!##2##1##(1991-12#1)(2012-12#1)
#1##4##1##(1995-1#1)(2007-12#1)(2008-12#1)(2011-2#1)
#2##2##1##(1995-1#1)(2008-12#1)
#3##2##1##(1995-1#1)(2008-12#1)
#4##2##1##(2008-10#1)(2008-12#1)
#ENTITYSTARTX00026##6##1##(2010-7#2)(2012-3#2)(2013-1#2)
$##5##1##(2008-12#5)
$1 million##3##2##(1992-8#1)(1995-12#2)
$1##25##1##(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
$10##4##1##(1991-3#1)(1994-2#1)(1996-1#1)(2008-10#1)
$100##6##1##(1993-3#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(2008-10#1)
$110##2##1##(1992-12#1)(2008-4#1)
$12##6##1##(1992-1#1)(1994-2#1)(1997-5#1)(2008-6#3)
$120##3##1##(1995-6#2)(1996-5#1)
$125##3##1##(1995-6#1)(1996-5#2)
$135##2##1##(1991-1#1)(2008-4#1)
$140##2##1##(1992-1#1)(1996-1#1)
$15##2##1##(1992-1#1)(1993-5#1)
$16##3##1##(1993-3#1)(1995-12#1)(1995-6#1)
$2 billion##2##2##(1992-11#1)(1992-3#1)
$2##14##1##(1992-11#1)(1992-3#1)(1993-1#2)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-6#1)
$200 million##2##2##(1992-11#1)(2007-9#1)
$200##3##1##(1992-11#1)(2007-9#1)(2008-5#1)
$25##2##1##(1991-12#1)(1996-5#1)
$267##2##1##(1995-6#2)
$29##4##1##(1990-11#1)(1992-1#1)(2008-11#1)(2013-1#1)
$3 billion##2##2##(1991-1#1)(2008-5#1)
$3##11##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-5#1)
$30 million##2##2##(1995-6#1)(1997-1#1)
$34##2##1##(1990-11#1)(2010-3#1)
$35##2##1##(1991-9#1)(1997-2#1)
$4##6##1##(1992-3#1)(1994-1#1)(1994-2#1)(1996-1#1)(2007-7#1)(2010-12#1)
$40##2##1##(1992-12#1)(1996-5#1)
$49##5##1##(1990-11#1)(1990-3#1)(1990-8#1)(1994-5#1)(2008-7#1)
$5 million##2##2##(1991-1#1)(1995-12#1)
$5##8##1##(1991-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(2008-11#1)(2008-6#1)
$50##4##1##(1990-2#1)(1990-8#1)(1993-5#1)(1995-12#1)
$500 million##3##2##(1994-9#2)(2008-10#1)
$500##6##1##(1991-3#1)(1993-1#1)(1994-9#2)(1997-5#1)(2008-10#1)
$59##3##1##(1990-8#1)(2008-7#1)(2011-2#1)
$592##2##1##(1995-2#1)(2008-7#1)
$6 billion in##2##3##(1996-3#1)(2013-8#1)
$6##5##1##(1992-1#1)(1996-1#1)(1996-3#1)(2007-12#1)(2013-8#1)
$60##4##1##(1995-6#2)(1996-3#1)(2007-8#1)
$640 million##3##2##(1996-5#1)(1997-5#2)
$69##2##1##(1995-12#1)(2008-4#1)
$7##3##1##(1994-2#1)(2007-7#1)(2008-5#1)
$75##3##1##(1995-12#1)(1996-5#1)(1997-2#1)
$79##4##1##(1990-3#1)(1990-8#1)(2008-4#2)
$8##3##1##(2007-12#1)(2008-11#1)(2010-12#1)
$80 million##2##2##(1991-9#1)(2008-10#1)
$80##4##1##(1990-3#1)(1991-9#1)(1993-3#1)(2008-10#1)
$90##3##1##(1990-11#1)(1994-2#1)(1995-12#1)
% (n =##2##3##(2008-10#1)(2012-3#1)
% A##5##2##(2008-5#5)
% B-48##3##2##(1990-8#3)
% H(2)SO(4)##2##2##(2008-3#1)(2013-1#1)
% IRIi##2##2##(2008-5#2)
% Nb##2##2##(2008-2#2)
% RSD##2##2##(2008-10#2)
% TiO(2)##2##2##(2008-10#1)(2008-3#1)
% and##12##2##(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
% at##2##2##(2010-10#1)(2012-12#1)
% confidence##4##2##(2011-1#1)(2011-2#2)(2012-12#1)
% for##5##2##(1997-8#1)(2008-10#1)(2008-8#1)(2012-12#2)
% had##7##2##(2008-12#1)(2011-2#1)(2012-12#5)
% hypochlorite##2##2##(2007-7#2)
% in case of the##2##5##(2008-10#2)
% in##15##2##(2008-10#3)(2008-5#3)(2008-8#2)(2010-10#1)(2011-2#1)(2012-12#3)(2012-2#2)
% male)##2##2##(2013-1#2)
% of NiS##2##3##(2008-10#2)
% of all##2##3##(2008-5#1)(2009-1#1)
% of cases##6##3##(1997-8#2)(2007-8#3)(2012-12#1)
% of patients##2##3##(1995-11#1)(2007-8#1)
% of the cases##4##4##(2007-8#3)(2012-12#1)
% of the children##3##4##(2012-12#3)
% of the cohort were##2##5##(2012-12#2)
% of the participants##2##4##(2011-2#2)
% of the total##3##4##(2007-5#1)(2007-7#1)(2008-9#1)
% of the##38##3##(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#3)(2011-2#6)(2012-12#15)(2013-1#1)
% of these##2##3##(2012-12#2)
% of##76##2##(1995-11#1)(1996-3#1)(1997-8#3)(2007-11#2)(2007-5#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#2)(2011-1#3)(2011-2#9)(2012-12#22)(2013-1#2)
% on##2##2##(2010-7#1)(2012-12#1)
% overBMI##4##2##(2008-3#4)
% overall##2##2##(1997-8#1)(2007-11#1)
% positive containers##3##3##(2008-5#3)
% potassium##2##2##(2008-10#2)
% tail DNA##4##3##(1997-4#2)(2010-5#2)
% to##2##2##(2007-12#1)(2011-2#1)
% vs##2##2##(1997-8#1)(2007-10#1)
% was##4##2##(2008-11#1)(2013-1#3)
% water##2##2##(2008-5#2)
% were##5##2##(2008-1#1)(2008-5#1)(2012-12#3)
% when##4##2##(1997-8#2)(2008-1#2)
% with##3##2##(1997-8#3)
% yr(-1))##2##2##(2012-2#2)
%##321##1##(1990-8#4)(1991-5#1)(1992-11#1)(1992-8#1)(1993-2#4)(1994-5#2)(1995-11#1)(1996-3#1)(1997-4#2)(1997-8#16)(2007-10#1)(2007-11#9)(2007-12#7)(2007-5#1)(2007-7#6)(2007-8#9)(2008-1#10)(2008-10#41)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#13)(2008-4#2)(2008-5#39)(2008-6#3)(2008-8#8)(2008-9#1)(2009-1#1)(2010-10#6)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#12)(2011-2#24)(2012-12#56)(2012-2#5)(2012-3#2)(2013-1#15)
%) Li(2)CO(3) and##2##3##(2008-10#2)
%) and in##2##3##(1997-8#1)(2013-1#1)
%) and##20##2##(1997-3#1)(1997-8#1)(2007-10#1)(2008-5#4)(2010-5#1)(2011-1#3)(2012-12#8)(2013-1#1)
%) cases##2##2##(1997-8#1)(2011-1#1)
%) core##2##2##(2007-11#2)
%) followed by##2##3##(2010-5#1)(2012-12#1)
%) had MIC##2##3##(2007-7#2)
%) had##3##2##(2007-7#2)(2008-1#1)
%) in the control group##2##5##(2011-2#1)(2012-12#1)
%) in the##3##3##(2007-10#1)(2011-2#1)(2012-12#1)
%) in##4##2##(2007-10#1)(2011-2#1)(2012-12#2)
%) of##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
%) or##3##2##(1997-8#1)(2012-12#2)
%) was##3##2##(1993-2#1)(1997-8#1)(2008-5#1)
%) were##5##2##(2008-10#2)(2008-3#1)(2010-5#2)
%) with##2##2##(2008-8#1)(2012-12#1)
%)##140##1##(1993-2#2)(1993-8#1)(1997-3#1)(1997-8#10)(2007-10#3)(2007-11#3)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#10)(2008-3#5)(2008-5#18)(2008-8#1)(2009-2#1)(2010-2#1)(2010-5#5)(2011-1#5)(2011-2#6)(2012-12#55)(2012-2#2)(2013-1#5)(2013-8#1)
%Ca##2##1##(2008-10#2)
%K##3##1##(2008-10#3)
%Mg##2##1##(2008-10#2)
%R##3##1##(2008-10#3)
%RDBP##2##1##(2012-2#2)
%vol##2##1##(1991-3#2)
&amp##469##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#1)(1992-6#10)(1992-7#1)(1993-1#1)(1993-11#8)(1993-12#2)(1993-3#6)(1993-8#7)(1994-12#2)(1994-3#2)(1994-5#12)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#13)(1995-3#1)(1995-4#1)(1995-5#7)(1995-6#1)(1996-11#2)(1996-12#3)(1996-3#3)(1996-4#1)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#2)(2007-10#9)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#3)(2008-1#5)(2008-10#5)(2008-11#48)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#18)(2008-6#13)(2008-7#68)(2008-9#4)(2009-10#1)(2009-11#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-6#6)(2010-7#4)(2010-8#5)(2011-1#1)(2011-2#24)(2012-1#3)(2012-12#3)(2012-2#27)(2012-3#20)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#22)(2013-7#4)(2013-8#6)
&gt##974##1##(1992-11#2)(1992-12#2)(1992-9#7)(1993-1#2)(1993-11#6)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#3)(1993-8#18)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#10)(1994-2#3)(1994-3#11)(1994-5#1)(1994-6#5)(1994-8#6)(1994-9#8)(1995-11#13)(1995-12#20)(1995-2#6)(1995-3#4)(1995-5#10)(1995-6#12)(1995-8#11)(1996-12#10)(1996-2#12)(1996-3#1)(1996-5#4)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#13)(1997-3#7)(1997-4#8)(1997-5#9)(1997-6#9)(1997-7#11)(1997-8#8)(1997-9#1)(2006-10#3)(2007-10#4)(2007-11#13)(2007-12#16)(2007-5#4)(2007-7#13)(2007-8#1)(2007-9#1)(2008-1#11)(2008-10#213)(2008-11#28)(2008-12#19)(2008-2#12)(2008-3#44)(2008-4#13)(2008-5#23)(2008-6#14)(2008-7#57)(2008-8#10)(2008-9#9)(2009-12#3)(2009-2#3)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#24)(2011-2#35)(2011-3#1)(2012-1#6)(2012-12#8)(2012-2#14)(2012-3#15)(2012-5#3)(2012-6#1)(2013-1#31)(2013-8#11)
&lt##2372##1##(1990-4#2)(1991-12#2)(1992-10#1)(1992-11#9)(1992-12#9)(1992-8#1)(1992-9#6)(1993-1#7)(1993-10#6)(1993-11#7)(1993-12#14)(1993-2#8)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#9)(1994-12#20)(1994-2#7)(1994-3#23)(1994-5#10)(1994-6#20)(1994-7#2)(1994-8#10)(1994-9#5)(1995-11#4)(1995-12#29)(1995-2#11)(1995-3#13)(1995-5#7)(1995-6#6)(1995-8#16)(1996-1#4)(1996-11#2)(1996-12#29)(1996-2#11)(1996-3#7)(1996-5#7)(1996-6#4)(1996-8#4)(1996-9#4)(1997-1#10)(1997-2#8)(1997-3#9)(1997-4#5)(1997-5#13)(1997-6#3)(1997-7#12)(1997-8#7)(2006-10#14)(2006-6#1)(2007-10#28)(2007-11#333)(2007-12#14)(2007-5#2)(2007-6#3)(2007-7#17)(2007-8#11)(2007-9#1)(2008-1#18)(2008-10#411)(2008-11#38)(2008-12#36)(2008-2#43)(2008-3#146)(2008-4#15)(2008-5#44)(2008-6#11)(2008-7#79)(2008-8#12)(2008-9#27)(2009-1#3)(2009-11#5)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#8)(2009-6#9)(2009-7#4)(2009-8#12)(2009-9#4)(2010-1#7)(2010-10#1)(2010-11#5)(2010-12#11)(2010-2#65)(2010-3#14)(2010-4#27)(2010-5#2)(2010-6#4)(2010-7#6)(2010-8#20)(2011-1#56)(2011-2#91)(2011-3#28)(2012-1#1)(2012-12#15)(2012-2#32)(2012-3#43)(2012-5#2)(2013-1#104)(2013-7#1)(2013-8#56)
&quot##3183##1##(1990-10#3)(1990-11#10)(1990-12#6)(1990-2#13)(1990-3#15)(1990-4#3)(1990-5#11)(1990-6#18)(1990-7#2)(1990-8#12)(1990-9#10)(1991-1#9)(1991-11#5)(1991-12#42)(1991-2#15)(1991-3#30)(1991-4#4)(1991-5#1)(1991-6#6)(1991-7#1)(1991-8#19)(1991-9#14)(1992-1#11)(1992-10#1)(1992-11#5)(1992-12#20)(1992-2#24)(1992-3#29)(1992-4#2)(1992-5#4)(1992-6#16)(1992-7#1)(1992-8#13)(1992-9#3)(1993-1#17)(1993-11#20)(1993-12#36)(1993-2#46)(1993-3#19)(1993-5#9)(1993-6#11)(1993-8#4)(1993-9#4)(1994-1#35)(1994-11#7)(1994-12#25)(1994-2#41)(1994-3#26)(1994-5#8)(1994-6#12)(1994-7#1)(1994-8#13)(1994-9#14)(1995-1#24)(1995-11#2)(1995-12#17)(1995-2#44)(1995-3#40)(1995-5#18)(1995-6#30)(1995-8#5)(1995-9#4)(1996-1#21)(1996-10#1)(1996-11#6)(1996-12#16)(1996-2#16)(1996-3#33)(1996-4#8)(1996-5#5)(1996-6#7)(1996-8#1)(1996-9#18)(1997-1#12)(1997-2#23)(1997-3#26)(1997-4#6)(1997-5#10)(1997-6#21)(1997-7#12)(1997-8#4)(2006-10#4)(2006-12#2)(2006-7#2)(2007-1#2)(2007-10#11)(2007-11#22)(2007-12#26)(2007-2#9)(2007-3#2)(2007-4#7)(2007-5#9)(2007-6#4)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#66)(2008-10#232)(2008-11#88)(2008-12#64)(2008-2#23)(2008-3#31)(2008-4#77)(2008-5#56)(2008-6#39)(2008-7#76)(2008-8#120)(2008-9#63)(2009-1#2)(2009-10#43)(2009-11#17)(2009-12#4)(2009-2#6)(2009-3#10)(2009-4#18)(2009-5#27)(2009-6#12)(2009-7#33)(2009-8#12)(2009-9#37)(2010-1#11)(2010-10#3)(2010-11#7)(2010-12#25)(2010-2#1)(2010-3#15)(2010-4#27)(2010-5#15)(2010-6#19)(2010-7#12)(2010-8#17)(2010-9#4)(2011-1#19)(2011-2#170)(2011-3#6)(2011-7#1)(2012-1#5)(2012-12#44)(2012-2#84)(2012-3#67)(2012-4#1)(2013-1#131)(2013-7#17)(2013-8#56)
' 'dilemma##3##2##(2008-8#3)
' These##2##2##(1995-5#1)(2008-5#1)
' and##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
' which consists in##2##4##(2012-2#2)
' which##3##2##(1995-11#1)(2012-2#2)
'##36##1##(1990-10#1)(1995-11#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2011-2#9)(2012-2#4)(2013-8#3)
'90s##7##1##(1990-4#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1994-3#2)
'97##2##1##(1993-8#1)(2008-11#1)
'A##2##1##(1992-2#1)(2010-5#1)
'Acala 44'##2##2##(2008-10#2)
'B'##3##1##(1997-6#3)
'Benifuuki'##2##1##(2008-11#2)
'Burley 21' transgenic lines##3##4##(2008-10#3)
'Burley 21'##7##2##(2008-10#7)
'CI##2##1##(2008-10#2)
'Candidatus Phytoplasma mali'##2##3##(2008-10#2)
'Candidatus##3##1##(2008-10#3)
'Canthatch' nullisomic 7D##2##3##(2008-10#2)
'Canthatch'##5##1##(2008-10#5)
'Caring encounters from the perspective of##3##6##(2010-10#3)
'Chardonnay' and 'Riesling'##2##3##(2008-10#2)
'Chardonnay'##4##1##(2008-10#4)
'Chinese Spring'##5##2##(2008-10#5)
'Clipsin'##2##1##(1992-8#2)
'Colorado'##2##1##(1990-11#2)
'Data##2##1##(2008-7#1)(2010-8#1)
'Dehalococcoides' spp##2##2##(2011-1#2)
'Denver'##3##1##(1990-11#3)
'Discovery'##2##1##(2008-10#2)
'Eltan'##2##1##(2008-10#2)
'Fiesta'##2##1##(2008-10#2)
'Florunner'##3##1##(2008-10#3)
'From##2##1##(2008-7#1)(2010-4#1)
'Gala' apple seedlings##2##3##(2008-10#2)
'Gala' apple##3##2##(2008-10#3)
'Golden Delicious' x##2##3##(2008-10#2)
'Golden Delicious'##4##2##(2008-10#4)
'Hass'##2##1##(2011-2#2)
'Health##2##1##(2008-1#1)(2012-3#1)
'Healthy Islands'##2##2##(2008-1#2)
'Healthy##3##1##(2008-1#2)(2008-5#1)
'I##2##1##(2010-10#1)(2013-8#1)
'Isabella' grapes##3##2##(2008-10#3)
'Isabella' volatiles##2##2##(2008-10#2)
'Isabella'##6##1##(2008-10#6)
'J##4##1##(2008-10#4)
'Jerseyglo'##2##1##(2008-10#2)
'Jumping to Conclusions'##2##3##(2012-1#2)
'K-326' F(1) hybrid##2##3##(2008-10#2)
'K-326'##4##1##(2008-10#4)
'Katahdin'##2##1##(2008-10#2)
'La##2##1##(2007-7#1)(2008-10#1)
'Lalbahadur'##2##1##(2008-10#2)
'Lepidium' isolates##2##2##(2008-10#2)
'Loring'##2##1##(2008-10#2)
'Minneola'##3##1##(2008-10#3)
'Montenegrina'##3##1##(2008-6#3)
'Murcott'##5##1##(2008-10#2)(2008-6#3)
'NK-184mm-O'##3##1##(2012-3#3)
'NK-310mm-O'##2##1##(2012-3#2)
'Non-specific antibodies'##2##2##(2011-1#2)
'Norin 4'##2##2##(2008-10#2)
'Nova'##4##1##(2008-10#4)
'Oketsu'##14##1##(2008-10#14)
'Okrun'##3##1##(2008-10#3)
'One##2##1##(1994-8#1)(2013-1#1)
'Orlando'##3##1##(2008-10#3)
'Otachibana'##3##1##(2008-10#3)
'Pavon 76' was##2##3##(2008-10#2)
'Pavon 76'##5##2##(2008-10#5)
'PhysioDirect'##2##1##(2011-2#2)
'Pi No##2##2##(2008-10#2)
'Pito'##3##1##(2008-10#3)
'Ranger Russet'##2##2##(2008-10#2)
'Redhaven'##2##1##(2008-10#2)
'Riesling'##3##1##(2008-10#3)
'Roditis' grapes (V##2##3##(2008-10#2)
'Seri 82' inoculated with##2##4##(2008-10#2)
'Seri 82'##4##2##(2008-10#4)
'Shafir'##3##1##(2008-10#3)
'Shepody'##2##1##(2008-10#2)
'Sumner'##3##1##(2008-10#3)
'Sunburst'##2##1##(2008-10#2)
'Thatcher'##4##1##(2008-10#4)
'The##5##1##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#2)
'Thermobaculum terrenum'##3##2##(2011-2#3)
'Thlaspi'##3##1##(2008-10#3)
'Variegata'##3##1##(2008-10#3)
'Védrantais'##2##1##(2008-10#2)
'What##2##1##(2008-11#1)(2008-12#1)
'Wichita'##2##1##(2008-10#2)
'a##3##1##(1995-2#1)(1997-8#1)(2013-8#1)
'acceptable'##2##1##(1996-12#1)(2009-8#1)
'active oxygen' in##2##3##(2008-10#2)
'active oxygen'##5##2##(2008-10#5)
'active##6##1##(2008-10#5)(2008-5#1)
'acute-phase' response##2##2##(1991-12#2)
'aged'##2##1##(2008-7#2)
'all##3##1##(1995-11#1)(2010-5#2)
'allowed'##2##1##(1994-3#2)
'ancient'##2##1##(1995-11#1)(2007-12#1)
'anthropogenic'##2##1##(2008-10#2)
'as##2##1##(2008-10#2)
'benifuuki' green tea containing##2##4##(2008-11#2)
'benifuuki' green tea##4##3##(2008-11#4)
'benifuuki'##6##1##(2008-11#6)
'best'##2##1##(2008-5#1)(2013-1#1)
'biological'##2##1##(2008-11#1)(2010-5#1)
'blunted##2##1##(2008-1#2)
'butterfly##2##1##(2012-12#2)
'change##2##1##(1995-8#1)(2008-7#1)
'clean'##2##1##(1993-9#1)(2008-11#1)
'communication'##2##1##(2013-8#2)
'concentration polarization'##2##2##(2008-9#2)
'critical##2##1##(2007-2#1)(2013-8#1)
'culture of##2##2##(1995-3#1)(2008-8#1)
'da##2##1##(2007-8#2)
'differentiation of##2##2##(2013-8#2)
'dilemma##4##1##(2008-8#4)
'dilemmaism'##2##1##(2008-8#2)
'direct'##2##1##(2008-10#1)(2011-2#1)
'doing##3##1##(2007-10#2)(2008-11#1)
'easy'##2##1##(1995-12#1)(2010-4#1)
'equal importance'##2##2##(2010-3#2)
'essential##2##1##(1996-1#1)(2007-10#1)
'essential'##2##1##(1996-1#1)(2009-5#1)
'excellent'##2##1##(2008-7#1)(2013-8#1)
'explicit'##2##1##(2010-8#2)
'extracellular##2##1##(2008-10#1)(2008-4#1)
'fat'##2##1##(2008-7#1)(2008-9#1)
'feeling##6##1##(2012-3#6)
'gassy'##2##1##(1997-8#2)
'global'##3##1##(2008-7#1)(2009-10#1)(2011-2#1)
'glucose sensors'##2##2##(1994-2#2)
'glucose##3##1##(1994-2#3)
'gold standard'##4##2##(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)
'good'##3##1##(2008-3#1)(2008-7#1)(2013-1#1)
'handle'##4##1##(2008-5#4)
'health promotion in##3##3##(2008-11#3)
'health##6##1##(2008-11#6)
'high##2##1##(1993-3#1)(2008-5#1)
'hot##3##1##(2008-11#1)(2008-9#1)(2011-1#1)
'hybrid'##2##1##(2007-8#1)(2008-10#1)
'in vivo'##2##2##(1997-1#2)
'in##3##1##(1997-1#2)(2008-10#1)
'incorrect' and 'unsocial'##3##3##(2008-11#3)
'incorrect' and##4##2##(2008-11#4)
'inductive'##2##1##(2007-11#2)
'inguinal' glands##2##2##(2008-7#2)
'internal##2##1##(2008-5#2)
'learning##2##1##(2008-11#1)(2009-10#1)
'less##2##1##(2008-10#1)(2009-5#1)
'long##3##1##(1996-2#1)(2008-7#2)
'low##2##1##(2008-11#1)(2008-5#1)
'man in the barrel' syndrome##2##5##(2008-7#2)
'managed##2##1##(2008-7#1)(2013-1#1)
'natural##4##1##(1994-12#1)(2008-11#1)(2009-2#1)(2010-2#1)
'natural'##7##1##(2008-10#1)(2008-5#5)(2008-7#1)
'new##2##1##(2008-6#1)(2008-7#1)
'no##3##1##(1991-1#1)(2008-11#1)(2008-7#1)
'non-Oketsu'##2##1##(2008-10#2)
'non-semantic' tasks##3##2##(2009-2#3)
'non-semantic'##5##1##(2009-2#5)
'normal'##3##1##(1990-5#1)(2008-8#1)(2008-9#1)
'not##3##1##(2008-10#1)(2008-9#1)(2012-2#1)
'nuez de##2##2##(2008-5#2)
'occupational##2##1##(2010-9#2)
'off campus'##2##2##(2008-11#2)
'off##5##1##(2006-10#1)(2008-10#2)(2008-11#2)
'off'##3##1##(2008-7#3)
'omic##4##1##(2012-12#4)
'omics##2##1##(2008-7#1)(2012-12#1)
'optimal'##2##1##(2008-10#1)(2008-11#1)
'orange peel'##2##2##(2008-5#2)
'out of date'##3##3##(2008-1#3)
'outlier'##2##1##(2012-5#2)
'overload phenomenon'##2##2##(2008-7#2)
'pseudodipeptides'##2##1##(2008-5#2)
'pure'##2##1##(2008-10#1)(2013-8#1)
'recovery' period##2##2##(1994-2#2)
'recovery'##3##1##(1994-2#3)
'red'##2##1##(1995-5#2)
'rescue' therapy constitutes an encouraging##2##5##(2010-12#2)
'rescue'##7##1##(1995-11#1)(2010-12#6)
'risk'##2##1##(2012-12#2)
'rule of nines'##3##3##(2012-1#3)
'rule of##4##2##(2012-1#4)
'rumpus room'##3##2##(2008-7#3)
's##13##1##(1991-9#2)(1993-12#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2013-1#1)
'secondary##2##1##(1994-6#1)(2008-10#1)
'seeking##2##1##(1990-10#1)(2008-11#1)
'self'##3##1##(2008-11#1)(2008-6#1)(2009-10#1)
'sensitive'##2##1##(2008-10#1)(2008-5#1)
'shear sensitivity'##3##2##(2008-11#3)
'short##2##1##(1995-3#1)(2012-2#1)
'social brain'##2##2##(2008-11#2)
'social##3##1##(2008-11#2)(2012-2#1)
'social'##4##1##(2008-11#4)
'specialized' physical therapists##3##3##(1993-12#3)
'specialized'##4##1##(1993-12#4)
'specials'##3##1##(2011-1#3)
'struggling to##4##2##(2012-3#4)
'student voice'##3##2##(2013-1#3)
'support##2##1##(2008-11#1)(2010-10#1)
'swallowing##2##1##(1993-2#2)
't##2##1##(1992-10#1)(2012-3#1)
'taque'##2##1##(2008-5#2)
'target'##2##1##(2008-10#1)(2008-7#1)
'the##7##1##(2008-2#1)(2008-4#1)(2010-10#1)(2013-1#2)(2013-8#2)
'theory of mind'##2##3##(2008-11#1)(2008-9#1)
'threshold' level##2##2##(1995-5#2)
'thrombolysis##2##1##(2008-11#1)(2010-11#1)
'time release'##2##2##(2008-5#2)
'time to##2##2##(1992-9#1)(2008-10#1)
'time##4##1##(1992-9#1)(2008-10#1)(2008-5#2)
'toxic second messengers'##2##3##(2008-5#2)
'toxic##3##1##(2008-5#3)
'tracers' in##2##2##(1995-12#2)
'treating different diseases by the same method'##3##7##(2013-8#3)
'treating different diseases by the same##4##6##(2013-8#4)
'true' AGT##2##2##(1995-12#2)
'true'##5##1##(1994-8#1)(1995-12#2)(2008-7#1)(2008-9#1)
'unmodifiable'##2##1##(2008-1#2)
'unsafe'##2##1##(1996-9#2)
'unsocial'##4##1##(2008-11#4)
'urgent'##5##1##(1994-3#5)
'virgin##2##1##(2007-12#1)(2008-10#1)
'what we##2##2##(2010-10#2)
'what##4##1##(1996-12#1)(2008-12#1)(2010-10#2)
'working##2##1##(2010-10#1)(2012-3#1)
'young' and##2##2##(2007-12#1)(2008-5#1)
'young'##3##1##(2007-12#1)(2008-5#1)(2008-7#1)
( P &lt##5##3##(1997-7#5)
( WAF-1 )##3##3##(2008-8#3)
( [Formula##2##2##(2008-10#2)
( alpha = 0##2##4##(2008-10#2)
( approximately 0##5##3##(2008-10#2)(2009-6#1)(2010-4#2)
( approximately 1##7##3##(2008-10#4)(2008-11#1)(2008-9#2)
( approximately 10##2##3##(2008-10#1)(2008-6#1)
( approximately 2##4##3##(2006-4#1)(2008-10#2)(2008-11#1)
( approximately 4##2##3##(2008-10#2)
( approximately 60##3##3##(2008-10#2)(2008-11#1)
( approximately 600##2##3##(2008-10#1)(2008-9#1)
( approximately 85%)##2##3##(2008-10#2)
( approximately##71##2##(1997-9#1)(2006-4#2)(2008-10#44)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#3)(2010-4#3)
( degrees##2##2##(2007-12#1)(2008-10#1)
( p &lt##3##3##(2008-11#3)
( partial differentialphi/ partial differentialV)##2##5##(2007-12#2)
( partial differentialphi/ partial##3##4##(2007-12#3)
(##158##1##(1990-5#1)(1991-12#2)(1991-9#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#2)(1996-9#1)(1997-7#5)(1997-9#1)(2006-4#2)(2007-1#1)(2007-12#4)(2008-1#6)(2008-10#67)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#3)(2009-8#8)(2009-9#1)(2010-11#1)(2010-4#3)(2010-8#1)(2013-1#8)
(#70)##2##1##(2011-7#2)
(%##20##1##(1990-8#1)(1992-8#1)(1994-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#6)(2010-5#1)(2012-2#1)
(%) of##2##2##(2008-10#1)(2008-12#1)
(%)##17##1##(1995-12#1)(2008-10#12)(2008-12#2)(2008-7#1)(2010-5#1)
(%R##4##1##(2008-10#4)
(&amp##4##1##(1996-2#4)
(&gt##197##1##(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#5)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-9#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-7#1)(2008-1#2)(2008-10#62)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#6)(2013-1#8)(2013-7#1)(2013-8#2)
(&lt##210##1##(1990-8#1)(1992-9#2)(1993-8#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#7)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#59)(2008-11#6)(2008-12#2)(2008-2#9)(2008-3#19)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
(&quot##94##1##(1990-11#1)(1990-2#2)(1991-1#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#3)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-6#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#2)(2013-1#3)(2013-8#2)
('difficulty##2##1##(2011-2#2)
('lateral diffusing capacity')##2##3##(2007-12#2)
((1##4##1##(1991-8#1)(1992-11#1)(1996-2#1)(1997-7#1)
((52)Cr ) to##2##3##(2008-10#2)
((64)Zn+(66)Zn)/(68)Zn##2##1##(2008-10#2)
((66)Zn )##2##2##(2008-10#2)
((R))##3##1##(2007-2#3)
() and##2##2##(2008-10#1)(2008-4#1)
()##15##1##(2008-10#1)(2008-11#9)(2008-4#3)(2008-5#2)
(+ )##3##2##(2008-10#3)
(+ 9##2##2##(1991-11#2)
(+ =##2##2##(2008-12#2)
(+##9##1##(1991-11#2)(2008-10#3)(2008-11#1)(2008-12#2)(2011-2#1)
(+) and##6##2##(2008-10#1)(2013-1#5)
(+) tumours##2##2##(2013-1#2)
(+)##41##1##(1990-5#1)(1991-1#1)(1997-4#4)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-11#1)(2011-2#2)(2012-12#2)(2013-1#16)
(+)-##2##1##(1992-12#1)(2008-8#1)
(+)-MT##3##1##(2008-10#3)
(+)-[3H]PN200-110##2##1##(1997-2#2)
(+)-catechin acts as##2##3##(2008-10#2)
(+)-catechin and##2##2##(1993-8#1)(2008-11#1)
(+)-catechin##8##1##(1992-9#1)(1993-8#1)(2008-10#4)(2008-11#1)(2012-1#1)
(+)-pentazocine##2##1##(1995-12#2)
(+)gauche##2##1##(1992-12#2)
(++)##2##1##(2007-10#1)(2012-3#1)
(+/+##2##1##(1997-7#1)(2008-3#1)
(+/+)##2##1##(1996-12#1)(2008-10#1)
(+/- 0##2##2##(1990-7#1)(2008-10#1)
(+/- S##2##2##(1991-5#2)
(+/- SD)##2##2##(1992-3#1)(2008-3#1)
(+/-##20##1##(1990-7#1)(1990-8#2)(1991-12#2)(1991-5#2)(1992-12#2)(1992-3#1)(1994-7#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#2)
(+/-)##4##1##(1995-11#1)(2008-11#2)(2012-2#1)
(+/-)-1##3##1##(1996-2#3)
(+/-)-9##2##1##(1996-2#2)
(+/-)-SB 209670##2##2##(1995-12#2)
(+/-)-synephrine##2##1##(2008-10#2)
(+/-0##14##1##(2007-8#2)(2008-10#9)(2008-2#1)(2008-5#2)
(+/-1##5##1##(2008-10#4)(2008-3#1)
(+/-3##3##1##(2007-11#1)(2008-10#2)
(+/-S##2##1##(2008-10#1)(2008-7#1)
(+/-SD)##6##1##(1993-10#1)(1994-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
(+0##10##1##(1992-5#1)(1996-5#3)(2008-10#4)(2013-7#2)
(+1 to##2##2##(1990-5#1)(2012-5#1)
(+1##4##1##(1990-5#1)(2008-5#1)(2012-5#1)(2012-6#1)
(+874)##2##1##(2011-1#2)
(-) and##2##2##(1991-1#1)(2012-2#1)
(-) diet##6##2##(1997-4#6)
(-) strand##2##2##(2008-10#2)
(-)##34##1##(1990-5#1)(1991-1#1)(1997-4#10)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
(-))##3##1##(2007-1#1)(2008-10#1)(2011-1#1)
(-)-1##2##1##(2010-2#2)
(-)-4-nitrophenyl-beta-d-glucopyranoside##2##1##(2008-10#2)
(-)-MT and (+)-MT##2##3##(2008-10#2)
(-)-MT##3##1##(2008-10#3)
(-)-N(6)-phenylisopropyladenosine##2##1##(1995-12#2)
(-)-carvone##2##1##(2008-11#2)
(-)-epicatechin gallate##2##2##(2008-10#1)(2008-11#1)
(-)-epicatechin##9##1##(1993-8#1)(2008-10#6)(2008-11#1)(2012-1#1)
(-)-epigallocatechin gallate##3##2##(2008-11#3)
(-)-epigallocatechin##5##1##(2008-10#1)(2008-11#4)
(-)-pindolol in##2##2##(1997-6#2)
(-)-pindolol##3##1##(1997-6#3)
(-)Deprenyl##2##1##(1994-6#2)
(-/+)##4##1##(2007-10#4)
(-/-) mice at##2##3##(2008-10#2)
(-/-) mice##5##2##(2008-10#5)
(-/-)##9##1##(1995-11#1)(1995-8#1)(2008-10#6)(2010-11#1)
(-0##12##1##(1990-5#2)(1992-5#1)(2008-10#1)(2008-5#6)(2009-7#1)(2013-1#1)
(-1##9##1##(2007-12#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#3)
(-1) spectral##2##2##(2007-12#2)
(-1)##11##1##(2007-11#5)(2007-12#4)(2008-10#1)(2008-3#1)
(-1))##2##1##(2007-12#1)(2008-10#1)
(-14)##2##1##(2007-12#1)(2008-2#1)
(-19##2##1##(2008-12#1)(2013-8#1)
(-2##5##1##(2008-10#1)(2008-3#1)(2010-10#1)(2010-4#1)(2013-8#1)
(-2-1##3##1##(2008-10#3)
(-274- + 109)##2##3##(1997-2#2)
(-3##3##1##(2008-5#1)(2013-1#2)
(-30%)##2##1##(1992-11#1)(1994-2#1)
(-4##3##1##(1997-2#1)(2008-7#1)(2013-8#1)
(-5##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
(-59##2##1##(2008-10#2)
(-7##2##1##(2008-10#1)(2008-4#1)
(-85 degrees##2##2##(2008-11#2)
(-85##3##1##(1995-2#1)(2008-11#2)
(0 &lt##3##2##(1990-4#1)(2008-11#2)
(0 =##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
(0 degrees##2##2##(2008-10#2)
(0 or##3##2##(2010-3#1)(2011-2#2)
(0 to 3##2##3##(2008-10#1)(2011-2#1)
(0 to##9##2##(2008-10#7)(2008-6#1)(2011-2#1)
(0 tumors/10 injections)##2##3##(2013-1#2)
(0 vs##3##2##(1990-2#1)(2013-1#2)
(0##991##1##(1990-11#2)(1990-12#2)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#7)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#12)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#6)(1991-9#3)(1992-10#2)(1992-11#9)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-8#8)(1992-9#2)(1993-1#1)(1993-11#9)(1993-12#6)(1993-3#5)(1993-5#1)(1993-6#8)(1993-8#3)(1993-9#5)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#9)(1994-8#8)(1994-9#2)(1995-11#2)(1995-12#23)(1995-3#8)(1995-5#1)(1995-6#3)(1995-8#5)(1995-9#2)(1996-11#1)(1996-12#6)(1996-2#17)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#4)(1997-1#2)(1997-2#18)(1997-4#8)(1997-7#2)(1997-8#1)(2006-10#4)(2006-6#3)(2007-10#8)(2007-11#7)(2007-12#6)(2007-2#1)(2007-7#5)(2007-8#11)(2008-1#3)(2008-10#308)(2008-11#20)(2008-12#34)(2008-2#16)(2008-3#38)(2008-4#2)(2008-5#23)(2008-6#11)(2008-7#20)(2008-8#13)(2008-9#12)(2009-1#1)(2009-11#5)(2009-12#2)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#8)(2010-4#4)(2010-6#2)(2010-8#2)(2011-1#17)(2011-2#41)(2011-3#4)(2012-1#3)(2012-12#4)(2012-2#14)(2012-3#9)(2012-4#1)(2012-7#3)(2013-1#20)(2013-7#5)(2013-8#9)
(0%##6##1##(2007-8#1)(2008-12#1)(2010-4#2)(2010-7#1)(2013-1#1)
(0%) in##3##2##(1993-1#2)(2011-2#1)
(0%)##4##1##(1993-1#2)(2007-10#1)(2011-2#1)
(0)##4##1##(2008-10#2)(2008-2#2)
(0-0##2##1##(2011-2#2)
(0-1##7##1##(1996-12#1)(1997-8#2)(2008-10#4)
(0-1)##2##1##(2008-10#1)(2013-1#1)
(0-10##2##1##(2008-12#2)
(0-100)##2##1##(2012-2#1)(2013-1#1)
(0-2##3##1##(1995-4#1)(1996-2#1)(2013-8#1)
(0-3##3##1##(1992-12#1)(2008-3#1)(2011-2#1)
(0-3)##2##1##(2008-3#1)(2008-6#1)
(0-4##2##1##(1991-5#1)(2008-10#1)
(0-40##4##1##(1991-2#1)(2008-3#1)(2008-5#2)
(0-6##2##1##(2010-4#1)(2011-2#1)
(001) surface##2##2##(2007-12#1)(2009-11#1)
(001)##4##1##(2007-11#1)(2007-12#1)(2009-11#2)
(0P was##3##2##(2010-12#3)
(1 -##8##2##(2008-10#5)(2008-3#2)(2011-2#1)
(1 0 0)##2##3##(2008-3#2)
(1 CR##2##2##(1992-2#1)(1995-4#1)
(1 Hz)##2##2##(2008-1#1)(2008-2#1)
(1 M##2##2##(1995-2#1)(2008-10#1)
(1 and 2)##2##3##(2008-10#1)(2013-1#1)
(1 and 3##3##3##(1993-12#2)(2011-2#1)
(1 and##8##2##(1993-12#2)(1995-12#1)(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)
(1 case)##8##2##(1990-12#1)(1990-6#1)(1997-6#1)(2007-8#2)(2008-11#3)
(1 cm##3##2##(2008-10#2)(2008-2#1)
(1 g/kg##2##2##(1995-11#1)(2010-5#1)
(1 group)##2##2##(2008-12#2)
(1 h)##3##2##(1990-12#1)(2008-5#1)(2009-6#1)
(1 mM##2##2##(1990-12#1)(1992-3#1)
(1 mM) or##2##3##(1990-2#1)(1990-7#1)
(1 mM)##10##2##(1990-11#1)(1990-2#2)(1990-7#4)(1993-8#1)(1995-11#1)(1996-2#1)
(1 mg L(-1)##2##3##(2008-12#2)
(1 mg##6##2##(1993-12#1)(2008-12#3)(2010-6#1)(2011-2#1)
(1 mg/kg i##3##3##(1991-2#1)(1992-3#1)(1996-2#1)
(1 mg/kg##5##2##(1991-2#1)(1992-3#1)(1993-6#1)(1996-2#1)(2008-10#1)
(1 mg/kg)##5##2##(1991-12#2)(1995-12#1)(1997-7#1)(2009-11#1)
(1 microM##2##2##(1990-12#1)(1997-1#1)
(1 microM) and##3##3##(1996-5#1)(1997-4#2)
(1 microM)##20##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-3#2)(1995-11#2)(1996-2#1)(1996-5#5)(1997-1#1)(1997-2#2)(1997-4#3)(2009-12#1)
(1 mm##3##2##(2008-10#2)(2008-7#1)
(1 mol l(-1))##2##3##(2008-10#2)
(1 mol##3##2##(2008-10#3)
(1 muM) showed##2##3##(2008-11#2)
(1 muM)##4##2##(2008-10#1)(2008-11#3)
(1 nM)##5##2##(1990-8#1)(1995-12#1)(1997-1#1)(2008-11#2)
(1 ng/ml)##3##2##(1990-5#1)(1990-8#1)(1993-12#1)
(1 of##3##2##(1993-6#1)(1996-3#2)
(1 or##2##2##(1990-12#1)(1993-12#1)
(1 patient)##3##2##(1992-8#2)(2007-11#1)
(1 strain)##2##2##(2011-1#2)
(1 to##9##2##(1990-6#1)(1991-5#1)(2008-10#6)(2008-6#1)
(1 week)##2##2##(1991-9#1)(2008-7#1)
(1 x 10(6)##3##3##(1992-12#1)(2008-10#2)
(1 x 10(8) CFU/ml) were##2##5##(2008-10#2)
(1 x##9##2##(1992-12#1)(2008-10#6)(2008-6#1)(2008-7#1)
(1##755##1##(1990-11#2)(1990-12#8)(1990-2#7)(1990-3#2)(1990-5#3)(1990-6#3)(1990-7#7)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#16)(1991-9#3)(1992-1#1)(1992-11#10)(1992-12#5)(1992-2#3)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#10)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#6)(1994-8#1)(1994-9#5)(1995-11#8)(1995-12#9)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#11)(1996-3#2)(1996-5#7)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#4)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-7#3)(2007-8#9)(2008-1#5)(2008-10#182)(2008-11#25)(2008-12#21)(2008-2#10)(2008-3#23)(2008-4#2)(2008-5#20)(2008-6#9)(2008-7#17)(2008-8#18)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#6)(2010-4#5)(2010-5#11)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#39)(2011-3#1)(2011-7#2)(2012-12#6)(2012-2#8)(2012-3#11)(2013-1#25)(2013-7#3)(2013-8#13)
(1%##8##1##(1993-11#1)(2007-11#1)(2008-10#6)
(1%) did##2##2##(2008-5#1)(2008-9#1)
(1%) patients##2##2##(1997-3#1)(2007-8#1)
(1%)##22##1##(1991-8#3)(1996-5#1)(1997-3#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#2)(2012-1#1)(2013-1#1)
(1) A##3##2##(2010-3#1)(2010-8#1)(2011-2#1)
(1) I##2##2##(2007-11#1)(2008-5#1)
(1) In##2##2##(1996-8#1)(2011-1#1)
(1) The##9##2##(1993-3#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
(1) What is the##2##4##(2008-3#1)(2008-4#1)
(1) What##3##2##(1996-1#1)(2008-3#1)(2008-4#1)
(1) When##2##2##(2008-10#1)(2008-5#1)
(1) a##12##2##(1993-5#1)(1997-3#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
(1) about##2##2##(1991-1#1)(1993-12#1)
(1) access##2##2##(1993-12#1)(2009-6#1)
(1) an##5##2##(1996-11#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-5#1)
(1) and (2)##6##3##(1992-3#1)(2008-10#2)(2008-5#2)(2013-1#1)
(1) and AA560##2##3##(1990-11#2)
(1) and##29##2##(1990-11#4)(1992-3#1)(1992-8#2)(1995-11#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-11#2)(2008-10#5)(2008-11#4)(2008-5#3)(2010-6#1)(2012-2#1)(2013-1#2)
(1) as##2##2##(1995-5#1)(2008-10#1)
(1) by##8##2##(1992-11#1)(1994-11#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)
(1) children's##2##2##(2007-12#1)(2012-12#1)
(1) designing the peptide sequence based on the sequence of the protein##2##12##(2008-4#2)
(1) from##2##2##(2008-10#1)(2008-11#1)
(1) greater##2##2##(1990-11#1)(1993-12#1)
(1) have##2##2##(2010-9#1)(2012-2#1)
(1) how##2##2##(2008-4#2)
(1) identification of a##2##4##(1992-3#1)(2008-9#1)
(1) identify##2##2##(2008-1#1)(2011-2#1)
(1) in##3##2##(1993-12#1)(1995-2#1)(2008-10#1)
(1) individual##2##2##(1994-12#1)(1997-4#1)
(1) is described##2##3##(2007-11#1)(2010-6#1)
(1) is##7##2##(1995-3#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-12#1)(2010-6#1)
(1) it##3##2##(1996-11#1)(2007-12#1)(2009-9#1)
(1) no##2##2##(1990-5#1)(2013-1#1)
(1) one##2##2##(2008-5#1)(2008-7#1)
(1) or##2##2##(1997-7#1)(2008-10#1)
(1) possible##2##2##(1996-12#1)(2008-3#1)
(1) that the##4##3##(1990-6#1)(1991-2#2)(1993-12#1)
(1) that##6##2##(1990-6#1)(1991-2#2)(1993-12#1)(1996-2#1)(2009-11#1)
(1) the contribution of##2##4##(1994-2#1)(2008-3#1)
(1) the use of##2##4##(1996-12#1)(2008-3#1)
(1) the##55##2##(1990-11#1)(1991-11#1)(1991-7#1)(1992-1#2)(1992-3#1)(1993-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(2007-10#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#1)
(1) their##2##2##(2008-12#1)(2008-3#1)
(1) there was##2##3##(1994-12#1)(2008-5#1)
(1) there##4##2##(1994-12#1)(1996-5#1)(2007-8#1)(2008-5#1)
(1) to describe##2##3##(1992-12#1)(2013-1#1)
(1) to evaluate the##2##4##(1994-1#1)(2013-1#1)
(1) to evaluate##3##3##(1993-12#1)(1994-1#1)(2013-1#1)
(1) to##14##2##(1992-12#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-2#1)(2009-1#1)(2009-5#1)(2010-8#2)(2013-1#3)
(1) using##2##2##(2008-3#1)(2011-2#1)
(1) were##2##2##(1990-5#1)(1996-2#1)
(1) what##3##2##(2008-4#1)(2008-7#1)(2013-1#1)
(1) whether##2##2##(2007-8#1)(2012-6#1)
(1) with the##2##3##(2007-11#1)(2010-5#1)
(1) with##7##2##(1996-5#3)(2007-11#3)(2010-5#1)
(1)##536##1##(1990-11#7)(1990-5#2)(1990-6#2)(1990-7#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#11)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#4)(1994-5#3)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#7)(1996-3#5)(1996-5#9)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#1)(1997-7#6)(2006-10#2)(2006-12#1)(2006-4#2)(2007-10#2)(2007-11#14)(2007-12#12)(2007-4#1)(2007-5#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#55)(2008-11#22)(2008-12#11)(2008-2#7)(2008-3#23)(2008-4#19)(2008-5#13)(2008-6#5)(2008-7#20)(2008-8#4)(2008-9#11)(2009-1#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#3)(2010-6#3)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#8)(2012-3#8)(2012-6#1)(2012-7#1)(2013-1#25)(2013-7#6)(2013-8#6)
(1)A(1g) --&gt##4##2##(1997-7#4)
(1)A(1g)##5##1##(1997-7#5)
(1)D at##4##2##(2008-10#4)
(1)D##10##1##(2008-10#10)
(1)E(1/2) = -0##4##3##(2009-9#4)
(1)E(g) and##2##2##(1997-7#2)
(1)H NMR data##3##3##(1996-5#1)(1997-7#1)(2009-9#1)
(1)H NMR spectra##4##3##(2008-10#3)(2008-9#1)
(1)H NMR spectroscopy##4##3##(1996-2#1)(2009-9#1)(2012-12#2)
(1)H NMR##25##2##(1996-2#1)(1996-5#1)(1997-7#2)(2008-10#8)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
(1)H and (13)C NMR analyses of this##2##7##(2008-10#2)
(1)H and (13)C NMR and IR spectroscopy##2##7##(1996-2#2)
(1)H and (13)C NMR##7##4##(1996-2#2)(2008-10#3)(2013-1#2)
(1)H and (13)C##8##3##(1996-2#2)(2008-10#3)(2013-1#3)
(1)H and##10##2##(1996-2#3)(2007-11#1)(2008-10#3)(2013-1#3)
(1)H##55##1##(1996-2#4)(1996-5#3)(1997-7#6)(2007-1#2)(2007-11#1)(2008-10#15)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#6)(2009-9#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)
(1)H- (1)H##2##2##(2007-1#2)
(1)H- and##2##2##(2007-11#2)
(1)H-##5##1##(2007-1#2)(2007-11#3)
(1)H-NMR spectra##2##2##(2008-10#2)
(1)H-NMR##8##1##(1996-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2010-4#1)
(1)H-nuclear magnetic resonance##2##3##(2008-10#1)(2008-5#1)
(1)P(1) transition at##2##3##(2007-12#2)
(1+1)##2##1##(2007-11#1)(2010-2#1)
(1- and##2##2##(1993-11#1)(2008-2#1)
(1-##4##1##(1993-11#1)(1995-3#1)(2008-10#1)(2008-2#1)
(1--&gt##10##1##(1992-12#1)(1993-11#3)(1995-11#6)
(1-1##2##1##(1994-8#1)(2008-10#1)
(1-10 microM)##2##2##(1990-7#1)(1995-12#1)
(1-10##8##1##(1990-7#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-5#1)(2008-8#1)(2010-11#1)
(1-10)##2##1##(2008-2#1)(2012-2#1)
(1-100##2##1##(1997-4#1)(2008-10#1)
(1-1000 nM)##3##2##(1994-8#1)(1994-9#2)
(1-106) months (p = 0##2##5##(1997-5#2)
(1-2##8##1##(1993-6#1)(1994-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-1#1)
(1-2)##3##1##(1997-4#1)(2010-8#1)(2013-7#1)
(1-20##2##1##(1995-12#2)
(1-3##4##1##(1990-11#1)(1992-6#2)(1995-6#1)
(1-3)##5##1##(1995-3#1)(1997-3#1)(2008-12#1)(2010-12#2)
(1-4##3##1##(1996-2#1)(2008-12#1)(2012-1#1)
(1-4)##2##1##(1993-8#1)(2008-10#1)
(1-40##2##1##(1990-7#1)(2008-10#1)
(1-49)##4##1##(1990-12#4)
(1-49)-CCK-58##2##1##(1991-8#2)
(1-5##4##1##(1994-11#1)(1995-2#1)(1997-1#1)(2013-1#1)
(1-5%)##2##1##(2008-5#2)
(1-50##3##1##(1994-10#1)(1994-8#1)(2008-10#1)
(1-6)##3##1##(2008-10#1)(2010-2#1)(2013-1#1)
(1-8##2##1##(1997-3#1)(2008-5#1)
(1-8)##2##1##(1992-8#1)(2010-6#1)
(1-84)##3##1##(1990-2#1)(1994-6#2)
(1-9##2##1##(1990-7#1)(1997-3#1)
(1-D)##4##1##(2008-3#4)
(1/10##2##1##(2008-10#1)(2008-11#1)
(1/2) years##2##2##(2008-1#2)
(1/2)##4##1##(1997-7#1)(2008-1#2)(2008-3#1)
(1/3)##2##1##(1996-9#2)
(1/4) and narasin (1/4)##3##4##(2007-6#3)
(1/4) and##4##2##(2007-6#4)
(1/4)##11##1##(1996-9#1)(2007-6#10)
(1/7)##2##1##(2007-6#1)(2012-3#1)
(10 and##3##2##(1992-5#1)(2010-5#1)(2010-6#1)
(10 cm)##2##2##(2008-10#1)(2008-5#1)
(10 from##2##2##(2008-10#1)(2010-4#1)
(10 mM)##4##2##(1990-2#1)(1990-7#1)(2008-11#2)
(10 male##3##2##(2008-2#1)(2011-2#1)(2012-3#1)
(10 mg kg-1##2##3##(1995-5#2)
(10 mg l(-1))##6##3##(2008-10#6)
(10 mg##10##2##(1993-12#1)(1995-5#2)(2008-10#7)
(10 mg)##2##2##(1990-12#1)(1990-6#1)
(10 mg/kg i##2##3##(1992-3#1)(1997-6#1)
(10 mg/kg##10##2##(1992-12#1)(1992-3#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)
(10 mg/kg)##8##2##(1990-7#1)(1991-12#1)(1992-8#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
(10 microM) and##4##3##(1993-8#1)(1995-11#1)(1996-5#1)(1997-2#1)
(10 microM) or##2##3##(1990-8#1)(1995-5#1)
(10 microM)##24##2##(1990-12#2)(1990-8#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#4)(1997-7#1)(2009-12#2)
(10 micrograms)##2##2##(1993-6#1)(1996-2#1)
(10 micrograms/ml)##4##2##(1993-12#2)(1994-3#2)
(10 mu M)##3##3##(1995-12#2)(2008-11#1)
(10 mu g kg-1 h-1)##2##5##(1995-12#2)
(10 mu##6##2##(1995-12#5)(2008-11#1)
(10 muM)##2##2##(2008-10#2)
(10 mul)##3##2##(2008-10#3)
(10 mumol/L)##2##2##(2008-8#2)
(10 nM)##3##2##(1991-5#1)(1994-8#1)(1995-11#1)
(10 ng ml-1)##2##3##(1995-5#2)
(10 ng##4##2##(1995-5#2)(2008-11#1)(2010-5#1)
(10 patients##2##2##(1991-8#1)(2008-1#1)
(10 patients)##2##2##(2008-7#1)(2012-2#1)
(10 per##5##2##(2008-10#3)(2008-5#2)
(10 to 15##2##3##(1992-8#1)(1995-12#1)
(10 to##7##2##(1992-8#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#1)(2012-3#2)
(10 x##3##2##(1992-2#1)(2008-2#1)(2013-1#1)
(10##264##1##(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#2)(1992-8#2)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-8#3)(1995-11#3)(1995-12#15)(1995-2#1)(1995-3#3)(1995-5#6)(1996-2#9)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-11#2)(2007-7#3)(2007-8#3)(2008-1#6)(2008-10#43)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#4)(2013-8#1)
(10% of##2##2##(1992-6#1)(2008-7#1)
(10% vs 16##2##3##(2010-4#2)
(10% vs##5##2##(2006-10#1)(2010-4#4)
(10%##14##1##(1992-6#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-4#4)(2010-9#1)(2011-3#1)
(10%) and##2##2##(1992-8#1)(1996-9#1)
(10%) were##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
(10%)##26##1##(1992-1#1)(1992-8#2)(1993-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#5)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
(10(-10) to 10(-7) M)##2##4##(1997-4#2)
(10(-10)##4##1##(1993-6#1)(1996-2#1)(1997-4#2)
(10(-2) mol##2##2##(2008-10#2)
(10(-2)##4##1##(2008-10#4)
(10(-3) M)##4##2##(1990-7#2)(2008-4#2)
(10(-3)##5##1##(1990-7#2)(2008-10#1)(2008-4#2)
(10(-4) M)##5##2##(1990-7#1)(1991-5#2)(2008-4#2)
(10(-5) M)##6##2##(1990-7#1)(1991-5#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-4#1)
(10(-5)M)##2##1##(1994-10#2)
(10(-6) M)##4##2##(1995-12#3)(2008-4#1)
(10(-6) to##2##2##(2008-10#2)
(10(-6)##8##1##(1994-2#1)(1995-12#3)(1997-4#1)(2008-10#2)(2008-4#1)
(10(-6)M)##2##1##(1991-12#1)(1994-11#1)
(10(-7) M##2##2##(1990-8#1)(2011-1#1)
(10(-7) M)##6##2##(1990-8#1)(1993-6#1)(1994-11#1)(1995-12#1)(1997-4#2)
(10(-7)##9##1##(1990-8#2)(1993-6#1)(1994-11#1)(1995-12#1)(1997-4#3)(2011-1#1)
(10(-7)M)##3##1##(1991-12#1)(1994-11#2)
(10(-8) M)##3##2##(1995-12#2)(1997-4#1)
(10(-8)##6##1##(1995-12#3)(1996-2#2)(1997-4#1)
(10(-9)##2##1##(1995-12#1)(2008-3#1)
(10(2)##2##1##(2008-10#1)(2008-9#1)
(10(3)##2##1##(2008-10#1)(2012-2#1)
(10(5)##2##1##(1992-3#1)(2008-10#1)
(10(6)##6##1##(1993-8#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)
(10(7)##3##1##(2008-10#1)(2008-9#1)(2013-1#1)
(10) and##4##2##(1992-12#1)(1996-5#1)(2009-11#1)(2011-2#1)
(10)##18##1##(1992-12#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#2)(2007-11#1)(2007-8#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#3)
(10-100##2##1##(1993-8#1)(1994-6#1)
(10-15##2##1##(2007-8#1)(2010-10#1)
(10-20##4##1##(1991-9#1)(1995-3#1)(2008-10#1)(2011-1#1)
(10-20%)##2##1##(2008-10#2)
(10-250##2##1##(2008-10#1)(2008-3#1)
(10-40##2##1##(2008-11#1)(2013-1#1)
(10-50##2##1##(1992-3#1)(1996-2#1)
(10-fold)##2##1##(1996-2#1)(2007-12#1)
(100 Hz)##2##2##(1996-12#1)(2010-1#1)
(100 and##3##2##(2011-3#2)(2012-2#1)
(100 degrees ) and##2##4##(2008-2#2)
(100 mg l(-1)##2##3##(2008-10#2)
(100 mg##3##2##(2008-10#3)
(100 mg)##2##2##(2008-5#2)
(100 mg/kg body##3##3##(1997-6#1)(2008-10#1)(2013-1#1)
(100 mg/kg##7##2##(1997-6#1)(2008-10#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
(100 mg/kg)##3##2##(1995-12#1)(2011-2#2)
(100 microM) and##2##3##(1990-12#1)(1996-2#1)
(100 microM) or methylene blue (2##2##6##(1993-8#2)
(100 microM) or##3##3##(1993-8#3)
(100 microM)##10##2##(1990-12#2)(1992-11#1)(1993-8#4)(1996-2#1)(1997-2#1)(1997-7#1)
(100 micrograms)##2##2##(1992-3#1)(1995-12#1)
(100 ml##3##2##(2008-10#2)(2008-11#1)
(100 mm x 2##2##4##(2011-1#1)(2011-3#1)
(100 mm x##3##3##(2011-1#2)(2011-3#1)
(100 mmole l(-1))##2##3##(2008-5#2)
(100 mul) was##2##3##(2008-10#2)
(100 mul)##4##2##(2008-10#4)
(100 mumol/l)##2##2##(1993-3#1)(1996-5#1)
(100 nM) in##2##3##(1992-3#1)(1996-5#1)
(100 nM)##10##2##(1991-5#1)(1991-6#1)(1992-3#1)(1995-12#3)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)
(100 to##4##2##(2008-10#4)
(100##120##1##(1990-11#2)(1990-12#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-11#1)(1992-3#3)(1992-6#1)(1993-3#2)(1993-8#4)(1994-2#2)(1994-8#1)(1994-9#1)(1995-12#7)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(2007-8#1)(2008-10#25)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-1#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#4)(2011-3#4)(2012-12#1)(2012-2#2)(2013-1#5)
(100% in young cirrhotics vs##2##5##(2012-3#2)
(100%##11##1##(1993-8#1)(1995-3#1)(1996-8#1)(2007-2#1)(2007-8#3)(2009-8#1)(2012-3#2)(2013-1#1)
(100%) patients##3##2##(2007-7#2)(2008-7#1)
(100%) with##2##2##(1993-6#1)(2008-7#1)
(100%)##27##1##(1991-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(1997-4#1)(1997-8#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2011-1#2)(2011-2#1)(2012-3#2)(2013-8#3)
(100)##3##1##(2007-11#1)(2007-7#1)(2008-8#1)
(100-200##2##1##(1992-3#1)(1993-12#1)
(100-500##2##1##(1990-11#1)(2008-10#1)
(100-fold##2##1##(2008-10#2)
(1000##5##1##(1990-8#2)(1997-8#1)(2008-3#1)(2011-2#1)
(101##4##1##(1990-7#2)(2011-2#1)(2013-1#1)
(103##2##1##(2007-8#1)(2008-8#1)
(103)Rh##2##1##(2008-10#2)
(105##5##1##(1995-5#1)(1997-2#1)(2007-2#1)(2008-10#1)(2013-1#1)
(1053##2##1##(1991-5#1)(2008-7#1)
(109##7##1##(1994-2#1)(1995-12#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#2)
(109)Ag##2##1##(2008-10#2)
(109)Cd##2##1##(2008-10#2)
(10mM) and##3##2##(1993-3#2)(2008-10#1)
(10mM)##5##1##(1993-3#4)(2008-10#1)
(10min##2##1##(2008-10#2)
(10mm##2##1##(2008-10#1)(2008-11#1)
(10mugL(-1)##2##1##(2008-10#2)
(10mul)##2##1##(2008-10#2)
(10sigma)##3##1##(2008-10#3)
(11 cases)##4##2##(1990-12#1)(1994-8#1)(2008-7#1)(2008-9#1)
(11 degrees##2##2##(2008-2#1)(2008-8#1)
(11 feet)##2##2##(1990-9#1)(2011-2#1)
(11 males and##2##3##(1992-9#1)(2008-4#1)
(11##74##1##(1990-11#2)(1990-12#2)(1990-9#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
(11%)##14##1##(1990-12#1)(1990-6#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
(11) and##2##2##(2007-7#2)
(11)##11##1##(1990-3#1)(1995-3#1)(1996-5#2)(2007-7#2)(2007-8#2)(2009-11#1)(2011-2#1)(2013-1#1)
(11/12) of##2##2##(2007-11#1)(2012-3#1)
(110 degrees##2##2##(2008-10#2)
(110##11##1##(1991-4#1)(1995-12#1)(2008-10#7)(2010-1#1)(2011-2#1)
(112)Cd##2##1##(2008-10#2)
(113##3##1##(1990-3#1)(2009-8#1)(2012-3#1)
(114##2##1##(1994-6#1)(1996-2#1)
(114)##2##1##(2007-6#1)(2010-10#1)
(115##5##1##(1996-2#1)(2008-12#2)(2008-5#1)(2013-7#1)
(116##2##1##(1994-12#1)(2013-8#1)
(117 +/-##2##2##(1994-2#1)(2011-3#1)
(118 +/- 7##2##3##(1993-12#1)(2008-5#1)
(118 +/-##3##2##(1993-12#1)(1996-9#1)(2008-5#1)
(118##4##1##(1991-11#1)(1993-12#1)(1996-9#1)(2008-5#1)
(12 degrees ) sprinklers##2##4##(2008-10#2)
(12 months old)##2##3##(1993-12#1)(1994-6#1)
(12 months##4##2##(1993-12#1)(1994-6#1)(2009-7#1)(2013-1#1)
(12 months)##2##2##(2008-3#1)(2013-7#1)
(12 to##3##2##(1995-3#1)(1996-11#1)(2008-10#1)
(12 women##2##2##(2007-8#2)
(12##110##1##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#5)(2007-11#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
(12%##2##1##(2008-6#1)(2008-9#1)
(12%) and##2##2##(2007-7#1)(2008-1#1)
(12%) of##3##2##(1991-8#1)(1997-8#1)(2007-11#1)
(12%) patients##2##2##(1997-3#1)(2007-11#1)
(12%)##19##1##(1991-2#2)(1991-8#1)(1993-5#1)(1996-12#1)(1997-3#2)(1997-8#1)(2007-11#2)(2007-7#3)(2008-1#2)(2008-12#1)(2008-5#1)(2010-8#1)(2013-8#1)
(12) showed##2##2##(2010-2#1)(2013-7#1)
(12)##12##1##(1990-12#1)(1991-6#1)(1992-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-4#2)(2010-2#1)(2011-2#2)(2013-7#1)
(12-17 years)##2##2##(2010-8#1)(2011-2#1)
(120 kDa)##2##2##(1990-7#1)(1991-8#1)
(120 kV) &gt##3##3##(1997-8#3)
(120 kV)##4##2##(1997-8#4)
(120##15##1##(1990-12#1)(1990-7#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-3#1)(1995-8#1)(1997-8#4)(2008-10#2)(2008-11#2)
(1200##2##1##(2007-12#1)(2008-10#1)
(121##3##1##(2008-2#1)(2011-2#1)(2012-12#1)
(122##5##1##(1991-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
(123##3##1##(1997-2#1)(2008-10#1)(2011-2#1)
(125##2##1##(1994-8#1)(1997-4#1)
(125)I##3##1##(2007-12#1)(2008-4#1)(2009-8#1)
(13 and##2##2##(1990-10#1)(1997-2#1)
(13 patients)##2##2##(1990-8#1)(2008-7#1)
(13 to##3##2##(1993-9#1)(1996-12#1)(2008-10#1)
(13##89##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-2#2)(1993-9#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-10#3)(2007-12#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#9)(2008-7#3)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#5)(2010-8#1)(2011-1#4)(2011-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
(13%##2##1##(1992-2#1)(2013-8#1)
(13%)##18##1##(1991-9#1)(1992-6#1)(1993-3#1)(1994-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-8#2)
(13)##12##1##(1990-12#1)(1995-3#1)(1996-5#1)(2007-8#2)(2008-12#1)(2008-9#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-9#2)
(13)C NMR and##4##3##(1996-2#2)(2008-10#1)(2008-5#1)
(13)C NMR spectral##2##3##(2008-10#2)
(13)C NMR spectroscopy##6##3##(2008-10#5)(2013-1#1)
(13)C NMR##27##2##(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#16)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#4)
(13)C at##2##2##(2008-4#2)
(13)C chemical##2##2##(2009-7#2)
(13)C##44##1##(1996-2#2)(1996-5#3)(1997-7#1)(2008-10#16)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#8)(2010-3#2)(2011-2#1)(2012-1#1)(2013-1#5)
(13)C-CPMAS##2##1##(2008-10#2)
(13)C-NMR and##2##2##(2007-11#1)(2008-10#1)
(13)C-NMR##4##1##(2007-11#3)(2008-10#1)
(13)C-depleted leaf litter##2##3##(2010-3#2)
(13)C-labeled##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
(13)CH(4) in ambient air##2##4##(2007-12#2)
(130##6##1##(1995-5#1)(1995-6#1)(2008-2#1)(2008-6#1)(2011-2#2)
(135##2##1##(1996-1#1)(2008-5#1)
(137 kV) &gt##2##3##(1997-8#2)
(137 kV)##3##2##(1997-8#3)
(137##5##1##(1997-8#3)(2008-12#1)(2008-8#1)
(137)Ba##5##1##(2010-8#5)
(138##3##1##(2008-10#2)(2008-6#1)
(14 cases)##2##2##(1990-2#1)(1994-8#1)
(14 of##2##2##(1990-5#1)(2007-8#1)
(14##71##1##(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#1)(2010-1#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-2#1)(2013-7#1)(2013-8#1)
(14%##2##1##(2007-11#1)(2013-1#1)
(14%) had##5##2##(1997-2#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
(14%) patients##2##2##(2008-7#1)(2011-2#1)
(14%)##29##1##(1991-6#2)(1992-3#1)(1993-8#1)(1995-12#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
(14)##8##1##(1990-12#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#1)
(14)C-labeled##3##1##(2008-10#2)(2008-7#1)
(14)CO(2)##2##1##(2008-10#2)
(140##3##1##(2008-10#2)(2008-3#1)
(141##4##1##(2007-8#1)(2008-11#1)(2008-6#1)(2011-1#1)
(145##4##1##(1995-6#1)(2006-4#1)(2008-10#1)(2008-11#1)
(149##3##1##(1994-2#1)(1994-3#1)(2008-6#1)
(15 %)##2##2##(2007-7#1)(2013-1#1)
(15 cm##2##2##(2008-10#2)
(15 mg/kg##5##2##(1992-8#1)(1993-11#1)(1995-3#1)(2008-10#2)
(15 min##2##2##(1995-11#1)(2008-12#1)
(15 min)##2##2##(1992-3#1)(2008-4#1)
(15 s)##2##2##(1993-11#1)(2008-12#1)
(15##98##1##(1990-11#1)(1990-2#1)(1990-9#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-6#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#18)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
(15%##6##1##(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)
(15%) and##2##2##(2007-11#1)(2011-2#1)
(15%)##23##1##(1991-3#1)(1992-12#2)(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-3#2)(2008-6#1)(2011-1#1)(2011-2#3)(2013-8#1)
(15) and##4##2##(1995-11#1)(1995-3#1)(1997-5#1)(2011-3#1)
(15)##8##1##(1995-11#1)(1995-2#1)(1995-3#1)(1997-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-3#1)
(15)N##9##1##(1996-5#1)(2008-4#1)(2009-7#7)
(15)N-labeled nucleosides##2##2##(2008-4#2)
(15)N-labeled##3##1##(2008-4#2)(2012-2#1)
(15)NH(3) laser##2##2##(2007-12#2)
(15)N]-labeled protein##2##2##(2009-7#2)
(15-fold##3##1##(1991-12#1)(1995-3#1)(2008-10#1)
(150 degrees )##3##3##(2008-2#3)
(150 degrees##5##2##(1996-2#1)(2008-2#3)(2012-2#1)
(150 mg##3##2##(1990-6#1)(2008-10#1)(2013-1#1)
(150 mg/kg##3##2##(1991-9#1)(1995-12#2)
(150 mg/kg)##2##2##(1995-12#1)(2012-2#1)
(150 ppm)##4##2##(2008-10#3)(2008-5#1)
(150##31##1##(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1993-3#1)(1995-12#3)(1996-2#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-4#2)(2011-2#1)(2012-2#2)(2013-1#1)
(1500 mg l(-1) level)##2##4##(2008-10#2)
(1500##4##1##(2008-10#2)(2008-6#1)(2009-6#1)
(150mmx4##2##1##(2008-10#2)
(157##2##1##(1990-2#1)(1991-11#1)
(159##2##1##(1995-5#1)(2008-8#1)
(15C5)##2##1##(2008-10#2)
(16 kDa)##2##2##(1993-11#1)(1994-5#1)
(16 mM)##2##2##(1996-2#1)(2008-11#1)
(16##79##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-7#4)(2007-8#4)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
(16%) of the##2##3##(1994-1#1)(2008-10#1)
(16%) of##3##2##(1994-1#1)(2007-10#1)(2008-10#1)
(16%)##16##1##(1990-6#1)(1990-9#1)(1992-5#1)(1994-1#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
(16)##8##1##(1992-12#1)(1993-1#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-3#1)
(16)O(3)##3##1##(2008-2#3)
(160##5##1##(1991-6#1)(1997-4#1)(2008-3#1)(2011-2#1)(2013-1#1)
(164)##2##1##(2008-5#1)(2009-4#1)
(169##4##1##(2007-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
(17 men and##2##3##(1992-2#1)(2008-7#1)
(17 mm)##2##2##(2012-2#2)
(17 patients) or##2##3##(2008-7#1)(2008-9#1)
(17##52##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-3#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#1)
(17%##2##1##(2006-10#1)(2008-7#1)
(17%) and##2##2##(1990-3#1)(1993-12#1)
(17%)##18##1##(1990-3#1)(1991-12#1)(1993-12#1)(1996-6#1)(1997-3#2)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
(17)##4##1##(1995-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
(170##2##1##(2008-10#1)(2008-3#1)
(171##3##1##(2008-10#1)(2009-12#1)(2013-8#1)
(172##2##1##(2008-3#1)(2008-9#1)
(176##2##1##(2008-5#1)(2008-9#1)
(178##4##1##(1994-6#1)(2008-12#1)(2011-1#1)(2011-2#1)
(17OHP)##2##1##(1990-11#2)
(18 cases)##2##2##(1994-9#1)(2011-2#1)
(18 children)##2##2##(2008-1#1)(2013-1#1)
(18 kDa)##4##2##(1993-11#1)(2012-2#3)
(18 to##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
(18##90##1##(1990-2#7)(1991-6#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#9)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#1)
(18%) and##3##2##(1992-5#1)(1996-9#1)(2012-2#1)
(18%) were##2##2##(1996-12#1)(2010-4#1)
(18%)##24##1##(1990-2#1)(1990-9#1)(1992-5#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#3)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
(18) and##2##2##(2008-11#1)(2013-1#1)
(18)##6##1##(1990-12#1)(1995-11#1)(2007-11#1)(2008-11#1)(2013-1#1)(2013-7#1)
(18)F##2##1##(2010-6#2)
(18)F-FB-PEG(3)-RGD-BBN##3##1##(2010-6#3)
(18)F-FDG##2##1##(2010-8#1)(2013-1#1)
(18)F-SKI249380##2##1##(2013-1#2)
(18)F-SKI249380-containing##3##1##(2013-1#3)
(18)O##2##1##(2008-2#1)(2008-4#1)
(18)O/(16)O##3##1##(1992-7#1)(2008-2#2)
(18-24 years)##2##2##(1992-6#2)
(18-24)##2##1##(2008-1#1)(2008-10#1)
(18-25##2##1##(2008-12#1)(2012-3#1)
(180##5##1##(1992-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-6#1)
(183##2##1##(1991-5#1)(1993-12#1)
(186)Os and (188)Os##3##3##(2008-10#3)
(187)Os##3##1##(2008-10#3)
(188##2##1##(2008-12#1)(2008-3#1)
(188)Re##3##1##(2007-10#3)
(18C6)##5##1##(2008-10#5)
(19 degrees##2##2##(2008-10#1)(2008-5#1)
(19##48##1##(1990-3#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-9#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#3)(2008-1#4)(2008-10#6)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#3)
(19%##3##1##(2008-7#1)(2010-3#1)(2011-2#1)
(19%) and##5##2##(1991-6#1)(1996-5#1)(2008-5#1)(2011-2#1)(2012-2#1)
(19%)##20##1##(1991-5#1)(1991-6#1)(1993-6#1)(1996-5#1)(1996-6#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
(19)##4##1##(1996-5#1)(2007-8#1)(2008-5#1)(2012-2#1)
(19)F NMR T(1)##2##3##(2008-10#1)(2008-7#1)
(19)F NMR allows the bioorganic chemist to##2##7##(2009-9#2)
(19)F NMR spectra##2##3##(1996-2#1)(1996-5#1)
(19)F NMR##7##2##(1996-2#1)(1996-5#1)(2008-10#1)(2008-7#1)(2009-9#2)(2012-3#1)
(19)F nuclear magnetic resonance##2##4##(2008-10#2)
(19)F##9##1##(1996-2#1)(1996-5#1)(2008-10#3)(2008-7#1)(2009-9#2)(2012-3#1)
(19)F-NMR##2##1##(2010-2#2)
(190##3##1##(1997-8#1)(2008-10#1)(2010-2#1)
(193- or 248-nm)##2##3##(2007-12#1)(2008-3#1)
(1938)##3##1##(2007-12#2)(2008-11#1)
(1941)##2##1##(2008-11#1)(2009-9#1)
(195##3##1##(1993-12#1)(2008-10#1)(2010-5#1)
(1954)##2##1##(1990-10#1)(2011-2#1)
(1959)##4##1##(2008-10#3)(2011-2#1)
(1961)##3##1##(2008-10#2)(2012-3#1)
(1966 to##2##2##(2008-11#1)(2009-2#1)
(1967)]##2##1##(2008-3#2)
(1971)]##2##1##(2007-11#1)(2008-3#1)
(1972)##3##1##(1990-10#1)(1990-8#1)(2008-11#1)
(1973)##3##1##(1990-5#2)(1991-5#1)
(1974)##6##1##(1990-8#1)(1992-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
(1975)]##2##1##(2008-2#1)(2008-3#1)
(1976)##4##1##(1990-8#2)(1990-9#1)(2008-10#1)
(1978) and##2##2##(2008-1#1)(2008-9#1)
(1978)##6##1##(1990-8#1)(1992-1#1)(1993-8#1)(2008-1#1)(2008-3#1)(2008-9#1)
(1979)##9##1##(1990-11#1)(1992-1#1)(1992-8#1)(1993-12#1)(1995-2#1)(1995-5#1)(2008-10#3)
(1980) are##2##2##(1990-10#1)(1991-12#1)
(1980)##7##1##(1990-10#1)(1990-2#1)(1991-12#1)(1991-2#1)(1994-5#1)(1995-2#1)(2009-10#1)
(1981)##3##1##(1990-11#1)(2008-10#1)(2008-9#1)
(1982) J##3##2##(1994-5#1)(1995-2#2)
(1982)##6##1##(1990-11#1)(1990-8#1)(1994-5#1)(1995-2#2)(2009-9#1)
(1983##2##1##(2008-11#2)
(1983) J##2##2##(1991-12#1)(1992-3#1)
(1983)##14##1##(1990-10#3)(1990-5#1)(1991-12#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-8#1)(1995-6#1)(1997-8#1)(2008-11#1)
(1984) J##2##2##(1991-8#1)(1993-8#1)
(1984)##13##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-12#1)(2008-1#1)
(1984)]##2##1##(2008-3#2)
(1985)##12##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
(1986##2##1##(1994-2#1)(2008-11#1)
(1986) and##2##2##(1992-1#1)(2011-2#1)
(1986)##13##1##(1990-11#1)(1991-5#1)(1992-1#3)(1993-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)
(1987) Biochemistry 26##3##3##(1992-3#1)(1993-11#1)(1995-6#1)
(1987) J##4##2##(1990-11#1)(1990-5#1)(1994-8#1)(1995-2#1)
(1987)##22##1##(1990-10#1)(1990-11#3)(1990-5#1)(1990-7#1)(1990-8#4)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)
(1987)]##3##1##(2008-2#1)(2008-3#2)
(1988##4##1##(2008-10#2)(2008-8#1)(2013-1#1)
(1988) Biochemistry 27##2##3##(1993-11#1)(1994-5#1)
(1988) FEBS Lett##2##3##(1990-7#1)(1992-12#1)
(1988) J##7##2##(1990-11#1)(1990-5#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-4#1)
(1988) Proc##2##2##(1992-6#2)
(1988)##26##1##(1990-11#1)(1990-5#5)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-8#1)(2008-12#1)(2008-9#1)
(1989) Biochemistry 28##5##3##(1990-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-2#1)
(1989) Eur##2##2##(1990-7#2)
(1989) J##2##2##(1991-12#1)(1995-2#1)
(1989)##30##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#2)(1993-11#1)(1994-12#4)(1994-2#2)(1995-2#2)(1995-6#1)(2008-5#1)
(1990##7##1##(1991-9#1)(1994-12#1)(1994-9#1)(1995-3#2)(1996-11#1)(2008-10#1)
(1990) Biochem##3##2##(1990-12#1)(1991-12#1)(1992-6#1)
(1990) Biochemistry 29##7##3##(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#2)(1995-2#1)(1995-5#1)
(1990) Biochemistry##8##2##(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#2)(1995-2#1)(1995-5#1)(1995-6#1)
(1990) Biopolymers##2##2##(1992-3#1)(1992-4#1)
(1990) FEBS Lett##3##3##(1991-7#1)(1992-6#1)(1997-8#1)
(1990) J##3##2##(1992-6#1)(1993-6#1)(1995-2#1)
(1990) Nature 343##2##3##(1995-2#1)(1995-5#1)
(1990) Nature##3##2##(1992-4#1)(1995-2#1)(1995-5#1)
(1990)##39##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#2)(1991-1#3)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-4#3)(1992-6#6)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#1)(1997-8#1)(2007-8#1)(2009-10#1)(2010-3#1)
(1990)]##3##1##(2008-2#2)(2008-3#1)
(1990-2000)##3##1##(2007-2#1)(2008-10#1)(2013-1#1)
(1991##5##1##(1992-3#2)(1997-2#1)(2008-11#1)(2009-10#1)
(1991) Biochemistry 30##5##3##(1991-8#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-5#1)
(1991) J##5##2##(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)
(1991) Proc##4##2##(1993-11#1)(1993-8#2)(1995-2#1)
(1991)##35##1##(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#5)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#2)(1995-6#2)(2007-12#1)(2007-8#2)
(1991)]##5##1##(2008-3#4)(2012-1#1)
(1992 to##2##2##(1997-3#1)(2008-10#1)
(1992##4##1##(1996-4#1)(1997-3#1)(2008-10#1)(2009-10#1)
(1992) Biochemistry 31##6##3##(1993-11#1)(1993-8#1)(1994-5#2)(1995-2#1)(1995-6#1)
(1992) J##8##2##(1992-12#2)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-6#2)
(1992) Proc##2##2##(1993-11#2)
(1992) Science##2##2##(1993-8#1)(1995-2#1)
(1992) of##2##2##(1994-5#1)(2009-10#1)
(1992)##49##1##(1992-12#2)(1992-8#2)(1993-11#4)(1993-12#5)(1993-3#3)(1993-8#4)(1994-12#3)(1994-2#1)(1994-5#4)(1995-12#1)(1995-2#2)(1995-6#5)(1995-8#1)(1996-12#1)(1997-2#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#2)
(1992)]##4##1##(2008-2#1)(2008-3#3)
(1993##3##1##(1994-9#1)(2008-10#1)(2013-1#1)
(1993) Biochemistry 32##3##3##(1993-11#1)(1994-5#1)(1995-2#1)
(1993) Development##2##2##(1995-6#2)
(1993) J##5##2##(1993-3#1)(1994-11#1)(1994-6#1)(1995-6#1)(1997-4#1)
(1993) Proc##5##2##(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)
(1993)##41##1##(1993-11#2)(1993-12#4)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#7)(1995-8#2)(1997-2#3)(1997-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)
(1993)]##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
(1994 to 2004)##2##3##(2008-10#2)
(1994##4##1##(1996-4#1)(2008-10#3)
(1994) EMBO J##2##3##(1995-2#2)
(1994) J##3##2##(1994-5#1)(1995-5#1)(1995-6#1)
(1994)##27##1##(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#6)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#3)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#2)(2011-2#1)
(1994)]##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
(1995) Biochemistry 34##3##3##(1995-2#1)(1995-5#2)
(1995)##14##1##(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#2)(2008-1#1)(2008-10#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
(1995)] is##2##2##(2008-2#1)(2008-3#1)
(1995)]##12##1##(2007-12#3)(2008-2#6)(2008-3#3)
(1996)##16##1##(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
(1996)]##8##1##(2007-12#1)(2008-2#2)(2008-3#5)
(1997)##13##1##(2007-12#1)(2008-10#5)(2008-2#3)(2008-9#1)(2010-7#1)(2011-1#1)(2012-1#1)
(1997)] is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
(1997)] that##2##2##(2008-2#1)(2008-3#1)
(1997)]##24##1##(1997-2#1)(2007-12#4)(2008-2#7)(2008-3#11)(2008-6#1)
(1998) (in press)]##2##3##(2008-10#2)
(1998)##23##1##(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-1#1)(2013-1#1)
(1998)] we##2##2##(2008-3#2)
(1998)]##20##1##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#12)
(1999)##11##1##(2006-4#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)
(1999)] in##2##2##(2008-3#2)
(1999)] presented##2##2##(2008-3#2)
(1999)]##19##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#15)
(19F##2##1##(2008-1#2)
(1E##2##1##(2010-2#2)
(1R##3##1##(1996-5#1)(2008-10#2)
(1S##11##1##(1990-7#1)(1995-12#1)(1996-5#6)(2008-10#3)
(1a##3##1##(1996-5#1)(1997-7#1)(2008-10#1)
(1a)##5##1##(1992-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2009-9#1)
(1b)##4##1##(1992-10#1)(1992-12#1)(1997-7#1)(2008-10#1)
(1m) cladding modes##3##3##(2008-3#3)
(1mM)##2##1##(2008-10#2)
(1n##2##1##(1990-2#1)(2009-10#1)
(1st year##2##2##(2008-12#2)
(1st##5##1##(2007-8#1)(2008-10#1)(2008-12#2)(2010-8#1)
(1 mg kg(-1)##2##1##(2012-2#2)
(1→6)-β-d-glucopyranoside##2##1##(2013-1#2)
(2 +/- 3) x##2##4##(2008-3#2)
(2 -##2##2##(2009-11#1)(2009-12#1)
(2 S##2##2##(2008-10#2)
(2 and 3)##4##3##(1996-2#1)(2008-10#3)
(2 cases)##4##2##(1990-12#2)(2007-8#1)(2008-11#1)
(2 h at##2##3##(2008-10#1)(2011-2#1)
(2 h)##2##2##(1990-2#1)(2008-12#1)
(2 mg##2##2##(1995-12#1)(2007-8#1)
(2 mg/kg) and##2##3##(1993-3#1)(2011-1#1)
(2 mg/kg)##5##2##(1993-3#3)(2010-6#1)(2011-1#1)
(2 months)##3##2##(1992-10#1)(2008-3#1)(2013-7#1)
(2 mug##2##2##(2008-10#1)(2008-5#1)
(2 nM)##2##2##(1997-4#2)
(2 of##3##2##(1992-5#1)(1996-3#1)(2007-8#1)
(2 to 5##2##3##(1991-5#1)(2008-10#1)
(2 to##11##2##(1991-5#1)(1993-1#1)(2008-10#6)(2008-7#1)(2011-2#1)(2012-3#1)
(2 with##4##2##(1992-8#1)(1994-12#1)(1997-6#1)(2012-3#1)
(2 x##5##2##(1995-2#1)(2008-10#3)(2008-11#1)
(2##485##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#3)(1991-7#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#6)(1996-3#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#6)(2008-10#133)(2008-11#16)(2008-12#11)(2008-2#8)(2008-3#13)(2008-5#14)(2008-6#6)(2008-7#10)(2008-8#6)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#4)(2010-4#10)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#25)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#17)(2013-7#1)(2013-8#9)
(2% LA)##2##2##(2008-5#2)
(2% w/v)##2##2##(1996-12#1)(2008-10#1)
(2%##11##1##(1994-8#1)(1996-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-2#2)(2011-3#1)(2013-1#1)
(2%) and##3##2##(1990-3#1)(2008-1#1)(2008-5#1)
(2%) without##2##2##(2007-10#2)
(2%)##20##1##(1990-3#2)(1990-9#1)(1996-12#1)(1997-3#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#3)
(2'-5')pA3##2##1##(1990-2#2)
(2'-5')phosphodiesterase##2##1##(1990-2#2)
(2'F-ANA)##3##1##(2008-4#3)
(2(nd)##2##1##(2011-1#1)(2013-1#1)
(2) = 0##5##3##(2008-10#3)(2008-9#1)(2013-8#1)
(2) =##7##2##(2008-10#3)(2008-9#3)(2013-8#1)
(2) The peak##2##3##(2007-11#1)(2011-1#1)
(2) The##9##2##(1992-12#1)(1993-3#1)(1995-9#1)(2007-11#1)(2008-11#1)(2011-1#2)(2011-2#1)(2013-8#1)
(2) To##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
(2) What are the##2##4##(1996-1#1)(1996-3#1)
(2) What##4##2##(1996-1#1)(1996-3#1)(2008-3#1)(2012-12#1)
(2) a##20##2##(1993-11#1)(1993-5#1)(1994-3#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#2)(2013-8#1)
(2) acute##2##2##(2009-11#1)(2012-1#1)
(2) an##5##2##(1992-9#1)(1996-11#1)(2007-9#1)(2009-5#1)(2013-1#1)
(2) and##14##2##(1990-11#1)(1990-12#1)(1994-11#1)(1997-7#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2013-8#1)
(2) are##2##2##(2008-10#1)(2010-9#1)
(2) by##7##2##(1992-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)
(2) glasses##2##2##(2007-12#2)
(2) have been##2##3##(1997-7#2)
(2) have##3##2##(1997-7#2)(2006-4#1)
(2) higher##2##2##(1993-12#1)(2008-12#1)
(2) how##3##2##(1993-3#1)(2008-4#2)
(2) human##2##2##(2008-5#1)(2013-1#1)
(2) in the##2##3##(1996-5#1)(2007-12#1)
(2) in##5##2##(1992-1#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-3#1)
(2) it##4##2##(1996-11#1)(2007-12#1)(2008-10#1)(2009-9#1)
(2) laser##3##2##(2007-11#1)(2007-12#2)
(2) no##2##2##(1992-2#1)(2013-1#1)
(2) obtain##2##2##(2008-3#1)(2008-9#1)
(2) over##2##2##(2008-10#1)(2008-11#1)
(2) sample##2##2##(2008-10#1)(2013-1#1)
(2) synthesizing the peptide##2##4##(2008-4#2)
(2) that##7##2##(1991-2#2)(1993-12#1)(1996-12#1)(1996-2#1)(2009-11#1)(2009-7#1)
(2) the##59##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-12#4)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#2)
(2) their##5##2##(1990-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)
(2) there##2##2##(1994-8#1)(2008-5#1)
(2) to##12##2##(1992-12#1)(1993-12#1)(1994-1#1)(1995-12#1)(2008-2#1)(2008-4#1)(2009-1#1)(2009-5#1)(2010-8#2)(2013-1#2)
(2) two##2##2##(2008-5#1)(2012-3#1)
(2) use of##2##3##(1992-3#1)(1993-12#1)
(2) use##3##2##(1992-3#1)(1993-12#1)(2008-7#1)
(2) using##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
(2) was##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2012-3#1)
(2) were isolated from the##2##5##(2007-11#1)(2008-11#1)
(2) were##4##2##(2007-11#2)(2008-10#1)(2008-11#1)
(2) what##2##2##(2008-4#1)(2013-1#1)
(2) with##2##2##(1996-5#1)(1997-7#1)
(2)##533##1##(1990-11#5)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#6)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#11)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#3)(1994-5#2)(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#7)(1996-3#5)(1996-5#6)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#4)(1997-7#13)(2006-4#2)(2007-10#2)(2007-11#15)(2007-12#26)(2007-4#1)(2007-5#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#61)(2008-11#23)(2008-12#13)(2008-2#8)(2008-3#21)(2008-4#19)(2008-5#13)(2008-6#5)(2008-7#19)(2008-8#3)(2008-9#13)(2009-1#1)(2009-11#6)(2009-2#1)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#11)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#24)(2013-7#6)(2013-8#7)
(2))##3##1##(2007-11#1)(2008-10#2)
(2)/W##2##1##(2007-11#1)(2007-12#1)
(2)D values##2##2##(2008-10#2)
(2)D##7##1##(2008-10#7)
(2)E(1/2) = -0##4##3##(2009-9#4)
(2)E(1/2) =##5##2##(2009-9#5)
(2)F(2) population##2##2##(2008-9#2)
(2)F(2)##3##1##(2008-9#3)
(2)S(1/2)-(2)D(5/2)##2##1##(2007-12#1)(2008-2#1)
(2) = 0##3##1##(2011-2#1)(2012-5#2)
(2+##2##1##(2010-3#1)(2011-1#1)
(2+)##8##1##(2008-10#2)(2008-8#1)(2010-11#5)
(2+1) -dimensional##6##2##(2007-11#2)(2007-12#4)
(2- to##2##2##(1991-12#1)(1995-11#1)
(2-##3##1##(1991-12#1)(1995-11#1)(1997-2#1)
(2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one)##2##1##(1995-8#1)(2008-4#1)
(2-)-ENX system##2##2##(2010-4#2)
(2-10##2##1##(2012-2#1)(2013-7#1)
(2-3##4##1##(2008-10#1)(2008-12#1)(2009-4#1)(2013-8#1)
(2-3)##2##1##(2008-12#1)(2008-8#1)
(2-4##6##1##(1991-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)
(2-6##4##1##(1994-12#1)(1995-11#1)(2008-10#1)(2010-6#1)
(2-9)##2##1##(2008-10#1)(2013-7#1)
(2-D##2##1##(2008-4#1)(2009-12#1)
(2-D)##11##1##(1993-3#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#1)
(2-TFMA)##3##1##(1995-3#3)
(2-ethylhexyl##3##1##(2008-5#3)
(2/37)##3##1##(1991-3#3)
(2/4)##6##1##(2007-6#4)(2008-1#1)(2008-6#1)
(2/7)##2##1##(2007-6#2)
(20 +/-##2##2##(1992-9#1)(2010-2#1)
(20 degrees 1##2##3##(2008-2#2)
(20 degrees##3##2##(2008-2#2)(2008-7#1)
(20 mM)##4##2##(1990-2#1)(1994-6#1)(1995-8#1)(2008-11#1)
(20 mg##2##2##(1996-11#1)(2006-10#1)
(20 mg/kg body wt##2##4##(1995-3#1)(2013-1#1)
(20 mg/kg##5##2##(1995-3#1)(1996-2#1)(2012-2#1)(2013-1#2)
(20 mg/kg)##8##2##(1993-3#1)(1995-12#1)(1995-2#1)(2010-3#1)(2011-2#1)(2012-2#3)
(20 microM)##2##2##(1990-6#1)(1995-2#1)
(20 mm##2##2##(1990-11#1)(2008-10#1)
(20 months)##2##2##(1995-5#1)(2013-7#1)
(20 ng/ml)##3##2##(1994-3#1)(2012-12#2)
(20 nm)##2##2##(2008-10#2)
(20 rats) was##2##3##(1992-9#2)
(20 rats)##3##2##(1992-9#3)
(20 to##5##2##(1990-5#1)(2008-10#2)(2008-12#1)(2011-1#1)
(20 x##2##2##(1991-6#1)(2008-12#1)
(20##145##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#4)(1997-6#1)(1997-8#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#33)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
(20% vs##2##2##(2010-4#2)
(20% w/w)##2##2##(1993-11#1)(2010-4#1)
(20%##14##1##(1992-9#1)(1993-11#1)(1996-2#1)(1997-3#1)(2008-10#4)(2010-4#4)(2013-8#2)
(20%) and##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
(20%) was##2##2##(2008-10#1)(2013-7#1)
(20%) were##2##2##(1990-3#1)(2008-9#1)
(20%)##30##1##(1990-3#1)(1992-3#1)(1992-6#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-9#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
(20)##6##1##(1990-8#1)(1995-11#1)(2007-8#1)(2008-11#1)(2010-4#1)(2013-1#1)
(20-30##2##1##(2008-10#1)(2008-6#1)
(20-40##2##1##(1994-10#1)(2008-5#1)
(20-fold)##2##1##(2008-10#1)(2008-8#1)
(200 mg##5##2##(1990-8#1)(2008-10#1)(2008-5#1)(2013-1#2)
(200 mg/kg##6##2##(1991-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
(200 nM)##2##2##(1994-8#1)(1994-9#1)
(200 ng ml-1)##2##3##(1995-5#2)
(200 to##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
(200##48##1##(1990-8#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-5#2)(1996-1#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)
(200-300##2##1##(1993-9#1)(1997-7#1)
(200-500##2##1##(1990-7#1)(2008-2#1)
(2000##4##1##(2008-11#1)(2010-11#1)(2011-3#1)(2012-1#1)
(2000) and##2##2##(2008-5#1)(2012-1#1)
(2000)##16##1##(2006-4#1)(2008-10#8)(2008-5#3)(2008-9#2)(2010-1#1)(2012-1#1)
(2000)]##9##1##(2007-11#3)(2007-12#2)(2008-3#4)
(2001) and##3##2##(2007-11#2)(2009-2#1)
(2001)##14##1##(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-12#1)(2009-2#1)(2011-1#1)
(2001)]##10##1##(2007-11#3)(2008-3#7)
(2002 to##2##2##(2008-10#2)
(2002##3##1##(2008-10#3)
(2002)##4##1##(2008-10#1)(2008-12#1)(2008-5#2)
(2003)##11##1##(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2013-1#1)(2013-8#1)
(2004)##8##1##(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#2)(2010-8#1)(2013-1#1)
(2005)##11##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-7#1)
(2006)##8##1##(2008-12#1)(2008-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#2)
(2007)##5##1##(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
(2008) provides##2##2##(2009-12#1)(2013-8#1)
(2008)##10##1##(2009-12#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
(2009##3##1##(2009-12#3)
(2009)##10##1##(2009-6#1)(2010-5#3)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#3)
(2011)##13##1##(2011-2#9)(2012-12#1)(2012-3#3)
(2012) Journal of Nursing Management20##4##5##(2012-3#4)
(2012)##7##1##(2012-3#4)(2013-1#2)(2013-8#1)
(203)Tl##2##1##(2008-10#2)
(206)Pb and##2##2##(2008-10#2)
(206Pb/207Pb##2##1##(1992-3#2)
(20mlg(-1) sample)##2##2##(2008-10#2)
(21 and##2##2##(2008-10#1)(2012-3#1)
(21 days##2##2##(1992-11#1)(2008-11#1)
(21 days)##3##2##(1993-1#2)(2008-11#1)
(21 of##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
(21 vs##2##2##(2007-8#1)(2010-11#1)
(21##57##1##(1990-11#1)(1990-5#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-1#1)(1994-3#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
(21%)##16##1##(1993-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2012-2#1)(2013-1#2)
(21)##5##1##(1995-11#2)(2008-10#1)(2008-2#1)(2011-2#1)
(213##3##1##(1992-2#1)(2008-10#1)(2011-3#1)
(22##54##1##(1990-11#2)(1990-9#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-7#3)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
(22%##2##1##(2008-8#1)(2013-1#1)
(22%) and##2##2##(1995-12#1)(2008-7#1)
(22%) at week##2##3##(2013-1#2)
(22%) were##2##2##(1996-12#1)(2008-10#1)
(22%)##19##1##(1990-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-7#1)(2009-9#1)(2011-1#1)(2013-1#2)
(22)##3##1##(1995-11#2)(2008-1#1)
(220##4##1##(2008-10#2)(2008-4#1)(2009-11#1)
(224##3##1##(1996-9#1)(2008-10#1)(2011-2#1)
(226##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
(23 and##3##2##(1992-12#1)(2009-2#1)(2012-3#1)
(23##46##1##(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-12#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-5#5)(2008-7#1)(2008-9#2)(2009-2#1)(2010-4#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
(23%##4##1##(2008-10#1)(2008-11#1)(2008-6#2)
(23%) and##3##2##(2009-4#1)(2011-1#1)(2011-2#1)
(23%) patients##2##2##(2007-10#1)(2013-8#1)
(23%) were##2##2##(1991-12#1)(1996-12#1)
(23%)##15##1##(1991-12#1)(1994-12#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(23)##4##1##(1995-11#1)(1996-5#1)(2007-7#1)(2008-10#1)
(23)Na MRI##2##2##(2012-2#2)
(23)Na##6##1##(1997-7#4)(2012-2#2)
(23+/-4mmHg)##2##1##(2008-7#2)
(23-25 months old)##2##3##(2008-7#2)
(234)Th ingrowth##2##2##(2008-10#2)
(234)Th##4##1##(2008-10#4)
(234)U/(238)U activity##3##2##(2008-10#3)
(235##3##1##(2008-10#1)(2010-5#1)(2013-8#1)
(239##2##1##(2008-10#1)(2011-1#1)
(24 h##4##2##(1997-4#1)(2008-5#2)(2010-2#1)
(24 h)##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
(24 months)##3##2##(2008-3#1)(2008-7#1)(2013-1#1)
(24 to##2##2##(1994-3#1)(2008-3#1)
(24##54##1##(1990-2#1)(1991-12#1)(1993-1#1)(1994-1#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#4)(2013-8#1)
(24%##4##1##(1992-12#1)(1992-5#1)(2008-8#1)(2013-1#1)
(24%) and##2##2##(1994-7#1)(2013-1#1)
(24%) had##2##2##(1991-8#1)(2008-3#1)
(24%)##15##1##(1991-6#3)(1991-8#1)(1992-5#1)(1994-7#1)(1997-8#1)(2008-1#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#3)
(240##5##1##(1990-3#1)(1994-3#1)(1994-5#1)(2008-10#2)
(244##2##1##(2008-1#1)(2011-3#1)
(245##2##1##(2010-8#1)(2012-3#1)
(25 and 50##2##3##(1996-2#1)(2008-12#1)
(25 and##4##2##(1992-10#1)(1996-2#1)(2008-10#1)(2008-12#1)
(25 cm x 4##2##4##(2008-10#1)(2009-8#1)
(25 degrees C##4##3##(1992-9#1)(2008-10#1)(2009-9#1)(2010-4#1)
(25 degrees C)##5##3##(2008-10#1)(2008-12#3)(2008-5#1)
(25 degrees##10##2##(1992-9#1)(2008-10#2)(2008-12#3)(2008-5#2)(2009-9#1)(2010-4#1)
(25 mM##2##2##(1992-8#1)(2011-1#1)
(25 mg/kg##4##2##(1992-3#1)(1993-11#1)(1995-12#1)(1997-2#1)
(25 ng/ml)##2##2##(1990-12#1)(1992-12#1)
(25 to##3##2##(2008-10#2)(2012-3#1)
(25##97##1##(1990-12#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-2#2)(1997-2#2)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#6)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
(25%##10##1##(1995-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
(25%) and##4##2##(1992-5#1)(2008-1#1)(2011-2#1)(2012-1#1)
(25%) had##3##2##(1992-12#1)(2007-10#1)(2012-12#1)
(25%) patients##3##2##(1992-12#1)(2008-6#1)(2012-2#1)
(25%)##26##1##(1992-12#2)(1992-5#1)(1995-12#2)(1997-2#1)(2007-10#2)(2007-7#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
(25(OH)D)##2##1##(2011-1#2)
(25)##3##1##(1996-5#1)(2008-5#1)(2008-7#1)
(25-45##2##1##(1996-12#1)(2008-5#1)
(25-fold)##2##1##(1995-11#1)(2008-10#1)
(250 +/-##2##2##(1994-3#1)(1996-2#1)
(250 mg##4##2##(1993-3#1)(1997-6#1)(2008-10#1)(2008-5#1)
(250 microM)##2##2##(1990-8#1)(1994-8#1)
(250 x 4##3##3##(1996-5#2)(2008-10#1)
(250 x##4##2##(1996-5#2)(2008-10#1)(2008-12#1)
(250##37##1##(1990-8#1)(1991-5#1)(1992-10#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)(2011-1#2)
(250mmx4##2##1##(2008-10#2)
(250x4##2##1##(2008-10#1)(2010-3#1)
(254 nm)##2##2##(2008-10#1)(2008-12#1)
(254##4##1##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
(25mugL(-1)##2##1##(2008-10#2)
(26 of##5##2##(1991-12#1)(1997-4#1)(2007-7#1)(2009-9#1)(2013-1#1)
(26##54##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
(26%##2##1##(1992-5#1)(2008-10#1)
(26%) and##2##2##(1995-1#1)(1996-5#1)
(26%) of##2##2##(1993-8#1)(2008-10#1)
(26%) were##2##2##(1990-6#1)(2008-1#1)
(26%)##19##1##(1990-6#1)(1991-9#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#2)(2011-2#1)(2012-3#1)
(266 nm)##3##2##(2007-12#1)(2008-3#2)
(27 +/-##2##2##(1994-11#1)(2008-5#1)
(27##50##1##(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#2)(2007-7#3)(2008-1#5)(2008-10#5)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
(27%##3##1##(2007-10#1)(2008-10#1)(2008-3#1)
(27%) of##2##2##(1990-3#1)(1997-8#1)
(27%) were##2##2##(1990-6#1)(2008-1#1)
(27%)##19##1##(1990-3#1)(1990-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
(27)##4##1##(1995-3#1)(2007-12#1)(2007-8#1)(2008-1#1)
(27)Al NMR and Raman spectra##2##5##(2008-10#2)
(27)Al NMR and Raman##3##4##(2008-10#3)
(27)Al NMR##4##2##(2008-10#4)
(270##3##1##(1993-8#1)(1995-12#1)(2012-12#1)
(271##2##1##(1992-3#1)(2013-1#1)
(28 degrees##2##2##(2007-9#1)(2011-2#1)
(28##37##1##(1990-8#1)(1991-5#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
(28%##2##1##(2008-10#1)(2008-8#1)
(28%) and##4##2##(2007-10#1)(2007-11#1)(2008-4#1)(2012-3#1)
(28%) of##3##2##(2008-10#2)(2011-1#1)
(28%)##22##1##(1990-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-1#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#2)
(28-32##2##1##(1993-8#1)(2010-1#1)
(288##3##1##(2008-10#1)(2008-9#1)(2011-1#1)
(289##3##1##(1992-3#1)(2008-3#1)(2009-5#1)
(29 pts)##2##2##(2007-7#2)
(29##39##1##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1993-1#1)(1993-6#1)(1994-2#1)(1997-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
(29%##2##1##(2010-9#1)(2011-1#1)
(29%) and##2##2##(2008-3#1)(2008-8#1)
(29%) of##2##2##(1990-8#1)(1996-3#1)
(29%) were##2##2##(1991-9#1)(1996-12#1)
(29%)##18##1##(1990-8#1)(1991-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#2)
(293##2##1##(1996-2#1)(2008-10#1)
(295##3##1##(1993-2#1)(2011-1#1)(2011-2#1)
(2A)##3##1##(1995-6#1)(2008-4#1)(2009-2#1)
(2D##2##1##(1992-6#1)(1997-8#1)
(2D)##25##1##(2007-11#3)(2007-12#5)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#2)(2012-4#1)(2013-1#1)
(2D-MS)##3##1##(2008-11#3)
(2F10##2##1##(1995-2#2)
(2R##3##1##(1996-5#3)
(2S##9##1##(1995-12#1)(1995-3#1)(1996-5#3)(2008-11#1)(2009-12#2)(2009-9#1)
(2a)##3##1##(1992-8#1)(1997-7#1)(2009-9#1)
(2b)##3##1##(1992-10#1)(1996-2#1)(2008-10#1)
(2e)##2##1##(2007-11#2)
(2f) signal was generated from absorption by##2##7##(2008-2#1)(2008-3#1)
(2f)##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
(2hPG)##2##1##(2011-2#1)(2012-7#1)
(2min##2##1##(2008-10#2)
(2n = 16+X)##2##3##(2008-12#2)
(2n = 28)##3##3##(2008-5#1)(2010-3#2)
(2n = 2x = 24)##3##5##(2009-12#3)
(2n = 32)##3##3##(2010-3#3)
(2n =##20##2##(1994-11#1)(2008-10#2)(2008-12#3)(2008-5#2)(2009-12#5)(2010-3#7)
(2n##22##1##(1990-2#1)(1994-11#1)(2008-10#2)(2008-12#3)(2008-5#2)(2009-10#1)(2009-12#5)(2010-3#7)
(2nd generation)##2##2##(2010-8#2)
(2nd operation)##2##2##(2007-8#2)
(2nd##8##1##(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#2)(2012-2#1)
(2p = 0##2##3##(1996-9#2)
(2p##3##1##(1996-9#3)
(2sigma##2##1##(2008-10#2)
(3 &lt##2##2##(2007-11#1)(2008-3#1)
(3 +/-##2##2##(1996-5#1)(1997-7#1)
(3 S/N)##2##2##(2008-10#2)
(3 alpha##2##2##(1990-11#2)
(3 and##6##2##(1992-10#1)(1992-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
(3 beta##2##2##(2008-11#2)
(3 cases)##5##2##(2007-11#2)(2007-8#2)(2008-11#1)
(3 degrees##2##2##(2007-11#1)(2009-9#1)
(3 mM##2##2##(1992-3#1)(2008-4#1)
(3 males and 1 female)##2##5##(1993-9#1)(2007-7#1)
(3 mg##2##2##(1995-5#1)(2011-2#1)
(3 mg/kg##2##2##(1995-12#1)(2011-2#1)
(3 microM)##8##2##(1993-3#1)(1995-11#1)(1997-4#3)(2013-1#3)
(3 months old)##2##3##(1994-6#1)(1996-5#1)
(3 months##3##2##(1994-6#1)(1996-5#1)(2012-1#1)
(3 months)##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
(3 of##5##2##(1990-5#1)(1992-5#2)(1993-3#1)(2008-6#1)
(3 s) of##2##3##(2008-10#2)
(3 s)##4##2##(2008-10#4)
(3 times a##2##3##(1992-11#1)(1994-6#1)
(3 to 24##2##3##(2008-10#1)(2008-4#1)
(3 to##9##2##(1995-3#1)(2008-10#6)(2008-4#1)(2013-1#1)
(3 x##2##2##(2008-10#1)(2008-3#1)
(3##324##1##(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#2)(1992-11#7)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#2)(1993-1#3)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#2)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#4)(1997-9#1)(2007-10#4)(2007-11#6)(2007-12#1)(2007-7#8)(2007-8#10)(2008-1#5)(2008-10#70)(2008-11#9)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#10)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#5)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#5)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#17)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#4)
(3%##4##1##(2007-11#1)(2011-2#1)(2013-1#2)
(3%) and##3##2##(1990-9#1)(2008-10#1)(2013-1#1)
(3%) of##2##2##(1995-5#1)(1997-8#1)
(3%)##20##1##(1990-10#1)(1990-12#1)(1990-9#2)(1995-11#1)(1995-5#1)(1996-5#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#2)(2010-8#1)(2013-1#2)
(3'##3##1##(1991-12#1)(1997-4#1)(2007-12#1)
(3) The##8##2##(1993-3#1)(1995-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-1#1)(2013-8#1)
(3) To##2##2##(2008-11#1)(2011-1#1)
(3) What##2##2##(1996-1#1)(2008-4#1)
(3) a##6##2##(1993-5#1)(1996-11#1)(2007-12#1)(2009-5#1)(2013-1#2)
(3) an##4##2##(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)
(3) and##9##2##(1992-9#1)(1994-5#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
(3) by##2##2##(2008-11#1)(2010-2#1)
(3) data##2##2##(2008-10#1)(2013-1#1)
(3) different##2##2##(2011-2#1)(2013-7#1)
(3) for##2##2##(2010-8#1)(2011-2#1)
(3) formation##2##2##(1994-2#1)(2008-4#1)
(3) from##2##2##(2008-10#1)(2008-11#1)
(3) have been isolated from##2##5##(1994-11#1)(2011-2#1)
(3) have been##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
(3) in##2##2##(2007-8#1)(2008-10#1)
(3) it has##2##3##(1996-11#1)(2013-1#1)
(3) it##3##2##(1996-11#1)(2007-12#1)(2013-1#1)
(3) no##2##2##(2008-10#1)(2008-5#1)
(3) other##2##2##(2008-6#1)(2011-2#1)
(3) preparing the immunogen either by coupling the synthetic peptide to a carrier protein or through the use of a multiple antigenic peptide (MAP)##2##24##(2008-4#2)
(3) study##2##2##(2008-1#1)(2008-7#1)
(3) that##3##2##(1993-12#1)(1996-12#1)(2008-10#1)
(3) the &quot##2##3##(2008-4#1)(2013-1#1)
(3) the presence##2##3##(2008-11#1)(2009-6#1)
(3) the##32##2##(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-5#1)(1996-8#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-6#1)(2013-1#1)
(3) their##2##2##(2007-12#1)(2008-3#1)
(3) to##7##2##(1992-12#1)(1995-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-5#1)
(3) was##2##2##(2008-11#1)(2012-3#1)
(3) were##2##2##(2007-11#1)(2008-10#1)
(3)##338##1##(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#9)(1993-3#4)(1993-5#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#5)(1996-8#1)(1997-2#3)(1997-3#5)(1997-4#2)(1997-7#8)(2006-10#1)(2006-4#2)(2007-11#9)(2007-12#12)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#17)(2008-12#9)(2008-2#5)(2008-3#9)(2008-4#15)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#6)(2009-1#1)(2009-11#2)(2009-2#1)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#22)(2013-7#5)(2013-8#4)
(3)-C-)##2##1##(1997-7#2)
(3)-CPh)(&amp##2##1##(1997-7#2)
(3)A(2g) --&gt##4##2##(1997-7#4)
(3)H-ecdysone##2##1##(2008-5#2)
(3)T(2g)##4##1##(1997-7#4)
(3+)##6##1##(2007-11#3)(2007-12#2)(2008-2#1)
(3- and##2##2##(1992-8#1)(2008-10#1)
(3-10##2##1##(1994-9#1)(1997-4#1)
(3-30##2##1##(1995-12#1)(1997-1#1)
(3-4##2##1##(1995-12#1)(2008-5#1)
(3-5##4##1##(2008-10#2)(2008-12#1)(2011-2#1)
(3-8##2##1##(2007-11#1)(2011-2#1)
(3-D)##38##1##(1994-3#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-2#4)(2008-3#19)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
(3-aminopropyl)triethoxysilane##2##1##(2008-10#1)(2011-1#1)
(3-day##2##1##(2012-2#2)
(3-fold##2##1##(1995-2#1)(2008-10#1)
(3-mercaptopropyl)trimethoxysilane-based networks##2##2##(2008-10#2)
(3/7)##2##1##(2007-6#2)
(30 and##4##2##(1991-12#1)(1994-9#1)(1997-2#1)(2008-5#1)
(30 degrees##2##2##(1996-2#1)(2008-10#1)
(30 mg/kg i##6##3##(1992-3#5)(1995-12#1)
(30 mg/kg##10##2##(1992-3#5)(1992-8#1)(1993-5#1)(1995-12#1)(1997-6#1)(2008-7#1)
(30 mg/kg)##4##2##(1992-8#1)(1993-3#2)(2008-11#1)
(30 microM)##5##2##(1992-8#1)(1993-6#1)(1995-5#1)(1996-2#2)
(30 mu M) failed to##2##5##(1995-12#2)
(30 mu M)##4##3##(1995-12#4)
(30 mul)##2##2##(2008-10#2)
(30 nM)##2##2##(1994-8#1)(2008-11#1)
(30 nmol)##2##2##(1997-4#2)
(30 to##2##2##(2008-10#1)(2011-2#1)
(30##114##1##(1990-12#1)(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#5)(1992-8#5)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
(30%##7##1##(1991-3#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-1#1)(2012-3#1)
(30%) and##7##2##(1996-9#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
(30%) of##2##2##(1996-11#1)(2013-8#1)
(30%)##29##1##(1990-10#1)(1992-12#1)(1992-5#1)(1996-11#1)(1996-12#1)(1996-9#3)(1997-6#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#2)
(30)##2##1##(1994-1#1)(2007-11#1)
(30-40##4##1##(1990-5#1)(1995-12#1)(2008-3#1)(2013-1#1)
(30-50##3##1##(1990-5#1)(2008-3#1)(2011-2#1)
(30-60##2##1##(1996-7#1)(2012-2#1)
(30-80%)##2##1##(1992-9#1)(2012-2#1)
(300 microM)##2##2##(1990-2#1)(1992-3#1)
(300 nM)##2##2##(1996-5#1)(1997-4#1)
(300 ng##2##2##(2008-10#1)(2013-1#1)
(300##23##1##(1990-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
(300-400##2##1##(1993-9#1)(1994-8#1)
(30th potency)##2##2##(2008-10#2)
(31 +/-##2##2##(1995-11#1)(2008-11#1)
(31 of##2##2##(1990-8#1)(1997-8#1)
(31##35##1##(1990-8#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-12#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
(31%##3##1##(2008-1#1)(2008-10#1)(2010-3#1)
(31%) and##4##2##(1995-12#1)(1995-4#1)(2011-2#1)(2013-1#1)
(31%) of##3##2##(1990-12#1)(2007-10#1)(2012-3#1)
(31%)##25##1##(1990-12#2)(1991-6#1)(1992-3#1)(1995-12#1)(1995-4#1)(1995-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
(31)##2##1##(1994-1#1)(2012-2#1)
(31)P NMR spectroscopy##2##3##(2008-10#1)(2008-11#1)
(31)P NMR##6##2##(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)
(31)P and##2##2##(2008-10#1)(2012-2#1)
(31)P##11##1##(1996-2#1)(1997-7#2)(2008-10#5)(2008-11#1)(2010-8#1)(2012-2#1)
(31)P-NMR spectroscopy##2##2##(2008-10#2)
(31)P-NMR##3##1##(2008-10#3)
(311)##2##1##(2008-3#2)
(312##2##1##(2008-4#1)(2013-1#1)
(313)##3##1##(2007-11#2)(2012-3#1)
(315##3##1##(1990-2#1)(2008-10#1)(2009-5#1)
(32 and##3##2##(1996-3#1)(2008-7#1)(2012-2#1)
(32##32##1##(1991-8#1)(1992-6#1)(1993-9#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-7#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)
(32%##3##1##(1996-3#1)(2008-10#1)(2011-2#1)
(32%) had##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
(32%) of##2##2##(1995-6#1)(2008-1#1)
(32%) were##2##2##(1996-12#1)(2007-10#1)
(32%)##24##1##(1993-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#2)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
(33 and##2##2##(1994-8#1)(2011-2#1)
(33 degrees C)##2##3##(1996-12#1)(2008-8#1)
(33 degrees##3##2##(1995-11#1)(1996-12#1)(2008-8#1)
(33##49##1##(1990-3#1)(1991-12#2)(1991-9#1)(1993-1#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-7#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
(33%##2##1##(2008-5#1)(2013-8#1)
(33%) had##2##2##(2008-12#1)(2008-7#1)
(33%) were##2##2##(1990-2#1)(2008-12#1)
(33%)##18##1##(1990-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
(335##2##1##(1991-11#1)(1995-3#1)
(34 kDa)##2##2##(1991-12#1)(1997-6#1)
(34 to##2##2##(2009-9#1)(2013-7#1)
(34##35##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
(34%##6##1##(1990-12#1)(1995-5#1)(1995-8#1)(2007-8#1)(2009-3#1)(2012-3#1)
(34%) and##2##2##(1990-6#1)(2012-12#1)
(34%) of the##2##3##(1991-12#1)(2008-4#1)
(34%)##15##1##(1990-10#2)(1990-6#1)(1991-12#2)(1991-8#1)(1992-2#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
(340##2##1##(1996-9#1)(2008-10#1)
(35##31##1##(1991-11#1)(1992-9#1)(1996-9#1)(1997-7#2)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-9#1)(2011-1#2)(2011-2#3)(2013-1#1)(2013-8#1)
(35%##3##1##(1991-9#1)(2009-10#1)(2010-11#1)
(35%) had##2##2##(2008-6#1)(2011-1#1)
(35%) or##2##2##(2008-11#1)(2008-9#1)
(35%)##25##1##(1992-8#1)(1993-1#1)(1994-9#2)(1996-12#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
(35)##2##1##(2007-11#1)(2011-2#1)
(350##3##1##(2008-10#1)(2008-2#1)(2009-10#1)
(353##2##1##(1997-2#1)(2008-10#1)
(354##2##1##(1995-12#1)(1997-4#1)
(36##38##1##(1990-12#1)(1990-6#1)(1991-7#1)(1994-2#1)(1995-12#2)(1997-8#2)(2007-10#2)(2007-11#1)(2007-7#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#1)
(36%##3##1##(1993-8#1)(1996-3#1)(2008-1#1)
(36%) and##2##2##(2007-7#1)(2013-8#1)
(36%) of##2##2##(1991-8#1)(2007-10#1)
(36%) were##2##2##(2008-6#1)(2013-8#1)
(36%)##14##1##(1990-2#1)(1991-8#1)(1993-5#1)(1994-12#1)(1997-3#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2013-8#2)
(37 degrees C##3##3##(1992-6#1)(2008-10#1)(2008-12#1)
(37 degrees##5##2##(1992-6#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-12#1)
(37##48##1##(1990-9#1)(1991-5#1)(1992-10#1)(1992-6#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#3)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
(37%) of##2##2##(2008-8#1)(2010-12#1)
(37%)##11##1##(1990-10#1)(1991-6#1)(1993-2#1)(1995-12#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
(37)##2##1##(2008-12#1)(2010-2#1)
(370##2##1##(1992-8#1)(1993-2#1)
(38##32##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-9#1)(1994-12#2)(1994-9#1)(1996-10#1)(1997-8#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-5#2)(2011-2#4)(2012-12#3)(2013-1#3)(2013-8#5)
(38%##5##1##(1991-8#1)(1992-8#1)(1994-5#1)(2008-10#1)(2008-7#1)
(38%) and##2##2##(2007-7#1)(2013-1#1)
(38%)##12##1##(1991-6#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
(38)##2##1##(2013-1#2)
(380##3##1##(2007-12#1)(2008-10#1)(2012-12#1)
(382##2##1##(1993-2#1)(1996-5#1)
(39 mN/m)##2##2##(1994-3#2)
(39##20##1##(1990-10#1)(1990-11#1)(1990-3#2)(1991-8#1)(1994-3#2)(1995-2#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-1#1)(2013-8#1)
(39%##2##1##(1992-9#1)(2008-7#1)
(39%) and##4##2##(2008-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
(39%)##15##1##(1992-3#1)(1994-1#1)(1994-9#1)(1996-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
(390##2##1##(1992-11#1)(2009-8#1)
(392##2##1##(1996-5#1)(2011-2#1)
(394##2##1##(1991-11#1)(2011-1#1)
(3D##2##1##(2007-11#1)(2011-3#1)
(3D) objects##2##2##(2008-3#1)(2012-2#1)
(3D)##38##1##(1995-11#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-7#2)(2008-8#2)(2009-11#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#1)
(3M ESPE##2##2##(2008-12#2)
(3M##3##1##(2008-12#2)(2013-1#1)
(3PP##2##1##(2008-11#2)
(3R##3##1##(2008-10#2)(2009-12#1)
(3S##5##1##(2007-12#5)
(3S/N)##4##1##(2008-10#4)
(3a)##3##1##(2008-10#1)(2009-9#1)(2011-2#1)
(3b)##2##1##(1992-10#1)(2008-10#1)
(3rd##3##1##(2007-8#1)(2008-11#1)(2010-8#1)
(3s)##7##1##(2008-10#7)
(3sigma criterion)##3##2##(2008-10#3)
(3sigma of##2##2##(2008-10#2)
(3sigma##11##1##(2008-10#11)
(3sigma(b)/S)##2##1##(2008-10#2)
(3sigma) and the relative standard##2##5##(2008-10#2)
(3sigma) and the##3##3##(2008-10#3)
(3sigma) and##7##2##(2008-10#7)
(3sigma) are##3##2##(2008-10#3)
(3sigma) for##4##2##(2008-10#4)
(3sigma) in the##2##3##(2008-10#2)
(3sigma) in##4##2##(2008-10#4)
(3sigma) is##3##2##(2008-10#3)
(3sigma) of 0##10##3##(2008-10#10)
(3sigma) of 1##3##3##(2008-10#3)
(3sigma) of##20##2##(2008-10#20)
(3sigma) was 0##6##3##(2008-10#6)
(3sigma) was##9##2##(2007-12#1)(2008-10#8)
(3sigma) were##7##2##(2008-10#7)
(3sigma)##69##1##(2007-12#1)(2008-10#68)
(4 cases)##2##2##(1990-12#1)(1996-6#1)
(4 degrees C for##2##4##(2008-10#1)(2008-11#1)
(4 degrees C##3##3##(2008-10#2)(2008-11#1)
(4 degrees C)##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
(4 degrees##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)
(4 g##2##2##(1992-10#1)(2008-5#1)
(4 mg/kg##4##2##(1992-3#3)(2008-10#1)
(4 months) and##2##3##(1991-12#1)(2008-7#1)
(4 to##2##2##(1994-12#1)(2008-10#1)
(4 x##3##2##(1993-9#1)(1995-8#1)(2008-10#1)
(4##229##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#38)(2008-11#4)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-9#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#16)(2013-3#1)(2013-7#1)(2013-8#6)
(4%##6##1##(1991-12#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
(4%) and##2##2##(2008-10#1)(2011-2#1)
(4%)##24##1##(1992-6#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#2)(2007-6#2)(2007-7#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-3#3)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#1)
(4'##3##1##(1991-3#2)(1992-3#1)
(4) In##2##2##(2011-1#1)(2011-2#1)
(4) The##2##2##(1995-9#1)(2008-7#1)
(4) a##2##2##(1991-11#1)(1991-3#1)
(4) access##2##2##(1995-12#1)(2007-4#1)
(4) and##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
(4) clinical##2##2##(1997-3#1)(2011-2#1)
(4) immunizing the host animal##2##5##(2008-4#2)
(4) in##2##2##(2008-11#1)(2010-6#1)
(4) it##2##2##(1996-11#1)(2007-12#1)
(4) management##2##2##(1993-3#1)(1997-3#1)
(4) minimum##2##2##(2013-1#1)(2013-7#1)
(4) number of##2##3##(1993-8#1)(2008-5#1)
(4) or##2##2##(1990-3#1)(1992-9#1)
(4) the##17##2##(1991-2#1)(1991-7#1)(1993-8#1)(1995-9#1)(2007-12#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
(4) using##2##2##(1995-5#1)(2009-6#1)
(4) was##2##2##(1992-3#1)(1992-8#1)
(4) were##3##2##(1992-8#1)(2008-9#1)(2010-6#1)
(4) with##3##2##(1995-11#1)(1996-2#1)(2007-11#1)
(4)##188##1##(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#4)(1992-9#2)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#2)(1994-2#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#3)(1997-3#3)(1997-7#5)(2007-11#7)(2007-12#8)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#7)(2008-9#5)(2009-11#2)(2009-2#1)(2009-6#3)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#3)(2013-8#4)
(4)A(2)##2##1##(2008-3#2)
(4)F(7/2)##2##1##(2007-12#1)(2008-3#1)
(4)I(13/2)##2##1##(2008-3#2)
(4)P(1/2) state##2##2##(2008-2#2)
(4)P(1/2)##3##1##(2008-2#3)
(4)S(3/2)##2##1##(2007-12#1)(2008-2#1)
(4-10##2##1##(1996-2#1)(2008-12#1)
(4-307) versus##2##2##(1997-5#2)
(4-6 months old)##2##3##(2008-7#2)
(4-6##7##1##(1994-5#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-12#1)
(4-6) and##2##2##(2008-7#1)(2010-12#1)
(4-6)##3##1##(2008-7#1)(2010-12#1)(2013-1#1)
(4-8##2##1##(1993-11#1)(2008-7#1)
(4-9)##2##1##(2008-10#2)
(4-AP)##4##1##(1990-12#1)(1996-5#1)(2008-10#1)(2008-9#1)
(4-VP)##4##1##(2008-10#4)
(4-hydroxyphenyl)##2##1##(2008-10#2)
(4-sulphophenylazo-)1-naphthylamine##2##1##(2008-10#2)
(4/12)##2##1##(1991-2#1)(2011-2#1)
(4/8)##2##1##(1992-9#1)(2012-3#1)
(4/9)##2##1##(2008-1#1)(2012-12#1)
(40 mg##4##2##(1993-12#1)(2007-10#1)(2008-10#1)(2008-12#1)
(40 mg/kg##3##2##(1992-5#1)(1997-2#1)(2008-4#1)
(40 micrograms##2##2##(1995-5#1)(1996-12#1)
(40 min)##2##2##(1995-12#1)(2007-8#1)
(40##72##1##(1990-12#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#4)(2006-11#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-12#1)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
(40% of##2##2##(1995-11#1)(2008-9#1)
(40%##4##1##(1995-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
(40%) and##4##2##(1997-8#1)(2007-7#1)(2008-10#1)(2011-2#1)
(40%) had##2##2##(1994-6#1)(1996-11#1)
(40%) of##2##2##(1993-11#1)(2008-12#1)
(40%)##29##1##(1992-12#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#2)
(400##15##1##(1991-11#1)(1992-2#1)(1994-10#1)(1995-12#1)(1995-8#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#2)(2013-1#1)
(4000##2##1##(1993-6#1)(1993-9#1)
(41##25##1##(1990-2#1)(1991-12#1)(1992-10#1)(1995-8#2)(1996-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
(41%##3##1##(1992-12#1)(2007-12#1)(2008-3#1)
(41%)##11##1##(1990-8#1)(1991-8#1)(1993-12#1)(1994-8#1)(1996-6#1)(2008-1#1)(2011-1#1)(2011-2#3)(2012-3#1)
(414##2##1##(1994-11#1)(2010-5#1)
(42 cases)##2##2##(1991-2#1)(1994-1#1)
(42##32##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-1#1)(1997-6#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(42%##3##1##(1993-2#1)(2010-3#1)(2011-2#1)
(42%) had##2##2##(2008-10#1)(2010-8#1)
(42%) were##2##2##(2011-2#1)(2012-12#1)
(42%)##16##1##(1990-5#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
(420 mug##2##2##(2008-10#2)
(420##3##1##(1991-12#1)(2008-10#2)
(43 degrees##2##2##(1992-11#1)(1997-7#1)
(43##28##1##(1990-9#1)(1991-12#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
(43% vs##2##2##(2006-10#1)(2008-10#1)
(43%##7##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2013-1#1)
(43%) and##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
(43%) had##2##2##(2008-10#1)(2008-3#1)
(43%) were##3##2##(1990-6#1)(2007-2#1)(2008-7#1)
(43%)##18##1##(1990-6#1)(1991-8#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#4)(2008-9#1)(2010-5#1)(2011-2#2)(2013-8#1)
(44 +/-##2##2##(2009-8#1)(2013-1#1)
(44##23##1##(1990-8#1)(1991-8#1)(1992-5#1)(1993-5#1)(1994-9#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
(44%##2##1##(1994-9#1)(2007-12#1)
(44%)##18##1##(1990-6#2)(1990-8#1)(1992-3#1)(1993-8#1)(1995-12#1)(1996-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#2)(2013-1#3)
(45 +/-##2##2##(1992-8#1)(1995-11#1)
(45 degrees C)##2##3##(2008-12#2)
(45 degrees##4##2##(2008-12#2)(2008-2#1)(2009-9#1)
(45 or 90 sec)##2##4##(2008-5#2)
(45##42##1##(1990-6#1)(1990-8#1)(1992-10#1)(1992-5#1)(1992-8#1)(1995-11#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
(45%##2##1##(1993-9#1)(2008-5#1)
(45%)##8##1##(1996-5#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
(450##4##1##(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
(45S5##2##1##(2008-5#2)
(46##30##1##(1990-2#1)(1990-6#1)(1991-12#1)(2007-10#1)(2007-2#1)(2008-1#4)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
(46%##2##1##(1991-7#1)(2008-3#1)
(46%) of##2##2##(2007-10#1)(2012-2#1)
(46%)##12##1##(1997-2#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(465##2##1##(2008-3#1)(2012-12#1)
(47##19##1##(1991-9#1)(1993-2#1)(1995-11#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
(47% vs##2##2##(1992-2#1)(2008-12#1)
(47%##4##1##(1992-2#1)(2007-8#1)(2008-12#1)(2009-8#1)
(47%) had##2##2##(1997-3#1)(2012-3#1)
(47%)##12##1##(1994-1#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-3#1)
(473##2##1##(1993-2#1)(2011-1#1)
(48 h)##4##2##(1996-5#1)(1997-4#1)(2008-10#1)(2013-8#1)
(48##31##1##(1991-4#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
(48%##2##1##(2007-11#1)(2010-3#1)
(48%)##12##1##(1990-6#1)(1990-8#1)(1992-12#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-7#2)(2011-2#1)
(48)##3##1##(1991-2#1)(1995-3#1)(2008-3#1)
(480##2##1##(2007-11#1)(2008-10#1)
(483##3##1##(1997-4#1)(2008-8#1)(2011-2#1)
(49##13##1##(1990-2#1)(1991-5#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
(49%##2##1##(2008-3#1)(2010-1#1)
(49%) were##2##2##(1997-8#1)(2010-11#1)
(49%)##8##1##(1990-8#1)(1995-5#1)(1997-3#1)(1997-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#1)
(4E##2##1##(1992-4#2)
(4R##3##1##(1995-11#3)
(4m##2##1##(2008-10#1)(2009-12#1)
(4p)(3)##2##1##(2008-2#2)
(5 IU)##2##2##(2008-5#2)
(5 and 10 mg/kg i##2##5##(1996-2#2)
(5 and 10##6##3##(1996-2#2)(2008-10#3)(2013-1#1)
(5 and##7##2##(1996-2#2)(2008-10#4)(2013-1#1)
(5 cases)##3##2##(1990-6#1)(1994-8#1)(2007-11#1)
(5 degrees##3##2##(2008-12#2)(2010-4#1)
(5 mM)##3##2##(1990-7#1)(1995-6#1)(1996-2#1)
(5 males##2##2##(1990-8#1)(2010-3#1)
(5 mg/kg##5##2##(1996-2#1)(1997-2#1)(1997-7#1)(2008-6#2)
(5 mg/kg/day)##2##2##(1994-2#1)(2012-2#1)
(5 mg/ml)##2##2##(2012-3#2)
(5 microM)##7##2##(1990-10#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2009-12#1)
(5 microg)##2##2##(1995-12#1)(2008-7#1)
(5 min##2##2##(1996-5#1)(2008-10#1)
(5 nM)##7##2##(1990-12#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-2#1)
(5 of##4##2##(1992-4#1)(1996-10#1)(2010-12#2)
(5 or##2##2##(2008-10#2)
(5 out of##2##3##(1993-12#1)(2008-8#1)
(5 patients##2##2##(1996-11#1)(2007-7#1)
(5 patients)##2##2##(1990-9#1)(2008-7#1)
(5 per##2##2##(1997-3#1)(2013-1#1)
(5 to##7##2##(1990-2#1)(2008-10#5)(2012-3#1)
(5 weeks at the room temperature##2##6##(2013-1#2)
(5 x 10(-8)##2##3##(1994-12#1)(2008-10#1)
(5 x##5##2##(1994-12#1)(2008-10#1)(2008-3#2)(2009-11#1)
(5 μg##2##2##(2012-2#1)(2012-3#1)
(5##281##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-8#3)(1995-11#2)(1995-12#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#3)(1996-2#6)(1996-5#5)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#77)(2008-11#3)(2008-12#10)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#7)(2008-7#6)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#9)(2013-1#12)
(5%##10##1##(1993-8#1)(1995-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)
(5%) and##2##2##(1996-5#1)(1996-9#1)
(5%) as##2##2##(1993-11#1)(2008-10#1)
(5%) had##2##2##(1996-9#1)(2012-3#1)
(5%) of##3##2##(1990-3#1)(1995-11#1)(2010-8#1)
(5%) were##2##2##(2008-1#1)(2008-10#1)
(5%)##24##1##(1990-3#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-5#1)(1996-9#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)
(5'GAATUC3')##2##1##(1992-3#2)
(5(2+))##2##1##(1996-2#2)
(5) and##3##2##(2008-12#1)(2009-2#1)(2010-6#1)
(5) assaying antibody titer in the host animal's serum##2##9##(2008-4#2)
(5) the##10##2##(1991-3#1)(1993-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
(5)##90##1##(1991-3#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-2#3)(1997-3#2)(1997-7#3)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#10)(2013-7#1)
(5)D(0)##2##1##(2007-12#1)(2008-3#1)
(5-15##4##1##(1990-8#1)(1991-6#1)(2008-10#1)(2010-8#1)
(5-30##4##1##(1990-8#1)(1997-2#1)(2008-10#1)(2008-6#1)
(5-7##4##1##(1997-8#2)(2006-6#1)(2007-7#1)
(5-Br-PADAP)##9##1##(2008-10#9)
(5-FU)##7##1##(1991-3#1)(1993-8#1)(1994-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)
(5-HT) and##4##2##(1992-1#1)(1994-6#1)(2008-3#1)(2008-5#1)
(5-HT)##21##1##(1992-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-6#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
(5-HT1A)##2##1##(1992-3#1)(1993-12#1)
(5-LO)##3##1##(1991-8#2)(1993-6#1)
(5-nitro-1##2##1##(2008-11#2)
(5-year##2##1##(2011-2#2)
(5/2)##2##1##(2007-12#1)(2008-3#1)
(5/5)##2##1##(1992-2#1)(2008-5#1)
(50 degrees##2##2##(2008-10#1)(2008-6#1)
(50 mM##2##2##(1997-6#1)(2008-10#1)
(50 mM)##2##2##(1996-5#1)(1997-4#1)
(50 mg##6##2##(1993-12#1)(1995-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
(50 mg)##2##2##(1990-6#1)(2010-6#1)
(50 mg/kg##2##2##(1996-2#1)(1997-2#1)
(50 mg/kg)##2##2##(1994-8#1)(1995-12#1)
(50 microM)##3##2##(1992-3#1)(1994-9#1)(2009-12#1)
(50 micrograms##2##2##(1992-2#1)(1996-1#1)
(50 micrograms)##2##2##(1995-12#1)(1996-1#1)
(50 micrograms/ml)##2##2##(1991-8#1)(1994-2#1)
(50 muM##2##2##(2008-10#2)
(50 muM)##2##2##(2008-10#2)
(50 nM##2##2##(1990-12#1)(1990-7#1)
(50 nM)##4##2##(1990-7#1)(1995-5#1)(1996-5#1)(1997-7#1)
(50 ppm##2##2##(2008-10#2)
(50 ppm)##2##2##(1992-9#1)(2008-5#1)
(50##118##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#22)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
(50% effective##4##2##(2008-10#3)(2011-3#1)
(50% of##4##2##(1990-12#1)(1993-2#1)(2008-10#1)(2008-11#1)
(50%##14##1##(1990-12#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2011-3#1)
(50%) and##7##2##(1990-5#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
(50%) had##2##2##(1991-3#1)(1997-6#1)
(50%) in##2##2##(1990-2#1)(1994-2#1)
(50%) of##4##2##(1991-3#1)(2007-10#1)(2007-11#1)(2011-1#1)
(50%) patients##3##2##(2012-3#1)(2013-1#2)
(50%)##38##1##(1990-2#1)(1990-5#1)(1991-3#2)(1994-12#1)(1994-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
(50-100 mM)##2##2##(1990-12#2)
(50-100##7##1##(1990-12#2)(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
(50/50)##2##1##(2008-10#2)
(500 and 1000##2##3##(1995-12#1)(2012-2#1)
(500 mg l(-1))##2##3##(2008-10#2)
(500 mg##4##2##(2008-10#3)(2011-1#1)
(500 microM) inhibited##3##3##(1990-12#2)(1992-3#1)
(500 microM)##5##2##(1990-12#2)(1992-3#2)(1994-11#1)
(500 mu M)##4##3##(1995-12#4)
(500##29##1##(1990-12#2)(1992-3#2)(1992-8#3)(1993-3#1)(1994-11#1)(1995-12#5)(1997-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
(5000##2##1##(2007-10#1)(2008-6#1)
(50mumx50mum)##2##1##(2007-12#2)
(51##20##1##(1993-1#2)(1993-2#1)(1994-1#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
(51%##7##1##(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-7#1)
(51%)##11##1##(1991-8#1)(1992-3#1)(1993-2#1)(1995-12#1)(1996-2#1)(2007-10#2)(2007-8#1)(2008-6#1)(2013-1#1)(2013-8#1)
(51)Cr##2##1##(2008-4#1)(2013-1#1)
(51)Cr-labeled target cells##3##3##(2008-4#3)
(51)Cr-release assay##2##2##(2008-4#2)
(510##2##1##(1996-6#1)(2008-2#1)
(512##2##1##(1994-11#1)(2007-12#1)
(517##2##1##(1990-11#1)(2008-3#1)
(52##22##1##(1990-11#1)(1990-9#1)(1992-5#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
(52% female)##2##2##(2010-10#1)(2010-7#1)
(52% reduction) in the IDDS group (P = 0##2##9##(2008-7#2)
(52%##6##1##(1995-6#1)(2007-7#1)(2008-7#2)(2010-10#1)(2010-7#1)
(52%) and##2##2##(1994-12#1)(2008-12#1)
(52%) were##2##2##(2012-2#1)(2013-1#1)
(52%)##12##1##(1990-2#1)(1991-11#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-12#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#2)
(53##26##1##(1991-3#1)(1994-9#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(53% vs##2##2##(1990-2#1)(2008-1#1)
(53%) were##2##2##(2008-10#1)(2011-2#1)
(53%)##11##1##(1997-6#1)(2008-10#2)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
(537 nm) and##2##3##(2008-10#1)(2008-9#1)
(54##18##1##(1990-7#1)(1991-3#1)(1993-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
(54%##4##1##(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
(54%) had##2##2##(2008-1#1)(2010-8#1)
(54%) were##2##2##(1996-2#1)(1997-3#1)
(54%)##11##1##(1996-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#3)(2008-4#1)(2010-8#1)(2011-1#2)
(543##2##1##(2007-12#1)(2008-3#1)
(55##30##1##(1992-2#2)(1993-9#1)(1994-2#1)(1995-12#1)(1997-8#1)(2007-2#1)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
(55%##2##1##(2008-3#2)
(55%) and##2##2##(1995-12#1)(2008-6#1)
(55%) had##2##2##(1997-6#1)(2008-1#1)
(55%) were##2##2##(2008-11#1)(2011-2#1)
(55%)##21##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-12#1)(1995-12#2)(1995-5#1)(1996-9#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#3)(2012-2#1)
(552##2##1##(2011-2#1)(2012-12#1)
(56 degrees C##2##3##(1990-12#1)(1992-9#1)
(56 degrees##3##2##(1990-12#1)(1992-9#1)(1997-3#1)
(56##27##1##(1990-12#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
(56%##3##1##(2008-11#1)(2010-1#1)(2013-8#1)
(56%) and##2##2##(2008-12#1)(2012-12#1)
(56%)##15##1##(1990-8#1)(1994-12#1)(1996-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
(57 +/-##2##2##(1995-12#1)(2009-11#1)
(57##24##1##(1990-6#1)(1990-7#1)(1992-9#1)(1995-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-8#1)(2009-11#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
(57%##3##1##(2008-10#1)(2010-4#1)(2012-2#1)
(57%) of the##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
(57%) of##4##2##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
(57%)##12##1##(1995-12#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
(570##2##1##(1990-12#1)(2008-10#1)
(58##23##1##(1990-3#1)(1990-6#1)(1991-11#1)(1992-9#1)(1997-4#2)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-6#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#1)
(58%) and##3##2##(1996-6#1)(2007-7#1)(2012-12#1)
(58%) of##3##2##(1991-8#1)(1992-1#1)(2008-3#1)
(58%) than##2##2##(1994-1#1)(1996-5#1)
(58%) who##2##2##(2007-7#1)(2010-10#1)
(58%)##20##1##(1991-8#1)(1992-1#1)(1994-1#2)(1996-5#1)(1996-6#1)(1996-9#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#1)(2012-12#2)(2013-1#1)
(58)##3##1##(2008-1#1)(2008-5#1)(2013-1#1)
(580##2##1##(2008-10#2)
(59##14##1##(1990-5#1)(1993-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
(59%)##15##1##(1990-8#1)(1991-3#1)(1991-8#1)(1993-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
(59)Co##2##1##(1997-7#2)
(590 nm)##2##2##(1993-11#1)(2008-10#1)
(595##2##1##(1993-2#1)(2007-12#1)
(5HT)##3##1##(1996-12#1)(2008-11#1)(2008-6#1)
(5RS##2##1##(1997-7#2)
(5Z##2##1##(1996-2#1)(2009-10#1)
(5mg/ml)##3##1##(2012-3#3)
(5th)##2##1##(1991-2#1)(1992-6#1)
(6 %)##2##2##(2008-5#1)(2012-12#1)
(6 and##4##2##(1997-8#1)(2008-1#1)(2008-10#1)(2010-2#1)
(6 cM)##2##2##(2008-10#2)
(6 degrees##2##2##(2008-10#1)(2008-2#1)
(6 mg##2##2##(1995-12#1)(2008-12#1)
(6 mg/kg)##2##2##(1990-6#1)(2011-1#1)
(6 months##2##2##(1993-12#1)(1995-6#1)
(6 months)##3##2##(2007-8#1)(2008-3#1)(2012-3#1)
(6 patients)##2##2##(1990-9#1)(2008-7#1)
(6 to##2##2##(2008-10#2)
(6##203##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-10#3)(1992-6#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#9)(2008-10#40)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-3#3)(2010-4#9)(2011-1#2)(2011-2#18)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#4)
(6%##3##1##(1992-9#1)(2008-10#1)(2010-8#1)
(6%) and##2##2##(1996-5#1)(2007-11#1)
(6%)##27##1##(1991-3#1)(1991-8#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-11#2)(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#2)
(6) and##8##2##(1991-5#1)(1992-8#1)(1995-11#1)(2008-10#3)(2008-11#2)
(6) the##2##2##(2008-11#1)(2011-2#1)
(6)##51##1##(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-8#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#4)(2011-3#1)(2013-1#6)(2013-8#1)
(6-10##2##1##(2007-10#2)
(6-4)##2##1##(1992-8#2)
(6-8##3##1##(1992-6#1)(2008-12#1)(2011-1#1)
(6-8)##2##1##(1996-5#1)(2008-10#1)
(6/7)##2##1##(1994-3#1)(2012-3#1)
(60 and##4##2##(1992-11#1)(1995-3#1)(2008-10#2)
(60 days)##2##2##(1990-12#1)(1994-7#1)
(60 degrees##2##2##(2008-10#1)(2008-2#1)
(60 kDa)##2##2##(1993-6#1)(1995-11#1)
(60 mg/kg)##2##2##(2011-1#2)
(60 min)##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
(60##55##1##(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-12#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-2#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-2#1)(2013-1#2)
(60% of the##2##3##(1991-9#1)(2008-5#1)
(60%##6##1##(1991-12#1)(1991-9#1)(1992-11#1)(2007-8#1)(2008-3#1)(2008-5#1)
(60%) and##2##2##(2009-11#1)(2010-12#1)
(60%) had##2##2##(1990-3#1)(1996-11#1)
(60%) of the##3##3##(1997-6#1)(2010-8#1)(2011-2#1)
(60%) of##4##2##(1997-6#1)(2008-5#1)(2010-8#1)(2011-2#1)
(60%) patients##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
(60%) were##3##2##(2006-10#1)(2008-7#1)(2012-2#1)
(60%)##32##1##(1990-12#1)(1990-3#1)(1993-9#1)(1995-5#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#2)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
(60)Co##2##1##(2008-11#1)(2008-9#1)
(60-70%)##3##1##(1997-2#1)(2008-10#1)(2010-11#1)
(600 mg/day)##2##2##(1991-9#1)(2011-1#1)
(600##13##1##(1991-9#2)(1992-8#2)(1994-2#1)(2008-10#4)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
(61##22##1##(1992-9#1)(1993-2#1)(1996-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
(61%##3##1##(2008-10#1)(2009-11#1)(2009-7#1)
(61%) had##2##2##(1992-3#1)(2012-3#1)
(61%) of##2##2##(2008-10#1)(2013-8#1)
(61%)##11##1##(1990-3#1)(1991-2#1)(1992-3#1)(2007-10#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
(62 from##2##2##(1996-5#1)(2008-10#1)
(62##29##1##(1990-9#1)(1991-3#1)(1993-2#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#2)(2010-11#1)(2011-1#2)(2013-1#1)(2013-8#2)
(62%##2##1##(2008-10#1)(2012-3#1)
(62%) and##3##2##(2008-10#1)(2013-1#1)(2013-7#1)
(62%) of##3##2##(1990-8#1)(1994-1#1)(2008-7#1)
(62%)##14##1##(1990-8#1)(1991-6#1)(1994-1#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
(620 nm)##2##2##(2008-10#2)
(620##3##1##(2008-10#3)
(63##19##1##(1991-12#1)(1991-8#1)(1994-12#1)(1996-5#1)(2007-10#1)(2008-1#1)(2008-4#2)(2008-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
(63%) and##2##2##(1995-11#1)(2012-2#1)
(63%)##16##1##(1990-10#1)(1991-8#1)(1993-5#1)(1995-11#2)(1996-8#1)(1997-8#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
(63)Cu##2##1##(2008-10#2)
(63)Ni ionization source##2##3##(2008-10#2)
(63)Ni##3##1##(2008-10#3)
(632##2##1##(1992-9#1)(2007-12#1)
(635##2##1##(2008-11#1)(2008-3#1)
(64##23##1##(1992-11#1)(1993-5#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
(64%##2##1##(2008-8#1)(2010-3#1)
(64%) and##2##2##(1990-10#1)(2012-1#1)
(64%) patients##2##2##(2008-10#1)(2008-6#1)
(64%)##13##1##(1990-10#1)(1990-6#1)(1992-8#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-1#1)
(64)Cu##2##1##(2010-6#2)
(64)Cu-NOTA-RGD-BBN and (68)Ga-NOTA-RGD-BBN##2##3##(2010-6#2)
(64)Cu-NOTA-RGD-BBN##3##1##(2010-6#3)
(65##24##1##(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-5#1)(2011-1#1)(2013-8#1)
(65%##2##1##(1995-5#1)(2013-1#1)
(65%) and##5##2##(1994-9#1)(1997-3#1)(2008-9#1)(2011-1#1)(2013-1#1)
(65%) of the##3##3##(1996-11#1)(2010-8#1)(2013-8#1)
(65%) of##6##2##(1990-3#1)(1996-11#1)(2008-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
(65%) patients##2##2##(1997-3#1)(2013-8#1)
(65%)##24##1##(1990-3#2)(1992-3#1)(1994-9#1)(1996-11#1)(1997-3#2)(1997-6#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#2)
(65)Cu##2##1##(2008-10#2)
(65+35##2##1##(2008-10#2)
(66 +/-##2##2##(1991-11#1)(1995-11#1)
(66 Gy)##2##2##(1990-6#1)(1993-8#1)
(66 to##2##2##(2008-10#2)
(66##31##1##(1990-6#1)(1991-11#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)
(66%) the##2##2##(1990-12#1)(2011-2#1)
(66%)##15##1##(1990-10#1)(1990-12#1)(1992-11#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)
(660##2##1##(2008-10#2)
(67##18##1##(1990-2#1)(1993-8#1)(1995-11#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
(67% vs##2##2##(1995-12#1)(2008-12#1)
(67%##4##1##(1990-3#1)(1991-12#1)(1995-12#1)(2008-12#1)
(67%)##3##1##(1990-2#1)(2008-1#1)(2011-2#1)
(67)Zn##3##1##(2010-2#3)
(670##2##1##(2008-12#1)(2010-9#1)
(674##2##1##(2008-3#1)(2008-9#1)
(68##26##1##(1991-10#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#4)
(68%##2##1##(1993-8#1)(2013-1#1)
(68%) and##3##2##(1990-9#1)(2008-8#1)(2011-1#1)
(68%) were##2##2##(1991-6#1)(2008-6#1)
(68%)##16##1##(1990-12#1)(1990-9#1)(1991-6#2)(1993-3#1)(1994-8#1)(1996-2#2)(1997-6#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
(68)Ga-NOTA-RGD-BBN##4##1##(2010-6#4)
(68)Zn##2##1##(2008-10#2)
(680##2##1##(2008-10#1)(2008-3#1)
(69##16##1##(1990-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#3)
(69%) and##2##2##(2008-4#1)(2013-1#1)
(69%)##13##1##(1992-11#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
(6PGD)##2##1##(2010-12#2)
(6a)##3##1##(1991-5#1)(2007-11#1)(2009-9#1)
(7 and##2##2##(1995-12#1)(1996-5#1)
(7 cases)##2##2##(1996-6#1)(2007-11#1)
(7 of##5##2##(1990-12#1)(1990-5#1)(1992-5#1)(1996-3#1)(2007-11#1)
(7 patients)##3##2##(1990-8#1)(1992-8#1)(2011-2#1)
(7 to 10##2##3##(2007-11#1)(2011-2#1)
(7 to##5##2##(2007-11#1)(2008-10#2)(2011-2#1)(2013-1#1)
(7##159##1##(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#27)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#4)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#9)(2011-2#12)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#11)
(7%##3##1##(1991-6#1)(2007-11#1)(2008-10#1)
(7%) and##2##2##(1995-5#1)(2010-7#1)
(7%) were##3##2##(1993-8#1)(1995-12#1)(2008-9#1)
(7%)##18##1##(1991-2#1)(1991-6#1)(1993-5#1)(1993-8#1)(1995-12#1)(1995-5#2)(1996-11#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
(7) Li(+)##2##2##(2012-7#2)
(7) and##2##2##(2007-11#1)(2011-3#1)
(7)##38##1##(1994-1#1)(1994-5#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-3#2)(1997-5#2)(1997-7#4)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-8#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-7#3)(2013-1#2)
(7-15)##2##1##(2013-1#2)
(7-8##2##1##(1994-12#1)(2013-8#1)
(7/7)##2##1##(1992-8#1)(2007-6#1)
(7/8) of##2##2##(2008-10#1)(2010-3#1)
(7/8)##3##1##(1992-8#1)(2008-10#1)(2010-3#1)
(70##35##1##(1990-11#1)(1992-6#1)(1994-11#1)(1995-12#2)(1995-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
(70%) and##3##2##(2007-7#1)(2008-1#1)(2012-2#1)
(70%) had##2##2##(2008-7#1)(2012-2#1)
(70%) patients##3##2##(1992-5#1)(2011-2#2)
(70%)##32##1##(1990-3#2)(1991-2#1)(1991-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
(700##2##1##(1994-8#1)(2008-3#1)
(71##9##1##(1991-12#1)(1992-9#1)(1994-2#1)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
(71%) and##3##2##(2008-1#1)(2010-3#1)(2012-3#1)
(71%) of the##2##3##(1997-3#1)(2008-1#1)
(71%) of##4##2##(1996-12#1)(1997-3#1)(2008-1#1)(2013-8#1)
(71%)##14##1##(1991-9#1)(1994-1#2)(1996-12#1)(1997-3#1)(2008-1#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
(72 h)##2##2##(1990-2#1)(1993-12#1)
(72##24##1##(1990-2#1)(1991-9#1)(1993-12#1)(1994-6#1)(1995-11#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
(72% of##3##2##(1991-12#1)(1996-12#1)(2011-2#1)
(72%##5##1##(1991-12#1)(1996-12#1)(1997-2#1)(2011-2#1)(2013-1#1)
(72%)##17##1##(1990-12#1)(1992-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-2#1)(2007-7#2)(2008-7#3)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)
(73##17##1##(1990-3#1)(1992-9#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)
(73%##2##1##(1994-3#1)(2008-10#1)
(73%)##7##1##(1992-5#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#3)
(74##18##1##(1995-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-12#3)(2013-1#1)
(74%##3##1##(1992-9#1)(2008-10#1)(2008-5#1)
(74%) and##2##2##(1990-3#1)(1992-8#1)
(74%)##15##1##(1990-3#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-3#1)
(75 mg##2##2##(1992-11#1)(2009-8#1)
(75 to##2##2##(2008-10#2)
(75##30##1##(1990-12#1)(1990-8#1)(1991-11#1)(1992-11#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-5#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
(75%##8##1##(1991-12#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
(75%) and##5##2##(1997-3#1)(2008-7#1)(2011-1#2)(2013-8#1)
(75%) had##2##2##(2008-1#1)(2012-2#1)
(75%) of the##2##3##(1991-12#1)(2011-2#1)
(75%) of##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
(75%)##23##1##(1991-12#1)(1992-12#1)(1997-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
(75)Se##2##1##(2008-10#2)
(750##2##1##(1990-12#1)(2008-2#1)
(76##19##1##(1990-12#1)(1990-8#1)(1991-12#1)(1994-6#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
(76%##2##1##(1993-9#1)(2008-12#1)
(76%) of##3##2##(1996-9#1)(2008-10#1)(2008-3#1)
(76%)##12##1##(1991-2#1)(1995-1#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-3#1)(2011-2#5)
(77##11##1##(1997-7#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-10#1)(2012-3#1)(2013-1#1)
(77%##2##1##(1992-6#1)(1993-12#1)
(77%) of##2##2##(2008-10#2)
(77%)##15##1##(1990-10#1)(1997-3#1)(2008-10#5)(2008-4#1)(2008-6#4)(2011-2#2)(2012-12#1)
(78##26##1##(1991-12#1)(1991-2#1)(1993-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#4)(2012-12#1)(2013-1#2)
(78%##2##1##(1991-12#1)(2009-7#1)
(78%) of all eligible Canadian public health nutritionists responded to a mailed questionnaire##2##13##(1993-1#1)(1993-2#1)
(78%) of##4##2##(1993-1#1)(1993-2#1)(2008-1#1)(2010-5#1)
(78%) were##2##2##(2008-4#1)(2013-8#1)
(78%)##17##1##(1990-12#1)(1993-1#1)(1993-2#1)(1995-6#2)(1996-1#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-9#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
(780##4##1##(2008-10#2)(2008-3#1)(2011-2#1)
(79 %)##2##2##(1997-8#1)(2008-1#1)
(79##17##1##(1990-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
(79%##2##1##(2007-11#1)(2013-7#1)
(79%) of##2##2##(2008-3#1)(2008-7#1)
(79%) with##2##2##(2008-7#1)(2009-5#1)
(79%)##8##1##(1991-5#1)(1993-8#1)(1997-3#1)(2007-11#1)(2008-3#1)(2008-7#2)(2009-5#1)
(79)Se is##2##2##(2008-10#2)
(798##2##1##(2007-12#1)(2008-10#1)
(7a)##2##1##(2007-11#1)(2009-9#1)
(8 cases)##2##2##(2008-11#2)
(8 degrees##3##2##(1992-8#1)(1997-7#1)(2008-5#1)
(8 males and##2##3##(2007-7#1)(2008-12#1)
(8 mg##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
(8 of##2##2##(1997-5#1)(2008-6#1)
(8 to##2##2##(2008-10#1)(2008-5#1)
(8 x##5##2##(1993-9#1)(1997-7#2)(2008-10#1)(2008-2#1)
(8##132##1##(1990-11#1)(1990-2#1)(1990-3#2)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(2007-10#7)(2007-11#3)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#19)(2008-11#5)(2008-12#9)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-8#2)(2011-2#8)(2012-12#2)(2012-3#3)(2013-1#3)
(8%##3##1##(1993-11#2)(2006-10#1)
(8%) and##6##2##(1993-2#1)(1995-12#1)(2008-10#1)(2009-3#1)(2010-3#1)(2012-12#1)
(8%)##22##1##(1991-6#2)(1993-2#1)(1995-12#1)(1995-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2009-3#1)(2010-3#2)(2010-5#1)(2012-12#2)(2013-1#1)
(8) and##2##2##(1995-5#1)(2008-5#1)
(8) was##2##2##(1995-3#2)
(8)##27##1##(1990-5#1)(1992-12#1)(1992-9#1)(1994-11#1)(1995-3#2)(1995-5#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#3)(2008-5#1)(2008-8#2)(2009-11#1)(2010-12#1)(2011-2#2)(2011-3#2)
(8-HQ)##2##1##(2008-10#2)
(8-OH-DPAT)##2##1##(1990-5#1)(1995-12#1)
(8-OHdG)##4##1##(1994-11#1)(1994-6#1)(2008-4#1)(2012-5#1)
(8-fold)##2##1##(1991-8#2)
(8/30)##2##1##(1991-3#2)
(8/42)##2##1##(2007-7#1)(2008-9#1)
(80 mg/day)##2##2##(2012-3#2)
(80##35##1##(1990-11#1)(1992-5#1)(1995-12#2)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
(80% vs##2##2##(1990-12#1)(2007-10#1)
(80%##8##1##(1990-12#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-2#1)(2013-1#1)
(80%) and##2##2##(2008-11#1)(2012-3#1)
(80%) of the##2##3##(1997-9#1)(2011-1#1)
(80%) of##3##2##(1995-2#1)(1997-9#1)(2011-1#1)
(80%) patients##3##2##(2008-1#2)(2013-8#1)
(80%)##27##1##(1990-8#1)(1991-6#1)(1995-1#1)(1995-2#1)(1997-6#2)(1997-9#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#3)(2013-8#1)
(800##3##1##(1996-6#1)(2008-11#1)(2008-5#1)
(81##16##1##(1990-3#1)(1991-12#1)(1991-2#1)(1995-12#1)(2007-7#2)(2008-1#1)(2008-10#3)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
(81%##2##1##(1997-2#1)(2007-7#1)
(81%)##6##1##(1990-5#1)(1991-6#1)(1992-6#2)(2011-2#1)(2013-1#1)
(82 to##2##2##(2008-10#2)
(82##19##1##(1995-3#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(82% of##2##2##(2008-5#1)(2010-11#1)
(82%) and##2##2##(2008-10#1)(2011-1#1)
(82%)##11##1##(1990-10#1)(1992-2#2)(1993-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
(824##2##1##(2008-10#1)(2011-1#1)
(83##15##1##(1994-12#2)(1995-12#1)(1995-3#1)(1995-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
(83%##2##1##(1994-12#1)(2013-1#1)
(83%) of##2##2##(1997-2#1)(2008-4#1)
(83%)##12##1##(1992-12#1)(1993-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
(84 +/-##2##2##(1991-11#1)(1993-12#1)
(84##17##1##(1991-11#1)(1991-9#1)(1993-12#1)(1994-12#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
(84%##2##1##(1994-2#1)(2013-1#1)
(84%)##11##1##(1990-9#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-1#1)(1996-5#1)(2007-7#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
(85##20##1##(1993-11#1)(1994-2#1)(1995-12#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
(85% of##2##2##(1991-9#1)(2011-3#1)
(85%##6##1##(1991-9#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2011-3#1)
(85%)##9##1##(1995-1#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
(85)Rb vapor##4##2##(2007-11#3)(2007-12#1)
(86##12##1##(1991-5#1)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
(86%##2##1##(2007-8#1)(2008-10#1)
(86%) were##2##2##(2008-12#1)(2008-8#1)
(86%)##11##1##(1992-11#1)(1993-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
(87##22##1##(1991-11#1)(1991-12#1)(1992-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
(87%##3##1##(1992-3#1)(1995-12#1)(2013-1#1)
(87%) and##2##2##(1991-3#1)(2011-2#1)
(87%)##9##1##(1991-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#2)
(87)Rb##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
(88 kDa)##2##2##(1994-12#2)
(88##18##1##(1991-11#1)(1994-12#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
(88%##5##1##(1991-6#1)(1994-9#1)(2007-11#1)(2008-8#1)(2012-12#1)
(88%) and##2##2##(1992-12#1)(2007-7#1)
(88%)##10##1##(1992-12#1)(1993-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2009-3#1)(2009-6#2)(2011-1#1)(2012-2#1)
(880 nm)##2##2##(2008-10#1)(2008-3#1)
(89##17##1##(1990-9#1)(1993-8#1)(1994-11#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-8#1)
(89%) and##3##2##(2008-12#1)(2008-8#2)
(89%)##10##1##(1995-1#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
(9 cases)##3##2##(1992-5#1)(2007-11#1)(2011-2#1)
(9 men and##2##3##(2013-1#2)
(9 patients)##3##2##(1990-12#1)(2007-11#1)(2011-2#1)
(9 subjects)##2##2##(1994-12#1)(2011-3#1)
(9 to##2##2##(2008-10#1)(2011-2#1)
(9##115##1##(1990-12#3)(1990-3#3)(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-5#2)(1992-6#1)(1994-12#3)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-10#1)(2007-11#5)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#2)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#15)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)
(9%##2##1##(2007-7#1)(2008-1#1)
(9%) had##4##2##(1994-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
(9%) of the##2##3##(1996-9#1)(2011-2#1)
(9%) of##3##2##(1996-9#1)(2007-8#1)(2011-2#1)
(9%) patients##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
(9%)##25##1##(1991-11#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-9#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-11#2)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
(9)##15##1##(1990-12#2)(1995-11#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2011-3#1)
(90 degrees )##2##3##(2008-10#1)(2008-3#1)
(90 degrees##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
(90##36##1##(1991-2#1)(1993-11#1)(1993-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
(90% of##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
(90%##9##1##(1990-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-4#1)(2013-1#1)
(90%) of##2##2##(1992-2#1)(2012-2#1)
(90%) were##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
(90%)##20##1##(1990-2#1)(1992-1#1)(1992-2#1)(1996-6#1)(1997-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#3)(2012-2#2)(2013-8#1)
(91##19##1##(1991-4#1)(1994-2#1)(1994-6#1)(1996-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
(91%) of##2##2##(2007-8#1)(2008-10#1)
(91%)##10##1##(1991-3#1)(1993-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#1)
(92##14##1##(1990-2#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#4)
(92%##2##1##(1991-2#1)(1994-12#1)
(92%) were##3##2##(1995-12#1)(2008-1#1)(2008-10#1)
(92%)##13##1##(1995-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
(93##17##1##(1990-6#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-3#3)
(93%##2##1##(1994-12#1)(2013-1#1)
(93%)##4##1##(1995-12#1)(2007-7#1)(2008-10#1)(2012-3#1)
(930##2##1##(1991-11#1)(2013-1#1)
(94##18##1##(1991-12#1)(1993-3#1)(1995-6#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
(94%##2##1##(2008-10#1)(2008-3#1)
(94%)##6##1##(1991-11#1)(1994-12#1)(1995-3#1)(2008-9#1)(2009-4#1)(2011-1#1)
(95 percent confidence interval##2##4##(1990-5#2)
(95 percent##5##2##(1990-5#2)(1996-1#3)
(95##18##1##(1990-5#2)(1990-9#1)(1991-8#1)(1996-1#3)(1997-7#1)(2008-10#3)(2008-6#1)(2010-6#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
(95% C##14##2##(1990-6#7)(1994-12#7)
(95% CI 0##10##3##(1992-2#1)(2009-9#1)(2010-3#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
(95% CI 1##7##3##(1995-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
(95% CI 2##3##3##(1995-6#1)(2013-1#2)
(95% CI 66##2##3##(2010-3#2)
(95% CI =##3##3##(2009-9#1)(2011-2#2)
(95% CI##99##2##(1990-6#1)(1992-2#2)(1993-2#1)(1995-6#2)(2006-10#1)(2007-10#5)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#7)(2008-6#3)(2008-7#3)(2009-9#2)(2010-3#12)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#14)(2013-8#3)
(95% CI) of##2##3##(2008-10#1)(2013-1#1)
(95% CI)##7##2##(2008-10#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#2)
(95% confidence interval (CI)##4##4##(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
(95% confidence interval 0##2##4##(2008-3#1)(2012-12#1)
(95% confidence interval 1##2##4##(2008-11#1)(2008-2#1)
(95% confidence interval 2##2##4##(2008-2#1)(2009-5#1)
(95% confidence interval [CI]##3##4##(2006-10#1)(2009-9#1)(2012-2#1)
(95% confidence interval##24##3##(1991-11#2)(1993-9#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
(95% confidence intervals##2##3##(2013-1#1)(2013-8#1)
(95% confidence level)##2##3##(2008-10#2)
(95% confidence limits 0##2##4##(2013-1#2)
(95% confidence limits##5##3##(1990-6#1)(1992-10#1)(1997-3#1)(2013-1#2)
(95% confidence##35##2##(1990-6#1)(1991-11#2)(1991-5#1)(1992-10#1)(1993-9#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#4)
(95%##166##1##(1990-12#1)(1990-3#1)(1990-6#9)(1991-11#2)(1991-5#1)(1992-10#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-9#1)(1994-12#7)(1995-6#2)(1997-3#1)(2006-10#2)(2007-10#5)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#9)(2008-11#6)(2008-12#8)(2008-2#2)(2008-3#3)(2008-6#3)(2008-7#5)(2009-5#1)(2009-9#3)(2010-11#1)(2010-3#13)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#25)(2013-8#7)
(95%)##15##1##(1993-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#2)(2013-1#1)
(95%-confidence interval##2##2##(1990-9#2)
(95%CI 0##4##2##(2008-12#4)
(95%CI##23##1##(2008-1#2)(2008-12#4)(2011-1#17)
(96 h)##2##2##(2008-12#1)(2008-4#1)
(96##14##1##(1997-3#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-4#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
(96%##2##1##(1997-7#1)(2013-1#1)
(96%) and##2##2##(1990-3#1)(1995-1#1)
(96%)##17##1##(1990-3#1)(1991-1#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
(97##7##1##(1993-8#1)(2007-10#1)(2008-10#2)(2008-5#1)(2012-2#2)
(97%##2##1##(2008-10#1)(2008-4#1)
(97%) and##2##2##(2008-8#1)(2011-1#1)
(97%)##10##1##(1991-4#1)(1994-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#3)(2010-6#1)(2011-1#1)
(98##14##1##(1990-12#1)(1994-2#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-7#1)(2012-12#1)(2012-2#2)
(98%##5##1##(2008-10#1)(2009-3#1)(2010-6#1)(2013-1#2)
(98%) and##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
(98%)##11##1##(1991-1#1)(1993-1#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
(99##15##1##(1995-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
(99%)##3##1##(1993-6#1)(2008-10#2)
(= 1##2##2##(1994-11#1)(1995-2#1)
(=##13##1##(1990-7#1)(1992-6#1)(1994-11#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)
(?##5##1##(2008-2#3)(2008-3#2)
(A =##3##2##(1996-2#1)(1997-7#1)(2008-8#1)
(A and B)##2##3##(1997-3#1)(1997-5#1)
(A and##4##2##(1997-3#1)(1997-4#1)(1997-5#1)(2008-4#1)
(A beta##4##2##(1994-11#1)(1996-2#2)(1996-5#1)
(A beta) is##2##3##(1994-8#1)(1996-2#1)
(A beta)##5##2##(1994-8#2)(1995-12#1)(1996-2#1)(1996-5#1)
(A through##2##2##(2008-10#1)(2012-2#1)
(A##52##1##(1990-5#1)(1992-3#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#4)(1996-5#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#14)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-2#1)
(A(1))##3##1##(1996-2#3)
(A) and##5##2##(1990-2#1)(1993-5#1)(1995-3#1)(1997-7#1)(2011-2#1)
(A) or##2##2##(1992-12#1)(1994-5#1)
(A)##39##1##(1990-2#1)(1991-12#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#3)(2008-5#1)(2008-9#2)(2010-4#3)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
(A)(+)##3##1##(2008-8#2)(2008-9#1)
(A1 and##2##2##(2008-10#1)(2008-12#1)
(A1##4##1##(2007-12#1)(2008-10#2)(2008-12#1)
(A3)##3##1##(1990-8#1)(2008-8#1)(2013-8#1)
(A5005##2##1##(2008-10#2)
(A506)##2##1##(2008-10#2)
(A549)##3##1##(1994-11#1)(2008-11#1)(2012-3#1)
(A9)##2##1##(1995-12#1)(2008-7#1)
(AA and##3##2##(1990-12#1)(2008-10#1)(2008-8#1)
(AA##5##1##(1990-12#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-8#1)
(AA) and##6##2##(1993-3#1)(2008-10#4)(2008-5#1)
(AA) is##4##2##(2008-10#3)(2008-5#1)
(AA)##38##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#2)(1993-3#1)(1993-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2010-9#1)
(AAA)##5##1##(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2013-1#1)
(AAC)(n) repeats##2##2##(2008-10#2)
(AAC)(n)##4##1##(2008-10#4)
(AAG)##3##1##(1990-8#1)(1991-8#1)(2008-10#1)
(AAI)##3##1##(1991-1#1)(1993-12#2)
(AAP)##2##1##(2008-10#2)
(AAPCC) payment##2##2##(1991-3#1)(1997-1#1)
(AAPCC)##5##1##(1991-3#1)(1993-3#3)(1997-1#1)
(AAPH)##3##1##(1991-1#1)(1994-6#1)(2008-10#1)
(AAS##3##1##(2008-10#3)
(AAS) and##2##2##(2008-10#1)(2010-4#1)
(AAS) method##2##2##(2008-10#2)
(AAS)##22##1##(1996-3#1)(2008-10#19)(2010-4#2)
(AAT)##2##1##(2008-4#1)(2008-5#1)
(AAV)##3##1##(1997-4#1)(2008-8#1)(2011-3#1)
(AB##2##1##(2008-10#1)(2011-2#1)
(AB)##7##1##(1990-12#1)(1996-7#1)(2008-10#4)(2009-4#1)
(ABC)##6##1##(1993-12#1)(1994-3#1)(2008-3#2)(2008-8#1)(2009-8#1)
(ABSTRACT TRUNCATED AT 250 WORDS)##164##5##(1990-12#3)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#3)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#8)(1993-11#6)(1993-12#8)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#8)(1993-9#4)(1994-1#1)(1994-12#3)(1994-2#10)(1994-3#3)(1994-5#16)(1994-8#3)(1995-2#13)(1995-3#3)(1995-5#16)(1996-1#1)(1996-2#4)
(ABSTRACT TRUNCATED AT 400 WORDS)##37##5##(1990-10#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)
(ABSTRACT TRUNCATED AT##201##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#13)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#10)(1993-9#4)(1994-1#1)(1994-12#4)(1994-2#11)(1994-3#4)(1994-5#19)(1994-8#4)(1994-9#1)(1995-2#14)(1995-3#4)(1995-5#16)(1995-6#2)(1996-1#1)(1996-2#4)
(ABSTRACT##202##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#13)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#10)(1993-9#4)(1994-1#1)(1994-12#4)(1994-2#11)(1994-3#4)(1994-5#19)(1994-8#4)(1994-9#1)(1995-2#14)(1995-3#4)(1995-5#16)(1995-6#2)(1996-1#1)(1996-2#4)(2008-9#1)
(ABTS)##3##1##(1997-2#1)(2008-10#2)
(AC##3##1##(2008-10#3)
(AC)##14##1##(1990-5#1)(1994-12#1)(1994-9#1)(2008-10#7)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
(ACA)##3##1##(2011-2#2)(2013-8#1)
(ACC) is##3##2##(1992-10#1)(2008-10#1)(2013-8#1)
(ACC)##14##1##(1991-11#1)(1991-6#1)(1992-10#1)(1993-6#1)(2007-8#1)(2008-10#5)(2009-6#1)(2011-10#1)(2012-3#1)(2013-8#1)
(ACD)##3##1##(2008-5#1)(2010-8#1)(2011-2#1)
(ACE) inhibitor##5##2##(1990-2#1)(1995-3#1)(2008-1#2)(2008-7#1)
(ACE)##13##1##(1990-2#2)(1993-12#1)(1995-3#1)(2006-7#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-2#1)
(ACE-R)##2##1##(2013-1#2)
(ACETBC)##3##1##(1994-7#1)(1997-7#2)
(ACG)##3##1##(1995-2#1)(1997-1#1)(2008-10#1)
(ACIS)##2##1##(2008-10#2)
(ACL)##10##1##(1996-9#1)(1997-8#2)(2012-2#1)(2013-1#6)
(ACNU)##2##1##(1995-9#1)(2008-11#1)
(ACP) were##2##2##(1991-11#1)(2013-8#1)
(ACP)##4##1##(1991-11#1)(1992-4#1)(1993-12#1)(2013-8#1)
(ACPD)##2##1##(1995-12#2)
(ACR)##4##1##(2007-8#1)(2008-10#2)(2008-5#1)
(ACS##2##1##(2008-3#1)(2011-2#1)
(ACS) and##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
(ACS)##11##1##(1997-1#1)(2008-10#1)(2008-3#5)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
(ACT)##7##1##(1991-1#1)(1991-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-4#1)(2011-2#1)
(ACTH) and##4##2##(1995-11#1)(1996-12#1)(2008-4#2)
(ACTH)##11##1##(1992-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-4#3)(2008-8#1)(2011-1#1)(2011-2#1)
(AChE) activity##3##2##(2008-11#3)
(AChE)##15##1##(1990-5#1)(1992-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-3#1)
(AD) and##7##2##(1990-11#1)(1995-12#2)(1996-5#1)(2007-8#1)(2008-5#2)
(AD) duration##2##2##(1992-12#1)(1994-2#1)
(AD) has been##2##3##(2008-10#1)(2012-2#1)
(AD) has##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
(AD) is an##2##3##(2008-7#1)(2012-2#1)
(AD) is##9##2##(1992-12#1)(1992-9#1)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(AD)##71##1##(1990-11#1)(1991-1#1)(1991-11#1)(1992-12#3)(1992-9#1)(1993-12#2)(1994-2#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#2)(1997-2#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#14)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
(ADA) has##2##2##(2008-10#1)(2008-5#1)
(ADA)##17##1##(1994-1#2)(1995-12#4)(1995-6#2)(1996-1#1)(1996-5#1)(1997-5#3)(2008-10#2)(2008-3#1)(2008-5#1)
(ADC)##9##1##(1992-12#1)(1996-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)
(ADE)##2##1##(2011-1#1)(2011-3#1)
(ADF)##2##1##(2008-9#1)(2010-2#1)
(ADH)##6##1##(1993-3#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
(ADHD)##17##1##(1996-6#1)(2008-2#6)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#2)
(ADL)##6##1##(1995-2#1)(2008-7#3)(2011-2#1)(2012-2#1)
(ADM)##3##1##(1992-3#1)(1993-12#1)(2013-1#1)
(ADP)##5##1##(1997-7#1)(2006-6#2)(2008-4#1)(2011-1#1)
(ADPKD)##5##1##(1997-1#2)(2010-6#1)(2013-1#2)
(ADR) and 5-fluorouracil##2##3##(1995-4#1)(1997-7#1)
(ADR) and##3##2##(1995-4#1)(1997-7#1)(2011-3#1)
(ADR)##10##1##(1990-2#1)(1993-12#1)(1994-6#1)(1994-7#1)(1995-4#1)(1997-7#1)(2008-10#2)(2011-2#1)(2011-3#1)
(ADRs)##5##1##(2008-11#1)(2008-3#2)(2011-2#2)
(ADS)##3##1##(2008-10#2)(2009-10#1)
(ADT)##4##1##(1994-2#1)(2008-2#1)(2008-7#1)(2012-2#1)
(ADX)##3##1##(1990-12#1)(1994-2#1)(2008-11#1)
(AE)##6##1##(1994-9#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
(AED)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
(AES)##2##1##(2008-2#1)(2009-11#1)
(AET)##3##1##(1992-9#1)(1994-5#2)
(AEs)##2##1##(2008-11#1)(2008-3#1)
(AF) is##2##2##(2007-8#1)(2008-6#1)
(AF) or##2##2##(1990-2#1)(1992-10#1)
(AF)##14##1##(1990-2#2)(1992-10#1)(2007-8#4)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
(AFB(1)) in##2##2##(2008-10#1)(2010-5#1)
(AFB)##2##1##(2007-7#1)(2007-8#1)
(AFB1)##2##1##(1992-9#1)(2008-10#1)
(AFC)##4##1##(1993-8#1)(2008-10#2)(2011-2#1)
(AFLP)##46##1##(2008-10#44)(2008-7#2)
(AFM)##35##1##(2007-12#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-7#2)(2012-2#1)(2013-8#1)
(AFP)##6##1##(1990-9#1)(1994-9#1)(2008-10#2)(2008-8#1)(2011-1#1)
(AFS)##7##1##(1996-12#1)(2008-10#6)
(AG##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
(AG)##8##1##(1995-2#1)(2008-10#4)(2008-12#1)(2012-3#1)(2013-8#1)
(AG)-5##2##1##(2008-10#2)
(AG-1-ID)##2##1##(2008-10#2)
(AGE)##3##1##(2008-1#1)(2011-2#1)(2012-12#1)
(AGEs)##6##1##(1994-6#1)(1996-12#1)(2008-1#2)(2011-1#2)
(AGP)##2##1##(1991-12#1)(1997-3#1)
(AGR)##2##1##(2008-10#1)(2012-2#1)
(AGT) is##2##2##(1993-11#1)(1995-5#1)
(AGT)##6##1##(1992-6#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-5#1)(2008-5#1)
(AH)##7##1##(1993-8#2)(1995-1#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
(AH8##4##1##(2010-5#4)
(AHA)##5##1##(1991-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
(AHP)##4##1##(1991-5#1)(1992-3#1)(2008-10#1)(2013-1#1)
(AI)##13##1##(2007-12#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2013-1#1)
(AI-2)##2##1##(2008-9#1)(2009-6#1)
(AIBN)##3##1##(2008-10#1)(2008-12#1)(2009-10#1)
(AICAR)##2##1##(1994-8#1)(2009-12#1)
(AIDS-KS)##2##1##(1992-2#1)(1992-3#1)
(AII) receptor##3##2##(1991-5#1)(1993-3#1)(1994-9#1)
(AII)##6##1##(1991-5#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)
(AIP)##2##1##(1990-2#1)(2013-1#1)
(AIS)##2##1##(2008-10#1)(2010-7#1)
(AL##3##1##(2008-5#1)(2009-8#1)(2010-4#1)
(AL)##3##1##(1992-12#1)(2008-10#1)(2011-2#1)
(AL-DIA) and##2##2##(1992-3#2)
(AL-DIA)##3##1##(1992-3#3)
(ALA)##6##1##(1992-3#1)(1992-8#1)(2008-1#1)(2008-6#1)(2012-1#1)(2012-3#1)
(ALC)##2##1##(1997-2#1)(1997-5#1)
(ALD)##2##1##(1993-12#1)(1995-2#1)
(ALDH7)##2##1##(1994-12#2)
(ALI)##3##1##(2008-8#1)(2010-12#1)(2011-2#1)
(ALIAS-II)##2##1##(2008-3#2)
(ALL)##10##1##(1991-2#1)(1991-8#1)(2008-12#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)
(ALP) activity and##2##3##(2008-11#1)(2013-1#1)
(ALP) activity##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
(ALP)##18##1##(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#4)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#3)
(ALS)##6##1##(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)
(ALT)##14##1##(1995-3#1)(2008-10#4)(2008-11#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
(AM##2##1##(2006-6#1)(2008-11#1)
(AM)##10##1##(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
(AM1)##4##1##(2008-10#3)(2008-11#1)
(AMA)##3##1##(1994-12#1)(1996-12#1)(2013-1#1)
(AMD) and##2##2##(2011-2#2)
(AMD)##13##1##(2008-10#2)(2009-12#1)(2010-2#1)(2011-2#7)(2011-7#1)(2013-1#1)
(AMH) is##2##2##(1995-2#1)(2008-4#1)
(AMH)##3##1##(1995-2#2)(2008-4#1)
(AMI)##15##1##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-11#1)(2010-12#1)
(AML) and##2##2##(2008-6#1)(2011-2#1)
(AML) is##3##2##(2008-5#1)(2010-4#1)(2013-1#1)
(AML)##18##1##(1992-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-4#2)(2011-2#5)(2012-12#2)(2013-1#1)
(AMOVA)##6##1##(2008-10#5)(2008-12#1)
(AMP)##6##1##(1995-3#1)(2008-10#2)(2008-4#1)(2011-2#2)
(AMPA)##5##1##(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(2011-1#1)
(AMT)##3##1##(2008-10#1)(2009-11#1)(2011-2#1)
(ANA)##6##1##(1991-2#1)(1993-3#1)(2008-10#2)(2013-1#2)
(ANCA)##3##1##(2008-1#1)(2013-1#2)
(ANCOVA)##2##1##(1994-6#1)(2012-1#1)
(ANG##3##1##(1991-5#1)(1994-11#1)(1994-8#1)
(ANN) model##5##2##(2008-10#5)
(ANN)##25##1##(2008-10#21)(2010-8#3)(2013-1#1)
(ANNs) are##4##2##(2008-10#4)
(ANNs)##13##1##(2008-10#13)
(ANOVA and##2##2##(1990-9#1)(2013-1#1)
(ANOVA p &lt##2##3##(2008-7#2)
(ANOVA##5##1##(1990-9#1)(2008-10#1)(2008-7#2)(2013-1#1)
(ANOVA)##14##1##(1994-2#1)(1994-6#1)(1995-2#1)(2008-10#7)(2009-1#1)(2009-2#1)(2012-2#1)(2013-1#1)
(ANS)##6##1##(1991-9#1)(1995-5#1)(2008-10#1)(2009-11#1)(2011-1#1)(2013-8#1)
(AO) imaging##2##2##(2007-11#1)(2008-3#1)
(AO)##15##1##(2007-11#1)(2008-10#3)(2008-12#2)(2008-2#4)(2008-3#3)(2008-9#1)(2011-1#1)
(AOA)##2##1##(1991-12#1)(2008-7#1)
(AOD)##4##1##(2008-2#1)(2012-12#2)(2012-3#1)
(AOP)##2##1##(2008-10#2)
(AOR =##3##2##(2011-2#1)(2013-1#2)
(AOS)##4##1##(2007-11#1)(2008-10#2)(2008-2#1)
(AOT)##4##1##(2008-10#1)(2008-3#1)(2009-12#1)(2013-1#1)
(AOTF)##5##1##(2007-12#1)(2008-10#2)(2008-2#2)
(AP##2##1##(1996-5#1)(2008-10#1)
(AP) is##4##2##(2009-8#1)(2013-1#3)
(AP)##23##1##(1991-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-8#2)(2010-2#1)(2012-3#1)(2012-6#1)(2013-1#4)
(APC) and##2##2##(1997-2#1)(2008-11#1)
(APC)##14##1##(1993-11#1)(1994-11#2)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#3)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
(APD)##4##1##(2010-12#1)(2010-2#1)(2011-10#1)(2013-8#1)
(APDC)##11##1##(2008-10#11)
(API)##3##1##(2008-5#1)(2011-2#1)(2013-8#1)
(APL)##6##1##(1991-9#1)(2007-4#1)(2008-7#1)(2008-8#1)(2013-1#2)
(APM)##3##1##(1997-5#1)(2008-10#1)(2008-3#1)
(APP) and##2##2##(1994-9#1)(1996-12#1)
(APP) is##2##2##(1992-12#1)(1996-12#1)
(APP)##19##1##(1991-2#1)(1991-9#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#2)(2008-10#2)(2008-11#1)
(APPI)##2##1##(1991-11#1)(2008-10#1)
(APPT)##2##1##(2008-10#1)(2008-7#1)
(APS)##6##1##(1991-12#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-8#1)
(APTES)##2##1##(2008-10#2)
(APs)##3##1##(1993-9#1)(2008-10#1)(2010-4#1)
(AQ) modified##2##2##(2008-10#2)
(AQ)##5##1##(2008-10#4)(2008-3#1)
(AQP1)##2##1##(2007-12#1)(2008-7#1)
(AR) and##5##2##(1992-8#1)(1995-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
(AR) is##2##2##(2008-10#1)(2008-3#1)
(AR)##21##1##(1990-11#2)(1991-9#1)(1992-8#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#2)
(ARA##2##1##(2008-10#1)(2012-1#1)
(ARC)##3##1##(1994-8#1)(2007-12#1)(2012-3#1)
(ARD)##2##1##(2008-8#1)(2012-12#1)
(ARDS) as a##2##3##(2010-5#1)(2011-2#1)
(ARDS)##10##1##(1991-9#1)(1993-2#1)(1997-1#2)(2008-8#1)(2010-5#2)(2011-2#2)(2012-3#1)
(ARF) are##2##2##(1992-12#1)(2008-4#1)
(ARF) in##3##2##(1993-6#1)(2008-4#2)
(ARF)##10##1##(1992-12#1)(1993-6#1)(2008-1#2)(2008-11#1)(2008-4#4)(2012-3#1)
(ARI)##2##1##(1997-3#1)(2008-10#1)
(ARM)##2##1##(2011-2#2)
(ARMD) and##2##2##(2011-2#2)
(ARMD)##4##1##(2011-1#2)(2011-2#2)
(ARRO)##2##1##(1994-3#2)
(ARS) in##2##2##(1996-2#1)(2008-10#1)
(ARS)##11##1##(1996-2#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-7#1)
(ART) in##3##2##(2010-4#1)(2012-12#2)
(ART)##11##1##(1992-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)
(ARVs) and##2##2##(2010-8#1)(2011-2#1)
(AS) and##5##2##(2007-7#1)(2008-12#1)(2011-2#1)(2013-8#2)
(AS) or##2##2##(2007-11#1)(2011-2#1)
(AS)##14##1##(1994-6#1)(1994-9#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-12#2)(2011-2#2)(2012-3#1)(2013-8#2)
(ASA)##10##1##(1994-3#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-7#2)
(ASAT)##2##1##(1996-12#1)(1997-2#1)
(ASC)##4##1##(2008-11#1)(2009-3#1)(2013-1#2)
(ASCA)##2##1##(2008-3#2)
(ASD) may##2##2##(2010-7#1)(2012-3#1)
(ASD)##10##1##(1996-6#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
(ASE)##10##1##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
(ASL)##3##1##(2011-1#1)(2011-2#2)
(ASM)##5##1##(2007-11#1)(2008-10#2)(2008-8#1)(2012-1#1)
(ASN)##2##1##(2008-10#1)(2013-1#1)
(ASR)##2##1##(1992-2#1)(1996-5#1)
(AST##2##1##(1996-10#1)(2008-2#1)
(AST) and##3##2##(2008-10#2)(2012-2#1)
(AST)##9##1##(1994-5#1)(1997-3#1)(2007-6#1)(2008-10#3)(2009-8#1)(2010-4#1)(2012-2#1)
(ASTM##3##1##(2008-10#3)
(ASV)##6##1##(2008-10#5)(2010-7#1)
(AT##2##1##(1993-6#1)(2008-7#1)
(AT)##8##1##(1991-4#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
(AT1) receptor##3##2##(1993-3#1)(2008-1#1)(2008-8#1)
(ATCC 31749 and IFO 13140)##2##5##(2008-6#2)
(ATCC##16##1##(1992-8#1)(1993-8#1)(2008-10#2)(2008-12#2)(2008-6#3)(2008-8#1)(2011-2#2)(2013-1#4)
(ATL)##5##1##(1991-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
(ATM)##2##1##(2007-7#1)(2008-3#1)
(ATMT)##2##1##(2008-10#1)(2008-5#1)
(ATP##8##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(2008-10#1)
(ATP) and##2##2##(1991-9#1)(2008-4#1)
(ATP)##10##1##(1990-5#1)(1991-9#2)(1992-6#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-4#2)(2009-4#1)
(ATPIII) criteria##3##2##(2008-11#1)(2008-3#2)
(ATPIII)##4##1##(2008-11#1)(2008-3#3)
(ATR)##7##1##(1990-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
(ATR-FTIR)##6##1##(2008-10#5)(2008-5#1)
(AUC##4##1##(2008-10#1)(2011-2#2)(2012-4#1)
(AUC)##14##1##(1994-12#1)(1996-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
(AUG) and##2##2##(1991-12#2)
(AUG)##3##1##(1991-12#2)(1997-4#1)
(AUROC = 71##2##3##(2008-3#2)
(AUROC =##3##2##(2008-3#3)
(AV)##4##1##(1997-6#1)(2007-7#1)(2008-3#1)(2011-3#1)
(AVF)##10##1##(1996-9#2)(2007-7#5)(2008-1#1)(2008-7#2)
(AVG)##2##1##(2007-7#1)(2008-10#1)
(AVM) and##2##2##(1991-3#1)(2012-2#1)
(AVM)##10##1##(1991-3#1)(1996-6#1)(2008-7#6)(2012-2#1)(2013-1#1)
(AVP)##6##1##(1990-5#1)(1992-8#1)(1993-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
(AVR)##2##1##(2007-8#1)(2008-10#1)
(AVS)##2##1##(2008-10#2)
(AW##2##1##(1994-8#1)(2012-9#1)
(AW)##2##1##(1994-8#1)(2008-2#1)
(AZ)##2##1##(2008-10#2)
(AZA)##3##1##(1992-8#1)(2010-12#1)(2011-2#1)
(AZT)##6##1##(1992-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(2008-10#1)(2011-3#1)
(Ab) to##3##2##(1993-12#1)(1996-12#1)(1997-4#1)
(Ab)##11##1##(1993-12#1)(1994-12#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#5)
(Ab-index)##2##1##(2011-2#2)
(Abbott##2##1##(2008-8#1)(2011-1#1)
(Abernathy##2##1##(2010-8#2)
(AcMNPV)##4##1##(1993-12#1)(1995-12#1)(1997-4#1)(2008-2#1)
(AcNPV)##8##1##(1994-11#1)(1997-3#1)(1997-4#2)(2008-11#2)(2008-7#1)(2008-8#1)
(AcP)##2##1##(2008-10#2)
(Acacia##2##1##(2008-10#2)
(Acanthaceae)##2##1##(2008-10#2)
(Acanthopagrus schlegeli)##2##2##(2008-7#1)(2010-5#1)
(Acari##8##1##(1996-12#1)(2007-12#2)(2008-12#1)(2011-2#4)
(Acariformes##2##1##(2007-12#2)
(Ad)##2##1##(1997-7#1)(2008-11#1)
(AdCSV)##2##1##(2008-10#2)
(AdSV)##3##1##(2008-10#3)
(Aedes albopictusC6/36)##2##2##(2008-7#2)
(Aedes##3##1##(2007-12#1)(2008-7#2)
(Aesculus hippocastanum)##2##2##(2008-5#2)
(Affi-Gel##2##1##(2008-4#1)(2008-7#1)
(African##2##1##(2008-11#1)(2009-7#1)
(Ag##4##1##(1991-2#1)(2008-10#3)
(Ag)##7##1##(1990-8#1)(1991-5#1)(1993-1#1)(2008-10#3)(2008-3#1)
(Ag/AgCl)##3##1##(2008-10#3)
(AgMNPV)##2##1##(2008-11#2)
(Agaricus bisporus)##4##2##(2008-10#4)
(Agavacea)##2##1##(2009-8#2)
(Ah) receptor##3##2##(1993-12#1)(1995-11#1)(2008-11#1)
(Al##4##1##(2008-10#4)
(Al) is##2##2##(2008-10#1)(2013-8#1)
(Al)##9##1##(1996-12#1)(1996-2#1)(2008-10#3)(2008-3#1)(2009-6#1)(2009-8#1)(2013-8#1)
(Ala)##3##1##(1990-8#1)(1997-2#1)(2008-10#1)
(Alb##2##1##(2008-7#2)
(Aldrich##2##1##(2007-11#1)(2008-10#1)
(Alizarin Red S)##2##3##(2008-10#2)
(Allium cepa##2##2##(2008-10#2)
(Allium##8##1##(1992-9#1)(2008-10#6)(2012-2#1)
(Alsberg's##2##1##(2007-11#2)
(Amaranthus##2##1##(2008-12#1)(2011-2#1)
(Amberlite##3##1##(2008-10#3)
(American Psychiatric##2##2##(2008-8#1)(2011-2#1)
(American##6##1##(1993-2#1)(1995-12#1)(1996-1#1)(2008-8#2)(2011-2#1)
(Amersham Biosciences##2##2##(2008-11#2)
(Anacardium occidentale)##3##2##(1992-2#1)(2012-2#2)
(Anal##2##1##(2008-10#2)
(Anamorph Septoria##2##2##(2008-10#2)
(Andean##3##1##(2008-10#3)
(Ang II)##4##2##(1992-9#2)(1996-9#1)(2008-1#1)
(Annelida##2##1##(2008-5#2)
(Annelida)##3##1##(2008-5#2)(2008-7#1)
(Anura##2##1##(2008-7#1)(2013-7#1)
(Apis mellifera)##4##2##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
(Apis##6##1##(2008-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
(ApoAI)##2##1##(1993-12#2)
(April and May)##2##3##(2008-10#2)
(April##8##1##(2007-7#1)(2008-10#3)(2008-4#1)(2009-2#1)(2013-1#2)
(Ara##3##1##(1997-3#2)(2008-5#1)
(Arabidopsis##3##1##(2008-7#1)(2008-9#1)(2009-10#1)
(Arachis hypogaea) with##2##3##(2008-10#2)
(Arachis hypogaea)##7##2##(2008-10#7)
(Arachis##10##1##(2008-10#8)(2011-2#2)
(Arachnida##5##1##(2007-12#3)(2008-5#2)
(Araliaceae)##2##1##(2010-2#2)
(Araneae##4##1##(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
(Arbutus##2##1##(2008-10#2)
(Arg##2##1##(1993-2#1)(2006-12#1)
(Arg)##2##1##(2008-10#1)(2008-11#1)
(Artiodactyla##2##1##(2008-5#1)(2013-7#1)
(As##7##1##(2008-10#7)
(As(2)O(3))##2##1##(2008-8#2)
(As(III)##4##1##(2008-10#4)
(As(III))##5##1##(2008-10#5)
(As(V)##2##1##(2008-10#2)
(As(V))##5##1##(2008-10#5)
(As)##8##1##(2008-10#7)(2013-1#1)
(AsA)##5##1##(1992-3#1)(2008-10#3)(2008-11#1)
(Asn##2##1##(1990-8#1)(1993-3#1)
(Asp##2##1##(1990-7#1)(1995-6#1)
(Asp)##2##1##(1991-5#1)(1997-4#1)
(Asteraceae)##5##1##(1990-7#2)(2008-11#1)(2013-7#2)
(Ateles geoffroyi)##2##2##(2008-5#2)
(Atr)##2##1##(2008-10#1)(2008-8#1)
(Atra-PBP1)##2##1##(2009-7#2)
(Au##4##1##(2008-10#4)
(Australia)##5##1##(2008-10#3)(2008-11#1)(2008-9#1)
(Avena sativa)##3##2##(2008-10#3)
(Avena##5##1##(2008-10#5)
(AxB(I))##2##1##(2008-10#2)
(B --&gt##2##2##(2011-3#2)
(B = 0##7##3##(1992-9#1)(2010-4#5)(2013-1#1)
(B =##9##2##(1992-9#1)(2008-3#1)(2010-4#6)(2013-1#1)
(B and##2##2##(2008-10#1)(2008-4#1)
(B##32##1##(1992-9#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#13)(2008-3#1)(2008-4#3)(2008-5#1)(2010-4#6)(2011-1#1)(2011-3#2)(2013-1#1)
(B) and##5##2##(2007-8#1)(2008-10#2)(2008-11#2)
(B) was##2##2##(2008-5#1)(2013-1#1)
(B)##28##1##(1990-2#1)(1992-12#1)(1993-8#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#3)(2008-10#10)(2008-11#3)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#2)
(B)]##2##1##(2008-10#1)(2013-1#1)
(B-type)##2##1##(1991-5#2)
(B1 and B2) were##2##4##(2008-11#2)
(B1 and B2)##3##3##(2008-10#1)(2008-11#2)
(B1##4##1##(2008-10#1)(2008-11#3)
(B18C6) and##2##2##(2008-10#2)
(B18C6)##3##1##(2008-10#3)
(B3LYP)##2##1##(2013-1#1)(2013-8#1)
(BA)##12##1##(1995-11#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-7#3)(2011-2#1)(2012-2#1)
(BAC) library##5##2##(2008-10#1)(2008-8#2)(2010-10#1)(2010-3#1)
(BAC)##11##1##(1997-8#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-3#1)
(BAE) is##2##2##(2010-12#1)(2012-3#1)
(BAL) fluid##2##2##(2008-10#1)(2008-12#1)
(BAL)##8##1##(1991-2#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
(BAT)##4##1##(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
(BB)##2##1##(2008-10#1)(2011-2#1)
(BBA)##2##1##(2008-11#2)
(BBD)##2##1##(1994-5#1)(2008-1#1)
(BBMV)##2##1##(1992-6#1)(2008-10#1)
(BBO)##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
(BBSV)##2##1##(1995-12#1)(2008-10#1)
(BC##3##1##(2008-10#2)(2013-1#1)
(BC)##8##1##(1992-8#1)(2007-5#1)(2008-10#4)(2008-6#1)(2013-1#1)
(BCA)##4##1##(2008-10#3)(2008-9#1)
(BCB)##2##1##(2008-10#1)(2008-3#1)
(BCC)##8##1##(1996-1#1)(1997-3#2)(2007-5#1)(2008-9#1)(2012-3#2)(2013-1#1)
(BCF)##2##1##(2008-12#2)
(BCG)##3##1##(1997-2#1)(2008-10#1)(2011-2#1)
(BCI)##2##1##(2012-12#1)(2013-8#1)
(BCS)##3##1##(2011-2#1)(2012-2#1)(2013-1#1)
(BCT)##3##1##(1994-12#1)(1995-4#1)(2008-6#1)
(BCVA)##4##1##(2011-2#3)(2013-1#1)
(BD) is##2##2##(2007-12#1)(2013-8#1)
(BD)##5##1##(2007-12#2)(2011-1#1)(2013-8#2)
(BDD) electrode##4##2##(2008-10#4)
(BDD)##8##1##(2008-10#7)(2012-12#1)
(BDL)##2##1##(2009-8#1)(2013-8#1)
(BDNF) is##2##2##(2009-8#1)(2013-8#1)
(BDNF)##18##1##(1994-8#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-6#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
(BE)##5##1##(2008-10#2)(2010-12#1)(2012-3#1)(2013-8#1)
(BEM)##4##1##(1993-1#1)(2008-11#1)(2008-3#1)(2009-11#1)
(BER)##5##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
(BET)##2##1##(2009-11#1)(2012-12#1)
(BEVS)##2##1##(2008-11#1)(2008-7#1)
(BF##2##1##(2008-5#1)(2012-2#1)
(BF) and##2##2##(2009-12#1)(2010-4#1)
(BF)##4##1##(2009-12#1)(2009-3#1)(2010-4#1)(2013-1#1)
(BG)##6##1##(1995-11#1)(2008-10#3)(2009-11#1)(2009-9#1)
(BGE)##3##1##(2008-10#3)
(BGL)##3##1##(1997-4#1)(2007-10#1)(2012-2#1)
(BGMV) is##2##2##(2008-10#2)
(BGMV)##3##1##(2008-10#3)
(BH4)##2##1##(1992-12#1)(1993-8#1)
(BHA) and##3##2##(2008-10#3)
(BHA)##4##1##(2008-10#4)
(BHT)##8##1##(1994-3#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-8#1)
(BHV-1)##2##1##(1995-9#1)(2008-11#1)
(BI) was##2##2##(2008-10#2)
(BI)##8##1##(2007-12#1)(2008-10#4)(2008-7#1)(2011-2#1)(2012-3#1)
(BII) phobia##2##2##(2012-2#1)(2013-1#1)
(BIRADS##2##1##(2011-2#2)
(BIRTH 39##3##2##(2013-1#3)
(BIS)##3##1##(2009-9#2)(2010-8#1)
(BK)##2##1##(1990-5#1)(2009-2#1)
(BL)##3##1##(1993-9#1)(2009-8#1)(2011-2#1)
(BLM)##3##1##(1990-12#1)(1997-7#1)(2008-10#1)
(BLS)##5##1##(2008-10#4)(2008-3#1)
(BM)##8##1##(2007-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
(BMA)##2##1##(2008-7#1)(2012-2#1)
(BMC##2##1##(1991-11#1)(2013-1#1)
(BMC)##3##1##(1991-11#1)(2010-8#1)(2011-2#1)
(BMDBM)##2##1##(2008-5#2)
(BMI &gt##4##2##(2008-10#1)(2008-3#1)(2009-9#1)(2013-1#1)
(BMI &lt##2##2##(1997-8#1)(2012-12#1)
(BMI -##2##2##(2008-3#1)(2012-12#1)
(BMI##11##1##(1997-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-9#1)(2012-12#3)(2013-1#1)
(BMI) and##8##2##(2007-12#3)(2007-8#2)(2008-3#1)(2012-3#1)(2013-1#1)
(BMI) were##3##2##(2008-7#1)(2010-1#1)(2011-2#1)
(BMI)##48##1##(1991-11#1)(1994-12#1)(2006-8#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-9#1)(2010-1#1)(2010-4#2)(2011-1#5)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
(BML)##2##1##(1996-11#1)(2012-3#1)
(BMM)##2##1##(1994-6#1)(2013-7#1)
(BMP-2)##2##1##(2011-2#1)(2012-3#1)
(BMSC)##2##1##(2008-8#1)(2011-1#1)
(BMT)##4##1##(2007-4#1)(2008-1#1)(2009-10#1)(2013-8#1)
(BMV)##2##1##(2008-10#2)
(BN)##5##1##(2007-7#2)(2008-10#3)
(BNCT)##5##1##(1994-3#4)(2013-1#1)
(BO(3))(3)##2##1##(2007-11#1)(2007-12#1)
(BOD)##3##1##(2008-10#3)
(BOLD) signal##2##2##(2009-6#2)
(BOLD)##4##1##(2008-11#1)(2009-6#2)(2009-9#1)
(BOX)##2##1##(2009-6#2)
(BP##2##1##(2008-10#1)(2008-7#1)
(BP) and##7##2##(1990-5#1)(1995-3#1)(2008-10#2)(2008-11#2)(2013-8#1)
(BP) for##2##2##(2008-10#1)(2010-8#1)
(BP) is##4##2##(1991-3#1)(2008-10#1)(2008-8#1)(2011-1#1)
(BP)##32##1##(1990-5#1)(1991-3#1)(1992-6#1)(1994-8#1)(1995-3#1)(1997-5#4)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-8#1)
(BPA) was##2##2##(2008-10#1)(2010-8#1)
(BPA)##8##1##(2008-10#4)(2008-4#1)(2009-8#1)(2010-8#1)(2010-9#1)
(BPD) is##2##2##(2009-8#1)(2009-9#1)
(BPD)##6##1##(1997-5#1)(2008-4#1)(2009-8#2)(2009-9#1)(2010-5#1)
(BPE##2##1##(1992-2#1)(1997-7#1)
(BPE)##2##1##(1994-5#1)(2013-7#1)
(BPH) and##2##2##(2006-12#1)(2008-5#1)
(BPI)##4##1##(1997-5#1)(2007-7#1)(2008-5#1)(2008-7#1)
(BPP)##2##1##(2007-12#2)
(BPSD)##2##1##(2009-10#1)(2012-2#1)
(BPTA-Tb(3+))##2##1##(2008-10#2)
(BR)##12##1##(1990-5#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-9#1)(2009-8#1)(2013-1#1)
(BRONJ)##2##1##(2012-12#2)
(BRTO)##2##1##(2009-9#1)(2013-1#1)
(BS)##3##1##(2008-10#2)(2013-1#1)
(BSA##2##1##(2008-10#1)(2011-2#1)
(BSA) and##6##2##(2008-10#5)(2008-7#1)
(BSA) in##5##2##(2008-10#3)(2008-11#2)
(BSA)##46##1##(1990-12#1)(1991-5#1)(1993-11#1)(1995-12#2)(1995-6#1)(1997-2#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2011-3#1)
(BSE)##6##1##(1994-6#1)(1997-3#1)(2007-10#1)(2010-4#1)(2011-2#2)
(BSM)##4##1##(1994-9#1)(2008-10#1)(2008-3#1)(2008-6#1)
(BSO)##4##1##(1993-9#1)(2007-12#1)(2009-10#1)(2012-2#1)
(BSTFA)##2##1##(2008-10#1)(2008-5#1)
(BT)##6##1##(1992-11#1)(2008-10#1)(2008-2#1)(2011-2#3)
(BTEX) compounds##2##2##(2008-10#2)
(BTEX)##4##1##(2008-10#3)(2008-11#1)
(BTH) significantly##2##2##(2008-10#2)
(BTH)##6##1##(2008-10#6)
(BU)##3##1##(2008-10#2)(2012-2#1)
(BV)##3##1##(1997-4#1)(2008-10#1)(2008-11#1)
(BW) were##2##2##(2008-10#1)(2013-1#1)
(BW)##6##1##(1994-8#1)(2008-10#2)(2010-7#1)(2012-2#1)(2013-1#1)
(BWYV)##2##1##(2008-10#2)
(BYDV-PAV)##2##1##(2008-10#2)
(BYMV)##2##1##(2008-10#2)
(BZ)##4##1##(1996-12#2)(2008-10#1)(2010-8#1)
(BZDs)##2##1##(2011-10#1)(2012-2#1)
(Bacillus subtilis)##3##2##(2008-10#2)(2008-5#1)
(Bacillus##11##1##(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2011-2#1)
(Bcl-2##2##1##(2011-2#1)(2012-2#1)
(Behav##2##1##(1992-11#1)(2008-11#1)
(Bemisia tabaci##2##2##(2008-10#2)
(Bemisia tabaci)##2##2##(2008-10#2)
(Bemisia##4##1##(2008-10#4)
(Beta =##2##2##(2008-7#2)
(Beta vulgaris L##2##3##(2012-3#2)
(Beta vulgaris)##2##2##(2008-10#2)
(Beta##6##1##(2008-10#2)(2008-7#2)(2012-3#2)
(Bignoniaceae)##3##1##(2008-10#1)(2008-5#1)(2010-3#1)
(Bio-Rad Laboratories##2##2##(2008-10#2)
(Biochemistry##2##1##(1990-8#1)(1997-2#1)
(Biochim##2##1##(1992-6#1)(1995-11#1)
(Biol##2##1##(2008-11#1)(2010-3#1)
(Bivalvia##4##1##(2008-12#1)(2008-5#2)(2011-2#1)
(Bloch##3##1##(2008-12#2)(2009-10#1)
(Bloch)##2##1##(2009-5#2)
(Block##2##1##(1992-8#1)(2009-8#1)
(Blumeria graminis f##4##3##(2008-10#4)
(BmNPV)##4##1##(1997-3#1)(1997-4#1)(2008-11#2)
(Bmax =##5##2##(1994-12#1)(1995-11#1)(1995-12#1)(1996-5#2)
(Bmax##7##1##(1990-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-5#2)(1996-7#1)
(Bmax)##5##1##(1993-6#1)(1995-12#1)(1996-5#1)(1996-7#1)(2008-6#1)
(Body##3##1##(2007-12#2)(2012-12#1)
(Bos indicus)##3##2##(2008-12#3)
(Bos##7##1##(2008-12#3)(2010-4#1)(2011-1#1)(2011-2#2)
(Botrytis cinerea)##2##2##(2008-10#2)
(Br##2##1##(2008-4#2)
(Br-PADAP)##2##1##(2008-10#2)
(Brassica napus) in##2##3##(2008-10#2)
(Brassica napus)##3##2##(2008-10#3)
(Brassica##12##1##(1997-2#2)(2008-10#5)(2008-12#2)(2011-1#3)
(Brazil)##8##1##(2008-10#2)(2008-5#1)(2009-10#1)(2009-11#1)(2010-8#1)(2013-7#2)
(Brazil)]##4##1##(1991-12#1)(1991-9#3)
(BrdU)##8##1##(1994-10#1)(1995-12#1)(1996-2#1)(1996-5#2)(2008-11#1)(2008-4#1)(2008-9#1)
(Brethaire##6##1##(1992-2#6)
(British##4##1##(1995-3#1)(2008-10#2)(2008-12#1)
(BsPFK)##2##1##(1995-2#1)(1995-5#1)
(Bubalus bubalis)##2##2##(2008-5#1)(2012-3#1)
(Bubalus##3##1##(2008-5#1)(2010-4#1)(2012-3#1)
(Bufo japonicus)##3##2##(2008-5#1)(2008-6#2)
(Bufo##4##1##(2008-5#1)(2008-6#2)(2013-1#1)
(C and##2##2##(2008-10#2)
(C##63##1##(1990-6#2)(1992-3#1)(1993-12#1)(1993-8#3)(1994-8#1)(1995-5#1)(1996-5#2)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-7#2)
(C&amp##2##1##(2008-11#1)(2013-7#1)
(C(18)##2##1##(2008-10#2)
(C(18))##3##1##(2008-10#3)
(C(L))##3##1##(2008-10#3)
(C(max))##2##1##(2008-11#1)(2008-12#1)
(C(p))##2##1##(2009-7#1)(2013-1#1)
(C) and##4##2##(1991-9#1)(1994-3#1)(2008-10#2)
(C) in##2##2##(2008-10#1)(2013-8#1)
(C) is##2##2##(2008-10#1)(2012-1#1)
(C) the##2##2##(2007-8#1)(2008-10#1)
(C) were##2##2##(1997-2#1)(2008-11#1)
(C)##32##1##(1990-2#1)(1990-5#1)(1991-9#2)(1993-3#1)(1993-8#2)(1994-3#1)(1997-2#1)(2007-8#2)(2008-10#10)(2008-11#3)(2008-4#2)(2008-6#2)(2010-4#1)(2012-1#1)(2013-8#2)
(C-6)##2##1##(2008-10#2)
(C-ADR)##7##1##(2012-12#7)
(C-reactive##2##1##(1997-8#1)(2008-3#1)
(C1##3##1##(1994-5#1)(2008-12#2)
(C14##5##1##(1990-8#1)(1995-6#2)(2008-10#1)(2011-1#1)
(C16##7##1##(1990-8#1)(1993-11#1)(2008-10#2)(2008-8#1)(2011-1#2)
(C18##8##1##(1996-6#2)(2008-10#4)(2008-11#2)
(C18)##3##1##(2008-10#2)(2012-2#1)
(C2 (1##5##2##(2010-3#5)
(C2##7##1##(1991-3#1)(2007-12#1)(2010-3#5)
(C2)##4##1##(1993-12#1)(2007-12#1)(2008-6#1)(2010-10#1)
(C20##2##1##(2008-10#2)
(C4)##4##1##(1995-2#1)(2008-5#1)(2011-1#1)(2013-1#1)
(C6)##2##1##(1995-12#2)
(C70)(2)-p-tert-butylcalix[6]arene##2##1##(2008-10#2)
(CA##8##1##(1994-12#1)(1996-2#1)(2007-7#1)(2008-10#4)(2012-1#1)
(CA) and##2##2##(2008-10#1)(2012-12#1)
(CA) were##2##2##(2008-10#1)(2010-5#1)
(CA)##33##1##(1992-6#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#13)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
(CA)n##2##1##(1997-9#1)(2008-5#1)
(CAA) in##3##2##(1990-11#1)(1996-12#1)(2008-11#1)
(CAA)##11##1##(1990-11#1)(1990-7#1)(1996-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2010-5#1)
(CAB##3##1##(1995-2#3)
(CABG)##13##1##(1994-12#1)(2006-8#1)(2007-11#1)(2007-8#6)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
(CAC)##2##1##(2008-3#1)(2013-8#1)
(CAC-TDI)##2##1##(2008-10#2)
(CAD) in##3##2##(2008-1#2)(2010-8#1)
(CAD)##21##1##(1991-8#1)(1993-12#1)(1994-5#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#4)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(CADR)##2##1##(2008-8#1)(2012-1#1)
(CAF) was##2##2##(2008-5#1)(2012-3#1)
(CAF)##3##1##(1997-7#1)(2008-5#1)(2012-3#1)
(CAH)##6##1##(2008-4#3)(2008-8#1)(2010-2#1)(2012-3#1)
(CAL)##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
(CALB) and##2##2##(1996-5#1)(2013-1#1)
(CALUX##3##1##(2008-10#3)
(CALUX) bioassay##2##2##(2008-10#2)
(CALUX)##3##1##(2008-10#3)
(CAM)##10##1##(2008-1#1)(2008-10#6)(2008-7#1)(2008-8#1)(2013-1#1)
(CAN)##4##1##(1990-9#1)(1997-4#1)(2009-7#1)(2012-2#1)
(CAP)##4##1##(2007-12#1)(2008-10#1)(2010-5#1)(2012-2#1)
(CAPB)##4##1##(2008-10#1)(2008-5#3)
(CAR)##4##1##(2008-11#1)(2008-6#2)(2013-1#1)
(CAR/PDMS)##3##1##(2008-10#2)(2009-8#1)
(CARICOMP)##3##1##(2007-5#2)(2011-2#1)
(CARS) of O(2) and##2##4##(2008-3#2)
(CARS)##10##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
(CART)##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
(CARs)##2##1##(2007-12#1)(2013-1#1)
(CAS No##9##2##(2008-8#1)(2008-9#8)
(CAS RN##5##2##(2008-5#5)
(CAS##14##1##(2008-5#5)(2008-8#1)(2008-9#8)
(CAS)##10##1##(2006-12#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#1)
(CASY)##2##1##(2008-11#2)
(CAT) activities##2##2##(1994-6#1)(2013-1#1)
(CAT) and##5##2##(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#1)
(CAT) expression##2##2##(1991-11#1)(1994-6#1)
(CAT) gene##4##2##(1992-12#1)(1992-6#1)(1993-8#1)(1997-8#1)
(CAT) reporter gene##2##3##(1991-2#1)(1992-12#1)
(CAT) reporter##3##2##(1991-2#1)(1992-12#1)(1995-2#1)
(CAT)##34##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-8#1)(1994-6#3)(1995-2#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
(CAs)##4##1##(1996-2#1)(2008-10#1)(2008-11#1)(2010-1#1)
(CB)##8##1##(1991-4#1)(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)
(CBB)##4##1##(2008-10#3)(2011-2#1)
(CBC)##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
(CBCT)##2##1##(2013-1#2)
(CBD)##5##1##(1995-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-9#1)
(CBP)##4##1##(1995-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
(CBP2)##2##1##(1997-7#2)
(CBS##2##1##(1996-6#1)(2008-7#1)
(CBS)##6##1##(1993-8#1)(2008-10#2)(2011-2#2)(2013-8#1)
(CBT) for the##2##3##(2011-2#2)
(CBT)##6##1##(2007-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
(CBs)##4##1##(2008-10#4)
(CC)##8##1##(1991-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-1#1)(2013-1#1)
(CCA)##5##1##(2007-12#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)
(CCD)##14##1##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
(CCF)##2##1##(1996-6#1)(1997-3#1)
(CCI) of##2##2##(1996-5#1)(2008-11#1)
(CCI)##4##1##(1996-5#2)(1997-2#1)(2008-11#1)
(CCK)##9##1##(1990-12#1)(1991-8#1)(1992-8#2)(1993-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-7#1)
(CCK-8)##2##1##(1994-2#1)(1995-12#1)
(CCM)##2##1##(1995-3#1)(2008-7#1)
(CCMV)##2##1##(2008-10#2)
(CCP)##2##1##(2008-3#1)(2009-8#1)
(CCR)##2##1##(2008-10#1)(2008-4#1)
(CCS)##2##1##(2008-10#1)(2013-1#1)
(CCT)##3##1##(1994-1#1)(2008-3#1)(2013-1#1)
(CCTS-NMDG)##2##1##(2008-10#2)
(CD) and the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
(CD) and##6##2##(1996-2#1)(2008-10#3)(2008-7#1)(2011-2#1)
(CD) is a##2##3##(2012-2#1)(2013-8#1)
(CD) is##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
(CD) of##3##2##(2008-10#1)(2008-4#1)(2012-1#1)
(CD) spectroscopy and##2##3##(1995-2#1)(2009-2#1)
(CD) spectroscopy##3##2##(1994-5#1)(1995-2#1)(2009-2#1)
(CD) with##2##2##(2008-10#1)(2008-6#1)
(CD)##51##1##(1990-5#2)(1990-8#1)(1990-9#1)(1992-6#3)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#18)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2009-12#1)(2009-2#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#2)
(CD-R)##3##1##(2008-10#1)(2008-3#2)
(CD11b/CD18)##2##1##(1994-5#1)(2008-11#1)
(CD20##2##1##(2008-5#1)(2013-8#1)
(CD4##2##1##(1990-12#1)(2012-12#1)
(CD4)##2##1##(1991-6#1)(2006-10#1)
(CD86)##3##1##(1995-12#1)(2008-11#1)(2008-7#1)
(CDA)##4##1##(1995-1#1)(1996-11#1)(2008-3#1)(2010-8#1)
(CDC##2##1##(2011-2#1)(2012-12#1)
(CDC)##15##1##(1995-12#3)(1995-6#3)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
(CDDP)##5##1##(1993-9#2)(2007-10#1)(2008-2#1)(2013-1#1)
(CDM)##2##1##(2008-10#1)(2011-2#1)
(CDP)##3##1##(1993-12#2)(1994-3#1)
(CDR)##3##1##(2008-4#1)(2008-7#1)(2013-1#1)
(CDS) and##3##2##(2008-3#2)(2009-9#1)
(CDS)##4##1##(1990-6#1)(2008-3#2)(2009-9#1)
(CDT)##3##1##(1993-8#1)(1997-2#1)(2011-2#1)
(CDV)##2##1##(2008-12#1)(2012-3#1)
(CDs)##8##1##(1996-5#1)(2008-10#6)(2009-8#1)
(CE) and##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
(CE) is##5##2##(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
(CE) separation##4##2##(1994-12#1)(2008-10#3)
(CE)##54##1##(1992-8#1)(1994-12#1)(1994-9#1)(1996-5#2)(1997-2#1)(2008-10#34)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
(CE-MRA)##2##1##(2008-7#2)
(CE-UV)##2##1##(2008-10#2)
(CEA) in##3##2##(1991-4#1)(2007-8#1)(2008-10#1)
(CEA)##14##1##(1990-5#1)(1991-4#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-11#1)
(CEC) and##2##2##(2008-10#1)(2010-1#1)
(CEC)##4##1##(2008-10#3)(2010-1#1)
(CEF)##4##1##(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
(CEI)##2##1##(1992-8#1)(2007-8#1)
(CELISA) for the detection of antibodies##2##6##(1990-12#2)
(CEO)##3##1##(1995-2#1)(1996-2#1)(2008-1#1)
(CER)##5##1##(1993-5#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)
(CEUS)##7##1##(2008-7#1)(2010-12#3)(2012-2#3)
(CF) and flow-injection (FI)##2##4##(2008-10#2)
(CF) and##4##2##(1997-6#1)(2008-10#2)(2011-3#1)
(CF) in##2##2##(2008-10#1)(2012-3#1)
(CF)##27##1##(1990-3#1)(1990-8#1)(1992-10#1)(1994-2#1)(1997-1#2)(1997-6#1)(2007-12#1)(2008-10#8)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2011-3#2)(2012-3#1)(2013-1#1)
(CFA)##7##1##(1995-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-2#1)
(CFC) propellants##4##2##(1992-3#2)(1996-1#2)
(CFC)##7##1##(1992-3#2)(1996-1#3)(1996-2#1)(2008-8#1)
(CFCs)##4##1##(1996-1#3)(1996-2#1)
(CFF)##2##1##(2008-10#1)(2012-2#1)
(CFU-GEMM)##2##1##(2008-11#1)(2008-7#1)
(CFU-GM and BFU-E)##2##3##(2008-11#1)(2008-8#1)
(CFU-GM)##2##1##(1992-5#1)(2008-7#1)
(CG)##3##1##(2008-1#1)(2008-7#1)(2013-1#1)
(CGA)##2##1##(1992-9#1)(2008-10#1)
(CGE)##2##1##(2008-10#1)(2010-4#1)
(CGH)##6##1##(2008-12#1)(2008-3#2)(2008-9#1)(2012-3#2)
(CGRP) was##2##2##(1992-9#1)(1997-3#1)
(CGRP)##10##1##(1990-7#1)(1992-9#1)(1993-3#1)(1997-3#2)(1997-4#1)(2007-2#1)(2008-4#3)
(CH(4)##2##1##(2008-10#1)(2008-2#1)
(CH)##3##1##(2008-1#1)(2008-10#1)(2012-2#1)
(CHA)##3##1##(1997-2#1)(2008-10#1)(2009-7#1)
(CHB)##2##1##(2009-8#1)(2013-1#1)
(CHC)##2##1##(2008-1#1)(2012-3#1)
(CHCs)##2##1##(2011-2#1)(2012-3#1)
(CHD)##16##1##(1990-3#1)(1993-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-4#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)
(CHI)##4##1##(1997-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
(CHO##3##1##(2008-11#3)
(CHO) and##3##2##(1996-5#1)(2008-11#2)
(CHO) cell line##5##3##(2008-11#5)
(CHO) cell##11##2##(1997-2#1)(2008-10#1)(2008-11#7)(2008-7#2)
(CHO) cells producing##2##3##(2008-11#1)(2008-7#1)
(CHO) cells##32##2##(1990-12#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#15)(2008-4#1)(2008-7#5)
(CHO)##53##1##(1990-12#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#27)(2008-4#1)(2008-7#7)(2013-1#1)(2013-8#1)
(CHX) and##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
(CHX)##6##1##(2008-11#2)(2011-3#1)(2012-3#1)(2013-1#2)
(CI 95%##2##2##(2011-2#2)
(CI##12##1##(1992-11#4)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#2)(2012-3#2)
(CI) 1##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
(CI) for##2##2##(2007-10#1)(2013-8#1)
(CI) was##2##2##(2011-2#1)(2013-1#1)
(CI) were##3##2##(1993-9#1)(2010-9#1)(2011-2#1)
(CI)##37##1##(1991-6#1)(1992-10#1)(1992-8#1)(1993-10#1)(1993-9#2)(1994-2#1)(2007-10#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
(CIA)##3##1##(1990-6#1)(1992-8#1)(2008-11#1)
(CIC)##3##1##(1990-12#1)(2007-11#1)(2008-10#1)
(CID)##4##1##(2008-10#3)(2008-8#1)
(CIDP) is##2##2##(2008-7#1)(2013-1#1)
(CIDR##2##1##(2008-12#2)
(CIE##3##1##(2008-2#1)(2010-2#1)(2013-1#1)
(CIE)##2##1##(1994-9#1)(2008-5#1)
(CIM)##2##1##(2012-3#2)
(CIN##3##1##(1991-2#1)(1992-8#1)(1994-2#1)
(CIN)##6##1##(1991-2#1)(1996-8#1)(2007-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
(CIP)##3##1##(2008-4#1)(2011-2#1)(2012-3#1)
(CIS)##3##1##(1994-1#1)(2007-12#1)(2008-10#1)
(CIs)##4##1##(2008-8#1)(2011-2#1)(2012-2#2)
(CK##2##1##(2008-9#1)(2013-1#1)
(CK-B)##2##1##(1991-6#2)
(CKD) patients##3##2##(2011-2#1)(2013-1#2)
(CKD)##9##1##(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
(CL) emission##2##2##(2008-10#2)
(CL) for the##2##3##(2008-10#1)(2012-3#1)
(CL) in the##2##3##(2007-7#1)(2008-10#1)
(CL) measurements##2##2##(2008-10#2)
(CL) method is proposed for the##4##6##(2008-10#4)
(CL) method is##5##3##(2008-10#5)
(CL) method##12##2##(2008-10#12)
(CL) system is proposed##2##4##(2008-10#2)
(CL) system##8##2##(2008-10#8)
(CL)##84##1##(1991-2#1)(1991-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-5#1)(2007-11#1)(2007-7#2)(2008-10#62)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-4#1)(2012-3#1)(2013-8#1)
(CLA)##3##1##(1993-8#1)(2008-5#2)
(CLB)##4##1##(2007-10#1)(2008-10#3)
(CLBO)##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
(CLD)##4##1##(1992-2#1)(2008-10#3)
(CLL)##8##1##(1991-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)
(CLM) in##2##2##(2007-2#1)(2008-10#1)
(CLM)##3##1##(2007-2#1)(2008-10#1)(2012-3#1)
(CLND)##2##1##(1997-2#1)(2008-10#1)
(CLP)##2##1##(2011-2#1)(2012-3#1)
(CLS)##10##1##(2008-10#9)(2012-3#1)
(CLSM)##6##1##(1992-9#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
(CM)##8##1##(1996-5#1)(2008-10#3)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
(CM-dextran)##2##1##(2008-10#2)
(CMC)##16##1##(1993-6#1)(1996-5#1)(2008-10#9)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
(CMD)##2##1##(2007-11#1)(2008-10#1)
(CME)##7##1##(2008-1#1)(2008-10#6)
(CMF##2##1##(1990-6#1)(1992-12#1)
(CMF)##3##1##(2007-5#1)(2009-1#1)(2009-4#1)
(CMH)##2##1##(1992-2#1)(1994-3#1)
(CMI 80 &gt##2##3##(2008-5#2)
(CMI##3##1##(2008-5#3)
(CMI)##5##1##(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
(CML)##12##1##(1990-2#1)(1991-4#1)(2006-10#1)(2007-11#1)(2009-7#2)(2010-11#1)(2010-4#2)(2011-2#1)(2012-12#2)
(CMM)##3##1##(2007-10#1)(2008-7#1)(2012-3#1)
(CMOS)##5##1##(2008-2#2)(2008-3#2)(2008-7#1)
(CMP)##2##1##(1990-11#1)(2008-4#1)
(CMR)##4##1##(2008-1#1)(2010-11#1)(2010-8#1)(2013-1#1)
(CMS)##6##1##(1995-2#1)(1996-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
(CMT)##5##1##(1997-3#1)(2007-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
(CMV) colitis##2##2##(2010-12#2)
(CMV) promoter##3##2##(1995-12#1)(2008-11#2)
(CMV) was##3##2##(1992-6#1)(2008-10#2)
(CMV)##29##1##(1992-6#1)(1995-12#1)(1997-6#1)(1997-8#1)(2007-7#2)(2008-10#12)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)(2010-12#2)(2012-12#1)(2012-2#1)
(CN IX)##2##2##(2011-2#2)
(CN##5##1##(2008-9#1)(2011-2#4)
(CN)##8##1##(1994-12#1)(1996-5#1)(2008-10#5)(2008-11#1)
(CNP)##5##1##(1991-5#1)(1993-11#1)(1994-11#1)(1994-8#1)(2009-5#1)
(CNP-53)##2##1##(1990-7#2)
(CNS) is##3##2##(2007-7#1)(2008-7#1)(2013-8#1)
(CNS)##53##1##(1991-12#2)(1991-2#1)(1991-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#3)(1997-2#1)(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
(CNV)##3##1##(2008-4#1)(2009-5#1)(2012-3#1)
(CO##3##1##(1991-2#1)(1992-1#1)(1996-12#1)
(CO(2)##3##1##(2008-10#1)(2010-7#1)(2012-2#1)
(CO) and##2##2##(2008-10#1)(2012-1#1)
(CO)##15##1##(1990-5#1)(1991-8#1)(1994-2#1)(1995-2#1)(1996-12#4)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-1#1)(2013-1#1)
(COD)##7##1##(2008-10#5)(2008-12#1)(2009-11#1)
(COHb)##2##1##(1996-12#1)(1997-2#1)
(COMT)##2##1##(2008-11#1)(2013-1#1)
(COOH)##3##1##(2008-10#2)(2011-2#1)
(COP)##4##1##(2008-2#1)(2010-12#1)(2010-9#1)(2012-12#1)
(COPE)##2##1##(1997-4#1)(2008-11#1)
(COS-7) cells##2##2##(1993-3#1)(1995-11#1)
(COX##2##1##(1991-6#1)(2008-10#1)
(COX)##6##1##(1991-6#2)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#1)
(COX-2)##8##1##(2006-10#1)(2007-4#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#3)
(CP) and##6##2##(2008-10#5)(2012-2#1)
(CP) of##3##2##(2008-10#3)
(CP) was##2##2##(1997-4#1)(2008-10#1)
(CP)##55##1##(1994-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#41)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
(CPA)##9##1##(1993-1#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-4#1)(1997-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
(CPB)##17##1##(1995-12#1)(2007-8#6)(2007-9#1)(2008-10#6)(2008-7#1)(2012-2#1)(2013-8#1)
(CPC) and##3##2##(2008-10#2)(2008-3#1)
(CPC)##11##1##(2008-10#8)(2008-2#1)(2008-3#1)(2013-8#1)
(CPD)##2##1##(1994-8#1)(2011-2#1)
(CPE) has been##2##3##(2008-10#2)
(CPE) in##2##2##(2008-10#1)(2008-11#1)
(CPE) was##2##2##(2008-10#1)(2011-3#1)
(CPE)##20##1##(1994-2#1)(2008-10#14)(2008-11#2)(2008-6#1)(2011-2#1)(2011-3#1)
(CPEs)##2##1##(2008-10#2)
(CPF)##2##1##(2007-8#1)(2011-1#1)
(CPI)##4##1##(1993-3#1)(2008-10#3)
(CPIB)##2##1##(1990-2#1)(1991-4#1)
(CPL)##3##1##(2008-10#1)(2008-11#1)(2010-12#1)
(CPM) was##2##2##(2007-8#1)(2008-7#1)
(CPM)##6##1##(1995-12#1)(2007-8#3)(2008-11#1)(2008-7#1)
(CPP)##6##1##(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
(CPPs)##3##1##(2008-12#1)(2010-10#1)(2011-3#1)
(CPR)##2##1##(2013-1#2)
(CPS)##4##1##(1990-7#2)(2008-10#1)(2008-4#1)
(CPT)##4##1##(1994-8#1)(2006-12#1)(2007-11#1)(2008-10#1)
(CPs)##7##1##(2008-10#4)(2009-5#1)(2012-8#1)(2013-1#1)
(CQI)##12##1##(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-3#1)(1997-2#1)
(CR) and##3##2##(1991-2#1)(1997-7#1)(2008-10#1)
(CR) in##2##2##(2008-10#1)(2008-6#1)
(CR) was##2##2##(2007-4#1)(2008-5#1)
(CR)##27##1##(1991-2#1)(1991-6#1)(1993-6#1)(1994-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-8#1)(2013-1#1)
(CRA)##2##1##(2013-1#2)
(CRB)##2##1##(2008-10#1)(2010-3#1)
(CRC)##13##1##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(CRE)##7##1##(1993-3#1)(1994-11#2)(1996-2#1)(1997-2#2)(2013-1#1)
(CREB)##6##1##(1996-12#2)(2008-10#1)(2008-7#1)(2009-3#1)(2012-3#1)
(CRF) and##2##2##(1990-12#1)(2009-3#1)
(CRF) has##2##2##(2007-7#1)(2008-4#1)
(CRF) in##2##2##(1996-12#1)(2007-7#1)
(CRF) is##3##2##(1990-3#1)(1997-4#1)(2008-1#1)
(CRF)##20##1##(1990-12#1)(1990-3#1)(1996-12#1)(1997-4#1)(2007-7#4)(2008-1#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
(CRM##4##1##(2008-10#4)
(CRM)##5##1##(2008-10#4)(2012-3#1)
(CRMs)##9##1##(2008-10#9)
(CRP##2##1##(1990-2#1)(2008-10#1)
(CRP) and##2##2##(1997-7#1)(2008-7#1)
(CRP)##20##1##(1990-12#1)(1994-12#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
(CRS)##6##1##(1991-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
(CRT)##5##1##(2008-10#1)(2008-6#1)(2010-6#1)(2011-2#2)
(CS) and##6##2##(1990-12#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-7#1)
(CS) is##2##2##(2010-8#1)(2011-2#1)
(CS) was##2##2##(2008-5#1)(2011-2#1)
(CS) with##2##2##(2012-3#1)(2013-1#1)
(CS)##26##1##(1990-12#1)(1991-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#4)
(CSA)##6##1##(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
(CSD)##4##1##(1993-12#1)(2007-10#1)(2008-10#2)
(CSDH)##2##1##(2008-7#1)(2011-1#1)
(CSE)##5##1##(1991-1#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
(CSF) was##2##2##(1990-2#1)(2008-9#1)
(CSF)##41##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#1)
(CSIC)##2##1##(2008-10#2)
(CSL)##2##1##(1990-2#1)(2008-6#1)
(CSLM)##3##1##(2008-1#1)(2008-10#1)(2008-7#1)
(CSP)##7##1##(1997-6#1)(2007-12#1)(2008-10#4)(2011-2#1)
(CSQ)##2##1##(1990-2#1)(2008-12#1)
(CSS)##3##1##(2008-10#1)(2008-3#1)(2010-6#1)
(CT scan)##2##2##(2008-1#1)(2010-3#1)
(CT##5##1##(2007-11#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-3#1)
(CT(4##2##1##(2008-5#2)
(CT) and magnetic resonance imaging (MRI)##2##6##(2010-9#1)(2013-7#1)
(CT) and magnetic resonance##4##4##(2010-9#1)(2011-2#2)(2013-7#1)
(CT) and##12##2##(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
(CT) scan and##3##3##(2007-10#1)(2008-7#1)(2013-8#1)
(CT) scan showed a##2##4##(2008-1#1)(2010-1#1)
(CT) scan showed##4##3##(2008-1#1)(2008-7#2)(2010-1#1)
(CT) scan##21##2##(1996-9#1)(2007-10#2)(2008-1#1)(2008-12#1)(2008-7#10)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
(CT) scans of the##2##4##(2008-1#1)(2013-8#1)
(CT) scans showed##2##3##(2008-1#1)(2008-7#1)
(CT) scans##10##2##(2007-10#1)(2008-1#4)(2008-5#1)(2008-7#2)(2011-2#1)(2013-8#1)
(CT) vs##2##2##(2012-12#2)
(CT) was##2##2##(2008-9#1)(2009-5#1)
(CT)##114##1##(1991-12#1)(1991-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-7#1)(2007-10#7)(2007-11#1)(2007-5#2)(2007-7#2)(2008-1#8)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#17)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
(CTA) and##2##2##(2008-10#1)(2008-12#1)
(CTA)##10##1##(1995-12#1)(2008-10#4)(2008-12#2)(2008-7#1)(2011-2#1)(2012-2#1)
(CTAB)##16##1##(2008-10#14)(2008-11#2)
(CTC)##8##1##(1997-8#2)(2008-1#1)(2008-10#4)(2008-8#1)
(CTEPH)##8##1##(2010-10#1)(2010-6#7)
(CTL)##11##1##(1991-9#1)(1993-9#1)(1995-12#1)(1995-3#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
(CTS)##5##1##(2008-10#1)(2008-9#3)(2010-8#1)
(CTV)##12##1##(2008-10#10)(2008-2#1)(2008-5#1)
(CUSUM)##2##1##(2008-10#2)
(CV &lt##2##2##(2008-10#2)
(CV =##3##2##(2008-10#1)(2008-8#2)
(CV##10##1##(2008-10#7)(2008-8#2)(2010-5#1)
(CV) and##10##2##(1993-12#1)(2008-10#9)
(CV) of##3##2##(2008-10#2)(2008-8#1)
(CV) was##4##2##(1990-12#1)(2008-10#3)
(CV)##36##1##(1990-12#1)(1993-12#1)(1993-2#1)(2008-10#30)(2008-11#1)(2008-8#1)(2010-5#1)
(CVAAS)##8##1##(2008-10#8)
(CVC)##2##1##(2008-10#1)(2008-7#1)
(CVD) has##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
(CVD)##33##1##(2008-1#1)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#4)(2009-4#2)(2009-9#2)(2010-12#3)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
(CVI)##2##1##(2011-2#1)(2012-12#1)
(CVP)##2##1##(2008-10#1)(2010-8#1)
(CVR)##2##1##(2008-10#1)(2012-3#1)
(CVS = 0##2##3##(2012-2#2)
(CVS)##2##1##(2008-4#1)(2012-2#1)
(CVs) of the##2##3##(2008-10#2)
(CVs)##3##1##(2008-10#2)(2008-9#1)
(CW)##2##1##(2008-10#1)(2011-1#1)
(CW/TPR##2##1##(2008-10#2)
(CXR)##2##1##(1997-8#1)(2011-2#1)
(CYC)##2##1##(2010-12#1)(2013-1#1)
(CYP##2##1##(2008-11#1)(2011-1#1)
(CYP)##6##1##(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
(CYP11A1)##2##1##(1991-12#1)(1997-2#1)
(CYP1A1)##3##1##(1994-6#1)(1994-8#1)(2008-11#1)
(CYP51A1)##2##1##(2008-10#1)(2008-5#1)
(Ca##8##1##(1992-9#1)(1997-4#1)(2008-10#5)(2011-1#1)
(Ca(2+))##2##1##(2008-11#1)(2008-4#1)
(Ca(2+)-release##2##1##(1992-3#2)
(Ca(v)1##4##1##(2008-8#4)
(CaCl(2))##2##1##(2008-10#1)(2009-7#1)
(CaM kinase##3##2##(1990-5#1)(1993-6#1)(1994-6#1)
(CaM)##4##1##(1994-12#1)(1994-3#1)(2008-8#2)
(CaMKII)##4##1##(1997-2#1)(2008-8#1)(2009-7#1)(2012-2#1)
(Cacatua##3##1##(1997-3#2)(2008-5#1)
(Cajanus cajan##2##2##(2008-10#1)(2010-10#1)
(Cajanus cajan)##2##2##(2008-10#1)(2010-10#1)
(Cajanus##4##1##(2008-10#2)(2010-10#2)
(Calidris##2##1##(2013-7#2)
(California##4##1##(1991-2#1)(1992-2#1)(1995-8#1)(2008-10#1)
(Canada)##3##1##(2012-3#1)(2013-1#2)
(Candida albicans##2##2##(2008-5#2)
(Candida##6##1##(2008-10#3)(2008-5#2)(2013-8#1)
(Canis##2##1##(1996-12#2)
(Capra hircus)##2##2##(2008-9#1)(2010-4#1)
(Capsicum annuum##2##2##(2008-10#2)
(Capsicum annuum) plants##2##3##(2008-10#2)
(Capsicum annuum)##4##2##(2008-10#4)
(Capsicum##6##1##(2008-10#6)
(Carassius auratus##3##2##(2008-5#2)(2008-8#1)
(Carassius auratus)##4##2##(2008-5#1)(2008-6#2)(2008-9#1)
(Carassius##7##1##(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)
(Cardiidae)##2##1##(2008-5#2)
(Catharanthus roseus)##2##2##(2008-10#2)
(Catharanthus##3##1##(2008-10#3)
(Cbl)##2##1##(1990-11#1)(2008-10#1)
(CcO)##2##1##(1995-2#1)(2013-1#1)
(Cd##2##1##(2008-10#2)
(Cd(2+)) and##2##2##(2008-10#2)
(Cd(2+))##5##1##(2008-10#5)
(Cd) and##4##2##(2008-10#3)(2008-11#1)
(Cd)##10##1##(1995-3#1)(2008-10#6)(2008-11#1)(2008-7#2)
(Cd2+)##2##1##(1991-12#1)(1995-12#1)
(Ce##4##1##(2007-12#1)(2008-10#1)(2008-3#2)
(Ce)##2##1##(2011-2#1)(2012-2#1)
(Central##4##1##(1991-12#2)(1995-3#1)(2008-10#1)
(Ceratitis capitata)##2##2##(2008-11#1)(2008-3#1)
(Ceratitis##3##1##(2008-11#2)(2008-3#1)
(Cervus nippon)##2##2##(2008-5#2)
(Cervus##5##1##(1993-2#2)(2008-5#3)
(ChAT)##6##1##(1991-9#1)(1992-8#1)(1993-3#1)(2009-11#1)(2009-3#1)(2011-2#1)
(ChE)##2##1##(2008-10#2)
(ChIP)##4##1##(2008-2#3)(2009-10#1)
(Chelex 100##2##2##(2008-10#2)
(Chelex##3##1##(2008-10#3)
(Chenopodium##2##1##(2008-10#1)(2008-12#1)
(Chile)##2##1##(2008-3#2)
(China##2##1##(2008-8#1)(2013-8#1)
(China)##3##1##(2008-10#1)(2013-8#2)
(Chinese##5##1##(1995-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
(Chiralpak IA)##2##2##(2008-10#2)
(Chiralpak##4##1##(2008-10#4)
(Chiroptera##2##1##(1994-11#1)(2008-5#1)
(Chlorophyta)##2##1##(2008-5#1)(2008-7#1)
(Chrysanthemum coronarium)##2##2##(2008-10#2)
(Chrysanthemum##4##1##(2008-10#4)
(Citrus reticulata)##2##2##(2008-10#2)
(Citrus sinensis##2##2##(2008-10#1)(2008-6#1)
(Citrus sinensis) and##3##3##(2008-10#2)(2012-12#1)
(Citrus sinensis)##5##2##(2008-10#4)(2012-12#1)
(Citrus##16##1##(2008-10#10)(2008-5#1)(2008-6#2)(2011-2#2)(2012-12#1)
(Cl)##6##1##(1995-8#1)(2008-2#2)(2008-8#1)(2011-1#1)(2013-1#1)
(ClO(4))##3##1##(2008-2#3)
(ClO(4))-doped PMMA##2##2##(2008-2#2)
(ClYVV)##2##1##(2008-10#2)
(Class III evidence)##2##3##(2012-3#2)
(Class##4##1##(1994-9#1)(2008-7#1)(2012-3#2)
(Clayton##2##1##(2008-10#2)
(Clinical##3##1##(1994-12#1)(1994-2#1)(2013-1#1)
(Clone##2##1##(2008-11#1)(2012-3#1)
(Cm)##2##1##(1991-9#1)(1995-8#1)
(Co##5##1##(1990-10#1)(2008-10#3)(2008-8#1)
(Co)##4##1##(2008-10#4)
(CoMFA)##3##1##(1995-3#1)(2010-12#1)(2011-2#1)
(CoQ10)##2##1##(1991-5#1)(2013-1#1)
(Coal##2##1##(2008-10#2)
(Coffea arabica)##2##2##(2008-10#2)
(Cohen's d##2##2##(2008-7#1)(2013-1#1)
(Cohen's##3##1##(2008-7#1)(2010-8#1)(2013-1#1)
(Coleoptera##32##1##(2007-12#8)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#3)(2011-2#10)(2013-7#1)(2013-8#4)
(Collembola)##2##1##(2008-8#2)
(Colombia)##2##1##(2012-12#2)
(Colombian##2##1##(2008-5#1)(2013-1#1)
(Compound##8##1##(1990-7#1)(1994-8#7)
(Computer##2##1##(2007-8#1)(2008-10#1)
(ConA)##4##1##(1995-12#2)(2008-10#2)
(Control =##2##2##(2010-2#2)
(Control##4##1##(2008-8#1)(2010-2#2)(2013-8#1)
(Copepoda##3##1##(2008-12#1)(2008-5#2)
(Corning##2##1##(2007-11#1)(2008-3#1)
(Corvus##2##1##(2012-2#2)
(Coturnix##7##1##(1997-3#2)(2008-12#2)(2008-6#2)(2010-4#1)
(CpCo)(3)(&amp##4##1##(1997-7#4)
(Cr##5##1##(1996-2#1)(2008-10#3)(2008-12#1)
(Cr(2)O(7)(2-))##2##1##(2008-10#2)
(Cr)##2##1##(1993-8#1)(2008-10#1)
(Cr2) for##2##2##(2008-10#2)
(Cr2)##3##1##(2008-10#3)
(Cresson)##4##1##(1990-11#1)(2008-6#2)(2010-2#1)
(Crocodylus##4##1##(2010-3#4)
(Cronartium ribicola)##2##2##(2008-10#2)
(Crustacea##4##1##(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
(Crystal data for##2##3##(1997-7#2)
(Cs##3##1##(2008-10#3)
(CsA) has been##2##3##(1994-8#1)(2007-7#1)
(CsA)##9##1##(1990-12#1)(1991-9#1)(1994-3#1)(1994-8#1)(1997-2#1)(2007-7#1)(2008-6#1)(2011-3#1)(2013-1#1)
(Ct##2##1##(2007-3#2)
(Ct)##3##1##(1990-5#1)(1996-3#1)(2008-10#1)
(Cu##10##1##(1991-12#1)(1993-2#2)(1995-6#1)(2008-10#5)(2008-3#1)
(Cu(2)O)##2##1##(2008-10#1)(2008-2#1)
(Cu)##9##1##(1995-3#1)(1997-4#1)(2008-10#4)(2010-5#1)(2012-2#1)(2013-8#1)
(CuHCF)##2##1##(2008-10#2)
(Cucumis melo##2##2##(2008-10#1)(2011-2#1)
(Cucumis##11##1##(2008-10#9)(2009-12#1)(2011-2#1)
(Cucurbita pepo)##3##2##(2008-10#3)
(Cucurbita##6##1##(1994-8#1)(2008-10#4)(2011-2#1)
(Cux##3##1##(2013-1#3)
(Cx43)##3##1##(2008-11#1)(2008-6#1)(2008-8#1)
(Cyanex##2##1##(2008-10#2)
(Cyclamen##2##1##(2008-10#2)
(CymMV) and##3##2##(2008-10#3)
(Cys) or##2##2##(2008-10#2)
(Cys)##7##1##(2008-10#5)(2008-4#1)(2010-11#1)
(Cyt##2##1##(2008-10#1)(2009-10#1)
(Czech##2##1##(1994-12#1)(2011-2#1)
(D approximately##2##2##(1997-7#1)(2008-7#1)
(D min##2##2##(2008-1#2)
(D##25##1##(1993-12#1)(1994-5#1)(1995-3#1)(1996-12#2)(1997-2#1)(1997-7#2)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-9#1)(2013-1#1)
(D(O2))##2##1##(2007-12#2)
(D) and -nondefoliating (ND)##2##4##(2008-10#2)
(D) and##5##2##(1990-8#1)(2008-10#4)
(D) is##3##2##(1991-9#1)(2008-10#2)
(D) of##2##2##(2008-10#1)(2008-6#1)
(D) to##2##2##(1991-9#1)(2008-10#1)
(D)##32##1##(1990-8#1)(1991-2#1)(1991-9#5)(1994-6#1)(1994-9#1)(1996-5#1)(2007-12#1)(2008-10#16)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-1#1)
(D2)##2##1##(1996-12#1)(2008-10#1)
(D4T)##2##1##(1991-3#1)(2008-7#1)
(D8S1179##2##1##(2008-12#2)
(DA) and##6##2##(1992-1#1)(1994-2#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-7#1)
(DA) is##2##2##(2008-10#1)(2008-5#1)
(DA)##38##1##(1992-1#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-2#1)(1997-7#1)(2008-10#11)(2008-5#1)(2008-6#2)(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
(DAB)##7##1##(1992-3#1)(2008-10#5)(2011-2#1)
(DABP)##2##1##(2007-11#1)(2007-8#1)
(DAD)##6##1##(2008-10#5)(2011-2#1)
(DAI)##4##1##(2008-10#3)(2011-3#1)
(DAPG)##4##1##(2008-10#4)
(DAPI) staining and##2##3##(1995-6#1)(2008-10#1)
(DAPI)##5##1##(1995-6#1)(2008-10#2)(2008-2#1)(2008-9#1)
(DAS)##5##1##(1992-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
(DASH)##2##1##(2008-9#2)
(DAST)##6##1##(2007-12#6)
(DAT)##8##1##(1994-12#1)(1996-11#1)(1996-12#3)(2008-12#1)(2008-6#1)(2012-2#1)
(DB18C6)##3##1##(2008-10#3)
(DBA)##4##1##(1990-7#1)(2008-10#2)(2013-1#1)
(DBBP)##4##1##(2008-10#4)
(DBE)##2##1##(2010-12#1)(2012-2#1)
(DBH)##5##1##(1995-11#1)(1995-12#1)(1995-5#1)(1997-3#1)(2013-1#1)
(DBP) as##2##2##(2008-10#2)
(DBP)##15##1##(1990-3#1)(1991-10#1)(1992-12#1)(2008-10#9)(2008-5#1)(2010-5#1)(2013-8#1)
(DBS(-))##2##1##(2008-10#2)
(DBS)##10##1##(2008-1#1)(2008-10#3)(2008-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-3#1)
(DBT)##2##1##(2008-10#1)(2008-11#1)
(DC##2##1##(2013-8#2)
(DC) and##2##2##(2008-10#1)(2013-1#1)
(DC) is##2##2##(2008-11#1)(2012-12#1)
(DC)##15##1##(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
(DCA)##5##1##(1995-3#1)(2008-10#2)(2008-4#1)(2011-1#1)
(DCC)##2##1##(1992-10#1)(2007-12#1)
(DCDHF)##2##1##(2008-6#1)(2010-2#1)
(DCE)##5##1##(1996-2#1)(1996-5#1)(2008-10#2)(2010-12#1)
(DCF)##3##1##(2008-10#2)(2008-11#1)
(DCG)##3##1##(1997-1#1)(2008-3#2)
(DCIS)##2##1##(1990-12#1)(1995-4#1)
(DCM)##5##1##(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
(DCP)##5##1##(1996-12#1)(2008-10#2)(2008-3#1)(2012-2#1)
(DCS)##4##1##(2011-1#2)(2012-2#1)(2013-1#1)
(DD)##7##1##(1994-8#1)(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-2#1)
(DD-PCR)##2##1##(2008-1#1)(2008-8#1)
(DDC)##3##1##(1990-12#1)(1997-2#1)(2008-10#1)
(DDD)##4##1##(2008-11#1)(2011-2#2)(2012-12#1)
(DDH)##6##1##(2007-11#1)(2007-8#2)(2008-10#1)(2013-7#1)(2013-8#1)
(DDP)##3##1##(1992-2#1)(1992-5#1)(2008-10#1)
(DDQ)##3##1##(1997-4#1)(2008-10#2)
(DDS)##2##1##(2010-10#1)(2011-2#1)
(DDSP)##3##1##(2008-3#2)(2011-1#1)
(DDT)##2##1##(2008-10#2)
(DDTP) and##2##2##(2008-10#2)
(DDTP)##4##1##(2008-10#4)
(DDVP)##2##1##(2008-10#2)
(DE)##4##1##(2008-10#3)(2008-6#1)
(DE3) cells##3##2##(1994-5#2)(2010-6#1)
(DE3)##6##1##(1994-5#2)(1995-12#1)(2009-3#1)(2010-6#1)(2011-2#1)
(DEA)##3##1##(2008-10#2)(2010-8#1)
(DEAE)##2##1##(2008-10#1)(2013-1#1)
(DEB)##3##1##(2008-4#1)(2008-7#1)(2010-4#1)
(DEC)##2##1##(2008-1#1)(2008-10#1)
(DEHP)##5##1##(2008-10#3)(2008-5#1)(2012-1#1)
(DEM)##2##1##(2007-5#1)(2013-1#1)
(DEP)##5##1##(2008-10#3)(2008-5#1)(2010-5#1)
(DEPC)##4##1##(1990-11#1)(1990-8#1)(1992-6#1)(1995-5#1)
(DFA)##2##1##(2007-7#1)(2008-10#1)
(DFB)##5##1##(2008-3#5)
(DFG)##3##1##(2008-2#1)(2008-3#1)(2012-2#1)
(DFO) and##3##2##(2008-10#2)(2012-2#1)
(DFS)##8##1##(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
(DFT)##3##1##(2008-2#1)(2013-8#2)
(DG)##10##1##(1991-2#1)(1991-5#1)(1993-8#1)(1994-3#1)(2007-7#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
(DGT)##3##1##(2008-10#3)
(DH) population derived from##2##4##(2008-10#1)(2008-4#1)
(DH) population##6##2##(2008-10#3)(2008-4#1)(2008-9#2)
(DH)##9##1##(1991-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
(DHA) in##3##2##(1994-8#1)(2010-1#1)(2012-1#1)
(DHA)##8##1##(1994-8#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-2#1)(2012-1#2)(2013-1#1)
(DHEA)##4##1##(1994-5#1)(1994-6#1)(2007-11#1)(2008-1#1)
(DHF)##2##1##(1992-5#1)(2007-2#1)
(DHFR)##5##1##(1992-6#1)(1994-12#1)(1994-9#1)(2008-11#1)(2008-2#1)
(DHI)##2##1##(2008-10#1)(2008-5#1)
(DHS)##3##1##(1997-1#1)(2008-10#1)(2013-1#1)
(DHT)##5##1##(1990-11#1)(1991-5#1)(1994-11#1)(2008-1#1)(2008-2#1)
(DI)##8##1##(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#1)(2012-12#1)
(DIA) and##2##2##(2008-10#1)(2013-8#1)
(DIA)##3##1##(2008-10#2)(2013-8#1)
(DIC)##7##1##(2008-10#1)(2008-7#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
(DIDS) and##2##2##(1990-2#1)(1992-3#1)
(DISC)##3##1##(2008-11#2)(2012-2#1)
(DIT)##2##1##(1992-2#1)(2008-10#1)
(DIV) in##2##2##(1996-5#1)(2008-10#1)
(DIV)##3##1##(1996-5#1)(2008-10#1)(2011-2#1)
(DL) and##2##2##(2008-5#1)(2008-7#1)
(DL)##14##1##(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
(DLBCL)##5##1##(2009-8#3)(2012-2#1)(2013-1#1)
(DLC)##2##1##(2008-10#1)(2008-12#1)
(DLD-1) and##2##2##(1995-6#1)(2012-3#1)
(DLPE)##2##1##(1992-9#1)(1994-3#1)
(DLS)##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
(DM##2##1##(2011-2#1)(2012-3#1)
(DM) and##2##2##(2008-7#1)(2010-2#1)
(DM)##34##1##(1997-4#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-3#4)(2008-7#2)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
(DM2)##4##1##(1994-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
(DMA) and##3##2##(2008-10#3)
(DMA) were##3##2##(2008-10#3)
(DMA)##17##1##(1995-11#1)(2008-10#16)
(DMC)##3##1##(1996-5#1)(2008-1#1)(2008-2#1)
(DMD) is##2##2##(2007-8#1)(2011-2#1)
(DMD)##4##1##(1990-7#1)(1995-12#1)(2007-8#1)(2011-2#1)
(DME)##4##1##(2008-1#1)(2008-10#1)(2011-2#1)(2011-7#1)
(DMEM)##4##1##(1990-2#1)(2008-11#1)(2013-1#2)
(DMF) and##8##2##(2008-10#7)(2013-8#1)
(DMF)##11##1##(2008-10#10)(2013-8#1)
(DMG)##3##1##(2008-10#3)
(DMI)##4##1##(2008-10#2)(2012-2#2)
(DMIs)##3##1##(2008-10#3)
(DMN)##3##1##(2008-9#1)(2012-3#1)(2013-8#1)
(DMP)##3##1##(1992-6#1)(2008-5#1)(2010-5#1)
(DMPC)##3##1##(1993-11#1)(1994-3#1)(2008-10#1)
(DMPD)##2##1##(2008-10#2)
(DMPO)##3##1##(1993-6#1)(1996-2#1)(2008-5#1)
(DMPP)##2##1##(1994-5#1)(1995-11#1)
(DMPS)##2##1##(1994-5#1)(1995-3#1)
(DMR)##2##1##(2008-10#1)(2012-2#1)
(DMSA)##4##1##(1992-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
(DMSO) and##3##2##(2008-10#3)
(DMSO) to##2##2##(2008-10#1)(2010-2#1)
(DMSO)##12##1##(1994-5#1)(1994-8#1)(2008-10#9)(2010-2#1)
(DMT)##3##1##(1992-3#1)(2007-10#1)(2008-10#1)
(DNA##10##1##(1991-12#1)(1992-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
(DNA)##6##1##(1991-9#1)(1994-8#1)(1996-9#1)(2008-10#2)(2013-7#1)
(DNB)##2##1##(1993-3#1)(2008-3#1)
(DNC)##2##1##(1997-4#1)(2010-2#1)
(DNP) as##2##2##(1990-12#1)(2012-2#1)
(DNP)##5##1##(1990-12#1)(2007-9#1)(2008-10#1)(2009-5#1)(2012-2#1)
(DNS)##2##1##(2008-6#1)(2013-8#1)
(DNT)##2##1##(2008-10#1)(2008-7#1)
(DO) 1##2##2##(2010-4#2)
(DO)##12##1##(2008-10#6)(2008-11#3)(2008-12#1)(2010-4#2)
(DOC)##3##1##(1992-9#1)(2008-10#1)(2008-4#1)
(DOE) is##2##2##(1994-12#1)(2007-12#1)
(DOE)##8##1##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)
(DOG) and##2##2##(1997-1#1)(2008-8#1)
(DOLT-3)##2##1##(2008-10#2)
(DON and##2##2##(2008-10#2)
(DON##3##1##(2008-10#3)
(DON)##12##1##(2008-10#11)(2013-1#1)
(DOP) as plasticizer##2##3##(2008-10#2)
(DOP)##15##1##(2008-10#13)(2008-2#1)(2008-3#1)
(DOPA)##3##1##(2009-9#2)(2010-2#1)
(DOS) and##2##2##(2008-10#2)
(DOS)##9##1##(2008-10#8)(2012-2#1)
(DOT)##11##1##(1996-11#1)(1996-3#6)(2010-4#1)(2011-1#2)(2013-8#1)
(DP##2##1##(1991-12#1)(1993-8#1)
(DP)##8##1##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-10#1)(2010-4#1)(2013-1#1)
(DPA)##9##1##(2008-10#6)(2008-8#1)(2010-7#1)(2011-2#1)
(DPB)##3##1##(1995-12#1)(1995-8#1)(2010-5#1)
(DPCSV)##4##1##(2008-10#4)
(DPDB)##2##1##(2008-9#2)
(DPE)##2##1##(2008-10#1)(2013-1#1)
(DPH)##3##1##(1991-5#1)(2008-1#1)(2008-10#1)
(DPI)##8##1##(1990-2#1)(1994-6#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-5#1)
(DPM)##2##1##(2008-5#1)(2008-7#1)
(DPN)##2##1##(2008-7#1)(2008-9#1)
(DPP)##11##1##(2008-10#11)
(DPPC)##7##1##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(2008-10#3)
(DPPH) radical##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
(DPPH)##11##1##(2008-10#5)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#1)(2013-1#2)
(DPTH-gel)##2##1##(2008-10#2)
(DPV) and##3##2##(2008-10#3)
(DPV)##17##1##(2008-10#17)
(DQDC)##2##1##(2008-10#2)
(DR)##8##1##(1993-12#1)(1996-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
(DR3 gene##2##2##(1991-11#2)
(DRD2)##2##1##(1997-5#1)(2012-1#1)
(DRE)##3##1##(1993-11#1)(1994-12#1)(2008-7#1)
(DRG) neurons##5##2##(1993-12#1)(1996-5#1)(2008-4#1)(2008-8#1)(2013-1#1)
(DRG)##13##1##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
(DRGs) and##2##2##(1994-12#1)(1994-3#1)
(DRGs)##9##1##(1991-12#1)(1992-12#1)(1992-2#2)(1994-12#3)(1994-3#1)(1995-3#1)
(DRIFT) spectroscopy and##2##3##(2008-1#1)(2008-10#1)
(DRIFT) spectroscopy##3##2##(2008-1#1)(2008-10#2)
(DRIFT)##4##1##(2008-1#1)(2008-10#3)
(DRIFTS)##2##1##(2008-10#2)
(DRS)##3##1##(2008-10#2)(2008-7#1)
(DS) and##2##2##(2008-10#1)(2012-3#1)
(DS)##21##1##(1991-1#1)(1993-12#2)(1996-2#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
(DSA) of##2##2##(1993-8#1)(2008-11#1)
(DSA)##8##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-2#2)
(DSB)##4##1##(1995-6#1)(2008-11#1)(2011-1#1)(2013-1#1)
(DSC)##12##1##(1990-7#2)(1990-8#1)(1992-10#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2009-3#1)
(DSH)##2##1##(1992-12#1)(1996-1#1)
(DSI)##2##1##(2008-3#1)(2012-3#1)
(DSM)##2##1##(1996-9#1)(2011-2#1)
(DSO)##2##1##(2008-10#1)(2011-2#1)
(DSP) is##2##2##(2008-3#1)(2010-6#1)
(DSP)##8##1##(1997-4#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-6#1)
(DSS)##2##1##(1994-2#1)(2011-2#1)
(DST)##3##1##(1990-11#1)(2008-11#1)(2011-2#1)
(DSTD)##4##1##(2008-10#4)
(DT##3##1##(1994-8#1)(1996-12#2)
(DT) is##2##2##(2008-3#1)(2008-6#1)
(DT)##9##1##(1993-3#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#2)(2013-1#1)
(DTA)##2##1##(2008-10#2)
(DTAODC)##2##1##(2008-10#2)
(DTC)##3##1##(1996-1#1)(2008-12#1)(2013-1#1)
(DTDC) and##2##2##(2008-10#2)
(DTG)##2##1##(1995-12#2)
(DTODC)##2##1##(2008-10#2)
(DTT)##8##1##(1990-11#1)(1990-12#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-8#1)(2010-11#1)(2012-2#1)
(DTs)##2##1##(2011-1#1)(2012-2#1)
(DUF1470)##2##1##(2010-10#2)
(DUM) neurones##2##2##(1994-2#2)
(DVT)##7##1##(1993-5#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)
(DW)##4##1##(2008-10#1)(2008-12#1)(2012-5#1)(2013-1#1)
(DWM)##2##1##(2008-5#1)(2010-11#1)
(DX +##2##2##(2008-10#2)
(DX##3##1##(2008-10#3)
(DX)##2##1##(1990-2#1)(2008-10#1)
(DXR)##2##1##(1994-12#1)(1994-8#1)
(DZ)##2##1##(1997-4#1)(2009-7#1)
(Daucus carota L##2##3##(1994-11#1)(2008-9#1)
(Daucus carota)##3##2##(2008-10#3)
(Daucus##5##1##(1994-11#1)(2008-10#3)(2008-9#1)
(Day##2##1##(2008-11#2)
(De##4##1##(2008-10#2)(2011-2#1)(2012-1#1)
(Decapoda##5##1##(2007-12#2)(2008-5#1)(2013-7#2)
(December##4##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
(December)##2##1##(2008-10#1)(2013-7#1)
(DeltaG degrees##3##2##(2008-10#3)
(DeltaH(HM))##2##1##(1996-2#2)
(Denizli)##3##1##(2008-12#3)
(Department of Health 1999)##2##4##(2008-11#2)
(Department of Health##4##3##(2008-11#4)
(Dictyoptera##2##1##(2011-2#2)
(Dioscorea##3##1##(2008-5#3)
(Diptera##52##1##(2007-12#11)(2008-11#1)(2008-5#6)(2008-6#4)(2008-8#3)(2009-9#1)(2010-4#1)(2011-2#17)(2013-1#6)(2013-8#2)
(Dipturus laevis)##2##2##(2009-4#2)
(Dns)##2##1##(1994-5#1)(1994-9#1)
(Dns-Thr)##2##1##(2008-10#2)
(Dogfish##2##1##(2008-10#2)
(Dysmicoccus spp##3##2##(2008-10#3)
(Dz)##2##1##(2008-10#2)
(E =##2##2##(2009-9#2)
(E and##2##2##(1990-5#1)(1994-11#1)
(E degrees##3##2##(1997-7#1)(2008-10#1)(2008-6#1)
(E sigma##2##2##(1990-12#1)(1993-12#1)
(E##42##1##(1990-12#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-5#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#14)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-5#1)
(E(2))##3##1##(2008-3#1)(2009-7#2)
(E) and##4##2##(1994-9#1)(1995-6#1)(2008-10#2)
(E)##25##1##(1992-12#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#11)(2008-5#1)(2008-7#1)(2009-4#1)(2012-4#1)(2013-1#1)(2013-7#1)
(E-102)##2##1##(2008-10#2)
(E1 and##2##2##(2008-10#2)
(E1##4##1##(1997-1#1)(2008-10#3)
(E1)##4##1##(1992-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
(E12)##2##1##(1991-12#1)(2008-7#1)
(E2) and##2##2##(1994-9#1)(2011-2#1)
(E2)##15##1##(1990-11#1)(1991-5#1)(1993-1#1)(1994-9#2)(1995-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
(E3)##2##1##(2008-10#1)(2008-11#1)
(E=0##2##1##(2008-10#2)
(EA) is##2##2##(2008-10#1)(2011-2#1)
(EA)##9##1##(1995-12#1)(1996-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
(EAA)##3##1##(1994-11#1)(2008-10#1)(2008-11#1)
(EAE) and##2##2##(1994-6#1)(2008-7#1)
(EAE)##7##1##(1994-6#1)(1995-12#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-2#2)
(EAFD)##3##1##(2008-10#3)
(EAP)##3##1##(1992-10#2)(1995-6#1)
(EAS)##4##1##(2007-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
(EASE)##2##1##(2008-11#2)
(EAT)##3##1##(1992-3#1)(2009-1#1)(2013-8#1)
(EB)##8##1##(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
(EBA)##2##1##(2008-4#1)(2012-3#1)
(EBL)##3##1##(2008-12#2)(2008-3#1)
(EBM)##4##1##(2009-7#1)(2012-12#1)(2013-8#2)
(EBV)##18##1##(1992-12#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#3)(2010-6#1)(2011-2#1)
(EC 1##14##2##(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#3)(2008-10#4)(2008-8#1)
(EC 2##7##2##(1990-8#1)(1992-6#1)(1993-12#1)(1993-9#1)(1997-2#1)(2008-6#1)(2011-1#1)
(EC 3##22##2##(1990-2#4)(1990-5#2)(1990-7#1)(1991-12#2)(1991-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-9#1)
(EC 4##2##2##(1991-12#1)(2012-2#1)
(EC 6##3##2##(1990-7#1)(1994-12#1)(2008-12#1)
(EC##58##1##(1990-11#1)(1990-2#4)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#3)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#2)(1995-2#1)(1995-6#1)(1995-8#4)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#2)
(EC(50) = 0##4##3##(2013-1#4)
(EC(50) = 1##3##3##(2013-1#3)
(EC(50) =##7##2##(2013-1#7)
(EC(50) values)##2##2##(2008-10#2)
(EC(50)##11##1##(2008-10#4)(2013-1#7)
(EC(50)) for##2##2##(2008-10#2)
(EC(50))##4##1##(2008-10#4)
(EC) and##3##2##(2008-7#1)(2009-10#1)(2012-2#1)
(EC) cells##2##2##(1994-9#1)(2012-12#1)
(EC) techniques##2##2##(2008-10#1)(2008-5#1)
(EC) was##2##2##(2008-10#2)
(EC)##30##1##(1990-12#1)(1990-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#2)
(EC50 0##2##2##(1995-11#1)(1997-1#1)
(EC50 =##8##2##(1993-3#1)(1994-11#1)(1995-11#3)(1995-12#2)(1997-7#1)
(EC50##20##1##(1991-12#1)(1992-8#1)(1993-3#1)(1994-11#3)(1995-11#4)(1995-12#2)(1995-2#5)(1997-1#2)(1997-7#1)
(EC50)##2##1##(1994-6#1)(2008-8#1)
(ECC)##2##1##(1992-2#1)(2008-2#1)
(ECD) of the##2##3##(1995-11#1)(1995-12#1)
(ECD) of##3##2##(1995-11#1)(1995-12#1)(2008-11#1)
(ECD)##10##1##(1995-11#1)(1995-12#1)(2008-10#7)(2008-11#1)
(ECG##2##1##(2008-10#1)(2008-7#1)
(ECG)##15##1##(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2010-1#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)
(ECL) behavior of##2##3##(2008-10#2)
(ECL)##13##1##(2008-10#10)(2010-7#1)(2012-2#2)
(ECM)##15##1##(1994-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-6#1)(2013-8#1)
(ECMO)##3##1##(2007-8#1)(2010-5#1)(2011-2#1)
(ECOD) and##2##2##(1990-7#1)(2008-11#1)
(ECOG)##4##1##(1992-2#1)(1992-8#1)(2008-6#1)(2008-7#1)
(ECT)##6##1##(1995-3#1)(2008-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
(ECV)##2##1##(1993-12#1)(2008-11#1)
(ECoG)##2##1##(2008-11#2)
(ED(50))##4##1##(2008-10#3)(2008-4#1)
(ED) at##2##2##(2008-11#1)(2010-8#1)
(ED) in##2##2##(2011-2#1)(2013-8#1)
(ED)##26##1##(1993-3#1)(2007-11#1)(2007-5#3)(2008-10#2)(2008-11#3)(2008-3#3)(2009-5#1)(2009-6#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
(ED50 0##2##2##(1995-12#2)
(ED50 = 5##3##3##(1994-3#1)(1995-11#1)(1995-3#1)
(ED50 =##4##2##(1994-3#2)(1995-11#1)(1995-3#1)
(ED50 values of##2##3##(1991-8#2)
(ED50##13##1##(1991-8#2)(1994-3#2)(1995-11#1)(1995-12#7)(1995-3#1)
(EDA)##2##1##(2008-10#2)
(EDC)##2##1##(2008-10#2)
(EDIN)##2##1##(1990-11#2)
(EDMD)##2##1##(2008-7#1)(2011-2#1)
(EDNRB)##2##1##(1994-12#2)
(EDTA) and##3##2##(2008-10#2)(2008-5#1)
(EDTA)##15##1##(1994-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
(EDX) analysis##2##2##(2008-10#1)(2008-2#1)
(EDX)##7##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#2)(2013-1#1)
(EDXRF) and##2##2##(2008-10#2)
(EDXRF)##6##1##(2008-10#5)(2008-12#1)
(EE)##4##1##(2009-11#1)(2013-1#1)(2013-8#2)
(EEG) and##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
(EEG)##17##1##(1990-6#1)(1993-6#1)(2008-11#1)(2008-4#2)(2008-7#4)(2009-8#3)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#1)
(EEM)##2##1##(2008-10#2)
(EF) of##2##2##(2008-10#2)
(EF)##10##1##(1993-9#1)(2008-10#6)(2008-4#1)(2013-1#2)
(EF-1alpha)##3##1##(2008-10#3)
(EFM)##2##1##(2008-2#1)(2008-5#1)
(EFS)##7##1##(1996-5#1)(1997-4#1)(2008-2#1)(2010-3#1)(2011-2#3)
(EFSUMB)##2##1##(2008-7#2)
(EG) as##3##2##(2008-10#2)(2013-8#1)
(EG)##6##1##(2008-10#4)(2008-8#1)(2013-8#1)
(EGCG)##2##1##(2008-10#1)(2008-11#1)
(EGF##2##1##(1992-2#1)(2008-8#1)
(EGF) receptors##2##2##(1992-7#1)(1993-3#1)
(EGF)##30##1##(1990-12#2)(1991-12#3)(1991-2#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-7#1)
(EGFP)##3##1##(2008-11#2)(2013-8#1)
(EGTA)##2##1##(2008-10#1)(2008-5#1)
(EH)##3##1##(1996-5#1)(2008-9#1)(2011-2#1)
(EHMC)##3##1##(2008-10#2)(2008-5#1)
(EHR)##4##1##(2007-12#1)(2008-7#1)(2010-8#1)(2012-2#1)
(EHRs)##2##1##(2007-12#1)(2010-8#1)
(EI) mode##2##2##(2008-10#1)(2011-1#1)
(EI)##6##1##(2008-10#3)(2011-1#1)(2013-1#2)
(EIA)##7##1##(1990-12#1)(1993-11#1)(1995-6#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-3#1)
(EIAs)##2##1##(1993-2#1)(1995-12#1)
(EIB)##2##1##(2010-1#1)(2010-5#1)
(EIS)##8##1##(2007-6#1)(2008-10#6)(2008-11#1)
(EIT)##4##1##(2007-11#1)(2007-12#2)(2011-2#1)
(EKFA)##2##1##(2008-10#2)
(EL)##3##1##(1996-5#1)(2008-4#1)(2013-1#1)
(ELISA) and##11##2##(1992-3#1)(1992-5#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-4#1)(2013-8#1)
(ELISA) for##9##2##(1990-2#1)(1994-3#1)(2008-10#4)(2008-11#1)(2011-2#2)
(ELISA)##74##1##(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-11#2)(1995-12#1)(1996-9#1)(1997-4#2)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#32)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#2)(2008-6#1)(2010-4#2)(2010-5#1)(2011-2#4)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
(EM) and##2##2##(2008-10#1)(2008-9#1)
(EM)##13##1##(1992-6#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-9#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
(EMA) and##2##2##(2006-12#1)(2012-3#1)
(EMA)##3##1##(2006-12#1)(2009-6#1)(2012-3#1)
(EMD)##2##1##(1994-12#1)(2006-8#1)
(EMF) on##2##2##(2011-2#2)
(EMF)##6##1##(2008-10#1)(2008-12#2)(2011-2#2)(2013-7#1)
(EMG) activity##2##2##(1997-7#1)(2008-3#1)
(EMG) of##2##2##(1990-6#1)(2012-2#1)
(EMG)##12##1##(1990-6#1)(1990-9#1)(1997-7#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(EMLA)##2##1##(1993-1#1)(2009-5#1)
(EMR)##2##1##(2010-8#2)
(EMS)##2##1##(1996-3#1)(2013-1#1)
(EN)##3##1##(2007-10#1)(2008-11#1)(2013-1#1)
(ENL)##2##1##(2009-5#1)(2011-2#1)
(ENOX2)##2##1##(2009-9#2)
(ENU)##3##1##(1992-9#1)(2008-4#1)(2010-8#1)
(EO)##8##1##(2007-11#2)(2008-2#2)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
(EOC)##4##1##(2007-7#1)(2010-7#1)(2010-8#1)(2011-1#1)
(EOS)##2##1##(2008-3#2)
(EOX)##2##1##(2008-10#2)
(EP) was##2##2##(2008-10#2)
(EP)##5##1##(1994-9#1)(2008-10#4)
(EPA##3##1##(1994-11#1)(2008-10#2)
(EPA) and##3##2##(2008-11#1)(2008-9#1)(2010-1#1)
(EPA)##10##1##(1992-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)
(EPC)##2##1##(2010-10#1)(2010-6#1)
(EPCs)##4##1##(2008-1#1)(2009-11#1)(2012-12#2)
(EPI)##2##1##(2008-9#1)(2013-8#1)
(EPO)##12##1##(1992-12#1)(2007-7#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)
(EPR)##10##1##(1990-2#1)(1991-9#1)(1993-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-5#1)(2012-12#1)
(EPS I)##2##2##(2008-10#2)
(EPS)##5##1##(2007-12#1)(2008-10#1)(2011-2#3)
(EPSPs)##3##1##(1995-5#1)(1996-5#1)(2008-9#1)
(EPT)##2##1##(1997-8#1)(2013-1#1)
(ER) and progesterone##4##3##(1991-12#1)(1997-7#1)(2011-2#1)(2013-8#1)
(ER) and##7##2##(1991-12#1)(1995-4#1)(1997-7#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-8#1)
(ER) are##2##2##(2008-7#1)(2012-2#1)
(ER)##45##1##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-4#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-8#2)
(ER+)##2##1##(1992-4#1)(2011-1#1)
(ERAS)##2##1##(2013-1#1)(2013-8#1)
(ERE)##3##1##(1991-2#1)(1992-6#1)(1995-11#1)
(ERG)##2##1##(2008-10#1)(2009-12#1)
(ERK##3##1##(1996-2#1)(2008-10#1)(2011-2#1)
(ERK)##5##1##(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
(ERK1/2)##4##1##(2008-4#2)(2010-12#1)(2011-2#1)
(ERM)##2##1##(2011-2#1)(2012-1#1)
(EROD) activity##3##2##(1992-8#1)(1993-12#1)(2008-7#1)
(EROD)##5##1##(1990-7#1)(1992-8#1)(1993-12#1)(1995-3#1)(2008-7#1)
(ERP)##4##1##(1995-5#1)(1996-5#1)(2008-11#1)(2013-8#1)
(ERT) for the##3##3##(2008-10#1)(2012-12#2)
(ERs)##3##1##(1997-7#1)(2008-4#1)(2008-8#1)
(ES##2##1##(1996-5#1)(2013-1#1)
(ES) cells are##2##3##(2008-9#1)(2012-12#1)
(ES) cells##16##2##(1992-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2012-12#1)
(ES)##33##1##(1992-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-11#6)(2008-12#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
(ESA)##4##1##(2008-11#2)(2008-3#2)
(ESBL)##3##1##(2007-7#2)(2011-2#1)
(ESBLs)##3##1##(2007-7#2)(2012-2#1)
(ESC)##5##1##(2008-10#1)(2008-11#2)(2011-2#1)(2012-3#1)
(ESD)##3##1##(1996-5#1)(2012-2#1)(2013-8#1)
(ESI) and##2##2##(2008-10#2)
(ESI)##7##1##(2008-10#4)(2011-1#2)(2011-2#1)
(ESI-MS)##9##1##(2008-10#5)(2008-5#1)(2011-1#3)
(ESLI)##2##1##(2008-3#2)
(ESM)##2##1##(2008-2#1)(2008-6#1)
(ESP)##2##1##(1994-12#1)(2008-1#1)
(ESPI)##4##1##(2008-2#1)(2008-3#2)(2009-7#1)
(ESR)##14##1##(1990-5#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#2)
(ESS)##7##1##(2008-8#2)(2008-9#3)(2009-5#1)(2012-3#1)
(EST)##9##1##(1995-9#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
(ESTs)##9##1##(1995-8#1)(1997-6#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-8#1)
(ESWL)##5##1##(1990-11#1)(1994-5#1)(2007-7#2)(2009-5#1)
(ET) is##3##2##(2008-7#2)(2012-3#1)
(ET)##17##1##(1990-12#1)(1990-2#2)(1994-9#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-7#3)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)
(ET-1) is##3##2##(1993-3#2)(2008-4#1)
(ET-1)##9##1##(1991-11#1)(1991-5#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(2008-4#1)
(ETAAS) determination of##3##3##(2008-10#3)
(ETAAS) is##6##2##(2008-10#6)
(ETAAS) method##3##2##(2008-10#3)
(ETAAS)##39##1##(2008-10#39)
(ETEC)##2##1##(1991-8#1)(2008-8#1)
(ETF)##2##1##(1995-2#1)(2011-1#1)
(ETH##2##1##(2008-10#2)
(EU)##5##1##(1996-1#1)(2008-10#2)(2011-2#1)(2013-8#1)
(EUS) in the##2##3##(2008-2#2)
(EUS) is##2##2##(1990-9#1)(2013-1#1)
(EUS)##7##1##(1990-9#1)(2008-2#3)(2010-12#1)(2013-1#2)
(EUV) emission##2##2##(2008-2#1)(2008-3#1)
(EUV) wavelengths##2##2##(2007-11#1)(2008-3#1)
(EUV)##14##1##(2007-11#2)(2008-2#1)(2008-3#11)
(EV71)##3##1##(2008-12#1)(2011-1#1)(2011-3#1)
(EVA)##4##1##(2008-10#2)(2008-11#2)
(EXAFS)##4##1##(1996-2#1)(2008-10#1)(2008-9#1)(2010-11#1)
(Eastern##3##1##(2010-9#1)(2011-2#1)(2013-8#1)
(Eating##2##1##(2011-2#1)(2013-1#1)
(Eds##10##1##(2007-2#7)(2008-12#3)
(Egyptian##3##1##(2008-10#2)(2010-11#1)
(Em)##2##1##(1991-8#1)(2008-8#1)
(Endo##3##1##(1990-11#1)(2008-4#2)
(Endo)##2##1##(1992-3#2)
(Endoloop)##3##1##(1995-1#3)
(England)##3##1##(2007-2#1)(2009-6#1)(2012-12#1)
(English##3##1##(2008-10#1)(2011-1#1)(2012-12#1)
(Enterocytozoon bieneusi) and Cyclospora cayetanensis##2##5##(2007-7#2)
(Epo)##5##1##(1991-12#1)(2008-11#4)
(Er)##2##1##(1990-5#1)(2008-10#1)
(Erwinia##2##1##(2008-10#2)
(Erwinia)##2##1##(1993-3#1)(2008-10#1)
(Escherichia coli##2##2##(2009-8#1)(2010-3#1)
(Escherichia##3##1##(2009-8#1)(2010-3#1)(2012-2#1)
(EtOH)##2##1##(2008-10#1)(2008-8#1)
(Eth)##3##1##(2008-1#1)(2008-10#2)
(Eu##2##1##(2008-10#1)(2008-11#1)
(Eucosma##2##1##(2008-10#1)(2013-1#1)
(Euphorbia##2##1##(2008-10#1)(2011-2#1)
(EuroSCORE##4##1##(2007-8#4)
(European##4##1##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
(Exam##3##1##(2012-2#3)
(Experiment 1)##3##2##(2008-4#1)(2013-1#2)
(Experiment 2)##4##2##(2008-4#1)(2009-2#1)(2013-1#2)
(Experiment##15##1##(2008-4#7)(2008-5#1)(2009-10#1)(2009-2#2)(2013-1#4)
(Experiments##2##1##(2008-5#1)(2011-1#1)
(F = 3##2##3##(2009-11#2)
(F = 4##2##3##(1990-2#1)(2010-9#1)
(F =##8##2##(1990-2#2)(2008-11#1)(2008-5#1)(2009-11#2)(2010-9#2)
(F##21##1##(1990-2#2)(1995-6#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#2)(2010-5#1)(2010-9#2)(2011-2#1)
(F(ST) =##2##2##(2008-10#1)(2013-1#1)
(F(ST)##4##1##(2008-10#2)(2012-3#1)(2013-1#1)
(F) and##2##2##(2008-10#2)
(F) to##2##2##(2008-10#1)(2010-4#1)
(F)##7##1##(1993-6#1)(2007-6#2)(2008-10#3)(2010-4#1)
(F-actin)##5##1##(1994-6#1)(1994-8#1)(1997-6#1)(2008-11#1)(2011-2#1)
(F1 and F3)##2##3##(2008-11#1)(2009-2#1)
(F1##4##1##(2008-10#2)(2008-11#1)(2009-2#1)
(F1)##3##1##(2008-12#1)(2009-2#1)(2010-2#1)
(F2##2##1##(2008-10#1)(2008-12#1)
(F2)##2##1##(2009-2#1)(2010-2#1)
(F3)##2##1##(2009-2#1)(2010-2#1)
(F=0##3##1##(2008-8#3)
(FA) and##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
(FA) has been##2##3##(1993-6#1)(2008-10#1)
(FA)##21##1##(1992-2#1)(1992-8#1)(1993-6#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
(FAAS) after##2##2##(2008-10#2)
(FAAS) and##7##2##(2008-10#7)
(FAAS) at##2##2##(2008-10#2)
(FAAS) was used##2##3##(2008-10#1)(2013-8#1)
(FAAS) was##5##2##(2008-10#4)(2013-8#1)
(FAAS)##58##1##(2008-10#57)(2013-8#1)
(FAB)##5##1##(1995-3#1)(2007-10#1)(2007-2#1)(2008-4#1)(2008-9#1)
(FACE)##4##1##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
(FACS)##4##1##(2008-4#1)(2009-11#1)(2010-8#1)(2011-2#1)
(FAD)##4##1##(1992-12#1)(1996-5#1)(2008-10#1)(2010-2#1)
(FAI)##3##1##(1990-11#2)(1990-8#1)
(FAM-MDR)##2##1##(2012-3#2)
(FAME) profiles##3##2##(2008-10#3)
(FAME)##7##1##(2008-10#6)(2009-3#1)
(FAP)##6##1##(2008-10#1)(2008-11#1)(2008-4#2)(2009-12#2)
(FASD)##2##1##(2008-11#1)(2013-1#1)
(FAT)##3##1##(2011-2#1)(2012-12#1)(2012-3#1)
(FBG)##4##1##(2007-11#2)(2008-10#1)(2008-3#1)
(FBP)##3##1##(1992-3#1)(1995-3#1)(2012-1#1)
(FBR)##2##1##(2008-6#1)(2009-11#1)
(FC)##5##1##(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
(FC))##2##1##(2008-11#2)
(FCM)##6##1##(2008-10#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
(FCPBSQ)##2##1##(2008-10#2)
(FCS)##5##1##(1994-2#1)(2008-11#2)(2008-7#1)(2013-1#1)
(FCU)##2##1##(2009-5#1)(2013-7#1)
(FD) and##2##2##(2008-3#1)(2008-7#1)
(FD)##7##1##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)
(FDC)##2##1##(2009-4#1)(2011-1#1)
(FDG)##2##1##(2008-1#1)(2011-2#1)
(FDP)##2##1##(2008-10#1)(2008-7#1)
(FDTD)##7##1##(2007-11#1)(2008-3#6)
(FE)##6##1##(1994-11#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
(FEP)##3##1##(1993-11#1)(2010-4#1)(2011-1#1)
(FET)##4##1##(1994-2#1)(2008-10#2)(2009-6#1)
(FF)##4##1##(1996-12#1)(2010-1#1)(2010-2#1)(2013-8#1)
(FFA)##4##1##(2007-8#1)(2008-10#2)(2008-6#1)
(FFE)##2##1##(2008-4#1)(2008-5#1)
(FFI)##2##1##(1990-8#1)(2007-11#1)
(FFP)##2##1##(2008-3#1)(2011-1#1)
(FFPE)##2##1##(2012-12#1)(2012-3#1)
(FFS)##12##1##(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#5)(2010-8#1)
(FFT)##6##1##(2007-11#2)(2008-10#1)(2008-3#2)(2009-12#1)
(FG##7##1##(2011-2#1)(2012-2#6)
(FG)##2##1##(1992-12#1)(2012-2#1)
(FGD)##2##1##(2010-8#1)(2011-1#1)
(FGF)##3##1##(1991-2#1)(1994-11#1)(2008-11#1)
(FH)##3##1##(1993-12#1)(2007-10#1)(2008-6#1)
(FHB)##16##1##(2008-10#14)(2011-10#1)(2012-3#1)
(FHL)##2##1##(2009-10#1)(2012-3#1)
(FHP)##2##1##(2009-7#1)(2010-9#1)
(FI) analysis##7##2##(2008-10#7)
(FI) method was developed##2##4##(2008-10#2)
(FI) method##9##2##(2008-10#9)
(FI) system##16##2##(2008-10#16)
(FI)##71##1##(2008-10#71)
(FI-CV-AAS)##2##1##(2008-10#2)
(FI-ICP-MS)##2##1##(2008-10#2)
(FIA) method was##2##3##(2008-10#2)
(FIA) method##3##2##(2008-10#3)
(FIA)##56##1##(2008-10#55)(2008-11#1)
(FID)##6##1##(2008-10#5)(2008-4#1)
(FIP)##2##1##(2008-10#2)
(FISH) and##3##2##(1994-12#1)(1997-2#1)(2011-1#1)
(FISH)##26##1##(1993-12#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
(FITC)##4##1##(2007-2#1)(2008-10#2)(2008-4#1)
(FKBP59)##2##1##(1993-8#2)
(FL)##8##1##(1991-3#1)(1992-9#1)(2008-10#4)(2010-11#2)
(FLAIR)##2##1##(2008-10#1)(2009-11#1)
(FLAP)##2##1##(1993-6#1)(2008-1#1)
(FLC)##3##1##(2008-2#1)(2008-3#1)(2012-3#1)
(FLIM)##3##1##(2007-11#1)(2009-4#1)(2011-1#1)
(FLIP)##3##1##(2008-1#2)(2011-2#1)
(FM)##10##1##(1997-4#1)(1997-8#1)(2007-11#2)(2008-10#2)(2009-11#1)(2010-12#2)(2012-2#1)
(FMD)##3##1##(2009-2#1)(2011-2#1)(2013-1#1)
(FMLP)##3##1##(1993-6#2)(2006-6#1)
(FMOC)##3##1##(2008-10#3)
(FMS)##3##1##(1990-6#1)(2011-2#2)
(FN)##10##1##(1990-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)(2012-5#1)
(FN=31)##2##1##(2008-12#2)
(FNA)##5##1##(2007-5#2)(2008-6#2)(2008-7#1)
(FNAB)##7##1##(1997-2#1)(2008-10#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
(FNAC)##5##1##(1990-6#1)(2007-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
(FOC##3##1##(2008-10#3)
(FP) and##2##2##(1996-1#1)(2009-2#1)
(FP)##10##1##(1996-1#1)(1996-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)
(FPA)##2##1##(1991-3#1)(2008-2#1)
(FPCA)##2##1##(2008-10#1)(2010-7#1)
(FPD)##3##1##(2008-7#1)(2011-1#2)
(FPL)##2##1##(1997-6#1)(2008-9#1)
(FPP)##2##1##(1990-2#1)(1993-9#1)
(FPs)##2##1##(2008-10#1)(2008-6#1)
(FQ)##2##1##(2008-3#1)(2012-3#1)
(FR)##5##1##(2008-1#1)(2008-10#1)(2011-1#1)(2013-8#2)
(FRC)##2##1##(1996-5#1)(2008-8#1)
(FRET) is##2##2##(2008-4#1)(2010-12#1)
(FRET)##16##1##(2008-1#1)(2008-10#3)(2008-4#4)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
(FRS)##2##1##(2011-1#1)(2013-8#1)
(FS) and##2##2##(2008-10#1)(2008-12#1)
(FS)##5##1##(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)
(FSA)##2##1##(1995-12#1)(2012-1#1)
(FSGS)##6##1##(2007-7#1)(2008-1#4)(2012-2#1)
(FSM)##4##1##(2008-1#3)(2013-8#1)
(FSS)##2##1##(2012-3#2)
(FT(4))##2##1##(2007-5#1)(2008-7#1)
(FT)##8##1##(1991-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
(FT-IR) and##2##2##(2008-10#1)(2008-5#1)
(FT-IR)##18##1##(1997-2#1)(2007-12#4)(2008-10#9)(2008-5#1)(2012-2#1)(2013-1#2)
(FT-Raman)##3##1##(2008-10#3)
(FTIR) and##4##2##(2008-10#3)(2008-7#1)
(FTIR) spectroscopy##8##2##(1994-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)
(FTIR)##35##1##(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#21)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2011-1#1)(2013-8#2)
(FTLE##4##1##(2008-10#4)
(FTS)##4##1##(2008-2#2)(2008-3#2)
(FVC##2##1##(2008-7#1)(2013-8#1)
(FVC)##5##1##(1997-3#1)(2007-2#1)(2008-1#1)(2011-2#1)(2012-2#1)
(FWHM of##2##2##(2008-2#1)(2008-3#1)
(FWHM) and the##2##3##(2008-3#2)
(FWHM) and##4##2##(2007-12#1)(2008-3#3)
(FWHM) were##2##2##(2007-12#1)(2008-3#1)
(FWHM)##14##1##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#6)
(FXS) is##2##2##(2009-5#1)(2010-4#1)
(FY)##4##1##(1992-12#1)(1993-12#1)(1996-1#1)(2012-2#1)
(Fabricius)##5##1##(2007-12#1)(2008-6#3)(2010-2#1)
(Family##2##1##(2008-10#1)(2013-1#1)
(Fasciola hepatica)##2##2##(2008-12#2)
(Fasciola##3##1##(2008-12#2)(2013-1#1)
(Fc)##2##1##(1997-7#1)(2008-10#1)
(Fe##3##1##(2008-10#2)(2010-11#1)
(Fe)##5##1##(1995-3#1)(1996-2#1)(2008-10#3)
(Fe- and Mn-TCPP(g)s)##2##3##(2008-10#2)
(Fe- and##3##2##(2008-10#3)
(February##2##1##(2008-5#1)(2009-2#1)
(Felis##3##1##(1996-12#3)
(Ficedula##2##1##(2008-8#1)(2008-9#1)
(Fig 1)##2##2##(1994-8#2)
(Fig##13##1##(1994-3#3)(1994-8#2)(2008-10#2)(2008-7#1)(2008-9#5)
(Figure 1)##2##2##(1995-3#1)(2012-3#1)
(Figure##5##1##(1995-3#1)(1995-9#1)(2008-5#1)(2012-3#1)(2013-1#1)
(Filtek##2##1##(2008-12#2)
(First##2##1##(2011-3#1)(2013-1#1)
(Fisher##2##1##(1991-7#1)(2011-2#1)
(Fisher's Exact##2##2##(2008-9#2)
(Fisher's##3##1##(2008-9#2)(2010-8#1)
(Florida##2##1##(2007-5#2)
(Forensic##2##1##(1995-2#2)
(Form##2##1##(2008-6#1)(2008-8#1)
(Forsskal)##2##1##(2009-5#2)
(Fourier) transform correlator##2##3##(2008-2#2)
(France) and##2##2##(2008-10#1)(2008-5#1)
(France)##10##1##(1990-8#1)(2008-10#7)(2008-3#1)(2008-5#1)
(French##2##1##(1992-3#1)(2008-5#1)
(Friedman test##2##2##(2010-9#2)
(Fuhrmann##2##1##(2011-2#2)
(Fusarium##7##1##(2008-10#7)
(G protein)##3##2##(1993-6#1)(1993-8#1)(2008-3#1)
(G##19##1##(1990-8#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-8#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)
(G(ST) = 0##7##3##(2008-10#7)
(G(ST))##3##1##(2008-10#3)
(G)##16##1##(1993-11#1)(1994-8#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)(2013-1#1)
(G1 and##2##2##(1997-6#1)(2008-10#1)
(G1##5##1##(1994-9#2)(1997-6#1)(2008-10#1)(2008-11#1)
(G1) and##2##2##(1993-8#1)(1994-6#1)
(G1)##3##1##(1993-8#1)(1994-6#1)(2008-12#1)
(G143A)##3##1##(2008-10#3)
(G2)##3##1##(1993-8#1)(1994-6#1)(2008-12#1)
(G3)##3##1##(1991-6#1)(2008-12#2)
(G4)##3##1##(1994-6#1)(2008-12#2)
(G418)##2##1##(1993-2#1)(2008-11#1)
(G6PD)##2##1##(1991-6#1)(2007-12#1)
(GA) and##3##2##(2008-3#1)(2008-6#1)(2008-8#1)
(GA) to##2##2##(2008-3#1)(2008-9#1)
(GA)##20##1##(1993-12#1)(1994-5#1)(2008-10#9)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)
(GAC)##2##1##(1992-5#1)(2013-1#1)
(GAD)##3##1##(1996-5#1)(2008-8#1)(2013-1#1)
(GAD67##2##1##(1996-12#1)(2013-8#1)
(GAF)##2##1##(1991-2#1)(1992-3#1)
(GAG)##4##1##(1990-8#1)(1991-8#1)(1992-9#1)(2012-3#1)
(GALAS)]##2##1##(2012-1#2)
(GAP)##6##1##(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1995-11#1)(2013-1#1)
(GAP-43)##2##1##(1993-12#1)(2008-11#1)
(GAPDH)##7##1##(1990-7#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-6#1)(2009-10#1)
(GARP)##3##1##(2008-8#3)
(GARS)##2##1##(1993-12#1)(2008-1#1)
(GAS)##3##1##(2007-8#1)(2008-11#1)(2008-8#1)
(GAU)##2##1##(2008-7#2)
(GB)##2##1##(2009-12#1)(2013-8#1)
(GBM)##4##1##(2007-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
(GBP)##2##1##(1992-6#1)(2008-10#1)
(GBS)##4##1##(2008-6#1)(2008-7#2)(2012-3#1)
(GBW##5##1##(2008-10#5)
(GC##9##1##(1994-12#1)(2008-10#6)(2008-11#1)(2010-3#1)
(GC) analysis was##2##3##(2008-10#1)(2010-5#1)
(GC) analysis##3##2##(2008-10#2)(2010-5#1)
(GC) and##3##2##(1993-12#1)(1997-1#1)(2008-10#1)
(GC) were##2##2##(2008-10#1)(2012-2#1)
(GC)##54##1##(1990-9#1)(1991-9#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#2)(2012-2#2)(2013-1#1)
(GC-ECD)##7##1##(2008-10#6)(2011-1#1)
(GC-FID)##2##1##(2008-5#1)(2012-1#1)
(GC-MS) in##3##2##(2008-10#3)
(GC-MS)##34##1##(1990-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-10#23)(2008-4#1)(2008-5#1)(2012-1#2)
(GC/MS)##7##1##(1995-11#1)(2008-10#5)(2013-1#1)
(GC/MS/MS)##2##1##(2008-10#2)
(GCC)##3##1##(1997-8#2)(2009-9#1)
(GCS)##7##1##(1991-2#1)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
(GCV)##2##1##(2008-10#1)(2013-2#1)
(GCs)##6##1##(2008-11#1)(2008-7#2)(2009-4#2)(2012-2#1)
(GD) and##2##2##(1995-2#1)(2010-2#1)
(GD)##8##1##(1995-2#1)(2007-8#1)(2008-10#4)(2010-2#1)(2013-8#1)
(GDC)##5##1##(1995-11#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-7#1)
(GDI)##3##1##(1991-2#1)(1996-10#1)(2013-1#1)
(GDM) and##2##2##(2011-2#1)(2013-1#1)
(GDM)##7##1##(2008-1#3)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
(GDP)##4##1##(1991-2#1)(1993-3#1)(1996-2#1)(2013-1#1)
(GE##2##1##(1990-2#1)(2010-3#1)
(GEE)##2##1##(1995-2#1)(1995-9#1)
(GEP)##4##1##(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
(GER)##2##1##(2008-10#1)(2009-3#1)
(GF)##2##1##(2008-7#1)(2013-1#1)
(GFAAS) and##2##2##(2008-10#2)
(GFAAS)##29##1##(2008-10#29)
(GFAP) and##2##2##(1997-3#1)(2011-2#1)
(GFAP)##7##1##(1990-7#1)(1994-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2011-2#1)
(GFD)##2##1##(1990-12#1)(2011-2#1)
(GFP##2##1##(2008-11#2)
(GFP)##27##1##(1996-6#1)(1997-4#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#2)(2011-2#1)(2011-3#1)(2013-8#1)
(GGGTCAT)n##2##1##(1993-12#2)
(GGT)##5##1##(1994-12#1)(1995-12#1)(2006-6#1)(2009-6#1)(2010-4#1)
(GH)##26##1##(1990-12#2)(1991-12#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-3#2)(2008-4#3)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
(GHD)##4##1##(2008-1#1)(2008-4#1)(2011-1#1)(2012-3#1)
(GHQ-12)##2##1##(2008-11#1)(2011-1#1)
(GI)##15##1##(1991-2#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(GIFT)##2##1##(1996-9#1)(2009-6#1)
(GIQE)##2##1##(2008-2#1)(2008-3#1)
(GIS) analysis##2##2##(2007-5#2)
(GIS)##7##1##(2007-5#2)(2008-10#1)(2008-8#2)(2010-2#1)(2011-2#1)
(GIST)##5##1##(2008-6#2)(2008-7#1)(2009-7#1)(2012-3#1)
(GISTs)##4##1##(2008-6#1)(2012-12#1)(2013-1#1)(2013-7#1)
(GL)##6##1##(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
(GLA)##3##1##(2008-5#1)(2008-7#1)(2008-8#1)
(GLF)##2##1##(1996-7#1)(2008-10#1)
(GLM)##2##1##(2008-10#1)(2009-6#1)
(GLP-1)##3##1##(1995-8#1)(1996-2#1)(2012-3#1)
(GLRaV-5)##2##1##(2008-10#2)
(GLS)##6##1##(1992-6#1)(2008-10#5)
(GLUT4)##4##1##(1990-8#1)(1994-11#2)(2008-11#1)
(GM)##5##1##(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-4#1)
(GME)##2##1##(2008-1#1)(2008-11#1)
(GMM)##3##1##(2009-7#1)(2012-3#1)(2013-1#1)
(GMR)##2##1##(2008-1#1)(2012-3#1)
(GMS)##3##1##(2008-1#1)(2008-11#1)(2008-8#1)
(GN)##10##1##(1997-8#1)(2007-7#1)(2008-1#6)(2008-10#1)(2011-1#1)
(GNP)##3##1##(2007-7#1)(2008-10#1)(2013-1#1)
(GO) and##2##2##(1997-7#1)(2008-9#1)
(GO) terms##2##2##(2010-4#1)(2010-5#1)
(GO)##11##1##(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
(GOCCNE)##2##1##(1991-4#2)
(GOME)##2##1##(2008-2#1)(2008-3#1)
(GOT)##2##1##(2008-11#1)(2008-7#1)
(GP##2##1##(2007-12#1)(2008-10#1)
(GP) and##2##2##(1995-3#1)(2011-2#1)
(GP)##7##1##(1990-9#1)(1993-3#1)(1993-6#1)(1995-3#1)(2007-12#1)(2011-1#1)(2011-2#1)
(GPA)##2##1##(1993-12#1)(2009-7#1)
(GPC)##9##1##(2007-11#2)(2008-10#1)(2008-12#3)(2009-2#1)(2010-2#1)(2011-1#1)
(GPCR)##2##1##(1995-8#1)(2008-7#1)
(GPI)##6##1##(1990-8#1)(1995-3#1)(1996-3#1)(1997-6#1)(2008-9#1)(2012-2#1)
(GPIIIa##4##1##(1997-7#4)
(GPIIb-IIIa)##2##1##(2006-6#2)
(GPL)##2##1##(1992-12#1)(1992-3#1)
(GPO)##2##1##(2007-9#1)(2008-10#1)
(GPS)##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
(GPT)##3##1##(2008-11#2)(2008-7#1)
(GPU)##4##1##(2008-6#1)(2009-6#1)(2011-1#1)(2012-2#1)
(GPX)##3##1##(2008-10#1)(2010-5#1)(2013-8#1)
(GR) and##2##2##(2008-12#1)(2011-2#1)
(GR)##9##1##(1994-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-2#3)(2013-1#1)
(GRIN)##3##1##(2007-12#1)(2008-3#2)
(GRP)##2##1##(1992-6#1)(1997-7#1)
(GS##3##1##(1993-12#1)(2011-2#1)(2012-2#1)
(GS) in the##2##3##(2008-11#1)(2010-8#1)
(GS) was##2##2##(2008-7#1)(2010-11#1)
(GS)##11##1##(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#3)(2010-11#1)(2010-8#1)(2011-2#1)
(GSC)##3##1##(2008-10#2)(2011-2#1)
(GSD)##2##1##(2010-3#1)(2012-2#1)
(GSH and##2##2##(2011-1#1)(2013-1#1)
(GSH##3##1##(1992-12#1)(2011-1#1)(2013-1#1)
(GSH) and##6##2##(1991-9#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
(GSH)##33##1##(1990-12#1)(1990-2#2)(1991-9#3)(1992-9#1)(1993-8#1)(1994-2#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)
(GSI)##3##1##(1994-3#1)(2008-12#1)(2008-7#1)
(GSM)##5##1##(2007-11#2)(2008-3#1)(2008-9#1)(2009-6#1)
(GSNO)##2##1##(1995-5#1)(1997-4#1)
(GSSG)##5##1##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
(GST) activities##2##2##(2008-4#1)(2011-10#1)
(GST) activity##2##2##(1994-2#1)(2008-7#1)
(GST)##16##1##(1990-2#1)(1991-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1997-7#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
(GST-P)##3##1##(1992-3#1)(1992-6#1)(2008-4#1)
(GSTs)##2##1##(2008-11#1)(2008-7#1)
(GT) is##2##2##(2006-6#1)(2008-9#1)
(GT)##5##1##(2006-6#1)(2008-5#2)(2008-9#1)(2009-5#1)
(GT1b)13BSA binding##3##2##(1994-12#3)
(GT1b)13BSA##5##1##(1994-12#5)
(GTC)##2##1##(1997-8#2)
(GTCGAC)##2##1##(1991-9#2)
(GTH-II)##2##1##(1994-8#1)(2008-5#1)
(GTP gamma S##2##3##(1991-6#1)(1992-8#1)
(GTP gamma S) and##2##4##(1990-8#1)(1993-8#1)
(GTP gamma S)##5##3##(1990-8#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-8#1)
(GTP gamma##7##2##(1990-8#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-3#1)(1995-8#1)
(GTP)##5##1##(1991-9#1)(1992-6#1)(1995-5#1)(1996-5#1)(2008-3#1)
(GUS) activity of##2##3##(2008-10#1)(2008-5#1)
(GUS) activity##4##2##(2008-10#3)(2008-5#1)
(GUS) gene##2##2##(2008-10#1)(2008-9#1)
(GUS)##9##1##(2008-10#7)(2008-5#1)(2008-9#1)
(GV)##2##1##(2008-9#1)(2013-1#1)
(GWAS)##3##1##(2009-4#1)(2010-12#1)(2011-2#1)
(GY)##2##1##(2008-11#1)(2008-12#1)
(Galicia##3##1##(2008-10#2)(2010-5#1)
(Gallus gallus)##2##2##(1997-3#1)(2010-4#1)
(Gallus##5##1##(1997-3#1)(2008-12#2)(2008-5#1)(2010-4#1)
(Gastropoda##2##1##(2008-5#1)(2011-2#1)
(Gd and Tb) separation##2##4##(2008-10#2)
(Gd)##3##1##(1997-8#2)(2012-2#1)
(Gd-DTPA)##3##1##(1990-2#1)(2008-10#1)(2009-6#1)
(GenBank accession number##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
(GenBank accession##4##2##(2008-10#2)(2008-9#1)(2011-1#1)
(GenBank##5##1##(1994-9#1)(2008-10#2)(2008-9#1)(2011-1#1)
(General##2##1##(2008-3#1)(2011-3#1)
(German##2##1##(2008-11#1)(2008-4#1)
(Germany)##3##1##(2008-10#1)(2008-11#2)
(Glaxo Wellcome##2##2##(2008-5#2)
(Glaxo##3##1##(2008-5#3)
(Globodera rostochiensis and G##3##4##(2008-10#3)
(Glu)##4##1##(1991-5#1)(1992-6#1)(1997-2#1)(2008-10#1)
(GluRS##2##1##(1994-8#2)
(Glx)3##2##1##(1992-12#2)
(Glycine Max)##2##2##(2010-11#2)
(Glycine max (L##2##3##(2011-2#2)
(Glycine max##5##2##(1990-5#1)(1997-6#1)(2008-12#1)(2011-2#2)
(Glycine max)##12##2##(1990-7#1)(1991-12#1)(2008-10#7)(2008-11#1)(2013-1#2)
(Glycine##20##1##(1990-5#1)(1990-7#1)(1991-12#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#2)(2011-2#2)(2013-1#2)
(GnRH) in##2##2##(1992-6#1)(2009-6#1)
(GnRH)##11##1##(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1996-2#1)(2008-5#1)(2008-6#1)(2009-6#1)
(Gossypium hirsutum L##3##3##(1993-3#1)(2011-2#2)
(Gossypium##9##1##(1993-3#1)(2008-10#4)(2008-9#1)(2011-2#3)
(Gr##5##1##(2008-10#5)
(Grade##3##1##(2007-8#1)(2008-10#1)(2009-12#1)
(Gram negative##2##2##(1997-3#1)(2010-10#1)
(Gram##4##1##(1997-3#1)(2008-5#1)(2010-10#2)
(Green##4##1##(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
(Group I##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
(Group I)##3##2##(2007-7#1)(2007-9#1)(2013-1#1)
(Group II)##3##2##(2007-7#1)(2007-9#1)(2013-1#1)
(Group##19##1##(1990-5#1)(1992-11#2)(2007-7#4)(2007-9#2)(2008-10#1)(2010-12#3)(2010-7#3)(2012-2#1)(2013-1#2)
(Gs##3##1##(1994-2#1)(1995-6#1)(2008-7#1)
(Guillain-Barré syndrome)##2##2##(1995-5#1)(2008-7#1)
(Gyllenhal)##2##1##(2011-2#2)
(H = 0##2##3##(2008-10#2)
(H =##3##2##(1995-2#1)(2008-10#2)
(H##13##1##(1991-2#1)(1995-2#1)(2008-10#6)(2008-5#1)(2009-9#2)(2011-2#1)(2013-8#1)
(H')##2##1##(2008-8#1)(2013-7#1)
(H(+)##2##1##(2008-10#2)
(H(+)-ISE)##2##1##(2008-10#2)
(H(0)##2##1##(2008-10#2)
(H(2)dmg =##2##2##(1997-7#2)
(H(S) = 0##3##3##(2008-10#3)
(H(T) = 0##2##3##(2008-10#2)
(H(o)##2##1##(2008-10#2)
(H) and##2##2##(2008-10#1)(2008-5#1)
(H) were##2##2##(2008-12#1)(2008-5#1)
(H)##23##1##(1993-12#1)(1995-6#1)(2007-10#1)(2008-10#12)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2011-2#1)
(H-2b)##2##1##(1990-3#1)(1995-2#1)
(H-7)##4##1##(1993-8#1)(1995-8#1)(1996-12#1)(1997-1#1)
(H-H)##2##1##(2008-12#1)(2010-4#1)
(H1##3##1##(1994-8#2)(2011-2#1)
(H120)##2##1##(2008-5#1)(2010-4#1)
(H1N1) 2009##11##2##(2010-2#1)(2011-1#1)(2011-2#7)(2013-1#2)
(H1N1)##20##1##(1990-5#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
(H2S)##2##1##(2008-6#1)(2013-8#1)
(H7)##3##1##(1990-8#1)(1994-6#1)(1997-9#1)
(HA) and##6##2##(2007-8#1)(2008-10#3)(2008-9#1)(2013-8#1)
(HA) are##2##2##(2008-10#1)(2013-8#1)
(HA) is##3##2##(2009-7#1)(2010-8#1)(2011-2#1)
(HA)##35##1##(1990-5#1)(1993-12#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#3)
(HAA)##4##1##(1994-6#1)(1997-2#1)(2008-10#1)(2009-10#1)
(HAART)##12##1##(2007-7#2)(2008-11#1)(2008-3#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)
(HAD)##3##1##(2008-10#1)(2008-2#1)(2011-1#1)
(HAE)##2##1##(1996-12#1)(2013-1#1)
(HAI-RTP)##2##1##(2008-10#2)
(HAP)##3##1##(1994-8#1)(2008-10#1)(2012-2#1)
(HAV)##6##1##(2007-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-12#1)
(HB) and##2##2##(2008-1#1)(2008-8#1)
(HB)##4##1##(2008-1#1)(2008-10#1)(2008-8#2)
(HBD-2 and IL-6) and##2##4##(2011-3#2)
(HBO)##2##1##(1993-12#1)(2007-8#1)
(HBS)##3##1##(2008-10#2)(2010-5#1)
(HBV) in##2##2##(2012-3#1)(2013-1#1)
(HBV)##40##1##(1990-8#1)(1991-11#1)(1993-8#1)(1995-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#3)
(HBr)##2##1##(1996-12#1)(2008-10#1)
(HBsAg)##12##1##(1994-11#2)(1995-2#1)(1997-4#2)(1997-6#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
(HC) of##2##2##(2008-10#2)
(HC)##13##1##(1991-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
(HC-Pro) of##2##2##(2008-10#2)
(HC-Pro)##5##1##(2008-10#5)
(HCA)##2##1##(2009-8#1)(2013-1#1)
(HCB)##3##1##(2008-10#2)(2008-11#1)
(HCC)##24##1##(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#3)(2010-12#2)(2011-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
(HCFA)##20##1##(1992-2#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#4)(1996-3#1)(1997-2#5)(1997-3#1)
(HCN)##4##1##(1996-12#2)(2008-10#1)(2012-2#1)
(HCP)##2##1##(2008-10#1)(2013-1#1)
(HCQ)##2##1##(2012-3#2)
(HCS)##2##1##(2008-10#1)(2008-9#1)
(HCT)##3##1##(2008-10#1)(2008-8#1)(2010-11#1)
(HCV) infection in##2##3##(2006-10#1)(2008-1#1)
(HCV) infection##10##2##(2006-10#1)(2007-7#2)(2008-1#2)(2009-8#1)(2012-2#1)(2013-1#3)
(HCV)##37##1##(1990-3#1)(1994-8#1)(2006-10#1)(2007-7#5)(2008-1#6)(2008-10#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#7)(2013-8#1)
(HCl or##2##2##(2008-10#2)
(HCl##6##1##(1991-5#1)(2008-10#4)(2008-3#1)
(HCl)##7##1##(1996-12#1)(2008-10#5)(2013-1#1)
(HClO(4))##2##1##(2008-10#2)
(HCs)##2##1##(1992-3#1)(2012-3#1)
(HD##5##1##(1995-12#3)(2008-10#1)(2011-2#1)
(HD) and##5##2##(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-2#1)
(HD) can be##2##3##(2011-2#1)(2013-1#1)
(HD) in##2##2##(1993-9#1)(2008-10#1)
(HD) patients in the##2##4##(2007-7#1)(2008-1#1)
(HD) patients##9##2##(2007-7#3)(2008-1#5)(2012-12#1)
(HD) was##2##2##(2008-7#1)(2011-2#1)
(HD)##45##1##(1992-8#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-8#1)(2007-12#1)(2007-7#10)(2007-8#2)(2008-1#10)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-10#1)(2011-2#6)(2011-8#1)(2012-12#1)(2013-1#1)
(HDC)##4##1##(1990-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
(HDL)##20##1##(1991-12#2)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#3)
(HDPE)##3##1##(2008-10#1)(2008-3#1)(2009-3#1)
(HDR)##3##1##(2007-11#1)(2009-11#1)(2013-1#1)
(HEBB)##2##1##(2008-11#2)
(HEC)##4##1##(1994-2#1)(2008-3#1)(2008-5#2)
(HEI)##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
(HEK293) were##2##2##(2008-11#2)
(HEK293)##4##1##(2008-11#3)(2008-4#1)
(HEL)##7##1##(1990-12#2)(1990-2#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)
(HER2)##2##1##(2008-11#1)(2009-9#1)
(HES)##3##1##(2007-7#1)(2012-1#1)(2012-12#1)
(HF) and##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
(HF)##19##1##(1992-10#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-8#3)
(HFA)##3##1##(1996-2#1)(2008-10#1)(2008-2#1)
(HFAs)##2##1##(1996-1#1)(2011-1#1)
(HFS)##2##1##(2008-12#1)(2008-7#1)
(HG) or##2##2##(2008-10#1)(2011-2#1)
(HG) were##2##2##(2008-10#2)
(HG)##14##1##(1993-11#1)(2008-10#11)(2008-11#1)(2011-2#1)
(HG-AFS)##5##1##(2008-10#5)
(HGAAS)##5##1##(2008-10#5)
(HGAFS)##4##1##(2008-10#4)
(HGF)##7##1##(1990-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
(HHT)##2##1##(1994-8#1)(2008-1#1)
(HI)##10##1##(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-5#1)(2013-1#1)
(HIA)##2##1##(2007-11#1)(2013-1#1)
(HIC)##5##1##(1991-9#1)(2008-10#2)(2011-1#1)(2013-1#1)
(HIS)##5##1##(1993-12#1)(2012-12#4)
(HIV) and##4##2##(2007-2#1)(2008-12#1)(2008-5#1)(2011-2#1)
(HIV) infection##9##2##(1990-3#1)(1993-12#1)(1996-9#1)(1997-8#1)(2007-7#1)(2008-2#1)(2008-8#1)(2009-8#1)(2013-8#1)
(HIV)##50##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#6)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
(HIV)-infected##2##1##(2008-3#1)(2012-12#1)
(HIV-1)##19##1##(1990-2#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(2007-7#1)(2008-11#1)(2008-2#8)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)
(HK) with##2##2##(1990-5#1)(2010-10#1)
(HK)##3##1##(1990-5#1)(1992-2#1)(2010-10#1)
(HL) in##2##2##(1991-2#1)(2008-7#1)
(HL)##7##1##(1990-12#1)(1991-2#2)(1992-12#1)(1994-8#1)(2008-10#1)(2008-7#1)
(HLA)##6##1##(1990-12#1)(2008-1#1)(2008-10#4)
(HLB)##2##1##(2008-10#2)
(HLH)##4##1##(1994-12#1)(2011-2#2)(2012-3#1)
(HM)##6##1##(1990-6#1)(2008-10#4)(2008-9#1)
(HMB)##2##1##(2008-10#1)(2008-5#1)
(HMC-1)##2##1##(2011-2#2)
(HMDE)##15##1##(2008-10#15)
(HMF)##4##1##(1996-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
(HMG)##3##1##(1990-3#1)(1995-8#1)(1997-6#1)
(HMG-CoA)##2##1##(1990-8#1)(1993-6#1)
(HMM)##4##1##(1996-12#1)(1997-2#1)(2008-7#1)(2009-7#1)
(HMOs) have##3##2##(1991-3#1)(1993-3#1)(1994-12#1)
(HMOs)##13##1##(1991-1#1)(1991-3#3)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-3#1)
(HMP)##2##1##(1993-3#1)(2008-10#1)
(HMTA)##2##1##(2008-10#1)(2013-1#1)
(HMX)##4##1##(2008-10#4)
(HN) gene##2##2##(2008-11#1)(2008-9#1)
(HN) protein##2##2##(2007-6#1)(2008-9#1)
(HN)##6##1##(2007-6#2)(2008-11#1)(2008-7#1)(2008-9#2)
(HNE) or##2##2##(1996-12#1)(2008-10#1)
(HNE)##4##1##(1996-12#1)(2008-10#1)(2008-5#2)
(HNO(3)) and##3##2##(2008-10#3)
(HNSCC)##2##1##(1997-7#1)(2013-8#1)
(HO##2##1##(1995-2#1)(2008-5#1)
(HO)##6##1##(1991-6#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-4#1)(2012-2#1)
(HOE)##2##1##(2008-3#2)
(HOMA-IR)##8##1##(2008-3#2)(2010-4#1)(2011-1#3)(2012-3#1)(2013-8#1)
(HP##2##1##(1995-3#1)(1996-5#1)
(HP) and##2##2##(1991-5#1)(1996-12#1)
(HP)##7##1##(1990-5#1)(1991-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
(HP-beta-CD)##2##1##(2008-10#2)
(HP1)##2##1##(1994-6#1)(2008-6#1)
(HPA) and##2##2##(1991-1#1)(2008-10#1)
(HPA) axis##6##2##(1990-3#1)(1994-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
(HPA)##10##1##(1990-3#1)(1990-7#1)(1991-1#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
(HPB)##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
(HPC)##2##1##(1992-5#1)(2008-10#1)
(HPD)##4##1##(1992-6#1)(1997-1#1)(2008-3#1)(2013-1#1)
(HPG)##2##1##(1994-2#1)(1995-2#1)
(HPI)##3##1##(1992-12#1)(1996-2#1)(2008-7#1)
(HPLC) analysis##2##2##(1997-6#1)(2008-10#1)
(HPLC) and##13##2##(1992-2#1)(1992-8#1)(2008-10#6)(2008-12#1)(2009-8#1)(2010-2#2)(2011-1#1)
(HPLC) method for simultaneous determination of##2##6##(2008-10#1)(2008-5#1)
(HPLC) method for##3##3##(2008-10#1)(2008-5#2)
(HPLC) method has been developed for the simultaneous determination of##2##10##(1990-8#1)(2008-10#1)
(HPLC) method is described for the##2##6##(2008-10#2)
(HPLC) method with fluorescence detection##2##5##(1996-5#1)(2008-10#1)
(HPLC) method with##4##3##(1996-5#1)(2008-10#3)
(HPLC) method##15##2##(1990-8#2)(1996-5#1)(2008-10#9)(2008-5#2)(2011-2#1)
(HPLC) methods##2##2##(2008-10#1)(2011-1#1)
(HPLC)##130##1##(1990-8#6)(1991-5#3)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-10#80)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#7)(2008-6#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#1)
(HPLC-ICPMS)##2##1##(2008-10#2)
(HPMC)##2##1##(2008-10#1)(2011-1#1)
(HPSAM) for##3##2##(2008-10#3)
(HPSAM)##11##1##(2008-10#11)
(HPTP)##2##1##(1996-12#2)
(HPV) are##2##2##(2011-1#1)(2013-7#1)
(HPV) infection##4##2##(1991-2#1)(1992-2#1)(1992-3#1)(2011-2#1)
(HPV)##15##1##(1991-2#2)(1992-2#1)(1992-3#1)(1994-1#1)(1996-12#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
(HQ)##5##1##(1992-3#1)(2008-10#4)
(HR = 2##3##3##(2013-1#1)(2013-8#2)
(HR##13##1##(1995-6#1)(1996-5#1)(2007-10#1)(2008-10#1)(2009-3#1)(2012-6#1)(2013-1#5)(2013-8#2)
(HR) and##6##2##(1992-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
(HR) at##2##2##(2008-10#1)(2008-3#1)
(HR) in##3##2##(1991-2#1)(2008-10#2)
(HR) on##2##2##(2008-10#2)
(HR)##39##1##(1990-5#1)(1991-2#1)(1992-12#1)(2007-11#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#5)
(HRCT)##7##1##(1991-12#2)(2007-8#2)(2008-7#1)(2011-2#2)
(HRQOL)##2##1##(2008-7#1)(2011-2#1)
(HRT)##7##1##(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(HRV) analysis##2##2##(2009-11#1)(2011-1#1)
(HRV) in##3##2##(2008-12#1)(2008-6#1)(2013-8#1)
(HRV)##9##1##(2008-12#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
(HRdown)##2##1##(2013-1#2)
(HRup) or##2##2##(2013-1#2)
(HS) and##4##2##(2008-10#3)(2013-8#1)
(HS)##21##1##(1991-12#1)(1991-9#1)(1994-11#1)(1995-2#1)(1996-2#1)(2008-10#11)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
(HS-SPME)##7##1##(2008-10#6)(2012-1#1)
(HSA) and##6##2##(1994-8#1)(2008-10#5)
(HSA) was##3##2##(2008-10#3)
(HSA)##24##1##(1994-8#1)(1994-9#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#18)(2011-2#1)
(HSC)##3##1##(1991-2#1)(2008-10#1)(2008-11#1)
(HSCT)##5##1##(2006-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
(HSCs) are##2##2##(2009-12#1)(2010-11#1)
(HSCs)##8##1##(1993-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-11#1)
(HSDB)##2##1##(1995-11#2)
(HSE)##3##1##(1994-8#1)(1995-5#1)(2010-2#1)
(HSF)##3##1##(1995-11#1)(2008-5#1)(2010-2#1)
(HSG)##3##1##(1993-1#1)(2011-2#2)
(HSGC)##2##1##(2008-10#2)
(HSI)##2##1##(2008-5#1)(2009-7#1)
(HSP 70)##2##2##(1996-9#1)(2008-10#1)
(HSP##3##1##(1991-2#1)(1996-9#1)(2008-10#1)
(HSP)##7##1##(1993-8#1)(1994-11#3)(1994-12#1)(2008-7#1)(2013-1#1)
(HSP70)##4##1##(1993-9#1)(2008-10#1)(2008-7#1)(2010-5#1)
(HSP90)##2##1##(1994-12#1)(1994-8#1)
(HSPs)##4##1##(1991-9#1)(2008-12#1)(2008-4#1)(2008-7#1)
(HSR)##2##1##(1992-3#1)(2010-2#1)
(HSV)##6##1##(1996-12#1)(1996-6#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
(HSV-1)##4##1##(1994-11#1)(2007-12#1)(2008-10#2)
(HSV-2)##2##1##(2008-10#1)(2013-8#1)
(HT)##6##1##(2008-11#1)(2008-8#2)(2011-2#2)(2013-8#1)
(HTA)##2##1##(1992-8#1)(2012-12#1)
(HTH)##2##1##(1992-4#1)(1996-5#1)
(HTLV-1)##3##1##(2011-2#1)(2012-12#2)
(HTLV-I)##3##1##(1991-12#1)(2008-11#1)(2008-4#1)
(HTN)##2##1##(2008-7#1)(2010-4#1)
(HTS)##6##1##(2008-10#2)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
(HU)##5##1##(1994-11#1)(1997-8#1)(2008-10#2)(2012-3#1)
(HUVEC)##11##1##(1993-11#1)(1994-8#1)(1997-1#1)(2008-11#1)(2008-8#2)(2008-9#2)(2010-3#1)(2012-2#1)(2013-8#1)
(HV)##3##1##(2008-10#1)(2010-6#1)(2011-2#1)
(HVA)##5##1##(1992-7#1)(1993-1#1)(1995-3#1)(2008-3#1)(2009-5#1)
(HX)##4##1##(1990-5#1)(1993-12#1)(2008-10#1)(2008-11#1)
(Hashimoto##2##1##(1996-2#1)(2008-6#1)
(Hb A)##2##2##(1990-8#1)(1992-3#1)
(Hb##8##1##(1990-11#1)(1990-8#1)(1992-3#1)(2008-7#4)(2011-2#1)
(Hb) was##3##2##(1990-2#1)(1991-2#1)(1995-11#1)
(Hb)##22##1##(1990-2#1)(1990-7#1)(1990-8#2)(1991-2#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-7#3)(2008-8#1)
(HbA1c) levels##2##2##(2007-10#1)(2012-5#1)
(HbF)##3##1##(2008-10#1)(2009-3#1)(2009-4#1)
(Hct)##5##1##(1994-12#1)(1994-6#1)(2008-1#1)(2008-12#1)(2011-3#1)
(Health##5##1##(1991-2#1)(1995-12#1)(2007-12#1)(2008-7#1)(2008-9#1)
(Helianthus annuus L##2##3##(2008-10#2)
(Helianthus annuus)##3##2##(2008-10#3)
(Helianthus##7##1##(2008-10#5)(2008-8#2)
(Hemiptera##22##1##(2007-12#6)(2008-12#1)(2008-6#4)(2008-7#2)(2011-2#6)(2013-7#1)(2013-8#2)
(HepG2)##2##1##(1990-5#1)(1993-6#1)
(Herceptin)##4##1##(2007-10#1)(2008-10#1)(2009-2#1)(2011-1#1)
(Heteroptera##5##1##(2007-12#1)(2008-5#2)(2011-2#2)
(Hexapeptide##2##1##(1992-12#2)
(Hg##4##1##(2008-10#4)
(Hg)##6##1##(1993-8#1)(1995-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
(Hg2+)##2##1##(1993-12#2)
(Hi)##2##1##(2008-5#2)
(High Fivetrade mark)##2##3##(2008-11#1)(2008-7#1)
(High Fivetrade##3##2##(2008-11#1)(2008-7#2)
(High##7##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)
(His)##2##1##(1994-11#1)(2008-10#1)
(Ho)##2##1##(2008-5#1)(2013-8#1)
(Holland##2##1##(1997-3#1)(2008-11#1)
(Homoptera##5##1##(2007-12#2)(2008-10#1)(2008-12#1)(2008-9#1)
(Hordeum vulgare)##3##2##(2008-10#2)(2008-8#1)
(Hordeum##10##1##(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)
(Hospital##9##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(2007-10#1)
(HpD)##3##1##(1990-6#1)(2008-7#1)(2008-9#1)
(Hs = 0##4##3##(2008-10#4)
(Hx)##4##1##(1994-8#1)(2008-10#3)
(Hyla##2##1##(2009-9#2)
(Hymenoptera##35##1##(1992-6#1)(2007-12#7)(2008-5#5)(2008-6#15)(2008-7#1)(2009-8#1)(2010-2#2)(2011-2#2)(2013-8#1)
(Hübner) (Lepidoptera##2##2##(2008-6#1)(2011-2#1)
(Hübner)##5##1##(2008-12#1)(2008-6#1)(2011-2#3)
(I =##2##2##(1990-8#1)(1997-7#1)
(I and II) of##2##4##(2008-10#2)
(I and II)##6##3##(2007-12#1)(2008-10#4)(2011-2#1)
(I##30##1##(1990-5#1)(1990-6#1)(1990-8#1)(1994-7#1)(1994-9#1)(1997-7#3)(2007-12#1)(2008-10#15)(2008-2#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#2)
(I(d))##2##1##(2008-10#2)
(I) and##13##2##(1991-2#1)(1991-5#2)(1994-9#1)(2007-11#1)(2008-10#7)(2009-3#1)
(I) as an##2##3##(2008-10#2)
(I) as electroactive material##2##4##(2008-10#2)
(I) as##6##2##(2008-10#6)
(I) was##5##2##(1994-12#1)(2008-10#4)
(I) with##4##2##(2008-10#4)
(I)##86##1##(1991-12#1)(1991-2#3)(1991-5#7)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#1)(2008-10#43)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-3#1)(2010-11#6)(2011-1#1)(2013-7#1)
(I-IV)##2##1##(2008-10#1)(2010-4#1)
(I-V)##5##1##(1990-9#1)(1993-12#1)(2008-10#2)(2010-7#1)
(I/R) injury##5##2##(2008-10#1)(2008-12#1)(2010-5#1)(2010-8#1)(2013-7#1)
(I/R)##7##1##(2008-10#1)(2008-12#1)(2010-1#1)(2010-5#1)(2010-8#1)(2013-7#2)
(I3)##2##1##(2008-12#1)(2013-1#1)
(IA) is##2##2##(2007-10#1)(2011-2#1)
(IA)##4##1##(2007-10#1)(2010-11#1)(2010-3#1)(2011-2#1)
(IAA) and##2##2##(1994-12#1)(2008-12#1)
(IAA) in##2##2##(2008-10#1)(2008-9#1)
(IAA)##9##1##(1994-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)
(IAAD)##2##1##(2012-1#2)
(IAC)##3##1##(2006-12#1)(2008-10#2)
(IAD)##2##1##(1996-5#1)(2013-8#1)
(IB-DCTFM)##2##1##(2010-8#2)
(IBD)##13##1##(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
(IBM)##2##1##(2008-8#1)(2011-1#1)
(IBMX)##3##1##(1992-3#1)(2008-11#1)(2008-5#1)
(IBS) is a##2##3##(2013-1#2)
(IBS)##5##1##(1997-6#1)(2010-6#1)(2013-1#3)
(IC _ 50##4##3##(2008-5#4)
(IC##6##1##(2008-10#1)(2008-5#4)(2011-2#1)
(IC(50) =##2##2##(2008-8#1)(2013-1#1)
(IC(50)##9##1##(2008-5#1)(2008-8#3)(2008-9#1)(2013-1#4)
(IC(50))##2##1##(2008-10#1)(2010-1#1)
(IC) method##2##2##(1994-9#1)(2008-10#1)
(IC)##17##1##(1994-9#1)(2008-10#15)(2011-2#1)
(IC-RT-PCR)##2##1##(2008-10#2)
(IC50 3##2##2##(1992-12#1)(2009-9#1)
(IC50 = 0##3##3##(1995-8#1)(1997-7#2)
(IC50 = 1 nM)##2##4##(1995-8#2)
(IC50 = 3##3##3##(1995-3#1)(1995-8#1)(1997-4#1)
(IC50 = 30 nM)##2##4##(1995-8#1)(2010-12#1)
(IC50 = approximately##2##3##(1993-11#2)
(IC50 =##21##2##(1992-5#2)(1993-11#2)(1993-8#1)(1994-8#1)(1995-3#2)(1995-5#1)(1995-8#5)(1996-2#1)(1997-4#1)(1997-7#2)(2008-5#1)(2010-12#2)
(IC50 approximately##2##2##(1990-5#1)(1994-12#1)
(IC50 of##3##2##(1991-8#2)(1992-3#1)
(IC50##58##1##(1990-5#2)(1991-8#3)(1992-12#4)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-8#5)(1996-2#1)(1997-4#1)(1997-7#2)(2008-5#11)(2009-9#2)(2010-12#2)
(IC50s =##2##2##(1995-3#2)
(IC50s##3##1##(1994-6#1)(1995-3#2)
(ICA)##17##1##(1994-12#2)(1996-12#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
(ICAM-1) on##2##2##(1995-2#1)(2009-10#1)
(ICAM-1)##4##1##(1995-12#1)(1995-2#1)(2009-10#1)(2010-1#1)
(ICC = 0##3##3##(2007-10#2)(2008-7#1)
(ICC)##9##1##(1995-3#1)(2008-7#1)(2009-12#2)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
(ICD-10##6##1##(1995-6#1)(1996-5#1)(2011-2#1)(2012-12#3)
(ICF)##6##1##(2007-12#1)(2008-3#3)(2011-2#1)(2012-12#1)
(ICG)##2##1##(2009-1#1)(2009-12#1)
(ICH) is##2##2##(2007-10#1)(2008-12#1)
(ICH)##8##1##(2007-10#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
(ICP)##12##1##(1992-3#1)(1993-1#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-7#3)(2010-5#1)(2011-2#1)(2012-2#1)
(ICP-AES and##2##2##(2008-10#2)
(ICP-AES) and##3##2##(2008-10#3)
(ICP-AES) method##2##2##(2008-10#2)
(ICP-AES) was##2##2##(2008-10#2)
(ICP-AES)##30##1##(2008-10#30)
(ICP-MS) and##3##2##(2008-10#3)
(ICP-MS) was##2##2##(2008-10#2)
(ICP-MS)##39##1##(2008-10#37)(2013-8#2)
(ICP-OES) after##4##2##(2008-10#3)(2011-2#1)
(ICP-OES)##20##1##(2008-10#18)(2010-5#1)(2011-2#1)
(ICP-TOFMS)##2##1##(2008-10#2)
(ICR)##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
(ICSI)##4##1##(1996-9#1)(1997-2#1)(2012-3#2)
(ICT)##3##1##(2008-10#1)(2009-9#1)(2012-12#1)
(ICU)##13##1##(1992-2#1)(1995-12#1)(2007-11#2)(2007-8#2)(2008-3#1)(2008-4#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#1)
(ICUs)##6##1##(1991-2#1)(2007-11#1)(2007-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
(ICs)##2##1##(2008-10#1)(2008-8#1)
(ID##2##1##(2008-10#1)(2009-10#1)
(ID)##7##1##(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
(ID50 = 0##3##3##(1991-2#1)(1997-7#2)
(ID50 =##8##2##(1991-12#2)(1991-2#2)(1994-6#1)(1997-7#3)
(ID50##10##1##(1991-12#2)(1991-2#2)(1992-8#1)(1994-6#2)(1997-7#3)
(IDA)##5##1##(1990-8#1)(2008-10#3)(2008-2#1)
(IDH)##2##1##(2008-9#1)(2012-5#1)
(IDHR)##2##1##(2008-10#2)
(IDL)##2##1##(1994-8#1)(2008-10#1)
(IDU)##4##1##(2008-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
(IE) and##2##2##(2011-2#1)(2013-1#1)
(IE)##6##1##(1995-12#1)(2006-6#1)(2008-6#1)(2011-2#2)(2013-1#1)
(IEC)##5##1##(1994-5#1)(2008-10#2)(2008-12#1)(2011-2#1)
(IEG)##2##1##(2008-11#2)
(IES)##2##1##(2008-1#1)(2012-3#1)
(IFA)##4##1##(1995-12#1)(2007-2#1)(2008-12#1)(2008-9#1)
(IFETS)##2##1##(1996-12#2)
(IFN##2##1##(1993-3#1)(2007-8#1)
(IFN)##8##1##(1992-2#1)(1993-2#1)(1993-8#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-7#1)
(IFN-alpha)##3##1##(1994-3#1)(2009-5#1)(2009-7#1)
(IFN-gamma) and interleukin##2##3##(2008-11#1)(2008-9#1)
(IFN-gamma)##11##1##(1993-12#1)(1994-6#1)(1996-12#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)
(IGBP)##2##1##(1996-12#2)
(IGF I##2##2##(1996-5#1)(2008-8#1)
(IGF)-I and -II##2##3##(1993-9#1)(1996-5#1)
(IGF)-I##5##1##(1993-9#1)(1996-5#1)(2008-11#1)(2013-1#2)
(IGF-1) and##3##2##(1992-12#1)(2011-1#1)(2011-2#1)
(IGF-1) axis##2##2##(2007-11#1)(2010-8#1)
(IGF-1)##7##1##(1990-12#1)(1992-12#1)(2007-11#1)(2007-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
(IGF-I##3##1##(2008-4#1)(2008-5#1)(2011-1#1)
(IGF-I) and transferrin##2##3##(2008-11#2)
(IGF-I) and##4##2##(2008-11#3)(2008-9#1)
(IGF-I)##20##1##(1991-12#1)(1991-5#2)(1992-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-7#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)
(IGFBP)-3##2##1##(2013-1#2)
(IGFBP-4)##2##1##(2011-1#2)
(IGS)##7##1##(2008-10#7)
(IH)##4##1##(1994-9#1)(2008-5#1)(2008-6#1)(2012-2#1)
(IHA)##4##1##(1992-5#1)(1994-6#1)(2008-7#1)(2008-9#1)
(IHC) for##2##2##(2008-10#1)(2011-2#1)
(IHC)##7##1##(2007-5#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
(IHI##2##1##(2008-7#2)
(IHI)##3##1##(1994-3#1)(2008-7#1)(2013-1#1)
(IHM)##2##1##(1997-3#1)(2007-12#1)
(II &gt##2##2##(2012-3#2)
(II##7##1##(1991-5#1)(2008-10#2)(2012-3#3)(2013-1#1)
(II) and mercury (II)##3##4##(2008-10#3)
(II) and##12##2##(1990-12#1)(1996-5#1)(2008-10#10)
(II) by##3##2##(1990-12#1)(2008-10#2)
(II) complex formation with two poly(acrylic acids) of high molecular weight (Mw=2##2##12##(2008-10#2)
(II) complex##3##2##(2008-10#3)
(II) from##3##2##(2008-10#3)
(II) in the##2##3##(2008-10#2)
(II) in##7##2##(2008-10#7)
(II) ion##4##2##(2008-10#4)
(II) ion-selective##2##2##(2008-10#2)
(II) ions##4##2##(2008-10#4)
(II) or##2##2##(2008-10#2)
(II) selective membrane##2##3##(2008-10#2)
(II) were##3##2##(2008-10#3)
(II) with##6##2##(2008-10#6)
(II)##101##1##(1990-12#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#75)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#2)(2009-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
(II)]##2##1##(1990-3#1)(1994-6#1)
(III and IV)##2##3##(2008-10#1)(2011-2#1)
(III##4##1##(1990-12#1)(1994-7#1)(2008-10#1)(2011-2#1)
(III) and thallium##3##3##(2008-10#3)
(III) and##13##2##(2008-10#13)
(III) are##3##2##(2008-10#3)
(III) at##2##2##(2008-10#1)(2013-8#1)
(III) can be##2##3##(2008-10#2)
(III) in##6##2##(2008-10#6)
(III) is##5##2##(2008-10#5)
(III) with##2##2##(2008-10#2)
(III)##82##1##(1991-12#1)(1992-5#2)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#71)(2008-2#1)(2008-8#1)(2013-7#1)(2013-8#2)
(III))##2##1##(2008-10#2)
(IIP)##4##1##(2008-10#3)(2009-11#1)
(IK(Ca))##2##1##(1996-5#1)(2009-12#1)
(IL)##2##1##(1992-12#1)(2008-11#1)
(IL)-1 alpha##2##2##(1995-5#1)(1996-12#1)
(IL)-1##3##1##(1995-5#1)(1996-12#1)(1996-5#1)
(IL-1 beta##2##2##(1993-8#1)(1996-12#1)
(IL-1 beta)##5##2##(1994-11#1)(1995-12#2)(1996-12#2)
(IL-1##11##1##(1993-8#1)(1994-11#1)(1995-12#3)(1996-12#4)(1996-2#1)(2008-8#1)
(IL-1)##11##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-8#2)(1993-6#1)(1995-2#1)(1995-6#1)
(IL-10)##4##1##(1993-8#1)(1994-8#1)(2009-12#1)(2011-1#1)
(IL-12)##3##1##(2008-11#3)
(IL-1beta##2##1##(2008-10#1)(2009-8#1)
(IL-1beta)##3##1##(2007-8#1)(2008-10#1)(2008-3#1)
(IL-2) and##4##2##(1993-8#1)(1994-11#1)(2008-11#1)(2008-5#1)
(IL-2)##17##1##(1990-2#1)(1991-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
(IL-4)##6##1##(1992-5#1)(1992-8#1)(1994-3#1)(2008-7#1)(2008-9#1)(2009-12#1)
(IL-5)##4##1##(1990-12#1)(1992-3#1)(1995-6#1)(2008-1#1)
(IL-6)##21##1##(1990-5#2)(1994-3#1)(1994-6#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
(IL-8) and##2##2##(2009-12#1)(2013-1#1)
(IL-8)##11##1##(1990-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
(IL-9)##3##1##(2008-4#1)(2011-2#2)
(ILI)##6##1##(2008-10#3)(2010-4#1)(2011-2#1)(2011-9#1)
(ILL)##2##1##(1992-2#1)(2008-3#1)
(ILS)##5##1##(2008-10#3)(2008-2#1)(2008-3#1)
(IM)##9##1##(1997-2#1)(2007-10#1)(2008-10#2)(2008-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#1)
(IMA)##5##1##(1994-9#1)(2007-5#1)(2007-8#2)(2009-10#1)
(IMAC)##3##1##(1997-2#1)(2011-2#1)(2012-3#1)
(IMC)##3##1##(1991-9#2)(2008-3#1)
(IMI)##2##1##(2008-10#1)(2013-1#1)
(IMP)##3##1##(1995-12#1)(1996-7#1)(2008-10#1)
(IMRT) for##2##2##(2010-5#1)(2011-2#1)
(IMRT)##6##1##(2008-2#2)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
(IMS)##12##1##(1995-5#1)(2008-10#8)(2008-5#1)(2010-9#1)(2012-2#1)
(IMSC)##2##1##(2008-7#2)
(IMT) has been##2##3##(2008-8#1)(2012-3#1)
(IMT)##7##1##(2008-1#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
(IN)##6##1##(2008-10#3)(2008-2#1)(2009-11#1)(2011-3#1)
(INA)##2##1##(2008-10#2)
(IND##4##1##(2008-10#4)
(INH)##4##1##(1997-2#1)(2008-1#1)(2008-10#2)
(INR)##3##1##(1991-3#1)(2011-1#1)(2011-2#1)
(IO)##2##1##(2008-10#2)
(IOP)##6##1##(2008-2#1)(2009-7#1)(2011-2#3)(2013-1#1)
(IORT)##3##1##(2008-6#2)(2011-2#1)
(IP)##5##1##(2008-10#1)(2008-7#2)(2009-11#1)(2012-3#1)
(IP-RPHPLC)##2##1##(2008-10#2)
(IP3) in##2##2##(1990-12#1)(1993-6#1)
(IP3) production##2##2##(1992-9#1)(1993-11#1)
(IP3)##6##1##(1990-12#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1997-4#1)
(IPA)##6##1##(1994-9#1)(1997-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
(IPC)##3##1##(2008-12#1)(2010-1#1)(2013-7#1)
(IPD)##3##1##(2008-10#1)(2008-7#1)(2013-7#1)
(IPL)##2##1##(2008-11#1)(2010-6#1)
(IPM)##5##1##(2007-12#1)(2008-10#3)(2011-2#1)
(IPS)##2##1##(2008-10#1)(2013-1#1)
(IPTG)##4##1##(1993-8#1)(1995-2#1)(2008-11#1)(2010-6#1)
(IPV)##6##1##(2008-12#1)(2008-4#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
(IR##4##1##(1991-12#1)(2007-11#1)(2010-3#2)
(IR) and##2##2##(2007-12#1)(2009-8#1)
(IR) was##2##2##(2008-10#1)(2008-3#1)
(IR)##36##1##(1990-5#1)(1990-7#1)(1992-6#1)(1992-9#1)(1994-9#1)(1995-8#2)(1997-4#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-3#6)(2008-5#2)(2008-7#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
(IRE)##2##1##(2007-12#1)(2008-10#1)
(IRES)##4##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
(IRI)##3##1##(1991-2#1)(1994-12#1)(2012-3#1)
(IRS)##3##1##(2008-12#1)(2008-3#1)(2013-8#1)
(IS) is##2##2##(2008-2#1)(2012-3#1)
(IS)##18##1##(1990-6#1)(1993-12#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#8)(2008-2#1)(2010-4#1)(2012-3#1)(2012-5#1)(2013-1#1)
(ISC)##2##1##(2008-11#1)(2008-7#1)
(ISE) array##2##2##(2008-10#2)
(ISE)##17##1##(1991-2#1)(2008-10#16)
(ISO)##2##1##(1990-11#1)(2011-2#1)
(ISR)##10##1##(2008-10#7)(2008-3#1)(2010-11#1)(2011-2#1)
(IST)##2##1##(1997-5#1)(2008-10#1)
(IT)##6##1##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
(ITA##2##1##(2007-8#1)(2008-5#1)
(ITS 1-5##2##2##(2008-10#2)
(ITS##3##1##(2008-10#3)
(ITS) of ribosomal##2##3##(2008-10#1)(2008-8#1)
(ITS) of##3##2##(2008-10#2)(2008-8#1)
(ITS)##44##1##(1991-2#1)(2008-10#38)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
(ITS1 and ITS2) and##2##4##(2008-10#1)(2008-12#1)
(ITS1 and ITS2)##3##3##(2008-10#2)(2008-12#1)
(ITS1##7##1##(2008-10#5)(2008-12#1)(2012-2#1)
(ITS1-5##2##1##(2008-10#2)
(ITT) is##2##2##(2008-10#1)(2012-3#1)
(ITT)##3##1##(2008-10#1)(2008-7#1)(2012-3#1)
(IUGR)##2##1##(2011-2#1)(2012-2#1)
(IV##4##1##(1994-7#1)(1996-5#1)(2008-10#2)
(IV) and##3##2##(2008-10#3)
(IV) in the presence of##2##5##(2008-10#2)
(IV) in the##3##3##(2008-10#3)
(IV) in##4##2##(2008-10#4)
(IV) was##2##2##(1990-12#1)(2008-10#1)
(IV) with##2##2##(2008-10#2)
(IV)##36##1##(1990-12#4)(1990-5#1)(1993-1#1)(1994-12#2)(2006-10#1)(2008-1#1)(2008-10#21)(2010-6#2)(2012-12#1)(2012-2#1)(2013-7#1)
(IVA)##2##1##(2009-6#2)
(IVC)##6##1##(1990-10#1)(2007-7#1)(2008-7#2)(2011-2#1)(2013-1#1)
(IVE)##2##1##(2010-4#1)(2013-1#1)
(IVF)##2##1##(1990-2#1)(2013-1#1)
(IVH)##4##1##(2007-10#1)(2008-7#2)(2011-2#1)
(IVS-2-654 C--&gt##4##2##(2008-8#4)
(IX)##2##1##(1996-5#1)(2008-10#1)
(Id)##3##1##(1994-2#1)(2008-10#1)(2008-6#1)
(Ig)##6##1##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-7#1)
(IgA)##6##1##(1991-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-8#1)
(IgG and##2##2##(1992-9#1)(2008-10#1)
(IgG##6##1##(1991-2#1)(1992-9#1)(1994-6#1)(2008-10#2)(2008-4#1)
(IgG)##6##1##(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2009-8#1)
(IgM)##3##1##(1994-3#1)(1996-12#1)(2008-7#1)
(Immunotech)##2##1##(1997-7#2)
(In##2##1##(2008-10#2)
(India)##5##1##(1990-6#2)(2007-7#2)(2013-7#1)
(Ins(1##3##1##(1990-12#1)(1990-7#1)(1997-1#1)
(InsP4)##2##1##(1990-7#1)(1991-12#1)
(Insecta##10##1##(1990-7#1)(2007-12#4)(2008-12#2)(2008-7#2)(2008-8#1)
(Insecta)##3##1##(2007-12#3)
(Institute##2##1##(1995-3#1)(2008-10#1)
(Int Marit Health 2010##11##4##(2011-2#11)
(International##9##1##(1991-12#1)(1992-12#1)(1992-2#1)(2007-10#1)(2008-10#3)(2008-2#1)(2013-8#1)
(Ipomoea batatas (L##3##3##(2008-10#3)
(Ipomoea batatas)##3##2##(2008-10#3)
(Ipomoea##6##1##(2008-10#6)
(Isoptera##10##1##(2007-12#2)(2009-5#1)(2011-2#6)(2013-8#1)
(Italian##3##1##(1992-2#1)(2008-10#1)(2011-10#1)
(Italy) and##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
(Italy)##21##1##(1990-8#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#6)
(IκB##2##1##(2012-2#1)(2012-3#1)
(J Clin Aesthetic Dermatol##5##4##(2010-8#5)
(J Hand Surg##2##3##(2008-9#2)
(J##27##1##(1990-8#4)(1991-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#2)(2010-8#5)
(J)##2##1##(2008-10#1)(2013-7#1)
(J2)##6##1##(2008-10#6)
(JH)##6##1##(1991-6#1)(1992-6#1)(1995-11#1)(2008-7#1)(2012-2#2)
(JNK##2##1##(2009-6#1)(2011-2#1)
(JST)##3##1##(1994-3#1)(2009-5#1)(2012-1#1)
(JTC)##6##1##(2008-2#2)(2008-3#3)(2012-1#1)
(January##5##1##(1994-12#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-1#1)
(Japan)##5##1##(1996-6#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-3#1)
(Japanese##5##1##(2008-10#3)(2013-1#2)
(Java##2##1##(1996-9#1)(2008-10#1)
(Jay) Rockefeller IV##2##3##(1995-1#2)
(Johnson and##2##2##(1990-10#1)(2008-10#1)
(July and August)##3##3##(2008-10#2)(2011-2#1)
(July##4##1##(2008-1#1)(2008-10#2)(2011-2#1)
(June##6##1##(2007-5#1)(2007-7#2)(2008-10#2)(2011-2#1)
(Jurkat)##2##1##(2008-7#1)(2008-9#1)
(K##4##1##(1992-4#1)(2008-4#2)(2008-5#1)
(K(+))##4##1##(2008-10#2)(2008-6#1)(2010-7#1)
(K(ATP))##2##1##(1997-7#1)(2008-8#1)
(K(D##3##1##(2008-10#3)
(K(MLA))##4##1##(2008-10#4)
(K(a))##2##1##(2008-10#2)
(K(app))##2##1##(2008-10#1)(2008-8#1)
(K(d))##3##1##(2008-10#1)(2008-2#2)
(K(ex##2##1##(2008-10#2)
(K(ex))##7##1##(2008-10#7)
(K(p)) of##2##2##(2008-10#2)
(K) and##3##2##(1995-8#1)(2008-10#2)
(K) of##2##2##(2008-10#1)(2008-6#1)
(K) was##3##2##(2008-10#1)(2008-6#1)(2012-1#1)
(K) were##2##2##(1991-2#1)(2008-6#1)
(K)##19##1##(1991-2#1)(1995-8#1)(2008-10#8)(2008-6#6)(2012-1#1)(2013-7#1)(2013-8#1)
(K+)##2##1##(1994-3#1)(2008-7#1)
(K0##2##1##(1990-11#1)(2008-3#1)
(K1)##2##1##(1996-2#1)(2011-1#1)
(KA)##2##1##(1995-5#1)(2008-10#1)
(KAP) of##2##2##(2010-8#1)(2011-2#1)
(KAP)##3##1##(1996-5#1)(2010-8#1)(2011-2#1)
(KATP)##3##1##(1995-5#1)(2008-5#2)
(KB##2##1##(1991-5#1)(2008-7#1)
(KB)##3##1##(1991-10#1)(1991-12#1)(2009-7#1)
(KCl)##2##1##(2008-10#2)
(KD = 0##3##3##(1993-6#1)(1997-2#2)
(KD =##5##2##(1992-9#1)(1993-6#1)(1994-12#1)(1997-2#2)
(KD##6##1##(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1997-2#2)
(KD) of##2##2##(1990-8#1)(1995-2#1)
(KD)##4##1##(1990-8#1)(1995-2#1)(2011-2#1)(2012-2#1)
(KE)##2##1##(2008-12#1)(2013-1#1)
(KF)##5##1##(1993-9#1)(1996-5#1)(2008-10#3)
(KGF)##2##1##(2008-10#1)(2009-12#1)
(KI)##4##1##(1996-5#1)(2008-10#3)
(KIE)##2##1##(1995-6#1)(2009-6#1)
(KOH)##5##1##(2007-7#2)(2008-10#3)
(KOSCHI Score##2##2##(2013-8#2)
(KP)##3##1##(2009-6#1)(2009-9#1)(2010-8#1)
(KPS)##2##1##(2008-7#1)(2011-2#1)
(KS)##9##1##(1990-9#1)(1991-12#1)(1991-8#1)(1992-3#1)(1996-8#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#1)
(KSA)##6##1##(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#2)(2013-8#1)
(KT) is##2##2##(2008-11#1)(2013-1#1)
(KT)##4##1##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
(KTP)##5##1##(2008-10#1)(2008-3#4)
(KTZ##3##1##(2008-5#3)
(KTpClPB) as##2##2##(2008-10#2)
(KTpClPB)##4##1##(2008-10#4)
(KV)##2##1##(2010-12#1)(2011-2#1)
(KW)##3##1##(2008-7#1)(2013-1#2)
(Ka = 1##2##3##(1990-11#1)(1991-8#1)
(Ka##3##1##(1990-11#1)(1991-8#1)(1995-2#1)
(Kampo)##2##1##(2008-10#2)
(Kaplan-Meier)##2##1##(2006-10#1)(2007-8#1)
(Kappa=0##2##1##(2007-8#2)
(Kb)##2##1##(1991-12#1)(1995-2#1)
(Kd =##16##2##(1990-5#1)(1990-8#1)(1993-11#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)
(Kd approximately##3##2##(1990-12#1)(1995-6#2)
(Kd##24##1##(1990-11#2)(1990-12#1)(1990-5#3)(1990-8#1)(1991-12#1)(1993-11#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#3)
(Kd)##5##1##(1990-11#1)(1990-12#1)(1993-6#3)
(Kd1##2##1##(1991-8#2)
(Kelex-100)##2##1##(2008-10#2)
(Khouzestan##2##1##(2011-2#2)
(Ki 3##2##2##(1995-12#2)
(Ki = 0##7##3##(1991-11#1)(1995-12#2)(1995-3#3)(1995-8#1)
(Ki = 2##2##3##(1993-11#1)(1994-8#1)
(Ki =##18##2##(1991-11#1)(1991-5#2)(1992-6#1)(1993-11#4)(1994-8#1)(1995-12#2)(1995-3#4)(1995-8#2)(1996-2#1)
(Ki##29##1##(1991-11#2)(1991-5#3)(1992-5#2)(1992-6#1)(1993-11#4)(1994-6#2)(1994-8#1)(1995-12#6)(1995-2#1)(1995-3#4)(1995-8#2)(1996-2#1)
(Ki)##4##1##(1992-8#1)(1995-5#1)(2008-7#1)(2009-3#1)
(Kir2##2##1##(2013-7#2)
(Kir3) channels##2##2##(2008-8#2)
(Kirkaldy##3##1##(2008-5#3)
(Kis = 0##2##3##(1995-3#2)
(Kis =##3##2##(1995-3#3)
(Km = 1##2##3##(1990-11#1)(1994-9#1)
(Km =##6##2##(1990-11#1)(1992-9#2)(1994-9#2)(1996-12#1)
(Km##11##1##(1990-11#1)(1990-8#1)(1992-3#1)(1992-8#1)(1992-9#2)(1994-12#1)(1994-9#2)(1995-6#1)(1996-12#1)
(Km)##2##1##(1994-8#1)(1995-11#1)
(Kmy1##3##1##(1997-8#3)
(L = THF##2##3##(1996-2#1)(2009-11#1)
(L =##4##2##(1996-2#3)(2009-11#1)
(L##57##1##(1994-3#1)(1995-6#1)(1996-2#3)(2006-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#6)(2008-5#2)(2008-6#2)(2008-7#2)(2009-11#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#15)(2012-2#2)(2013-1#2)
(L(1))##2##1##(2008-10#2)
(L(2))##3##1##(2008-10#2)(2008-5#1)
(L(u))##2##1##(2008-2#1)(2008-3#1)
(L) and##3##2##(2008-10#3)
(L)##30##1##(1993-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
(L-DOPA)##2##1##(1995-3#1)(2008-7#1)
(L-Glu)##2##1##(1996-5#1)(1997-2#1)
(L-NAME)##7##1##(1992-3#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-11#1)
(L-NMMA)##4##1##(1991-9#1)(1996-5#1)(2009-4#1)(2011-2#1)
(L-dT)##2##1##(2008-4#2)
(L1)##2##1##(1995-2#1)(2008-10#1)
(L2)##2##1##(1996-5#1)(2008-10#1)
(L27dhis##2##1##(1991-8#2)
(LA##3##1##(1994-11#1)(1995-12#1)(2009-8#1)
(LA)##17##1##(1992-5#1)(1994-3#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-8#1)(2009-3#1)(2013-1#3)
(LAD##3##1##(2011-2#1)(2013-7#2)
(LAD)##7##1##(2007-8#2)(2008-4#2)(2013-1#3)
(LAI)##4##1##(1991-12#1)(2008-12#3)
(LAK cells)##2##2##(1992-2#1)(2008-4#1)
(LAN)##2##1##(2007-12#1)(2008-3#1)
(LAP)##3##1##(1993-3#1)(2008-2#1)(2011-2#1)
(LAT)##2##1##(1990-6#1)(1992-6#1)
(LAV)##4##1##(2008-10#4)
(LAVH)##5##1##(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(2010-3#1)
(LB) and##3##2##(2008-11#2)(2012-2#1)
(LB)##15##1##(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-1#1)
(LBO)##2##1##(2007-12#1)(2008-3#1)
(LBR)##2##1##(2011-2#1)(2013-1#1)
(LBW)##2##1##(2008-12#1)(2012-3#1)
(LC)##30##1##(1992-6#1)(1995-12#1)(1996-12#1)(2008-10#22)(2008-3#3)(2008-4#1)(2011-2#1)
(LC-ESI-MS)##4##1##(2008-10#2)(2010-4#2)
(LC-MS)##6##1##(2008-10#2)(2008-12#1)(2010-4#1)(2011-1#1)(2012-1#1)
(LC-MS/MS)##8##1##(2008-10#3)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
(LC50) and##2##2##(2008-12#1)(2011-2#1)
(LC50)##3##1##(2008-12#1)(2008-6#1)(2011-2#1)
(LCA)##4##1##(1997-4#1)(1997-6#1)(2008-11#1)(2010-10#1)
(LCAT)##3##1##(1993-6#2)(2008-7#1)
(LCD)##3##1##(2008-2#1)(2008-3#1)(2010-9#1)
(LCFG's)##2##1##(2008-3#2)
(LCH)##4##1##(2007-10#1)(2010-10#1)(2011-1#1)(2012-3#1)
(LCM)##6##1##(2008-11#2)(2009-8#1)(2010-12#2)(2010-6#1)
(LCR)##3##1##(2008-10#1)(2008-8#2)
(LCs)##4##1##(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)
(LD) is the most##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
(LD)##21##1##(1994-8#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2012-5#1)
(LD50##2##1##(2008-10#1)(2008-11#1)
(LDA) was##2##2##(1996-2#1)(2008-10#1)
(LDA)##12##1##(1996-2#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#1)
(LDF)##2##1##(2007-7#1)(2011-2#1)
(LDH)##18##1##(1992-11#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#4)(2010-4#1)(2011-2#1)(2013-1#1)
(LDL) and##4##2##(1993-8#1)(1994-3#1)(2008-10#1)(2008-6#1)
(LDL) by##2##2##(1993-6#1)(1994-9#1)
(LDL) to##2##2##(1991-5#1)(1995-5#1)
(LDL)##44##1##(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-3#1)(2008-10#5)(2008-3#3)(2008-6#4)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
(LDLR)##3##1##(1995-2#1)(2012-2#1)(2013-1#1)
(LDR)##5##1##(2008-10#2)(2008-6#1)(2008-7#1)(2013-1#1)
(LDS)##2##1##(2008-10#1)(2008-3#1)
(LE) and##2##2##(1992-6#1)(2008-10#1)
(LE)##5##1##(1992-6#1)(1995-8#1)(2008-10#2)(2013-1#1)
(LEA3 and LEA14)##2##3##(2008-10#2)
(LED) and##3##2##(2008-10#3)
(LED) as##3##2##(2008-10#3)
(LED)##10##1##(2008-10#9)(2008-11#1)
(LEH)##2##1##(1994-11#1)(1994-12#1)
(LEL)##2##1##(2009-8#1)(2011-2#1)
(LESS)##2##1##(2007-8#1)(2009-2#1)
(LF)##4##1##(2008-10#2)(2008-4#1)(2013-8#1)
(LFD)##2##1##(2008-10#2)
(LFP) and##2##2##(1990-5#1)(2008-11#1)
(LFP)##3##1##(1990-5#1)(2008-11#2)
(LG)##7##1##(1995-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)
(LGL)##4##1##(1990-12#2)(1992-5#1)(2010-1#1)
(LGR)##2##1##(2008-10#1)(2012-2#1)
(LH##2##1##(1995-2#1)(2008-8#1)
(LH) and##4##2##(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#1)
(LH)##14##1##(1995-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
(LI##2##1##(2012-3#1)(2013-1#1)
(LI)##2##1##(2008-10#1)(2008-4#1)
(LIBS)##7##1##(2008-10#4)(2008-2#1)(2012-12#1)(2013-8#1)
(LIF) and##3##2##(1994-9#1)(2008-2#1)(2009-3#1)
(LIF) is##2##2##(2008-10#1)(2008-11#1)
(LIF)##29##1##(1991-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#2)(2009-3#2)
(LII)##4##1##(2008-2#2)(2008-3#1)(2011-1#1)
(LITA) and##2##2##(2007-8#1)(2011-2#1)
(LITA)##5##1##(2007-12#1)(2007-8#2)(2008-3#1)(2011-2#1)
(LL)##2##1##(2010-4#1)(2011-2#1)
(LLETZ) as##2##2##(1994-2#1)(2012-3#1)
(LLME)##2##1##(2008-10#1)(2008-11#1)
(LLNA)##4##1##(2008-10#3)(2008-5#1)
(LLS)##2##1##(2008-10#1)(2008-3#1)
(LM) and##3##2##(1990-6#1)(2008-10#1)(2010-4#1)
(LM)##8##1##(1990-6#1)(1992-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
(LMS)##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
(LMWH)##5##1##(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)
(LN) and##2##2##(1993-9#1)(2008-10#1)
(LN)##7##1##(1993-9#1)(1995-1#1)(2007-11#1)(2008-1#3)(2008-10#1)
(LNG)##2##1##(2008-10#1)(2013-1#1)
(LNT) model##4##2##(2008-7#2)(2013-1#2)
(LNT)##11##1##(2008-12#1)(2008-7#6)(2008-9#2)(2013-1#2)
(LOD##7##1##(2008-10#6)(2010-4#1)
(LOD) and##10##2##(2008-10#10)
(LOD) of##11##2##(2008-10#11)
(LOD) were##3##2##(2008-10#3)
(LOD)##58##1##(2008-10#55)(2008-6#1)(2010-5#1)(2012-1#1)
(LODs) of##2##2##(2008-10#2)
(LODs)##11##1##(1996-5#1)(2008-10#10)
(LOH)##5##1##(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
(LOQ) and##2##2##(2008-10#2)
(LOQ) is##2##2##(2008-10#2)
(LOQ) were##4##2##(2008-10#3)(2011-1#1)
(LOQ)##21##1##(1992-8#1)(1996-5#1)(2008-10#18)(2011-1#1)
(LOS)##11##1##(1991-12#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2012-2#1)
(LOV)##3##1##(2008-10#2)(2011-1#1)
(LOX)##2##1##(2008-6#1)(2011-10#1)
(LP)##13##1##(1994-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
(LPA)##4##1##(2010-3#2)(2011-2#1)(2013-1#1)
(LPC)##4##1##(1992-10#1)(1995-3#1)(2009-9#1)(2013-1#1)
(LPC2)##2##1##(1994-2#2)
(LPG)##4##1##(2007-11#1)(2008-10#3)
(LPO)##5##1##(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#2)
(LPP)##2##1##(1994-8#1)(2008-5#1)
(LPS##2##1##(1995-12#2)
(LPS) in combination with##2##4##(1992-3#1)(1993-8#1)
(LPS) in##4##2##(1992-3#1)(1993-8#1)(1994-8#1)(1997-1#1)
(LPS)##19##1##(1992-3#1)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-12#1)(2010-8#1)
(LR)##4##1##(2007-8#1)(2008-10#2)(2008-6#1)
(LRD)##2##1##(2008-1#2)
(LRPs)##2##1##(1995-2#1)(2008-4#1)
(LRR)##3##1##(2008-8#1)(2009-6#1)(2009-8#1)
(LRS)##2##1##(2008-9#1)(2011-2#1)
(LS##2##1##(2008-10#2)
(LS) method##2##2##(2008-10#2)
(LS)##9##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-7#1)
(LSC)##3##1##(2008-9#2)(2013-1#1)
(LSCSV)##2##1##(2008-10#2)
(LSD)##4##1##(1997-7#1)(2007-7#1)(2008-10#2)
(LSI)##2##1##(2008-10#1)(2010-11#1)
(LT(50))##2##1##(2009-2#2)
(LT) and##2##2##(1994-2#1)(2008-3#1)
(LT)##8##1##(1994-2#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-3#1)(2013-1#1)
(LTC)##10##1##(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1997-3#1)(2007-5#1)(2008-7#1)(2010-10#1)
(LTH)##2##1##(1993-5#1)(2008-10#1)
(LTP) in the##4##3##(1990-5#1)(1992-12#1)(2008-7#2)
(LTP) in##6##2##(1990-5#1)(1992-12#1)(1996-5#1)(2008-7#2)(2008-9#1)
(LTP)##20##1##(1990-5#1)(1992-12#1)(1993-12#2)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#4)(2008-9#1)(2009-8#2)(2012-3#1)
(LTR##2##1##(1991-2#1)(2008-9#1)
(LTR)##5##1##(1992-12#1)(1993-8#1)(1997-8#1)(2008-11#1)(2008-3#1)
(LV)##8##1##(1991-3#1)(1992-8#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
(LVS)##2##1##(1990-11#1)(2012-2#1)
(LVs)##2##1##(2008-11#1)(2008-4#1)
(La(3+)##2##1##(2008-10#2)
(La)##2##1##(1992-11#1)(2012-2#1)
(Lactuca##3##1##(2008-10#2)(2008-5#1)
(Lamiales##2##1##(2013-8#2)
(Laureth 4)##2##2##(2008-5#2)
(Lee et al##4##3##(1994-8#1)(1997-6#1)(2008-7#1)(2011-2#1)
(Lee##5##1##(1994-8#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
(Leguminosae)##2##1##(2008-10#1)(2008-11#1)
(Lemna pausicostata L##2##3##(2008-10#2)
(Lens##2##1##(2008-10#2)
(Lepidoptera##30##1##(1990-8#1)(1992-6#1)(2007-12#3)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#5)(2010-11#1)(2011-2#11)(2013-8#3)
(Lepidoptera)##2##1##(2007-12#1)(2008-5#1)
(Lepomis macrochirus)##2##2##(2008-10#1)(2008-6#1)
(Leptosphaeria maculans)##2##2##(2008-10#2)
(Leu##2##1##(1992-8#2)
(Leu) and##2##2##(2008-4#1)(2008-8#1)
(Leu) was##2##2##(2008-4#2)
(Leu)##6##1##(2008-4#4)(2008-8#2)
(Levin##2##1##(1997-3#2)
(Levovist) infusion on##2##3##(2007-10#2)
(Lewisites)##2##1##(2008-11#2)
(Li##4##1##(1991-12#1)(2008-10#2)(2010-4#1)
(Li(0##4##1##(2008-10#4)
(Linn)##3##1##(2008-10#1)(2008-12#1)(2010-5#1)
(Linnaeus##6##1##(2008-5#6)
(Lithocarpus##2##1##(2008-10#2)
(Ln =##3##2##(1997-7#1)(2010-4#2)
(Loew) (Diptera##2##2##(2011-2#2)
(Lolium perenne)##5##2##(2008-10#5)
(Lolium##7##1##(2008-10#6)(2012-2#1)
(Low##2##1##(2008-3#1)(2012-7#1)
(Lp(a)##2##1##(1993-12#1)(1993-2#1)
(Lp(a))##3##1##(1993-2#1)(1995-2#1)(1995-6#1)
(Lucent/ARPA/COOP)##2##1##(2008-2#1)(2008-3#1)
(Lycopersicon esculentum)##9##2##(2008-10#9)
(Lycopersicon##10##1##(2008-10#10)
(M (age) =##2##3##(2009-7#1)(2010-7#1)
(M = 14##2##3##(2009-7#2)
(M = 15##3##3##(2009-7#1)(2010-10#2)
(M =##18##2##(1996-2#2)(1997-7#3)(2008-12#1)(2008-5#1)(2009-5#1)(2009-7#3)(2010-10#6)(2012-3#1)
(M age =##3##3##(2009-7#1)(2009-8#1)(2010-1#1)
(M##53##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#3)(1994-5#1)(1995-2#1)(1996-2#2)(1996-4#2)(1997-7#4)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#5)(2009-8#1)(2010-1#1)(2010-10#6)(2010-7#1)(2011-2#3)(2012-3#1)
(M(1) =##2##2##(2008-12#2)
(M(1)##4##1##(2008-10#1)(2008-12#2)(2011-2#1)
(M(2) =##2##2##(2007-12#1)(2008-2#1)
(M(2) approximately##2##2##(2008-2#1)(2008-3#1)
(M(2)##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
(M(2)&lt##4##1##(2007-12#4)
(M(2+))##2##1##(2008-10#2)
(M(r)##7##1##(1992-9#1)(1993-9#1)(1994-11#2)(1995-2#1)(1996-5#1)(1996-6#1)
(M) and##4##2##(1994-9#1)(1997-4#1)(2008-10#1)(2010-8#1)
(M)##23##1##(1990-5#1)(1993-6#1)(1994-9#1)(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-5#3)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
(M1##3##1##(1994-9#2)(2008-10#1)
(M1)##3##1##(1993-9#1)(1996-5#1)(2012-2#1)
(M3)##2##1##(1996-5#1)(2011-2#1)
(M4)##2##1##(1996-5#1)(1997-2#1)
(M=mol dm(-3))##2##2##(2008-10#2)
(MA##2##1##(2008-10#1)(2008-12#1)
(MA) and##3##2##(1996-12#1)(2008-12#1)(2008-3#1)
(MA)##20##1##(1990-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
(MAA)##5##1##(1990-12#1)(1994-11#1)(2008-10#3)
(MABR)##2##1##(2009-11#1)(2013-1#1)
(MAC)##6##1##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
(MACE)##3##1##(2008-11#1)(2008-3#2)
(MAD)##2##1##(2008-10#1)(2010-10#1)
(MAE) for##3##2##(2008-10#2)(2008-11#1)
(MAE)##6##1##(2008-10#5)(2008-11#1)
(MAF)##4##1##(2010-11#1)(2011-1#3)
(MAIS)##2##1##(2011-1#1)(2012-2#1)
(MALDI-TOF MS)##2##2##(2008-10#1)(2008-11#1)
(MALT##2##1##(2008-5#1)(2009-8#1)
(MALT)##7##1##(1991-6#1)(1997-1#1)(2008-1#1)(2008-5#1)(2009-8#2)(2013-1#1)
(MAO)##5##1##(1991-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(2008-3#1)
(MAO-A)##2##1##(1994-8#1)(2008-7#1)
(MAO-B)##4##1##(1992-11#2)(1994-8#1)(1996-5#1)
(MAP) in##2##2##(2008-5#1)(2008-7#1)
(MAP) is##2##2##(2008-4#1)(2009-7#1)
(MAP) kinase and##2##3##(1994-11#1)(1996-2#1)
(MAP) kinase##7##2##(1992-8#1)(1994-11#1)(1996-2#2)(2008-4#2)(2008-7#1)
(MAP)##23##1##(1991-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#1)(2008-4#5)(2008-5#1)(2008-7#2)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#2)
(MAPK)##16##1##(1995-2#2)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#2)
(MAR)##4##1##(1992-10#1)(1994-5#1)(2008-10#1)(2008-8#1)
(MAS)##9##1##(1996-2#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
(MAT)##4##1##(1991-8#1)(1992-6#1)(2007-7#1)(2008-10#1)
(MAV)##2##1##(2008-10#1)(2008-9#1)
(MAb)##13##1##(1993-9#1)(1994-5#3)(1996-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)
(MB) and##4##2##(1993-8#1)(2008-10#3)
(MB) in##3##2##(2008-10#3)
(MB)##23##1##(1993-8#1)(1996-2#1)(2008-10#19)(2011-2#1)(2013-1#1)
(MBAS)##2##1##(2007-12#2)
(MBC)##2##1##(1991-5#1)(2008-10#1)
(MBCT)##2##1##(2012-2#1)(2013-1#1)
(MBL)##4##1##(2008-4#1)(2010-11#1)(2012-2#1)(2012-3#1)
(MBP)##10##1##(1992-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#3)(1996-5#1)(2008-8#1)
(MBR) and##2##2##(2013-1#2)
(MBR)##3##1##(2013-1#3)
(MBT)##2##1##(2008-10#1)(2008-11#1)
(MC##2##1##(1996-5#1)(2008-9#1)
(MC) in##2##2##(1992-3#1)(2011-2#1)
(MC) is a##2##3##(1993-11#1)(1995-3#1)
(MC) is##3##2##(1993-11#1)(1995-3#1)(2007-11#1)
(MC)##19##1##(1990-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#1)(2013-7#1)
(MCA)##12##1##(1992-2#1)(1992-3#1)(1995-6#1)(1996-5#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)
(MCAO)##5##1##(1997-2#1)(2007-10#3)(2008-10#1)
(MCC)##4##1##(2011-2#1)(2013-1#2)(2013-8#1)
(MCF)##2##1##(2007-11#1)(2008-10#1)
(MCF-7)##2##1##(1995-12#1)(2009-2#1)
(MCF7)##2##1##(1995-6#1)(2011-2#1)
(MCFA)##3##1##(2008-10#2)(2011-1#1)
(MCFIA)##3##1##(2008-10#3)
(MCH) and##2##2##(2008-12#1)(2008-7#1)
(MCH)##4##1##(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
(MCHC)##2##1##(2008-10#1)(2008-12#1)
(MCL)##6##1##(2008-10#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)
(MCM)##2##1##(2008-3#1)(2008-5#1)
(MCP) and##2##2##(1992-11#1)(2006-10#1)
(MCP)##5##1##(1992-11#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-2#1)
(MCP-1)##5##1##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
(MCR)##2##1##(1990-11#1)(2008-11#1)
(MCR-ALS)##3##1##(2007-12#1)(2008-10#2)
(MCS)##10##1##(1993-12#1)(1994-12#4)(2007-7#1)(2007-8#1)(2008-11#1)(2010-3#1)(2011-2#1)
(MCTSI)##2##1##(2009-8#2)
(MCV) and##2##2##(2008-10#1)(2008-5#1)
(MCV)##4##1##(2008-10#2)(2008-12#1)(2008-5#1)
(MCs) are##2##2##(2008-11#1)(2012-12#1)
(MCs)##7##1##(1992-6#1)(2007-11#1)(2008-11#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
(MD) and##2##2##(1993-11#1)(2011-1#1)
(MD) simulation##2##2##(1992-9#1)(2012-2#1)
(MD)##16##1##(1992-9#1)(1993-11#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#5)(2008-5#1)(2009-5#1)(2011-1#1)(2012-2#2)
(MDA)##13##1##(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
(MDA-MB-231)##2##1##(2012-2#1)(2013-1#1)
(MDC)##3##1##(1990-8#1)(2010-3#1)(2013-7#1)
(MDCT) has##2##2##(2008-7#1)(2012-2#1)
(MDCT)##11##1##(2008-12#1)(2008-7#4)(2011-2#3)(2012-2#3)
(MDD) and##2##2##(1997-5#1)(2008-4#1)
(MDD)##8##1##(1997-5#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
(MDI) aerosols##2##2##(1992-3#2)
(MDI)##15##1##(1992-3#5)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2009-11#1)(2012-4#1)
(MDL)##7##1##(1996-2#1)(2008-10#6)
(MDM)##3##1##(2008-3#2)(2008-4#1)
(MDP)##3##1##(2007-10#1)(2008-10#1)(2008-11#1)
(MDR)##8##1##(1993-3#1)(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
(MDR-TB)##3##1##(2007-7#1)(2010-5#1)(2013-8#1)
(MDR1) gene##3##2##(1991-12#1)(1994-5#1)(2007-10#1)
(MDR1)##4##1##(1991-12#1)(1994-5#1)(2007-10#1)(2008-11#1)
(MDS##5##1##(1994-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)
(MDS)##10##1##(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)
(MDV)##2##1##(2007-6#1)(2008-5#1)
(MDs)##2##1##(2008-7#1)(2012-2#1)
(ME)##5##1##(1995-2#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
(MEA)##3##1##(2008-10#1)(2009-12#1)(2013-1#1)
(MED)##2##1##(2008-5#2)
(MEDPAR)##4##1##(1992-12#1)(1993-12#2)(1995-2#1)
(MEG)##4##1##(1996-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
(MEI)##2##1##(1992-2#1)(1994-1#1)
(MEK)##2##1##(1995-2#1)(2008-10#1)
(MEL)##5##1##(1991-2#1)(1993-6#1)(2008-11#2)(2010-8#1)
(MELD) score##2##2##(2010-6#1)(2011-2#1)
(MEM)##2##1##(2008-3#1)(2008-7#1)
(MEMS)##3##1##(2007-12#1)(2008-2#1)(2009-9#1)
(MEN##2##1##(1993-3#1)(2008-1#1)
(MEN)##2##1##(2009-4#2)
(MEP)##6##1##(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
(MEPS)##2##1##(2010-3#1)(2013-1#1)
(MF##2##1##(1994-6#2)
(MF)##4##1##(1992-5#1)(2008-10#1)(2010-9#1)(2013-1#1)
(MFA)##3##1##(1997-6#1)(2008-10#1)(2009-3#1)
(MFC)##2##1##(2008-5#1)(2010-9#1)
(MFS)##9##1##(1994-1#3)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-7#1)
(MG)##14##1##(1993-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-6#1)
(MGN)##3##1##(2008-1#2)(2008-3#1)
(MH)##3##1##(2008-9#1)(2010-4#1)(2012-1#1)
(MHC) class I##5##3##(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)(2008-7#1)
(MHC) class II##2##3##(1994-11#1)(2008-4#1)
(MHC) class##7##2##(1994-11#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)(2008-4#1)(2008-7#1)
(MHC)##16##1##(1990-5#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-9#3)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)
(MHO)##2##1##(2013-1#2)
(MHPG)##3##1##(1993-1#1)(1996-7#1)(2008-10#1)
(MI) and##4##2##(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
(MI) is a##2##3##(2010-10#1)(2013-8#1)
(MI) is##3##2##(2007-11#1)(2010-10#1)(2013-8#1)
(MI)##28##1##(1990-2#1)(1993-8#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#3)
(MIA)##2##1##(2008-4#1)(2011-2#1)
(MIBG)##3##1##(2008-7#1)(2010-9#1)(2012-2#1)
(MIBK)##5##1##(2008-10#5)
(MIC =##3##2##(2007-11#1)(2008-12#2)
(MIC##11##1##(1990-6#1)(1991-8#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-12#4)(2008-5#1)(2012-3#1)
(MIC) for##2##2##(1994-12#1)(2010-2#1)
(MIC) of##4##2##(1991-8#1)(2007-7#1)(2008-10#1)(2008-5#1)
(MIC) was##2##2##(2008-5#1)(2008-8#1)
(MIC)##16##1##(1991-8#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
(MIDCAB)##3##1##(2007-8#3)
(MIF)##3##1##(2008-10#1)(2009-6#1)(2012-2#1)
(MIH)##2##1##(2008-7#1)(2013-1#1)
(MIN)##2##1##(2008-10#1)(2008-2#1)
(MIP)##8##1##(1993-2#1)(1995-11#1)(2008-10#4)(2009-9#2)
(MIR)##2##1##(2007-12#1)(2008-10#1)
(MIS)##4##1##(1993-12#1)(2008-8#1)(2011-2#2)
(MK-0906)##2##1##(1994-11#2)
(MK-801)##3##1##(1994-8#1)(1996-12#1)(2012-2#1)
(ML)##6##1##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2013-8#1)
(MLA)##4##1##(1996-9#2)(2008-10#1)(2008-3#1)
(MLD)##2##1##(1997-3#1)(2008-10#1)
(MLM)##2##1##(2008-3#1)(2009-8#1)
(MLN)##2##1##(2008-11#2)
(MLP)##3##1##(2008-10#3)
(MLPNN)##2##1##(2010-8#2)
(MLR)##7##1##(2008-10#7)
(MLTC)##2##1##(1993-9#1)(1995-3#1)
(MLV)##2##1##(2008-10#2)
(MM)##12##1##(1990-12#1)(1991-8#1)(2008-1#1)(2008-10#5)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
(MMA) and##3##2##(1995-11#1)(2007-9#1)(2009-7#1)
(MMA)##13##1##(1995-11#2)(2007-9#1)(2008-10#7)(2008-12#1)(2009-7#1)(2010-8#1)
(MMC)##6##1##(1992-12#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#2)
(MMD##2##1##(1994-12#1)(1995-3#1)
(MMD)##4##1##(1993-2#1)(1995-3#1)(2008-10#1)(2013-1#1)
(MMI)##2##1##(2007-12#1)(2012-3#1)
(MMN)##7##1##(1995-12#1)(1995-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
(MMP)##5##1##(1997-4#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
(MMP-2) and##2##2##(1992-9#1)(2008-9#1)
(MMP-2)##5##1##(1992-9#1)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#1)
(MMPs)##8##1##(2008-11#2)(2008-4#4)(2008-5#1)(2013-1#1)
(MMS)##4##1##(1994-12#2)(1997-4#1)(2011-1#1)
(MMSE) score##2##2##(2008-6#1)(2008-7#1)
(MMSE)##10##1##(2008-6#2)(2008-7#6)(2010-12#1)(2013-1#1)
(MNC)##4##1##(1991-2#1)(1993-8#1)(2008-5#1)(2010-6#1)
(MNCs)##4##1##(2008-11#3)(2008-9#1)
(MNNG##2##1##(1997-4#2)
(MNNG)##4##1##(1995-9#1)(1997-4#3)
(MO)##9##1##(1994-3#1)(1995-12#1)(2008-10#3)(2008-3#3)(2013-8#1)
(MOF)##5##1##(1992-5#1)(1997-1#1)(2008-10#1)(2008-4#1)(2009-7#1)
(MORE)##2##1##(2009-1#1)(2013-1#1)
(MP) and##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
(MP)##13##1##(1991-8#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-9#4)(2010-2#1)(2013-1#1)
(MP-PCR)##3##1##(2008-10#2)(2008-5#1)
(MPA)##12##1##(1993-1#2)(1993-8#1)(1994-9#2)(1995-11#1)(1995-4#1)(2008-10#3)(2012-12#1)(2013-8#1)
(MPC) of the##2##3##(1996-2#1)(2008-10#1)
(MPC)##6##1##(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
(MPCs)##2##1##(2008-11#1)(2011-2#1)
(MPD)##4##1##(2008-10#1)(2008-5#1)(2012-2#2)
(MPI)##6##1##(1995-2#1)(1995-6#1)(2008-2#1)(2010-8#1)(2013-1#2)
(MPLS)##2##1##(2008-10#2)
(MPM)##7##1##(1997-4#1)(2008-10#6)
(MPN)##3##1##(2008-10#1)(2009-4#1)(2009-8#1)
(MPO)##3##1##(1992-10#1)(2011-1#1)(2013-1#1)
(MPOA)##3##1##(1992-12#1)(1992-5#1)(1994-2#1)
(MPP##2##1##(1993-8#1)(2007-11#1)
(MPP)##2##1##(2008-2#1)(2009-7#1)
(MPP+)##7##1##(1990-5#2)(1990-7#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-12#1)
(MPR)##2##1##(2011-2#2)
(MPS)##2##1##(2008-10#2)
(MPTP)##9##1##(1990-7#1)(1992-11#1)(1995-11#1)(1995-5#2)(1996-12#1)(2008-7#2)(2012-2#1)
(MPs)##3##1##(1997-3#1)(2007-11#1)(2008-7#1)
(MQ)##2##1##(2008-10#1)(2008-7#1)
(MR) and##2##2##(2008-10#1)(2008-7#1)
(MR) findings of##2##3##(2011-2#1)(2012-2#1)
(MR)##27##1##(1990-10#1)(1990-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)
(MRA) is##3##2##(2008-7#3)
(MRA)##10##1##(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#5)(2012-2#1)
(MRF)##2##1##(2008-3#1)(2008-6#1)
(MRI) for##2##2##(2012-12#2)
(MRI) of##5##2##(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
(MRI) were##2##2##(2008-1#1)(2012-3#1)
(MRI)##82##1##(1992-3#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#12)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#12)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
(MRL)##2##1##(2008-10#1)(2008-7#1)
(MRM)##8##1##(1995-4#1)(2008-10#1)(2011-1#3)(2011-3#2)(2013-1#1)
(MRP)##4##1##(1997-4#1)(2008-11#2)(2010-1#1)
(MS##3##1##(2008-10#2)(2008-11#1)
(MS) and##5##2##(1997-2#1)(2008-10#2)(2011-2#1)(2012-3#1)
(MS) as##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
(MS) has##2##2##(2008-3#1)(2010-7#1)
(MS) is a##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
(MS) is##5##2##(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
(MS) medium##2##2##(2008-10#1)(2008-8#1)
(MS)##55##1##(1994-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#3)(2011-7#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
(MSA) and##2##2##(2008-10#1)(2012-3#1)
(MSA)##6##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
(MSC)##8##1##(2008-10#2)(2008-5#1)(2011-1#1)(2012-12#2)(2012-7#1)(2013-8#1)
(MSD)##6##1##(1992-9#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)
(MSFA)##4##1##(2008-10#4)
(MSFIA)##6##1##(2008-10#6)
(MSM)##7##1##(2008-10#1)(2008-3#1)(2009-5#4)(2011-2#1)
(MSP)##3##1##(2008-10#1)(2008-7#1)(2008-8#1)
(MSTS)##2##1##(2008-6#2)
(MSU)##3##1##(1992-12#1)(2007-10#1)(2010-8#1)
(MT##2##1##(1995-3#1)(2009-11#1)
(MT) and##5##2##(1990-5#1)(1995-3#1)(1996-7#1)(2008-10#2)
(MT) in##2##2##(2008-11#1)(2013-7#1)
(MT) isoforms##2##2##(2008-10#2)
(MT)##30##1##(1990-5#1)(1993-12#2)(1994-11#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-7#1)(2008-10#15)(2008-11#2)(2008-5#1)(2008-7#1)(2013-1#2)(2013-7#1)
(MT-2##2##1##(1991-12#2)
(MTB)##4##1##(2008-10#3)(2011-1#1)
(MTC)##3##1##(2008-7#3)
(MTEC1)##2##1##(2008-8#2)
(MTF)##8##1##(2008-2#6)(2008-3#2)
(MTP)##2##1##(2006-10#1)(2007-8#1)
(MTS)##2##1##(1994-12#1)(2007-9#1)
(MTSC4)##2##1##(2008-8#2)
(MTT assay)##2##2##(1991-12#1)(1993-9#1)
(MTT##4##1##(1991-12#1)(1993-9#1)(2008-11#2)
(MTT)##3##1##(2007-10#1)(2008-11#1)(2012-3#1)
(MTU)##2##1##(1992-12#1)(2008-10#1)
(MTX)##10##1##(1990-8#1)(1991-4#1)(1992-8#1)(1994-9#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
(MTs) is##2##2##(1992-6#1)(2008-10#1)
(MTs)##9##1##(1992-6#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
(MU)##2##1##(2008-10#1)(2012-2#1)
(MUFA)##4##1##(2008-10#1)(2010-2#1)(2010-4#1)(2013-1#1)
(MUSS)##2##1##(2011-1#1)(2012-2#1)
(MV)##5##1##(1997-6#1)(2008-10#1)(2009-4#1)(2012-2#1)(2013-8#1)
(MVA)##4##1##(1995-12#1)(2008-11#1)(2011-1#1)(2012-2#1)
(MVC)##4##1##(1993-12#1)(2008-10#1)(2010-6#1)(2013-8#1)
(MVD)##4##1##(2010-12#1)(2011-2#2)(2012-2#1)
(MVK)##2##1##(1996-5#1)(2008-7#1)
(MW approximately##2##2##(1992-12#2)
(MW##10##1##(1990-7#2)(1992-12#2)(2008-10#3)(2008-11#2)(2008-5#1)
(MW) and##2##2##(2008-10#1)(2011-2#1)
(MW) irradiation##2##2##(2008-10#2)
(MW)##12##1##(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
(MW=348)##2##1##(2008-10#2)
(MWC)##2##1##(2008-10#1)(2012-1#1)
(MWO(4)##2##1##(2009-11#2)
(MY(2-)+H(2)Y(2-))##2##1##(2008-10#2)
(MZ) and##2##2##(1997-4#1)(2009-7#1)
(Mab)##4##1##(2007-10#2)(2008-10#1)(2008-11#1)
(Macaca fascicularis)##4##2##(1992-11#1)(1994-3#1)(2008-10#1)(2012-2#1)
(Macaca##5##1##(1992-11#1)(1994-3#1)(1997-2#1)(2008-10#1)(2012-2#1)
(Malaysia##2##1##(2008-12#1)(2010-2#1)
(Mallophaga)##3##1##(2007-12#2)(2011-2#1)
(Malpighiales##2##1##(2013-8#2)
(Malus domestica)##4##2##(2008-10#3)(2009-8#1)
(Malus##8##1##(2008-10#4)(2008-9#2)(2009-8#1)(2011-2#1)
(Malvales##2##1##(2013-8#2)
(Mangifera indica)##2##2##(2008-10#2)
(Mann-Whitney U-test##2##2##(2010-9#1)(2013-8#1)
(March##4##1##(2007-11#1)(2008-12#1)(2008-5#2)
(Mark##2##1##(2008-10#1)(2008-4#1)
(Maryland##2##1##(2008-10#2)
(Mathematical##2##1##(1997-3#1)(2008-7#1)
(May and June)##2##3##(2011-2#1)(2013-8#1)
(May and##4##2##(2008-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
(Mayr) and##2##2##(2008-5#1)(2008-6#1)
(Mayr)##4##1##(2008-5#1)(2008-6#3)
(Mb)##7##1##(1994-5#1)(2008-10#4)(2009-10#1)(2010-4#1)
(MbSA and##3##2##(2011-2#3)
(MeHg)##2##1##(2008-10#1)(2008-7#1)
(MeOH)##6##1##(2008-10#4)(2008-11#1)(2008-12#1)
(MeSH)##4##1##(1992-12#1)(1993-3#1)(1995-1#1)(2008-6#1)
(Medicago sativa) plants##2##3##(2008-10#2)
(Medicago sativa)##6##2##(2008-10#4)(2008-12#2)
(Medicago##11##1##(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2011-2#1)(2012-3#1)
(Medical##2##1##(1991-2#1)(2008-9#1)
(Medicare##6##1##(1992-2#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-1#1)
(Medivance##2##1##(2007-10#2)
(Meloidogyne incognita)##3##2##(2008-10#3)
(Meloidogyne spp##2##2##(2008-10#2)
(Meloidogyne##5##1##(2008-10#5)
(Merck##4##1##(2008-10#2)(2008-12#1)(2008-5#1)
(Met)##3##1##(2008-10#1)(2008-4#1)(2010-11#1)
(Met352----Arg)##3##1##(1990-8#3)
(Metavir##2##1##(2013-1#2)
(Method##3##1##(2008-10#3)
(Mex-)##2##1##(1992-3#2)
(Mg##3##1##(2008-10#1)(2013-1#2)
(Mg)##2##1##(2008-10#1)(2012-2#1)
(MgF(2))##2##1##(2008-2#1)(2008-3#1)
(Microsporidia##2##1##(2011-2#2)
(Microtus arvalis)##2##2##(1991-8#2)
(Microtus##4##1##(1991-8#2)(2008-9#2)
(Mn##3##1##(2008-10#3)
(Mn)##5##1##(2008-10#5)
(MoM)##2##1##(1996-12#2)
(Model##2##1##(2008-2#1)(2008-3#1)
(Mollusca##4##1##(1993-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
(Mount##3##1##(1992-3#1)(2008-10#1)(2008-5#1)
(Mr##13##1##(1990-11#1)(1990-5#5)(1991-2#2)(1991-5#1)(1992-3#2)(1997-7#2)
(Multi-TCCCN)##2##1##(2008-10#2)
(Multiplex##2##1##(2008-4#2)
(Musa##2##1##(2008-1#1)(2008-10#1)
(Myrmicinae)##2##1##(2007-12#2)
(Mytilus galloprovincialis)##2##2##(2008-10#2)
(Mytilus##3##1##(1995-8#1)(2008-10#2)
(Myzus persicae)##4##2##(2008-10#3)(2012-2#1)
(N = 1##2##3##(2009-7#2)
(N = 12)##2##3##(2008-10#1)(2012-3#1)
(N = 2##3##3##(1993-1#2)(2008-5#1)
(N = 20)##2##3##(2008-10#2)
(N = 22##2##3##(2008-5#1)(2010-2#1)
(N = 70)##2##3##(1996-2#1)(2012-3#1)
(N = 9)##2##3##(1994-8#1)(1995-5#1)
(N =##91##2##(1992-11#1)(1992-6#1)(1993-1#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-5#3)(1996-1#2)(1996-2#4)(1997-5#1)(2007-12#6)(2008-1#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2010-10#1)(2010-2#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#8)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#2)
(N##115##1##(1991-12#1)(1992-11#1)(1992-6#1)(1993-1#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-2#5)(1997-5#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#9)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#2)
(N(2)##4##1##(2007-12#1)(2008-10#2)(2008-2#1)
(N(2))##2##1##(2008-10#1)(2010-12#1)
(N) and##3##2##(2008-10#1)(2011-1#1)(2012-5#1)
(N)##27##1##(1990-6#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
(N)D tensor voting##2##3##(2008-6#2)
(N)D tensor##3##2##(2008-6#3)
(N)D##4##1##(2008-6#4)
(N-acetyl-5-methoxytryptamine)##2##1##(1990-5#1)(1995-11#1)
(N2##2##1##(1997-2#1)(2013-8#1)
(N5) haploinsufficient] mice (dermal studies)##2##5##(2008-9#2)
(N5) haploinsufficient] mice (drinking water studies)##2##6##(2008-9#2)
(N5) haploinsufficient] mice (drinking water##3##5##(2008-9#3)
(N5) haploinsufficient] mice##6##3##(2008-8#1)(2008-9#5)
(N5)##7##1##(2008-8#1)(2008-9#6)
(N=10)##2##1##(2008-10#1)(2009-10#1)
(N=11)##4##1##(2008-10#3)(2008-3#1)
(N=193)##2##1##(2010-8#1)(2012-3#1)
(N=6##2##1##(2013-7#2)
(N=76)##2##1##(2008-12#1)(2008-4#1)
(NA) and##4##2##(2008-10#3)(2011-1#1)
(NA) is a##2##3##(2008-10#1)(2010-11#1)
(NA)##27##1##(1994-6#1)(1994-8#1)(1995-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-3#4)(2008-7#2)(2008-9#1)(2010-11#1)(2011-1#1)
(NAA##2##1##(2008-12#1)(2013-1#1)
(NAA)##7##1##(1996-5#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-7#1)
(NAC) and##2##2##(1996-5#1)(2008-10#1)
(NAC)##12##1##(1991-9#2)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-2#1)
(NAD(+))##2##1##(2008-10#1)(2008-11#1)
(NAD)##3##1##(1991-9#1)(2008-10#1)(2008-7#1)
(NADH)##7##1##(1994-9#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#1)
(NADPH-d)##2##1##(1995-12#1)(1997-2#1)
(NAG) and##2##2##(1991-5#1)(1996-12#1)
(NAG)##4##1##(1991-5#1)(1993-12#1)(1994-5#1)(1996-12#1)
(NAP)##2##1##(2008-10#1)(2009-11#1)
(NAR) and##2##2##(1992-11#1)(2008-12#1)
(NAS)##6##1##(1993-12#1)(1993-6#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
(NAT)##7##1##(1994-2#1)(1995-11#1)(1995-3#1)(2011-1#1)(2011-2#2)(2013-8#1)
(NAT2)##3##1##(1993-3#2)(1995-9#1)
(NB)##6##1##(1991-9#1)(2008-10#3)(2008-3#1)(2013-8#1)
(NB1-RGB)##2##1##(2008-11#2)
(NBD-Cl)##2##1##(1992-6#1)(2008-10#1)
(NBD-PE)##2##1##(2008-10#1)(2008-7#1)
(NBL)##4##1##(2008-3#1)(2011-2#3)
(NBM) and##2##2##(1995-12#1)(2008-9#1)
(NBM)##5##1##(1991-12#1)(1993-3#1)(1995-12#1)(2008-8#1)(2008-9#1)
(NBS SRM 85b)##2##3##(2008-10#2)
(NBS SRM##3##2##(2008-10#3)
(NBS) and##2##2##(2008-10#1)(2008-8#1)
(NBS)##10##1##(1992-6#1)(1995-2#1)(2008-10#6)(2008-8#1)(2010-10#1)
(NC)##10##1##(1996-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-7#1)(2010-2#1)
(NCAM)##2##1##(1993-6#1)(2009-8#1)
(NCCLS)##2##1##(2008-5#2)
(NCCTG) phase##2##2##(2008-11#1)(2008-12#1)
(NCEP)##3##1##(1991-8#1)(2008-1#1)(2008-3#1)
(NCHS)##3##1##(1991-12#1)(1997-3#1)(2008-12#1)
(NCI)##5##1##(1997-1#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
(NCP)##2##1##(1993-12#1)(2008-1#1)
(NCPM)##2##1##(2007-11#1)(2007-12#1)
(NCR)##2##1##(2008-4#1)(2008-9#1)
(NCS)##2##1##(2008-10#1)(2013-1#1)
(NCT)##2##1##(2008-10#1)(2013-1#1)
(ND)##7##1##(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#3)(2013-8#1)
(NDGA)##2##1##(1994-9#1)(1995-11#1)
(NDI)##2##1##(1993-6#1)(2012-12#1)
(NDV) isolated from##2##3##(2007-6#2)
(NDV)##8##1##(1997-3#1)(1997-6#1)(2007-6#2)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
(NE) and##3##2##(1996-12#1)(2008-2#1)(2008-7#1)
(NE) is##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
(NE)##14##1##(1991-11#1)(1993-3#1)(1996-12#1)(1996-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
(NED)##4##1##(2008-10#3)(2013-1#1)
(NEHAP)##2##1##(2008-1#2)
(NEM)##3##1##(1990-2#1)(1995-8#1)(2008-11#1)
(NER)##3##1##(2008-11#3)
(NET)##2##1##(1996-12#1)(2007-10#1)
(NF)##5##1##(1991-3#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-12#1)
(NF-L)##2##1##(1996-5#1)(1997-2#1)
(NF-κB)##4##1##(2012-2#1)(2012-3#2)(2013-1#1)
(NF2)##4##1##(1997-3#2)(2008-10#1)(2010-11#1)
(NFC)##2##1##(2007-12#1)(2012-2#1)
(NFL)##2##1##(1991-10#1)(1991-5#1)
(NFM)##2##1##(1991-5#1)(2008-10#1)
(NFP)##2##1##(2008-10#1)(2008-11#1)
(NGF) and##2##2##(1991-12#1)(2008-11#1)
(NGF)##26##1##(1991-12#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-11#5)(2008-4#1)(2008-5#4)(2010-8#2)
(NGS)##2##1##(2008-12#1)(2012-2#1)
(NH(4))(2)CO(3)##3##1##(2008-10#3)
(NH(4))(2)SO(4)##8##1##(2008-10#7)(2008-8#1)
(NH4)2SO4##2##1##(1996-5#1)(1997-4#1)
(NHA)##2##1##(1993-2#1)(1997-1#1)
(NHC)##2##1##(2010-7#1)(2013-8#1)
(NHE)##3##1##(1991-8#1)(1993-5#1)(1997-7#1)
(NHEJ)##3##1##(1997-7#1)(2008-7#1)(2011-1#1)
(NHI)##3##1##(2008-12#1)(2010-8#1)(2011-1#1)
(NHL)##9##1##(1990-12#1)(1996-8#1)(2007-10#2)(2009-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
(NHP)##2##1##(2009-3#1)(2010-9#1)
(NHS)##9##1##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
(NI)##4##1##(1993-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
(NIC)##2##1##(2008-3#1)(2013-1#1)
(NICE)##4##1##(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
(NICU)##4##1##(1991-1#1)(1991-12#1)(1993-3#1)(1994-2#1)
(NIES No##2##2##(2008-10#2)
(NIES##3##1##(2008-10#3)
(NIF)##2##1##(2008-10#1)(2008-3#1)
(NIH##2##1##(1993-8#1)(1997-1#1)
(NIIRS)##2##1##(2008-2#1)(2008-3#1)
(NIR) spectroscopy##7##2##(2007-12#1)(2008-10#5)(2011-1#1)
(NIR)##27##1##(2007-12#2)(2008-1#1)(2008-10#15)(2008-3#4)(2009-12#1)(2010-1#1)(2011-1#2)(2012-2#1)
(NIS)##2##1##(1995-3#1)(2008-3#1)
(NIST SRM##4##2##(2008-10#4)
(NIST##10##1##(2008-10#10)
(NIST) and##2##2##(2008-10#2)
(NIST)##6##1##(2008-10#3)(2008-2#1)(2008-3#2)
(NJ)##2##1##(2008-4#1)(2008-9#1)
(NKK CRM No##3##3##(2008-10#3)
(NL)##3##1##(1992-12#1)(2008-7#1)(2008-8#1)
(NLM)##6##1##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-1#1)(1995-11#1)
(NLS)##2##1##(1997-7#1)(2008-3#1)
(NM)##2##1##(1995-5#1)(2010-12#1)
(NMDA##3##1##(1995-12#2)(1997-2#1)
(NMDA) glutamate receptor##4##3##(1994-8#1)(1995-2#1)(1997-6#1)(2012-12#1)
(NMDA) receptor##8##2##(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-7#1)
(NMDA)##28##1##(1992-8#1)(1993-12#1)(1993-5#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#3)(1997-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
(NMDAR)##2##1##(2009-7#1)(2012-2#1)
(NMF)##2##1##(2008-10#2)
(NMR)##23##1##(1991-5#1)(1992-3#1)(1992-4#1)(1993-3#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2009-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
(NMS)##3##1##(1996-5#1)(2012-2#1)(2012-3#1)
(NMU)##2##1##(2013-1#1)(2013-7#1)
(NN)##6##1##(1996-2#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-8#1)
(NNK)##4##1##(1990-6#1)(1992-9#1)(1993-11#1)(2011-1#1)
(NNS)##2##1##(2008-10#1)(2009-6#1)
(NO##3##1##(2008-10#3)
(NO(2) 0##2##2##(2008-10#2)
(NO)##66##1##(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
(NO2 +##2##2##(1996-12#2)
(NOC)##2##1##(2011-1#1)(2013-1#1)
(NOE)##3##1##(1992-3#1)(1993-8#1)(2008-11#1)
(NOM)##4##1##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
(NOR)##8##1##(2008-10#4)(2008-12#1)(2008-5#2)(2013-8#1)
(NOS)##17##1##(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#2)(1996-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-1#1)
(NOTES)##2##1##(2009-2#1)(2009-8#1)
(NP) and##2##2##(1993-12#1)(2008-10#1)
(NP)##8##1##(1993-12#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-1#1)(2013-8#1)
(NPC) is##2##2##(1990-8#1)(2011-2#1)
(NPC)##8##1##(1990-8#1)(1992-6#1)(2008-8#1)(2008-9#1)(2011-2#3)(2013-1#1)
(NPCs)##3##1##(2008-7#1)(2011-2#1)(2013-7#1)
(NPD)##2##1##(2008-12#1)(2008-9#1)
(NPH)##2##1##(2007-7#1)(2011-1#1)
(NPOE)##7##1##(2008-10#7)
(NPP)##2##1##(2008-12#1)(2011-2#1)
(NPRS)##2##1##(2008-12#2)
(NPS)##2##1##(2008-7#1)(2008-9#1)
(NPT)##2##1##(2011-2#2)
(NPV)##3##1##(2008-10#1)(2008-6#1)(2011-2#1)
(NPs)##4##1##(1997-3#1)(2010-5#1)(2012-12#1)(2012-6#1)
(NQS)##4##1##(2008-10#4)
(NR)##9##1##(1993-6#2)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)
(NRC)##2##1##(2008-12#1)(2011-1#1)
(NRT) and##2##2##(2008-9#1)(2011-2#1)
(NRT)##5##1##(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#2)
(NS) in the##2##3##(2008-10#2)
(NS)##8##1##(1996-5#1)(2007-8#1)(2008-10#4)(2009-1#1)(2012-2#1)
(NSAID)##7##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)
(NSAIDs)##15##1##(1993-2#1)(1995-5#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
(NSC##3##1##(1992-9#1)(2008-4#2)
(NSC)##3##1##(2009-10#1)(2011-2#1)(2012-5#1)
(NSCLC)##22##1##(1990-2#1)(1991-2#1)(1993-2#1)(1993-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-8#2)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(NSS)##2##1##(2008-10#1)(2008-9#1)
(NST)##2##1##(1993-12#1)(2008-5#1)
(NSTEMI)##3##1##(2011-2#2)(2012-3#1)
(NSs)##3##1##(2008-10#3)
(NT##2##1##(1994-8#1)(2008-10#1)
(NT) and##2##2##(1996-2#1)(2008-9#1)
(NT)##11##1##(1990-5#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-8#1)
(NT-3)##3##1##(1994-8#1)(2008-5#1)(2009-10#1)
(NT-proBNP)##3##1##(2008-3#1)(2008-7#1)(2011-2#1)
(NTA)##2##1##(2008-10#2)
(NTD)##2##1##(2009-7#1)(2012-1#1)
(NTE)##2##1##(1996-12#1)(2008-10#1)
(NTP)##2##1##(2008-11#1)(2010-8#1)
(NTPDases##2##1##(2008-4#2)
(NTRs)##2##1##(2009-10#1)(2011-2#1)
(NTS) of##3##2##(1997-2#2)(2008-8#1)
(NTS)##5##1##(1992-3#1)(1997-2#2)(2008-10#1)(2008-8#1)
(NYHA##4##1##(1991-6#2)(1996-8#1)(2008-10#1)
(Na##4##1##(2008-10#3)(2013-1#1)
(Na)##2##1##(1995-8#2)
(NaCl##2##1##(2008-10#1)(2008-7#1)
(NaCl)##5##1##(1990-5#1)(1992-3#1)(2007-3#1)(2008-10#1)(2008-8#1)
(NaF)##6##1##(1990-7#1)(2008-10#4)(2013-1#1)
(NaNO(3)##3##1##(2008-10#3)
(NaNO(3))##2##1##(2008-10#2)
(NaTPB) as an##3##3##(2008-10#3)
(NaTPB) as anion##2##3##(2008-10#2)
(NaTPB) as##6##2##(2008-10#6)
(NaTPB)##8##1##(2008-10#8)
(NalR)##2##1##(1994-12#1)(1995-8#1)
(National Association##2##2##(1991-3#1)(1992-2#1)
(National Institute##2##2##(2008-10#1)(2013-8#1)
(National##13##1##(1990-12#2)(1991-3#1)(1992-2#1)(1992-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#2)(2013-8#1)
(Nc)##2##1##(2008-10#2)
(Nd##2##1##(2007-11#1)(2008-3#1)
(Ne)##2##1##(1996-5#1)(2008-8#1)
(Nebraska##2##1##(2008-8#1)(2009-4#1)
(Nei's coefficient of gene differentiation [G(ST)] = 0##2##8##(2008-10#2)
(Nematoda##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
(New##2##1##(2007-8#1)(2012-12#1)
(Newton##2##1##(1995-6#1)(2011-2#1)
(Ni##2##1##(2008-10#1)(2008-6#1)
(Ni)##10##1##(1997-4#1)(2008-10#8)(2008-6#1)
(NiCoTs)##2##1##(2013-1#2)
(NiFe) and (NiFeSe) hydrogenases##3##4##(1990-8#3)
(NiFe) and (NiFeSe)##4##3##(1990-8#4)
(NiFe)##5##1##(1990-8#5)
(NiFeSe) hydrogenase##2##2##(1990-8#2)
(NiFeSe)##5##1##(1990-8#5)
(NiHCF)##3##1##(2008-10#3)
(Nicotiana tabacum cv##2##3##(2008-10#1)(2008-9#1)
(Nicotiana tabacum##4##2##(2008-10#3)(2008-9#1)
(Nicotiana##9##1##(2008-10#5)(2008-9#2)(2011-2#1)(2013-1#1)
(Nit) mutants##2##2##(2008-10#2)
(Nm##3##1##(2008-10#3)
(Nm)##2##1##(2008-10#2)
(No##15##1##(1996-2#6)(1997-7#3)(2007-8#2)(2008-12#2)(2010-3#1)(2012-2#1)
(North##6##1##(1991-8#2)(2008-10#3)(2008-3#1)
(Northern##2##1##(1995-11#1)(2008-7#1)
(NotI##2##1##(1994-12#2)
(Nt+1 = f(Nt##2##3##(2008-9#2)
(Nuc)##2##1##(1992-8#1)(2008-10#1)
(O##7##1##(1991-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)
(O) for##2##2##(1991-1#1)(2008-10#1)
(O)##7##1##(1991-1#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#1)
(O-sulfo)-MK-447 was a##2##3##(1991-8#2)
(O2##4##1##(1994-11#1)(1995-6#1)(2008-5#1)(2013-8#1)
(O2)##4##1##(1996-12#1)(2009-10#1)(2011-1#1)(2013-8#1)
(O2-##2##1##(1991-9#1)(1995-8#1)
(O2-)##3##1##(1992-5#1)(1994-8#1)(1996-2#1)
(O45rel)##2##1##(1995-11#2)
(OA##2##1##(1993-2#1)(2007-11#1)
(OA)##16##1##(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-1#1)(2013-1#3)
(OAG)##2##1##(1990-12#1)(1993-3#1)
(OATP)##2##1##(2008-11#1)(2008-8#1)
(OB)##5##1##(1990-7#1)(1996-5#1)(2008-2#1)(2012-2#1)(2013-1#1)
(OBC)##2##1##(2008-2#1)(2010-5#1)
(OBP)##2##1##(2008-10#1)(2008-8#1)
(OC)##5##1##(1994-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
(OCD) is##2##2##(2008-11#1)(2013-1#1)
(OCD)##9##1##(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-9#1)(2013-1#2)
(OCT) and##2##2##(2008-5#1)(2011-2#1)
(OCT) in##3##2##(2007-11#1)(2008-7#1)(2011-7#1)
(OCT) is an##2##3##(2011-2#1)(2011-7#1)
(OCT) is##3##2##(2011-2#1)(2011-7#1)(2012-2#1)
(OCT) system is##2##3##(2007-12#1)(2008-3#1)
(OCT) system##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
(OCT)##33##1##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#3)(2011-7#8)(2012-2#1)(2013-1#2)
(OD)##4##1##(1990-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
(ODA)##3##1##(2008-10#2)(2010-5#1)
(ODC)##5##1##(1993-8#1)(1994-12#1)(1995-8#1)(2008-10#2)
(ODN)##3##1##(2008-10#2)(2011-2#1)
(ODNs)##5##1##(1991-9#1)(1994-12#1)(1996-12#1)(2008-10#2)
(ODS)##5##1##(1991-5#1)(2008-10#4)
(ODT)##3##1##(2007-12#1)(2008-10#1)(2009-6#1)
(OE)##2##1##(2007-12#1)(2008-3#1)
(OF)##2##1##(2008-10#1)(2008-3#1)
(OFLX)##2##1##(2008-10#2)
(OG)##2##1##(1994-5#1)(1995-12#1)
(OH##3##1##(1995-12#1)(2008-10#1)(2008-3#1)
(OH) and##3##2##(2009-4#1)(2012-3#2)
(OH)##13##1##(2008-10#1)(2008-3#1)(2009-4#1)(2012-3#8)(2013-1#2)
(OH-NA)##3##1##(2008-10#3)
(OHA)##2##1##(1992-6#1)(1994-3#1)
(OHS)##3##1##(1995-12#1)(2011-1#1)(2012-12#1)
(OKT3)##2##1##(2007-7#1)(2008-1#1)
(OL)##2##1##(1995-5#1)(2007-12#1)
(OLS)##2##1##(1995-2#1)(2008-10#1)
(OM)##8##1##(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#1)(2012-4#1)(2013-1#1)(2013-8#1)
(OMC)##2##1##(1995-12#1)(2008-5#1)
(OMP)##6##1##(1990-12#1)(1993-9#1)(1994-8#1)(1995-12#1)(2008-12#1)(2008-5#1)
(OMT)##2##1##(2008-10#1)(2013-1#1)
(ON) and##2##2##(1995-12#1)(2008-7#1)
(ON)##3##1##(1995-12#1)(2008-7#1)(2011-7#1)
(OO)##2##1##(2008-2#1)(2013-1#1)
(OP) and##2##2##(1996-2#1)(2010-12#1)
(OP) pesticides##3##2##(2010-5#1)(2013-1#2)
(OP)##15##1##(1996-2#1)(1997-4#1)(2008-10#4)(2008-12#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#2)
(OPA) in##2##2##(2008-10#1)(2008-2#1)
(OPA)##9##1##(1991-5#1)(2007-11#1)(2008-10#6)(2008-2#1)
(OPA-NAC)##2##1##(2008-10#2)
(OPC)##4##1##(1997-4#1)(2008-5#2)(2010-10#1)
(OPCAB)##3##1##(2007-8#2)(2010-8#1)
(OPD)##8##1##(1995-11#1)(2008-10#2)(2008-3#5)
(OPO)##30##1##(2007-11#6)(2007-12#10)(2008-10#1)(2008-2#4)(2008-3#8)(2008-5#1)
(OPSS-PEG-NHS)##2##1##(2008-10#2)
(OR 0##3##2##(2009-9#1)(2011-1#1)(2012-12#1)
(OR 1##6##2##(2007-2#2)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
(OR 2##5##2##(2007-10#1)(2010-9#1)(2011-1#1)(2011-2#2)
(OR 3##2##2##(2013-1#2)
(OR 4##2##2##(2012-12#1)(2013-1#1)
(OR = 0##13##3##(1994-12#1)(2008-6#1)(2008-7#1)(2010-11#4)(2011-1#3)(2012-3#3)
(OR = 1##19##3##(1994-12#5)(2010-11#3)(2010-12#1)(2011-1#8)(2012-1#2)
(OR = 2##17##3##(1992-10#1)(1993-12#1)(1994-12#1)(2008-12#2)(2008-3#2)(2008-7#1)(2010-10#1)(2011-1#6)(2011-2#1)(2012-1#1)
(OR = 3##9##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#3)(2011-2#2)
(OR = 4##2##3##(2011-1#1)(2011-2#1)
(OR = 5##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
(OR =##67##2##(1991-12#1)(1992-10#1)(1993-12#3)(1994-12#7)(2008-10#1)(2008-12#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2010-10#1)(2010-11#7)(2010-12#1)(2010-2#1)(2011-1#21)(2011-2#6)(2012-1#3)(2012-3#3)
(OR [95% CI]##2##3##(2012-2#2)
(OR##99##1##(1991-12#1)(1992-10#1)(1993-12#3)(1994-12#7)(2007-10#3)(2007-2#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#3)(2009-9#2)(2010-10#1)(2010-11#7)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#24)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)
(OR) for##5##2##(2008-3#1)(2008-6#1)(2009-9#1)(2012-3#1)(2013-1#1)
(OR) were##2##2##(2011-2#1)(2012-12#1)
(OR)##22##1##(1992-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
(OR--1##6##1##(2007-10#6)
(OR=0##4##1##(2009-9#3)(2011-2#1)
(OR=1##3##1##(2008-10#1)(2008-11#1)(2012-12#1)
(OR=2##4##1##(2011-2#1)(2012-12#3)
(OR=4##5##1##(2011-2#1)(2012-12#4)
(ORF##7##1##(2008-10#7)
(ORF) and##3##2##(1992-3#1)(1994-12#1)(1997-4#1)
(ORF)##41##1##(1990-11#2)(1991-9#1)(1992-3#1)(1993-12#4)(1993-6#1)(1994-11#1)(1994-12#6)(1995-6#1)(1995-8#4)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2008-10#5)(2008-7#2)(2008-8#3)(2008-9#1)(2010-5#1)(2013-1#1)
(ORF1)##2##1##(2008-8#1)(2008-9#1)
(ORS)##3##1##(1991-9#1)(2008-1#1)(2008-10#1)
(ORSV)##3##1##(2008-10#3)
(ORs)##3##1##(2008-2#1)(2008-8#1)(2011-2#1)
(OR = 0##5##1##(2011-2#3)(2012-12#2)
(OR = 3##2##1##(2011-2#2)
(OS) and##4##2##(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)
(OS)##18##1##(1991-8#1)(1992-10#1)(1993-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-3#4)(2011-2#4)
(OSA)##4##1##(2009-9#1)(2010-5#1)(2012-2#1)(2013-7#1)
(OSC)##5##1##(1992-8#1)(2008-10#2)(2008-5#1)(2008-6#1)
(OSCE)##7##1##(1994-2#1)(2008-11#5)(2012-3#1)
(OT)##3##1##(1996-12#1)(2008-10#1)(2010-12#1)
(OTC)##9##1##(2008-10#5)(2008-7#2)(2009-8#1)(2012-7#1)
(OV)##4##1##(1997-4#3)(2008-11#1)
(OVA)##3##1##(1993-12#1)(2008-10#1)(2008-11#1)
(OWG)##2##1##(2008-10#2)
(Och##5##1##(2013-1#5)
(October##2##1##(2013-1#1)(2013-7#1)
(Office of##2##2##(1992-5#1)(1994-2#1)
(Oil(prenatal)/DES(adult))##2##1##(2008-10#2)
(Oncogenes##2##1##(2013-1#2)
(Oncorhynchus##9##1##(1993-3#1)(1993-5#1)(1995-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)
(One-way parametric ANOVA##3##3##(2008-10#3)
(Onrigin™)##2##1##(2010-11#2)
(Orthoptera##6##1##(2007-12#2)(2008-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
(Oryza sativa L##14##3##(1992-8#1)(1994-11#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-9#7)
(Oryza sativa##17##2##(1992-8#1)(1994-11#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-9#8)(2009-10#2)
(Oryza sativa)##7##2##(2008-10#4)(2008-7#2)(2009-10#1)
(Oryza##26##1##(1992-8#1)(1994-11#1)(1996-12#1)(1997-4#2)(2008-10#6)(2008-4#1)(2008-7#2)(2008-9#8)(2009-10#4)
(Oryzias latipes)##4##2##(2008-11#1)(2008-5#1)(2008-8#2)
(Ovis##4##1##(1995-2#1)(2008-9#1)(2009-4#2)
(Ox)##2##1##(1993-6#1)(2008-10#1)
(Ox-LDL)##2##1##(1990-8#2)
(OxLDL)##2##1##(1995-2#1)(2013-7#1)
(Oxine)##2##1##(2008-10#2)
(P &gt##28##2##(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#11)(2008-7#2)(2008-9#2)(2010-2#2)(2011-1#2)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
(P &lt##490##2##(1992-11#3)(1992-12#5)(1992-9#3)(1993-1#4)(1993-10#6)(1993-11#1)(1993-12#8)(1993-2#6)(1993-8#3)(1993-9#1)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#1)(1994-7#1)(1994-8#5)(1995-12#9)(1995-2#3)(1995-6#1)(1995-8#5)(1996-12#21)(1996-6#4)(1997-1#1)(1997-3#1)(1997-5#6)(1997-7#1)(1997-8#4)(2006-6#1)(2007-10#14)(2007-8#2)(2008-1#1)(2008-10#107)(2008-11#3)(2008-3#11)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#21)(2008-8#1)(2008-9#7)(2009-11#3)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#55)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#13)(2011-2#16)(2011-3#13)(2012-1#1)(2012-2#8)(2012-3#22)(2013-1#30)(2013-8#5)
(P = 0##189##3##(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#2)(1994-2#1)(1994-3#2)(1995-12#4)(1995-3#3)(1995-6#2)(1995-8#2)(1996-1#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-5#7)(2007-10#1)(2007-8#3)(2008-10#67)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#17)(2008-8#3)(2010-1#2)(2010-2#4)(2011-1#4)(2011-2#9)(2012-2#1)(2012-3#4)(2013-1#20)(2013-8#7)
(P = n/s)##2##3##(2012-1#2)
(P =##250##2##(1990-2#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#2)(1994-2#1)(1994-3#2)(1995-12#4)(1995-3#3)(1995-6#2)(1995-8#2)(1996-1#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-5#7)(2007-10#21)(2007-8#3)(2008-10#68)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#17)(2008-8#4)(2009-1#1)(2009-10#1)(2009-8#2)(2010-1#2)(2010-2#4)(2010-4#1)(2010-8#9)(2011-1#4)(2011-2#14)(2012-1#2)(2012-2#1)(2012-3#8)(2013-1#31)(2013-8#7)
(P from 0##6##3##(2011-1#6)
(P less than 0##35##4##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#5)(1991-8#1)(1991-9#7)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#2)(1996-2#1)
(P less than or equal to 0##3##7##(1990-3#3)
(P less than##39##3##(1990-11#2)(1990-12#2)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#5)(1991-8#1)(1991-9#7)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#2)(1996-2#2)
(P value &lt##2##3##(2008-4#2)
(P ≤ 0##2##3##(2012-3#2)
(P ≤##3##2##(2010-12#1)(2012-3#2)
(P##859##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#4)(1991-5#5)(1991-8#1)(1991-9#7)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#4)(1993-10#6)(1993-11#1)(1993-12#8)(1993-2#8)(1993-3#2)(1993-8#3)(1993-9#1)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-12#13)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#7)(1996-1#2)(1996-12#22)(1996-2#2)(1996-3#2)(1996-6#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#13)(1997-7#3)(1997-8#4)(2006-6#1)(2007-10#36)(2007-8#5)(2008-1#1)(2008-10#205)(2008-11#3)(2008-3#19)(2008-4#9)(2008-5#16)(2008-6#1)(2008-7#41)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#4)(2010-12#3)(2010-2#61)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#11)(2011-1#26)(2011-10#1)(2011-2#36)(2011-3#14)(2012-1#3)(2012-2#11)(2012-3#32)(2013-1#64)(2013-8#13)
(P&gt##17##1##(2007-10#1)(2008-10#1)(2008-12#3)(2008-7#3)(2008-9#1)(2009-3#2)(2010-4#2)(2012-2#1)(2013-1#2)(2013-8#1)
(P&lt##159##1##(1993-10#1)(1995-12#4)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#5)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#24)(2008-1#1)(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#27)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#6)(2009-4#12)(2009-5#1)(2010-2#3)(2010-3#3)(2010-4#8)(2010-5#4)(2011-1#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
(P(1))##3##1##(2008-10#3)
(P(2))##4##1##(2008-10#4)
(P) and##2##2##(2008-10#1)(2011-1#1)
(P) concentrations##2##2##(1994-9#1)(1995-8#1)
(P) in##4##2##(2008-10#4)
(P) with##2##2##(1995-6#1)(2008-10#1)
(P)##34##1##(1993-8#1)(1994-9#2)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#14)(2008-5#4)(2008-9#1)(2010-4#1)(2011-1#3)(2012-3#1)(2013-8#1)
(P-450(11 beta)##2##2##(1990-5#2)
(P-gp)##5##1##(2008-11#2)(2008-7#1)(2011-3#1)(2012-3#1)
(P1)##6##1##(1990-11#1)(1991-9#1)(1997-8#1)(2008-10#1)(2011-1#1)(2012-3#1)
(P2##3##1##(1993-1#2)(2012-3#1)
(P388/S) and##2##2##(1991-12#1)(1991-4#1)
(P450##4##1##(1992-11#1)(1992-8#1)(1993-8#1)(1994-8#1)
(P450(14DM))##2##1##(1994-6#2)
(P450s)##2##1##(2008-9#1)(2009-8#1)
(P567)##2##1##(2008-2#1)(2008-3#1)
(P64 and P68)##2##3##(1991-8#2)
(P= 0##3##2##(1997-7#1)(2008-4#1)(2012-3#1)
(P=##7##1##(1997-7#1)(2007-10#1)(2008-4#1)(2010-6#3)(2012-3#1)
(P=0##70##1##(2006-6#1)(2007-2#4)(2007-7#1)(2007-8#25)(2008-10#10)(2008-11#1)(2008-12#8)(2008-3#1)(2008-7#6)(2008-8#3)(2009-4#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
(P=NS)##2##1##(2007-8#2)
(P=not significant)##3##2##(2007-8#2)(2008-8#1)
(PA =##3##2##(2008-12#3)
(PA##4##1##(2008-10#1)(2008-12#3)
(PA) and##4##2##(1995-2#1)(1995-3#1)(2007-12#1)(2008-11#1)
(PA) is##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
(PA) or##2##2##(1991-5#1)(2008-8#1)
(PA)##27##1##(1991-5#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#2)(2009-3#2)(2009-6#1)(2011-2#2)(2012-2#2)(2013-1#2)
(PAA)##6##1##(2008-10#5)(2009-12#1)
(PAC)##3##1##(1995-5#1)(1997-8#1)(2008-10#1)
(PACAP)##3##1##(1990-12#2)(1995-11#1)
(PAD) and##2##2##(2008-10#2)
(PAD)##8##1##(1991-7#1)(2008-10#4)(2008-8#2)(2012-2#1)
(PAF)##7##1##(1991-5#1)(1995-3#1)(1997-7#2)(2008-3#1)(2009-3#1)(2013-1#1)
(PAGE)##6##1##(1990-11#1)(1992-8#1)(1995-12#1)(2008-5#2)(2010-3#1)
(PAH) in##4##2##(2008-10#3)(2010-10#1)
(PAH)##19##1##(1990-3#1)(1994-5#1)(1995-11#1)(2008-10#7)(2008-11#1)(2009-10#1)(2010-10#5)(2010-5#1)(2011-1#1)
(PAI)##3##1##(1990-8#1)(1995-2#1)(2008-10#1)
(PAI-1)##8##1##(1993-12#1)(1994-9#2)(1995-8#1)(2008-3#2)(2008-4#1)(2013-1#1)
(PAK)##2##1##(1995-2#1)(2012-12#1)
(PAL)##3##1##(2008-10#2)(2008-4#1)
(PALA)##2##1##(1990-8#1)(1995-6#1)
(PAM) process##2##2##(2008-7#2)
(PAM)##8##1##(1993-8#1)(1994-11#1)(1996-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-12#1)
(PAN) and##2##2##(2008-10#2)
(PAN) as##2##2##(2008-10#2)
(PAN) in##2##2##(2008-10#2)
(PAN)##18##1##(2006-10#1)(2008-10#16)(2009-6#1)
(PANAS)##3##1##(2008-11#1)(2013-8#2)
(PANDAS)##2##1##(2011-2#2)
(PANI)##2##1##(2008-10#2)
(PAP) is##2##2##(2008-12#1)(2010-7#1)
(PAP)##12##1##(1990-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-1#1)(2010-7#1)(2010-8#1)
(PAR) and##4##2##(2008-10#4)
(PAR) chelates##2##2##(2008-10#2)
(PAR) in##2##2##(2008-10#2)
(PAR)##21##1##(2008-10#16)(2008-3#3)(2008-7#1)(2012-12#1)
(PARAFAC) and##2##2##(2008-10#2)
(PARAFAC)##6##1##(2008-10#6)
(PAS)##6##1##(1994-2#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-9#1)(2009-7#1)
(PAT)##3##1##(2008-5#1)(2011-2#1)(2012-3#1)
(PB and CuHCF##2##3##(2008-10#2)
(PB##3##1##(2008-10#3)
(PB) and##2##2##(2008-10#2)
(PB)##12##1##(1990-7#1)(2008-10#9)(2008-4#1)(2008-5#1)
(PBD)##3##1##(1992-12#1)(2008-10#2)
(PBDEs) in##3##2##(2008-10#3)
(PBDEs)##5##1##(2008-10#4)(2008-7#1)
(PBL) and##3##2##(1995-12#1)(2008-7#1)(2013-8#1)
(PBL) is##3##2##(2007-5#1)(2011-1#1)(2012-2#1)
(PBL)##19##1##(1991-9#1)(1992-2#1)(1993-9#1)(1995-12#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
(PBMC)##10##1##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2011-2#1)(2011-3#1)
(PBN)##3##1##(1993-6#1)(2008-5#1)(2009-10#1)
(PBS##2##1##(2008-10#1)(2011-3#1)
(PBS) is##2##2##(2008-10#1)(2008-3#1)
(PBS)##10##1##(1990-6#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-3#1)
(PBT)##2##1##(1995-2#1)(2008-6#1)
(PC##4##1##(1992-10#1)(2008-10#3)
(PC) and##6##2##(1994-12#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
(PC) is##2##2##(2008-10#1)(2008-7#1)
(PC) slab##2##2##(2007-11#2)
(PC) was##2##2##(1995-8#1)(2008-11#1)
(PC) were##2##2##(2008-10#1)(2009-8#1)
(PC)##42##1##(1990-11#1)(1990-6#1)(1991-5#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-5#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
(PC1)##2##1##(2008-10#2)
(PC12)##5##1##(1992-12#1)(1994-11#1)(1995-12#1)(2008-4#1)(2013-8#1)
(PCA) in##2##2##(2007-5#1)(2010-5#1)
(PCA) is a##3##3##(2008-10#1)(2010-7#1)(2011-1#1)
(PCA) is##4##2##(2008-10#1)(2010-7#1)(2011-1#1)(2013-8#1)
(PCA) with##2##2##(2008-10#1)(2012-3#1)
(PCA)##59##1##(1995-11#1)(1996-5#2)(1997-6#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#39)(2008-7#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
(PCB)##4##1##(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
(PCC)##3##1##(2008-10#1)(2013-8#2)
(PCD)##6##1##(1994-10#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#2)
(PCDD/Fs)##2##1##(2008-10#2)
(PCE) and##2##2##(1993-8#1)(2008-10#1)
(PCE)##4##1##(1993-8#1)(2008-10#1)(2009-2#1)(2012-12#1)
(PCI)##10##1##(2008-11#1)(2008-3#4)(2009-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
(PCL)##7##1##(2008-10#1)(2008-5#1)(2009-7#1)(2010-4#1)(2012-7#1)(2013-1#2)
(PCM)##2##1##(1997-7#1)(2008-2#1)
(PCNB)##2##1##(1997-6#1)(2008-10#1)
(PCNL)##2##1##(2007-7#1)(2012-12#1)
(PCOS)##13##1##(2008-3#2)(2008-4#9)(2013-1#1)(2013-8#1)
(PCP)##10##1##(1991-1#2)(2007-12#2)(2008-10#4)(2008-8#1)(2009-3#1)
(PCR##2##1##(1997-8#1)(2009-8#1)
(PCR) and##19##2##(2008-10#13)(2008-12#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
(PCR) in##6##2##(1994-1#1)(1995-8#1)(2008-1#1)(2008-10#3)
(PCR) method##3##2##(1996-12#1)(2008-10#1)(2008-12#1)
(PCR) using degenerate oligonucleotides##2##4##(1993-8#1)(1996-8#1)
(PCR) using##8##2##(1993-8#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
(PCR) was##2##2##(1991-4#1)(2008-10#1)
(PCR) were##2##2##(2008-10#2)
(PCR) with##4##2##(2008-10#4)
(PCR)##173##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-10#2)(1996-12#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#99)(2008-11#2)(2008-12#5)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
(PCR-RFLP) and##2##2##(2008-10#2)
(PCR-RFLP)##5##1##(1997-8#1)(2008-10#4)
(PCS)##5##1##(1995-5#1)(2007-7#1)(2007-8#1)(2013-1#2)
(PCT)##5##1##(2007-11#1)(2008-10#1)(2008-5#2)(2010-2#1)
(PCV)##5##1##(2008-10#3)(2013-1#1)(2013-8#1)
(PCs) of the##2##3##(1994-2#1)(2008-10#1)
(PCs)##8##1##(1994-2#1)(2008-10#5)(2008-11#1)(2010-9#1)
(PD##2##1##(2011-2#1)(2013-7#1)
(PD) and##11##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2012-3#1)(2013-1#1)
(PD) are##4##2##(2007-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
(PD) is a##7##3##(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)
(PD) is an##3##3##(2008-10#1)(2008-7#2)
(PD) is##13##2##(2008-10#1)(2008-12#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
(PD) patients are##2##3##(2008-7#1)(2011-2#1)
(PD) patients##11##2##(1995-12#1)(2007-12#1)(2008-7#5)(2011-2#3)(2013-1#1)
(PD) was##2##2##(2008-1#1)(2008-7#1)
(PD)##94##1##(1990-2#1)(1990-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-12#4)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#33)(2008-8#1)(2009-10#1)(2009-4#2)(2010-12#2)(2010-8#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
(PDA) and##3##2##(2007-8#1)(2008-10#2)
(PDA) for##2##2##(2008-10#2)
(PDA)##15##1##(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
(PDAs)##2##1##(2008-12#1)(2012-2#1)
(PDB ID##2##2##(2012-2#1)(2013-7#1)
(PDB##3##1##(2007-11#1)(2012-2#1)(2013-7#1)
(PDB)##3##1##(2008-10#1)(2008-4#1)(2011-3#1)
(PDC)##3##1##(2007-7#1)(2008-10#2)
(PDE)##5##1##(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
(PDF)##2##1##(2008-6#1)(2011-1#1)
(PDGFRA)##2##1##(2013-1#1)(2013-8#1)
(PDH)##2##1##(1994-11#1)(2013-1#1)
(PDI)##4##1##(1990-7#1)(2008-3#1)(2008-7#1)(2013-1#1)
(PDL)##7##1##(1995-8#1)(2008-11#2)(2008-3#2)(2008-5#1)(2013-1#1)
(PDLC)##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
(PDMS) and##2##2##(2008-10#1)(2009-11#1)
(PDMS) microfluidic##3##2##(2008-10#3)
(PDMS)##13##1##(1990-8#1)(1992-3#1)(2008-10#6)(2008-5#1)(2009-11#2)(2009-2#1)(2010-8#1)
(PDMS/DVB##2##1##(2008-10#2)
(PDR) in##2##2##(2008-10#1)(2013-1#1)
(PDS) were##2##2##(1995-2#1)(2012-12#1)
(PDS)##10##1##(1992-1#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
(PDT)##25##1##(1990-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-1#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#4)(2010-8#1)(2012-3#3)(2013-8#2)
(PDTC)##2##1##(1993-3#1)(2008-3#1)
(PDV)##3##1##(1993-12#1)(2008-10#2)
(PE##2##1##(2008-2#1)(2008-9#1)
(PE) and##3##2##(1995-8#1)(2008-3#1)(2011-2#1)
(PE) is##2##2##(2008-7#1)(2010-6#1)
(PE)##20##1##(1991-1#1)(1992-10#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)
(PEA)##2##1##(1996-5#1)(2012-2#1)
(PEB)##2##1##(2007-12#1)(2008-3#1)
(PED)##2##1##(2008-10#1)(2011-2#1)
(PEDOT)##2##1##(2008-10#1)(2013-1#1)
(PEG##7##1##(2008-10#1)(2008-12#4)(2008-5#1)(2008-6#1)
(PEG) and##2##2##(2008-6#1)(2012-1#1)
(PEG)##19##1##(1990-12#1)(2008-10#6)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
(PEI) and##2##2##(2009-11#1)(2010-4#1)
(PEI) as##2##2##(1992-9#1)(2008-10#1)
(PEI) was##2##2##(1992-11#1)(1994-5#1)
(PEI)##12##1##(1992-11#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-10#5)(2008-11#1)(2009-11#1)(2010-4#1)
(PEM)##4##1##(1990-12#1)(1993-2#1)(2008-10#1)(2008-8#1)
(PEO)##5##1##(2008-10#4)(2008-5#1)
(PEP)##6##1##(1995-5#1)(1997-3#1)(2007-2#1)(2008-4#2)(2009-12#1)
(PES)##2##1##(1996-1#1)(2008-10#1)
(PET##2##1##(2011-3#1)(2013-8#1)
(PET) and##4##2##(1996-5#2)(2008-8#2)
(PET)##27##1##(1990-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#4)(1996-7#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
(PET/CT)##3##1##(2009-2#1)(2012-12#1)(2013-1#1)
(PEX)##2##1##(2011-2#2)
(PF) and##2##2##(2008-2#1)(2008-9#1)
(PF)##5##1##(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
(PFA)##2##1##(1996-2#1)(2008-10#1)
(PFBBr)##2##1##(2008-10#2)
(PFC)##15##1##(1993-12#1)(1996-1#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-7#1)(2013-8#2)
(PFD)##2##1##(1993-12#1)(2010-10#1)
(PFG)##2##1##(2008-3#2)
(PFS)##5##1##(1991-8#1)(1996-3#1)(2008-10#2)(2008-11#1)
(PFT)##3##1##(1995-2#1)(2012-2#1)(2013-1#1)
(PG) and##4##2##(1994-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
(PG) in##2##2##(1994-9#1)(2008-10#1)
(PG)##22##1##(1990-2#1)(1991-9#1)(1994-8#1)(1994-9#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
(PGA)##2##1##(2009-8#1)(2011-2#1)
(PGD)##3##1##(2008-1#1)(2008-4#1)(2012-3#1)
(PGE)##4##1##(2008-11#2)(2008-8#1)(2011-3#1)
(PGE2)##11##1##(1990-11#1)(1990-2#1)(1991-8#1)(1993-11#1)(1993-12#2)(1995-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2013-8#1)
(PGH)##2##1##(1991-8#1)(1992-3#1)
(PGI) was##2##2##(1990-11#1)(2010-10#1)
(PGI)##3##1##(1990-11#1)(2010-10#2)
(PGP)##3##1##(1997-3#1)(1997-4#1)(2008-5#1)
(PGs)##7##1##(1990-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-10#1)
(PH) in##2##2##(2008-10#1)(2009-4#1)
(PH)##13##1##(1992-9#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-6#1)(2011-1#1)
(PHA##2##1##(1995-3#1)(2008-6#1)
(PHA)##4##1##(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
(PHB) by Alcaligenes eutrophus##2##4##(2008-7#2)
(PHB)##5##1##(2008-10#1)(2008-6#2)(2008-7#2)
(PHC)##3##1##(1994-3#1)(2011-1#1)(2011-2#1)
(PHL)##2##1##(2008-11#1)(2012-12#1)
(PHO)##2##1##(2008-10#1)(2013-1#1)
(PHT)##2##1##(1995-10#1)(2009-8#1)
(PI is from##2##3##(2008-9#2)
(PI##15##1##(1992-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#2)
(PI) and##6##2##(1993-11#1)(1996-6#1)(2008-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
(PI) hydrolysis##3##2##(1992-11#1)(1997-4#2)
(PI)##35##1##(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#2)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#4)(2009-6#2)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
(PI3)##2##1##(2008-11#1)(2010-11#1)
(PIA)##3##1##(1994-3#1)(1997-3#1)(2008-10#1)
(PIBs)##2##1##(2008-11#2)
(PIC)##3##1##(2008-12#1)(2009-11#1)(2010-3#1)
(PICs)##2##1##(2008-8#1)(2011-2#1)
(PID)##2##1##(2007-7#1)(2013-1#1)
(PIF)##2##1##(2008-10#1)(2008-9#1)
(PIH)##2##1##(1994-3#1)(2012-2#1)
(PIO)##2##1##(2009-11#1)(2011-2#1)
(PIP(2))##2##1##(2008-4#1)(2008-8#1)
(PIP)##4##1##(2008-8#1)(2008-9#3)
(PIP2)##5##1##(1992-9#1)(1993-6#1)(1993-8#1)(2008-8#2)
(PIPDMAHA)##2##1##(2008-10#2)
(PIR)##2##1##(2008-3#1)(2008-5#1)
(PIV)##4##1##(2008-2#2)(2008-3#1)(2012-2#1)
(PIXE)##2##1##(2008-10#2)
(PIs)##2##1##(2008-2#1)(2011-2#1)
(PK##2##1##(1990-5#1)(2011-2#1)
(PK)##11##1##(1993-2#2)(1993-9#1)(1994-11#1)(1997-6#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#2)
(PKA) and##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
(PKA)##17##1##(1990-12#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-7#1)(2010-11#1)
(PKC##3##1##(1993-12#1)(1993-8#1)(1994-5#1)
(PKC) has##2##2##(1992-6#1)(1993-12#1)
(PKC)##55##1##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-8#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#2)(2013-8#2)
(PKC1)##2##1##(1996-6#1)(1997-3#1)
(PL##4##1##(1997-4#3)(2008-5#1)
(PL) and##4##2##(1990-8#1)(1994-11#1)(2008-1#1)(2008-10#1)
(PL)##15##1##(1990-12#1)(1990-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#1)(2013-8#1)
(PLA)##3##1##(2008-5#2)(2008-6#1)
(PLC)##4##1##(1991-2#1)(1997-4#1)(2007-11#1)(2011-2#1)
(PLGA)##6##1##(2008-11#1)(2009-11#3)(2009-7#2)
(PLL)##6##1##(1991-5#1)(2008-10#4)(2012-5#1)
(PLS) analysis##2##2##(2007-11#1)(2008-10#1)
(PLS) and##8##2##(2008-10#8)
(PLS) calibration approach##2##3##(2008-10#2)
(PLS) calibration##7##2##(2008-10#7)
(PLS) model##3##2##(2008-10#3)
(PLS) multivariate calibration##4##3##(2008-10#4)
(PLS) regression##9##2##(2007-12#1)(2008-10#7)(2013-8#1)
(PLS) was developed##2##3##(2008-10#2)
(PLS) was##4##2##(2008-10#3)(2008-5#1)
(PLS)##62##1##(1994-12#1)(2007-11#2)(2007-12#1)(2008-10#54)(2008-5#2)(2009-10#1)(2013-8#1)
(PLS-1 and PLS-2)##2##3##(2008-10#2)
(PLS-1##3##1##(2008-10#3)
(PLS-1) and##3##2##(2008-10#3)
(PLS-1)##6##1##(2008-10#6)
(PLSR)##3##1##(2008-10#2)(2013-8#1)
(PLSVC) is the most common##2##5##(2010-11#1)(2011-2#1)
(PLSVC)##3##1##(2010-11#1)(2011-2#1)(2012-2#1)
(PM)##15##1##(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-7#1)(2013-1#1)
(PMA) and##4##2##(1993-3#1)(1993-6#1)(1994-3#1)(2008-11#1)
(PMA) as##2##2##(1991-2#1)(2008-11#1)
(PMA) or##2##2##(1991-5#1)(2008-11#1)
(PMA)##25##1##(1990-2#1)(1991-2#1)(1991-5#1)(1991-9#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-1#1)(1997-4#1)(2006-6#1)(2008-11#4)(2008-5#1)
(PMC)##2##1##(1992-3#1)(2008-5#1)
(PMD)##12##1##(2007-11#7)(2007-12#2)(2008-3#2)(2011-2#1)
(PME)##3##1##(2008-10#1)(2008-2#1)(2008-8#1)
(PMI)##3##1##(2007-8#1)(2008-6#1)(2009-10#1)
(PML)##2##1##(2008-3#1)(2010-2#1)
(PMMA)##14##1##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2009-11#1)(2009-9#1)(2010-4#2)
(PMN)##8##1##(1991-2#1)(1991-8#1)(1993-11#1)(1993-6#1)(2008-10#2)(2008-4#2)
(PMNL)##2##1##(2006-6#2)
(PMNS) in Cape Town##2##4##(2010-3#2)
(PMNs) in##2##2##(2008-12#2)
(PMNs) may##2##2##(1991-9#1)(2009-10#1)
(PMNs)##9##1##(1991-9#1)(1992-5#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-10#1)
(PMP)##4##1##(1992-6#1)(2008-10#1)(2008-3#1)(2009-5#1)
(PMS)##2##1##(2008-10#1)(2008-11#1)
(PMSG)##2##1##(2008-5#1)(2008-8#1)
(PMT)##3##1##(2008-10#2)(2008-5#1)
(PN)##7##1##(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
(PNAs)##3##1##(1994-9#1)(2008-4#2)
(PND)##2##1##(1996-5#1)(2008-10#1)
(PNET)##3##1##(2007-7#1)(2008-7#1)(2012-12#1)
(PNMT)##2##1##(1997-3#1)(2013-1#1)
(PNS)##3##1##(1993-6#1)(1996-12#1)(2011-2#1)
(PO(4)(3-))##2##1##(2008-10#1)(2013-1#1)
(PO)##6##1##(1993-8#1)(1997-2#1)(2008-10#2)(2008-7#1)(2011-10#1)
(PO-CL)##2##1##(2008-10#2)
(PO2)##2##1##(1993-12#1)(2013-8#1)
(POA)##3##1##(1991-12#1)(1991-5#1)(2008-8#1)
(POC)##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
(POD)##4##1##(2007-7#1)(2008-10#2)(2013-8#1)
(POI)##2##1##(2008-10#1)(2010-4#1)
(POMC)##6##1##(1993-5#1)(1995-12#1)(1996-12#1)(2008-4#2)(2009-8#1)
(POMS)##2##1##(2008-12#1)(2008-3#1)
(PONPE 5##2##2##(2008-10#2)
(POPC)##4##1##(1990-7#1)(1992-6#1)(1994-3#1)(1994-5#1)
(POPS)##2##1##(1990-7#1)(2008-3#1)
(POR)##3##1##(1993-1#1)(1995-5#1)(2009-9#1)
(POST)##3##1##(2008-5#1)(2012-2#1)(2013-1#1)
(POX +##2##2##(1997-4#2)
(POX)##2##1##(1997-4#1)(2008-10#1)
(PP) and spleen (SPL)##2##4##(2008-11#2)
(PP) and##3##2##(2008-11#2)(2008-5#1)
(PP)##12##1##(1991-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
(PP1)##2##1##(1995-6#1)(2012-12#1)
(PPA)##3##1##(1990-9#1)(1996-2#1)(2008-10#1)
(PPC)##3##1##(2008-10#2)(2008-7#1)
(PPD) and##2##2##(1996-12#1)(2007-2#1)
(PPD) as##2##2##(2008-10#1)(2008-5#1)
(PPD)##10##1##(1996-12#2)(1997-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#2)
(PPE)##8##1##(1991-3#1)(1991-9#1)(1996-12#2)(2008-5#3)(2012-1#1)
(PPG)##3##1##(2008-12#2)(2008-9#1)
(PPH)##2##1##(1997-5#1)(2011-2#1)
(PPI)##15##1##(1991-1#1)(1993-3#1)(1996-5#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
(PPL)##2##1##(1996-3#1)(2013-1#1)
(PPLN)##9##1##(2007-12#7)(2008-3#2)
(PPM)##3##1##(2008-3#1)(2011-2#1)(2012-1#1)
(PPO##2##1##(2008-10#2)
(PPO)##10##1##(1992-2#1)(2008-10#9)
(PPR)##2##1##(1995-12#1)(2011-2#1)
(PPS)##19##1##(1991-2#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-3#1)(2008-2#1)(2008-7#1)
(PPT)##4##1##(1992-9#1)(2008-10#1)(2009-5#1)(2010-12#1)
(PPV) isolates##2##2##(2008-10#2)
(PPV) of##2##2##(2007-10#1)(2011-2#1)
(PPV)##9##1##(1995-3#1)(2007-10#1)(2008-10#6)(2011-2#1)
(PPY)##3##1##(1997-6#1)(2008-10#2)
(PR) in##3##2##(2008-10#3)
(PR) proteins##4##2##(1997-6#1)(2008-10#3)
(PR)##28##1##(1991-2#1)(1991-8#1)(1993-9#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-7#2)(2008-10#15)(2008-3#1)(2010-1#1)(2013-1#1)(2013-8#2)
(PRC)##3##1##(2007-12#1)(2008-12#1)(2010-12#1)
(PRE)##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
(PRF)##2##1##(1994-2#1)(2008-10#1)
(PRI)##2##1##(1994-3#1)(2010-9#1)
(PRK)##2##1##(2008-3#1)(2009-10#1)
(PRL) secretion##2##2##(1990-7#1)(1994-3#1)
(PRL)##8##1##(1990-7#1)(1991-12#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
(PRN)##2##1##(1997-6#1)(2013-8#1)
(PRO)##4##1##(1995-12#1)(1996-2#1)(2008-10#1)(2009-11#1)
(PRO-C3 and P4NP7S)##2##3##(2013-8#2)
(PROM)##2##1##(2011-2#1)(2012-3#1)
(PRP)##7##1##(1990-12#1)(1997-7#1)(2007-9#2)(2008-7#1)(2011-2#1)(2013-1#1)
(PRPSE)##3##1##(2008-2#1)(2008-3#2)
(PRX)##2##1##(2008-5#2)
(PRs)##2##1##(1994-9#1)(2008-12#1)
(PS##4##1##(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
(PS) and##4##2##(1995-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
(PS) were##2##2##(2007-11#1)(2012-2#1)
(PS)##25##1##(1990-12#1)(1992-10#1)(1993-11#1)(1995-12#1)(1995-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#2)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(PSA##2##1##(2010-11#2)
(PSA) and##2##2##(2010-12#1)(2010-8#1)
(PSA) was##3##2##(1990-9#1)(2008-10#1)(2008-4#1)
(PSA)##15##1##(1990-9#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
(PSB)##2##1##(1996-9#1)(2008-7#1)
(PSCs)##2##1##(2010-10#1)(2011-2#1)
(PSD's)##2##1##(2008-3#2)
(PSD) of##2##2##(2008-3#1)(2010-8#1)
(PSD)##9##1##(1996-12#2)(2008-10#2)(2008-11#1)(2008-3#3)(2010-8#1)
(PSF)##8##1##(2008-2#2)(2008-3#5)(2009-10#1)
(PSG)##2##1##(1990-5#1)(2012-3#1)
(PSI)##4##1##(2008-7#2)(2008-8#1)(2010-12#1)
(PSJTC)##2##1##(2008-2#1)(2008-3#1)
(PSO)##2##1##(2007-9#1)(2012-12#1)
(PSP) is##2##2##(2008-3#1)(2012-12#1)
(PSP)##9##1##(1992-8#1)(1994-12#1)(1996-7#3)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
(PSS) and##2##2##(2008-10#1)(2009-11#1)
(PSS)##7##1##(2007-10#1)(2008-10#3)(2008-3#1)(2009-11#1)(2010-1#1)
(PST) is##2##2##(1994-11#1)(2008-9#1)
(PST)##4##1##(1990-12#1)(1994-11#1)(2008-10#1)(2008-9#1)
(PSV)##6##1##(2007-10#1)(2008-1#1)(2008-10#3)(2013-8#1)
(PT) and##2##2##(1995-11#1)(2013-1#1)
(PT)##8##1##(1993-12#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
(PTA)##7##1##(1990-2#1)(1995-2#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-1#1)
(PTB)##4##1##(2008-1#1)(2008-2#1)(2011-1#1)(2013-8#1)
(PTC) and##2##2##(2008-10#1)(2008-5#1)
(PTC)##3##1##(2008-10#1)(2008-12#1)(2008-5#1)
(PTFE) grafts##3##2##(2007-7#2)(2008-1#1)
(PTFE) turnings##3##2##(2008-10#3)
(PTFE)##18##1##(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2011-2#1)
(PTH##5##1##(1991-6#1)(1993-12#1)(1993-6#1)(1997-7#1)(2008-8#1)
(PTH) and##3##2##(1994-11#1)(1995-6#1)(2008-1#1)
(PTH) as##2##2##(1991-12#1)(2008-8#1)
(PTH)##17##1##(1990-11#1)(1990-2#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-5#1)(2008-8#2)(2009-7#1)(2011-1#3)(2012-12#1)(2013-8#1)
(PTHrP)##3##1##(1993-3#1)(1994-7#1)(2013-7#1)
(PTM)##4##1##(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)
(PTO)##2##1##(1993-1#1)(2008-5#1)
(PTP)##3##1##(1994-6#1)(1997-8#1)(2008-7#1)
(PTS)##4##1##(1992-3#1)(2007-11#1)(2008-7#1)(2011-2#1)
(PTSD##2##1##(2009-11#2)
(PTSD) and##2##2##(2008-10#1)(2008-8#1)
(PTSD)##16##1##(1991-2#1)(1996-7#1)(2008-10#1)(2008-6#3)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
(PTTH)##2##1##(1995-11#2)
(PTV)##5##1##(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)
(PTX)##4##1##(2008-4#2)(2008-8#1)(2008-9#1)
(PTs) in##2##2##(1993-1#1)(2008-7#1)
(PU) problem##2##2##(2008-2#2)
(PU)##3##1##(2008-2#2)(2009-9#1)
(PUF)##7##1##(2008-10#5)(2008-11#2)
(PUFA)##5##1##(1995-8#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
(PUO)##3##1##(2007-7#1)(2008-10#2)
(PUV)##2##1##(2008-10#2)
(PV)##7##1##(1996-5#1)(2008-10#3)(2008-11#1)(2011-2#2)
(PVA##2##1##(2008-10#2)
(PVA) hydrogel##2##2##(2009-11#1)(2009-12#1)
(PVA)##13##1##(2008-10#6)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2012-3#1)
(PVC##3##1##(2008-10#3)
(PVC) based membranes##3##3##(2008-10#3)
(PVC) matrix membrane##2##3##(2008-10#2)
(PVC) matrix##6##2##(2008-10#6)
(PVC) membrane electrode##4##3##(2008-10#4)
(PVC) membrane##10##2##(2008-10#10)
(PVC) membranes##6##2##(2008-10#6)
(PVC)##34##1##(2007-7#1)(2008-10#33)
(PVDF) membranes##2##2##(1992-3#1)(2008-7#1)
(PVDF)##3##1##(1992-3#1)(2008-11#1)(2008-7#1)
(PVM)##2##1##(2012-2#1)(2013-8#1)
(PVN)##7##1##(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
(PVP)##6##1##(1990-12#1)(2008-10#3)(2008-5#1)(2010-4#1)
(PVY##4##1##(2008-10#4)
(PWB)##2##1##(2008-10#1)(2010-8#1)
(PX)##3##1##(2008-10#2)(2009-10#1)
(PY)##2##1##(2008-9#1)(2012-2#1)
(PYR)##2##1##(1992-8#1)(2008-10#1)
(Panax quinquefolius)##4##2##(2008-10#4)
(Panax##6##1##(1997-2#2)(2008-10#4)
(Pandinus imperator)##2##2##(1990-8#1)(2009-4#1)
(Panthera pardus)##2##2##(1996-12#2)
(Panthera##7##1##(1996-12#5)(2009-4#2)
(Park##2##1##(2011-2#1)(2013-8#1)
(Part##5##1##(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2011-2#1)
(Parus##4##1##(1994-3#1)(2008-5#3)
(Pb##3##1##(2008-10#3)
(Pb(2+)) and##3##2##(2008-10#3)
(Pb(2+))##5##1##(2008-10#5)
(Pb)##12##1##(1995-3#1)(1997-4#1)(2008-10#9)(2008-7#1)
(Pdx)##2##1##(1994-5#2)
(Pearson r = -0##2##4##(2011-3#2)
(Pearson r = 0##2##4##(2011-3#2)
(Pearson r =##4##3##(2011-3#4)
(Pearson's##2##1##(1991-8#1)(2008-10#1)
(Ped##2##1##(2008-5#2)
(Pemulen##2##1##(2008-5#2)
(PepMoV)##2##1##(2008-10#2)
(Perciformes##6##1##(2007-5#1)(2008-5#1)(2013-7#4)
(Period##3##1##(2010-8#3)
(Persea americana)##4##2##(2008-10#4)
(Pesticides and##2##2##(2008-8#2)
(PgR)##2##1##(1991-12#1)(2011-2#1)
(Ph##2##1##(1996-2#1)(2008-10#1)
(Phase##5##1##(2008-10#2)(2008-8#3)
(Phaseolus vulgaris L##4##3##(2008-12#2)(2011-2#1)(2013-8#1)
(Phaseolus vulgaris##6##2##(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#1)(2013-8#1)
(Phaseolus vulgaris) in##2##3##(2008-10#2)
(Phaseolus vulgaris)##16##2##(2008-10#16)
(Phaseolus##24##1##(2008-10#18)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
(Phe##2##1##(2008-10#1)(2008-9#1)
(Phi =##2##2##(2008-10#1)(2008-3#1)
(Phoenix dactylifera L##3##3##(2008-10#2)(2013-1#1)
(Phoenix##5##1##(2008-10#3)(2013-1#2)
(Phytophthora##3##1##(2008-10#3)
(Pi) and##2##2##(1990-5#1)(2010-8#1)
(Pi)##3##1##(1990-5#1)(1993-12#1)(2010-8#1)
(Picea##4##1##(2008-10#3)(2012-2#1)
(Pichia##3##1##(2008-10#3)
(Pima S-7 x NemX)##2##4##(2008-10#2)
(Pinus monticola)##4##2##(2008-10#4)
(Pinus strobus)##2##2##(2008-10#2)
(Pinus##15##1##(2008-10#14)(2013-1#1)
(Pisces##6##1##(2008-5#5)(2008-8#1)
(Pmax)##2##1##(1997-4#1)(2013-1#1)
(Po-210)##2##1##(2008-7#2)
(Poecilia reticulata)##3##2##(2008-8#3)
(Pol III##2##2##(1992-3#2)
(Poland)##2##1##(1994-12#2)
(Polish##2##1##(2007-11#1)(2008-12#1)
(Polychaeta##3##1##(1996-2#2)(2008-5#1)
(Populus spp##2##2##(2008-10#1)(2011-2#1)
(Populus##3##1##(2008-10#2)(2011-2#1)
(Portugal)##2##1##(1994-5#1)(2008-10#1)
(Pr)##3##1##(2007-12#1)(2008-10#1)(2012-2#1)
(PrEP) in preventing##2##3##(2012-2#1)(2013-1#1)
(Prajer##2##1##(2008-12#2)
(PreOp##2##1##(2011-2#2)
(President##2##1##(2008-5#2)
(Principal##2##1##(2008-10#2)
(Pro)2##2##1##(1992-12#2)
(Proc##2##1##(1990-8#1)(2008-4#1)
(Prunus##8##1##(2008-10#8)
(Pseudomonas aeruginosa##2##2##(2008-5#1)(2011-2#1)
(Pseudomonas##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
(Pt##3##1##(2008-10#1)(2008-11#2)
(Pteropus##2##1##(2008-12#1)(2009-4#1)
(Ptr##2##1##(2008-10#2)
(Public Law##10##2##(1991-1#1)(1991-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-3#3)
(Public##11##1##(1991-1#1)(1991-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-3#3)(2008-9#1)
(Puccinia triticina)##2##2##(2008-10#2)
(Puccinia##7##1##(2008-10#7)
(Pueraria##4##1##(2008-12#2)(2008-6#2)
(Pusa hispida)##2##2##(2008-10#2)
(Py-GC/MS)##2##1##(2008-10#1)(2013-1#1)
(P &lt##7##1##(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-3#1)
(P &lt##38##1##(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#16)(2013-1#17)
(P = 0##9##1##(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
(P = ##2##1##(2012-12#2)
(P = 0##3##1##(2012-2#3)
(Q (10) =##2##3##(2008-7#2)
(Q##6##1##(2008-7#2)(2012-5#3)(2012-6#1)
(Q(o)I)##2##1##(2008-10#2)
(Q) or##2##2##(1997-8#1)(2008-10#1)
(Q)##8##1##(1991-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-8#1)(2012-2#1)
(Q-FISH)##3##1##(2008-1#3)
(Q-RT-PCR)##3##1##(2008-10#1)(2008-9#2)
(QA)##11##1##(1994-2#3)(1995-3#3)(1995-5#1)(1996-2#2)(1996-5#1)(2007-7#1)
(QAAMS)##2##1##(2008-6#2)
(QC) lasers##2##2##(2007-12#1)(2008-3#1)
(QC)##7##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)
(QCM)##13##1##(2008-10#13)
(QD)##2##1##(2008-7#1)(2013-1#1)
(QI)##4##1##(1994-12#1)(1994-3#1)(2012-3#1)(2013-1#1)
(QIP)##2##1##(1992-3#2)
(QIs)##3##1##(1996-2#2)(2013-1#1)
(QM)##2##1##(2008-10#1)(2009-8#1)
(QOL)##12##1##(1994-12#1)(1995-4#1)(2008-6#1)(2008-7#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
(QPCR)##2##1##(2008-10#1)(2012-2#1)
(QPM)##5##1##(2007-11#1)(2007-12#3)(2012-2#1)
(QS)##5##1##(2008-10#1)(2009-6#1)(2010-10#1)(2013-1#2)
(QSAR) study##2##2##(2007-11#1)(2009-3#1)
(QSAR)##5##1##(2007-11#2)(2008-10#2)(2009-3#1)
(QSR International##2##2##(2011-1#2)
(QSRR)##4##1##(1996-5#1)(2008-10#3)
(QTL) analysis##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
(QTL) for partial resistance to##2##5##(2008-10#2)
(QTL) for##8##2##(2008-10#8)
(QTL) mapping##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
(QTL)##49##1##(2008-10#36)(2008-7#2)(2008-8#5)(2009-5#1)(2011-1#1)(2012-3#3)(2013-8#1)
(QTLs)##9##1##(2008-10#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)
(QTc)##2##1##(2008-8#1)(2011-1#1)
(Qa-2(a)##2##1##(2008-5#2)
(QoL)##9##1##(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
(Quercus##5##1##(2008-10#3)(2012-5#1)(2012-7#1)
(R (2) = 0##2##4##(2008-10#2)
(R = -0##3##3##(1990-12#1)(2008-10#1)(2008-12#1)
(R = 0##13##3##(1992-3#1)(1995-3#1)(2007-10#3)(2007-11#2)(2008-10#4)(2008-3#1)(2008-9#1)
(R = Ph##2##3##(1996-2#2)
(R =##21##2##(1990-12#1)(1992-3#1)(1995-3#1)(1996-2#3)(1997-7#1)(2007-10#3)(2007-11#2)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)
(R##227##1##(1990-12#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-6#2)(1995-12#1)(1995-3#1)(1996-2#24)(1997-7#1)(2007-10#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#174)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)
(R&amp##5##1##(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)
(R' =##2##2##(2008-11#1)(2008-5#1)
(R(2) &gt##2##2##(2008-10#2)
(R(2) = 0##22##3##(2007-11#3)(2008-10#18)(2012-2#1)
(R(2)##28##1##(2007-11#3)(2008-10#21)(2008-5#2)(2008-7#1)(2012-2#1)
(R(2)&gt##3##1##(2008-10#3)
(R(2)) and##2##2##(2008-10#2)
(R(2))##6##1##(2008-10#6)
(R(2)=0##14##1##(2008-10#12)(2008-11#1)(2010-4#1)
(R(f) 0##3##2##(2008-10#3)
(R(f) value of 0##2##4##(2008-10#2)
(R(f)##5##1##(2008-10#5)
(R(t)##2##1##(2010-3#2)
(R) and##2##2##(2008-10#1)(2013-8#1)
(R) for##2##2##(2008-10#2)
(R) gene##2##2##(1996-5#1)(2009-6#1)
(R) is##2##2##(2008-1#1)(2013-8#1)
(R) strains##2##2##(1995-8#1)(2008-10#1)
(R) were##2##2##(2008-10#2)
(R)##38##1##(1990-5#1)(1990-8#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-8#1)(2009-6#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
(R)- and##2##2##(1994-9#1)(1995-3#1)
(R)-1##4##1##(1997-4#2)(2008-10#2)
(R)-levocetirizine##6##1##(2010-4#6)
(R-M) system##3##2##(1991-9#1)(1993-9#1)(1994-12#1)
(R0)##3##1##(2008-8#1)(2011-2#2)
(R1)##4##1##(1995-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
(R2 0##2##2##(2009-4#2)
(R2 = 0##5##3##(1990-4#1)(1991-5#1)(1992-12#1)(2008-3#1)(2013-8#1)
(R2 =##6##2##(1990-4#1)(1991-5#1)(1992-12#1)(1995-2#1)(2008-3#1)(2013-8#1)
(R2##9##1##(1990-4#1)(1991-5#1)(1992-12#1)(1995-2#1)(2008-3#1)(2009-4#2)(2013-1#1)(2013-8#1)
(R2)##6##1##(1991-11#1)(1993-12#1)(1995-2#1)(2008-12#2)(2011-2#1)
(R338W)##2##1##(1995-8#2)
(R68A##2##1##(1995-6#2)
(R=-0##4##1##(2008-7#4)
(R=0##17##1##(2008-10#11)(2008-12#1)(2011-1#1)(2012-1#1)(2013-1#3)
(RA##2##1##(1993-2#1)(1995-6#1)
(RA) and##2##2##(1994-6#1)(2008-7#1)
(RA) in##4##2##(1994-11#1)(1995-9#1)(2012-3#2)
(RA) is##3##2##(2008-5#1)(2012-1#1)(2012-2#1)
(RA)##41##1##(1990-11#1)(1990-6#1)(1992-5#1)(1993-9#1)(1994-11#2)(1994-6#2)(1994-9#1)(1995-9#1)(1996-5#2)(2006-10#2)(2007-8#3)(2008-10#4)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#3)(2013-8#1)
(RAFT)##3##1##(2008-12#2)(2009-10#1)
(RAG-1)##2##1##(1991-9#1)(1994-11#1)
(RAGE)##2##1##(1997-7#1)(2008-1#1)
(RAM)##2##1##(2008-10#1)(2012-2#1)
(RANK)##3##1##(2007-11#1)(2007-8#1)(2008-7#1)
(RANKL) and##2##2##(2011-1#1)(2013-8#1)
(RANKL)##5##1##(2008-11#1)(2008-7#1)(2011-1#2)(2013-8#1)
(RAP##2##1##(1991-12#1)(2008-3#1)
(RAPD)##49##1##(1995-6#1)(1996-10#1)(2008-10#43)(2008-5#3)(2013-7#1)
(RAPD-PCR)##3##1##(2007-12#1)(2008-12#1)(2011-2#1)
(RAPs)##2##1##(1994-3#1)(2008-10#1)
(RAS)##4##1##(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
(RAW 264##2##2##(2011-2#1)(2012-12#1)
(RB) and##2##2##(1994-12#1)(2008-10#1)
(RB)##13##1##(1992-8#2)(1994-12#1)(1995-11#1)(2008-10#8)(2013-1#1)
(RBC##3##1##(2008-5#1)(2010-2#1)(2013-8#1)
(RBC)##6##1##(1996-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
(RBE)##2##1##(1994-3#1)(2008-3#1)
(RBRVS)##4##1##(1992-3#1)(1993-12#1)(1994-12#2)
(RBS)##2##1##(1997-4#1)(2012-2#1)
(RC)##8##1##(1993-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
(RCA)##4##1##(2007-8#1)(2008-10#1)(2008-11#1)(2013-2#1)
(RCC)##10##1##(1990-2#1)(2007-4#1)(2008-1#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
(RCCs)##2##1##(2010-8#1)(2012-3#1)
(RCT)##8##1##(2008-10#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-2#2)(2013-1#2)
(RD)##3##1##(1991-4#1)(1991-9#1)(2008-7#1)
(RDA)##4##1##(2008-2#3)(2010-4#1)
(RDS)##5##1##(1995-5#1)(2007-11#1)(2008-10#1)(2009-9#1)(2013-1#1)
(RDX) and its nitroso-metabolites in animal liver tissue##2##8##(2008-10#2)
(RDX) and##3##2##(2008-10#3)
(RDX) using##2##2##(2008-10#2)
(RDX)##11##1##(2008-10#10)(2008-3#1)
(RE)##6##1##(2008-10#5)(2008-8#1)
(REE)##8##1##(2008-10#7)(2012-2#1)
(REM)##6##1##(1990-7#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
(REMS)##2##1##(2012-3#1)(2013-1#1)
(REP##2##1##(2008-10#2)
(RER)##7##1##(1992-12#1)(1992-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
(RES)##3##1##(1990-2#1)(1992-3#1)(2010-2#1)
(RET)##2##1##(2008-2#2)
(REV)##2##1##(2008-5#1)(2013-8#1)
(RF)##14##1##(1992-4#1)(2007-8#1)(2008-11#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
(RFA)##3##1##(2010-8#1)(2012-2#2)
(RFLP) of##2##2##(1993-2#1)(2008-10#1)
(RFLP)##45##1##(1993-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#33)(2008-4#1)(2008-5#1)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
(RFS)##6##1##(2008-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
(RGD)##3##1##(2008-11#1)(2008-7#1)(2010-12#1)
(RH)##25##1##(1994-12#1)(1996-12#1)(2007-11#1)(2008-10#19)(2008-2#1)(2008-8#1)(2009-2#1)
(RHD)##2##1##(2012-12#1)(2012-3#1)
(RI)##13##1##(1991-7#1)(1994-5#1)(1994-8#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2013-1#1)(2013-8#1)
(RIA) in##2##2##(1990-11#1)(2009-12#1)
(RIA)##12##1##(1990-11#2)(1990-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)
(RIANA)##3##1##(2008-10#3)
(RICH)##2##1##(2011-2#2)
(RICM)##2##1##(2008-2#2)
(RID)##2##1##(2007-10#1)(2012-12#1)
(RIP)##7##1##(2008-10#2)(2008-2#1)(2010-11#4)
(RIWs)##2##1##(1991-12#2)
(RIfS)##2##1##(2008-10#2)
(RL##2##1##(2008-10#1)(2008-5#1)
(RL) and##2##2##(1992-9#1)(2008-10#1)
(RL)##3##1##(1992-9#1)(2008-10#1)(2008-11#1)
(RLS) signals##3##2##(2008-10#3)
(RLS)##14##1##(1997-4#1)(2008-10#11)(2012-12#1)(2012-3#1)
(RM)##8##1##(1991-7#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-8#1)(2010-4#1)(2013-1#1)
(RMS) of##2##2##(2008-10#1)(2012-12#1)
(RMS)##4##1##(2008-10#1)(2010-9#1)(2011-1#1)(2012-12#1)
(RMSD)##2##1##(2008-10#1)(2008-8#1)
(RMSECV)##2##1##(2008-10#1)(2013-8#1)
(RMSEP)##4##1##(2008-10#3)(2013-8#1)
(RN)##2##1##(2008-11#1)(2010-2#1)
(RNA##3##1##(1991-12#1)(2008-1#1)(2009-11#1)
(RNA)##4##1##(2008-10#1)(2009-11#1)(2010-9#1)(2013-8#1)
(RNase##5##1##(1990-7#1)(1992-4#1)(2008-10#1)(2010-2#1)(2011-2#1)
(ROH)##2##1##(2008-10#2)
(ROI)##5##1##(2009-3#1)(2010-2#1)(2010-8#2)(2011-1#1)
(ROIs)##2##1##(2008-7#1)(2012-1#1)
(ROS 17/2##2##2##(1990-11#1)(1991-3#1)
(ROS##3##1##(1990-11#1)(1991-3#1)(2009-8#1)
(ROS) and##4##2##(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
(ROS) generation##2##2##(2012-2#2)
(ROS)##58##1##(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-5#1)(2006-10#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#2)
(RP) or##2##2##(2009-11#1)(2009-12#1)
(RP)##10##1##(1995-3#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)
(RP-HPLC)##13##1##(1990-2#1)(1990-8#1)(1995-6#1)(2008-10#9)(2011-1#1)
(RPA)##2##1##(2008-10#2)
(RPE)##4##1##(2008-4#1)(2013-1#1)(2013-8#2)
(RPP)##2##1##(2007-12#2)
(RQA)##2##1##(2008-11#2)
(RR 0##3##2##(1993-9#2)(2011-1#1)
(RR 2##2##2##(2011-1#2)
(RR =##3##2##(1992-5#2)(2011-2#1)
(RR##10##1##(1992-5#2)(1993-9#4)(2011-1#3)(2011-2#1)
(RR) of##4##2##(1992-11#1)(1993-9#1)(2008-10#1)(2011-1#1)
(RR)##15##1##(1992-11#1)(1992-12#1)(1993-9#3)(1995-5#1)(2008-10#2)(2010-10#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
(RR=1##2##1##(2008-8#2)
(RRs)##2##1##(2008-7#1)(2013-1#1)
(RS)##9##1##(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#2)
(RS4(XL))##3##1##(2010-8#3)
(RSA)##2##1##(2010-10#1)(2010-3#1)
(RSD approximately##3##2##(2008-10#3)
(RSD for##2##2##(2008-10#2)
(RSD less than##2##3##(2008-10#2)
(RSD values lower than 4##2##5##(2008-10#2)
(RSD##23##1##(2008-10#21)(2010-4#1)(2011-1#1)
(RSD&lt##4##1##(2008-10#2)(2013-1#2)
(RSD) for##5##2##(2008-10#4)(2008-5#1)
(RSD) of##6##2##(2008-10#6)
(RSD)##31##1##(2008-10#25)(2008-5#1)(2009-8#1)(2012-1#2)(2013-8#2)
(RSF)##2##1##(2008-10#1)(2008-8#1)
(RSP)##3##1##(2008-10#1)(2008-3#1)(2010-9#1)
(RT##2##1##(2010-8#1)(2011-2#1)
(RT) and##3##2##(1994-6#1)(1997-6#1)(2013-1#1)
(RT) is##4##2##(1990-11#1)(2007-10#1)(2008-11#1)(2013-1#1)
(RT) to##2##2##(1992-9#1)(2008-11#1)
(RT)##23##1##(1990-11#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-5#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#3)
(RT-PCR) and##9##2##(1994-11#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
(RT-PCR) in##6##2##(1995-12#1)(2007-10#1)(2008-10#2)(2008-7#1)(2013-1#1)
(RT-PCR) was##6##2##(1993-8#1)(1994-11#1)(2007-10#1)(2008-10#3)
(RT-PCR)##66##1##(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#3)(1996-12#3)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2007-10#2)(2007-6#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2012-2#2)(2013-1#1)
(RTA)##2##1##(1992-3#1)(2008-3#1)
(RTIs)##2##1##(2008-10#1)(2011-2#1)
(RTK)##3##1##(1991-5#1)(1995-8#1)(2010-4#1)
(RTKs)##3##1##(1993-8#1)(2009-8#1)(2009-9#1)
(RTP) and##2##2##(2008-10#2)
(RTP)##14##1##(1993-9#1)(2008-10#13)
(RTS)##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
(RTT)##2##1##(2008-7#1)(2012-2#1)
(RU) after##2##2##(2008-11#1)(2008-7#1)
(RUG-III)##2##1##(1994-12#1)(1997-1#1)
(RV)##2##1##(1996-2#1)(2013-1#1)
(RVR)##2##1##(2008-3#1)(2013-1#1)
(RVS)##2##1##(1992-3#1)(2008-10#1)
(RXR##3##1##(1993-3#3)
(RXR)##3##1##(1995-8#2)(2008-5#1)
(Radiology Management 16##2##3##(1995-3#2)
(Raman##2##1##(2008-2#1)(2013-8#1)
(Ramphastos sulfuratus) and spider##2##4##(2008-5#2)
(Rana##6##1##(1991-5#2)(1996-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
(Rattus norvegicus)##4##2##(2008-10#2)(2008-12#1)(2009-11#1)
(Rchb##2##1##(2008-11#2)
(Rdc1##2##1##(2008-10#2)
(Red##2##1##(2008-10#1)(2008-12#1)
(Reference##2##1##(2008-10#1)(2008-11#1)
(Region##3##1##(1997-2#3)
(Relative##2##1##(2008-5#1)(2011-1#1)
(Rep)##4##1##(2008-10#4)
(Resource Utilization##2##2##(1994-12#2)
(Rev)##2##1##(1993-12#1)(2007-6#1)
(Rh##3##1##(2008-10#2)(2008-2#1)
(Rhea americana)##2##2##(2013-1#2)
(Rhea pennata)##2##2##(2013-1#2)
(Rhea##4##1##(2013-1#4)
(Rho##2##1##(2008-7#1)(2013-1#1)
(Rhodophyta)##2##1##(2008-11#1)(2008-5#1)
(Right##2##1##(2013-8#2)
(Rio##4##1##(2008-10#2)(2008-8#1)(2013-7#1)
(Rocc)##2##1##(2008-1#2)
(Rodentia##6##1##(2008-5#6)
(Rosa spp##2##2##(2008-10#1)(2011-2#1)
(Rosa##3##1##(2008-10#2)(2011-2#1)
(Rp)##2##1##(1994-12#1)(1995-8#1)
(Rp-cAMPS)##3##1##(1990-12#1)(1993-6#1)(1995-11#1)
(Rs)##2##1##(1995-8#1)(2008-10#1)
(Ru##2##1##(2008-10#2)
(Ru-red)##2##1##(2008-10#2)
(Rubiaceae)##2##1##(2012-2#2)
(Rubisco)##3##1##(1993-12#2)(2009-10#1)
(S and##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
(S##59##1##(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-3#3)(1993-8#2)(1994-5#1)(1995-12#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-3#1)(2008-10#27)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-2#2)(2010-10#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-1#1)
(S) and##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
(S) of##2##2##(1997-3#1)(2008-10#1)
(S) or##2##2##(1994-9#1)(2008-12#1)
(S)##24##1##(1991-2#2)(1993-8#1)(1994-9#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-8#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
(S)-1##2##1##(1993-1#2)
(S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG)##2##2##(1995-12#2)
(S)-N-dodecoxycarbonylvaline##3##1##(1994-9#3)
(S-1)##3##1##(1991-5#1)(1994-8#1)(1995-2#1)
(S-180)##3##1##(1992-3#1)(2008-4#1)(2008-5#1)
(S-ODNs)##2##1##(1991-9#2)
(S-phase##2##1##(1993-11#1)(1994-10#1)
(S-type)##2##1##(1995-8#1)(2008-10#1)
(S/N = 3)##2##3##(2008-10#1)(2011-1#1)
(S/N =##3##2##(2008-10#2)(2011-1#1)
(S/N##7##1##(2008-10#4)(2011-1#2)(2012-1#1)
(S/N=2)##3##1##(2008-10#3)
(S/N=3) and the##2##3##(2008-10#2)
(S/N=3) and##4##2##(2008-10#4)
(S/N=3) are##5##2##(2008-10#5)
(S/N=3) for##5##2##(2008-10#5)
(S/N=3) is##3##2##(2008-10#3)
(S/N=3) of 0##3##3##(2008-10#3)
(S/N=3) of##11##2##(2008-10#11)
(S/N=3) was 0##4##3##(2008-10#4)
(S/N=3) was##7##2##(2008-10#7)
(S/N=3) were##2##2##(2008-10#2)
(S/N=3)##55##1##(2008-10#54)(2008-11#1)
(S/N=4)##2##1##(2008-10#2)
(S1##5##1##(1995-2#1)(1995-6#1)(2008-4#1)(2008-6#1)(2009-8#1)
(S1)##2##1##(1992-3#1)(1994-5#1)
(S3)##2##1##(1997-9#1)(2008-1#1)
(S8)##2##1##(2008-10#2)
(S9)##3##1##(1992-2#1)(1996-12#1)(2008-8#1)
(S=+/-0##2##1##(2008-10#2)
(SA) and##5##2##(2008-10#3)(2009-8#1)(2013-1#1)
(SA) in the##2##3##(1995-12#1)(2008-10#1)
(SA) in##4##2##(1995-12#1)(2008-10#2)(2009-8#1)
(SA)##31##1##(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-8#2)(2011-1#1)(2011-2#3)(2013-1#2)
(SAA)##4##1##(1991-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
(SABP)##3##1##(1997-6#1)(2007-11#1)(2007-8#1)
(SAD)##5##1##(1995-11#1)(1997-6#1)(2008-6#1)(2012-2#1)(2012-3#1)
(SADIE)##5##1##(2008-10#5)
(SAF)##2##1##(2008-6#1)(2009-10#1)
(SAGE)##3##1##(2008-1#1)(2008-2#2)
(SAH) due to##2##3##(1995-5#1)(2008-7#1)
(SAH)##15##1##(1995-5#1)(2007-10#3)(2008-7#6)(2009-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
(SAM) and##3##2##(1995-11#1)(2007-12#1)(2008-10#1)
(SAM) as##2##2##(2008-8#1)(2013-8#1)
(SAM)##23##1##(1991-1#1)(1991-12#1)(1995-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-8#1)(2009-8#2)(2012-2#1)(2013-8#1)
(SAMs)##5##1##(2008-10#4)(2010-4#1)
(SANS)##2##1##(2008-10#1)(2009-12#1)
(SAP)##5##1##(2008-5#1)(2013-1#3)(2013-8#1)
(SAR) and##2##2##(2008-3#1)(2013-1#1)
(SAR) in##2##2##(2008-10#1)(2008-8#1)
(SAR) is##2##2##(2008-10#1)(2013-1#1)
(SAR) of##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
(SAR)##18##1##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#3)(2011-10#1)(2013-1#2)
(SARS)##5##1##(2007-7#2)(2008-10#1)(2008-2#1)(2010-2#1)
(SAS)##3##1##(2008-10#1)(2008-7#1)(2009-8#1)
(SAW)##7##1##(2007-12#1)(2008-10#5)(2008-3#1)
(SAX)##2##1##(2008-10#2)
(SAXS)##5##1##(2008-10#3)(2008-5#1)(2009-6#1)
(SAs)##2##1##(2008-10#1)(2013-1#1)
(SB)##7##1##(1992-2#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
(SBC)##2##1##(2008-10#1)(2009-2#1)
(SBE)##3##1##(2008-9#2)(2010-12#1)
(SBP) and diastolic##2##3##(1991-10#1)(2013-8#1)
(SBP)##9##1##(1990-7#1)(1991-10#1)(1992-12#1)(2009-8#1)(2009-9#1)(2010-4#1)(2013-1#1)(2013-8#2)
(SBR)##2##1##(2007-11#1)(2008-10#1)
(SBS)##8##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-11#2)(2009-8#1)
(SBTKR)##2##1##(2008-8#2)
(SC) and##4##2##(2008-10#3)(2008-5#1)
(SC) of##2##2##(1993-3#1)(2008-5#1)
(SC)##28##1##(1993-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#12)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
(SCA##2##1##(1991-8#1)(2011-2#1)
(SCA)##5##1##(2008-7#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-7#1)
(SCAA)##2##1##(2008-5#2)
(SCAD)##2##1##(1995-5#1)(2010-1#1)
(SCC)##2##1##(2012-3#2)
(SCD) in##2##2##(2007-7#1)(2012-3#1)
(SCD)##6##1##(1994-9#1)(2007-7#1)(2009-4#2)(2009-9#1)(2012-3#1)
(SCE)##6##1##(1990-6#1)(1992-8#1)(2008-10#3)(2008-11#1)
(SCEs)##4##1##(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)
(SCF)##4##1##(1992-3#1)(2008-7#2)(2011-2#1)
(SCG)##5##1##(1991-12#1)(1994-8#1)(1996-5#1)(2008-10#2)
(SCGE)##2##1##(1997-4#1)(2008-10#1)
(SCI)##6##1##(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2013-1#1)
(SCIT) and##2##2##(2011-2#2)
(SCK)##3##1##(2009-9#2)(2010-2#1)
(SCL-90-R##2##1##(2008-3#2)
(SCMV)##3##1##(2008-10#2)(2008-9#1)
(SCO)##2##1##(2008-10#2)
(SCP)##2##1##(1997-2#1)(2008-10#1)
(SCR) and##2##2##(2011-2#2)
(SCS)##3##1##(1994-5#1)(1997-2#1)(2008-12#1)
(SCT)##2##1##(1993-12#1)(2008-10#1)
(SD +/-##4##2##(1990-11#4)
(SD 0##3##2##(2010-3#2)(2011-1#1)
(SD 1##2##2##(1990-2#1)(2012-12#1)
(SD 6##2##2##(2008-12#1)(2009-3#1)
(SD =##6##2##(2008-10#1)(2008-5#3)(2009-8#1)(2010-3#1)
(SD##28##1##(1990-11#4)(1990-2#1)(1990-3#1)(1992-2#1)(2008-10#1)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2012-4#1)
(SD) and##3##2##(1993-12#1)(1996-5#1)(2011-1#1)
(SD) in##2##2##(2008-10#1)(2013-1#1)
(SD) of##2##2##(2011-1#1)(2012-5#1)
(SD) rats##5##2##(1993-12#1)(1996-12#1)(2008-10#1)(2012-1#1)(2012-3#1)
(SD)##32##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1993-12#3)(1996-12#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#2)(2009-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)
(SD-OCT)##3##1##(2011-7#3)
(SDA)##2##1##(2008-10#1)(2008-12#1)
(SDB)##2##1##(1995-3#1)(2008-10#1)
(SDC)##2##1##(2008-10#1)(2008-3#1)
(SDS##2##1##(1996-5#1)(2008-10#1)
(SDS) and##7##2##(1994-9#1)(2008-10#5)(2008-12#1)
(SDS) as##2##2##(2008-10#1)(2013-8#1)
(SDS) in##3##2##(2008-10#3)
(SDS) medium##2##2##(2008-10#2)
(SDS) solutions##2##2##(2008-10#2)
(SDS)##48##1##(1990-11#1)(1994-9#3)(1995-5#1)(1996-5#1)(2008-10#31)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2011-1#3)(2012-2#2)(2013-8#1)
(SD = 1##2##1##(2011-2#2)
(SE##5##1##(1996-12#4)(2008-7#1)
(SE) and##3##2##(1990-12#1)(2008-3#1)(2009-8#1)
(SE)##8##1##(1990-12#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-8#1)
(SEA)##4##1##(1993-6#2)(2011-2#1)(2013-1#1)
(SEAP)##5##1##(2008-11#3)(2008-7#1)(2011-2#1)
(SEE)##2##1##(2007-11#1)(2007-5#1)
(SEM 2##2##2##(1992-6#2)
(SEM and##2##2##(2008-11#1)(2013-7#1)
(SEM##5##1##(1992-6#3)(2008-11#1)(2013-7#1)
(SEM) equipped with an##2##4##(2008-10#1)(2008-11#1)
(SEM) for##2##2##(1990-11#1)(2008-10#1)
(SEM) images##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2012-1#1)
(SEM) plasma##2##2##(1990-5#1)(1991-8#1)
(SEM) showed##2##2##(2008-10#1)(2013-1#1)
(SEM) was used to##3##4##(2008-10#1)(2008-6#1)(2009-7#1)
(SEM) was##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)
(SEM)##59##1##(1990-11#1)(1990-5#1)(1991-8#1)(1992-2#1)(1996-3#1)(2007-12#3)(2008-10#19)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#3)(2009-3#1)(2009-7#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
(SEM-EDXS)##2##1##(2008-10#2)
(SEP)##5##1##(2008-10#4)(2009-3#1)
(SERS)##16##1##(2007-12#3)(2008-10#6)(2008-2#1)(2008-7#1)(2010-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
(SES)##6##1##(2008-11#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)
(SEST)##2##1##(2008-10#1)(2013-1#1)
(SF)##4##1##(1994-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
(SF-36)##4##1##(2007-11#1)(2008-10#1)(2012-12#2)
(SF-CO(2))##3##1##(2008-10#3)
(SFA)##12##1##(2008-10#6)(2008-11#1)(2008-3#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
(SFC)##5##1##(2008-10#4)(2008-6#1)
(SFG)##2##1##(1995-12#1)(2008-10#1)
(SFM)##4##1##(1991-8#1)(2008-11#2)(2008-7#1)
(SFO)##3##1##(1992-5#1)(1994-2#1)(2013-1#1)
(SFS)##3##1##(2008-10#2)(2008-3#1)
(SFT)##4##1##(2007-5#1)(2007-8#1)(2012-2#1)(2013-1#1)
(SFV)##4##1##(2008-1#1)(2008-11#2)(2008-4#1)
(SG##2##1##(1993-12#1)(2008-6#1)
(SG)##5##1##(2008-10#2)(2008-12#1)(2012-2#1)(2013-8#1)
(SGA)##5##1##(1994-3#1)(2011-1#2)(2013-1#2)
(SGC)##2##1##(1995-2#1)(2008-3#1)
(SGD)##2##1##(2008-1#1)(2013-8#1)
(SGFL)##2##1##(2008-10#2)
(SGLT1)##3##1##(1991-12#3)
(SGP)##2##1##(1994-11#1)(2013-1#1)
(SH)##7##1##(1991-9#1)(1995-3#1)(2007-12#2)(2008-10#2)(2009-2#1)
(SHAM)##2##1##(1991-5#1)(1997-2#1)
(SHEP)##4##1##(1991-12#1)(1993-1#1)(1997-3#2)
(SHG)##21##1##(2007-11#7)(2007-12#8)(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
(SHLI)##2##1##(2011-2#2)
(SHM)##2##1##(2008-8#1)(2011-2#1)
(SHR) and##3##2##(1990-7#1)(1996-5#1)(1997-6#1)
(SHR)##9##1##(1990-7#1)(1994-2#1)(1994-8#1)(1996-5#1)(1997-6#1)(2006-8#1)(2010-2#1)(2011-1#2)
(SHS)##2##1##(1997-3#1)(2008-10#1)
(SI##3##1##(2008-10#3)
(SI) of##2##2##(2007-7#1)(2008-5#1)
(SI) on##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
(SI)##22##1##(1993-10#1)(1995-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#2)
(SIA) and##4##2##(2008-10#4)
(SIA) technique was##3##3##(2008-10#3)
(SIA) technique##4##2##(2008-10#4)
(SIA)##36##1##(2008-10#36)
(SIADH)##2##1##(2008-1#1)(2011-2#1)
(SIB)##3##1##(2008-11#1)(2008-3#1)(2009-10#1)
(SIDS)##12##1##(1991-11#3)(1992-11#2)(1992-4#1)(1993-12#1)(2007-10#1)(2008-1#2)(2011-1#1)(2013-1#1)
(SIL)##5##1##(1994-12#1)(2008-3#3)(2012-12#1)
(SILS)##2##1##(2012-12#1)(2013-1#1)
(SIM)##13##1##(2007-12#1)(2008-10#10)(2008-5#1)(2013-8#1)
(SIMCA)##6##1##(2008-10#5)(2013-8#1)
(SIN)##4##1##(2008-3#2)(2008-4#1)(2012-2#1)
(SIN-1)##2##1##(1995-11#1)(1997-4#1)
(SIP)##3##1##(1993-6#1)(2008-3#1)(2011-2#1)
(SIR =##5##2##(1990-2#4)(1993-9#1)
(SIR)##6##1##(1990-2#1)(1993-9#2)(1997-3#1)(2008-10#1)(2008-9#1)
(SIT) is##3##2##(2011-2#2)(2012-12#1)
(SIT)##6##1##(2008-10#1)(2009-9#1)(2011-2#3)(2012-12#1)
(SL) to##2##2##(2008-11#2)
(SL)##6##1##(1991-4#1)(2008-11#2)(2008-5#1)(2013-7#2)
(SLDA)##2##1##(2008-10#2)
(SLE) and##4##2##(1994-6#1)(2006-10#1)(2008-1#1)(2008-10#1)
(SLE)##24##1##(1990-12#1)(1994-6#1)(2006-10#4)(2008-1#5)(2008-10#3)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#2)
(SLES)##3##1##(2008-10#1)(2008-5#2)
(SLI)##5##1##(2008-11#1)(2009-8#1)(2011-1#1)(2012-3#2)
(SLIT)##3##1##(2008-8#1)(2011-2#2)
(SLM)##19##1##(2007-11#2)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#6)(2009-7#1)(2012-1#1)
(SLN)##5##1##(1993-12#1)(2008-10#1)(2008-5#2)(2013-1#1)
(SLS)##5##1##(2008-10#4)(2008-5#1)
(SLT)##2##1##(2011-2#1)(2012-2#1)
(SM)##8##1##(2008-10#2)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
(SMA)##5##1##(1994-2#1)(1994-8#1)(2008-9#1)(2009-7#1)(2009-9#1)
(SMC)##6##1##(1993-11#1)(1994-11#1)(2008-10#1)(2008-4#2)(2009-11#1)
(SMD) simulations##2##2##(2009-7#1)(2009-9#1)
(SMD)##4##1##(2008-10#1)(2009-7#1)(2009-9#1)(2013-8#1)
(SMF)##2##1##(2007-11#1)(2008-10#1)
(SMP)##2##1##(1994-11#1)(2008-3#1)
(SMR)##4##1##(1995-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
(SMS)##2##1##(1991-2#1)(1997-3#1)
(SMT)##3##1##(2007-11#1)(2013-1#2)
(SN)##7##1##(1993-9#1)(1994-2#1)(2007-6#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
(SNC)##2##1##(1996-12#1)(2008-10#1)
(SNK)##2##1##(2008-10#2)
(SNOM)##3##1##(2008-3#3)
(SNP)##17##1##(1995-11#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#2)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
(SNPs)##23##1##(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
(SNR)##17##1##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
(SNc)##2##1##(2008-12#1)(2008-7#1)
(SO)##10##1##(1990-8#1)(1996-7#2)(1997-4#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
(SOA)##3##1##(2007-12#1)(2008-2#1)(2010-8#1)
(SOC)##3##1##(2008-7#1)(2008-8#1)(2012-12#1)
(SOC/EXEC)##2##1##(2008-4#1)(2009-9#1)
(SOD)##34##1##(1990-11#1)(1991-9#2)(1992-9#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
(SOD1)##3##1##(1994-6#1)(1996-5#1)(2008-4#1)
(SOG)##2##1##(2008-2#1)(2008-9#1)
(SOM)##4##1##(1992-1#1)(2008-4#1)(2012-3#1)(2013-8#1)
(SON) and##3##2##(1993-12#1)(1995-12#1)(2008-7#1)
(SON)##4##1##(1993-12#1)(1995-12#1)(2008-7#1)(2008-8#1)
(SOP)##2##1##(2008-7#1)(2009-5#1)
(SOR)##3##1##(2008-10#1)(2008-6#1)(2011-2#1)
(SOS)##2##1##(2008-10#2)
(SP)##18##1##(1991-6#1)(1992-3#1)(1992-9#1)(1994-9#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-6#1)
(SPA) is##2##2##(1994-12#1)(2008-4#1)
(SPA)##8##1##(1990-5#1)(1994-12#1)(2008-10#2)(2008-4#2)(2008-9#1)(2012-12#1)
(SPAN)##3##1##(1995-12#1)(2008-10#2)
(SPC) mode##2##2##(2011-1#2)
(SPC)##6##1##(1995-2#1)(1996-1#1)(2008-10#2)(2011-1#2)
(SPD)##5##1##(1995-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#1)
(SPE) and##6##2##(2008-10#5)(2008-11#1)
(SPE) with##2##2##(2008-10#2)
(SPE)##61##1##(1997-2#1)(2008-10#57)(2008-11#1)(2011-1#1)(2013-1#1)
(SPECT)##8##1##(1994-1#1)(1996-12#1)(1996-5#2)(1996-7#1)(2008-8#1)(2009-12#1)(2009-8#1)
(SPF) of##4##2##(2008-5#4)
(SPF)##12##1##(1992-5#1)(1993-1#1)(2008-5#9)(2008-6#1)
(SPFMV)##2##1##(2008-10#2)
(SPL)##5##1##(1996-2#1)(2008-11#2)(2008-8#1)(2011-1#1)
(SPM)##4##1##(2008-10#2)(2008-2#1)(2012-2#1)
(SPME) and##3##2##(2008-10#3)
(SPME)##29##1##(2008-10#26)(2009-8#1)(2012-1#1)(2012-12#1)
(SPR) and##2##2##(2008-10#2)
(SPR)##27##1##(1995-2#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#1)
(SPS##2##1##(2008-7#1)(2011-2#1)
(SPS) and##2##2##(2008-12#1)(2011-2#1)
(SPS)##5##1##(2008-10#2)(2008-12#2)(2011-2#1)
(SPSS)##2##1##(2011-1#1)(2012-2#1)
(SPT)##3##1##(2008-10#2)(2012-3#1)
(SPs)##2##1##(2010-4#1)(2013-1#1)
(SQ)##2##1##(1994-9#1)(2008-5#1)
(SR##3##1##(1993-3#1)(1995-6#2)
(SR) in##2##2##(1995-6#1)(2013-8#1)
(SR)##16##1##(1994-8#1)(1995-6#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-8#2)(2013-8#1)
(SRBC)##11##1##(1992-2#1)(2008-10#5)(2008-4#4)(2008-7#1)
(SRE)##2##1##(1994-11#1)(2008-9#1)
(SRI)##2##1##(2008-10#1)(2009-8#1)
(SRIF)##3##1##(1995-2#1)(1997-2#1)(2008-4#1)
(SRM##5##1##(2008-10#5)
(SRM)##3##1##(2008-10#2)(2009-9#1)
(SRO)##3##1##(2007-12#2)(2007-7#1)
(SRR)##2##1##(2013-1#1)(2013-8#1)
(SRS)##3##1##(2008-2#1)(2008-3#2)
(SS##2##1##(2008-10#1)(2011-2#1)
(SS) and##5##2##(1993-12#1)(1993-8#1)(2007-2#1)(2010-4#1)(2011-2#1)
(SS)##19##1##(1993-12#1)(1993-8#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-4#1)(2010-5#1)(2011-2#3)(2013-8#1)
(SS-ETAAS)##2##1##(2008-10#2)
(SSA)##10##1##(1990-7#1)(1997-2#1)(2008-10#3)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#2)
(SSB) in##2##2##(1992-3#1)(2013-1#1)
(SSB)##6##1##(1992-3#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
(SSC)##3##1##(2008-10#1)(2009-8#1)(2012-2#1)
(SSCP) analysis##5##2##(1992-8#1)(2008-10#3)(2008-12#1)
(SSCP)##8##1##(1992-8#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-8#1)
(SSE)##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
(SSEA-1)##2##1##(2008-11#2)
(SSG)##2##1##(1995-11#1)(2010-3#1)
(SSH)##4##1##(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)
(SSM)##2##1##(2008-5#2)
(SSP)##4##1##(1991-3#1)(1993-1#1)(2010-2#1)(2011-2#1)
(SSPE)##2##1##(2008-10#1)(2012-12#1)
(SSR) markers##6##2##(2008-10#4)(2008-9#2)
(SSR)##14##1##(1997-2#1)(2008-10#10)(2008-5#1)(2008-9#2)
(SSRs)##3##1##(1996-8#1)(2008-10#2)
(SST)##4##1##(1992-7#1)(2007-4#1)(2008-2#1)(2013-1#1)
(SSU)##2##1##(1993-12#1)(2013-1#1)
(SSc)##4##1##(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)
(ST 36)##2##2##(2012-3#1)(2013-1#1)
(ST##4##1##(2010-7#2)(2012-3#1)(2013-1#1)
(ST)##5##1##(1993-12#1)(1994-2#1)(2007-12#1)(2008-10#2)
(ST3)##2##1##(2008-4#1)(2010-12#1)
(STA)##2##1##(2008-10#2)
(STB)##5##1##(2008-10#5)
(STD)##3##1##(1990-3#1)(1990-6#1)(1996-12#1)
(STEMI)##3##1##(2008-3#2)(2012-3#1)
(STI)##3##1##(2008-12#1)(2011-2#2)
(STLR)##2##1##(2008-11#2)
(STM) and##2##2##(2008-8#1)(2010-9#1)
(STM)##6##1##(1993-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#1)
(STP)##3##1##(1994-11#1)(1995-12#1)(2008-10#1)
(STR) and##2##2##(2008-10#1)(2008-7#1)
(STR) profiling##2##2##(1995-11#1)(2008-12#1)
(STR)##10##1##(1995-11#2)(2008-10#1)(2008-12#5)(2008-4#1)(2008-7#1)
(STS) has##2##2##(2008-6#1)(2013-8#1)
(STS)##18##1##(1994-12#1)(1996-10#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#8)(2009-2#1)(2013-8#1)
(STZ##2##1##(2011-3#1)(2012-3#1)
(STZ)##4##1##(1996-12#1)(2008-10#1)(2010-11#1)(2011-3#1)
(STZ)-induced diabetic rats##2##3##(1991-12#1)(2011-1#1)
(STZ)-induced diabetic##3##2##(1991-12#1)(2008-4#1)(2011-1#1)
(STZ)-induced##4##1##(1991-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
(SU)##2##1##(2008-10#2)
(SUD)##2##1##(2009-11#1)(2009-9#1)
(SUS)##2##1##(2012-3#1)(2013-1#1)
(SUVs) of 1##2##3##(2008-10#2)
(SV)##3##1##(1991-12#1)(2007-7#1)(2011-2#1)
(SV40##2##1##(1996-5#1)(1997-7#1)
(SVD)##3##1##(1990-8#1)(1994-11#1)(2011-2#1)
(SVM)##6##1##(2008-2#1)(2008-7#1)(2010-8#4)
(SVR)##5##1##(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
(SVV)##2##1##(2008-10#1)(2013-1#1)
(SW##4##1##(2008-10#3)(2008-11#1)
(SW)##8##1##(1991-8#1)(2008-10#6)(2011-2#1)
(SWATLD)##3##1##(2008-10#3)
(SWI)##2##1##(2007-8#1)(2012-2#1)
(SWNTs)##9##1##(2008-10#2)(2008-7#6)(2009-11#1)
(SWS)##3##1##(1990-7#1)(2007-12#1)(2008-11#1)
(SWV)##11##1##(2008-10#11)
(SYSV)##2##1##(2008-10#2)
(SZ)##4##1##(1997-5#3)(2009-7#1)
(Sabellidae)##2##1##(2008-5#1)(2011-2#1)
(Saccharomyces cerevisiae)##5##2##(1990-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-2#1)
(Saccharomyces##6##1##(1990-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2012-2#1)
(Salmo##8##1##(1992-9#1)(1994-7#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2013-1#1)
(San##2##1##(2008-5#1)(2010-8#1)
(Santiago de Cuba##2##3##(2007-10#2)
(Santiago##3##1##(1990-6#1)(2007-10#2)
(Sar)##2##1##(1993-2#1)(1994-9#1)
(Say)##5##1##(2008-12#1)(2011-2#4)
(Sb(V))##2##1##(2008-10#2)
(Sc)##4##1##(1995-8#2)(1997-7#1)(2008-7#1)
(Schaeffer)##2##1##(2011-2#2)
(Schott##3##1##(2007-12#2)(2011-1#1)
(Schrank##2##1##(2011-2#2)
(Schrank)##2##1##(2007-12#1)(2013-8#1)
(Science##2##1##(1994-12#1)(2010-10#1)
(Se(IV))##5##1##(2008-10#5)
(Se(VI))##4##1##(2008-10#4)
(Se)##8##1##(1991-12#1)(2008-10#4)(2011-1#1)(2011-2#1)(2012-2#1)
(SeCys(2))##2##1##(2008-10#2)
(SeGPx)##2##1##(2008-4#1)(2008-7#1)
(SeMet)##5##1##(2008-10#5)
(Sephadex QAE A-25) previously loaded with the fluorogenic reagent##2##9##(2008-10#2)
(Sephadex##3##1##(2008-10#3)
(September and##2##2##(2011-2#1)(2013-7#1)
(September##3##1##(2008-12#1)(2011-2#1)(2013-7#1)
(September)##2##1##(1996-12#1)(2008-5#1)
(Ser 536)##5##2##(2010-3#5)
(Ser##8##1##(1990-2#1)(1992-9#1)(1993-8#1)(2010-3#5)
(Ser(727)##2##1##(2011-2#2)
(Serpentes##2##1##(2008-5#2)
(Sf9)##7##1##(1992-3#1)(1997-4#1)(2008-11#4)(2008-7#1)
(Short##2##1##(1992-3#1)(2012-3#1)
(Si)##9##1##(2008-10#5)(2008-3#1)(2008-9#1)(2009-11#1)(2012-2#1)
(SiO(-)NH(4)(+))##2##1##(2008-10#2)
(SiO(2))##2##1##(1992-7#1)(2008-3#1)
(Sigma)##2##1##(2008-10#1)(2008-11#1)
(Siluriformes##2##1##(2008-12#1)(2008-9#1)
(Single##2##1##(2008-12#1)(2008-7#1)
(SjAb)##3##1##(2008-10#3)
(Skull Base 2001##2##3##(2006-12#2)
(Sma##3##1##(1992-6#2)(1992-8#1)
(Smith##2##1##(1991-12#1)(2008-11#1)
(Snodgraft)##2##1##(2008-10#2)
(Snyder et al##2##3##(2008-11#2)
(Solanaceae)##5##1##(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#1)
(Solanum tuberosum L##2##3##(2008-10#2)
(Solanum tuberosum)##3##2##(2008-10#3)
(Solanum##8##1##(2008-10#6)(2008-12#1)(2008-5#1)
(Southern Italy)##2##2##(1994-2#1)(2010-4#1)
(Southern##4##1##(1994-2#1)(2008-10#2)(2010-4#1)
(Sp)##2##1##(1995-8#1)(1996-5#1)
(Spain)##19##1##(1996-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2011-2#1)(2013-1#1)
(Spain)]##4##1##(2011-2#4)
(Spearman's r =##2##3##(2007-10#2)
(Spearman's##3##1##(2007-10#2)(2008-6#1)
(Spielberger##2##1##(1995-12#2)
(Spinacia oleracea)##3##2##(2008-10#3)
(Spodoptera frugiperda)##2##2##(2008-10#1)(2008-9#1)
(Spring##2##1##(1996-2#1)(2010-8#1)
(Squamata##5##1##(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)(2013-7#1)
(Sr##2##1##(2008-10#1)(2008-3#1)
(Sr)##2##1##(2008-10#1)(2012-2#1)
(St##4##1##(1990-3#1)(2008-3#1)(2008-5#1)(2008-7#1)
(St)##2##1##(1996-5#1)(2008-12#1)
(StAR)##2##1##(1995-12#1)(2008-4#1)
(Stage##3##1##(1992-12#1)(2007-8#2)
(Standard##2##1##(2012-2#1)(2013-7#1)
(Stark##3##1##(1996-3#2)(2007-12#1)
(State##2##1##(1990-11#1)(2010-8#1)
(Stenotaphrum secundatum)##2##2##(2008-10#2)
(Sternorrhyncha##2##1##(2007-12#2)
(Stratum##3##1##(2008-9#3)
(Streptococcus##2##1##(1995-8#1)(2008-5#1)
(Student's##4##1##(1990-6#1)(1997-8#1)(2008-3#2)
(Study 1)##3##2##(2009-11#1)(2009-9#1)(2012-12#1)
(Study 2)##4##2##(2007-12#1)(2009-11#1)(2009-9#1)(2012-12#1)
(Study##10##1##(2007-12#1)(2009-11#3)(2009-9#2)(2012-12#2)(2013-1#1)(2013-8#1)
(StxB)##2##1##(2008-8#1)(2011-1#1)
(Sus scrofa)##2##2##(2010-4#1)(2013-7#1)
(Sus##3##1##(2010-4#1)(2011-2#1)(2013-7#1)
(Sweden)##3##1##(1992-8#1)(2008-3#1)(2008-5#1)
(T =##3##2##(2008-10#1)(2008-2#1)(2010-9#1)
(T##17##1##(1990-11#1)(1990-7#1)(1992-8#1)(1993-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-3#1)
(T&amp##2##1##(1996-1#1)(2012-2#1)
(T(0))##2##1##(2008-10#1)(2008-5#1)
(T(1)##2##1##(2007-8#1)(2011-2#1)
(T(1))##2##1##(2008-10#1)(2010-4#1)
(T(3)) and##2##2##(2008-10#1)(2009-12#1)
(T(3))##3##1##(2008-10#1)(2008-11#1)(2009-12#1)
(T(4))##3##1##(2009-12#1)(2010-4#1)(2010-8#1)
(T(50))##3##1##(2008-10#3)
(T(g))##3##1##(2008-9#1)(2009-7#1)(2010-4#1)
(T(in))##2##1##(1995-2#1)(2008-4#1)
(T(max))##2##1##(2008-10#1)(2008-11#1)
(T) and lymph node##2##4##(1990-6#1)(1995-1#1)
(T) and##5##2##(1990-11#1)(1990-6#1)(1995-1#1)(1996-2#1)(2008-10#1)
(T) is##2##2##(2008-10#1)(2013-8#1)
(T)##30##1##(1990-11#2)(1990-6#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#2)(1996-2#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-8#1)
(T--&gt##2##1##(1994-8#1)(2008-7#1)
(T0)##4##1##(2006-12#1)(2007-8#1)(2008-12#1)(2013-7#1)
(T1##3##1##(2008-10#1)(2009-10#1)(2011-2#1)
(T1)##12##1##(1991-5#1)(1996-12#2)(1997-2#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2011-2#1)(2013-1#1)
(T2##3##1##(2007-8#1)(2009-10#1)(2011-2#1)
(T2)##9##1##(1996-12#2)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#1)
(T2D) and##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
(T2D)##8##1##(2008-1#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#1)
(T2DM)##10##1##(2008-1#1)(2008-3#2)(2009-11#2)(2009-9#1)(2010-10#1)(2011-1#1)(2013-1#2)
(T3##2##1##(1996-5#1)(2011-2#1)
(T3)##13##1##(1991-12#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-11#2)(1997-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)
(T4##3##1##(1991-4#1)(2012-2#1)(2013-8#1)
(T4) and##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
(T4)##8##1##(1991-12#1)(1992-12#1)(1995-8#1)(2008-12#1)(2008-6#2)(2008-7#2)
(T90)##2##1##(1990-5#1)(2013-8#1)
(TA)##14##1##(1991-9#1)(1997-8#4)(2007-10#1)(2007-8#1)(2008-10#4)(2009-10#1)(2013-1#2)
(TAC)##4##1##(2008-10#4)
(TAD)##2##1##(1995-3#1)(2008-10#1)
(TAH)##2##1##(1994-2#1)(2010-8#1)
(TAIR##2##1##(2008-4#1)(2008-7#1)
(TAM)##9##1##(1993-1#2)(1994-7#2)(1997-7#2)(2008-10#2)(2008-12#1)
(TAN)##3##1##(2008-10#3)
(TAO)##2##1##(2006-10#1)(2011-3#1)
(TAP)##2##1##(1991-8#1)(2008-7#1)
(TAPP) and##2##2##(2008-10#1)(2011-2#1)
(TAPP)##3##1##(2008-10#2)(2011-2#1)
(TAR)##2##1##(1994-8#1)(2009-6#1)
(TAT)##8##1##(1991-3#1)(1997-4#1)(2008-11#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)
(TB##2##1##(2008-10#2)
(TB) incidence##2##2##(2007-2#1)(2010-4#1)
(TB) is an##2##3##(2011-2#1)(2012-12#1)
(TB) is##7##2##(2006-10#1)(2008-1#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
(TB)##30##1##(1996-3#4)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
(TBA##2##1##(1992-9#1)(2008-10#1)
(TBA)##5##1##(2008-10#4)(2008-5#1)
(TBAB) and##3##2##(1995-12#1)(2008-10#2)
(TBARS) in##3##2##(1993-2#1)(1994-6#1)(1995-3#1)
(TBARS)##11##1##(1993-2#1)(1994-6#1)(1995-3#1)(2008-10#2)(2010-4#1)(2011-2#3)(2012-2#1)(2012-5#1)
(TBAs)##3##1##(1994-3#2)(2009-12#1)
(TBHQ)##3##1##(2008-10#3)
(TBI) is##2##2##(2007-11#1)(2008-6#1)
(TBI) patients##2##2##(2008-10#1)(2012-2#1)
(TBI)##13##1##(1993-12#1)(1995-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
(TBII)##4##1##(1991-12#1)(1991-5#1)(1991-9#1)(1995-12#1)
(TBP)##16##1##(1993-2#3)(1993-8#1)(1993-9#1)(1997-2#1)(2008-1#1)(2008-10#9)
(TBZ)##2##1##(2008-10#1)(2011-10#1)
(TC##2##1##(1991-12#1)(2008-10#1)
(TC) and##2##2##(1992-10#1)(2009-5#1)
(TC)##15##1##(1990-2#1)(1992-10#1)(1993-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
(TC)(n) repeats##2##2##(2008-10#2)
(TC)(n)##4##1##(2008-10#4)
(TCA)##12##1##(1993-6#1)(1995-3#1)(2008-10#5)(2008-4#2)(2010-1#1)(2010-12#1)(2012-1#1)
(TCAs)##3##1##(1996-7#1)(2008-10#1)(2008-6#1)
(TCB)##2##1##(1995-12#1)(2008-2#1)
(TCC) of the##2##3##(2008-10#2)
(TCC)##8##1##(1992-12#1)(1993-11#1)(1993-6#1)(1997-7#1)(2007-10#1)(2008-10#2)(2012-3#1)
(TCD)##8##1##(1996-2#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
(TCDD) was##2##2##(2008-10#1)(2008-11#1)
(TCDD)##16##1##(1992-12#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-3#3)(2008-10#8)(2008-11#1)
(TCE)##8##1##(2008-10#6)(2010-4#1)(2012-12#1)
(TCGA)##2##1##(1994-12#1)(2012-2#1)
(TCM)##3##1##(2008-10#1)(2009-6#1)(2012-2#1)
(TCMTB)##2##1##(2008-10#2)
(TCP)##5##1##(1992-6#1)(1994-2#1)(2008-10#1)(2008-5#1)(2009-8#1)
(TCPC)##2##1##(2007-12#1)(2007-8#1)
(TCPP)##2##1##(2008-10#2)
(TCR) and##2##2##(2011-1#1)(2012-2#1)
(TCR)##10##1##(1994-3#1)(2008-11#4)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
(TCT)##2##1##(1991-8#1)(2008-7#1)
(TCs)##2##1##(1992-6#1)(2008-10#1)
(TD)##10##1##(1997-3#1)(2007-7#2)(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#1)
(TDAR)##7##1##(2008-10#7)
(TDF)##3##1##(2008-6#1)(2009-10#1)(2013-1#1)
(TDM)##8##1##(1991-11#1)(2007-12#2)(2008-12#3)(2008-3#1)(2008-7#1)
(TDT)##2##1##(2008-7#1)(2008-9#1)
(TDX system)##2##2##(1993-8#2)
(TE##2##1##(2008-10#2)
(TE)##6##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)
(TEA) and a##2##3##(2008-10#1)(2008-3#1)
(TEA) and##3##2##(2008-10#2)(2008-3#1)
(TEA)##14##1##(1996-5#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-1#1)
(TEA)(+)##2##1##(2008-10#2)
(TEAC)##2##1##(2008-10#1)(2008-5#1)
(TEE)##4##1##(2008-7#2)(2010-8#1)(2011-2#1)
(TEF)##2##1##(1990-5#1)(2008-1#1)
(TEFRA)##3##1##(1993-12#1)(1994-3#1)(1997-1#1)
(TEG)##2##1##(1997-4#1)(2013-1#1)
(TEHP) and##2##2##(2008-10#2)
(TEHP)##4##1##(2008-10#4)
(TEM) and##2##2##(2007-12#1)(2008-12#1)
(TEM)##25##1##(1992-6#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#3)(2009-9#1)(2011-2#3)(2012-3#1)(2013-8#1)
(TEOS)##5##1##(2008-10#4)(2008-5#1)
(TEP)##5##1##(2008-10#4)(2011-2#1)
(TEQ)##5##1##(2008-10#5)
(TER)##3##1##(2008-10#1)(2008-11#2)
(TES)##5##1##(1996-2#1)(2008-2#1)(2008-3#2)(2009-10#1)
(TESS)##2##1##(2008-3#1)(2008-6#1)
(TEWL) and##4##2##(2008-5#4)
(TEWL)##12##1##(2008-5#11)(2012-2#1)
(TF)##3##1##(1994-9#2)(1995-6#1)
(TFA) in the##2##3##(2008-10#1)(2012-2#1)
(TFA)##6##1##(2008-10#3)(2008-7#1)(2012-2#1)(2013-1#1)
(TFs)##6##1##(2008-7#1)(2008-9#1)(2010-7#2)(2011-2#1)(2012-2#1)
(TG) and##2##2##(2008-10#2)
(TG) within##2##2##(2008-10#1)(2009-12#1)
(TG)##17##1##(1996-5#1)(2008-10#6)(2008-7#1)(2009-12#2)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
(TG-DTG)##2##1##(2008-10#2)
(TGA)##9##1##(1992-8#1)(2008-10#6)(2009-3#1)(2009-6#1)
(TGF##5##1##(1991-12#1)(1992-8#2)(1992-9#1)(1997-1#1)
(TGF-alpha)##2##1##(1992-9#1)(1993-9#1)
(TGF-beta##7##1##(1990-8#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-2#2)(2008-6#1)
(TGF-beta) is a##2##3##(1993-8#1)(2008-9#1)
(TGF-beta) on##2##2##(2008-11#1)(2008-12#1)
(TGF-beta)##14##1##(1990-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-3#1)
(TGF-β)##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
(TGT)##2##1##(1997-3#1)(2010-11#1)
(TH) and##2##2##(1996-5#1)(2013-1#1)
(TH)##16##1##(1990-6#1)(1990-7#1)(1992-12#1)(1993-8#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
(THA)##10##1##(1994-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
(THC)##2##1##(1991-1#1)(1996-5#1)
(THD)##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
(THF)##6##1##(1990-7#1)(1992-10#1)(1996-5#1)(2008-10#2)(2008-5#1)
(THG)##7##1##(2007-11#2)(2007-12#2)(2008-3#3)
(THz)##18##1##(2007-11#8)(2007-12#8)(2008-3#1)(2012-2#1)
(TI)##4##1##(1992-8#1)(2008-10#2)(2010-4#1)
(TIA)##5##1##(1991-11#1)(2008-8#2)(2009-7#1)(2011-2#1)
(TIC)##3##1##(1991-12#1)(2008-10#2)
(TIMP-1##2##1##(1992-9#1)(2008-9#1)
(TIMP-1)##2##1##(1997-4#1)(2008-5#1)
(TIMP-2)##2##1##(1992-2#1)(2010-1#1)
(TIP)##4##1##(2008-10#1)(2009-5#2)(2011-2#1)
(TIR)##2##1##(2008-3#2)
(TIRF)##2##1##(2008-10#2)
(TIS)##3##1##(1993-3#1)(2008-2#1)(2008-3#1)
(TJ) permeability##2##2##(2008-11#2)
(TJ)##5##1##(2008-11#2)(2009-10#1)(2012-2#2)
(TKA) is##2##2##(2007-8#2)
(TKA)##13##1##(1994-3#1)(2007-8#2)(2008-8#2)(2009-3#2)(2011-2#2)(2013-1#4)
(TKR)##5##1##(1995-3#1)(2007-8#1)(2008-8#2)(2013-1#1)
(TL)##6##1##(1995-12#1)(2008-11#1)(2008-3#3)(2008-8#1)
(TLC)##9##1##(1992-11#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-12#2)(2008-4#1)
(TLD)##2##1##(2007-10#1)(2009-11#1)
(TLS)##5##1##(2008-10#3)(2008-7#2)
(TM)##2##1##(1994-3#1)(2009-7#1)
(TMA) in##2##2##(1995-11#1)(2008-10#1)
(TMA)##9##1##(1995-11#1)(2008-10#8)
(TMA-DPH)##3##1##(1990-11#1)(1993-11#1)(2008-10#1)
(TMAO)##3##1##(2008-10#3)
(TMD)##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
(TMP(*)(+))Mn(III)(ClO(4))(2)##2##1##(1997-7#2)
(TMS)##5##1##(2008-10#1)(2009-12#1)(2010-7#2)(2011-2#1)
(TMV)##6##1##(2008-10#6)
(TN)##2##1##(2008-10#1)(2011-2#1)
(TNB)##2##1##(2008-10#2)
(TNF##5##1##(1991-9#1)(1993-6#1)(1995-12#1)(1995-2#1)(2012-3#1)
(TNF) is an##2##3##(1992-7#1)(2008-9#1)
(TNF) is##3##2##(1990-12#1)(1992-7#1)(2008-9#1)
(TNF)##25##1##(1990-12#2)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-2#2)(1994-8#1)(1996-2#2)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#3)(2012-3#2)
(TNF-alpha##2##1##(2008-11#2)
(TNF-alpha) and##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
(TNF-alpha)##21##1##(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1995-12#2)(1995-9#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-7#1)(2012-2#1)
(TNF-α)##4##1##(2010-12#1)(2011-1#1)(2012-3#2)
(TNFa)##2##1##(2008-4#1)(2009-10#1)
(TNFalpha##2##1##(2008-10#1)(2008-6#1)
(TNP)##3##1##(2008-10#2)(2012-3#1)
(TNT) using##3##2##(2008-10#3)
(TNT)##20##1##(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)
(TNT-H)(-)##3##1##(2008-10#3)
(TO)##3##1##(1993-5#1)(1994-3#1)(2008-7#1)
(TOA)##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
(TOF) and##3##2##(2008-10#2)(2008-7#1)
(TOF)##7##1##(1997-2#1)(2008-10#3)(2008-7#3)
(TOF-SIMS)##2##1##(2009-10#1)(2012-12#1)
(TOM)##3##1##(2008-4#2)(2012-2#1)
(TOP)##2##1##(2008-10#1)(2008-11#1)
(TP)##6##1##(2008-10#2)(2008-3#1)(2009-8#1)(2012-2#2)
(TPA) and##3##2##(1993-9#1)(1994-12#1)(1995-8#1)
(TPA)##22##1##(1990-12#1)(1990-8#2)(1992-8#1)(1992-9#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-8#1)(2008-9#1)
(TPA)-induced##2##1##(1994-12#1)(1997-2#1)
(TPB)##3##1##(2008-10#2)(2011-1#1)
(TPE)##3##1##(2011-1#1)(2011-2#2)
(TPF)##5##1##(2007-11#1)(2008-10#1)(2008-3#2)(2010-12#1)
(TPL)##2##1##(1997-8#1)(2010-1#1)
(TPO)##5##1##(2008-4#1)(2008-8#3)(2011-1#1)
(TPP)##7##1##(2007-5#1)(2008-10#3)(2009-8#1)(2010-6#1)(2013-1#1)
(TPP)Ru(NO)(ONO)##5##1##(1996-2#5)
(TPS)##2##1##(1991-12#1)(2008-10#1)
(TPW)##2##1##(2008-10#1)(2008-2#1)
(TQM) has##2##2##(1992-2#1)(1996-2#1)
(TQM) is a##2##3##(1995-3#1)(1996-2#1)
(TQM) is##3##2##(1994-2#1)(1995-3#1)(1996-2#1)
(TQM)##21##1##(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#5)(1995-1#2)(1995-3#4)(1996-2#2)(1996-3#1)
(TR =##3##2##(1996-2#1)(1997-8#2)
(TR##4##1##(1996-2#1)(1997-8#3)
(TR)##5##1##(1990-12#1)(1990-8#1)(1995-8#1)(2008-3#1)(2008-7#1)
(TRA)##3##1##(2011-1#1)(2011-2#2)
(TRAMP)##2##1##(2008-4#1)(2008-5#1)
(TRAP)##2##1##(2008-1#1)(2008-11#1)
(TRE)##3##1##(1993-3#1)(1993-8#1)(1995-8#1)
(TRH)##11##1##(1991-12#1)(1992-2#1)(1992-6#1)(1994-6#1)(1995-5#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-7#1)
(TRIS) buffer##2##2##(2008-10#2)
(TRIS)##4##1##(2008-10#4)
(TRP) channels##2##2##(2008-8#1)(2009-12#1)
(TRP)##4##1##(1996-7#1)(2008-7#1)(2008-8#1)(2009-12#1)
(TRSV)##2##1##(2008-10#2)
(TRUS)##2##1##(1997-8#1)(2011-2#1)
(TRbeta)##2##1##(1997-1#1)(2008-7#1)
(TS)##7##1##(1990-7#1)(1992-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
(TS/pH##2##1##(2008-11#2)
(TSA)##7##1##(1990-6#1)(1995-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)
(TSAb)##3##1##(1991-12#1)(1991-5#1)(1991-9#1)
(TSC)##3##1##(1992-1#1)(1993-12#1)(2008-4#1)
(TSD)##2##1##(2008-2#1)(2010-3#1)
(TSH##4##1##(2007-8#1)(2012-12#1)(2012-3#2)
(TSH)##12##1##(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-9#1)(1995-5#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
(TSK##2##1##(1990-8#1)(1997-8#1)
(TSK) and##2##2##(1990-8#1)(2008-10#1)
(TSK)##4##1##(1990-8#1)(1997-8#2)(2008-10#1)
(TSLS)##2##1##(1992-2#1)(2008-11#1)
(TSM)##3##1##(1992-9#1)(2008-10#1)(2008-2#1)
(TSP)##5##1##(1991-11#1)(1993-6#1)(1993-9#1)(2007-3#1)(2009-10#1)
(TSPO) (18 kDa)##2##3##(2012-2#2)
(TSPO) (18##3##2##(2012-2#3)
(TSPO) in##4##2##(2012-2#4)
(TSPO)##16##1##(2012-2#16)
(TSS)##3##1##(2008-10#1)(2008-4#1)(2013-8#1)
(TST)##6##1##(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
(TSWV) is##2##2##(2008-10#2)
(TSWV) was##2##2##(2008-10#2)
(TSWV)##20##1##(2008-10#20)
(TT##2##1##(1992-6#1)(2008-10#1)
(TT)##2##1##(2008-10#1)(2009-11#1)
(TTA)##2##1##(2007-11#1)(2008-10#1)
(TTD)##3##1##(2008-3#3)
(TTF)##2##1##(1996-5#1)(2008-8#1)
(TTM)##6##1##(2007-12#1)(2008-12#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
(TTP)##4##1##(1991-3#1)(2007-11#1)(2008-10#1)(2009-4#1)
(TTR)##4##1##(1992-8#2)(1993-12#1)(2008-12#1)
(TTS)##2##1##(2008-10#1)(2008-5#1)
(TTTAGGG)(n)##2##1##(2008-8#2)
(TU)##3##1##(2008-9#1)(2011-2#1)(2013-8#1)
(TULS)##2##1##(2008-3#1)(2013-8#1)
(TUNEL)##4##1##(2008-8#3)(2008-9#1)
(TV)##3##1##(2008-3#1)(2012-1#1)(2012-2#1)
(TVB-N)##2##1##(2008-10#1)(2012-2#1)
(TXRF)##2##1##(2008-10#2)
(TYLCV)-Sr by TYLCV-Is##2##3##(2008-10#2)
(TZDs)##4##1##(2008-1#1)(2008-3#2)(2010-10#1)
(Taiwan##2##1##(1997-7#2)
(Takayasu's disease)##2##2##(2012-3#2)
(Takayasu's##3##1##(2012-12#1)(2012-3#2)
(Tanzania)##2##1##(2009-10#2)
(TaqMan)##5##1##(2008-10#5)
(Tb) and##3##2##(2008-6#3)
(Tb)##5##1##(2008-6#3)(2008-8#1)(2012-2#1)
(Teleostei##7##1##(2008-5#1)(2008-7#4)(2010-8#2)
(Texas##2##1##(2008-10#1)(2008-3#1)
(Tg)##2##1##(1991-6#1)(2013-1#1)
(Th)##3##1##(1994-8#1)(1995-12#1)(2008-11#1)
(Th1)##3##1##(2008-10#1)(2008-11#2)
(The##15##1##(1992-6#1)(1994-12#1)(1996-3#1)(1996-9#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
(Thelephoraceae)##2##1##(2013-7#2)
(Theobroma cacao)##2##2##(2008-10#1)(2008-5#1)
(There##3##1##(2008-3#1)(2009-3#2)
(These##2##1##(1994-5#1)(2008-7#1)
(Thevetia##2##1##(2008-12#2)
(Thinopyrum##2##1##(2008-10#2)
(This##3##1##(1990-3#1)(2008-2#1)(2011-2#1)
(Thysanoptera##3##1##(2008-10#1)(2011-2#2)
(Ti##3##1##(2007-12#2)(2008-2#1)
(Ti)##3##1##(2007-2#1)(2008-10#1)(2009-7#1)
(TiO(2)##3##1##(2008-10#2)(2009-11#1)
(Time 1##2##2##(2009-9#2)
(Tiron)##2##1##(2008-10#2)
(Tm approximately##2##2##(1992-8#2)
(Tm##5##1##(1990-7#2)(1992-8#2)(2008-2#1)
(Tmax)##3##1##(2008-8#1)(2012-12#1)(2012-3#1)
(ToM)##2##1##(2008-12#1)(2013-1#1)
(Tomato##2##1##(2008-10#2)
(Topo##4##1##(1994-8#4)
(Toxic##2##1##(1992-1#1)(2008-10#1)
(Toxicology##2##1##(1995-11#1)(1996-12#1)
(Trace Elements in##2##3##(2008-10#2)
(Trace##3##1##(2008-10#3)
(Treatment##2##1##(2008-7#2)
(Treg)##3##1##(2008-4#1)(2011-1#1)(2013-8#1)
(Trematoda##2##1##(2007-6#1)(2008-5#1)
(Trends Endocrinol Metab 1997##4##4##(2008-4#4)
(Trichoplusia##2##1##(2008-7#1)(2008-9#1)
(Tridacnidae)##2##1##(2008-5#2)
(Triticum aestivum L##7##3##(2008-11#1)(2008-12#4)(2008-5#2)
(Triticum aestivum##8##2##(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#2)
(Triticum aestivum)##15##2##(2008-10#12)(2008-11#1)(2008-12#1)(2008-9#1)
(Triticum turgidum##2##2##(2008-10#1)(2012-3#1)
(Triticum##33##1##(2008-10#18)(2008-11#2)(2008-12#8)(2008-5#2)(2008-9#1)(2012-3#2)
(Triton X-100) and##2##3##(2008-10#1)(2008-8#1)
(Triton X-114) after centrifugation##2##4##(2008-10#2)
(Triton##5##1##(2008-10#3)(2008-7#1)(2008-8#1)
(Trx)##2##1##(1991-6#2)
(Ts)##3##1##(1993-12#1)(2008-3#1)(2008-9#1)
(TuMV)##5##1##(2008-10#5)
(Tyr(701)##2##1##(2011-2#2)
(Tyr) and##2##2##(2008-10#1)(2013-1#1)
(Tyr)##3##1##(2008-10#2)(2013-1#1)
(U##10##1##(1992-3#2)(1996-12#1)(2008-10#4)(2008-12#1)(2010-8#1)(2012-12#1)
(U)##3##1##(2008-10#2)(2008-11#1)
(U-shaped)##2##1##(2008-7#2)
(U1##2##1##(2007-12#1)(2013-8#1)
(U74389F)##2##1##(1992-5#1)(1995-12#1)
(UA)##7##1##(2008-10#6)(2013-1#1)
(UAA)##4##1##(1990-11#1)(1990-7#1)(1992-11#1)(2008-9#1)
(UAE)##2##1##(2008-10#1)(2013-8#1)
(UC##2##1##(2008-10#1)(2009-7#1)
(UC)##10##1##(2008-9#1)(2009-12#1)(2010-12#3)(2011-2#2)(2012-2#1)(2013-8#2)
(UCB)##2##1##(2011-2#1)(2013-1#1)
(UCS)##3##1##(1995-12#1)(2008-11#1)(2010-8#1)
(UDPGT)##3##1##(1990-12#1)(2008-11#2)
(UER)##2##1##(2008-5#1)(2011-2#1)
(UF)##2##1##(1994-2#1)(2010-5#1)
(UFH)##4##1##(2007-7#1)(2008-1#1)(2008-10#1)(2013-8#1)
(UGT)##2##1##(1991-2#1)(1992-8#1)
(UI)##4##1##(1991-2#1)(1994-5#1)(2010-10#1)(2011-1#1)
(UK)##6##1##(1995-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)
(UKCC##3##1##(1997-7#1)(2008-11#2)
(UL)##2##1##(1993-9#1)(2013-1#1)
(UM)##4##1##(1992-1#1)(1996-1#1)(1997-2#1)(2008-10#1)
(UN)##3##1##(1996-1#1)(2008-10#1)(2009-2#1)
(UNIT##4##1##(2008-2#2)(2008-4#2)
(UO(2))(2)(DET) [Formula##3##2##(2008-10#3)
(UO(2))(DET)(2) [Formula##2##2##(2008-10#2)
(UOx)##2##1##(2008-10#2)
(UPDRS) and##3##2##(2008-7#3)
(UPDRS)##4##1##(2008-7#4)
(UPLC)##3##1##(2008-10#1)(2011-1#2)
(UPR)##3##1##(1997-5#2)(2009-8#1)
(US##5##1##(1992-12#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
(US$##3##1##(2007-2#2)(2009-8#1)
(US) examination##2##2##(2011-2#1)(2013-8#1)
(US) findings##2##2##(2011-2#1)(2012-2#1)
(US) is##2##2##(2008-7#1)(2010-12#1)
(US)##15##1##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#4)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
(US-1##4##1##(2008-10#4)
(US-8##4##1##(2008-10#4)
(USA)##8##1##(2007-5#1)(2008-10#2)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#1)
(USC)##2##1##(1992-12#1)(2010-12#1)
(USE)##2##1##(1994-9#1)(2008-10#1)
(USG)##2##1##(2011-1#1)(2012-12#1)
(USN)##2##1##(2008-10#2)
(USP)##3##1##(2007-7#1)(2008-10#2)
(UTI)##10##1##(1994-3#1)(2007-7#2)(2008-1#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-2#2)
(UTR) of the##3##3##(1993-12#1)(1996-5#1)(2008-10#1)
(UTR)##10##1##(1990-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#3)
(UV) irradiation##2##2##(2008-10#1)(2012-2#1)
(UV)##23##1##(1991-6#1)(1994-6#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#6)(2011-2#1)(2012-2#1)(2013-7#1)
(UV)-induced##3##1##(2008-10#1)(2008-5#2)
(UV-Vis)##2##1##(2008-10#2)
(UV-vis)##4##1##(2008-10#3)(2009-11#1)
(UV/Vis)##2##1##(2007-12#1)(2008-10#1)
(UVB)##4##1##(2008-11#2)(2008-5#2)
(Uncinula necator)##2##2##(2008-10#2)
(Uncinula##3##1##(2008-10#3)
(Uni-TCCCN) and##2##2##(2008-10#2)
(United Kingdom)##2##2##(2007-12#2)
(United States##2##2##(2008-8#1)(2013-8#1)
(United States) and##2##3##(2008-10#2)
(United States)##4##2##(1995-3#1)(2008-10#3)
(United##10##1##(1992-3#1)(1995-3#1)(2007-12#2)(2008-10#3)(2008-8#1)(2013-1#1)(2013-8#1)
(University of##4##2##(1990-2#1)(1992-12#1)(2008-5#1)(2012-3#1)
(V##13##1##(1994-7#1)(2008-10#7)(2008-8#1)(2009-8#1)(2012-1#2)(2013-8#1)
(V(D0)##2##1##(2011-2#2)
(V) and##2##2##(1990-12#1)(2008-10#1)
(V) in##2##2##(2008-10#1)(2010-5#1)
(V) to##2##2##(1991-5#1)(2008-10#1)
(V) were##2##2##(2008-10#2)
(V)##25##1##(1990-12#1)(1990-2#1)(1991-5#1)(1996-5#1)(1997-6#1)(2008-10#14)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
(V-ATPase##2##1##(2008-11#2)
(V-VI)##3##1##(1993-12#3)
(V/V)##2##1##(2008-10#1)(2008-5#1)
(V106-P322)##4##1##(2008-8#4)
(VA) and##2##2##(2012-2#1)(2012-3#1)
(VA)##10##1##(1993-12#1)(2007-7#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
(VAD)##4##1##(2008-9#1)(2010-8#1)(2012-1#1)(2013-8#1)
(VAM)##2##1##(2008-10#1)(2008-9#1)
(VAP)##2##1##(1995-5#1)(2010-7#1)
(VAS) and##2##2##(2007-7#1)(2007-8#1)
(VAS) for pain##2##3##(1996-3#1)(2012-2#1)
(VAS) for##3##2##(1996-3#1)(2007-11#1)(2012-2#1)
(VAS)##13##1##(1996-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
(VAT)##4##1##(2008-12#1)(2008-5#2)(2008-7#1)
(VB)##4##1##(2008-1#1)(2008-10#2)(2013-1#1)
(VBNC)##2##1##(2008-10#1)(2008-9#1)
(VC)##5##1##(2008-10#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
(VCG) diversity##2##2##(2008-10#2)
(VCG)##10##1##(2008-10#9)(2010-8#1)
(VDCC)##3##1##(1997-4#1)(2008-8#1)(2009-12#1)
(VDR)##8##1##(1992-12#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
(VDRE)##3##1##(1992-12#1)(1995-8#1)(2012-12#1)
(VEGF-A)##2##1##(2008-10#1)(2013-1#1)
(VEP)##2##1##(1995-12#1)(1996-2#1)
(VH) and##2##2##(1994-12#1)(1995-1#1)
(VHF)##3##1##(1995-6#2)(2008-1#1)
(VHL)##2##1##(2008-7#1)(2011-1#1)
(VHN) of##2##2##(2008-12#2)
(VI##4##1##(1990-12#1)(1994-7#1)(1997-6#1)(2008-10#1)
(VI) and##3##2##(2008-10#3)
(VI) by##2##2##(2008-10#2)
(VI) from##2##2##(2008-10#2)
(VI) in##6##2##(2008-10#6)
(VI) species##3##2##(2008-10#3)
(VI) with##5##2##(2008-10#5)
(VI)##50##1##(1993-3#1)(1994-11#3)(1996-12#2)(1997-6#1)(2008-10#40)(2009-11#1)(2013-7#1)(2013-8#1)
(VII) and p-cresol (VIII)##2##4##(1991-5#2)
(VII)##6##1##(1991-5#2)(1996-5#1)(2008-10#3)
(VIII)##3##1##(1991-5#2)(2008-10#1)
(VIP)##12##1##(1990-5#1)(1990-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-5#1)(2008-4#1)(2011-2#1)(2012-3#1)
(VL)##4##1##(1994-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
(VLC)##2##1##(1995-6#1)(2007-12#1)
(VLDL)##11##1##(1990-8#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#1)
(VLP)##3##1##(1993-3#1)(2008-10#2)
(VM)##2##1##(2008-10#1)(2012-3#1)
(VMA)##2##1##(2008-10#2)
(VNTR) and##2##2##(1994-8#1)(2008-10#1)
(VNTR)##4##1##(1994-8#1)(1997-5#1)(2008-10#2)
(VO2)##2##1##(1992-12#1)(2008-5#1)
(VOCs) in##3##2##(2008-10#2)(2011-1#1)
(VOCs)##9##1##(2007-11#1)(2008-10#7)(2011-1#1)
(VP)##7##1##(1994-9#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)
(VP2##2##1##(1997-4#1)(2008-11#1)
(VPA)##8##1##(1996-5#2)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
(VPD) of##3##2##(2008-10#3)
(VPD)##4##1##(2008-10#4)
(VR)##5##1##(1992-3#1)(1994-12#1)(2008-3#1)(2009-11#1)(2010-4#1)
(VR1)##2##1##(2008-11#2)
(VRT)##2##1##(2007-11#1)(2012-1#1)
(VS)##2##1##(2008-11#1)(2011-2#1)
(VSM)##2##1##(1993-8#1)(2012-2#1)
(VSMC)##8##1##(1990-12#1)(1992-9#1)(1993-2#1)(1994-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)
(VTEC)##2##1##(1991-8#1)(2007-12#1)
(VUV)##3##1##(2007-11#1)(2008-2#1)(2010-4#1)
(Vaccinium##2##1##(2008-10#1)(2009-6#1)
(Valle del Cauca##2##3##(2012-12#2)
(Vicia##4##1##(2008-10#3)(2009-8#1)
(Vident)##2##1##(2009-8#2)
(Vigna##4##1##(2008-10#2)(2008-12#2)
(Vitadur Alpha##3##2##(2009-8#3)
(Vitex agnus castus)##2##3##(2008-12#2)
(Vitis labrusca)##2##2##(2008-10#2)
(Vitis vinifera L##2##3##(2008-10#1)(2013-1#1)
(Vitis vinifera##3##2##(2008-10#2)(2013-1#1)
(Vitis vinifera)##4##2##(2008-10#4)
(Vitis##9##1##(2008-10#8)(2013-1#1)
(Vmax##3##1##(1990-5#1)(1995-8#1)(1996-7#1)
(Vmax)##3##1##(1990-12#1)(1993-8#1)(1995-11#1)
(Vultur gryphus)##2##2##(1997-6#2)
(W) interface##2##2##(2008-10#2)
(W)##7##1##(1993-12#1)(2008-10#3)(2008-9#1)(2013-1#1)(2013-7#1)
(W/O)##2##1##(2008-10#1)(2008-5#1)
(W2)##2##1##(2009-10#1)(2011-3#1)
(W370)##2##1##(2008-10#2)
(W54S)##2##1##(1997-2#2)
(W=0##2##1##(2013-7#2)
(WA)##3##1##(2008-10#3)
(WB##2##1##(1993-11#1)(2008-10#1)
(WB)##5##1##(1993-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
(WBC)##5##1##(1992-5#1)(2008-10#2)(2008-4#1)(2013-1#1)
(WBI)##2##1##(2008-1#1)(2011-2#1)
(WC)##4##1##(1993-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
(WD)##3##1##(2008-10#2)(2010-12#1)
(WDM)##6##1##(2007-11#1)(2008-2#3)(2008-3#2)
(WE)##2##1##(2008-10#1)(2011-1#1)
(WFA)##2##1##(1990-7#1)(2008-8#1)
(WFNS)##2##1##(2011-2#1)(2012-3#1)
(WG##2##1##(2008-10#1)(2008-11#1)
(WG)##3##1##(2008-1#1)(2008-7#1)(2013-7#1)
(WHC)##3##1##(1997-3#1)(2011-2#1)(2012-2#1)
(WHO grade##2##2##(1991-4#1)(2012-12#1)
(WHO##4##1##(1991-3#1)(1991-4#1)(2012-12#2)
(WHO)##25##1##(1994-9#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
(WKY) and##3##2##(1994-2#1)(1997-6#1)(2008-2#1)
(WKY) rats##2##2##(1993-12#1)(1996-5#1)
(WKY)##6##1##(1993-12#1)(1994-2#1)(1996-5#1)(1997-6#1)(2008-2#1)(2011-1#1)
(WLC)##2##1##(2007-11#1)(2008-7#1)
(WM) diode-laser##2##2##(2008-3#2)
(WM)##8##1##(1994-8#2)(2008-3#3)(2010-7#1)(2012-2#1)(2013-1#1)
(WMS)##4##1##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
(WP)##2##1##(2008-7#1)(2009-2#1)
(WR)##2##1##(2008-6#1)(2008-7#1)
(WRAP)##2##1##(2008-11#2)
(WT) and##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
(WT) mice##2##2##(2010-2#1)(2012-12#1)
(WT)##22##1##(1991-10#1)(1995-6#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
(WWTP) and##2##2##(2008-10#2)
(WWTP)##5##1##(2008-10#4)(2013-1#1)
(Walker)##5##1##(2008-6#2)(2010-2#1)(2011-2#1)(2013-8#1)
(Waters)##2##1##(1997-2#1)(2008-10#1)
(Weiser)##2##1##(2008-5#1)(2011-2#1)
(Western##2##1##(2011-2#1)(2013-8#1)
(Westheide##2##1##(2008-5#2)
(White##2##1##(1996-1#1)(2013-1#1)
(Wied##4##1##(2008-11#1)(2008-6#3)
(Wld(S))##3##1##(1997-3#3)
(World##2##1##(1990-11#1)(2011-1#1)
(X =##2##2##(1995-5#1)(1997-7#1)
(X bar =##3##3##(2010-3#3)
(X##18##1##(1995-5#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#3)
(X) in##2##2##(2008-10#2)
(X)##6##1##(1996-5#1)(2008-10#4)(2008-5#1)
(X-ray##2##1##(2008-10#1)(2010-4#1)
(XO)##6##1##(2008-10#5)(2008-11#1)
(XPS) and##2##2##(2008-10#1)(2009-11#1)
(XPS)##11##1##(2008-10#7)(2008-2#1)(2009-11#1)(2013-8#2)
(XRD) and scanning##2##3##(2008-10#2)
(XRD) and##9##2##(2008-10#8)(2012-2#1)
(XRD)##24##1##(2008-10#16)(2008-5#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-8#2)
(XRF)##6##1##(2008-10#4)(2008-5#1)(2013-8#1)
(Xanthomonas##3##1##(2008-10#3)
(Xiphophorus##3##1##(2008-12#2)(2009-9#1)
(Xoo)##2##1##(1993-9#1)(2008-8#1)
(Y =##4##2##(2008-10#3)(2011-1#1)
(Y##5##1##(2008-10#4)(2011-1#1)
(Y)##6##1##(2008-10#4)(2011-1#1)(2012-2#1)
(Y-BOCS)##2##1##(2008-3#2)
(YGG)##2##1##(2008-10#1)(2008-6#1)
(YS)##2##1##(2008-6#1)(2012-2#1)
(Yang##2##1##(1994-5#2)
(Yb##5##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
(Yb(3+)##2##1##(2008-3#2)
(Yb) and##2##2##(1997-8#2)
(Z =##2##2##(1996-2#1)(2013-1#1)
(Z##7##1##(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2013-1#1)
(Z)-3-hexen-1-ol##2##1##(2008-10#2)
(ZM##2##1##(2008-12#1)(2008-2#1)
(ZMA)##2##1##(2008-5#2)
(Zea mays L##10##3##(2008-10#3)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#3)
(Zea mays##12##2##(2008-10#3)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#3)
(Zea mays)##7##2##(2008-10#6)(2012-2#1)
(Zea##19##1##(2008-10#9)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#2)(2012-3#3)
(Zip)##2##1##(2008-10#1)(2012-2#1)
(Ziram)##2##1##(2008-10#2)
(Zn##7##1##(1993-12#1)(1994-6#1)(2008-10#4)(2008-5#1)
(Zn)##10##1##(1995-3#2)(1997-4#1)(2008-10#3)(2008-5#1)(2010-2#1)(2012-2#2)
(Zoladex)##2##1##(1994-9#1)(1996-2#1)
([Ca(2+)](i))##4##1##(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
([Ca2+]i##2##1##(1990-12#1)(1996-2#1)
([Ca2+]i) in##4##2##(1992-3#1)(1992-6#1)(1994-6#1)(1994-9#1)
([Ca2+]i)##13##1##(1990-5#1)(1992-3#1)(1992-6#2)(1992-9#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-11#1)(1997-1#1)
([Ca2+]o)##2##1##(1990-12#1)(2008-10#1)
([Formula##2##1##(2008-8#2)
([Mg2+]i)##2##1##(1993-11#1)(1994-6#1)
(a &quot##3##2##(2013-1#3)
(a 1##3##2##(1992-3#1)(1993-11#2)
(a benzimidazole) and vinclozolin (a dicarboximide) (S(T)S(V))##2##7##(2008-10#2)
(a calcium channel##2##3##(1995-12#1)(2008-10#1)
(a case##2##2##(2008-12#1)(2008-7#1)
(a combination of##2##3##(1990-8#1)(2008-10#1)
(a few##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)
(a high##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
(a major##2##2##(1993-11#1)(2008-10#1)
(a measure of the##2##4##(2008-10#1)(2008-4#1)
(a measure of##3##3##(2008-10#2)(2008-4#1)
(a measure##4##2##(2008-10#3)(2008-4#1)
(a minor##2##2##(1992-8#1)(2008-10#1)
(a mixture of##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
(a relatively##2##2##(1991-12#1)(2010-1#1)
(a representative of subgroup##2##4##(2008-10#2)
(a selective D1##2##3##(1992-3#2)
(a selective D2##2##3##(1992-3#2)
(a selective##6##2##(1992-3#4)(1995-12#1)(2008-9#1)
(a single##2##2##(2007-11#1)(2008-10#1)
(a total of##2##3##(2011-2#2)
(a##236##1##(1990-12#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-11#2)(1992-12#1)(1992-3#6)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#4)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#47)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#5)(2008-9#9)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#1)
(a) The##2##2##(2008-3#1)(2008-7#1)
(a) What##2##2##(2008-12#1)(2009-5#1)
(a) a##10##2##(1991-1#1)(1992-1#1)(1994-1#3)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-9#1)
(a) all##2##2##(2007-12#1)(2011-2#1)
(a) and##3##2##(2008-2#1)(2008-3#1)(2013-7#1)
(a) data##2##2##(2008-7#1)(2011-1#1)
(a) following##2##2##(1992-3#1)(2008-7#1)
(a) in##4##2##(1991-12#1)(1993-12#1)(2008-1#1)(2008-11#1)
(a) is##4##2##(1992-12#1)(1997-2#1)(2008-9#1)(2009-2#1)
(a) no##2##2##(1990-6#1)(2008-2#1)
(a) reduction##2##2##(1997-2#1)(2008-11#1)
(a) the use of##2##4##(1991-12#1)(2008-7#1)
(a) the##25##2##(1990-11#1)(1990-7#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
(a) to##3##2##(1991-12#1)(2008-7#2)
(a)##184##1##(1990-11#1)(1990-12#5)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#3)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#4)(1997-3#1)(1997-8#3)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#5)(2008-7#19)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
(a1)##2##1##(2013-8#2)
(aFGF)##4##1##(1990-8#1)(1991-12#1)(1997-7#1)(2008-7#1)
(aOR 2##2##2##(2008-11#2)
(aOR##8##1##(2008-11#3)(2013-1#5)
(aa##3##1##(1994-12#3)
(aa) changes##2##2##(1993-12#1)(1993-6#1)
(aa) of##2##2##(1993-2#1)(1994-8#1)
(aa) protein##6##2##(1993-12#1)(1993-9#1)(1994-12#2)(1995-8#1)(1997-7#1)
(aa) sequence of##4##3##(1990-11#1)(1991-6#1)(1993-12#1)(1993-6#1)
(aa) sequence##13##2##(1990-11#2)(1990-7#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#3)(1995-8#1)
(aa)##63##1##(1990-11#5)(1990-5#1)(1990-7#1)(1991-11#1)(1991-6#4)(1991-7#1)(1991-9#2)(1993-12#7)(1993-2#5)(1993-6#8)(1993-9#3)(1994-12#11)(1994-8#1)(1995-12#1)(1995-8#3)(1996-6#1)(1997-4#1)(1997-7#3)(2008-10#2)(2010-5#1)(2013-1#1)
(abdominal##2##1##(1997-8#1)(2010-4#1)
(ability to##2##2##(2007-5#1)(2008-8#1)
(about 1##2##2##(1990-5#1)(2011-1#1)
(about 30 min)##2##3##(2008-10#2)
(about 4##4##2##(1990-11#1)(1992-11#1)(1995-6#1)(2008-7#1)
(about a##2##2##(2009-1#1)(2009-5#1)
(about##40##1##(1990-11#1)(1990-3#1)(1990-5#3)(1991-12#1)(1992-11#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-6#2)(2007-12#2)(2007-8#1)(2008-10#12)(2008-7#2)(2009-1#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-8#1)
(above##7##1##(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
(absent##2##1##(2008-3#1)(2011-1#1)
(absolute##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
(absolute)##3##1##(2008-10#1)(2008-3#2)
(absorbance##2##1##(2008-10#2)
(absorbed##2##1##(2007-11#1)(2008-3#1)
(absorption##6##1##(1994-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
(acac = pentane-2##2##3##(2007-11#2)
(according to##5##2##(1995-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
(accuracy##6##1##(1990-9#1)(2008-10#4)(2013-1#1)
(acetic acid)##2##2##(2008-10#1)(2008-7#1)
(acetic##4##1##(2008-10#3)(2008-7#1)
(acetic-acetate)##2##1##(2008-10#2)
(acetone##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
(act##3##1##(2008-11#1)(2008-8#2)
(actin)##2##1##(2008-6#1)(2012-2#1)
(acting as##2##2##(2008-10#2)
(activated##4##1##(1991-12#1)(1993-11#2)(2008-10#1)
(activation of##2##2##(1993-12#2)
(active##7##1##(2008-10#3)(2008-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
(active) forms of##2##3##(2008-9#2)
(active)##3##1##(2008-9#2)(2013-1#1)
(activin##2##1##(1992-8#1)(1993-8#1)
(activity##3##1##(1994-12#2)(1995-4#1)
(actual##3##1##(2008-3#1)(2013-1#2)
(acute##11##1##(1990-5#1)(1992-3#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
(added##2##1##(2007-8#1)(2008-10#1)
(adding##2##1##(1995-2#1)(2008-10#1)
(adhesion##2##1##(1992-12#1)(2009-12#1)
(adhesive knobs)##2##2##(2008-10#2)
(adhesive networks)##2##2##(2008-10#2)
(adhesive##5##1##(2007-11#1)(2008-10#4)
(adjusted OR 0##3##3##(2008-10#3)
(adjusted OR 1##3##3##(2008-10#2)(2011-2#1)
(adjusted OR##8##2##(2008-10#6)(2011-2#1)(2013-1#1)
(adjusted odds ratio 1##3##4##(2011-1#1)(2011-2#2)
(adjusted odds ratio##7##3##(2007-10#1)(2011-1#1)(2011-2#3)(2013-1#2)
(adjusted r(2) = 0##2##4##(2008-10#2)
(adjusted r(2)##3##2##(2008-10#3)
(adjusted to pH 3##2##4##(2008-10#1)(2010-3#1)
(adjusted to pH##5##3##(2008-10#4)(2010-3#1)
(adjusted to##6##2##(1995-5#1)(2008-10#4)(2010-3#1)
(adjusted##30##1##(1993-3#1)(1995-5#1)(1997-1#2)(2007-10#1)(2008-10#15)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)
(adsorption)##2##1##(2008-10#2)
(adult##3##1##(2007-11#1)(2008-10#1)(2010-8#1)
(adult) and##2##2##(1995-8#1)(2008-7#1)
(adult)##5##1##(1990-7#1)(1995-8#1)(2008-12#2)(2008-7#1)
(advanced##2##1##(2008-8#1)(2010-6#1)
(adverse)##2##1##(2007-11#1)(2008-11#1)
(aerosol##2##1##(2008-11#1)(2008-3#1)
(after oxidation##2##2##(2008-10#2)
(after##22##1##(1990-12#2)(1990-7#1)(1994-12#1)(1995-3#1)(2007-11#2)(2008-10#7)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-12#1)
(against amino acid sequence##2##4##(1996-12#2)
(against##3##1##(1996-12#2)(1997-7#1)
(age &gt##2##2##(2008-11#1)(2012-3#1)
(age and##2##2##(2011-2#1)(2013-8#1)
(age group##2##2##(1993-6#2)
(age range##3##2##(1994-9#1)(1995-12#1)(1997-3#1)
(age##44##1##(1990-2#1)(1991-8#1)(1992-5#1)(1993-12#2)(1993-6#2)(1994-9#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#11)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
(age)##3##1##(2009-7#1)(2010-7#1)(2011-1#1)
(age- and##2##2##(2008-7#1)(2013-1#1)
(aged 12##2##2##(2008-11#1)(2008-3#1)
(aged##26##1##(1992-12#1)(1992-6#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#2)(2009-7#2)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
(ages##6##1##(1993-8#1)(2007-7#1)(2009-3#1)(2009-7#2)(2011-2#1)
(aggrecan)##2##1##(1991-5#1)(1993-2#1)
(aggregation##3##1##(1990-5#2)(1994-12#1)
(air##2##1##(2008-11#1)(2008-7#1)
(albeit##3##1##(1990-7#1)(2008-3#1)(2009-9#1)
(albumin##2##1##(2008-10#1)(2008-11#1)
(alcohol##2##1##(1992-8#1)(2010-7#1)
(alfalfa##2##1##(2008-10#1)(2008-5#1)
(all P &lt##2##3##(1995-12#1)(2012-3#1)
(all P##4##2##(1995-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
(all at##2##2##(2008-10#1)(2008-11#1)
(all p &gt##2##3##(2011-2#1)(2013-8#1)
(all p &lt##2##3##(2007-12#1)(2013-7#1)
(all p values &lt##2##4##(2008-3#2)
(all p##6##2##(2007-12#1)(2008-3#2)(2011-2#1)(2013-7#1)(2013-8#1)
(all p&gt##2##2##(1997-7#2)
(all##38##1##(1991-2#2)(1992-4#3)(1993-5#1)(1995-12#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
(allele##8##1##(1993-3#1)(1993-6#1)(1997-4#1)(2008-12#1)(2010-2#4)
(allocentric##2##1##(1994-3#1)(1994-8#1)
(almost##4##1##(1990-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
(along the##3##2##(1993-3#1)(2008-1#1)(2008-2#1)
(along##4##1##(1993-3#1)(2008-1#1)(2008-2#1)(2011-1#1)
(alpha 1##4##2##(1990-8#1)(1994-8#1)(1995-2#2)
(alpha = 0##4##3##(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
(alpha =##6##2##(1995-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
(alpha beta##2##2##(1990-8#1)(1993-8#1)
(alpha##37##1##(1990-4#1)(1990-8#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-8#2)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-2#2)(1995-6#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-5#2)(2009-8#1)
(alpha&lt##2##1##(2009-2#2)
(alpha) and##5##2##(1991-5#1)(1995-5#1)(2008-1#1)(2008-10#2)
(alpha) of##2##2##(2008-10#1)(2008-11#1)
(alpha)##11##1##(1991-5#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-10#5)(2008-11#2)
(alpha-1##2##1##(1997-4#1)(2008-10#1)
(alpha-tocopherol)##3##1##(1995-12#1)(1996-3#1)(2008-10#1)
(alpha2##2##1##(1996-7#1)(2008-11#1)
(alpha2A +##2##2##(1997-7#2)
(alpha=0##4##1##(2008-10#2)(2008-12#1)(2008-7#1)
(also called the##2##3##(2007-12#1)(2008-11#1)
(also called##9##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
(also known as##6##3##(1990-12#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-5#1)
(also named##2##2##(1995-2#1)(2011-2#1)
(also##23##1##(1990-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#2)
(alt)##6##1##(2008-9#6)
(although##9##1##(1993-11#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2012-3#1)
(aluminium##2##1##(2008-10#1)(2010-5#1)
(ambient##2##1##(2008-10#1)(2008-5#1)
(amiloride)##2##1##(2008-1#1)(2008-10#1)
(amino acid residues##12##3##(1990-12#1)(1991-12#3)(1991-5#1)(1991-9#2)(1992-8#3)(1993-11#2)
(amino acids##6##2##(1990-12#1)(1995-11#1)(1995-12#1)(1995-6#2)(2008-8#1)
(amino##18##1##(1990-12#2)(1991-12#3)(1991-5#1)(1991-9#2)(1992-8#3)(1993-11#2)(1995-11#1)(1995-12#1)(1995-6#2)(2008-8#1)
(ammonium##5##1##(2008-10#5)
(among##8##1##(1991-12#1)(1996-12#1)(2008-10#1)(2008-8#2)(2010-12#1)(2013-1#2)
(amount of##2##2##(2008-10#2)
(amyloid##2##1##(1992-9#1)(1994-11#1)
(an 1##3##2##(2008-11#3)
(an additional##2##2##(1991-2#1)(2011-2#1)
(an analog of##2##3##(2008-2#1)(2008-5#1)
(an angiotensin##2##2##(2008-1#2)
(an index of##4##3##(1993-8#1)(2008-2#2)(2008-6#1)
(an##48##1##(1990-5#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-4#2)(2007-5#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
(analysis of##2##2##(2008-3#2)
(analyte##2##1##(2008-10#2)
(anamorph Fusarium##2##2##(2008-10#2)
(anamorph Phoma##2##2##(2008-10#2)
(anamorph Septoria##4##2##(2008-10#4)
(anamorph##17##1##(1997-2#1)(2008-10#15)(2010-3#1)
(and II)##2##2##(1995-2#1)(1996-6#1)
(and a##2##2##(2008-11#1)(2009-6#1)
(and also P##2##3##(1995-5#1)(2008-10#1)
(and also##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
(and associated##2##2##(2008-10#1)(2008-2#1)
(and hence the##2##3##(1995-11#1)(2008-3#1)
(and hence##7##2##(1992-6#1)(1993-12#1)(1995-11#2)(2007-12#1)(2008-3#1)(2010-7#1)
(and in##2##2##(2008-2#1)(2009-10#1)
(and increase##2##2##(2008-3#1)(2008-9#1)
(and not##5##2##(1992-3#1)(1993-9#1)(2008-10#1)(2009-4#1)(2010-2#1)
(and other##7##2##(1991-8#1)(1995-11#1)(1995-2#1)(2008-7#1)(2008-9#2)(2013-1#1)
(and others)##2##2##(1992-3#1)(2011-1#1)
(and possibly##4##2##(1995-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
(and potentially##2##2##(2008-3#1)(2011-2#1)
(and sometimes##2##2##(2008-11#1)(2011-2#1)
(and the##9##2##(2008-3#3)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
(and their##3##2##(2008-10#2)(2008-12#1)
(and thereby##3##2##(2008-10#1)(2008-8#2)
(and therefore the##2##3##(2008-5#2)
(and therefore##4##2##(1996-1#1)(2008-3#1)(2008-5#2)
(and thus##5##2##(1992-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)
(and##158##1##(1990-8#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-3#4)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#5)(2012-3#1)(2013-1#4)
(and/or##3##1##(1994-6#1)(1997-5#1)(2008-10#1)
(animal##2##1##(2008-10#2)
(anion##3##1##(1996-2#2)(2008-10#1)
(anisotropy##3##1##(2008-10#2)(2008-9#1)
(another##3##1##(1993-11#1)(2008-10#1)(2008-7#1)
(anterior##2##1##(2008-12#2)
(anterolateral approach##2##2##(2011-2#2)
(anti-CCP)##2##1##(2011-2#1)(2012-2#1)
(antibody##2##1##(1992-6#1)(2008-7#1)
(antioxidant##2##1##(2008-10#1)(2012-6#1)
(anxiety and##2##2##(2007-12#1)(2010-1#1)
(anxiety##3##1##(2007-12#1)(2010-1#1)(2012-12#1)
(aorta##2##1##(2013-8#2)
(aortic arch##2##2##(1997-8#2)
(apical##2##1##(2012-2#1)(2013-8#1)
(apo##8##1##(1990-11#1)(1990-12#1)(1990-7#2)(1993-6#2)(1993-9#1)(1997-8#1)
(apo) B##2##2##(1990-8#1)(2008-6#1)
(apo) B-100##2##2##(1992-11#1)(1993-2#1)
(apo)##9##1##(1990-8#2)(1991-8#1)(1992-11#1)(1993-2#1)(1995-6#1)(2008-6#3)
(apparent K(i)##2##2##(1992-8#2)
(apparent Km##2##2##(1991-5#1)(1994-8#1)
(apparent##8##1##(1991-5#1)(1992-8#2)(1992-9#1)(1994-8#3)(2008-10#1)
(approx##4##1##(1992-9#1)(1994-12#1)(1994-2#1)(1994-8#1)
(approximate##3##1##(2008-10#1)(2009-7#2)
(approximately 0##2##2##(1994-5#1)(2010-3#1)
(approximately 1##7##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)
(approximately 10##4##2##(1992-9#1)(1997-1#1)(2008-10#1)(2008-7#1)
(approximately 10%##2##2##(2008-2#1)(2008-9#1)
(approximately 100##4##2##(1993-3#1)(1995-3#1)(2008-2#1)(2008-3#1)
(approximately 2##2##2##(1995-2#1)(2008-9#1)
(approximately 200##2##2##(1992-6#1)(2009-7#1)
(approximately 4##2##2##(2008-1#1)(2008-8#1)
(approximately 400##2##2##(2008-3#1)(2008-4#1)
(approximately 5##4##2##(1991-9#1)(1997-5#1)(2008-3#1)(2013-7#1)
(approximately 5-10##2##2##(1995-2#1)(2008-3#1)
(approximately 50%)##3##2##(1995-12#1)(1995-2#1)(2010-8#1)
(approximately 60##2##2##(1991-9#1)(2010-3#1)
(approximately 60%)##2##2##(1995-11#1)(1995-2#1)
(approximately 90##2##2##(1991-5#1)(2007-8#1)
(approximately equal##2##2##(1992-1#1)(2008-3#1)
(approximately##117##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#2)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#5)(1995-12#1)(1995-2#7)(1995-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#3)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#12)(2008-2#6)(2008-3#28)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
(aquatic##2##1##(2008-10#1)(2008-5#1)
(aqueous##2##1##(2008-7#1)(2013-1#1)
(ara-C)##2##1##(1990-2#1)(1992-5#1)
(area under the##4##3##(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#1)
(area under##6##2##(2007-8#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
(area##10##1##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
(areas##3##1##(1994-3#1)(2013-1#1)(2013-8#1)
(around##4##1##(1992-2#1)(1993-11#1)(1993-3#1)(2008-10#1)
(arsenite##2##1##(2008-10#2)
(as a result of##2##4##(2008-10#1)(2010-6#1)
(as a##12##2##(1995-6#1)(1996-6#1)(2008-10#7)(2008-9#2)(2010-6#1)
(as an##3##2##(1990-3#1)(2008-10#1)(2008-8#1)
(as assessed by##2##3##(1990-8#1)(1996-7#1)
(as assessed##3##2##(1990-8#1)(1996-7#1)(2010-12#1)
(as compared with##2##3##(2008-10#1)(2011-2#1)
(as compared##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
(as defined##2##2##(1996-7#1)(2013-1#1)
(as determined by##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
(as distinct from##2##3##(1993-1#1)(1994-2#1)
(as evidenced by##2##3##(2008-7#1)(2013-7#1)
(as for##2##2##(1995-2#1)(2008-10#1)
(as high as##3##3##(1996-7#1)(2008-2#1)(2008-3#1)
(as in##4##2##(2008-10#3)(2008-9#1)
(as is the case##2##4##(1992-5#1)(2008-9#1)
(as it##2##2##(2008-10#1)(2008-7#1)
(as mean##2##2##(2008-4#2)
(as measured by a##2##4##(2008-3#1)(2013-1#1)
(as measured by##10##3##(1991-9#1)(1995-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2013-1#1)
(as opposed to##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)
(as the##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
(as well as##9##3##(1994-2#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
(as##134##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-1#1)(1994-2#3)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#41)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#8)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
(ascorbic acid##3##2##(2008-10#2)(2008-5#1)
(ascorbic acid)##2##2##(1993-12#1)(2008-10#1)
(ascorbic##5##1##(1993-12#1)(2008-10#3)(2008-5#1)
(ascospores and##2##2##(2008-10#2)
(aspartate##3##1##(1990-7#1)(1995-6#1)(2008-10#1)
(assessed by##7##2##(1992-8#1)(1993-6#2)(1994-6#1)(1995-12#2)(1997-6#1)
(assessed##11##1##(1992-8#1)(1993-6#2)(1994-6#1)(1995-12#2)(1997-6#1)(2008-10#4)
(associated with##2##2##(2013-1#1)(2013-8#1)
(assuming##2##1##(1993-1#1)(2009-10#1)
(at &gt##3##2##(1995-8#1)(1997-1#1)(2008-2#1)
(at 0##2##2##(2008-10#2)
(at 1##5##2##(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)
(at 10##3##2##(1992-12#1)(2008-10#2)
(at 12##2##2##(1994-6#1)(2008-10#1)
(at 20##2##2##(2008-10#2)
(at 2400 degrees C)##2##4##(2008-10#2)
(at 25 degrees C)##2##4##(2008-10#2)
(at 37 degrees##2##3##(1992-3#1)(2008-11#1)
(at 50 mug l(-1))##2##4##(2008-10#2)
(at 50##3##2##(1995-12#1)(2008-10#2)
(at 6##2##2##(1994-6#1)(1995-2#1)
(at 95%##3##2##(2008-10#3)
(at a##4##2##(1997-8#1)(2008-10#2)(2008-12#1)
(at least 99% pure) in##2##5##(2008-9#2)
(at least in the##2##4##(2011-2#1)(2012-2#1)
(at least in##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
(at least##19##2##(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1995-11#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-9#4)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
(at pH =##2##3##(2009-12#2)
(at pH##6##2##(1993-11#1)(2008-10#3)(2009-12#2)
(at the same##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
(at the##9##2##(1992-4#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#2)
(at##115##1##(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#50)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#1)
(atmospheric##3##1##(2008-11#1)(2008-2#1)(2008-3#1)
(atomic##2##1##(1994-3#1)(2008-11#1)
(atrazine)##2##1##(2008-10#2)
(atrial natriuretic##2##2##(1995-11#1)(2008-8#1)
(attached)##2##1##(2008-1#1)(2008-10#1)
(auditory##3##1##(1994-3#1)(2008-9#2)
(av##4##1##(2008-4#1)(2008-7#3)
(average =##3##2##(1996-2#2)(2008-10#1)
(average age of##2##3##(2010-9#2)
(average age##15##2##(1992-9#1)(1993-11#2)(2007-11#2)(2007-8#2)(2008-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-2#2)
(average kappa = 0##2##4##(1997-8#2)
(average##51##1##(1990-6#1)(1991-2#1)(1992-9#1)(1993-11#2)(1996-2#2)(1996-9#1)(1997-5#1)(1997-8#2)(2007-11#3)(2007-8#4)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)
(average)##2##1##(1990-5#1)(2007-11#1)
(averaged over the##2##3##(2008-2#1)(2011-1#1)
(axis##2##1##(2008-10#2)
(b##2##1##(2010-12#1)(2010-7#1)
(b) How##2##2##(2009-5#1)(2010-12#1)
(b) The##4##2##(2008-3#1)(2008-5#1)(2008-7#2)
(b) What##2##2##(2008-12#1)(2008-5#1)
(b) a##5##2##(1991-1#1)(1994-1#3)(1997-2#1)
(b) greater##2##2##(1992-3#1)(2008-10#1)
(b) is##2##2##(1992-12#1)(2009-2#1)
(b) the##28##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-12#2)(1994-6#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
(b) to##4##2##(1991-12#1)(2008-7#2)(2013-1#1)
(b)##164##1##(1990-11#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#4)(1997-3#1)(1997-8#3)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#5)(2008-7#20)(2008-8#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
(bFGF)##12##1##(1991-12#2)(1992-3#1)(1992-9#1)(1994-11#1)(1995-12#3)(1997-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
(bacterial##3##1##(1990-12#1)(1997-2#1)(2008-10#1)
(bait##2##1##(2008-2#2)
(bandwidth##2##1##(2007-11#1)(2008-3#1)
(basal##3##1##(1994-3#1)(2009-10#1)(2012-2#1)
(base##6##1##(1990-11#1)(1993-9#1)(2008-10#3)(2008-5#1)
(based on the##8##3##(1990-8#1)(1994-9#1)(2008-10#2)(2008-6#2)(2010-11#1)(2011-1#1)
(based on visual##2##3##(2008-10#2)
(based on##27##2##(1990-8#1)(1993-11#1)(1994-9#1)(1997-4#1)(2008-10#12)(2008-3#2)(2008-4#1)(2008-6#2)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)
(based##28##1##(1990-8#1)(1992-1#1)(1993-11#1)(1994-9#1)(1997-4#1)(2008-10#12)(2008-3#2)(2008-4#1)(2008-6#2)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)
(baseline##3##1##(1990-8#1)(1994-11#1)(2008-10#1)
(baseline)##3##1##(1995-2#1)(2012-3#1)(2013-1#1)
(bases##2##1##(1990-5#1)(1996-5#1)
(batch##2##1##(2008-10#1)(2008-5#1)
(batch)##2##1##(2008-10#2)
(beam##2##1##(2008-10#1)(2008-2#1)
(bean and##2##2##(2008-10#2)
(because of the##2##3##(1993-12#1)(2008-10#1)
(because the##2##2##(2008-11#1)(2008-8#1)
(because##6##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
(beef##2##1##(1990-5#2)
(before the past 12 months)##2##5##(2009-5#2)
(before the##3##2##(2009-5#2)(2012-3#1)
(before##20##1##(1995-2#1)(1995-4#1)(1996-11#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-5#2)(2009-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
(beliefs)##2##1##(2008-12#1)(2010-11#1)
(below 1##2##2##(2007-12#1)(2008-5#1)
(below##8##1##(1996-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-5#1)
(benign##2##1##(1993-9#1)(2011-2#1)
(benzene##2##1##(2008-10#2)
(besides##3##1##(2008-10#3)
(best##2##1##(2010-10#1)(2011-2#1)
(beta -##2##2##(2008-11#2)
(beta 1##2##2##(1991-5#1)(1994-8#1)
(beta = -0##5##3##(2010-2#2)(2010-4#3)
(beta = 0##7##3##(2010-2#2)(2010-4#4)(2011-2#1)
(beta =##12##2##(2010-2#4)(2010-4#7)(2011-2#1)
(beta APP)##4##2##(1991-10#1)(1991-11#1)(1992-8#1)(1992-9#1)
(beta ARK)##2##2##(1992-3#2)
(beta b = 0##2##4##(1997-1#2)
(beta b =##5##3##(1997-1#5)
(beta b##7##2##(1997-1#7)
(beta##54##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#7)(1997-3#1)(1997-4#2)(2007-10#1)(2008-11#2)(2009-4#1)(2010-2#4)(2010-4#7)(2011-2#1)
(beta) and##2##2##(2008-10#2)
(beta) of##2##2##(1993-8#1)(2007-11#1)
(beta)##6##1##(1993-11#1)(1993-8#1)(2007-11#1)(2008-10#2)(2008-12#1)
(beta-1##3##1##(2008-10#3)
(beta-CD) and##5##2##(2008-10#5)
(beta-CD)##21##1##(1994-3#1)(1996-5#1)(2008-10#18)(2011-1#1)
(beta-HCG)##2##1##(2007-10#1)(2008-6#1)
(beta-NAD(+))##2##1##(2008-10#2)
(beta-carboline-3-carboxylate##2##1##(1995-11#2)
(beta-cyclodextrin##2##1##(2008-10#1)(2008-11#1)
(beta/alpha)8-barrel##2##1##(1997-4#2)
(beta=##3##1##(2008-4#3)
(better than##3##2##(2007-12#1)(2008-10#1)(2010-1#1)
(better##5##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-1#1)
(between 0##2##2##(2008-10#2)
(between environments)##2##2##(2008-8#2)
(between the##2##2##(2007-10#1)(2009-3#1)
(between##24##1##(1996-12#1)(1997-5#1)(2007-10#1)(2008-10#10)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)
(bifenthrin##2##1##(2011-2#2)
(big##2##1##(1990-12#1)(1990-2#1)
(bilateral##4##1##(2007-10#2)(2011-2#2)
(bin##2##1##(2008-10#2)
(binary)##2##1##(2008-5#1)(2009-12#1)
(biological##3##1##(2008-10#1)(2010-10#1)(2010-12#1)
(biomass##2##1##(2008-11#1)(2008-7#1)
(bis(2-pyridylmethyl)amino)acetate)##2##1##(1997-7#2)
(blank##2##1##(2008-10#2)
(bleaches)##2##1##(2008-10#2)
(bleaching)##2##1##(2007-11#1)(2007-12#1)
(blood##7##1##(1990-12#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
(blue light)##2##2##(2013-1#2)
(blue##3##1##(2013-1#2)(2013-8#1)
(body mass index##2##3##(2009-7#1)(2012-12#1)
(body mass##5##2##(2008-9#2)(2009-7#1)(2012-12#1)(2013-8#1)
(body temperature##2##2##(2008-7#2)
(body##9##1##(2007-12#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-7#1)(2012-12#1)(2013-8#1)
(bond order##2##2##(1995-5#2)
(bond##3##1##(1991-8#1)(1995-5#2)
(bone marrow##2##2##(2008-12#1)(2010-11#1)
(bone##5##1##(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-11#1)
(both p &lt##3##3##(2008-3#1)(2013-1#2)
(both##60##1##(1990-3#1)(1991-12#1)(1992-10#1)(1992-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#10)
(bound##2##1##(2008-10#1)(2012-12#1)
(bovine##4##1##(1997-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
(bp)##12##1##(1990-12#1)(1991-1#1)(1992-12#1)(1992-8#1)(1993-3#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
(bppz)##2##1##(1997-7#2)
(brain##2##1##(1990-11#1)(2013-1#1)
(branched-chain amino##3##2##(1995-11#1)(1995-8#2)
(breast##3##1##(2008-12#2)(2008-3#1)
(broccoli##2##1##(2008-10#2)
(bulk##3##1##(2007-11#2)(2012-2#1)
(but not the##5##3##(1994-8#1)(1995-2#1)(2008-9#1)(2010-3#1)(2010-7#1)
(but not##40##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)
(but only##2##2##(1992-10#1)(1996-3#1)
(but##54##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)
(butylated##2##1##(1996-2#2)
(by a##3##2##(1995-2#1)(2008-5#1)(2011-2#1)
(by about 50%)##2##3##(2009-8#2)
(by about##4##2##(2009-8#4)
(by adding##2##2##(2008-10#2)
(by comparison with##2##3##(2008-10#2)
(by comparison##3##2##(2008-10#2)(2008-7#1)
(by decreasing the##2##3##(2008-11#1)(2009-5#1)
(by the##5##2##(1991-8#1)(1992-3#1)(2006-12#1)(2008-10#2)
(by using##4##2##(2008-10#1)(2008-2#1)(2011-2#2)
(by##69##1##(1990-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-6#2)(1995-2#1)(1996-12#1)(1996-5#2)(2006-10#1)(2006-12#1)(2007-12#3)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#4)(2011-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
(c##19##1##(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-8#7)(2011-1#2)(2012-12#1)
(c(L)=1##2##1##(2008-10#2)
(c) 1997 John Wiley &amp##62##5##(2008-7#62)
(c) 1997##66##2##(2008-4#4)(2008-7#62)
(c) 2008 Wiley-Liss##7##3##(2009-4#7)
(c) a##3##2##(1991-1#1)(1994-1#1)(2009-5#1)
(c) has##2##2##(1992-12#1)(1993-8#1)
(c) the##16##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-1#1)(1994-6#1)(1996-12#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#2)(2012-2#1)
(c)##216##1##(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#1)(1997-8#2)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#39)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#70)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#8)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
(cAMP)##9##1##(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#2)
(cDNA)##7##1##(1990-12#1)(1993-6#1)(2008-10#3)(2008-7#1)(2008-9#1)
(cGMP##2##1##(2007-10#1)(2011-1#1)
(cGMP)##5##1##(1991-9#1)(1995-2#1)(1995-8#1)(2008-4#1)(2012-2#1)
(cM) of the##2##3##(1993-12#1)(2008-10#1)
(cM)##9##1##(1993-12#1)(2008-10#8)
(ca##29##1##(1993-8#1)(1997-4#2)(2008-10#17)(2008-5#3)(2009-4#1)(2009-6#1)(2010-2#1)(2011-2#2)(2013-7#1)
(cadmium##3##1##(2008-10#2)(2008-11#1)
(calcium##3##1##(1993-2#1)(2008-10#1)(2008-2#1)
(calculated as##3##2##(2008-10#3)
(calculated##6##1##(1990-11#1)(1991-6#1)(2008-10#4)
(called &quot##2##2##(2006-10#1)(2008-8#1)
(called##11##1##(1992-4#2)(1995-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#2)
(calpain##2##1##(1994-5#1)(2013-1#1)
(calprotectin and lactoferrin)##2##3##(2013-8#2)
(cancer##3##1##(2008-3#1)(2008-7#1)(2009-9#1)
(canine##2##1##(1994-6#1)(2008-9#1)
(captopril##2##1##(1990-3#1)(1997-4#1)
(carbachol) and##2##2##(1992-8#1)(1995-12#1)
(carbaryl)##2##1##(2008-10#2)
(carbendazim##4##1##(1997-4#2)(2008-10#2)
(carbon##4##1##(1990-11#1)(2008-10#3)
(cardiac##2##1##(1990-5#1)(1995-6#1)
(cardiovascular##2##1##(2008-7#1)(2011-3#1)
(caregiver##2##1##(2010-11#1)(2011-2#1)
(carotid intima-media thickness##2##3##(2008-11#2)
(carries Bs1 + Bs2 + Bs3)##2##6##(2008-10#2)
(carries Bs1 + Bs2)##2##4##(2008-10#2)
(carries Bs1 + Bs3)##2##4##(2008-10#2)
(carries Bs1 +##6##3##(2008-10#6)
(carries Bs1)##2##2##(2008-10#2)
(carries Bs2)##2##2##(2008-10#2)
(carries##13##1##(2008-10#13)
(carrying##3##1##(2008-10#3)
(case##6##1##(1992-12#1)(2008-12#1)(2008-2#1)(2009-2#2)(2012-2#1)
(catechin##2##1##(2008-5#1)(2011-2#1)
(causal agent of##4##3##(2008-10#4)
(causal agent##5##2##(2008-10#5)
(caused by Phialophora gregata)##2##4##(2008-10#2)
(caused by the##2##3##(1993-6#1)(2008-10#1)
(caused by##15##2##(1993-6#1)(2008-10#14)
(caused##16##1##(1993-6#1)(2008-1#1)(2008-10#14)
(causing##5##1##(2007-12#1)(2008-10#4)
(cava and champagne)##2##3##(2008-10#2)
(cdc17-1##2##1##(1990-5#2)
(cell##10##1##(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2012-1#1)(2012-4#1)
(cellular##4##1##(1990-12#1)(2006-10#1)(2008-4#1)(2011-2#1)
(central##8##1##(1991-12#1)(1994-12#1)(2008-10#3)(2008-8#1)(2012-2#1)(2013-1#1)
(cervical##3##1##(1993-9#1)(2012-3#1)(2013-1#1)
(cf##2##1##(1992-12#1)(2008-10#1)
(change##2##1##(2008-10#1)(2008-2#1)
(changes in##4##2##(1994-6#1)(1995-12#1)(2013-8#2)
(channel##2##1##(2008-10#1)(2008-7#1)
(characterized by##2##2##(2008-10#1)(2009-12#1)
(charge##2##1##(2008-10#1)(2008-4#1)
(chemical##2##1##(2008-10#2)
(chemotherapy##2##1##(2007-11#1)(2009-10#1)
(chest##3##1##(1993-5#1)(2007-8#1)(2010-1#1)
(chi 2 =##2##3##(1997-8#2)
(chi##3##1##(1993-3#1)(1997-8#2)
(chi(2) = 0##2##3##(2008-10#2)
(chi(2)##3##1##(2008-10#2)(2010-2#1)
(chi2 =##7##2##(2008-12#1)(2008-6#2)(2009-6#2)(2011-2#2)
(chicken##2##1##(1990-5#1)(1997-9#1)
(children with##3##2##(1995-3#1)(2008-9#1)(2013-1#1)
(children##6##1##(1992-3#1)(1995-3#1)(2008-9#1)(2009-9#1)(2013-1#2)
(chimaera monstrosa)##2##2##(1991-6#2)
(chl)##2##1##(1990-5#1)(2008-9#1)
(chloride##3##1##(2008-10#3)
(chloroform##2##1##(2008-10#2)
(choice of##2##2##(2008-10#1)(2011-2#1)
(choice##3##1##(2008-10#2)(2011-2#1)
(cholesterol##5##1##(1992-12#1)(1994-3#1)(2008-2#1)(2008-4#1)(2013-1#1)
(chr##4##1##(1995-6#3)(1996-3#1)
(chromosome##4##1##(2008-10#1)(2008-12#1)(2009-10#1)(2009-5#1)
(chromosomes##2##1##(2008-10#2)
(chronic##3##1##(1992-3#1)(2008-10#1)(2008-5#1)
(cisplatin##2##1##(2010-12#1)(2010-8#1)
(cisplatin) and##2##2##(1993-8#1)(2008-11#1)
(cisplatin)##3##1##(1993-8#1)(2007-11#1)(2008-11#1)
(civil##2##1##(2007-7#2)
(class III activity)##2##3##(1992-3#2)
(class##10##1##(1992-3#3)(1994-7#1)(1994-9#1)(1995-2#1)(2008-10#3)(2010-9#1)
(cleft##2##1##(2010-8#1)(2012-12#1)
(clinical and##2##2##(1995-5#1)(2013-1#1)
(clinical##7##1##(1994-12#1)(1995-5#1)(1997-8#1)(2008-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
(clone##2##1##(1995-3#1)(2008-5#1)
(close to##5##2##(1990-5#2)(1990-7#1)(2008-10#1)(2010-10#1)
(cloud##2##1##(2008-10#1)(2008-3#1)
(cluster##2##1##(2008-10#1)(2008-7#1)
(coarse spatial scale)##2##3##(2013-7#2)
(coarse##3##1##(2008-10#1)(2013-7#2)
(coding for##2##2##(1992-8#1)(2008-4#1)
(coding##3##1##(1992-8#1)(2008-4#1)(2008-9#1)
(codons##3##1##(1992-3#1)(1994-8#1)(1995-6#1)
(coefficient of variation##2##3##(2008-10#2)
(coefficient of##3##2##(1995-2#1)(2008-10#2)
(coefficients of variation##2##3##(2008-10#2)
(coefficients of##3##2##(2008-10#2)(2012-1#1)
(cognitive##2##1##(2007-12#2)
(cold##5##1##(1990-5#1)(1991-5#1)(2008-10#2)(2008-5#1)
(collagen##4##1##(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
(collected##2##1##(2008-10#1)(2008-5#1)
(colonization)##2##1##(2008-10#1)(2008-5#1)
(colony forming units##2##3##(1997-2#1)(2008-10#1)
(column##2##1##(2007-8#1)(2008-10#1)
(combined effect of Thompson disc grades##2##6##(2011-2#2)
(combined##6##1##(1994-2#1)(2007-8#1)(2010-7#1)(2011-2#2)(2013-1#1)
(comet) assay##2##2##(1997-4#1)(2013-1#1)
(commercial##4##1##(2008-10#3)(2008-8#1)
(common and##2##2##(2008-2#1)(2010-8#1)
(common##8##1##(1997-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#1)(2011-2#1)
(commonly called##4##2##(2008-10#1)(2009-11#1)(2013-1#2)
(commonly##7##1##(1992-1#1)(2008-10#2)(2008-4#1)(2009-11#1)(2013-1#2)
(community health information##6##3##(1996-1#6)
(compared to a##2##3##(2012-1#1)(2013-1#1)
(compared to##7##2##(1997-2#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
(compared with##6##2##(1994-2#1)(1995-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
(compared##13##1##(1994-2#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
(comparing##3##1##(2010-7#1)(2012-9#2)
(competitive##3##1##(1995-2#1)(2008-10#1)(2009-7#1)
(complete##4##1##(1991-5#1)(1997-3#1)(2008-5#1)(2012-12#1)
(composed##2##1##(2008-12#1)(2011-2#1)
(concentration of##2##2##(2008-10#2)
(concentration##7##1##(2008-10#3)(2008-6#2)(2009-4#1)(2011-10#1)
(concentrations of##3##2##(2008-10#1)(2008-3#2)
(concentrations##6##1##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
(confidence interval of##2##3##(2008-10#2)
(confidence interval##5##2##(2008-10#3)(2009-11#1)(2011-2#1)
(congenital or##3##2##(2011-2#1)(2013-1#2)
(conservative##2##1##(2008-10#1)(2008-3#1)
(considered##2##1##(2008-1#1)(2008-2#1)
(consistent with##3##2##(1995-2#1)(1997-4#2)
(consisting of##2##2##(1992-6#1)(2011-1#1)
(constant##5##1##(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
(containing 0##2##2##(2008-10#1)(2011-1#1)
(containing the##2##2##(1991-5#1)(2008-10#1)
(containing##16##1##(1990-5#2)(1991-5#1)(1992-6#1)(1994-8#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
(continuous)##3##1##(2008-5#1)(2008-9#1)(2009-12#1)
(control group##2##2##(1993-12#1)(2007-8#1)
(control group)##8##2##(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2011-1#1)
(control##25##1##(1990-6#1)(1991-2#1)(1993-12#1)(1993-8#1)(1995-12#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2011-1#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#2)
(control) to##2##2##(1992-6#1)(1995-5#1)
(control)##22##1##(1992-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-3#1)(2008-10#1)(2008-12#6)(2009-6#1)(2010-4#1)(2011-2#2)(2013-1#4)
(controlling##2##1##(2008-10#1)(2010-8#1)
(controls##3##1##(1995-12#1)(2011-2#2)
(controls)##4##1##(1991-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
(conventional##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
(corn oil) and##2##3##(1990-7#1)(2013-1#1)
(corn##3##1##(1990-7#1)(2008-10#1)(2013-1#1)
(coronary artery disease##2##3##(2012-2#2)
(coronary##4##1##(2008-3#1)(2008-5#1)(2012-2#2)
(corrected##2##1##(2008-10#1)(2011-2#1)
(corrected)##2##1##(1995-8#1)(2009-7#1)
(correlation coefficient =##2##3##(1990-12#1)(2008-3#1)
(correlation coefficient##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
(correlation coefficients##4##2##(2008-10#3)(2013-8#1)
(correlation##10##1##(1990-12#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
(corresponding to 0##2##3##(2008-10#1)(2010-4#1)
(corresponding to the##3##3##(1994-5#1)(2008-6#2)
(corresponding to##10##2##(1991-5#1)(1994-5#1)(2008-10#4)(2008-6#2)(2010-12#1)(2010-4#1)
(cover##2##1##(1995-3#1)(2009-11#1)
(craniopharyngioma##2##1##(2012-3#2)
(cross##3##1##(2008-3#2)(2013-8#1)
(cross-validation R(2)=0##4##2##(2009-7#4)
(crustacea##3##1##(2008-6#1)(2008-7#2)
(crystal##2##1##(2008-3#1)(2012-2#1)
(cumulative##2##1##(1990-3#1)(1991-12#1)
(currently##2##1##(2010-1#2)
(cut##3##1##(2008-2#1)(2010-4#1)(2010-8#1)
(cut-off##3##1##(2008-10#2)(2010-2#1)
(cv##15##1##(2008-10#14)(2008-8#1)
(cw) laser##3##2##(2008-2#2)(2008-3#1)
(cw)##13##1##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)(2011-1#1)
(cyclophosphamide##2##1##(1995-8#1)(1996-2#1)
(cyclosporine##2##1##(2008-1#1)(2008-3#1)
(cytochrome##2##1##(2013-7#1)(2013-8#1)
(cytotoxic##2##1##(2008-10#1)(2011-2#1)
(d &lt##2##2##(1993-12#1)(1995-6#1)
(d =##4##2##(2007-6#1)(2008-5#3)
(d##10##1##(1992-6#1)(1993-12#1)(1995-6#1)(2007-6#1)(2008-5#3)(2011-2#1)(2013-1#1)(2013-7#1)
(d) the##4##2##(1992-1#1)(1994-12#1)(2008-4#1)(2012-2#1)
(d)##49##1##(1990-5#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-7#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-7#1)(2012-2#2)(2012-3#1)
(d=##2##1##(2008-4#2)
(dA)n##8##1##(1995-5#8)
(dA-dT)##2##1##(1994-8#2)
(dB(f)/dT) determine the temperature characteristics of##2##6##(2008-2#2)
(dG)##3##1##(1994-11#1)(1994-8#1)(2008-4#1)
(dT)n##15##1##(1995-5#15)
(dark##2##1##(2007-12#1)(2008-10#1)
(data##6##1##(1992-2#4)(1993-2#1)(2008-10#1)
(day##6##1##(1995-11#2)(1995-2#2)(1997-6#1)(2007-9#1)
(days##7##1##(1994-3#2)(1994-6#1)(1995-11#2)(2008-7#1)(2013-8#1)
(days)##2##1##(2008-10#1)(2008-12#1)
(db/db)##2##1##(2008-3#1)(2012-12#1)
(de##2##1##(1997-1#1)(2013-8#1)
(death##3##1##(1990-9#1)(2008-8#1)(2011-2#1)
(decrease##3##1##(2008-11#2)(2008-4#1)
(deep##3##1##(2008-11#1)(2008-6#1)(2011-2#1)
(deeper##2##1##(2007-11#1)(2008-5#1)
(defined as the##2##3##(2008-10#2)
(defined as##13##2##(1990-12#1)(1990-5#1)(1992-2#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-7#1)(2008-9#2)
(defined based on##2##3##(2008-10#2)
(defined by the##2##3##(2007-11#1)(2008-6#1)
(defined by##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
(defined##19##1##(1990-12#1)(1990-5#1)(1992-2#1)(1996-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-9#2)(2012-12#1)
(delta C/CL)##2##2##(1990-7#2)
(delta##20##1##(1990-7#2)(1990-8#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-7#1)(2008-2#1)
(delta(13)C(vsPDB) approximately from##2##3##(2010-3#2)
(delta(13)C(vsPDB) approximately##3##2##(2010-3#3)
(delta)##2##1##(2008-10#2)
(denoted as##5##2##(1997-2#3)(2008-10#1)(2012-2#1)
(denoted##9##1##(1997-2#3)(1997-8#1)(2008-10#4)(2012-2#1)
(density##2##1##(2007-5#1)(2008-9#1)
(dependence of##2##2##(2008-10#2)
(dependence##3##1##(2008-10#2)(2008-7#1)
(depending on the##3##3##(2008-10#2)(2009-4#1)
(depending on##5##2##(2007-11#1)(2008-10#2)(2009-4#1)(2010-10#1)
(depending##6##1##(2007-11#1)(2008-10#2)(2009-4#1)(2010-10#1)(2010-4#1)
(derived from the##2##3##(1997-7#1)(2008-10#1)
(derived from##6##2##(1994-6#1)(1997-7#1)(2008-10#4)
(described by##2##2##(1997-2#1)(2008-10#1)
(described##3##1##(1997-2#1)(2008-10#1)(2008-11#1)
(designated as##6##2##(1990-7#1)(1997-4#2)(2008-9#1)(2009-2#1)(2012-3#1)
(designated##23##1##(1990-7#1)(1991-8#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-9#2)(2008-10#6)(2008-9#1)(2009-2#1)(2011-2#2)(2012-3#1)
(desmopressin)##2##1##(1992-11#1)(2013-8#1)
(detection at##3##2##(2008-10#2)(2012-2#1)
(detection based on##2##3##(2008-2#2)
(detection limit 0##4##3##(1992-11#1)(2008-10#3)
(detection limit approximately 0##2##4##(2008-10#2)
(detection limit##12##2##(1992-11#1)(2008-10#11)
(detection limits##2##2##(2008-10#2)
(detection of the##2##3##(2008-10#2)
(detection of##5##2##(1992-9#1)(2008-10#3)(2008-2#1)
(detection##24##1##(1992-11#1)(1992-9#1)(2008-10#18)(2008-2#3)(2012-2#1)
(determination of##2##2##(2008-10#2)
(determined by##2##2##(1994-7#1)(2008-8#1)
(determined via##2##2##(2008-7#1)(2011-2#1)
(determined##5##1##(1994-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
(diabetes mellitus##2##2##(2011-2#1)(2013-7#1)
(diabetes##8##1##(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#5)
(diagnostic##2##1##(2007-11#1)(2009-3#1)
(dialysis or##2##2##(2008-10#1)(2011-2#1)
(diameter##13##1##(1990-11#1)(1991-4#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-1#1)
(dibutyl##2##1##(2008-10#2)
(diet##7##1##(1996-11#1)(2008-10#1)(2008-12#5)
(diethylenetriamine and##2##2##(2008-10#2)
(diethylenetriamine##3##1##(2008-10#3)
(difference##2##1##(2008-11#1)(2013-1#1)
(different##4##1##(2008-10#1)(2008-2#1)(2008-7#2)
(difficult)##2##1##(2007-6#2)
(dilution##2##1##(2008-10#2)
(dimethyl##2##1##(2008-10#1)(2011-1#1)
(dimethylsulfoxide (DMSO)##2##2##(1994-5#1)(2008-10#1)
(direct##9##1##(1991-4#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
(direct)##2##1##(2008-4#1)(2008-7#1)
(direction of##2##2##(2007-12#1)(2008-3#1)
(directly or##2##2##(1995-6#1)(2011-1#1)
(directly##3##1##(1995-6#1)(2008-10#1)(2011-1#1)
(discrete##3##1##(1993-5#1)(2008-10#1)(2011-2#1)
(disease severity##2##2##(2008-10#2)
(disease##4##1##(2008-10#3)(2011-2#1)
(dishabituation)##3##1##(1994-3#1)(2008-6#2)
(dissolved##2##1##(2008-3#1)(2010-4#1)
(dithizone)##2##1##(2008-10#2)
(dominant##2##1##(2008-10#1)(2008-9#1)
(donor##2##1##(2008-10#2)
(dopamine##6##1##(1991-5#1)(1996-2#2)(2008-10#1)(2008-7#1)(2013-7#1)
(dorsal##3##1##(1993-6#1)(2008-11#1)(2010-8#1)
(dose optimization points##2##3##(2009-2#2)
(dose##6##1##(1992-8#1)(2009-2#2)(2009-7#1)(2011-1#2)
(dot-blot##3##1##(1990-8#3)
(double or triple##2##3##(1990-5#1)(1995-11#1)
(double##4##1##(1990-5#1)(1995-11#1)(2008-10#1)(2008-11#1)
(double-stranded##2##1##(1994-5#1)(2013-1#1)
(down to##3##2##(2008-10#2)(2008-3#1)
(driven by##2##2##(2008-9#2)
(drug##3##1##(1992-9#1)(2008-10#1)(2011-1#1)
(drugs##2##1##(1990-8#1)(2008-10#1)
(dry wt##3##2##(2007-1#1)(2007-5#2)
(dry##11##1##(2007-1#1)(2007-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)
(ds) DNA##3##2##(2008-10#2)(2008-2#1)
(ds) RNA##3##2##(2008-10#3)
(ds)##8##1##(2008-10#7)(2008-2#1)
(dsDNA)##6##1##(1995-2#1)(2008-10#5)
(due to the##2##3##(2008-10#1)(2008-5#1)
(due to##8##2##(1994-8#1)(1995-2#1)(1996-3#2)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
(duration##2##1##(2009-12#1)(2010-2#1)
(during a##2##2##(2008-1#2)
(during##5##1##(2008-1#2)(2008-10#2)(2010-6#1)
(dw)##3##1##(2008-11#2)(2011-1#1)
(dynamic)##3##1##(1997-2#1)(2008-10#1)(2013-1#1)
(e##504##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#4)(1990-9#1)(1991-5#3)(1991-6#1)(1991-8#2)(1992-3#4)(1992-5#1)(1992-8#3)(1992-9#2)(1993-11#1)(1994-1#2)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#4)(1995-5#4)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#8)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2006-6#3)(2007-10#1)(2007-11#2)(2007-12#10)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#77)(2008-11#28)(2008-12#6)(2008-2#8)(2008-3#30)(2008-4#32)(2008-5#17)(2008-6#4)(2008-7#27)(2008-8#27)(2008-9#12)(2009-10#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#8)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#9)(2010-12#2)(2010-2#6)(2010-3#4)(2010-4#4)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#20)(2012-1#5)(2012-12#6)(2012-2#10)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#6)
(e) the##4##2##(1996-12#1)(2007-12#1)(2008-11#1)(2012-2#1)
(e)##25##1##(1991-9#1)(1992-1#1)(1992-2#1)(1996-12#2)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
(eNOS)##3##1##(2008-8#1)(2009-10#1)(2010-4#1)
(ePTFE)##2##1##(2007-10#1)(2011-3#1)
(each##7##1##(1992-12#1)(1995-1#1)(1997-7#1)(2007-10#1)(2010-3#2)(2012-1#1)
(early##8##1##(2008-10#4)(2008-7#2)(2011-2#1)(2013-1#1)
(eastern##2##1##(2008-10#1)(2010-11#1)
(easy)##3##1##(2007-6#2)(2008-9#1)
(eat##3##1##(2011-2#3)
(efe)##2##1##(2008-10#2)
(effect##2##1##(1992-6#1)(2008-10#1)
(effective##3##1##(1997-4#1)(2008-11#1)(2012-2#1)
(eg##35##1##(2007-10#2)(2007-12#4)(2007-2#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#3)(2008-7#3)(2009-5#2)(2010-1#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2013-8#1)
(egocentric##2##1##(1994-3#1)(1994-8#1)
(eight##3##1##(2008-10#3)
(either##16##1##(1993-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(2007-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#1)(2011-2#2)
(elderly##2##1##(1990-9#1)(2011-2#1)
(electrical##2##1##(2008-10#2)
(elevated##3##1##(1994-8#1)(2010-3#1)(2011-2#1)
(elite##2##1##(2009-7#2)
(em##4##1##(2008-10#4)
(emergency##2##1##(1991-6#1)(1992-3#1)
(emotional##3##1##(2007-4#1)(2008-11#1)(2008-5#1)
(en)##2##1##(1993-2#1)(1996-2#1)
(encoded by##4##2##(1993-9#1)(1994-12#1)(1995-2#1)(2013-7#1)
(encoding the##6##2##(1990-8#1)(1991-9#1)(1993-12#1)(1993-9#2)(1994-12#1)
(encoding##15##1##(1990-8#2)(1991-9#1)(1993-12#2)(1993-9#2)(1994-12#5)(1997-4#1)(2008-10#1)(2011-1#1)
(end of##2##2##(2008-5#1)(2013-7#1)
(endoPG) and##2##2##(2008-10#2)
(endurance##2##1##(1991-8#1)(2012-3#1)
(energy##3##1##(2007-12#1)(2008-10#1)(2013-8#1)
(enhanced##2##1##(2009-11#1)(2012-2#1)
(environmental##3##1##(2008-11#1)(2008-7#1)(2012-2#1)
(enzyme-linked immunosorbent assay) and##2##4##(2008-10#1)(2008-8#1)
(enzyme-linked immunosorbent assay)##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
(epidemiological##2##1##(2010-4#1)(2010-8#1)
(epidermis##2##1##(1992-9#1)(2008-3#1)
(epithelial##2##1##(2008-7#1)(2013-8#1)
(epoetin##2##1##(2008-10#1)(2008-7#1)
(epsilon =##3##2##(1997-7#3)
(epsilon##6##1##(1990-11#1)(1993-11#2)(1997-7#3)
(epsilon) of##2##2##(2008-10#2)
(epsilon)##4##1##(2008-10#4)
(epsilon=7##2##1##(2008-10#2)
(equilibrium##3##1##(2008-10#2)(2012-2#1)
(equipped with##2##2##(2008-10#2)
(equivalent to average daily doses of approximately##12##7##(2008-8#3)(2008-9#9)
(equivalent to##18##2##(2008-10#2)(2008-5#2)(2008-8#3)(2008-9#11)
(equivalent##19##1##(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#11)
(error##3##1##(2008-10#2)(2011-2#1)
(especially at##2##2##(2007-12#1)(2008-11#1)
(especially in##4##2##(1993-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
(especially of##2##2##(2008-1#1)(2008-9#1)
(especially the##5##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
(especially with##2##2##(1997-5#1)(2011-2#1)
(especially##35##1##(1990-8#1)(1991-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
(essential##2##1##(2008-9#1)(2012-12#1)
(estimated by##3##2##(2008-9#1)(2009-8#2)
(estimated##7##1##(1992-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#2)(2012-3#1)
(eta) and##2##2##(2008-10#2)
(ethanol##2##1##(2008-10#2)
(ethanol) and##2##2##(2008-9#1)(2009-7#1)
(ethanol)##4##1##(2008-10#2)(2008-9#1)(2009-7#1)
(ethylene##3##1##(2008-10#3)
(evaluated by##2##2##(1990-12#1)(2008-5#1)
(evaluated##4##1##(1990-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
(evaluation##2##1##(2008-10#1)(2009-9#1)
(even if##2##2##(2008-8#2)
(even##11##1##(1991-1#1)(1994-2#1)(1995-11#1)(2008-10#3)(2008-4#1)(2008-8#3)(2008-9#1)
(event rate/quartile##2##2##(1996-9#2)
(event##3##1##(1996-9#2)(2011-2#1)
(every##5##1##(1991-4#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
(ex##5##1##(2008-10#2)(2008-3#1)(2011-2#2)
(except for the##2##3##(2008-10#1)(2008-12#1)
(except for##16##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-5#1)(1994-3#1)(1995-5#1)(2008-1#1)(2008-10#6)(2008-12#1)(2010-12#1)(2011-2#1)
(except in##2##2##(1992-10#1)(2008-7#1)
(except##33##1##(1990-11#1)(1990-8#1)(1991-11#1)(1992-10#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-5#1)
(excitation at##5##2##(1995-2#1)(2008-10#4)
(excitation wavelength##2##2##(2008-10#2)
(excitation##9##1##(1990-8#1)(1995-2#1)(2008-10#7)
(excitation)##2##1##(1993-2#1)(2008-2#1)
(excluding the##3##2##(1991-7#1)(2008-2#1)(2013-8#1)
(excluding##9##1##(1991-7#1)(2008-11#3)(2008-2#1)(2008-3#2)(2010-4#1)(2013-8#1)
(executive##2##1##(1993-2#1)(2012-2#1)
(exon##2##1##(1994-12#1)(2008-10#1)
(experimental group)##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
(experimental##5##1##(2008-11#1)(2008-5#1)(2008-9#2)(2011-1#1)
(exposure##2##1##(2008-10#1)(2008-2#1)
(expressed as##8##2##(1996-12#1)(2008-10#6)(2008-8#1)
(expressed sequence##2##2##(2008-10#1)(2008-9#1)
(expressed##14##1##(1993-1#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-8#1)(2008-9#1)
(extended##3##1##(2007-8#1)(2008-10#1)(2008-7#1)
(extending from##2##2##(1992-9#1)(1997-7#1)
(extraction in##2##2##(2008-10#2)
(extraction step##3##2##(2008-10#3)
(extraction##7##1##(2008-10#7)
(f##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
(f(1)##2##1##(2008-3#2)
(f)##9##1##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
(fMLP) and##2##2##(1996-2#1)(2008-4#1)
(fMLP)##4##1##(1991-9#1)(1995-6#1)(1996-2#1)(2008-4#1)
(fMRI) in##2##2##(2009-9#1)(2010-2#1)
(fMRI)##16##1##(1995-12#1)(2008-11#5)(2009-2#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
(fa/fa) rats##2##2##(1994-11#1)(1996-12#1)
(fa/fa)##6##1##(1994-11#1)(1996-12#4)(2011-2#1)
(factor##2##1##(1995-2#1)(1997-3#1)
(false##2##1##(1991-12#1)(2010-12#1)
(family##10##1##(1990-10#1)(1995-3#1)(2008-10#5)(2008-7#1)(2009-5#1)(2013-1#1)
(fasting##2##1##(1993-12#1)(2008-1#1)
(fatty acid##3##2##(1996-3#1)(1997-2#1)(2008-5#1)
(features of##2##2##(2011-1#2)
(feed##4##1##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
(females##2##1##(2008-5#1)(2008-9#1)
(females)##4##1##(1994-2#2)(2008-10#1)(2008-8#1)
(ferbam)##3##1##(2008-10#3)
(fever##3##1##(1990-8#1)(1992-2#1)(2009-10#1)
(fg##2##1##(2008-10#2)
(field##2##1##(1991-12#1)(2008-10#1)
(field)##2##1##(2008-10#2)
(final concentration##4##2##(1990-10#1)(2008-5#1)(2008-7#2)
(final concentration) in 0##2##4##(2008-10#2)
(final##11##1##(1990-10#1)(1990-11#1)(1990-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)
(first##16##1##(1990-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2011-2#1)
(five cases)##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
(five##18##1##(1990-3#1)(1995-3#1)(1995-5#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
(five)##2##1##(2007-12#1)(2013-7#1)
(fixed)##2##1##(1995-3#1)(1996-3#1)
(flattened##2##1##(1993-1#1)(1995-6#1)
(flip##2##1##(1997-8#1)(2008-9#1)
(flow injection##4##2##(2008-10#4)
(flow rate of##2##3##(2008-10#2)
(flow rate##7##2##(2008-10#7)
(flow##15##1##(1993-6#1)(2008-10#12)(2008-7#1)(2008-9#1)
(fluorescence##2##1##(2007-11#1)(2008-10#1)
(fluoride##2##1##(2008-10#1)(2008-3#1)
(focal##5##1##(1994-9#2)(2008-10#1)(2012-2#1)(2013-1#1)
(follow-up##4##1##(1997-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
(food##3##1##(1993-12#1)(2007-8#1)(2008-11#1)
(for 1##3##2##(2008-10#3)
(for 2##2##2##(2008-10#2)
(for 45 min)##2##3##(2008-11#2)
(for a##6##2##(2007-11#1)(2008-10#4)(2008-3#1)
(for ages##2##2##(1996-1#2)
(for all##2##2##(2008-10#1)(2008-2#1)
(for an increment of 5 years RR 1##2##8##(1993-9#2)
(for an##3##2##(1993-9#2)(2008-10#1)
(for both##4##2##(1995-9#1)(2008-10#1)(2008-3#2)
(for example##18##2##(1991-5#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
(for instance##2##2##(1995-8#2)
(for movement##2##2##(1991-5#2)
(for subsequent##2##2##(2008-9#1)(2012-12#1)
(for the assay of##2##4##(2008-10#2)
(for the##11##2##(1996-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
(for which##2##2##(1994-9#1)(2007-12#1)
(for##151##1##(1990-5#2)(1991-1#1)(1991-5#3)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-8#1)(2008-10#53)(2008-11#6)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#4)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
(form##3##1##(1994-8#1)(1997-1#2)
(formaldehyde##2##1##(2008-10#2)
(formerly called##2##2##(1991-12#1)(2008-10#1)
(formerly known as##2##3##(2008-4#1)(2011-2#1)
(formerly##17##1##(1991-1#1)(1991-12#1)(1992-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
(forward##2##1##(2011-1#1)(2012-12#1)
(four isolates)##2##2##(2008-10#2)
(four weeks)##2##2##(1990-3#1)(2008-7#1)
(four##18##1##(1990-3#1)(1990-6#1)(1992-3#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
(fourth##2##1##(2008-10#1)(2011-2#1)
(fragment##3##1##(1995-6#1)(1997-6#2)
(free and glycine and taurine conjugates)##2##6##(1990-8#2)
(free of##2##2##(1993-8#1)(2011-2#1)
(free or bound##2##3##(2008-10#2)
(free##13##1##(1990-8#2)(1993-8#1)(1997-7#1)(2008-10#6)(2010-3#1)(2011-2#2)
(free)##2##1##(1992-5#1)(2008-10#1)
(frequency##4##1##(2008-10#2)(2008-7#1)(2010-8#1)
(frequency)##2##1##(2008-2#2)
(fresh##5##1##(1995-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2013-7#1)
(from 0##10##2##(1996-2#3)(1997-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2012-2#1)
(from 1 to##5##3##(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#2)
(from 1##10##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
(from 12##2##2##(1995-12#1)(2008-3#1)
(from 15##2##2##(2007-8#1)(2008-5#1)
(from 2##2##2##(1991-8#1)(2008-10#1)
(from 3##6##2##(1995-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#1)
(from 7##2##2##(2008-10#1)(2008-5#1)
(from 9##2##2##(1995-9#1)(2013-8#1)
(from 92##2##2##(2012-3#1)(2013-1#1)
(from a total of##2##4##(2008-6#2)
(from a##3##2##(2008-12#1)(2008-6#2)
(from method##2##2##(2008-10#2)
(from the##10##2##(1991-3#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)
(from two countries)##3##3##(2013-8#3)
(from two##4##2##(2011-2#1)(2013-8#3)
(from##155##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#3)(1993-12#1)(1994-5#1)(1995-12#2)(1995-9#2)(1996-12#1)(1996-2#4)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#7)(2008-5#2)(2008-6#7)(2008-7#4)(2008-8#2)(2008-9#7)(2009-2#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#7)
(fruit##2##1##(2007-5#1)(2008-10#1)
(fs)##3##1##(2007-11#1)(2007-12#1)(2011-1#1)
(full width at##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
(functional##2##1##(1991-11#1)(2008-5#1)
(functional) iron deficiency##2##3##(2011-1#2)
(fused##3##1##(2008-10#1)(2008-2#1)(2008-4#1)
(g l(-1) of##2##3##(2008-10#2)
(g l(-1)##3##2##(2008-10#3)
(g##7##1##(1992-8#1)(2008-10#3)(2008-2#1)(2008-5#2)
(g-dry wt##2##2##(2008-6#2)
(gadobenate dimeglumine##2##2##(2008-7#2)
(gallic##2##1##(2008-10#1)(2012-3#1)
(gamma##4##1##(1993-8#1)(1995-11#1)(2008-10#1)(2010-4#1)
(gamma)##2##1##(1990-5#1)(2007-11#1)
(gamma-GT)##3##1##(1990-3#1)(1990-9#1)(1994-5#1)
(gamma-aminobutyric acid)##3##2##(1992-3#1)(1992-7#1)(1993-3#1)
(gamma-aminobutyric##4##1##(1992-3#1)(1992-7#1)(1993-3#1)(1995-11#1)
(gas##4##1##(1990-8#1)(2007-5#1)(2008-10#1)(2011-2#1)
(gender##2##1##(2009-9#1)(2011-2#1)
(gene##3##1##(2008-10#1)(2008-7#1)(2009-10#1)
(gene)##4##1##(2008-10#1)(2008-8#3)
(general##4##1##(1995-9#1)(2008-10#2)(2009-5#1)
(generally##7##1##(2008-10#4)(2008-5#2)(2008-8#1)
(generated##2##1##(2008-10#1)(2008-5#1)
(generation##2##1##(1996-5#1)(2012-3#1)
(genetic##2##1##(2008-11#2)
(genomic##2##1##(2008-7#1)(2008-9#1)
(genotype##4##1##(2008-10#4)
(genus Begomovirus##2##2##(2008-10#2)
(genus##6##1##(2008-10#5)(2010-3#1)
(geographic##2##1##(1991-6#1)(2009-3#1)
(germinal##2##1##(2007-12#1)(2013-8#1)
(gfg)##2##1##(1994-11#2)
(giant-cell arteritis)##2##2##(2012-3#2)
(given##3##1##(1997-7#1)(2008-10#1)(2008-11#1)
(glial##2##1##(2008-7#2)
(global##3##1##(2008-11#1)(2008-6#1)(2013-1#1)
(glucose plus##2##2##(2008-10#1)(2008-6#1)
(glucose##5##1##(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)
(good##4##1##(2007-11#1)(2007-8#1)(2008-9#1)(2013-1#1)
(grade I##2##2##(2007-11#1)(2008-12#1)
(grade##13##1##(1990-9#1)(1992-10#1)(1997-3#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-6#2)(2011-2#1)
(graphite##4##1##(2008-10#4)
(grass##2##1##(2008-11#1)(2013-1#1)
(gray##4##1##(2007-12#1)(2008-10#1)(2008-3#2)
(great##3##1##(1992-5#1)(2008-10#1)(2008-9#1)
(greater than 0##2##3##(2008-10#1)(2008-11#1)
(greater than 3##2##3##(1991-6#1)(1992-3#1)
(greater than 400 ng/ml)##2##4##(1992-3#2)
(greater than 5##2##3##(1992-3#1)(1992-6#1)
(greater than 90%)##2##3##(1990-11#1)(1992-8#1)
(greater than 98% pure) for##2##5##(2008-8#1)(2008-9#1)
(greater than 98% pure)##3##4##(2008-8#1)(2008-9#2)
(greater than or equal to##4##5##(1990-12#2)(1990-6#1)(1991-4#1)
(greater than##32##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#3)
(greater##33##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#3)
(green##5##1##(1994-11#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
(green)##2##1##(2008-10#2)
(ground##2##1##(2008-10#2)
(group 1)##8##2##(1990-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)(2012-3#1)(2012-4#1)
(group 2) and##2##3##(2008-1#1)(2009-6#1)
(group 2)##9##2##(1990-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)(2012-3#1)(2012-4#1)
(group 3)##6##2##(2008-1#2)(2008-12#1)(2009-6#1)(2012-3#1)(2012-4#1)
(group 4)##3##2##(2008-1#1)(2008-12#1)(2012-3#1)
(group A) and##3##3##(1990-6#1)(2007-8#1)(2008-5#1)
(group A)##5##2##(1990-6#1)(1996-6#1)(2007-8#2)(2008-5#1)
(group B)##5##2##(1990-6#1)(1996-6#1)(2007-8#2)(2008-5#1)
(group D)##2##2##(1996-1#1)(2007-8#1)
(group I) and##2##3##(1991-3#1)(2007-8#1)
(group I)##4##2##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#1)
(group II)##4##2##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#1)
(group P)##2##2##(1996-1#1)(2007-8#1)
(group S)##2##2##(1996-3#1)(2007-8#1)
(group##68##1##(1990-6#2)(1990-8#2)(1991-3#2)(1992-12#1)(1996-1#2)(1996-3#2)(1996-6#2)(2007-11#3)(2007-8#14)(2008-1#7)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#3)(2008-7#2)(2009-10#2)(2009-6#3)(2011-1#2)(2011-2#3)(2012-3#4)(2012-4#3)
(group-I) and##2##2##(2007-8#2)
(group-II)##2##1##(2007-8#2)
(growth in##2##2##(2011-2#1)(2012-12#1)
(growth##7##1##(1994-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
(h)##6##1##(2008-10#3)(2008-2#1)(2010-8#1)(2011-1#1)
(h-TR beta 1)##2##3##(1991-2#1)(1993-8#1)
(hCG)##8##1##(1990-5#1)(1992-8#2)(1993-6#1)(1994-8#1)(1995-8#1)(1997-1#1)(2011-1#1)
(hESC)##3##1##(2008-11#2)(2008-9#1)
(hFIXR338A)##2##1##(2008-9#2)
(hIL-6)##5##1##(1992-8#1)(2008-11#2)(2008-8#2)
(hMSCs)##4##1##(2008-11#2)(2010-8#1)(2012-7#1)
(hTR)##2##1##(1991-6#1)(2008-9#1)
(habitat##2##1##(2008-11#1)(2012-3#1)
(hair##2##1##(2008-10#2)
(half maximal##2##2##(1994-8#1)(2011-2#1)
(half-life##2##1##(2008-10#2)
(hard)##2##1##(2008-10#1)(2008-9#1)
(hardback)##2##1##(1997-6#2)
(hardness##2##1##(2008-5#1)(2009-7#1)
(harsh##2##1##(2009-9#2)
(hazard ratio##2##2##(2009-6#1)(2013-8#1)
(hazard##3##1##(1996-3#1)(2009-6#1)(2013-8#1)
(hcp)##2##1##(2009-7#2)
(head##4##1##(1993-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
(health##3##1##(1994-3#1)(2008-11#1)(2009-3#1)
(health)##4##1##(1997-6#4)
(healthy##2##1##(2007-7#1)(2008-10#1)
(healthy)##2##1##(2008-10#2)
(heart##4##1##(2008-11#1)(2008-5#1)(2009-8#1)(2013-8#1)
(heat##4##1##(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)
(heating##2##1##(2008-10#1)(2013-8#1)
(height##5##1##(2008-10#2)(2008-5#2)(2012-3#1)
(helper##2##1##(2008-10#1)(2008-4#1)
(hematocrit##2##1##(2008-2#1)(2008-9#1)
(hemoglobin##2##1##(2008-7#2)
(hence the##2##2##(2008-6#1)(2008-8#1)
(hence##4##1##(1997-6#1)(2008-2#1)(2008-6#1)(2008-8#1)
(hepatic##2##1##(1990-8#1)(1994-7#1)
(hereafter##3##1##(2008-3#1)(2009-5#1)(2012-2#1)
(hereditary##2##1##(2008-7#1)(2011-2#1)
(heritability##2##1##(2008-10#2)
(high LET##2##2##(2008-7#2)
(high performance liquid chromatography##2##4##(2008-10#1)(2008-5#1)
(high##31##1##(1991-3#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-7#1)
(high)##2##1##(2008-10#1)(2013-8#1)
(higher##7##1##(1992-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-6#1)
(highest fluorescence intensity at##2##4##(2007-11#2)
(highest##4##1##(2007-11#2)(2008-10#1)(2013-8#1)
(highest)##2##1##(2008-10#1)(2013-8#1)
(highly##2##1##(2008-10#2)
(hoary##2##1##(2008-5#2)
(home##3##1##(1997-4#1)(2007-10#1)(2009-3#1)
(homocysteine##2##1##(2008-10#2)
(homologous and heterologous)##2##3##(2007-6#1)(2011-2#1)
(hormesis)##2##1##(2008-12#1)(2008-7#1)
(hospital##3##1##(1990-3#1)(1993-12#1)(2007-11#1)
(host##4##1##(2008-10#2)(2008-2#1)(2008-9#1)
(host)##3##1##(2008-1#1)(2008-10#1)(2009-10#1)
(hours##2##1##(2008-10#1)(2008-11#1)
(how##3##1##(2008-8#1)(2008-9#2)
(hpr3)##2##1##(1990-5#2)
(hs-CRP)##5##1##(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
(hsp70)##5##1##(1993-11#1)(1994-11#2)(1994-8#1)(1995-2#1)
(http##35##1##(2008-10#4)(2008-11#4)(2008-4#1)(2008-7#16)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)
(human##27##1##(1991-11#1)(1991-9#1)(1992-9#2)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1997-4#2)(1997-9#1)(2008-10#3)(2008-11#5)(2008-6#1)(2008-7#1)(2011-1#1)
(human) and##2##2##(1994-3#2)
(human)##3##1##(1994-3#2)(2008-1#1)
(hydride##2##1##(2008-10#2)
(hydrochloric acid)##2##2##(2008-10#2)
(hydrochloric##3##1##(2008-10#3)
(hydrodilatation)##2##1##(2007-11#2)
(hydrodynamic diameter##2##2##(2008-10#2)
(i##544##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-3#8)(1992-6#1)(1992-8#7)(1993-11#2)(1993-12#6)(1993-3#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#9)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#8)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#8)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#6)(2008-10#121)(2008-11#20)(2008-12#3)(2008-2#12)(2008-3#16)(2008-4#20)(2008-5#8)(2008-6#4)(2008-7#13)(2008-8#22)(2008-9#18)(2009-10#4)(2009-11#4)(2009-2#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#10)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#3)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#21)(2012-1#3)(2012-12#6)(2012-2#12)(2012-3#3)(2012-9#2)(2013-1#14)(2013-8#5)
(i) The##10##2##(1992-6#1)(1992-8#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
(i) a##13##2##(1992-12#1)(1994-2#1)(1996-4#1)(2008-10#5)(2008-3#2)(2008-8#1)(2010-5#1)(2013-1#1)
(i) an##5##2##(1990-7#1)(1995-6#1)(2008-10#2)(2008-5#1)
(i) at##2##2##(1990-5#1)(1990-9#1)
(i) both##2##2##(1995-2#1)(2008-8#1)
(i) evaluate##2##2##(2008-10#1)(2011-2#1)
(i) in##7##2##(1994-3#1)(1994-8#1)(1995-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)
(i) increased##2##2##(1995-2#1)(2008-10#1)
(i) is##2##2##(1994-8#1)(2008-10#1)
(i) no##2##2##(2008-3#1)(2008-5#1)
(i) that##2##2##(1994-8#1)(2008-5#1)
(i) the transfer##2##3##(2008-10#1)(2008-9#1)
(i) the two##2##3##(2008-8#1)(2012-5#1)
(i) the##51##2##(1990-11#1)(1990-3#1)(1990-9#1)(1992-7#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#3)
(i) to determine##2##3##(2008-10#1)(2008-8#1)
(i) to##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)
(i) whether##2##2##(1992-9#1)(2008-11#1)
(i)##274##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#4)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#5)(1995-11#2)(1995-12#1)(1995-2#6)(1995-5#1)(1995-6#4)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#86)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#21)(2008-9#13)(2009-12#1)(2009-2#1)(2009-7#3)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#8)(2013-8#1)
(iNOS)##11##1##(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)
(ideal##2##1##(2008-11#1)(2012-12#1)
(identified##3##1##(2008-10#2)(2012-1#1)
(identity##2##1##(2008-10#1)(2008-5#1)
(ie##21##1##(1990-3#1)(1992-6#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-1#1)(2010-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
(if the##2##2##(2008-3#2)
(if##11##1##(1990-12#2)(1990-7#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
(ii) A##3##2##(1994-5#1)(2008-8#2)
(ii) The##5##2##(1992-8#1)(2008-10#1)(2008-7#1)(2008-9#2)
(ii) a##12##2##(1990-7#1)(1992-12#1)(1993-12#1)(1994-5#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2012-5#1)
(ii) an##2##2##(2008-3#1)(2010-5#1)
(ii) at##2##2##(1990-5#1)(1990-9#1)
(ii) decreased##2##2##(2008-10#2)
(ii) for##2##2##(1994-3#1)(1995-12#1)
(ii) identify and##2##3##(2008-10#1)(2011-2#1)
(ii) identify##4##2##(2008-10#3)(2011-2#1)
(ii) in##2##2##(1995-2#1)(2008-8#1)
(ii) increased##2##2##(2008-10#2)
(ii) its##3##2##(1995-6#1)(2008-5#1)(2013-1#1)
(ii) placing##2##2##(2008-10#1)(2008-3#1)
(ii) sensitivity##2##2##(2008-10#1)(2008-8#1)
(ii) that the##2##3##(1992-9#1)(1993-5#1)
(ii) that##4##2##(1992-9#1)(1993-5#1)(1994-8#1)(2008-5#1)
(ii) the use of##5##4##(1991-9#1)(2008-10#2)(2008-9#1)(2012-2#1)
(ii) the##53##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-9#1)(1993-8#2)(1993-9#1)(1994-8#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-10#14)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-12#1)(2009-7#2)(2010-10#1)(2012-2#1)(2013-1#2)
(ii) to##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)
(ii) with##2##2##(2007-12#1)(2008-10#1)
(ii)##272##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#4)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#5)(1995-11#2)(1995-12#1)(1995-2#6)(1995-5#1)(1995-6#4)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#85)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#22)(2008-9#12)(2009-12#1)(2009-2#1)(2009-7#3)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#7)(2013-8#1)
(iii) The##5##2##(1992-6#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-9#1)
(iii) a##10##2##(1995-5#1)(2008-10#5)(2008-3#1)(2008-8#2)(2010-5#1)
(iii) both##2##2##(1993-9#1)(2008-10#1)
(iii) by##2##2##(1996-4#1)(2008-8#1)
(iii) in##3##2##(1996-6#1)(2008-8#2)
(iii) increased##2##2##(2008-10#1)(2008-7#1)
(iii) it is##2##3##(2008-9#1)(2013-1#1)
(iii) it##3##2##(1995-6#1)(2008-9#1)(2013-1#1)
(iii) no##3##2##(1991-9#1)(2008-9#1)(2009-7#1)
(iii) on##2##2##(2008-10#1)(2008-9#1)
(iii) the##24##2##(1990-9#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#2)(2009-7#1)(2010-10#1)(2013-1#1)
(iii) to##3##2##(2008-10#2)(2008-5#1)
(iii)##155##1##(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#53)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#13)(2008-9#8)(2009-2#1)(2009-7#3)(2010-10#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)
(iloperidone##2##1##(1995-3#1)(2009-6#1)
(immobilised##3##1##(1990-12#1)(2008-10#2)
(immobilized##2##1##(2008-10#2)
(immune##2##1##(2010-3#2)
(implying involvement of##2##3##(2006-6#2)
(in 0##3##2##(2008-10#3)
(in 10(-3)%)##2##2##(2008-10#2)
(in 15##2##2##(1991-6#1)(2011-2#1)
(in Pascals)##2##2##(2008-5#2)
(in a##8##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2013-8#1)
(in addition to the##2##4##(1990-6#1)(2011-2#1)
(in addition to##5##3##(1990-6#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
(in base##2##2##(2008-10#1)(2008-3#1)
(in comparison##2##2##(2008-10#1)(2008-8#1)
(in contrast to##2##3##(2010-4#1)(2012-3#1)
(in degrees##2##2##(1995-6#2)
(in fact##2##2##(1993-8#1)(2009-9#1)
(in millimeters##2##2##(1995-6#2)
(in most##2##2##(2008-2#1)(2011-2#1)
(in particular##10##2##(1990-3#1)(1991-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
(in press)]##3##2##(1994-5#1)(2008-10#2)
(in situ##2##2##(2008-10#1)(2008-3#1)
(in terms of the##2##4##(2008-3#1)(2008-9#1)
(in terms of##6##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
(in the 1##2##3##(2008-3#2)
(in the absence of##2##4##(1990-8#1)(1996-5#1)
(in the absence##3##3##(1990-8#1)(1996-5#1)(2008-11#1)
(in the case of##4##4##(2008-10#1)(2008-11#1)(2008-7#2)
(in the form of##5##4##(2008-10#4)(2010-4#1)
(in the presence of##2##4##(1994-6#1)(1996-5#1)
(in the range of##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
(in the range##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
(in the ribo##2##3##(1995-3#2)
(in the##46##2##(1990-8#1)(1992-12#1)(1994-2#1)(1994-6#1)(1995-3#2)(1996-5#2)(1996-9#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-8#2)
(in this case##3##3##(1992-12#1)(2008-4#1)(2008-7#1)
(in this##4##2##(1992-12#1)(2008-2#1)(2008-4#1)(2008-7#1)
(in vitro##3##2##(2008-10#2)(2008-11#1)
(in vitro)##6##2##(2008-10#2)(2008-2#1)(2008-5#2)(2012-3#1)
(in vivo##2##2##(2008-10#2)
(in water)##2##2##(1990-8#1)(2008-10#1)
(in which the##2##3##(2008-4#1)(2013-1#1)
(in which##8##2##(1997-5#1)(2008-4#1)(2008-9#2)(2011-1#1)(2012-12#2)(2013-1#1)
(in##228##1##(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#3)(1992-8#1)(1992-9#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-3#2)(1995-5#2)(1995-6#4)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#53)(2008-11#7)(2008-12#7)(2008-2#9)(2008-3#14)(2008-4#6)(2008-5#12)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#6)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#2)(2010-6#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#4)
(inadequate##2##1##(1990-2#1)(2013-7#1)
(incidence##6##1##(1993-5#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-9#1)
(including TASER devices)##2##3##(2010-1#2)
(including a##3##2##(2007-12#1)(2008-10#2)
(including hospital##2##2##(1991-12#1)(2007-8#1)
(including the##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
(including those##3##2##(1992-12#1)(1992-3#1)(2008-7#1)
(including##89##1##(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-12#3)(1994-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#3)(2006-12#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-12#1)(2009-7#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-3#1)(2013-1#6)
(incorporating##2##1##(1994-5#1)(2008-10#1)
(increase or decrease)##2##3##(2008-10#2)
(increase##3##1##(2008-10#2)(2009-9#1)
(increase)##3##1##(2008-10#2)(2009-12#1)
(increased by##2##2##(1997-7#1)(2013-8#1)
(increased##9##1##(1995-11#1)(1996-9#1)(1997-7#1)(2010-12#1)(2012-1#1)(2013-7#1)(2013-8#3)
(increasing##2##1##(1990-6#1)(1992-3#1)
(independently of##2##2##(2008-7#2)
(independently##3##1##(2008-10#1)(2008-7#2)
(index of##2##2##(2008-10#1)(2008-2#1)
(index##4##1##(2007-11#1)(2008-10#2)(2008-2#1)
(indicated##2##1##(1996-5#1)(2009-9#1)
(indigenous##2##1##(2008-10#2)
(indirect##2##1##(2008-10#1)(2008-11#1)
(individuals##2##1##(1992-2#1)(2009-7#1)
(induced by##3##2##(1995-8#2)(2010-12#1)
(induced)##2##1##(2008-5#2)
(inducing##2##1##(2008-10#1)(2008-12#1)
(inflammation##2##1##(2010-1#1)(2011-1#1)
(information##4##1##(1993-2#2)(2008-7#1)(2008-9#1)
(inhaled##2##1##(1996-12#1)(2008-11#1)
(inhibitor of##2##2##(1994-12#1)(2008-10#1)
(inhibitor##3##1##(1994-12#1)(1997-2#1)(2008-10#1)
(initial##5##1##(1991-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
(initially##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
(injection##2##1##(2008-10#1)(2008-7#1)
(innate immunity)##2##2##(2009-7#1)(2010-11#1)
(inner diameter##2##2##(2007-12#1)(2008-5#1)
(inner##4##1##(2007-12#1)(2008-5#1)(2010-4#1)(2010-8#1)
(inputs##2##1##(1996-12#1)(2008-11#1)
(instantaneous value##2##2##(2008-10#2)
(instead of##2##2##(2008-10#1)(2008-2#1)
(institutional##2##1##(2009-4#1)(2012-12#1)
(insulin##8##1##(1990-8#1)(1994-3#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-11#1)
(integration##3##1##(2007-12#1)(2008-8#1)(2010-8#1)
(intermediate##2##1##(2008-10#1)(2008-5#1)
(intermediate)##2##1##(1992-3#1)(2008-10#1)
(internal standard)##3##2##(1990-8#1)(2008-10#1)(2011-3#1)
(internal vs##2##2##(2008-8#1)(2010-2#1)
(internal##12##1##(1990-8#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-2#2)(2011-3#1)
(interval##2##1##(1995-12#1)(2008-6#1)
(intervention##2##1##(2008-8#1)(2010-10#1)
(interventional##2##1##(2011-2#1)(2012-2#1)
(intra-##3##1##(1993-9#1)(2008-10#1)(2012-12#1)
(intraductal##2##1##(1992-8#1)(1994-8#1)
(intraoperative##2##1##(2007-8#2)
(introduced##2##1##(2008-8#2)
(invalid##2##1##(2008-2#1)(2010-5#1)
(inverse)##5##1##(1993-9#1)(2008-7#4)
(involving both the##2##3##(2011-2#2)
(involving##3##1##(2008-10#1)(2011-2#2)
(ion exchanger##2##2##(2008-10#2)
(ion-exchanger)##2##1##(2008-10#2)
(ionic##3##1##(2008-10#3)
(iron##3##1##(1991-2#1)(2008-12#1)(2008-3#1)
(irrespective of##2##2##(2008-12#1)(2008-3#1)
(irrigation##2##1##(2008-10#1)(2008-12#1)
(isoenzyme##2##1##(2008-5#2)
(isoform##2##1##(2009-10#1)(2013-1#1)
(isolate from##2##2##(2008-10#2)
(isolate##6##1##(1997-3#1)(2008-10#4)(2008-5#1)
(isolated##3##1##(1994-8#1)(2008-10#1)(2008-11#1)
(it is##3##2##(2008-9#2)(2009-1#1)
(it##4##1##(1991-8#1)(2008-9#2)(2009-1#1)
(its##4##1##(1995-6#1)(1996-4#1)(2008-10#1)(2008-6#1)
(iv) The##2##2##(1997-2#1)(2008-9#1)
(iv) a##2##2##(2008-10#1)(2008-7#1)
(iv) increased##2##2##(2008-10#2)
(iv) the##13##2##(1990-9#1)(1991-9#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-4#1)(2008-11#1)(2008-8#3)(2008-9#2)(2009-7#1)
(iv)##57##1##(1990-9#1)(1991-9#1)(1992-8#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-7#1)(2011-1#1)(2013-1#1)
(japonica)##2##1##(2008-8#1)(2009-10#1)
(k &gt##2##2##(2008-2#1)(2008-3#1)
(k =##3##2##(1996-2#1)(2011-2#1)(2013-1#1)
(k##9##1##(1996-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#2)
(k(373K) =##2##2##(1996-5#2)
(k(a))##2##1##(2008-11#1)(2008-12#1)
(k) and##2##2##(2008-10#1)(2013-1#1)
(k) for##2##2##(1996-2#1)(2008-10#1)
(k)##7##1##(1996-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
(k=0##2##1##(2013-1#2)
(k=3)##2##1##(2008-10#1)(2008-12#1)
(kH/kD =##2##2##(1991-3#1)(1992-6#1)
(kappa = 0##7##3##(1993-12#1)(1997-8#2)(2007-10#1)(2008-11#2)(2008-3#1)
(kappa##9##1##(1993-12#1)(1997-8#2)(2007-10#2)(2008-11#2)(2008-12#1)(2008-3#1)
(kappa)##3##1##(1993-1#1)(2007-10#1)(2008-10#1)
(kb)##6##1##(1992-12#1)(1997-9#1)(2008-10#3)(2011-2#1)
(kcat/Km = 1##2##3##(1991-9#1)(1992-12#1)
(kcat/Km =##7##2##(1991-9#1)(1992-12#2)(1994-5#1)(1995-6#3)
(kidney##2##1##(2008-9#1)(2009-8#1)
(kinoforms)##2##1##(2008-2#2)
(known as##4##2##(1995-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
(known##5##1##(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
(l##2##1##(2008-10#1)(2008-3#1)
(labeling)##2##1##(2008-4#1)(2008-6#1)
(labelled##2##1##(1993-9#1)(2008-10#1)
(laboratory##2##1##(1992-12#1)(2008-10#1)
(lacking the##2##2##(1990-12#1)(1992-8#1)
(lacking##6##1##(1990-12#1)(1992-8#1)(2008-10#2)(2008-2#1)(2008-9#1)
(lactate dehydrogenase##2##2##(1995-12#1)(1995-3#1)
(lake##3##1##(2008-10#2)(2008-12#1)
(lambda &gt##3##2##(1996-5#1)(2008-11#1)(2008-2#1)
(lambda = 0##2##3##(2008-3#2)
(lambda = 1##2##3##(2007-11#1)(2008-2#1)
(lambda = 2##2##3##(2008-2#1)(2008-3#1)
(lambda = 830 nm)##2##4##(2007-12#1)(2008-3#1)
(lambda =##14##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#10)
(lambda approximately##3##2##(2007-12#1)(2008-3#2)
(lambda##24##1##(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#13)
(lambda')(-5##2##1##(2008-2#2)
(lambda(ex)##4##1##(1996-5#1)(2008-10#2)(2009-11#1)
(lambda(ex)=480 nm##2##2##(2008-10#2)
(lambda(max)##6##1##(2007-12#1)(2008-10#2)(2010-5#3)
(lambda(max)=460 nm)##2##2##(2008-10#2)
(lambda(pump) =##2##2##(2008-3#2)
(lambda)##6##1##(2008-2#3)(2008-5#1)(2011-2#2)
(lamina##2##1##(1995-12#1)(1996-12#1)
(laminin##2##1##(1992-9#1)(2008-5#1)
(large##3##1##(1993-11#1)(1997-1#1)(2013-1#1)
(largest##2##1##(2008-10#2)
(laser##6##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
(late stage##2##2##(2008-10#1)(2008-7#1)
(late##13##1##(1991-6#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
(latent##3##1##(2008-10#3)
(lateral##2##1##(1996-5#1)(2013-1#1)
(latitude##2##1##(2008-10#1)(2008-5#1)
(lead##2##1##(2008-10#2)
(leaf##8##1##(2008-10#7)(2008-12#1)
(learning)##3##1##(2008-11#1)(2008-3#1)(2008-4#1)
(left masseter muscle)##2##3##(2008-10#2)
(left or##2##2##(1993-11#1)(2008-10#1)
(left##6##1##(1993-11#1)(2008-10#3)(2008-5#1)(2012-3#1)
(left)##3##1##(1996-2#1)(1997-3#1)(2011-2#1)
(length and##2##2##(2007-11#1)(2008-10#1)
(length of##2##2##(2013-1#2)
(length##6##1##(1997-4#1)(2007-11#1)(2008-10#2)(2013-1#2)
(lesion##2##1##(2008-10#1)(2011-2#1)
(lesions##4##1##(2008-10#1)(2013-1#3)
(less than 0##8##3##(1990-2#1)(1990-5#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)
(less than 1##3##3##(1991-12#1)(1992-3#1)(2011-2#1)
(less than 10##2##3##(1992-8#1)(2008-3#1)
(less than 2##3##3##(1990-12#1)(1991-6#1)(2008-10#1)
(less than 30##3##3##(1990-12#1)(1990-5#1)(2013-1#1)
(less than 5##2##3##(1990-5#1)(2008-2#1)
(less than##41##2##(1990-12#2)(1990-2#2)(1990-5#3)(1990-8#2)(1991-12#1)(1991-6#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1997-2#2)(1997-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2011-2#1)(2013-1#2)
(less##47##1##(1990-12#2)(1990-2#2)(1990-5#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-5#1)(1997-2#2)(1997-9#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#2)(2011-2#1)(2013-1#2)
(lettuce##2##1##(2008-10#1)(2008-11#1)
(level##3##1##(1993-3#1)(2009-6#1)(2011-2#1)
(lichen##2##1##(1992-3#1)(2008-10#1)
(lichenase)##2##1##(1991-5#2)
(lidar)##2##1##(2008-10#1)(2008-2#1)
(light intensity##2##2##(1994-8#1)(2008-10#1)
(light##9##1##(1992-12#1)(1994-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
(lights off##2##2##(1997-6#2)
(like##3##1##(2008-9#1)(2009-6#1)(2011-2#1)
(limit of##4##2##(1996-5#1)(2008-10#2)(2013-8#1)
(limits of##2##2##(1995-2#1)(2008-10#1)
(limits##3##1##(1995-2#1)(2008-1#1)(2008-10#1)
(limonene##2##1##(2008-11#1)(2008-5#1)
(lindane)##2##1##(2008-11#1)(2010-6#1)
(line##3##1##(1995-8#1)(2008-11#1)(2008-3#1)
(linear range 10(-5)-10(-2) mol l(-1) detection limit##2##7##(2008-10#2)
(linear range##5##2##(2008-10#5)
(linear sweep##2##2##(2008-10#2)
(linear transfer function)##2##3##(2008-10#2)
(linear##12##1##(2008-10#9)(2008-3#2)(2008-7#1)
(linkage##2##1##(2008-7#1)(2008-8#1)
(linoleic##2##1##(1990-3#1)(2008-5#1)
(lipids##2##1##(1995-2#1)(2012-3#1)
(liquid##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
(literature##2##1##(2011-2#1)(2012-3#1)
(litter##2##1##(1994-8#1)(2008-11#1)
(live##3##1##(2008-11#1)(2008-8#1)(2011-2#1)
(liver##5##1##(1990-11#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)
(living##2##1##(1991-11#1)(2008-6#1)
(local##6##1##(1990-9#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
(located##2##1##(1997-3#1)(2008-10#1)
(log 3##2##2##(2008-10#2)
(log K##3##2##(2008-10#3)
(log k)##2##2##(1996-2#1)(2007-11#1)
(log rank##3##2##(1990-6#1)(2007-8#1)(2013-8#1)
(log##25##1##(1990-6#1)(1996-2#2)(2007-11#2)(2007-8#1)(2008-10#17)(2008-5#1)(2013-8#1)
(log-rank test##5##2##(1997-7#4)(2011-2#1)
(logK(ex)=-6##2##1##(2008-10#2)
(logic##4##1##(2008-10#4)
(logistic##2##1##(1991-8#1)(2008-4#1)
(logrank##2##1##(1994-7#1)(1997-7#1)
(long axis view) (p##2##4##(2008-10#2)
(long##5##1##(2008-10#3)(2008-12#1)(2008-4#1)
(loss of##4##2##(1995-12#1)(2008-5#1)(2008-8#1)(2009-9#1)
(loss##7##1##(1995-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)
(low temperature##2##2##(2008-10#2)
(low##24##1##(1992-3#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-5#1)(2008-10#7)(2008-2#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
(low)##2##1##(2008-10#1)(2013-1#1)
(lower limit 95% CI##2##4##(2008-12#2)
(lower limit##3##2##(2008-10#1)(2008-12#2)
(lower than##2##2##(2008-3#1)(2010-11#1)
(lower##12##1##(1990-7#1)(1991-5#1)(1996-5#1)(2008-10#3)(2008-12#2)(2008-3#1)(2010-11#1)(2010-4#1)(2013-1#1)
(luminol CL##4##2##(1991-9#4)
(lung##2##1##(1992-5#1)(2010-9#1)
(lux) genes##2##2##(2007-12#1)(2011-1#1)
(lux)##3##1##(2007-12#1)(2008-10#1)(2011-1#1)
(lymph##2##1##(2008-11#1)(2012-12#1)
(lysine##2##1##(1990-12#1)(1994-8#1)
(m##6##1##(1992-3#1)(1994-11#1)(1997-4#1)(2008-10#2)(2013-1#1)
(m(2))##2##1##(2008-10#1)(2008-2#1)
(m)##8##1##(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#3)
(m/m)##4##1##(2008-10#4)
(m/v)##9##1##(2008-10#7)(2009-6#2)
(mAb) in a##2##3##(1997-4#1)(2008-11#1)
(mAb)##12##1##(1994-12#1)(1996-12#1)(1997-4#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
(mAbs##2##1##(1996-12#2)
(mPFC)##5##1##(2008-11#2)(2008-6#2)(2008-7#1)
(mREN-2)27 rats##2##2##(1996-5#1)(2008-12#1)
(mRNA)##9##1##(1992-9#1)(1994-8#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
(mW)(2)##2##1##(2007-11#2)
(macro##3##1##(1991-2#1)(1996-3#1)(2008-10#1)
(macrocycle##2##1##(2008-10#2)
(magnetic##2##1##(2008-10#1)(2012-12#1)
(main##4##1##(1996-5#1)(2008-10#2)(2008-5#1)
(mainly##25##1##(1992-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-5#1)(2012-1#1)
(major and minor##2##3##(1993-12#1)(2008-10#1)
(major##6##1##(1993-11#1)(1993-12#1)(2008-10#3)(2013-8#1)
(making##2##1##(1992-6#1)(2010-10#1)
(malachite##2##1##(2008-8#1)(2010-5#1)
(male##8##1##(2007-12#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-7#1)
(male/female##2##1##(2011-2#2)
(males)##2##1##(2008-10#1)(2008-7#1)
(malondialdehyde)##2##1##(1996-2#1)(2008-10#1)
(maltose##2##1##(1994-12#1)(1995-5#1)
(many of which##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
(marked by##2##2##(2009-12#2)
(marker of##2##2##(2012-1#2)
(marker##3##1##(1991-4#1)(2012-1#2)
(mass##5##1##(1996-2#1)(2008-10#4)
(maternal##4##1##(2008-10#2)(2008-9#1)(2012-3#1)
(matrix##4##1##(1992-2#1)(1997-3#1)(2008-10#1)(2013-7#1)
(matrix)##2##1##(2008-10#1)(2012-2#1)
(max)##5##1##(2011-2#5)
(max)) were##2##2##(2011-2#2)
(max))##3##1##(2011-2#3)
(maximal at lambda ex =##2##5##(1994-5#2)
(maximal diameter##3##2##(1997-3#3)
(maximal##11##1##(1990-5#1)(1991-6#1)(1992-3#1)(1994-2#1)(1994-5#2)(1995-5#1)(1997-3#3)(2008-11#1)
(maximum of##2##2##(2008-10#2)
(maximum##20##1##(1992-10#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-1#1)(1996-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)
(mean +##2##2##(1993-8#1)(1994-12#1)
(mean +/- S##7##3##(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-8#1)
(mean +/- SD##4##3##(1991-9#1)(2008-5#1)(2009-7#1)(2011-3#1)
(mean +/- SD)##7##3##(1990-5#1)(1993-1#1)(1996-9#1)(2009-6#2)(2010-2#1)(2011-2#1)
(mean +/- SE##2##3##(1994-6#1)(1997-6#1)
(mean +/- SE)##2##3##(1994-12#1)(2007-5#1)
(mean +/- SEM fmol/mg protein##2##5##(1994-6#2)
(mean +/- standard deviation##2##4##(2008-10#1)(2010-5#1)
(mean +/- standard##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
(mean +/-##29##2##(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-12#1)(1995-8#1)(1996-9#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#2)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
(mean 2##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
(mean 21##2##2##(2008-10#1)(2008-7#1)
(mean 3##8##2##(1996-11#1)(1997-3#1)(2007-11#2)(2008-7#1)(2013-1#3)
(mean 4##3##2##(1994-12#1)(2007-11#1)(2013-1#1)
(mean 5##3##2##(1996-11#1)(2007-11#1)(2008-10#1)
(mean 54##2##2##(1992-9#1)(2007-11#1)
(mean = 0##3##3##(2008-10#1)(2010-8#2)
(mean = 1##2##3##(2009-8#1)(2011-2#1)
(mean = 3##2##3##(2007-7#1)(2009-8#1)
(mean =##13##2##(1992-9#1)(2007-7#1)(2008-10#3)(2008-9#1)(2009-8#4)(2010-8#2)(2011-2#1)
(mean abstinence =##2##3##(1996-7#2)
(mean age 30##2##3##(1992-2#1)(2008-12#1)
(mean age 34##2##3##(2008-12#1)(2008-8#1)
(mean age 62##2##3##(1990-5#1)(2008-4#1)
(mean age =##6##3##(1995-11#3)(2009-7#1)(2011-2#1)(2013-1#1)
(mean age of##3##3##(2008-10#1)(2008-4#2)
(mean age##53##2##(1990-5#2)(1991-5#1)(1992-2#1)(1993-1#1)(1995-11#3)(1997-2#2)(2007-10#3)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#2)(2009-7#1)(2010-1#2)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#5)
(mean ages##2##2##(2008-1#2)
(mean blood pressure##2##3##(1994-11#1)(2013-1#1)
(mean blood##3##2##(1994-11#1)(2012-3#1)(2013-1#1)
(mean body mass##3##3##(2007-12#2)(2013-1#1)
(mean change##2##2##(2008-8#2)
(mean changes##2##2##(2013-7#2)
(mean difference##5##2##(2010-4#4)(2013-1#1)
(mean disease##3##2##(2008-10#3)
(mean follow-up time##2##3##(2007-5#2)
(mean follow-up##4##2##(1994-3#1)(2007-5#2)(2008-7#1)
(mean length##3##2##(2009-1#3)
(mean rectal temperature##2##3##(2013-7#2)
(mean survival##2##2##(2008-9#2)
(mean ± SD##4##3##(2013-1#2)(2013-8#2)
(mean ±##5##2##(2013-1#3)(2013-8#2)
(mean##246##1##(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#1)(1991-11#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#4)(1995-11#3)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#4)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#1)(1997-9#2)(2007-10#5)(2007-11#13)(2007-12#2)(2007-5#3)(2007-7#5)(2007-8#4)(2008-1#7)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#17)(2008-8#3)(2008-9#13)(2009-1#3)(2009-3#3)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#3)(2012-3#4)(2013-1#21)(2013-7#5)(2013-8#3)
(means +/-##2##2##(1994-6#1)(1995-12#1)
(means##3##1##(1993-2#1)(1994-6#1)(1995-12#1)
(measured as##6##2##(1992-3#1)(1992-9#1)(2008-5#1)(2008-9#3)
(measured by##5##2##(1995-11#1)(2009-6#1)(2009-9#1)(2011-1#2)
(measured in a previous study)##2##5##(2008-9#2)
(measured in a##3##3##(2008-3#1)(2008-9#2)
(measured using##2##2##(2008-6#1)(2013-1#1)
(measured##18##1##(1991-11#1)(1992-3#1)(1992-9#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#5)(2009-6#1)(2009-9#1)(2011-1#2)(2013-1#1)
(measurement##3##1##(2007-11#1)(2008-3#1)(2008-4#1)
(mechanical##3##1##(1994-8#1)(2008-7#1)(2010-7#1)
(median 1##2##2##(2007-8#1)(2013-8#1)
(median 10##2##2##(1990-3#1)(1995-8#1)
(median 14##2##2##(1997-4#1)(2007-8#1)
(median 20) years##2##3##(1997-3#2)
(median 4##2##2##(1994-2#1)(2007-10#1)
(median 5##2##2##(1994-2#1)(2008-10#1)
(median =##12##2##(1991-2#2)(1993-12#1)(2006-10#1)(2011-1#8)
(median age##3##2##(2008-6#1)(2011-2#2)
(median coefficient of variation##2##4##(2008-5#1)(2008-8#1)
(median value 1##2##3##(1996-9#2)
(median value##3##2##(1996-9#3)
(median##60##1##(1990-3#2)(1991-2#2)(1991-5#1)(1992-12#1)(1993-12#2)(1993-8#3)(1994-12#1)(1994-2#2)(1995-8#3)(1996-8#1)(1996-9#3)(1997-3#6)(1997-4#3)(2006-10#1)(2007-10#1)(2007-8#4)(2008-10#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2011-1#8)(2011-2#4)(2013-7#1)(2013-8#1)
(median)##3##1##(2007-7#1)(2010-4#2)
(medical and##2##2##(2013-1#2)
(medical##4##1##(2008-7#1)(2010-8#1)(2013-1#2)
(medium##4##1##(1996-2#1)(2008-5#1)(2008-7#2)
(melanoma##2##1##(1994-3#1)(1995-12#1)
(melatonin##2##1##(1995-12#1)(1996-2#1)
(membrane##3##1##(1994-8#1)(2008-7#1)(2009-3#1)
(men##4##1##(1991-4#1)(1997-8#1)(2008-11#2)
(mental##2##1##(1995-12#1)(2012-12#1)
(metal##6##1##(2008-10#6)
(methanol in DMDTPA)##2##3##(2008-10#2)
(methanol##8##1##(1992-6#1)(2008-10#5)(2008-11#1)(2008-3#1)
(methanol)##2##1##(1994-9#1)(2008-10#1)
(method A)##2##2##(2008-10#1)(2008-6#1)
(method B)##2##2##(2008-10#1)(2008-6#1)
(method C)##2##2##(2008-10#1)(2008-6#1)
(method##12##1##(2008-10#9)(2008-6#3)
(methotrexate##3##1##(1993-6#1)(2010-3#2)
(methyl##11##1##(1992-12#2)(1995-11#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#4)(2011-2#1)
(mg dm(-2))##2##2##(2008-12#2)
(mg l(-1)) of##3##3##(2008-11#3)
(mg l(-1))##4##2##(2008-10#1)(2008-11#3)
(mg##10##1##(2008-10#4)(2008-11#3)(2008-12#3)
(mg/dL)##2##1##(2010-2#2)
(mg/m2)##2##1##(2011-3#2)
(mg/mL)##2##1##(2008-10#1)(2013-1#1)
(miRNAs) are##3##2##(2008-7#1)(2010-7#1)(2013-1#1)
(miRNAs) play##2##2##(2010-1#1)(2011-1#1)
(miRNAs)##13##1##(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#2)
(microgram/g) of##2##2##(1995-2#2)
(microgram/g)##5##1##(1995-2#5)
(micromol/l)##3##1##(2007-10#3)
(mild##8##1##(1990-5#1)(1990-6#1)(1992-9#1)(1996-7#1)(2007-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
(milk##2##1##(2008-10#1)(2011-2#1)
(min##4##1##(1992-9#2)(1993-9#1)(2008-6#1)
(minK)##2##1##(1994-12#2)
(minimal##2##1##(2008-10#1)(2011-2#1)
(minimally invasive##2##2##(1993-3#1)(2011-2#1)
(minimum inhibitory##2##2##(2008-5#1)(2012-3#1)
(minimum##6##1##(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
(minutes)##4##1##(2008-11#2)(2008-3#1)(2013-8#1)
(mitogens)##2##1##(2008-4#2)
(mixed##4##1##(1990-8#1)(1991-12#1)(2008-7#1)(2012-3#1)
(mixture of##2##2##(2008-10#1)(2012-12#1)
(ml##3##1##(2008-10#3)
(mm(2))##3##1##(2008-10#1)(2011-2#1)(2012-3#1)
(mm)##2##1##(2008-10#1)(2008-11#1)
(mmol##2##1##(2008-10#2)
(model##2##1##(2008-10#1)(2008-8#1)
(moderate)##2##1##(2008-11#1)(2010-3#1)
(modified##10##1##(1992-5#1)(1993-9#1)(1997-5#1)(2008-10#5)(2008-8#1)(2011-2#1)
(moisture index##2##2##(2008-10#2)
(moisture##4##1##(2008-10#3)(2008-5#1)
(mol##8##1##(2007-11#2)(2008-10#6)
(mol/L)(-1)##2##1##(2008-8#2)
(molar##4##1##(1994-3#1)(2008-10#2)(2008-7#1)
(mole##2##1##(1992-6#1)(2008-10#1)
(molecular##7##1##(1990-5#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-7#1)
(monitored by##2##2##(1995-3#1)(2008-10#1)
(monitored##3##1##(1995-3#1)(2008-10#2)
(mono-##4##1##(1993-8#1)(2008-10#2)(2009-8#1)
(monomer)##2##1##(1990-7#1)(1991-9#1)
(monopolar##2##1##(2010-8#1)(2011-2#1)
(monthly##2##1##(2007-8#1)(2008-10#1)
(more than 1##2##3##(2008-10#1)(2009-11#1)
(more than 50%##3##3##(1993-5#2)(1995-4#1)
(more than 90%)##2##3##(1992-9#1)(2008-6#1)
(more than##25##2##(1991-11#1)(1992-9#1)(1993-5#3)(1995-3#1)(1995-4#2)(1996-12#2)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#1)
(more##32##1##(1991-11#1)(1992-9#1)(1993-5#3)(1995-3#1)(1995-4#2)(1996-12#2)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
(mortality##2##1##(2008-10#1)(2009-2#1)
(mortality)##2##1##(2007-2#1)(2012-12#1)
(most##4##1##(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
(mostly##19##1##(1990-6#1)(1992-2#1)(1993-9#2)(1995-5#1)(1996-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
(mother and##2##2##(1991-3#1)(2012-12#1)
(mu =##2##2##(2007-12#1)(2008-11#1)
(mu##3##1##(2007-11#1)(2007-12#1)(2008-11#1)
(mu(a)) and reduced scattering (mu(s)')##3##5##(2008-3#3)
(mu(a))##4##1##(2008-3#4)
(mu) and##3##2##(1996-5#1)(2008-11#1)(2010-4#1)
(mu)##4##1##(1996-5#1)(2008-11#2)(2010-4#1)
(mu=0##2##1##(2008-10#2)
(muTAS)##4##1##(2008-10#4)
(mucous##2##1##(1995-8#1)(2008-5#1)
(mug l(-1))##2##2##(2008-10#2)
(mug ml(-1))##2##2##(2008-10#2)
(mug##7##1##(2008-10#7)
(mull(-1)) for##2##2##(2008-10#2)
(multi)##3##1##(2008-8#3)
(multidrug##2##1##(2008-11#1)(2011-2#1)
(multiple##6##1##(1991-6#1)(1995-9#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
(multiplex##2##1##(2012-12#1)(2013-8#1)
(mumol##2##1##(2008-10#2)
(murine##2##1##(2008-11#1)(2009-12#1)
(muscle##2##1##(1992-3#1)(2008-3#1)
(muscle)##4##1##(1994-11#1)(1997-4#1)(2010-9#1)(2013-8#1)
(muscularis propria)##2##2##(2011-2#1)(2013-1#1)
(mutants beta delta##2##3##(1993-11#2)
(mutants##3##1##(1993-11#2)(2008-7#1)
(n -##2##2##(1995-6#1)(2008-3#1)
(n = 1##8##3##(1996-8#1)(1997-7#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#2)
(n = 1) and##5##4##(1994-10#1)(1994-3#1)(1996-11#1)(2009-2#1)(2011-2#1)
(n = 1)##25##3##(1993-2#2)(1994-10#2)(1994-3#7)(1996-11#3)(1997-8#1)(2009-11#1)(2009-2#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)
(n = 10) and##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
(n = 10) for##2##4##(2008-10#2)
(n = 10) or##2##4##(1995-12#2)
(n = 10) received##3##4##(2007-10#3)
(n = 10) were##3##4##(2008-10#2)(2011-1#1)
(n = 10)##34##3##(1990-7#2)(1993-6#1)(1995-12#4)(1995-2#2)(1996-5#1)(1996-7#2)(2007-10#3)(2008-10#11)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
(n = 11)##7##3##(1993-12#1)(1995-5#3)(1996-3#1)(2008-10#1)(2008-7#1)
(n = 114)##2##3##(2009-7#1)(2010-8#1)
(n = 117)##2##3##(2007-10#1)(2012-3#1)
(n = 12##2##3##(2010-9#1)(2011-2#1)
(n = 12) and##3##4##(2007-8#1)(2008-5#1)(2008-7#1)
(n = 12) of##2##4##(1991-5#1)(1995-12#1)
(n = 12) or##3##4##(1993-3#1)(1994-5#1)(2011-2#1)
(n = 12) were##2##4##(1993-3#1)(1994-2#1)
(n = 12)##27##3##(1991-5#2)(1993-1#1)(1993-3#3)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#3)
(n = 120)##2##3##(2009-8#1)(2012-3#1)
(n = 127)##3##3##(1992-9#1)(2010-10#2)
(n = 129)##2##3##(1994-10#1)(2010-8#1)
(n = 13##3##3##(1992-6#1)(2009-10#1)(2010-8#1)
(n = 13)##6##3##(1994-3#1)(2008-10#2)(2010-2#1)(2013-1#1)(2013-8#1)
(n = 14##2##3##(2011-1#1)(2011-2#1)
(n = 14) and##4##4##(1995-12#1)(1996-7#1)(2008-7#1)(2013-8#1)
(n = 14) or##2##4##(2007-10#1)(2009-8#1)
(n = 14)##7##3##(1995-12#1)(1996-7#1)(2007-10#1)(2008-7#1)(2009-8#1)(2013-8#2)
(n = 141)##2##3##(1996-8#1)(1997-8#1)
(n = 15) and##3##4##(1997-3#1)(2008-6#1)(2008-7#1)
(n = 15) were##2##4##(1996-7#1)(2008-10#1)
(n = 15)##10##3##(1996-7#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)
(n = 16)##6##3##(1990-2#2)(1992-1#1)(2008-7#2)(2013-1#1)
(n = 17)##7##3##(1992-9#1)(1993-1#1)(2008-4#1)(2008-6#2)(2008-7#1)(2012-3#1)
(n = 18##2##3##(1995-11#1)(2008-1#1)
(n = 18)##11##3##(1992-1#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
(n = 19)##6##3##(1990-2#1)(1990-9#1)(1993-6#1)(1994-2#1)(2008-10#1)(2011-2#1)
(n = 198)##2##3##(2010-6#1)(2013-1#1)
(n = 2##5##3##(1996-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
(n = 2)##13##3##(1993-2#4)(1994-3#1)(1997-8#2)(2008-11#1)(2009-11#1)(2010-6#1)(2012-3#2)(2013-1#1)
(n = 20) were##2##4##(1993-3#1)(2008-10#1)
(n = 20)##11##3##(1993-1#1)(1993-3#2)(1995-11#1)(1997-8#1)(2008-10#2)(2013-1#4)
(n = 21)##6##3##(1994-10#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
(n = 22)##5##3##(1992-5#1)(1992-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
(n = 23)##4##3##(1990-2#1)(2008-12#1)(2012-3#1)(2013-8#1)
(n = 24) and##2##4##(2012-3#1)(2013-1#1)
(n = 24)##7##3##(1990-5#1)(1992-5#1)(2008-7#1)(2012-3#2)(2013-1#2)
(n = 25) and##2##4##(1993-9#1)(2008-5#1)
(n = 25)##6##3##(1993-9#2)(1996-7#1)(2008-12#1)(2008-5#1)(2008-7#1)
(n = 26)##6##3##(1990-2#1)(1992-10#1)(1994-7#1)(2008-10#1)(2008-6#1)(2010-8#1)
(n = 27##3##3##(1994-1#1)(2008-5#1)(2012-2#1)
(n = 27)##6##3##(1990-8#1)(1994-7#1)(1996-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
(n = 28)##4##3##(1992-1#1)(1994-6#1)(2008-6#1)(2008-8#1)
(n = 29)##4##3##(2008-10#1)(2008-9#1)(2012-12#1)(2013-8#1)
(n = 3) and##2##4##(1993-2#1)(1994-3#1)
(n = 3) was##2##4##(2008-10#1)(2008-9#1)
(n = 3)##20##3##(1990-8#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
(n = 30##2##3##(2008-12#1)(2013-1#1)
(n = 30)##13##3##(1990-8#1)(1993-1#1)(1994-3#1)(2007-6#3)(2009-1#1)(2009-9#1)(2010-3#1)(2012-3#1)(2013-8#3)
(n = 32)##4##3##(1996-7#1)(2008-12#1)(2008-6#1)(2010-4#1)
(n = 33)##2##3##(2012-3#1)(2013-1#1)
(n = 34)##3##3##(2008-7#2)(2010-4#1)
(n = 38)##2##3##(2007-5#1)(2008-4#1)
(n = 39)##2##3##(2012-3#2)
(n = 4##3##3##(1994-3#1)(1996-2#1)(1997-1#1)
(n = 4) and##3##4##(1995-2#1)(2007-10#1)(2008-5#1)
(n = 4) was##2##4##(2007-10#1)(2008-11#1)
(n = 4) were##2##4##(2011-2#1)(2012-12#1)
(n = 4)##22##3##(1990-5#4)(1992-3#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-6#2)(1995-2#1)(2007-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
(n = 40)##4##3##(1996-7#1)(2008-10#1)(2013-1#2)
(n = 41) to Borderline##2##5##(2011-2#2)
(n = 41)##4##3##(1993-12#1)(1994-3#1)(2011-2#2)
(n = 42)##3##3##(2008-3#1)(2009-1#1)(2012-2#1)
(n = 43)##2##3##(1991-2#1)(2008-6#1)
(n = 45)##5##3##(1991-2#1)(1992-8#1)(2008-5#1)(2008-6#1)(2013-1#1)
(n = 48)##2##3##(2008-11#1)(2008-7#1)
(n = 5) &lt##2##4##(2008-10#2)
(n = 5) and##2##4##(1990-7#1)(1996-12#1)
(n = 5)##22##3##(1990-2#1)(1990-7#1)(1993-12#1)(1994-11#1)(1994-3#3)(1995-2#1)(1996-12#2)(2007-10#1)(2008-10#8)(2008-5#1)(2009-11#1)(2009-8#1)
(n = 50)##5##3##(1990-8#2)(2008-10#2)(2008-12#1)
(n = 51)##2##3##(1993-1#1)(2010-8#1)
(n = 521)##4##3##(1991-8#4)
(n = 54)##2##3##(1993-12#1)(2008-10#1)
(n = 56)##2##3##(1993-8#1)(2008-3#1)
(n = 57)##4##3##(1993-1#1)(1997-8#1)(2008-9#1)(2012-3#1)
(n = 6##3##3##(1995-2#1)(1996-11#1)(2008-10#1)
(n = 6) and##5##4##(1993-2#1)(1993-8#1)(1996-5#1)(2007-10#1)(2009-2#1)
(n = 6) were##2##4##(1997-8#1)(2012-3#1)
(n = 6)##19##3##(1991-5#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#4)(1997-8#2)(2007-10#1)(2009-2#1)(2010-6#2)(2012-3#1)
(n = 60)##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
(n = 64)##2##3##(1993-1#1)(2010-8#1)
(n = 68)##2##3##(2008-7#2)
(n = 7##3##3##(2008-12#3)
(n = 7) or##3##4##(1993-2#1)(1996-5#1)(2008-5#1)
(n = 7)##12##3##(1991-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-5#2)(2007-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
(n = 70)##2##3##(1995-12#1)(2007-5#1)
(n = 73)##2##3##(1990-11#1)(2008-9#1)
(n = 78) or##2##4##(1990-5#1)(1994-7#1)
(n = 78)##3##3##(1990-5#1)(1994-7#1)(2008-12#1)
(n = 8##3##3##(1992-9#1)(1996-11#1)(2011-2#1)
(n = 8) and##2##4##(1993-12#1)(2008-10#1)
(n = 8) were##2##4##(1993-12#1)(2008-10#1)
(n = 8)##23##3##(1990-5#2)(1993-12#6)(1993-6#1)(1994-5#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
(n = 9##3##3##(1992-9#1)(2011-2#2)
(n = 9) had##2##4##(1993-8#1)(2008-7#1)
(n = 9)##19##3##(1990-12#1)(1993-12#2)(1993-8#1)(1995-12#1)(1995-2#1)(1995-6#3)(1997-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-3#2)
(n =##629##2##(1990-11#1)(1990-12#1)(1990-2#6)(1990-5#11)(1990-7#3)(1990-8#5)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#6)(1992-1#4)(1992-10#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#6)(1993-1#8)(1993-12#14)(1993-2#16)(1993-3#7)(1993-6#4)(1993-8#6)(1993-9#2)(1994-1#1)(1994-10#5)(1994-11#1)(1994-2#5)(1994-3#20)(1994-5#3)(1994-6#6)(1994-7#5)(1994-9#1)(1995-11#2)(1995-12#11)(1995-2#7)(1995-3#1)(1995-5#6)(1995-6#3)(1995-8#1)(1996-11#7)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#8)(1996-7#11)(1996-8#5)(1996-9#3)(1997-1#2)(1997-3#2)(1997-7#2)(1997-8#10)(2007-10#23)(2007-12#2)(2007-5#2)(2007-6#3)(2007-8#2)(2008-1#2)(2008-10#57)(2008-11#10)(2008-12#11)(2008-3#5)(2008-4#2)(2008-5#16)(2008-6#12)(2008-7#30)(2008-8#8)(2008-9#10)(2009-1#2)(2009-10#1)(2009-11#4)(2009-2#4)(2009-7#4)(2009-8#3)(2009-9#3)(2010-10#2)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#13)(2010-9#4)(2011-1#4)(2011-2#26)(2012-12#10)(2012-2#7)(2012-3#32)(2013-1#28)(2013-8#11)
(n and m values)##2##4##(2008-10#2)
(n and##3##2##(2008-10#2)(2008-2#1)
(n##662##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-5#11)(1990-7#3)(1990-8#5)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#6)(1992-1#4)(1992-10#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#6)(1993-1#8)(1993-12#14)(1993-2#16)(1993-3#7)(1993-6#4)(1993-8#6)(1993-9#2)(1994-1#1)(1994-10#5)(1994-11#1)(1994-2#5)(1994-3#20)(1994-5#4)(1994-6#6)(1994-7#5)(1994-9#1)(1995-11#2)(1995-12#11)(1995-2#7)(1995-3#1)(1995-5#6)(1995-6#4)(1995-8#1)(1996-11#7)(1996-12#4)(1996-2#5)(1996-3#1)(1996-5#8)(1996-7#11)(1996-8#5)(1996-9#3)(1997-1#2)(1997-3#2)(1997-7#2)(1997-8#10)(2007-10#23)(2007-12#2)(2007-5#2)(2007-6#3)(2007-8#2)(2008-1#2)(2008-10#67)(2008-11#10)(2008-12#11)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#26)(2008-6#12)(2008-7#30)(2008-8#8)(2008-9#10)(2009-1#2)(2009-10#1)(2009-11#4)(2009-2#4)(2009-7#4)(2009-8#3)(2009-9#3)(2010-10#2)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#13)(2010-9#5)(2011-1#4)(2011-2#28)(2012-12#11)(2012-2#7)(2012-3#32)(2013-1#31)(2013-8#11)
(n) and##3##2##(1996-12#1)(2008-10#1)(2009-12#1)
(n) at##2##2##(2008-10#1)(2008-8#1)
(n)##12##1##(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#5)(2008-8#1)(2009-12#2)(2011-2#1)
(n)Bu-P2DA##2##1##(2012-12#2)
(n-3) PUFA##2##2##(2012-2#2)
(n-3)##4##1##(1994-2#1)(2012-2#3)
(n-6)##3##1##(1994-2#2)(2008-7#1)
(n=##10##1##(2008-10#3)(2010-5#1)(2012-12#1)(2012-3#2)(2013-1#3)
(n=1##2##1##(2008-11#1)(2012-12#1)
(n=1) and##2##2##(2008-10#1)(2008-5#1)
(n=1)##10##1##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2011-2#3)
(n=10) and##5##2##(2008-10#4)(2008-7#1)
(n=10) at the##2##3##(2008-10#2)
(n=10) at##3##2##(2008-10#3)
(n=10) for##4##2##(2008-10#4)
(n=10) was##6##2##(2008-10#6)
(n=10) were##3##2##(2008-10#2)(2008-12#1)
(n=10)##54##1##(2008-10#45)(2008-12#2)(2008-7#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#3)
(n=100)##2##1##(2007-7#1)(2010-5#1)
(n=11##3##1##(2008-10#3)
(n=11) is 1##2##3##(2008-10#2)
(n=11) was##3##2##(2008-10#3)
(n=11)##22##1##(2008-10#18)(2008-12#1)(2008-6#2)(2011-2#1)
(n=12##4##1##(2007-9#1)(2008-1#1)(2008-4#1)(2010-5#1)
(n=12) and##2##2##(2008-10#1)(2008-11#1)
(n=12) for##2##2##(2008-10#2)
(n=12)##10##1##(2008-10#8)(2008-11#2)
(n=12)] and the##2##3##(2008-10#2)
(n=121)##2##1##(2008-11#1)(2013-1#1)
(n=13)##5##1##(2008-10#1)(2010-2#1)(2011-2#3)
(n=15)##8##1##(2007-10#1)(2008-10#5)(2012-1#1)(2013-1#1)
(n=16##2##1##(2010-3#1)(2010-6#1)
(n=16)##5##1##(2008-10#1)(2008-12#2)(2012-12#1)(2013-1#1)
(n=2)##10##1##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#4)(2012-12#1)
(n=20##6##1##(2008-10#3)(2011-2#3)
(n=20)##9##1##(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)
(n=21##2##1##(2008-10#2)
(n=21)##2##1##(2008-11#1)(2008-12#1)
(n=22)##3##1##(2008-12#1)(2008-9#1)(2011-1#1)
(n=24)##2##1##(2008-12#1)(2009-7#1)
(n=25##2##1##(2008-10#1)(2008-4#1)
(n=25)##4##1##(2007-4#1)(2008-11#2)(2012-12#1)
(n=26) or##2##2##(2007-11#1)(2013-1#1)
(n=26)##7##1##(2007-11#3)(2012-2#2)(2013-1#2)
(n=29)##2##1##(2008-12#1)(2012-1#1)
(n=3##4##1##(2008-10#2)(2008-6#1)(2013-1#1)
(n=3) and##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
(n=3) of##2##2##(2008-10#2)
(n=3)##17##1##(2008-10#12)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
(n=30) for##2##2##(2010-7#2)
(n=30)##6##1##(2007-9#2)(2008-7#1)(2010-7#2)(2013-1#1)
(n=31)##2##1##(2008-12#1)(2011-1#1)
(n=32) were##2##2##(2008-12#1)(2012-12#1)
(n=32)##3##1##(2008-12#2)(2012-12#1)
(n=35)##2##1##(2010-6#1)(2011-2#1)
(n=37)##2##1##(1993-6#1)(2011-2#1)
(n=4##2##1##(2008-10#2)
(n=4) and##2##2##(2008-10#1)(2008-12#1)
(n=4) for##2##2##(2008-10#2)
(n=4)##17##1##(2007-8#2)(2008-10#12)(2008-12#3)
(n=43)##2##1##(2011-1#2)
(n=44)##2##1##(2008-12#1)(2013-1#1)
(n=5##2##1##(2008-10#2)
(n=5) and##2##2##(2008-10#2)
(n=5) at##2##2##(2008-10#2)
(n=5) for a##2##3##(2008-10#2)
(n=5) for##9##2##(2008-10#9)
(n=5) of 2##2##3##(2008-10#2)
(n=5) of##5##2##(2008-10#5)
(n=5) was##3##2##(2008-10#3)
(n=5) were##3##2##(2007-10#2)(2008-10#1)
(n=5)##51##1##(2007-10#2)(2008-10#42)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
(n=50##2##1##(2008-10#1)(2008-4#1)
(n=50)##2##1##(2008-10#1)(2010-5#1)
(n=6) was##3##2##(2008-10#3)
(n=6)##19##1##(2007-8#2)(2008-10#12)(2008-11#1)(2010-6#2)(2011-2#1)(2012-2#1)
(n=7##2##1##(2008-1#2)
(n=7) and##2##2##(2008-10#2)
(n=7) for 0##2##3##(2008-10#2)
(n=7) for##4##2##(2008-10#4)
(n=7)##26##1##(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#22)(2008-7#1)
(n=70)##3##1##(2007-11#1)(2009-4#1)(2012-12#1)
(n=8##2##1##(2008-10#2)
(n=8) for##2##2##(2008-10#2)
(n=8) or##2##2##(2007-8#2)
(n=8) with##2##2##(1997-7#1)(2008-10#1)
(n=8)##24##1##(1997-7#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-12#1)(2009-12#3)(2013-1#1)
(n=9##4##1##(2008-10#4)
(n=9) and##4##2##(2008-10#3)(2011-2#1)
(n=9)##18##1##(1995-11#1)(2007-12#1)(2008-10#9)(2008-6#1)(2010-2#1)(2011-2#3)(2011-3#1)(2013-1#1)
(n=number of possible salt bridges)##2##5##(2008-10#2)
(n=number of##3##2##(2008-10#3)
(nAChR)##3##1##(1994-5#1)(2008-8#1)(2009-6#1)
(nM##2##1##(2008-4#1)(2009-3#1)
(nadir##2##1##(2007-10#1)(2008-2#1)
(named &quot##4##2##(2008-6#2)(2012-2#2)
(named antigenic##2##2##(2010-4#2)
(named##13##1##(1994-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#2)(2012-2#2)(2013-1#1)
(namely##16##1##(2008-10#11)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
(naphazoline##2##1##(2008-10#2)
(natural or##2##2##(2008-10#1)(2008-8#1)
(natural##6##1##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)
(ncRNA)##3##1##(2007-11#1)(2008-4#1)(2012-3#1)
(near the##2##2##(2007-12#1)(2008-3#1)
(near##9##1##(1996-2#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)
(nebulizer##3##1##(1995-3#2)(2008-10#1)
(negative##7##1##(1996-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-12#1)
(neo##2##1##(1992-12#1)(2008-11#1)
(neo)##4##1##(1995-2#1)(1997-8#1)(2008-11#1)(2013-1#1)
(neoadjuvant)##2##1##(2007-5#1)(2010-3#1)
(neocuproine##2##1##(2008-10#2)
(nerve growth##2##2##(2008-11#1)(2008-5#1)
(nerve##4##1##(2008-11#1)(2008-5#1)(2008-9#2)
(nest##3##1##(2008-1#1)(2008-8#2)
(net##2##1##(2008-9#1)(2013-7#1)
(neutral##3##1##(1991-7#1)(1994-5#1)(2011-2#1)
(neutral)##2##1##(1996-2#1)(2008-6#1)
(new##4##1##(1991-3#1)(2008-5#1)(2012-3#1)(2013-7#1)
(new)##2##1##(1993-6#1)(2008-10#1)
(ng l(-1))##2##2##(2008-10#2)
(ng ml(-1))##2##2##(2008-10#2)
(ng##7##1##(2008-10#7)
(ng/ml)##2##1##(2008-10#2)
(nidus##2##1##(1995-11#1)(2008-7#1)
(nine out of 20)##2##4##(2008-5#2)
(nine##10##1##(1994-3#1)(2008-10#2)(2008-5#3)(2008-7#3)(2011-10#1)
(nit) mutant of##2##3##(2008-10#2)
(nit) mutants##3##2##(2008-10#3)
(nit)##8##1##(2008-10#8)
(nitrate##2##1##(2008-11#1)(2010-4#1)
(nitric and##2##2##(2008-10#2)
(nitric##3##1##(2008-10#2)(2010-9#1)
(nitrogen##2##1##(2008-10#1)(2008-8#1)
(no symptoms##2##2##(2008-10#2)
(no##39##1##(1990-11#2)(1990-5#1)(1990-6#2)(1991-12#1)(1992-4#1)(1992-9#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#2)(2009-11#1)(2010-5#1)(2012-8#1)(2013-1#3)(2013-8#2)
(nominal##2##1##(2008-10#1)(2008-5#1)
(nominal)##2##1##(2008-11#1)(2008-2#1)
(non-freezing water)##2##2##(1995-11#1)(2008-5#1)
(nonideal##2##1##(2008-2#1)(2008-3#1)
(nonparametric)##2##1##(2007-12#1)(2008-10#1)
(normal less than##2##3##(2012-3#2)
(normal range##4##2##(1993-3#2)(1994-11#2)
(normal##20##1##(1993-3#2)(1994-11#2)(1994-3#1)(1994-6#1)(1995-5#1)(1997-3#1)(2007-10#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
(normal)##2##1##(2012-2#1)(2013-1#1)
(normalized to##2##2##(1994-8#1)(2008-3#1)
(normalized##5##1##(1994-8#1)(2008-10#1)(2008-3#2)(2011-2#1)
(northeast##2##1##(1996-12#1)(2008-10#1)
(northern##6##1##(1992-8#1)(2008-10#2)(2008-4#2)(2013-1#1)
(not a##2##2##(2008-10#2)
(not in the##2##3##(2008-10#2)
(not including##2##2##(2008-1#1)(2008-8#1)
(not statistically##2##2##(1994-8#1)(2013-1#1)
(not the##2##2##(1997-1#1)(2008-3#1)
(not##32##1##(1991-7#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
(now called##2##2##(1996-3#1)(2008-1#1)
(now##4##1##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
(np-BNR)##2##1##(2008-10#2)
(ns =##2##2##(1993-6#2)
(nt##5##1##(1995-2#1)(1995-8#4)
(nt) and##5##2##(1993-12#1)(1993-2#2)(2008-8#2)
(nt) differences##2##2##(1991-6#1)(1993-6#1)
(nt) sequence##17##2##(1990-11#2)(1991-6#2)(1991-7#1)(1993-12#5)(1993-2#1)(1994-12#2)(1997-4#2)(1997-7#1)(2008-10#1)
(nt)##50##1##(1990-11#2)(1990-5#1)(1991-6#5)(1991-7#1)(1991-9#1)(1993-12#8)(1993-2#5)(1993-3#1)(1993-6#5)(1994-12#5)(1994-9#1)(1995-8#1)(1997-4#4)(1997-7#1)(2008-10#6)(2008-8#2)(2013-1#1)
(nu(0) =##2##2##(2008-3#2)
(nuclear##3##1##(2008-9#1)(2009-8#1)(2013-1#1)
(nucleotide##2##1##(1995-6#1)(2007-6#1)
(nucleotides##5##1##(1995-6#1)(2008-10#2)(2008-8#2)
(number of seeds##3##3##(2008-9#2)(2009-12#1)
(number of##23##2##(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)
(number per##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
(number##27##1##(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)
(n = 7)##2##1##(2011-2#2)
(n = 53)##3##1##(2012-2#3)
(o##4##1##(1991-5#1)(2008-10#3)
(o)##2##1##(1995-11#1)(2008-3#1)
(o-NPOE)##7##1##(2008-10#7)
(o-hydroxyphenyl)##2##1##(2008-10#2)
(o/w) emulsions##2##2##(2008-5#2)
(o/w)##4##1##(2008-11#1)(2008-5#3)
(oak)##2##1##(2008-10#1)(2008-8#1)
(oasis)##2##1##(2008-2#2)
(obesity)##2##1##(1997-4#1)(2008-11#1)
(objects)##2##1##(2007-12#1)(2008-10#1)
(obtained in##2##2##(2011-2#1)(2012-8#1)
(obtained##3##1##(1994-8#1)(2011-2#1)(2012-8#1)
(odds ratio (OR) =##3##4##(1992-10#1)(2008-4#1)(2011-1#1)
(odds ratio (OR)##5##3##(1992-10#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#1)
(odds ratio 0##2##3##(2010-6#1)(2012-3#1)
(odds ratio 1##3##3##(2007-10#1)(2012-3#1)(2013-1#1)
(odds ratio 2##2##3##(2007-10#1)(2011-1#1)
(odds ratio 3##4##3##(1991-8#1)(2007-10#1)(2011-1#1)(2011-2#1)
(odds ratio 4##2##3##(1990-6#1)(2012-3#1)
(odds ratio =##3##3##(2008-3#2)(2013-8#1)
(odds ratio [OR] =##2##4##(2008-3#1)(2010-10#1)
(odds ratio [OR]##3##3##(2008-3#1)(2010-10#1)(2011-2#1)
(odds ratio##36##2##(1990-6#1)(1991-8#1)(1992-10#1)(1994-3#2)(2006-10#2)(2007-10#4)(2007-2#1)(2008-1#2)(2008-3#4)(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
(odds##37##1##(1990-6#1)(1991-8#1)(1992-10#1)(1994-3#2)(2006-10#2)(2007-10#4)(2007-2#1)(2008-1#2)(2008-3#4)(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
(of the order of##2##4##(1995-12#1)(2008-3#1)
(of the##3##2##(1995-12#1)(2007-2#1)(2008-3#1)
(of##24##1##(1990-6#1)(1992-7#1)(1993-6#1)(1995-12#2)(1995-2#1)(1996-5#1)(1996-7#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
(off New Zealand)##2##3##(2011-2#2)
(off-pump coronary artery bypass##2##4##(2007-8#1)(2008-10#1)
(off-pump##3##1##(2007-8#1)(2008-10#2)
(often referred to as##3##4##(2008-4#1)(2008-7#1)(2009-5#1)
(often##8##1##(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2013-1#1)
(oil##3##1##(2008-10#2)(2008-5#1)
(oil)##4##1##(2008-10#3)(2008-5#1)
(omega 35##2##2##(1997-2#2)
(omega##4##1##(1997-2#3)(2008-9#1)
(on a scale of 0 to##2##6##(2010-6#1)(2010-8#1)
(on a##4##2##(2008-4#1)(2010-12#1)(2010-6#1)(2010-8#1)
(on the order of##2##4##(1995-3#1)(2008-3#1)
(on the##7##2##(1992-6#1)(1993-3#1)(1995-3#1)(2007-11#1)(2008-3#1)(2008-8#1)(2013-7#1)
(on##22##1##(1992-6#1)(1993-3#1)(1994-1#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-7#1)
(one isolate)##3##2##(2008-10#3)
(one of the##2##3##(2008-10#1)(2008-9#1)
(one of##5##2##(2008-10#4)(2008-9#1)
(one or##2##2##(1990-6#1)(2008-10#1)
(one vs##3##2##(2007-8#2)(2008-11#1)
(one##57##1##(1990-5#1)(1990-6#2)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(2007-11#1)(2007-8#2)(2008-1#4)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#1)
(one- and two-stage)##2##3##(2008-6#2)
(one-step##2##1##(2008-10#1)(2008-11#1)
(one-way ANOVA##2##2##(2007-8#1)(2012-3#1)
(ones##2##1##(2008-4#1)(2008-8#1)
(onion)##2##1##(1993-12#1)(2008-10#1)
(only##16##1##(1991-12#2)(1993-12#1)(1993-8#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#3)(2011-2#1)(2012-2#1)
(open and closed##2##3##(2009-9#1)(2012-12#1)
(open##4##1##(2008-10#2)(2009-9#1)(2012-12#1)
(operating##2##1##(1991-6#1)(2008-10#1)
(optical##4##1##(2007-11#1)(2011-1#2)(2012-2#1)
(optimum concentration of##2##3##(1994-12#2)
(optimum##3##1##(1994-12#2)(2008-10#1)
(or &quot##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
(or a##2##2##(2008-3#2)
(or by##2##2##(1993-8#1)(2008-2#1)
(or have##2##2##(2008-10#1)(2012-2#1)
(or more)##3##2##(2008-8#1)(2012-1#1)(2012-2#1)
(or not)##2##2##(2007-12#1)(2012-2#1)
(or other##2##2##(1992-12#1)(2012-3#1)
(or oxygen)##2##2##(1993-8#1)(2008-10#1)
(or sample)##2##2##(2008-10#2)
(or the##4##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
(or with##2##2##(2006-10#1)(2012-12#1)
(or##189##1##(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#10)(2008-5#5)(2008-7#8)(2008-8#7)(2008-9#3)(2009-12#1)(2009-3#1)(2009-7#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#1)
(oral and topical) can be more effective in##2##8##(2008-5#2)
(oral##6##1##(1990-12#1)(2008-11#1)(2008-5#2)(2009-5#2)
(order##2##1##(2008-8#1)(2010-3#1)
(organic##3##1##(1990-8#1)(1991-9#1)(2008-10#1)
(oriC)##2##1##(1990-11#1)(1994-12#1)
(original##2##1##(1996-2#1)(2013-8#1)
(originating from##2##2##(2009-9#1)(2012-5#1)
(osteoblastic##2##1##(2007-11#2)
(osteocalcin##2##1##(2008-7#1)(2012-1#1)
(our##2##1##(2008-10#1)(2009-4#1)
(out of##8##2##(1990-2#1)(1992-8#1)(2008-10#6)
(output##2##1##(2008-10#1)(2008-3#1)
(over##19##1##(1991-12#1)(1994-12#1)(1994-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-3#1)
(overall##9##1##(1992-6#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
(overall)##4##1##(2008-10#1)(2010-12#1)(2013-1#2)
(overnight##2##1##(2011-1#1)(2011-2#1)
(oxidative##2##1##(2008-10#1)(2009-6#1)
(p &gt##29##2##(1993-3#1)(2008-10#1)(2008-12#5)(2008-5#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#2)(2011-1#3)(2011-2#4)(2012-2#2)(2013-8#2)
(p &lt##349##2##(1991-12#2)(1992-12#1)(1993-1#1)(1993-11#6)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#8)(1994-2#3)(1994-3#8)(1994-6#6)(1994-9#1)(1995-12#6)(1995-3#5)(1995-5#2)(1996-1#2)(1996-11#2)(1996-5#4)(1996-8#4)(1997-1#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#11)(2007-10#1)(2007-11#4)(2007-7#10)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#12)(2008-12#24)(2008-3#19)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#1)(2008-8#2)(2008-9#8)(2009-1#2)(2009-12#3)(2009-5#6)(2009-6#5)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#5)(2010-3#2)(2010-4#4)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#16)(2011-2#26)(2012-12#2)(2012-2#15)(2012-3#1)(2013-1#22)(2013-8#23)
(p = 0##189##3##(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#4)(1993-1#5)(1993-11#3)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#3)(1997-5#2)(1997-6#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#7)(2008-10#7)(2008-11#2)(2008-12#8)(2008-3#7)(2008-5#7)(2008-7#14)(2008-8#2)(2008-9#8)(2009-10#1)(2009-8#3)(2010-6#3)(2010-8#6)(2010-9#3)(2011-1#2)(2011-2#41)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#16)
(p =##211##2##(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#4)(1993-1#5)(1993-11#3)(1993-2#1)(1994-12#2)(1994-9#1)(1995-3#1)(1996-2#1)(1996-9#3)(1997-2#3)(1997-5#2)(1997-6#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#7)(2008-10#7)(2008-11#5)(2008-12#10)(2008-3#11)(2008-5#7)(2008-7#14)(2008-8#2)(2008-9#8)(2009-10#1)(2009-8#3)(2010-10#2)(2010-6#3)(2010-8#6)(2010-9#3)(2011-1#2)(2011-2#43)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#18)
(p for##3##2##(1993-9#1)(2010-11#1)(2013-1#1)
(p less than 0##57##4##(1990-12#4)(1990-2#8)(1990-3#2)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#7)(1992-12#1)(1992-2#5)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#2)(1994-1#4)(1994-3#1)(1995-1#1)
(p less than##63##3##(1990-12#4)(1990-2#8)(1990-3#2)(1990-6#2)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#7)(1992-12#1)(1992-2#5)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#2)(1993-2#5)(1994-1#4)(1994-3#1)(1995-1#1)
(p value &lt##2##3##(2007-7#1)(2008-9#1)
(p value d0##2##3##(2009-3#2)
(p value##5##2##(2007-7#1)(2008-9#1)(2009-3#2)(2013-8#1)
(p ・・0##6##2##(2011-2#6)
(p##684##1##(1990-12#4)(1990-2#8)(1990-3#2)(1990-6#2)(1990-9#2)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#4)(1991-8#7)(1991-9#7)(1992-12#2)(1992-2#5)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#8)(1993-11#9)(1993-2#7)(1993-3#5)(1993-6#1)(1993-9#2)(1994-1#4)(1994-11#8)(1994-12#2)(1994-2#3)(1994-3#9)(1994-6#6)(1994-9#2)(1995-1#1)(1995-12#6)(1995-3#6)(1995-5#2)(1996-1#2)(1996-11#2)(1996-2#1)(1996-5#4)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#3)(1997-4#5)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#2)(2006-10#11)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#11)(2007-8#4)(2008-1#9)(2008-10#23)(2008-11#17)(2008-12#39)(2008-3#32)(2008-4#3)(2008-5#18)(2008-6#6)(2008-7#19)(2008-8#4)(2008-9#17)(2009-1#2)(2009-10#1)(2009-12#3)(2009-3#2)(2009-5#6)(2009-6#6)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#4)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#21)(2011-2#80)(2012-12#5)(2012-2#21)(2012-3#3)(2013-1#34)(2013-7#3)(2013-8#44)
(p&gt##27##1##(2008-12#4)(2008-5#4)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#8)(2013-7#1)
(p&lt##205##1##(1994-12#2)(1995-4#2)(1996-3#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#11)(2008-10#16)(2008-11#4)(2008-12#19)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-12#4)(2009-2#2)(2009-9#1)(2010-12#9)(2010-3#3)(2010-4#11)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-2#14)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#34)(2013-7#8)(2013-8#2)
(p)##2##1##(1993-11#1)(2008-10#1)
(p-benzoquinone##2##1##(2008-10#2)
(p27(Kip1)##2##1##(2008-10#1)(2011-2#1)
(p53##2##1##(2008-4#1)(2012-1#1)
(p53) that##2##2##(2008-10#1)(2008-7#1)
(p75)##2##1##(1995-2#1)(1996-12#1)
(p= 0##5##2##(2008-8#2)(2011-2#3)
(p=##7##1##(2008-1#1)(2008-5#1)(2008-8#2)(2011-2#3)
(p=&lt##3##1##(2008-10#1)(2008-4#1)(2011-1#1)
(p=0##100##1##(1994-7#1)(2006-8#5)(2007-2#3)(2007-7#4)(2008-1#5)(2008-10#17)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#9)(2008-7#12)(2008-8#3)(2008-9#1)(2009-6#2)(2010-3#1)(2011-1#6)(2011-2#3)(2012-12#7)(2012-2#1)(2012-3#5)(2013-1#7)
(pA2##3##1##(1995-12#3)
(pH 1##8##2##(1996-5#2)(2008-10#6)
(pH 10##8##2##(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#5)
(pH 2##16##2##(1994-8#1)(1995-3#1)(1996-5#1)(2008-10#11)(2010-3#1)(2012-12#1)
(pH 3##12##2##(2008-10#9)(2008-9#1)(2010-5#1)(2011-1#1)
(pH 4##20##2##(1990-9#1)(1991-12#1)(2008-10#17)(2008-3#1)
(pH 4)##2##2##(2008-10#1)(2010-4#1)
(pH 5##12##2##(2008-10#9)(2008-12#1)(2009-11#1)(2010-3#1)
(pH 5)##3##2##(1991-8#1)(2008-10#2)
(pH 6##19##2##(1990-11#1)(1991-12#1)(1994-8#1)(2008-10#15)(2008-4#1)
(pH 6)##2##2##(2008-10#2)
(pH 7##40##2##(1990-2#1)(1990-8#1)(1992-10#1)(1994-3#1)(1995-5#2)(1995-6#1)(1997-4#1)(2008-10#27)(2009-11#1)(2010-5#2)(2013-1#1)(2013-8#1)
(pH 7)##6##2##(2008-10#4)(2010-7#2)
(pH 8##14##2##(1995-5#1)(1996-5#2)(1997-2#1)(2008-10#9)(2008-11#1)
(pH 9##11##2##(1994-9#1)(1996-5#2)(2008-10#8)
(pH 9)##2##2##(2008-10#1)(2011-1#1)
(pH = 5##2##3##(2008-5#2)
(pH =##4##2##(2008-10#1)(2008-5#2)(2009-11#1)
(pH and##3##2##(2008-10#2)(2010-4#1)
(pH##220##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-8#1)(1994-3#1)(1994-8#3)(1994-9#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-5#8)(1997-2#1)(1997-4#2)(2008-10#156)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-11#4)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(pH&gt##2##1##(2008-10#2)
(pH&lt##4##1##(2008-10#4)
(pH)##4##1##(2008-10#3)(2008-4#1)
(pH=3##3##1##(2008-10#3)
(pH=5##2##1##(2008-10#2)
(pI 4##6##2##(1990-8#2)(1991-8#1)(1993-8#1)(1994-11#1)(2008-10#1)
(pI 5##5##2##(1990-8#1)(1992-3#4)
(pI##14##1##(1990-5#1)(1990-8#3)(1991-8#1)(1992-3#4)(1993-8#1)(1994-11#2)(1995-6#1)(2008-10#1)
(pIC50##2##1##(1994-11#2)
(pIND9)##2##1##(2008-10#2)
(pK(a)) of##3##2##(2008-10#3)
(pMHC##2##1##(2013-8#2)
(pO(2)) in the##2##3##(2008-11#2)
(pRB)##2##1##(1995-2#1)(2008-11#1)
(pTRKH1##2##1##(1993-12#2)
(packed##3##1##(2008-10#3)
(pain##4##1##(1992-12#1)(2008-7#1)(2010-11#1)(2010-12#1)
(pancreatic##2##1##(1993-9#1)(2013-1#1)
(paper##2##1##(2008-10#1)(2008-4#1)
(paracetamol)##2##1##(1991-9#1)(2008-10#1)
(parent##2##1##(2008-10#1)(2010-1#1)
(part 1)##2##2##(2007-8#1)(2013-8#1)
(part I)##2##2##(2007-11#1)(2008-2#1)
(part##6##1##(1995-2#1)(2007-11#1)(2007-8#1)(2008-2#2)(2013-8#1)
(partial least-squares##2##2##(2008-10#2)
(partial##6##1##(2007-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
(partially resistant)##2##2##(2008-10#2)
(partially##3##1##(2008-10#2)(2009-4#1)
(partially)##3##1##(1991-2#1)(1996-5#1)(2007-11#1)
(particularly in##4##2##(1991-1#1)(2008-4#1)(2008-6#1)(2012-12#1)
(particularly the##2##2##(1996-11#1)(2008-5#1)
(particularly those##2##2##(2008-9#1)(2012-3#1)
(particularly##16##1##(1991-1#1)(1991-2#1)(1996-1#1)(1996-11#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
(parts in 10(9)##2##3##(2008-2#1)(2008-3#1)
(parts in##7##2##(2008-2#1)(2008-3#6)
(parts per billion by##2##4##(2008-10#1)(2008-3#1)
(parts##9##1##(2008-10#1)(2008-2#1)(2008-3#7)
(passive##3##1##(1993-12#1)(1994-5#1)(2008-11#1)
(paste##2##1##(2008-10#2)
(patency##2##1##(1994-11#2)
(pathologic##2##1##(1991-2#1)(2012-3#1)
(patient##4##1##(1996-5#1)(2007-11#1)(2007-2#1)(2008-2#1)
(patients whose height##2##3##(2011-1#2)
(patients whose##3##2##(2011-1#2)(2012-12#1)
(patients##9##1##(1995-5#3)(2006-10#1)(2007-8#1)(2009-9#1)(2011-1#2)(2012-12#1)
(pcbAB##2##1##(2011-1#2)
(peak at -1##2##3##(2008-10#2)
(peak height)##3##2##(2008-10#3)
(peak to##2##2##(2008-10#1)(2008-3#1)
(peak##9##1##(2008-10#8)(2008-3#1)
(peak-to-peak##2##1##(2008-10#1)(2008-2#1)
(pedicle##2##1##(2008-8#1)(2012-12#1)
(pelvic##2##1##(1996-3#1)(2008-12#1)
(peptide##2##1##(2008-9#2)
(per strand)##2##2##(1993-11#2)
(per##10##1##(1993-11#2)(1993-6#2)(1994-12#1)(2008-10#3)(2012-5#1)(2013-8#1)
(perceived##2##1##(2007-12#1)(2009-7#1)
(percent of##3##2##(2009-11#3)
(percent##6##1##(2008-10#3)(2009-11#3)
(percentage of##3##2##(1994-7#1)(2008-10#1)(2008-3#1)
(percentage##5##1##(1994-7#1)(2008-10#3)(2008-3#1)
(performed##2##1##(2007-12#1)(2011-1#1)
(period##6##1##(1993-8#1)(2007-12#2)(2008-3#1)(2010-8#2)
(peripheral##2##1##(1994-12#1)(2008-4#1)
(peritoneal##3##1##(1992-5#1)(1995-12#1)(2012-3#1)
(peroxisome proliferator-activated##2##2##(2008-3#1)(2008-5#1)
(peroxisome##3##1##(2006-8#1)(2008-3#1)(2008-5#1)
(pesta)##2##1##(2008-10#2)
(petroleum##2##1##(2008-11#1)(2011-1#1)
(pf)##2##1##(1993-12#1)(1997-9#1)
(pharaonis hRblue)##2##2##(1994-5#2)
(pharaonis##3##1##(1994-5#3)
(phase I##3##2##(2008-8#2)(2011-2#1)
(phase##11##1##(1991-3#2)(1995-12#1)(2008-11#1)(2008-3#1)(2008-8#4)(2010-12#1)(2011-2#1)
(phases##3##1##(2008-10#1)(2009-12#2)
(phen)##7##1##(1996-2#1)(2008-10#6)
(phenol)##2##1##(1992-8#1)(2008-10#1)
(phenotype class##3##2##(2008-10#3)
(phenyl##2##1##(1990-8#1)(2007-11#1)
(phi = 0##2##3##(1991-11#1)(2008-2#1)
(phi =##3##2##(1991-11#1)(2008-2#2)
(phi##4##1##(1991-11#1)(2008-2#3)
(phi(STAT) =##2##2##(2008-10#2)
(phi)##2##1##(2008-10#1)(2008-3#1)
(phosphate##4##1##(1997-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
(phyB)##2##1##(1993-8#2)
(phylum##2##1##(2011-2#1)(2013-1#1)
(physical##7##1##(1996-8#1)(2007-11#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
(physiological##5##1##(1996-2#1)(2008-10#2)(2011-2#1)(2013-8#1)
(pi)##4##1##(1997-7#1)(2008-10#1)(2008-8#1)(2010-8#1)
(pig)##3##1##(1992-8#2)(2008-10#1)
(placebo##3##1##(1992-5#1)(2008-7#1)(2011-2#1)
(placebo)##3##1##(1991-12#1)(2008-10#1)(2008-3#1)
(plane##2##1##(2008-10#1)(2008-3#1)
(plant##9##1##(1991-7#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)
(plasma##4##1##(1992-3#1)(2008-10#2)(2009-8#1)
(plasmodiophorids)##2##1##(2012-2#2)
(point##3##1##(2008-10#2)(2008-3#1)
(point)##2##1##(2007-8#1)(2012-2#1)
(polh)##2##1##(1997-4#2)
(poly##2##1##(2008-10#2)
(poly)ammonium##2##1##(2008-10#2)
(polyethylene##2##1##(2008-10#1)(2012-1#1)
(pooled##2##1##(2008-8#2)
(poor##2##1##(1997-3#1)(2012-12#1)
(population##9##1##(1994-5#1)(1996-11#3)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
(position##3##1##(1992-9#1)(2008-10#2)
(positions##2##1##(1991-12#1)(2008-10#1)
(positive control##3##2##(2008-10#2)(2013-1#1)
(positive##15##1##(1990-12#1)(1990-2#2)(1990-6#1)(1994-9#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)(2010-4#1)(2013-1#2)
(positive)##3##1##(1993-9#2)(2008-5#1)
(possibly with##2##2##(2008-3#1)(2011-2#1)
(possibly##6##1##(1992-6#1)(1993-1#1)(1997-6#1)(2008-3#2)(2011-2#1)
(postoperative)##2##1##(1991-6#1)(2011-2#1)
(potassium##5##1##(2008-10#4)(2008-2#1)
(potential##3##1##(2008-10#1)(2008-5#1)(2009-6#1)
(ppb) were##2##2##(2008-10#1)(2008-3#1)
(ppb)##6##1##(2008-10#2)(2008-2#2)(2008-3#2)
(ppm)##4##1##(2008-10#1)(2008-3#3)
(ppoFEV1) calculated##2##2##(2007-8#2)
(pre##2##1##(1996-2#1)(2010-7#1)
(pre-test N = 70 and post-test N =##2##8##(1994-1#2)
(precision##3##1##(2008-10#3)
(preconcentration factor##2##2##(2008-10#2)
(preconcentration##3##1##(2008-10#3)
(predator exposure)##2##2##(2008-11#1)(2008-7#1)
(predicted##4##1##(1993-2#1)(2008-10#2)(2008-5#1)
(predominantly##5##1##(1991-11#1)(1993-12#1)(1995-9#1)(1996-12#1)(2008-7#1)
(preferably##2##1##(2008-3#2)
(prenatal##2##1##(1991-11#1)(2010-7#1)
(prepared##4##1##(1993-11#1)(2008-10#2)(2008-5#1)
(presence of##6##2##(1993-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
(present##2##1##(2008-6#1)(2010-10#1)
(presenting##2##1##(1996-9#1)(2013-7#1)
(presumably##3##1##(1991-11#1)(1994-8#1)(2008-8#1)
(prevalence##3##1##(1997-3#1)(2011-1#1)(2013-1#1)
(previous##2##1##(2008-5#1)(2008-9#1)
(previously##2##1##(2008-10#2)
(primarily##4##1##(1994-3#1)(2008-10#2)(2012-2#1)
(primary and##2##2##(2008-7#1)(2013-1#1)
(primary##12##1##(1992-6#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#2)(2013-1#1)
(primary)##4##1##(1991-8#1)(2007-12#1)(2007-7#1)(2013-1#1)
(prior to##2##2##(2008-10#1)(2013-1#1)
(prior)##2##1##(1997-4#1)(2008-2#1)
(private versus##2##2##(2008-10#1)(2008-12#1)
(private##3##1##(1997-5#1)(2008-10#1)(2008-12#1)
(proE375--&gt##3##1##(1994-5#3)
(probability##2##1##(1996-4#1)(2008-10#1)
(probably##3##1##(1990-5#1)(2008-4#1)(2009-7#1)
(procedure##2##1##(2008-10#2)
(produced by##5##2##(1991-5#1)(1993-6#1)(1996-12#1)(2011-2#1)(2013-1#1)
(product concentration##2##2##(1996-12#1)(2013-1#1)
(programmed cell death)##5##3##(1993-2#1)(1993-9#1)(1994-11#1)(1995-8#1)(2009-11#1)
(proliferation##2##1##(2008-10#1)(2008-5#1)
(pronounced##2##1##(2008-1#1)(2010-4#1)
(proportion of##6##2##(2008-10#4)(2008-5#1)(2008-8#1)
(protein##6##1##(1993-8#2)(1994-9#1)(2008-10#1)(2008-7#1)(2009-2#1)
(provided##2##1##(1992-3#1)(2008-3#1)
(providing##2##1##(2011-2#1)(2013-1#1)
(proximal##3##1##(1995-10#1)(2008-7#1)(2009-8#1)
(ps &lt##3##2##(2010-2#3)
(psi)##3##1##(1990-8#1)(1993-8#1)(2011-2#1)
(pth)##3##1##(1994-12#1)(2008-10#2)
(pulmonary##2##1##(2010-8#1)(2012-2#1)
(pulse##6##1##(2007-11#1)(2007-12#3)(2008-10#1)(2009-5#1)
(pulsed##2##1##(2007-11#1)(2008-10#1)
(pummelo##2##1##(2008-10#1)(2008-5#1)
(pure##4##1##(2008-10#3)(2013-8#1)
(putative##2##1##(2008-10#2)
(putative)##2##1##(2008-10#1)(2011-1#1)
(putrescine##4##1##(1991-5#1)(1994-9#1)(2008-10#1)(2009-8#1)
(pvd-inaZ)##6##1##(2008-10#6)
(pyrrolo[2##3##1##(2008-4#3)
(pz =##2##2##(1996-2#2)
(p &lt##5##1##(2013-1#2)(2013-8#3)
(p = 0##19##1##(2012-12#2)(2012-5#6)(2013-8#11)
(p &lt##3##1##(2011-2#2)(2012-2#1)
(p = 0##2##1##(2012-2#2)
(p &lt##18##1##(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#10)(2013-7#1)
(p = 0##7##1##(2011-2#2)(2012-12#2)(2012-2#2)(2012-7#1)
(q##3##1##(2008-10#2)(2008-11#1)
(qPCR)##6##1##(2008-4#1)(2009-6#2)(2012-3#1)(2013-8#2)
(quadratic##3##1##(1993-5#1)(2008-10#1)(2013-8#1)
(quality of##4##2##(1993-2#1)(1995-8#1)(2008-11#1)(2008-7#1)
(qv)##2##1##(2008-5#2)
(r &gt##2##2##(2008-10#1)(2011-1#1)
(r (2) = 0##2##4##(2008-10#1)(2008-9#1)
(r = -##2##3##(2010-9#1)(2012-3#1)
(r = -0##46##3##(1991-2#1)(1991-3#1)(1992-9#1)(1993-2#5)(1994-5#1)(1995-11#3)(1995-8#3)(1996-12#1)(2008-1#5)(2008-10#7)(2008-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#8)
(r = 0##120##3##(1990-2#1)(1990-3#2)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#5)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#3)(1994-6#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#6)(1996-12#1)(1996-2#1)(1997-6#3)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#7)(2011-1#2)(2011-2#7)(2011-3#1)(2012-3#2)(2013-1#10)(2013-8#1)
(r =##171##2##(1990-2#1)(1990-3#2)(1990-7#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-2#6)(1993-8#1)(1994-12#1)(1994-5#4)(1994-6#3)(1995-11#5)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#9)(1996-12#2)(1996-2#1)(1997-6#3)(2008-1#6)(2008-10#33)(2008-11#3)(2008-12#2)(2008-3#5)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-4#8)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#18)(2013-8#1)
(r##190##1##(1990-2#1)(1990-3#2)(1990-7#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#6)(1993-8#1)(1994-12#1)(1994-5#4)(1994-6#3)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-8#9)(1996-12#2)(1996-2#1)(1997-6#3)(2008-1#6)(2008-10#39)(2008-11#4)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2010-2#1)(2010-4#8)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#19)(2013-8#1)
(r&gt##9##1##(2008-10#9)
(r(2) &gt##2##2##(2008-10#1)(2009-8#1)
(r(2) = 0##23##3##(2008-10#16)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)
(r(2)##29##1##(2007-11#1)(2008-10#18)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-8#1)(2012-1#1)
(r(2)&gt##2##1##(2008-10#1)(2008-11#1)
(r(2)) of##2##2##(2008-10#2)
(r(2))##3##1##(2008-10#3)
(r(2)=0##18##1##(2008-10#14)(2010-4#4)
(r) and R##3##3##(2008-10#3)
(r) and##5##2##(2008-10#5)
(r) between##2##2##(2008-10#1)(2008-9#1)
(r) protein##2##2##(1991-6#1)(2008-11#1)
(r)##21##1##(1991-6#1)(1993-8#1)(1994-8#1)(2008-10#14)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
(r))##2##1##(2008-10#1)(2008-11#1)
(r2 = 0##7##3##(1995-11#1)(1997-2#1)(2008-5#5)
(r= 0##3##2##(1997-6#1)(2008-10#1)(2012-3#1)
(r=-0##9##1##(2008-7#2)(2011-1#4)(2013-1#1)(2013-7#2)
(r=0##59##1##(2007-8#1)(2008-10#39)(2008-6#1)(2008-7#4)(2011-1#5)(2012-12#2)(2013-7#7)
(rDNA) and the##2##3##(2008-10#2)
(rDNA)##10##1##(1995-8#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#1)
(rFIA)##2##1##(2008-10#2)
(rGGCGAGCC)2##3##1##(1993-11#3)
(rIL-2)##2##1##(1990-12#1)(1991-8#1)
(rTMS)##10##1##(2008-12#1)(2008-9#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#2)
(rTNF-alpha)##2##1##(1991-12#1)(1994-8#1)
(race##8##1##(2008-10#8)
(races##2##1##(2008-10#2)
(radiation##3##1##(1997-4#1)(2008-11#1)(2008-3#1)
(radical##3##1##(1990-12#1)(2008-10#1)(2010-11#1)
(radius##2##1##(2008-3#1)(2010-4#1)
(random##4##1##(2007-12#1)(2008-10#1)(2008-8#1)(2013-8#1)
(range 0##8##2##(1990-6#1)(1993-10#1)(1993-11#1)(1995-5#1)(1996-2#1)(2008-12#1)(2011-1#1)(2012-2#1)
(range 1-10##2##2##(1995-5#1)(2013-8#1)
(range 1-16)##2##2##(1992-8#1)(2013-1#1)
(range 2##4##2##(1992-8#1)(2008-4#1)(2008-9#1)(2012-12#1)
(range 3##3##2##(2008-1#1)(2008-6#1)(2008-8#1)
(range 4##3##2##(2007-8#1)(2008-8#1)(2012-3#1)
(range 5##3##2##(2008-10#2)(2012-2#1)
(range from##4##2##(2007-7#1)(2008-1#1)(2008-10#2)
(range of##5##2##(2008-1#4)(2008-7#1)
(range##236##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-6#2)(1990-8#2)(1991-2#5)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#3)(1992-12#1)(1992-2#4)(1992-5#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#2)(1993-2#2)(1993-9#3)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#2)(2007-11#3)(2007-5#1)(2007-7#9)(2007-8#17)(2008-1#15)(2008-10#7)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#11)(2008-7#5)(2008-8#5)(2008-9#16)(2009-10#4)(2009-3#3)(2009-8#4)(2010-1#1)(2010-12#2)(2010-3#4)(2010-6#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#7)(2013-1#14)(2013-8#7)
(range)##6##1##(1992-3#1)(1993-12#1)(1994-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
(ranged from##2##2##(2008-10#1)(2009-8#1)
(ranging from 0##3##3##(2008-10#2)(2013-1#1)
(ranging from 30 to##4##4##(2008-10#4)
(ranging from 5##3##3##(1991-2#1)(1994-5#1)(2008-10#1)
(ranging from##20##2##(1991-2#1)(1994-5#1)(1997-7#2)(2007-10#1)(2008-10#9)(2008-3#2)(2009-7#1)(2010-3#1)(2013-1#2)
(ranging##21##1##(1991-2#1)(1994-5#1)(1997-7#2)(2007-10#1)(2008-10#10)(2008-3#2)(2009-7#1)(2010-3#1)(2013-1#2)
(rapid##2##1##(1994-12#1)(2010-1#1)
(rat##9##1##(1992-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-8#1)
(rat) nM for the##2##4##(1994-3#2)
(rat)##7##1##(1992-11#1)(1992-8#2)(1993-12#1)(1994-3#2)(2008-10#1)
(rate##3##1##(1991-11#1)(1993-9#1)(2008-9#1)
(rather than a##2##3##(2007-12#1)(2008-10#1)
(rather than the##3##3##(1994-5#1)(2008-3#2)
(rather than##15##2##(1994-5#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-4#1)(2013-1#1)(2013-8#1)
(raw##6##1##(2008-10#4)(2009-4#1)(2010-2#1)
(re-) coarctation##3##2##(2007-8#3)
(re-)##4##1##(1997-4#1)(2007-8#3)
(reactive##3##1##(1996-11#1)(2008-10#2)
(reading##2##1##(1996-3#1)(2012-3#1)
(real##2##1##(2008-10#2)
(recent##2##1##(1995-6#1)(2013-8#1)
(receptor##2##1##(1995-11#1)(2008-5#1)
(recombinant##2##1##(1992-9#1)(1994-6#1)
(recommended##7##1##(2008-10#7)
(recoveries##7##1##(2008-10#7)
(recovery##5##1##(1992-11#1)(1996-5#1)(2008-10#2)(2009-8#1)
(red light)##2##2##(2013-1#2)
(red##6##1##(2008-2#1)(2008-8#1)(2013-1#2)(2013-8#2)
(redox##2##1##(2008-10#2)
(reduced##4##1##(1996-2#1)(2007-6#1)(2008-10#2)
(reduction##2##1##(2008-10#1)(2009-7#1)
(ref##7##1##(1990-5#2)(1991-2#1)(1993-9#2)(1995-8#2)
(reference##6##1##(1990-8#1)(1993-3#1)(1996-12#1)(2007-7#1)(2008-10#1)(2012-2#1)
(reference)##3##1##(2008-1#1)(2008-3#1)(2011-2#1)
(referred to as##4##3##(2007-12#1)(2008-10#1)(2008-9#2)
(referred to here as##3##4##(1994-2#1)(2008-3#1)(2008-4#1)
(referred to##11##2##(1994-2#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#2)(2013-8#1)
(referred##12##1##(1994-2#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2013-8#1)
(reflectance##2##1##(2007-12#1)(2008-10#1)
(reflux##2##1##(1996-5#1)(2011-3#1)
(refs##5##1##(1990-5#3)(1991-2#2)
(regression##2##1##(2007-12#1)(2008-10#1)
(regulatory##2##1##(2008-1#1)(2009-6#1)
(reinforced)##2##1##(2008-11#1)(2008-7#1)
(related##2##1##(2008-3#1)(2008-7#1)
(relative decrease##2##2##(1991-8#2)
(relative humidity##2##2##(2008-10#2)
(relative increase##2##2##(1991-8#2)
(relative mobility##2##2##(1991-12#2)
(relative risk =##2##3##(1991-2#1)(2008-1#1)
(relative risk##3##2##(1991-2#1)(1997-3#1)(2008-1#1)
(relative standard deviation (R##3##4##(2008-10#3)
(relative standard deviation##9##3##(2008-10#8)(2013-1#1)
(relative standard deviation)##4##3##(2008-10#3)(2008-12#1)
(relative standard##14##2##(2008-10#12)(2008-12#1)(2013-1#1)
(relative to the##4##3##(2008-10#1)(2008-8#2)(2012-2#1)
(relative to##10##2##(1993-12#1)(1994-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2012-2#1)
(relative##44##1##(1990-2#1)(1991-12#2)(1991-2#1)(1991-8#4)(1993-12#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-7#1)(2012-2#1)(2013-1#2)
(relatively##3##1##(1991-5#1)(2008-11#2)
(release##2##1##(1990-7#1)(1994-3#1)
(removal of##2##2##(1996-2#1)(2013-1#1)
(renal##4##1##(2007-12#1)(2007-8#2)(2013-1#1)
(rep-PCR) was##2##2##(2008-10#2)
(rep-PCR)##12##1##(2008-10#12)
(repeat##2##1##(2008-10#1)(2008-6#1)
(repeatability##2##1##(2008-10#2)
(repeatability)##3##1##(2008-10#2)(2009-1#1)
(repo)##2##1##(2007-12#2)
(reported##2##1##(1995-12#1)(2010-1#1)
(representing about##2##2##(2007-8#1)(2012-12#1)
(representing##6##1##(1990-12#1)(1993-8#1)(1995-2#1)(2007-8#1)(2008-8#1)(2012-12#1)
(reproducibility##2##1##(2008-10#2)
(required##3##1##(1997-7#1)(2008-8#2)
(requiring##3##1##(1994-3#1)(2007-11#1)(2010-8#1)
(residue##4##1##(1997-6#2)(1997-8#1)(2008-7#1)
(residues##30##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-5#5)(1993-8#1)(1995-2#1)(1995-5#5)(1995-6#3)(1996-5#1)(1997-3#3)(1997-9#1)(2008-9#4)(2009-7#1)(2012-2#1)
(resistant to##8##2##(1996-12#1)(2008-10#5)(2008-4#1)(2011-3#1)
(resistant##10##1##(1996-12#1)(2008-10#6)(2008-4#1)(2010-8#1)(2011-3#1)
(resistant) and##3##2##(2008-10#3)
(resistant) were inoculated##2##3##(2008-10#2)
(resistant)##9##1##(2007-6#1)(2008-10#8)
(resistant/susceptible)##2##1##(2008-10#2)
(resolution##3##1##(1992-8#1)(2008-3#1)(2011-1#1)
(resolutions##2##1##(2008-3#2)
(resp##4##1##(2008-8#4)
(respectively p = 0##2##4##(2007-11#1)(2007-7#1)
(respectively##5##1##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-3#1)
(respectively)##2##1##(1990-7#1)(2013-1#1)
(respiratory##2##1##(2008-7#1)(2013-1#1)
(response rate##11##2##(1991-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-2#1)(2011-2#4)(2013-1#1)
(response rates##2##2##(2007-10#1)(2009-4#1)
(response##14##1##(1991-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2011-2#4)(2013-1#1)
(rest##4##1##(1991-8#2)(2010-12#1)(2011-2#1)
(restriction##2##1##(2008-10#1)(2013-1#1)
(resulting in an increase in##2##5##(1993-3#1)(2007-12#1)
(retardation##2##1##(1991-6#1)(2010-3#1)
(retention time##2##2##(2008-10#2)
(retention##3##1##(1994-2#1)(2008-10#2)
(reversal of##2##2##(1991-8#1)(2008-8#1)
(reverse##6##1##(1992-12#1)(1992-9#1)(1995-6#1)(2008-10#1)(2008-7#1)(2011-3#1)
(reviewed in##2##2##(2008-8#1)(2008-9#1)
(revised##2##1##(2008-10#1)(2010-2#1)
(rhizosphere##2##1##(2008-10#2)
(rho = 0##3##3##(1994-11#1)(1996-12#2)
(rho##4##1##(1994-11#1)(1994-8#1)(1996-12#2)
(rho)##2##1##(2008-10#2)
(ribosomal##2##1##(1993-12#1)(1995-8#1)
(rice##2##1##(1997-4#1)(2008-10#1)
(rice)##2##1##(2008-10#1)(2008-9#1)
(right##14##1##(1990-11#1)(1991-5#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-4#1)(2010-8#1)(2012-12#4)(2013-1#1)
(river##7##1##(2008-10#6)(2008-5#1)
(rms)##4##1##(1992-4#1)(1995-5#1)(2008-2#1)(2008-3#1)
(room##3##1##(1996-12#1)(2008-11#1)(2013-1#1)
(root##2##1##(2008-10#1)(2008-7#1)
(rotenone##3##1##(1995-11#1)(1996-5#1)(2011-1#1)
(roughness##2##1##(2008-3#1)(2009-7#1)
(route##2##1##(2008-3#2)
(rs3173798##2##1##(2010-2#2)
(rt-PA)##3##1##(1991-6#1)(2007-10#1)(2008-7#1)
(rutile)##2##1##(2008-10#1)(2008-5#1)
(r = 0##10##1##(2012-4#3)(2012-5#3)(2012-7#2)(2013-1#2)
(r = 0##2##1##(2011-2#1)(2012-1#1)
(s##3##1##(1996-2#1)(2011-2#1)(2011-3#1)
(s(r)=0##2##1##(2008-10#2)
(s)##4##1##(1994-12#1)(2008-12#2)(2008-7#1)
(s/n=3)##4##1##(2008-10#4)
(s=+/-0##2##1##(2008-10#2)
(sICAM-1)##2##1##(1993-8#2)
(sIg)##2##1##(1990-12#1)(2008-4#1)
(sRBC)##2##1##(1993-12#1)(2008-10#1)
(salicylic acid##2##2##(2008-10#2)
(salicylic##3##1##(2008-10#3)
(saline##3##1##(1994-2#1)(2008-10#1)(2013-1#1)
(salt##4##1##(1995-5#1)(2008-9#3)
(same##2##1##(2008-5#1)(2011-1#1)
(sample and##3##2##(2008-10#3)
(sample of##2##2##(2009-12#2)
(sample pH##2##2##(2008-10#2)
(sample volume##3##2##(2008-10#3)
(sample##13##1##(2008-10#11)(2009-12#2)
(samples)##2##1##(2008-10#2)
(sampling##3##1##(2008-10#3)
(saturated##5##1##(2008-10#4)(2013-1#1)
(sc)##3##1##(1994-6#1)(1997-3#1)(2008-10#1)
(scFv) antibodies##2##2##(2008-10#1)(2010-12#1)
(scFv)##8##1##(2008-10#4)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)
(scFvs)##5##1##(2008-10#4)(2008-4#1)
(screening)##3##1##(1993-2#1)(2008-10#1)(2013-1#1)
(sd)##2##1##(2011-1#1)(2011-2#1)
(sd=0##4##1##(2011-2#4)
(sea##7##1##(1995-5#1)(2008-10#2)(2008-7#1)(2011-2#3)
(second##8##1##(1992-5#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)
(secondary##7##1##(1990-6#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
(secreting##2##1##(2009-4#2)
(section##3##1##(1992-8#1)(2008-10#1)(2008-3#1)
(sedentary##2##1##(1992-3#1)(2013-1#1)
(see Basic Protocol##2##3##(2008-4#2)
(see RFN##3##2##(1996-5#2)(1997-2#1)
(see##27##1##(1992-8#1)(1994-5#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-4#7)(2008-9#1)(2009-5#2)(2010-7#1)(2012-3#6)(2013-8#2)
(seed##2##1##(2008-8#2)
(selective##4##1##(1993-12#1)(2007-8#2)(2008-7#1)
(self-broadening##2##1##(2008-2#2)
(semantic##2##1##(2009-2#1)(2011-2#1)
(sensitivity 0##2##2##(1993-2#1)(2011-2#1)
(sensitivity 60##2##2##(1997-8#2)
(sensitivity 77##2##2##(1997-8#1)(2011-1#1)
(sensitivity##16##1##(1991-4#1)(1992-3#3)(1993-2#1)(1997-8#3)(2008-10#2)(2011-1#5)(2011-2#1)
(sensitized with##2##2##(1990-12#2)
(sensu lato)##2##2##(2008-10#1)(2008-6#1)
(sensu##3##1##(2008-10#2)(2008-6#1)
(sequence##2##1##(1992-9#1)(2008-9#1)
(serine##3##1##(1997-4#1)(2008-4#1)(2011-2#1)
(serotonin and##2##2##(1991-5#1)(2008-4#1)
(serotonin##5##1##(1990-5#1)(1991-5#1)(1993-12#1)(2008-4#1)(2012-3#1)
(serotype A)##2##2##(1991-12#1)(2010-7#1)
(serotype##4##1##(1991-12#1)(2008-7#2)(2010-7#1)
(serovar##2##1##(2012-2#2)
(serum and##2##2##(2008-10#2)
(serum##6##1##(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-2#1)
(serum) and##2##2##(2008-10#2)
(serum)##3##1##(2008-10#3)
(seven##9##1##(1994-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
(severe##2##1##(1990-5#1)(2008-10#1)
(sex ratio##2##2##(2007-8#1)(2013-7#1)
(sex##6##1##(1993-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2013-7#1)
(sexual##2##1##(1993-12#1)(2011-1#1)
(short stature##2##2##(2008-7#1)(2013-1#1)
(short##10##1##(1990-3#1)(1997-3#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2013-1#1)
(short-term##2##1##(2008-10#1)(2008-7#1)
(shorter##2##1##(2008-6#1)(2013-1#1)
(sigma)##2##1##(2008-10#1)(2008-3#1)
(sigmoid##3##1##(2008-10#1)(2010-8#2)
(signal to noise ratio = 2)##2##6##(2008-10#2)
(signal to noise ratio##3##4##(2008-10#3)
(signal to noise ratio=2) and the linearity is maintained in the concentration range 0##2##14##(2008-10#2)
(signal to noise ratio=2)##3##4##(2008-10#3)
(signal to noise##6##3##(2008-10#6)
(signal##11##1##(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2009-3#1)
(signal)##4##1##(1994-8#1)(2007-11#1)(2007-12#2)
(signal-to-noise ratio = 3)##2##4##(1990-8#1)(2008-10#1)
(signal-to-noise ratio of##2##3##(2008-3#2)
(signal-to-noise ratio##7##2##(1990-8#1)(2008-10#3)(2008-3#3)
(signal-to-noise ratio=3)##2##2##(2008-10#2)
(signal-to-noise##10##1##(1990-8#1)(2008-10#6)(2008-3#3)
(signaling##2##1##(2012-2#1)(2013-8#1)
(significant##3##1##(2008-1#1)(2008-10#1)(2008-12#1)
(silicon##2##1##(2008-10#1)(2010-5#1)
(silver##2##1##(2008-10#1)(2008-3#1)
(simple##2##1##(2008-10#1)(2008-7#1)
(simulating##2##1##(2008-3#1)(2008-8#1)
(simultaneous##2##1##(1996-6#1)(2008-10#1)
(simultaneously##2##1##(1997-7#1)(2008-2#1)
(since##6##1##(1990-8#1)(1992-9#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
(single nucleotide polymorphism)##2##3##(2010-10#1)(2012-12#1)
(single##13##1##(1991-2#1)(1994-6#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2012-12#1)(2013-8#1)
(six species)##2##2##(2007-5#1)(2013-7#1)
(six##17##1##(1991-8#1)(1994-9#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#2)(2011-2#2)(2013-7#1)
(size and##2##2##(2008-5#1)(2011-2#1)
(size##5##1##(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
(skin##6##1##(1997-3#1)(2007-8#1)(2008-5#3)(2012-3#1)
(sl)##2##1##(1994-12#1)(2008-5#1)
(slope##4##1##(1996-5#1)(2008-10#3)
(small##11##1##(1994-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-9#1)
(smooth and##2##2##(2008-10#1)(2008-5#1)
(snRNP)##2##1##(1991-6#1)(2007-12#1)
(so called##2##2##(2007-7#1)(2011-2#1)
(social##2##1##(1995-5#1)(2008-11#1)
(sodium azide and##2##3##(1995-11#1)(2008-11#1)
(sodium salt of##2##3##(2008-10#2)
(sodium##18##1##(1994-2#1)(1995-11#1)(1995-6#1)(1996-2#1)(2007-8#1)(2008-10#8)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
(soft##3##1##(1995-3#1)(2007-12#1)(2008-10#1)
(soil##2##1##(2008-10#2)
(solid phase##2##2##(2008-10#2)
(solid##5##1##(1994-12#1)(2008-10#3)(2008-5#1)
(soluble##3##1##(1996-5#1)(2008-10#1)(2010-5#1)
(solute##3##1##(1995-3#1)(2008-7#2)
(solvent##5##1##(1990-8#1)(2008-10#2)(2011-1#2)
(some##4##1##(2008-11#1)(2008-8#1)(2009-10#1)(2009-8#1)
(sometimes##3##1##(2007-8#1)(2008-6#1)(2010-11#1)
(soon##2##1##(1994-3#1)(2008-4#1)
(source##2##1##(2008-10#1)(2008-3#1)
(south##2##1##(2008-12#1)(2008-5#1)
(southern##2##1##(2008-10#1)(2008-3#1)
(space group##3##2##(1995-2#1)(1997-7#1)(2008-10#1)
(space##4##1##(1995-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
(spatial##6##1##(1993-3#1)(1993-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
(special##2##1##(2008-10#1)(2008-4#1)
(specially##2##1##(2008-10#1)(2008-8#1)
(species##4##1##(2008-10#2)(2008-8#2)
(specific activity##2##2##(1994-5#1)(2008-10#1)
(specific##5##1##(1994-5#1)(2008-10#4)
(specifically##4##1##(1996-1#1)(2008-3#1)(2008-4#1)(2011-2#1)
(spectral##3##1##(2008-3#2)(2008-5#1)
(spike##2##1##(2008-10#1)(2009-8#1)
(spiral)##2##1##(2008-3#1)(2008-6#1)
(spontaneous##2##1##(1997-7#1)(2008-11#1)
(spores per##2##2##(2008-10#2)
(spray##2##1##(2008-10#2)
(spring##6##1##(2008-10#4)(2008-5#1)(2008-8#1)
(squamous cell##2##2##(1992-2#1)(2008-5#1)
(ss) DNA##3##2##(1997-2#1)(2008-1#1)(2008-2#1)
(ss) and##2##2##(2008-10#2)
(ss)##5##1##(1997-2#1)(2008-1#1)(2008-10#2)(2008-2#1)
(ssDNA)##8##1##(1991-5#1)(1995-2#1)(2008-10#4)(2008-7#1)(2012-3#1)
(stage 1)##2##2##(2008-10#1)(2008-11#1)
(stage e)##2##2##(2008-7#2)
(stage##15##1##(1991-3#1)(1991-7#1)(2008-10#3)(2008-11#2)(2008-7#5)(2011-2#2)(2012-2#1)
(stages##2##1##(2008-10#2)
(standard deviation##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2010-3#1)
(standard error of##3##3##(2007-12#2)(2008-10#1)
(standard##14##1##(1996-12#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
(state##2##1##(1994-8#2)
(static##2##1##(1992-12#1)(2008-11#1)
(static)##2##1##(2008-3#1)(2013-1#1)
(statins)##3##1##(1991-6#1)(2008-1#1)(2011-1#1)
(statistical significance at##2##3##(1995-8#2)
(statistical##3##1##(1995-8#2)(2007-11#1)
(steady##2##1##(1995-3#1)(2012-2#1)
(steroids##2##1##(2006-10#1)(2007-11#1)
(still##2##1##(2007-12#1)(2009-4#1)
(stock##2##1##(2007-6#1)(2008-8#1)
(straight##2##1##(2008-9#1)(2011-2#1)
(strain 7)##2##2##(2008-5#2)
(strain rate##2##2##(2012-2#2)
(strain##20##1##(1990-7#1)(1991-9#1)(1993-11#1)(1994-3#1)(1997-3#1)(2008-10#6)(2008-5#3)(2008-7#2)(2009-2#1)(2011-2#1)(2012-2#2)
(strains##5##1##(2008-10#4)(2008-5#1)
(stress##2##1##(2008-2#1)(2009-5#1)
(strong##5##1##(1997-5#1)(2008-10#3)(2008-11#1)
(strong)##2##1##(1996-2#1)(2010-3#1)
(strongly##3##1##(2008-11#1)(2008-3#1)(2009-8#1)
(structured##2##1##(2010-8#2)
(study##4##1##(2008-10#1)(2011-1#1)(2013-1#2)
(subfascial)##2##1##(1990-12#2)
(subfrontal approach) versus##2##3##(2011-2#2)
(subgroup II)##4##2##(2008-10#4)
(subgroup##11##1##(1992-3#1)(2007-6#1)(2008-10#7)(2011-1#2)
(substance##3##1##(1994-2#1)(2008-11#1)(2012-3#1)
(substrate##5##1##(2007-10#1)(2010-11#4)
(success rate##2##2##(2008-6#1)(2011-1#1)
(such as a##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
(such as the##9##3##(1995-3#1)(1996-11#1)(1996-12#1)(2007-12#3)(2008-10#1)(2008-9#1)(2012-2#1)
(such as those##3##3##(1996-12#1)(2006-12#1)(2010-1#1)
(such as##73##2##(1990-11#1)(1990-8#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#4)(1997-2#3)(2006-12#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
(sucrose)##2##1##(2008-10#1)(2012-2#1)
(sudden##2##1##(1995-12#1)(2011-2#1)
(suitable for##2##2##(2008-11#1)(2008-4#1)
(sum of##5##2##(1997-7#3)(2008-10#1)(2009-12#1)
(sunken##2##1##(2008-10#1)(2011-2#1)
(supplement)##5##1##(1996-12#2)(1996-2#1)(1996-6#2)
(suppressor of##2##2##(1997-8#1)(2009-6#1)
(surface##2##1##(2008-10#1)(2008-12#1)
(surfactants)##2##1##(2008-10#1)(2008-5#1)
(surgery##2##1##(1995-8#1)(2009-4#1)
(surgical##5##1##(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
(survival##2##1##(2008-12#1)(2011-2#1)
(survival)##2##1##(1995-2#1)(2009-6#1)
(susceptible##5##1##(2008-10#5)
(susceptible) and##4##2##(2008-10#3)(2011-2#1)
(susceptible) were##2##2##(2008-10#2)
(susceptible) x##2##2##(2008-10#2)
(susceptible)##12##1##(2008-10#11)(2011-2#1)
(sweet##2##1##(2008-10#1)(2008-5#1)
(symptoms##2##1##(1996-9#1)(2013-7#1)
(syn##10##1##(2008-10#6)(2008-11#1)(2011-1#3)
(synonym##2##1##(2008-10#2)
(synonymous with##2##2##(2008-10#1)(2008-7#1)
(systematic##2##1##(2011-1#1)(2012-12#1)
(systemic##3##1##(1995-5#1)(2008-7#1)(2011-2#1)
(systemic)##2##1##(2008-9#1)(2011-1#1)
(systole##2##1##(2008-10#2)
(systolic##2##1##(2008-1#1)(2011-2#1)
(systolic)##2##1##(2008-4#1)(2010-4#1)
(t = 2##4##3##(1990-12#3)(1996-12#1)
(t =##7##2##(1990-12#3)(1993-2#1)(1996-12#2)(2013-8#1)
(t##11##1##(1990-12#3)(1993-2#1)(1996-12#2)(2008-10#4)(2013-8#1)
(t(1/2)##2##1##(1995-8#1)(2008-10#1)
(t(50%)##2##1##(2010-3#2)
(t(m))##2##1##(2008-10#2)
(t(max))##2##1##(2008-12#1)(2010-8#1)
(t)##5##1##(1995-2#1)(2008-10#2)(2008-2#1)(2008-9#1)
(t-PA) for##2##2##(2007-10#1)(2007-9#1)
(t-PA)##6##1##(1994-3#1)(1995-8#1)(2007-10#1)(2007-9#1)(2008-11#2)
(t-test##2##1##(2008-10#1)(2008-3#1)
(t1/2 =##7##2##(1992-8#5)(1993-1#1)(1996-1#1)
(t1/2##15##1##(1991-5#1)(1992-8#5)(1993-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-1#1)
(t1/2)##2##1##(2012-12#1)(2012-3#1)
(t=-3##2##1##(2008-11#1)(2010-6#1)
(t=-4##3##1##(2010-6#3)
(t=4##3##1##(2008-11#2)(2010-6#1)
(tPA) were##2##2##(2008-10#1)(2008-11#1)
(tPA)##6##1##(1992-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)
(tR =##2##2##(1997-2#2)
(tablets and##4##2##(2008-10#4)
(tablets)##4##1##(2008-10#4)
(taken as##3##2##(2008-10#2)(2009-8#1)
(taken##4##1##(2008-10#2)(2008-7#1)(2009-8#1)
(tap##4##1##(2008-10#4)
(target##5##1##(1993-6#1)(1994-12#1)(2007-10#1)(2008-8#1)(2011-1#1)
(target)##3##1##(1995-5#1)(2008-10#1)(2008-4#1)
(targeted##2##1##(2008-6#1)(2012-12#1)
(tau =##4##2##(1995-5#1)(1996-1#1)(2008-2#2)
(tau##8##1##(1991-12#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-5#2)(2008-2#2)
(tea##2##1##(2008-10#2)
(technical##3##1##(1996-2#1)(2008-9#2)
(teleomorph##14##1##(2008-10#13)(2008-8#1)
(temperature and##2##2##(1997-6#1)(2008-10#1)
(temperature##10##1##(1996-12#1)(1997-6#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)
(temperatures##2##1##(2008-10#1)(2008-5#1)
(temporal##2##1##(1993-5#1)(2008-7#1)
(ten##4##1##(2008-10#2)(2008-5#1)(2011-2#1)
(tentatively##2##1##(1993-11#1)(2008-10#1)
(termed##8##1##(1992-8#1)(1995-3#2)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#2)
(tested##2##1##(1995-11#1)(2008-11#1)
(tetanus##2##1##(2008-7#1)(2010-8#1)
(tetra##2##1##(1990-12#1)(2008-10#1)
(tetracycline##2##1##(2008-10#2)
(text##2##1##(2008-12#1)(2010-8#1)
(that activates##2##2##(2010-10#2)
(that is##8##2##(1992-9#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-2#1)
(that##17##1##(1991-3#1)(1992-9#1)(1995-3#1)(1997-8#1)(2008-10#4)(2008-4#2)(2008-7#1)(2009-2#1)(2009-5#1)(2010-10#2)(2013-1#2)
(the &quot##11##2##(1995-3#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-8#4)
(the Michaelis constant##3##3##(2008-10#3)
(the Netherlands)##2##2##(2008-10#2)
(the among-group component of##2##4##(2008-8#2)
(the average delta delta Gu value is##2##7##(1992-6#2)
(the average##4##2##(1992-6#2)(2008-3#2)
(the causative agent of##2##4##(2011-2#2)
(the first##2##2##(1991-12#1)(2012-2#1)
(the latter is##2##3##(2006-10#1)(2007-12#1)
(the latter##5##2##(2006-10#1)(2007-12#1)(2008-10#1)(2012-12#2)
(the length##2##2##(2011-3#1)(2012-3#1)
(the major##2##2##(1990-2#1)(2008-10#1)
(the maximum##2##2##(1997-4#1)(2008-12#1)
(the mean##2##2##(2008-7#1)(2012-2#1)
(the most common##2##3##(2010-4#1)(2013-8#1)
(the most##8##2##(1995-5#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
(the number of##6##3##(1997-5#1)(2008-10#3)(2009-12#1)(2013-7#1)
(the primary##2##2##(2008-7#2)
(the range of C2##2##4##(2007-12#2)
(the range##3##2##(2007-12#2)(2008-10#1)
(the ratio of the##3##4##(1990-11#1)(2008-1#1)(2008-3#1)
(the ratio of##4##3##(1990-11#1)(2008-1#1)(2008-3#1)(2008-5#1)
(the so-called##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
(the standard##2##2##(2007-11#1)(2008-10#1)
(the type of##2##3##(1990-5#1)(2007-11#1)
(the##319##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#10)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#4)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#9)(2007-7#2)(2008-1#3)(2008-10#58)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#18)(2008-9#8)(2009-11#1)(2009-12#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#7)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#7)(2013-7#4)(2013-8#7)
(thermogravimetry##2##1##(2007-11#1)(2008-10#1)
(theta =##2##2##(2008-10#2)
(theta##7##1##(1990-5#1)(1995-5#2)(2007-12#1)(2008-10#2)(2008-11#1)
(theta)##5##1##(1993-12#1)(1997-5#1)(2008-10#2)(2008-12#1)
(thickness##2##1##(2008-2#1)(2010-4#1)
(third##4##1##(1993-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
(this##3##1##(1993-8#1)(2009-9#1)(2011-2#1)
(those##7##1##(1990-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-1#1)
(though##3##1##(1993-3#1)(2008-10#1)(2009-9#1)
(three cases)##2##2##(2008-5#1)(2011-2#1)
(three isolates)##3##2##(2008-10#3)
(three times##2##2##(1990-8#1)(2008-10#1)
(three##23##1##(1990-11#1)(1990-8#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
(three)##2##1##(1996-12#2)
(through the##2##2##(2008-7#1)(2011-2#1)
(through##8##1##(1992-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
(thus##4##1##(1991-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
(time 0)##2##2##(2008-5#2)
(time from##3##2##(1990-12#2)(2008-10#1)
(time peak##2##2##(2008-7#2)
(time##15##1##(1990-12#2)(1991-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#2)(2010-8#1)(2011-2#1)(2013-8#1)
(time-place)##2##1##(2008-8#2)
(tissue##2##1##(1990-5#1)(2011-2#1)
(tissue)##2##1##(2007-12#1)(2010-10#1)
(to approx##2##2##(1994-8#2)
(to be##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
(to our knowledge)##2##3##(2008-2#1)(2008-3#1)
(to the##7##2##(1996-5#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
(to within##2##2##(2008-2#1)(2008-3#1)
(to##40##1##(1990-2#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#2)(1996-5#2)(1997-1#1)(1997-8#2)(2006-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
(tobacco)##2##1##(2008-10#2)
(together with the##2##3##(2008-3#1)(2008-4#1)
(together with##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
(toluene)##2##1##(2008-10#2)
(too##3##1##(2007-5#1)(2008-8#2)
(total and##2##2##(2008-12#1)(2008-7#1)
(total dose##6##2##(1990-2#1)(1991-11#1)(1992-12#1)(1995-3#1)(2007-7#1)(2008-7#1)
(total hip replacement)##2##3##(2007-11#2)
(total phenolics##2##2##(2013-1#2)
(total##34##1##(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#2)(2007-11#3)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-1#1)(2010-8#1)(2012-12#1)(2013-1#4)(2013-7#1)
(tox-I)##2##1##(2008-10#2)
(tox-S) and##2##2##(2008-10#2)
(traditional##3##1##(1994-3#1)(2008-1#1)(2008-10#1)
(transepidermal water loss##2##3##(2008-5#2)
(transient receptor potential)##2##3##(1996-12#1)(2013-1#1)
(transmission##2##1##(2008-10#2)
(trapped by##2##2##(1995-5#2)
(treated with##2##2##(2008-12#1)(2011-2#1)
(treatment##4##1##(2008-5#4)
(treatment)##4##1##(2008-12#1)(2008-4#1)(2013-1#2)
(trend##2##1##(2009-9#1)(2011-1#1)
(trisomy##2##1##(1995-8#1)(1997-4#1)
(ts) mutants##2##2##(1995-9#1)(2008-10#1)
(ts)##4##1##(1994-12#1)(1995-9#1)(2008-10#2)
(tsp)##12##1##(1991-6#1)(1991-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-11#1)
(tumor##2##1##(1990-10#1)(1994-11#1)
(tumour##2##1##(2007-5#1)(2008-2#1)
(twice##2##1##(2008-12#1)(2011-3#1)
(two cases)##4##2##(1996-12#1)(2008-5#2)(2011-2#1)
(two orders of magnitude##2##4##(2008-6#1)(2011-1#1)
(two patients)##2##2##(1997-4#1)(2008-7#1)
(two proteins##2##2##(1990-11#2)
(two species)##2##2##(2007-5#1)(2013-7#1)
(two##49##1##(1990-11#2)(1990-5#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#12)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2009-12#1)(2011-1#1)(2011-2#3)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
(type 1##2##2##(1993-2#1)(1995-12#1)
(type 2##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
(type A##2##2##(1991-8#1)(1997-6#1)
(type I and type II)##2##5##(1995-11#1)(2011-2#1)
(type I and##3##3##(1995-11#1)(2008-11#1)(2011-2#1)
(type I##5##2##(1995-11#1)(1996-2#1)(2008-11#1)(2011-2#2)
(type I) and##3##3##(1992-8#1)(2008-10#2)
(type I)##6##2##(1992-8#1)(1993-11#1)(1995-5#1)(2008-10#3)
(type II##4##2##(1996-2#1)(2008-10#1)(2010-8#1)(2011-2#1)
(type II)##5##2##(1990-6#1)(1992-8#1)(2008-10#3)
(type III##2##2##(2007-11#1)(2011-2#1)
(type##45##1##(1990-5#3)(1990-6#1)(1991-8#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-2#2)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#4)
(types##2##1##(2010-8#1)(2012-12#1)
(typical for##4##2##(2007-8#4)
(typical##8##1##(2007-8#4)(2008-10#3)(2012-4#1)
(typically 1##2##2##(2008-3#1)(2008-4#1)
(typically##11##1##(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)
(tyrosine##2##1##(2008-10#1)(2011-2#1)
(u##2##1##(2008-3#1)(2011-1#1)
(u-PA)##4##1##(1993-12#1)(1994-3#2)(2008-11#1)
(uPA) and##2##2##(1997-4#1)(2008-7#1)
(uPA)##5##1##(1990-12#1)(1992-6#1)(1997-4#1)(2008-11#1)(2008-7#1)
(un)dress of the mad poor##2##5##(2008-7#2)
(un)said about AIDS in##2##4##(2012-3#2)
(undamaged##2##1##(2007-10#1)(2011-2#1)
(under the##2##2##(1996-5#1)(2008-3#1)
(under##8##1##(1993-3#1)(1994-2#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2009-8#2)
(unilateral or bilateral)##2##3##(2008-12#1)(2013-1#1)
(until##2##1##(2012-9#1)(2013-7#1)
(untreated##2##1##(1991-5#1)(1993-12#1)
(untreated)##4##1##(1996-5#1)(1996-8#1)(2007-12#1)(2008-8#1)
(up to 1##6##3##(1992-3#1)(1997-4#1)(2008-10#3)(2013-8#1)
(up to 10##2##3##(2008-10#1)(2008-3#1)
(up to 100##2##3##(1992-9#1)(2010-4#1)
(up to 12##3##3##(1990-7#1)(1994-11#1)(2008-10#1)
(up to 20##2##3##(1997-2#1)(2006-10#1)
(up to 3##3##3##(1993-6#1)(2008-10#1)(2013-8#1)
(up to 30##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
(up to 4##2##3##(1995-5#1)(2008-10#1)
(up to 48##2##3##(2008-10#2)
(up to 50##2##3##(1993-12#1)(1995-2#1)
(up to about##2##3##(2009-8#2)
(up to approximately##2##3##(2008-7#2)
(up to##92##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#5)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#26)(2008-11#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#4)(2009-12#1)(2009-8#2)(2010-11#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
(up##93##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#5)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#26)(2008-11#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#4)(2009-12#1)(2009-8#2)(2010-11#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
(upper##3##1##(1990-7#1)(2008-12#1)(2010-12#1)
(upward##2##1##(2008-10#1)(2008-3#1)
(urban or rural)##2##3##(2007-8#1)(2008-10#1)
(urban##4##1##(1991-1#1)(2007-8#1)(2008-10#2)
(urine##3##1##(2008-10#3)
(urine)##2##1##(2008-10#2)
(use of##2##2##(2007-7#2)
(used as##3##2##(2008-10#3)
(used at##2##2##(1990-12#1)(1997-3#1)
(used for##3##2##(2008-10#2)(2008-6#1)
(used##9##1##(1990-12#1)(1994-8#1)(1997-3#1)(2008-10#5)(2008-6#1)
(using a##2##2##(1992-9#1)(2010-9#1)
(using the##2##2##(1991-12#2)
(using##27##1##(1991-12#2)(1992-9#1)(1997-4#1)(2007-10#1)(2007-6#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
(usually a##3##2##(1992-5#1)(2008-4#1)(2008-8#1)
(usually##14##1##(1992-5#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-9#1)
(usually)##2##1##(1994-3#1)(2012-3#1)
(v##4##1##(1992-1#1)(2007-12#1)(2008-10#2)
(v&quot##3##1##(2008-3#3)
(v)##17##1##(1992-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#9)(2008-5#1)(2008-9#2)(2013-7#1)
(v)M2 index is##2##3##(2007-11#2)
(v)M2 index##4##2##(2007-11#4)
(v/v) FBS##2##2##(2008-11#2)
(v/v) HNO(3)##6##2##(2008-10#6)
(v/v) Triton X-100##5##3##(2008-10#5)
(v/v) acetic acid##3##3##(2008-10#3)
(v/v) acetic##4##2##(2008-10#3)(2011-1#1)
(v/v) acetonitrile as##2##3##(2008-10#2)
(v/v) acetonitrile##3##2##(2008-10#3)
(v/v) and##3##2##(1996-5#1)(2008-10#1)(2013-1#1)
(v/v) concentrated hydrofluoric acid##2##4##(2008-10#2)
(v/v) content of methanol for##3##5##(2008-10#3)
(v/v) ethanol##5##2##(2008-10#4)(2008-6#1)
(v/v) in the##3##3##(2008-10#3)
(v/v) in##4##2##(2008-10#4)
(v/v) into the##2##3##(2008-10#2)
(v/v) methanol and##2##3##(1996-5#1)(2008-10#1)
(v/v) methanol##9##2##(1996-5#1)(2008-10#7)(2008-7#1)
(v/v) nitric acid##5##3##(2008-10#5)
(v/v) non-aqueous content##2##3##(2008-10#2)
(v/v) of##8##2##(2008-10#7)(2011-1#1)
(v/v) raw milk##2##3##(2008-10#2)
(v/v)##105##1##(1991-5#1)(1996-5#3)(2008-10#88)(2008-11#3)(2008-6#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-1#4)(2013-1#1)
(v/v)) as##2##2##(2008-10#2)
(v/v))##13##1##(2008-10#12)(2012-12#1)
(v? = 2)##2##3##(2008-2#2)
(v?##4##1##(2008-2#2)(2008-3#2)
(vWF)##5##1##(1993-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
(valence)##2##1##(2008-11#1)(2008-5#1)
(valid trials)##2##2##(2008-2#1)(2010-5#1)
(values##4##1##(2008-10#3)(2013-1#1)
(vanillin and##2##2##(2008-10#1)(2011-2#1)
(varepsilon=4##2##1##(2008-10#2)
(variation##2##1##(2008-10#2)
(varied##2##1##(2008-3#1)(2012-1#1)
(varphi##2##1##(2008-10#1)(2008-11#1)
(varying##2##1##(1993-6#1)(2008-10#1)
(vascular##3##1##(1991-9#1)(2008-10#1)(2010-6#1)
(vastus lateralis##2##2##(1996-5#1)(2011-2#1)
(ventricular##3##1##(1996-5#1)(2008-6#1)(2011-1#1)
(verapamil or##2##2##(1995-11#1)(2008-7#1)
(verapamil##4##1##(1994-9#1)(1995-11#1)(1996-5#1)(2008-7#1)
(version 3##2##2##(2008-10#1)(2012-12#1)
(version##5##1##(2008-10#1)(2008-9#1)(2012-12#2)(2013-1#1)
(versus Ag/AgCl reference electrode) detection potential (E(det)) for##2##8##(2008-10#2)
(versus Ag/AgCl reference electrode) oxidation potential (E(oxd)) for 70ms oxidation time (t(oxd)) and 250mV (versus Ag/AgCl reference electrode) reduction potentail (E(red)) for 400ms reactivation time (t(red))##2##26##(2008-10#2)
(versus Ag/AgCl reference electrode)##6##4##(2008-10#6)
(versus Ag/AgCl##9##2##(2008-10#9)
(versus Ag/AgCl)##13##2##(2008-10#13)
(versus SCE)##9##2##(2008-10#9)
(versus##43##1##(1995-12#1)(2007-12#1)(2008-10#38)(2008-9#1)(2009-8#2)
(very weak)##2##2##(1996-2#1)(2012-2#1)
(very##7##1##(1991-12#1)(1996-2#1)(2007-12#1)(2008-3#1)(2012-2#3)
(vi)##5##1##(1992-8#1)(1995-2#1)(2008-10#2)(2008-9#1)
(via##10##1##(1990-2#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-12#1)(2008-4#2)(2008-8#1)(2012-12#1)
(viable##2##1##(2008-11#2)
(view##2##1##(2012-2#2)
(vii)##3##1##(1992-8#1)(2008-10#1)(2008-9#1)
(visceral##2##1##(2008-7#1)(2013-1#1)
(vital##2##1##(2011-1#1)(2012-12#1)
(vitamin C##2##2##(2008-10#2)
(vitamin C)##5##2##(1992-9#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
(vitamin E)##2##2##(1992-9#1)(2008-12#1)
(vitamin##17##1##(1992-9#2)(1993-8#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2009-7#1)(2011-1#2)
(vitamins##4##1##(1997-7#1)(2008-5#3)
(viz##7##1##(2008-10#6)(2013-8#1)
(vol/vol)##7##1##(1995-2#1)(2008-10#6)
(volume##5##1##(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)
(vs##43##1##(1995-5#1)(2008-10#24)(2008-5#10)(2009-5#1)(2012-2#4)(2012-3#3)
(w##2##1##(1991-5#1)(2008-10#1)
(w) ?##2##2##(2008-2#2)
(w)##7##1##(2008-10#2)(2008-2#3)(2010-4#1)(2012-2#1)
(w/v) Ni##2##2##(2008-10#2)
(w/v) acetic acid##3##3##(2008-6#3)
(w/v) in##2##2##(2008-10#2)
(w/v) of##6##2##(2007-3#1)(2008-10#3)(2008-6#1)(2008-8#1)
(w/v)##39##1##(1990-2#1)(1996-5#1)(2007-3#1)(2008-10#21)(2008-11#2)(2008-6#11)(2008-8#1)(2013-1#1)
(w/w##2##1##(2008-10#1)(2008-6#1)
(w/w) FF##3##2##(2010-2#3)
(w/w) KOH at 60 degrees C for 30 min##2##9##(2008-6#2)
(w/w) KOH##3##2##(2008-6#3)
(w/w) and##5##2##(2008-10#5)
(w/w) by##2##2##(2008-10#2)
(w/w) exhibits##2##2##(2008-10#2)
(w/w) of PVC##2##3##(2008-10#2)
(w/w) of the##2##3##(2008-10#2)
(w/w) of##9##2##(2008-10#9)
(w/w) was##3##2##(2008-10#2)(2008-5#1)
(w/w) were found##2##3##(2008-10#2)
(w/w)##57##1##(1990-12#1)(1997-2#1)(2008-10#41)(2008-12#1)(2008-5#3)(2008-6#3)(2010-2#3)(2011-2#3)(2012-2#1)
(water##12##1##(1990-6#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-5#3)(2013-1#1)
(water)##3##1##(2008-10#1)(2008-5#1)(2008-7#1)
(wavelength##2##1##(1996-5#1)(2007-12#1)
(we call them##2##3##(2009-9#1)(2011-3#1)
(we call##3##2##(2009-9#1)(2011-3#1)(2013-8#1)
(we##5##1##(2008-3#1)(2008-9#1)(2009-9#1)(2011-3#1)(2013-8#1)
(weak##2##1##(2007-11#1)(2008-12#1)
(week##4##1##(2008-3#2)(2013-8#2)
(weeks##2##1##(1994-9#1)(2008-5#1)
(weight##4##1##(2008-10#1)(2008-12#2)(2008-6#1)
(western##2##1##(2008-10#1)(2008-4#1)
(wet##4##1##(1990-5#1)(1994-5#1)(1995-6#1)(2010-8#1)
(what##3##1##(1992-9#1)(2008-10#1)(2008-4#1)
(when the##2##2##(2008-3#1)(2008-6#1)
(when##14##1##(1992-3#1)(1993-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-4#1)
(where 1##3##2##(2008-10#1)(2008-2#2)
(where##22##1##(1991-8#1)(1993-12#1)(1995-2#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
(whether##3##1##(2008-1#1)(2008-11#1)(2012-3#1)
(which are##8##2##(1994-8#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
(which binds mAb##2##3##(1997-3#2)
(which can##2##2##(2008-10#1)(2008-4#1)
(which cleave##2##2##(2008-4#2)
(which constitute the major##2##4##(1997-8#2)
(which contains##3##2##(1990-5#1)(1991-5#1)(2008-2#1)
(which exhibits##3##2##(1992-3#1)(2008-10#2)
(which includes##2##2##(2008-3#1)(2013-1#1)
(which inhibits##2##2##(2008-10#2)
(which is a##2##3##(2008-10#1)(2008-3#1)
(which is##12##2##(1991-6#1)(1994-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
(which makes##2##2##(2008-10#2)
(which may##2##2##(2007-11#1)(2011-2#1)
(which secrete##5##2##(2008-1#5)
(which was##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
(which##88##1##(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#6)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-6#5)(2008-7#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-9#1)(2010-10#2)(2011-2#4)(2012-3#1)(2013-1#4)
(white##3##1##(2008-5#1)(2013-1#2)
(who showed a mean difference of##2##6##(2007-10#2)
(who were##2##2##(1994-3#1)(2009-7#1)
(who##8##1##(1994-3#1)(2007-10#2)(2008-11#1)(2008-4#2)(2009-7#2)
(whole milk powder##2##3##(2008-10#2)
(whole milk##3##2##(2008-10#3)
(whole##4##1##(2008-10#4)
(winter##3##1##(2008-10#2)(2011-2#1)
(with a##19##2##(1991-11#1)(1993-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
(with an##5##2##(2007-12#1)(2008-10#3)(2008-12#1)
(with and##2##2##(1997-5#1)(2008-10#1)
(with dynamics described by##2##4##(2008-8#2)
(with high##2##2##(1993-8#1)(2013-8#1)
(with no##3##2##(1991-4#1)(2008-10#2)
(with one##2##2##(2007-12#1)(2011-2#1)
(with or without##5##3##(1990-12#1)(1992-12#1)(1995-3#1)(2007-12#1)(2008-12#1)
(with respect to the##3##4##(1991-2#1)(2007-12#1)(2008-2#1)
(with slope of##2##3##(2008-10#2)
(with the##10##2##(1994-5#1)(2007-12#1)(2008-10#5)(2008-9#2)(2011-2#1)
(with##140##1##(1990-12#2)(1990-2#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#3)(1994-10#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-5#2)(2007-11#2)(2007-12#7)(2007-8#3)(2008-10#35)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#7)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#2)(2010-4#2)(2010-8#3)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#2)(2013-8#3)
(within 1##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
(within 2##2##2##(2008-10#1)(2010-5#1)
(within the##2##2##(2008-10#1)(2008-7#1)
(within##26##1##(1990-8#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-12#2)(2008-2#2)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
(within-day##2##1##(1992-11#1)(2008-10#1)
(without any##2##2##(2007-11#1)(2008-3#1)
(without the##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
(without##32##1##(1995-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
(working volume##2##2##(2008-11#2)
(working##6##1##(1993-3#1)(2008-10#1)(2008-11#3)(2008-9#1)
(wpi)##2##1##(2008-12#1)(2009-8#1)
(wt)##5##1##(1990-5#1)(1992-8#1)(1997-2#1)(1997-7#1)(2008-10#1)
(wt/vol)##3##1##(2008-10#3)
(wt/wt)##4##1##(2008-10#3)(2008-5#1)
(www##9##1##(2008-12#3)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
(x =##4##2##(1997-7#1)(2008-5#3)
(x##9##1##(1992-11#1)(1997-7#1)(2008-2#1)(2008-3#2)(2008-5#4)
(x)##5##1##(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-9#1)
(x1##2##1##(2008-5#2)
(x=0##2##1##(2007-12#1)(2012-2#1)
(y = 0##2##3##(1990-8#1)(2008-10#1)
(y =##6##2##(1990-8#2)(1994-8#1)(2008-10#1)(2008-3#2)
(y) and##2##2##(1994-8#1)(1995-2#1)
(y)##3##1##(1994-8#1)(1995-2#1)(2007-11#1)
(yeast##2##1##(2008-5#1)(2009-9#1)
(yield##2##1##(2008-10#1)(2008-8#1)
(young##2##1##(1995-3#1)(2008-7#1)
(young)##2##1##(1995-3#1)(1995-8#1)
(z = 2##2##3##(1993-12#1)(1995-8#1)
(z =##4##2##(1993-12#1)(1995-8#2)(2008-3#1)
(zero##8##1##(1991-5#1)(2008-10#4)(2008-2#1)(2010-5#2)
(zeta)##2##1##(1991-5#1)(1994-8#1)
(zolpidem##2##1##(2011-2#2)
(~0##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
(~1##2##1##(2009-3#1)(2010-11#1)
(~3##3##1##(2007-11#1)(2009-3#1)(2011-1#1)
(±0##2##1##(2011-2#1)(2013-1#1)
(±1##4##1##(2010-10#4)
(±3##3##1##(2010-10#3)
(ΔE=3##2##1##(2013-1#2)
(α##2##1##(2011-1#1)(2012-1#1)
(α=0##7##1##(2013-1#7)
(β = 0##3##3##(2011-2#3)
(β##4##1##(2011-2#3)(2013-1#1)
(β=0##3##1##(2012-1#3)
(λ##2##1##(2011-1#1)(2011-2#1)
(μ=0##2##1##(2010-10#2)
(π(i) = 0##2##3##(2012-3#2)
(χ(2) = 6##3##3##(2011-1#3)
(χ(2) =##5##2##(2011-1#5)
(χ(2)##6##1##(2011-1#6)
(∼15%)##2##1##(2013-1#2)
(∼300##2##1##(2013-1#2)
(∼50%##2##1##(2013-1#1)(2013-8#1)
) &lt##4##2##(2008-10#4)
) (Diptera##2##2##(2008-6#1)(2011-2#1)
) (Lepidoptera##3##2##(2008-12#1)(2011-2#2)
) 1##2##2##(1991-2#1)(2008-10#1)
) 30 min prior to MCAO significantly##2##7##(2011-2#2)
) 30 min prior to##3##5##(1993-12#1)(2011-2#2)
) 30 min##4##3##(1993-12#1)(2008-10#1)(2011-2#2)
) Bail##3##2##(2008-10#3)
) Baill##2##2##(2008-8#2)
) Lam##4##2##(2008-10#3)(2011-2#1)
) Merr##5##2##(2011-2#5)
) Millsp##2##2##(2008-10#1)(2010-3#1)
) Moench##2##2##(2006-11#1)(2008-11#1)
) Pits##2##2##(2008-10#1)(2013-1#1)
) Sesquipedalis subspecies##2##3##(2008-12#2)
) Sorok##2##2##(2008-6#2)
) The##7##2##(1990-3#1)(1992-6#1)(1994-5#1)(2008-10#2)(2008-3#2)
) This##2##2##(2008-10#1)(2008-2#1)
) Vuill##2##2##(2008-6#2)
) administration in##2##3##(1995-12#1)(2006-12#1)
) administration of substance P##2##5##(1992-3#1)(1994-8#1)
) administration of##4##3##(1992-3#1)(1994-8#1)(1996-2#2)
) administration##8##2##(1992-3#1)(1994-8#1)(1995-12#1)(1996-2#2)(2006-12#1)(2007-10#1)(2010-5#1)
) and a##3##3##(1997-2#1)(1997-4#1)(2011-2#1)
) and an##2##3##(1992-1#1)(2008-10#1)
) and cashew apple (Anacardium occidentale)##2##6##(2012-2#2)
) and in##2##3##(1997-7#1)(2008-10#1)
) and its##2##3##(2008-10#2)
) and relative standard error (R##2##6##(2008-10#2)
) and relative##3##3##(2008-10#3)
) and the selective 5-HT1A receptor##2##6##(1995-12#2)
) and the##10##3##(1990-6#1)(1992-2#1)(1995-12#2)(1996-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)
) and was##2##3##(2008-11#1)(2008-9#1)
) and##104##2##(1990-5#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#2)(1995-11#2)(1995-12#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#2)(2011-2#4)(2011-7#1)(2012-2#5)(2012-4#1)(2012-7#2)(2013-1#7)(2013-8#2)
) are discussed##2##3##(2008-11#1)(2009-3#1)
) are##10##2##(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#2)
) as a model##2##4##(2008-8#1)(2009-6#1)
) as a##4##3##(1992-12#2)(2008-8#1)(2009-6#1)
) as##9##2##(1992-12#2)(1994-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
) at##5##2##(1995-5#1)(1996-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
) better than##2##3##(2008-10#2)
) between##2##2##(1991-5#1)(2008-9#1)
) but##3##2##(1996-2#2)(2008-10#1)
) by the##2##3##(2008-10#2)
) by##6##2##(2008-10#4)(2008-6#1)(2008-9#1)
) can be##2##3##(2008-2#1)(2009-7#1)
) caused a##2##3##(1996-2#1)(1997-6#1)
) caused##3##2##(1996-2#1)(1997-6#1)(2008-10#1)
) column with methanol##2##4##(2008-10#2)
) column##4##2##(2008-10#3)(2008-4#1)
) cultivars##6##2##(2008-10#1)(2008-12#4)(2008-9#1)
) did not##2##3##(1995-12#1)(2013-8#1)
) dose dependently##2##3##(1990-5#1)(1995-12#1)
) for 10##2##3##(2008-10#1)(2011-2#1)
) for 11##2##3##(2008-10#2)
) for five replicates of a##2##6##(2008-10#2)
) for the##10##3##(1996-12#1)(2008-10#7)(2008-12#2)
) for##34##2##(1994-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#22)(2008-12#2)(2008-3#1)(2010-5#1)(2011-2#3)
) from the##2##3##(2008-10#1)(2012-2#1)
) from##7##2##(1997-1#1)(1997-4#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
) had##2##2##(1995-12#1)(2008-2#1)
) has been##4##3##(1990-9#1)(2008-1#1)(2008-10#1)(2008-7#1)
) has##7##2##(1990-6#1)(1990-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
) have been##2##3##(2009-11#1)(2010-1#1)
) in a##4##3##(1991-12#1)(2011-2#1)(2012-12#1)(2012-7#1)
) in the range 0##2##5##(2008-10#2)
) in the##6##3##(1991-9#1)(2008-10#2)(2008-4#1)(2011-1#1)(2013-1#1)
) in##28##2##(1991-12#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#1)
) induced##3##2##(1995-5#1)(1996-2#1)(1997-2#1)
) injection of##7##3##(1994-2#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-2#1)(2013-1#1)
) injection##8##2##(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-2#1)(2013-1#1)
) injections of##3##3##(1992-8#1)(1995-12#1)(1996-2#1)
) is 4##3##3##(2008-10#3)
) is a##2##3##(2010-6#1)(2011-1#1)
) is##11##2##(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
) less than 1%##2##4##(2008-10#2)
) longicornis##2##2##(2008-5#2)
) m(-2)##2##2##(2007-5#2)
) may comment by clicking on ABSTRACT on the issue's contents page##6##12##(2012-3#6)
) mice##2##2##(1997-4#1)(2008-10#1)
) obtained for##2##3##(2008-10#2)
) of 0##4##3##(1995-12#1)(2008-10#3)
) of 3##5##3##(2008-10#5)
) of As at##2##4##(2008-10#2)
) of the proposed##2##4##(2008-10#2)
) of the##11##3##(1996-5#1)(2008-10#9)(2008-2#1)
) of##44##2##(1991-1#1)(1993-8#2)(1995-12#2)(1996-5#1)(1997-7#1)(2008-10#33)(2008-2#1)(2011-2#2)(2013-1#1)
) on days##2##3##(1990-2#1)(2008-6#1)
) on the##2##3##(2008-12#2)
) on##8##2##(1990-2#1)(1995-12#1)(2008-12#3)(2008-6#1)(2011-2#1)(2013-1#1)
) or vehicle##2##3##(1993-12#1)(1993-6#1)
) or##16##2##(1991-2#1)(1992-3#3)(1993-12#1)(1993-6#1)(1995-12#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
) pipiens pipiens biotype molestus##2##5##(2013-1#2)
) pipiens##3##2##(2013-1#3)
) plants##3##2##(2008-10#1)(2008-12#2)
) production##2##2##(1997-3#1)(2008-10#1)
) protein##2##2##(2008-5#2)
) seeds##3##2##(1992-8#1)(2008-12#1)(2013-1#1)
) significantly##3##2##(1995-3#1)(2012-2#2)
) silage##2##2##(2012-2#2)
) that##5##2##(2008-2#2)(2008-3#2)(2009-8#1)
) the optimal##2##3##(2008-5#2)
) the##7##2##(1991-3#1)(2008-5#5)(2008-7#1)
) to##10##2##(1990-7#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-3#1)
) under##2##2##(2008-12#1)(2011-1#1)
) using##3##2##(2008-5#2)(2008-9#1)
) values for##2##3##(2008-10#2)
) values were##2##3##(2008-10#2)
) values##7##2##(2008-10#7)
) was 0##2##3##(2008-10#2)
) was 1##6##3##(2008-10#6)
) was calculated##2##3##(2008-10#1)(2010-8#1)
) was evaluated##2##3##(2011-2#1)(2012-3#1)
) was found to be##2##5##(1991-5#1)(2008-10#1)
) was found to##3##4##(1991-5#1)(2008-10#1)(2008-12#1)
) was found##5##3##(1991-5#1)(1993-12#1)(2008-10#2)(2008-12#1)
) was studied##2##3##(2010-5#1)(2012-2#1)
) was used as##2##4##(2008-10#1)(2012-3#1)
) was used##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
) was##49##2##(1991-5#3)(1993-12#1)(1995-12#4)(1995-3#1)(2008-10#25)(2008-12#2)(2008-5#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#2)
) were##23##2##(1992-3#3)(1993-3#1)(1995-12#2)(1996-2#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)
) where the##2##3##(2008-10#1)(2008-12#1)
) where##3##2##(2008-10#2)(2008-12#1)
) which is##2##3##(1990-2#1)(2008-10#1)
) with a##2##3##(2007-8#1)(2008-4#1)
) with the##2##3##(2008-5#1)(2008-8#1)
) with##14##2##(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-5#1)(2012-12#1)
)##1135##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#11)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#16)(1992-5#1)(1992-6#2)(1992-8#6)(1993-11#2)(1993-12#12)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-7#5)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#33)(1995-3#6)(1995-5#5)(1995-6#3)(1995-8#1)(1996-1#5)(1996-10#1)(1996-12#7)(1996-2#19)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1997-1#1)(1997-2#12)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#15)(1997-8#1)(2006-11#2)(2006-12#1)(2006-6#1)(2007-10#4)(2007-11#3)(2007-12#11)(2007-2#12)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#8)(2008-10#312)(2008-11#26)(2008-12#41)(2008-2#16)(2008-3#16)(2008-4#10)(2008-5#42)(2008-6#21)(2008-7#29)(2008-8#24)(2008-9#22)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#14)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#5)(2010-6#2)(2010-8#12)(2011-1#6)(2011-2#70)(2011-7#2)(2012-12#8)(2012-2#23)(2012-3#19)(2012-4#2)(2012-7#4)(2012-8#1)(2013-1#45)(2013-7#1)(2013-8#12)
)&lt##2##1##(2008-10#2)
))##10##1##(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)
)-induced##3##1##(1995-12#2)(1997-7#1)
)=-1##2##1##(2008-10#2)
)C##4##1##(2007-12#1)(2008-10#2)(2008-5#1)
)]##3##1##(2011-2#2)(2011-3#1)
)s bases##3##2##(2008-10#3)
* Influence of the##2##4##(2008-5#2)
* s(-1)##4##2##(2008-8#2)(2008-9#2)
*##35##1##(1991-1#2)(1997-8#4)(2007-11#1)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#6)(2008-8#6)(2008-9#4)(2012-2#4)
*) and##5##2##(2008-10#1)(2010-4#4)
*)##24##1##(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#21)
*2##2##1##(2013-1#2)
*3A##2##1##(2013-1#2)
+ 0##30##2##(1991-5#1)(1994-12#1)(1994-9#2)(1995-6#1)(2007-11#1)(2008-1#10)(2008-10#3)(2008-12#9)(2011-1#2)
+ 1##27##2##(1990-12#1)(1991-3#1)(1995-1#1)(1995-6#6)(1996-7#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#1)
+ 1)##3##2##(1996-5#1)(2007-12#1)(2008-10#1)
+ 10##2##2##(2008-1#2)
+ 109)##3##2##(1997-2#3)
+ 12##2##2##(1993-12#1)(2008-3#1)
+ 2##13##2##(1990-12#1)(1990-5#4)(1993-8#1)(1995-2#1)(1995-6#2)(1996-7#1)(2008-3#1)(2008-7#2)
+ 2]##4##2##(1996-5#2)(2010-4#1)(2012-3#1)
+ 3##12##2##(1990-5#4)(1991-3#1)(1995-6#4)(2008-10#1)(2008-3#2)
+ 35##2##2##(1997-4#2)
+ 4##6##2##(1990-12#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#2)
+ 6##2##2##(1992-8#1)(1995-2#1)
+ 7##3##2##(1995-6#2)(2007-3#1)
+ ALO and##2##3##(1997-4#2)
+ ALO##3##2##(1997-4#3)
+ BVDV-1-like virus (group##2##4##(2012-3#2)
+ BVDV-1-like virus##3##3##(2012-3#3)
+ BY(2) + CXY + DX + EY +##2##9##(2008-10#2)
+ Bs3) and##2##3##(2008-10#2)
+ Bs3) than on##2##4##(2008-10#2)
+ Bs3)##5##2##(2008-10#5)
+ CO2)##3##2##(1996-12#3)
+ Con##2##2##(1991-12#2)
+ Cu(II)##3##2##(2008-10#3)
+ FeSO(4)##3##2##(2008-11#3)
+ GEN##2##2##(2010-10#2)
+ M##3##2##(1992-6#1)(1996-3#1)(2008-10#1)
+ NH(4)NO(3)##5##2##(2008-10#5)
+ PCB##2##2##(2008-10#2)
+ TPA##2##2##(1993-6#1)(2013-1#1)
+ VI)##4##2##(2008-10#4)
+ XRT##4##2##(1991-4#4)
+ cells)##2##2##(1996-12#1)(1996-2#1)
+ direct##2##2##(2008-10#2)
+ epirubicin##2##2##(1992-10#2)
+ glyceraldehyde 3-phosphate) to be quantified as##2##7##(2008-7#2)
+ hydrocortisone##2##2##(1991-12#2)
+ leaf mold##4##3##(2008-12#4)
+ mancozeb)##2##2##(2008-10#2)
+ nasal##2##2##(2008-3#2)
+ nu(3)##3##2##(2008-2#2)(2008-3#1)
+ vitamin D supplements##2##4##(2010-3#2)
+##465##1##(1990-11#5)(1990-12#5)(1990-5#10)(1990-7#6)(1990-8#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#3)(1992-10#2)(1992-2#7)(1992-3#2)(1992-6#3)(1992-8#5)(1993-12#2)(1993-2#1)(1993-3#6)(1993-6#2)(1993-8#3)(1994-12#4)(1994-2#1)(1994-5#7)(1994-6#3)(1994-7#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#3)(1995-6#16)(1996-12#7)(1996-2#4)(1996-3#2)(1996-5#9)(1996-6#3)(1996-7#2)(1996-9#1)(1997-2#4)(1997-4#8)(1997-6#3)(1997-7#8)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#5)(2008-1#17)(2008-10#87)(2008-11#5)(2008-12#21)(2008-2#9)(2008-3#27)(2008-4#2)(2008-5#15)(2008-7#15)(2008-8#16)(2008-9#2)(2009-12#3)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#10)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#5)(2013-1#8)(2013-8#7)
+) and##3##2##(2008-10#2)(2008-5#1)
+) were##2##2##(2008-10#1)(2009-11#1)
+)##23##1##(1996-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2009-11#1)(2009-8#2)(2010-1#1)(2012-2#1)
+))##4##1##(2008-10#4)
+/+ mice##2##2##(1993-3#1)(1997-8#1)
+/+##4##1##(1993-3#1)(1997-8#1)(2008-12#1)(2012-3#1)
+/- 0##504##2##(1990-12#1)(1990-2#16)(1990-3#1)(1990-5#4)(1990-7#5)(1990-8#3)(1991-11#1)(1991-12#7)(1991-2#2)(1991-5#8)(1991-8#2)(1991-9#8)(1992-10#1)(1992-11#4)(1992-3#22)(1992-5#3)(1992-6#5)(1992-9#8)(1993-1#8)(1993-11#3)(1993-2#2)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#8)(1994-3#2)(1994-5#7)(1994-6#6)(1994-8#3)(1994-9#1)(1995-11#7)(1995-12#18)(1995-2#9)(1995-3#1)(1995-5#5)(1996-12#6)(1996-2#13)(1996-3#2)(1996-7#1)(1996-9#6)(1997-1#2)(1997-2#13)(1997-7#7)(2007-10#9)(2007-12#1)(2007-8#3)(2008-1#6)(2008-10#42)(2008-11#15)(2008-12#21)(2008-2#10)(2008-3#27)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#11)(2009-11#10)(2009-6#1)(2009-8#5)(2009-9#2)(2010-1#8)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#6)(2010-9#3)(2011-2#28)(2011-3#6)(2012-3#5)(2013-1#12)
+/- 1 and##2##3##(1995-12#1)(2008-10#1)
+/- 1 degree C##2##4##(1996-2#1)(2007-5#1)
+/- 1 degrees C##2##4##(2011-2#2)
+/- 1 masculineC##2##3##(2008-6#2)
+/- 1 to##2##3##(1990-3#1)(2008-1#1)
+/- 1 x##2##3##(1991-5#1)(2008-3#1)
+/- 1 yr)##2##3##(2009-11#2)
+/- 1##181##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#3)(1991-11#3)(1991-12#1)(1991-5#2)(1991-9#5)(1992-10#3)(1992-12#1)(1992-2#5)(1992-3#2)(1993-11#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#8)(1995-5#1)(1996-12#2)(1996-2#5)(1996-9#1)(1997-4#1)(1997-6#3)(1997-8#1)(2007-10#6)(2007-5#2)(2007-7#2)(2008-1#4)(2008-10#12)(2008-12#12)(2008-2#1)(2008-3#11)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#3)(2009-10#2)(2009-11#2)(2009-8#6)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#6)(2011-3#6)(2012-3#3)(2013-1#2)
+/- 1%##5##2##(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-3#1)
+/- 1)##2##2##(1991-2#1)(1997-7#1)
+/- 10##29##2##(1990-7#1)(1991-9#1)(1992-10#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#3)(1995-12#3)(1996-5#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-7#2)(2011-2#3)(2012-3#1)(2013-8#1)
+/- 10%##4##2##(1994-2#1)(1997-7#1)(2008-10#1)(2008-6#1)
+/- 100##3##2##(1991-4#1)(1996-2#1)(2008-2#1)
+/- 104##2##2##(2008-4#1)(2009-3#1)
+/- 11 vs##2##3##(1992-11#1)(2009-8#1)
+/- 11##24##2##(1992-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#2)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
+/- 11%##3##2##(1992-11#1)(1995-12#1)(2009-4#1)
+/- 12 mmHg##2##3##(2008-10#2)
+/- 12 years##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
+/- 12##25##2##(1990-8#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1996-12#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#3)(2009-1#1)(2010-4#1)(2011-2#1)(2013-8#1)
+/- 13 microM##2##3##(1994-6#2)
+/- 13 years##2##3##(1995-10#1)(2011-2#1)
+/- 13##15##2##(1991-6#1)(1993-12#1)(1994-6#3)(1995-10#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)
+/- 135##2##2##(1991-4#1)(1996-7#1)
+/- 14 mmHg##2##3##(1991-6#2)
+/- 14 nM##2##3##(1990-8#1)(2008-4#1)
+/- 14##19##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-6#3)(1992-9#1)(1993-12#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-7#1)(2013-1#1)
+/- 145##2##2##(1995-12#1)(2008-3#1)
+/- 15##12##2##(1994-2#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
+/- 15% of##3##3##(1991-11#1)(1994-2#1)(1995-11#1)
+/- 15%##6##2##(1991-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-3#1)
+/- 15%)##2##2##(1994-2#1)(1995-11#1)
+/- 16##13##2##(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-6#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-3#1)
+/- 17##12##2##(1991-6#1)(1995-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
+/- 18##10##2##(1990-5#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-6#1)(1996-5#1)(2008-5#1)(2010-6#1)(2011-2#1)
+/- 19##6##2##(1994-6#1)(2008-1#2)(2008-4#1)(2008-8#1)(2011-2#1)
+/- 1mumolL(-1)##2##2##(2008-10#2)
+/- 2 degrees C##2##4##(2008-10#1)(2008-12#1)
+/- 2 for##2##3##(1994-5#1)(2010-1#1)
+/- 2 years##2##3##(2007-7#1)(2008-3#1)
+/- 2##104##2##(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-2#5)(1992-3#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-8#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-10#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#4)(2008-7#3)(2009-1#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
+/- 2%##8##2##(1993-8#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-3#1)(2009-8#1)(2011-2#1)
+/- 20##8##2##(1995-12#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)
+/- 21##5##2##(1994-6#1)(2008-1#1)(2008-4#1)(2011-2#2)
+/- 22##10##2##(1996-3#2)(1996-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#2)(2013-1#1)
+/- 22%##2##2##(1995-12#1)(2008-10#1)
+/- 23##6##2##(1994-3#1)(1994-6#1)(1996-12#1)(2008-1#1)(2008-3#2)
+/- 23%##2##2##(1991-11#1)(2008-10#1)
+/- 24##7##2##(1995-12#1)(1995-3#1)(2007-7#1)(2008-3#1)(2010-2#1)(2011-2#2)
+/- 25##3##2##(1994-12#1)(2007-11#1)(2008-8#1)
+/- 25%##2##2##(1991-11#1)(2008-12#1)
+/- 26##5##2##(1991-4#1)(1995-3#1)(2008-10#1)(2009-6#1)(2011-3#1)
+/- 27##5##2##(1994-6#1)(1995-3#1)(1996-2#1)(2008-3#1)(2011-2#1)
+/- 28##3##2##(1995-3#1)(2008-8#1)(2011-2#1)
+/- 29##2##2##(1995-3#1)(2008-10#1)
+/- 3 and##2##3##(1997-1#1)(2008-10#1)
+/- 3 mm##3##3##(1995-12#1)(2008-12#1)(2010-7#1)
+/- 3 ms)##2##3##(2013-1#2)
+/- 3##101##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-7#3)(1995-12#8)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(2007-12#1)(2007-7#4)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#8)(2008-5#3)(2008-7#4)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#2)(2010-4#3)(2010-7#2)(2010-8#1)(2011-2#4)(2011-3#2)(2012-3#1)(2013-1#2)
+/- 3% vs##2##3##(1991-5#2)
+/- 3%##7##2##(1991-5#3)(1995-12#1)(1997-7#1)(2008-10#2)
+/- 30##4##2##(1995-3#1)(1996-2#1)(2008-5#1)(2008-7#1)
+/- 33##6##2##(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#1)
+/- 34##4##2##(1994-12#1)(1995-11#1)(2008-1#1)(2011-2#1)
+/- 35##4##2##(1994-6#1)(2007-11#1)(2007-7#1)(2008-1#1)
+/- 37##2##2##(1996-2#1)(2008-7#1)
+/- 38##4##2##(1996-2#2)(2007-7#1)(2011-1#1)
+/- 4 days##2##3##(2007-10#1)(2007-7#1)
+/- 4 nM##2##3##(1990-7#1)(1996-2#1)
+/- 4##52##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-12#3)(1995-5#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(2007-10#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2010-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
+/- 4% (n =##2##4##(1991-8#1)(1995-5#1)
+/- 4% of##2##3##(1995-12#2)
+/- 4%##8##2##(1991-6#1)(1991-8#1)(1992-8#1)(1994-8#1)(1995-12#2)(1995-5#1)(2008-10#1)
+/- 40##4##2##(1990-12#1)(2008-10#1)(2011-2#2)
+/- 41##3##2##(1994-6#1)(1997-3#1)(2008-3#1)
+/- 42##3##2##(1993-3#1)(1994-3#1)(1996-12#1)
+/- 45##3##2##(1993-8#1)(2008-8#1)(2009-3#1)
+/- 48##2##2##(2008-1#1)(2008-3#1)
+/- 49##2##2##(1995-12#1)(2008-1#1)
+/- 5 degrees##2##3##(1993-11#1)(2008-3#1)
+/- 5##54##2##(1990-8#1)(1991-2#3)(1991-9#1)(1992-10#1)(1992-11#2)(1993-11#1)(1993-2#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2013-1#1)
+/- 5% and##2##3##(1995-12#1)(1996-5#1)
+/- 5% at##3##3##(1996-5#2)(2008-1#1)
+/- 5% of##2##3##(1992-8#1)(2008-6#1)
+/- 5% with##2##3##(1993-8#2)
+/- 5%##14##2##(1992-8#1)(1993-8#2)(1995-12#1)(1996-5#5)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)
+/- 5%)##3##2##(1995-12#1)(1996-5#2)
+/- 50##4##2##(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
+/- 51##2##2##(1994-6#1)(2009-8#1)
+/- 52##3##2##(1990-7#1)(1993-3#1)(1997-6#1)
+/- 6##38##2##(1990-12#3)(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#2)(1997-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-1#1)
+/- 6%##8##2##(1990-5#1)(1995-12#2)(1995-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
+/- 6%)##5##2##(1994-11#1)(1995-11#3)(2008-11#1)
+/- 7 g)##3##3##(1993-12#3)
+/- 7##31##2##(1990-3#1)(1991-9#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#2)(2010-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#1)
+/- 7%##5##2##(1990-5#1)(1991-5#1)(1992-11#2)(1994-8#1)
+/- 70##2##2##(2008-10#1)(2008-2#1)
+/- 72##2##2##(2008-4#1)(2012-3#1)
+/- 8 and##2##3##(1993-12#1)(2008-12#1)
+/- 8##29##2##(1990-7#1)(1993-12#5)(1993-3#1)(1994-2#1)(1995-8#1)(1996-2#2)(1996-3#1)(1997-4#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2009-5#3)(2011-2#2)
+/- 8%##4##2##(1991-5#1)(2008-10#2)(2011-2#1)
+/- 82##2##2##(2008-6#1)(2008-7#1)
+/- 89##2##2##(1992-10#1)(2011-1#1)
+/- 9##26##2##(1990-8#1)(1991-6#1)(1992-12#1)(1993-12#2)(1993-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#4)(2008-7#1)(2009-1#1)(2012-3#2)
+/- 90##3##2##(1990-12#1)(2008-2#1)(2011-2#1)
+/- S##12##2##(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#1)(1993-12#1)(1994-3#2)(1995-12#1)(1995-8#1)(1997-1#1)(1997-3#1)
+/- SD =##2##3##(1995-1#1)(2009-7#1)
+/- SD##9##2##(1991-9#1)(1993-3#1)(1995-1#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
+/- SD)##9##2##(1990-5#1)(1991-12#1)(1992-6#1)(1993-1#1)(1996-9#1)(2009-6#2)(2010-2#1)(2011-2#1)
+/- SE##4##2##(1994-6#1)(1997-6#1)(2008-10#1)(2008-12#1)
+/- SE)##5##2##(1990-5#2)(1994-12#1)(1994-6#1)(2007-5#1)
+/- SEM##5##2##(1992-3#1)(1994-6#2)(1995-12#1)(2011-2#1)
+/- adjuvant therapy is##2##4##(2008-6#2)
+/- standard error of##2##4##(2011-2#1)(2013-1#1)
+/- standard##6##2##(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
+/- std dev##3##3##(2011-1#3)
+/-##1692##1##(1990-11#6)(1990-12#13)(1990-2#19)(1990-3#4)(1990-5#17)(1990-7#14)(1990-8#16)(1991-11#11)(1991-12#12)(1991-2#10)(1991-4#6)(1991-5#22)(1991-6#14)(1991-8#7)(1991-9#20)(1992-10#8)(1992-11#14)(1992-12#3)(1992-2#11)(1992-3#29)(1992-5#3)(1992-6#6)(1992-8#3)(1992-9#11)(1993-1#10)(1993-11#11)(1993-12#20)(1993-2#12)(1993-3#10)(1993-6#1)(1993-8#16)(1993-9#1)(1994-11#16)(1994-12#22)(1994-2#14)(1994-3#12)(1994-5#11)(1994-6#32)(1994-7#5)(1994-8#12)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#19)(1995-12#73)(1995-2#12)(1995-3#12)(1995-5#13)(1995-6#2)(1995-8#10)(1996-1#5)(1996-12#13)(1996-2#38)(1996-3#10)(1996-5#10)(1996-7#4)(1996-8#1)(1996-9#16)(1997-1#8)(1997-2#19)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#13)(1997-7#13)(1997-8#4)(2007-10#26)(2007-11#3)(2007-12#2)(2007-5#4)(2007-7#26)(2007-8#12)(2007-9#2)(2008-1#47)(2008-10#128)(2008-11#28)(2008-12#52)(2008-2#19)(2008-3#91)(2008-4#29)(2008-5#62)(2008-6#8)(2008-7#38)(2008-8#24)(2008-9#1)(2009-1#3)(2009-10#2)(2009-11#12)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#20)(2009-9#3)(2010-1#18)(2010-2#8)(2010-4#11)(2010-5#4)(2010-6#3)(2010-7#9)(2010-8#9)(2010-9#3)(2011-1#8)(2011-2#88)(2011-3#20)(2012-2#5)(2012-3#18)(2013-1#27)(2013-7#2)(2013-8#6)
+/-0##48##1##(2007-11#2)(2008-10#21)(2008-2#3)(2008-3#14)(2008-8#5)(2008-9#3)
+/-1##18##1##(2007-5#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#6)(2008-5#1)
+/-1%##3##1##(2008-10#2)(2008-3#1)
+/-10%##5##1##(2008-10#3)(2008-3#2)
+/-100##2##1##(2008-1#1)(2008-2#1)
+/-15%##2##1##(2008-10#1)(2008-2#1)
+/-18##2##1##(2007-8#1)(2008-8#1)
+/-2##8##1##(2007-11#1)(2008-10#7)
+/-2%##4##1##(2008-10#3)(2008-2#1)
+/-2%)##2##1##(2008-10#1)(2008-2#1)
+/-20% for##2##2##(2008-10#2)
+/-20%##4##1##(2008-10#4)
+/-3##5##1##(2008-10#2)(2008-3#2)(2008-8#1)
+/-3%##6##1##(2008-10#4)(2008-3#2)
+/-4##2##1##(2008-2#2)
+/-4%##2##1##(2008-10#1)(2008-3#1)
+/-5##5##1##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)
+/-5% for##2##2##(2008-3#2)
+/-5% of the##2##3##(2008-2#2)
+/-5%##7##1##(2008-2#3)(2008-3#4)
+/-50##2##1##(2008-3#2)
+/-50%##5##1##(2008-3#5)
+/-s##4##1##(2010-8#4)
+0##44##1##(1994-11#1)(1995-12#1)(2007-6#1)(2008-10#39)(2010-5#2)
+1 and -1##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
+1 and##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
+1##20##1##(1990-5#2)(1991-9#1)(1992-3#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#5)(2008-5#1)(2010-8#1)
+10 dB##2##2##(2008-9#2)
+10##5##1##(1993-8#2)(1996-4#1)(2008-9#2)
+12##2##1##(1991-2#1)(1995-2#1)
+13##6##1##(1990-5#2)(1993-9#1)(2008-10#1)(2009-9#1)(2012-2#1)
+14##2##1##(1995-2#1)(1997-7#1)
+16##2##1##(1991-2#1)(1995-2#1)
+180##2##1##(2008-10#1)(2008-9#1)
+2 and##2##2##(1997-4#1)(2007-12#1)
+2##11##1##(1994-11#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-2#2)(2009-6#1)
+20##4##1##(1995-2#1)(1995-3#1)(1996-4#1)(1997-2#1)
+2000V##2##1##(2008-10#2)
+24##3##1##(1992-11#1)(1995-6#2)
+3##7##1##(1992-3#1)(1994-11#2)(1996-2#1)(1997-4#1)(2008-3#1)(2009-5#1)
+4 degrees C##2##3##(2008-10#1)(2008-11#1)
+4##3##1##(2008-10#1)(2008-11#1)(2009-2#1)
+45T &gt##3##2##(2011-1#3)
+5 and##2##2##(2008-3#1)(2008-9#1)
+5##7##1##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#2)(2011-2#2)
+50%##2##1##(2008-12#1)(2008-2#1)
+61 G/A polymorphism and glioma risk in a Chinese Han population##2##11##(2011-2#2)
+61 G/A polymorphism##3##3##(2011-2#3)
+61##4##1##(2011-2#4)
+8##4##1##(1992-3#1)(1993-9#1)(1994-11#1)(2007-4#1)
+ve##5##1##(2008-1#4)(2008-10#1)
- 0##25##2##(1991-12#1)(1993-8#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#4)(2008-7#3)(2011-1#4)(2011-2#2)(2012-3#1)
- 1 patient##4##3##(2007-11#2)(2013-1#2)
- 1##33##2##(1993-8#1)(1996-7#1)(1997-8#1)(2007-11#8)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-7#1)(2011-1#3)(2011-2#10)(2013-1#2)
- 1)##2##2##(1995-6#1)(2010-4#1)
- 1)(n))##2##2##(2010-2#2)
- 10##5##2##(2007-11#2)(2011-1#1)(2013-1#2)
- 10(-6) M)##2##3##(1995-12#2)
- 100##2##2##(1990-12#1)(1995-12#1)
- 12##6##2##(2007-11#1)(2008-11#1)(2011-1#1)(2012-12#2)(2012-2#1)
- 13##3##2##(2007-11#1)(2013-1#2)
- 15##2##2##(2007-11#1)(2008-7#1)
- 16##4##2##(2007-11#2)(2011-1#1)(2013-8#1)
- 1996##2##2##(1996-3#1)(2008-1#1)
- 2 patients##2##3##(2007-11#1)(2013-1#1)
- 2##17##2##(1993-2#1)(1996-7#1)(2007-11#1)(2011-1#11)(2012-1#1)(2012-3#1)(2013-1#1)
- 20##3##2##(2008-5#1)(2011-1#2)
- 26##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
- 3##18##2##(1993-2#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#6)(2012-3#1)(2013-1#1)
- 34##2##2##(2011-1#2)
- 35##3##2##(2008-10#2)(2008-8#1)
- 4##13##2##(1994-5#1)(2007-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#4)(2012-3#1)(2013-1#1)
- 4)##2##2##(1996-4#1)(2007-11#1)
- 4-6##2##2##(2007-11#2)
- 40##6##2##(2008-11#1)(2008-7#1)(2011-1#4)
- 45##2##2##(2008-11#1)(2011-2#1)
- 49##3##2##(2007-11#2)(2011-1#1)
- 5 months##2##3##(2007-11#2)
- 5##14##2##(2007-11#4)(2007-12#1)(2008-10#1)(2008-12#1)(2011-1#6)(2012-3#1)
- 6##14##2##(1990-12#1)(1993-2#1)(2006-11#1)(2007-11#3)(2008-11#1)(2011-1#2)(2012-3#1)(2013-1#4)
- 60##2##2##(2009-11#1)(2011-2#1)
- 68##2##2##(2007-11#2)
- 7##3##2##(2007-12#1)(2008-8#1)(2011-1#1)
- 76##2##2##(2008-11#1)(2010-4#1)
- 8##4##2##(1993-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
- 9##3##2##(1995-2#1)(2008-12#1)(2013-1#1)
- 90##2##2##(2007-7#1)(2008-12#1)
- 94##2##2##(2011-1#2)
- A Case##2##3##(2010-12#1)(2010-7#1)
- A case##2##3##(2010-4#1)(2012-1#1)
- A comment##3##3##(2013-8#3)
- A reply##3##3##(2007-4#1)(2013-8#2)
- A##30##2##(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#6)
- An ex vivo study##2##5##(2013-1#2)
- An##5##2##(2007-12#1)(2008-12#2)(2013-1#2)
- Answer##3##2##(2007-5#3)
- How##2##2##(2007-12#1)(2008-1#1)
- I##3##2##(2009-10#1)(2009-4#1)(2012-2#1)
- IV##2##2##(2007-11#1)(2011-2#1)
- Is##2##2##(2008-11#1)(2011-2#1)
- Revised##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
- The study##2##3##(2008-11#2)
- The##8##2##(2007-8#1)(2008-11#5)(2008-12#1)(2009-9#1)
- VASOACTIVE PEPTIDE SYMPOSIUM##2##4##(2009-11#2)
- We##2##2##(2008-11#2)
- a case report##10##4##(2007-10#1)(2007-7#6)(2007-8#1)(2010-7#1)(2012-12#1)
- a case##12##3##(2007-10#1)(2007-7#6)(2007-8#1)(2008-11#1)(2010-7#1)(2012-12#1)(2013-7#1)
- a new##4##3##(2007-7#1)(2008-2#1)(2008-8#1)(2013-8#1)
- a preliminary report##2##4##(2007-7#2)
- a preliminary study##2##4##(2007-11#1)(2012-2#1)
- a preliminary##4##3##(2007-11#1)(2007-7#2)(2012-2#1)
- a prospective##2##3##(2007-7#1)(2012-2#1)
- a randomized##2##3##(2012-2#2)
- a rare##2##3##(2012-2#1)(2012-3#1)
- a report##2##3##(2007-7#1)(2007-8#1)
- a review##5##3##(2008-10#1)(2008-5#1)(2010-7#1)(2012-2#2)
- a##84##2##(1991-12#1)(1991-6#1)(2007-10#1)(2007-11#1)(2007-7#12)(2007-8#2)(2008-10#7)(2008-11#11)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#1)(2009-2#1)(2010-10#3)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
- an overview##2##3##(2009-10#1)(2011-1#1)
- an unusual##2##3##(2009-9#1)(2012-12#1)
- an##14##2##(1990-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
- and##11##2##(1990-12#1)(1990-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-7#1)
- are##4##2##(2008-11#2)(2008-7#1)(2013-1#1)
- as well as##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
- as##6##2##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#1)
- associated##3##2##(2007-5#1)(2008-11#1)(2012-12#1)
- at least##3##3##(1996-3#1)(2008-11#1)(2013-8#1)
- both##2##2##(2007-11#1)(2008-11#1)
- by##2##2##(2007-8#1)(2009-2#1)
- case report##3##3##(2007-11#1)(2012-12#2)
- case##5##2##(2007-11#1)(2010-3#1)(2012-12#2)(2013-7#1)
- control##5##2##(2008-11#4)(2011-2#1)
- do##2##2##(2008-7#1)(2013-8#1)
- does##2##2##(2008-11#1)(2008-7#1)
- drug##2##2##(2008-11#2)
- especially##3##2##(2007-11#1)(2008-12#1)(2010-5#1)
- first##2##2##(2007-12#1)(2011-1#1)
- for##5##2##(1991-3#1)(2008-11#3)(2010-10#1)
- from##6##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-9#1)(2013-1#1)
- g##2##2##(2008-2#1)(2009-5#1)
- gene##2##2##(2008-10#1)(2010-1#1)
- glycidyl butyrate##2##3##(2012-2#2)
- good##2##2##(2007-11#2)
- group##2##2##(2008-11#1)(2013-1#1)
- has##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
- have##2##2##(2008-10#1)(2012-12#1)
- hereditary##2##2##(2009-12#1)(2013-8#1)
- i##5##2##(2007-11#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
- in the##3##3##(1996-3#1)(2008-7#1)(2009-12#1)
- in##13##2##(1996-3#1)(2007-11#2)(2008-7#2)(2009-12#1)(2009-9#1)(2011-2#4)(2013-1#2)
- including##2##2##(2008-4#1)(2008-7#1)
- induced##4##2##(1991-5#1)(1995-12#1)(2008-1#1)(2012-2#1)
- is there a##3##4##(2008-11#3)
- is there##4##3##(2007-7#1)(2008-11#3)
- is##10##2##(2007-11#1)(2007-7#1)(2008-11#3)(2008-7#2)(2008-9#1)(2010-10#1)(2012-12#1)
- it##2##2##(2010-10#1)(2012-2#1)
- joint##2##2##(2007-8#2)
- kappa##2##2##(1990-5#1)(2007-11#1)
- known##2##2##(2012-1#1)(2012-2#1)
- management in general practice##2##5##(2011-2#2)
- management##3##2##(2008-7#1)(2011-2#2)
- may be##2##3##(2008-5#2)
- may##4##2##(2008-5#2)(2010-5#2)
- micro(s))]##2##2##(2008-3#2)
- n =##5##3##(2008-7#5)
- new##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
- no##3##2##(2007-11#2)(2008-6#1)
- not##3##2##(1991-6#1)(2011-2#1)(2012-2#1)
- of##3##2##(1990-12#1)(2007-11#1)(2008-9#1)
- on the##2##3##(2008-2#1)(2009-4#1)
- on##3##2##(2007-10#1)(2008-2#1)(2009-4#1)
- one##6##2##(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-10#1)
- or##2##2##(2007-11#1)(2009-12#1)
- own##2##2##(2007-11#1)(2007-8#1)
- part 1##3##3##(2012-2#1)(2012-3#2)
- part##4##2##(2012-2#2)(2012-3#2)
- patients with##2##3##(2007-11#2)
- patients##3##2##(2007-11#3)
- preliminary results##2##3##(2012-2#2)
- presentation##2##2##(2008-1#1)(2013-8#1)
- radical and##2##3##(1994-11#2)
- radicals##3##2##(1994-11#3)
- sometimes##2##2##(2007-11#1)(2012-2#1)
- specifically##2##2##(2008-4#1)(2012-12#1)
- that##5##2##(2008-12#1)(2008-7#1)(2009-9#1)(2010-2#1)(2013-1#1)
- the case of##2##4##(2009-11#1)(2013-1#1)
- the new##2##3##(2008-11#1)(2009-7#1)
- the##45##2##(1996-3#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#4)(2008-2#1)(2008-5#6)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#2)(2009-9#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#4)
- they##2##2##(2008-2#1)(2013-8#1)
- to quantify##2##3##(2008-11#2)
- to##5##2##(2008-11#2)(2008-7#1)(2009-12#1)(2013-1#1)
- towards##2##2##(2008-7#1)(2011-1#1)
- using##2##2##(2008-10#2)
- was##9##2##(2008-11#4)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2013-1#1)
- we##3##2##(2009-2#1)(2010-3#2)
- were##6##2##(2007-11#1)(2008-11#2)(2008-5#2)(2008-7#1)
- whereas##2##2##(1995-12#1)(2008-8#1)
- whether##3##2##(1995-12#1)(2008-11#1)(2009-11#1)
- which##5##2##(1991-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
- who##2##2##(2008-9#1)(2010-11#1)
- with the##4##3##(2008-10#2)(2008-11#1)(2010-11#1)
- with##7##2##(1994-11#1)(2008-10#2)(2008-11#2)(2009-11#1)(2010-11#1)
-##1222##1##(1990-12#8)(1990-5#1)(1990-7#1)(1990-9#2)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#4)(1993-8#4)(1994-11#6)(1994-5#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-6#2)(1996-3#6)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-8#8)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#4)(2007-11#117)(2007-12#18)(2007-2#1)(2007-4#3)(2007-5#6)(2007-6#1)(2007-7#25)(2007-8#28)(2008-1#13)(2008-10#79)(2008-11#149)(2008-12#22)(2008-2#17)(2008-3#13)(2008-4#10)(2008-5#44)(2008-6#6)(2008-7#61)(2008-8#9)(2008-9#19)(2009-1#1)(2009-10#5)(2009-11#12)(2009-12#15)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#7)(2009-6#3)(2009-7#10)(2009-8#2)(2009-9#10)(2010-1#1)(2010-10#14)(2010-11#6)(2010-12#8)(2010-2#3)(2010-3#6)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#8)(2010-8#5)(2010-9#1)(2011-1#82)(2011-10#2)(2011-2#60)(2011-3#4)(2011-7#1)(2012-1#10)(2012-12#23)(2012-2#48)(2012-3#27)(2012-8#1)(2012-9#2)(2013-1#55)(2013-7#14)(2013-8#28)
-) and##2##2##(2008-5#2)
-)##8##1##(1994-11#2)(1995-6#1)(2008-12#1)(2008-5#3)(2013-8#1)
-- a review##2##3##(1997-4#2)
-- a##7##2##(1994-7#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-4#2)(2008-6#1)
--##37##1##(1991-9#1)(1993-3#1)(1994-7#2)(1994-8#1)(1994-9#2)(1996-12#7)(1996-4#1)(1996-8#2)(1997-4#2)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#3)(2009-4#2)(2012-12#1)
--&gt##67##1##(1992-8#1)(1993-11#2)(1995-5#3)(1995-6#3)(1996-2#4)(1997-1#1)(1997-7#10)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#13)(2008-4#7)(2008-6#2)(2008-7#3)(2011-2#5)(2011-3#7)
--Ksiaz##2##1##(2009-5#2)
--a##5##1##(1994-1#1)(1996-1#1)(1996-6#1)(1997-2#1)(2012-2#1)
--an##2##1##(1994-1#1)(1997-6#1)
--the##2##1##(1991-12#1)(2012-2#1)
-/+ 0##7##2##(2008-11#4)(2008-5#3)
-/+##13##1##(2008-11#9)(2008-5#4)
-/-##3##1##(1995-11#1)(2008-12#1)(2009-3#1)
-/-)##2##1##(1997-7#1)(2010-11#1)
-0##267##1##(1990-12#1)(1990-5#1)(1991-2#2)(1991-3#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-2#5)(1994-12#1)(1994-5#1)(1995-11#3)(1995-8#3)(1996-12#1)(1996-2#2)(1997-7#1)(2007-10#6)(2007-11#1)(2007-12#5)(2008-1#5)(2008-10#136)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#9)(2010-2#2)(2010-4#11)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#20)(2013-7#2)(2013-8#5)
-1 and##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
-1 diffraction##2##2##(2007-12#1)(2008-3#1)
-1 kPa##2##2##(2008-10#2)
-1##90##1##(1991-11#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#44)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#2)(2012-9#1)(2013-1#2)(2013-8#3)
-10 degrees C##2##3##(2008-10#1)(2008-2#1)
-10 degrees##3##2##(1994-12#1)(2008-10#1)(2008-2#1)
-10 kPa##3##2##(2008-10#3)
-10##18##1##(1991-9#1)(1993-1#1)(1994-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
-100 mV##2##2##(2008-10#2)
-100##7##1##(1995-6#3)(1996-2#2)(2008-10#2)
-1035 to +24##2##3##(1995-6#2)
-1035 to##3##2##(1995-6#3)
-108##2##1##(1995-6#1)(1997-7#1)
-1082##4##1##(2011-1#2)(2012-12#2)
-11##6##1##(1993-3#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-8#1)
-110##2##1##(1993-3#1)(1997-7#1)
-11377C &gt##6##2##(2011-1#6)
-12##5##1##(1991-5#1)(1996-5#1)(2008-10#2)(2012-2#1)
-120##3##1##(1993-3#1)(2007-11#1)(2008-10#1)
-13##4##1##(1997-7#1)(2008-10#1)(2009-12#1)(2011-1#1)
-14##5##1##(1993-9#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
-140 x 10(3)##3##3##(2008-10#3)
-140##5##1##(2007-11#1)(2008-10#3)(2008-9#1)
-146##2##1##(1991-5#2)
-15 degrees##2##2##(1995-2#1)(2011-2#1)
-15##11##1##(1990-11#1)(1991-3#2)(1994-5#1)(1995-2#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-4#1)(2011-2#1)
-150##3##1##(1996-2#2)(2008-10#1)
-156##2##1##(1993-9#1)(1994-9#1)
-16##4##1##(1995-2#1)(1997-4#1)(2008-5#1)(2011-1#1)
-17##2##1##(1994-12#1)(2008-5#1)
-172##2##1##(1991-2#1)(2011-2#1)
-174##2##1##(1991-3#1)(1997-7#1)
-18##9##1##(1992-10#1)(1992-12#1)(1993-8#2)(1993-9#1)(1994-5#1)(2008-10#1)(2010-1#1)(2010-3#1)
-19 mV##2##2##(1997-7#1)(2008-8#1)
-19##7##1##(1996-2#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#1)
-2 and -3 had successively borne litters through those rounds##2##10##(1997-4#2)
-2 and -3##4##3##(1997-4#2)(2008-4#1)(2008-9#1)
-2##47##1##(1990-2#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-5#2)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#3)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#5)
-2-2 IIIB##2##2##(2008-10#2)
-2-2 IV##2##2##(2008-10#2)
-2-2 LP##2##2##(2008-10#2)
-2-2##6##1##(2008-10#6)
-2-3##3##1##(1992-6#1)(2008-10#2)
-20 and##3##2##(2008-10#2)(2011-2#1)
-20 degrees C for##2##4##(2008-10#1)(2008-11#1)
-20 degrees C##10##3##(1992-9#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-3#1)
-20 degrees##11##2##(1992-9#1)(1995-2#1)(1996-2#2)(2008-10#3)(2008-11#2)(2008-3#1)(2010-3#1)
-20 to##2##2##(2008-3#1)(2008-7#1)
-20##29##1##(1990-5#1)(1992-9#1)(1995-2#1)(1996-2#2)(1997-7#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2010-3#1)(2011-2#1)(2013-7#4)
-200 mV##3##2##(2008-10#3)
-200##4##1##(2008-10#4)
-200mV##3##1##(2008-10#3)
-21##2##1##(2008-3#1)(2010-1#1)
-22##5##1##(1992-12#1)(1993-3#1)(1993-8#1)(2010-12#2)
-225##2##1##(1990-5#1)(1993-2#1)
-23##5##1##(1992-6#1)(1997-7#1)(2008-10#1)(2008-3#2)
-24##2##1##(2007-8#1)(2008-8#1)
-25##7##1##(1991-6#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-12#2)
-25%##3##1##(2008-11#3)
-2548 G/A##3##2##(2008-10#3)
-2548##4##1##(2008-10#4)
-26##2##1##(1993-12#1)(2008-10#1)
-27 dB and##2##3##(2008-3#2)
-27##3##1##(2008-10#1)(2008-3#2)
-28##3##1##(1991-6#1)(2008-10#1)(2008-2#1)
-3 dB##3##2##(2008-3#1)(2009-5#2)
-3 degrees C##2##3##(2008-10#2)
-3 in##2##2##(2008-9#2)
-3##34##1##(1990-2#1)(1990-8#1)(1991-12#2)(1993-3#1)(1994-12#1)(1995-2#2)(1997-4#3)(1997-7#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-9#4)(2009-4#1)(2009-5#2)(2011-1#1)(2011-2#2)
-3)##2##1##(2008-9#1)(2012-2#1)
-30##3##1##(1995-2#1)(1996-5#1)(2007-12#1)
-300 mV (versus##2##3##(2008-10#2)
-300 mV##3##2##(2008-10#3)
-300##5##1##(2008-10#3)(2008-3#1)(2011-2#1)
-305##2##1##(1996-5#2)
-31##2##1##(1994-12#2)
-32##5##1##(1994-12#3)(1995-6#1)(2008-2#1)
-33##2##1##(1997-7#1)(2008-8#1)
-330 x 10(3) Pa##2##4##(2008-10#2)
-34##2##1##(1994-12#2)
-344##2##1##(2008-9#2)
-35##7##1##(1991-9#1)(1992-12#1)(1997-7#3)(2008-12#1)(2010-3#1)
-37##2##1##(1994-12#1)(2008-8#1)
-374##2##1##(2008-9#2)
-38##4##1##(1992-3#1)(1997-7#1)(2008-6#1)(2010-3#1)
-4##27##1##(1991-11#1)(1991-9#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-9#2)(1995-2#3)(1996-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#2)(2013-8#3)
-4%##2##1##(2008-2#1)(2008-5#1)
-4/+4##3##1##(1992-6#3)
-40 degrees C##4##3##(1996-6#1)(1997-4#3)
-40 kPa##3##2##(2008-10#3)
-40 mV##3##2##(1995-12#1)(1996-5#1)(2008-8#1)
-40 to##2##2##(1995-6#1)(2008-3#1)
-40##21##1##(1992-8#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-4#3)(1997-7#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#3)(2011-2#1)
-404 G→T##2##2##(2013-1#2)
-404##3##1##(2013-1#3)
-414##2##1##(2008-9#2)
-42##3##1##(1992-11#1)(2008-10#1)(2010-3#1)
-42%##3##1##(1991-9#1)(1992-11#1)(1996-12#1)
-43##2##1##(2010-3#1)(2012-9#1)
-46##6##1##(1994-12#4)(2008-10#1)(2008-12#1)
-48##3##1##(1991-2#1)(1992-10#1)(2008-10#1)
-480##2##1##(1994-12#2)
-484##2##1##(2008-9#2)
-5 and##3##2##(1995-5#1)(2008-10#2)
-5 degrees C##4##3##(2008-10#4)
-5##22##1##(1991-8#1)(1994-11#1)(1994-7#1)(1995-2#2)(1995-5#1)(2008-10#11)(2008-3#2)(2011-1#1)(2013-8#2)
-50 mV versus##2##3##(2008-10#2)
-50 mV##3##2##(2008-10#3)
-50##5##1##(2008-10#4)(2008-2#1)
-50%##3##1##(2008-11#2)(2008-2#1)
-50mV versus Ag/AgCl##2##3##(2008-10#2)
-540##2##1##(2008-9#2)
-55 +/-##2##2##(1991-5#1)(1992-10#1)
-55 degrees C##2##3##(2007-11#1)(2008-2#1)
-55##6##1##(1991-5#1)(1992-10#1)(2007-11#1)(2008-10#2)(2008-2#1)
-56##4##1##(1996-5#1)(2008-10#3)
-565##2##1##(1996-5#2)
-57##2##1##(2008-10#2)
-570##2##1##(1991-11#2)
-58##4##1##(2007-11#1)(2008-10#3)
-580##2##1##(2008-9#2)
-59##4##1##(2008-10#2)(2008-12#1)(2008-6#1)
-592##4##1##(1991-11#2)(1997-3#1)(2012-12#1)
-6 and -7##2##3##(2011-2#2)
-6##20##1##(1990-11#1)(1990-5#1)(1991-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2009-5#1)(2010-1#1)(2010-11#1)(2011-2#2)(2013-8#1)
-60 +/-##2##2##(1991-5#2)
-60##8##1##(1991-5#2)(1996-5#1)(1997-7#1)(2008-3#2)(2008-4#1)(2012-12#1)
-612##2##1##(1991-11#2)
-615##2##1##(1990-5#2)
-66##2##1##(1996-2#1)(1997-7#1)
-7 x 10(3)##3##3##(2008-10#3)
-7##20##1##(1990-8#1)(1991-8#1)(1992-9#1)(2008-10#12)(2008-4#1)(2010-1#1)(2011-2#3)
-70 degrees##3##2##(1992-3#1)(1996-12#1)(2008-2#1)
-70##4##1##(1992-3#1)(1996-12#1)(2008-2#1)(2008-3#1)
-73##2##1##(1991-12#1)(1991-5#1)
-74##2##1##(2008-10#1)(2011-2#1)
-75 degrees##2##2##(1997-8#1)(2008-3#1)
-75##3##1##(1997-8#1)(2007-7#1)(2008-3#1)
-75%##2##1##(2008-2#1)(2008-8#1)
-78 degrees##6##2##(1992-4#1)(1996-5#5)
-8##14##1##(1991-6#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-4#1)(2009-2#1)(2010-4#1)(2013-8#1)
-80 C##2##2##(2008-8#2)
-80 degrees C##2##3##(1993-12#1)(1996-5#1)
-80 degrees##3##2##(1993-12#1)(1996-5#1)(2008-3#1)
-80##9##1##(1990-7#1)(1993-12#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#3)
-85##2##1##(1993-2#1)(1995-6#1)
-87##2##1##(1990-7#1)(1993-12#1)
-9 and##4##2##(1992-8#1)(2008-4#2)(2009-4#1)
-9##13##1##(1991-5#1)(1992-8#1)(2007-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-2#1)(2013-7#1)
-90##3##1##(1991-2#1)(2008-3#2)
-93 to -100##2##3##(1995-6#2)
-95##2##1##(2011-2#1)(2012-12#1)
-?##3##1##(2007-12#3)
-B and##2##2##(1996-6#1)(2013-1#1)
-B##9##1##(1992-12#1)(1993-12#1)(1995-5#1)(1996-6#1)(1997-4#1)(2008-10#3)(2013-1#1)
-Both may##2##2##(1996-12#2)
-Both##6##1##(1996-12#6)
-C##4##1##(1993-11#1)(1995-6#1)(1996-6#1)(2008-8#1)
-C)##2##1##(1993-12#1)(2013-1#1)
-CpPPh(2))](2)(2+)##2##1##(1996-2#2)
-D##2##1##(1994-12#1)(2008-10#1)
-DPD level##2##2##(2008-10#2)
-DPD##3##1##(2008-10#3)
-DQ##2##1##(1997-8#1)(1997-9#1)
-DeltaH(HM) values range from##2##4##(1996-2#2)
-E##4##1##(1992-12#1)(1994-12#2)(1994-9#1)
-ELE regions##2##2##(1992-9#2)
-F##3##1##(1990-5#2)(1995-2#1)
-G##2##1##(1997-8#1)(2008-10#1)
-H##2##1##(1992-8#1)(1997-3#1)
-I and##3##2##(1994-3#2)(2008-11#1)
-I##6##1##(1994-3#4)(2008-10#1)(2008-11#1)
-II##6##1##(1993-11#1)(1993-9#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
-II&quot##2##1##(1993-11#2)
-II'##2##1##(1993-11#2)
-III##3##1##(1991-12#1)(1993-11#2)
-K##3##1##(1993-3#1)(1993-8#1)(1996-5#1)
-M##5##1##(1990-12#1)(1992-3#1)(1992-8#1)(1995-6#1)(2008-4#1)
-Mo##2##1##(2008-10#2)
-OH##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
-P-P)]##2##1##(1996-2#2)
-PPh(2))(3)Ph(PPh(3))(2)##2##1##(1996-2#2)
-S##2##1##(1994-9#1)(2008-10#1)
-SH##4##1##(1990-12#1)(1996-12#1)(2008-10#2)
-The##3##1##(1994-3#1)(2008-10#1)(2008-11#1)
-X##2##1##(2008-2#1)(2008-3#1)
-Y##2##1##(1993-9#1)(1994-8#1)
-YY##2##1##(1997-3#2)
-a##4##1##(1997-3#1)(2007-4#1)(2008-10#1)(2011-2#1)
-amyloid##2##1##(2007-8#2)
-based##3##1##(2007-11#1)(2007-12#1)(2008-12#1)
-beta and -gamma##2##3##(1994-12#1)(2007-11#1)
-beta and##3##2##(1994-12#1)(2007-11#2)
-blockers##2##1##(2008-1#1)(2013-1#1)
-chiro-inositol##6##1##(2008-11#6)
-chloroethyl)amino]phenyl]butanoic acid##2##2##(1995-3#2)
-cladding layer##2##2##(2007-12#2)
-conjugated##2##1##(2007-11#1)(2007-12#1)
-cut##3##1##(2007-12#1)(2008-3#2)
-deficient##7##1##(1997-4#6)(2008-11#1)
-dependent##6##1##(1995-10#1)(1995-11#1)(2008-5#1)(2008-6#2)(2008-8#1)
-diameter##4##1##(2007-11#3)(2007-12#1)
-dominant HSG cells)##2##3##(2011-2#2)
-dominant HSG##3##2##(2011-2#3)
-doped##17##1##(2007-11#9)(2007-12#8)
-expressing##2##1##(1995-11#1)(2013-1#1)
-free##2##1##(2008-5#1)(2013-1#1)
-gamma##5##1##(1994-12#1)(1994-6#2)(2007-11#2)
-glucuronidase##2##1##(2008-5#2)
-hrB##2##1##(1994-12#2)
-lactamase production was##2##3##(2007-7#2)
-lactamase##5##1##(2007-7#5)
-lactate##2##1##(2008-11#1)(2011-2#1)
-long##2##1##(2007-11#1)(2007-12#1)
-lysine/alginate (APA)##2##2##(2008-11#2)
-merging zone##2##2##(2008-10#2)
-mode##2##1##(2007-12#1)(2007-9#1)
-old##2##1##(2007-7#1)(2011-2#1)
-omics##3##1##(2011-2#1)(2012-3#2)
-pinitol##2##1##(2008-11#2)
-positive##4##1##(1991-6#1)(1993-9#1)(2008-10#1)(2012-3#1)
-sensitive##2##1##(2008-10#1)(2013-1#1)
-specific##3##1##(2008-10#1)(2012-5#2)
-switched Nd##7##2##(2007-11#6)(2007-12#1)
-switched##26##1##(2007-11#14)(2007-12#11)(2008-2#1)
-test##4##1##(2008-10#1)(2008-11#3)
-thick##5##1##(2007-11#4)(2007-12#1)
-tryptophan##2##1##(2008-11#2)
-type##5##1##(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)
/ *##2##2##(1991-1#2)
/##40##1##(1991-1#3)(1995-3#1)(1996-3#1)(1997-6#3)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
/(see text)/##4##2##(2013-8#4)
//dx##5##1##(2013-8#5)
//fbpe/img/rmc/v141n3/art19-a##2##1##(2013-8#2)
//www##74##1##(2007-6#1)(2008-10#5)(2008-11#5)(2008-3#2)(2008-4#2)(2008-7#16)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-1#15)(2011-2#12)(2012-1#10)
/10cm2##2##1##(2013-7#2)
/= 0##43##2##(2006-10#5)(2008-10#27)(2008-3#9)(2008-7#1)(2008-9#1)
/= 1 dose of##2##4##(2008-7#2)
/= 1 g/dL##3##3##(2008-7#3)
/= 1##10##2##(2008-2#1)(2008-7#9)
/= 10##2##2##(2008-10#1)(2008-6#1)
/= 11 g/dL##2##3##(2008-7#2)
/= 11 g/dL)##2##3##(2008-7#2)
/= 11##4##2##(2008-7#4)
/= 12 g/dL##2##3##(2008-7#2)
/= 12##4##2##(2008-10#1)(2008-7#3)
/= 14##2##2##(2008-7#2)
/= 2##3##2##(1996-2#1)(2008-7#1)(2009-2#1)
/= 25##2##2##(2008-10#1)(2008-3#1)
/= 25%)##2##2##(2008-10#2)
/= 3##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
/= 45##2##2##(2008-10#1)(2008-7#1)
/= 5##2##2##(2008-7#2)
/= 6##2##2##(2008-3#1)(2008-7#1)
/= 65 years##2##3##(2008-7#2)
/= 70% (range##2##3##(2008-12#2)
/= 8##2##2##(2008-7#2)
/= 90%##2##2##(2008-10#1)(2009-2#1)
/= Hgb &lt##7##3##(2008-7#7)
/= N &lt##2##3##(2008-2#2)
/= phi &lt##2##3##(2008-3#2)
/= phi(min)##2##2##(2008-3#2)
/=##138##1##(1996-2#1)(1997-7#1)(2006-10#5)(2008-10#47)(2008-12#4)(2008-2#11)(2008-3#19)(2008-6#2)(2008-7#40)(2008-9#1)(2009-2#3)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)
/=0##21##1##(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-5#1)(2010-8#2)
/=1##14##1##(2007-11#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-7#1)(2008-8#1)
/=10 000##2##2##(2008-10#1)(2008-11#1)
/=10##7##1##(2008-10#5)(2008-11#1)(2008-6#1)
/=10%##2##1##(2008-10#1)(2008-3#1)
/=120##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
/=18##3##1##(2008-10#2)(2008-11#1)
/=2##6##1##(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)
/=2% for##2##2##(2008-10#2)
/=2%##3##1##(2008-10#3)
/=20##3##1##(2008-10#3)
/=3##9##1##(2008-10#6)(2008-12#2)(2008-6#1)
/=4##7##1##(2008-10#6)(2010-4#1)
/=48 h##2##2##(2008-10#2)
/=5##3##1##(2008-10#3)
/=50 mug l(-1) As##3##4##(2008-10#3)
/=50##5##1##(2008-10#4)(2010-8#1)
/=50%##3##1##(2008-10#3)
/=6##4##1##(2007-11#1)(2008-10#3)
/=7##3##1##(2008-10#2)(2009-12#1)
/=90##2##1##(2010-3#2)
/=90%##3##1##(2008-10#2)(2008-6#1)
/=95%##2##1##(2008-10#2)
/=I&lt##2##1##(2008-10#2)
/=I/molkg(-1)&lt##3##1##(2008-10#3)
/=x(2pr)&lt##2##1##(2008-10#2)
/L)##2##1##(2008-6#2)
/P##3##1##(2007-2#3)
/V##2##1##(2007-11#2)
/day##4##1##(2007-8#1)(2011-1#2)(2013-1#1)
/etaeee/ and /etaneeee/##2##3##(2010-2#2)
/etaeee/##3##1##(2010-2#3)
/etaetaetaeta/##4##1##(2010-2#4)
/font&gt##2##1##(2010-11#2)
/kg##2##1##(2011-2#2)
/m2##2##1##(2013-7#2)
/ml##4##1##(2008-10#4)
0 %##4##2##(1997-8#1)(2008-8#1)(2012-12#2)
0 %)##4##2##(2007-10#2)(2008-3#1)(2011-2#1)
0 &gt##2##2##(1995-6#1)(2013-8#1)
0 &lt##5##2##(2008-3#4)(2013-1#1)
0 (0##4##2##(2008-10#3)(2008-5#1)
0 (1##5##2##(1993-12#1)(1994-9#1)(2012-3#1)(2013-8#2)
0 (C##2##2##(2008-7#1)(2013-1#1)
0 (I)##2##2##(2008-10#2)
0 (II)##2##2##(2008-10#2)
0 +/- 0##18##3##(1990-5#2)(1991-12#2)(1991-5#1)(1991-9#2)(1992-3#1)(1993-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1997-7#1)(2008-2#2)(2010-8#1)(2011-2#1)
0 +/- 1##4##3##(1991-5#1)(1992-2#1)(1994-2#1)(2009-8#1)
0 +/- 10##2##3##(1993-12#1)(2011-2#1)
0 +/- 16##2##3##(1993-3#1)(2008-1#1)
0 +/- 2##3##3##(1994-7#1)(2008-10#1)(2008-5#1)
0 +/- 3##3##3##(1994-7#1)(2010-1#1)(2010-7#1)
0 +/- 4##3##3##(1994-6#1)(2008-3#1)(2012-2#1)
0 +/- 5##3##3##(1991-9#1)(1994-2#1)(2008-11#1)
0 +/- 9##2##3##(2008-10#1)(2008-5#1)
0 +/-##52##2##(1990-5#2)(1991-12#2)(1991-5#2)(1991-9#3)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-2#2)(1994-6#1)(1994-7#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1997-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)
0 -##6##2##(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
0 =##5##2##(2008-10#1)(2008-11#1)(2013-1#3)
0 ? 0##2##3##(2008-2#1)(2008-3#1)
0 ?##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
0 A resolution##4##3##(1992-11#1)(1995-3#2)(1995-5#1)
0 A##9##2##(1992-11#1)(1995-3#3)(1995-5#1)(2008-8#4)
0 GW/cm(2))##2##2##(2007-11#2)
0 K##3##2##(1997-7#2)(2008-3#1)
0 LPC concentration##5##3##(2008-8#5)
0 LPC in the##2##4##(2008-8#2)
0 LPC##9##2##(2008-8#9)
0 LPC/DPPC##5##2##(2008-8#5)
0 M HCl##3##3##(2008-10#3)
0 M acid##2##3##(2008-10#2)
0 M urea##3##3##(1995-2#2)(2008-10#1)
0 M##18##2##(1990-5#1)(1993-12#1)(1995-2#2)(2008-10#13)(2009-10#1)
0 MPa##6##2##(2008-10#4)(2009-7#2)
0 Primary Scale##2##3##(2008-10#2)
0 Tesla##2##2##(2008-10#1)(2008-9#1)
0 V vs##2##3##(2008-10#2)
0 V##13##2##(2008-10#13)
0 V)##2##2##(2008-10#2)
0 W##2##2##(2008-3#2)
0 and 0##19##3##(1990-6#1)(1993-3#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-6#3)
0 and 1##11##3##(1991-5#1)(1994-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-12#1)
0 and 10##10##3##(1991-10#1)(1993-12#2)(1994-11#1)(1997-2#1)(2008-10#3)(2008-6#1)(2011-1#1)
0 and 12##4##3##(2008-10#2)(2008-6#1)(2013-1#1)
0 and 14##3##3##(1990-8#1)(2013-1#1)(2013-7#1)
0 and 15##2##3##(2008-10#2)
0 and 18##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
0 and 2##13##3##(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#6)(2008-11#2)(2011-2#2)
0 and 25##2##3##(2007-5#1)(2008-10#1)
0 and 3##10##3##(1994-3#1)(1996-12#1)(2008-10#6)(2008-3#1)(2011-1#1)
0 and 30##3##3##(1991-6#1)(2008-10#1)(2010-5#1)
0 and 300##2##3##(1993-12#1)(2008-10#1)
0 and 33##2##3##(2008-10#1)(2008-2#1)
0 and 37 degrees C##2##5##(1992-11#1)(2008-10#1)
0 and 4##10##3##(1990-7#1)(1996-12#1)(2008-10#8)
0 and 5##7##3##(1992-11#1)(2008-10#6)
0 and 6##8##3##(1990-8#1)(1994-9#1)(1996-12#1)(2008-10#4)(2008-5#1)
0 and 7##6##3##(1990-8#1)(2008-10#5)
0 and 80##2##3##(2008-10#1)(2008-3#1)
0 and 9##2##3##(1990-8#1)(2008-10#1)
0 and 98##2##3##(2008-10#2)
0 and 99##2##3##(2008-10#2)
0 and a detection limit of 3##2##7##(2008-10#2)
0 and a##4##3##(1995-12#1)(2008-10#2)(2010-3#1)
0 and analysis time was##2##5##(2008-10#2)
0 and at##6##3##(2008-10#4)(2008-6#1)(2013-1#1)
0 and in##2##3##(2008-10#2)
0 and the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
0 and then##2##3##(2008-10#2)
0 and##205##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-4#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#117)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#10)(2008-7#3)(2008-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2013-1#3)(2013-7#1)
0 approximately##2##2##(2008-10#2)
0 as the##3##3##(2008-10#2)(2008-11#1)
0 as##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
0 at##6##2##(1994-6#1)(2008-10#4)(2011-1#1)
0 band centered at##2##4##(1993-11#2)
0 billion##2##2##(1992-2#1)(1994-1#1)
0 buffer##2##2##(2008-10#2)
0 by##4##2##(1995-6#1)(2008-10#1)(2008-6#1)(2012-2#1)
0 cM)##2##2##(2008-10#2)
0 cells##2##2##(2008-11#2)
0 cm in##2##3##(2008-12#1)(2012-12#1)
0 cm##10##2##(1995-4#2)(2007-8#1)(2008-10#2)(2008-12#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
0 cm(-)(1)##2##2##(1997-7#2)
0 cm/s##2##2##(2008-7#2)
0 cm/sec##2##2##(1991-9#2)
0 compared with pH##2##4##(2008-10#2)
0 compared with##3##3##(2008-1#1)(2008-10#2)
0 containing##5##2##(1993-9#1)(2008-10#4)
0 dB##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
0 degree##4##2##(1992-9#1)(1993-11#1)(1993-8#1)(1995-2#1)
0 degrees &lt##2##3##(2008-2#1)(2008-3#1)
0 degrees C and##2##4##(1991-5#1)(1997-4#1)
0 degrees C for##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
0 degrees C##29##3##(1990-8#1)(1991-5#1)(1992-8#2)(1993-8#1)(1996-2#2)(1997-4#2)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#3)
0 degrees C)##7##3##(2007-10#2)(2008-10#3)(2008-2#1)(2010-8#1)
0 degrees and 90 degrees##2##5##(2008-2#2)
0 degrees and##3##3##(2008-2#2)(2008-8#1)
0 degrees to##4##3##(1996-2#1)(2007-12#2)(2008-3#1)
0 degrees##52##2##(1990-8#1)(1991-5#1)(1992-8#2)(1993-8#1)(1996-2#3)(1997-4#2)(2007-10#2)(2007-12#3)(2008-10#14)(2008-2#7)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#4)
0 diethanolamine-typed dendrimer##2##3##(2008-10#2)
0 each (g/L/h or g/g/h) at a dilution rate of 0##2##11##(2008-6#2)
0 for Cu##2##3##(2008-10#2)
0 for both##2##3##(1991-9#1)(2008-10#1)
0 for the##7##3##(1993-8#2)(2008-10#5)
0 for##31##2##(1990-8#1)(1991-9#1)(1993-8#2)(1993-9#2)(1994-6#1)(2008-1#1)(2008-10#19)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
0 from##2##2##(2008-10#1)(2012-3#1)
0 g l(-1) of fraction##2##5##(2008-11#2)
0 g l(-1)##3##3##(2008-10#1)(2008-11#2)
0 g of##8##3##(2008-10#7)(2008-5#1)
0 g##19##2##(2007-5#1)(2008-10#12)(2008-11#2)(2008-5#3)(2010-2#1)
0 h##3##2##(1995-12#2)(2008-11#1)
0 if##3##2##(2008-10#3)
0 in presence of##3##4##(2008-10#3)
0 in the presence of##2##5##(1992-6#1)(1994-5#1)
0 in the##6##3##(1992-6#1)(1994-5#1)(1995-2#1)(2007-5#1)(2008-10#1)(2009-7#1)
0 in##19##2##(1990-12#2)(1992-5#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(2007-5#1)(2008-1#1)(2008-10#7)(2009-7#1)(2012-2#1)
0 is##9##2##(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#2)
0 kDa##3##2##(2008-10#3)
0 kb in##2##3##(1990-2#1)(1997-2#1)
0 kb mRNA##2##3##(1994-9#1)(1997-2#1)
0 kb transcript##3##3##(1990-12#1)(1991-9#1)(1997-2#1)
0 kb##18##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-9#1)(1993-6#1)(1994-6#2)(1994-9#1)(1996-2#1)(1997-2#3)(2008-10#1)(2008-8#4)
0 kb) was##2##3##(1993-3#1)(1993-8#1)
0 kb)##4##2##(1993-3#3)(1993-8#1)
0 kcal mol-1##2##3##(1997-2#2)
0 kcal/mol for##2##3##(1996-2#2)
0 kcal/mol##6##2##(1993-8#2)(1996-2#2)(2012-12#2)
0 kcal/mol)##2##2##(1990-8#1)(1992-6#1)
0 kg##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)
0 kg/ha##2##2##(2011-1#2)
0 l and##2##3##(2008-10#2)
0 l##4##2##(2008-10#4)
0 log##2##2##(2008-10#1)(2008-5#1)
0 log10##2##2##(2007-6#2)
0 lyso-PC##4##2##(2008-8#4)
0 lyso-PC/DPPS molar##2##3##(2008-8#2)
0 m##9##2##(2008-10#4)(2008-3#4)(2008-8#1)
0 m)##2##2##(2008-10#1)(2008-5#1)
0 mL min(-1) and##2##4##(2008-5#2)
0 mL##5##2##(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
0 mL/min##2##2##(2008-10#1)(2011-1#1)
0 mM for##2##3##(1992-11#2)
0 mM with a##2##4##(1992-11#1)(2008-10#1)
0 mM##21##2##(1990-11#1)(1992-11#4)(1992-3#1)(1997-2#1)(2008-10#9)(2008-8#3)(2009-6#1)(2011-2#1)
0 mM)##3##2##(2009-6#1)(2011-2#2)
0 mV##7##2##(1993-8#1)(1995-12#1)(1996-5#1)(2008-10#4)
0 mV)##2##2##(1990-5#1)(1996-5#1)
0 mV/decade##2##2##(2008-10#2)
0 mg L(-1) 2##2##4##(2008-12#2)
0 mg L(-1) BAP##2##4##(2008-12#2)
0 mg L(-1)##5##3##(2008-10#1)(2008-12#4)
0 mg and##2##3##(1993-2#1)(2008-10#1)
0 mg kg(-1) for##2##4##(2008-12#2)
0 mg l(-1) for##2##4##(2008-10#2)
0 mg l(-1) of##3##4##(2008-10#3)
0 mg l(-1) with a##2##5##(2008-10#2)
0 mg l(-1)##17##3##(2008-10#17)
0 mg mL(-1)##4##3##(2008-5#4)
0 mg##35##2##(1992-5#1)(1993-2#1)(2008-10#21)(2008-12#6)(2008-5#4)(2012-2#1)(2013-8#1)
0 mg/L 6-BA and 0##2##5##(2008-8#2)
0 mg/L##5##2##(2008-10#1)(2008-8#3)(2011-1#1)
0 mg/L)##2##2##(2013-1#2)
0 mg/h##2##2##(1992-5#2)
0 mg/kg body weight##2##4##(2008-4#2)
0 mg/kg##15##2##(1990-12#1)(1991-10#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-4#4)(2008-7#2)
0 mg/kg)##3##2##(1990-7#1)(1991-10#1)(1996-2#1)
0 mg/ml##2##2##(2008-11#2)
0 mgl(-1)##4##2##(2008-10#4)
0 microM##6##2##(1990-10#1)(1992-11#1)(1992-3#2)(1993-8#1)(1995-6#1)
0 microM) and##2##3##(1990-5#1)(2008-8#1)
0 microM)##4##2##(1990-5#1)(1992-3#1)(1994-6#1)(2008-8#1)
0 microW/cm(2) UVA##2##3##(2008-11#2)
0 microW/cm(2)##4##2##(2008-11#4)
0 microg l(-1)##2##3##(2008-10#2)
0 microg ml(-1)##3##3##(2008-10#3)
0 microg##14##2##(2008-10#10)(2008-5#1)(2010-5#2)(2011-1#1)
0 microg/l for##2##3##(2008-10#2)
0 microg/l##3##2##(2008-10#3)
0 microgml(-1)##2##2##(2008-10#2)
0 micrograms##2##2##(1990-5#1)(1993-8#1)
0 micrograms/ml##2##2##(1990-5#1)(1997-4#1)
0 micrograms/side)##2##2##(1993-12#2)
0 microm##8##2##(1996-12#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
0 micromol L(-1)##2##3##(2008-10#2)
0 micromol##3##2##(2008-10#3)
0 min for##3##3##(2008-10#2)(2008-3#1)
0 min region on the linkage map (supplement)##2##8##(1996-12#1)(1996-6#1)
0 min region on the linkage map##4##7##(1996-12#2)(1996-6#2)
0 min region on the##5##5##(1996-12#3)(1996-6#2)
0 min region##6##3##(1996-12#4)(1996-6#2)
0 min##15##2##(1996-12#4)(1996-6#2)(1996-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2013-1#1)
0 ml min(-1) for##3##4##(2008-10#3)
0 ml min(-1)##15##3##(2008-10#15)
0 ml min(-1))##2##3##(2008-10#2)
0 ml of sample volume)##2##5##(2008-10#2)
0 ml of##5##3##(2008-10#5)
0 ml##27##2##(1993-3#1)(2008-10#26)
0 ml/min##3##2##(1995-6#1)(2009-8#1)(2010-3#1)
0 mlmin(-1)##3##2##(2008-10#3)
0 mm Hg##2##3##(1994-11#1)(2008-3#1)
0 mm for##2##3##(2008-12#1)(2009-2#1)
0 mm##25##2##(1994-11#1)(1996-5#1)(2007-5#1)(2008-10#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-8#4)(2010-8#2)(2011-1#1)
0 mm)##5##2##(2008-12#1)(2008-9#1)(2009-8#2)(2012-2#1)
0 mmHg##2##2##(2008-11#2)
0 mmol l(-1)##2##3##(2008-10#2)
0 mmol##3##2##(2008-10#2)(2008-9#1)
0 mmol/kg##4##2##(1992-12#2)(1996-12#2)
0 mol dm(-3)##4##3##(2008-10#4)
0 mol dm(-3))##4##3##(2008-10#4)
0 mol l(-1) HCl##2##4##(2008-10#2)
0 mol l(-1) NaOH##2##4##(2008-10#2)
0 mol l(-1)##8##3##(2008-10#8)
0 mol l(-1))##2##3##(2008-10#2)
0 mol##21##2##(2007-12#1)(2008-10#20)
0 mol% 16##2##3##(2008-8#2)
0 mol%##5##2##(2008-5#2)(2008-8#3)
0 mol/L##4##2##(2008-4#1)(2011-1#3)
0 ms##3##2##(1991-2#1)(1993-3#1)(1994-3#1)
0 muM (R=0##2##3##(2008-10#2)
0 muM##4##2##(2008-10#4)
0 mug As l(-1)##2##4##(2008-10#2)
0 mug Cd l(-1)##2##4##(2008-10#2)
0 mug Mo l(-1)##2##4##(2008-10#2)
0 mug Mo##3##3##(2008-10#3)
0 mug g(-1)##2##3##(2008-10#2)
0 mug in##2##3##(2008-10#2)
0 mug l(-1)##16##3##(2008-10#16)
0 mug ml(-1) cobalt##2##4##(2008-10#2)
0 mug ml(-1) for both##2##5##(2008-10#2)
0 mug ml(-1) for calf thymus DNA##2##7##(2008-10#2)
0 mug ml(-1) for fish sperm DNA##2##7##(2008-10#2)
0 mug ml(-1) for yeast RNA##2##6##(2008-10#2)
0 mug ml(-1) for##18##4##(2008-10#18)
0 mug ml(-1) of##5##4##(2008-10#5)
0 mug ml(-1)##38##3##(2008-10#37)(2008-11#1)
0 mug ml(-1))##2##3##(2008-10#2)
0 mug of cobalt##2##4##(2008-10#2)
0 mug of##6##3##(2008-10#6)
0 mug##82##2##(2008-10#79)(2008-11#1)(2008-5#2)
0 mug/g BW)##2##3##(2008-10#2)
0 mug/l##2##2##(2008-10#2)
0 mug/ml##5##2##(2008-10#3)(2010-3#2)
0 mugl(-1) for##2##3##(2008-10#2)
0 mum##17##2##(1992-2#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-8#2)
0 mumol of##2##3##(2008-10#2)
0 mumol##7##2##(1990-7#4)(1996-12#1)(2008-10#2)
0 ng for##4##3##(2008-10#4)
0 ng ml(-1) and##2##4##(2008-10#2)
0 ng ml(-1) for##5##4##(2008-10#5)
0 ng ml(-1) vanadium##2##4##(2008-10#2)
0 ng ml(-1) was##2##4##(2008-10#2)
0 ng ml(-1)##25##3##(2008-10#25)
0 ng##42##2##(2008-10#40)(2010-5#2)
0 ng/mL##2##2##(2008-10#1)(2011-1#1)
0 ngcm(-3))##2##2##(2008-10#2)
0 nm##16##2##(1992-6#2)(2008-10#7)(2008-3#3)(2009-11#1)(2010-5#3)
0 of##5##2##(1990-6#1)(1996-12#1)(2008-10#3)
0 on##3##2##(1991-3#1)(2008-10#2)
0 or 1##3##3##(1991-4#1)(2008-10#2)
0 or 2##4##3##(2008-10#4)
0 or 3##2##3##(1994-11#1)(2008-5#1)
0 or##13##2##(1991-4#1)(1994-11#1)(2007-12#1)(2008-10#9)(2008-5#1)
0 per##4##2##(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)
0 percent##3##2##(1991-1#1)(2008-1#1)(2008-8#1)
0 pg for##2##3##(2008-10#2)
0 pg##3##2##(2008-10#3)
0 pg)##2##2##(2008-10#2)
0 phosphate buffer##2##3##(2008-10#2)
0 photoperiod##2##2##(2008-7#2)
0 pmol for##3##3##(1990-8#2)(2008-10#1)
0 ppb for##2##3##(2008-10#2)
0 ppb##5##2##(2008-10#5)
0 ppm of ozone##2##4##(1991-9#2)
0 ppm with##2##3##(2008-10#2)
0 ppm##9##2##(1991-9#2)(2008-10#7)
0 ppm)##2##2##(1993-11#1)(2008-10#1)
0 pyrrolidine-phosphoric acid buffer solution##2##5##(2008-10#2)
0 pyrrolidine-phosphoric acid buffer##3##4##(2008-10#3)
0 respectively##2##2##(1996-12#1)(2013-8#1)
0 sigma(I)) converged to a final R =##2##8##(1997-7#2)
0 the##2##2##(1995-2#1)(2008-10#1)
0 then##2##2##(2012-3#2)
0 to 0##10##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-4#1)(2011-1#1)
0 to 1##10##3##(2008-10#7)(2008-5#1)(2009-6#1)(2011-2#1)
0 to 10##6##3##(2008-10#2)(2008-5#1)(2008-7#2)(2009-11#1)
0 to 100##6##3##(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)
0 to 12##4##3##(2008-10#3)(2012-1#1)
0 to 13##3##3##(1993-6#1)(2008-10#1)(2008-3#1)
0 to 150 kg N##2##5##(2008-12#2)
0 to 150##3##3##(2008-10#1)(2008-12#2)
0 to 16##4##3##(2008-10#3)(2008-5#1)
0 to 17##2##3##(2008-5#1)(2013-8#1)
0 to 18##2##3##(1995-5#1)(2008-10#1)
0 to 2##4##3##(1996-2#1)(2008-10#1)(2010-8#1)(2012-12#1)
0 to 20##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
0 to 200##2##3##(2008-10#1)(2008-3#1)
0 to 25%##2##3##(2008-10#2)
0 to 3##8##3##(1994-3#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)
0 to 30 degrees##2##4##(2007-8#1)(2008-10#1)
0 to 30##8##3##(1990-12#1)(2007-8#1)(2008-10#5)(2013-1#1)
0 to 35##2##3##(2008-10#2)
0 to 4##4##3##(1995-12#1)(2008-11#1)(2009-2#1)(2010-7#1)
0 to 40##2##3##(2008-10#2)
0 to 5 x##2##4##(2008-10#1)(2008-3#1)
0 to 5##7##3##(1990-11#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-6#1)
0 to 6##5##3##(1991-9#1)(2007-6#2)(2008-10#2)
0 to 65##2##3##(1991-11#1)(2008-3#1)
0 to 7##8##3##(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
0 to 72##2##3##(2008-10#1)(2010-8#1)
0 to 8##5##3##(1994-3#1)(1995-5#1)(2007-8#1)(2008-10#2)
0 to 9##2##3##(2008-10#1)(2013-8#1)
0 to##195##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#93)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#11)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-6#2)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#2)
0 versus##3##2##(1997-6#2)(2013-1#1)
0 vs##17##2##(1991-5#1)(1995-12#1)(2007-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-8#1)
0 was used##2##3##(2008-10#1)(2011-1#1)
0 was##10##2##(1992-3#1)(1994-2#1)(2008-10#5)(2008-2#1)(2011-1#1)(2011-3#1)
0 weeks##2##2##(2008-3#1)(2013-8#1)
0 were##4##2##(2008-10#1)(2008-11#2)(2011-1#1)
0 when the flow rate##2##5##(2008-10#2)
0 when##3##2##(2008-10#2)(2008-3#1)
0 with a fast response time of approximately##2##8##(2008-10#2)
0 with a fast response time of##3##7##(2008-10#3)
0 with a##5##3##(2008-10#5)
0 with##16##2##(1991-8#1)(2008-10#11)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
0 wt%##2##2##(2008-5#1)(2009-11#1)
0 x 10(-1) mol 1(-1) and##2##6##(2008-10#2)
0 x 10(-1) mol##3##4##(2008-10#3)
0 x 10(-1)##4##3##(2008-10#4)
0 x 10(-1)M##4##3##(2008-10#4)
0 x 10(-10) M##2##4##(1994-5#1)(1995-12#1)
0 x 10(-10)##4##3##(1994-5#1)(1995-12#1)(2008-10#1)(2008-3#1)
0 x 10(-2)##2##3##(2008-10#2)
0 x 10(-2)-2##2##3##(2008-10#2)
0 x 10(-3) mol l(-1)##2##5##(2008-10#2)
0 x 10(-3)##4##3##(1996-2#1)(2008-10#3)
0 x 10(-3)-1##2##3##(2008-10#2)
0 x 10(-4) mol l(-1)##2##5##(2008-10#2)
0 x 10(-4)##4##3##(2008-10#3)(2008-2#1)
0 x 10(-5) M##2##4##(2008-10#2)
0 x 10(-5) to 1##2##5##(2008-10#2)
0 x 10(-5) to##3##4##(2008-10#3)
0 x 10(-5)##6##3##(2008-10#6)
0 x 10(-5)M##4##3##(2008-10#4)
0 x 10(-6) and 1##2##5##(2008-10#2)
0 x 10(-6) and##3##4##(2008-10#3)
0 x 10(-6) mol l(-1)##2##5##(2008-10#2)
0 x 10(-6) mol##4##4##(2008-10#3)(2013-8#1)
0 x 10(-6)##11##3##(1990-8#1)(1992-5#1)(2008-10#8)(2013-8#1)
0 x 10(-6)mol##2##3##(2008-10#2)
0 x 10(-7) mol l(-1) concentration range##2##7##(2008-10#2)
0 x 10(-7) mol l(-1) for##2##6##(2008-10#2)
0 x 10(-7) mol l(-1)##6##5##(2008-10#6)
0 x 10(-7) mol##7##4##(2008-10#7)
0 x 10(-7) to 1##5##5##(2008-10#5)
0 x 10(-7) to##8##4##(2008-10#7)(2008-3#1)
0 x 10(-7)##16##3##(2008-10#15)(2008-3#1)
0 x 10(-7)M##2##3##(2008-10#2)
0 x 10(-7)mol L(-1) and##2##5##(2008-10#2)
0 x 10(-7)molL(-1)##2##3##(2008-10#2)
0 x 10(-8) g ml(-1)##2##5##(2008-10#2)
0 x 10(-8) to 1##2##5##(2008-10#1)(2013-8#1)
0 x 10(-8) to 2##2##5##(2008-10#2)
0 x 10(-8) to##4##4##(2008-10#3)(2013-8#1)
0 x 10(-8)##7##3##(2008-10#6)(2013-8#1)
0 x 10(-9)##3##3##(2008-10#3)
0 x 10(-9)M##2##3##(2008-10#2)
0 x 10(4) M(-1)##2##4##(2008-10#1)(2008-8#1)
0 x 10(4)##3##3##(2008-10#2)(2008-8#1)
0 x 10(5)##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
0 x 10(6)##3##3##(1994-5#2)(2008-11#1)
0 x 105 cells mL-1##2##5##(2008-11#2)
0 x 109/l with a median of##2##7##(2008-10#2)
0 x 109/l##3##3##(2008-10#3)
0 x##122##2##(1990-8#1)(1992-5#1)(1993-8#1)(1994-5#3)(1995-12#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-10#100)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2013-8#2)
0 year##3##2##(2010-8#3)
0 years##5##2##(1990-9#1)(1992-9#1)(2008-11#1)(2008-7#1)(2009-8#1)
0 years)##5##2##(1997-2#1)(2008-7#1)(2009-7#1)(2012-12#1)(2013-8#1)
0 ± 0##2##3##(2012-3#1)(2013-1#1)
0 ±##5##2##(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
0 × 10(7) copies/ml group##2##5##(2011-1#2)
0 × 10(7) copies/ml##3##4##(2011-1#3)
0##13310##1##(1990-10#6)(1990-11#20)(1990-12#34)(1990-2#54)(1990-3#17)(1990-4#2)(1990-5#31)(1990-6#18)(1990-7#32)(1990-8#44)(1990-9#8)(1991-1#1)(1991-10#8)(1991-11#34)(1991-12#39)(1991-2#21)(1991-3#16)(1991-4#5)(1991-5#49)(1991-6#9)(1991-7#5)(1991-8#33)(1991-9#56)(1992-10#10)(1992-11#55)(1992-12#39)(1992-2#25)(1992-3#69)(1992-4#5)(1992-5#16)(1992-6#47)(1992-7#3)(1992-8#19)(1992-9#34)(1993-1#40)(1993-10#8)(1993-11#28)(1993-12#48)(1993-2#37)(1993-3#26)(1993-6#14)(1993-8#54)(1993-9#27)(1994-1#5)(1994-10#3)(1994-11#27)(1994-12#54)(1994-2#30)(1994-3#43)(1994-5#45)(1994-6#51)(1994-7#9)(1994-8#40)(1994-9#33)(1995-1#2)(1995-11#25)(1995-12#103)(1995-2#77)(1995-3#49)(1995-4#6)(1995-5#28)(1995-6#32)(1995-8#38)(1995-9#6)(1996-1#7)(1996-11#2)(1996-12#79)(1996-2#87)(1996-3#14)(1996-4#1)(1996-5#38)(1996-6#12)(1996-7#8)(1996-8#9)(1996-9#12)(1997-1#10)(1997-2#59)(1997-3#14)(1997-4#41)(1997-5#28)(1997-6#25)(1997-7#53)(1997-8#27)(2006-10#28)(2006-4#2)(2006-6#2)(2006-8#3)(2007-1#3)(2007-10#46)(2007-11#131)(2007-12#127)(2007-2#12)(2007-3#4)(2007-5#22)(2007-6#4)(2007-7#33)(2007-8#93)(2007-9#7)(2008-1#100)(2008-10#5154)(2008-11#278)(2008-12#237)(2008-2#240)(2008-3#580)(2008-4#41)(2008-5#327)(2008-6#115)(2008-7#321)(2008-8#179)(2008-9#188)(2009-1#4)(2009-10#9)(2009-11#33)(2009-12#11)(2009-2#13)(2009-3#22)(2009-4#19)(2009-5#6)(2009-6#20)(2009-7#18)(2009-8#45)(2009-9#28)(2010-1#33)(2010-10#12)(2010-11#33)(2010-12#31)(2010-2#93)(2010-3#48)(2010-4#89)(2010-5#32)(2010-6#32)(2010-7#19)(2010-8#65)(2010-9#21)(2011-1#288)(2011-2#437)(2011-3#54)(2012-1#31)(2012-12#106)(2012-2#161)(2012-3#139)(2012-7#3)(2012-8#1)(2013-1#438)(2013-7#57)(2013-8#204)
0% (P &lt##2##3##(2008-11#1)(2013-1#1)
0% (n=10)##3##2##(2008-10#3)
0% (v/v)##2##2##(2008-10#2)
0% against##3##2##(1995-6#1)(2008-5#2)
0% and 0##2##3##(2008-10#2)
0% and 66##2##3##(1990-12#1)(2008-8#1)
0% and 95##2##3##(1990-8#1)(2013-1#1)
0% and a##2##3##(2008-10#1)(2008-3#1)
0% and the##4##3##(1991-2#1)(2008-10#2)(2008-2#1)
0% and##36##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#5)(2011-3#1)(2012-2#1)(2013-1#2)
0% arginine##4##2##(2011-2#4)
0% as##2##2##(1994-6#1)(2007-8#1)
0% at 5 years##2##4##(2007-8#2)
0% at the##4##3##(1996-5#1)(2008-10#3)
0% at##10##2##(1995-12#1)(1996-5#1)(2007-11#1)(2007-8#4)(2008-10#3)
0% by##2##2##(2008-10#1)(2012-2#1)
0% for a##2##3##(2008-10#2)
0% for all##2##3##(2008-10#2)
0% for the##4##3##(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#1)
0% for##30##2##(1994-11#1)(1997-2#1)(1997-7#1)(2008-10#21)(2008-3#4)(2012-12#1)(2012-3#1)
0% in the control##2##4##(1994-8#1)(2012-12#1)
0% in the##5##3##(1990-2#1)(1994-8#1)(2008-2#1)(2012-12#1)(2012-2#1)
0% in##22##2##(1990-2#1)(1990-9#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-4#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
0% increase##2##2##(2013-1#2)
0% knew##2##2##(2008-11#2)
0% of the##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
0% of##19##2##(1990-2#1)(1991-6#1)(2008-10#4)(2008-12#2)(2008-5#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
0% relative standard deviation (R##2##5##(2008-10#2)
0% respectively##5##2##(1990-2#1)(2010-3#2)(2010-8#1)(2013-8#1)
0% to##8##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
0% v/v##9##2##(2008-10#3)(2008-5#6)
0% versus##2##2##(1991-6#1)(1995-3#1)
0% vs##5##2##(1990-3#1)(1991-4#1)(1994-2#1)(2011-2#1)(2013-8#1)
0% was##2##2##(2008-10#1)(2013-1#1)
0% were obtained for##2##4##(2008-10#2)
0% were obtained##4##3##(2008-10#4)
0% were##8##2##(2008-10#6)(2012-2#1)(2012-3#1)
0% with##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
0%##374##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-6#3)(1992-3#1)(1992-6#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#9)(2008-1#1)(2008-10#162)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#10)(2008-5#15)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-4#2)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-8#3)(2011-1#21)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#14)(2013-1#10)(2013-8#6)
0%) and is##2##3##(2008-10#1)(2008-6#1)
0%) and##11##2##(1992-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
0%) had##4##2##(1994-12#1)(1996-6#1)(2008-8#1)(2012-3#1)
0%) in group P##2##4##(2007-8#2)
0%) in##5##2##(1993-1#1)(2007-8#2)(2008-1#1)(2013-8#1)
0%) of##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
0%) on##2##2##(2012-3#2)
0%) or##2##2##(1990-3#1)(2012-3#1)
0%) people##2##2##(2008-11#2)
0%) were##7##2##(1995-3#1)(1997-7#1)(2007-10#2)(2007-7#1)(2008-10#1)(2012-3#1)
0%)##100##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#2)(1995-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#6)(2010-4#2)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#10)(2013-1#3)(2013-8#4)
0&lt##4##1##(2008-10#4)
0(2##5##1##(1996-5#3)(2007-11#1)(2008-10#1)
0) and BALB/cByJ (mean##2##4##(2008-5#2)
0) and a##2##3##(1990-9#1)(1991-12#1)
0) and the##2##3##(1991-12#1)(2011-1#1)
0) and##33##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#2)(1994-8#1)(1995-12#1)(1995-6#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#1)
0) are##2##2##(2008-3#1)(2008-8#1)
0) at##4##2##(1990-9#1)(1994-3#1)(1995-8#1)(1997-2#1)
0) band of OH##2##4##(2008-2#1)(2008-3#1)
0) band##3##2##(2008-2#2)(2008-3#1)
0) containing##4##2##(1994-9#1)(2008-10#3)
0) could detect fsDNA over the range of##2##8##(2008-10#2)
0) for##4##2##(1997-4#1)(2008-10#3)
0) g/L and 0##2##4##(2008-8#2)
0) in the##3##3##(1994-12#1)(2008-10#2)
0) in##10##2##(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#6)(2013-1#1)
0) is##2##2##(2008-10#1)(2008-11#1)
0) or##4##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#1)
0) to##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
0) transitions##2##2##(2008-3#2)
0) using##2##2##(2011-2#1)(2013-1#1)
0) was##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
0) weeks##2##2##(1991-8#2)
0) were##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
0) when##2##2##(2008-10#1)(2008-6#1)
0) with a##2##3##(1996-5#1)(2008-10#1)
0) with##3##2##(1996-5#1)(2008-10#2)
0) x##2##2##(1991-12#1)(2008-9#1)
0)##208##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-8#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#81)(2008-11#8)(2008-12#1)(2008-2#11)(2008-3#14)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#1)
0))##3##1##(2008-10#2)(2012-3#1)
0)/I(294##3##1##(2008-10#3)
0)G(0##3##1##(2008-5#3)
0)R(1##3##1##(2008-5#3)
0+ to##2##2##(2008-10#1)(2010-8#1)
0+##4##1##(2008-10#3)(2010-8#1)
0+/-0##24##1##(2007-12#1)(2007-8#3)(2008-10#19)(2008-7#1)
0+/-1##8##1##(2008-10#7)(2008-7#1)
0- and##4##2##(1990-2#1)(1993-8#1)(2008-10#2)
0- to##4##2##(2008-10#3)(2012-3#1)
0-##16##1##(1990-12#1)(1990-2#1)(1993-8#1)(1995-6#1)(2007-11#2)(2008-10#6)(2008-11#1)(2012-2#2)(2012-3#1)
0--&gt##3##1##(2008-10#3)
0-0##17##1##(1992-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)
0-1##11##1##(2007-11#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
0-10 min##2##2##(1994-12#1)(1995-11#1)
0-10##25##1##(1994-12#1)(1995-1#1)(1995-11#1)(2008-10#15)(2008-7#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
0-100##10##1##(1990-5#1)(2008-10#7)(2008-3#1)(2008-9#1)
0-100% of##2##2##(1993-12#1)(2012-8#1)
0-100%##3##1##(1993-12#1)(2012-3#1)(2012-8#1)
0-100)##2##1##(2008-10#2)
0-1000ngmL(-1)##2##1##(2008-10#2)
0-11##5##1##(2008-10#5)
0-12##13##1##(1993-6#1)(2007-11#1)(2008-10#7)(2008-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
0-13##2##1##(2008-10#2)
0-14 years##2##2##(1997-3#1)(2010-3#1)
0-14##4##1##(1994-12#1)(1997-3#1)(2010-3#1)(2012-3#1)
0-140##2##1##(2007-12#1)(2008-10#1)
0-15 years##2##2##(1994-6#1)(2011-1#1)
0-15##4##1##(1994-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
0-150##4##1##(2008-10#4)
0-17##3##1##(2008-10#2)(2013-8#1)
0-18##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
0-180##2##1##(2008-10#1)(2008-2#1)
0-19##4##1##(2007-11#1)(2008-10#1)(2010-3#2)
0-2##23##1##(1990-2#2)(1992-6#1)(1995-4#2)(2007-8#1)(2008-10#12)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
0-20##5##1##(2008-10#4)(2013-8#1)
0-200##3##1##(2008-10#3)
0-24##2##1##(2008-10#1)(2008-7#1)
0-25##4##1##(2008-10#3)(2010-5#1)
0-29##2##1##(2010-3#1)(2013-1#1)
0-3##21##1##(1990-5#1)(1990-8#1)(1993-8#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-10#7)(2008-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
0-30##5##1##(2008-10#3)(2010-3#1)(2012-3#1)
0-300##2##1##(2008-10#2)
0-32##2##1##(1996-9#1)(2008-10#1)
0-3R)##2##1##(2013-8#2)
0-4##13##1##(1990-7#1)(1991-12#1)(1991-3#1)(1993-8#1)(2007-12#1)(2008-10#6)(2008-5#1)(2012-3#1)
0-40##9##1##(1996-12#3)(2008-10#5)(2010-3#1)
0-5 years##2##2##(2012-2#1)(2013-8#1)
0-5##29##1##(1991-11#1)(1991-12#1)(1992-12#1)(1996-2#1)(2008-10#11)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
0-50##4##1##(1992-3#1)(2008-10#3)
0-500##2##1##(1996-5#1)(2008-10#1)
0-6##22##1##(1992-3#1)(1993-8#1)(1994-11#1)(2006-6#1)(2008-10#16)(2008-6#1)(2010-4#1)
0-60##4##1##(2008-10#3)(2008-8#1)
0-7##27##1##(1991-5#1)(1996-5#1)(2007-12#1)(2008-10#22)(2008-11#1)(2013-1#1)
0-74##2##1##(1992-2#1)(2008-10#1)
0-75##2##1##(2008-10#1)(2008-3#1)
0-8##25##1##(1990-5#1)(1991-12#1)(1994-12#1)(2008-10#20)(2008-4#1)(2012-3#1)
0-80##2##1##(2008-10#2)
0-9##13##1##(1995-12#1)(1996-5#1)(1997-6#1)(2008-10#8)(2008-6#1)(2008-7#1)
0-II##2##1##(2008-5#1)(2013-1#1)
0-fold##4##1##(1993-9#1)(1994-6#1)(2008-8#1)(2011-2#1)
0-kb##3##1##(1994-12#2)(1997-8#1)
0-mm##2##1##(2007-11#1)(2012-1#1)
0-mum wavelength range##2##3##(2008-3#2)
0-mum##3##1##(2008-2#1)(2008-3#2)
0-nm wavelength range##2##3##(2008-3#2)
0/1 lymphocytic##2##2##(1993-9#2)
0/1##3##1##(1992-8#1)(1993-9#2)
0/10##3##1##(2008-12#1)(2012-2#2)
0/18##8##1##(1990-2#5)(1990-8#1)(1995-8#2)
0/20##5##1##(1990-2#5)
00 (+/-0##2##2##(2008-10#2)
00 (95% CI##2##3##(2008-12#2)
00 +/- 0##2##3##(2011-2#1)(2011-3#1)
00 +/-##3##2##(2011-2#1)(2011-3#2)
00 M##2##2##(2008-10#2)
00 U##2##2##(2008-10#1)(2010-10#1)
00 and 3##3##3##(2008-10#3)
00 and##7##2##(2008-10#5)(2012-12#2)
00 degrees##2##2##(2008-10#1)(2013-1#1)
00 for##2##2##(1997-5#1)(2008-10#1)
00 g##2##2##(2008-10#2)
00 h##9##2##(1993-12#6)(1995-11#2)(2008-3#1)
00 hours##4##2##(2008-5#1)(2009-9#2)(2012-12#1)
00 in##4##2##(1994-2#2)(2007-12#1)(2008-10#1)
00 mg l(-1)##2##3##(2008-10#2)
00 mg##4##2##(2008-10#4)
00 mg/kg##4##2##(1992-11#2)(2008-4#1)(2011-1#1)
00 micrometer##2##2##(2013-1#2)
00 ml of##2##3##(2008-10#2)
00 ml##4##2##(2008-10#4)
00 mol l(-1) NaCl were##2##5##(2008-10#2)
00 mol l(-1) NaCl##3##4##(2008-10#3)
00 mol l(-1)##4##3##(2008-10#4)
00 mug l(-1)##2##3##(2008-10#2)
00 mug ml(-1) for##3##4##(2008-10#3)
00 mug ml(-1) of##3##4##(2008-10#3)
00 mug ml(-1)##12##3##(2008-10#12)
00 mug##14##2##(2008-10#14)
00 p##2##2##(1990-2#1)(1992-12#1)
00 phosphate buffer##2##3##(2008-10#2)
00 to 0##6##3##(2008-10#6)
00 to 22##2##3##(2012-12#2)
00 to 3##2##3##(2008-10#2)
00 to##21##2##(1992-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-10#10)(2012-12#5)(2013-1#1)
00 x 10(-2)) and (5##2##5##(2008-10#2)
00 x 10(-2))M in##2##4##(2008-10#2)
00 x##6##2##(2008-10#6)
00##188##1##(1990-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#1)(1993-12#7)(1993-9#1)(1994-11#1)(1994-2#3)(1995-11#3)(1995-12#3)(1995-6#1)(1997-4#2)(1997-5#1)(1997-6#5)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#86)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#3)(2008-7#5)(2009-12#1)(2009-9#2)(2010-10#2)(2011-1#6)(2011-2#4)(2011-3#2)(2012-12#11)(2013-1#5)(2013-8#1)
00%##11##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#3)(2012-12#1)(2012-2#1)
00)##14##1##(1995-3#2)(1997-3#1)(1997-4#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
00+/-0##3##1##(2008-10#2)(2008-11#1)
00-3##2##1##(2008-10#2)
00-50##4##1##(2008-10#4)
00/##3##1##(2008-4#3)
00/lb##3##1##(2008-6#3)
000 (1998)##3##2##(2007-12#3)
000 (DARPP-32)##2##2##(1991-10#2)
000 (activated##2##2##(1993-11#2)
000 (p34)##2##2##(1990-11#2)
000 (p40) and 34##2##4##(1990-11#2)
000 -##2##2##(2008-7#1)(2011-1#1)
000 AIDS cases##2##3##(1993-8#1)(1995-12#1)
000 AIDS##3##2##(1993-8#1)(1995-12#1)(2010-8#1)
000 Da protein##2##3##(1991-5#1)(1992-12#1)
000 Da##6##2##(1991-5#1)(1992-12#1)(1993-3#1)(2008-10#1)(2008-5#1)(2010-12#1)
000 Da)##3##2##(2008-10#2)(2008-5#1)
000 IU##2##2##(1994-3#1)(2008-7#1)
000 J2##2##2##(2008-10#2)
000 K##2##2##(2008-2#1)(2008-7#1)
000 MW##2##2##(1992-3#2)
000 Medicare##2##2##(1993-12#1)(1994-3#1)
000 PY (95% CI##2##4##(2012-2#2)
000 PY (95%##3##3##(2012-2#3)
000 PY)##3##2##(2012-2#3)
000 U once weekly##6##4##(2008-7#6)
000 U subcutaneously##2##3##(2008-7#2)
000 U##12##2##(2007-12#1)(2008-7#8)(2011-1#2)(2011-2#1)
000 and 0##3##3##(2011-1#3)
000 and 1##2##3##(2008-10#1)(2012-12#1)
000 and 2##4##3##(2008-5#1)(2008-9#3)
000 and is##2##3##(1990-2#1)(2008-8#1)
000 and##36##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#3)(2011-1#3)(2012-12#1)(2012-2#1)
000 are##3##2##(1997-6#1)(2008-10#2)
000 as##2##2##(1990-7#1)(2011-2#1)
000 at##3##2##(1996-2#1)(1997-6#1)(2008-3#1)
000 award##2##2##(1995-6#2)
000 births##2##2##(1995-2#1)(2012-12#1)
000 by the year 2000##2##5##(1997-6#2)
000 by the##3##3##(1990-12#1)(1997-6#2)
000 by##4##2##(1990-12#1)(1990-2#1)(1997-6#2)
000 cancer##2##2##(1990-10#1)(1991-3#1)
000 cases of##3##3##(1990-3#1)(1995-12#1)(2012-12#1)
000 cases##7##2##(1990-3#1)(1992-9#1)(1993-8#1)(1995-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
000 cells##5##2##(2008-10#2)(2008-11#1)(2008-7#2)
000 cells/ml##3##2##(1993-2#1)(1994-2#1)(1996-8#1)
000 children##7##2##(1990-2#1)(1997-6#2)(2008-1#1)(2008-11#1)(2008-6#1)(2012-12#1)
000 chlamydospores g(1) of soil##2##5##(2008-10#2)
000 chlamydospores per g of##2##5##(2008-10#2)
000 chlamydospores per gram of soil)##3##6##(2008-10#3)
000 chlamydospores per gram of##4##5##(2008-10#4)
000 chlamydospores per##6##3##(2008-10#6)
000 chlamydospores##8##2##(2008-10#8)
000 clones were##2##3##(2008-8#1)(2010-10#1)
000 clones##3##2##(2008-8#1)(2010-10#1)(2011-1#1)
000 cm(-1)##3##2##(2007-11#1)(2008-3#2)
000 consecutive##2##2##(1994-3#1)(2012-2#1)
000 copies##2##2##(1996-12#1)(2009-8#1)
000 daltons##2##2##(1990-2#1)(2008-10#1)
000 deaths per year##2##4##(2010-3#1)(2012-2#1)
000 deaths##4##2##(1997-2#1)(2010-3#2)(2012-2#1)
000 epinephrine##3##2##(1993-1#3)
000 exposed##2##2##(2007-12#2)
000 expressed sequence tags##2##4##(2008-8#1)(2010-10#1)
000 females##2##2##(1991-6#1)(1997-4#1)
000 for the##4##3##(1995-2#1)(1997-4#3)
000 for##10##2##(1995-2#1)(1996-1#1)(1996-5#2)(1997-4#3)(2008-1#1)(2008-3#1)(2012-12#1)
000 forms##3##2##(1994-5#3)
000 from##2##2##(1996-11#1)(2007-12#1)
000 g)##2##2##(1990-11#1)(2008-5#1)
000 genes##3##2##(2008-1#1)(2008-4#1)(2008-7#1)
000 habitants)##2##2##(2008-9#1)(2013-8#1)
000 in emotional distress damages##2##5##(1996-5#1)(1997-5#1)
000 in the##2##3##(1990-11#1)(1990-7#1)
000 in##15##2##(1990-11#1)(1990-7#1)(1992-10#1)(1992-12#1)(1992-4#2)(1993-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-11#1)
000 individuals##9##2##(1990-3#1)(1992-9#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-8#1)(2013-1#1)
000 infectious units/cell##2##3##(2008-11#2)
000 inhabitants per year##2##4##(2007-2#1)(2012-2#1)
000 inhabitants##10##2##(1990-12#1)(1995-8#1)(1996-3#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
000 inhabitants)##2##2##(1991-2#1)(1993-9#1)
000 km##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
000 liter/ha##2##2##(2011-2#2)
000 live births##6##3##(1991-11#1)(1992-4#1)(1994-3#1)(2013-1#3)
000 live##8##2##(1991-11#1)(1992-4#1)(1994-3#1)(2008-7#1)(2013-1#4)
000 m##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
000 mg/L dichloroacetic acid for 26 weeks with additional groups of 10 males and 10 females exposed for 41 weeks##2##20##(2008-9#2)
000 mg/L dichloroacetic acid for##3##5##(2008-9#3)
000 mg/L for##2##3##(2008-9#2)
000 mg/L males and females##2##5##(2008-9#2)
000 mg/L##11##2##(2008-9#11)
000 mg/kg dose##2##3##(2008-5#2)
000 mg/kg##3##2##(2008-5#3)
000 microg ml(-1) from##2##4##(2008-10#2)
000 microg##3##2##(2008-10#2)(2010-5#1)
000 mm 3 ±##2##4##(2013-8#2)
000 molecular weight##3##3##(1990-2#1)(1991-2#1)(2008-10#1)
000 mug##2##2##(2008-10#2)
000 mug/ml##2##2##(2008-10#2)
000 new##4##2##(2008-10#1)(2008-4#1)(2010-10#1)(2012-2#1)
000 ng##2##2##(2008-10#2)
000 ng/ml##2##2##(1992-8#1)(1993-9#1)
000 of##5##2##(1990-10#1)(1997-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
000 on SDS-PAGE##2##3##(1993-11#1)(2008-8#1)
000 on##3##2##(1990-11#1)(1993-11#1)(2008-8#1)
000 or more##3##3##(1992-12#1)(1993-1#1)(2008-11#1)
000 or##5##2##(1992-12#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#1)
000 orphans##2##2##(1990-12#1)(1997-6#1)
000 patient##2##2##(2007-12#1)(2013-1#1)
000 patients have##2##3##(2007-12#2)
000 patients##7##2##(1991-1#1)(1994-3#1)(2007-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
000 people die##2##3##(1990-6#1)(2009-10#1)
000 people in##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
000 people were##3##3##(1992-9#1)(1996-6#2)
000 people##20##2##(1990-2#1)(1990-6#1)(1992-9#1)(1996-6#3)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
000 per year##6##3##(1992-1#1)(1993-3#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-12#1)
000 per##8##2##(1992-1#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#1)
000 persons had##2##3##(1994-9#2)
000 persons##6##2##(1991-6#1)(1993-1#1)(1994-9#2)(1996-6#1)(2009-7#1)
000 plates##2##2##(2008-10#2)
000 population in##4##3##(1996-7#1)(2011-2#3)
000 population##9##2##(1996-7#3)(2007-10#1)(2011-2#5)
000 pounds)##2##2##(1990-12#1)(1991-9#1)
000 ppm aspartame (equivalent to average daily doses of approximately 490##2##11##(2008-8#2)
000 ppm aspartame##4##3##(2008-8#4)
000 ppm of##3##3##(2008-10#3)
000 ppm##10##2##(2008-10#3)(2008-8#7)
000 pulses##2##2##(2008-3#2)
000 randomly selected##2##3##(1993-1#1)(1997-1#1)
000 single##2##2##(1993-6#1)(2012-3#1)
000 sites/platelet##2##2##(1991-8#2)
000 sites/platelet)##2##2##(1991-8#2)
000 spores##2##2##(2008-10#1)(2010-5#1)
000 subjects##2##2##(1994-2#1)(2008-7#1)
000 substrate##3##2##(1990-10#3)
000 times per##2##3##(2011-2#1)(2012-12#1)
000 times that of##2##4##(2008-10#2)
000 times##10##2##(1995-11#1)(2008-10#6)(2008-7#1)(2011-2#1)(2012-12#1)
000 to 500##2##3##(2008-11#1)(2009-2#1)
000 to##21##2##(1991-11#1)(1991-9#1)(1992-6#1)(1992-9#2)(1995-6#3)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-12#3)(2012-2#1)
000 transformants##2##2##(1994-8#1)(1997-6#1)
000 units##2##2##(2008-7#2)
000 was##6##2##(1990-11#2)(1990-7#1)(1991-5#1)(1992-3#1)(1994-2#1)
000 were##2##2##(1997-4#1)(2007-10#1)
000 which##2##2##(1990-7#1)(1991-5#1)
000 with a##2##3##(1990-11#1)(1994-9#1)
000 with the##3##3##(1995-3#1)(2008-3#2)
000 with##7##2##(1990-11#1)(1990-5#1)(1994-9#1)(1995-3#1)(2008-3#2)(2011-2#1)
000 women##2##2##(1993-2#1)(2011-2#1)
000 women-year in the##2##4##(1992-10#1)(1992-2#1)
000 words##2##2##(2008-11#1)(2008-6#1)
000 x g##2##3##(1992-8#1)(1994-11#1)
000 x##3##2##(1992-11#1)(1992-8#1)(1994-11#1)
000 years ago##2##3##(1994-3#1)(2012-3#1)
000 years##7##2##(1994-3#3)(2009-2#1)(2010-5#1)(2012-3#1)(2013-8#1)
000 zoospores per##2##3##(2008-10#2)
000##813##1##(1990-10#8)(1990-11#16)(1990-12#10)(1990-2#11)(1990-3#5)(1990-5#8)(1990-6#5)(1990-7#8)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#7)(1991-6#3)(1991-8#4)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#6)(1992-4#4)(1992-6#4)(1992-7#1)(1992-8#7)(1992-9#6)(1993-1#6)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#11)(1993-6#2)(1993-8#7)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#12)(1994-3#11)(1994-5#5)(1994-6#3)(1994-8#3)(1994-9#6)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#11)(1995-8#3)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#7)(1996-6#5)(1996-7#3)(1996-8#4)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#4)(1997-6#15)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#2)(2007-10#3)(2007-11#5)(2007-12#19)(2007-2#3)(2007-9#1)(2008-1#11)(2008-10#104)(2008-11#19)(2008-12#2)(2008-2#5)(2008-3#19)(2008-4#5)(2008-5#20)(2008-6#6)(2008-7#32)(2008-8#23)(2008-9#23)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-3#6)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#18)(2011-2#29)(2012-1#1)(2012-12#21)(2012-2#21)(2012-3#5)(2013-1#17)(2013-8#11)
000) and##2##2##(2009-8#1)(2010-8#1)
000) in##2##2##(1994-9#1)(2008-7#1)
000) is##4##2##(1990-5#2)(1997-3#1)(2008-2#1)
000) over##2##2##(2009-8#2)
000) was##4##2##(1992-3#1)(1994-12#1)(2008-10#1)(2008-5#1)
000)##58##1##(1990-5#4)(1991-12#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#4)(2010-10#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#1)
000+/-2000##2##1##(2008-10#2)
000-10##2##1##(1996-6#1)(2008-1#1)
000-100##2##1##(1996-8#1)(2008-10#1)
000-300##2##1##(1990-3#1)(2008-10#1)
000-4##2##1##(2008-11#2)
000-50 000##2##2##(2008-10#1)(2013-1#1)
000-50##3##1##(2008-1#1)(2008-10#1)(2013-1#1)
000-bp##2##1##(2008-10#1)(2010-5#1)
000-dalton protein##3##2##(1991-9#3)
000-dalton##4##1##(1991-9#3)(1994-5#1)
000-fold##9##1##(1992-6#2)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-4#2)(2008-8#1)
000-grain weight##2##2##(2008-10#1)(2008-9#1)
000/QALY##2##1##(2009-8#2)
000/day##2##1##(2008-1#2)
000/microliters##2##1##(1994-3#2)
000/microliters)##2##1##(1990-11#1)(1995-3#1)
000/mm(2)##2##1##(2007-5#2)
000/mm3##4##1##(1990-12#1)(2011-2#3)
000/year)##2##1##(1997-3#2)
0000)##2##1##(2007-8#1)(2008-3#1)
00001##2##1##(1993-9#1)(2008-10#1)
00001) and##4##2##(1993-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
00001)##5##1##(1993-2#1)(2008-5#1)(2010-2#2)(2011-2#1)
000061##2##1##(2011-2#2)
0001 and##2##2##(2007-11#1)(2008-3#1)
0001 for##4##2##(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)
0001##44##1##(1992-12#3)(1992-2#1)(1993-12#1)(1994-12#2)(1995-8#2)(1996-3#4)(2007-10#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2010-8#4)(2012-3#1)(2013-1#4)
0001) after##2##2##(2006-10#1)(2008-7#1)
0001) and##24##2##(1993-2#1)(1995-8#1)(2006-10#1)(2007-10#1)(2007-8#6)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#5)
0001) between##2##2##(2008-10#2)
0001) by##2##2##(2008-10#2)
0001) compared with##2##3##(2008-10#2)
0001) enhanced##2##2##(2008-10#2)
0001) in##7##2##(1994-11#1)(1997-1#1)(1997-4#1)(2008-12#1)(2008-7#1)(2013-1#2)
0001) lower##2##2##(2008-5#1)(2012-3#1)
0001) more##2##2##(2008-9#1)(2010-8#1)
0001) or##2##2##(2007-8#1)(2012-12#1)
0001) than##3##2##(2008-10#1)(2009-1#1)(2010-1#1)
0001) was##3##2##(2010-3#1)(2012-12#1)(2013-8#1)
0001) were more frequent in##2##5##(2007-8#2)
0001) were##5##2##(2007-8#2)(2008-5#1)(2011-2#1)(2013-1#1)
0001) with##2##2##(2006-10#1)(2012-6#1)
0001)##195##1##(1990-4#1)(1991-12#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#3)(2007-10#3)(2007-11#1)(2007-7#2)(2007-8#18)(2008-1#6)(2008-10#31)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#8)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#1)(2010-1#2)(2010-11#7)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#7)(2010-8#4)(2011-1#1)(2011-2#12)(2012-12#4)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#24)(2013-8#4)
000107##2##1##(2008-9#2)
0001]##2##1##(2007-7#1)(2010-4#1)
0002##4##1##(1995-2#1)(2008-10#2)(2011-2#1)
0002)##9##1##(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
0003##2##1##(2008-10#1)(2008-2#1)
0003)##6##1##(1991-8#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
000308##3##1##(2008-9#3)
0004##3##1##(2007-11#1)(2008-10#1)(2008-3#1)
0004)##5##1##(2008-3#1)(2008-7#2)(2009-10#1)(2009-8#1)
0005##7##1##(1996-3#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-4#2)(2012-3#1)
0005) and##4##2##(1990-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
0005)##17##1##(1990-3#3)(1994-3#1)(1996-11#1)(2008-10#3)(2008-12#3)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
000567 and 0##2##3##(2011-2#2)
0006 m(-1) at##2##3##(2008-2#2)
0006##4##1##(2008-10#2)(2008-2#2)
0006)##5##1##(1991-9#1)(2007-7#1)(2008-1#1)(2012-12#1)(2013-1#1)
0007 to 0##2##3##(1995-2#1)(2008-10#1)
0007##8##1##(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)
0007)##5##1##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
0008)##5##1##(1993-11#1)(2008-3#1)(2008-7#2)(2012-6#1)
0009)##3##1##(1997-5#1)(2008-1#1)(2013-8#1)
000g##2##1##(1992-12#2)
000mgkg(-1) dry weight##2##3##(2008-10#2)
000mgkg(-1)##3##1##(2008-10#3)
001 &amp##3##2##(2010-6#3)
001 -##2##2##(2008-10#1)(2011-1#1)
001 M##2##2##(1990-3#1)(2008-10#1)
001 and 0##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
001 and##12##2##(1994-12#1)(2007-11#1)(2008-10#4)(2008-7#1)(2011-1#2)(2012-12#1)(2013-8#2)
001 for the##2##3##(1994-12#1)(2010-12#1)
001 for##12##2##(1990-12#1)(1991-12#1)(1992-11#2)(1994-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)
001 in the##2##3##(2008-10#2)
001 mg (1##2##3##(1994-12#2)
001 mg##3##2##(1994-12#2)(2008-10#1)
001 respectively)##2##2##(2006-8#1)(2011-2#1)
001 to 0##2##3##(2008-10#2)
001 vs##6##2##(1990-2#1)(1991-9#2)(1997-8#1)(2013-8#2)
001##117##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#3)(1992-11#2)(1993-12#1)(1994-11#2)(1994-12#5)(1995-12#1)(1995-2#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#3)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#7)(2013-8#12)
001% and##2##2##(2008-10#1)(2010-1#1)
001%##6##1##(1990-2#1)(2008-10#3)(2010-1#1)(2013-1#1)
001) and a significantly##2##4##(2007-10#1)(2008-11#1)
001) and a##4##3##(1994-3#1)(1995-9#1)(2007-10#1)(2008-11#1)
001) and decreased##2##3##(2008-3#1)(2013-3#1)
001) and in##2##3##(1994-12#1)(2012-7#1)
001) and the##4##3##(1997-4#1)(2008-10#1)(2010-9#1)(2012-5#1)
001) and was##2##3##(2008-10#1)(2008-4#1)
001) and with##2##3##(2011-1#1)(2013-1#1)
001) and##71##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-9#3)(1992-9#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-9#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#1)(2010-2#3)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#8)(2013-3#1)(2013-8#3)
001) as compared to##2##4##(2008-3#1)(2011-2#1)
001) as##4##2##(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
001) associated with##2##3##(1996-12#1)(2009-4#1)
001) at##2##2##(2008-10#1)(2013-8#1)
001) between the##3##3##(1993-8#1)(1994-12#1)(1996-1#1)
001) between##6##2##(1993-8#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
001) but not##3##3##(1991-2#1)(2012-5#1)(2013-1#1)
001) but##9##2##(1991-2#1)(1995-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)
001) by##4##2##(1994-8#1)(1996-6#1)(2011-3#2)
001) compared to##6##3##(1993-1#1)(1994-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
001) compared##7##2##(1993-1#1)(1994-3#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
001) correlated to##2##3##(1992-11#2)
001) during the##2##3##(2008-10#1)(2008-12#1)
001) for##5##2##(2007-8#3)(2008-10#1)(2008-3#1)
001) from##3##2##(1994-6#2)(2008-10#1)
001) higher in##2##3##(2008-11#1)(2012-2#1)
001) higher##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
001) in both##2##3##(2008-10#1)(2008-5#1)
001) in the##4##3##(1995-12#1)(2008-10#1)(2013-1#2)
001) in##10##2##(1993-1#1)(1994-7#1)(1995-12#1)(2008-10#2)(2008-5#1)(2013-1#3)(2013-8#1)
001) of##4##2##(1993-8#1)(2008-10#2)(2012-3#1)
001) positive##2##2##(2008-10#2)
001) respectively##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
001) than in normal##3##4##(1996-12#2)(1996-5#1)
001) than in##4##3##(1996-12#2)(1996-5#1)(2012-12#1)
001) than the##3##3##(1993-8#1)(2008-1#1)(2008-3#1)
001) than##12##2##(1993-8#1)(1996-12#2)(1996-5#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
001) to##2##2##(2008-10#1)(2012-3#1)
001) was found between the##2##5##(2007-10#1)(2008-10#1)
001) was found between##3##4##(2007-10#1)(2008-10#2)
001) was found in the##2##5##(2008-11#1)(2008-5#1)
001) was found##5##3##(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
001) was##6##2##(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
001) were##4##2##(1996-5#1)(2007-10#1)(2008-10#1)(2013-1#1)
001) with##5##2##(1992-12#1)(2009-11#1)(2013-1#3)
001)##584##1##(1990-12#1)(1990-2#6)(1990-3#3)(1990-6#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#8)(1992-11#2)(1992-12#3)(1992-2#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-12#2)(1993-2#10)(1993-3#2)(1993-8#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#4)(1994-7#1)(1994-8#1)(1995-12#5)(1995-3#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-12#8)(1996-5#3)(1996-6#1)(1996-8#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2006-10#2)(2006-8#2)(2007-10#11)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#15)(2007-9#1)(2008-1#10)(2008-10#58)(2008-11#9)(2008-12#7)(2008-3#32)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#21)(2008-8#7)(2008-9#7)(2009-11#3)(2009-12#3)(2009-3#6)(2009-4#4)(2009-5#5)(2009-6#1)(2009-8#4)(2009-9#1)(2010-12#7)(2010-2#7)(2010-3#5)(2010-4#6)(2010-6#7)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#25)(2011-2#32)(2011-3#3)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#22)(2012-5#2)(2012-7#2)(2013-1#64)(2013-3#1)(2013-7#3)(2013-8#18)
001)]##2##1##(2008-10#2)
001-0##6##1##(1993-11#1)(2008-10#5)
001-1##4##1##(2008-10#3)(2012-2#1)
0012##3##1##(2008-10#2)(2008-12#1)
0013##2##1##(2008-8#1)(2009-11#1)
0014##3##1##(1995-2#1)(2008-10#1)(2008-11#1)
0015##3##1##(1990-11#1)(2011-2#2)
0015)##2##1##(1993-12#1)(1997-5#1)
0015-0##2##1##(2008-10#1)(2010-4#1)
0017##2##1##(2008-10#1)(2012-12#1)
0018##2##1##(2009-11#1)(2011-2#1)
0018)##2##1##(2008-10#1)(2013-8#1)
0019##2##1##(2008-10#1)(2009-7#1)
002 and 0##2##3##(2008-10#2)
002 bp##2##2##(1997-3#2)
002 mg (2##2##3##(1994-12#2)
002 mg##3##2##(1994-12#2)(2008-10#1)
002 mug ml(-1)##2##3##(2008-10#2)
002 mug##3##2##(2008-10#3)
002 nm##2##2##(2007-12#1)(2008-9#1)
002##33##1##(1993-2#1)(1994-12#2)(1994-2#1)(1996-5#1)(1997-3#2)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#6)(2013-1#1)
002%##3##1##(2008-10#1)(2008-8#1)(2010-1#1)
002) and##6##2##(1994-11#1)(1994-9#1)(2008-10#1)(2008-7#1)(2013-1#2)
002) was##2##2##(2008-10#1)(2009-3#1)
002)##50##1##(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-11#2)(1994-9#1)(1995-3#1)(1997-5#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#4)
002-0##4##1##(2008-10#4)
0023##2##1##(2008-3#1)(2010-4#1)
0023)##6##1##(2012-2#6)
0024)##2##1##(2008-5#1)(2013-8#1)
0025##2##1##(2007-11#1)(2008-10#1)
0028##2##1##(2008-3#1)(2013-1#1)
002]##2##1##(2013-1#1)(2013-8#1)
002mm)##2##1##(2008-10#2)
003 +/- 0##2##3##(2008-7#1)(2010-1#1)
003 and 0##2##3##(2008-10#1)(2011-1#1)
003 and##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
003##24##1##(1990-8#1)(1991-9#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#1)(2013-8#1)
003%##2##1##(1996-5#1)(2008-10#1)
003) and##5##2##(2007-2#1)(2007-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
003) with##2##2##(2008-10#1)(2013-8#1)
003)##34##1##(1991-5#1)(1992-3#1)(1993-1#1)(1993-11#2)(2007-10#4)(2007-2#1)(2007-8#4)(2008-10#2)(2008-4#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
0034)##2##1##(2008-10#1)(2011-1#1)
0035##3##1##(2008-10#2)(2008-7#1)
0035)##2##1##(1992-2#1)(2007-8#1)
0036##2##1##(1991-8#1)(2008-3#1)
004 and##5##2##(1996-12#1)(2006-8#1)(2008-12#1)(2008-8#1)(2013-8#1)
004 mg l(-1)##3##3##(2008-10#3)
004 to 0##3##3##(2008-10#2)(2013-1#1)
004##24##1##(1996-12#1)(2006-8#1)(2008-10#13)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
004% and##2##2##(2008-10#1)(2010-1#1)
004%##3##1##(2007-11#1)(2008-10#1)(2010-1#1)
004) and##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
004)##26##1##(1994-1#1)(1997-5#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-8#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#1)
0042##2##1##(2008-10#2)
0044##3##1##(2008-10#2)(2008-2#1)
0044)##2##1##(2008-10#2)
0044s##2##1##(2008-10#2)
0045)##2##1##(2008-10#1)(2012-12#1)
0048##4##1##(2008-10#2)(2009-8#1)(2010-4#1)
005 M##3##2##(2008-10#3)
005 and 0##2##3##(2008-10#2)
005 and##8##2##(1997-2#1)(2008-10#5)(2008-3#1)(2008-7#1)
005 at##3##2##(2008-10#1)(2012-2#2)
005 degrees##2##2##(2007-11#1)(2008-2#1)
005 mg##2##2##(1994-12#2)
005 mug l(-1)##2##3##(2008-10#2)
005 mug##3##2##(2008-10#3)
005 to 0##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
005##46##1##(1990-7#1)(1993-8#2)(1994-12#2)(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#2)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
005%##7##1##(1994-6#1)(2008-10#4)(2008-3#1)(2011-2#1)
005) and the##2##3##(2007-8#1)(2010-1#1)
005) and##5##2##(1991-11#1)(1994-11#1)(2007-8#1)(2010-1#1)(2010-4#1)
005)##43##1##(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-9#2)(1994-11#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
005-0##9##1##(2008-10#5)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
0050molL(-1)##2##1##(2008-10#2)
0051##2##1##(2010-4#1)(2011-2#1)
0056##2##1##(1995-2#1)(2008-10#1)
006 and 0##3##3##(2008-10#3)
006 and##5##2##(1991-12#1)(2008-10#3)(2013-1#1)
006 g/ml)##2##2##(1993-12#1)(1995-6#1)
006##16##1##(1991-12#1)(1993-12#2)(1995-6#1)(1997-5#1)(2007-10#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
006%##2##1##(2009-11#1)(2009-5#1)
006) in##2##2##(1992-9#1)(1993-11#1)
006)##21##1##(1992-3#1)(1992-9#1)(1993-11#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-5#1)(2013-8#4)
007 mol/l##2##2##(2008-10#2)
007 s##2##2##(2008-10#1)(2010-1#1)
007 to##2##2##(2007-1#1)(2008-2#1)
007 vs 0##2##3##(2010-1#2)
007##25##1##(2007-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#1)(2010-1#3)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
007%##2##1##(2008-10#1)(2011-2#1)
007)##18##1##(1993-9#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
007-0##3##1##(2008-10#1)(2013-8#2)
0079 g of Al##2##4##(2008-10#2)
008 and##2##2##(2009-4#1)(2011-1#1)
008##18##1##(1993-6#1)(1994-3#1)(1997-5#1)(2007-5#1)(2008-10#7)(2008-11#3)(2009-4#1)(2010-1#1)(2011-1#1)(2011-3#1)
008)##22##1##(1991-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1997-2#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-1#3)
0082##4##1##(2008-10#3)(2010-4#1)
0083##3##1##(2008-10#2)(2008-5#1)
009 and##3##2##(2008-10#3)
009 mg l(-1)##2##3##(2008-10#2)
009 mg##3##2##(2008-10#3)
009##15##1##(1993-9#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
009%##3##1##(2007-1#1)(2008-10#2)
009)##9##1##(1996-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
0096)##2##1##(2007-8#1)(2011-2#1)
0099)##2##1##(2008-10#2)
00V##3##1##(2008-10#3)
00h##2##1##(2012-12#2)
00l)##2##1##(2007-2#2)
00mgl(-1)##2##1##(2008-10#2)
00mug/ml##3##1##(2008-10#3)
00x10(-9)##2##1##(2008-10#2)
00x10(-9)-1##2##1##(2008-10#2)
01 &lt##2##2##(1997-1#1)(2008-9#1)
01 (substrate##2##2##(2010-11#2)
01 +/- 0##2##3##(2007-10#1)(2008-1#1)
01 +/-##3##2##(1992-12#1)(2007-10#1)(2008-1#1)
01 M quinine##2##3##(1992-11#1)(1993-12#1)
01 M sodium##3##3##(1990-3#1)(1992-3#1)(2008-10#1)
01 M##20##2##(1990-3#1)(1992-11#1)(1992-3#1)(1993-12#3)(1995-2#1)(1997-7#1)(2008-10#11)(2010-3#1)
01 M)##2##2##(2008-10#2)
01 Ogawa Biotype##2##3##(2012-3#2)
01 and 0##5##3##(1996-2#1)(2008-10#3)(2013-8#1)
01 and 1##3##3##(2008-10#2)(2008-6#1)
01 and p &lt##2##4##(2009-5#1)(2011-2#1)
01 and p##3##3##(1990-9#1)(2009-5#1)(2011-2#1)
01 and r =##2##4##(1991-2#2)
01 and##22##2##(1990-9#1)(1991-2#2)(1995-2#1)(1996-2#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
01 at##5##2##(2007-8#1)(2008-2#3)(2012-2#1)
01 for 0##2##3##(2008-10#2)
01 for both##3##3##(1994-11#2)(2008-2#1)
01 for##9##2##(1994-11#2)(1995-2#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)
01 g##4##2##(2008-10#3)(2008-12#1)
01 in##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
01 mM##6##2##(1995-3#1)(2008-10#5)
01 mg l(-1)##6##3##(2008-10#6)
01 mg##7##2##(2008-10#7)
01 mg/kg##2##2##(2011-1#1)(2012-3#1)
01 microg##2##2##(2008-10#2)
01 micrograms##2##2##(1991-12#1)(1995-2#1)
01 ml##2##2##(2012-3#2)
01 mol l(-1)##6##3##(2008-10#6)
01 mug ml(-1) of##2##4##(2008-10#2)
01 mug ml(-1)##8##3##(2008-10#8)
01 mug##9##2##(2008-10#9)
01 ng ml(-1)##3##3##(2008-10#3)
01 ng##5##2##(2008-10#5)
01 nm##2##2##(2007-12#1)(2008-3#1)
01 or P &lt##2##4##(2008-10#2)
01 or##3##2##(2008-10#3)
01 ppm##2##2##(2008-10#2)
01 ppm)##2##2##(2008-10#2)
01 respectively##2##2##(2008-5#1)(2012-2#1)
01 to 0##8##3##(1992-11#1)(1994-8#1)(2008-1#1)(2008-10#4)(2008-11#1)
01 to 1##3##3##(1992-11#1)(2007-12#1)(2008-10#1)
01 to##15##2##(1992-11#2)(1992-8#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2009-7#1)
01 vs##4##2##(1991-9#1)(1994-2#1)(1994-5#1)(2013-1#1)
01 was##2##2##(2008-7#1)(2010-12#1)
01 x 10(-5))-(1##2##3##(2008-10#2)
01 x##3##2##(2008-10#2)(2008-11#1)
01##268##1##(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#5)(1991-8#2)(1991-9#2)(1992-11#4)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#3)(1993-6#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-12#1)(1995-2#8)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#103)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2011-3#4)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#5)
01% of the##2##3##(1991-6#1)(1992-11#1)
01% of##3##2##(1991-6#1)(1992-11#1)(1994-6#1)
01% tropicamide##2##2##(2008-7#2)
01%##20##1##(1991-6#1)(1992-11#1)(1994-5#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
01%)##6##1##(1990-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2011-2#1)
01) after##3##2##(2007-10#1)(2008-9#1)(2013-1#1)
01) and the##2##3##(2008-7#1)(2010-12#1)
01) and##26##2##(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#2)
01) as##4##2##(2006-10#1)(2009-6#1)(2012-2#2)
01) at##2##2##(2008-10#1)(2011-1#1)
01) between the##2##3##(1996-3#1)(2008-10#1)
01) between##5##2##(1990-11#1)(1996-3#1)(2008-10#1)(2008-5#1)(2013-7#1)
01) but not##2##3##(2008-10#1)(2012-5#1)
01) but##5##2##(1991-9#1)(1995-3#1)(1996-2#1)(2008-10#1)(2012-5#1)
01) compared to normal##2##4##(2009-1#2)
01) compared with##2##3##(2008-5#1)(2008-9#1)
01) compared##4##2##(2008-5#1)(2008-9#1)(2009-1#2)
01) decrease in the##2##4##(2010-5#2)
01) for##3##2##(1990-11#1)(2008-10#2)
01) from##2##2##(2008-10#2)
01) in a dose-dependent fashion##2##5##(1992-12#2)
01) in the##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
01) in##17##2##(1990-6#1)(1992-12#3)(1997-8#1)(2008-10#2)(2008-6#1)(2009-4#3)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#2)
01) increase in##2##3##(2010-5#2)
01) increase##3##2##(1993-12#1)(2010-5#2)
01) increased##2##2##(1993-1#1)(2008-12#1)
01) reductions in##2##3##(1992-8#1)(2008-3#1)
01) than controls##2##3##(2013-1#2)
01) than##5##2##(1992-3#1)(2008-5#1)(2013-1#3)
01) to##2##2##(1996-2#1)(1997-1#1)
01) was found between##3##4##(1996-12#1)(2008-10#1)(2013-1#1)
01) was observed##2##3##(2008-3#1)(2009-4#1)
01) was##7##2##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-1#1)
01) were##3##2##(2008-7#1)(2009-4#1)(2010-6#1)
01) with the##2##3##(2008-10#1)(2009-4#1)
01) with##5##2##(2008-10#3)(2009-4#1)(2010-9#1)
01)##385##1##(1990-11#2)(1990-12#5)(1990-6#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#3)(1993-10#5)(1993-12#4)(1993-2#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#5)(1994-5#4)(1994-6#2)(1994-9#2)(1995-12#9)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#5)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#9)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#5)(2007-8#2)(2008-1#3)(2008-10#45)(2008-12#5)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#10)(2008-6#4)(2008-7#21)(2008-8#2)(2008-9#12)(2009-1#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-9#3)(2011-1#7)(2011-2#24)(2011-3#9)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#4)(2012-5#3)(2013-1#31)(2013-7#1)(2013-8#10)
01+/-1##2##1##(2008-10#1)(2008-5#1)
01-0##23##1##(1990-6#1)(1991-9#1)(1992-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-8#1)(1996-2#2)(2008-10#7)(2008-2#1)(2008-3#1)(2012-2#1)
01-1##8##1##(1990-5#1)(2007-2#1)(2008-10#4)(2011-2#1)(2012-2#1)
01-10##3##1##(1992-3#1)(2006-6#1)(2008-3#1)
01-2##5##1##(2008-10#3)(2011-2#1)(2011-3#1)
01-5##2##1##(2008-10#1)(2013-1#1)
01-50##2##1##(2008-10#2)
01-6##2##1##(2007-10#1)(2008-10#1)
01-7##2##1##(2008-10#2)
010 M##2##2##(2008-10#2)
010 mM##2##2##(2008-10#2)
010 mug##2##2##(2008-10#2)
010##10##1##(2008-10#7)(2008-11#2)(2013-1#1)
010)##3##1##(2008-3#1)(2012-3#2)
0102)##2##1##(2008-7#1)(2013-1#1)
010molL(-1) KCl##2##2##(2008-10#2)
010molL(-1)##3##1##(2008-10#3)
011##10##1##(1992-3#1)(2008-10#6)(2008-7#1)(2011-2#1)(2012-7#1)
011)##6##1##(2007-7#1)(2008-10#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)
0111##2##1##(1992-8#1)(2008-10#1)
0116##2##1##(2008-10#1)(2010-12#1)
012 and 0##2##3##(2008-10#2)
012 and##3##2##(2008-10#3)
012 mg##2##2##(2008-10#1)(2008-5#1)
012##13##1##(1990-6#1)(1993-9#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-1#1)
012)##8##1##(1991-8#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-4#1)(2011-1#1)
0125##2##1##(1997-2#1)(2008-10#1)
013 A##2##2##(1997-4#1)(2008-10#1)
013 microT##2##2##(2008-12#2)
013##14##1##(1992-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-12#2)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
013)##8##1##(1992-3#1)(2007-8#1)(2008-10#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
014 and##2##2##(2008-12#1)(2008-8#1)
014##15##1##(1993-8#1)(1997-2#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#1)
014) and##2##2##(2008-12#1)(2011-2#1)
014)##8##1##(1994-7#1)(1996-1#1)(2007-8#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-7#1)
015 M of##2##3##(2008-10#2)
015 and##2##2##(1997-5#1)(2008-10#1)
015 mug##2##2##(2008-10#2)
015##17##1##(1991-3#1)(1992-3#1)(1997-5#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
015%##4##1##(2008-10#2)(2013-1#2)
015) and##2##2##(2012-2#1)(2012-3#1)
015)##9##1##(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
0157##2##1##(2007-12#1)(2008-10#1)
0158##2##1##(2008-10#2)
016##8##1##(1993-1#1)(2007-10#1)(2008-10#5)(2008-2#1)
016)##12##1##(1991-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-10#1)(2010-9#1)(2011-2#3)(2012-5#2)(2013-1#1)
017 (6-[benzoylamino]-7-methyl-2-propyl-3-[[2'-(N-(3-methyl-1-butoxy)##2##2##(1995-12#2)
017 also##3##2##(1995-12#3)
017 with##2##2##(1995-12#1)(1997-2#1)
017##22##1##(1992-3#1)(1995-12#11)(1997-2#1)(2008-10#3)(2008-3#1)(2008-7#2)(2010-3#1)(2011-1#1)(2013-1#1)
017)##2##1##(2008-7#1)(2013-8#1)
018##6##1##(1992-4#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-8#1)
018)##4##1##(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
019##6##1##(2008-11#1)(2008-3#2)(2008-4#1)(2011-1#1)(2012-12#1)
019)##7##1##(1997-5#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
0194##2##1##(2008-10#2)
01M##8##1##(2008-10#8)
01] and##2##2##(2013-8#2)
01]##10##1##(1994-6#3)(2008-7#1)(2008-8#1)(2013-8#5)
01molL(-1)##2##1##(2008-10#2)
01mum##2##1##(2007-11#1)(2007-12#1)
02 +/- 0##6##3##(1994-6#1)(1995-11#1)(1996-12#1)(2007-10#1)(2008-5#1)(2010-4#1)
02 +/-##8##2##(1994-6#1)(1995-11#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-3#1)
02 M##7##2##(1992-10#3)(1992-11#1)(1997-7#1)(2008-10#2)
02 OSM##2##2##(1991-11#2)
02 V##2##2##(2008-10#1)(2008-8#1)
02 and 0##7##3##(2008-10#5)(2008-3#1)(2013-1#1)
02 and 1##2##3##(2008-10#1)(2008-3#1)
02 and P &lt##3##4##(1992-9#1)(1994-12#1)(1994-3#1)
02 and##20##2##(1992-9#1)(1994-12#1)(1994-3#1)(2007-7#1)(2008-10#12)(2008-3#2)(2011-3#1)(2013-1#1)
02 for##2##2##(1994-11#1)(1995-2#1)
02 mM##4##2##(1994-5#1)(1995-3#1)(2008-11#1)(2011-1#1)
02 mg l(-1)##2##3##(2008-10#2)
02 mg##3##2##(2008-10#3)
02 mol l(-1)##4##3##(2008-10#4)
02 mol##7##2##(1996-5#1)(2008-10#6)
02 mug g(-1)##2##3##(2008-10#2)
02 mug ml(-1)##5##3##(2008-10#5)
02 mug##8##2##(2008-10#8)
02 ng ml(-1)##6##3##(2008-10#6)
02 ng##8##2##(1996-2#1)(2008-10#7)
02 nm##2##2##(2007-12#2)
02 to 0##2##3##(2008-10#2)
02 to##4##2##(2008-10#3)(2011-1#1)
02 years##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
02##156##1##(1990-2#2)(1991-11#2)(1991-12#2)(1991-3#1)(1992-10#3)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#2)(2007-10#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-10#66)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#6)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
02% and##2##2##(1995-12#1)(2008-10#1)
02% for##2##2##(1992-9#1)(2008-10#1)
02% sodium##3##2##(1991-3#1)(2008-10#2)
02% thiourea##3##2##(2008-10#3)
02%##25##1##(1991-3#1)(1992-9#1)(1994-8#1)(1995-12#1)(2007-8#1)(2008-10#15)(2008-5#1)(2008-6#1)(2008-8#2)(2012-2#1)
02%)##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
02(2) degrees##2##2##(1996-2#2)
02) and the##2##3##(1991-5#1)(2010-2#1)
02) and##14##2##(1991-5#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
02) in the##2##3##(2008-10#1)(2008-5#1)
02) in##6##2##(1993-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
02) of##2##2##(2008-1#1)(2008-9#1)
02) was##2##2##(2006-10#1)(2008-11#1)
02) were##3##2##(1991-8#1)(2011-2#2)
02)##83##1##(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-2#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-10#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-5#1)(2013-1#6)(2013-8#1)
02-0##12##1##(1994-11#1)(1995-2#1)(2008-10#8)(2008-2#1)(2013-7#1)
02-1##4##1##(1994-12#1)(2008-10#3)
02-2##6##1##(2008-10#5)(2008-12#1)
02-3##7##1##(2008-10#6)(2013-1#1)
02-4##2##1##(2008-10#2)
02-6##2##1##(2008-10#1)(2011-2#1)
020 patients##2##2##(2011-2#2)
020##10##1##(1992-3#1)(1992-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-2#2)
020)##2##1##(2008-10#1)(2008-7#1)
020-0##3##1##(2008-10#3)
021 and 0##4##3##(2008-10#4)
021 and##6##2##(2006-8#1)(2008-10#4)(2011-1#1)
021##9##1##(2006-8#1)(2008-10#6)(2011-1#1)(2011-2#1)
021)##5##1##(1993-11#1)(2008-10#1)(2010-1#1)(2011-2#2)
021-0##2##1##(2008-10#1)(2011-2#1)
022 and##2##2##(1993-8#1)(2011-2#1)
022##8##1##(1993-8#1)(1996-2#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#1)
022)##8##1##(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#2)(2012-2#1)
023 to 0##2##3##(2008-10#2)
023##11##1##(1991-5#1)(1991-9#1)(1996-1#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)
023) and##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
023)##10##1##(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#2)(2010-3#1)(2011-1#1)(2013-1#1)
024 and##3##2##(2008-10#2)(2008-2#1)
024##14##1##(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)
024)##6##1##(1997-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2011-1#1)
02428##2##1##(2008-9#2)
0248##2##1##(2008-11#2)
025 M##3##2##(1997-2#1)(2008-10#2)
025 and 0##4##3##(2008-10#4)
025 and##5##2##(2008-10#5)
025 mug ml(-1)##2##3##(2008-10#2)
025 ng##2##2##(1995-12#2)
025##27##1##(1990-6#1)(1992-10#1)(1994-12#1)(1995-12#5)(1997-2#1)(2008-10#14)(2008-2#2)(2008-6#1)(2008-9#1)
025)##10##1##(1990-2#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
025-0##4##1##(1996-5#1)(2007-10#1)(2008-10#2)
026##6##1##(1994-5#1)(1996-2#1)(2008-10#3)(2012-12#1)
026%##3##1##(2008-10#2)(2010-4#1)
026)##6##1##(1992-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#2)
0260 and##2##2##(2008-10#2)
0261##2##1##(2008-10#2)
027##8##1##(1993-8#1)(2008-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
027)##6##1##(2007-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#1)
027s##2##1##(2008-8#2)
028 and 0##2##3##(2008-10#1)(2008-11#1)
028 is##2##2##(2008-3#2)
028 mug ml(-1)##2##3##(2008-10#2)
028 mug##3##2##(2008-10#3)
028##16##1##(1991-5#1)(1995-8#1)(1997-2#1)(2006-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2009-11#1)
028)##6##1##(2008-10#1)(2008-9#1)(2010-1#1)(2011-2#3)
029##6##1##(1996-2#1)(2008-10#1)(2008-11#2)(2009-7#1)(2011-2#1)
029)##2##1##(2009-6#1)(2011-1#1)
02moll(-1)##2##1##(2008-10#2)
02mug/ml##2##1##(2008-10#2)
02mugg(-1)##2##1##(2008-10#2)
02mugl(-1)##3##1##(2008-10#3)
02mugml(-1)##2##1##(2008-10#2)
03 M HCl)##2##3##(1993-12#1)(2008-10#1)
03 and 0##2##3##(2008-10#2)
03 and 1##2##3##(2008-10#2)
03 and log 5##2##4##(2008-10#2)
03 and##12##2##(2008-10#11)(2009-4#1)
03 for##3##2##(1995-2#1)(2008-10#1)(2010-3#1)
03 in the wire nut technique compared with 0##2##9##(2011-2#2)
03 in the##3##3##(2008-10#1)(2011-2#2)
03 in##5##2##(2008-10#2)(2010-12#1)(2011-2#2)
03 mM)##2##2##(1997-2#1)(2008-10#1)
03 mV##2##2##(2008-10#2)
03 mg##3##2##(2008-10#3)
03 microM##2##2##(1991-12#1)(1996-2#1)
03 mmol##2##2##(2008-10#2)
03 mug ml(-1)##3##3##(2008-10#3)
03 mug##6##2##(2008-10#6)
03 pmole/mg protein) over that of control##2##7##(2008-11#2)
03 to 0##3##3##(2008-10#2)(2011-1#1)
03 to 2##2##3##(2007-12#1)(2008-10#1)
03 to##10##2##(1994-6#1)(2007-12#1)(2008-10#6)(2011-1#1)(2011-2#1)
03 x##3##2##(1991-12#1)(2007-11#1)(2008-9#1)
03 ± 0##2##3##(2010-10#1)(2010-9#1)
03 Å##3##2##(1996-2#1)(1997-7#2)
03##147##1##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-2#2)(1996-9#2)(1997-2#2)(1997-7#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#66)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
03% and##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
03% for##2##2##(2008-10#2)
03% of##2##2##(1990-11#1)(2012-12#1)
03%##21##1##(1990-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)
03%)##5##1##(1990-3#1)(2008-10#2)(2008-2#1)(2012-3#1)
03(3)##2##1##(1996-2#1)(2008-10#1)
03) and##9##2##(1991-12#1)(1991-5#1)(1991-8#1)(2007-10#1)(2007-2#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)
03)##57##1##(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-2#1)(1994-9#1)(1995-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-2#1)(2013-1#4)(2013-8#1)
03+/-0##2##1##(2008-10#2)
03-0##10##1##(2008-10#6)(2008-3#1)(2008-8#1)(2012-3#1)(2013-7#1)
03-1##2##1##(2008-10#2)
03-2##3##1##(2009-6#1)(2012-12#1)(2013-8#1)
030##5##1##(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#2)
031##5##1##(1993-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
031)##5##1##(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)
0317)##2##1##(2011-2#1)(2012-3#1)
032##6##1##(1993-6#1)(1994-12#1)(2008-10#3)(2008-9#1)
032)##3##1##(2007-8#1)(2011-1#1)(2012-12#1)
033 bp##2##2##(2008-7#2)
033##6##1##(2008-10#3)(2008-3#1)(2008-7#2)
034##7##1##(1994-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#2)
034)##3##1##(2007-10#1)(2008-6#1)(2013-1#1)
035 mol##2##2##(1990-8#1)(2008-10#1)
035##10##1##(1990-8#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2011-2#1)
035)##7##1##(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
036##3##1##(2010-12#1)(2010-8#1)(2011-3#1)
036)##4##1##(2008-7#1)(2012-12#1)(2013-8#2)
037##2##1##(1991-9#1)(2008-10#1)
038##2##1##(2008-10#1)(2008-3#1)
038)##5##1##(2007-11#1)(2011-2#1)(2013-1#3)
039##5##1##(2008-10#3)(2008-11#1)(2008-2#1)
039)##4##1##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
04 +/- 0##3##3##(1991-5#1)(1996-12#1)(1997-2#1)
04 +/-##6##2##(1991-5#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-4#1)(2011-2#1)
04 M##3##2##(2008-10#3)
04 and 0##5##3##(2008-10#1)(2008-2#1)(2008-9#2)(2011-2#1)
04 and 2##2##3##(1995-12#1)(2008-10#1)
04 and##11##2##(1990-2#1)(1995-12#1)(2008-10#5)(2008-2#1)(2008-9#2)(2011-2#1)
04 degrees 1)(II)-00 degrees 0##2##5##(2008-2#2)
04 degrees C##2##3##(2007-12#1)(2008-3#1)
04 degrees##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
04 for##2##2##(2007-10#1)(2008-8#1)
04 in##2##2##(2008-10#1)(2010-4#1)
04 mM##2##2##(1995-3#2)
04 mV##2##2##(1991-9#1)(1992-5#1)
04 mm##2##2##(2009-3#1)(2010-8#1)
04 mol/l##2##2##(2008-10#1)(2008-11#1)
04 mug ml(-1)##5##3##(2008-10#5)
04 mug##6##2##(2008-10#6)
04 ng ml(-1)##2##3##(2008-10#2)
04 to 0##7##3##(1993-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)
04 to 1##2##3##(2008-10#2)
04 to##13##2##(1993-9#1)(1996-12#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
04 x 10(6)##2##3##(2008-11#2)
04 x##3##2##(2008-10#1)(2008-11#2)
04##131##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-5#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-12#2)(1997-2#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#45)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#2)
04% w/w (C(4##3##3##(2008-5#3)
04%##18##1##(1992-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
04%)##2##1##(2007-7#1)(2010-4#1)
04) and##6##2##(2008-10#2)(2011-2#2)(2011-3#1)(2013-1#1)
04) was##2##2##(1997-8#1)(2012-3#1)
04)##51##1##(1991-11#2)(1991-4#1)(1991-6#1)(1994-3#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
04))##3##1##(2008-5#3)
04+/-0##2##1##(2008-10#2)
04-0##11##1##(1995-2#1)(2008-10#8)(2008-11#1)(2012-12#1)
04-1##5##1##(2007-12#1)(2008-10#3)(2011-2#1)
04-10##2##1##(2008-10#2)
04-2##2##1##(2008-10#2)
04/h to approx##2##3##(2008-6#2)
04/h##4##1##(2008-6#4)
040##6##1##(2008-10#4)(2008-11#1)(2008-5#1)
041##5##1##(1993-1#1)(1994-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
041)##2##1##(2008-10#1)(2008-12#1)
042##9##1##(1990-2#1)(1991-5#1)(1993-8#1)(1996-2#1)(2008-10#2)(2008-6#1)(2011-1#1)(2011-2#1)
042/h##2##1##(2008-6#2)
043 and 0##2##3##(2008-10#1)(2008-7#1)
043##5##1##(2008-10#3)(2008-7#1)(2011-2#1)
043)##4##1##(2007-8#1)(2008-8#1)(2010-1#1)(2012-7#1)
044##8##1##(1997-8#2)(2008-10#5)(2008-8#1)
044)##3##1##(2007-8#1)(2008-10#1)(2011-1#1)
045##6##1##(1990-6#1)(1994-6#1)(2007-11#1)(2007-7#1)(2011-1#2)
045)##5##1##(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)
046 and 0##3##3##(2008-10#2)(2011-1#1)
046 and##4##2##(2008-10#3)(2011-1#1)
046##8##1##(2008-10#4)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
046)##7##1##(1993-2#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-12#2)(2013-1#1)
047##7##1##(1990-2#1)(2008-10#3)(2008-7#1)(2011-1#2)
047) and##2##2##(2008-11#1)(2013-7#1)
047) for##2##2##(2008-11#1)(2011-2#1)
047)##8##1##(2008-11#2)(2009-8#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-7#1)
048##13##1##(1992-6#1)(1994-12#1)(1994-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2010-8#1)(2012-2#1)(2013-8#1)
048)##4##1##(2008-12#1)(2011-2#2)(2012-3#1)
049##4##1##(2008-10#2)(2008-2#1)(2011-2#1)
04mugg(-1)##2##1##(2008-10#2)
05 M citrate buffer##2##4##(2008-10#2)
05 M phosphate buffer (pH 2##2##6##(2008-10#2)
05 M phosphate buffer##3##4##(2008-10#3)
05 M potassium phosphate buffer (pH 7##2##7##(2008-10#2)
05 M##19##2##(1992-11#1)(2008-10#18)
05 V##2##2##(2008-10#2)
05 after##2##2##(2011-1#1)(2011-2#1)
05 and 0##15##3##(1992-11#1)(1992-3#1)(1995-12#1)(2008-10#11)(2010-8#1)
05 and 1##2##3##(2008-10#1)(2013-1#1)
05 and 2##2##3##(2008-10#2)
05 and P##3##3##(1991-12#1)(1995-6#1)(2012-2#1)
05 and##34##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1995-12#1)(1995-6#1)(2008-10#18)(2008-11#1)(2008-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
05 at##2##2##(1990-12#1)(2007-8#1)
05 compared##2##2##(1997-7#1)(2011-2#1)
05 degrees##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
05 for##6##2##(1994-3#1)(1995-12#2)(1996-2#1)(2008-10#1)(2012-12#1)
05 g##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
05 in##3##2##(1994-12#1)(2008-3#1)(2011-2#1)
05 level of significance##2##4##(1992-2#1)(2009-7#1)
05 level##3##2##(1992-2#1)(1997-5#1)(2009-7#1)
05 mL##2##2##(2011-2#2)
05 mM##3##2##(1994-11#1)(2008-10#2)
05 mg l(-1)##2##3##(2008-10#2)
05 mg##4##2##(1992-3#1)(2008-10#2)(2008-12#1)
05 microg l(-1)##3##3##(2008-10#3)
05 microm##2##2##(2008-3#2)
05 ml of##3##3##(2008-10#1)(2008-9#2)
05 ml##5##2##(1993-3#1)(1994-8#1)(2008-10#1)(2008-9#2)
05 mol kg(-1) potassium hydrogen phthalate##2##6##(2008-10#2)
05 mol l(-1)##9##3##(2008-10#9)
05 mol##13##2##(1990-10#1)(1996-5#1)(2008-10#11)
05 muM##2##2##(2008-10#1)(2008-11#1)
05 mug l(-1)##2##3##(2008-10#2)
05 mug ml(-1) and##2##4##(2008-10#2)
05 mug ml(-1)##5##3##(2008-10#5)
05 mug##9##2##(2008-10#9)
05 ng ml(-1)##2##3##(2008-10#2)
05 ng##3##2##(2008-10#3)
05 or P &lt##2##4##(2011-3#2)
05 or##4##2##(2008-10#1)(2010-4#1)(2011-3#2)
05 pmole/mg protein)##2##3##(2008-11#2)
05 ppm##4##2##(1991-8#1)(2008-10#3)
05 to 0##6##3##(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
05 to 1##2##3##(2008-10#1)(2011-1#1)
05 to 2##3##3##(2008-10#2)(2011-1#1)
05 to 3##4##3##(2008-10#3)(2013-1#1)
05 to p&lt##2##3##(2007-2#2)
05 to##24##2##(2007-2#3)(2008-10#10)(2008-11#1)(2008-7#1)(2011-1#5)(2011-2#1)(2012-3#1)(2013-1#2)
05 was considered##2##3##(2011-2#1)(2013-1#1)
05 was##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
05 were##2##2##(1995-1#1)(2011-2#1)
05 x##2##2##(2008-10#1)(2008-7#1)
05 years for##2##3##(2013-1#2)
05 years##3##2##(1995-11#1)(2013-1#2)
05##327##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-3#1)(1995-6#1)(1996-2#4)(1996-5#2)(1997-1#1)(1997-5#2)(1997-7#1)(2007-10#2)(2007-11#4)(2007-2#3)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#124)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#11)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#19)(2011-3#8)(2012-12#8)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#1)
05% NaF for 3 min##2##5##(2013-1#2)
05% NaF##3##2##(2013-1#3)
05% Trypsin-EDTA##2##2##(2008-8#2)
05% Tween 20##2##3##(1991-5#1)(2008-7#1)
05% Tween##3##2##(1991-5#1)(2008-10#1)(2008-7#1)
05% and##2##2##(1996-5#1)(2011-2#1)
05% at##2##2##(1995-12#1)(2008-5#1)
05% m/v##2##2##(2008-10#2)
05% of the##3##3##(1991-6#1)(2008-2#1)(2012-12#1)
05% w/w##2##2##(2008-5#1)(2008-7#1)
05%##39##1##(1990-6#1)(1991-5#1)(1991-6#1)(1992-6#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
05%)##4##1##(2007-7#2)(2008-10#1)(2008-5#1)
05) after##3##2##(1992-8#1)(2008-10#1)(2008-5#1)
05) and group##2##3##(1996-12#1)(2008-7#1)
05) and higher##2##3##(2008-7#1)(2010-4#1)
05) and in the##2##4##(1994-12#1)(1995-12#1)
05) and in##3##3##(1994-12#1)(1995-12#1)(2011-1#1)
05) and the##5##3##(1991-5#1)(1995-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
05) and with##2##3##(1990-2#1)(2010-2#1)
05) and##51##2##(1990-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-5#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#4)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#4)(2010-4#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
05) at##6##2##(1991-5#1)(2008-10#3)(2008-5#1)(2013-8#1)
05) better##2##2##(2008-10#1)(2013-1#1)
05) between 3##2##3##(2008-5#2)
05) between 7##2##3##(2008-5#2)
05) between Valsalva max##2##4##(2008-7#2)
05) between baroceptor sensitivity and##2##5##(2008-7#2)
05) between the##5##3##(1994-12#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
05) between##16##2##(1994-12#1)(2008-10#1)(2008-5#5)(2008-7#4)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
05) but##5##2##(2008-7#2)(2009-4#1)(2010-2#1)(2013-1#1)
05) by addition of##2##4##(2010-2#2)
05) by the rate of##2##5##(2010-11#2)
05) by##11##2##(1997-7#1)(2008-10#2)(2009-2#1)(2010-11#2)(2010-2#5)
05) compared to##4##3##(1993-1#1)(2008-5#1)(2010-4#1)(2012-3#1)
05) compared with##2##3##(2008-10#1)(2012-2#1)
05) compared##6##2##(1993-1#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)(2012-3#1)
05) correlations between##2##3##(2008-10#2)
05) decreased##3##2##(2010-2#1)(2010-4#2)
05) difference##2##2##(2008-12#2)
05) differences among##2##3##(2008-10#1)(2011-2#1)
05) differences were observed##2##4##(2013-1#2)
05) differences were##3##3##(2012-12#1)(2013-1#2)
05) differences##7##2##(2008-10#3)(2011-2#1)(2012-12#1)(2013-1#2)
05) differentiated##2##2##(2008-10#2)
05) effect##2##2##(2008-12#2)
05) for##4##2##(1993-12#1)(1996-12#1)(2012-2#1)(2013-7#1)
05) from the##4##3##(2008-10#4)
05) from##7##2##(1994-3#1)(2008-10#4)(2008-5#1)(2010-4#1)
05) greater than that##2##4##(1994-2#1)(2010-4#1)
05) greater than##4##3##(1994-2#1)(2008-10#2)(2010-4#1)
05) greater##7##2##(1994-2#1)(1996-8#1)(2008-10#3)(2010-4#1)(2013-1#1)
05) had##2##2##(1991-12#1)(2011-2#1)
05) higher in##5##3##(2008-10#2)(2008-12#2)(2013-1#1)
05) higher than##5##3##(1993-3#1)(2008-12#3)(2008-3#1)
05) higher##10##2##(1993-3#1)(2008-10#2)(2008-12#5)(2008-3#1)(2013-1#1)
05) in % overBMI##2##4##(2008-3#2)
05) in T1 and T2 than in C##6##8##(2010-2#6)
05) in T1 than in##2##5##(2010-2#2)
05) in T1 than##3##4##(2010-2#3)
05) in T1##9##3##(2010-2#9)
05) in T2 than in C##2##6##(2010-2#2)
05) in T2 than in##3##5##(2010-2#3)
05) in all##2##3##(2008-12#1)(2012-1#1)
05) in cheetahs##2##3##(2009-4#2)
05) in pigs with HGR##2##5##(2012-2#2)
05) in the SER##2##4##(2011-2#2)
05) in the##6##3##(2010-2#1)(2011-2#3)(2012-2#1)(2013-8#1)
05) in##54##2##(1990-8#1)(1992-12#1)(1994-8#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#3)(2009-7#1)(2010-2#14)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
05) increase in##4##3##(2008-4#1)(2010-4#1)(2012-2#2)
05) increased the##2##3##(2008-10#1)(2013-1#1)
05) increased##7##2##(2008-10#2)(2008-11#1)(2010-2#2)(2010-4#1)(2013-1#1)
05) inhibitory effect##2##3##(2008-10#1)(2010-4#1)
05) levels##2##2##(2013-1#1)(2013-8#1)
05) lower in##2##3##(2008-10#2)
05) lower than those##2##4##(1997-6#1)(2010-7#1)
05) lower##5##2##(1997-6#1)(2008-10#3)(2010-7#1)
05) more##2##2##(2008-10#1)(2013-1#1)
05) of##4##2##(2008-7#1)(2010-3#1)(2010-5#1)(2013-1#1)
05) on##2##2##(1997-5#2)
05) reduced the##2##3##(2012-2#1)(2012-3#1)
05) reduced##7##2##(2008-10#3)(2010-2#1)(2012-2#2)(2012-3#1)
05) reduction in the##2##4##(2008-4#1)(2010-4#1)
05) reduction in##3##3##(1995-12#1)(2008-4#1)(2010-4#1)
05) relative to##2##3##(2008-10#1)(2012-2#1)
05) suppressed##2##2##(2008-10#1)(2008-11#1)
05) than in the##2##4##(2013-1#1)(2013-7#1)
05) than in##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
05) than the##2##3##(2008-10#1)(2008-7#1)
05) than those in##2##4##(1994-12#1)(2008-4#1)
05) than those of##2##4##(2008-10#1)(2011-2#1)
05) than those##5##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
05) than##13##2##(1991-8#1)(1993-2#1)(1994-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
05) the##4##2##(2010-2#1)(2013-1#3)
05) to##3##2##(1990-12#1)(2008-12#1)(2013-1#1)
05) was found##2##3##(2007-10#1)(2008-12#1)
05) was observed##2##3##(2010-2#1)(2011-1#1)
05) was##5##2##(2007-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
05) were found##3##3##(2006-10#1)(2008-10#2)
05) were observed in##2##4##(2008-5#2)
05) were observed##4##3##(2008-5#2)(2013-1#2)
05) were##10##2##(2006-10#1)(2008-10#2)(2008-5#2)(2011-1#1)(2012-3#1)(2013-1#3)
05) when##2##2##(2008-12#1)(2010-9#1)
05) while##2##2##(1995-12#1)(2008-10#1)
05) with the##3##3##(2008-10#1)(2010-10#1)(2010-2#1)
05) with##9##2##(2008-10#2)(2008-3#1)(2008-4#1)(2010-10#1)(2010-2#2)(2013-1#2)
05) within groups##2##3##(1996-6#2)
05)##896##1##(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#8)(1994-2#5)(1994-3#6)(1994-6#4)(1994-8#2)(1995-12#16)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#12)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-5#5)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#7)(2007-10#7)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#101)(2008-11#13)(2008-12#47)(2008-2#1)(2008-3#12)(2008-4#12)(2008-5#25)(2008-6#8)(2008-7#52)(2008-8#1)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#50)(2010-3#8)(2010-4#25)(2010-5#1)(2010-6#3)(2010-7#10)(2010-8#5)(2010-9#2)(2011-1#48)(2011-2#44)(2011-3#5)(2012-1#4)(2012-12#11)(2012-2#34)(2012-3#12)(2013-1#78)(2013-7#14)(2013-8#30)
05))##2##1##(2008-11#1)(2008-5#1)
05+/-0##3##1##(2007-11#1)(2008-10#1)(2008-11#1)
05-0##19##1##(1990-2#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-4#2)(2012-2#1)(2013-1#2)
05-1##11##1##(1997-2#1)(2008-10#9)(2011-2#1)
05-2##8##1##(1994-12#1)(2008-10#7)
05-3##2##1##(2008-10#2)
05-4##2##1##(2008-10#2)
05-5##4##1##(2008-10#4)
05-6##3##1##(2008-10#3)
05-7##4##1##(2008-10#3)(2008-2#1)
05-8##2##1##(2008-10#2)
050##9##1##(1990-11#1)(1993-2#1)(2008-10#3)(2009-8#1)(2011-2#1)(2011-7#1)(2013-8#1)
050)##2##1##(1991-8#1)(2008-7#1)
0500##2##1##(1997-7#1)(2008-10#1)
051 to##2##2##(2008-11#1)(2011-2#1)
051##7##1##(1994-6#1)(1997-2#1)(2008-11#1)(2010-3#1)(2010-9#1)(2011-2#2)
052##3##1##(1994-12#1)(2008-10#1)(2011-2#1)
052)##2##1##(2008-7#1)(2008-8#1)
053##5##1##(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#1)
054##2##1##(2008-10#2)
055 and##2##2##(2008-10#1)(2010-11#1)
055##8##1##(1991-5#1)(2008-10#3)(2008-5#1)(2009-11#1)(2010-11#1)(2010-8#1)
056##2##1##(2008-10#2)
057##5##1##(1991-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-8#1)
058##3##1##(1996-2#1)(1997-7#1)(2008-11#1)
059##4##1##(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)
05M phosphate buffer##2##3##(2008-10#2)
05M##12##1##(2008-10#12)
05V##2##1##(2008-10#2)
05mM##2##1##(2008-10#2)
05molL(-1)##5##1##(2008-10#5)
05muM##2##1##(2008-10#2)
05mugl(-1)##2##1##(2008-10#2)
05mugml(-1)##2##1##(2008-10#2)
05ngml(-1)##2##1##(2008-10#2)
06 +/- 0##4##3##(1990-2#1)(1991-11#1)(1997-1#1)(2008-12#1)
06 +/-##8##2##(1990-2#1)(1991-11#1)(1997-1#1)(1997-2#1)(2008-12#2)(2012-3#1)(2013-1#1)
06 V##2##2##(2008-10#2)
06 and 0##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
06 and##9##2##(1992-3#1)(2008-10#6)(2011-2#2)
06 g##2##2##(2008-12#2)
06 in##3##2##(1994-11#1)(2008-10#1)(2012-12#1)
06 mM##3##2##(1990-7#1)(1994-3#2)
06 microM##2##2##(1993-8#1)(2008-10#1)
06 microm##2##2##(2008-3#2)
06 mm##3##2##(2007-8#1)(2008-3#1)(2010-8#1)
06 mm)##2##2##(2013-1#2)
06 mmol/L##2##2##(2008-4#1)(2011-2#1)
06 mug l(-1) for##2##4##(2008-10#2)
06 mug l(-1)##4##3##(2008-10#4)
06 mug ml(-1)##2##3##(2008-10#2)
06 mug##6##2##(2008-10#6)
06 mum and##2##3##(2008-3#2)
06 mum##7##2##(2008-2#5)(2008-3#2)
06 ng ml(-1)##2##3##(2008-10#2)
06 ng##4##2##(1996-2#1)(2008-10#3)
06 to 0##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
06 to##6##2##(2008-10#4)(2012-12#1)(2013-1#1)
06 x##2##2##(2008-10#2)
06##119##1##(1990-12#1)(1990-2#3)(1990-7#2)(1991-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-3#3)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#42)(2008-11#2)(2008-12#5)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
06%##8##1##(1992-11#1)(1992-9#1)(2008-10#4)(2008-3#1)(2012-3#1)
06%)##4##1##(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
06) for##2##2##(1991-11#1)(2008-3#1)
06)##18##1##(1991-11#2)(1992-11#1)(1993-11#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-6#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
06+/-0##3##1##(2008-10#2)(2009-12#1)
06-##3##1##(2008-3#1)(2013-1#2)
06-0##3##1##(2008-10#2)(2008-3#1)
06-6##2##1##(2008-10#1)(2008-7#1)
06-microm##3##1##(2007-11#1)(2008-2#2)
060##4##1##(1991-9#1)(1992-8#1)(1996-2#1)(2011-2#1)
0600 PST##3##2##(2008-10#3)
0600 to##3##2##(2008-10#3)
0600##7##1##(1992-11#1)(2008-10#6)
061 and##2##2##(2008-10#1)(2010-8#1)
061##6##1##(1995-11#1)(1997-3#1)(2008-10#3)(2010-8#1)
062 bp##2##2##(1997-8#2)
062##5##1##(1992-12#1)(1997-8#2)(2010-11#1)(2012-12#1)
062)##4##1##(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)
063##4##1##(1992-5#1)(2008-10#2)(2010-5#1)
064 microm and##2##3##(2007-11#1)(2008-3#1)
064 microm##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
064 mum##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
064##12##1##(2007-1#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)
064)##2##1##(1992-3#1)(2010-6#1)
064-mum##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
0642 microm##2##2##(2008-2#1)(2008-3#1)
0642##4##1##(1996-2#1)(2008-2#2)(2008-3#1)
064mum##3##1##(2007-12#3)
065##4##1##(2008-10#3)(2008-11#1)
065-2##2##1##(1991-12#2)
066##4##1##(1990-2#1)(1995-3#1)(2008-10#1)(2008-12#1)
066-mum Ho##2##2##(2008-2#2)
067##6##1##(2008-10#2)(2008-2#2)(2008-3#1)(2012-1#1)
067)##2##1##(2008-1#1)(2008-10#1)
068##4##1##(2008-2#1)(2008-5#2)(2010-10#1)
069##3##1##(2009-11#1)(2011-2#1)(2013-1#1)
06ms##2##1##(2008-10#2)
06mugL(-1)##2##1##(2008-10#2)
06mugl(-1)##2##1##(2008-10#2)
07 +/- 0##3##3##(1992-9#1)(2009-8#1)(2011-2#1)
07 +/-##4##2##(1992-9#1)(2007-7#1)(2009-8#1)(2011-2#1)
07 and 0##6##3##(1992-3#1)(1997-4#1)(2008-10#3)(2008-3#1)
07 and##8##2##(1992-3#1)(1997-4#1)(2008-10#5)(2008-3#1)
07 microg##2##2##(2008-10#2)
07 mol l(-1) ammonium sulfate##2##5##(2008-10#2)
07 to 0##4##3##(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
07 to##8##2##(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
07##67##1##(1992-3#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-6#1)(1997-4#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
07%##7##1##(2008-10#2)(2008-3#1)(2008-5#2)(2009-8#1)(2013-8#1)
07%)##8##1##(2007-11#1)(2007-7#1)(2008-12#4)(2009-8#1)(2013-1#1)
07) and##3##2##(1996-9#1)(2007-2#1)(2008-1#1)
07)##16##1##(1992-11#1)(1995-12#1)(1996-9#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
07-0##4##1##(2008-10#3)(2012-12#1)
07-3##2##1##(2007-2#1)(2011-2#1)
070##2##1##(1997-4#1)(2008-10#1)
071##2##1##(1994-12#1)(1997-2#1)
072##7##1##(1990-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2011-3#1)(2013-7#1)
073##3##1##(2008-10#2)(2008-11#1)
074)##2##1##(1994-3#1)(2008-10#1)
074-microm##2##1##(2008-3#2)
075##9##1##(1990-5#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-2#1)(2013-7#1)
076##5##1##(1990-2#1)(1991-11#2)(2010-11#1)(2010-9#1)
076)##2##1##(2008-10#1)(2008-9#1)
078##10##1##(1992-3#1)(1993-8#1)(1996-2#1)(1996-8#1)(2008-10#3)(2010-9#1)(2011-2#1)(2012-3#1)
078)##2##1##(2008-10#1)(2011-1#1)
079)##4##1##(1991-8#1)(1997-7#1)(2008-10#1)(2008-11#1)
0795##2##1##(2008-2#2)
07mgL(-1)##2##1##(2008-10#2)
07mugml(-1)##2##1##(2008-10#2)
08 +/- 0##5##3##(1992-5#1)(1994-6#1)(1995-11#1)(2008-10#1)(2011-2#1)
08 +/-##6##2##(1992-5#1)(1994-6#1)(1995-11#1)(2007-5#1)(2008-10#1)(2011-2#1)
08 M to 1##2##4##(1997-2#2)
08 M##3##2##(1997-2#3)
08 and 0##8##3##(1993-8#1)(1994-8#1)(2008-10#4)(2008-2#1)(2010-11#1)
08 and##14##2##(1992-9#1)(1993-8#1)(1994-8#1)(1997-4#1)(2008-10#7)(2008-12#1)(2008-2#1)(2010-11#1)
08 for the##2##3##(1994-11#1)(2009-1#1)
08 for##4##2##(1994-11#1)(2009-1#3)
08 mM##2##2##(2008-10#2)
08 mg##2##2##(2008-10#2)
08 mg/kg##2##2##(2008-10#1)(2012-3#1)
08 microg##2##2##(2008-9#2)
08 mug ml(-1)##2##3##(2008-10#2)
08 mug##3##2##(2008-10#3)
08 nm##2##2##(2008-2#2)
08 ppb##2##2##(2008-10#2)
08 to 0##5##3##(2008-10#5)
08 to##6##2##(2008-10#6)
08 vs##2##2##(1993-2#1)(2010-6#1)
08 x##2##2##(2007-11#1)(2008-10#1)
08 ± 0##3##3##(2011-2#1)(2013-7#2)
08##106##1##(1990-6#1)(1991-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#3)(1996-7#1)(1996-9#1)(1997-2#4)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#42)(2008-11#2)(2008-12#3)(2008-2#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-1#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-3#1)(2013-1#1)(2013-7#3)
08% of##3##2##(1993-11#1)(2007-11#1)(2011-1#1)
08%##8##1##(1993-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-1#2)(2012-3#1)
08%)##3##1##(2008-10#1)(2008-9#1)(2012-2#1)
08) and##2##2##(2007-10#1)(2008-2#1)
08)##16##1##(1990-7#1)(1990-8#1)(1993-12#1)(1995-8#1)(1995-9#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
08+/-0##2##1##(1997-4#1)(2008-10#1)
08-0##6##1##(1995-2#1)(2008-10#5)
08-1##6##1##(1994-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
08-10##2##1##(2008-10#2)
08-2##2##1##(2008-10#1)(2011-2#1)
08-4##2##1##(2008-10#2)
080##3##1##(2008-10#2)(2008-11#1)
0800 h##4##2##(1992-11#1)(2008-10#3)
0800##5##1##(1992-11#1)(2008-10#4)
081 for##2##2##(2008-10#1)(2011-2#1)
081##8##1##(1990-8#1)(2008-10#2)(2008-6#1)(2011-2#2)(2012-3#2)
082##3##1##(2008-10#1)(2008-3#2)
083##5##1##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
084##2##1##(2008-8#1)(2010-8#1)
085##5##1##(1996-5#1)(2008-7#1)(2011-1#1)(2011-2#2)
086##4##1##(1994-1#1)(2008-10#1)(2010-11#1)(2011-2#1)
087##4##1##(1993-8#1)(2008-10#2)(2008-11#1)
087)##2##1##(2011-2#1)(2013-1#1)
088##4##1##(2008-10#2)(2011-1#1)(2011-2#1)
09 and 0##4##3##(1994-9#1)(2008-10#3)
09 and##7##2##(1994-9#1)(2008-10#5)(2012-3#1)
09 degrees##2##2##(2008-2#1)(2008-3#1)
09 for##2##2##(1995-2#1)(2008-10#1)
09 to 0##3##3##(1992-3#1)(2008-2#1)(2011-1#1)
09 to##7##2##(1992-3#1)(2008-10#1)(2008-2#1)(2011-1#2)(2012-2#1)(2013-1#1)
09##63##1##(1990-6#1)(1992-11#2)(1992-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-12#1)(2008-2#2)(2008-3#2)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
09%##11##1##(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
09%) and##2##2##(2011-2#1)(2013-8#1)
09%)##9##1##(1992-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#3)(2013-8#1)
09)##11##1##(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2011-2#1)
09-0##2##1##(1990-7#1)(2012-1#1)
09-1##2##1##(1994-3#1)(2013-1#1)
0900##2##1##(2008-10#2)
091##2##1##(2008-10#1)(2011-1#1)
092##4##1##(1995-11#1)(2008-10#2)(2013-7#1)
095##4##1##(1992-10#1)(2008-10#2)(2009-7#1)
096##3##1##(2009-5#1)(2010-4#1)(2013-7#1)
097##4##1##(2008-10#2)(2011-1#1)(2011-2#1)
0975##2##1##(2008-5#2)
098##7##1##(2008-10#3)(2010-10#1)(2011-1#2)(2012-3#1)
09]##2##1##(1992-11#1)(2012-2#1)
09mgkg(-1)##2##1##(2008-10#2)
0D##4##1##(2008-6#1)(2010-5#1)(2010-8#2)
0L##2##1##(2010-8#2)
0M##5##1##(2008-10#5)
0V versus Ag/AgCl##2##3##(2008-10#2)
0V##7##1##(2008-10#7)
0] undecanes##3##2##(2009-8#3)
0]##6##1##(1996-2#1)(2007-11#1)(2009-8#3)(2012-3#1)
0]octenes##3##1##(1996-5#3)
0anteiso##2##1##(2011-1#2)
0cm##2##1##(2008-10#1)(2013-7#1)
0g##2##1##(2008-10#2)
0mL of##2##2##(2008-10#2)
0mL##3##1##(2008-10#3)
0mLmin(-1)##5##1##(2008-10#5)
0mM##9##1##(2008-10#7)(2011-2#2)
0mg##4##1##(2008-10#4)
0mg/L##4##1##(2008-10#3)(2013-1#1)
0mg/kg##2##1##(1990-5#1)(2008-10#1)
0mgL(-1)##10##1##(2008-10#10)
0mgkg(-1)##2##1##(2008-10#2)
0mgl(-1) for a##2##3##(2008-10#2)
0mgl(-1)##8##1##(2008-10#8)
0min of##2##2##(2008-10#2)
0min##5##1##(2008-10#5)
0ml of 2M##2##3##(2008-10#2)
0ml of##8##2##(2008-10#8)
0ml##16##1##(2008-10#16)
0mlmin(-1) and##3##2##(2008-10#3)
0mlmin(-1)##7##1##(2008-10#7)
0mm##3##1##(2008-10#2)(2008-2#1)
0mmolL(-1))##2##1##(2008-10#2)
0mmolkg(-1))##2##1##(2008-10#2)
0mmoll(-1)##2##1##(2008-10#2)
0molL(-1)##4##1##(2008-10#4)
0moll(-1) HCl##2##2##(2008-10#2)
0moll(-1)##4##1##(2008-10#4)
0muM##2##1##(2008-10#2)
0mug of##2##2##(2008-10#2)
0mug##4##1##(2008-10#4)
0mug/mL##2##1##(2008-10#2)
0mug/ml##2##1##(2008-10#2)
0mugL(-1) of As(III)##2##3##(2008-10#2)
0mugL(-1)##3##1##(2008-10#3)
0mugg(-1)##4##1##(2008-10#4)
0mugl(-1) Cd)##2##2##(2008-10#2)
0mugl(-1) of##3##2##(2008-10#3)
0mugl(-1)##18##1##(2008-10#18)
0mugmL(-1)##2##1##(2008-10#2)
0mugml(-1) and the detection limit was##2##6##(2008-10#2)
0mugml(-1) for##3##2##(2008-10#3)
0mugml(-1) of##2##2##(2008-10#2)
0mugml(-1)##18##1##(2008-10#18)
0mul of##2##2##(2008-10#2)
0mumol/L##3##1##(2008-10#3)
0ng##2##1##(2008-10#2)
0ngl(-1)##3##1##(2008-10#3)
0ngmL(-1) for##3##2##(2008-10#3)
0ngml(-1) for##2##2##(2008-10#2)
0ngml(-1) with a limit of##2##5##(2008-10#2)
0ngml(-1)##12##1##(2008-10#12)
0nm##5##1##(2008-10#5)
0ppm##2##1##(2008-10#2)
0sigma(I)##2##1##(1996-2#2)
0th-order##2##1##(2008-2#1)(2008-3#1)
0wt##3##1##(2008-10#1)(2013-1#2)
0wt%Zn-0##3##1##(2012-2#3)
0x10##3##1##(2008-10#3)
0x10(-1) M with##2##3##(2008-10#2)
0x10(-1) M##4##2##(2008-10#4)
0x10(-1)##8##1##(2008-10#8)
0x10(-1)) with a##2##3##(2008-10#2)
0x10(-1)-1##3##1##(2008-10#3)
0x10(-1)M (detection limit##2##3##(2008-10#2)
0x10(-1)M and##2##2##(2008-10#2)
0x10(-1)M with a slope##2##4##(2008-10#2)
0x10(-1)M##7##1##(2008-10#7)
0x10(-1)moll(-1)##2##1##(2008-10#2)
0x10(-10)##4##1##(2008-10#4)
0x10(-10)-1##2##1##(2008-10#2)
0x10(-11)##5##1##(2008-10#5)
0x10(-2) M for##2##3##(2008-10#2)
0x10(-2) M##6##2##(2008-10#6)
0x10(-2) mol l(-1) Hepes buffer at pH 8##2##8##(2008-10#2)
0x10(-2) mol l(-1)##5##3##(2008-10#5)
0x10(-2)##11##1##(2008-10#11)
0x10(-2)-1##2##1##(2008-10#2)
0x10(-2)-7##2##1##(2008-10#2)
0x10(-2)M##3##1##(2008-10#3)
0x10(-2)moll(-1)##3##1##(2008-10#3)
0x10(-3) M##5##2##(2008-10#5)
0x10(-3) and##3##2##(2008-10#3)
0x10(-3) mol l(-1)##5##3##(2008-10#5)
0x10(-3) to##3##2##(2008-10#3)
0x10(-3)##16##1##(2008-10#16)
0x10(-3)% (m/v)##2##2##(2008-10#2)
0x10(-3)M##4##1##(2008-10#4)
0x10(-3)molL(-1) with a##2##3##(2008-10#2)
0x10(-3)molL(-1)##4##1##(2008-10#4)
0x10(-3)moll(-1) with a detection limit of##2##6##(2008-10#2)
0x10(-3)moll(-1)##3##1##(2008-10#3)
0x10(-4) M for##2##3##(2008-10#2)
0x10(-4) M##7##2##(2008-10#7)
0x10(-4) M)##2##2##(2008-10#2)
0x10(-4) mol l(-1) with##2##4##(2008-10#2)
0x10(-4) mol l(-1)##8##3##(2008-10#8)
0x10(-4) mol##9##2##(2008-10#9)
0x10(-4) to##2##2##(2008-10#2)
0x10(-4)##25##1##(2008-10#25)
0x10(-4)M##4##1##(2008-10#4)
0x10(-4)moll(-1)##5##1##(2008-10#5)
0x10(-5) M for##2##3##(2008-10#2)
0x10(-5) M with a detection limit of##2##7##(2008-10#2)
0x10(-5) M##16##2##(2008-10#16)
0x10(-5) and 1##2##3##(2008-10#2)
0x10(-5) and##4##2##(2008-10#4)
0x10(-5) mol l(-1) with##2##4##(2008-10#2)
0x10(-5) mol l(-1)##11##3##(2008-10#11)
0x10(-5) mol##12##2##(2008-10#12)
0x10(-5) to 1##6##3##(2008-10#6)
0x10(-5) to 2##2##3##(2008-10#2)
0x10(-5) to##10##2##(2008-10#10)
0x10(-5)##45##1##(2007-12#1)(2008-10#44)
0x10(-5)-2##2##1##(2008-10#2)
0x10(-5)M##5##1##(2008-10#5)
0x10(-5)molL(-1) for##2##2##(2008-10#2)
0x10(-5)molL(-1)##4##1##(2008-10#4)
0x10(-5)moll(-1)##2##1##(2008-10#2)
0x10(-6) M##11##2##(2008-10#11)
0x10(-6) M)##2##2##(2008-10#2)
0x10(-6) and 1##2##3##(2008-10#2)
0x10(-6) and##4##2##(2008-10#4)
0x10(-6) mol l(-1)##12##3##(2008-10#12)
0x10(-6) to 1##6##3##(2008-10#6)
0x10(-6) to 2##3##3##(2008-10#3)
0x10(-6) to##12##2##(2008-10#12)
0x10(-6)##42##1##(2008-10#42)
0x10(-6)-1##7##1##(2008-10#7)
0x10(-6)-2##2##1##(2008-10#2)
0x10(-6)-3##2##1##(2008-10#2)
0x10(-6)gml(-1)##3##1##(2008-10#3)
0x10(-6)mol/l##3##1##(2008-10#3)
0x10(-6)molL(-1)##3##1##(2008-10#3)
0x10(-6)moll(-1)##4##1##(2008-10#4)
0x10(-7) M for##2##3##(2008-10#2)
0x10(-7) M##12##2##(2008-10#12)
0x10(-7) M)##2##2##(2008-10#2)
0x10(-7) and 1##3##3##(2008-10#3)
0x10(-7) and##4##2##(2008-10#4)
0x10(-7) mol l(-1)##11##3##(2008-10#11)
0x10(-7) mol##13##2##(2008-10#13)
0x10(-7) mol/l##2##2##(2008-10#2)
0x10(-7) to 1##4##3##(2008-10#4)
0x10(-7) to 2##3##3##(2008-10#3)
0x10(-7) to##8##2##(2008-10#8)
0x10(-7)##45##1##(2008-10#45)
0x10(-7)-1##8##1##(2008-10#8)
0x10(-7)-2##2##1##(2008-10#2)
0x10(-7)M##6##1##(2008-10#6)
0x10(-7)mol/l##3##1##(2008-10#3)
0x10(-7)moll(-1)##3##1##(2008-10#3)
0x10(-8) M##3##2##(2008-10#3)
0x10(-8) gml(-1)##2##2##(2008-10#2)
0x10(-8) mol l(-1) and the##2##5##(2008-10#2)
0x10(-8) mol l(-1)##7##3##(2008-10#7)
0x10(-8) to 1##4##3##(2008-10#4)
0x10(-8) to 2##2##3##(2008-10#2)
0x10(-8) to##7##2##(2008-10#7)
0x10(-8)##20##1##(2008-10#20)
0x10(-8)-2##2##1##(2008-10#2)
0x10(-8)-3##2##1##(2008-10#2)
0x10(-8)M with a 0##2##4##(2008-10#2)
0x10(-8)M##5##1##(2008-10#5)
0x10(-9) M##5##2##(2008-10#5)
0x10(-9) mol l(-1)##2##3##(2008-10#2)
0x10(-9) to 2##2##3##(2008-10#2)
0x10(-9) to 4##2##3##(2008-10#2)
0x10(-9) to##8##2##(2008-10#8)
0x10(-9)##16##1##(2008-10#16)
0x10(-9)-1##2##1##(2008-10#2)
0x10(-9)M##2##1##(2008-10#2)
0x10(3)##2##1##(2008-10#2)
0x10(4) l mol(-1) cm(-1)##2##4##(2008-10#2)
0x10(4)##3##1##(2008-10#3)
0zeta##2##1##(2008-10#2)
0 pg cell(-1))##2##1##(2012-1#2)
0 μM##2##1##(2013-8#2)
0±0##3##1##(2010-12#1)(2011-1#1)(2012-12#1)
0 ± 0##2##1##(2012-1#2)
1 % RSA##2##3##(2010-10#2)
1 % of the##2##4##(2007-5#1)(2012-12#1)
1 %##12##2##(1997-8#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-10#2)(2010-8#1)(2011-2#1)(2012-12#1)
1 %) and##2##3##(1997-8#1)(2012-12#1)
1 %)##10##2##(1997-8#1)(2008-3#1)(2012-12#8)
1 &amp##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
1 &gt##3##2##(1995-6#1)(1997-4#1)(2008-12#1)
1 &lt##2##2##(2008-10#1)(2008-2#1)
1 (+/-0##2##2##(2007-8#1)(2008-10#1)
1 (0##9##2##(1991-8#2)(1995-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#2)(2013-8#1)
1 (1##3##2##(1990-5#1)(2008-10#1)(2012-12#1)
1 (1%) of##2##3##(1991-8#2)
1 (10##2##2##(1996-3#1)(2010-6#1)
1 (2##6##2##(1990-8#2)(1991-3#3)(2013-8#1)
1 (2005)##2##2##(2008-4#2)
1 (22##3##2##(1996-3#1)(2008-7#1)(2011-2#1)
1 (95% CI##3##3##(1995-6#1)(2010-3#1)(2012-3#1)
1 (95%##4##2##(1995-6#1)(2009-5#1)(2010-3#1)(2012-3#1)
1 (AT1) receptor##2##3##(2008-1#1)(2008-8#1)
1 (HA1)##2##2##(1994-8#1)(2011-2#1)
1 (IC50 =##2##3##(1995-8#1)(1997-7#1)
1 (IL-1)##5##2##(1990-11#2)(1990-12#1)(1990-2#1)(1995-2#1)
1 (IL1) and tumour necrosis factor (TNF)##2##7##(1996-2#2)
1 (ITS1)##5##2##(2008-10#5)
1 (MDR1)##2##2##(2007-10#1)(2008-11#1)
1 (P &lt##2##3##(1993-2#1)(2010-2#1)
1 (P##3##2##(1993-2#1)(2008-10#1)(2010-2#1)
1 (TGF-beta 1)##4##3##(1990-8#1)(1991-12#1)(1992-3#1)(1994-11#1)
1 (Th1)##2##2##(2008-10#1)(2008-11#1)
1 (codon##3##2##(2008-11#3)
1 (n =##2##3##(2008-10#1)(2012-12#1)
1 (v/v)##4##2##(2008-10#4)
1 (v/v))##2##2##(2008-10#2)
1 + 2 +##5##4##(1990-12#1)(1990-5#4)
1 +##6##2##(1990-12#1)(1990-5#4)(2008-7#1)
1 +/- 0##17##3##(1990-7#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-7#2)(2008-11#1)(2008-12#2)(2008-3#1)(2012-3#1)(2013-1#1)
1 +/- 1##8##3##(1990-12#1)(1990-7#1)(1991-11#1)(1992-10#1)(1993-2#1)(1996-2#1)(2008-3#1)(2008-5#1)
1 +/- 2##6##3##(1991-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
1 +/- 3##5##3##(1995-12#1)(1997-6#1)(2007-7#1)(2008-3#1)(2008-7#1)
1 +/- 5##5##3##(1990-8#1)(1991-2#1)(1995-12#1)(2008-8#1)(2010-1#1)
1 +/- 6##3##3##(1995-5#1)(1996-3#1)(2008-4#1)
1 +/- 7##3##3##(1996-3#1)(2008-7#1)(2011-3#1)
1 +/- 8##3##3##(1996-3#1)(1997-4#1)(2008-10#1)
1 +/- 9##2##3##(1990-8#1)(2008-1#1)
1 +/-##60##2##(1990-12#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-5#2)(1996-2#3)(1996-3#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-1#1)(2010-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
1 - 3##2##3##(2007-11#1)(2011-1#1)
1 -##15##2##(1995-2#2)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)
1 1/2##2##2##(1994-2#1)(2012-2#1)
1 375##3##2##(2013-8#3)
1 3FD##2##2##(1990-7#2)
1 621##2##2##(2013-8#2)
1 =##6##2##(1990-8#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
1 ? 0##2##3##(2007-12#1)(2008-3#1)
1 A##6##2##(1990-12#1)(1995-8#1)(2008-3#2)(2008-7#1)(2010-10#1)
1 CFU/g##2##2##(2012-2#2)
1 Diabetes##4##2##(2008-1#1)(2009-3#1)(2010-11#1)(2013-1#1)
1 E##2##2##(2010-6#1)(2011-2#1)
1 GHz##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
1 Gy##5##2##(2008-7#2)(2013-1#1)(2013-8#2)
1 Hz##7##2##(1991-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
1 Hz)##2##2##(2008-3#1)(2008-9#1)
1 In##3##2##(2009-8#2)(2013-8#1)
1 J##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
1 January 1991##4##3##(1992-5#1)(1992-9#2)(1997-8#1)
1 January 2000##2##3##(1996-1#1)(2012-12#1)
1 January 2005##2##3##(2008-8#1)(2011-2#1)
1 January##13##2##(1990-12#1)(1990-2#1)(1992-5#1)(1992-9#2)(1996-1#3)(1997-8#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
1 K in the##2##4##(2008-2#2)
1 K##4##2##(1992-10#1)(1996-2#1)(2008-2#2)
1 Kb##2##2##(1992-3#1)(1993-11#1)
1 L##5##2##(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#2)
1 M (H##2##3##(2008-10#2)
1 M H(2)SO(4)##2##3##(2008-10#2)
1 M HCl##4##3##(2008-10#4)
1 M HF medium##2##4##(2008-10#2)
1 M HNO(3) and##2##4##(2008-10#2)
1 M HNO(3)##8##3##(2008-10#8)
1 M KCl##4##3##(1990-8#1)(1993-8#2)(2008-10#1)
1 M KOH ethanol solution containing##2##6##(2008-10#2)
1 M NaCl##9##3##(1990-8#1)(1991-8#1)(1992-3#1)(1993-3#1)(1995-6#2)(1997-2#1)(2008-10#2)
1 M NaClO(4)##2##3##(2008-10#2)
1 M NaNO(3) solution##2##4##(2008-10#2)
1 M NaNO(3)##3##3##(2008-10#2)(2008-5#1)
1 M NaOH##4##3##(1995-6#1)(2008-10#2)(2008-6#1)
1 M hydrochloric acid solution##2##5##(2008-10#2)
1 M hydrochloric acid##4##4##(2008-10#4)
1 M ionic strength##2##4##(2008-10#2)
1 M nitric acid##2##4##(2008-10#2)
1 M sodium##2##3##(2008-10#2)
1 M##91##2##(1990-12#2)(1990-2#1)(1990-8#2)(1991-8#1)(1992-3#2)(1992-6#2)(1993-3#2)(1993-8#2)(1994-2#1)(1994-8#1)(1995-2#2)(1995-6#4)(1996-2#1)(1997-2#3)(2008-10#61)(2008-5#1)(2008-6#1)(2008-9#2)
1 M)##4##2##(1990-8#1)(1993-3#1)(1996-2#1)(2008-10#1)
1 MHz and##3##3##(2008-3#2)(2008-9#1)
1 MHz##10##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-11#1)
1 MPa##3##2##(2007-12#1)(2008-10#2)
1 Mb##2##2##(1995-8#1)(1996-8#1)
1 N##2##2##(1995-3#1)(2008-10#1)
1 R and NuMA##2##4##(2010-5#2)
1 R##7##2##(2010-5#7)
1 S##4##2##(1990-6#1)(1997-8#2)(2010-6#1)
1 SD in##2##3##(1996-7#2)
1 SD##3##2##(1996-7#3)
1 This assessment##10##3##(2013-8#10)
1 V for##2##3##(2008-10#2)
1 V versus##2##3##(2008-10#2)
1 V vs##3##3##(2008-10#2)(2010-4#1)
1 V was##3##3##(2008-10#2)(2008-2#1)
1 V##15##2##(1996-5#1)(2008-10#12)(2008-2#1)(2010-4#1)
1 V)##2##2##(2008-10#1)(2009-6#1)
1 W and##3##3##(2007-12#2)(2008-2#1)
1 W of average output power##2##6##(2007-11#1)(2007-12#1)
1 W of##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
1 W##18##2##(2007-11#4)(2007-12#8)(2008-2#3)(2008-3#3)
1 We##2##2##(2009-8#2)
1 actin##2##2##(1991-5#1)(1992-3#1)
1 activity##4##2##(1991-12#2)(2008-9#1)(2012-12#1)
1 added##2##2##(1993-3#1)(2008-9#1)
1 after##4##2##(1991-3#2)(1992-3#1)(1995-12#1)
1 alpha##13##2##(1990-5#1)(1991-12#1)(1992-12#5)(1994-9#4)(2008-1#1)(2008-3#1)
1 ammonia and estimated spectrophotometrically with pyrimidine-2-thiol##2##7##(2008-10#2)
1 and 0##22##3##(1992-9#1)(1994-8#1)(1995-12#2)(1995-2#1)(2008-10#15)(2008-12#1)(2008-5#1)
1 and 1##30##3##(1992-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#22)(2008-3#1)(2008-5#1)(2009-10#1)
1 and 10##9##3##(1990-8#1)(1992-3#1)(1993-12#1)(1995-12#1)(2008-10#4)(2011-1#1)
1 and 100##2##3##(2008-10#2)
1 and 11##3##3##(1997-2#1)(1997-4#1)(2008-12#1)
1 and 13##2##3##(1994-2#1)(2008-10#1)
1 and 17##2##3##(2008-12#1)(2010-11#1)
1 and 2 and the##3##5##(1997-1#1)(2008-10#1)(2008-8#1)
1 and 2 and##5##4##(1995-3#1)(1997-1#1)(2008-10#2)(2008-8#1)
1 and 2 are##2##4##(2008-7#1)(2010-5#1)
1 and 2 months##2##4##(2007-10#1)(2008-10#1)
1 and 2 of##5##4##(1996-9#1)(2008-10#4)
1 and 2 orders of magnitude##2##6##(2008-10#1)(2008-3#1)
1 and 2 t##2##4##(2008-12#2)
1 and 2 were##9##4##(1994-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2013-1#1)
1 and 2##108##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#3)(1994-9#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#9)(2008-12#5)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-6#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#1)
1 and 2) in##2##4##(2011-2#1)(2012-12#1)
1 and 2)##10##3##(1990-11#2)(1994-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-12#1)
1 and 28##2##3##(1994-8#1)(2010-6#1)
1 and 2A##8##3##(1991-5#1)(1992-12#3)(1992-8#1)(1994-11#2)(2008-10#1)
1 and 3 in##4##4##(2008-10#1)(2012-3#3)
1 and 3##31##3##(1993-12#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-11#1)(2011-2#4)(2012-3#5)(2013-1#1)(2013-8#1)
1 and 4##13##3##(1993-6#1)(1993-9#1)(1994-8#1)(1997-2#1)(2008-10#6)(2008-7#2)(2011-2#1)
1 and 5##14##3##(1990-9#1)(1991-9#1)(1994-9#1)(2008-10#6)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
1 and 6##8##3##(1991-2#1)(1996-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-1#1)(2012-2#1)
1 and 7##8##3##(1996-2#1)(2007-10#1)(2008-10#2)(2008-7#1)(2009-11#1)(2012-1#1)(2013-1#1)
1 and 8 and##3##4##(2008-10#3)
1 and 8##10##3##(1994-7#1)(1995-12#1)(2008-10#8)
1 and 9##3##3##(1995-11#1)(2008-10#1)(2012-12#1)
1 and MAX##3##3##(1995-6#3)
1 and a##4##3##(1995-2#1)(1995-5#1)(2008-9#1)(2009-2#1)
1 and beta 2##3##4##(1993-12#2)(1995-11#1)
1 and its##2##3##(1990-5#1)(2008-10#1)
1 and that##2##3##(2008-10#1)(2011-2#1)
1 and the##11##3##(1995-3#1)(1995-8#1)(1997-7#1)(2008-10#5)(2008-6#1)(2008-7#1)(2012-12#1)
1 and type##20##3##(1990-12#1)(1992-8#1)(1993-2#3)(1997-3#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-4#2)(2013-1#3)
1 and##473##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-2#3)(1991-5#2)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#5)(1993-12#7)(1993-2#4)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#6)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#2)(1995-11#2)(1995-12#6)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#7)(1997-8#2)(2007-10#3)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#161)(2008-11#12)(2008-12#11)(2008-2#4)(2008-3#13)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#10)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#4)(2011-1#3)(2011-2#15)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#13)(2012-4#2)(2013-1#15)(2013-7#1)(2013-8#2)
1 antibodies##4##2##(1993-8#1)(2009-8#3)
1 approximately##3##2##(2008-10#2)(2008-11#1)
1 are##7##2##(1995-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
1 as##2##2##(2008-10#1)(2008-8#1)
1 association##2##2##(1994-12#1)(2008-10#1)
1 at saturation by S1##2##5##(1992-3#2)
1 at the##3##3##(2008-10#2)(2011-1#1)
1 at##15##2##(1992-3#3)(1994-6#2)(2008-10#4)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-2#1)
1 axis##2##2##(2008-3#2)
1 based##2##2##(2008-10#2)
1 beta##9##2##(1990-8#1)(1992-12#3)(1993-8#3)(1995-11#2)
1 billion##3##2##(1992-3#1)(1994-9#1)(2008-6#1)
1 binding to##2##3##(1994-12#2)
1 binding##5##2##(1994-12#3)(1997-7#1)(2008-10#1)
1 binds##2##2##(1994-5#1)(2008-12#1)
1 but not##2##3##(1991-8#1)(2008-10#1)
1 but##3##2##(1991-8#1)(2008-10#2)
1 by##5##2##(1991-2#1)(1994-12#1)(1995-8#1)(2007-10#1)(2007-12#1)
1 cM##4##2##(1997-2#1)(2008-10#1)(2008-9#2)
1 cM)##2##2##(2008-10#2)
1 case developed##2##3##(2013-1#2)
1 case of##14##3##(1994-1#1)(1994-12#4)(2007-10#1)(2007-8#1)(2010-6#1)(2012-3#3)(2013-8#3)
1 case##36##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-4#1)(1992-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1996-2#1)(1996-6#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-11#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#4)(2013-1#4)(2013-8#4)
1 caused##2##2##(2007-8#1)(2008-11#1)
1 cells are##3##3##(2007-12#1)(2008-11#1)(2010-12#1)
1 cells transfected with##2##4##(1995-12#1)(2008-11#1)
1 cells##22##2##(1994-11#2)(1994-12#1)(1995-12#4)(2007-12#3)(2008-11#10)(2008-7#1)(2010-12#1)
1 cells)##2##2##(1995-12#1)(2008-11#1)
1 centimorgans (cM)##2##3##(2008-10#2)
1 chain##3##2##(1992-2#2)(1994-12#1)
1 channel protein##2##3##(1997-2#1)(2008-8#1)
1 channel##3##2##(1997-2#1)(2008-8#2)
1 channels expressed##2##3##(2008-8#2)
1 channels##13##2##(1997-2#1)(2008-8#10)(2010-12#2)
1 cm and##2##3##(1997-4#1)(2008-10#1)
1 cm##20##2##(1993-3#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
1 cm(-1)##2##2##(2007-12#1)(2008-10#1)
1 cm(-1))##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
1 cm(3)##2##2##(2008-10#2)
1 cm- and 2 cm-high heel lifts##2##7##(2010-3#2)
1 complex formed##2##3##(2007-11#1)(2008-10#1)
1 complex of##2##3##(1995-3#1)(2008-10#1)
1 complex was formed##2##4##(1995-11#1)(2008-10#1)
1 complex was##3##3##(1995-11#2)(2008-10#1)
1 complex with##2##3##(2008-10#2)
1 complex##15##2##(1995-11#3)(1995-3#1)(2007-11#1)(2008-10#10)
1 complexes were determined at 25 degrees C##2##8##(2008-10#2)
1 complexes were determined##5##4##(2008-10#5)
1 complexes with the alkali metal##2##6##(2008-10#2)
1 complexes with the##3##4##(2008-10#3)
1 complexes##13##2##(2008-10#13)
1 could##2##2##(1990-8#1)(1993-3#1)
1 cultivars##2##2##(2008-10#1)(2008-12#1)
1 d##4##2##(1990-11#1)(1992-6#2)(2008-9#1)
1 dB for the##2##4##(2007-12#1)(2008-2#1)
1 dB for##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
1 dB were##2##3##(2008-2#1)(2008-3#1)
1 dB##10##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)(2008-4#1)
1 dS m(-1)) and##2##4##(2008-10#2)
1 dS m(-1))##4##3##(2008-10#4)
1 day after##6##3##(1991-2#1)(1992-6#1)(2006-12#1)(2007-11#1)(2008-10#2)
1 day before##3##3##(2007-12#1)(2008-10#2)
1 day of##4##3##(1990-11#1)(1997-7#1)(2008-11#1)(2012-3#1)
1 day prior to##3##4##(2008-10#2)(2012-3#1)
1 day##34##2##(1990-11#1)(1991-2#1)(1992-6#1)(1995-12#1)(1996-12#2)(1997-3#2)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-7#1)(2012-3#2)
1 days##11##2##(1991-12#2)(1992-12#1)(1996-3#1)(2008-1#1)(2008-12#2)(2008-4#1)(2010-2#2)(2013-1#1)
1 degree of freedom##3##4##(1992-6#1)(1997-3#2)
1 degree##7##2##(1992-6#1)(1996-2#1)(1997-3#2)(2007-5#1)(2008-5#1)(2011-1#1)
1 degrees C and ionic strength##2##6##(2008-10#2)
1 degrees C and##3##4##(2008-10#2)(2008-3#1)
1 degrees C with##2##4##(1994-3#1)(2008-2#1)
1 degrees C##20##3##(1994-3#2)(2007-11#1)(2008-10#10)(2008-2#2)(2008-3#3)(2011-2#2)
1 degrees and##2##3##(1995-5#1)(2008-2#1)
1 degrees##32##2##(1990-11#1)(1994-3#2)(1995-5#1)(2007-11#2)(2008-10#10)(2008-2#7)(2008-3#6)(2008-8#1)(2011-2#2)
1 demonstrated##2##2##(2008-11#1)(2008-3#1)
1 developed##2##2##(1990-9#1)(2008-6#1)
1 diabetes (T1D)##4##3##(2007-5#1)(2010-5#2)(2013-8#1)
1 diabetes in##4##3##(1994-12#1)(2007-5#1)(2008-11#1)(2008-4#1)
1 diabetes mellitus##18##3##(1990-6#1)(1991-12#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2012-1#1)(2013-1#2)
1 diabetes##79##2##(1990-6#1)(1991-12#1)(1992-9#1)(1994-12#2)(2007-5#2)(2008-1#9)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#3)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#1)(2010-5#6)(2010-9#2)(2011-1#6)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-4#2)(2013-1#11)(2013-8#2)
1 diabetic patients##5##3##(2010-10#1)(2010-12#1)(2012-1#1)(2012-4#2)
1 diabetic##8##2##(2008-1#2)(2010-10#1)(2010-12#1)(2012-1#1)(2012-4#2)(2013-1#1)
1 did not##3##3##(1992-3#1)(1994-6#1)(2008-10#1)
1 dose##4##2##(2008-7#4)
1 employed a##2##3##(1991-2#1)(2008-3#1)
1 equiv of##4##3##(1992-6#2)(1996-2#2)
1 established by spectrophotometry##2##4##(2008-10#2)
1 expression##2##2##(1993-8#1)(1993-9#1)
1 false##2##2##(1990-6#1)(2008-7#1)
1 female in##2##3##(1990-3#2)
1 female##5##2##(1990-3#2)(1992-9#1)(2012-3#1)(2013-7#1)
1 fg of##2##3##(2008-10#2)
1 fg##3##2##(2008-10#3)
1 for 18##2##3##(1995-2#1)(2008-10#1)
1 for AP and AP's cover)##2##6##(2012-3#2)
1 for AP and##3##4##(2012-3#3)
1 for the##3##3##(1992-9#2)(2008-3#1)
1 for##20##2##(1992-9#2)(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2012-3#4)(2013-1#1)
1 from##9##2##(1990-5#1)(1993-6#1)(2007-12#1)(2008-10#6)
1 g Amberlite##2##3##(2008-10#2)
1 g L(-1)##2##3##(2008-11#2)
1 g l(-1)##2##3##(2008-11#2)
1 g of##3##3##(1992-9#1)(2008-10#2)
1 g##21##2##(1990-11#1)(1990-6#1)(1992-9#1)(1995-2#1)(1996-11#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-7#1)(2013-1#1)
1 g/dL##4##2##(2008-7#4)
1 g/day##3##2##(2008-1#2)(2008-8#1)
1 gastric##2##2##(1992-10#1)(1997-1#1)
1 gating modifier##3##3##(2010-12#3)
1 gating##4##2##(2008-8#1)(2010-12#3)
1 gave##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
1 gene product##2##3##(1991-5#1)(1995-6#1)
1 gene##7##2##(1991-5#1)(1992-8#1)(1995-6#2)(1996-2#2)(2008-8#1)
1 gene/4##2##2##(1997-6#1)(1997-8#1)
1 h after the##4##4##(1992-12#1)(2008-10#2)(2008-11#1)
1 h after##12##3##(1991-2#1)(1992-12#1)(1994-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
1 h and##3##3##(1995-3#1)(1995-5#2)
1 h at##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
1 h before##6##3##(1991-2#1)(1992-8#1)(1995-3#1)(2008-12#1)(2008-5#1)(2008-7#1)
1 h of handcycling exercise##2##5##(2013-1#2)
1 h of##9##3##(1992-8#1)(1993-3#1)(1995-12#1)(1995-8#1)(1997-2#1)(2008-10#2)(2013-1#2)
1 h prior to##2##4##(2008-10#1)(2011-2#1)
1 h prior##3##3##(2008-10#2)(2011-2#1)
1 h to##3##3##(1993-5#1)(2008-10#1)(2008-9#1)
1 h##81##2##(1990-12#2)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#2)(1994-5#1)(1995-12#2)(1995-3#3)(1995-5#3)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#2)(2013-1#4)
1 h)##6##2##(1993-12#1)(1997-7#1)(2008-10#2)(2013-1#1)(2013-8#1)
1 had a##2##3##(2008-3#1)(2012-3#1)
1 had only##2##3##(1990-2#1)(2010-1#1)
1 had##9##2##(1990-2#1)(1990-9#1)(2008-11#1)(2008-3#2)(2010-1#1)(2011-2#2)(2012-3#1)
1 has##3##2##(1990-5#1)(2007-11#1)(2012-12#1)
1 have##3##2##(1997-7#2)(2013-1#1)
1 host-guest complex with##2##4##(2008-10#2)
1 hour after##3##3##(1991-12#1)(1993-11#1)(2008-7#1)
1 hour##14##2##(1991-12#1)(1991-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1996-3#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-7#1)(2013-8#1)
1 hr after i##2##4##(1992-9#1)(2008-11#1)
1 hr after##4##3##(1992-9#1)(2008-11#2)(2008-6#1)
1 hr##9##2##(1992-9#1)(1993-9#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-6#2)(2009-11#1)
1 in 10##4##3##(1996-1#1)(2008-11#1)(2008-6#1)(2012-12#1)
1 in 100##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
1 in 200##2##3##(1997-3#1)(2008-5#1)
1 in 4000##2##3##(2012-1#1)(2012-12#1)
1 in 8##2##3##(1991-8#1)(2008-9#1)
1 in a##3##3##(1996-12#1)(2007-12#1)(2007-6#1)
1 in frontal cortex##2##4##(1996-2#2)
1 in human##2##3##(1990-8#1)(2011-2#1)
1 in normal human fibroblasts extracts##2##6##(2009-8#2)
1 in the Pedon##2##4##(2008-12#2)
1 in the mixed sample##2##5##(2008-10#2)
1 in the presence of##2##5##(1993-6#1)(2009-11#1)
1 in the##26##3##(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2009-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
1 in##94##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#5)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#3)
1 inclusion complex with##2##4##(2008-10#2)
1 inclusion complex##4##3##(2007-11#1)(2008-10#3)
1 infected##2##2##(1993-8#1)(2007-2#1)
1 integrin##2##2##(1992-2#1)(1993-9#1)
1 is a##4##3##(1994-5#1)(2007-7#1)(2008-11#2)
1 is##16##2##(1990-7#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#3)(2009-10#1)(2012-3#1)(2013-1#2)
1 isoform##2##2##(1991-2#1)(2008-4#1)
1 isolate##6##2##(2008-10#4)(2011-1#2)
1 kDa##5##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-4#1)
1 kHz##10##2##(2007-11#1)(2007-12#2)(2008-3#7)
1 kHz)##2##2##(2007-12#1)(2008-2#1)
1 kJ##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
1 kPa##2##2##(2007-12#2)
1 kb DNA##2##3##(1997-8#2)
1 kb by Northern blotting##2##5##(1996-6#2)
1 kb fragment##3##3##(1995-9#2)(2008-5#1)
1 kb region##2##3##(2008-11#1)(2008-12#1)
1 kb##22##2##(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-8#3)(1995-9#2)(1996-6#2)(1997-6#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)
1 kg##8##2##(1990-8#1)(1994-5#1)(2007-5#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-3#1)(2013-1#1)
1 km##8##2##(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2013-1#1)
1 l min(-1)##2##3##(2008-10#2)
1 l##5##2##(2008-10#3)(2008-11#2)
1 lesion##2##2##(2008-10#1)(2011-2#1)
1 log##2##2##(2008-10#1)(2008-5#1)
1 m of the##2##4##(2008-10#2)
1 m of##3##3##(2008-10#3)
1 m wide##2##3##(2008-10#2)
1 m##18##2##(2007-10#1)(2008-10#12)(2008-3#3)(2008-7#1)(2011-2#1)
1 m(2)##3##2##(2008-10#3)
1 m/sec(2)##2##2##(2008-11#2)
1 mJ of##2##3##(2007-12#1)(2008-3#1)
1 mJ##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
1 mL##3##2##(2008-5#1)(2008-9#1)(2011-3#1)
1 mL/min##2##2##(2011-1#2)
1 mM Ca2+##5##3##(1990-5#1)(1990-7#1)(1990-8#2)(1992-6#1)
1 mM at##2##3##(2008-7#1)(2009-12#1)
1 mM for##3##3##(1995-3#1)(1996-5#1)(2008-11#1)
1 mM glyoxylic acid##2##4##(1990-11#2)
1 mM of##5##3##(1992-12#1)(1996-5#1)(2008-10#1)(2010-4#1)(2010-5#1)
1 mM sodium##2##3##(2008-10#1)(2008-11#1)
1 mM##73##2##(1990-11#3)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-3#1)(1991-8#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-5#2)(1997-1#3)(1997-2#1)(2006-11#1)(2008-10#16)(2008-11#5)(2008-6#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)
1 mM) and##2##3##(1990-5#1)(1996-2#1)
1 mM)##12##2##(1990-5#1)(1990-7#1)(1992-3#2)(1993-8#1)(1995-12#1)(1995-6#2)(1996-2#2)(1997-2#2)
1 mRNA##2##2##(1994-11#1)(1994-8#1)
1 mV per decade##2##4##(2008-10#2)
1 mV##7##2##(1991-9#2)(2008-10#3)(2008-7#1)(2009-9#1)
1 mW##9##2##(2007-11#2)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#3)
1 macrophage-like cells##2##3##(1996-12#2)
1 maternal-to-paternal genome ratio##2##4##(2009-12#2)
1 media with##3##3##(2008-10#3)
1 media##5##2##(2008-10#5)
1 mediates##3##2##(1993-3#2)(2013-8#1)
1 medium##3##2##(2008-10#2)(2008-12#1)
1 mg l(-1) and##2##4##(2008-10#2)
1 mg l(-1) for##2##4##(2008-10#2)
1 mg l(-1)##11##3##(2008-10#10)(2008-11#1)
1 mg of##4##3##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
1 mg##32##2##(1992-3#1)(1992-5#1)(1994-3#1)(1994-5#1)(1996-5#1)(1997-4#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#4)(2011-2#1)
1 mg/dL##2##2##(2008-5#1)(2008-7#1)
1 mg/kg BW)##2##3##(2012-3#2)
1 mg/kg i##3##3##(1993-6#1)(1996-2#2)
1 mg/kg per##2##3##(1995-12#1)(1997-7#1)
1 mg/kg subcutaneous) on CAR without any increase in catalepsy##2##10##(2008-6#2)
1 mg/kg##22##2##(1993-6#1)(1995-12#3)(1996-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-9#1)(2011-1#2)(2012-3#2)(2013-8#1)
1 mg/kg) and##2##3##(2007-10#1)(2010-3#1)
1 mg/kg) or##2##3##(1992-11#1)(1993-6#1)
1 mg/kg)##5##2##(1992-11#1)(1993-6#1)(1995-12#1)(2007-10#1)(2010-3#1)
1 mg/l##3##2##(1992-11#1)(2008-10#2)
1 mg/liter##2##2##(2008-10#2)
1 mg/ml##2##2##(2008-2#1)(2008-5#1)
1 microM ICI D1694##2##4##(1994-8#2)
1 microM TPA##2##3##(1993-9#1)(1995-11#1)
1 microM and a Vmax##2##5##(1992-3#2)
1 microM and a##3##4##(1992-3#2)(1993-12#1)
1 microM and##7##3##(1990-8#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-11#1)(1997-6#1)
1 microM extracellular calcium##2##4##(1991-12#2)
1 microM of##2##3##(1992-11#1)(1996-12#1)
1 microM to##2##3##(1992-3#1)(1993-6#1)
1 microM##54##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1991-12#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-11#5)(1995-12#3)(1995-2#3)(1996-12#1)(1997-4#2)(1997-6#1)(1997-7#3)(2008-11#1)(2009-12#1)
1 microM) did not##2##4##(1995-8#1)(1997-4#1)
1 microM)##10##2##(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-8#2)(1997-4#4)
1 microcarriers##4##2##(2008-11#4)
1 microg l(-1)##2##3##(2008-10#2)
1 microg ml(-1) of##2##4##(2008-10#1)(2008-11#1)
1 microg of total RNA##2##5##(2008-1#1)(2008-4#1)
1 microg##11##2##(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
1 microgram##2##2##(1990-2#1)(1996-12#1)
1 microgram/ml##2##2##(1990-12#1)(1990-2#1)
1 microliter##2##2##(1997-4#2)
1 microm##12##2##(2007-11#3)(2008-2#2)(2008-3#5)(2008-8#1)(2012-2#1)
1 microm)##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
1 micromol/L##2##2##(2008-2#1)(2008-8#1)
1 micron##3##2##(1994-6#1)(1995-3#1)(1997-4#1)
1 microns##2##2##(1991-5#1)(1997-4#1)
1 microns)##2##2##(1994-12#1)(1997-1#1)
1 micros)##2##2##(2008-3#1)(2009-3#1)
1 miles##2##2##(2008-8#2)
1 million in##2##3##(1991-12#1)(1992-6#1)
1 million##12##2##(1990-11#1)(1991-12#2)(1992-6#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-6#2)(2010-11#1)(2012-3#1)
1 min before##2##3##(1997-7#1)(2011-2#1)
1 min of##3##3##(2007-12#1)(2008-4#1)(2008-6#1)
1 min region on the linkage map##2##7##(1996-12#2)
1 min region on the##3##5##(1996-12#3)
1 min##41##2##(1990-2#1)(1991-12#1)(1992-10#1)(1992-11#1)(1995-12#1)(1996-12#3)(1996-2#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)
1 minute##3##2##(2011-2#2)(2012-3#1)
1 mixture of the##3##4##(1994-2#1)(2007-11#1)(2008-10#1)
1 mixture of##9##3##(1994-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2010-3#1)(2010-7#1)
1 mixture##10##2##(1994-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2010-3#1)(2010-7#1)
1 ml min(-1)##9##3##(2008-10#9)
1 ml of 1##2##4##(2008-10#2)
1 ml of a##2##4##(2008-10#2)
1 ml of methanol##2##4##(2008-10#2)
1 ml of##21##3##(1990-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-5#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)
1 ml##38##2##(1990-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-5#1)(1996-12#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
1 ml)##3##2##(1993-9#1)(1997-2#1)(2011-2#1)
1 ml/min##5##2##(1997-2#2)(2008-10#1)(2010-3#1)(2012-2#1)
1 mm and##2##3##(2008-3#2)
1 mm day(-1)##2##3##(2008-10#2)
1 mm diameter##2##3##(1990-2#1)(2009-8#1)
1 mm long##2##3##(2008-10#1)(2008-3#1)
1 mm of##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
1 mm trench##2##3##(1991-2#2)
1 mm x##2##3##(2008-3#1)(2012-3#1)
1 mm##43##2##(1990-2#1)(1991-2#2)(1991-6#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#2)(2008-9#3)(2009-2#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
1 mm)##4##2##(2007-12#1)(2008-11#2)(2010-9#1)
1 mmol g(-1)##2##3##(2008-10#1)(2008-5#1)
1 mmol l(-1)##2##3##(2008-10#2)
1 mmol##6##2##(1997-8#1)(2008-10#4)(2008-5#1)
1 mmol/L##3##2##(2008-9#3)
1 mol L(-1)##2##3##(2008-10#2)
1 mol dm(-3)##7##3##(2008-10#7)
1 mol each of##2##4##(1990-7#1)(1992-3#1)
1 mol l(-1) HCl##5##4##(2008-10#5)
1 mol l(-1) of##2##4##(2008-10#2)
1 mol l(-1) phosphate buffer (pH 7##2##7##(2008-10#2)
1 mol l(-1)##29##3##(2008-10#29)
1 mol of tightly bound##2##5##(1990-10#1)(1994-5#1)
1 mol of zinc per subunit##2##6##(1994-5#2)
1 mol of##14##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#3)(1992-3#1)(1993-11#1)(1994-11#1)(1994-5#3)(2008-6#2)
1 mol##60##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-5#3)(1992-3#2)(1993-11#1)(1994-11#1)(1994-5#3)(2008-10#40)(2008-2#1)(2008-6#2)(2008-9#1)(2010-4#1)
1 mol% and 27##2##4##(2008-8#2)
1 mol(-1) cm(-1)##2##3##(2008-10#2)
1 mol(-1)##3##2##(2008-10#3)
1 mol/L##3##2##(2008-10#2)(2008-4#1)
1 molar ratio##2##3##(1990-7#1)(1995-5#1)
1 molar##3##2##(1990-7#1)(1995-5#1)(2008-5#1)
1 molecule##2##2##(1992-8#1)(1994-5#1)
1 moll(-1)##2##2##(2008-10#2)
1 monkey##2##2##(2008-10#2)
1 month after the##2##4##(2008-10#2)
1 month after##11##3##(2008-10#6)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
1 month and##3##3##(2007-11#1)(2008-12#1)(2008-5#1)
1 month following##2##3##(2008-10#1)(2010-6#1)
1 month of##6##3##(1990-2#1)(1991-12#1)(2008-10#3)(2008-7#1)
1 month to 15##2##4##(2007-8#1)(2011-2#1)
1 month to##4##3##(2007-8#1)(2008-5#1)(2011-2#2)
1 month##56##2##(1990-2#1)(1990-6#1)(1991-12#1)(1993-9#1)(1995-12#1)(1995-2#2)(1996-9#1)(2006-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
1 month)##4##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
1 months##3##2##(1992-12#1)(2007-8#1)(2008-1#1)
1 morbidity##2##2##(1992-5#1)(2008-10#1)
1 ms##9##2##(1991-2#1)(1992-3#1)(1997-8#1)(2007-12#3)(2008-3#2)(2009-12#1)
1 mu M noradrenaline##2##4##(1995-12#2)
1 mu M##3##3##(1995-12#3)
1 mu g ml(-1)##2##4##(2008-11#2)
1 mu##6##2##(1995-12#3)(2007-12#1)(2008-11#2)
1 muM for##3##3##(2008-10#3)
1 muM##17##2##(2008-10#14)(2008-11#2)(2008-6#1)
1 mug l(-1) for##3##4##(2008-10#3)
1 mug l(-1)##13##3##(2008-10#13)
1 mug ml(-1) and##3##4##(2008-10#3)
1 mug ml(-1) of##3##4##(2008-10#3)
1 mug ml(-1)##11##3##(2008-10#11)
1 mug##36##2##(2008-10#36)
1 mug/ml##8##2##(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)
1 mugml(-1)##2##2##(2008-10#2)
1 mul##3##2##(2008-10#3)
1 mum##14##2##(1992-2#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-6#1)(2010-4#1)
1 mumol l(-1)##2##3##(2008-10#2)
1 mumol##4##2##(1996-12#1)(2008-10#3)
1 mumol/L)##3##2##(2008-8#3)
1 mumol/l##3##2##(1994-5#1)(1994-6#2)
1 nM neuropeptide Y##2##4##(1995-12#2)
1 nM neuropeptide##3##3##(1995-12#3)
1 nM##15##2##(1990-12#1)(1991-2#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-2#1)(2008-11#4)
1 nM)##6##2##(1993-11#1)(1994-12#1)(1995-2#1)(1995-8#2)(1997-2#1)
1 ng for##2##3##(2008-10#1)(2008-5#1)
1 ng in##2##3##(2008-10#1)(2012-3#1)
1 ng ml(-1) for##2##4##(2008-10#2)
1 ng ml(-1)##10##3##(2008-10#10)
1 ng of##4##3##(2008-10#4)
1 ng##29##2##(1995-12#1)(1997-2#1)(2008-10#24)(2008-12#1)(2008-5#1)(2012-3#1)
1 ng/L##3##2##(2008-10#3)
1 ng/cc in##2##3##(2011-2#2)
1 ng/ml of##2##3##(1995-11#1)(2008-11#1)
1 ng/ml##10##2##(1990-8#1)(1992-3#1)(1992-8#1)(1995-11#1)(1996-5#1)(2008-10#4)(2008-11#1)
1 nm and##2##3##(2008-2#1)(2008-3#1)
1 nm at##2##3##(2007-11#1)(2008-3#1)
1 nm in diameter##2##4##(2008-10#1)(2009-7#1)
1 nm##15##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#6)(2009-7#1)
1 nm)##2##2##(2007-11#1)(2008-3#1)
1 nmol##5##2##(1997-2#3)(1997-6#1)(2008-10#1)
1 nmol/min/mg protein##2##3##(1996-12#2)
1 nmol/min/mg##3##2##(1996-12#2)(2008-5#1)
1 nmole##2##2##(1997-6#1)(2008-10#1)
1 ns##3##2##(1993-11#1)(1995-5#1)(2008-3#1)
1 of 3##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
1 of 5##2##3##(1994-8#1)(1994-9#1)
1 of 7##2##3##(2008-7#1)(2012-3#1)
1 of Fusarium##2##3##(2008-10#2)
1 of the##10##3##(1991-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(2008-10#1)(2010-4#1)(2010-6#1)(2011-1#2)(2013-1#1)
1 of these##2##3##(1992-6#1)(2012-3#1)
1 of this article##3##4##(1995-1#1)(1995-3#1)(2008-10#1)
1 of this##5##3##(1995-1#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-4#1)
1 of##48##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-11#2)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
1 on##9##2##(1990-2#1)(1990-5#2)(1990-8#1)(2007-12#1)(2008-10#2)(2011-1#1)(2012-2#1)
1 or 0##2##3##(1995-12#1)(2009-6#1)
1 or 1 mT)##2##4##(2011-2#2)
1 or 1##3##3##(2011-2#2)(2012-7#1)
1 or 10##2##3##(1990-12#1)(1993-6#1)
1 or 2 days##2##4##(2008-10#2)
1 or 2##10##3##(1990-11#1)(1992-10#1)(1992-6#1)(1995-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#2)
1 or 5##2##3##(1995-12#1)(2008-11#1)
1 or more##2##3##(2012-12#1)(2013-8#1)
1 or##34##2##(1990-11#1)(1990-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-7#1)(2013-1#2)(2013-8#1)
1 order of magnitude larger than that for spheres with##2##10##(2008-3#2)
1 order of magnitude larger than##4##6##(2007-11#1)(2007-12#1)(2008-3#2)
1 order of magnitude more##2##5##(1992-3#1)(2008-2#1)
1 order of magnitude##11##4##(1992-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
1 out of##6##3##(2008-1#1)(2008-5#2)(2008-7#1)(2009-5#2)
1 pM##2##2##(1994-8#2)
1 part in##2##3##(2008-3#2)
1 part##4##2##(1990-2#1)(2008-3#3)
1 patient after##2##3##(2007-11#2)
1 patient in##2##3##(1992-2#1)(2007-9#1)
1 patient with##3##3##(1994-3#1)(2008-7#2)
1 patient##36##2##(1990-3#1)(1990-6#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-12#3)(1994-3#1)(2007-10#3)(2007-11#8)(2007-9#2)(2008-1#2)(2008-10#2)(2008-7#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
1 patients##6##2##(1991-5#1)(1992-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
1 per 1##2##3##(2008-8#1)(2013-1#1)
1 per##8##2##(1990-3#1)(1996-8#1)(2008-10#2)(2008-8#2)(2013-1#2)
1 percent had##2##3##(1991-3#1)(2008-1#1)
1 percent of##3##3##(1993-3#1)(1994-12#1)(2013-1#1)
1 percent##11##2##(1990-5#1)(1991-3#1)(1992-1#1)(1993-3#2)(1994-12#1)(1994-6#1)(2008-1#1)(2008-5#1)(2010-3#1)(2013-1#1)
1 pg##6##2##(1990-8#1)(1996-12#1)(2008-10#4)
1 pg)##2##2##(2008-10#2)
1 pg/ml##2##2##(1994-7#2)
1 pmol for##4##3##(2008-10#4)
1 pmol##9##2##(1991-5#1)(1991-8#1)(1996-5#1)(1997-6#2)(2008-10#4)
1 points##2##2##(2008-7#1)(2012-1#1)
1 potassium channel##2##3##(1997-2#1)(2008-8#1)
1 ppb (1##2##3##(2008-10#1)(2008-3#1)
1 ppb##7##2##(2008-10#4)(2008-2#1)(2008-3#2)
1 ppm for##3##3##(2008-10#3)
1 ppm##13##2##(2008-10#12)(2008-3#1)
1 ppm)##2##2##(1993-6#1)(2008-10#1)
1 presented##2##2##(1990-9#1)(2008-2#1)
1 protein##5##2##(1993-6#1)(2008-8#2)(2011-1#1)(2013-1#1)
1 ps##6##2##(2007-1#1)(2007-12#2)(2008-2#1)(2008-3#2)
1 rather than##2##3##(2008-10#1)(2008-11#1)
1 ratio and##2##3##(2008-10#2)
1 ratio in##2##3##(2008-10#1)(2008-8#1)
1 ratio of##6##3##(1992-11#1)(2008-10#5)
1 ratio##26##2##(1990-12#1)(1991-8#1)(1992-11#1)(1997-8#1)(2008-10#20)(2008-7#1)(2008-8#1)
1 ratios in##2##3##(2008-10#2)
1 received##2##2##(1991-3#1)(2010-4#1)
1 receptor##12##2##(1991-2#1)(1992-3#2)(1994-11#1)(1994-6#1)(1995-11#2)(1995-2#1)(2008-9#1)(2012-2#2)(2013-1#1)
1 receptors##5##2##(1992-12#1)(1995-5#4)
1 recurrent##2##2##(2011-2#1)(2013-1#1)
1 region of##3##3##(2008-10#3)
1 region##7##2##(1992-10#1)(1995-6#1)(2008-10#5)
1 reported##2##2##(2008-7#1)(2013-1#1)
1 responses##2##2##(1995-11#1)(2008-10#1)
1 s##12##2##(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)
1 s) and##2##3##(2008-10#1)(2008-3#1)
1 s)##5##2##(2008-10#1)(2008-3#3)(2009-8#1)
1 sec##2##2##(1990-2#1)(2007-10#1)
1 should be##2##3##(2008-7#1)(2008-9#1)
1 showed##6##2##(1990-9#1)(1991-3#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-9#1)
1 shows##2##2##(1994-11#1)(2012-2#1)
1 software##2##2##(2012-3#2)
1 starting molar percentage of##2##5##(2008-10#2)
1 stoichiometry of##2##3##(2008-10#2)
1 stoichiometry##9##2##(1991-3#1)(1992-3#1)(2008-10#7)
1 strains from##2##3##(2008-10#2)
1 strains##6##2##(2007-10#2)(2008-10#4)
1 study##2##2##(2007-11#1)(2009-1#1)
1 subunit##7##2##(1992-2#1)(1994-6#4)(1996-2#1)(1997-4#1)
1 tablet twice##2##3##(1990-11#1)(1990-8#1)
1 tablet##4##2##(1990-11#2)(1990-8#2)
1 that##2##2##(1994-5#1)(2010-4#1)
1 the##4##2##(2007-6#1)(2008-3#1)(2009-8#1)(2009-9#1)
1 through 6##2##3##(2008-10#1)(2011-2#1)
1 through##4##2##(1995-6#1)(2008-10#2)(2011-2#1)
1 times##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
1 to 0##9##3##(1990-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2012-2#1)
1 to 1##19##3##(1992-11#1)(1992-2#1)(1992-6#1)(1993-9#1)(1997-7#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-7#1)(2011-1#1)
1 to 10 muM##3##4##(2008-10#3)
1 to 10 mug a##2##5##(2008-10#2)
1 to 10##15##3##(1990-12#1)(1995-3#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-7#1)(2010-8#1)(2013-1#2)
1 to 100##5##3##(1992-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
1 to 1000##2##3##(2008-10#1)(2008-7#1)
1 to 12##5##3##(2008-10#4)(2008-2#1)
1 to 13##3##3##(2008-10#3)
1 to 14##2##3##(2008-10#1)(2008-7#1)
1 to 2 h##2##4##(2008-10#2)
1 to 2 log##2##4##(2008-10#1)(2012-2#1)
1 to 2##24##3##(1990-12#1)(1993-9#1)(1995-5#1)(2007-11#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
1 to 20##4##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
1 to 21 days##2##4##(2007-10#1)(2010-4#1)
1 to 21##3##3##(1991-12#1)(2007-10#1)(2010-4#1)
1 to 28##2##3##(1997-3#1)(2008-10#1)
1 to 3 weeks##3##4##(1997-6#1)(2009-5#1)(2012-12#1)
1 to 3##12##3##(1991-4#1)(1993-6#1)(1997-3#1)(1997-6#2)(2007-10#1)(2008-10#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
1 to 4 weeks##2##4##(2008-10#1)(2008-11#1)
1 to 4##16##3##(1991-1#1)(1992-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-6#1)(2011-2#2)(2013-1#1)
1 to 5##13##3##(1992-3#1)(2008-1#1)(2008-10#8)(2008-3#1)(2011-2#1)(2012-3#1)
1 to 50##2##3##(1997-3#1)(2007-11#1)
1 to 6##5##3##(2008-10#4)(2013-1#1)
1 to 7##7##3##(1991-4#1)(1994-6#1)(1994-7#1)(1995-9#1)(2008-10#3)
1 to 8##4##3##(1993-8#1)(2008-10#2)(2010-4#1)
1 to 9##7##3##(1997-6#1)(2007-5#1)(2008-10#3)(2008-6#1)(2008-9#1)
1 to##223##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-3#4)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#6)(2007-12#6)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#89)(2008-11#9)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
1 trial##2##2##(2007-10#1)(2007-11#1)
1 type##3##2##(1994-5#1)(2008-12#1)(2009-12#1)
1 using##4##2##(1995-3#1)(1996-10#1)(2008-10#1)(2009-2#1)
1 v/v)##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
1 virus##3##2##(2008-11#1)(2009-7#2)
1 vs##9##2##(1993-2#2)(1994-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-8#1)(2012-1#1)
1 was found##2##3##(1992-11#1)(2009-11#1)
1 was increased##2##3##(1995-6#1)(2008-8#1)
1 was similar##2##3##(1990-3#1)(1992-3#1)
1 was the##3##3##(1992-3#1)(1992-8#1)(2011-1#1)
1 was used##3##3##(2008-11#2)(2013-8#1)
1 was##35##2##(1990-3#2)(1992-11#1)(1992-3#5)(1992-8#1)(1993-8#2)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2011-1#3)(2011-3#1)(2013-8#2)
1 waters##7##2##(2008-2#4)(2008-3#3)
1 week after##7##3##(1996-12#2)(1996-5#1)(2008-10#3)(2008-11#1)
1 week in the##4##4##(2008-10#2)(2008-11#2)
1 week in##6##3##(1992-9#1)(2008-10#2)(2008-11#2)(2008-5#1)
1 week later##7##3##(1997-8#1)(2008-10#2)(2008-11#2)(2010-12#1)(2012-12#1)
1 week of##6##3##(1992-9#1)(1994-12#1)(1996-5#1)(2008-10#2)(2011-2#1)
1 week prior to##2##4##(1997-2#1)(2007-2#1)
1 week##55##2##(1990-11#1)(1992-9#2)(1994-12#1)(1995-12#1)(1996-12#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-2#1)(2008-10#16)(2008-11#6)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
1 were significantly higher##2##4##(1991-8#1)(1995-11#1)
1 were the##2##3##(1993-3#1)(2007-7#1)
1 were##21##2##(1991-8#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#2)(2013-8#3)
1 where##2##2##(1997-8#1)(2008-10#1)
1 which##2##2##(1992-7#1)(1995-8#1)
1 with a##2##3##(2008-10#1)(2008-3#1)
1 with eight##2##3##(1992-12#1)(1997-8#1)
1 with the##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
1 with##29##2##(1990-2#1)(1990-3#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-3#1)(1996-10#1)(1996-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-3#1)
1 within##2##2##(1993-11#1)(2008-10#1)
1 woman##2##2##(1990-9#1)(1993-8#1)
1 x 10(-10)##2##3##(1991-5#1)(2008-2#1)
1 x 10(-12)##2##3##(1991-5#1)(2008-8#1)
1 x 10(-3)##3##3##(2008-2#2)(2008-3#1)
1 x 10(-4) M##4##4##(1991-8#1)(1992-8#2)(2008-10#1)
1 x 10(-4) mg##2##4##(2008-10#2)
1 x 10(-4)##8##3##(1991-8#1)(1992-8#2)(2008-10#3)(2008-3#2)
1 x 10(-4))##2##3##(2007-12#1)(2008-3#1)
1 x 10(-5) M##2##4##(1993-8#1)(1994-5#1)
1 x 10(-5)##6##3##(1993-8#2)(1994-5#1)(2007-11#1)(2008-10#2)
1 x 10(-6)##2##3##(2008-10#1)(2008-5#1)
1 x 10(-7)##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
1 x 10(-8) M##3##4##(1992-8#1)(2008-10#2)
1 x 10(-8)##4##3##(1992-8#1)(2008-10#3)
1 x 10(-9)##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
1 x 10(-9)M##2##3##(1994-6#1)(2008-10#1)
1 x 10(4)##2##3##(2008-10#1)(2009-3#1)
1 x 10(5)##4##3##(2008-10#4)
1 x 10(6)##6##3##(1991-12#1)(2008-10#4)(2008-11#1)
1 x 10(7)##5##3##(2008-10#4)(2008-2#1)
1 x##81##2##(1991-12#1)(1991-5#2)(1991-8#1)(1992-8#3)(1993-8#3)(1994-5#1)(1994-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#42)(2008-11#1)(2008-2#5)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#3)(2009-3#1)(2009-6#1)(2010-6#1)(2011-2#1)
1 year (P =##4##4##(2010-8#1)(2013-1#3)
1 year after a##2##4##(1994-12#1)(2010-3#1)
1 year after the operation##2##5##(1994-3#1)(2007-8#1)
1 year after the##7##4##(1994-3#1)(1997-1#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
1 year after##17##3##(1992-8#1)(1994-12#1)(1994-3#1)(1997-1#1)(2007-11#1)(2007-8#2)(2008-10#2)(2009-10#1)(2010-3#1)(2011-2#4)(2012-1#1)(2013-1#1)
1 year and##6##3##(1991-2#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
1 year in##2##3##(2008-10#1)(2008-9#1)
1 year later##2##3##(2009-7#1)(2013-8#1)
1 year of age##7##4##(1995-8#1)(2008-10#1)(2011-2#5)
1 year of##12##3##(1995-8#1)(1997-4#2)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#5)(2013-1#1)
1 year postoperatively##2##3##(2009-10#1)(2013-8#1)
1 year showed##2##3##(2008-7#2)
1 year to##3##3##(1995-3#1)(1995-6#1)(2008-10#1)
1 year was##2##3##(2008-9#1)(2012-2#1)
1 year##110##2##(1990-12#1)(1991-2#2)(1991-8#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#2)(2007-10#1)(2007-11#3)(2007-8#8)(2008-10#14)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-7#4)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#14)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
1 years (range##4##3##(2008-1#2)(2009-3#1)(2012-12#1)
1 years##17##2##(1991-8#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#4)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
1 years)##6##2##(2007-8#2)(2008-3#1)(2011-2#2)(2013-8#1)
1 yr##2##2##(2008-8#1)(2008-9#1)
1 ± 0##2##3##(2013-1#2)
1 ±##6##2##(2012-3#1)(2013-1#5)
1 ×##5##2##(2012-12#1)(2012-2#1)(2013-1#3)
1 μg/kg##2##2##(2013-8#2)
1##10938##1##(1990-10#6)(1990-11#46)(1990-12#49)(1990-2#67)(1990-3#18)(1990-4#2)(1990-5#60)(1990-6#19)(1990-7#44)(1990-8#55)(1990-9#21)(1991-1#4)(1991-10#3)(1991-11#19)(1991-12#47)(1991-2#36)(1991-3#22)(1991-4#7)(1991-5#50)(1991-6#12)(1991-8#42)(1991-9#30)(1992-1#11)(1992-10#18)(1992-11#25)(1992-12#57)(1992-2#29)(1992-3#82)(1992-4#13)(1992-5#16)(1992-6#60)(1992-7#5)(1992-8#37)(1992-9#43)(1993-1#11)(1993-10#1)(1993-11#48)(1993-12#47)(1993-2#26)(1993-3#44)(1993-5#1)(1993-6#36)(1993-8#71)(1993-9#56)(1994-1#4)(1994-10#2)(1994-11#48)(1994-12#68)(1994-2#36)(1994-3#38)(1994-5#44)(1994-6#40)(1994-7#5)(1994-8#64)(1994-9#17)(1995-1#7)(1995-11#61)(1995-12#70)(1995-2#78)(1995-3#40)(1995-4#1)(1995-5#34)(1995-6#49)(1995-8#40)(1995-9#5)(1996-1#12)(1996-10#12)(1996-11#16)(1996-12#60)(1996-2#87)(1996-3#14)(1996-5#64)(1996-6#26)(1996-7#8)(1996-8#10)(1996-9#8)(1997-1#26)(1997-2#50)(1997-3#37)(1997-4#54)(1997-5#17)(1997-6#43)(1997-7#54)(1997-8#54)(1997-9#2)(2006-10#12)(2006-11#1)(2006-12#5)(2006-5#2)(2006-8#1)(2007-1#3)(2007-10#67)(2007-11#248)(2007-12#252)(2007-2#15)(2007-5#12)(2007-6#6)(2007-7#30)(2007-8#60)(2007-9#3)(2008-1#93)(2008-10#3299)(2008-11#306)(2008-12#166)(2008-2#247)(2008-3#436)(2008-4#79)(2008-5#210)(2008-6#93)(2008-7#189)(2008-8#186)(2008-9#165)(2009-1#8)(2009-10#22)(2009-11#27)(2009-12#27)(2009-2#13)(2009-3#16)(2009-4#12)(2009-5#16)(2009-6#16)(2009-7#25)(2009-8#51)(2009-9#18)(2010-1#6)(2010-10#20)(2010-11#19)(2010-12#28)(2010-2#17)(2010-3#37)(2010-4#43)(2010-5#49)(2010-6#25)(2010-7#12)(2010-8#29)(2010-9#13)(2011-1#154)(2011-10#1)(2011-2#340)(2011-3#17)(2012-1#38)(2012-12#107)(2012-2#131)(2012-3#170)(2012-4#6)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#279)(2013-7#13)(2013-8#142)
1% (95% CI##2##3##(2007-2#1)(2013-1#1)
1% (P &lt##3##3##(2008-9#1)(2010-2#1)(2013-1#1)
1% (P =##2##3##(1996-3#1)(2012-1#1)
1% (P##5##2##(1996-3#1)(2008-9#1)(2010-2#1)(2012-1#1)(2013-1#1)
1% (m/v)##3##2##(2008-10#2)(2009-6#1)
1% (n =##2##3##(1992-9#1)(2008-10#1)
1% (v/v) formic##2##3##(2011-1#2)
1% (v/v)##7##2##(2008-10#5)(2011-1#2)
1% (w/v)##5##2##(2008-10#2)(2008-11#2)(2008-6#1)
1% (w/w) KOH##2##3##(2008-6#2)
1% NaCl##3##2##(1992-3#1)(2008-10#2)
1% Nonidet##2##2##(1994-8#2)
1% R##2##2##(2008-10#2)
1% SDS##2##2##(1990-2#1)(2012-2#1)
1% Triton X-100##3##3##(2008-10#2)(2008-8#1)
1% acetic acid in##2##4##(2011-1#2)
1% after##2##2##(1992-9#1)(2007-7#1)
1% among##2##2##(2011-1#2)
1% and 0##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
1% and 1##2##3##(1993-6#1)(2008-3#1)
1% and 2##2##3##(1996-3#1)(2008-10#1)
1% and 2%##2##3##(1992-2#2)
1% and 81##2##3##(1997-4#1)(2013-1#1)
1% and 89##2##3##(1990-9#1)(2011-1#1)
1% and a##3##3##(2007-12#1)(2008-10#2)
1% and an##2##3##(2008-10#2)
1% and the##2##3##(2008-10#1)(2008-9#1)
1% and##52##2##(1990-9#1)(1991-6#1)(1992-2#2)(1993-6#1)(1993-8#1)(1995-8#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
1% as##2##2##(1994-12#1)(2010-3#1)
1% at 10##2##3##(1990-8#1)(2008-11#1)
1% at a##2##3##(2008-10#2)
1% at the 0##2##4##(2008-10#2)
1% at the##3##3##(2008-10#3)
1% at##13##2##(1990-8#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#1)
1% clindamycin##2##2##(2007-7#2)
1% cream in##3##3##(2007-11#1)(2008-5#2)
1% cream was##2##3##(2007-11#1)(2008-5#1)
1% cream##7##2##(1990-9#1)(2007-11#2)(2008-5#4)
1% error##2##2##(2008-2#1)(2008-3#1)
1% for 1##2##3##(2008-10#2)
1% for peak##3##3##(2008-10#3)
1% for the##3##3##(1996-5#1)(2008-8#1)(2012-3#1)
1% for##36##2##(1990-2#1)(1994-11#2)(1996-5#1)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#4)(2008-8#1)(2010-4#1)(2012-2#2)(2012-3#4)
1% formic acid in##3##4##(2008-10#1)(2011-3#1)(2012-3#1)
1% had no droplet and##2##5##(2008-12#2)
1% had##6##2##(1992-1#1)(2008-12#2)(2010-1#1)(2013-1#1)(2013-8#1)
1% in the##12##3##(1990-12#1)(1994-11#1)(2006-8#1)(2007-8#2)(2008-10#5)(2008-5#1)(2013-1#1)
1% in young and adult cirrhotics respectively)##2##7##(2012-3#2)
1% in##31##2##(1990-12#1)(1994-11#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
1% ketoconazole##3##2##(2008-5#3)
1% mass fraction by weight for the##2##7##(2008-10#2)
1% methanol##2##2##(2008-10#1)(2008-8#1)
1% nitric##2##2##(2008-10#2)
1% of all##8##3##(1990-9#1)(1996-12#1)(1997-1#1)(2008-4#1)(2008-6#1)(2010-3#1)(2013-7#2)
1% of cases##2##3##(1995-12#1)(2011-1#1)
1% of patients##2##3##(1996-11#1)(2012-3#1)
1% of the adult population##4##5##(2008-8#1)(2013-8#3)
1% of the cases##2##4##(1990-10#1)(2012-3#1)
1% of the children with##2##5##(2008-11#2)
1% of the population##6##4##(2008-10#2)(2008-2#1)(2008-5#1)(2010-7#1)(2012-3#1)
1% of the total##3##4##(1993-8#1)(2008-10#2)
1% of the##43##3##(1990-10#2)(1991-12#2)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-5#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
1% of##85##2##(1990-10#2)(1990-6#1)(1990-9#1)(1991-12#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#4)
1% on##2##2##(2008-9#1)(2010-1#1)
1% or##2##2##(2007-12#1)(2008-10#1)
1% per##2##2##(2008-10#2)
1% piroctone olamine##3##3##(2008-5#3)
1% presented comorbidities##2##3##(2013-1#2)
1% reduction in##2##3##(1991-8#1)(2007-12#1)
1% respectively##3##2##(2008-1#1)(2008-8#1)(2011-1#1)
1% rms##2##2##(2008-2#2)
1% sodium##5##2##(1990-2#1)(1992-3#1)(2008-10#1)(2009-9#1)(2013-1#1)
1% the##2##2##(1992-12#1)(2008-3#1)
1% to 107%##2##3##(2008-10#1)(2011-1#1)
1% to 2%##2##3##(1993-8#1)(2009-3#1)
1% to##15##2##(1991-9#1)(1993-8#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-3#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#2)
1% used##2##2##(2008-11#1)(2008-3#1)
1% versus##2##2##(1990-9#1)(2013-1#1)
1% vs##6##2##(1990-11#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
1% w/w##4##2##(2008-10#1)(2008-5#2)(2011-2#1)
1% was##6##2##(2007-8#1)(2008-10#5)
1% were##9##2##(1990-12#1)(1990-6#2)(2006-8#1)(2008-10#2)(2008-5#1)(2013-1#2)
1% with##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
1% zinc pyrithione##2##3##(2008-5#2)
1%##694##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#7)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#5)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-5#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#4)(1995-12#4)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#5)(2007-10#4)(2007-11#16)(2007-12#9)(2007-2#2)(2007-5#2)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#202)(2008-11#17)(2008-12#6)(2008-2#14)(2008-3#39)(2008-4#2)(2008-5#34)(2008-6#7)(2008-7#10)(2008-8#10)(2008-9#16)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#19)(2011-2#13)(2011-3#2)(2012-1#4)(2012-12#10)(2012-2#10)(2012-3#21)(2013-1#32)(2013-7#3)(2013-8#12)
1%) and hematuria##2##3##(2008-1#2)
1%) and the##2##3##(2008-10#1)(2008-5#1)
1%) and##18##2##(1992-10#1)(1992-9#1)(1996-12#1)(2007-12#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
1%) cases##2##2##(2007-7#1)(2008-7#1)
1%) followed by##2##3##(2008-1#1)(2008-10#1)
1%) had##5##2##(2007-7#2)(2008-1#1)(2008-10#1)(2013-8#1)
1%) in##7##2##(1993-1#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)
1%) of the##2##3##(1994-6#1)(2012-12#1)
1%) of##6##2##(1994-6#1)(1996-6#1)(2007-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
1%) patients##3##2##(2008-1#1)(2010-8#1)(2012-3#1)
1%) reported##3##2##(2011-2#1)(2013-1#2)
1%) than##2##2##(1994-2#1)(2008-12#1)
1%) was##3##2##(1993-8#1)(2008-11#1)(2011-2#1)
1%) were found in the##2##5##(2008-11#1)(2013-8#1)
1%) were##7##2##(2008-10#1)(2008-11#1)(2008-8#2)(2010-4#1)(2011-1#1)(2013-8#1)
1%) when compared to##2##4##(2008-11#1)(2013-8#1)
1%) when##3##2##(1994-12#1)(2008-11#1)(2013-8#1)
1%)##160##1##(1990-11#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#1)(1995-12#1)(1996-11#3)(1996-12#1)(1996-6#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#7)(2007-8#2)(2008-1#11)(2008-10#18)(2008-11#9)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2010-12#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#8)(2013-1#7)(2013-8#7)
1&lt##4##1##(2008-10#4)
1&quot##4##1##(1992-3#1)(2008-11#1)(2009-9#1)(2013-8#1)
1'##6##1##(1993-11#4)(2008-10#1)(2008-11#1)
1'- and 2'-acetonaphthone##4##3##(2011-2#4)
1'-(5##2##1##(2012-3#2)
1'-[(1##2##1##(2008-10#2)
1'-bi-2-naphthol dibenzoate##2##2##(2008-10#2)
1'-bi-2-naphthol##3##1##(1995-2#1)(2008-10#2)
1'-carbonyldiimidazole##2##1##(2008-4#1)(2008-5#1)
1'-dioctadecyl-3##2##1##(1997-3#2)
1'-thiocarbonyldiimidazole##2##1##(2008-10#2)
1'SR)-5-benzyl-3-(3'-morpholino-1'-phenylpropyl)-1##2##1##(1997-7#2)
1']-biphenyl-4-yl]methyl]-3H-imidazo[4##2##1##(1995-12#2)
1(##2##1##(2008-5#1)(2011-2#1)
1(-1) and a##2##3##(2008-10#2)
1(-1) and##3##2##(2008-10#3)
1(-1) with##4##2##(1996-5#1)(2008-10#3)
1(-1)##20##1##(1991-12#1)(1996-5#2)(2008-10#17)
1(st)##3##1##(2008-10#1)(2012-12#1)(2013-8#1)
1) (p=0##2##2##(2012-12#2)
1) The##5##2##(1990-11#1)(1991-2#1)(1992-2#1)(1992-6#1)(2011-2#1)
1) a##5##2##(1990-2#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)
1) an##2##2##(1997-2#1)(2011-1#1)
1) and##33##2##(1992-12#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#2)(2010-10#1)(2011-2#1)(2013-1#2)
1) as##3##2##(2007-11#1)(2008-10#2)
1) at rest##2##3##(2008-5#1)(2008-7#1)
1) at##5##2##(2008-10#1)(2008-5#1)(2008-7#2)(2012-3#1)
1) between##2##2##(2007-11#1)(2008-10#1)
1) for##4##2##(2007-10#1)(2008-10#2)(2012-1#1)
1) from##2##2##(1994-8#1)(2008-9#1)
1) gene##2##2##(2012-1#1)(2013-1#1)
1) in the##2##3##(1990-5#1)(2008-10#1)
1) in vivo##2##3##(1996-2#1)(2008-11#1)
1) in which##2##3##(1995-5#1)(2008-8#1)
1) in##10##2##(1990-5#1)(1990-8#1)(1991-5#1)(1995-5#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
1) is##7##2##(1990-2#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
1) low##2##2##(1990-8#1)(2012-2#1)
1) of the##3##3##(1991-2#1)(1995-6#1)(2008-10#1)
1) of##7##2##(1991-2#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-3#2)
1) patient##2##2##(2011-2#2)
1) s##4##2##(2013-8#4)
1) showed##2##2##(2008-10#1)(2008-12#1)
1) the##10##2##(1991-3#1)(1992-5#1)(1995-11#1)(1995-6#1)(1997-5#1)(1997-6#1)(2007-6#1)(2008-6#1)(2008-8#1)(2013-8#1)
1) to develop##2##3##(1995-2#1)(2008-10#1)
1) to##9##2##(1990-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-10#4)(2008-3#1)
1) values = 0##2##4##(2008-9#2)
1) was##9##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-2#1)
1) were##4##2##(1992-3#1)(1997-8#1)(2008-10#2)
1) when the##3##3##(1991-11#1)(1993-6#1)(1995-12#1)
1) with##3##2##(1990-8#1)(1997-1#1)(1997-7#1)
1) x##3##2##(1992-6#1)(1994-5#1)(1997-7#1)
1) years##3##2##(2007-2#2)(2013-8#1)
1) μm##2##2##(2010-10#2)
1)##430##1##(1990-11#3)(1990-12#2)(1990-2#6)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#5)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#3)(1993-1#2)(1993-11#1)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#2)(1994-3#9)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#2)(2007-10#6)(2007-11#4)(2007-12#4)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#75)(2008-11#22)(2008-12#5)(2008-2#9)(2008-3#16)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#10)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#5)(2010-4#3)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#13)(2011-9#1)(2012-1#4)(2012-12#7)(2012-2#5)(2012-3#7)(2012-4#1)(2013-1#9)(2013-7#1)(2013-8#11)
1)%##2##1##(2008-10#1)(2008-3#1)
1)(T )=10##2##2##(2008-10#2)
1)(T##5##1##(2008-10#5)
1))##2##1##(2008-5#1)(2008-8#1)
1)-2##2##1##(1993-11#2)
1+##3##1##(1993-8#1)(2010-3#1)(2010-8#1)
1+/-0##17##1##(2007-8#2)(2008-10#12)(2008-7#2)(2008-9#1)
1+/-1##2##1##(2008-10#1)(2008-7#1)
1+2##2##1##(2008-10#2)
1- and 2-naphthol##3##3##(2008-10#3)
1- and 2-year survival rates##2##5##(2012-1#1)(2012-2#1)
1- and 2-year##3##3##(2008-2#1)(2012-1#1)(2012-2#1)
1- and##22##2##(1991-6#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-9#1)(1996-12#2)(1996-2#1)(1997-4#1)(2008-10#6)(2008-2#1)(2011-2#3)(2012-1#1)(2012-2#1)
1- or##2##2##(1990-12#1)(2013-1#1)
1- to 2-days-old quail chicks (Coturnix japonica)##2##7##(2008-6#2)
1- to##8##2##(1990-9#1)(1997-4#1)(2008-10#1)(2008-6#2)(2012-12#3)
1-##41##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-9#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-4#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-6#3)(2008-7#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
1-(1##2##1##(1996-5#1)(2008-5#1)
1-(1-naphthyl)ethylcarbamate##2##1##(1995-3#2)
1-(2##2##1##(2008-10#2)
1-(2-pyridylazo) 2-naphtol (PAN) impregnated Ambersorb 563 resin##2##7##(2008-10#2)
1-(2-pyridylazo)-2-naphthol (PAN)##6##2##(2008-10#6)
1-(2-pyridylazo)-2-naphthol##15##1##(2008-10#15)
1-(2-pyrimidinyl)piperazine##2##1##(1995-12#2)
1-(2-thiasolylazo)-2-naphthol##3##1##(2008-10#3)
1-(2-thiazolylazo)-2-naphthol##2##1##(2008-10#2)
1-(3##4##1##(2008-10#3)(2008-5#1)
1-(4-trimethylammoniumphenyl)-6-phenyl-1##2##1##(1990-5#1)(1993-11#1)
1-(4H##2##1##(2012-3#2)
1-(5-bromo-2-pyridylazo)-2-naphthol-6-sulphonic acid##2##2##(2008-10#2)
1--&gt##2##1##(1994-5#1)(1995-2#1)
1-0##26##1##(1990-5#1)(1990-7#1)(1992-6#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
1-1 microM)##2##2##(1992-8#1)(1997-4#1)
1-1##24##1##(1990-5#1)(1992-8#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2009-6#1)(2013-1#1)
1-1%##2##1##(2007-12#1)(2008-10#1)
1-10 mM)##2##2##(1995-11#2)
1-10 microM)##4##2##(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)
1-10 mugml(-1)##2##2##(2008-10#2)
1-10 mumol##2##2##(2008-10#2)
1-10 ng ml(-1)##2##3##(2008-10#2)
1-10##33##1##(1991-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-6#1)(2008-10#13)(2009-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
1-10)##2##1##(1994-12#1)(2008-10#1)
1-100 mg##2##2##(2008-10#1)(2008-11#1)
1-100 microM##2##2##(1990-7#1)(2008-10#1)
1-100 mug ml(-1)##2##3##(2008-10#2)
1-100 nM)##2##2##(1993-3#1)(1997-4#1)
1-100##17##1##(1990-7#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-3#2)
1-1000 ng ml(-1)##2##3##(2008-10#2)
1-1000##5##1##(1992-6#1)(1992-8#1)(2008-10#3)
1-102##3##1##(1992-4#1)(2008-10#2)
1-11##5##1##(1995-11#1)(1997-3#1)(2008-2#1)(2008-6#1)(2012-12#1)
1-12##13##1##(1994-11#5)(2008-10#5)(2008-3#2)(2009-5#1)
1-12)##2##1##(1990-6#1)(2008-10#1)
1-14##3##1##(1992-3#1)(1996-12#1)(2008-7#1)
1-15##7##1##(1991-3#1)(2008-10#4)(2012-2#1)(2013-1#1)
1-16##2##1##(1993-6#1)(2011-2#1)
1-17##2##1##(2008-10#1)(2013-1#1)
1-2 M##2##2##(1995-2#1)(1995-5#1)
1-2 cm##2##2##(1992-9#1)(2008-1#1)
1-2 days##2##2##(1991-3#1)(2008-8#1)
1-2 h##2##2##(2008-7#1)(2012-12#1)
1-2 min##2##2##(1990-7#1)(1992-3#1)
1-2 weeks##2##2##(1993-12#1)(2012-2#1)
1-2##60##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#1)(2007-10#1)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
1-2% of##3##2##(1990-6#1)(1996-11#1)(2013-8#1)
1-2%##7##1##(1990-6#1)(1996-11#1)(2008-10#3)(2008-3#1)(2013-8#1)
1-2)##5##1##(1991-12#1)(1991-6#1)(2007-8#1)(2008-10#1)(2008-6#1)
1-2-(thiazolylazo)-2-naphthol##2##1##(2008-10#2)
1-2-3##3##1##(1992-12#1)(1997-2#1)(2008-10#1)
1-20 and 0##2##3##(2008-10#2)
1-20 mug##2##2##(2008-10#2)
1-20##14##1##(2007-12#1)(2008-10#8)(2008-12#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
1-25##3##1##(1991-11#1)(2008-10#1)(2008-11#1)
1-29##2##1##(1992-3#1)(1992-9#1)
1-2H2]-1##4##1##(1992-11#4)
1-2min##2##1##(2008-10#2)
1-3 days##2##2##(2007-11#1)(2008-5#1)
1-3 h##2##2##(1995-3#1)(2008-10#1)
1-3 hr##2##2##(2008-6#2)
1-3##52##1##(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-3#1)(1996-12#3)(1996-2#1)(1997-3#1)(1997-4#2)(2007-11#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#4)(2009-8#2)(2011-2#1)(2011-3#1)(2012-1#1)
1-3% of##2##2##(2008-10#1)(2008-7#1)
1-3%##5##1##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
1-3)##3##1##(1990-2#1)(1990-7#1)(2007-12#1)
1-3)GalNAc(beta##2##1##(1990-7#2)
1-30 mug ml(-1)##2##3##(2008-10#2)
1-30##7##1##(1995-12#1)(1996-5#1)(2008-10#5)
1-34##2##1##(1991-6#1)(1994-11#1)
1-36##2##1##(2008-10#1)(2008-3#1)
1-4 and##2##2##(1993-11#1)(2008-10#1)
1-4##29##1##(1991-11#1)(1991-2#1)(1991-5#1)(1993-11#2)(1994-12#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-2#1)(2013-1#4)
1-4%##4##1##(1997-7#1)(2008-10#1)(2008-2#1)(2011-3#1)
1-4)##4##1##(1995-2#1)(2008-6#2)(2010-3#1)
1-4)Glc(beta 1-1)Cer##2##2##(1990-7#2)
1-40 OH##5##2##(1992-9#5)
1-40##14##1##(1992-9#5)(1994-11#5)(2008-10#4)
1-400##2##1##(2008-10#2)
1-43##2##1##(1997-4#1)(1997-7#1)
1-5 and##2##2##(2007-11#1)(2008-10#1)
1-5 mug ml(-1)##2##3##(2008-10#2)
1-5##37##1##(1990-2#3)(1992-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-12#2)(2008-3#2)(2008-5#2)(2009-10#1)(2011-3#1)(2012-1#1)
1-5% of the##2##3##(1997-4#1)(2008-7#1)
1-5% of##3##2##(1997-4#1)(2008-7#1)(2009-8#1)
1-5%##10##1##(1992-3#2)(1997-4#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)
1-5)##2##1##(1990-12#1)(2009-10#1)
1-50##9##1##(1993-12#1)(1996-12#3)(2008-10#3)(2008-3#1)(2010-8#1)
1-6 years##2##2##(1997-4#1)(2011-2#1)
1-6##14##1##(1993-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#2)
1-62##3##1##(1997-4#1)(2008-11#2)
1-7##10##1##(2007-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-8#1)
1-7)##3##1##(1990-7#1)(1992-8#1)(2008-4#1)
1-8##11##1##(1990-12#1)(1992-12#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-6#1)(2008-8#1)
1-8)##2##1##(1990-11#1)(2008-7#1)
1-84##2##1##(1990-9#1)(2008-6#1)
1-9##10##1##(1992-12#1)(1995-12#2)(2007-10#1)(2008-5#1)(2008-6#1)(2010-11#1)(2013-1#3)
1-90##2##1##(2008-10#1)(2010-3#1)
1-98##3##1##(1990-12#3)
1-D and 2-D##2##3##(2008-3#1)(2008-4#1)
1-D##8##1##(1992-6#1)(2008-2#1)(2008-3#5)(2008-4#1)
1-GW##2##1##(2007-12#2)
1-IB##3##1##(2008-10#3)
1-J##2##1##(2008-2#1)(2008-3#1)
1-MHz##2##1##(2007-12#1)(2008-2#1)
1-MT and MTH-trp##3##3##(2008-11#3)
1-MeIm in##2##2##(1995-5#2)
1-MeTIQ##4##1##(1994-2#4)
1-N-way resonator based on beam splitting and beam combining effects in rectangular cross-sectional multimode waveguides##2##15##(2008-3#2)
1-N-way##5##1##(2008-3#5)
1-NAA##4##1##(2008-10#4)
1-NO(2) naphthalene##2##2##(2008-11#2)
1-O-hexadecyl molecular species of##2##4##(1991-5#2)
1-O-hexadecyl-2-O-methylglycerol##2##1##(2008-11#2)
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine##2##1##(1995-3#2)
1-PP##5##1##(1995-12#5)
1-RM and##2##2##(2008-5#2)
1-RM bench press and##2##4##(2008-5#2)
1-RM bench press##3##3##(2008-5#3)
1-RM squat##2##2##(2008-5#2)
1-RM##7##1##(2008-5#7)
1-T74A##2##1##(2008-8#2)
1-W average output power##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
1-W average##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
1-W##11##1##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)
1-[G'(1)]##3##1##(1996-5#3)
1-[G'(1)]-1-[G'(4)]##4##1##(1996-5#4)
1-[G'(4)]##2##1##(1996-5#2)
1-[pyridyl-(2)-azo]-naphthol-(2)##2##1##(2008-10#2)
1-a]fluoranthene##2##1##(1990-7#2)
1-acid glycoprotein##4##2##(1991-12#2)(1992-12#2)
1-acylindazol-3-ols as##2##2##(2008-10#2)
1-alkyl-3-methylimidazolium##3##1##(2008-10#2)(2012-1#1)
1-alpha##5##1##(1995-9#2)(2008-10#2)(2013-1#1)
1-aminocyclopropane-1-carboxylic acid (ACC)##2##3##(2008-10#1)(2011-10#1)
1-aminocyclopropane-1-carboxylic acid##3##2##(1995-2#1)(2008-10#1)(2011-10#1)
1-anilinonaphthalene-8-sulfonic acid##2##2##(1991-9#1)(1995-5#1)
1-antitrypsin##7##1##(1990-12#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-3#1)
1-b]thiazole##2##1##(1995-3#2)
1-b]thiazoles##4##1##(1995-3#4)
1-benzoxazin-4-one##2##1##(2007-11#2)
1-butanol##2##1##(1992-6#2)
1-butyl-3-methylimidazolium##2##1##(2008-10#1)(2013-1#1)
1-chloro-2##2##1##(1994-11#1)(1995-6#1)
1-chloronaphthalene (CN)##2##2##(2008-10#2)
1-cm##6##1##(1992-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
1-d##2##1##(1997-3#2)
1-dB##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
1-day##4##1##(1990-7#1)(2008-10#2)(2010-6#1)
1-day-old chicks##4##2##(1997-3#1)(1997-6#1)(2008-5#2)
1-day-old##9##1##(1991-5#1)(1997-3#2)(1997-6#1)(2007-6#3)(2008-5#2)
1-decyl-3-methylimidazolium bromide##2##2##(2008-10#2)
1-deoxy##3##1##(1992-12#3)
1-dichloro-2##2##1##(2008-10#2)
1-diphenyl-2-picryl hydrazyl (DPPH)##2##3##(2009-6#1)(2011-1#1)
1-diphenyl-2-picryl hydrazyl radical##3##3##(2010-5#3)
1-diphenyl-2-picryl hydrazyl##6##2##(2008-5#1)(2009-6#1)(2010-5#3)(2011-1#1)
1-diphenyl-2-picrylhydrazyl radical##2##2##(2008-11#1)(2008-5#1)
1-diphenyl-2-picrylhydrazyl##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
1-dopa##3##1##(2008-7#3)
1-ethyl-3-methylimidazolium##2##1##(2008-10#2)
1-fluoro-2-nitro-4-azidobenzene (FNAB)##2##2##(2008-10#2)
1-fold##4##1##(1994-8#1)(2008-10#1)(2009-3#1)(2010-5#1)
1-h Post##3##2##(2013-1#3)
1-h exposure to##2##3##(1992-11#1)(1997-4#1)
1-h##12##1##(1992-11#1)(1992-3#1)(1997-4#3)(2008-10#1)(2008-3#1)(2008-6#2)(2013-1#3)
1-hour##6##1##(1993-12#1)(2007-10#1)(2010-7#1)(2012-1#1)(2013-1#2)
1-hr exposure to##2##3##(1992-9#1)(1993-9#1)
1-hydroxypyrene##5##1##(1992-3#5)
1-induced##2##1##(1997-6#1)(2008-9#1)
1-kHz laser##2##2##(2007-11#1)(2007-12#1)
1-kHz repetition rate##14##3##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#5)
1-kHz##22##1##(2007-11#5)(2007-12#9)(2008-2#1)(2008-3#7)
1-kb fragment##2##2##(1991-6#1)(1995-8#1)
1-kb##6##1##(1991-6#1)(1991-9#1)(1994-12#1)(1995-8#1)(2008-10#2)
1-m##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-6#1)
1-m(2)##3##1##(2008-10#3)
1-m-long fiber##2##2##(2007-11#1)(2007-12#1)
1-m-long##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
1-mJ##4##1##(2007-12#2)(2008-3#2)
1-mW##2##1##(2007-11#1)(2008-3#1)
1-methyl##2##1##(1994-2#1)(2008-10#1)
1-methyl-1##2##1##(1990-7#1)(1994-2#1)
1-methyl-4-phenyl-1##9##1##(1990-7#1)(1992-11#1)(1995-11#1)(1995-5#2)(1996-12#1)(2008-7#3)
1-methyl-4-phenylpyridinium (MPP+)##5##2##(1990-5#2)(1990-7#1)(1995-5#1)(1996-12#1)
1-methyl-4-phenylpyridinium##9##1##(1990-5#2)(1990-7#1)(1991-12#2)(1995-11#2)(1995-5#1)(1996-12#1)
1-methyladenosine##7##1##(1992-3#5)(1993-8#1)(1997-2#1)
1-mg##2##1##(2011-2#2)
1-microm wavelength##3##2##(2008-2#2)(2008-3#1)
1-microm##7##1##(2008-2#3)(2008-3#4)
1-microm-sized##2##1##(2007-11#1)(2008-3#1)
1-mm##9##1##(1994-2#1)(2007-12#1)(2008-10#3)(2008-12#3)(2008-3#1)
1-mm-diameter##2##1##(2007-12#2)
1-mm-thick##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
1-month period##2##2##(2008-10#2)
1-month##7##1##(2007-10#1)(2008-10#4)(2008-5#1)(2008-8#1)
1-month-old##3##1##(1993-12#1)(2008-3#2)
1-ms##3##1##(2008-2#1)(2008-3#2)
1-muJ##2##1##(2008-2#2)
1-mum##7##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
1-naphthalenacetamide in##2##2##(2008-10#2)
1-naphthalenacetamide##3##1##(2008-10#3)
1-naphthol and testosterone##3##3##(1992-8#3)
1-naphthol and##5##2##(1992-8#3)(2008-11#2)
1-naphthol##9##1##(1992-8#5)(2008-10#1)(2008-11#2)(2008-5#1)
1-naphthyl##2##1##(2008-10#1)(2008-5#1)
1-naphthylacetic acid (NAA)##2##3##(1996-5#1)(2008-10#1)
1-naphthylacetic acid##3##2##(1996-5#1)(2008-10#2)
1-naphthylamine##2##1##(2008-10#2)
1-nitroso-2-naphthol##6##1##(2008-10#6)
1-nm linewidth and a##2##4##(2008-2#1)(2008-3#1)
1-nm##6##1##(2008-2#1)(2008-3#5)
1-ns##2##1##(2008-3#2)
1-octanol##3##1##(2008-10#2)(2012-1#1)
1-octyl-3-methylimidazolium hexafluorophosphate##2##2##(2008-10#2)
1-palmitoyl-2-oleoylphosphatidylcholine (POPC) and##2##3##(1990-7#1)(1994-3#1)
1-palmitoyl-2-oleoylphosphatidylcholine (POPC)##3##2##(1990-7#1)(1992-6#1)(1994-3#1)
1-phosphate##3##1##(1990-7#2)(1995-2#1)
1-propanol##3##1##(1992-6#2)(2008-10#1)
1-ps pulses##2##2##(2007-11#1)(2007-12#1)
1-ps##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
1-q13##2##1##(1997-8#2)
1-s##3##1##(2008-3#3)
1-specific##2##1##(2008-5#1)(2012-2#1)
1-stearoyl##2##1##(1993-8#2)
1-substituted##2##1##(1996-5#1)(2007-11#1)
1-tailed##2##1##(1993-2#1)(1995-6#1)
1-tris(N-ethyl-N-phenylamino-carboxylmethoxymethyl) propane##2##2##(2008-10#2)
1-week##2##1##(2007-11#1)(2009-4#1)
1-year PRWE score was##2##4##(2008-9#2)
1-year PRWE score##3##3##(2008-9#3)
1-year follow-up##10##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
1-year followup##2##2##(1991-1#1)(2010-8#1)
1-year old##3##2##(2012-12#3)
1-year prospective cohort study##2##4##(2013-1#2)
1-year##42##1##(1990-11#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#5)(2009-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#3)
1-year-old##12##1##(1997-8#1)(2008-10#4)(2008-7#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2012-8#1)
1-yr##3##1##(2008-8#2)(2010-10#1)
1/1 and##2##2##(2008-10#1)(2012-2#1)
1/1##6##1##(1993-9#1)(1996-2#1)(2008-10#2)(2012-2#1)(2013-1#1)
1/10##4##1##(1990-12#1)(1990-6#1)(1995-11#1)(2008-10#1)
1/100 of the##2##3##(2007-11#1)(2008-5#1)
1/100##7##1##(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
1/1000##4##1##(1990-2#1)(1990-3#1)(1996-8#1)(2008-3#1)
1/1061##2##1##(2007-11#2)
1/12##2##1##(1994-11#1)(2012-2#1)
1/2 and##2##2##(1994-3#1)(2008-10#1)
1/2 year##2##2##(1992-11#1)(1994-6#1)
1/2 years of##2##3##(1990-6#1)(2007-2#1)
1/2 years##8##2##(1990-6#4)(1992-1#1)(2007-2#1)(2012-2#2)
1/2##27##1##(1990-6#4)(1992-1#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#3)
1/2)##2##1##(2008-10#1)(2008-3#1)
1/20##2##1##(1990-2#1)(1991-5#1)
1/3 of the##6##3##(1991-6#1)(1991-9#1)(1993-6#1)(1995-6#1)(1995-9#1)(2013-1#1)
1/3 of##10##2##(1991-6#1)(1991-9#1)(1993-6#1)(1995-6#1)(1995-9#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
1/3##17##1##(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-8#1)(1993-6#1)(1995-6#1)(1995-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#1)
1/3(rd) of the bone##2##4##(2013-8#2)
1/4 of the##2##3##(1993-6#1)(2013-8#1)
1/4 of##4##2##(1993-6#1)(2008-3#1)(2010-11#1)(2013-8#1)
1/4##6##1##(1993-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-8#1)
1/5##2##1##(1992-3#1)(2008-7#1)
1/6##3##1##(1995-11#1)(2007-12#1)(2008-5#1)
1/8##4##1##(1991-12#1)(1997-6#1)(2008-3#2)
1/80##2##1##(1991-5#1)(2008-3#1)
1/Kir3##2##1##(1996-2#1)(2008-8#1)
1/L(2)##2##1##(2007-11#2)
1/T##2##1##(1997-2#1)(2012-1#1)
1/e(2)##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
1/n##3##1##(2008-10#3)
1/n=0##2##1##(2008-10#2)
1/pI5##2##1##(1991-12#2)
1/pump##2##1##(2007-11#2)
1/q##2##1##(2008-3#2)
10 % of##3##3##(1997-8#1)(2007-7#1)(2012-12#1)
10 %##6##2##(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-12#1)
10 (1##2##2##(2011-2#1)(2013-1#1)
10 (95%##2##2##(2008-11#1)(2013-1#1)
10 )##5##2##(2008-10#1)(2008-7#4)
10 +/-##6##2##(1994-5#1)(1995-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-7#1)
10 -##3##2##(2009-11#2)(2011-2#1)
10 000##6##2##(2008-10#2)(2008-7#1)(2011-1#1)(2013-8#2)
10 =##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
10 A##4##2##(1992-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
10 Commandments##4##2##(2008-12#4)
10 December##2##2##(1993-3#1)(2008-3#1)
10 GHz##4##2##(2007-11#2)(2007-12#2)
10 HIV##2##2##(2013-8#2)
10 Hz##7##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)
10 M##7##2##(1990-5#1)(2008-10#6)
10 MPa##2##2##(2008-10#1)(2008-5#1)
10 March##2##2##(1995-3#1)(2008-3#1)
10 OSM to##2##3##(1991-11#2)
10 OSM##3##2##(1991-11#3)
10 Pa##3##2##(2008-11#3)
10 QTLs##2##2##(2008-10#1)(2008-8#1)
10 V##2##2##(2008-10#2)
10 W##2##2##(2007-12#1)(2008-2#1)
10 accessions##2##2##(2008-10#2)
10 adults##2##2##(2008-3#1)(2013-7#1)
10 and 0##4##3##(2008-10#3)(2008-5#1)
10 and 100##3##3##(1992-3#1)(2008-10#2)
10 and 1000 µg/L##2##3##(2013-1#2)
10 and 11##5##3##(1994-12#2)(2008-7#1)(2008-8#1)(2009-10#1)
10 and 12##8##3##(1996-12#5)(2008-10#1)(2008-5#1)(2011-1#1)
10 and 13##5##3##(1990-8#1)(2008-10#2)(2008-12#1)(2010-3#1)
10 and 15 years##2##4##(1993-9#1)(2013-1#1)
10 and 15##10##3##(1993-12#1)(1993-9#1)(1994-8#1)(2008-10#2)(2008-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
10 and 16##2##3##(2008-10#1)(2008-11#1)
10 and 18##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
10 and 20 s##2##4##(1996-5#2)
10 and 20##8##3##(1996-5#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
10 and 20%##2##3##(2008-10#1)(2008-11#1)
10 and 30##6##3##(1991-2#1)(1995-8#1)(1997-4#1)(2008-11#1)(2009-12#1)(2012-3#1)
10 and 5%##2##3##(2008-10#2)
10 and 50 mg/kg##2##4##(2008-10#2)
10 and 50##7##3##(1994-9#1)(2008-10#5)(2008-12#1)
10 and a##2##3##(1992-9#1)(2008-2#1)
10 and about##2##3##(1996-12#1)(2008-10#1)
10 and in##2##3##(2008-10#1)(2008-5#1)
10 and##124##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#7)(1996-5#2)(1997-2#1)(1997-4#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
10 animals##2##2##(2008-5#2)
10 are##2##2##(1993-6#1)(2008-10#1)
10 as##5##2##(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#2)
10 at##5##2##(1995-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
10 but##2##2##(1990-7#1)(1995-5#1)
10 by##2##2##(2007-11#1)(2008-9#1)
10 cases and##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
10 cases##17##2##(1990-2#1)(1991-1#1)(1991-2#1)(1993-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#3)(2008-7#2)(2008-9#1)(2011-2#2)
10 cm in diameter and##2##5##(2007-8#1)(2008-3#1)
10 cm in diameter##3##4##(2007-8#1)(2008-3#1)(2009-8#1)
10 cm in##4##3##(2007-8#1)(2008-3#1)(2009-8#1)(2013-8#1)
10 cm##23##2##(1995-3#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#3)(2008-10#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2013-1#2)(2013-8#3)
10 commandments##2##2##(2008-12#2)
10 commercial##2##2##(2008-10#1)(2011-2#1)
10 commonly##2##2##(2008-10#1)(2011-1#1)
10 consecutive##7##2##(2008-10#4)(2011-2#2)(2013-8#1)
10 control##2##2##(2007-10#1)(2013-1#1)
10 copies of##2##3##(1997-2#1)(2013-1#1)
10 dB##5##2##(2007-12#4)(2011-2#1)
10 day##2##2##(1990-8#1)(2008-12#1)
10 days a##2##3##(1995-2#1)(1997-2#1)
10 days after the last##2##5##(1990-7#1)(1993-12#1)
10 days after##8##3##(1990-7#1)(1993-12#1)(1996-5#1)(2008-10#4)(2012-2#1)
10 days and##4##3##(1992-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
10 days apart##2##3##(2008-10#2)
10 days in##2##3##(1991-8#1)(2009-7#1)
10 days later##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
10 days of##7##3##(1991-12#1)(1992-12#2)(1997-6#1)(2007-10#1)(2008-10#1)(2008-5#1)
10 days old##2##3##(1997-6#1)(2008-10#1)
10 days on##3##3##(2007-6#2)(2008-10#1)
10 days through##2##3##(1990-7#1)(2008-7#1)
10 days to##3##3##(1990-12#1)(2008-10#2)
10 days##78##2##(1990-12#2)(1990-6#1)(1990-7#2)(1991-12#1)(1991-8#1)(1992-12#4)(1992-6#1)(1993-12#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
10 days) on##2##3##(1992-11#1)(2008-12#1)
10 days)##7##2##(1990-12#1)(1992-11#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-10#1)(2011-1#1)
10 deg##2##2##(2008-3#2)
10 degrees C##13##3##(1995-3#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-8#1)(2010-4#1)
10 degrees##28##2##(1995-3#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#2)(2010-4#1)(2011-2#1)
10 determinations of##3##3##(2008-10#3)
10 different##9##2##(1990-7#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
10 elements##2##2##(2008-10#2)
10 enzymes##2##2##(1992-7#1)(2008-5#1)
10 female Tg##7##3##(2008-9#7)
10 female##17##2##(2008-9#17)
10 fg##2##2##(2008-10#2)
10 fmol##3##2##(1997-2#3)
10 fold higher##2##3##(1994-11#1)(2008-11#1)
10 fold##3##2##(1991-5#1)(1994-11#1)(2008-11#1)
10 for the##2##3##(2008-10#2)
10 for##11##2##(1990-5#2)(1993-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-8#1)
10 fractions##2##2##(2007-11#1)(2008-7#1)
10 g##4##2##(2008-10#2)(2008-5#1)(2009-12#1)
10 g)##2##2##(1994-11#1)(2008-10#1)
10 genes##3##2##(1996-2#1)(2008-11#2)
10 gm/m(2)##2##2##(2008-6#2)
10 h after##4##3##(1990-2#1)(1994-5#2)(2008-3#1)
10 h and##2##3##(2008-11#1)(2008-12#1)
10 h in##3##3##(2008-10#2)(2008-6#1)
10 h was##2##3##(2008-10#2)
10 h##21##2##(1990-2#1)(1992-8#1)(1994-5#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
10 h(-1) with##2##3##(2008-10#2)
10 had##2##2##(1990-3#1)(1995-12#1)
10 healthy subjects##2##3##(2008-7#1)(2011-2#1)
10 healthy volunteers##2##3##(2007-10#2)
10 healthy##6##2##(2006-10#1)(2007-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
10 hospitals##2##2##(1994-3#2)
10 hours##4##2##(1991-9#1)(2007-10#2)(2008-7#1)
10 impacted##2##2##(2008-7#2)
10 in##9##2##(1992-3#1)(2007-11#1)(2008-10#3)(2008-3#2)(2011-2#1)(2013-1#1)
10 individuals##4##2##(1994-8#1)(2006-12#1)(2008-5#1)(2010-6#1)
10 injections of##2##3##(1993-3#1)(2008-10#1)
10 injections##3##2##(1993-3#1)(2008-10#2)
10 isolates were##2##3##(2008-10#1)(2008-9#1)
10 isolates##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
10 kDa##3##2##(1992-10#1)(1992-6#1)(2011-2#1)
10 kHz##5##2##(2007-11#2)(2007-12#3)
10 kb##6##2##(1993-2#1)(1994-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-8#1)
10 km##5##2##(1990-11#1)(1996-4#1)(1997-5#1)(2008-8#2)
10 laser diode bars##2##4##(2007-11#2)
10 m##11##2##(2007-10#1)(2007-12#1)(2008-10#4)(2008-3#3)(2008-5#1)(2011-2#1)
10 mJ##2##2##(2007-11#1)(2008-10#1)
10 mM K+##2##3##(1997-1#1)(2008-11#1)
10 mM NaCl##2##3##(1992-6#2)
10 mM and##3##3##(1992-7#1)(1993-9#1)(2008-10#1)
10 mM dithiothreitol##2##3##(1991-2#1)(2008-6#1)
10 mM sodium##2##3##(2008-10#1)(2008-11#1)
10 mM##48##2##(1990-11#2)(1990-7#1)(1991-2#1)(1992-6#6)(1992-7#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#2)(2008-10#13)(2008-11#3)(2008-6#2)(2008-8#1)
10 mM)##2##2##(1993-11#2)
10 mV##4##2##(2008-10#4)
10 mW##6##2##(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)
10 male patients##2##3##(1990-2#1)(2009-7#1)
10 male##20##2##(1990-2#1)(2008-12#1)(2008-9#15)(2009-10#1)(2009-7#1)(2011-2#1)
10 males##4##2##(1996-12#1)(2008-9#3)
10 measurements of 0##2##4##(2008-10#2)
10 men##2##2##(2008-1#1)(2013-1#1)
10 mg daily##2##3##(1990-11#2)
10 mg l(-1)##7##3##(2008-10#7)
10 mg of##3##3##(1993-1#1)(1995-5#1)(2008-2#1)
10 mg##32##2##(1990-11#2)(1991-6#1)(1993-1#1)(1995-12#1)(1995-5#1)(2007-10#3)(2008-10#10)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)
10 mg)##2##2##(1991-5#1)(2007-10#1)
10 mg/day##3##2##(1990-2#1)(2008-5#2)
10 mg/kg##13##2##(1991-12#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-12#2)(1996-2#2)(1997-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
10 mg/kg/day##3##2##(1992-11#2)(1995-8#1)
10 mg/l##3##2##(1990-12#1)(1993-8#1)(2008-10#1)
10 mg/m2##2##2##(1991-4#1)(1992-12#1)
10 microM BQ-788##2##3##(1994-11#2)
10 microM and##3##3##(1990-7#1)(1994-5#1)(1996-2#1)
10 microM##25##2##(1990-7#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-4#2)(2008-10#1)
10 microM) and##2##3##(1995-11#1)(1996-2#1)
10 microM)##12##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#2)(1992-3#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)
10 microg l(-1)##3##3##(2008-10#3)
10 microg of##3##3##(1997-4#1)(2007-10#1)(2008-10#1)
10 microg##7##2##(1997-4#1)(2007-10#1)(2008-10#5)
10 micrograms of##3##3##(1990-2#1)(1992-6#1)(1996-12#1)
10 micrograms##6##2##(1990-2#1)(1992-6#1)(1993-6#1)(1996-12#1)(1996-2#2)
10 micrograms/dl##4##2##(1995-11#1)(1995-3#1)(1997-4#2)
10 micrograms/kg##2##2##(1992-3#1)(1994-8#1)
10 micrograms/ml##5##2##(1990-2#1)(1991-2#1)(1994-11#3)
10 microm is##2##3##(2007-12#1)(2008-3#1)
10 microm long##2##3##(2007-12#1)(2008-7#1)
10 microm##14##2##(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-7#1)
10 micromol##2##2##(2008-10#2)
10 microns##4##2##(1991-5#1)(1995-11#1)(1995-3#1)(1997-1#1)
10 million##5##2##(1993-6#1)(2008-6#2)(2008-7#1)(2013-1#1)
10 min after##4##3##(1993-1#1)(1997-2#1)(1997-7#2)
10 min and##2##3##(2008-10#1)(2013-1#1)
10 min at##2##3##(1994-11#1)(1995-12#1)
10 min before the##2##4##(1995-12#1)(2011-2#1)
10 min for##2##3##(2008-10#1)(2008-3#1)
10 min in a##2##4##(1990-12#1)(2008-10#1)
10 min in the##2##4##(1990-8#1)(1993-1#1)
10 min in##5##3##(1990-12#1)(1990-8#1)(1993-1#1)(1994-9#1)(2008-10#1)
10 min incubation##2##3##(1992-3#1)(2008-10#1)
10 min of incubation##2##4##(1991-2#1)(1993-11#1)
10 min of##6##3##(1991-12#1)(1991-2#1)(1993-11#1)(1995-5#1)(1996-12#1)(2008-10#1)
10 min per sample##2##4##(2008-10#2)
10 min sampling##2##3##(2008-10#2)
10 min static##2##3##(2008-10#2)
10 min##84##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-3#1)(1993-1#2)(1993-11#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#2)(1996-12#1)(1996-5#2)(1997-2#2)(1997-7#2)(2006-11#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-10#28)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
10 min)##6##2##(1990-2#1)(1991-6#1)(1992-8#1)(1997-2#1)(2008-10#1)(2008-3#1)
10 minute pH##2##3##(1994-7#2)
10 minute##3##2##(1994-7#2)(2008-11#1)
10 minutes after the##2##4##(1992-1#1)(2012-3#1)
10 minutes after##4##3##(1992-1#1)(2007-9#1)(2012-3#2)
10 minutes at##2##3##(2008-11#1)(2012-2#1)
10 minutes of##3##3##(2010-1#1)(2011-1#1)(2013-1#1)
10 minutes##15##2##(1991-1#1)(1992-1#1)(1994-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-1#2)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
10 minutes)##2##2##(1990-5#1)(2010-5#1)
10 ml of 0##2##4##(1995-3#1)(2008-10#1)
10 ml of 1%##2##4##(2008-10#2)
10 ml of sample##3##4##(2008-10#3)
10 ml of##18##3##(1995-3#1)(2008-10#17)
10 ml sample##4##3##(2008-10#4)
10 ml##30##2##(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#27)
10 mm Hg##3##3##(1990-3#1)(1997-5#1)(2010-4#1)
10 mm in##7##3##(1990-2#2)(2008-10#3)(2008-3#1)(2010-10#1)
10 mm long##3##3##(1990-2#1)(2007-11#1)(2008-10#1)
10 mm##32##2##(1990-2#3)(1990-3#1)(1991-12#1)(1994-9#2)(1995-2#2)(1997-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
10 mm)##3##2##(2010-12#1)(2011-7#1)(2013-1#1)
10 mmol/l##4##2##(1991-11#1)(1991-6#1)(1992-12#1)(2010-4#1)
10 mol l(-1) Tris-SO(4) buffer##2##5##(2008-10#2)
10 mol l(-1)##4##3##(2008-10#4)
10 moles of##2##3##(2008-10#2)
10 months (range##2##3##(1990-8#1)(2013-1#1)
10 months after surgery##2##4##(2011-2#2)
10 months after the##2##4##(1996-2#1)(2011-2#1)
10 months after##10##3##(1991-6#1)(1991-8#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2011-2#3)
10 months later##3##3##(2008-7#2)(2009-1#1)
10 months of##2##3##(2008-10#1)(2008-9#1)
10 months##38##2##(1990-2#1)(1990-8#1)(1991-4#1)(1991-6#2)(1991-8#1)(1996-2#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-6#4)(2008-7#3)(2008-9#3)(2009-1#1)(2009-2#1)(2010-1#1)(2010-2#1)(2011-2#3)(2013-1#1)(2013-8#1)
10 ms)##2##2##(1996-5#1)(2008-6#1)
10 mu##2##2##(1995-12#1)(2008-10#1)
10 muM cytokinin##2##3##(2008-7#2)
10 muM of##2##3##(2008-10#2)
10 muM##14##2##(2008-10#8)(2008-11#2)(2008-4#1)(2008-7#3)
10 mug l(-1) and##2##4##(2008-10#2)
10 mug l(-1)##6##3##(2008-10#6)
10 mug l(-1))##2##3##(2008-10#2)
10 mug ml(-1)##5##3##(2008-10#4)(2008-11#1)
10 mug of##2##3##(2008-10#1)(2008-7#1)
10 mug##23##2##(2008-10#21)(2008-11#1)(2008-7#1)
10 mug/kg##2##2##(2008-10#1)(2008-11#1)
10 mug/ml##3##2##(2008-10#3)
10 mul of##3##3##(2008-10#3)
10 mul##6##2##(2008-10#6)
10 mum##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
10 mumol##2##2##(2008-10#2)
10 nM T4 at##2##4##(2008-6#2)
10 nM T4##3##3##(2008-6#3)
10 nM hormone##2##3##(1995-12#2)
10 nM##21##2##(1990-12#1)(1992-3#3)(1992-6#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-6#3)
10 nM)##2##2##(1993-6#1)(2008-6#1)
10 nematodes per cm(3) of##2##5##(2008-10#2)
10 nematodes##4##2##(2008-10#4)
10 new##2##2##(1994-3#1)(2008-10#1)
10 newborns delivered by##2##4##(2009-8#2)
10 ng ml(-1) level##2##4##(2008-10#2)
10 ng ml(-1)##6##3##(2008-10#6)
10 ng##14##2##(2008-10#14)
10 ng/ml##9##2##(1990-12#2)(1993-6#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-6#1)
10 ngml(-1)##2##2##(2008-10#2)
10 nm and##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
10 nm filaments##3##3##(2008-8#3)
10 nm in##3##3##(2007-11#1)(2008-10#2)
10 nm##22##2##(1993-11#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-5#2)(2011-1#2)
10 nmol##2##2##(1993-12#1)(2008-10#1)
10 nmol)##2##2##(1993-12#1)(1995-12#1)
10 normal##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
10 of 13##2##3##(2008-10#1)(2008-12#1)
10 of the 14##2##4##(1996-12#1)(2008-10#1)
10 of the##10##3##(1991-4#1)(1995-8#1)(1996-12#2)(1996-8#1)(2008-10#4)(2008-5#1)
10 of##22##2##(1991-4#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-8#1)(2008-10#7)(2008-12#1)(2008-5#1)(2013-1#1)
10 or 14##2##3##(2007-2#1)(2007-8#1)
10 or##12##2##(1992-10#1)(1994-12#1)(1994-6#1)(1995-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)
10 out of 12##2##4##(2008-5#1)(2013-1#1)
10 out of 18##2##4##(2008-10#2)
10 out of##7##3##(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)
10 pM and##3##3##(1990-5#1)(1991-2#1)(1993-11#1)
10 pM##4##2##(1990-5#1)(1991-2#1)(1993-11#1)(1995-6#1)
10 pM)##3##2##(1990-8#2)(1994-8#1)
10 parallel##2##2##(2008-10#2)
10 parathyroid adenomas and##2##4##(2008-5#2)
10 parts##2##2##(1990-2#1)(2007-12#1)
10 passages##2##2##(2007-6#1)(2008-10#1)
10 patients of##2##3##(2008-7#1)(2012-2#1)
10 patients treated##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
10 patients were##2##3##(2011-2#1)(2012-3#1)
10 patients who had##2##4##(1993-10#1)(2008-6#1)
10 patients who##4##3##(1993-10#1)(2007-5#1)(2008-1#1)(2008-6#1)
10 patients with chronic##3##4##(2007-10#1)(2007-11#1)(2010-12#1)
10 patients with##18##3##(1990-12#1)(1991-4#1)(1991-5#2)(1996-2#2)(1996-9#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2010-12#1)
10 patients##55##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-5#2)(1993-1#1)(1993-10#2)(1995-11#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
10 per thousand SW##4##4##(2008-7#4)
10 per##9##2##(1996-9#1)(2008-7#4)(2010-2#1)(2012-12#1)(2013-1#2)
10 percent of the##4##4##(1992-3#1)(1995-3#1)(1995-6#1)(2011-2#1)
10 percent of##7##3##(1991-3#1)(1992-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(2010-8#1)(2011-2#1)
10 percent##12##2##(1991-1#1)(1991-11#1)(1991-3#1)(1992-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1995-6#2)(2007-9#1)(2010-8#1)(2011-2#1)
10 pg and##3##3##(1990-8#1)(2008-10#2)
10 pg of##2##3##(2008-10#2)
10 pg##10##2##(1990-8#1)(2008-10#7)(2008-11#1)(2011-3#1)
10 points##2##2##(2012-1#2)
10 ppb##3##2##(2008-10#3)
10 ppm##6##2##(1993-6#2)(2008-10#3)(2010-1#1)
10 pregnant##2##2##(1991-3#1)(2008-11#1)
10 presented##2##2##(2007-8#2)
10 prune orchards##3##3##(2008-10#3)
10 ps##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
10 rats of each sex were treated with##2##8##(2013-1#2)
10 rats##4##2##(1993-3#2)(2013-1#2)
10 replicate determinations of##4##4##(2008-10#4)
10 replicate determinations##8##3##(2008-10#8)
10 replicate injections of##2##4##(2008-10#2)
10 replicate injections##3##3##(2008-10#3)
10 replicate##11##2##(2008-10#11)
10 replicates##3##2##(2008-10#3)
10 s and can be used for at least##3##9##(2008-10#3)
10 s and##8##3##(1993-11#1)(2008-10#7)
10 s##19##2##(1990-8#1)(1993-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#12)(2008-2#1)(2008-3#1)
10 samples of##2##3##(1997-4#1)(2013-1#1)
10 samples per hour##2##4##(2008-10#2)
10 samples per##3##3##(2008-10#3)
10 samples##10##2##(1992-3#1)(1997-4#1)(2008-10#5)(2008-5#1)(2010-6#1)(2013-1#1)
10 seconds##3##2##(1990-2#1)(1993-3#1)(2013-1#1)
10 sessions##2##2##(2012-1#1)(2013-1#1)
10 showed##3##2##(1993-11#1)(1995-12#1)(2009-12#1)
10 specimens##3##2##(2008-12#1)(2009-4#1)(2011-2#1)
10 strains of##2##3##(2008-1#1)(2008-10#1)
10 strains##4##2##(2008-1#1)(2008-10#2)(2008-6#1)
10 studies##3##2##(1993-1#1)(1995-2#1)(2008-7#1)
10 subjects##2##2##(1996-5#1)(2009-1#1)
10 successive##3##2##(2008-10#2)(2011-1#1)
10 times higher than##2##4##(2012-3#1)(2013-8#1)
10 times higher##4##3##(1995-11#1)(2007-12#1)(2012-3#1)(2013-8#1)
10 times lower##2##3##(2008-11#1)(2008-7#1)
10 times more##3##3##(1991-12#1)(1996-12#1)(2008-10#1)
10 times that##2##3##(1994-11#1)(2008-7#1)
10 times##21##2##(1991-12#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-8#1)
10 to 0##3##3##(2008-10#2)(2012-2#1)
10 to 1##3##3##(2008-10#2)(2008-8#1)
10 to 10##3##3##(1993-9#1)(2008-10#2)
10 to 100##3##3##(2008-10#2)(2008-4#1)
10 to 12##5##3##(1997-2#1)(2008-10#2)(2008-2#1)(2011-2#1)
10 to 14 days##2##4##(2008-10#2)
10 to 14##5##3##(1993-6#1)(2008-10#2)(2013-1#2)
10 to 15 years##2##4##(2007-11#1)(2008-11#1)
10 to 15##6##3##(1991-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
10 to 18##2##3##(2008-10#1)(2009-7#1)
10 to 20##6##3##(1990-5#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
10 to 30 cells##2##4##(2008-2#1)(2008-4#1)
10 to 30##10##3##(1994-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)
10 to 37##2##3##(2008-10#1)(2008-6#1)
10 to 5##4##3##(2008-10#3)(2008-6#1)
10 to##102##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#54)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
10 w/w% Ag-zeolite##2##3##(2008-5#2)
10 was##7##2##(1996-5#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#1)
10 week##2##2##(2010-4#1)(2010-8#1)
10 weeks after##2##3##(2008-10#1)(2008-11#1)
10 weeks at##2##3##(1995-3#1)(2012-12#1)
10 weeks##14##2##(1994-11#1)(1995-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2010-3#1)(2012-12#1)
10 were found##2##3##(2008-10#1)(2008-12#1)
10 were treated##2##3##(2008-10#1)(2011-2#1)
10 were##12##2##(1991-2#1)(1993-1#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
10 when the##2##3##(2008-10#1)(2008-7#1)
10 when##3##2##(2008-10#2)(2008-7#1)
10 with a##3##3##(2008-10#3)
10 with##4##2##(1996-1#1)(2008-10#3)
10 women and##2##3##(1991-8#1)(2008-10#1)
10 women##4##2##(1991-8#1)(1995-1#1)(2008-10#1)(2011-2#1)
10 women)##3##2##(2007-8#1)(2008-7#1)(2010-9#1)
10 x 10##4##3##(1993-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
10 x 10(9)##2##3##(2008-8#1)(2010-4#1)
10 x##10##2##(1990-8#1)(1993-9#1)(1994-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
10 year old##2##3##(1992-1#1)(2008-7#1)
10 year period##4##3##(1990-2#1)(1992-11#1)(2007-8#1)(2008-5#1)
10 year##11##2##(1990-2#1)(1992-1#1)(1992-11#1)(1993-1#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-1#1)
10 years after the##2##4##(2008-1#1)(2010-3#1)
10 years after##6##3##(1997-8#1)(2008-1#1)(2010-3#1)(2013-1#3)
10 years ago##3##3##(2008-7#1)(2010-7#1)(2012-3#1)
10 years and##5##3##(2008-10#2)(2009-3#1)(2010-3#1)(2012-12#1)
10 years are##3##3##(1997-3#1)(2007-12#1)(2008-11#1)
10 years before##3##3##(1991-7#1)(2008-1#1)(2011-2#1)
10 years in prison##2##4##(1996-5#2)
10 years in##8##3##(1996-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
10 years it##2##3##(1995-9#1)(2009-1#1)
10 years of age and##2##5##(2008-12#1)(2012-12#1)
10 years of age##7##4##(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2012-12#2)
10 years of##16##3##(1992-8#1)(1997-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#1)
10 years old##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
10 years or##2##3##(2008-10#1)(2008-9#1)
10 years period##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
10 years to##2##3##(1990-2#1)(2012-3#1)
10 years was##2##3##(1991-6#1)(2006-10#1)
10 years with##2##3##(2010-2#1)(2013-7#1)
10 years##129##2##(1990-2#1)(1990-9#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#7)(2007-8#4)(2008-1#4)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#10)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
10 years)##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
10 young##2##2##(1995-8#1)(2011-2#1)
10 yr##3##2##(2008-9#1)(2009-10#1)(2010-4#1)
10 µm)##2##2##(2010-11#1)(2010-9#1)
10 μg##3##2##(2012-3#2)(2013-1#1)
10##3062##1##(1990-11#9)(1990-12#18)(1990-2#23)(1990-3#8)(1990-5#11)(1990-6#5)(1990-7#11)(1990-8#14)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#10)(1991-2#9)(1991-3#7)(1991-4#6)(1991-5#14)(1991-6#15)(1991-7#2)(1991-8#10)(1991-9#8)(1992-1#2)(1992-10#5)(1992-11#12)(1992-12#14)(1992-2#2)(1992-3#19)(1992-4#1)(1992-5#3)(1992-6#14)(1992-7#4)(1992-8#6)(1992-9#5)(1993-1#10)(1993-10#2)(1993-11#13)(1993-12#15)(1993-2#8)(1993-3#16)(1993-6#14)(1993-8#9)(1993-9#17)(1994-1#1)(1994-11#16)(1994-12#11)(1994-2#5)(1994-3#7)(1994-5#5)(1994-6#9)(1994-7#6)(1994-8#14)(1994-9#10)(1995-1#3)(1995-10#1)(1995-11#18)(1995-12#26)(1995-2#14)(1995-3#16)(1995-4#1)(1995-5#13)(1995-6#9)(1995-8#13)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#24)(1996-2#30)(1996-3#4)(1996-4#1)(1996-5#28)(1996-6#2)(1996-8#2)(1996-9#10)(1997-1#10)(1997-2#21)(1997-3#15)(1997-4#12)(1997-5#9)(1997-6#8)(1997-7#14)(1997-8#9)(1997-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-6#1)(2006-8#1)(2007-10#23)(2007-11#54)(2007-12#49)(2007-2#8)(2007-3#1)(2007-5#2)(2007-6#8)(2007-7#18)(2007-8#29)(2007-9#3)(2008-1#25)(2008-10#849)(2008-11#102)(2008-12#55)(2008-2#43)(2008-3#99)(2008-4#15)(2008-5#85)(2008-6#42)(2008-7#91)(2008-8#30)(2008-9#79)(2009-1#3)(2009-10#9)(2009-11#6)(2009-12#13)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#7)(2009-6#1)(2009-7#8)(2009-8#13)(2009-9#1)(2010-1#9)(2010-10#3)(2010-11#5)(2010-12#10)(2010-2#7)(2010-3#13)(2010-4#11)(2010-5#9)(2010-6#4)(2010-7#7)(2010-8#9)(2010-9#5)(2011-1#38)(2011-10#2)(2011-2#104)(2011-3#7)(2011-7#1)(2012-1#7)(2012-12#33)(2012-2#34)(2012-3#32)(2013-1#89)(2013-7#8)(2013-8#34)
10% (v/v)##3##2##(2008-10#2)(2008-11#1)
10% (w/v)##2##2##(2008-6#1)(2013-1#1)
10% FBS and##2##3##(2007-11#1)(2008-11#1)
10% FBS##7##2##(1994-2#3)(2007-11#2)(2008-11#2)
10% Genapol X-080##2##3##(2008-10#2)
10% HCl##3##2##(2008-10#3)
10% RSD##2##2##(2007-12#1)(2008-10#1)
10% after##4##2##(2008-10#2)(2008-4#1)(2013-8#1)
10% and 15%##2##3##(2008-5#1)(2010-8#1)
10% and 20%##2##3##(2008-11#1)(2010-4#1)
10% and##24##2##(1995-3#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
10% are##5##2##(1991-12#1)(2008-3#2)(2010-5#1)(2013-1#1)
10% at the##3##3##(1991-6#1)(2008-10#2)
10% at##6##2##(1991-6#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
10% fetal bovine serum (FBS)##2##5##(1995-3#1)(2008-11#1)
10% fetal bovine serum##3##4##(1995-3#1)(2008-11#2)
10% fetal##4##2##(1990-7#1)(1995-3#1)(2008-11#2)
10% for##13##2##(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)
10% formalin and##2##3##(1996-12#1)(2007-7#1)
10% formalin##4##2##(1996-12#2)(2007-7#1)(2008-12#1)
10% from##3##2##(2008-10#1)(2009-9#1)(2012-2#1)
10% glucose and 0##2##4##(1996-5#2)
10% glucose##3##2##(1995-11#1)(1996-5#2)
10% had##2##2##(1994-11#1)(1995-5#1)
10% have had##2##3##(2013-1#2)
10% higher##2##2##(2008-10#1)(2008-2#1)
10% in the##2##3##(1990-6#1)(2008-3#1)
10% in##13##2##(1990-6#1)(1993-9#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#2)(2013-7#1)
10% of all##4##3##(1991-11#1)(1995-5#1)(2008-10#1)(2008-4#1)
10% of cases##4##3##(1990-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
10% of children##2##3##(2008-4#1)(2010-12#1)
10% of patients##6##3##(1991-9#1)(1996-11#1)(2006-8#1)(2008-7#2)(2009-12#1)
10% of the cases##3##4##(1991-8#1)(2008-7#1)(2008-9#1)
10% of the total##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2013-7#1)
10% of the##39##3##(1990-2#2)(1991-8#1)(1992-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-3#1)(1997-5#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#10)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-3#1)(2013-7#1)
10% of total##4##3##(1990-2#1)(1992-8#1)(2008-9#1)(2010-11#1)
10% of##101##2##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-8#3)(2010-11#2)(2010-12#2)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
10% or more of##2##4##(1997-7#1)(2008-7#1)
10% or##5##2##(1997-7#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
10% oxygen##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
10% serum or##2##3##(1996-5#2)
10% serum##4##2##(1992-11#1)(1996-5#2)(2008-11#1)
10% sucrose##2##2##(1993-6#1)(2008-10#1)
10% to##8##2##(2008-1#2)(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#2)
10% w/v##2##2##(2008-10#2)
10% was##3##2##(2007-11#1)(2008-10#2)
10% were##7##2##(1990-12#1)(2007-12#1)(2008-10#4)(2010-11#1)
10% when the##2##3##(2007-7#1)(2013-8#1)
10% when##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
10% with##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
10%##436##1##(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-2#8)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-8#1)(1996-11#4)(1996-12#4)(1996-3#1)(1996-5#5)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(2006-8#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#112)(2008-11#19)(2008-12#7)(2008-2#11)(2008-3#31)(2008-4#4)(2008-5#13)(2008-6#7)(2008-7#9)(2008-8#2)(2008-9#8)(2009-12#3)(2009-3#3)(2009-4#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#5)(2011-1#6)(2011-2#18)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#6)
10%) and##6##2##(2008-10#4)(2008-3#1)(2012-3#1)
10%) for##2##2##(2007-7#1)(2008-10#1)
10%) of##3##2##(2007-8#1)(2008-1#1)(2012-3#1)
10%) were##2##2##(2007-7#1)(2008-10#1)
10%)##30##1##(1994-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-9#1)(2010-4#3)(2011-2#1)(2012-3#3)(2013-7#1)
10(-1) M##3##2##(2008-10#3)
10(-1) M)##2##2##(2008-10#2)
10(-1) mol l(-1)##2##3##(2008-10#2)
10(-1) mol##6##2##(2008-10#6)
10(-1)##15##1##(1992-12#1)(2008-10#14)
10(-1)M with a##2##3##(2008-10#2)
10(-1)M##6##1##(2008-10#6)
10(-10) M##14##2##(1990-8#1)(1991-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-4#2)(2008-10#2)
10(-10) M)##3##2##(1991-5#1)(1995-5#1)(1996-5#1)
10(-10) and##5##2##(1995-11#1)(1996-5#1)(2008-10#2)(2008-3#1)
10(-10) to##3##2##(2008-10#2)(2008-4#1)
10(-10)##38##1##(1990-8#1)(1991-12#1)(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-4#2)(2007-11#1)(2007-12#2)(2008-10#9)(2008-2#3)(2008-3#3)(2008-4#1)(2013-8#1)
10(-10)-10(-7)##2##1##(1993-11#1)(2008-11#1)
10(-11) M and##2##3##(1994-6#1)(1997-4#1)
10(-11) M##4##2##(1994-6#1)(1997-4#1)(2008-10#1)(2008-11#1)
10(-11)##12##1##(1994-6#1)(1995-11#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)
10(-12) to##2##2##(2008-10#2)
10(-12)##11##1##(1991-5#1)(1993-9#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)
10(-13)##4##1##(1990-12#1)(2008-3#2)(2010-4#1)
10(-14) M to##2##3##(1997-4#2)
10(-14) M##3##2##(1997-4#3)
10(-14)##7##1##(1997-4#3)(2008-3#3)(2008-5#1)
10(-15)##4##1##(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)
10(-16)##4##1##(2007-12#1)(2008-3#2)(2008-5#1)
10(-17) W/##2##2##(2008-3#2)
10(-17)##3##1##(2007-12#1)(2008-3#2)
10(-18)##3##1##(2008-11#1)(2008-12#1)(2008-3#1)
10(-2) M##4##2##(2008-10#4)
10(-2) mol##3##2##(2008-10#3)
10(-2) mul##4##2##(2008-11#4)
10(-2) to##2##2##(2007-12#1)(2008-10#1)
10(-2)##26##1##(1991-5#1)(1995-2#1)(1996-6#4)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#4)(2008-3#2)(2009-6#1)(2011-2#2)
10(-2))##4##1##(2008-10#3)(2008-3#1)
10(-20)##6##1##(2008-10#1)(2008-2#3)(2008-3#2)
10(-3) M##7##2##(2008-10#6)(2008-5#1)
10(-3) and 10(-2) mul ml(-1) concentrations of TE were used for 48 h to##2##14##(2008-11#2)
10(-3) and 10(-2) mul ml(-1) concentrations##3##6##(2008-11#3)
10(-3) and##6##2##(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)
10(-3) cm(-1)##3##2##(2008-2#1)(2008-3#2)
10(-3) mol l(-1)##5##3##(2008-10#5)
10(-3) or##2##2##(2008-10#1)(2008-3#1)
10(-3) s-1##4##2##(1992-6#1)(1994-5#1)(1995-11#1)(1995-2#1)
10(-3) to##5##2##(2008-10#5)
10(-3)##63##1##(1990-8#1)(1991-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-12#2)(2008-10#24)(2008-11#3)(2008-2#8)(2008-3#15)(2008-5#1)(2008-7#2)
10(-3))##3##1##(1993-8#1)(2007-11#1)(2008-10#1)
10(-4) M H2O2##2##3##(1992-12#2)
10(-4) M##18##2##(1991-8#1)(1992-12#3)(1992-8#2)(1993-12#1)(1994-8#1)(1994-9#1)(2008-10#6)(2008-11#1)(2008-2#2)
10(-4) mol l(-1)##5##3##(2008-10#5)
10(-4) mol##6##2##(2008-10#6)
10(-4) to 10(-2) M##2##4##(2008-10#2)
10(-4) to##8##2##(2007-12#1)(2008-10#6)(2008-2#1)
10(-4)##97##1##(1990-8#1)(1991-8#1)(1992-12#4)(1992-6#2)(1992-8#2)(1993-12#1)(1993-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#28)(2008-11#6)(2008-2#10)(2008-3#24)(2010-12#1)(2011-2#1)(2013-1#2)
10(-4)-1##2##1##(2008-10#2)
10(-5) M in##2##3##(2008-10#2)
10(-5) M of##2##3##(1997-4#2)
10(-5) M##26##2##(1990-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-5#2)(1997-4#3)(2008-10#13)
10(-5) M)##5##2##(1991-9#1)(1992-5#1)(1994-2#1)(1995-12#1)(1997-4#1)
10(-5) and##3##2##(2008-10#2)(2008-3#1)
10(-5) are##2##2##(2007-12#1)(2008-2#1)
10(-5) mol l(-1)##4##3##(2008-10#4)
10(-5) mol##6##2##(1996-5#1)(2008-10#5)
10(-5) mol/l##2##2##(2011-2#2)
10(-5) s-1##2##2##(1991-5#2)
10(-5) to##11##2##(2008-10#11)
10(-5)##86##1##(1990-11#1)(1990-8#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#2)(1993-8#3)(1994-11#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-5#1)(1997-4#4)(2007-11#1)(2007-12#1)(2008-10#36)(2008-11#2)(2008-2#8)(2008-3#7)(2010-1#1)(2010-4#1)(2011-2#2)(2012-2#1)
10(-5))##4##1##(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
10(-5)-10(-2) M##2##2##(2008-10#2)
10(-5)-10(-2)##4##1##(2008-10#4)
10(-5)-10(-4) M##2##2##(1990-7#1)(2008-10#1)
10(-5)M##8##1##(1995-8#1)(2008-10#7)
10(-5)moll(-1) with##2##2##(2008-10#2)
10(-5)moll(-1)##3##1##(2008-10#3)
10(-6) M RA##2##3##(1993-9#2)
10(-6) M or##2##3##(1994-5#1)(1997-4#1)
10(-6) M##27##2##(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-9#3)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#3)(1997-4#2)(2008-10#2)(2008-11#1)(2008-4#2)
10(-6) M)##7##2##(1990-12#1)(1991-5#1)(1992-5#1)(1995-12#2)(1997-4#1)(2008-10#1)
10(-6) and 1##6##3##(1995-11#2)(2008-10#4)
10(-6) and##11##2##(1995-11#2)(1995-12#1)(2008-10#7)(2008-3#1)
10(-6) cells day(-1)##2##3##(2008-11#2)
10(-6) mol l(-1)##6##3##(2008-10#6)
10(-6) mol##9##2##(2008-10#8)(2013-8#1)
10(-6) to##8##2##(2008-10#8)
10(-6)##87##1##(1990-11#1)(1990-12#1)(1990-8#2)(1991-5#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-9#3)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#3)(1995-12#4)(1996-12#1)(1996-2#3)(1997-2#1)(1997-4#4)(1997-8#1)(2008-10#29)(2008-11#4)(2008-3#10)(2008-4#2)(2008-5#1)(2009-11#1)(2013-8#1)
10(-6)-10(-2) mol l(-1)##2##3##(2008-10#2)
10(-6)-10(-2)##3##1##(2008-10#3)
10(-6)-10(-3) M##2##2##(2008-10#2)
10(-6)-10(-3)##4##1##(2008-10#4)
10(-6)M##8##1##(2008-10#8)
10(-7) M RA##4##3##(1993-9#4)
10(-7) M in##2##3##(1990-11#1)(2008-10#1)
10(-7) M##25##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#4)(1991-5#1)(1993-11#1)(1993-8#1)(1993-9#4)(1995-11#1)(2008-10#8)(2008-11#1)
10(-7) M)##7##2##(1990-5#1)(1992-5#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-4#2)
10(-7) and##3##2##(1990-11#1)(1993-9#1)(2008-10#1)
10(-7) mol dm(-3)##2##3##(2008-10#2)
10(-7) mol l(-1)##8##3##(2008-10#8)
10(-7) mol##13##2##(2008-10#13)
10(-7) to##13##2##(1991-9#1)(2008-10#11)(2008-3#1)
10(-7)##76##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#5)(1990-8#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-8#1)(1993-9#5)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-4#2)(1997-5#1)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-9#1)(2013-8#1)
10(-7)M##8##1##(1993-6#1)(2008-10#7)
10(-8) M of somatostatin released##2##5##(1997-4#2)
10(-8) M##21##2##(1990-5#1)(1991-5#1)(1992-5#2)(1992-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-4#3)(2008-10#9)
10(-8) M)##3##2##(1996-2#1)(1996-5#1)(2008-10#1)
10(-8) and 10(-7) M RA increased##2##6##(1993-9#2)
10(-8) and 10(-7) M RA##3##5##(1993-9#3)
10(-8) and##4##2##(1993-9#3)(2008-10#1)
10(-8) to 10(-6) M##2##4##(1994-9#2)
10(-8) to##11##2##(1994-12#1)(1994-9#2)(2008-10#7)(2013-8#1)
10(-8)##59##1##(1990-5#1)(1991-5#1)(1992-5#3)(1992-8#1)(1993-9#5)(1994-12#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-4#3)(2008-10#24)(2008-3#8)(2009-11#1)(2009-6#1)(2013-8#1)
10(-8))##2##1##(2007-12#1)(2012-3#1)
10(-8)moll(-1)##3##1##(2008-10#3)
10(-9) M for##3##3##(1993-11#1)(1993-9#1)(2008-10#1)
10(-9) M##20##2##(1990-11#1)(1990-7#1)(1991-5#1)(1993-11#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-4#3)(2008-10#7)
10(-9) and##7##2##(1995-11#1)(2008-10#5)(2008-3#1)
10(-9) mol##2##2##(2008-10#2)
10(-9) to##3##2##(1995-12#1)(2008-10#2)
10(-9)##57##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-11#2)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#1)(1996-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#19)(2008-2#2)(2008-3#7)(2008-8#1)(2010-1#1)(2011-2#2)
10(-9)M##5##1##(1994-6#1)(2008-10#4)
10(-9)mol##3##1##(2008-10#3)
10(10) M-1)##2##2##(1991-8#1)(1994-8#1)
10(10)##11##1##(1991-8#1)(1993-6#1)(1994-8#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)
10(10))##2##1##(2008-3#1)(2008-7#1)
10(11)##6##1##(2007-12#1)(2008-3#1)(2008-8#3)(2010-1#1)
10(12) s(-1)##2##2##(1996-7#2)
10(12)##10##1##(1994-12#1)(1996-7#2)(2007-12#2)(2008-3#3)(2008-7#1)(2008-9#1)
10(13)##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
10(17)##2##1##(2008-11#1)(2008-3#1)
10(18)##3##1##(2007-11#1)(2008-3#2)
10(2) to##3##2##(2008-10#1)(2008-4#1)(2009-7#1)
10(2)##11##1##(1995-2#1)(2008-10#4)(2008-4#1)(2009-3#1)(2009-6#1)(2009-7#1)(2012-2#1)(2013-8#1)
10(3) and##4##2##(2008-10#3)(2008-3#1)
10(3) cells##3##2##(1991-11#1)(2008-10#2)
10(3) to##5##2##(2008-10#4)(2008-2#1)
10(3)##59##1##(1990-2#1)(1991-11#2)(1991-12#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-12#4)(1996-5#1)(1997-7#5)(2007-12#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)(2013-8#1)
10(3)/mm(3))##2##1##(2010-2#2)
10(4##3##1##(2008-10#2)(2012-3#1)
10(4) CFU per##2##3##(2008-10#2)
10(4) CFU/cm(2)##2##2##(2008-10#2)
10(4) CFU/g of##3##3##(2008-10#3)
10(4) cells##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
10(4) to 10(5)##2##3##(2008-10#2)
10(4) to 10(6)##3##3##(1995-2#1)(2008-10#2)
10(4) to##7##2##(1995-2#1)(2008-10#6)
10(4)##65##1##(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#4)(1995-8#1)(1995-9#2)(1996-7#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-6#1)
10(4)-10(5) CFU/ml)##2##2##(2012-2#2)
10(4)-10(5)##3##1##(2008-8#1)(2012-2#2)
10(4)-fold##3##1##(1995-2#1)(2008-10#2)
10(5) CFU/g##2##2##(2008-10#2)
10(5) M-1##2##2##(1992-10#1)(1995-2#1)
10(5) and##5##2##(1994-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
10(5) cells##7##2##(1995-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-6#1)
10(5) theoretical plates##2##3##(2008-10#2)
10(5) times##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
10(5) to 10(7)##2##3##(2008-10#2)
10(5) to##4##2##(1996-7#1)(2008-10#3)
10(5)##84##1##(1990-5#2)(1992-10#1)(1992-7#1)(1993-12#1)(1994-5#4)(1994-8#1)(1995-2#4)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-12#2)(2008-10#36)(2008-11#6)(2008-2#2)(2008-3#10)(2008-7#1)(2008-9#2)(2010-4#2)(2010-6#1)(2012-2#1)(2013-8#1)
10(5))##6##1##(1991-9#1)(1997-2#1)(1997-9#1)(2008-10#2)(2008-4#1)
10(5)-10(6)##2##1##(1997-5#1)(2008-3#1)
10(5)-fold##3##1##(1992-5#1)(1995-2#1)(1995-5#1)
10(6##3##1##(2008-10#1)(2008-11#2)
10(6) CFU##4##2##(2008-10#4)
10(6) CFU/ml##4##2##(2008-10#3)(2012-2#1)
10(6) V/cm##2##2##(2008-3#2)
10(6) cells ml(-1))##4##3##(2008-11#4)
10(6) cells##15##2##(1991-12#1)(2008-10#2)(2008-11#10)(2011-2#2)
10(6) cells/ml##6##2##(2008-11#4)(2008-7#2)
10(6) for##5##2##(1990-8#1)(2008-2#2)(2008-3#2)
10(6) in##2##2##(1996-5#1)(2008-2#1)
10(6) or##2##2##(1991-11#1)(2008-10#1)
10(6) times##2##2##(1992-3#1)(2008-2#1)
10(6) to##4##2##(1994-5#1)(2008-10#2)(2008-11#1)
10(6)##131##1##(1990-12#2)(1990-8#5)(1991-11#1)(1991-12#4)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1993-1#1)(1993-8#1)(1993-9#1)(1994-5#6)(1995-2#3)(1996-5#2)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#2)(2008-10#33)(2008-11#25)(2008-2#7)(2008-3#12)(2008-6#1)(2008-7#5)(2008-9#3)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
10(6))##4##1##(2008-10#1)(2008-11#1)(2008-3#2)
10(6)-10(7)##2##1##(1997-4#1)(2012-1#1)
10(7) CFU##6##2##(2008-10#6)
10(7) CFU/ml##3##2##(2008-10#3)
10(7) conidia per##3##3##(2008-10#3)
10(7) ml(-1)##2##2##(2008-11#2)
10(7) or##2##2##(2008-10#2)
10(7)##51##1##(1990-8#1)(1991-8#1)(1994-5#2)(1995-2#4)(1997-5#1)(2007-12#1)(2008-10#21)(2008-11#11)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-1#3)(2012-3#1)
10(7))##2##1##(1990-12#1)(2010-11#1)
10(8) CFU/ml##2##2##(2008-10#2)
10(8) CFU/ml)##3##2##(2008-10#3)
10(8) and##4##2##(1990-12#1)(1996-7#1)(1997-5#1)(2007-11#1)
10(8) pfu##2##2##(2008-9#2)
10(8) to##2##2##(2008-10#2)
10(8)##36##1##(1990-12#3)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-8#1)(1996-2#1)(1996-7#1)(1997-5#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#2)(2012-2#2)
10(9) CFU/ml##3##2##(2008-10#3)
10(9) cells##5##2##(2008-10#2)(2008-11#3)
10(9) pfu##2##2##(2008-9#2)
10(9)##45##1##(1990-11#2)(1995-2#1)(1997-1#1)(1997-5#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#4)(2008-2#4)(2008-3#8)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2010-4#1)(2012-2#3)
10) and the##2##3##(2008-10#1)(2008-3#1)
10) and##9##2##(1993-12#1)(1995-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
10) at##2##2##(2008-10#2)
10) or##3##2##(1995-12#2)(2013-1#1)
10) were##4##2##(2008-10#2)(2011-1#2)
10) with##2##2##(2008-10#1)(2011-1#1)
10)##96##1##(1990-3#1)(1990-7#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#3)(1993-6#1)(1994-2#1)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#3)(1996-4#1)(1996-5#1)(1996-7#2)(1997-3#1)(2007-10#3)(2007-8#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-2#4)(2011-1#6)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#1)
10+/-0##2##1##(2008-10#2)
10- and##7##2##(1990-12#1)(1994-8#1)(2008-10#3)(2008-3#1)(2010-8#1)
10- or##2##2##(1995-12#1)(2008-3#1)
10- to##7##2##(1992-9#1)(1994-2#1)(1996-12#2)(2008-10#2)(2008-9#1)
10-##23##1##(1990-12#1)(1991-12#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-9#1)(2007-11#3)(2008-10#5)(2008-3#2)(2008-9#1)(2010-8#1)(2013-1#1)
10-0##2##1##(1995-2#1)(2008-10#1)
10-1##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
10-10##3##1##(1990-7#1)(2008-10#1)(2008-11#1)
10-100##10##1##(1991-12#1)(1994-8#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)
10-1000##3##1##(1990-12#1)(1991-2#1)(2008-10#1)
10-11##3##1##(1996-9#1)(2010-5#1)(2013-8#1)
10-12 months##2##2##(1994-11#1)(2013-1#1)
10-12##14##1##(1994-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
10-12%##2##1##(2008-10#1)(2013-7#1)
10-120##2##1##(2008-10#1)(2008-3#1)
10-13##6##1##(1990-6#1)(1995-8#3)(2008-11#1)(2013-1#1)
10-14 days##2##2##(2008-10#1)(2011-1#1)
10-14##6##1##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
10-15 min##3##2##(1995-12#1)(1997-4#1)(2008-10#1)
10-15 years##5##2##(1992-5#1)(1994-2#1)(2008-8#1)(2009-6#1)(2013-8#1)
10-15##14##1##(1991-12#1)(1992-5#1)(1994-2#1)(1995-12#1)(1996-11#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-6#1)(2013-8#1)
10-15% of the##2##3##(2008-10#1)(2008-2#1)
10-15% of##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
10-15%##8##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-2#1)
10-20##13##1##(1991-2#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2010-8#1)
10-20% of cases##2##3##(2008-7#1)(2012-3#1)
10-20% of the##2##3##(1990-9#1)(2008-5#1)
10-20% of##6##2##(1990-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
10-20%##11##1##(1990-9#1)(1992-6#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-3#1)
10-200 mM##2##2##(1993-9#2)
10-200##3##1##(1993-9#2)(2008-11#1)
10-27##2##1##(1995-3#2)
10-30##4##1##(1995-2#1)(2008-12#1)(2008-5#1)(2008-7#1)
10-30% of the##2##3##(2008-10#1)(2008-5#1)
10-30%##5##1##(2007-7#1)(2008-10#2)(2008-5#1)(2012-2#1)
10-4##4##1##(2008-10#2)(2010-2#2)
10-40 degrees C##2##3##(1995-2#1)(2008-9#1)
10-40##8##1##(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
10-40%##2##1##(2008-10#1)(2013-8#1)
10-5 m##2##2##(2008-5#2)
10-5##4##1##(2008-10#2)(2008-5#2)
10-50##4##1##(1990-12#1)(2008-3#2)(2008-6#1)
10-50%##2##1##(1994-2#1)(2008-8#1)
10-6##2##1##(2008-10#1)(2008-11#1)
10-60##5##1##(1995-11#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
10-60%##2##1##(1990-8#1)(1991-3#1)
10-7##2##1##(2008-10#1)(2008-5#1)
10-800##2##1##(2008-10#2)
10-9##2##1##(2008-10#2)
10-90%##2##1##(2007-11#1)(2008-10#1)
10-GHz repetition rate##2##3##(2007-11#1)(2007-12#1)
10-GHz##4##1##(2007-11#3)(2007-12#1)
10-Gbit/s##6##1##(2007-11#1)(2007-12#5)
10-Hydroxy-2-decenoic acid##2##2##(2008-10#2)
10-Hz repetition rate##3##3##(2007-12#1)(2008-2#2)
10-Hz##7##1##(2007-11#1)(2007-12#1)(2008-2#5)
10-Methylenetetrahydrofolate reductase##2##2##(2008-8#2)
10-W##5##1##(2007-11#1)(2008-2#2)(2008-3#2)
10-Year##2##1##(2008-7#1)(2013-1#1)
10-amino acid residue##3##3##(2008-4#3)
10-anthraquinone derivatives in##2##3##(2008-10#2)
10-anthraquinone derivatives##4##2##(2008-10#4)
10-anthraquinone##6##1##(2008-10#6)
10-channel##2##1##(2008-10#1)(2008-3#1)
10-cm##5##1##(2007-12#1)(2008-10#3)(2008-12#1)
10-cm-long##2##1##(2008-3#2)
10-dB##2##1##(2007-11#1)(2008-3#1)
10-day##10##1##(1992-12#1)(2008-10#4)(2008-11#2)(2010-5#2)(2013-8#1)
10-day-old##4##1##(2008-10#4)
10-diaza-2##3##1##(2008-10#3)
10-dideazatetrahydrofolate##2##1##(1995-2#2)
10-dihydro-9##2##1##(2007-11#2)
10-dihydrodiol##2##1##(2011-1#2)
10-dione##3##1##(2008-10#1)(2008-11#2)
10-diphenylanthracene##2##1##(1995-6#1)(2008-10#1)
10-epoxide##2##1##(1992-2#2)
10-fold and##2##2##(1990-7#1)(1992-1#1)
10-fold greater##3##2##(1991-5#1)(1997-4#1)(2010-5#1)
10-fold higher in##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
10-fold higher than that##2##4##(1991-9#1)(1994-6#1)
10-fold higher##6##2##(1991-9#1)(1994-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
10-fold in##2##2##(1995-6#1)(1996-3#1)
10-fold increase in the##2##4##(1992-3#1)(2008-11#1)
10-fold increase in##5##3##(1990-6#1)(1992-3#1)(2008-10#1)(2008-11#1)(2010-1#1)
10-fold increase##6##2##(1990-6#1)(1992-3#2)(2008-10#1)(2008-11#1)(2010-1#1)
10-fold lower##2##2##(1993-3#1)(1994-6#1)
10-fold molar excess##2##3##(1992-6#1)(1993-11#1)
10-fold more##5##2##(1990-12#1)(1992-9#1)(1995-3#1)(1995-8#2)
10-fold over##3##2##(1997-3#2)(2008-7#1)
10-fold stimulation##2##2##(1994-12#1)(2011-1#1)
10-fold when##2##2##(2008-10#1)(2008-7#1)
10-fold##62##1##(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-3#1)(1997-3#3)(1997-4#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#2)(2010-1#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
10-fold)##2##1##(1992-12#1)(1993-12#1)
10-fs##2##1##(2007-11#1)(2008-3#1)
10-item##3##1##(2008-11#1)(2008-12#1)(2008-9#1)
10-kDa proguanylin##2##2##(1994-12#2)
10-kDa##3##1##(1990-5#1)(1994-12#2)
10-mW##2##1##(2007-11#1)(2008-2#1)
10-mer primers##2##2##(2008-10#1)(2008-8#1)
10-mer##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
10-methylene-THF##3##1##(1990-7#3)
10-methylenetetrahydrofolate##4##1##(1990-7#2)(1993-11#1)(1997-5#1)
10-mg##2##1##(1990-12#1)(1996-5#1)
10-microm##3##1##(2007-11#1)(2008-3#2)
10-min##4##1##(1994-2#1)(1996-5#1)(2008-10#1)(2012-1#1)
10-mm##2##1##(2007-12#1)(2012-2#1)
10-month##4##1##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
10-month-old##4##1##(1994-12#2)(2007-8#1)(2008-11#1)
10-mum##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
10-mum-thick##2##1##(2007-12#1)(2008-3#1)
10-mus##2##1##(2007-11#1)(2008-2#1)
10-nm##7##1##(1996-12#1)(2007-12#3)(2008-2#1)(2008-3#1)(2011-2#1)
10-ns##2##1##(2008-2#1)(2008-3#1)
10-phenanthrolinate) on##2##2##(2008-10#2)
10-phenanthrolinate)##3##1##(2008-10#3)
10-phenanthroline (phen) and##2##3##(1996-2#1)(2008-10#1)
10-phenanthroline (phen)##6##2##(1996-2#1)(2008-10#5)
10-phenanthroline and##4##2##(2008-10#4)
10-phenanthroline as complexing agent##2##4##(2008-10#2)
10-phenanthroline as##6##2##(2008-10#6)
10-phenanthroline complex##3##2##(2008-10#3)
10-phenanthroline sub-unit##2##2##(2008-10#2)
10-phenanthroline##43##1##(1996-2#2)(2008-10#41)
10-phenanthroline)##2##1##(2008-10#1)(2013-1#1)
10-phenanthroline-5##2##1##(2008-6#2)
10-phenantroline##3##1##(1996-2#1)(2008-10#2)
10-s##3##1##(1996-12#1)(2008-10#2)
10-second##3##1##(1995-6#1)(2008-11#1)(2010-8#1)
10-times##3##1##(1990-5#1)(1994-5#1)(1994-8#1)
10-undecenoic##2##1##(2008-5#2)
10-week##6##1##(2012-12#3)(2012-3#1)(2013-1#2)
10-year actuarial##3##2##(1991-8#2)(2008-3#1)
10-year experience##2##2##(1991-2#1)(2008-9#1)
10-year period##12##2##(1990-10#1)(1991-8#1)(1992-2#1)(1993-2#1)(1997-2#1)(1997-6#1)(2007-2#1)(2008-10#3)(2008-7#2)
10-year results##2##2##(1993-11#1)(2009-5#1)
10-year survival rates##2##3##(2007-8#1)(2011-2#1)
10-year survival##4##2##(1996-9#1)(2007-8#1)(2010-3#1)(2011-2#1)
10-year survivorship##2##2##(2013-1#2)
10-year##49##1##(1990-10#1)(1991-2#2)(1991-8#3)(1991-9#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#6)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
10-year-old girl##2##2##(2008-7#1)(2012-12#1)
10-year-old##7##1##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2012-12#1)(2013-1#1)
10/100##2##1##(2007-12#1)(2008-10#1)
10/11##3##1##(1991-2#1)(1993-9#1)(2012-3#1)
10/16##2##1##(1992-2#1)(2007-2#1)
10/h##4##1##(2008-6#4)
10/lb##2##1##(2008-6#2)
100 % of##2##3##(2012-12#2)
100 +/- 1##2##3##(2008-10#2)
100 +/- 5##2##3##(1995-3#1)(1995-6#1)
100 +/-##6##2##(1991-6#1)(1995-3#1)(1995-6#1)(2008-10#3)
100 000 and##2##3##(2008-10#1)(2008-5#1)
100 000##9##2##(1996-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)
100 A##2##2##(1995-11#1)(2008-4#1)
100 E coli/100 mL##2##4##(2008-10#2)
100 GHz##6##2##(2007-11#2)(2008-3#4)
100 Hz EA##4##3##(1996-12#4)
100 Hz##9##2##(1996-12#4)(2008-2#1)(2008-3#3)(2010-1#1)
100 K##5##2##(1996-2#2)(2008-2#2)(2008-7#1)
100 L##2##2##(2008-11#1)(2008-6#1)
100 M##2##2##(2008-10#1)(2011-3#1)
100 MHz##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
100 MPa for 20 min##2##5##(2008-11#2)
100 RP-18##2##2##(2008-10#1)(2008-5#1)
100 U ml-1##2##3##(1995-11#1)(1996-2#1)
100 U##3##2##(1995-11#1)(1996-2#1)(2008-11#1)
100 W##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
100 amino acids##4##3##(1995-6#1)(1996-3#1)(1997-3#2)
100 amino##5##2##(1995-6#2)(1996-3#1)(1997-3#2)
100 and 150##3##3##(2007-7#1)(2008-10#1)(2008-12#1)
100 and 200 mg/kg females##2##5##(2008-9#2)
100 and 200 mg/kg##7##4##(1992-5#1)(2008-10#1)(2008-9#3)(2012-2#2)
100 and 200##10##3##(1992-5#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-9#3)(2012-2#2)
100 and 200mg/##2##3##(2013-7#2)
100 and##30##2##(1991-6#1)(1992-5#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-9#3)(2011-2#1)(2012-2#2)(2013-7#2)
100 cases in##2##3##(1993-9#1)(2013-1#1)
100 cases##3##2##(1993-9#1)(2008-10#1)(2013-1#1)
100 cells##3##2##(2008-10#2)(2013-1#1)
100 chlamydospores per##2##3##(2008-10#2)
100 cm##5##2##(2008-10#4)(2008-3#1)
100 cm(-1)##2##2##(2008-10#1)(2008-2#1)
100 codons##2##2##(1996-3#1)(1996-6#1)
100 consecutive patients##2##3##(2006-10#1)(2011-2#1)
100 consecutive##6##2##(1990-2#1)(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
100 days##8##2##(1992-12#1)(1992-4#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
100 degrees C and##2##4##(1994-11#1)(2008-5#1)
100 degrees C for##4##4##(1992-9#1)(1995-2#1)(2007-11#1)(2008-12#1)
100 degrees C##22##3##(1992-9#1)(1994-11#4)(1995-2#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2010-2#1)(2013-8#2)
100 degrees C)##2##3##(2008-10#2)
100 degrees##28##2##(1992-9#1)(1994-11#4)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-3#1)(2010-2#1)(2013-8#2)
100 different##4##2##(2008-7#1)(2008-9#1)(2011-2#2)
100 females##2##2##(1995-6#1)(1997-3#1)
100 for##2##2##(1990-11#1)(2008-10#1)
100 g##3##2##(2008-7#1)(2011-2#2)
100 g/L##3##2##(2008-6#1)(2008-7#2)
100 grams##2##2##(1993-11#1)(2008-10#1)
100 h##2##2##(2007-11#1)(2008-7#1)
100 healthy volunteers##2##3##(2011-2#1)(2012-2#1)
100 healthy##5##2##(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
100 in the##2##3##(1992-2#1)(2007-7#1)
100 in##5##2##(1992-2#1)(2007-7#1)(2008-10#2)(2008-3#1)
100 kDa and##2##3##(2008-10#2)
100 kDa##10##2##(1990-5#2)(1991-9#1)(1995-3#1)(1996-10#1)(2008-10#4)(2009-8#1)
100 kHz##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
100 kW/cm(2)##2##2##(2008-3#2)
100 kbp##2##2##(1993-6#1)(2008-11#1)
100 km##2##2##(1997-5#1)(2010-8#1)
100 l scale##2##3##(2008-11#2)
100 l##6##2##(2008-10#1)(2008-11#5)
100 lice##3##2##(1996-12#3)
100 m##10##2##(1996-4#2)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2010-8#1)
100 m/s##2##2##(2009-7#2)
100 mJ##2##2##(2007-11#1)(2008-10#1)
100 mL##3##2##(2008-6#1)(2008-9#2)
100 mM NaCl solution)##2##4##(2009-12#2)
100 mM alcohol##3##3##(1994-11#3)
100 mM ethanol##2##3##(1992-7#2)
100 mM##16##2##(1992-7#2)(1994-11#3)(1994-9#1)(1996-5#2)(2008-10#4)(2008-7#1)(2009-12#2)(2010-5#1)
100 mV##5##2##(2008-10#5)
100 mW at##2##3##(2007-11#2)
100 mW of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
100 mW##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
100 mg M/kg or##2##4##(2008-5#2)
100 mg M/kg##3##3##(2008-5#3)
100 mg kg(-1) DW##2##4##(2008-12#2)
100 mg kg(-1)##4##3##(2008-12#4)
100 mg l(-1)##5##3##(2008-10#5)
100 mg of##11##3##(1994-5#1)(1996-5#1)(1997-4#1)(2008-10#4)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
100 mg thalidomide or placebo##2##5##(2008-5#2)
100 mg##38##2##(1994-5#1)(1996-5#1)(1997-4#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-12#4)(2008-5#9)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#2)(2012-3#1)
100 mg/L##2##2##(2008-9#2)
100 mg/kg and##2##3##(2008-10#1)(2008-9#1)
100 mg/kg females and##2##4##(2008-9#2)
100 mg/kg females was significantly greater##2##6##(2008-9#2)
100 mg/kg females was##3##4##(2008-9#3)
100 mg/kg females were##3##4##(2008-9#3)
100 mg/kg females##9##3##(2008-9#9)
100 mg/kg males were##6##4##(2008-9#6)
100 mg/kg males##8##3##(2008-9#8)
100 mg/kg##29##2##(1991-3#1)(1992-2#1)(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#21)(2011-2#1)(2013-1#1)
100 mg/kg)##2##2##(2011-2#2)
100 mg/m(2)##3##2##(2007-10#1)(2008-6#2)
100 microL##2##2##(2008-9#1)(2011-1#1)
100 microM ferrous ions##2##4##(1990-12#2)
100 microM forskolin##2##3##(1990-8#1)(1993-3#1)
100 microM to the##2##4##(1995-12#1)(1995-5#1)
100 microM##23##2##(1990-12#3)(1990-2#1)(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-3#1)(1995-11#2)(1995-12#2)(1995-5#2)(1996-2#1)(1997-4#1)(2008-10#1)(2009-6#1)
100 microM)##10##2##(1991-5#1)(1992-8#1)(1992-9#1)(1995-12#3)(1995-3#1)(1997-4#1)(2008-12#1)(2009-12#1)
100 microg##3##2##(1995-12#1)(2008-10#2)
100 micrograms##4##2##(1990-6#1)(1991-12#1)(1992-3#1)(1996-12#1)
100 micrograms/g##2##2##(1990-5#1)(1995-3#1)
100 microm##3##2##(2007-12#1)(2008-3#1)(2010-5#1)
100 microm)##2##2##(2007-12#1)(2008-1#1)
100 micromol L(-1)##2##3##(2008-10#1)(2011-3#1)
100 microns##5##2##(1993-6#1)(1994-5#2)(1995-12#1)(2013-1#1)
100 microseconds##2##2##(1994-3#1)(2008-8#1)
100 million##3##2##(1992-9#1)(1994-5#1)(2008-10#1)
100 ml min(-1)##3##3##(2008-10#2)(2010-4#1)
100 ml of water##2##4##(2008-10#1)(2008-5#1)
100 ml of##5##3##(2008-10#4)(2008-5#1)
100 ml##16##2##(1993-2#1)(2008-10#12)(2008-11#1)(2008-5#1)(2010-4#1)
100 ml)##2##2##(2008-10#1)(2013-1#1)
100 mm##2##2##(2008-10#1)(2008-3#1)
100 mmHg##2##2##(2008-7#1)(2008-8#1)
100 molecules of##2##3##(2008-10#1)(2008-9#1)
100 molecules##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
100 ms##4##2##(2007-11#1)(2008-3#3)
100 muM of##2##3##(2008-10#1)(2008-7#1)
100 muM##6##2##(2008-10#3)(2008-11#1)(2008-7#2)
100 mug l(-1)##11##3##(2008-10#11)
100 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
100 mug of##3##3##(2008-10#3)
100 mug##20##2##(2008-10#19)(2008-11#1)
100 mul of sample##2##4##(2008-10#2)
100 mul of##7##3##(2008-10#7)
100 mul##16##2##(2008-10#14)(2008-4#2)
100 mum PDMS##3##3##(2008-10#3)
100 mum pore##2##3##(2008-11#2)
100 mum##9##2##(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)
100 nM of##2##3##(2008-11#1)(2008-5#1)
100 nM to##2##3##(1994-5#1)(1995-12#1)
100 nM##25##2##(1990-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#3)(1997-4#1)(2008-11#2)(2008-5#1)(2009-11#1)
100 nM)##2##2##(1994-11#1)(1995-3#1)
100 ng ml(-1) of##2##4##(2008-10#2)
100 ng ml(-1)##10##3##(2008-10#10)
100 ng##12##2##(2008-10#11)(2009-6#1)
100 ng/ml could##2##3##(1990-2#1)(1995-6#1)
100 ng/ml##10##2##(1990-2#1)(1995-6#2)(2007-7#4)(2008-10#1)(2008-12#1)(2010-3#1)
100 ng/ml)##4##2##(1990-12#1)(2008-6#2)(2010-5#1)
100 nm with##2##3##(2007-11#2)
100 nm##20##2##(1996-12#1)(1997-3#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-11#1)(2011-1#1)
100 nm)##4##2##(1996-5#1)(2009-11#1)(2010-4#1)(2011-1#1)
100 nmol/L##2##2##(2008-8#2)
100 nmolml(-1)##3##2##(2013-1#3)
100 ns and##2##3##(2007-11#1)(2008-3#1)
100 nt##2##2##(2007-12#2)
100 of##3##2##(1996-3#1)(2010-2#1)(2011-3#1)
100 on##2##2##(1990-8#1)(2008-9#1)
100 or 200##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
100 or##7##2##(1995-3#1)(2008-10#4)(2008-3#1)(2008-5#1)
100 parts per##2##3##(2008-10#1)(2008-2#1)
100 parts##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
100 patients who##3##3##(1996-9#2)(2008-9#1)
100 patients with##3##3##(1990-6#1)(1991-4#1)(1992-9#1)
100 patients##25##2##(1990-6#2)(1990-9#1)(1991-1#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-5#1)(1996-9#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#5)
100 percent juice exposure##2##4##(2012-2#2)
100 percent juice##3##3##(2012-2#3)
100 percent##6##2##(1992-6#1)(1993-3#1)(2008-11#1)(2012-2#3)
100 pg of##2##3##(2008-10#2)
100 pg##3##2##(2008-10#2)(2011-3#1)
100 plant extracts##3##3##(2008-5#3)
100 ppb##2##2##(2008-10#1)(2008-2#1)
100 ppm##5##2##(2008-10#3)(2008-5#2)
100 pregnant women##2##3##(1990-5#1)(2011-1#1)
100 ps##6##2##(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
100 s##6##2##(2008-10#5)(2008-3#1)
100 samples##3##2##(2008-10#2)(2008-2#1)
100 species were##2##3##(2008-8#2)
100 species##3##2##(2007-5#1)(2008-8#2)
100 subjects##3##2##(1990-6#1)(2008-5#1)(2013-1#1)
100 thousand in 2002##2##4##(2013-7#2)
100 thousand in##4##3##(2013-7#4)
100 times excess of##2##4##(2008-10#2)
100 times more sensitive than##2##5##(2008-10#2)
100 times##16##2##(1992-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-3#1)
100 to 10##2##3##(2008-10#1)(2013-8#1)
100 to 150##3##3##(2008-1#1)(2008-11#1)(2008-6#1)
100 to##28##2##(1990-10#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#2)(2013-1#1)(2013-8#1)
100 trials##2##2##(2008-11#1)(2013-8#1)
100 units/ml##2##2##(1994-11#1)(2008-10#1)
100 was achieved##2##3##(2008-10#2)
100 was##4##2##(2008-10#4)
100 x##2##2##(1993-12#1)(2007-11#1)
100 years ago##4##3##(2007-8#1)(2008-11#1)(2008-8#2)
100 years of age##2##4##(2008-7#1)(2012-12#1)
100 years of##3##3##(1996-6#1)(2008-7#1)(2012-12#1)
100 years##20##2##(1992-3#1)(1993-6#1)(1996-6#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-5#1)(2011-2#1)(2012-12#2)
100 °C##4##2##(2010-12#1)(2011-2#3)
100 µg/mL##3##2##(2011-1#3)
100 μmolL(-1)##2##2##(2013-1#2)
100##1120##1##(1990-10#2)(1990-11#1)(1990-12#8)(1990-2#5)(1990-5#4)(1990-6#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#6)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#9)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#7)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#3)(1993-9#3)(1994-11#11)(1994-12#3)(1994-3#4)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#4)(1995-11#9)(1995-12#16)(1995-2#8)(1995-3#6)(1995-5#5)(1995-6#7)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#11)(1996-2#7)(1996-3#7)(1996-4#2)(1996-5#6)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#4)(1997-3#5)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2006-10#3)(2007-10#7)(2007-11#26)(2007-12#25)(2007-2#2)(2007-5#3)(2007-7#12)(2007-8#2)(2008-1#6)(2008-10#300)(2008-11#43)(2008-12#16)(2008-2#25)(2008-3#55)(2008-4#8)(2008-5#38)(2008-6#10)(2008-7#27)(2008-8#18)(2008-9#45)(2009-11#5)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#5)(2010-4#6)(2010-5#8)(2010-7#2)(2010-8#2)(2011-1#19)(2011-2#40)(2011-3#4)(2012-1#2)(2012-12#10)(2012-2#15)(2012-3#4)(2013-1#23)(2013-7#8)(2013-8#14)
100% 5-FU##2##2##(1993-8#2)
100% RH but not##2##4##(2008-10#2)
100% RH but##3##3##(2008-10#3)
100% RH##4##2##(1996-12#1)(2008-10#3)
100% and 100% for Candida##2##5##(2008-5#2)
100% and a##2##3##(1997-3#1)(2008-10#1)
100% and##19##2##(1990-3#1)(1996-12#1)(1997-3#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
100% at##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
100% by##2##2##(2008-10#1)(2008-2#1)
100% correct##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
100% effective##2##2##(2008-9#1)(2010-9#1)
100% efficiency##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
100% for all##2##3##(2008-10#1)(2008-5#1)
100% for##16##2##(1997-2#1)(2008-10#9)(2008-5#3)(2011-2#1)(2013-1#2)
100% higher than that##2##4##(2008-11#2)
100% higher##3##2##(1992-8#1)(2008-11#2)
100% homology with##3##3##(1990-11#1)(1997-4#1)(2011-2#1)
100% homology##4##2##(1990-11#1)(1997-4#1)(2008-10#1)(2011-2#1)
100% identical to##4##3##(1993-2#1)(1993-3#1)(1995-9#2)
100% identical##5##2##(1993-2#1)(1993-3#1)(1995-9#2)(2008-10#1)
100% identity##2##2##(1993-2#1)(1993-8#1)
100% in all##3##3##(2008-10#1)(2011-2#2)
100% in the##3##3##(1990-2#1)(1994-12#1)(2012-12#1)
100% in##13##2##(1990-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#3)(2011-2#3)(2012-12#1)(2012-3#1)
100% of patients with##2##4##(1990-3#1)(1996-1#1)
100% of patients##3##3##(1990-3#1)(1996-1#1)(2008-5#1)
100% of the##7##3##(1993-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
100% of##30##2##(1990-3#1)(1991-2#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
100% on##3##2##(2008-10#2)(2008-6#1)
100% oxygen##6##2##(1993-12#2)(2008-10#2)(2011-2#1)(2012-3#1)
100% polarization##2##2##(2008-3#2)
100% protection##2##2##(2013-1#2)
100% recovery##2##2##(2008-10#2)
100% relative humidity and##3##4##(2008-10#3)
100% relative humidity##6##3##(2008-10#6)
100% relative##7##2##(2008-10#7)
100% sequence##2##2##(1994-11#1)(1997-4#1)
100% specificity##4##2##(2009-8#1)(2010-8#1)(2011-2#2)
100% to##4##2##(1990-6#1)(2008-10#1)(2008-2#1)(2011-1#1)
100% union##2##2##(2012-2#2)
100% water mobile phase##5##4##(2008-10#5)
100% water##6##2##(2008-10#6)
100% were mature at##2##4##(2007-7#2)
100% were observed##2##3##(1990-8#1)(2008-10#1)
100% were obtained##2##3##(2008-10#2)
100% were##8##2##(1990-8#1)(2007-7#2)(2008-10#4)(2008-6#1)
100% with##7##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-9#1)
100%##343##1##(1990-10#2)(1990-11#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#3)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-12#3)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#3)(1997-6#1)(2007-10#3)(2007-11#9)(2007-12#5)(2007-2#1)(2007-7#7)(2007-8#5)(2008-1#2)(2008-10#113)(2008-11#9)(2008-12#5)(2008-2#8)(2008-3#6)(2008-5#16)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#4)(2009-11#1)(2009-4#1)(2009-7#2)(2009-8#4)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#18)(2012-12#4)(2012-2#6)(2012-3#11)(2013-1#8)(2013-7#1)(2013-8#3)
100%) and##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
100%)##19##1##(1996-12#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2010-10#1)(2010-6#1)(2011-2#3)(2013-1#1)
100)##12##1##(1991-2#1)(1993-11#1)(1997-1#1)(2008-10#5)(2008-3#2)(2010-12#1)(2010-8#1)
100+/-1##3##1##(2008-10#3)
100-##3##1##(1994-8#1)(1997-4#1)(2008-10#1)
100-1##2##1##(1994-5#1)(2008-10#1)
100-1000 times of excess of Fe(III)##2##6##(2008-10#2)
100-1000##5##1##(1992-12#1)(1996-12#1)(2008-10#3)
100-110%##2##1##(2008-10#1)(2013-1#1)
100-150##4##1##(1990-9#1)(1993-11#1)(1997-3#1)(2013-1#1)
100-200##9##1##(1995-2#1)(1995-6#1)(1996-11#1)(2008-10#4)(2008-3#1)(2008-7#1)
100-2000##2##1##(2008-10#2)
100-250##2##1##(2008-10#1)(2008-3#1)
100-300##2##1##(1996-5#1)(2008-10#1)
100-Gbit/s word##2##2##(2008-3#2)
100-Gbit/s##4##1##(2007-12#1)(2008-3#3)
100-fold greater##2##2##(1995-6#1)(2008-10#1)
100-fold higher than##2##3##(1992-6#1)(2008-10#1)
100-fold more##3##2##(1994-5#1)(2008-11#2)
100-fold##29##1##(1991-12#1)(1992-6#1)(1992-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-2#2)(2008-10#12)(2008-11#5)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
100-fs pulses at##2##3##(2007-12#2)
100-fs pulses##5##2##(2007-11#1)(2007-12#4)
100-fs##11##1##(2007-11#4)(2007-12#6)(2008-3#1)
100-kb##2##1##(2008-10#2)
100-km##2##1##(2007-11#1)(2007-12#1)
100-m##2##1##(2007-11#1)(2008-8#1)
100-mJ##3##1##(2007-11#3)
100-mW average##2##2##(2007-11#2)
100-mW##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
100-microm##2##1##(2007-12#2)
100-mum##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
100-nm##4##1##(2008-2#3)(2008-7#1)
100-percent##3##1##(1997-2#1)(2010-8#2)
100-μl##2##1##(2013-1#2)
1000 PST##2##2##(2008-10#2)
1000 and##8##2##(2007-11#1)(2008-10#6)(2008-7#1)
1000 cc##3##2##(2008-5#3)
1000 cm(-1)##2##2##(2008-2#1)(2008-3#1)
1000 degrees C##4##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)
1000 g or##2##3##(1991-6#1)(2008-11#1)
1000 g##3##2##(1991-6#1)(2007-11#1)(2008-11#1)
1000 h##5##2##(1990-3#2)(2007-12#1)(2008-10#1)(2008-11#1)
1000 lines/mm##2##2##(2007-12#1)(2008-2#1)
1000 m##6##2##(1996-12#4)(2008-3#1)(2008-8#1)
1000 mGy##2##2##(2008-7#2)
1000 mg##4##2##(1994-6#1)(2007-10#1)(2008-10#2)
1000 mg/kg B##2##3##(2013-1#2)
1000 mg/kg per day##5##4##(1995-3#5)
1000 mg/kg##11##2##(1995-3#7)(2008-7#1)(2012-2#1)(2013-1#2)
1000 microM)##2##2##(1997-7#1)(2009-6#1)
1000 ml##5##2##(2008-10#5)
1000 mug##3##2##(2008-10#3)
1000 mul##2##2##(2008-10#2)
1000 ng/0##2##2##(1995-12#2)
1000 nm##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
1000 ppm##4##2##(1995-11#1)(2008-10#2)(2008-3#1)
1000 times more##2##3##(1997-5#1)(2008-10#1)
1000 times##6##2##(1990-7#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
1000 to 1400##2##3##(2008-10#2)
1000 to##4##2##(2008-10#3)(2008-2#1)
1000 unrelated individuals from the Lodz region of Poland##2##9##(2008-12#2)
1000 x##2##2##(2007-12#1)(2008-3#1)
1000##187##1##(1990-3#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#8)(1995-5#2)(1995-6#1)(1996-12#5)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-5#4)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#13)(2007-8#1)(2008-10#39)(2008-11#8)(2008-12#5)(2008-2#8)(2008-3#11)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#2)(2010-1#2)(2010-2#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
1000)##6##1##(1995-5#1)(1997-2#3)(2008-10#1)(2008-11#1)
1000-1200 degrees C##2##3##(1995-6#1)(2007-11#1)
1000-1200##3##1##(1995-6#1)(2007-11#1)(2008-3#1)
1000-2000##2##1##(2008-10#1)(2008-3#1)
1000-W##3##1##(2008-11#1)(2008-3#2)
1000-fold##10##1##(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#4)(2008-8#1)
1000-kernel weight##2##2##(2008-12#2)
10000##2##1##(2008-10#1)(2011-3#1)
1000ml##3##1##(2008-10#3)
1000 µg/L##3##1##(2013-1#3)
1002/tcr##3##1##(2011-2#3)
1003##2##1##(2008-3#2)
1008##2##1##(1993-12#1)(2008-11#1)
100K##3##1##(1993-9#1)(2009-8#2)
100g##2##1##(2008-10#1)(2010-4#1)
100mL##2##1##(2008-10#2)
100mM##4##1##(2008-10#3)(2011-2#1)
100mg of##4##2##(2008-10#3)(2011-2#1)
100mg##5##1##(2008-10#4)(2011-2#1)
100ml of##2##2##(2008-10#2)
100ml##4##1##(2008-10#4)
100ms##2##1##(2008-10#2)
100mug/L##2##1##(2008-10#2)
100mugL(-1)##3##1##(2008-10#3)
100mugl(-1) of##2##2##(2008-10#2)
100mugl(-1)##5##1##(2008-10#5)
100mugml(-1)##2##1##(2008-10#2)
100mul##3##1##(2008-10#3)
100mum##2##1##(2007-11#1)(2008-10#1)
100nM##2##1##(1992-12#1)(2008-10#1)
100ngml(-1)##2##1##(2008-10#2)
100pmoll(-1)##3##1##(2008-10#3)
100x##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
101 patients with##2##3##(1992-5#1)(2008-8#1)
101 patients##7##2##(1992-1#1)(1992-5#1)(1993-9#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
101##70##1##(1990-11#1)(1990-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-9#2)(1994-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
101% for##3##2##(2008-10#3)
101%##10##1##(2008-10#10)
101)##3##1##(1996-7#1)(2008-8#1)(2009-10#1)
101-109##2##1##(2006-6#2)
1011##2##1##(1991-6#1)(2010-6#1)
1012##3##1##(1996-7#1)(2008-1#1)(2013-8#1)
1014##2##1##(2008-10#1)(2008-12#1)
1015 (1999)]##2##2##(2008-3#2)
1015##4##1##(2008-11#2)(2008-3#2)
1016##2##1##(2011-2#1)(2012-3#1)
1016/j##8##1##(2008-11#5)(2008-7#1)(2010-4#1)(2012-3#1)
1018##2##1##(2011-1#1)(2011-2#1)
101F6 protein##4##2##(2009-9#4)
101F6##5##1##(2009-9#5)
102 +/-##2##2##(1993-12#1)(1995-2#1)
102 kd##2##2##(1991-5#2)
102 patients with##3##3##(1990-8#1)(1993-9#1)(2007-8#1)
102 patients##11##2##(1990-8#1)(1993-9#1)(1994-9#1)(2007-10#1)(2007-11#4)(2007-8#2)(2008-8#1)
102 strains##2##2##(2008-10#2)
102##75##1##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-5#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#5)(2007-7#1)(2007-8#2)(2008-10#23)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)
102%##10##1##(1995-2#1)(2008-10#9)
1020##3##1##(1992-6#1)(2008-12#1)(2008-2#1)
1024##4##1##(2007-11#2)(2008-10#1)(2008-2#1)
1026##2##1##(1997-6#1)(2007-7#1)
1028##2##1##(1997-4#1)(2007-11#1)
103 cases##4##2##(1991-8#1)(2008-5#1)(2008-9#1)(2011-2#1)
103 patients##4##2##(1991-8#1)(1994-2#1)(1995-5#1)(2007-11#1)
103 women##2##2##(2010-8#1)(2011-2#1)
103 x magnification of##2##4##(2007-12#2)
103##61##1##(1990-2#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-2#1)(1994-2#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-12#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#14)(2008-3#3)(2008-5#2)(2008-8#3)(2008-9#4)(2009-11#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
103% for##6##2##(2008-10#6)
103%##16##1##(2008-10#15)(2011-1#1)
1032##3##1##(2007-11#1)(2007-12#1)(2009-9#1)
1035##2##1##(2007-8#1)(2008-2#1)
104 cases##2##2##(2007-8#2)
104 infants##2##2##(2011-2#2)
104 participants##2##2##(1997-3#1)(2008-8#1)
104 patients##2##2##(2011-2#1)(2012-3#1)
104##63##1##(1991-1#1)(1991-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-8#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#2)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#3)(2013-7#1)
104% were obtained##2##3##(2008-10#2)
104%##11##1##(2008-10#11)
104-THz##2##1##(2007-12#2)
1040##3##1##(1997-7#1)(2007-11#1)(2007-2#1)
1043##2##1##(1990-6#1)(2008-2#1)
1044##2##1##(2008-2#1)(2013-1#1)
1045##2##1##(2007-12#2)
1046##2##1##(2008-3#1)(2012-3#1)
1047-1051##2##1##(2008-11#1)(2008-3#1)
1047-nm##4##1##(2008-3#4)
105 A-group isolates##2##3##(2008-10#2)
105 and##3##2##(1995-12#1)(2008-10#2)
105 cases of##2##3##(1991-8#1)(2013-1#1)
105 cases##3##2##(1991-8#1)(2013-1#2)
105 degrees##3##2##(2008-10#2)(2009-3#1)
105 kDa##3##2##(1990-7#1)(1995-12#1)(2008-10#1)
105 patients##2##2##(2008-7#1)(2012-3#1)
105##77##1##(1990-11#1)(1990-2#3)(1990-7#1)(1991-8#1)(1993-11#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
105%##14##1##(2008-10#12)(2008-6#1)(2008-7#1)
105)##2##1##(1994-7#1)(2010-3#1)
105-kDa##2##1##(1993-11#2)
1050 nm##3##2##(2007-11#1)(2008-2#2)
1050##5##1##(1994-11#1)(2007-11#1)(2008-2#2)(2009-8#1)
1051##6##1##(2007-11#1)(2008-10#4)(2008-11#1)
1052##2##1##(1991-11#1)(2008-3#1)
1054##8##1##(1994-11#1)(1995-8#3)(2007-12#2)(2008-2#1)(2011-3#1)
1059##4##1##(1994-11#1)(1995-2#1)(2008-10#2)
106 (74##2##2##(2007-7#2)
106 individuals##2##2##(1993-3#1)(2012-3#1)
106 involved##2##2##(2011-2#2)
106 isolates of##2##3##(2008-10#2)
106 patients##5##2##(1997-8#1)(2007-8#2)(2011-2#1)(2012-3#1)
106##53##1##(1990-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)
106%##11##1##(1995-2#1)(2008-10#9)(2011-1#1)
1060 nm##3##2##(2007-11#1)(2007-12#2)
1060##4##1##(2007-11#1)(2007-12#2)(2008-11#1)
1061##3##1##(2007-11#1)(2008-1#1)(2012-12#1)
1064 and##3##2##(2007-11#2)(2007-12#1)
1064 nm and##3##3##(2007-12#1)(2008-3#2)
1064 nm with##2##3##(2007-12#1)(2008-2#1)
1064 nm##28##2##(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#6)(2008-3#12)
1064 nm)##2##2##(2007-12#1)(2008-3#1)
1064##37##1##(2007-11#6)(2007-12#5)(2008-10#3)(2008-2#8)(2008-3#15)
1064-nm Nd##3##2##(2008-2#2)(2008-3#1)
1064-nm pump##2##2##(2007-12#1)(2008-3#1)
1064-nm radiation##2##2##(2007-12#1)(2008-3#1)
1064-nm##13##1##(2007-12#3)(2008-2#3)(2008-3#7)
10644##5##1##(2008-10#5)
1064nm##2##1##(2007-11#1)(2007-12#1)
1066##2##1##(2008-10#2)
1068 nm##2##2##(2007-11#2)
1068##3##1##(1997-3#1)(2007-11#2)
1069##2##1##(1992-1#1)(1992-8#1)
107 patients with##2##3##(2011-2#1)(2013-1#1)
107 patients##3##2##(2011-2#2)(2013-1#1)
107##36##1##(1991-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-8#1)(1996-2#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#3)
107%##4##1##(2008-10#3)(2011-1#1)
108 mug##2##2##(2008-10#2)
108 patients##4##2##(2007-8#1)(2008-1#1)(2013-1#2)
108##43##1##(1990-6#1)(1991-5#1)(1994-8#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-3#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-1#3)
1084-nm##2##1##(2007-11#2)
1088##2##1##(1997-6#1)(2008-2#1)
109 children##2##2##(2007-8#1)(2010-5#1)
109 patients##2##2##(1992-6#1)(2010-3#1)
109##36##1##(1990-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
109%##5##1##(2008-10#4)(2008-5#1)
109)##4##1##(1992-11#1)(1997-2#3)
1091##2##1##(2007-8#1)(2008-3#1)
1093##3##1##(1990-8#1)(1994-3#1)(2008-10#1)
1095##3##1##(1991-12#1)(1994-11#1)(2007-11#1)
1098##2##1##(2008-10#1)(2008-11#1)
10Dq##2##1##(1997-7#2)
10HDA##3##1##(2008-10#3)
10L##4##1##(2008-11#2)(2008-5#1)(2010-8#1)
10M##2##1##(2008-10#2)
10V##3##1##(2008-10#1)(2013-1#2)
10Z-syn##3##1##(1990-8#1)(1992-3#2)
10]##2##1##(1991-2#1)(2008-11#1)
10a beta##2##2##(1990-11#2)
10a##3##1##(1990-11#2)(2008-10#1)
10cm of##2##2##(2008-10#2)
10cm##4##1##(2008-10#3)(2013-7#1)
10gl(-1)##2##1##(2008-10#1)(2013-1#1)
10h(-1)##4##1##(2008-10#4)
10kDa##2##1##(2007-12#1)(2008-10#1)
10mL##3##1##(2008-10#3)
10mM phosphate##2##2##(2008-10#2)
10mM sodium##2##2##(2008-10#2)
10mM were found##2##3##(2008-10#2)
10mM##14##1##(1990-11#1)(2008-10#12)(2011-2#1)
10mg of##2##2##(2008-10#1)(2008-7#1)
10mg once daily##2##3##(2008-3#2)
10mg##10##1##(2008-10#3)(2008-3#6)(2008-7#1)
10mg/l##2##1##(2008-10#2)
10mgL(-1)##2##1##(2008-10#2)
10mgl(-1)##3##1##(2008-10#3)
10min and##2##2##(2008-10#2)
10min##25##1##(2008-10#25)
10ml##7##1##(2008-10#7)
10mmoll(-1)##2##1##(2008-10#2)
10muM##5##1##(2008-10#5)
10mug##2##1##(2008-10#2)
10mugL(-1)##3##1##(2008-10#3)
10mugl(-1) of##2##2##(2008-10#2)
10mugl(-1)##6##1##(2008-10#6)
10mugml(-1)##6##1##(2008-10#6)
10mul of##3##2##(2008-10#3)
10mul##7##1##(2008-10#7)
10mum##3##1##(2007-11#1)(2008-10#1)(2008-2#1)
10mumol/L##2##1##(2008-10#2)
10nM##4##1##(2008-10#4)
10ngmL(-1)##3##1##(2008-10#3)
10ngml(-1)##10##1##(2008-10#10)
10pM##2##1##(1992-8#1)(2008-10#1)
10ppb##3##1##(2008-10#3)
10ppm##3##1##(2008-10#3)
10s and##3##2##(2008-10#3)
10s##12##1##(2008-10#9)(2008-11#1)(2008-4#1)(2013-1#1)
10s)##3##1##(2008-10#3)
10th Annual##2##2##(2010-11#1)(2010-4#1)
10th day##2##2##(2008-5#1)(2012-3#1)
10th##19##1##(1991-11#1)(1991-2#1)(1992-3#1)(1995-3#1)(1996-6#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
10x##7##1##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#2)(2011-2#1)
10°C##6##1##(2011-2#6)
10 min##2##1##(2011-1#1)(2013-1#1)
10 mg benazepril##2##2##(2012-3#2)
11 (0##2##2##(2008-12#1)(2011-1#1)
11 (1##2##2##(2012-3#1)(2013-1#1)
11 (10##2##2##(2007-8#2)
11 (73##2##2##(2013-7#2)
11 (9##2##2##(2011-2#2)
11 +/-##3##2##(1995-12#1)(2008-5#1)(2011-2#1)
11 -##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
11 May 2007]##2##3##(2009-5#2)
11 against##2##2##(2012-3#2)
11 and 1##2##3##(2007-11#1)(2008-9#1)
11 and 12##7##3##(1990-8#1)(1996-12#1)(1996-5#1)(2008-3#1)(2008-4#1)(2009-8#1)(2013-8#1)
11 and 13##2##3##(1996-5#1)(2008-3#1)
11 and 19##3##3##(1990-11#1)(1990-2#1)(1995-6#1)
11 and 8##2##3##(2008-9#1)(2013-1#1)
11 and a##2##3##(2008-10#1)(2008-12#1)
11 and##40##2##(1990-11#1)(1990-2#1)(1990-8#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#11)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
11 are##2##2##(1995-5#1)(2008-5#1)
11 at##2##2##(1991-3#1)(2008-10#1)
11 beta-hydroxylation##3##2##(1990-11#3)
11 beta-hydroxysteroid dehydrogenase##3##3##(1990-11#2)(1996-5#1)
11 by##4##2##(1996-3#1)(1997-6#1)(2008-10#2)
11 cDNA library by hybridization to mouse transferase cDNA clone##2##10##(2008-11#2)
11 cDNA library##4##3##(1990-7#1)(2008-11#2)(2008-8#1)
11 cases##9##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-12#1)(1994-7#1)(1995-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
11 children##4##2##(1991-6#1)(2008-12#1)(2010-9#1)(2011-1#1)
11 clones##2##2##(2008-10#1)(2008-9#1)
11 cm##2##2##(2008-9#1)(2013-7#1)
11 compounds##2##2##(2008-10#2)
11 consecutive##2##2##(2008-10#1)(2012-2#1)
11 control##4##2##(1990-12#1)(1996-9#1)(2008-10#1)(2008-7#1)
11 days##7##2##(1993-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2012-12#1)
11 degrees C##5##3##(2008-10#3)(2008-12#2)
11 degrees##6##2##(2008-10#4)(2008-12#2)
11 determinations##2##2##(2008-10#1)(2010-4#1)
11 different##3##2##(2008-10#2)(2008-7#1)
11 female##2##2##(1997-8#1)(2013-8#1)
11 general##2##2##(1991-9#1)(1995-11#1)
11 genes##2##2##(2008-10#2)
11 groups##2##2##(2008-10#2)
11 healthy volunteers##2##3##(2008-7#1)(2011-2#1)
11 in##5##2##(1990-12#1)(1992-6#1)(2008-10#1)(2010-3#1)(2013-1#1)
11 infections##2##2##(2007-2#1)(2013-8#1)
11 isolates of##2##3##(2008-10#2)
11 isolates##6##2##(2008-10#6)
11 kb of genomic DNA##2##5##(1997-6#1)(1997-7#1)
11 kb of##3##3##(1997-6#1)(1997-7#1)(2008-10#1)
11 kb##5##2##(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)
11 mM##3##2##(1995-3#1)(1995-5#1)(1995-8#1)
11 microm relative emissivity##2##4##(2013-8#2)
11 microm##3##2##(2008-3#1)(2013-8#2)
11 million##2##2##(1997-4#1)(2008-10#1)
11 min##2##2##(1995-5#1)(2008-10#1)
11 mm##2##2##(2008-10#1)(2010-8#1)
11 months after##4##3##(2007-6#1)(2007-7#1)(2008-10#1)(2008-9#1)
11 months##17##2##(1990-8#1)(1990-9#1)(1991-6#1)(1993-11#1)(1995-2#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-8#1)
11 new##2##2##(2008-10#1)(2008-9#1)
11 of the##4##3##(1997-5#1)(2008-1#1)(2008-5#1)(2008-7#1)
11 of them##3##3##(1994-8#1)(2008-2#1)(2010-8#1)
11 of whom##2##3##(2010-3#2)
11 of##18##2##(1991-5#1)(1992-2#1)(1994-8#1)(1996-12#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#2)(2010-8#1)(2013-1#2)
11 out of##5##3##(1990-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-8#1)
11 patient with##2##3##(2012-3#2)
11 patient##3##2##(2012-3#3)
11 patients (55%)##2##3##(1996-9#2)
11 patients and##2##3##(1992-5#1)(1996-7#1)
11 patients have##2##3##(2007-11#1)(2008-10#1)
11 patients the##2##3##(1996-9#1)(2007-11#1)
11 patients were##2##3##(1990-6#1)(1995-11#1)
11 patients with##12##3##(1990-6#1)(1992-11#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#2)(2007-8#3)(2008-7#2)
11 patients##48##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#1)(1994-7#1)(1995-11#1)(1996-5#1)(1996-7#1)(1996-9#4)(1997-4#1)(1997-7#1)(2007-11#7)(2007-8#4)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#3)(2010-3#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
11 percent##3##2##(1996-3#1)(1997-3#1)(2012-2#1)
11 potato differentials##2##3##(2008-10#2)
11 potato##3##2##(2008-10#3)
11 red flag items##2##4##(2008-12#2)
11 replicate determinations of##4##4##(2008-10#4)
11 replicate measurements##2##3##(2008-10#2)
11 replicate##8##2##(2008-10#8)
11 samples containing##2##3##(2008-10#2)
11 samples##3##2##(2008-10#3)
11 sites##2##2##(2008-10#1)(2008-9#1)
11 species of##6##3##(1995-8#1)(2008-10#1)(2010-4#1)(2013-1#2)(2013-7#1)
11 species##7##2##(1995-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#2)(2013-7#1)
11 strains of##2##3##(1991-8#1)(2008-10#1)
11 studies##2##2##(2008-6#1)(2011-2#1)
11 subjects##2##2##(1996-8#1)(2013-1#1)
11 times##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
11 to 13##2##3##(2008-10#1)(2012-3#1)
11 to 15##2##3##(2008-9#1)(2013-1#1)
11 to 20##2##3##(1990-7#1)(1995-2#1)
11 to##18##2##(1990-7#1)(1992-3#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#6)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
11 voles##2##2##(1991-8#2)
11 weeks of##2##3##(1992-8#1)(1995-8#1)
11 weeks##5##2##(1991-2#1)(1992-8#1)(1995-8#1)(2008-10#2)
11 were##4##2##(1993-9#1)(1994-12#1)(1995-11#1)(2008-10#1)
11 with##4##2##(1990-3#1)(1991-8#1)(1994-3#1)(2010-3#1)
11 x##4##2##(1993-8#1)(2007-12#1)(2008-10#2)
11 year##4##2##(1996-6#1)(2008-1#1)(2009-10#1)(2012-3#1)
11 years of##3##3##(1995-2#1)(2008-4#1)(2011-2#1)
11 years who##2##3##(1997-2#1)(2008-9#1)
11 years##15##2##(1992-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
11##1030##1##(1990-11#11)(1990-12#5)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#4)(1990-8#8)(1990-9#4)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#5)(1991-8#7)(1991-9#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#4)(1992-6#6)(1992-8#4)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#2)(1993-8#4)(1993-9#4)(1994-1#2)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#2)(1994-6#2)(1994-7#2)(1994-8#3)(1995-11#7)(1995-12#5)(1995-2#6)(1995-3#7)(1995-5#5)(1995-6#6)(1995-8#6)(1995-9#4)(1996-11#1)(1996-12#11)(1996-2#10)(1996-3#3)(1996-5#11)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#7)(1997-2#2)(1997-3#7)(1997-4#8)(1997-5#5)(1997-6#4)(1997-7#9)(1997-8#2)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#10)(2007-11#17)(2007-12#5)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#20)(2008-1#13)(2008-10#229)(2008-11#21)(2008-12#26)(2008-2#5)(2008-3#30)(2008-4#11)(2008-5#27)(2008-6#6)(2008-7#34)(2008-8#11)(2008-9#22)(2009-10#8)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#2)(2010-12#2)(2010-3#8)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#8)(2010-9#3)(2011-1#18)(2011-2#38)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#14)(2012-3#29)(2013-1#41)(2013-7#4)(2013-8#20)
11% and##5##2##(1990-12#1)(1993-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
11% for##4##2##(2007-12#2)(2008-10#1)(2008-2#1)
11% in##2##2##(1992-6#1)(1997-4#1)
11% of the##7##3##(1991-3#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-4#1)
11% of##14##2##(1990-12#1)(1990-6#1)(1991-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2009-2#1)
11% the##2##2##(1990-9#1)(2010-12#1)
11%##72##1##(1990-11#1)(1990-12#2)(1990-6#2)(1990-7#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(2006-8#1)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#15)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#3)(2009-2#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
11%)##6##1##(1996-11#1)(2008-10#1)(2011-2#3)(2012-2#1)
11) =##2##2##(2013-8#2)
11) and##5##2##(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-1#1)
11) at##2##2##(1991-11#1)(2010-3#1)
11) have##2##2##(1996-3#1)(2012-3#1)
11) of##2##2##(2008-10#1)(2008-8#1)
11) were##3##2##(2008-10#1)(2010-1#1)(2010-8#1)
11)##48##1##(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-10#1)(1996-3#2)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
11+/-0##2##1##(2008-10#2)
11-##2##1##(2008-7#1)(2013-1#1)
11-0##4##1##(1995-12#1)(2008-10#2)(2008-5#1)
11-12##8##1##(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
11-13 years##2##2##(2009-12#1)(2012-2#1)
11-13##4##1##(1990-3#1)(2008-3#1)(2009-12#1)(2012-2#1)
11-14 weeks of gestation##2##4##(2008-11#2)
11-14##7##1##(1996-9#1)(2008-11#2)(2009-7#1)(2010-10#1)(2010-3#1)(2011-1#1)
11-15##8##1##(1991-12#1)(1993-12#2)(1995-6#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-1#1)
11-15%##2##1##(1995-2#1)(2008-8#1)
11-18##3##1##(2008-10#1)(2009-7#1)(2012-12#1)
11-20##3##1##(2008-8#1)(2010-7#1)(2011-2#1)
11-5##2##1##(1996-5#1)(2008-3#1)
11-KT##2##1##(2010-8#2)
11-aza-(20S)-camptothecin##3##1##(1995-3#3)
11-azacamptothecin analogs##2##2##(1995-3#2)
11-beta##2##1##(1996-5#2)
11-day-old##2##1##(1997-6#1)(2008-1#1)
11-deoxycorticosterone##4##1##(1990-11#2)(1990-5#1)(2008-4#1)
11-diene##2##1##(2008-10#2)
11-hydroxynaphthacene-5##2##1##(2008-10#2)
11-mm/h##2##1##(2008-10#2)
11-month-old##5##1##(1994-6#1)(2008-12#3)(2012-3#1)
11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol##2##1##(2013-1#2)
11-point##3##1##(2007-8#1)(2008-12#1)(2012-2#1)
11-tetraazacyclotetradeca-4##2##1##(1997-7#1)(2008-10#1)
11-year-old boy##7##2##(2008-1#1)(2008-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
11-year-old child##2##2##(2008-10#1)(2008-11#1)
11-year-old##15##1##(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
11/12##2##1##(1990-8#1)(1996-2#1)
110 amino##2##2##(1992-3#1)(1995-5#1)
110 and##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
110 days##5##2##(1992-12#1)(2008-10#2)(2013-8#2)
110 isolates##3##2##(2008-10#3)
110 kDa and##3##3##(1993-6#1)(2009-2#1)(2011-1#1)
110 kDa##6##2##(1990-11#1)(1993-6#1)(1995-12#1)(1995-6#1)(2009-2#1)(2011-1#1)
110 mW##2##2##(2007-11#1)(2007-12#1)
110 mg##2##2##(2008-10#1)(2008-11#1)
110 microM and##2##3##(1992-3#1)(1995-8#1)
110 microm##3##2##(2008-3#1)(2009-8#2)
110 min##2##2##(1993-1#1)(2013-8#1)
110 nm##2##2##(2007-12#1)(2008-10#1)
110 patients##3##2##(1996-7#1)(2007-7#1)(2011-3#1)
110##84##1##(1990-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#3)(1992-8#2)(1993-1#1)(1993-6#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#2)(2007-11#1)(2007-12#6)(2007-7#5)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#3)
110%##6##1##(2008-10#5)(2013-8#1)
110-fold##2##1##(1995-3#1)(2008-10#1)
110-fs##2##1##(2007-11#1)(2007-12#1)
110-kDa protein##2##2##(1993-12#2)
110-kDa##3##1##(1993-12#2)(1995-6#1)
1100 and##2##2##(2008-10#2)
1100 degrees C##5##3##(2008-10#3)(2010-4#2)
1100##18##1##(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-7#2)(2009-7#1)(2010-4#2)(2011-1#1)
1100-kb chromosome##2##2##(1996-6#2)
1100-kb##3##1##(1996-6#3)
1101 subjects##2##2##(2008-3#2)
1103##2##1##(1996-8#1)(2008-3#1)
110 ms##2##1##(2012-2#2)
111 patients##3##2##(1990-2#1)(1992-11#1)(2013-1#1)
111##28##1##(1990-2#1)(1992-11#1)(1993-5#2)(1994-11#1)(1994-12#1)(1994-7#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
111%##3##1##(1996-5#1)(2008-10#2)
1115 waivers##2##2##(1996-1#2)
1115##8##1##(1996-1#7)(2008-1#1)
11195 to##2##2##(2008-6#1)(2012-2#1)
11195##4##1##(2008-6#1)(2012-2#3)
112 mug/ml##3##2##(2008-10#3)
112 of which##2##3##(2008-10#2)
112 participants##2##2##(2008-11#1)(2012-12#1)
112 patients##3##2##(1990-3#1)(2011-2#1)(2013-1#1)
112 with##2##2##(1993-12#1)(2008-10#1)
112##53##1##(1990-11#1)(1990-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#4)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-4#1)(2009-11#1)(2009-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
112% for##2##2##(2008-10#2)
112%##5##1##(1993-3#1)(2008-10#4)
112)##2##1##(1990-2#1)(2011-1#1)
1124##2##1##(2007-8#1)(2008-6#1)
1129##2##1##(1996-12#1)(1996-6#1)
113##32##1##(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-7#1)(1995-12#2)(1996-12#2)(1996-2#4)(1997-5#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
113)##2##1##(1991-2#1)(2013-1#1)
114 Saudi##2##2##(2008-4#2)
114 amino acids##3##3##(1994-11#1)(1994-12#2)
114 of##2##2##(1990-5#1)(2012-2#1)
114 patients with##2##3##(2007-10#1)(2007-11#1)
114 patients##3##2##(2007-10#1)(2007-11#1)(2012-3#1)
114 strains##3##2##(2008-10#2)(2013-8#1)
114##37##1##(1990-5#1)(1990-7#1)(1991-12#1)(1992-5#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-5#1)(1995-6#1)(1996-2#3)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
114)##4##1##(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)
115 children##2##2##(2008-1#1)(2011-2#1)
115 degrees##2##2##(1990-8#1)(2008-3#1)
115 fs##2##2##(2007-11#1)(2007-12#1)
115 kDa and##2##3##(1992-12#1)(1993-11#1)
115 kDa##5##2##(1990-11#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-3#1)
115 patients with##4##3##(1992-8#1)(1996-1#1)(2008-7#1)(2013-1#1)
115 patients##5##2##(1992-8#1)(1996-1#1)(2007-8#1)(2008-7#1)(2013-1#1)
115##38##1##(1990-11#2)(1990-8#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
115%##2##1##(2008-10#1)(2013-8#1)
115-kDa##3##1##(1993-11#2)(1994-11#1)
1150##2##1##(1991-12#1)(2008-10#1)
1159##2##1##(1994-3#1)(2012-3#1)
116 amino##2##2##(2008-8#1)(2009-7#1)
116 isolates##2##2##(2008-10#2)
116##26##1##(1990-12#1)(1990-7#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-1#1)(2012-2#1)
117 isolates##2##2##(2008-10#2)
117 patients##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
117##37##1##(1991-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#3)(1996-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
117)##5##1##(1995-6#1)(2007-10#1)(2008-11#1)(2012-3#2)
1170##2##1##(1997-4#1)(2007-8#1)
1176##2##1##(2007-12#1)(2008-5#1)
1179##2##1##(1993-8#1)(2013-8#1)
118 IPMNs##2##2##(2012-2#2)
118 consecutive##2##2##(2007-8#1)(2008-3#1)
118##36##1##(1991-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#2)(1996-1#3)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#2)(2012-3#1)
118)##5##1##(1993-8#1)(2007-7#2)(2009-4#1)(2013-1#1)
1180 nm##2##2##(2007-11#2)
1188##2##1##(2008-9#1)(2013-1#1)
119##33##1##(1992-5#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-6#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#3)(2012-2#1)(2013-7#1)(2013-8#3)
119)##2##1##(1993-8#1)(2008-10#1)
1191##2##1##(2008-12#1)(2012-12#1)
11B NMR##3##2##(1993-11#3)
11B##4##1##(1993-11#3)(2011-2#1)
11C-raclopride and##2##2##(1996-5#2)
11C-raclopride##4##1##(1996-5#4)
11Z##3##1##(2009-10#3)
11a beta##2##2##(1990-11#2)
11alpha-hydroxyprogesterone##2##1##(2008-10#2)
11b##2##1##(1990-11#2)
11beta##2##1##(2008-11#2)
11beta-hydroxylase##2##1##(1995-8#1)(2008-4#1)
11p13##2##1##(1990-11#1)(1991-10#1)
11q##2##1##(1993-9#1)(2007-6#1)
11q13##5##1##(1993-9#1)(1997-7#1)(1997-8#3)
11q22##2##1##(1995-6#2)
11th##8##1##(2007-8#1)(2008-11#3)(2008-7#1)(2010-3#1)(2013-1#2)
11β-HSD1 activity##2##2##(2013-1#2)
11β-HSD1 enzyme##2##2##(2013-1#2)
11β-HSD1##8##1##(2013-1#8)
12 (1##2##2##(2008-10#1)(2013-1#1)
12 (2##2##2##(2008-1#1)(2008-9#1)
12 +/- 0##5##3##(1993-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)
12 +/-##10##2##(1992-8#1)(1993-1#1)(1994-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#2)(2009-8#1)(2011-2#1)
12 000##2##2##(1996-6#1)(2008-10#1)
12 A##2##2##(1992-4#1)(2008-3#1)
12 Australian##2##2##(1997-5#2)
12 GHz##2##2##(2007-12#2)
12 MHz##3##2##(2008-10#1)(2008-3#2)
12 October##3##2##(2008-10#1)(2008-3#2)
12 PAHs##2##2##(2008-10#2)
12 W##3##2##(2007-11#3)
12 alleles##2##2##(2008-10#1)(2008-9#1)
12 alpha##2##2##(1991-5#2)
12 amino acid residues##2##4##(1991-9#1)(2008-10#1)
12 amino acid##3##3##(1990-2#1)(1991-9#1)(2008-10#1)
12 amino acids##2##3##(1991-12#1)(2013-1#1)
12 amino##5##2##(1990-2#1)(1991-12#1)(1991-9#1)(2008-10#1)(2013-1#1)
12 and 1##5##3##(1990-2#1)(1992-8#1)(1993-12#1)(2008-10#2)
12 and 15##3##3##(1990-2#1)(2007-8#1)(2008-2#1)
12 and 18 months of##2##5##(1990-2#1)(1993-12#1)
12 and 18 months##3##4##(1990-2#1)(1993-1#1)(1993-12#1)
12 and 20##3##3##(1997-3#1)(2007-12#1)(2010-5#1)
12 and 24 months##2##4##(2007-7#1)(2010-8#1)
12 and 24##3##3##(2007-7#1)(2008-5#1)(2010-8#1)
12 and 36 h after##2##5##(1996-12#1)(2008-10#1)
12 and 36##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
12 and the##2##3##(2008-8#1)(2010-12#1)
12 and##51##2##(1990-2#3)(1990-8#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#2)(1995-12#2)(1996-12#2)(1996-5#2)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
12 antimicrobial agents##2##3##(1991-8#1)(2008-7#1)
12 as##3##2##(1996-12#1)(2007-11#1)(2008-10#1)
12 at##2##2##(1991-3#1)(2007-5#1)
12 bacterial##2##2##(2008-10#1)(2008-7#1)
12 bit##3##2##(2011-1#2)(2013-8#1)
12 cases and##2##3##(2008-7#1)(2012-1#1)
12 cases of##5##3##(1990-6#1)(1991-6#1)(2007-10#1)(2007-7#1)(2008-5#1)
12 cases##15##2##(1990-6#1)(1991-6#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
12 chromosomes##2##2##(2009-10#1)(2011-3#1)
12 cm##2##2##(2008-12#1)(2012-3#1)
12 compared with##2##3##(2008-10#1)(2013-1#1)
12 conjectures##2##2##(2008-7#2)
12 control##2##2##(1995-12#1)(1996-9#1)
12 countries##2##2##(2007-11#1)(2008-8#1)
12 cultivars##3##2##(2008-10#3)
12 d##5##2##(2011-2#5)
12 days after##4##3##(1992-1#1)(1996-12#1)(2008-10#2)
12 days of##2##3##(1992-11#1)(2008-11#1)
12 days##19##2##(1992-1#1)(1992-11#2)(1992-3#1)(1995-12#2)(1996-12#1)(1997-3#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#4)
12 days)##2##2##(2008-7#1)(2011-2#1)
12 degrees C##7##3##(1991-8#1)(1992-6#1)(2008-10#4)(2011-2#1)
12 degrees##11##2##(1991-8#1)(1992-6#1)(2007-8#1)(2008-10#5)(2008-3#2)(2011-2#1)
12 different##4##2##(1990-2#1)(2008-10#2)(2009-3#1)
12 elements##2##2##(2008-10#2)
12 enzyme systems##2##3##(2008-12#1)(2008-8#1)
12 for A##2##3##(1992-12#1)(2008-5#1)
12 for##6##2##(1992-12#1)(1993-3#2)(2008-10#1)(2008-5#1)(2013-1#1)
12 g##2##2##(2008-12#1)(2008-3#1)
12 g/dL##6##2##(2008-7#6)
12 g/dL)##3##2##(2008-7#3)
12 genes##3##2##(2009-10#2)(2011-2#1)
12 groups##2##2##(2008-10#1)(2008-12#1)
12 h after##9##3##(1993-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-2#1)(2012-3#1)
12 h at##2##3##(2008-10#2)
12 h for##3##3##(1992-8#1)(1995-12#2)
12 h of##3##3##(1995-12#2)(2008-10#1)
12 h##46##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-12#4)(1996-12#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#4)(2008-9#2)(2009-11#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
12 h)##3##2##(1994-6#1)(2008-10#2)
12 healthy individuals##2##3##(2008-11#1)(2008-3#1)
12 healthy##6##2##(1996-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
12 hours after##2##3##(1991-6#1)(2012-12#1)
12 hours of##8##3##(1994-11#1)(2007-10#4)(2008-3#1)(2011-2#1)(2013-7#1)
12 hours##22##2##(1990-12#1)(1990-2#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(2007-10#6)(2008-3#1)(2009-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
12 hr##6##2##(2008-11#1)(2008-5#1)(2008-6#3)(2013-1#1)
12 in##2##2##(2008-10#1)(2011-2#1)
12 isolates##4##2##(1997-3#1)(2008-10#3)
12 kg##2##2##(2007-5#1)(2008-3#1)
12 mM glutamate##2##3##(2008-11#2)
12 mM##4##2##(1994-8#1)(2008-11#2)(2011-2#1)
12 major##2##2##(2008-10#2)
12 mg l(-1)##5##3##(2008-10#5)
12 mg##15##2##(2008-10#6)(2008-9#9)
12 mg/kg females were##2##4##(2008-9#2)
12 mg/kg females##7##3##(2008-9#7)
12 mg/kg male##2##3##(2008-9#2)
12 mg/kg males and females##7##5##(2008-9#7)
12 mg/kg males and##11##4##(2008-9#11)
12 mg/kg males##16##3##(2008-9#16)
12 mg/kg##42##2##(2008-9#42)
12 microg/mL##2##2##(2007-11#1)(2011-2#1)
12 microm and##2##3##(2007-11#1)(2007-12#1)
12 microm##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2013-8#2)
12 microsatellite markers##3##3##(1997-5#1)(2008-11#1)(2008-12#1)
12 million##2##2##(1997-2#1)(2008-10#1)
12 min and##2##3##(1993-2#1)(2008-10#1)
12 min in##3##3##(2008-10#3)
12 min##9##2##(1993-2#1)(2008-10#8)
12 mm from##2##3##(2008-12#1)(2011-2#1)
12 mm##5##2##(2008-1#1)(2008-12#2)(2011-2#1)(2013-1#1)
12 months after the##3##4##(2007-11#1)(2007-8#1)(2013-1#1)
12 months after##13##3##(1996-11#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-10#2)(2009-8#1)(2011-1#1)(2013-1#1)
12 months and##4##3##(2007-10#1)(2011-2#2)(2012-12#1)
12 months follow-up##2##3##(2008-1#1)(2008-7#1)
12 months following##2##3##(2008-12#1)(2011-2#1)
12 months from##2##3##(1996-6#1)(2007-11#1)
12 months in##4##3##(1990-6#1)(1994-8#1)(2008-10#1)(2011-1#1)
12 months of age##5##4##(2007-8#5)
12 months of follow-up##3##4##(1990-8#1)(2013-1#2)
12 months of##14##3##(1990-2#1)(1990-8#1)(1995-1#1)(2007-8#5)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#2)
12 months or##2##3##(1990-12#1)(2009-5#1)
12 months was##5##3##(2007-7#2)(2009-5#1)(2010-10#1)(2012-1#1)
12 months were##5##3##(1994-12#1)(2007-7#1)(2009-5#2)(2013-1#1)
12 months##136##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1993-1#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#3)(2007-11#4)(2007-5#3)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#5)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-5#6)(2009-8#2)(2010-1#3)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#3)(2013-1#11)
12 months)##3##2##(2009-5#3)
12 mug l(-1)##5##3##(2008-10#5)
12 mug##6##2##(2008-10#5)(2008-11#1)
12 mum##2##2##(2008-3#2)
12 new##4##2##(1996-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
12 ng##3##2##(1994-7#1)(2008-10#2)
12 of the##6##3##(1992-12#1)(1993-2#1)(1997-8#1)(2008-3#1)(2012-3#1)(2013-7#1)
12 of these##2##3##(2008-11#1)(2012-3#1)
12 of which##2##3##(1997-2#1)(2008-10#1)
12 of whom##2##3##(1991-6#1)(1995-11#1)
12 of##23##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-7#1)
12 on##2##2##(2008-10#2)
12 or 24##3##3##(1996-12#1)(2007-10#1)(2008-5#1)
12 or##8##2##(1992-11#1)(1995-2#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
12 patients had##2##3##(1997-3#1)(2011-2#1)
12 patients the##2##3##(1996-3#1)(2013-1#1)
12 patients who underwent##2##4##(2007-11#1)(2007-8#1)
12 patients who##4##3##(1997-7#1)(2007-11#1)(2007-8#1)(2013-1#1)
12 patients with##7##3##(1991-5#1)(1993-2#1)(1995-12#1)(2006-10#2)(2008-5#1)(2013-1#1)
12 patients##43##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-11#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2011-2#3)(2011-3#1)(2012-5#1)(2013-1#4)
12 phosphomolybdic##2##2##(2008-10#2)
12 putative transmembrane##2##3##(1993-3#1)(1995-2#1)
12 putative##3##2##(1993-3#1)(1995-2#1)(1997-7#1)
12 rice##2##2##(2008-10#1)(2008-9#1)
12 s##2##2##(2007-8#1)(2008-10#1)
12 samples per hour##2##4##(2008-10#2)
12 samples##6##2##(2008-10#6)
12 segments of##2##3##(2008-10#2)
12 segments##3##2##(2007-8#1)(2008-10#2)
12 species##2##2##(2011-2#1)(2012-3#1)
12 subjects##2##2##(2013-8#2)
12 times##6##2##(1990-8#1)(1991-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-2#1)
12 to 1##2##3##(2008-8#1)(2009-12#1)
12 to 17##2##3##(1990-5#1)(2008-10#1)
12 to 18##5##3##(1993-11#2)(2009-7#1)(2013-1#2)
12 to 24 h##4##4##(2008-10#4)
12 to 24 hours##2##4##(2007-10#2)
12 to 24##9##3##(2007-10#2)(2008-10#6)(2008-11#1)
12 to 25##4##3##(1993-8#1)(1997-5#1)(2008-10#2)
12 to##53##2##(1990-5#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-9#1)(1997-5#1)(1997-8#1)(2007-10#2)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#2)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
12 vs##2##2##(2007-10#1)(2007-8#1)
12 was##6##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
12 weeks after the##3##4##(2008-7#1)(2008-9#1)(2009-7#1)
12 weeks after##8##3##(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2013-8#1)
12 weeks and##3##3##(2008-10#1)(2008-5#2)
12 weeks of age##2##4##(2008-10#2)
12 weeks of treatment with##2##5##(1992-11#1)(2007-7#1)
12 weeks of treatment##3##4##(1992-11#1)(2007-7#1)(2008-3#1)
12 weeks of##11##3##(1992-11#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2013-1#1)
12 weeks post##2##3##(2007-11#2)
12 weeks##76##2##(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1994-9#1)(1997-5#1)(2006-10#3)(2007-10#3)(2007-11#8)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#3)(2008-9#2)(2009-11#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
12 were##6##2##(1990-2#1)(1996-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-3#1)
12 with##4##2##(1990-11#1)(1993-8#1)(1995-3#1)(1996-5#1)
12 x 10(6)##2##3##(1990-8#1)(2008-11#1)
12 x##3##2##(1990-8#1)(2008-11#1)(2011-2#1)
12 year-old##2##2##(1996-9#1)(2011-1#1)
12 years following##2##3##(2007-8#2)
12 years in##2##3##(2008-10#1)(2008-6#1)
12 years of age##5##4##(1991-2#1)(1993-1#1)(1993-2#1)(2009-10#1)(2010-10#1)
12 years of##6##3##(1991-2#1)(1993-1#1)(1993-2#1)(1995-11#1)(2009-10#1)(2010-10#1)
12 years old##2##3##(2008-1#1)(2011-2#1)
12 years##37##2##(1991-2#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-6#1)(1995-11#2)(1996-6#1)(1997-3#1)(1997-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#3)(2011-2#2)(2012-3#1)
12 years) in##2##3##(2007-12#1)(2008-10#1)
12 years)##4##2##(1990-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
12##1655##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#15)(1990-3#1)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#9)(1990-9#5)(1991-1#2)(1991-11#3)(1991-12#7)(1991-2#8)(1991-3#3)(1991-5#7)(1991-6#7)(1991-8#5)(1991-9#4)(1992-1#3)(1992-11#9)(1992-12#6)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#6)(1992-9#4)(1993-1#6)(1993-11#3)(1993-12#10)(1993-2#5)(1993-3#8)(1993-6#2)(1993-8#7)(1993-9#3)(1994-11#8)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#5)(1994-7#3)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#7)(1995-12#17)(1995-2#7)(1995-3#7)(1995-5#3)(1995-6#4)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#18)(1996-2#11)(1996-3#7)(1996-5#8)(1996-6#8)(1996-7#3)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#5)(1997-3#9)(1997-4#4)(1997-5#12)(1997-6#3)(1997-7#10)(1997-8#7)(2006-10#5)(2007-1#2)(2007-10#20)(2007-11#35)(2007-12#16)(2007-2#1)(2007-3#1)(2007-5#5)(2007-7#16)(2007-8#33)(2007-9#1)(2008-1#20)(2008-10#333)(2008-11#45)(2008-12#36)(2008-2#18)(2008-3#52)(2008-4#16)(2008-5#55)(2008-6#16)(2008-7#60)(2008-8#22)(2008-9#80)(2009-1#1)(2009-10#12)(2009-11#3)(2009-12#5)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#12)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#3)(2010-1#5)(2010-10#3)(2010-11#4)(2010-12#10)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#5)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#20)(2011-10#1)(2011-2#65)(2011-3#5)(2012-1#4)(2012-12#13)(2012-2#25)(2012-3#29)(2012-4#1)(2012-5#1)(2013-1#75)(2013-7#8)(2013-8#24)
12% and##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
12% at##2##2##(2008-10#1)(2011-2#1)
12% for##5##2##(2008-10#4)(2012-12#1)
12% in##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
12% increase in##2##3##(2011-2#1)(2012-1#1)
12% less##2##2##(1995-8#1)(2007-11#1)
12% of all##2##3##(2009-5#1)(2013-1#1)
12% of the##14##3##(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
12% of##21##2##(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1996-1#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
12% to##2##2##(2008-5#1)(2008-8#1)
12%##90##1##(1990-2#2)(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#3)(1994-3#1)(1995-8#1)(1996-1#2)(1996-5#1)(1996-9#3)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
12%)##4##1##(1990-3#1)(1995-11#1)(1995-4#1)(2011-2#1)
12(2)##2##1##(1996-2#1)(2008-11#1)
12(4)##2##1##(2008-11#2)
12(R)-HETE##2##1##(1992-8#2)
12) and##9##2##(1994-11#1)(1995-2#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#2)(2013-1#1)
12) of##3##2##(1991-5#1)(1995-12#1)(2008-2#1)
12) or##6##2##(1993-3#1)(1994-5#1)(1995-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
12) was##2##2##(1991-5#1)(2013-1#1)
12) were##3##2##(1993-3#1)(1994-2#1)(2008-10#1)
12)##68##1##(1990-3#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-1#1)(1993-3#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#3)(1997-2#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-10#11)(2008-11#2)(2008-2#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#3)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#1)
12+/-0##3##1##(2008-10#3)
12- and##5##2##(1991-12#2)(2008-10#1)(2008-4#1)(2013-7#1)
12-##10##1##(1991-12#2)(1994-11#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2013-7#1)
12-0##4##1##(2007-10#1)(2008-10#3)
12-13##5##1##(1996-9#1)(1997-8#1)(2008-10#3)
12-14 years old##2##3##(2011-2#1)(2012-3#1)
12-14 years##3##2##(2011-2#2)(2012-3#1)
12-14##9##1##(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#4)(2012-3#1)
12-15##5##1##(1993-8#1)(1994-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
12-16##10##1##(1994-12#3)(1995-12#1)(1995-5#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-3#1)(2011-2#1)
12-18##4##1##(1992-10#1)(1996-5#1)(1997-6#1)(2012-2#1)
12-2##3##1##(2010-4#1)(2011-1#1)(2011-2#1)
12-20##3##1##(1991-12#1)(1992-3#1)(2008-3#1)
12-24 h##2##2##(1996-12#1)(2011-2#1)
12-24 hours##2##2##(1990-11#1)(1996-9#1)
12-24##4##1##(1990-11#1)(1996-12#1)(1996-9#1)(2011-2#1)
12-25##2##1##(2008-5#1)(2009-3#1)
12-26 fragment##2##2##(1990-5#2)
12-3##2##1##(2008-7#1)(2012-1#1)
12-O-tetradecanoyl phorbol 13-acetate (TPA) caused##2##5##(1994-6#1)(1995-11#1)
12-O-tetradecanoyl phorbol 13-acetate (TPA)##3##4##(1990-8#1)(1994-6#1)(1995-11#1)
12-O-tetradecanoyl phorbol-13-acetate (TPA) and##2##4##(1994-12#1)(1995-8#1)
12-O-tetradecanoyl##5##1##(1990-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#1)
12-O-tetradecanoyl-phorbol-13-acetate (TPA)##3##2##(1992-9#2)(1993-8#1)
12-O-tetradecanoyl-phorbol-13-acetate##5##1##(1992-9#2)(1993-3#1)(1993-8#1)(1995-6#1)
12-O-tetradecanoylphorbol 13-acetate (TPA)##2##3##(1994-11#1)(1996-12#1)
12-O-tetradecanoylphorbol 13-acetate##3##2##(1994-11#1)(1996-12#1)(1997-2#1)
12-O-tetradecanoylphorbol-13-acetate (TPA)##4##2##(1992-8#1)(1993-9#1)(1997-1#1)(2008-9#1)
12-O-tetradecanoylphorbol-13-acetate per 100 mL acetone 3 days per week for 28 weeks##2##12##(2008-9#2)
12-O-tetradecanoylphorbol-13-acetate##14##1##(1990-2#1)(1992-8#4)(1993-9#2)(1994-12#1)(1995-12#1)(1997-1#1)(2008-9#3)(2013-1#1)
12-bit##2##1##(2008-10#1)(2011-1#1)
12-dibenzo-18-crown-6##2##1##(2008-10#2)
12-dimethylbenz[a]anthracene (DMBA)##3##2##(1990-7#1)(1995-11#1)(1996-12#1)
12-dimethylbenz[a]anthracene##4##1##(1990-7#1)(1995-11#1)(1996-12#2)
12-fold more##2##2##(2008-11#2)
12-fold##7##1##(1992-9#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#2)
12-h periods of##2##3##(2008-10#2)
12-h##12##1##(1994-8#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#3)(2013-1#1)
12-hour period##2##2##(2007-10#1)(2011-2#1)
12-hydroxy 5##2##2##(1994-8#2)
12-kDa fragment##2##2##(1995-6#2)
12-kDa##3##1##(1991-6#1)(1995-6#2)
12-lead ECG##3##2##(2008-3#1)(2009-10#1)(2009-4#1)
12-lead electrocardiogram##3##2##(1997-8#1)(2007-8#1)(2008-3#1)
12-lead##9##1##(1997-8#1)(2007-8#1)(2008-3#3)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)
12-lipoxygenase##8##1##(1991-8#1)(1992-8#1)(1994-11#5)(1994-8#1)
12-methoxycalanolide##2##1##(1992-8#2)
12-mo-old##3##1##(2008-8#3)
12-month follow-up##3##2##(2008-3#1)(2009-1#1)(2013-1#1)
12-month##12##1##(1992-1#1)(1994-9#1)(2007-10#2)(2008-10#1)(2008-12#2)(2008-3#1)(2009-1#1)(2010-4#1)(2010-5#1)(2013-1#1)
12-month-old rats##3##2##(1991-12#1)(1995-8#1)(2009-8#1)
12-month-old##5##1##(1991-12#1)(1993-12#1)(1995-8#1)(2009-8#1)(2012-3#1)
12-myristate 13-acetate (PMA) and##2##4##(1993-3#1)(1994-3#1)
12-myristate 13-acetate (PMA)##12##3##(1990-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#2)(2008-5#1)
12-myristate 13-acetate##15##2##(1990-2#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-5#1)
12-myristate##19##1##(1990-2#2)(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-5#1)(2013-1#1)
12-prostaglandin##2##1##(1991-9#2)
12-quinone and flame atomic absorption spectrometry##2##6##(2008-10#2)
12-quinone##3##1##(1994-8#1)(2008-10#2)
12-step activities##2##2##(2008-6#2)
12-step##7##1##(2008-6#7)
12-tetraaza cyclotetradeca-1##2##2##(2008-10#2)
12-tetradecadienyl acetate##2##2##(2008-10#2)
12-week open-label##2##2##(2008-7#1)(2012-3#1)
12-week##17##1##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-7#2)(2009-10#1)(2012-3#1)(2013-1#1)
12-week-old females##2##2##(2013-7#2)
12-weeks##2##1##(2008-5#2)
12-wks##2##1##(2008-5#2)
12-year-old boy with##4##3##(2008-10#1)(2008-11#2)(2011-1#1)
12-year-old boy##7##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
12-year-old girl with##3##3##(2007-12#1)(2007-8#1)(2011-1#1)
12-year-old girl##6##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)
12-year-old##15##1##(1992-1#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
120 amino##2##2##(1990-8#1)(1995-8#1)
120 and 60##2##3##(2008-10#2)
120 and##9##2##(1991-2#1)(1991-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)
120 cm in##3##3##(2008-10#2)(2008-6#1)
120 cm##5##2##(2008-10#4)(2008-6#1)
120 consecutive##2##2##(1996-3#1)(2007-8#1)
120 days after##2##3##(1995-11#1)(2013-1#1)
120 days##7##2##(1995-11#1)(2008-10#3)(2013-1#3)
120 degrees C##5##3##(1995-2#2)(2008-10#1)(2008-3#1)(2008-6#1)
120 degrees and##2##3##(2007-11#1)(2008-3#1)
120 degrees parhelia##2##3##(2008-2#2)
120 degrees##15##2##(1995-2#2)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-6#1)(2008-8#1)(2013-1#2)
120 for##2##2##(2008-10#2)
120 h##4##2##(2007-6#1)(2008-8#3)
120 h(-1)##2##2##(2008-10#2)
120 kDa and##2##3##(1990-5#1)(1994-2#1)
120 kDa##4##2##(1990-5#1)(1992-9#2)(1994-2#1)
120 kb##2##2##(1993-12#1)(1997-7#1)
120 mg##2##2##(1992-8#1)(2008-5#1)
120 mg/kg/day of##2##3##(2011-2#2)
120 min of##2##3##(2012-2#1)(2013-1#1)
120 min##10##2##(1991-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-2#2)(2012-2#1)(2013-1#1)
120 minutes##2##2##(1996-6#1)(2008-1#1)
120 mmol##2##2##(2008-9#2)
120 nm##2##2##(2007-11#1)(2008-2#1)
120 of##3##2##(1995-5#1)(1995-8#1)(2008-4#1)
120 patients with##3##3##(1992-5#1)(2008-3#1)(2011-2#1)
120 patients##5##2##(1992-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
120 s in##2##3##(1996-12#1)(2008-10#1)
120 s of##2##3##(2008-10#2)
120 s##23##2##(1993-11#1)(1996-12#1)(2008-10#20)(2008-12#1)
120 to##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)
120 were##2##2##(1995-2#1)(2008-10#1)
120##214##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#5)(2008-1#6)(2008-10#66)(2008-11#2)(2008-12#3)(2008-2#9)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#1)
120% of##2##2##(1993-2#1)(2008-10#1)
120%##9##1##(1993-2#1)(2007-8#1)(2008-10#7)
120) and##2##2##(2013-1#1)(2013-8#1)
120) in the##2##3##(2008-10#1)(2009-8#1)
120)##8##1##(2007-7#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
120-W##2##1##(2007-12#2)
120-mW##3##1##(2007-12#3)
1200 J/cm(2)##2##2##(2008-7#2)
1200 and##3##2##(1994-6#1)(1995-5#1)(2008-10#1)
1200 mg##3##2##(1992-12#1)(2008-10#1)(2008-5#1)
1200 nm##2##2##(2007-11#2)
1200##22##1##(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
1200-lines/mm##2##1##(2008-2#2)
1201##2##1##(2007-3#1)(2013-1#1)
1206##2##1##(2008-10#1)(2008-3#1)
120mV##2##1##(2008-10#2)
120s preconcentration time##2##3##(2008-10#2)
120s##7##1##(2008-10#7)
120°##2##1##(2012-3#2)
121 amino acids##2##3##(2008-10#2)
121 degrees C##2##3##(1995-11#1)(2010-2#1)
121 patients##2##2##(1992-6#1)(2007-10#1)
121##35##1##(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-8#1)(1995-11#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
121%##3##1##(2008-10#2)(2010-2#1)
1210##2##1##(2007-11#1)(2008-11#1)
1213##2##1##(1991-5#1)(2007-12#1)
1216 (1999)]##2##2##(2008-3#2)
122 patients with##2##3##(1991-6#1)(2012-3#1)
122 patients##5##2##(1991-6#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-3#1)
122##32##1##(1990-2#1)(1991-11#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
122)##6##1##(2007-7#2)(2008-10#3)(2008-5#1)
1221##2##1##(1994-12#1)(1996-2#1)
1224##4##1##(1994-8#1)(1995-11#1)(1997-7#1)(2013-8#1)
1226##2##1##(2008-12#1)(2008-5#1)
123 (1973)##2##2##(1990-5#2)
123 +/-##2##2##(1992-3#1)(1993-12#1)
123 patients##4##2##(1997-8#1)(2008-4#1)(2010-3#1)(2013-8#1)
123##54##1##(1990-5#2)(1991-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
123)##2##1##(2008-10#1)(2013-1#1)
123-I MIBG imaging##5##3##(2012-2#5)
1230 nm##2##2##(2007-11#1)(2007-12#1)
1230##5##1##(2007-11#2)(2007-12#1)(2010-4#1)(2013-8#1)
1231##4##1##(1997-7#1)(2008-12#1)(2012-3#2)
1233##3##1##(1996-12#1)(2007-12#1)(2008-11#1)
124 +/-##2##2##(1992-3#1)(2011-2#1)
124 patients##2##2##(1996-3#1)(2008-8#1)
124 women##2##2##(2011-2#1)(2013-1#1)
124##28##1##(1990-12#1)(1990-8#2)(1991-3#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-3#1)
124) and##2##2##(1990-2#1)(2008-10#1)
12449##4##1##(2008-10#4)
1245##4##1##(1997-7#1)(2007-6#1)(2010-3#1)(2013-8#1)
125 and##4##2##(1991-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
125 degrees C##3##3##(2008-10#2)(2008-2#1)
125 in##2##2##(1991-4#1)(2011-2#1)
125 patients##3##2##(2008-3#2)(2008-4#1)
125 to##4##2##(1995-3#1)(1997-6#1)(2008-3#1)(2008-5#1)
125##82##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#7)(1993-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-3#3)(1995-6#1)(1996-11#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-7#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
125)##3##1##(2007-7#1)(2008-9#1)(2011-3#1)
1250 (1987)]##2##2##(2008-2#1)(2008-3#1)
1250##7##1##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
1251##2##1##(1992-8#1)(2011-2#1)
1254 was##2##2##(1991-5#1)(1993-8#1)
1254##7##1##(1991-5#1)(1993-8#2)(1996-12#2)(2008-10#2)
1258##3##1##(1990-8#1)(1994-11#1)(2008-12#1)
1259##2##1##(1994-5#1)(2008-10#1)
125I assay##2##2##(1996-12#2)
125I##6##1##(1992-9#1)(1994-3#1)(1996-12#4)
125I-##2##1##(1993-11#2)
125I-EGF##4##1##(1991-7#1)(1993-3#3)
125I-FGF##3##1##(1991-12#3)
125I-GxTX-1E##2##1##(2010-12#2)
125I-IGF-I##2##1##(1991-5#2)
125I-IGF-II binding##3##2##(1990-5#3)
125I-IGF-II##9##1##(1990-5#8)(1991-12#1)
125I-LDL##3##1##(1993-6#1)(1994-8#2)
125I-NGF was##2##2##(1991-12#2)
125I-Tyr-CRH##3##1##(1990-12#3)
125I-VEGF##2##1##(1992-9#2)
125I-[Sar1##3##1##(1995-12#3)
125I-[Y39] exendin-4##2##2##(1994-8#2)
125I-[Y39]exendin-4##3##1##(1994-8#3)
125I-acetylated LDL##2##2##(1993-8#2)
125I-bFGF into the##2##3##(1991-12#2)
125I-bFGF##5##1##(1991-12#5)
125I-endothelin-1##2##1##(1990-2#2)
125I-hANF##3##1##(1990-2#3)
125I-insulin##4##1##(1996-3#1)(1997-1#3)
125I-labeled recombinant human##2##3##(1990-5#1)(1996-5#1)
125I-labeled##8##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-3#2)(1995-2#1)(1996-5#1)
125I-labelled##3##1##(1991-5#1)(1994-2#1)(1996-12#1)
125IUdR in##2##2##(1993-11#2)
125IUdR##7##1##(1993-11#7)
126 patients##2##2##(2007-8#1)(2009-8#1)
126##34##1##(1990-12#2)(1991-6#1)(1993-11#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-5#2)
1262##2##1##(2008-10#1)(2008-7#1)
1266##3##1##(2007-12#1)(2008-10#2)
127 and##2##2##(2008-10#1)(2010-2#1)
127 kDa polypeptide##2##3##(1990-11#2)
127 kDa protein##2##3##(1990-11#2)
127 kDa##4##2##(1990-11#4)
127##35##1##(1990-11#7)(1990-5#2)(1991-9#1)(1993-11#1)(1995-3#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
127)##5##1##(1992-9#1)(1995-12#1)(2009-4#1)(2010-10#2)
1272##2##1##(1997-2#1)(1997-6#1)
1279##2##1##(2011-2#2)
128 +/-##3##2##(1995-12#1)(1995-3#1)(2008-5#1)
128 and 256 mg/kg##3##4##(2008-9#3)
128 cases##2##2##(2007-5#1)(2011-2#1)
128 days##2##2##(2008-7#1)(2011-2#1)
128 to##2##2##(2008-10#2)
128 x 128##3##3##(1991-2#1)(2008-2#2)
128##56##1##(1990-3#1)(1991-2#2)(1992-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-6#2)(1997-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#8)(2009-4#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
128%##2##1##(1995-5#1)(2008-11#1)
129 +/-##2##2##(1994-6#1)(1995-11#1)
129 to##2##2##(2008-10#1)(2008-5#1)
129 were##2##2##(1997-6#1)(2008-7#1)
129##31##1##(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-5#1)(1997-6#1)(1997-8#2)(2007-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
129)##4##1##(1994-10#1)(1995-12#1)(2008-10#1)(2010-8#1)
129-Trp53(tm1Brd) (N5) haploinsufficient] mice (drinking water##2##6##(2008-9#2)
129-Trp53(tm1Brd) (N5)##3##2##(2008-9#3)
129-Trp53tm1Brd (N5) haploinsufficient] mice##3##4##(2008-8#1)(2008-9#2)
1295-22##4##1##(2008-10#4)
12D##4##1##(2007-5#1)(2008-11#1)(2010-8#2)
12L##4##1##(2007-5#1)(2008-11#1)(2010-8#2)
12R/59T/116Y mutations##2##2##(1993-11#2)
12S##4##1##(1991-2#2)(2008-6#1)(2010-4#1)
12h immersion treatment##2##3##(2013-7#2)
12h immersion##3##2##(2013-7#3)
12h##9##1##(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#3)(2013-7#3)
12mM##2##1##(2008-10#2)
12min##3##1##(2008-10#2)(2012-2#1)
12mugl(-1)##5##1##(2008-10#5)
12q13##2##1##(1993-9#1)(1997-4#1)
12th Annual##2##2##(2008-11#1)(2008-7#1)
12th##17##1##(1990-5#1)(1991-3#1)(1992-8#2)(1993-9#1)(1994-6#1)(1996-6#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
12 h##2##1##(2010-4#2)
12 months##2##1##(2010-11#1)(2011-1#1)
12 months##2##1##(2012-2#2)
12 weeks##3##1##(2011-1#1)(2011-2#2)
13 (1992)##2##2##(1994-12#1)(1995-6#1)
13 +/- 0##3##3##(1995-12#1)(1995-2#1)(2011-2#1)
13 +/-##9##2##(1991-6#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
13 North American##2##3##(1991-12#1)(2008-10#1)
13 accessions##3##2##(2008-10#3)
13 amino acids##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
13 and 12##2##3##(1995-8#1)(2008-6#1)
13 and 17##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
13 and 4##2##3##(2008-10#1)(2008-12#1)
13 and##22##2##(1991-12#1)(1991-5#1)(1992-2#2)(1993-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
13 are##3##2##(1991-8#1)(2008-10#1)(2008-3#1)
13 billion##3##2##(2010-8#1)(2012-12#2)
13 cases of##2##3##(1993-9#1)(1997-8#1)
13 cases##12##2##(1991-12#1)(1993-9#1)(1996-3#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-8#1)
13 cm)##2##2##(2008-12#1)(2011-2#1)
13 countries##2##2##(2008-5#1)(2011-2#1)
13 days##9##2##(1990-11#1)(1992-12#1)(1996-5#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)
13 degrees C##6##3##(2008-10#3)(2010-8#2)(2013-1#1)
13 degrees##8##2##(2007-11#1)(2008-10#4)(2010-8#2)(2013-1#1)
13 diabetic patients##2##3##(2007-7#2)
13 different##2##2##(1994-5#1)(2012-2#1)
13 distinct##3##2##(1997-4#1)(2008-10#2)
13 exons##3##2##(1991-5#1)(1996-10#1)(2009-9#1)
13 female##2##2##(2011-2#1)(2012-3#1)
13 females##3##2##(1990-6#1)(1993-11#1)(1996-12#1)
13 for##2##2##(1992-12#1)(2008-9#1)
13 from##2##2##(1990-2#1)(2012-2#1)
13 g##3##2##(1997-4#2)(2008-10#1)
13 generations##2##2##(2008-9#1)(2012-3#1)
13 genes were##2##3##(1995-8#2)
13 genes##3##2##(1995-8#2)(2011-2#1)
13 had##3##2##(1992-11#1)(2008-5#1)(2012-3#1)
13 healthy##2##2##(2009-6#1)(2012-1#1)
13 in the##2##3##(1993-11#1)(2008-10#1)
13 in##4##2##(1991-2#1)(1993-11#1)(1997-5#1)(2008-10#1)
13 isolates##2##2##(2008-10#2)
13 kb##2##2##(1991-6#1)(2008-10#1)
13 mJ##2##2##(2007-11#1)(2007-12#1)
13 men##3##2##(2007-11#1)(2008-7#2)
13 mg##2##2##(2008-10#1)(2008-11#1)
13 min##3##2##(1996-9#1)(2008-10#2)
13 mm##5##2##(1995-3#1)(1996-11#1)(2007-12#1)(2012-12#1)(2013-8#1)
13 months after##3##3##(2008-11#1)(2008-6#1)(2009-1#1)
13 months##12##2##(1990-8#1)(1991-6#1)(1992-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-1#1)(2010-3#1)(2012-3#1)
13 mug##3##2##(2008-10#3)
13 mum##3##2##(2008-11#1)(2008-3#2)
13 ng ml(-1)##2##3##(2008-10#2)
13 ng##3##2##(2008-10#3)
13 nm##4##2##(2007-12#2)(2008-3#1)(2008-5#1)
13 of the##4##3##(1993-3#1)(2008-7#1)(2011-2#2)
13 of these##2##3##(2008-7#1)(2008-9#1)
13 of##11##2##(1991-11#1)(1992-6#1)(1993-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
13 or##2##2##(2008-10#2)
13 other##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
13 out of the##2##4##(2008-10#1)(2010-8#1)
13 out of##5##3##(1990-11#1)(2008-10#2)(2010-8#1)(2011-1#1)
13 patients experienced##2##3##(1992-1#1)(2008-7#1)
13 patients in##2##3##(1996-6#1)(2008-5#1)
13 patients were##3##3##(1990-2#1)(1990-6#1)(1996-9#1)
13 patients who##2##3##(1994-12#1)(2007-8#1)
13 patients with##14##3##(1991-11#1)(1994-10#1)(1995-11#1)(2007-10#1)(2007-11#2)(2008-3#2)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
13 patients##41##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
13 percent##2##2##(1992-3#1)(1992-5#1)
13 populations##2##2##(2008-10#1)(2009-5#1)
13 s-1)##2##2##(1990-9#2)
13 studies##5##2##(1993-1#1)(1994-2#1)(2007-8#1)(2011-2#1)(2012-2#1)
13 subjects##2##2##(2008-12#1)(2008-7#1)
13 to##14##2##(1991-4#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)
13 underwent##2##2##(1990-2#1)(1991-2#1)
13 variable sites##2##3##(2008-10#2)
13 was##3##2##(1992-12#1)(2007-11#1)(2009-11#1)
13 weeks##5##2##(2008-9#4)(2013-1#1)
13 were##5##2##(1993-12#1)(2008-10#1)(2012-2#2)(2012-3#1)
13 with##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
13 women##3##2##(1990-5#1)(2007-11#1)(2011-2#1)
13 wpi##2##2##(2008-12#2)
13 years after##2##3##(1991-11#1)(2013-1#1)
13 years later##2##3##(1993-6#1)(2008-7#1)
13 years of##3##3##(2007-12#1)(2008-11#1)(2008-12#1)
13 years old##3##3##(2010-12#1)(2013-1#2)
13 years##23##2##(1990-8#1)(1991-11#1)(1993-12#1)(1993-6#1)(1995-10#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#3)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)
13##821##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#4)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#5)(1991-8#2)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#8)(1992-3#2)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#8)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#3)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#7)(1995-12#5)(1995-2#12)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#8)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#10)(1996-3#2)(1996-5#6)(1996-6#3)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#8)(1997-5#5)(1997-6#5)(1997-7#8)(1997-8#5)(2006-10#1)(2006-8#1)(2007-10#5)(2007-11#22)(2007-12#10)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#1)(2008-1#16)(2008-10#134)(2008-11#20)(2008-12#16)(2008-2#6)(2008-3#27)(2008-4#4)(2008-5#18)(2008-6#8)(2008-7#28)(2008-8#7)(2008-9#20)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#8)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#6)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#13)(2011-10#1)(2011-2#39)(2012-1#1)(2012-12#9)(2012-2#11)(2012-3#13)(2012-5#2)(2012-6#1)(2013-1#21)(2013-7#1)(2013-8#11)
13% (v/v)##2##2##(2008-10#2)
13% and##2##2##(1990-6#1)(2008-10#1)
13% for##4##2##(1990-6#1)(2008-10#2)(2008-3#1)
13% from##2##2##(1990-12#1)(2007-11#1)
13% in##4##2##(1990-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
13% increase in##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
13% of all##3##3##(1992-4#1)(2008-11#1)(2011-9#1)
13% of patients##2##3##(2006-8#1)(2011-2#1)
13% of the##2##3##(2008-8#1)(2013-8#1)
13% of##17##2##(1990-12#1)(1992-4#1)(1993-9#1)(1997-3#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2011-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
13% to##4##2##(2007-7#1)(2008-10#1)(2013-1#1)(2013-8#1)
13% were##2##2##(1991-9#1)(2008-10#1)
13%##67##1##(1990-12#3)(1990-6#2)(1990-8#1)(1991-9#1)(1992-4#1)(1993-9#2)(1996-12#1)(1996-9#1)(1997-3#2)(2006-8#1)(2007-10#3)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#21)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#2)(2011-9#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#3)
13%)##4##1##(2007-7#1)(2008-10#1)(2008-5#2)
13) and##3##2##(2007-8#1)(2009-8#1)(2013-1#1)
13) in##2##2##(2008-12#1)(2008-6#1)
13) were##2##2##(2008-10#2)
13)##40##1##(1991-2#1)(1991-4#1)(1991-5#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
13-0##2##1##(1995-2#1)(2008-3#1)
13-1##2##1##(2008-10#1)(2012-12#1)
13-14##2##1##(2007-12#1)(2011-2#1)
13-15##5##1##(2007-12#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
13-16##4##1##(2007-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
13-17##2##1##(2008-11#2)
13-19##2##1##(1995-9#1)(2010-5#1)
13-2##2##1##(2011-2#1)(2013-1#1)
13-24 years old##3##3##(1995-9#2)(2013-1#1)
13-24##5##1##(1995-4#2)(1995-9#2)(2013-1#1)
13-HPODE##4##1##(1995-5#4)
13-WEEK STUDY IN##2##3##(2008-9#2)
13-acetate (PMA)##13##2##(1990-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#2)(2008-5#1)
13-acetate (TPA)##6##2##(1990-8#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-11#1)(1996-12#1)
13-acetate##23##1##(1990-2#1)(1990-8#1)(1992-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#3)(2008-5#1)
13-cis-RA##2##1##(1996-5#2)
13-diacetate##3##1##(1995-11#1)(1995-2#2)
13-dibutyrate lower##2##2##(1990-12#2)
13-dibutyrate##3##1##(1990-12#2)(1997-1#1)
13-fold##6##1##(1995-11#1)(1996-5#1)(2006-6#1)(2008-11#1)(2012-3#1)(2013-1#1)
13-microm##2##1##(2008-3#2)
13-month##2##1##(2008-8#2)
13-nm##2##1##(2008-3#1)(2010-4#1)
13-pentaoxa-16-azacyclooctadecane##2##1##(2008-10#2)
13-tetraoxa-7##7##1##(2008-10#7)
13-tetrathiacyclotetradec-1-oxy)hexanoic acid##2##2##(2008-10#2)
13-year##4##1##(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#1)
13-year-old boy##5##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
13-year-old girl##2##2##(2007-9#1)(2012-2#1)
13-year-old##9##1##(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#2)
13-yr##3##1##(2008-9#3)
13/14##2##1##(1992-12#1)(2006-10#1)
130 active##2##2##(2008-1#1)(2013-1#1)
130 bp deletion##2##3##(1990-7#2)
130 bp##3##2##(1990-7#3)
130 kDa##3##2##(1994-8#1)(2008-11#2)
130 km##2##2##(1997-5#1)(2007-8#1)
130 million##3##2##(2007-12#1)(2009-5#1)(2012-2#1)
130 to##2##2##(2008-10#1)(2008-5#1)
130 years##3##2##(1990-3#1)(1991-2#1)(2009-8#1)
130##70##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#3)(1991-2#1)(1992-12#2)(1993-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-5#1)(2007-12#5)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#4)
130%##4##1##(1997-6#1)(2008-10#2)(2008-3#1)
130) of##2##2##(1993-3#1)(2013-8#1)
130)##3##1##(1993-3#1)(2009-4#1)(2013-8#1)
130-fold##3##1##(1997-2#1)(2008-11#2)
130-fs##2##1##(2007-12#2)
1300 degrees C##6##3##(2008-10#6)
1300 nm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
1300##22##1##(1990-5#1)(1991-11#1)(1991-5#1)(1994-7#1)(1995-5#1)(2007-11#2)(2007-7#1)(2008-10#9)(2008-2#3)(2008-3#2)
1301##3##1##(1995-5#1)(1997-4#1)(2011-2#1)
131 and##2##2##(2008-10#2)
131 bp segment##2##3##(2006-8#2)
131##32##1##(1990-11#1)(1990-8#2)(1991-11#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-11#1)(2006-8#2)(2007-7#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
1314##2##1##(2007-11#1)(2007-12#1)
1319 nm##3##2##(2007-11#1)(2008-2#2)
1319-nm##2##1##(2007-11#1)(2008-2#1)
131I##3##1##(1990-8#1)(1993-9#1)(1994-2#1)
131I-MIBG##4##1##(1990-10#4)
132 (2000)]##2##2##(2007-12#2)
132 consecutive##2##2##(1990-12#1)(2010-2#1)
132 patients##2##2##(1990-12#1)(2008-1#1)
132##29##1##(1990-12#2)(1990-8#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-2#2)(1996-1#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
1320 nm##2##2##(2007-11#1)(2008-3#1)
1320##3##1##(2007-11#1)(2008-1#1)(2008-3#1)
1321N1 cells##3##2##(1997-2#1)(1997-7#2)
1321N1##5##1##(1997-2#2)(1997-7#3)
1328##2##1##(2008-10#1)(2008-3#1)
133 +/-##4##2##(1991-6#1)(2008-5#2)(2010-2#1)
133 isolates##2##2##(2008-10#2)
133##39##1##(1990-5#1)(1990-6#1)(1990-7#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-6#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)
133Xe##2##1##(1995-5#1)(2007-10#1)
134 and 0##2##3##(2008-10#1)(2008-9#1)
134 and##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
134 for##2##2##(2008-10#2)
134##20##1##(1990-10#2)(1991-6#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)
134-control-channel##2##1##(2007-11#2)
1340##2##1##(2007-12#1)(2008-5#1)
135 amino acids##2##3##(1990-2#1)(1993-2#1)
135 and##3##2##(1996-10#1)(2008-3#1)(2012-12#1)
135 cases##2##2##(1997-8#1)(2008-4#1)
135 degrees##4##2##(2008-10#2)(2008-3#2)
135 mm##2##2##(2008-10#1)(2008-5#1)
135 patients##4##2##(1991-8#1)(2011-2#1)(2012-12#2)
135##63##1##(1990-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#2)(2008-8#4)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#1)(2013-8#1)
1350 degrees C##3##3##(2008-10#3)
1350##4##1##(2008-10#3)(2008-6#1)
1350-kb chromosome##2##2##(1996-6#2)
1350-kb##3##1##(1996-6#3)
136 +/-##2##2##(1992-3#1)(1995-11#1)
136 micromol/L/year and progressed to ESRD in a mean##2##9##(2008-1#2)
136##25##1##(1992-3#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
1364##3##1##(2008-8#3)
137 bp##2##2##(2008-12#1)(2011-2#1)
137 communities##2##2##(2011-1#2)
137 isolates##2##2##(2008-10#2)
137##24##1##(1993-2#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)
1370##2##1##(2008-10#2)
1378- and 1385-nm##2##3##(2008-3#2)
138 cases##3##2##(1990-3#1)(2012-12#1)(2012-3#1)
138 mg/dl##2##2##(1993-12#1)(1994-11#1)
138 of##2##2##(1992-2#1)(2008-10#1)
138 patients treated##2##3##(2007-11#1)(2007-8#1)
138 patients##6##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-3#1)
138##28##1##(1990-3#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(2007-11#2)(2007-8#4)(2008-10#5)(2008-7#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
139 cases##2##2##(2008-3#1)(2013-1#1)
139 men##2##2##(1991-7#1)(2008-7#1)
139 patients##2##2##(2008-7#1)(2012-2#1)
139##30##1##(1990-8#3)(1991-7#1)(1991-9#1)(1994-1#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
139) and##2##2##(2008-4#1)(2008-5#1)
139)##4##1##(1990-8#1)(2008-11#1)(2008-4#1)(2008-5#1)
1392##2##1##(2008-3#2)
13C NMR and##2##3##(2008-11#1)(2013-8#1)
13C NMR chemical shift##2##4##(1993-11#1)(2009-7#1)
13C NMR spectra##5##3##(1992-10#1)(1992-12#3)(1995-11#1)
13C NMR spectroscopy##6##3##(1990-11#1)(1991-5#1)(1993-3#1)(1995-11#2)(1996-5#1)
13C NMR##28##2##(1990-11#2)(1991-5#1)(1992-10#3)(1992-12#5)(1992-3#1)(1993-11#3)(1993-3#1)(1994-11#1)(1995-11#5)(1996-5#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-3#1)(2013-8#1)
13C and 15N NMR assignments of Duck HBV##2##8##(2009-7#2)
13C and 15N NMR assignments of##3##6##(2009-7#3)
13C and 15N NMR##4##4##(1992-3#1)(2009-7#3)
13C and 15N resonance assignment of##2##6##(2009-7#2)
13C and 15N resonance assignments of the##2##7##(2009-7#2)
13C and 15N resonance assignments of##4##6##(2009-7#4)
13C and 15N resonance assignments##5##5##(2009-7#5)
13C and 15N resonance##7##4##(2009-7#7)
13C and 15N##13##3##(1992-3#1)(2009-7#12)
13C and##14##2##(1992-3#1)(2009-7#13)
13C resonance assignment of##2##4##(2009-7#2)
13C##73##1##(1990-11#2)(1990-9#1)(1991-5#2)(1992-10#3)(1992-12#5)(1992-3#2)(1993-11#5)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#6)(1995-5#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-12#1)(2009-7#35)(2011-3#1)(2012-3#1)(2013-8#2)
13C(alpha)##2##1##(2009-7#2)
13C(beta)##3##1##(2009-7#3)
13C-1H##2##1##(1992-4#2)
13C-NMR spectra##2##2##(1994-3#1)(1995-11#1)
13C-NMR spectroscopy##2##2##(1994-3#1)(1995-2#1)
13C-NMR##8##1##(1990-5#1)(1994-3#2)(1995-11#1)(1995-2#1)(1997-1#2)(2007-11#1)
13C-label##2##1##(1997-1#2)
13C-labelled##5##1##(1997-1#5)
13S##2##1##(1993-2#1)(2007-12#1)
13]##3##1##(1991-2#1)(2008-10#1)(2013-1#1)
13q##2##1##(1993-9#1)(2007-6#1)
13q14-32##2##1##(1997-5#2)
13th day##2##2##(2008-8#1)(2011-2#1)
13th##11##1##(1992-4#1)(1992-8#1)(1993-3#1)(1996-5#1)(1997-6#1)(2008-11#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
14 (0##2##2##(1993-1#1)(1994-6#1)
14 (1994)##3##2##(1996-12#1)(1996-5#1)(1997-2#1)
14 +/- 0##7##3##(1993-1#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-10#2)(2011-3#1)
14 +/-##12##2##(1993-1#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-7#1)(2010-4#1)(2011-2#1)(2011-3#1)
14 S(T)S(V)##2##2##(2008-10#2)
14 Spanish isolates##2##3##(2008-10#2)
14 a##2##2##(1991-11#1)(1991-6#1)
14 after##3##2##(2006-6#1)(2008-9#1)(2011-2#1)
14 alpha-methyl demethylase##2##3##(1991-5#2)
14 amino acid##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
14 amino acids##2##3##(2008-10#2)
14 amino##6##2##(1991-8#1)(2008-10#3)(2008-8#1)(2011-2#1)
14 and 0##2##3##(1993-8#1)(2008-10#1)
14 and 15##3##3##(1996-5#1)(2008-10#2)
14 and 17 in##2##4##(1990-3#1)(1995-3#1)
14 and 19 months##2##4##(1990-5#2)
14 and 19##3##3##(1990-5#2)(2009-5#1)
14 and 19F##2##3##(2012-12#2)
14 and 21##8##3##(1996-5#1)(2008-10#1)(2008-5#6)
14 and 4##2##3##(2008-10#1)(2008-5#1)
14 and later##2##3##(1997-7#1)(2008-7#1)
14 and##43##2##(1990-3#1)(1990-5#2)(1990-6#1)(1993-11#1)(1993-8#2)(1994-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-7#1)(2008-10#11)(2008-5#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
14 case-control studies##3##3##(1992-11#2)(1994-2#1)
14 cases##9##2##(1990-2#1)(1990-6#1)(1991-11#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#2)
14 centers##2##2##(2008-8#1)(2011-2#1)
14 colleagues##2##2##(2012-2#2)
14 d##2##2##(2008-8#1)(2011-2#1)
14 days (p less than 0##2##6##(1990-12#2)
14 days after inoculation##3##4##(2008-10#3)
14 days after##10##3##(1993-12#1)(1995-12#1)(1997-1#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#1)
14 days aged##2##3##(2010-4#2)
14 days later##2##3##(2007-2#1)(2013-1#1)
14 days of administration of##3##5##(1995-3#3)
14 days of age##2##4##(1996-2#1)(1997-6#1)
14 days of exposure##2##4##(2008-10#1)(2008-12#1)
14 days of##14##3##(1995-3#3)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2013-1#1)
14 days##74##2##(1990-12#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-12#2)(1994-1#1)(1994-6#1)(1995-12#3)(1995-3#4)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#16)(2008-11#5)(2008-12#4)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
14 days)##5##2##(1992-9#1)(1995-12#1)(2008-10#2)(2011-2#1)
14 degrees C##4##3##(1991-2#1)(2008-10#3)
14 degrees##5##2##(1991-2#1)(2008-10#4)
14 different##5##2##(1991-11#1)(1997-6#1)(2008-10#2)(2008-3#1)
14 dpi##6##2##(2008-10#6)
14 farms##2##2##(2008-10#2)
14 females##2##2##(1990-11#1)(2008-6#1)
14 for##2##2##(2008-10#1)(2008-7#1)
14 g##2##2##(1997-4#2)
14 g/dL##4##2##(2008-7#4)
14 g/liter carbon##2##3##(2008-10#2)
14 groups##2##2##(2008-10#2)
14 h##3##2##(2008-10#2)(2010-5#1)
14 healthy subjects##2##3##(1990-8#1)(2010-3#1)
14 healthy##3##2##(1990-8#1)(2010-3#1)(2010-8#1)
14 hospitals##2##2##(1992-2#1)(1997-2#1)
14 hr after##2##3##(2007-5#1)(2008-5#1)
14 in##5##2##(1996-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)
14 individuals##2##2##(1991-12#1)(2010-4#1)
14 isolates of##3##3##(2007-7#1)(2008-10#2)
14 isolates##4##2##(2007-7#1)(2008-10#3)
14 kDa##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
14 kcal/mol##2##2##(1996-2#2)
14 m##3##2##(2007-5#1)(2008-3#1)(2011-2#1)
14 men##2##2##(2007-12#1)(2011-2#1)
14 microM##3##2##(1991-5#1)(1994-8#1)(2008-10#1)
14 mm Hg##2##3##(1992-5#1)(2008-5#1)
14 mm##6##2##(1990-2#1)(1992-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
14 mm)##3##2##(2007-8#1)(2012-1#1)(2012-3#1)
14 month##3##2##(2008-7#1)(2012-2#2)
14 months after##2##3##(2011-2#1)(2013-1#1)
14 months##11##2##(1990-6#1)(1991-2#1)(1991-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
14 mug##2##2##(2008-10#2)
14 multi-stakeholder alliances participating in the Aligning Forces for Quality##2##10##(2013-1#2)
14 multi-stakeholder##3##2##(2013-1#3)
14 mum##2##2##(2008-2#1)(2008-3#1)
14 ng##3##2##(2008-10#3)
14 nmol GRF-antagonist##2##3##(1991-9#2)
14 nmol##4##2##(1991-9#3)(1993-9#1)
14 of the##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
14 of them##3##3##(1995-12#2)(2011-2#1)
14 of these##2##3##(2008-7#1)(2008-9#1)
14 of which##2##3##(2008-10#1)(2010-9#1)
14 of##16##2##(1990-9#1)(1991-6#1)(1994-1#1)(1995-12#2)(1995-3#1)(2008-10#3)(2008-7#2)(2008-9#2)(2010-9#1)(2011-2#1)(2013-1#1)
14 or##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
14 out of##3##3##(1991-9#1)(2008-4#1)(2008-9#1)
14 papers##2##2##(2008-2#1)(2008-8#1)
14 patients were##3##3##(1995-11#1)(2007-11#1)(2008-6#1)
14 patients with##14##3##(1990-2#1)(1990-3#1)(1990-9#2)(1991-4#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-1#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-9#1)(2011-2#1)
14 patients##39##2##(1990-2#2)(1990-3#1)(1990-9#2)(1991-4#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-8#1)(1993-1#1)(1995-11#2)(1995-12#1)(1996-11#3)(1996-5#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-11#5)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)(2013-1#3)
14 peptides##2##2##(1993-8#1)(2009-6#1)
14 plants##2##2##(2008-5#1)(2009-10#1)
14 reported##2##2##(1993-3#1)(2008-7#1)
14 species of##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
14 species##7##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)
14 studies##2##2##(1992-4#1)(2008-12#1)
14 subscales##3##2##(2012-2#3)
14 times##4##2##(1995-12#1)(1996-11#1)(2008-3#1)(2008-7#1)
14 to 18##4##3##(1991-5#1)(2007-12#1)(2008-10#2)
14 to##23##2##(1991-5#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-1#3)(2008-10#8)(2008-2#2)(2008-7#2)(2008-9#1)(2009-12#1)
14 types of##2##3##(2009-4#1)(2010-3#1)
14 types##3##2##(2008-5#1)(2009-4#1)(2010-3#1)
14 vs##2##2##(1992-11#1)(2011-1#1)
14 was##2##2##(1990-3#1)(2007-12#1)
14 weeks in##2##3##(1994-12#1)(1997-6#1)
14 weeks##13##2##(1991-5#1)(1991-6#1)(1994-12#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-9#4)(2010-7#1)(2013-1#1)
14 were##5##2##(1990-12#1)(1990-2#1)(1995-2#1)(1997-8#1)(2007-10#1)
14 with##4##2##(2007-2#1)(2008-2#1)(2008-6#1)(2008-7#1)
14 women with##2##3##(1990-11#1)(2008-7#1)
14 x##2##2##(2008-10#2)
14 years after##3##3##(2008-7#2)(2011-2#1)
14 years and##2##3##(2009-3#1)(2013-8#1)
14 years of age##3##4##(2012-12#1)(2013-1#1)(2013-7#1)
14 years##21##2##(1991-11#1)(1991-2#1)(2007-8#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
14 years]##2##2##(2011-2#1)(2013-1#1)
14 ± 0##3##3##(2013-1#1)(2013-7#1)(2013-8#1)
14##986##1##(1990-11#2)(1990-12#8)(1990-2#11)(1990-3#8)(1990-5#5)(1990-6#4)(1990-8#6)(1990-9#5)(1991-11#6)(1991-12#7)(1991-2#7)(1991-4#4)(1991-5#10)(1991-6#10)(1991-8#8)(1991-9#5)(1992-10#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#8)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#10)(1993-9#4)(1994-1#2)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#7)(1994-8#5)(1994-9#3)(1995-11#5)(1995-12#11)(1995-2#6)(1995-3#10)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#5)(1996-2#9)(1996-3#4)(1996-5#13)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#6)(1997-5#5)(1997-6#5)(1997-7#9)(1997-8#3)(1997-9#1)(2006-12#1)(2006-4#2)(2006-6#3)(2006-8#1)(2007-10#13)(2007-11#18)(2007-12#13)(2007-2#3)(2007-5#3)(2007-7#5)(2007-8#14)(2008-1#13)(2008-10#166)(2008-11#15)(2008-12#19)(2008-2#10)(2008-3#19)(2008-4#5)(2008-5#34)(2008-6#12)(2008-7#39)(2008-8#20)(2008-9#19)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#6)(2010-10#1)(2010-11#4)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#9)(2011-2#40)(2011-3#3)(2012-1#1)(2012-12#13)(2012-2#20)(2012-3#10)(2013-1#43)(2013-7#6)(2013-8#13)
14% and##4##2##(1991-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
14% had##4##2##(1992-11#1)(1994-6#1)(2007-11#1)(2008-10#1)
14% in##2##2##(2008-10#1)(2013-1#1)
14% of all##2##3##(1992-6#1)(2008-7#1)
14% of that##2##3##(1994-12#1)(1997-2#1)
14% of the students##2##4##(1992-6#1)(1993-3#1)
14% of the##7##3##(1991-5#1)(1992-6#1)(1993-3#1)(1997-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
14% of##15##2##(1990-12#1)(1991-5#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#1)
14% were##2##2##(2007-10#1)(2008-10#1)
14%##70##1##(1990-12#2)(1990-6#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
14%) patients and non stage-IV disease in##2##7##(2012-12#2)
14%) were##2##2##(2012-12#1)(2013-8#1)
14%)##12##1##(1994-6#1)(2008-12#2)(2011-1#1)(2011-2#2)(2012-12#3)(2013-7#1)(2013-8#2)
14) and##10##2##(1995-12#1)(1996-7#1)(2008-10#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
14) are##2##2##(2008-7#1)(2011-2#1)
14) were##2##2##(1996-11#1)(2012-1#1)
14)##44##1##(1990-11#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-7#1)(1997-7#2)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#2)
14+/-0##2##1##(2008-10#2)
14- and##5##2##(1990-11#1)(2008-10#4)
14-##7##1##(1990-11#1)(2008-10#5)(2013-1#1)
14-0##3##1##(1991-8#1)(1995-12#1)(2012-3#1)
14-16##8##1##(1991-6#1)(1994-3#1)(1995-2#1)(1996-9#1)(2008-5#1)(2011-2#2)(2012-1#1)
14-18##4##1##(1990-5#1)(1993-8#1)(2007-8#1)(2011-1#1)
14-2##2##1##(2008-10#2)
14-25##2##1##(1996-5#1)(2007-12#1)
14-26##2##1##(2008-6#1)(2013-1#1)
14-3-3 family##2##2##(2008-11#2)
14-3-3 protein##5##2##(1997-3#1)(2008-11#3)(2010-12#1)
14-3-3 proteins and CK8##3##4##(2008-11#3)
14-3-3 proteins and##4##3##(2008-11#4)
14-3-3 proteins##5##2##(2008-11#4)(2012-12#1)
14-3-3 σ protein##2##3##(2010-12#2)
14-3-3 σ##4##2##(2010-12#4)
14-3-3##20##1##(1997-3#1)(2008-11#10)(2008-9#1)(2010-12#6)(2012-12#2)
14-3-3beta##5##1##(2008-9#5)
14-day-old##2##1##(2008-5#2)
14-eicosatetraenoic acid##2##2##(1992-8#1)(1994-8#1)
14-eicosatetraenoic##3##1##(1992-8#1)(1994-8#1)(1995-11#1)
14-fold##3##1##(1997-7#1)(2008-10#1)(2008-3#1)
14-fs pulses at 1##2##4##(2007-11#2)
14-kDa product##2##2##(1991-12#2)
14-kDa protein##4##2##(2008-10#3)(2009-5#1)
14-kDa subunit##2##2##(1995-6#2)
14-kDa subunits##2##2##(1995-6#2)
14-kDa trypsin inhibitor##2##3##(2008-10#2)
14-kDa##14##1##(1991-12#2)(1995-6#4)(2008-10#7)(2009-5#1)
14-membered##2##1##(2008-10#1)(2009-10#1)
14-year-old boy##3##2##(2007-5#1)(2011-1#1)(2012-12#1)
14-year-old girl with##3##3##(2006-12#1)(2007-7#1)(2008-9#1)
14-year-old girl##8##2##(2006-12#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)(2013-1#1)
14-year-old male##3##2##(2008-10#1)(2008-6#1)(2010-5#1)
14-year-old##16##1##(2006-12#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
14/15##2##1##(2008-12#1)(2013-1#1)
140 and##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
140 degrees C##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
140 fs##2##2##(2007-11#1)(2008-2#1)
140 mM##2##2##(1995-11#1)(1995-12#1)
140 microM##2##2##(1994-8#1)(1995-2#1)
140 microm##2##2##(2008-3#1)(2008-5#1)
140 min##2##2##(2008-10#1)(2010-8#1)
140 mm##4##2##(2008-11#3)(2008-3#1)
140 mmHg##2##2##(2007-8#1)(2008-1#1)
140 mul##2##2##(2008-10#2)
140 ng##2##2##(2008-10#1)(2012-12#1)
140##76##1##(1990-11#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-6#1)(1992-3#5)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#2)(1996-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#5)(2013-8#1)
140%##3##1##(1990-7#1)(2008-11#1)(2008-12#1)
140-145]##2##1##(1995-2#1)(1995-5#1)
140-kDa protein##3##2##(1992-3#1)(1994-12#2)
140-kDa##6##1##(1990-12#1)(1992-3#2)(1994-12#3)
140/90 mm Hg##2##3##(2010-4#1)(2011-1#1)
140/90##4##1##(2008-1#1)(2008-10#1)(2010-4#1)(2011-1#1)
1400 degrees C##3##3##(1995-6#1)(2008-10#2)
1400 mg##2##2##(2008-3#2)
1400##16##1##(1990-5#1)(1995-6#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-3#5)(2013-8#1)
1401##2##1##(1995-3#1)(1997-6#1)
1407-nm Raman##2##2##(2007-12#2)
141##16##1##(1990-8#1)(1993-2#1)(1995-8#1)(1996-5#1)(1997-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#2)(2013-8#1)
142 patients##3##2##(1996-6#1)(2007-1#1)(2008-9#1)
142##18##1##(1990-2#1)(1990-8#1)(1992-10#1)(1992-3#1)(1996-11#1)(1996-6#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-7#1)
142-bp##2##1##(1996-6#2)
1420##2##1##(2008-3#1)(2009-10#1)
1424 bp##2##2##(1990-11#1)(1993-8#1)
143 and##2##2##(1991-11#1)(2008-10#1)
143##31##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1992-9#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
143)##3##1##(2008-10#2)(2008-5#1)
1430##2##1##(1997-7#1)(2008-3#1)
144 h##3##2##(2008-10#1)(2008-6#2)
144 patients##3##2##(2007-11#1)(2010-8#1)(2011-2#1)
144##39##1##(1990-6#1)(1990-7#1)(1992-6#1)(1992-8#1)(1996-2#1)(1997-8#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)
145 beta##2##2##(1992-3#2)
145##23##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-3#2)(1995-12#1)(1996-6#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#4)(2012-12#1)
1450 ppm fluoride##5##3##(2011-2#5)
1450##8##1##(1990-10#1)(2008-10#1)(2008-5#1)(2011-2#5)
146 +/-##2##2##(1991-5#1)(1995-3#1)
146##27##1##(1991-5#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#2)(2006-10#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
147##23##1##(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-8#2)(1996-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
147%##2##1##(2008-9#1)(2010-8#1)
147)##3##1##(1990-8#1)(1995-3#1)(2008-8#1)
1470##3##1##(1996-6#1)(2008-10#2)
148 +/-##2##2##(1992-3#1)(1994-6#1)
148 women##2##2##(1992-2#1)(2008-7#1)
148##27##1##(1991-6#1)(1992-2#2)(1992-3#1)(1993-6#1)(1994-6#1)(1994-8#4)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
1480##2##1##(2007-12#1)(2008-11#1)
149 +/-##3##2##(1994-6#1)(2007-10#1)(2007-7#1)
149 patients##2##2##(1990-3#1)(2011-1#1)
149##27##1##(1990-3#1)(1990-5#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
149)##6##1##(1997-4#1)(2010-3#5)
14C##5##1##(1991-12#1)(1991-3#1)(2008-5#3)
14C-labeled##2##1##(1992-6#1)(1994-8#1)
14C2H2-inhibited##2##1##(1992-3#2)
14CNO##2##1##(2008-5#2)
14CO2 generated from##2##3##(1991-3#2)
14CO2 generated##3##2##(1991-3#3)
14CO2 production via##2##3##(1991-3#2)
14CO2 production##3##2##(1991-3#3)
14CO2##11##1##(1991-3#8)(1992-12#1)(1992-9#1)(1994-8#1)
14D##2##1##(2008-5#1)(2010-8#1)
14F7 Mab##2##2##(2012-3#2)
14F7##6##1##(2012-3#6)
14L##2##1##(2008-5#1)(2010-8#1)
14ngml(-1)##2##1##(2008-10#2)
14q subtelomeric DNA##2##3##(1997-6#2)
14q##4##1##(1997-6#4)
14th##9##1##(1990-12#1)(1990-9#2)(2007-11#1)(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#2)
15 (3##2##2##(2007-7#1)(2011-2#1)
15 (5##2##2##(2008-9#1)(2011-2#1)
15 +/- 0##3##3##(1991-12#1)(1992-5#1)(1992-9#1)
15 +/- 1##2##3##(1996-2#1)(2013-1#1)
15 +/- 5%##2##3##(1992-8#1)(1996-5#1)
15 +/-##9##2##(1991-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-7#1)(2013-1#1)
15 000##2##2##(2008-4#1)(2008-5#1)
15 A##2##2##(1992-4#1)(2008-10#1)
15 August##2##2##(2008-10#2)
15 GHz##2##2##(2008-10#1)(2008-3#1)
15 Gy##3##2##(2008-11#2)(2008-6#1)
15 K##3##2##(2008-10#2)(2008-7#1)
15 M NaCl##3##3##(1992-10#2)(2008-11#1)
15 M##6##2##(1992-10#3)(1994-8#1)(2008-10#1)(2008-11#1)
15 MV##6##2##(2008-3#1)(2009-11#2)(2013-1#3)
15 New##2##2##(1995-3#1)(2008-9#1)
15 P##2##2##(2011-2#1)(2013-8#1)
15 STR loci##3##3##(2008-12#3)
15 STR markers##2##3##(2008-12#2)
15 STR##6##2##(2008-12#6)
15 V##5##2##(2007-11#1)(2008-10#4)
15 W of##2##3##(2007-12#1)(2008-2#1)
15 W##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
15 amino##2##2##(1992-8#1)(2008-11#1)
15 and 20 degrees C##2##5##(2008-10#2)
15 and 20##6##3##(1991-12#2)(2006-12#1)(2008-10#2)(2013-8#1)
15 and 22##2##3##(1996-8#1)(2008-10#1)
15 and 25 degrees C##2##5##(2008-10#1)(2008-12#1)
15 and 25##4##3##(1990-7#1)(2008-10#1)(2008-12#1)(2009-5#1)
15 and 30##3##3##(2008-10#2)(2011-2#1)
15 and 35##2##3##(1990-6#1)(2008-10#1)
15 and 45##2##3##(2008-2#1)(2008-9#1)
15 and X##2##3##(1993-11#2)
15 and##55##2##(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#2)(1996-8#1)(2006-12#1)(2007-11#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
15 autosomal STR loci in##2##5##(2008-12#2)
15 base##2##2##(1994-9#1)(2008-10#1)
15 cases of##3##3##(2007-8#1)(2008-7#2)
15 cases##13##2##(1991-6#1)(1994-7#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-7#3)(2009-3#1)(2009-4#1)(2011-2#2)(2013-1#1)
15 cigarettes##2##2##(1994-6#1)(2007-12#1)
15 cm##12##2##(1996-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2013-8#2)
15 d##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
15 dB##2##2##(1995-6#1)(2007-11#1)
15 day##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
15 days after the##2##4##(2007-11#1)(2007-8#1)
15 days after##7##3##(2007-11#1)(2007-8#2)(2008-10#4)
15 days and##4##3##(1996-6#1)(2008-10#3)
15 days before##2##3##(2008-10#1)(2013-8#1)
15 days for##2##3##(2008-10#1)(2008-11#1)
15 days of##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
15 days post##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
15 days post-implantation##2##3##(2008-5#2)
15 days to##3##3##(1996-5#1)(2008-10#2)
15 days##58##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1995-2#2)(1996-5#1)(1996-6#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-5#7)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#4)
15 degrees C and##4##4##(2008-10#2)(2008-8#1)(2011-2#1)
15 degrees C with##3##4##(2008-10#1)(2008-2#2)
15 degrees C##26##3##(1990-8#1)(1997-4#1)(2008-10#19)(2008-2#2)(2008-8#1)(2008-9#1)(2011-2#1)
15 degrees##34##2##(1990-8#1)(1997-4#1)(2007-11#1)(2008-10#20)(2008-2#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2011-2#2)
15 different##7##2##(1997-4#1)(2007-7#1)(2008-10#4)(2008-5#1)
15 exons##2##2##(1995-8#1)(2008-4#1)
15 families##2##2##(1995-1#1)(2008-5#1)
15 female mice##3##3##(2008-9#3)
15 female p53 haploinsufficient mice##7##5##(2008-8#1)(2008-9#6)
15 female##23##2##(2008-8#3)(2008-9#19)(2011-2#1)
15 females##4##2##(1990-10#1)(1991-12#2)(2008-7#1)
15 fg##2##2##(2008-10#2)
15 for##2##2##(2008-10#2)
15 g##4##2##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
15 generations##3##2##(1995-8#1)(2008-10#2)
15 genotypes##2##2##(2008-10#2)
15 h##3##2##(1994-2#1)(2008-5#1)(2008-7#1)
15 h(-1)##3##2##(2008-10#3)
15 had##2##2##(1994-2#1)(1994-8#1)
15 healthy individuals##2##3##(2008-5#1)(2008-7#1)
15 healthy volunteers##2##3##(2010-6#1)(2011-2#1)
15 healthy##6##2##(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
15 in##5##2##(1990-2#1)(1990-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
15 isolates from##2##3##(2008-10#2)
15 isolates##3##2##(2008-10#3)
15 kDa##4##2##(1991-2#1)(1992-3#1)(1995-8#1)(2008-10#1)
15 kV##2##2##(2008-10#2)
15 km##3##2##(2007-12#1)(2008-3#2)
15 loci##3##2##(2008-12#3)
15 m##2##2##(2008-10#1)(2008-3#1)
15 mM sodium##3##3##(2008-10#3)
15 mM##13##2##(1990-5#2)(1991-12#1)(1994-5#1)(1995-8#1)(2008-10#7)(2008-7#1)
15 mW##2##2##(2007-11#1)(2008-2#1)
15 male and##21##3##(2008-1#1)(2008-8#3)(2008-9#17)
15 males##3##2##(2007-7#1)(2008-5#1)(2008-9#1)
15 mg l(-1)##2##3##(2008-10#2)
15 mg of##2##3##(1992-8#1)(2008-11#1)
15 mg##12##2##(1992-8#1)(1996-12#1)(1997-4#2)(2008-10#3)(2008-11#2)(2008-9#2)(2012-12#1)
15 mg/kg##3##2##(1991-8#1)(1992-3#1)(2008-7#1)
15 mg/m2##2##2##(1990-2#1)(1991-5#1)
15 microM##6##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-9#1)(1995-5#1)(1995-6#1)
15 micromol##2##2##(2008-10#2)
15 micromol/l##3##2##(2008-7#3)
15 million##2##2##(1993-1#1)(1993-6#1)
15 min after##6##3##(1990-5#1)(1995-12#1)(2006-6#1)(2008-6#1)(2013-1#2)
15 min and##3##3##(1994-8#1)(2008-7#1)(2012-3#1)
15 min at##2##3##(1997-1#1)(2009-8#1)
15 min before the##2##4##(1993-12#1)(2006-6#1)
15 min before##4##3##(1992-12#1)(1993-12#1)(1994-2#1)(2006-6#1)
15 min in##2##3##(1992-8#1)(1995-5#1)
15 min light##2##3##(2008-5#2)
15 min of##7##3##(1993-9#1)(1996-12#1)(2008-10#2)(2010-3#2)(2011-2#1)
15 min##71##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#4)(1994-8#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-12#1)(1997-1#1)(2006-6#2)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#2)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
15 min)##7##2##(1992-8#1)(1993-1#1)(1995-3#1)(1995-8#1)(1997-4#1)(2010-3#1)(2013-8#1)
15 minutes##12##2##(1991-1#1)(1992-3#1)(1994-7#2)(1994-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
15 ml and##2##3##(2008-10#1)(2008-11#1)
15 ml of##4##3##(2008-10#4)
15 ml##8##2##(2008-10#7)(2008-11#1)
15 mm in##3##3##(1995-12#2)(2008-8#1)
15 mm##9##2##(1995-12#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)
15 mol##2##2##(2008-10#2)
15 months after##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
15 months##16##2##(1992-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2010-12#1)(2010-6#5)(2011-2#1)(2012-2#1)(2013-1#1)
15 mug ml(-1)##5##3##(2008-10#5)
15 mug##7##2##(2008-10#7)
15 mum##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
15 mumol l(-1)##2##3##(2008-10#2)
15 nM)##2##2##(1991-5#1)(1995-3#1)
15 nationalities as##2##3##(1995-6#2)
15 nm##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#1)(2009-7#1)
15 of the 18##2##4##(1997-7#1)(2008-10#1)
15 of the##6##3##(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
15 of these##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
15 of##13##2##(1990-8#1)(1991-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
15 or 20 min##2##4##(2008-11#1)(2010-2#1)
15 or 30##3##3##(1994-2#1)(1995-12#1)(2008-10#1)
15 or##7##2##(1994-2#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-2#1)(2013-1#1)
15 other##4##2##(1995-9#1)(2008-10#3)
15 out of##8##3##(1990-5#1)(1990-6#1)(1996-7#1)(1996-9#1)(2008-10#2)(2009-8#1)(2011-1#1)
15 papers##2##2##(2008-3#1)(2013-1#1)
15 patent##2##2##(2010-12#2)
15 patients had##3##3##(1991-12#1)(1992-6#1)(1997-6#1)
15 patients underwent##2##3##(1994-3#1)(2007-8#1)
15 patients with##9##3##(1990-2#1)(1990-8#1)(1990-9#1)(1991-9#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
15 patients##36##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-6#3)(2008-7#3)(2008-9#2)(2011-2#2)(2012-3#3)
15 patients)##2##2##(1993-2#1)(2007-11#1)
15 percent of##4##3##(1992-3#1)(1995-12#1)(1996-6#1)(2011-2#1)
15 percent##7##2##(1992-3#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(2011-2#1)
15 pg##3##2##(2008-10#2)(2011-3#1)
15 points##2##2##(2008-3#1)(2008-9#1)
15 ppm##2##2##(2008-10#1)(2010-1#1)
15 pts##2##2##(1996-3#1)(2010-3#1)
15 pts)##3##2##(2010-12#3)
15 rabbits in the##2##4##(2008-11#2)
15 s and##4##3##(2008-10#4)
15 s##10##2##(1991-10#1)(2008-10#7)(2008-5#1)(2009-7#1)
15 samples h(-1)##3##3##(2008-10#3)
15 samples##6##2##(2008-10#4)(2013-1#2)
15 schools##2##2##(2009-2#1)(2013-1#1)
15 sec##3##2##(1991-12#1)(1992-9#1)(2010-7#1)
15 species##5##2##(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#2)
15 strains of##2##3##(2008-1#1)(2008-10#1)
15 studies##3##2##(1990-6#1)(2012-12#1)(2013-8#1)
15 subjects##3##2##(1995-5#1)(2008-7#1)(2008-9#1)
15 times##5##2##(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
15 to 0##2##3##(2008-10#1)(2008-5#1)
15 to 17##2##3##(1992-3#1)(2008-5#1)
15 to 18##2##3##(2008-10#2)
15 to 20 degrees C##2##5##(2008-10#2)
15 to 20##6##3##(1991-12#1)(2008-10#2)(2008-11#1)(2009-7#2)
15 to 20%##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
15 to 25##3##3##(2007-6#1)(2008-10#1)(2009-8#1)
15 to 30 min##2##4##(1990-12#1)(2008-10#1)
15 to 30##5##3##(1990-12#1)(2008-10#3)(2008-2#1)
15 to##39##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#1)(1995-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2011-1#2)(2013-1#2)
15 undergoing##2##2##(1994-2#2)
15 weeks after injury##2##4##(2012-3#2)
15 weeks after inoculation##2##4##(2008-10#2)
15 weeks after##5##3##(2008-10#2)(2008-9#1)(2012-3#2)
15 weeks##11##2##(1995-11#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#2)(2012-3#2)
15 were##5##2##(1993-2#1)(2008-11#2)(2008-4#1)(2010-3#1)
15 with##5##2##(1990-2#1)(2008-11#1)(2008-5#1)(2008-6#2)
15 women##3##2##(2008-9#1)(2010-6#1)(2011-2#1)
15 women)##2##2##(1992-2#1)(1992-3#1)
15 x##2##2##(1990-10#1)(2012-3#1)
15 year##2##2##(1997-3#1)(2007-7#1)
15 years after##3##3##(1991-6#1)(2008-12#1)(2013-1#1)
15 years ago##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
15 years and##3##3##(2008-10#1)(2013-1#2)
15 years have##3##3##(1996-1#1)(2008-10#1)(2008-7#1)
15 years of age##7##4##(1995-11#1)(2006-10#1)(2007-7#1)(2008-6#1)(2009-7#1)(2013-1#2)
15 years of##12##3##(1995-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-5#1)(2013-1#2)(2013-8#1)
15 years old##4##3##(1993-6#1)(2008-6#1)(2011-1#1)(2011-2#1)
15 years or##4##3##(1994-6#2)(2008-10#1)(2011-1#1)
15 years since##2##3##(1997-5#1)(2010-5#1)
15 years##81##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-6#3)(1995-11#1)(1996-1#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-3#1)(2009-7#1)(2010-12#3)(2010-3#2)(2010-5#3)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#5)(2013-1#8)(2013-8#2)
15 years)##2##2##(1995-5#1)(2013-1#1)
15##1450##1##(1990-10#2)(1990-11#1)(1990-12#9)(1990-2#11)(1990-3#4)(1990-5#8)(1990-6#8)(1990-7#3)(1990-8#8)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#14)(1991-2#4)(1991-3#1)(1991-5#7)(1991-6#6)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#9)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#8)(1992-9#3)(1993-1#6)(1993-11#6)(1993-12#8)(1993-2#4)(1993-3#4)(1993-6#3)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#4)(1994-2#11)(1994-3#3)(1994-5#3)(1994-6#12)(1994-7#4)(1994-8#7)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#10)(1995-2#4)(1995-3#5)(1995-5#9)(1995-6#7)(1995-8#7)(1995-9#3)(1996-1#1)(1996-12#8)(1996-2#5)(1996-3#4)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#8)(1997-5#6)(1997-6#9)(1997-7#5)(1997-8#9)(2006-10#2)(2006-12#2)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#19)(2007-12#16)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#17)(2008-1#14)(2008-10#341)(2008-11#40)(2008-12#31)(2008-2#21)(2008-3#37)(2008-4#11)(2008-5#52)(2008-6#24)(2008-7#38)(2008-8#19)(2008-9#67)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#11)(2009-8#5)(2009-9#1)(2010-1#5)(2010-10#4)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#11)(2010-4#3)(2010-5#8)(2010-6#8)(2010-7#3)(2010-8#5)(2011-1#13)(2011-2#57)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#9)(2012-2#23)(2012-3#18)(2013-1#48)(2013-7#6)(2013-8#23)
15% after##2##2##(1990-2#1)(2011-2#1)
15% and##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-1#1)
15% at##3##2##(1991-5#1)(1992-12#1)(2008-10#1)
15% by##2##2##(2008-11#1)(2008-3#1)
15% enzyme##2##2##(2008-5#2)
15% flaxseed flour##3##3##(2010-4#3)
15% for##5##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
15% had##2##2##(1997-6#1)(2008-7#1)
15% in##6##2##(2008-10#2)(2008-2#1)(2009-10#1)(2013-1#1)(2013-8#1)
15% increase in##3##3##(2008-3#1)(2008-4#1)(2012-1#1)
15% of normal##2##3##(1991-11#1)(2008-9#1)
15% of patients##2##3##(1993-9#1)(2007-7#1)
15% of the cases##2##4##(1992-6#1)(2008-9#1)
15% of the##15##3##(1991-11#1)(1992-11#1)(1992-6#1)(1995-11#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
15% of women##3##3##(1990-6#1)(2008-1#1)(2011-2#1)
15% of##44##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-4#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#2)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
15% to 30% of##2##4##(2007-12#1)(2008-10#1)
15% to##3##2##(2007-12#1)(2007-5#1)(2008-10#1)
15% vs##2##2##(1995-2#1)(2011-1#1)
15% was##2##2##(2007-12#1)(2008-10#1)
15% with##3##2##(1991-3#1)(2008-3#1)(2008-8#1)
15%##171##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#4)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#38)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
15%) and##2##2##(2012-3#1)(2013-1#1)
15%)##12##1##(1993-9#1)(1994-2#1)(1995-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
15%-25%##2##1##(2008-8#1)(2013-8#1)
15'- monooxygenase##2##2##(2009-6#2)
15) and##9##2##(1997-3#1)(2007-2#1)(2008-10#3)(2008-6#1)(2008-7#2)(2013-1#1)
15) or##2##2##(1994-5#1)(2008-7#1)
15) were##3##2##(1991-12#1)(1996-7#1)(2008-10#1)
15)##38##1##(1990-8#1)(1991-11#1)(1991-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#4)(2009-8#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
15)]##2##1##(2008-4#1)(2013-1#1)
15+/-0##7##1##(2008-10#5)(2008-11#2)
15- and 22-month-old##2##3##(1994-3#2)
15- and##5##2##(1994-3#3)(2008-2#1)(2013-1#1)
15-##8##1##(1994-3#4)(2008-10#1)(2008-2#1)(2008-6#1)(2013-1#1)
15-(2##2##1##(2008-10#2)
15-0##5##1##(2008-10#3)(2008-3#1)(2008-7#1)
15-1##4##1##(1996-12#1)(2008-10#2)(2011-2#1)
15-16##4##1##(1995-3#1)(2008-4#1)(2008-5#1)(2010-4#1)
15-17##4##1##(1992-3#1)(1993-2#1)(1995-3#1)(2010-1#1)
15-18##3##1##(1995-12#1)(2007-10#1)(2007-6#1)
15-19 years old##2##3##(1996-6#1)(2008-12#1)
15-19 years##3##2##(1996-6#1)(2008-12#1)(2013-1#1)
15-19##5##1##(1994-2#1)(1996-6#1)(2008-12#1)(2009-9#1)(2013-1#1)
15-20 min##2##2##(2007-8#2)
15-20##9##1##(1994-3#1)(1996-5#1)(2007-10#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
15-24 year##2##2##(1997-6#1)(2013-8#1)
15-24##4##1##(1997-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
15-25 min and##2##3##(1997-2#1)(2008-10#1)
15-25##4##1##(1997-2#1)(2007-12#1)(2008-10#1)(2013-8#1)
15-25% of##2##2##(1992-12#1)(2010-3#1)
15-25%##4##1##(1992-12#1)(1994-6#1)(2010-3#1)(2012-2#1)
15-29-years age##2##2##(1994-12#2)
15-30 min##2##2##(1993-9#1)(1995-8#1)
15-30##7##1##(1993-9#1)(1994-8#1)(1995-8#1)(1996-11#1)(2007-7#1)(2008-10#1)(2013-1#1)
15-45##5##1##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
15-49 years##3##2##(1993-11#1)(2009-7#1)(2012-3#1)
15-60##2##1##(1991-9#1)(2012-3#1)
15-EET##3##1##(1990-2#3)
15-acetyldeoxynivalenol##5##1##(1997-6#3)(2008-10#2)
15-amino acid##2##2##(1994-12#2)
15-crown-5##3##1##(2008-10#3)
15-day##3##1##(2008-10#1)(2008-11#1)(2008-6#1)
15-deoxyspergualin##2##1##(1993-8#2)
15-fold stimulation of##2##3##(1991-2#1)(1993-6#1)
15-fold##9##1##(1990-10#1)(1991-2#1)(1993-6#2)(1995-8#1)(2008-10#3)(2011-2#1)
15-item##2##1##(1993-2#1)(2007-12#1)
15-lipoxygenase##7##1##(1995-5#5)(2008-5#2)
15-lipoxygenases##2##1##(1995-5#2)
15-m##2##1##(1990-8#1)(1994-9#1)
15-mJ##2##1##(2007-12#1)(2008-3#1)
15-mer##2##1##(2008-10#1)(2008-8#1)
15-min##2##1##(2008-11#1)(2013-1#1)
15-month##4##1##(1994-3#1)(2008-3#2)(2012-3#1)
15-nt##2##1##(1995-8#1)(1997-7#1)
15-year period##2##2##(1991-8#1)(2011-2#1)
15-year##5##1##(1991-8#1)(2007-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
15-year-old boy##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
15-year-old female##2##2##(2012-2#1)(2013-1#1)
15-year-old##18##1##(2007-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
15/15##2##1##(2008-10#2)
150 +/-##2##2##(1990-12#1)(1995-3#1)
150 F(2)##2##2##(2008-10#2)
150 F(8) RILs##2##3##(2008-10#2)
150 Hz)##2##2##(2008-3#1)(2013-8#1)
150 V##2##2##(2007-12#1)(2008-10#1)
150 W##2##2##(2007-11#1)(2007-12#1)
150 and##6##2##(1995-2#1)(1997-2#1)(2008-10#2)(2008-12#1)(2011-1#1)
150 cases##4##2##(1990-12#1)(1996-3#1)(2011-2#1)(2013-1#1)
150 cells##2##2##(2009-12#2)
150 degrees C##11##3##(1997-2#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2013-8#2)
150 degrees##12##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2013-8#2)
150 kDa##4##2##(1990-5#2)(1997-2#2)
150 kg N ha(-1)##2##4##(2008-12#2)
150 kg N##3##3##(2008-12#3)
150 km##2##2##(1997-5#1)(2008-10#1)
150 m##2##2##(2008-10#1)(2008-3#1)
150 mM NaCl##2##3##(1990-8#1)(1994-5#1)
150 mM##8##2##(1990-8#1)(1991-5#1)(1994-5#2)(1996-5#1)(1997-2#1)(2008-12#2)
150 mOsm kg(-1)##3##3##(2008-11#3)
150 medicinal plants##2##3##(2008-5#2)
150 men##2##2##(2008-5#1)(2008-9#1)
150 mg/day##2##2##(2008-1#2)
150 mg/kg##3##2##(1991-9#1)(2008-10#2)
150 microm##2##2##(2008-10#1)(2010-8#1)
150 min##2##2##(2008-10#1)(2008-5#1)
150 ml##3##2##(2008-10#3)
150 mm##5##2##(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)(2012-3#1)
150 mum##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
150 nM##3##2##(1993-6#1)(1994-9#2)
150 ng##2##2##(1994-7#1)(2008-10#1)
150 nm##3##2##(2007-12#2)(2008-3#1)
150 patients with##4##3##(1991-11#1)(1995-11#1)(2007-7#1)(2009-11#1)
150 patients##10##2##(1990-8#1)(1991-11#1)(1992-1#1)(1995-11#2)(1996-3#1)(2007-7#1)(2009-11#1)(2010-6#1)(2013-1#1)
150 pulses/train##2##2##(2008-9#2)
150 s##2##2##(2007-11#1)(2008-10#1)
150 samples of##2##3##(2007-10#1)(2008-5#1)
150 samples##3##2##(2007-10#1)(2008-10#1)(2008-5#1)
150 to##3##2##(1993-1#1)(2008-9#1)(2013-1#1)
150 x##2##2##(2008-10#1)(2008-3#1)
150##240##1##(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#2)(1990-8#2)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#5)(1997-5#2)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#51)(2008-11#6)(2008-12#6)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#12)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
150%##6##1##(1993-3#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
150)##3##1##(1992-3#1)(1995-2#1)(2008-3#1)
150-200##5##1##(1990-2#1)(1993-6#1)(2008-10#1)(2008-11#1)(2009-11#1)
150-300##2##1##(2008-1#1)(2011-2#1)
150-350##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
150-W##2##1##(2008-10#1)(2008-3#1)
150-fs##4##1##(2007-11#2)(2008-3#2)
150-m vertical##2##2##(2008-2#2)
150-mul##2##1##(2008-10#2)
1500 and 2000##2##3##(2007-11#1)(2008-10#1)
1500 and##4##2##(2007-11#1)(2008-10#3)
1500 degrees C##4##3##(2008-10#1)(2008-2#1)(2009-7#2)
1500 degrees##5##2##(2008-10#2)(2008-2#1)(2009-7#2)
1500 g##4##2##(1992-2#1)(2007-11#1)(2008-11#2)
1500 paediatric patients##2##3##(2013-1#2)
1500 patients##2##2##(1994-3#1)(2008-5#1)
1500##37##1##(1990-3#1)(1991-12#1)(1991-5#1)(1992-2#2)(1993-8#1)(1994-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#2)(2009-9#1)(2013-1#3)
1505##5##1##(2008-10#3)(2008-3#1)(2012-3#1)
150IU 3 times##2##3##(2007-11#2)
150W##4##1##(2008-10#2)(2013-1#2)
150mul##2##1##(2008-10#2)
151 patients##3##2##(1990-9#2)(2011-1#1)
151##26##1##(1990-2#1)(1990-9#2)(1991-3#1)(1992-3#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-5#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
1515 Apple##2##2##(2008-10#2)
1515 to##2##2##(2007-11#1)(2008-2#1)
1515##6##1##(2007-11#1)(2008-10#3)(2008-2#1)(2011-1#1)
1515)##2##1##(2008-10#2)
152 patients##2##2##(2008-4#1)(2012-12#1)
152##28##1##(1990-3#1)(1993-12#1)(1993-9#1)(1994-8#1)(1996-2#2)(1997-4#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
153 and##4##2##(1997-8#3)(2008-10#1)
153##40##1##(1990-5#2)(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#2)(1997-8#4)(2007-11#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
1530##2##1##(1995-12#1)(1996-12#1)
1531##2##1##(2007-11#2)
1535-1555-nm##2##1##(2007-12#2)
153N##2##1##(2008-10#2)
154##22##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-11#1)(1997-2#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#5)(2012-3#1)(2013-8#2)
1540 nm##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
1540##8##1##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)
1545##2##1##(2007-11#2)
1547##2##1##(2007-12#1)(2008-10#1)
1549##2##1##(2007-12#1)(2013-1#1)
155 bp##2##2##(2008-10#2)
155 kDa##2##2##(1990-7#1)(1996-5#1)
155 patients##2##2##(1994-3#1)(2008-10#1)
155##28##1##(1990-7#1)(1993-3#1)(1994-3#1)(1996-5#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-7#1)(2013-8#2)
155%##3##1##(1990-2#1)(2008-11#1)(2011-2#1)
1550 nm and##2##3##(2007-12#1)(2008-2#1)
1550 nm is##2##3##(2007-12#1)(2008-3#1)
1550 nm##14##2##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#5)
1550##18##1##(1997-8#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#5)
1550-nm wavelength##2##2##(2008-2#1)(2008-3#1)
1550-nm##6##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
1553 and 1593 cm(-1)##2##4##(2008-10#2)
1553##4##1##(2007-11#1)(2008-10#2)(2010-4#1)
1558##2##1##(2008-3#1)(2009-8#1)
156 +/-##2##2##(1992-3#1)(2008-10#1)
156 and##2##2##(2008-2#1)(2008-6#1)
156 cases##2##2##(1994-12#1)(2007-11#1)
156 children##2##2##(2011-1#1)(2011-2#1)
156 instruments were collected (from 1 to 10 per ward) evaluating 55 different actual or potential patient problems##2##18##(2013-1#2)
156 patients with##2##3##(1996-6#1)(2007-10#1)
156 patients##5##2##(1996-6#1)(2007-10#1)(2010-12#1)(2011-2#2)
156##32##1##(1991-2#1)(1992-3#1)(1994-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2013-1#2)
1560##2##1##(2007-10#1)(2007-11#1)
1560-nm##2##1##(2008-2#2)
1562##2##1##(2008-10#2)
1563##2##1##(2007-11#2)
1566##2##1##(2007-11#1)(2008-2#1)
157 and##2##2##(1997-7#1)(2013-1#1)
157 in##2##2##(2008-2#1)(2008-5#1)
157 nm##3##2##(2007-12#1)(2008-3#2)
157##37##1##(1991-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1994-8#1)(1996-2#1)(1997-7#10)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#2)(2013-7#1)
157-nm##4##1##(2007-11#3)(2007-12#1)
1572##2##1##(2008-10#1)(2013-1#1)
1573##2##1##(2008-10#1)(2008-3#1)
158 (GUG)##2##2##(1991-12#2)
158 patients##3##2##(1991-8#1)(1994-11#1)(2007-11#1)
158##24##1##(1990-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-9#1)(2012-2#1)(2013-1#1)
1580 nm##3##2##(2007-11#2)(2008-3#1)
1580##4##1##(2007-11#2)(2008-3#2)
1580-nm-band##2##1##(2007-11#2)
159 females and##2##3##(2011-2#1)(2013-7#1)
159 nations##2##2##(2013-7#2)
159##23##1##(1990-2#1)(1991-8#1)(1993-12#1)(1993-8#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#3)
1590##2##1##(2008-2#1)(2008-4#1)
15C5 complexes##2##2##(2008-10#2)
15C5##5##1##(2008-10#5)
15C5-774##2##1##(2008-10#2)
15N and 1H NMR spectroscopy##2##5##(1992-3#1)(1993-11#1)
15N and##5##2##(1992-3#2)(1993-11#1)(2009-7#2)
15N resonances##4##2##(1992-3#1)(1995-2#1)(2009-7#2)
15N##50##1##(1992-3#6)(1993-11#3)(1995-2#1)(1995-5#2)(2008-11#1)(2009-7#37)
15N-NMR##2##1##(1997-1#2)
15N-labeled##4##1##(1995-2#1)(1995-5#1)(2008-4#2)
15V##3##1##(2008-10#3)
15Z)##2##1##(1992-4#2)
15Z-anti##3##1##(1990-8#1)(1992-3#2)
15cm of##2##2##(2008-10#1)(2013-7#1)
15cm##3##1##(2008-10#1)(2013-7#2)
15h(-1)##2##1##(2008-10#2)
15kV and##2##2##(2008-10#2)
15kV##3##1##(2008-10#3)
15mM##2##1##(2008-10#2)
15mgl(-1)##3##1##(2008-10#3)
15min at##2##2##(2008-10#2)
15min was##2##2##(2008-10#1)(2013-1#1)
15min##17##1##(2008-10#15)(2013-1#2)
15ml##2##1##(2008-10#2)
15mug of##2##2##(2008-10#2)
15mugl(-1) of##3##2##(2008-10#3)
15mugl(-1)##7##1##(2008-10#7)
15mugml(-1) of##2##2##(2008-10#2)
15ng/mL##2##1##(2008-10#2)
15ngml(-1)##2##1##(2008-10#2)
15nm##2##1##(2008-10#1)(2013-1#1)
15ppm##2##1##(2008-10#2)
15q##2##1##(1997-6#2)
15s##3##1##(2008-10#3)
15s)##3##1##(2008-10#2)(2013-1#1)
15th day##2##2##(2008-7#1)(2008-8#1)
15th week of gestation##2##4##(1990-2#1)(2011-1#1)
15th##14##1##(1990-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
15years ofage##2##2##(2013-8#2)
15years##4##1##(2009-8#1)(2012-2#1)(2013-8#2)
16 (1##3##2##(1993-9#1)(2007-8#1)(2011-2#1)
16 (6##2##2##(2008-4#1)(2008-7#1)
16 (8##2##2##(1992-9#1)(2008-12#1)
16 +/- 0##6##3##(1990-2#1)(1993-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
16 +/-##10##2##(1990-2#1)(1993-1#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
16 000##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
16 PAHs##2##2##(2008-10#1)(2010-5#1)
16 Y-chromosome STR loci##2##4##(2008-12#2)
16 alpha-OHE1##4##2##(1995-9#4)
16 alpha-hydroxylation##3##2##(1995-12#1)(1995-9#2)
16 amino acid##2##3##(1991-2#1)(2008-8#1)
16 and 18 in##2##4##(1990-5#1)(2012-12#1)
16 and 18##7##3##(1990-5#1)(1993-3#1)(1996-5#2)(2008-10#1)(2008-11#1)(2012-12#1)
16 and 2##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
16 and 42##2##3##(1992-8#1)(2013-1#1)
16 and##37##2##(1990-5#1)(1990-9#1)(1992-8#1)(1993-3#1)(1994-12#1)(1996-5#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
16 animals##2##2##(2010-2#1)(2012-3#1)
16 are##3##2##(1995-2#1)(2008-8#1)(2013-1#1)
16 at##2##2##(2008-1#1)(2009-7#1)
16 cases##9##2##(1990-2#1)(1990-5#1)(1995-11#1)(2007-11#3)(2008-11#2)(2009-8#1)
16 children##2##2##(2008-1#1)(2013-8#1)
16 cm##2##2##(2009-10#2)
16 compounds##2##2##(1996-2#1)(2008-8#1)
16 control subjects##2##3##(1991-5#1)(1995-12#1)
16 countries##2##2##(2007-5#1)(2013-8#1)
16 d##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
16 days at##2##3##(2008-5#1)(2012-2#1)
16 days of##2##3##(1996-3#1)(2008-11#1)
16 days##11##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#2)
16 degrees C##2##3##(2008-10#2)
16 diaza-2##2##2##(2008-10#2)
16 different##6##2##(1990-2#1)(1993-9#1)(1995-6#1)(1996-5#1)(2008-10#1)(2010-3#1)
16 exons##2##2##(1997-2#2)
16 h of##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
16 h##16##2##(1997-1#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#3)(2010-8#1)(2011-2#1)(2012-2#1)
16 human##2##2##(1996-2#1)(2013-1#1)
16 in##2##2##(1997-5#1)(2011-2#1)
16 infants##2##2##(1995-5#1)(2011-2#1)
16 isolates##5##2##(2008-10#5)
16 males##3##2##(1994-12#1)(2008-7#1)(2012-3#1)
16 mg##2##2##(2008-10#1)(2010-12#1)
16 mg/kg##2##2##(1992-5#1)(1997-7#1)
16 mm (95% CI 0##2##5##(2013-1#2)
16 mmol/L##2##2##(1993-1#2)
16 months (range##2##3##(1996-3#1)(2007-8#1)
16 months after##2##3##(2008-9#1)(2013-8#1)
16 months##12##2##(1991-11#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
16 mug ml(-1)##2##3##(2008-10#2)
16 mug##3##2##(2008-10#3)
16 multi-stakeholder##2##2##(2013-1#2)
16 nM##2##2##(1994-9#1)(1995-2#1)
16 ng##2##2##(2008-10#2)
16 nm##3##2##(2007-12#2)(2009-9#1)
16 of the##2##3##(1997-5#1)(2008-10#1)
16 of##6##2##(1994-1#1)(1997-5#1)(2007-2#1)(2008-10#2)(2011-2#1)
16 or##3##2##(1990-5#1)(1991-12#1)(2008-7#1)
16 out of##3##3##(1991-2#1)(1994-6#1)(2008-9#1)
16 papers##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
16 participants##2##2##(1994-12#1)(2013-1#1)
16 patients had##2##3##(2007-7#1)(2012-4#1)
16 patients with##9##3##(1991-2#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#2)(2013-8#1)
16 patients##38##2##(1990-2#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-6#1)(1997-4#1)(1997-8#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
16 per##2##2##(1992-5#1)(2008-2#1)
16 percent##7##2##(1991-1#1)(1991-12#1)(1991-2#1)(1997-3#1)(2008-11#1)(2009-9#1)(2011-2#1)
16 previously##3##2##(1990-6#1)(2008-12#1)(2008-7#1)
16 species##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
16 studies##7##2##(2008-2#1)(2009-6#6)
16 tissues examined##2##3##(1994-11#1)(2008-9#1)
16 to 20##2##3##(1990-6#1)(2006-11#1)
16 to 24##2##3##(2008-10#1)(2008-3#1)
16 to##22##2##(1990-6#1)(1994-12#1)(1996-12#1)(2006-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#2)
16 weeks and##2##3##(2008-9#1)(2012-3#1)
16 weeks of##5##3##(1994-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
16 weeks##22##2##(1992-10#1)(1994-2#2)(1995-3#2)(1995-8#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
16 were##5##2##(1993-9#1)(2008-10#2)(2008-4#1)(2008-5#1)
16 with a##2##3##(1996-5#1)(2008-7#1)
16 with##8##2##(1994-12#1)(1996-5#1)(2007-11#1)(2008-5#2)(2008-7#2)(2012-3#1)
16 women##6##2##(1990-8#1)(1991-8#1)(1994-3#1)(2007-12#1)(2013-1#2)
16 x##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
16 years after##3##3##(2007-8#2)(2008-6#1)
16 years and##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
16 years of age##9##4##(1991-8#2)(1995-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2009-10#1)(2009-8#1)(2013-1#1)
16 years of##10##3##(1991-8#2)(1995-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
16 years##34##2##(1991-6#1)(1991-8#2)(1995-2#1)(1995-6#3)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-6#4)(2009-10#1)(2009-8#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)
16##918##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#14)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#1)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#6)(1992-10#1)(1992-12#9)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#7)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#7)(1994-1#5)(1994-11#2)(1994-12#8)(1994-2#4)(1994-3#3)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#7)(1995-2#9)(1995-3#8)(1995-4#2)(1995-5#3)(1995-6#6)(1995-8#2)(1995-9#8)(1996-1#1)(1996-12#4)(1996-2#10)(1996-3#2)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#11)(1997-3#4)(1997-4#4)(1997-5#8)(1997-6#4)(1997-7#5)(1997-8#5)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#17)(2007-12#15)(2007-2#1)(2007-5#1)(2007-7#11)(2007-8#11)(2007-9#1)(2008-1#8)(2008-10#144)(2008-11#21)(2008-12#16)(2008-2#15)(2008-3#27)(2008-4#10)(2008-5#30)(2008-6#14)(2008-7#21)(2008-8#38)(2008-9#17)(2009-10#6)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#10)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#4)(2010-12#1)(2010-2#3)(2010-3#8)(2010-4#5)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#14)(2011-2#38)(2012-1#4)(2012-12#4)(2012-2#20)(2012-3#16)(2012-4#1)(2012-9#1)(2013-1#40)(2013-7#1)(2013-8#24)
16% and##4##2##(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)
16% at##2##2##(1993-9#1)(2008-10#1)
16% in##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
16% of all##2##3##(2007-8#1)(2011-1#1)
16% of the##6##3##(1991-9#1)(1993-9#1)(1997-8#1)(2008-5#1)(2010-10#1)(2013-8#1)
16% of##13##2##(1991-9#1)(1993-12#1)(1993-9#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
16% to##3##2##(1990-3#1)(1995-8#1)(2010-12#1)
16%##68##1##(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
16%) of##2##2##(1990-8#1)(2008-10#1)
16%)##4##1##(1990-8#1)(2008-10#3)
16)##25##1##(1990-2#2)(1990-8#1)(1992-1#1)(1992-12#1)(1992-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
16-1##3##1##(1995-6#1)(2008-10#2)
16-18##4##1##(1992-12#1)(1997-2#1)(2011-2#1)(2013-8#1)
16-19##5##1##(1990-2#1)(1997-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
16-20##4##1##(1990-12#1)(1991-12#1)(2008-11#1)(2008-7#1)
16-20%##2##1##(1991-11#1)(2012-2#1)
16-21##2##1##(1997-2#1)(2008-2#1)
16-26##2##1##(2008-5#1)(2013-8#1)
16-48##3##1##(1994-11#1)(2008-12#1)(2008-5#1)
16-bit##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
16-crown-5##3##1##(2008-10#3)
16-diazacyclooctadecane##5##1##(2008-10#5)
16-dimethyl-15-dehydroprostaglandin B1)##2##2##(1994-6#2)
16-fold##3##1##(1994-11#1)(2008-10#1)(2008-11#1)
16-item##3##1##(1994-12#1)(1996-7#1)(2008-12#1)
16-kDa##2##1##(1990-5#1)(1997-1#1)
16-membered cyclic##3##2##(2008-10#3)
16-way valve##2##2##(2008-10#2)
16-way##4##1##(2008-10#4)
16-week##3##1##(2010-4#3)
16-wk period##2##2##(1991-5#2)
16-year old female##2##3##(2008-1#1)(2011-2#1)
16-year##3##1##(1992-3#1)(2008-1#1)(2011-2#1)
16-year-old girl with##3##3##(2007-10#1)(2011-1#1)(2013-1#1)
16-year-old girl##4##2##(2007-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
16-year-old male##4##2##(2008-7#1)(2010-1#1)(2010-5#1)(2013-1#1)
16-year-old##11##1##(2007-10#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
16/23S spacer region##3##3##(2008-10#3)
16/83-E1##2##1##(2008-10#2)
160 (rest of the Netherlands)##2##5##(1991-8#2)
160 +/-##2##2##(1991-12#1)(2008-1#1)
160 K##3##2##(2008-2#1)(2008-3#2)
160 and##2##2##(1992-6#1)(1994-8#1)
160 degrees##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
160 h##2##2##(2008-11#2)
160 isolates##2##2##(2008-10#2)
160 kDa##3##2##(1991-12#2)(1991-5#1)
160 mW##2##2##(2007-12#2)
160 microg/ml collagen##2##3##(1997-7#2)
160 mumol/kg##2##2##(1993-12#2)
160 nM##2##2##(2008-10#1)(2008-9#1)
160 patients with##3##3##(1990-9#1)(2008-12#1)(2011-2#1)
160 patients##5##2##(1990-9#2)(2007-7#1)(2008-12#1)(2011-2#1)
160##81##1##(1990-8#2)(1990-9#2)(1991-12#4)(1991-5#2)(1991-6#1)(1991-8#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#2)(1997-6#1)(1997-7#2)(2007-11#3)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
160%##3##1##(2008-11#1)(2008-12#1)(2008-3#1)
160)##2##1##(1996-9#1)(2013-8#1)
160-##2##1##(2006-6#1)(2008-10#1)
160-170 degrees C##2##3##(2008-10#2)
160-fold##2##1##(2008-10#2)
1600 degrees C##2##3##(1995-6#1)(2007-12#1)
1600 nm##4##2##(2007-12#3)(2008-10#1)
1600##15##1##(1992-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(2007-12#5)(2008-10#5)(2008-3#1)
1605##2##1##(1993-8#1)(2012-2#1)
1607##2##1##(2008-10#1)(2013-8#1)
1609 cells##2##2##(2008-10#2)
1609##7##1##(2008-10#7)
161 has been changed to a##2##6##(1995-5#2)
161 patients##2##2##(1997-8#1)(2011-1#1)
161##27##1##(1994-12#1)(1995-5#8)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
162 nt##2##2##(1995-2#2)
162##13##1##(1990-11#1)(1992-9#1)(1995-2#3)(1995-8#1)(1997-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
162)##2##1##(2008-7#1)(2011-2#1)
1620##4##1##(1995-12#2)(2008-2#1)(2008-8#1)
1628##2##1##(2008-10#1)(2008-9#1)
1629-bp open reading frame##2##4##(1993-12#2)
1629-bp##4##1##(1993-12#4)
163 and##2##2##(1997-3#1)(2013-1#1)
163##23##1##(1992-11#3)(1993-2#1)(1993-8#1)(1995-11#1)(1996-7#1)(1997-3#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
163(6)##27##1##(2013-1#27)
1632c##3##1##(2008-1#1)(2008-10#2)
164 amino##2##2##(1990-11#1)(1993-6#1)
164##22##1##(1990-11#1)(1990-3#1)(1990-7#1)(1992-3#3)(1992-7#1)(1992-8#2)(1993-2#1)(1993-6#1)(1995-11#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
164)##2##1##(1992-8#1)(1995-3#1)
1640##6##1##(2008-10#1)(2008-11#5)
1648##17##1##(2006-6#1)(2008-10#15)(2008-7#1)
1648)##2##1##(2008-10#2)
1649##4##1##(2007-12#1)(2007-7#1)(2008-10#2)
1649a##4##1##(2008-10#4)
165 +/-##2##2##(2008-11#1)(2013-1#1)
165 episodes of fungemia##2##4##(2008-5#2)
165 kDa##3##2##(1990-12#3)
165##33##1##(1990-12#4)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#3)
1650##4##1##(2008-12#1)(2008-6#3)
166 and##2##2##(2008-10#1)(2008-3#1)
166##16##1##(1991-5#1)(1992-6#1)(1996-5#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#5)(2010-5#1)
1666##2##1##(1995-5#1)(2010-11#1)
167 patients##2##2##(1990-11#1)(2007-11#1)
167##14##1##(1990-11#1)(1991-11#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)
167) and##2##2##(2011-1#1)(2012-3#1)
167)##3##1##(2010-8#1)(2011-1#1)(2012-3#1)
168 +/-##2##2##(1993-12#1)(2008-11#1)
168 h##4##2##(1992-8#2)(2013-1#2)
168##32##1##(1990-9#2)(1991-3#1)(1992-8#2)(1993-12#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-12#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
168)##3##1##(1992-3#1)(1995-11#1)(2013-1#1)
168-hr dosimeter##2##2##(1993-1#2)
169##21##1##(1990-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
169-175##2##1##(1990-11#1)(2007-12#1)
1691 G-A##2##2##(2012-12#2)
16C5##8##1##(2008-10#8)
16D##3##1##(2008-9#3)
16S and 23S##2##3##(1992-3#1)(2008-10#1)
16S and##3##2##(1992-3#1)(1995-8#1)(2008-10#1)
16S rDNA and hrpL genes##2##5##(2008-10#2)
16S rDNA and##4##3##(2008-10#4)
16S rDNA##20##2##(1997-3#1)(2008-10#14)(2008-12#2)(2008-5#1)(2013-7#2)
16S rRNA and##3##3##(1992-6#2)(2008-10#1)
16S rRNA gene sequence##5##4##(2009-6#2)(2010-6#1)(2011-2#2)
16S rRNA gene sequences##3##4##(2008-10#2)(2011-2#1)
16S rRNA gene##21##3##(2008-10#6)(2008-12#1)(2009-6#3)(2010-6#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
16S rRNA genes##6##3##(2008-10#4)(2011-2#1)(2012-2#1)
16S rRNA sequence##2##3##(2011-2#1)(2012-2#1)
16S rRNA##45##2##(1992-6#2)(1993-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#3)(2010-6#2)(2011-1#2)(2011-2#7)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
16S ribosomal RNA gene##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
16S ribosomal RNA##5##3##(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
16S ribosomal##6##2##(2008-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
16S##81##1##(1992-3#1)(1992-6#3)(1993-11#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#33)(2008-12#3)(2008-5#3)(2008-9#1)(2009-6#3)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#9)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
16S-23S rDNA##5##2##(2008-10#5)
16S-23S##8##1##(2008-10#8)
16SrI-A##6##1##(2008-10#6)
16SrI-B##5##1##(2008-10#5)
16min##2##1##(2008-10#2)
16p##2##1##(1994-11#2)
16p12##3##1##(1994-11#1)(2007-7#2)
16p13##4##1##(1993-12#1)(1997-5#3)
16s##3##1##(2008-10#2)(2008-12#1)
16th##8##1##(1990-10#1)(1990-2#1)(1996-11#1)(1997-4#1)(2008-11#2)(2008-7#1)(2012-3#1)
17 (10##2##2##(1990-12#1)(2008-5#1)
17 (E17)##2##2##(1995-5#1)(2008-7#1)
17 +/- 0##4##3##(1992-3#1)(1997-2#1)(2008-10#1)(2008-5#1)
17 +/- 1##2##3##(2008-12#1)(2008-4#1)
17 +/-##7##2##(1992-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
17 000##2##2##(2008-10#1)(2008-5#1)
17 GHz##2##2##(2007-12#1)(2008-3#1)
17 ORFs##2##2##(1995-12#1)(1996-3#1)
17 PCDD/F##2##2##(2008-10#2)
17 Y-STR loci##2##3##(2008-12#2)
17 amino##2##2##(1990-2#1)(1996-5#1)
17 and 0##2##3##(1996-2#1)(2008-10#1)
17 and 18##4##3##(1997-6#1)(2008-8#3)
17 and 22##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
17 and 3##2##3##(1991-3#1)(2008-10#1)
17 and##21##2##(1991-3#1)(1992-6#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-6#1)(2008-10#7)(2008-7#2)(2008-8#3)
17 beta##3##2##(1994-6#2)(2008-5#1)
17 beta-(N-alkylformamides)##2##2##(1995-3#2)
17 beta-HSD3 deficiency##3##3##(2008-1#3)
17 beta-HSD3 gene##2##3##(2008-1#2)
17 beta-HSD3##7##2##(2008-1#7)
17 beta-diol (5##2##3##(1990-11#2)
17 beta-diol##7##2##(1990-11#6)(1992-3#1)
17 beta-estradiol (E2)##2##3##(1990-11#1)(2008-11#1)
17 beta-estradiol##19##2##(1990-11#1)(1990-2#1)(1991-12#1)(1993-9#6)(1995-11#3)(1995-6#1)(1996-5#4)(2008-11#2)
17 beta-hydroxysteroid dehydrogenase##2##3##(1995-11#1)(2008-1#1)
17 beta-hydroxysteroid##5##2##(1990-12#2)(1994-6#1)(1995-11#1)(2008-1#1)
17 cases of##2##3##(2008-6#1)(2008-7#1)
17 cases##9##2##(1991-12#1)(1994-9#1)(2007-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2013-1#1)
17 cells##2##2##(1993-3#1)(2008-10#1)
17 children##2##2##(2008-12#1)(2008-9#1)
17 dB##4##2##(2007-12#4)
17 days##6##2##(2007-7#1)(2008-10#1)(2008-9#2)(2011-2#1)(2012-2#1)
17 different##4##2##(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)
17 elements##3##2##(2008-10#3)
17 exons##2##2##(1992-12#1)(1993-11#1)
17 female##2##2##(2008-5#1)(2011-2#1)
17 h after##2##3##(2007-8#1)(2008-10#1)
17 h##3##2##(1995-5#1)(2007-8#1)(2008-10#1)
17 h(-1)##2##2##(2008-10#2)
17 had##4##2##(1993-12#1)(2012-3#1)(2012-4#1)(2013-1#1)
17 healthy##2##2##(1990-9#1)(2008-5#1)
17 in##4##2##(1990-3#1)(1994-3#1)(1995-3#1)(2013-8#1)
17 is##2##2##(2007-11#1)(2008-7#1)
17 kDa##8##2##(1990-12#3)(1990-7#1)(1992-12#1)(1992-9#1)(1995-12#1)(2008-10#1)
17 loci##2##2##(2008-10#1)(2008-8#1)
17 mM##2##2##(1992-6#1)(2008-10#1)
17 male##2##2##(1993-12#1)(2011-2#1)
17 males##2##2##(1990-3#1)(1991-8#1)
17 mg##2##2##(1995-12#1)(2013-8#1)
17 microM)##2##2##(1992-5#1)(1995-3#1)
17 microm##2##2##(2007-12#1)(2008-3#1)
17 min##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
17 mm##2##2##(1996-6#1)(2008-5#1)
17 months##6##2##(1996-12#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#1)
17 of the##4##3##(1992-5#1)(1996-3#1)(2008-10#1)(2008-6#1)
17 of##9##2##(1992-5#1)(1996-3#1)(1996-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-4#2)
17 or##2##2##(1993-8#1)(2008-7#1)
17 other##2##2##(2008-10#1)(2008-7#1)
17 out of 18##2##4##(1990-8#1)(2009-8#1)
17 out of##3##3##(1990-8#1)(2008-6#1)(2009-8#1)
17 partial responses##2##3##(1992-10#1)(1992-8#1)
17 patients (9##2##3##(2011-2#1)(2013-1#1)
17 patients with##5##3##(1990-2#1)(1991-4#1)(1994-1#1)(1995-11#1)(1995-12#1)
17 patients##36##2##(1990-11#1)(1990-2#2)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#1)(1994-1#2)(1994-11#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-7#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-4#1)(2011-2#2)(2013-1#3)
17 percent##4##2##(1992-5#1)(1993-1#1)(1995-1#1)(1996-5#1)
17 samples##2##2##(2008-10#2)
17 species##2##2##(2008-9#1)(2011-2#1)
17 studies##2##2##(2008-3#1)(2009-2#1)
17 to 0##3##3##(1996-2#1)(2006-10#1)(2008-10#1)
17 to 20##2##3##(2008-11#1)(2009-4#1)
17 to 45 years##2##4##(1997-4#1)(2012-2#1)
17 to 45##3##3##(1994-3#1)(1997-4#1)(2012-2#1)
17 to##18##2##(1990-2#1)(1990-7#1)(1994-3#1)(1996-2#2)(1997-4#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#2)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
17 were##7##2##(1992-5#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2013-8#2)
17 with##2##2##(1997-6#1)(2007-11#1)
17 women##3##2##(1991-8#1)(2011-2#2)
17 x##3##2##(1990-11#1)(2008-3#2)
17 years after##4##3##(1990-2#1)(2007-8#2)(2008-10#1)
17 years of age##2##4##(1993-12#1)(2011-2#1)
17 years of##3##3##(1993-12#1)(2011-2#1)(2012-12#1)
17 years old##4##3##(2007-10#1)(2008-6#1)(2008-9#1)(2012-12#1)
17 years##16##2##(1990-2#1)(1990-6#1)(1992-4#1)(1992-9#1)(1993-12#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-3#1)
17 yr##2##2##(2008-9#2)
17##731##1##(1990-10#1)(1990-11#12)(1990-12#8)(1990-2#8)(1990-3#4)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#2)(1991-6#3)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-8#4)(1993-9#10)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#4)(1994-6#6)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#5)(1995-2#3)(1995-3#16)(1995-5#6)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#3)(1996-2#11)(1996-3#4)(1996-5#16)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#8)(1997-3#7)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#3)(2006-10#2)(2006-8#1)(2007-10#7)(2007-11#11)(2007-12#10)(2007-2#2)(2007-7#7)(2007-8#9)(2008-1#17)(2008-10#100)(2008-11#16)(2008-12#22)(2008-2#1)(2008-3#16)(2008-4#5)(2008-5#23)(2008-6#15)(2008-7#17)(2008-8#15)(2008-9#21)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#21)(2011-2#36)(2012-12#7)(2012-2#8)(2012-3#22)(2012-4#1)(2013-1#18)(2013-7#1)(2013-8#8)
17% (p##2##2##(1993-3#1)(2008-5#1)
17% and##4##2##(1994-8#1)(2008-4#1)(2008-6#1)(2010-6#1)
17% for##2##2##(2008-10#2)
17% of all##3##3##(1990-6#1)(2008-11#1)(2011-1#1)
17% of the##4##3##(1997-1#1)(2008-5#1)(2010-5#1)(2011-1#1)
17% of##17##2##(1990-6#1)(1991-11#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2010-5#1)(2011-1#3)(2012-2#1)(2013-1#1)
17%##65##1##(1990-3#1)(1990-6#1)(1991-11#2)(1993-11#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
17%)##3##1##(2007-11#1)(2008-12#1)(2011-2#1)
17)##22##1##(1991-9#2)(1992-1#1)(1992-9#1)(1993-1#1)(1994-8#1)(1996-3#1)(1996-5#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-3#1)
17+/-0##3##1##(2008-10#3)
17-##2##1##(2007-5#1)(2013-1#1)
17-0##3##1##(1990-11#1)(2007-12#1)(2008-10#1)
17-1##2##1##(1996-9#1)(2008-10#1)
17-19##6##1##(1990-9#1)(1993-2#1)(1997-1#1)(2008-10#2)(2008-7#1)
17-20##4##1##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
17-23 years##2##2##(1995-3#1)(2012-3#1)
17-25]##2##1##(1993-12#1)(2008-9#1)
17-49##2##1##(2008-10#1)(2009-3#1)
17-MT and GH##2##3##(2013-7#2)
17-MT and##6##2##(2013-7#6)
17-MT##9##1##(2013-7#9)
17-Year##2##1##(2008-12#1)(2011-1#1)
17-amino-acid##2##1##(1994-9#2)
17-dione##6##1##(2007-11#5)(2008-10#1)
17-fold##2##1##(1993-12#1)(1994-2#1)
17-kDa protein was##2##3##(2008-10#2)
17-kDa protein##7##2##(2008-10#7)
17-kDa##10##1##(1994-6#1)(1995-2#1)(2008-10#8)
17-keto-4-azasteroids##2##1##(1995-3#2)
17-tetrapropionic acid or coproporphyrin-I (CPI) with##2##6##(2008-10#2)
17-year-old##5##1##(1992-9#1)(2009-9#1)(2010-10#1)(2012-3#1)(2013-7#1)
17-yr cicadas##2##2##(2008-9#2)
17-yr##3##1##(2008-9#3)
17/2##4##1##(1990-11#1)(1991-3#2)(1993-3#1)
170 +/-##2##2##(2008-12#1)(2008-2#1)
170 and##2##2##(1997-2#1)(2008-10#1)
170 degrees C##3##3##(2007-11#1)(2008-10#2)
170 kDa##3##2##(1990-7#1)(2008-11#1)(2008-7#1)
170##45##1##(1990-7#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
1700##8##1##(1994-12#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)
1701 residents##2##2##(2013-8#2)
17025##2##1##(2008-12#1)(2011-2#1)
1708##2##1##(1990-10#2)
1709 (1996)]##2##2##(2008-3#2)
171 in##2##2##(2008-7#1)(2013-1#1)
171 patients##3##2##(1993-2#1)(1994-6#1)(2006-10#1)
171##26##1##(1990-10#1)(1991-12#1)(1991-9#1)(1993-2#3)(1994-6#1)(1995-12#1)(1995-8#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
171-260)##2##1##(1990-12#2)
172 cases##2##2##(1993-6#1)(2013-1#1)
172##14##1##(1993-6#1)(1995-6#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
173 bp##3##2##(1996-5#2)(2008-9#1)
173 patients##2##2##(1992-11#1)(1997-8#1)
173##29##1##(1990-5#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-5#4)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
173)##3##1##(1992-3#1)(2008-8#1)(2010-8#1)
1733##2##1##(2010-4#1)(2012-12#1)
1737cm(-1)##2##1##(2008-10#2)
174##15##1##(1992-11#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-3#1)(2009-1#1)(2012-1#1)(2013-1#1)
1747##2##1##(1991-2#1)(2008-10#1)
175 adolescents##2##2##(1993-3#2)
175 and##3##2##(2008-10#2)(2008-3#1)
175 degrees##3##2##(2007-11#1)(2008-2#2)
175##34##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#1)(1992-12#1)(1993-3#2)(1994-2#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#7)(2010-3#1)(2011-2#1)(2013-1#1)
175%##3##1##(1990-8#1)(1996-5#1)(2013-1#1)
175-kDa##3##1##(1992-3#3)
1750##3##1##(2008-2#1)(2008-3#1)(2011-2#1)
1758##6##1##(1994-9#1)(2007-12#3)(2008-5#1)(2013-1#1)
1758)##7##1##(2008-12#2)(2008-5#4)(2011-2#1)
175R protein##4##2##(1993-2#4)
175R##9##1##(1993-2#9)
176##19##1##(1990-6#1)(1991-12#4)(1991-3#1)(1992-8#1)(2007-8#2)(2008-10#3)(2008-3#2)(2009-4#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-1#1)
1760##3##1##(2007-10#1)(2011-2#1)(2013-1#1)
1763##2##1##(2008-12#1)(2012-3#1)
1765##2##1##(1993-6#1)(2008-10#1)
1767##2##1##(1997-4#1)(2008-3#1)
177 patients with##2##3##(2007-8#1)(2009-4#1)
177 patients##3##2##(1990-11#1)(2007-8#1)(2009-4#1)
177##24##1##(1990-11#1)(1992-3#4)(1993-2#1)(1994-11#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#3)(2009-9#1)(2010-12#1)(2012-1#1)
177)##2##1##(2007-12#1)(2008-8#1)
178 patients##2##2##(1992-5#1)(2013-1#1)
178##18##1##(1990-3#1)(1992-5#1)(1995-3#1)(1995-8#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
1781##2##1##(2007-12#1)(2008-5#1)
1782)##2##1##(2008-12#2)
1788##5##1##(1990-12#4)(2008-7#1)
179 bp##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
179 with##2##2##(1995-3#1)(2012-12#1)
179##22##1##(1990-5#1)(1990-7#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
1795##2##1##(1995-5#1)(2012-2#1)
17E8##6##1##(1995-2#6)
17HSDI gene##2##2##(1994-6#2)
17HSDI##4##1##(1994-6#4)
17HSDII##2##1##(1994-6#2)
17XL##3##1##(1994-12#3)
17[44] cells##2##2##(1990-11#2)
17[44]##4##1##(1990-11#4)
17beta-Estradiol##2##1##(1995-12#2)
17beta-HSD##4##1##(2008-4#4)
17beta-diol##6##1##(1990-11#1)(2007-11#5)
17beta-estradiol (E(2))##2##2##(2009-7#2)
17beta-estradiol by##2##2##(1995-12#1)(2008-10#1)
17beta-estradiol##10##1##(1995-12#5)(2008-10#2)(2009-4#1)(2009-7#2)
17beta-hydroxysteroid##2##1##(2008-4#2)
17betaE(2) induced##2##2##(2008-4#2)
17betaE(2)##8##1##(2008-4#8)
17mM##3##1##(2008-10#2)(2008-7#1)
17p in##2##2##(2008-4#1)(2009-8#1)
17p##6##1##(1993-9#1)(1994-12#1)(2008-4#2)(2009-8#2)
17p11##5##1##(1993-9#1)(1997-3#3)(2011-2#1)
17p12##2##1##(1997-3#2)
17p13##6##1##(1993-11#1)(1997-3#3)(2008-8#1)(2010-3#1)
17q##2##1##(1993-11#1)(2007-6#1)
17th International Congress##2##3##(1997-7#1)(2013-1#1)
17th International##3##2##(1997-7#1)(2009-5#1)(2013-1#1)
17th##14##1##(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
17β-estradiol##2##1##(2012-2#2)
18 (25##2##2##(2013-1#2)
18 (40%)##2##2##(1993-11#1)(1996-11#1)
18 (43%)##2##2##(1990-6#1)(2011-2#1)
18 +/- 0##2##3##(1990-2#1)(2011-3#1)
18 +/-##8##2##(1990-2#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-2#2)(2011-3#1)(2012-3#1)
18 -##3##2##(2008-11#2)(2011-1#1)
18 July##2##2##(1995-6#2)
18 and 0##3##3##(1994-9#1)(2008-10#2)
18 and 19##3##3##(1996-5#1)(2007-11#1)(2011-2#1)
18 and 20##2##3##(1995-11#1)(1995-12#1)
18 and 33##2##3##(1993-9#1)(2008-10#1)
18 and 36##2##3##(2007-11#1)(2008-10#1)
18 and 7##2##3##(2008-10#2)
18 and##38##2##(1991-2#1)(1991-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#3)(1997-5#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
18 bp##2##2##(2008-9#2)
18 cases of##2##3##(2008-9#1)(2013-1#1)
18 cases##13##2##(1990-12#1)(1992-3#1)(1993-6#1)(2007-11#2)(2007-8#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#2)
18 children##2##2##(2007-8#1)(2008-10#1)
18 crown 6##5##3##(2008-10#5)
18 days after##2##3##(2008-10#1)(2013-7#1)
18 days##6##2##(2008-10#3)(2008-11#1)(2009-4#1)(2013-7#1)
18 degrees C in the##2##5##(1995-3#1)(2008-10#1)
18 degrees C in##4##4##(1995-3#1)(2008-10#2)(2008-12#1)
18 degrees C##18##3##(1990-7#1)(1994-3#2)(1995-3#1)(2008-10#11)(2008-12#1)(2008-7#2)
18 degrees##23##2##(1990-7#1)(1994-3#2)(1995-3#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)
18 different##2##2##(2008-2#1)(2008-4#1)
18 female##2##2##(2008-7#1)(2009-10#1)
18 fields##2##2##(2008-10#2)
18 h after##2##3##(1991-2#1)(2008-10#1)
18 h of##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
18 h##23##2##(1990-6#1)(1991-2#1)(1994-6#1)(1995-11#5)(1996-2#1)(1997-2#1)(1997-4#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
18 h(-1)##3##2##(2008-10#2)(2011-2#1)
18 h)##2##2##(1994-6#1)(1997-4#1)
18 had##5##2##(1991-6#1)(1993-3#1)(2008-10#1)(2008-7#2)
18 hours after##2##3##(1994-11#1)(2008-12#1)
18 hours##8##2##(1991-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-1#1)
18 in the##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
18 in##11##2##(1990-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2012-12#1)
18 isolates##3##2##(2008-10#3)
18 kDa Translocator Protein (TSPO)##2##5##(2012-2#2)
18 kDa##7##2##(1994-11#1)(2008-10#1)(2012-2#5)
18 kb##2##2##(1997-7#1)(1997-8#1)
18 km##2##2##(2008-3#1)(2008-8#1)
18 m##2##2##(2008-10#1)(2008-3#1)
18 m)##2##2##(2011-2#2)
18 males##2##2##(2007-7#1)(2013-7#1)
18 men##2##2##(2008-12#2)
18 mg##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
18 mg/L##2##2##(2007-10#2)
18 microM##2##2##(1991-12#1)(1992-3#1)
18 mm##4##2##(1990-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
18 months after the##2##4##(1995-2#1)(2007-10#1)
18 months after##4##3##(1994-12#1)(1995-2#1)(2007-10#1)(2013-1#1)
18 months in##2##3##(2008-11#1)(2013-1#1)
18 months of age##7##4##(1993-12#2)(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#2)
18 months of follow-up##2##4##(1990-2#1)(2006-10#1)
18 months of##10##3##(1990-2#1)(1990-6#1)(1993-12#2)(1994-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#2)
18 months old##3##3##(2010-6#1)(2011-2#1)(2013-1#1)
18 months previously##2##3##(1994-2#1)(2010-6#1)
18 months##63##2##(1990-2#1)(1990-6#3)(1991-11#1)(1991-8#2)(1993-1#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-6#3)(1995-2#1)(1996-1#1)(1996-3#2)(1996-7#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-2#1)(2010-6#3)(2011-2#5)(2013-1#7)
18 months)##2##2##(1990-6#1)(1996-11#1)
18 mug l(-1) for##2##4##(2008-10#2)
18 mug##5##2##(2008-10#5)
18 mum##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)
18 of the##4##3##(1992-12#1)(2008-10#1)(2008-8#2)
18 of##16##2##(1990-5#1)(1992-11#1)(1992-12#1)(1994-3#1)(2008-10#2)(2008-4#1)(2008-8#5)(2009-8#1)(2011-2#1)(2013-1#2)
18 or##2##2##(1993-9#1)(2008-10#1)
18 patients and##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
18 patients had##2##3##(1995-12#2)
18 patients who##2##3##(1992-6#1)(2008-1#1)
18 patients with##8##3##(1990-2#1)(1990-8#1)(1991-4#1)(1992-11#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-7#1)
18 patients##34##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-6#2)(1993-3#1)(1995-12#2)(1996-11#1)(1996-5#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#3)
18 percent##2##2##(1996-12#1)(2011-2#1)
18 s-1)##2##2##(1990-9#2)
18 samples of##2##3##(2008-10#2)
18 samples##5##2##(2008-10#5)
18 sessions##2##2##(2008-5#1)(2012-2#1)
18 species##2##2##(2008-12#1)(2008-5#1)
18 studies##3##2##(1997-5#1)(2007-12#1)(2008-8#1)
18 subjects##4##2##(1995-5#1)(1996-6#1)(2008-6#1)(2008-8#1)
18 times##2##2##(2007-12#1)(2013-1#1)
18 to 28##2##3##(2008-10#1)(2013-1#1)
18 to 54##2##3##(2008-1#1)(2008-4#1)
18 to 69 years##2##4##(1996-2#1)(2007-11#1)
18 to##23##2##(1992-1#2)(1996-2#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#3)
18 volatile organohalogen compounds##2##4##(2008-10#2)
18 vs##2##2##(1993-3#1)(2007-10#1)
18 weeks of##2##3##(1993-3#1)(2008-5#1)
18 weeks##7##2##(1993-3#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-12#2)(2012-3#1)
18 were##6##2##(1994-12#1)(1996-5#1)(2008-10#2)(2008-7#1)(2012-12#1)
18 with##2##2##(1990-3#1)(1996-5#1)
18 x##4##2##(1990-8#1)(2008-12#1)(2008-2#1)(2009-5#1)
18 years after##3##3##(1990-9#1)(1994-9#1)(2013-1#1)
18 years and##2##3##(2011-1#2)
18 years of age##3##4##(2007-8#1)(2010-3#1)(2011-2#1)
18 years old##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
18 years or older##2##4##(2009-8#1)(2013-8#1)
18 years were##2##3##(1997-3#1)(2011-1#1)
18 years##30##2##(1990-9#1)(1994-9#1)(1996-4#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-1#4)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
18 years)##2##2##(2007-8#1)(2011-2#1)
18 ± 17##2##3##(2013-1#2)
18 ±##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
18##893##1##(1990-11#3)(1990-12#4)(1990-2#10)(1990-3#5)(1990-5#6)(1990-6#9)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#5)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-6#5)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#8)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#5)(1994-12#3)(1994-2#5)(1994-3#6)(1994-6#6)(1994-7#2)(1994-9#2)(1995-11#9)(1995-12#5)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#4)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#17)(1996-3#4)(1996-4#1)(1996-5#9)(1996-6#2)(1996-7#1)(1996-9#3)(1997-2#2)(1997-3#6)(1997-4#5)(1997-5#6)(1997-6#3)(1997-7#9)(1997-8#3)(2006-10#2)(2007-10#6)(2007-11#15)(2007-12#16)(2007-7#6)(2007-8#13)(2007-9#1)(2008-1#9)(2008-10#167)(2008-11#23)(2008-12#17)(2008-2#12)(2008-3#25)(2008-4#11)(2008-5#23)(2008-6#4)(2008-7#24)(2008-8#23)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#8)(2010-1#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#6)(2010-8#1)(2011-1#13)(2011-2#42)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#16)(2013-1#49)(2013-7#3)(2013-8#13)
18% and 30%##2##3##(2007-11#1)(2008-5#1)
18% and##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
18% glucose##2##2##(2010-2#2)
18% in##2##2##(1991-11#1)(2008-10#1)
18% of patients with##2##4##(1991-8#1)(2012-3#1)
18% of the##9##3##(1990-12#1)(1990-2#1)(1991-8#1)(1993-11#2)(1993-6#1)(2008-10#2)(2008-11#1)
18% of##15##2##(1990-12#1)(1990-2#1)(1991-8#2)(1992-5#1)(1993-11#2)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
18% to##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
18%##61##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-8#2)(1992-5#3)(1993-11#3)(1993-6#1)(1993-8#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
18%)##7##1##(1990-2#1)(1990-3#1)(1996-11#1)(2008-1#1)(2008-6#1)(2011-2#1)(2013-1#1)
18) or##3##2##(1994-8#1)(2008-9#1)(2009-8#1)
18) were##2##2##(2008-5#1)(2013-1#1)
18)##30##1##(1991-2#1)(1992-1#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
18)(q32##2##1##(2009-8#1)(2010-11#1)
18)+##2##1##(2009-8#2)
18-##3##1##(2011-2#1)(2012-12#2)
18-19##2##1##(2008-5#2)
18-20 years##2##2##(2010-1#1)(2012-2#1)
18-20##4##1##(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)
18-21##2##1##(1995-12#1)(2008-10#1)
18-24 years##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
18-24##5##1##(1995-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
18-30##2##1##(1997-1#1)(2011-2#1)
18-40##3##1##(1996-2#2)(2013-1#1)
18-5##2##1##(2007-11#2)
18-64 years##2##2##(1990-8#1)(2011-2#1)
18-crown-6 (18C6)##2##2##(2008-10#2)
18-crown-6 and##4##2##(2008-10#4)
18-crown-6 ether##4##2##(2008-10#4)
18-crown-6##13##1##(2008-10#13)
18-day##2##1##(1995-11#1)(2008-10#1)
18-fold##2##1##(2008-10#1)(2008-11#1)
18-gauge##2##1##(2007-12#1)(2009-3#1)
18-hydroxycorticosterone##3##1##(1990-11#1)(1990-5#1)(2008-4#1)
18-kDa peptide##2##2##(1995-12#1)(2008-10#1)
18-kDa##5##1##(1991-8#1)(1993-9#1)(1995-12#1)(2008-10#2)
18-month follow-up##2##2##(2008-5#1)(2011-2#1)
18-month##12##1##(1993-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
18-month-old##8##1##(1993-12#1)(1993-2#1)(1994-5#1)(2008-10#2)(2008-9#1)(2010-6#1)(2013-1#1)
18-octabromo-5##3##1##(2008-10#3)
18-tetramethyl-21H##2##1##(2008-10#2)
18-week-old females##2##2##(2013-7#2)
18-week-old##3##1##(2013-7#3)
18-year old##3##2##(2007-7#2)(2008-10#1)
18-year##4##1##(2007-7#2)(2008-10#1)(2012-7#1)
18-year-old male##2##2##(1996-7#1)(2010-12#1)
18-year-old##6##1##(1991-2#1)(1996-7#1)(2007-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
180 children with##2##3##(2007-8#1)(2008-10#1)
180 days##5##2##(1990-12#1)(1990-5#1)(2008-10#2)(2011-2#1)
180 deg##2##2##(2008-3#2)
180 degrees -phase##2##3##(2008-10#1)(2008-8#1)
180 degrees C##2##3##(2008-2#1)(2009-11#1)
180 degrees backscatter##3##3##(2008-2#3)
180 degrees##25##2##(1991-12#1)(2007-12#3)(2008-10#3)(2008-2#6)(2008-3#6)(2008-8#1)(2009-11#1)(2009-9#2)(2011-2#2)
180 in##2##2##(2008-2#1)(2008-9#1)
180 isolates##2##2##(2008-10#2)
180 kDa##3##2##(1992-10#1)(1996-5#2)
180 kb##2##2##(1993-6#1)(1997-3#1)
180 mW of##2##3##(2008-2#1)(2008-3#1)
180 mW##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
180 min after##2##3##(1996-12#1)(2008-7#1)
180 nm##2##2##(2008-3#1)(2009-10#1)
180 s preconcentration time##2##4##(2008-10#2)
180 s##5##2##(2008-10#5)
180 to##2##2##(1995-3#1)(2009-11#1)
180##103##1##(1990-12#1)(1990-5#3)(1990-7#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-8#2)(1993-6#1)(1995-3#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#4)(2008-10#24)(2008-12#2)(2008-2#9)(2008-3#10)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-7#1)(2009-9#2)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
180-200##2##1##(2008-10#1)(2010-4#1)
180-fold##2##1##(2011-1#1)(2011-2#1)
180-kDa##2##1##(1994-8#1)(1995-6#1)
1800 h##2##2##(1992-11#1)(2008-10#1)
1800##14##1##(1992-11#1)(1992-12#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-8#1)(2011-2#1)
1800s##4##1##(2008-10#1)(2008-8#1)(2010-3#1)(2012-12#1)
1803##2##1##(1993-6#2)
180s)##2##1##(2008-10#2)
180°C##5##1##(2012-1#3)(2013-1#2)
181##14##1##(1990-11#1)(1990-12#1)(1991-2#1)(1992-8#2)(1994-6#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)
181)##2##1##(2007-12#1)(2008-10#1)
181-bp PRE##3##2##(2012-3#3)
181-bp##4##1##(2008-10#1)(2012-3#3)
1810##2##1##(2012-12#2)
1818##2##1##(1996-2#1)(2008-5#1)
182##32##1##(1991-6#1)(1992-8#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-9#1)(2007-10#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
182)##4##1##(1990-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
1829##4##1##(1993-6#1)(2007-2#1)(2011-2#2)
1829)##2##1##(2008-5#1)(2011-2#1)
183##17##1##(1990-3#1)(1990-6#2)(1992-8#1)(1995-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)
183-aa##2##1##(1993-2#1)(2013-8#1)
1830##2##1##(2007-12#1)(2008-2#1)
1836) and Camerotrombidium pexatum (C##2##5##(2007-12#2)
184##16##1##(1993-11#2)(1993-3#1)(1994-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-1#1)
1840##3##1##(1994-12#1)(2008-12#1)(2012-12#1)
1841)##2##1##(2007-12#2)
1842)##2##1##(1996-12#1)(2008-5#1)
1848##5##1##(1992-6#1)(1993-3#2)(2012-2#2)
185 mg##2##2##(2008-10#1)(2008-11#1)
185 microm##2##2##(2008-2#2)
185##20##1##(1990-7#1)(1994-2#1)(1994-6#1)(1994-9#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-6#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)
185%##2##1##(1992-6#1)(2008-11#1)
1850##5##1##(2007-6#1)(2008-3#1)(2009-10#1)(2009-7#1)(2011-2#1)
1854##3##1##(1993-3#1)(2008-11#2)
1855##2##1##(1993-11#1)(2009-7#1)
18558 and##2##2##(2008-10#2)
1859##2##1##(1993-6#1)(2008-5#1)
186 patients with##2##3##(2007-7#1)(2011-2#1)
186 patients##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
186 were##2##2##(2007-7#2)
186##18##1##(1993-3#1)(1994-8#1)(1996-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-1#1)
1860##4##1##(1994-12#1)(2007-11#2)(2009-7#1)
1863##3##1##(2008-5#1)(2008-7#1)(2008-8#1)
1863) (Vaejovidae##2##2##(2007-12#2)
1863)##4##1##(2007-12#4)
1869##2##1##(2011-1#2)
187 and##3##2##(1990-7#2)(2006-6#1)
187 patients##5##2##(1990-6#2)(2007-11#1)(2011-2#1)(2012-5#1)
187##29##1##(1990-3#1)(1990-6#2)(1990-7#2)(1991-8#1)(1992-6#1)(1993-3#3)(1996-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-5#1)
1870##5##1##(2008-8#3)(2009-7#1)(2011-2#1)
1872##2##1##(2008-12#1)(2013-1#1)
1873##3##1##(1996-3#1)(2011-1#1)(2013-1#1)
1874##2##1##(2009-10#2)
1877##3##1##(1991-12#1)(2007-12#1)(2007-5#1)
1879##2##1##(2007-4#1)(2008-10#1)
188##12##1##(1990-7#2)(1992-2#1)(1993-9#1)(1994-12#2)(1995-12#1)(1997-6#1)(2008-1#1)(2010-8#1)(2011-3#1)(2012-12#1)
188) and##2##2##(1993-3#1)(1993-9#1)
188)##3##1##(1993-3#1)(1993-9#1)(1996-9#1)
1880##4##1##(2008-11#1)(2009-7#3)
1883)##2##1##(2011-2#2)
1884##3##1##(2008-5#1)(2008-9#1)(2009-7#1)
189 women with##2##3##(1990-12#1)(1993-9#1)
189 women##3##2##(1990-12#1)(1993-9#2)
189##15##1##(1990-12#1)(1992-10#1)(1992-6#1)(1993-9#3)(1994-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-2#2)(2013-8#2)
1890##2##1##(1996-3#1)(2008-10#1)
1897##3##1##(1991-6#1)(2008-3#1)(2008-7#1)
1897)##2##1##(2008-5#2)
1898##3##1##(1990-6#1)(2010-1#1)(2012-2#1)
1898)##2##1##(2008-5#1)(2011-2#1)
18C6##7##1##(2008-10#7)
18F##2##1##(2007-8#1)(2010-3#1)
18F-FDG##3##1##(2011-2#1)(2012-3#2)
18F-N-methylspiroperidol##2##1##(1996-5#2)
18F-fluorodeoxyglucose positron emission tomography##2##4##(2008-1#1)(2012-3#1)
18F-fluorodeoxyglucose##3##1##(1996-5#1)(2008-1#1)(2012-3#1)
18FDG - PET##3##3##(2008-1#3)
18O##5##1##(1991-9#3)(1995-5#2)
18O-labeled##4##1##(2008-4#3)(2009-2#1)
18S and 5##2##3##(2008-10#1)(2008-9#1)
18S rDNA##3##2##(2008-10#1)(2010-3#1)(2013-1#1)
18S rRNA##3##2##(2008-9#2)(2013-1#1)
18S ribosomal DNA##2##3##(2008-10#2)
18S##16##1##(2008-10#8)(2008-5#1)(2008-9#4)(2010-3#1)(2013-1#2)
18S-5##3##1##(2008-5#3)
18]##3##1##(1990-3#1)(2011-2#1)(2012-3#1)
18min##2##1##(2008-10#2)
18mugl(-1)##2##1##(2008-10#2)
18q##3##1##(1997-3#1)(1997-5#1)(1997-6#1)
18th century##6##2##(1993-11#2)(2008-12#2)(2010-1#1)(2012-2#1)
18th##15##1##(1993-11#3)(2008-1#1)(2008-10#1)(2008-12#3)(2008-6#2)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)
18 years##2##1##(2011-2#1)(2012-2#1)
18 nm##2##1##(2012-2#2)
18 weeks##2##1##(2013-8#2)
19 %##2##2##(2008-1#1)(2012-12#1)
19 (18##2##2##(2007-8#2)
19 (53%)##2##2##(2011-2#1)(2013-1#1)
19 (58%)##2##2##(2012-12#1)(2013-1#1)
19 +/- 0##2##3##(1994-11#1)(2009-11#1)
19 +/-##4##2##(1994-11#1)(2009-11#1)(2011-1#1)(2011-2#1)
19 -##3##2##(2008-11#2)(2009-12#1)
19 after##2##2##(1994-6#1)(2008-1#1)
19 and 22##3##3##(1994-3#1)(2008-10#2)
19 and 9##2##3##(1992-8#1)(2008-3#1)
19 and##19##2##(1990-7#1)(1992-1#1)(1992-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-7#2)(2011-2#1)(2013-1#1)
19 cases##12##2##(1990-2#1)(1991-11#2)(1994-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#2)(2011-2#1)(2013-1#1)
19 counties##2##2##(1991-6#1)(1995-2#1)
19 d##2##2##(1990-11#1)(2008-8#1)
19 days##3##2##(1994-9#1)(2007-8#1)(2008-12#1)
19 degrees C##3##3##(2008-10#3)
19 degrees##4##2##(2008-10#3)(2008-5#1)
19 different##3##2##(2008-10#1)(2008-5#2)
19 elements##2##2##(2008-10#2)
19 exons##2##2##(1993-6#1)(2008-7#1)
19 for##2##2##(2008-10#1)(2011-1#1)
19 had##2##2##(1993-3#1)(2007-8#1)
19 heterozygous##2##2##(1997-7#1)(2007-7#1)
19 in##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
19 kDa##2##2##(1994-8#1)(2007-12#1)
19 men##3##2##(2007-11#1)(2007-8#1)(2008-7#1)
19 mmol l(-1)##2##3##(2008-10#2)
19 months after##3##3##(1990-5#1)(1994-12#1)(2008-10#1)
19 months##9##2##(1990-5#2)(1990-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-3#1)(2007-10#1)(2008-10#1)
19 non-flashbackers##2##2##(1996-7#2)
19 of the##6##3##(1990-7#1)(2008-10#1)(2008-7#2)(2011-2#2)
19 of##10##2##(1990-7#2)(1990-8#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-7#2)(2011-2#2)
19 patients were##3##3##(1993-2#1)(1993-3#1)(2012-3#1)
19 patients##27##2##(1991-6#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#4)(2012-3#2)(2013-1#1)
19 percent##3##2##(1992-5#1)(1993-3#1)(1995-3#1)
19 polymorphic##2##2##(2008-10#1)(2013-8#1)
19 races##2##2##(2008-10#2)
19 selected##2##2##(2008-10#1)(2010-4#1)
19 species##2##2##(2008-12#1)(2010-3#1)
19 subjects##2##2##(1990-6#1)(2008-5#1)
19 tetraploid##2##2##(2008-5#2)
19 to 3##2##3##(1993-9#1)(2008-11#1)
19 to##12##2##(1990-3#2)(1991-5#1)(1993-9#1)(2007-6#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
19 transgenic##2##2##(2008-10#2)
19 weeks##3##2##(1995-9#1)(2008-10#2)
19 were##5##2##(1990-2#2)(2008-10#1)(2013-1#2)
19 year old##2##3##(1994-5#1)(2013-1#1)
19 years##9##2##(1995-6#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
19 years)##2##2##(2008-11#1)(2010-1#1)
19 ±##2##2##(2011-2#1)(2013-8#1)
19##551##1##(1990-11#1)(1990-2#6)(1990-3#5)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#6)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#6)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#5)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#8)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#3)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#4)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#8)(2007-5#1)(2007-6#2)(2007-7#10)(2007-8#9)(2008-1#9)(2008-10#97)(2008-11#13)(2008-12#15)(2008-2#2)(2008-3#13)(2008-4#3)(2008-5#16)(2008-6#6)(2008-7#15)(2008-8#13)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-9#1)(2011-1#13)(2011-10#1)(2011-2#27)(2012-1#1)(2012-12#9)(2012-2#4)(2012-3#8)(2013-1#23)(2013-7#1)(2013-8#11)
19% and##2##2##(2012-3#1)(2013-1#1)
19% at##2##2##(2008-12#1)(2011-2#1)
19% for##2##2##(1992-3#1)(2008-10#1)
19% of cases##2##3##(1992-5#1)(1994-3#1)
19% of the##5##3##(1993-2#1)(1995-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
19% of##13##2##(1990-3#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
19%##50##1##(1990-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-10#3)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#4)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
19%)##5##1##(2008-10#1)(2008-5#2)(2010-5#1)(2012-2#1)
19(1)##2##1##(1996-2#1)(2008-9#1)
19(th)##4##1##(2008-12#2)(2009-8#1)(2013-1#1)
19) in##3##2##(1991-8#1)(2008-11#1)(2009-9#1)
19) was##2##2##(1991-12#1)(2011-2#1)
19)##17##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-8#1)(1993-6#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-9#1)(2011-2#1)(2011-3#1)
19-20##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
19-21##4##1##(1995-6#1)(1997-6#1)(2006-8#1)(2009-9#1)
19-22##2##1##(2008-8#1)(2012-3#1)
19-23##2##1##(1992-6#1)(2008-7#1)
19-crown-6##2##1##(2008-10#2)
19-day-old##3##1##(1996-12#2)(2008-10#1)
19-fluorine##2##1##(1996-2#1)(2009-9#1)
19-kDa##2##1##(1993-2#1)(1995-3#1)
19-mer##5##1##(1993-8#1)(1995-2#4)
19-norandrogens##2##1##(1992-3#2)
19-year-old##5##1##(1990-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
190 and##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
190 bp##2##2##(1992-12#1)(2008-10#1)
190 kDa##3##2##(1991-8#2)(1992-10#1)
190 patients##2##2##(1997-8#1)(2011-2#1)
190##36##1##(1990-12#2)(1990-2#1)(1991-8#2)(1992-10#1)(1992-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#3)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
1900##13##1##(1990-11#1)(1993-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#2)(2011-2#1)
1900s##4##1##(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)
1901##5##1##(2007-5#1)(2009-4#1)(2011-2#3)
1901)##2##1##(2008-5#2)
1902##3##1##(2008-10#1)(2010-1#2)
1903 to##2##2##(2008-10#2)
1904##2##1##(2007-12#1)(2010-1#1)
1905)##2##1##(1990-8#2)
1906 earthquake##2##2##(1990-11#1)(1996-4#1)
1906##10##1##(1990-11#3)(1996-4#1)(2007-5#2)(2008-10#2)(2009-7#1)(2011-4#1)
1907##3##1##(2008-10#1)(2008-12#1)(2008-7#1)
191##19##1##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#1)(1993-8#1)(1994-6#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)
1910##5##1##(1991-8#1)(2007-5#1)(2010-1#1)(2010-8#1)(2011-2#1)
1912 to 1998##2##3##(2008-10#2)
1912 to##3##2##(2008-10#3)
1912##8##1##(2008-10#4)(2008-12#1)(2008-8#3)
1912-1927##2##1##(2013-1#2)
1913##6##1##(1991-8#1)(2007-8#1)(2011-2#2)(2011-4#1)(2013-8#1)
1913)##2##1##(2011-2#2)
1914 to##2##2##(2008-10#2)
1914##3##1##(2008-10#2)(2008-5#1)
1915 to##2##2##(2008-10#2)
1915##4##1##(2008-10#3)(2010-1#1)
1916##2##1##(1991-12#1)(2009-7#1)
1917##6##1##(1993-3#1)(2009-7#1)(2010-1#1)(2011-2#3)
1917)##2##1##(2010-10#1)(2010-7#1)
1918##4##1##(2008-10#1)(2010-1#1)(2010-5#1)(2013-8#1)
1918-1919##8##1##(2009-7#3)(2011-2#5)
1919 to##3##2##(2007-5#1)(2008-10#2)
1919##5##1##(2007-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
192 patients treated##2##3##(1997-8#1)(2012-2#1)
192 patients##3##2##(1994-12#1)(1997-8#1)(2012-2#1)
192 to##2##2##(1991-3#1)(2008-3#1)
192##30##1##(1991-3#1)(1991-8#2)(1992-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
1920##7##1##(2007-11#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-7#1)
1921 to##2##2##(1991-3#1)(2008-10#1)
1921##5##1##(1991-3#1)(1996-9#1)(2008-10#1)(2011-2#2)
1922##3##1##(2011-1#2)(2012-3#1)
1923##3##1##(1993-6#1)(2008-10#1)(2011-2#1)
1925##4##1##(1990-2#1)(2010-1#1)(2011-2#1)(2012-12#1)
1926##4##1##(2008-10#2)(2010-8#1)(2012-2#1)
1927 and##2##2##(2010-1#1)(2010-7#1)
1927##7##1##(2008-10#2)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#2)
1928##4##1##(2007-5#1)(2008-10#2)(2008-7#1)
193 and##2##2##(1991-3#1)(1991-8#1)
193 fattening pigs with normal skin and##2##7##(1990-3#2)
193 nm##11##2##(2007-12#1)(2008-2#1)(2008-3#9)
193##25##1##(1990-3#2)(1990-8#2)(1991-3#1)(1991-8#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#9)(2009-4#1)(2010-8#1)(2013-8#2)
193-nm light##2##2##(2007-12#1)(2008-2#1)
193-nm##14##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#9)
1930 to 2003##2##3##(2008-10#2)
1930##6##1##(1991-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
1930s##9##1##(1990-6#1)(1991-12#1)(1993-12#1)(2007-12#1)(2007-5#2)(2008-8#1)(2010-1#1)(2013-8#1)
1932 to##2##2##(2007-6#1)(2008-10#1)
1932##4##1##(1993-6#1)(2007-6#1)(2008-10#1)(2010-12#1)
1933##3##1##(2006-10#1)(2007-5#2)
1935##2##1##(2008-7#1)(2011-4#1)
1936 to##2##2##(2008-10#2)
1936##3##1##(2008-10#2)(2011-2#1)
1938##2##1##(1996-2#1)(2009-5#1)
194##16##1##(1991-3#1)(1992-9#1)(1993-3#1)(1995-1#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
1940##7##1##(1990-6#1)(1990-8#1)(1994-5#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-7#1)
1940s##9##1##(1991-12#1)(1992-12#1)(1993-6#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
1941##2##1##(1990-6#1)(2008-12#1)
1942##5##1##(1994-12#1)(1995-11#1)(2007-5#1)(2011-2#2)
1943##2##1##(2009-7#1)(2013-1#1)
1944##7##1##(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#1)
1945##4##1##(1995-2#1)(2007-5#2)(2008-5#1)
1946##5##1##(1991-1#1)(1991-12#1)(1997-8#1)(2011-4#2)
1947##2##1##(2008-10#1)(2010-1#1)
1949##4##1##(1994-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
195 and##4##2##(1991-3#1)(1992-9#1)(2011-2#1)(2012-12#1)
195 children##2##2##(2007-7#2)
195 isolates##3##2##(2008-10#3)
195 to##2##2##(1991-3#1)(2008-5#1)
195##39##1##(1990-11#1)(1990-3#1)(1991-3#3)(1992-12#1)(1992-9#1)(1993-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
195)##2##1##(2008-5#1)(2009-8#1)
1950 and##3##2##(1990-8#2)(1995-1#1)
1950 to##2##2##(1996-1#1)(2011-1#1)
1950##12##1##(1990-8#2)(1991-3#1)(1993-6#1)(1995-1#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2009-7#1)(2011-1#1)
1950s##20##1##(1991-4#1)(1992-1#1)(1993-6#1)(1994-9#1)(1997-3#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-10#1)(2012-2#1)
1951##3##1##(1992-1#1)(2008-10#1)(2010-8#1)
1952##3##1##(1997-1#1)(2007-12#1)(2008-9#1)
1953 to##2##2##(2008-10#1)(2008-7#1)
1953##4##1##(2008-10#1)(2008-7#2)(2012-3#1)
1954##5##1##(1994-9#1)(2007-7#1)(2008-12#1)(2010-8#1)(2012-2#1)
1955##5##1##(1994-3#1)(2009-7#1)(2010-3#1)(2013-1#1)(2013-7#1)
1955-1989##2##1##(2006-8#2)
1956##5##1##(1996-1#1)(2008-10#3)(2009-7#1)
1956)##2##1##(1993-3#1)(2011-2#1)
1957##6##1##(1997-8#1)(2007-5#1)(2008-3#1)(2008-9#2)(2013-1#1)
1958##5##1##(1993-12#1)(2008-2#1)(2008-9#1)(2009-7#1)(2012-12#1)
1959 and##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
1959##9##1##(1991-12#2)(2008-10#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#1)
196 K and##2##3##(2008-3#2)
196 K##3##2##(2008-3#3)
196 and##2##2##(2008-3#1)(2011-1#1)
196##18##1##(1990-7#1)(1991-11#1)(1994-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#6)(2008-8#1)(2011-1#1)(2013-1#1)
196)##2##1##(2008-10#1)(2009-7#1)
1960 to##10##2##(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#2)
1960##21##1##(1991-2#1)(1992-1#1)(1993-6#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-1#2)
1960s by##2##2##(2008-10#1)(2010-7#1)
1960s##29##1##(1992-1#1)(1992-3#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
1961##5##1##(1992-1#1)(2008-5#2)(2011-2#2)
1962##3##1##(1996-8#1)(2008-10#1)(2012-3#1)
1963##4##1##(1990-9#1)(1991-1#1)(1992-9#1)(2008-10#1)
1964##10##1##(1991-5#1)(1992-6#1)(1994-1#1)(1995-1#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2012-2#1)
1965 to##4##2##(1991-12#1)(2008-10#1)(2009-5#1)(2012-1#1)
1965##13##1##(1991-12#1)(1992-6#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
1966 and##2##2##(1990-3#1)(1992-3#1)
1966 to##4##2##(1992-10#1)(2008-7#2)(2008-8#1)
1966##12##1##(1990-3#1)(1991-1#1)(1992-10#1)(1992-3#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#2)(2010-8#1)
1967 is##2##2##(2011-2#1)(2012-3#1)
1967##7##1##(1990-12#1)(1993-5#1)(1997-3#1)(2008-10#1)(2011-2#2)(2012-3#1)
1967)##2##1##(1997-3#1)(2008-5#1)
1967-1971##2##1##(1995-8#1)(2009-7#1)
1968##6##1##(1990-2#1)(1992-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
1969##7##1##(1990-2#1)(1991-1#1)(1991-12#1)(1995-2#1)(1996-8#1)(2008-11#1)(2008-5#1)
1969)##2##1##(1990-8#1)(2011-2#1)
197 patients##2##2##(1990-3#1)(1992-3#1)
197##15##1##(1990-12#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
1970 and##4##2##(1990-12#1)(1997-4#1)(2008-7#1)(2012-12#1)
1970 to##7##2##(1991-2#1)(1994-9#1)(1997-4#2)(1997-8#1)(2008-12#1)(2008-2#1)
1970##34##1##(1990-11#2)(1990-12#1)(1990-6#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-3#1)(1997-4#4)(1997-5#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#2)(2010-6#1)(2010-8#2)(2012-12#1)(2013-1#1)
1970's##2##1##(2008-10#1)(2008-5#1)
1970-1987##2##1##(1992-2#2)
1970s and 1980s##4##3##(1996-9#1)(2008-1#1)(2008-10#1)(2008-12#1)
1970s and##6##2##(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
1970s the##2##2##(1991-3#1)(2008-11#1)
1970s##49##1##(1991-2#2)(1991-3#3)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-3#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
1971 - 2011##2##3##(2012-12#2)
1971##10##1##(1991-6#1)(1993-6#1)(1994-9#1)(1997-6#1)(2007-10#1)(2007-3#1)(2008-10#2)(2012-12#2)
1972 through##2##2##(1991-3#1)(1996-3#1)
1972 to##3##2##(1990-6#1)(1991-9#1)(1992-9#1)
1972##17##1##(1990-2#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-9#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
1973 to##2##2##(1991-6#1)(1991-8#1)
1973##6##1##(1991-6#1)(1991-8#1)(1992-1#1)(2006-10#1)(2007-10#1)(2008-5#1)
1973)##2##1##(1995-12#1)(2011-1#1)
1974 and##3##2##(1990-6#1)(1993-5#1)(2007-8#1)
1974 to 1994##2##3##(1995-11#1)(1995-12#1)
1974 to##7##2##(1990-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#1)
1974##19##1##(1990-3#1)(1990-5#1)(1990-6#2)(1993-5#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
1974)##2##1##(2008-5#2)
1975 and##4##2##(1992-6#1)(1994-3#1)(1997-2#1)(2012-12#1)
1975##25##1##(1990-9#1)(1991-4#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-5#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#2)
1976 and##4##2##(1990-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
1976##18##1##(1990-9#1)(1992-10#2)(1996-3#2)(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#2)(2013-1#1)
1977 and##4##2##(1991-11#1)(1992-9#1)(1993-12#1)(2010-3#1)
1977 to 1992##2##3##(1993-12#2)
1977 to##5##2##(1991-8#1)(1993-12#2)(2008-8#1)(2011-1#1)
1977##16##1##(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-12#3)(1994-9#2)(1995-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)
1977)##2##1##(1994-2#1)(2008-10#1)
1978 and##5##2##(1990-3#1)(1991-1#1)(1992-2#1)(1997-5#1)(2007-11#1)
1978 to##3##2##(1991-2#1)(1993-2#1)(1993-6#1)
1978##24##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-4#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-6#1)(2011-2#2)(2012-12#1)
1978-93##2##1##(1996-3#2)
1979 and##7##2##(1992-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-5#1)(2012-12#1)(2013-8#1)
1979 to##6##2##(1996-4#1)(2008-12#1)(2012-12#2)(2012-3#2)
1979##26##1##(1990-6#1)(1992-3#1)(1993-12#2)(1994-5#1)(1995-2#1)(1996-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
1979-88##2##1##(1990-6#2)
198 patients with##2##3##(1994-12#1)(2007-7#1)
198 patients##3##2##(1994-12#1)(2007-7#1)(2013-8#1)
198##13##1##(1991-12#1)(1993-12#1)(1994-12#1)(1995-3#1)(1997-2#2)(2007-11#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
1980 and 1986##2##3##(1990-2#1)(1993-9#1)
1980 and 1989##2##3##(1990-9#1)(1993-2#1)
1980 and 1995##2##3##(2008-7#1)(2010-7#1)
1980 and 2005##2##3##(2010-3#1)(2013-1#1)
1980 and##20##2##(1990-2#1)(1990-3#1)(1990-9#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-3#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#2)
1980 through##4##2##(1991-3#1)(1993-6#1)(2008-7#1)(2008-8#1)
1980 to 1988##2##3##(1990-3#1)(1990-5#1)
1980 to 1989##2##3##(1996-9#1)(1997-8#1)
1980 to##12##2##(1990-3#1)(1990-5#1)(1994-2#1)(1994-3#1)(1996-9#1)(1997-8#1)(2008-10#1)(2009-5#1)(2012-2#4)
1980##57##1##(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-3#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-7#2)(2008-8#3)(2009-4#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#5)(2013-1#3)
1980's##5##1##(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#2)
1980-1994##2##1##(1997-1#2)
1980-87##3##1##(1990-2#1)(1990-9#1)(1996-2#1)
1980-89##3##1##(1990-9#1)(1991-6#1)(1997-8#1)
1980-90##2##1##(1993-3#1)(1994-2#1)
1980-92##2##1##(1996-3#2)
1980s and early 1990s##2##4##(1997-1#1)(2008-10#1)
1980s and##7##2##(1991-3#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-5#1)
1980s is##2##2##(1991-3#1)(2008-5#1)
1980s##63##1##(1990-4#1)(1991-11#1)(1991-3#2)(1992-2#4)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2013-1#1)
1981 and##9##2##(1991-2#1)(1991-8#1)(1992-12#1)(1994-7#1)(1995-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
1981 to##4##2##(1990-12#1)(1990-3#1)(1997-1#1)(2008-10#1)
1981##30##1##(1990-12#2)(1990-3#2)(1991-1#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-1#2)(1994-3#1)(1994-7#1)(1995-12#1)(1997-1#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
1981) and##3##2##(1992-10#1)(1997-3#1)(2012-12#1)
1981)##6##1##(1992-1#1)(1992-10#2)(1997-3#1)(2011-2#1)(2012-12#1)
1981-84##2##1##(1992-12#1)(1993-3#1)
1981/1982##3##1##(2009-10#3)
1982 New Beneficiary Survey##2##4##(1993-1#1)(1995-2#1)
1982 and##12##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-8#1)(1993-6#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
1982 by##2##2##(2008-1#1)(2010-3#1)
1982 to 1987##3##3##(1991-4#1)(1992-1#1)(1992-5#1)
1982 to 1992##2##3##(1995-3#2)
1982 to##9##2##(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#1)(1994-7#1)(1994-9#1)(1995-3#2)
1982##45##1##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-3#1)(2011-2#2)(2013-1#1)
1982-83##2##1##(1993-3#2)
1982-87##3##1##(1991-3#1)(1992-10#2)
1982-90##2##1##(1995-3#2)
1983 and##7##2##(1990-12#2)(1990-3#1)(1991-6#1)(2007-11#1)(2008-6#1)(2011-2#1)
1983 in##2##2##(1992-3#1)(2011-1#1)
1983 the##2##2##(1990-3#1)(1990-9#1)
1983 through 1986##2##3##(1991-12#2)
1983 to 1991##2##3##(2008-10#2)
1983 to 2000##2##3##(2008-10#2)
1983 to##9##2##(1991-9#1)(1992-1#1)(1993-12#1)(1994-2#1)(1996-6#1)(2008-10#4)
1983##58##1##(1990-11#1)(1990-12#2)(1990-3#5)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#5)(1992-3#1)(1993-12#2)(1994-2#2)(1994-8#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-6#1)(2007-11#1)(2008-10#8)(2008-6#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#5)
1983)##4##1##(1995-12#1)(2008-12#2)(2011-2#1)
1984 National Long-Term Care##2##4##(1991-1#1)(1993-3#1)
1984 and 1985##3##3##(1991-6#1)(1993-3#1)(1996-11#1)
1984 and##13##2##(1990-6#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#2)(1993-1#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-8#1)
1984 through##4##2##(1992-12#1)(1996-1#1)(2008-8#2)
1984 to 1989##2##3##(1993-8#1)(1994-3#1)
1984 to##14##2##(1991-12#1)(1991-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-9#1)(1997-2#2)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#1)
1984##68##1##(1990-3#2)(1990-6#4)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#2)(1993-1#3)(1993-3#3)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-5#2)(1997-6#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2011-2#1)
1984)##3##1##(1990-8#1)(1992-9#1)(2011-2#1)
1984-92##2##1##(1995-12#1)(1996-1#1)
1985 and 1990##2##3##(1991-6#1)(1997-6#1)
1985 and the end of##2##5##(2008-1#1)(2011-2#1)
1985 and the##3##3##(1991-1#1)(2008-1#1)(2011-2#1)
1985 and##12##2##(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-10#1)(1995-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
1985 by##2##2##(1991-3#1)(2012-1#1)
1985 through 1987##3##3##(1991-12#1)(1993-1#1)(1993-12#1)
1985 through##6##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#1)
1985 to##13##2##(1991-2#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-1#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
1985##84##1##(1990-2#3)(1990-3#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
1985)##5##1##(1992-3#2)(2008-5#1)(2008-8#1)(2012-12#1)
1985-1988##2##1##(1990-12#1)(1995-1#1)
1985-1989##3##1##(1990-12#1)(1991-1#1)(1991-11#1)
1985-88##2##1##(1991-3#1)(1992-12#1)
1985-89##2##1##(1991-11#1)(1992-1#1)
1985-90##3##1##(1991-6#2)(1993-3#1)
1986 and 1988##3##3##(1992-2#1)(1993-1#2)
1986 and##14##2##(1990-2#1)(1990-3#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-9#2)(1994-6#2)(1995-2#1)(2008-10#1)(2013-1#1)
1986 the##4##2##(1990-2#1)(1991-1#1)(1991-6#1)(1991-7#1)
1986 through##3##2##(1990-6#1)(1993-11#1)(2008-1#1)
1986 to 1989##3##3##(2007-8#1)(2008-10#2)
1986 to 2001##2##3##(2007-11#1)(2011-2#1)
1986 to##16##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-3#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
1986 were##2##2##(1991-1#1)(1992-5#1)
1986##97##1##(1990-11#1)(1990-12#3)(1990-2#6)(1990-3#2)(1990-6#2)(1990-8#1)(1991-1#3)(1991-12#4)(1991-2#9)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-2#2)(1994-3#1)(1994-6#3)(1995-2#3)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#3)(2013-1#3)
1986-1989##3##1##(1991-8#2)(1992-6#1)
1986-1991##3##1##(1994-12#1)(1994-2#1)(1996-1#1)
1986]##2##1##(1993-2#1)(2008-12#1)
1987 and 1988##2##3##(1991-1#1)(1992-2#1)
1987 and 1989##2##3##(1992-12#1)(2008-10#1)
1987 and December##2##3##(1990-12#1)(1994-12#1)
1987 and##18##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)
1987 for##3##2##(1991-12#1)(1993-12#1)(1993-3#1)
1987 in##2##2##(1990-2#1)(1990-6#1)
1987 to 1989##2##3##(1992-11#1)(1994-3#1)
1987 to 1992##2##3##(1995-3#1)(2008-10#1)
1987 to December##2##3##(1991-2#1)(1995-3#1)
1987 to##12##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-3#2)(1996-6#1)(2008-10#2)(2008-5#1)
1987##101##1##(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#3)(1990-6#2)(1990-8#1)(1991-1#4)(1991-12#6)(1991-2#7)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-6#3)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2011-3#1)
1987)##5##1##(1990-9#1)(1991-12#1)(1991-9#1)(2008-7#1)(2011-2#1)
1987-88 and##2##2##(1995-6#2)
1987-88##5##1##(1990-2#1)(1995-6#3)(1996-1#1)
1988 a##2##2##(1990-5#1)(1991-9#1)
1988 and 2000##3##3##(1991-1#2)(2008-1#1)
1988 and##16##2##(1990-10#1)(1990-6#1)(1991-1#2)(1992-2#1)(1994-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
1988 to June 1990##2##4##(1991-2#1)(1994-3#1)
1988 to##14##2##(1991-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#2)
1988##149##1##(1990-10#1)(1990-12#8)(1990-2#4)(1990-3#5)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#2)(1991-1#4)(1991-12#1)(1991-2#8)(1991-3#8)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#1)(1992-8#1)(1993-1#5)(1993-12#1)(1993-3#3)(1993-6#1)(1994-1#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#6)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#3)(2012-2#1)(2012-3#1)
1988)##8##1##(1991-1#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-8#2)(2008-11#1)(2012-2#1)
1988-1992##3##1##(1994-9#1)(1997-7#2)
1988-1994##2##1##(2008-12#1)(2010-12#1)
1989 a##2##2##(1991-11#1)(2008-10#1)
1989 and 1991##4##3##(1992-4#2)(1995-1#1)(1996-1#1)
1989 and 1996##2##3##(1997-8#1)(2008-10#1)
1989 and##20##2##(1991-8#1)(1992-12#2)(1992-2#1)(1992-4#3)(1994-3#1)(1995-1#2)(1996-1#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2009-7#1)
1989 in##3##2##(1992-5#1)(1993-2#1)(2008-2#1)
1989 physician payment##2##3##(1994-1#1)(1995-12#1)
1989 the##2##2##(1994-11#1)(2007-8#1)
1989 through##3##2##(1995-1#1)(1997-2#1)(2008-10#1)
1989 to##18##2##(1990-12#1)(1990-2#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-9#1)
1989 using##2##2##(1990-2#1)(1994-3#1)
1989 was##3##2##(1990-6#2)(1994-1#1)
1989##188##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#4)(1990-6#6)(1990-8#3)(1990-9#3)(1991-1#7)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#6)(1991-5#3)(1991-6#3)(1991-8#4)(1991-9#5)(1992-1#4)(1992-11#1)(1992-12#11)(1992-2#9)(1992-3#6)(1992-4#5)(1992-5#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#4)(1995-12#1)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)
1989)##15##1##(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1994-3#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
1989-1990##4##1##(1990-12#1)(1993-1#1)(1996-1#1)(2008-10#1)
1989-1991##2##1##(1994-11#1)(2008-2#1)
1989-1992##2##1##(1993-12#1)(1997-6#1)
1989-1993##2##1##(1997-6#1)(2011-1#1)
1989-2002##3##1##(2007-11#2)(2008-1#1)
1989-90##5##1##(1992-6#4)(1994-3#1)
1989-92##2##1##(1993-3#2)
1989/90##3##1##(1990-9#1)(1996-6#2)
1989]##5##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)
199 patients##2##2##(1994-12#1)(2012-6#1)
199##17##1##(1990-11#1)(1993-2#1)(1994-11#1)(1994-12#2)(1995-12#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-6#1)
1990 a##3##2##(1991-6#1)(1992-5#1)(2008-11#1)
1990 and 1991##2##3##(1994-2#1)(2008-10#1)
1990 and 1994##2##3##(1997-4#1)(2008-10#1)
1990 and 1995##2##3##(1996-11#2)
1990 and 2002##2##3##(2007-8#1)(2008-9#1)
1990 and December##3##3##(1993-12#1)(2007-8#1)(2010-3#1)
1990 and##30##2##(1991-11#1)(1991-12#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1996-11#2)(1997-4#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-9#2)(2009-4#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
1990 contract##2##2##(1990-3#2)
1990 for the##2##3##(1993-9#2)
1990 in##4##2##(1990-12#1)(1992-3#1)(1995-3#1)(1996-6#1)
1990 is##3##2##(2008-5#1)(2009-10#1)(2011-2#1)
1990 national##2##2##(1992-3#1)(1996-8#1)
1990 the##2##2##(1991-11#1)(1992-2#1)
1990 to the##2##3##(1994-3#1)(2013-1#1)
1990 to##25##2##(1991-11#1)(1991-2#1)(1992-2#2)(1994-3#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-12#1)(2007-2#2)(2008-10#6)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
1990 were##2##2##(1992-8#1)(2008-10#1)
1990##221##1##(1990-10#2)(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#3)(1990-8#2)(1991-1#2)(1991-11#5)(1991-12#12)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#4)(1992-12#2)(1992-2#7)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#3)(1994-1#4)(1994-12#3)(1994-2#6)(1994-3#3)(1994-6#2)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#3)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#3)(2008-3#1)(2008-5#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
1990's##5##1##(1991-3#1)(2008-10#1)(2008-11#2)(2010-8#1)
1990)##16##1##(1991-11#1)(1991-12#3)(1992-12#1)(1992-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
1990-1991##5##1##(1991-8#1)(1994-6#2)(1996-3#1)(2011-2#1)
1990-1994##2##1##(1996-11#1)(1997-4#1)
1990-2005##4##1##(1992-3#1)(1993-1#1)(2008-12#2)
1990-91##6##1##(1991-1#1)(1992-6#3)(1994-1#1)(1995-8#1)
1990-93##3##1##(1995-6#2)(1996-7#1)
1990/91##4##1##(1995-5#1)(2008-5#3)
1990]##4##1##(1990-2#1)(1991-2#1)(1991-6#1)(1992-5#1)
1990s by the##2##3##(2008-10#1)(2010-5#1)
1990s by##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
1990s##90##1##(1990-11#2)(1990-6#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#6)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(2007-12#3)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
1991 and 1992##3##3##(1997-6#1)(2008-10#2)
1991 and 1994##2##3##(1995-11#1)(2008-10#1)
1991 and 1995##2##3##(1997-6#1)(2008-7#1)
1991 and##24##2##(1992-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-8#2)
1991 are##3##2##(1992-9#1)(1994-2#1)(1996-1#1)
1991 for##2##2##(1993-9#1)(1997-1#1)
1991 is##2##2##(1993-9#1)(2011-2#1)
1991 showed##2##2##(1992-4#1)(2008-10#1)
1991 survey##2##2##(1993-1#1)(1995-3#1)
1991 the##6##2##(1992-2#1)(1992-5#2)(1993-1#1)(1993-6#1)(1997-4#1)
1991 to 1993##3##3##(1995-12#1)(1995-3#1)(2008-10#1)
1991 to December##2##3##(2008-1#1)(2008-2#1)
1991 to##25##2##(1992-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#5)(2009-11#1)(2010-12#2)(2012-3#1)(2013-1#1)
1991 was##2##2##(1992-2#1)(1995-1#1)
1991##199##1##(1991-11#1)(1991-12#5)(1991-5#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#7)(1992-4#3)(1992-5#5)(1992-6#5)(1992-8#1)(1992-9#4)(1993-1#6)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#3)(1994-1#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1994-7#2)(1994-9#3)(1995-1#6)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#4)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#5)(1997-8#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#15)(2008-12#2)(2008-2#7)(2008-5#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-3#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
1991)##12##1##(1991-12#2)(1991-8#1)(1992-4#1)(1992-9#1)(1994-5#1)(1994-6#1)(1997-6#1)(2008-11#2)(2009-10#1)(2011-2#1)
1991-1994##2##1##(1992-9#1)(2007-11#1)
1991-2005##2##1##(2011-2#1)(2012-2#1)
1991-2008##2##1##(2010-12#1)(2011-1#1)
1991-92##4##1##(1993-2#1)(1996-1#2)(1997-1#1)
1991/1992##3##1##(2009-10#3)
1991]##3##1##(1993-6#1)(1997-3#1)(2008-9#1)
1992 Medicare##3##2##(1995-3#1)(1996-3#1)(1997-1#1)
1992 and 1993##8##3##(1994-11#1)(1995-12#1)(2008-10#5)(2008-5#1)
1992 and 1994##2##3##(2007-5#2)
1992 and##19##2##(1994-11#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-9#2)(1997-3#1)(2006-12#1)(2007-5#2)(2008-10#5)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
1992 at##2##2##(1993-8#1)(1996-3#1)
1992 data##2##2##(1996-3#1)(1996-5#1)
1992 from##2##2##(1994-9#1)(2008-10#1)
1992 the##2##2##(1993-6#1)(1994-3#1)
1992 there##3##2##(1993-8#2)(1996-3#1)
1992 to 1995##4##3##(1997-3#1)(2008-10#3)
1992 to##19##2##(1993-12#1)(1994-6#1)(1995-5#1)(1996-9#1)(1997-3#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#2)(2009-10#1)(2010-8#1)(2012-3#1)
1992##197##1##(1990-12#1)(1990-6#1)(1991-3#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#4)(1993-8#7)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#5)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#4)(1995-2#6)(1995-3#7)(1995-5#2)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#14)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#5)(1997-6#2)(2006-12#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#2)(2008-5#7)(2008-7#1)(2009-10#2)(2010-10#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
1992)##14##1##(1994-2#1)(1994-8#2)(1997-1#2)(1997-3#3)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-3#1)
1992-1993##2##1##(1996-1#1)(2008-3#1)
1992-1994##2##1##(1997-3#1)(2012-2#1)
1992-2002##2##1##(2007-11#1)(2007-5#1)
1992-93##3##1##(1994-3#1)(1994-9#1)(1995-12#1)
1992]##4##1##(1992-5#1)(1993-3#1)(1994-11#1)(1996-8#1)
1993 and 1994##2##3##(1996-6#1)(2008-10#1)
1993 and 1995##2##3##(1996-3#1)(1997-3#1)
1993 and##11##2##(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
1993 from##2##2##(2008-10#1)(2011-2#1)
1993 in##3##2##(1995-2#1)(2008-5#1)(2011-1#1)
1993 on##2##2##(1995-12#1)(2008-10#1)
1993 through##2##2##(1994-9#1)(2008-10#1)
1993 to 1995##2##3##(2008-10#2)
1993 to 1997##2##3##(2008-10#1)(2008-5#1)
1993 to 1998##3##3##(2008-1#1)(2008-10#2)
1993 to December##2##3##(2007-10#1)(2007-8#1)
1993 to May##2##3##(1996-9#1)(2008-2#1)
1993 to##18##2##(1996-9#1)(2007-10#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)
1993 were##4##2##(1995-11#1)(1995-5#1)(1997-4#1)(2008-10#1)
1993##178##1##(1993-11#1)(1993-12#1)(1993-6#2)(1994-1#2)(1994-11#3)(1994-12#5)(1994-3#10)(1994-5#1)(1994-6#4)(1994-9#6)(1995-1#2)(1995-11#5)(1995-12#6)(1995-2#1)(1995-3#10)(1995-5#2)(1995-6#2)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#5)(1996-5#1)(1996-6#5)(1996-9#4)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
1993)##9##1##(1994-11#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-9#1)(1997-7#1)(2008-4#1)(2013-1#1)
1993)]##2##1##(2008-2#1)(2008-4#1)
1993-1994##3##1##(1995-3#1)(1996-12#1)(2008-11#1)
1993-2002##2##1##(2007-11#2)
1993-94##3##1##(1994-9#1)(1997-2#1)(2007-10#1)
1993]##3##1##(1994-2#1)(1994-5#1)(1997-3#1)
1994 Joint Commission on the Accreditation of Healthcare Organizations (JCAHO)##2##10##(1995-2#2)
1994 Joint##3##2##(1995-2#3)
1994 a##2##2##(1996-2#1)(2008-11#1)
1994 and 1995##9##3##(1995-6#1)(1996-11#1)(1996-3#1)(1997-6#1)(2008-10#5)
1994 and June##2##3##(2007-7#1)(2008-1#1)
1994 and March##2##3##(2007-10#1)(2007-8#1)
1994 and##29##2##(1995-6#1)(1996-11#1)(1996-3#2)(1997-3#2)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-9#2)(2011-2#1)(2012-3#1)
1994 from##3##2##(2008-2#1)(2008-5#2)
1994 has##2##2##(1995-3#1)(2010-7#1)
1994 in##4##2##(1996-2#1)(1996-7#1)(2008-10#1)(2008-7#1)
1994 issue##2##2##(1995-2#2)
1994 samples##3##2##(1997-4#3)
1994 through 1996##4##3##(2008-10#4)
1994 to 1995##2##3##(1997-6#1)(2008-10#1)
1994 to 1996##6##3##(1994-1#1)(1997-6#1)(2008-10#4)
1994 to##24##2##(1994-1#1)(1996-7#1)(1997-6#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-3#1)
1994 with##2##2##(1997-3#1)(2007-5#1)
1994##235##1##(1992-9#1)(1994-1#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#11)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#11)(1995-5#3)(1995-6#2)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#12)(1996-3#9)(1996-6#2)(1996-7#2)(1997-1#5)(1997-2#7)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#7)(2007-10#3)(2007-12#1)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#45)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-6#1)(2010-7#1)(2011-2#6)(2012-3#2)(2012-6#1)
1994) presented##2##2##(1995-3#2)
1994)##25##1##(1994-11#2)(1994-5#2)(1995-3#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-11#4)(2009-10#1)(2011-2#1)
1994-1995##3##1##(1995-6#1)(2008-2#1)(2008-3#1)
1994-1995]##2##1##(1997-5#1)(2008-9#1)
1994-1998##4##1##(2007-11#1)(2007-7#1)(2007-8#2)
1994-2002##2##1##(2007-11#1)(2007-8#1)
1994-2005##2##1##(1996-2#1)(1997-1#1)
1994/95##3##1##(1996-6#2)(1997-6#1)
1994]##2##1##(1997-2#1)(2008-12#1)
1995 and 1996##10##3##(2008-10#10)
1995 and 1999 respectively##2##4##(2007-11#2)
1995 and 1999 respectively)##3##4##(2007-11#3)
1995 and 1999##7##3##(2007-11#6)(2008-10#1)
1995 and 2001##3##3##(2007-2#1)(2007-8#1)(2009-3#1)
1995 and 2002##2##3##(2007-11#1)(2007-8#1)
1995 and July##2##3##(2008-10#1)(2008-9#1)
1995 and were##2##3##(1997-2#1)(2008-10#1)
1995 and##46##2##(1993-12#1)(1995-6#1)(1997-2#2)(2007-10#1)(2007-11#7)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
1995 are##2##2##(1995-12#1)(2008-7#1)
1995 as part of a##2##5##(1995-6#1)(2008-2#1)
1995 for##2##2##(2008-11#1)(2008-7#1)
1995 in the##2##3##(1990-3#1)(2008-10#1)
1995 in##3##2##(1990-3#1)(2008-10#2)
1995 the##5##2##(1996-11#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-7#1)
1995 to 1996 and##2##4##(2008-10#1)(2011-1#1)
1995 to 1996##5##3##(2008-10#4)(2011-1#1)
1995 to 1997##4##3##(2007-12#1)(2008-10#3)
1995 to 1998##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
1995 to December##3##3##(2007-7#1)(2007-8#1)(2008-4#1)
1995 to the##2##3##(2008-12#1)(2008-2#1)
1995 to##31##2##(1995-6#1)(1997-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)
1995 was##2##2##(1996-11#1)(1997-3#1)
1995 we##4##2##(1996-11#1)(1996-9#1)(2007-8#1)(2008-7#1)
1995 were##3##2##(1997-6#1)(2008-2#1)(2008-7#1)
1995##225##1##(1990-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#8)(1995-3#3)(1995-6#5)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#8)(1996-12#7)(1996-3#7)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-3#7)(1997-5#1)(1997-6#3)(1997-8#3)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-6#4)(2007-7#2)(2007-8#5)(2008-10#54)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#10)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)
1995)##15##1##(1992-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
1995-96##2##1##(1995-6#1)(2008-10#1)
1995]##3##1##(1995-12#1)(1997-3#2)
1996 and 1997##16##3##(1996-1#1)(2008-10#13)(2008-11#2)
1996 and 1999##2##3##(2007-6#1)(2008-11#1)
1996 and 2002##2##3##(2007-11#1)(2011-2#1)
1996 and the##3##3##(2007-5#1)(2008-2#1)(2011-1#1)
1996 and##37##2##(1996-1#1)(2006-8#1)(2007-11#1)(2007-5#2)(2007-6#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-6#1)
1996 as##2##2##(2008-11#2)
1996 at##3##2##(2006-8#1)(2008-10#2)
1996 field##2##2##(2007-6#1)(2008-3#1)
1996 in the##2##3##(2008-10#1)(2008-11#1)
1996 in##5##2##(1997-6#1)(2008-10#3)(2008-11#1)
1996 is the type species of the genus##3##8##(2011-2#3)
1996 is##4##2##(1994-1#1)(2011-2#3)
1996 to 1997##4##3##(2008-10#4)
1996 to 1998##3##3##(2007-12#1)(2008-10#2)
1996 to August##3##3##(2007-7#1)(2008-3#1)(2008-5#1)
1996 to##21##2##(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2011-7#1)(2012-12#1)(2013-1#1)
1996 was##2##2##(2007-6#1)(2008-10#1)
1996 were##6##2##(1997-6#2)(2008-10#2)(2008-4#1)(2008-7#1)
1996##230##1##(1994-1#1)(1995-6#2)(1996-1#2)(1996-11#7)(1996-12#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#16)(1997-8#3)(2006-10#1)(2006-8#3)(2007-11#2)(2007-12#4)(2007-5#2)(2007-6#7)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#77)(2008-11#13)(2008-12#2)(2008-2#9)(2008-3#8)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#8)(2008-9#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)
1996)##14##1##(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)
1996-2002##2##1##(2007-11#1)(2007-7#1)
1996-97##2##1##(2008-10#2)
1996]##6##1##(1996-9#2)(1997-2#1)(1997-5#1)(2008-11#1)(2008-12#1)
1997 (P = 0##2##4##(2008-10#2)
1997 and 1998##11##3##(2008-10#9)(2008-5#2)
1997 and 1999##3##3##(2008-10#2)(2013-8#1)
1997 and 2001##2##3##(2008-11#1)(2008-7#1)
1997 and 2006##2##3##(2013-8#2)
1997 and December##2##3##(2007-7#1)(2011-1#1)
1997 and March##2##3##(2007-7#1)(2008-10#1)
1997 and##39##2##(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#4)
1997 by##2##2##(1997-5#1)(2008-10#1)
1997 for the##2##3##(2008-10#2)
1997 for##3##2##(2008-10#2)(2008-8#1)
1997 in##6##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)
1997 of the##2##3##(2008-11#1)(2008-9#1)
1997 the##2##2##(2008-12#1)(2008-3#1)
1997 through##4##2##(2007-7#1)(2008-10#2)(2008-3#1)
1997 to 1998##3##3##(2008-10#2)(2011-1#1)
1997 to 1999##3##3##(2007-12#1)(2008-10#2)
1997 to 2000##2##3##(2008-10#2)
1997 to 2007##2##3##(2011-2#2)
1997 to##20##2##(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
1997 was##2##2##(2008-10#2)
1997 were##5##2##(2008-10#4)(2008-3#1)
1997 with##2##2##(2008-11#1)(2008-2#1)
1997##394##1##(1994-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#2)(2007-5#3)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#96)(2008-11#11)(2008-12#8)(2008-2#6)(2008-3#11)(2008-4#13)(2008-5#29)(2008-6#1)(2008-7#131)(2008-8#4)(2008-9#2)(2009-12#3)(2009-4#1)(2009-5#2)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#7)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#8)
1997) with a##2##3##(2008-10#1)(2008-11#1)
1997)##16##1##(1997-7#1)(2007-3#1)(2008-10#3)(2008-11#6)(2008-5#2)(2008-7#1)(2010-5#1)(2012-2#1)
1997-1998##4##1##(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
1997-2002##2##1##(2007-7#1)(2007-8#1)
1997-98##4##1##(1995-6#1)(2008-10#3)
1997a##2##1##(2008-11#2)
1998 Québec##2##2##(2008-2#2)
1998 also##2##2##(2008-10#1)(2011-1#1)
1998 and 1999 were##2##4##(2008-10#2)
1998 and 1999##9##3##(2008-10#9)
1998 and 2001##2##3##(2007-11#1)(2008-10#1)
1998 and 2008##3##3##(2011-2#2)(2012-12#1)
1998 and December##2##3##(2007-12#1)(2008-10#1)
1998 and##30##2##(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#2)(2012-12#3)
1998 at##2##2##(2008-2#1)(2008-3#1)
1998 by##2##2##(2008-11#1)(2008-3#1)
1998 in##3##2##(2008-10#1)(2008-5#2)
1998 is the type##2##4##(2011-2#2)
1998 through##3##2##(2008-10#2)(2008-12#1)
1998 to 1999##4##3##(2007-12#1)(2008-10#3)
1998 to 2000##4##3##(2008-10#4)
1998 to##23##2##(2007-12#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)
1998 was##2##2##(2008-10#1)(2011-1#1)
1998 we have##2##3##(2007-8#2)
1998 we##4##2##(2007-8#3)(2010-8#1)
1998 were##5##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
1998##278##1##(1992-2#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#9)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#7)(2008-10#95)(2008-11#14)(2008-12#4)(2008-2#7)(2008-3#14)(2008-4#7)(2008-5#58)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#5)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#8)(2011-2#11)(2012-12#3)(2012-2#2)(2013-1#2)
1998)##12##1##(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)
1998-1999##3##1##(2008-10#2)(2010-1#1)
1998-2002##4##1##(2007-11#4)
1998-99 and 1999-2000##2##3##(2008-10#2)
1998-99##3##1##(2008-10#3)
1998b)##2##1##(2008-11#2)
1999 and 2000##10##3##(2007-7#1)(2008-10#7)(2008-3#1)(2008-5#1)
1999 and 2001##5##3##(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#1)
1999 and the##2##3##(2007-2#1)(2007-6#1)
1999 and##34##2##(2006-10#1)(2007-11#2)(2007-2#1)(2007-6#4)(2007-7#3)(2007-8#3)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#2)(2009-6#1)(2011-2#1)(2013-8#1)
1999 at##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
1999 growing##2##2##(2008-10#2)
1999 in##3##2##(2008-10#2)(2009-10#1)
1999 is the type species of the genus##2##8##(2011-2#2)
1999 the##3##2##(2007-11#1)(2007-6#1)(2007-8#1)
1999 to February##2##3##(2007-7#1)(2007-8#1)
1999 to June 30##2##4##(2007-12#2)
1999 to June##3##3##(2007-12#2)(2007-7#1)
1999 to##23##2##(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-8#1)
1999 was##2##2##(2006-10#1)(2007-8#1)
1999 were##6##2##(2007-2#1)(2008-10#4)(2008-9#1)
1999 with##2##2##(2006-10#1)(2008-5#1)
1999##221##1##(2006-10#4)(2006-9#1)(2007-10#2)(2007-11#10)(2007-12#4)(2007-2#5)(2007-5#2)(2007-6#8)(2007-7#6)(2007-8#8)(2008-1#4)(2008-10#76)(2008-11#24)(2008-12#2)(2008-3#7)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#5)(2009-10#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#3)
1999)##22##1##(2007-7#1)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)
1999-2000##6##1##(2008-10#5)(2011-3#1)
1999-2001##2##1##(2008-12#1)(2008-8#1)
1999-2002##6##1##(2007-11#1)(2008-10#2)(2010-8#1)(2012-2#2)
1999-2003##3##1##(2007-2#1)(2012-1#1)(2013-8#1)
1999]##2##1##(2008-11#2)
1999a##2##1##(2008-11#2)
1999a)##2##1##(2008-11#2)
1999b##2##1##(2008-11#2)
19C6##7##1##(2008-10#7)
19F NMR spectroscopy##3##3##(1994-8#3)
19F NMR##5##2##(1993-11#1)(1994-8#4)
19F##12##1##(1990-7#1)(1993-11#2)(1994-8#4)(1996-2#1)(2008-7#1)(2012-12#3)
19F-NMR##2##1##(1990-7#2)
19NUIG##2##1##(2008-11#2)
19mM for Sherry wines##2##4##(2008-10#2)
19q13##2##1##(2008-9#2)
19th century##19##2##(1991-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
19th century]##3##2##(1993-11#1)(2009-10#2)
19th##29##1##(1990-10#1)(1991-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-10#4)(2009-7#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
1A is##2##2##(1997-3#1)(2008-1#1)
1A##26##1##(1992-3#1)(1993-12#2)(1995-12#2)(1997-3#1)(2008-1#5)(2008-10#8)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)
1A1##3##1##(1994-8#1)(2008-11#1)(2011-1#1)
1A2##3##1##(2007-11#2)(2008-8#1)
1AS##4##1##(2008-10#4)
1B chromosome##3##2##(2008-10#3)
1B##15##1##(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2012-2#1)
1B1##2##1##(2011-2#2)
1BL##3##1##(2008-10#3)
1BS##2##1##(2008-10#2)
1D and 2D NMR techniques and##2##6##(2008-9#1)(2013-1#1)
1D and 2D NMR##5##4##(1995-2#1)(2008-9#1)(2010-6#1)(2013-1#2)
1D and 2D##6##3##(1992-12#1)(1995-2#1)(2008-9#1)(2010-6#1)(2013-1#2)
1D and##7##2##(1992-12#1)(1995-2#1)(2008-9#1)(2010-11#1)(2010-6#1)(2013-1#2)
1D hopping model##2##3##(2009-11#2)
1D objects##2##2##(2008-6#2)
1D##23##1##(1992-12#1)(1993-12#2)(1995-2#2)(2008-10#4)(2008-6#3)(2008-9#2)(2009-11#3)(2010-11#1)(2010-6#1)(2012-1#2)(2013-1#2)
1D-##2##1##(1994-3#1)(2007-1#1)
1DUVS##4##1##(2008-10#4)
1H MAS NMR (magic-angle spinning nuclear magnetic resonance)##2##8##(2008-1#2)
1H MAS NMR##4##3##(2008-1#4)
1H NMR and##2##3##(1993-11#1)(2011-3#1)
1H NMR spectra##3##3##(1994-5#1)(1995-2#1)(2008-10#1)
1H NMR spectroscopy##5##3##(1992-3#2)(1993-11#1)(1994-5#1)(1996-5#1)
1H NMR studies##3##3##(1992-3#1)(1994-5#2)
1H NMR##27##2##(1990-9#2)(1992-12#1)(1992-3#3)(1993-11#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#8)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#1)(2011-3#2)
1H and 13C NMR spectroscopy##2##5##(1991-5#1)(1995-11#1)
1H and 13C NMR##6##4##(1991-5#1)(1992-12#1)(1995-11#2)(2008-11#1)(2008-12#1)
1H and 15N##3##3##(1993-11#2)(1995-2#1)
1H and 31P##2##3##(1994-2#1)(1995-3#1)
1H and##13##2##(1991-5#1)(1992-12#1)(1993-11#2)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
1H chemical##2##2##(1992-8#1)(2009-7#1)
1H magnetic resonance imaging##3##4##(1996-5#2)(2008-11#1)
1H magnetic resonance##4##3##(1996-5#2)(2008-11#2)
1H spectra##2##2##(1994-2#1)(1994-3#1)
1H##96##1##(1990-9#2)(1991-11#1)(1991-5#1)(1992-12#2)(1992-3#3)(1992-8#1)(1993-11#5)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#10)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-5#4)(1997-2#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#1)(2009-7#35)(2011-3#2)
1H-15N##2##1##(1992-3#1)(1995-2#1)
1H-NMR and molecular modeling##3##4##(1994-5#2)(1995-3#1)
1H-NMR spectroscopy has been used to##2##6##(1990-8#1)(1991-12#1)
1H-NMR spectroscopy of##2##3##(1990-11#1)(1991-12#1)
1H-NMR spectroscopy##8##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#3)(1994-11#1)(1994-3#1)
1H-NMR urinalysis is##2##3##(1993-2#2)
1H-NMR urinalysis##4##2##(1993-2#4)
1H-NMR##26##1##(1990-11#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#4)(1992-3#1)(1993-2#4)(1994-11#1)(1994-3#1)(1994-5#2)(1995-3#3)(2007-11#1)(2010-4#1)
1LT Kenneth R##2##3##(2011-2#2)
1M (NH(4))(2)CO(3)##2##2##(2008-10#2)
1M HCl##7##2##(2008-10#7)
1M KCl##4##2##(2008-10#3)(2008-7#1)
1M NaOH##2##2##(2008-10#1)(2011-2#1)
1M phosphate buffer##3##3##(2008-10#3)
1M potassium##2##2##(2008-10#2)
1M##43##1##(2008-10#39)(2008-7#1)(2011-2#3)
1O2##2##1##(1992-9#2)
1O2*##3##1##(1994-12#3)
1OLD##2##1##(2007-11#2)
1P##4##1##(2010-12#4)
1PP)##2##1##(2008-11#2)
1PS paper was##2##3##(2008-10#2)
1PS paper##8##2##(2008-10#8)
1PS##10##1##(2008-10#10)
1R##3##1##(2007-11#1)(2008-5#1)(2010-5#1)
1RS##2##1##(2008-10#2)
1S##7##1##(1995-12#3)(2008-10#2)(2012-3#2)
1]##13##1##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1993-5#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)
1]octadiene##2##1##(2009-9#2)
1]octane##6##1##(1996-5#3)(2007-11#1)(2008-8#1)(2009-9#1)
1a and 1b##4##3##(1992-12#1)(1994-6#2)(2008-10#1)
1a##22##1##(1992-12#1)(1994-6#4)(1995-11#1)(1996-2#1)(1996-5#4)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-9#1)
1a)##2##1##(1994-3#1)(2009-9#1)
1a-1##2##1##(1993-11#2)
1a-2##2##1##(1993-11#2)
1alpha##18##1##(1997-1#2)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#2)(2009-8#1)
1b##12##1##(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-6#4)(1995-11#1)(1996-5#1)(1997-7#1)(2008-10#1)
1b)##2##1##(1994-3#1)(2008-10#1)
1beta##3##1##(2006-6#1)(2008-10#1)(2008-3#1)
1c and##2##2##(1996-5#1)(2011-2#1)
1c##5##1##(1994-6#2)(1996-5#1)(1997-7#1)(2011-2#1)
1cm##2##1##(2008-10#2)
1er trimestre##2##2##(2011-2#1)(2013-1#1)
1g of##4##2##(2008-10#4)
1g##9##1##(1993-8#2)(2008-10#6)(2008-7#1)
1h##12##1##(2007-8#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-5#1)(2010-6#1)(2013-1#2)
1l##2##1##(2008-10#2)
1mL of##2##2##(2008-10#2)
1mL##4##1##(2008-10#4)
1mM##11##1##(1996-2#1)(2008-10#9)(2012-2#1)
1mV##2##1##(2008-10#2)
1mVdecade(-1)##2##1##(2008-10#2)
1mg##4##1##(2008-10#4)
1mgL(-1)##3##1##(2008-10#3)
1mgl(-1)##4##1##(2008-10#4)
1min##9##1##(2008-10#9)
1ml of a##3##3##(2008-10#3)
1ml of##7##2##(2008-10#7)
1ml sample##2##2##(2008-10#2)
1ml##12##1##(2008-10#12)
1mm##3##1##(2008-10#3)
1mol/L##2##1##(2008-10#2)
1molL(-1)##3##1##(2008-10#3)
1moll(-1)##8##1##(2008-10#8)
1muM##3##1##(2008-10#3)
1mug/mL##2##1##(2008-10#2)
1mugL(-1)##5##1##(2008-10#5)
1mugl(-1) and##2##2##(2008-10#2)
1mugl(-1) for##2##2##(2008-10#2)
1mugl(-1) of##2##2##(2008-10#2)
1mugl(-1)##14##1##(2008-10#14)
1mugl(-1))##2##1##(2008-10#2)
1mugml(-1) of##2##2##(2008-10#2)
1mugml(-1)##8##1##(2008-10#8)
1mum in##2##2##(2007-12#1)(2008-10#1)
1mum##5##1##(2007-12#2)(2008-10#3)
1mumolL(-1)##4##1##(2008-10#4)
1nM##5##1##(1992-8#1)(1993-3#1)(2008-10#3)
1ng/ml##2##1##(2008-10#1)(2013-1#1)
1ngg(-1) for##2##2##(2008-10#2)
1ngml(-1) for##2##2##(2008-10#2)
1ngml(-1)##5##1##(2008-10#5)
1nm to##2##2##(2008-10#2)
1nm##3##1##(2007-12#1)(2008-10#2)
1p##2##1##(1993-9#1)(2009-5#1)
1p)##2##1##(2009-12#2)
1p36##3##1##(1994-12#2)(2007-7#1)
1ppb##4##1##(2008-10#4)
1ppm and##2##2##(2008-10#2)
1ppm##4##1##(2008-10#4)
1s##3##1##(2007-8#1)(2008-10#2)
1st Ed##2##2##(2007-2#2)
1st European Conference##2##3##(2008-7#2)
1st European##3##2##(2008-4#1)(2008-7#2)
1st and 2nd##3##3##(1990-10#1)(1992-12#1)(2010-5#1)
1st and##6##2##(1990-10#2)(1992-12#1)(2008-7#1)(2010-5#1)(2011-1#1)
1st generation##2##2##(2009-7#1)(2010-8#1)
1st month##2##2##(1990-8#1)(2011-2#1)
1st or 2nd##2##3##(1995-8#1)(2008-1#1)
1st##53##1##(1990-10#3)(1990-12#2)(1990-3#1)(1990-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-8#2)(1997-3#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-2#1)(2013-8#1)
1x##6##1##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)
1x10(-1) to##2##2##(2008-10#2)
1x10(-1)##3##1##(2008-10#3)
1x10(-2) and##2##2##(2008-10#2)
1x10(-2)##6##1##(2008-10#6)
1x10(-3) M##4##2##(2008-10#4)
1x10(-3) mol l(-1)##3##3##(2008-10#3)
1x10(-3) to##3##2##(2008-10#3)
1x10(-3)##12##1##(2007-11#1)(2008-10#11)
1x10(-3)M##5##1##(2008-10#5)
1x10(-4) M##2##2##(2008-10#1)(2008-5#1)
1x10(-4) mol l(-1)##3##3##(2008-10#3)
1x10(-4) mol##4##2##(2008-10#4)
1x10(-4)##7##1##(2008-10#6)(2008-5#1)
1x10(-4)M##2##1##(2008-10#2)
1x10(-5) M##4##2##(2008-10#3)(2008-5#1)
1x10(-5) to##6##2##(2008-10#6)
1x10(-5)##16##1##(2008-10#15)(2008-5#1)
1x10(-5)M##3##1##(2008-10#3)
1x10(-6) M##4##2##(2008-10#4)
1x10(-6) to##5##2##(2008-10#5)
1x10(-6)##13##1##(2008-10#13)
1x10(-6)moldm(-3)##2##1##(2008-10#2)
1x10(-7) M##3##2##(2008-10#3)
1x10(-7) mol l(-1)##2##3##(2008-10#2)
1x10(-7) to##4##2##(2008-10#4)
1x10(-7)##9##1##(2008-10#9)
1x10(-7)M and##2##2##(2008-10#2)
1x10(-7)moldm(-3)##2##1##(2008-10#2)
1x10(-8) mol l(-1)##2##3##(2008-10#2)
1x10(-8)##6##1##(2008-10#6)
1x10(-8)M##5##1##(2008-10#5)
1x10(-9) M##3##2##(2008-10#3)
1x10(-9)##5##1##(2008-10#5)
1x10(4) l mol(-1)##2##3##(2008-10#2)
1x10(5)##2##1##(2008-10#2)
1xRDA##2##1##(2011-1#2)
1year##3##1##(2008-7#2)(2011-3#1)
1}##2##1##(2008-2#1)(2008-3#1)
1 year##2##1##(2011-1#1)(2011-2#1)
1 mg/kg##2##1##(2013-1#2)
2 %##10##2##(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#1)
2 %)##4##2##(2012-12#3)(2013-8#1)
2 &lt##2##2##(2008-3#2)
2 (0##4##2##(1990-5#1)(1994-9#1)(2008-12#2)
2 (1##4##2##(1990-8#1)(1991-8#1)(2007-8#1)(2013-8#1)
2 (30##2##2##(1992-9#1)(2012-12#1)
2 (5##4##2##(1990-8#1)(1996-2#1)(2008-2#1)(2010-5#1)
2 (6##4##2##(1996-2#1)(2008-10#1)(2011-2#2)
2 (9##2##2##(1990-3#2)
2 (95%##2##2##(1991-11#1)(1994-12#1)
2 (CD86)##2##2##(2008-11#1)(2008-7#1)
2 (COX-2)##3##2##(2007-4#1)(2008-7#1)(2013-8#1)
2 (N##2##2##(2007-11#1)(2007-12#1)
2 (NF2)##3##2##(1997-3#2)(2010-11#1)
2 (metal to ligand)##2##4##(2008-10#2)
2 (metal##3##2##(2008-10#3)
2 (n =##2##3##(2008-10#1)(2010-10#1)
2 +##9##2##(1990-12#1)(1990-5#4)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
2 +/- 0##17##3##(1992-3#1)(1992-6#1)(1992-9#1)(1995-12#3)(1996-12#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)
2 +/- 1##16##3##(1991-11#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-8#1)
2 +/- 10##2##3##(2008-10#1)(2010-7#1)
2 +/- 13##2##3##(1994-6#1)(2011-2#1)
2 +/- 16##3##3##(1996-2#1)(2008-3#2)
2 +/- 2##3##3##(1990-2#1)(2007-10#2)
2 +/- 3##8##3##(1991-5#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-9#1)(2007-7#1)(2008-1#1)(2010-4#1)
2 +/- 4##4##3##(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#1)
2 +/- 5##2##3##(1995-12#1)(2008-1#1)
2 +/- 6##3##3##(1995-5#1)(2008-3#1)(2011-2#1)
2 +/- 8##2##3##(2008-5#1)(2011-2#1)
2 +/- 9##4##3##(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#1)
2 +/-##70##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#5)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-9#2)(1997-2#1)(1997-4#1)(2007-10#4)(2007-7#2)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#7)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-7#1)(2011-2#3)
2 - 3##2##3##(2007-12#2)
2 - 4##2##3##(1994-5#1)(2011-1#1)
2 -##11##2##(1990-9#1)(1994-5#1)(2007-11#3)(2007-12#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
2 1/2 years##2##3##(2007-2#1)(2012-2#1)
2 1/2##3##2##(1994-6#1)(2007-2#1)(2012-2#1)
2 100##2##2##(1996-2#1)(2008-8#1)
2 =##7##2##(1990-8#1)(1997-3#1)(1997-8#2)(2008-8#1)(2011-2#1)(2013-1#1)
2 ? 0##2##3##(2008-2#1)(2008-3#1)
2 ?##3##2##(2008-2#1)(2008-3#2)
2 A##5##2##(1997-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
2 ATA oxygen##3##3##(1993-12#3)
2 DM and##2##3##(2007-7#1)(2012-2#1)
2 DM##6##2##(2007-7#1)(2008-3#3)(2012-2#2)
2 GHz##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
2 Gy##5##2##(1992-10#1)(2008-10#1)(2008-6#2)(2008-7#1)
2 Hz and 100 Hz EA##2##6##(1996-12#2)
2 Hz and##3##3##(1996-12#2)(2011-2#1)
2 Hz##9##2##(1991-10#1)(1996-12#3)(2008-10#1)(2011-2#4)
2 J/cm(2))##3##2##(2012-2#3)
2 June 2012)##3##3##(2013-1#3)
2 K##7##2##(2008-10#4)(2008-2#1)(2008-3#2)
2 L##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
2 M HCl##2##3##(2008-10#2)
2 M HNO(3)##2##3##(2008-10#2)
2 M NaCl##5##3##(1991-9#1)(1992-8#1)(2008-10#2)(2011-2#1)
2 M sodium##2##3##(2008-10#2)
2 M##28##2##(1990-8#1)(1991-9#1)(1992-8#2)(1994-8#2)(1995-2#1)(2008-10#17)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)
2 M)##2##2##(1992-6#1)(1995-6#1)
2 MAbs##2##2##(1992-2#2)
2 MHz##4##2##(2007-12#1)(2008-2#1)(2008-8#2)
2 MPa##2##2##(2008-3#1)(2009-7#1)
2 Mb##2##2##(1995-6#1)(1996-6#1)
2 Mcllvaine buffer##2##3##(2008-10#2)
2 S##2##2##(1993-8#2)
2 SD in##2##3##(1996-7#2)
2 SD##3##2##(1996-7#2)(2013-1#1)
2 THz##4##2##(2007-12#3)(2008-3#1)
2 U/ml##2##2##(1993-1#1)(2013-1#1)
2 V##8##2##(2007-12#1)(2008-10#7)
2 W of average##2##4##(2007-12#2)
2 W of##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
2 W##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
2 W/kg##3##2##(1992-3#3)
2 [3##2##2##(2012-2#1)(2012-3#1)
2 adjusted##2##2##(2008-10#2)
2 allele##2##2##(1995-12#1)(1997-7#1)
2 also##5##2##(1996-2#1)(2007-8#1)(2008-10#1)(2008-8#2)
2 and 0##14##3##(1996-7#1)(2008-10#9)(2008-12#1)(2008-6#2)(2008-8#1)
2 and 1##14##3##(1993-11#1)(1993-3#1)(2008-10#10)(2008-2#1)(2011-1#1)
2 and 10##4##3##(1993-9#1)(2008-10#2)(2008-7#1)
2 and 11##4##3##(1992-8#1)(1994-3#1)(2008-10#1)(2011-1#1)
2 and 13##2##3##(2008-10#1)(2008-4#1)
2 and 15##4##3##(2008-10#3)(2013-1#1)
2 and 16##2##3##(1996-12#2)
2 and 2##10##3##(1993-11#1)(1995-5#1)(1997-4#1)(2008-10#6)(2010-4#1)
2 and 20##2##3##(1990-8#1)(2008-10#1)
2 and 23##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
2 and 24##5##3##(1992-9#1)(1994-8#1)(1995-12#1)(2009-8#1)(2012-12#1)
2 and 25##2##3##(2008-1#1)(2008-10#1)
2 and 3 are##2##4##(1996-2#1)(2008-6#1)
2 and 3 days##3##4##(2007-10#2)(2010-12#1)
2 and 3 of the##2##5##(1992-3#1)(1995-5#1)
2 and 3 of##3##4##(1991-2#1)(1992-3#1)(1995-5#1)
2 and 3 trials##2##4##(2008-11#1)(2013-1#1)
2 and 3 weeks##2##4##(2008-5#2)
2 and 3 were##4##4##(1995-3#1)(2008-1#1)(2008-10#2)
2 and 3##48##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-7#2)(2007-10#3)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
2 and 33##2##3##(2008-10#2)
2 and 4 h##2##4##(1994-12#1)(1995-11#1)
2 and 4 hr##2##4##(1990-12#1)(2008-5#1)
2 and 4 weeks of##2##5##(2008-10#1)(2008-7#1)
2 and 4 weeks##5##4##(2008-10#3)(2008-7#1)(2009-3#1)
2 and 4##22##3##(1990-12#1)(1991-6#1)(1994-12#1)(1995-11#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-3#1)
2 and 40##2##3##(1990-12#1)(1995-6#1)
2 and 5##17##3##(1993-3#1)(1994-9#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2012-2#1)
2 and 6 weeks##2##4##(2007-11#1)(2011-2#1)
2 and 6##9##3##(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
2 and 6%##2##3##(2008-10#2)
2 and 7 days##2##4##(2007-10#1)(2008-12#1)
2 and 7##13##3##(1990-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
2 and 8 h##2##4##(1996-2#1)(2011-1#1)
2 and 8##10##3##(1991-9#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
2 and 9##3##3##(1997-7#1)(2008-10#2)
2 and Km*3##2##3##(1997-8#2)
2 and a##3##3##(2007-12#1)(2008-7#1)(2010-11#1)
2 and ferritin &lt##2##4##(2007-7#2)
2 and ferritin&gt##2##3##(2007-7#2)
2 and glucose##3##3##(2012-5#3)
2 and that##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
2 and the##5##3##(1990-8#1)(1992-6#1)(1997-1#1)(2008-10#1)(2008-8#1)
2 and then##2##3##(2007-12#1)(2008-10#1)
2 and##320##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#4)(1991-2#3)(1991-6#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2007-10#4)(2007-11#4)(2007-12#6)(2007-7#4)(2007-8#3)(2008-1#6)(2008-10#101)(2008-11#7)(2008-12#10)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#18)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-5#3)(2013-1#7)(2013-7#1)(2013-8#3)
2 approximately##2##2##(2008-10#2)
2 are##7##2##(1991-3#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)
2 as##2##2##(1997-8#1)(2008-10#1)
2 at the##2##3##(1992-1#1)(1992-3#1)
2 at##5##2##(1991-9#1)(1992-1#1)(1992-3#1)(2008-10#1)(2008-3#1)
2 atoms of zinc bound per molecule##2##7##(1991-9#2)
2 beats/min##2##2##(2008-7#1)(2013-1#1)
2 beta##3##2##(1990-8#1)(1993-8#1)(1994-5#1)
2 between##4##2##(1992-6#1)(2007-11#1)(2008-8#1)(2008-9#1)
2 billion people##2##3##(2009-8#1)(2012-2#1)
2 billion##3##2##(2009-8#1)(2010-12#1)(2012-2#1)
2 blue complex##3##3##(2008-10#3)
2 but##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
2 by##6##2##(1993-3#2)(1993-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
2 cM from acitric##2##4##(2008-5#2)
2 cM from##3##3##(2008-10#1)(2008-5#2)
2 cM##6##2##(2008-10#3)(2008-5#2)(2008-9#1)
2 carotid##2##2##(1996-6#2)
2 case##2##2##(2008-11#1)(2012-1#1)
2 cases in##2##3##(1995-3#1)(2012-2#1)
2 cases of##15##3##(1991-11#1)(1991-6#1)(1992-8#1)(1994-12#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
2 cases were##3##3##(1991-12#1)(1994-7#1)(2013-8#1)
2 cases##55##2##(1990-2#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1992-12#2)(1992-8#2)(1993-2#2)(1993-9#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-3#1)(1996-6#2)(1997-3#1)(2006-10#2)(2007-11#5)(2007-2#1)(2007-8#3)(2008-11#1)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#3)
2 cases]##5##2##(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1996-3#1)
2 cell lines##2##3##(1992-9#1)(1993-9#1)
2 cell##3##2##(1992-9#1)(1993-9#1)(2008-11#1)
2 cells##2##2##(2008-11#1)(2008-7#1)
2 children##6##2##(1990-9#1)(1991-8#1)(1992-4#2)(2008-10#1)(2012-2#1)
2 chromosomes##2##2##(1997-2#1)(2008-10#1)
2 clinical trial##2##3##(2011-2#2)
2 clinical##6##2##(1990-5#1)(1991-5#1)(1994-9#1)(1997-4#1)(2011-2#2)
2 cm in##6##3##(1991-4#2)(1992-10#1)(2008-12#1)(2010-6#1)(2012-12#1)
2 cm to##2##3##(1993-12#1)(2012-12#1)
2 cm was##2##3##(1991-12#1)(1994-7#1)
2 cm x 2 cm##2##5##(2008-3#2)
2 cm##33##2##(1990-9#2)(1991-12#1)(1991-4#2)(1992-10#1)(1993-12#1)(1994-7#1)(1995-4#2)(1997-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#1)(2012-12#3)
2 cm(-1)##3##2##(2008-10#1)(2008-2#2)
2 complex of##2##3##(2008-10#2)
2 complex##6##2##(1995-11#1)(2008-10#4)(2009-7#1)
2 complexes##3##2##(1992-2#1)(2008-10#2)
2 consecutive##2##2##(2010-1#1)(2013-1#1)
2 consisted of##3##3##(2008-10#1)(2010-3#1)(2010-8#1)
2 could##2##2##(2008-10#1)(2010-4#1)
2 courses##3##2##(1990-12#1)(2007-4#1)(2008-10#1)
2 cross-link##2##2##(1993-11#1)(2008-11#1)
2 crystallizes in the##2##4##(1996-2#1)(2007-11#1)
2 dB##8##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-7#1)
2 days after the##2##4##(1993-12#1)(2007-10#1)
2 days after##12##3##(1993-12#1)(1993-5#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-5#2)(2009-3#1)(2010-12#1)(2012-12#1)
2 days and##6##3##(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
2 days before##2##3##(2008-10#1)(2009-6#1)
2 days for##2##3##(2008-10#2)
2 days in##3##3##(1996-5#1)(2007-10#1)(2011-2#1)
2 days of##4##3##(1995-12#1)(2008-10#1)(2008-12#1)(2010-2#1)
2 days prior to##3##4##(2008-10#1)(2008-7#2)
2 days with##2##3##(1993-2#1)(2010-6#1)
2 days##63##2##(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#2)(1997-8#1)(2007-10#2)(2007-12#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-5#3)(2008-7#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
2 decades##10##2##(1992-8#1)(1994-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)
2 degrees )##2##3##(2007-12#1)(2008-12#1)
2 degrees C##15##3##(1991-8#1)(2007-3#1)(2008-10#9)(2008-12#2)(2011-2#1)(2012-2#1)
2 degrees C)##3##3##(2008-10#2)(2008-5#1)
2 degrees##30##2##(1991-2#1)(1991-8#1)(1992-9#1)(1997-7#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#11)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
2 deletion syndrome##2##3##(1997-3#2)
2 deletion##4##2##(1997-3#3)(2012-12#1)
2 describes##5##2##(2008-11#1)(2008-4#3)(2008-9#1)
2 diabetes (T2D)##6##3##(2008-1#1)(2009-3#1)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#1)
2 diabetes and##13##3##(1994-12#1)(2008-1#3)(2008-11#1)(2008-7#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#2)
2 diabetes has been##2##4##(2008-4#1)(2012-5#1)
2 diabetes has##5##3##(2008-3#3)(2008-4#1)(2012-5#1)
2 diabetes in##18##3##(1994-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2009-12#2)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
2 diabetes is##5##3##(2008-1#2)(2008-3#1)(2008-7#1)(2010-12#1)
2 diabetes mellitus (DM)##4##4##(2007-7#1)(2008-3#2)(2011-1#1)
2 diabetes mellitus (DM2)##2##4##(2008-3#1)(2012-3#1)
2 diabetes mellitus (T2DM)##8##4##(2008-1#1)(2008-3#1)(2009-11#2)(2009-9#1)(2010-10#1)(2011-1#1)(2013-1#1)
2 diabetes mellitus and##10##4##(2007-5#1)(2008-1#2)(2008-3#3)(2012-2#2)(2013-1#2)
2 diabetes mellitus is##3##4##(2008-1#1)(2008-3#2)
2 diabetes mellitus were##2##4##(2008-3#1)(2012-12#1)
2 diabetes mellitus##59##3##(1990-2#1)(2007-5#2)(2007-7#1)(2008-1#7)(2008-10#1)(2008-3#17)(2008-6#1)(2008-7#1)(2009-11#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#2)
2 diabetes patients##11##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#2)(2011-1#1)(2011-2#2)(2012-12#1)
2 diabetes##225##2##(1990-2#1)(1994-12#3)(1996-11#3)(2007-5#3)(2007-7#1)(2008-1#34)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#39)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#8)(2009-12#3)(2009-3#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#8)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#8)(2011-2#11)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#11)(2012-4#4)(2012-5#4)(2012-6#2)(2013-1#11)(2013-7#1)(2013-8#4)
2 diabetic patients##11##3##(1991-5#1)(1993-2#3)(2008-1#2)(2010-10#1)(2011-2#4)
2 diabetic##20##2##(1991-5#1)(1993-2#3)(1994-12#1)(2008-1#4)(2008-3#1)(2010-10#1)(2011-2#4)(2012-12#2)(2012-3#1)(2012-5#1)(2013-8#1)
2 diabetics with##2##3##(2008-3#1)(2013-8#1)
2 diabetics##3##2##(1990-2#1)(2008-3#1)(2013-8#1)
2 diaminopropane##2##2##(2008-10#2)
2 did not##3##3##(1993-6#1)(2008-10#2)
2 died because of##2##4##(2011-2#2)
2 different##4##2##(2010-8#2)(2013-8#2)
2 domain##3##2##(2009-6#1)(2013-1#2)
2 equiv##2##2##(1996-2#1)(2010-5#1)
2 examined##2##2##(2008-12#1)(2009-5#1)
2 exons##2##2##(1997-2#1)(2008-12#1)
2 extended##2##2##(2008-5#1)(2010-4#1)
2 features##2##2##(2010-3#1)(2011-2#1)
2 female##2##2##(1996-11#1)(2008-5#1)
2 fold##5##2##(1990-12#1)(1990-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
2 for the##2##3##(1990-6#1)(1990-7#1)
2 for##16##2##(1990-6#1)(1990-7#1)(1992-8#1)(1993-9#1)(1994-5#1)(2008-10#7)(2008-2#1)(2008-4#1)(2010-1#1)(2011-3#1)
2 from the##2##3##(2011-1#1)(2011-2#1)
2 from##7##2##(1994-11#1)(1997-8#1)(2008-10#3)(2011-1#1)(2011-2#1)
2 g of##2##3##(2008-10#2)
2 g##8##2##(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
2 g/d##2##2##(2008-5#2)
2 g/dL##3##2##(2008-7#2)(2009-8#1)
2 gastric neuroendocrine tumor##2##4##(1997-1#2)
2 gene expression##2##3##(2009-8#1)(2012-3#1)
2 gene##6##2##(1994-11#1)(2008-2#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
2 genes##2##2##(1992-3#1)(2008-8#1)
2 groups of patients##3##4##(1993-9#1)(2009-3#1)(2009-7#1)
2 groups of##4##3##(1993-9#1)(2009-3#1)(2009-7#1)(2010-1#1)
2 groups##24##2##(1990-2#1)(1990-3#1)(1991-11#5)(1993-9#1)(1994-6#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#2)(2010-1#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)
2 h after light initiation##3##5##(2008-10#3)
2 h after surgery##2##4##(1995-3#2)
2 h after the##4##4##(1990-5#1)(1996-2#1)(2008-10#2)
2 h after##14##3##(1990-5#1)(1991-2#1)(1995-3#2)(1996-2#1)(2008-10#7)(2008-7#1)(2008-8#1)
2 h and##6##3##(1990-5#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#2)
2 h at##2##3##(1995-8#1)(2008-10#1)
2 h before##3##3##(1993-3#1)(2008-10#2)
2 h following##3##3##(1996-2#1)(2008-7#1)(2010-8#1)
2 h of incubation##2##4##(1994-8#1)(2008-10#1)
2 h of##8##3##(1992-11#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-5#1)
2 h was##2##3##(1990-2#1)(2008-7#1)
2 h##82##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#3)(1996-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#27)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
2 had no##2##3##(2008-3#1)(2009-8#1)
2 had##14##2##(1990-9#2)(1991-12#1)(1991-2#1)(1993-12#2)(1994-12#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-2#1)
2 half##2##2##(2007-11#1)(2008-7#1)
2 has been##2##3##(1997-7#1)(2008-7#1)
2 has##5##2##(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-7#1)
2 hours post-impact##2##3##(2008-7#2)
2 hours##16##2##(1990-11#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-3#2)(1995-5#1)(2007-7#1)(2007-8#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
2 hr##5##2##(1993-8#1)(2008-11#2)(2008-6#1)(2008-7#1)
2 hrs##3##2##(1994-11#1)(2011-2#1)(2012-2#1)
2 identified a##2##3##(1993-6#1)(2008-10#1)
2 in rats##2##3##(1992-9#1)(2013-1#1)
2 in the##11##3##(1990-3#1)(1991-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
2 in##46##2##(1990-3#3)(1991-2#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-6#3)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#4)
2 included##2##2##(2008-10#1)(2008-3#1)
2 inclusion##2##2##(2008-10#2)
2 individuals with##2##3##(1990-3#1)(1994-8#1)
2 individuals##3##2##(1990-3#1)(1994-8#1)(2010-3#1)
2 is reported##2##3##(1994-11#1)(2008-5#1)
2 is##16##2##(1991-2#2)(1992-6#1)(1994-11#2)(1994-12#2)(1995-3#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-5#1)
2 isolate##4##2##(2008-10#4)
2 isolates were##3##3##(2008-10#3)
2 isolates##8##2##(2008-10#8)
2 kDa##7##2##(1993-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-12#1)
2 kHz##7##2##(2006-12#1)(2008-3#4)(2010-9#1)(2012-3#1)
2 kJ mol(-1)##4##3##(1996-2#1)(2008-10#3)
2 kJ##6##2##(1992-10#1)(1996-2#1)(2008-10#3)(2008-9#1)
2 kW##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
2 kb of##2##3##(1991-6#1)(1993-2#1)
2 kb##14##2##(1990-11#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1996-10#1)(1997-6#1)(2008-11#1)(2008-8#2)(2008-9#1)
2 kbp##2##2##(1994-8#1)(1996-12#1)
2 kcal##2##2##(1992-3#1)(1997-2#1)
2 kcal/mol##4##2##(1991-8#1)(1996-2#1)(2012-12#2)
2 keV##2##2##(2008-2#2)
2 kg##4##2##(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)
2 kg/m(2)##2##2##(2006-8#1)(2008-7#1)
2 kinds of##3##3##(2008-5#1)(2010-8#2)
2 km##2##2##(2008-2#1)(2008-3#1)
2 l##3##2##(2008-10#1)(2008-11#2)
2 l/min##2##2##(2011-2#2)
2 lasers##4##2##(1991-3#2)(1992-12#1)(1992-9#1)
2 lead ECG##3##3##(2009-3#3)
2 lead ECGs##2##3##(2009-3#2)
2 lead##5##2##(2009-3#5)
2 log units##2##3##(2008-10#2)
2 log##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
2 log(10)##2##2##(2008-11#1)(2013-1#1)
2 lymphomas##2##2##(2013-8#2)
2 m##9##2##(2008-10#4)(2008-3#2)(2008-5#2)(2010-8#1)
2 m)##2##2##(2008-10#1)(2008-5#1)
2 m/s##2##2##(2007-12#1)(2008-2#1)
2 mJ##3##2##(2008-10#1)(2008-2#2)
2 mL)##2##2##(1996-3#1)(2010-1#1)
2 mM MnCl2##2##3##(1992-6#2)
2 mM in##2##3##(1994-11#1)(2008-4#1)
2 mM sodium##2##3##(1994-9#2)
2 mM##32##2##(1990-12#1)(1990-7#2)(1991-9#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-8#2)(1994-11#4)(1994-5#1)(1994-6#1)(1994-9#3)(1995-2#1)(1996-5#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2011-2#1)
2 mM)##5##2##(1992-11#1)(1994-8#1)(1995-8#1)(1996-9#1)(1997-1#1)
2 mV decade(-1)##2##3##(2008-10#2)
2 mV##8##2##(1991-9#1)(2008-10#7)
2 mW##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
2 main##3##2##(2008-12#1)(2010-8#1)(2013-1#1)
2 major##3##2##(1993-9#1)(2009-8#1)(2010-3#1)
2 mediated##2##2##(2008-4#1)(2008-8#1)
2 methods##2##2##(1990-2#1)(1993-9#1)
2 mg L(-1)##3##3##(2008-10#1)(2008-12#2)
2 mg l(-1) of##2##4##(2008-10#2)
2 mg l(-1)##11##3##(2008-10#11)
2 mg of##5##3##(2008-10#1)(2008-11#1)(2010-12#2)(2010-6#1)
2 mg##38##2##(1990-11#1)(1991-5#1)(1993-2#1)(1995-5#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#1)
2 mg/L##3##2##(2008-8#3)
2 mg/kg##13##2##(1991-10#1)(1991-5#1)(1992-11#2)(1993-1#1)(1996-12#1)(1997-7#3)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
2 mg/kg)##2##2##(1995-12#1)(1996-2#1)
2 mg/mL lysozyme##2##3##(2011-2#2)
2 mgl(-1)##3##2##(2008-10#2)(2008-11#1)
2 microM for##2##3##(1992-12#1)(2008-10#1)
2 microM##19##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)
2 microM) &lt##2##3##(1994-6#2)
2 microM)##10##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)
2 microg##4##2##(2008-1#1)(2008-10#3)
2 microg/L##2##2##(2008-8#1)(2011-1#1)
2 microg/kg per hour##2##4##(2011-2#2)
2 microg/ml##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
2 micrograms##2##2##(1990-5#1)(1992-8#1)
2 micrograms/kg##2##2##(1993-1#1)(1995-3#1)
2 micrograms/ml##2##2##(1990-8#1)(1993-6#1)
2 microl##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
2 microm and##2##3##(2007-12#1)(2008-3#1)
2 microm##10##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2010-10#1)
2 micromol L(-1)##2##3##(2008-10#1)(2011-3#1)
2 micromol##3##2##(2008-10#2)(2011-3#1)
2 micron plasmid##2##3##(1993-9#1)(1996-6#1)
2 microns plasmid##5##3##(1993-9#4)(1996-6#1)
2 microns##8##2##(1991-5#1)(1993-9#4)(1996-3#1)(1996-6#2)
2 microns)##2##2##(1997-1#1)(1997-2#1)
2 million##15##2##(1992-6#1)(1993-6#1)(1993-8#1)(1996-1#1)(1997-5#1)(2007-2#1)(2008-10#2)(2008-11#3)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#1)
2 min after ejaculation##2##4##(1992-12#2)
2 min after##3##3##(1992-12#2)(1997-2#1)
2 min and##2##3##(1992-3#1)(1993-11#1)
2 min for##3##3##(1996-2#1)(2008-10#2)
2 min of##4##3##(1990-7#1)(1992-11#1)(2008-10#1)(2009-12#1)
2 min##34##2##(1990-7#4)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-11#1)(1994-11#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-10#13)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#2)
2 min)##5##2##(1995-12#1)(1995-6#2)(2008-10#2)
2 min-1##2##2##(1992-6#1)(1995-6#1)
2 minutes##2##2##(1990-5#1)(1996-9#1)
2 ml and##2##3##(2010-5#2)
2 ml min(-1)##4##3##(2008-10#4)
2 ml of Ringer water solution##2##6##(2008-12#2)
2 ml of##7##3##(2008-10#5)(2008-12#2)
2 ml##21##2##(1996-12#1)(2007-11#1)(2008-10#12)(2008-12#2)(2010-5#4)(2011-2#1)
2 mm and a##2##4##(2007-11#1)(2007-12#1)
2 mm and##5##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2010-8#1)
2 mm in##2##3##(2008-5#1)(2010-7#1)
2 mm##36##2##(1997-2#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-7#1)(2010-8#3)(2012-1#1)(2013-1#3)
2 mm)##5##2##(1991-4#1)(2008-11#1)(2009-12#1)(2009-7#1)(2013-1#1)
2 mmol l(-1)##3##3##(2008-10#3)
2 mmol##4##2##(2008-10#3)(2008-5#1)
2 mmol/L##5##2##(2008-1#1)(2008-4#1)(2008-8#2)(2011-2#1)
2 mmol/kg##4##2##(1994-2#1)(1994-5#2)(2009-12#1)
2 mmol/kg)##3##2##(1994-5#3)
2 mmol/l##4##2##(1992-11#3)(1995-11#1)
2 mmol/l)##2##2##(1992-6#1)(1992-9#1)
2 mol l(-1) HCl##4##4##(2008-10#4)
2 mol l(-1) HNO(3)##3##4##(2008-10#3)
2 mol l(-1) NH(4)-oxalate buffer##2##5##(2008-10#2)
2 mol l(-1)##16##3##(2008-10#16)
2 mol of##2##3##(1994-5#1)(1995-6#1)
2 mol##20##2##(1994-5#1)(1995-6#1)(2008-10#17)(2009-2#1)
2 mol%)##2##2##(2008-10#2)
2 molar ratio##2##3##(1990-5#1)(1993-8#1)
2 month##2##2##(1994-3#1)(2008-3#1)
2 months (range##2##3##(2007-8#1)(2009-10#1)
2 months after the##2##4##(2008-11#1)(2012-12#1)
2 months after##8##3##(1996-12#2)(2007-10#3)(2008-11#1)(2012-12#2)
2 months and##5##3##(1992-10#1)(1996-12#1)(2008-10#2)(2008-5#1)
2 months before##5##3##(1990-9#1)(1992-10#1)(1996-5#1)(2008-10#1)(2010-10#1)
2 months in##2##3##(2008-10#2)
2 months later##6##3##(1992-10#2)(2007-8#1)(2008-12#1)(2008-4#1)(2009-3#1)
2 months of age##3##4##(2006-5#2)(2010-11#1)
2 months of##10##3##(1996-12#2)(2006-5#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#1)
2 months old##2##3##(2008-10#1)(2012-12#1)
2 months to##2##3##(1996-12#1)(2009-3#1)
2 months without##3##3##(2008-10#3)
2 months##93##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-10#4)(1993-6#1)(1994-12#2)(1996-12#7)(1996-5#1)(2006-10#1)(2006-5#2)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#3)(2010-10#2)(2010-11#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
2 months)##5##2##(2008-10#2)(2008-12#1)(2009-3#1)(2011-3#1)
2 more##2##2##(1993-12#1)(2007-10#1)
2 ms##2##2##(2007-11#1)(2008-7#1)
2 ms)##2##2##(1997-8#1)(2007-12#1)
2 muM##3##2##(2008-10#3)
2 mug g(-1)##3##3##(2008-10#3)
2 mug l(-1) for##7##4##(2008-10#7)
2 mug l(-1)##15##3##(2008-10#15)
2 mug ml(-1) of##3##4##(2008-10#3)
2 mug ml(-1)##8##3##(2008-10#8)
2 mug ml(-1))##2##3##(2008-10#2)
2 mug rvWF/106 cells x day##2##6##(2008-11#2)
2 mug##38##2##(2008-10#33)(2008-11#3)(2008-5#1)(2008-9#1)
2 mug/ml##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
2 mugml(-1) for##2##3##(2008-10#2)
2 mugml(-1)##3##2##(2008-10#3)
2 mul##2##2##(2008-10#2)
2 multiple##2##2##(2011-3#1)(2013-8#1)
2 mum in diameter)##2##4##(2008-5#2)
2 mum in the##2##4##(2007-12#1)(2008-3#1)
2 mum in##4##3##(2007-12#1)(2008-3#1)(2008-5#2)
2 mum##14##2##(1993-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#2)
2 mum)##4##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-6#1)
2 mumol g(-1)##2##3##(2008-10#2)
2 mumol##5##2##(2008-10#5)
2 mumol/l for##2##3##(1994-6#2)
2 mumol/l##3##2##(1994-6#2)(2008-10#1)
2 murine##2##2##(1993-8#1)(2008-10#1)
2 nM and##2##3##(1991-5#1)(1993-11#1)
2 nM##8##2##(1990-5#1)(1991-5#2)(1991-9#1)(1993-11#1)(1993-3#1)(1994-8#1)(1994-9#1)
2 nM)##2##2##(1993-11#1)(1994-3#1)
2 ng m(-3)##2##3##(2008-10#2)
2 ng ml(-1) for##4##4##(2008-10#4)
2 ng ml(-1)##15##3##(2008-10#15)
2 ng##25##2##(1990-12#1)(2008-10#23)(2012-3#1)
2 ng/mL##2##2##(2010-12#1)(2011-1#1)
2 ng/ml##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
2 nm##8##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)
2 nm)##2##2##(2008-2#1)(2008-3#1)
2 nmol##4##2##(1990-11#1)(1991-8#1)(1997-6#1)(2008-10#1)
2 nmol/h/mg protein##2##3##(1990-5#1)(1991-12#1)
2 nmol/l##2##2##(1990-12#1)(1994-6#1)
2 ns##5##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
2 of 24##2##3##(1990-3#1)(1994-12#1)
2 of 3 strains in##2##5##(2007-11#2)
2 of 3 years##2##4##(2008-10#2)
2 of 3##7##3##(2007-10#1)(2007-11#3)(2008-10#2)(2008-7#1)
2 of 90##2##3##(2008-10#2)
2 of both##2##3##(2008-10#2)
2 of the##13##3##(1991-2#1)(1991-5#1)(1994-7#1)(1995-5#1)(1996-12#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-1#1)(2011-2#1)
2 of them##2##3##(1992-5#1)(2006-10#1)
2 of these patients##2##4##(1990-8#1)(2011-2#1)
2 of##55##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#2)(1992-5#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-7#2)(1995-5#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#16)(2008-2#1)(2008-7#2)(2008-9#2)(2009-1#1)(2011-2#2)
2 on a##2##3##(1995-8#1)(2013-1#1)
2 on the##5##3##(1990-8#1)(1993-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
2 on##10##2##(1990-8#1)(1993-11#1)(1995-12#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#2)
2 or 24##2##3##(1995-12#1)(2008-11#1)
2 or 3##8##3##(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
2 or 4 weeks after##2##5##(2013-1#2)
2 or 4##4##3##(2008-7#1)(2011-2#1)(2013-1#2)
2 or more##3##3##(1991-3#1)(1991-9#1)(2008-10#1)
2 or##28##2##(1991-3#1)(1991-6#1)(1991-9#1)(1993-11#2)(1995-11#2)(1995-12#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#5)
2 orders of magnitude and##2##5##(2007-12#1)(2008-3#1)
2 orders of magnitude higher than##3##6##(2007-11#1)(2007-12#1)(2008-10#1)
2 orders of magnitude higher##4##5##(2007-11#1)(2007-12#2)(2008-10#1)
2 orders of magnitude in the##2##6##(2008-2#1)(2008-3#1)
2 orders of magnitude##19##4##(1994-5#1)(1995-2#2)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#2)(2008-3#4)(2010-4#1)
2 other##2##2##(1993-9#1)(2007-11#1)
2 others##2##2##(1990-6#1)(2008-5#1)
2 out of##7##3##(1990-12#1)(1990-6#1)(1996-8#1)(2008-1#1)(2008-5#2)(2010-2#1)
2 over a range##3##4##(2007-11#1)(2008-10#2)
2 patients (1##2##3##(2007-11#2)
2 patients and##4##3##(2006-10#2)(2007-8#1)(2012-12#1)
2 patients died##2##3##(1994-12#1)(2013-1#1)
2 patients had a##2##4##(1991-8#1)(2008-7#1)
2 patients had##4##3##(1991-8#1)(1992-10#1)(1994-3#1)(2008-7#1)
2 patients were##6##3##(1990-12#1)(1992-8#1)(1993-12#1)(1996-11#1)(1997-3#1)(2008-10#1)
2 patients who##3##3##(1992-10#1)(1992-12#1)(2007-10#1)
2 patients with low##2##4##(2013-1#2)
2 patients with##9##3##(1991-6#1)(1991-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#2)(2013-1#2)
2 patients##68##2##(1990-10#1)(1990-12#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-6#1)(1991-8#4)(1992-10#2)(1992-12#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-3#1)(1997-3#2)(1997-4#1)(2006-10#4)(2007-10#2)(2007-11#10)(2007-8#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#5)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#5)
2 per 100 thousand in##2##5##(2013-7#2)
2 per 1000##2##3##(1995-5#1)(2011-2#1)
2 per##8##2##(1995-5#1)(2007-7#2)(2008-2#1)(2011-2#1)(2013-7#2)(2013-8#1)
2 percent of##3##3##(1991-1#1)(1991-12#1)(2008-11#1)
2 percent##12##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1994-6#1)(1995-3#2)(2008-11#1)
2 pg##4##2##(1990-8#1)(1994-9#1)(2008-10#2)
2 pg/ml##3##2##(1990-11#1)(1990-5#1)(1994-7#1)
2 pi##3##2##(1996-2#1)(2008-3#2)
2 pmol##2##2##(1997-6#1)(2008-10#1)
2 points##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
2 population##2##2##(2008-10#1)(2008-8#1)
2 populations##2##2##(2007-10#2)
2 ppb##3##2##(2008-10#1)(2008-3#2)
2 ppm##4##2##(1990-8#1)(2008-10#2)(2008-2#1)
2 precursors##2##2##(2013-1#2)
2 presented##2##2##(1991-3#1)(2010-5#1)
2 promoter##2##2##(2009-8#1)(2013-1#1)
2 protein##2##2##(2007-12#1)(2008-9#1)
2 proteins##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
2 provides##2##2##(1995-3#1)(2008-4#1)
2 ps##3##2##(2007-1#1)(2008-3#1)(2009-9#1)
2 pts##3##2##(2010-3#3)
2 radiation##2##2##(2009-2#1)(2013-1#1)
2 receptor##8##2##(1990-6#1)(1994-11#2)(1994-8#2)(2008-11#1)(2011-1#1)(2012-1#1)
2 region alone or the##2##5##(2008-10#2)
2 renal##2##2##(2006-10#1)(2008-7#1)
2 required##2##2##(1992-12#1)(2009-10#1)
2 resulted in##2##3##(2008-10#2)
2 s and##2##3##(1992-11#1)(2008-10#1)
2 s##7##2##(1992-11#1)(1992-9#1)(1996-2#1)(2008-10#3)(2008-3#1)
2 s)##2##2##(2008-10#1)(2010-3#1)
2 s-1##2##2##(1992-6#1)(1995-2#1)
2 seconds##3##2##(2007-9#1)(2011-1#1)(2013-8#1)
2 sensilla##2##2##(2007-12#2)
2 showed that##3##3##(1993-6#1)(2008-10#1)(2009-9#1)
2 showed##7##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-6#1)(2013-1#1)
2 sites##3##2##(1994-8#1)(2012-3#1)(2013-1#1)
2 species of##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
2 species##8##2##(2008-10#2)(2008-5#1)(2009-10#1)(2010-3#2)(2011-2#1)(2013-1#1)
2 strain##2##2##(2008-10#1)(2013-1#1)
2 strains##5##2##(2008-1#1)(2008-10#4)
2 subunit##8##2##(1993-8#1)(1995-11#4)(1995-12#3)
2 t gypsum ha(-1)##2##4##(2008-12#2)
2 t##3##2##(2008-12#3)
2 test##2##2##(1994-9#1)(2008-12#1)
2 than##3##2##(1991-8#1)(2008-10#1)(2009-6#1)
2 that##2##2##(2007-11#1)(2012-2#1)
2 the##4##2##(2007-6#1)(2008-10#2)(2009-9#1)
2 times greater##2##3##(2008-10#1)(2013-8#1)
2 times higher##3##3##(1990-11#1)(2008-6#1)(2011-2#1)
2 times##16##2##(1990-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#3)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
2 to -19##2##3##(2009-2#1)(2011-2#1)
2 to 0##5##3##(1990-11#1)(2008-10#2)(2010-5#1)(2013-1#1)
2 to 1##5##3##(1990-7#1)(2008-10#4)
2 to 10##7##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)
2 to 11##2##3##(2008-10#1)(2008-12#1)
2 to 13##2##3##(1990-5#1)(2010-9#1)
2 to 14##2##3##(1991-2#1)(2008-10#1)
2 to 15##5##3##(1994-6#1)(1996-5#1)(2008-10#2)(2008-3#1)
2 to 17##2##3##(2008-10#1)(2012-3#1)
2 to 19##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
2 to 2##3##3##(1991-5#1)(1993-3#1)(2008-3#1)
2 to 20##4##3##(1993-2#1)(1997-8#1)(2008-10#2)
2 to 25##2##3##(1993-1#1)(2008-6#1)
2 to 3 days in##2##5##(2007-10#1)(2008-10#1)
2 to 3 days##6##4##(1991-6#1)(2007-10#1)(2008-10#4)
2 to 3 weeks##2##4##(2008-10#2)
2 to 3 years of##2##5##(1991-8#1)(2010-4#1)
2 to 3 years##3##4##(1991-8#1)(2010-4#1)(2013-1#1)
2 to 3##19##3##(1991-6#1)(1991-8#1)(1993-9#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#2)(2013-1#1)
2 to 4 weeks##5##4##(2008-10#5)
2 to 4 years##2##4##(2008-10#1)(2008-9#1)
2 to 4##16##3##(1992-3#1)(2008-10#9)(2008-3#1)(2008-9#2)(2012-2#1)(2013-1#1)(2013-8#1)
2 to 5##7##3##(1992-11#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)
2 to 5% of##2##4##(2008-1#1)(2008-10#1)
2 to 5%##4##3##(1997-3#1)(2008-1#1)(2008-10#1)(2009-12#1)
2 to 6 days##2##4##(2008-10#2)
2 to 6##8##3##(1991-8#1)(1992-12#1)(1992-8#1)(1996-5#1)(2008-10#3)(2009-12#1)
2 to 7##6##3##(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#1)
2 to 8##7##3##(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(2008-10#1)(2010-5#1)(2012-1#1)
2 to 9##3##3##(1993-3#1)(2008-10#2)
2 to##170##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#70)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#2)(2009-2#1)(2009-3#1)(2010-4#2)(2010-5#4)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
2 trials##3##2##(1993-3#1)(2007-11#1)(2012-3#1)
2 using##3##2##(2008-10#2)(2011-2#1)
2 vasopressin receptor##2##3##(1993-6#2)
2 versus##4##2##(1990-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
2 vs##12##2##(1990-12#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
2 w/w% triclosan##2##3##(2008-5#2)
2 was determined##2##3##(2008-10#1)(2008-9#1)
2 was found##4##3##(2008-5#3)(2010-11#1)
2 was the##2##3##(2008-1#1)(2008-10#1)
2 was used##3##3##(1990-8#1)(2008-11#1)(2008-5#1)
2 was##35##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#2)(1993-11#1)(1994-2#1)(1995-2#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#4)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-1#2)
2 week##4##2##(1995-12#1)(2007-10#1)(2008-11#2)
2 weeks after inoculation##4##4##(2008-10#4)
2 weeks after the##3##4##(1991-5#1)(1996-12#1)(2010-9#1)
2 weeks after##18##3##(1991-5#1)(1991-8#1)(1992-10#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#8)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
2 weeks and they matured##2##5##(2008-11#2)
2 weeks and##8##3##(1996-2#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#2)
2 weeks before being##2##4##(1990-12#1)(1996-12#1)
2 weeks before##4##3##(1990-12#1)(1996-12#1)(2008-10#2)
2 weeks following the##2##4##(2008-7#1)(2009-3#1)
2 weeks in##4##3##(1996-5#1)(1996-7#1)(1997-8#1)(2008-7#1)
2 weeks later##5##3##(1992-1#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-12#1)
2 weeks of age##2##4##(1990-11#1)(1995-3#1)
2 weeks of treatment##5##4##(1996-2#1)(1996-5#1)(2008-1#1)(2008-6#2)
2 weeks of##13##3##(1990-11#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2011-2#1)
2 weeks or##3##3##(1995-12#1)(2008-9#2)
2 weeks postinoculation##2##3##(2008-10#2)
2 weeks to##5##3##(1995-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-5#1)
2 weeks was##3##3##(1992-10#1)(2008-10#1)(2008-6#1)
2 weeks were##3##3##(1991-12#1)(1996-12#1)(2007-10#1)
2 weeks with##3##3##(1995-12#1)(2008-5#1)(2010-3#1)
2 weeks##144##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-3#1)(1992-8#2)(1993-11#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#4)(1996-2#2)(1996-5#3)(1996-7#2)(1997-3#1)(1997-6#1)(1997-8#2)(2006-12#1)(2007-10#3)(2007-11#2)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#39)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#6)(2008-7#9)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
2 weeks)##5##2##(1992-8#1)(1995-2#1)(1996-5#1)(2008-10#1)(2013-1#1)
2 were##27##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-7#1)(2009-4#1)(2013-1#1)
2 which##3##2##(2008-10#2)(2008-12#1)
2 with a##2##3##(1992-6#1)(2008-3#1)
2 with respect to##2##4##(2008-10#1)(2008-5#1)
2 with##11##2##(1991-5#1)(1992-5#1)(1992-6#1)(1994-3#1)(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
2 wk after surgery##2##4##(2013-1#2)
2 wk##3##2##(1993-1#1)(2013-1#2)
2 women##3##2##(1993-12#1)(2009-10#1)(2011-3#1)
2 x 1 optical fiber coupler##2##6##(2007-12#2)
2 x 10(-)(3)##2##3##(1997-7#2)
2 x 10(-10)##2##3##(1990-8#1)(2008-10#1)
2 x 10(-3) mg/L for##2##5##(2008-10#2)
2 x 10(-3)##4##3##(2008-10#3)(2008-2#1)
2 x 10(-4)##4##3##(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
2 x 10(-4)moll(-1)##2##3##(2008-10#2)
2 x 10(-5)##2##3##(1993-8#1)(2008-10#1)
2 x 10(-6) M##2##4##(1991-5#1)(2008-10#1)
2 x 10(-6)##8##3##(1991-5#1)(1997-2#1)(2008-10#3)(2008-3#2)(2009-11#1)
2 x 10(-7)##3##3##(1990-10#1)(1994-12#1)(2008-10#1)
2 x 10(-8) M and##2##5##(1992-5#1)(2008-10#1)
2 x 10(-8) M##3##4##(1992-5#1)(1995-5#1)(2008-10#1)
2 x 10(-8)##4##3##(1992-5#1)(1995-5#1)(2008-10#1)(2008-3#1)
2 x 10(3)##2##3##(1997-7#1)(2008-10#1)
2 x 10(4)##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
2 x 10(5)##6##3##(1990-5#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
2 x 10(6) and##2##4##(1994-5#1)(2008-7#1)
2 x 10(6)##14##3##(1991-12#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-5#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)
2 x 10(7) CFU ml(-1)##2##5##(2008-10#2)
2 x 10(7) CFU##3##4##(2008-10#3)
2 x 10(7)##4##3##(2008-10#4)
2 x 10(8)##3##3##(1991-5#1)(2008-10#2)
2 x 2 cm##2##4##(1994-7#1)(2011-2#1)
2 x 2 couplers##2##4##(2008-2#1)(2008-3#1)
2 x 2 switch##3##4##(2008-2#1)(2008-3#2)
2 x 2 tables##2##4##(1995-2#1)(1995-9#1)
2 x 2##19##3##(1994-3#1)(1994-7#1)(1995-2#1)(1995-9#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2010-2#1)(2011-2#2)
2 x##108##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-4#1)(1992-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-7#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-9#2)(1996-12#1)(1997-2#1)(1997-7#3)(2007-12#3)(2008-10#38)(2008-11#6)(2008-2#8)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-2#1)(2011-2#2)
2 year old##2##3##(1991-11#1)(2012-2#1)
2 year##4##2##(1991-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
2 years (P##3##3##(2007-10#1)(2013-1#2)
2 years (mean##2##3##(1997-3#1)(2009-8#1)
2 years (range##7##3##(2007-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2012-2#1)(2013-8#1)
2 years after surgery##3##4##(2007-8#1)(2012-2#1)(2013-1#1)
2 years after the##6##4##(1994-5#1)(1997-4#1)(2008-10#2)(2008-6#1)(2012-12#1)
2 years after##18##3##(1994-5#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
2 years and##7##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
2 years at the##2##4##(2007-7#1)(2008-10#1)
2 years at##3##3##(1995-11#1)(2007-7#1)(2008-10#1)
2 years by##2##3##(2008-10#1)(2012-3#1)
2 years for##2##3##(2008-10#1)(2010-10#1)
2 years in##4##3##(1994-7#1)(2007-10#1)(2008-10#2)
2 years of age##2##4##(2012-1#1)(2013-1#1)
2 years of experience##2##4##(1994-3#1)(2008-8#1)
2 years of follow-up##2##4##(2008-6#1)(2011-1#1)
2 years of life##2##4##(2010-5#1)(2012-12#1)
2 years of the study##2##5##(2008-10#2)
2 years of the##3##4##(2008-10#2)(2011-2#1)
2 years of##19##3##(1994-3#1)(1995-1#1)(2008-10#6)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
2 years old##2##3##(1997-2#1)(1997-7#1)
2 years postoperatively##2##3##(2008-8#1)(2008-9#1)
2 years was##2##3##(1991-11#1)(2008-9#1)
2 years without##2##3##(2008-10#1)(2008-11#1)
2 years##152##2##(1990-6#1)(1991-11#2)(1992-2#1)(1992-8#1)(1993-1#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#7)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#6)(2008-1#5)(2008-10#34)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#10)(2008-8#2)(2008-9#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
2 years)##12##2##(1992-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#1)
2 yellow complex##2##3##(2008-10#2)
2 yr##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
2 ± 0##4##3##(2012-3#2)(2013-1#2)
2 ± 1##2##3##(2010-9#1)(2011-2#1)
2 ± 4##3##3##(2010-11#2)(2011-2#1)
2 ±##12##2##(2010-11#2)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#4)
2##8214##1##(1990-10#7)(1990-11#22)(1990-12#49)(1990-2#32)(1990-3#18)(1990-5#35)(1990-6#16)(1990-7#32)(1990-8#53)(1990-9#13)(1991-1#5)(1991-10#5)(1991-11#23)(1991-12#26)(1991-2#34)(1991-3#17)(1991-4#5)(1991-5#40)(1991-6#17)(1991-7#2)(1991-8#40)(1991-9#20)(1992-1#9)(1992-10#19)(1992-11#25)(1992-12#39)(1992-2#26)(1992-3#58)(1992-4#12)(1992-5#12)(1992-6#42)(1992-8#44)(1992-9#28)(1993-1#15)(1993-11#26)(1993-12#36)(1993-2#34)(1993-3#31)(1993-5#2)(1993-6#27)(1993-8#36)(1993-9#43)(1994-1#2)(1994-11#32)(1994-12#54)(1994-2#21)(1994-3#35)(1994-5#36)(1994-6#26)(1994-7#11)(1994-8#46)(1994-9#24)(1995-1#6)(1995-11#58)(1995-12#65)(1995-2#45)(1995-3#53)(1995-4#3)(1995-5#35)(1995-6#32)(1995-8#23)(1995-9#8)(1996-1#4)(1996-10#4)(1996-11#11)(1996-12#47)(1996-2#78)(1996-3#13)(1996-5#58)(1996-6#16)(1996-7#8)(1996-8#3)(1996-9#8)(1997-1#7)(1997-2#37)(1997-3#34)(1997-4#29)(1997-5#11)(1997-6#23)(1997-7#49)(1997-8#27)(1997-9#3)(2006-10#18)(2006-12#5)(2006-4#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#65)(2007-11#174)(2007-12#173)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#5)(2007-6#10)(2007-7#35)(2007-8#66)(2007-9#4)(2008-1#102)(2008-10#2300)(2008-11#241)(2008-12#128)(2008-2#126)(2008-3#310)(2008-4#60)(2008-5#203)(2008-6#86)(2008-7#183)(2008-8#115)(2008-9#92)(2009-1#6)(2009-10#21)(2009-11#18)(2009-12#25)(2009-2#17)(2009-3#26)(2009-4#8)(2009-5#19)(2009-6#17)(2009-7#12)(2009-8#42)(2009-9#23)(2010-1#14)(2010-10#20)(2010-11#16)(2010-12#22)(2010-2#14)(2010-3#39)(2010-4#34)(2010-5#30)(2010-6#20)(2010-7#8)(2010-8#40)(2010-9#11)(2011-1#118)(2011-10#1)(2011-2#266)(2011-3#18)(2012-1#19)(2012-12#80)(2012-2#98)(2012-3#88)(2012-4#4)(2012-5#9)(2012-6#4)(2012-7#1)(2013-1#223)(2013-7#22)(2013-8#83)
2% &lt##2##2##(1996-2#1)(2008-7#1)
2% (95% CI##4##3##(2007-2#1)(2010-3#2)(2013-1#1)
2% (n =##3##3##(1994-2#1)(2008-10#2)
2% (n=10)##3##2##(2008-10#3)
2% (p &lt##2##3##(2011-2#2)
2% (p##3##2##(2011-2#2)(2013-1#1)
2% (range##2##2##(2008-7#1)(2008-8#1)
2% (v/v) HNO(3)##2##3##(2008-10#2)
2% (v/v)##4##2##(2008-10#3)(2011-1#1)
2% (w/v) of##2##3##(2008-10#2)
2% (w/v)##4##2##(1990-2#1)(2008-10#3)
2% (w/w)##2##2##(2008-10#1)(2008-6#1)
2% C##2##2##(2013-1#2)
2% HNO(3)##3##2##(2008-10#3)
2% NaF for 3 min##2##5##(2013-1#2)
2% NaF##3##2##(2013-1#3)
2% R##5##2##(2008-10#5)
2% RSD##2##2##(2008-10#2)
2% and 3##2##3##(1992-3#1)(2008-3#1)
2% and 6##2##3##(2008-10#2)
2% and 66##2##3##(1991-8#1)(2008-1#1)
2% and 9##2##3##(1991-6#1)(2011-1#1)
2% and 90##2##3##(2007-12#1)(2008-1#1)
2% and##45##2##(1990-6#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#1)(2010-1#1)(2011-1#2)(2011-10#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
2% as##2##2##(2008-10#1)(2008-6#1)
2% at 20##2##3##(2008-10#1)(2008-3#1)
2% at a##2##3##(2007-11#1)(2008-2#1)
2% at the 5##2##4##(2008-10#2)
2% at the##3##3##(2008-10#3)
2% at##20##2##(1990-5#1)(1990-8#1)(1993-9#1)(1995-9#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2011-2#1)(2013-1#1)
2% bupivacaine-lipospheres##4##2##(1993-1#4)
2% chlorhexidine gluconate (CHX)##2##4##(2013-1#2)
2% clinical isolates were revealed##2##5##(2011-1#2)
2% during##2##2##(2008-10#1)(2012-3#1)
2% female##2##2##(2009-8#1)(2011-2#1)
2% females)##2##2##(2008-3#1)(2012-12#1)
2% for a##3##3##(2008-10#2)(2008-12#1)
2% for both##2##3##(1997-7#1)(2007-12#1)
2% for molybdenum##2##3##(2008-10#2)
2% for the##8##3##(1991-9#1)(1997-7#2)(2008-10#3)(2008-3#1)(2009-11#1)
2% for##41##2##(1991-4#1)(1991-9#1)(1994-11#1)(1997-7#3)(2007-12#1)(2007-8#3)(2008-10#19)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-3#1)
2% had DD and PD##2##5##(2008-12#2)
2% had history of rheumatological conditions in their family##2##9##(2013-1#2)
2% had##8##2##(1991-11#1)(1995-10#1)(2008-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
2% higher than##2##3##(2008-10#1)(2008-11#1)
2% higher##3##2##(2008-10#2)(2008-11#1)
2% identity with##2##3##(1996-2#1)(2008-10#1)
2% in males##2##3##(1991-6#1)(2008-3#1)
2% in the##7##3##(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-1#1)
2% in##20##2##(1991-6#1)(1993-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#2)(2009-6#1)(2011-2#2)(2012-1#1)(2013-8#1)
2% lidocaine##3##2##(1993-1#2)(1993-12#1)
2% males##2##2##(1994-6#2)
2% nitric acid##2##3##(2008-10#2)
2% of all##7##3##(1992-9#1)(2007-5#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
2% of cases##2##3##(2007-11#1)(2008-6#1)
2% of its##2##3##(1995-12#1)(2008-10#1)
2% of patients had##2##4##(2007-7#1)(2008-11#1)
2% of patients##7##3##(1992-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-3#2)(2013-8#1)
2% of the cases##6##4##(1991-12#1)(1992-5#1)(2007-7#2)(2010-1#1)(2011-2#1)
2% of the genome##2##4##(2008-11#1)(2012-12#1)
2% of the phenotypic##2##4##(2008-10#2)
2% of the total##4##4##(2008-1#1)(2008-10#1)(2011-10#1)(2011-2#1)
2% of the variance##2##4##(2010-2#1)(2010-5#1)
2% of the##43##3##(1991-12#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-7#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-12#1)(2013-1#3)
2% of total##2##3##(1992-6#1)(2008-5#1)
2% of##95##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
2% or##3##2##(2008-10#1)(2009-7#1)(2012-7#1)
2% per year)##2##3##(2008-7#1)(2008-8#1)
2% relative##3##2##(1992-3#1)(2008-10#2)
2% respectively##5##2##(1997-8#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
2% shampoo in##2##3##(2007-7#2)
2% sodium##2##2##(2008-10#2)
2% to 7%##4##3##(2008-2#1)(2010-1#1)(2010-4#1)(2012-12#1)
2% to##18##2##(1991-11#1)(1992-11#1)(1995-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
2% v/v##3##2##(2008-10#2)(2008-5#1)
2% versus##2##2##(2008-3#1)(2013-1#1)
2% vs##5##2##(1995-2#1)(2007-8#1)(2008-3#1)(2009-8#1)(2011-1#1)
2% w/w##2##2##(2008-10#2)
2% was##3##2##(1991-3#1)(2007-7#1)(2007-8#1)
2% were##14##2##(1993-6#1)(1996-8#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2010-1#1)(2013-1#2)(2013-8#1)
2% when##2##2##(2008-3#1)(2008-7#1)
2%##669##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#5)(1991-9#2)(1992-11#2)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#6)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-10#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#4)(1997-6#4)(1997-7#4)(1997-8#3)(2007-10#3)(2007-11#6)(2007-12#11)(2007-2#2)(2007-5#2)(2007-7#18)(2007-8#11)(2008-1#10)(2008-10#206)(2008-11#19)(2008-12#9)(2008-2#10)(2008-3#24)(2008-4#1)(2008-5#15)(2008-6#10)(2008-7#9)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#2)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#4)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#15)(2011-10#2)(2011-2#31)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#5)(2012-3#11)(2012-7#1)(2013-1#37)(2013-7#2)(2013-8#12)
2%) and in agreement with##2##5##(2008-10#2)
2%) and the##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
2%) and##21##2##(1990-9#1)(1991-12#1)(1992-9#1)(1995-3#1)(1995-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
2%) believed##2##2##(2007-7#1)(2008-1#1)
2%) followed by##2##3##(2007-7#1)(2008-1#1)
2%) had CIN##2##3##(2011-2#2)
2%) had##5##2##(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#2)
2%) in##5##2##(1990-12#2)(1990-9#1)(2007-8#1)(2008-1#1)
2%) lesions had en-block resection with##2##6##(2013-8#2)
2%) of the##5##3##(1992-6#1)(1995-11#1)(2008-12#1)(2013-1#2)
2%) of##10##2##(1992-6#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2013-1#2)
2%) patients##6##2##(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
2%) to##2##2##(2008-10#1)(2008-5#1)
2%) were##9##2##(1991-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)
2%) with##3##2##(2008-10#1)(2008-4#1)(2009-7#1)
2%)##151##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-8#1)(1990-9#2)(1991-12#3)(1991-3#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-12#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#9)(2007-8#6)(2008-1#12)(2008-10#21)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-7#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#11)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#7)
2&gt##2##1##(2008-10#2)
2&quot##2##1##(1992-3#1)(2008-3#1)
2'##26##1##(1990-10#2)(1990-9#1)(1991-12#1)(1991-3#1)(1993-11#2)(1993-12#4)(1994-11#2)(1994-8#1)(1995-3#1)(1996-12#3)(2008-10#3)(2008-11#2)(2008-4#3)
2'- and##2##2##(1993-8#1)(1995-3#1)
2'-##3##1##(1993-11#1)(1993-8#1)(1995-3#1)
2'-O-TOM-5'-O-dimethoxytrityl-N-acetyl ribonucleosides##2##2##(2008-4#2)
2'-O-dimethyladenosine##3##1##(2012-2#3)
2'-O-methylribonucleosides##3##1##(2008-4#3)
2'-[1##2##1##(2008-10#2)
2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)##3##2##(2008-10#3)
2'-bipyridine##3##1##(2008-10#3)
2'-bipyridine)##5##1##(2008-10#4)(2008-12#1)
2'-bipyridine)ruthenium(II)##5##1##(2008-10#4)(2008-6#1)
2'-bipyridyl in##2##2##(2008-10#2)
2'-bipyridyl##4##1##(2008-10#4)
2'-bipyridyl) ruthenium##2##2##(2008-10#2)
2'-bipyridyl) ruthenium(II)##2##2##(2008-10#2)
2'-bipyridyl)##5##1##(2008-10#5)
2'-bipyridyl)ruthenium(II) chemiluminescence detection##5##3##(2008-10#5)
2'-bipyridyl)ruthenium(II) chemiluminescence##6##2##(2008-10#6)
2'-bipyridyl)ruthenium(II) electrochemiluminescence detection##2##3##(2008-10#2)
2'-bipyridyl)ruthenium(II)##13##1##(2008-10#13)
2'-carbamate##2##1##(2008-4#2)
2'-carbamates##2##1##(2008-4#2)
2'-deoxynucleosides##2##1##(2008-4#2)
2'-deoxyribonucleosides and 2'-O-methylribonucleosides##2##3##(2008-4#2)
2'-deoxyribonucleosides and##3##2##(2008-4#3)
2'-deoxyribonucleosides are##2##2##(2008-4#2)
2'-deoxyribonucleosides in##2##2##(2008-4#2)
2'-deoxyribonucleosides##10##1##(2008-4#10)
2'-dipyridyl##3##1##(2008-10#3)
2'-dipyridyl-2-pyridylhydrazone (DPPH)##3##2##(2008-10#3)
2'-dipyridyl-2-pyridylhydrazone complex formation##2##3##(2008-10#2)
2'-dipyridyl-2-pyridylhydrazone##5##1##(2008-10#5)
2'-disulfonic acid##2##2##(1992-9#1)(1994-6#1)
2'-disulfonic##3##1##(1992-12#1)(1992-9#1)(1994-6#1)
2'-dithiodianiline##3##1##(2008-10#3)
2'-hydroxyl##3##1##(1993-1#2)(2008-4#1)
2'-silylation##2##1##(2008-4#2)
2'-substituted deoxycytidine analogs##3##3##(1994-8#3)
2'3'-dideoxyadenosine##2##1##(1994-8#2)
2(2) factorial with a center point##2##6##(2008-10#2)
2(2)##3##1##(2008-10#2)(2011-2#1)
2(2+)##7##1##(1996-2#7)
2(3) factorial design##2##3##(2008-10#1)(2008-6#1)
2(3) full factorial##2##3##(2008-10#1)(2008-11#1)
2(3)##5##1##(2008-10#3)(2008-11#1)(2008-6#1)
2(4)##2##1##(2008-10#1)(2008-5#1)
2(4-1) factorial##2##2##(2008-10#2)
2(4-1)##4##1##(2008-10#3)(2011-2#1)
2(5)##2##1##(1996-2#1)(2008-6#1)
2(5-nitro-2-pyridylazo)-5-(N-propyl-N-3-sulfopropylamino)phenol(5-NO(2)##2##1##(2008-10#2)
2(7)##6##1##(1997-7#1)(2010-8#5)
2(Sr0##2##1##(2008-3#2)
2(dA)n is##3##2##(1995-5#3)
2(dA)n##10##1##(1995-5#10)
2(dT)n##3##1##(1995-5#3)
2(n) codes##2##2##(2008-2#2)
2(n) extended-prime codes##2##3##(2008-2#2)
2(n) prime codes##3##3##(2008-2#3)
2(n)##10##1##(2008-2#7)(2008-7#3)
2) In##2##2##(1991-2#1)(2008-5#1)
2) a##3##2##(2007-6#1)(2012-1#1)(2012-2#1)
2) and the calibration curve is linear##2##7##(2008-10#2)
2) and the##4##3##(1993-2#1)(1994-12#1)(2008-10#2)
2) and##29##2##(1990-12#1)(1990-5#1)(1993-2#1)(1994-12#2)(1994-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
2) as##7##2##(1992-3#2)(1992-7#1)(2008-1#1)(2008-10#3)
2) at##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
2) deletion of##2##3##(1993-3#1)(1995-6#1)
2) for##2##2##(2008-10#2)
2) from##4##2##(1990-5#1)(1990-8#1)(2008-9#1)(2012-12#1)
2) have been##2##3##(2008-1#1)(2008-2#1)
2) have##3##2##(2008-1#1)(2008-2#1)(2012-12#1)
2) high##2##2##(1990-8#1)(2011-1#1)
2) in the##2##3##(1997-5#1)(2008-10#1)
2) in##9##2##(1992-3#1)(1993-6#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-12#1)
2) is a##3##3##(1994-12#1)(2006-8#1)(2008-1#1)
2) is##10##2##(1990-8#1)(1994-12#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
2) mixed vesicles##2##3##(1994-12#2)
2) of the##2##3##(1992-3#1)(1994-12#1)
2) of##4##2##(1992-3#1)(1993-6#1)(1994-12#1)(1995-5#1)
2) or##2##2##(1994-12#1)(1997-8#1)
2) the patient##2##3##(2007-8#1)(2013-8#1)
2) the##17##2##(1991-3#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
2) to##7##2##(1995-2#1)(1995-3#1)(1996-1#1)(2008-10#2)(2012-12#1)(2012-3#1)
2) was observed##2##3##(1995-8#1)(1997-3#1)
2) was##5##2##(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
2) were##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2010-2#1)(2013-1#1)
2) with a##2##3##(2007-8#1)(2008-6#1)
2) with##3##2##(2007-11#1)(2007-8#1)(2008-6#1)
2) x##2##2##(1992-10#1)(2008-2#1)
2) years##2##2##(2012-12#1)(2012-3#1)
2) μm to 8##2##4##(2010-10#2)
2) μm to##3##3##(2010-10#3)
2)##360##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#5)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#5)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#2)(1993-2#5)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#10)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#62)(2008-11#16)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#3)(2009-11#3)(2009-2#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#6)(2011-2#14)(2011-9#1)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#6)(2012-4#1)(2013-1#12)(2013-7#1)(2013-8#8)
2))##3##1##(1990-5#1)(1994-12#1)(1995-2#1)
2))(0)##3##1##(2008-10#3)
2)-6-deoxy-L-talose##2##1##(1992-12#2)
2)-O-[6-deoxy-alpha-L-mannopyranosyl-(1--&gt##2##1##(2008-11#2)
2)-beta-D-glucopyranoside##2##1##(2010-6#2)
2)O(3-δ)##2##1##(2012-2#2)
2+ (score 8)##2##3##(1993-12#2)
2+##10##1##(1993-11#1)(1993-12#4)(1993-8#2)(1994-6#1)(2010-3#1)(2010-8#1)
2+/-0##20##1##(2007-8#2)(2008-10#17)(2008-11#1)
2+/-1##5##1##(2007-8#1)(2008-10#3)(2008-7#1)
2+/-12##3##1##(2007-8#1)(2008-7#1)(2009-7#1)
2- and 1##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
2- and 12-day-old rats##2##4##(1997-2#2)
2- and##23##2##(1992-3#1)(1992-9#1)(1993-11#1)(1995-3#4)(1995-6#1)(1995-9#1)(1997-2#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2012-12#1)
2- or##3##2##(1990-5#1)(2008-4#1)(2011-2#1)
2- to 3-fold##2##3##(1993-6#1)(1995-2#1)
2- to 5##2##3##(1993-6#1)(1997-4#1)
2- to##14##2##(1993-6#3)(1993-9#1)(1995-11#1)(1995-2#1)(1996-5#2)(1997-4#2)(2008-10#2)(2008-4#1)(2010-1#1)
2-##59##1##(1990-2#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-6#1)(1995-9#1)(1996-5#2)(1997-2#2)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#2)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
2-(1##2##1##(1996-5#2)
2-(2##3##1##(1994-12#2)(2007-11#1)
2-(2-quinolylazo)-5-diethylaminoaniline##2##1##(2008-10#2)
2-(2-thiazolylazo)-5-diethylaminophenol##2##1##(2008-10#2)
2-(3##5##1##(2007-11#1)(2008-10#3)(2008-5#1)
2-(5-bromo-2-pyridylazo)-5-(diethylamino)phenol##2##1##(2008-10#2)
2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP)##5##2##(2008-10#5)
2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##13##1##(2008-10#13)
2-(6-nitrobenzo[1##2##1##(2007-11#2)
2-(9-carbazole)-ethyl chloroformate (CEOC)##2##3##(2008-10#2)
2-(Ph(2)P)(2)-1##2##1##(1996-2#2)
2-(alpha-pyridyl) thioquinaldinamide##2##2##(2008-10#2)
2-(dimethylthio)ethanol##2##1##(1994-8#2)
2-(methylthio)ethanol##2##1##(1994-8#2)
2-(thiopyran-4-ylidene)-1##2##1##(1996-5#2)
2-/3-methylbutanal##2##1##(2008-10#2)
2-0##11##1##(1990-5#1)(1991-6#1)(1995-11#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
2-1##14##1##(2008-10#12)(2011-2#2)
2-10 and##2##2##(2008-10#2)
2-10 mug ml(-1)##2##3##(2008-10#2)
2-10##12##1##(1990-6#1)(1995-3#1)(2008-10#7)(2008-2#1)(2008-9#1)(2010-5#1)
2-10% of##2##2##(1992-6#1)(1997-2#1)
2-10%##3##1##(1992-6#1)(1997-2#1)(2008-3#1)
2-100##3##1##(2008-10#3)
2-11##4##1##(2007-11#1)(2008-10#3)
2-12##5##1##(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)
2-13##4##1##(1991-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
2-15##5##1##(2007-7#1)(2008-10#2)(2012-1#1)(2012-12#1)
2-18##3##1##(1992-5#1)(2008-1#1)(2008-10#1)
2-2##15##1##(1993-12#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-6#1)(2012-2#1)
2-20##4##1##(2008-10#3)(2010-4#1)
2-22##3##1##(1994-12#1)(1997-6#1)(2011-2#1)
2-24##4##1##(1994-9#1)(1996-12#1)(2008-2#1)(2010-3#1)
2-3 and##7##2##(1996-2#1)(2007-11#1)(2008-12#3)(2008-8#1)(2012-3#1)
2-3 days##2##2##(1992-6#1)(2008-12#1)
2-3 fold higher##3##3##(1990-7#1)(1993-8#1)(2008-11#1)
2-3 fold##7##2##(1990-2#1)(1990-7#1)(1991-2#1)(1992-7#1)(1993-8#1)(2008-11#1)(2012-2#1)
2-3 h##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
2-3 mm##2##2##(1992-1#1)(2008-12#1)
2-3 months##3##2##(1994-11#1)(1995-11#1)(1996-2#1)
2-3 nm##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
2-3 orders of magnitude##3##4##(2008-10#2)(2008-3#1)
2-3 times greater##2##3##(1992-8#1)(2008-1#1)
2-3 times more##2##3##(1993-12#1)(1994-5#1)
2-3 times##9##2##(1990-7#1)(1992-6#1)(1992-8#1)(1993-12#3)(1994-5#1)(2008-1#1)(2008-5#1)
2-3 weeks##4##2##(1993-2#1)(2008-10#3)
2-3 years##3##2##(1990-6#1)(1993-3#1)(2008-12#1)
2-3##75##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-2#2)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2012-2#1)(2012-3#1)
2-3%##4##1##(2008-10#2)(2008-3#2)
2-3)##2##1##(2008-10#1)(2011-1#1)
2-3-fold##2##1##(1992-9#1)(1995-6#1)
2-30##4##1##(2008-10#2)(2010-5#1)(2012-2#1)
2-33##2##1##(2008-10#2)
2-4 and##2##2##(2008-8#1)(2010-5#1)
2-4 h##2##2##(1996-2#1)(2013-8#1)
2-4 times##3##2##(1990-5#1)(2008-11#1)(2008-2#1)
2-4 weeks##4##2##(1990-10#1)(1995-11#1)(2007-8#1)(2010-5#1)
2-4 weeks)##2##2##(2011-2#2)
2-4##37##1##(1990-10#1)(1990-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-3#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-5#2)(2011-2#3)(2012-12#1)(2013-8#2)
2-4% of##2##2##(2008-11#1)(2011-1#1)
2-4%##4##1##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
2-40##5##1##(1991-5#1)(1995-3#1)(2007-7#1)(2008-10#2)
2-5 days##2##2##(1994-12#1)(1995-12#1)
2-5##22##1##(1991-9#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)
2-5% of##2##2##(1997-7#1)(2008-1#1)
2-5%##5##1##(1991-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2013-7#1)
2-5A##3##1##(1990-2#2)(2008-10#1)
2-6 fold##2##2##(2008-1#1)(2008-10#1)
2-6##19##1##(1992-5#1)(1995-11#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-4#2)(2013-8#1)
2-7##13##1##(1992-12#1)(1994-1#1)(1994-2#1)(1994-5#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)
2-8 mug ml(-1)##2##3##(2008-10#2)
2-8 years)##2##2##(2008-9#2)
2-8##19##1##(1990-7#1)(1994-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-9#2)(2010-9#1)(2011-2#1)
2-8)##2##1##(1992-2#1)(1994-12#1)
2-ABA##2##1##(1990-7#2)
2-BP##2##1##(2008-10#2)
2-C(2)B(10)H(10)]##2##1##(1996-2#2)
2-CTC and 3-CTC##2##3##(1992-9#2)
2-CTC##4##1##(1992-9#4)
2-D gel electrophoresis##3##3##(1992-12#1)(2008-4#1)(2008-7#1)
2-D gels##3##2##(2008-4#2)(2008-7#1)
2-D liquid separations of##2##4##(2008-4#2)
2-D liquid##4##2##(2008-4#4)
2-D spatial##2##2##(2008-3#2)
2-D##34##1##(1992-12#2)(1997-7#1)(2008-11#2)(2008-2#2)(2008-3#10)(2008-4#7)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#2)(2010-8#1)(2012-1#1)
2-DE##6##1##(2008-12#1)(2008-7#1)(2010-12#2)(2011-3#2)
2-HPbetaCD##6##1##(2008-11#6)
2-J##2##1##(2008-3#2)
2-MHz##2##1##(2007-11#1)(2008-3#1)
2-MeSADP##2##1##(2008-4#2)
2-NBA and 4-NBA##2##3##(1990-7#2)
2-NBA##3##1##(1990-7#3)
2-OH##2##1##(1993-8#1)(2009-8#1)
2-Substituted 1-azabicycloalkanes##2##2##(1992-8#2)
2-VO rats##3##2##(1997-2#3)
2-VO##5##1##(1997-2#5)
2-W##2##1##(2007-12#1)(2008-3#1)
2-WEEK STUDY IN B6C3F(1) MICE##2##5##(2008-9#2)
2-WEEK STUDY IN RATS##2##4##(2008-9#2)
2-WEEK STUDY IN##4##3##(2008-9#4)
2-[125I]BraMT##2##1##(1993-6#2)
2-[125I]iodomelatonin binding##3##2##(1995-12#3)
2-[125I]iodomelatonin##5##1##(1993-6#1)(1995-12#4)
2-[2-(2##5##1##(2011-1#5)
2-a] imidazole]##2##2##(1991-8#2)
2-a]##3##1##(1990-7#1)(1991-8#2)
2-a]pyrazinone derivatives##3##2##(2007-11#3)
2-acetyl##2##1##(1990-12#1)(2008-10#1)
2-acetyl-1-pyrroline##5##1##(2011-1#5)
2-alkylsulfanyl-6-benzyl-3##2##1##(2011-2#2)
2-alkynyl derivatives##2##2##(2008-4#2)
2-amino and##2##2##(1993-11#2)
2-amino##5##1##(1993-11#2)(1995-2#2)(2008-4#1)
2-amino-1##3##1##(2008-10#3)
2-amino-1-butanol##2##1##(2008-10#2)
2-amino-1-methoxy-propane##2##1##(2008-10#2)
2-amino-1-pentanol##2##1##(2008-10#2)
2-amino-1-propanol##2##1##(2008-10#2)
2-amino-2##2##1##(1996-5#1)(2007-11#1)
2-amino-3##3##1##(1992-2#2)(2008-10#1)
2-amino-3-hydroxypyridine##2##1##(2008-10#2)
2-amino-4##3##1##(1995-6#1)(2008-10#1)(2008-11#1)
2-amino-5-hydroxycyclohex-1-enecarboxyl-CoA##2##1##(1990-7#2)
2-aminobenzoyl-CoA##2##1##(1990-7#2)
2-aminoethyl##2##1##(2008-4#1)(2009-10#1)
2-aminofluorene##2##1##(1992-6#1)(1993-11#1)
2-aminothiophenol##3##1##(2008-10#2)(2012-2#1)
2-arachidonoyl glycerol##2##2##(1993-8#2)
2-at##2##1##(2007-11#2)
2-aza-2##2##1##(1994-3#2)
2-azabicyclo[3##4##1##(2009-9#4)
2-azaoctanoyl-CoA##2##1##(1995-5#2)
2-azido-[32P]ATP##7##1##(1995-6#7)
2-b]fluoranthene##2##1##(1990-7#2)
2-benzisoxazoles##2##1##(1995-3#2)
2-benzo-3##9##1##(2008-10#9)
2-benzosemiquinone##2##1##(1996-2#2)
2-benzoylpyridine-2-pyridylhydrazone##2##1##(2008-10#2)
2-bis(4-chlorophenyl)-1##2##1##(2008-10#2)
2-bis(4-chlorophenyl)ethane (p##2##2##(2008-10#2)
2-bis(diphenylphosphino)ethane##2##1##(1996-2#2)
2-bit##2##1##(2007-12#2)
2-butanone##3##1##(2008-10#2)(2008-12#1)
2-butyne##2##1##(2010-7#2)
2-c]pyrimidine-1##2##1##(2010-2#2)
2-carboxylate and 2-phosphonate##2##3##(2009-5#2)
2-chloro-1-methylpyridinium iodide##3##2##(2008-10#3)
2-chloro-4##2##1##(2007-11#1)(2010-2#1)
2-chloro-adenosine##2##1##(1995-5#1)(1995-8#1)
2-chloroadenosine##2##1##(1994-8#1)(2008-2#1)
2-cm##4##1##(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
2-component##2##1##(1995-8#1)(2008-10#1)
2-day##5##1##(1993-3#1)(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
2-deoxy-D-ribose##3##1##(1994-6#3)
2-deoxyglucose transport##2##2##(1994-11#1)(1994-8#1)
2-deoxyglucose uptake##2##2##(1995-6#2)
2-deoxyglucose##5##1##(1994-11#1)(1994-8#1)(1995-6#2)(2009-4#1)
2-deoxyribosylation of Glu-98##2##3##(1995-6#2)
2-deoxyribosyltransferase##5##1##(1995-6#5)
2-diacylglycerol (DG)##2##2##(1991-2#1)(1991-5#1)
2-diacylglycerol##5##1##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-8#1)
2-diaminobenzene) film##2##2##(2008-10#2)
2-diaminobenzene)-coated platinum electrode##2##3##(2008-10#2)
2-dicarboxylic anhydride##5##2##(1995-11#5)
2-dichlorobenzene##2##1##(2008-10#2)
2-dichloroethane (DCE) at##2##3##(1996-2#1)(2008-10#1)
2-dichloroethane (DCE)##3##2##(1996-2#1)(2008-10#2)
2-dichloroethane as##2##2##(2008-10#2)
2-dichloroethane solution##2##2##(2008-10#2)
2-dichloroethane##15##1##(1996-2#1)(2008-10#14)
2-dihydro-2-methyl-3-phenylpyrido[3##2##1##(1993-1#2)
2-dihydroxy-1##3##1##(2008-10#3)
2-dihydroxybenzene##3##1##(2008-10#3)
2-diiminocyclohexane##2##1##(2008-10#2)
2-dimensional##9##1##(1990-11#2)(1992-6#1)(1992-9#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-8#1)(2012-2#1)
2-dioctanoylglycerol##2##1##(1993-6#1)(1997-1#1)
2-diolein##3##1##(1990-10#2)(1994-3#1)
2-diphenyl-1-picrylhydrazyl##3##1##(2008-11#1)(2008-5#2)
2-diphenyl-1-picrylhydrazyl) assay##2##2##(2008-5#1)(2012-1#1)
2-ethanediamine##2##1##(2008-10#2)
2-ethoxyethanol in complex matrices##2##4##(2008-5#2)
2-ethoxyethanol in##4##2##(2008-5#4)
2-ethoxyethanol##10##1##(2007-12#3)(2008-5#7)
2-ethylhexyl 4-methoxycinnamate##2##2##(2008-5#2)
2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester##3##5##(2008-10#3)
2-ethylhexyl##9##1##(2008-10#3)(2008-5#6)
2-exo##2##1##(1996-5#2)
2-fold axis##3##2##(1992-4#1)(2008-4#2)
2-fold greater##2##2##(1991-8#1)(1992-2#1)
2-fold higher than that of##2##5##(1991-5#1)(1993-9#1)
2-fold higher than that##3##4##(1991-5#1)(1993-9#1)(2008-11#1)
2-fold higher##6##2##(1991-5#1)(1993-9#1)(1995-2#2)(2008-10#1)(2008-11#1)
2-fold in##2##2##(1990-5#1)(1992-1#1)
2-fold increase in the##3##4##(1993-3#1)(2008-11#1)(2010-1#1)
2-fold increase in##9##3##(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-11#2)(2010-1#1)(2013-1#1)
2-fold symmetry##2##2##(1992-8#1)(1994-3#1)
2-fold##57##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#5)(1995-3#1)(1995-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#6)(2008-4#2)(2008-5#1)(2010-1#1)(2011-3#2)(2012-2#1)(2013-1#2)(2013-7#1)
2-fold)##4##1##(1992-6#1)(1993-12#1)(2008-10#2)
2-glycoprotein##4##1##(1993-3#1)(1994-6#2)(1994-9#1)
2-h##9##1##(1994-12#2)(1995-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-7#1)
2-heptanone##3##1##(2008-10#3)
2-hour##2##1##(2007-10#1)(2008-8#1)
2-hr##2##1##(1994-8#1)(2008-11#1)
2-hydroxy fatty##2##2##(1994-6#2)
2-hydroxy-1-naphthaldehyde thiosemicarbazone (Fe(III)-HNT)##2##3##(2008-10#2)
2-hydroxyethyl methacrylate##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
2-hydroxyethyl##6##1##(1993-11#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
2-hydroxylation##4##1##(1995-12#1)(1995-9#3)
2-hydroxypropyl-beta-cyclodextrin##5##1##(2008-10#2)(2008-11#2)(2008-5#1)
2-hydroxysaclofen##4##1##(1993-12#1)(2008-8#3)
2-iminobiotin EC50##2##2##(1995-2#2)
2-iminobiotin##5##1##(1995-2#5)
2-iodomelatonin##2##1##(1993-6#1)(1995-12#1)
2-kHz##2##1##(2007-11#2)
2-kb region##2##2##(1990-5#1)(1994-12#1)
2-kb transcripts##2##2##(1992-9#2)
2-kb##15##1##(1990-5#1)(1992-3#1)(1992-9#3)(1993-12#2)(1994-12#1)(1994-9#1)(1995-11#2)(1995-2#1)(1997-3#1)(2008-10#2)
2-kinase##2##1##(1995-2#2)
2-linked series##2##2##(1991-12#2)
2-m##3##1##(2008-10#1)(2008-3#2)
2-mJ##2##1##(2008-3#2)
2-macroglobulin##3##1##(1992-9#1)(1993-3#1)(2008-11#1)
2-mercaptobenzothiazole loaded##2##2##(2008-10#2)
2-mercaptobenzothiazole self-assembled monolayer##2##3##(2008-10#2)
2-mercaptobenzothiazole##7##1##(2008-10#6)(2012-12#1)
2-mercaptoethanol and##2##2##(1994-8#1)(2008-10#1)
2-mercaptoethanol to##3##2##(1990-8#1)(1994-8#2)
2-mercaptoethanol##17##1##(1990-8#2)(1991-12#1)(1992-12#1)(1993-11#1)(1994-8#5)(1996-5#1)(2008-10#5)(2010-11#1)
2-mercaptopyridine##3##1##(2008-10#3)
2-mercaptopyrimidine (I) and##2##3##(2008-10#2)
2-methacryloyloxyethyl phosphorylcholine (MPC)##2##3##(2008-11#1)(2010-4#1)
2-methacryloyloxyethyl phosphorylcholine##4##2##(2008-11#2)(2010-4#2)
2-methacryloyloxyethyl##5##1##(2008-11#3)(2010-4#2)
2-methoxy-1##4##1##(1996-5#4)
2-methyl-2##2##1##(1992-8#1)(1993-8#1)
2-methyl-3-methoxy-4-phenylbutanoic acid (MMPB)##2##3##(2012-12#2)
2-methyl-8-quinolinol (HMQ)##4##2##(2008-10#4)
2-methyl-8-quinolinol##7##1##(2008-10#7)
2-methyl-thio ATP##2##2##(1995-12#2)
2-methylfuran##2##1##(2007-11#1)(2008-6#1)
2-methylthio-ATP##2##1##(1995-8#2)
2-microglobulin##12##1##(1990-11#1)(1991-2#1)(1994-5#1)(1994-6#2)(1995-12#4)(1995-2#1)(1996-12#1)(1997-3#1)
2-microm##2##1##(2007-11#1)(2008-3#1)
2-min preconcentration##2##2##(2008-10#2)
2-min##10##1##(1994-3#2)(1996-5#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-8#1)
2-mm##10##1##(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2013-1#3)
2-mm-diameter##2##1##(2007-12#1)(2008-3#1)
2-mm-thick##3##1##(2007-12#1)(2008-2#1)(2013-1#1)
2-mm-thick-substrate optical disks##2##3##(2008-3#2)
2-month follow-up##3##2##(2009-9#1)(2010-10#2)
2-month##6##1##(2008-10#1)(2008-5#1)(2009-9#1)(2010-10#2)(2011-2#1)
2-month-old##8##1##(1990-7#1)(1993-12#1)(1996-12#1)(2007-5#2)(2008-10#1)(2010-6#2)
2-mum output##2##2##(2008-3#2)
2-mum##6##1##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
2-naphthol##4##1##(2008-10#4)
2-nd##2##1##(2008-11#2)
2-nitrobenzyl##2##1##(1994-6#1)(2008-5#1)
2-nitrophenyl octyl ether (NPOE)##3##4##(2008-10#3)
2-nitrophenyl octyl ether##6##3##(2008-10#6)
2-nitroso-1-naphthol-4-sulfonic##3##1##(2008-10#3)
2-nm##6##1##(2007-11#2)(2007-12#1)(2008-2#3)
2-ns##2##1##(2007-12#1)(2008-3#1)
2-oxathiaphospholane)s##2##1##(2008-4#2)
2-oxoacid dehydrogenase complexes and##2##4##(1995-3#2)
2-oxoglutarate##10##1##(1991-3#4)(1992-6#1)(1993-9#1)(1994-8#1)(2008-10#2)(2012-1#1)
2-oxoglutarate/malate##5##1##(1995-2#4)(1997-7#1)
2-phenylenediamine##2##1##(2008-10#1)(2009-6#1)
2-phenylethyl isothiocyanate and##2##3##(2008-10#2)
2-phenylhistamines##2##1##(2008-12#2)
2-phosphate##2##1##(1993-8#1)(2008-7#1)
2-photon##2##1##(2008-10#1)(2012-2#1)
2-picolyl##2##1##(2008-10#2)
2-propanedione-2-oxime##2##1##(2008-10#2)
2-propanol and##3##2##(2008-10#3)
2-propanol##17##1##(1992-6#1)(1994-9#1)(1995-6#1)(2008-10#14)
2-ps##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
2-pyrrolidone##4##1##(1990-5#3)(2010-5#1)
2-subunit##3##1##(1994-9#1)(1996-12#2)
2-thioorotic acid (V)##2##3##(2008-10#2)
2-thiophenaldehyde-4-phenyl-3-thiosemicarbazone##2##1##(2008-10#2)
2-thioxothiazolidine-4-carboxylic##2##1##(2008-10#2)
2-vessel disease##2##2##(2008-3#1)(2008-7#1)
2-week period##6##2##(1993-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)
2-week##28##1##(1991-2#2)(1993-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
2-week-old seedlings##2##2##(2008-10#2)
2-week-old##7##1##(1991-9#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-8#1)
2-year actuarial##2##2##(2007-12#1)(2008-10#1)
2-year clinical##2##2##(2009-12#1)(2011-2#1)
2-year follow-up##4##2##(2008-2#1)(2008-8#2)(2012-12#1)
2-year rodent cancer##3##3##(2008-8#2)(2008-9#1)
2-year study in##2##3##(2008-10#1)(2012-2#1)
2-year study##3##2##(2008-10#2)(2012-2#1)
2-year survival for##3##3##(1990-6#1)(1990-8#2)
2-year survival rate##3##3##(2007-12#1)(2007-8#1)(2013-1#1)
2-year survival##11##2##(1990-3#1)(1990-6#2)(1990-8#2)(2007-12#1)(2007-8#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
2-year##55##1##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-12#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-8#2)(2008-10#9)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#4)(2008-9#2)(2009-1#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#5)
2-year-old boy##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
2-year-old##14##1##(1996-2#1)(1997-9#1)(2007-10#1)(2008-10#5)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
2-{[1-(3##2##1##(2008-10#2)
2/100##2##1##(1991-6#1)(2008-10#1)
2/3 of the##5##3##(1990-6#1)(1994-9#1)(1996-12#1)(2008-11#1)(2013-1#1)
2/3 of##8##2##(1990-6#2)(1992-8#1)(1994-9#1)(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
2/3##14##1##(1990-6#3)(1992-8#1)(1993-9#1)(1994-9#1)(1996-12#1)(2007-8#1)(2008-11#3)(2008-5#1)(2013-1#2)
2/37 (5##2##2##(2011-2#2)
2/4##3##1##(2008-11#1)(2008-6#1)(2011-2#1)
2/6##3##1##(2008-5#2)(2013-8#1)
2/C12##2##1##(1995-6#2)
2/h##3##1##(2008-5#2)(2008-6#1)
20 (95% CI##2##3##(2008-12#1)(2008-6#1)
20 +/- 0##3##3##(1990-2#1)(2008-10#1)(2008-12#1)
20 +/-##6##2##(1990-2#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
20 -##3##2##(1992-2#1)(2011-1#1)(2011-2#1)
20 000 Yuan (OR = 2##2##6##(2011-1#2)
20 000##4##2##(2008-10#1)(2008-7#1)(2011-1#2)
20 GHz##2##2##(2008-10#1)(2008-2#1)
20 July##3##2##(1995-6#1)(2008-3#2)
20 MHz##4##2##(2007-12#1)(2008-2#1)(2008-5#1)(2010-8#1)
20 THz##2##2##(2007-11#1)(2008-3#1)
20 V##3##2##(2008-10#2)(2009-9#1)
20 W##2##2##(2007-11#1)(2007-12#1)
20 after##2##2##(1990-2#1)(1995-12#1)
20 alpha HSD mRNA##2##4##(1994-6#2)
20 alpha HSD##4##3##(1994-6#4)
20 alpha##5##2##(1994-6#5)
20 amino acids##2##3##(1992-6#1)(1995-12#1)
20 and 0##6##3##(1992-6#1)(2008-10#5)
20 and 10##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
20 and 100##4##3##(1992-12#1)(1992-6#1)(1996-2#1)(2008-6#1)
20 and 2##2##3##(2008-10#2)
20 and 22##2##3##(2008-10#2)
20 and 25 degrees C##3##5##(2008-10#3)
20 and 25##5##3##(1994-8#1)(2008-10#3)(2009-7#1)
20 and 30 degrees C##2##5##(2008-10#2)
20 and 30##8##3##(1994-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#1)
20 and 35##2##3##(1997-6#1)(2010-3#1)
20 and 4##2##3##(2008-10#2)
20 and 40##3##3##(1991-6#1)(2007-10#1)(2008-5#1)
20 and 50 mg/kg/dose##2##4##(2008-10#2)
20 and 50##3##3##(2008-10#3)
20 and 80##2##3##(1990-5#1)(2008-10#1)
20 and##71##2##(1990-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1993-8#1)(1994-3#2)(1994-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
20 approximately##2##2##(2008-10#2)
20 bases##2##2##(1991-9#1)(1995-12#1)
20 by##2##2##(2008-10#1)(2008-11#1)
20 cM##2##2##(1995-9#1)(2008-10#1)
20 cases of##3##3##(1991-11#1)(2007-8#1)(2008-9#1)
20 cases##10##2##(1991-11#1)(1994-9#1)(1997-5#1)(2007-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
20 children##2##2##(1994-5#1)(2008-9#1)
20 cm from the##3##4##(2008-4#1)(2013-8#2)
20 cm##11##2##(1994-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2013-8#3)
20 consecutive patients##2##3##(2008-6#1)(2012-12#1)
20 consecutive##3##2##(1997-4#1)(2008-6#1)(2012-12#1)
20 controls##3##2##(1994-9#1)(2009-6#1)(2013-1#1)
20 cycles##2##2##(2008-10#1)(2008-11#1)
20 d after##2##3##(2006-11#1)(2010-12#1)
20 d##4##2##(2006-11#1)(2008-6#1)(2008-9#1)(2010-12#1)
20 dB##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
20 days after anthesis##2##4##(2008-10#1)(2008-12#1)
20 days after##11##3##(1995-12#2)(2008-10#3)(2008-12#2)(2008-9#1)(2012-3#1)(2013-8#2)
20 days of##2##3##(2008-10#1)(2010-4#1)
20 days the##2##3##(1994-6#1)(2008-1#1)
20 days##29##2##(1991-8#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-12#2)(1995-3#1)(1997-3#1)(1997-4#1)(1997-9#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#2)
20 days-old##2##2##(1990-7#2)
20 deg##2##2##(2008-3#2)
20 degrees C and##8##4##(1995-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-4#1)
20 degrees C with##2##4##(2008-10#2)
20 degrees C##56##3##(1990-7#1)(1990-8#1)(1991-5#1)(1994-3#1)(1995-2#3)(1995-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#36)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)
20 degrees C) and##2##4##(2008-10#2)
20 degrees C)##7##3##(2008-10#7)
20 degrees and 30 degrees##2##5##(2007-8#2)
20 degrees##74##2##(1990-7#1)(1990-8#1)(1991-5#1)(1993-1#1)(1994-3#1)(1995-2#3)(1995-8#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#43)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
20 different##3##2##(2008-10#2)(2008-7#1)
20 enzymes##2##2##(1994-8#1)(2011-1#1)
20 families##2##2##(2008-5#1)(2013-7#1)
20 fertilizer##3##2##(2008-10#3)
20 fmol for##2##3##(2008-10#2)
20 fs##2##2##(2007-12#2)
20 g of##2##3##(2008-10#2)
20 g##6##2##(1993-3#1)(2008-10#5)
20 g/day)##2##2##(1997-8#1)(2008-3#1)
20 g/l##2##2##(1997-3#1)(2008-1#1)
20 general practitioners##2##3##(1993-11#1)(1994-6#1)
20 generations##2##2##(2008-10#2)
20 genes##6##2##(1996-2#2)(2007-11#1)(2008-10#2)(2008-7#1)
20 h after stimulation##2##4##(1995-11#1)(2008-5#1)
20 h after##4##3##(1992-3#1)(1995-11#1)(2008-11#1)(2008-5#1)
20 h##14##2##(1992-3#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2010-5#2)(2012-2#1)
20 h(-1)##4##2##(2008-10#4)
20 healthy Japanese##2##3##(2008-5#2)
20 healthy volunteers##2##3##(1995-11#1)(2013-8#1)
20 healthy##13##2##(1992-12#1)(1995-11#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
20 hr##3##2##(1993-9#1)(1994-2#1)(2008-11#1)
20 important characteristics##2##3##(2008-12#2)
20 in the mixed sample##2##5##(2008-10#2)
20 in the##3##3##(2008-10#2)(2009-11#1)
20 in##6##2##(2008-10#2)(2009-11#1)(2011-2#2)(2012-3#1)
20 injections##3##2##(1990-8#1)(2008-10#2)
20 isolated##2##2##(2008-10#1)(2008-5#1)
20 isolates of##2##3##(2008-10#2)
20 isolates##4##2##(2008-10#3)(2011-1#1)
20 kDa bifunctional##2##3##(1992-8#2)
20 kDa myosin light chain##2##5##(1990-11#1)(1994-11#1)
20 kDa##8##2##(1990-11#1)(1992-8#2)(1994-11#1)(1995-12#2)(1997-7#1)(2011-2#1)
20 kHz##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
20 kb##3##2##(1995-5#1)(2012-3#2)
20 kg##2##2##(2008-9#1)(2010-2#1)
20 km##4##2##(1996-4#1)(1997-5#1)(2008-12#1)(2008-2#1)
20 m##5##2##(1991-6#1)(2007-11#1)(2008-10#2)(2008-3#1)
20 mM##20##2##(1990-8#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-9#1)(1996-5#2)(1997-2#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-6#1)(2011-2#2)
20 mM)##2##2##(1997-2#1)(2009-6#1)
20 mV##2##2##(1990-5#1)(2008-10#1)
20 mW of##2##3##(2007-12#1)(2008-3#1)
20 mcg##2##2##(1994-5#1)(2008-12#1)
20 medical##2##2##(1997-2#1)(2008-11#1)
20 men)##3##2##(1996-6#1)(2007-11#1)(2011-2#1)
20 meqg(-1) of##2##3##(2008-10#2)
20 mg l(-1) for##2##4##(2008-10#2)
20 mg l(-1)##3##3##(2008-10#3)
20 mg of##2##3##(2008-10#1)(2012-2#1)
20 mg##10##2##(1990-2#1)(1991-2#1)(1991-8#1)(2008-10#5)(2008-3#1)(2012-2#1)
20 mg/day##7##2##(1994-7#1)(2006-10#1)(2008-5#5)
20 mg/kg##10##2##(1992-5#1)(1993-2#1)(1993-3#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)
20 mg/m2##2##2##(1991-2#1)(1994-8#1)
20 microL##3##2##(2008-5#1)(2010-5#1)(2011-1#1)
20 microM and##2##3##(1994-8#1)(2008-10#1)
20 microM##12##2##(1990-5#1)(1993-3#2)(1994-8#2)(1995-2#1)(1995-8#3)(1996-2#1)(2008-10#2)
20 microM)##4##2##(1994-11#2)(1995-8#1)(2009-9#1)
20 microg ml(-1)##2##3##(2008-10#2)
20 microg of##2##3##(2007-12#2)
20 microg##6##2##(2007-12#2)(2008-10#3)(2010-8#1)
20 micrograms##2##2##(1994-5#1)(1996-2#1)
20 microm##6##2##(2007-12#1)(2008-11#1)(2008-3#4)
20 million##2##2##(2012-12#1)(2012-2#1)
20 min in##2##3##(2008-10#2)
20 min of exercise##2##4##(2008-7#1)(2013-8#1)
20 min of##5##3##(1994-12#2)(2008-10#1)(2008-7#1)(2013-8#1)
20 min to##2##3##(1992-3#1)(1994-8#1)
20 min with##2##3##(1990-2#1)(2008-10#1)
20 min##52##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-12#2)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-4#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-2#1)(2013-8#2)
20 minutes for##2##3##(2011-2#1)(2013-8#1)
20 minutes##9##2##(1994-6#1)(2006-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
20 minutes)##2##2##(1990-5#2)
20 ml of##6##3##(2008-10#4)(2008-2#1)(2008-7#1)
20 ml##9##2##(2008-10#7)(2008-2#1)(2008-7#1)
20 mm##11##2##(1990-2#1)(1990-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2012-2#1)
20 mmol##2##2##(2008-10#2)
20 mmol/L##4##2##(1993-1#1)(2008-8#1)(2008-9#1)(2011-1#1)
20 mole percent cholesterol##2##4##(1990-2#2)
20 mole percent##3##3##(1990-2#3)
20 months follow-up##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
20 months of##2##3##(2008-6#1)(2011-2#1)
20 months on##2##3##(2012-12#2)
20 months##12##2##(1995-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#3)(2012-2#1)
20 months)##2##2##(1992-9#1)(2008-10#1)
20 ms##2##2##(1996-2#1)(2008-11#1)
20 muM##6##2##(2008-10#4)(2008-11#2)
20 mug l(-1)##3##3##(2008-10#3)
20 mug ml(-1)##4##3##(2008-10#3)(2008-11#1)
20 mug##14##2##(2008-10#12)(2008-11#2)
20 mug/ml##4##2##(2008-10#3)(2008-11#1)
20 mul injection volume##2##4##(2008-10#2)
20 mul of##4##3##(2008-10#3)(2008-11#1)
20 mul volumes##3##3##(2008-10#3)
20 mul##18##2##(2008-10#16)(2008-11#2)
20 mum##9##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)
20 nM##4##2##(1990-8#1)(1992-6#1)(1995-3#1)(1996-2#1)
20 ng ml(-1) and##2##4##(2008-10#2)
20 ng ml(-1) for##3##4##(2008-10#3)
20 ng ml(-1)##9##3##(2008-10#9)
20 ng of##2##3##(2008-10#2)
20 ng##16##2##(1990-8#1)(2008-10#15)
20 ng/g##3##2##(2008-10#3)
20 ng/mL##2##2##(2008-10#1)(2010-4#1)
20 ng/ml##5##2##(1993-3#1)(1997-1#1)(2012-12#2)(2012-2#1)
20 nm and##2##3##(2009-9#2)
20 nm##15##2##(1990-7#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-7#1)(2009-9#2)(2010-2#1)(2013-8#1)
20 nmol/l cells##2##3##(1995-8#2)
20 ns##2##2##(2007-12#2)
20 of pregnancy##2##3##(1995-12#1)(1996-12#1)
20 of the##2##3##(1995-9#1)(2008-1#1)
20 of these##3##3##(2007-11#1)(2008-6#1)(2010-3#1)
20 of##12##2##(1993-12#1)(1993-6#1)(1995-12#1)(1995-9#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2013-1#1)
20 on##2##2##(2008-6#1)(2008-9#1)
20 or more##2##3##(1991-12#1)(2008-7#1)
20 or##8##2##(1991-12#1)(1993-8#1)(2008-10#3)(2008-7#1)(2008-9#2)
20 out of the##2##4##(1997-6#1)(2010-5#1)
20 out of##3##3##(1997-6#1)(2008-12#1)(2010-5#1)
20 patients (62##2##3##(2008-10#2)
20 patients in##2##3##(1992-6#1)(2013-8#1)
20 patients treated with##4##4##(1990-6#1)(2008-11#1)(2008-9#2)
20 patients was##2##3##(1994-12#1)(2008-6#1)
20 patients were##5##3##(1990-9#1)(2008-6#2)(2009-8#1)(2013-8#1)
20 patients with chronic##3##4##(2008-1#1)(2009-8#1)(2010-4#1)
20 patients with##13##3##(1990-8#1)(1991-11#1)(1992-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-4#1)(2013-1#4)
20 patients##56##2##(1990-12#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-12#2)(1996-6#1)(1996-9#2)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-6#7)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#6)(2013-8#2)
20 people with##2##3##(2013-1#2)
20 per##2##2##(2008-5#2)
20 percent of the##3##4##(1991-1#1)(1997-2#1)(2008-10#1)
20 percent of##7##3##(1991-1#1)(1994-12#1)(1994-2#2)(1997-2#1)(2008-10#1)(2011-2#1)
20 percent##8##2##(1991-1#1)(1994-12#1)(1994-2#2)(1996-1#1)(1997-2#1)(2008-10#1)(2011-2#1)
20 ppb##3##2##(2008-10#3)
20 ppm##2##2##(2008-10#2)
20 ps##2##2##(2007-11#1)(2008-3#1)
20 repeated##2##2##(1992-3#1)(2013-1#1)
20 rpm##2##2##(2008-11#2)
20 s after##2##3##(1990-2#1)(1996-5#1)
20 s and can be used for##2##7##(2008-10#2)
20 s##15##2##(1990-2#1)(1996-5#2)(2008-10#8)(2008-3#1)(2008-7#2)(2013-1#1)
20 s)##2##2##(2008-10#1)(2010-3#1)
20 sample##2##2##(2008-10#1)(2008-12#1)
20 samples h(-1)##3##3##(2008-10#3)
20 samples per h##2##4##(2008-10#2)
20 samples per hour##4##4##(2008-10#4)
20 samples per##6##3##(2008-10#6)
20 samples##11##2##(2008-10#10)(2013-7#1)
20 sites##2##2##(1993-3#1)(1996-12#1)
20 soybean stem pieces##2##4##(2008-10#2)
20 soybean##3##2##(2008-10#3)
20 species##4##2##(2008-5#2)(2008-6#1)(2013-8#1)
20 strains of##2##3##(2008-10#1)(2008-5#1)
20 strains##3##2##(2008-10#1)(2008-5#2)
20 studies##2##2##(1996-9#1)(2008-3#1)
20 times higher than##2##4##(1992-8#1)(2008-8#1)
20 times higher##4##3##(1992-8#1)(1995-12#1)(2008-6#1)(2008-8#1)
20 times##13##2##(1992-8#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-8#2)
20 to 0##3##3##(2008-10#2)(2011-2#1)
20 to 100%##2##3##(1997-2#1)(1997-3#1)
20 to 200##2##3##(1997-6#1)(2008-10#1)
20 to 23##2##3##(2008-7#1)(2013-8#1)
20 to 24##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
20 to 25 degrees C##4##5##(2008-10#4)
20 to 25##6##3##(2008-10#4)(2008-5#1)(2009-1#1)
20 to 25%##2##3##(1997-5#1)(2013-1#1)
20 to 30##7##3##(1993-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-5#1)(2012-12#1)
20 to 30% in##2##4##(2008-10#2)
20 to 40##7##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-9#3)
20 to 60 years##2##4##(2008-1#1)(2010-7#1)
20 to 60##3##3##(2008-1#1)(2008-10#1)(2010-7#1)
20 to 60%##2##3##(1996-12#1)(2008-10#1)
20 to 90##2##3##(1997-6#1)(2008-10#1)
20 to##77##2##(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#35)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#3)
20 treated with##2##3##(1996-1#1)(2007-7#1)
20 vs##2##2##(1991-12#1)(1995-12#1)
20 was##2##2##(2008-10#1)(2008-7#1)
20 weeks of pregnancy##2##4##(1994-3#1)(2009-1#1)
20 weeks##17##2##(1990-7#1)(1991-2#1)(1992-2#2)(1993-6#1)(1994-3#1)(2007-11#1)(2008-12#1)(2008-9#4)(2009-1#1)(2011-2#4)
20 were##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
20 with##3##2##(1995-11#1)(1996-5#1)(2008-10#1)
20 women##2##2##(2008-5#1)(2010-12#1)
20 x##6##2##(1992-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)
20 year##5##2##(1991-12#1)(1994-3#1)(2008-6#1)(2008-7#2)
20 years after##4##3##(2007-4#1)(2008-10#1)(2008-12#1)(2011-2#1)
20 years ago##15##3##(1991-2#1)(1995-4#1)(1997-5#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
20 years and##2##3##(1997-3#1)(2008-1#1)
20 years earlier##2##3##(2008-7#1)(2013-8#1)
20 years in##4##3##(1995-12#1)(1996-5#1)(2008-10#2)
20 years of age##2##4##(1997-4#1)(2013-1#1)
20 years of experience##2##4##(2008-10#1)(2010-12#1)
20 years of##6##3##(1991-12#1)(1997-4#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
20 years or more##2##4##(1990-2#1)(1995-2#1)
20 years or##3##3##(1990-2#1)(1995-2#1)(1997-8#1)
20 years to##2##3##(2010-3#1)(2010-7#1)
20 years were##3##3##(1991-12#1)(1994-3#1)(2008-7#1)
20 years##90##2##(1990-2#1)(1991-12#3)(1991-2#1)(1991-4#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
20 young##3##2##(1991-12#1)(1996-7#1)(2008-5#1)
20 yr##2##2##(2008-8#2)
20 ×##2##2##(2011-2#2)
20##1654##1##(1990-11#3)(1990-12#6)(1990-2#14)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#7)(1990-8#14)(1990-9#3)(1991-1#4)(1991-11#6)(1991-12#11)(1991-2#10)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#11)(1992-8#5)(1992-9#2)(1993-1#6)(1993-10#1)(1993-11#3)(1993-12#9)(1993-2#3)(1993-3#9)(1993-6#3)(1993-8#9)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#12)(1994-5#3)(1994-6#13)(1994-7#3)(1994-8#9)(1994-9#6)(1995-1#1)(1995-11#8)(1995-12#21)(1995-2#8)(1995-3#8)(1995-4#2)(1995-5#4)(1995-6#5)(1995-8#11)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#11)(1996-2#13)(1996-3#1)(1996-4#1)(1996-5#11)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#6)(1997-1#7)(1997-2#10)(1997-3#7)(1997-4#8)(1997-5#7)(1997-6#8)(1997-7#1)(1997-8#7)(1997-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#26)(2007-12#30)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#18)(2007-9#1)(2008-1#16)(2008-10#454)(2008-11#46)(2008-12#31)(2008-2#26)(2008-3#65)(2008-4#8)(2008-5#54)(2008-6#32)(2008-7#55)(2008-8#18)(2008-9#29)(2009-1#2)(2009-10#1)(2009-11#2)(2009-3#3)(2009-4#1)(2009-5#8)(2009-6#6)(2009-7#4)(2009-8#7)(2009-9#12)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#6)(2010-3#5)(2010-4#8)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#18)(2011-2#51)(2011-3#3)(2012-1#5)(2012-12#12)(2012-2#19)(2012-3#11)(2013-1#41)(2013-7#5)(2013-8#31)
20% KOH aqueous solution##2##4##(2007-7#2)
20% after##3##2##(1993-5#1)(2008-5#1)(2010-8#1)
20% and 30%##3##3##(2008-10#1)(2010-4#1)(2013-8#1)
20% and##9##2##(1995-3#1)(2008-10#3)(2009-5#1)(2010-4#1)(2011-2#1)(2013-8#2)
20% are##2##2##(1995-8#1)(2008-3#1)
20% at##2##2##(2008-2#1)(2008-6#1)
20% but##3##2##(1994-8#1)(1995-1#1)(2007-8#1)
20% ethanol##4##2##(1994-7#3)(2008-10#1)
20% for##8##2##(1992-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-3#1)(2011-2#1)
20% glycerin##3##2##(2008-5#3)
20% had##2##2##(1997-6#1)(2008-11#1)
20% have had##2##3##(2013-1#2)
20% in the##2##3##(2008-5#1)(2008-7#1)
20% in##5##2##(1990-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
20% more##3##2##(1993-8#1)(2008-4#1)(2010-12#1)
20% of all##6##3##(1992-12#1)(1992-6#1)(1995-3#1)(2009-6#1)(2013-1#2)
20% of cases##2##3##(2007-8#1)(2010-12#1)
20% of patients##8##3##(1996-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
20% of that##2##3##(1995-5#1)(1996-5#1)
20% of the cases##6##4##(1991-8#1)(1992-5#1)(1995-12#1)(1996-3#1)(2008-1#1)(2013-1#1)
20% of the patients##3##4##(1992-5#1)(1993-12#1)(1997-4#1)
20% of the##34##3##(1991-8#1)(1992-5#3)(1993-12#2)(1993-5#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
20% of those##2##3##(1992-6#1)(2008-10#1)
20% of total##2##3##(1992-3#1)(2008-11#1)
20% of##79##2##(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#8)
20% overall##2##2##(1995-12#1)(1996-3#1)
20% per##2##2##(1992-2#1)(2008-8#1)
20% to##3##2##(2008-7#1)(2009-8#1)(2010-4#1)
20% total body surface area burn injury##2##7##(2008-8#2)
20% were##3##2##(1990-9#1)(2008-11#2)
20% when##2##2##(1992-12#1)(2008-6#1)
20%##275##1##(1990-2#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-7#3)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#7)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#41)(2008-11#17)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#6)(2008-8#7)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-3#2)(2010-4#4)(2010-6#4)(2010-8#2)(2011-1#2)(2011-2#13)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#11)(2013-8#6)
20%) and##2##2##(2008-10#2)
20%) in##2##2##(2008-10#1)(2013-1#1)
20%)##15##1##(1992-9#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
20%-efficient##2##1##(2007-11#1)(2007-12#1)
20%fatigue and 60%fatigue##2##3##(2013-8#2)
20%fatigue##3##1##(2013-8#3)
20'##2##1##(2007-12#1)(2013-8#1)
20) and##4##2##(2008-10#1)(2008-5#2)(2009-8#1)
20) that##2##2##(1993-3#1)(2008-1#1)
20) was##2##2##(2007-12#1)(2008-12#1)
20) were##7##2##(1993-3#1)(2008-10#4)(2008-5#1)(2010-8#1)
20)##46##1##(1990-11#1)(1990-5#1)(1993-1#1)(1993-3#3)(1995-11#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-8#4)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2013-1#5)
20+/-0##3##1##(2008-10#3)
20+/-2 degrees C##2##3##(2008-10#2)
20- to##4##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-8#1)
20-##9##1##(1990-5#1)(1995-8#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2013-1#1)
20-1##2##1##(2008-10#2)
20-100##6##1##(1995-12#1)(2008-10#3)(2008-5#1)(2009-12#1)
20-15##2##1##(2008-10#2)
20-2##2##1##(2008-10#2)
20-21##3##1##(1992-8#1)(2008-10#1)(2008-7#1)
20-22##3##1##(1992-8#1)(2008-6#1)(2011-2#1)
20-23##3##1##(1991-6#1)(2008-7#1)(2013-8#1)
20-24##4##1##(1994-1#1)(1995-9#1)(2008-10#1)(2008-11#1)
20-25##8##1##(1990-5#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-2#2)
20-25%##4##1##(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
20-3##2##1##(2008-10#1)(2013-1#1)
20-30 degrees##2##2##(2007-11#1)(2008-3#1)
20-30 ms##2##2##(2008-10#1)(2008-11#1)
20-30 s##2##2##(1991-12#1)(1992-11#1)
20-30##21##1##(1991-12#1)(1992-11#1)(1992-5#1)(1996-11#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
20-30% of the##4##3##(1992-5#1)(1994-5#1)(1996-4#1)(1997-3#1)
20-30% of##6##2##(1992-5#1)(1993-12#1)(1994-5#1)(1996-4#1)(1997-3#1)(2009-9#1)
20-30%##12##1##(1990-5#1)(1992-5#1)(1993-12#1)(1994-5#1)(1996-4#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#2)(2011-3#1)
20-32##2##1##(1995-6#1)(1996-3#1)
20-37##2##1##(1996-1#1)(2012-12#1)
20-40 years##2##2##(1994-5#1)(1995-6#1)
20-40##7##1##(1990-5#1)(1994-2#1)(1994-5#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
20-40% of##2##2##(1996-9#1)(2013-7#1)
20-40%##3##1##(1996-5#1)(1996-9#1)(2013-7#1)
20-45##2##1##(2007-12#1)(2008-10#1)
20-50##4##1##(1994-6#1)(1994-8#1)(2008-3#1)(2008-5#1)
20-50%##5##1##(1990-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-4#1)
20-500 mug l(-1)##2##3##(2008-10#2)
20-500##3##1##(2008-10#3)
20-60##2##1##(2008-10#1)(2008-11#1)
20-64)##2##1##(2008-3#1)(2011-2#1)
20-68##2##1##(1994-3#1)(2012-3#1)
20-80##2##1##(1994-11#1)(2008-7#1)
20-L bioreactor##2##2##(2008-7#2)
20-W diode##2##2##(2007-11#1)(2007-12#1)
20-W##3##1##(2007-11#1)(2007-12#2)
20-WEEK STUDY IN##2##3##(2008-9#2)
20-alpha-hydroxy-4- pregnen-3-one##2##2##(1990-11#2)
20-dB##2##1##(2008-3#2)
20-day##2##1##(1991-5#1)(2010-5#1)
20-dione##3##1##(1992-5#2)(1995-12#1)
20-diphenylporphyrin and 5##2##3##(2008-10#2)
20-diphenylporphyrin##4##1##(2008-10#4)
20-fold higher than##2##3##(1993-9#1)(1997-3#1)
20-fold##16##1##(1990-10#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)
20-folds##2##1##(2008-10#2)
20-fs laser pulses##2##3##(2008-3#2)
20-hydroxyecdysone##2##1##(1995-11#1)(2008-5#1)
20-item##2##1##(2008-1#1)(2008-9#1)
20-kDa##3##1##(1993-11#2)(1994-11#1)
20-kHz repetition rate with##2##4##(2008-2#2)
20-mer##2##1##(2008-10#1)(2008-4#1)
20-microm##5##1##(2007-11#1)(2008-3#4)
20-min MRI scans at a##2##5##(1992-3#2)
20-min MRI##3##2##(1992-3#3)
20-min##5##1##(1991-9#1)(1992-3#3)(2011-2#1)
20-month-old rat##2##2##(1990-7#2)
20-month-old##3##1##(1990-7#2)(2010-9#1)
20-nm##4##1##(2007-11#1)(2008-3#3)
20-oxidase##6##1##(1994-8#6)
20-percent##3##1##(1991-12#2)(1994-12#1)
20-ps pulses##2##2##(2007-12#1)(2008-3#1)
20-s integration time##2##3##(2008-2#1)(2008-3#1)
20-s##4##1##(2008-12#1)(2008-2#1)(2008-3#2)
20-tetrakis (4-N-trimethylammino-phenyl) porphyrin##2##3##(2008-10#2)
20-tetrakis##5##1##(2008-10#5)
20-tetrakis(4-carboxylphenyl)porphyrin##2##1##(2008-10#2)
20-tetrakis(4-sulfonatophenyl)porphyrin##3##1##(2008-10#3)
20-tetraphenylporphyrin##3##1##(1996-2#1)(2008-10#2)
20-triphenylporphyrin##2##1##(2008-10#2)
20-year experience##3##2##(1993-9#1)(2009-11#1)(2011-2#1)
20-year period##3##2##(1992-10#1)(2013-8#2)
20-year##9##1##(1992-10#1)(1993-8#1)(1993-9#1)(2009-11#1)(2011-2#1)(2013-1#2)(2013-8#2)
20-year-old male##2##2##(1994-11#1)(2008-7#1)
20-year-old man##6##2##(1992-2#2)(2007-7#1)(2008-7#1)(2008-9#1)(2010-6#1)
20-year-old##13##1##(1992-2#2)(1994-11#1)(1994-6#1)(2007-7#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-6#2)(2012-3#1)
20/100 bp##2##2##(2008-10#2)
20/100##5##1##(2008-10#2)(2010-10#1)(2010-9#1)(2011-1#1)
20/60##2##1##(2011-1#1)(2011-2#1)
200 (w/w)##2##2##(2008-10#2)
200 ?##2##2##(2008-2#2)
200 GHz##2##2##(2008-3#2)
200 Hz and##2##3##(2007-11#1)(2008-2#1)
200 Hz##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
200 IU##2##2##(2008-5#1)(2011-1#1)
200 MHz##6##2##(1997-7#1)(2007-12#2)(2008-3#3)
200 MPa##2##2##(1990-7#1)(2013-8#1)
200 Torr of ammonia##2##4##(2008-10#2)
200 aM##2##2##(1994-2#2)
200 and 400 mg/kg##3##4##(2008-10#1)(2010-3#2)
200 and 400##5##3##(2008-10#2)(2008-11#1)(2010-3#2)
200 and##20##2##(1992-11#1)(1995-2#2)(1997-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-2#1)(2010-3#2)(2012-3#1)
200 base pairs (bp)##2##4##(2008-10#1)(2008-11#1)
200 consecutive##2##2##(1992-2#1)(2007-10#1)
200 days##2##2##(1990-8#1)(2008-10#1)
200 degrees C is##2##4##(2007-11#1)(2008-10#1)
200 degrees C##6##3##(2007-11#1)(2008-10#4)(2008-3#1)
200 degrees C)##2##3##(2008-6#1)(2009-5#1)
200 degrees##8##2##(2007-11#1)(2008-10#4)(2008-3#1)(2008-6#1)(2009-5#1)
200 for##2##2##(1990-11#1)(2008-10#1)
200 fs##3##2##(2007-12#2)(2008-10#1)
200 g of##4##3##(2008-10#3)(2010-2#1)
200 g##5##2##(1997-7#1)(2008-10#3)(2010-2#1)
200 healthy##3##2##(1992-3#2)(2013-1#1)
200 in##5##2##(1991-11#1)(1997-2#1)(2008-5#1)(2012-1#2)
200 individuals##2##2##(1996-3#1)(2009-4#1)
200 kDa##7##2##(1990-5#1)(1991-5#2)(1994-2#1)(1996-12#2)(2008-6#1)
200 km##2##2##(2008-10#1)(2010-4#1)
200 l##2##2##(1992-11#1)(2008-10#1)
200 laboratories##2##2##(2008-4#1)(2008-7#1)
200 lines/mm##2##2##(2008-3#2)
200 mM##3##2##(1990-2#1)(1995-2#1)(1996-5#1)
200 mV##4##2##(2008-10#4)
200 mW of##2##3##(2007-11#1)(2007-12#1)
200 mW##8##2##(2007-11#2)(2007-12#3)(2008-3#3)
200 mg l(-1)##3##3##(2008-10#3)
200 mg of##2##3##(2008-10#1)(2008-5#1)
200 mg##16##2##(1997-2#1)(2007-8#1)(2008-10#4)(2008-5#4)(2008-9#4)(2010-5#1)(2011-1#1)
200 mg/day##3##2##(2008-1#2)(2008-5#1)
200 mg/kg##16##2##(1991-12#2)(1991-6#1)(1992-5#1)(1995-3#2)(2008-10#2)(2008-9#6)(2012-2#2)
200 microM and##2##3##(1990-12#1)(1997-4#1)
200 microM##8##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-11#1)(1997-4#1)
200 microg##2##2##(2008-10#1)(2011-2#1)
200 micrograms ml-1##2##3##(1996-2#2)
200 micrograms##6##2##(1990-6#1)(1995-5#1)(1996-12#1)(1996-2#3)
200 microl##3##2##(2008-10#3)
200 microm##3##2##(2007-12#1)(2008-10#1)(2010-5#1)
200 million people##2##3##(2008-10#1)(2008-7#1)
200 million##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
200 ml of##2##3##(2008-10#2)
200 ml##3##2##(2008-10#3)
200 mm##4##2##(1990-2#1)(2008-3#2)(2008-7#1)
200 ms##6##2##(1994-11#1)(2008-11#1)(2008-3#2)(2010-6#1)(2010-9#1)
200 muM SA to##2##4##(2008-10#2)
200 muM SA##3##3##(2008-10#3)
200 muM##4##2##(2008-10#4)
200 mug##2##2##(2008-10#2)
200 mug/ml##4##2##(2008-10#4)
200 mul of##2##3##(2008-10#1)(2008-11#1)
200 mul##4##2##(2008-10#3)(2008-11#1)
200 mul)##4##2##(2008-10#3)(2008-11#1)
200 mum##4##2##(2008-2#2)(2008-3#2)
200 nM##7##2##(1990-2#1)(1990-5#1)(1991-8#1)(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#1)
200 nM)##2##2##(1992-6#1)(1994-12#1)
200 ng##6##2##(1990-8#1)(2008-10#3)(2008-11#2)
200 nm and##3##3##(2007-12#1)(2008-3#1)(2009-7#1)
200 nm##17##2##(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#1)(2009-7#1)(2011-1#1)
200 ns##2##2##(2008-2#1)(2008-3#1)
200 participants##2##2##(2008-10#1)(2008-5#1)
200 patients with##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
200 patients##7##2##(1996-3#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2011-2#1)
200 plants##2##2##(2008-10#1)(2013-7#1)
200 ppb##2##2##(2008-10#1)(2008-3#1)
200 ppm##2##2##(2008-10#2)
200 replicates##2##2##(2012-3#2)
200 sows were##2##3##(1990-3#2)
200 species##2##2##(2008-10#1)(2010-3#1)
200 times##5##2##(2008-10#2)(2008-7#1)(2010-5#1)(2012-2#1)
200 to 1##2##3##(2008-10#2)
200 to 400##3##3##(2007-11#1)(2008-10#2)
200 to##12##2##(1990-2#1)(1991-12#1)(2007-11#2)(2008-10#5)(2008-12#1)(2012-12#1)(2012-2#1)
200 x##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
200 years ago##2##3##(1992-7#1)(1994-12#1)
200##465##1##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-7#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#2)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#14)(2007-12#14)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#124)(2008-11#9)(2008-12#5)(2008-2#20)(2008-3#32)(2008-4#4)(2008-5#13)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#13)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
200%##5##1##(1996-2#1)(2008-1#2)(2008-10#1)(2008-12#1)
200)##5##1##(1993-12#1)(1995-6#1)(2008-10#1)(2010-3#1)(2010-8#1)
200-1000##2##1##(2008-10#2)
200-230-nm##2##1##(2008-2#2)
200-250##2##1##(2008-10#1)(2008-5#1)
200-300##6##1##(1994-12#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-5#1)
200-500##3##1##(2008-10#2)(2008-11#1)
200-W##3##1##(2007-11#2)(2008-3#1)
200-bed##2##1##(2008-8#2)
200-bp intron##4##2##(2008-10#4)
200-bp##6##1##(1993-9#1)(2008-10#4)(2010-5#1)
200-fold##14##1##(1990-4#1)(1990-7#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#6)(2008-5#1)
200-fs pulses##2##2##(2007-11#1)(2007-12#1)
200-fs##6##1##(2007-11#1)(2007-12#4)(2008-2#1)
200-kDa##2##1##(1993-5#1)(1997-4#1)
200-ps##4##1##(1992-9#1)(2007-11#3)
2000 Hz##4##2##(2006-12#3)(2008-4#1)
2000 Journal of Advanced Nursing 31(1)##2##6##(2008-11#2)
2000 and 2001##8##3##(2008-10#7)(2008-5#1)
2000 and 2004##6##3##(2008-11#3)(2008-5#1)(2009-10#1)(2011-2#1)
2000 and 2005##3##3##(2008-10#1)(2008-12#2)
2000 and 2007##2##3##(2010-12#1)(2013-8#1)
2000 and December##3##3##(2007-8#1)(2008-1#1)(2008-8#1)
2000 and beyond##4##3##(1993-2#1)(1997-3#1)(2007-12#1)(2008-1#1)
2000 and##55##2##(1993-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#2)(2008-5#4)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#7)
2000 as##2##2##(2008-7#2)
2000 at##3##2##(2007-7#1)(2008-10#1)(2008-6#1)
2000 by##2##2##(1997-3#1)(2008-10#1)
2000 for##4##2##(2006-12#1)(2008-10#2)(2008-5#1)
2000 g##2##2##(2007-11#1)(2008-5#1)
2000 h##3##2##(1992-11#1)(2008-10#1)(2008-3#1)
2000 had##3##2##(2008-10#3)
2000 human##2##2##(2007-7#1)(2013-1#1)
2000 in##7##2##(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)
2000 is the##2##3##(2011-2#2)
2000 is##4##2##(1992-11#1)(1996-11#1)(2011-2#2)
2000 mg/kg/day##2##2##(2010-1#2)
2000 ng mL(-1)##2##3##(2008-10#1)(2011-3#1)
2000 to 2001##3##3##(2007-5#1)(2008-10#1)(2008-8#1)
2000 to 2002##2##3##(2007-10#2)
2000 to 2005##5##3##(2008-10#2)(2008-11#2)(2008-12#1)
2000 to 2007##2##3##(2010-12#1)(2011-2#1)
2000 to 2010##2##3##(2013-1#2)
2000 to February##2##3##(2008-1#1)(2010-8#1)
2000 to March##2##3##(2008-12#1)(2013-7#1)
2000 to##34##2##(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#2)(2013-7#1)
2000 using##2##2##(2008-10#2)
2000 was##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
2000 were##6##2##(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)
2000 when##2##2##(1995-2#1)(2008-11#1)
2000 with##2##2##(2007-7#1)(2008-5#1)
2000##422##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#3)(1991-5#1)(1991-9#1)(1992-11#3)(1992-3#3)(1993-12#1)(1993-2#2)(1993-3#1)(1994-3#4)(1994-9#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#3)(1997-3#3)(1997-6#4)(2006-10#1)(2006-12#4)(2007-10#6)(2007-11#6)(2007-12#2)(2007-2#7)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#3)(2008-1#8)(2008-10#93)(2008-11#76)(2008-12#10)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#19)(2008-6#7)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#1)(2009-4#3)(2009-7#1)(2010-1#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#20)(2011-3#2)(2012-12#4)(2012-2#4)(2012-3#2)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#9)
2000) and##2##2##(2008-11#1)(2012-12#1)
2000)##14##1##(2007-10#1)(2007-3#1)(2008-10#2)(2008-11#5)(2008-9#1)(2010-10#1)(2011-1#2)(2012-12#1)
2000-2004##2##1##(2008-10#1)(2011-1#1)
2000-2006##3##1##(2010-8#1)(2011-2#1)(2012-12#1)
2000-2007##3##1##(2011-2#1)(2011-3#1)(2013-1#1)
2000-2008##3##1##(2011-2#2)(2013-1#1)
2000-3000 mg kg(-1)##2##3##(2008-12#2)
2000s##4##1##(2007-12#1)(2008-10#2)(2012-3#1)
2001 and 2002##8##3##(2008-10#6)(2008-12#2)
2001 and July 2002##2##4##(2008-1#1)(2008-10#1)
2001 and May 2002##2##4##(2007-7#1)(2008-10#1)
2001 and##29##2##(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#11)(2008-12#3)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
2001 at##2##2##(2007-10#1)(2008-10#1)
2001 in##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
2001 there##2##2##(2007-8#1)(2011-2#1)
2001 through##2##2##(2008-10#1)(2013-1#1)
2001 to 2003##2##3##(2008-10#1)(2008-11#1)
2001 to March 2003##2##4##(2007-8#1)(2008-9#1)
2001 to March##4##3##(2007-8#2)(2008-5#1)(2008-9#1)
2001 to##27##2##(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-8#5)
2001 was##2##2##(2007-12#1)(2008-10#1)
2001##219##1##(1991-2#1)(2006-10#1)(2006-12#2)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#6)(2007-4#1)(2007-5#5)(2007-6#8)(2007-7#2)(2007-8#10)(2008-1#6)(2008-10#57)(2008-11#22)(2008-12#10)(2008-3#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#5)(2009-11#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#5)
2001)##14##1##(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#2)(2008-9#2)
2001)]##2##1##(2008-4#2)
2001-2002##2##1##(2007-8#1)(2008-6#1)
2001-2006)##2##1##(2011-2#2)
2002 National Health Interview##2##4##(2008-10#2)
2002 and 2003##11##3##(2008-10#6)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)
2002 and 2004##3##3##(2008-10#2)(2011-2#1)
2002 and March##2##3##(2009-3#1)(2013-1#1)
2002 and a##2##3##(2007-8#1)(2010-4#1)
2002 and##33##2##(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-5#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
2002 by the##2##3##(2007-8#1)(2010-5#1)
2002 by##3##2##(2007-8#1)(2008-10#1)(2010-5#1)
2002 have been##2##3##(2008-1#1)(2008-10#1)
2002 in##3##2##(2008-1#1)(2008-11#1)(2010-4#1)
2002 to##15##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#2)
2002 until##2##2##(2008-10#1)(2008-8#1)
2002 using##2##2##(2007-8#1)(2008-1#1)
2002 were##2##2##(2007-11#1)(2008-10#1)
2002 with##2##2##(2007-12#1)(2007-5#1)
2002##194##1##(2007-10#6)(2007-11#8)(2007-12#5)(2007-2#3)(2007-5#3)(2007-7#5)(2007-8#12)(2008-1#6)(2008-10#50)(2008-11#17)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#10)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#4)(2013-8#1)
2002)##16##1##(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#2)(2009-11#1)(2010-3#2)(2011-2#1)
2002)]##2##1##(2008-4#2)
2002-2003##4##1##(2008-3#1)(2009-5#1)(2010-8#1)(2011-2#1)
2002-2005 we##2##2##(2011-1#1)(2011-2#1)
2002-2006##2##1##(2008-12#1)(2011-2#1)
2002-2007##2##1##(2009-7#1)(2012-2#1)
2003 and 2004##6##3##(2008-10#4)(2010-3#1)(2011-2#1)
2003 and##16##2##(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-8#1)
2003 from##2##2##(2008-10#1)(2011-2#1)
2003 in##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
2003 is##2##2##(2008-5#1)(2011-2#1)
2003 on##2##2##(2007-5#1)(2008-10#1)
2003 to 2007##2##3##(2009-12#1)(2009-4#1)
2003 to##16##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-2#1)
2003 until##2##2##(2008-10#1)(2013-1#1)
2003 using##2##2##(2008-7#1)(2008-9#1)
2003 were##2##2##(2007-8#1)(2012-2#1)
2003 with##3##2##(2008-5#1)(2008-8#1)(2010-3#1)
2003##176##1##(2007-11#4)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#39)(2008-11#25)(2008-12#9)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#4)(2009-12#1)(2009-4#3)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#6)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
2003) of##2##2##(2008-10#2)
2003) was##2##2##(2008-12#1)(2012-3#1)
2003)##18##1##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
2003-2004##4##1##(2008-10#3)(2008-12#1)
2003-2007##2##1##(2010-8#1)(2012-12#1)
2003-2009##3##1##(2011-2#2)(2012-3#1)
2004 and 2005##9##3##(2008-10#4)(2008-12#4)(2010-2#1)
2004 and##17##2##(2008-10#7)(2008-12#4)(2010-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
2004 in##5##2##(2008-11#1)(2008-6#1)(2011-2#2)(2013-8#1)
2004 is the##2##3##(2011-2#2)
2004 the##4##2##(2008-1#1)(2008-4#1)(2011-2#1)(2012-2#1)
2004 through##2##2##(2008-9#1)(2011-2#1)
2004 to 2008##2##3##(2012-3#1)(2013-8#1)
2004 to February##2##3##(2008-12#1)(2008-7#1)
2004 to June 2005##2##4##(2008-12#1)(2008-8#1)
2004 to##17##2##(2007-12#1)(2008-12#3)(2008-7#1)(2008-8#3)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#4)
2004 was##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
2004 were identified##2##3##(2008-7#1)(2008-8#1)
2004 were##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
2004 with the aim of##2##5##(2010-12#1)(2010-6#1)
2004 with##3##2##(2008-10#1)(2010-12#1)(2010-6#1)
2004##198##1##(1996-2#2)(2006-8#1)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#8)(2008-10#39)(2008-11#19)(2008-12#13)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#7)(2011-1#1)(2011-2#22)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#6)
2004)##15##1##(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
2004-2005##3##1##(2008-10#1)(2010-11#1)(2011-2#1)
2004-2006##5##1##(2008-12#2)(2009-3#1)(2011-2#1)(2013-1#1)
2004-2008##2##1##(2011-1#1)(2012-1#1)
2004-2009##2##1##(2010-2#1)(2012-3#1)
2004/2005##2##1##(2008-11#1)(2009-4#1)
2005 and 2006##9##3##(2008-12#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)
2005 and 2008##7##3##(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)
2005 and 2011 in##2##4##(2013-1#2)
2005 and 2011##5##3##(2012-12#2)(2013-1#2)(2013-8#1)
2005 and##31##2##(2008-10#1)(2008-12#2)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
2005 in##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
2005 is##2##2##(2008-8#1)(2011-2#1)
2005 or##2##2##(2008-1#1)(2011-2#1)
2005 to March##2##3##(2008-12#1)(2011-2#1)
2005 to##17##2##(2008-12#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-3#4)(2013-1#2)(2013-8#2)
2005 was##2##2##(2011-2#1)(2012-12#1)
2005 were##3##2##(2008-12#1)(2008-8#1)(2012-3#1)
2005 with##2##2##(2010-5#1)(2011-2#1)
2005##206##1##(1994-2#1)(1995-12#1)(1996-2#3)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#21)(2008-11#19)(2008-12#20)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-8#8)(2010-9#1)(2011-1#6)(2011-2#29)(2011-3#1)(2012-12#13)(2012-2#2)(2012-3#8)(2012-6#2)(2013-1#12)(2013-7#2)(2013-8#4)
2005)##12##1##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#2)(2012-2#1)(2013-1#2)
2005-2006##4##1##(2008-12#2)(2011-1#1)(2013-1#1)
2005-2010##2##1##(2012-3#1)(2013-1#1)
2005-2010]##2##1##(2012-3#2)
2005-2011##2##1##(2012-12#1)(2013-1#1)
2005]##2##1##(2009-10#1)(2012-12#1)
2006 Helsingborg##2##2##(2008-8#2)
2006 and 2007##5##3##(2009-2#1)(2010-4#1)(2011-2#2)(2013-1#1)
2006 and##21##2##(2008-8#1)(2009-2#1)(2009-4#1)(2010-4#2)(2010-7#1)(2011-2#7)(2012-12#2)(2013-1#5)(2013-8#1)
2006 by using##2##3##(2011-2#1)(2013-1#1)
2006 in##5##2##(2008-12#1)(2009-3#2)(2011-2#1)(2012-12#1)
2006 is the type and##2##5##(2011-2#2)
2006 the##2##2##(2008-9#1)(2011-2#1)
2006 to 2007##2##3##(2010-4#1)(2011-2#1)
2006 to 2008##2##3##(2010-4#1)(2011-1#1)
2006 to 2009##2##3##(2011-9#2)
2006 to March 2007##2##4##(2010-8#1)(2013-8#1)
2006 to March##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
2006 to##19##2##(2008-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-9#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
2006 was##4##2##(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)
2006 were##3##2##(2010-3#1)(2012-3#1)(2013-8#1)
2006 with##3##2##(2008-12#1)(2008-8#1)(2010-10#1)
2006##218##1##(2008-10#13)(2008-11#16)(2008-12#15)(2008-4#3)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#5)(2009-10#1)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#5)(2011-2#40)(2011-3#1)(2011-9#3)(2012-12#9)(2012-2#4)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#11)
2006)##13##1##(2008-11#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#2)(2013-8#1)
2006-2007##6##1##(2008-11#1)(2008-12#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-2#1)
2006-2008##4##1##(2012-12#2)(2013-1#1)(2013-7#1)
2007 and 2008##4##3##(2011-2#2)(2012-5#1)(2013-8#1)
2007 and 2009##3##3##(2012-3#2)(2013-1#1)
2007 and##18##2##(2010-12#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
2007 consecutive##2##2##(1991-12#2)
2007 for##2##2##(2010-10#1)(2010-11#1)
2007 in##3##2##(2008-10#1)(2009-12#1)(2011-2#1)
2007 to##12##2##(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
2007 we##2##2##(2009-4#2)
2007 were##3##2##(2009-2#1)(2009-5#1)(2011-2#1)
2007##166##1##(1991-12#2)(2008-10#6)(2008-11#13)(2008-12#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#10)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#5)(2011-1#8)(2011-2#33)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#6)(2012-5#2)(2013-1#11)(2013-7#3)(2013-8#8)
2007) for##2##2##(2011-2#1)(2012-2#1)
2007)##14##1##(2008-8#1)(2009-2#2)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
2007-08 was##2##2##(2011-1#2)
2007-2008##4##1##(2011-1#1)(2011-2#1)(2013-8#2)
2007-2009##2##1##(2012-12#2)
2007-2010##4##1##(2010-3#3)(2013-8#1)
2007]##8##1##(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#2)(2013-1#2)
2007b)##2##1##(2008-12#1)(2009-5#1)
2008 Beijing##2##2##(2010-1#1)(2013-8#1)
2008 and 2009##4##3##(2011-2#1)(2013-1#3)
2008 and##14##2##(2010-4#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
2008 at##2##2##(2010-7#1)(2011-2#1)
2008 for##4##2##(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
2008 in##5##2##(2009-12#1)(2011-1#1)(2011-2#3)
2008 to January 2009##2##4##(2011-1#1)(2012-3#1)
2008 to##9##2##(2011-1#1)(2011-2#2)(2011-7#1)(2012-3#3)(2013-7#1)(2013-8#1)
2008 update##2##2##(2009-8#1)(2012-12#1)
2008 were##5##2##(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
2008##237##1##(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#17)(2009-5#4)(2009-6#7)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#3)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#14)(2011-2#59)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#13)(2012-2#8)(2012-3#15)(2012-5#1)(2013-1#16)(2013-7#2)(2013-8#15)
2008)##9##1##(2009-2#1)(2009-3#3)(2010-6#1)(2011-1#2)(2013-7#1)(2013-8#1)
2008-09##3##1##(2010-3#2)(2013-8#1)
2008-2009##4##1##(2010-3#3)(2013-1#1)
2008]##2##1##(2010-12#1)(2013-1#1)
2009 and 2010##3##3##(2013-1#3)
2009 and December##2##3##(2011-2#1)(2013-1#1)
2009 and##12##2##(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#1)
2009 in##3##2##(2010-5#1)(2011-2#2)
2009 influenza##4##2##(2010-2#1)(2011-2#1)(2012-12#2)
2009 pandemic A/H1##3##3##(2011-2#3)
2009 pandemic##5##2##(2011-1#1)(2011-2#3)(2013-1#1)
2009 to##9##2##(2010-12#1)(2012-2#2)(2012-3#3)(2013-7#2)(2013-8#1)
2009 using##2##2##(2012-12#1)(2012-2#1)
2009 virus##5##2##(2011-2#5)
2009 was conducted##2##3##(2012-2#1)(2012-3#1)
2009 was##3##2##(2010-12#1)(2012-2#1)(2012-3#1)
2009 were##4##2##(2011-2#3)(2012-5#1)
2009##214##1##(2009-10#1)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#1)(2010-6#2)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#77)(2011-3#1)(2011-9#4)(2012-1#2)(2012-12#16)(2012-2#12)(2012-3#22)(2012-5#2)(2013-1#23)(2013-7#5)(2013-8#8)
2009)##11##1##(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
2009]##5##1##(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
200mgL(-1)##2##1##(2008-10#2)
200mugl(-1)##2##1##(2008-10#2)
200mul##3##1##(2008-10#3)
200°C##5##1##(2013-1#5)
201##19##1##(1990-3#2)(1990-6#1)(1990-7#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-9#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
2010 Antarctic ozone hole##2##4##(2012-2#2)
2010 and in##2##3##(2012-2#1)(2013-8#1)
2010 and##11##2##(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
2010 in the##2##3##(2011-2#1)(2013-1#1)
2010 in##4##2##(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
2010 showed that##3##3##(2012-3#3)
2010 to##2##2##(2012-3#1)(2013-1#1)
2010 were retrospectively reviewed##2##4##(2012-3#1)(2013-8#1)
2010 were##5##2##(2012-3#3)(2013-1#1)(2013-8#1)
2010##245##1##(1996-1#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#7)(2011-2#102)(2011-3#1)(2011-7#3)(2012-1#4)(2012-12#13)(2012-2#15)(2012-3#23)(2013-1#36)(2013-7#7)(2013-8#24)
2010)##11##1##(2008-12#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
2010-2011##3##1##(2011-2#1)(2012-12#1)(2013-7#1)
2010-2011]##2##1##(2013-1#2)
2010/2009##3##1##(2013-1#3)
2010]##8##1##(2011-2#2)(2012-3#5)(2013-8#1)
2011 2011##2##2##(2013-1#2)
2011 at##2##2##(2013-8#2)
2011 in##4##2##(2010-11#1)(2013-1#3)
2011 to##5##2##(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
2011 were##3##2##(2012-12#2)(2013-7#1)
2011##191##1##(2009-6#1)(2010-11#1)(2011-1#16)(2011-2#64)(2011-6#1)(2012-1#4)(2012-12#23)(2012-2#17)(2012-3#23)(2013-1#22)(2013-7#4)(2013-8#15)
2011) was##2##2##(2013-1#2)
2011)##5##1##(2012-1#1)(2012-12#1)(2013-1#3)
2011]##6##1##(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
2012 were##2##2##(2013-1#1)(2013-8#1)
2012##108##1##(2011-4#1)(2012-1#10)(2012-12#6)(2012-2#5)(2012-3#5)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#54)(2013-7#2)(2013-8#17)
2012)##7##1##(2012-2#1)(2013-1#5)(2013-8#1)
2012]##2##1##(2013-8#2)
2013##10##1##(1993-12#1)(2008-1#1)(2012-12#2)(2013-1#2)(2013-7#2)(2013-8#2)
2015 in##2##2##(2008-8#2)
2015##8##1##(1994-9#1)(2008-11#1)(2008-12#1)(2008-8#3)(2010-12#1)(2012-2#1)
202 microm mesh##2##3##(2011-2#2)
202 patients##2##2##(2008-7#1)(2009-6#1)
202##24##1##(1990-7#1)(1991-2#1)(1992-8#1)(1994-11#1)(1995-12#1)(1997-3#1)(1997-8#1)(2007-10#3)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#2)(2013-1#2)
2020##11##1##(1991-11#1)(1992-2#2)(2008-1#2)(2009-10#2)(2011-1#1)(2011-2#3)
2025##3##1##(1991-11#1)(1996-2#1)(2013-1#1)
203##14##1##(1990-3#1)(1995-12#1)(1997-2#3)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
203-207##2##1##(1993-3#1)(2008-1#1)
2030##7##1##(1993-3#2)(2008-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
204 amino##2##2##(1997-7#1)(2010-5#1)
204##15##1##(1991-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#4)
204)##2##1##(2010-10#1)(2010-6#1)
2044##2##1##(1994-3#1)(1994-6#1)
205 ± 8##2##3##(2012-2#2)
205##17##1##(1993-6#1)(1994-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
205)##3##1##(1993-8#1)(1994-11#1)(2008-7#1)
206 male##2##2##(1996-12#1)(2008-5#1)
206 patients##2##2##(1992-6#1)(2007-8#1)
206##15##1##(1991-2#2)(1992-6#1)(1994-11#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#3)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)
2067##2##1##(2008-11#1)(2008-3#1)
207 microT##2##2##(2008-12#2)
207##16##1##(1990-3#1)(1997-4#1)(2008-10#2)(2008-12#3)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#2)
208 and##2##2##(1990-5#1)(2011-1#1)
208##24##1##(1990-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
208)##2##1##(2009-8#1)(2013-7#1)
208-W##2##1##(2007-12#2)
209##13##1##(1990-11#1)(1991-6#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-4#1)(2011-2#1)(2013-8#1)
209)##2##1##(2008-10#2)
2090##3##1##(1996-2#1)(2007-11#2)
2092##3##1##(2008-3#3)
209670##3##1##(1995-12#3)
2097##3##1##(2007-12#2)(2008-6#1)
20Gy/5##2##1##(2008-10#2)
20S proteasome##8##2##(2008-4#5)(2008-5#2)(2010-7#1)
20S##10##1##(2008-4#6)(2008-5#3)(2010-7#1)
20h(-1)##2##1##(2008-10#2)
20mM phosphate##2##2##(2008-10#2)
20mM##7##1##(2008-10#5)(2008-11#1)(2008-6#1)
20mg of##3##2##(2008-10#3)
20mg##9##1##(2007-11#1)(2008-10#3)(2008-3#3)(2011-2#1)(2013-1#1)
20mgl(-1)##2##1##(2008-10#2)
20min with a##2##3##(2008-10#2)
20min##12##1##(2008-10#11)(2013-1#1)
20ml##6##1##(2008-10#6)
20mug##3##1##(2008-10#3)
20mugL(-1)##4##1##(2008-10#4)
20mugl(-1)##4##1##(2008-10#4)
20mugml(-1)##4##1##(2008-10#4)
20mul of##2##2##(2008-10#2)
20mul##3##1##(2008-10#3)
20ngg(-1)##2##1##(2008-10#2)
20s##10##1##(1997-3#1)(2008-10#7)(2011-2#2)
20th Century##2##2##(1997-8#1)(2008-8#1)
20th International Symposium on##2##4##(1997-2#1)(2008-11#1)
20th and##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
20th century##28##2##(1994-12#1)(1995-1#1)(2006-10#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-7#4)(2010-1#1)(2010-10#1)(2011-1#1)(2011-7#1)(2012-12#1)
20th postnatal day)##2##3##(1993-12#2)
20th postnatal##3##2##(1993-12#3)
20th week of pregnancy##2##4##(1990-9#1)(2012-3#1)
20th##48##1##(1990-9#1)(1992-6#1)(1993-12#3)(1994-12#1)(1995-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#4)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
20x##3##1##(2007-11#1)(2008-10#1)(2008-9#1)
21 +/- 0##3##3##(1996-7#1)(2008-3#1)(2011-3#1)
21 +/-##7##2##(1996-7#1)(1997-7#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-3#1)
21 CFR Part 11##3##4##(2008-10#3)
21 CFR Part##4##3##(2008-10#4)
21 CFR##5##2##(1994-1#1)(2008-10#4)
21 MeV##2##2##(2008-3#1)(2012-1#1)
21 R genes##2##3##(2011-2#2)
21 V##2##2##(2009-9#2)
21 accessions##2##2##(2008-5#2)
21 after##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
21 amino acid vasoconstrictor peptide##2##5##(1991-8#1)(1995-11#1)
21 amino acid##4##3##(1991-8#1)(1992-8#1)(1995-11#1)(1995-2#1)
21 and 0##3##3##(2008-10#2)(2008-12#1)
21 and 23##2##3##(1996-5#2)
21 and##24##2##(1990-11#1)(1990-8#1)(1991-5#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(2008-10#9)(2008-11#2)(2008-12#1)(2009-6#1)(2012-3#1)(2013-1#1)
21 cases were##2##3##(2007-7#1)(2008-6#1)
21 cases##9##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-8#1)(1992-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-6#1)
21 day##3##2##(1991-8#1)(1996-12#1)(2012-2#1)
21 days after##4##3##(2007-2#1)(2008-10#3)
21 days were##2##3##(2011-1#1)(2013-1#1)
21 days##42##2##(1991-4#1)(1991-6#1)(1994-3#2)(1994-6#2)(1995-11#2)(1995-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
21 days)##4##2##(1996-2#3)(2010-11#1)
21 degrees C##11##3##(1995-5#1)(2008-10#8)(2008-5#1)(2010-5#1)
21 different plant##2##3##(2008-10#2)
21 different##4##2##(1992-9#1)(2008-10#3)
21 for##2##2##(1996-5#1)(2008-12#1)
21 h with##2##3##(1995-12#1)(2008-6#1)
21 h##5##2##(1995-12#2)(1996-5#1)(2008-5#1)(2008-6#1)
21 healthy##2##2##(1992-3#1)(2008-3#1)
21 in##7##2##(1992-12#1)(2006-6#1)(2008-1#1)(2008-9#1)(2010-1#1)(2010-5#1)(2013-1#1)
21 kDa##6##2##(1990-7#1)(1993-6#4)(1995-12#1)
21 men##4##2##(2007-11#2)(2008-11#1)(2011-2#1)
21 min##3##2##(2008-10#1)(2008-7#2)
21 mm##2##2##(1990-11#1)(2008-7#1)
21 months##6##2##(1990-12#1)(1991-12#1)(2007-7#1)(2008-6#1)(2010-11#1)(2011-1#1)
21 ng ml(-1)##2##3##(2008-10#2)
21 ng##3##2##(2008-10#3)
21 nucleotides were##2##3##(1990-12#1)(2008-10#1)
21 of the##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
21 of these##2##3##(1997-4#1)(2009-10#1)
21 of##8##2##(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
21 out of##2##3##(2009-8#1)(2011-2#1)
21 p##6##2##(2008-5#6)
21 papers##2##2##(2008-10#1)(2008-3#1)
21 patients (33##2##3##(2008-7#1)(2008-8#1)
21 patients the##2##3##(1991-5#1)(2007-8#1)
21 patients were##3##3##(1990-9#1)(1992-8#1)(2007-11#1)
21 patients with##9##3##(1990-8#1)(1992-11#1)(1993-9#1)(1995-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
21 patients##36##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-12#1)(1996-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
21 per cent##2##3##(1991-6#1)(1995-9#1)
21 samples##2##2##(2008-10#2)
21 times##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
21 to 0##2##3##(2008-10#1)(2008-7#1)
21 to 1##2##3##(2008-10#1)(2008-8#1)
21 to 28 days in##2##5##(2007-10#2)
21 to##14##2##(1990-11#1)(1991-5#1)(1994-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
21 weeks##2##2##(2008-11#1)(2013-1#1)
21 women##2##2##(2008-1#1)(2008-11#1)
21 x 21##2##3##(2008-3#2)
21 x##3##2##(2008-10#1)(2008-3#2)
21 years after the##2##4##(2007-10#1)(2013-8#1)
21 years after##3##3##(1994-7#1)(2007-10#1)(2013-8#1)
21 years old##2##3##(2010-7#1)(2011-2#1)
21 years##8##2##(1991-12#1)(1994-7#2)(2007-10#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
21##604##1##(1990-11#6)(1990-12#5)(1990-2#5)(1990-3#4)(1990-5#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#4)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#4)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-3#3)(1994-6#6)(1994-7#3)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#8)(1995-2#4)(1995-3#2)(1995-5#5)(1995-6#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#14)(1996-3#3)(1996-5#8)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#1)(1997-7#3)(1997-8#2)(2006-6#2)(2006-8#1)(2007-10#6)(2007-11#7)(2007-12#3)(2007-2#1)(2007-7#11)(2007-8#6)(2007-9#1)(2008-1#10)(2008-10#105)(2008-11#22)(2008-12#8)(2008-2#4)(2008-3#16)(2008-4#2)(2008-5#28)(2008-6#12)(2008-7#20)(2008-8#7)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#29)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#10)(2012-6#1)(2013-1#20)(2013-7#3)(2013-8#8)
21% and##3##2##(1995-8#1)(2007-12#1)(2013-1#1)
21% at##2##2##(1990-3#1)(2008-2#1)
21% of patients##2##3##(1992-2#1)(2013-1#1)
21% of the##6##3##(1991-3#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)
21% of##13##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
21% were##2##2##(2007-12#1)(2013-8#1)
21%##45##1##(1990-3#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-9#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
21%)##2##1##(2008-10#1)(2008-12#1)
21'##8##1##(2008-10#7)(2008-5#1)
21(st)##3##1##(2008-11#1)(2008-7#1)(2012-12#1)
21) and##4##2##(1997-2#1)(2010-1#1)(2011-2#1)(2011-3#1)
21) from##2##2##(1991-12#2)
21)##27##1##(1990-8#1)(1991-12#2)(1993-11#1)(1994-10#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
21+/-0##2##1##(2007-12#1)(2008-10#1)
21- and 40-kDa GBFs##2##4##(1995-5#2)
21- and##3##2##(1992-11#1)(1995-5#2)
21-##6##1##(1992-11#1)(1995-5#2)(2008-1#1)(2008-10#1)(2008-5#1)
21-1##2##1##(2008-10#1)(2011-2#1)
21-22##3##1##(1997-5#1)(2008-11#1)(2012-12#1)
21-23##3##1##(2008-11#1)(2008-3#1)(2011-2#1)
21-3##2##1##(2008-12#2)
21-30%##2##1##(1990-5#1)(2012-3#1)
21-40##3##1##(2009-10#1)(2010-5#1)(2011-2#1)
21-69 years in age##2##4##(2008-12#2)
21-[4-(2##2##1##(1992-5#1)(1995-12#1)
21-aminosteroid##3##1##(1992-5#1)(1995-12#2)
21-bp##3##1##(1994-11#2)(2008-2#1)
21-day intervals##2##2##(2008-10#2)
21-day##6##1##(2008-10#3)(2008-11#1)(2008-7#1)(2012-3#1)
21-fold##2##1##(1995-3#1)(2008-11#1)
21-hydroxylase deficiency##4##2##(1990-11#2)(2008-1#1)(2010-2#1)
21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease##2##12##(1992-8#2)
21-hydroxylase##11##1##(1990-11#2)(1992-8#6)(1993-11#1)(2008-1#1)(2010-2#1)
21-kDa##2##1##(1992-12#1)(1995-5#1)
21-year##2##1##(2011-2#1)(2013-1#1)
21-year-old man was##2##3##(2008-1#1)(2008-9#1)
21-year-old man##3##2##(2007-12#1)(2008-1#1)(2008-9#1)
21-year-old##9##1##(1991-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-1#1)(2009-7#1)(2012-8#1)(2013-1#1)
210 bp##2##2##(1997-2#1)(2008-8#1)
210 nm##8##2##(1991-12#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2010-3#1)
210 patients##2##2##(1992-10#1)(2008-6#1)
210##53##1##(1990-2#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-9#2)(1995-2#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
2100 degrees C##2##3##(2008-10#2)
2100##9##1##(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-11#1)(2010-8#1)
2109##2##1##(1994-3#2)
210Pb##5##1##(1994-9#4)(2008-10#1)
210Po and 210Pb in##2##4##(1994-9#1)(2008-10#1)
210Po and 210Pb##4##3##(1994-9#3)(2008-10#1)
210Po and##5##2##(1994-9#4)(2008-10#1)
211 A##2##2##(2008-3#2)
211 and##2##2##(2008-11#1)(2013-1#1)
211##15##1##(1990-8#1)(1991-2#1)(1991-3#1)(1993-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-9#1)(2010-4#1)(2013-1#1)
212##16##1##(1994-3#1)(1995-2#3)(1996-3#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-8#1)(2013-1#1)
213 mg/l##2##2##(2008-7#2)
213##19##1##(1990-10#1)(1990-5#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-3#1)(2008-7#2)(2008-8#1)(2010-11#1)(2013-1#1)
213) and##2##2##(2009-4#1)(2013-8#1)
214 nm##2##2##(2008-10#2)
214 to 2##2##3##(2008-10#2)
214##21##1##(1990-12#1)(1992-3#1)(1993-11#2)(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-4#1)(2012-2#3)(2013-8#1)
215 nm##6##2##(1996-5#1)(2008-10#4)(2008-2#1)
215 patients##2##2##(2008-4#1)(2013-8#1)
215##23##1##(1993-3#1)(1994-6#1)(1995-3#2)(1996-5#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
215)##2##1##(2008-5#1)(2011-1#1)
2150##2##1##(2007-7#1)(2008-10#1)
216##14##1##(1996-3#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-10#1)(2010-11#1)(2011-2#1)
21680##2##1##(1996-5#2)
217##10##1##(1990-3#1)(1992-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2013-8#1)
217-230##2##1##(2010-3#2)
218##18##1##(1990-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1996-1#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)
219##11##1##(1990-8#1)(1991-5#1)(1993-6#1)(1994-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-4#1)(2013-1#2)
2198##2##1##(1996-2#1)(2008-8#1)
21CFR11##3##1##(2008-10#3)
21q##7##1##(1996-6#1)(1997-5#6)
21q22##7##1##(1997-2#3)(1997-8#4)
21st Century##6##2##(1994-1#1)(1995-12#1)(1995-3#1)(2007-10#1)(2011-1#1)(2011-2#1)
21st century##61##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-12#2)(2008-1#9)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
21st##79##1##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#5)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#10)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
22 (sensitivity##2##2##(2011-1#2)
22 +/- 0##3##3##(1996-2#1)(2008-10#1)(2008-12#1)
22 +/- 1##4##3##(1997-8#1)(2007-5#1)(2008-6#1)(2011-3#1)
22 +/-##8##2##(1996-2#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-3#1)
22 -##2##2##(2008-11#1)(2008-8#1)
22 ACL graft patients##2##4##(1997-8#2)
22 V##3##2##(2008-10#2)(2009-9#1)
22 aa##2##2##(1990-11#1)(1993-2#1)
22 alpha##2##2##(2008-11#2)
22 amino acids##2##3##(1993-6#1)(1994-3#1)
22 and 1##2##3##(2008-10#2)
22 and##21##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-8#2)(1993-12#1)(1993-3#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
22 by##2##2##(1992-11#1)(2008-11#1)
22 cases##2##2##(2007-8#1)(2013-8#1)
22 cm and##2##3##(2008-12#1)(2008-5#1)
22 cm##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
22 cochlear implant##2##3##(2008-9#1)(2012-2#1)
22 days##12##2##(1992-12#1)(2007-6#3)(2008-10#3)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
22 degrees C and##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
22 degrees C##23##3##(1991-2#1)(1992-3#1)(1995-11#1)(1996-5#2)(2008-10#11)(2008-11#4)(2008-2#1)(2008-9#1)(2011-2#1)
22 degrees C)##2##3##(2008-7#1)(2013-1#1)
22 degrees##30##2##(1991-2#1)(1992-3#1)(1994-8#1)(1995-11#1)(1996-5#2)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
22 distinct##2##2##(1997-2#1)(2008-10#1)
22 families##2##2##(2008-7#1)(2013-7#1)
22 for##4##2##(1996-2#1)(2008-10#3)
22 genes were##2##3##(1996-10#1)(2010-4#1)
22 h##4##2##(1992-8#1)(2007-8#1)(2008-12#1)(2008-6#1)
22 healthy##3##2##(1992-3#1)(2008-11#1)(2011-2#1)
22 hr##2##2##(2008-11#1)(2011-2#1)
22 in##3##2##(1990-3#1)(2010-2#1)(2011-1#1)
22 isolates##2##2##(2008-10#2)
22 kDa c-type cytochrome##2##4##(1994-11#2)
22 kDa##4##2##(1994-11#2)(2008-10#1)(2013-1#1)
22 kHz ultrasonic vocalization##3##4##(1994-8#3)
22 males)##2##2##(2008-8#1)(2011-2#1)
22 microg##2##2##(2008-10#2)
22 microm##2##2##(2007-12#1)(2011-1#1)
22 mm##3##2##(2008-8#2)(2012-1#1)
22 months##7##2##(1991-11#1)(1994-2#1)(1996-6#1)(2008-6#1)(2011-2#2)(2013-7#1)
22 nm##2##2##(2008-8#1)(2013-8#1)
22 of them##2##3##(1993-6#1)(2008-10#1)
22 of##8##2##(1991-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(2008-10#1)(2010-10#1)(2010-11#1)(2011-2#1)
22 out of##3##3##(1994-3#1)(2007-11#2)
22 pairs##2##2##(2008-10#1)(2011-2#1)
22 patients had been##2##4##(2012-3#1)(2013-1#1)
22 patients had##3##3##(2007-2#1)(2012-3#1)(2013-1#1)
22 patients were##2##3##(2012-3#1)(2013-1#1)
22 patients with##12##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-8#1)
22 patients##29##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-9#1)(1995-12#1)(1997-3#1)(2006-12#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
22 residues##3##2##(1990-5#1)(1990-7#1)(2012-2#1)
22 species##3##2##(2008-5#1)(2008-7#1)(2013-7#1)
22 strains##2##2##(2008-10#2)
22 to 0##2##3##(2008-10#1)(2008-7#1)
22 to 23##2##3##(1992-3#1)(2008-10#1)
22 to 26 degrees C##3##5##(2008-10#3)
22 to 3##2##3##(2007-12#1)(2008-10#1)
22 to##18##2##(1992-3#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
22 were##5##2##(1992-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
22 with##3##2##(1996-2#1)(2008-11#1)(2010-1#1)
22 women##6##2##(1994-5#1)(1995-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
22 x##2##2##(2008-10#1)(2008-11#1)
22 year old female##2##4##(1993-5#1)(2012-2#1)
22 years old female contact lenses wearer##2##7##(2011-2#2)
22 years##5##2##(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)
22 ±##3##2##(2013-1#1)(2013-7#1)(2013-8#1)
22##544##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#4)(1991-8#5)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#7)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#6)(1994-5#2)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#4)(1997-7#2)(1997-8#5)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-11#16)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#96)(2008-11#19)(2008-12#8)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#11)(2008-6#10)(2008-7#20)(2008-8#9)(2008-9#11)(2009-10#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#42)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#11)(2012-3#9)(2013-1#15)(2013-7#5)(2013-8#18)
22% and##8##2##(1992-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
22% for##2##2##(2008-10#2)
22% in the##2##3##(2008-11#1)(2008-3#1)
22% of cases##2##3##(1990-3#1)(2010-12#1)
22% of control##2##3##(1992-3#1)(1997-2#1)
22% of the##11##3##(1991-2#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)(2010-9#1)
22% of women##2##3##(1997-8#1)(2011-1#1)
22% of##21##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
22% with##3##2##(2008-10#2)(2011-2#1)
22%##70##1##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-8#1)
22%)##3##1##(1995-8#1)(2008-10#1)(2013-8#1)
22)##19##1##(1990-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
22)(q25##2##1##(2007-11#2)
22)(q34##2##1##(2007-11#1)(2012-12#1)
22+/-0##2##1##(2008-10#2)
22-1##2##1##(2008-10#1)(2008-11#1)
22-23##2##1##(1990-3#1)(2008-5#1)
22-24##5##1##(1995-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
22-25##3##1##(2008-5#1)(2008-8#1)(2011-2#1)
22-26 kda bFGFs were converted to smaller##2##7##(1990-12#2)
22-26 kda##3##2##(1990-12#3)
22-26##4##1##(1990-12#3)(1990-8#1)
22-W##2##1##(2007-11#1)(2008-2#1)
22-fold##2##1##(1990-11#1)(1997-2#1)
22-kDa##4##1##(1991-7#1)(1995-6#2)(2008-10#1)
22-mm##2##1##(2007-9#1)(2009-8#1)
22-month animals##2##2##(1994-3#2)
22-month-old animals##2##2##(1994-3#2)
22-month-old rats##2##2##(1994-3#1)(1994-6#1)
22-month-old##5##1##(1994-3#4)(1994-6#1)
22-year-old female patient##2##3##(2010-3#1)(2011-2#1)
22-year-old female##4##2##(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
22-year-old male##2##2##(2008-6#1)(2012-3#1)
22-year-old##7##1##(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
220 +/-##2##2##(1993-3#1)(1994-11#1)
220 cases##2##2##(2008-7#1)(2013-8#1)
220 degrees##2##2##(1997-7#1)(2008-10#1)
220 ng##2##2##(2008-10#2)
220 nm##5##2##(1995-5#1)(2008-10#3)(2010-5#1)
220 patients were##2##3##(2008-3#1)(2012-3#1)
220 patients##5##2##(1995-11#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
220##43##1##(1990-5#1)(1990-8#1)(1991-2#1)(1993-11#3)(1993-3#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#4)
220-fs##2##1##(2007-11#1)(2007-12#1)
2200 degrees C##2##3##(2008-10#2)
2200##4##1##(2008-10#2)(2008-2#1)(2012-2#1)
221##7##1##(1996-6#1)(2008-12#1)(2008-5#1)(2011-2#3)(2013-1#1)
222 and##2##2##(2008-10#2)
222 nm##5##2##(1990-5#1)(1993-11#1)(1996-5#1)(2007-12#1)(2008-4#1)
222 patients##2##2##(1993-8#1)(2010-12#1)
222##19##1##(1990-5#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
222)##2##1##(2008-9#1)(2009-10#1)
223 and 243 nm by##2##5##(2008-2#2)
223 and##3##2##(1990-2#1)(2008-2#2)
223##19##1##(1990-2#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-8#1)(2009-7#1)(2010-3#1)(2012-1#1)(2013-1#2)
2233##2##1##(1996-2#1)(2007-12#1)
224 to##2##2##(2008-1#1)(2008-10#1)
224##18##1##(1992-6#1)(1992-9#1)(1994-1#1)(1996-1#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
224-nm radiation##3##2##(2008-2#3)
224-nm##5##1##(2008-2#5)
2249##3##1##(1996-2#2)(2010-8#1)
225 and##3##2##(1995-6#1)(2008-10#2)
225 isolates##2##2##(2008-10#2)
225 kg##3##2##(2008-12#3)
225 nm##2##2##(1997-2#1)(2008-10#1)
225##35##1##(1990-2#1)(1992-6#2)(1995-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#11)(2008-12#4)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
226 local##2##2##(2008-10#2)
226 nm##5##2##(2008-10#2)(2008-2#2)(2012-2#1)
226##17##1##(1995-6#1)(1996-9#1)(1997-2#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
227 nm##4##2##(2008-3#3)(2011-1#1)
227##13##1##(1993-2#1)(1994-12#1)(1996-2#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
227)##4##1##(1990-2#1)(1992-3#1)(2008-10#1)(2012-3#1)
228 (North Holland)##2##3##(1991-8#2)
228##18##1##(1990-5#1)(1990-6#1)(1991-8#2)(1992-10#1)(1993-2#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
2280##2##1##(1996-8#2)
229##8##1##(1992-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
22nd##5##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(2011-2#1)
22q11##10##1##(1997-3#6)(2009-5#1)(2012-12#3)
22 nm##2##1##(2012-2#2)
23 (##2##2##(2013-1#2)
23 (35%)##2##2##(1996-12#1)(2008-1#1)
23 (4##2##2##(2007-12#1)(2011-2#1)
23 +/- 0##5##3##(1993-1#1)(2008-10#1)(2009-8#1)(2013-1#2)
23 +/-##7##2##(1993-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-1#1)(2013-1#2)
23 ?##2##2##(2008-2#1)(2008-3#1)
23 V##2##2##(2008-10#1)(2009-9#1)
23 amino##3##2##(1990-8#1)(1993-8#1)(1994-11#1)
23 and##9##2##(1992-12#1)(1994-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-6#1)(2013-8#1)
23 cases##5##2##(1997-8#1)(2007-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
23 days##5##2##(2008-10#2)(2008-7#1)(2010-4#1)(2011-3#1)
23 degrees C in##2##4##(1997-2#1)(2007-11#1)
23 degrees C##14##3##(1990-7#1)(1992-3#2)(1993-9#2)(1997-2#1)(2007-11#1)(2008-10#6)(2010-5#1)
23 degrees##17##2##(1990-7#1)(1992-3#2)(1993-8#1)(1993-9#2)(1997-2#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-8#1)(2010-5#1)
23 females##3##2##(2008-1#1)(2008-5#1)(2012-3#1)
23 followed by##2##3##(1996-5#1)(2008-12#1)
23 g##2##2##(2008-10#1)(2008-5#1)
23 h##4##2##(2008-10#4)
23 in##2##2##(1990-12#1)(2009-10#1)
23 isolates##4##2##(2008-10#4)
23 items##2##2##(2010-10#2)
23 kDa form of IGFBP-5##2##5##(1993-8#2)
23 kDa##7##2##(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#3)(2008-10#1)
23 kb##4##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
23 mg##2##2##(1997-4#1)(2008-10#1)
23 min##2##2##(1996-5#1)(2008-10#1)
23 mm##6##2##(2007-12#1)(2007-8#2)(2008-5#1)(2010-8#1)(2012-12#1)
23 months##4##2##(1992-12#1)(1994-2#1)(2008-7#1)(2010-5#1)
23 mothers##3##2##(1991-9#3)
23 mug l(-1)##2##3##(2008-10#2)
23 mug##4##2##(2008-10#3)(2008-11#1)
23 mum##2##2##(2008-3#1)(2008-7#1)
23 nM##2##2##(1993-9#1)(1994-6#1)
23 of the##2##3##(1995-6#1)(2013-1#1)
23 of##4##2##(1995-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
23 pairs of chromosomes##2##4##(2012-3#2)
23 patients who##4##3##(1991-2#1)(1996-6#1)(2008-6#1)(2013-1#1)
23 patients with##5##3##(1991-2#1)(1996-12#1)(2007-8#2)(2013-1#1)
23 patients##20##2##(1991-2#2)(1991-3#1)(1992-6#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#2)
23 percent of##2##3##(1992-3#1)(1997-2#1)
23 percent##5##2##(1992-3#1)(1992-5#1)(1997-2#1)(1997-5#1)(2011-2#1)
23 strains from##2##3##(2008-10#2)
23 times##2##2##(2008-11#1)(2012-1#1)
23 to##7##2##(1990-11#1)(1990-2#1)(1995-1#1)(1995-3#1)(1996-5#1)(2008-10#1)(2009-3#1)
23 were##3##2##(1992-5#1)(2006-10#1)(2011-2#1)
23 with##2##2##(1995-3#1)(2008-1#1)
23 x##2##2##(2008-10#1)(2008-3#1)
23 years before##2##3##(1990-3#1)(1991-7#1)
23 years of##3##3##(1992-6#1)(1994-7#1)(2008-7#1)
23 years##7##2##(1990-3#1)(1991-2#1)(1991-7#1)(1992-6#1)(1994-7#2)(2008-7#1)
23 years]##2##2##(1992-3#1)(1994-7#1)
23##448##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#3)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#8)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#6)(2008-10#81)(2008-11#8)(2008-12#9)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#13)(2008-6#10)(2008-7#11)(2008-8#6)(2008-9#10)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#9)(2013-1#18)(2013-7#2)(2013-8#12)
23% and##5##2##(2007-7#1)(2009-6#1)(2011-1#2)(2011-2#1)
23% for##3##2##(1997-4#1)(2008-10#1)(2012-1#1)
23% in##3##2##(1996-3#1)(2009-5#1)(2011-2#1)
23% of the patients##2##4##(2008-7#1)(2009-3#1)
23% of the##9##3##(1996-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
23% of##18##2##(1991-11#1)(1992-1#1)(1993-12#1)(1993-3#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
23% were##2##2##(2008-12#1)(2012-2#1)
23%##71##1##(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#2)(2007-12#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
23%)##6##1##(1992-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)
23) and##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
23)##16##1##(1990-2#1)(1991-12#1)(1992-3#1)(1994-8#1)(1995-8#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
23+/-0##3##1##(2008-10#1)(2008-11#2)
23-##2##1##(1993-8#1)(2011-1#1)
23-1##3##1##(1994-12#1)(2008-10#1)(2012-1#1)
23-17-1b##2##1##(2008-10#2)
23-24##4##1##(1996-5#1)(2008-5#2)(2012-2#1)
23-25##3##1##(2008-5#1)(2011-2#1)(2012-2#1)
23-26##3##1##(1995-12#1)(1996-2#1)(2008-10#1)
23-fold##2##1##(1997-4#1)(2008-11#1)
23-kDa##6##1##(1990-5#1)(1993-6#2)(1996-10#2)(2009-11#1)
23-year##2##1##(2007-12#1)(2009-4#1)
23-year-old##11##1##(1990-6#1)(1994-6#1)(1997-8#1)(2007-8#1)(2008-7#2)(2009-5#1)(2010-12#1)(2013-1#2)(2013-8#1)
230 and##3##2##(1994-5#1)(2008-3#2)
230 bp##2##2##(1994-2#1)(2008-10#1)
230 nm##5##2##(2007-11#1)(2008-10#4)
230##43##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-5#1)(1995-6#3)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
2300 degrees C##4##3##(2008-10#4)
2300 hours##2##2##(2010-8#2)
2300##11##1##(2008-10#6)(2009-11#1)(2009-9#1)(2010-8#2)(2012-2#1)
2302##9##1##(1992-4#1)(2008-10#8)
2308##5##1##(1996-12#5)
230nm##4##1##(2008-10#4)
231##15##1##(1991-2#1)(1992-8#1)(1993-2#1)(1994-10#6)(1997-6#1)(2008-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
232 patients##2##2##(2007-7#1)(2011-1#1)
232##14##1##(1991-2#1)(1991-9#1)(1993-11#1)(1994-11#1)(1995-5#1)(1997-3#1)(1997-5#2)(2007-7#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-7#1)
232-CG##2##1##(2008-10#2)
2327##2##1##(2008-10#2)
233 patients with##3##3##(1992-9#1)(2013-1#2)
233 patients##4##2##(1992-9#1)(2011-2#1)(2013-1#2)
233##18##1##(1990-7#1)(1992-9#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
23390##3##1##(1994-2#1)(1996-2#1)(2013-1#1)
234##14##1##(1994-11#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
2340 cm-1 for the##2##4##(2008-10#2)
235##29##1##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-10#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
2350##3##1##(2011-2#1)(2012-9#1)(2013-1#1)
236 controls##2##2##(2008-8#1)(2012-2#1)
236##13##1##(1990-3#1)(1991-3#1)(1996-5#1)(1997-6#2)(2008-10#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
237 nm##2##2##(2007-12#1)(2008-10#1)
237##11##1##(1991-2#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-7#1)(2012-3#2)
238 patients##2##2##(1993-3#1)(2010-11#1)
238##18##1##(1990-6#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#5)(2008-11#3)(2010-1#1)(2010-11#1)
238)##3##1##(1993-3#1)(1996-2#1)(2008-10#1)
239 nm##2##2##(1997-2#1)(2008-10#1)
239##13##1##(1990-6#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-5#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
23H-porphine-2##2##1##(2008-10#2)
23Na NMR##2##2##(1991-8#2)
23Na##5##1##(1991-8#3)(1994-3#2)
23S rDNA##4##2##(1995-8#3)(2008-10#1)
23S rRNA##5##2##(1992-6#3)(1995-8#2)
23S ribosomal##3##2##(1992-3#1)(1995-8#2)
23S##14##1##(1992-3#2)(1992-6#3)(1995-8#8)(2008-10#1)
23c##3##1##(1996-5#3)
23rd##7##1##(1990-3#1)(1993-6#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-9#1)(2012-2#1)
24 (39##2##2##(2008-8#1)(2008-9#1)
24 (SD##2##2##(2011-2#1)(2012-12#1)
24 +/- 0##5##3##(1993-1#1)(1994-11#1)(1996-2#2)(1997-2#1)
24 +/- 2##2##3##(1993-11#1)(2008-12#1)
24 +/- 3##2##3##(1990-5#1)(2008-3#1)
24 +/-##12##2##(1990-5#1)(1993-1#1)(1993-11#1)(1994-11#1)(1996-2#2)(1996-5#1)(1997-2#1)(2008-12#1)(2008-3#1)(2009-5#1)(2011-2#1)
24 -##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
24 Kd##3##2##(1993-8#3)
24 amino##2##2##(1994-9#1)(1995-12#1)
24 and 0##2##3##(2008-10#2)
24 and 29##2##3##(2008-6#1)(2013-1#1)
24 and 30##2##3##(1995-8#1)(2008-10#1)
24 and 48 h##3##4##(2008-7#2)(2010-5#1)
24 and 48 hours##2##4##(2013-1#2)
24 and 48##6##3##(2008-5#1)(2008-7#2)(2010-5#1)(2013-1#2)
24 and 96 h##2##4##(2008-12#2)
24 and##26##2##(1991-6#1)(1992-2#1)(1994-8#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-5#1)(2013-1#3)(2013-8#1)
24 barley genotypes##2##3##(2008-10#2)
24 cases##6##2##(1993-5#1)(1996-2#1)(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#1)
24 children##6##2##(1994-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
24 cochlear implant##9##3##(2008-9#9)
24 cochlear##10##2##(2008-9#10)
24 days##3##2##(1990-10#1)(1995-12#1)(2008-10#1)
24 degrees C and##2##4##(2008-10#1)(2008-11#1)
24 degrees C was##2##4##(2008-10#2)
24 degrees C##23##3##(1997-1#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-5#1)
24 degrees##24##2##(1997-1#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)
24 females)##2##2##(2007-7#1)(2008-7#1)
24 genes##2##2##(2008-7#1)(2010-4#1)
24 h after inoculation##5##4##(2008-10#5)
24 h after the last##4##5##(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#1)
24 h after the##8##4##(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-8#1)
24 h after treatment##3##4##(1992-8#1)(2008-10#2)
24 h after##36##3##(1990-5#1)(1992-11#1)(1992-8#1)(1994-5#1)(1995-12#3)(1995-3#1)(1995-5#2)(1996-12#1)(1997-7#2)(2008-10#13)(2008-11#2)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
24 h and##10##3##(1991-9#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-9#3)
24 h at##6##3##(1990-5#1)(1994-3#1)(2008-10#3)(2008-12#1)
24 h before inoculation with##2##5##(2008-10#2)
24 h before the##2##4##(1995-5#1)(2008-7#1)
24 h before##6##3##(1995-5#2)(2008-10#2)(2008-7#1)(2010-8#1)
24 h cultures##2##3##(2008-12#1)(2013-1#1)
24 h exposure##2##3##(1997-7#1)(2008-10#1)
24 h following##5##3##(1992-3#1)(1994-8#1)(1995-12#1)(2008-10#1)(2009-8#1)
24 h for##2##3##(2008-10#1)(2008-6#1)
24 h in a##2##4##(2008-8#1)(2012-3#1)
24 h in the##2##4##(2008-6#1)(2009-6#1)
24 h in##11##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
24 h later##5##3##(1992-8#1)(1993-12#1)(1994-2#1)(2008-11#1)(2013-7#1)
24 h of exposure to##2##5##(2008-10#1)(2008-7#1)
24 h of exposure##3##4##(2008-10#2)(2008-7#1)
24 h of##17##3##(1990-10#1)(1992-12#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#4)(2012-2#1)
24 h or##2##3##(1995-12#1)(2008-10#1)
24 h period##3##3##(1990-2#1)(2008-10#1)(2013-1#1)
24 h post-mortem##3##3##(2008-7#3)
24 h postinoculation##3##3##(2008-10#3)
24 h posttraining##2##3##(1993-5#2)
24 h prior to##2##4##(1995-12#1)(2008-7#1)
24 h to##2##3##(1996-5#1)(2011-2#1)
24 h urine##2##3##(1997-2#1)(2011-3#1)
24 h when a##2##4##(2008-10#2)
24 h with##4##3##(1995-3#1)(2008-11#2)(2008-7#1)
24 h withdrawal##2##3##(1996-12#2)
24 h##239##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-5#2)(1991-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-12#2)(1993-5#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1995-12#11)(1995-2#1)(1995-3#2)(1995-5#6)(1995-6#1)(1996-12#7)(1996-2#4)(1996-5#2)(1997-2#2)(1997-4#3)(1997-7#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#61)(2008-11#10)(2008-12#7)(2008-2#1)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#18)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
24 h(-1)##2##2##(2008-10#2)
24 h)##6##2##(1997-1#2)(2008-10#2)(2009-3#1)(2012-3#1)
24 healthy##3##2##(1990-5#1)(1996-5#1)(2008-5#1)
24 hour##7##2##(1990-3#1)(1991-12#1)(1993-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2013-8#1)
24 hours after the##2##4##(2007-10#1)(2010-1#1)
24 hours after##10##3##(1990-12#2)(1992-5#1)(2007-10#3)(2010-1#1)(2012-12#2)(2013-1#1)
24 hours before##2##3##(1993-11#1)(2008-10#1)
24 hours following##2##3##(2008-12#1)(2012-12#1)
24 hours later##2##3##(1996-9#1)(2013-1#1)
24 hours of acute food intake##2##6##(2011-1#2)
24 hours of acute food##3##5##(2011-1#3)
24 hours of food deprivation (p &lt##3##7##(2011-1#3)
24 hours of food deprivation##5##5##(2011-1#5)
24 hours of food##6##4##(2011-1#6)
24 hours of##20##3##(1990-5#1)(1992-2#1)(1993-2#1)(2007-10#3)(2007-7#1)(2008-5#1)(2011-1#10)(2011-2#1)(2012-3#1)
24 hours post-infection##3##3##(2008-7#1)(2012-12#2)
24 hours the##2##3##(1992-6#1)(2011-2#1)
24 hours##76##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-9#3)(1997-3#1)(2007-10#12)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#2)(2010-1#1)(2011-1#10)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
24 hours/day##2##2##(2008-7#1)(2012-12#1)
24 hr after##4##3##(1993-9#1)(1994-8#1)(2008-10#1)(2013-1#1)
24 hr##20##2##(1993-9#2)(1994-11#1)(1994-8#2)(1995-2#2)(1996-3#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
24 hrs##7##2##(1992-11#1)(2008-10#4)(2008-12#1)(2010-11#1)
24 human##2##2##(1990-11#1)(1991-5#1)
24 individuals##2##2##(2008-1#1)(2012-3#1)
24 isolates##3##2##(2008-10#3)
24 kDa##3##2##(1992-8#1)(2008-10#2)
24 lines with the##2##4##(2008-10#2)
24 masculineC to 30 masculineC on C##2##7##(2008-6#2)
24 men##2##2##(1994-11#1)(2008-9#1)
24 mg##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
24 mg/cm(2)##2##2##(2009-12#2)
24 mg/kg##3##2##(2008-9#3)
24 min##3##2##(1990-8#1)(2008-10#2)
24 months after surgery##3##4##(1990-6#1)(1992-9#1)(1994-8#1)
24 months after##4##3##(1990-6#1)(1992-9#1)(1994-8#1)(2010-8#1)
24 months later##2##3##(2007-8#1)(2008-4#1)
24 months of##5##3##(1990-3#1)(1991-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
24 months with##2##3##(2007-7#1)(2011-2#1)
24 months##35##2##(1990-3#1)(1990-6#2)(1991-12#2)(1992-9#1)(1993-11#1)(1994-6#2)(1994-8#1)(1995-1#1)(1996-3#1)(1997-9#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-3#1)
24 nM##2##2##(1990-5#1)(1991-5#1)
24 of them##3##3##(2006-10#1)(2008-10#1)(2010-12#1)
24 of##8##2##(1990-12#1)(1995-11#1)(2006-10#1)(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)
24 or 48 h##3##4##(1991-2#1)(2008-10#2)
24 or 48##4##3##(1991-2#1)(2008-10#2)(2008-9#1)
24 or##5##2##(1991-2#1)(2008-10#2)(2008-8#1)(2008-9#1)
24 patients (14##2##3##(2007-11#1)(2007-8#1)
24 patients treated with##2##4##(1993-12#1)(2008-7#1)
24 patients treated##3##3##(1990-6#1)(1993-12#1)(2008-7#1)
24 patients with##8##3##(1992-3#1)(1994-11#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2013-1#1)
24 patients##26##2##(1990-3#1)(1990-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
24 percent##2##2##(2008-11#1)(2008-6#1)
24 points in the##2##4##(2008-3#1)(2011-1#1)
24 proteins##3##2##(1997-6#1)(2007-12#1)(2011-1#1)
24 samples##4##2##(2008-10#4)
24 sites##2##2##(1996-2#1)(2012-6#1)
24 species##2##2##(2008-10#1)(2009-2#1)
24 strains##2##2##(2008-10#1)(2008-6#1)
24 surface esters##2##3##(2010-8#2)
24 to 0##2##3##(2008-10#1)(2008-11#1)
24 to 29##2##3##(1993-12#1)(2008-10#1)
24 to 36##3##3##(1993-3#1)(2008-11#1)(2008-2#1)
24 to 48 h##3##4##(2008-10#3)
24 to 48##5##3##(2008-1#1)(2008-10#3)(2010-12#1)
24 to##23##2##(1990-7#1)(1991-4#1)(1993-12#2)(1993-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
24 vs##2##2##(2008-10#1)(2008-3#1)
24 was##3##2##(1994-12#1)(1996-12#1)(2013-1#1)
24 weeks in##2##3##(2008-10#1)(2008-5#1)
24 weeks of##5##3##(2007-8#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)
24 weeks##15##2##(2007-11#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-8#1)(2009-8#2)(2010-4#2)(2011-2#1)(2012-3#1)(2013-8#1)
24 were##4##2##(1991-8#1)(1996-3#1)(2008-10#2)
24 with##3##2##(1990-11#1)(1990-3#1)(2008-7#1)
24 women##2##2##(2011-2#1)(2013-1#1)
24 years##4##2##(1993-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
24##996##1##(1990-10#2)(1990-11#8)(1990-12#11)(1990-2#2)(1990-3#4)(1990-5#12)(1990-6#3)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#7)(1992-5#1)(1992-6#7)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#4)(1993-3#4)(1993-5#3)(1993-6#3)(1993-8#7)(1993-9#3)(1994-1#2)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#8)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#17)(1995-2#3)(1995-3#4)(1995-5#8)(1995-6#5)(1995-8#3)(1995-9#2)(1996-12#10)(1996-2#11)(1996-3#7)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#4)(1997-6#2)(1997-7#7)(1997-8#2)(1997-9#1)(2006-10#1)(2006-8#1)(2007-10#15)(2007-11#12)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#13)(2007-8#12)(2008-1#10)(2008-10#190)(2008-11#25)(2008-12#27)(2008-2#5)(2008-3#22)(2008-4#5)(2008-5#36)(2008-6#16)(2008-7#44)(2008-8#15)(2008-9#38)(2009-1#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#5)(2010-11#5)(2010-12#6)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#3)(2010-8#10)(2010-9#2)(2011-1#19)(2011-2#32)(2011-3#2)(2012-1#1)(2012-12#15)(2012-2#6)(2012-3#15)(2012-6#1)(2013-1#27)(2013-7#6)(2013-8#13)
24% and##5##2##(1994-6#1)(2007-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
24% at##2##2##(2007-11#1)(2008-11#1)
24% for##3##2##(1990-6#1)(2008-10#2)
24% had##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
24% of the##4##3##(1990-2#1)(1992-6#1)(2008-10#2)
24% of##12##2##(1990-2#1)(1992-6#1)(1994-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2012-1#1)(2012-2#1)
24% were##2##2##(2008-10#1)(2008-11#1)
24%##52##1##(1990-2#1)(1990-6#1)(1990-8#1)(1992-6#1)(1994-2#1)(1994-3#2)(1994-6#1)(1996-9#1)(2007-10#2)(2007-11#3)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#2)
24%)##6##1##(1994-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
24(R##3##1##(1991-5#3)
24) and##5##2##(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
24)##26##1##(1990-11#1)(1990-5#1)(1992-5#1)(1993-2#1)(1995-2#2)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#4)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)
24+/-0##2##1##(2008-10#2)
24- and##2##2##(2007-12#1)(2008-11#1)
24-##4##1##(2007-12#1)(2008-11#2)(2013-1#1)
24-0##2##1##(1993-9#1)(2013-1#1)
24-18-7##3##1##(2008-10#3)
24-25##4##1##(1993-12#1)(1996-2#1)(1996-5#1)(2008-8#1)
24-26##2##1##(2008-8#1)(2011-2#1)
24-27##3##1##(2008-10#1)(2008-11#1)(2009-6#1)
24-29##3##1##(1991-9#1)(1997-7#1)(2008-5#1)
24-35##2##1##(1991-8#1)(1992-3#1)
24-48 h##2##2##(1996-2#1)(2010-11#1)
24-48##3##1##(1994-8#1)(1996-2#1)(2010-11#1)
24-69 years of age##2##4##(2008-12#2)
24-base pair##2##2##(1995-6#2)
24-base##3##1##(1993-2#1)(1995-6#2)
24-bit##2##1##(2008-12#1)(2011-1#1)
24-channel##2##1##(2008-2#2)
24-h exposure##2##2##(2008-10#1)(2011-2#1)
24-h faecal excretion of arsenic##2##5##(1995-11#2)
24-h period##3##2##(1994-8#1)(2008-3#1)(2008-9#1)
24-h urinary excretion of arsenic metabolites##3##6##(1995-11#3)
24-h urinary excretion of both##2##5##(1995-11#2)
24-h urinary excretion of##7##4##(1995-11#7)
24-h##45##1##(1990-12#1)(1990-3#2)(1992-5#1)(1992-8#1)(1994-8#2)(1995-11#11)(1995-12#1)(1997-4#4)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#2)
24-hour PAS##4##2##(1996-1#4)
24-hour control##2##2##(1992-8#2)
24-hour dietary##2##2##(1991-12#1)(2011-1#1)
24-hour period##3##2##(1996-9#1)(2008-3#1)(2013-1#1)
24-hour recall##2##2##(1991-2#1)(2013-1#1)
24-hour##38##1##(1990-11#4)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#4)(1993-11#1)(1994-2#1)(1995-9#3)(1996-1#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-8#2)(2007-10#1)(2008-3#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#4)
24-hr Holter ECG##2##3##(1996-3#2)
24-hr oesophageal pH-metry and Holter ECG monitoring##2##7##(1996-3#2)
24-hr##5##1##(1996-3#4)(2008-10#1)
24-hydroxylase##4##1##(1994-11#4)
24-kDa oleosin##3##2##(2009-10#3)
24-kDa protein##2##2##(1995-6#2)
24-kDa##7##1##(1995-6#2)(1997-4#1)(2008-10#1)(2009-10#3)
24-kilodalton##2##1##(1990-11#2)
24-mer##3##1##(2008-10#3)
24-methylene-24##2##1##(1992-3#2)
24-month##6##1##(2008-4#2)(2012-12#1)(2013-1#3)
24-month-old animals##2##2##(1997-9#1)(2008-3#1)
24-month-old##4##1##(1997-9#1)(2008-3#3)
24-residue DDT-binding##2##2##(1991-9#2)
24-residue##3##1##(1991-9#2)(2008-7#1)
24-week##5##1##(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
24-well plates##2##2##(2007-11#1)(2012-3#1)
24-well##3##1##(2007-11#1)(2008-11#1)(2012-3#1)
24-year-old##8##1##(2007-7#2)(2008-10#1)(2008-9#1)(2010-11#1)(2010-9#1)(2012-2#2)
240 and##2##2##(2007-12#1)(2008-10#1)
240 min##6##2##(1995-11#1)(1996-12#1)(2008-6#1)(2008-7#1)(2010-1#2)
240 nm##2##2##(1995-2#1)(2008-3#1)
240 questionnaires##2##2##(2007-7#1)(2013-1#1)
240 s##2##2##(2008-10#2)
240 to##4##2##(2008-10#2)(2008-2#2)
240##62##1##(1990-5#1)(1990-7#1)(1992-6#1)(1992-8#2)(1994-12#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2009-11#1)(2009-3#1)(2010-1#2)(2010-4#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
240-fs##2##1##(2007-11#2)
240-m distance##2##2##(2008-3#2)
240-s##2##1##(2008-10#1)(2008-2#1)
2400 K##2##2##(2008-2#1)(2008-3#1)
2400 degrees C##2##3##(2008-10#2)
2400 degrees##4##2##(2008-10#4)
2400 grooves/mm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
2400##15##1##(1990-5#2)(1992-11#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2011-2#1)
240nm##2##1##(2008-10#2)
241##12##1##(1990-5#1)(1991-11#1)(1993-9#2)(2007-8#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#3)
242##16##1##(1992-4#1)(1993-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#2)(2013-1#1)
242-nm radiation##2##2##(2007-12#2)
243 in##2##2##(1990-12#1)(1991-3#1)
243##22##1##(1990-11#1)(1990-12#2)(1991-3#1)(1995-5#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
244 patients##2##2##(2007-7#1)(2008-7#1)
244##16##1##(1990-10#3)(1991-1#1)(1991-12#1)(1992-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-1#1)(2010-11#1)(2012-1#1)
245 K##2##2##(2008-10#2)
245 and##2##2##(1994-5#1)(2013-8#1)
245 bp##2##2##(1997-6#1)(1997-8#1)
245 isolates##2##2##(2008-10#2)
245##16##1##(1994-5#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-10#8)(2009-7#2)(2013-1#1)(2013-8#1)
245-310##2##1##(2008-10#2)
2450##3##1##(2008-12#1)(2008-3#1)(2010-8#1)
246 amino acid##2##3##(1990-7#1)(1993-11#1)
246##14##1##(1990-7#1)(1993-11#3)(1995-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2011-2#1)
247##14##1##(1991-5#1)(1993-11#1)(1994-3#1)(1997-4#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-8#2)(2011-2#1)(2013-1#1)
248 nm##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
248 patients##2##2##(2008-10#1)(2011-1#1)
248##21##1##(1990-5#1)(1994-12#1)(1996-6#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#2)(2011-1#2)(2013-8#1)
249 bp AT rich region##2##5##(2008-8#2)
249##17##1##(1991-11#5)(1992-6#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-3#1)
24D##2##1##(2010-8#2)
24L##2##1##(2010-8#2)
24a and 24b##2##3##(1995-3#1)(1996-5#1)
24c##3##1##(1996-5#3)
24h after##2##2##(2008-12#1)(2012-2#1)
24h in##2##2##(2008-10#2)
24h of##2##2##(2008-10#2)
24h##25##1##(1990-11#1)(1993-6#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-7#1)(2009-4#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)
24th##6##1##(1993-8#1)(1994-3#1)(1995-8#2)(1996-11#1)(2008-4#1)
24 h##2##1##(2010-4#1)(2012-1#1)
24 h##2##1##(2012-7#1)(2013-1#1)
24 hours post##4##2##(2013-1#4)
25 % of the##2##4##(2011-2#1)(2013-1#1)
25 % of##4##3##(2009-1#1)(2011-2#2)(2013-1#1)
25 %##5##2##(2009-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
25 (OH) vitamin D were##2##5##(2013-1#2)
25 (OH) vitamin D##6##4##(2012-3#4)(2013-1#2)
25 (OH)##10##2##(2012-3#8)(2013-1#2)
25 (OH)2-vitamin D3##2##3##(1992-12#2)
25 (environmental)##3##2##(1997-4#3)
25 +/- 0##6##3##(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
25 +/- 1##4##3##(2008-1#1)(2008-6#1)(2011-2#2)
25 +/- 2##2##3##(2008-10#1)(2008-7#1)
25 +/-##17##2##(1993-8#1)(1994-7#1)(1996-2#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#3)
25 -##5##2##(2011-1#5)
25 000##2##2##(2008-10#1)(2013-8#1)
25 A resolution##2##3##(1992-8#2)
25 A##3##2##(1992-8#2)(2008-10#1)
25 Gy##3##2##(2008-11#2)(2008-6#1)
25 M sodium##2##3##(1996-5#1)(2008-10#1)
25 M##10##2##(1991-7#1)(1992-6#1)(1995-2#3)(1996-5#1)(2008-10#4)
25 V (vs##2##3##(2008-10#2)
25 V##3##2##(2008-10#3)
25 adult patients##2##3##(2007-8#1)(2008-9#1)
25 amino acids##2##3##(1991-8#1)(2008-8#1)
25 amino##3##2##(1990-12#1)(1991-8#1)(2008-8#1)
25 and 0##8##3##(1991-2#1)(2008-10#5)(2008-5#1)(2012-12#1)
25 and 1##2##3##(2008-1#1)(2008-10#1)
25 and 100##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
25 and 12##2##3##(2008-11#1)(2009-12#1)
25 and 26##2##3##(1992-12#1)(2008-10#1)
25 and 30##6##3##(1993-12#5)(2008-12#1)
25 and 37 degrees C were##2##6##(1992-6#1)(2008-10#1)
25 and 37 degrees C##3##5##(1992-6#1)(2008-10#2)
25 and 50 mg/kg##2##4##(2008-9#1)(2010-1#1)
25 and 50##4##3##(1993-3#1)(2008-12#1)(2008-9#1)(2010-1#1)
25 and##60##2##(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#5)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2010-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
25 cases and##2##3##(1995-5#1)(2010-9#1)
25 cases of##2##3##(2007-7#1)(2008-10#1)
25 cases##7##2##(1990-6#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-9#1)
25 cm##5##2##(2008-10#4)(2013-8#1)
25 dB##2##2##(2007-12#1)(2008-2#1)
25 days##8##2##(2007-6#1)(2008-10#4)(2008-5#1)(2008-7#2)
25 degrees C and##26##4##(1995-5#1)(2008-10#20)(2008-3#1)(2008-5#2)(2008-6#1)(2011-1#1)
25 degrees C are##4##4##(2008-10#4)
25 degrees C but##2##4##(2008-10#2)
25 degrees C by##5##4##(2008-10#5)
25 degrees C for##6##4##(2006-11#1)(2008-10#4)(2008-6#1)
25 degrees C in the##4##5##(1990-7#1)(1995-11#1)(2008-10#2)
25 degrees C in##7##4##(1990-7#1)(1995-11#1)(2008-10#5)
25 degrees C is##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
25 degrees C was##2##4##(2008-10#1)(2008-5#1)
25 degrees C were##5##4##(1993-8#1)(2008-10#3)(2008-11#1)
25 degrees C##178##3##(1990-10#1)(1990-12#1)(1990-7#3)(1990-8#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-8#2)(1994-3#2)(1995-11#1)(1995-5#4)(1996-5#1)(1997-2#1)(1997-7#1)(2006-11#1)(2008-10#124)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#7)(2009-6#1)(2009-7#2)(2010-4#1)(2011-1#1)(2013-8#1)
25 degrees C) in##2##4##(1997-7#1)(2008-10#1)
25 degrees C)##13##3##(1995-5#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-4#1)
25 degrees##199##2##(1990-10#1)(1990-12#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#1)(1992-5#1)(1993-8#2)(1994-3#2)(1995-11#1)(1995-5#5)(1996-5#1)(1997-2#1)(1997-7#2)(2006-11#1)(2007-8#1)(2008-10#133)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#1)(2009-6#1)(2009-7#2)(2010-4#1)(2011-1#1)(2013-8#1)
25 different##2##2##(2010-11#1)(2012-1#1)
25 dihydroxyvitamin##2##2##(1992-3#1)(2008-7#1)
25 eggs##2##2##(1991-4#1)(2008-9#1)
25 ethnic groups##2##3##(2008-9#2)
25 female##2##2##(1997-8#1)(2013-7#1)
25 fold##2##2##(1993-8#1)(1997-2#1)
25 for##2##2##(2008-10#1)(2010-3#1)
25 g##5##2##(2008-10#2)(2008-5#1)(2009-7#1)(2013-1#1)
25 h##2##2##(2008-10#1)(2008-3#1)
25 h(-1)##2##2##(2008-10#2)
25 had##4##2##(1994-12#1)(1996-3#1)(2008-8#1)(2011-2#1)
25 healthy##2##2##(2008-5#1)(2012-1#1)
25 hours##2##2##(1993-8#1)(2011-2#1)
25 in##4##2##(2008-10#2)(2008-5#1)(2009-8#1)
25 is##2##2##(2008-10#1)(2008-3#1)
25 isolates##2##2##(2008-10#1)(2008-5#1)
25 kDa##7##2##(1992-8#2)(1993-2#1)(1995-12#1)(1997-7#1)(2008-11#2)
25 kGy##3##2##(1997-4#1)(2008-10#2)
25 kV##4##2##(2008-10#3)(2008-2#1)
25 kb##2##2##(2008-8#2)
25 m##2##2##(2008-10#1)(2008-3#1)
25 mL##3##2##(1993-1#1)(2008-10#2)
25 mM borate buffer##2##4##(1996-5#1)(2008-10#1)
25 mM##14##2##(1993-12#2)(1995-8#1)(1996-5#1)(2008-10#9)(2008-5#1)
25 mW of##2##3##(2007-11#1)(2008-3#1)
25 mW##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
25 mg DBTC/L##3##3##(2008-10#3)
25 mg l(-1)##2##3##(2008-10#2)
25 mg##12##2##(1991-9#1)(2008-10#7)(2010-7#1)(2011-2#2)(2012-2#1)
25 mg/0##2##2##(2011-2#2)
25 mg/kg males##3##3##(2008-9#3)
25 mg/kg per##2##3##(1994-6#1)(1995-12#1)
25 mg/kg##8##2##(1992-12#1)(1994-6#2)(1995-12#2)(2008-9#3)
25 mg/l##2##2##(2008-7#1)(2011-1#1)
25 microg##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
25 microg/L##2##2##(2007-11#1)(2011-1#1)
25 microg/ml##2##2##(1997-7#1)(2008-1#1)
25 micrograms##2##2##(1991-12#1)(1995-5#1)
25 micrograms/ml##2##2##(1990-2#1)(1992-8#1)
25 microm##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
25 microm)##2##2##(2008-8#1)(2011-1#1)
25 microns##2##2##(1991-2#1)(1996-12#1)
25 million##3##2##(1993-6#1)(2008-10#1)(2009-10#1)
25 min##11##2##(1991-2#1)(1993-1#1)(1993-2#1)(1994-3#1)(1997-2#1)(2008-10#5)(2008-7#1)
25 ml of##4##3##(2008-10#4)
25 ml##12##2##(2008-10#11)(2011-1#1)
25 mm calibration and its##2##5##(2013-1#2)
25 mm calibration##3##3##(2013-1#3)
25 mm##15##2##(1990-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)(2013-1#6)
25 mol l(-1) Na(2)SO(4)##2##4##(2008-10#2)
25 mol l(-1)##5##3##(2008-10#5)
25 months##5##2##(1990-12#1)(1991-8#1)(1997-3#1)(1997-5#1)(2008-7#1)
25 ms##2##2##(1992-11#1)(1993-3#1)
25 mu##2##2##(2008-10#1)(2008-11#1)
25 muM##4##2##(2008-10#3)(2008-11#1)
25 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
25 mug##9##2##(2008-10#6)(2008-11#1)(2008-9#1)(2010-2#1)
25 mum##9##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
25 nM)##2##2##(1991-11#1)(2009-12#1)
25 ng ml(-1)##2##3##(2008-10#2)
25 ng/ml##2##2##(1996-5#1)(2008-10#1)
25 nm and 0##2##4##(2008-3#2)
25 nm and##3##3##(2008-3#3)
25 nm in##2##3##(2008-10#1)(2008-3#1)
25 nm resolution##2##3##(2008-8#1)(2008-9#1)
25 nm##16##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#6)(2008-8#4)(2008-9#1)(2009-5#2)
25 normal##2##2##(1993-12#1)(2008-7#1)
25 of the##2##3##(1996-12#1)(2013-1#1)
25 of them##2##3##(1992-8#1)(2007-7#1)
25 of which were##2##4##(2008-10#1)(2012-2#1)
25 of##11##2##(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
25 or 50##2##3##(2008-10#1)(2008-5#1)
25 or##4##2##(2008-10#3)(2008-5#1)
25 out of##2##3##(2007-11#1)(2013-1#1)
25 patients of##2##3##(2008-3#1)(2012-3#1)
25 patients or more##3##4##(2011-2#3)
25 patients with##5##3##(2007-11#1)(2008-1#1)(2008-7#3)
25 patients##29##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-2#1)(2007-11#2)(2007-8#2)(2008-1#2)(2008-3#1)(2008-7#4)(2011-2#9)(2012-3#1)
25 per##3##2##(1990-3#1)(1994-7#1)(2011-2#1)
25 percent of the##3##4##(1991-5#1)(1994-6#1)(2007-12#1)
25 percent of##7##3##(1991-5#1)(1993-2#1)(1994-6#1)(1996-3#1)(1997-1#2)(2007-12#1)
25 percent##10##2##(1991-5#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-1#2)(2007-12#1)(2008-6#1)
25 ppm##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
25 randomly selected##3##3##(1993-12#2)(2008-10#1)
25 samples per hour##3##4##(2008-10#3)
25 samples per##4##3##(2008-10#4)
25 samples##9##2##(2008-10#9)
25 sites##2##2##(2008-2#1)(2008-8#1)
25 species of##2##3##(2008-10#1)(2008-5#1)
25 species##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
25 strains##2##2##(2008-1#1)(2008-10#1)
25 times##2##2##(2008-11#1)(2008-2#1)
25 to 1##2##3##(2008-10#1)(2011-1#1)
25 to 30##3##3##(2008-10#2)(2008-11#1)
25 to 35 degrees C##2##5##(2008-10#2)
25 to 35##5##3##(2008-10#2)(2013-1#3)
25 to 5##2##3##(1991-8#1)(2008-10#1)
25 to##37##2##(1991-12#1)(1991-8#1)(1993-3#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#3)(2013-1#3)(2013-8#1)
25 weeks##3##2##(1996-5#1)(1997-2#1)(2008-10#1)
25 were##3##2##(1990-6#1)(1991-12#1)(2013-8#1)
25 with##3##2##(2007-2#1)(2008-1#1)(2008-10#1)
25 x 10(-5)##2##3##(1990-8#1)(1992-6#1)
25 x##11##2##(1990-8#1)(1992-6#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2013-8#1)
25 years ago##3##3##(1996-3#1)(2008-5#1)(2009-3#1)
25 years##37##2##(1992-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
25 years)##2##2##(2008-5#1)(2013-1#1)
25##1172##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#4)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#7)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#12)(1993-2#5)(1993-3#3)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#5)(1994-7#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#7)(1995-2#5)(1995-3#3)(1995-5#10)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#2)(1997-4#8)(1997-5#4)(1997-7#7)(1997-8#5)(2006-11#1)(2007-10#2)(2007-11#16)(2007-12#15)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#10)(2008-1#18)(2008-10#371)(2008-11#32)(2008-12#20)(2008-2#18)(2008-3#40)(2008-4#3)(2008-5#39)(2008-6#12)(2008-7#34)(2008-8#28)(2008-9#33)(2009-1#3)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#22)(2011-2#41)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#22)(2013-1#39)(2013-7#4)(2013-8#12)
25% (v/v)##4##2##(2008-10#4)
25% and 27%##2##3##(1996-12#1)(2008-2#1)
25% and the##2##3##(1991-8#1)(2008-11#1)
25% and##12##2##(1991-8#1)(1993-9#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)
25% at##4##2##(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)
25% bupivacaine##2##2##(2007-8#1)(2008-7#1)
25% for both##2##3##(2008-2#1)(2008-9#1)
25% for##4##2##(2008-2#1)(2008-9#1)(2010-6#1)(2011-2#1)
25% from##2##2##(2007-12#1)(2008-3#1)
25% higher##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
25% in the##4##3##(1990-12#1)(1993-11#1)(1997-4#1)(2008-10#1)
25% in##10##2##(1990-12#1)(1992-2#1)(1993-11#1)(1997-4#1)(2008-10#2)(2008-7#2)(2008-8#1)(2013-1#1)
25% licorice extract##2##3##(2008-5#2)
25% lower##2##2##(1994-2#1)(2008-5#1)
25% of all##5##3##(1992-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
25% of cases##4##3##(2007-8#1)(2008-7#1)(2010-3#1)(2011-2#1)
25% of patients##4##3##(1991-8#1)(2008-5#1)(2008-8#1)(2012-12#1)
25% of the cases##2##4##(1992-6#1)(1995-8#1)
25% of the cells##2##4##(1994-8#1)(2008-11#1)
25% of the phenotypic##2##4##(2008-10#1)(2008-8#1)
25% of the total##2##4##(2008-5#2)
25% of the##26##3##(1990-8#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-8#1)(1997-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2013-1#1)
25% of##55##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-8#1)(1997-9#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2009-5#1)(2010-2#1)(2010-3#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
25% on##2##2##(2008-3#1)(2010-1#1)
25% or##2##2##(2008-5#1)(2012-12#1)
25% pentaerythritol triacrylate when the approximately##2##6##(2008-9#2)
25% suppressive soil##2##3##(2008-10#2)
25% to##5##2##(1994-2#1)(2007-10#1)(2008-1#1)(2008-7#1)(2012-3#1)
25% were##6##2##(1992-12#1)(2007-12#1)(2008-6#1)(2010-1#1)(2011-2#1)(2013-8#1)
25% with##2##2##(2008-10#1)(2011-2#1)
25%##227##1##(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-1#4)(2008-10#41)(2008-11#7)(2008-12#5)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#7)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#9)(2013-8#2)
25%) and##4##2##(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)
25%) of the##2##3##(2006-4#1)(2008-5#1)
25%)##20##1##(1991-8#1)(2006-4#1)(2007-12#1)(2008-1#4)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
25(OH)(2)D(3)##3##1##(2008-11#3)
25(OH)2 vitamin D3##2##3##(1991-12#1)(1997-7#1)
25(OH)2D##5##1##(1994-11#5)
25(OH)2D3 and##2##2##(1990-11#1)(1995-2#1)
25(OH)2D3 in##2##2##(1990-11#1)(1995-2#1)
25(OH)2D3 on##2##2##(1990-2#1)(1992-1#1)
25(OH)2D3 or##3##2##(1990-11#3)
25(OH)2D3 receptor##2##2##(1992-12#2)
25(OH)2D3##31##1##(1990-11#11)(1990-2#3)(1992-1#2)(1992-12#3)(1993-6#2)(1995-12#4)(1995-2#2)(1997-1#4)
25(OH)2D3)##4##1##(1992-1#1)(1992-12#1)(1995-12#1)(1997-1#1)
25(OH)2D3]##2##1##(1992-12#1)(1995-2#1)
25(OH)D concentration##2##2##(2011-2#2)
25(OH)D level##2##2##(2011-1#2)
25(OH)D levels##6##2##(2011-1#5)(2011-2#1)
25(OH)D##11##1##(2011-1#7)(2011-2#4)
25)##18##1##(1993-6#1)(1993-9#2)(1994-5#1)(1996-7#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
25)0##2##1##(2008-3#2)
25+/-0##7##1##(2008-10#6)(2008-5#1)
25+0##2##1##(2008-10#2)
25- and##3##2##(2008-10#1)(2008-3#2)
25-##4##1##(1993-11#1)(2008-10#1)(2008-3#2)
25-(OH)(2)-D(3)##2##1##(2008-10#2)
25-(OH)2-D3##2##1##(1991-5#2)
25-(OH)2D3 formation##2##2##(1994-3#2)
25-(OH)2D3##6##1##(1993-8#1)(1994-3#4)(1994-9#1)
25-0##9##1##(1992-8#1)(1994-11#1)(1994-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#2)
25-1##3##1##(1995-12#1)(2008-10#1)(2008-12#1)
25-100##3##1##(1993-8#1)(2008-10#2)
25-2##2##1##(2008-10#1)(2008-3#1)
25-200##2##1##(1995-8#1)(2008-10#1)
25-25##2##1##(2008-10#2)
25-26##2##1##(1997-8#1)(2007-8#1)
25-29 years##2##2##(1991-2#1)(2008-7#1)
25-3##2##1##(1992-11#1)(2008-10#1)
25-30 samples##2##2##(2008-10#2)
25-30##7##1##(1990-8#1)(1996-5#2)(2008-10#2)(2008-11#1)(2012-2#1)
25-30%##2##1##(2008-3#1)(2008-5#1)
25-300##3##1##(2008-10#3)
25-35##5##1##(1994-11#1)(1995-5#1)(2008-10#2)(2008-7#1)
25-36##2##1##(2008-1#1)(2008-12#1)
25-4##2##1##(2008-10#2)
25-40##2##1##(1990-12#1)(2011-2#1)
25-40%##3##1##(2008-11#1)(2011-2#1)(2013-7#1)
25-5##3##1##(1996-5#1)(2008-10#2)
25-50##3##1##(2011-2#3)
25-50% of the##2##3##(1993-3#1)(2008-10#1)
25-50%##5##1##(1993-3#1)(1993-9#1)(1995-11#1)(2008-10#1)(2008-3#1)
25-500 ng ml(-1)##2##3##(2008-10#2)
25-55##2##1##(1997-4#1)(2013-1#1)
25-75##2##1##(2008-10#1)(2008-3#1)
25-OH vitamin D levels among##2##5##(2012-12#2)
25-OH vitamin D levels##5##4##(2012-12#5)
25-OH vitamin D##6##3##(2012-12#6)
25-W##2##1##(2007-9#1)(2008-10#1)
25-bp##2##1##(1990-11#1)(2008-10#1)
25-dihydrolanosterol##4##1##(1992-3#4)
25-dihydroxy-vitamin##2##1##(1997-1#2)
25-dihydroxyvitamin D##2##2##(1994-11#1)(2008-1#1)
25-dihydroxyvitamin D(3)##4##2##(2008-11#1)(2008-4#2)(2012-12#1)
25-dihydroxyvitamin D-24-hydroxylase##2##2##(1994-11#2)
25-dihydroxyvitamin D3 (1##5##3##(1992-1#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-12#1)
25-dihydroxyvitamin D3 receptor in a bacterial expression system##2##8##(1992-12#2)
25-dihydroxyvitamin D3 receptor##9##3##(1990-12#2)(1992-12#4)(1993-3#3)
25-dihydroxyvitamin D3##22##2##(1990-12#3)(1992-1#1)(1992-12#5)(1993-3#5)(1994-11#1)(1994-3#1)(1994-9#2)(1995-12#2)(1995-2#1)(2008-11#1)
25-dihydroxyvitamin##31##1##(1990-12#3)(1992-1#1)(1992-12#5)(1993-3#6)(1994-11#4)(1994-3#1)(1994-9#2)(1995-12#2)(1995-2#1)(2008-1#1)(2008-11#2)(2008-4#2)(2012-12#1)
25-fold in##2##2##(1993-9#1)(1995-8#1)
25-fold increase in##2##3##(1993-12#1)(1995-2#1)
25-fold lower##2##2##(1996-2#1)(2008-10#1)
25-fold##13##1##(1990-5#1)(1993-12#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#5)
25-hydroxyvitamin D##6##2##(2008-1#1)(2011-1#1)(2011-2#2)(2012-2#2)
25-hydroxyvitamin D3##2##2##(1995-12#1)(2008-1#1)
25-hydroxyvitamin##9##1##(1995-12#1)(2008-1#2)(2008-10#1)(2011-1#1)(2011-2#2)(2012-2#2)
25-kDa fragment##2##2##(1993-11#1)(1995-6#1)
25-kDa##4##1##(1993-11#2)(1995-6#1)(2008-10#1)
25-microm##2##1##(2007-11#1)(2007-12#1)
25-mum##2##1##(2007-11#1)(2008-3#1)
25-year period##2##2##(2008-10#1)(2008-7#1)
25-year##7##1##(1995-3#1)(1996-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
25-year-old##10##1##(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
250 Hz##6##2##(2006-12#4)(2007-11#1)(2011-2#1)
250 K##2##2##(2008-3#2)
250 and 500##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
250 and##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
250 days##2##2##(1997-6#1)(2008-10#1)
250 degrees C and##2##4##(2008-10#1)(2011-1#1)
250 degrees C##7##3##(2007-12#1)(2008-10#4)(2011-1#2)
250 g##2##2##(2008-10#1)(2010-2#1)
250 kb downstream from c-myc##2##5##(1993-2#2)
250 kb##3##2##(1993-2#2)(2008-8#1)
250 mM##2##2##(1991-5#1)(1993-9#1)
250 mW of##2##3##(2007-11#1)(2008-3#1)
250 mW##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
250 mg l(-1)##3##3##(2008-10#3)
250 mg##7##2##(1996-3#1)(2008-10#4)(2008-12#1)(2008-5#1)
250 mg/dl##3##2##(1990-2#3)
250 microM mipafox)##2##3##(1996-12#2)
250 microg##2##2##(2011-2#2)
250 micrograms/g liver##2##3##(1995-3#2)
250 micrograms/kg##2##2##(1994-8#2)
250 ml sample volume##2##4##(2008-10#2)
250 ml sample##3##3##(2008-10#3)
250 ml##7##2##(2008-10#7)
250 mm##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
250 muM##2##2##(2008-6#2)
250 mug/ml##2##2##(2008-11#1)(2008-5#1)
250 nm and##2##3##(2008-10#2)
250 nm##4##2##(1996-2#1)(2007-11#1)(2008-10#2)
250 occupations##3##2##(1991-1#1)(1993-1#1)(1995-1#1)
250 or##2##2##(2008-5#1)(2008-9#1)
250 ppm##2##2##(2008-10#1)(2008-8#1)
250 to##8##2##(1994-3#1)(2008-10#4)(2008-2#2)(2013-8#1)
250##333##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#4)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#3)(1991-8#5)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#4)(1992-6#8)(1992-9#1)(1993-1#2)(1993-11#7)(1993-12#10)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#8)(1993-9#5)(1994-1#1)(1994-12#3)(1994-2#10)(1994-3#4)(1994-5#16)(1994-6#1)(1994-8#5)(1995-1#1)(1995-11#1)(1995-2#13)(1995-3#5)(1995-5#16)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-12#4)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#48)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#9)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#8)(2008-9#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#3)
250%##2##1##(1996-12#1)(1996-2#1)
250-300##2##1##(2008-10#1)(2008-12#1)
250-GHz##2##1##(2007-9#2)
250-fold##5##1##(1991-12#1)(2008-10#3)(2010-3#1)
2500##21##1##(1991-2#1)(1994-3#2)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2010-11#1)(2013-1#2)
250mugl(-1)##3##1##(2008-10#3)
251##12##1##(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2013-1#1)
252##11##1##(1990-6#1)(1992-8#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)
253##14##1##(1990-8#2)(1991-2#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#3)
254 nm and##2##3##(2008-10#1)(2011-1#1)
254 nm##10##2##(1990-8#1)(1995-2#1)(1996-5#1)(2008-10#5)(2009-8#1)(2011-1#1)
254##18##1##(1990-8#1)(1995-2#1)(1996-5#1)(2008-10#8)(2008-11#2)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
254nm##5##1##(2008-10#4)(2011-2#1)
255##19##1##(1990-9#1)(1991-11#1)(1991-3#1)(1993-8#1)(1993-9#1)(1995-8#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
256 mg/kg females##5##3##(2008-9#5)
256 mg/kg males and##3##4##(2008-9#3)
256 mg/kg males##7##3##(2008-9#7)
256 mg/kg##13##2##(2008-9#13)
256 patients##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
256 x##3##2##(1997-8#1)(2008-3#2)
256##37##1##(1990-6#1)(1992-5#1)(1993-11#1)(1993-8#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#16)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
257 patients##3##2##(1996-11#1)(1997-2#1)(2011-2#1)
257##20##1##(1991-12#3)(1992-11#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
258 +/-##2##2##(1995-12#1)(1996-1#1)
258 bp##2##2##(1991-12#1)(2011-2#1)
258##21##1##(1990-10#1)(1990-12#1)(1991-12#1)(1991-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#2)(2008-10#2)(2008-6#1)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#2)(2013-8#1)
259##10##1##(1991-5#1)(1991-8#1)(1992-9#1)(1993-8#1)(1995-6#1)(1997-6#2)(1997-8#1)(2008-1#1)(2008-5#1)
2596 and##3##2##(2008-10#3)
2596##5##1##(2008-10#5)
25D##7##1##(2008-7#2)(2011-2#1)(2012-12#4)
25D)##2##1##(2008-7#1)(2012-12#1)
25D-induced differentiation of##2##3##(2012-12#2)
25D-induced##3##1##(2012-12#3)
25M##2##1##(2008-10#2)
25h(-1)##3##1##(2008-10#3)
25kV##2##1##(2008-10#2)
25mL##4##1##(2008-10#4)
25mM##3##1##(2008-10#2)(2011-2#1)
25mg of##4##2##(2008-10#4)
25mg##5##1##(2008-10#4)(2010-7#1)
25mgL(-1)##3##1##(2008-10#2)(2012-1#1)
25mgl(-1)##2##1##(2008-10#2)
25min##2##1##(2008-10#2)
25ml of##2##2##(2008-10#2)
25ml##5##1##(2008-10#5)
25mug##3##1##(2008-10#3)
25mug/ml##2##1##(2008-10#2)
25mugL(-1)##2##1##(2008-10#2)
25mugl(-1) of##2##2##(2008-10#2)
25mugl(-1)##5##1##(2008-10#5)
25ngml(-1)##3##1##(2008-10#3)
25ppb##2##1##(2008-10#2)
25th##4##1##(1991-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
25x10(-5)##3##1##(2008-10#3)
26 +/- 0##2##3##(1997-2#1)(2012-3#1)
26 +/- 1##2##3##(1995-11#1)(2012-3#1)
26 +/-##5##2##(1995-11#1)(1997-2#1)(2008-1#1)(2012-3#2)
26 V##2##2##(2008-10#2)
26 X##2##2##(1991-12#1)(2008-10#1)
26 and 0##3##3##(1994-8#1)(2008-10#1)(2011-1#1)
26 and##14##2##(1991-6#1)(1994-8#1)(1996-11#1)(1996-5#1)(2007-11#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
26 boys##2##2##(2007-11#1)(2007-8#1)
26 cases##5##2##(1990-9#1)(1996-11#2)(2007-11#1)(2012-3#1)
26 days##3##2##(1991-6#1)(2008-11#1)(2012-2#1)
26 degrees C as##2##4##(1997-6#1)(2008-10#1)
26 degrees C##6##3##(1997-6#1)(2008-10#5)
26 dogs##2##2##(2008-12#1)(2011-2#1)
26 horses##2##2##(1991-6#2)
26 in##3##2##(1990-12#1)(2007-7#1)(2011-2#1)
26 kDa##3##2##(1993-12#1)(1996-11#1)(2009-9#1)
26 mAbs##2##2##(1997-6#2)
26 mM##2##2##(1991-12#1)(1991-8#1)
26 months after##2##3##(2007-8#1)(2011-2#1)
26 months)##3##2##(1992-12#1)(2008-3#1)(2012-2#1)
26 mum and##3##3##(2007-12#1)(2008-2#2)
26 mum##4##2##(2007-12#2)(2008-2#2)
26 nM##2##2##(1990-5#1)(1995-3#1)
26 neurons##4##2##(1991-2#1)(1993-12#3)
26 of the##2##3##(1992-12#1)(1997-8#1)
26 of them##2##3##(1996-6#1)(1997-7#1)
26 of##5##2##(1992-12#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-9#1)
26 or##13##2##(2008-10#1)(2008-9#12)
26 patients treated with##2##4##(1992-6#1)(2006-10#1)
26 patients treated##4##3##(1992-6#1)(2006-10#1)(2007-11#1)(2008-6#1)
26 patients were##2##3##(1997-8#1)(2008-8#1)
26 patients who##2##3##(1995-2#1)(2009-10#1)
26 patients with##6##3##(1990-2#1)(1991-4#1)(1992-11#1)(1992-8#1)(2007-10#1)(2007-11#1)
26 patients##26##2##(1990-2#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-9#2)(1995-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#3)
26 s##2##2##(2007-12#1)(2013-1#1)
26 to 1##2##3##(1993-9#1)(2008-10#1)
26 to##9##2##(1993-9#1)(1995-3#1)(2007-12#1)(2008-10#5)(2012-2#1)
26 weeks and##3##3##(2008-9#3)
26 weeks of##2##3##(1995-2#1)(2008-7#1)
26 weeks##30##2##(1992-2#1)(1995-2#1)(2007-10#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#20)(2010-11#1)
26 were##5##2##(1995-12#1)(1995-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
26 with##4##2##(1991-3#1)(1992-11#1)(2007-10#2)
26 women##2##2##(2011-2#2)
26 year old##2##3##(1997-4#1)(2010-12#1)
26 years old##2##3##(2012-2#1)(2013-1#1)
26 years##7##2##(1992-12#1)(1993-11#1)(1994-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
26##440##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#4)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#4)(1993-12#7)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-12#6)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#6)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-4#3)(1997-6#3)(1997-7#4)(1997-8#2)(2006-10#1)(2007-10#7)(2007-11#12)(2007-12#5)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#61)(2008-11#9)(2008-12#9)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#41)(2009-10#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#9)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#16)(2013-8#6)
26% and##4##2##(1993-8#1)(1994-11#1)(2007-7#1)(2008-1#1)
26% for##2##2##(1994-6#1)(2013-1#1)
26% in the##2##3##(1994-6#1)(2010-4#1)
26% of the##10##3##(1993-2#1)(1995-2#1)(1995-8#1)(1996-1#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)
26% of##20##2##(1993-2#1)(1995-2#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-1#2)(2011-2#1)(2012-12#1)
26% reported##2##2##(2007-11#1)(2010-8#1)
26%##58##1##(1990-11#1)(1991-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#2)(1995-2#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
26%)##6##1##(1994-6#2)(2008-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
26) in the##2##3##(1990-5#1)(2011-2#1)
26)##18##1##(1990-2#1)(1990-5#2)(1992-10#1)(1993-12#1)(1994-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
26+/-0##3##1##(2007-11#1)(2008-10#2)
26- AND 41-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
26- AND 41-WEEK GAVAGE STUDIES IN##2##6##(2008-9#2)
26- AND 41-WEEK##4##3##(2008-9#4)
26- AND 42-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
26- AND##7##2##(2008-9#7)
26- and 39-WEEK DERMAL STUDIES IN Tg##2##7##(2008-9#2)
26-##9##1##(2008-9#9)
26-0##4##1##(1992-2#1)(1995-2#1)(1997-8#1)(2008-7#1)
26-2-1a##2##1##(2008-10#2)
26-27##2##1##(1993-12#1)(2008-6#1)
26-28##2##1##(1993-2#1)(2008-11#1)
26-29##5##1##(1994-5#1)(2008-5#1)(2008-8#2)(2010-8#1)
26-30##2##1##(1993-6#1)(2008-2#1)
26-fold##2##1##(1995-11#2)
26-kDa##3##1##(1996-5#1)(2008-10#2)
26-month-old rats than in##2##4##(1991-12#2)
26-month-old##4##1##(1991-12#4)
26-week##4##1##(2008-9#3)(2012-1#1)
26-year-old man presented with##2##4##(2008-7#1)(2010-1#1)
26-year-old man##3##2##(2008-12#1)(2008-7#1)(2010-1#1)
26-year-old woman##3##2##(1994-12#1)(2007-7#1)(2009-10#1)
26-year-old##9##1##(1990-3#1)(1993-3#1)(1994-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-6#1)
260 days##2##2##(1991-8#2)
260 mg##2##2##(1997-4#1)(2008-10#1)
260 nm##4##2##(1992-12#1)(1992-8#1)(2008-10#1)(2011-1#1)
260 patients with##2##3##(1991-2#1)(2007-11#1)
260 patients##5##2##(1991-2#1)(1993-2#1)(2007-11#1)(2008-7#1)(2010-8#1)
260##39##1##(1990-2#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#1)(1995-12#2)(1995-8#1)(1996-2#2)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#6)(2012-2#1)
2600##2##1##(1994-5#1)(2008-7#1)
261 patients##2##2##(1990-8#1)(2012-2#1)
261##10##1##(1990-5#1)(1990-8#1)(1992-9#1)(1995-1#1)(2008-10#3)(2008-7#1)(2012-2#1)(2012-3#1)
262 HCC cases##2##3##(2013-8#2)
262##12##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-9#1)(1993-10#1)(1994-8#1)(2008-3#2)(2008-9#1)(2013-7#1)(2013-8#2)
263 patients##2##2##(1990-9#1)(2008-3#1)
263##18##1##(1990-11#1)(1990-5#2)(1990-9#1)(1991-8#2)(1992-4#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)
264##28##1##(1990-7#1)(1990-8#1)(1991-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-6#2)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#3)(2013-8#1)
265##18##1##(1990-11#1)(1990-8#1)(1991-12#2)(1992-6#2)(1993-3#1)(1993-6#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2010-8#1)(2012-1#1)(2013-1#1)
266 nm##11##2##(1994-5#1)(2008-2#1)(2008-3#6)(2012-2#3)
266##29##1##(1991-6#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2011-2#1)(2012-2#3)
266-nm##7##1##(2007-11#1)(2007-12#4)(2008-3#2)
266nm##2##1##(2008-10#2)
267 to##2##2##(1990-11#1)(2008-2#1)
267##17##1##(1990-11#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)
267)##2##1##(2013-1#1)(2013-7#1)
268 and##3##2##(1997-3#2)(2012-12#1)
268##17##1##(1993-3#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-6#1)(1997-3#2)(1997-6#1)(2006-10#1)(2008-2#2)(2009-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
268)##2##1##(1994-2#1)(2013-7#1)
269##10##1##(1990-6#1)(1991-7#1)(1994-11#2)(1994-9#1)(1995-6#1)(1997-2#1)(2007-5#1)(2008-10#1)(2011-1#1)
2692##2##1##(2008-10#1)(2008-12#1)
26S proteasome##3##2##(1993-9#1)(2008-4#2)
26S##5##1##(1993-9#1)(2008-4#3)(2008-5#1)
26th##3##1##(1992-3#1)(2010-5#1)(2012-2#1)
27 %##2##2##(2012-12#1)(2012-2#1)
27 +/- 0##5##3##(1996-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
27 +/- 7##2##3##(1997-2#1)(2008-1#1)
27 +/-##9##2##(1994-6#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
27 and 0##2##3##(2008-10#1)(2013-7#1)
27 and 29##2##3##(1991-1#1)(2010-3#1)
27 and##15##2##(1991-1#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-2#2)(2013-7#1)
27 cases##5##2##(1990-8#1)(1997-3#1)(1997-8#1)(2008-6#2)
27 children##2##2##(2007-7#1)(2013-8#1)
27 cm##2##2##(2010-7#2)
27 dB##3##2##(1995-6#1)(2007-11#1)(2007-12#1)
27 days##5##2##(2008-10#4)(2008-5#1)
27 degrees C##9##3##(1990-9#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#1)
27 different##3##2##(1990-11#1)(1992-11#1)(2008-10#1)
27 for##2##2##(2008-10#2)
27 g##2##2##(2009-7#2)
27 h##3##2##(2008-6#1)(2008-7#2)
27 hours##2##2##(2007-10#1)(2008-7#1)
27 individuals##2##2##(1992-6#1)(2010-4#1)
27 kD heat shock protein##2##5##(1990-7#1)(1991-12#1)
27 kD protein##3##3##(1990-7#3)
27 kD##7##2##(1990-7#5)(1991-12#1)(2008-5#1)
27 kDa##6##2##(1990-12#1)(1990-5#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-6#1)
27 males)##2##2##(2011-2#1)(2013-1#1)
27 masculineC##2##2##(2008-6#2)
27 men##3##2##(1990-3#1)(2008-12#2)
27 months##3##2##(1994-11#1)(2008-11#1)(2008-6#1)
27 mug##2##2##(2008-10#2)
27 of the##2##3##(1990-9#2)
27 of##10##2##(1990-9#2)(1994-1#1)(1994-6#1)(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#1)
27 or##5##2##(2007-12#1)(2008-9#4)
27 patients with##5##3##(1990-11#1)(1997-3#1)(2007-11#1)(2008-6#2)
27 patients##10##2##(1990-11#1)(1992-6#1)(1992-9#1)(1995-11#1)(1997-3#1)(2007-11#1)(2008-6#2)(2013-1#2)
27 residues##3##2##(1990-7#2)(1995-2#1)
27 samples per hour##3##4##(2008-10#3)
27 samples per##4##3##(2008-10#4)
27 to##6##2##(1995-3#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)
27 vs##2##2##(1997-2#1)(2008-9#1)
27 weeks of##2##3##(1991-7#1)(2008-10#1)
27 weeks##17##2##(1991-7#1)(1994-12#1)(2008-10#1)(2008-9#14)
27 were##5##2##(1993-12#1)(2008-10#2)(2010-8#1)(2013-8#1)
27 x##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
27 year old##2##3##(1990-2#1)(1991-1#1)
27 years##2##2##(2008-10#1)(2012-3#1)
27##431##1##(1990-11#5)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#10)(1990-8#3)(1990-9#3)(1991-1#3)(1991-12#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#3)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#6)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#5)(1997-7#1)(1997-8#3)(2007-10#2)(2007-11#7)(2007-12#4)(2007-7#5)(2007-8#2)(2008-1#11)(2008-10#70)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#13)(2008-4#2)(2008-5#17)(2008-6#12)(2008-7#15)(2008-8#10)(2008-9#22)(2009-11#1)(2009-4#8)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2011-1#7)(2011-2#27)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#7)
27% and##2##2##(1990-6#1)(2011-1#1)
27% for##2##2##(2008-10#1)(2012-3#1)
27% had##3##2##(2007-10#2)(2008-12#1)
27% in##4##2##(1995-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
27% of patients##2##3##(2008-6#1)(2013-1#1)
27% of the##5##3##(1991-9#1)(1992-3#1)(1994-3#1)(1996-12#1)(2011-1#1)
27% of##11##2##(1991-9#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-6#2)(2011-1#1)(2012-1#1)(2013-1#1)
27% were##2##2##(2013-7#2)
27%##65##1##(1990-6#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-3#1)(2007-10#3)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
27%)##4##1##(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
27) was##2##2##(2008-10#1)(2010-10#1)
27)##20##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-5#1)(1996-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
27- AND 43-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
27-31##2##1##(2008-10#1)(2008-5#1)
27-Hydroxycholesterol##2##1##(1994-8#2)
27-WEEK STUDY IN##2##3##(2008-9#2)
27-bis(1-propyloxy)calix[4]arene##2##1##(2008-10#2)
27-dibenzoiloxy-26##2##1##(2008-10#2)
27-hydroxylase##4##1##(1994-8#4)
27-week##3##1##(2008-9#2)(2009-12#1)
27-year-old##7##1##(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
270 kDa##3##2##(1991-2#1)(1995-2#1)(2009-7#1)
270 nm with##2##3##(1994-6#1)(2008-10#1)
270 nm##6##2##(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#2)
270 samples##2##2##(2008-10#2)
270##40##1##(1990-12#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#14)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
2700##4##1##(1994-3#1)(2008-10#3)
271##4##1##(1996-6#1)(1997-4#1)(2008-10#2)
272##12##1##(1990-11#1)(1993-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-9#1)(2011-2#1)
273##10##1##(1997-5#1)(2008-10#2)(2008-7#3)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)
2733##2##1##(1995-2#1)(2008-12#1)
274##8##1##(1996-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
275##12##1##(1992-8#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
276 aa##2##2##(1991-7#1)(1991-9#1)
276##10##1##(1991-7#1)(1991-9#1)(1994-8#1)(2007-12#2)(2007-7#1)(2008-2#1)(2011-1#1)(2011-3#1)(2012-3#1)
277##8##1##(1990-6#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2011-3#1)
278##10##1##(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
278)##2##1##(1992-1#1)(2008-10#1)
279 for##2##2##(2008-10#2)
279##14##1##(1992-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2011-2#2)(2013-7#1)(2013-8#2)
27th##6##1##(2008-10#2)(2008-7#2)(2010-3#1)(2013-8#1)
28 +##2##2##(1995-6#1)(2008-1#1)
28 +/- 0##4##3##(1990-2#1)(1996-2#1)(2011-2#1)(2011-3#1)
28 +/-##6##2##(1990-2#1)(1994-12#1)(1996-2#1)(2008-1#1)(2011-2#1)(2011-3#1)
28 OSM)##2##2##(1991-11#2)
28 and 1##2##3##(2008-10#1)(2011-2#1)
28 and 31 degrees C##2##5##(2008-5#2)
28 and 32 degrees C)##2##5##(2008-5#1)(2010-4#1)
28 and##18##2##(1990-6#1)(1991-8#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#4)(2010-4#1)(2010-6#1)(2011-2#2)
28 cases##5##2##(1991-12#1)(1994-2#1)(2011-2#1)(2013-1#2)
28 consecutive patients##2##3##(2007-8#1)(2008-9#1)
28 consecutive##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
28 dB##3##2##(2007-11#1)(2008-3#2)
28 days after##4##3##(1992-2#1)(1994-9#1)(2008-10#1)(2011-2#1)
28 days and##3##3##(1992-2#1)(1994-6#1)(2008-5#1)
28 days in##3##3##(1994-6#1)(2007-10#2)
28 days of age##2##4##(2008-12#1)(2010-4#1)
28 days of##6##3##(1996-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
28 days was##3##3##(2008-6#1)(2008-8#1)(2010-11#1)
28 days##43##2##(1990-2#1)(1992-2#3)(1992-3#1)(1994-6#2)(1994-9#1)(1996-12#3)(1997-3#1)(2007-10#3)(2007-12#1)(2008-10#8)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#4)
28 degrees C and 37 degrees C)##2##7##(2008-10#2)
28 degrees C and 37 degrees##3##6##(2008-10#2)(2008-5#1)
28 degrees C and##4##4##(2008-10#3)(2008-5#1)
28 degrees C##22##3##(2008-10#16)(2008-11#1)(2008-5#1)(2008-6#2)(2010-1#1)(2011-2#1)
28 degrees##25##2##(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2010-1#1)(2011-2#1)(2012-3#1)
28 dpi##3##2##(2008-10#3)
28 flashbackers##2##2##(1996-7#2)
28 for##4##2##(1996-5#1)(2008-2#1)(2008-6#1)(2008-7#1)
28 in the##2##3##(2008-11#1)(2009-12#1)
28 in##3##2##(2007-11#1)(2008-11#1)(2009-12#1)
28 isolates of F##2##4##(2008-10#2)
28 isolates of##4##3##(2008-10#4)
28 isolates##5##2##(2008-10#5)
28 kDa fragment##2##3##(1992-6#2)
28 kDa##8##2##(1992-6#2)(1993-2#2)(1993-6#1)(1994-12#1)(1995-11#1)(2008-10#1)
28 kb##2##2##(1993-2#1)(1993-3#1)
28 mM##2##2##(1994-8#2)
28 men##2##2##(2007-11#1)(2007-12#1)
28 min##2##2##(1997-2#1)(2008-8#1)
28 mm##2##2##(1995-4#1)(2007-8#1)
28 mmHg##2##2##(2011-2#2)
28 months##5##2##(1990-3#1)(1990-6#1)(2008-6#1)(2008-9#1)(2011-2#1)
28 ng##2##2##(2008-10#1)(2008-8#1)
28 nm##2##2##(2008-3#1)(2010-11#1)
28 of##5##2##(1990-8#1)(1994-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
28 patients with##6##3##(1990-2#1)(1991-4#1)(1997-2#1)(2009-9#1)(2011-2#1)(2013-1#1)
28 patients##16##2##(1990-2#1)(1991-4#1)(1992-8#1)(1994-3#1)(1997-2#1)(2007-10#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
28 pituitary adenomas##2##3##(1990-12#2)
28 samples##2##2##(2008-10#2)
28 species##2##2##(2008-10#1)(2008-5#1)
28 to 0##2##3##(2008-1#1)(2008-10#1)
28 to##10##2##(1991-11#1)(1993-9#1)(1994-6#1)(1995-1#1)(2008-1#1)(2008-10#4)(2013-1#1)
28 weeks of gestation##4##4##(2007-7#1)(2011-1#1)(2013-1#2)
28 weeks of##5##3##(2007-7#1)(2008-7#1)(2011-1#1)(2013-1#2)
28 weeks postconception##2##3##(1995-8#2)
28 weeks##10##2##(1995-8#2)(2007-7#1)(2008-7#1)(2008-9#3)(2011-1#1)(2013-1#2)
28 weeks' gestation##2##3##(2008-1#1)(2008-11#1)
28 were##3##2##(2008-10#2)(2010-6#1)
28 with##2##2##(1997-7#1)(2007-8#1)
28 x##2##2##(2008-10#2)
28 years##9##2##(1992-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
28 ±##3##2##(2011-1#1)(2013-1#2)
28##474##1##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-11#4)(1991-12#2)(1991-3#3)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#8)(1996-2#4)(1996-5#4)(1996-6#2)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#3)(2006-10#2)(2006-8#1)(2007-10#5)(2007-11#7)(2007-12#4)(2007-7#5)(2007-8#8)(2008-1#9)(2008-10#92)(2008-11#5)(2008-12#9)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#23)(2008-6#9)(2008-7#21)(2008-8#5)(2008-9#11)(2009-10#2)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#4)(2010-9#2)(2011-1#7)(2011-2#29)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#29)(2013-8#4)
28% and##5##2##(1991-12#1)(1994-12#1)(2008-11#1)(2008-3#1)(2012-3#1)
28% had##2##2##(1995-10#1)(2008-9#1)
28% in the##2##3##(2008-3#1)(2013-1#1)
28% in##9##2##(1990-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
28% of the patients##2##4##(2008-8#2)
28% of the##8##3##(1991-12#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2013-8#1)
28% of##13##2##(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#2)(2008-10#2)(2008-11#1)(2008-8#2)(2010-8#1)(2013-8#1)
28% with##2##2##(2008-9#1)(2012-2#1)
28%##64##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-2#1)(1995-10#1)(1995-3#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
28%)##8##1##(2007-11#1)(2008-10#2)(2009-7#1)(2010-4#1)(2011-2#2)(2013-1#1)
28) and##2##2##(2007-8#1)(2011-2#1)
28)##18##1##(1992-1#1)(1994-6#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#2)(2011-2#1)(2012-2#2)
28-0##2##1##(1990-5#1)(2008-3#1)
28-29##3##1##(1993-12#1)(1994-11#1)(2013-8#1)
28-30##4##1##(1995-5#1)(2008-10#1)(2008-8#1)(2010-3#1)
28-bis-[3-propyloxy]-calix[4]arene-bonded silica gel##2##3##(2008-10#2)
28-day and 12-month case-fatalities##2##4##(2007-10#2)
28-day cycles of##2##3##(2008-10#1)(2009-12#1)
28-day period##2##2##(2008-7#1)(2010-6#1)
28-day##9##1##(2007-10#2)(2008-10#4)(2008-7#1)(2009-12#1)(2010-6#1)
28-day-old##2##1##(2008-7#1)(2011-1#1)
28-fold##5##1##(1994-8#1)(1997-2#1)(2007-10#1)(2008-3#1)(2012-12#1)
28-kDa glutathione S-transferase##2##3##(1993-2#2)
28-kDa##8##1##(1990-5#1)(1991-10#1)(1993-2#3)(1994-2#1)(1995-6#1)(1997-4#1)
28-kb DNA##2##2##(2008-8#2)
28-kb##4##1##(1996-10#2)(2008-8#2)
28-year-old male with##2##3##(2007-5#1)(2013-1#1)
28-year-old male##7##2##(2007-10#1)(2007-5#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
28-year-old##16##1##(2007-10#1)(2007-4#1)(2007-5#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#2)
280 and##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
280 mg/kg##3##2##(2008-8#1)(2013-1#2)
280 nm##11##2##(1992-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-7#1)(2012-3#1)
280 nm)##3##2##(1994-5#1)(1996-5#1)(2008-10#1)
280##46##1##(1992-12#1)(1994-5#2)(1994-8#1)(1996-5#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
280-fs##2##1##(2007-11#2)
280-nm##5##1##(1995-5#4)(2008-2#1)
281##6##1##(1991-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
282##17##1##(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1996-3#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
282)##2##1##(1995-12#1)(2008-10#1)
283##11##1##(1992-12#1)(1993-2#1)(1994-12#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#2)
283)##2##1##(1993-8#1)(2007-10#1)
283/Coulter##2##1##(2008-10#2)
284 patients##2##2##(2007-9#1)(2008-3#1)
284##13##1##(1996-10#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
285 and##3##2##(2008-10#3)
285 nm##6##2##(1996-12#1)(1997-2#1)(2008-10#4)
285##24##1##(1991-12#1)(1992-8#1)(1996-12#1)(1997-2#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#1)
285-298##2##1##(2012-3#2)
2857##2##1##(2007-11#1)(2008-5#1)
286##17##1##(1990-8#1)(1993-9#1)(1995-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-8#2)
287##17##1##(1990-8#1)(1991-6#1)(1993-2#1)(1993-8#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-10#2)(2011-2#1)(2013-1#4)
288##9##1##(1990-8#1)(1991-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-2#1)(2010-4#1)(2012-12#1)(2013-7#1)
288)##2##1##(1996-2#1)(2008-11#1)
289##8##1##(1992-3#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
28S rRNA##6##2##(1992-3#2)(1994-12#1)(1995-3#1)(2008-5#1)(2010-4#1)
28S##12##1##(1992-3#2)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-4#1)(2011-1#1)
28th##5##1##(1995-6#1)(1996-12#1)(2008-10#1)(2010-11#2)
29 (27%)##2##2##(2008-1#2)
29 +/-##3##2##(1994-3#1)(2007-5#1)(2008-12#1)
29 -##2##2##(2008-11#1)(2008-8#1)
29 V##2##2##(1996-2#1)(2008-10#1)
29 amino acids##3##3##(1992-8#1)(1994-12#1)(1994-9#1)
29 amino##4##2##(1990-12#1)(1992-8#1)(1994-12#1)(1994-9#1)
29 and 1##2##3##(2008-10#2)
29 and 36##2##3##(1990-2#1)(2008-10#1)
29 and##11##2##(1990-2#1)(1993-5#1)(1996-9#1)(2008-10#5)(2008-12#1)(2008-8#1)(2011-2#1)
29 cases##7##2##(1991-12#1)(1992-12#1)(1992-9#1)(1996-9#1)(2008-10#1)(2008-6#1)(2008-8#1)
29 children##4##2##(1996-9#2)(2008-9#1)(2009-3#1)
29 days##5##2##(1992-11#2)(2006-5#1)(2008-11#1)(2010-8#1)
29 degrees C##2##3##(2008-10#1)(2008-6#1)
29 degrees##3##2##(2007-8#1)(2008-10#1)(2008-6#1)
29 h##2##2##(2008-11#2)
29 healthy##2##2##(1990-2#1)(2010-12#1)
29 in the##2##3##(1993-6#1)(2011-2#1)
29 in##4##2##(1993-6#1)(1997-4#1)(2008-10#1)(2011-2#1)
29 isolates of##2##3##(2008-10#2)
29 kDa##2##2##(1990-11#1)(1995-6#1)
29 men##2##2##(2009-11#1)(2013-8#1)
29 mg##2##2##(2008-10#2)
29 mgxl(-1)##3##2##(2008-5#3)
29 mm##2##2##(1996-6#1)(2010-5#1)
29 months##7##2##(1992-10#1)(1997-3#1)(2006-10#1)(2007-11#1)(2010-1#1)(2010-2#1)(2011-2#1)
29 nm##2##2##(2007-11#1)(2008-10#1)
29 of##2##2##(1990-12#1)(2008-10#1)
29 patients treated##2##3##(1991-2#2)
29 patients with##4##3##(1991-4#1)(2008-7#1)(2009-9#1)(2012-3#1)
29 patients##21##2##(1990-9#1)(1991-2#2)(1991-4#1)(1993-5#1)(1997-2#1)(1997-4#1)(2007-8#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
29 percent of##2##3##(1994-2#1)(2009-9#1)
29 percent##3##2##(1991-12#1)(1994-2#1)(2009-9#1)
29 pine (Pinus) species##2##4##(2008-8#2)
29 plant species##2##3##(2008-10#2)
29 plant##3##2##(2008-10#3)
29 to##10##2##(1990-8#1)(1993-1#1)(1993-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-6#1)(2012-12#1)
29 year-old##2##2##(1992-4#1)(1995-2#1)
29 years of##2##3##(2007-12#1)(2008-11#1)
29 years##8##2##(1990-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-3#1)(2013-8#2)
29##342##1##(1990-11#1)(1990-12#3)(1990-2#4)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-5#2)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#4)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-5#2)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#10)(2008-1#5)(2008-10#49)(2008-11#10)(2008-12#9)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#4)(2011-2#17)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#15)(2013-8#5)
29% (p##2##2##(2008-11#1)(2013-1#1)
29% and##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
29% in##3##2##(1993-11#1)(2007-10#1)(2008-10#1)
29% of the##8##3##(1990-2#1)(1991-9#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2013-1#1)
29% of##12##2##(1990-2#1)(1991-9#1)(1994-11#1)(1995-8#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2012-2#1)(2013-1#1)
29% to##2##2##(1990-12#1)(2012-3#1)
29%##51##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1995-8#1)(2006-8#1)(2007-10#4)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)
29%)##2##1##(2007-8#1)(2011-1#1)
29)##14##1##(1990-5#2)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#2)(2012-12#1)(2013-1#2)(2013-8#1)
29+/-0##2##1##(2008-10#1)(2008-8#1)
29-##2##1##(2008-10#1)(2012-7#1)
29-0##2##1##(1997-8#2)
29-30 October 1998##2##3##(2008-10#2)
29-30##3##1##(1996-10#1)(2008-10#2)
29-kDa##2##1##(1994-2#1)(1995-6#1)
29-year-old male##5##2##(1990-3#1)(1990-9#1)(2008-12#1)(2010-7#1)(2013-1#1)
29-year-old##11##1##(1990-3#1)(1990-9#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
290 K##2##2##(1994-5#1)(2008-3#1)
290 nm##5##2##(2008-10#3)(2008-2#1)(2008-5#1)
290 nm)##2##2##(1995-2#1)(2008-11#1)
290##29##1##(1992-12#1)(1994-5#1)(1995-2#1)(1996-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
290)##2##1##(1997-8#1)(2011-2#1)
2900##2##1##(1993-5#1)(2012-9#1)
291##7##1##(1991-8#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)
291)##2##1##(1997-6#1)(2008-10#1)
292 bp##2##2##(2008-10#1)(2008-8#1)
292##13##1##(1990-3#1)(1991-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
293 and##3##2##(1996-2#2)(2011-2#1)
293 cell line##2##3##(2008-11#2)
293 cell##3##2##(2008-11#3)
293 cells adapted to suspension growth in serum-free medium in##2##10##(2008-11#2)
293 cells and##4##3##(1992-10#1)(1995-2#1)(2008-11#1)(2008-9#1)
293 cells in##2##3##(2008-11#2)
293 cells is##2##3##(2008-11#2)
293 cells on##2##3##(2008-11#2)
293 cells were##2##3##(2008-11#2)
293 cells##34##2##(1990-8#1)(1992-10#3)(1995-2#1)(1997-4#1)(2008-11#23)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#2)
293##58##1##(1990-12#1)(1990-8#3)(1992-10#3)(1992-12#1)(1995-2#1)(1995-5#3)(1996-2#4)(1997-4#1)(2007-7#1)(2008-11#31)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
293(EBNA) cells grown in serum-free suspension culture##2##7##(2008-11#2)
293(EBNA) cells##3##2##(2008-11#3)
293-EBNA##2##1##(2008-11#2)
293cells##2##1##(2008-11#2)
294 K##5##2##(2007-12#1)(2008-3#4)
294##13##1##(1990-11#1)(1994-11#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#4)(2011-2#1)(2013-1#1)
295 amino##2##2##(1993-8#1)(2008-8#1)
295 nm##4##2##(1992-12#2)(2008-10#2)
295 pregnant women##2##3##(2011-2#2)
295 to##2##2##(2008-10#1)(2008-8#1)
295##19##1##(1992-12#2)(1993-8#1)(1994-9#1)(1996-11#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#2)(2009-4#1)(2011-2#2)(2013-1#1)
2955 microm##2##2##(2008-2#1)(2008-3#1)
296 isolates##2##2##(2008-10#2)
296##17##1##(1991-3#1)(1995-6#1)(1997-6#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
297##5##1##(1996-11#1)(2010-1#1)(2010-5#2)(2011-1#1)
298##21##1##(1990-5#1)(1991-11#1)(1993-1#1)(1994-8#1)(1996-2#2)(2008-10#11)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)
299##11##1##(1991-3#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2011-1#2)(2013-8#1)
29G11 is##2##2##(1995-2#2)
29G11##4##1##(1995-2#4)
29eV##2##1##(2013-1#2)
2A and##4##2##(1995-3#1)(1995-6#1)(1995-8#2)
2A##40##1##(1990-12#1)(1991-5#1)(1992-12#3)(1992-8#1)(1992-9#12)(1994-11#2)(1994-9#2)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#3)(1997-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#2)
2A-like##2##1##(1995-3#1)(2012-2#1)
2A1-9E-1 was##2##2##(2008-11#2)
2AID##5##1##(2008-5#5)
2B (NR2B)##2##2##(1996-5#1)(1997-2#1)
2B and##2##2##(2008-1#1)(2008-10#1)
2B particles##2##2##(2008-5#2)
2B##11##1##(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-5#3)(2013-8#1)
2B)##2##1##(2008-5#2)
2B1##3##1##(1994-6#2)(2008-8#1)
2B1/2##3##1##(1995-3#1)(2008-11#1)(2008-8#1)
2BL##2##1##(2008-10#2)
2C##8##1##(1993-6#2)(1993-8#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)
2C(12)N(+)PA(-) films##2##2##(2008-10#2)
2C(12)N(+)PA(-)##5##1##(2008-10#5)
2C)##2##1##(2009-2#1)(2011-2#1)
2C11##2##1##(1993-6#1)(2008-10#1)
2C9 and##4##2##(2008-10#1)(2011-1#3)
2C9##5##1##(2008-10#2)(2011-1#3)
2C9*3 +##4##2##(2011-1#4)
2CA##3##1##(2008-2#3)
2CE fluorescence imaging##2##3##(2008-3#2)
2CE fluorescence##4##2##(2008-3#4)
2CE##5##1##(2008-3#5)
2D FGM model##2##3##(2008-5#2)
2D NMR experiments##3##3##(1994-5#1)(2011-2#1)(2013-1#1)
2D NMR spectroscopy##2##3##(1994-5#1)(1995-2#1)
2D NMR techniques##4##3##(1991-11#1)(2007-1#1)(2008-9#1)(2013-1#1)
2D NMR##14##2##(1991-11#1)(1994-5#3)(1995-2#1)(2007-1#1)(2007-11#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-8#1)(2013-1#2)
2D and 3D##6##3##(2008-11#1)(2008-2#1)(2010-12#2)(2010-8#1)(2013-1#1)
2D and##8##2##(2008-11#1)(2008-2#1)(2009-10#1)(2010-12#2)(2010-8#1)(2012-3#1)(2013-1#1)
2D axial images##2##3##(2010-12#1)(2012-1#1)
2D crystal##2##2##(2007-12#1)(2008-4#1)
2D gel electrophoresis##2##3##(1993-8#1)(1994-11#1)
2D generalized##2##2##(2011-1#2)
2D image##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
2D information spaces##2##3##(2008-6#2)
2D or 3D##2##3##(2008-6#2)
2D separation##3##2##(2008-10#3)
2D##98##1##(1990-12#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#3)(1995-2#2)(1996-2#1)(1996-9#1)(2007-1#1)(2007-11#6)(2007-12#6)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#8)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#3)(2011-7#3)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#1)
2D)##2##1##(2007-12#1)(2011-2#1)
2D-PAGE##3##1##(2008-4#1)(2008-7#2)
2D/E##2##1##(1995-12#2)
2D6 (CYP2D6)##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
2D6##4##1##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
2DG uptake in##2##3##(1991-10#2)
2DG uptake##3##2##(1991-10#3)
2E and##2##2##(1996-12#1)(2008-10#1)
2E##3##1##(1996-12#1)(2008-10#2)
2E1##4##1##(1995-3#1)(2007-11#3)
2E3-O##3##1##(2008-11#3)
2F10##3##1##(1995-2#3)
2H NMR##3##2##(1990-12#1)(1994-5#2)
2H##8##1##(1990-12#1)(1992-3#1)(1994-2#1)(1994-5#2)(2008-10#2)(2009-11#1)
2H(2)O##2##1##(1997-7#1)(2008-10#1)
2H(2)O-H(2)O system##3##2##(2008-10#3)
2H-pyran-2-one moiety of##2##3##(2008-11#2)
2H2O##2##1##(2007-11#2)
2H3##4##1##(1996-5#1)(2009-12#1)(2011-2#2)
2HE-NECA and NECA##3##3##(1995-12#3)
2L##9##1##(1995-11#5)(2008-11#2)(2008-9#2)
2M in##2##2##(1994-6#1)(1995-1#1)
2M nitric acid##4##3##(2008-10#4)
2M##27##1##(1993-3#4)(1994-12#1)(1994-6#7)(1995-1#1)(2008-10#10)(2008-2#1)(2013-1#3)
2M)##3##1##(1993-3#1)(1994-6#2)
2M2##3##1##(2009-8#3)
2Man##2##1##(1992-10#2)
2MeS-ADP##3##1##(2008-4#3)
2MeSADP##2##1##(2008-4#2)
2MeSATP##3##1##(1995-11#3)
2N##7##1##(2008-12#4)(2008-3#2)(2010-3#1)
2P##4##1##(2010-12#4)
2R##4##1##(1990-8#2)(1992-9#1)(2009-9#1)
2S##8##1##(1990-11#1)(1992-3#1)(1995-11#2)(1996-5#1)(1997-7#1)(2009-9#2)
2T##2##1##(1993-3#1)(2008-10#1)
2V##4##1##(1994-11#1)(2008-10#3)
2]##19##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-8#1)(1996-2#1)(1996-5#2)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
2]octane-2##4##1##(1996-5#4)
2]p##2##1##(2008-10#2)
2a protein##2##2##(2008-10#2)
2a##19##1##(1992-12#1)(1996-6#6)(1997-7#1)(2007-7#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-9#1)(2012-3#1)(2013-1#2)
2a-5a##2##1##(2009-8#2)
2a-g##2##1##(2012-3#2)
2alpha-epoxy-4##2##1##(2007-11#2)
2b protein##3##2##(2012-2#3)
2b##16##1##(1992-12#1)(1993-12#1)(1996-2#1)(1996-5#2)(2007-12#1)(2008-10#1)(2009-10#1)(2012-2#5)(2013-1#3)
2b)##2##1##(1992-12#1)(2008-10#1)
2c##5##1##(2007-12#5)
2cm(-1)##2##1##(2007-11#1)(2008-10#1)
2d##5##1##(1990-10#1)(1990-3#1)(2007-3#2)(2010-7#1)
2d(2)##2##1##(2008-3#2)
2f background##2##2##(2008-3#2)
2f detection##4##2##(2008-3#4)
2f##9##1##(2008-3#9)
2g##4##1##(2007-11#1)(2008-10#2)(2008-3#1)
2h##7##1##(2008-10#4)(2011-2#1)(2012-3#1)(2013-1#1)
2hPG##2##1##(2012-7#2)
2l##2##1##(2008-10#1)(2008-3#1)
2m(th)-order##2##1##(2013-1#2)
2mL##4##1##(2008-10#3)(2008-8#1)
2mM##5##1##(2008-10#5)
2mV)##2##1##(2008-10#2)
2mg of##2##2##(2008-10#2)
2mg##5##1##(2008-10#3)(2008-11#1)(2010-7#1)
2mgl(-1)##2##1##(2008-10#2)
2min##9##1##(2008-10#9)
2ml of sample##2##3##(2008-10#2)
2ml of##7##2##(2008-10#7)
2ml samples##2##2##(2008-10#2)
2ml##13##1##(2008-10#12)(2012-2#1)
2mlmin(-1)##2##1##(2008-10#2)
2mm##2##1##(2007-10#1)(2008-10#1)
2mmolL(-1))##2##1##(2008-10#2)
2moll(-1) HCl##3##2##(2008-10#3)
2moll(-1)##7##1##(2008-10#7)
2muM##4##1##(2008-10#4)
2mug##2##1##(2008-10#2)
2mugL(-1)##6##1##(2008-10#6)
2mugg(-1)##2##1##(2008-10#2)
2mugl(-1) for##3##2##(2008-10#3)
2mugl(-1)##8##1##(2008-10#8)
2mugml(-1) of##2##2##(2008-10#2)
2mugml(-1)##5##1##(2008-10#5)
2mum##2##1##(2007-11#1)(2007-12#1)
2mumoll(-1)##2##1##(2008-10#2)
2n - 6##3##3##(2013-1#3)
2n = 2x =##2##4##(2008-10#1)(2009-12#1)
2n = 40##2##3##(2010-3#2)
2n =##7##2##(2008-10#2)(2008-8#1)(2009-12#2)(2010-3#2)
2n##13##1##(2008-10#2)(2008-3#2)(2008-8#2)(2009-12#2)(2010-3#2)(2013-1#3)
2nM##4##1##(1993-3#2)(2008-10#2)
2nM)##2##1##(1990-11#1)(2008-10#1)
2nd Annual##2##2##(2007-7#1)(2008-7#1)
2nd Helsingborg##4##2##(2008-8#4)
2nd International Congress on Leukemia##2##5##(2010-11#2)
2nd and 3rd##8##3##(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)
2nd and##9##2##(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)
2nd dose of##2##3##(1995-8#1)(2007-7#1)
2nd dose##3##2##(1995-8#2)(2007-7#1)
2nd ed##2##2##(2007-2#2)
2nd generation youth##3##3##(2009-7#3)
2nd generation##4##2##(2009-7#4)
2nd group##2##2##(1991-8#1)(2011-1#1)
2nd year##2##2##(2008-12#2)
2nd##54##1##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1995-8#3)(2007-12#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-10#4)(2008-12#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-4#1)(2009-7#4)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2012-3#1)
2ng##3##1##(2008-10#2)(2013-1#1)
2ngg(-1) for##2##2##(2008-10#2)
2ngg(-1)##4##1##(2008-10#4)
2ngmL(-1)##2##1##(2008-10#2)
2ngml(-1)##6##1##(2008-10#6)
2nu(2) + nu(3)##2##3##(2008-2#1)(2008-3#1)
2nu(2)##3##1##(2008-2#2)(2008-3#1)
2p##2##1##(2008-4#2)
2p)##2##1##(2008-10#1)(2009-9#1)
2pi##16##1##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#9)
2ppm##2##1##(2008-10#2)
2s##5##1##(2008-10#4)(2013-1#1)
2sigma level##2##2##(2008-10#2)
2sigma##3##1##(2008-10#2)(2013-8#1)
2sigma(I)]##2##1##(1997-7#2)
2x##11##1##(1993-8#1)(2007-12#1)(2008-10#2)(2009-12#7)
2x10(-10) mol##2##2##(2008-10#2)
2x10(-10)##4##1##(2008-10#4)
2x10(-2)##3##1##(2008-10#3)
2x10(-3) M with a##2##4##(2008-10#2)
2x10(-3) M##8##2##(2008-10#8)
2x10(-4) M##3##2##(2008-10#2)(2008-11#1)
2x10(-4) and##2##2##(2008-10#2)
2x10(-4) moll(-1)##2##2##(2008-10#2)
2x10(-4) to##3##2##(2008-10#3)
2x10(-4)##15##1##(2007-12#1)(2008-10#13)(2008-11#1)
2x10(-4)moll(-1)##2##1##(2008-10#2)
2x10(-5) M##3##2##(2008-10#3)
2x10(-5) mol l(-1)##3##3##(2008-10#3)
2x10(-5) to##2##2##(2008-10#2)
2x10(-5)##8##1##(2008-10#8)
2x10(-5)moll(-1)##2##1##(2008-10#2)
2x10(-6) M##4##2##(2008-10#4)
2x10(-6) and##3##2##(2008-10#3)
2x10(-6) mol l(-1)##2##3##(2008-10#2)
2x10(-6) to##2##2##(2008-10#2)
2x10(-6)##11##1##(2008-10#11)
2x10(-7) M for##2##3##(2008-10#2)
2x10(-7) M##3##2##(2008-10#3)
2x10(-7) to 2x10(-3) M for##2##5##(2008-10#2)
2x10(-7) to##4##2##(2008-10#4)
2x10(-7)##9##1##(2007-11#1)(2008-10#8)
2x10(-8) moll(-1)##2##2##(2008-10#2)
2x10(-8)##5##1##(2008-10#5)
2x10(-8)M##2##1##(2008-10#2)
2x10(-9) mol dm(-3)##2##3##(2008-10#2)
2x10(-9) mol##4##2##(2008-10#4)
2x10(-9)##8##1##(2008-10#8)
2x10(4)##2##1##(2008-10#2)
2x10(6)##4##1##(2007-12#1)(2008-10#2)(2008-11#1)
2x2##7##1##(2007-11#1)(2007-12#2)(2008-1#1)(2010-1#2)(2010-3#1)
2xRDA##2##1##(2011-1#2)
2y were##2##2##(2008-10#2)
2y##3##1##(2008-10#3)
2 h##2##1##(2012-3#1)(2013-1#1)
2 years##2##1##(2011-1#1)(2011-2#1)
2 ± 0##2##1##(2013-1#2)
2 ± 16##2##1##(2013-1#1)(2013-8#1)
2±0##3##1##(2012-1#1)(2012-12#1)(2012-2#1)
2 h##2##1##(2012-2#2)
2 cm##2##1##(2013-1#2)
2 weeks##2##1##(2013-8#2)
3 % of##3##3##(2007-8#1)(2008-5#2)
3 %##10##2##(1997-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#4)(2011-2#1)(2012-12#1)
3 %) and##2##3##(2012-12#2)
3 %)##14##2##(1997-8#1)(2008-5#1)(2011-1#2)(2012-12#9)(2012-2#1)
3 &amp##3##2##(1995-4#1)(2008-11#2)
3 (0##4##2##(2008-12#2)(2008-8#1)(2013-8#1)
3 (1##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
3 (12%)##2##2##(1991-2#2)
3 (15%)##2##2##(1992-12#1)(2013-8#1)
3 (2##2##2##(2007-8#1)(2008-3#1)
3 (20%)##2##2##(1997-8#2)
3 (4%) patients##3##3##(2011-2#2)(2012-3#1)
3 (4%)##4##2##(2011-2#3)(2012-3#1)
3 (8##2##2##(2008-7#1)(2011-2#1)
3 (95% CI##2##3##(1995-6#1)(2013-1#1)
3 (95%##3##2##(1991-11#1)(1995-6#1)(2013-1#1)
3 +/- 0##22##3##(1990-5#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#1)
3 +/- 1##12##3##(1990-7#1)(1991-12#1)(1991-9#3)(1992-12#1)(1995-12#1)(1996-12#1)(2007-10#2)(2008-1#1)(2008-3#1)
3 +/- 10##2##3##(1991-9#1)(1994-11#1)
3 +/- 11##2##3##(2008-5#2)
3 +/- 12##2##3##(2007-7#1)(2008-5#1)
3 +/- 17##2##3##(2007-8#1)(2008-1#1)
3 +/- 2##4##3##(1993-8#1)(1995-12#1)(2007-10#1)(2008-1#1)
3 +/- 3##4##3##(1990-12#1)(1995-12#1)(2007-7#1)(2008-5#1)
3 +/- 4##3##3##(1994-12#1)(1995-12#1)(2010-1#1)
3 +/- 5##5##3##(1994-12#2)(1995-2#1)(1996-12#1)(2008-7#1)
3 +/-##71##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#3)(1995-12#5)(1995-2#1)(1995-5#1)(1996-12#3)(1996-2#2)(1997-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)
3 -##3##2##(2007-7#1)(2008-3#1)(2011-2#1)
3 =##5##2##(1990-8#1)(1997-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
3 ?##2##2##(2008-2#1)(2008-3#1)
3 A##9##2##(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-12#1)
3 Hz##2##2##(2008-2#1)(2013-1#1)
3 J cm(-2)##2##3##(2008-2#1)(2008-3#1)
3 J##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
3 L##3##2##(2007-12#1)(2008-8#1)(2011-2#1)
3 M HCl or##2##4##(1997-2#1)(2008-10#1)
3 M HCl##3##3##(1997-2#1)(2008-10#2)
3 M KCl and##2##4##(2008-10#2)
3 M KCl##3##3##(1992-11#1)(2008-10#2)
3 M NaCl##5##3##(1990-8#1)(1992-11#1)(1993-12#1)(1996-5#2)
3 M##20##2##(1990-8#1)(1991-7#1)(1992-11#4)(1993-12#2)(1995-11#1)(1996-5#2)(1997-2#1)(2008-1#1)(2008-10#7)
3 MPa and##2##3##(2008-10#1)(2009-7#1)
3 MPa##4##2##(2008-10#2)(2009-7#1)(2010-4#1)
3 MT##3##2##(2008-10#3)
3 T##4##2##(2008-3#1)(2010-8#2)(2011-2#1)
3 THz##2##2##(2008-3#1)(2010-5#1)
3 Tesla##2##2##(2009-6#1)(2010-8#1)
3 U##2##2##(1992-11#1)(2008-12#1)
3 V##3##2##(2008-10#3)
3 W of##2##3##(2008-2#1)(2008-3#1)
3 W##9##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#1)(2008-9#1)
3 X 10(-7) M##4##4##(1990-5#4)
3 X##5##2##(1990-5#5)
3 Zr alloy is##2##4##(2009-7#2)
3 after##3##2##(2007-12#1)(2007-8#1)(2013-1#1)
3 alpha##8##2##(1990-11#6)(1995-6#1)(1996-2#1)
3 alpha-##2##2##(1990-11#1)(1990-8#1)
3 alpha-DIOL-G##2##2##(1990-11#2)
3 alpha-DIOL-S##2##2##(1990-11#2)
3 alpha-HSOR##2##2##(1990-11#2)
3 alpha-hydroxysteroid dehydrogenase##2##3##(1990-11#2)
3 alpha-hydroxysteroid oxidoreductase##2##3##(1990-11#2)
3 alpha-hydroxysteroid##5##2##(1990-11#4)(1990-12#1)
3 alpha-reduction of##2##3##(1990-11#2)
3 also##2##2##(2007-12#1)(2011-2#1)
3 amino acid##3##3##(2008-8#1)(2010-11#1)(2011-1#1)
3 and &lt##2##3##(2007-12#1)(2008-10#1)
3 and 0##13##3##(2008-10#7)(2008-12#2)(2008-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
3 and 1##14##3##(1990-8#1)(1992-9#1)(1993-8#1)(1997-4#1)(2007-11#2)(2008-10#7)(2008-3#1)
3 and 10##5##3##(1991-8#1)(1995-5#1)(2008-10#2)(2008-3#1)
3 and 100##2##3##(2008-10#1)(2010-4#1)
3 and 11##2##3##(2008-7#1)(2009-10#1)
3 and 12##3##3##(1991-2#1)(2008-10#1)(2013-1#1)
3 and 13##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
3 and 14##3##3##(1991-9#1)(2008-10#1)(2010-4#1)
3 and 15##2##3##(2006-10#1)(2008-10#1)
3 and 2##9##3##(1990-2#1)(1990-7#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
3 and 2%##2##3##(2008-10#2)
3 and 3##3##3##(2008-10#2)(2008-12#1)
3 and 30##3##3##(1994-8#1)(1997-7#2)
3 and 35##2##3##(2008-10#1)(2008-12#1)
3 and 4 of##3##4##(2008-10#2)(2011-2#1)
3 and 4 weeks##2##4##(1997-3#1)(2009-7#1)
3 and 4 were##5##4##(2007-11#1)(2008-1#1)(2008-7#1)(2011-2#2)
3 and 4##44##3##(1990-12#1)(1991-8#3)(1994-12#1)(1995-3#1)(1997-3#3)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
3 and 5 h##2##4##(2008-10#1)(2008-11#1)
3 and 5 years##3##4##(2007-7#1)(2007-8#1)(2008-9#1)
3 and 5##17##3##(1992-5#1)(1993-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-9#1)(2009-2#1)(2013-1#2)
3 and 5%##2##3##(2008-10#2)
3 and 6 months after##3##5##(2008-7#1)(2009-11#1)(2011-2#1)
3 and 6 months##9##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#2)(2011-2#1)(2013-1#1)
3 and 6##24##3##(1990-7#1)(1993-12#1)(1994-9#1)(1997-2#1)(2007-10#1)(2007-11#3)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2011-2#1)(2013-1#1)
3 and 7 days##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
3 and 7##9##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)
3 and 8##8##3##(1993-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2011-1#1)
3 and 8)##3##3##(1995-8#1)(2008-4#2)
3 and 9##2##3##(1994-7#1)(2013-8#1)
3 and 93##2##3##(1997-1#1)(2008-12#1)
3 and 98##4##3##(2008-10#3)(2013-1#1)
3 and MCA##3##3##(1990-8#3)
3 and a##2##3##(2008-3#1)(2009-9#1)
3 and the##3##3##(2008-10#1)(2008-8#2)
3 and##272##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-7#7)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#92)(2008-11#7)(2008-12#14)(2008-2#2)(2008-3#9)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#5)(2013-1#9)(2013-8#1)
3 and/or##2##2##(1990-8#1)(2011-2#1)
3 approximately##3##2##(1997-7#1)(2008-10#2)
3 are##6##2##(1992-6#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-6#1)(2013-8#1)
3 as##3##2##(2008-10#2)(2013-8#1)
3 at##5##2##(1990-5#1)(1994-6#1)(1996-5#1)(2008-10#2)
3 before##2##2##(2008-10#1)(2008-7#1)
3 being##2##2##(2010-6#1)(2011-1#1)
3 beta##12##2##(1992-3#1)(1992-4#1)(1995-11#8)(1995-12#1)(1995-6#1)
3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one##2##3##(1992-3#1)(1993-6#1)
3 beta-hydroxy-5##3##2##(1992-3#2)(1993-6#1)
3 beta-hydroxy-5-cholestenoic acid##4##3##(1994-8#4)
3 billion##3##2##(1995-6#1)(2008-10#1)(2011-2#1)
3 by##4##2##(1992-3#1)(1997-7#1)(2008-10#1)(2008-7#1)
3 cM from##2##3##(2008-10#1)(2008-9#1)
3 cM##4##2##(1997-5#1)(2008-10#2)(2008-9#1)
3 cM)##3##2##(2008-10#3)
3 cas##2##2##(2013-1#2)
3 cases of a##2##4##(1990-9#1)(2011-2#1)
3 cases of##13##3##(1990-9#1)(1991-8#1)(1992-2#1)(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
3 cases with##2##3##(2007-5#2)
3 cases##45##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-4#1)(1997-8#1)(2007-11#5)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-8#2)
3 cases]##3##2##(1991-11#1)(2008-11#1)(2011-2#1)
3 children##2##2##(2010-5#1)(2012-2#1)
3 clinical##3##2##(1990-2#1)(2011-2#1)(2012-12#1)
3 clinics in Namibia##2##4##(2011-1#2)
3 clones are genes involved in##2##6##(2008-9#2)
3 cm in##2##3##(2008-10#1)(2013-1#1)
3 cm##13##2##(1992-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-1#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
3 cm/s and##2##3##(2008-7#2)
3 cm/s##4##2##(2008-6#2)(2008-7#2)
3 compared to##3##3##(1997-6#2)(2009-5#1)
3 compared##4##2##(1997-6#2)(2008-5#1)(2009-5#1)
3 consecutive days##3##3##(1995-5#1)(1995-6#1)(2007-7#1)
3 consecutive##7##2##(1991-8#1)(1993-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-7#1)(2009-10#1)
3 cross-link##2##2##(1993-11#1)(2008-11#1)
3 cycles of##2##3##(1992-12#1)(2008-10#1)
3 cycles##4##2##(1992-12#1)(1992-8#1)(1993-2#1)(2008-10#1)
3 d post-injection##2##3##(2008-10#2)
3 d##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
3 dB##3##2##(2007-11#1)(2008-2#2)
3 day##2##2##(1994-8#1)(2008-5#1)
3 days after inoculation##4##4##(2008-10#4)
3 days after surgery##2##4##(2011-2#2)
3 days after the##2##4##(1996-12#1)(2010-12#1)
3 days after##14##3##(1990-5#1)(1991-5#1)(1996-12#1)(1996-2#1)(2008-10#4)(2010-12#1)(2011-2#4)(2013-1#1)
3 days and##8##3##(1991-2#1)(1994-7#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-7#1)
3 days at##3##3##(1992-3#1)(1994-3#1)(2008-10#1)
3 days following##2##3##(2008-3#1)(2008-5#1)
3 days for##3##3##(2008-10#2)(2008-6#1)
3 days in the##3##4##(1995-2#1)(2007-10#2)
3 days in##6##3##(1995-2#1)(2007-10#4)(2008-10#1)
3 days later##2##3##(2008-5#1)(2012-8#1)
3 days of exposure##2##4##(1997-4#1)(2008-10#1)
3 days of##9##3##(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)
3 days per week##4##4##(2008-10#1)(2008-9#2)(2013-1#1)
3 days post-transfection##2##3##(2011-2#2)
3 days prior to sampling##2##5##(1996-12#2)
3 days prior to##5##4##(1996-12#3)(2008-10#2)
3 days to##3##3##(2008-10#2)(2010-6#1)
3 days with##2##3##(1993-2#1)(2008-10#1)
3 days##117##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#3)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#3)(2006-10#1)(2007-10#6)(2007-7#1)(2007-8#4)(2008-10#27)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#1)
3 days)##4##2##(1996-5#1)(2008-10#2)(2009-12#1)
3 decades##3##2##(1994-2#1)(2010-3#1)(2012-2#1)
3 deg##2##2##(2008-2#1)(2008-3#1)
3 degrees C##4##3##(1991-5#1)(1991-8#1)(1994-3#1)(2008-3#1)
3 degrees C)##2##3##(2007-11#1)(2008-10#1)
3 degrees and##3##3##(2008-2#2)(2009-10#1)
3 degrees##21##2##(1991-5#1)(1991-8#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)
3 deletion##2##2##(2008-10#1)(2011-2#1)
3 different##8##2##(1991-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
3 dimensional##3##2##(2009-12#1)(2012-12#2)
3 domains##2##2##(1993-11#1)(2009-11#1)
3 doses##4##2##(1991-3#1)(1994-9#1)(1997-4#1)(2008-7#1)
3 drugs##3##2##(2008-10#2)(2010-12#1)
3 episodes##2##2##(1990-6#1)(2008-1#1)
3 families##2##2##(2008-9#2)
3 fold##3##2##(1990-12#1)(2008-11#1)(2008-5#1)
3 for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
3 for##7##2##(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)
3 forms##2##2##(2008-12#1)(2013-1#1)
3 from the##2##3##(1992-8#1)(1993-6#1)
3 from##5##2##(1992-8#1)(1993-6#2)(2008-10#1)(2008-8#1)
3 fs##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
3 fucosyltransferase##2##2##(1992-8#2)
3 g##5##2##(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#1)
3 g/L##2##2##(2008-6#2)
3 g/dL##2##2##(2007-12#1)(2008-7#1)
3 g/l##2##2##(1990-12#1)(2008-11#1)
3 groups of##4##3##(1991-2#1)(1997-4#1)(2007-10#1)(2007-11#1)
3 groups##15##2##(1991-2#1)(1997-4#1)(2007-10#3)(2007-11#1)(2008-10#2)(2008-12#1)(2009-3#1)(2011-2#1)(2012-4#1)(2013-1#2)(2013-7#1)
3 h after the##2##4##(1995-3#1)(2008-10#1)
3 h after##6##3##(1991-9#1)(1995-3#2)(2008-10#3)
3 h and##3##3##(1990-7#1)(1995-3#1)(2008-12#1)
3 h at##5##3##(1993-12#1)(2008-10#1)(2013-1#3)
3 h before##3##3##(1995-3#1)(2008-12#1)(2010-8#1)
3 h for##2##3##(2008-5#1)(2011-2#1)
3 h of##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
3 h##52##2##(1990-7#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-5#1)(1995-11#1)(1995-3#5)(1995-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-10#14)(2008-12#4)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)
3 h) and##2##3##(2008-10#1)(2011-3#1)
3 h)##3##2##(2007-8#1)(2008-10#1)(2011-3#1)
3 had a##4##3##(1996-6#1)(2008-6#1)(2012-3#1)(2013-1#1)
3 had the##2##3##(2008-10#1)(2008-11#1)
3 had##13##2##(1991-11#1)(1992-12#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#3)(2012-3#1)(2013-1#2)
3 has been##2##3##(1995-3#1)(1996-2#1)
3 have a##2##3##(1990-5#1)(2013-8#1)
3 have##3##2##(1990-5#1)(2013-8#2)
3 hospitals##3##2##(1990-6#2)(1995-1#1)
3 hours of##2##3##(2007-9#1)(2013-1#1)
3 hours##13##2##(1993-3#1)(1994-11#1)(1994-6#1)(2007-10#2)(2007-9#1)(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
3 hr##4##2##(1993-1#1)(1995-2#2)(2008-9#1)
3 in the B##2##4##(2008-10#2)
3 in the##8##3##(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#4)(2011-2#1)
3 in##26##2##(1992-12#1)(1992-2#1)(1993-11#1)(1994-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#3)
3 is a##2##3##(2007-7#1)(2012-3#1)
3 is##11##2##(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2012-3#1)(2013-7#1)
3 isolates##5##2##(2008-10#5)
3 kDa##4##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
3 kJ mol(-1)##2##3##(1996-2#1)(2008-10#1)
3 kJ##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
3 kb in##2##3##(1994-11#1)(2008-8#1)
3 kb of##2##3##(1990-8#1)(2008-12#1)
3 kb to##2##3##(1997-2#1)(2012-3#1)
3 kb##28##2##(1990-12#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-9#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
3 kb)##2##2##(2008-10#1)(2010-3#1)
3 kcal/mol##4##2##(1990-3#2)(1993-8#1)(1994-3#1)
3 kg##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-3#1)
3 kilobases##2##2##(1990-11#1)(1997-9#1)
3 km##3##2##(2008-2#1)(2008-3#2)
3 l/min##2##2##(2007-8#2)
3 lesions##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
3 logs##2##2##(1997-6#1)(2012-2#1)
3 m##5##2##(2007-5#4)(2008-10#1)
3 m)##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
3 mL of##3##3##(2008-6#1)(2013-1#2)
3 mL##5##2##(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#2)
3 mM FeEDDHA##2##3##(2008-10#2)
3 mM NEM##2##3##(1995-8#2)
3 mM and##2##3##(1995-5#1)(2008-6#1)
3 mM for##2##3##(1991-12#1)(1991-5#1)
3 mM##24##2##(1990-11#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#3)(1997-2#1)(2008-10#5)(2008-6#1)(2011-2#1)
3 mM) in##2##3##(1992-6#1)(2010-11#1)
3 mM)##8##2##(1992-11#1)(1992-6#1)(1992-9#1)(1995-8#2)(2008-10#1)(2010-11#1)(2011-2#1)
3 mV per concentration##2##4##(2008-10#2)
3 mV##4##2##(1991-9#1)(2008-10#3)
3 mW##2##2##(2007-12#1)(2008-3#1)
3 major##2##2##(1991-11#1)(2012-2#1)
3 mg 6-APA h(-1) mg(-1) wet##2##6##(2008-12#2)
3 mg l(-1)##2##3##(2008-10#2)
3 mg of##3##3##(2008-10#1)(2010-12#2)
3 mg##21##2##(1995-11#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)
3 mg/dL##3##2##(2006-10#2)(2008-7#1)
3 mg/kg body weight)##2##4##(2007-7#1)(2012-2#1)
3 mg/kg i##3##3##(1995-12#1)(1996-2#2)
3 mg/kg or greater##3##4##(2008-9#3)
3 mg/kg or##5##3##(2008-9#5)
3 mg/kg##27##2##(1994-2#1)(1995-12#2)(1996-12#3)(1996-2#2)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#13)(2012-2#1)
3 mg/kg)##2##2##(1993-12#1)(2013-1#1)
3 mg/l##2##2##(1990-2#1)(2012-2#1)
3 mg/liter propiconazole)##2##3##(2008-10#2)
3 mg/m2##2##2##(1990-2#1)(1992-12#1)
3 microM and##2##3##(1990-8#1)(1995-8#1)
3 microM for##3##3##(1992-12#1)(1994-8#1)(1997-4#1)
3 microM##15##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-8#3)(1992-12#2)(1994-11#1)(1994-8#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)
3 microM) and##2##3##(1993-3#1)(2013-1#1)
3 microM)##5##2##(1992-9#1)(1993-3#1)(1994-11#1)(1997-4#1)(2013-1#1)
3 microg l(-1)##5##3##(2008-10#5)
3 microg##8##2##(1997-4#1)(2008-10#5)(2008-7#1)(2009-6#1)
3 micrograms##2##2##(1990-8#1)(1992-3#1)
3 micrograms/ml in the##2##4##(1992-2#2)
3 microm for##2##3##(2008-2#1)(2008-3#1)
3 microm##17##2##(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)
3 microm)##2##2##(2008-10#1)(2011-1#1)
3 microns)##2##2##(1991-5#1)(1996-5#1)
3 microrad##2##2##(2008-3#2)
3 million##11##2##(1992-6#2)(1994-9#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
3 million)##3##2##(1996-11#3)
3 min after##2##3##(1993-8#1)(2013-8#1)
3 min exposure##2##3##(1991-2#1)(2008-11#1)
3 min of##4##3##(2008-10#4)
3 min##35##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1992-11#1)(1993-8#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2013-1#5)(2013-8#1)
3 minutes##2##2##(1994-7#1)(2007-10#1)
3 ml min(-1)##2##3##(2008-10#2)
3 ml of 1##2##4##(2008-10#2)
3 ml of##6##3##(2008-10#6)
3 ml##14##2##(1995-3#1)(1996-12#1)(2008-10#12)
3 mm Hg##3##3##(1992-5#1)(1995-12#1)(2008-3#1)
3 mm and##2##3##(2008-2#1)(2013-1#1)
3 mm for##2##3##(2007-7#1)(2012-1#1)
3 mm in diameter##4##4##(2007-8#2)(2008-12#1)(2011-2#1)
3 mm in##5##3##(2007-8#2)(2008-12#1)(2011-2#1)(2013-1#1)
3 mm of the floret##2##5##(2008-10#2)
3 mm of##5##3##(2008-10#3)(2010-10#1)(2013-1#1)
3 mm x##2##3##(2007-12#1)(2008-3#1)
3 mm##45##2##(1991-5#2)(1992-5#1)(1992-9#1)(1993-1#1)(1994-5#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)
3 mm)##3##2##(1990-7#1)(2008-12#1)(2012-3#1)
3 mmHg)##2##2##(1997-3#1)(2008-11#1)
3 mmol/1##2##2##(1995-12#2)
3 mmol/l##5##2##(1991-11#1)(1993-3#1)(1995-11#3)
3 mo##2##2##(2010-3#1)(2011-2#1)
3 mol l(-1)##4##3##(2008-10#4)
3 mol##6##2##(1994-5#1)(2008-10#5)
3 monoclonal##2##2##(1991-2#1)(2008-5#1)
3 month##5##2##(1993-9#1)(2007-10#1)(2007-2#1)(2008-12#1)(2011-2#1)
3 months after surgery##2##4##(2008-7#1)(2011-2#1)
3 months after the##3##4##(1994-1#1)(2008-5#1)(2013-1#1)
3 months after##18##3##(1990-6#1)(1991-6#1)(1993-12#1)(1994-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)
3 months and##3##3##(1997-3#1)(2007-11#1)(2012-12#1)
3 months at##3##3##(2008-10#2)(2008-5#1)
3 months later##6##3##(1993-3#1)(1994-12#1)(1995-6#1)(2007-11#1)(2008-10#1)(2011-2#1)
3 months of age##6##4##(1992-5#1)(1993-12#1)(1995-8#2)(2008-9#1)(2009-6#1)
3 months of the##2##4##(2008-3#1)(2008-5#1)
3 months of##18##3##(1991-8#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-8#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
3 months previously##2##3##(2008-5#1)(2010-6#1)
3 months prior to##2##4##(2007-12#1)(2008-10#1)
3 months to##2##3##(2007-8#1)(2008-9#1)
3 months was##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
3 months with##3##3##(2008-10#2)(2013-1#1)
3 months without any##7##4##(2008-10#7)
3 months without##8##3##(2008-10#8)
3 months##166##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-5#2)(1993-12#4)(1993-3#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#37)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#8)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#4)(2010-7#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#4)
3 months)##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
3 ms##2##2##(1993-3#1)(1997-8#1)
3 ms)##3##2##(2012-12#1)(2013-1#2)
3 mu g##3##3##(1995-12#3)
3 mu##4##2##(1995-12#4)
3 mug kg(-1)##3##3##(2008-10#1)(2008-5#2)
3 mug l(-1) for the##2##5##(2008-10#2)
3 mug l(-1) for##4##4##(2008-10#4)
3 mug l(-1)##7##3##(2008-10#7)
3 mug ml(-1)##6##3##(2008-10#5)(2008-11#1)
3 mug##24##2##(2008-10#20)(2008-11#1)(2008-5#3)
3 mum for##2##3##(2008-10#1)(2008-2#1)
3 mum##9##2##(1992-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)
3 mum)##2##2##(2007-12#1)(2008-10#1)
3 nM##7##2##(1990-7#1)(1991-8#1)(1992-6#1)(1995-12#2)(1995-8#1)(2008-9#1)
3 nM) and##2##3##(1994-8#1)(1995-8#1)
3 nM)##7##2##(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)
3 ng cm(-2)##2##3##(2008-10#2)
3 ng l(-1)##2##3##(2008-10#2)
3 ng ml(-1) for##2##4##(2008-10#2)
3 ng ml(-1)##5##3##(2008-10#5)
3 ng##19##2##(1990-8#1)(1995-12#2)(1995-2#1)(2008-10#15)
3 ng/ml##2##2##(1991-4#1)(2008-7#1)
3 ngl(-1))##2##2##(2008-10#2)
3 nm for##2##3##(2007-11#1)(2008-8#1)
3 nm resolution##2##3##(2008-4#1)(2008-8#1)
3 nm##18##2##(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#3)
3 nmol##2##2##(1997-6#1)(2008-10#1)
3 novel genetic variations##2##4##(2013-1#2)
3 ns##3##2##(2007-11#1)(2008-3#2)
3 of 7##2##3##(1993-3#1)(2008-7#1)
3 of the 4##2##4##(1990-7#1)(2008-10#1)
3 of the substrate/product##2##4##(1995-5#2)
3 of the##15##3##(1990-7#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1995-5#2)(2008-10#3)(2008-11#1)(2008-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
3 of whom##2##3##(1991-3#1)(1996-6#1)
3 of##51##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
3 on##3##2##(1996-12#1)(2008-10#2)
3 or 4 of##2##4##(1990-7#1)(2008-10#1)
3 or 4 were##2##4##(1993-1#1)(2007-8#1)
3 or 4##9##3##(1990-7#1)(1993-1#1)(1993-12#1)(1996-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2009-4#1)(2011-2#1)
3 or 4)##2##3##(2008-10#2)
3 or 5##5##3##(1992-8#1)(1994-11#1)(1996-3#1)(2008-10#1)(2013-1#1)
3 or 6##3##3##(1997-2#1)(1997-3#1)(2008-9#1)
3 or MCA##2##3##(1990-8#2)
3 or more##3##3##(1992-2#1)(1993-9#1)(2008-3#1)
3 or##32##2##(1990-7#1)(1990-8#2)(1992-2#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#3)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
3 orders of magnitude lower than##2##6##(2008-2#1)(2008-3#1)
3 orders of magnitude##11##4##(1990-7#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)
3 orders##12##2##(1990-7#1)(1992-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)
3 other##4##2##(1990-2#1)(2008-5#1)(2009-11#1)(2011-2#1)
3 out of##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
3 pairs##2##2##(1993-3#1)(2008-5#1)
3 patients are still##2##4##(1990-2#1)(2011-2#1)
3 patients had##5##3##(2008-11#1)(2008-7#1)(2009-3#1)(2010-3#2)
3 patients in##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
3 patients showed a##2##4##(1994-12#1)(2007-10#1)
3 patients were##2##3##(1991-8#1)(1996-11#1)
3 patients who##2##3##(2007-9#1)(2008-1#1)
3 patients with##5##3##(1996-11#1)(2007-11#2)(2007-8#1)(2011-2#1)
3 patients##54##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-2#1)(1991-8#4)(1992-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-11#1)(1996-11#2)(1996-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#8)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2009-3#1)(2010-3#2)(2011-2#5)(2013-1#2)
3 peptides##2##2##(1991-5#1)(2011-2#1)
3 per cent of##2##4##(1994-7#1)(2008-7#1)
3 per cent##3##3##(1990-6#1)(1994-7#1)(2008-7#1)
3 per##4##2##(1990-6#1)(1994-7#1)(2008-7#1)(2012-3#1)
3 percent##6##2##(1990-5#1)(1991-3#1)(1996-2#1)(1997-3#1)(2008-1#1)(2010-8#1)
3 pg (recommended##2##3##(2008-10#2)
3 pg##6##2##(1995-5#1)(2008-10#5)
3 pm##2##2##(2008-2#1)(2008-5#1)
3 pmol##2##2##(1990-8#1)(2011-3#1)
3 pmol/l##2##2##(1993-12#2)
3 points##4##2##(1994-6#1)(2007-11#1)(2008-3#1)(2013-1#1)
3 points)##2##2##(2008-7#1)(2008-9#1)
3 pops##2##2##(2008-12#2)
3 ppb##3##2##(2008-10#3)
3 ppm##6##2##(1993-6#1)(1995-5#1)(2008-10#3)(2008-5#1)
3 protein##2##2##(2008-9#2)
3 ratio##2##2##(2008-10#2)
3 recovery##2##2##(2008-5#1)(2008-8#1)
3 recurrences##2##2##(1990-3#1)(2008-11#1)
3 region##2##2##(1997-2#1)(1997-7#1)
3 s##3##2##(1992-5#1)(1996-5#1)(2008-11#1)
3 s)##2##2##(2008-10#2)
3 secretory cells##2##3##(2007-12#2)
3 secretory##3##2##(2007-12#3)
3 showed##3##2##(1992-12#1)(1994-7#1)(2011-2#1)
3 sialylated##2##2##(1992-12#1)(1992-8#1)
3 stage##2##2##(2010-6#1)(2011-2#1)
3 strain##2##2##(1993-12#2)
3 strains in 1##2##4##(2007-11#2)
3 strains in##4##3##(2007-11#4)
3 strains##6##2##(2007-11#4)(2008-10#2)
3 studies##2##2##(2008-7#2)
3 subunit of the##2##4##(1995-11#1)(1997-4#1)
3 subunit##5##2##(1995-11#1)(1997-4#3)(2010-12#1)
3 successive generations##2##3##(2007-10#2)
3 successive##3##2##(2007-10#2)(2008-10#1)
3 that is##2##3##(1997-2#1)(2010-3#1)
3 that##5##2##(1995-6#1)(1997-2#1)(2008-3#1)(2010-3#1)(2012-12#1)
3 through##3##2##(1995-1#1)(2008-8#1)(2009-7#1)
3 time points##2##3##(2008-5#1)(2013-1#1)
3 times a day##2##4##(1996-2#1)(2007-11#1)
3 times a##4##3##(1996-2#1)(1996-6#1)(2007-11#1)(2013-1#1)
3 times and##2##3##(2008-8#1)(2011-1#1)
3 times higher than##2##4##(1994-11#1)(2008-11#1)
3 times higher##5##3##(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
3 times more##2##3##(1996-12#1)(2008-11#1)
3 times of that##2##4##(2008-3#1)(2008-8#1)
3 times per week for##2##5##(2013-1#1)(2013-8#1)
3 times smaller than##2##4##(1994-5#1)(2008-2#1)
3 times that##2##3##(2008-11#1)(2008-3#1)
3 times the##2##3##(2008-10#1)(2009-4#1)
3 times##37##2##(1992-6#1)(1993-12#1)(1994-11#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
3 times/week##2##2##(2007-7#2)
3 to 0##3##3##(1996-7#1)(2008-2#1)(2013-1#1)
3 to 1##10##3##(1992-3#1)(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2012-12#2)
3 to 10##4##3##(2008-10#2)(2010-2#1)(2010-5#1)
3 to 102##3##3##(2008-10#3)
3 to 108##3##3##(2008-10#3)
3 to 11##2##3##(2008-10#1)(2008-5#1)
3 to 12##2##3##(2008-10#1)(2013-8#1)
3 to 2##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
3 to 20##2##3##(1991-12#1)(2008-10#1)
3 to 22##3##3##(1991-9#1)(2008-10#1)(2008-7#1)
3 to 23##2##3##(2008-10#1)(2009-7#1)
3 to 4 days##3##4##(2008-10#2)(2009-3#1)
3 to 4 months##2##4##(2008-1#1)(2008-10#1)
3 to 4 weeks##2##4##(2008-10#1)(2008-5#1)
3 to 4##12##3##(1992-5#1)(2008-1#2)(2008-10#6)(2008-5#1)(2008-7#1)(2009-3#1)
3 to 4%##2##3##(1997-6#1)(2008-9#1)
3 to 5 weeks##4##4##(2008-10#3)(2011-2#1)
3 to 5##15##3##(1991-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2010-1#2)(2011-2#1)
3 to 6 months##2##4##(2007-10#1)(2011-2#1)
3 to 6 weeks##2##4##(2007-7#1)(2008-9#1)
3 to 6##6##3##(2007-10#2)(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
3 to 7 days in other 2 models##2##8##(2007-10#2)
3 to 7##5##3##(1990-11#1)(1996-5#1)(2007-10#2)(2007-2#1)
3 to 8 weeks of age##2##6##(2008-10#1)(2011-2#1)
3 to 8 weeks of##3##5##(1991-3#1)(2008-10#1)(2011-2#1)
3 to 8##10##3##(1990-11#1)(1991-3#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#2)
3 to 9 months##2##4##(2007-8#1)(2012-3#1)
3 to 9##3##3##(2007-8#1)(2008-10#1)(2012-3#1)
3 to 97##2##3##(2008-10#1)(2012-3#1)
3 to##145##2##(1990-11#2)(1990-5#2)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#4)(2007-11#5)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#55)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#4)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-3#2)(2013-1#4)(2013-8#2)
3 trials##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
3 types of##3##3##(1997-4#1)(2011-1#1)(2012-3#1)
3 types##6##2##(1997-4#1)(2007-10#3)(2011-1#1)(2012-3#1)
3 university##2##2##(1990-12#2)
3 using##3##2##(1991-9#1)(1997-8#1)(2008-8#1)
3 versus##2##2##(2007-7#1)(2008-10#1)
3 vs##11##2##(1997-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-4#2)(2011-2#3)(2012-3#1)
3 was##25##2##(1991-8#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-4#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)
3 week##2##2##(1996-5#2)
3 weeks after inoculation##2##4##(2008-10#2)
3 weeks after the##2##4##(1994-9#1)(1996-2#1)
3 weeks after##7##3##(1994-5#1)(1994-9#1)(1996-2#1)(2008-10#4)
3 weeks before##3##3##(2008-10#3)
3 weeks later##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
3 weeks of age##2##4##(1997-6#1)(2008-9#1)
3 weeks of treatment##2##4##(1996-5#1)(2008-11#1)
3 weeks of##12##3##(1993-8#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-5#3)(2008-9#1)(2010-1#1)(2011-2#1)
3 weeks to##2##3##(2008-2#1)(2008-7#1)
3 weeks##73##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-2#1)(1991-6#2)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#2)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
3 weeks)##3##2##(1992-12#1)(2007-11#1)(2008-10#1)
3 were located##2##3##(2008-6#1)(2013-1#1)
3 were not##2##3##(2010-10#1)(2012-12#1)
3 were obtained by##2##4##(1995-3#1)(2008-10#1)
3 were treated with##2##4##(2008-7#2)
3 were##22##2##(1991-2#1)(1992-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
3 with##15##2##(1990-5#1)(1990-9#2)(1992-12#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#2)
3 women##3##2##(1990-9#1)(2008-11#1)(2012-12#1)
3 x 10(-10)##2##3##(2007-12#1)(2013-8#1)
3 x 10(-3)##2##3##(2008-3#2)
3 x 10(-4)##3##3##(1994-5#1)(2008-3#2)
3 x 10(-5) M##2##4##(1991-8#1)(1994-11#1)
3 x 10(-5)##5##3##(1991-8#1)(1994-11#1)(2008-2#2)(2008-3#1)
3 x 10(-6)##3##3##(1992-3#1)(1997-8#1)(2008-3#1)
3 x 10(-9) M##3##4##(1991-5#1)(1994-2#1)(1995-11#1)
3 x 10(-9)##5##3##(1991-5#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-3#1)
3 x 10(3)##2##3##(1992-12#1)(2008-10#1)
3 x 10(5)##2##3##(1994-5#1)(2008-3#1)
3 x 10(6) M-1)##2##4##(1992-4#2)
3 x 10(6)##8##3##(1990-12#1)(1992-4#2)(1993-1#1)(1996-5#1)(2008-10#2)(2008-11#1)
3 x 10(7)##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
3 x##65##2##(1990-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#2)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-11#2)(1995-2#1)(1996-5#2)(1997-4#1)(1997-8#3)(2007-12#2)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2013-8#1)
3 year period##3##3##(2008-7#2)(2010-6#1)
3 year##6##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-6#1)
3 years after##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
3 years and 9 months##2##5##(1997-7#1)(2012-3#1)
3 years and##8##3##(1994-1#1)(1994-9#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
3 years at three##2##4##(2008-10#2)
3 years at##3##3##(2008-10#3)
3 years earlier##3##3##(2008-2#1)(2008-7#1)(2010-6#1)
3 years for##2##3##(1990-9#1)(2013-7#1)
3 years in##3##3##(1990-6#1)(2008-10#1)(2013-8#1)
3 years of age##4##4##(1994-1#1)(2007-11#1)(2007-8#1)(2011-2#1)
3 years of field##2##4##(2008-10#2)
3 years of the study##2##5##(2008-10#2)
3 years of##22##3##(1991-8#1)(1992-6#1)(1994-1#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
3 years##115##2##(1990-6#1)(1990-9#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-9#2)(1995-12#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#9)(2008-1#1)(2008-10#37)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#3)(2009-9#1)(2010-1#1)(2010-3#4)(2010-4#1)(2010-6#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
3 years)##8##2##(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-1#1)
3 yr##5##2##(2008-7#5)
3 ± 0##2##3##(2010-10#1)(2012-12#1)
3 ±##9##2##(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#4)
3 Å##3##2##(1997-7#1)(2009-11#1)(2012-2#1)
3##5879##1##(1990-10#3)(1990-11#48)(1990-12#33)(1990-2#31)(1990-3#8)(1990-5#38)(1990-6#12)(1990-7#30)(1990-8#31)(1990-9#10)(1991-1#4)(1991-10#1)(1991-11#16)(1991-12#29)(1991-2#26)(1991-3#13)(1991-4#3)(1991-5#29)(1991-6#12)(1991-7#1)(1991-8#36)(1991-9#21)(1992-1#2)(1992-10#3)(1992-11#15)(1992-12#33)(1992-2#18)(1992-3#37)(1992-4#8)(1992-5#14)(1992-6#28)(1992-7#1)(1992-8#21)(1992-9#17)(1993-1#10)(1993-11#29)(1993-12#39)(1993-2#13)(1993-3#16)(1993-5#3)(1993-6#16)(1993-8#34)(1993-9#14)(1994-1#4)(1994-11#23)(1994-12#28)(1994-2#24)(1994-3#22)(1994-5#19)(1994-6#11)(1994-7#10)(1994-8#28)(1994-9#14)(1995-1#4)(1995-10#1)(1995-11#51)(1995-12#46)(1995-2#17)(1995-3#40)(1995-4#4)(1995-5#22)(1995-6#21)(1995-8#25)(1995-9#3)(1996-10#1)(1996-11#12)(1996-12#27)(1996-2#54)(1996-3#5)(1996-4#1)(1996-5#43)(1996-6#10)(1996-7#1)(1996-8#4)(1996-9#8)(1997-1#10)(1997-2#29)(1997-3#28)(1997-4#43)(1997-5#10)(1997-6#24)(1997-7#45)(1997-8#24)(1997-9#7)(2006-10#8)(2006-12#3)(2007-10#51)(2007-11#132)(2007-12#111)(2007-2#8)(2007-4#3)(2007-5#12)(2007-6#1)(2007-7#34)(2007-8#74)(2007-9#3)(2008-1#46)(2008-10#1602)(2008-11#157)(2008-12#90)(2008-2#94)(2008-3#194)(2008-4#43)(2008-5#129)(2008-6#54)(2008-7#138)(2008-8#88)(2008-9#121)(2009-1#4)(2009-10#10)(2009-11#15)(2009-12#8)(2009-2#8)(2009-3#7)(2009-4#5)(2009-5#12)(2009-6#11)(2009-7#17)(2009-8#10)(2009-9#10)(2010-1#9)(2010-10#8)(2010-11#7)(2010-12#11)(2010-2#11)(2010-3#33)(2010-4#20)(2010-5#17)(2010-6#20)(2010-7#5)(2010-8#25)(2010-9#4)(2011-1#84)(2011-2#214)(2011-3#12)(2012-1#8)(2012-12#69)(2012-2#64)(2012-3#76)(2012-4#1)(2012-6#3)(2012-7#3)(2012-8#1)(2013-1#168)(2013-3#1)(2013-7#11)(2013-8#72)
3% (n=10)##3##2##(2008-10#3)
3% (n=5)##2##2##(2008-10#2)
3% (p = 0##2##4##(1993-1#1)(2013-1#1)
3% (v/v)##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
3% (w/v)##3##2##(2008-10#2)(2008-6#1)
3% (w/w)##3##2##(2008-10#2)(2010-2#1)
3% R##2##2##(2008-10#2)
3% SDS##2##2##(2012-2#2)
3% after##2##2##(2008-10#2)
3% and 1##3##3##(2008-10#3)
3% and 100##2##3##(2008-10#1)(2011-1#1)
3% and 2##3##3##(2007-11#1)(2007-8#1)(2008-9#1)
3% and 64##2##3##(2008-12#1)(2011-2#1)
3% and 99##3##3##(2008-5#3)
3% and a##2##3##(2012-3#1)(2013-1#1)
3% and by##2##3##(2007-7#1)(2007-8#1)
3% and that of##2##4##(2008-10#1)(2008-3#1)
3% and the##8##3##(1993-3#1)(1996-12#1)(2008-10#5)(2008-7#1)
3% and##58##2##(1990-11#1)(1990-2#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#4)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
3% are##2##2##(2007-5#1)(2013-1#1)
3% at 10##3##3##(1993-9#1)(2007-11#1)(2008-10#1)
3% at the##3##3##(1993-6#1)(2008-10#2)
3% at##12##2##(1991-8#1)(1993-6#1)(1993-9#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2012-12#1)
3% by the gel##2##4##(2011-1#2)
3% by##3##2##(2008-5#1)(2011-1#2)
3% expressed##2##2##(2008-10#2)
3% for all##3##3##(2008-10#1)(2008-3#2)
3% for the##6##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
3% for##38##2##(1991-3#1)(1991-9#1)(1992-11#1)(1996-12#1)(1996-5#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
3% had had##2##3##(1991-11#1)(2010-6#1)
3% had##8##2##(1991-11#1)(1993-6#1)(1997-4#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-3#1)(2013-8#1)
3% husbands##2##2##(2007-7#2)
3% in 2##2##3##(2010-8#2)
3% in a##2##3##(2008-2#1)(2008-3#1)
3% in children##2##3##(2011-2#1)(2013-8#1)
3% in group##2##3##(2008-1#2)
3% in the##7##3##(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#1)
3% in young cirrhotics vs##2##5##(2012-3#2)
3% in##35##2##(1991-5#1)(1995-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#2)(2010-8#4)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#2)
3% increase##2##2##(1995-5#1)(2013-8#1)
3% indicating##2##2##(2008-10#2)
3% kojic acid##2##3##(2008-5#2)
3% of all##2##3##(1997-2#1)(2008-10#1)
3% of cases##2##3##(2007-8#1)(2013-1#1)
3% of patients##5##3##(2007-11#2)(2007-8#1)(2012-3#1)(2013-1#1)
3% of the cases##2##4##(1991-12#1)(2008-11#1)
3% of the elderly and##2##5##(1994-6#2)
3% of the patients##4##4##(1990-12#1)(1990-2#1)(1991-3#1)(2009-3#1)
3% of the samples from##2##5##(2008-12#2)
3% of the samples##3##4##(2008-12#2)(2013-1#1)
3% of the total##6##4##(1990-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-11#1)(2013-1#1)
3% of the variance##2##4##(2012-1#1)(2013-1#1)
3% of the##43##3##(1990-12#2)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-6#4)(1995-2#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
3% of them##2##3##(2007-7#1)(2008-7#1)
3% of total##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
3% of##92##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#3)(2007-11#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#9)(2013-8#1)
3% p &lt##2##3##(2009-8#2)
3% reagent in xylene from##2##5##(2008-10#2)
3% relative standard deviation##2##4##(2008-10#2)
3% respectively##3##2##(2013-1#2)(2013-8#1)
3% to 6##2##3##(1993-3#1)(2007-10#1)
3% to##8##2##(1990-3#1)(1993-3#1)(1994-12#1)(2007-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
3% versus##3##2##(2008-10#1)(2013-1#2)
3% vs 0%)##2##3##(2010-4#2)
3% vs 26##2##3##(2010-4#2)
3% vs 6##3##3##(2010-4#3)
3% vs##19##2##(1991-5#2)(1993-1#1)(2007-10#1)(2008-4#1)(2009-8#1)(2010-4#9)(2011-2#2)(2012-3#1)(2013-8#1)
3% w/v##2##2##(2008-10#2)
3% was##2##2##(1991-3#1)(2008-10#1)
3% were male and 46##2##5##(2013-1#2)
3% were##12##2##(1995-6#1)(2007-11#1)(2008-10#4)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
3% with a##2##3##(2008-5#1)(2011-3#1)
3% with##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-3#1)
3%##621##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#3)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-3#3)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#6)(1994-8#1)(1994-9#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#8)(2007-11#9)(2007-12#4)(2007-2#2)(2007-5#2)(2007-7#8)(2007-8#12)(2008-1#7)(2008-10#177)(2008-11#14)(2008-12#15)(2008-2#9)(2008-3#25)(2008-4#2)(2008-5#17)(2008-6#7)(2008-7#11)(2008-8#6)(2008-9#17)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#4)(2010-2#1)(2010-3#5)(2010-4#11)(2010-5#1)(2010-6#2)(2010-8#7)(2011-1#14)(2011-2#26)(2011-3#1)(2012-1#5)(2012-12#10)(2012-2#10)(2012-3#15)(2013-1#33)(2013-8#17)
3%) and in##2##3##(1990-8#1)(2013-1#1)
3%) and##27##2##(1990-11#1)(1990-8#1)(1991-9#1)(1996-9#1)(1997-8#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#2)(2011-2#1)(2013-1#4)(2013-8#1)
3%) are##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
3%) as compared to##2##4##(1991-9#1)(2007-7#1)
3%) cases##3##2##(2007-7#2)(2011-2#1)
3%) for##6##2##(2007-7#1)(2008-10#3)(2011-2#1)(2012-2#1)
3%) had##5##2##(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
3%) in the##5##3##(1991-12#1)(1992-3#1)(2007-8#1)(2008-10#2)
3%) in##10##2##(1991-12#1)(1992-3#1)(1993-1#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2011-1#2)
3%) of mammary##2##3##(1992-9#2)
3%) of the##2##3##(2008-9#1)(2010-4#1)
3%) of##9##2##(1992-9#2)(2007-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#1)(2013-8#1)
3%) patients and##2##3##(1997-8#1)(2008-1#1)
3%) patients##11##2##(1995-12#1)(1997-8#2)(2007-7#1)(2008-1#3)(2008-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
3%) than in##2##3##(1991-6#1)(2011-2#1)
3%) than##4##2##(1991-6#1)(1992-5#1)(2008-1#1)(2011-2#1)
3%) underwent##2##2##(2008-11#1)(2008-8#1)
3%) was##7##2##(1990-8#1)(1992-6#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
3%) were the##2##3##(2008-4#1)(2011-1#1)
3%) were##15##2##(1990-2#1)(1994-12#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)
3%)##247##1##(1990-11#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1994-12#1)(1995-12#2)(1996-1#1)(1996-9#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#14)(2007-8#10)(2008-1#17)(2008-10#18)(2008-11#7)(2008-12#10)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#13)(2009-10#1)(2009-8#1)(2010-11#3)(2010-3#3)(2010-4#18)(2010-6#3)(2010-8#1)(2011-1#12)(2011-2#15)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#13)(2013-8#6)
3&lt##2##1##(2008-10#1)(2013-1#1)
3' UTR of##5##3##(1996-12#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
3' UTR##10##2##(1996-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
3' and 5'##2##3##(1994-8#1)(2008-2#1)
3' and##3##2##(1994-8#1)(2008-2#1)(2008-5#1)
3' end formation##3##3##(1997-4#2)(2007-12#1)
3' end of the##19##4##(1991-7#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-4#1)(2013-1#1)
3' end of##29##3##(1991-7#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#2)(2013-1#1)
3' end sequences of##2##4##(2008-11#1)(2008-8#1)
3' end with##2##3##(2008-10#1)(2008-8#1)
3' end##48##2##(1990-2#1)(1991-7#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#6)(1997-7#2)(2007-12#2)(2008-10#11)(2008-11#2)(2008-4#1)(2008-8#6)(2013-1#1)(2013-8#1)
3' ends of the##3##4##(1994-12#1)(1994-8#1)(1995-2#1)
3' ends of##5##3##(1994-12#1)(1994-8#1)(1995-2#1)(2008-8#1)(2008-9#1)
3' ends##12##2##(1992-8#1)(1994-12#1)(1994-8#2)(1995-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
3' exon##2##2##(2008-9#1)(2012-3#1)
3' expression##3##2##(2012-3#3)
3' flanking region of##2##4##(1993-12#2)
3' genomic region##2##3##(2008-10#2)
3' half molecule##2##3##(2008-8#2)
3' kinase##3##2##(1996-2#3)
3' non-coding region##3##3##(1990-7#1)(1993-12#1)(2008-8#1)
3' non-coding##4##2##(1990-7#1)(1993-12#1)(1997-7#1)(2008-8#1)
3' nontranslated regions##2##3##(1992-12#1)(1993-3#1)
3' nontranslated##3##2##(1992-12#1)(1993-3#1)(2008-10#1)
3' or 5'##2##3##(2008-10#1)(2008-7#1)
3' rapid amplification of cDNA ends (RACE)##2##7##(1992-12#1)(2010-5#1)
3' regions of the##2##4##(1997-6#1)(2008-10#1)
3' regions of##3##3##(1992-8#1)(1997-6#1)(2008-10#1)
3' splice site##2##3##(1993-6#1)(1993-8#1)
3' splice##3##2##(1993-6#2)(1993-8#1)
3' splice-site selection##3##3##(1993-6#3)
3' splice-site##4##2##(1993-6#4)
3' termini##6##2##(1990-7#1)(2008-10#2)(2008-5#1)(2008-8#2)
3' terminus of##2##3##(1994-8#1)(2008-10#1)
3' terminus##3##2##(1994-8#1)(2008-10#2)
3' to the##3##3##(1992-11#1)(1995-2#1)(2008-10#1)
3' untranslated region (3' UTR)##2##5##(1997-4#1)(2007-12#1)
3' untranslated region (UTR)##2##4##(1992-8#1)(2008-10#1)
3' untranslated region of##6##4##(1994-11#2)(1995-2#1)(1997-6#2)(2008-7#1)
3' untranslated region##20##3##(1991-9#1)(1992-8#1)(1993-12#1)(1994-11#3)(1994-8#1)(1995-2#2)(1996-12#1)(1997-4#1)(1997-6#3)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#1)
3' untranslated regions of the##2##5##(1990-5#1)(1993-2#1)
3' untranslated regions of##3##4##(1990-5#1)(1993-2#1)(2010-9#1)
3' untranslated regions##4##3##(1990-5#1)(1993-2#1)(1997-8#1)(2010-9#1)
3' untranslated sequence##2##3##(1992-3#1)(1993-8#1)
3' untranslated##27##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#3)(1994-8#1)(1995-2#2)(1996-12#1)(1997-4#1)(1997-6#3)(1997-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#1)
3'##273##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#5)(1991-2#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#7)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#1)(1993-6#7)(1993-8#4)(1993-9#1)(1994-11#8)(1994-12#3)(1994-2#1)(1994-8#8)(1994-9#5)(1995-12#1)(1995-2#5)(1995-3#1)(1995-8#7)(1996-12#7)(1996-2#3)(1996-6#2)(1997-2#5)(1997-3#6)(1997-4#9)(1997-6#5)(1997-7#11)(1997-8#2)(2007-12#4)(2008-1#1)(2008-10#56)(2008-11#6)(2008-2#1)(2008-4#8)(2008-5#3)(2008-7#3)(2008-8#19)(2008-9#4)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#4)(2010-9#2)(2011-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
3'- and##5##2##(1991-9#1)(2008-4#3)(2010-5#1)
3'-##10##1##(1990-5#1)(1991-9#1)(1993-11#1)(1995-3#2)(1997-6#1)(2008-4#3)(2010-5#1)
3'--&gt##2##1##(2008-1#2)
3'-5' exonuclease##7##2##(1997-6#7)
3'-DNA##2##1##(2008-3#2)
3'-NTR##3##1##(2008-10#3)
3'-NTR)##2##1##(2008-10#2)
3'-PAP##2##1##(1991-12#2)
3'-UTR of##2##2##(2008-9#1)(2013-1#1)
3'-UTR##6##1##(1990-12#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-9#1)(2013-1#1)
3'-azido-3'-deoxythymidine (AZT)##2##2##(1992-9#1)(1993-8#1)
3'-azido-3'-deoxythymidine##3##1##(1992-9#2)(1993-8#1)
3'-deoxythymidine diphosphate##2##2##(1992-6#2)
3'-dideoxycytidine##2##1##(1994-11#2)
3'-directed cDNA##3##2##(1996-10#2)(1996-2#1)
3'-end joining##2##2##(1997-3#2)
3'-end processing and joining##2##4##(1997-3#2)
3'-end processing and##3##3##(1997-3#3)
3'-end processing##4##2##(1997-3#4)
3'-end##17##1##(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1997-3#6)(2008-10#3)(2008-4#1)(2008-8#1)(2013-1#2)
3'-methyl-3-hydroxy-chalcone##2##1##(1993-9#2)
3'-noncoding region of##3##3##(1997-2#3)
3'-noncoding##4##1##(1991-2#1)(1997-2#3)
3'-nontranslated region##2##2##(1993-8#1)(2008-10#1)
3'-phosphate##2##1##(1991-3#2)
3'-phosphoglycolate and##2##2##(1991-3#2)
3'-phosphoglycolate##3##1##(1991-3#3)
3'-terminal regions of##2##3##(2008-10#2)
3'-terminal sequence (5'-AUUGCUCU-3')##2##3##(2008-10#2)
3'-terminal##10##1##(1993-8#1)(1997-2#1)(2008-10#6)(2008-8#1)(2008-9#1)
3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1)##2##3##(1993-11#2)
3'-triiodo-L-thyronine##2##1##(1991-5#1)(2008-10#1)
3'-triiodo-l-thyronine##2##1##(2008-10#2)
3'-untranslated region (3'-UTR)##2##3##(1995-12#1)(2013-1#1)
3'-untranslated region and##2##3##(1993-12#1)(2008-10#1)
3'-untranslated region of##2##3##(1995-12#1)(2011-2#1)
3'-untranslated region##10##2##(1990-11#1)(1993-12#1)(1993-2#1)(1995-12#2)(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)
3'-untranslated regions##5##2##(1993-12#1)(1997-4#2)(2008-9#1)(2009-3#1)
3'-untranslated##16##1##(1990-11#1)(1993-12#2)(1993-2#2)(1995-12#2)(1997-4#2)(2008-10#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
3'3'-tetramethylindocarbocyanine perchlorate##2##2##(1997-3#2)
3'ESTs##2##1##(2008-9#2)
3'Me-3-C##3##1##(1993-9#3)
3'NTR##3##1##(2008-10#3)
3'UTR alone##2##2##(2008-10#2)
3'UTR##10##1##(1994-12#3)(2008-10#2)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#1)
3'untranslated region##3##2##(2008-11#3)
3'untranslated##4##1##(2008-11#4)
3(1/2)-6(1/2) years##2##2##(2007-12#2)
3(10)-helical conformation in##2##3##(1995-2#2)
3(10)-helical conformation##4##2##(1995-2#4)
3(10)-helix##2##1##(2008-9#1)(2012-2#1)
3(rd)##4##1##(2008-5#1)(2011-1#2)(2012-2#1)
3) The##2##2##(1992-6#1)(2011-2#1)
3) a##5##2##(1993-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
3) and##16##2##(1993-12#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-8#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
3) are##3##2##(1994-12#1)(1994-8#1)(1996-2#1)
3) families derived from##2##4##(2008-10#2)
3) families##5##2##(2008-10#4)(2008-4#1)
3) for##2##2##(2008-10#1)(2008-3#1)
3) from##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
3) in the##6##3##(1992-6#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)
3) in##11##2##(1992-6#1)(1992-9#1)(1995-2#1)(1996-4#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
3) is##5##2##(2008-10#3)(2010-2#1)(2012-2#1)
3) of##3##2##(1990-8#1)(1993-6#1)(2008-10#1)
3) pg/ml in venous plasma from the##2##7##(1990-5#2)
3) relationship##2##2##(2008-2#2)
3) s##2##2##(2013-8#2)
3) the##7##2##(1991-3#1)(1995-11#1)(1995-6#1)(1997-5#1)(1997-6#1)(2008-7#1)(2008-8#1)
3) there##2##2##(2008-6#1)(2013-8#1)
3) to##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
3) was 0##2##3##(2008-10#1)(2011-1#1)
3) was##12##2##(1990-11#1)(1992-10#2)(1994-5#1)(2008-10#6)(2008-9#1)(2011-1#1)
3) were##5##2##(1990-9#1)(1997-8#1)(2008-10#2)(2013-8#1)
3) x##5##2##(1992-10#1)(1994-5#1)(1995-2#1)(2008-3#2)
3) years##2##2##(1994-12#1)(2008-12#1)
3)##275##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#5)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#4)(1992-3#2)(1992-4#1)(1992-6#7)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-4#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#2)(2007-8#2)(2008-1#2)(2008-10#49)(2008-11#9)(2008-12#6)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#9)(2011-9#1)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#4)(2012-4#1)(2013-1#3)(2013-8#7)
3)-alpha-L-Rhap-(1--&gt##2##1##(1993-11#2)
3)-beta-D-Glcp-(1--&gt##3##1##(1993-11#3)
3)-specific##3##1##(1992-6#2)(1994-12#1)
3)Te(5)##3##1##(2008-3#3)
3)]##2##1##(2008-10#2)
3+##6##1##(1992-9#1)(1994-12#1)(2010-3#1)(2010-4#1)(2010-8#2)
3+/-0##16##1##(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#2)
3+/-1##3##1##(2007-8#1)(2008-10#1)(2008-5#1)
3+/-10##2##1##(2007-8#1)(2008-10#1)
3+/-2##2##1##(2007-11#1)(2008-10#1)
3+/-3##3##1##(2007-8#1)(2008-10#2)
3+1##2##1##(2008-10#1)(2012-3#1)
3- and 1##2##3##(2007-12#1)(2008-2#1)
3- and 15-acetyldeoxynivalenol##2##3##(2008-10#2)
3- and 2##3##3##(1992-9#2)(2007-12#1)
3- and##22##2##(1990-3#2)(1990-8#1)(1991-5#1)(1992-9#2)(1994-8#1)(1995-2#1)(1995-8#1)(1997-8#2)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2012-3#1)
3- or##3##2##(1991-5#1)(2008-11#1)(2008-2#1)
3- to 4-week-old##2##3##(2008-10#1)(2008-9#1)
3- to##5##2##(2008-10#2)(2008-9#1)(2009-11#1)(2013-1#1)
3-##47##1##(1990-2#2)(1990-3#2)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-9#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#2)
3-(2-pyridyl)-5##3##1##(2008-10#3)
3-(3##2##1##(2008-11#1)(2008-5#1)
3-(4##2##1##(2008-11#1)(2012-3#1)
3-(4-thiazolyl)alanine##2##1##(1995-3#2)
3-(N-tert-butylcarboxamido)-1-propyl##3##1##(2008-4#3)
3-0##6##1##(1993-9#1)(1995-6#1)(2008-10#1)(2008-3#2)(2011-2#1)
3-1##12##1##(1990-2#1)(1991-5#2)(1992-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#2)
3-10##7##1##(1991-12#1)(1992-2#1)(1994-12#1)(2007-11#1)(2008-10#1)(2009-11#1)(2013-1#1)
3-101##2##1##(2008-10#2)
3-103##3##1##(2008-10#3)
3-11##4##1##(1995-5#1)(2007-11#1)(2008-3#1)(2008-7#1)
3-12##9##1##(1990-2#1)(1994-3#1)(1995-3#1)(1995-4#2)(2008-10#2)(2008-8#1)(2013-1#1)
3-13##2##1##(2011-1#1)(2012-2#1)
3-15##3##1##(2007-12#1)(2008-3#1)(2008-4#1)
3-2##9##1##(1993-12#1)(1995-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
3-20##6##1##(2008-10#4)(2008-2#1)(2008-7#1)
3-23##2##1##(1991-8#1)(2008-10#1)
3-27##2##1##(2011-3#1)(2013-8#1)
3-3##17##1##(1990-5#1)(1992-8#1)(1995-12#2)(1996-4#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-5#1)(2012-12#1)
3-30##4##1##(1993-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
3-4 days before##2##3##(1990-10#1)(2011-2#1)
3-4 days##9##2##(1990-10#1)(1994-2#1)(1995-2#1)(2008-11#3)(2008-5#1)(2008-8#1)(2011-2#1)
3-4 h##2##2##(1993-12#1)(2008-9#1)
3-4 mole percent##2##3##(1992-6#2)
3-4 months##3##2##(1991-3#1)(1992-4#1)(1994-7#1)
3-4 years##3##2##(1994-12#1)(1994-9#1)(2012-1#1)
3-4##46##1##(1990-10#1)(1991-3#1)(1992-4#1)(1992-6#4)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-2#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)
3-4%##4##1##(1990-6#1)(1996-12#1)(2008-10#1)(2010-5#1)
3-4-fold##5##1##(1994-12#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-8#1)
3-48##2##1##(2008-10#1)(2008-9#1)
3-5 and##2##2##(1997-4#1)(2008-10#1)
3-5 days##2##2##(2007-11#1)(2008-11#1)
3-5 nm##2##2##(2008-2#1)(2013-8#1)
3-5 years##2##2##(1995-8#1)(2008-9#1)
3-5##32##1##(1990-8#1)(1991-6#1)(1992-2#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
3-5%##5##1##(1993-2#1)(2008-10#2)(2013-1#1)(2013-7#1)
3-5)##2##1##(1996-2#1)(2007-8#1)
3-6 h##2##2##(2008-2#1)(2008-9#1)
3-6 months##2##2##(2010-3#1)(2011-2#1)
3-6##19##1##(1994-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
3-7 days##2##2##(1995-2#1)(2008-5#1)
3-7##10##1##(1991-9#2)(1993-2#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-3#2)(2012-12#1)
3-8 weeks##2##2##(1993-12#1)(2008-2#1)
3-8##11##1##(1993-12#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
3-8%##2##1##(2008-7#1)(2011-2#1)
3-9##5##1##(1992-6#1)(1993-6#1)(2008-10#2)(2012-1#1)
3-98##2##1##(2008-10#1)(2013-1#1)
3-99##2##1##(1994-12#1)(2008-10#1)
3-A resolution##3##2##(1993-8#3)
3-A##4##1##(1993-8#3)(2008-3#1)
3-BZ-2 and 2##3##3##(1995-12#3)
3-BZ-2##5##1##(1995-12#5)
3-BZ-2)##2##1##(1995-12#2)
3-BZ-2M##5##1##(1995-12#5)
3-Bromopyruvate##2##1##(2009-4#2)
3-CTC##3##1##(1992-9#3)
3-D CB-EZW##2##2##(2008-3#2)
3-D and##2##2##(2008-10#1)(2011-2#1)
3-D coordinates##2##2##(2008-3#2)
3-D counting##2##2##(2008-4#2)
3-D culture##5##2##(2008-11#4)(2009-3#1)
3-D display##2##2##(2008-2#1)(2008-3#1)
3-D follicles with##2##3##(2012-3#2)
3-D image reconstruction##3##3##(2007-11#1)(2008-3#2)
3-D image##7##2##(2007-11#2)(2008-2#1)(2008-3#3)(2008-5#1)
3-D images##3##2##(2007-11#2)(2008-5#1)
3-D imaging##3##2##(2008-3#2)(2011-1#1)
3-D information##2##2##(2008-3#2)
3-D light##2##2##(2007-12#2)
3-D matrix##2##2##(2008-11#2)
3-D model##6##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-3#1)
3-D object##4##2##(2008-3#4)
3-D objects##2##2##(2008-3#2)
3-D pattern##2##2##(2007-11#1)(2010-5#1)
3-D reconstruction##3##2##(2008-4#3)
3-D structure##4##2##(2008-4#1)(2008-8#2)(2011-1#1)
3-D##114##1##(1994-5#1)(2007-11#6)(2007-12#4)(2007-8#2)(2008-10#1)(2008-11#14)(2008-12#1)(2008-2#7)(2008-3#38)(2008-4#8)(2008-5#2)(2008-8#5)(2009-3#2)(2009-5#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-2#5)(2012-3#2)(2013-1#1)
3-DNB##3##1##(2008-10#3)
3-DNB)##2##1##(2008-10#2)
3-DPG##2##1##(1990-8#2)
3-Deazaadenosine##2##1##(2011-2#2)
3-Epoxy##2##1##(1996-5#2)
3-Glucanase Genes in##2##3##(2008-10#2)
3-Glucanase##7##1##(2008-10#7)
3-MONTH STUDY IN B6C3F(1) MICE##2##5##(2008-9#2)
3-MONTH STUDY IN RATS##2##4##(2008-9#2)
3-MONTH STUDY IN##4##3##(2008-9#4)
3-Mb##2##1##(1997-8#2)
3-Methylcholanthrene (1 nM)##2##3##(2008-11#2)
3-O-Carbonate##2##1##(2008-5#2)
3-O-methyltransferase##2##1##(2008-11#2)
3-OH##2##1##(2008-9#1)(2010-11#1)
3-OHDBTL##3##1##(1993-12#3)
3-TFMPD##2##1##(1995-3#2)
3-W##2##1##(2007-11#1)(2008-3#1)
3-WEEK STUDY IN##2##3##(2008-9#2)
3-alternate calix[4]azacrown ethers##2##3##(2008-10#2)
3-alternate conformation##3##2##(2008-10#3)
3-alternate thiacalix[4]biscrown-6##3##2##(2008-10#3)
3-alternate##11##1##(2008-10#11)
3-amino-1##4##1##(1997-4#1)(2008-10#1)(2008-2#1)(2009-2#1)
3-amino-4-hydroxyphenylarsonic acid##2##2##(2008-10#2)
3-amino-benzamide##2##1##(1991-9#1)(1992-3#1)
3-aminoalkylated indoles##3##2##(2012-3#3)
3-aminopropyltriethoxysilane##2##1##(1991-5#1)(2008-10#1)
3-benzenedisulfonic acid##3##2##(2008-10#3)
3-benzodiazepine##2##1##(1995-12#2)
3-benzodiazepines##4##1##(1995-12#4)
3-beta-glucanases##2##1##(2008-10#2)
3-bis(2-chloroethyl)-1-nitrosourea##2##1##(1992-9#2)
3-bit##3##1##(2008-2#2)(2008-3#1)
3-butadiene##3##1##(1992-11#1)(1996-5#2)
3-butanediol to acetoin##2##3##(2013-1#2)
3-butanediol##6##1##(2008-6#1)(2013-1#5)
3-butanedione monoxime##2##2##(2008-11#2)
3-butanedione##5##1##(1990-11#1)(2008-10#2)(2008-11#2)
3-carboxy A-ring aryl steroids##3##4##(1990-11#3)
3-cd)pyrene##2##1##(2008-10#2)
3-chlorophenol##2##1##(2008-10#2)
3-cyclohexanedione dithiosemicarbazone monohydrochloride##2##3##(2008-10#2)
3-cyclohexanedione##3##1##(2008-10#3)
3-dB bandwidth of##2##3##(2007-11#1)(2008-3#1)
3-dB bandwidth##3##2##(2007-11#1)(2008-3#2)
3-dB##10##1##(2007-11#5)(2008-2#3)(2008-3#2)
3-d][1##2##1##(1996-5#2)
3-d]pyrimidine) 2'-deoxyribonucleosides##2##2##(2008-4#2)
3-day##12##1##(1993-12#1)(1996-5#1)(2008-10#4)(2008-3#2)(2011-2#3)(2013-1#1)
3-day-old##3##1##(2008-11#1)(2008-5#1)(2012-3#1)
3-di-O-glycosyl derivatives of methyl alpha-L-rhamnopyranoside##2##5##(1992-12#2)
3-diamino esters##2##2##(2008-11#2)
3-diamino-2##2##1##(1995-11#2)
3-diaminobenzene)##2##1##(2008-10#2)
3-diaminophenazine##2##1##(2008-10#2)
3-diaminopropane##4##1##(1992-11#1)(2008-10#3)
3-dicarboxaldehyde##2##1##(2008-10#2)
3-dichloro-2-propyl) phosphate##2##2##(2013-1#2)
3-dichloro-5##8##1##(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)
3-dichlorobenzene##2##1##(2008-10#2)
3-dichloropropene##3##1##(2008-10#3)
3-dichloroquinoxaline##2##1##(2008-10#2)
3-dihydro-1##2##1##(1995-12#1)(2007-11#1)
3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1##2##1##(1995-12#2)
3-dihydrosqualene##2##1##(1994-3#2)
3-dimensional models##3##2##(1996-6#2)(2008-5#1)
3-dimensional structure of the##3##4##(2008-11#1)(2011-2#2)
3-dimensional##16##1##(1992-11#1)(1996-6#3)(2008-11#1)(2008-5#2)(2009-10#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
3-dimercaptopropane##2##1##(1994-5#1)(1995-3#1)
3-dimercaptosuccinic acid (DMSA)##2##3##(1992-12#1)(2008-8#1)
3-dimercaptosuccinic acid##4##2##(1992-12#2)(1995-3#1)(2008-8#1)
3-dimethyl-4-quinolone##2##1##(2008-10#2)
3-dimethylnaphthalene##2##1##(2008-3#2)
3-dinitrobenzene##4##1##(1994-11#1)(2008-10#3)
3-dione core##2##2##(2010-2#2)
3-dione##11##1##(1994-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-2#2)
3-dioxane##2##1##(1996-5#2)
3-dioxo-2-indanylidene) acetonitrile derivatives##2##3##(2008-10#2)
3-dioxo-2-indanylidene) acetonitrile##7##2##(2008-10#7)
3-dioxobutyl)thio]adenosine 5'-diphosphate##2##2##(1990-7#2)
3-dioxolan-2-yl]nucleosides##2##1##(1996-5#2)
3-dioxolane rings##2##2##(2007-11#2)
3-dioxolane##5##1##(1996-5#3)(2007-11#2)
3-dioxygenase (IDO)##3##2##(1992-11#1)(2008-11#2)
3-dioxygenase##8##1##(1990-5#1)(1992-11#2)(1994-12#1)(1995-3#1)(2008-11#3)
3-diphenylpropenoic##2##1##(2007-11#2)
3-diphosphoglycerate##5##1##(1990-8#4)(1994-12#1)
3-dipolar cycloaddition reactions##2##3##(1997-4#1)(2012-3#1)
3-dipolar cycloaddition##5##2##(1997-4#1)(2007-11#2)(2012-2#1)(2012-3#1)
3-disubstituted##3##1##(1992-12#1)(1996-5#1)(2010-3#1)
3-dithiolan-2-yl]nucleosides##2##1##(1996-5#2)
3-dithiole (TPDT)##2##2##(1996-5#2)
3-dithiole##4##1##(1996-5#4)
3-fluoro-4-demethoxydaunomycin##2##1##(1990-7#2)
3-fold greater than##2##3##(1994-5#1)(2010-11#1)
3-fold greater##3##2##(1993-6#1)(1994-5#1)(2010-11#1)
3-fold higher in##2##3##(2008-11#1)(2012-12#1)
3-fold higher than that##2##4##(1991-5#1)(2008-11#1)
3-fold higher than##5##3##(1990-11#1)(1991-5#1)(1995-2#1)(2008-11#2)
3-fold higher##9##2##(1990-11#1)(1991-5#1)(1994-12#1)(1995-2#2)(2008-11#3)(2012-12#1)
3-fold in the##2##3##(1990-5#1)(2008-11#1)
3-fold in##5##2##(1990-12#1)(1990-5#1)(1995-6#1)(2008-11#1)(2012-3#1)
3-fold increase in##5##3##(1990-7#1)(1994-8#1)(1995-2#2)(2008-3#1)
3-fold increase##8##2##(1990-7#1)(1994-12#1)(1994-8#1)(1995-2#2)(2008-11#1)(2008-3#1)(2008-5#1)
3-fold lower##2##2##(1990-11#1)(1992-10#1)
3-fold more##3##2##(1994-8#1)(2008-8#1)(2013-8#1)
3-fold##47##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-2#4)(1995-6#2)(1995-8#3)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
3-gallate##2##1##(2008-10#2)
3-glucan##2##1##(2008-10#1)(2008-11#1)
3-glucanase (EC 3##2##3##(2008-10#2)
3-glucanase activities##4##2##(2008-10#4)
3-glucanase activity in##4##3##(2008-10#4)
3-glucanase activity##12##2##(2008-10#12)
3-glucanase and##4##2##(2008-10#4)
3-glucanase in##2##2##(2008-10#2)
3-glucanase isoforms##3##2##(2008-10#3)
3-glucanase##46##1##(1997-6#6)(2008-10#39)(2009-8#1)
3-glucanase)##4##1##(2008-10#4)
3-glucanases##5##1##(2008-10#5)
3-h##7##1##(1993-6#2)(2008-10#4)(2008-5#1)
3-hour##4##1##(1990-9#1)(2007-10#2)(2008-11#1)
3-hydroxy BaP##2##2##(2011-1#2)
3-hydroxy-3-methylglutaryl coenzyme A##2##3##(1991-6#1)(1993-6#1)
3-hydroxy-3-methylglutaryl##3##1##(1990-8#1)(1991-6#1)(1993-6#1)
3-hydroxy-3-methylglutaryl-CoA lyase deficiency##2##3##(1990-8#2)
3-hydroxy-3-methylglutaryl-CoA lyase##3##2##(1990-8#3)
3-hydroxyanthranilic acid##4##2##(1991-5#4)
3-hydroxyl##2##1##(2008-11#1)(2013-8#1)
3-indanedione##4##1##(2008-10#4)
3-indoxyl phosphate (3-IP)##2##3##(2008-10#2)
3-indoxyl phosphate##3##2##(2008-10#3)
3-isobutyl-1-methylxanthine##2##1##(1995-12#1)(1995-8#1)
3-kDa##3##1##(1990-5#2)(1995-6#1)
3-kb##12##1##(1991-2#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-9#1)(1996-10#1)(1996-2#1)(2008-10#4)
3-keto##2##1##(1990-11#1)(1996-5#1)
3-ketoacyl-ACP##2##1##(1992-4#2)
3-ketobutylidene##2##1##(1991-5#2)
3-kinase (PI 3-kinase)##7##3##(1993-8#1)(1994-11#2)(1994-6#1)(1995-8#1)(1996-2#1)(2008-11#1)
3-kinase (PI##8##2##(1993-8#1)(1994-11#2)(1994-6#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-7#1)
3-kinase (PI3K) activity##2##3##(2008-11#1)(2011-1#1)
3-kinase (PI3K)##4##2##(1996-2#1)(2008-11#1)(2011-1#1)(2011-2#1)
3-kinase activity##5##2##(1992-12#2)(1994-11#3)
3-kinase and##4##2##(1994-11#1)(1995-8#1)(2008-3#1)(2008-7#1)
3-kinase is required for the regulation of PEPCK gene expression by insulin##2##12##(1995-6#1)(1996-2#1)
3-kinase is##4##2##(1994-11#1)(1995-6#1)(1996-2#1)(2008-11#1)
3-kinase was##2##2##(1992-12#1)(1997-6#1)
3-kinase##48##1##(1992-12#8)(1993-6#1)(1993-8#1)(1994-11#10)(1994-6#2)(1995-6#4)(1995-8#2)(1996-2#4)(1997-6#1)(2008-1#1)(2008-11#5)(2008-3#3)(2008-7#3)(2011-1#1)(2011-2#1)(2012-3#1)
3-kinase)##8##1##(1992-12#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-8#1)(1996-2#1)(2008-11#1)
3-kinases##3##1##(1996-2#2)(2010-9#1)
3-lead##2##1##(2010-8#2)
3-linked##2##1##(1993-11#1)(2012-3#1)
3-mJ##3##1##(2008-3#3)
3-mercaptopropionic acid##2##2##(1993-9#1)(2008-10#1)
3-methoxy-4-hydroxyphenylglycol (MHPG)##2##2##(1993-1#1)(1996-7#1)
3-methoxy-4-hydroxyphenylglycol##3##1##(1993-1#1)(1995-3#1)(1996-7#1)
3-methoxytyramine##2##1##(1996-7#1)(1997-7#1)
3-methyl-2-hexenoic acid##2##2##(2008-5#2)
3-methylcholanthrene (MC)##2##2##(1990-7#1)(2008-11#1)
3-methylcholanthrene treated rats##2##3##(1991-12#2)
3-methylcholanthrene##10##1##(1990-7#1)(1991-12#2)(1992-8#1)(1994-8#1)(2008-11#5)
3-microm GaInNAs saturable Bragg reflector##2##5##(2007-11#2)
3-microm beam##2##2##(2008-2#2)
3-microm infrared##2##2##(2008-3#2)
3-microm##12##1##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#5)
3-min##5##1##(1992-3#1)(2008-10#3)(2009-1#1)
3-mm diameter##2##2##(2008-2#1)(2008-3#1)
3-mm##6##1##(1996-6#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
3-mm-thick##2##1##(2007-12#1)(2008-3#1)
3-month follow-up##3##2##(2009-11#1)(2011-2#1)(2012-3#1)
3-month interval##2##2##(2008-10#1)(2008-3#1)
3-month##24##1##(1990-9#1)(1994-3#2)(1997-8#1)(2007-8#1)(2008-10#6)(2008-3#2)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
3-month-old##6##1##(1990-3#2)(1991-12#1)(1994-3#1)(2008-10#2)
3-mum wavelengths##2##2##(2007-11#1)(2007-12#1)
3-mum##7##1##(1994-2#1)(2007-11#2)(2007-12#3)(2008-3#1)
3-naphthalene disulfonic acid##2##3##(2008-10#2)
3-naphthalene##3##1##(2008-10#3)
3-nitrofluoranthene##2##1##(2008-10#1)(2008-11#1)
3-nm##4##1##(2008-3#3)(2008-7#1)
3-ns laser##2##2##(2008-2#1)(2008-3#1)
3-ns pulses##2##2##(2007-11#2)
3-ns##5##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
3-oxathiolan-2-yl]nucleosides##2##1##(1996-5#2)
3-oxazolidine-2-thione##3##1##(2008-10#3)
3-oxo##4##1##(1990-11#2)(2009-5#2)
3-pentadecylcatechol##3##1##(2008-10#3)
3-phenyl-4-benzoyl-5-isoxazolone (HPBI)##2##2##(2008-10#2)
3-phenyl-4-benzoyl-5-isoxazolone##4##1##(2008-10#4)
3-phosphate and##2##2##(1990-5#1)(1991-2#1)
3-phosphate##10##1##(1990-5#1)(1991-2#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-9#3)(2009-10#1)
3-phosphoglycerate##4##1##(1990-5#2)(1991-9#2)
3-point##2##1##(2012-7#1)(2013-1#1)
3-propanediol##3##1##(2008-10#3)
3-propanetricarboxylate##3##1##(2008-10#3)
3-propanetriol 1##2##2##(2008-5#2)
3-ps##3##1##(2007-11#2)(2007-12#1)
3-q31##3##1##(1994-6#2)(1997-3#1)
3-s##4##1##(1992-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
3-selenadiazole derivatives##2##2##(2007-11#2)
3-selenadiazole##3##1##(2007-11#3)
3-sialyltransferase##3##1##(1992-12#1)(2008-11#2)
3-substituted##2##1##(1995-3#2)
3-tert-butyl-4-hydroxyanisole (BHA) and##2##3##(2008-10#2)
3-tert-butyl-4-hydroxyanisole##3##1##(2008-10#3)
3-thiadiazole and 1##2##3##(2007-11#2)
3-thiadiazole##3##1##(2007-11#3)
3-thiaoctanoyl-CoA##2##1##(1995-5#2)
3-times##2##1##(1992-6#1)(2008-3#1)
3-to##2##1##(1996-5#1)(2008-9#1)
3-triazole products in##2##3##(2012-3#2)
3-triazole##3##1##(2009-2#1)(2012-3#2)
3-trimethyl-2-oxabicyclo[2##2##1##(2008-5#2)
3-vessel disease##2##2##(2008-3#1)(2008-7#1)
3-week follow-up##2##2##(2008-12#2)
3-week period##2##2##(2007-12#1)(2008-5#1)
3-week##12##1##(1996-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-5#3)(2008-6#2)(2013-8#1)
3-week-old##4##1##(1996-2#1)(2008-10#2)(2008-5#1)
3-year period##11##2##(1993-12#1)(1995-1#1)(2008-1#1)(2008-10#4)(2008-9#2)(2012-12#1)(2012-2#1)
3-year retrospective case-control study##2##4##(2010-10#2)
3-year##33##1##(1991-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-9#2)(2009-7#1)(2010-10#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
3-year-old girl##3##2##(1994-2#1)(2008-10#1)(2011-1#1)
3-year-old##9##1##(1994-2#1)(2007-10#1)(2008-10#3)(2008-9#1)(2011-1#2)(2012-3#1)
3/10##2##1##(2008-8#1)(2013-1#1)
3/4##5##1##(1991-4#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-12#1)
3/4-fucosyltransferase##2##1##(1995-2#2)
30 % of##3##3##(1997-8#1)(2007-8#1)(2011-2#1)
30 +/- 0##8##3##(1991-12#1)(1991-5#1)(1991-9#1)(1995-11#1)(1995-2#1)(2007-10#1)(2008-1#1)(2013-1#1)
30 +/- 6##2##3##(1997-2#1)(2008-1#1)
30 +/-##14##2##(1991-12#1)(1991-5#1)(1991-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2011-3#1)(2013-1#1)
30 -##2##2##(2011-1#2)
30 000##2##2##(2008-10#2)
30 Gy##2##2##(1997-4#1)(2013-1#1)
30 June##3##2##(1990-2#1)(1992-9#1)(2008-10#1)
30 K##2##2##(1996-2#1)(2008-8#1)
30 V##3##2##(2008-10#3)
30 aged##2##2##(2008-7#2)
30 amino acids##3##3##(1993-2#2)(1995-6#1)
30 amino##4##2##(1993-2#2)(1995-6#1)(2011-3#1)
30 and 35##2##3##(2008-10#1)(2008-6#1)
30 and 40##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
30 and 40%##2##3##(1991-11#1)(2012-2#1)
30 and 45 days' incubation##3##5##(2008-5#3)
30 and 45 min##2##4##(2013-1#2)
30 and 45##7##3##(2008-11#1)(2008-5#3)(2013-1#2)(2013-7#1)
30 and 50##3##3##(1997-3#1)(2006-6#1)(2008-7#1)
30 and 60 days post-MCAO##2##5##(2007-10#2)
30 and 60 min##4##4##(1990-12#1)(1995-3#1)(2008-10#1)(2008-7#1)
30 and 60##7##3##(1990-12#1)(1994-11#1)(1995-3#1)(2007-10#2)(2008-10#1)(2008-7#1)
30 and 70%##4##3##(2008-10#3)(2008-5#1)
30 and##57##2##(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-5#5)(2008-6#2)(2008-7#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#2)
30 cases of##2##3##(2007-11#1)(2008-10#1)
30 cases##10##2##(1990-2#1)(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#1)
30 cc##2##2##(2007-10#2)
30 children##5##2##(1995-1#1)(1996-1#1)(1996-11#1)(1997-2#1)(2012-2#1)
30 cm##7##2##(1991-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)
30 consecutive##2##2##(2008-10#1)(2008-7#1)
30 d##2##2##(2008-6#1)(2008-9#1)
30 dB##3##2##(2007-11#1)(2008-3#2)
30 days after inoculation##4##4##(2008-10#4)
30 days after the##3##4##(1991-5#1)(2008-10#1)(2011-2#1)
30 days after##9##3##(1991-5#1)(1995-5#1)(2008-10#5)(2008-12#1)(2011-2#1)
30 days and##3##3##(2008-11#2)(2012-3#1)
30 days in##2##3##(2008-10#1)(2008-11#1)
30 days of age##2##4##(2008-5#1)(2012-2#1)
30 days of##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
30 days to##2##3##(1997-4#1)(2010-5#1)
30 days##65##2##(1990-12#2)(1990-3#1)(1991-2#1)(1991-5#2)(1993-3#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-10#2)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#5)(2008-7#1)(2009-11#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#2)
30 days)##9##2##(1991-2#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
30 degrees C and at##2##5##(1994-3#1)(2008-10#1)
30 degrees C and##10##4##(1994-3#2)(2008-10#7)(2008-6#1)
30 degrees C during##2##4##(2008-10#2)
30 degrees C for##2##4##(2008-10#2)
30 degrees C had##2##4##(1997-8#1)(2008-10#1)
30 degrees C in##2##4##(2008-10#1)(2010-4#1)
30 degrees C with##2##4##(2008-10#1)(2008-9#1)
30 degrees C##65##3##(1990-7#1)(1990-8#1)(1992-8#1)(1994-3#5)(1995-12#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-10#41)(2008-12#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
30 degrees C)##4##3##(1990-7#1)(2008-10#3)
30 degrees##86##2##(1990-7#2)(1990-8#1)(1992-8#1)(1993-8#1)(1994-3#5)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#3)(2007-8#3)(2008-10#44)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
30 elderly##2##2##(2008-6#1)(2008-7#1)
30 g##5##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)
30 g/L##2##2##(2008-6#2)
30 genes##3##2##(1996-10#1)(1996-12#1)(2008-7#1)
30 h##4##2##(1994-3#1)(1997-2#1)(2008-2#1)(2008-7#1)
30 h(-1)##7##2##(2008-10#7)
30 healthy controls##2##3##(1991-4#1)(2013-8#1)
30 healthy subjects##4##3##(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
30 healthy##11##2##(1991-4#1)(2007-8#1)(2008-5#1)(2008-7#3)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
30 hours##2##2##(1991-12#1)(1994-11#1)
30 in the##2##3##(1990-2#1)(1993-9#1)
30 in##7##2##(1990-2#1)(1992-8#1)(1993-9#1)(2006-6#1)(2009-10#1)(2011-2#2)
30 kDa##11##2##(1990-5#1)(1992-9#1)(1994-11#2)(1995-6#2)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
30 kDa) and##2##3##(1991-12#1)(1993-8#1)
30 kGy##2##2##(2009-7#2)
30 kb##2##2##(1993-3#1)(1995-8#1)
30 km##3##2##(2008-2#1)(2008-3#2)
30 ku##3##2##(2008-8#1)(2008-9#2)
30 m##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)(2013-1#1)
30 mM##11##2##(1990-8#1)(1992-4#1)(1993-6#1)(1995-2#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#2)(2011-2#2)
30 mg##10##2##(2006-10#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-3#2)(2013-8#1)
30 mg/day##3##2##(1997-7#2)(2006-10#1)
30 mg/day)##2##2##(2006-10#1)(2008-1#1)
30 mg/kg##7##2##(1992-3#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#1)
30 mg/kg/day##2##2##(2011-2#2)
30 microM of##2##3##(1990-11#2)
30 microM##11##2##(1990-11#2)(1992-3#2)(1992-8#1)(1993-6#2)(1995-8#1)(1997-8#2)(2009-12#1)
30 microM)##2##2##(2008-10#1)(2009-12#1)
30 microg/ml##2##2##(2008-10#2)
30 microl of##3##3##(2008-10#3)
30 microl saline##2##3##(2008-10#2)
30 microl##7##2##(2008-10#6)(2008-4#1)
30 million##3##2##(1995-11#1)(2009-4#1)(2012-2#1)
30 min after the##3##4##(2008-7#1)(2010-10#1)(2011-2#1)
30 min after##10##3##(1990-7#1)(1994-2#2)(1995-12#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
30 min and the##2##4##(1990-12#1)(1994-3#1)
30 min and##9##3##(1990-12#1)(1991-5#1)(1992-9#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
30 min aromatherapy massage##2##4##(2008-10#2)
30 min at##4##3##(1992-12#1)(1994-11#1)(2008-10#1)(2010-1#1)
30 min before the##3##4##(1994-2#1)(1995-12#1)(2008-10#1)
30 min before##10##3##(1994-2#1)(1994-5#4)(1995-12#2)(2008-10#1)(2013-1#2)
30 min dynamic##2##3##(2008-10#2)
30 min following##2##3##(1993-1#1)(2008-7#1)
30 min in##4##3##(1992-6#1)(1997-4#1)(2008-10#2)
30 min incubation with##3##4##(1994-3#2)(1997-4#1)
30 min incubation##6##3##(1994-3#2)(1994-8#1)(1995-3#1)(1997-4#1)(2008-9#1)
30 min of##9##3##(1996-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
30 min pretreatment##2##3##(1995-12#2)
30 min prior to##5##4##(1992-3#1)(1993-12#1)(1995-12#1)(2011-2#2)
30 min to##2##3##(1995-12#1)(2008-9#1)
30 min was##7##3##(1994-3#3)(2008-7#3)(2013-1#1)
30 min##137##2##(1990-12#3)(1990-7#1)(1990-8#1)(1991-5#4)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#4)(1993-12#2)(1994-11#1)(1994-2#3)(1994-3#6)(1994-5#5)(1994-8#2)(1995-11#1)(1995-12#10)(1995-2#2)(1995-3#2)(1996-12#3)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#35)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#3)(2008-7#11)(2008-9#2)(2009-2#1)(2010-1#2)(2010-10#2)(2010-3#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
30 min) and##2##3##(1990-12#1)(2008-10#1)
30 min)##17##2##(1990-11#1)(1990-12#2)(1990-8#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-8#1)(1997-3#1)(2008-10#3)(2009-9#2)(2012-3#3)
30 minutes after the##2##4##(1990-8#1)(2008-5#1)
30 minutes and##2##3##(1997-2#1)(2011-1#1)
30 minutes at##2##3##(1992-6#1)(1994-3#1)
30 minutes of##2##3##(1991-12#1)(2012-12#1)
30 minutes##27##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-3#4)(1997-2#3)(1997-4#1)(2006-12#1)(2007-10#2)(2007-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#2)
30 ml##2##2##(2008-10#2)
30 mm##7##2##(1991-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
30 mmol##2##2##(2008-10#2)
30 mol %##2##3##(1994-5#2)
30 months after##2##3##(2007-8#1)(2008-9#1)
30 months of##2##3##(1993-1#1)(2008-9#1)
30 months##12##2##(1990-12#1)(1992-10#1)(1993-1#1)(1993-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-3#1)
30 ms at##2##3##(1995-5#1)(2008-2#1)
30 ms##5##2##(1995-5#1)(1996-2#1)(2008-2#1)(2008-3#1)(2011-1#1)
30 muM##2##2##(2008-10#1)(2008-11#1)
30 mug l(-1)##5##3##(2008-10#5)
30 mug##9##2##(2008-10#7)(2008-11#1)(2010-2#1)
30 mul of##2##3##(2008-10#2)
30 mul##4##2##(2008-10#4)
30 mum##2##2##(2008-2#2)
30 nM##5##2##(1991-2#1)(1991-5#1)(1991-8#1)(1994-11#1)(1995-12#1)
30 nM)##3##2##(1995-8#1)(2008-10#1)(2010-12#1)
30 ng ml(-1)##3##3##(2008-10#3)
30 ng##4##2##(2008-10#4)
30 ng/ml##2##2##(1994-11#1)(2012-12#1)
30 nm in diameter##2##4##(2008-10#2)
30 nm##13##2##(2007-12#1)(2008-10#3)(2008-3#4)(2008-8#1)(2009-11#2)(2009-5#1)(2009-9#1)
30 nucleotides in##2##3##(2008-10#1)(2008-2#1)
30 nucleotides##3##2##(2008-10#2)(2008-2#1)
30 of these##2##3##(1993-12#1)(2008-10#1)
30 of##8##2##(1992-2#1)(1993-12#1)(1997-8#1)(2008-10#3)(2008-4#1)(2011-1#1)
30 or more##3##3##(1991-12#1)(1992-1#2)
30 or##5##2##(1991-12#1)(1992-1#2)(1995-12#1)(2011-2#1)
30 patients (75%)##2##3##(2008-10#1)(2012-2#1)
30 patients that##2##3##(1997-6#1)(2007-8#1)
30 patients who##2##3##(1991-2#1)(2008-3#1)
30 patients with##7##3##(1991-12#1)(1997-1#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
30 patients##37##2##(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
30 per##2##2##(1992-5#1)(1995-3#1)
30 percent of the##2##4##(1990-5#2)
30 percent of##3##3##(1990-5#2)(1995-2#1)
30 percent##9##2##(1990-5#2)(1991-1#1)(1995-2#1)(1995-3#1)(1997-1#1)(2010-12#1)(2010-8#1)(2013-1#1)
30 persons##2##2##(2007-8#2)
30 pg##3##2##(2008-10#3)
30 placentas of pregnant women of age##2##7##(2011-1#2)
30 s and##3##3##(1996-5#1)(2008-10#2)
30 s##28##2##(1990-5#1)(1992-8#1)(1996-5#1)(1997-2#1)(2008-10#15)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
30 s)##3##2##(2008-10#2)(2013-1#1)
30 samples can be##2##4##(2008-10#2)
30 samples h(-1)##3##3##(2008-10#3)
30 samples per hour can be##2##6##(2008-10#2)
30 samples per hour##5##4##(2008-10#5)
30 samples per##7##3##(2008-10#7)
30 samples##14##2##(2008-10#13)(2010-4#1)
30 samplesh(-1)##3##2##(2008-10#3)
30 seconds##5##2##(1991-5#1)(1992-6#1)(2008-12#1)(2009-11#1)(2011-2#1)
30 species##2##2##(2008-10#1)(2010-3#1)
30 subjects##2##2##(2008-12#1)(2008-5#1)
30 times##5##2##(1993-8#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-3#1)
30 to 0##2##3##(1990-11#1)(2008-10#1)
30 to 100##2##3##(1993-12#1)(2007-11#1)
30 to 40 years##2##4##(2008-10#1)(2008-9#1)
30 to 40##7##3##(1994-12#1)(2008-10#5)(2008-9#1)
30 to 40%##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
30 to 50##4##3##(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)
30 to 50%##2##3##(2011-2#1)(2012-12#1)
30 to 60##4##3##(1993-1#1)(2008-10#3)
30 to##58##2##(1990-11#1)(1991-9#2)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
30 tumors##2##2##(1995-4#2)
30 vs##2##2##(2007-8#2)
30 weeks of##2##3##(1991-8#1)(2012-1#1)
30 weeks##6##2##(1991-8#1)(1995-8#1)(2007-12#1)(2009-12#2)(2012-1#1)
30 were##2##2##(1996-5#1)(2007-11#1)
30 with##2##2##(1993-8#1)(2008-10#1)
30 women##3##2##(1992-2#1)(1994-2#1)(2011-2#1)
30 y##2##2##(2007-11#1)(2009-9#1)
30 years ago##5##3##(2007-6#1)(2008-10#1)(2010-1#1)(2010-11#1)(2011-2#1)
30 years and##2##3##(2012-2#2)
30 years before##2##3##(2008-1#1)(2008-7#1)
30 years have##3##3##(1994-2#1)(2008-9#1)(2010-1#1)
30 years in the##2##4##(1993-11#1)(2011-2#1)
30 years in##3##3##(1993-11#1)(1996-11#1)(2011-2#1)
30 years later##4##3##(1990-6#2)(2011-2#1)(2012-2#1)
30 years of age##3##4##(1994-2#1)(2007-12#1)(2007-7#1)
30 years of##8##3##(1993-12#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-8#1)(2012-12#1)
30 years old##3##3##(1990-10#1)(1997-2#1)(1997-3#1)
30 years##83##2##(1990-10#1)(1990-3#1)(1990-6#2)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-11#2)(1996-3#2)(1996-4#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-3#2)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
30 years)##2##2##(1997-2#1)(2013-1#1)
30 ±##2##2##(2012-3#1)(2013-1#1)
30##1468##1##(1990-10#1)(1990-11#7)(1990-12#13)(1990-2#6)(1990-3#4)(1990-5#6)(1990-6#3)(1990-7#3)(1990-8#12)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#10)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#11)(1991-6#4)(1991-7#1)(1991-8#7)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#11)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#10)(1992-9#7)(1993-1#8)(1993-11#1)(1993-12#15)(1993-2#3)(1993-3#8)(1993-6#3)(1993-8#5)(1993-9#4)(1994-1#2)(1994-11#9)(1994-12#5)(1994-2#7)(1994-3#16)(1994-5#10)(1994-6#1)(1994-7#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#14)(1995-2#8)(1995-3#12)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#7)(1996-1#3)(1996-10#1)(1996-11#8)(1996-12#5)(1996-2#8)(1996-3#2)(1996-4#3)(1996-5#10)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#13)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#14)(1997-8#17)(1997-9#1)(2006-10#5)(2006-12#1)(2006-6#2)(2007-10#12)(2007-11#19)(2007-12#13)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#18)(2008-1#18)(2008-10#354)(2008-11#22)(2008-12#29)(2008-2#22)(2008-3#40)(2008-4#12)(2008-5#41)(2008-6#22)(2008-7#55)(2008-8#13)(2008-9#21)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#8)(2009-8#5)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#5)(2010-12#3)(2010-2#4)(2010-3#7)(2010-4#4)(2010-5#7)(2010-6#2)(2010-7#4)(2010-8#10)(2010-9#1)(2011-1#18)(2011-2#50)(2011-3#5)(2012-1#4)(2012-12#11)(2012-2#25)(2012-3#19)(2012-7#1)(2013-1#52)(2013-7#5)(2013-8#15)
30% (P##2##2##(1990-8#1)(2008-9#1)
30% (v/v)##2##2##(1996-5#1)(2008-7#1)
30% (w/w)##3##2##(2008-10#3)
30% and##3##2##(1994-2#1)(2007-8#1)(2009-10#1)
30% at##4##2##(1991-6#1)(1996-5#1)(2008-10#1)(2009-5#1)
30% by##2##2##(1993-3#1)(2013-8#1)
30% cu-doped Cd1-x##2##3##(2013-8#2)
30% for##4##2##(1990-6#1)(1995-3#1)(1997-4#1)(2008-3#1)
30% had##3##2##(2008-3#1)(2013-1#2)
30% higher than##2##3##(2008-10#1)(2011-2#1)
30% higher##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
30% in the##3##3##(1990-12#1)(2008-8#1)(2013-1#1)
30% in##15##2##(1990-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-9#2)(1997-9#1)(2008-10#3)(2008-8#1)(2009-4#1)(2013-1#2)(2013-8#1)
30% increase in##2##3##(1996-12#1)(2010-6#1)
30% lower than##2##3##(2008-10#1)(2008-5#1)
30% lower##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
30% of all##3##3##(1990-6#1)(1992-6#1)(2013-1#1)
30% of ethanol##2##3##(2008-10#2)
30% of patients##2##3##(2013-1#2)
30% of the cells##2##4##(1992-6#1)(1996-5#1)
30% of the energy##2##4##(2008-3#2)
30% of the overall##2##4##(1991-5#1)(2008-10#1)
30% of the patients##2##4##(2008-1#1)(2012-12#1)
30% of the total##3##4##(2007-7#1)(2008-10#1)(2008-8#1)
30% of the##31##3##(1990-10#1)(1990-6#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
30% of##68##2##(1990-10#1)(1990-6#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-4#1)(1996-5#2)(1996-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)
30% reduction##3##2##(2008-10#2)(2008-6#1)
30% relative##2##2##(2007-12#1)(2008-10#1)
30% to 50%##2##3##(2008-7#1)(2012-12#1)
30% to 60%##2##3##(2010-12#1)(2012-12#1)
30% to##8##2##(2008-7#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#2)
30% were##2##2##(2013-1#1)(2013-8#1)
30%##235##1##(1990-10#1)(1990-12#4)(1990-2#1)(1990-6#3)(1990-8#1)(1991-11#2)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#2)(1996-12#2)(1996-5#4)(1996-9#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2007-10#4)(2007-11#7)(2007-12#7)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#45)(2008-11#8)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#5)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#7)
30%) and##5##2##(2008-12#1)(2010-4#2)(2011-2#2)
30%) in##2##2##(1994-6#1)(2007-9#1)
30%) patients##2##2##(2011-2#2)
30%) were##2##2##(2007-9#1)(2013-1#1)
30%)##21##1##(1990-2#1)(1990-5#1)(1994-6#1)(1996-7#1)(1997-2#1)(2007-9#2)(2008-11#1)(2008-12#3)(2009-8#1)(2010-4#2)(2011-2#6)(2013-1#1)
30%-40%##2##1##(2008-12#1)(2009-7#1)
30) and##7##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)
30) in the##2##3##(2008-10#1)(2008-5#1)
30) of the##2##3##(2008-8#1)(2010-3#1)
30) or##2##2##(1992-6#1)(2007-10#1)
30)##33##1##(1990-8#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-6#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-3#2)(2012-3#1)(2013-8#3)
30+##2##1##(1992-1#2)
30+/-0##4##1##(2007-8#1)(2008-10#3)
30+/-1##4##1##(2008-10#4)
30+/-2##2##1##(2008-10#2)
30- and##6##2##(1991-12#2)(1993-11#1)(1995-3#1)(2007-10#1)(2008-6#1)
30- to##4##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#1)
30-##14##1##(1991-12#2)(1991-9#1)(1993-11#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-6#1)
30-100##3##1##(1994-11#1)(2008-10#1)(2008-3#1)
30-120##2##1##(2008-10#1)(2008-6#1)
30-32%##2##1##(2008-10#1)(2008-5#1)
30-35% of##2##2##(1991-3#1)(2012-8#1)
30-4##3##1##(2008-10#3)
30-40 microm##2##2##(2008-3#2)
30-40 years##2##2##(1995-2#1)(1995-5#1)
30-40##14##1##(1991-5#1)(1992-5#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#3)(2008-12#1)(2008-3#2)(2010-4#1)(2010-5#1)
30-40% in##2##2##(1994-8#1)(2013-8#1)
30-40% of##3##2##(1990-11#1)(1993-3#1)(1995-8#1)
30-40% was##2##2##(1990-11#1)(2011-1#1)
30-40%##11##1##(1990-11#2)(1993-3#1)(1994-8#1)(1995-8#1)(2008-1#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
30-41 and 120-145##2##3##(1995-12#2)
30-50 years##2##2##(2008-1#2)
30-50##4##1##(1995-5#1)(2008-1#2)(2008-6#1)
30-50% of##3##2##(1996-11#1)(1996-6#1)(2010-1#1)
30-50%##10##1##(1995-2#1)(1996-11#1)(1996-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-4#1)(2012-2#1)
30-60 min##3##2##(1996-2#1)(1996-6#1)(2008-10#1)
30-60 minutes##2##2##(2007-11#1)(2008-5#1)
30-60 years##2##2##(1995-8#1)(2012-2#1)
30-60##9##1##(1995-8#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-9#1)(2012-2#1)
30-60%##2##1##(1992-3#1)(1994-9#1)
30-70% of##3##2##(1997-2#1)(2007-11#1)(2011-1#1)
30-70%##5##1##(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)
30-80%##2##1##(2007-11#1)(2009-7#1)
30-cm##2##1##(2008-10#1)(2008-3#1)
30-cm-diameter##2##1##(2008-2#2)
30-day mortality##3##2##(2007-10#1)(2010-6#1)(2011-3#1)
30-day period##3##2##(1990-8#1)(2008-10#2)
30-day readmission rates##2##3##(1996-1#2)
30-day##18##1##(1990-8#1)(1994-3#1)(1995-2#1)(1996-1#2)(2007-10#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-7#1)(2010-6#1)(2011-3#1)(2013-1#1)
30-fold more##2##2##(1995-12#1)(2008-5#1)
30-fold##10##1##(1990-5#1)(1995-11#1)(1995-12#2)(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
30-kDa enzyme from red blood cells##2##6##(1994-11#2)
30-kDa enzyme##3##2##(1994-11#3)
30-kDa##7##1##(1992-9#2)(1994-11#3)(1995-2#1)(2008-10#1)
30-m##3##1##(1994-9#1)(2008-10#2)
30-mJ##2##1##(2008-3#2)
30-mer ODNs##2##2##(2008-10#2)
30-mer##3##1##(2008-10#3)
30-microm##2##1##(2007-11#1)(2008-2#1)
30-min##8##1##(1991-5#1)(1993-6#2)(1997-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-12#1)
30-minute##5##1##(1994-3#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-2#1)
30-mm/h##2##1##(2008-10#2)
30-month-old##4##1##(1990-3#3)(1993-2#1)
30-mum##2##1##(2007-12#1)(2008-3#1)
30-s##2##1##(1993-6#1)(2008-3#1)
30-second##2##1##(2007-6#1)(2010-11#1)
30-year period##3##2##(2007-4#1)(2008-10#1)(2008-7#1)
30-year##6##1##(2007-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)
30-year-old##11##1##(1990-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
30-years##2##1##(1994-12#1)(2011-1#1)
300 000##3##2##(2008-10#3)
300 IU##2##2##(2011-1#2)
300 K##7##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
300 and 1025 nm##2##4##(2008-2#2)
300 and 450 mW/cm2##2##4##(1993-8#2)
300 and##14##2##(1993-8#2)(2008-10#9)(2008-2#2)(2011-10#1)
300 bp##5##2##(1995-12#2)(1995-9#1)(1996-3#1)(2008-12#1)
300 cases of##2##3##(2008-10#1)(2008-7#1)
300 cases##4##2##(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
300 days##2##2##(1995-2#1)(2010-4#1)
300 degrees C and##3##4##(2008-10#2)(2011-1#1)
300 degrees C for##4##4##(2008-10#1)(2008-2#2)(2011-1#1)
300 degrees C##13##3##(1995-6#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#3)
300 from##2##2##(1992-5#2)
300 g##2##2##(1997-4#1)(2008-7#1)
300 in##2##2##(2008-10#1)(2008-12#1)
300 kHz##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
300 km in##2##3##(1997-5#1)(2008-10#1)
300 mOsm##3##2##(2008-11#3)
300 mW##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
300 mg##19##2##(1990-12#1)(1990-2#1)(1990-9#3)(1991-11#2)(1991-3#2)(1992-11#1)(1993-2#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)
300 mg%##2##2##(2008-10#2)
300 microM##4##2##(1992-12#1)(1995-3#1)(1997-1#1)(2008-8#1)
300 micrograms##2##2##(1992-3#1)(1996-2#1)
300 million##2##2##(2012-12#1)(2012-2#1)
300 ml##2##2##(2008-10#2)
300 ms##3##2##(1995-12#1)(1997-2#1)(2008-11#1)
300 muM##2##2##(2008-11#2)
300 mug##3##2##(2008-10#2)(2008-11#1)
300 mul##2##2##(2008-10#2)
300 nM##4##2##(1992-9#1)(1994-11#1)(1994-12#1)(2008-8#1)
300 nm to##2##3##(2007-12#1)(2008-3#1)
300 nm##8##2##(1993-11#1)(2007-11#1)(2007-12#2)(2008-3#4)
300 of##2##2##(1997-6#1)(2012-12#1)
300 patients##4##2##(1993-6#2)(2008-11#2)
300 ps##2##2##(2007-11#1)(2008-2#1)
300 s##2##2##(2008-10#2)
300 times##3##2##(2008-10#2)(2009-5#1)
300 to##12##2##(1992-9#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#4)
300##256##1##(1990-12#3)(1990-2#2)(1990-9#4)(1991-11#2)(1991-3#4)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#8)(2007-12#7)(2007-8#1)(2008-1#4)(2008-10#65)(2008-11#20)(2008-12#3)(2008-2#12)(2008-3#18)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#10)(2011-10#1)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
300)##5##1##(1990-7#1)(1990-8#1)(1997-1#1)(2008-11#1)(2008-3#1)
300-400##3##1##(1991-2#1)(2008-10#1)(2008-4#1)
300-500##2##1##(2010-8#1)(2011-2#1)
300-fold##5##1##(1990-8#1)(1995-3#1)(2008-10#1)(2009-7#1)(2013-1#1)
300-fs##2##1##(2007-12#2)
300-m##3##1##(2008-3#3)
300-mm##2##1##(2008-2#2)
300-mm-aperture##2##1##(2008-3#2)
300-mum##3##1##(2008-10#1)(2008-2#2)
300-nm##2##1##(2008-3#1)(2009-10#1)
3000 and##3##2##(2008-12#2)(2012-1#1)
3000 cases##2##2##(2007-12#1)(2012-3#1)
3000 genes##2##2##(2008-7#1)(2012-2#1)
3000 ppm##2##2##(1990-5#1)(2008-10#1)
3000##35##1##(1990-5#1)(1990-8#1)(1990-9#1)(1992-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
3000-fold##2##1##(1995-5#1)(2013-1#1)
300mg gallic acid per liter##2##5##(2008-10#2)
300mg##3##1##(2008-10#3)
300nm##2##1##(2008-10#2)
301 and##2##2##(2008-10#2)
301 var##3##2##(2008-12#3)
301##20##1##(1997-2#1)(2008-10#10)(2008-12#8)(2008-2#1)
301)##3##1##(2008-10#2)(2011-1#1)
3010##2##1##(2008-5#1)(2013-1#1)
302##13##1##(1995-2#3)(1996-2#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#2)
303##15##1##(1993-6#1)(1995-5#5)(2008-1#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
304 A##3##2##(2008-3#3)
304##17##1##(1990-5#1)(1992-6#1)(1992-9#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#2)
305 nm##2##2##(2008-5#1)(2010-8#1)
305##14##1##(1993-12#1)(1994-12#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)
305-nm##2##1##(2008-2#2)
3057##3##1##(1990-8#1)(2007-11#1)(2008-3#1)
306##10##1##(1990-8#1)(1993-8#1)(2007-7#1)(2008-10#4)(2010-1#1)(2011-2#1)(2012-3#1)
307##10##1##(1992-6#1)(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-5#3)(2012-12#1)
307)##2##1##(1992-3#1)(2010-8#1)
308##8##1##(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-12#1)
308)##2##1##(1993-1#1)(2013-1#1)
309##7##1##(1993-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
30Gy/10##2##1##(2008-10#2)
30K##2##1##(1997-3#2)
30S##7##1##(1992-6#1)(1993-11#2)(2009-9#4)
30h(-1)##3##1##(2008-10#3)
30mM##3##1##(2008-10#3)
30mg##3##1##(2007-11#1)(2008-10#2)
30mgL(-1)##2##1##(2008-10#2)
30min after##2##2##(2008-7#2)
30min and##2##2##(2008-10#1)(2008-7#1)
30min gave##2##2##(2008-10#1)(2013-1#1)
30min##19##1##(2007-12#1)(2008-10#14)(2008-7#3)(2013-1#1)
30mug##3##1##(2008-10#1)(2010-7#2)
30mugl(-1)##3##1##(2008-10#3)
30mum##2##1##(2008-10#2)
30s and##5##2##(2008-10#5)
30s##15##1##(1992-4#1)(1994-1#2)(2008-10#11)(2008-8#1)
30s)##2##1##(2008-10#1)(2012-1#1)
30th day of##2##3##(2008-12#1)(2012-3#1)
30th day##3##2##(2008-12#1)(2008-7#1)(2012-3#1)
30th##10##1##(1995-8#1)(2007-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2011-2#1)(2011-4#1)(2012-3#1)
30 days##2##1##(2011-2#2)
30 years##4##1##(2011-2#1)(2012-2#3)
30°C and 40°C##2##3##(2012-2#2)
30°C and##3##2##(2012-2#3)
30°C##11##1##(2010-10#1)(2011-2#7)(2012-2#3)
31 (1##2##2##(2011-2#1)(2013-1#1)
31 +/- 0##7##3##(1990-2#1)(1994-5#1)(1995-12#1)(1997-7#1)(2009-8#1)(2010-4#1)(2010-8#1)
31 +/-##12##2##(1990-2#1)(1991-5#1)(1994-5#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-7#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-8#1)
31 December 1990##2##3##(1991-12#2)
31 December##6##2##(1991-12#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
31 and 0##2##3##(2008-10#1)(2008-2#1)
31 and##7##2##(1990-7#1)(2008-10#3)(2008-2#1)(2010-10#1)(2013-1#1)
31 cases with##2##3##(2006-12#1)(2008-5#1)
31 cases##3##2##(1993-9#1)(2006-12#1)(2008-5#1)
31 children##2##2##(1994-6#1)(2007-11#1)
31 days##5##2##(1997-6#1)(2008-10#3)(2012-2#1)
31 degrees C for##2##4##(2008-11#2)
31 degrees C##9##3##(2008-10#2)(2008-11#3)(2008-5#4)
31 degrees##11##2##(2008-10#2)(2008-11#3)(2008-5#4)(2008-7#1)(2013-1#1)
31 individuals##2##2##(2007-11#1)(2008-7#1)
31 kDa protein##3##3##(1990-2#3)
31 kDa##6##2##(1990-2#3)(1990-5#1)(1993-8#1)(2007-10#1)
31 microm/bit##2##2##(2008-3#2)
31 min##2##2##(1996-12#1)(1997-2#1)
31 patients and##2##3##(2008-11#1)(2011-2#1)
31 patients were##2##3##(1991-8#1)(2008-6#1)
31 patients with##7##3##(1990-3#1)(1990-6#1)(1991-2#1)(2007-11#2)(2008-5#1)(2013-7#1)
31 patients##22##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1996-3#1)(2007-11#3)(2007-8#3)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#2)(2013-7#1)
31 strains##2##2##(2008-10#2)
31 to 0##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
31 to##9##2##(1990-12#1)(1995-8#1)(2007-12#1)(2008-10#3)(2010-4#1)(2011-2#1)(2012-2#1)
31 with##2##2##(1990-3#1)(2013-7#1)
31 years##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
31##337##1##(1990-11#1)(1990-12#2)(1990-2#7)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#5)(1991-9#1)(1992-1#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#3)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-6#2)(1995-8#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#6)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#8)(2008-1#5)(2008-10#48)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#15)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#2)(2009-4#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#3)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#29)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#19)(2013-7#4)(2013-8#7)
31% for##2##2##(1997-4#1)(2008-11#1)
31% in the##2##3##(2007-8#1)(2011-2#1)
31% in##4##2##(2007-8#1)(2011-10#1)(2011-2#1)(2013-1#1)
31% of the total##2##4##(2007-7#1)(2008-10#1)
31% of the##8##3##(1990-2#1)(1994-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#1)(2010-10#1)
31% of##15##2##(1990-2#1)(1992-9#1)(1994-2#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
31%##50##1##(1990-2#1)(1990-9#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-8#2)(1994-9#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
31%) and##2##2##(1996-5#1)(2009-4#1)
31%)##4##1##(1996-5#1)(2008-10#1)(2009-4#1)(2011-2#1)
31) and##3##2##(2008-10#2)(2011-1#1)
31)##9##1##(1996-11#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
31-0##3##1##(2007-12#1)(2007-8#1)(2008-12#1)
31-35##3##1##(1994-11#1)(1994-9#1)(2008-12#1)
31-40##2##1##(1995-3#1)(2007-7#1)
31-67##5##1##(1990-12#5)
31-kDa##2##1##(1992-4#1)(2009-2#1)
31-year-old woman with a##2##4##(1990-6#1)(1992-10#1)
31-year-old woman##3##2##(1990-6#1)(1992-10#1)(2011-2#1)
31-year-old##5##1##(1990-6#1)(1992-10#1)(2009-10#1)(2011-2#1)(2012-3#1)
310 and##2##2##(2008-10#1)(2008-5#1)
310 cases##2##2##(1994-11#1)(1995-12#1)
310##18##1##(1993-9#1)(1994-11#1)(1995-12#1)(1996-5#1)(1997-7#2)(2008-10#7)(2008-3#2)(2008-5#3)
310%##2##1##(1994-11#1)(2008-3#1)
311##12##1##(1990-2#1)(1990-7#1)(1993-6#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-2#2)
311-2##2##1##(2008-11#2)
312 bp##2##2##(2011-2#2)
312 nm##2##2##(2008-10#1)(2013-8#1)
312##13##1##(1993-12#1)(1994-6#1)(2007-3#1)(2008-10#4)(2010-10#1)(2010-4#1)(2011-2#3)(2013-8#1)
3125##2##1##(2008-7#2)
313 liver##2##2##(1993-9#2)
313##10##1##(1991-12#1)(1991-6#1)(1993-8#1)(1993-9#2)(1995-2#1)(2008-8#1)(2009-5#1)(2009-7#1)(2013-8#1)
314 kg/ha##2##2##(2008-10#2)
314##9##1##(1996-12#1)(2008-10#5)(2008-5#1)(2008-6#1)(2011-2#1)
315 nm##2##2##(2008-10#1)(2008-2#1)
315##11##1##(1992-9#1)(1994-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-8#1)
316##11##1##(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
316-319##2##1##(2012-3#2)
317 for##2##2##(2008-10#1)(2010-3#1)
317 pp##2##2##(1997-6#1)(2013-1#1)
317##16##1##(1991-2#1)(1991-7#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
317)##3##1##(1995-3#1)(2008-10#1)(2008-5#1)
31749##3##1##(2008-6#3)
318##7##1##(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#2)(2013-1#1)
318029 participants##2##2##(2008-12#2)
318029##3##1##(2008-12#3)
319 mum##2##2##(2007-12#2)
319 stool samples##2##3##(2011-1#2)
319##10##1##(1992-9#1)(1994-11#1)(2007-12#2)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#2)(2011-2#1)
31P NMR study##2##3##(1994-2#1)(1995-12#1)
31P NMR##7##2##(1992-12#2)(1993-11#2)(1994-12#1)(1994-2#1)(1995-12#1)
31P and##2##2##(1993-11#1)(1994-2#1)
31P magnetic resonance spectroscopy##2##4##(1994-2#1)(2008-11#1)
31P nuclear magnetic resonance spectroscopy##2##5##(1995-12#1)(2008-10#1)
31P nuclear magnetic resonance##3##4##(1995-12#1)(2008-10#1)(2010-8#1)
31P##17##1##(1992-12#2)(1992-6#1)(1993-11#3)(1994-12#1)(1994-2#4)(1995-12#2)(1995-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
31P- and 1H-NMR spectroscopy##2##4##(1990-11#1)(1994-3#1)
31P- and 1H-NMR##3##3##(1990-11#2)(1994-3#1)
31P-NMR spectroscopy##2##2##(1991-5#1)(1994-3#1)
31P-NMR##6##1##(1990-2#1)(1990-8#2)(1991-5#1)(1994-3#1)(1997-2#1)
31P-nuclear magnetic resonance##2##3##(1990-2#1)(1991-5#1)
31st##5##1##(1997-3#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-8#1)
32 +/- 0##3##3##(2007-8#1)(2008-12#2)
32 +/-##5##2##(1996-2#1)(2007-8#1)(2008-10#1)(2008-12#2)
32 and 0##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
32 and##13##2##(1994-2#1)(1995-8#1)(1996-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-8#2)
32 cases##5##2##(1993-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2011-2#1)
32 compared to##2##3##(1990-2#1)(1994-9#1)
32 degrees C and##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
32 degrees C##24##3##(1991-2#3)(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-5#4)
32 degrees C)##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#1)
32 degrees##31##2##(1991-2#3)(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-5#5)(2008-8#1)(2010-4#1)
32 different##3##2##(1995-6#1)(2008-10#1)(2013-8#1)
32 for##2##2##(2007-10#1)(2008-10#1)
32 h##2##2##(2008-10#1)(2008-5#1)
32 healthy##4##2##(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)
32 is##17##2##(1997-3#1)(2008-10#1)(2011-1#15)
32 kDa##5##2##(1993-3#1)(1997-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
32 mg kg(-1)##2##3##(2008-12#2)
32 mg l(-1)##2##3##(2008-10#2)
32 mg##4##2##(2008-10#2)(2008-12#2)
32 microM##4##2##(1991-5#1)(1994-8#1)(2008-10#2)
32 min##2##2##(2008-10#1)(2009-12#1)
32 months##5##2##(1991-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)
32 ng ml(-1) for##2##4##(2008-10#2)
32 ng ml(-1)##4##3##(2008-10#4)
32 ng##6##2##(2008-10#6)
32 nm##3##2##(2007-11#1)(2008-3#2)
32 of##4##2##(1990-5#1)(1997-8#1)(2008-1#1)(2008-10#1)
32 patients with##7##3##(1995-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)
32 patients##18##2##(1993-5#1)(1994-3#1)(1995-2#1)(1996-3#2)(1997-4#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
32 per##2##2##(1990-12#1)(1992-2#1)
32 percent##2##2##(1993-3#1)(1996-3#1)
32 primary##2##2##(1994-12#1)(2008-11#1)
32 samples of##2##3##(2008-10#1)(2008-11#1)
32 samples##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
32 the##2##2##(2011-2#1)(2013-1#1)
32 times##2##2##(2008-10#1)(2012-3#1)
32 to##6##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
32 vesicocentesis and amnioinfusion procedures##2##5##(2008-7#2)
32 was##2##2##(2008-10#1)(2008-9#1)
32 weeks##5##2##(1991-6#1)(2008-10#2)(2013-1#1)(2013-8#1)
32 were##2##2##(2008-9#1)(2013-8#1)
32 with##3##2##(1991-8#1)(1997-5#1)(2011-2#1)
32 women##3##2##(1996-2#1)(2008-3#1)(2013-8#1)
32 x 32##2##3##(2008-3#2)
32 year old##2##3##(1997-6#1)(2007-8#1)
32 years old##2##3##(1996-8#1)(2007-8#1)
32 years##6##2##(1996-8#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
32 ±##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
32##433##1##(1990-11#1)(1990-12#6)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-3#3)(1993-5#2)(1993-8#1)(1993-9#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#7)(1997-7#3)(1997-8#6)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#12)(2007-9#2)(2008-1#10)(2008-10#81)(2008-11#14)(2008-12#10)(2008-2#9)(2008-3#21)(2008-4#7)(2008-5#11)(2008-6#7)(2008-7#11)(2008-8#7)(2008-9#6)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#21)(2011-2#11)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#14)
32% and##2##2##(1997-6#1)(2012-2#1)
32% for##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
32% in the##2##3##(2008-2#1)(2012-3#1)
32% in##3##2##(1996-9#1)(2008-2#1)(2012-3#1)
32% increase##2##2##(2008-1#1)(2008-10#1)
32% of patients##2##3##(2006-12#1)(2006-8#1)
32% of the##4##3##(2008-10#3)(2008-5#1)
32% of##13##2##(1992-1#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#2)
32% reduction##2##2##(2007-12#1)(2007-8#1)
32% were##2##2##(2008-10#1)(2010-8#1)
32%##52##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
32%)##4##1##(2008-10#2)(2008-7#1)(2011-2#1)
32) and##3##2##(1994-3#1)(2009-5#1)(2012-2#1)
32)##20##1##(1990-12#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-3#3)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
32+/-0##4##1##(2008-10#2)(2008-5#1)(2008-8#1)
32+/-2##2##1##(2008-10#1)(2008-6#1)
32- and##2##2##(1995-6#1)(2006-6#1)
32-##5##1##(1995-6#1)(2006-6#1)(2008-10#2)(2013-1#1)
32-0##4##1##(2008-10#2)(2008-3#2)
32-40##2##1##(1995-3#1)(2008-10#1)
32-channel##3##1##(1992-8#1)(2008-2#1)(2008-3#1)
32-fold range of##2##3##(1994-8#1)(2010-3#1)
32-fold##5##1##(1994-8#1)(1995-11#1)(2008-10#1)(2010-3#1)(2011-2#1)
32-kDa##4##1##(1992-4#1)(1994-11#1)(2008-10#2)
32-year##2##1##(2008-7#1)(2011-1#1)
32-year-old man presenting with##2##4##(2012-12#1)(2012-3#1)
32-year-old man with##2##3##(2009-1#1)(2011-2#1)
32-year-old man##6##2##(2007-10#1)(2009-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
32-year-old primipara##2##2##(2008-4#1)(2013-1#1)
32-year-old woman##3##2##(2007-10#1)(2007-5#1)(2008-7#1)
32-year-old##21##1##(1994-12#1)(1995-12#1)(2007-10#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
320 m##2##2##(2007-8#1)(2008-3#1)
320 nm##4##2##(1991-3#1)(1995-3#1)(2008-10#1)(2012-2#1)
320 nm)##2##2##(2009-11#1)(2010-4#1)
320##32##1##(1991-2#2)(1991-3#1)(1992-6#1)(1992-8#1)(1994-6#1)(1995-3#1)(1996-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-2#1)
320)##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
3200 to##2##2##(2008-1#1)(2012-9#1)
3200##4##1##(1991-2#1)(2008-1#1)(2011-2#1)(2012-9#1)
320937##2##1##(2008-10#2)
321##7##1##(1992-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
322##8##1##(1990-11#1)(1990-7#2)(1994-11#1)(1995-6#1)(2008-12#1)(2011-2#1)(2012-7#1)
323##9##1##(1994-6#2)(2007-7#2)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)
3235##2##1##(2008-10#2)
324 and##2##2##(1997-7#2)
324 nm##2##2##(2008-10#2)
324##16##1##(1991-5#1)(1992-6#1)(1995-11#1)(1997-3#1)(1997-7#5)(2008-10#4)(2008-7#2)(2011-2#1)
3243A&gt##5##1##(2013-8#5)
325##11##1##(1992-10#1)(1996-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-8#1)
325-nm##2##1##(2008-2#2)
326##6##1##(2007-10#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-2#1)
327 microm##2##2##(2007-12#2)
327##9##1##(1990-7#1)(1992-12#1)(2007-12#2)(2008-10#2)(2008-5#1)(2011-2#2)
327)##3##1##(2007-12#1)(2008-10#1)(2012-12#1)
327-nm##2##1##(2008-3#2)
328 to##2##2##(2007-12#1)(2009-4#1)
328##16##1##(1992-3#1)(1993-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-4#5)(2010-11#1)(2010-12#1)(2010-3#1)(2012-2#1)
329 +/-##2##2##(1992-10#1)(2009-8#1)
329 amino acids##2##3##(1995-8#1)(2008-8#1)
329##12##1##(1992-10#2)(1995-8#1)(1996-6#1)(1996-9#1)(2008-10#2)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
32D cells##3##2##(1997-7#3)
32D##4##1##(1997-7#4)
32P incorporation into##2##3##(1993-11#1)(1997-1#1)
32P incorporation##3##2##(1993-11#1)(1997-1#1)(1997-2#1)
32P##8##1##(1993-11#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#1)
32P-labeled##9##1##(1990-11#2)(1990-2#1)(1991-1#1)(1992-8#1)(1992-9#1)(1995-2#2)(1995-6#1)
32P-labelled##2##1##(1994-6#1)(1996-2#1)
32nd##3##1##(1996-11#1)(2008-8#2)
32 ng/mL)##2##1##(2012-3#1)(2013-1#1)
33 (1994)##2##2##(1997-2#2)
33 +/- 0##2##3##(2007-10#1)(2013-1#1)
33 +/-##7##2##(1995-10#1)(1995-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
33 V##2##2##(2008-10#1)(2009-9#1)
33 abattoir workers##2##3##(2011-2#2)
33 amino##2##2##(1993-3#1)(1996-3#1)
33 and 1##2##3##(2008-12#1)(2008-3#1)
33 and##15##2##(1991-9#1)(1996-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2012-3#1)
33 cases of##2##3##(1991-11#1)(1996-6#1)
33 cases##5##2##(1991-11#2)(1996-6#1)(2008-10#1)(2008-12#1)
33 days##2##2##(1993-8#1)(1994-12#1)
33 degrees C##8##3##(1991-8#1)(1995-11#1)(2008-11#3)(2011-2#3)
33 degrees C-FM3A##2##3##(1995-11#2)
33 degrees C-cells##3##3##(1995-11#3)
33 degrees##16##2##(1991-8#1)(1995-11#7)(2008-11#3)(2008-9#1)(2011-2#4)
33 different##2##2##(2008-10#1)(2008-7#1)
33 hospitals##2##2##(1990-2#1)(1990-6#1)
33 in##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
33 kD##2##2##(1990-7#1)(2008-11#1)
33 kDa##2##2##(1990-8#1)(2008-10#1)
33 men##2##2##(2008-4#1)(2009-5#1)
33 mg##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
33 microM##2##2##(1991-5#1)(1995-6#1)
33 microm##2##2##(2008-2#1)(2008-3#1)
33 mug##3##2##(2008-10#3)
33 mugl(-1) for##2##3##(2008-10#2)
33 nm##2##2##(2007-11#1)(2009-11#1)
33 of the##2##3##(1996-12#1)(2011-2#1)
33 of##3##2##(1996-12#2)(2011-2#1)
33 patients with##3##3##(1997-7#1)(2008-7#2)
33 patients##11##2##(1991-9#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-7#2)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
33 percent##2##2##(1991-12#1)(2011-2#1)
33 to##7##2##(1991-5#1)(1995-3#1)(1997-4#1)(2008-10#3)(2008-5#1)
33 vs##2##2##(2008-3#1)(2010-8#1)
33 weeks##3##2##(1990-8#1)(2008-7#1)(2013-1#1)
33 women##3##2##(1994-2#2)(2007-11#1)
33 x##3##2##(2008-10#2)(2008-11#1)
33 years##6##2##(1992-11#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
33 years)##2##2##(1996-3#1)(2008-5#1)
33 ±##2##2##(2011-1#1)(2013-1#1)
33##350##1##(1990-2#2)(1990-3#1)(1990-6#2)(1990-7#3)(1990-8#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#5)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#8)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#5)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#65)(2008-11#10)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#2)(2010-3#4)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#17)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#5)
33% and##3##2##(1990-6#1)(2011-2#1)(2013-1#1)
33% at##2##2##(2007-11#2)
33% in##4##2##(1990-6#1)(1994-12#1)(2008-10#1)(2008-6#1)
33% of patients##3##3##(1990-3#1)(2011-2#1)(2013-1#1)
33% of the##5##3##(1990-5#1)(1992-9#1)(2008-10#2)(2008-12#1)
33% of##17##2##(1990-3#1)(1990-5#1)(1992-9#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
33% vs##2##2##(2007-7#1)(2012-3#1)
33%##68##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1991-2#2)(1992-1#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-12#1)(1997-7#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
33%) and##2##2##(2008-12#1)(2011-2#1)
33%)##14##1##(1994-6#1)(2008-1#1)(2008-10#1)(2008-12#4)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
33) compared##2##2##(2008-12#1)(2008-8#1)
33)##22##1##(1992-6#1)(1994-3#1)(1994-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-8#2)(2012-3#1)(2013-1#2)(2013-8#1)
33)Fe(2)As(2)##3##1##(2012-2#3)
33-0##2##1##(1990-8#1)(2008-10#1)
33-1##2##1##(2008-10#1)(2008-3#1)
33-6##2##1##(2008-10#1)(2009-5#1)
33-fold##2##1##(1996-3#1)(2007-10#1)
33-kD##3##1##(1992-12#3)
33-year-old man##4##2##(2007-8#2)(2008-9#1)(2012-12#1)
33-year-old##9##1##(1997-5#1)(1997-7#1)(2007-8#3)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
330##20##1##(1990-10#1)(1991-11#2)(1995-8#1)(1997-8#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-3#1)
3300##2##1##(1996-6#1)(2008-10#1)
331 patients##3##2##(1990-2#1)(1990-9#1)(2012-2#1)
331##7##1##(1990-2#1)(1990-9#1)(1997-2#1)(2008-10#1)(2008-4#2)(2012-2#1)
3316##2##1##(2012-3#2)
332##18##1##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#12)
33258##2##1##(1992-11#1)(1994-6#1)
332Arg-333Val##2##1##(1993-11#2)
333 (95%CI##3##2##(2011-1#3)
333##14##1##(1992-10#1)(1992-6#1)(1994-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
334##13##1##(1992-5#1)(1993-3#1)(2008-10#4)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
334- and 824-bp##2##3##(2008-10#2)
335##7##1##(1991-2#1)(1992-12#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
336 K##2##2##(1992-10#2)
336 nm##2##2##(2008-10#1)(2008-2#1)
336##13##1##(1990-11#1)(1992-10#2)(1993-12#1)(2008-10#5)(2008-2#1)(2010-1#1)(2011-1#1)(2013-1#1)
337##13##1##(1991-9#2)(1993-12#2)(1995-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-7#1)
338##7##1##(1992-8#1)(1996-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
339##11##1##(1991-2#2)(2008-10#2)(2008-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#1)
33rd Annual##3##2##(1991-12#1)(2011-1#1)(2011-2#1)
34 (1995)##2##2##(1997-2#2)
34 +/- 0##4##3##(1994-6#1)(1996-2#1)(2008-10#2)
34 +/- 3##2##3##(1995-12#1)(2008-10#1)
34 +/-##8##2##(1994-6#1)(1995-12#1)(1996-2#1)(2007-7#1)(2008-10#3)(2009-8#1)
34 adverse drug reactions##2##4##(2010-5#2)
34 and 0##3##3##(2008-10#3)
34 and 1##2##3##(2008-10#1)(2008-3#1)
34 and 54 kDa##2##4##(1995-5#2)
34 and##10##2##(1995-5#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)
34 cases##4##2##(1992-5#1)(1997-3#1)(2007-11#1)(2012-3#1)
34 days##2##2##(2008-10#1)(2010-12#1)
34 degrees C##2##3##(2008-11#2)
34 degrees##3##2##(2007-10#1)(2008-11#2)
34 individuals##2##2##(1997-3#1)(2007-2#1)
34 kDa polypeptide##2##3##(1995-5#2)
34 kDa##11##2##(1991-12#2)(1995-5#2)(1997-6#1)(2008-10#1)(2008-11#1)(2009-7#4)
34 microm##2##2##(1991-5#1)(2008-3#1)
34 nucleotides##2##2##(1990-8#1)(1994-11#1)
34 of##5##2##(1990-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2009-10#1)
34 patients with##2##3##(1995-4#1)(2012-5#1)
34 patients##10##2##(1990-6#1)(1990-8#2)(1995-4#1)(2008-7#2)(2011-2#2)(2012-2#1)(2012-5#1)
34 percent##3##2##(1995-2#1)(1995-3#1)(1997-1#1)
34 s##2##2##(2007-12#1)(2008-10#1)
34 samples##2##2##(2008-6#1)(2011-2#1)
34 subjects##2##2##(2008-7#1)(2011-2#1)
34 to 0##2##3##(2008-10#1)(2013-7#1)
34 to##5##2##(2007-6#1)(2008-10#2)(2008-3#1)(2013-7#1)
34 vs##2##2##(2008-3#1)(2011-2#1)
34 weeks##2##2##(2007-7#1)(2012-12#1)
34 year##3##2##(1991-8#1)(1993-2#1)(2007-7#1)
34 years##6##2##(2007-8#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
34 years)##2##2##(1993-11#1)(2009-7#1)
34##308##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#7)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#2)(1997-9#1)(2007-10#3)(2007-11#6)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#5)(2008-10#44)(2008-11#7)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#2)(2009-2#1)(2009-4#2)(2009-7#5)(2009-8#2)(2010-1#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#9)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#5)
34% and##4##2##(1990-8#1)(2007-10#1)(2008-2#1)(2008-3#1)
34% in##2##2##(2008-10#1)(2011-2#1)
34% of patients##2##3##(2007-11#1)(2011-2#1)
34% of the##2##3##(2007-7#1)(2008-4#1)
34% of##8##2##(1994-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
34%##46##1##(1990-3#1)(1990-8#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#3)(2013-8#1)
34%)##6##1##(2007-8#2)(2008-10#2)(2008-12#2)
34)##11##1##(1990-5#1)(1990-8#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2013-8#1)
34+/-0##2##1##(2007-12#1)(2013-7#1)
34-0##3##1##(2008-10#1)(2010-3#1)(2012-3#1)
34-39##2##1##(2008-11#1)(2008-9#1)
34-kDa protein##3##2##(1993-6#2)(1993-9#1)
34-kDa##8##1##(1990-5#1)(1993-6#3)(1993-9#1)(1997-4#3)
34-microm##2##1##(2008-3#2)
34-ps##2##1##(2008-3#2)
34-year-old female##3##2##(1993-3#1)(2007-7#1)(2013-1#1)
34-year-old##9##1##(1993-3#1)(1996-5#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2009-3#1)(2013-1#1)
340 and##3##2##(1990-8#2)(1995-5#1)
340 nm##5##2##(1990-5#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-5#1)
340##27##1##(1990-2#3)(1990-5#1)(1990-8#2)(1993-3#1)(1993-9#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
340)##2##1##(1992-2#1)(2008-8#1)
341##7##1##(1990-11#1)(1991-6#1)(1993-3#2)(2008-10#1)(2010-11#1)(2013-1#1)
342##10##1##(1994-11#1)(1997-8#1)(2008-8#1)(2009-4#1)(2011-2#3)(2012-2#2)(2013-8#1)
343##12##1##(1991-11#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(2007-10#1)(2008-10#2)(2012-3#1)(2013-1#1)
3435##2##1##(1995-12#2)
344 rats##16##2##(1990-3#1)(1990-6#3)(1992-12#2)(1993-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-9#1)(2008-3#3)(2008-7#1)
344##23##1##(1990-3#1)(1990-6#3)(1990-8#1)(1992-12#2)(1993-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2013-1#1)
345##13##1##(1993-8#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
346##16##1##(1990-6#1)(1992-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#2)(2012-3#1)(2013-8#1)
347##10##1##(1991-8#1)(1992-4#1)(1993-12#2)(1993-6#1)(1996-2#1)(1997-6#1)(2010-7#2)(2011-2#1)
348##7##1##(1993-9#1)(1995-8#1)(2008-10#2)(2008-3#2)(2013-1#1)
349##5##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
349)##2##1##(2008-10#1)(2008-7#1)
34th##4##1##(1997-8#1)(2007-8#1)(2008-11#1)(2008-5#1)
35 %##3##2##(2008-5#3)
35 &gt##2##2##(1997-2#1)(1997-4#1)
35 +/- 0##2##3##(2008-12#1)(2008-5#1)
35 +/-##4##2##(1996-2#1)(2008-12#1)(2008-5#1)(2009-4#1)
35 D/year##2##2##(2012-12#2)
35 DPI##3##2##(2008-10#3)
35 GHz##2##2##(2008-2#1)(2008-3#1)
35 Ncm##3##2##(2013-1#3)
35 U/ml##3##2##(1991-4#2)(1992-9#1)
35 V##2##2##(2008-10#1)(2009-9#1)
35 amino acids##2##3##(1991-12#1)(2010-10#1)
35 amino##4##2##(1991-12#1)(1997-4#1)(2008-6#1)(2010-10#1)
35 and 0##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#2)
35 and 1##2##3##(1990-9#1)(2008-10#1)
35 and 36##3##3##(2008-10#2)(2008-11#1)
35 and 45 degrees##2##4##(2008-12#1)(2008-7#1)
35 and 45##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
35 and##36##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1993-12#1)(1995-6#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)
35 cases##3##2##(1991-8#1)(1993-9#1)(2007-10#1)
35 days##5##2##(1997-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#1)
35 degrees C and##6##4##(2008-10#4)(2008-5#1)(2008-6#1)
35 degrees C was##2##4##(2007-10#1)(2008-10#1)
35 degrees C##39##3##(1990-2#1)(1997-6#1)(2007-10#1)(2008-10#26)(2008-2#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-8#1)(2011-2#2)
35 degrees C)##3##3##(1995-5#1)(2008-10#2)
35 degrees##43##2##(1990-2#1)(1995-5#1)(1997-6#1)(2007-10#1)(2008-10#28)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-8#1)(2011-2#2)
35 for##2##2##(1996-5#1)(2008-10#1)
35 g##3##2##(1997-2#1)(2008-5#1)(2008-7#1)
35 healthy##3##2##(1996-7#1)(2008-1#1)(2011-2#1)
35 high risk patients on##2##5##(2010-10#2)
35 in##5##2##(1990-6#1)(1996-3#1)(2008-8#1)(2008-9#1)(2010-2#1)
35 kDa##5##2##(1996-6#1)(1997-8#1)(2008-10#3)
35 ku##3##2##(2008-8#1)(2008-9#2)
35 mM sodium##2##3##(2008-10#2)
35 mM##3##2##(1993-8#1)(2008-10#2)
35 mM)##3##2##(2008-10#2)(2008-5#1)
35 medulloblastomas##2##2##(1991-2#2)
35 mg##2##2##(1996-5#1)(2008-10#1)
35 microm##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
35 min##3##2##(1996-5#1)(2008-10#2)
35 mm##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
35 months##2##2##(2008-6#1)(2011-2#1)
35 mum##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
35 nM##2##2##(1995-3#1)(2008-10#1)
35 nM)##2##2##(1994-8#1)(1995-2#1)
35 nm##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
35 of the##3##3##(1991-4#1)(1993-9#1)(2012-12#1)
35 of##6##2##(1991-2#1)(1991-4#1)(1993-9#1)(2008-10#1)(2008-4#1)(2012-12#1)
35 or more##2##3##(1991-12#1)(2012-12#1)
35 or##4##2##(1991-12#1)(2008-7#1)(2009-7#1)(2012-12#1)
35 pathosystems##2##2##(2008-10#2)
35 patients who##2##3##(2007-10#1)(2007-11#1)
35 patients with##3##3##(1990-3#1)(1990-9#1)(2008-9#1)
35 patients##17##2##(1990-3#1)(1990-9#2)(1991-3#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
35 percent of##4##3##(1991-12#1)(1994-2#1)(1994-3#1)(1997-1#1)
35 times##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
35 to 0##3##3##(2008-1#1)(2008-10#2)
35 to 40##2##3##(2008-10#1)(2009-7#1)
35 to##14##2##(1994-6#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)
35 vs##2##2##(2007-10#2)
35 weeks##4##2##(1992-9#1)(1994-12#1)(2007-8#1)(2013-1#1)
35 x##4##2##(1995-11#1)(2008-10#3)
35 year##2##2##(2006-8#1)(2013-8#1)
35 years after##2##3##(1995-11#1)(2009-5#1)
35 years and##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
35 years of age##7##4##(2007-5#2)(2008-10#2)(2010-3#1)(2012-3#2)
35 years of##8##3##(2007-5#2)(2008-10#2)(2010-3#1)(2012-3#3)
35 years##25##2##(1991-3#1)(1992-3#1)(1995-1#1)(1995-11#1)(2007-5#2)(2008-1#1)(2008-10#5)(2008-7#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#5)(2013-1#1)
35##525##1##(1990-11#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#4)(1991-12#5)(1991-2#3)(1991-3#4)(1991-4#4)(1991-5#2)(1991-8#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#2)(1997-8#3)(2006-8#1)(2007-10#10)(2007-11#5)(2007-12#5)(2007-2#3)(2007-5#2)(2007-7#4)(2007-8#9)(2008-1#5)(2008-10#139)(2008-11#6)(2008-12#9)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#16)(2008-6#12)(2008-7#11)(2008-8#5)(2008-9#14)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-8#3)(2011-1#5)(2011-2#19)(2012-1#3)(2012-12#13)(2012-2#12)(2012-3#11)(2012-4#1)(2012-8#1)(2013-1#19)(2013-7#1)(2013-8#5)
35% and##2##2##(2008-8#1)(2012-2#1)
35% at##2##2##(2008-10#1)(2008-3#1)
35% fish meal##2##3##(2008-12#2)
35% had##3##2##(1990-12#1)(2006-10#1)(2012-2#1)
35% in##4##2##(1995-3#1)(2008-1#2)(2012-2#1)
35% of the##14##3##(1990-12#1)(1990-5#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-8#1)(2013-8#1)
35% of total##2##3##(2008-10#1)(2009-3#1)
35% of##28##2##(1990-12#1)(1990-5#2)(1994-2#1)(1995-2#2)(1996-6#1)(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
35% to##3##2##(2007-7#1)(2008-6#1)(2009-8#1)
35% with respect to##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
35% with##4##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)
35%##91##1##(1990-12#2)(1990-5#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#5)(2008-10#20)(2008-11#3)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2009-8#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#4)
35%) and##2##2##(2008-4#1)(2008-7#1)
35%)##12##1##(1990-7#1)(2007-7#4)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
35) and##2##2##(2008-11#1)(2012-12#1)
35)##13##1##(1993-1#1)(1993-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
35- to##2##2##(2008-10#1)(2008-11#1)
35-0##2##1##(1991-8#1)(2008-7#1)
35-39##2##1##(1990-6#1)(2008-12#1)
35-45##2##1##(1990-5#1)(1993-12#1)
35-64 years##3##2##(2008-7#1)(2009-10#1)(2012-12#1)
35-64##4##1##(1992-10#1)(2008-7#1)(2009-10#1)(2012-12#1)
35-fold##4##1##(1990-10#1)(1992-3#1)(1996-10#1)(2008-10#1)
35-kDa protein##2##2##(1990-5#1)(1991-8#1)
35-kDa##4##1##(1990-5#1)(1991-8#1)(1992-9#1)(1995-6#1)
35-min##2##1##(1993-6#1)(2009-11#1)
35-mm##2##1##(1995-11#1)(2008-11#1)
35-ps pulses##2##2##(2007-11#1)(2008-3#1)
35-year-old man##2##2##(2012-2#1)(2012-3#1)
35-year-old##12##1##(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
350 and 700 mg/L males were significantly less than those of the control group##3##14##(2008-9#3)
350 and 700 mg/L males were significantly##4##7##(2008-9#4)
350 and 700 mg/L males were##6##6##(2008-9#6)
350 and 700 mg/L males##8##5##(2008-9#8)
350 and 700 mg/L##9##4##(2008-9#9)
350 and##10##2##(2008-11#1)(2008-9#9)
350 cases##5##2##(1990-12#1)(1991-8#1)(2007-8#1)(2010-7#2)
350 g##4##2##(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
350 h##2##2##(2008-11#1)(2008-2#1)
350 kb and##2##3##(1996-12#1)(1997-2#1)
350 kb##4##2##(1996-10#2)(1996-12#1)(1997-2#1)
350 nm##7##2##(1991-5#1)(1992-6#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
350 ns##2##2##(2008-3#2)
350 ppm##2##2##(2008-10#2)
350 to##9##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-4#1)
350##101##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#2)(1996-12#1)(1996-2#2)(1997-2#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#17)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)
3500##5##1##(1993-3#1)(1993-6#1)(1995-3#1)(2008-2#1)(2008-5#1)
351##9##1##(1990-9#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-6#1)(2008-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
352 nm##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
352##9##1##(1992-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2013-8#1)
353 cattle with tuberculous lesions##2##5##(1997-8#2)
353##7##1##(1991-8#1)(1992-9#1)(1995-2#1)(1997-8#2)(2007-7#1)(2011-2#1)
354##7##1##(1990-11#1)(1991-12#1)(1991-9#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-7#1)
354)##2##1##(1997-5#1)(2008-10#1)
355 and 532 nm for##2##5##(2008-3#2)
355 and 532 nm##3##4##(2008-3#3)
355 and##6##2##(2008-3#5)(2012-2#1)
355 nm were##2##3##(2008-2#1)(2008-3#1)
355 nm##14##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#6)(2011-1#1)(2012-2#1)
355##33##1##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#16)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
355-nm generation##2##2##(2007-12#1)(2008-2#1)
355-nm##7##1##(2007-12#2)(2008-2#3)(2008-3#2)
356##4##1##(1997-3#1)(1997-7#1)(2007-11#1)(2010-5#1)
357 patients##3##2##(2008-7#3)
357##15##1##(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
358 amino##2##2##(1990-11#1)(1991-9#1)
358##6##1##(1990-11#1)(1991-9#1)(1993-2#1)(2008-12#1)(2010-2#1)(2013-1#1)
359##8##1##(1991-5#1)(1992-3#1)(1995-8#1)(2007-11#1)(2008-5#1)(2011-2#2)(2012-12#1)
35S promoter and terminator##2##4##(2008-8#2)
35S promoter and##3##3##(1997-6#1)(2008-8#2)
35S promoter was##2##3##(2008-8#1)(2008-9#1)
35S promoter##15##2##(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-8#3)(2008-9#3)(2009-8#1)(2011-10#1)
35S##19##1##(1990-5#2)(1993-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-8#3)(2008-9#4)(2009-8#1)(2011-10#1)
35S-labeled##6##1##(1992-8#1)(1992-9#1)(1993-5#1)(1994-8#1)(1995-2#1)(1997-4#1)
35S-labelled##3##1##(1995-11#1)(1996-12#1)(1996-2#1)
35SO4##2##1##(1991-12#1)(1992-9#1)
35V##2##1##(2008-10#2)
35min##3##1##(2008-10#3)
35mugl(-1)##2##1##(2008-10#2)
35s##2##1##(2008-10#2)
35th##2##1##(2008-4#1)(2008-7#1)
35 min##2##1##(2013-1#2)
36 (SF-36)##2##2##(2012-12#2)
36 +/- 0##5##3##(2008-11#2)(2010-8#1)(2011-2#1)(2013-1#1)
36 +/-##8##2##(1990-5#1)(1991-5#1)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
36 V##3##2##(2008-10#1)(2009-9#2)
36 adult##2##2##(2008-12#1)(2008-5#1)
36 and 48##3##3##(1991-8#1)(2008-10#1)(2008-12#1)
36 and##11##2##(1991-8#1)(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-12#2)(2008-8#1)(2011-2#1)
36 cases##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
36 children##2##2##(1995-5#1)(1995-6#1)
36 days##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
36 degrees C##9##3##(1995-8#1)(2008-10#7)(2008-2#1)
36 degrees##10##2##(1994-3#1)(1995-8#1)(2008-10#7)(2008-2#1)
36 different##2##2##(1997-1#1)(2008-5#1)
36 for##3##2##(2008-10#3)
36 h after inoculation##3##4##(2008-10#2)(2008-11#1)
36 h after##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
36 h at##2##3##(2008-10#2)
36 h of##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
36 h##15##2##(1996-12#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-8#1)(2008-9#1)
36 h(-1)##2##2##(2008-10#2)
36 hours##3##2##(1992-9#1)(1993-3#1)(2008-3#1)
36 in##3##2##(1995-12#1)(2007-8#1)(2010-4#1)
36 isolates of##2##3##(2008-10#1)(2011-2#1)
36 isolates##4##2##(2008-10#3)(2011-2#1)
36 kDa##3##2##(1994-6#1)(1994-8#1)(1995-6#1)
36 kDa)##2##2##(2011-2#2)
36 mg##4##2##(1997-4#1)(2008-10#2)(2008-2#1)
36 million##2##2##(1997-3#1)(2007-9#1)
36 months of##2##3##(1995-1#1)(2012-2#1)
36 months##11##2##(1990-6#1)(1993-6#1)(1995-1#1)(2007-11#1)(2008-11#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
36 of##4##2##(1995-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
36 patients with##5##3##(1991-3#1)(2007-11#1)(2007-8#1)(2008-7#2)
36 patients##20##2##(1990-11#2)(1991-2#1)(1991-3#2)(1994-3#1)(1995-10#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-7#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
36 per##2##2##(2008-10#1)(2012-3#1)
36 percent of##2##3##(1993-1#1)(1995-1#1)
36 percent##3##2##(1993-1#1)(1995-1#1)(2011-2#1)
36 samples##2##2##(2008-10#2)
36 to 0##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
36 to##14##2##(2007-11#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
36 was##2##2##(2008-10#1)(2013-1#1)
36 weeks##3##2##(1990-10#1)(1994-12#1)(2011-2#1)
36 were##3##2##(1997-6#1)(2008-5#1)(2008-6#1)
36 women##2##2##(1994-2#1)(2013-1#1)
36 years##3##2##(2008-1#1)(2008-6#1)(2010-8#1)
36##404##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#90)(2008-11#15)(2008-12#10)(2008-2#11)(2008-3#17)(2008-4#2)(2008-5#15)(2008-6#6)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#23)(2011-3#1)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#17)(2013-8#3)
36% and##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
36% for the##2##3##(2008-10#2)
36% for##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
36% in##2##2##(2008-10#1)(2008-2#1)
36% increase in##2##3##(1993-12#1)(1995-2#1)
36% of the##4##3##(1991-4#1)(2008-1#1)(2008-10#1)(2011-2#1)
36% of##13##2##(1990-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-8#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
36% when compared with##2##4##(2008-10#1)(2008-3#1)
36%##59##1##(1990-2#4)(1991-4#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#3)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
36%)##5##1##(1994-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
36(1) Å##2##2##(1996-2#2)
36) and##3##2##(2008-10#1)(2010-9#1)(2013-1#1)
36)##15##1##(2008-1#1)(2008-10#3)(2009-12#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
36+/-0##2##1##(2008-10#1)(2009-7#1)
36-0##2##1##(1997-8#1)(2008-10#1)
36-2##4##1##(2008-10#3)(2011-2#1)
36-40##3##1##(2007-12#1)(2008-7#1)(2008-8#1)
36-kDa subunits##2##2##(1992-11#2)
36-kDa##5##1##(1992-11#2)(1995-3#1)(1995-6#1)(2008-10#1)
36-residue peptide##2##2##(1995-2#2)
36-year-old male presented with##2##4##(2010-6#1)(2012-12#1)
36-year-old male##3##2##(2010-6#1)(2012-12#1)(2012-2#1)
36-year-old man with##2##3##(2009-5#1)(2012-3#1)
36-year-old man##4##2##(1990-11#1)(2009-5#1)(2010-6#1)(2012-3#1)
36-year-old##9##1##(1990-11#1)(2009-11#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
360 and##4##2##(2008-10#4)
360 degrees##3##2##(2007-12#1)(2008-3#2)
360 mg/day##2##2##(1992-8#2)
360 nm and##3##3##(1996-2#1)(2007-11#1)(2008-10#1)
360 nm##8##2##(1993-2#1)(1995-5#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-5#1)
360##44##1##(1990-7#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-8#3)(1993-2#1)(1993-8#2)(1995-5#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#18)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-5#1)
3600##2##1##(2008-11#1)(2008-2#1)
3607##2##1##(1995-5#2)
360nm##3##1##(2008-10#3)
361 and 362##2##3##(1990-8#1)(2008-10#1)
361##9##1##(1990-8#1)(1991-11#1)(1993-9#1)(2008-10#2)(2008-11#1)(2011-1#2)(2012-2#1)
362##8##1##(1990-8#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
363 amino acid residues##2##4##(1994-11#1)(1994-9#1)
363##9##1##(1991-11#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
364##6##1##(1995-8#1)(2008-10#3)(2013-1#1)(2013-8#1)
365 days##2##2##(1990-12#2)
365 nm##5##2##(1993-8#2)(2008-10#2)(2009-11#1)
365##12##1##(1990-12#2)(1993-8#2)(1995-6#1)(2008-10#3)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)
365)##3##1##(2008-10#3)
366 mOsmol kg-1 was##2##4##(2008-11#2)
366 mOsmol kg-1##4##3##(2008-11#4)
366 mOsmol##5##2##(2008-11#5)
366##10##1##(1992-10#1)(1993-12#1)(2008-10#1)(2008-11#5)(2008-7#2)
367##9##1##(1994-6#3)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
368 nm##2##2##(2008-10#1)(2008-2#1)
368##7##1##(1991-12#1)(1996-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)
368)##2##1##(1991-2#1)(2010-10#1)
369##4##1##(1995-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
369)##3##1##(2008-10#3)
36Cl- uptake##3##2##(1990-2#2)(1994-2#1)
36c##2##1##(1996-5#2)
37 +/- 0##3##3##(1991-5#1)(1992-3#1)(1994-5#1)
37 +/-##6##2##(1990-5#1)(1991-5#1)(1992-3#1)(1994-5#1)(2009-10#1)(2013-1#1)
37 W##2##2##(2008-2#1)(2008-3#1)
37 and 33 degrees##2##4##(1995-11#2)
37 and 38##2##3##(1995-11#1)(2008-8#1)
37 and 43 degrees C##4##5##(2008-12#4)
37 and##11##2##(1993-2#1)(1995-11#3)(1997-4#1)(2008-12#4)(2008-8#1)(2013-8#1)
37 cases##2##2##(2006-10#1)(2007-11#1)
37 degrees C and##10##4##(1990-12#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2010-1#1)
37 degrees C in##7##4##(1993-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(2008-10#2)(2010-3#1)
37 degrees C than##2##4##(1990-2#1)(1994-3#1)
37 degrees C##121##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#4)(1991-9#1)(1992-11#2)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#7)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#3)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#14)(2008-11#17)(2008-12#1)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#4)(2011-2#1)
37 degrees C)##7##3##(1990-12#1)(1992-3#2)(2008-10#3)(2008-11#1)
37 degrees C-cells##2##3##(1995-11#2)
37 degrees C-grown C##2##4##(2008-5#2)
37 degrees C-grown##3##3##(2008-5#3)
37 degrees##141##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#4)(1991-9#1)(1992-11#2)(1992-3#5)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#7)(1994-6#1)(1994-8#4)(1995-11#4)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#3)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#18)(2008-11#18)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#6)(2011-2#1)
37 different##2##2##(2008-10#2)
37 for##2##2##(2008-10#2)
37 in##3##2##(1995-1#1)(2008-1#1)(2008-9#1)
37 kDa protein##2##3##(1990-8#1)(1996-2#1)
37 kDa##5##2##(1990-8#2)(1994-6#1)(1996-2#2)
37 microM##2##2##(1990-2#1)(1996-2#1)
37 mm##2##2##(2008-10#1)(2008-7#1)
37 mm)##2##2##(2008-5#1)(2008-7#1)
37 months##3##2##(1991-2#1)(2007-11#1)(2010-10#1)
37 nm were##2##3##(2008-3#2)
37 nm##5##2##(2007-11#1)(2008-3#4)
37 of##7##2##(1991-8#2)(1993-9#1)(1994-1#1)(2008-10#2)(2008-4#1)
37 patients were##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
37 patients with##2##3##(1991-6#1)(2008-10#1)
37 patients##16##2##(1990-9#1)(1991-6#1)(1992-8#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#2)
37 percent of##2##3##(1993-1#1)(2007-12#1)
37 times##2##2##(1991-3#1)(2008-4#1)
37 to 2##2##3##(1996-2#1)(2008-10#1)
37 to 32 degrees C##2##5##(1997-7#1)(2008-11#1)
37 to##12##2##(1992-9#1)(1996-2#2)(1997-7#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-7#1)
37 weeks##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
37 weeks' gestation##3##3##(2007-12#1)(2011-2#2)
37 weeks)##2##2##(1994-3#1)(2011-2#1)
37 were##2##2##(2007-2#1)(2008-5#1)
37 years##4##2##(1994-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
37 years)##2##2##(1990-2#1)(2007-6#1)
37##437##1##(1990-11#2)(1990-12#3)(1990-2#5)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#8)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#3)(1993-9#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#9)(1994-5#2)(1994-6#3)(1994-8#4)(1995-1#1)(1995-11#8)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#9)(1996-3#1)(1996-5#5)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#51)(2008-11#29)(2008-12#11)(2008-2#6)(2008-3#20)(2008-4#7)(2008-5#22)(2008-6#9)(2008-7#12)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#7)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#17)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#5)
37% for##6##2##(2007-12#1)(2007-7#1)(2008-10#4)
37% in##4##2##(1992-8#1)(1994-8#1)(2008-10#1)(2011-1#1)
37% less##2##2##(1990-3#1)(2008-2#1)
37% of patients##2##3##(2008-7#1)(2013-1#1)
37% of the patients##3##4##(1991-2#1)(1994-3#1)(2007-10#1)
37% of the##5##3##(1991-2#1)(1993-6#1)(1994-3#1)(1997-8#1)(2007-10#1)
37% of##18##2##(1990-6#1)(1991-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
37%##59##1##(1990-3#1)(1990-6#2)(1991-11#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1996-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
37%)##5##1##(1990-3#1)(1992-2#1)(1992-6#1)(2007-8#1)(2011-2#1)
37)##8##1##(1990-2#1)(1997-2#1)(1997-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
37-2##3##1##(2008-10#3)
37-amino acid peptide##2##3##(1992-6#2)
37-amino acid##3##2##(1992-6#3)
37-year-old female##2##2##(1997-6#1)(2008-12#1)
37-year-old male##2##2##(2011-2#1)(2013-1#1)
37-year-old woman##2##2##(1991-3#1)(2013-7#1)
37-year-old##7##1##(1991-3#1)(1997-6#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
370 and##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
370##18##1##(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#3)(2010-6#1)(2010-8#1)(2012-2#1)
370)##2##1##(1992-3#1)(2008-10#1)
371##5##1##(1995-1#1)(1997-4#1)(2008-7#1)(2010-11#1)(2012-3#1)
372##10##1##(1992-8#1)(1993-2#1)(1993-8#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
373##7##1##(1996-5#1)(1997-8#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-3#1)
374##7##1##(1990-11#1)(1990-5#1)(2008-8#1)(2011-2#3)(2013-1#1)
375 amino acids##2##3##(1995-8#1)(1996-3#1)
375 amino##3##2##(1995-8#1)(1996-3#1)(1997-7#1)
375 and##3##2##(1992-3#1)(2013-8#2)
375##15##1##(1992-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2013-8#3)
376##10##1##(1990-5#1)(1991-8#1)(1993-3#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
377##9##1##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-9#1)(2009-3#1)
378##7##1##(1990-2#1)(2008-10#3)(2008-12#1)(2010-8#1)(2011-1#1)
379##6##1##(1990-2#1)(1996-2#1)(2007-8#1)(2008-3#1)(2009-10#1)(2013-8#1)
37]##3##1##(1994-8#1)(2009-7#1)(2013-8#1)
37th##5##1##(2007-11#1)(2007-7#1)(2008-4#2)(2008-5#1)
37°C##4##1##(2013-1#4)
37ºC##2##1##(2013-1#2)
38 +/- 0##4##3##(1991-5#1)(1996-9#1)(1997-7#1)(2008-1#1)
38 +/-##5##2##(1991-5#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-3#1)
38 -##2##2##(2011-1#2)
38 and 0##2##3##(2008-10#2)
38 and##9##2##(1991-6#1)(1996-12#1)(2008-10#4)(2008-5#1)(2011-2#1)(2013-1#1)
38 benign lesions##2##3##(1991-12#2)
38 cases##2##2##(2011-2#1)(2013-8#1)
38 children##2##2##(1991-2#1)(2010-8#1)
38 degrees C and##2##4##(1990-11#1)(2011-2#1)
38 degrees C##6##3##(1990-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2011-2#1)
38 degrees##8##2##(1990-11#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2011-2#1)
38 g##2##2##(2008-6#1)(2011-1#1)
38 genes##2##2##(2011-2#2)
38 in##2##2##(1992-6#1)(1997-5#1)
38 kDa##3##2##(1993-11#1)(1995-11#1)(2008-10#1)
38 ku##4##2##(2008-9#4)
38 men##2##2##(1990-5#1)(2013-1#1)
38 microM##2##2##(1994-3#1)(1995-12#1)
38 min##3##2##(1992-5#1)(1995-3#1)(2008-10#1)
38 mmol g(-1)##2##3##(2008-10#2)
38 mug##2##2##(2008-10#1)(2008-11#1)
38 of these##2##3##(1991-11#1)(2012-2#1)
38 of##4##2##(1991-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
38 patients with##3##3##(2007-8#1)(2008-7#2)
38 patients##11##2##(1990-3#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#2)(2012-3#2)(2013-1#1)
38 samples per##2##3##(2008-10#2)
38 subjects##2##2##(1991-8#1)(2008-10#1)
38 to 0##2##3##(2008-1#1)(2008-10#1)
38 to##5##2##(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)
38 weeks##2##2##(1992-3#1)(1993-12#1)
38 x##2##2##(2008-11#1)(2008-9#1)
38##295##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#3)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-8#2)(1994-1#5)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#51)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#16)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#11)(2009-3#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#14)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#5)
38% and##9##2##(1991-6#1)(1991-8#1)(1996-12#1)(2007-7#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
38% for##3##2##(1997-2#1)(2007-7#1)(2008-10#1)
38% in##7##2##(2007-11#1)(2008-10#3)(2008-7#2)(2013-1#1)
38% of the total##2##4##(2008-7#1)(2011-2#1)
38% of the##6##3##(1990-6#1)(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
38% of##11##2##(1990-6#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
38% to##2##2##(2007-7#1)(2009-4#1)
38%##60##1##(1990-6#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
38%)##5##1##(1996-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
38) and##7##2##(2007-11#1)(2007-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
38)##11##1##(1994-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#2)
38))(2)CO(3)##2##1##(2008-10#2)
38-42##2##1##(2007-7#1)(2011-1#1)
38-year-old man##2##2##(1997-3#2)
38-year-old woman##6##2##(1992-5#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-2#1)
38-year-old##13##1##(1992-5#1)(1997-3#2)(2006-10#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
380 and##2##2##(1990-11#1)(2008-8#1)
380 nm##2##2##(2008-10#1)(2008-3#1)
380##16##1##(1990-11#1)(1991-2#1)(1996-2#1)(1997-4#2)(2007-7#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
381##6##1##(1990-7#1)(1993-2#2)(1994-9#1)(2008-10#1)(2011-2#1)
382##18##1##(1991-9#1)(1993-8#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-7#3)(2011-2#1)(2012-12#1)
383##5##1##(1992-5#1)(1994-11#1)(1996-12#1)(1997-2#1)(2008-10#1)
38393##2##1##(1996-2#2)
384 hr##2##2##(2012-12#2)
384##13##1##(1990-11#1)(1992-12#1)(1993-8#1)(2007-12#2)(2008-10#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
384)##2##1##(1993-8#1)(2013-1#1)
384-well##4##1##(2008-10#1)(2008-9#1)(2010-12#1)(2012-3#1)
384-wells##2##1##(2008-10#2)
385 K##2##2##(2008-10#2)
385 and##3##2##(2008-11#1)(2008-2#1)(2011-1#1)
385##17##1##(1992-6#1)(2008-10#11)(2008-11#1)(2008-2#2)(2011-1#2)
385)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
386##6##1##(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#2)(2011-1#1)
386)##2##1##(2008-10#1)(2012-3#1)
387##6##1##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
388 g##2##2##(2008-10#1)(2008-12#1)
388##5##1##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
389 patients##2##2##(2011-2#1)(2013-1#1)
389##13##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
38th##4##1##(1997-8#1)(2011-1#2)(2012-12#1)
39 +/- 0##4##3##(1997-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
39 +/- 1##2##3##(2008-12#1)(2011-3#1)
39 +/-##9##2##(1991-4#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
39 V##2##2##(2008-10#2)
39 amino acid##2##3##(1991-2#1)(1995-6#1)
39 and 0##3##3##(2008-10#3)
39 and 52##2##3##(1992-4#1)(1995-8#1)
39 and##17##2##(1990-5#1)(1992-4#1)(1995-8#1)(1996-2#1)(2008-10#7)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#2)
39 cases##2##2##(1991-6#1)(2008-7#1)
39 degrees##4##2##(1991-8#1)(1994-12#1)(2007-12#1)(2008-10#1)
39 kDa##4##2##(1991-9#1)(2008-5#3)
39 microg/ml##2##2##(2008-5#2)
39 microm##5##2##(2007-12#1)(2008-3#2)(2008-5#2)
39 or##2##2##(2008-10#1)(2008-9#1)
39 patients with##2##3##(1991-3#1)(1995-6#1)
39 patients##13##2##(1990-6#1)(1990-9#2)(1991-3#1)(1991-6#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
39 pg##2##2##(2008-10#2)
39 times##2##2##(2008-10#1)(2010-3#1)
39 to##7##2##(2007-8#1)(2008-1#1)(2008-10#4)(2012-1#1)
39 vs##2##2##(2008-10#1)(2013-1#1)
39 weeks and##2##3##(1996-11#1)(2008-9#1)
39 weeks##20##2##(1995-8#1)(1996-11#1)(2007-12#1)(2008-9#17)
39 were##3##2##(1990-2#1)(1991-6#1)(2011-2#1)
39 years and##2##3##(2007-12#1)(2009-5#1)
39 years##3##2##(2007-12#1)(2009-5#1)(2010-3#1)
39 years)##2##2##(1993-11#1)(2008-4#1)
39 ± 0##2##3##(2010-9#1)(2011-1#1)
39##281##1##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#4)(1991-9#3)(1992-11#1)(1992-2#3)(1992-4#1)(1992-5#8)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-6#3)(1997-7#2)(1997-8#2)(2007-10#2)(2007-11#4)(2007-12#9)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#8)(2008-1#8)(2008-10#48)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#20)(2009-5#2)(2009-8#2)(2010-3#5)(2010-7#1)(2010-9#2)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#16)(2013-7#2)(2013-8#3)
39% had##2##2##(1991-12#1)(2011-1#1)
39% of the##5##3##(1996-9#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
39% of##10##2##(1996-9#1)(1997-8#1)(2008-10#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
39%##34##1##(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
39)##12##1##(1996-7#1)(2008-10#5)(2008-7#1)(2009-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
39-52##4##1##(1992-4#4)
39-WEEK DERMAL STUDIES IN Tg##3##5##(2008-9#3)
39-kDa protein##2##2##(1992-11#1)(1992-6#1)
39-kDa##4##1##(1991-10#1)(1992-11#1)(1992-6#2)
39-year old##3##2##(1997-6#1)(2010-2#1)(2013-1#1)
39-year-old man with##2##3##(1997-5#1)(2009-3#1)
39-year-old man##4##2##(1997-5#1)(2009-3#2)(2010-2#1)
39-year-old woman##2##2##(2009-3#1)(2013-8#1)
39-year-old##8##1##(1997-5#1)(2009-3#3)(2010-2#1)(2013-1#1)(2013-8#2)
390 bp##2##2##(1993-8#1)(1997-6#1)
390 isolates##2##2##(2008-10#2)
390 nm##3##2##(2007-12#1)(2008-10#2)
390##21##1##(1993-8#1)(1995-6#2)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
390-nm##2##1##(2007-12#2)
3900 polypeptide species##2##3##(2008-7#2)
3900##3##1##(2008-7#2)(2011-2#1)
390nm##2##1##(2008-10#2)
391##6##1##(1991-9#1)(1996-12#1)(1997-8#2)(2011-2#1)(2013-8#1)
392##8##1##(1995-1#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
393 microm##2##2##(2008-2#1)(2008-3#1)
393##9##1##(1996-1#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
394##9##1##(1992-12#1)(1992-9#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
395##11##1##(1990-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-8#1)(2009-11#1)
396##6##1##(1996-1#1)(1996-12#1)(2008-10#2)(2008-12#1)(2011-1#1)
39676##2##1##(2008-6#2)
397##7##1##(1997-4#1)(2007-10#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
398##6##1##(1991-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#2)
398D97 and##3##2##(2008-10#3)
398D97##4##1##(2008-10#4)
399##5##1##(2008-1#1)(2008-5#3)(2013-8#1)
39K deletion##2##2##(1997-3#2)
39K##5##1##(1997-3#5)
39th##2##1##(2008-7#1)(2011-1#1)
39x10(5) l##2##2##(2008-10#2)
3A##5##1##(2008-10#2)(2010-8#1)(2013-1#2)
3A4 (CYP3A4)##2##2##(2008-3#1)(2012-3#1)
3A4##8##1##(1994-5#1)(2008-10#2)(2008-3#3)(2012-3#2)
3A6##2##1##(2011-1#2)
3AS##2##1##(2008-10#1)(2008-8#1)
3B##3##1##(1996-12#1)(2008-10#2)
3BS##2##1##(2008-10#2)
3C protease##4##2##(1991-5#3)(2008-10#1)
3C##6##1##(1991-5#3)(1995-8#1)(2008-10#1)(2008-5#1)
3CaO##4##1##(2008-10#4)
3D CT##5##2##(2007-11#3)(2010-3#2)
3D PC##2##2##(1995-11#2)
3D analysis##2##2##(2008-5#1)(2008-9#1)
3D and 4D QSAR##2##4##(2007-11#2)
3D cell culture within##2##4##(2011-2#2)
3D cell culture##3##3##(2010-10#1)(2011-2#2)
3D culture##4##2##(2008-11#2)(2010-10#2)
3D data##4##2##(2007-12#1)(2008-6#1)(2008-9#2)
3D display##4##2##(1995-11#3)(2008-3#1)
3D endoscopic##2##2##(2010-8#2)
3D finite element##2##3##(2008-7#1)(2013-1#1)
3D image##5##2##(2008-3#1)(2008-9#2)(2010-12#1)(2010-8#1)
3D images##5##2##(2008-7#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-1#1)
3D imaging##3##2##(2007-11#1)(2007-12#1)(2010-5#1)
3D information##3##2##(2008-3#2)(2013-8#1)
3D interaction position##3##3##(2010-3#3)
3D matrix##4##2##(2012-1#4)
3D measurements of##2##3##(2007-12#1)(2008-3#1)
3D model##4##2##(2008-6#1)(2008-9#1)(2009-7#1)(2010-10#1)
3D modelling of##2##3##(2011-1#1)(2013-1#1)
3D models##2##2##(2008-2#1)(2012-3#1)
3D object##7##2##(2007-12#1)(2008-3#6)
3D objects##2##2##(2008-3#1)(2012-2#1)
3D optical##2##2##(2007-12#1)(2011-1#1)
3D option##2##2##(2007-11#2)
3D real space##2##3##(2012-1#2)
3D reconstruction of the##3##4##(2009-1#1)(2012-3#2)
3D reconstruction of##5##3##(2009-1#1)(2009-3#1)(2009-7#1)(2012-3#2)
3D reconstruction##8##2##(2009-1#2)(2009-3#1)(2009-7#1)(2012-2#1)(2012-3#3)
3D reconstructions##3##2##(2007-11#1)(2010-12#1)(2011-2#1)
3D retinal renderings##2##3##(2011-7#2)
3D retinal##3##2##(2011-7#3)
3D scaffold##2##2##(2009-12#2)
3D strain distributions and##2##4##(2008-8#2)
3D strain distributions##3##3##(2008-8#3)
3D structural templates##2##3##(2008-7#2)
3D structural##3##2##(2008-7#3)
3D structures##2##2##(2008-7#2)
3D texture features##2##3##(2010-8#2)
3D texture##3##2##(2010-8#3)
3D trabecular bone explant co-culture model##2##6##(2010-9#2)
3D##209##1##(1995-11#6)(1996-2#1)(1997-8#1)(2007-11#12)(2007-12#12)(2007-8#1)(2008-10#3)(2008-11#5)(2008-2#6)(2008-3#23)(2008-5#1)(2008-6#10)(2008-7#8)(2008-8#3)(2008-9#7)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#8)(2009-3#2)(2009-7#2)(2010-10#5)(2010-12#4)(2010-3#7)(2010-5#3)(2010-8#13)(2010-9#2)(2011-1#2)(2011-2#10)(2011-7#4)(2012-1#12)(2012-12#1)(2012-2#6)(2012-3#8)(2012-4#1)(2013-1#8)(2013-7#2)(2013-8#4)
3D-CRT##2##1##(2013-1#2)
3D-CT##2##1##(2010-8#1)(2012-2#1)
3D-CTA is##2##2##(2008-7#2)
3D-CTA##5##1##(2008-7#4)(2012-2#1)
3D-QSAR##2##1##(2009-3#1)(2012-3#1)
3D-TOF enhanced MRA##2##3##(2008-7#2)
3D-TOF##5##1##(2008-7#5)
3D5##2##1##(2008-8#2)
3E)-dienes##2##1##(2010-2#2)
3E10##2##1##(1996-12#1)(2008-11#1)
3E9##3##1##(2008-11#3)
3FD##5##1##(1990-7#5)
3G##2##1##(2008-9#1)(2010-8#1)
3G11##2##1##(2008-9#2)
3H and##3##2##(1991-12#1)(2008-10#2)
3H##8##1##(1991-12#1)(2008-10#7)
3H(2)O##2##1##(2008-10#2)
3H-PN200-110 binding##3##2##(1995-3#3)
3H-PN200-110##5##1##(1995-3#5)
3H-glucosamine##3##1##(1992-8#2)(1992-9#1)
3H-labelled##2##1##(1990-5#1)(1993-8#1)
3H-leucine incorporation into##2##3##(1991-6#1)(1994-6#1)
3H-leucine##3##1##(1991-6#1)(1994-6#2)
3H-quinazoline-2##2##1##(2007-11#2)
3H-thymidine incorporation and##2##3##(1991-6#1)(1992-9#1)
3H-thymidine incorporation##6##2##(1991-4#2)(1991-6#1)(1992-9#1)(1994-8#1)(1995-3#1)
3H-thymidine uptake##2##2##(1994-8#1)(1995-3#1)
3H-thymidine##10##1##(1991-4#2)(1991-6#1)(1992-9#1)(1993-6#1)(1994-8#2)(1995-3#2)(2008-7#1)
3H-uridine uptake##2##2##(1992-11#2)
3H-uridine##3##1##(1991-4#1)(1992-11#2)
3HV##3##1##(2008-6#3)
3He##3##1##(1990-12#1)(1996-12#1)(1996-9#1)
3JH alpha##2##2##(1992-4#2)
3JNHC alpha H##2##3##(1992-3#2)
3KB-CNPG5##2##1##(1991-5#2)
3LL##3##1##(1991-6#2)(2008-9#1)
3M ESPE)##2##2##(2009-8#2)
3M KCl##2##2##(2008-10#1)(2008-6#1)
3M##14##1##(1995-1#3)(1996-2#2)(1997-2#1)(2008-10#4)(2008-6#1)(2009-8#3)
3MC-induced##3##1##(1994-8#3)
3N##2##1##(2008-12#2)
3P##2##1##(2007-12#1)(2010-12#1)
3R##5##1##(1997-7#1)(2008-10#2)(2008-9#1)(2010-4#1)
3R)-ACPD##3##1##(1996-5#3)
3S##4##1##(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#1)
3S-1##2##1##(2013-1#2)
3S-isocitrate##2##1##(1990-8#2)
3SR##2##1##(1997-6#2)
3T##3##1##(2008-3#1)(2010-8#1)(2012-3#1)
3T3 and##2##2##(1992-7#1)(1997-6#1)
3T3 cells were##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
3T3 cells##31##2##(1990-2#4)(1991-12#2)(1993-11#3)(1993-8#3)(1993-9#2)(1994-11#1)(1994-3#4)(1994-8#1)(1995-2#4)(1997-7#2)(2008-11#4)(2008-9#1)
3T3##40##1##(1990-2#4)(1991-12#2)(1992-7#1)(1993-11#4)(1993-8#3)(1993-9#2)(1994-11#1)(1994-3#4)(1994-8#3)(1995-2#4)(1997-1#1)(1997-6#2)(1997-7#2)(2008-11#4)(2008-9#1)(2009-12#1)(2012-12#1)
3T3-F442A cells##3##2##(1995-11#1)(2008-11#1)(2012-2#1)
3T3-F442A##4##1##(1995-11#1)(2008-11#2)(2012-2#1)
3T3-L1 adipocytes##9##2##(1991-12#3)(1993-8#2)(1995-8#4)
3T3-L1 cells##4##2##(2008-11#1)(2008-3#3)
3T3-L1 preadipocytes##3##2##(2008-3#2)(2008-5#1)
3T3-L1##16##1##(1991-12#3)(1993-8#2)(1995-8#4)(2008-11#1)(2008-3#5)(2008-5#1)
3V versus##2##2##(2008-10#2)
3V##5##1##(2008-10#3)(2012-12#1)(2013-1#1)
3]##5##1##(1997-3#1)(2008-10#1)(2008-5#3)
3]dioxole with##2##2##(2007-11#2)
3]dioxole-6##2##1##(1996-5#2)
3a and 3b##3##3##(1993-11#2)(2007-11#1)
3a and##5##2##(1993-11#2)(2007-11#1)(2008-8#1)(2011-1#1)
3a##17##1##(1990-11#3)(1993-11#2)(1996-5#2)(1997-7#4)(2007-11#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-1#1)
3a)##2##1##(2008-4#1)(2009-9#1)
3a-Ld##3##1##(2008-10#3)
3a-d##3##1##(1996-5#3)
3aS##2##1##(2009-12#2)
3alpha-hydroxysteroid dehydrogenase##2##2##(2008-10#2)
3alpha-hydroxysteroids##2##1##(2008-8#2)
3alphaOHT and 3betaOHT##2##3##(2008-10#2)
3alphaOHT##4##1##(2008-10#4)
3b##6##1##(1993-11#3)(1996-5#1)(2007-11#2)
3b)##5##1##(1992-12#2)(1994-7#1)(2008-4#1)(2011-1#1)
3beta-HSD deficiency CAH##3##3##(2008-4#3)
3beta-HSD deficiency##4##2##(2008-4#4)
3beta-HSD##6##1##(2008-4#6)
3beta-hydroxysteroid dehydrogenase##2##2##(2008-4#2)
3betaOHT##3##1##(2008-10#3)
3c##2##1##(1996-5#2)
3d##11##1##(1990-9#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-3#2)(2012-12#3)(2012-2#1)
3dB##2##1##(2007-11#1)(2008-9#1)
3delta) for##2##2##(2008-10#2)
3delta)##3##1##(2008-10#3)
3gl(-1)##2##1##(2008-10#2)
3h after##3##2##(1993-6#1)(1994-11#1)(2008-10#1)
3h of##3##2##(2008-10#3)
3h##9##1##(1993-6#1)(1994-11#1)(2008-10#6)(2013-1#1)
3m##4##1##(1996-8#1)(2007-5#1)(2008-2#1)(2008-3#1)
3mM##2##1##(2008-10#2)
3mV per##2##2##(2008-10#2)
3mV/decade##2##1##(2008-10#2)
3mVdecade(-1)##2##1##(2008-10#2)
3mgkg(-1)##2##1##(2008-10#2)
3min##9##1##(2008-10#8)(2008-11#1)
3mm##3##1##(2008-12#2)(2012-12#1)
3moll(-1)##3##1##(2008-10#3)
3mu-1S##2##1##(2008-11#2)
3muM##2##1##(2008-10#2)
3mugl(-1) for##2##2##(2008-10#2)
3mugl(-1)##6##1##(2008-10#6)
3mugml(-1)##2##1##(2008-10#2)
3mum##3##1##(2007-11#2)(2008-10#1)
3nM##2##1##(2008-10#2)
3ngml(-1)##6##1##(2008-10#6)
3nm##2##1##(2007-12#1)(2008-10#1)
3p##6##1##(1993-5#1)(2007-12#1)(2008-4#3)(2009-9#1)
3pi/2##3##1##(2008-3#3)
3rd and 4th##4##3##(1992-9#1)(1994-11#1)(2008-12#1)(2008-5#1)
3rd and 6th##3##3##(2007-8#1)(2012-2#2)
3rd and##10##2##(1992-5#1)(1992-9#1)(1994-11#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-2#2)
3rd day##2##2##(1990-9#1)(2013-1#1)
3rd degree##2##2##(1997-6#1)(2007-10#1)
3rd generation##2##2##(2010-8#2)
3rd instar larvae##3##3##(2007-12#2)(2013-8#1)
3rd instar##4##2##(2007-12#2)(2008-10#1)(2013-8#1)
3rd month##5##2##(1990-8#1)(1994-6#1)(2007-11#1)(2007-7#1)(2011-2#1)
3rd##60##1##(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#2)(1992-5#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
3s##6##1##(2008-10#5)(2008-11#1)
3sigma detection limit##5##3##(2008-10#5)
3sigma detection limits##3##3##(2008-10#3)
3sigma detection##8##2##(2008-10#8)
3sigma limit of detection##3##4##(2008-10#3)
3sigma##17##1##(2008-10#17)
3sigma)##3##1##(2008-10#1)(2010-4#1)(2010-5#1)
3th month##3##2##(2011-2#3)
3x##4##1##(2007-12#1)(2009-12#1)(2011-2#2)
3x10(-11)##2##1##(2008-10#2)
3x10(-3) mol l(-1)##2##3##(2008-10#2)
3x10(-3)##5##1##(2007-11#1)(2007-12#1)(2008-10#3)
3x10(-4)##2##1##(2008-10#2)
3x10(-4)M##2##1##(2008-10#2)
3x10(-5)##5##1##(2007-11#1)(2008-10#3)(2008-5#1)
3x10(-5)M##2##1##(2008-10#2)
3x10(-6) M##2##2##(2008-10#2)
3x10(-6)##4##1##(2008-10#4)
3x10(-7) M##3##2##(2008-10#3)
3x10(-7)##4##1##(2008-10#4)
3x10(-8) g ml(-1)##2##3##(2008-10#2)
3x10(-8)##4##1##(2008-10#4)
3x10(-9) mol l(-1)##2##3##(2008-10#2)
3x10(-9)##6##1##(2008-10#6)
3 years##3##1##(2010-10#1)(2011-1#1)(2013-1#1)
3±0##2##1##(2011-1#1)(2012-2#1)
3±1##2##1##(2010-12#1)(2011-1#1)
3±13##2##1##(2012-12#1)(2013-1#1)
3μM##2##1##(2012-12#1)(2013-1#1)
3 days##2##1##(2011-2#1)(2013-1#1)
3 months##2##1##(2011-2#2)
3 years##3##1##(2011-2#1)(2012-6#1)(2012-9#1)
4 % of##2##3##(2008-9#1)(2012-12#1)
4 %##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
4 %) and##2##3##(2012-12#2)
4 %)##10##2##(1997-8#1)(2010-5#1)(2012-12#7)(2013-1#1)
4 (13##2##2##(2007-10#1)(2011-1#1)
4 (2##2##2##(1990-5#1)(2011-2#1)
4 (20##2##2##(1992-8#1)(1992-9#1)
4 (26##2##2##(2013-7#2)
4 (3##2##2##(1997-8#1)(2011-2#1)
4 (5%)##2##2##(2008-10#1)(2011-2#1)
4 (95% confidence interval##2##4##(2006-10#1)(2008-11#1)
4 (95% confidence##3##3##(2006-10#1)(2008-11#1)(2013-8#1)
4 (SD##2##2##(2012-3#2)
4 (range##2##2##(2010-12#1)(2011-1#1)
4 +/- 0##17##3##(1990-12#1)(1991-2#2)(1991-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)
4 +/- 1##10##3##(1992-2#1)(1994-11#1)(1996-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-2#1)(2013-1#1)
4 +/- 10##2##3##(1993-12#1)(2011-2#1)
4 +/- 11##2##3##(1994-6#1)(2012-2#1)
4 +/- 2##6##3##(1990-8#1)(1992-2#2)(2008-3#1)(2009-7#1)(2011-2#1)
4 +/- 3##6##3##(1993-8#1)(1994-7#1)(1995-5#1)(2009-8#1)(2011-2#2)
4 +/- 4##4##3##(1996-9#1)(2008-1#1)(2010-1#1)(2013-7#1)
4 +/- 5##3##3##(1991-2#1)(1992-10#1)(1995-8#1)
4 +/- 6##3##3##(1990-12#1)(1991-9#1)(2013-1#1)
4 +/- 7##2##3##(2007-8#1)(2010-1#1)
4 +/-##70##2##(1990-12#2)(1990-8#1)(1991-2#3)(1991-9#2)(1992-10#1)(1992-2#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#4)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-1#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-2#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-7#1)
4 -##4##2##(1993-8#1)(2006-11#1)(2008-12#1)(2011-1#1)
4 2##2##2##(2007-8#2)
4 =##3##2##(1990-8#1)(1997-3#1)(2013-1#1)
4 A##3##2##(2008-10#2)(2009-11#1)
4 Gy##2##2##(2008-10#1)(2008-6#1)
4 Hz##4##2##(1991-12#1)(1996-5#1)(2007-12#1)(2008-7#1)
4 K##2##2##(2008-3#1)(2009-5#1)
4 M HCl##3##3##(2008-10#3)
4 M NaCl##2##3##(1990-5#1)(1994-5#1)
4 M guanidine##2##3##(1992-3#1)(1993-6#1)
4 M##18##2##(1990-5#1)(1992-3#2)(1993-6#1)(1994-5#1)(1995-5#1)(1997-2#2)(2008-10#10)
4 MHz##2##2##(2007-11#1)(2008-3#1)
4 MPa##2##2##(2008-10#1)(2008-3#1)
4 Mb##2##2##(1996-6#1)(2010-6#1)
4 THz##2##2##(2007-11#1)(2008-3#1)
4 V##8##2##(2008-10#7)(2008-3#1)
4 W at##2##3##(2007-11#1)(2008-3#1)
4 W of##3##3##(2007-11#1)(2007-12#2)
4 W##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
4 a##2##2##(1990-2#1)(2008-8#1)
4 adult##3##2##(2011-1#2)(2013-8#1)
4 after##2##2##(1991-8#1)(1995-3#1)
4 alpha##2##2##(1992-4#1)(2008-1#1)
4 amino acids##4##3##(1990-8#1)(1992-8#2)(2008-11#1)
4 and 0##11##3##(1992-12#1)(2008-10#8)(2008-3#1)(2009-2#1)
4 and 1##11##3##(1994-5#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
4 and 10##4##3##(1990-7#1)(2008-10#2)(2008-9#1)
4 and 12##3##3##(1990-8#1)(1992-11#1)(2008-5#1)
4 and 13##3##3##(2008-10#2)(2010-8#1)
4 and 19##2##3##(1997-8#1)(2008-12#1)
4 and 2##13##3##(1991-12#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-3#1)
4 and 20 degrees C##2##5##(2008-10#2)
4 and 20 ng##2##4##(2008-10#2)
4 and 20##5##3##(2008-10#5)
4 and 3##6##3##(1993-3#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-7#1)
4 and 37 degrees C##2##5##(1996-2#1)(2008-4#1)
4 and 4##3##3##(2008-10#2)(2008-11#1)
4 and 5 received##2##4##(2010-4#2)
4 and 5 weeks##3##4##(1990-5#1)(1997-3#1)(2013-8#1)
4 and 5##26##3##(1990-5#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-3#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
4 and 6 ml/kg body##2##5##(2008-10#2)
4 and 6##17##3##(1991-12#1)(1992-12#1)(1993-9#1)(2007-9#1)(2008-10#10)(2008-5#2)(2008-8#1)
4 and 6%##2##3##(2008-10#1)(2010-2#1)
4 and 7 were##2##4##(1997-2#2)
4 and 7##9##3##(1990-2#1)(1994-5#1)(1997-2#3)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
4 and 8 hrs respectively##2##5##(2013-1#2)
4 and 8 hrs##3##4##(2013-1#3)
4 and 8 mg L(-1))##2##5##(2008-12#2)
4 and 8##14##3##(1996-12#1)(2008-10#2)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#4)(2013-8#1)
4 and 90##2##3##(2008-10#1)(2008-8#1)
4 and at##3##3##(1992-2#1)(2008-10#2)
4 and the##4##3##(2008-10#2)(2008-12#1)(2008-2#1)
4 and##199##2##(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-5#3)(1995-11#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#77)(2008-11#2)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-2#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#2)
4 are##4##2##(1996-2#1)(2007-5#1)(2008-9#1)(2012-2#1)
4 as##3##2##(1992-12#1)(1997-7#1)(2010-11#1)
4 beta-methyl group of substrate##2##5##(1992-3#2)
4 beta-methyl group of##3##4##(1992-3#3)
4 beta-methyl group##4##3##(1992-3#4)
4 billion##4##2##(1993-8#1)(1995-6#1)(2008-10#1)(2008-2#1)
4 by##3##2##(2008-10#3)
4 cDNA and##2##3##(1995-11#2)
4 cDNA##4##2##(1993-3#1)(1995-11#2)(1996-10#1)
4 cM from##2##3##(2008-10#1)(2008-9#1)
4 cM##3##2##(2008-10#1)(2008-9#2)
4 cM)##4##2##(2008-10#4)
4 cases and##2##3##(1991-8#1)(2012-3#1)
4 cases in##2##3##(1996-11#1)(2013-1#1)
4 cases of##4##3##(1994-12#1)(2007-11#1)(2011-1#1)(2012-3#1)
4 cases the##3##3##(1991-3#1)(2007-11#2)
4 cases with brain##2##4##(1991-2#2)
4 cases with##3##3##(1991-1#1)(1991-2#2)
4 cases##33##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-8#1)(1994-12#1)(1996-11#1)(2007-11#4)(2007-5#1)(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#6)(2012-3#2)(2013-1#1)(2013-8#1)
4 cases]##2##2##(1997-5#1)(2007-8#1)
4 channels##2##2##(2008-8#2)
4 children##5##2##(1992-4#3)(2011-2#1)(2012-2#1)
4 classes##2##2##(1995-8#1)(2009-10#1)
4 clones are##2##3##(2008-9#2)
4 cm x##2##3##(2008-3#1)(2010-3#1)
4 cm##14##2##(1991-3#1)(1993-10#1)(1993-9#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
4 cm(-1)##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
4 cm3)##2##2##(1997-4#1)(2008-3#1)
4 compared##2##2##(2007-12#1)(2013-1#1)
4 complex##2##2##(2007-11#1)(2013-1#1)
4 confirmed##2##2##(2012-3#2)
4 consecutive##2##2##(1992-6#1)(2008-3#1)
4 cycles and##2##3##(1991-6#1)(2008-10#1)
4 cycles##5##2##(1991-6#1)(2007-10#1)(2008-10#1)(2009-4#1)(2013-1#1)
4 d##5##2##(1990-12#1)(2008-6#1)(2008-8#1)(2011-2#2)
4 dB##6##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)
4 day##2##2##(2009-3#1)(2011-2#1)
4 days (range##2##3##(2007-8#2)
4 days +/- 1##2##4##(1996-2#2)
4 days after inoculation##3##4##(2008-10#3)
4 days after the##3##4##(1995-11#1)(1995-12#1)(2009-3#1)
4 days after##10##3##(1991-2#1)(1995-11#1)(1995-12#1)(2008-10#6)(2009-3#1)
4 days and##7##3##(1996-2#2)(2008-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)
4 days in##2##3##(1993-3#1)(2007-8#1)
4 days later##5##3##(1994-9#1)(2007-6#1)(2008-10#1)(2010-5#1)(2010-7#1)
4 days of treatment##2##4##(1995-2#1)(2008-10#1)
4 days of##7##3##(1994-6#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#2)
4 days with##2##3##(2007-10#1)(2008-12#1)
4 days##67##2##(1990-2#1)(1991-12#2)(1991-2#1)(1992-7#1)(1992-8#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#4)(1996-3#1)(1997-2#2)(2007-10#3)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2009-3#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
4 degrees C and##4##4##(2008-10#2)(2008-11#1)(2010-4#1)
4 degrees C at##2##4##(1990-11#1)(1996-12#1)
4 degrees C cultures##3##4##(2008-10#3)
4 degrees C for##8##4##(1990-12#2)(1991-11#1)(1991-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
4 degrees C in the##3##5##(2008-10#2)(2008-3#1)
4 degrees C treatments (mean = 0##2##7##(2010-8#2)
4 degrees C##78##3##(1990-11#3)(1990-12#2)(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-8#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-4#1)(2007-12#1)(2008-10#36)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#2)(2012-2#3)
4 degrees C)##4##3##(1990-12#1)(1995-11#1)(2007-11#1)(2008-10#1)
4 degrees##92##2##(1990-11#4)(1990-12#3)(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#38)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#2)(2012-2#3)
4 died##3##2##(1992-12#1)(1994-12#1)(2011-2#1)
4 different##5##2##(1991-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2013-8#1)
4 doses##3##2##(1993-9#1)(1994-2#1)(2008-10#1)
4 eV and##2##3##(1996-7#2)
4 eV##5##2##(1996-7#2)(2007-11#1)(2010-4#2)
4 females##2##2##(2008-10#1)(2012-2#1)
4 fold higher than##2##4##(1993-8#1)(2011-2#1)
4 fold##5##2##(1991-2#1)(1992-8#1)(1993-8#1)(1996-12#1)(2011-2#1)
4 for##14##2##(1992-11#1)(1993-9#1)(1994-5#1)(1997-7#2)(2008-10#4)(2008-12#1)(2008-7#2)(2008-9#1)(2012-1#1)
4 from##3##2##(1993-12#1)(2008-10#1)(2009-10#1)
4 g##12##2##(1990-9#1)(1992-8#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
4 g/dL##3##2##(2007-12#2)(2008-7#1)
4 gene##2##2##(2008-3#1)(2013-1#1)
4 genes##5##2##(1990-11#1)(1997-7#2)(2008-11#1)(2008-7#1)
4 groups of##3##3##(1991-2#1)(2008-6#1)(2009-12#1)
4 groups##15##2##(1990-7#1)(1991-2#1)(1992-9#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
4 h after angiotensin II stimulation##3##6##(1995-11#3)
4 h after inoculation##2##4##(2008-10#2)
4 h after the##2##4##(1994-5#1)(2008-11#1)
4 h after##15##3##(1991-8#1)(1994-5#1)(1995-11#3)(1995-3#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-9#1)(2012-1#1)
4 h and##3##3##(1992-8#1)(2008-10#2)
4 h at 37 degrees C##2##6##(1990-12#1)(1992-6#1)
4 h at 37 degrees##3##5##(1990-12#2)(1992-6#1)
4 h at##4##3##(1990-12#2)(1992-6#1)(2008-5#1)
4 h for##2##3##(2008-10#2)
4 h of wetness##2##4##(2008-10#2)
4 h of##9##3##(1994-8#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2013-1#1)
4 h post-infection##2##3##(1996-12#2)
4 h##68##2##(1990-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#4)(1995-12#2)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#5)(1997-4#2)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-2#1)(2012-1#1)(2013-1#4)
4 h)##3##2##(1994-6#1)(2008-10#1)(2012-2#1)
4 had##2##2##(1995-12#1)(2008-5#1)
4 has##3##2##(1992-8#1)(1993-3#1)(2009-10#1)
4 hours after injection##2##4##(1990-12#1)(2008-7#1)
4 hours after##4##3##(1990-12#1)(1992-5#1)(1993-8#1)(2008-7#1)
4 hours##13##2##(1990-12#1)(1992-12#1)(1992-5#1)(1993-8#1)(1997-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
4 hr after##2##3##(1990-12#1)(2011-2#1)
4 hr##5##2##(1990-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
4 hydrotropic agents##2##3##(2012-2#2)
4 in the##5##3##(1994-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
4 in##24##2##(1991-3#1)(1991-8#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
4 is a##2##3##(1992-8#1)(2008-4#1)
4 is the##2##3##(1995-11#1)(2009-8#1)
4 is##10##2##(1991-8#2)(1992-4#1)(1992-8#1)(1994-8#1)(1995-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)
4 kDa##2##2##(1990-5#1)(1995-6#1)
4 kHz##3##2##(1990-12#1)(2009-5#2)
4 kb##9##2##(1991-6#1)(1993-2#1)(1993-6#1)(1996-12#1)(2008-10#2)(2008-8#3)
4 kcal/mol##3##2##(2007-11#1)(2008-11#2)
4 keV Mössbauer photon##2##4##(2006-4#2)
4 kg (SE##2##3##(1996-12#2)
4 kg##4##2##(1996-12#2)(2008-12#1)(2010-8#1)
4 knees were tested under##2##5##(2009-3#2)
4 l min(-1)##2##3##(2008-10#2)
4 l##3##2##(2008-10#2)(2011-2#1)
4 l/min##6##2##(2007-8#2)(2011-2#4)
4 lesions##2##2##(2011-2#2)
4 m waveguide##2##3##(2008-10#2)
4 m##7##2##(2008-10#5)(2008-3#2)
4 mJ##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
4 mL of##2##3##(1993-1#2)
4 mL##3##2##(1993-1#2)(2008-10#1)
4 mM##12##2##(1990-12#1)(1992-12#1)(1992-6#2)(1992-9#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
4 mM)##2##2##(1995-12#1)(2008-7#1)
4 mV per decade##2##4##(2008-10#2)
4 mV##3##2##(2008-10#3)
4 mW##2##2##(2008-2#2)
4 main##2##2##(2008-9#1)(2013-1#1)
4 mers##2##2##(2008-10#2)
4 mg L(-1)##3##3##(2008-10#2)(2008-7#1)
4 mg g(-1) for##2##4##(2008-10#2)
4 mg l(-1)##4##3##(2008-10#3)(2008-11#1)
4 mg of##3##3##(2009-4#1)(2011-1#2)
4 mg##19##2##(1992-3#1)(1993-2#1)(2008-10#9)(2008-11#3)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#2)
4 mg/L##2##2##(1990-8#1)(2008-1#1)
4 mg/dl##2##2##(1994-12#1)(2013-8#1)
4 mg/kg##5##2##(2008-1#2)(2008-10#2)(2010-4#1)
4 mg/liter##2##2##(2008-10#2)
4 mg/ml##2##2##(2008-10#1)(2008-5#1)
4 microM and##2##3##(1994-12#1)(1997-6#1)
4 microM##8##2##(1990-5#1)(1990-7#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-3#1)(1995-5#1)(1997-6#1)
4 microM)##3##2##(1990-11#1)(1996-2#1)(1997-4#1)
4 microg mL(-1)##2##3##(2008-5#1)(2011-3#1)
4 microg##8##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#2)(2011-3#1)
4 microg/l##2##2##(2007-5#1)(2008-10#1)
4 microg/ml##2##2##(2008-1#1)(2008-10#1)
4 microm at##2##3##(2008-2#1)(2008-3#1)
4 microm##6##2##(2008-2#1)(2008-3#5)
4 microm) are##2##3##(2007-12#1)(2008-2#1)
4 microm)##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
4 million units##2##3##(1997-5#1)(2012-12#1)
4 million##10##2##(1994-3#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-5#1)(2008-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
4 min for##2##3##(2007-11#1)(2008-7#1)
4 min with##2##3##(2008-10#2)
4 min##21##2##(1990-7#1)(1994-8#2)(1996-9#1)(2007-11#1)(2008-10#11)(2008-2#1)(2008-7#1)(2012-2#2)(2013-1#1)
4 min)##3##2##(1993-1#1)(2008-10#1)(2010-3#1)
4 minutes##3##2##(1992-2#2)(2008-6#1)
4 ml fRBCs##2##3##(2011-2#2)
4 ml##7##2##(1996-2#1)(2008-10#3)(2011-1#1)(2011-2#2)
4 mm and##2##3##(2009-7#1)(2013-1#1)
4 mm x 4 mm##2##5##(2007-12#2)
4 mm x##3##3##(2007-12#2)(2008-3#1)
4 mm##26##2##(1995-12#1)(1996-6#1)(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
4 mm)##7##2##(1991-4#1)(2008-3#3)(2008-5#1)(2010-8#1)(2013-1#1)
4 mmol l(-1)##2##3##(2008-10#2)
4 mmol m(-2) for##2##4##(2008-10#2)
4 mmol##4##2##(2008-10#4)
4 mol l(-1)##2##3##(2008-10#2)
4 mol##5##2##(2008-10#4)(2008-9#1)
4 mol/l MgCl2##4##3##(1995-12#4)
4 months (range##4##3##(1992-8#1)(2008-6#1)(2008-9#1)(2009-10#1)
4 months after treatment##4##4##(2013-1#4)
4 months after##8##3##(2008-1#1)(2008-7#1)(2010-5#1)(2013-1#5)
4 months and##4##3##(1991-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
4 months in##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
4 months later##4##3##(1993-1#1)(1993-12#1)(2013-1#2)
4 months of age##4##4##(1991-11#1)(1995-12#1)(2008-11#1)(2011-2#1)
4 months of##13##3##(1991-1#1)(1991-11#1)(1991-6#1)(1992-2#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
4 months to##3##3##(1997-3#1)(2008-5#1)(2008-9#1)
4 months##78##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-8#3)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1995-12#3)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#11)
4 months)##7##2##(1992-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
4 ms##3##2##(1993-12#1)(1996-5#1)(2008-2#1)
4 muM##7##2##(2007-11#1)(2008-10#6)
4 mug l(-1)##6##3##(2008-10#6)
4 mug m(-3))##2##3##(2009-7#2)
4 mug ml(-1)##7##3##(2008-10#7)
4 mug##19##2##(2008-10#17)(2009-7#2)
4 mug/ml)##4##2##(2008-5#4)
4 mum##11##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2009-5#1)
4 mumol/l##2##2##(1994-5#1)(1995-2#1)
4 nA##2##2##(2008-10#2)
4 nM and##3##3##(1990-2#1)(1993-6#1)(2008-10#1)
4 nM##12##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-6#1)(1995-3#2)(1996-2#1)(2008-10#3)
4 nM)##2##2##(1990-11#1)(2010-12#1)
4 ng g(-1)##2##3##(2008-10#1)(2010-5#1)
4 ng ml(-1) (S/N=3) for##2##5##(2008-10#2)
4 ng ml(-1) (S/N=3)##3##4##(2008-10#3)
4 ng ml(-1) for##2##4##(2008-10#2)
4 ng ml(-1)##10##3##(2008-10#10)
4 ng##18##2##(1991-8#1)(2008-10#15)(2010-5#2)
4 ng/ml##2##2##(2008-10#1)(2011-2#1)
4 nm##20##2##(1992-6#3)(2007-11#6)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#1)(2008-8#1)(2008-9#1)
4 nm)##2##2##(2007-11#1)(2008-10#1)
4 nmol##3##2##(1990-11#1)(1991-3#1)(2008-10#1)
4 nmol/h/mg##2##2##(1991-12#2)
4 ns##2##2##(1993-11#1)(1995-5#1)
4 ns)##2##2##(1991-12#1)(2008-3#1)
4 of the 7##2##4##(2008-5#1)(2012-12#1)
4 of the##12##3##(1990-8#1)(1991-9#1)(1993-12#1)(1994-9#1)(1995-11#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#1)
4 of##33##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#1)(1993-12#1)(1994-1#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-5#1)(2007-8#1)(2008-10#6)(2008-12#3)(2008-5#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
4 or 1##2##3##(2008-10#2)
4 or 6##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
4 or more##2##3##(2008-10#1)(2008-12#1)
4 or##21##2##(1992-3#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-11#1)(1997-2#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-9#1)
4 orders of magnitude##2##4##(2008-10#1)(2008-3#1)
4 orders of##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
4 out of##5##3##(1992-3#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-10#1)
4 parameters of coagulation and fibrinolysis##2##6##(2010-3#2)
4 patients (3##2##3##(1993-9#1)(2007-8#1)
4 patients had##2##3##(1991-3#1)(1992-12#1)
4 patients in group A##2##5##(1996-6#1)(2007-9#1)
4 patients in##4##3##(1996-6#1)(2007-9#1)(2008-7#1)(2011-2#1)
4 patients were alive##2##4##(1991-2#1)(1991-8#1)
4 patients were##6##3##(1991-2#1)(1991-8#1)(1996-3#1)(2007-8#1)(2011-2#2)
4 patients who##2##3##(1997-7#1)(2007-5#1)
4 patients with##6##3##(1990-8#1)(1991-4#1)(1997-4#1)(2007-11#1)(2011-1#1)(2013-1#1)
4 patients##58##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-9#1)(1994-1#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#6)(2009-8#1)(2011-1#1)(2011-2#7)(2012-3#2)(2013-1#4)
4 per 1##2##3##(1992-4#2)
4 per cent##2##3##(1991-6#1)(1996-8#1)
4 per##10##2##(1991-6#1)(1992-4#2)(1995-5#1)(1996-8#2)(2010-3#1)(2011-2#2)(2012-12#1)
4 percent of##2##3##(1992-3#1)(1996-3#1)
4 percent##10##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-3#1)(2013-1#1)
4 percent)##2##2##(1994-1#1)(1997-3#1)
4 phases##3##2##(2013-8#3)
4 pmol##2##2##(1990-8#1)(2008-10#1)
4 points##2##2##(2008-10#1)(2013-1#1)
4 ppb##2##2##(2008-10#2)
4 ppm for##2##3##(2008-10#2)
4 ppm##8##2##(1991-8#1)(1997-7#1)(2008-10#5)(2008-4#1)
4 primary##2##2##(1990-12#1)(1993-8#1)
4 ps##2##2##(2007-1#1)(2007-11#1)
4 represents##2##2##(1992-3#1)(1995-2#1)
4 respectively##2##2##(1996-11#1)(1997-3#1)
4 rural##2##2##(2011-1#2)
4 separate##2##2##(1990-5#1)(2012-3#1)
4 show that##2##3##(2007-11#1)(2008-10#1)
4 smaller##2##2##(2008-3#1)(2008-5#1)
4 stages##4##2##(2008-3#1)(2009-2#1)(2009-3#1)(2013-8#1)
4 strains in##2##3##(2008-10#1)(2011-2#1)
4 strains##4##2##(2008-10#3)(2011-2#1)
4 subunit##3##2##(1995-11#3)
4 than##2##2##(1991-8#1)(2013-1#1)
4 through##3##2##(1992-6#1)(1993-9#1)(2008-12#1)
4 times faster##2##3##(2008-8#1)(2012-3#1)
4 times greater##2##3##(1992-3#1)(2009-5#1)
4 times higher##2##3##(2008-10#1)(2008-7#1)
4 times more likely to##2##5##(2007-12#1)(2011-1#1)
4 times more##4##3##(1995-12#1)(1997-3#1)(2007-12#1)(2011-1#1)
4 times per##2##3##(1993-9#1)(2007-8#1)
4 times the##3##3##(2008-2#1)(2008-3#1)(2010-3#1)
4 times##26##2##(1990-9#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
4 to 0##4##3##(1993-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
4 to 1##5##3##(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
4 to 10##3##3##(1991-4#1)(2008-10#1)(2008-11#1)
4 to 11 years##2##4##(2008-10#1)(2008-9#1)
4 to 11##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
4 to 14##4##3##(2007-11#1)(2008-1#1)(2008-10#2)
4 to 16##2##3##(1997-7#1)(2013-8#1)
4 to 2##2##3##(2008-10#2)
4 to 20%##2##3##(2008-10#2)
4 to 24##2##3##(2008-10#2)
4 to 3##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
4 to 30##2##3##(2007-11#1)(2008-10#1)
4 to 4##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
4 to 5 days##2##4##(2007-6#1)(2008-10#1)
4 to 5 months##2##4##(2013-1#2)
4 to 5 years##3##4##(2012-12#3)
4 to 5##15##3##(1992-11#1)(2007-6#1)(2008-10#4)(2008-2#2)(2010-5#1)(2011-1#1)(2012-12#3)(2013-1#2)
4 to 56##2##3##(2008-10#1)(2010-12#1)
4 to 6 weeks##4##4##(1996-8#1)(2007-7#1)(2008-10#1)(2008-5#1)
4 to 6##8##3##(1990-2#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#2)
4 to 7##6##3##(1992-8#1)(1996-11#1)(1997-5#1)(1997-7#1)(2008-10#1)(2013-1#1)
4 to 8##5##3##(1993-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2012-12#1)
4 to 9##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
4 to approximately##2##3##(1990-12#1)(1991-8#1)
4 to the##2##3##(1994-5#1)(2008-11#1)
4 to##125##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#49)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#7)(2008-6#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#5)(2013-8#1)
4 training trials##3##3##(1993-6#3)
4 training##4##2##(1993-6#3)(1994-12#1)
4 treatment##2##2##(1992-10#1)(2013-8#1)
4 units##3##2##(1990-3#1)(1990-7#1)(2013-1#1)
4 vs 1##2##3##(2013-1#2)
4 vs##13##2##(1991-9#1)(1994-12#1)(1994-2#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#3)
4 was##17##2##(1990-5#1)(1992-3#2)(1992-8#1)(1995-3#2)(2007-11#1)(2008-10#8)(2008-2#1)(2008-5#1)
4 week##7##2##(1991-8#1)(1994-11#1)(1996-1#2)(1996-12#1)(2008-11#2)
4 weeks (n =##3##4##(2007-10#2)(2008-7#1)
4 weeks after bloom##2##4##(2008-10#2)
4 weeks after surgery##2##4##(1997-2#1)(2012-1#1)
4 weeks after the##4##4##(1994-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
4 weeks after##15##3##(1992-12#1)(1994-12#1)(1997-2#1)(2008-10#5)(2008-7#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
4 weeks and##4##3##(2008-3#1)(2008-7#1)(2011-2#2)
4 weeks in##7##3##(1993-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2013-8#1)
4 weeks later##4##3##(2007-2#1)(2007-7#1)(2008-10#2)
4 weeks of TRZ##2##4##(1996-12#2)
4 weeks of age##3##4##(1997-6#1)(2008-5#1)(2008-7#1)
4 weeks of treatment##4##4##(2008-10#1)(2008-5#1)(2008-7#2)
4 weeks of##17##3##(1996-12#2)(1997-6#1)(2007-7#1)(2008-10#2)(2008-5#3)(2008-7#5)(2009-3#1)(2009-7#1)(2013-1#1)
4 weeks postbloom##2##3##(2008-10#2)
4 weeks##110##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#2)(1994-12#1)(1995-3#1)(1996-12#5)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-2#1)(2007-7#5)(2008-10#33)(2008-11#6)(2008-12#2)(2008-3#3)(2008-5#7)(2008-7#10)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#2)
4 weeks)##3##2##(1992-12#2)(1996-7#1)
4 were reduced##2##3##(1994-12#1)(1997-4#1)
4 were##27##2##(1991-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
4 which##4##2##(1993-3#1)(2008-12#1)(2008-4#1)(2009-8#1)
4 with methyl vinyl ether##2##5##(1996-5#2)
4 with the##2##3##(1995-3#1)(1996-5#1)
4 with##16##2##(1990-9#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(2007-11#1)(2007-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
4 women with##2##3##(2007-8#1)(2008-11#1)
4 x 10(-2)##2##3##(1996-6#1)(2008-3#1)
4 x 10(-3)##4##3##(1994-5#1)(2008-10#1)(2008-3#2)
4 x 10(-4)##3##3##(1990-8#1)(2008-10#1)(2008-2#1)
4 x 10(-5)##2##3##(2008-10#1)(2008-3#1)
4 x 10(-8)##2##3##(2008-10#2)
4 x 10(-9)##3##3##(1992-5#1)(2008-10#1)(2008-3#1)
4 x 10(6)##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
4 x 10(7) M-1##2##4##(1995-2#2)
4 x 10(7)##3##3##(1995-2#2)(2008-11#1)
4 x 10(8)##3##3##(1997-5#1)(2008-11#1)(2008-8#1)
4 x 10(9)##2##3##(1997-5#1)(2008-11#1)
4 x 4##8##3##(2007-11#1)(2008-2#3)(2008-3#4)
4 x##51##2##(1990-8#1)(1992-5#1)(1994-5#1)(1995-11#1)(1995-2#2)(1996-6#1)(1997-5#2)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#4)(2008-2#4)(2008-3#12)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)
4 years (range##2##3##(2007-8#2)
4 years after surgery##2##4##(1991-2#1)(2008-7#1)
4 years after##7##3##(1991-2#1)(1994-12#1)(2007-5#1)(2008-7#2)(2011-3#1)(2013-1#1)
4 years ago##6##3##(1996-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#2)
4 years and##3##3##(1997-6#1)(2007-2#1)(2008-10#1)
4 years at the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
4 years at##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
4 years following##2##3##(1993-9#1)(2008-4#1)
4 years for##2##3##(2008-10#1)(2008-4#1)
4 years of age##2##4##(2009-8#1)(2011-2#1)
4 years of##9##3##(1990-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
4 years##84##2##(1990-9#1)(1991-2#2)(1991-8#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#4)(1995-3#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-6#2)(1997-8#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#16)(2008-12#1)(2008-4#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
4 years) with##2##3##(1990-3#1)(2008-6#1)
4 years)##10##2##(1990-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2013-1#2)
4 ± 0##2##3##(2013-1#1)(2013-8#1)
4 ± 1##2##3##(2013-1#2)
4 ± 7##2##3##(2011-2#1)(2013-8#1)
4 ±##10##2##(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
4##4642##1##(1990-10#2)(1990-11#21)(1990-12#37)(1990-2#31)(1990-3#12)(1990-5#26)(1990-6#8)(1990-7#24)(1990-8#27)(1990-9#9)(1991-1#5)(1991-10#4)(1991-11#7)(1991-12#27)(1991-2#20)(1991-3#15)(1991-4#6)(1991-5#15)(1991-6#10)(1991-8#46)(1991-9#11)(1992-10#5)(1992-11#28)(1992-12#23)(1992-2#16)(1992-3#25)(1992-4#10)(1992-5#14)(1992-6#21)(1992-7#1)(1992-8#22)(1992-9#12)(1993-1#11)(1993-10#1)(1993-11#9)(1993-12#20)(1993-2#16)(1993-3#21)(1993-5#1)(1993-6#20)(1993-8#32)(1993-9#22)(1994-1#4)(1994-11#22)(1994-12#37)(1994-2#13)(1994-3#17)(1994-5#19)(1994-6#15)(1994-7#5)(1994-8#21)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#48)(1995-12#39)(1995-2#29)(1995-3#26)(1995-4#3)(1995-5#15)(1995-6#10)(1995-8#13)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#11)(1996-12#33)(1996-2#54)(1996-3#9)(1996-5#32)(1996-6#7)(1996-7#4)(1996-8#4)(1996-9#6)(1997-1#18)(1997-2#41)(1997-3#13)(1997-4#22)(1997-5#10)(1997-6#10)(1997-7#34)(1997-8#19)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-10#23)(2007-11#81)(2007-12#55)(2007-2#6)(2007-5#9)(2007-6#3)(2007-7#28)(2007-8#50)(2007-9#4)(2008-1#38)(2008-10#1249)(2008-11#105)(2008-12#72)(2008-2#71)(2008-3#144)(2008-4#26)(2008-5#126)(2008-6#39)(2008-7#110)(2008-8#56)(2008-9#72)(2009-1#3)(2009-10#17)(2009-11#6)(2009-12#7)(2009-2#8)(2009-3#16)(2009-4#9)(2009-5#10)(2009-6#3)(2009-7#15)(2009-8#16)(2009-9#3)(2010-1#7)(2010-10#4)(2010-11#7)(2010-12#7)(2010-2#7)(2010-3#23)(2010-4#14)(2010-5#30)(2010-6#5)(2010-7#9)(2010-8#20)(2010-9#5)(2011-1#74)(2011-2#167)(2011-3#9)(2012-1#10)(2012-12#56)(2012-2#52)(2012-3#61)(2012-4#1)(2012-9#1)(2013-1#159)(2013-3#1)(2013-7#7)(2013-8#42)
4% (P##3##2##(1991-5#1)(2012-1#1)(2013-1#1)
4% (n =##4##3##(1991-8#1)(1995-5#1)(2008-10#2)
4% (n=5)##2##2##(2008-10#2)
4% (v/v) Triton X-100##3##4##(2008-10#3)
4% (v/v)##6##2##(2008-10#6)
4% =##2##2##(1991-6#2)
4% R##2##2##(2008-10#2)
4% acetic acid##2##3##(1997-4#1)(2008-10#1)
4% and a##2##3##(2008-10#1)(2008-3#1)
4% and the##2##3##(2008-10#2)
4% and vein graft patency was##2##6##(2007-8#2)
4% and##38##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-8#1)(1994-12#1)(2007-12#2)(2007-7#3)(2007-8#3)(2008-10#7)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
4% as##3##2##(1994-12#1)(2007-10#1)(2008-3#1)
4% at a##2##3##(2007-11#1)(2008-2#1)
4% at##14##2##(1991-8#1)(1992-4#1)(1995-12#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-2#1)(2013-1#1)
4% females)##3##2##(1994-6#2)(2008-3#1)
4% for 1##2##3##(2008-10#2)
4% for 10##4##3##(2008-10#3)(2013-1#1)
4% for a##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
4% for the##3##3##(2008-10#3)
4% for##50##2##(1992-11#1)(1994-11#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#30)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
4% had##7##2##(1993-2#1)(1994-12#1)(1995-5#1)(2008-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
4% identity with##2##3##(2008-10#1)(2009-6#1)
4% in adult cirrhotics) and##2##5##(2012-3#2)
4% in adult cirrhotics)##4##4##(2012-3#4)
4% in the##5##3##(1991-9#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-3#1)
4% in##32##2##(1990-9#1)(1991-9#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(2008-1#2)(2008-10#4)(2008-3#4)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#5)(2013-1#1)
4% of all##5##3##(1990-2#2)(2010-12#1)(2011-2#1)(2013-1#1)
4% of genomic DNA##2##4##(1993-12#2)
4% of patients had##2##4##(2007-11#1)(2007-8#1)
4% of patients with##2##4##(2007-10#1)(2013-1#1)
4% of patients##8##3##(1996-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
4% of respondents##2##3##(2008-12#1)(2013-1#1)
4% of the cases##3##4##(2007-7#2)(2008-4#1)
4% of the isolates##2##4##(2008-10#1)(2010-8#1)
4% of the patients##4##4##(1991-12#1)(2008-10#2)(2011-2#1)
4% of the sample##2##4##(2013-1#1)(2013-8#1)
4% of the samples##2##4##(2011-2#1)(2012-2#1)
4% of the total##4##4##(2008-1#1)(2008-5#1)(2008-9#1)(2012-3#1)
4% of the variance in##3##5##(1996-1#1)(2008-4#1)(2008-9#1)
4% of the##41##3##(1990-11#1)(1991-12#1)(1992-6#1)(1992-9#1)(1994-6#1)(1996-1#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
4% of##87##2##(1990-11#1)(1990-2#2)(1990-6#2)(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-6#2)(1995-12#2)(1996-1#2)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#4)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
4% optical-to-optical conversion efficiency and##2##5##(2008-2#2)
4% or##2##2##(2008-10#2)
4% reported##2##2##(2008-11#1)(2008-12#1)
4% respectively##3##2##(1993-1#1)(2008-5#1)(2011-1#1)
4% sequence##2##2##(1995-8#1)(2011-2#1)
4% that##2##2##(2008-10#2)
4% to 8##2##3##(2008-10#2)
4% to##9##2##(1992-11#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2011-1#2)
4% vs##6##2##(1993-2#1)(1993-8#1)(1995-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
4% w/w) of##2##3##(2008-5#2)
4% was##4##2##(2007-12#1)(2008-10#3)
4% were NPD and##2##4##(2008-12#2)
4% were NPD##3##3##(2008-12#3)
4% were##15##2##(1993-8#1)(1995-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#3)(2013-8#1)
4% when##2##2##(2007-10#1)(2008-2#1)
4% with##2##2##(2008-10#2)
4%##565##1##(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#2)(1990-6#4)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#4)(1991-8#3)(1991-9#3)(1992-11#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#1)(1994-6#5)(1994-8#2)(1994-9#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#2)(2006-8#1)(2007-10#3)(2007-11#8)(2007-12#9)(2007-2#1)(2007-7#15)(2007-8#15)(2008-1#7)(2008-10#160)(2008-11#11)(2008-12#16)(2008-2#9)(2008-3#22)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#6)(2008-8#5)(2008-9#6)(2009-4#1)(2009-6#1)(2009-7#5)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#3)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#8)(2011-1#11)(2011-2#29)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#15)(2013-1#23)(2013-7#1)(2013-8#9)
4%) and##25##2##(2007-8#1)(2008-1#4)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
4%) at##2##2##(1997-8#1)(2010-3#1)
4%) for##3##2##(2008-10#2)(2012-2#1)
4%) had##11##2##(2008-1#3)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
4%) in stage##3##3##(1990-9#2)(1993-1#1)
4%) in##8##2##(1990-9#2)(1993-1#1)(1994-9#1)(2007-8#1)(2009-10#1)(2011-1#2)
4%) is##2##2##(1990-2#1)(2008-2#1)
4%) of patients##2##3##(2012-3#1)(2013-1#1)
4%) of##11##2##(1990-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#2)(2012-3#1)(2013-1#2)
4%) patients and##2##3##(2008-1#1)(2011-2#1)
4%) patients were##3##3##(2007-10#1)(2007-8#1)(2008-1#1)
4%) patients with##2##3##(2008-1#2)
4%) patients##18##2##(1995-8#1)(2007-10#1)(2007-8#2)(2008-1#9)(2008-4#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
4%) were positive for##2##4##(2007-7#1)(2011-2#1)
4%) were##12##2##(1990-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
4%) with##3##2##(1990-11#1)(2008-5#1)(2008-7#1)
4%)##198##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-8#1)(1992-10#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#11)(2007-8#7)(2008-1#21)(2008-10#12)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#6)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2010-10#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#9)(2013-8#7)
4&lt##3##1##(2007-11#1)(2008-10#1)(2013-1#1)
4'##28##1##(1993-11#2)(1993-12#3)(1994-8#1)(1996-12#3)(1996-5#1)(2008-10#15)(2008-11#2)(2008-9#1)
4''##2##1##(2008-10#2)
4'''-tetraaminophthalocyanine##2##1##(2008-10#2)
4''-disulphonate (ferrozine)##2##2##(2008-10#2)
4'-##3##1##(1991-3#2)(1995-3#1)
4'-6-diamidino-2-phenylindole##2##1##(2008-10#1)(2013-1#1)
4'-chemistry##4##1##(1991-3#4)
4'-diaminodiphenylether##2##1##(2008-10#2)
4'-diaminophenyl)-difluoroboradiaza-s-indacence##2##1##(2008-10#2)
4'-diaminophenyl)-difluoroboradiaza-s-indacene##2##1##(2008-10#2)
4'-dichlorodithizone##2##1##(2008-10#2)
4'-dimethoxytrityl)-2-mercaptoethyl]-N##2##1##(2008-4#2)
4'-methylenebis(N##2##1##(2008-10#2)
4'-tetraphenylferrocene##2##1##(2008-10#2)
4(th)##2##1##(2011-1#1)(2013-1#1)
4) and the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
4) and##17##2##(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-2#1)
4) are##2##2##(2008-3#1)(2011-2#1)
4) as##2##2##(2008-5#1)(2010-5#1)
4) at##2##2##(1997-1#1)(2008-10#1)
4) have been##2##3##(2008-10#2)
4) in the##2##3##(1994-12#1)(1997-5#1)
4) in##3##2##(1994-12#1)(1997-5#1)(2011-1#1)
4) of##2##2##(2012-12#1)(2013-1#1)
4) on##2##2##(2008-8#1)(2013-1#1)
4) or##2##2##(1994-6#1)(2008-12#1)
4) the##6##2##(1991-3#1)(1995-11#1)(1997-6#1)(2008-3#1)(2008-6#1)(2008-8#1)
4) was##8##2##(1990-5#1)(1992-3#1)(1992-6#1)(1995-3#1)(2007-10#1)(2008-11#1)(2009-11#1)(2011-3#1)
4) were identified##2##3##(2008-10#1)(2011-1#1)
4) were similar##2##3##(2008-10#1)(2012-3#1)
4) were##9##2##(1992-3#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
4) which##2##2##(1990-11#1)(1993-3#1)
4) who##2##2##(2007-12#1)(2013-8#1)
4) with##2##2##(2007-10#1)(2008-10#1)
4) x 10(-19)##2##3##(2008-3#2)
4) x##5##2##(1992-6#1)(1995-2#1)(2008-2#1)(2008-3#2)
4)##214##1##(1990-11#2)(1990-2#1)(1990-5#9)(1990-7#2)(1990-8#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#3)(1991-9#1)(1992-3#4)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#3)(1996-4#2)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#29)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#8)(2008-9#4)(2009-11#2)(2009-2#1)(2009-3#1)(2009-8#2)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#7)(2011-2#9)(2011-3#1)(2011-9#1)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#4)
4)-##2##1##(1992-12#1)(1995-11#1)
4)-O-(2-O-methyl-alpha-L-fucopyranosyl)-(1--&gt##2##1##(1992-12#2)
4)-linked##2##1##(1995-11#2)
4)]-beta-D-glucopyranoside##2##1##(2008-11#2)
4)]octane##2##1##(1996-5#2)
4+/-0##11##1##(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)
4+/-1##10##1##(2007-8#1)(2008-10#8)(2010-3#1)
4+/-15##2##1##(2007-8#1)(2008-7#1)
4+/-3##2##1##(2008-10#1)(2009-3#1)
4- and 2##3##3##(2008-10#3)
4- and##10##2##(1990-2#1)(1991-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)
4- to 3##2##3##(1993-8#1)(2008-10#1)
4- to 5-fold##2##3##(1990-12#1)(1993-9#1)
4- to##12##2##(1990-12#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-3#1)(2010-1#1)(2012-3#1)
4-##35##1##(1990-12#1)(1990-2#3)(1991-5#1)(1992-1#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
4-(1-aryl-3-oxo-5-phenylpentylamino)##2##1##(2011-3#2)
4-(2-pyridylazo) resorcinol (PAR)##4##3##(2008-10#4)
4-(2-pyridylazo) resorcinol##5##2##(2008-10#5)
4-(2-pyridylazo)##6##1##(2008-10#6)
4-(2-pyridylazo)-resorcinol (PAR)##3##2##(2008-10#3)
4-(2-pyridylazo)-resorcinol##4##1##(2008-10#4)
4-(2-pyridylazo)resorcinol (PAR)##6##2##(2008-10#6)
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)##2##2##(1992-9#1)(1993-11#1)
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone##3##1##(1990-6#1)(1992-9#1)(1993-11#1)
4-0##3##1##(2008-10#1)(2012-2#1)(2013-8#1)
4-1##7##1##(1990-2#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-3#2)
4-10##3##1##(1994-3#1)(2008-10#1)(2012-2#1)
4-10% and##2##2##(2008-10#1)(2010-6#1)
4-10%##3##1##(2008-10#1)(2010-6#1)(2013-8#1)
4-12##6##1##(2007-7#2)(2008-10#4)
4-14##3##1##(1990-12#1)(1994-5#1)(2008-11#1)
4-18##3##1##(2006-8#1)(2008-1#1)(2008-10#1)
4-2##6##1##(1992-12#1)(2008-10#4)(2008-11#1)
4-25##3##1##(1995-6#1)(2008-10#1)(2013-8#1)
4-27##3##1##(1990-8#1)(2008-10#1)(2008-4#1)
4-3##8##1##(1991-9#1)(1994-12#1)(2008-10#4)(2012-3#1)(2013-1#1)
4-4##7##1##(1990-5#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
4-4-20 antigen-binding fragment##3##3##(1995-5#3)
4-4-20##11##1##(1991-8#4)(1992-6#4)(1995-5#3)
4-5 h##2##2##(1997-4#1)(2008-9#1)
4-5 nm##3##2##(2007-12#2)(2008-10#1)
4-5##30##1##(1992-4#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2011-3#1)
4-5%##3##1##(2007-8#1)(2008-10#1)(2008-3#1)
4-5)##3##1##(1994-2#2)(1996-5#1)
4-6 hours##2##2##(1994-2#1)(2008-6#1)
4-6 weeks##7##2##(1994-11#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
4-6##35##1##(1991-1#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
4-7##9##1##(1993-3#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
4-7)##2##1##(2007-8#1)(2008-10#1)
4-75##2##1##(2007-7#1)(2008-10#1)
4-8##12##1##(1990-10#1)(1992-4#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
4-9##4##1##(1995-12#1)(2008-10#3)
4-BP##3##1##(2008-10#3)
4-D and 2##2##3##(2008-10#1)(2008-12#1)
4-D and##6##2##(2008-10#3)(2008-12#3)
4-D are##2##2##(2008-10#1)(2008-11#1)
4-D esters##2##2##(2008-10#2)
4-D for##2##2##(2008-12#2)
4-D in##3##2##(2008-10#3)
4-D is##3##2##(2008-10#1)(2008-11#2)
4-D were##2##2##(2008-10#2)
4-D with##2##2##(2008-10#1)(2008-12#1)
4-D##43##1##(1990-9#1)(2008-10#22)(2008-11#8)(2008-12#12)
4-D) and##3##2##(2008-10#3)
4-D) in##2##2##(2008-10#2)
4-D) is##2##2##(2008-10#2)
4-D) were##2##2##(2008-10#1)(2008-11#1)
4-D)##15##1##(2008-10#10)(2008-11#2)(2008-12#2)(2008-8#1)
4-DAP##2##1##(2008-8#2)
4-DAPG producers and##3##3##(2008-10#3)
4-DAPG producers in the##2##4##(2008-10#2)
4-DAPG producers in##3##3##(2008-10#3)
4-DAPG producers##13##2##(2008-10#13)
4-DAPG##22##1##(2008-10#22)
4-DAPG) are##2##2##(2008-10#2)
4-DAPG) play a##2##3##(2008-10#2)
4-DAPG)##6##1##(2008-10#6)
4-DAPG-producing P##3##2##(2008-10#3)
4-DAPG-producing Pseudomonas spp##3##3##(2008-10#3)
4-DAPG-producing fluorescent Pseudomonas spp##2##4##(2008-10#2)
4-DAPG-producing##11##1##(2008-10#11)
4-DBP##2##1##(2008-10#2)
4-DCP##3##1##(2008-10#3)
4-DCP)##3##1##(2008-10#3)
4-DHP##2##1##(2012-3#2)
4-DNT and##2##2##(2008-10#2)
4-DNT##11##1##(2008-10#11)
4-DNT)##3##1##(2008-10#2)(2008-11#1)
4-Diacetylphloroglucinol##2##1##(2008-10#2)
4-Diacetylphloroglucinol-Producing Fluorescent Pseudomonas spp##2##4##(2008-10#2)
4-Diacetylphloroglucinol-Producing Pseudomonas fluorescens in the Rhizosphere##2##6##(2008-10#2)
4-Diacetylphloroglucinol-Producing Pseudomonas fluorescens##3##3##(2008-10#3)
4-Diacetylphloroglucinol-Producing Pseudomonas##4##2##(2008-10#4)
4-Diacetylphloroglucinol-Producing##6##1##(2008-10#6)
4-Dihydroxyphenyl)methylidene]amino}benzoic acid##2##2##(2008-10#2)
4-GHz##2##1##(2007-11#1)(2007-9#1)
4-N##5##1##(1990-5#1)(1995-2#1)(2007-11#1)(2007-12#2)
4-NP was##2##2##(2008-10#2)
4-NP##7##1##(2008-10#7)
4-Nonylphenol##2##1##(2008-10#1)(2008-11#1)
4-S-cysteaminylphenol##2##1##(1992-3#2)
4-TFMPD##3##1##(1995-3#3)
4-W##7##1##(2007-11#1)(2007-12#4)(2008-2#2)
4-amine##4##1##(1995-3#4)
4-amino-2##11##1##(1994-5#9)(1995-6#1)(2008-10#1)
4-amino-5-(furan-2-yl or benzyl)-4H-1##2##3##(2007-11#2)
4-aminoantipyrine in##4##2##(2008-10#4)
4-aminoantipyrine##8##1##(2008-10#8)
4-aminobicyclo[2##2##1##(2007-11#2)
4-aminophenol and##3##2##(2008-10#3)
4-aminophenol in##2##2##(2008-10#2)
4-aminophenol##11##1##(1990-2#1)(2008-10#10)
4-aminopyridine (10mM)##2##2##(1993-3#2)
4-aminopyridine (4-AP)##2##2##(1990-12#1)(1996-5#1)
4-aminopyridine##6##1##(1990-12#1)(1992-11#1)(1993-3#2)(1996-5#1)(2008-8#1)
4-aminoquinoline derivatives##2##2##(1993-8#2)
4-androstadien-3##2##1##(2007-11#2)
4-benzenetriol##5##1##(2008-10#5)
4-benzodiazepin++##2##1##(1995-12#2)
4-benzoquinone in##2##2##(2007-11#1)(2008-11#1)
4-benzoquinone##14##1##(1990-7#1)(1995-5#1)(2007-11#1)(2008-10#8)(2008-11#2)(2009-9#1)
4-benzoxazin-3(4H)-one)##2##1##(2008-10#2)
4-beta-glucanase##3##1##(1991-5#1)(2008-10#2)
4-bis(3-indolyl)-1H-pyrrole-2##2##1##(2008-10#2)
4-bis(naphth[2##2##1##(2008-10#2)
4-bis(prop-2'-enyloxy)-9##2##1##(2008-10#2)
4-bis-(N-methyl-acetohydroxamic##2##1##(2008-10#2)
4-bisphosphate##2##1##(1993-8#2)
4-branched triantennary complex-type sugar chains##2##5##(1993-11#2)
4-bromophenacyl bromide##2##2##(2012-3#2)
4-butanetetracarboxylate##2##1##(2008-10#2)
4-catechol##3##1##(2008-11#3)
4-cell stage##3##2##(1993-3#2)(2007-12#1)
4-cell##6##1##(1993-3#2)(2007-12#1)(2008-9#3)
4-chloro-1##3##1##(1991-3#1)(1992-9#1)(2009-6#1)
4-chloro-3-methylphenol##2##1##(2008-10#2)
4-chlorophenol##7##1##(2008-10#7)
4-cm##4##1##(1994-8#1)(2007-11#1)(2007-12#1)(2012-2#1)
4-cm(-1)##2##1##(2008-3#2)
4-d##2##1##(2008-11#1)(2011-2#1)
4-d]pyrimidine molecules##2##2##(2013-7#2)
4-d]pyrimidine##3##1##(2008-4#1)(2013-7#2)
4-d]pyrimidines##2##1##(2013-7#2)
4-deoxy-4-[(4R##2##1##(1995-11#2)
4-diacetylphloroglucinol (2##5##2##(2008-10#5)
4-diacetylphloroglucinol##9##1##(2008-10#9)
4-diamino##2##1##(1995-3#2)
4-diaminotoluene##2##1##(2008-10#2)
4-diaryl-3-azabicyclo[3##2##1##(1996-5#2)
4-dicarboxylic acid##2##2##(1995-12#1)(2008-10#1)
4-dichloroaniline##3##1##(2008-10#3)
4-dichlorobenzene##2##1##(2008-10#2)
4-dichlorobenzophenone##2##1##(2008-10#2)
4-dichlorophenol (2##3##2##(2008-10#2)(2008-11#1)
4-dichlorophenol (DCP)##2##2##(2008-10#2)
4-dichlorophenol and##2##2##(2008-10#1)(2008-11#1)
4-dichlorophenol##16##1##(2008-10#14)(2008-11#2)
4-dichlorophenol)##2##1##(2008-10#1)(2008-11#1)
4-dichlorophenoxy acetic acid (2##3##4##(2008-10#2)(2008-8#1)
4-dichlorophenoxy acetic acid##5##3##(2008-10#4)(2008-8#1)
4-dichlorophenoxyacetic acid (2##7##3##(2008-10#5)(2008-11#2)
4-dichlorophenoxyacetic acid##11##2##(2008-10#8)(2008-11#3)
4-dichlorophthalazine reactive##2##2##(2008-10#2)
4-dichlorophthalazine##3##1##(2008-10#3)
4-dienoate hydrolase in Pseudomonas putida F1##2##6##(1991-7#2)
4-difluoro-1##2##1##(2008-10#2)
4-dihydro-2##3##1##(2012-3#3)
4-dihydrocarbazole functional group##2##3##(2008-10#2)
4-dihydrocarbazole-9-ethyl chloroformate (BCEOC)##2##3##(2008-10#2)
4-dihydrocarbazole-9-ethyl##3##1##(2008-10#3)
4-dihydrolutidine##2##1##(2008-10#2)
4-dihydropyridine##3##1##(2008-10#2)(2008-5#1)
4-dihydropyridines##3##1##(2008-10#3)
4-dihydroxy##3##1##(2008-10#2)(2008-11#1)
4-dihydroxybenzoic acid and##3##3##(2008-10#3)
4-dihydroxybenzoic acid##7##2##(2008-10#7)
4-dihydroxyphenylacetic acid (DOPAC) and##2##4##(1992-7#1)(1995-3#1)
4-dihydroxyphenylacetic acid (DOPAC)##5##3##(1992-7#1)(1994-2#1)(1995-3#1)(2008-10#2)
4-dihydroxyphenylacetic acid##7##2##(1992-7#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#3)
4-dihydroxyphenylalanine##3##1##(2008-10#1)(2008-7#1)(2009-9#1)
4-dimensional##2##1##(2012-12#1)(2012-2#1)
4-dimethyl-1##3##1##(1997-7#1)(2008-10#1)(2008-5#1)
4-dimethyl-l-glutamine##2##1##(2007-12#2)
4-dimethylaminoazobenzene##2##1##(2008-10#2)
4-dimethylimidazo[4##2##1##(1992-2#2)
4-dimethylphenylformamide at##2##2##(2008-10#2)
4-dimethylthiazolium dipolar ion##2##3##(1993-8#2)
4-dinitrobenzamide##3##1##(1995-3#3)
4-dinitrobenzene##5##1##(1994-11#1)(1995-6#1)(2008-10#2)(2008-3#1)
4-dinitrophenol##4##1##(1990-12#1)(1994-8#1)(2008-10#1)(2008-7#1)
4-dinitrophenyl##7##1##(1991-9#1)(1992-8#1)(2008-10#5)
4-dinitrophenylhydrazine (DNPH)##2##2##(2008-10#2)
4-dinitrophenylhydrazine##5##1##(2008-10#5)
4-dinitrophenylhydrazones by gas chromatography##2##4##(2008-10#2)
4-dinitrotoluene (2##3##2##(2008-10#2)(2008-11#1)
4-dinitrotoluene##10##1##(1994-11#1)(2008-10#8)(2008-11#1)
4-dione##7##1##(2007-11#4)(2008-10#3)
4-dione)##2##1##(2007-11#2)
4-dioxane##2##1##(2008-12#1)(2008-2#1)
4-disubstituted##2##1##(2008-10#1)(2012-2#1)
4-en-VPA##5##1##(1996-5#5)
4-epi-doxorubicin and mitomycin C##2##4##(1990-2#2)
4-epi-doxorubicin##4##1##(1990-2#4)
4-ethylenedioxythiophene##3##1##(2008-10#1)(2013-1#2)
4-ethylenedioxythiophene)##4##1##(2008-10#3)(2009-11#1)
4-exoglucanase##2##1##(2008-10#2)
4-f system and##2##3##(2007-12#1)(2008-3#1)
4-f##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
4-fold at##2##2##(1990-10#1)(2008-11#1)
4-fold diluted##2##2##(2008-10#1)(2013-1#1)
4-fold during the post-reproductive period##2##5##(1997-4#2)
4-fold higher than##2##3##(1994-8#1)(2007-11#1)
4-fold in##2##2##(1991-12#1)(2009-12#1)
4-fold increase in##4##3##(1990-7#1)(1993-6#1)(2008-11#1)(2013-7#1)
4-fold increase##5##2##(1990-7#1)(1993-6#1)(1996-12#1)(2008-11#1)(2013-7#1)
4-fold or##2##2##(1992-10#1)(1993-12#1)
4-fold##34##1##(1990-10#1)(1990-7#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-12#3)(1993-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
4-fold)##4##1##(1993-1#1)(1993-11#1)(1993-8#1)(1996-2#1)
4-galactosyltransferase##3##1##(2008-9#3)
4-glucanase and beta-1##2##3##(1992-11#2)
4-glucanase##4##1##(1991-5#1)(1992-11#2)(2008-10#1)
4-glucanases and beta-1##2##3##(1992-7#2)
4-glucosidic##2##1##(1991-5#1)(1997-4#1)
4-h incubation##2##2##(1991-12#1)(2008-9#1)
4-h##10##1##(1991-12#1)(1994-8#1)(2008-10#6)(2008-6#1)(2008-9#1)
4-hour##3##1##(2007-10#1)(2011-2#2)
4-hydroxy-2##2##1##(1996-5#1)(2008-10#1)
4-hydroxy-3-methoxyphenylacetic##2##1##(1992-7#1)(2008-10#1)
4-hydroxy-5-methyl-3(2H)-furanone##2##1##(1996-2#2)
4-hydroxy-6-methyl-2-pyrone##2##1##(2007-11#2)
4-hydroxybenzaldehyde##2##1##(2008-10#2)
4-hydroxybenzoate##2##1##(2008-5#2)
4-hydroxybenzoic acid##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
4-hydroxycoumarin##3##1##(1990-6#1)(2007-11#1)(2008-10#1)
4-hydroxyestrone##2##1##(2008-11#2)
4-hydroxylamine and 4-amine##2##3##(1995-3#2)
4-hydroxylamine and##3##2##(1995-3#3)
4-hydroxylamine##4##1##(1995-3#4)
4-hydroxylase##5##1##(1992-11#2)(1993-6#1)(2008-10#2)
4-hydroxynonenal (HNE)##2##2##(2008-10#1)(2008-5#1)
4-hydroxynonenal##7##1##(1990-5#2)(1996-12#1)(2008-10#1)(2008-5#1)(2009-8#2)
4-hydroxytamoxifen##3##1##(1990-12#2)(1995-2#1)
4-kDa##2##1##(1990-5#1)(1992-11#1)
4-kb fragment of##2##3##(1990-5#1)(1994-12#1)
4-kb##14##1##(1990-5#2)(1991-6#1)(1994-12#3)(1994-9#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
4-kg object##2##2##(2012-12#2)
4-kinase##6##1##(1991-8#4)(1997-8#2)
4-linkages##2##1##(1991-5#1)(1993-11#1)
4-m##2##1##(2007-9#1)(2008-2#1)
4-methoxycinnamate##3##1##(2008-5#3)
4-methylcatechol##2##1##(2013-8#2)
4-methylfecosterol##2##1##(1992-11#2)
4-methylthio-1-butyl group for##2##3##(2008-4#2)
4-methylthio-1-butyl##3##1##(2008-4#3)
4-microm##4##1##(2008-2#1)(2008-3#3)
4-min##3##1##(2008-10#2)(2013-8#1)
4-mm-long##4##1##(2007-12#2)(2008-3#2)
4-month##5##1##(1991-8#2)(1993-1#1)(2013-1#1)(2013-7#1)
4-month-old##3##1##(2008-11#2)(2008-5#1)
4-mu##3##1##(2007-12#3)
4-mum##2##1##(2007-12#1)(2008-3#1)
4-n-NP was##2##2##(2008-11#2)
4-n-NP##4##1##(2008-11#4)
4-n-heptylphenol##2##1##(2008-10#2)
4-n-hexylphenol##2##1##(2008-10#2)
4-n-nonylphenol##3##1##(2008-10#1)(2008-11#2)
4-n-octylphenol##2##1##(2008-10#2)
4-n-pentylphenol##2##1##(2008-10#2)
4-naphthoquinone##8##1##(1993-8#1)(2008-10#2)(2008-11#3)(2009-9#2)
4-nitrophenyl##2##1##(1991-5#1)(2008-10#1)
4-nitrotoluene##3##1##(2008-10#3)
4-nm wavelength##2##2##(2007-11#1)(2007-12#1)
4-nm##4##1##(1992-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
4-oxadiazol-2-yl)-3##2##1##(2010-6#2)
4-oxopentyl groups##2##2##(2008-4#2)
4-oxopentyl##3##1##(2008-4#3)
4-pentamethylene-1##3##1##(2008-4#3)
4-phenylene)bis(3-aryl-1H-pyrazole-5##2##1##(2012-3#2)
4-phenylenediamine##3##1##(2008-10#3)
4-phosphate##6##1##(1993-8#1)(1997-8#2)(2008-7#1)(2008-8#1)(2013-8#1)
4-pyridinoporphirazinatocopper(II)##2##1##(2008-10#2)
4-quinolone antibacterials##2##2##(2008-10#2)
4-slice scanners##2##2##(2008-7#2)
4-styrenesulfonate)-coated##3##1##(2008-10#3)
4-substituted aniline##2##2##(1992-11#1)(1995-3#1)
4-substituted thiosemicarbazides##2##2##(2007-11#2)
4-substituted##6##1##(1992-11#1)(1995-11#1)(1995-3#1)(2007-11#2)(2008-12#1)
4-tert-butylcalix[4]arene##2##1##(2008-10#2)
4-tetrahydroisoquinoline##6##1##(1994-2#3)(1995-5#2)(2007-11#1)
4-thiadiazole##2##1##(2008-10#2)
4-thiadiazole-2##2##1##(2008-10#2)
4-thiadiazole-2-sulfonamide##3##1##(2008-10#3)
4-times##2##1##(1993-12#1)(1994-5#1)
4-triazine##3##1##(2008-10#2)(2008-11#1)
4-triazine-4'##2##1##(2008-10#2)
4-triazol-5-ones##3##1##(2007-11#3)
4-triazole (amitrole)##2##2##(2008-10#2)
4-triazole##5##1##(1994-11#1)(2008-10#2)(2010-12#1)(2012-2#1)
4-triazole-3-thiols 7 and 10##2##4##(2007-11#2)
4-triazole-3-thiols##3##1##(2007-11#3)
4-trifluoro-1-(2-thienyl)-1##2##1##(2008-10#2)
4-trisusbtituted tetrahydrothiophenes##2##2##(2007-11#2)
4-vinylpyridine (4-VP) and##2##3##(2008-10#2)
4-vinylpyridine (4-VP)##3##2##(2008-10#3)
4-vinylpyridine##4##1##(2008-10#3)(2010-4#1)
4-week intervals##2##2##(2008-10#2)
4-week period##3##2##(1997-8#1)(2008-3#1)(2012-3#1)
4-week##18##1##(1992-8#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#1)(2012-3#1)
4-week-old##6##1##(1995-12#1)(2008-10#4)(2008-9#1)
4-xylanase from the##2##3##(1992-11#2)
4-xylanases##3##1##(1992-7#2)(2008-10#1)
4-year data set##2##3##(2008-10#2)
4-year follow-up##3##2##(1991-1#1)(1995-9#1)(2013-1#1)
4-year period##7##2##(1994-12#1)(2008-10#5)(2008-5#1)
4-year survival##2##2##(2007-8#2)
4-year##27##1##(1991-1#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-9#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-5#1)(2010-6#1)(2012-3#1)(2013-1#1)
4-year-old boy##2##2##(2008-10#1)(2008-7#1)
4-year-old girl##3##2##(1997-3#1)(2008-10#2)
4-year-old##12##1##(1997-3#1)(2008-10#3)(2008-2#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
4/10##4##1##(1995-12#2)(2008-12#1)(2008-9#1)
4/100##2##1##(1991-6#1)(1992-2#1)
4/13##2##1##(1992-12#1)(2011-2#1)
4/4 and##2##2##(2008-10#2)
4/4##7##1##(2008-10#6)(2008-11#1)
4/5##5##1##(1994-8#2)(2009-2#1)(2011-2#1)(2013-8#1)
40 %##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
40 +/-##3##2##(1996-5#1)(1997-7#1)(2011-2#1)
40 -##3##2##(2007-2#1)(2008-11#1)(2011-1#1)
40 000##2##2##(2008-10#1)(2009-12#1)
40 GHz##2##2##(2007-11#2)
40 Gy##5##2##(1992-11#1)(2008-6#1)(2009-11#1)(2013-1#2)
40 T antigen##2##3##(1995-6#1)(1997-6#1)
40 T##3##2##(1995-6#2)(1997-6#1)
40 W of##2##3##(2007-11#1)(2011-2#1)
40 and 2##2##3##(2008-5#1)(2011-2#1)
40 and 20##2##3##(2008-10#1)(2008-5#1)
40 and 200##2##3##(2008-10#1)(2008-3#1)
40 and 49##2##3##(1995-10#1)(2012-12#1)
40 and 60##2##3##(1997-1#1)(2013-8#1)
40 and 7##2##3##(2008-10#1)(2008-7#1)
40 and 80##2##3##(1995-12#1)(2008-7#1)
40 and##39##2##(1990-5#1)(1990-9#2)(1991-12#1)(1992-7#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
40 blood##2##2##(1996-12#1)(2008-10#1)
40 cases##8##2##(1990-6#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)
40 children##3##2##(1990-2#1)(1991-3#1)(2013-1#1)
40 chromosomes##2##2##(1994-6#1)(2010-3#1)
40 clinical##2##2##(1993-3#1)(1995-9#1)
40 cm##7##2##(2008-10#4)(2008-2#1)(2008-3#1)(2012-12#1)
40 dB##2##2##(2007-12#2)
40 days##7##2##(1990-11#1)(2008-10#3)(2008-5#1)(2012-1#1)(2013-8#1)
40 deg##2##2##(2008-3#2)
40 degrees C and##2##4##(1997-7#1)(2008-12#1)
40 degrees C for##4##4##(1997-2#2)(2008-10#2)
40 degrees C hyperthermia##2##4##(2008-4#2)
40 degrees C under##2##4##(2007-12#1)(2008-10#1)
40 degrees C##39##3##(1991-12#1)(1994-12#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-12#1)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
40 degrees##43##2##(1991-12#1)(1994-12#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#1)
40 different##4##2##(1991-2#1)(1993-2#1)(2008-11#1)(2008-3#1)
40 female students##2##3##(2008-1#1)(2012-2#1)
40 g kg(-1)##2##3##(2008-12#2)
40 g/L##2##2##(2008-4#1)(2008-6#1)
40 h##4##2##(2008-11#1)(2008-6#1)(2008-7#2)
40 h(-1)##5##2##(2008-10#5)
40 in##2##2##(2008-3#1)(2011-2#1)
40 isolates##2##2##(2008-10#2)
40 kDa protein in the##2##5##(1991-9#1)(1995-11#1)
40 kDa##10##2##(1990-7#1)(1991-9#1)(1992-10#1)(1993-1#1)(1993-8#1)(1994-6#1)(1995-11#1)(1997-4#1)(1997-7#1)(2009-7#1)
40 kb##2##2##(1993-6#1)(1994-11#1)
40 keV##3##2##(2008-2#1)(2008-8#1)(2009-2#1)
40 km##5##2##(2008-2#1)(2008-3#4)
40 mJ/cm(2)##2##2##(2008-2#1)(2008-3#1)
40 mM##5##2##(1990-11#1)(1996-5#1)(1997-2#1)(2008-6#1)(2009-8#1)
40 mW##2##2##(2007-12#1)(2008-3#1)
40 mg daily##3##3##(1994-3#1)(1997-8#1)(2008-1#1)
40 mg l(-1)##2##3##(2008-10#2)
40 mg of##3##3##(1995-12#1)(2012-12#1)(2012-3#1)
40 mg##17##2##(1991-6#2)(1994-3#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
40 mg/kg/day##3##2##(1991-5#1)(1995-8#2)
40 mg/m2##3##2##(1990-2#1)(1991-2#1)(1991-4#1)
40 microM##4##2##(1990-12#1)(1990-5#1)(1996-12#2)
40 microg g(-1)##2##3##(2010-8#2)
40 micrograms##2##2##(1994-11#1)(1994-3#1)
40 million uninsured##2##3##(1997-3#2)
40 min after##2##3##(1995-3#1)(2008-7#1)
40 min##14##2##(1992-10#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-12#1)
40 minutes##4##2##(1991-9#1)(1994-12#1)(1996-1#1)(2007-10#1)
40 ml##5##2##(1992-11#1)(2008-10#4)
40 mm and##2##3##(1992-5#1)(2008-3#1)
40 mm or larger##2##4##(1992-5#2)
40 mm x 40 mm##2##5##(2008-3#2)
40 mm x##4##3##(2008-10#1)(2008-3#3)
40 mm##14##2##(1992-5#3)(1995-12#1)(1996-6#1)(2008-10#1)(2008-3#5)(2008-7#1)(2010-4#1)(2011-2#1)
40 mmHg##3##2##(1995-12#1)(2008-5#1)(2013-1#1)
40 mug l(-1)##2##3##(2008-10#2)
40 mug##6##2##(2008-10#5)(2008-11#1)
40 mul##3##2##(2008-10#3)
40 mumol##2##2##(1992-11#1)(2008-10#1)
40 ng ml(-1)##3##3##(2008-10#3)
40 nm##5##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
40 of##4##2##(1990-8#1)(1991-8#1)(2008-10#2)
40 or##5##2##(1991-3#1)(1994-2#1)(1995-8#1)(2008-9#1)(2009-5#1)
40 patients suffering from##2##4##(2008-5#1)(2012-3#1)
40 patients were##2##3##(2007-8#1)(2008-4#1)
40 patients with##5##3##(1990-2#1)(2007-11#1)(2008-10#1)(2013-1#2)
40 patients##24##2##(1990-2#1)(1990-9#1)(1991-3#1)(1994-9#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)
40 per cent##2##3##(2011-1#1)(2012-8#1)
40 per##4##2##(2008-5#2)(2011-1#1)(2012-8#1)
40 percent of##4##3##(1994-3#2)(2008-10#1)(2008-3#1)
40 percent##10##2##(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
40 ppm##4##2##(2008-10#1)(2008-3#1)(2009-12#1)(2013-8#1)
40 samples per hour##4##4##(2008-10#4)
40 samples per##5##3##(2008-10#5)
40 samples##7##2##(2008-10#7)
40 seconds##2##2##(1992-4#1)(2009-9#1)
40 subjects##2##2##(1990-12#1)(1993-2#1)
40 times faster##2##3##(1996-2#1)(2008-10#1)
40 times##11##2##(1991-5#1)(1995-2#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
40 to 60%##3##3##(2008-10#2)(2011-2#1)
40 to##25##2##(1993-8#1)(1995-9#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
40 volunteers##2##2##(1997-4#1)(2010-5#1)
40 was##3##2##(1996-5#1)(2008-3#1)(2009-9#1)
40 weeks##10##2##(1995-8#1)(2007-11#1)(2008-8#3)(2008-9#2)(2012-12#2)(2013-1#1)
40 were##2##2##(1994-11#1)(1994-9#1)
40 with##3##2##(1994-11#1)(2007-2#1)(2008-3#1)
40 women##2##2##(2008-3#1)(2012-3#1)
40 x 10(6)##2##3##(2008-10#1)(2008-11#1)
40 x##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
40 years ago##7##3##(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-1#1)(2013-1#1)
40 years and##2##3##(2011-2#2)
40 years of age##8##4##(1990-6#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
40 years of##10##3##(1990-6#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
40 years old##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
40 years##48##2##(1990-10#2)(1990-6#1)(1991-12#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2009-8#1)(2010-12#3)(2010-3#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
40 years)##2##2##(1994-9#1)(2012-3#1)
40##840##1##(1990-10#4)(1990-11#6)(1990-12#5)(1990-2#7)(1990-5#5)(1990-6#3)(1990-7#7)(1990-8#2)(1990-9#4)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#4)(1992-2#1)(1992-4#2)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#4)(1994-11#8)(1994-12#4)(1994-2#2)(1994-3#5)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#11)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#7)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#8)(1996-2#5)(1996-5#6)(1996-6#4)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#6)(2007-10#3)(2007-11#14)(2007-12#15)(2007-2#2)(2007-7#5)(2007-8#4)(2008-1#7)(2008-10#167)(2008-11#20)(2008-12#21)(2008-2#13)(2008-3#44)(2008-4#11)(2008-5#27)(2008-6#14)(2008-7#29)(2008-8#12)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#6)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#11)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#14)(2011-2#30)(2011-3#2)(2012-1#4)(2012-12#18)(2012-2#9)(2012-3#14)(2012-8#1)(2013-1#26)(2013-7#2)(2013-8#18)
40% (P &lt##2##3##(1995-12#1)(2008-5#1)
40% (v/v)##4##2##(2008-10#4)
40% and 50% of##2##4##(1990-7#1)(2008-5#1)
40% and 60% of maximal voluntary contraction##2##7##(2010-6#1)(2010-9#1)
40% and##16##2##(1990-7#2)(1991-12#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
40% at##3##2##(1992-6#1)(2008-5#1)(2008-6#1)
40% by##4##2##(1995-12#1)(2008-3#2)(2013-1#1)
40% cases##3##2##(1996-9#1)(2007-8#1)(2010-7#1)
40% for##4##2##(1990-6#1)(1991-5#1)(2008-3#1)(2008-6#1)
40% in the##4##3##(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)
40% in##15##2##(1994-9#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)
40% more##2##2##(2008-10#1)(2008-3#1)
40% of all##2##3##(1991-11#1)(2013-1#1)
40% of cases##6##3##(1991-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
40% of patients##7##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
40% of the baseline##2##4##(1991-9#1)(2008-7#1)
40% of the mothers##2##4##(1990-12#1)(1991-11#1)
40% of the patients with##2##5##(1995-5#1)(2008-7#1)
40% of the patients##4##4##(1995-5#1)(1997-6#1)(2008-5#1)(2008-7#1)
40% of the##28##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-6#1)(1997-6#1)(2007-5#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
40% of total##3##3##(1990-2#1)(1994-8#1)(2008-8#1)
40% of##69##2##(1990-12#1)(1990-2#2)(1991-11#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
40% reduction##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
40% to##3##2##(2007-10#1)(2008-11#1)(2009-5#1)
40% were##2##2##(2008-10#1)(2013-8#1)
40% when##2##2##(2008-3#1)(2011-2#1)
40%##227##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#3)(1991-12#3)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-8#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#2)(1996-9#2)(1997-3#3)(1997-6#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#28)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#16)(2008-4#4)(2008-5#11)(2008-6#6)(2008-7#10)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#7)(2013-8#3)
40%)##4##1##(1992-4#1)(2008-12#1)(2008-4#1)(2010-5#1)
40) and##2##2##(2008-4#1)(2013-1#1)
40) were studied##2##3##(2008-6#1)(2011-2#1)
40)##20##1##(1990-5#1)(1994-7#1)(1996-7#1)(1997-5#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
40+##6##1##(2008-9#6)
40- and##5##2##(1995-5#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-7#1)
40-##7##1##(1995-5#1)(1995-8#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-7#1)
40-1000##2##1##(2008-10#2)
40-2##4##1##(2008-10#1)(2010-11#1)(2010-2#2)
40-50##8##1##(1990-5#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
40-50% of##4##2##(2007-7#1)(2008-10#1)(2008-9#2)
40-50%##7##1##(1990-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#2)
40-60##7##1##(1994-9#1)(1996-9#1)(2008-10#3)(2008-5#1)(2011-2#1)
40-60% of##2##2##(2008-6#1)(2008-7#1)
40-60%##4##1##(1994-8#1)(2007-7#1)(2008-6#1)(2008-7#1)
40-70%##2##1##(1997-2#1)(1997-7#1)
40-Gbit/s##2##1##(2007-11#2)
40-MHz##2##1##(2007-12#1)(2008-2#1)
40-fold##5##1##(1994-5#1)(1997-2#2)(2008-10#2)
40-kDa protein##2##2##(1993-9#1)(1995-2#1)
40-kDa##14##1##(1993-1#1)(1993-11#1)(1993-9#4)(1995-2#1)(1995-5#3)(1997-1#4)
40-m##2##1##(1994-9#1)(2008-3#1)
40-ps##2##1##(2007-11#1)(2007-12#1)
40-s##2##1##(2008-12#1)(2008-2#1)
40-year##4##1##(1994-11#2)(2010-11#1)(2012-12#1)
40-year-old male##2##2##(1996-9#1)(2012-2#1)
40-year-old man##2##2##(2008-6#1)(2008-7#1)
40-year-old woman with##2##3##(2007-5#1)(2008-7#1)
40-year-old woman##7##2##(1991-6#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)(2013-7#1)
40-year-old##17##1##(1991-6#1)(1996-9#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#3)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
40/40+##2##1##(2008-9#2)
40/min##2##1##(1994-11#1)(2008-9#1)
400 Da##2##2##(1994-12#1)(1995-5#1)
400 IU##2##2##(1991-11#1)(2008-12#1)
400 MHz##4##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
400 and 800 mg/L females##4##5##(2008-9#4)
400 and 800 mg/L males##2##5##(2008-9#2)
400 and 800 mg/L##6##4##(2008-9#6)
400 and 800##9##3##(2008-10#2)(2008-9#7)
400 and##17##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#7)(2010-5#1)
400 cm(-1)##2##2##(2007-12#1)(2013-8#1)
400 degrees C and##2##4##(1995-6#1)(2009-2#1)
400 degrees C##6##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-2#1)
400 fattening pigs##2##3##(1990-3#2)
400 lx##2##2##(2008-10#1)(2008-3#1)
400 m##2##2##(2008-3#1)(2013-1#1)
400 mOsm##3##2##(2008-11#3)
400 mOsmol kg-1##2##3##(2008-11#2)
400 mV##2##2##(2008-10#2)
400 mW##2##2##(2007-11#1)(2008-2#1)
400 mg##8##2##(1991-3#1)(1993-2#1)(1994-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
400 mg/L##2##2##(2008-9#2)
400 mg/day##3##2##(2007-8#1)(2008-1#2)
400 mg/kg to##2##3##(2008-8#1)(2008-9#1)
400 mg/kg##6##2##(2008-10#1)(2008-8#1)(2008-9#2)(2010-3#2)
400 mg/kg)##2##2##(2010-3#1)(2012-2#1)
400 microg/day##2##2##(2007-11#2)
400 micrograms##4##2##(1991-3#1)(1992-2#1)(1992-8#1)(1995-12#1)
400 million years of evolution##2##5##(1994-11#1)(2009-8#1)
400 million years##3##3##(1994-11#1)(2009-8#2)
400 million##5##2##(1994-11#1)(1996-2#1)(2009-8#2)(2012-12#1)
400 ml##2##2##(2008-10#1)(2010-4#1)
400 mm##2##2##(2008-2#1)(2008-3#1)
400 ng/ml##3##2##(1992-11#1)(1992-3#1)(1993-2#1)
400 nm after##2##3##(2008-10#1)(2010-1#1)
400 nm##19##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-1#1)
400 nm)##3##2##(1994-8#1)(2008-10#1)(2010-1#1)
400 nmol##2##2##(1993-2#1)(2008-10#1)
400 patients##5##2##(2007-12#1)(2008-5#1)(2008-8#1)(2010-3#2)
400 times lower than the##2##5##(1990-8#1)(2008-10#1)
400 times##5##2##(1990-8#1)(2008-10#4)
400 to 800##2##3##(2008-10#1)(2008-3#1)
400 to##15##2##(1990-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)
400##280##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#7)(1992-6#1)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#2)(1993-2#3)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#5)(2007-11#10)(2007-12#12)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#49)(2008-11#11)(2008-12#3)(2008-2#8)(2008-3#16)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#20)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-3#6)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
400% in the##2##3##(2008-2#1)(2008-7#1)
400%##5##1##(1992-9#1)(2008-10#2)(2008-2#1)(2008-7#1)
400-500##2##1##(1992-12#1)(2008-10#1)
400-700nm##2##1##(2008-10#1)(2013-1#1)
400-fold##3##1##(1994-11#1)(1995-2#1)(2008-7#1)
400-fs##2##1##(2007-11#1)(2008-2#1)
400-mum core-diameter optical##2##3##(2008-3#2)
4000##21##1##(1992-11#1)(1994-9#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2010-2#3)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
4000)##2##1##(1990-11#1)(2008-11#1)
400nm##3##1##(2008-10#3)
401##6##1##(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
401(K)##4##1##(2011-2#4)
401(k) account balance##2##3##(2011-2#2)
401(k) account##3##2##(2011-2#3)
401(k) participants##3##2##(2011-2#3)
401(k) plan##2##2##(2008-4#1)(2011-2#1)
401(k)##16##1##(2008-4#1)(2011-2#15)
402 women##2##2##(2011-1#2)
402##7##1##(1991-2#1)(1992-12#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-1#2)
403##4##1##(1992-8#1)(1996-12#1)(2007-11#1)(2008-1#1)
404##8##1##(1991-3#1)(1992-2#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)
405 nm##2##2##(2007-11#1)(2013-8#1)
405 to##2##2##(2008-2#1)(2013-1#1)
405##10##1##(1993-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
406##2##1##(1991-9#1)(2010-7#1)
407##8##1##(1990-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2013-8#1)
408 and##2##2##(1993-9#1)(2008-10#1)
408##7##1##(1993-2#1)(1993-9#1)(1995-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-2#1)
409##8##1##(1993-11#1)(2008-10#2)(2009-2#1)(2010-4#1)(2012-3#2)(2013-8#1)
40mM##2##1##(2008-10#2)
40mg##5##1##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
40min##3##1##(2008-10#1)(2010-4#2)
40ml##2##1##(2008-10#2)
40mul of##2##2##(2008-10#2)
40s##4##1##(1992-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
40th##2##1##(2008-7#1)(2011-1#1)
41 +/- 0##2##3##(1992-3#1)(2008-12#1)
41 +/-##5##2##(1992-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)
41 and##10##2##(1991-8#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-8#1)
41 cases##4##2##(1990-2#1)(1990-8#1)(2007-11#1)(2010-3#1)
41 children and##2##3##(1995-8#1)(1996-1#1)
41 children##3##2##(1995-8#1)(1996-1#1)(2013-1#1)
41 degrees##2##2##(1994-12#1)(1995-12#1)
41 for##2##2##(2008-10#1)(2009-8#1)
41 hpm##2##2##(2013-1#2)
41 kDa##3##2##(1994-6#2)(2008-10#1)
41 minutes##2##2##(2007-7#1)(2013-1#1)
41 nm##4##2##(2008-8#2)(2010-11#1)(2013-8#1)
41 of##2##2##(1994-11#1)(2008-10#1)
41 patients with##6##3##(1990-12#1)(1990-2#1)(1990-6#1)(1996-11#1)(2007-10#1)(2008-5#1)
41 patients##12##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-8#1)(1993-8#1)(1996-11#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)
41 races##2##2##(2008-10#2)
41 to##5##2##(1993-8#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-6#1)
41 weeks##15##2##(2008-9#14)(2011-1#1)
41 were##2##2##(2008-10#1)(2011-2#1)
41 years##2##2##(2012-2#1)(2012-3#1)
41##243##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#8)(1993-9#1)(1994-11#1)(1994-12#4)(1994-6#4)(1994-7#1)(1994-9#2)(1995-12#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-7#7)(2007-8#3)(2008-1#6)(2008-10#43)(2008-11#7)(2008-12#5)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#15)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#12)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#2)
41% and##2##2##(1995-2#1)(2011-2#1)
41% at##2##2##(2008-7#1)(2010-3#1)
41% in##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
41% of the##7##3##(1992-2#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)
41% of##9##2##(1992-2#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
41% within##2##2##(1995-2#1)(1996-2#1)
41%##43##1##(1990-2#1)(1991-8#1)(1992-2#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-2#1)(2007-11#2)(2008-1#2)(2008-10#10)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
41%) and##2##2##(2008-10#2)
41%)##4##1##(2008-10#2)(2008-6#1)(2008-9#1)
41) and##3##2##(1991-3#1)(2009-5#2)
41)##12##1##(1991-3#1)(1993-12#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-3#1)(2011-2#2)
41-##2##1##(1995-11#1)(2007-2#1)
41-year-old female patient##2##3##(1993-6#1)(2008-12#1)
41-year-old female##3##2##(1993-6#1)(2008-12#1)(2012-3#1)
41-year-old##11##1##(1993-6#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-7#1)(2012-1#1)(2012-3#2)(2013-1#1)
410 nm##4##2##(1990-11#1)(1993-2#1)(2008-10#2)
410##14##1##(1990-11#1)(1993-2#1)(1994-11#1)(1996-11#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2011-2#1)
410)##2##1##(1996-2#1)(2013-7#1)
4109##2##1##(1990-11#2)
411 nm##2##2##(2007-12#1)(2008-10#1)
411 or keoxifene##2##3##(1992-5#2)
411##13##1##(1992-5#7)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-7#1)
4111##2##1##(2008-1#1)(2008-3#1)
412 demented patients##2##3##(2008-7#2)
412##9##1##(1990-11#1)(2008-3#2)(2008-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2013-8#1)
413##4##1##(1993-11#2)(2007-10#1)(2012-12#1)
414##9##1##(1992-10#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#2)
414)##2##1##(2008-10#1)(2009-9#1)
415 and##2##2##(2008-10#1)(2008-2#1)
415##12##1##(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
415nm##2##1##(2008-10#2)
416##7##1##(1991-6#1)(1992-3#1)(1996-8#1)(2008-5#2)(2011-1#2)
417##6##1##(1991-6#1)(1995-2#1)(1997-8#1)(2008-8#1)(2011-2#2)
418##7##1##(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-2#1)(2011-2#2)
419##8##1##(1990-12#1)(1991-2#1)(1995-2#4)(2008-10#1)(2008-7#1)
41st week##2##2##(2011-1#2)
41st##3##1##(2008-7#1)(2011-1#2)
42 %##2##2##(2008-5#1)(2012-12#1)
42 (p##2##2##(2008-1#1)(2008-3#1)
42 +/- 0##4##3##(1990-3#1)(1996-2#1)(1996-9#1)(2008-12#1)
42 +/-##7##2##(1990-3#1)(1996-2#1)(1996-9#1)(1997-1#1)(2008-12#1)(2008-3#1)(2011-2#1)
42 V##2##2##(1990-5#1)(2008-10#1)
42 and##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
42 cases##3##2##(1990-9#1)(2008-7#1)(2012-2#1)
42 children##2##2##(1994-3#1)(1996-9#1)
42 days##7##2##(1991-2#1)(2008-10#4)(2008-7#1)(2013-1#1)
42 degrees C for##2##4##(2008-10#2)
42 degrees C##9##3##(1990-11#1)(1991-5#1)(1994-12#3)(2008-10#2)(2008-5#1)(2010-5#1)
42 degrees C)##2##3##(2008-10#1)(2008-5#1)
42 degrees##13##2##(1990-11#1)(1991-5#1)(1994-12#3)(2008-10#3)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)
42 exhibited##2##2##(1994-5#1)(2008-10#1)
42 for##3##2##(1996-5#1)(2008-10#2)
42 h##2##2##(1990-5#1)(2008-10#1)
42 health##2##2##(1990-3#1)(1991-2#1)
42 in##6##2##(1995-5#1)(1996-5#3)(2008-9#1)(2010-2#1)
42 isolates of##2##3##(2008-10#2)
42 isolates##3##2##(2008-10#3)
42 kDa##2##2##(1994-11#1)(2008-11#1)
42 mm##3##2##(2007-11#1)(2009-7#1)(2013-1#1)
42 months##3##2##(1992-8#1)(2007-11#1)(2008-5#1)
42 mug l(-1)##2##3##(2008-10#2)
42 mum##2##2##(2008-10#1)(2008-3#1)
42 of##2##2##(1991-3#1)(1995-8#1)
42 patients with gross cystic disease##2##6##(1994-7#2)
42 patients with##7##3##(1990-3#1)(1990-9#1)(1992-6#1)(1994-7#2)(2008-7#1)(2013-1#1)
42 patients##19##2##(1990-3#1)(1990-9#1)(1992-6#1)(1994-7#2)(2007-10#1)(2007-11#1)(2007-8#2)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#3)(2013-1#2)(2013-8#2)
42 species##3##2##(1995-12#1)(1996-5#1)(2008-9#1)
42 to##6##2##(2007-11#2)(2008-10#2)(2011-2#2)
42 was##2##2##(1996-5#2)
42 weeks##5##2##(1993-3#1)(2008-9#4)
42 were##2##2##(2008-5#1)(2011-2#1)
42 year old##2##3##(1994-8#1)(2011-2#1)
42 year##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
42 years##4##2##(1992-5#1)(2007-8#2)(2013-1#1)
42##321##1##(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#4)(1990-5#2)(1990-6#2)(1990-9#2)(1991-11#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#3)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-8#4)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#7)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#1)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#7)(2008-10#60)(2008-11#8)(2008-12#8)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#9)(2009-7#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#7)(2011-2#23)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#5)
42% and##4##2##(1997-1#1)(1997-7#1)(2008-3#2)
42% for##2##2##(2008-10#2)
42% identity with##3##3##(1992-3#1)(1993-2#1)(2008-10#1)
42% identity##4##2##(1992-3#1)(1993-2#1)(1994-8#1)(2008-10#1)
42% in##5##2##(1991-6#1)(1993-5#1)(1995-3#1)(2008-10#1)(2008-2#1)
42% of patients##2##3##(2008-9#1)(2013-1#1)
42% of the##5##3##(1995-11#1)(2008-10#3)(2013-8#1)
42% of##14##2##(1994-2#1)(1995-11#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
42% were##3##2##(1993-2#1)(2007-7#1)(2013-1#1)
42%##60##1##(1990-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#5)(2013-7#1)(2013-8#3)
42%)##2##1##(2007-7#1)(2009-9#1)
42)##16##1##(1991-5#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
42-55##2##1##(1992-3#1)(1992-4#1)
42-day rounds of pregnancy/lactation (PL mice)##3##6##(1997-4#3)
42-year-old man with no##2##4##(2012-3#1)(2013-8#1)
42-year-old man with##3##3##(1991-5#1)(2012-3#1)(2013-8#1)
42-year-old man##4##2##(1991-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
42-year-old##8##1##(1991-5#1)(1991-6#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
420 and##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
420 nm and##2##3##(2008-2#2)
420 nm##10##2##(1991-3#1)(2008-10#6)(2008-2#2)(2009-11#1)
420 to##2##2##(1994-8#1)(1995-2#1)
420##30##1##(1990-3#1)(1991-3#2)(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)
421##5##1##(1991-8#1)(1993-2#1)(2009-12#1)(2011-1#1)(2013-1#1)
42112A##4##1##(1991-12#4)
422##5##1##(1993-2#1)(2010-11#1)(2011-2#1)(2013-1#2)
422)##2##1##(2008-7#1)(2012-3#1)
423 nm##3##2##(2008-10#1)(2008-3#2)
423##11##1##(1991-12#1)(1993-2#1)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)
424 bp##2##2##(1993-8#2)
424##6##1##(1991-11#1)(1993-8#2)(1994-8#1)(2008-5#1)(2010-9#1)
425 nm##3##2##(2008-10#3)
425##11##1##(1992-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
426 nm##3##2##(2007-12#1)(2008-3#2)
426##13##1##(1996-6#1)(1996-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
426)##2##1##(2013-1#1)(2013-8#1)
427##8##1##(1994-9#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-2#1)(2012-3#1)
428##6##1##(1995-12#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
429##9##1##(1992-3#1)(1996-8#2)(1997-2#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
4297/najms##2##1##(2012-3#2)
42mm##2##1##(2008-10#2)
42mmolg(-1) for##2##2##(2008-10#2)
42nd Street##2##2##(2008-8#2)
42nd##5##1##(1993-6#1)(2008-11#1)(2008-8#3)
43 +/- 0##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)
43 +/-##7##2##(1990-7#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-3#1)
43 U/mg##2##2##(1995-8#2)
43 and##5##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
43 cases##2##2##(1993-9#1)(2008-12#1)
43 days##3##2##(2008-11#2)(2008-12#1)
43 degrees C##11##3##(1995-12#1)(2008-11#1)(2008-12#8)(2010-5#1)
43 degrees##12##2##(1992-8#1)(1995-12#1)(2008-11#1)(2008-12#8)(2010-5#1)
43 episodes##2##2##(1993-1#1)(2012-3#1)
43 g##2##2##(2008-10#2)
43 in the##2##3##(1994-11#1)(2008-1#1)
43 in##3##2##(1994-11#1)(1995-12#1)(2008-1#1)
43 kD##2##2##(1993-3#2)
43 kDa##5##2##(1991-12#2)(1996-6#1)(2009-7#1)(2010-12#1)
43 kb##2##2##(1996-3#1)(2008-10#1)
43 mg##2##2##(1993-2#1)(2008-10#1)
43 microm##2##2##(2007-12#2)
43 mm##2##2##(2011-2#1)(2012-3#1)
43 months##4##2##(1991-3#1)(1993-11#1)(1994-11#1)(2008-5#1)
43 patients with##3##3##(1991-5#1)(2007-10#1)(2008-7#1)
43 patients##8##2##(1991-4#1)(1991-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-7#3)
43 pg/mL##2##2##(2011-1#2)
43 to##7##2##(1991-5#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-3#1)
43 weeks##14##2##(2008-9#14)
43 women##2##2##(1990-11#1)(2007-11#1)
43 x##2##2##(2008-10#1)(2008-3#1)
43 years (range##2##3##(2007-7#1)(2008-9#1)
43 years##6##2##(1991-8#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
43##235##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-6#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-8#3)(1995-9#2)(1996-3#2)(1996-5#1)(1996-6#3)(1997-3#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#32)(2008-11#9)(2008-12#15)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#21)(2009-11#1)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#7)(2012-5#1)(2013-1#6)(2013-8#3)
43% and##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
43% compared to##2##3##(1995-12#1)(2012-3#1)
43% compared##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
43% in##4##2##(1997-6#1)(2008-10#2)(2010-12#1)
43% of the##5##3##(1993-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2013-8#1)
43% of##11##2##(1990-6#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
43%##48##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
43%)##3##1##(2007-8#1)(2011-2#1)(2013-8#1)
43) and##4##2##(1994-3#1)(2008-10#1)(2008-12#2)
43)##18##1##(1991-2#1)(1992-6#1)(1994-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-12#1)(2013-1#1)
43-kDa##2##1##(1990-5#1)(1991-9#1)
43-year-old man##3##2##(2007-12#1)(2008-1#1)(2010-7#1)
43-year-old woman##3##2##(1995-3#1)(1996-11#1)(2007-10#1)
43-year-old##11##1##(1991-6#1)(1995-3#1)(1996-11#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-7#1)(2013-8#1)
430 nm##5##2##(2007-11#2)(2008-10#3)
430##21##1##(1994-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
432##4##1##(1997-6#1)(2008-10#2)(2008-3#1)
433 GPs##2##2##(2007-2#2)
433##5##1##(1995-8#1)(2007-2#2)(2008-11#1)(2011-2#1)
434 and##3##2##(2008-10#1)(2011-2#2)
434 repressor##5##2##(1990-5#1)(2008-8#4)
434##16##1##(1990-5#2)(1990-6#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-8#5)(2011-2#3)
4343##2##1##(2008-3#1)(2013-8#1)
435##19##1##(1990-11#1)(1991-1#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#2)
436 nm##2##2##(2008-10#1)(2013-8#1)
436##4##1##(1997-6#1)(2008-10#2)(2013-8#1)
437##3##1##(2008-10#2)(2011-2#1)
438##9##1##(1990-11#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
439 patients##2##2##(1990-8#1)(2008-11#1)
439##5##1##(1990-8#1)(1995-1#1)(2007-12#1)(2008-11#1)(2010-8#1)
43K+ and##2##2##(1992-11#2)
43K+##4##1##(1992-11#4)
43rd##2##1##(1993-11#1)(2007-1#1)
44 %##3##2##(1997-8#1)(2007-11#1)(2012-2#1)
44 +/- 0##3##3##(1992-6#1)(2011-2#1)(2013-1#1)
44 +/-##6##2##(1992-6#1)(1995-3#1)(2007-7#1)(2008-3#1)(2011-2#1)(2013-1#1)
44 Hz##3##2##(2008-2#3)
44 and 0##3##3##(1997-4#1)(1997-8#1)(2008-10#1)
44 and##11##2##(1992-6#1)(1993-8#2)(1996-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#4)
44 cases##3##2##(1990-12#1)(1994-12#1)(2013-8#1)
44 degrees##3##2##(2008-2#2)(2013-8#1)
44 for##5##2##(1992-6#1)(1995-11#1)(2008-10#3)
44 in##5##2##(1991-7#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)
44 keV##2##2##(2008-3#2)
44 mg kg(-1))##2##3##(2008-12#2)
44 patients who were##2##4##(2008-7#1)(2013-1#1)
44 patients##9##2##(1990-2#1)(1991-8#2)(1993-9#1)(1994-6#1)(2008-12#1)(2008-7#1)(2013-1#2)
44 to##4##2##(2008-10#3)(2010-11#1)
44 years##5##2##(1990-12#1)(1991-9#1)(2008-6#1)(2010-4#1)(2011-2#1)
44##208##1##(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-5#1)(1992-6#7)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-11#2)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#3)(2008-12#6)(2008-2#9)(2008-3#7)(2008-5#5)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#5)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#7)
44% and##6##2##(1990-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
44% had##2##2##(2008-10#1)(2008-4#1)
44% of the##13##3##(1990-10#1)(1990-9#1)(1992-2#1)(1994-12#1)(1995-1#1)(2008-10#6)(2008-5#1)(2013-8#1)
44% of##19##2##(1990-10#1)(1990-9#1)(1992-2#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-2#1)(2008-10#6)(2008-5#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
44% were##2##2##(2008-10#1)(2013-1#1)
44%##61##1##(1990-10#1)(1990-11#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-10#2)(2007-9#1)(2008-10#15)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
44%)##6##1##(1994-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
44) and##2##2##(1991-2#1)(2008-5#1)
44)##10##1##(1991-2#1)(1994-3#1)(2008-10#2)(2008-5#3)(2011-2#1)(2013-1#2)
44+/-0##3##1##(2008-10#3)
44-0##2##1##(1990-7#1)(2013-1#1)
44-year-old female##2##2##(2012-3#1)(2013-7#1)
44-year-old##13##1##(1994-9#1)(1996-3#1)(2007-8#2)(2008-12#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
440 K##2##2##(2008-10#2)
440 mOsmol kg-1##2##3##(2008-11#2)
440 nm##9##2##(1990-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)
440##24##1##(1990-8#1)(1991-11#1)(1993-3#1)(1996-11#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-8#1)(2009-9#1)(2010-8#2)(2011-2#1)(2013-8#1)
4400##2##1##(1997-6#1)(2008-12#1)
440nm##3##1##(2008-10#3)
441##5##1##(2008-2#1)(2008-3#2)(2010-11#1)(2013-1#1)
442##8##1##(1995-5#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)
443##10##1##(1995-12#1)(1995-2#1)(1997-7#1)(2008-2#3)(2008-3#2)(2009-2#1)(2010-11#1)
444##8##1##(1991-8#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-3#1)
445##3##1##(1992-12#1)(2007-7#1)(2008-7#1)
447##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
448 nm##2##2##(2008-10#2)
448##8##1##(2008-10#3)(2008-5#1)(2008-9#1)(2010-3#1)(2013-8#2)
449##6##1##(1994-11#1)(2008-10#1)(2011-1#2)(2012-2#1)(2013-7#1)
45 %##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
45 +/- 0##4##3##(1993-6#1)(1994-12#1)(2008-3#1)(2011-2#1)
45 +/-##5##2##(1993-6#1)(1994-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
45 Chinese herbs##3##3##(2008-10#3)
45 and 0##4##3##(1992-6#1)(1995-12#1)(2008-2#1)(2009-3#1)
45 and 60##2##3##(1991-3#1)(2008-12#1)
45 and 65 years##3##4##(1993-9#1)(2008-5#1)(2009-11#1)
45 and##23##2##(1990-5#1)(1991-11#1)(1991-3#1)(1992-6#1)(1993-9#1)(1995-11#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#2)(2010-2#1)(2011-2#1)(2013-1#1)
45 cases##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#1)
45 cm##5##2##(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)
45 consecutive##2##2##(2007-10#1)(2013-1#1)
45 d##2##2##(2008-11#2)
45 days##9##2##(1990-3#1)(2008-10#4)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
45 degrees C and##4##4##(1997-2#1)(2008-10#3)
45 degrees C for##9##4##(1994-8#2)(2008-10#2)(2008-5#2)(2008-6#1)(2010-4#2)
45 degrees C##31##3##(1994-8#2)(1997-2#1)(2008-10#16)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#3)(2010-4#2)(2011-1#1)
45 degrees and##3##3##(2008-2#1)(2011-2#2)
45 degrees of abduction##2##4##(2008-8#1)(2011-2#1)
45 degrees to##2##3##(2007-11#1)(2008-7#1)
45 degrees##63##2##(1994-8#2)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#18)(2008-12#3)(2008-2#6)(2008-3#10)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-3#1)
45 families##2##2##(1995-1#1)(2008-6#1)
45 from##2##2##(2008-10#1)(2008-3#1)
45 h##2##2##(1993-12#1)(2007-8#1)
45 kDa##6##2##(1991-8#1)(1992-3#1)(1993-1#2)(1993-3#1)(2008-4#1)
45 m##2##2##(2008-5#1)(2010-8#1)
45 mg##2##2##(2008-9#2)
45 min after##2##3##(1995-3#1)(2010-11#1)
45 min##21##2##(1990-12#1)(1991-5#1)(1993-1#1)(1994-11#2)(1994-9#1)(1995-3#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
45 min)##3##2##(1997-7#1)(2008-11#2)
45 minutes after dosing and remained in that range for##2##10##(2012-12#2)
45 minutes after##3##3##(2008-5#1)(2012-12#2)
45 minutes##5##2##(2008-5#1)(2010-6#1)(2012-12#2)(2013-8#1)
45 mug l(-1)##2##3##(2008-10#2)
45 mug##3##2##(2008-10#3)
45 mum##2##2##(2008-2#1)(2008-5#1)
45 mumol##2##2##(2008-10#2)
45 ng##2##2##(2008-10#2)
45 nm in diameter##3##4##(1994-3#1)(1997-8#1)(2008-10#1)
45 of##6##2##(1993-11#1)(1993-2#1)(1994-1#2)(2009-3#1)(2013-8#1)
45 patients were##2##3##(2007-7#1)(2012-3#1)
45 patients with##5##3##(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
45 patients##17##2##(1990-3#1)(1991-11#1)(1992-5#1)(1992-9#1)(1996-11#1)(1996-3#2)(1996-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
45 s##4##2##(1995-12#1)(2008-10#3)
45 samples per hour##2##4##(2008-10#2)
45 samples per##3##3##(2008-10#3)
45 samples##4##2##(2008-10#3)(2008-12#1)
45 to 1##2##3##(1995-9#1)(2008-2#1)
45 to##19##2##(1991-5#1)(1992-11#1)(1992-2#1)(1993-3#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
45 vs##2##2##(1991-7#1)(1996-2#1)
45 was##2##2##(1991-12#1)(2008-7#1)
45 weeks##2##2##(1991-6#1)(2007-8#1)
45 were##2##2##(2008-10#1)(2008-9#1)
45 years and##2##3##(1990-12#1)(2012-2#1)
45 years of age##3##4##(2011-1#1)(2013-8#2)
45 years##15##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-1#1)(1997-4#1)(2008-7#1)(2010-3#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
45 years)##3##2##(2008-1#2)(2008-11#1)
45 ±##3##2##(2011-1#1)(2013-1#1)(2013-8#1)
45##474##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#6)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#12)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#7)(2008-1#9)(2008-10#94)(2008-11#12)(2008-12#13)(2008-2#11)(2008-3#22)(2008-4#3)(2008-5#14)(2008-6#7)(2008-7#18)(2008-8#6)(2008-9#15)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#7)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#23)(2011-3#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#18)(2013-7#1)(2013-8#10)
45% and##6##2##(1990-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#2)
45% for##3##2##(2008-10#2)(2008-8#1)
45% had##2##2##(1992-6#1)(1996-8#1)
45% in##4##2##(1992-11#1)(1992-12#1)(1997-4#1)(2008-3#1)
45% of patients##2##3##(2012-3#1)(2013-8#1)
45% of the total##2##4##(2008-10#1)(2008-8#1)
45% of the##6##3##(1991-2#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
45% of##17##2##(1991-2#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
45% with##3##2##(2007-10#1)(2008-3#1)(2013-1#1)
45%##77##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#3)(2007-10#1)(2007-12#2)(2007-7#3)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
45%)##4##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
45) and##2##2##(2008-6#1)(2011-2#1)
45)##17##1##(1990-5#1)(1990-6#1)(1991-2#1)(1992-8#2)(1996-2#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2011-2#3)(2013-1#1)(2013-8#1)
45+/-0##4##1##(2008-10#3)(2009-12#1)
45- and##2##2##(1992-9#1)(2008-9#1)
45-0##3##1##(2008-3#1)(2009-4#1)(2013-7#1)
45-3##2##1##(2007-12#1)(2008-10#1)
45-50##2##1##(1995-6#1)(2008-10#1)
45-50% and##2##2##(2011-2#1)(2012-8#1)
45-59##2##1##(2008-2#1)(2008-3#1)
45-64##2##1##(1993-9#1)(2013-8#1)
45-aa##2##1##(1990-11#1)(1993-2#1)
45-fold##4##1##(1993-1#2)(1994-5#1)(2011-2#1)
45-kDa catalytic fragment of PKC alpha##2##6##(1995-11#2)
45-kDa protein##3##2##(1991-8#1)(1993-12#1)(1994-11#1)
45-kDa##8##1##(1990-12#1)(1991-8#1)(1993-1#1)(1993-12#1)(1994-11#1)(1995-11#2)(1995-6#1)
45-min##2##1##(2013-1#2)
45-year-old man##3##2##(2007-12#1)(2010-5#1)(2013-8#1)
45-year-old woman##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
45-year-old##11##1##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
450 W##2##2##(2008-10#2)
450 bp##2##2##(1995-8#1)(1996-6#1)
450 g of kenkey##2##4##(1997-4#2)
450 g of##3##3##(1997-4#2)(2010-2#1)
450 g##4##2##(1997-4#2)(2010-2#1)(2012-2#1)
450 kDa##3##2##(1990-5#1)(1995-11#1)(1996-2#1)
450 ng ml(-1)##3##3##(2008-11#3)
450 nm##7##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)
450##63##1##(1990-2#1)(1990-5#1)(1991-2#1)(1992-1#1)(1993-8#3)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
4500)##2##1##(1990-11#1)(1991-2#1)
450nm##4##1##(2008-10#3)(2013-1#1)
451##5##1##(1997-4#1)(2007-2#1)(2009-5#2)(2009-9#1)
452##6##1##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
453##8##1##(1993-8#1)(1994-12#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-5#1)
454##10##1##(1990-12#1)(1995-6#1)(1997-3#1)(2007-7#1)(2008-9#1)(2011-2#3)(2013-8#2)
454-sequencing##2##1##(2012-2#2)
455##5##1##(2008-11#3)(2009-5#1)(2011-2#1)
456##4##1##(2008-12#2)(2011-1#1)(2012-3#1)
457##7##1##(1994-12#1)(2007-7#1)(2008-11#1)(2010-5#2)(2011-2#1)(2013-8#1)
458 nm##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
458##7##1##(1996-10#1)(2007-11#2)(2008-10#2)(2008-9#1)(2011-2#1)
459##7##1##(1992-3#1)(1993-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
459+1G &gt##2##2##(1997-3#2)
45Ca and##2##2##(1995-3#2)
45Ca efflux##5##2##(1990-2#5)
45Ca fluxes##2##2##(1993-3#2)
45Ca release##3##2##(1995-3#3)
45Ca uptake##5##2##(1993-3#4)(1995-5#1)
45Ca##22##1##(1990-2#6)(1993-3#8)(1993-6#1)(1995-3#6)(1995-5#1)
45Ca2+ uptake and##2##3##(1995-11#2)
45Ca2+ uptake in##3##3##(1990-7#2)(1997-1#1)
45Ca2+ uptake##11##2##(1990-7#2)(1992-11#1)(1994-5#1)(1995-11#2)(1997-1#5)
45Ca2+ was##3##2##(1997-2#3)
45Ca2+##18##1##(1990-12#1)(1990-7#2)(1992-11#1)(1994-11#1)(1994-5#1)(1995-11#2)(1996-5#1)(1997-1#5)(1997-2#4)
45Gy##2##1##(2008-10#2)
45S5 bioactive glass##2##3##(2008-5#1)(2009-7#1)
45S5 glass##2##2##(2008-5#2)
45S5##9##1##(2008-5#7)(2009-7#2)
45V##2##1##(2008-10#2)
45min##5##1##(2008-10#2)(2008-7#1)(2010-4#1)(2012-1#1)
45ngml(-1)##2##1##(2008-10#2)
45th Annual Meeting##2##3##(2008-10#2)
45th##3##1##(2008-10#2)(2008-7#1)
45°C##2##1##(2012-2#2)
45 Å##2##1##(2010-10#2)
46 +/- 0##5##3##(1993-1#1)(2008-3#1)(2008-8#1)(2013-1#2)
46 +/-##8##2##(1993-1#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-8#1)(2013-1#2)
46 V##2##2##(1990-5#1)(2008-10#1)
46 and##6##2##(1997-2#1)(2008-10#3)(2008-12#1)(2012-12#1)
46 degrees##2##2##(2008-2#1)(2010-5#1)
46 healthy##3##2##(1990-2#1)(2007-10#1)(2008-3#1)
46 in##2##2##(1994-8#1)(2008-3#1)
46 kD##2##2##(1990-11#2)
46 kDa##3##2##(1994-11#1)(1995-5#1)(2008-10#1)
46 mg##3##2##(2008-10#3)
46 nm##2##2##(2007-11#1)(2007-12#1)
46 patients were identified##2##4##(2008-6#1)(2012-3#1)
46 patients who##2##3##(1991-3#2)
46 patients with##5##3##(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(2011-1#1)
46 patients##17##2##(1990-2#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#1)(1997-3#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
46 to 0##2##3##(2008-10#1)(2010-4#1)
46 to 1##2##3##(2008-5#1)(2009-11#1)
46 to##7##2##(2008-10#2)(2008-5#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
46 were##2##2##(2007-10#1)(2008-10#1)
46 x##4##2##(2008-10#2)(2008-3#2)
46 years##5##2##(1990-6#1)(1992-4#1)(2012-12#2)(2013-1#1)
46##221##1##(1990-11#2)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#1)(1991-12#3)(1991-3#4)(1991-5#1)(1991-6#4)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#2)(1997-2#4)(1997-3#5)(1997-6#2)(2007-10#5)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#40)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#7)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#3)
46% and##2##2##(2007-11#1)(2008-10#1)
46% in##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
46% of the##7##3##(1993-11#1)(1993-12#1)(2008-10#2)(2008-12#1)(2010-4#1)(2013-8#1)
46% of##13##2##(1990-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(2008-10#5)(2008-12#1)(2010-12#1)(2010-4#1)(2013-8#1)
46%##45##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(2007-11#2)(2007-7#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#2)
46%)##3##1##(2008-10#2)(2011-2#1)
46(2)##2##1##(1997-7#2)
46)##12##1##(1990-6#1)(1991-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
46-2##2##1##(2013-1#1)(2013-7#1)
46-60-kDa component##2##2##(1995-6#2)
46-year-old male with##2##3##(2008-7#1)(2013-8#1)
46-year-old male##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
46-year-old man##4##2##(1996-6#1)(2007-10#1)(2008-12#1)(2008-9#1)
46-year-old##12##1##(1996-6#2)(2007-10#1)(2008-12#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
460 nm for##3##3##(2008-10#3)
460 nm##7##2##(2007-12#1)(2008-10#6)
460##23##1##(1991-12#1)(1993-8#1)(1995-2#2)(2007-12#1)(2007-7#2)(2008-10#9)(2008-11#1)(2008-3#3)(2009-3#1)(2011-2#2)
460-GHz##2##1##(2011-1#2)
460-nm light##2##2##(2007-11#2)
461##5##1##(1994-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
462##6##1##(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
463 and##2##2##(2008-10#1)(2008-12#1)
463##9##1##(2007-12#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
464 patients##2##2##(2007-10#2)
464##4##1##(2007-10#2)(2008-3#1)(2010-3#1)
465 nm##6##2##(1994-3#1)(1996-2#1)(2007-12#3)(2008-10#1)
465##14##1##(1990-8#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-5#2)(2013-1#1)
465-nm radiation##2##2##(2007-12#2)
4658##2##1##(2008-3#2)
466##6##1##(1990-5#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-7#1)
467##8##1##(1992-3#1)(1994-12#1)(1994-6#1)(2008-6#1)(2008-7#2)(2009-12#1)(2013-8#1)
468 nm)##2##2##(1995-5#1)(2008-10#1)
468##6##1##(1993-3#2)(1994-12#1)(1995-5#1)(1997-2#1)(2008-10#1)
469##13##1##(1990-3#2)(1992-12#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-10#3)(2008-11#2)(2009-7#1)(2011-2#1)
46mM##2##1##(2008-10#1)(2013-1#1)
47 (33##2##2##(2007-7#2)
47 +/- 0##3##3##(1994-3#1)(1994-5#1)(2013-1#1)
47 +/-##6##2##(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2008-3#1)(2013-1#1)
47 and 1##2##3##(1997-4#1)(2008-3#1)
47 and##8##2##(1990-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#2)(2013-8#1)
47 cases##3##2##(2007-11#1)(2007-8#1)(2008-12#1)
47 degrees C##5##3##(2007-10#1)(2008-10#3)(2010-5#1)
47 different##2##2##(2008-10#1)(2013-8#1)
47 mmol/l) are &quot##2##4##(1990-2#2)
47 mmol/l)##3##2##(1990-2#3)
47 nM)##2##2##(1993-6#1)(1996-5#1)
47 patients with##2##3##(1991-8#1)(2013-1#1)
47 patients##10##2##(1991-8#1)(1992-5#1)(1993-9#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
47 to##6##2##(1992-3#1)(1993-12#1)(1994-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
47 women##2##2##(1990-11#1)(2007-8#1)
47 years##3##2##(2009-12#1)(2011-2#2)
47##187##1##(1990-11#1)(1990-2#5)(1990-3#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#3)(1995-6#3)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#8)(2007-4#1)(2007-7#5)(2007-8#7)(2008-1#3)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#6)
47% in the##2##3##(1990-2#1)(2008-11#1)
47% in##5##2##(1990-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
47% of the##7##3##(1990-8#1)(1992-6#1)(1994-9#1)(2008-1#1)(2008-10#2)(2013-8#1)
47% of##16##2##(1990-6#1)(1990-8#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
47% was##2##2##(2008-10#1)(2010-4#1)
47%##54##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1992-1#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-9#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-10#4)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
47%)##6##1##(1990-6#1)(2007-7#2)(2008-10#1)(2011-2#1)(2013-8#1)
47)##9##1##(1996-9#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)
47-year-old##4##1##(2008-6#1)(2009-9#1)(2013-1#1)(2013-8#1)
470 K##2##2##(2008-3#2)
470 and##2##2##(1997-7#1)(2008-10#1)
470 nm##10##2##(1997-2#1)(2008-10#7)(2008-11#2)
470##27##1##(1992-9#1)(1993-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
470nm##5##1##(2008-10#5)
471##3##1##(2008-10#1)(2008-7#1)(2009-5#1)
472##6##1##(1991-2#1)(1992-12#1)(1994-9#1)(2007-10#1)(2008-10#1)(2008-3#1)
473 K##2##2##(2008-3#2)
473##7##1##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
474##8##1##(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
475 nm##6##2##(2008-10#4)(2008-2#1)(2013-8#1)
475##13##1##(1990-2#1)(1992-12#1)(1993-2#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-8#1)(2013-8#2)
476 patients##2##2##(1993-6#1)(2008-7#1)
476##7##1##(1993-6#1)(1996-10#1)(2008-5#1)(2008-7#2)(2012-3#1)(2012-6#1)
477##4##1##(1993-11#1)(1997-7#1)(2010-8#1)(2012-3#1)
478##4##1##(1996-12#1)(2008-10#2)(2008-2#1)
4780 and##2##2##(2008-10#2)
4780##7##1##(2008-10#7)
479##8##1##(1991-12#1)(1991-8#1)(1993-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2013-1#1)
47]##2##1##(2007-8#1)(2012-2#1)
48 (95% CI##2##3##(2008-6#1)(2013-1#1)
48 +/- 0##4##3##(1990-2#1)(1992-3#1)(1996-2#1)(2007-8#1)
48 +/- 1##2##3##(1990-8#1)(2009-8#1)
48 +/-##9##2##(1990-2#1)(1990-8#1)(1992-3#1)(1993-12#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-8#1)
48 and 0##3##3##(2007-3#1)(2008-10#1)(2008-2#1)
48 and 1##2##3##(2008-10#1)(2008-4#1)
48 and 72 h##3##4##(1996-12#1)(2008-10#2)
48 and 72##5##3##(1993-8#1)(1996-12#1)(2008-10#2)(2008-5#1)
48 and##15##2##(1993-8#1)(1994-11#1)(1996-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)
48 cases##5##2##(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#2)
48 cells##2##2##(1994-6#2)
48 children##2##2##(2007-8#1)(2012-2#1)
48 cosmetics##2##2##(2008-5#2)
48 days##4##2##(1994-6#3)(2013-8#1)
48 degrees C##6##3##(1994-12#1)(1995-8#2)(2008-3#1)(2011-2#1)(2013-1#1)
48 degrees##8##2##(1994-12#1)(1995-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
48 for##2##2##(2008-10#2)
48 h after inoculation##6##4##(2008-10#6)
48 h after##16##3##(1990-6#1)(1992-12#1)(1992-3#1)(1996-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-7#1)(2010-5#1)(2012-3#1)
48 h and##6##3##(1995-3#1)(1996-12#1)(2008-10#3)(2008-12#1)
48 h in##3##3##(1991-2#1)(2008-10#2)
48 h later##2##3##(1993-12#1)(1993-5#1)
48 h of inoculation##2##4##(2008-10#2)
48 h of##16##3##(1992-6#1)(1995-12#1)(1996-2#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)
48 h on##2##3##(2008-10#1)(2013-1#1)
48 h prior to##3##4##(2008-10#3)
48 h##105##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-3#1)(1996-12#3)(1996-2#1)(2007-2#1)(2007-8#2)(2008-10#40)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
48 h)##5##2##(1991-3#2)(2008-10#1)(2008-11#1)(2010-2#1)
48 hours after##5##3##(1992-4#1)(2007-10#1)(2008-9#1)(2010-12#1)(2012-12#1)
48 hours and##2##3##(2007-10#1)(2013-8#1)
48 hours in##2##3##(1994-6#1)(2007-8#1)
48 hours of##7##3##(1994-6#1)(2007-10#3)(2011-2#1)(2012-12#1)(2013-1#1)
48 hours##37##2##(1990-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-6#2)(2007-10#13)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
48 hr after##3##3##(1992-9#2)(1995-2#1)
48 hr of##2##3##(2008-11#2)
48 hr##12##2##(1992-9#2)(1994-8#1)(1995-2#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2012-12#1)
48 hrs of##2##3##(2008-8#1)(2012-3#1)
48 hrs##6##2##(2008-12#2)(2008-8#3)(2012-3#1)
48 mm##3##2##(1994-5#2)(2008-3#1)
48 months##8##2##(1990-12#2)(1991-8#1)(1992-12#1)(2007-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
48 months)##3##2##(2008-7#1)(2012-12#2)
48 nm##2##2##(1991-5#1)(2008-2#1)
48 of the##2##3##(1992-12#1)(1997-3#1)
48 of##4##2##(1990-9#1)(1992-12#1)(1997-3#1)(2008-12#1)
48 or##3##2##(2008-1#1)(2008-12#1)(2008-7#1)
48 patients with##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
48 patients##7##2##(1994-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)
48 samples##3##2##(2008-10#3)
48 to 72 h after inoculation##3##6##(2008-10#3)
48 to 72 h##4##4##(2008-10#4)
48 to 72 hours##2##4##(1990-6#1)(1992-2#1)
48 to 72##6##3##(1990-6#1)(1992-2#1)(2008-10#4)
48 to##15##2##(1990-10#1)(1990-6#2)(1992-2#1)(2007-11#1)(2008-10#7)(2008-8#1)(2012-3#1)(2013-1#1)
48 weeks##3##2##(1990-6#1)(1992-11#1)(2008-5#1)
48 years##4##2##(1992-2#1)(2008-3#1)(2008-9#2)
48 ±##2##2##(2012-3#1)(2013-8#1)
48##436##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-8#1)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-5#3)(1994-6#7)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#6)(1995-2#2)(1995-3#4)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-10#14)(2007-11#7)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#8)(2008-1#9)(2008-10#84)(2008-11#19)(2008-12#10)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#21)(2008-6#8)(2008-7#12)(2008-8#12)(2008-9#6)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#15)(2012-12#6)(2012-2#4)(2012-3#11)(2013-1#19)(2013-7#1)(2013-8#6)
48% and##4##2##(2008-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
48% of the##3##3##(1990-5#1)(1991-2#1)(2008-5#1)
48% of##8##2##(1990-5#1)(1991-2#1)(1992-11#1)(2008-5#1)(2010-8#1)(2011-1#2)(2011-2#1)
48% respectively##2##2##(1991-12#1)(1991-6#1)
48%##43##1##(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-6#1)(1995-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
48%)##4##1##(2007-7#1)(2008-12#1)(2010-4#1)(2010-5#1)
48)##11##1##(1994-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#1)
48-##3##1##(1990-12#1)(1995-3#1)(2007-12#1)
48-72##3##1##(1993-6#1)(2008-5#1)(2013-7#1)
48-h CT treatment##2##3##(1994-2#2)
48-h##8##1##(1993-6#1)(1994-2#2)(1994-8#1)(2008-10#3)(2011-2#1)
48-kDa proteins##2##2##(2008-10#2)
48-kDa##4##1##(1994-12#1)(2008-10#3)
48-well##4##1##(1992-6#1)(2008-11#2)(2013-1#1)
48-year-old female##2##2##(2009-2#1)(2010-5#1)
48-year-old##11##1##(2008-6#1)(2009-1#1)(2009-2#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
48/80##10##1##(1992-3#7)(2008-10#3)
48/80-induced##2##1##(1992-3#1)(2008-10#1)
480 and##2##2##(1994-11#1)(2008-3#1)
480 mW##2##2##(2007-11#1)(2007-12#1)
480 nm##5##2##(1996-2#1)(2008-10#3)(2008-11#1)
480##34##1##(1990-2#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-8#1)(1994-11#1)(1996-2#2)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#2)(2013-1#1)
4800##5##1##(2008-1#1)(2008-11#1)(2008-3#2)(2009-10#1)
481##6##1##(1990-3#1)(1991-2#1)(1994-11#1)(1995-9#1)(2008-10#1)(2013-8#1)
482##7##1##(1993-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-3#2)(2012-12#1)
483##4##1##(2008-10#2)(2011-1#1)(2013-1#1)
484 mutation##2##2##(1992-9#2)
484##8##1##(1990-8#1)(1991-12#2)(1991-5#1)(1992-9#4)
485##5##1##(1990-8#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-7#1)
486##9##1##(1992-1#1)(1992-6#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
487##5##1##(1991-12#1)(2008-10#1)(2008-3#1)(2011-1#2)
488 nm##6##2##(2008-2#3)(2008-3#2)(2008-9#1)
488##12##1##(2007-12#2)(2007-5#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-12#1)(2011-2#1)
488-nm##5##1##(2008-2#1)(2008-3#1)(2008-9#3)
488H is##2##2##(1991-1#2)
488H##11##1##(1991-1#4)(1993-12#4)(1997-2#3)
489##5##1##(1997-2#1)(2007-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
48968##5##1##(1993-3#5)
48h##4##1##(2010-4#2)(2013-1#1)(2013-7#1)
48 h##3##1##(2012-3#1)(2013-1#2)
49 +/- 0##3##3##(1994-6#1)(2008-5#1)(2011-2#1)
49 +/-##5##2##(1994-6#1)(2008-5#1)(2008-7#2)(2011-2#1)
49 and##10##2##(1991-5#1)(1995-2#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)
49 cases##4##2##(1997-3#1)(2007-11#3)
49 nm##2##2##(2008-3#1)(2008-9#1)
49 patients with##2##3##(2007-10#1)(2008-7#1)
49 patients##6##2##(1990-8#1)(2007-10#1)(2008-1#2)(2008-5#1)(2008-7#1)
49 to##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
49 years of age##5##4##(1991-3#2)(2007-2#1)(2011-1#1)(2011-2#1)
49 years or older##3##4##(1992-9#3)
49 years##15##2##(1990-10#1)(1991-3#2)(1992-9#6)(1995-9#1)(2007-2#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)
49##177##1##(1990-10#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-9#7)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#8)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#8)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#7)(2008-10#21)(2008-11#2)(2008-12#9)(2008-3#9)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#2)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#2)
49% and##2##2##(2007-7#1)(2008-4#1)
49% for##2##2##(2008-3#1)(2010-12#1)
49% in##3##2##(1994-2#1)(2007-12#1)(2012-2#1)
49% of the##4##3##(1991-8#1)(2008-10#2)(2008-6#1)
49% of##6##2##(1991-8#1)(1994-8#1)(2008-10#3)(2008-6#1)
49% reported##2##2##(2012-12#1)(2013-1#1)
49%##40##1##(1991-4#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
49%)##5##1##(1990-2#1)(2008-10#2)(2008-4#1)(2008-9#1)
49)##7##1##(1995-2#1)(1997-7#1)(2007-10#1)(2008-8#1)(2010-10#1)(2012-2#2)
49-56 (1991)]##2##2##(2008-3#2)
49-year-old woman with##2##3##(2008-5#1)(2013-1#1)
49-year-old##4##1##(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
490 nm##9##2##(1993-11#1)(2008-10#6)(2008-5#1)(2008-7#1)
490##25##1##(1993-11#1)(1994-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#4)
491##2##1##(2007-12#1)(2011-2#1)
491)##2##1##(1997-2#1)(2008-8#1)
492##4##1##(1993-6#2)(2007-2#1)(2008-10#1)
493 patients##2##2##(1996-9#1)(2008-3#1)
493##6##1##(1996-6#1)(1996-9#1)(2008-3#2)(2011-2#1)(2012-2#1)
494##6##1##(1992-12#2)(2007-12#2)(2008-10#1)(2009-4#1)
495 nm##4##2##(2008-10#3)(2008-3#1)
495##12##1##(1991-12#1)(1991-5#1)(1992-6#2)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
496##6##1##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)
497 bp##2##2##(1993-8#1)(2011-2#1)
497##6##1##(1993-3#1)(1993-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
498 nm##2##2##(2008-10#1)(2008-8#1)
498##5##1##(1995-3#1)(2008-10#3)(2008-8#1)
499##5##1##(1997-8#2)(2008-10#1)(2011-2#1)(2012-12#1)
49th##3##1##(2008-9#1)(2009-4#1)(2010-1#1)
4?2m##2##1##(2008-2#2)
4A##8##1##(1995-3#3)(1995-6#1)(1996-12#1)(2008-10#3)
4AP##3##1##(2008-10#3)
4B##8##1##(1990-11#1)(1991-9#1)(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
4BL##3##1##(2008-10#3)
4C and##2##2##(2008-11#1)(2013-1#1)
4C##5##1##(2008-11#1)(2013-1#4)
4Cl-D-Phe2##2##1##(1994-8#2)
4D THRIVE##3##2##(2010-12#3)
4D movies##3##2##(2012-1#3)
4D##18##1##(2007-11#2)(2008-10#2)(2008-11#1)(2010-12#3)(2010-5#3)(2012-1#6)(2012-2#1)
4F(3/2)##2##1##(2008-3#2)
4F(3/2)--&gt##2##1##(2008-3#2)
4Fe-4S center to##2##3##(1995-2#2)
4GlcNAc beta 1##3##3##(1992-10#3)
4GlcNAc beta##4##2##(1990-12#1)(1992-10#3)
4H##3##1##(2008-10#3)
4H(2)O##2##1##(1997-7#2)
4H-SiC##2##1##(2008-3#2)
4HA was##2##2##(1995-6#2)
4HA##5##1##(1995-6#5)
4He##2##1##(1996-12#1)(1996-9#1)
4Int$)##2##1##(2013-7#2)
4M##6##1##(1990-5#1)(2008-10#3)(2010-8#2)
4M5NC##5##1##(2008-10#5)
4MC##4##1##(2013-8#4)
4N##2##1##(2008-12#2)
4P2##2##1##(1993-6#2)
4Pi confocal microscopy##2##3##(2008-3#2)
4Pi confocal##4##2##(2008-3#4)
4Pi##9##1##(2007-12#2)(2008-3#7)
4R (PR) in##2##3##(2008-10#2)
4R##12##1##(2008-10#11)(2009-9#1)
4R)-3##5##1##(2007-12#5)
4S##5##1##(1996-5#2)(2007-12#1)(2009-9#2)
4S)-I and (S)-II##2##3##(2008-10#2)
4V versus##2##2##(2008-10#2)
4V##4##1##(2008-10#3)(2013-1#1)
4]##4##1##(1990-2#1)(1991-3#1)(1996-2#1)(2008-5#1)
4]B##2##1##(1991-3#2)
4a##7##1##(1992-3#1)(2008-10#3)(2008-4#1)(2009-9#1)(2010-7#1)
4a-diaza-s-indacene##2##1##(2008-10#2)
4b##4##1##(1996-5#1)(2012-3#3)
4b)##2##1##(2012-2#1)(2013-8#1)
4cm(-1)##2##1##(2008-10#2)
4d##2##1##(1996-5#1)(2008-8#1)
4days##2##1##(2008-11#1)(2013-1#1)
4f and##2##2##(2008-3#2)
4f##12##1##(2008-2#2)(2008-3#9)(2013-8#1)
4g##3##1##(2008-10#1)(2010-12#2)
4g/dl##4##1##(1996-12#3)(2008-10#1)
4g/kg##2##1##(2007-8#2)
4h in##2##2##(2008-10#2)
4h of##2##2##(2008-10#1)(2013-1#1)
4h##8##1##(2008-10#7)(2013-1#1)
4mV per decade of activity##2##5##(2008-10#2)
4mV per decade##3##3##(2008-10#3)
4mgcm(-3) for##2##2##(2008-10#2)
4min##6##1##(2008-10#6)
4ml##2##1##(2008-10#2)
4mlmin(-1)##2##1##(2008-10#2)
4mm##6##1##(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
4muM##2##1##(2008-10#2)
4mug/kg##2##1##(2008-10#2)
4mugl(-1) and##2##2##(2008-10#2)
4mugl(-1)##4##1##(2008-10#4)
4mul##2##1##(2008-10#2)
4mumolL(-1)##2##1##(2008-10#2)
4n-6 and 22##2##3##(1992-3#2)
4n-6##4##1##(1992-3#4)
4n-6)##2##1##(1992-3#2)
4nM##2##1##(1993-3#1)(2008-10#1)
4ng##2##1##(2008-10#2)
4ngg(-1)##5##1##(2008-10#5)
4ngml(-1)##3##1##(2008-10#3)
4pg for##2##2##(2008-10#2)
4pi##4##1##(2007-11#3)(2008-3#1)
4q##5##1##(1997-5#1)(2012-3#4)
4q32→q35##3##1##(2012-3#3)
4r##2##1##(2012-3#2)
4s##3##1##(1994-10#1)(2008-10#2)
4th age##2##2##(1992-9#2)
4th and 5th h post incubation##2##6##(2008-12#2)
4th and 5th##3##3##(2007-7#1)(2008-12#2)
4th and##6##2##(2007-7#2)(2008-12#2)(2008-5#1)(2013-1#1)
4th ed##2##2##(2007-2#1)(2008-7#1)
4th larval instar##3##3##(2008-12#2)(2008-5#1)
4th sampling##2##2##(2008-7#2)
4th##46##1##(1990-12#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-10#4)(2008-12#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
4x##3##1##(2007-11#3)
4x10(-3)##2##1##(2007-12#1)(2008-10#1)
4x10(-4)##3##1##(2008-10#3)
4x10(-5)##4##1##(2007-11#1)(2008-10#3)
4x10(-6)##4##1##(2008-10#3)(2008-11#1)
4x10(-7) M##2##2##(2008-10#2)
4x10(-7)##4##1##(2008-10#4)
4x10(-8) mol l(-1)##3##3##(2008-10#3)
4x10(-8) to##5##2##(2008-10#5)
4x10(-8)##10##1##(2008-10#10)
4x10(-8)M##2##1##(2008-10#2)
4x10(-9)##2##1##(2007-12#1)(2008-10#1)
4x10(2)##2##1##(2008-10#2)
4x10(3)##2##1##(2008-10#2)
4x4##2##1##(2008-3#2)
4 T1##2##1##(2011-1#2)
4°C##2##1##(2011-1#1)(2013-1#1)
4±0##2##1##(2011-1#1)(2012-2#1)
4×##2##1##(2013-1#2)
4 weeks##2##1##(2011-2#1)(2013-1#1)
4 ± 0##2##1##(2012-2#2)
4 weeks after##2##2##(2012-7#2)
5 % in##3##3##(2012-12#1)(2012-2#2)
5 % of##2##3##(2007-7#1)(2008-5#1)
5 %##16##2##(1997-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)
5 %) of##2##3##(2008-5#1)(2012-12#1)
5 %)##7##2##(2008-5#2)(2011-2#1)(2012-12#3)(2013-1#1)
5 &lt##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
5 (0##6##2##(1991-8#1)(1993-12#1)(1995-9#1)(2008-12#1)(2010-3#2)
5 (12##3##2##(2007-10#3)
5 (4##2##2##(2008-10#1)(2013-1#1)
5 (6##2##2##(1994-12#1)(2008-1#1)
5 (83##2##2##(2008-10#1)(2013-8#1)
5 (95% CI##4##3##(2011-2#2)(2012-3#1)(2013-1#1)
5 (95%##5##2##(1993-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
5 (range##2##2##(2008-12#1)(2013-1#1)
5 (wt/wt)##3##2##(2008-10#3)
5 +/- 0##16##3##(1992-6#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)
5 +/- 1##7##3##(1990-12#1)(1994-8#1)(1995-12#1)(1997-6#2)(2007-7#1)(2008-12#1)
5 +/- 2##4##3##(1992-2#1)(2007-7#1)(2008-11#1)(2008-12#1)
5 +/- 3##10##3##(1993-8#1)(1994-12#1)(1994-7#1)(1995-12#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-1#1)(2011-2#1)
5 +/- 4##4##3##(1997-6#1)(2007-7#1)(2008-12#1)(2008-5#1)
5 +/- 5##9##3##(1993-8#1)(1994-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-7#1)(2010-8#1)
5 +/- 9##4##3##(1996-3#1)(1997-6#1)(2007-8#1)(2009-1#1)
5 +/-##71##2##(1990-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-8#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#4)(1995-5#1)(1996-3#2)(1996-9#1)(1997-6#4)(1997-7#2)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#3)
5 -##7##2##(1995-12#1)(1996-3#1)(2007-11#1)(2008-5#1)(2011-1#1)(2011-3#2)
5 =##3##2##(1990-11#1)(1993-2#1)(1997-3#1)
5 A Day Program is##2##5##(1997-1#1)(2012-2#1)
5 A Day Program##3##4##(1997-1#2)(2012-2#1)
5 A Day for Better Health Program##2##7##(1997-1#2)
5 A Day##5##3##(1997-1#4)(2012-2#1)
5 A##13##2##(1992-3#1)(1993-11#1)(1995-2#2)(1997-1#4)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
5 FU##2##2##(1997-6#2)
5 GHz and##2##3##(2007-11#1)(2007-12#1)
5 GHz##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
5 Gy##4##2##(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
5 Hz##13##2##(2006-12#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2013-1#1)
5 Hz)##2##2##(1996-2#1)(2008-9#1)
5 J##2##2##(2007-11#1)(2008-10#1)
5 J/cm(2) at 1064 nm##2##5##(2008-2#2)
5 J/cm(2)##3##2##(2008-2#2)(2008-3#1)
5 J/cm2##2##2##(2012-2#1)(2013-1#1)
5 K##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-6#1)
5 Kb was##2##3##(1992-12#2)
5 Kb##4##2##(1992-12#2)(1992-3#1)(2008-11#1)
5 L##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
5 M CdCl(2)##2##3##(2008-10#2)
5 M GdnHCl##2##3##(1992-6#2)
5 M H(2)SO(4)##3##3##(2008-10#3)
5 M HCl##3##3##(2008-10#3)
5 M HNO(3)##2##3##(2008-10#2)
5 M KNO(3)##2##3##(2008-10#2)
5 M NaCl##8##3##(1990-12#2)(1993-12#2)(1993-3#1)(2008-10#3)
5 M for##4##3##(2008-10#4)
5 M hydrochloric acid##2##4##(2008-10#2)
5 M##47##2##(1990-12#2)(1990-7#1)(1991-7#1)(1992-11#3)(1992-6#2)(1993-12#2)(1993-3#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-10#27)(2008-6#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)
5 M)##2##2##(2008-10#2)
5 MHz in##2##3##(2007-11#2)
5 MHz##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
5 MPa##2##2##(2008-10#1)(2008-3#1)
5 Mb of##2##3##(2008-7#1)(2009-10#1)
5 Mb##3##2##(1996-10#1)(2008-7#1)(2009-10#1)
5 Na(+) channels##2##3##(2008-8#2)
5 Pa##2##2##(2008-7#1)(2011-3#1)
5 T##8##2##(1995-11#1)(1997-8#2)(2008-3#3)(2010-8#2)
5 THz##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
5 Torr of oxygen##2##4##(2008-10#2)
5 V versus Ag/AgCl##2##4##(2008-10#2)
5 V vs##2##3##(2008-10#2)
5 V##7##2##(2008-10#7)
5 W at##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
5 W of##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
5 W##15##2##(2007-11#6)(2007-12#3)(2008-2#1)(2008-3#4)(2008-9#1)
5 W-1##2##2##(2009-7#2)
5 We##2##2##(2009-6#2)
5 a##2##2##(1997-1#1)(2012-2#1)
5 acetate##2##2##(2008-10#2)
5 adjusted with##2##3##(2008-10#2)
5 after##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
5 alpha SR2 gene##2##4##(2008-2#2)
5 alpha steroid reductase##3##4##(2008-2#3)
5 alpha##6##2##(2008-2#6)
5 alpha-DHP##3##2##(1990-11#3)
5 alpha-androstane-3 alpha##3##3##(1990-11#3)
5 alpha-dihydroprogesterone##3##2##(1990-11#2)(1996-2#1)
5 alpha-dihydrotestosterone##4##2##(1990-11#1)(1991-5#1)(1996-2#2)
5 alpha-reductase 2##3##3##(1994-11#3)
5 alpha-reductase activity##2##3##(1990-11#1)(1995-9#1)
5 alpha-reductase inhibitor##2##3##(1992-3#2)
5 alpha-reductase##18##2##(1990-11#4)(1992-3#3)(1994-11#5)(1995-3#5)(1995-9#1)
5 alpha-reductases##2##2##(1990-11#1)(1995-3#1)
5 alpha-tetrahydroprogesterone##2##2##(1990-11#1)(1996-2#1)
5 amino acid##2##3##(1991-12#1)(1994-9#1)
5 amino##4##2##(1991-12#1)(1994-9#1)(1997-9#1)(2008-11#1)
5 among##2##2##(1991-8#2)
5 and 0##12##3##(1993-8#1)(1997-8#1)(2008-10#9)(2008-7#1)
5 and 1##26##3##(1993-9#2)(1994-2#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
5 and 10 micrograms/ml##2##4##(1990-2#1)(1994-11#1)
5 and 10 years##4##4##(1990-9#1)(2006-10#1)(2010-3#2)
5 and 10##21##3##(1990-2#1)(1990-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1997-3#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#2)(2012-2#1)
5 and 10%##3##3##(2008-10#2)(2013-1#1)
5 and 100##4##3##(1995-2#1)(2008-10#3)
5 and 102##2##3##(2008-10#2)
5 and 103##3##3##(2008-10#3)
5 and 104##2##3##(2008-10#2)
5 and 10years##2##3##(2011-3#2)
5 and 11##2##3##(2008-3#1)(2008-5#1)
5 and 11%##2##3##(2008-10#2)
5 and 12##3##3##(1990-12#1)(2008-6#1)(2008-7#1)
5 and 14##2##3##(1992-12#1)(2008-10#1)
5 and 15 min##2##4##(1993-1#1)(2008-10#1)
5 and 15##6##3##(1993-1#1)(1993-9#1)(2007-7#1)(2008-10#2)(2011-2#1)
5 and 15%##2##3##(2008-10#2)
5 and 18##3##3##(2008-10#2)(2011-1#1)
5 and 2##16##3##(1993-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-8#1)
5 and 20##7##3##(1993-8#1)(1995-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#2)
5 and 25 degrees C##4##5##(2008-10#2)(2008-6#1)(2009-7#1)
5 and 25##7##3##(1994-2#1)(2008-10#4)(2008-6#1)(2009-7#1)
5 and 3##13##3##(1990-2#1)(1991-8#1)(1995-3#1)(2008-10#8)(2008-5#1)(2011-2#1)
5 and 30##2##3##(2008-10#1)(2011-2#1)
5 and 37##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
5 and 4##8##3##(1990-2#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)
5 and 40##2##3##(1991-12#1)(2008-3#1)
5 and 45 degrees C##2##5##(2008-12#1)(2008-7#1)
5 and 5##12##3##(1992-3#1)(1993-8#2)(2008-10#7)(2008-12#1)(2008-5#1)
5 and 50 degrees C##2##5##(1994-11#1)(2008-8#1)
5 and 50##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
5 and 6 of the##2##5##(1993-11#1)(1993-6#1)
5 and 6##23##3##(1991-3#1)(1991-8#3)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
5 and 60##2##3##(2008-10#1)(2008-3#1)
5 and 632##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
5 and 7 days##2##4##(2008-5#1)(2010-11#1)
5 and 7##6##3##(2008-10#1)(2008-4#2)(2008-5#2)(2010-11#1)
5 and 7%##2##3##(2007-8#1)(2008-12#1)
5 and 77##2##3##(2008-10#1)(2008-6#1)
5 and 8##11##3##(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)
5 and 9##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
5 and E(f) = 2##2##5##(2008-6#2)
5 and a##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
5 and decreased when p approached 0 or 1##2##9##(2008-10#2)
5 and in##3##3##(1993-8#1)(2008-10#2)
5 and the##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
5 and then##2##3##(1993-8#1)(2008-10#1)
5 and were##2##3##(2008-10#2)
5 and with##2##3##(2007-10#1)(2008-3#1)
5 and##341##2##(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#4)(1992-12#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#9)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#3)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#3)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-8#3)(2008-10#165)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#13)(2008-6#8)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
5 approximately##3##2##(2008-10#2)(2008-11#1)
5 arc sec##2##3##(2008-3#2)
5 are##5##2##(1993-3#1)(2007-12#1)(2008-10#2)(2012-2#1)
5 at an##2##3##(1997-7#1)(2007-11#1)
5 at##9##2##(1993-11#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-3#1)(2010-5#1)
5 base pairs##2##3##(1994-8#1)(2008-4#1)
5 beta-cholestane-3 alpha##2##3##(1991-5#2)
5 billion##5##2##(1996-5#2)(1997-3#1)(2008-10#1)(2008-11#1)
5 buffers##2##2##(2008-10#2)
5 by##4##2##(1996-2#1)(1997-4#1)(2008-10#2)
5 cM##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
5 cM)##2##2##(1997-5#1)(2008-10#1)
5 cases in##3##3##(1990-9#1)(1991-8#1)(2007-11#1)
5 cases per##2##3##(1990-9#1)(1997-5#1)
5 cases were##2##3##(1991-8#1)(2007-11#1)
5 cases with##3##3##(1991-11#1)(1993-2#1)(1993-6#1)
5 cases##26##2##(1990-2#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-8#3)(1992-8#2)(1993-2#1)(1993-6#1)(1993-9#1)(1995-4#1)(1997-5#1)(2007-11#3)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
5 children##2##2##(1991-8#1)(2011-2#1)
5 cm depth##2##3##(2008-10#1)(2009-11#1)
5 cm in diameter)##2##4##(2007-5#1)(2012-3#1)
5 cm in##3##3##(2007-5#1)(2012-3#1)(2013-8#1)
5 cm length##2##3##(2008-10#1)(2010-5#1)
5 cm was##4##3##(1991-12#1)(1995-3#1)(2008-12#1)(2013-1#1)
5 cm##46##2##(1991-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#4)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
5 cm(-1)##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
5 cm(3)##2##2##(2008-10#2)
5 cm)##4##2##(1991-6#1)(2008-12#1)(2008-5#1)(2008-7#1)
5 cm2 or less##2##4##(1996-1#2)
5 cm2 or##3##3##(1996-1#3)
5 compared with the##2##4##(2008-2#1)(2008-3#1)
5 compared##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
5 consecutive days##2##3##(1991-2#1)(2008-10#1)
5 consecutive##3##2##(1991-2#1)(1994-11#1)(2008-10#1)
5 control##2##2##(1992-5#1)(2009-6#1)
5 could be##2##3##(1997-5#1)(2008-10#1)
5 d##2##2##(2008-6#1)(2011-2#1)
5 dB##13##2##(1995-6#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)(2008-7#1)
5 daily##2##2##(1990-10#1)(1992-12#1)
5 day##2##2##(2010-8#2)
5 days (range##2##3##(2007-7#1)(2011-2#1)
5 days a week for##2##5##(2008-9#2)
5 days a week##3##4##(2007-8#1)(2008-9#2)
5 days after inoculation##3##4##(2008-10#3)
5 days after the##3##4##(1991-9#1)(2007-5#1)(2008-10#1)
5 days after##17##3##(1991-9#1)(1992-3#1)(1993-12#1)(1996-5#2)(2007-10#1)(2007-5#1)(2008-10#8)(2009-3#1)(2010-8#1)
5 days and then##3##4##(1996-5#1)(2008-10#2)
5 days and##6##3##(1991-12#1)(1996-5#2)(2008-10#2)(2010-5#1)
5 days at##4##3##(2008-10#4)
5 days before parturition##2##4##(2010-2#2)
5 days before##3##3##(1991-8#1)(2010-2#2)
5 days in##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
5 days later##2##3##(1996-5#1)(2008-7#1)
5 days of age##2##4##(1996-5#1)(2007-6#1)
5 days of culture##2##4##(1993-6#1)(1995-3#1)
5 days of gestation##2##4##(2010-2#1)(2013-1#1)
5 days of##13##3##(1990-7#1)(1993-6#1)(1995-3#1)(1996-5#1)(1996-6#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
5 days per week for 13 weeks##2##7##(2008-9#2)
5 days per week for 26 weeks##4##7##(2008-9#4)
5 days per week for 3 weeks##2##7##(2008-9#2)
5 days per week for up to##2##7##(2008-9#2)
5 days per week for##23##5##(2008-9#22)(2013-1#1)
5 days per week##24##4##(2008-9#22)(2013-1#2)
5 days per##25##3##(2008-9#22)(2012-12#1)(2013-1#2)
5 days was##2##3##(1997-4#2)
5 days##121##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-3#4)(1996-5#7)(1996-6#1)(1997-4#2)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#23)(2008-11#2)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#24)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
5 days)##6##2##(1992-2#2)(1995-3#1)(2007-8#2)(2011-2#1)
5 degrees C and##4##4##(2008-10#2)(2010-4#1)(2011-2#1)
5 degrees C during##2##4##(1990-3#1)(2009-2#1)
5 degrees C for##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
5 degrees C##46##3##(1990-3#1)(1992-7#2)(1993-2#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)
5 degrees C)##8##3##(1997-2#1)(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#3)
5 degrees and 45 degrees##2##5##(2007-11#1)(2008-3#1)
5 degrees and##5##3##(2007-11#1)(2008-3#3)(2009-10#1)
5 degrees for##2##3##(1990-11#1)(2008-3#1)
5 degrees##83##2##(1990-11#2)(1990-3#2)(1992-7#2)(1993-11#2)(1993-2#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#6)(2012-2#1)(2013-1#2)
5 different##5##2##(1991-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
5 dpc##4##2##(1997-4#3)(2008-10#1)
5 dph##3##2##(2008-7#1)(2010-8#2)
5 exhibited##2##2##(2008-11#1)(2013-8#1)
5 fluorouracil##2##2##(1991-2#1)(1992-10#1)
5 fmol of##2##3##(2008-10#1)(2008-6#1)
5 fmol##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
5 fold higher##2##3##(1992-3#1)(2008-6#1)
5 fold##6##2##(1990-8#1)(1992-3#2)(1993-8#1)(2008-11#1)(2008-6#1)
5 for##13##2##(1992-11#1)(1992-6#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)
5 fractions##2##2##(2007-11#1)(2008-10#1)
5 from##6##2##(1992-3#1)(1996-10#1)(2007-12#1)(2008-10#3)
5 g kg(-1))##3##3##(2008-10#3)
5 g l(-1)##4##3##(2008-10#3)(2008-11#1)
5 g of sample is##2##5##(2008-10#2)
5 g of##7##3##(2008-10#4)(2008-12#2)(2008-5#1)
5 g##24##2##(1990-11#2)(1991-11#1)(1991-3#1)(1997-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
5 g)##2##2##(1990-12#1)(1993-12#1)
5 g/L of the##2##4##(2008-11#2)
5 g/L of##3##3##(2008-11#2)(2008-7#1)
5 g/L##6##2##(2008-11#3)(2008-6#1)(2008-7#2)
5 g/l##4##2##(1990-12#1)(2008-11#1)(2008-5#2)
5 h after##7##3##(1995-11#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)
5 h and then##3##4##(1997-2#2)(2008-8#1)
5 h and##7##3##(1992-3#1)(1997-2#2)(2008-10#3)(2008-8#1)
5 h in##4##3##(1994-6#1)(1995-6#1)(2008-10#2)
5 h of##3##3##(1995-3#1)(2007-2#1)(2008-2#1)
5 h##37##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-1#2)(1997-2#2)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)
5 had##3##2##(1992-8#1)(2012-2#1)(2013-1#1)
5 has been##2##3##(1997-7#1)(2008-10#1)
5 has##4##2##(1996-12#1)(1997-7#1)(2008-10#1)(2008-8#1)
5 have been##5##3##(1991-6#1)(1994-11#1)(2008-10#1)(2009-8#1)(2011-1#1)
5 have##6##2##(1991-6#2)(1994-11#1)(2008-10#1)(2009-8#1)(2011-1#1)
5 hours##9##2##(1991-12#1)(1992-6#1)(1993-3#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-8#1)(2011-2#1)
5 hr##4##2##(1991-8#1)(1992-11#1)(2008-11#1)(2011-2#1)
5 in the presence of##2##5##(1992-12#1)(2008-10#1)
5 in the##9##3##(1992-12#1)(1992-2#1)(1992-6#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-7#1)
5 in##27##2##(1990-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#1)(1996-5#4)(1997-6#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)
5 infected##2##2##(1990-6#1)(2008-10#1)
5 is##7##2##(1994-12#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
5 isolates##2##2##(2007-12#1)(2008-10#1)
5 kD##2##2##(1993-6#1)(1994-9#1)
5 kDa##21##2##(1990-5#2)(1991-12#2)(1991-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)
5 kDa) and##2##3##(1995-11#1)(2008-10#1)
5 kDa)##4##2##(1995-11#1)(2008-10#2)(2010-11#1)
5 kHz is##2##3##(2007-12#1)(2008-3#1)
5 kHz##9##2##(2007-12#5)(2008-10#1)(2008-3#3)
5 kJ##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
5 kPa##2##2##(2008-10#2)
5 kW##2##2##(2007-12#1)(2008-3#1)
5 kb DNA##2##3##(1995-6#1)(1997-3#1)
5 kb and##3##3##(1993-12#1)(1994-11#1)(2008-11#1)
5 kb in length##2##4##(1993-2#2)
5 kb in the##3##4##(1990-2#1)(2008-11#2)
5 kb in##6##3##(1990-2#1)(1993-2#2)(2008-11#2)(2008-4#1)
5 kb of##2##3##(1993-2#1)(1996-12#1)
5 kb on##2##3##(1996-6#1)(1997-7#1)
5 kb##28##2##(1990-12#1)(1990-2#2)(1991-12#2)(1993-12#2)(1993-2#3)(1993-3#1)(1994-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-11#3)(2008-4#1)(2012-3#1)
5 kb) was##2##3##(1991-12#1)(1993-3#1)
5 kb)##6##2##(1991-12#1)(1993-3#1)(1994-11#1)(1995-6#1)(1997-2#1)(2008-10#1)
5 kcal mol-1##2##3##(1995-5#1)(1997-2#1)
5 kcal##3##2##(1992-6#1)(1995-5#1)(1997-2#1)
5 kcal/mol##3##2##(1991-8#1)(1992-6#1)(1993-8#1)
5 keV##2##2##(2007-11#2)
5 keV)##3##2##(2008-2#2)(2008-3#1)
5 kg##5##2##(1994-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
5 km from the##3##4##(2008-3#2)(2011-1#1)
5 km##8##2##(1997-5#1)(2008-2#1)(2008-3#4)(2008-7#1)(2011-1#1)
5 ku##2##2##(2008-8#2)
5 l##4##2##(2008-11#4)
5 l/min##2##2##(2007-8#1)(2010-6#1)
5 labeled anti-BSM monoclonal antibody##2##5##(2008-10#2)
5 log reduction##2##3##(2007-7#2)
5 log##4##2##(1995-12#1)(2007-7#3)
5 m s(-1)##2##3##(2008-10#1)(2008-3#1)
5 m##19##2##(2008-10#7)(2008-3#10)(2010-8#2)
5 m)##4##2##(2008-10#1)(2008-3#1)(2008-5#2)
5 m/s##3##2##(2008-3#1)(2009-7#2)
5 mJ at##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
5 mJ##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
5 mM Ca2+##4##3##(1995-6#2)(1996-2#1)(1997-2#1)
5 mM and##5##3##(1992-8#1)(1994-6#1)(2008-11#2)(2011-2#1)
5 mM aspirin##3##3##(2008-11#3)
5 mM glucose##10##3##(1990-12#2)(1992-8#5)(1995-8#1)(1997-1#1)(2008-10#1)
5 mM or 27##2##4##(1992-8#2)
5 mM phosphate buffer (pH##2##5##(2008-10#2)
5 mM potassium##3##3##(1994-9#1)(2008-10#2)
5 mM##79##2##(1990-11#3)(1990-12#2)(1990-7#1)(1990-8#2)(1992-11#1)(1992-3#2)(1992-8#8)(1992-9#2)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-2#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#25)(2008-11#9)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
5 mM)##10##2##(1992-3#1)(1993-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-9#1)(2008-10#1)(2008-11#1)
5 mV per decade##6##4##(2008-10#6)
5 mV##11##2##(1991-9#2)(1992-11#1)(2008-10#7)(2008-6#1)
5 mW at##2##3##(2007-11#1)(2008-2#1)
5 mW##9##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#1)
5 may be##2##3##(1997-8#1)(2008-12#1)
5 mg DBTC/kg BW##2##4##(2008-10#2)
5 mg DBTC/kg##3##3##(2008-10#3)
5 mg L(-1) BAP##2##4##(2008-12#2)
5 mg L(-1)##5##3##(2008-12#4)(2012-12#1)
5 mg for##2##3##(1993-2#1)(2007-10#1)
5 mg i##2##3##(1990-12#2)
5 mg kg(-1)##4##3##(2008-10#2)(2012-2#2)
5 mg l(-1) Cl##2##4##(2008-10#2)
5 mg l(-1) copper##2##4##(2008-10#2)
5 mg l(-1) for##2##4##(2008-10#2)
5 mg l(-1)##16##3##(2008-10#16)
5 mg l(-1)) was##2##4##(2008-10#2)
5 mg l(-1))##5##3##(2008-10#5)
5 mg ml(-1)##2##3##(2008-10#2)
5 mg of##6##3##(1992-12#1)(1997-1#1)(2008-10#2)(2008-11#2)
5 mg plain bupivacaine##2##4##(2011-2#2)
5 mg##71##2##(1990-12#2)(1992-12#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(2007-10#5)(2007-11#1)(2008-10#34)(2008-11#2)(2008-12#5)(2008-3#2)(2008-5#2)(2008-7#2)(2009-3#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
5 mg)##3##2##(1990-6#1)(2008-10#1)(2009-4#1)
5 mg/L for##3##3##(2008-10#3)
5 mg/L##4##2##(2008-10#3)(2013-1#1)
5 mg/L)##2##2##(2013-1#2)
5 mg/day##2##2##(2008-1#1)(2008-5#1)
5 mg/dl##3##2##(1994-12#1)(2008-3#1)(2012-3#1)
5 mg/dl)##2##2##(1995-3#1)(2012-3#1)
5 mg/kg body##2##3##(1995-3#1)(2008-4#1)
5 mg/kg bw/day##2##3##(2008-7#2)
5 mg/kg females##2##3##(2008-9#2)
5 mg/kg i##6##3##(1991-2#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-7#1)
5 mg/kg of##2##3##(2008-10#1)(2012-2#1)
5 mg/kg or greater females##2##5##(2008-9#2)
5 mg/kg or greater##5##4##(2008-9#5)
5 mg/kg or##6##3##(2008-4#1)(2008-9#5)
5 mg/kg##46##2##(1990-7#1)(1991-2#2)(1992-3#2)(1993-12#1)(1993-3#1)(1994-2#3)(1994-6#2)(1995-11#1)(1995-12#4)(1995-3#1)(1996-2#4)(1997-4#1)(1997-7#2)(2006-10#1)(2008-10#2)(2008-4#2)(2008-7#2)(2008-9#11)(2011-1#1)(2011-2#1)(2012-2#1)
5 mg/kg)##10##2##(1991-2#1)(1992-8#2)(1993-6#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-10#1)(2012-12#1)(2012-2#1)
5 mg/kg/day##2##2##(1992-11#1)(1994-6#1)
5 mg/l##2##2##(2008-6#1)(2008-7#1)
5 mg/liter##4##2##(2008-10#4)
5 mg/mL and sodium citrate 40 mg/mL (4%)##2##8##(2010-3#2)
5 mg/mL##3##2##(2010-3#3)
5 mg/ml##5##2##(1990-9#1)(2008-10#1)(2012-3#3)
5 microM##28##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-8#3)
5 microM) were##2##3##(1990-2#1)(2008-8#1)
5 microM)##12##2##(1990-2#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-6#1)(1995-11#3)(1995-3#1)(1996-5#1)(2008-8#1)
5 microg l(-1)##5##3##(2008-10#5)
5 microg ml(-1)##3##3##(2008-10#3)
5 microg of##2##3##(2007-12#1)(2008-10#1)
5 microg##15##2##(1997-4#1)(2007-12#1)(2008-10#12)(2008-5#1)
5 microg/kg remifentanil##2##3##(2011-2#2)
5 microg/l##2##2##(2008-10#1)(2009-10#1)
5 microg/ml##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
5 micrograms of##2##3##(1990-7#1)(1993-9#1)
5 micrograms##6##2##(1990-7#1)(1992-3#2)(1992-8#1)(1993-9#1)(1995-5#1)
5 micrograms/ml##4##2##(1990-6#1)(1991-8#1)(1993-6#1)(1994-11#1)
5 micrograms/ml)##2##2##(1991-8#1)(1992-2#1)
5 microl##4##2##(1995-12#1)(2008-10#3)
5 microliters of##2##3##(1990-8#1)(1994-2#1)
5 microliters) injected into##2##4##(1995-12#2)
5 microliters)##5##2##(1993-6#1)(1995-12#4)
5 microm by##2##3##(2007-11#1)(2008-3#1)
5 microm in##2##3##(2007-11#1)(2008-7#1)
5 microm##26##2##(2007-11#6)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#10)(2008-7#1)
5 microm) with##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
5 microm)##9##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-3#1)
5 micromol/l##2##2##(2011-1#2)
5 micron##4##2##(1992-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
5 million##11##2##(1992-1#1)(1992-6#1)(1993-6#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-2#2)(2012-3#1)
5 min accumulation##2##3##(2008-10#2)
5 min after CPB##2##4##(2007-8#2)
5 min after histamine treatment##2##5##(2008-12#2)
5 min after##9##3##(1990-8#1)(1993-3#1)(2007-8#2)(2008-12#3)(2010-10#1)(2012-3#1)
5 min and##7##3##(1990-2#1)(1990-5#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
5 min at##3##3##(1995-2#1)(2008-10#2)
5 min before##2##3##(1997-7#1)(2012-3#1)
5 min by##2##3##(2008-10#1)(2011-1#1)
5 min for the##2##4##(2007-8#1)(2008-10#1)
5 min for##6##3##(1992-11#1)(2007-8#1)(2008-10#3)(2008-12#1)
5 min from##2##3##(2008-5#1)(2013-8#1)
5 min is##2##3##(2008-10#1)(2008-2#1)
5 min of##8##3##(1991-2#1)(1993-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(2008-10#3)
5 min to##3##3##(1994-8#1)(1997-2#1)(2008-7#1)
5 min with##3##3##(2008-10#2)(2009-12#1)
5 min##109##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-8#2)(1995-12#2)(1995-2#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2007-12#1)(2007-8#5)(2008-10#44)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
5 min(-1)##2##2##(2008-10#1)(2011-3#1)
5 min)##10##2##(1990-5#1)(1993-1#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
5 minutes of##3##3##(1995-6#1)(1996-9#2)
5 minutes##9##2##(1991-12#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-9#3)(2012-3#1)(2013-1#1)
5 ml min(-1)##5##3##(2008-10#5)
5 ml of a##3##4##(2008-10#3)
5 ml of dimethylformamide##5##4##(2008-10#5)
5 ml of##27##3##(2008-10#24)(2008-4#1)(2010-4#1)(2013-1#1)
5 ml sample##3##3##(1994-2#1)(2008-10#2)
5 ml##52##2##(1992-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#43)(2008-4#1)(2008-5#1)(2010-4#1)(2013-1#2)
5 ml/min##4##2##(1991-5#1)(1996-5#1)(1997-2#1)(2008-4#1)
5 mm and##4##3##(1994-7#1)(2007-8#1)(2008-2#1)(2013-1#1)
5 mm calcium hydroxide apical plug##2##6##(2013-1#2)
5 mm from the##3##4##(1994-12#1)(2007-8#1)(2008-7#1)
5 mm height##2##3##(2009-12#1)(2013-1#1)
5 mm i##2##3##(2008-10#2)
5 mm in diameter##4##4##(2008-10#2)(2008-2#1)(2009-4#1)
5 mm in##6##3##(2008-10#3)(2008-2#1)(2009-4#1)(2013-1#1)
5 mm is##2##3##(2008-10#1)(2011-2#1)
5 mm thick##2##3##(2007-11#1)(2008-2#1)
5 mm thick)##2##3##(2009-7#1)(2010-9#1)
5 mm to##2##3##(2008-7#1)(2009-7#1)
5 mm with##2##3##(2013-1#2)
5 mm x 0##2##4##(2008-2#2)
5 mm x##3##3##(2008-2#2)(2008-3#1)
5 mm##79##2##(1991-1#2)(1991-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#6)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#4)(2009-12#2)(2009-4#1)(2009-7#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#14)(2013-8#1)
5 mm)##10##2##(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#3)
5 mm/min##3##2##(2008-12#2)(2013-1#1)
5 mm/min)##2##2##(2008-12#1)(2013-1#1)
5 mmHg##2##2##(1991-6#1)(2007-8#1)
5 mmHg)##2##2##(1997-3#1)(2008-7#1)
5 mmol l(-1)##3##3##(2008-10#3)
5 mmol##7##2##(1990-8#1)(2008-10#6)
5 mmol/L##7##2##(2007-11#3)(2007-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
5 mmol/kg##3##2##(1992-12#1)(1994-5#1)(2008-11#1)
5 mmol/l##8##2##(1990-2#1)(1990-6#1)(1991-11#1)(1993-12#1)(1994-6#2)(1995-11#1)(1995-2#1)
5 model##2##2##(2008-5#1)(2012-2#1)
5 mol dm(-3)##4##3##(2008-10#4)
5 mol l(-1) HCl##3##4##(2008-10#3)
5 mol l(-1) sulfuric acid for##2##6##(2008-10#2)
5 mol l(-1)##12##3##(2008-10#12)
5 mol##21##2##(1992-6#1)(1993-8#1)(2007-11#1)(2008-10#16)(2008-6#1)(2009-2#1)
5 mol%##2##2##(1992-6#1)(1997-4#1)
5 month##2##2##(1994-6#1)(2011-2#1)
5 months (range##5##3##(2007-11#1)(2008-10#1)(2008-9#2)(2010-3#1)
5 months after the##2##4##(1994-6#1)(1996-12#1)
5 months after##5##3##(1991-2#1)(1994-6#1)(1996-12#1)(2013-1#1)(2013-8#1)
5 months and the##2##4##(2008-10#1)(2013-1#1)
5 months and##7##3##(1990-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
5 months for##2##3##(1994-8#1)(2011-2#1)
5 months later##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
5 months respectively##2##3##(2007-11#1)(2008-10#1)
5 months to##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
5 months with##2##3##(2008-10#2)
5 months without any##2##4##(2008-10#2)
5 months without##3##3##(2008-10#3)
5 months##74##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#4)(1991-8#1)(1992-2#1)(1994-6#2)(1994-8#3)(1995-2#2)(1995-8#1)(1996-12#1)(1996-9#3)(2007-11#10)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#16)(2008-2#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-2#4)(2012-12#1)(2013-1#6)(2013-8#1)
5 months)##4##2##(1997-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
5 mouse##3##2##(1997-7#1)(2008-10#2)
5 ms at##2##3##(1995-5#1)(1996-5#1)
5 ms##5##2##(1994-3#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-3#1)
5 mu l)##3##3##(1995-12#3)
5 mu##5##2##(1995-12#3)(2008-10#1)(2008-11#1)
5 muA##2##2##(2008-10#2)
5 muM##8##2##(2008-10#6)(2008-11#2)
5 muM)##3##2##(2008-10#2)(2008-5#1)
5 mug a##2##3##(2008-10#2)
5 mug g(-1)##4##3##(2008-10#4)
5 mug l(-1) for##7##4##(2008-10#7)
5 mug l(-1)##14##3##(2008-10#14)
5 mug ml(-1) and##2##4##(2008-10#2)
5 mug ml(-1) for##4##4##(2008-10#4)
5 mug ml(-1)##14##3##(2008-10#14)
5 mug ml(-1))##2##3##(2008-10#2)
5 mug of##2##3##(2008-10#2)
5 mug##46##2##(2008-10#42)(2008-11#2)(2008-5#2)
5 mug/ml and##3##3##(2010-3#3)
5 mug/ml##7##2##(2008-10#1)(2008-11#1)(2010-3#4)(2010-5#1)
5 mug/ml)##2##2##(2008-10#1)(2008-5#1)
5 mul##2##2##(2008-10#2)
5 mum and##3##3##(2008-11#1)(2008-3#2)
5 mum were##2##3##(2008-3#2)
5 mum with a##2##4##(2007-12#1)(2008-2#1)
5 mum with##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
5 mum##33##2##(1993-2#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#10)(2008-7#1)(2009-8#1)(2010-3#2)
5 mumol##2##2##(2008-10#2)
5 mumol/L##2##2##(2007-10#1)(2008-9#1)
5 mumoll(-1))##2##2##(2008-10#2)
5 murad##2##2##(2008-2#2)
5 nJ##2##2##(2007-12#2)
5 nM##15##2##(1990-12#1)(1990-5#1)(1990-8#1)(1993-6#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-5#1)
5 nM)##5##2##(1991-5#1)(1994-8#1)(1995-3#3)
5 ng ml(-1) for##3##4##(2008-10#3)
5 ng ml(-1)##14##3##(2008-10#14)
5 ng of##6##3##(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#1)
5 ng##28##2##(1996-5#1)(1997-4#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-5#1)
5 ng/g for##2##3##(2008-10#2)
5 ng/ml in##2##3##(1990-12#2)
5 ng/ml##8##2##(1990-12#2)(1992-6#1)(1994-3#1)(1995-12#2)(2008-10#2)
5 ngml(-1)##2##2##(2008-10#2)
5 nm (lambda(max) of ornidazole)##2##5##(2010-5#2)
5 nm and##4##3##(2008-2#1)(2008-3#2)(2009-11#1)
5 nm in diameter##2##4##(2009-11#1)(2010-12#1)
5 nm in the##2##4##(2008-3#2)
5 nm in##5##3##(2008-3#3)(2009-11#1)(2010-12#1)
5 nm resolution by##2##4##(2008-4#1)(2008-8#1)
5 nm##47##2##(2007-11#5)(2007-12#2)(2008-10#5)(2008-2#5)(2008-3#14)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#3)(2009-5#2)(2010-12#1)(2010-5#3)(2011-1#1)(2013-8#1)
5 nm)##6##2##(1993-11#2)(1994-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
5 nmol beta##2##3##(1991-5#2)
5 nmol##7##2##(1991-3#1)(1991-5#4)(1997-6#1)(2010-4#1)
5 nmol/mol##2##2##(2008-3#2)
5 ns##5##2##(1995-3#1)(2007-11#1)(2007-12#2)(2009-9#1)
5 nucleotides##2##2##(1994-3#1)(1997-2#1)
5 of 7##3##3##(2006-10#1)(2007-11#1)(2008-7#1)
5 of the##9##3##(1994-2#1)(1997-7#1)(2007-12#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
5 of these##7##3##(1991-4#1)(1991-6#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-6#1)
5 of##39##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#2)(1992-8#1)(1994-2#1)(1995-12#1)(1996-11#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
5 on the##2##3##(2008-10#1)(2008-12#1)
5 on##6##2##(2008-10#4)(2008-12#1)(2008-7#1)
5 or 10 microg/kg/min toborinone##2##5##(2008-5#2)
5 or 10##5##3##(2008-10#2)(2008-5#2)(2013-8#1)
5 or 5##3##3##(1992-5#1)(2007-10#1)(2008-11#1)
5 or 7##2##3##(1997-4#1)(2008-5#1)
5 or higher##2##3##(1992-12#1)(2008-10#1)
5 or more affected teeth##2##5##(2008-1#2)
5 or more##5##3##(1993-9#1)(2008-1#2)(2011-1#2)
5 or##27##2##(1992-11#1)(1992-12#1)(1992-5#1)(1993-9#1)(1996-2#1)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#3)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
5 orders of magnitude##7##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
5 other##2##2##(1991-8#1)(2013-1#1)
5 out of##2##3##(2011-2#1)(2013-1#1)
5 over a##2##3##(1992-3#1)(2008-10#1)
5 over##3##2##(1992-3#1)(2008-10#2)
5 pH range##2##3##(2008-10#1)(2010-5#1)
5 pM##2##2##(2008-10#1)(2008-11#1)
5 pairs of##2##3##(2008-8#1)(2010-3#1)
5 parts in 10(5)##2##4##(2007-12#1)(2008-3#1)
5 parts in##3##3##(2007-12#1)(2008-3#2)
5 patients (3##2##3##(1990-10#1)(2007-11#1)
5 patients are##2##3##(1991-11#1)(1992-9#1)
5 patients had##5##3##(1992-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2012-2#1)
5 patients we##3##3##(1991-11#1)(2008-5#1)(2011-2#1)
5 patients who did not##2##5##(1994-12#1)(2013-1#1)
5 patients who received##2##4##(1991-5#1)(2008-1#1)
5 patients who##5##3##(1991-5#1)(1994-12#1)(2007-10#1)(2008-1#1)(2013-1#1)
5 patients with##7##3##(1990-3#1)(1993-10#1)(2007-10#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
5 patients##50##2##(1990-10#2)(1990-12#1)(1990-3#2)(1991-11#2)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-2#1)(1994-12#3)(2006-10#1)(2007-10#4)(2007-11#5)(2008-1#6)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#3)(2013-1#1)
5 per cent##4##3##(1990-6#1)(1992-5#1)(1996-6#2)
5 per cent)##3##3##(1990-3#1)(1991-11#2)
5 per##11##2##(1990-3#1)(1990-6#1)(1991-11#2)(1992-5#1)(1996-6#2)(2008-10#3)(2010-3#1)
5 percent of their total##2##5##(1996-3#2)
5 percent of##5##3##(1992-2#1)(1994-1#1)(1994-3#1)(1996-3#2)
5 percent##16##2##(1991-3#3)(1992-2#2)(1994-1#1)(1994-12#1)(1994-3#2)(1995-6#2)(1996-3#2)(1997-3#1)(2008-5#1)(2011-2#1)
5 pg ml(-1)##2##3##(2008-10#2)
5 pg##8##2##(1994-2#1)(2008-10#7)
5 pg)##2##2##(2008-10#2)
5 pg/ml##2##2##(1995-8#1)(2011-2#1)
5 plants##2##2##(2008-10#1)(2008-8#1)
5 pmol/ml of##2##3##(1990-8#2)
5 points##2##2##(1991-2#1)(2012-3#1)
5 polymorphisms##2##2##(2008-2#2)
5 ppb (for##2##3##(2008-10#2)
5 ppb aflatoxin##2##3##(2008-12#2)
5 ppb for##2##3##(2008-10#2)
5 ppb##10##2##(2008-10#6)(2008-12#2)(2008-5#2)
5 ppm Cd-exposed##2##3##(1997-4#2)
5 ppm of##2##3##(2008-10#2)
5 ppm##16##2##(1990-3#1)(1997-2#1)(1997-4#3)(1997-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2012-12#1)
5 ps##7##2##(1993-11#1)(2008-2#2)(2008-3#4)
5 range##2##2##(1992-2#1)(2008-3#1)
5 residues##2##2##(1991-8#1)(1995-6#1)
5 respectively##2##2##(2008-7#2)
5 resulted in##3##3##(2007-10#1)(2008-10#1)(2008-6#1)
5 revealed a##2##3##(1995-6#1)(1996-6#1)
5 s with##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
5 s##15##2##(1991-9#1)(1993-5#1)(1993-6#1)(1995-11#1)(1996-5#1)(1997-1#1)(1997-2#3)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)
5 samples##2##2##(2008-10#2)
5 seasons##2##2##(1996-6#1)(2010-1#1)
5 sec##2##2##(2008-5#1)(2010-7#1)
5 sets of##2##3##(2009-1#2)
5 software##2##2##(2008-10#2)
5 the##4##2##(1990-6#1)(1994-5#1)(2008-3#1)(2011-1#1)
5 times as##3##3##(1994-9#1)(2008-2#1)(2013-8#1)
5 times at##2##3##(1992-11#1)(2013-1#1)
5 times for##2##3##(2008-10#1)(2009-8#1)
5 times greater than the##2##5##(1991-2#1)(1996-2#1)
5 times greater than##3##4##(1991-2#1)(1996-2#1)(2008-3#1)
5 times greater##5##3##(1991-2#1)(1996-2#1)(2008-11#1)(2008-3#1)(2012-3#1)
5 times higher##2##3##(2008-11#2)
5 times that of##2##4##(2006-10#1)(2008-2#1)
5 times the##3##3##(1992-9#1)(2008-2#1)(2010-3#1)
5 times##30##2##(1991-2#1)(1992-11#1)(1992-4#1)(1992-9#1)(1994-9#1)(1996-2#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#2)(2009-8#1)(2010-3#1)(2012-3#2)(2013-1#2)(2013-8#2)
5 to $4##2##3##(1992-3#1)(1994-1#1)
5 to +2##2##3##(2008-10#2)
5 to 0##7##3##(2007-8#1)(2008-10#4)(2008-12#1)(2012-3#1)
5 to 1##15##3##(1990-7#1)(1993-11#1)(1993-3#1)(1994-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)
5 to 10 mm##2##4##(2008-10#1)(2008-2#1)
5 to 10 pM) alone##2##5##(1990-8#2)
5 to 10##13##3##(1990-8#2)(2007-10#1)(2007-12#1)(2008-10#7)(2008-2#1)(2009-10#1)
5 to 10% of##2##4##(1996-12#1)(2009-12#1)
5 to 10%##3##3##(1996-12#1)(2009-12#1)(2011-1#1)
5 to 101##2##3##(2008-10#2)
5 to 11##5##3##(2008-10#4)(2012-3#1)
5 to 12##2##3##(1996-3#1)(2007-12#1)
5 to 14 years##2##4##(2007-8#1)(2012-12#1)
5 to 14##6##3##(2007-8#2)(2008-10#1)(2011-2#1)(2012-12#2)
5 to 15##5##3##(2007-12#1)(2008-10#3)(2008-6#1)
5 to 19##2##3##(2008-11#1)(2011-2#1)
5 to 2##4##3##(1990-8#1)(2007-12#1)(2008-10#2)
5 to 20##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
5 to 25##5##3##(1995-3#1)(2008-10#4)
5 to 3##8##3##(2007-7#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
5 to 30##6##3##(1995-2#1)(2007-11#2)(2008-2#2)(2008-3#1)
5 to 35##2##3##(2007-12#1)(2013-1#1)
5 to 4##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
5 to 40##2##3##(2008-10#1)(2013-1#1)
5 to 5##11##3##(1990-2#1)(1990-5#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2012-12#1)(2013-1#1)
5 to 50##5##3##(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#2)
5 to 6 days##2##4##(2008-10#1)(2008-11#1)
5 to 6 weeks##2##4##(2008-10#1)(2013-1#1)
5 to 6##12##3##(1990-3#1)(1990-9#1)(2008-10#6)(2008-11#1)(2013-1#3)
5 to 60##2##3##(2008-10#1)(2008-9#1)
5 to 7 weeks##2##4##(2008-10#1)(2013-1#1)
5 to 7##6##3##(2008-10#4)(2013-1#1)(2013-8#1)
5 to 8##4##3##(2008-10#2)(2009-7#1)(2011-2#1)
5 to 8%##2##3##(1991-5#1)(2008-11#1)
5 to 9##5##3##(1994-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-3#1)
5 to##215##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-1#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#94)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#6)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#10)(2013-8#2)
5 triphosphate##2##2##(1997-8#1)(2012-12#1)
5 tumors per mouse##2##4##(1990-7#2)
5 using##3##2##(1997-4#1)(2008-10#1)(2011-1#1)
5 versus##3##2##(1997-6#1)(2008-4#1)(2010-11#1)
5 vs##9##2##(1994-8#1)(2006-10#1)(2007-10#3)(2010-1#1)(2011-2#2)(2012-3#1)
5 was achieved for##2##4##(2008-10#2)
5 was achieved##3##3##(2008-10#3)
5 was constructed##2##3##(1996-10#1)(2011-2#1)
5 was##21##2##(1990-3#1)(1992-12#1)(1996-10#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
5 week##2##2##(1995-12#2)
5 weeks after the##2##4##(1995-12#1)(2010-6#1)
5 weeks after##6##3##(1995-12#1)(1995-2#1)(2008-10#2)(2010-6#1)(2013-8#1)
5 weeks before##2##3##(2008-10#2)
5 weeks of age##7##4##(1992-3#1)(1997-3#2)(1997-6#2)(2011-2#2)
5 weeks of##9##3##(1992-3#1)(1997-3#2)(1997-6#2)(2008-5#1)(2011-2#2)(2013-8#1)
5 weeks to##2##3##(2009-6#1)(2011-2#1)
5 weeks without any##2##4##(1994-2#1)(2008-10#1)
5 weeks##33##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-6#1)(1994-2#2)(1995-12#1)(1995-2#1)(1997-3#2)(1997-6#3)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#2)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
5 were##19##2##(1990-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-4#1)(1997-6#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
5 with glutaraldehyde 0##3##4##(2008-5#3)
5 with##16##2##(1991-11#1)(1994-5#1)(1995-4#1)(1996-5#4)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#2)
5 without##3##2##(2008-10#2)(2011-2#1)
5 wt##11##2##(2008-10#8)(2008-5#2)(2010-4#1)
5 x 0##2##3##(2008-10#2)
5 x 10##2##3##(1995-12#1)(2008-3#1)
5 x 10(-10)##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
5 x 10(-11) to##2##4##(2008-10#2)
5 x 10(-11)##4##3##(2008-10#4)
5 x 10(-3) cm(-1)##2##4##(2008-3#2)
5 x 10(-3)##6##3##(2008-2#2)(2008-3#4)
5 x 10(-4) M##3##4##(2008-10#1)(2008-2#2)
5 x 10(-4)##7##3##(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
5 x 10(-5)##6##3##(1994-5#1)(2007-12#1)(2008-10#3)(2010-1#1)
5 x 10(-6) M##4##4##(1991-5#1)(1991-8#1)(1994-5#1)(2008-10#1)
5 x 10(-6) to##2##4##(2008-10#2)
5 x 10(-6)##12##3##(1991-5#1)(1991-8#1)(1994-5#1)(2008-10#6)(2008-3#3)
5 x 10(-6)-1 x##2##4##(2008-10#2)
5 x 10(-7) mol##2##4##(2008-10#2)
5 x 10(-7)##9##3##(1990-2#1)(1990-8#1)(1997-5#1)(2008-10#3)(2008-2#2)(2008-3#1)
5 x 10(-9) M##2##4##(1993-11#1)(2008-10#1)
5 x 10(-9)##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
5 x 10(3) CFU##2##4##(1996-12#2)
5 x 10(3)##8##3##(1996-12#3)(1996-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
5 x 10(4)##4##3##(1993-8#1)(2008-10#3)
5 x 10(5) and##2##4##(2008-10#2)
5 x 10(5) pulses##2##4##(2008-2#1)(2008-3#1)
5 x 10(5)##8##3##(1997-4#1)(2008-10#5)(2008-2#1)(2008-3#1)
5 x 10(6) cells##2##4##(2008-11#2)
5 x 10(6) cells/ml##2##4##(2008-7#2)
5 x 10(6)##5##3##(2008-11#3)(2008-7#2)
5 x 10(7)##3##3##(1994-5#2)(2008-10#1)
5 x 10(9) cells##2##4##(2008-10#1)(2008-11#1)
5 x 10(9)##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2009-2#1)
5 x 5##3##3##(2008-2#2)(2008-3#1)
5 x##120##2##(1990-2#1)(1990-8#1)(1991-5#2)(1991-8#1)(1993-11#1)(1993-8#1)(1994-5#4)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-12#4)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-12#2)(2008-10#47)(2008-11#4)(2008-2#10)(2008-3#19)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#1)
5 year study##2##3##(2008-10#1)(2011-2#1)
5 year survival rate##2##4##(1990-6#2)
5 year survival##4##3##(1990-10#1)(1990-6#2)(2011-2#1)
5 year##11##2##(1990-10#1)(1990-6#2)(1993-9#1)(1997-8#1)(2008-10#3)(2008-12#1)(2011-2#2)
5 years (mean##3##3##(2007-5#1)(2008-9#1)(2009-8#1)
5 years (range##5##3##(1991-8#1)(2007-8#1)(2008-9#1)(2013-1#2)
5 years after surgery##2##4##(1991-6#1)(2007-8#1)
5 years after the initial operation##2##6##(2008-7#1)(2011-2#1)
5 years after the##4##4##(2007-8#1)(2008-7#1)(2009-3#1)(2011-2#1)
5 years after their##2##4##(2008-7#1)(2013-1#1)
5 years after##15##3##(1991-6#1)(1997-3#1)(2007-10#1)(2007-8#3)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
5 years ago##2##3##(2010-6#1)(2011-2#1)
5 years and##8##3##(1991-8#1)(1993-9#1)(1995-4#1)(2007-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
5 years at##2##3##(2008-10#1)(2012-2#1)
5 years experience##2##3##(1991-2#1)(1994-12#1)
5 years for##2##3##(2011-2#1)(2013-1#1)
5 years from##3##3##(2007-5#1)(2008-10#1)(2009-5#1)
5 years in##4##3##(1997-7#1)(2008-5#1)(2010-6#1)(2011-2#1)
5 years later##2##3##(1995-3#1)(2008-11#1)
5 years of age##5##4##(2008-1#1)(2008-10#1)(2008-11#2)(2013-1#1)
5 years of##16##3##(1990-6#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2012-3#1)(2013-1#2)
5 years old##5##3##(1994-9#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-5#1)
5 years postoperatively##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
5 years to##3##3##(1997-2#1)(2011-2#1)(2012-2#1)
5 years were##5##3##(1994-12#1)(2008-6#1)(2010-3#1)(2012-12#1)(2013-1#1)
5 years with##2##3##(2007-7#1)(2012-2#1)
5 years##186##2##(1990-2#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#4)(1992-1#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-9#4)(1994-12#4)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-4#1)(1996-11#3)(1996-12#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-5#3)(2007-7#3)(2007-8#9)(2008-1#3)(2008-10#15)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#9)(2008-7#8)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#15)(2013-8#5)
5 years) and##2##3##(1996-2#1)(2008-10#1)
5 years) treated##2##3##(2008-2#1)(2009-3#1)
5 years) with##2##3##(2007-8#1)(2011-2#1)
5 years)##15##2##(1990-12#1)(1993-9#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#3)
5 yr##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
5 ± 0##7##3##(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#2)
5 ±##12##2##(2010-10#1)(2010-11#2)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
5 × 10³##2##3##(2013-1#2)
5 ×##6##2##(2010-12#1)(2012-3#1)(2013-1#4)
5 μm##3##2##(2012-12#1)(2012-2#2)
5##6124##1##(1990-10#7)(1990-11#54)(1990-12#34)(1990-2#20)(1990-3#18)(1990-5#20)(1990-6#22)(1990-7#30)(1990-8#23)(1990-9#14)(1991-1#3)(1991-10#2)(1991-11#15)(1991-12#35)(1991-2#28)(1991-3#9)(1991-4#3)(1991-5#27)(1991-6#11)(1991-7#3)(1991-8#44)(1991-9#18)(1992-1#2)(1992-10#2)(1992-11#34)(1992-12#22)(1992-2#17)(1992-3#40)(1992-4#4)(1992-5#13)(1992-6#25)(1992-7#3)(1992-8#27)(1992-9#15)(1993-1#7)(1993-10#2)(1993-11#27)(1993-12#29)(1993-2#17)(1993-3#23)(1993-5#3)(1993-6#24)(1993-8#40)(1993-9#26)(1994-1#3)(1994-11#32)(1994-12#29)(1994-2#18)(1994-3#14)(1994-5#23)(1994-6#31)(1994-7#5)(1994-8#22)(1994-9#16)(1995-1#4)(1995-11#39)(1995-12#44)(1995-2#37)(1995-3#38)(1995-4#5)(1995-5#13)(1995-6#28)(1995-8#14)(1995-9#5)(1996-1#4)(1996-10#9)(1996-11#7)(1996-12#26)(1996-2#40)(1996-3#12)(1996-4#1)(1996-5#53)(1996-6#11)(1996-8#1)(1996-9#10)(1997-1#14)(1997-2#39)(1997-3#19)(1997-4#33)(1997-5#14)(1997-6#28)(1997-7#29)(1997-8#31)(1997-9#3)(2006-10#11)(2006-12#6)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#46)(2007-11#117)(2007-12#91)(2007-2#3)(2007-5#11)(2007-6#2)(2007-7#25)(2007-8#60)(2008-1#33)(2008-10#1895)(2008-11#164)(2008-12#91)(2008-2#117)(2008-3#248)(2008-4#39)(2008-5#168)(2008-6#83)(2008-7#120)(2008-8#74)(2008-9#121)(2009-1#5)(2009-10#12)(2009-11#12)(2009-12#9)(2009-2#9)(2009-3#13)(2009-4#3)(2009-5#6)(2009-6#12)(2009-7#14)(2009-8#12)(2009-9#7)(2010-1#11)(2010-10#6)(2010-11#20)(2010-12#9)(2010-2#9)(2010-3#28)(2010-4#18)(2010-5#20)(2010-6#14)(2010-7#5)(2010-8#22)(2010-9#3)(2011-1#76)(2011-2#181)(2011-3#10)(2012-1#10)(2012-12#40)(2012-2#69)(2012-3#72)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#150)(2013-3#2)(2013-7#3)(2013-8#55)
5% (4##2##2##(2008-7#1)(2013-1#1)
5% (95% CI##2##3##(2010-3#1)(2013-1#1)
5% (P &lt##2##3##(2008-3#1)(2013-1#1)
5% (n =##2##3##(2008-10#2)
5% (n=5) for##2##3##(2008-10#2)
5% (n=5)##3##2##(2008-10#3)
5% (v/v) acetic acid##2##4##(2008-10#2)
5% (v/v) nitric acid##2##4##(2008-10#2)
5% (v/v)##11##2##(1991-5#1)(2008-10#10)
5% (w/v) of##2##3##(2008-10#1)(2008-8#1)
5% (w/v) sodium##2##3##(2008-10#2)
5% (w/v)##7##2##(2008-10#4)(2008-6#2)(2008-8#1)
5% (w/w) of##3##3##(2008-10#3)
5% (w/w)##4##2##(2008-10#4)
5% Alkamuls##2##2##(2008-10#2)
5% BSA##2##2##(2008-10#2)
5% CO(2) supply##3##3##(2008-11#3)
5% CO(2)##9##2##(2008-11#9)
5% CO(2))##2##2##(2008-11#1)(2008-3#1)
5% CO2##5##2##(1996-2#1)(2008-5#2)(2008-6#1)(2013-1#1)
5% FBS##3##2##(1997-8#1)(2008-11#1)(2008-9#1)
5% H(2)##2##2##(2008-10#2)
5% NaCl intake##2##3##(1997-4#2)
5% NaCl##4##2##(1997-4#3)(2008-10#1)
5% NaOCl##3##2##(2013-1#3)
5% PEG##2##2##(1990-12#1)(2012-1#1)
5% PP##2##2##(2010-4#2)
5% R##6##2##(2008-10#6)
5% RSD##3##2##(2008-10#3)
5% acetic acid##2##3##(1991-2#2)
5% acetic##3##2##(1991-2#2)(2008-10#1)
5% acetonitrile##2##2##(2008-10#2)
5% and 10% formalin##2##4##(1996-12#2)
5% and 10%##3##3##(1996-12#2)(2008-5#1)
5% and 2##6##3##(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
5% and 67##2##3##(2007-7#1)(2012-2#1)
5% and R##2##3##(2008-10#2)
5% and a##7##3##(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2013-1#1)
5% and temperature##2##3##(2008-2#2)
5% and that##2##3##(2008-3#1)(2008-8#1)
5% and the##6##3##(1996-3#1)(2008-10#4)(2008-3#1)
5% and##89##2##(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#7)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#1)
5% as##2##2##(1994-12#1)(1994-8#1)
5% at a##2##3##(2008-10#1)(2008-3#1)
5% at the##5##3##(1990-11#1)(2008-10#2)(2008-2#2)
5% at##24##2##(1990-11#1)(1991-9#1)(1996-5#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
5% being##2##2##(2008-6#1)(2012-2#1)
5% between##4##2##(1997-2#1)(1997-7#1)(2008-10#2)
5% bupivacaine with##2##3##(1993-1#2)
5% bupivacaine##4##2##(1993-1#3)(1995-3#1)
5% citric acid##2##3##(2012-2#1)(2013-1#1)
5% confidence##2##2##(2008-10#1)(2010-4#1)
5% could##2##2##(2008-10#1)(2008-3#1)
5% during##2##2##(2008-10#1)(2008-2#1)
5% ethanol##2##2##(1993-8#1)(2008-10#1)
5% for a##2##3##(2008-10#2)
5% for both##5##3##(2008-10#4)(2008-3#1)
5% for ten##2##3##(2008-10#2)
5% for the##10##3##(2008-10#7)(2008-3#1)(2010-11#1)(2011-2#1)
5% for##50##2##(1991-6#1)(1994-12#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2010-11#1)(2011-1#1)(2011-2#2)
5% formalin##4##2##(1996-12#2)(2013-7#2)
5% from##2##2##(2007-12#1)(2008-3#1)
5% glucose##3##2##(2007-7#1)(2008-10#1)(2009-6#1)
5% had##7##2##(1992-1#1)(2008-1#2)(2008-12#2)(2011-2#1)(2013-8#1)
5% has been##2##3##(2008-10#1)(2010-8#1)
5% higher than##2##3##(2009-3#1)(2013-1#1)
5% in 1970##2##3##(1994-9#1)(2009-4#1)
5% in 2000##3##3##(2008-9#1)(2009-4#2)
5% in group##2##3##(2008-10#2)
5% in the first##2##4##(2008-10#1)(2012-1#1)
5% in the##14##3##(1993-8#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
5% in those##2##3##(2007-12#1)(2010-11#1)
5% in##44##2##(1990-6#1)(1990-9#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-4#4)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
5% increase##2##2##(1995-5#1)(1996-5#1)
5% increase)##2##2##(1995-5#1)(2013-1#1)
5% lidocaine##2##2##(2008-4#1)(2008-9#1)
5% lower in##2##3##(1991-6#1)(2011-2#1)
5% lower##3##2##(1991-6#1)(2008-1#1)(2011-2#1)
5% methanol##2##2##(1995-8#1)(2008-10#1)
5% nitric acid+Triton X-100##2##4##(2008-10#2)
5% of all##10##3##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#2)(2013-1#1)
5% of cases##6##3##(1993-9#1)(2007-7#1)(2007-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
5% of females##2##3##(1994-6#2)
5% of its##2##3##(1995-6#1)(2013-1#1)
5% of patients with##2##4##(2007-10#1)(2008-10#1)
5% of patients##9##3##(1990-6#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
5% of the cases##4##4##(1990-9#1)(2007-8#1)(2008-1#1)(2008-5#1)
5% of the children##2##4##(1990-12#1)(1997-4#1)
5% of the patients with##2##5##(1992-11#1)(2007-7#1)
5% of the patients##6##4##(1990-11#1)(1992-11#1)(2007-7#2)(2008-1#1)(2012-3#1)
5% of the samples##3##4##(2008-12#1)(2008-5#1)(2012-3#1)
5% of the total variance##2##5##(1993-8#1)(2010-2#1)
5% of the total##5##4##(1993-8#1)(2008-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
5% of the##56##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#2)(1995-2#3)(1997-2#1)(1997-4#1)(1997-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-8#3)
5% of them##3##3##(1991-2#1)(2007-8#1)(2011-2#1)
5% of those##4##3##(1992-11#1)(1994-3#2)(2008-1#1)
5% of total##3##3##(1995-12#1)(2007-7#1)(2008-4#1)
5% of##142##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#4)(1995-12#1)(1995-2#3)(1995-6#1)(1996-2#2)(1997-2#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-7#5)(2007-8#7)(2008-1#8)(2008-10#22)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#3)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#3)
5% on##3##2##(2008-10#2)(2008-3#1)
5% or##4##2##(1995-5#1)(1996-1#1)(2008-10#1)(2010-4#1)
5% per##2##2##(1994-6#1)(2007-2#1)
5% polarization in spectral regions with##2##6##(2008-3#2)
5% respectively and A##2##4##(2011-1#2)
5% respectively##8##2##(1990-9#1)(2008-10#4)(2011-1#3)
5% respectively)##2##2##(1990-12#1)(2007-11#1)
5% rms##2##2##(2008-2#1)(2008-3#1)
5% serum and##2##3##(1996-12#2)
5% serum##3##2##(1995-3#1)(1996-12#2)
5% sodium##4##2##(1992-3#1)(2008-10#2)(2010-3#1)
5% the##2##2##(1995-11#1)(1996-2#1)
5% to 10%##6##3##(2007-12#1)(2008-3#2)(2008-9#1)(2010-1#1)(2010-8#1)
5% to##21##2##(1994-3#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
5% total##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
5% tri-n-octylphosphine oxide (TOPO) dissolved in##2##6##(2008-10#2)
5% underwent##2##2##(2008-10#1)(2008-6#1)
5% v/v)##3##2##(2008-10#1)(2008-7#2)
5% vs##5##2##(1994-2#1)(1995-8#1)(2011-2#2)(2012-3#1)
5% w/w##2##2##(1992-11#1)(2008-5#1)
5% was found##2##3##(1990-6#1)(2008-10#1)
5% was##4##2##(1990-6#1)(2008-10#2)(2008-3#1)
5% were males and##2##4##(2008-1#1)(2013-8#1)
5% were obtained##3##3##(1993-8#1)(2008-10#2)
5% were##18##2##(1991-2#1)(1993-8#1)(1994-2#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2009-10#2)(2012-3#1)(2013-1#4)(2013-8#2)
5% when##3##2##(1997-1#1)(2008-10#1)(2008-2#1)
5% with##12##2##(1993-8#2)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
5%##1066##1##(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#2)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#4)(1991-12#3)(1991-2#5)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#4)(1992-1#2)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#9)(1993-9#4)(1994-11#1)(1994-12#4)(1994-2#6)(1994-3#5)(1994-6#6)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#6)(1995-6#2)(1995-8#7)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#12)(1996-2#4)(1996-3#4)(1996-5#5)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#3)(1997-8#3)(2006-10#1)(2006-12#1)(2006-8#3)(2007-10#5)(2007-11#18)(2007-12#10)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#18)(2007-8#19)(2007-9#2)(2008-1#19)(2008-10#293)(2008-11#27)(2008-12#17)(2008-2#30)(2008-3#47)(2008-4#7)(2008-5#41)(2008-6#14)(2008-7#25)(2008-8#15)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#5)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#9)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#22)(2011-2#47)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#21)(2012-3#12)(2012-7#2)(2013-1#44)(2013-7#3)(2013-8#18)
5%) and##25##2##(1990-8#1)(1991-12#1)(1992-9#1)(1993-12#1)(1995-12#1)(1997-4#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)
5%) at S200-299##2##3##(1995-12#2)
5%) by##2##2##(1991-3#2)
5%) cases##4##2##(2007-7#1)(2008-12#1)(2011-2#1)(2012-3#1)
5%) did not##2##3##(2007-8#1)(2008-9#1)
5%) for##2##2##(2011-2#1)(2012-2#1)
5%) had a##2##3##(1990-3#1)(2013-8#1)
5%) had##14##2##(1990-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-2#2)(2013-8#1)
5%) has been achieved##2##4##(2008-10#2)
5%) have##2##2##(1991-3#1)(2011-2#1)
5%) in the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
5%) in##8##2##(1990-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
5%) of the samples##2##4##(1994-6#2)
5%) of the##7##3##(1994-6#2)(2008-1#1)(2008-10#2)(2008-9#1)(2010-8#1)
5%) of##22##2##(1990-3#1)(1990-6#1)(1991-8#1)(1992-2#1)(1994-6#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#2)
5%) or##3##2##(2007-3#1)(2010-11#1)(2012-12#1)
5%) patients and##2##3##(2011-2#1)(2013-8#1)
5%) patients had##3##3##(1997-8#1)(2008-8#1)(2012-3#1)
5%) patients in the##2##4##(2008-1#2)
5%) patients returned##2##3##(2007-2#1)(2008-1#1)
5%) patients##14##2##(1991-12#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#5)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
5%) showed##2##2##(1991-3#1)(2012-2#1)
5%) than in the##2##4##(2007-11#2)
5%) than##4##2##(2007-11#2)(2008-7#1)(2013-1#1)
5%) to the##2##3##(1996-6#1)(2008-2#1)
5%) to##5##2##(1996-6#1)(2008-10#2)(2008-2#1)(2013-1#1)
5%) was##4##2##(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
5%) were found##2##3##(2008-5#1)(2012-2#1)
5%) were identified as##2##4##(2008-8#1)(2011-2#1)
5%) were##25##2##(1992-9#1)(1993-3#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
5%) with##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
5%)##320##1##(1990-11#1)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#2)(1991-3#5)(1991-8#1)(1991-9#1)(1992-2#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#3)(1994-7#1)(1995-12#5)(1995-3#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#21)(2007-8#5)(2008-1#34)(2008-10#32)(2008-11#5)(2008-12#11)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#7)(2009-10#1)(2009-5#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#3)(2010-4#4)(2010-5#1)(2010-8#4)(2011-1#5)(2011-2#19)(2012-1#2)(2012-12#5)(2012-2#13)(2012-3#10)(2012-7#1)(2013-1#10)(2013-8#5)
5' NCR##4##2##(2008-9#4)
5' RACE protocol##2##3##(1994-11#2)
5' RACE##3##2##(1994-11#2)(1994-12#1)
5' UTR##6##2##(1993-12#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-3#1)
5' and 3' ends of##2##5##(1994-8#1)(2008-8#1)
5' and 3' ends##5##4##(1994-8#2)(2008-10#2)(2008-8#1)
5' and 3'##17##3##(1990-7#2)(1992-3#1)(1992-8#1)(1993-2#1)(1994-8#2)(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-5#2)
5' and the 3'##2##4##(1997-6#1)(2008-10#1)
5' and the##3##3##(1997-6#1)(2008-10#2)
5' and##21##2##(1990-7#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-8#2)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-8#2)(2010-5#2)
5' end and##2##3##(2008-8#1)(2013-8#1)
5' end of the##18##4##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#2)(1994-8#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
5' end of##21##3##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#2)(1994-12#1)(1994-8#1)(1997-7#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
5' end to##2##3##(1992-6#1)(2008-8#1)
5' end##33##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#3)(1992-6#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-7#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#1)(2012-3#1)(2013-8#1)
5' ends of the##2##4##(1993-12#1)(1994-12#1)
5' ends of##3##3##(1993-12#1)(1994-12#1)(2007-12#1)
5' ends##5##2##(1993-12#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
5' exonuclease##4##2##(1997-8#4)
5' flanking DNA of##2##4##(2008-11#2)
5' flanking DNA##3##3##(1991-6#1)(2008-11#2)
5' flanking region of##3##4##(1991-5#1)(1993-12#1)(1993-3#1)
5' flanking region##12##3##(1991-5#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-11#1)(1996-10#1)(2008-7#1)
5' flanking regions##3##3##(1992-3#1)(1993-6#1)(1994-11#1)
5' flanking sequence##3##3##(1990-12#1)(1990-8#1)(1993-12#1)
5' flanking sequences##3##3##(1994-12#2)(2011-10#1)
5' flanking##27##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#4)(1994-11#2)(1994-12#2)(1995-2#1)(1996-10#1)(2008-11#2)(2008-7#1)(2011-10#1)
5' leader##3##2##(2008-10#1)(2008-9#2)
5' leaders##2##2##(2008-9#2)
5' long terminal repeat (LTR)##2##5##(1993-8#1)(1997-8#1)
5' long terminal repeat##4##4##(1993-8#2)(1994-12#1)(1997-8#1)
5' non-coding region of##2##4##(1991-9#2)
5' non-coding region##3##3##(1991-9#2)(1995-6#1)
5' non-coding##4##2##(1991-9#2)(1993-12#1)(1995-6#1)
5' noncoding region##2##3##(1995-5#1)(2008-9#1)
5' noncoding##5##2##(1993-8#1)(1995-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
5' of the##3##3##(1996-6#2)(2008-7#1)
5' of##4##2##(1991-6#1)(1996-6#2)(2008-7#1)
5' position##2##2##(1994-8#1)(2008-8#1)
5' region of the gene##2##5##(1997-7#1)(2008-8#1)
5' region of the human##3##5##(1991-6#1)(1991-7#2)
5' region of the##10##4##(1991-6#3)(1991-7#2)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
5' region of##12##3##(1990-12#1)(1991-6#3)(1991-7#2)(1992-3#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
5' region##16##2##(1990-12#3)(1991-6#4)(1991-7#2)(1992-3#1)(1995-2#1)(1995-8#1)(1997-7#2)(2008-10#1)(2008-8#1)
5' regions##3##2##(1992-8#1)(1994-12#1)(1995-8#1)
5' regulatory##4##2##(1991-9#1)(1994-12#1)(1997-6#1)(2008-11#1)
5' sequence of##2##3##(1992-12#1)(1997-2#1)
5' sequence##3##2##(1992-12#1)(1993-12#1)(1997-2#1)
5' sequences are##2##3##(1990-8#1)(1994-8#1)
5' termini##3##2##(2008-2#1)(2008-4#1)(2008-8#1)
5' terminus of the##5##4##(1992-11#1)(2008-11#1)(2008-4#3)
5' terminus of##9##3##(1992-11#1)(2008-11#1)(2008-4#7)
5' terminus##12##2##(1991-2#1)(1992-11#1)(2008-10#2)(2008-11#1)(2008-4#7)
5' to the transcription start##2##5##(1993-12#1)(1995-2#1)
5' to the##9##3##(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#2)(1996-10#1)
5' to##11##2##(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-2#2)(1996-10#1)(2008-10#1)
5' untranslated region of##5##4##(1991-9#1)(1992-11#1)(1997-8#1)(2008-11#1)(2012-2#1)
5' untranslated region##14##3##(1991-9#1)(1992-11#3)(1992-3#1)(1993-6#1)(1994-11#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)
5' untranslated regions##3##3##(1993-12#2)(1994-11#1)
5' untranslated sequence##3##3##(1992-11#2)(1992-3#1)
5' untranslated##22##2##(1991-9#1)(1992-11#5)(1992-3#2)(1993-12#2)(1993-6#1)(1994-11#2)(1994-12#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)
5' upstream region of##2##4##(1992-12#1)(2008-9#1)
5' upstream region##4##3##(1992-12#1)(1995-2#2)(2008-9#1)
5' upstream regions of##2##4##(1993-6#1)(2008-9#1)
5' upstream##7##2##(1992-12#1)(1993-6#1)(1995-2#2)(1997-2#1)(2008-9#2)
5'##279##1##(1990-11#1)(1990-12#5)(1990-5#1)(1990-7#3)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#5)(1991-6#8)(1991-7#2)(1991-9#6)(1992-11#8)(1992-12#6)(1992-3#7)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#14)(1993-2#4)(1993-3#3)(1993-6#12)(1993-8#4)(1994-11#9)(1994-12#13)(1994-2#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-2#6)(1995-5#1)(1995-6#2)(1995-8#4)(1996-10#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#9)(1997-8#9)(2007-12#2)(2008-1#2)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#10)(2008-7#4)(2008-8#16)(2008-9#13)(2009-5#1)(2010-5#4)(2011-10#1)(2012-2#2)(2012-3#2)(2013-8#1)
5'''-P1##5##1##(1997-7#5)
5')##2##1##(1991-3#2)
5'- and 3'-terminal##2##3##(2008-10#2)
5'- and 3'-untranslated regions##3##4##(1993-12#1)(1997-4#1)(2008-9#1)
5'- and##8##2##(1993-12#1)(1997-4#2)(2008-10#3)(2008-4#1)(2008-9#1)
5'-##9##1##(1993-12#1)(1997-4#2)(2008-10#4)(2008-4#1)(2008-9#1)
5'-(1##2##1##(2012-3#2)
5'-0-(3-thiotriphosphate)##4##1##(1991-6#1)(1995-8#3)
5'-3'##2##1##(1991-1#1)(1997-6#1)
5'-GC##3##1##(1993-12#1)(2008-11#2)
5'-GC-3'##3##1##(1990-7#1)(1993-11#2)
5'-GNNC-3'##2##1##(1993-11#2)
5'-N-ethylcarboxamidoadenosine (NECA)##2##2##(1994-6#1)(1995-12#1)
5'-O-DMTr-N-protected-deoxyribonucleoside-3'-O-(2-thio-spiro-4##2##1##(2008-4#2)
5'-O-dimethoxytritylated##2##1##(2008-4#2)
5'-O-levulinylated##2##1##(2008-4#2)
5'-OH##3##1##(2008-4#3)
5'-RACE##3##1##(1994-12#2)(2010-5#1)
5'-TGCAC-3'##2##1##(1993-11#2)
5'-TGTCA-3'##2##1##(1993-11#2)
5'-UTR##10##1##(1996-5#6)(2008-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
5'-amino##3##1##(2008-4#3)
5'-biotinylated##3##1##(1995-6#1)(1995-8#1)(2008-12#1)
5'-chemistry##2##1##(1991-3#2)
5'-cyclic monophosphate (cGMP)##2##3##(1995-8#1)(2008-4#1)
5'-cyclic monophosphate##5##2##(1994-11#1)(1995-8#3)(2008-4#1)
5'-cyclic##9##1##(1990-12#1)(1993-6#1)(1994-11#1)(1995-8#3)(1997-7#1)(2008-4#1)(2009-2#1)
5'-decyl-2##3##1##(2008-10#3)
5'-deiodinase##6##1##(1990-11#2)(1990-12#4)
5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine##2##1##(1992-8#2)
5'-deoxyadenosine##2##1##(1990-8#1)(1994-8#1)
5'-diphosphate##5##1##(1990-10#1)(1990-7#2)(1993-11#2)
5'-dithiobis(2-nitrobenzoic##3##1##(1993-8#1)(1995-2#1)(2008-10#1)
5'-dithiobis-(2-nitrobenzoic acid)##2##2##(2008-10#2)
5'-end of the oligonucleotide##2##4##(2008-10#2)
5'-end of the##3##3##(1993-8#1)(2008-10#2)
5'-end of##4##2##(1993-8#1)(1995-8#1)(2008-10#2)
5'-end##7##1##(1990-5#1)(1993-8#1)(1995-8#1)(2008-10#3)(2008-4#1)
5'-ends##2##1##(1991-9#1)(1993-11#1)
5'-flanking DNA sequence of the##2##5##(1994-2#1)(1997-1#1)
5'-flanking DNA sequence##4##3##(1994-2#3)(1997-1#1)
5'-flanking DNA##5##2##(1991-11#1)(1994-2#3)(1997-1#1)
5'-flanking region and the first##2##5##(1994-11#1)(2010-5#1)
5'-flanking region and##3##3##(1991-7#1)(1994-11#1)(2010-5#1)
5'-flanking region of human Cu/Zn superoxide dismutase##2##7##(1994-6#2)
5'-flanking region of human##3##4##(1994-6#3)
5'-flanking region of the gene##3##5##(1993-8#1)(1997-6#2)
5'-flanking region of the##11##4##(1991-2#1)(1993-8#3)(1994-9#1)(1995-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-9#1)
5'-flanking region of##17##3##(1991-2#2)(1992-12#1)(1993-8#3)(1994-6#3)(1994-9#1)(1995-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2008-9#1)
5'-flanking region##34##2##(1991-11#2)(1991-2#2)(1991-6#1)(1991-7#2)(1992-12#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#1)(1994-6#3)(1994-9#1)(1995-2#1)(1997-6#2)(1997-7#2)(1997-8#2)(2008-9#1)(2010-5#4)
5'-flanking sequence of the##2##4##(1990-8#1)(1993-3#1)
5'-flanking sequence of##3##3##(1990-8#1)(1993-3#1)(2008-8#1)
5'-flanking sequence##5##2##(1990-8#1)(1993-3#1)(1995-6#1)(1997-7#1)(2008-8#1)
5'-flanking sequences##3##2##(1995-2#1)(1995-6#2)
5'-flanking##49##1##(1990-11#1)(1990-8#1)(1991-11#3)(1991-2#2)(1991-6#1)(1991-7#3)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#1)(1994-2#3)(1994-6#3)(1994-9#1)(1995-2#2)(1995-6#3)(1997-1#1)(1997-6#2)(1997-7#3)(1997-8#2)(2008-8#1)(2008-9#1)(2010-5#4)
5'-hydroxyl##2##1##(2008-4#2)
5'-monophosphate (cAMP)##2##2##(1994-9#2)
5'-monophosphate##13##1##(1990-2#2)(1991-10#1)(1994-11#3)(1994-8#1)(1994-9#3)(1995-2#1)(2006-4#1)(2011-1#1)
5'-monophosphates##3##1##(1995-3#1)(2008-11#2)
5'-noncoding region##4##2##(1991-2#1)(2008-9#3)
5'-nucleotidase activity##5##2##(1994-12#1)(1994-2#2)(1997-7#2)
5'-nucleotidase##12##1##(1990-11#1)(1991-11#1)(1994-11#3)(1994-12#1)(1994-2#3)(1997-7#3)
5'-phosphate##9##1##(1991-12#1)(1992-6#3)(1996-5#1)(1997-7#1)(2008-10#1)(2008-4#2)
5'-phosphodiester##2##1##(1994-11#1)(2008-4#1)
5'-region##2##1##(1992-6#1)(2008-11#1)
5'-splice sites##3##2##(1993-11#2)(1995-6#1)
5'-splice##4##1##(1993-11#2)(1995-6#2)
5'-terminal##6##1##(1993-11#2)(1993-3#1)(1994-8#1)(2008-10#2)
5'-tetramethylbenzidine (TMB)##4##2##(1992-3#1)(2008-10#3)
5'-tetramethylbenzidine using##2##2##(2008-10#2)
5'-tetramethylbenzidine##10##1##(1990-12#1)(1992-3#1)(2008-10#8)
5'-triphosphate##12##1##(1990-5#1)(1990-7#2)(1993-6#1)(1993-8#2)(1995-5#1)(2008-3#1)(2008-4#3)(2009-12#1)
5'-triphosphates##2##1##(1993-3#1)(2008-4#1)
5'-untranslated region (UTR)##5##3##(1990-12#1)(1994-12#1)(1996-5#1)(1997-7#1)(2008-10#1)
5'-untranslated region and##3##3##(1990-11#1)(1991-6#1)(2010-5#1)
5'-untranslated region##14##2##(1990-11#1)(1990-12#1)(1991-6#1)(1991-7#2)(1992-11#1)(1993-12#1)(1994-12#2)(1996-5#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-5#1)
5'-untranslated regions##3##2##(1991-7#1)(1993-2#1)(1996-8#1)
5'-untranslated##18##1##(1990-11#1)(1990-12#1)(1991-6#1)(1991-7#3)(1992-11#1)(1993-12#1)(1993-2#1)(1994-12#3)(1996-5#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-5#1)
5'-upstream region of the IA-1 gene##2##6##(1997-7#2)
5'-upstream region of##5##3##(1993-12#1)(1996-3#2)(1997-7#2)
5'-upstream region##7##2##(1993-12#1)(1994-12#1)(1996-3#2)(1997-7#3)
5'-upstream##9##1##(1993-12#1)(1994-12#1)(1996-3#2)(1997-7#3)(2008-11#1)(2008-4#1)
5'AMP##4##1##(2008-4#4)
5'UTR##2##1##(2008-11#1)(2010-5#1)
5(2)##11##1##(1996-2#1)(2008-11#1)(2011-2#9)
5(3)##2##1##(1996-2#1)(2008-10#1)
5(b)##6##1##(2012-12#6)
5) and 0##2##3##(2007-8#1)(2009-11#1)
5) and a##2##3##(1997-4#1)(2008-2#1)
5) and the##3##3##(1990-5#1)(1996-12#1)(2008-3#1)
5) and##34##2##(1990-11#1)(1990-5#1)(1990-7#1)(1993-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-4#1)
5) are##2##2##(2008-10#2)
5) as##2##2##(2008-10#1)(2009-8#1)
5) at##2##2##(2008-10#2)
5) concentration and##2##3##(2008-5#2)
5) concentration##3##2##(2008-5#3)
5) containing##3##2##(1995-6#1)(1996-5#1)(2008-10#1)
5) elemental concentrations##2##3##(2008-5#2)
5) gene had been##2##4##(1995-2#2)
5) in the##4##3##(1994-12#1)(2008-1#1)(2008-10#2)
5) instilled mice##2##3##(2008-10#2)
5) is a##2##3##(1994-6#1)(1997-6#1)
5) is##3##2##(1994-6#1)(1997-6#1)(2008-10#1)
5) of the##2##3##(2008-10#1)(2009-6#1)
5) of##6##2##(2008-10#3)(2009-6#1)(2011-1#1)(2012-2#1)
5) or a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
5) or##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
5) solution##2##2##(2008-10#2)
5) than##2##2##(1991-11#1)(1991-12#1)
5) to##5##2##(1990-2#1)(1990-5#1)(2008-10#2)(2008-2#1)
5) triphosphate##2##2##(1990-12#2)
5) was used##2##3##(2008-10#1)(2008-4#1)
5) was##7##2##(1991-6#1)(1991-8#1)(1994-5#1)(2008-10#3)(2008-4#1)
5) were##6##2##(1992-6#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#2)
5) when compared##2##3##(2006-10#1)(2010-9#1)
5) with lambda(exc)=230 nm and##2##5##(2008-10#2)
5) with##4##2##(2008-10#4)
5)##263##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#4)(1995-5#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#4)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#84)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#5)(2008-5#18)(2008-6#2)(2008-7#3)(2009-11#4)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#7)(2011-2#7)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#8)(2013-8#3)
5)) and##2##2##(2008-5#2)
5))##5##1##(2008-10#1)(2008-5#2)(2008-8#1)(2012-3#1)
5)-bisphosphate##2##1##(1993-12#1)(2008-4#1)
5)-trisphosphate##4##1##(1990-7#2)(1991-8#1)(1996-2#1)
5)0##2##1##(2008-3#2)
5)C(0##2##1##(2008-5#2)
5)G(0##6##1##(2008-5#6)
5)IP3##9##1##(1991-8#9)
5)Na(0##2##1##(2009-5#2)
5)P(2) in##2##2##(2009-6#2)
5)P(2)##3##1##(2009-6#3)
5)P3 accumulation##4##2##(1994-8#4)
5)P3 content of human blood##2##5##(1990-7#2)
5)P3 content of human##3##4##(1990-7#3)
5)P3 content##5##2##(1990-7#4)(1997-1#1)
5)P3 production##3##2##(1997-1#3)
5)P3##17##1##(1990-12#3)(1990-7#6)(1994-8#4)(1997-1#4)
5)P3)##3##1##(1990-12#1)(1990-7#1)(1997-1#1)
5)P3]##2##1##(1994-8#1)(2012-2#1)
5)P4##2##1##(1990-7#2)
5)R(0##2##1##(2008-5#2)
5)T(0##2##1##(2008-5#2)
5)]}##2##1##(2008-10#2)
5)trisphosphate production##2##2##(1994-11#2)
5)trisphosphate##5##1##(1994-11#5)
5+/-0##23##1##(2007-12#1)(2007-8#3)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)
5+/-1##4##1##(2008-10#4)
5+/-2##2##1##(2008-10#2)
5+/-5##2##1##(2008-7#1)(2009-4#1)
5- and 10-year OS rates##2##5##(2010-3#2)
5- and 10-year##7##3##(1991-8#1)(1993-11#1)(2010-3#5)
5- and 2##3##3##(1993-6#1)(1994-8#2)
5- and##14##2##(1990-12#1)(1991-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#2)(2008-10#1)(2010-3#5)(2011-2#1)
5- to##10##2##(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-12#1)
5-##37##1##(1990-12#1)(1990-5#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-3#1)(1996-2#1)(1997-6#1)(1997-9#2)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-3#5)(2011-2#1)(2012-12#1)
5-(N##2##1##(1992-5#1)(2010-5#1)
5-(PO(4))(3)##2##1##(2008-3#2)
5-(biotinamido)pentylamine##2##1##(1992-8#2)
5-0##7##1##(1990-5#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-11#1)
5-1##19##1##(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#1)(1994-2#1)(2007-11#1)(2008-10#4)(2008-3#3)(2008-5#1)(2009-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
5-10 kDa##2##2##(1990-7#1)(2008-10#1)
5-10 min at##2##3##(1990-7#1)(2008-10#1)
5-10 ml##3##2##(1994-9#1)(2008-10#2)
5-10 times##2##2##(1995-12#1)(2008-3#1)
5-10 years##5##2##(1990-12#1)(1994-9#1)(1997-2#1)(2009-10#1)(2013-8#1)
5-10##48##1##(1990-11#1)(1990-12#1)(1990-7#3)(1992-6#1)(1992-9#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#2)(2008-10#18)(2008-3#3)(2009-10#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-8#1)
5-10% and##2##2##(2008-3#2)
5-10% of the##2##3##(1991-5#1)(1993-12#1)
5-10% of##4##2##(1991-5#1)(1992-4#1)(1993-12#1)(2008-7#1)
5-10%##17##1##(1990-2#1)(1990-6#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-2#1)(1996-7#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-8#1)(2010-11#1)
5-100 mug l(-1)##2##3##(2008-10#2)
5-100 mug##3##2##(2008-10#3)
5-100##5##1##(1994-6#1)(2008-10#4)
5-100%##2##1##(2008-10#2)
5-1000 ng ml(-1)##2##3##(2008-10#2)
5-1000##4##1##(2008-10#3)(2008-12#1)
5-102##2##1##(2008-10#2)
5-11##6##1##(1992-11#1)(1996-2#1)(1997-3#1)(2008-10#2)(2012-12#1)
5-12##7##1##(1993-10#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)
5-13##3##1##(2008-10#1)(2008-3#1)(2008-6#1)
5-14##3##1##(2008-3#3)
5-15 min after##2##3##(1992-6#1)(1997-2#1)
5-15##12##1##(1992-6#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)
5-15%##3##1##(1991-5#1)(2008-10#1)(2013-1#1)
5-17##4##1##(1996-12#1)(2008-10#1)(2010-6#1)(2013-1#1)
5-19##2##1##(2008-10#2)
5-2##34##1##(1992-3#1)(1992-5#1)(1993-12#2)(1996-12#2)(1996-2#1)(2007-12#2)(2007-2#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
5-2-1-AN behaviors##2##2##(2010-8#2)
5-2-1-AN##6##1##(2010-8#6)
5-20##9##1##(1993-8#1)(1995-11#1)(2008-10#6)(2008-4#1)
5-200##6##1##(1994-9#1)(1996-5#1)(2007-12#1)(2008-10#3)
5-200mugl(-1)##3##1##(2008-10#3)
5-22##4##1##(2008-10#2)(2008-12#1)(2010-4#1)
5-220##3##1##(2008-10#2)(2008-11#1)
5-23##2##1##(2008-10#2)
5-24##5##1##(1993-9#1)(1995-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
5-25##7##1##(1993-11#1)(2007-2#1)(2008-10#4)(2010-5#1)
5-28##2##1##(1990-6#1)(2008-10#1)
5-29##2##1##(1990-10#1)(2009-10#1)
5-3##19##1##(1992-6#1)(1992-8#1)(1993-9#1)(1995-6#1)(2008-10#11)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)
5-30##6##1##(1994-12#1)(1997-4#1)(2008-10#4)
5-36##2##1##(1995-6#1)(2007-11#1)
5-38##2##1##(2008-11#1)(2008-9#1)
5-4##22##1##(1992-12#1)(1992-6#1)(2008-10#16)(2008-2#1)(2008-3#2)(2010-3#1)
5-40##4##1##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
5-5##20##1##(1991-8#1)(1996-5#1)(2008-10#11)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
5-5%##3##1##(1991-6#1)(2008-11#1)(2011-3#1)
5-50##5##1##(1990-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
5-50%##2##1##(2007-10#1)(2008-11#1)
5-500 ng ml(-1) of##2##4##(2008-10#2)
5-500##4##1##(2008-10#3)(2008-11#1)
5-50muM##2##1##(2008-10#2)
5-55##2##1##(2008-10#1)(2013-8#1)
5-6 and##2##2##(2008-10#1)(2011-1#1)
5-6 h##2##2##(2008-10#1)(2008-9#1)
5-6 million##2##2##(1992-6#2)
5-6 times##5##2##(1991-6#1)(2007-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
5-6 weeks##2##2##(2008-11#1)(2008-7#1)
5-6##46##1##(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-1#1)
5-6%##2##1##(2008-10#2)
5-6-fold##2##1##(1993-8#1)(1995-5#1)
5-60##2##1##(2008-10#1)(2013-1#1)
5-7 (R##2##2##(2008-10#2)
5-7 days##2##2##(1995-8#1)(2007-8#1)
5-7 with a lower detection limit of 0##2##8##(2008-10#2)
5-7##27##1##(1995-8#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#18)(2008-5#1)(2008-7#1)(2013-1#1)
5-8##25##1##(1990-5#2)(1993-10#1)(1993-12#1)(1995-2#2)(2007-11#1)(2008-10#12)(2008-11#1)(2008-2#2)(2009-8#1)(2011-1#1)(2011-2#1)
5-8%##2##1##(2007-11#1)(2008-10#1)
5-80##2##1##(2008-10#2)
5-9##20##1##(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#2)
5-A##2##1##(1993-8#1)(1994-5#1)
5-ADIOL-S and##2##2##(1990-11#2)
5-ASA##5##1##(2008-10#2)(2011-3#3)
5-Bis(hydroxymethyl)-1##3##1##(1996-5#3)
5-Br-PADAP##7##1##(2008-10#7)
5-Br-PSAA##2##1##(2008-10#2)
5-CLA##4##1##(1992-3#4)
5-CLA-PBGS is##2##2##(1992-3#2)
5-CLA-PBGS##4##1##(1992-3#4)
5-DMCOD##2##1##(1996-2#2)
5-FCyt##2##1##(1994-5#2)
5-FU U2##2##2##(1993-8#2)
5-FU and##3##2##(1994-7#2)(2008-8#1)
5-FU in##2##2##(1991-3#2)
5-FU incorporation##4##2##(1993-8#4)
5-FU##22##1##(1991-3#4)(1993-8#8)(1994-7#2)(2008-10#2)(2008-11#2)(2008-6#2)(2008-8#1)(2010-12#1)
5-FU-induced##2##1##(2008-10#2)
5-Fluorouracil##3##1##(1997-7#1)(2008-6#2)
5-GHz##3##1##(2007-11#1)(2007-12#2)
5-Gbit/s##2##1##(2007-12#1)(2008-3#1)
5-HIAA and##3##2##(1992-11#1)(2008-3#2)
5-HIAA levels##2##2##(1992-1#2)
5-HIAA##11##1##(1992-1#2)(1992-11#1)(1993-1#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-3#4)
5-HT and##6##2##(1994-2#1)(1995-12#1)(2008-3#2)(2008-7#1)(2012-12#1)
5-HT content in##2##3##(1993-12#1)(2008-6#1)
5-HT content##4##2##(1993-12#1)(1995-12#1)(1996-12#1)(2008-6#1)
5-HT could##2##2##(1990-5#1)(1993-12#1)
5-HT fiber##2##2##(1996-12#2)
5-HT fibers##3##2##(1996-12#3)
5-HT in the##3##3##(1991-2#1)(1995-12#1)(2008-6#1)
5-HT in this##2##3##(1994-2#1)(1995-12#1)
5-HT in##8##2##(1990-5#1)(1991-2#1)(1992-11#1)(1994-2#1)(1995-12#2)(2008-6#1)(2012-12#1)
5-HT injections##2##2##(1991-2#2)
5-HT is##3##2##(2008-7#3)
5-HT levels in##3##3##(1994-2#1)(1997-6#2)
5-HT levels##6##2##(1992-1#1)(1994-2#2)(1997-6#3)
5-HT mediated##2##2##(1993-9#2)
5-HT metabolism##2##2##(1995-3#1)(2008-7#1)
5-HT neurons##3##2##(1995-5#1)(1996-12#1)(1997-6#1)
5-HT pharmacotherapies##3##2##(2008-2#3)
5-HT receptor##3##2##(1990-5#1)(1994-2#1)(2008-7#1)
5-HT receptors##3##2##(1995-12#1)(2008-5#2)
5-HT release in##3##3##(1995-12#1)(2008-7#2)
5-HT release##7##2##(1995-12#2)(2008-7#5)
5-HT transporter##5##2##(1994-2#2)(2008-7#3)
5-HT uptake##2##2##(1996-5#1)(2008-7#1)
5-HT##123##1##(1990-5#6)(1991-2#6)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#3)(1993-12#6)(1993-3#2)(1993-9#5)(1994-2#9)(1994-6#1)(1995-12#13)(1995-3#1)(1995-5#1)(1996-12#10)(1996-5#3)(1997-6#4)(2008-10#1)(2008-2#6)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#25)(2008-8#3)(2011-3#1)(2012-12#5)(2012-3#2)
5-HT(1A) and##2##2##(2007-11#1)(2008-7#1)
5-HT(1A)##5##1##(2007-11#3)(2008-7#2)
5-HT(1B/1D)##2##1##(2008-7#2)
5-HT(2A) receptor##2##2##(2008-9#2)
5-HT(2A) receptors##3##2##(2007-11#2)(2008-11#1)
5-HT(2A)##6##1##(2007-11#2)(2008-11#2)(2008-9#2)
5-HT(2C) receptor##2##2##(2008-9#2)
5-HT(3) receptors##3##2##(2008-11#1)(2008-7#2)
5-HT(3)##5##1##(2008-11#2)(2008-7#3)
5-HT(7)##2##1##(2008-7#2)
5-HT)##6##1##(1990-5#1)(1993-2#1)(1995-12#3)(2008-2#1)
5-HT-induced##5##1##(1992-8#1)(2011-3#4)
5-HT1 and 5-HT2##2##3##(1994-6#2)
5-HT1 and##3##2##(1994-6#3)
5-HT1##6##1##(1994-2#1)(1994-6#4)(2008-5#1)
5-HT1A and 5-HT2 receptors and##2##5##(1994-2#2)
5-HT1A and 5-HT2 receptors##3##4##(1993-9#1)(1994-2#2)
5-HT1A and 5-HT2##4##3##(1993-9#1)(1994-2#3)
5-HT1A and##5##2##(1992-12#1)(1993-9#1)(1994-2#3)
5-HT1A receptor agonists##2##3##(1994-2#2)
5-HT1A receptor antagonist##2##3##(1994-2#1)(1995-12#1)
5-HT1A receptor densities##2##3##(1994-2#2)
5-HT1A receptor gene##2##3##(1993-3#2)
5-HT1A receptor ligand##2##3##(1993-3#1)(1995-12#1)
5-HT1A receptor ligands##3##3##(1995-12#1)(1995-3#1)(2007-11#1)
5-HT1A receptor mRNA##2##3##(1993-3#1)(1994-2#1)
5-HT1A receptor##22##2##(1993-3#7)(1993-9#1)(1994-2#7)(1995-12#5)(1995-3#1)(2007-11#1)
5-HT1A receptors represented the##2##4##(1994-2#2)
5-HT1A receptors##13##2##(1990-5#1)(1993-12#1)(1994-2#6)(1995-12#4)(2012-3#1)
5-HT1A##50##1##(1990-5#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#7)(1993-9#5)(1994-2#19)(1995-12#10)(1995-3#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
5-HT1B knock-out mice##2##3##(1995-12#2)
5-HT1B receptor agonist##2##3##(1994-2#1)(1995-12#1)
5-HT1B receptor##4##2##(1994-2#1)(1995-12#3)
5-HT1B receptors##5##2##(1995-12#5)
5-HT1B##17##1##(1994-2#1)(1995-12#16)
5-HT1C receptors##5##2##(1990-5#1)(1991-12#4)
5-HT1C##6##1##(1990-5#1)(1991-12#5)
5-HT1D and 5-HT1A receptors##2##4##(1995-12#2)
5-HT1D and 5-HT1E binding sites##2##5##(1994-2#2)
5-HT1D and 5-HT1E sites##2##4##(1994-2#2)
5-HT1D and 5-HT1E##4##3##(1994-2#4)
5-HT1D and##6##2##(1994-2#4)(1995-12#2)
5-HT1D receptor##2##2##(1995-12#2)
5-HT1D sites##3##2##(1994-2#3)
5-HT1D##14##1##(1994-2#8)(1995-12#6)
5-HT1E sites represented##2##3##(1994-2#2)
5-HT1E sites##7##2##(1994-2#7)
5-HT1E##11##1##(1994-2#11)
5-HT2 and 5-HT1C receptors##3##4##(1991-12#3)
5-HT2 and 5-HT1C##4##3##(1991-12#4)
5-HT2 receptor densities##2##3##(1994-2#2)
5-HT2 receptor##9##2##(1991-12#1)(1993-9#3)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#1)
5-HT2 receptors and the##3##4##(1994-2#1)(1995-12#2)
5-HT2 receptors and##5##3##(1994-2#2)(1995-12#3)
5-HT2 receptors in##2##3##(1993-9#1)(1996-5#1)
5-HT2 receptors##11##2##(1991-2#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-12#4)(1995-3#1)(1996-5#1)
5-HT2##30##1##(1990-5#1)(1991-12#5)(1991-2#1)(1993-9#4)(1994-2#5)(1994-6#3)(1995-12#5)(1995-3#4)(1996-5#1)(2008-5#1)
5-HT2A##4##1##(1995-3#4)
5-HT2C receptor##6##2##(1996-12#6)
5-HT2C##8##1##(1995-3#1)(1996-12#7)
5-HT3 antagonist##3##2##(1993-12#1)(1994-2#2)
5-HT3 receptor antagonist##2##3##(1990-12#1)(1993-12#1)
5-HT3 receptor##5##2##(1990-12#1)(1993-12#1)(1994-2#2)(2008-11#1)
5-HT3##10##1##(1990-12#1)(1993-12#2)(1994-2#5)(2008-11#1)(2008-5#1)
5-HT4 receptors##3##2##(1996-12#2)(2008-5#1)
5-HT4##4##1##(1996-12#3)(2008-5#1)
5-HT7 receptor##5##2##(2008-5#5)
5-HT7##7##1##(2008-5#7)
5-HTP (150 mg/kg i##2##4##(1995-12#2)
5-HTP##4##1##(1995-12#4)
5-HTR1D##2##1##(1993-2#2)
5-HTT sites were##2##3##(1995-5#2)
5-HTT sites##3##2##(1995-5#3)
5-HTT##5##1##(1995-5#3)(1996-12#2)
5-HTT55 and 5-HTT315##2##3##(1996-12#2)
5-HTT55##3##1##(1996-12#3)
5-HTTLPR##3##1##(2008-9#1)(2012-1#2)
5-HTTN##5##1##(1996-12#5)
5-LO##7##1##(1991-8#3)(1993-6#4)
5-MHz##2##1##(2007-12#1)(2008-2#1)
5-MTA##3##1##(1995-12#3)
5-MTO##3##1##(1995-12#3)
5-Mb##2##1##(1997-3#2)
5-Me(2)pz)(3)##2##1##(1996-2#2)
5-Me(2)pz)(3)](2)Tl}PF(6)##3##1##(1996-2#3)
5-Me(2)pz)(3)]Tl}PF(6)##3##1##(1996-2#3)
5-Mec##2##1##(1993-9#2)
5-N##3##1##(2009-12#1)(2009-2#2)
5-N927K Na(+) channels##3##3##(2008-8#3)
5-N927K##4##1##(2008-8#4)
5-NO(2)##3##1##(2008-10#3)
5-OglycolylNeu5Gc was##4##2##(1994-11#4)
5-OglycolylNeu5Gc##5##1##(1994-11#5)
5-P3##2##1##(1997-1#2)
5-P4 accumulation##3##2##(1997-1#3)
5-P4##5##1##(1997-1#5)
5-T##2##1##(1997-8#1)(2008-7#1)
5-T)##2##1##(2008-10#2)
5-THT##2##1##(2008-10#2)
5-VOT in##2##2##(2008-10#2)
5-VOT##8##1##(2008-10#8)
5-W##6##1##(2007-11#1)(2007-12#4)(2008-10#1)
5-[N##2##1##(1995-3#2)
5-alpha-reductase##4##1##(1990-11#1)(2008-10#1)(2008-5#2)
5-amino-1##2##1##(2008-10#2)
5-aminoisoxazoles##2##1##(2007-11#2)
5-aminolevulinic acid##5##2##(1992-8#1)(1992-9#2)(2012-3#2)
5-aminosalicylate##3##1##(1997-3#1)(2012-12#2)
5-aminosalicylic acid##2##2##(2008-10#2)
5-anhydrohexitol building blocks for oligonucleotide synthesis##2##6##(2008-4#2)
5-anhydrohexitol##3##1##(2008-4#3)
5-aza##3##1##(1990-5#1)(2007-11#2)
5-aza-2'-deoxycytidine##2##1##(2008-5#1)(2013-1#1)
5-azacytidine##8##1##(1992-3#2)(2008-11#1)(2008-5#1)(2008-9#3)(2013-8#1)
5-b]pyridine (PhIP)##2##2##(1995-9#1)(1997-4#1)
5-b]pyridine)##2##1##(1995-12#1)(1997-2#1)
5-benzo[1##2##1##(1996-5#2)
5-bis(2-pyridyl)-3-sulphophenyl methylene thiocarbonohydrazide##2##3##(2008-10#2)
5-bis(hydroxymethyl)-1##3##1##(1996-5#3)
5-bisphosphate (PIP2)##3##2##(1992-9#1)(1993-6#1)(1993-8#1)
5-bisphosphate carboxylase/oxygenase##2##2##(1993-12#1)(1994-8#1)
5-bisphosphate carboxylases/oxygenases##2##2##(1997-6#2)
5-bisphosphate in##2##2##(1997-1#1)(2008-7#1)
5-bisphosphate were##2##2##(1997-6#2)
5-bisphosphate##16##1##(1990-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1997-1#1)(1997-6#4)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
5-bromo-2'-deoxyuridine (BrdU)##4##2##(1995-12#1)(1996-5#1)(2008-11#1)(2008-4#1)
5-bromo-2'-deoxyuridine##5##1##(1992-5#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-4#1)
5-bromodeoxyuridine (BrdU)##2##2##(1996-2#1)(2008-9#1)
5-bromodeoxyuridine##3##1##(1996-2#1)(2008-9#2)
5-c]pyrimidin-5(6H)ones##2##1##(1992-9#2)
5-chloro-8-quinolinol##2##1##(2008-10#2)
5-choice serial reaction time task##4##5##(1992-11#2)(2008-4#2)
5-cm##3##1##(2007-12#2)(2008-3#1)
5-cm-long##3##1##(2007-12#2)(2008-3#1)
5-cyclooctadiene (1##2##2##(1996-2#2)
5-cyclooctadiene##4##1##(1996-2#3)(2009-11#1)
5-day##9##1##(1991-12#1)(1991-8#1)(1992-12#1)(2007-8#1)(2008-10#4)(2008-6#1)
5-day-old##3##1##(2008-10#1)(2011-2#2)
5-deazafolate##2##1##(1995-2#2)
5-di-tert-butyl-1##2##1##(1996-2#2)
5-diacetyl-1##2##1##(2008-10#2)
5-diamino-6-chloropyrazinecarboxyl) guanidine##2##2##(2008-10#2)
5-diaminopentane##3##1##(1992-11#2)(2008-10#1)
5-dibromothiophene-2-carboxaldehyde##2##1##(2008-11#2)
5-dicarboxylates (2a-g)##2##2##(2012-3#2)
5-dicarboxylates (3a-g)##2##2##(2012-3#2)
5-dicarboxylates##5##1##(2012-3#5)
5-dichloro-3##2##1##(2008-10#2)
5-dichlorophenol and influent wastewater##2##4##(2008-10#2)
5-dichlorophenol##3##1##(2008-10#3)
5-dihydro-1H-1##4##1##(2007-11#4)
5-dihydro-1H-imidazolyl-1-oxyl-3-oxide##2##1##(2008-10#2)
5-dihydro-1H-pyrazol-3-yl-amino)-6##2##1##(2011-1#2)
5-dihydroxy-1##2##1##(2008-10#2)
5-dihydroxycinnimate##2##1##(1996-12#2)
5-dihydroxyphenyl]squaraine##2##1##(2008-10#2)
5-dimercapto-1##2##1##(2008-10#2)
5-dimethoxyaniline##2##1##(2008-10#2)
5-dimethyl-1##3##1##(1996-2#3)
5-dimethylcyclohexane-1##2##1##(2008-10#2)
5-dimethylhydantoin##2##1##(2008-10#2)
5-dimethylimidazol-2-ylidene)##2##1##(2010-5#2)
5-dimethylphenyl carbamate) chiral stationary phase##2##5##(2008-10#2)
5-dimethylphenyl carbamate)##3##2##(2008-10#3)
5-dimethylphenylcarbamate) chiral stationary phases##2##4##(2008-10#2)
5-dimethylphenylcarbamate) chiral stationary##3##3##(2008-10#3)
5-dimethylphenylcarbamate)##4##1##(2008-10#4)
5-dimethylpyrazolyl)borate)##2##1##(1996-2#2)
5-dinitrobenzoic acid##2##2##(2008-10#2)
5-diol##2##1##(1996-5#2)
5-dione##5##1##(1996-5#2)(2008-10#2)(2008-4#1)
5-diones##2##1##(1996-5#2)
5-dioxahexyl)-15-methyl-16-crown-5##2##1##(2008-10#2)
5-diphenylcarbazide##4##1##(2008-10#4)
5-diphenylcarbazone complex##2##2##(2008-10#2)
5-diphenylcarbohydrazide##2##1##(2008-10#2)
5-disubstituted 1H-pyrazole##2##2##(2008-10#2)
5-disulfonate##2##1##(2008-10#2)
5-enolpyruvylshikimate 3-phosphate synthase##3##3##(2008-9#3)
5-epi-aristolochene synthase##2##2##(1994-8#2)
5-exo-trig##3##1##(2007-11#3)
5-f]quinoxaline)##2##1##(1997-2#2)
5-factor##2##1##(2008-10#2)
5-field##2##1##(2007-10#2)
5-fluorouracil (5-FU)##4##2##(1994-7#1)(2008-10#1)(2008-8#1)(2010-12#1)
5-fluorouracil (5FU)##3##2##(1992-2#1)(1995-4#1)(2008-5#1)
5-fluorouracil and##4##2##(1990-10#1)(1991-2#1)(1991-4#1)(1993-1#1)
5-fluorouracil in##4##2##(1990-12#1)(1990-8#2)(1991-4#1)
5-fluorouracil on##4##2##(1990-2#1)(1992-8#2)(1997-6#1)
5-fluorouracil treated##2##2##(1991-9#1)(1992-8#1)
5-fluorouracil##43##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-8#3)(1991-2#2)(1991-4#3)(1991-9#1)(1992-12#2)(1992-2#4)(1992-8#4)(1993-1#1)(1994-7#1)(1995-4#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-12#1)(2011-2#1)(2013-7#2)
5-fluorouridine##4##1##(1990-8#1)(1993-8#3)
5-fold after##2##2##(1991-12#1)(2008-7#1)
5-fold by##2##2##(1994-11#1)(1995-8#1)
5-fold decrease in##4##3##(1994-8#1)(1994-9#1)(1995-2#1)(2011-10#1)
5-fold greater##2##2##(1990-12#1)(1991-5#1)
5-fold higher than##2##3##(1993-9#1)(2008-11#1)
5-fold higher##8##2##(1993-2#1)(1993-9#2)(1995-6#1)(1997-4#1)(2008-11#1)(2008-5#2)
5-fold in PL versus NP groups during the reproductive period and about 1##2##13##(1997-4#2)
5-fold in##6##2##(1993-3#1)(1996-5#1)(1997-4#2)(1997-6#1)(2008-7#1)
5-fold increase in the##3##4##(1990-5#1)(1990-7#1)(1994-12#1)
5-fold increase in##9##3##(1990-5#1)(1990-7#2)(1994-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
5-fold increase##10##2##(1990-5#1)(1990-7#2)(1994-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
5-fold lower##2##2##(2009-10#1)(2010-1#1)
5-fold more than##2##3##(2008-10#2)
5-fold more##3##2##(2008-10#2)(2012-12#1)
5-fold reduction in##3##3##(1993-6#1)(1995-9#1)(2008-10#1)
5-fold##68##1##(1990-10#1)(1990-12#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-5#2)(1997-4#4)(1997-6#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-10#1)(2010-1#2)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
5-fold)##5##1##(1990-12#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-2#1)
5-fs pulses##5##2##(2007-11#3)(2007-12#2)
5-fs##7##1##(2007-11#4)(2007-12#3)
5-hexatriene##2##1##(1991-5#1)(2008-10#1)
5-hydroxyindole-3-acetic acid##3##2##(1995-3#1)(2008-10#2)
5-hydroxyindoleacetic acid (5-HIAA)##4##3##(1992-1#1)(1993-1#1)(1995-12#1)(2008-3#1)
5-hydroxyindoleacetic acid##5##2##(1992-1#1)(1993-1#1)(1995-12#1)(1997-7#1)(2008-3#1)
5-hydroxytryptamine (5-HT)##3##2##(1994-6#1)(1995-12#1)(2008-10#1)
5-hydroxytryptamine 1D##2##2##(1993-12#2)
5-hydroxytryptamine##17##1##(1990-12#1)(1990-5#2)(1993-12#2)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-4#2)(2008-6#2)(2012-3#1)
5-hydroxytryptamine-3##2##1##(2008-7#2)
5-hydroxytryptophan##4##1##(1995-12#2)(1995-3#1)(2008-10#1)
5-inositol trisphosphate##2##2##(1991-12#1)(1994-11#1)
5-item##2##1##(2009-11#1)(2010-4#1)
5-kDa##3##1##(1990-5#1)(1992-4#1)(1996-10#1)
5-kHz##3##1##(2007-11#1)(2008-3#2)
5-kb DNA fragment##2##3##(1991-5#1)(2008-10#1)
5-kb PstI fragments##2##3##(1990-12#2)
5-kb PstI##3##2##(1990-12#2)(1997-7#1)
5-kb fraction##2##2##(1995-2#2)
5-kb fragment##3##2##(1994-12#1)(1997-7#1)(2008-10#1)
5-kb##20##1##(1990-12#2)(1990-5#2)(1991-5#1)(1993-2#1)(1993-9#1)(1994-12#2)(1995-2#3)(1997-7#4)(2008-10#3)(2008-6#1)
5-km##2##1##(2007-12#1)(2008-3#1)
5-lipoxygenase activity##2##2##(1993-6#2)
5-lipoxygenase##7##1##(1991-8#2)(1993-6#3)(2008-11#1)(2013-1#1)
5-m##7##1##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
5-mJ##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
5-methoxytryptamine##4##1##(1993-6#2)(1995-12#1)(2008-5#1)
5-methoxytryptophol##2##1##(1995-12#2)
5-methyl-BDY-3-dodecanoic acid##2##2##(1992-9#2)
5-methyl-urapidil##4##1##(1995-12#4)
5-methylcytosine##5##1##(1990-8#1)(1991-5#1)(1992-11#1)(1993-11#2)
5-methylidene-1##2##1##(2007-11#2)
5-methyltetrahydrofolate##5##1##(1994-6#5)
5-methyltryptophan##4##1##(1994-6#4)
5-methylurapidil##2##1##(1995-12#2)
5-microm##13##1##(2007-11#2)(2007-12#6)(2008-3#5)
5-microm)##2##1##(2008-2#1)(2008-3#1)
5-microns##2##1##(1991-5#1)(1997-2#1)
5-min temporal##2##2##(2008-2#2)
5-min##12##1##(1991-2#1)(2008-10#3)(2008-2#3)(2008-5#3)(2008-9#1)(2011-2#1)
5-ml##5##1##(2008-10#5)
5-mm diameter##2##2##(2007-10#1)(2007-12#1)
5-mm laparoscopic##3##2##(1996-2#2)(2009-9#1)
5-mm##15##1##(1996-2#2)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)
5-mm-diameter##3##1##(2007-11#1)(2008-3#1)(2010-9#1)
5-mm-long##5##1##(2007-12#3)(2008-2#1)(2008-3#1)
5-mm-thick##2##1##(2007-12#2)
5-mol##2##1##(2008-2#2)
5-month##2##1##(2010-5#1)(2012-2#1)
5-month-old##7##1##(1995-8#1)(1996-1#1)(1997-9#3)(2009-11#1)(2011-1#1)
5-mum band##2##2##(2007-12#1)(2008-3#1)
5-mum emissions from##2##3##(2007-12#2)
5-mum spatial resolution at##2##4##(2008-3#2)
5-mum##15##1##(2007-12#7)(2008-10#3)(2008-2#1)(2008-3#4)
5-n-Alkylresorcinols from##2##2##(2008-11#2)
5-nm##6##1##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)
5-ns pulses##2##2##(2007-11#1)(2007-12#1)
5-ns##6##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
5-ns)##2##1##(2007-11#1)(2008-3#1)
5-pentachlorobiphenyl##2##1##(1996-12#2)
5-phosphate##2##1##(2008-7#2)
5-point##2##1##(2008-10#1)(2009-5#1)
5-ps##2##1##(2007-11#1)(2008-3#1)
5-s##2##1##(1996-6#1)(2008-2#1)
5-sulfaminouracil##3##1##(2008-10#3)
5-sulfosalicylic##3##1##(2008-10#3)
5-tetrachlorophenol##2##1##(2008-10#2)
5-tetrakisphosphate##2##1##(1991-12#2)
5-tetramethyl-4##2##1##(2008-10#2)
5-triazine (RDX)##3##2##(2008-10#3)
5-triazine modified carbon paste electrode##2##5##(2008-10#2)
5-triazine##9##1##(2008-10#8)(2008-11#1)
5-trichlorophenoxyacetic acid (2##2##3##(2008-10#2)
5-trichlorophenoxyacetic##3##1##(2008-10#3)
5-triiodo-L-thyronine##2##1##(1993-8#2)
5-triiodothyronine##3##1##(1990-12#1)(1992-12#2)
5-trimethylcyclohexanol##3##1##(1994-8#3)
5-trimethylene-2##5##1##(2008-10#5)
5-trinitro-1##4##1##(2008-10#3)(2008-7#1)
5-trinitro-s-triazine (RDX)##2##2##(2008-10#1)(2008-3#1)
5-trinitrobenzene##4##1##(2008-10#4)
5-triphosphate##2##1##(1993-6#1)(2011-1#1)
5-trisphosphate (IP3)##4##2##(1990-12#1)(1992-9#1)(1993-8#1)(1997-4#1)
5-trisphosphate [PtdIns(3##2##2##(2009-7#1)(2012-2#1)
5-trisphosphate receptor##2##2##(1991-2#1)(2008-8#1)
5-trisphosphate##28##1##(1990-12#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-8#4)(1994-11#1)(1994-8#2)(1995-11#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-8#2)(2009-7#2)(2012-2#1)(2013-1#1)
5-vinyl-1##2##1##(2007-11#1)(2008-10#1)
5-week##3##1##(1992-6#1)(2011-2#1)(2013-8#1)
5-year EFS##4##2##(2010-3#2)(2011-2#2)
5-year age##2##2##(2008-3#1)(2008-7#1)
5-year disease-free survival##5##3##(1991-8#1)(1994-7#2)(1997-7#2)
5-year disease-free##6##2##(1991-8#1)(1994-7#2)(1997-7#3)
5-year follow-up##3##2##(2008-10#1)(2008-7#2)
5-year mortality##2##2##(2008-7#2)
5-year overall survival##2##3##(1994-7#1)(2011-2#1)
5-year period##10##2##(1991-2#1)(1995-9#1)(1997-8#1)(2007-2#1)(2007-8#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
5-year rate##2##2##(1991-4#1)(2010-3#1)
5-year survival for patients with##2##5##(2008-3#2)
5-year survival in##2##3##(1990-8#1)(2011-3#1)
5-year survival of##2##3##(2010-12#1)(2011-1#1)
5-year survival rate was##5##4##(1990-9#1)(1997-7#2)(2007-8#1)(2008-8#1)
5-year survival rate##10##3##(1990-9#1)(1997-7#3)(2007-8#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
5-year survival rates##2##3##(2012-3#1)(2013-8#1)
5-year survival was##2##3##(1995-8#1)(2008-6#1)
5-year survival##23##2##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1995-8#1)(1997-7#3)(2007-8#1)(2008-1#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
5-year##78##1##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-7#3)(1995-8#1)(1995-9#1)(1996-2#1)(1997-7#10)(1997-8#2)(2007-2#2)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-6#3)(2008-7#5)(2008-8#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-3#4)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
5-year-old Labrador retriever##2##3##(2013-8#2)
5-year-old boy##3##2##(1990-6#1)(2008-10#1)(2013-1#1)
5-year-old##11##1##(1990-6#1)(2008-10#3)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
5/100 complex##2##2##(2008-10#2)
5/100##5##1##(1992-10#1)(1997-3#1)(2007-12#1)(2008-10#2)
5/12##2##1##(1990-3#1)(1993-9#1)
5/14##3##1##(1990-2#1)(1992-9#1)(2008-4#1)
5/16##3##1##(1991-6#1)(2012-3#2)
5/20##3##1##(2008-10#3)
5/5##3##1##(2008-10#2)(2008-9#1)
50 % of the##3##4##(2012-12#3)
50 %##5##2##(2008-5#2)(2012-12#3)
50 (v/v)##3##2##(2008-10#3)
50 +/- 0##4##3##(2008-2#1)(2008-3#2)(2011-2#1)
50 +/-##7##2##(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
50 -##2##2##(2011-1#1)(2012-3#1)
50 000##2##2##(2008-10#1)(2013-1#1)
50 GHz##4##2##(2007-11#3)(2007-12#1)
50 Hz##3##2##(2007-11#1)(2008-12#1)(2008-3#1)
50 V##3##2##(2008-10#3)
50 after##2##2##(1990-9#1)(2006-6#1)
50 and 0##4##3##(2008-10#1)(2008-5#1)(2009-3#1)(2012-12#1)
50 and 10##2##3##(2008-10#2)
50 and 100 mg##2##4##(2008-5#2)
50 and 100 mg/kg##2##4##(2008-9#1)(2013-1#1)
50 and 100##6##3##(2008-3#1)(2008-5#2)(2008-9#2)(2013-1#1)
50 and 100%##2##3##(2008-10#1)(2012-12#1)
50 and 200##5##3##(1991-12#1)(1995-6#1)(2007-5#1)(2008-10#1)(2008-2#1)
50 and 250 mg##2##4##(2008-10#1)(2008-12#1)
50 and 4##2##3##(1997-4#1)(2008-12#1)
50 and 500##2##3##(2008-10#2)
50 and 70##4##3##(2007-10#1)(2007-11#1)(2008-10#1)(2010-8#1)
50 and 70%##2##3##(2008-10#2)
50 and older##3##3##(1995-2#2)(1997-1#1)
50 and##65##2##(1991-12#1)(1993-2#1)(1994-12#1)(1995-12#2)(1995-2#3)(1995-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#28)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#2)(2009-3#1)(2010-3#1)(2010-8#2)(2012-12#2)(2013-1#2)
50 bp##2##2##(1991-5#1)(1991-6#1)
50 cases of##3##3##(1990-6#1)(1994-2#1)(2011-1#1)
50 cases##5##2##(1990-6#1)(1994-2#1)(2008-10#1)(2009-7#1)(2011-1#1)
50 children##4##2##(1991-2#2)(1995-6#1)(2013-1#1)
50 cm##6##2##(1996-5#2)(2008-10#3)(2008-3#1)
50 consecutive##2##2##(1996-9#1)(2008-8#1)
50 cows##2##2##(1992-2#2)
50 cycles of##2##3##(2008-10#2)
50 cycles##3##2##(2008-10#2)(2008-8#1)
50 days##4##2##(2008-10#2)(2008-5#1)(2009-3#1)
50 degrees C and##6##4##(1990-2#1)(2008-10#5)
50 degrees C for both##2##5##(2008-5#1)(2008-7#1)
50 degrees C for##6##4##(1993-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)
50 degrees C##38##3##(1990-2#1)(1991-5#2)(1993-11#1)(1994-11#2)(1994-5#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-9#2)
50 degrees##44##2##(1990-2#1)(1991-5#2)(1993-11#1)(1994-11#2)(1994-5#1)(1995-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#18)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2009-9#2)(2013-1#1)
50 female##2##2##(2008-11#1)(2009-7#1)
50 fg of##2##3##(1994-2#1)(2008-10#1)
50 fg##4##2##(1994-2#1)(2008-10#2)(2012-3#1)
50 g of##3##3##(2008-10#2)(2012-3#1)
50 g##7##2##(2008-1#1)(2008-10#3)(2008-12#2)(2012-3#1)
50 general practitioners##2##3##(1990-2#1)(1994-11#1)
50 generations##2##2##(1993-9#1)(1994-3#1)
50 h##4##2##(2008-10#2)(2008-11#2)
50 h(-1)##3##2##(2008-10#3)
50 healthy##3##2##(2008-7#1)(2011-2#2)
50 in##5##2##(1990-9#1)(2007-7#1)(2008-10#3)
50 is##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
50 isolates##2##2##(2008-10#2)
50 kDa in##2##3##(2008-10#2)
50 kDa##8##2##(1992-3#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#4)
50 kHz##4##2##(2007-5#1)(2008-3#3)
50 kg##3##2##(2008-12#2)(2011-2#1)
50 km##2##2##(2008-10#1)(2008-3#1)
50 location-years##2##2##(2008-10#2)
50 mA cm(-2) for##2##4##(2008-10#2)
50 mM K+##2##3##(1994-2#2)
50 mM phosphate buffer (pH##2##5##(1996-5#1)(2008-4#1)
50 mM phosphate buffer##3##4##(1996-5#1)(2008-10#1)(2008-4#1)
50 mM sodium##2##3##(2008-10#2)
50 mM##15##2##(1990-12#2)(1990-8#1)(1994-2#3)(1994-9#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)
50 mM) and 35 degrees C were obtained as the optimum##2##11##(2008-10#2)
50 mM) and 35 degrees C were##3##7##(2008-10#3)
50 mM)##4##2##(1992-8#1)(2008-10#3)
50 mV##7##2##(1995-12#1)(1995-5#1)(2008-10#5)
50 mW##2##2##(2008-2#2)
50 males##2##2##(1993-11#1)(2011-2#1)
50 mg Pl(-1)) for the##2##5##(2008-10#2)
50 mg kg(-1) for##2##4##(2008-12#2)
50 mg kg(-1)##3##3##(2008-10#1)(2008-12#2)
50 mg l(-1)##3##3##(2008-10#3)
50 mg of##4##3##(1991-11#1)(2008-10#2)(2011-1#1)
50 mg per##2##3##(1995-11#1)(2008-10#1)
50 mg##28##2##(1990-11#2)(1991-11#1)(1994-8#1)(1995-11#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-5#2)(2011-1#1)
50 mg)##2##2##(2008-10#1)(2008-6#1)
50 mg/kg females##2##3##(2008-9#2)
50 mg/kg##19##2##(1991-12#2)(1994-12#1)(1996-2#1)(2008-10#5)(2008-9#9)(2010-1#1)
50 mg/kg)##2##2##(1995-12#2)
50 mg/kg/dose##4##2##(2008-10#4)
50 microM PDTC was added##2##5##(1993-3#2)
50 microM PDTC##4##3##(1993-3#4)
50 microM histamine##2##3##(1996-5#2)
50 microM of##3##3##(1990-7#1)(1992-8#1)(1997-4#1)
50 microM peptide##2##3##(1993-11#2)
50 microM##28##2##(1990-12#1)(1990-2#2)(1990-7#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#4)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-5#2)(1997-4#1)(2010-3#1)(2010-6#1)
50 microM)##5##2##(1992-8#1)(1993-12#1)(1994-9#1)(1995-5#1)(1995-6#1)
50 microg l(-1)##4##3##(2008-10#4)
50 microg of GXM##2##4##(2007-10#2)
50 microg##6##2##(2007-10#2)(2008-10#4)
50 microg/ml##2##2##(2007-1#1)(2008-5#1)
50 micrograms##5##2##(1992-9#1)(1995-2#2)(1995-5#1)(1996-2#1)
50 microm##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
50 microm)##2##2##(1997-3#2)
50 million people##2##3##(2008-10#1)(2010-11#1)
50 million##3##2##(2008-10#1)(2009-8#1)(2010-11#1)
50 min of##2##3##(2013-8#2)
50 min##7##2##(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2013-8#2)
50 mix of##2##3##(2008-8#1)(2009-12#1)
50 ml of##3##3##(2008-10#3)
50 ml##16##2##(1991-2#1)(1993-2#2)(1995-6#1)(2008-10#9)(2008-12#2)(2008-8#1)
50 mm Hg##2##3##(1997-5#1)(2013-8#1)
50 mm##11##2##(1990-7#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
50 muM apicidin resulted in##2##5##(2008-10#2)
50 muM apicidin##3##3##(2008-10#3)
50 muM##10##2##(2008-10#9)(2008-11#1)
50 mug l(-1)##8##3##(2008-10#8)
50 mug l(-1))##3##3##(2008-10#3)
50 mug ml(-1) with a##2##5##(2008-10#2)
50 mug ml(-1) with##3##4##(2008-10#3)
50 mug ml(-1)##6##3##(2008-10#6)
50 mug##18##2##(2008-10#18)
50 mugl(-1)##2##2##(2008-10#2)
50 mul##5##2##(2008-10#5)
50 mum##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)
50 mumol l(-1)##2##3##(2008-10#2)
50 nM##6##2##(1990-2#1)(1990-8#1)(1995-8#1)(2007-11#1)(2008-10#2)
50 nM)##2##2##(1993-11#1)(2008-6#1)
50 ng ml(-1)##2##3##(2008-10#2)
50 ng##6##2##(1995-8#1)(2008-10#4)(2009-6#1)
50 ng/ml##4##2##(1993-3#1)(1994-8#1)(1996-5#1)(2008-10#1)
50 nm in diameter##3##4##(2008-7#2)(2009-10#1)
50 nm in##5##3##(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)
50 nm##16##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)
50 nmol/l##2##2##(2011-2#1)(2012-3#1)
50 ns##4##2##(2007-12#1)(2008-3#2)(2009-5#1)
50 of the##3##3##(1992-8#1)(1992-9#1)(2008-10#1)
50 of##5##2##(1992-8#1)(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
50 on##2##2##(2008-5#1)(2008-7#1)
50 or 100##2##3##(2008-5#1)(2008-9#1)
50 or##6##2##(1990-6#1)(2008-5#1)(2008-9#1)(2011-1#2)(2012-12#1)
50 pM##2##2##(1992-6#1)(2008-11#1)
50 patients (100 joints) undergoing bilateral total##2##7##(2009-3#2)
50 patients in##2##3##(1993-2#1)(2011-2#1)
50 patients suffering from##2##4##(1991-2#1)(2011-2#1)
50 patients were treated##2##4##(2008-5#1)(2011-2#1)
50 patients were##3##3##(2008-5#1)(2009-3#1)(2011-2#1)
50 patients##28##2##(1990-12#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1996-6#1)(1997-3#1)(2007-7#3)(2008-5#3)(2008-7#2)(2009-3#3)(2011-2#6)(2012-12#1)(2012-3#1)
50 people##2##2##(1996-3#1)(2008-5#1)
50 per cent of##2##4##(1990-9#1)(1997-5#1)
50 per##4##2##(1990-9#1)(1991-2#1)(1997-5#1)(2008-9#1)
50 percent of the##3##4##(1994-3#1)(1996-2#1)(1996-6#1)
50 percent##11##2##(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-6#1)(2009-9#1)(2011-1#1)
50 pg of##2##3##(2008-10#1)(2008-5#1)
50 pg##4##2##(2008-10#3)(2008-5#1)
50 plane-wave holograms##2##3##(2007-12#2)
50 poly[DL-lactide-co-glycolide] microspheres##2##3##(1993-1#2)
50 ppm Cd##5##3##(1997-4#5)
50 ppm psoralen##2##3##(2008-11#2)
50 ppm##12##2##(1997-4#5)(2008-11#3)(2008-3#1)(2008-5#3)
50 s##5##2##(1990-5#1)(2008-10#4)
50 samples per hour##2##4##(2008-10#2)
50 samples per##3##3##(2008-10#3)
50 samples##7##2##(1995-2#1)(2008-10#6)
50 than 5 ppm##2##4##(1997-4#2)
50 times with##2##3##(2008-10#1)(2008-3#1)
50 times##10##2##(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)
50 to 100##2##3##(2008-10#2)
50 to 100%##3##3##(2008-10#3)
50 to 350##2##3##(1990-2#1)(2012-2#1)
50 to 60##2##3##(2007-11#1)(2008-7#1)
50 to 64##2##3##(1992-12#1)(2008-6#1)
50 to 75##2##3##(1996-9#1)(2013-1#1)
50 to 80%##2##3##(2008-5#1)(2008-7#1)
50 to 90%##2##3##(2008-10#1)(2008-5#1)
50 to##46##2##(1990-2#1)(1990-3#1)(1990-6#1)(1992-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
50 vs##3##2##(1997-4#1)(2007-10#1)(2009-8#1)
50 ways to fix your life##7##6##(2008-5#7)
50 x##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)
50 year old##2##3##(2008-7#1)(2012-12#1)
50 year##3##2##(2008-12#1)(2008-7#1)(2012-12#1)
50 years after the first##2##5##(2007-2#1)(2013-1#1)
50 years ago##2##3##(2008-3#1)(2011-2#1)
50 years and##2##3##(1990-9#1)(2008-10#1)
50 years from##2##3##(2008-10#1)(2008-7#1)
50 years in##2##3##(1990-6#1)(2008-8#1)
50 years of##5##3##(1993-2#1)(1995-4#1)(2008-8#1)(2011-3#1)(2013-8#1)
50 years old##3##3##(2007-10#1)(2008-1#1)(2010-8#1)
50 years or##2##3##(1990-9#1)(2012-3#1)
50 years##54##2##(1990-6#1)(1990-9#2)(1993-2#2)(1993-8#1)(1994-12#1)(1995-2#1)(1995-4#2)(1997-4#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
50 years)##2##2##(2008-1#1)(2008-11#1)
50 °C##2##2##(2011-1#1)(2011-2#1)
50 ±##2##2##(2012-12#1)(2013-1#1)
50##1135##1##(1990-11#7)(1990-12#7)(1990-2#6)(1990-3#5)(1990-5#8)(1990-6#5)(1990-7#5)(1990-8#5)(1990-9#5)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#1)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#5)(1992-8#5)(1992-9#4)(1993-1#5)(1993-11#9)(1993-12#4)(1993-2#6)(1993-3#7)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#8)(1994-3#8)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-11#4)(1995-12#10)(1995-2#9)(1995-3#2)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#7)(1996-1#3)(1996-2#5)(1996-3#5)(1996-5#11)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#16)(1997-5#4)(1997-6#4)(1997-7#1)(1997-9#1)(2006-6#2)(2007-1#1)(2007-10#12)(2007-11#18)(2007-12#19)(2007-2#3)(2007-5#3)(2007-7#17)(2007-8#3)(2008-1#9)(2008-10#336)(2008-11#20)(2008-12#25)(2008-2#14)(2008-3#46)(2008-4#8)(2008-5#53)(2008-6#19)(2008-7#29)(2008-8#22)(2008-9#28)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#9)(2011-2#38)(2011-3#2)(2012-1#2)(2012-12#22)(2012-2#7)(2012-3#8)(2013-1#24)(2013-7#4)(2013-8#9)
50% (2/4)##2##2##(2008-1#1)(2008-6#1)
50% (v/v) ethanol-water medium##2##4##(2008-10#2)
50% (v/v)##6##2##(2008-10#6)
50% after##4##2##(1992-5#1)(1993-11#1)(2007-10#1)(2008-10#1)
50% and 70% of##2##4##(1994-5#1)(2013-8#1)
50% and 80%##2##3##(1993-3#1)(2008-10#1)
50% and##16##2##(1990-2#1)(1990-8#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
50% aqueous##2##2##(1994-5#1)(2008-10#1)
50% are##3##2##(2008-12#1)(2008-2#1)(2008-4#1)
50% as compared##2##3##(2008-10#2)
50% as##4##2##(1992-11#1)(2008-10#3)
50% at##4##2##(1996-5#1)(1997-1#1)(2008-10#1)(2008-12#1)
50% by##4##2##(2008-10#1)(2008-11#2)(2011-1#1)
50% compared to##2##3##(2008-1#1)(2008-9#1)
50% drop in##2##3##(1994-11#1)(2008-4#1)
50% during the##2##3##(2008-10#1)(2008-7#1)
50% during##3##2##(1990-3#1)(2008-10#1)(2008-7#1)
50% duty cycle##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
50% effective concentration##2##3##(2008-10#2)
50% effective dose##2##3##(2008-10#2)
50% effective##5##2##(2008-10#5)
50% ethanol##3##2##(2011-1#1)(2013-8#2)
50% for##5##2##(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#1)
50% from##2##2##(2008-10#1)(2012-3#1)
50% greater than##2##3##(1997-1#1)(2008-9#1)
50% growth##2##2##(2008-10#2)
50% had##3##2##(1990-6#1)(2011-2#1)(2012-12#1)
50% have##2##2##(2008-3#2)
50% higher##3##2##(2008-10#2)(2013-1#1)
50% identity##2##2##(1991-10#1)(1994-12#1)
50% in the##4##3##(1990-5#1)(2008-11#1)(2008-5#2)
50% in##16##2##(1990-5#1)(1991-12#1)(1994-6#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
50% increase##2##2##(1995-11#1)(2008-10#1)
50% inhibition at##4##3##(1993-11#3)(1995-2#1)
50% inhibition##7##2##(1993-11#3)(1993-12#1)(1995-2#1)(2008-11#1)(2011-3#1)
50% inhibitory concentration##2##3##(1995-11#1)(2013-1#1)
50% inhibitory##3##2##(1992-2#1)(1995-11#1)(2013-1#1)
50% less##2##2##(1994-11#1)(2008-2#1)
50% lower than##2##3##(2008-11#1)(2008-7#1)
50% micorwave power##2##3##(2008-10#2)
50% more##3##2##(1990-12#1)(2008-10#1)(2013-1#1)
50% of all##6##3##(1994-11#1)(2007-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
50% of cases##7##3##(1991-2#1)(1993-3#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2011-2#1)
50% of maximum##2##3##(1992-11#1)(1993-12#1)
50% of patients##10##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
50% of score##2##3##(2013-1#2)
50% of that##4##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
50% of the cases##3##4##(1990-2#1)(1997-6#1)(2012-12#1)
50% of the control##2##4##(1992-6#1)(2008-11#1)
50% of the global##2##4##(2007-5#1)(2009-8#1)
50% of the inoculated##2##4##(2008-10#1)(2008-5#1)
50% of the maximum##5##4##(1990-7#1)(1997-2#1)(2008-10#2)(2011-2#1)
50% of the output##2##4##(2007-12#1)(2008-2#1)
50% of the patients##3##4##(2007-10#1)(2008-11#1)(2011-1#1)
50% of the sample##2##4##(1993-1#1)(2008-10#1)
50% of the total##3##4##(1990-7#1)(2008-10#1)(2010-4#1)
50% of the##71##3##(1990-12#1)(1990-2#1)(1990-7#2)(1991-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-10#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-10#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
50% of their##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
50% of these##6##3##(1993-12#1)(1995-2#1)(1995-6#1)(2007-10#1)(2011-2#1)(2013-1#1)
50% of total##3##3##(1990-5#1)(1997-7#1)(2008-4#1)
50% of whom##2##3##(1990-6#1)(2012-12#1)
50% of women##2##3##(2008-1#1)(2011-2#1)
50% of##173##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#2)(1991-12#2)(1991-2#2)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-10#4)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#2)
50% on##2##2##(2008-10#1)(2008-11#1)
50% or greater##2##3##(1994-3#1)(2008-12#1)
50% or more##3##3##(2007-8#1)(2008-9#1)(2011-2#1)
50% or##6##2##(1994-3#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
50% oxygen##2##2##(1995-6#1)(2011-2#1)
50% reduction at##2##3##(2008-4#1)(2008-6#1)
50% reduction in size of##2##5##(2008-10#1)(2011-1#1)
50% reduction in##7##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2011-1#1)(2013-1#1)
50% reduction of##2##3##(2008-10#2)
50% reduction##11##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-6#2)(2011-1#1)(2013-1#1)
50% relative humidity##2##3##(1995-3#1)(2008-5#1)
50% residual##2##2##(1994-5#1)(2009-5#1)
50% suppression of UFC##2##4##(2011-2#2)
50% suppression of##3##3##(1996-12#1)(2011-2#2)
50% the##2##2##(1994-11#1)(1995-8#1)
50% to 80%##2##3##(2008-2#1)(2008-7#1)
50% to##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
50% total##2##2##(2008-10#2)
50% v/v##2##2##(2008-10#2)
50% was##2##2##(1990-12#1)(2008-10#1)
50% were##7##2##(2008-11#2)(2008-3#1)(2011-2#1)(2013-1#3)
50% when##2##2##(1996-12#1)(2008-11#1)
50% with##5##2##(1990-6#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-12#1)
50% within##2##2##(2008-10#1)(2008-3#1)
50% without##3##2##(1993-3#1)(2010-12#1)(2010-8#1)
50%##544##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#6)(1994-8#1)(1994-9#1)(1995-11#8)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#6)(2006-10#1)(2007-10#5)(2007-11#6)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#10)(2008-10#105)(2008-11#23)(2008-12#7)(2008-2#10)(2008-3#19)(2008-4#10)(2008-5#12)(2008-6#12)(2008-7#20)(2008-8#4)(2008-9#9)(2009-10#5)(2009-4#1)(2009-5#3)(2009-8#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#27)(2011-3#2)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#28)(2013-8#11)
50%) in the##2##3##(1990-12#1)(2009-8#1)
50%) in##4##2##(1990-12#1)(1995-2#1)(2008-11#1)(2009-8#1)
50%)##26##1##(1990-12#2)(1990-2#2)(1995-12#1)(1995-2#2)(1997-5#1)(1997-6#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-8#3)(2010-2#1)(2010-8#1)(2011-1#1)
50(3)##2##1##(2008-10#2)
50)##24##1##(1990-6#1)(1990-8#2)(1991-5#1)(1993-11#1)(2007-10#1)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-3#1)(2012-2#2)(2013-1#1)
50+/-0##5##1##(2007-8#2)(2008-5#1)(2009-12#1)(2010-5#1)
50-##4##1##(1991-9#1)(2007-4#1)(2007-8#1)(2008-10#1)
50-0##2##1##(2008-10#2)
50-10##2##1##(2008-10#2)
50-100##7##1##(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#1)
50-103##2##1##(2008-10#1)(2008-5#1)
50-150%##2##1##(1992-3#1)(2012-2#1)
50-200##2##1##(1996-4#1)(2007-11#1)
50-250##2##1##(2008-10#1)(2012-2#1)
50-300##4##1##(2008-10#3)(2010-6#1)
50-500##5##1##(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)
50-59 years##2##2##(1990-6#1)(1992-2#1)
50-60 degrees C##2##3##(1997-2#1)(2008-10#1)
50-60 years##2##2##(1990-2#1)(2008-5#1)
50-60##11##1##(1990-11#1)(1990-2#1)(1990-5#1)(1994-3#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2013-8#1)
50-60% of##5##2##(1993-12#1)(2008-1#1)(2008-7#1)(2013-1#2)
50-60%##11##1##(1990-8#1)(1993-11#1)(1993-12#1)(2008-1#1)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#2)
50-69##2##1##(1990-6#1)(2008-7#1)
50-70##3##1##(1991-2#1)(1996-2#1)(2013-7#1)
50-75%##2##1##(1993-2#1)(1997-2#1)
50-80##3##1##(1997-4#1)(2008-1#1)(2008-3#1)
50-Hz##2##1##(2007-12#1)(2008-3#1)
50-W average-power##2##2##(2007-11#2)
50-W##3##1##(2007-11#3)
50-day-old fruit##2##2##(2008-10#2)
50-day-old##3##1##(1996-12#1)(2008-10#2)
50-fold higher##2##2##(1993-6#1)(1994-8#1)
50-fold in##3##2##(1992-11#1)(1993-3#1)(2008-10#1)
50-fold increase in the##2##4##(1990-5#1)(2008-3#1)
50-fold##14##1##(1990-11#2)(1990-5#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#1)
50-fs laser##2##2##(2007-11#2)
50-fs##3##1##(2007-11#3)
50-ha##3##1##(2008-8#2)(2008-9#1)
50-kDa protein##3##2##(1993-6#2)(2008-10#1)
50-kDa##7##1##(1993-12#1)(1993-6#2)(1995-6#1)(2008-10#3)
50-mJ##2##1##(2008-3#2)
50-microg/cm2-treated filter paper##2##3##(2011-2#2)
50-microm##2##1##(2007-12#1)(2008-3#1)
50-mum##3##1##(2007-11#1)(2008-10#1)(2008-2#1)
50-nm thickness##2##2##(2008-2#1)(2008-3#1)
50-nm##6##1##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
50-ns##2##1##(2007-12#1)(2008-3#1)
50-ps##2##1##(2007-11#1)(2007-12#1)
50-year old##2##2##(1993-11#1)(2011-2#1)
50-year##4##1##(1993-11#1)(2007-4#1)(2008-11#1)(2011-2#1)
50-year-old woman##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
50-year-old##10##1##(1992-10#1)(2007-8#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
50/50##5##1##(1993-12#1)(2007-12#2)(2008-10#1)(2009-8#1)
500 +/-##2##2##(1994-3#2)
500 Hz pure tone##2##4##(2008-2#2)
500 Hz##3##2##(2008-2#2)(2009-1#1)
500 MHz##2##2##(1993-3#1)(2008-3#1)
500 V##2##2##(2008-10#1)(2008-3#1)
500 and 100##2##3##(1992-8#1)(2008-11#1)
500 and 1000 mg/kg##2##4##(2008-7#1)(2013-1#1)
500 and 4##2##3##(1994-2#1)(2010-8#1)
500 and 750##2##3##(1996-12#1)(2008-10#1)
500 and an##2##3##(1997-4#1)(2008-2#1)
500 and##24##2##(1992-8#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
500 bar##2##2##(2008-10#2)
500 bp##2##2##(1995-6#1)(2008-10#1)
500 bp)##2##2##(1991-1#1)(2012-3#1)
500 cells##2##2##(2008-10#1)(2012-12#1)
500 g##3##2##(1994-1#1)(2012-2#2)
500 hygromycin-resistant##2##2##(2008-10#2)
500 in##2##2##(1991-8#1)(1994-9#1)
500 kb##2##2##(1997-8#2)
500 km##2##2##(2007-12#2)
500 m##4##2##(2008-3#1)(2008-5#1)(2008-8#2)
500 mW##4##2##(2007-12#3)(2008-2#1)
500 mg b##2##3##(2008-5#1)(2011-2#1)
500 mg kg(-1)##3##3##(2008-10#2)(2008-11#1)
500 mg of##3##3##(1990-3#1)(2008-11#1)(2008-7#1)
500 mg x 2/day by##2##5##(2011-2#2)
500 mg x 2/day##3##4##(2011-2#3)
500 mg##23##2##(1990-3#1)(1991-4#1)(1993-1#1)(1996-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#5)
500 mg/L##2##2##(2008-9#2)
500 mg/kg B##2##3##(2013-1#2)
500 mg/kg females##2##3##(2008-9#2)
500 mg/kg males and females at##2##6##(2008-9#2)
500 mg/kg males and females##3##5##(2008-9#3)
500 mg/kg males##5##3##(2008-9#5)
500 mg/kg##15##2##(1995-3#1)(2008-9#10)(2013-1#4)
500 microM##6##2##(1993-8#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-8#1)(2009-6#1)
500 microg##2##2##(2008-10#2)
500 micrograms##2##2##(1991-5#1)(1995-12#1)
500 microm##5##2##(2008-10#1)(2008-11#1)(2008-3#3)
500 microns##3##2##(1994-5#2)(1995-3#1)
500 ml min(-1)##2##3##(2008-10#2)
500 ml of##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
500 ml##9##2##(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)
500 mug l(-1)##3##3##(2008-10#3)
500 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
500 mug##8##2##(2008-10#6)(2008-11#2)
500 mul of##3##3##(2008-10#3)
500 mul##4##2##(2008-10#4)
500 mum pore##2##3##(2008-11#2)
500 mum##8##2##(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#3)
500 nM##5##2##(1991-5#1)(1991-9#2)(1996-2#1)(2008-10#1)
500 ng ml(-1)##2##3##(2008-10#1)(2008-5#1)
500 ng##4##2##(2008-10#3)(2008-5#1)
500 ng/0##2##2##(1995-12#2)
500 nm or##2##3##(2008-10#1)(2008-3#1)
500 nm##14##2##(1997-7#1)(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#2)(2013-8#1)
500 nm)##2##2##(2008-10#1)(2008-3#1)
500 or 1000 mg/kg per day##2##6##(1995-3#2)
500 or 1000##4##3##(1995-11#1)(1995-3#2)(2010-2#1)
500 pM##2##2##(2008-11#2)
500 patients##5##2##(1990-2#1)(1991-3#1)(1995-10#2)(2010-5#1)
500 pg/mL##2##2##(2008-3#2)
500 ppm##2##2##(1995-11#1)(1996-12#1)
500 rpm##5##2##(2008-10#1)(2008-11#3)(2008-6#1)
500 to##7##2##(1992-1#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
500 years##2##2##(1996-11#1)(2012-3#1)
500##343##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-2#1)(1992-8#3)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#2)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#5)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-11#3)(2007-12#7)(2007-7#3)(2008-1#4)(2008-10#77)(2008-11#24)(2008-12#1)(2008-2#16)(2008-3#22)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#12)(2008-9#21)(2009-1#1)(2009-12#1)(2009-2#1)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
500)##4##1##(1991-12#1)(1997-7#1)(2008-5#1)(2010-5#1)
500-1000##2##1##(1994-11#1)(2008-4#1)
500-700 nm##2##2##(1990-8#1)(2008-10#1)
500-fold##8##1##(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-2#1)
500-fs##3##1##(2007-11#2)(2008-3#1)
500-mW##2##1##(2007-12#1)(2008-2#1)
500-mg##2##1##(2008-10#2)
5000##21##1##(1990-3#1)(1990-9#1)(1991-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
50000##2##1##(1992-12#1)(2008-10#1)
500ml##5##1##(2008-10#5)
500mul of a homogeneous bead suspension of an##2##8##(2008-10#2)
500mul##3##1##(2008-10#3)
500ngml(-1) of##3##2##(2008-10#3)
500ngml(-1)##4##1##(2008-10#4)
500nm##3##1##(2008-10#3)
500 mg ciprofloxacin##2##2##(2011-2#2)
501##7##1##(1993-2#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-10#1)(2011-2#2)
502##11##1##(1991-12#5)(1995-5#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-3#1)
503 amino acid##2##3##(1990-11#1)(1995-8#1)
503 amino##3##2##(1990-11#1)(1991-12#1)(1995-8#1)
503 subjects##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
503##12##1##(1990-11#1)(1991-12#1)(1993-8#1)(1995-8#1)(2008-10#2)(2008-3#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
505 nm##6##2##(2008-10#4)(2008-5#1)(2008-7#1)
505##14##1##(1993-8#1)(1994-12#1)(1995-2#1)(1997-6#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
5052 aluminum alloy##2##3##(2013-8#2)
506 base##2##2##(1997-7#1)(1997-9#1)
506##5##1##(1997-7#1)(1997-9#1)(2007-11#1)(2011-1#2)
5064##7##1##(2008-10#7)
507##2##1##(2007-8#1)(2013-1#1)
508 nm##2##2##(2007-11#1)(2008-10#1)
508##6##1##(1990-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
509##6##1##(1994-12#1)(1997-7#1)(2008-10#2)(2008-7#2)
50V##2##1##(2008-10#2)
50W##7##1##(2008-10#5)(2013-8#2)
50mM##6##1##(1990-9#1)(2008-10#4)(2012-1#1)
50mg/m2/day on days##2##3##(2008-10#2)
50ml##2##1##(2008-10#2)
50mmolL(-1)##2##1##(2008-10#2)
50moll(-1)##3##1##(2008-10#3)
50mugl(-1) of Bi##2##3##(2008-10#2)
50mugl(-1)##4##1##(2008-10#4)
50mugml(-1) of##2##2##(2008-10#2)
50mugml(-1)##3##1##(2008-10#3)
50mul##2##1##(2008-10#2)
50mum spot size for 50s at 10Hz##2##7##(2008-10#2)
50mum##5##1##(2008-10#5)
50mum)##2##1##(2007-12#1)(2008-10#1)
50ngml(-1) of##2##2##(2008-10#2)
50nm##2##1##(2008-10#2)
50th##6##1##(1991-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
50wt##2##1##(2008-10#2)
50x10(3)##2##1##(2008-10#2)
51 (19##2##2##(2008-1#1)(2010-8#1)
51 (1979) 844]##2##3##(2008-10#2)
51 +/- 0##2##3##(1992-3#1)(2009-9#1)
51 +/- 1##4##3##(1993-3#1)(1994-11#1)(2008-3#1)(2008-4#1)
51 +/-##9##2##(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-7#1)
51 and##5##2##(1996-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
51 cases of##2##3##(1990-9#1)(2008-7#1)
51 consecutive##2##2##(1991-6#1)(2013-1#1)
51 for##3##2##(2008-10#3)
51 males##2##2##(2013-1#1)(2013-7#1)
51 min##2##2##(2008-10#1)(2013-8#1)
51 patients##9##2##(1990-5#1)(1995-3#1)(2007-11#2)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
51 samples##2##2##(2008-10#1)(2008-12#1)
51 symptoms##2##2##(2007-11#1)(2008-7#1)
51 to##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
51 women##3##2##(1996-12#3)
51 years##4##2##(1993-5#1)(2008-12#1)(2013-1#2)
51 ±##2##2##(2011-2#1)(2013-1#1)
51##193##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#5)(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#4)(1995-5#2)(1995-6#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#32)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#15)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#5)
51% in the##2##3##(2008-10#1)(2012-2#1)
51% in##4##2##(2008-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
51% of the##2##3##(2008-10#2)
51% of##7##2##(1990-6#1)(1991-9#1)(1992-1#1)(2008-1#1)(2008-10#3)
51% were##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
51%##36##1##(1990-6#1)(1991-9#1)(1992-1#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
51)##9##1##(1993-1#1)(1995-11#1)(2008-10#2)(2008-12#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-2#1)
51-100##2##1##(2011-2#2)
51-year-old man##3##2##(2008-6#1)(2012-12#1)(2013-1#1)
51-year-old woman##4##2##(2007-8#1)(2008-5#1)(2008-6#1)(2013-1#1)
51-year-old##14##1##(1994-12#1)(1995-3#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#3)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
510 nm##5##2##(2008-10#4)(2008-11#1)
510##16##1##(1991-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-5#1)(2013-1#1)
511 and##2##2##(1992-6#1)(1995-6#1)
511 keV photons##2##3##(2012-12#2)
511 keV##4##2##(2012-12#4)
511##12##1##(1992-12#1)(1992-6#1)(1995-6#1)(1996-11#1)(2008-1#1)(2010-4#2)(2012-12#4)(2013-8#1)
512 x 512##2##3##(2008-3#2)
512 x##3##2##(2007-12#1)(2008-3#2)
512##15##1##(1992-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#4)(2009-3#1)(2010-1#1)(2013-7#1)
513##8##1##(1991-9#1)(2007-12#1)(2008-10#4)(2008-7#1)(2013-7#1)
514##17##1##(1996-6#1)(1997-7#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-1#1)(2013-8#1)
515 nm##4##2##(1996-4#1)(2008-10#3)
515 women##2##2##(1990-12#1)(2012-3#1)
515##12##1##(1990-12#1)(1990-3#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-6#1)(2011-3#1)(2012-3#1)(2013-1#1)
516##8##1##(1991-3#1)(1993-1#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#2)
516)##2##1##(1990-8#1)(2012-2#1)
517##8##1##(1990-2#1)(1994-2#1)(2010-2#6)
518##5##1##(1990-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2012-3#1)
519##2##1##(2008-10#1)(2012-12#1)
51Cr release assay##2##3##(1990-12#1)(2008-4#1)
51Cr release##3##2##(1990-12#1)(1991-9#1)(2008-4#1)
51Cr##6##1##(1990-12#2)(1991-9#1)(1993-8#1)(1994-12#1)(2008-4#1)
52 %##3##2##(2007-8#1)(2008-5#1)(2012-12#1)
52 (sd=0##2##2##(2011-2#2)
52 +/- 0##4##3##(1997-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
52 +/-##8##2##(1991-4#1)(1992-11#1)(1992-12#1)(1997-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
52 C##2##2##(2008-10#2)
52 and##6##2##(1992-4#1)(1993-1#1)(1995-12#1)(1995-3#1)(2008-10#1)(2012-2#1)
52 cases of##3##3##(1991-12#1)(2011-2#2)
52 cases##4##2##(1991-12#1)(1995-6#1)(2011-2#2)
52 colorectal##2##2##(1993-9#2)
52 degrees C##7##3##(1991-5#1)(1993-3#1)(1997-2#2)(2008-10#2)(2008-5#1)
52 for##2##2##(2008-10#2)
52 kDa##3##2##(1991-9#1)(1994-8#1)(2008-10#1)
52 m##2##2##(1994-9#1)(2008-10#1)
52 mug##2##2##(2008-10#2)
52 nm##2##2##(2007-11#1)(2008-8#1)
52 patients were##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
52 patients with##2##3##(1993-2#1)(2008-7#1)
52 patients##13##2##(1990-9#1)(1993-2#1)(1993-8#1)(1997-5#1)(1997-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2011-2#2)
52 to##7##2##(1990-11#1)(1993-12#1)(1995-5#1)(1997-2#1)(2008-10#3)
52 weeks##3##2##(1995-8#2)(2013-7#1)
52 were##2##2##(1991-2#1)(2013-8#1)
52 years##4##2##(1991-6#1)(1995-8#1)(2007-10#1)(2007-7#1)
52##234##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#6)(2008-10#41)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#4)(2013-1#8)(2013-7#2)(2013-8#5)
52% and##3##2##(1993-8#1)(2007-12#1)(2011-3#1)
52% for##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)
52% of##5##2##(1992-12#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
52% with##2##2##(1991-2#1)(1994-12#1)
52%##40##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-12#3)(1992-3#1)(1993-8#1)(1994-12#2)(1996-10#2)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
52%)##3##1##(1997-6#1)(2007-7#1)(2008-12#1)
52) and##3##2##(1994-1#1)(2008-10#1)(2008-7#1)
52)##14##1##(1991-7#1)(1994-1#1)(1997-2#1)(2007-10#2)(2008-10#4)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
52)Na(0##2##1##(2008-10#2)
52+/-0##2##1##(2007-11#1)(2008-10#1)
52-##2##1##(1993-1#1)(1994-8#1)
52-0##3##1##(1994-8#1)(2008-5#1)(2013-7#1)
52-year-old woman##3##2##(1992-12#1)(2011-1#1)(2011-2#1)
52-year-old##13##1##(1992-12#1)(1994-7#1)(2007-7#2)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
520 children##2##2##(2007-7#1)(2008-12#1)
520 nm with##2##3##(2008-10#2)
520 nm##9##2##(2008-10#9)
520##21##1##(1992-12#1)(1997-6#1)(2007-7#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)
5200##2##1##(1997-8#1)(2008-2#1)
521 cases##2##2##(2011-2#2)
521##3##1##(2007-10#1)(2011-2#2)
521)##5##1##(1991-8#4)(2008-10#1)
5217##2##1##(1990-2#2)
522##4##1##(2008-10#2)(2008-2#1)(2008-8#1)
523##5##1##(1996-3#1)(2007-12#1)(2008-10#2)(2013-1#1)
524##3##1##(1993-6#1)(1994-12#1)(2013-1#1)
525 nm##7##2##(2008-10#6)(2008-11#1)
525 patients##2##2##(2008-10#2)
525##17##1##(1990-5#1)(1996-12#1)(2008-10#8)(2008-11#4)(2008-2#1)(2011-2#1)(2012-3#1)
527##4##1##(1993-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
528##5##1##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
529 amino acid##3##3##(2008-11#2)(2008-4#1)
529##5##1##(1990-2#1)(1992-12#1)(2008-11#2)(2008-4#1)
5294##2##1##(2008-10#2)
52nd##3##1##(1991-1#1)(2011-2#1)(2012-2#1)
52 nm##3##1##(2012-2#3)
53 +/- 0##5##3##(1990-2#1)(2008-3#1)(2009-6#1)(2011-2#2)
53 +/-##8##2##(1990-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#2)(2012-3#1)
53 and 0##2##3##(2008-10#1)(2008-7#1)
53 and##10##2##(1990-12#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2012-2#1)
53 cases of##3##3##(1990-3#1)(1991-8#1)(2007-7#1)
53 cm)##2##2##(2009-2#1)(2010-9#1)
53 degrees C##2##3##(2008-10#1)(2008-3#1)
53 degrees##3##2##(1992-8#1)(2008-10#1)(2008-3#1)
53 healthy##2##2##(2008-10#2)
53 kDa##3##2##(1993-11#1)(1995-12#1)(1995-6#1)
53 mum##8##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#2)
53 patients who##4##3##(1994-3#1)(2011-2#2)(2012-5#1)
53 patients with##4##3##(1990-3#1)(2007-8#1)(2008-5#1)(2013-1#1)
53 patients##13##2##(1990-3#1)(1992-5#1)(1993-5#1)(1994-3#1)(2007-8#1)(2008-5#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)
53 to##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
53 year old##3##3##(1991-5#1)(2008-1#1)(2009-8#1)
53 years##4##2##(1997-6#1)(2011-7#1)(2013-1#1)(2013-8#1)
53 years)##2##2##(2008-9#1)(2011-2#1)
53 ±##2##2##(2011-1#1)(2011-2#1)
53##194##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#4)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#3)(2008-10#23)(2008-11#1)(2008-12#6)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#6)(2011-2#18)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2012-5#2)(2013-1#9)(2013-8#5)
53% and##9##2##(1994-1#1)(1994-5#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
53% at 1##2##3##(2008-6#1)(2011-2#1)
53% at##5##2##(1993-9#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
53% homology##2##2##(1993-6#1)(1994-8#1)
53% in##2##2##(2008-10#1)(2008-9#1)
53% of patients##3##3##(1990-6#1)(1991-11#1)(2010-12#1)
53% of the##7##3##(1990-11#1)(1990-12#1)(1993-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2009-11#1)
53% of##15##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1993-2#1)(1994-12#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-12#2)(2012-12#1)(2013-1#1)
53%##66##1##(1990-11#2)(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#2)(1994-8#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
53%)##2##1##(2008-10#1)(2013-8#1)
53)##7##1##(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
53-day##3##1##(2008-7#3)
53-kDa##4##1##(1993-8#3)(1995-9#1)
53-year-old man##4##2##(1992-6#1)(2007-10#1)(2008-11#1)(2013-1#1)
53-year-old woman##2##2##(2006-10#1)(2012-3#1)
53-year-old##9##1##(1992-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
530 nm with an##2##4##(2008-10#1)(2008-3#1)
530 nm with##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
530 nm##6##2##(1997-2#1)(2008-10#4)(2008-3#1)
530##20##1##(1990-8#1)(1994-12#1)(1995-11#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
530-##2##1##(2008-10#2)
531 nm##2##2##(2008-10#1)(2008-2#1)
531##7##1##(1991-2#1)(1997-3#1)(2008-10#1)(2008-2#2)(2012-12#1)(2012-3#1)
532 and##3##2##(1991-5#1)(2008-2#1)(2008-3#1)
532 nm and##2##3##(2007-12#2)
532 nm for##4##3##(2008-2#1)(2008-3#3)
532 nm in##3##3##(2007-12#2)(2008-3#1)
532 nm##32##2##(2007-11#2)(2007-12#9)(2008-1#1)(2008-2#6)(2008-3#14)
532##54##1##(1991-5#10)(2007-11#2)(2007-12#9)(2008-1#1)(2008-2#11)(2008-3#21)
532)##2##1##(1991-2#2)
532-nm laser##2##2##(2007-12#2)
532-nm##13##1##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#5)
532-nm-pumped singly resonant optical parametric oscillator##2##6##(2007-12#2)
533##5##1##(2007-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
533)##2##1##(1994-2#1)(2012-2#1)
534##2##1##(1991-12#1)(1997-7#1)
535 nm##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
535##7##1##(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-12#1)
536##2##1##(1991-8#1)(2008-2#1)
537##4##1##(1991-3#1)(1996-11#1)(2008-10#1)(2011-2#1)
538##7##1##(1992-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#2)
539##4##1##(1994-11#1)(2007-2#1)(2008-10#1)(2011-1#1)
539)##2##1##(2008-11#1)(2008-12#1)
54 +/- 0##3##3##(1992-9#1)(2009-11#2)
54 +/-##4##2##(1992-9#1)(1996-5#1)(2009-11#2)
54 and 1##2##3##(1997-2#1)(2008-10#1)
54 and##14##2##(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2013-1#1)
54 cases of##2##3##(1990-9#1)(2008-11#1)
54 cases##6##2##(1990-2#1)(1990-9#1)(1996-11#2)(2008-10#1)(2008-11#1)
54 days##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
54 h(-1)##2##2##(2008-10#2)
54 kDa##3##2##(1995-5#3)
54 mV##2##2##(1997-7#1)(2008-10#1)
54 microm##5##2##(2008-3#5)
54 mum##3##2##(2008-3#3)
54 ng##2##2##(2008-10#2)
54 patients was##2##3##(1992-5#1)(2007-11#1)
54 patients were##2##3##(2008-5#1)(2013-1#1)
54 patients with##4##3##(2008-1#2)(2012-1#1)(2013-1#1)
54 patients##13##2##(1991-11#1)(1991-2#1)(1992-5#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#3)
54 scores of the m/z##2##5##(2008-10#2)
54 subjects with##2##3##(1996-2#1)(2013-1#1)
54 to##8##2##(1995-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-11#1)(2013-1#2)
54 were##2##2##(1990-2#1)(2008-1#1)
54 years##10##2##(1992-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2011-1#4)(2012-12#1)
54 years)##2##2##(1990-6#1)(1992-9#1)
54 ± 0##2##3##(2011-2#1)(2012-12#1)
54##216##1##(1990-11#2)(1990-2#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-3#3)(1995-5#5)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#49)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#14)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-7#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#10)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#15)(2013-7#1)(2013-8#1)
54% (n =##2##3##(2008-6#1)(2010-3#1)
54% and##3##2##(1996-10#1)(2008-11#1)(2008-3#1)
54% in##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
54% of the##2##3##(2008-5#1)(2011-2#1)
54% of##5##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
54%##40##1##(1990-7#1)(1991-3#1)(1992-2#1)(1996-10#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-8#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#3)
54%)##6##1##(2008-10#1)(2008-7#2)(2010-5#1)(2011-2#2)
54)##10##1##(1991-9#1)(1993-12#1)(2008-10#2)(2008-7#1)(2009-7#1)(2012-2#2)(2013-1#2)
54+/-0##3##1##(2008-10#3)
54-##2##1##(1995-2#1)(2008-3#1)
54-fs##2##1##(2007-12#2)
54-kDa##3##1##(1994-11#1)(1995-8#2)
54-microm##3##1##(2008-3#3)
54-mum##2##1##(2008-3#2)
54-year-old man##5##2##(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-12#1)
54-year-old woman##4##2##(2008-1#1)(2009-3#1)(2013-1#2)
54-year-old##12##1##(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
540 (MC540)##2##2##(1994-12#1)(2008-10#1)
540 individuals from 97 families##2##5##(1997-5#2)
540 individuals##3##2##(1997-5#3)
540 km##3##2##(1992-6#1)(2008-8#2)
540 mg/day##2##2##(1992-8#2)
540 nm##7##2##(2008-10#6)(2008-5#1)
540 nm)##2##2##(2008-10#2)
540##30##1##(1992-6#3)(1992-8#2)(1994-12#1)(1997-5#6)(2007-12#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)
5400##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
541##5##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-8#1)
542##4##1##(2007-10#1)(2007-11#1)(2008-10#2)
543##8##1##(1997-7#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#1)
544##4##1##(2007-11#1)(2008-11#1)(2011-2#1)(2013-8#1)
545##9##1##(1992-8#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
546##11##1##(1997-4#3)(2008-10#2)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
546)##2##1##(1990-11#1)(2011-1#1)
5460S##4##1##(2008-8#4)
547##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
548##3##1##(2007-7#1)(2008-10#1)(2008-7#1)
549##4##1##(1996-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
55 +/- 0##2##3##(2008-5#1)(2010-6#1)
55 +/- 2##2##3##(1994-11#1)(2008-4#1)
55 +/-##10##2##(1994-11#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-6#1)
55 amino##2##2##(1997-3#1)(2012-3#1)
55 and 0##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
55 and 1##2##3##(2008-10#2)
55 and 58 kDa##2##4##(1996-12#2)
55 and##17##2##(1990-8#2)(1996-12#2)(2007-11#2)(2008-10#6)(2008-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
55 children##2##2##(1995-3#1)(1997-8#1)
55 dB##2##2##(2007-12#1)(2010-4#1)
55 degrees C and pH 8##2##6##(2008-6#2)
55 degrees C and##3##4##(2008-12#1)(2008-6#2)
55 degrees C for##2##4##(1992-8#1)(2008-12#1)
55 degrees C##12##3##(1990-5#1)(1992-8#1)(2008-10#6)(2008-12#2)(2008-6#2)
55 degrees##16##2##(1990-5#1)(1990-9#1)(1992-8#1)(1993-3#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-6#2)(2008-9#1)
55 isolates##2##2##(2008-10#2)
55 kD##5##2##(1992-11#1)(1992-8#1)(1997-7#1)(2008-11#2)
55 kDa##6##2##(1990-2#1)(1990-7#1)(1994-11#1)(1994-2#2)(1996-6#1)
55 ku##2##2##(2008-8#2)
55 microM##2##2##(1995-6#1)(2008-11#1)
55 microm is##2##3##(2008-3#2)
55 microm##17##2##(2007-11#7)(2007-12#3)(2008-2#1)(2008-3#6)
55 min##2##2##(2008-10#2)
55 mmol/l##2##2##(1991-6#2)
55 mul##2##2##(2008-10#2)
55 mum##10##2##(2007-11#2)(2007-12#4)(2008-3#4)
55 of##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
55 or##2##2##(2008-5#1)(2012-2#1)
55 patients##7##2##(2006-6#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
55 percent of##2##3##(1993-2#1)(1997-2#1)
55 percent##3##2##(1993-2#1)(1997-2#1)(2009-9#1)
55 to 1##2##3##(2007-11#1)(2007-12#1)
55 to##14##2##(1991-3#1)(1991-5#2)(1992-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#1)(2013-1#2)
55 vs##2##2##(2008-10#1)(2008-9#1)
55 years##7##2##(1990-8#1)(1991-11#1)(1991-5#2)(1992-12#1)(2011-2#2)
55##307##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-11#5)(1991-12#3)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#3)(2007-11#16)(2007-12#9)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#59)(2008-11#5)(2008-12#6)(2008-2#8)(2008-3#21)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#14)(2008-8#4)(2008-9#3)(2009-10#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#16)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#2)
55% after##4##2##(1990-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
55% and##2##2##(1997-4#1)(2008-10#1)
55% of the##9##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
55% of##14##2##(1991-6#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
55% respectively##2##2##(1997-2#1)(2013-8#1)
55%##53##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-11#2)(1995-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#3)(2013-7#1)(2013-8#2)
55%)##5##1##(1990-7#1)(1995-5#1)(1997-6#1)(2008-10#1)(2011-2#1)
55(2)##2##1##(1996-2#1)(1997-7#1)
55)##9##1##(1994-1#1)(1997-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-9#2)(2013-1#1)(2013-8#1)
55+/-0##2##1##(2008-10#2)
55-65##2##1##(1993-8#1)(2008-7#1)
55-kDa##2##1##(1994-2#1)(2008-10#1)
55-mW##2##1##(2007-12#1)(2008-3#1)
55-microm distributed-feedback diode laser##2##4##(2008-2#2)
55-microm wavelength##2##2##(2008-3#2)
55-microm##7##1##(2008-2#4)(2008-3#3)
55-mum wavelength##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
55-mum##13##1##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#6)
55-year-old male patient##2##3##(2006-12#1)(2011-2#1)
55-year-old man##2##2##(1992-12#1)(2008-10#1)
55-year-old woman##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
55-year-old##10##1##(1992-12#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#2)
550 and##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
550 nm with an##2##4##(2008-10#2)
550 nm##7##2##(1990-11#1)(2008-10#4)(2008-2#1)(2008-5#1)
550##32##1##(1990-11#3)(1991-6#1)(1992-1#1)(1993-1#1)(1994-3#2)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
5500##2##1##(2008-1#1)(2008-3#1)
551 nm##3##2##(2008-10#3)
551##5##1##(2008-10#4)(2008-3#1)
552##5##1##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
553##2##1##(2007-12#1)(2012-2#1)
554##4##1##(2008-10#3)(2011-1#1)
555 nm##5##2##(2008-10#3)(2008-3#2)
555##7##1##(1990-11#1)(2008-10#4)(2008-3#2)
556 nm##2##2##(2007-12#1)(2008-10#1)
556##7##1##(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
557##5##1##(2008-3#1)(2010-8#1)(2012-12#1)(2013-1#2)
558##5##1##(2007-12#1)(2008-10#3)(2010-12#1)
559##2##1##(2008-4#1)(2012-12#1)
55K##3##1##(1992-8#3)
55microm##2##1##(2007-12#2)
55mum##2##1##(2007-11#1)(2007-12#1)
55°C##3##1##(2011-2#1)(2013-1#2)
56 +/- 0##2##3##(1992-9#1)(1993-1#1)
56 +/-##3##2##(1992-9#1)(1993-1#1)(2009-8#1)
56 and 64##2##3##(1991-1#2)
56 and##8##2##(1991-1#2)(1995-12#1)(2008-10#4)(2011-2#1)
56 cases##2##2##(2008-7#1)(2013-1#1)
56 days##5##2##(1993-1#1)(2008-10#2)(2010-5#1)(2011-2#1)
56 degrees##4##2##(1992-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
56 females)##2##2##(1993-5#1)(1995-6#1)
56 isolates##2##2##(1992-2#1)(2008-10#1)
56 kDa##3##2##(1990-12#2)(1995-5#1)
56 mg/kg)##2##2##(1995-12#1)(1997-8#1)
56 min##3##2##(1994-3#1)(2008-10#1)(2010-5#1)
56 mum##2##2##(2007-12#1)(2008-3#1)
56 of##2##2##(1997-3#1)(2008-5#1)
56 patients##5##2##(1996-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2012-12#1)
56 percent of##2##3##(1996-3#1)(2009-9#1)
56 to 3##2##3##(1996-5#1)(2009-7#1)
56 to##5##2##(1996-5#1)(2008-11#1)(2008-5#1)(2009-7#2)
56 were##2##2##(2008-3#1)(2008-6#1)
56 x 10(-5)##2##3##(1992-6#1)(2010-4#1)
56 x##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2010-4#1)
56 years##5##2##(1995-4#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
56##270##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#2)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#35)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#55)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#10)(2013-8#5)
56% and##3##2##(1991-2#1)(2011-2#1)(2012-3#1)
56% of the##4##3##(2007-7#1)(2008-10#1)(2009-12#1)(2013-7#1)
56% of##13##2##(1990-10#1)(1992-1#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-7#1)
56%##49##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-1#1)(1995-3#1)(1996-12#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-5#3)(2009-12#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
56%)##3##1##(1990-8#1)(2007-10#1)(2008-5#1)
56(2)##2##1##(1996-2#2)
56)##9##1##(1993-8#1)(2007-7#1)(2008-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#2)
56-kDa##2##1##(1994-11#1)(1995-2#1)
56-year-old woman with##2##3##(2007-8#1)(2013-1#1)
56-year-old woman##7##2##(2007-10#2)(2007-8#1)(2010-6#2)(2013-1#2)
56-year-old##13##1##(1997-6#1)(2007-10#2)(2007-2#1)(2007-8#2)(2010-12#1)(2010-6#2)(2010-9#1)(2011-2#1)(2013-1#2)
560 mW##2##2##(2007-12#1)(2008-2#1)
560 nm)##2##2##(2008-10#2)
560##20##1##(1990-11#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)
5600##4##1##(1995-2#1)(1995-6#1)(1996-2#1)(1997-5#1)
560nm for##2##2##(2008-10#2)
561##9##1##(1993-8#1)(1994-11#1)(1997-4#1)(2008-12#1)(2008-5#1)(2009-9#2)(2010-8#1)(2013-1#1)
561)##3##1##(2008-6#1)(2011-1#1)(2013-7#1)
562 nm##5##2##(2008-10#4)(2008-3#1)
562##8##1##(1995-3#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-8#1)
5623##2##1##(1991-12#2)
563##7##1##(1990-3#1)(2008-10#2)(2008-5#2)(2011-2#1)(2012-3#1)
564##4##1##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
565##7##1##(1990-2#1)(1994-2#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
566##5##1##(1990-3#1)(2008-3#2)(2008-4#1)(2013-8#1)
567##5##1##(1993-3#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-3#1)
569##7##1##(1992-12#2)(1994-6#1)(1995-2#1)(1996-12#1)(2007-7#1)(2011-2#1)
57 +/-##3##2##(2008-12#1)(2010-4#1)(2011-3#1)
57 000##2##2##(1997-9#1)(2008-8#1)
57 and 0##2##3##(2008-10#2)
57 and##11##2##(1993-2#1)(1994-5#1)(1995-3#1)(1997-5#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
57 cm(-1)##2##2##(2008-2#2)
57 dB##2##2##(2007-12#1)(2013-8#1)
57 kDa##2##2##(1991-9#1)(1993-6#1)
57 male)##2##2##(2012-12#1)(2013-1#1)
57 nM##2##2##(1990-12#1)(1990-5#1)
57 patients with##3##3##(1991-8#1)(2007-11#1)(2008-4#1)
57 patients##10##2##(1990-8#2)(1991-8#1)(1993-1#1)(1993-11#1)(2007-11#2)(2008-4#1)(2008-7#1)(2012-3#1)
57 samples##2##2##(1991-2#1)(2012-12#1)
57 to##4##2##(1991-3#1)(1993-9#1)(2008-10#2)
57 vs 1##2##3##(2012-3#1)(2013-1#1)
57 with##2##2##(1991-8#1)(2013-1#1)
57 years##5##2##(1991-4#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-12#1)
57##193##1##(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#3)(1996-12#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#3)(2007-11#6)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#8)(2008-10#26)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-7#2)(2010-1#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#11)(2013-8#6)
57% and##2##2##(2008-7#1)(2011-2#1)
57% of patients##3##3##(1994-10#1)(2006-8#1)(2010-4#1)
57% of the##4##3##(2008-10#1)(2008-4#1)(2010-3#1)(2013-8#1)
57% of##10##2##(1990-8#1)(1994-10#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-3#1)(2010-4#1)(2013-8#1)
57% were##3##2##(1991-6#1)(2007-7#1)(2008-12#1)
57%##40##1##(1990-8#1)(1991-6#1)(1992-3#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#2)
57) and##2##2##(2008-10#2)
57)##12##1##(1990-8#1)(1993-1#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
57-kDa##5##1##(1994-11#1)(1994-8#1)(1995-8#3)
57-year-old man##6##2##(1997-8#1)(2008-12#2)(2011-2#2)(2013-1#1)
57-year-old woman##3##2##(1991-12#1)(2008-7#1)(2013-7#1)
57-year-old##10##1##(1991-12#1)(1997-8#1)(2008-12#2)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)
570 nm)##2##2##(2008-10#1)(2011-2#1)
570##9##1##(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#2)
571##2##1##(1990-10#1)(2011-2#1)
572##3##1##(1992-6#1)(2006-8#1)(2008-3#1)
573##7##1##(1992-1#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#2)
575##6##1##(1990-12#1)(1997-4#1)(2008-11#1)(2008-8#1)(2011-1#2)
576 which##2##2##(2008-11#2)
576##5##1##(1997-2#1)(2008-11#2)(2008-3#1)(2011-2#1)
577 nm##2##2##(1994-5#1)(2008-10#1)
577##8##1##(1994-5#1)(1997-3#1)(2008-10#2)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)
578##8##1##(1993-2#1)(2008-2#3)(2008-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
579##2##1##(1996-3#1)(2011-2#1)
57th##2##1##(2009-6#2)
58 +/-##5##2##(1990-8#1)(2008-1#1)(2008-10#2)(2008-3#1)
58 TKAs##2##2##(2009-3#2)
58 V##2##2##(2008-10#1)(2009-9#1)
58 and##7##2##(2007-8#1)(2008-10#5)(2011-2#1)
58 bp##2##2##(1993-12#1)(1993-3#1)
58 different##2##2##(2008-5#2)
58 kDa##4##2##(1995-12#1)(1996-12#2)(2008-10#1)
58 mg##2##2##(2008-10#1)(2008-7#1)
58 of the##2##3##(1992-8#1)(1994-5#1)
58 of##3##2##(1992-8#1)(1994-5#1)(2013-8#1)
58 patients##5##2##(1994-2#1)(1994-6#1)(2007-7#1)(2008-1#1)(2008-7#1)
58 to##5##2##(2008-10#3)(2011-2#2)
58 with##2##2##(2008-7#1)(2013-1#1)
58 x##4##2##(2008-10#4)
58 years##2##2##(1990-3#1)(2009-8#1)
58 years)##2##2##(1990-2#2)
58##182##1##(1990-2#4)(1990-3#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#2)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-10#1)(1996-12#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#48)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#3)
58% for##4##2##(2008-10#3)(2013-1#1)
58% in##3##2##(1992-2#1)(1993-1#1)(1995-12#1)
58% of the##8##3##(1991-9#1)(1993-8#1)(1994-2#2)(1994-8#1)(2008-10#2)(2013-1#1)
58% of##12##2##(1990-6#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-2#2)(1994-8#1)(2008-10#3)(2008-11#1)(2013-1#1)
58% with##2##2##(2008-2#1)(2010-8#1)
58%##44##1##(1990-12#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
58%)##5##1##(1992-2#1)(2007-7#1)(2008-10#2)(2011-1#1)
58)##11##1##(1997-9#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#3)
58+/-0##4##1##(2008-10#3)(2013-7#1)
58-kDa##4##1##(1992-3#1)(1994-11#1)(1995-12#1)(1995-6#1)
58-year-old man##5##2##(1990-2#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
58-year-old##14##1##(1990-2#1)(1991-2#1)(1992-5#1)(2007-8#1)(2008-7#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
580 nm##7##2##(2008-10#6)(2008-8#1)
580##20##1##(1992-11#1)(1994-5#1)(1995-8#1)(2007-12#1)(2007-7#2)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
5800##2##1##(2013-1#2)
580nm for##2##2##(2008-10#2)
580nm##3##1##(2008-10#3)
581##3##1##(1994-5#1)(2008-11#1)(2011-2#1)
582##2##1##(1996-9#1)(1997-7#1)
584 A##3##2##(2008-3#3)
584##8##1##(2008-3#4)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
585 nm##6##2##(1992-6#1)(1994-8#1)(1996-11#1)(2008-10#2)(2008-3#1)
585##12##1##(1992-6#1)(1994-8#1)(1996-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
586##3##1##(2008-11#1)(2012-3#2)
587##5##1##(1994-12#2)(1996-3#1)(2008-10#1)(2008-6#1)
588 nm##2##2##(2007-11#1)(2008-10#1)
588##5##1##(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#1)
5883##2##1##(2008-10#2)
589 nm##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
589##7##1##(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
58K MP##3##2##(1997-3#3)
58K protein##2##2##(2008-8#2)
58K##6##1##(1997-3#3)(2008-8#3)
58K-like protein in##2##3##(2008-8#2)
58K-like protein##4##2##(2008-8#4)
59 (1955) 34-39)##2##3##(2008-10#2)
59 +/- 11##2##3##(2008-7#1)(2010-7#1)
59 +/-##5##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)
59 and##8##2##(1992-5#1)(1994-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)
59 cases##4##2##(1991-8#1)(1993-9#1)(2010-3#1)(2013-1#1)
59 isolates of##2##3##(2008-10#1)(2012-3#1)
59 isolates##3##2##(2008-10#2)(2012-3#1)
59 months##3##2##(2007-11#1)(2008-6#1)(2008-9#1)
59 of##2##2##(1995-6#1)(1996-12#1)
59 percent##2##2##(1994-1#1)(1997-3#1)
59 strains##2##2##(1990-6#1)(2008-10#1)
59 to##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
59 year old##2##3##(2007-6#1)(2012-3#1)
59 years old##2##3##(1990-6#1)(1993-2#1)
59 years##7##2##(1990-6#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2013-1#1)
59##148##1##(1990-5#1)(1990-6#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#4)
59% and##2##2##(1992-9#1)(2012-1#1)
59% of the##2##3##(2007-7#1)(2008-7#1)
59% of##5##2##(1995-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)
59%##26##1##(1990-3#1)(1990-7#1)(1992-9#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
59%) and##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
59%)##8##1##(1991-4#1)(1993-8#1)(2008-10#1)(2012-2#1)(2013-1#3)(2013-8#1)
59) for##3##2##(1995-2#1)(2007-11#1)(2008-1#1)
59)##11##1##(1993-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-3#1)
59-61##3##1##(1993-11#1)(1994-5#1)(1995-6#1)
59-76)##2##1##(2006-12#2)
59-kDa protein was##3##3##(1990-5#3)
59-kDa protein##7##2##(1990-5#7)
59-year-old male##2##2##(2011-2#1)(2012-12#1)
59-year-old man##4##2##(2007-8#2)(2008-1#1)(2009-8#1)
59-year-old woman##3##2##(2008-7#1)(2012-12#1)(2013-8#1)
59-year-old##11##1##(2007-8#2)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
590 nm##4##2##(1993-11#1)(2008-10#1)(2008-2#2)
590##12##1##(1993-11#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-9#1)(2010-10#1)
591##6##1##(1991-3#1)(1995-5#1)(2008-10#3)(2012-2#1)
592##6##1##(1996-11#1)(1996-9#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
593##7##1##(1991-1#1)(1994-9#1)(2007-12#1)(2008-10#3)(2013-7#1)
594##3##1##(1997-7#1)(2008-10#1)(2013-1#1)
595 were##2##2##(2007-10#1)(2013-8#1)
595##20##1##(1990-12#1)(1990-5#6)(1993-12#1)(2007-10#1)(2008-10#7)(2010-12#1)(2011-2#1)(2012-5#1)(2013-8#1)
596##7##1##(2008-9#1)(2011-2#2)(2012-3#3)(2013-1#1)
597##5##1##(1997-9#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
598##3##1##(2008-10#1)(2008-12#1)(2008-9#1)
599##4##1##(1996-6#1)(2008-10#1)(2008-9#1)(2013-8#1)
59Fe(III)##3##1##(1992-6#3)
59mug/l##2##1##(2008-10#2)
5A##2##1##(1994-11#1)(1997-1#1)
5BL##4##1##(2008-10#4)
5BSL3##2##1##(2013-1#2)
5CH3OH##2##1##(2007-11#2)
5D##2##1##(2007-12#1)(2008-6#1)
5D4##4##1##(2008-8#4)
5F##3##1##(1997-3#3)
5FLR patients##3##2##(2007-10#3)
5FU##6##1##(1992-2#4)(1995-4#1)(2008-5#1)
5H(2)dmg##2##1##(1997-7#2)
5H)-diyl))diethanones##2##1##(2012-3#2)
5HT 2a receptor T102C polymorphism and schizophrenia##6##7##(1996-6#6)
5HT and DA##3##3##(1996-12#3)
5HT##21##1##(1995-11#1)(1996-12#5)(1996-6#6)(1996-7#4)(2008-6#5)
5HT(3) receptor##2##2##(2010-12#2)
5HT)##2##1##(1995-11#1)(1996-7#1)
5HT1A##3##1##(2008-6#3)
5HT1D alpha##4##2##(1993-12#4)
5HT1D pseudogene##3##2##(1993-12#3)
5HT1D receptor##3##2##(2008-6#3)
5HT1D##13##1##(1993-12#9)(2008-6#4)
5HT2##3##1##(1994-6#1)(1996-7#2)
5HT2A receptor##5##2##(1996-7#5)
5HT2A##6##1##(1996-7#6)
5HT3##4##1##(1991-1#1)(2008-6#3)
5HTT##2##1##(2012-1#2)
5J/cm(2) and##2##2##(2012-3#2)
5J/cm(2) was##2##2##(2012-3#2)
5J/cm(2)##7##1##(2012-3#7)
5M H(2)SO(4)##2##2##(2008-10#2)
5M HCl##2##2##(2008-10#2)
5M HNO(3)##2##2##(2008-10#2)
5M##15##1##(1996-8#1)(2008-10#13)(2008-3#1)
5M1##2##1##(2009-8#2)
5MTN##2##1##(2012-2#2)
5Na0##2##1##(2008-3#2)
5P##2##1##(1990-2#1)(2010-12#1)
5P(2)##4##1##(2013-1#4)
5P(3/2)##4##1##(2008-2#1)(2008-3#3)
5P3 and##2##2##(1993-6#2)
5P3##5##1##(1993-6#5)
5R##2##1##(1991-12#1)(1995-12#1)
5RZ107##2##1##(2008-9#2)
5S NGF##2##2##(1990-8#2)
5S and 18S-5##2##3##(2008-5#2)
5S and##5##2##(2008-10#2)(2008-5#3)
5S gene##2##2##(1997-2#1)(2008-10#1)
5S rDNA spacer sequence analysis##2##5##(2008-8#1)(2008-9#1)
5S rRNA##9##2##(1997-7#3)(2007-12#4)(2008-5#2)
5S##30##1##(1990-11#3)(1990-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1997-2#1)(1997-7#4)(2007-12#4)(2008-10#5)(2008-5#5)(2008-8#1)(2008-9#1)(2012-3#1)
5S)-5-hydroxy-4-(hydroxymethyl)-1##2##1##(1995-11#2)
5T##3##1##(2008-3#1)(2008-5#1)(2010-12#1)
5V (logic 1) to 1##2##5##(2008-10#2)
5V##3##1##(2008-10#3)
5Z-anti##2##1##(1990-8#1)(1992-3#1)
5]##3##1##(1990-3#1)(1990-6#1)(2011-2#1)
5a##3##1##(1993-11#1)(2007-11#1)(2009-9#1)
5a-m##2##1##(2011-1#2)
5alpha##2##1##(2008-5#1)(2008-8#1)
5alpha-reductase##5##1##(2008-4#3)(2008-5#2)
5alphaR##7##1##(2008-5#7)
5b)##2##1##(2008-4#1)(2013-8#1)
5cm##4##1##(2008-10#2)(2008-12#1)(2009-1#1)
5dfol##5##1##(1995-2#5)
5e##2##1##(2007-11#1)(2008-3#1)
5g of##3##2##(2008-10#3)
5g##4##1##(2008-10#4)
5g/L)##2##1##(2013-1#2)
5h##3##1##(2008-10#2)(2012-1#1)
5kg##2##1##(2013-1#1)(2013-7#1)
5lambda and##2##2##(2008-3#2)
5lambda##6##1##(2008-3#6)
5mL of##3##2##(2008-10#3)
5mL##4##1##(2008-10#4)
5mLmin(-1)##4##1##(2008-10#4)
5mM##17##1##(1990-11#3)(2008-10#12)(2008-4#1)(2011-2#1)
5mV per pl-carnitine##2##3##(2008-10#2)
5mV per##3##2##(2008-10#3)
5mV##4##1##(2008-10#4)
5mg##8##1##(2008-10#4)(2008-3#2)(2010-7#1)(2013-1#1)
5mgL(-1)##4##1##(2008-10#4)
5mgkg(-1))##2##1##(2008-10#2)
5mgl(-1)##8##1##(2008-10#8)
5microm##5##1##(2007-11#3)(2007-12#2)
5min at the##2##3##(2008-10#1)(2012-1#1)
5min at##3##2##(2008-10#2)(2012-1#1)
5min was##2##2##(2008-10#2)
5min##32##1##(2008-10#30)(2012-1#2)
5ml of 1##2##3##(2008-10#2)
5ml of a##2##3##(2008-10#2)
5ml of##5##2##(2008-10#5)
5ml portion of a 0##2##5##(2008-10#2)
5ml##16##1##(2008-10#16)
5mlmin(-1)##3##1##(2008-10#3)
5mlmin(-1))##2##1##(2008-10#2)
5mm##3##1##(2007-12#1)(2008-10#1)(2011-2#1)
5mmoll(-1) phosphate buffer##2##3##(2008-10#2)
5mmoll(-1)##3##1##(2008-10#3)
5molL(-1) HNO(3)##2##2##(2008-10#2)
5molL(-1)##5##1##(2008-10#5)
5muM##4##1##(2008-10#4)
5mug##3##1##(2008-10#2)(2008-5#1)
5mug)##2##1##(2008-10#2)
5mug/l##3##1##(2008-10#3)
5mugL(-1)##6##1##(2008-10#6)
5mugl(-1) formaldehyde##2##2##(2008-10#2)
5mugl(-1)##15##1##(2008-10#15)
5mugl(-1)) and##2##2##(2008-10#2)
5mugml(-1)##10##1##(2008-10#10)
5mul##5##1##(2008-10#5)
5mum column##2##2##(2008-10#2)
5mum particle##2##2##(2008-10#2)
5mum##10##1##(2007-11#1)(2007-12#1)(2008-10#8)
5mum)##4##1##(2008-10#4)
5mumolL(-1)##2##1##(2008-10#2)
5nM##4##1##(1993-3#1)(2008-10#3)
5ng##2##1##(2008-10#2)
5ng/ml##2##1##(2008-10#2)
5ngmL(-1) for##2##2##(2008-10#2)
5ngmL(-1)##3##1##(2008-10#3)
5ngml(-1)##8##1##(2008-10#8)
5nm##2##1##(2008-10#2)
5pg for##2##2##(2008-10#2)
5ppm##5##1##(2008-10#5)
5q-syndrome##2##1##(2012-12#2)
5s##3##1##(2008-10#3)
5th and##2##2##(2008-2#1)(2008-7#1)
5th##26##1##(1991-2#1)(1991-9#3)(1995-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#3)(2009-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
5wt##2##1##(2013-1#2)
5wt%##2##1##(2012-2#2)
5wt%Sr##4##1##(2012-2#4)
5x10##2##1##(1992-12#1)(2008-10#1)
5x10(-10)##3##1##(2008-10#3)
5x10(-10)M##2##1##(2008-10#2)
5x10(-11)##2##1##(2008-10#2)
5x10(-2) M##3##2##(2008-10#3)
5x10(-2) mol l(-1)##2##3##(2008-10#2)
5x10(-2)##6##1##(2008-10#6)
5x10(-3) M with a detection limit of##2##7##(2008-10#2)
5x10(-3) M##3##2##(2008-10#3)
5x10(-3) mol l(-1)##3##3##(2008-10#3)
5x10(-3) mol##4##2##(2008-10#4)
5x10(-3)##11##1##(2007-11#1)(2007-12#1)(2008-10#9)
5x10(-3)M##2##1##(2008-10#2)
5x10(-3)molL(-1) for##2##2##(2008-10#2)
5x10(-4) mol l(-1)##3##3##(2008-10#3)
5x10(-4) to##4##2##(2008-10#4)
5x10(-4)##13##1##(2008-10#13)
5x10(-4)%##2##1##(2008-10#2)
5x10(-4)moll(-1)##2##1##(2008-10#2)
5x10(-5) M##3##2##(2008-10#3)
5x10(-5) mol l(-1)##5##3##(2008-10#5)
5x10(-5) mol##6##2##(2008-10#6)
5x10(-5) to 1##2##3##(2008-10#2)
5x10(-5) to##3##2##(2008-10#3)
5x10(-5)##14##1##(2008-10#14)
5x10(-5)-5x10(-4)##2##1##(2008-10#2)
5x10(-5)M with##2##2##(2008-10#2)
5x10(-5)M##5##1##(2008-10#5)
5x10(-5)moll(-1)##3##1##(2008-10#3)
5x10(-6) M##6##2##(2008-10#6)
5x10(-6) and##2##2##(2008-10#2)
5x10(-6) g##2##2##(2008-10#2)
5x10(-6) mol/l##2##2##(2008-10#2)
5x10(-6) to##4##2##(2008-10#4)
5x10(-6)##17##1##(2008-10#17)
5x10(-6)-5##2##1##(2008-10#2)
5x10(-6)molL(-1)##2##1##(2008-10#2)
5x10(-7) M for##2##3##(2008-10#2)
5x10(-7) M##5##2##(2008-10#5)
5x10(-7) mol l(-1)##3##3##(2008-10#3)
5x10(-7) to##3##2##(2008-10#3)
5x10(-7)##11##1##(2008-10#11)
5x10(-7)molL(-1)##3##1##(2008-10#3)
5x10(-7)moll(-1)##2##1##(2008-10#2)
5x10(-8) M##2##2##(2008-10#2)
5x10(-8) moll(-1) for##2##3##(2008-10#2)
5x10(-8) to 1x10(-5)##2##3##(2008-10#2)
5x10(-8) to##3##2##(2008-10#3)
5x10(-8)##9##1##(2008-10#9)
5x10(-8)-3##2##1##(2008-10#2)
5x10(-8)M##4##1##(2008-10#4)
5x10(-9) M##2##2##(2008-10#2)
5x10(-9) and##2##2##(2008-10#2)
5x10(-9) mol l(-1)##2##3##(2008-10#2)
5x10(-9)##8##1##(2008-10#8)
5x10(3)##2##1##(2008-10#2)
5x10(5)##5##1##(2008-10#2)(2008-11#2)(2008-12#1)
5x10(6)##2##1##(2008-10#1)(2008-11#1)
5x10(7)##2##1##(2008-11#1)(2008-8#1)
5 days##2##1##(2010-4#1)(2011-2#1)
5 mg/L##2##1##(2010-4#1)(2013-1#1)
5 mg/L) and cyclic##2##3##(2010-4#2)
5 mg/L) and##3##2##(2010-4#3)
5 mg/L)##5##1##(2010-4#5)
5 months##2##1##(2010-8#1)(2011-2#1)
5 weeks##2##1##(2012-1#2)
5 years##2##1##(2012-1#1)(2012-6#1)
5°C##5##1##(2011-1#2)(2011-2#2)(2013-1#1)
5±0##2##1##(2011-1#1)(2013-1#1)
5±1##3##1##(2010-12#2)(2011-1#1)
5±3##2##1##(2010-12#1)(2013-1#1)
5±4##2##1##(2010-12#1)(2011-1#1)
5 mg/kg##2##1##(2012-1#1)(2013-1#1)
5 min##2##1##(2013-1#2)
5 years##2##1##(2011-1#2)
5 Å resolution##2##2##(2010-10#2)
6 %##6##2##(1997-8#1)(2007-7#1)(2007-8#1)(2012-12#3)
6 %)##5##2##(2008-5#1)(2010-5#1)(2012-12#1)(2013-1#2)
6 (0##2##2##(1991-8#1)(2009-12#1)
6 (17##2##2##(1994-6#1)(2008-7#1)
6 (2##3##2##(1990-5#1)(2009-2#1)(2013-8#1)
6 (2)##2##2##(2008-10#2)
6 (21##2##2##(1992-11#1)(2008-10#1)
6 (3##2##2##(2008-5#2)
6 (3)##2##2##(2008-11#1)(2008-12#1)
6 (IL-6)##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
6 (n##3##2##(1994-10#1)(2013-1#2)
6 (range##3##2##(1992-5#1)(1993-11#1)(2008-1#1)
6 +##6##2##(1994-12#1)(1995-2#1)(2007-10#1)(2008-1#2)(2008-10#1)
6 +/- 0##14##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1993-11#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
6 +/- 1##11##3##(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)
6 +/- 11##2##3##(2007-10#1)(2008-10#1)
6 +/- 14##2##3##(2007-10#1)(2008-3#1)
6 +/- 2##9##3##(1990-12#1)(1994-12#1)(1995-11#1)(1997-5#1)(2007-8#2)(2010-1#1)(2012-2#1)(2013-7#1)
6 +/- 22##2##3##(1996-3#1)(2011-2#1)
6 +/- 3##7##3##(1990-2#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-9#1)(1997-6#1)(2008-12#1)
6 +/- 4##3##3##(1991-2#1)(1995-12#1)(1995-5#1)
6 +/- 5##3##3##(1991-2#1)(1993-8#1)(2011-2#1)
6 +/- 6##5##3##(1995-12#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
6 +/-##71##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#2)(1991-2#2)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1995-11#2)(1995-12#5)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)
6 - 1##2##3##(2007-12#1)(2008-5#1)
6 -##5##2##(1993-2#2)(2007-12#1)(2008-5#1)(2013-1#1)
6 =##2##2##(2009-7#2)
6 A##3##2##(1992-9#1)(1995-2#1)(2008-3#1)
6 CRF07_BC infected##2##3##(2013-8#2)
6 GHz##3##2##(2007-11#1)(2007-9#1)(2008-3#1)
6 Gy##3##2##(2009-2#3)
6 Hz##2##2##(2007-11#2)
6 J##2##2##(1996-2#1)(2011-1#1)
6 K##2##2##(2008-2#1)(2008-3#1)
6 L##2##2##(2007-12#2)
6 L/min##2##2##(1996-3#1)(2010-7#1)
6 M##8##2##(1992-6#1)(1993-6#1)(2008-10#5)(2008-11#1)
6 M-4##2##2##(2008-11#2)
6 M-4-TR7##2##2##(2008-11#2)
6 MV##4##2##(1991-2#1)(2008-3#1)(2012-1#1)(2013-1#1)
6 Mb##3##2##(1996-12#1)(1997-6#1)(2008-10#1)
6 THz##2##2##(2007-11#1)(2007-12#1)
6 V##7##2##(2007-11#2)(2008-10#4)(2009-10#1)
6 W of incident##2##4##(2007-11#1)(2008-3#1)
6 W##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
6 X##2##2##(1996-2#2)
6 alpha##2##2##(1991-5#2)
6 and +/- 1##2##4##(2008-10#2)
6 and 0##6##3##(1990-7#1)(1995-5#1)(2008-10#2)(2008-5#1)(2011-1#1)
6 and 1##12##3##(1991-8#1)(1992-12#1)(1996-12#1)(2008-10#5)(2008-12#2)(2008-7#1)(2009-11#1)
6 and 10##8##3##(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)
6 and 100##2##3##(2008-10#2)
6 and 11##2##3##(1993-9#1)(1994-2#1)
6 and 12 mg/kg females##2##5##(2008-9#2)
6 and 12 mg/kg males and females##5##7##(2008-9#5)
6 and 12 mg/kg males and##8##6##(2008-9#8)
6 and 12 mg/kg##12##4##(2008-9#12)
6 and 12 months after##2##5##(2007-8#1)(2008-3#1)
6 and 12 months##9##4##(1993-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2013-1#1)
6 and 12 weeks##4##4##(2006-10#1)(2007-11#1)(2007-8#1)(2013-1#1)
6 and 12##30##3##(1992-3#1)(1993-12#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#13)(2010-5#1)(2011-2#3)(2013-1#2)
6 and 14##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
6 and 15 MV##2##4##(2008-3#1)(2013-1#1)
6 and 15##4##3##(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
6 and 18 weeks##2##4##(2010-12#2)
6 and 18##5##3##(1994-3#1)(1995-5#1)(2009-5#1)(2010-12#2)
6 and 2##8##3##(1995-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-2#1)
6 and 24##2##3##(1990-12#1)(2008-10#1)
6 and 25##2##3##(1990-7#1)(2009-10#1)
6 and 3##4##3##(1994-11#1)(2008-10#3)
6 and 4##4##3##(1997-2#1)(2008-10#2)(2009-3#1)
6 and 5##8##3##(1990-9#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)
6 and 6##2##3##(2008-10#1)(2008-4#1)
6 and 7 December 2007##2##5##(2009-4#2)
6 and 7 of##2##4##(2008-10#1)(2010-3#1)
6 and 7##15##3##(1996-5#1)(2008-10#7)(2008-11#1)(2009-4#2)(2010-3#1)(2011-2#2)(2013-1#1)
6 and 8 mm##4##4##(2013-1#4)
6 and 8##18##3##(1990-2#1)(1990-8#1)(1991-3#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#5)(2013-1#5)
6 and 9##3##3##(1996-5#1)(1997-2#1)(2011-2#1)
6 and a##3##3##(1990-6#1)(1996-2#1)(2008-10#1)
6 and at##2##3##(2008-10#2)
6 and the##3##3##(1991-5#1)(2008-10#2)
6 and was##3##3##(2008-10#2)(2008-7#1)
6 and##206##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#67)(2008-11#3)(2008-12#5)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#14)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#11)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)
6 are##2##2##(1996-2#1)(2008-5#1)
6 as well as##2##4##(2008-10#1)(2012-3#1)
6 as##4##2##(2007-11#1)(2008-10#2)(2012-3#1)
6 at##5##2##(1990-7#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-3#1)
6 basic##2##2##(1995-6#2)
6 billion##2##2##(1992-2#1)(2008-11#1)
6 by##2##2##(1992-3#1)(2010-7#1)
6 cM##5##2##(1996-10#1)(2008-10#2)(2008-9#1)(2012-3#1)
6 cases of##3##3##(1990-6#1)(1991-8#1)(2008-7#1)
6 cases##17##2##(1990-6#3)(1991-1#1)(1991-8#1)(1992-12#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
6 categories##2##2##(2008-10#1)(2010-1#1)
6 caused less disease on##2##5##(2008-10#2)
6 caused##3##2##(2008-10#3)
6 cells##2##2##(1994-2#1)(1997-1#1)
6 centimorgans##2##2##(2008-10#2)
6 chemotherapy##2##2##(2011-2#1)(2012-1#1)
6 children##2##2##(1990-9#1)(2011-2#1)
6 cm in diameter##3##4##(1992-2#1)(2008-7#1)(2012-3#1)
6 cm##18##2##(1992-2#1)(1992-9#1)(1993-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
6 cm(-1)##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
6 cycles of##7##3##(1991-6#1)(1994-5#1)(2007-7#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-3#1)
6 d##3##2##(2007-5#1)(2008-11#1)(2011-2#1)
6 dB##4##2##(2007-11#2)(2008-2#1)(2009-9#1)
6 days after treatment##2##4##(1990-10#1)(2008-10#1)
6 days after##8##3##(1990-10#1)(1991-5#1)(1995-3#1)(2008-10#5)
6 days and then##2##4##(2008-10#1)(2008-11#1)
6 days and##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
6 days at##2##3##(1995-8#1)(2008-10#1)
6 days in##3##3##(1995-8#2)(2008-10#1)
6 days later##2##3##(1994-2#1)(2008-10#1)
6 days##43##2##(1990-10#1)(1991-5#1)(1992-11#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#4)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-10#11)(2008-11#5)(2008-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#4)
6 days)##2##2##(1990-6#1)(1995-3#1)
6 degrees C for##2##4##(2006-11#1)(2008-10#1)
6 degrees C##10##3##(1997-7#1)(2006-11#1)(2008-10#6)(2008-2#1)(2008-6#1)
6 degrees##19##2##(1992-4#1)(1997-7#1)(2006-11#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-10#1)(2013-1#1)
6 different##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#2)
6 eggs##2##2##(1991-5#1)(2008-12#1)
6 fold by##2##3##(1994-11#1)(2011-3#1)
6 fold##4##2##(1990-2#1)(1993-6#1)(1994-11#1)(2011-3#1)
6 for##14##2##(1991-8#2)(1993-9#2)(1995-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
6 g kg(-1)##2##3##(2008-10#1)(2008-12#1)
6 g##4##2##(2008-10#3)(2008-12#1)
6 g/l##3##2##(1991-6#1)(2008-1#1)(2008-5#1)
6 good##2##2##(2007-11#1)(2008-12#1)
6 groups##4##2##(1996-6#1)(2008-12#1)(2013-1#1)(2013-7#1)
6 h after##13##3##(1991-2#1)(1993-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)
6 h in##2##3##(1995-11#1)(2008-11#1)
6 h of##6##3##(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
6 h##56##2##(1990-12#2)(1991-2#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#2)(1997-4#1)(2008-10#14)(2008-11#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2010-5#2)
6 h)##3##2##(1992-8#1)(1993-12#1)(1995-2#1)
6 healthy##2##2##(1990-5#1)(2011-2#1)
6 hours after##3##3##(1994-11#1)(2007-9#1)(2012-2#1)
6 hours##15##2##(1990-2#1)(1993-8#1)(1994-11#2)(2007-10#4)(2007-9#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
6 hr and 12 hr##2##5##(2008-6#2)
6 hr and##3##3##(2008-5#1)(2008-6#2)
6 hr##7##2##(1995-2#1)(2008-5#2)(2008-6#4)
6 in a##3##3##(1995-6#1)(2008-10#2)
6 in the presence of##2##5##(1990-8#1)(2008-10#1)
6 in the##10##3##(1990-8#1)(1991-3#1)(1992-2#2)(1997-7#1)(2007-11#1)(2008-10#3)(2008-7#1)
6 in##26##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-2#2)(1995-2#1)(1995-5#1)(1995-6#1)(1997-5#1)(1997-7#4)(2007-11#1)(2008-10#8)(2008-7#2)(2011-2#1)(2013-1#1)
6 is a##2##3##(1997-7#1)(2008-8#1)
6 is##3##2##(1997-7#1)(2008-2#1)(2008-8#1)
6 kDa maltodextrin##2##3##(2007-11#2)
6 kDa##7##2##(1990-12#1)(1993-6#1)(1995-11#1)(2007-11#2)(2008-12#1)(2011-2#1)
6 kHz##2##2##(2007-12#1)(2008-3#1)
6 kb DNA fragment##2##4##(2008-8#1)(2008-9#1)
6 kb mRNA##2##3##(1993-8#1)(1997-2#1)
6 kb##17##2##(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-6#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
6 kbp##2##2##(1990-12#1)(2008-10#1)
6 kcal/mol##3##2##(1990-8#1)(1993-8#1)(2008-6#1)
6 kg##4##2##(2007-7#1)(2008-3#1)(2008-9#1)(2012-3#1)
6 km)##2##2##(2008-10#1)(2010-6#1)
6 km2##2##2##(2008-8#1)(2011-2#1)
6 l/min##2##2##(1993-2#1)(2007-8#1)
6 lesions per##2##3##(2008-10#2)
6 lesions##3##2##(2008-10#2)(2008-5#1)
6 m wide##2##3##(2008-10#2)
6 m##6##2##(2008-10#5)(2011-2#1)
6 mJ##2##2##(2007-11#1)(2008-5#1)
6 mM calcium##3##3##(1994-3#3)
6 mM##9##2##(1992-11#1)(1994-3#3)(2008-10#4)(2011-2#1)
6 mV per##2##3##(2008-10#2)
6 mg l(-1) of##2##4##(2008-10#2)
6 mg l(-1)##5##3##(2008-10#3)(2008-11#2)
6 mg##15##2##(1992-8#1)(1993-2#1)(1997-4#1)(2008-10#4)(2008-11#4)(2008-9#2)(2010-8#1)(2013-8#1)
6 mg/dL##3##2##(2008-3#1)(2008-7#1)(2011-1#1)
6 mg/kg males##3##3##(2008-9#3)
6 mg/kg rocuronium##2##3##(2011-2#2)
6 mg/kg##12##2##(1992-12#1)(1992-3#1)(2008-10#1)(2008-9#6)(2011-2#3)
6 microM##8##2##(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-7#1)(2009-9#1)
6 microM)##3##2##(1990-11#1)(1992-12#1)(1994-6#1)
6 microW##2##2##(2008-9#2)
6 microg l(-1)##2##3##(2008-10#2)
6 microg##4##2##(2007-12#1)(2008-10#3)
6 microg/l##2##2##(2008-10#2)
6 microm##9##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)
6 microns##3##2##(1991-5#1)(1996-2#1)(1996-3#1)
6 microns)##2##2##(1995-3#1)(1996-2#1)
6 million people##2##3##(2008-10#1)(2008-7#1)
6 million##8##2##(1990-3#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-8#1)
6 min for##3##3##(1996-1#1)(1996-2#1)(2008-3#1)
6 min##20##2##(1990-11#1)(1990-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#9)(2008-3#1)
6 min)##2##2##(2008-10#1)(2011-2#1)
6 ml##2##2##(2008-10#2)
6 mm I##4##3##(1990-8#1)(1991-5#1)(1996-5#1)(1997-2#1)
6 mm and##2##3##(2008-12#1)(2008-2#1)
6 mm for##2##3##(2008-12#1)(2008-7#1)
6 mm i##8##3##(2008-10#6)(2008-5#1)(2010-3#1)
6 mm in##2##3##(1991-2#1)(2008-10#1)
6 mm##39##2##(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
6 mm)##5##2##(2008-10#2)(2009-8#1)(2011-2#1)(2011-3#1)
6 mmHg##3##2##(1991-10#1)(2008-10#1)(2008-11#1)
6 mmHg)##2##2##(1991-6#1)(2008-11#1)
6 mmol##3##2##(1994-2#1)(2008-10#2)
6 mmol/l##5##2##(1990-6#1)(1991-11#3)(2008-7#1)
6 mo##2##2##(2012-2#2)
6 mol l(-1)##2##3##(2008-10#2)
6 mol of##2##3##(1993-11#1)(1994-5#1)
6 mol##5##2##(1990-10#1)(1993-11#1)(1994-5#1)(2008-10#2)
6 month juveniles##2##3##(2010-8#2)
6 month##6##2##(1993-6#1)(1996-5#1)(2010-8#2)(2011-2#1)(2013-1#1)
6 months after initial##2##4##(2011-2#1)(2013-1#1)
6 months after surgery##2##4##(2007-8#1)(2008-1#1)
6 months after the##6##4##(1991-8#1)(2007-11#1)(2007-7#1)(2008-7#2)(2011-2#1)
6 months after##26##3##(1991-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#6)(2013-1#2)(2013-8#1)
6 months and##12##3##(1990-12#1)(1991-3#1)(2007-10#4)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
6 months at room temperature##2##5##(2008-10#1)(2008-8#1)
6 months at room##3##4##(2008-10#2)(2008-8#1)
6 months at##5##3##(2007-11#1)(2008-10#3)(2008-8#1)
6 months before##4##3##(2008-1#1)(2011-2#1)(2013-1#2)
6 months following the start of##2##6##(2008-1#1)(2008-10#1)
6 months following##3##3##(2008-1#1)(2008-10#2)
6 months for##3##3##(1991-8#1)(2013-1#2)
6 months in the##5##4##(2007-8#2)(2008-10#2)(2008-11#1)
6 months in##11##3##(1990-6#1)(1995-6#2)(1996-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
6 months is##2##3##(2011-1#1)(2011-2#1)
6 months later##6##3##(1990-2#1)(1997-5#1)(2007-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
6 months of age##9##4##(1991-2#1)(1995-5#1)(2007-8#1)(2008-3#1)(2010-6#1)(2012-12#2)(2012-3#2)
6 months of life##3##4##(2008-10#2)(2011-2#1)
6 months of treatment##8##4##(1991-8#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-8#1)(2012-3#2)(2013-8#1)
6 months of##33##3##(1991-2#1)(1991-8#1)(1995-5#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-3#4)(2008-6#1)(2008-8#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#1)(2013-8#3)
6 months old##3##3##(1993-12#1)(2007-8#1)(2008-10#1)
6 months to 6 years##2##5##(2007-7#1)(2007-8#1)
6 months to##4##3##(2007-7#1)(2007-8#1)(2010-5#1)(2013-1#1)
6 months was##4##3##(2008-10#1)(2012-12#1)(2013-1#2)
6 months were##3##3##(1991-12#1)(1997-2#1)(2007-10#1)
6 months##227##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-8#3)(1992-10#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#10)(2007-11#12)(2007-12#1)(2007-7#5)(2007-8#12)(2008-1#5)(2008-10#24)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#12)(2009-11#2)(2009-5#2)(2010-10#2)(2010-3#1)(2010-5#3)(2010-6#3)(2011-1#1)(2011-2#20)(2012-12#8)(2012-3#6)(2013-1#26)(2013-8#9)
6 months)##4##2##(1996-11#1)(1997-3#1)(2010-12#1)(2011-2#1)
6 mug l(-1) for##2##4##(2008-10#2)
6 mug l(-1)##4##3##(2008-10#4)
6 mug ml(-1)##7##3##(2008-10#7)
6 mug ml(-1))##2##3##(2008-10#2)
6 mug##19##2##(2008-10#17)(2008-11#1)(2008-5#1)
6 mum##14##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#4)(2008-7#1)
6 mum)##3##2##(2007-12#1)(2008-3#2)
6 mumol##2##2##(1996-12#1)(2008-10#1)
6 nM##6##2##(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-10#2)
6 ng g(-1)##2##3##(2008-10#2)
6 ng ml(-1) for##2##4##(2008-10#2)
6 ng ml(-1)##11##3##(2008-10#11)
6 ng##16##2##(2008-10#16)
6 nm##16##2##(1990-11#1)(2007-11#4)(2008-10#3)(2008-2#2)(2008-3#4)(2008-8#1)(2013-8#1)
6 nm)##6##2##(2007-11#1)(2008-2#2)(2008-3#2)(2013-8#1)
6 ns##3##2##(1995-5#1)(2008-2#1)(2008-3#1)
6 of 7 patients##2##4##(2008-7#1)(2009-10#1)
6 of 7##3##3##(2008-7#1)(2009-10#1)(2009-3#1)
6 of the##7##3##(1990-3#2)(1993-11#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-2#1)
6 of##30##2##(1990-3#2)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-2#1)(2012-2#1)
6 or 10 h after CCl4##2##6##(1994-5#2)
6 or 10##3##3##(1994-5#2)(2009-5#1)
6 or 11##2##3##(1994-1#1)(2008-6#1)
6 or lower##2##3##(2008-10#2)
6 or more##2##3##(1995-3#1)(2007-8#1)
6 or##14##2##(1990-3#1)(1991-5#1)(1994-1#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-5#1)
6 orders of magnitude##2##4##(2007-12#2)
6 out of 10##2##4##(1996-9#1)(2008-12#1)
6 out of##5##3##(1992-5#1)(1996-9#1)(2008-12#3)
6 parts per##2##3##(2008-10#1)(2008-3#1)
6 patients had##3##3##(1990-12#1)(2008-1#1)(2008-10#1)
6 patients were treated##2##4##(2008-5#1)(2008-7#1)
6 patients were##4##3##(1992-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
6 patients who underwent##2##4##(2008-1#1)(2009-3#1)
6 patients who##3##3##(2008-1#2)(2009-3#1)
6 patients with intracystic papilloma##2##5##(1994-7#2)
6 patients with intracystic##3##4##(1994-7#3)
6 patients with##10##3##(1991-5#1)(1994-7#3)(1995-12#1)(1997-3#1)(1997-4#1)(2010-8#2)(2012-2#1)
6 patients##42##2##(1990-12#2)(1991-3#1)(1991-5#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-7#3)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
6 per cent##3##3##(1990-6#1)(1992-2#1)(2008-7#1)
6 per##7##2##(1990-6#1)(1992-2#1)(1996-3#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-3#1)
6 percent of##3##3##(1991-3#1)(1992-12#1)(1993-2#1)
6 percent per year##2##4##(1994-12#1)(2007-9#1)
6 percent##14##2##(1990-5#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#2)(2007-9#1)(2008-11#2)
6 percent) were knowledgeable##2##4##(2013-1#2)
6 percent)##3##2##(1997-3#1)(2013-1#2)
6 pg##2##2##(2008-10#2)
6 pm##2##2##(2008-12#1)(2008-5#1)
6 points##2##2##(2010-11#1)(2013-7#1)
6 ppm##4##2##(2008-10#3)(2010-1#1)
6 ps##2##2##(2007-1#1)(2007-11#1)
6 reduced##2##2##(2008-10#2)
6 respectively##3##2##(1996-12#1)(2008-8#1)(2011-2#1)
6 strains##2##2##(2008-10#2)
6 this##2##2##(1994-3#1)(2008-10#1)
6 through##2##2##(2008-10#1)(2009-7#1)
6 times for##2##3##(1995-6#1)(2008-6#1)
6 times higher than##2##4##(2008-7#1)(2013-8#1)
6 times in##2##3##(1995-8#1)(2010-12#1)
6 times more likely to##2##5##(2007-12#1)(2013-8#1)
6 times more##3##3##(1992-6#1)(2007-12#1)(2013-8#1)
6 times per##2##3##(2007-8#2)
6 times that##2##3##(2008-11#1)(2008-3#1)
6 times##20##2##(1992-6#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-3#1)(2013-8#2)
6 to 0##5##3##(2008-10#4)(2008-3#1)
6 to 10##4##3##(1992-1#1)(2007-10#1)(2008-10#1)(2008-9#1)
6 to 100##2##3##(2008-10#1)(2008-11#1)
6 to 102##2##3##(2008-10#2)
6 to 12##5##3##(1994-9#1)(2007-8#1)(2008-10#1)(2011-1#2)
6 to 16 years##2##4##(2007-8#1)(2009-10#1)
6 to 16##3##3##(2007-12#1)(2007-8#1)(2009-10#1)
6 to 17##3##3##(2008-10#2)(2012-12#1)
6 to 18##4##3##(1990-7#1)(2007-8#1)(2008-10#2)
6 to 20##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
6 to 24 months##2##4##(1995-1#1)(2012-3#1)
6 to 3##3##3##(2008-10#2)(2013-1#1)
6 to 30##2##3##(2008-10#2)
6 to 5##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
6 to 7 weeks##2##4##(2008-10#2)
6 to 7##3##3##(1996-12#1)(2008-10#2)
6 to 75##2##3##(1997-7#1)(2008-10#1)
6 to 8 days##2##4##(1997-3#1)(2008-10#1)
6 to 8 weeks##5##4##(1992-11#1)(2008-10#2)(2009-11#1)(2009-5#1)
6 to 8##11##3##(1992-11#1)(1994-9#1)(1997-3#1)(2008-10#5)(2009-11#1)(2009-5#1)(2009-8#1)
6 to 9##5##3##(2008-10#2)(2008-12#1)(2010-5#1)(2011-2#1)
6 to 95##2##3##(1995-3#1)(2012-2#1)
6 to##105##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#4)(2008-10#43)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-5#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
6 using##2##2##(1991-3#1)(1995-6#1)
6 vs##12##2##(1991-5#1)(1991-9#2)(1997-4#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-3#1)
6 was##6##2##(1995-2#1)(1995-5#1)(2008-10#2)(2008-3#1)(2011-2#1)
6 week##2##2##(2007-11#1)(2013-1#1)
6 weeks after being##2##4##(1994-8#1)(2012-12#1)
6 weeks after inoculation##3##4##(2008-10#3)
6 weeks after surgery##3##4##(2007-11#2)(2009-5#1)
6 weeks after the##2##4##(1990-12#1)(2008-7#1)
6 weeks after##18##3##(1990-12#1)(1992-3#1)(1994-8#1)(1996-8#1)(2007-11#2)(2008-10#6)(2008-7#1)(2009-5#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
6 weeks and##5##3##(1991-11#1)(1991-2#1)(1994-3#1)(2007-8#1)(2008-7#1)
6 weeks following##3##3##(2007-11#1)(2008-4#1)(2008-5#1)
6 weeks in case of##2##5##(1993-2#1)(1996-6#1)
6 weeks in##5##3##(1993-2#1)(1996-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
6 weeks later##3##3##(1997-3#1)(2007-8#1)(2008-8#1)
6 weeks of age##2##4##(2008-10#1)(2013-1#1)
6 weeks of life##2##4##(2008-10#1)(2011-1#1)
6 weeks of##8##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)(2013-1#2)
6 weeks or##2##3##(2008-9#2)
6 weeks post##2##3##(2007-11#1)(2007-8#1)
6 weeks to##2##3##(2007-11#1)(2008-5#1)
6 weeks##118##2##(1990-10#1)(1990-12#2)(1990-9#1)(1991-11#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-7#2)(2007-8#4)(2008-10#23)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#5)(2009-1#1)(2009-5#1)(2010-3#2)(2010-6#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
6 weeks)##5##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
6 were treated with##2##4##(2007-11#1)(2011-2#1)
6 were##22##2##(1990-6#1)(1994-5#1)(1995-11#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
6 which##2##2##(2008-10#1)(2008-7#1)
6 with##14##2##(1990-3#1)(1991-3#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
6 women##3##2##(1990-2#1)(1995-3#1)(2009-5#1)
6 x 10(-10)##3##3##(1993-8#1)(1995-11#1)(2008-2#1)
6 x 10(-3)##2##3##(2008-3#2)
6 x 10(-4)##3##3##(2008-10#1)(2008-2#2)
6 x 10(-6)##2##3##(1992-3#1)(1995-11#1)
6 x 10(-6)-1##2##3##(2008-10#2)
6 x 10(-7)##3##3##(2008-10#2)(2008-3#1)
6 x 10(-8)##4##3##(1995-11#1)(2008-10#2)(2008-3#1)
6 x 10(3)##2##3##(2008-10#1)(2010-4#1)
6 x 10(4)##3##3##(1994-5#1)(1997-3#1)(2010-4#1)
6 x 10(5)##4##3##(1994-8#1)(2008-11#1)(2008-3#1)(2010-4#1)
6 x 10(6)##5##3##(1990-8#1)(1995-2#1)(2008-10#1)(2008-9#1)(2010-4#1)
6 x 10(7)##2##3##(2008-11#1)(2008-9#1)
6 x 10(8)##3##3##(1990-12#1)(2008-8#1)(2008-9#1)
6 x 10(9)##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
6 x His##2##3##(1995-8#1)(1997-4#1)
6 x##58##2##(1990-12#2)(1990-8#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-8#2)(1997-3#1)(1997-4#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-3#8)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-4#5)
6 y 9 h after inoculation##2##6##(2008-5#2)
6 years (mean##2##3##(2013-1#2)
6 years (range##4##3##(1993-2#1)(2008-8#1)(2011-1#1)(2012-12#1)
6 years after stereotactic radiosurgery##2##5##(2011-2#2)
6 years after##5##3##(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
6 years and##2##3##(2009-3#1)(2011-2#1)
6 years in##2##3##(2008-10#1)(2013-1#1)
6 years of the##2##4##(2008-10#1)(2009-4#1)
6 years of##3##3##(1995-4#1)(2008-10#1)(2009-4#1)
6 years were##2##3##(2007-7#1)(2007-8#1)
6 years##55##2##(1990-3#1)(1990-6#1)(1991-3#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-4#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#4)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-4#2)(2011-1#1)(2011-2#8)(2012-12#2)(2013-1#4)(2013-8#1)
6 years) than##2##3##(2008-10#1)(2011-2#1)
6 years)##7##2##(1993-1#1)(1994-2#1)(2008-10#1)(2010-9#1)(2011-2#2)(2013-1#1)
6 ±##4##2##(2011-2#2)(2013-1#2)
6##3469##1##(1990-10#5)(1990-11#11)(1990-12#25)(1990-2#14)(1990-3#9)(1990-5#12)(1990-6#14)(1990-7#20)(1990-8#13)(1990-9#5)(1991-1#3)(1991-10#1)(1991-11#10)(1991-12#11)(1991-2#21)(1991-3#15)(1991-5#24)(1991-6#4)(1991-7#1)(1991-8#23)(1991-9#14)(1992-1#3)(1992-10#2)(1992-11#11)(1992-12#16)(1992-2#10)(1992-3#15)(1992-4#4)(1992-5#3)(1992-6#18)(1992-8#8)(1992-9#7)(1993-1#3)(1993-10#2)(1993-11#8)(1993-12#16)(1993-2#14)(1993-3#8)(1993-6#11)(1993-8#19)(1993-9#12)(1994-1#2)(1994-10#1)(1994-11#11)(1994-12#20)(1994-2#9)(1994-3#15)(1994-5#11)(1994-6#16)(1994-7#5)(1994-8#15)(1994-9#11)(1995-1#1)(1995-11#22)(1995-12#24)(1995-2#36)(1995-3#13)(1995-4#1)(1995-5#17)(1995-6#10)(1995-8#20)(1995-9#1)(1996-1#3)(1996-10#6)(1996-11#5)(1996-12#22)(1996-2#30)(1996-3#10)(1996-4#2)(1996-5#20)(1996-6#7)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#17)(1997-3#14)(1997-4#12)(1997-5#10)(1997-6#9)(1997-7#31)(1997-8#8)(1997-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#32)(2007-11#107)(2007-12#40)(2007-2#2)(2007-3#4)(2007-5#4)(2007-6#2)(2007-7#22)(2007-8#64)(2007-9#4)(2008-1#30)(2008-10#866)(2008-11#95)(2008-12#65)(2008-2#44)(2008-3#121)(2008-4#24)(2008-5#73)(2008-6#48)(2008-7#72)(2008-8#49)(2008-9#87)(2009-1#2)(2009-10#6)(2009-11#10)(2009-12#4)(2009-2#9)(2009-3#10)(2009-4#10)(2009-5#12)(2009-6#3)(2009-7#7)(2009-8#11)(2009-9#5)(2010-1#5)(2010-10#6)(2010-11#2)(2010-12#7)(2010-2#10)(2010-3#12)(2010-4#17)(2010-5#18)(2010-6#7)(2010-7#8)(2010-8#10)(2010-9#2)(2011-1#53)(2011-2#122)(2011-3#10)(2012-1#8)(2012-12#31)(2012-2#33)(2012-3#41)(2013-1#130)(2013-3#1)(2013-7#8)(2013-8#50)
6% (SEM##2##2##(1992-6#2)
6% (at##2##2##(2008-10#2)
6% (n =##2##3##(1995-8#1)(2012-3#1)
6% (n=9)##2##2##(2008-10#2)
6% (w/w)##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
6% acetonitrile in##2##3##(2008-10#2)
6% and a##2##3##(2008-10#1)(2008-8#1)
6% and the##3##3##(2008-10#3)
6% and##35##2##(1990-12#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-3#1)(2007-11#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#4)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
6% are##3##2##(1990-3#1)(2008-10#1)(2013-8#1)
6% at the##6##3##(2008-1#1)(2008-10#5)
6% at##16##2##(1990-8#1)(1995-12#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-7#1)
6% before##2##2##(1996-12#1)(2008-3#1)
6% benzoyl peroxide##2##3##(2010-8#2)
6% for Candida##2##3##(2008-5#2)
6% for ten determinations of##2##5##(2008-10#2)
6% for the##3##3##(1997-7#1)(2008-10#2)
6% for##40##2##(1990-5#1)(1991-6#1)(1994-3#1)(1994-9#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#4)
6% had##4##2##(1995-10#1)(2007-7#1)(2008-12#2)
6% identity with##3##3##(2008-10#2)(2008-7#1)
6% identity##4##2##(1991-12#1)(2008-10#2)(2008-7#1)
6% in 2000##2##3##(2007-2#2)
6% in the##10##3##(1996-5#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#1)(2013-8#1)
6% in##33##2##(1990-8#2)(1991-6#1)(1994-3#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-2#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
6% nucleotide identity##2##3##(2008-10#1)(2008-8#1)
6% nucleotide##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
6% of all##5##3##(1991-3#1)(1995-1#1)(2007-11#1)(2008-6#1)(2008-7#1)
6% of cases##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2009-10#1)
6% of males##3##3##(1990-6#1)(1994-6#2)
6% of patients##7##3##(1991-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-3#1)
6% of the cases##2##4##(1990-12#1)(2008-1#1)
6% of the patients##8##4##(1990-9#1)(1991-3#1)(1991-6#1)(1995-12#1)(2007-8#2)(2008-1#1)(2008-11#1)
6% of the phenotypic##2##4##(2008-10#2)
6% of the respondents##2##4##(2008-9#1)(2013-8#1)
6% of the total##5##4##(1990-3#1)(1992-8#1)(2008-10#1)(2010-1#1)(2011-2#1)
6% of the##47##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
6% of total##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
6% of##99##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
6% on##2##2##(2010-1#1)(2013-1#1)
6% presented##2##2##(2008-12#1)(2008-5#1)
6% recovery##2##2##(2008-10#2)
6% reported##2##2##(2008-12#1)(2013-8#1)
6% respectively##2##2##(2007-2#1)(2013-8#1)
6% slope efficiency##2##3##(2008-2#2)
6% stated that the##2##4##(1993-3#1)(2011-2#1)
6% to##12##2##(1991-9#1)(1993-3#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-1#2)
6% vs##5##2##(1993-2#1)(1993-8#1)(2007-8#1)(2011-1#1)(2011-2#1)
6% was##4##2##(1995-6#1)(2008-10#2)(2009-7#1)
6% were female with mean age of 48##2##8##(2013-1#2)
6% were##10##2##(1993-3#1)(1994-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#4)
6% with a##2##3##(1990-12#1)(2007-11#1)
6% with that of##2##4##(2008-10#1)(2008-8#1)
6% with the relative standard##2##5##(2008-10#1)(2011-1#1)
6% with##10##2##(1990-12#1)(1995-3#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
6%##579##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#7)(1991-9#3)(1992-11#2)(1992-3#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#6)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#7)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#5)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#9)(2007-12#3)(2007-2#5)(2007-5#3)(2007-7#12)(2007-8#17)(2007-9#1)(2008-1#13)(2008-10#145)(2008-11#11)(2008-12#11)(2008-2#10)(2008-3#16)(2008-4#2)(2008-5#14)(2008-6#7)(2008-7#12)(2008-8#10)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#2)(2010-8#9)(2011-1#12)(2011-2#19)(2012-1#2)(2012-12#7)(2012-2#13)(2012-3#12)(2013-1#31)(2013-7#3)(2013-8#19)
6%) and in##2##3##(1992-6#1)(2013-1#1)
6%) and the##3##3##(2007-2#1)(2010-8#1)(2013-8#1)
6%) and was##2##3##(2008-1#1)(2010-5#1)
6%) and##30##2##(1991-12#2)(1992-11#1)(1992-6#1)(1992-8#1)(1996-11#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
6%) cases##2##2##(2008-7#1)(2013-8#1)
6%) followed by##3##3##(1992-10#1)(2007-7#2)
6%) for##2##2##(2007-7#1)(2012-2#1)
6%) had##7##2##(1990-12#1)(1992-9#1)(2008-8#1)(2010-5#1)(2011-2#3)
6%) in##2##2##(2008-1#1)(2008-3#1)
6%) of the##4##3##(1995-11#1)(2007-7#1)(2010-8#1)(2011-2#1)
6%) of##10##2##(1995-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
6%) or##2##2##(2008-1#1)(2011-2#1)
6%) patients##7##2##(1997-8#2)(2008-1#1)(2011-2#3)(2013-1#1)
6%) physicians answered the questionnaire##2##5##(2007-7#1)(2008-1#1)
6%) respondents##3##2##(2007-7#2)(2008-1#1)
6%) showed##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
6%) the##2##2##(1991-5#1)(2011-2#1)
6%) was##3##2##(1995-11#1)(2007-11#1)(2008-10#1)
6%) were##8##2##(1996-6#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
6%) with##5##2##(1991-6#1)(1997-4#1)(2008-11#1)(2008-7#1)(2011-2#1)
6%)##196##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#3)(1996-11#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#14)(2007-8#6)(2008-1#16)(2008-10#11)(2008-11#3)(2008-12#5)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#1)(2009-6#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#7)(2011-2#21)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#4)
6'##7##1##(1991-12#4)(1993-12#2)(2008-10#1)
6'-nonaCB##2##1##(1993-12#2)
6'-tetrachloro-1##2##1##(1993-11#2)
6) and a##2##3##(2008-10#2)
6) and##17##2##(1990-5#1)(1993-2#1)(1993-8#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#6)(2009-2#1)(2009-6#1)(2010-9#1)(2011-2#1)(2013-8#1)
6) are##2##2##(1996-2#1)(2008-10#1)
6) containing##3##2##(1994-9#1)(2008-10#2)
6) could##2##2##(1997-2#1)(2011-2#1)
6) for the range##2##4##(2010-3#2)
6) for the##3##3##(2008-7#1)(2010-3#2)
6) for##6##2##(1993-12#1)(2008-7#1)(2010-3#2)(2010-6#1)(2011-2#1)
6) in##2##2##(1992-4#1)(2008-10#1)
6) or##3##2##(1993-11#1)(2008-10#1)(2010-6#1)
6) was##2##2##(1997-8#1)(2008-10#1)
6) were##6##2##(1997-8#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
6) x##4##2##(1992-6#1)(2008-3#3)
6)##124##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#3)
6)-linked octamannan##3##2##(2009-12#3)
6)-linked##5##1##(1995-11#2)(2009-12#3)
6)IP4 and (1##2##3##(1992-11#2)
6)IP4##12##1##(1992-11#12)
6)IP4)##2##1##(1992-11#2)
6+/-0##17##1##(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#8)(2008-2#1)(2008-7#2)
6+/-11##2##1##(2008-12#1)(2009-7#1)
6+/-3##2##1##(2007-8#1)(2008-10#1)
6- and 1##2##3##(2008-3#2)
6- and##9##2##(1993-12#1)(1993-9#2)(2008-10#2)(2008-2#1)(2008-3#3)
6- or 24-month-old##2##3##(2008-3#2)
6- tetrahydropyrimidin-2-yl]amino-alpha##2##2##(1995-11#2)
6- tetrahydropyrimidine hydrochloride##3##3##(1995-11#3)
6- to 11-year-old##2##3##(1996-1#1)(2010-8#1)
6- to##4##2##(1995-11#1)(1996-1#1)(2008-10#1)(2010-8#1)
6-##30##1##(1990-8#1)(1993-12#1)(1993-9#2)(1994-6#1)(1995-11#6)(1996-1#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2010-8#2)(2011-2#1)
6-0##3##1##(1997-8#1)(2008-8#1)(2008-9#1)
6-1##6##1##(2008-10#4)(2008-3#1)(2011-2#1)
6-10##13##1##(1991-12#1)(1992-11#2)(1994-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
6-10%##2##1##(2008-3#1)(2011-2#1)
6-100##2##1##(2008-10#1)(2008-11#1)
6-103##2##1##(2008-10#1)(2011-2#1)
6-11 years##2##2##(2010-8#2)
6-11##4##1##(2008-10#1)(2010-8#2)(2012-12#1)
6-12 hours after##2##3##(1990-12#1)(2009-11#1)
6-12 months after the##3##4##(2007-11#1)(2008-1#1)(2013-8#1)
6-12 months after##4##3##(2007-11#1)(2008-1#1)(2013-8#2)
6-12 months##5##2##(2007-11#1)(2007-8#1)(2008-1#1)(2013-8#2)
6-12 weeks##2##2##(1996-2#1)(2011-1#1)
6-12##14##1##(1990-12#1)(1996-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2009-11#1)(2011-1#1)(2012-1#1)(2013-8#2)
6-15##4##1##(1991-2#1)(1995-12#2)(2008-10#1)
6-16##2##1##(2007-10#1)(2013-1#1)
6-18 months##3##2##(2007-2#1)(2008-1#2)
6-18##5##1##(2007-2#1)(2008-1#2)(2011-2#1)(2013-8#1)
6-2##6##1##(1990-5#1)(1996-5#1)(2007-11#1)(2008-10#3)
6-20##2##1##(2008-10#1)(2011-2#1)
6-21##2##1##(1994-12#1)(2008-2#1)
6-23##2##1##(1995-3#1)(2010-6#1)
6-24##2##1##(2013-1#2)
6-3##8##1##(1993-12#1)(2008-10#2)(2008-3#3)(2012-12#2)
6-4##5##1##(2008-10#5)
6-5##5##1##(1991-12#1)(2008-10#2)(2010-3#1)(2013-8#1)
6-60##2##1##(2008-10#1)(2013-8#1)
6-7 days##2##2##(1994-9#1)(2011-1#1)
6-7 weeks##2##2##(2008-7#1)(2013-1#1)
6-7##10##1##(1994-9#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
6-8 weeks##7##2##(1993-10#1)(1993-11#2)(1993-6#1)(2007-7#1)(2011-2#1)(2012-2#1)
6-8##25##1##(1990-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-3#1)(2007-12#2)(2007-7#2)(2008-10#4)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#2)
6-9##10##1##(1992-10#1)(1994-8#1)(1995-2#2)(1997-2#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-5#1)
6-90##2##1##(2008-10#2)
6-APA##8##1##(2008-12#8)
6-DBP##3##1##(2008-10#3)
6-DCP##2##1##(2008-10#2)
6-DNP##4##1##(2008-10#4)
6-Hydroxydopamine##2##1##(1995-12#1)(1997-2#1)
6-MM##2##1##(2008-10#2)
6-MONTH STUDY IN Tg##2##4##(2008-9#2)
6-MP##9##1##(1992-9#4)(2008-10#4)(2010-12#1)
6-Mb chromosome in 84R-62B##2##4##(2008-10#2)
6-Mb chromosome##3##2##(2008-10#3)
6-Mb region##2##2##(1996-2#2)
6-Mb##6##1##(1996-2#3)(2008-10#3)
6-Me-4)(HOC(6)H(2)(CH(2)NMe(2))(2)-2##2##1##(1996-2#2)
6-Me-4)](2)##2##1##(1996-2#2)
6-O-benzylidene-D-glucopyranose##2##1##(1995-11#2)
6-OHDA was infused into the##2##5##(1993-12#2)
6-OHDA##7##1##(1993-12#3)(1995-12#3)(1995-5#1)
6-P2 content##4##2##(1994-3#4)
6-P2 levels##2##2##(1992-3#2)
6-P2##9##1##(1992-3#2)(1994-3#7)
6-P2)##2##1##(1992-3#1)(1994-3#1)
6-TBA##2##1##(2008-10#2)
6-TBP##2##1##(2008-10#2)
6-TBP)##2##1##(2008-10#2)
6-TNT##3##1##(2008-10#3)
6-W##6##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
6-amidino-2-naphthyl p-guanidinobenzoate##2##2##(1990-5#2)
6-amino##2##1##(1993-11#2)
6-amino-2-n-pentylthiobenzothiazole##2##1##(1992-11#2)
6-aminopenicillanic acid##2##2##(1995-3#1)(2008-12#1)
6-aminoquinolinium##2##1##(2008-10#2)
6-androstadien-3beta##3##1##(2007-11#3)
6-anhydro##2##1##(1996-5#2)
6-bisphosphatase and##2##2##(1994-8#1)(1995-2#1)
6-bisphosphatase to##3##2##(2008-9#3)
6-bisphosphatase##12##1##(1990-5#3)(1994-8#1)(1995-2#2)(2008-9#6)
6-bisphosphate aldolase##2##2##(1992-8#1)(1995-8#1)
6-bisphosphate##8##1##(1990-5#2)(1992-3#1)(1992-8#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-6#1)
6-bromo-2-naphthol##4##1##(2008-10#4)
6-chloronicotinic acid##3##2##(2008-10#3)
6-cm##4##1##(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)
6-d##2##1##(2011-2#2)
6-dap##2##1##(1996-2#2)
6-day culture##2##2##(1995-8#1)(2008-11#1)
6-day##3##1##(1992-8#1)(1995-8#1)(2008-11#1)
6-deoxy-6-[(4R##2##1##(1995-11#2)
6-diamidino-2-phenylindole (DAPI)##2##2##(2008-10#1)(2008-9#1)
6-diamidino-2-phenylindole##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
6-diamino-1##2##1##(2008-10#2)
6-dicarbethoxy-8-(3'##2##1##(2008-10#2)
6-dichloro##2##1##(2008-10#1)(2011-1#1)
6-dichlorophenol bath concentrations of 5 x##2##6##(1994-5#2)
6-dichlorophenol bath concentrations of##3##4##(1994-5#3)
6-dichlorophenol##10##1##(1994-5#9)(2008-10#1)
6-dichlorophenolindophenol##4##1##(2008-10#4)
6-dicyano-1##5##1##(2007-11#1)(2008-10#2)(2008-11#2)
6-dihydrouridine##2##1##(1990-8#2)
6-diisopropylphenol##3##1##(1993-6#3)
6-dimethyl##2##1##(1991-5#1)(1991-9#1)
6-dimethyl-2##2##1##(1990-11#2)
6-dimethyl-2-mercaptopyrimidine (III)##2##2##(2008-10#2)
6-dimethyl-4-(3-aryl-1-phenyl-4-pyrazolyl)pyridine-3##4##1##(2012-3#4)
6-dimethyl-Tyr1##2##1##(1992-3#2)
6-dimethyl-benzimidazole##2##1##(2008-10#2)
6-dinitro-o-cresol (4##2##2##(2008-10#2)
6-dinitrophenol##3##1##(2008-10#3)
6-dinitrotoluene to mutagenic metabolites##2##4##(1990-6#2)
6-dinitrotoluene##10##1##(1990-6#3)(1995-6#4)(2008-10#3)
6-dione analogues##2##2##(2008-10#2)
6-dione) (2##2##2##(2008-6#2)
6-dioxaoctanediamide##2##1##(2008-10#2)
6-diphenyl-1##5##1##(1991-5#1)(2008-10#4)
6-diphenyl-4-benzo-9-crown-3-pyridine##3##1##(2008-10#3)
6-disulfonate##2##1##(2008-10#2)
6-disulfonic acid##5##2##(2008-10#5)
6-disulfonic##6##1##(2008-10#6)
6-endo##2##1##(2009-10#2)
6-eta)-1##2##1##(1996-2#2)
6-exo##2##1##(2008-9#2)
6-fluorobenzo(c)phenanthrene##2##1##(1991-12#2)
6-fold decrease in the##2##4##(1993-6#1)(1993-9#1)
6-fold decrease in##3##3##(1993-6#1)(1993-9#1)(1995-2#1)
6-fold higher in PL than NP mice##2##7##(1997-4#2)
6-fold in##2##2##(1994-9#1)(2011-2#1)
6-fold increase in##6##3##(1991-12#1)(1992-11#1)(1993-3#1)(1995-11#1)(2008-3#1)(2008-9#1)
6-fold more##4##2##(1991-12#1)(1994-8#1)(1997-1#1)(2008-11#1)
6-fold##24##1##(1991-12#3)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-4#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
6-fold)##3##1##(1993-8#1)(1995-11#1)(1996-5#1)
6-hour##2##1##(2008-3#1)(2008-6#1)
6-hydroxydopamine (6-OHDA)##3##2##(1993-12#1)(1995-12#1)(1995-5#1)
6-hydroxydopamine lesions of the##2##4##(1996-5#1)(1997-6#1)
6-hydroxydopamine lesions##4##2##(1996-5#1)(1997-2#1)(1997-6#2)
6-hydroxydopamine##16##1##(1992-10#1)(1993-12#1)(1993-3#1)(1995-12#3)(1995-2#1)(1995-5#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#2)(2008-7#1)(2012-2#1)
6-item self-administered questionnaires##2##3##(2010-4#2)
6-kb##9##1##(1990-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-10#1)
6-keto PGF1 alpha##3##3##(1991-5#1)(1994-9#2)
6-linkage##2##1##(1993-11#1)(2008-11#1)
6-linked##3##1##(1993-11#2)(1995-5#1)
6-mercaptopurine (6-MP)##3##2##(1992-9#1)(2008-10#1)(2010-12#1)
6-mercaptopurine##7##1##(1992-9#2)(2008-10#4)(2010-12#1)
6-methyl##4##1##(1996-5#1)(2008-10#1)(2008-11#2)
6-methyl-##2##1##(1992-12#2)
6-microm##3##1##(2008-2#1)(2008-3#2)
6-min walk distance##2##3##(2013-1#2)
6-min##4##1##(1994-8#1)(2007-8#1)(2013-1#2)
6-minute walk##2##2##(2010-10#1)(2011-2#1)
6-minutes walking test##2##3##(2013-1#2)
6-mm##5##1##(2007-10#1)(2007-11#1)(2008-10#1)(2013-1#2)
6-month follow up##2##3##(2007-8#1)(2008-10#1)
6-month follow-up##9##2##(1997-2#1)(2007-8#1)(2008-8#1)(2008-9#4)(2010-10#1)(2013-1#1)
6-month period##6##2##(1991-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-3#1)
6-month randomized controlled##2##3##(2010-10#1)(2012-3#1)
6-month##31##1##(1990-6#1)(1991-1#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-8#2)(2008-9#4)(2010-10#3)(2010-12#1)(2012-12#2)(2012-3#3)(2013-1#2)
6-month-old##4##1##(1990-3#1)(2008-12#1)(2012-3#1)(2013-8#1)
6-mum track pitch##2##3##(2008-2#1)(2008-3#1)
6-mum##6##1##(2008-2#4)(2008-3#2)
6-naphthalenedisulphonic##2##1##(2008-10#2)
6-nm##3##1##(2008-2#1)(2008-3#2)
6-ns duration##2##2##(2007-11#1)(2008-3#1)
6-ns##5##1##(2007-11#2)(2008-2#1)(2008-3#2)
6-o'-clock Nd##3##2##(2011-2#3)
6-pentakisphosphate##2##1##(1992-11#2)
6-phosphate and##3##2##(1990-7#1)(1996-6#1)(2008-5#1)
6-phosphate##12##1##(1990-7#4)(1995-2#1)(1995-6#2)(1996-6#2)(2008-10#1)(2008-5#1)(2008-7#1)
6-phosphogluconate dehydrogenase##4##2##(1991-5#1)(1997-3#2)(2010-12#1)
6-phosphogluconate##5##1##(1991-5#1)(1994-12#1)(1997-3#2)(2010-12#1)
6-point##3##1##(2008-12#1)(2008-6#1)(2012-2#1)
6-pyridinediamine##2##1##(2008-10#2)
6-pyruvoyl tetrahydropterin##2##2##(1997-8#2)
6-quinone##3##1##(1994-8#3)
6-response categories version##2##3##(2010-1#2)
6-sialyltransferase##3##1##(2008-11#3)
6-sulphatoxymelatonin##2##1##(1996-7#2)
6-tetra-O-acyl-alpha-D-Glcp##2##1##(1993-11#2)
6-tetrachloro-1##2##1##(2008-10#2)
6-tetrafluoro-1##2##1##(2007-11#1)(2008-10#1)
6-tetrahydrophthalic anhydride##2##2##(1995-11#2)
6-tetrahydropyri##2##1##(1995-11#2)
6-tetrahydropyridine (MPTP)##7##2##(1990-7#1)(1995-11#1)(1995-5#2)(1996-12#1)(2008-7#2)
6-tetrahydropyridine##10##1##(1990-7#2)(1995-11#1)(1995-5#2)(1996-12#1)(2008-5#1)(2008-7#3)
6-tetrakisphosphate##2##1##(1992-11#2)
6-tetrathiapentalene##2##1##(1996-5#2)
6-thienylimidazo[2##2##1##(1995-3#2)
6-thiopurine##2##1##(2008-10#2)
6-tri(3##2##1##(2008-10#2)
6-trichlorobenzoic acid##2##2##(2008-10#2)
6-trimethyl-1##2##1##(1996-5#2)
6-trinitramine (RDX)##4##2##(2008-10#4)
6-trinitramine##5##1##(2008-10#5)
6-trinitrobenzenesulfonic acid##2##2##(2008-4#1)(2011-1#1)
6-trinitrotoluene (TNT) using##2##3##(2008-10#2)
6-trinitrotoluene (TNT)##17##2##(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)
6-trinitrotoluene##23##1##(1994-11#1)(1995-6#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)
6-week aerobic dance##2##3##(2007-12#2)
6-week follow-up##3##2##(2006-12#1)(2008-4#1)(2012-2#1)
6-week trial##2##2##(2010-2#2)
6-week##13##1##(1995-3#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-2#2)(2011-2#3)(2012-2#1)(2013-1#1)
6-week-old rats##3##2##(1994-5#1)(2008-11#2)
6-week-old##4##1##(1994-5#1)(2008-10#1)(2008-11#2)
6-well##2##1##(2008-11#2)
6-year experience##3##2##(1997-4#1)(2007-8#1)(2008-11#1)
6-year period##5##2##(2007-8#1)(2008-10#3)(2013-1#1)
6-year##13##1##(1997-4#1)(2007-8#2)(2008-10#4)(2008-11#1)(2009-11#1)(2010-4#1)(2013-1#3)
6-year-old boy##3##2##(1995-11#1)(2007-8#1)(2010-5#1)
6-year-old children##3##2##(2008-2#3)
6-year-old patient##2##2##(2007-8#1)(2010-6#1)
6-year-old##12##1##(1995-11#1)(1995-4#1)(2007-8#2)(2008-10#1)(2008-2#3)(2008-9#1)(2010-3#1)(2010-5#1)(2010-6#1)
6/1##2##1##(2013-1#2)
6/10##2##1##(2008-12#1)(2008-9#1)
6/12##3##1##(1991-6#1)(2010-10#1)(2012-3#1)
6/18##2##1##(2010-8#1)(2013-7#1)
6/7##4##1##(1992-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
6/9##2##1##(1995-11#1)(2012-3#1)
60 (95% CI##2##3##(2009-9#1)(2011-1#1)
60 +/-##6##2##(1990-7#1)(2008-10#1)(2008-3#3)(2009-8#1)
60 Gy##7##2##(1991-2#1)(1991-4#1)(1992-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
60 Hz##2##2##(1992-11#1)(2008-11#1)
60 V##2##2##(2008-10#2)
60 and 0##4##3##(2007-12#1)(2008-10#2)(2010-4#1)
60 and 30##2##3##(1993-12#1)(2013-8#1)
60 and 70##2##3##(2009-5#2)
60 and 80##2##3##(2010-2#1)(2011-2#1)
60 and##29##2##(1990-5#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
60 bp##3##2##(1990-12#1)(1993-6#1)(2013-1#1)
60 cases with##2##3##(1992-8#1)(2013-8#1)
60 cases##10##2##(1992-8#1)(2008-12#1)(2008-7#2)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#3)
60 cm##4##2##(2008-10#3)(2008-12#1)
60 cycles per minute##2##4##(1994-11#1)(2008-6#1)
60 days after##2##3##(1992-1#1)(1993-3#1)
60 days in##3##3##(1994-6#1)(1995-5#1)(1997-5#1)
60 days of age##2##4##(2006-5#1)(2013-1#1)
60 days of##8##3##(1991-3#1)(1992-3#2)(2006-5#1)(2007-10#2)(2008-5#1)(2013-1#1)
60 days##33##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-3#3)(1993-12#1)(1993-3#2)(1994-6#1)(1995-5#1)(1997-5#1)(2006-5#1)(2007-10#5)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2013-1#4)(2013-8#1)
60 degrees C and##6##4##(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)
60 degrees C for##7##4##(2008-10#4)(2008-5#1)(2008-6#2)
60 degrees C##25##3##(1996-2#1)(2007-12#1)(2008-10#14)(2008-3#2)(2008-5#1)(2008-6#6)
60 degrees C)##3##3##(2008-10#3)
60 degrees##36##2##(1993-3#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#17)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#6)(2008-9#1)(2013-1#1)
60 determinations per hour##2##4##(2008-10#2)
60 determinations##3##2##(2008-10#3)
60 for##2##2##(2008-10#1)(2008-7#1)
60 g##3##2##(1993-3#1)(2011-2#1)(2013-1#1)
60 h(-1)##9##2##(2008-10#9)
60 in##2##2##(1992-2#1)(2012-7#1)
60 injections##2##2##(2008-10#2)
60 isolates of F##2##4##(2008-10#2)
60 isolates##3##2##(2008-10#3)
60 kDa IGBP##3##3##(1996-12#3)
60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme##3##7##(1997-2#3)
60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase##5##6##(1997-2#5)
60 kDa##16##2##(1990-7#1)(1996-12#7)(1997-2#6)(2008-10#2)
60 mM##2##2##(2008-12#1)(2008-7#1)
60 mV##2##2##(1997-2#1)(2008-10#1)
60 mW at 465 nm##2##5##(2007-12#2)
60 mW of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
60 mW##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
60 mg##7##2##(1991-2#1)(1991-3#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
60 mg/L##2##2##(2008-7#2)
60 mg/dL##2##2##(2010-2#2)
60 mg/kg##5##2##(1991-5#1)(1991-8#1)(1995-12#1)(2011-1#2)
60 mg/m2##3##2##(1991-5#1)(1992-12#1)(2008-5#1)
60 microm##2##2##(2007-12#1)(2008-3#1)
60 million##2##2##(1995-3#1)(2012-2#1)
60 min after the##2##4##(1995-12#1)(2008-10#1)
60 min after##5##3##(1991-3#1)(1992-3#1)(1995-12#1)(1997-1#1)(2008-10#1)
60 min and##3##3##(1991-5#1)(1992-5#1)(2011-2#1)
60 min in##4##3##(1993-9#1)(1994-2#1)(1997-1#1)(2008-7#1)
60 min incubation##2##3##(1995-3#1)(1997-8#1)
60 min of##7##3##(1990-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(2008-10#1)(2013-8#2)
60 min##56##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-12#1)(1997-1#3)(1997-8#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-11#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#2)
60 min)##2##2##(1991-9#1)(1996-12#1)
60 minutes of##4##3##(1991-12#1)(1996-9#2)(2007-10#1)
60 minutes##13##2##(1991-12#1)(1992-12#1)(1994-11#1)(1994-3#1)(1996-9#2)(2007-10#3)(2008-12#1)(2010-3#1)(2010-5#1)(2013-1#1)
60 ml##3##2##(2008-10#3)
60 mm##5##2##(2007-9#1)(2008-11#2)(2008-3#1)(2009-3#1)
60 mmHg##2##2##(2008-7#1)(2008-9#1)
60 mmol/l##2##2##(1992-12#2)
60 months##7##2##(1991-8#1)(2008-12#2)(2011-2#1)(2012-12#2)(2013-1#1)
60 mug l(-1)##2##3##(2008-10#2)
60 mug ml(-1)##2##3##(2008-10#2)
60 mug##4##2##(2008-10#4)
60 ng ml(-1)##2##3##(2008-10#2)
60 nm##4##2##(2007-12#2)(2008-3#1)(2009-11#1)
60 nmol##2##2##(1993-12#1)(2008-10#1)
60 normal##2##2##(2008-7#1)(2012-12#1)
60 or##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
60 participants##2##2##(2012-12#1)(2013-8#1)
60 patients who underwent##2##4##(2007-9#1)(2013-1#1)
60 patients with bone metastases##2##5##(2007-11#1)(2008-10#1)
60 patients with##8##3##(1992-2#1)(1997-8#1)(2007-11#2)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
60 patients##20##2##(1991-6#1)(1992-2#1)(1997-8#1)(2007-11#4)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)
60 per cent of the##2##5##(1991-6#1)(1994-7#1)
60 per##3##2##(1991-6#1)(1994-7#1)(1995-12#1)
60 percent of##2##3##(1997-1#1)(2011-2#1)
60 percent##3##2##(1995-3#1)(1997-1#1)(2011-2#1)
60 s##21##2##(1993-11#1)(1993-8#1)(2008-10#15)(2008-12#2)(2008-3#1)(2008-7#1)
60 s)##2##2##(1996-7#1)(2010-3#1)
60 samples h(-1)##4##3##(2008-10#4)
60 samples per hour##2##4##(2008-10#2)
60 samples##9##2##(2008-10#9)
60 scenarios##2##2##(2009-10#2)
60 sec##2##2##(1990-7#1)(1993-11#1)
60 species##2##2##(1997-4#1)(2008-4#1)
60 subjects##2##2##(1991-3#1)(2008-5#1)
60 times##4##2##(1997-6#1)(2008-10#2)(2008-11#1)
60 to 1##2##3##(2008-11#1)(2008-3#1)
60 to 120 cm##3##4##(2008-10#3)
60 to 120##4##3##(1993-1#1)(2008-10#3)
60 to 70%##2##3##(1991-4#1)(2008-10#1)
60 to 90##3##3##(1994-12#1)(2008-10#2)
60 to##22##2##(1991-4#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-7#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2013-8#1)
60 with##3##2##(1991-9#1)(1995-5#1)(2008-7#1)
60 women##2##2##(2008-5#1)(2011-2#1)
60 years and##4##3##(2008-10#1)(2011-1#2)(2012-3#1)
60 years of age##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
60 years old##3##3##(2008-7#1)(2012-3#2)
60 years old)##2##3##(2013-8#2)
60 years##35##2##(1990-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#3)
60##704##1##(1990-10#1)(1990-12#4)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#6)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#5)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#1)(1996-11#1)(1996-12#14)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#3)(1997-1#4)(1997-2#10)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#5)(2006-5#1)(2007-10#9)(2007-11#9)(2007-12#15)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#11)(2008-10#167)(2008-11#12)(2008-12#16)(2008-2#5)(2008-3#25)(2008-4#6)(2008-5#14)(2008-6#16)(2008-7#33)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#3)(2010-2#7)(2010-3#4)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#11)(2011-2#36)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#8)(2012-3#11)(2012-5#1)(2012-7#1)(2013-1#17)(2013-7#2)(2013-8#18)
60% and##8##2##(1992-8#1)(1993-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
60% compared with##2##3##(2008-10#2)
60% compared##3##2##(2008-10#2)(2008-11#1)
60% for##3##2##(1996-12#1)(2008-10#1)(2010-12#1)
60% homology##2##2##(1993-12#1)(1994-6#1)
60% identical##2##2##(1991-9#1)(1993-8#1)
60% identity with##2##3##(1992-3#1)(2008-10#1)
60% identity##4##2##(1992-3#1)(1996-6#1)(2008-10#2)
60% in##4##2##(2008-10#2)(2010-7#1)(2012-3#1)
60% methanol##4##2##(1995-3#4)
60% of all patients##2##4##(1992-11#1)(2011-2#1)
60% of all##8##3##(1992-11#1)(1993-8#1)(1994-2#1)(1996-11#1)(2008-5#1)(2011-2#3)
60% of cases##3##3##(1993-9#1)(2011-2#1)(2013-1#1)
60% of control##2##3##(2008-11#1)(2008-7#1)
60% of hospital##2##3##(1992-1#1)(1997-6#1)
60% of patients##2##3##(2007-7#1)(2009-5#1)
60% of the cases##2##4##(1993-2#1)(2008-10#1)
60% of the level##2##4##(1993-11#1)(1997-2#1)
60% of the patients##4##4##(1994-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
60% of the total##2##4##(1996-10#1)(2007-5#1)
60% of the variance in##2##5##(2007-10#1)(2009-10#1)
60% of the##39##3##(1990-12#2)(1990-3#1)(1991-8#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1994-2#3)(1994-9#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
60% of these##2##3##(1992-12#1)(2008-1#1)
60% of total##2##3##(1992-12#1)(2008-8#1)
60% of##89##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-9#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#9)(2012-12#4)(2013-1#4)(2013-7#1)(2013-8#2)
60% or##2##2##(1995-12#1)(2009-12#1)
60% to 80%##2##3##(2008-4#1)(2010-4#1)
60% to##6##2##(1993-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)
60% was##3##2##(1992-3#1)(1994-12#1)(2008-11#1)
60% were##5##2##(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)
60% when##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
60% with##2##2##(2007-12#1)(2008-11#1)
60%##224##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-6#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#25)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#2)
60%)##8##1##(1992-9#1)(1995-11#1)(1995-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
60%fatigue##4##1##(2013-8#4)
60) and##2##2##(1991-5#1)(2013-1#1)
60)##16##1##(1991-2#1)(1991-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-7#1)(2009-9#1)(2013-1#2)
60+/-0##3##1##(2008-10#2)(2008-11#1)
60- to##2##2##(2008-11#1)(2008-9#1)
60-##3##1##(2008-11#1)(2008-9#1)(2011-1#1)
60-65 years and##2##3##(1992-6#1)(2011-2#1)
60-70 kDa##2##2##(1990-7#1)(1991-2#1)
60-70##5##1##(1990-7#1)(1991-2#1)(1992-2#1)(1993-6#1)(2008-2#1)
60-70% of the##2##3##(1995-2#1)(1995-8#1)
60-70% of##4##2##(1990-7#1)(1995-2#1)(1995-8#1)(2008-5#1)
60-70%##8##1##(1990-7#1)(1993-11#1)(1995-2#1)(1995-8#1)(2008-5#1)(2009-2#1)(2010-3#2)
60-72 h##2##2##(1997-4#1)(2008-11#1)
60-80% of the##2##3##(1990-5#1)(2009-10#1)
60-80%##4##1##(1990-5#1)(2008-10#2)(2009-10#1)
60-90##2##1##(2008-10#1)(2008-2#1)
60-90%##4##1##(1993-11#1)(1995-5#1)(2008-12#1)(2009-7#1)
60-day##4##1##(1991-12#2)(2012-2#1)(2012-8#1)
60-fold##2##1##(1995-5#1)(2008-1#1)
60-kDa##4##1##(1990-12#1)(1990-5#1)(1994-6#1)(1995-6#1)
60-mm##3##1##(2008-2#1)(2008-3#2)
60-ns##2##1##(2007-11#1)(2008-3#1)
60-ps pulses##2##2##(2007-12#1)(2008-3#1)
60-ps##3##1##(2007-12#2)(2008-3#1)
60-s##3##1##(2008-10#1)(2008-12#1)(2008-3#1)
60-year-old male##4##2##(1997-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
60-year-old man##5##2##(1996-6#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-11#1)
60-year-old woman with##2##3##(2008-8#1)(2009-1#1)
60-year-old woman##6##2##(2007-8#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-3#1)(2012-3#1)
60-year-old##17##1##(1990-2#1)(1996-6#1)(1997-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2012-1#1)(2012-3#2)(2013-1#1)
60/40##2##1##(2008-10#2)
600 MHz##2##2##(2007-12#1)(2008-9#1)
600 and##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
600 bp of##2##3##(1994-2#1)(2008-9#1)
600 bp##4##2##(1993-6#2)(1994-2#1)(2008-9#1)
600 degrees C##6##3##(1995-6#2)(2007-12#1)(2008-10#1)(2008-2#2)
600 degrees##7##2##(1995-6#2)(2007-12#1)(2008-10#2)(2008-2#2)
600 mg daily##2##3##(1990-5#1)(2008-9#1)
600 mg##9##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-9#1)
600 microM##4##2##(1990-8#2)(1995-6#1)(2008-10#1)
600 mul of##2##3##(2008-10#2)
600 mum##3##2##(1992-1#1)(2007-11#1)(2008-2#1)
600 nm##7##2##(1993-11#1)(1993-12#1)(1994-5#1)(2008-10#4)
600 patients##2##2##(2007-11#1)(2008-11#1)
600 per##2##2##(1990-12#1)(2008-7#1)
600 s##3##2##(1991-2#1)(1996-7#1)(2008-10#1)
600 species##2##2##(2008-5#1)(2012-3#1)
600 to##6##2##(1991-5#1)(2007-11#1)(2008-10#3)(2009-5#1)
600##137##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#4)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#2)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-3#2)(1996-7#1)(1997-2#1)(2007-11#4)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#4)(2009-5#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
600)##3##1##(1995-12#1)(1997-4#1)(2010-8#1)
600-1000##2##1##(2007-11#1)(2008-10#1)
600-700##2##1##(1994-12#1)(2007-11#1)
600-fs##2##1##(2007-11#2)
6000 and##3##2##(1991-8#1)(2008-12#1)(2012-1#1)
6000 was##2##2##(2008-10#2)
6000##25##1##(1990-2#1)(1991-5#1)(1991-8#1)(2008-10#2)(2008-12#7)(2008-2#1)(2008-3#4)(2009-5#1)(2009-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#1)
600nm##3##1##(2008-10#3)
601##5##1##(1990-5#1)(1997-4#1)(2008-8#2)(2009-7#1)
602 patients##2##2##(2007-7#2)
602##3##1##(2007-7#2)(2008-10#1)
603 bp for D##2##4##(2008-10#2)
603##5##1##(2008-10#2)(2011-1#1)(2011-2#2)
604##6##1##(1995-3#1)(2008-10#4)(2012-3#1)
605 nm##3##2##(2008-10#2)(2008-11#1)
605##6##1##(1991-11#1)(1992-6#1)(2008-10#3)(2008-11#1)
606##5##1##(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
607##2##1##(2008-2#1)(2008-6#1)
609##8##1##(1995-11#1)(2008-10#1)(2008-3#4)(2009-10#1)(2011-1#1)
60K##2##1##(1996-12#2)
60cm##2##1##(2008-10#2)
60min##5##1##(2008-10#4)(2013-1#1)
60mugl(-1)##3##1##(2008-10#3)
60s deposition time##2##3##(2008-10#2)
60s##9##1##(2008-10#7)(2009-4#1)(2011-2#1)
60s)##2##1##(2008-10#1)(2008-12#1)
60th##2##1##(2007-10#1)(2012-2#1)
60x##3##1##(2008-3#2)(2008-7#1)
60x10(-6)##2##1##(2008-10#2)
61 +/-##2##2##(2008-12#2)
61 and 0##2##3##(2008-10#1)(2008-5#1)
61 and##5##2##(1990-11#1)(1992-3#1)(1992-4#1)(2008-10#1)(2008-5#1)
61 children##2##2##(1997-2#1)(2008-12#1)
61 days##2##2##(2008-10#1)(2009-11#1)
61 in##2##2##(2008-10#1)(2008-12#1)
61 kD##2##2##(1990-11#2)
61 mg##2##2##(2008-10#1)(2008-9#1)
61 min##2##2##(2008-10#2)
61 patients were treated##2##4##(1991-2#1)(2006-10#1)
61 patients with##2##3##(1994-12#1)(2008-12#1)
61 patients##13##2##(1991-11#1)(1991-2#1)(1994-12#1)(2006-10#1)(2008-1#1)(2008-12#4)(2008-8#1)(2011-2#3)
61 to##5##2##(1996-12#1)(2007-10#1)(2008-10#2)(2009-3#1)
61 years)##2##2##(1994-9#1)(2007-8#1)
61##154##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#22)(2008-11#2)(2008-12#11)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#4)(2011-2#20)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#4)
61% and##3##2##(1990-11#1)(1994-2#1)(2012-1#1)
61% for##2##2##(1990-12#1)(2013-8#1)
61% in##2##2##(2008-10#1)(2008-11#1)
61% of the##3##3##(1992-9#1)(2008-11#1)(2008-12#1)
61% of##12##2##(1990-8#1)(1992-9#1)(1993-9#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
61%##35##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-4#2)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#2)
61%) and##3##2##(2008-12#1)(2010-5#1)(2011-2#1)
61%)##6##1##(1996-5#1)(2007-11#1)(2008-12#2)(2010-5#1)(2011-2#1)
61(2)##3##1##(1996-2#1)(2008-10#2)
61) and##3##2##(2008-10#2)(2008-9#1)
61)##10##1##(1992-5#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-4#1)
61+/-0##3##1##(2008-10#2)(2008-5#1)
61-0##2##1##(1993-9#1)(1995-2#1)
61-69##3##1##(1992-4#3)
61-8##2##1##(2008-10#1)(2010-10#1)
61-year-old male##2##2##(2007-12#1)(2013-8#1)
61-year-old man##3##2##(1991-2#1)(2008-11#1)(2011-2#1)
61-year-old woman with##2##3##(1991-2#1)(2010-8#1)
61-year-old woman##5##2##(1991-2#1)(1992-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
61-year-old##14##1##(1991-2#2)(1992-8#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
610 nm##5##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-2#1)
610##10##1##(1990-2#1)(1997-4#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
6100##2##1##(2008-10#2)
610nm was##2##2##(2008-10#2)
610nm##4##1##(2008-10#4)
611##8##1##(1991-9#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
612 and##2##2##(2008-10#2)
612 nm##4##2##(1994-8#1)(2008-10#3)
612##13##1##(1994-8#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-8#1)(2011-1#1)(2013-8#1)
613##3##1##(2007-8#1)(2008-10#1)(2011-1#1)
614##2##1##(2007-12#1)(2009-9#1)
615 nm##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
615##7##1##(1990-11#1)(1992-8#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-2#1)
616##4##1##(2008-10#2)(2008-8#1)(2013-1#1)
619##4##1##(1993-9#1)(2007-8#1)(2008-2#1)(2008-3#1)
62 +/- 0##5##3##(1990-7#1)(2008-3#2)(2011-2#1)(2012-3#1)
62 +/- 2##2##3##(2008-4#1)(2008-5#1)
62 +/-##9##2##(1990-7#1)(1995-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
62 A resolution##2##3##(1995-3#2)
62 and##9##2##(1996-6#1)(2008-10#5)(2011-1#1)(2012-12#1)(2012-2#1)
62 cases##2##2##(2009-10#1)(2009-5#1)
62 days##2##2##(2008-11#1)(2010-5#1)
62 degrees##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
62 in##5##2##(2008-11#1)(2008-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
62 is##6##2##(2011-1#1)(2011-2#5)
62 kDa##3##2##(1990-11#2)(1990-7#1)
62 of##2##2##(1991-3#1)(2012-2#1)
62 patients with##4##3##(1991-11#1)(1992-3#1)(2007-11#1)(2013-1#1)
62 patients##6##2##(1991-11#1)(1992-3#1)(2007-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
62 percent##2##2##(1995-12#1)(1996-1#1)
62 to 0##2##3##(2008-10#1)(2012-3#1)
62 to##4##2##(2008-10#3)(2012-3#1)
62 years##2##2##(1990-9#1)(2009-3#1)
62 years)##2##2##(1991-2#1)(2007-5#1)
62 ±##2##2##(2013-1#1)(2013-8#1)
62##174##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#27)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#6)
62% for##2##2##(1993-1#1)(2008-10#1)
62% of patients##2##3##(2007-10#1)(2010-11#1)
62% of the##4##3##(1993-10#1)(1993-12#1)(1996-10#1)(2010-4#1)
62% of##10##2##(1993-10#1)(1993-12#2)(1996-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-4#1)(2012-12#1)
62%##42##1##(1990-8#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-5#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
62%)##5##1##(1990-3#1)(1991-3#1)(2007-7#1)(2008-12#1)(2008-7#1)
62)##17##1##(1992-5#1)(1996-2#2)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-8#2)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
62+/-0##2##1##(2008-10#2)
62-kb##2##1##(2008-10#2)
62-year-old man who##2##3##(2008-4#1)(2009-8#1)
62-year-old man##4##2##(1994-3#1)(2008-4#1)(2008-6#1)(2009-8#1)
62-year-old woman##5##2##(1991-11#1)(1991-9#1)(1994-6#1)(2008-10#1)(2009-3#1)
62-year-old##10##1##(1991-11#1)(1991-9#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-8#1)
620 nm##3##2##(2008-10#2)(2008-8#1)
620 to##2##2##(2008-10#1)(2008-3#1)
620##15##1##(1992-11#1)(1993-11#1)(1995-2#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2013-1#1)
6209##2##1##(1997-7#1)(2013-1#1)
621##8##1##(1995-12#1)(1997-6#1)(1997-8#1)(2008-10#3)(2013-8#2)
623##2##1##(2008-10#1)(2013-1#1)
624##9##1##(1997-1#1)(2008-10#1)(2008-3#4)(2013-1#2)(2013-8#1)
625##5##1##(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
627##6##1##(1996-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-10#1)
628##2##1##(1992-9#1)(1994-12#1)
629##3##1##(1991-2#1)(2008-8#1)(2011-3#1)
629-nm##3##1##(2007-12#3)
62±0##2##1##(2010-12#1)(2012-2#1)
63 +/- 0##2##3##(1993-1#1)(2009-11#1)
63 +/-##4##2##(1993-1#1)(1995-3#1)(2009-11#1)(2011-3#1)
63 adolescents##2##2##(2011-1#1)(2013-1#1)
63 and 0##4##3##(2008-10#3)(2013-8#1)
63 and##10##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2013-7#1)(2013-8#1)
63 cases##2##2##(2012-12#2)
63 days##2##2##(1995-5#1)(1995-8#1)
63 kDa##4##2##(1995-2#1)(1997-2#1)(1997-7#1)(2008-11#1)
63 mmol l(-1)N##2##3##(2008-10#2)
63 of the##2##3##(2012-2#2)
63 of##3##2##(2008-10#1)(2012-2#2)
63 patients with##3##3##(1990-6#1)(1992-11#1)(2008-1#1)
63 patients##6##2##(1990-6#1)(1992-11#1)(1993-11#1)(1996-11#1)(1997-8#1)(2008-1#1)
63 times##3##2##(2008-10#2)(2008-11#1)
63 to##2##2##(1994-6#1)(2008-10#1)
63 x##2##2##(2008-10#2)
63 years##8##2##(1991-11#1)(1991-2#1)(1991-7#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-7#1)
63 ±##2##2##(2010-9#1)(2011-1#1)
63##188##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#4)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#38)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-11#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#7)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#2)
63% and##3##2##(1993-11#1)(2007-10#1)(2011-1#1)
63% at##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
63% for##2##2##(2008-10#2)
63% in##4##2##(1995-12#1)(2007-10#1)(2008-10#2)
63% of the##4##3##(1993-3#1)(1995-8#1)(2008-10#2)
63% of##9##2##(1990-12#1)(1990-9#1)(1993-3#1)(1995-8#1)(2008-10#4)(2010-6#1)
63% to##2##2##(2010-8#1)(2013-8#1)
63%##43##1##(1990-10#1)(1990-12#1)(1990-9#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#1)(1997-5#1)(2007-10#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
63%)##3##1##(2007-10#1)(2008-12#1)(2008-2#1)
63(9)##2##1##(2012-3#2)
63)##9##1##(1992-8#1)(1993-8#1)(1993-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)
63-year-old man##2##2##(2008-11#1)(2012-12#1)
63-year-old woman##5##2##(1991-8#1)(2007-5#1)(2007-7#1)(2008-5#1)(2013-8#1)
63-year-old##12##1##(1991-8#1)(1994-7#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#2)
630 days##3##2##(2008-10#3)
630 nm##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
630##19##1##(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
6300##2##1##(2008-10#1)(2008-3#1)
631##6##1##(1996-7#1)(2008-10#4)(2013-1#1)
632##22##1##(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#8)(2010-5#1)(2011-2#1)
6328##2##1##(2008-2#1)(2008-3#1)
633 microm##2##2##(2008-3#2)
633 nm##12##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#8)
633 nm)##3##2##(2008-3#3)
633##23##1##(1993-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#15)(2013-1#1)
633-nm##5##1##(2007-11#2)(2007-12#1)(2008-3#2)
634 children##2##2##(2011-2#2)
634##7##1##(1991-2#1)(1994-6#1)(2008-6#1)(2011-2#3)(2012-2#1)
635 nm##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
636 and##2##2##(1993-1#1)(2008-12#1)
636##4##1##(1993-1#1)(2008-12#1)(2010-1#1)(2010-8#1)
637##2##1##(1992-5#1)(2007-12#1)
637-bp##2##1##(1997-4#2)
638##11##1##(1993-9#1)(1997-2#1)(2007-10#2)(2008-10#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#3)
639##3##1##(2008-8#1)(2011-3#1)(2013-1#1)
64 (32%)##2##2##(2008-1#1)(2013-8#1)
64 +/-##3##2##(1992-3#1)(2008-12#1)(2008-7#1)
64 and##10##2##(1990-12#1)(1991-8#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-7#2)
64 cases##2##2##(2010-8#1)(2013-1#1)
64 clones from the##2##4##(2008-9#2)
64 days##3##2##(2008-10#2)(2008-5#1)
64 in##2##2##(2008-10#1)(2010-8#1)
64 isolates##2##2##(2008-10#1)(2008-5#1)
64 kDa##3##2##(1994-8#1)(1996-12#2)
64 microm mesh net##2##4##(2011-2#2)
64 microm##3##2##(2008-3#1)(2011-2#2)
64 mm##2##2##(2008-2#1)(2010-4#1)
64 patients with##2##3##(1992-5#1)(1993-1#1)
64 patients##5##2##(1992-5#1)(1993-1#1)(2007-7#1)(2010-6#1)(2011-2#1)
64 to##3##2##(2008-10#3)
64 years##3##2##(1991-1#1)(1994-6#1)(2011-2#1)
64##216##1##(1990-10#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#4)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-1#2)(1993-11#2)(1993-2#5)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-8#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#14)(2008-8#4)(2008-9#7)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#4)
64% and##3##2##(1995-12#1)(2008-1#1)(2010-3#1)
64% for##2##2##(2008-10#2)
64% of the##6##3##(1992-9#1)(2007-10#1)(2008-10#3)(2008-12#1)
64% of##8##2##(1992-9#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-11#1)
64% to 92% of the genome##3##6##(1995-8#2)(1996-6#1)
64%##39##1##(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-7#2)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#2)
64%)##4##1##(1996-1#1)(2007-7#1)(2008-12#1)(2013-8#1)
64)##11##1##(1993-1#1)(1994-11#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-8#1)(2013-1#2)
64-##3##1##(1992-8#1)(1995-3#1)(2008-10#1)
64-81##2##1##(1990-12#1)(1994-1#1)
64-kDa##2##1##(1995-6#2)
64-row##2##1##(2008-7#2)
64-slice multidetector##2##2##(2008-12#1)(2009-10#1)
64-slice##6##1##(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-5#1)
64-year old##2##2##(1995-3#1)(2008-9#1)
64-year-old female##3##2##(2013-1#3)
64-year-old male##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
64-year-old man##2##2##(2007-10#1)(2013-8#1)
64-year-old##10##1##(1996-11#1)(2007-10#1)(2008-12#1)(2012-12#1)(2013-1#5)(2013-8#1)
640 and##3##2##(2008-10#3)
640 nm##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
640##14##1##(1992-11#1)(1992-6#1)(1996-12#1)(1997-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)
641##4##1##(1997-4#1)(2008-1#1)(2008-10#1)(2012-2#1)
641)##2##1##(1994-2#1)(2007-8#1)
642##4##1##(1997-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
642)##2##1##(1994-8#1)(2008-3#1)
6421##2##1##(2008-2#1)(2008-3#1)
643##5##1##(1992-12#1)(2007-9#1)(2008-9#1)(2011-1#1)(2011-2#1)
644##4##1##(1990-5#1)(2007-7#1)(2008-3#1)(2012-3#1)
645##5##1##(1991-9#1)(1994-5#2)(2007-10#1)(2008-2#1)
646##3##1##(2007-8#1)(2008-10#1)(2013-1#1)
647##2##1##(2011-2#2)
648##3##1##(1990-12#1)(1992-8#1)(2008-10#1)
649##4##1##(1995-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
649)##2##1##(2012-2#1)(2013-8#1)
65 +/- 0##2##3##(1996-9#1)(1997-2#1)
65 +/- 2%##2##3##(1995-12#1)(2011-2#1)
65 +/-##4##2##(1995-12#1)(1996-9#1)(1997-2#1)(2011-2#1)
65 and 0##3##3##(2008-10#2)(2008-12#1)
65 and##17##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1994-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
65 bp##2##2##(1993-2#1)(2010-5#1)
65 by##2##2##(1996-1#1)(2008-3#1)
65 children##2##2##(2011-1#1)(2011-2#1)
65 degrees C##9##3##(1992-8#2)(1995-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)
65 degrees##13##2##(1992-6#1)(1992-8#2)(1995-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#2)(2012-12#1)(2013-8#1)
65 in##2##2##(2008-3#1)(2010-4#1)
65 kDa##5##2##(1990-11#1)(1993-12#1)(1993-6#2)(1996-12#1)
65 mg/kg to males and##2##5##(2008-9#2)
65 min##2##2##(2008-10#1)(2013-8#1)
65 mm##2##2##(2008-3#1)(2011-1#1)
65 mmol##2##2##(2008-10#2)
65 months##2##2##(2007-8#1)(2008-6#1)
65 mum##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
65 nm##2##2##(2007-12#1)(2008-10#1)
65 of##4##2##(1991-11#1)(1991-12#1)(2008-10#1)(2011-2#1)
65 or##3##2##(1990-12#2)(1993-1#1)
65 patients (10##2##3##(2012-3#2)
65 patients with##2##3##(1991-8#1)(2008-7#1)
65 patients##11##2##(1990-3#1)(1991-8#1)(1993-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-7#1)(2012-3#2)
65 percent##2##2##(1991-5#1)(2008-1#1)
65 to##9##2##(1991-9#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-10#5)
65 was##2##2##(1993-1#1)(2008-10#1)
65 with##2##2##(2007-11#1)(2010-4#1)
65 years and##4##3##(1994-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
65 years of age or over##3##6##(1991-12#1)(1991-3#1)(1992-1#1)
65 years of age##14##4##(1991-12#1)(1991-3#1)(1992-1#1)(1995-12#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#4)
65 years old##6##3##(1993-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
65 years was##2##3##(2010-3#1)(2010-4#1)
65 years##55##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-11#1)(2009-8#5)(2010-3#3)(2010-4#2)(2011-1#1)(2011-2#12)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
65 years)##2##2##(1990-3#1)(2008-7#1)
65 °C##2##2##(2011-1#1)(2011-2#1)
65##325##1##(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#3)(1990-5#1)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#3)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#5)(2007-8#6)(2008-1#6)(2008-10#47)(2008-11#8)(2008-12#10)(2008-2#2)(2008-3#15)(2008-5#8)(2008-6#4)(2008-7#14)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#4)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#12)(2011-2#26)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#16)(2013-8#5)
65% at##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
65% for##2##2##(2008-10#1)(2008-8#1)
65% of the &quot##2##4##(1990-12#1)(1995-6#1)
65% of the##10##3##(1990-12#1)(1991-9#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-7#1)(2012-12#1)
65% of##25##2##(1990-12#2)(1990-6#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
65% similarity##2##2##(1993-12#1)(1994-8#1)
65% was##2##2##(1990-3#1)(2008-2#1)
65% were##5##2##(1993-1#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
65%##93##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
65%)##4##1##(1991-8#1)(2006-10#1)(2008-12#1)(2008-4#1)
65)##8##1##(1996-2#1)(1996-9#1)(2007-5#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
65-##3##1##(2007-8#1)(2008-10#1)(2011-1#1)
65-0##2##1##(1993-9#1)(2010-4#1)
65-1##2##1##(2008-2#1)(2012-2#1)
65-74 years##3##2##(1992-6#1)(2008-10#1)(2013-8#1)
65-74##4##1##(1992-6#1)(2008-10#1)(2010-10#1)(2013-8#1)
65-75##3##1##(1992-6#1)(1994-3#1)(2013-8#1)
65-fold##2##1##(2008-10#1)(2008-11#1)
65-year-old female##3##2##(2010-5#1)(2011-2#1)(2012-2#1)
65-year-old male##2##2##(1992-10#1)(2007-7#1)
65-year-old woman##5##2##(2007-10#2)(2008-11#1)(2012-3#1)(2013-8#1)
65-year-old##13##1##(1992-10#1)(1993-9#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
650 and##2##2##(2008-12#1)(2011-1#1)
650 bp##2##2##(2008-10#1)(2011-2#1)
650##22##1##(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
650-##2##1##(2008-10#1)(2008-3#1)
650-nucleotide##2##1##(1991-9#1)(2008-10#1)
650nm##2##1##(2008-10#2)
652##2##1##(2012-3#1)(2013-1#1)
653##9##1##(1992-8#1)(2008-10#2)(2008-11#2)(2010-8#1)(2011-2#2)(2012-1#1)
653-microm##2##1##(2008-3#2)
6535##2##1##(1996-12#1)(2007-8#1)
654##4##1##(1992-5#1)(2008-10#1)(2008-7#1)(2010-3#1)
655##8##1##(1990-7#1)(1992-12#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
656##6##1##(1990-11#1)(1990-6#1)(1991-12#1)(1995-2#1)(2008-7#1)(2012-3#1)
657##3##1##(2007-12#1)(2008-10#2)
659##8##1##(1993-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-7#1)(2012-2#1)
65mumol/L##2##1##(2008-10#2)
66 +/-##3##2##(1995-5#1)(2008-3#1)(2008-4#1)
66 and 56 kDa##2##4##(1990-12#2)
66 and##9##2##(1990-12#2)(1997-2#1)(2007-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
66 children##3##2##(1994-6#2)(2008-12#1)
66 degrees##5##2##(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
66 kDa##5##2##(1990-11#1)(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
66 mg##2##2##(2008-10#1)(2008-12#1)
66 mum and 15 at##2##5##(2008-3#2)
66 of##3##2##(1990-2#1)(1991-8#1)(1997-6#1)
66 patients with##2##3##(2007-11#1)(2012-3#1)
66 patients##5##2##(2007-11#1)(2007-8#1)(2008-4#1)(2012-3#1)(2013-1#1)
66 to##5##2##(2007-12#1)(2008-10#2)(2009-8#1)(2011-2#1)
66 years##5##2##(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
66##172##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-8#3)(1992-2#1)(1992-3#2)(1992-6#6)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#6)(1994-6#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#3)(2008-1#5)(2008-10#22)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#4)(2011-1#6)(2011-2#8)(2012-12#4)(2012-2#2)(2012-3#7)(2013-1#4)(2013-8#3)
66% and##4##2##(1990-12#1)(2008-10#1)(2008-2#1)(2010-3#1)
66% for##2##2##(1994-8#1)(2008-10#1)
66% in##4##2##(2008-11#1)(2008-12#1)(2013-7#2)
66% of the patients##2##4##(1997-3#1)(2007-8#1)
66% of the##5##3##(1997-3#1)(2007-8#1)(2008-10#2)(2008-6#1)
66% of##8##2##(1996-12#1)(1997-3#1)(1997-7#1)(2007-8#2)(2008-10#2)(2008-6#1)
66% over##2##2##(2008-10#1)(2008-12#1)
66%##43##1##(1990-12#1)(1991-5#1)(1992-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#2)
66%) and##2##2##(1997-3#1)(2011-2#1)
66%)##8##1##(1991-5#1)(1997-3#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
66)##7##1##(1993-11#1)(2007-10#2)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
66+/-0##2##1##(2008-10#2)
66-year-old female##2##2##(2007-8#1)(2013-1#1)
66-year-old man##5##2##(1994-3#1)(2008-6#1)(2009-1#1)(2011-2#1)(2012-12#1)
66-year-old woman who##2##3##(2007-8#1)(2008-10#1)
66-year-old woman##4##2##(1992-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
66-year-old##12##1##(1992-2#1)(1994-3#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
660 nm##3##2##(2008-10#2)(2012-2#1)
660##18##1##(1990-11#1)(1990-5#1)(1991-6#1)(1992-1#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
661##2##1##(1995-12#1)(2010-4#1)
663##2##1##(1994-12#1)(2008-10#1)
663)##2##1##(1995-2#1)(2008-10#1)
664##9##1##(1997-4#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)(2013-7#1)
665 attending##2##2##(2008-9#2)
665##8##1##(1997-8#1)(2008-10#3)(2008-9#3)(2011-1#1)
667##5##1##(1992-3#1)(1995-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
668##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
669##3##1##(2008-5#1)(2011-2#2)
67 +/-##4##2##(2008-12#1)(2008-4#1)(2011-1#2)
67 K outer membrane protein##2##5##(1995-12#2)
67 K##9##2##(1995-12#9)
67 and##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
67 cases of##2##3##(1990-9#1)(2011-2#1)
67 cases##4##2##(1990-9#3)(2011-2#1)
67 days##2##2##(1997-6#1)(2010-8#1)
67 microm##3##2##(2008-3#3)
67 mol/l##2##2##(2008-10#2)
67 patients with##2##3##(1994-12#1)(2008-12#1)
67 patients##7##2##(1990-12#1)(1991-9#1)(1994-12#1)(1997-8#1)(2008-12#1)(2008-7#1)(2013-8#1)
67 x##2##2##(1993-11#1)(2008-10#1)
67 years##4##2##(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#1)
67 ±##2##2##(2013-1#1)(2013-8#1)
67##162##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#4)(1991-3#1)(1991-9#2)(1992-3#3)(1992-5#1)(1992-6#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#12)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#7)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#3)(2011-1#7)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#6)
67% and##8##2##(1992-3#1)(1994-8#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-4#1)(2012-12#1)
67% for##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
67% in##2##2##(2008-10#2)
67% of patients##3##3##(1990-3#1)(2008-11#1)(2008-6#1)
67% of the cases##2##4##(1990-12#1)(2007-7#1)
67% of the##5##3##(1990-12#1)(2007-7#1)(2008-10#2)(2013-1#1)
67% of##17##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1993-5#1)(1996-9#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2012-2#1)(2013-1#2)
67%##60##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-6#1)(1991-8#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-6#2)(2008-7#3)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
67%) belonged to##2##3##(2008-10#2)
67%)##13##1##(1994-8#1)(2007-7#1)(2008-10#10)(2013-1#1)
67)##12##1##(1991-8#1)(1992-9#1)(1995-11#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
67)K(0##2##1##(2012-2#2)
67+/-0##2##1##(2007-8#1)(2008-10#1)
67+/-4##2##1##(2008-10#2)
67-0##3##1##(1991-11#1)(2007-10#1)(2008-12#1)
67-7##2##1##(2008-12#1)(2011-2#1)
670 nm##2##2##(2007-11#1)(2008-2#1)
670##12##1##(1990-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#1)(2010-9#1)
670-nm##3##1##(2007-12#1)(2008-3#2)
670nm##2##1##(2008-10#1)(2013-1#1)
671##3##1##(2007-12#1)(2008-10#1)(2013-8#1)
672 and##2##2##(2008-3#2)
672##8##1##(1995-2#1)(1995-3#1)(1997-6#1)(2008-3#2)(2008-7#2)(2013-8#1)
675 nm##4##2##(2008-10#1)(2008-3#3)
675 nm)##2##2##(1990-11#1)(2008-2#1)
675##9##1##(1990-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2011-1#1)(2011-2#1)
676##4##1##(1991-11#1)(2008-11#1)(2011-2#1)(2013-7#1)
677##2##1##(2008-10#1)(2011-3#1)
678##4##1##(1995-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
679##4##1##(2008-12#2)(2010-7#1)(2010-8#1)
68 +/- 0##2##3##(1992-3#1)(1997-2#1)
68 +/-##5##2##(1992-3#1)(1993-12#1)(1997-1#1)(1997-2#1)(2008-12#1)
68 and##9##2##(1990-12#1)(1990-2#1)(1993-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
68 cases##2##2##(2007-11#1)(2008-9#1)
68 days##5##2##(1997-4#3)(2007-7#1)(2008-10#1)
68 isolates of##3##3##(2008-10#3)
68 isolates##4##2##(2008-10#3)(2013-8#1)
68 kDa##6##2##(1991-5#1)(1994-5#2)(1995-12#1)(1997-2#1)(2010-3#1)
68 mg##2##2##(2008-10#1)(2013-8#1)
68 ng ml(-1) for##2##4##(2008-10#2)
68 ng ml(-1)##3##3##(2008-10#3)
68 patients with##2##3##(1992-6#1)(2007-11#1)
68 patients##12##2##(1990-2#1)(1991-8#1)(1992-6#2)(2007-11#2)(2008-1#1)(2008-3#2)(2008-9#1)(2010-3#1)(2012-4#1)
68 per cent##2##3##(1993-2#1)(1994-7#1)
68 to##6##2##(1995-6#1)(2008-10#3)(2010-4#1)(2012-12#1)
68 were##2##2##(1996-10#1)(2008-10#1)
68 with##2##2##(1995-3#1)(2008-10#1)
68##181##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#3)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-12#6)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#4)(2013-8#5)
68% and##2##2##(2008-1#1)(2008-11#1)
68% for##2##2##(2008-10#1)(2008-5#1)
68% identity to##2##3##(1993-6#1)(2008-10#1)
68% in##2##2##(2007-12#1)(2013-8#1)
68% of the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
68% of##6##2##(1992-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2013-8#1)
68% received##2##2##(2006-8#1)(2011-2#1)
68%##42##1##(1990-10#1)(1990-6#1)(1992-1#1)(1993-6#1)(1993-9#1)(1995-8#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#2)
68%) and##2##2##(1997-6#1)(2008-5#1)
68%)##7##1##(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
68)##7##1##(1993-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2013-1#1)
68+/-0##3##1##(2008-10#3)
68-4##2##1##(2007-10#1)(2008-3#1)
68-kDa##3##1##(1992-6#1)(1995-6#1)(2008-4#1)
68-year-old man##2##2##(1993-9#1)(2010-12#1)
68-year-old##5##1##(1993-9#1)(2008-1#1)(2008-12#1)(2010-12#1)(2012-12#1)
680 nm##3##2##(1990-12#1)(1996-2#1)(2008-10#1)
680##16##1##(1990-12#1)(1990-3#1)(1993-8#1)(1995-6#1)(1996-2#2)(1997-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2010-12#1)(2012-6#1)
6803##3##1##(1996-12#2)(1996-8#1)
681##4##1##(1996-6#1)(2007-7#1)(2008-10#1)(2009-5#1)
682##4##1##(1994-12#1)(1996-9#1)(2008-8#1)(2012-3#1)
683 nm##2##2##(2007-12#1)(2008-3#1)
683##3##1##(1994-9#1)(2007-12#1)(2008-3#1)
684##8##1##(1990-7#1)(1991-11#1)(1992-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-5#1)
685##2##1##(2008-12#1)(2008-3#1)
685-kb##2##1##(1997-2#2)
686##2##1##(1990-9#1)(2007-10#1)
687##8##1##(1991-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
688##4##1##(1994-6#1)(1997-2#1)(2008-10#1)(2011-2#1)
68hours##2##1##(2011-2#2)
69 +/- 0##2##3##(1992-3#1)(2011-2#1)
69 +/-##5##2##(1991-11#1)(1991-5#1)(1992-3#1)(1993-12#1)(2011-2#1)
69 and##6##2##(1992-3#1)(1994-12#1)(2008-10#3)(2008-8#1)
69 carcinomas##2##2##(1991-12#2)
69 dogs##2##2##(1993-2#2)
69 micromol##2##2##(1997-1#1)(2008-6#1)
69 patients and##2##3##(1994-2#1)(2013-1#1)
69 patients with##2##3##(1996-8#1)(2007-11#1)
69 patients##11##2##(1992-11#1)(1994-2#1)(1996-8#1)(2007-11#2)(2007-8#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
69 to##4##2##(2007-8#1)(2008-10#2)(2012-12#1)
69 were##2##2##(1992-5#1)(2009-8#1)
69 years##8##2##(1996-2#1)(1997-5#1)(2007-11#1)(2008-9#2)(2011-2#1)(2012-12#2)
69##146##1##(1990-11#1)(1990-5#2)(1990-8#3)(1991-11#2)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#4)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#1)(1996-10#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#20)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#7)
69% and##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
69% of patients##2##3##(2008-3#1)(2011-1#1)
69% of the##2##3##(1995-6#1)(1996-9#1)
69% of##10##2##(1993-3#1)(1995-6#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-8#1)(2011-1#1)
69% were##2##2##(2007-7#1)(2008-4#1)
69%##32##1##(1990-3#1)(1992-8#1)(1993-3#1)(1995-6#2)(1995-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-7#2)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#2)
69%) patients##2##2##(2011-2#1)(2013-1#1)
69%)##5##1##(2008-12#1)(2008-5#2)(2011-2#1)(2013-1#1)
69) and##3##2##(1995-11#1)(2011-3#1)(2012-4#1)
69)##8##1##(1995-11#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#1)
69+/-0##4##1##(2007-11#1)(2008-10#3)
69-year-old male##2##2##(2010-6#1)(2013-1#1)
69-year-old##3##1##(2008-7#1)(2010-6#1)(2013-1#1)
690##6##1##(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#1)
691##2##1##(2011-2#1)(2013-7#1)
692##4##1##(1997-4#1)(2008-11#1)(2008-12#1)(2009-10#1)
693##4##1##(1993-9#1)(1994-8#1)(2008-8#1)(2013-8#1)
694##5##1##(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
695##11##1##(1991-9#1)(1992-12#2)(1992-9#1)(1993-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-3#1)(2012-3#1)
697##4##1##(1996-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
698##3##1##(2008-10#1)(2010-10#1)(2013-8#1)
699##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
6A-1##2##1##(1997-7#2)
6A8 cDNA##2##2##(2008-8#2)
6A8##10##1##(2008-8#10)
6B##9##1##(1991-12#2)(1993-11#1)(1996-2#1)(2008-10#3)(2008-8#1)(2012-12#1)
6C10##2##1##(2008-9#2)
6C10(-)##2##1##(2008-9#2)
6DNOC) was##2##2##(2008-10#2)
6DNOC)##3##1##(2008-10#3)
6G and phosphomolybdate##2##3##(2008-10#2)
6G and##5##2##(2008-10#4)(2008-3#1)
6G##35##1##(2007-11#1)(2007-12#1)(2008-10#19)(2008-2#6)(2008-3#8)
6H(2)O##3##1##(2008-10#2)(2010-4#1)
6M HCl##2##2##(2008-10#2)
6M##3##1##(2008-10#3)
6MP##6##1##(2008-10#6)
6PGD gene expression pattern##2##4##(2010-12#2)
6PGD gene##3##2##(2010-12#3)
6PGD##6##1##(1997-3#1)(2010-12#5)
6S and COST is much##2##5##(2013-8#2)
6S and##4##2##(2008-10#2)(2013-8#2)
6S##9##1##(1991-12#1)(2008-10#4)(2013-8#4)
6WT##2##1##(2013-1#2)
6]##4##1##(1993-11#1)(1994-8#2)(2007-11#1)
6a-m##2##1##(2011-1#2)
6alpha##2##1##(2007-11#2)
6b DNA##2##2##(1994-8#1)(2011-1#1)
6b E7##6##2##(2011-1#6)
6b E7-specific antibodies##2##3##(2011-1#2)
6b E7-specific##3##2##(2011-1#3)
6b##14##1##(1994-8#1)(2011-1#13)
6cm##2##1##(2009-1#2)
6d##3##1##(1995-3#3)
6f detection##2##2##(2008-3#2)
6g/100g##2##1##(2013-7#2)
6h##7##1##(1993-12#1)(2008-10#1)(2009-5#1)(2013-1#4)
6kg##3##1##(2010-4#2)(2013-1#1)
6m2 cells##3##2##(1991-8#3)
6m2##5##1##(1991-8#5)
6mLmin(-1)##3##1##(2008-10#3)
6mV per decade##2##3##(2008-10#2)
6mV per##3##2##(2008-10#3)
6mg for##2##2##(2008-10#2)
6mg##5##1##(2008-10#4)(2012-2#1)
6microm##4##1##(2007-11#3)(2007-12#1)
6min##3##1##(2008-10#3)
6mlmin(-1)##3##1##(2008-10#3)
6mm i##3##2##(2008-10#3)
6mm##10##1##(2007-11#1)(2008-10#8)(2011-1#1)
6mm)##3##1##(2007-8#1)(2008-10#2)
6months##2##1##(2008-7#1)(2011-3#1)
6mug/kg##3##1##(2008-10#3)
6mugg(-1)##2##1##(2008-10#2)
6mugl(-1)##3##1##(2008-10#3)
6mugml(-1)##2##1##(2008-10#2)
6mum##2##1##(2007-12#2)
6ngml(-1) for##2##2##(2008-10#2)
6ngml(-1)##4##1##(2008-10#4)
6p##5##1##(1997-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
6p21##4##1##(1997-6#1)(2008-1#2)(2011-1#1)
6p24-22##6##1##(1997-5#6)
6pg##2##1##(2008-10#2)
6q##6##1##(1993-9#1)(1997-6#2)(2009-4#1)(2012-3#2)
6q21 region##2##2##(1997-3#2)
6q21##3##1##(1993-9#1)(1997-3#2)
6q26-27##2##1##(1994-11#1)(2012-2#1)
6th FECS##2##2##(2008-11#2)
6th International##2##2##(1994-9#1)(2011-2#1)
6th month##4##2##(2007-8#1)(2011-2#3)
6th through 8th##2##3##(1993-6#1)(2013-7#1)
6th to 7th##2##3##(2007-5#1)(2013-7#1)
6th to##3##2##(1997-6#1)(2007-5#1)(2013-7#1)
6th##31##1##(1993-6#1)(1994-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#4)(2011-4#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
6x##3##1##(1993-12#1)(2008-10#1)(2008-9#1)
6x10(-3) mol##2##2##(2008-10#2)
6x10(-3)##4##1##(2007-11#1)(2008-10#3)
6x10(-5)##2##1##(2008-10#2)
6x10(-6) M##2##2##(2008-10#2)
6x10(-6)##3##1##(2008-10#3)
6x10(-7) M##2##2##(2008-10#2)
6x10(-7) mol l(-1)##2##3##(2008-10#2)
6x10(-7)##5##1##(2008-10#5)
6x10(-7)moll(-1)##2##1##(2008-10#2)
6x10(-8) M##3##2##(2008-10#3)
6x10(-8)##5##1##(2008-10#5)
6x10(-9)##3##1##(2008-10#3)
6x10(4)##3##1##(2008-10#3)
6x10(5) l mol(-1) cm(-1)##2##4##(2008-10#2)
6x10(5)##3##1##(2008-10#3)
6x10(7) PIBs ml(-1))##2##3##(2008-11#2)
6year##2##1##(2008-7#2)
6years##2##1##(2008-7#1)(2011-3#1)
6°C##2##1##(2011-1#1)(2011-2#1)
6±8##2##1##(2013-1#2)
6 weeks##2##1##(2013-8#2)
7 % positive containers##2##4##(2008-5#2)
7 %##13##2##(1997-8#3)(2008-10#1)(2008-5#3)(2011-2#1)(2012-12#5)
7 %) and##3##3##(2008-5#1)(2011-1#1)(2012-12#1)
7 %)##9##2##(2007-7#1)(2008-5#2)(2011-1#1)(2012-12#5)
7 &lt##2##2##(2008-2#1)(2010-8#1)
7 (0##2##2##(1990-8#1)(2013-8#1)
7 (1##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
7 (25%)##2##2##(2008-6#1)(2012-12#1)
7 (5##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
7 (6##6##2##(1997-8#2)(2007-8#1)(2011-2#2)(2013-8#1)
7 (95% CI##3##3##(2010-9#1)(2012-3#1)(2013-1#1)
7 (SD+/-12##2##2##(2007-2#2)
7 (p &lt##2##3##(2006-10#1)(2008-3#1)
7 (range##2##2##(1996-2#1)(2013-1#1)
7 +/- 0##12##3##(1990-7#1)(1992-3#1)(1992-5#1)(1992-6#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
7 +/- 1##12##3##(1991-9#1)(1992-10#1)(1994-5#1)(1995-1#1)(1995-12#1)(2007-10#2)(2008-5#1)(2010-7#1)(2011-2#2)(2011-3#1)
7 +/- 10##2##3##(1990-7#1)(1995-12#1)
7 +/- 11##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
7 +/- 13##2##3##(1996-2#1)(2007-8#1)
7 +/- 2##7##3##(1990-2#1)(1992-2#1)(1993-11#1)(2007-8#1)(2008-5#1)(2009-1#1)(2011-2#1)
7 +/- 3##2##3##(1991-5#1)(1994-11#1)
7 +/- 4##2##3##(1990-12#1)(2012-3#1)
7 +/- 6##2##3##(1994-6#1)(1996-3#1)
7 +/- 8##3##3##(1994-2#1)(2008-1#1)(2008-10#1)
7 +/-##58##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#4)(1996-12#1)(1996-2#1)(1996-3#2)(2007-10#3)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-1#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-3#1)
7 95 %CI)##2##3##(2012-12#2)
7 A resolution##2##3##(1997-4#2)
7 A##5##2##(1992-9#1)(1995-2#1)(1997-4#2)(2008-10#1)
7 GHz##3##2##(2007-11#2)(2013-8#1)
7 Hz##2##2##(1997-7#1)(2008-3#1)
7 M##3##2##(1990-11#1)(2007-11#1)(2008-10#1)
7 MPa##3##2##(2008-10#3)
7 Mb##2##2##(2010-3#1)(2013-1#1)
7 Tesla##2##2##(2012-12#1)(2012-2#1)
7 V##4##2##(2008-10#4)
7 W of##4##3##(2007-11#2)(2007-12#2)
7 W##8##2##(2007-11#3)(2007-12#2)(2008-3#2)(2011-1#1)
7 after##2##2##(2008-10#1)(2013-8#1)
7 alpha##2##2##(1991-5#2)
7 amino acid##2##3##(2008-5#1)(2011-1#1)
7 amino acids##3##3##(2008-10#2)(2008-9#1)
7 amino##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
7 and 0##9##3##(2007-8#1)(2008-10#5)(2008-12#1)(2009-11#1)(2011-1#1)
7 and 1##9##3##(1992-5#1)(1994-11#1)(2008-10#6)(2008-12#1)
7 and 10##7##3##(1993-9#1)(2007-11#2)(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
7 and 102##2##3##(2008-10#2)
7 and 11##2##3##(2008-10#1)(2008-12#1)
7 and 13##2##3##(2008-12#1)(2011-2#1)
7 and 14 days of##4##5##(1995-3#2)(2008-10#1)(2008-12#1)
7 and 14 days##6##4##(1995-3#2)(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
7 and 14##11##3##(1991-8#1)(1995-3#2)(1996-12#1)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#1)
7 and 15##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
7 and 16##3##3##(1995-12#1)(2008-11#1)(2008-5#1)
7 and 16%##2##3##(2008-10#2)
7 and 2##6##3##(1991-9#1)(2008-10#3)(2008-12#1)(2011-3#1)
7 and 28##2##3##(1996-12#1)(2008-7#1)
7 and 3##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
7 and 37##2##3##(1992-3#1)(2013-1#1)
7 and 4##6##3##(1994-5#1)(1995-12#1)(2008-10#1)(2008-12#1)(2012-1#1)(2013-1#1)
7 and 5##3##3##(1991-8#1)(1991-9#1)(1995-3#1)
7 and 6##3##3##(2007-8#1)(2008-10#2)
7 and 7##2##3##(1992-3#1)(2008-11#1)
7 and 8 were##3##4##(1992-8#1)(2008-6#2)
7 and 8##12##3##(1992-8#1)(1993-8#2)(2007-12#2)(2008-10#3)(2008-3#1)(2008-6#2)(2010-2#1)
7 and 9##2##3##(1995-12#1)(2008-8#1)
7 and an##2##3##(2008-10#1)(2008-3#1)
7 and##145##2##(1990-5#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#4)(1995-3#4)(1996-12#3)(1996-2#1)(1997-6#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#3)(2008-10#48)(2008-11#4)(2008-12#8)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#5)(2013-8#1)
7 approximately##2##2##(2008-10#1)(2008-11#1)
7 as##2##2##(2008-10#1)(2008-11#1)
7 at##3##2##(1994-6#1)(2008-10#1)(2013-8#1)
7 bp##2##2##(1997-2#1)(2008-9#1)
7 cM##3##2##(1996-10#1)(2008-10#2)
7 cM) and##2##3##(2008-10#2)
7 cM)##3##2##(2008-10#3)
7 cases of##2##3##(2011-2#2)
7 cases with##2##3##(2007-10#1)(2007-11#1)
7 cases##20##2##(1991-11#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-4#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-12#1)(2009-6#2)(2011-2#2)(2013-1#1)(2013-8#1)
7 cells and RBL 2H3##2##5##(2011-2#2)
7 cells##13##2##(1990-12#1)(1997-1#1)(2008-11#6)(2009-12#1)(2011-2#3)(2012-12#1)
7 children##2##2##(1991-2#1)(2007-5#1)
7 cm vestibular schwannoma##2##4##(2010-4#2)
7 cm##13##2##(1990-3#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#2)
7 cm(-1)##2##2##(2007-12#1)(2008-3#1)
7 consecutive days##6##3##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)
7 consecutive##7##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-2#2)
7 d after##3##3##(2008-8#2)(2011-2#1)
7 d##7##2##(1992-8#1)(1994-5#1)(2007-5#1)(2008-8#2)(2011-2#2)
7 d)##3##2##(2008-10#2)(2011-2#1)
7 days after inoculation##10##4##(2008-10#10)
7 days after surgery##3##4##(2007-8#1)(2011-2#1)(2012-1#1)
7 days after the onset##2##5##(2008-10#1)(2010-4#1)
7 days after the##4##4##(1995-8#1)(1996-12#1)(2008-10#1)(2010-4#1)
7 days after##24##3##(1990-2#1)(1992-2#1)(1994-5#1)(1995-8#1)(1996-12#1)(2007-10#2)(2007-8#1)(2008-10#13)(2010-4#1)(2011-2#1)(2012-1#1)
7 days and##6##3##(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
7 days before##2##3##(2008-10#2)
7 days in##5##3##(2007-10#4)(2008-5#1)
7 days of administration##2##4##(1995-3#2)
7 days of culture##2##4##(2010-11#2)
7 days of treatment##2##4##(2008-5#1)(2008-8#1)
7 days of##14##3##(1993-6#1)(1995-3#3)(1996-5#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-8#2)(2010-11#2)
7 days old##2##3##(2008-10#1)(2008-12#1)
7 days or##3##3##(1994-3#1)(1996-12#1)(2008-10#1)
7 days prior to anthesis##3##5##(2008-10#3)
7 days prior to##6##4##(1996-12#2)(2008-10#4)
7 days to##2##3##(2008-12#1)(2008-5#1)
7 days##125##2##(1990-2#3)(1990-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#4)(1995-8#2)(1996-12#4)(1996-5#1)(1997-3#1)(1997-4#3)(1997-5#1)(2007-10#11)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#33)(2008-11#4)(2008-12#6)(2008-5#7)(2008-7#4)(2008-8#3)(2009-12#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
7 days)##4##2##(1994-6#1)(2008-10#2)(2008-11#1)
7 degrees C and##2##4##(2008-10#2)
7 degrees C for##4##4##(2007-10#1)(2008-10#1)(2008-3#1)(2011-2#1)
7 degrees C##10##3##(2007-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)
7 degrees##18##2##(1994-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#3)(2008-5#1)(2009-10#2)(2011-2#1)(2012-2#2)(2013-1#1)
7 drainages##2##2##(1991-3#2)
7 exons##2##2##(1990-12#1)(1997-2#1)
7 families##2##2##(2008-6#2)
7 for##8##2##(1990-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#1)
7 from##3##2##(2008-10#2)(2008-11#1)
7 g##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
7 g/L##4##2##(2008-6#3)(2008-7#1)
7 genes##2##2##(1995-8#1)(2013-1#1)
7 h for##2##3##(2008-10#1)(2010-8#1)
7 h of##2##3##(1992-8#1)(2008-10#1)
7 h##7##2##(1992-8#1)(1993-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-8#1)
7 had##3##2##(1994-12#1)(2013-1#2)
7 healthy##2##2##(1995-5#1)(2008-7#1)
7 hyperplastic glands##2##3##(2008-5#2)
7 in the##4##3##(2008-10#3)(2009-3#1)
7 in##10##2##(1991-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2009-3#1)
7 individuals##2##2##(1990-3#1)(2008-5#1)
7 is##5##2##(1991-8#1)(2007-12#2)(2011-2#2)
7 isoforms##2##2##(1991-12#2)
7 kDa##4##2##(1991-12#1)(1995-8#1)(2008-10#2)
7 kDa)##2##2##(1995-11#1)(2008-10#1)
7 kJ mol(-1) n(-1)##2##4##(2008-10#2)
7 kJ mol(-1)##3##3##(2008-10#3)
7 kb and##2##3##(1992-8#1)(2008-8#1)
7 kb in##2##3##(1997-7#1)(2008-8#1)
7 kb insert##2##3##(1997-6#2)
7 kb segment##3##3##(1996-6#2)(2008-11#1)
7 kb##18##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-8#2)(1993-8#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(2008-11#1)(2008-8#2)
7 kb)##4##2##(1991-12#1)(2008-11#1)(2008-6#2)
7 kcal/mol##7##2##(1990-3#1)(1990-8#1)(1992-6#1)(1994-3#1)(1996-2#1)(2012-12#2)
7 kcal/mol)##2##2##(1993-8#2)
7 kg##2##2##(1990-11#1)(2008-12#1)
7 kg/ha##2##2##(2011-1#2)
7 log(10)##2##2##(2008-10#1)(2013-1#1)
7 m(2)##2##2##(2008-10#1)(2009-11#1)
7 m)##2##2##(2008-10#1)(2008-3#1)
7 m/s##2##2##(1993-3#1)(2008-2#1)
7 mM and##2##3##(1991-5#1)(1994-3#1)
7 mM##5##2##(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-8#1)
7 mV per concentration decade##2##5##(2008-10#2)
7 mV##6##2##(2008-10#5)(2012-2#1)
7 mW##2##2##(2007-11#1)(2008-2#1)
7 mg##13##2##(1993-2#1)(1996-12#1)(2008-10#6)(2008-12#2)(2008-9#1)(2009-6#1)(2013-8#1)
7 mg/kg##6##2##(1990-6#1)(1991-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
7 mg/l##2##2##(2007-7#1)(2008-1#1)
7 mg/ml)##2##2##(1992-3#2)
7 micro##2##2##(2008-10#1)(2013-1#1)
7 microM and##2##3##(1997-6#2)
7 microM##5##2##(1990-7#1)(1992-8#1)(1997-6#2)(2008-10#1)
7 microM)##5##2##(1992-12#1)(1992-3#1)(1993-8#2)(1995-3#1)
7 microg l(-1)##4##3##(2008-10#4)
7 microg##8##2##(1997-4#1)(2008-10#4)(2008-12#1)(2008-5#1)(2013-8#1)
7 microm##4##2##(2007-11#1)(2008-10#1)(2009-11#1)(2011-2#1)
7 microm) with##2##3##(2011-1#1)(2012-3#1)
7 micromol##2##2##(2008-10#2)
7 million##5##2##(1992-6#1)(1996-3#1)(2007-5#1)(2008-11#1)(2012-1#1)
7 min in##2##3##(2008-10#2)
7 min##11##2##(1992-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#1)
7 ml of##3##3##(2008-10#3)
7 ml##7##2##(2008-10#6)(2008-7#1)
7 mm and##3##3##(1996-2#1)(2013-1#2)
7 mm respectively##2##3##(2013-1#2)
7 mm##16##2##(1996-2#1)(2007-8#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#4)
7 mm)##3##2##(2008-5#1)(2009-8#2)
7 mmol/l##2##2##(1990-6#1)(1991-11#1)
7 mol##3##2##(1993-8#1)(1995-6#1)(2008-10#1)
7 months (range##7##3##(1990-2#1)(1991-2#1)(1992-2#1)(1992-8#1)(2008-6#2)(2012-3#1)
7 months after the##2##4##(2011-1#1)(2013-8#1)
7 months for##2##3##(2008-6#1)(2011-2#1)
7 months later##2##3##(2007-8#1)(2013-8#1)
7 months of##3##3##(1995-8#1)(2008-10#2)
7 months to##4##3##(1990-12#1)(1991-8#1)(1996-11#1)(2012-2#1)
7 months##37##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-11#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
7 mug l(-1)##2##3##(2008-10#2)
7 mug ml(-1) for##2##4##(2008-10#2)
7 mug ml(-1)##4##3##(2008-10#4)
7 mug##14##2##(2008-10#12)(2008-11#2)
7 mug/ml)##2##2##(2008-5#2)
7 mum in##2##3##(2007-12#1)(2008-3#1)
7 mum##12##2##(1992-2#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#2)
7 mumol##3##2##(1996-12#1)(2008-10#2)
7 nAChR##2##2##(2007-8#2)
7 nAChRs##3##2##(2007-8#3)
7 ng ml(-1) for##2##4##(2008-10#2)
7 ng ml(-1)##3##3##(2008-10#3)
7 ng##7##2##(2008-10#7)
7 ng/dl)##2##2##(1994-3#1)(2008-4#1)
7 nm##12##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)(2011-1#1)
7 nucleotides##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
7 of the##13##3##(1993-3#2)(1994-5#1)(1995-2#2)(2008-10#4)(2008-2#1)(2009-11#1)(2010-4#1)(2011-2#1)
7 of##29##2##(1991-8#1)(1992-10#1)(1993-3#2)(1994-5#1)(1995-2#2)(1996-12#1)(1996-5#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#3)
7 or 10##2##3##(1990-12#1)(1993-12#1)
7 or 14 days##2##4##(1993-12#1)(1995-3#1)
7 or 8##2##3##(2008-1#1)(2008-6#1)
7 or##9##2##(1990-12#1)(1990-6#1)(1990-8#1)(1993-12#2)(1995-3#1)(2008-1#1)(2008-10#1)(2008-6#1)
7 orders of magnitude##2##4##(2007-11#1)(2008-3#1)
7 orders##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
7 out of##5##3##(1990-12#1)(1991-11#1)(1992-8#1)(2008-7#1)(2013-1#1)
7 parts##2##2##(2008-2#1)(2008-3#1)
7 patients and##5##3##(1991-2#1)(1991-4#1)(1993-2#1)(2009-10#1)(2011-2#1)
7 patients in##2##3##(2008-1#1)(2010-12#1)
7 patients with primary##3##4##(1991-5#1)(2008-6#1)(2012-12#1)
7 patients with##9##3##(1991-5#1)(1993-11#1)(1995-12#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-6#1)(2012-12#1)
7 patients##46##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-5#1)(2007-11#4)(2008-1#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2009-10#2)(2009-2#1)(2010-12#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#3)
7 per##7##2##(1996-11#1)(2008-2#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
7 percent of the##2##4##(1990-3#1)(1991-1#1)
7 percent##9##2##(1990-3#1)(1991-1#1)(1992-6#1)(1994-12#2)(2011-2#2)(2013-1#2)
7 pg/ml##3##2##(1994-3#1)(1994-7#1)(2011-2#1)
7 position##2##2##(1997-2#1)(2008-4#1)
7 ppm##4##2##(2008-1#1)(2008-10#3)
7 ps##3##2##(2007-1#1)(2007-11#1)(2008-8#1)
7 relapsing##2##2##(1991-2#2)
7 s-1##3##2##(1993-9#1)(1995-2#1)(1995-8#1)
7 showed##2##2##(2008-10#2)
7 subunit##3##2##(1996-12#2)(2010-8#1)
7 testudinum coverage##2##3##(2007-5#2)
7 that##2##2##(1996-12#1)(2013-1#1)
7 through##2##2##(2008-10#1)(2012-2#1)
7 times higher than##2##4##(1995-4#1)(2008-7#1)
7 times more##2##3##(1991-8#1)(2008-10#1)
7 times##12##2##(1991-8#1)(1995-2#1)(1995-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#2)(2012-2#1)
7 to 1##4##3##(1993-11#1)(2007-12#1)(2007-8#1)(2012-3#1)
7 to 10 years##3##4##(2008-10#2)(2012-12#1)
7 to 10##11##3##(1991-11#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#5)(2008-4#1)(2012-12#1)
7 to 11##3##3##(2008-10#3)
7 to 18##2##3##(2008-10#2)
7 to 19##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
7 to 2##6##3##(1993-3#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-11#1)
7 to 25##2##3##(2008-10#1)(2012-12#1)
7 to 28##2##3##(1996-6#1)(2007-8#1)
7 to 3##3##3##(2009-5#1)(2012-12#2)
7 to 4##3##3##(2008-10#2)(2012-3#1)
7 to 5##3##3##(1991-8#1)(2008-10#2)
7 to 50##2##3##(2008-10#1)(2008-3#1)
7 to 9##2##3##(1992-8#1)(2012-1#1)
7 to##82##2##(1991-11#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-8#3)(2008-10#37)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#3)(2013-1#2)(2013-8#1)
7 vs##5##2##(1994-2#1)(1994-8#1)(1995-12#1)(2007-10#1)(2011-2#1)
7 was determined##2##3##(1994-5#1)(2008-10#1)
7 was##9##2##(1990-11#1)(1992-12#1)(1994-5#1)(2008-10#4)(2011-2#1)(2012-12#1)
7 weeks after##2##3##(1997-6#2)
7 weeks of age##2##4##(1991-6#1)(1992-3#1)
7 weeks##13##2##(1991-2#1)(1991-6#1)(1992-3#1)(1997-6#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
7 were##11##2##(1991-6#1)(1992-3#1)(1993-1#1)(1993-3#1)(1997-2#2)(2008-10#3)(2008-7#1)(2013-8#1)
7 with##9##2##(1990-8#1)(1994-12#1)(2008-10#2)(2008-7#3)(2011-2#2)
7 women##2##2##(1992-2#1)(1995-8#1)
7 x 10(-10) M##2##4##(1993-3#1)(1995-11#1)
7 x 10(-10)##3##3##(1993-3#1)(1995-11#1)(1995-5#1)
7 x 10(-11)##2##3##(2007-12#1)(2008-10#1)
7 x 10(-4)##2##3##(2007-11#1)(2008-3#1)
7 x 10(-5)##2##3##(2008-2#1)(2008-3#1)
7 x 10(-6)##2##3##(1991-5#1)(2008-3#1)
7 x 10(4)##2##3##(1994-5#1)(2008-10#1)
7 x 10(5)##2##3##(1995-2#1)(2008-11#1)
7 x 10(6)##2##3##(2008-11#2)
7 x 10(7)##2##3##(2008-11#2)
7 x##33##2##(1990-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#4)(2012-3#1)
7 y##2##2##(2008-5#2)
7 year##3##2##(2007-10#1)(2007-7#1)(2008-11#1)
7 years (range##3##3##(2008-7#1)(2009-10#1)(2012-12#1)
7 years after##2##3##(1992-2#1)(2012-2#1)
7 years and##2##3##(1993-6#1)(2007-7#1)
7 years of##2##3##(2012-12#1)(2013-1#1)
7 years##33##2##(1990-9#1)(1991-11#1)(1991-8#1)(1992-2#1)(1993-6#1)(1996-11#1)(1996-5#1)(1997-7#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)
7 years)##5##2##(1992-9#2)(1996-7#1)(1997-2#1)(2008-10#1)
7 yr##3##2##(2008-7#2)(2008-8#1)
7 ±##3##2##(2013-1#2)(2013-8#1)
7##2789##1##(1990-11#13)(1990-12#15)(1990-2#17)(1990-3#15)(1990-5#8)(1990-6#8)(1990-7#9)(1990-8#18)(1990-9#5)(1991-1#2)(1991-11#9)(1991-12#22)(1991-2#12)(1991-3#3)(1991-4#3)(1991-5#16)(1991-6#4)(1991-7#1)(1991-8#20)(1991-9#8)(1992-10#11)(1992-11#2)(1992-12#8)(1992-2#19)(1992-3#16)(1992-4#2)(1992-5#8)(1992-6#5)(1992-8#24)(1992-9#6)(1993-1#7)(1993-11#9)(1993-12#16)(1993-2#6)(1993-3#16)(1993-5#1)(1993-6#7)(1993-8#29)(1993-9#7)(1994-1#1)(1994-11#8)(1994-12#15)(1994-2#4)(1994-3#12)(1994-5#21)(1994-6#8)(1994-7#3)(1994-8#14)(1994-9#6)(1995-1#1)(1995-11#13)(1995-12#21)(1995-2#17)(1995-3#27)(1995-4#2)(1995-5#9)(1995-6#7)(1995-8#13)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#10)(1996-12#30)(1996-2#19)(1996-3#5)(1996-4#1)(1996-5#14)(1996-6#11)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#19)(1997-3#6)(1997-4#9)(1997-5#5)(1997-6#10)(1997-7#20)(1997-8#9)(1997-9#1)(2006-10#7)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#31)(2007-11#53)(2007-12#34)(2007-2#8)(2007-3#1)(2007-5#7)(2007-7#12)(2007-8#34)(2008-1#22)(2008-10#774)(2008-11#85)(2008-12#44)(2008-2#39)(2008-3#58)(2008-4#15)(2008-5#85)(2008-6#37)(2008-7#77)(2008-8#39)(2008-9#25)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#5)(2009-2#2)(2009-3#9)(2009-4#7)(2009-5#6)(2009-6#7)(2009-7#5)(2009-8#10)(2009-9#2)(2010-1#7)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#13)(2010-9#2)(2011-1#41)(2011-2#99)(2011-3#10)(2012-1#11)(2012-12#42)(2012-2#17)(2012-3#29)(2012-9#1)(2013-1#94)(2013-7#1)(2013-8#33)
7% (n = 2)##2##4##(2012-3#2)
7% (n =##4##3##(2012-3#4)
7% (n=5)##2##2##(2008-10#2)
7% HIV infection##2##3##(2007-7#1)(2013-1#1)
7% O2 in N2##2##4##(2008-10#2)
7% R##5##2##(1994-9#1)(2008-10#4)
7% amino acid##2##3##(2008-10#1)(2008-4#1)
7% and 13##2##3##(1994-5#1)(2008-8#1)
7% and 2##2##3##(2008-10#1)(2012-2#1)
7% and 50##2##3##(2008-10#2)
7% and 78##2##3##(2011-2#1)(2012-3#1)
7% and a##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
7% and active IDU##2##4##(2012-1#2)
7% and active##3##3##(2012-1#2)(2013-1#1)
7% and the##4##3##(2008-10#2)(2011-1#1)(2012-12#1)
7% and##47##2##(1990-3#1)(1991-8#2)(1994-5#1)(1994-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
7% at##8##2##(1990-5#1)(2008-10#3)(2008-3#1)(2013-1#3)
7% between##2##2##(2008-10#1)(2008-3#1)
7% by##2##2##(2008-10#1)(2010-11#1)
7% compared##2##2##(2008-3#1)(2012-2#1)
7% confidence level##3##3##(2008-10#3)
7% confidence level) and##2##4##(2008-10#2)
7% confidence##5##2##(2008-10#5)
7% for Fe##2##3##(2008-10#2)
7% for a##3##3##(2008-10#3)
7% for the##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
7% for##31##2##(1992-11#2)(1993-8#1)(1994-11#1)(1994-12#2)(1997-7#1)(2008-10#21)(2008-2#1)(2008-5#2)
7% had##4##2##(2007-7#1)(2008-5#1)(2010-1#1)(2010-6#1)
7% in the##10##3##(1991-6#1)(1996-6#1)(2007-8#3)(2008-10#3)(2008-7#2)
7% in those who##2##4##(1990-6#1)(2012-3#1)
7% in those##3##3##(1990-6#1)(2007-12#1)(2012-3#1)
7% in##35##2##(1990-6#1)(1991-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#2)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#2)
7% increase##2##2##(1995-5#1)(2013-1#1)
7% increase)##2##2##(1995-5#1)(2013-1#1)
7% negative predictive value##2##4##(2011-2#2)
7% nucleotide##2##2##(2008-10#2)
7% of all##4##3##(1992-10#1)(1997-4#1)(2007-8#1)(2011-2#1)
7% of cases##4##3##(1990-3#1)(2007-7#1)(2007-8#1)(2013-1#1)
7% of participants##2##3##(2009-3#1)(2010-1#1)
7% of patients##5##3##(1991-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
7% of subjects##2##3##(2008-7#1)(2012-2#1)
7% of the cases##3##4##(1991-2#1)(2008-11#1)(2013-8#1)
7% of the patients had##2##5##(1990-2#1)(2010-6#1)
7% of the patients##4##4##(1990-12#1)(1990-2#1)(1994-11#1)(2010-6#1)
7% of the phenotypic##2##4##(2008-10#2)
7% of the samples##3##4##(2008-6#1)(2011-1#1)(2013-8#1)
7% of the total##2##4##(2008-10#1)(2008-5#1)
7% of the##27##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1993-2#1)(1994-11#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
7% of total##2##3##(2008-11#1)(2012-3#1)
7% of##70##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-10#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
7% patients##2##2##(1991-8#1)(2012-2#1)
7% respectively##2##2##(2010-8#1)(2012-12#1)
7% to##9##2##(1991-3#1)(2007-12#2)(2008-1#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#2)
7% versus##4##2##(1991-11#1)(1995-3#1)(1995-8#1)(2013-1#1)
7% via##2##2##(1993-8#2)
7% vs 13##2##3##(2010-4#2)
7% vs 16##2##3##(2010-4#2)
7% vs##16##2##(1995-8#1)(2009-8#1)(2010-3#1)(2010-4#9)(2011-2#1)(2012-3#1)(2013-8#2)
7% was##2##2##(2007-11#1)(2008-1#1)
7% were African-Americans##2##3##(2007-7#2)
7% were##15##2##(1993-8#1)(1994-12#1)(1997-7#1)(2007-7#4)(2008-10#3)(2008-12#2)(2010-1#1)(2011-1#1)(2013-8#1)
7% when##2##2##(2008-10#1)(2010-6#1)
7% with the human and##2##5##(1996-12#2)
7% with the##4##3##(1996-12#3)(2009-11#1)
7% with##7##2##(1996-12#3)(2008-10#1)(2008-5#1)(2009-11#1)(2013-1#1)
7%##560##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#5)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#5)(1993-9#3)(1994-11#3)(1994-12#6)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#17)(2007-8#12)(2008-1#8)(2008-10#139)(2008-11#10)(2008-12#7)(2008-2#13)(2008-3#11)(2008-4#5)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#8)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#4)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#12)(2010-5#1)(2010-6#4)(2010-8#4)(2011-1#17)(2011-2#28)(2012-1#3)(2012-12#11)(2012-2#11)(2012-3#18)(2013-1#27)(2013-8#14)
7%) and a##2##3##(2008-10#1)(2013-8#1)
7%) and##23##2##(1991-8#1)(1991-9#1)(2007-10#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
7%) are##2##2##(2008-7#2)
7%) cases##2##2##(2008-3#1)(2011-2#1)
7%) followed by##2##3##(2007-7#1)(2008-6#1)
7%) for##2##2##(2010-3#1)(2013-1#1)
7%) had##4##2##(1994-12#1)(2007-10#1)(2008-7#1)(2012-3#1)
7%) in##2##2##(2007-12#1)(2009-10#1)
7%) of the wards did not use any instrument##2##9##(2013-1#2)
7%) of the##5##3##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
7%) of##12##2##(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-2#2)(2013-1#3)
7%) patients##8##2##(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
7%) reported##2##2##(2011-2#2)
7%) than those##2##3##(1990-6#1)(2011-1#1)
7%) than##4##2##(1990-6#1)(2011-1#1)(2012-3#2)
7%) the##2##2##(1992-5#1)(1994-6#1)
7%) were classified into##2##4##(2011-1#2)
7%) were the most##2##4##(2008-1#1)(2008-11#1)
7%) were##12##2##(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-4#1)(2011-1#2)(2012-3#1)
7%) with##5##2##(1993-1#1)(1994-12#1)(1997-7#1)(2013-1#2)
7%)##194##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-6#2)(1994-9#1)(1996-11#3)(1996-6#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#9)(2007-8#7)(2008-1#11)(2008-10#15)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#5)(2009-10#3)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#15)(2010-8#2)(2011-1#10)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#21)(2013-8#5)
7) and##12##2##(1995-12#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)
7) has been##2##3##(2010-7#1)(2013-1#1)
7) has##3##2##(2008-7#1)(2010-7#1)(2013-1#1)
7) in##2##2##(1993-1#1)(2011-2#1)
7) of the##2##3##(1991-8#1)(1995-3#1)
7) of##3##2##(1991-8#1)(1995-3#1)(1997-7#1)
7) than##2##2##(1996-11#1)(2008-3#1)
7) to##2##2##(1990-5#1)(2009-12#1)
7) was##3##2##(2008-10#2)(2008-12#1)
7) with##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
7)##113##1##(1990-5#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#2)(1997-1#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#20)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-2#5)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#6)
7)%##4##1##(2008-10#2)(2008-3#2)
7+/-0##16##1##(2007-12#2)(2007-8#1)(2008-10#11)(2008-7#2)
7+/-1##3##1##(2008-10#3)
7+/-2##2##1##(2008-10#1)(2009-3#1)
7+/-3##2##1##(2007-8#1)(2008-10#1)
7+/-4##2##1##(2008-10#2)
7- and 2##2##3##(1993-12#1)(1993-9#1)
7- and##4##2##(1993-12#1)(1993-6#1)(1993-9#1)(2008-8#1)
7- to##6##2##(2008-10#6)
7-##14##1##(1993-12#1)(1993-6#1)(1993-9#1)(2008-10#7)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
7-1##9##1##(1990-11#1)(1993-12#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)
7-10##7##1##(1990-8#1)(1994-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-3#1)(2013-8#1)
7-10%##2##1##(1991-9#1)(2012-2#1)
7-100##3##1##(1993-2#1)(2008-10#2)
7-12##5##1##(2008-3#2)(2009-7#1)(2012-3#2)
7-14##7##1##(1992-9#1)(1997-4#1)(2008-10#1)(2010-11#1)(2011-2#3)
7-15##4##1##(1992-11#1)(2007-10#1)(2008-4#1)(2009-7#1)
7-16##2##1##(2008-10#1)(2008-12#1)
7-17##3##1##(1991-6#1)(1996-12#1)(2008-11#1)
7-18##2##1##(2008-10#1)(2009-7#1)
7-2##8##1##(1993-2#1)(2007-12#2)(2008-10#3)(2008-7#1)(2008-8#1)
7-28##2##1##(1996-6#2)
7-3##4##1##(2008-10#3)(2013-8#1)
7-4##3##1##(2008-10#2)(2013-1#1)
7-40##2##1##(1991-9#1)(2008-11#1)
7-5##2##1##(1997-5#1)(2007-12#1)
7-6##6##1##(2007-11#1)(2008-10#4)(2012-1#1)
7-7##4##1##(2008-10#2)(2008-5#1)(2008-8#1)
7-8##13##1##(1992-11#1)(1994-3#2)(1995-2#1)(1997-8#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-6#1)(2013-1#3)
7-9##12##1##(1991-12#2)(1991-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-3#1)
7-A##2##1##(1992-4#2)
7-AAD##2##1##(2008-10#1)(2008-9#1)
7-DAM is##2##2##(1995-2#2)
7-DAM##4##1##(1995-2#4)
7-DAY##2##1##(2008-11#2)
7-DCKA##2##1##(1995-11#2)
7-DHT injected animals##4##3##(2008-5#4)
7-DHT injected##5##2##(2008-5#5)
7-DHT##8##1##(2008-5#6)(2008-6#2)
7-DHT)##3##1##(1991-7#1)(2008-5#1)(2008-6#1)
7-ERD##3##1##(1992-3#3)
7-O-beta-(6-O-malonyl)glucopyranoside##2##1##(2010-6#2)
7-O-beta-D-glucopyranosiduronic acid-(1--&gt##2##2##(2010-6#2)
7-O-beta-D-glucoside##4##1##(2008-11#4)
7-O-oxazinanone##2##1##(2009-2#2)
7-W##6##1##(2007-12#4)(2008-3#2)
7-bis-(3-trifluoromethylphenyl)-1##2##1##(1995-3#2)
7-bis-(4-trifluoromethylphenyl)-1##2##1##(1995-3#2)
7-bit##2##1##(2008-3#2)
7-dap##3##1##(1996-2#3)
7-day intervals##2##2##(2008-10#2)
7-day##7##1##(1992-12#1)(1992-2#1)(2008-10#3)(2009-11#1)(2012-3#1)
7-day-old##4##1##(1994-6#1)(1996-12#1)(1997-3#1)(2008-11#1)
7-deazapurine (pyrrolo[2##2##2##(2008-4#2)
7-deazapurine##4##1##(2008-4#4)
7-dehydrocholesterol##2##1##(1990-2#2)
7-deoxycholic amide##3##2##(2008-10#3)
7-diaminoheptane##4##1##(1992-11#1)(1997-1#2)(2008-10#1)
7-diaminomitosene##2##1##(1995-2#2)
7-dicarboxylic acid##2##2##(1996-5#2)
7-dichloroquinoline-8-ol modified benzophenone##2##3##(2008-10#2)
7-dichloroquinoline-8-ol##4##1##(2008-10#4)
7-dihydro-[5H]-pyrrolo[1##4##1##(1991-8#4)
7-dihydroxytryptamine (5##2##2##(2008-5#1)(2008-6#1)
7-dihydroxytryptamine##3##1##(1996-12#1)(2008-5#1)(2008-6#1)
7-dihydroxyxanthone##2##1##(2008-11#2)
7-dioxadiazocane##4##1##(1995-3#4)
7-diphenyl-1##3##1##(2008-10#3)
7-ethoxyresorufin O-deethylase##2##2##(1992-3#1)(1992-8#1)
7-ethyl-dGp adducts##2##2##(2008-12#2)
7-ethyl-dGp levels##2##2##(2008-12#2)
7-ethyl-dGp##7##1##(2008-12#7)
7-fold and##2##2##(1995-11#1)(2008-11#1)
7-fold increase in##2##3##(1990-12#1)(1996-5#1)
7-fold lower##2##2##(2008-10#1)(2008-3#1)
7-fold##18##1##(1990-12#2)(1990-5#1)(1991-5#1)(1992-3#2)(1994-8#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)
7-gas N-Gas Model##2##3##(1996-12#2)
7-gas##3##1##(1996-12#3)
7-hydroxy##2##1##(2008-10#1)(2009-3#1)
7-hydroxycoumarin##2##1##(1990-6#2)
7-hydroxymethylnalidixic acid (OH-NA)##2##3##(2008-10#2)
7-hydroxymethylnalidixic acid##3##2##(2008-10#3)
7-kDa##4##1##(1992-6#1)(2008-10#2)(2011-2#1)
7-kHz##3##1##(2007-11#1)(2007-12#2)
7-kb fragment containing##2##3##(1994-12#1)(1996-8#1)
7-kb region of##3##3##(1993-6#1)(1994-12#1)(2008-10#1)
7-kb##8##1##(1990-12#1)(1993-6#1)(1994-12#2)(1996-8#1)(1997-7#1)(2008-10#2)
7-m-diameter liquid mirror##2##3##(2008-3#2)
7-mJ##3##1##(2007-12#2)(2008-3#1)
7-methyl-dGp##4##1##(2008-12#4)
7-methylxanthine##2##1##(2010-1#2)
7-microm##3##1##(2008-2#1)(2008-3#2)
7-month-old##3##1##(1995-8#1)(1997-3#1)(2008-10#1)
7-mx for##2##2##(2010-1#2)
7-mx##5##1##(2010-1#5)
7-nm##2##1##(2007-11#1)(2007-12#1)
7-order S-matrix##2##2##(2013-8#2)
7-pentahydroxyflavone##2##1##(2008-10#2)
7-pentahydroxyflavone)##2##1##(2008-10#2)
7-substituted##2##1##(1991-3#1)(2008-4#1)
7-tetramethyl-2##2##1##(2008-10#2)
7-tetramethyl-4-bora-3a##2##1##(2008-10#2)
7-tetramethyl-8-(3'##2##1##(2008-10#2)
7-tetranitro-1##3##1##(2008-10#3)
7-tetrazocine (HMX)##3##2##(2008-10#3)
7-tetrazocine##4##1##(2008-10#3)(2008-11#1)
7-transmembrane##2##1##(1992-3#1)(2008-4#1)
7-trihydroxyl-6-fluorone##2##1##(2008-10#2)
7-trinitro-9-fluorenon##2##1##(2008-10#2)
7-triphenylheptyl-UDP##3##1##(1992-8#3)
7-week##4##1##(1994-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
7-year period##3##2##(1994-1#1)(2008-10#1)(2011-2#1)
7-year##6##1##(1991-11#1)(1994-1#1)(2008-10#1)(2010-6#1)(2011-2#2)
7-year-old boy##3##2##(2008-10#1)(2010-9#1)(2012-12#1)
7-year-old##9##1##(2008-10#3)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
7/10##2##1##(2008-9#1)(2011-2#1)
7/100##2##1##(1993-2#1)(2007-12#1)
7/1000##4##1##(1990-3#1)(1991-3#1)(1995-9#2)
7/12##2##1##(1990-3#1)(2007-7#1)
70 %##2##2##(2008-8#1)(2012-12#1)
70 +/- 0##2##3##(2008-10#2)
70 +/-##8##2##(1991-11#1)(1991-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#2)
70 A##2##2##(1991-12#1)(1995-11#1)
70 K##2##2##(1993-11#1)(2008-2#1)
70 V##2##2##(2008-10#2)
70 and##17##2##(1993-2#1)(1994-1#2)(1997-6#1)(2008-10#12)(2010-4#1)
70 cases of##2##3##(1990-6#1)(2007-8#1)
70 chicken autosomal##2##3##(2012-1#2)
70 children##2##2##(2009-9#1)(2011-2#1)
70 cm##2##2##(2008-10#2)
70 days##7##2##(1997-4#3)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)
70 degrees C for##2##4##(2008-10#2)
70 degrees C##8##3##(2008-10#5)(2008-11#1)(2008-3#2)
70 degrees##14##2##(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-6#1)(2009-3#1)
70 family##2##2##(1994-12#1)(1995-11#1)
70 fs##2##2##(2007-11#1)(2012-2#1)
70 h##2##2##(2008-11#2)
70 in##5##2##(1992-2#1)(1994-8#1)(2012-1#1)(2012-3#2)
70 isolates of##2##3##(2008-10#2)
70 kD rat liver nucleoplasmic protein binding##2##7##(1993-8#2)
70 kD rat liver nucleoplasmic protein##3##6##(1993-8#3)
70 kDa##10##2##(1990-8#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1997-2#1)
70 kb##3##2##(1991-6#1)(2008-10#2)
70 mJ##2##2##(2007-12#1)(2008-3#1)
70 mg##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
70 mg/kg##4##2##(2008-9#4)
70 mg/m2##2##2##(1991-5#1)(1992-12#1)
70 microM##2##2##(1994-8#1)(1996-12#1)
70 min##3##2##(1990-8#1)(1993-12#1)(1994-9#1)
70 mothers##2##2##(2011-1#2)
70 mug##3##2##(2008-10#3)
70 ng l(-1)##2##3##(2008-10#2)
70 ng##3##2##(2008-10#3)
70 ng/ml##2##2##(2007-8#1)(2008-5#1)
70 nm##2##2##(2008-3#1)(2008-8#1)
70 on the Karnofski scale##2##5##(2008-1#2)
70 on the##4##3##(2008-1#3)(2010-6#1)
70 patients##6##2##(1990-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)
70 percent of the##2##4##(1994-2#1)(1995-3#1)
70 percent of##3##3##(1994-2#1)(1995-3#1)(1996-3#1)
70 percent##5##2##(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(2010-8#1)
70 protein##3##2##(1995-6#1)(2008-10#1)(2010-12#1)
70 samples##3##2##(2008-10#2)(2009-4#1)
70 scientists##2##2##(2008-5#2)
70 to 0##2##3##(2008-10#1)(2008-5#1)
70 to 79##2##3##(2008-7#1)(2013-1#1)
70 to 80##2##3##(1992-8#1)(2008-5#1)
70 to 90##2##3##(1992-2#1)(1995-6#1)
70 to##16##2##(1992-2#1)(1992-8#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
70 wards were included##2##4##(2013-1#2)
70 were##2##2##(1990-9#1)(2008-10#1)
70 years ago##2##3##(2008-10#2)
70 years and##5##3##(1993-12#1)(1996-3#1)(1996-9#1)(2008-7#2)
70 years of age##4##4##(2008-1#1)(2008-7#2)(2009-7#1)
70 years old##3##3##(1990-6#1)(2008-1#1)(2008-7#1)
70 years##25##2##(1990-12#1)(1990-6#1)(1993-12#1)(1996-3#1)(1996-9#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#6)(2009-7#1)(2011-2#3)
70 ± 0##3##3##(2010-11#1)(2010-9#1)(2013-1#1)
70##405##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#1)(1993-8#5)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#9)(1995-2#3)(1995-3#3)(1995-6#2)(1996-12#1)(1996-3#3)(1996-5#2)(1996-9#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-7#1)(2007-8#6)(2008-1#13)(2008-10#96)(2008-11#8)(2008-12#6)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#12)(2008-6#6)(2008-7#17)(2008-8#8)(2008-9#8)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#2)
70% (w/w)##2##2##(2008-10#2)
70% and##7##2##(1994-9#2)(1997-7#1)(2008-5#2)(2008-6#1)(2011-2#1)
70% at##5##2##(1992-6#1)(1997-6#1)(2008-3#1)(2008-7#1)(2012-2#1)
70% decrease in##2##3##(1992-12#1)(1994-11#1)
70% ethanol##4##2##(2008-10#1)(2008-5#1)(2013-8#2)
70% for##2##2##(2008-6#1)(2008-8#1)
70% had##3##2##(1990-9#1)(1996-8#1)(2012-2#1)
70% higher than##2##3##(2008-11#1)(2008-3#1)
70% identical to##2##3##(1994-9#1)(1995-6#1)
70% identical##3##2##(1991-9#1)(1994-9#1)(1995-6#1)
70% in##3##2##(1991-4#1)(1996-1#1)(2007-11#1)
70% of all##3##3##(1996-1#1)(2008-4#1)(2012-12#1)
70% of cases##2##3##(2012-2#1)(2013-1#1)
70% of its##2##3##(1991-5#1)(2013-1#1)
70% of oxygen uptake reserve##3##5##(2013-8#3)
70% of patients##2##3##(2008-4#1)(2008-7#1)
70% of the total##2##4##(2007-5#1)(2008-10#1)
70% of the##29##3##(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2013-1#1)
70% of##63##2##(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-4#3)(2008-7#3)(2008-8#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#3)
70% reduction##2##2##(1995-2#1)(1997-2#1)
70% relative humidity##2##3##(2008-10#1)(2008-5#1)
70% reported##2##2##(1993-1#1)(2009-5#1)
70% were##2##2##(2008-10#2)
70%##175##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#2)(2009-5#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#7)
70%) of##2##2##(2008-10#1)(2013-8#1)
70%) were##2##2##(2007-10#1)(2013-8#1)
70%)##10##1##(2007-10#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#2)
70's##2##1##(1990-6#1)(2013-1#1)
70) and##6##2##(1995-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
70)##17##1##(1990-3#1)(1993-9#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-9#1)(2007-5#1)(2008-1#1)(2008-10#4)(2012-2#1)(2012-3#2)(2013-1#1)
70+/-0##3##1##(2008-10#2)(2008-11#1)
70-##2##1##(2008-12#1)(2011-1#1)
70-100##2##1##(1996-11#1)(2008-2#1)
70-110##2##1##(1990-3#1)(2008-12#1)
70-5##2##1##(2008-10#1)(2011-2#1)
70-80% of the##2##3##(1990-5#1)(1997-5#1)
70-80% of##6##2##(1990-5#1)(1994-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2013-1#1)
70-80%##10##1##(1990-11#1)(1990-5#1)(1994-3#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2013-1#1)
70-85%##3##1##(1990-11#1)(1994-9#1)(2008-3#1)
70-fold##4##1##(1993-12#1)(1994-8#1)(1996-3#1)(2008-10#1)
70-fs##2##1##(2007-11#1)(2007-12#1)
70-kDa protein##2##2##(1993-6#1)(1995-11#1)
70-kDa##3##1##(1993-6#1)(1994-8#1)(1995-11#1)
70-year-old female##2##2##(1993-6#1)(2013-1#1)
70-year-old woman##5##2##(1991-12#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
70-year-old##12##1##(1991-12#1)(1992-2#1)(1993-6#1)(2008-12#3)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
70-years old##2##2##(2011-2#1)(2013-8#1)
70/30 ethanol/water##4##2##(2009-9#4)
700 and##2##2##(2008-10#1)(2008-3#1)
700 cm(-1)##3##2##(2008-10#2)(2008-2#1)
700 degrees C##3##3##(2008-10#2)(2008-3#1)
700 in##2##2##(1991-11#1)(2008-3#1)
700 kDa##2##2##(2008-10#1)(2008-6#1)
700 mg/L females were less##2##5##(2008-9#2)
700 mg/L females were significantly greater than those in the control##2##11##(2008-9#2)
700 mg/L females were##5##4##(2008-9#5)
700 mg/L females##6##3##(2008-9#6)
700 mg/L males were significantly##5##5##(2008-9#5)
700 mg/L males were##8##4##(2008-9#8)
700 mg/L males##11##3##(2008-9#11)
700 mg/L##23##2##(2008-9#23)
700 mg/kg to##2##3##(2008-9#2)
700 microm##2##2##(2007-12#1)(2008-2#1)
700 nm##9##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)
700##81##1##(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-9#2)(1994-8#1)(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#26)(2010-3#1)(2012-12#1)(2013-1#2)
700-MHz##2##1##(2007-12#1)(2011-1#1)
700-bp##3##1##(1991-6#1)(1994-11#1)(2008-8#1)
700-mW##2##1##(2007-11#2)
700-nm##2##1##(2008-10#1)(2008-2#1)
7000##9##1##(1990-2#1)(1990-3#1)(1990-5#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-9#1)
700nm##5##1##(2008-10#5)
701##5##1##(1993-3#1)(1996-9#1)(2008-10#2)(2010-4#1)
702##2##1##(2008-10#1)(2011-2#1)
704 var##3##2##(2008-12#3)
704 variety were higher than 301 variety##2##7##(2008-12#2)
704 variety##3##2##(2008-12#3)
704##11##1##(1997-2#1)(2008-12#7)(2008-3#1)(2008-6#1)(2008-9#1)
7041##2##1##(2008-11#2)
705##3##1##(2008-10#2)(2011-2#1)
706##2##1##(1996-8#1)(2008-11#1)
706)##2##1##(1991-2#2)
707##4##1##(1997-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
707)##3##1##(1996-2#2)(2009-2#1)
708 secondary mutation##2##3##(1992-9#2)
708##3##1##(1991-12#1)(1992-9#2)
70K##2##1##(1991-6#1)(1993-9#1)
70S ribosomes##2##2##(1991-12#1)(1993-11#1)
70S##3##1##(1991-12#1)(1992-6#1)(1993-11#1)
70T01##11##1##(2008-10#11)
70V##3##1##(2007-12#1)(2008-10#2)
70ms##3##1##(2008-10#3)
70mugL(-1)##2##1##(2008-10#2)
70mum##2##1##(2007-12#1)(2008-10#1)
70th birthday##3##2##(1992-5#1)(1997-6#2)
70th##4##1##(1992-5#1)(1997-6#2)(2008-12#1)
71 %##2##2##(2012-12#2)
71 (EV71)##2##2##(2008-12#1)(2011-1#1)
71 +/-##8##2##(1990-5#1)(1991-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
71 and##3##2##(2008-12#1)(2008-8#1)(2013-7#1)
71 cm)##2##2##(2008-12#1)(2010-9#1)
71 degrees##2##2##(2008-12#1)(2008-5#1)
71 in##2##2##(2008-11#1)(2013-8#1)
71 months##2##2##(2008-6#1)(2009-3#1)
71 mum##2##2##(2007-12#1)(2008-2#1)
71 patients with##2##3##(2007-11#1)(2008-4#1)
71 patients##3##2##(2007-11#1)(2008-1#1)(2008-4#1)
71 to 3##2##3##(2007-12#1)(2008-5#1)
71 to##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)(2013-8#1)
71 years##4##2##(2007-8#1)(2008-7#1)(2010-4#1)(2012-2#1)
71##134##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-12#1)(1996-12#3)(1997-2#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#19)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#6)
71% and 57%##2##3##(1996-5#1)(2006-8#1)
71% and##5##2##(1996-5#1)(1997-2#1)(2006-8#1)(2010-8#1)(2013-8#1)
71% concordance##2##2##(1990-12#1)(2008-5#1)
71% in##3##2##(1993-1#1)(2008-10#1)(2008-12#1)
71% of the patients##2##4##(1994-6#1)(2007-8#1)
71% of the##7##3##(1992-11#1)(1994-6#1)(2007-8#1)(2008-10#4)
71% of##11##2##(1992-11#1)(1992-9#1)(1994-6#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2013-8#1)
71% with##2##2##(1990-9#1)(2008-9#1)
71%##47##1##(1990-12#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-6#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
71%) of##2##2##(2007-7#1)(2011-2#1)
71%)##9##1##(1997-4#1)(2007-7#2)(2008-10#1)(2008-12#2)(2011-2#1)(2013-8#2)
71)##8##1##(2007-6#1)(2008-12#2)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
71+/-0##5##1##(2008-10#4)(2008-8#1)
71-year-old male with##2##3##(2007-5#1)(2010-4#1)
71-year-old male##3##2##(2007-5#1)(2007-8#1)(2010-4#1)
71-year-old man with##2##3##(1992-12#1)(2013-1#1)
71-year-old##8##1##(1992-12#1)(1992-2#1)(1994-9#1)(2007-5#1)(2007-8#1)(2010-12#1)(2010-4#1)(2013-1#1)
710 nm##3##2##(2008-10#2)(2008-2#1)
710##6##1##(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#2)
7100##4##1##(1993-11#1)(2007-12#1)(2008-8#2)
711##4##1##(1994-12#1)(2007-11#1)(2008-5#2)
7117##2##1##(2008-3#2)
712##3##1##(2008-10#2)(2008-11#1)
713##6##1##(1990-9#1)(2008-10#4)(2011-2#1)
714##12##1##(1991-9#7)(1997-4#3)(2008-12#1)(2008-5#1)
715##4##1##(1990-9#1)(2008-5#1)(2013-1#2)
716##3##1##(2007-3#1)(2008-9#1)(2013-1#1)
717##3##1##(2008-10#2)(2008-5#1)
718 patients##2##2##(2011-2#2)
718##12##1##(1995-11#3)(1995-12#1)(1996-6#1)(2008-10#3)(2010-11#1)(2011-2#2)(2013-8#1)
7185##2##1##(2008-3#2)
719##2##1##(1990-2#1)(1997-3#1)
71V##2##1##(2008-10#2)
72 (2000)##2##2##(2008-10#2)
72 +/- 2##2##3##(1997-8#1)(2008-11#1)
72 +/-##4##2##(1993-12#1)(1997-8#1)(2007-7#1)(2008-11#1)
72 and##7##2##(1995-12#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-1#1)(2013-1#1)
72 cases##5##2##(1991-2#1)(1994-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
72 cm from the##2##4##(2008-10#2)
72 cm##3##2##(1994-9#1)(2008-10#2)
72 degrees##2##2##(1997-4#1)(2008-10#1)
72 h after inoculation##6##4##(2008-10#6)
72 h after##8##3##(2008-10#7)(2011-2#1)
72 h and##4##3##(1992-8#1)(1995-2#1)(2008-10#1)(2008-12#1)
72 h following##3##3##(1992-8#1)(1996-12#1)(2008-10#1)
72 h in##2##3##(2008-10#1)(2008-9#1)
72 h of incubation##2##4##(2008-12#1)(2008-7#1)
72 h of##10##3##(1990-3#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
72 h post-infection##2##3##(1997-4#2)
72 h##56##2##(1990-3#1)(1991-12#1)(1991-9#1)(1992-8#2)(1993-11#1)(1993-12#2)(1995-11#2)(1995-2#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
72 h) was##2##3##(1993-6#2)
72 hours after##4##3##(1993-11#1)(1997-3#1)(2008-8#1)(2013-1#1)
72 hours and##3##3##(2007-10#1)(2010-1#1)(2011-3#1)
72 hours of##3##3##(2007-10#1)(2013-1#2)
72 hours##18##2##(1990-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-11#1)(1997-3#1)(2007-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-3#1)(2013-1#5)
72 hr##6##2##(1994-8#1)(2008-2#1)(2008-5#1)(2008-8#2)(2012-12#1)
72 in##3##2##(1992-2#1)(1995-5#1)(2007-11#1)
72 isolates##3##2##(2008-10#3)
72 kD##2##2##(1995-5#1)(2008-5#1)
72 months##2##2##(1992-5#1)(1995-1#1)
72 patients##4##2##(1992-5#1)(1997-8#1)(2008-7#1)(2013-1#1)
72 proteins##2##2##(1996-8#1)(1997-2#1)
72 to 0##2##3##(2008-10#2)
72 to##5##2##(1992-12#1)(2008-10#3)(2010-11#1)
72 years##3##2##(1993-8#1)(1997-8#1)(2011-2#1)
72 ±##2##2##(2012-3#2)
72##268##1##(1990-3#1)(1990-5#1)(1990-6#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#3)(1993-6#3)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#2)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#4)(2007-11#2)(2007-12#3)(2007-7#3)(2008-1#1)(2008-10#54)(2008-11#3)(2008-12#11)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#5)(2009-1#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#15)(2013-8#4)
72% and##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
72% at##2##2##(2008-10#1)(2008-5#1)
72% identity##2##2##(1993-11#1)(2008-10#1)
72% in##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
72% of the patients##2##4##(1992-4#1)(1997-2#1)
72% of the##4##3##(1992-4#1)(1997-2#1)(2007-11#1)(2008-10#1)
72% of##7##2##(1992-1#1)(1992-4#1)(1997-2#1)(2007-11#1)(2008-10#1)(2013-1#2)
72%##40##1##(1990-10#1)(1990-12#2)(1992-1#1)(1992-4#1)(1993-11#1)(1993-5#1)(1994-2#1)(1996-2#1)(1996-6#1)(1997-2#3)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
72%)##2##1##(2007-7#1)(2013-1#1)
72)##12##1##(1996-8#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
72+/-0##2##1##(2008-10#2)
72-h hydrolysis of the SPCS substrate##2##6##(2011-2#2)
72-h##7##1##(1995-12#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#2)
72-kDa##4##1##(1992-2#1)(1992-6#1)(1992-9#1)(1993-6#1)
72-year-old man##4##2##(2007-12#1)(2008-12#1)(2010-6#1)(2011-2#1)
72-year-old##13##1##(1997-7#1)(2007-12#1)(2007-8#1)(2008-12#2)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#1)
720 mg/liter##3##2##(2008-10#3)
720 nm##2##2##(2007-11#1)(2008-2#1)
720##14##1##(1990-12#1)(1991-8#1)(1992-12#1)(1996-9#1)(2007-11#1)(2008-10#7)(2008-2#1)(2013-1#1)
721##5##1##(1990-5#1)(1993-11#1)(1995-11#1)(2011-2#1)(2011-3#1)
722##3##1##(1996-5#2)(2008-10#1)
723##10##1##(2008-10#3)(2008-3#4)(2011-2#1)(2012-2#1)(2013-8#1)
7233##2##1##(2008-12#2)
724##2##1##(2007-11#1)(2011-1#1)
725##7##1##(2008-10#3)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
726##4##1##(1994-2#1)(2010-11#1)(2011-1#1)(2011-2#1)
727##5##1##(1994-11#1)(1996-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
727)##2##1##(2008-10#1)(2012-2#1)
727-736##2##1##(2008-3#1)(2008-7#1)
728##6##1##(2008-10#1)(2008-11#1)(2011-3#1)(2012-12#1)(2013-8#2)
729##2##1##(2008-9#1)(2011-2#1)
72h##3##1##(1991-9#1)(2012-2#1)(2013-1#1)
72mugl(-1)##2##1##(2008-10#2)
73 (2##2##2##(2008-10#1)(2013-1#1)
73 (2001) 4301'##2##3##(2008-10#2)
73 (2001)##3##2##(2008-10#3)
73 (95%##2##2##(2012-12#1)(2013-1#1)
73 +/-##3##2##(2008-1#1)(2008-10#1)(2010-8#1)
73 -##3##2##(2007-12#1)(2008-11#1)(2011-1#1)
73 amino##2##2##(1990-5#1)(1994-11#1)
73 and 1##2##3##(2008-10#1)(2008-12#1)
73 and##6##2##(2008-10#3)(2008-12#2)(2013-1#1)
73 cases of##2##3##(1991-11#1)(2013-1#1)
73 cases##3##2##(1991-11#1)(2007-11#1)(2013-1#1)
73 for##2##2##(2008-10#2)
73 in##2##2##(1992-2#1)(1994-11#1)
73 kDa##3##2##(1992-8#1)(1993-6#1)(1993-8#1)
73 mW##2##2##(2007-12#1)(2008-3#1)
73 microm##2##2##(2007-12#2)
73 patients##2##2##(1991-11#1)(2007-8#1)
73 percent##2##2##(1993-12#1)(1995-3#1)
73 to##5##2##(1993-12#1)(2008-10#4)
73 was##2##2##(2007-12#1)(2008-10#1)
73##154##1##(1990-11#1)(1990-5#1)(1991-11#5)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#34)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#7)(2008-6#4)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-12#4)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#11)(2013-8#5)
73% and 74%##2##3##(1992-9#1)(2008-6#1)
73% and##8##2##(1990-10#1)(1992-9#1)(1994-2#1)(1994-9#1)(2008-6#1)(2008-7#1)(2011-2#2)
73% for##4##2##(1993-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
73% in##3##2##(1997-2#1)(2008-10#2)
73% nucleotide identity and##2##4##(1993-3#1)(2008-10#1)
73% of the##7##3##(1992-9#1)(2007-7#1)(2008-10#3)(2008-12#1)(2012-2#1)
73% of##14##2##(1991-4#1)(1992-9#2)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-9#1)(2012-2#1)
73% were##2##2##(2008-3#1)(2009-10#1)
73%##53##1##(1990-10#1)(1991-4#1)(1992-11#1)(1992-9#3)(1993-3#2)(1993-5#1)(1993-8#1)(1994-2#2)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
73%)##7##1##(1991-2#1)(1993-8#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-9#1)(2013-1#1)
73) and##2##2##(2008-10#1)(2008-9#1)
73)##14##1##(1990-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#2)
73-kDa A subunit##2##3##(1995-6#2)
73-year-old man##3##2##(2008-7#1)(2013-1#2)
73-year-old##6##1##(2007-12#1)(2008-7#2)(2010-6#1)(2013-1#2)
730 nm##2##2##(2008-10#1)(2008-2#1)
730##8##1##(1994-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-1#1)
731##5##1##(2010-3#1)(2011-2#3)(2013-8#1)
732##6##1##(1991-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
734##2##1##(2008-10#1)(2011-2#1)
735##7##1##(2008-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
736##2##1##(2011-1#1)(2012-3#1)
739##2##1##(1994-2#1)(2012-12#1)
74 +/- 0##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2009-11#1)
74 +/-##5##2##(1992-3#1)(2008-10#2)(2008-5#1)(2009-11#1)
74 and##6##2##(1993-1#1)(1996-12#1)(2008-10#3)(2012-7#1)
74 kDa##2##2##(1992-10#1)(1995-11#1)
74 markers##4##2##(1996-12#3)(1997-5#1)
74 microm##2##2##(2008-3#2)
74 months##2##2##(1993-9#1)(2008-1#1)
74 patients with##2##3##(1991-4#1)(2011-2#1)
74 patients##3##2##(1991-4#1)(2011-2#1)(2013-7#1)
74 to##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
74 were##2##2##(2007-7#1)(2011-2#1)
74 years##3##2##(1991-9#1)(2008-7#1)(2010-12#1)
74##131##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-3#2)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#1)
74% and##3##2##(1994-12#1)(2007-12#1)(2011-2#1)
74% in##3##2##(1996-9#1)(2008-10#2)
74% of the##5##3##(1992-8#1)(2008-10#1)(2008-6#1)(2009-12#1)(2013-1#1)
74% of##10##2##(1992-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-12#1)(2010-3#1)(2013-1#1)
74% were##2##2##(1996-9#1)(2010-1#1)
74%##41##1##(1991-4#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-9#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#3)(2008-7#1)(2009-12#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
74%)##4##1##(1990-3#1)(1994-11#1)(2008-10#1)(2011-2#1)
74) and##2##2##(2008-12#1)(2009-4#1)
74)##7##1##(1997-2#1)(1997-8#1)(2008-12#1)(2009-4#1)(2012-2#1)(2012-4#2)
74+/-0##2##1##(2008-10#2)
74-year-old male##2##2##(2010-6#1)(2013-1#1)
74-year-old man##2##2##(1990-11#1)(2011-2#1)
74-year-old woman##4##2##(2009-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
74-year-old##9##1##(1990-11#1)(2009-1#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
740##12##1##(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#2)
740nm##2##1##(2008-10#2)
743##5##1##(2008-10#1)(2008-5#1)(2011-1#2)(2012-1#1)
744##3##1##(1991-11#1)(2008-10#1)(2012-3#1)
745 bp##2##2##(1997-6#1)(1997-7#1)
745 cm(-1)##2##2##(2008-10#2)
745 individuals##2##2##(2008-5#1)(2013-8#1)
745##9##1##(1997-6#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-5#1)(2012-12#1)(2013-8#1)
746##7##1##(1991-12#2)(1991-3#1)(1991-9#1)(2007-11#1)(2008-10#2)
747 bp##2##2##(1990-8#1)(2011-2#1)
747##7##1##(1990-8#1)(1997-7#1)(2008-10#3)(2008-7#1)(2011-2#1)
748##4##1##(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
749##2##1##(2008-3#1)(2009-4#1)
74M913 was##2##2##(2008-10#2)
75 % of##2##3##(2012-12#1)(2013-1#1)
75 %##5##2##(2008-8#1)(2012-12#3)(2013-1#1)
75 +/- 0##3##3##(1994-5#1)(1997-2#2)
75 +/-##13##2##(1991-11#1)(1991-6#1)(1994-5#1)(1995-12#1)(1997-2#2)(2007-9#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-6#1)(2010-7#2)
75 Gy##3##2##(2008-6#2)(2011-2#1)
75 and 0##2##3##(2008-10#2)
75 and 1##2##3##(2008-12#1)(2011-2#1)
75 and 90%##2##3##(2008-10#2)
75 and##25##2##(1993-11#1)(1997-4#1)(1997-9#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
75 cases##2##2##(1994-12#1)(2007-8#1)
75 cm##2##2##(2008-10#2)
75 days##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
75 degrees C##5##3##(2008-10#1)(2008-3#2)(2008-6#2)
75 degrees##11##2##(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-8#1)(2013-1#1)
75 females)##2##2##(1993-6#1)(2013-1#1)
75 for##2##2##(1992-11#1)(2007-10#1)
75 fs##3##2##(2007-11#2)(2007-12#1)
75 kDa (pig) and 78 kDa (rat)##2##7##(1992-8#2)
75 kDa##12##2##(1990-8#2)(1992-8#3)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#3)
75 m##2##2##(2008-2#1)(2008-3#1)
75 mg l(-1)##2##3##(2008-10#2)
75 mg##8##2##(1991-11#2)(2008-10#3)(2008-11#2)(2008-5#1)
75 mg/kg##2##2##(1994-2#1)(2008-9#1)
75 mg/m(2)##3##2##(2008-6#2)(2009-4#1)
75 microM##5##2##(1992-3#1)(1993-6#2)(1994-8#1)(1997-2#1)
75 microm##2##2##(1994-9#1)(2008-10#1)
75 mm##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2013-1#1)
75 mug##3##2##(2008-10#3)
75 mum##2##2##(2008-10#2)
75 ng##4##2##(2008-10#3)(2013-8#1)
75 of##3##2##(1990-11#1)(1994-9#1)(2008-5#1)
75 or##4##2##(1992-9#1)(1997-7#1)(2008-10#1)(2008-8#1)
75 patients were##2##3##(1994-2#1)(2011-2#1)
75 patients with##3##3##(1990-9#1)(2007-7#1)(2011-2#1)
75 patients##9##2##(1990-12#1)(1990-9#1)(1994-2#1)(2007-7#2)(2011-2#3)(2012-2#1)
75 percent##4##2##(1994-12#1)(1996-9#1)(1997-3#2)
75 times##2##2##(2008-10#1)(2009-2#1)
75 to 0##3##3##(2008-3#1)(2013-1#2)
75 to##15##2##(1994-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
75 years is##2##3##(1990-9#1)(2008-4#1)
75 years of age##5##4##(1990-9#1)(2008-3#1)(2011-2#3)
75 years of##6##3##(1990-9#1)(2007-8#1)(2008-3#1)(2011-2#3)
75 years old##6##3##(1991-9#1)(1993-9#3)(2008-5#1)(2013-1#1)
75 years##25##2##(1990-9#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-9#3)(2007-11#1)(2007-8#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2011-2#4)(2013-1#1)
75##371##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#2)(1990-9#4)(1991-11#4)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#4)(1992-9#5)(1993-11#2)(1993-12#2)(1993-6#4)(1993-8#2)(1993-9#3)(1994-12#3)(1994-2#2)(1994-5#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#82)(2008-11#10)(2008-12#4)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#14)(2008-6#8)(2008-7#11)(2008-8#6)(2008-9#23)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#19)(2012-12#5)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#6)
75% (w/v) acetic acid##2##4##(2008-6#2)
75% (w/v)##3##2##(2008-6#3)
75% and the##2##3##(2008-10#2)
75% and##12##2##(1991-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#2)(2013-8#1)
75% ethanol##2##2##(2008-10#1)(2008-12#1)
75% for the##2##3##(1993-1#1)(1995-3#1)
75% for##7##2##(1990-6#1)(1993-1#1)(1995-3#1)(2008-11#1)(2008-8#1)(2012-1#2)
75% in##2##2##(1993-3#1)(2013-1#1)
75% of all##3##3##(1996-1#1)(2007-11#1)(2011-2#1)
75% of cases##2##3##(2008-1#1)(2013-1#1)
75% of patients##4##3##(1990-3#1)(1993-6#1)(2007-11#1)(2010-6#1)
75% of the cases##2##4##(1992-11#1)(2007-7#1)
75% of the patients##2##4##(1992-4#1)(1996-11#1)
75% of the women##2##4##(1995-8#1)(2013-1#1)
75% of the##16##3##(1992-11#1)(1992-12#1)(1992-4#1)(1995-8#1)(1996-11#1)(1997-3#1)(2007-7#1)(2008-10#3)(2008-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
75% of these##2##3##(2011-1#1)(2012-3#1)
75% of##48##2##(1990-3#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-11#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
75% or##2##2##(2009-12#1)(2011-2#1)
75% reduction##2##2##(2008-11#2)
75%##133##1##(1990-3#1)(1990-6#1)(1991-4#1)(1992-11#3)(1992-12#2)(1992-4#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#7)(2011-3#2)(2012-1#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
75%) and##2##2##(1995-5#1)(2013-8#1)
75%) by a##2##3##(1994-6#1)(1995-11#1)
75%) of##2##2##(2010-3#1)(2012-2#1)
75%)##22##1##(1991-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
75)##9##1##(1992-2#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-9#1)(2012-3#2)(2013-1#1)(2013-8#1)
75+/-0##3##1##(2008-10#1)(2008-7#1)(2013-7#1)
75-79##3##1##(1994-11#1)(2010-3#1)(2012-12#1)
75-80##2##1##(1996-3#1)(2008-10#1)
75-84##2##1##(1994-2#1)(2008-7#1)
75-85%##2##1##(1996-12#1)(1997-4#1)
75-kDa##3##1##(1994-2#2)(2008-10#1)
75-m##2##1##(2007-11#1)(2008-2#1)
75-percent clearance##2##2##(2010-8#2)
75-year##2##1##(2007-8#1)(2013-8#1)
75-year-old female patient##2##3##(2012-1#1)(2013-1#1)
75-year-old female##4##2##(1994-7#1)(2012-1#1)(2013-1#2)
75-year-old male##3##2##(2008-7#1)(2012-2#2)
75-year-old##11##1##(1991-11#1)(1991-8#1)(1994-7#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
750 nm##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
750 women##2##2##(1992-1#2)
750##32##1##(1992-1#2)(1996-12#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#4)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
7500##2##1##(2007-12#1)(2008-12#1)
751##6##1##(1992-12#1)(1992-9#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-12#1)
752##4##1##(1990-11#1)(1995-12#1)(2012-12#2)
753 and##2##2##(1991-5#1)(2011-2#1)
753##11##1##(1990-11#1)(1990-6#1)(1991-5#4)(1991-7#1)(2008-1#1)(2008-9#1)(2009-10#1)(2011-2#1)
754##5##1##(1993-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
7554/eLife##5##1##(2013-8#5)
756 and##2##2##(2013-1#2)
756##6##1##(2008-10#3)(2011-2#1)(2013-1#2)
757 and discrimination power from 0##2##6##(2013-1#2)
757##7##1##(1993-1#1)(1996-12#2)(2008-10#1)(2008-3#1)(2013-1#2)
758##2##1##(2010-8#1)(2011-3#1)
759##2##1##(1991-12#1)(2008-10#1)
75Ba0##2##1##(2008-3#2)
75mg/m2##2##1##(2008-10#2)
75min##2##1##(2008-10#2)
75mug##2##1##(2008-10#2)
75th anniversary of##2##3##(1997-3#1)(2007-8#1)
75th##4##1##(1997-3#1)(2007-11#1)(2007-8#1)(2013-1#1)
76 +/-##2##2##(1997-3#1)(2008-7#1)
76 and 0##3##3##(2008-10#2)(2008-5#1)
76 and##10##2##(1997-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2010-10#1)
76 degrees##2##2##(2008-3#1)(2012-2#1)
76 kDa##4##2##(1992-6#1)(1992-8#1)(2008-10#1)(2009-6#1)
76 patients with##2##3##(1991-8#1)(2011-2#1)
76 patients##7##2##(1990-8#1)(1991-8#1)(2007-7#1)(2011-2#4)
76 percent##2##2##(1994-1#1)(1996-1#1)
76 to##2##2##(2008-10#1)(2013-8#1)
76 women##2##2##(1990-6#1)(1995-2#1)
76 x##3##2##(2008-10#2)(2008-11#1)
76 years##4##2##(1991-2#1)(1992-9#1)(2008-11#1)(2008-12#1)
76##144##1##(1990-11#1)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#29)(2008-11#5)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#11)(2012-1#1)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#3)
76% and##3##2##(1997-2#1)(2008-7#1)(2012-3#1)
76% in##4##2##(1990-8#1)(2007-10#1)(2007-11#1)(2007-8#1)
76% of patients##3##3##(1992-5#1)(2007-10#1)(2009-3#1)
76% of the##4##3##(1992-3#1)(1994-11#1)(2007-8#1)(2008-7#1)
76% of##12##2##(1992-3#1)(1992-5#1)(1994-11#1)(1994-2#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-1#1)
76%##48##1##(1990-8#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
76%) had TSH levels between 4##2##6##(2012-3#2)
76%)##4##1##(2008-10#1)(2011-2#1)(2012-3#2)
76) had##2##2##(2008-6#1)(2011-1#1)
76)##6##1##(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#2)(2013-1#1)
760##8##1##(2008-10#4)(2008-2#1)(2008-3#3)
761##2##1##(1991-6#1)(1993-6#1)
762##4##1##(1990-7#1)(2008-10#1)(2008-8#1)(2010-6#1)
763##6##1##(1993-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)
765##8##1##(1991-5#1)(1994-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)
765-nm band##3##2##(2008-2#2)(2008-3#1)
765-nm##4##1##(2008-2#3)(2008-3#1)
766##2##1##(2007-12#1)(2008-10#1)
767##3##1##(2008-10#1)(2011-2#2)
7676 bp##2##2##(1996-6#2)
768##2##1##(2008-10#1)(2008-11#1)
769##6##1##(1993-2#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
77 %##2##2##(1997-8#1)(2008-5#1)
77 +/-##2##2##(2009-10#1)(2011-2#1)
77 K##13##2##(1993-11#1)(1994-8#1)(2007-12#2)(2008-10#2)(2009-11#3)(2010-2#4)
77 and##7##2##(1991-1#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2011-1#1)
77 microg l(-1)##2##3##(2008-10#2)
77 patients##5##2##(1994-2#1)(2007-8#1)(2011-2#1)(2013-1#2)
77 to 0##2##3##(2008-10#1)(2012-1#1)
77 to 1##2##3##(2007-12#2)
77 to##9##2##(1993-3#1)(1994-3#1)(2007-12#2)(2008-10#4)(2012-1#1)
77 x##3##2##(1990-8#1)(1991-12#1)(2008-10#1)
77 years##3##2##(1990-2#1)(2010-1#1)(2011-2#1)
77 ±##3##2##(2010-11#1)(2012-2#1)(2013-8#1)
77##153##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#4)(2008-1#3)(2008-10#34)(2008-11#3)(2008-12#6)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#3)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#4)(2010-7#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#10)(2013-7#1)(2013-8#2)
77% and##2##2##(1990-9#1)(2008-10#1)
77% identical to##2##3##(1992-10#2)
77% of the##5##3##(1991-2#1)(1991-6#1)(1992-12#1)(1997-6#1)(2008-10#1)
77% of##11##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-7#1)
77%##39##1##(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-9#2)(1997-6#1)(2008-10#13)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
77%)##3##1##(1995-12#1)(2008-12#1)(2013-1#1)
77) and##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
77)##14##1##(1990-5#1)(1994-12#1)(1996-12#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-1#1)(2013-1#3)
77-3##3##1##(2008-10#3)
77-year-old female##2##2##(2007-10#1)(2007-12#1)
77-year-old man##2##2##(2009-8#1)(2011-2#1)
77-year-old##8##1##(1993-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
770##12##1##(1990-11#1)(1990-3#1)(1992-12#1)(1992-9#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-2#2)(2008-8#1)(2012-12#1)(2013-1#1)
7700##3##1##(2008-10#1)(2008-4#1)(2011-2#1)
771##5##1##(1995-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
772##4##1##(1993-9#1)(1995-6#1)(2008-2#1)(2010-8#1)
773##3##1##(2008-3#1)(2009-12#1)(2010-12#1)
774##4##1##(1991-12#1)(2008-10#1)(2008-11#1)(2010-10#1)
775##2##1##(1990-3#1)(1997-7#1)
776##2##1##(2011-1#1)(2013-8#1)
777##3##1##(1994-11#1)(1997-6#1)(2009-3#1)
778 nm##3##2##(2007-11#1)(2007-12#2)
778##4##1##(1994-6#1)(2007-11#1)(2007-12#2)
779 (1998)]##2##2##(2008-2#1)(2008-3#1)
779##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
77K##2##1##(1990-5#1)(1995-6#1)
77]##2##1##(2007-8#1)(2008-11#1)
78 (95%##2##2##(2008-12#1)(2008-2#1)
78 +/- 0##2##3##(1991-5#1)(2008-10#1)
78 +/-##4##2##(1991-5#1)(2007-7#1)(2008-10#1)(2011-2#1)
78 - 0##2##3##(2008-3#1)(2008-7#1)
78 K##2##2##(1996-2#1)(2007-12#1)
78 and##6##2##(1990-12#1)(1993-12#1)(1994-12#1)(1997-7#1)(2011-1#1)(2013-7#1)
78 kDa##6##2##(1992-6#1)(1992-8#3)(1993-12#1)(1995-11#1)
78 mW at##2##3##(2007-12#1)(2008-3#1)
78 of##2##2##(1993-11#1)(2008-10#1)
78 patients with##2##3##(2007-8#1)(2011-2#1)
78 patients##8##2##(1991-3#1)(1994-7#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2011-2#1)
78 to 0##4##3##(2008-10#1)(2010-6#1)(2011-1#1)(2013-1#1)
78 to##7##2##(2008-10#2)(2008-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
78 women with##2##3##(2011-2#2)
78 ± 0##2##3##(2010-11#1)(2013-8#1)
78##160##1##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-12#4)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-7#1)(1995-11#3)(1995-2#4)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-7#1)(2007-11#4)(2007-12#3)(2007-7#3)(2007-8#4)(2008-1#4)(2008-10#27)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
78% and 71%##2##3##(2008-9#1)(2013-1#1)
78% and##7##2##(1993-2#1)(1997-7#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
78% for##2##2##(1990-12#1)(2008-10#1)
78% nucleotide identity##2##3##(2008-10#2)
78% of the##7##3##(1991-6#1)(1994-11#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-3#1)
78% of##10##2##(1991-6#1)(1992-9#1)(1994-11#1)(1996-9#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-3#1)(2013-8#1)
78%##48##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-11#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
78%)##6##1##(2007-11#1)(2008-10#2)(2008-12#2)(2008-9#1)
78) and##2##2##(2008-12#1)(2009-9#1)
78)##16##1##(1990-5#1)(1992-9#1)(1994-7#1)(1995-2#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
78-62##5##1##(2008-10#5)
78-GHz##3##1##(2007-11#3)
78-year-old man##3##2##(1990-8#1)(2010-12#1)(2011-2#1)
78-year-old##8##1##(1990-8#1)(1992-6#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
780 nm and a##2##4##(2008-2#1)(2008-3#1)
780 nm and##3##3##(2008-2#1)(2008-3#2)
780 nm##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
780##20##1##(1991-12#1)(1991-8#1)(2007-10#2)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#4)(2010-10#1)(2012-12#1)(2013-1#2)
780-nm##4##1##(2008-2#2)(2008-3#2)
780-nm-wavelength light##2##2##(2008-3#2)
781##3##1##(1991-2#1)(2008-10#1)(2009-7#1)
782 bp##2##2##(2011-2#2)
782##7##1##(1995-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)
783##2##1##(2011-1#1)(2011-2#1)
784##2##1##(2008-2#1)(2011-2#1)
785 nm was##2##3##(2007-11#1)(2008-3#1)
785 nm##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
785##9##1##(1993-6#1)(2007-11#1)(2008-2#2)(2008-3#3)(2010-8#1)(2011-1#1)
786##3##1##(1991-12#1)(2007-12#1)(2008-7#1)
787##2##1##(2007-11#1)(2008-3#1)
788##7##1##(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2013-8#1)
789##2##1##(2008-11#1)(2011-3#1)
78V##2##1##(2008-10#2)
79 +/-##6##2##(1991-6#1)(1992-11#1)(1997-1#1)(1997-3#1)(2008-1#1)(2010-8#1)
79 and 0##3##3##(1993-2#1)(2008-10#2)
79 and 80##2##3##(1991-5#1)(2008-9#1)
79 and##13##2##(1991-5#1)(1992-10#1)(1993-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)
79 degrees C##2##3##(2008-10#2)
79 degrees##3##2##(2008-10#2)(2008-2#1)
79 in##3##2##(2008-10#1)(2008-4#2)
79 is##2##2##(2008-10#1)(2008-4#1)
79 kDa##2##2##(1997-2#2)
79 patients##2##2##(2007-11#1)(2008-7#1)
79 percent##2##2##(2009-9#1)(2010-8#1)
79 to##4##2##(2008-10#4)
79##132##1##(1990-6#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#2)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#1)
79% and a##2##3##(1992-2#1)(1994-2#1)
79% and##3##2##(1991-6#1)(1992-2#1)(1994-2#1)
79% for##2##2##(2012-2#1)(2013-8#1)
79% of the total##2##4##(2008-1#1)(2008-12#1)
79% of the##8##3##(1992-2#1)(1993-2#1)(1995-6#1)(1996-9#1)(2008-1#1)(2008-12#1)(2011-1#1)(2013-8#1)
79% of##14##2##(1990-2#1)(1992-2#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-9#1)(2008-1#1)(2008-12#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
79%##34##1##(1990-2#1)(1991-6#2)(1992-10#1)(1992-2#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
79%)##5##1##(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)
79)##14##1##(1990-2#1)(1991-6#1)(2007-11#1)(2007-7#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
79+/-1##2##1##(2008-10#2)
79-0##2##1##(2008-10#1)(2008-12#1)
79-microm wavelength##2##2##(2008-3#2)
79-year-old##3##1##(2008-11#1)(2011-2#1)(2013-7#1)
790##5##1##(1997-7#1)(2007-12#2)(2010-9#1)(2011-2#1)
791 to##2##2##(2008-2#1)(2012-12#1)
791##7##1##(1990-2#1)(1990-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-7#1)(2012-12#1)
792##4##1##(2007-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
793##6##1##(1990-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
793/B isolates##3##2##(2008-5#3)
793/B##7##1##(2008-5#7)
795##6##1##(2007-11#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-7#1)
796##3##1##(1993-3#1)(1995-12#1)(2008-3#1)
798##3##1##(2008-3#1)(2011-2#1)(2012-12#1)
799##6##1##(2008-10#3)(2008-12#1)(2011-2#1)(2011-3#1)
799)##3##1##(1991-2#1)(2011-1#1)(2013-1#1)
7998##5##1##(2008-10#5)
799BglIIalpha-AE##2##1##(2008-11#2)
7A in##2##2##(2008-10#2)
7A of##3##2##(2008-10#3)
7A##13##1##(2008-10#10)(2008-5#3)
7B##2##1##(2008-10#1)(2008-5#1)
7CPB on##2##2##(2007-12#2)
7CPB##3##1##(2007-12#3)
7D of##2##2##(2008-10#2)
7D##12##1##(2008-10#6)(2008-11#2)(2008-5#4)
7DL##6##1##(2008-10#6)
7DS##8##1##(2008-10#8)
7M##3##1##(2008-10#3)
7MENT##4##1##(1990-11#4)
7NSK2##5##1##(2008-10#5)
7S##3##1##(1991-12#1)(1992-6#1)(2008-10#1)
7V (logic##2##2##(2008-10#2)
7V versus##2##2##(2008-10#2)
7V##4##1##(2008-10#4)
7]##5##1##(1990-5#1)(1990-9#1)(2008-10#3)
7a##2##1##(1992-3#2)
7cm##2##1##(2008-10#1)(2009-1#1)
7cm)##3##1##(2007-12#1)(2009-1#1)(2013-7#1)
7min##5##1##(2008-10#5)
7ml##2##1##(2008-10#2)
7muM##3##1##(2008-10#3)
7mugL(-1) for##2##2##(2008-10#2)
7mugL(-1)##3##1##(2008-10#3)
7mugml(-1)##2##1##(2008-10#2)
7nAChRs##2##1##(2007-8#2)
7ngg(-1) As in levender and rose oil##2##7##(2008-10#2)
7ngg(-1)##3##1##(2008-10#3)
7ngml(-1)##2##1##(2008-10#2)
7p##2##1##(1993-9#1)(1997-5#1)
7q and 14q##2##3##(1997-6#2)
7q##7##1##(1991-4#1)(1993-9#1)(1997-5#1)(1997-6#4)
7q11##2##1##(2008-12#2)
7s##6##1##(1993-8#5)(2008-10#1)
7th and 14th days##2##4##(1990-9#1)(2007-2#1)
7th and##3##2##(1990-9#1)(1991-9#1)(2007-2#1)
7th day##4##2##(1990-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
7th grade##2##2##(1994-5#1)(1996-6#1)
7th grades##2##2##(2009-7#1)(2013-7#1)
7th##26##1##(1990-9#2)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-8#1)(1994-5#1)(1996-6#1)(1997-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
7x10(-10)##3##1##(2008-10#2)(2008-7#1)
7x10(-4) M##2##2##(2008-10#2)
7x10(-5) M##2##2##(2008-10#2)
7x10(-9)##3##1##(2008-10#3)
7x10(3)##4##1##(2008-10#4)
7 cm##2##1##(2010-12#1)(2013-8#1)
7 days##4##1##(2011-1#3)(2011-2#1)
7 mg g(-1)##2##1##(2011-1#2)
7±0##2##1##(2013-1#2)
7±6##2##1##(2013-1#2)
7 days##2##1##(2012-4#1)(2012-7#1)
8 % of the##2##4##(2011-1#1)(2012-12#1)
8 % of##3##3##(2007-8#1)(2011-1#1)(2012-12#1)
8 %##9##2##(2007-8#1)(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
8 %)##4##2##(2010-5#1)(2011-2#1)(2012-12#2)
8 (1##4##2##(1993-12#2)(2008-7#2)
8 (36##2##2##(1995-12#1)(2007-10#1)
8 (6##4##2##(2008-3#2)(2011-2#2)
8 (95%##2##2##(1994-12#1)(2007-10#1)
8 (R##2##2##(2008-10#2)
8 (p##2##2##(2008-7#1)(2009-12#1)
8 (range##3##2##(1992-2#1)(2008-1#1)(2013-1#1)
8 + 0##2##3##(2008-12#2)
8 +##3##2##(1995-1#1)(2008-12#2)
8 +/- 0##14##3##(1991-9#3)(1993-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
8 +/- 1##10##3##(1992-2#1)(1992-3#1)(1995-12#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)
8 +/- 14##3##3##(1990-8#1)(1991-2#1)(1997-6#1)
8 +/- 17##2##3##(2007-7#1)(2008-1#1)
8 +/- 2##10##3##(1990-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-12#1)(2008-3#1)(2011-2#1)
8 +/- 3##5##3##(1993-2#1)(1994-2#1)(1997-2#1)(2008-5#1)(2012-3#1)
8 +/- 4##4##3##(1993-8#1)(2007-10#1)(2007-8#1)(2008-4#1)
8 +/- 5##2##3##(1997-6#1)(2008-10#1)
8 +/- 6##2##3##(1990-12#1)(2008-10#1)
8 +/- 7##3##3##(1991-9#1)(1993-1#1)(2008-8#1)
8 +/-##68##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-9#4)(1992-11#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-9#1)(1997-2#2)(1997-6#4)(2007-10#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-6#1)(2011-2#5)(2012-3#2)
8 ? 0##2##3##(2008-3#2)
8 A resolution##2##3##(1995-11#1)(1995-5#1)
8 A##10##2##(1992-3#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1997-7#1)(2008-8#1)
8 GPa##2##2##(2010-12#1)(2012-2#1)
8 Gy##2##2##(2008-10#1)(2010-3#1)
8 Kb##2##2##(1990-2#1)(1992-12#1)
8 M##6##2##(1991-9#1)(1993-6#1)(1995-5#1)(2008-10#1)(2009-7#2)
8 MHz##2##2##(1991-12#1)(2008-3#1)
8 MPa##2##2##(2009-7#1)(2010-4#1)
8 U/ml##2##2##(1993-1#2)
8 V##3##2##(2008-10#3)
8 W of##2##3##(2007-11#2)
8 W##5##2##(2007-11#2)(2007-12#1)(2008-10#2)
8 against##2##2##(2012-3#2)
8 amino acids##3##3##(1995-11#1)(1995-2#1)(1997-7#1)
8 and 0##7##3##(2008-10#5)(2008-12#1)(2011-1#1)
8 and 1##6##3##(1991-8#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
8 and 10##8##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#2)
8 and 11##2##3##(1993-8#1)(1995-8#1)
8 and 12##8##3##(1991-2#1)(1991-6#1)(1992-9#1)(2008-10#1)(2008-5#2)(2009-10#1)(2011-1#1)
8 and 12 weeks##2##3##(2011-2#2)
8 and 15##2##3##(1996-12#1)(2008-10#1)
8 and 18##2##3##(1991-5#1)(2013-1#1)
8 and 2##10##3##(1991-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)
8 and 20##2##3##(1990-12#1)(1991-5#1)
8 and 24##3##3##(1995-12#1)(2008-10#2)
8 and 28##2##3##(2008-12#2)
8 and 3##5##3##(1994-8#1)(2008-10#4)
8 and 37##2##3##(2008-11#1)(2008-8#1)
8 and 4##6##3##(1991-4#1)(1997-6#1)(2008-10#4)
8 and 5##3##3##(1992-8#1)(2008-10#1)(2013-8#1)
8 and 6##5##3##(2008-10#3)(2008-11#1)(2010-1#1)
8 and 7##3##3##(2008-10#2)(2013-1#1)
8 and 8##3##3##(1991-9#1)(2008-10#2)
8 and 9##9##3##(1990-6#1)(1996-12#4)(1997-8#1)(2008-10#2)(2008-7#1)
8 and 98##2##3##(2008-10#1)(2013-1#1)
8 and the##2##3##(1990-5#1)(2008-10#1)
8 and##141##2##(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#6)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#56)(2008-11#4)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#2)(2009-10#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#6)(2012-4#1)(2013-1#5)(2013-8#1)
8 are##4##2##(1997-8#1)(2007-12#1)(2008-2#1)(2008-4#1)
8 billion##2##2##(1991-1#1)(1992-12#1)
8 bp##2##2##(1995-8#2)
8 by##2##2##(2008-10#1)(2008-8#1)
8 cM##3##2##(1997-2#1)(2008-10#2)
8 cases and##3##3##(2007-11#1)(2007-7#1)(2013-1#1)
8 cases of##4##3##(1990-10#1)(2009-4#1)(2013-1#1)(2013-8#1)
8 cases##21##2##(1990-10#1)(1991-11#1)(1991-2#1)(1993-2#1)(1995-4#1)(1996-11#1)(2007-11#4)(2007-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#2)
8 children##4##2##(1990-6#1)(1991-8#1)(2007-11#1)(2013-7#1)
8 cm in##2##3##(1990-10#1)(2013-1#1)
8 cm##11##2##(1990-10#1)(1994-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#2)(2012-12#1)(2012-3#1)(2013-1#1)
8 cm(-)(1)##2##2##(1997-7#2)
8 cm(-1))##2##2##(2008-10#1)(2008-3#1)
8 cm)##2##2##(1993-9#1)(2008-12#1)
8 congeners##2##2##(2008-10#2)
8 d##2##2##(2007-5#1)(2011-2#1)
8 dB##6##2##(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
8 dB/0##2##2##(2010-8#2)
8 days after inoculation##4##4##(2008-10#4)
8 days after##9##3##(1992-8#1)(1996-2#1)(2008-10#6)(2008-7#1)
8 days at##2##3##(2008-10#1)(2008-12#1)
8 days postlesion##2##3##(1997-3#2)
8 days##34##2##(1991-11#1)(1992-8#1)(1994-2#2)(1994-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)
8 degrees C##15##3##(1991-8#1)(1993-8#2)(1997-7#1)(2007-12#1)(2008-10#9)(2009-10#1)
8 degrees C) is##2##4##(2007-11#2)
8 degrees C)##4##3##(2007-11#2)(2008-10#2)
8 degrees##29##2##(1991-8#1)(1992-4#1)(1993-8#2)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#12)(2008-12#1)(2008-3#5)(2008-5#1)(2009-10#1)
8 different##2##2##(2008-12#1)(2008-4#1)
8 exons##2##2##(1996-8#1)(2008-9#1)
8 expression in##2##3##(2008-8#1)(2012-3#1)
8 expression##3##2##(2008-8#1)(2012-3#2)
8 expressions##2##2##(2012-3#2)
8 fmol for##2##3##(2008-10#2)
8 fold##2##2##(1990-8#1)(1993-12#1)
8 for##10##2##(1990-9#1)(1993-12#1)(1993-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(2008-10#3)(2012-1#1)
8 from##2##2##(2008-10#2)
8 g l(-1)##2##3##(2008-10#1)(2008-11#1)
8 g sucrose·kg-1·h-1##2##3##(2013-1#2)
8 g##7##2##(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#2)
8 g)##2##2##(1993-12#1)(2009-9#1)
8 g/L##3##2##(2008-6#2)(2008-7#1)
8 h after a single GH injection##3##7##(1995-12#3)
8 h after the##2##4##(1992-10#1)(2008-10#1)
8 h after##9##3##(1990-2#1)(1992-10#1)(1995-12#4)(1995-3#1)(2008-10#2)
8 h or##2##3##(2008-10#2)
8 h post-infection in##2##4##(1996-12#2)
8 h post-mortem with##2##4##(2008-7#2)
8 h with##4##3##(1995-11#1)(2008-10#1)(2008-7#2)
8 h##41##2##(1990-2#1)(1992-10#1)(1992-8#1)(1995-11#1)(1995-12#4)(1995-3#1)(1996-12#2)(1996-2#2)(1996-7#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#6)(2009-12#1)(2009-6#1)(2011-1#2)(2013-8#1)
8 had a##2##3##(2012-2#1)(2013-1#1)
8 had##4##2##(1995-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
8 has been##2##3##(1996-5#2)
8 hours##8##2##(1990-6#1)(1992-12#1)(1994-9#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
8 hrs##4##2##(1993-8#1)(2013-1#3)
8 in the##4##3##(1993-8#1)(1996-12#1)(2008-3#1)(2008-7#1)
8 in##12##2##(1990-2#1)(1993-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
8 isolates from##3##3##(2008-10#3)
8 isolates##4##2##(2008-10#3)(2011-1#1)
8 kDa protein##2##3##(1990-7#2)
8 kDa##9##2##(1990-12#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#1)
8 kDa)##2##2##(2008-10#2)
8 kHz##2##2##(2007-12#2)
8 kb DNA##2##3##(1992-3#1)(2008-8#1)
8 kb of DNA##2##4##(1991-6#1)(1993-12#1)
8 kb on the 3' side##2##6##(1993-12#1)(1993-6#1)
8 kb##17##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1995-12#1)(1996-10#2)(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#2)
8 kb)##3##2##(1992-12#1)(1994-11#1)(2008-11#1)
8 kcal/mol##4##2##(1996-2#1)(2008-11#1)(2012-12#2)
8 kcal/mol)##2##2##(1993-8#2)
8 kg##6##2##(1994-3#1)(2008-12#1)(2008-4#1)(2008-5#3)
8 kg)##2##2##(2007-8#1)(2009-1#1)
8 l##2##2##(2008-10#2)
8 m##2##2##(2007-11#1)(2008-3#1)
8 m)##2##2##(2008-3#1)(2009-8#1)
8 mA##2##2##(2007-11#1)(2008-10#1)
8 mM##6##2##(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2009-12#1)
8 mV##2##2##(2008-10#1)(2009-12#1)
8 mW of##2##3##(2007-11#1)(2007-12#1)
8 mW##4##2##(2007-11#1)(2007-12#3)
8 mean years follow-up##2##4##(2008-4#2)
8 mg l(-1) of##4##4##(2008-10#4)
8 mg l(-1)##8##3##(2008-10#8)
8 mg of##2##3##(2008-10#2)
8 mg##19##2##(1997-2#1)(2008-10#12)(2008-12#3)(2011-2#2)(2013-8#1)
8 mg)##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
8 mg/dL##2##2##(2008-5#1)(2011-1#1)
8 mg/kg##7##2##(1991-6#1)(1991-7#1)(1995-3#2)(1996-2#1)(1996-5#1)(2008-7#1)
8 mg/kg)##5##2##(1991-7#3)(2006-6#2)
8 mg/l##2##2##(2007-7#2)
8 mgl(-1)##2##2##(2008-10#1)(2008-11#1)
8 microM##5##2##(1990-2#1)(1990-5#1)(1992-6#1)(1995-3#1)(1995-8#1)
8 microM)##2##2##(1994-8#1)(1995-6#1)
8 microg of##3##3##(2008-10#1)(2009-5#2)
8 microg##6##2##(2008-10#1)(2008-12#1)(2009-5#2)(2010-5#1)(2011-3#1)
8 microg/ml##2##2##(2008-10#1)(2008-5#1)
8 microm##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
8 microns s-1##2##3##(1993-9#2)
8 million##6##2##(1991-3#1)(1992-5#1)(1994-3#1)(1997-2#1)(2008-11#1)(2009-9#1)
8 min##10##2##(1993-12#1)(1996-1#1)(2008-10#8)
8 ml min(-1)##6##3##(2008-10#6)
8 ml of##2##3##(2008-10#2)
8 ml##11##2##(1997-8#1)(2008-10#10)
8 mm in diameter##2##4##(2008-5#1)(2008-8#1)
8 mm in##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)
8 mm respectively##2##3##(2013-1#2)
8 mm x##2##3##(2008-3#2)
8 mm##27##2##(1991-2#1)(1995-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#6)(2013-8#1)
8 mm)##4##2##(1990-7#1)(2008-3#1)(2008-9#1)(2013-1#1)
8 mmHg##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
8 mmHg)##2##2##(2008-5#1)(2008-7#1)
8 mmol##5##2##(1991-12#1)(2008-10#3)(2008-11#1)
8 mmol/l##2##2##(1991-6#1)(2008-7#1)
8 mol l(-1) NaCl medium##2##5##(2008-10#2)
8 mol of##2##3##(1990-2#1)(1994-9#1)
8 mol##6##2##(1990-2#1)(1994-9#1)(2007-12#2)(2008-10#2)
8 mol/L##2##2##(2008-4#1)(2008-9#1)
8 months (range##3##3##(2008-3#1)(2008-6#1)(2012-3#1)
8 months after##5##3##(1990-8#1)(1995-4#1)(2007-11#1)(2008-10#1)(2008-7#1)
8 months and##2##3##(1990-2#1)(2010-3#1)
8 months of##4##3##(1992-1#1)(2008-10#1)(2008-9#2)
8 months##44##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-4#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#4)(2009-6#1)(2010-3#3)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
8 months)##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
8 muM##2##2##(2008-11#2)
8 muM)##2##2##(2008-10#1)(2008-8#1)
8 mug l(-1) for##2##4##(2008-10#2)
8 mug l(-1)##7##3##(2008-10#7)
8 mug ml(-1)##7##3##(2008-10#7)
8 mug##17##2##(2008-10#16)(2008-5#1)
8 mug/ml for##2##3##(2008-10#1)(2008-5#1)
8 mugml(-1)##2##2##(2008-10#2)
8 mum##14##2##(1992-2#3)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#2)(2008-6#1)
8 nM##2##2##(1995-3#1)(2008-6#1)
8 nM)##5##2##(1993-11#1)(1993-8#1)(1994-3#1)(1996-12#1)(2008-10#1)
8 ng l(-1)##2##3##(2008-10#2)
8 ng ml(-1)##4##3##(2008-10#4)
8 ng##11##2##(1996-12#1)(2008-10#10)
8 ng/ml##3##2##(1990-2#1)(1992-11#1)(2013-1#1)
8 nm and approximately 5##2##5##(2008-10#1)(2008-3#1)
8 nm and the##2##4##(2009-11#1)(2013-8#1)
8 nm and##7##3##(2008-10#2)(2008-3#3)(2009-11#1)(2013-8#1)
8 nm is also##2##4##(2007-12#2)
8 nm to##2##3##(2008-10#1)(2008-2#1)
8 nm##28##2##(2007-11#3)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#5)(2009-11#1)(2013-8#4)
8 nm)##7##2##(2008-2#1)(2008-3#5)(2010-5#1)
8 nmol##2##2##(1997-6#1)(2008-10#1)
8 of 9##2##3##(1994-9#1)(2009-11#1)
8 of the##5##3##(1993-2#1)(1993-8#1)(1995-3#1)(1996-2#1)(2012-2#1)
8 of them##2##3##(1990-6#1)(2007-11#1)
8 of these##2##3##(1991-2#1)(1991-8#1)
8 of##27##2##(1990-6#1)(1991-2#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-7#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-2#2)
8 on a scale of 0-10##2##6##(2013-1#2)
8 on##3##2##(1990-8#1)(2013-1#2)
8 optical##2##2##(2008-2#1)(2008-3#1)
8 or##8##2##(2007-11#2)(2008-10#3)(2008-7#1)(2008-8#1)(2010-8#1)
8 other##2##2##(1991-4#1)(1995-11#1)
8 out of##5##3##(1990-8#1)(1991-5#1)(1992-9#1)(2009-8#1)(2013-1#1)
8 out##6##2##(1990-8#1)(1991-5#1)(1992-9#1)(1997-3#1)(2009-8#1)(2013-1#1)
8 parts in##2##3##(2007-12#1)(2008-3#1)
8 patients had##2##3##(1994-12#1)(2010-3#1)
8 patients were##2##3##(1997-8#1)(2011-2#1)
8 patients with##2##3##(1991-11#1)(1991-5#1)
8 patients##26##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1994-12#1)(1996-3#1)(1996-7#1)(1997-8#2)(2007-11#4)(2007-7#1)(2008-7#2)(2010-3#2)(2011-2#2)(2013-1#1)
8 per cent##3##3##(1990-6#2)(1992-5#1)
8 per##5##2##(1990-6#2)(1991-11#1)(1992-5#1)(2010-3#1)
8 percent of##3##3##(1992-2#1)(1993-2#2)
8 percent##9##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
8 pg##4##2##(2008-10#3)(2011-3#1)
8 pg/ml##2##2##(1994-7#1)(2011-2#1)
8 phosphate##2##2##(2010-3#2)
8 pixels##2##2##(2008-3#2)
8 ppm##2##2##(1990-8#1)(2008-5#1)
8 respectively##2##2##(1996-12#1)(2008-9#1)
8 sec)##2##2##(2007-10#2)
8 somatic mutations##2##3##(2008-2#2)
8 through##2##2##(1994-12#1)(2007-12#1)
8 times for##2##3##(1995-6#2)
8 times in##2##3##(2010-12#2)
8 times##11##2##(1993-6#1)(1994-5#1)(1995-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)
8 to 1##3##3##(2007-8#1)(2008-10#2)
8 to 10 days##2##4##(2008-10#1)(2012-12#1)
8 to 10##6##3##(2008-10#4)(2008-3#1)(2012-12#1)
8 to 100##2##3##(2008-10#2)
8 to 12##5##3##(1994-12#1)(1994-8#1)(2007-12#1)(2008-10#1)(2009-9#1)
8 to 15##2##3##(1993-2#1)(2010-1#1)
8 to 16##4##3##(1991-12#1)(2008-10#2)(2008-2#1)
8 to 17##2##3##(2008-10#1)(2008-12#1)
8 to 42##2##3##(2008-10#1)(2010-8#1)
8 to 5##2##3##(2008-10#2)
8 to 7##4##3##(1995-3#1)(1997-7#1)(2006-10#1)(2008-6#1)
8 to 81##2##3##(2007-10#1)(2008-10#1)
8 to 98##2##3##(2008-10#2)
8 to##63##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#2)(1995-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
8 versus##3##2##(2007-8#2)(2008-4#1)
8 vs##13##2##(1991-9#1)(1994-2#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-12#2)(2013-1#2)
8 was##2##2##(1994-12#1)(1996-5#1)
8 weeks after the##2##4##(2008-10#1)(2009-3#1)
8 weeks after##6##3##(1990-9#1)(2007-7#1)(2008-10#3)(2009-3#1)
8 weeks and##5##3##(2008-10#1)(2008-4#1)(2008-5#2)(2012-3#1)
8 weeks following##3##3##(2008-10#2)(2009-3#1)
8 weeks in##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
8 weeks later##2##3##(1996-11#1)(2008-10#1)
8 weeks of treatment##2##4##(1991-11#1)(2013-1#1)
8 weeks of##11##3##(1991-11#1)(1991-3#1)(1992-11#1)(1992-6#1)(2008-10#2)(2011-2#1)(2013-1#4)
8 weeks on##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
8 weeks post-immunization##2##3##(2009-5#2)
8 weeks##68##2##(1990-9#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-6#1)(1997-6#1)(2007-7#4)(2008-10#19)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#6)(2009-5#3)(2010-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#6)
8 were##11##2##(1992-8#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-6#2)(2010-1#1)(2011-2#2)
8 while##2##2##(2008-10#1)(2009-3#1)
8 with##11##2##(1991-11#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-3#2)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#2)
8 x 10(-18)##2##3##(2008-11#1)(2008-12#1)
8 x 10(-4)##2##3##(2008-10#1)(2008-2#1)
8 x 10(-6)##2##3##(1991-5#1)(2008-10#1)
8 x 10(-7)##2##3##(1992-5#1)(2008-10#1)
8 x 10(-9)##3##3##(1995-11#1)(2008-10#2)
8 x 10(4)##7##3##(1993-1#1)(2008-10#5)(2008-7#1)
8 x 10(6)##4##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
8 x 10(8)##2##3##(1990-12#1)(2008-10#1)
8 x 8##9##3##(1993-9#1)(2008-10#1)(2008-2#4)(2008-3#3)
8 x##48##2##(1990-12#2)(1991-5#1)(1992-5#2)(1993-1#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1997-5#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#2)(2011-2#1)
8 years (range##2##3##(2007-11#1)(2008-6#1)
8 years after##2##3##(2008-10#1)(2009-7#1)
8 years earlier##2##3##(1993-12#1)(2011-2#1)
8 years of##2##3##(1996-6#1)(2013-1#1)
8 years were##2##3##(2007-7#1)(2012-12#1)
8 years##44##2##(1990-2#1)(1991-11#2)(1993-12#1)(1994-1#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#2)(2009-6#1)(2009-7#2)(2010-11#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
8 years) who##2##3##(1990-5#1)(2011-2#1)
8 years)##14##2##(1990-5#1)(1991-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#2)(2013-1#1)
8 ±##4##2##(2011-2#1)(2013-1#2)(2013-8#1)
8 ×##3##2##(2010-11#1)(2013-1#2)
8##2516##1##(1990-10#3)(1990-11#7)(1990-12#13)(1990-2#18)(1990-3#1)(1990-5#15)(1990-6#12)(1990-7#7)(1990-8#23)(1990-9#4)(1991-1#1)(1991-11#11)(1991-12#7)(1991-2#8)(1991-3#7)(1991-4#3)(1991-5#8)(1991-6#8)(1991-7#4)(1991-8#8)(1991-9#15)(1992-1#2)(1992-10#1)(1992-11#8)(1992-12#11)(1992-2#9)(1992-3#6)(1992-4#1)(1992-5#8)(1992-6#6)(1992-8#7)(1992-9#6)(1993-1#4)(1993-11#4)(1993-12#21)(1993-2#11)(1993-3#7)(1993-6#7)(1993-8#23)(1993-9#10)(1994-1#1)(1994-11#10)(1994-12#17)(1994-2#7)(1994-3#10)(1994-5#7)(1994-6#3)(1994-7#3)(1994-8#9)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#16)(1995-12#18)(1995-2#11)(1995-3#17)(1995-4#3)(1995-5#6)(1995-6#12)(1995-8#7)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#6)(1996-12#19)(1996-2#12)(1996-3#9)(1996-5#18)(1996-6#3)(1996-7#7)(1996-8#1)(1996-9#1)(1997-2#16)(1997-3#6)(1997-4#9)(1997-5#3)(1997-6#12)(1997-7#24)(1997-8#10)(1997-9#1)(2006-10#4)(2006-6#2)(2006-8#1)(2007-10#26)(2007-11#54)(2007-12#50)(2007-3#1)(2007-5#8)(2007-7#27)(2007-8#15)(2007-9#1)(2008-1#25)(2008-10#667)(2008-11#62)(2008-12#48)(2008-2#39)(2008-3#93)(2008-4#35)(2008-5#57)(2008-6#30)(2008-7#59)(2008-8#41)(2008-9#40)(2009-1#2)(2009-10#12)(2009-11#6)(2009-12#6)(2009-2#1)(2009-3#16)(2009-4#5)(2009-5#9)(2009-6#7)(2009-7#10)(2009-8#10)(2009-9#5)(2010-1#7)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#15)(2010-4#3)(2010-5#5)(2010-6#2)(2010-8#8)(2011-1#34)(2011-2#96)(2011-3#4)(2012-1#4)(2012-12#23)(2012-2#20)(2012-3#27)(2012-4#1)(2013-1#76)(2013-7#5)(2013-8#31)
8% (95% CI##2##3##(2010-3#1)(2010-4#1)
8% (P &lt##3##3##(2008-9#1)(2013-1#2)
8% (P less than 0##2##5##(1991-5#2)
8% (P##5##2##(1991-5#2)(2008-9#1)(2013-1#2)
8% (n =##5##3##(1992-9#2)(2008-10#1)(2012-3#2)
8% (v/v)##2##2##(2008-10#1)(2008-11#1)
8% -##2##2##(2011-1#2)
8% L-menthol##3##2##(2012-2#3)
8% after##5##2##(2007-7#1)(2007-8#1)(2008-10#3)
8% and 1##2##3##(1992-3#1)(2012-2#1)
8% and 2##2##3##(2008-10#1)(2010-5#1)
8% and 9##2##3##(1995-2#1)(2008-10#1)
8% and 95##2##3##(1990-2#1)(2013-8#1)
8% and the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
8% and##43##2##(1990-2#1)(1991-6#1)(1991-8#2)(1992-3#1)(1993-1#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-3#1)(2007-8#2)(2008-10#9)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-8#2)
8% at 2##2##3##(2008-10#1)(2013-1#1)
8% at the##2##3##(2008-10#2)
8% at##15##2##(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#2)
8% efficiencies##2##2##(2010-10#2)
8% for 20##2##3##(2008-10#2)
8% for all##2##3##(2008-10#1)(2008-5#1)
8% for the##4##3##(1996-5#1)(2008-10#2)(2008-3#1)
8% for##50##2##(1991-3#1)(1991-4#1)(1994-11#2)(1996-12#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#30)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
8% from##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
8% had anemia of chronic disease##2##6##(2013-1#2)
8% had positive joint dysfunction findings in their physical examination while 25##2##12##(2013-1#2)
8% had##13##2##(1990-6#1)(1991-2#1)(1992-1#1)(1995-10#1)(1995-5#1)(2008-12#1)(2010-1#1)(2013-1#4)(2013-8#2)
8% higher than##2##3##(2008-3#1)(2008-7#1)
8% higher##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
8% identity##2##2##(1995-8#1)(2009-6#1)
8% in the##7##3##(1991-4#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
8% in##28##2##(1991-4#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
8% of all patients##2##4##(1994-5#1)(2007-10#1)
8% of all##6##3##(1994-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-10#1)
8% of participants##2##3##(2009-3#1)(2012-3#1)
8% of patients##6##3##(1991-11#1)(1993-2#1)(1994-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
8% of the cases##2##4##(2008-1#1)(2011-1#1)
8% of the patients had history of nonmechanical joint disease##2##10##(2013-1#2)
8% of the patients##8##4##(1991-3#1)(1992-5#2)(2008-1#2)(2008-10#1)(2013-1#2)
8% of the subjects##2##4##(2008-1#1)(2008-7#1)
8% of the total##2##4##(2007-10#1)(2008-10#1)
8% of the##30##3##(1990-5#1)(1991-3#1)(1992-5#2)(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(2007-10#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-8#1)
8% of those##3##3##(1994-8#1)(1995-8#1)(2011-2#1)
8% of total##2##3##(2008-10#1)(2013-8#1)
8% of##64##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-5#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#5)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
8% over##2##2##(1995-8#1)(2008-12#1)
8% reduction in##2##3##(2008-3#1)(2008-8#1)
8% relative standard deviation (R##2##5##(2008-10#2)
8% relative standard deviation##3##4##(2008-10#3)
8% respectively##5##2##(1994-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
8% sensitivity##3##2##(2007-7#1)(2011-2#2)
8% showed##2##2##(1990-6#1)(2012-2#1)
8% specificity##2##2##(2011-2#1)(2012-12#1)
8% to##7##2##(2007-7#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
8% using##2##2##(2008-10#1)(2012-12#1)
8% versus##2##2##(1991-9#1)(2013-1#1)
8% vs##9##2##(1990-12#1)(1990-3#1)(1992-2#1)(1995-12#2)(1995-2#1)(2009-8#1)(2011-1#1)(2013-8#1)
8% w/w##2##2##(2008-10#1)(2010-3#1)
8% was##2##2##(2008-1#1)(2008-10#1)
8% were obtained for##2##4##(2008-10#2)
8% were obtained##4##3##(2008-10#4)
8% were##15##2##(1990-12#1)(1990-2#2)(1991-2#1)(1993-2#1)(1993-8#1)(2007-10#1)(2008-10#5)(2008-8#1)(2009-9#1)(2010-8#1)
8% while the##2##3##(2007-8#1)(2008-10#1)
8% with##4##2##(1996-12#1)(2008-6#1)(2008-8#1)(2009-11#1)
8% ±##2##2##(2012-12#1)(2013-8#1)
8%##573##1##(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#5)(1996-3#2)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#6)(2007-12#6)(2007-2#2)(2007-7#11)(2007-8#12)(2008-1#12)(2008-10#154)(2008-11#8)(2008-12#9)(2008-2#8)(2008-3#19)(2008-4#1)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#10)(2008-9#7)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#13)(2011-2#25)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#17)(2012-3#10)(2013-1#23)(2013-7#1)(2013-8#16)
8%) and##21##2##(1992-2#1)(1992-9#1)(1996-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2009-10#1)(2010-1#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
8%) at the##2##3##(2008-8#1)(2013-1#1)
8%) at##3##2##(1991-12#1)(2008-8#1)(2013-1#1)
8%) for##3##2##(2007-7#1)(2009-11#1)(2012-2#1)
8%) had##5##2##(2007-12#1)(2008-7#1)(2013-1#2)(2013-8#1)
8%) of the##3##3##(2007-12#1)(2008-1#1)(2013-8#1)
8%) of##8##2##(1990-6#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2013-8#1)
8%) patients##8##2##(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#2)
8%) received##2##2##(2008-7#1)(2011-2#1)
8%) reported##2##2##(2013-1#2)
8%) than those##2##3##(2008-8#1)(2011-1#1)
8%) was observed in EMR-F and EMR-A groups##2##8##(2008-12#2)
8%) was##4##2##(2008-12#2)(2011-2#1)(2012-5#1)
8%) were found to have##2##5##(2008-1#1)(2008-4#1)
8%) were found##3##3##(2008-1#1)(2008-4#1)(2012-3#1)
8%) were obtained##3##3##(1992-8#1)(2008-10#2)
8%) were positive##3##3##(2007-7#2)(2011-2#1)
8%) were##21##2##(1990-8#1)(1990-9#1)(1992-8#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-2#2)(2012-3#1)
8%) with##4##2##(1991-6#1)(2008-5#1)(2008-7#1)(2009-10#1)
8%)##191##1##(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#2)(1992-9#3)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#13)(2007-8#7)(2008-1#10)(2008-10#17)(2008-11#3)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#11)(2011-2#11)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#14)(2013-8#8)
8&quot##3##1##(2008-8#1)(2013-1#2)
8) and##11##2##(1993-12#1)(1996-3#1)(1997-3#1)(2008-10#4)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
8) as compared to##2##4##(2008-10#1)(2008-8#1)
8) as##3##2##(2008-10#2)(2008-8#1)
8) at##2##2##(2007-8#1)(2008-10#1)
8) compared##2##2##(2007-11#1)(2008-6#1)
8) in##2##2##(1990-12#1)(1994-5#1)
8) is##2##2##(1995-11#1)(1996-5#1)
8) or##5##2##(1993-12#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-7#1)
8) translocation##2##2##(1993-2#1)(2009-2#1)
8) was##2##2##(2008-10#1)(2012-3#1)
8) were##3##2##(1993-12#1)(2008-10#2)
8)##126##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#8)(1993-2#2)(1993-6#3)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#4)
8)%##2##1##(2008-3#2)
8)(p12##4##1##(2009-2#4)
8)Fe(0##2##1##(2012-2#2)
8+/-0##17##1##(2007-12#1)(2007-8#3)(2008-10#10)(2008-2#1)(2008-5#1)(2008-7#1)
8+/-1##2##1##(2008-10#1)(2008-7#1)
8+/-2##2##1##(2008-10#1)(2008-7#1)
8+/-4##2##1##(2007-8#1)(2008-7#1)
8+/-8##2##1##(2008-10#1)(2008-7#1)
8- and##6##2##(1990-10#1)(1992-12#1)(1992-4#1)(1994-12#1)(2012-2#1)(2013-1#1)
8- to##3##2##(1995-11#1)(1997-6#1)(2008-10#1)
8-##12##1##(1990-10#1)(1992-12#1)(1992-4#1)(1994-12#1)(1995-11#1)(1996-2#2)(1997-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
8-1##3##1##(2007-11#1)(2008-10#2)
8-10 years##3##2##(1995-1#1)(1997-4#1)(2011-1#1)
8-10##10##1##(1994-5#1)(1995-1#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-7#1)(2010-3#1)(2011-1#1)
8-10%##2##1##(2007-8#2)
8-11 years##2##2##(1991-6#2)
8-11##4##1##(1991-6#2)(1996-5#1)(2009-4#1)
8-12##12##1##(1990-12#1)(1994-3#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-7#1)(2012-2#2)
8-12%##2##1##(2008-10#1)(2012-2#1)
8-125##2##1##(2008-10#2)
8-13##2##1##(1997-6#1)(2008-3#1)
8-14##6##1##(1991-11#1)(1991-9#2)(2007-11#1)(2008-3#1)(2008-9#1)
8-15##2##1##(1995-11#1)(1996-6#1)
8-16##3##1##(1992-12#3)
8-2##7##1##(1993-12#1)(1994-12#1)(1997-1#1)(2008-10#3)(2008-8#1)
8-3##4##1##(1992-11#1)(2008-10#3)
8-4##5##1##(2008-10#3)(2008-3#2)
8-5##10##1##(1993-3#1)(1994-11#1)(2008-10#6)(2008-11#1)(2012-2#1)
8-6##4##1##(1990-5#1)(2007-10#1)(2008-10#1)(2008-7#1)
8-7##3##1##(1993-8#1)(2008-10#2)
8-87##2##1##(1995-3#1)(2008-10#1)
8-9##12##1##(1994-12#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2010-5#1)(2011-2#1)
8-BDB-TA-5'-TP##4##1##(1990-7#4)
8-BrcAMP##3##1##(1994-11#3)
8-C2B9H11]##3##1##(1995-2#3)
8-DHD and BPDE binding to##2##5##(1992-2#2)
8-DHD and BPDE##5##3##(1992-2#5)
8-DHD and##7##2##(1992-2#7)
8-Hydroxyquinoline##2##1##(2008-10#2)
8-MeV##2##1##(2007-12#2)
8-OH-DPAT (0-5##2##2##(1991-2#2)
8-OH-DPAT in##3##2##(1990-5#2)(1993-3#1)
8-OH-DPAT produced##2##2##(1990-5#1)(1993-3#1)
8-OH-DPAT##21##1##(1990-5#5)(1991-2#8)(1993-3#3)(1994-2#4)(1995-12#1)
8-OHdG formation##3##2##(2008-4#3)
8-OHdG##7##1##(1994-11#1)(1994-6#2)(2008-4#3)(2012-5#1)
8-TCDD##4##1##(2008-10#3)(2008-7#1)
8-aminoquinoline and##3##2##(2008-10#3)
8-azabicyclo[3##2##1##(2008-8#2)
8-azido-ATP##3##1##(1995-2#3)
8-benzoflavone##6##1##(1994-5#6)
8-bp sequence##5##2##(1995-6#4)(1996-2#1)
8-bromo cAMP##3##2##(1991-2#3)
8-bromo##5##1##(1990-12#1)(1991-2#3)(1996-5#1)
8-bromo-cAMP##4##1##(1994-11#1)(1994-9#2)(1995-6#1)
8-cell stage##2##2##(2008-9#1)(2012-3#1)
8-cell##3##1##(1996-5#1)(2008-9#1)(2012-3#1)
8-cineole##5##1##(2008-10#1)(2008-5#1)(2010-5#3)
8-dB##2##1##(2008-2#1)(2008-3#1)
8-day##5##1##(1990-11#1)(2009-8#1)(2012-2#3)
8-diaminonaphthalen##2##1##(2008-10#2)
8-dibromoquinazolin-4(3H) ones##2##2##(2011-1#2)
8-diene##2##1##(2008-10#2)
8-difluorobenzo[c]cinnoline##3##1##(2008-10#3)
8-dihydro-2'-deoxyguanosine##2##1##(2008-10#2)
8-dihydrodiol and##2##2##(1992-2#1)(2011-1#1)
8-dihydrodiol##4##1##(1992-2#2)(2011-1#2)
8-dihydrodiol-9##2##1##(1992-2#2)
8-dihydroguanine##2##1##(2008-10#2)
8-dihydroxy-1##2##1##(2008-10#2)
8-dihydroxy-3##2##1##(2008-10#2)
8-dihydroxy-9##2##1##(2008-10#2)
8-fold increase in##3##3##(1994-11#1)(1994-9#1)(2008-11#1)
8-fold to##2##2##(2011-2#2)
8-fold##16##1##(1991-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-5#1)(2011-2#2)
8-fs##2##1##(2007-11#1)(2007-12#1)
8-h##5##1##(2008-10#2)(2008-7#1)(2010-10#1)(2013-1#1)
8-hour##2##1##(2008-8#2)
8-hydroxy##3##1##(2008-10#2)(2009-3#1)
8-hydroxy-2'-deoxyguanosine (8-OHdG)##3##2##(1994-11#1)(1994-6#1)(2008-4#1)
8-hydroxy-2'-deoxyguanosine##8##1##(1990-7#1)(1994-11#1)(1994-6#2)(2008-10#2)(2008-4#2)
8-hydroxydeoxyguanosine##2##1##(1995-6#1)(2012-5#1)
8-hydroxyguanine##3##1##(1990-7#2)(2008-11#1)
8-hydroxyquinoline immobilized##4##2##(2008-10#4)
8-hydroxyquinoline##14##1##(1990-2#1)(2008-10#13)
8-hydroxyquinoline-5-sulphonic acid cellulose##2##3##(2008-10#2)
8-iso-PGF2α##2##1##(2012-5#2)
8-kDa##2##1##(2008-10#2)
8-kb DNA##2##2##(2008-10#1)(2008-6#1)
8-kb RNA was##2##3##(2008-10#2)
8-kb RNA were##2##3##(2008-10#2)
8-kb RNA##6##2##(2008-10#6)
8-kb dsRNA##2##2##(2008-10#2)
8-kb fragment##2##2##(1994-12#1)(2008-10#1)
8-kb mRNA##3##2##(1992-9#1)(1993-2#1)(1994-12#1)
8-kb##25##1##(1992-12#1)(1992-9#1)(1993-2#1)(1994-12#4)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#12)(2008-11#1)(2008-6#1)
8-methoxypsoralen##2##1##(1997-4#2)
8-microm##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
8-mm##5##1##(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-5#1)
8-mum##2##1##(2007-11#1)(2008-2#1)
8-nm Nd##2##2##(2008-3#2)
8-nm##3##1##(2008-3#3)
8-ns pulses##2##2##(2007-11#1)(2007-12#1)
8-oxo-7##4##1##(2008-10#4)
8-oxoGua and 8-oxodGuo##3##3##(2008-10#3)
8-oxoGua##4##1##(2008-10#4)
8-pCPT-2'-O-Me-cAMP-AM##2##1##(2010-11#2)
8-position##2##1##(1993-1#1)(2008-4#1)
8-ps##2##1##(2007-12#1)(2008-2#1)
8-quinolinol##5##1##(2008-10#5)
8-quinolinolato metal chelates##2##3##(2008-10#2)
8-quinolinolato##3##1##(2008-10#3)
8-sphingadienine##2##1##(1994-3#2)
8-substituted##2##1##(1994-8#1)(2008-4#1)
8-sulfonamidoquinoline##2##1##(2008-10#2)
8-tetrachlorodibenzo-p-dioxin (TCDD##2##2##(1993-11#1)(2008-10#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) and##2##3##(1995-3#1)(2008-10#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) in##2##3##(1992-8#1)(1995-11#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) is##2##3##(1992-12#1)(1995-3#1)
8-tetrachlorodibenzo-p-dioxin (TCDD)##9##2##(1992-12#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-3#3)(2008-10#2)
8-tetrachlorodibenzo-p-dioxin##17##1##(1992-12#2)(1992-8#2)(1993-11#1)(1993-6#1)(1994-5#2)(1995-11#1)(1995-3#4)(2008-10#4)
8-tetracyanoquinodimethane (TCNQ)##2##2##(2008-10#2)
8-tetracyanoquinodimethane##3##1##(2008-10#3)
8-week clinical##2##2##(2011-2#2)
8-week treatment period##2##3##(1994-12#2)
8-week treatment##4##2##(1994-12#2)(2008-11#1)(2012-3#1)
8-week##12##1##(1994-12#3)(2008-11#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
8-week-old rats##2##2##(1991-9#2)
8-week-old##3##1##(1991-9#2)(2008-10#1)
8-weeks##3##1##(2008-5#3)
8-year##9##1##(1990-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
8-year-old##8##1##(1996-5#1)(1997-3#1)(2007-5#1)(2007-8#2)(2010-5#1)(2012-12#1)(2012-3#1)
8/16##2##1##(1991-6#1)(1996-7#1)
80 % of##3##3##(1997-8#1)(2007-8#1)(2011-2#1)
80 %##4##2##(1997-8#1)(2007-8#1)(2011-2#1)(2012-12#1)
80 +/-##3##2##(1994-6#1)(2008-12#1)(2008-6#1)
80 -##2##2##(2008-9#1)(2011-1#1)
80 -40##2##2##(2011-1#2)
80 A##2##2##(1994-5#1)(2007-11#1)
80 Hz##2##2##(1997-6#1)(2007-12#1)
80 Ncm)##2##2##(2013-1#2)
80 V##2##2##(2008-10#2)
80 and 0##4##3##(2008-10#3)(2008-9#1)
80 and 100##4##3##(1995-5#1)(2008-10#1)(2008-5#1)(2013-8#1)
80 and 85 years##2##4##(2008-7#2)
80 and##38##2##(1991-6#1)(1992-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
80 at##2##2##(1996-3#1)(2008-12#1)
80 degrees C for##5##4##(2008-10#4)(2011-1#1)
80 degrees C##24##3##(1991-5#1)(2007-12#1)(2008-10#16)(2008-3#1)(2008-7#1)(2009-9#3)(2011-1#1)
80 degrees##26##2##(1991-5#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#3)(2011-1#1)
80 for##2##2##(2008-10#2)
80 g##3##2##(1993-3#1)(2008-7#2)
80 generations##2##2##(2008-10#1)(2008-7#1)
80 in the##2##3##(1992-2#1)(2008-3#1)
80 in##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
80 isolates##2##2##(2008-10#2)
80 kDa form##3##3##(1992-6#3)
80 kDa protein##2##3##(1995-8#2)
80 kDa##10##2##(1992-6#3)(1992-8#1)(1992-9#1)(1995-8#2)(1996-2#1)(2008-11#1)(2011-2#1)
80 mM##4##2##(1991-9#1)(1992-9#1)(1995-12#1)(2008-10#1)
80 mW##2##2##(2007-11#1)(2007-12#1)
80 mg##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)
80 mg/day##3##2##(1992-11#1)(2008-5#2)
80 min##6##2##(1997-1#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-12#1)(2013-8#1)
80 mm##2##2##(2008-2#1)(2008-3#1)
80 mol/l##2##2##(2008-10#2)
80 mug##3##2##(2008-10#2)(2008-11#1)
80 nM##2##2##(1990-12#1)(2008-10#1)
80 nm##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
80 nmol)##2##2##(1997-4#2)
80 ns##2##2##(2008-2#1)(2008-3#1)
80 of the##2##3##(1991-5#1)(2008-1#1)
80 of##3##2##(1991-5#1)(2007-6#1)(2008-1#1)
80 patients with##2##3##(1992-3#1)(2010-3#1)
80 patients##7##2##(1992-3#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-3#1)
80 per cent of the##2##5##(1995-9#1)(1996-3#1)
80 per cent of##4##4##(1992-9#1)(1994-11#1)(1995-9#1)(1996-3#1)
80 per cent##6##3##(1992-9#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-3#1)(2012-12#1)
80 percent of the##2##4##(1992-12#2)
80 percent of##6##3##(1992-12#2)(1994-2#2)(2009-9#1)(2013-1#1)
80 ps##2##2##(2007-12#1)(2008-3#1)
80 s##2##2##(1992-8#1)(2008-11#1)
80 samples per hour with a relative standard deviation for the##2##11##(2008-10#2)
80 samples per hour##5##4##(2008-10#5)
80 to 86%##2##3##(2008-10#2)
80 to 90%##3##3##(1990-3#1)(1997-8#1)(2008-10#1)
80 to##21##2##(1990-3#1)(1991-11#1)(1991-5#1)(1995-3#1)(1997-8#1)(2008-10#13)(2008-3#1)(2008-7#1)(2012-2#1)
80 years (mean##2##3##(1990-5#1)(2008-1#1)
80 years old##2##3##(1992-6#1)(2008-9#1)
80 years##19##2##(1990-5#1)(1991-1#1)(1992-6#1)(1995-11#1)(1995-2#1)(1996-7#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#2)(2012-2#2)(2013-1#2)
80##462##1##(1990-10#6)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#4)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#4)(2007-10#1)(2007-11#15)(2007-12#10)(2007-6#1)(2007-8#6)(2008-1#4)(2008-10#128)(2008-11#9)(2008-12#6)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#27)(2008-8#4)(2008-9#11)(2009-10#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-2#14)(2012-1#4)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#15)(2013-8#8)
80% and##8##2##(1990-10#1)(1990-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(2007-8#1)(2012-3#1)
80% at the##2##3##(2008-3#1)(2008-5#1)
80% at##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
80% by##4##2##(1990-5#1)(1995-5#2)(1997-3#1)
80% correct##2##2##(2007-11#1)(2013-8#1)
80% ethanol##2##2##(2008-12#1)(2008-6#1)
80% for##6##2##(2007-12#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-8#1)
80% in##6##2##(1994-9#2)(1997-3#1)(2007-11#1)(2008-7#1)(2012-12#1)
80% methanol##2##2##(2008-5#2)
80% of all##3##3##(1992-6#1)(2008-6#1)(2013-1#1)
80% of cases##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
80% of patients##10##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-3#2)(2010-4#2)(2011-2#1)
80% of the activity##3##4##(1990-2#1)(1991-11#1)(1995-2#1)
80% of the cases##4##4##(1990-10#1)(1990-9#1)(2010-8#1)(2013-1#1)
80% of the patients##3##4##(1991-2#1)(2008-1#1)(2010-3#1)
80% of the total##4##4##(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
80% of the variation##2##4##(2008-10#2)
80% of the##45##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
80% of##103##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#2)(2009-9#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#2)
80% similarity##3##2##(1993-2#1)(1997-7#1)(2008-10#1)
80% to 90% of##2##4##(1990-9#1)(2008-1#1)
80% to##5##2##(1990-9#1)(1997-7#1)(2008-1#1)(2011-2#1)(2013-8#1)
80% were##3##2##(2007-12#1)(2008-7#1)(2008-8#1)
80%##260##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#42)(2008-11#4)(2008-12#5)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#9)(2008-6#8)(2008-7#7)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#3)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#6)
80%) and##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
80%) in##2##2##(1995-11#1)(2008-11#1)
80%) of##3##2##(2008-10#3)
80%)##18##1##(1993-5#2)(1995-11#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
80) and##2##2##(2008-10#1)(2008-12#1)
80)##12##1##(1990-12#1)(1993-11#1)(1993-9#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-9#1)(2013-1#2)
80+/-0##3##1##(2008-10#3)
80-##3##1##(1992-11#1)(2008-10#1)(2011-1#1)
80-100##5##1##(1990-5#1)(1990-7#1)(1993-8#2)(1994-2#1)
80-90% of the total##2##4##(2008-6#2)
80-90% of##5##2##(2007-9#1)(2008-1#1)(2008-6#3)
80-90%##8##1##(1992-6#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#3)
80-95%##3##1##(2007-8#1)(2008-10#1)(2013-8#1)
80-MHz##2##1##(2007-11#1)(2008-3#1)
80-cm(3)##2##1##(2008-10#2)
80-fold##6##1##(1994-8#2)(1995-2#1)(1995-5#1)(2008-10#2)
80-kDa##4##1##(1992-9#3)(1995-11#1)
80-mW##2##1##(2007-11#1)(2008-3#1)
80-ps##2##1##(2007-11#1)(2008-2#1)
80-year-old##4##1##(1994-12#1)(2008-12#1)(2008-7#1)(2009-1#1)
800 and##5##2##(2008-10#4)(2010-4#1)
800 bp##2##2##(1990-12#1)(1990-8#1)
800 degrees C for##2##4##(2008-10#2)
800 degrees C##3##3##(2008-10#3)
800 fg##2##2##(2008-10#2)
800 mW##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
800 mg##3##2##(1993-2#1)(2008-9#1)(2012-12#1)
800 mg/L females at##3##4##(2008-9#3)
800 mg/L females in both studies##2##6##(2008-9#2)
800 mg/L females##7##3##(2008-9#7)
800 mg/L males and females at 43 weeks##2##8##(2008-9#2)
800 mg/L males and females at##3##6##(2008-9#3)
800 mg/L males and females##5##5##(2008-9#5)
800 mg/L males at##4##4##(2008-9#4)
800 mg/L males##9##3##(2008-9#9)
800 mg/L##21##2##(2008-9#21)
800 microm##2##2##(2008-3#1)(2008-7#1)
800 nm and##2##3##(2008-2#1)(2008-3#1)
800 nm##22##2##(2007-11#3)(2007-12#5)(2008-10#3)(2008-2#7)(2008-3#3)(2010-1#1)
800 nm)##2##2##(2008-11#1)(2008-3#1)
800 to##9##2##(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2011-7#1)
800##134##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-11#4)(2007-12#10)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#26)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
800%##2##1##(2008-10#1)(2008-8#1)
800-##3##1##(2008-3#2)(2008-4#1)
800-MHz##3##1##(2007-12#2)(2008-3#1)
800-nm femtosecond##2##2##(2007-12#1)(2008-3#1)
800-nm##8##1##(2007-11#2)(2007-12#3)(2008-3#3)
8000##9##1##(1990-2#1)(1991-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#2)
800T)##2##1##(2008-10#2)
800nm##3##1##(2007-11#1)(2007-12#1)(2008-10#1)
801##2##1##(1994-2#1)(2010-8#1)
802##6##1##(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)
803##10##1##(1990-11#1)(1990-12#2)(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)(2013-8#1)
8036E27##4##1##(2008-10#4)
804 bp##2##2##(1997-6#1)(2011-2#1)
804##9##1##(1997-6#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
805##9##1##(1990-5#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
806##6##1##(1993-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)
807##6##1##(1990-8#1)(1991-12#2)(1992-6#1)(2013-8#2)
808##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
808-nm##3##1##(2007-12#1)(2008-3#2)
809 and##2##2##(2008-8#1)(2013-7#1)
809##10##1##(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
80h(-1)##2##1##(2008-10#2)
80kD protein on##2##3##(1992-11#2)
80mg##2##1##(2011-2#1)(2012-2#1)
80mugml(-1)##2##1##(2008-10#2)
80nM##2##1##(2008-10#2)
80s##2##1##(2008-10#2)
80 mmol/L##2##1##(2012-6#2)
80°C##3##1##(2012-1#3)
80 kg##3##1##(2013-1#3)
81 +/- 1##4##3##(2008-12#1)(2008-3#1)(2009-8#1)(2010-2#1)
81 +/-##6##2##(1991-12#1)(1992-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-2#1)
81 amino acids##2##3##(1993-3#1)(1994-6#1)
81 amino##3##2##(1993-3#1)(1993-8#1)(1994-6#1)
81 and##2##2##(2008-10#2)
81 cases##2##2##(2008-7#2)
81 degrees##2##2##(2008-3#1)(2008-9#1)
81 isolates of##2##3##(2008-10#2)
81 to##6##2##(1993-6#1)(2008-10#4)(2012-3#1)
81 years##2##2##(2008-4#1)(2011-2#1)
81 years)##2##2##(2008-7#1)(2012-2#1)
81##138##1##(1990-12#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1997-4#1)(1997-8#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#33)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#5)(2009-1#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
81% amino acid##2##3##(1994-5#1)(2008-8#1)
81% for##2##2##(2008-10#2)
81% from##2##2##(1995-3#1)(2011-2#1)
81% of patients##2##3##(2008-9#1)(2011-1#1)
81% of the##4##3##(1996-9#1)(2008-8#1)(2010-6#1)(2013-8#1)
81% of##9##2##(1990-12#1)(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-7#1)(2013-8#1)
81%##37##1##(1990-12#1)(1991-9#1)(1992-5#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
81%)##3##1##(1996-5#2)(2011-2#1)
81) and##2##2##(2008-10#1)(2009-9#1)
81)##11##1##(1993-12#1)(1994-12#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
810 and##2##2##(2007-12#1)(2008-4#1)
810 nm##2##2##(2007-12#1)(2008-10#1)
810 nm)##2##2##(2007-8#1)(2008-10#1)
810##10##1##(1997-4#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)
811##3##1##(2008-2#1)(2008-3#1)(2008-5#1)
812##9##1##(1990-6#2)(1991-12#1)(1992-12#1)(1994-9#1)(2008-10#2)(2010-11#1)(2010-8#1)
813##7##1##(1996-12#1)(2007-11#2)(2008-10#1)(2011-2#2)(2013-1#1)
814##4##1##(1990-5#1)(2008-10#2)(2010-7#1)
815##2##1##(2007-12#1)(2008-9#1)
816##2##1##(2008-10#1)(2012-12#1)
817##2##1##(2008-1#1)(2008-10#1)
818##6##1##(1992-10#1)(1993-3#1)(1995-12#1)(1995-8#1)(1997-6#1)(2008-3#1)
819##3##1##(1991-3#1)(2008-10#1)(2011-3#1)
82 %##2##2##(2010-10#1)(2011-2#1)
82 +/-##4##2##(1992-3#1)(2008-10#2)(2009-5#1)
82 and##11##2##(1995-11#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
82 mW##2##2##(1995-2#1)(2007-12#1)
82 patients who underwent##2##4##(2013-1#2)
82 patients##5##2##(1997-8#1)(2007-11#2)(2013-1#2)
82 to 0##2##3##(2008-10#1)(2010-6#1)
82 to##7##2##(1993-12#1)(2008-10#5)(2010-6#1)
82 vs##2##2##(2008-9#1)(2010-8#1)
82 x##3##2##(2008-10#3)
82##154##1##(1990-10#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#2)(1991-5#2)(1991-6#1)(1992-3#3)(1992-7#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-12#3)(1996-2#2)(1996-7#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#36)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#5)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#2)
82% and the##2##3##(1991-8#1)(2013-8#1)
82% and##7##2##(1991-12#1)(1991-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-8#2)
82% in the##2##3##(1990-12#1)(2008-8#1)
82% of patients##2##3##(2006-8#1)(2008-7#1)
82% of the patients##3##4##(1990-9#1)(1996-9#1)(2008-5#1)
82% of the##6##3##(1990-9#1)(1993-2#1)(1996-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
82% of##14##2##(1990-2#1)(1990-9#1)(1993-2#1)(1996-9#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
82% specificity)##2##2##(1991-12#2)
82%##53##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#1)(1991-12#3)(1991-6#1)(1991-8#1)(1991-9#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#2)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
82%)##10##1##(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
82)##2##1##(2010-12#2)
820##6##1##(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
821##6##1##(2008-10#5)(2011-2#1)
822##6##1##(2008-5#1)(2011-1#1)(2011-2#2)(2013-1#2)
823##5##1##(1994-5#1)(2008-5#1)(2012-12#1)(2013-1#2)
824##6##1##(1995-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
825)##2##1##(2008-5#1)(2010-8#1)
826##5##1##(1995-12#1)(1997-6#2)(2008-10#1)(2010-6#1)
827##4##1##(2007-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
828##4##1##(1997-7#1)(2007-8#1)(2011-2#1)(2013-8#1)
829##2##1##(1992-8#1)(2011-2#1)
83 +/-##3##2##(1991-12#1)(1994-2#1)(1994-8#1)
83 3##2##2##(2008-10#2)
83 and##3##2##(2008-12#1)(2008-8#1)(2010-11#1)
83 for##2##2##(2008-10#2)
83 from##2##2##(1996-5#1)(2007-8#1)
83 kDa peptide##4##3##(1990-11#4)
83 patients##2##2##(2007-11#1)(2007-2#1)
83 species##2##2##(2008-5#1)(2011-2#1)
83 to##4##2##(1992-12#1)(1997-2#1)(2007-11#1)(2008-10#1)
83 years##2##2##(1990-12#1)(2008-7#1)
83##127##1##(1990-11#5)(1990-12#2)(1990-8#2)(1991-11#2)(1991-12#2)(1991-6#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#27)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#4)
83% and##4##2##(1995-2#1)(2007-10#1)(2008-6#1)(2009-6#1)
83% for##2##2##(2007-7#1)(2008-10#1)
83% identity##2##2##(2008-10#1)(2009-2#1)
83% in##4##2##(1990-9#1)(1996-9#1)(2007-8#1)(2008-10#1)
83% of the##6##3##(1990-2#1)(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-3#1)
83% of##14##2##(1990-2#1)(1992-6#1)(1994-9#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-9#3)(2010-3#1)(2013-8#1)
83% were##2##2##(1993-3#1)(2007-12#1)
83%##54##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2007-10#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#12)(2008-5#1)(2008-6#1)(2008-9#3)(2009-2#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
83%)##6##1##(1991-8#1)(2007-8#1)(2008-12#1)(2009-4#1)(2011-1#1)(2013-8#1)
83) and##2##2##(2008-11#1)(2008-8#1)
83)##12##1##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
83+/-0##6##1##(2008-10#6)
83-year-old woman##2##2##(1993-9#1)(2013-1#1)
83-year-old##4##1##(1991-6#1)(1993-9#1)(2012-2#1)(2013-1#1)
830 +/-##2##2##(2008-5#1)(2010-9#1)
830 nm)##4##2##(2007-12#1)(2008-3#2)(2011-1#1)
830##10##1##(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-9#1)(2011-1#1)(2011-3#1)(2013-8#1)
831##3##1##(1991-12#1)(1996-12#1)(2010-12#1)
832##3##1##(2008-10#1)(2010-9#1)(2013-7#1)
833##5##1##(1993-8#3)(2008-10#1)(2008-7#1)
834##2##1##(1993-1#1)(1997-4#1)
835##3##1##(2008-10#1)(2008-12#1)(2008-3#1)
837##4##1##(2010-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
838##2##1##(1995-3#1)(2008-8#1)
839##2##1##(2008-3#1)(2013-8#1)
84 % of the##2##4##(2007-8#1)(2012-12#1)
84 +/-##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
84 and 0##3##3##(2008-10#3)
84 and##13##2##(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#8)(2009-12#1)(2012-1#1)
84 days##4##2##(1996-12#2)(2008-10#2)
84 degrees##2##2##(2008-3#1)(2008-5#1)
84 h##2##2##(2008-10#1)(2010-8#1)
84 hemorrhages##3##2##(2012-3#3)
84 kDa##2##2##(1992-10#1)(2008-10#1)
84 patients##6##2##(1994-3#1)(2007-7#1)(2008-3#2)(2008-5#1)(2012-3#1)
84 per##2##2##(1994-7#1)(2008-1#1)
84 samples##2##2##(1993-2#2)
84 vs##2##2##(2008-10#1)(2011-1#1)
84 were##2##2##(2008-10#1)(2013-8#1)
84 years##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
84##155##1##(1990-10#1)(1990-11#2)(1990-6#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-7#1)(2007-10#1)(2007-12#2)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#38)(2008-11#1)(2008-12#5)(2008-3#5)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-8#3)(2011-1#4)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#11)(2012-6#1)(2013-1#5)(2013-8#3)
84% and##6##2##(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#2)
84% for##2##2##(1990-12#1)(2008-10#1)
84% identity to##2##3##(1993-2#1)(1996-12#1)
84% identity with##2##3##(1993-3#1)(2008-10#1)
84% identity##6##2##(1990-7#1)(1993-2#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-7#1)
84% in##3##2##(1996-9#1)(2007-12#1)(2008-10#1)
84% of cases##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
84% of the##4##3##(1997-8#1)(2008-10#3)
84% of##19##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-5#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
84%##55##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#6)
84%)##5##1##(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-3#1)
84) and##2##2##(2008-10#1)(2013-7#1)
84) was##2##2##(2010-4#1)(2013-8#1)
84)##7##1##(2008-10#3)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
84-A resolution##2##2##(1992-4#2)
84-year-old##3##1##(1995-3#1)(2008-7#1)(2010-6#1)
840 nm##2##2##(2008-10#1)(2008-2#1)
840##10##1##(1990-12#1)(1994-6#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#2)(2009-3#1)
840)##2##1##(1991-3#1)(2007-11#1)
842##3##1##(1993-1#1)(1995-12#1)(2011-2#1)
843 nm##2##2##(2008-10#1)(2008-3#1)
843##5##1##(1990-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
844 and##2##2##(2008-10#1)(2008-12#1)
844##6##1##(1992-9#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-8#1)
845##4##1##(1993-8#2)(2008-7#1)(2012-12#1)
846##3##1##(2008-2#1)(2008-3#1)(2008-8#1)
848##2##1##(1992-3#1)(1996-10#1)
849##3##1##(2008-3#1)(2010-11#2)
84R-62B and Y93-245c-2##2##3##(2008-10#2)
84R-62B##5##1##(2008-10#5)
85 +/- 0##2##3##(2008-3#2)
85 +/-##5##2##(2008-10#1)(2008-3#3)(2008-5#1)
85 -##3##2##(2007-7#1)(2011-1#1)(2011-2#1)
85 and 1##2##3##(2008-10#2)
85 and##15##2##(1991-8#1)(1993-3#1)(1994-5#2)(1994-9#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-6#2)
85 dB (A)##2##3##(2011-2#2)
85 dB##3##2##(2008-2#1)(2011-2#2)
85 degrees C##5##3##(2008-10#2)(2008-2#2)(2008-7#1)
85 degrees##6##2##(2008-10#3)(2008-2#2)(2008-7#1)
85 in##3##2##(1990-9#1)(2007-12#1)(2009-4#1)
85 microm##2##2##(2007-11#1)(2008-3#1)
85 mm##2##2##(1994-6#1)(2013-8#1)
85 mug##2##2##(2008-10#2)
85 mum PA##2##3##(2008-10#2)
85 mum##3##2##(2008-10#3)
85 nM##2##2##(1990-11#1)(1995-12#1)
85 nm##2##2##(2007-11#1)(2008-3#1)
85 patients who were##2##4##(2008-8#2)
85 patients with##2##3##(1996-7#1)(2009-8#1)
85 patients##5##2##(1996-7#1)(2008-8#3)(2009-8#1)
85 per cent##2##3##(1990-6#1)(1992-5#1)
85 percent##2##2##(2008-1#1)(2008-11#1)
85 samples##3##2##(2007-7#2)(2008-10#1)
85 to 95%##2##3##(2008-10#2)
85 to##8##2##(1995-12#1)(1996-12#1)(2008-10#6)
85 units##2##2##(2011-2#2)
85 vs##3##2##(2012-3#3)
85 x##2##2##(2008-10#1)(2008-3#1)
85 years old##2##3##(2008-7#1)(2009-8#1)
85 years or older##3##4##(2007-10#3)
85 years##13##2##(1990-5#1)(1994-5#1)(2007-10#3)(2008-7#4)(2009-8#2)(2012-12#1)(2013-1#1)
85##208##1##(1990-11#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-5#1)(1992-6#3)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(2007-10#5)(2007-11#6)(2007-12#5)(2007-7#5)(2007-8#2)(2008-1#4)(2008-10#49)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#9)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#5)(2009-4#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-12#1)(2011-1#4)(2011-2#13)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#4)(2013-8#6)
85% after##2##2##(2013-1#1)(2013-7#1)
85% and##5##2##(2007-12#1)(2008-10#1)(2008-8#2)(2011-1#1)
85% answered##2##2##(1990-6#1)(1996-6#1)
85% at##3##2##(1996-11#1)(2008-10#1)(2008-5#1)
85% for##4##2##(1995-3#1)(2008-10#2)(2011-2#1)
85% homology##3##2##(1991-6#1)(1992-8#2)
85% in##4##2##(1994-9#1)(2007-11#1)(2009-8#1)(2010-5#1)
85% of all##2##3##(2010-12#1)(2011-2#1)
85% of patients##3##3##(2007-10#1)(2010-3#1)(2010-4#1)
85% of the total variance for##2##6##(2008-10#2)
85% of the##11##3##(1990-2#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-12#1)(2010-12#1)
85% of##30##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
85% relative humidity##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
85% respectively##2##2##(2007-7#1)(2011-1#1)
85% solid tubular component)##2##4##(1995-4#2)
85% vs##2##2##(2007-10#2)
85% were##2##2##(1992-6#1)(2007-7#1)
85% ±##2##2##(2013-8#2)
85%##118##1##(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1994-9#2)(1995-3#1)(1995-4#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
85%) and##2##2##(2008-10#1)(2008-12#1)
85%) were##2##2##(2012-3#1)(2013-8#1)
85%)##15##1##(1992-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
85) and##2##2##(1993-2#1)(2013-1#1)
85)##8##1##(1993-2#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
85-1##2##1##(2007-10#2)
85-90%##3##1##(1996-5#1)(2008-11#1)(2012-2#1)
85-95%##2##1##(2008-10#2)
85-kDa##3##1##(1992-10#1)(1992-12#1)(1993-11#1)
850 and##2##2##(1990-12#1)(2008-2#1)
850 kb##2##2##(1995-6#1)(1996-6#1)
850 m##3##2##(2008-12#3)
850 nm##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
850##31##1##(1990-12#4)(1995-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#3)
851##4##1##(1990-12#2)(2008-10#1)(2008-8#1)
852##6##1##(1990-12#2)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
852-nm##2##1##(2007-12#1)(2008-2#1)
854##5##1##(1990-12#1)(1994-2#1)(1994-6#1)(2010-7#1)(2013-1#1)
855##2##1##(2008-11#1)(2013-7#1)
856 nm##2##2##(2008-10#2)
856 nm)##2##2##(2008-10#1)(2008-3#1)
856##6##1##(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#1)
857##3##1##(1990-2#1)(1996-12#1)(2010-12#1)
858##4##1##(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
859##8##1##(1993-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
86 +/-##3##2##(1996-2#1)(2008-4#1)(2011-1#1)
86 and##10##2##(1997-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-4#2)(2011-2#2)
86 km)##2##2##(2008-3#2)
86 mg##2##2##(1997-8#1)(2008-10#1)
86 of the##2##3##(2008-10#1)(2008-12#1)
86 patients##4##2##(1990-2#1)(2007-11#2)(2013-1#1)
86 to 100%##2##3##(1990-11#1)(2008-10#1)
86 to##7##2##(1990-11#1)(1993-11#1)(2008-10#5)
86 x##6##2##(2008-10#5)(2008-11#1)
86 years##2##2##(2008-4#1)(2008-7#1)
86##134##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#2)(2008-10#40)(2008-11#5)(2008-12#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
86% and##4##2##(2008-6#2)(2008-7#1)(2013-8#1)
86% for##2##2##(1990-12#1)(2008-11#1)
86% identity with##2##3##(1997-4#1)(2008-10#1)
86% in##2##2##(2008-10#1)(2008-6#1)
86% of patients with##2##4##(2008-3#1)(2013-1#1)
86% of the##3##3##(1993-3#1)(1995-8#1)(1997-2#1)
86% of##11##2##(1992-6#1)(1993-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-3#2)(2008-7#1)(2013-1#1)
86%##45##1##(1990-12#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#5)(2008-7#2)(2008-9#1)(2012-12#1)(2013-1#3)(2013-8#3)
86%) and##2##2##(1996-5#1)(2007-7#1)
86%) patients##2##2##(2012-12#2)
86%)##6##1##(1996-5#1)(2007-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
86) and##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
86)##14##1##(1991-8#1)(1993-2#1)(1997-8#2)(2007-12#2)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#2)
86+/-0##2##1##(2008-10#2)
860##7##1##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2011-7#1)
862##4##1##(1990-5#1)(2007-12#1)(2008-10#1)(2008-6#1)
863##2##1##(1997-2#1)(2012-12#1)
864##6##1##(1993-6#1)(2008-10#4)(2013-7#1)
865 nm##6##2##(2008-2#5)(2008-3#1)
865##11##1##(1991-9#2)(1994-12#1)(2007-12#1)(2008-2#5)(2008-3#1)(2012-12#1)
866 isolates##3##2##(2008-10#3)
866##4##1##(2008-10#3)(2011-2#1)
868##2##1##(1992-10#1)(2009-3#1)
869##3##1##(1990-7#1)(2008-3#1)(2011-2#1)
86Rb efflux##2##2##(1994-3#2)
86Rb##3##1##(1994-3#3)
87 +/- 0##4##3##(1995-12#1)(2008-5#1)(2008-7#1)(2010-4#1)
87 +/-##8##2##(1990-3#1)(1995-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-3#1)
87 and##9##2##(1991-12#1)(1993-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)
87 individuals##2##2##(2008-5#2)
87 patients##4##2##(1994-3#1)(1995-4#1)(2007-8#1)(2008-3#1)
87##122##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#5)(2008-1#5)(2008-10#26)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-4#2)(2009-8#1)(2010-10#2)(2010-4#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
87% and##2##2##(1991-12#1)(2008-3#1)
87% for##3##2##(1994-2#1)(2007-7#1)(2007-8#1)
87% in##3##2##(2007-8#1)(2011-2#2)
87% of the patients##2##4##(1994-11#1)(2008-7#1)
87% of the##7##3##(1994-11#1)(1994-9#1)(1995-9#1)(1996-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
87% of##12##2##(1994-11#1)(1994-2#1)(1994-9#1)(1995-9#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-12#2)(2013-8#1)
87% were##2##2##(2008-10#1)(2011-1#1)
87%##44##1##(1991-12#2)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#2)(1994-9#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-8#3)
87%)##6##1##(2008-10#2)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
87)##15##1##(1991-5#1)(1992-9#1)(1993-9#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
870 nm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
870##12##1##(1995-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)
871##2##1##(2007-11#1)(2013-1#1)
8710 (1997)]##2##2##(2008-3#2)
872##6##1##(1995-11#3)(2011-2#3)
873##3##1##(1994-2#1)(2008-3#1)(2008-8#1)
873)##2##1##(1995-3#2)
874##6##1##(1995-1#1)(1997-6#1)(2008-10#3)(2008-11#1)
875##6##1##(1990-11#1)(2007-12#1)(2008-11#1)(2011-1#2)(2011-2#1)
877##4##1##(2008-11#1)(2008-8#2)(2012-12#1)
878##5##1##(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#1)
879##2##1##(1997-4#1)(2012-3#1)
87A7##2##1##(1995-2#2)
88 and##2##2##(2008-10#1)(2008-12#1)
88 consecutive##2##2##(2009-3#1)(2011-1#1)
88 farms##2##2##(1990-3#2)
88 for##2##2##(2008-9#1)(2011-2#1)
88 patients##4##2##(1991-8#1)(1996-6#1)(2007-8#1)(2009-9#1)
88 percent##2##2##(1996-3#1)(1997-2#1)
88 to 0##3##3##(2008-10#1)(2013-1#2)
88 to##12##2##(1993-12#1)(2008-10#7)(2008-8#1)(2013-1#2)(2013-8#1)
88##128##1##(1990-10#1)(1990-3#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-8#2)(1994-12#1)(1994-9#2)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-5#3)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#5)(2012-2#5)(2013-1#4)(2013-8#4)
88% and##5##2##(1990-12#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-7#1)
88% homology with##2##3##(1993-11#1)(1996-10#1)
88% identity to the##2##4##(1996-12#1)(1997-3#1)
88% in##3##2##(1994-8#1)(2010-12#1)(2010-4#1)
88% of the##7##3##(1992-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)
88% of##20##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1995-9#1)(1997-3#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-11#1)(2010-7#1)
88%##71##1##(1990-11#1)(1990-12#3)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1997-3#3)(1997-4#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
88%)##3##1##(1990-6#1)(2008-10#1)(2011-1#1)
88)##6##1##(1991-5#1)(1997-2#1)(2007-10#1)(2008-10#1)(2013-1#2)
88+/-0##3##1##(2008-10#2)(2008-5#1)
880 and 945 nm)##2##4##(2008-11#2)
880 and 945##3##3##(2008-11#3)
880##8##1##(2008-10#1)(2008-11#4)(2010-1#1)(2011-2#2)
8800##2##1##(1997-3#1)(2008-1#1)
881##4##1##(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
882##2##1##(2007-8#1)(2012-12#1)
883##2##1##(2012-3#1)(2013-1#1)
887##3##1##(2007-8#1)(2008-10#1)(2008-12#1)
88788##8##1##(2008-10#8)
889##5##1##(1991-12#1)(1994-9#1)(2012-3#3)
89 %##2##2##(2010-10#1)(2011-1#1)
89 +/- 0##3##3##(1995-12#1)(2008-3#1)(2008-8#1)
89 +/-##6##2##(1994-11#1)(1994-6#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
89 GHz##2##2##(2008-10#1)(2013-8#1)
89 and 0##3##3##(2008-10#3)
89 and##10##2##(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2012-3#1)
89 hospitals##2##2##(2008-8#2)
89 in##2##2##(2007-11#1)(2008-10#1)
89 isolates##2##2##(2008-10#1)(2011-1#1)
89 of##2##2##(2008-10#1)(2008-5#1)
89 patients with##2##3##(1990-2#1)(2011-1#1)
89 patients##5##2##(1990-2#1)(1992-11#1)(1992-9#1)(2009-11#1)(2011-1#1)
89 per##2##2##(1991-11#1)(1995-12#1)
89 to##2##2##(2008-10#2)
89##118##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-6#1)(1995-12#2)(1996-12#1)(1997-5#1)(2007-10#2)(2007-11#8)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#29)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#11)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
89% compared with##2##3##(1990-9#1)(2008-6#1)
89% compared##3##2##(1990-9#1)(2007-8#1)(2008-6#1)
89% for##2##2##(2008-10#2)
89% in##2##2##(2007-10#1)(2008-10#1)
89% of the##8##3##(1991-2#1)(1995-2#1)(2007-8#1)(2008-10#2)(2009-4#1)(2011-1#1)(2013-1#1)
89% of##10##2##(1991-2#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
89% to##2##2##(2008-12#1)(2009-7#1)
89% with##2##2##(1997-4#1)(2008-10#1)
89%##49##1##(1990-9#1)(1991-2#2)(1991-4#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-12#2)(1995-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
89%)##4##1##(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
89)##10##1##(1993-9#1)(1996-8#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#2)
890##5##1##(1996-2#1)(1997-8#1)(2008-5#1)(2008-8#2)
891##4##1##(1994-2#1)(1996-1#1)(2008-10#1)(2012-3#1)
892##2##1##(2007-7#1)(2011-1#1)
893##15##1##(1997-3#1)(2007-12#1)(2008-10#11)(2009-4#1)(2011-2#1)
894##2##1##(2008-4#1)(2009-10#1)
895##2##1##(2008-10#1)(2008-9#1)
896##4##1##(2008-10#1)(2008-2#1)(2011-2#2)
89B61##3##1##(2008-10#3)
8CH exchange##2##2##(1992-4#2)
8CH##5##1##(1992-4#5)
8Gy##5##1##(2008-10#5)
8H##2##1##(1995-2#1)(2009-9#1)
8Kb##2##1##(1991-12#2)
8M##3##1##(2008-10#3)
8N + 0##2##3##(2008-12#2)
8N##3##1##(2008-12#2)(2008-3#1)
8Neu5Gc##4##1##(1994-11#4)
8S and##2##2##(1997-7#1)(2010-10#1)
8S gene##2##2##(2008-10#2)
8S rDNA and##2##3##(2008-10#2)
8S rDNA##5##2##(2008-10#4)(2012-2#1)
8S rRNA##2##2##(2008-10#2)
8S regions of##2##3##(2008-10#1)(2010-10#1)
8S regions##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
8S ribosomal DNA##3##3##(2008-10#3)
8S ribosomal##4##2##(2008-10#4)
8S to##2##2##(1995-2#1)(2008-10#1)
8S##28##1##(1995-2#2)(1997-7#1)(2008-10#18)(2008-12#2)(2008-8#1)(2008-9#1)(2010-10#2)(2012-2#1)
8S-26S rRNA##2##2##(2008-5#2)
8S-26S##3##1##(2008-5#3)
8S-ITS 2)##2##2##(2008-10#2)
8S-ITS2 sequences##2##2##(2008-10#2)
8S-ITS2##3##1##(2008-10#3)
8U of##2##2##(2008-10#2)
8Z##3##1##(2009-10#3)
8]##4##1##(1990-10#2)(2008-10#2)
8a##3##1##(1996-5#3)
8cm##2##1##(2008-10#1)(2013-8#1)
8cm)##2##1##(2009-1#1)(2009-10#1)
8h##4##1##(2008-10#3)(2008-6#1)
8mM##3##1##(2008-10#3)
8mV/decade##2##1##(2008-10#2)
8microm##2##1##(2007-12#2)
8min##4##1##(2008-10#4)
8ml##2##1##(2008-10#2)
8mlmin(-1)##2##1##(2008-10#2)
8muM##2##1##(2008-10#2)
8mugl(-1)##2##1##(2008-10#2)
8mugml(-1)##5##1##(2008-10#5)
8mum with##2##2##(2007-11#2)
8mum##4##1##(2007-11#3)(2007-12#1)
8ngml(-1)##3##1##(2008-10#3)
8nm##2##1##(2008-10#2)
8s##4##1##(2008-10#4)
8th and##2##2##(1991-3#1)(2012-3#1)
8th grade##3##2##(1993-6#1)(2010-4#1)(2013-7#1)
8th##19##1##(1991-3#1)(1992-3#1)(1993-6#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-4#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)
8x##2##1##(2008-2#1)(2008-3#1)
8x10(-10) and##2##2##(2008-10#2)
8x10(-10)##3##1##(2008-10#3)
8x10(-3) mol l(-1)##2##3##(2008-10#2)
8x10(-3) mol##3##2##(2008-10#3)
8x10(-3)##4##1##(2008-10#4)
8x10(-4)##2##1##(2008-10#2)
8x10(-5) M##4##2##(2008-10#3)(2008-11#1)
8x10(-5)##5##1##(2008-10#4)(2008-11#1)
8x10(-6)##2##1##(2008-10#2)
8x10(-6)M and##2##2##(2008-10#2)
8x10(-6)M##5##1##(2008-10#5)
8x10(-7)##3##1##(2008-10#3)
8x10(-8)##2##1##(2008-10#2)
8x10(-9) to##3##2##(2008-10#3)
8x10(-9)##4##1##(2008-10#4)
8x10(4)##3##1##(2008-10#3)
8°C and average humidity##2##4##(2011-1#2)
8±12##2##1##(2012-12#1)(2013-1#1)
8 weeks after ESD##2##3##(2012-2#2)
8 weeks##4##1##(2012-2#4)
9 % of the##2##4##(2011-1#1)(2012-12#1)
9 % of##3##3##(2007-11#1)(2011-1#1)(2012-12#1)
9 %##8##2##(2007-10#1)(2007-11#2)(2011-1#1)(2011-2#1)(2012-12#3)
9 %)##6##2##(2011-2#1)(2012-12#5)
9 (+/-0##2##2##(2008-10#1)(2008-2#1)
9 (1##5##2##(1990-8#2)(1996-12#1)(2011-2#1)(2013-8#1)
9 (26##2##2##(2007-10#1)(2008-7#1)
9 (4##2##2##(2008-1#1)(2013-8#1)
9 (75%)##2##2##(1991-12#1)(1992-12#1)
9 (95% C##3##3##(1994-12#3)
9 (95% CI##3##3##(2006-10#1)(2007-10#2)
9 (95%##7##2##(1994-12#3)(2006-10#1)(2007-10#2)(2013-1#1)
9 (SD##2##2##(2008-5#1)(2012-12#1)
9 (range##3##2##(2007-11#1)(2008-12#1)(2012-12#1)
9 (±1##2##2##(2010-10#2)
9 + 2##2##3##(2008-7#2)
9 +##3##2##(2008-7#3)
9 +/- 0##9##3##(1991-5#1)(1996-2#1)(2007-10#1)(2008-10#5)(2008-12#1)
9 +/- 1##7##3##(1990-5#1)(1991-11#1)(1993-8#1)(1995-12#2)(2008-3#1)(2008-5#1)
9 +/- 2##7##3##(1990-12#1)(1990-7#1)(1991-9#1)(1994-2#1)(1995-11#1)(2008-10#1)(2013-1#1)
9 +/- 3##4##3##(1991-4#1)(1995-12#2)(2008-10#1)
9 +/- 4##5##3##(1993-2#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-3#1)
9 +/- 5##3##3##(1992-11#1)(1996-3#1)(1997-4#1)
9 +/- 6##3##3##(1990-12#1)(1994-2#1)(2008-11#1)
9 +/- 8##2##3##(1990-7#1)(1995-8#1)
9 +/-##52##2##(1990-12#2)(1990-5#1)(1990-7#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-8#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#5)(1995-5#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-4#1)(2007-10#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)
9 5FLR patients##2##3##(2007-10#2)
9 =##3##2##(2007-11#2)(2008-10#1)
9 A##4##2##(1992-9#1)(1995-2#1)(2008-8#1)(2009-11#1)
9 August 1998##3##3##(2008-3#3)
9 Hz##2##2##(1991-12#1)(2007-12#1)
9 M##2##2##(1992-6#1)(2008-10#1)
9 N/mm##2##2##(2009-4#2)
9 Registry##3##2##(2008-3#3)
9 U/ml##2##2##(1993-1#2)
9 W of##2##3##(2007-11#1)(2007-12#1)
9 W##7##2##(2007-11#2)(2007-12#4)(2008-2#1)
9 [0##2##2##(1990-3#1)(1991-8#1)
9 am##2##2##(1990-3#1)(2008-5#1)
9 and 1##5##3##(1995-6#1)(2008-10#3)(2008-12#1)
9 and 10##6##3##(1996-5#1)(2008-10#2)(2008-5#1)(2013-1#2)
9 and 11 of Actinobacillus pleuropneumoniae##2##6##(1996-12#2)
9 and 11##6##3##(1996-12#4)(2008-3#1)(2008-9#1)
9 and 12 months##2##4##(2013-1#2)
9 and 12##3##3##(2011-2#1)(2013-1#2)
9 and 13##2##3##(2007-12#1)(2008-10#1)
9 and 14##2##3##(1991-4#1)(2013-1#1)
9 and 15##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
9 and 2##3##3##(1995-2#1)(2007-11#1)(2008-10#1)
9 and 20##2##3##(1994-9#1)(2011-2#1)
9 and 22##3##3##(2007-11#2)(2012-12#1)
9 and 3##4##3##(2008-10#3)(2008-11#1)
9 and 4##8##3##(1995-12#1)(2007-8#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)
9 and inhibited##2##3##(2008-10#1)(2012-3#1)
9 and##88##2##(1990-8#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#31)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#2)(2011-2#3)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#7)
9 billion##4##2##(1992-3#1)(1994-1#1)(2008-11#1)(2010-12#1)
9 by##4##2##(1997-7#1)(1997-8#1)(2008-10#1)(2012-1#1)
9 cM##2##2##(1997-5#1)(2008-10#1)
9 cases with##2##3##(1994-7#1)(2011-1#1)
9 cases##10##2##(1991-11#1)(1993-9#1)(1994-7#1)(1997-8#1)(2007-11#2)(2007-7#1)(2009-3#1)(2011-1#1)(2013-8#1)
9 cases]##3##2##(1993-2#1)(2009-5#1)(2013-1#1)
9 cm H(2)O (range##2##4##(1993-10#2)
9 cm in##2##3##(2008-10#1)(2009-3#1)
9 cm##9##2##(1993-10#2)(1995-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-3#1)
9 cm(-1)##2##2##(2007-11#1)(2008-2#1)
9 d yielded##2##3##(2011-2#2)
9 d##6##2##(2011-2#6)
9 dB##6##2##(1995-6#1)(2007-11#1)(2008-3#3)(2008-7#1)
9 days after inoculation##2##4##(2008-10#2)
9 days after##3##3##(1995-12#1)(2008-10#2)
9 days and##2##3##(1995-3#1)(2011-2#1)
9 days for##2##3##(1991-5#1)(2008-6#1)
9 days##26##2##(1990-6#1)(1991-5#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-3#1)(2007-6#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
9 degrees C##6##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
9 degrees##11##2##(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#3)(2009-10#2)(2012-2#1)
9 fish species of the genus Puntius Hamilton 1822##2##9##(2008-12#2)
9 fish species##3##3##(2008-12#3)
9 for the##2##3##(2008-10#1)(2008-7#1)
9 for##8##2##(1993-9#1)(1994-6#1)(2007-11#1)(2008-10#4)(2008-7#1)
9 from##2##2##(2007-11#1)(2008-10#1)
9 g dry wt##2##4##(2007-5#2)
9 g##4##2##(2007-5#2)(2008-12#1)(2008-6#1)
9 h after inoculation##3##4##(2008-10#1)(2008-5#2)
9 h of##2##3##(1992-3#1)(1994-2#1)
9 h##7##2##(1992-3#1)(1994-2#1)(2008-10#2)(2008-5#2)(2009-3#1)
9 had##2##2##(1993-3#1)(1994-7#1)
9 hours##4##2##(1994-6#1)(2008-12#1)(2008-3#1)(2008-7#1)
9 in a##2##3##(1995-12#1)(2008-8#1)
9 in##12##2##(1991-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
9 is##2##2##(1997-7#1)(2008-10#1)
9 kDa arabinogalactan##2##3##(1995-11#2)
9 kDa##6##2##(1992-12#1)(1993-8#1)(1995-11#2)(2008-10#2)
9 kJ##2##2##(1993-11#1)(1996-2#1)
9 kb in##2##3##(2008-10#1)(2008-8#1)
9 kb of##2##3##(1996-12#1)(2008-10#1)
9 kb on the 5' side and by 1##2##9##(1993-12#1)(1993-6#1)
9 kb##11##2##(1992-3#2)(1993-12#1)(1993-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
9 kcal/mol##2##2##(1990-7#1)(1996-2#1)
9 kg##4##2##(1997-4#2)(2007-5#1)(2008-5#1)
9 m##2##2##(2007-5#1)(2008-10#1)
9 mM and##2##3##(1990-12#1)(1995-2#1)
9 mM dodecyl sulfate and##2##5##(1990-11#2)
9 mM dodecyl sulfate##3##4##(1990-11#3)
9 mM##8##2##(1990-11#3)(1990-12#1)(1991-12#1)(1994-9#1)(1995-2#1)(1995-5#1)
9 mW##2##2##(2007-12#1)(2008-3#1)
9 mg##8##2##(2008-10#5)(2008-11#1)(2010-12#1)(2013-8#1)
9 mg/kg##3##2##(1993-12#1)(1995-12#1)(2011-2#1)
9 microM##5##2##(1990-5#1)(1992-3#1)(2008-12#2)(2008-8#1)
9 microg##3##2##(1997-4#1)(2008-10#2)
9 microg/l##2##2##(2008-10#1)(2009-10#1)
9 microm##6##2##(2007-12#2)(2008-3#3)(2010-10#1)
9 microm)##2##2##(2008-2#1)(2008-3#1)
9 million in##2##3##(1992-6#1)(1997-3#1)
9 million years##2##3##(1994-3#1)(2008-10#1)
9 million##7##2##(1991-3#1)(1992-12#1)(1992-6#1)(1994-3#1)(1996-3#1)(1997-3#1)(2008-10#1)
9 min##2##2##(1996-2#1)(2007-8#1)
9 minutes##4##2##(2007-2#1)(2008-6#1)(2013-1#2)
9 ml min(-1))##2##3##(2008-10#2)
9 ml##4##2##(2008-10#4)
9 ml/100 g brain/min)##2##4##(2007-10#2)
9 mm Hg)##3##3##(1991-5#1)(2007-10#1)(2010-4#1)
9 mm and##2##3##(2013-1#2)
9 mm diameter wire##2##4##(2007-8#2)
9 mm##21##2##(1991-5#2)(1996-2#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-2#1)(2010-4#1)(2013-1#3)(2013-8#1)
9 mm)##2##2##(2007-12#1)(2008-5#1)
9 mmHg##2##2##(1991-6#1)(2009-8#1)
9 mmol##2##2##(2008-10#2)
9 mmol/l##3##2##(1994-12#2)(1994-3#1)
9 months (range##3##3##(1990-12#1)(2010-3#1)(2011-2#1)
9 months after the##2##4##(1991-12#1)(1997-8#1)
9 months after##5##3##(1991-12#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-6#1)
9 months following##2##3##(2011-2#1)(2013-1#1)
9 months of age##4##4##(1990-3#2)(1992-2#1)(1992-5#1)
9 months of treatment##2##4##(2007-11#1)(2007-12#1)
9 months of##9##3##(1990-3#2)(1992-2#1)(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
9 months to##2##3##(1995-3#1)(2008-7#1)
9 months##41##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
9 ms##2##2##(2008-10#1)(2011-2#1)
9 ms)##2##2##(1997-8#1)(2007-12#1)
9 mug ml(-1)##2##3##(2008-10#1)(2008-11#1)
9 mug##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
9 mum##5##2##(1993-2#1)(2008-2#3)(2008-7#1)
9 mum)##3##2##(1992-2#1)(2007-11#1)(2008-10#1)
9 mumol##2##2##(2008-10#2)
9 nM and##2##3##(1992-9#1)(2008-4#1)
9 nM##6##2##(1991-5#1)(1992-9#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-4#1)
9 ng g(-1)##2##3##(2008-10#1)(2010-5#1)
9 ng ml(-1)##3##3##(2008-10#3)
9 ng##9##2##(2008-10#8)(2010-5#1)
9 ng/ml of##2##3##(2008-10#2)
9 ng/ml) and##2##3##(1990-2#1)(2009-3#1)
9 nm##12##2##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#2)(2009-11#1)
9 ns##2##2##(2008-2#1)(2008-3#1)
9 of 11##2##3##(2008-10#2)
9 of the##8##3##(1990-2#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
9 of whom##2##3##(2011-1#2)
9 of##22##2##(1990-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-7#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
9 or less is associated with increased risk for both coronary heart disease and total cardiovascular disease morbidity and mortality##2##20##(1993-12#2)
9 or##4##2##(1993-12#2)(2008-10#1)(2008-6#1)
9 out of##6##3##(1990-12#2)(1992-9#1)(2008-12#2)(2013-1#1)
9 patients had##5##3##(1995-12#1)(2007-10#1)(2008-1#1)(2010-3#1)(2011-2#1)
9 patients who##2##3##(2008-3#1)(2008-7#1)
9 patients with##6##3##(1990-8#1)(1991-5#1)(1992-8#1)(2007-10#1)(2007-11#1)(2011-2#1)
9 patients##30##2##(1990-8#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-8#2)(1994-11#1)(1995-12#1)(1995-4#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-3#1)(2011-2#5)
9 per cent##2##3##(1992-5#1)(1997-8#1)
9 per cent) of the##3##5##(1990-3#2)(1997-8#1)
9 per cent)##6##3##(1990-3#2)(1996-8#3)(1997-8#1)
9 per##10##2##(1990-3#2)(1992-5#1)(1996-8#3)(1997-8#2)(2011-2#1)(2012-12#1)
9 percent of the##2##4##(1991-3#1)(1996-2#1)
9 percent##10##2##(1990-5#1)(1991-3#2)(1992-6#1)(1993-1#1)(1994-1#1)(1996-2#1)(2008-5#1)(2008-8#1)(2011-2#1)
9 persons##2##2##(2007-11#1)(2012-3#1)
9 pg##2##2##(2008-10#2)
9 pigeons##2##2##(2011-2#2)
9 pmol##3##2##(2008-10#2)(2008-7#1)
9 pmol/mg (n =##2##4##(2008-8#2)
9 points##3##2##(1994-6#1)(2011-2#1)(2012-2#1)
9 respectively##2##2##(2011-1#1)(2012-12#1)
9 s-1##2##2##(1995-8#2)
9 samples##3##2##(1990-2#1)(2007-10#1)(2008-9#1)
9 showed##3##2##(1994-7#1)(2008-10#1)(2013-1#1)
9 species##4##2##(2008-12#3)(2010-3#1)
9 subjects##2##2##(1996-7#1)(2009-1#1)
9 times higher than that of##2##6##(2008-9#1)(2011-3#1)
9 times higher##3##3##(2008-10#1)(2008-9#1)(2011-3#1)
9 times##4##2##(2008-10#1)(2008-9#1)(2011-3#1)(2013-1#1)
9 to 1##2##3##(2009-7#1)(2011-2#1)
9 to 10##3##3##(1992-3#1)(2008-10#2)
9 to 104##2##3##(2008-10#2)
9 to 11##2##3##(2008-10#2)
9 to 12##2##3##(1991-12#1)(2008-10#1)
9 to 15##2##3##(2006-8#1)(2008-10#1)
9 to 18##2##3##(2008-10#1)(2012-2#1)
9 to 21##2##3##(2008-1#1)(2008-10#1)
9 to 4##2##3##(2007-5#1)(2008-5#1)
9 to 5##2##3##(2007-8#1)(2008-3#1)
9 to 6##2##3##(2008-11#1)(2012-2#1)
9 to 8##2##3##(2008-10#1)(2011-2#1)
9 to 93##2##3##(2008-12#1)(2010-11#1)
9 to##54##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-11#1)(1992-3#1)(1996-12#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#27)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#2)
9 tumors##3##2##(1990-7#1)(1994-12#1)(1997-7#1)
9 vs##9##2##(1994-12#1)(1995-12#2)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
9 was##6##2##(1995-3#1)(2008-10#4)(2008-9#1)
9 weeks##11##2##(1990-3#1)(1994-5#1)(1996-5#1)(1996-6#1)(2007-7#1)(2008-11#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
9 were##2##2##(1996-12#1)(2008-10#1)
9 when##2##2##(1996-12#1)(2008-3#1)
9 with##4##2##(1991-7#1)(1996-12#1)(2008-10#1)(2008-7#1)
9 x 10(-3)##2##3##(2008-10#1)(2008-3#1)
9 x 10(-4)##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
9 x 10(-5)##2##3##(2008-10#1)(2008-2#1)
9 x 10(-6)##2##3##(1995-11#1)(2008-3#1)
9 x 10(-8)##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
9 x 10(5)##4##3##(1994-5#1)(1996-2#1)(2008-10#2)
9 x 10(6)##2##3##(1990-8#1)(2008-11#1)
9 x##30##2##(1990-8#2)(1994-5#1)(1995-11#2)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#4)(2008-8#1)(2009-11#1)(2010-6#1)(2011-1#1)
9 years after closure of a large ventricular septal defect##2##10##(2007-8#2)
9 years after##3##3##(2007-8#2)(2011-2#1)
9 years old##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
9 years##29##2##(1990-11#1)(1991-12#1)(1994-12#2)(1996-6#1)(1997-6#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
9 years)##7##2##(1991-8#1)(1993-12#1)(2008-1#1)(2008-7#1)(2012-12#1)(2013-1#2)
9 ± 12##2##3##(2013-1#1)(2013-8#1)
9 ±##7##2##(2010-9#1)(2012-3#2)(2013-1#2)(2013-8#2)
9 µm##2##2##(2013-1#2)
9##1752##1##(1990-11#9)(1990-12#13)(1990-2#9)(1990-3#13)(1990-5#7)(1990-6#6)(1990-7#6)(1990-8#14)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#7)(1991-12#11)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#10)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#11)(1992-2#4)(1992-3#8)(1992-4#2)(1992-5#4)(1992-6#8)(1992-8#3)(1992-9#11)(1993-1#5)(1993-10#2)(1993-11#2)(1993-12#8)(1993-2#6)(1993-3#9)(1993-6#6)(1993-8#13)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#15)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#9)(1994-7#4)(1994-8#6)(1994-9#7)(1995-11#10)(1995-12#21)(1995-2#14)(1995-3#12)(1995-4#2)(1995-5#4)(1995-6#13)(1995-8#5)(1995-9#2)(1996-11#3)(1996-12#20)(1996-2#17)(1996-3#10)(1996-5#12)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#4)(1997-2#7)(1997-3#6)(1997-4#11)(1997-5#5)(1997-6#5)(1997-7#15)(1997-8#10)(1997-9#1)(2006-10#2)(2006-8#2)(2007-10#21)(2007-11#52)(2007-12#32)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#3)(2007-7#11)(2007-8#20)(2007-9#1)(2008-1#15)(2008-10#403)(2008-11#33)(2008-12#36)(2008-2#26)(2008-3#57)(2008-4#15)(2008-5#24)(2008-6#17)(2008-7#46)(2008-8#28)(2008-9#18)(2009-1#2)(2009-10#7)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#7)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#7)(2010-3#5)(2010-4#6)(2010-5#6)(2010-6#4)(2010-8#3)(2010-9#2)(2011-1#21)(2011-2#67)(2011-3#5)(2012-1#4)(2012-12#22)(2012-2#15)(2012-3#34)(2012-7#1)(2013-1#69)(2013-3#1)(2013-7#1)(2013-8#25)
9% (95%##2##2##(2010-3#1)(2012-2#1)
9% (n=10)##2##2##(2008-10#2)
9% (v/v) of##2##3##(2008-10#1)(2011-1#1)
9% (w/w)##2##2##(2010-2#1)(2011-2#1)
9% NaCl##3##2##(1994-8#1)(2008-12#1)(2012-3#1)
9% NaCl)##2##2##(2008-5#1)(2012-3#1)
9% SI to S##2##4##(2008-10#2)
9% and 10##2##3##(1991-9#1)(2011-2#1)
9% and 2##2##3##(1992-3#1)(2011-1#1)
9% and 6##2##3##(2011-1#2)
9% and the##2##3##(1990-12#1)(1995-2#1)
9% and##26##2##(1990-12#1)(1991-4#1)(1991-9#1)(1992-3#2)(1995-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
9% as##2##2##(2008-10#1)(2012-12#1)
9% at##2##2##(2007-7#1)(2008-10#1)
9% belonged to##2##3##(2007-7#2)
9% by##4##2##(1990-12#1)(1997-6#1)(2008-11#1)(2011-1#1)
9% compared with##2##3##(2008-10#1)(2012-3#1)
9% for a##2##3##(2008-10#2)
9% for the##6##3##(1996-5#1)(1997-7#1)(2008-10#3)(2012-3#1)
9% for##26##2##(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
9% had a##2##3##(1994-12#1)(2008-7#1)
9% had##6##2##(1990-8#1)(1994-12#1)(1995-2#1)(2008-12#1)(2008-7#1)(2013-8#1)
9% improvement##2##2##(2008-2#1)(2010-10#1)
9% in 2005##2##3##(2012-12#1)(2013-1#1)
9% in the##7##3##(1991-4#1)(1996-6#1)(2008-10#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
9% in##22##2##(1990-12#1)(1991-4#1)(1992-9#1)(1994-6#1)(1995-3#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
9% isolates were resistant to##2##5##(2008-5#2)
9% of all##4##3##(1990-2#1)(1991-3#1)(1992-10#1)(2010-3#1)
9% of cases##2##3##(1995-12#1)(2010-6#1)
9% of patients (n =##2##5##(2008-7#1)(2012-3#1)
9% of patients##5##3##(2007-7#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
9% of the patients had##2##5##(2011-1#2)
9% of the population##2##4##(2008-7#1)(2012-2#1)
9% of the total##2##4##(2008-10#2)
9% of the##21##3##(1994-6#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
9% of##57##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-10#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)
9% saline##4##2##(1995-3#1)(2011-2#1)(2013-1#2)
9% to##9##2##(1991-9#1)(1995-9#1)(2008-4#1)(2011-1#3)(2013-1#3)
9% vs##7##2##(1990-7#1)(1994-3#1)(2007-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
9% was##3##2##(1991-12#1)(1994-6#1)(2009-1#1)
9% were not formally validated##2##5##(2013-1#2)
9% were##11##2##(1992-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-1#1)(2013-1#3)(2013-8#1)
9% with##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
9%##414##1##(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#3)(1994-9#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#14)(2007-8#4)(2008-1#3)(2008-10#89)(2008-11#8)(2008-12#12)(2008-2#3)(2008-3#17)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#5)(2009-1#1)(2009-4#3)(2009-7#3)(2010-1#4)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#22)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#10)(2012-3#9)(2013-1#27)(2013-8#11)
9%) and##12##2##(1990-3#1)(1991-12#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
9%) had a##2##3##(2012-2#1)(2013-8#1)
9%) had##5##2##(2007-8#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
9%) in##5##2##(2007-8#1)(2008-10#1)(2008-12#1)(2010-3#1)(2013-1#1)
9%) of the parents/guardians##2##4##(2008-9#2)
9%) of the##3##3##(2008-10#1)(2008-9#2)
9%) of##7##2##(1992-11#1)(2007-7#1)(2008-10#1)(2008-9#2)(2013-1#1)(2013-8#1)
9%) patients##2##2##(2011-1#1)(2012-12#1)
9%) than##3##2##(1995-8#1)(2012-12#1)(2012-3#1)
9%) was##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
9%) were found##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
9%) were##15##2##(1992-9#1)(1996-3#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
9%) with##4##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
9%)##141##1##(1990-3#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#3)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-7#6)(2007-8#6)(2008-1#10)(2008-10#8)(2008-11#2)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#9)(2008-7#3)(2008-8#3)(2008-9#6)(2009-6#1)(2010-11#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#13)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#9)
9(11)-dehydro-17alpha-methyl-testosterone##2##1##(2008-11#2)
9(3)##2##1##(1996-11#1)(1996-2#1)
9(th)##2##1##(2008-10#1)(2012-2#1)
9) and##10##2##(1993-12#3)(1995-1#1)(1995-12#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
9) mmHg##2##2##(2007-10#2)
9) was##2##2##(1990-7#1)(2010-3#1)
9) were##2##2##(2008-10#2)
9) μm based on##2##4##(2010-10#2)
9)##106##1##(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-12#6)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1996-4#1)(1997-3#1)(2007-10#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2010-10#2)(2010-2#1)(2010-3#3)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
9+/-0##18##1##(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-7#1)
9+/-1##10##1##(2007-8#3)(2008-10#3)(2008-7#3)(2010-3#1)
9+/-4##3##1##(2008-7#2)(2009-10#1)
9- and##2##2##(2007-12#1)(2008-10#1)
9-##7##1##(1990-11#1)(1990-12#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
9-(2##2##1##(1995-3#2)
9-(4-tert-butylphenyl)-3##2##1##(2010-4#2)
9-1##5##1##(1992-11#1)(1992-8#1)(1993-2#1)(2008-10#2)
9-10##6##1##(1991-12#1)(1992-8#1)(2007-11#1)(2008-10#2)(2008-5#1)
9-10-h lag##2##2##(1993-6#2)
9-100##2##1##(2008-10#2)
9-11##7##1##(1995-5#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
9-12##6##1##(1994-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
9-14##2##1##(2008-10#1)(2008-8#1)
9-15##4##1##(2008-7#2)(2012-2#1)(2013-1#1)
9-16##3##1##(1990-5#2)(2013-8#1)
9-18##2##1##(2008-10#1)(2008-9#1)
9-2##6##1##(2008-10#2)(2008-11#2)(2012-2#1)(2013-8#1)
9-3##3##1##(2008-10#1)(2008-5#1)(2012-3#1)
9-5##5##1##(2008-10#3)(2008-6#1)(2013-1#1)
9-89##2##1##(2010-3#1)(2013-7#1)
9-9##2##1##(1990-8#1)(2008-10#1)
9-MONTH STUDY IN Tg##2##4##(2008-8#1)(2008-9#1)
9-MONTH STUDY IN p53 HAPLOINSUFFICIENT MICE##2##6##(2008-8#1)(2008-9#1)
9-MONTH STUDY IN##5##3##(2008-8#3)(2008-9#2)
9-[2-fluoro-4-hydroxy-3-hydroxymethyl-2-butenyl]adenine and its related compounds##2##5##(2008-11#2)
9-aminoacridine##2##1##(1992-11#2)
9-cis-RA and##2##2##(1996-5#2)
9-cis-retinoic acid##2##2##(1994-6#1)(2008-4#1)
9-dimethyl-1##4##1##(2008-10#4)
9-fluorenylmethoxycarbonyl##2##1##(2008-10#1)(2011-1#1)
9-fluorenylmethyl chloroformate (FMOC)##2##3##(2008-10#2)
9-fluorenylmethyl chloroformate##4##2##(1995-2#1)(2008-10#3)
9-fold increase in##4##3##(1991-11#1)(1993-6#1)(2012-12#2)
9-fold increase##5##2##(1990-5#1)(1991-11#1)(1993-6#1)(2012-12#2)
9-fold##11##1##(1990-5#1)(1991-11#1)(1993-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#2)
9-hour period##2##2##(2007-8#1)(2008-3#1)
9-hour##3##1##(2007-8#2)(2008-3#1)
9-hydroxy##2##1##(1990-12#1)(2011-1#1)
9-kDa##3##1##(1992-3#1)(2008-10#1)(2011-2#1)
9-kb##4##1##(2008-10#3)(2008-11#1)
9-microm scintillometer##2##2##(2008-2#2)
9-month##6##1##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)
9-month-old##2##1##(2007-7#1)(2013-8#1)
9-nm##2##1##(2007-12#1)(2008-3#1)
9-ps##2##1##(2007-12#2)
9-tetrahydrocannabinol##5##1##(1991-10#2)(1991-4#2)(1996-2#1)
9-times##2##1##(2008-3#1)(2011-1#1)
9-trienoic acid##2##2##(1990-7#2)
9-year-old##8##1##(1991-6#1)(1994-3#1)(1996-6#1)(2008-10#1)(2012-12#3)(2013-1#1)
9/10##4##1##(1992-8#1)(1995-12#1)(2008-8#1)(2012-3#1)
9/14##2##1##(1991-4#1)(2008-4#1)
9/2##2##1##(1991-5#1)(2013-1#1)
90 % of the##2##4##(2007-7#1)(2012-12#1)
90 % of##3##3##(2007-7#1)(2012-12#2)
90 +/-##3##2##(1995-12#1)(2008-8#1)(2011-2#1)
90 MHz##2##2##(2007-12#1)(2009-5#1)
90 amino acids##3##3##(1991-2#1)(1995-6#1)(2008-10#1)
90 and 0##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
90 and 120##2##3##(2008-1#1)(2010-2#1)
90 and##22##2##(1990-2#1)(1993-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-8#1)
90 compounds##2##2##(2008-10#1)(2008-11#1)
90 days after##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
90 days of##3##3##(1997-4#1)(2008-6#1)(2013-1#1)
90 days##28##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#4)(2013-1#1)
90 days)##2##2##(2008-10#1)(2013-8#1)
90 degrees C for##2##4##(2008-10#2)
90 degrees C##9##3##(1990-2#2)(2008-10#5)(2008-12#1)(2008-7#1)
90 degrees and##2##3##(2007-11#1)(2008-2#1)
90 degrees from the##2##4##(2007-12#2)
90 degrees phase##4##3##(2008-2#1)(2008-3#2)(2009-6#1)
90 degrees to##2##3##(2008-3#1)(2009-3#1)
90 degrees##49##2##(1990-2#2)(1991-7#1)(1992-11#1)(1993-8#4)(1996-2#1)(1997-7#2)(2007-11#5)(2007-12#3)(2008-10#5)(2008-12#1)(2008-2#10)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#2)(2009-6#1)(2013-1#1)
90 determinations per##2##3##(2008-10#2)
90 for##2##2##(2008-10#1)(2008-6#1)
90 h##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
90 h(-1)##6##2##(2008-10#6)
90 in##2##2##(2008-7#1)(2012-1#1)
90 injections##2##2##(2008-10#2)
90 kDa protein##3##3##(1997-3#1)(2008-7#2)
90 kDa##9##2##(1997-3#1)(1997-4#1)(2008-7#3)(2009-8#1)(2012-1#3)
90 m##2##2##(2008-10#2)
90 mg##2##2##(2008-7#2)
90 microM##2##2##(1990-12#1)(2011-2#1)
90 min after##2##3##(1992-12#2)
90 min of ischemia##2##4##(1995-12#2)
90 min of##4##3##(1990-5#1)(1994-2#1)(1995-12#2)
90 min##18##2##(1990-5#1)(1992-12#3)(1992-6#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2013-1#1)
90 minutes at##2##3##(1994-3#1)(2008-12#1)
90 minutes##6##2##(1994-3#1)(2008-10#2)(2008-12#1)(2012-2#1)(2013-1#1)
90 mm##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
90 mmol##2##2##(2008-10#2)
90 mug/ml##2##2##(2008-10#1)(2008-11#1)
90 ng##3##2##(2008-10#3)
90 patients##5##2##(2008-1#1)(2008-5#1)(2012-2#2)(2013-1#1)
90 per##3##2##(1990-9#1)(1992-2#1)(1992-6#1)
90 s##7##2##(2008-10#6)(2008-3#1)
90 samples##2##2##(2008-10#2)
90 to 120##2##3##(2008-10#1)(2008-7#1)
90 to##14##2##(1990-2#1)(1996-12#1)(2008-10#11)(2008-7#1)
90 tubers##2##2##(2008-10#2)
90 years of##3##3##(1995-1#1)(2007-8#1)(2011-1#1)
90 years##7##2##(1995-1#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-2#1)
90##421##1##(1990-11#1)(1990-12#2)(1990-2#7)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1993-12#3)(1993-3#1)(1993-6#3)(1993-8#5)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-5#2)(1995-6#7)(1996-12#3)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#11)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#9)(2008-10#105)(2008-11#11)(2008-12#7)(2008-2#13)(2008-3#15)(2008-4#3)(2008-5#12)(2008-6#6)(2008-7#14)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#9)(2011-2#17)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#12)(2013-8#7)
90% RH##2##2##(2011-2#2)
90% and the##4##3##(1996-12#1)(2008-10#2)(2012-12#1)
90% and##13##2##(1993-11#1)(1993-8#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
90% are##2##2##(2008-1#1)(2008-3#1)
90% confidence interval 1##2##4##(2007-10#2)
90% confidence interval##3##3##(2007-10#2)(2008-7#1)
90% confidence##6##2##(2007-10#2)(2008-10#2)(2008-2#1)(2008-7#1)
90% depending on the##2##4##(2008-5#1)(2012-12#1)
90% for the##2##3##(1992-3#1)(2008-10#1)
90% for##7##2##(1992-3#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2012-3#1)
90% had##2##2##(2008-10#1)(2011-2#1)
90% identical##2##2##(1991-6#1)(1997-4#1)
90% in the##3##3##(1992-11#1)(1993-6#1)(2008-10#1)
90% in##12##2##(1990-12#1)(1992-11#1)(1992-12#1)(1993-6#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
90% inhibition##2##2##(2008-10#1)(2008-5#1)
90% leaf##2##2##(2008-10#2)
90% mastery##2##2##(2008-12#2)
90% of cases##6##3##(1990-6#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-12#1)
90% of children and adolescents with Hodgkin's disease (HD)##2##9##(2011-2#2)
90% of patients with##3##4##(2012-2#2)(2013-1#1)
90% of patients##9##3##(1991-6#1)(2007-7#2)(2008-6#2)(2010-4#1)(2012-2#2)(2013-1#1)
90% of the patients##7##4##(1990-12#1)(1992-1#1)(1992-4#1)(1994-9#1)(2007-7#1)(2008-9#1)(2010-8#1)
90% of the time##2##4##(1997-6#1)(2008-9#1)
90% of the total variance##2##5##(2008-10#2)
90% of the total##5##4##(1993-11#1)(2007-11#1)(2008-10#3)
90% of the##47##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1994-9#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
90% of those##2##3##(2008-10#1)(2008-5#1)
90% of##106##2##(1990-12#1)(1990-6#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#5)(2013-1#3)(2013-7#1)
90% probability##2##2##(2008-10#1)(2010-5#1)
90% relative to##2##3##(1994-9#1)(2008-10#1)
90% relative##4##2##(1994-9#1)(2008-10#2)(2008-3#1)
90% survival##2##2##(1996-11#1)(2008-8#1)
90% transmission##2##2##(2007-11#2)
90% tumor##3##2##(1992-6#1)(2008-9#1)(2010-3#1)
90% were##6##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-12#1)(2010-6#1)(2013-1#1)
90% when compared##2##3##(2008-10#1)(2008-7#1)
90% with##4##2##(1991-5#1)(1993-6#1)(2008-10#1)(2013-1#1)
90% within##2##2##(1992-11#1)(2011-2#1)
90%##311##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-7#2)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#76)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#9)(2008-6#7)(2008-7#12)(2008-8#5)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#6)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#2)
90%) and##2##2##(2011-1#1)(2011-2#1)
90%) of##2##2##(1990-7#1)(2008-6#1)
90%) were##2##2##(2008-10#2)
90%)##15##1##(1990-11#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-6#1)(2008-10#5)(2008-6#2)(2011-1#1)(2011-2#1)
90's##5##1##(1993-3#1)(1993-9#1)(2007-8#1)(2008-1#1)(2008-7#1)
90) for##2##2##(2008-3#1)(2012-12#1)
90) with##2##2##(2008-10#1)(2008-12#1)
90)##19##1##(1993-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
90-100% of##2##2##(2008-12#1)(2008-5#1)
90-100%##3##1##(2008-10#1)(2008-12#1)(2008-5#1)
90-120##2##1##(1997-4#1)(2008-10#1)
90-166##7##1##(2008-10#7)
90-day##4##1##(2007-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
90-fs pulses##3##2##(2007-12#2)(2008-3#1)
90-kDa##2##1##(1994-11#1)(1996-12#1)
90-min##2##1##(2008-10#1)(2011-2#1)
90-nm##2##1##(2008-7#1)(2008-9#1)
90-ns pulse duration##2##3##(2008-3#2)
90-nt region##2##2##(1997-4#2)
90-sec##2##1##(2013-1#2)
900 degrees C for##3##4##(2008-10#3)
900 degrees C##5##3##(2008-10#5)
900 degrees##6##2##(2008-10#6)
900 nm##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
900##43##1##(1990-5#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#12)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
900- and##2##2##(2008-10#2)
900-bp intron##3##2##(2008-10#3)
9000##6##1##(1990-8#1)(1991-8#1)(1992-12#1)(1992-2#1)(2007-12#2)
901 patients##2##2##(2009-5#1)(2010-3#1)
903##2##1##(1993-8#1)(2008-8#1)
904##2##1##(2008-3#1)(2012-2#1)
905##2##1##(1994-12#1)(2011-1#1)
906##4##1##(1992-5#1)(1992-9#1)(1997-7#1)(2010-5#1)
907##2##1##(1994-9#1)(2008-4#1)
908##2##1##(2008-10#1)(2010-10#1)
908)##2##1##(2008-10#1)(2008-12#1)
909##3##1##(1993-6#1)(2012-2#1)(2013-8#1)
90min##3##1##(2008-10#2)(2012-2#1)
90s##11##1##(1991-12#1)(1991-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(2008-10#6)
90°##2##1##(2008-11#1)(2012-2#1)
90°C for##2##2##(2013-1#2)
90°C##4##1##(2011-1#2)(2013-1#2)
91 +/- 0##5##3##(1992-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(2008-3#1)
91 +/- 3##2##3##(2008-10#1)(2008-3#1)
91 +/-##10##2##(1990-8#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-3#2)(2011-2#1)
91 and##5##2##(1992-4#1)(2007-10#1)(2008-10#3)
91 log(10) CFU/g##2##3##(2007-3#2)
91 mm##2##2##(2008-11#1)(2011-1#1)
91 patients##2##2##(1995-9#1)(2012-3#1)
91 per cent##2##3##(1992-5#1)(1995-9#1)
91 per##3##2##(1992-5#1)(1995-9#1)(2007-8#1)
91 to##13##2##(1990-12#1)(1993-12#1)(1993-9#1)(2008-10#9)(2010-11#1)
91##143##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#2)(1996-2#2)(1996-7#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#37)(2008-11#3)(2008-12#4)(2008-3#3)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#5)(2011-2#7)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
91% and##2##2##(1990-2#1)(2010-5#1)
91% of the##5##3##(1993-6#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
91% of##11##2##(1993-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
91%##32##1##(1990-2#1)(1990-8#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(1996-10#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
91%)##7##1##(1994-11#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
91) in##2##2##(2007-10#1)(2013-1#1)
91)##13##1##(1993-2#2)(1993-8#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
91-year-old##3##1##(1992-12#1)(1996-5#1)(2008-11#1)
911##5##1##(1997-6#1)(2007-10#1)(2008-10#1)(2010-11#1)(2011-1#1)
9129 (1997)]##2##2##(2008-2#2)
913##4##1##(1993-8#1)(2008-4#1)(2009-7#1)(2010-10#1)
914##5##1##(2007-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
915##3##1##(1997-4#1)(2007-12#1)(2013-1#1)
916##3##1##(2007-11#1)(2008-10#1)(2011-3#1)
917 was##2##2##(2008-10#2)
917##14##1##(1990-12#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#6)(2010-3#1)(2011-1#1)(2011-2#1)
918##4##1##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
92 +/- 0##2##3##(2008-12#1)(2011-2#1)
92 -##2##2##(2011-1#1)(2011-2#1)
92 and a##2##3##(2008-10#1)(2013-1#1)
92 and##16##2##(1993-3#1)(2008-10#12)(2008-5#1)(2008-6#1)(2013-1#1)
92 g pot(-1)##3##3##(2008-10#3)
92 g/dL ±##2##3##(2013-8#2)
92 is the##2##3##(1992-3#2)
92 is##3##2##(1992-3#2)(2008-10#1)
92 kDa##2##2##(1990-7#1)(1994-8#1)
92 mm x##2##3##(1994-5#2)
92 patients were##2##3##(1992-5#1)(2007-8#1)
92 patients##7##2##(1992-5#1)(1996-3#2)(1997-3#1)(2007-8#1)(2013-1#1)(2013-8#1)
92 to##5##2##(2008-10#5)
92 was##2##2##(1994-8#1)(2008-10#1)
92##175##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#1)(1992-3#3)(1992-5#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-6#2)(1996-12#1)(1996-2#4)(1996-3#3)(1997-3#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#57)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#5)
92% and##6##2##(1991-8#1)(1992-11#1)(1993-6#1)(1995-11#1)(1996-2#1)(2012-2#1)
92% compared to##2##3##(2008-10#1)(2012-3#1)
92% for##4##2##(1992-3#1)(1996-12#1)(2008-10#1)(2009-11#1)
92% identical##2##2##(1994-11#1)(2008-10#1)
92% in##4##2##(1994-7#1)(1996-9#1)(2007-8#1)(2008-9#1)
92% of the##11##3##(1992-12#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
92% of##18##2##(1990-12#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
92%##63##1##(1990-12#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1993-6#1)(1994-11#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
92%)##6##1##(2008-10#3)(2010-9#1)(2011-1#1)(2013-1#1)
92)##15##1##(1990-8#1)(1993-12#1)(1994-8#1)(1996-2#1)(2008-12#4)(2008-5#2)(2008-9#3)(2013-1#1)(2013-8#1)
92-0##2##1##(2008-7#1)(2011-2#1)
92-kDa##2##1##(1992-9#1)(1994-8#1)
920##3##1##(1991-6#1)(2008-10#1)(2008-2#1)
9200##3##1##(1992-11#1)(2007-12#1)(2010-8#1)
921 clinical specimens##2##3##(2013-8#2)
921##5##1##(2008-10#1)(2009-7#1)(2011-2#1)(2013-8#2)
923##10##1##(1990-2#1)(2008-1#1)(2008-10#7)(2008-7#1)
924##6##1##(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
924)##2##1##(1993-8#1)(2009-3#1)
925##5##1##(2007-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
926##2##1##(2008-12#1)(2013-8#1)
927##4##1##(1992-2#1)(2007-12#1)(2008-10#1)(2012-3#1)
928##2##1##(1990-11#1)(2008-7#1)
93 +/- 0##2##3##(2008-10#1)(2008-5#1)
93 +/-##6##2##(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
93 K##4##2##(1996-2#4)
93 and 0##2##3##(2008-10#2)
93 and##8##2##(2008-10#7)(2008-3#1)
93 for##2##2##(2008-10#1)(2011-2#1)
93 patients##3##2##(1995-12#1)(1996-9#1)(2008-1#1)
93 per##4##2##(1992-4#1)(1992-5#1)(1997-2#1)(2011-2#1)
93 to 1##2##3##(2008-8#1)(2009-12#1)
93 to##6##2##(2008-10#4)(2008-8#1)(2009-12#1)
93##138##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-2#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#36)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#3)
93% and##2##2##(1995-3#1)(2008-10#1)
93% for##3##2##(1995-2#1)(2008-10#2)
93% homology##2##2##(1990-8#1)(2008-8#1)
93% identical##3##2##(1990-11#1)(1993-8#2)
93% in the##2##3##(1996-9#1)(2007-7#1)
93% in##3##2##(1996-9#1)(2007-7#1)(2008-10#1)
93% of patients##4##3##(1993-9#1)(2008-3#1)(2008-9#1)(2009-3#1)
93% of the##8##3##(1994-11#1)(1996-1#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
93% of##16##2##(1993-11#1)(1993-9#1)(1994-11#1)(1996-1#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
93% to##2##2##(1990-6#1)(2008-10#1)
93% was##2##2##(2008-10#1)(2008-2#1)
93% were##2##2##(1994-2#1)(2007-7#1)
93%##68##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-7#3)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
93%)##4##1##(1990-3#1)(1991-4#1)(2008-12#1)(2011-2#1)
93) and##2##2##(2010-12#1)(2013-1#1)
93)##10##1##(1994-3#1)(2007-11#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
93+/-2##2##1##(2007-11#1)(2008-10#1)
930##3##1##(1990-5#1)(1995-6#1)(2007-12#1)
931##5##1##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
932##2##1##(1991-2#1)(2008-3#1)
933##5##1##(1995-12#1)(2007-10#1)(2008-6#2)(2013-1#1)
934##5##1##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
935##3##1##(1993-8#1)(2008-1#1)(2008-4#1)
936 women##2##2##(2007-8#1)(2013-1#1)
936##10##1##(1997-3#1)(2007-8#1)(2008-2#2)(2008-9#1)(2011-2#1)(2013-1#4)
937##3##1##(2008-10#1)(2008-2#1)(2013-1#1)
9375 mW/cm(2)##2##2##(2008-7#2)
938 nm##2##2##(2008-2#1)(2013-8#1)
938##4##1##(2008-11#1)(2008-2#1)(2010-5#1)(2013-8#1)
938)##2##1##(2008-10#1)(2011-3#1)
93ID6##3##1##(2008-10#3)
94 +/-##7##2##(1991-5#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-8#2)(2010-4#1)
94 and 1##2##3##(2008-10#2)
94 and##10##2##(1993-6#1)(1995-8#1)(1997-4#1)(2008-10#6)(2010-11#1)
94 for##3##2##(1993-2#1)(2008-10#2)
94 kDa protein##2##3##(1993-3#2)
94 microm##2##2##(2008-2#1)(2008-3#1)
94 mum##3##2##(2007-12#2)(2008-2#1)
94 mum) laser may be##2##5##(1991-2#2)
94 mum) laser##3##3##(1991-2#3)
94 patients##3##2##(2007-8#2)(2010-3#1)
94 per##2##2##(1995-12#1)(2006-10#1)
94 to 0##2##3##(2013-1#2)
94 to##8##2##(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#2)
94 years##2##2##(2008-10#1)(2008-3#1)
94##162##1##(1990-10#1)(1990-5#2)(1990-9#1)(1991-2#3)(1991-5#1)(1991-6#2)(1991-9#3)(1992-11#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-3#1)(1995-12#2)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#41)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#5)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#13)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
94% and the##2##3##(1996-12#1)(2008-2#1)
94% and##3##2##(1996-12#1)(2008-10#1)(2008-2#1)
94% identical with##2##3##(1993-3#1)(2008-10#1)
94% in##2##2##(1991-3#1)(1994-7#1)
94% of the total##2##4##(2008-10#2)
94% of the##4##3##(1992-6#1)(2008-10#2)(2011-2#1)
94% of##13##2##(1992-11#1)(1992-6#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-6#2)(2011-2#1)(2013-1#1)
94% was##2##2##(2008-3#1)(2010-3#1)
94% were##3##2##(1994-8#1)(1996-8#1)(2008-10#1)
94% with##2##2##(2007-10#1)(2008-10#1)
94%##52##1##(1990-11#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-11#3)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2010-3#2)(2011-2#2)(2013-1#1)
94%)##7##1##(2008-6#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
94) and##5##2##(1993-2#1)(2007-10#1)(2007-11#1)(2009-11#1)(2010-6#1)
94) in##2##2##(2008-12#1)(2013-1#1)
94) was##2##2##(2008-10#2)
94)##20##1##(1990-5#1)(1991-12#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-12#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-6#1)(2010-9#1)(2013-1#1)
94-##2##1##(1995-2#1)(2012-2#1)
94-100%##3##1##(2008-10#3)
94-kDa protein##3##2##(1991-9#1)(2008-10#2)
94-kDa##6##1##(1991-9#1)(1992-3#1)(2008-10#4)
940 nm##2##2##(2007-11#1)(2010-6#1)
940##6##1##(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#1)
943##2##1##(1994-12#1)(2011-2#1)
944##3##1##(2008-10#1)(2012-3#1)(2013-8#1)
9445-9450]##2##1##(1993-11#2)
945##7##1##(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-5#1)
946 nm##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
946##10##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#1)(2012-12#1)
946-nm Nd##4##2##(2007-12#1)(2008-2#3)
946-nm##5##1##(2007-12#1)(2008-2#4)
947##2##1##(1991-8#1)(2008-10#1)
948##4##1##(2007-11#1)(2008-10#2)(2011-2#1)
949##3##1##(1995-2#1)(2008-10#1)(2012-2#1)
94x10(-6) to##2##2##(2008-10#2)
94x10(-6)##3##1##(2008-10#3)
95 % confidence intervals##2##4##(2011-2#2)
95 % confidence##3##3##(2011-2#2)(2012-12#1)
95 %##6##2##(1997-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
95 %CI) and##2##3##(2011-2#1)(2012-12#1)
95 %CI)##9##2##(2011-2#5)(2012-12#4)
95 (0##2##2##(2008-3#1)(2011-2#1)
95 +/-##5##2##(1990-3#1)(1990-8#1)(2008-12#2)(2008-4#1)
95 CI##2##2##(2007-5#2)
95 V##3##2##(2008-10#3)
95 amino acid##2##3##(1994-2#1)(1997-2#1)
95 amino##3##2##(1990-2#1)(1994-2#1)(1997-2#1)
95 and##12##2##(1991-12#1)(2008-10#6)(2008-5#1)(2009-11#1)(2010-4#2)(2012-12#1)
95 cases##2##2##(1992-5#1)(2012-2#1)
95 degrees C##3##3##(1995-5#1)(2007-12#1)(2008-10#1)
95 degrees##4##2##(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
95 environments##2##2##(2008-8#2)
95 mum##2##2##(2007-12#2)
95 of##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
95 percent of##3##3##(1992-12#1)(1995-6#1)(2010-2#1)
95 percent##7##2##(1992-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(2008-11#1)(2010-2#1)
95 to 98%##2##3##(2008-10#2)
95 to##10##2##(2008-10#7)(2008-3#1)(2008-7#2)
95 years##2##2##(1991-5#1)(2008-6#1)
95 ±##2##2##(2013-1#1)(2013-8#1)
95##227##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-6#3)(1997-7#1)(1997-8#4)(2006-12#1)(2007-10#1)(2007-12#6)(2007-2#4)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#66)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#7)(2011-2#17)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#4)
95% 1##4##2##(2010-9#1)(2011-1#1)(2013-1#2)
95% C##2##2##(1991-12#2)
95% CI (1##2##3##(2007-7#1)(2008-6#1)
95% CI 0##17##3##(2007-10#1)(2008-12#1)(2008-8#1)(2009-9#2)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
95% CI 1##25##3##(1993-12#1)(2007-2#4)(2008-11#2)(2011-2#13)(2012-1#1)(2012-12#1)(2013-1#3)
95% CI 2##7##3##(1993-12#1)(2010-9#1)(2011-2#4)(2012-12#1)
95% CI 3##2##3##(2008-11#1)(2011-2#1)
95% CI = 0##2##4##(2008-7#2)
95% CI =##5##3##(2008-7#2)(2009-7#2)(2010-10#1)
95% CI##132##2##(1992-10#1)(1993-12#2)(1993-9#1)(1994-12#7)(2007-10#4)(2007-2#4)(2007-7#2)(2008-10#7)(2008-11#4)(2008-12#11)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#2)(2009-9#5)(2010-10#1)(2010-11#1)(2010-4#10)(2010-9#2)(2011-1#5)(2011-2#23)(2012-1#3)(2012-12#8)(2012-2#1)(2012-3#7)(2013-1#15)
95% CI)##2##2##(2007-10#1)(2013-1#1)
95% CI--0##6##2##(2007-10#6)
95% CI--1##2##2##(2007-10#2)
95% CI=1##2##2##(2008-10#1)(2011-1#1)
95% CL =##2##3##(2008-4#2)
95% Cl##7##2##(1991-8#1)(2008-7#1)(2011-1#5)
95% [CI] = 1##2##4##(2011-2#2)
95% accuracy##2##2##(2008-7#1)(2011-2#1)
95% and the##5##3##(2008-10#2)(2008-12#1)(2013-8#2)
95% and##16##2##(1990-7#1)(1994-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
95% at the##2##3##(2008-10#2)
95% at##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
95% by##3##2##(1994-3#1)(1995-6#1)(2008-2#1)
95% confidence interval (CI) 0##2##5##(1993-9#1)(2008-6#1)
95% confidence interval (CI) 1##2##5##(2011-2#1)(2012-12#1)
95% confidence interval (CI)##10##4##(1992-10#1)(1993-9#2)(2007-10#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
95% confidence interval 0##3##4##(1990-6#1)(1991-11#1)(2010-6#1)
95% confidence interval 1##3##4##(2008-1#1)(2011-2#2)
95% confidence interval [CI]##4##4##(1993-12#1)(2010-10#1)(2010-4#2)
95% confidence interval for##4##4##(1991-2#1)(1991-5#1)(1994-2#1)(2013-8#1)
95% confidence interval of##3##4##(1991-7#1)(2008-10#1)(2010-3#1)
95% confidence interval##46##3##(1990-6#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-10#1)(1993-12#1)(1993-9#2)(1994-2#1)(1997-4#1)(2006-10#2)(2007-10#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#3)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#2)
95% confidence intervals (CI) were##2##5##(2010-9#1)(2011-2#1)
95% confidence intervals 1##2##4##(2013-1#2)
95% confidence intervals of##2##4##(2008-9#1)(2010-3#1)
95% confidence intervals##16##3##(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2010-3#2)(2010-9#1)(2011-2#5)(2013-1#3)
95% confidence level and##3##4##(2008-10#3)
95% confidence level was observed##6##5##(2008-10#6)
95% confidence level were##2##4##(2008-10#2)
95% confidence level##51##3##(1995-5#1)(2008-10#49)(2008-3#1)
95% confidence level)##2##3##(2008-10#2)
95% confidence limit##3##3##(1992-5#1)(2008-10#1)(2008-4#1)
95% confidence limits##4##3##(1991-4#1)(1994-3#2)(1997-3#1)
95% confidence##128##2##(1990-6#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-3#2)(1995-5#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#2)(2008-1#1)(2008-10#58)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-6#2)(2010-9#1)(2011-2#9)(2012-12#1)(2013-1#7)(2013-8#2)
95% control##2##2##(2008-10#2)
95% credible##2##2##(2008-10#2)
95% ethanol##2##2##(2008-10#1)(2013-8#1)
95% for##7##2##(1996-12#1)(2007-9#1)(2008-10#3)(2011-2#2)
95% identity##2##2##(1994-11#1)(2013-1#1)
95% in the##3##3##(2008-10#2)(2012-2#1)
95% in##6##2##(1997-3#1)(2008-10#3)(2012-2#1)(2013-8#1)
95% level##2##2##(2008-10#2)
95% of confidence##2##3##(2008-10#2)
95% of patients##4##3##(1996-1#1)(1996-9#1)(2008-11#1)(2008-7#1)
95% of the cases##2##4##(2007-8#1)(2010-8#1)
95% of the##17##3##(2007-8#1)(2008-10#11)(2008-6#2)(2008-9#1)(2010-8#1)(2011-1#1)
95% of these##2##3##(1994-6#1)(2012-2#1)
95% of##42##2##(1990-12#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-9#1)(2007-2#1)(2007-8#2)(2008-10#17)(2008-11#2)(2008-6#3)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
95% or more##2##3##(2008-10#1)(2011-2#1)
95% or##3##2##(2008-10#2)(2011-2#1)
95% power frequencies existed among##2##5##(2012-2#2)
95% power frequencies##3##3##(2012-2#3)
95% power##4##2##(2012-2#4)
95% probability##3##2##(1990-10#1)(2008-10#2)
95% pure and##2##3##(1991-5#1)(2013-1#1)
95% pure##3##2##(1991-5#1)(1997-4#1)(2013-1#1)
95% relative humidity##2##3##(2008-5#1)(2013-1#1)
95% to##2##2##(2007-11#1)(2013-8#1)
95% when##2##2##(1990-10#1)(2008-11#1)
95% with##2##2##(2008-10#1)(2009-8#1)
95%##477##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#7)(1994-2#3)(1994-3#4)(1994-6#1)(1994-8#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-8#1)(2006-10#2)(2007-10#15)(2007-11#1)(2007-2#5)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#139)(2008-11#11)(2008-12#13)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#1)(2008-6#10)(2008-7#7)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#13)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#15)(2011-2#41)(2012-1#3)(2012-12#9)(2012-2#9)(2012-3#8)(2013-1#32)(2013-8#11)
95%) and##2##2##(1997-8#1)(2008-10#1)
95%) at##2##2##(2008-10#2)
95%)##16##1##(1990-7#1)(1994-12#1)(1996-5#1)(1997-8#2)(2007-11#1)(2008-10#9)(2013-1#1)
95%CI 1##5##2##(2008-10#1)(2013-1#1)(2013-8#3)
95%CI 2##2##2##(2011-2#1)(2013-1#1)
95%CI##27##1##(2008-1#3)(2008-10#1)(2008-9#1)(2011-1#13)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#3)
95%CI)##2##1##(2012-12#2)
95) and##2##2##(2008-7#1)(2013-1#1)
95) p &lt##2##3##(2010-8#2)
95)##14##1##(1990-6#2)(1994-6#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
95-1##2##1##(2006-6#1)(2013-1#1)
95-105% for##3##2##(2008-10#3)
95-105%##6##1##(2008-10#6)
95-kDa##2##1##(1996-12#2)
950 degrees C##2##3##(2010-4#2)
950##12##1##(1995-12#1)(1995-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2010-4#2)(2010-8#1)(2011-2#1)(2013-1#2)
951##4##1##(1992-10#1)(1994-11#1)(2009-7#1)(2010-4#1)
952##2##1##(1994-9#1)(2013-1#1)
953##4##1##(1992-4#1)(1993-9#1)(2008-2#1)(2011-2#1)
954##3##1##(1990-12#1)(2008-10#1)(2013-1#1)
956 nm)##2##2##(2008-3#2)
956##5##1##(1990-6#1)(2008-2#1)(2008-3#2)(2011-2#1)
957##2##1##(1993-6#1)(2008-10#1)
958##2##1##(1991-6#1)(2013-1#1)
95]##2##1##(2011-2#1)(2012-3#1)
95th##3##1##(1996-12#1)(2009-9#1)(2012-3#1)
95x10(-5) to 1x10(-1)moldm(-3) and##2##4##(2008-10#2)
96 +/- 0##3##3##(1992-11#2)(1994-11#1)
96 +/-##5##2##(1992-11#2)(1993-11#1)(1994-11#1)(2008-5#1)
96 and 0##2##3##(1990-6#1)(2008-10#1)
96 and##13##2##(1990-2#1)(1990-6#1)(2008-10#9)(2008-8#1)(2010-12#1)
96 for the##2##3##(2008-10#2)
96 for##4##2##(2008-10#3)(2008-12#1)
96 h LC50##2##3##(2008-12#2)
96 h after##5##3##(2008-10#5)
96 h at##2##3##(2008-10#1)(2010-3#1)
96 h of incubation##2##4##(1992-8#2)
96 h of##5##3##(1992-8#2)(2008-12#1)(2008-6#1)(2008-7#1)
96 h to##2##3##(1997-1#1)(2007-12#1)
96 h##40##2##(1992-8#3)(1993-6#1)(1997-1#1)(2007-12#1)(2007-6#1)(2008-10#17)(2008-12#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#4)
96 h)##3##2##(1995-2#1)(2008-10#2)
96 hours##6##2##(1990-5#1)(1994-5#1)(2007-11#1)(2011-2#2)(2012-2#1)
96 hr##7##2##(1993-9#3)(1994-11#3)(2007-5#1)
96 hrs##2##2##(1993-8#1)(2008-8#1)
96 nM##2##2##(2008-10#2)
96 patients##5##2##(1991-8#1)(1993-12#1)(1995-11#1)(2007-8#1)(2008-1#1)
96 study patients##2##3##(2007-7#2)
96 well plates##2##3##(2008-11#2)
96 well##4##2##(2008-10#1)(2008-11#3)
96 x##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
96##260##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#6)(2008-1#1)(2008-10#97)(2008-11#8)(2008-12#13)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#4)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#6)
96% and the##2##3##(2008-10#2)
96% and##3##2##(1992-3#1)(2008-10#2)
96% for##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
96% of the patients##3##4##(1992-11#1)(2008-5#1)(2011-2#1)
96% of the total##2##4##(2008-8#1)(2013-1#1)
96% of the##9##3##(1992-11#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
96% of##15##2##(1992-11#1)(1994-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
96% to##2##2##(2008-10#1)(2011-1#1)
96% with a##2##3##(2008-10#1)(2012-3#1)
96% with##3##2##(2008-10#2)(2012-3#1)
96%##67##1##(1990-6#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
96%)##7##1##(1996-5#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2013-8#1)
96) and##2##2##(1993-9#1)(2012-12#1)
96)##11##1##(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-5#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
96-103%##2##1##(2008-10#2)
96-105%##2##1##(2008-10#2)
96-microwell plate##2##2##(2008-10#2)
96-well microtiter plate##5##3##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
96-well microtiter##6##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
96-well plates##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
96-well##25##1##(1997-7#1)(2008-10#8)(2008-11#10)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#2)
960##16##1##(1994-6#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-10#1)(2013-1#1)
961##2##1##(1997-8#1)(2008-11#1)
963##3##1##(2007-12#1)(2008-11#1)(2008-4#1)
964##7##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-1#1)
965##2##1##(2008-1#1)(2008-2#1)
966##4##1##(1994-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
967##7##1##(1994-2#1)(1996-2#1)(2008-10#4)(2012-2#1)
968##3##1##(1991-6#1)(1993-12#1)(1995-2#1)
96h##2##1##(2008-10#1)(2013-8#1)
96mug/l##2##1##(2008-10#2)
97 %##2##2##(2008-4#1)(2008-8#1)
97 +/-##2##2##(1994-12#1)(2008-1#1)
97 and##7##2##(1993-2#1)(2008-10#5)(2008-4#1)
97 cases##2##2##(1996-11#1)(2011-2#1)
97 families##5##2##(1997-5#5)
97 for the##4##3##(1993-12#2)(2009-3#1)(2012-3#1)
97 in##2##2##(1994-8#1)(2008-10#1)
97 patients with##3##3##(1992-2#1)(1994-11#1)(2013-1#1)
97 patients##4##2##(1992-2#1)(1994-11#1)(2008-12#1)(2013-1#1)
97 per cent##2##3##(1992-5#1)(1995-12#1)
97 to 100%##2##3##(2008-10#2)
97 to 99%##2##3##(2008-10#2)
97 to##9##2##(2008-10#8)(2009-12#1)
97 years##3##2##(1993-12#1)(1995-6#1)(2013-7#1)
97 years-old##2##2##(2012-12#2)
97##184##1##(1990-12#2)(1990-6#1)(1991-12#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-5#5)(1997-6#1)(1997-7#3)(2007-10#2)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#61)(2008-11#1)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#2)(2013-8#1)
97% and##2##2##(1990-2#1)(2008-5#1)
97% for##3##2##(2008-10#2)(2008-5#1)
97% identical##2##2##(1993-6#1)(1994-9#1)
97% identity with##2##3##(1995-6#1)(2008-10#1)
97% identity##3##2##(1995-6#1)(2008-10#1)(2009-5#1)
97% in the##4##3##(2008-10#2)(2008-7#1)(2010-10#1)
97% in##6##2##(2008-10#3)(2008-3#1)(2008-7#1)(2010-10#1)
97% of the##4##3##(1991-2#1)(2008-10#2)(2008-3#1)
97% of##14##2##(1991-2#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
97% with##2##2##(2008-10#2)
97%##73##1##(1990-10#1)(1990-2#1)(1990-6#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
97%) and##2##2##(2008-10#1)(2008-12#1)
97%)##9##1##(1993-6#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)
97) and##3##2##(1990-8#1)(2008-10#1)(2013-1#1)
97)##15##1##(1990-8#3)(2007-10#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
97)Mo##2##1##(1997-7#2)
97+/-5%##2##1##(2008-10#2)
97-100%##2##1##(2008-1#1)(2008-10#1)
97-kDa##3##1##(1993-11#1)(1995-2#2)
970 nm##2##2##(2007-12#1)(2008-3#1)
970##10##1##(1991-12#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
970-nm diode-pumped Yb##2##3##(2008-3#2)
971##3##1##(2008-12#1)(2010-11#1)(2013-8#1)
972##3##1##(2007-12#1)(2008-3#1)(2008-7#1)
973##3##1##(2007-11#1)(2009-7#1)(2011-2#1)
974##4##1##(1994-11#1)(1995-2#1)(2008-10#1)(2008-3#1)
975##8##1##(1996-10#1)(1996-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2013-8#1)
976##2##1##(2008-11#1)(2011-2#1)
976)##4##1##(1990-12#1)(1995-2#1)(2008-10#1)(2011-1#1)
977##3##1##(2008-3#2)(2013-1#1)
978##4##1##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
979##3##1##(1992-6#1)(2008-10#2)
98 +/- 0##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
98 +/-##7##2##(1993-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
98 and##5##2##(1994-6#1)(2008-10#3)(2012-3#1)
98 cases##2##2##(2008-7#2)
98 for the##2##3##(2008-10#1)(2009-3#1)
98 kDa##3##2##(1993-8#1)(1994-6#2)
98 mM##2##2##(1994-9#1)(2008-8#1)
98 patients##5##2##(1990-3#1)(1993-8#1)(1995-5#1)(2007-8#1)(2011-2#1)
98 to 99%##2##3##(2008-10#2)
98 to##6##2##(2008-10#3)(2008-6#1)(2010-6#1)(2013-1#1)
98 years##2##2##(2010-12#1)(2013-1#1)
98##197##1##(1990-12#1)(1990-2#1)(1990-3#4)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-11#3)(1992-5#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#68)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#3)(2009-3#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#5)
98% amino acid##2##3##(1992-3#1)(2008-10#1)
98% and##4##2##(1990-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
98% ee)##2##2##(1996-5#2)
98% identical##5##2##(1993-2#1)(1993-6#1)(2008-10#2)(2012-3#1)
98% identity##2##2##(1997-6#1)(2008-10#1)
98% of all##2##3##(1992-6#1)(2008-10#1)
98% of enzyme activity##2##4##(1997-6#2)
98% of the##8##3##(1996-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-7#1)
98% of##20##2##(1990-5#1)(1992-6#1)(1994-2#1)(1996-6#1)(1996-9#1)(1997-6#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-6#2)(2010-12#1)(2011-2#1)(2013-7#1)
98% to##3##2##(2008-10#2)(2011-2#1)
98% was obtained##2##3##(1994-6#1)(2008-10#1)
98% were##2##2##(2008-12#1)(2009-3#1)
98%##93##1##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-6#3)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#38)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
98%)##10##1##(1997-3#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
98) and##3##2##(2008-10#2)(2008-12#1)
98)##16##1##(1991-12#1)(1992-2#1)(1993-9#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
98+/-0##2##1##(2009-12#2)
98-101%##2##1##(2008-10#2)
980 nm##7##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
980##15##1##(1990-11#1)(1990-2#1)(1993-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
980-nm pump##2##2##(2007-12#1)(2008-3#1)
980-nm##5##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
981##13##1##(2007-11#12)(2008-5#1)
9816##2##1##(2008-10#1)(2009-7#1)
983##3##1##(1990-8#1)(2008-10#1)(2008-5#1)
984##8##1##(1992-11#1)(1994-11#1)(2007-11#2)(2008-10#2)(2008-2#1)(2011-2#1)
985##8##1##(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#3)
986##2##1##(2011-2#1)(2013-8#1)
986)##2##1##(2008-10#2)
987##3##1##(1995-8#1)(2008-10#1)(2012-2#1)
988##13##1##(1990-8#1)(1992-9#1)(1996-2#4)(2008-1#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
989##5##1##(1993-11#3)(1996-2#1)(2008-10#1)
99 +/-##2##2##(2008-10#2)
99 MPa##2##2##(2009-4#2)
99 and##5##2##(1993-12#1)(1993-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
99 for##2##2##(2008-10#1)(2009-8#1)
99 isolates##2##2##(2008-10#2)
99 kDa polypeptide##2##3##(1991-9#2)
99 kDa protein##2##3##(1991-9#2)
99 kDa##4##2##(1991-9#4)
99 mTc-MIBI-SPECT##2##2##(1997-8#2)
99 patients##5##2##(2007-8#2)(2008-1#1)(2008-5#1)(2013-1#1)
99 to##9##2##(1993-9#1)(2008-10#6)(2008-3#1)(2010-12#1)
99 vs##2##2##(1996-2#1)(2008-9#1)
99 were##3##2##(1993-9#1)(2007-2#1)(2008-10#1)
99##248##1##(1990-11#1)(1990-9#1)(1991-11#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#1)(1995-2#4)(1995-8#2)(1996-12#1)(1996-2#4)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#114)(2008-11#2)(2008-12#7)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#7)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#3)
99% and##5##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
99% for##4##2##(1996-12#1)(2008-10#3)
99% in the##2##3##(2008-10#1)(2008-12#1)
99% in##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
99% of all##2##3##(2008-10#2)
99% of patients##2##3##(1992-2#1)(2008-1#1)
99% of the##8##3##(1993-8#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-8#2)(2012-3#1)
99% of##19##2##(1992-2#1)(1993-8#1)(1995-3#1)(1997-7#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)
99% pure)##3##2##(2008-9#3)
99% relative humidity##2##3##(2008-10#2)
99% were obtained by elution of the##2##7##(2008-10#2)
99% were##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
99%##88##1##(1990-11#1)(1990-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#34)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
99%) of##2##2##(1992-11#1)(2008-2#1)
99%)##12##1##(1992-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-5#1)(2012-3#1)(2013-8#1)
99) and##2##2##(1994-12#1)(2008-10#1)
99) for##4##2##(1993-9#1)(2008-10#1)(2011-1#1)(2013-1#1)
99)##17##1##(1993-9#1)(1994-12#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-12#2)(2011-1#2)(2012-12#1)(2013-1#1)
99+/-0##2##1##(2008-10#2)
99+/-1##2##1##(2008-10#2)
99-100%##2##1##(2008-10#1)(2008-5#1)
99-457##3##1##(1991-12#2)(1994-1#1)
99-kb##3##1##(1995-12#1)(1996-8#2)
990##7##1##(1993-11#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
990)##2##1##(1993-11#1)(2008-11#1)
991##4##1##(2008-10#1)(2011-2#1)(2012-12#2)
991)##2##1##(2008-10#1)(2013-1#1)
992 and##4##2##(2008-10#4)
992##10##1##(1990-2#1)(1997-7#1)(2008-10#7)(2008-5#1)
9927)##2##1##(2008-10#2)
993##3##1##(1997-2#1)(2007-8#1)(2013-8#1)
994##8##1##(1990-7#1)(1992-2#1)(2008-10#3)(2008-11#2)(2011-1#1)
994)##2##1##(2007-12#1)(2010-8#1)
995##6##1##(2008-10#5)(2011-1#1)
995)##4##1##(1991-12#1)(2008-10#3)
9954##2##1##(2008-10#2)
9957##2##1##(1994-9#1)(2008-10#1)
9959)##2##1##(2008-10#2)
996##8##1##(1990-8#1)(1994-11#1)(2008-10#6)
996)##2##1##(2007-12#1)(2013-1#1)
9961##3##1##(2008-10#1)(2008-5#2)
9962)##2##1##(2008-10#2)
997##10##1##(1993-12#1)(1993-3#1)(2008-10#5)(2008-3#1)(2009-8#1)(2013-8#1)
997)##3##1##(1997-6#1)(2008-10#1)(2010-5#1)
9975##2##1##(2008-10#2)
9978##5##1##(2008-10#4)(2008-5#1)
998 and a detection limit of 0##2##7##(2008-10#2)
998 and##3##2##(2008-10#3)
998##16##1##(1992-2#1)(2007-12#1)(2008-10#12)(2008-3#1)(2013-1#1)
998) tarabine PFS and for##2##5##(2008-10#2)
998) with##2##2##(2008-10#2)
998)##10##1##(2008-10#9)(2013-1#1)
9984##4##1##(2008-10#4)
9985##3##1##(2008-10#3)
9987##3##1##(2008-10#3)
9988)##2##1##(2008-10#1)(2012-1#1)
9989##5##1##(2008-10#5)
999 9##2##2##(2011-1#2)
999 and relative standard deviation of##2##6##(2008-10#2)
999 and##5##2##(1990-8#1)(2008-10#4)
999 for##2##2##(2008-10#1)(2008-2#1)
999##28##1##(1990-8#1)(2008-10#21)(2008-2#1)(2011-1#4)(2012-3#1)
999) adriblastina##2##2##(2008-10#2)
999) and##2##2##(2008-10#2)
999)##23##1##(1997-6#2)(2008-10#20)(2013-1#1)
999+/-0##2##1##(2008-10#2)
9990##2##1##(2008-10#2)
9991##2##1##(2008-10#2)
9991)##3##1##(2008-10#3)
9992 and 0##2##3##(2008-10#2)
9992##5##1##(2008-10#5)
9992) for##2##2##(2008-10#2)
9992)##5##1##(2008-10#5)
9993##4##1##(1994-9#1)(2008-10#3)
9993)##2##1##(2008-10#2)
9994 and relative standard deviation##2##5##(2008-10#2)
9994##8##1##(2008-10#7)(2010-4#1)
9994)##2##1##(2008-10#2)
9995 and##2##2##(2008-10#1)(2008-5#1)
9995##6##1##(2008-10#5)(2008-5#1)
9995)##3##1##(2008-10#3)
9996##6##1##(2008-10#6)
9996)##4##1##(2008-10#4)
9997 and relative standard deviation##2##5##(2008-10#2)
9997##9##1##(2008-10#8)(2012-2#1)
9997)##3##1##(1997-2#1)(2008-10#2)
9998##5##1##(2008-10#4)(2008-5#1)
9998)##3##1##(2008-10#3)
9999 and##2##2##(2008-10#1)(2008-5#1)
9999##10##1##(2008-10#9)(2008-5#1)
9999) and##3##2##(2008-10#3)
9999) with##2##2##(2008-10#2)
9999)##14##1##(1991-5#1)(2008-10#13)
99m##3##1##(1992-2#1)(2007-11#1)(2008-1#1)
99mTc labelled##3##2##(1990-12#2)(1996-1#1)
99mTc##9##1##(1990-12#4)(1994-2#2)(1996-1#1)(2008-10#1)(2008-7#1)
99mTc-HMPAO##2##1##(1995-5#1)(1996-12#1)
99mTc-HYNIC-TOC in the##2##3##(2008-7#2)
99mTc-HYNIC-TOC##4##1##(2008-7#4)
9L##4##1##(1992-9#3)(2009-12#1)
9MC##2##1##(1994-6#2)
9N##2##1##(2008-12#1)(2010-4#1)
9S##2##1##(1990-11#1)(1995-2#1)
9V##4##1##(1994-9#1)(2008-10#2)(2012-12#1)
9alpha##2##1##(2008-11#2)
9alpha-hydroxylase system##3##2##(2008-11#3)
9alpha-hydroxylase##11##1##(2008-11#11)
9h##2##1##(2007-8#1)(2008-6#1)
9mV per##2##2##(2008-10#2)
9mm##2##1##(2008-10#2)
9muM##2##1##(2008-10#2)
9mugl(-1)##4##1##(2008-10#4)
9nM##2##1##(2008-10#2)
9ngml(-1)##2##1##(2008-10#2)
9p-linking hereditary melanoma##2##3##(1997-7#2)
9p-linking##3##1##(1997-7#3)
9p21##3##1##(1997-7#2)(2009-12#1)
9q22##3##1##(1994-6#1)(1997-3#1)(2008-1#1)
9th International Symposium on Thrombolysis and Acute Stroke Therapy (TAST 2006)##2##11##(2008-8#2)
9th International##5##2##(2008-12#1)(2008-7#1)(2008-8#3)
9th and 10th##5##3##(1992-3#1)(2007-12#1)(2010-4#1)(2013-1#2)
9th day of##2##3##(1994-7#1)(2008-4#1)
9th day##4##2##(1994-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
9th grade##4##2##(1991-9#4)
9th##28##1##(1991-9#4)(1992-3#1)(1993-3#1)(1994-7#1)(1997-5#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-2#1)(2010-4#1)(2013-1#3)
9x10(-6) to 1##2##3##(2008-10#2)
9x10(-6)##4##1##(2008-10#4)
9x10(-6)M##3##1##(2008-10#3)
9x10(-7) mol##2##2##(2008-10#2)
9x10(-7) to 3##2##3##(2008-10#2)
9x10(-7)##4##1##(2008-10#4)
9x10(-8) to##2##2##(2008-10#2)
9±0##4##1##(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
9±1##4##1##(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
9 ± 5##2##1##(2013-1#2)
9 mU/l)##2##1##(2012-3#2)
</AbstractText> </Abstract> <Affiliation>Department of Clinical Studies##2##6##(2013-8#2)
</AbstractText> </Abstract> <Affiliation>Department of##5##4##(1994-5#1)(2013-8#4)
</AbstractText> </Abstract> <AuthorList CompleteYN="Y"> <Author ValidYN="Y">##2##6##(1996-11#1)(1996-12#1)
</AbstractText> </Abstract>##14##2##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
</Affiliation> <AuthorList CompleteYN="Y"> <Author ValidYN="Y">##12##5##(1994-5#1)(1997-4#1)(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>Canada</Country> <MedlineTA>Can Vet J</MedlineTA> <NlmUniqueID>0004653</NlmUniqueID> <ISSNLinking>0008-5286</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="fre" Type="Publisher"> <AbstractText>Abstract available from the publisher##10##25##(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo>##11##9##(1996-11#1)(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType>##13##6##(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList>##14##4##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
</Author> <Author ValidYN="Y">##35##3##(1994-5#9)(1997-4#1)(2013-8#25)
</Author>##49##1##(1994-5#10)(1996-11#1)(1996-12#1)(1997-4#2)(2013-8#35)
</Chemical> </ChemicalList> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##2##4##(1994-5#1)(1997-4#1)
</Chemical> </ChemicalList>##3##2##(1994-5#1)(1996-11#1)(1997-4#1)
</Chemical> <Chemical> <RegistryNumber>0</RegistryNumber>##2##3##(1994-5#1)(1996-11#1)
</Chemical> <Chemical>##5##2##(1994-5#3)(1996-11#2)
</Chemical>##8##1##(1994-5#4)(1996-11#3)(1997-4#1)
</CommentsCorrections> </CommentsCorrectionsList> <MeshHeadingList> <MeshHeading> <DescriptorName##2##5##(1994-5#1)(1996-11#1)
</CommentsCorrections> <CommentsCorrections RefType="Cites">##3##3##(1996-11#3)
</CommentsCorrections> <CommentsCorrections##4##2##(1996-11#4)
</CommentsCorrections>##6##1##(1994-5#1)(1996-11#5)
</MedlineJournalInfo> <ChemicalList> <Chemical> <RegistryNumber>0</RegistryNumber>##3##4##(1994-5#1)(1996-11#1)(1997-4#1)
</MedlineJournalInfo> <CitationSubset>IM</CitationSubset>##11##2##(1996-12#1)(2013-8#10)
</MedlineJournalInfo>##14##1##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
</MeshHeading> </MeshHeadingList> <OtherID##3##3##(1994-5#1)(1996-11#1)(1997-4#1)
</MeshHeading> </MeshHeadingList>##4##2##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Female</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##3##11##(1994-5#1)(1996-11#1)(1996-12#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##4##7##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Infant##3##4##(1997-4#3)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="Y">Food##2##4##(1997-4#2)
</MeshHeading> <MeshHeading> <DescriptorName##45##3##(1994-5#9)(1996-11#13)(1996-12#12)(1997-4#11)
</MeshHeading>##49##1##(1994-5#10)(1996-11#14)(1996-12#13)(1997-4#12)
</PublicationTypeList> </Article> <MedlineJournalInfo> <Country>NETHERLANDS</Country> <MedlineTA>Acta Trop</MedlineTA> <NlmUniqueID>0370374</NlmUniqueID> <ISSNLinking>0001-706X</ISSNLinking> </MedlineJournalInfo>##2##9##(1996-12#1)(1997-4#1)
</PublicationTypeList> </Article> <MedlineJournalInfo>##14##3##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
<Author ValidYN="Y">##49##2##(1994-5#10)(1996-11#1)(1996-12#1)(1997-4#2)(2013-8#35)
<AuthorList CompleteYN="Y"> <Author ValidYN="Y">##14##4##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
<Chemical> <RegistryNumber>0</RegistryNumber>##5##2##(1994-5#2)(1996-11#2)(1997-4#1)
<Chemical>##8##1##(1994-5#4)(1996-11#3)(1997-4#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <CommentsCorrectionsList> <CommentsCorrections##2##4##(1994-5#1)(1996-11#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <MeshHeadingList> <MeshHeading> <DescriptorName##2##5##(1996-12#1)(1997-4#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##4##2##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)
<CitationSubset>IM</CitationSubset>##14##1##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
<CommentsCorrections RefType="Cites">##4##2##(1996-11#4)
<CommentsCorrections##6##1##(1994-5#1)(1996-11#5)
<ForeName>A##2##1##(1994-5#1)(1996-12#1)
<ForeName>A</ForeName> <Initials>A</Initials> </Author> <Author ValidYN="Y">##3##5##(1994-5#2)(1997-4#1)
<ForeName>A</ForeName> <Initials>A</Initials> </Author>##4##3##(1994-5#3)(1997-4#1)
<ForeName>G</ForeName> <Initials>G</Initials> </Author> <Author ValidYN="Y">##2##5##(1994-5#2)
<ForeName>J##2##1##(1997-4#1)(2013-8#1)
<ForeName>M</ForeName> <Initials>M</Initials> </Author> <Author ValidYN="Y">##2##5##(1994-5#2)
<Initials>A</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList>##2##5##(1994-5#1)(2013-8#1)
<Initials>A</Initials> </Author> <Author ValidYN="Y">##7##4##(1994-5#2)(1997-4#1)(2013-8#4)
<Initials>A</Initials> </Author>##9##2##(1994-5#3)(1997-4#1)(2013-8#5)
<Initials>D</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>Canada</Country> <MedlineTA>Can Vet J</MedlineTA> <NlmUniqueID>0004653</NlmUniqueID> <ISSNLinking>0008-5286</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="fre" Type="Publisher"> <AbstractText>Abstract available from the publisher##2##26##(2013-8#2)
<Initials>D</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
<Initials>D</Initials> </Author>##4##2##(2013-8#4)
<Initials>G</Initials> </Author> <Author ValidYN="Y">##3##4##(1994-5#2)(2013-8#1)
<Initials>L</Initials> </Author> <Author ValidYN="Y">##2##4##(1994-5#1)(2013-8#1)
<Initials>M</Initials> </Author> <Author ValidYN="Y">##4##4##(1994-5#2)(2013-8#2)
<MeshHeading> <DescriptorName##49##2##(1994-5#10)(1996-11#14)(1996-12#13)(1997-4#12)
<MeshHeadingList> <MeshHeading> <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##11##(1994-5#1)(1996-12#1)
<MeshHeadingList> <MeshHeading> <DescriptorName##4##3##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)
<OtherAbstract Type="PIP"> <AbstractText>In##2##3##(1994-5#1)(1996-12#1)
<OtherAbstract Type="PIP">##4##2##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)
<OtherAbstract##14##1##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
<OtherID##10##1##(1994-5#2)(1996-11#4)(1996-12#2)(1997-4#2)
<PMID##5##1##(1996-11#5)
<PublicationType>Journal Article</PublicationType>##14##2##(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2013-8#10)
<QualifierName MajorTopicYN="N">administration &amp##2##3##(1996-11#2)
<QualifierName MajorTopicYN="N">pathology</QualifierName>##2##2##(1994-5#2)
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##2##6##(1994-5#2)
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName> </MeshHeading>##3##4##(1994-5#3)
<QualifierName##17##1##(1994-5#7)(1996-11#2)(1996-12#4)(1997-4#4)
<RefSource>BMJ##2##1##(1996-11#2)
= &gt##2##2##(2008-10#1)(2008-8#1)
= &lt##4##2##(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)
= (0##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#2)
= (1##2##2##(2008-10#2)
= (2##3##2##(1995-2#1)(2008-2#1)(2008-3#1)
= (CpCo)(3)(&amp##2##2##(1997-7#2)
= -##5##2##(2008-5#1)(2008-9#2)(2010-9#1)(2012-3#1)
= -0##82##2##(1990-12#1)(1991-2#2)(1991-3#2)(1992-9#1)(1993-2#5)(1994-5#1)(1995-11#3)(1995-8#3)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-1#5)(2008-10#11)(2008-12#4)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#9)(2010-2#2)(2010-4#5)(2010-6#1)(2011-2#2)(2011-3#2)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#2)
= -1##4##2##(1993-8#1)(2008-2#1)(2013-8#2)
= -2##3##2##(2008-10#2)(2013-8#1)
= -38##2##2##(1997-7#1)(2008-6#1)
= 0 -##2##3##(2008-3#1)(2010-4#1)
= 0 ?##2##3##(2007-12#1)(2008-3#1)
= 0 and##3##3##(1991-5#1)(1996-4#1)(2008-10#1)
= 0##1325##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#9)(1991-11#6)(1991-12#6)(1991-2#5)(1991-3#6)(1991-5#12)(1991-8#10)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#7)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#4)(1993-1#9)(1993-11#5)(1993-12#5)(1993-2#9)(1993-6#1)(1993-8#9)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#8)(1995-11#5)(1995-12#9)(1995-2#9)(1995-3#10)(1995-5#2)(1995-6#5)(1995-8#13)(1995-9#4)(1996-1#3)(1996-12#7)(1996-2#32)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#8)(1997-4#1)(1997-5#13)(1997-6#4)(1997-7#11)(1997-8#6)(2006-10#4)(2007-10#10)(2007-11#25)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#14)(2008-10#259)(2008-11#23)(2008-12#18)(2008-2#10)(2008-3#70)(2008-4#7)(2008-5#34)(2008-6#7)(2008-7#84)(2008-8#14)(2008-9#24)(2009-10#1)(2009-11#5)(2009-2#1)(2009-3#2)(2009-8#5)(2009-9#2)(2010-1#7)(2010-11#5)(2010-2#18)(2010-3#6)(2010-4#17)(2010-6#3)(2010-8#14)(2010-9#6)(2011-1#33)(2011-2#96)(2011-3#6)(2012-1#1)(2012-12#9)(2012-2#11)(2012-3#29)(2013-1#73)(2013-7#7)(2013-8#42)
= 0)##9##2##(2008-10#2)(2008-11#1)(2008-3#6)
= 1 -##6##3##(1995-2#1)(2007-11#3)(2008-10#1)(2008-11#1)
= 1 and##3##3##(2008-3#1)(2008-9#1)(2012-12#1)
= 1 nM)##3##3##(1994-12#1)(1995-8#2)
= 1##197##2##(1990-11#3)(1990-2#1)(1990-7#1)(1990-8#5)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-12#1)(1994-10#1)(1994-12#6)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-5#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#4)(1997-8#1)(2007-11#6)(2007-12#5)(2008-10#12)(2008-11#2)(2008-12#7)(2008-2#17)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#2)(2009-11#1)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#9)(2012-1#2)(2012-12#4)(2012-3#6)(2013-1#7)(2013-8#1)
= 1)##30##2##(1990-4#1)(1993-2#2)(1994-10#2)(1994-3#7)(1996-11#3)(1997-7#1)(1997-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-2#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)
= 1/2##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
= 10 +/-##2##3##(1994-5#1)(2010-7#1)
= 10##39##2##(1992-8#1)(1993-11#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-2#9)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#4)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)
= 10%##2##2##(1994-5#1)(2007-12#1)
= 10(5)##2##2##(1996-12#1)(2008-3#1)
= 10) and##5##3##(2008-10#3)(2008-6#1)(2013-1#1)
= 10)##45##2##(1990-7#2)(1992-11#1)(1993-6#1)(1995-12#4)(1995-2#2)(1996-5#1)(1996-7#2)(2007-10#3)(2008-10#14)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)
= 100##14##2##(1993-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-2#1)(2011-2#2)(2012-3#1)
= 1000##2##2##(1997-5#1)(2009-11#1)
= 101)##2##2##(1996-7#1)(2008-8#1)
= 102##3##2##(1996-2#2)(2008-10#1)
= 104##2##2##(1994-8#1)(1996-2#1)
= 108##3##2##(1991-5#1)(1996-2#2)
= 11##16##2##(1992-8#1)(1993-11#1)(1993-12#1)(1996-2#5)(1997-7#3)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
= 11) or##2##3##(1995-5#1)(2008-1#1)
= 11)##12##2##(1993-12#1)(1993-3#1)(1995-5#3)(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)
= 110##2##2##(1992-3#1)(1996-2#1)
= 112##6##2##(1992-12#1)(1996-2#1)(1997-7#4)
= 113##4##2##(1995-12#1)(1996-2#2)(2007-11#1)
= 114##2##2##(1996-2#2)
= 114)##3##2##(2008-7#1)(2009-7#1)(2010-8#1)
= 117)##3##2##(2007-10#1)(2012-3#2)
= 118)##2##2##(1993-8#1)(2013-1#1)
= 12##27##2##(1990-8#1)(1996-2#9)(1997-7#3)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)
= 12) or##4##3##(1993-3#1)(1994-5#1)(2011-2#1)(2012-3#1)
= 12)##32##2##(1991-5#2)(1993-1#1)(1993-3#3)(1994-2#2)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#4)
= 120)##4##2##(2008-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
= 122##2##2##(1995-5#1)(1997-7#1)
= 127)##4##2##(1992-9#1)(2009-4#1)(2010-10#2)
= 13##28##2##(1992-6#1)(1996-2#9)(1997-7#5)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)
= 13)##7##2##(1994-3#1)(1996-2#1)(2008-10#2)(2010-2#1)(2013-1#1)(2013-8#1)
= 130)##2##2##(1993-3#1)(2009-4#1)
= 135##2##2##(1992-9#1)(2011-1#1)
= 14##20##2##(1990-8#1)(1992-12#1)(1995-3#1)(1996-2#2)(1997-7#4)(2008-10#3)(2008-5#2)(2008-9#1)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#1)
= 14)##11##2##(1991-5#1)(1995-12#1)(1996-7#1)(2007-10#1)(2008-7#3)(2009-12#1)(2009-8#1)(2013-8#2)
= 145)##2##2##(2008-9#1)(2009-7#1)
= 15##20##2##(1994-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-7#3)(2008-10#4)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-3#1)
= 15)##13##2##(1990-8#1)(1996-7#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)
= 155)##2##2##(2010-10#1)(2010-4#1)
= 16##11##2##(1993-1#1)(1996-2#4)(1997-7#1)(2008-10#1)(2008-5#1)(2009-7#2)(2013-8#1)
= 16)##11##2##(1990-2#2)(1990-8#1)(1992-1#1)(1997-1#1)(2007-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
= 17##14##2##(1996-2#3)(1997-7#3)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-10#1)(2011-2#2)(2013-8#1)
= 171##2##2##(2009-7#1)(2011-2#1)
= 18##25##2##(1990-12#1)(1995-11#1)(1996-2#9)(1996-5#1)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)(2008-9#1)(2010-1#1)
= 18)##12##2##(1992-1#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
= 180)##2##2##(2008-12#2)
= 183)##2##2##(2008-7#1)(2012-3#1)
= 19##12##2##(1994-6#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#1)(2009-1#1)(2010-10#1)(2012-3#1)
= 19)##7##2##(1990-2#1)(1990-9#1)(1993-6#1)(1994-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
= 2 and##2##3##(1997-7#1)(2008-5#1)
= 2##143##2##(1990-12#3)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-10#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#15)(1997-7#6)(2007-11#4)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#10)(2008-5#8)(2008-6#5)(2008-7#2)(2008-8#1)(2009-8#2)(2010-10#2)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#8)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
= 2) and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
= 2)##24##2##(1992-8#1)(1993-2#4)(1994-3#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
= 20##24##2##(1995-5#1)(1995-8#4)(1996-2#5)(1997-1#2)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-7#1)(2013-8#1)
= 20) and##2##3##(2008-10#1)(2009-8#1)
= 20) were##3##3##(1993-3#1)(2008-10#2)
= 20)##18##2##(1993-1#1)(1993-3#2)(1995-11#1)(1997-8#1)(2008-10#4)(2009-8#4)(2011-1#1)(2013-1#4)
= 200##8##2##(1991-12#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-6#3)(1996-2#1)
= 21##15##2##(1993-8#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-2#5)(1997-2#1)(1997-7#2)(2008-10#1)(2008-5#1)(2010-9#1)
= 21)##9##2##(1990-8#1)(1993-11#1)(1994-10#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
= 22##7##2##(1996-2#1)(1997-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)
= 22)##7##2##(1992-12#1)(1992-5#1)(1992-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-8#1)
= 227)##2##2##(1990-2#1)(2012-3#1)
= 23##7##2##(1991-5#1)(1993-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)
= 238)##2##2##(1993-3#1)(1996-2#1)
= 24##6##2##(1992-12#1)(1996-2#3)(1996-7#1)(2008-10#1)
= 24) and##4##3##(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
= 24)##12##2##(1990-5#1)(1992-5#1)(2008-10#1)(2008-7#1)(2009-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
= 25 +/- 3##2##4##(1996-2#1)(2010-8#1)
= 25##11##2##(1991-12#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-8#1)
= 25%##2##2##(2008-10#1)(2008-6#1)
= 25)##9##2##(1993-9#2)(1996-7#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
= 250##2##2##(1990-7#1)(1997-4#1)
= 26##4##2##(1991-5#1)(2008-7#2)(2009-6#1)
= 260)##2##2##(1992-6#1)(2008-10#1)
= 266##2##2##(1996-5#1)(2008-2#1)
= 27##8##2##(1990-11#1)(1994-1#1)(1996-2#1)(2008-10#1)(2008-5#2)(2010-8#1)(2012-2#1)
= 27)##8##2##(1990-8#1)(1994-7#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
= 270)##2##2##(2008-10#1)(2010-5#1)
= 271)##2##2##(1992-11#1)(2010-5#1)
= 28##5##2##(1990-5#1)(1992-5#1)(1996-2#1)(2008-1#1)(2008-12#1)
= 28)##7##2##(1992-1#1)(1994-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#2)
= 29##3##2##(1996-2#1)(2008-3#1)(2012-2#1)
= 2x =##5##3##(2008-10#1)(2009-12#4)
= 3##92##2##(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#4)(1992-2#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-8#5)(1994-3#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-7#1)(2009-8#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
= 3%)##3##2##(2008-10#2)(2008-11#1)
= 3) and##3##3##(1993-2#1)(1994-3#1)(2008-10#1)
= 3) was##5##3##(2008-10#3)(2008-9#1)(2011-1#1)
= 3)##32##2##(1990-8#2)(1991-8#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#2)(1996-2#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#1)
= 3-6##2##2##(2007-7#1)(2009-2#1)
= 30 degrees##3##3##(1997-8#1)(2008-12#1)(2008-2#1)
= 30##19##2##(1994-12#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-12#3)(2008-2#2)(2008-3#2)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)
= 30) and##4##3##(1990-8#1)(2008-4#2)(2008-5#1)
= 30)##20##2##(1990-8#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-8#1)(2007-6#3)(2008-4#2)(2008-5#2)(2009-1#1)(2009-9#1)(2010-3#2)(2012-3#1)(2013-8#3)
= 31##3##2##(1996-1#1)(1997-7#1)(2009-6#1)
= 32##5##2##(1990-12#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-12#1)
= 32)##7##2##(1996-7#1)(2008-12#1)(2008-6#1)(2010-3#3)(2010-4#1)
= 327)##2##2##(2007-12#1)(2008-10#1)
= 33##3##2##(1990-7#1)(1995-11#1)(2010-8#1)
= 33)##4##2##(1996-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
= 34##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
= 34)##4##2##(2008-7#2)(2010-4#1)(2013-8#1)
= 35 g##2##3##(1997-2#1)(2008-7#1)
= 35##8##2##(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-12#1)(2008-7#1)(2012-3#2)
= 350##2##2##(1990-11#1)(1993-3#1)
= 36##5##2##(1996-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
= 36)##2##2##(2008-10#1)(2009-12#1)
= 37##5##2##(1994-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)
= 37)##2##2##(2008-3#1)(2008-6#1)
= 38##6##2##(1993-1#1)(1993-8#1)(1997-7#1)(2008-3#1)(2010-3#2)
= 39) and##2##3##(2008-10#1)(2012-3#1)
= 39)##5##2##(1996-7#1)(2008-10#1)(2012-3#2)(2013-1#1)
= 4##85##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#3)(1995-3#3)(1995-8#1)(1996-1#1)(1996-2#21)(1996-5#2)(1997-1#1)(1997-7#10)(1997-8#2)(2007-11#2)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
= 4)##29##2##(1990-5#4)(1991-8#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-2#2)(1997-1#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
= 40##9##2##(1994-9#2)(1995-12#2)(1996-9#1)(2008-10#1)(2008-8#1)(2010-3#2)
= 40)##5##2##(1996-7#1)(2008-10#1)(2011-2#1)(2013-1#2)
= 400##2##2##(2008-2#1)(2011-2#1)
= 41##6##2##(1992-5#1)(1994-12#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-4#1)
= 42##8##2##(1992-3#1)(1993-8#2)(1994-11#1)(1994-6#1)(1996-1#1)(2008-10#1)(2010-2#1)
= 424)##2##2##(1995-3#1)(2007-12#1)
= 43)##5##2##(1991-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
= 44##2##2##(2008-6#1)(2008-8#1)
= 45)##6##2##(1991-2#1)(1992-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
= 46##4##2##(1991-12#1)(1992-8#1)(2007-12#1)(2008-5#1)
= 47##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
= 48##2##2##(1996-2#1)(2009-7#1)
= 48)##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
= 49##3##2##(1995-2#1)(1996-2#1)(2008-10#1)
= 5 and##4##3##(1990-5#1)(1991-8#3)
= 5 nM)##2##3##(1991-5#1)(1995-3#1)
= 5##57##2##(1990-5#2)(1991-5#1)(1991-8#3)(1992-8#2)(1992-9#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-5#2)(1997-7#2)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-3#2)(2013-8#2)
= 5) and##3##3##(1990-7#1)(1996-12#1)(2009-11#1)
= 5) of##2##3##(2008-10#1)(2011-1#1)
= 5) received##2##3##(2008-5#2)
= 5)##30##2##(1990-2#1)(1990-7#1)(1993-12#1)(1994-11#1)(1994-3#3)(1995-2#1)(1996-12#2)(2007-10#1)(2007-8#1)(2008-10#9)(2008-5#2)(2009-11#4)(2009-8#1)(2011-1#2)
= 50##5##2##(1990-12#1)(1996-1#1)(1997-5#1)(2008-5#1)(2011-2#1)
= 50)##8##2##(1990-8#2)(1993-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-9#1)
= 52##2##2##(2007-10#1)(2008-3#1)
= 52) and##2##3##(1994-1#1)(2008-10#1)
= 55##2##2##(1992-9#1)(1995-5#1)
= 55)##3##2##(1994-1#1)(2008-9#2)
= 58##4##2##(1995-6#1)(1996-1#1)(2007-11#1)(2008-6#1)
= 6##42##2##(1990-8#1)(1992-11#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-7#4)(2007-11#2)(2008-10#3)(2008-12#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#2)(2010-7#2)(2011-1#3)(2013-8#1)
= 6) and##6##3##(1993-2#1)(1993-8#1)(1996-5#1)(2007-10#1)(2009-2#1)(2010-9#1)
= 6) or##2##3##(2008-10#1)(2010-6#1)
= 6)##23##2##(1991-5#1)(1992-3#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#4)(1997-8#2)(2007-10#1)(2008-10#2)(2009-2#1)(2010-6#2)(2010-9#1)(2012-3#1)
= 60 degrees##2##3##(1993-3#1)(2008-3#1)
= 60##7##2##(1993-3#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
= 60)##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
= 61)##2##2##(2008-9#1)(2010-4#1)
= 62)##4##2##(1996-2#1)(2008-8#2)(2012-12#1)
= 64##5##2##(1990-7#1)(1993-1#1)(1993-11#1)(1997-7#1)(2011-1#1)
= 64)##3##2##(1993-1#1)(1996-2#1)(2010-8#1)
= 65##4##2##(1990-11#1)(2008-2#1)(2010-1#1)(2011-2#1)
= 65)##2##2##(1996-2#1)(2012-2#1)
= 66##3##2##(1992-3#1)(1994-5#1)(2012-12#1)
= 69##2##2##(2008-9#1)(2010-3#1)
= 7##37##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-8#3)(1995-11#3)(1995-2#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
= 7) and##3##3##(2007-10#1)(2007-11#1)(2008-5#1)
= 7)##18##2##(1991-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-5#2)(2007-10#2)(2007-11#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-12#1)(2012-3#1)
= 70 degrees##2##3##(2008-3#2)
= 70##11##2##(1992-3#1)(1994-1#2)(1995-11#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-12#1)
= 70)##4##2##(1995-12#1)(1996-2#1)(2007-5#1)(2012-3#1)
= 71##6##2##(2008-3#2)(2009-1#1)(2009-7#1)(2010-1#1)(2011-1#1)
= 72##7##2##(1992-3#1)(1995-11#1)(1996-1#1)(1996-2#1)(2008-3#1)(2009-1#1)(2009-4#1)
= 73##2##2##(1992-9#1)(1996-2#1)
= 75##3##2##(1991-2#1)(1992-3#1)(1992-9#1)
= 76##3##2##(1995-11#1)(2007-10#1)(2008-12#1)
= 78##4##2##(1992-9#1)(1996-2#1)(2007-11#1)(2012-2#1)
= 8##51##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-9#2)(1993-11#1)(1993-12#1)(1995-11#2)(1995-3#2)(1995-8#1)(1996-11#1)(1996-2#4)(1996-5#1)(1997-7#11)(1997-8#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
= 8)##29##2##(1990-5#2)(1991-9#1)(1993-12#6)(1993-6#2)(1994-5#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
= 80##7##2##(1990-10#5)(1990-11#1)(2007-11#1)
= 83##2##2##(2007-11#1)(2008-5#1)
= 88##2##2##(1992-11#1)(2008-7#1)
= 89##2##2##(1990-7#1)(1994-11#1)
= 9##29##2##(1992-9#1)(1993-6#1)(1993-8#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-2#4)(1997-7#3)(2007-11#3)(2008-10#3)(2010-2#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
= 9) and##3##3##(1993-12#2)(2008-10#1)
= 9)##27##2##(1990-12#1)(1990-7#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-3#2)
= 90 degrees##4##3##(1992-11#1)(1997-7#2)(2008-8#1)
= 90##7##2##(1992-11#1)(1995-6#1)(1997-7#4)(2008-8#1)
= 90)##2##2##(2008-8#1)(2009-5#1)
= 91)##2##2##(2007-10#1)(2012-2#1)
= 92##6##2##(1996-2#4)(2007-11#1)(2008-10#1)
= 92)##3##2##(2008-5#2)(2008-9#1)
= 93##3##2##(1997-7#2)(2008-5#1)
= 95##2##2##(1992-8#1)(1997-7#1)
= 97##8##2##(1992-9#1)(1993-2#1)(1996-2#3)(1997-7#3)
= 99##2##2##(1996-2#1)(2007-12#1)
= A##3##2##(1995-5#2)(2008-2#1)
= ADP##2##2##(1995-8#2)
= ATP##2##2##(1995-11#1)(1995-8#1)
= Ala##2##2##(1990-5#2)
= C##3##2##(1992-6#1)(1995-5#1)(2009-9#1)
= Demineralized enamel##2##3##(2013-1#2)
= Et##3##2##(1996-2#1)(1997-7#1)(2009-9#1)
= H##2##2##(1996-5#1)(2009-9#1)
= K##2##2##(1997-7#2)
= Li##2##2##(1997-7#2)
= Mn##4##2##(1996-2#2)(2008-10#1)(2009-11#1)
= NS)##3##2##(1994-12#2)(2013-1#1)
= O stretching##4##3##(1990-2#3)(1994-3#1)
= O##11##2##(1990-2#5)(1992-6#1)(1994-3#3)(1994-5#1)(1995-5#1)
= Ph##3##2##(1996-2#3)
= Remineralized enamel##2##3##(2013-1#2)
= Ti##2##2##(1997-7#2)
= UTP##3##2##(1993-8#1)(1995-8#2)
= Y##3##2##(1997-7#3)
= approximately##4##2##(1992-5#2)(1993-11#2)
= dppe##2##2##(1996-2#1)(2009-9#1)
= gamma##5##2##(1992-11#1)(1997-7#2)(2008-3#2)
= most##2##2##(2008-10#2)
= n##2##2##(2008-3#1)(2010-8#1)
= non##2##2##(1994-11#1)(2008-11#1)
= pyridine##2##2##(1997-7#1)(2009-11#1)
= the incidence of seed or spikelet infection at##2##9##(2008-10#2)
= the##9##2##(1997-7#1)(2008-10#8)
=##4366##1##(1990-10#5)(1990-11#9)(1990-12#9)(1990-2#21)(1990-3#2)(1990-4#3)(1990-5#29)(1990-6#4)(1990-7#14)(1990-8#34)(1990-9#1)(1991-11#6)(1991-12#19)(1991-2#18)(1991-3#10)(1991-5#27)(1991-6#4)(1991-8#32)(1991-9#5)(1992-1#4)(1992-10#4)(1992-11#15)(1992-12#12)(1992-2#9)(1992-3#21)(1992-5#8)(1992-6#11)(1992-8#12)(1992-9#24)(1993-1#26)(1993-11#17)(1993-12#24)(1993-2#35)(1993-3#13)(1993-6#8)(1993-8#48)(1993-9#6)(1994-1#5)(1994-10#6)(1994-11#12)(1994-12#26)(1994-2#10)(1994-3#41)(1994-5#18)(1994-6#21)(1994-7#6)(1994-8#14)(1994-9#16)(1995-1#1)(1995-11#33)(1995-12#35)(1995-2#23)(1995-3#26)(1995-5#28)(1995-6#20)(1995-8#43)(1995-9#4)(1996-1#11)(1996-11#8)(1996-12#24)(1996-2#277)(1996-3#3)(1996-4#3)(1996-5#27)(1996-6#2)(1996-7#15)(1996-8#8)(1996-9#12)(1997-1#11)(1997-2#21)(1997-3#8)(1997-4#4)(1997-5#28)(1997-6#8)(1997-7#173)(1997-8#28)(2006-10#5)(2006-6#1)(2007-10#70)(2007-11#76)(2007-12#32)(2007-5#3)(2007-6#4)(2007-7#4)(2007-8#11)(2008-1#26)(2008-10#493)(2008-11#61)(2008-12#77)(2008-2#82)(2008-3#218)(2008-4#22)(2008-5#126)(2008-6#46)(2008-7#153)(2008-8#56)(2008-9#57)(2009-1#7)(2009-10#8)(2009-11#28)(2009-12#14)(2009-2#7)(2009-3#2)(2009-4#5)(2009-5#12)(2009-6#3)(2009-7#34)(2009-8#36)(2009-9#38)(2010-1#15)(2010-10#15)(2010-11#8)(2010-12#6)(2010-2#37)(2010-3#34)(2010-4#43)(2010-5#6)(2010-6#10)(2010-7#6)(2010-8#45)(2010-9#18)(2011-1#89)(2011-2#184)(2011-3#10)(2012-1#6)(2012-12#35)(2012-2#34)(2012-3#95)(2013-1#162)(2013-7#7)(2013-8#76)
=)##2##1##(2008-3#2)
=-0##2##1##(2008-7#1)(2009-3#1)
=0##21##1##(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
=0)##4##1##(2008-3#4)
=1##14##1##(2007-12#1)(2008-10#7)(2008-12#3)(2011-2#1)(2012-12#1)(2012-3#1)
=10##3##1##(2008-1#1)(2008-10#1)(2010-3#1)
=120##2##1##(2008-10#1)(2008-8#1)
=2##6##1##(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#1)
=3##7##1##(2008-10#6)(2008-7#1)
=4##5##1##(1997-5#1)(2008-10#3)(2011-2#1)
=7##3##1##(1997-7#1)(2007-11#1)(2009-11#1)
=8##2##1##(2008-1#1)(2011-2#1)
=9##2##1##(2008-10#2)
==&gt##3##1##(1993-8#1)(2008-11#2)
? 0##22##2##(2007-12#1)(2008-2#13)(2008-3#8)
? 3##3##2##(2008-2#1)(2008-3#2)
? 5%##2##2##(2008-2#2)
? 5P(3/2)##2##2##(2008-2#1)(2008-3#1)
? 7)%##2##2##(2008-3#2)
? A##3##2##(2008-2#2)(2009-7#1)
?##90##1##(1994-1#2)(1994-10#1)(2007-11#2)(2007-12#9)(2007-4#1)(2008-12#1)(2008-2#39)(2008-3#30)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
?)##2##1##(2008-2#2)
?0##13##1##(2007-11#1)(2008-2#5)(2008-3#7)
?1##2##1##(2007-11#1)(2008-3#1)
?10%##4##1##(2008-2#2)(2008-3#2)
????best##2##1##(2012-2#2)
?]##2##1##(2008-2#1)(2008-4#1)
?erenkov##5##1##(2008-2#5)
?f?##3##1##(2008-3#3)
?t(i)?##2##1##(2007-12#2)
@##2##1##(2008-10#1)(2013-1#1)
A &gt##6##2##(1995-11#2)(1995-5#2)(1997-6#1)(2008-5#1)
A &quot##9##2##(1994-1#1)(2008-10#4)(2008-4#1)(2009-10#1)(2010-11#1)(2010-7#1)
A (1) and##2##3##(1992-8#2)
A (1)##4##2##(1992-8#3)(2009-12#1)
A (50##2##2##(1995-12#1)(2012-3#1)
A (ASA)##2##2##(1994-3#1)(1997-3#1)
A (BPA) in the presence of phenol##2##7##(2008-10#2)
A (BPA) in##3##3##(2008-10#2)(2009-8#1)
A (BPA)##7##2##(2008-10#4)(2008-4#1)(2009-8#1)(2010-9#1)
A (Con A) and##2##4##(2008-10#1)(2012-3#1)
A (Con A)##7##3##(1990-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#2)(2012-3#1)
A (Con##8##2##(1990-6#1)(1991-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#2)(2012-3#1)
A (ConA)##3##2##(1995-12#2)(2008-10#1)
A (CsA)##5##2##(1990-12#1)(1991-9#1)(1994-3#1)(1994-8#1)(1997-2#1)
A (CyA) and its major##2##5##(2008-10#2)
A (H1N1) 2009##5##3##(2010-2#1)(2011-1#1)(2011-2#3)
A (H1N1)##11##2##(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-12#1)
A (H3N2)##2##2##(2011-2#1)(2013-8#1)
A (HeII p --&gt##2##4##(2008-3#2)
A (NKA)##2##2##(1990-12#1)(2008-4#1)
A (OTA)##4##2##(2008-10#3)(2011-2#1)
A (SAA)##3##2##(1991-12#1)(2008-7#1)(2009-10#1)
A (w)##2##2##(2008-2#2)
A + T##2##3##(1993-2#1)(2008-8#1)
A +##5##2##(1991-12#2)(1993-2#1)(1994-12#1)(2008-8#1)
A 0##6##2##(2008-10#4)(2008-8#1)(2012-12#1)
A 1##11##2##(1993-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2011-1#1)
A 10-year material]##2##3##(1994-2#1)(1995-2#1)
A 10-year##5##2##(1994-2#1)(1995-2#1)(1996-9#1)(1997-8#1)(2012-12#1)
A 12##3##2##(1996-9#1)(2008-10#1)(2008-12#1)
A 12-year-old##2##2##(2011-1#2)
A 13-year-old##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
A 14##3##2##(2008-2#2)(2008-8#1)
A 14-year-old girl##2##3##(2007-7#1)(2008-8#1)
A 14-year-old male presented with##2##5##(2008-10#1)(2008-6#1)
A 14-year-old##5##2##(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)
A 15##2##2##(1994-2#1)(2008-2#1)
A 16-year-old male presented##2##4##(2008-7#1)(2010-5#1)
A 16-year-old male##3##3##(2008-7#1)(2010-5#1)(2013-1#1)
A 16-year-old##4##2##(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
A 180##2##2##(1997-3#1)(2008-8#1)
A 19##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
A 19-year-old##2##2##(1990-5#1)(2012-2#1)
A 19-years-old##2##2##(1992-5#1)(1997-5#1)
A 2##8##2##(1994-12#2)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-7#1)
A 2(IV)(6-2) fractional factorial design was employed for##2##8##(2008-10#2)
A 2-min##2##2##(1996-5#1)(2011-2#1)
A 2-year##4##2##(2008-10#2)(2012-12#1)(2012-2#1)
A 2-year-old boy##2##3##(2008-10#1)(2013-8#1)
A 2-year-old##3##2##(2008-10#1)(2013-8#2)
A 20##2##2##(1992-8#1)(2008-11#1)
A 20-year-old man presented with##2##5##(2007-7#1)(2010-6#1)
A 20-year-old man was##2##4##(1992-2#1)(2008-7#1)
A 20-year-old man##4##3##(1992-2#1)(2007-7#1)(2008-7#1)(2010-6#1)
A 20-year-old##7##2##(1992-2#1)(1994-6#1)(2007-7#1)(2008-7#2)(2010-6#1)(2012-3#1)
A 21-year-old man##2##3##(2007-12#1)(2008-1#1)
A 21-year-old##4##2##(2007-12#1)(2008-1#1)(2009-1#1)(2012-8#1)
A 22 years##2##3##(2008-7#1)(2011-2#1)
A 22##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
A 22-year-old female##2##3##(2010-3#1)(2012-2#1)
A 22-year-old##4##2##(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
A 24-year-old##2##2##(2008-9#1)(2010-11#1)
A 25-year-old male presented with##2##5##(2007-7#1)(2011-2#1)
A 25-year-old male##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
A 25-year-old##5##2##(2007-7#1)(2007-8#1)(2009-3#1)(2010-3#1)(2011-2#1)
A 26##2##2##(1997-4#1)(2013-1#1)
A 26-year-old man##2##3##(2008-12#1)(2010-1#1)
A 26-year-old##3##2##(1993-3#1)(2008-12#1)(2010-1#1)
A 27-year-old##2##2##(2007-8#1)(2008-6#1)
A 28-year-old male##2##3##(2007-5#1)(2013-8#1)
A 28-year-old##6##2##(2007-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
A 29##2##2##(1995-2#1)(2007-8#1)
A 29-year-old##2##2##(1994-3#1)(2011-1#1)
A 2Sigma+(v' = 1##2##4##(2008-2#2)
A 3##5##2##(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
A 3-D##2##2##(2008-3#1)(2010-9#1)
A 3-year##4##2##(1997-8#1)(2008-10#2)(2013-7#1)
A 3-year-old girl##2##3##(2008-10#1)(2011-1#1)
A 32##2##2##(1997-6#1)(2007-8#1)
A 32-year-old##3##2##(2007-5#1)(2011-2#1)(2012-1#1)
A 33-year-old##4##2##(1997-5#1)(1997-7#1)(2007-8#2)
A 34-year-old woman##3##3##(2007-8#1)(2008-1#1)(2009-3#1)
A 34-year-old##4##2##(2007-8#1)(2008-1#1)(2009-3#1)(2013-1#1)
A 36-year-old male##2##3##(2010-6#1)(2012-2#1)
A 36-year-old man##2##3##(1990-11#1)(2010-6#1)
A 36-year-old##5##2##(1990-11#1)(2010-6#2)(2011-2#1)(2012-2#1)
A 37-year-old##2##2##(1997-6#1)(2013-7#1)
A 38-year-old woman##2##3##(2008-12#1)(2011-2#1)
A 38-year-old##3##2##(1997-3#1)(2008-12#1)(2011-2#1)
A 39-year-old##2##2##(2009-3#2)
A 3D##5##2##(2007-12#1)(2008-3#1)(2008-6#1)(2013-1#2)
A 4##4##2##(1990-11#1)(2007-11#1)(2008-8#1)(2009-5#1)
A 4-year-old girl##2##3##(1997-3#1)(2008-10#1)
A 4-year-old##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
A 40%##2##2##(1992-5#1)(2007-12#1)
A 40-Year Perspective##2##3##(2013-1#2)
A 40-year-old woman##3##3##(2007-5#1)(2009-3#1)(2013-7#1)
A 40-year-old##7##2##(1996-9#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-7#1)
A 41-year-old man was##2##4##(2007-8#1)(2008-12#1)
A 41-year-old man##4##3##(2007-8#1)(2008-12#2)(2012-1#1)
A 41-year-old##5##2##(1993-6#1)(2007-8#1)(2008-12#2)(2012-1#1)
A 43##3##2##(1995-9#2)(1997-6#1)
A 43-year-old man##2##3##(2008-1#1)(2010-7#1)
A 43-year-old woman##2##3##(1995-3#1)(1996-11#1)
A 43-year-old##4##2##(1995-3#1)(1996-11#1)(2008-1#1)(2010-7#1)
A 44-year-old man##5##3##(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#1)
A 44-year-old patient##2##3##(1996-3#1)(2007-8#1)
A 44-year-old##8##2##(1996-3#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#1)
A 46-year-old male##2##3##(2008-9#1)(2013-8#1)
A 46-year-old man was##2##4##(2007-10#1)(2008-12#1)
A 46-year-old##4##2##(2007-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40##2##14##(1996-12#2)
A 47-year-old##2##2##(2013-1#1)(2013-8#1)
A 48-year-old##3##2##(2009-2#1)(2013-1#1)(2013-8#1)
A 5##5##2##(1990-12#1)(1993-11#1)(1994-3#1)(2008-3#1)(2013-1#1)
A 5'##2##2##(1992-12#1)(1997-7#1)
A 5-year##2##2##(2007-2#1)(2012-12#1)
A 5-year-old##2##2##(2008-10#1)(2013-8#1)
A 50##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
A 50-year-old##2##2##(1992-10#1)(2012-3#1)
A 51 year old##2##4##(1990-9#1)(2008-7#1)
A 51-year-old##4##2##(2007-8#2)(2008-1#1)(2008-6#1)
A 52-year-old Japanese woman##2##4##(1994-7#1)(2012-3#1)
A 52-year-old man##2##3##(2007-8#1)(2008-7#1)
A 52-year-old##7##2##(1992-12#1)(1994-7#1)(2007-7#2)(2007-8#1)(2008-7#1)(2012-3#1)
A 53-year-old##4##2##(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#1)
A 54-year-old man##2##3##(2007-7#1)(2012-12#1)
A 54-year-old woman##2##3##(2008-1#1)(2009-3#1)
A 54-year-old##5##2##(2007-7#1)(2008-1#1)(2009-3#1)(2012-12#1)(2012-2#1)
A 55-year-old##5##2##(2006-12#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
A 56-year old##2##3##(2010-5#1)(2011-2#1)
A 56-year-old woman##5##3##(2007-10#1)(2007-8#1)(2010-6#2)(2013-1#1)
A 56-year-old##9##2##(1997-6#1)(2007-10#1)(2007-2#1)(2007-8#2)(2010-6#2)(2011-2#1)(2013-1#1)
A 57-year-old woman##2##3##(1991-12#1)(2008-7#1)
A 57-year-old##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28##2##14##(1996-12#2)
A 58-year-old##4##2##(1992-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
A 59-year-old man##2##3##(2007-8#1)(2008-1#1)
A 59-year-old##5##2##(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
A 6##3##2##(1996-2#1)(2008-3#1)(2008-9#1)
A 6-month##2##2##(1996-3#1)(2010-10#1)
A 6-year-old##2##2##(1995-11#1)(2007-8#1)
A 60##3##2##(2008-10#2)(2008-3#1)
A 60-year-old##5##2##(1990-2#1)(2007-7#1)(2007-8#1)(2009-11#1)(2012-3#1)
A 61-year-old##4##2##(1991-2#1)(2007-12#1)(2007-7#1)(2011-2#1)
A 62-year-old man##2##3##(1994-3#1)(2008-6#1)
A 62-year-old##3##2##(1991-9#1)(1994-3#1)(2008-6#1)
A 63-year-old woman##2##3##(1991-8#1)(2007-7#1)
A 63-year-old##4##2##(1991-8#1)(2007-7#1)(2010-6#1)(2011-2#1)
A 64-year-old female##2##3##(2013-1#2)
A 64-year-old##4##2##(2008-12#1)(2013-1#2)(2013-8#1)
A 65-year-old man##2##3##(1993-9#1)(2008-6#1)
A 65-year-old woman presented with##2##5##(2007-10#1)(2013-8#1)
A 65-year-old##6##2##(1993-9#1)(2007-10#1)(2007-7#1)(2008-6#1)(2011-2#1)(2013-8#1)
A 66-year-old##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
A 7##4##2##(1996-9#1)(2007-8#1)(2008-6#1)(2008-7#1)
A 7-year-old boy presented##2##4##(2008-10#1)(2012-12#1)
A 7-year-old##4##2##(2008-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
A 70-year-old##3##2##(1993-6#1)(2008-12#2)
A 700-bp fragment##2##3##(1991-6#1)(1994-11#1)
A 71-year-old male##2##3##(2007-8#1)(2010-4#1)
A 71-year-old##4##2##(1994-9#1)(2007-8#1)(2010-4#1)(2013-1#1)
A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12##2##14##(1996-6#2)
A 72-year-old man with##2##4##(2008-12#1)(2011-2#1)
A 72-year-old##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
A 73-year-old##3##2##(2008-7#2)(2010-6#1)
A 74-year-old##4##2##(1990-11#1)(2010-6#1)(2011-2#2)
A 75-year-old female##3##3##(1994-7#1)(2013-1#2)
A 75-year-old##6##2##(1991-8#1)(1994-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
A 77-year-old woman##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
A 77-year-old##5##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
A 78-year-old man##2##3##(2010-12#1)(2011-2#1)
A 78-year-old##3##2##(1992-6#1)(2010-12#1)(2011-2#1)
A 799 (1998)##2##3##(2008-10#2)
A 9##2##2##(1995-11#1)(2008-7#1)
A 95##2##2##(2008-4#1)(2012-12#1)
A =##2##2##(2008-11#1)(2008-4#1)
A Bayesian approach##2##3##(2009-12#1)(2011-2#1)
A Bayesian##4##2##(1995-2#1)(2008-11#1)(2009-12#1)(2011-2#1)
A Benchmark Test Suite for Proton Transfer Energies and its Use to Test Electronic Structure Model Chemistries##2##17##(2012-12#2)
A Bragg grating with a##2##5##(2008-2#2)
A Bragg##3##2##(1992-8#1)(2008-2#2)
A Brief##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
A C(18)##2##2##(2008-10#1)(2008-5#1)
A C-terminal##2##2##(1993-8#1)(2008-2#1)
A CCD camera##2##3##(2008-3#2)
A CCD##3##2##(2007-12#1)(2008-3#2)
A CT scan##5##3##(1992-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
A CT-guided##2##2##(1996-9#1)(2008-6#1)
A Canadian perspective##2##3##(2007-12#1)(2008-11#1)
A Canadian##7##2##(2007-12#4)(2008-11#2)(2010-11#1)
A Case Report and Review of the Literature##2##8##(2008-4#1)(2011-2#1)
A Case Report and Review of##3##6##(2008-1#1)(2008-4#1)(2011-2#1)
A Case Report and##4##4##(2008-1#1)(2008-4#1)(2011-2#2)
A Case Report##19##3##(1997-7#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
A Case Series##2##3##(2008-12#1)(2008-3#1)
A Case Study##3##3##(2009-12#1)(2010-12#1)(2012-12#1)
A Case of##7##3##(1994-7#1)(2008-1#1)(2008-6#1)(2010-6#2)(2012-12#2)
A Case##34##2##(1994-12#1)(1994-7#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#8)(2013-8#1)
A Chinese##2##2##(1992-2#1)(2008-11#1)
A Clinical##2##2##(2007-10#1)(2008-5#1)
A Combination of##2##3##(2008-10#1)(2010-6#1)
A Combination##3##2##(1997-7#1)(2008-10#1)(2010-6#1)
A Community-based Study##2##3##(2010-6#1)(2012-2#1)
A Comparative Crossover Study##2##4##(2007-7#1)(2008-1#1)
A Comparative Study of##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
A Comparative Study##4##3##(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
A Comparative##8##2##(2007-7#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
A Comparison of the##2##4##(2011-1#1)(2013-1#1)
A Comparison of##7##3##(1995-4#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
A Comparison with##2##3##(2008-10#1)(2012-12#1)
A Comparison##11##2##(1995-4#1)(2007-10#1)(2008-10#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
A Comprehensive##2##2##(1996-2#1)(2012-2#1)
A Controversial##2##2##(1997-7#1)(2011-2#1)
A Convenient##2##2##(1996-5#1)(2009-12#1)
A Cross-sectional##2##2##(2009-10#1)(2012-2#1)
A DNA##7##2##(1995-5#1)(1997-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)
A DNA-based piezoelectric biosensor##2##4##(2008-10#2)
A Decision##2##2##(2010-8#1)(2012-3#1)
A Delphi##3##2##(1996-3#1)(1997-7#1)(2013-1#1)
A Density Functional##2##3##(1996-2#1)(2008-10#1)
A Diffusion Tensor Imaging Study##2##5##(2010-6#1)(2010-7#1)
A Doehlert matrix was used##2##5##(2008-10#2)
A Doehlert matrix was##3##4##(2008-10#3)
A Drosophila melanogaster##2##3##(1994-12#2)
A Feasibility Study##2##3##(2008-6#1)(2013-7#1)
A Federal judge has refused to##2##6##(1995-12#1)(1995-6#1)
A Federal judge has##3##4##(1995-12#2)(1995-6#1)
A Federal judge##4##3##(1995-12#2)(1995-6#1)(1997-5#1)
A Field##3##2##(1996-9#1)(2008-10#1)(2009-6#1)
A Fourier##2##2##(2008-1#1)(2008-2#1)
A Gene-for-Gene Relationship##2##3##(2008-10#2)
A General##3##2##(1996-9#1)(1997-7#1)(2009-5#1)
A Genesis##2##2##(2008-10#1)(2010-3#1)
A Guide##2##2##(2007-2#1)(2013-1#1)
A HEPES-buffered solution is used to form a calcium phosphate precipitate that is directly layered onto the cells##2##18##(2008-1#1)(2008-2#1)
A HPLC method##3##3##(2008-10#3)
A Hamilton##2##2##(2008-10#2)
A Key to##2##3##(2008-10#1)(2011-2#1)
A Markov##2##2##(2009-4#1)(2012-12#1)
A Minor##2##2##(1993-12#1)(1993-3#1)
A Model for##3##3##(2008-10#2)(2008-11#1)
A Model##4##2##(2008-10#3)(2008-11#1)
A Molecular Marker##2##3##(2008-10#2)
A Monte Carlo simulation##3##4##(2008-2#1)(2008-3#2)
A Monte Carlo##7##3##(2008-10#1)(2008-2#2)(2008-3#4)
A Multivariate##2##2##(2008-8#1)(2009-12#1)
A Narrative Review##2##3##(2012-12#1)(2012-2#1)
A Neurosurgical##2##2##(2012-1#1)(2012-3#1)
A New Approach for##2##4##(2008-10#1)(2011-2#1)
A New Family of##2##4##(1996-5#1)(1997-7#1)
A New Way of Doing##2##5##(2012-2#2)
A New##19##2##(1995-6#1)(1996-5#4)(1997-7#1)(2007-1#1)(2008-10#5)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
A Newly##2##2##(2008-10#2)
A Newton-Raphson inversion algorithm##2##4##(2008-3#2)
A Norwegian##3##2##(1992-11#1)(1995-2#1)(2010-10#1)
A Novel##12##2##(1996-5#3)(1996-9#1)(2008-10#3)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
A PVC membrane electrode for##4##5##(2008-10#4)
A PVC membrane electrode##5##4##(2008-10#5)
A PVC membrane##7##3##(2008-10#7)
A PVC-based##3##2##(2008-10#3)
A Pilot Study##6##3##(2008-12#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
A Plackett-Burmann design is used for the study of the factors that influence the absorption signal##2##16##(2008-10#2)
A Point##2##2##(2008-10#1)(2009-9#1)
A Polymerase Chain##2##3##(2008-10#2)
A Population-based##2##2##(2012-3#1)(2013-1#1)
A Possible##2##2##(2008-10#1)(2008-2#1)
A Potential##2##2##(2011-2#1)(2013-8#1)
A Practical Approach##2##3##(2008-7#2)
A Prospective Cohort##2##3##(2013-1#2)
A Prospective##4##2##(2008-1#1)(2008-6#1)(2013-1#2)
A Q-switched##2##2##(2008-2#1)(2008-3#1)
A QSAR toxicity##2##3##(2007-11#2)
A QTL##4##2##(2008-10#3)(2012-3#1)
A Qualitative Study of##2##4##(2011-1#1)(2012-12#1)
A Qualitative##5##2##(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
A Quantitative##2##2##(2008-10#2)
A Randomized Trial##2##3##(2008-12#1)(2013-1#1)
A Randomized##4##2##(2006-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
A Rapid##3##2##(2008-10#3)
A Rare Cause of##2##4##(2012-3#1)(2013-1#1)
A Rare##3##2##(2012-12#1)(2012-3#1)(2013-1#1)
A Report##2##2##(2008-6#1)(2013-1#1)
A Retrospective##3##2##(1990-3#1)(2013-8#2)
A Review of the Literature##2##5##(2007-11#1)(2013-1#1)
A Review of##7##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-1#1)(2013-1#1)
A Review##11##2##(2007-11#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-6#1)(2010-10#1)(2011-1#1)(2013-1#2)
A Search for##2##3##(2010-8#1)(2012-2#1)
A Second##2##2##(2008-12#1)(2009-8#1)
A Short##2##2##(1996-5#1)(2008-6#1)
A Simple and##2##3##(2008-11#1)(2009-12#1)
A Simple##5##2##(1997-7#1)(2008-11#1)(2009-12#1)(2013-1#2)
A Single##5##2##(1995-11#1)(2008-10#3)(2008-4#1)
A Statistical##2##2##(1996-9#1)(2008-10#1)
A Study of the##2##4##(2008-12#1)(2010-1#1)
A Study of##3##3##(2008-12#1)(2009-10#1)(2010-1#1)
A Study##5##2##(2008-12#1)(2008-5#1)(2009-10#1)(2010-1#1)(2013-1#1)
A Support Protocol##3##3##(2008-4#2)(2008-9#1)
A Survey of##2##3##(2009-3#1)(2009-5#1)
A Survey##3##2##(2009-3#1)(2009-5#1)(2013-1#1)
A Systematic Approach##2##3##(2009-9#1)(2012-2#1)
A Systematic Review##4##3##(2008-7#1)(2010-8#1)(2013-1#2)
A Systematic##6##2##(2008-7#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
A T-flask##2##2##(2008-11#2)
A Teflon##2##2##(2008-10#2)
A UV##3##2##(2008-10#2)(2008-5#1)
A Useful Tool for Changing Clinicians' Practice##2##7##(2007-11#2)
A Useful##3##2##(2007-11#2)(2010-6#1)
A activity##6##2##(1991-3#1)(1992-9#1)(1994-3#1)(1994-8#2)(2006-6#1)
A allele##2##2##(2008-10#1)(2009-5#1)
A also##3##2##(1992-12#1)(1992-6#1)(2008-10#1)
A and B alleles##2##4##(2008-12#2)
A and B and##7##4##(1990-5#1)(1990-8#1)(1994-12#1)(2007-2#1)(2008-3#2)(2008-5#1)
A and B are##5##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
A and B components were##2##5##(2008-10#2)
A and B components##4##4##(2008-10#4)
A and B strains##3##4##(1997-6#1)(2008-10#2)
A and B was##5##4##(1990-12#1)(2008-10#1)(2008-4#2)(2008-5#1)
A and B were found##2##5##(2007-8#1)(2008-10#1)
A and B were##10##4##(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
A and B##96##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-12#2)(1994-5#2)(1995-2#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#3)(2007-2#1)(2007-8#5)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#2)(2010-6#1)(2011-2#6)(2013-1#3)
A and C##17##3##(1990-7#1)(1990-8#1)(1992-12#7)(1995-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
A and C=0##3##3##(2008-10#3)
A and E##5##3##(1990-5#1)(1991-5#1)(2007-7#2)(2008-10#1)
A and M##2##3##(2008-10#1)(2012-2#1)
A and a##2##3##(1997-4#1)(2008-3#1)
A and glycogen##2##3##(2008-10#2)
A and the##4##3##(1990-7#1)(1990-8#1)(1991-1#1)(1994-11#1)
A and##220##2##(1990-11#3)(1990-12#3)(1990-5#5)(1990-7#2)(1990-8#3)(1991-1#1)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#11)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#5)(1994-6#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#3)(2008-3#12)(2008-4#4)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#3)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#10)(2012-2#5)(2012-3#1)(2013-1#5)
A approximately##2##2##(1990-8#1)(1997-3#1)
A are##5##2##(1990-12#1)(1991-1#1)(1996-2#1)(2008-10#1)(2008-4#1)
A as a##2##3##(2008-3#1)(2009-10#1)
A as##8##2##(1990-12#1)(1990-5#1)(1995-12#1)(1997-6#1)(2008-12#1)(2008-3#1)(2009-10#1)(2012-3#1)
A at##3##2##(1991-1#1)(2008-3#1)(2010-7#1)
A balanced scorecard##2##3##(1995-12#2)
A balanced##5##2##(1995-12#2)(2007-11#1)(2008-11#1)(2008-8#1)
A band of##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
A band##6##2##(1994-2#1)(2008-10#1)(2008-3#3)(2008-7#1)
A baseline##3##2##(1992-10#1)(2008-10#1)(2011-2#1)
A basic protocol for array hybridization on nylon filters is provided because such filters are available in every laboratory##2##19##(2008-2#1)(2008-4#1)
A basic protocol for##3##4##(2008-2#1)(2008-4#2)
A basic protocol##5##3##(2008-2#1)(2008-4#4)
A basic##14##2##(1994-12#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#1)(2012-2#1)
A bayesian##2##2##(1997-8#1)(2011-2#1)
A behavioral##2##2##(1992-11#1)(2013-8#1)
A benefit of##3##3##(1990-10#1)(2008-2#1)(2010-5#1)
A benign##2##2##(2011-1#2)
A best evidence topic in cardiac surgery was written according to a structured protocol##11##14##(2007-8#11)
A best evidence topic in##12##5##(2007-8#12)
A best##13##2##(2007-8#12)(2008-3#1)
A beta 1-40 was##2##4##(1994-11#2)
A beta 1-40##5##3##(1994-11#5)
A beta 1-42/43##5##3##(1994-11#5)
A beta 40 and A beta 42 species##2##8##(1995-12#1)(1996-5#1)
A beta 40 and A beta 42##3##7##(1995-12#2)(1996-5#1)
A beta 40##5##3##(1995-12#2)(1996-5#3)
A beta 42 in##3##4##(1996-5#3)
A beta 42##7##3##(1995-12#2)(1996-5#5)
A beta amyloid##3##3##(1994-8#3)
A beta deposits##2##3##(1994-11#1)(1996-5#1)
A beta in##2##3##(1994-8#2)
A beta peptides##2##3##(1996-2#1)(1996-5#1)
A beta production and##2##4##(1996-12#1)(1996-5#1)
A beta species##2##3##(1994-11#1)(1995-12#1)
A beta##64##2##(1994-11#17)(1994-8#12)(1995-12#10)(1996-12#3)(1996-2#7)(1996-5#13)(2010-5#1)(2012-2#1)
A beta-(1-42)##2##2##(1994-8#2)
A beta-amyloid##2##2##(1996-5#2)
A better knowledge of##2##4##(2008-10#1)(2008-4#1)
A better understanding of the##5##5##(2008-10#2)(2008-5#1)(2010-7#1)(2012-1#1)
A better understanding of##11##4##(1993-3#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#1)
A better##20##2##(1993-3#1)(1995-2#1)(1996-11#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
A between##2##2##(2011-1#1)(2012-2#1)
A big loop##2##3##(2008-11#2)
A big##3##2##(2008-11#2)(2009-1#1)
A bimodal##2##2##(1992-1#1)(2009-9#1)
A binding site##2##3##(1994-5#1)(1997-8#1)
A binding##7##2##(1992-12#1)(1993-6#1)(1994-5#1)(1995-5#3)(1997-8#1)
A bioassay##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
A biochemical##2##2##(1992-6#1)(2010-3#1)
A biological##6##2##(1992-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-3#1)
A biopsy specimen##2##3##(2009-8#1)(2013-8#1)
A biopsy##3##2##(2008-12#1)(2009-8#1)(2013-8#1)
A biosensor based on##2##4##(2008-10#2)
A biosensor for the specific determination of##2##7##(2008-10#2)
A biosensor for##3##3##(2008-10#3)
A biosensor##5##2##(2008-10#5)
A biphasic##2##2##(1996-12#1)(2008-7#1)
A bivariate##2##2##(2008-10#1)(2013-1#1)
A blind study##2##3##(1990-3#2)
A blood##2##2##(2008-1#1)(2010-2#1)
A body of##2##3##(2008-11#1)(2010-10#1)
A bonding##2##2##(1995-5#1)(2008-3#1)
A bone##3##2##(2006-10#2)(2009-1#1)
A book to make you think##3##6##(2008-8#3)
A boy of##2##3##(1991-11#1)(1992-11#1)
A brief comment##2##3##(2008-5#1)(2010-7#1)
A brief description of the##3##5##(1992-2#1)(2008-11#2)
A brief description of##4##4##(1992-2#1)(1997-3#1)(2008-11#2)
A brief discussion of the##2##5##(2008-10#1)(2009-4#1)
A brief discussion##3##3##(2008-10#1)(2009-3#1)(2009-4#1)
A brief history of##3##4##(2008-11#1)(2008-5#1)(2012-2#1)
A brief history##5##3##(1995-5#1)(1996-12#1)(2008-11#1)(2008-5#1)(2012-2#1)
A brief introduction##2##3##(2008-10#1)(2009-11#1)
A brief overview of the##2##5##(1992-12#1)(2008-10#1)
A brief overview of##4##4##(1992-12#1)(2008-10#2)(2008-5#1)
A brief overview##7##3##(1992-1#1)(1992-12#1)(1995-9#1)(2008-10#2)(2008-5#2)
A brief review of the##2##5##(1990-3#1)(2010-1#1)
A brief review of##3##4##(1990-3#1)(2010-1#1)(2010-9#1)
A brief review##4##3##(1990-3#1)(2009-12#1)(2010-1#1)(2010-9#1)
A brief##38##2##(1990-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(2007-2#1)(2008-10#6)(2008-11#4)(2008-4#2)(2008-5#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
A broad range of##4##4##(1997-8#1)(2008-10#2)(2008-8#1)
A broad##9##2##(1992-3#1)(1996-4#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-8#1)(2011-2#1)
A broader##2##2##(1997-3#1)(2012-2#1)
A but not by##2##4##(1995-11#1)(2010-5#1)
A but not##3##3##(1994-8#1)(1995-11#1)(2010-5#1)
A by##4##2##(1993-6#1)(1995-2#1)(1997-2#1)(2008-10#1)
A cDNA clone encoding the##2##5##(1993-2#1)(1995-6#1)
A cDNA clone encoding##5##4##(1990-11#1)(1990-2#1)(1993-2#1)(1995-6#1)(1997-1#1)
A cDNA clone for##3##4##(1990-12#1)(1992-10#1)(2008-5#1)
A cDNA clone of##2##4##(1994-12#1)(2008-8#1)
A cDNA clone##10##3##(1990-11#1)(1990-12#1)(1990-2#1)(1992-10#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-1#1)(2008-5#1)(2008-8#1)
A cDNA coding for##2##4##(1992-3#1)(1994-11#1)
A cDNA encoding the human##2##5##(1992-8#1)(1993-8#1)
A cDNA encoding the##5##4##(1992-8#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#1)
A cDNA encoding##7##3##(1991-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)
A cDNA for a##2##4##(1993-3#1)(1997-8#1)
A cDNA for##4##3##(1990-11#1)(1990-8#1)(1993-3#1)(1997-8#1)
A cDNA fragment##3##3##(1994-6#1)(1997-7#1)(2008-10#1)
A cDNA from##2##3##(1991-6#1)(1993-11#1)
A cDNA library was##2##4##(1994-11#1)(2008-9#1)
A cDNA library##4##3##(1990-12#1)(1990-8#1)(1994-11#1)(2008-9#1)
A cDNA##38##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
A calcium##2##2##(2008-10#1)(2008-3#1)
A calibration curve was constructed##2##5##(2008-10#2)
A calibration curve was##4##4##(2008-10#4)
A calibration curve##7##3##(2008-10#7)
A calibration graph##2##3##(2008-10#2)
A calibration method##3##3##(2008-10#2)(2008-2#1)
A calibration procedure##2##3##(2008-10#1)(2008-3#1)
A calibration##19##2##(2008-10#15)(2008-2#2)(2008-3#1)(2008-6#1)
A call for##4##3##(1997-1#1)(2008-11#3)
A call to##3##3##(1992-2#1)(1993-1#1)(2007-12#1)
A call##7##2##(1992-2#1)(1993-1#1)(1997-1#1)(2007-12#1)(2008-11#3)
A can be##3##3##(2008-3#2)(2011-1#1)
A can##7##2##(1992-12#2)(1993-11#1)(2008-3#2)(2010-4#1)(2011-1#1)
A capillary electrophoresis method has been developed for the##2##9##(2008-10#2)
A capillary electrophoresis method##3##4##(2008-10#2)(2008-4#1)
A capillary electrophoresis##5##3##(2008-10#3)(2008-4#2)
A capillary electrophoretic##2##3##(1996-5#1)(2008-10#1)
A capillary##8##2##(1996-5#1)(2008-10#5)(2008-4#2)
A carbohydrate-restricted##2##2##(2008-3#2)
A carbon fiber##2##3##(2008-10#2)
A carbon##3##2##(2008-10#3)
A careful##10##2##(1990-12#1)(1991-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-8#1)
A carefully##2##2##(1995-12#1)(2008-7#1)
A case control study##2##4##(2010-5#1)(2012-12#1)
A case control##3##3##(2010-5#1)(2011-2#1)(2012-12#1)
A case for##3##3##(1996-2#1)(2008-1#1)(2008-10#1)
A case history is presented of##2##6##(1993-2#1)(1996-7#1)
A case history##3##3##(1992-2#1)(1993-2#1)(1996-7#1)
A case is presented of##3##5##(1992-2#1)(2010-3#1)(2013-7#1)
A case is presented##6##4##(1992-2#1)(1993-1#1)(1994-11#1)(2008-7#1)(2010-3#1)(2013-7#1)
A case is##9##3##(1990-6#1)(1992-2#2)(1993-1#1)(1994-11#1)(2008-10#1)(2008-7#1)(2010-3#1)(2013-7#1)
A case of a##17##4##(1991-2#1)(2007-8#1)(2008-11#2)(2008-7#5)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
A case of acute##2##4##(1990-6#1)(1991-4#1)
A case of an##3##4##(2007-5#1)(2008-10#1)(2011-1#1)
A case of bilateral##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
A case of chronic##2##4##(2007-7#1)(2013-1#1)
A case of early##2##4##(1990-8#1)(2008-9#1)
A case of fatal##2##4##(1995-11#1)(2011-2#1)
A case of hereditary##2##4##(2010-6#1)(2013-1#1)
A case of hypocontractile neurogenic bladder associated with agenesis of##2##10##(2008-7#2)
A case of idiopathic##2##4##(1997-8#1)(2010-10#1)
A case of primary##3##4##(1992-2#1)(2009-5#1)(2009-8#1)
A case of pulmonary##2##4##(1990-10#1)(2012-12#1)
A case of severe##4##4##(1991-9#1)(1992-11#1)(2011-2#1)(2013-1#1)
A case of spontaneous##2##4##(1993-8#1)(2007-12#1)
A case of unusual##2##4##(2008-7#1)(2008-9#1)
A case of##155##3##(1990-10#1)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-8#1)(1995-11#2)(1995-3#1)(1996-6#1)(1996-9#2)(1997-8#2)(2007-10#3)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#22)(2008-9#4)(2009-10#1)(2009-5#4)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#8)(2011-1#3)(2011-2#13)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#1)
A case report and review of literature##4##7##(2009-5#1)(2010-11#1)(2010-12#1)(2013-1#1)
A case report and review of the literature##3##8##(2008-10#1)(2010-10#1)(2013-1#1)
A case report and review of the##4##7##(1993-9#1)(2008-10#1)(2010-10#1)(2013-1#1)
A case report and review of##8##6##(1993-9#1)(2008-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2013-1#2)
A case report and review##9##5##(1993-9#1)(2008-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
A case report and##10##4##(1993-9#1)(2007-2#1)(2008-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
A case report of##6##4##(2007-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
A case report on##3##4##(1990-3#1)(2008-6#1)(2013-1#1)
A case report with##2##4##(1994-8#1)(1997-2#1)
A case report##77##3##(1990-12#4)(1990-3#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-8#2)(1992-10#2)(1992-2#8)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-6#2)(1994-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
A case report]##10##3##(1991-6#1)(1992-6#1)(1992-9#1)(1995-8#1)(1997-8#1)(2007-8#1)(2009-5#1)(2011-2#2)(2012-2#1)
A case series of##2##4##(2008-10#1)(2009-10#1)
A case series##6##3##(2008-10#3)(2009-10#1)(2012-12#1)(2012-3#1)
A case study in##2##4##(1995-2#1)(2008-10#1)
A case study of##6##4##(1994-12#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)
A case study##20##3##(1993-2#2)(1994-12#2)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-12#1)
A case##295##2##(1990-10#1)(1990-12#4)(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#4)(1991-4#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#3)(1992-11#1)(1992-2#12)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-8#3)(2007-10#3)(2007-11#1)(2007-12#9)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#8)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#24)(2008-9#8)(2009-10#2)(2009-5#6)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#8)(2011-1#3)(2011-2#19)(2012-1#3)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#16)(2013-7#5)(2013-8#1)
A case-control study##5##3##(1990-8#1)(1992-9#1)(2008-9#1)(2011-1#1)(2013-7#1)
A catalytic##4##2##(2008-10#3)(2010-12#1)
A cause##2##2##(1992-1#1)(2008-11#1)
A caused##2##2##(2008-10#1)(2008-6#1)
A cell##3##2##(1991-12#1)(2008-11#1)(2008-7#1)
A central composite design was##3##5##(2008-10#2)(2008-11#1)
A central##8##2##(1992-6#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)(2013-8#1)
A century##2##2##(2008-10#1)(2008-8#1)
A certain##2##2##(1996-3#1)(2007-10#1)
A chain##11##2##(1990-12#3)(1992-3#3)(1993-11#2)(1997-4#1)(2008-6#1)(2008-9#1)
A challenge for##3##3##(1991-11#1)(1994-2#1)(2008-11#1)
A challenge##6##2##(1991-11#1)(1994-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-1#1)
A change in the##2##4##(1995-1#1)(2008-9#1)
A change in##7##3##(1993-3#1)(1995-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-12#1)
A change to##2##3##(1993-2#1)(2008-4#1)
A change##11##2##(1993-2#1)(1993-3#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-12#1)
A changed##2##2##(1994-3#1)(2007-11#1)
A changing##2##2##(1991-6#1)(2009-1#1)
A characteristic mass of##2##4##(2008-10#2)
A characteristic##5##2##(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)
A characterization##2##2##(1995-11#1)(2008-3#1)
A chart review was performed of##2##6##(2008-3#1)(2008-9#1)
A checkerboard##2##2##(1994-8#1)(2008-10#1)
A checklist##3##2##(2010-3#1)(2011-2#2)
A chelating resin##2##3##(2008-10#2)
A chelating##3##2##(2008-10#3)
A chemical##3##2##(2008-10#3)
A chemically modified carbon paste electrode with##2##7##(2008-10#2)
A chemically modified electrode##3##4##(2008-10#3)
A chemically modified##5##3##(2008-10#5)
A chemiluminescence (CL)##3##3##(2008-10#3)
A chemiluminescence##5##2##(1995-8#1)(2008-10#4)
A chemiluminescent method using flow injection is described for the determination of##2##12##(2008-10#2)
A chemometric approach was##2##4##(2008-10#2)
A chemometric methodology##2##3##(2008-10#2)
A chemometric##7##2##(2008-10#7)
A chest radiograph##2##3##(2007-12#1)(2011-1#1)
A chicken##2##2##(1990-12#1)(2008-5#1)
A child with##2##3##(1992-3#1)(2008-10#1)
A child##7##2##(1992-3#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)
A chromatographic method##2##3##(1990-8#1)(2008-10#1)
A chromatographic##5##2##(1990-8#1)(2008-10#3)(2008-8#1)
A chromosome##2##2##(1992-2#1)(2008-5#1)
A chronic##3##2##(1994-5#1)(1997-1#1)(1997-2#1)
A circular##2##2##(1990-8#1)(2008-2#1)
A cis-acting##2##2##(1994-8#1)(1995-6#1)
A class of##4##3##(1995-3#1)(2008-2#1)(2008-3#1)(2009-12#1)
A classification system##2##3##(1992-2#1)(1996-6#1)
A classification##4##2##(1992-2#1)(1996-6#1)(2008-10#2)
A clean##3##2##(2007-9#1)(2008-10#2)
A clear difference in survival##2##5##(1990-8#1)(1991-8#1)
A clear##11##2##(1990-12#1)(1990-8#1)(1991-8#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
A climate-based##2##2##(2008-10#1)(2008-11#1)
A clinical and investigational study of##2##6##(2007-7#2)
A clinical and##4##3##(1990-9#1)(2007-7#2)(2008-3#1)
A clinical assessment of##2##4##(1997-2#1)(2008-10#1)
A clinical assessment##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
A clinical case##4##3##(1990-3#1)(1991-3#2)(1996-3#1)
A clinical diagnosis##2##3##(2012-12#2)
A clinical observation##2##3##(1996-3#1)(2013-7#1)
A clinical study of##2##4##(1990-6#1)(2012-3#1)
A clinical study##4##3##(1990-6#1)(2007-9#1)(2012-3#2)
A clinical##43##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
A clinically##4##2##(1993-12#1)(2008-12#1)(2008-4#1)(2011-2#1)
A clinico-pathologic study##2##3##(1991-2#1)(1991-8#1)
A clinicopathologic##2##2##(1990-6#1)(1993-8#1)
A clone containing##2##3##(1990-5#1)(1993-8#1)
A clone##5##2##(1990-11#2)(1990-5#2)(1993-8#1)
A cloned gene##2##3##(1992-1#1)(2008-8#1)
A cloned##3##2##(1992-1#1)(1994-6#1)(2008-8#1)
A close association##2##3##(2008-10#1)(2008-12#1)
A close examination##2##3##(2008-2#1)(2008-8#1)
A close##11##2##(1991-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)
A closed##2##2##(2008-10#1)(2008-3#1)
A closed-form##2##2##(2008-3#1)(2008-6#1)
A closed-loop##2##2##(2008-3#1)(2008-7#1)
A closer look at the##2##5##(1993-1#1)(1994-11#1)
A closer look##3##3##(1993-1#1)(1993-3#1)(1994-11#1)
A closer##5##2##(1993-1#1)(1993-3#1)(1994-11#1)(2008-10#1)(2013-1#1)
A cluster analysis##2##3##(2008-10#2)
A cluster of##3##3##(1990-8#1)(1996-6#1)(2008-10#1)
A cluster##5##2##(1990-8#1)(1996-6#1)(2008-10#3)
A coated##4##2##(2008-10#3)(2008-3#1)
A code##2##2##(1992-11#1)(2012-3#1)
A coding##3##2##(1992-6#1)(1993-8#1)(1994-12#1)
A coherent##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
A cohort of##6##3##(1990-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
A collaborative##2##2##(2007-2#1)(2007-5#1)
A collection of##6##3##(1995-12#1)(2007-6#1)(2008-10#4)
A collection##8##2##(1995-12#1)(2007-6#1)(2008-10#5)(2012-3#1)
A colorimetric##4##2##(1992-11#1)(1997-4#1)(2008-10#2)
A column##3##2##(2008-10#2)(2008-8#1)
A combination of high##2##4##(2008-10#1)(2008-12#1)
A combination of the##4##4##(1997-3#1)(2007-11#1)(2008-3#1)(2008-4#1)
A combination of these##3##4##(1990-8#1)(1991-6#1)(1996-12#1)
A combination of##34##3##(1990-8#1)(1991-12#1)(1991-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
A combination##37##2##(1990-8#1)(1991-12#1)(1991-6#3)(1994-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
A combined##8##2##(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-7#1)(2010-3#1)
A comment##5##2##(1993-3#1)(2007-12#1)(2013-8#3)
A commercial##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
A commercially available##3##3##(2008-10#3)
A common approach to##2##4##(2008-11#1)(2008-2#1)
A common feature of##2##4##(2008-11#2)
A common method##2##3##(2008-10#1)(2008-8#1)
A common peptide##2##3##(1990-7#2)
A common theme##2##3##(2008-12#1)(2008-6#1)
A common##27##2##(1990-7#2)(1992-9#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#1)
A community of##2##3##(2008-4#1)(2012-1#1)
A community##6##2##(1992-1#1)(1994-12#1)(2006-10#1)(2008-4#1)(2012-1#1)(2013-1#1)
A community-based##3##2##(2008-3#1)(2010-10#1)(2013-1#1)
A compact##20##2##(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#4)(2008-3#6)
A companion##5##2##(2008-3#3)(2009-8#1)(2010-8#1)
A company##2##2##(1992-12#1)(2009-11#1)
A comparable##3##2##(1991-3#1)(1992-5#1)(2008-10#1)
A comparative analysis of the##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
A comparative analysis of##9##4##(1993-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
A comparative analysis##12##3##(1993-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
A comparative evaluation of##2##4##(2010-3#1)(2013-1#1)
A comparative perspective##3##3##(1992-3#1)(1995-2#1)(2009-8#1)
A comparative study of the##8##5##(1993-6#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#1)
A comparative study of##29##4##(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#10)(2008-2#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#3)
A comparative study on the effect of##2##7##(2007-10#1)(2008-10#1)
A comparative study on the##4##5##(2007-10#1)(2008-10#1)(2010-12#1)(2010-6#1)
A comparative study was made##2##5##(2008-10#2)
A comparative study was##4##4##(2008-10#3)(2012-3#1)
A comparative study with##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
A comparative study##51##3##(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#4)
A comparative##79##2##(1990-5#1)(1992-3#1)(1993-6#2)(1994-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#6)
A comparison between the##5##4##(2008-10#2)(2008-3#3)
A comparison between##19##3##(1991-12#1)(1995-2#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#1)(2012-2#1)
A comparison is made between the##2##6##(1992-5#1)(2008-10#1)
A comparison is made with##3##5##(2008-2#1)(2008-3#1)(2010-7#1)
A comparison is made##6##4##(1992-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-3#1)
A comparison is presented##2##4##(2008-10#1)(2010-2#1)
A comparison is##9##3##(1992-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-2#1)(2010-7#1)(2012-3#1)
A comparison of biological##2##4##(1995-8#1)(2008-5#1)
A comparison of experimental##2##4##(2008-3#2)
A comparison of laparoscopically assisted vaginal hysterectomy##2##7##(1993-12#1)(1994-2#1)
A comparison of methods for##2##5##(1995-9#1)(2008-10#1)
A comparison of physical##2##4##(1993-3#1)(2011-2#1)
A comparison of several##2##4##(2008-10#1)(2008-3#1)
A comparison of the amino acid##2##6##(1991-12#1)(2008-10#1)
A comparison of the deduced amino acid##2##7##(1991-6#1)(1993-2#1)
A comparison of the deduced##4##5##(1991-6#1)(1993-2#1)(1993-6#2)
A comparison of the effects of##2##6##(1993-1#1)(1995-12#1)
A comparison of the experimental and##2##6##(2008-3#2)
A comparison of the##41##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2009-8#2)(2013-1#2)(2013-8#1)
A comparison of these##2##4##(1995-2#1)(2008-3#1)
A comparison of two##6##4##(1991-1#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
A comparison of##117##3##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#16)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#2)
A comparison study##2##3##(1992-2#1)(2008-10#1)
A comparison was made between##2##5##(1994-3#1)(2007-10#1)
A comparison was made##3##4##(1991-3#1)(1994-3#1)(2007-10#1)
A comparison was##4##3##(1991-3#1)(1994-3#1)(2007-10#1)(2010-3#1)
A comparison with the##4##4##(1994-1#1)(2008-10#2)(2008-11#1)
A comparison with##11##3##(1994-1#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2012-12#1)
A comparison##166##2##(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#25)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
A competition##2##2##(1990-7#1)(2008-4#1)
A competitive##7##2##(1991-9#1)(1995-12#1)(2008-10#2)(2008-11#3)
A compilation of##2##3##(1997-3#1)(2008-7#1)
A complement##2##2##(2008-5#1)(2012-12#1)
A complementary##2##2##(2008-3#1)(2008-9#1)
A complete analysis##3##3##(2008-10#3)
A complete response##2##3##(2008-5#1)(2008-6#1)
A complete theoretical##2##3##(2007-12#1)(2008-3#1)
A complete##27##2##(1991-8#1)(1992-2#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)
A complex##17##2##(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
A component of the##2##4##(1993-3#1)(1994-11#1)
A component of##4##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-11#1)
A component##5##2##(1993-3#1)(1994-11#2)(2008-10#1)(2008-11#1)
A composite##3##2##(2008-10#2)(2008-8#1)
A comprehensive assessment of##2##4##(1994-2#1)(2010-12#1)
A comprehensive assessment##3##3##(1994-1#1)(1994-2#1)(2010-12#1)
A comprehensive comparison was made among the modifiers##2##8##(2008-10#2)
A comprehensive evaluation of##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
A comprehensive evaluation##4##3##(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
A comprehensive model of##2##4##(2008-3#1)(2009-8#1)
A comprehensive model##4##3##(1997-1#1)(2008-3#1)(2008-7#1)(2009-8#1)
A comprehensive review of the##2##5##(2008-10#1)(2013-1#1)
A comprehensive review of##4##4##(2008-10#1)(2010-8#1)(2013-1#2)
A comprehensive review##6##3##(2008-10#2)(2008-5#1)(2010-8#1)(2013-1#2)
A comprehensive search##2##3##(2012-1#1)(2012-3#1)
A comprehensive##40##2##(1991-2#1)(1993-12#2)(1994-1#1)(1994-2#2)(1994-9#1)(1997-1#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
A compression##2##2##(2007-8#1)(2008-3#1)
A computational strategy##2##3##(2008-3#1)(2008-7#1)
A computational##5##2##(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
A computed tomographic (CT) scan showed##2##6##(2008-1#1)(2008-7#1)
A computed tomographic##3##3##(2008-1#1)(2008-7#2)
A computed tomography (CT)##2##4##(2008-8#1)(2012-3#1)
A computed tomography scan##4##4##(2007-12#1)(2010-10#1)(2010-12#1)(2012-2#1)
A computed tomography##6##3##(2007-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
A computed##10##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
A computer database search##2##4##(1992-3#1)(2013-1#1)
A computer program##5##3##(1993-3#1)(2008-10#2)(2008-3#2)
A computer search of the##2##5##(1990-2#1)(1996-2#1)
A computer simulation of##2##4##(2007-12#1)(2008-3#1)
A computer simulation##4##3##(1995-2#1)(2007-12#1)(2008-3#2)
A computer##19##2##(1990-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
A computer-aided##2##2##(1991-1#1)(2008-10#1)
A computer-based##3##2##(1992-2#1)(2008-2#1)(2008-3#1)
A computer-controlled##4##2##(2008-10#3)(2008-4#1)
A computer-generated hologram##2##3##(2007-12#1)(2008-3#1)
A computerized##2##2##(1994-3#1)(2008-5#1)
A concentration of##3##3##(1997-4#1)(2008-10#2)
A concentration##7##2##(1991-12#1)(1997-4#1)(2008-10#4)(2013-1#1)
A concept of##2##3##(1990-6#1)(1991-6#1)
A concept##5##2##(1990-6#1)(1991-6#1)(1997-1#1)(2008-3#1)(2012-12#1)
A conceptual framework for##2##4##(1992-2#1)(1995-12#1)
A conceptual framework##3##3##(1992-2#1)(1995-12#1)(2008-12#1)
A conceptual model##2##3##(2008-10#1)(2012-3#1)
A conceptual##7##2##(1992-2#1)(1992-3#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
A concerted##2##2##(1996-12#1)(2008-10#1)
A concise##5##2##(2008-10#3)(2009-11#1)(2009-5#1)
A confocal microscope##2##3##(2008-3#2)
A confocal##3##2##(2008-3#2)(2008-4#1)
A conformational change##2##3##(1990-7#1)(1995-6#1)
A conformational##5##2##(1990-5#1)(1990-7#1)(1993-5#1)(1995-6#1)(2011-2#1)
A consecutive series of##2##4##(2008-9#2)
A consecutive##4##2##(1993-2#1)(2007-12#1)(2008-9#2)
A consensus paper from the EU Thematic Network &quot##2##9##(2008-10#2)
A consensus##5##2##(1991-11#1)(1992-1#1)(1994-12#1)(2008-10#2)
A conservative##2##2##(1991-6#1)(2012-3#1)
A conserved##2##2##(2010-10#1)(2013-1#1)
A considerable amount of##2##4##(1991-1#1)(2008-7#1)
A considerable number of##2##4##(1996-5#2)
A considerable proportion of##2##4##(2008-1#1)(2008-10#1)
A considerable##11##2##(1991-1#1)(1991-3#1)(1993-3#1)(1996-5#2)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
A consideration of the##2##4##(1993-3#1)(2009-12#1)
A consideration of##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2009-12#1)
A consisted of##2##3##(1994-7#1)(2011-2#1)
A consistent##3##2##(1990-12#1)(1996-2#1)(2008-11#1)
A consortium of##2##3##(1997-1#1)(2008-7#1)
A constant##4##2##(1995-3#1)(2008-10#1)(2008-11#2)
A contemporary##2##2##(1995-12#1)(2008-8#1)
A continuing##4##2##(2007-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
A continuous flow system##2##4##(2008-10#2)
A continuous flow##3##3##(1990-12#1)(2008-10#2)
A continuous##11##2##(1990-12#1)(1992-12#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#5)(2012-2#1)
A continuous-flow##3##2##(2008-10#3)
A contribution to##2##3##(1992-11#1)(1993-8#1)
A contribution##4##2##(1990-11#1)(1992-11#1)(1993-8#1)(1995-2#1)
A control group of##2##4##(1991-4#1)(2013-1#1)
A control group##5##3##(1991-4#1)(2007-10#1)(2009-12#1)(2013-1#2)
A control strategy##2##3##(1997-2#1)(2012-2#1)
A control##12##2##(1991-4#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
A controlled randomized trial was conducted to compare the effectiveness of a##2##12##(1994-7#1)(1995-4#1)
A controlled trial of##3##4##(1991-12#1)(1997-7#2)
A controlled##11##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-7#1)(1995-4#1)(1997-3#1)(1997-7#2)(2008-7#1)(2011-2#1)
A convenience sample of 37##2##5##(2008-12#1)(2013-8#1)
A convenience sample of##6##4##(1993-2#1)(2007-10#1)(2007-11#1)(2008-12#1)(2010-11#1)(2013-8#1)
A convenient##3##2##(1991-5#1)(2008-11#1)(2008-2#1)
A conventional##2##2##(2008-10#1)(2008-3#1)
A conversion##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
A cooperative effort to##2##4##(1994-12#1)(1996-1#1)
A cooperative##6##2##(1990-8#1)(1994-12#1)(1996-1#1)(2008-3#1)(2008-5#1)(2009-5#1)
A copper##2##2##(2008-10#1)(2010-5#1)
A core##3##2##(1991-3#1)(1995-2#1)(2007-12#1)
A correct##5##2##(1992-11#1)(2008-10#2)(2008-2#1)(2008-6#1)
A correction algorithm##2##3##(2008-10#1)(2008-3#1)
A correction factor##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
A correction##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
A correlation between the##2##4##(1994-6#1)(2008-3#1)
A correlation between##4##3##(1994-6#1)(2008-10#1)(2008-3#1)(2013-8#1)
A correlation coefficient of 0##2##5##(1997-4#1)(2008-10#1)
A correlation was established##2##4##(2008-10#2)
A correlation was found between##2##5##(2008-7#1)(2011-2#1)
A correlation was##5##3##(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
A correlation##13##2##(1994-6#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
A cost##3##2##(1994-3#1)(1997-2#1)(2008-11#1)
A cost-benefit analysis of##2##4##(2009-12#1)(2010-12#1)
A coulometric##3##2##(2008-10#3)
A coupling##2##2##(2007-11#1)(2008-2#1)
A critical analysis of the##2##5##(1992-1#1)(1997-5#1)
A critical analysis of##3##4##(1992-1#1)(1995-1#1)(1997-5#1)
A critical analysis##4##3##(1992-1#1)(1995-1#1)(1997-5#1)(2008-3#1)
A critical and##2##3##(2008-10#1)(2008-7#1)
A critical comparison of the various##2##6##(2008-10#2)
A critical comparison of##3##4##(1992-3#1)(2008-10#2)
A critical discussion##2##3##(2008-10#1)(2008-11#1)
A critical evaluation of##3##4##(1990-5#1)(2008-2#1)(2013-8#1)
A critical examination of##2##4##(2008-10#2)
A critical review of##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
A critical review##5##3##(1995-6#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
A critical step##2##3##(2008-9#1)(2011-2#1)
A critical##32##2##(1990-5#1)(1990-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-6#1)(1997-5#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
A cross sectional study##3##4##(2008-8#1)(2011-1#1)(2013-8#1)
A cross sectional##5##3##(2007-7#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
A cross-cultural study##2##3##(1996-12#1)(2007-12#1)
A cross-sectional study of##3##4##(2007-12#1)(2009-5#1)(2013-8#1)
A cross-sectional study was carried out in##2##7##(2011-1#1)(2013-8#1)
A cross-sectional study was carried out##4##6##(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
A cross-sectional study was conducted##4##5##(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
A cross-sectional study was##9##4##(2007-7#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
A cross-sectional study##19##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
A cross-sectional survey was administered##2##5##(2011-2#1)(2013-1#1)
A cross-sectional survey was##3##4##(2011-2#2)(2013-1#1)
A cross-sectional survey##6##3##(2008-7#1)(2011-1#2)(2011-2#2)(2013-1#1)
A cross-sectional##37##2##(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-10#1)(2011-1#5)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#4)
A culture##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
A cumulative##3##2##(1990-10#1)(2008-3#1)(2013-1#1)
A current model##2##3##(1994-8#1)(2011-2#1)
A current##10##2##(1991-11#1)(1992-1#1)(1994-8#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
A custom-built##2##2##(2007-8#1)(2008-10#1)
A cw##3##2##(2007-12#1)(2008-3#2)
A cycle time of 10 min allowed##2##7##(2008-11#2)
A cycle##3##2##(1992-6#1)(2008-11#2)
A cylindrical##2##2##(2008-3#1)(2008-5#1)
A cylindrically##2##2##(1995-3#1)(2008-3#1)
A cystic##2##2##(2008-10#1)(2011-2#1)
A cystoscopy##2##2##(2008-10#1)(2012-2#1)
A cytochrome##2##2##(1990-11#1)(2008-5#1)
A cytological##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
A daily##2##2##(2009-7#1)(2011-2#1)
A data base##2##3##(1991-2#1)(2008-11#1)
A data##5##2##(1991-2#1)(1996-2#1)(2008-11#1)(2009-12#1)(2011-2#1)
A database for##2##3##(1994-9#1)(2008-1#1)
A database##7##2##(1994-9#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-2#1)
A decade ago##3##3##(1993-2#1)(2008-10#1)(2010-7#1)
A decade of research##2##4##(1990-11#1)(2009-10#1)
A decade of##4##3##(1990-11#1)(1992-3#1)(1994-3#1)(2009-10#1)
A decade##7##2##(1990-11#1)(1992-3#1)(1993-2#1)(1994-3#1)(2008-10#1)(2009-10#1)(2010-7#1)
A decision##7##2##(1994-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
A decrease in the##6##4##(1990-12#1)(1990-7#1)(1994-6#1)(2007-12#1)(2008-10#1)(2012-3#1)
A decrease in##15##3##(1990-12#2)(1990-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2012-3#1)
A decrease of##3##3##(1994-5#1)(2008-10#1)(2012-12#1)
A decrease##20##2##(1990-11#1)(1990-12#2)(1990-7#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#1)
A deep##2##2##(2006-10#1)(2007-12#1)
A deficiency among children##2##4##(1991-8#1)(2008-9#1)
A deficiency among##3##3##(1991-8#2)(2008-9#1)
A deficiency##15##2##(1991-8#6)(1992-9#2)(2007-11#2)(2008-9#1)(2012-1#4)
A definition of##4##3##(1991-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
A definitive##4##2##(1994-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
A degree of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
A deletion##3##2##(1993-6#1)(1997-2#1)(2008-10#1)
A deliberative process##2##3##(2008-7#2)
A demographic##2##2##(1993-1#1)(2010-9#1)
A demonstration##3##2##(2006-4#1)(2008-10#2)
A demonstrator##2##2##(2008-3#2)
A dendrogram##2##2##(2008-10#2)
A dependence##2##2##(1994-5#1)(2008-5#1)
A description of the##6##4##(1992-1#1)(1993-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)
A description of##9##3##(1992-1#2)(1993-1#1)(1994-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-5#1)
A descriptive analysis##2##3##(2011-2#1)(2012-2#1)
A descriptive and##3##3##(1997-4#1)(2008-8#1)(2012-12#1)
A descriptive cross-sectional study##2##4##(2011-2#1)(2012-12#1)
A descriptive study##3##3##(2007-12#1)(2012-12#2)
A descriptive survey was##3##4##(2010-3#1)(2010-8#1)(2013-8#1)
A descriptive survey##4##3##(2008-12#1)(2010-3#1)(2010-8#1)(2013-8#1)
A descriptive##22##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#6)(2012-2#1)(2013-1#4)(2013-8#1)
A design for##2##3##(2008-2#1)(2008-3#1)
A design method##2##3##(2008-3#2)
A design##9##2##(1996-12#1)(1996-3#1)(2008-2#1)(2008-3#6)
A desirable##2##2##(1996-2#1)(2011-2#1)
A detailed analysis of the##5##5##(1995-5#1)(2008-3#3)(2009-10#1)
A detailed analysis of##8##4##(1995-5#1)(2008-1#1)(2008-10#1)(2008-3#4)(2009-10#1)
A detailed comparison##2##3##(2008-10#2)
A detailed description of the##3##5##(2007-11#1)(2008-5#1)(2008-7#1)
A detailed description of##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
A detailed description##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
A detailed evaluation of the##2##5##(2008-3#1)(2008-5#1)
A detailed evaluation of##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
A detailed evaluation##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
A detailed examination of the##2##5##(1994-2#1)(1997-3#1)
A detailed experimental##2##3##(2008-2#1)(2008-3#1)
A detailed investigation##2##3##(1993-11#1)(2008-3#1)
A detailed method is##2##4##(2008-4#2)
A detailed study of##6##4##(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
A detailed study##7##3##(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
A detailed##53##2##(1991-8#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2013-8#1)
A detection limit (3sigma) of 0##2##6##(2008-10#2)
A detection limit for##2##4##(2008-10#2)
A detection limit of 0##4##5##(2008-10#4)
A detection limit of 2##2##5##(2007-12#1)(2008-10#1)
A detection limit of 3##2##5##(2007-12#1)(2008-10#1)
A detection limit of 6##2##5##(2008-10#2)
A detection limit of##19##4##(2007-12#3)(2008-10#16)
A detection limit##26##3##(2007-12#3)(2008-10#22)(2008-3#1)
A detection##33##2##(2007-12#3)(2008-10#26)(2008-3#4)
A device is##2##3##(2008-2#1)(2008-3#1)
A device##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
A diagnosis of a##2##4##(2011-1#1)(2013-1#1)
A diagnosis of##18##3##(1990-3#1)(1992-8#1)(2007-7#2)(2008-1#2)(2008-12#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
A diagnosis##20##2##(1990-3#1)(1992-8#1)(1993-6#1)(2007-7#2)(2008-1#2)(2008-12#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
A diagnostic dilemma##2##3##(2012-2#1)(2013-1#1)
A diagnostic procedure##2##3##(2007-12#1)(2008-10#1)
A diagnostic##11##2##(1991-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
A dielectric##3##2##(2007-12#1)(2008-2#1)(2013-8#1)
A difference in##4##3##(1995-6#1)(1997-4#1)(2007-11#1)(2013-8#1)
A difference##7##2##(1990-3#1)(1992-2#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2013-8#1)
A different##5##2##(1994-12#1)(1994-5#1)(2007-12#1)(2010-11#1)(2013-1#1)
A differential diagnosis of##2##4##(1992-4#1)(2008-10#1)
A differential diagnosis##3##3##(1990-12#1)(1992-4#1)(2008-10#1)
A differential pulse##2##3##(2008-10#2)
A differential##8##2##(1990-12#1)(1992-4#1)(1995-6#1)(2008-10#4)(2008-2#1)
A differentiation##2##2##(1997-2#1)(2008-11#1)
A difficult##2##2##(2009-7#1)(2012-1#1)
A diffraction efficiency of##2##4##(2007-12#1)(2008-3#1)
A diffraction##4##2##(2007-12#1)(2008-3#3)
A diffraction-limited##2##2##(2008-2#1)(2008-3#1)
A diffractive##3##2##(2008-2#1)(2008-3#2)
A digital signal processor##2##4##(2008-3#2)
A digital signal##3##3##(1994-12#1)(2008-3#2)
A digital##8##2##(1994-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#4)
A dilemma in##2##3##(1994-12#1)(2009-5#1)
A diode laser##2##3##(2008-10#1)(2008-2#1)
A diode##3##2##(2008-10#2)(2008-2#1)
A diode-pumped##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
A direct comparison##3##3##(1996-12#1)(2007-12#1)(2008-7#1)
A direct correlation was##2##4##(1995-5#1)(2007-7#1)
A direct correlation##3##3##(1994-11#1)(1995-5#1)(2007-7#1)
A direct pathological role of P2 receptors is reinforced by recent evidence showing that##2##14##(2008-4#2)
A direct##25##2##(1994-11#2)(1995-3#1)(1995-5#1)(1996-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)
A disadvantage of##3##3##(1997-2#1)(2008-1#1)(2012-2#1)
A disadvantage##4##2##(1997-2#1)(2008-1#1)(2008-8#1)(2012-2#1)
A discrepancy##2##2##(1992-6#1)(2008-3#1)
A discrete##4##2##(1997-3#1)(2007-12#1)(2008-2#1)(2008-8#1)
A discriminant##2##2##(1994-2#1)(2008-7#1)
A discussion of the##3##4##(2008-3#2)(2011-2#1)
A discussion of##10##3##(1992-3#1)(1997-3#1)(2008-3#2)(2008-4#2)(2008-6#1)(2009-9#1)(2011-2#1)(2012-3#1)
A discussion on the##2##4##(2008-10#1)(2008-3#1)
A discussion on##3##3##(2008-10#1)(2008-3#1)(2011-3#1)
A discussion##14##2##(1992-3#1)(1997-3#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-6#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
A dispersion##2##2##(2007-11#1)(2013-1#1)
A distinct##2##2##(1993-12#1)(2007-12#1)
A distinction is##2##3##(1991-1#1)(1996-4#1)
A distinction##3##2##(1991-1#1)(1996-4#1)(2010-1#1)
A distinctive feature of##3##4##(1993-1#1)(1995-2#1)(2008-2#1)
A distinctive##4##2##(1993-1#1)(1995-2#1)(2008-2#1)(2011-1#1)
A diverse##2##2##(2008-10#1)(2011-2#1)
A does not##3##3##(1993-6#1)(1994-3#1)(2008-10#1)
A dominant gene##2##3##(2008-10#2)
A dose of##3##3##(1995-12#1)(2010-3#1)(2012-2#1)
A dose##5##2##(1995-12#1)(1996-5#1)(2008-11#1)(2010-3#1)(2012-2#1)
A dose-dependent##3##2##(1993-9#1)(2008-10#1)(2013-1#1)
A double blind clinical##2##4##(1996-9#1)(2008-11#1)
A double blind##3##3##(1996-9#1)(2008-11#1)(2008-7#1)
A double##8##2##(1994-12#1)(1995-9#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)
A double-blind randomized vehicle-controlled clinical##2##5##(2008-5#2)
A double-blind##10##2##(1990-5#1)(1991-1#1)(1994-6#1)(1996-1#2)(2008-5#3)(2008-6#1)(2012-3#1)
A doubled haploid (DH) population##2##5##(2008-10#1)(2008-4#1)
A doubled haploid##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
A dramatic##3##2##(1990-12#1)(2008-8#1)(2012-2#1)
A drop##2##2##(1993-2#1)(2008-9#1)
A dual column system##2##4##(2008-10#2)
A dual##5##2##(1997-3#1)(2008-10#3)(2008-2#1)
A dual-wavelength resonance##2##3##(2008-10#2)
A dual-wavelength##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
A dynamic##9##2##(1995-8#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
A expression##3##2##(1993-6#1)(1996-12#1)(2013-7#1)
A facile method##2##3##(2008-4#2)
A facile synthesis of##2##4##(2007-11#1)(2012-3#1)
A facile##9##2##(1997-7#1)(2007-11#2)(2008-12#1)(2008-4#2)(2010-2#1)(2012-3#2)
A factor##6##2##(1990-11#1)(1991-11#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-3#1)
A factorial design was used##2##5##(2008-10#2)
A factorial design was##3##4##(2008-10#3)
A factorial design##7##3##(2008-10#6)(2008-6#1)
A factorial##8##2##(2008-10#7)(2008-6#1)
A fair##2##2##(1995-2#1)(2012-2#1)
A family of##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
A family##4##2##(1992-5#1)(2007-12#1)(2008-2#1)(2008-8#1)
A fast and simple method##2##5##(2007-11#1)(2008-10#1)
A fast and simple##3##4##(2007-11#1)(2008-10#2)
A fast and##9##3##(2007-11#1)(2008-10#7)(2008-3#1)
A fast method for##2##4##(2008-10#2)
A fast##22##2##(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#3)(2012-2#1)
A fatal case of##3##4##(1992-9#1)(2011-1#1)(2012-3#1)
A favorable outcome##2##3##(2007-10#1)(2008-7#1)
A favourable##2##2##(2007-8#1)(2011-2#1)
A feasibility study of##2##4##(1990-12#1)(1994-6#1)
A feasibility study##3##3##(1990-12#1)(1994-6#1)(2013-1#1)
A fee##2##2##(1992-5#1)(1997-5#1)
A female##4##2##(1991-6#1)(1994-12#1)(2008-7#1)(2012-3#1)
A femtosecond##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
A few recent##2##3##(2008-10#1)(2008-11#1)
A few studies##4##3##(2009-5#1)(2011-1#1)(2013-1#2)
A few words about the quest for mercy##3##8##(2008-8#3)
A few years##2##3##(1997-7#1)(2008-8#1)
A few##39##2##(1992-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#4)(2009-5#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
A fiber Bragg##2##3##(2007-12#2)
A fiber optic##2##3##(2008-10#1)(2008-2#1)
A fiber##9##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)
A fiber-optic##10##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2011-1#1)
A field experiment was conducted to##2##6##(2008-10#1)(2008-9#1)
A field experiment was conducted##3##5##(2008-10#1)(2008-12#1)(2008-9#1)
A field experiment was##5##4##(2008-10#2)(2008-12#2)(2008-9#1)
A field study at##2##4##(2008-10#1)(2008-12#1)
A field##15##2##(1994-2#1)(1995-3#1)(1997-6#1)(2008-10#6)(2008-12#3)(2008-3#1)(2008-9#1)(2009-8#1)
A field-programmable##2##2##(2008-2#1)(2008-3#1)
A fifth##4##2##(1990-12#1)(1997-8#1)(2008-10#1)(2012-12#1)
A film##2##2##(2008-10#1)(2008-3#1)
A final support protocol describes the photography of fluorescently stained proteins##2##11##(2008-2#1)(2008-4#1)
A final##8##2##(1995-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)
A fine##3##2##(1992-3#1)(1992-5#1)(2008-3#1)
A finite-difference time-domain##2##3##(2008-2#1)(2008-3#1)
A firm##3##2##(1994-7#1)(2010-3#1)(2013-8#1)
A first##14##2##(1991-5#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2011-1#1)
A first-order##2##2##(2008-3#2)
A five-step##2##2##(1996-5#1)(1997-3#1)
A fixed##2##2##(1996-12#1)(2008-3#1)
A flat##2##2##(2008-10#1)(2008-3#1)
A flexible##2##2##(2008-9#1)(2013-8#1)
A flow cell##3##3##(2008-10#3)
A flow cytometer##2##3##(2008-9#2)
A flow injection (FI) method##2##5##(2008-10#2)
A flow injection (FI) spectrophotometric##3##5##(2008-10#3)
A flow injection (FI)##7##4##(2008-10#7)
A flow injection analysis (FIA)##3##5##(2008-10#2)(2008-11#1)
A flow injection analysis##7##4##(2008-10#6)(2008-11#1)
A flow injection method for the##2##6##(2008-10#2)
A flow injection method has been##2##6##(2008-10#2)
A flow injection method is##3##5##(2008-10#3)
A flow injection method on the basis of gas phase molecular absorption is described for the##2##16##(2008-10#2)
A flow injection method##9##4##(2008-10#9)
A flow injection spectrophotometric method##2##5##(2008-10#2)
A flow injection system##2##4##(2008-10#2)
A flow injection##38##3##(2008-10#37)(2008-11#1)
A flow system for the spectrophotometric determination of lead in##2##10##(2008-10#2)
A flow system for the##3##5##(2008-10#3)
A flow system with##2##4##(2008-10#2)
A flow system##8##3##(2008-10#8)
A flow type##2##3##(2008-10#2)
A flow##60##2##(1993-8#1)(2008-10#54)(2008-11#1)(2008-4#2)(2008-9#2)
A flow-based enzyme-linked immunosorbent assay##2##5##(2008-10#2)
A flow-based##3##2##(2008-10#3)
A flow-batch##2##2##(2008-10#2)
A flow-injection analysis##2##3##(1992-11#1)(2008-10#1)
A flow-injection chemiluminescence##2##3##(2008-10#2)
A flow-injection method for the##2##5##(2008-10#2)
A flow-injection method##3##3##(2008-10#3)
A flow-injection procedure for##2##4##(2008-10#2)
A flow-injection procedure##3##3##(2008-10#3)
A flow-injection spectrophotometric##2##3##(2008-10#2)
A flow-injection system##2##3##(2008-10#2)
A flow-injection##23##2##(1992-11#1)(2008-10#22)
A flow-through fluorescent sensor##2##4##(2008-10#2)
A flow-through##5##2##(2008-10#5)
A fluorescence##5##2##(1994-8#1)(1995-5#1)(2008-10#2)(2008-2#1)
A fluorescent chemical sensor for Hg(II)##2##6##(2008-10#2)
A fluorescent##9##2##(1993-11#1)(2008-10#7)(2008-4#1)
A fluorimetric##2##2##(1990-2#1)(2008-10#1)
A fluorometric##2##2##(1991-9#1)(1996-12#1)
A flurry of##2##3##(2009-4#1)(2009-6#1)
A focus group##2##3##(2008-9#1)(2010-2#1)
A focus on##5##3##(1994-2#1)(2008-4#1)(2011-2#2)(2012-3#1)
A focus##7##2##(1994-2#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-3#1)
A focused##4##2##(2007-11#1)(2008-3#2)(2009-7#1)
A follow-up of##2##3##(1991-9#1)(1993-9#1)
A follow-up study of##2##4##(1995-1#1)(1997-4#1)
A follow-up study##3##3##(1994-3#1)(1995-1#1)(1997-4#1)
A follow-up survey##2##3##(1997-1#1)(2008-9#1)
A follow-up##15##2##(1990-3#1)(1991-9#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
A for all heavy atoms##3##5##(1994-5#2)(1995-5#1)
A for all##5##3##(1994-5#3)(1995-5#1)(2008-2#1)
A for backbone atoms and 0##2##6##(1994-5#1)(1995-5#1)
A for backbone atoms and##3##5##(1994-5#2)(1995-5#1)
A for the##3##3##(1994-5#1)(2008-3#2)
A for##13##2##(1992-4#1)(1993-8#1)(1994-5#6)(1995-5#2)(2008-2#1)(2008-3#2)
A force##2##2##(1994-9#1)(2012-3#1)
A forensic##2##2##(2008-12#1)(2011-2#1)
A formal##2##2##(1996-1#1)(2008-6#1)
A formalism is##2##3##(2007-11#1)(2008-3#1)
A formalism##3##2##(2007-11#1)(2008-3#2)
A formula for the##2##4##(1997-3#1)(2008-8#1)
A formula for##4##3##(1997-3#1)(2008-3#2)(2008-8#1)
A formula##6##2##(1997-3#1)(2008-3#3)(2008-5#1)(2008-8#1)
A formulation of##2##3##(2008-2#1)(2008-3#1)
A forward##2##2##(1990-12#1)(1995-3#1)
A four##3##2##(1992-12#1)(2008-5#1)(2012-3#1)
A fourth##2##2##(2008-10#1)(2008-3#1)
A fraction of##2##3##(2008-10#1)(2008-3#1)
A fraction##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
A fractional##2##2##(2008-10#1)(2008-3#1)
A fragment of##2##3##(1990-12#1)(1995-8#1)
A framework for##4##3##(1991-12#1)(1997-1#1)(2008-12#1)(2010-12#1)
A framework to##3##3##(2007-9#1)(2008-11#1)(2008-8#1)
A framework##8##2##(1991-12#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#1)
A frequency##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
A from Staphylococcus aureus##2##4##(1990-12#1)(1996-12#1)
A from human liver##3##4##(1990-12#2)(1991-12#1)
A from the##5##3##(1991-12#1)(1992-3#1)(1992-4#1)(1993-6#1)(1997-2#1)
A from##17##2##(1990-12#3)(1991-12#3)(1992-3#1)(1992-4#1)(1993-11#1)(1993-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
A full understanding of the##2##5##(2008-10#1)(2008-11#1)
A full##11##2##(1991-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#2)(2010-7#1)
A full-length cDNA clone encoding##2##5##(1991-2#1)(1994-11#1)
A full-length cDNA clone##3##4##(1991-2#1)(1994-11#1)(1994-6#1)
A full-length cDNA##5##3##(1991-2#1)(1994-11#1)(1994-6#1)(1996-3#1)(2008-8#1)
A full-length##8##2##(1991-2#1)(1992-3#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-3#1)(2008-8#1)(2011-1#1)
A fully automated##10##3##(1990-8#1)(1993-2#1)(1997-3#1)(2008-10#6)(2008-3#1)
A fully automatic##2##3##(2008-10#1)(2008-2#1)
A fully##16##2##(1990-8#1)(1993-2#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#2)
A functional##6##2##(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-9#1)
A functionally##2##2##(1993-12#2)
A fundamental##7##2##(1992-12#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
A further##23##2##(1991-5#1)(1993-11#1)(1994-3#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
A fusion##3##2##(1995-12#1)(2008-11#1)(2009-6#1)
A fuzzy##2##2##(1992-12#1)(2008-10#1)
A gain of##2##3##(2007-12#2)
A game##3##2##(2008-8#1)(2008-9#2)
A gas Chromatographic method for the detection and determination of##2##10##(2008-11#2)
A gas chromatography##2##3##(2008-10#1)(2008-5#1)
A gas diffusion##2##3##(2008-10#2)
A gas##12##2##(1992-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2011-1#2)
A gave##2##2##(2010-2#2)
A gender##3##2##(2008-11#1)(2009-5#1)(2009-7#1)
A gene encoding##3##3##(1992-9#1)(2008-10#1)(2008-7#1)
A gene of##2##3##(1996-8#1)(1997-6#1)
A gene that##2##3##(2008-10#2)
A gene##24##2##(1991-5#3)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-5#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-6#1)(1997-9#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
A gene-for-gene##2##2##(2008-10#2)
A general method for##4##4##(1990-11#1)(2008-3#2)(2009-3#1)
A general method##5##3##(1990-11#1)(2008-2#1)(2008-3#2)(2009-3#1)
A general setting for halo theory##2##6##(2008-2#2)
A general theory of##2##4##(2008-2#1)(2008-9#1)
A general##34##2##(1990-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1997-6#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
A generalized##8##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)
A generic##2##2##(1994-12#1)(2008-11#1)
A genetic algorithm##2##3##(2008-10#1)(2008-2#1)
A genetic linkage##2##3##(2008-10#1)(2011-3#1)
A genetic map##2##3##(2008-10#2)
A genetic model##2##3##(2008-10#1)(2008-8#1)
A genetic predisposition to##2##4##(2008-7#1)(2010-3#1)
A genetic##20##2##(1990-11#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2011-3#1)(2013-1#1)
A genome##2##2##(2008-10#2)
A genome-wide##2##2##(1996-2#1)(2009-10#1)
A genomic clone of##2##4##(1993-6#1)(1996-6#1)
A genomic clone##5##3##(1990-12#1)(1993-3#1)(1993-6#1)(1996-6#1)(1996-8#1)
A genomic##10##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
A genotype##6##2##(2008-10#6)
A genotypes##2##2##(2008-10#2)
A glass electrode##2##3##(2008-10#2)
A glass##4##2##(2008-10#4)
A glimpse into##2##3##(2008-2#1)(2010-12#1)
A glimpse##4##2##(1994-12#1)(2008-2#1)(2008-6#1)(2010-12#1)
A global##4##2##(2008-10#1)(2010-12#1)(2010-3#1)(2011-1#1)
A glucose biosensor##3##3##(2008-10#3)
A gold##2##2##(2008-10#2)
A good agreement between##2##4##(1992-5#1)(2008-10#1)
A good agreement was##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
A good agreement##6##3##(1992-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
A good correlation between findings with the##2##7##(2008-10#2)
A good correlation was found between the##2##7##(2007-12#1)(2008-10#1)
A good correlation was observed between the##2##7##(2008-10#1)(2008-7#1)
A good correlation was observed##3##5##(2007-7#1)(2008-10#1)(2008-7#1)
A good correlation was##6##4##(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)
A good correlation##12##3##(1990-12#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-7#1)
A good linear##3##3##(2008-10#3)
A good result was##2##4##(2008-10#1)(2008-9#1)
A good separation of##2##4##(2008-10#2)
A good understanding of##4##4##(2008-1#1)(2008-3#1)(2010-8#1)(2013-1#1)
A good##51##2##(1990-12#1)(1992-4#1)(1992-5#1)(1993-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#25)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-12#1)(2013-1#1)
A gradient anion exchange chromatographic##2##5##(2008-10#2)
A gradient##3##2##(2008-10#2)(2008-3#1)
A graphic##2##2##(2008-2#1)(2008-5#1)
A graphical##3##2##(1992-12#1)(2008-7#1)(2008-9#1)
A graphite furnace atomic absorption method##3##6##(2008-10#3)
A graphite furnace atomic absorption##4##5##(2008-10#4)
A graphite##5##2##(2008-10#5)
A grating is projected onto the object surface##2##8##(2008-3#2)
A gravida##2##2##(1992-9#1)(1994-12#1)
A great amount of##2##4##(2008-10#1)(2008-12#1)
A great deal of##3##4##(1994-12#1)(2008-3#1)(2008-7#1)
A great proportion##2##3##(2008-7#1)(2009-8#1)
A great variety of##2##4##(1992-5#1)(2011-2#1)
A great##12##2##(1992-5#1)(1994-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)
A greater percentage of##2##4##(1995-3#1)(1996-2#1)
A greater than##2##3##(2008-3#2)
A greater understanding of the##3##5##(2008-10#1)(2008-8#1)(2012-1#1)
A greater##14##2##(1992-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#2)
A green##4##2##(2008-10#3)(2008-12#1)
A ground-based##2##2##(2008-10#1)(2008-3#1)
A grounded theory approach##2##4##(2009-11#1)(2012-3#1)
A group of new##2##4##(1994-11#1)(2010-2#1)
A group of##23##3##(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
A group##26##2##(1992-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
A growing body of evidence##2##5##(1990-9#1)(2008-7#1)
A growing body of##3##4##(1990-9#1)(2008-11#1)(2008-7#1)
A growing crisis in patient access to emergency##2##8##(2008-6#2)
A growing number of studies##2##5##(2011-2#1)(2012-12#1)
A growing number of##5##4##(1994-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
A growing##13##2##(1990-9#1)(1994-12#2)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
A guide for##3##3##(1995-12#2)(2011-2#1)
A guide to##8##3##(1993-12#1)(1995-11#1)(1995-2#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)
A guide##11##2##(1993-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#2)
A guideline##2##2##(1990-11#1)(2012-2#1)
A had##4##2##(1990-12#1)(1997-3#1)(2008-10#1)(2008-9#1)
A hallmark of##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
A has been##2##3##(1992-8#1)(1993-3#1)
A has##5##2##(1992-8#1)(1993-3#1)(1997-3#1)(2007-12#2)
A have##2##2##(2008-3#1)(2010-8#1)
A headspace##2##2##(2008-10#1)(2011-1#1)
A health care##2##3##(1993-1#1)(1997-3#1)
A health##8##2##(1992-5#1)(1993-1#1)(1997-3#1)(2008-1#1)(2010-12#2)(2011-2#1)(2012-3#1)
A healthy##5##2##(1997-2#1)(2007-7#1)(2008-8#1)(2009-9#1)(2013-8#1)
A heat##2##2##(1993-6#1)(1995-6#1)
A hematopoietic disorder (myelodysplasia) also occurred in##2##7##(2008-9#2)
A hematopoietic disorder (myelodysplasia) occurred in##2##6##(2008-9#2)
A hematopoietic disorder (myelodysplasia)##4##4##(2008-9#4)
A heterogeneous##2##2##(1990-12#1)(1990-2#1)
A heterologous##2##2##(2008-5#1)(2008-9#1)
A hierarchical analysis##2##3##(2008-10#2)
A hierarchical##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
A hierarchy of##3##3##(1991-8#1)(2008-7#1)(2009-5#1)
A high degree of##7##4##(1991-2#1)(1991-6#1)(1993-12#1)(1993-2#1)(1996-5#1)(1996-6#1)(2008-2#1)
A high frequency##2##3##(1990-6#1)(2012-12#1)
A high index of suspicion is required to diagnose##2##9##(2007-7#1)(2012-12#1)
A high index of suspicion is##3##6##(2007-7#2)(2012-12#1)
A high level of##4##4##(1993-3#1)(1993-6#1)(2007-12#1)(2008-6#1)
A high level##5##3##(1993-3#1)(1993-6#1)(2007-12#1)(2008-6#1)(2011-1#1)
A high percentage of##5##4##(1991-6#1)(2010-5#1)(2012-12#2)(2012-3#1)
A high percentage##6##3##(1991-6#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)
A high performance liquid chromatography (HPLC) method##2##7##(2008-10#2)
A high performance liquid chromatography (HPLC)##3##6##(2008-10#3)
A high performance liquid chromatography##5##5##(2008-10#5)
A high performance liquid##9##4##(1990-12#1)(2008-10#6)(2011-1#2)
A high phosphorylation state and increased activity of##2##8##(1991-9#2)
A high preconcentration##2##3##(2008-10#2)
A high prevalence of##2##4##(2007-7#1)(2012-3#1)
A high resolution##2##3##(1992-8#1)(2008-3#1)
A high##74##2##(1990-12#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#3)(2007-7#3)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-1#4)(2012-12#5)(2012-2#2)(2012-3#2)(2013-8#1)
A high-contrast##2##2##(2007-12#1)(2008-2#1)
A high-performance liquid chromatographic (HPLC) method was##2##7##(1990-8#1)(2008-10#1)
A high-performance liquid chromatographic (HPLC) method##4##6##(1990-8#2)(2008-10#2)
A high-performance liquid chromatographic method for the determination of##2##9##(1990-8#1)(1993-9#1)
A high-performance liquid chromatographic method##4##5##(1990-8#1)(1993-9#1)(1997-2#2)
A high-performance liquid chromatographic##8##4##(1990-8#3)(1993-9#1)(1997-2#2)(2008-10#2)
A high-performance liquid##9##3##(1990-8#3)(1993-9#1)(1997-2#2)(2008-10#3)
A high-power##2##2##(2007-11#2)
A high-resolution##2##2##(1994-5#1)(2008-3#1)
A high-speed##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
A higher level of##2##4##(2008-10#1)(2013-1#1)
A higher percentage of the##2##5##(1992-6#1)(2008-10#1)
A higher percentage##3##3##(1992-6#1)(2008-10#1)(2010-4#1)
A higher proportion of##2##4##(2008-11#1)(2012-3#1)
A higher##23##2##(1992-6#1)(1994-6#2)(2008-10#4)(2008-11#3)(2008-7#1)(2010-12#1)(2010-4#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
A highly efficient##2##3##(2007-11#1)(2008-3#1)
A highly selective and sensitive##3##5##(2008-10#3)
A highly selective##10##3##(2008-10#10)
A highly sensitive and selective method##2##6##(2008-10#2)
A highly sensitive and selective second derivative spectrophotometric method has been developed for the determination of##2##16##(2008-10#2)
A highly sensitive and selective spectrophotometric method##2##7##(2008-10#2)
A highly sensitive and selective##8##5##(2008-10#7)(2013-1#1)
A highly sensitive and simple##2##5##(2008-10#2)
A highly sensitive and##12##4##(1995-11#1)(2008-10#10)(2013-1#1)
A highly sensitive optical##2##4##(2008-10#2)
A highly sensitive potentiometric flow injection##2##6##(2008-10#2)
A highly sensitive procedure##2##4##(2008-10#2)
A highly sensitive spectrophotometric##2##4##(2008-10#2)
A highly sensitive##32##3##(1991-5#1)(1995-11#1)(2008-10#29)(2013-1#1)
A highly significant##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
A highly##61##2##(1990-11#1)(1991-5#1)(1995-11#1)(1997-9#1)(2007-11#1)(2008-10#43)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
A hippocampal##2##2##(1993-6#1)(1997-6#1)
A histological study##2##3##(2008-10#1)(2012-3#1)
A histological##3##2##(2008-10#2)(2012-3#1)
A histologically##2##2##(1990-2#1)(1994-1#1)
A historical review##2##3##(1990-10#1)(2008-10#1)
A historical##7##2##(1990-10#1)(1991-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
A history of the##2##4##(1994-12#1)(2011-2#1)
A history of##11##3##(1991-3#1)(1993-2#1)(1993-5#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
A hitherto##3##2##(1995-2#1)(2008-11#1)(2010-2#1)
A holistic##2##2##(1997-3#1)(2009-9#1)
A holographic grating##2##3##(2007-11#1)(2008-3#1)
A holographic##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
A home made##2##3##(2008-10#2)
A home##3##2##(1997-6#1)(2008-10#2)
A homogeneous##2##2##(2008-2#2)
A homologous series of##2##4##(1992-8#1)(2013-8#1)
A homology search for the products deduced from the##2##9##(1996-8#1)(1997-7#1)
A homology search for the##3##5##(1995-12#1)(1996-8#1)(1997-7#1)
A hospital based##2##3##(1991-2#1)(2007-7#1)
A hospital##9##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-3#1)(2007-7#1)(2008-11#1)(2010-8#1)(2011-2#1)
A host##3##2##(1995-2#1)(2011-2#1)(2013-7#1)
A human small##2##3##(1990-8#1)(1994-8#1)
A human##10##2##(1990-8#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-2#1)(1997-1#1)
A hundred and##3##3##(2010-1#1)(2010-6#1)(2011-2#1)
A hybrid approach##2##3##(2008-3#2)
A hybrid method##2##3##(2008-3#2)
A hybrid##9##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#5)
A hydride generation##4##3##(2008-10#4)
A hydrogen peroxide biosensor##2##4##(2008-10#2)
A hydrogen##4##2##(2008-10#4)
A hydrophobic##3##2##(2008-10#3)
A hypothesis of##2##3##(2008-8#1)(2008-9#1)
A hypothesis##5##2##(1992-11#1)(2008-12#1)(2008-8#1)(2008-9#2)
A hypothetical##2##2##(1997-3#1)(2008-10#1)
A in diameter and##3##4##(1991-12#1)(1995-11#1)(1997-4#1)
A in the presence of##2##5##(1990-12#1)(1994-11#1)
A in the##9##3##(1990-12#1)(1990-5#1)(1991-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
A in##53##2##(1990-11#2)(1990-12#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#4)(1991-5#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2007-11#1)(2007-12#3)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)
A increased [Ca2+]i in##2##4##(1992-6#2)
A induced a##3##3##(1995-8#3)
A inhibited##3##2##(1994-8#1)(1995-11#1)(1997-7#1)
A inhibition##2##2##(1994-8#1)(1997-7#1)
A inhibits##2##2##(1993-8#1)(1997-7#1)
A into##5##2##(1997-1#2)(2008-10#3)
A is a##5##3##(1995-8#1)(2008-3#2)(2008-9#1)(2013-1#1)
A is an X-linked##2##4##(2008-12#1)(2011-2#1)
A is an##4##3##(1994-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
A is the##4##3##(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
A is##27##2##(1990-11#1)(1990-12#1)(1994-8#1)(1995-8#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#3)(2012-1#1)(2013-1#1)
A isolates##2##2##(1997-3#1)(2008-10#1)
A joint transform correlator##2##4##(2008-3#2)
A joint##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
A journey##2##2##(1997-3#1)(2008-10#1)
A jury##2##2##(1996-5#1)(1997-5#1)
A key feature of the##3##5##(1996-12#1)(2008-10#1)(2008-9#1)
A key goal##2##3##(2007-8#1)(2008-7#1)
A key issue##2##3##(1996-5#1)(2009-5#1)
A key question##2##3##(2008-11#1)(2008-7#1)
A key to##2##3##(1992-3#1)(2009-6#1)
A key##32##2##(1992-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
A kind of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
A kinetic method for the##2##5##(2008-10#2)
A kinetic model for##2##4##(1994-5#1)(2013-1#1)
A kinetic model of##2##4##(2008-11#1)(2009-11#1)
A kinetic model##5##3##(1994-5#1)(2008-11#2)(2009-11#1)(2013-1#1)
A kinetic study##3##3##(2008-10#2)(2008-7#1)
A kinetic##12##2##(1990-5#1)(1991-3#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-11#1)(2013-1#1)
A knowledge of the##2##4##(1996-11#1)(2008-9#1)
A known##2##2##(2008-11#1)(2008-3#1)
A labile##2##2##(1993-11#1)(2009-10#1)
A laboratory##7##2##(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#1)
A lack of animal models has##2##6##(1995-2#1)(2008-9#1)
A lack of##5##3##(1995-2#1)(2008-10#1)(2008-9#1)(2010-4#1)(2011-2#1)
A large amount of##2##4##(1994-12#1)(1995-5#1)
A large body of##3##4##(1992-5#1)(2008-6#1)(2009-3#1)
A large linear dynamic range from##2##6##(2008-10#2)
A large majority##3##3##(1997-2#1)(2010-8#1)(2011-2#1)
A large number of different##2##5##(2008-10#1)(2008-11#1)
A large number of##20##4##(1990-6#1)(1991-6#1)(1997-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
A large number##21##3##(1990-6#1)(1991-6#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
A large portion##2##3##(2007-5#1)(2008-6#1)
A large proportion of the##3##5##(1996-9#1)(2008-5#2)
A large proportion of##6##4##(1996-9#1)(2008-11#1)(2008-5#2)(2009-7#1)(2013-8#1)
A large sample##2##3##(2008-12#1)(2012-2#1)
A large##66##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-6#2)(1992-5#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-9#1)(2007-12#4)(2007-5#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
A large-scale##2##2##(1992-12#1)(2008-10#1)
A larger value of##3##4##(2008-10#3)
A larger##8##2##(1992-3#1)(2008-10#5)(2009-8#1)(2010-10#1)
A laser##4##2##(2008-2#2)(2008-3#2)
A laser-diode-pumped##2##2##(2008-2#1)(2008-3#1)
A least-squares##3##2##(1992-8#1)(2008-2#1)(2008-3#1)
A left##8##2##(1997-3#1)(1997-8#1)(2008-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
A length of##2##3##(1995-3#1)(2007-8#1)
A lesson in##2##3##(1991-3#1)(1995-12#1)
A lesson##3##2##(1991-3#1)(1995-12#1)(2008-7#1)
A level##2##2##(1994-11#1)(2008-10#1)
A library of##7##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-8#1)(2007-12#1)(2008-7#1)(2011-1#1)
A life##2##2##(1992-11#1)(2008-12#1)
A light and electron##2##4##(1996-5#1)(2007-12#1)
A light##10##2##(1990-5#1)(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2012-3#1)
A likelihood ratio##2##3##(2008-10#1)(2008-11#1)
A likelihood##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
A limit of detection of##5##5##(2008-1#1)(2008-10#4)
A limit of detection##7##4##(2008-1#1)(2008-10#6)
A limit of##9##3##(2008-1#1)(2008-10#8)
A limited number of##2##4##(1995-5#1)(2008-10#1)
A limited##9##2##(1992-3#1)(1994-5#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
A linear calibration curve was##2##5##(2008-10#2)
A linear calibration curve##5##4##(2008-10#5)
A linear calibration graph was obtained in the##2##8##(2008-10#2)
A linear calibration graph was obtained##7##6##(2008-10#7)
A linear calibration graph##10##4##(2008-10#10)
A linear calibration was obtained in the range of##2##9##(2008-10#2)
A linear calibration##19##3##(2008-10#19)
A linear correlation was found##2##5##(1995-8#1)(2008-10#1)
A linear correlation##4##3##(1995-8#1)(2008-10#3)
A linear dependence of##2##4##(2008-10#2)
A linear discriminant##2##3##(2007-11#1)(2008-10#1)
A linear dynamic range##2##4##(2008-10#2)
A linear model##2##3##(2008-10#1)(2008-8#1)
A linear range##2##3##(2008-10#2)
A linear relation between the##2##5##(2008-3#2)
A linear relationship between the concentration of cationic polyelectrolyte and the end-point volume of the titrant exists in the concentration range from##2##22##(2008-10#2)
A linear relationship between the concentration of##3##7##(2008-10#3)
A linear relationship between the##6##5##(2008-10#5)(2010-4#1)
A linear relationship between##9##4##(2008-10#7)(2008-12#1)(2010-4#1)
A linear relationship was found between##2##6##(1995-8#1)(2008-10#1)
A linear relationship was found##3##5##(1995-8#1)(2008-10#2)
A linear relationship was observed between##3##6##(1990-7#1)(2008-10#2)
A linear relationship was obtained between the##2##7##(1990-2#1)(2008-10#1)
A linear relationship was##11##4##(1990-2#1)(1990-7#1)(1995-8#1)(2008-10#8)
A linear relationship##22##3##(1990-2#1)(1990-7#1)(1995-8#1)(2008-10#17)(2008-12#1)(2010-4#1)
A linear response is observed##2##5##(2008-10#2)
A linear response is##3##4##(2008-10#3)
A linear response range of##2##5##(2008-10#2)
A linear response was obtained between the detection limit##2##9##(2008-10#2)
A linear response was obtained##3##5##(2008-10#3)
A linear response was##4##4##(2008-10#4)
A linear response##13##3##(2008-10#13)
A linear working##2##3##(2008-10#2)
A linear##78##2##(1990-2#1)(1990-7#1)(1995-8#2)(2007-11#1)(2008-10#64)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-8#1)(2010-4#1)
A linkage group##2##3##(2008-10#2)
A linkage##3##2##(2008-10#3)
A liquid##10##2##(2008-10#5)(2008-5#1)(2011-1#2)(2011-3#1)(2013-8#1)
A liquid-crystal##4##2##(2007-11#2)(2008-3#2)
A liquid-liquid extraction method using##2##5##(2008-10#2)
A list of##4##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-5#1)
A literature review of##3##4##(2008-12#1)(2009-7#1)(2010-9#1)
A literature review was##2##4##(2008-10#1)(2012-12#1)
A literature review##12##3##(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
A literature search##5##3##(1997-8#1)(2008-10#1)(2008-3#1)(2013-1#2)
A literature##19##2##(1997-8#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
A little##2##2##(1994-3#1)(2010-8#1)
A liver##2##2##(1991-6#1)(2011-2#1)
A local##8##2##(1990-6#1)(1995-6#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
A locus##4##2##(1993-11#1)(1997-5#1)(2008-10#1)(2009-7#1)
A logical##2##2##(1991-5#1)(2008-8#1)
A logistic regression analysis##2##4##(2008-7#1)(2013-8#1)
A logistic regression##5##3##(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
A logistic##6##2##(2007-8#1)(2008-10#2)(2008-7#1)(2013-1#1)(2013-8#1)
A long follow-up##2##3##(1992-6#1)(2012-2#1)
A long##8##2##(1991-12#1)(1992-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#1)
A long-term##6##2##(1993-6#1)(1995-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-8#1)
A longer##4##2##(1990-7#1)(1991-12#1)(1992-9#1)(2008-10#1)
A longitudinal study of the##3##5##(2008-11#1)(2009-7#1)(2010-10#1)
A longitudinal study##4##3##(2007-2#1)(2008-11#1)(2009-7#1)(2010-10#1)
A longitudinal##8##2##(1993-1#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
A look at the##3##4##(1991-3#1)(1995-12#1)(2011-2#1)
A look at##5##3##(1991-3#1)(1995-12#1)(1995-3#1)(2011-2#1)(2012-2#1)
A look back##2##3##(2008-1#1)(2012-3#1)
A look##10##2##(1991-3#1)(1995-12#1)(1995-3#1)(2008-1#2)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
A lookup table of##2##4##(2007-11#1)(2008-3#1)
A lot of##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
A lot##4##2##(1990-6#1)(2007-9#1)(2008-10#1)(2010-8#1)
A low dose##2##3##(2008-4#1)(2008-8#1)
A low temperature##2##3##(2008-10#2)
A low##22##2##(1990-12#1)(1991-2#1)(1992-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
A low-cost##4##2##(1997-3#1)(2008-10#2)(2008-6#1)
A low-dose##2##2##(2008-7#2)
A lower##5##2##(1995-5#1)(2008-10#2)(2008-2#1)(2012-12#1)
A lung##2##2##(1992-3#1)(2012-2#1)
A lyase##2##2##(1990-8#2)
A lymph node biopsy##2##4##(1991-3#1)(2013-1#1)
A m(-2)##2##2##(2009-12#1)(2012-12#1)
A mRNA##2##2##(1993-6#2)
A magnetic resonance imaging scan##2##5##(2006-10#1)(2009-8#1)
A magnetic resonance imaging##4##4##(2006-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
A magnetic resonance##6##3##(1997-8#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
A magnetic##8##2##(1996-12#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
A magneto-optic##2##2##(2007-12#1)(2008-3#1)
A mail survey##2##3##(1991-2#1)(1994-2#1)
A mail##3##2##(1991-2#1)(1994-2#1)(1996-2#1)
A main theme##2##3##(2007-8#1)(2012-3#1)
A major QTL##2##3##(2008-10#1)(2012-3#1)
A major advantage of##2##4##(2008-4#1)(2012-12#1)
A major challenge for##2##4##(2008-11#1)(2008-7#1)
A major challenge in##3##4##(1996-11#1)(2009-12#1)(2010-8#1)
A major challenge##8##3##(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
A major component of##2##4##(1994-1#1)(2008-7#1)
A major focus##3##3##(1996-2#1)(1997-3#1)(2008-9#1)
A major gene for resistance to##2##6##(2008-10#2)
A major gene for##3##4##(2008-10#3)
A major goal##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
A major limitation of##2##4##(2008-11#1)(2010-10#1)
A major limitation##3##3##(1997-1#1)(2008-11#1)(2010-10#1)
A major obstacle to the##2##5##(2008-11#1)(2009-11#1)
A major quantitative trait locus for##2##6##(2008-10#2)
A major reason is that##2##5##(2008-4#1)(2013-1#1)
A major##69##2##(1990-11#1)(1991-9#1)(1992-12#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
A majority of patients##2##4##(2007-7#1)(2008-7#1)
A majority of the##6##4##(1993-2#1)(2008-10#2)(2009-6#1)(2012-12#1)(2013-8#1)
A majority of##17##3##(1992-2#1)(1993-2#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
A majority##19##2##(1992-2#1)(1993-1#1)(1993-2#1)(1995-11#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
A male infant##2##3##(2007-8#2)
A male##3##2##(2007-8#2)(2008-10#1)
A mammalian##3##2##(1992-8#1)(1994-12#1)(2008-11#1)
A man with##2##3##(2012-3#1)(2013-8#1)
A managed care##3##3##(1995-2#1)(1997-2#1)(1997-3#1)
A mapping population of##3##4##(2008-10#3)
A marked##4##2##(1992-3#1)(1993-12#1)(1996-12#1)(2012-12#1)
A marriage##2##2##(1993-2#1)(1995-3#1)
A mass##5##2##(1991-3#1)(2008-10#2)(2008-11#1)(2010-5#1)
A material##2##2##(2007-12#1)(2009-7#1)
A mathematical model for##3##4##(2007-12#1)(2008-7#1)(2013-7#1)
A mathematical model is presented to##2##6##(2008-2#1)(2008-7#1)
A mathematical model is presented##3##5##(2008-2#1)(2008-7#2)
A mathematical model is##4##4##(2008-2#1)(2008-7#3)
A mathematical model of##4##4##(2008-10#1)(2008-7#2)(2013-8#1)
A mathematical model to##2##4##(2008-7#1)(2011-2#1)
A mathematical model##18##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#8)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
A mathematical##24##2##(1992-9#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#9)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
A matrix##2##2##(2007-12#1)(2009-4#1)
A maximal##3##2##(1995-8#1)(2007-12#1)(2013-1#1)
A maximum increase##2##3##(1993-8#1)(2013-1#1)
A maximum output power of##4##5##(2007-12#3)(2008-2#1)
A maximum output##5##3##(2007-12#3)(2008-2#2)
A maximum##22##2##(1993-8#1)(1994-3#1)(1995-6#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2013-1#1)
A may be##3##3##(1990-11#1)(1990-12#1)(1993-8#1)
A may##4##2##(1990-11#1)(1990-12#1)(1993-8#1)(1994-6#1)
A mean##7##2##(1997-8#1)(2008-10#2)(2008-3#2)(2012-2#1)(2012-3#1)
A measure of##2##3##(1993-3#1)(2007-12#1)
A measurement##4##2##(2008-2#1)(2008-3#3)
A mechanical##2##2##(1995-2#1)(2008-3#1)
A mechanism for the##4##4##(1995-2#1)(2008-10#1)(2008-8#1)(2009-6#1)
A mechanism for##8##3##(1992-12#1)(1995-2#2)(1995-8#1)(2008-10#2)(2008-8#1)(2009-6#1)
A mechanism is proposed to##2##5##(1996-5#1)(2008-10#1)
A mechanism is proposed##3##4##(1996-5#1)(2008-10#2)
A mechanism of##3##3##(1992-6#1)(2008-2#1)(2009-8#1)
A mechanism##20##2##(1992-12#1)(1992-6#1)(1995-2#2)(1995-8#1)(1996-5#3)(2008-10#6)(2008-2#1)(2008-8#3)(2009-6#1)(2009-8#1)
A mechanistic##3##2##(2008-10#1)(2009-2#1)(2012-12#1)
A media##2##2##(2010-2#1)(2010-8#1)
A median##2##2##(1992-8#1)(1994-8#1)
A mediator-free##2##2##(2008-10#2)
A medical##6##2##(1990-6#1)(1991-12#1)(1992-5#1)(1996-2#1)(1997-1#1)(2012-3#1)
A meeting of##2##3##(1992-5#1)(1996-3#1)
A membrane##4##2##(1991-5#1)(2008-10#3)
A mentor##2##2##(1993-12#1)(2008-7#1)
A meta-analysis of the##3##4##(1990-9#1)(1992-11#1)(2008-10#1)
A meta-analysis of##7##3##(1990-9#1)(1992-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-1#1)
A meta-analysis was##2##3##(2007-6#1)(2011-2#1)
A meta-analysis##17##2##(1990-9#1)(1992-11#1)(1992-7#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
A metabolic##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
A methanol extract##2##3##(2008-11#2)
A method based on the##3##5##(2008-10#3)
A method based on##13##4##(2008-10#10)(2008-3#1)(2008-5#1)(2010-8#1)
A method developed##2##3##(2008-10#1)(2009-6#1)
A method for calculating the##2##5##(2008-2#1)(2008-3#1)
A method for calculating##3##4##(2008-2#1)(2008-3#2)
A method for detecting##2##4##(1990-2#1)(2008-10#1)
A method for determination of##2##5##(2008-10#2)
A method for determining the##2##5##(2008-3#2)
A method for identifying##2##4##(1995-2#1)(2009-4#1)
A method for improving the##2##5##(2008-3#2)
A method for isolating##2##4##(1994-2#1)(2008-2#1)
A method for measuring##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
A method for obtaining##3##4##(2008-2#1)(2008-3#2)
A method for preconcentrating Zr from large volumes of seawater using MnO(2)-impregnated fibers##2##13##(2008-10#2)
A method for quantifying##2##4##(2008-10#1)(2008-8#1)
A method for simultaneous##2##4##(2008-10#2)
A method for spectrophotometric determination of##2##6##(2008-10#2)
A method for the determination of the##3##7##(1991-5#1)(2008-10#2)
A method for the determination of total##2##7##(2008-10#2)
A method for the determination of trace amounts of##2##9##(2008-10#2)
A method for the determination of##22##6##(1991-5#1)(2008-10#20)(2008-5#1)
A method for the measurement of##2##6##(1990-11#1)(2008-11#1)
A method for the preconcentration and##2##6##(2008-10#2)
A method for the preconcentration##3##5##(2008-10#3)
A method for the preparation of##2##6##(1990-12#1)(2008-11#1)
A method for the simultaneous determination of##3##7##(2008-10#2)(2011-1#1)
A method for the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
A method for the simultaneous##6##5##(2008-10#5)(2011-1#1)
A method for the trace analysis of##2##7##(2008-10#2)
A method for the##52##4##(1990-11#1)(1990-12#1)(1991-5#1)(2008-10#40)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)
A method for##120##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#3)(1992-1#1)(1994-2#1)(1995-2#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#60)(2008-11#3)(2008-2#9)(2008-3#19)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#2)(2013-1#1)
A method has been described for the direct##2##8##(2008-10#2)
A method has been developed for the##2##7##(2008-10#2)
A method has been developed for##5##6##(2008-10#3)(2008-11#1)(2008-3#1)
A method has been developed##6##5##(1992-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
A method has been##8##4##(1992-12#1)(2008-10#5)(2008-11#1)(2008-3#1)
A method is described for the##4##6##(2008-10#2)(2008-2#1)(2012-2#1)
A method is described for##7##5##(2008-10#2)(2008-11#2)(2008-2#2)(2012-2#1)
A method is described##9##4##(1991-2#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2012-2#1)
A method is developed for the##2##6##(2008-10#1)(2008-2#1)
A method is developed for##4##5##(2008-10#2)(2008-2#2)
A method is presented to##2##5##(2008-3#1)(2008-8#1)
A method is presented##3##4##(2008-3#2)(2008-8#1)
A method is proposed for the extraction and individual separation of trivalent gallium##2##13##(2008-10#2)
A method is proposed for the simultaneous determination of##3##9##(2008-10#3)
A method is proposed for the##7##6##(2008-10#7)
A method is proposed for##9##5##(2007-11#1)(2008-10#7)(2008-3#1)
A method is proposed##10##4##(2007-11#1)(2008-10#7)(2008-3#2)
A method is reported##2##4##(1990-2#1)(2008-2#1)
A method is##30##3##(1990-2#1)(1991-2#1)(1995-12#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#1)(2008-8#1)(2012-2#1)
A method of measuring##2##4##(2007-12#2)
A method of producing##2##4##(2007-11#1)(2008-4#1)
A method of##34##3##(1992-2#1)(1993-1#1)(1994-11#1)(2007-11#1)(2007-12#5)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
A method that##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
A method to##10##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-9#1)(2011-1#1)
A method using a##3##4##(2008-10#2)(2011-2#1)
A method using##4##3##(2008-10#3)(2011-2#1)
A method was developed for the determination of##3##8##(2008-10#2)(2011-1#1)
A method was developed for the##5##6##(2008-10#4)(2011-1#1)
A method was developed for##7##5##(2008-10#5)(2008-2#1)(2011-1#1)
A method was developed to##3##5##(1997-2#1)(2008-10#2)
A method was developed##10##4##(1997-2#1)(2008-10#7)(2008-2#1)(2011-1#1)
A method was##11##3##(1997-2#1)(2008-10#7)(2008-2#1)(2011-1#1)(2013-8#1)
A method##247##2##(1990-11#1)(1990-12#2)(1990-2#2)(1991-12#1)(1991-2#1)(1991-5#3)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#7)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#109)(2008-11#8)(2008-12#1)(2008-2#22)(2008-3#41)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
A methodology based on##2##4##(2008-10#1)(2011-2#1)
A methodology for##4##3##(1994-12#1)(2008-10#2)(2008-4#1)
A methodology was developed##2##4##(2007-10#1)(2008-10#1)
A methodology##10##2##(1994-12#1)(2007-10#1)(2008-10#5)(2008-4#1)(2008-6#1)(2011-2#1)
A micellar##2##2##(2008-10#2)
A micro##3##2##(2008-10#2)(2008-8#1)
A microbiological and##2##3##(1990-6#1)(2013-1#1)
A microchip##2##2##(2007-12#1)(2008-10#1)
A microcomputer##2##2##(2008-10#2)
A microdrop of##2##3##(2008-10#2)
A microfabricated##3##2##(2008-10#3)
A microscopic##2##2##(2007-12#1)(2008-10#1)
A microspray nozzle##2##3##(1994-2#2)
A microwave assisted##2##3##(2008-10#1)(2010-5#1)
A microwave digestion##3##3##(2008-10#3)
A microwave##5##2##(2008-10#4)(2010-5#1)
A microwave-assisted##2##2##(2008-10#2)
A middle##3##2##(1993-9#1)(2011-2#1)(2013-1#1)
A middle-aged man##2##3##(2008-11#1)(2012-12#1)
A mild##3##2##(2008-4#1)(2009-5#1)(2010-2#1)
A miniature##2##2##(1994-5#1)(2008-10#1)
A minimal##4##2##(2006-8#1)(2007-12#1)(2008-8#1)(2008-9#1)
A minimally##2##2##(2011-2#1)(2012-2#1)
A minimum detectable absorption##2##4##(2008-3#2)
A minimum detectable##3##3##(2007-12#1)(2008-3#2)
A minimum of##5##3##(1990-9#1)(1992-9#1)(1993-9#1)(2008-10#2)
A minimum##12##2##(1990-9#1)(1992-9#1)(1993-9#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2013-1#1)
A minor procedure? Paediatr Child Health 2007##2##7##(2008-11#2)
A minor procedure?##3##3##(2008-11#3)
A minor##6##2##(1996-11#1)(2008-11#3)(2008-7#1)(2012-12#1)
A mirror##2##2##(2007-11#1)(2008-6#1)
A missense mutation##3##3##(1993-3#1)(1993-6#1)(1994-12#1)
A mitochondrial##2##2##(1992-9#1)(1997-3#1)
A mixed##11##2##(1991-5#2)(1992-8#1)(2008-10#5)(2008-6#1)(2009-9#1)(2012-12#1)
A mixture of TNT##2##4##(2008-10#2)
A mixture of##13##3##(1991-2#1)(1996-5#1)(2008-10#7)(2008-11#2)(2008-7#2)
A mixture##15##2##(1991-2#1)(1996-5#1)(2008-10#9)(2008-11#2)(2008-7#2)
A model analysis##2##3##(2008-3#1)(2008-7#1)
A model based on##4##4##(2007-11#2)(2008-10#1)(2008-7#1)
A model for the solution structure of##2##7##(1994-5#2)
A model for the##8##4##(1994-5#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
A model for##22##3##(1990-8#1)(1992-6#2)(1994-3#1)(1994-5#2)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2011-2#1)
A model is proposed for##2##5##(1990-8#1)(1996-2#1)
A model is proposed##4##4##(1990-2#1)(1990-8#1)(1996-2#1)(2007-11#1)
A model is##7##3##(1990-2#1)(1990-8#1)(1996-2#2)(2007-11#1)(2008-2#1)(2008-8#1)
A model of movement dysfunction provides a classification system guiding diagnosis and therapeutic care in spinal pain and related musculoskeletal syndromes##2##21##(2008-12#2)
A model of the complex##2##5##(2008-1#1)(2008-10#1)
A model of the##9##4##(1990-6#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-8#2)(2009-9#1)
A model of##20##3##(1990-6#1)(1991-1#1)(1992-4#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-9#1)
A model system for##2##4##(2008-6#1)(2009-8#1)
A model system##3##3##(1995-9#1)(2008-6#1)(2009-8#1)
A model that takes into account##2##6##(2008-2#1)(2009-2#1)
A model to##2##3##(1994-5#1)(1997-4#1)
A model was developed to##2##5##(2008-10#1)(2008-3#1)
A model was developed##6##4##(2008-10#3)(2008-3#3)
A model##85##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-8#1)(1994-3#2)(1994-5#4)(1994-9#1)(1995-3#1)(1995-9#1)(1996-2#3)(1996-3#1)(1997-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#3)(2008-2#3)(2008-3#10)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
A model-based approach##2##3##(2008-10#1)(2013-8#1)
A modeling##2##2##(1994-3#1)(2008-2#1)
A modern##5##2##(1991-8#1)(2008-3#2)(2012-12#1)(2013-1#1)
A modification of the##8##4##(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)
A modification of this##2##4##(2008-2#2)
A modification of##12##3##(1994-8#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#2)(2008-9#1)
A modified##33##2##(1990-12#1)(1991-12#1)(1993-1#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-5#1)(2007-11#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#2)(2009-10#2)(2010-3#1)(2013-7#1)
A modular##2##2##(2011-2#2)
A moiety##2##2##(2011-1#1)(2011-2#1)
A molecular marker##2##3##(2008-10#2)
A molecular##11##2##(1991-5#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-7#2)(2011-2#3)
A monoclonal antibody against##2##4##(1995-6#1)(1997-1#1)
A monoclonal antibody to##2##4##(1995-12#1)(2008-11#1)
A monoclonal antibody##10##3##(1992-3#2)(1992-8#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-6#1)
A monoclonal##11##2##(1992-3#2)(1992-5#1)(1992-8#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-6#1)
A more complete understanding of##3##5##(2008-4#1)(2008-8#1)(2011-1#1)
A more complete##6##3##(1990-12#1)(1990-7#1)(2008-4#2)(2008-8#1)(2011-1#1)
A more objective##2##3##(1997-4#1)(2008-10#1)
A more##33##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1992-8#1)(1993-3#1)(1994-7#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
A morphological study##2##3##(2008-7#1)(2011-2#1)
A morphological##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
A morphometric study of##2##4##(1995-6#1)(2012-3#1)
A mouse##4##2##(1994-2#1)(1996-12#1)(2008-4#1)(2008-9#1)
A much higher##3##3##(1991-9#1)(1995-8#1)(2006-8#1)
A much##4##2##(1991-9#1)(1995-8#1)(2006-8#1)(2008-11#1)
A multi-center##2##2##(1997-7#1)(2008-11#1)
A multi-method##2##2##(2008-11#1)(2008-12#1)
A multicenter##3##2##(1990-12#1)(2007-7#1)(2008-5#1)
A multicentre study##2##3##(1990-3#1)(2008-5#1)
A multicentre##3##2##(1990-3#1)(2008-3#1)(2008-5#1)
A multichannel##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A multicommutated##3##2##(2008-10#3)
A multicommutation-based##2##2##(2008-10#2)
A multicommuted flow system for##2##5##(2008-10#2)
A multicommuted flow system##3##4##(2008-10#3)
A multidisciplinary approach is##2##4##(2009-4#1)(2011-2#1)
A multidisciplinary approach##6##3##(1991-3#1)(1994-1#1)(1994-3#1)(2009-4#1)(2011-2#2)
A multidisciplinary program##2##3##(1993-2#1)(2013-8#1)
A multidisciplinary team was##2##4##(2012-8#1)(2013-1#1)
A multidisciplinary##14##2##(1991-3#1)(1991-6#1)(1993-2#1)(1994-1#1)(1994-3#1)(1996-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-8#1)(2013-1#1)(2013-8#1)
A multifaceted##2##2##(2008-8#1)(2012-3#1)
A multifunctional##2##2##(1995-3#1)(2010-5#1)
A multilayer##3##2##(2008-2#1)(2008-3#2)
A multilevel##3##2##(2008-12#1)(2012-12#1)(2013-8#1)
A multimodal##3##2##(2007-8#1)(2012-2#2)
A multiple regression model##3##4##(1992-1#1)(2008-10#1)(2013-1#1)
A multivariate##8##2##(1990-8#1)(1991-3#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-5#1)
A multiwavelength spectrophotometric##2##3##(2008-10#2)
A multiwavelength##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
A murine model of##3##4##(2006-10#1)(2008-4#1)(2010-6#1)
A murine##7##2##(1992-12#1)(1992-8#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-6#1)
A mutant##9##2##(1991-9#1)(1992-6#1)(1995-2#2)(1995-5#1)(1995-6#1)(2008-9#2)(2013-1#1)
A mutation in the##2##4##(1990-11#1)(1995-2#1)
A mutation in##4##3##(1990-11#1)(1995-12#1)(1995-2#1)(1997-2#1)
A mutation of residue at##2##5##(1994-11#2)
A mutation##8##2##(1990-11#1)(1991-12#1)(1994-11#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)
A myriad of##2##3##(1996-2#1)(2008-6#1)
A narrative analysis of the interviews was performed and provided insights into the nature of their spiritual experiences##2##18##(2013-1#2)
A narrow##3##2##(1997-3#1)(2008-11#1)(2008-3#1)
A national consensus on approved and validated instruments for nursing assessment should be made available in the wards as a priority##2##21##(2013-1#2)
A national survey##2##3##(1991-11#1)(1991-12#1)
A national##13##2##(1991-11#1)(1991-12#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
A natural##5##2##(1994-12#1)(1997-6#1)(2008-10#2)(2008-7#1)
A naturally occurring##4##3##(1992-12#1)(1994-11#1)(2008-10#1)(2010-2#1)
A naturally##5##2##(1992-12#1)(1994-11#1)(1995-9#1)(2008-10#1)(2010-2#1)
A near-infrared##2##2##(2008-3#2)
A nearly##2##2##(2008-10#1)(2008-4#1)
A nebulizer system##2##3##(1995-3#2)
A negative correlation between##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
A negative correlation was found between the##2##7##(1996-12#1)(2008-11#1)
A negative correlation##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
A negative effect of##2##4##(1992-11#1)(2008-10#1)
A negative##14##2##(1992-11#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
A neighbor-joining##2##2##(2008-12#1)(2013-8#1)
A neonatal##2##2##(2008-10#1)(2013-7#1)
A neonate with a challenging##2##5##(2013-8#2)
A nephropathy##3##2##(2008-8#2)(2013-1#1)
A nested##3##2##(2008-10#2)(2008-12#1)
A net drop in##2##4##(2008-12#2)
A network of##4##3##(1990-6#1)(2007-12#2)(2011-2#1)
A network##5##2##(1990-6#1)(1996-1#1)(2007-12#2)(2011-2#1)
A neural network model##2##4##(2008-11#1)(2008-8#1)
A neural##4##2##(2008-11#2)(2008-8#1)(2009-5#1)
A new PVC membrane##2##4##(2008-10#2)
A new algorithm for##3##4##(2008-10#1)(2008-3#2)
A new algorithm##5##3##(2008-10#1)(2008-3#3)(2013-8#1)
A new amperometric biosensor##2##4##(2008-10#2)
A new amperometric##3##3##(2008-10#3)
A new analytical method for the determination of##3##8##(2008-10#3)
A new analytical method for the##4##6##(2008-10#4)
A new analytical method##5##4##(2008-10#5)
A new analytical procedure for the##2##6##(2008-10#2)
A new analytical procedure##3##4##(2008-10#3)
A new analytical##9##3##(2008-10#8)(2010-11#1)
A new and simple method##2##5##(2008-10#2)
A new and##9##3##(1992-6#1)(1992-9#1)(2008-10#6)(2008-3#1)
A new antibody immobilization strategy##2##5##(2008-10#2)
A new application of##3##4##(2008-10#2)(2008-11#1)
A new approach for developing##2##5##(2007-12#1)(2008-10#1)
A new approach for##7##4##(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)
A new approach has been developed and##2##7##(2008-10#1)(2008-11#1)
A new approach to the##2##5##(2008-10#1)(2012-2#1)
A new approach to##17##4##(1992-1#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#3)(2011-1#1)(2012-2#1)
A new approach##31##3##(1992-1#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
A new bulk acoustic wave (BAW)##2##6##(2008-10#2)
A new capillary electrophoresis (CE)##2##5##(2008-10#2)
A new case of##2##4##(1990-12#1)(2007-12#1)
A new catalytic kinetic##2##4##(2008-10#2)
A new catalytic##3##3##(2008-10#3)
A new chelating polymeric sorbent has been developed using Merrifield chloromethylated resin anchored with##2##14##(2008-10#2)
A new chelating polymeric sorbent##4##5##(2008-10#4)
A new chelating resin##3##4##(2008-10#3)
A new chelating##10##3##(2008-10#10)
A new chemiluminescence (CL) method##2##5##(2008-10#2)
A new chemiluminescence (CL)##3##4##(2008-10#3)
A new class of##11##4##(1994-9#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-9#1)(2010-4#1)
A new concept for##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
A new design for an##2##5##(2008-3#2)
A new design##3##3##(2008-10#1)(2008-3#2)
A new device##3##3##(1995-1#2)(2008-5#1)
A new electrochemical immunoassay strategy##2##5##(2008-10#2)
A new electrochemical##3##3##(2008-10#3)
A new era##3##3##(1991-2#1)(1994-3#1)(1997-2#1)
A new experimental method##2##4##(2008-3#2)
A new experimental##4##3##(2008-3#2)(2008-5#1)(2008-9#1)
A new family of##3##4##(1996-5#1)(2008-12#1)(2008-2#1)
A new flavone glycoside##2##4##(1994-11#2)
A new flow injection on-line##2##5##(2008-10#2)
A new flow injection##6##4##(2008-10#6)
A new flow##7##3##(2008-10#7)
A new flow-injection##2##3##(2008-10#2)
A new functionalized resin##2##4##(2008-10#2)
A new functionalized##3##3##(2008-10#3)
A new gene##4##3##(1993-3#1)(2008-10#1)(2008-8#2)
A new general##2##3##(1994-3#1)(2008-3#1)
A new generation of##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
A new genus##2##3##(2008-5#1)(2010-10#1)
A new graphical method##2##4##(1995-12#1)(2008-10#1)
A new highly sensitive and selective chromogenic reagent##2##8##(2008-10#2)
A new highly sensitive##3##4##(2008-10#3)
A new highly##4##3##(2008-10#4)
A new image##2##3##(2008-3#2)
A new instrument##3##3##(2008-3#2)(2009-3#1)
A new ion-selective##2##3##(2008-10#2)
A new kind of##2##4##(2008-10#2)
A new kinetic##2##3##(2008-10#2)
A new laser##2##3##(1992-12#1)(2008-2#1)
A new look at##3##4##(1996-2#1)(2008-4#1)(2008-9#1)
A new measure of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
A new mechanism of##3##4##(1992-8#1)(2008-5#1)(2008-8#1)
A new method for determination of##2##6##(2008-10#2)
A new method for the cytofluorimetric analysis of mitochondrial membrane potential##2##11##(1993-11#2)
A new method for the determination of##9##7##(2008-10#8)(2008-3#1)
A new method for the##19##5##(1993-11#2)(1993-8#1)(2008-10#14)(2008-3#1)(2008-5#1)
A new method for##36##4##(1990-12#1)(1993-11#2)(1993-8#1)(1994-11#1)(1995-3#1)(2007-12#1)(2008-10#22)(2008-3#5)(2008-5#2)
A new method has been developed##3##6##(2008-10#2)(2008-6#1)
A new method has been##5##5##(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)
A new method is described for determining the##2##8##(1990-11#1)(2007-12#1)
A new method is described for##3##6##(1990-11#1)(2007-12#1)(2008-10#1)
A new method is presented##2##5##(2008-10#1)(2008-2#1)
A new method is proposed##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
A new method is##8##4##(1990-11#1)(2007-12#2)(2008-10#3)(2008-2#2)
A new method of preparing fiber-optic DNA biosensor and its array for##2##12##(2008-9#2)
A new method of##10##4##(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#2)(2008-9#2)
A new method to##7##4##(1993-3#1)(2008-10#2)(2008-3#2)(2008-5#2)
A new method using a microcolumn packed with##2##8##(2008-10#2)
A new method using a##3##5##(2008-10#3)
A new method using##5##4##(2008-10#5)
A new method was developed##2##5##(2008-10#2)
A new method##80##3##(1990-11#1)(1990-12#1)(1990-2#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-3#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#42)(2008-2#2)(2008-3#11)(2008-5#4)(2008-6#1)(2008-9#2)
A new micelle-mediated phase separation of metal ions##2##8##(2008-10#2)
A new mobile##2##3##(1995-8#1)(2011-3#1)
A new model for##4##4##(1991-7#1)(1994-12#1)(2008-12#1)(2008-9#1)
A new model of##2##4##(2008-8#1)(2010-6#1)
A new model##7##3##(1991-7#1)(1994-12#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-6#1)
A new numerical##2##3##(2008-3#1)(2009-11#1)
A new optical##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
A new pH-metric method##2##4##(2008-10#2)
A new paradigm for##3##4##(1993-2#1)(2008-4#1)(2013-1#1)
A new phase-shifting##2##3##(2008-3#2)
A new phase-unwrapping algorithm based on##2##6##(2008-3#2)
A new potentiometric##2##3##(2008-10#2)
A new preparation##2##3##(1994-11#1)(2008-11#1)
A new procedure for##2##4##(2008-10#2)
A new procedure is presented for##2##6##(2008-10#1)(2008-3#1)
A new procedure is##3##4##(2008-10#2)(2008-3#1)
A new procedure##7##3##(2008-10#6)(2008-3#1)
A new program##2##3##(1991-2#1)(2008-8#1)
A new protocol##2##3##(2007-11#1)(2008-10#1)
A new rapid and##2##4##(1994-5#1)(2008-10#1)
A new resin##2##3##(2008-10#2)
A new sample preparation procedure##2##5##(2008-10#2)
A new sample preparation##3##4##(2008-10#3)
A new sandwich-ELISA##2##3##(1990-12#2)
A new scheme for##2##4##(2008-3#2)
A new scheme##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
A new selenite##2##3##(2008-10#2)
A new sensitive##10##3##(1990-2#1)(1995-11#1)(1996-5#1)(2008-10#7)
A new sequential injection##2##4##(2008-10#2)
A new series of##3##4##(1991-9#1)(1996-6#1)(2008-11#1)
A new simple and reliable method##2##6##(2008-10#2)
A new simple and##5##4##(2008-10#5)
A new simple##8##3##(2008-10#8)
A new solid-phase##2##3##(1995-6#1)(2008-10#1)
A new species of the##2##5##(2008-5#1)(2008-6#1)
A new species of##4##4##(2008-5#2)(2008-6#2)
A new spectrofluorimetric##2##3##(2008-10#2)
A new spectrophotometric method##2##4##(2008-10#2)
A new strategy for##5##4##(1995-3#1)(2008-10#4)
A new strategy##6##3##(1995-3#1)(2008-10#5)
A new study of the##2##5##(2008-10#2)
A new study##3##3##(1994-8#1)(2008-10#2)
A new technique for##9##4##(1990-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2013-1#1)
A new technique is presented for##2##6##(2008-10#1)(2008-2#1)
A new technique##15##3##(1990-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2013-1#1)
A new theoretical##2##3##(2008-3#2)
A new tool for##2##4##(2008-6#1)(2011-2#1)
A new tool##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
A new treatment##2##3##(1994-6#1)(1996-8#1)
A new type of a##3##5##(2007-12#1)(2008-10#2)
A new type of##20##4##(1990-12#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-11#1)(2012-3#1)
A new way to##3##4##(1995-12#1)(2008-6#1)(2013-7#1)
A new way##4##3##(1995-12#1)(2008-6#2)(2013-7#1)
A new##703##2##(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#19)(2007-12#28)(2007-7#3)(2007-8#7)(2008-10#291)(2008-11#20)(2008-12#6)(2008-2#25)(2008-3#77)(2008-4#2)(2008-5#19)(2008-6#10)(2008-7#6)(2008-8#11)(2008-9#7)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#2)(2012-1#1)(2012-2#4)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#5)
A newer##2##2##(2008-10#1)(2008-5#1)
A newly developed##2##3##(1991-1#1)(2008-10#1)
A newly synthesized##2##3##(2008-10#2)
A newly##8##2##(1991-1#1)(1997-8#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#1)
A nine-year-old##2##2##(2007-12#1)(2008-1#1)
A noise##2##2##(2008-2#1)(2008-3#1)
A noise-equivalent##3##2##(2008-3#2)(2009-5#1)
A non##2##2##(2010-5#1)(2013-8#1)
A non-ionic##2##2##(2008-10#2)
A noncollinear##2##2##(2008-2#1)(2008-3#1)
A nonlinear##5##2##(2007-12#1)(2008-3#4)
A normal##3##2##(1992-10#1)(2010-4#1)(2011-2#1)
A normalized##2##2##(2008-10#1)(2013-8#1)
A not##2##2##(2008-10#1)(2008-7#1)
A notable advantage of the method is that##2##8##(2008-10#1)(2008-3#1)
A notable feature##2##3##(1992-3#1)(1996-6#1)
A notable##4##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-3#1)
A note from NIDA's##2##4##(2008-6#2)
A note on##3##3##(1992-9#1)(2007-12#1)(2008-12#1)
A note##6##2##(1992-9#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-6#2)
A novel [99m]technetium-labeled##2##3##(1993-6#2)
A novel analytical##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
A novel and simple##3##4##(2007-12#1)(2008-10#2)
A novel and##8##3##(2007-12#1)(2008-10#6)(2008-9#1)
A novel approach for##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
A novel approach to##6##4##(1995-9#1)(2007-11#1)(2008-10#3)(2012-12#1)
A novel approach##15##3##(1993-11#1)(1993-8#1)(1995-9#1)(2007-11#1)(2008-10#6)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
A novel biosensor for##2##4##(2008-10#2)
A novel capillary microliter##2##4##(2008-10#2)
A novel capillary##3##3##(2008-10#3)
A novel chemiluminescence (CL) flow system for the determination of##2##10##(2008-10#2)
A novel chemiluminescence (CL) system for##2##6##(2008-10#2)
A novel chemiluminescence (CL) system##4##5##(2008-10#4)
A novel chemiluminescence (CL)##9##4##(2008-10#9)
A novel chemiluminescence##10##3##(2008-10#10)
A novel class of##2##4##(1990-7#1)(2007-12#1)
A novel concept##2##3##(2007-11#1)(2007-12#1)
A novel design##2##3##(2007-12#1)(2010-8#1)
A novel electrochemical sensor##2##4##(2008-10#2)
A novel electrochemical##3##3##(2008-10#3)
A novel ex vivo technique##2##5##(2008-5#2)
A novel feeding strategy##2##4##(2008-7#2)
A novel film##2##3##(2008-10#2)
A novel flow##3##3##(1990-12#1)(2008-10#2)
A novel flow-injection chemiluminescence##2##4##(2008-10#2)
A novel flow-injection##4##3##(2008-10#4)
A novel fluorescent##4##3##(1992-3#1)(1992-9#1)(2008-10#2)
A novel gene encoding a##2##5##(1992-9#1)(1997-7#1)
A novel gene##3##3##(1992-9#1)(1995-8#1)(1997-7#1)
A novel hybrid##2##3##(2007-11#1)(2008-7#1)
A novel in vitro technique##2##5##(2008-5#2)
A novel kinetic##2##3##(2008-10#2)
A novel mechanism##2##3##(1990-5#1)(1997-3#1)
A novel method for determination of##2##6##(2008-10#2)
A novel method for storage of medical records and documents##2##10##(1994-3#2)
A novel method for the determination of##4##7##(2007-11#1)(2008-10#3)
A novel method for the##9##5##(2007-11#1)(2008-10#6)(2008-8#1)(2009-11#1)
A novel method for##26##4##(1994-3#2)(1995-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#11)(2008-3#2)(2008-8#2)(2009-11#1)(2010-6#1)(2010-8#1)
A novel method is described for##2##6##(2007-12#1)(2008-10#1)
A novel method is proposed for the##2##7##(2008-10#2)
A novel method is##6##4##(2007-12#1)(2008-10#3)(2008-3#2)
A novel method of##3##4##(2008-10#2)(2011-2#1)
A novel method##38##3##(1994-3#2)(1995-3#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#16)(2008-3#5)(2008-6#1)(2008-8#2)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#1)
A novel optical##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
A novel potentiometric##2##3##(2008-10#2)
A novel procedure##3##3##(2008-10#2)(2008-6#1)
A novel scheme for##2##4##(2007-11#2)
A novel sensitive##2##3##(2008-10#2)
A novel simple##2##3##(2008-10#1)(2008-5#1)
A novel spectrofluorimetric##2##3##(2008-10#2)
A novel spectrophotometric##2##3##(2008-10#2)
A novel stopped flow injection-amperometric##2##5##(2008-10#2)
A novel strategy for##2##4##(2008-10#1)(2008-8#1)
A novel strategy##4##3##(2007-11#1)(2008-10#2)(2008-8#1)
A novel synthesis##2##3##(2007-11#1)(2012-2#1)
A novel system for##2##4##(2008-3#2)
A novel system##3##3##(2008-3#2)(2012-3#1)
A novel technique for##6##4##(1990-5#1)(2007-11#2)(2007-12#3)
A novel technique to##3##4##(2008-3#1)(2008-9#1)(2010-8#1)
A novel technique##12##3##(1990-5#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)
A novel tetrachlorothallate##2##3##(2008-10#2)
A novel thin-layer amperometric detector##2##5##(2008-10#2)
A novel transthyretin##2##3##(1992-8#2)
A novel##381##2##(1990-11#1)(1990-12#1)(1990-5#5)(1990-7#2)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-3#2)(1995-8#2)(1995-9#1)(1996-2#2)(1996-5#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#30)(2007-12#19)(2007-7#2)(2007-8#1)(2008-10#142)(2008-11#8)(2008-12#2)(2008-2#16)(2008-3#37)(2008-5#6)(2008-6#6)(2008-7#6)(2008-8#14)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
A nuclear##3##2##(1992-1#1)(1995-11#1)(2008-7#1)
A nucleotide sequence##2##3##(1995-6#1)(2008-9#1)
A nulling##2##2##(2007-11#2)
A number of cell##2##4##(1992-3#1)(1992-8#1)
A number of factors##3##4##(1992-6#1)(2008-12#1)(2012-2#1)
A number of key##2##4##(1992-8#1)(2008-8#1)
A number of methods have##2##5##(2008-10#1)(2008-2#1)
A number of new crown-formazans with 14 and 15 membered rings have been##2##13##(2008-10#2)
A number of other##2##4##(1990-11#1)(1994-12#1)
A number of regulatory##2##4##(2008-10#1)(2010-10#1)
A number of studies have##3##5##(1992-2#1)(2008-11#1)(2008-12#1)
A number of studies##4##4##(1992-2#1)(2008-11#1)(2008-12#1)(2009-3#1)
A number of synthetic peptides are significant commercial or pharmaceutical products##2##11##(2008-4#2)
A number of these##2##4##(1997-8#1)(2007-11#1)
A number of##119##3##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-12#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#20)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-4#1)(2013-8#1)
A numerical analysis##2##3##(2008-3#2)
A numerical method was used##2##5##(2008-3#1)(2009-6#1)
A numerical model is developed##2##5##(2008-3#2)
A numerical model that##2##4##(2008-3#2)
A numerical model##8##3##(1990-11#1)(2008-3#7)
A numerical simulation##2##3##(2007-11#1)(2008-3#1)
A numerical study##2##3##(2008-10#1)(2013-8#1)
A numerical##20##2##(1990-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#13)(2009-6#1)(2013-8#1)
A nursing##2##2##(1991-2#1)(2008-11#1)
A of applied current##2##4##(2008-10#2)
A of the##4##3##(1990-5#1)(1994-5#1)(2007-6#1)(2008-3#1)
A of##8##2##(1990-5#1)(1994-5#1)(1995-5#1)(2007-6#1)(2008-10#2)(2008-3#2)
A on the##4##3##(1992-6#1)(2008-3#1)(2008-4#1)(2011-1#1)
A on##7##2##(1992-12#1)(1992-6#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
A one year##2##3##(2011-1#1)(2013-1#1)
A one##3##2##(2009-10#1)(2011-1#1)(2013-1#1)
A one-dimensional##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
A one-step reverse transcription-polymerase chain reaction (RT-PCR)##2##7##(2008-10#1)(2008-9#1)
A one-step reverse transcription-polymerase chain reaction##3##6##(2008-10#2)(2008-9#1)
A one-step##5##2##(1990-12#1)(2008-10#3)(2008-9#1)
A one-year##2##2##(2007-12#1)(2010-8#1)
A or B##9##3##(1993-11#1)(1997-5#4)(1997-6#1)(2008-10#2)(2008-9#1)
A or B)##2##3##(1994-5#1)(1997-6#1)
A or##28##2##(1990-11#1)(1990-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-8#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#2)(2007-2#1)(2008-10#4)(2008-4#2)(2008-8#1)(2008-9#1)
A pH##3##2##(2008-10#3)
A pKa of##2##3##(1990-8#1)(1995-5#1)
A pair of well-defined redox waves##2##6##(2008-10#2)
A pair of##16##3##(1991-12#1)(1991-6#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-8#1)(2011-3#1)(2013-8#1)
A panel data##2##3##(2008-7#1)(2009-11#1)
A panel of##10##3##(1991-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-6#1)(2007-12#2)(2008-10#2)(2008-5#1)
A panel##12##2##(1991-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-6#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)
A paradigm shift in##2##4##(1996-2#1)(2012-1#1)
A paradigm shift##4##3##(1996-2#1)(2010-3#1)(2012-1#1)(2013-1#1)
A paradigm##5##2##(1996-2#1)(2008-11#1)(2010-3#1)(2012-1#1)(2013-1#1)
A paradox##2##2##(2012-3#1)(2013-8#1)
A parallel##9##2##(1994-8#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
A parameter##2##2##(2010-9#1)(2013-1#1)
A parent##2##2##(2008-11#1)(2008-12#1)
A parent's perspective##2##3##(1991-3#1)(1992-3#1)
A parent's##3##2##(1991-3#1)(1992-3#1)(2008-11#1)
A part of the##3##4##(1992-12#1)(2008-11#1)(2011-3#1)
A partial cDNA##2##3##(1993-6#1)(1995-2#1)
A partial least squares##2##4##(2008-10#2)
A partial response##2##3##(1992-10#1)(1992-12#1)
A partial##21##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
A partially##4##2##(1995-5#1)(1997-3#1)(2007-11#1)(2008-3#1)
A particular emphasis##2##3##(2007-6#1)(2013-8#1)
A particular##8##2##(1990-11#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
A particularly##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
A passive##3##2##(2008-10#2)(2008-2#1)
A path##2##2##(2008-8#1)(2009-7#1)
A patient who developed##2##4##(2007-12#1)(2008-8#1)
A patient who had##2##4##(1990-3#1)(2008-9#1)
A patient who##9##3##(1990-3#1)(1992-3#1)(1992-9#1)(2007-12#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
A patient with a##2##4##(2007-8#2)
A patient with##16##3##(1990-12#1)(1991-12#1)(1991-4#1)(1993-9#1)(1994-9#1)(1996-9#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#1)
A patient##38##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-9#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
A patients##6##2##(1990-2#1)(2008-1#3)(2010-7#1)(2012-12#1)
A pattern of##2##3##(2008-7#1)(2010-8#1)
A pattern##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
A paucity of##2##3##(2009-11#1)(2013-1#1)
A peak##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
A peculiar##2##2##(1990-5#1)(2008-5#1)
A pediatric##2##2##(2011-2#1)(2013-1#1)
A peptide that##2##3##(1990-2#1)(2008-6#1)
A peptide##6##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-9#1)(2008-6#1)
A period of##2##3##(2008-5#2)
A periodic##2##2##(2007-11#1)(2012-3#1)
A permanent##4##2##(1991-11#1)(1991-6#1)(1996-1#1)(2008-5#1)
A person##2##2##(2012-12#1)(2013-1#1)
A personal perspective on##2##4##(1993-12#1)(2008-11#1)
A personal perspective##3##3##(1993-12#1)(2008-11#2)
A personal view of##2##4##(1994-12#1)(1995-12#1)
A personal##7##2##(1993-12#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-11#3)
A perspective of##2##3##(2008-1#1)(2008-10#1)
A perspective on management development in##2##6##(1994-1#2)
A perspective on##4##3##(1994-1#2)(1995-5#1)(2007-12#1)
A perspective##6##2##(1994-1#2)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)
A perturbation##2##2##(2008-2#1)(2010-10#1)
A phantom##2##2##(2007-4#1)(2008-3#1)
A phase I study##2##4##(1992-10#1)(2008-5#1)
A phase I##4##3##(1992-10#1)(2008-5#3)
A phase II study##3##4##(1992-2#1)(1993-2#1)(2007-4#1)
A phase II trial##3##4##(2008-5#3)
A phase II##7##3##(1992-2#1)(1993-2#1)(2007-4#1)(2008-5#4)
A phase III##2##3##(1997-8#1)(2008-7#1)
A phase modulator##2##3##(2007-11#1)(2007-12#1)
A phase##22##2##(1992-10#1)(1992-2#1)(1993-2#1)(1993-8#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-2#3)(2008-5#7)(2008-7#1)(2012-2#1)
A phase-shifting interferometer records##2##4##(2008-3#2)
A phase-stepping##2##2##(2007-11#1)(2008-3#1)
A phenetic analysis##2##3##(2008-10#1)(2008-5#1)
A phenomenological study##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
A phenomenological##9##2##(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
A phloem-restricted##2##2##(2008-10#2)
A photoacoustic##4##2##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
A photochemical##2##2##(2008-10#2)
A photorefractive##2##2##(2008-2#2)
A phylogenetic analysis of##2##4##(2008-10#2)
A phylogenetic analysis##3##3##(2008-10#2)(2008-5#1)
A phylogenetic tree##4##3##(1997-7#1)(2008-10#3)
A phylogenetic##9##2##(1997-7#1)(2007-12#1)(2008-10#5)(2008-5#1)(2010-6#1)
A physical map of##2##4##(1996-10#1)(1996-3#1)
A physical map##3##3##(1996-10#2)(1996-3#1)
A physical##10##2##(1996-10#2)(1996-3#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
A piezoelectric##5##2##(2008-10#4)(2008-3#1)
A pilot study of##3##4##(2009-12#1)(2010-12#1)(2010-7#1)
A pilot study was##3##4##(1991-12#1)(1997-1#1)(2008-10#1)
A pilot study##12##3##(1990-6#1)(1991-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-7#1)(2013-1#2)(2013-8#1)
A pilot##19##2##(1990-6#1)(1991-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-2#1)(2013-1#4)(2013-8#1)
A pioneer##2##2##(1991-6#1)(2007-8#1)
A place##3##2##(1991-12#1)(1997-3#1)(2009-5#1)
A placebo-controlled##3##2##(1991-2#1)(2008-5#1)(2012-3#1)
A planar waveguide##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2010-5#1)
A planar##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2010-5#1)
A plasmid##6##2##(1990-5#1)(1992-9#1)(1995-2#1)(2008-11#2)(2008-2#1)
A platinum##2##2##(1993-11#1)(2008-10#1)
A plausible##3##2##(1993-6#1)(1997-2#1)(2008-3#1)
A plot of##4##3##(1991-5#1)(1994-12#1)(1995-5#1)(1997-2#1)
A point mutation in the##2##5##(1990-12#1)(1994-8#1)
A point mutation in##3##4##(1990-12#1)(1994-8#1)(2008-1#1)
A point mutation##5##3##(1990-12#1)(1992-8#1)(1994-8#1)(1996-2#1)(2008-1#1)
A point source##2##3##(2008-2#1)(2008-3#1)
A point##8##2##(1990-12#1)(1992-8#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
A polarization##2##2##(2008-3#2)
A polarized##2##2##(2007-12#1)(2008-3#1)
A polarographic##2##2##(2008-10#2)
A policy##3##2##(2007-8#1)(2009-4#1)(2013-1#1)
A polyclonal antibody raised against##2##5##(1995-2#1)(2007-12#1)
A polyclonal antibody##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
A polyclonal##5##2##(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#2)
A polyethylene glycol##2##3##(1990-12#1)(2008-10#1)
A polyethylene##3##2##(1990-12#1)(2008-10#2)
A polymerase chain reaction (PCR)##3##5##(1996-12#1)(2008-10#2)
A polymerase chain reaction (PCR)-based method##2##6##(2008-10#2)
A polymerase chain reaction (PCR)-based##3##5##(2008-10#3)
A polymerase chain reaction##8##4##(1996-12#1)(2008-10#7)
A polymerase chain##11##3##(1996-12#1)(2008-10#10)
A pool of##2##3##(1990-5#1)(2008-9#1)
A population of##9##3##(1991-11#1)(1991-12#1)(2008-10#6)(2008-2#1)
A population##11##2##(1991-11#1)(1991-12#1)(2008-10#6)(2008-2#1)(2008-5#1)(2013-1#1)
A population-based case-control study of##3##5##(1992-10#3)
A population-based study##2##3##(2007-12#1)(2008-11#1)
A population-based##7##2##(1992-10#3)(2007-12#1)(2008-11#1)(2008-6#1)(2010-12#1)
A porous##3##2##(1994-5#1)(2008-10#2)
A portable and##2##3##(2008-10#1)(2012-12#1)
A portable##4##2##(2008-10#3)(2012-12#1)
A portion of the##6##4##(1991-2#1)(1993-1#1)(1993-11#1)(1994-6#1)(2008-10#2)
A portion of##10##3##(1991-2#1)(1993-1#1)(1993-11#1)(1994-6#1)(1994-8#1)(2008-10#3)(2008-12#1)(2008-5#1)
A positive correlation was found between##2##6##(2008-10#1)(2008-8#1)
A positive correlation was observed between##2##6##(1995-12#1)(2008-1#1)
A positive correlation was##5##4##(1995-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)
A positive correlation##6##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
A positive test##2##3##(1990-2#1)(1990-5#1)
A positive##22##2##(1990-2#1)(1990-5#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-3#1)(1997-5#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#2)(2011-2#1)(2013-1#1)
A possible explanation is##2##4##(2008-3#1)(2008-7#1)
A possible explanation##5##3##(1995-8#1)(1996-12#1)(2008-3#1)(2008-7#1)(2010-1#1)
A possible mechanism for the##2##5##(2008-10#2)
A possible mechanism for##4##4##(2007-11#1)(2008-10#2)(2010-4#1)
A possible mechanism of the extraction is discussed##2##8##(2008-10#2)
A possible mechanism of the##3##5##(2008-10#3)
A possible mechanism of##4##4##(2008-10#4)
A possible mechanism##9##3##(1992-4#1)(2007-11#1)(2008-10#6)(2010-4#1)
A possible new##2##3##(1990-8#2)
A possible relationship between##2##4##(1992-2#1)(1993-12#1)
A possible role##2##3##(2006-12#1)(2008-12#1)
A possible##41##2##(1990-8#3)(1991-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-8#1)(1996-12#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#3)(2008-2#2)(2008-3#2)(2008-7#3)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)
A post hoc##2##3##(2009-2#1)(2009-8#1)
A postal questionnaire was##2##4##(1995-5#1)(2007-2#1)
A postal questionnaire##3##3##(1995-5#1)(2007-2#1)(2008-1#1)
A postal survey was sent to##2##6##(2011-2#1)(2012-2#1)
A postal survey was##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
A postal survey##4##3##(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
A postal##7##2##(1995-5#1)(2007-2#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
A potassium niobate crystal##2##4##(2007-12#1)(2008-3#1)
A potent##2##2##(1993-6#1)(2008-8#1)
A potential##15##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-7#1)(1993-10#1)(1993-5#1)(1994-8#1)(2008-10#5)(2008-2#1)(2008-9#1)(2009-2#1)
A potentiometric flow injection determination method for##2##7##(2008-10#2)
A potentiometric flow injection##3##4##(2008-10#3)
A potentiometric##12##2##(2008-10#12)
A powerful##3##2##(2007-10#1)(2008-2#1)(2012-2#1)
A practical approach to##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
A practical approach##4##3##(2008-11#2)(2008-6#1)(2012-2#1)
A practical guide for##2##4##(1993-12#1)(2008-10#1)
A practical guide##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
A practical implication##2##3##(2008-10#1)(2008-7#1)
A practical method##2##3##(2008-10#1)(2008-3#1)
A practical##22##2##(1993-12#1)(1996-3#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
A pragmatic##2##2##(1994-2#1)(2008-3#1)
A pre-column derivatization method for the sensitive determination of##2##9##(2008-10#2)
A pre-column derivatization method##3##4##(2008-10#2)(2011-1#1)
A preadmission telephone call##2##4##(2008-8#2)
A precise##3##2##(2008-10#3)
A precision of##2##3##(2008-10#2)
A precision##5##2##(2008-10#3)(2008-2#2)
A precolumn##2##2##(1990-8#1)(2008-10#1)
A preconcentration factor of##6##4##(2008-10#6)
A preconcentration factor##7##3##(2008-10#7)
A preconcentration method##2##3##(2008-10#2)
A preconcentration##12##2##(2008-10#12)
A prediction##2##2##(2008-2#1)(2012-2#1)
A predictive model for production of apothecia##2##7##(2008-10#2)
A predictive model for##3##4##(2008-10#3)
A predictive model##4##3##(2008-10#3)(2012-12#1)
A preliminary study of the##2##5##(2008-2#1)(2010-10#1)
A preliminary study of##3##4##(2008-2#1)(2010-10#1)(2010-7#1)
A preliminary study on the##2##5##(2008-9#1)(2012-3#1)
A preliminary study on##3##4##(2008-9#1)(2012-2#1)(2012-3#1)
A preliminary study##8##3##(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
A preliminary##22##2##(1991-12#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
A prescription for##2##3##(1993-12#1)(1995-1#1)
A presentation of the##3##4##(1994-2#1)(1997-6#1)(2008-11#1)
A prevalence##2##2##(1993-6#1)(1995-11#1)
A preventive##2##2##(2009-9#1)(2010-1#1)
A previous report##3##3##(2008-7#2)(2012-3#1)
A previous study reported that##2##5##(1991-12#1)(1994-3#1)
A previous study##5##3##(1991-12#1)(1994-3#1)(2008-10#2)(2011-2#1)
A previous##13##2##(1991-12#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)
A previously healthy##2##3##(2008-10#1)(2008-7#1)
A previously undescribed##3##3##(2008-10#2)(2011-1#1)
A previously##13##2##(2008-10#7)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)
A primary goal in##2##4##(2007-11#1)(2008-6#1)
A primary step in##2##4##(2008-5#1)(2009-10#1)
A primary##12##2##(1995-2#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
A primer on##2##3##(1994-3#1)(2011-2#1)
A primer##7##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
A principal component analysis based##2##5##(2008-10#1)(2013-7#1)
A principal component##4##3##(2008-10#3)(2013-7#1)
A principal components analysis##2##4##(2008-10#2)
A principal##6##2##(2008-10#5)(2013-7#1)
A principle##2##2##(2007-12#1)(2008-10#1)
A prior##2##2##(1993-3#1)(1994-8#1)
A probabilistic##2##2##(2011-2#1)(2012-12#1)
A probe##4##2##(1993-6#1)(1995-6#1)(1996-12#1)(2008-3#1)
A problem of##2##3##(2008-3#1)(2012-12#1)
A problem##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
A procedure for the determination of##7##6##(2008-10#6)(2008-5#1)
A procedure for the simultaneous##2##5##(2008-10#2)
A procedure for the##13##4##(2008-10#11)(2008-3#1)(2008-5#1)
A procedure for##29##3##(1995-12#1)(2008-10#18)(2008-3#7)(2008-4#2)(2008-5#1)
A procedure has been developed for the##3##7##(2008-10#2)(2009-5#1)
A procedure has been developed for##4##6##(2008-10#3)(2009-5#1)
A procedure is described for the##3##6##(1993-11#1)(2008-10#2)
A procedure is described for##5##5##(1993-11#1)(2008-10#2)(2008-4#2)
A procedure is described##6##4##(1990-8#1)(1993-11#1)(2008-10#2)(2008-4#2)
A procedure is##11##3##(1990-8#1)(1993-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)
A procedure to##5##3##(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
A procedure was developed for##2##5##(2008-10#2)
A procedure##55##2##(1990-8#1)(1993-11#1)(1994-8#1)(1995-12#1)(2008-10#30)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#1)(2008-9#2)(2009-5#1)(2012-2#1)
A process for##2##3##(1992-3#1)(2008-6#1)
A process of##2##3##(2008-11#1)(2012-1#1)
A process##5##2##(1992-3#1)(2008-11#2)(2008-6#1)(2012-1#1)
A produced##2##2##(1995-11#1)(2007-12#1)
A professional##2##2##(1993-6#1)(2009-10#1)
A proficient mentor##2##3##(2008-7#2)
A profile of the##2##4##(1995-2#1)(2008-2#1)
A profile of##3##3##(1995-2#1)(1995-3#1)(2008-2#1)
A program for##4##3##(1992-3#1)(1995-9#1)(2007-2#1)(2008-10#1)
A program to##3##3##(1995-12#1)(2008-4#2)
A program##10##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-9#1)(2007-2#1)(2008-10#1)(2008-4#2)
A project within the Health and Unequality program in Finnmark]##2##10##(1995-6#2)
A project##3##2##(1994-6#1)(1995-6#2)
A prolonged##2##2##(1995-6#1)(2008-7#1)
A prominent##2##2##(1997-5#1)(2013-8#1)
A promising approach##2##3##(1993-11#1)(2007-12#1)
A promising new method##2##4##(2009-8#1)(2010-8#1)
A promising strategy##2##3##(2010-10#1)(2012-2#1)
A promising##15##2##(1993-11#1)(1994-6#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#1)
A pronounced##2##2##(2008-10#1)(2012-2#1)
A proper##2##2##(2007-11#1)(2010-11#1)
A proposal for a##3##4##(1993-11#1)(1996-12#1)(2008-3#1)
A proposal for##6##3##(1993-11#1)(1993-2#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-3#1)
A proposed mechanism##3##3##(2007-6#1)(2008-5#1)(2012-3#1)
A proposed new##2##3##(2008-3#1)(2011-2#1)
A proposed##9##2##(1995-12#1)(1995-3#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)
A prospective cohort of patients##2##5##(2012-12#1)(2012-6#1)
A prospective cohort of##4##4##(2008-8#1)(2012-12#1)(2012-6#1)(2013-1#1)
A prospective cohort study##3##4##(2009-5#1)(2011-1#1)(2012-12#1)
A prospective cohort##7##3##(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-6#1)(2013-1#1)
A prospective longitudinal##2##3##(2012-12#1)(2013-1#1)
A prospective pilot study##3##4##(1994-1#1)(2012-3#1)(2013-1#1)
A prospective randomized##4##3##(1991-2#1)(2007-12#1)(2008-10#1)(2010-7#1)
A prospective study of##4##4##(1992-6#1)(2007-12#1)(2008-1#1)(2009-8#1)
A prospective study on##2##4##(1990-3#1)(2008-10#1)
A prospective study was conducted##3##5##(2009-10#1)(2012-3#1)(2013-1#1)
A prospective study was performed##2##5##(1992-12#1)(2008-7#1)
A prospective study was##7##4##(1992-12#1)(2008-7#2)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
A prospective study##17##3##(1990-3#1)(1990-9#1)(1992-12#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
A prospective study]##2##3##(1990-3#1)(1990-6#1)
A prospective##55##2##(1990-3#2)(1990-6#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-6#1)(1994-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#6)(2012-3#3)(2012-5#1)(2012-6#1)(2013-1#5)(2013-8#2)
A protein of##2##3##(1990-5#1)(1994-8#1)
A protein with a##2##4##(1994-8#1)(2008-11#1)
A protein##12##2##(1990-5#2)(1991-6#2)(1993-8#1)(1994-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)
A protocol for the analysis of synthetic oligonucleotides in a flowable matrix is described in this unit##2##17##(2008-2#1)(2008-4#1)
A protocol for the##5##4##(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#2)
A protocol for##9##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#5)
A protocol is also provided for##2##6##(2008-1#1)(2008-4#1)
A protocol is provided for##3##5##(2008-4#3)
A protocol is##6##3##(2008-1#1)(2008-4#5)
A protocol##18##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#12)
A prototype device##2##3##(2008-2#1)(2008-3#1)
A prototype of##2##3##(2008-11#1)(2008-2#1)
A prototype##16##2##(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2011-1#1)
A proven##2##2##(1996-12#1)(2008-6#1)
A public health##4##3##(1992-1#1)(1997-1#1)(1997-5#1)(2012-12#1)
A public##5##2##(1992-1#1)(1997-1#1)(1997-5#1)(2012-12#1)(2013-1#1)
A pulse##4##2##(2007-11#2)(2008-3#1)(2008-4#1)
A pulsed##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
A purposive##3##2##(2008-11#1)(2009-9#1)(2010-3#1)
A putative##11##2##(1991-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-8#1)(2009-9#1)
A quadratic##2##2##(2007-12#1)(2008-2#1)
A quadruple##2##2##(2007-11#1)(2008-1#1)
A quadruplex real-time qPCR assay##2##5##(2008-12#2)
A qualitative and##2##3##(1996-5#1)(2012-3#1)
A qualitative case study##2##4##(2008-11#1)(2010-8#1)
A qualitative descriptive study##2##4##(2010-10#1)(2011-1#1)
A qualitative research methodology was used##2##6##(1995-3#1)(2008-9#1)
A qualitative research##5##3##(1995-3#1)(2008-1#1)(2008-9#1)(2011-1#1)(2012-3#1)
A qualitative study among##2##4##(1995-6#1)(2013-1#1)
A qualitative study of##3##4##(1996-3#1)(2009-6#1)(2011-1#1)
A qualitative study##11##3##(1995-6#1)(1996-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-6#1)(2011-1#2)(2012-1#1)(2013-1#1)(2013-8#1)
A qualitative##32##2##(1990-6#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-3#3)(2013-1#3)(2013-8#1)
A quality assurance##2##3##(1994-3#1)(2012-12#1)
A quality improvement##2##3##(1994-12#1)(1996-2#1)
A quality##6##2##(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(2012-12#1)
A quantitative analysis of the##3##5##(1997-7#1)(2007-11#1)(2008-2#1)
A quantitative analysis of##5##4##(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
A quantitative analysis##6##3##(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
A quantitative analytical method##2##4##(2008-10#1)(2012-2#1)
A quantitative assessment of the##2##5##(2008-11#1)(2008-2#1)
A quantitative assessment of##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
A quantitative relationship##2##3##(2008-10#1)(2008-12#1)
A quantitative review of##2##4##(2008-10#2)
A quantitative trait##2##3##(2008-10#2)
A quantitative##36##2##(1993-12#1)(1993-6#1)(1996-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2012-2#2)
A quarter##3##2##(1997-7#1)(2008-7#1)(2011-2#1)
A quasi-experimental design##2##3##(2010-12#1)(2013-1#1)
A quasi-experimental study##3##3##(2008-4#1)(2013-1#2)
A quasi-experimental##6##2##(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#3)
A question of##2##3##(2007-6#1)(2008-11#1)
A question##3##2##(1993-6#1)(2007-6#1)(2008-11#1)
A questionnaire among Norwegian##2##4##(1992-6#1)(1996-9#1)
A questionnaire study##3##3##(1992-6#1)(1993-6#1)(1995-2#1)
A questionnaire study]##2##3##(1992-11#1)(1993-2#1)
A questionnaire survey of##2##4##(1992-11#1)(1994-6#1)
A questionnaire survey was carried out##2##6##(1997-3#1)(2010-5#1)
A questionnaire survey was conducted##2##5##(1992-6#1)(2012-2#1)
A questionnaire survey was##6##4##(1992-6#1)(1997-3#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)
A questionnaire survey##10##3##(1992-11#1)(1992-6#2)(1994-6#1)(1997-3#1)(2008-11#1)(2008-8#2)(2010-5#1)(2012-2#1)
A questionnaire was developed and##2##5##(1992-1#1)(1995-12#1)
A questionnaire was given##2##4##(1993-12#1)(2011-2#1)
A questionnaire was sent to a##4##6##(1991-6#1)(1993-2#1)(1997-3#1)(2013-1#1)
A questionnaire was sent to all preregistration house officers who had recently##2##12##(1995-6#2)
A questionnaire was sent to all##3##6##(1995-6#3)
A questionnaire was sent to##12##5##(1990-2#1)(1991-6#1)(1993-2#2)(1995-6#3)(1996-1#1)(1997-3#1)(2007-7#1)(2008-1#1)(2013-1#1)
A questionnaire was used to##2##5##(1990-9#1)(2008-10#1)
A questionnaire was used##3##4##(1990-9#1)(2008-10#1)(2012-12#1)
A questionnaire was##21##3##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#2)(1995-12#1)(1995-6#3)(1996-1#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
A questionnaire##50##2##(1990-2#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-6#5)(1993-12#2)(1993-2#3)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-9#2)(1997-3#3)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
A quick and##2##3##(2008-10#1)(2008-9#1)
A quick##8##2##(2008-10#5)(2008-5#2)(2008-9#1)
A rabbit##4##2##(1995-6#1)(2008-10#2)(2008-5#1)
A radiation##2##2##(1995-8#1)(2008-6#1)
A radioassay##2##2##(1992-3#2)
A radiological##2##2##(1992-12#1)(1995-6#1)
A radiology##2##2##(1993-3#1)(1996-3#1)
A rain##2##2##(2008-10#1)(2008-8#1)
A random sample of##9##4##(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
A random##15##2##(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-7#2)(2008-8#1)(2011-2#1)
A random-effects regression##2##3##(1995-2#2)
A random-effects##3##2##(1995-2#2)(2008-10#1)
A randomised##3##2##(1991-11#1)(2010-5#1)(2013-8#1)
A randomized clinical trial##3##4##(2012-12#2)(2013-1#1)
A randomized controlled trial##5##4##(2007-7#1)(2010-3#1)(2012-3#1)(2013-1#2)
A randomized controlled##7##3##(2007-7#1)(2010-3#1)(2012-3#1)(2013-1#4)
A randomized study of##2##4##(1993-12#1)(1994-12#1)
A randomized trial of##4##4##(1991-11#1)(1994-3#1)(1997-7#1)(2010-4#1)
A randomized trial##6##3##(1991-11#1)(1993-11#1)(1994-3#1)(1997-7#1)(2010-4#1)(2012-1#1)
A randomized##33##2##(1990-5#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#8)
A range of##14##3##(1992-9#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#2)
A rapid and sensitive flow injection chemiluminescence##2##7##(2008-10#2)
A rapid and sensitive immunoassay for the determination of##2##9##(2008-10#2)
A rapid and sensitive method for the determination of##2##9##(2008-10#2)
A rapid and sensitive method for the trace level determination of##2##11##(2008-10#2)
A rapid and sensitive method for the##5##7##(2008-10#5)
A rapid and sensitive method is described for the##2##9##(2008-10#2)
A rapid and sensitive method##9##5##(1991-5#1)(2008-10#8)
A rapid and sensitive##20##4##(1991-5#1)(1993-12#1)(1993-9#1)(2008-10#17)
A rapid and simple##4##4##(2008-10#4)
A rapid and##31##3##(1991-5#1)(1993-12#1)(1993-9#1)(1994-11#1)(2008-10#25)(2008-7#1)(2012-2#1)
A rapid determination of##2##4##(2008-10#1)(2011-2#1)
A rapid method for the##3##5##(2008-10#2)(2011-1#1)
A rapid method for##5##4##(2008-10#4)(2011-1#1)
A rapid method##8##3##(2008-10#7)(2011-1#1)
A rapid ultrasound-assisted##2##3##(2008-10#2)
A rapid##73##2##(1990-12#2)(1990-2#2)(1990-8#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-10#50)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
A rapidly##2##2##(2009-12#1)(2012-12#1)
A rare and##2##3##(2008-11#1)(2008-9#1)
A rare but##2##3##(2008-9#1)(2012-3#1)
A rare case of a##3##5##(2008-7#3)
A rare case of##19##4##(1992-2#1)(1993-8#1)(2007-8#1)(2008-10#3)(2008-7#5)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)
A rare case report##2##4##(2010-10#1)(2013-1#1)
A rare case##23##3##(1992-2#1)(1993-8#1)(2007-8#1)(2008-10#3)(2008-7#6)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
A rare cause is##2##4##(1996-6#1)(2013-1#1)
A rare cause of##4##4##(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
A rare cause##7##3##(1996-6#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
A rare complication of##4##4##(1991-5#1)(2009-5#1)(2011-2#1)(2012-3#1)
A rare complication##5##3##(1991-5#1)(2007-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
A rare presentation##2##3##(2012-2#1)(2012-3#1)
A rare##56##2##(1991-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-8#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#6)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-5#3)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#1)
A rarity##2##2##(1992-9#1)(2013-1#1)
A rat brain##2##3##(1992-6#2)
A rat##7##2##(1991-12#1)(1992-3#2)(1992-6#2)(1992-9#1)(2011-2#1)
A rating scale of##2##4##(1993-2#1)(2007-11#1)
A rating##3##2##(1993-2#1)(1993-3#1)(2007-11#1)
A ratio of##3##3##(1992-3#1)(2008-3#1)(2009-10#1)
A rational##2##2##(2008-7#1)(2012-2#1)
A ray##2##2##(2008-2#1)(2008-3#1)
A reaction##4##2##(2008-10#3)(2008-6#1)
A real##2##2##(1996-2#1)(2010-11#1)
A real-time polymerase chain reaction (PCR) assay was developed##2##9##(2008-10#2)
A real-time##7##2##(2007-11#1)(2008-10#4)(2008-2#1)(2011-1#1)
A reasonable##2##2##(1993-3#1)(2008-10#1)
A recent paper##2##3##(2008-3#1)(2008-4#1)
A recent report##3##3##(1992-8#3)
A recent study##4##3##(1997-2#1)(1997-7#1)(2009-5#1)(2011-2#1)
A recent survey##2##3##(2006-12#1)(2008-3#1)
A recent##30##2##(1992-8#3)(1997-2#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#2)
A recently developed##2##3##(2007-12#1)(2008-10#1)
A recently proposed##2##3##(1994-9#1)(2008-2#1)
A recently##6##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
A reciprocal##2##2##(2008-3#1)(2009-7#1)
A reciprocity inequality##2##3##(2007-12#2)
A recombinant adenoviral vector carrying human TIMP-2 was##2##8##(2010-1#2)
A recombinant adenovirus##2##3##(1997-4#1)(2010-1#1)
A recombinant strain##2##3##(2008-8#2)
A recombinant##19##2##(1990-5#1)(1992-9#1)(1993-8#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-1#3)(2010-4#1)
A recovery of##4##3##(1994-12#1)(2008-10#2)(2009-8#1)
A recovery##6##2##(1994-12#1)(2008-10#3)(2008-2#1)(2009-8#1)
A recurring##2##2##(1997-4#1)(2008-7#1)
A redox##2##2##(1997-7#1)(2008-10#1)
A reduced##3##2##(1992-8#1)(1997-2#1)(2008-10#1)
A reduction in the AAI to 0##2##7##(1993-12#2)
A reduction in the##5##4##(1991-9#1)(1993-12#2)(1994-8#1)(2008-10#1)
A reduction in##13##3##(1991-9#1)(1993-1#1)(1993-12#2)(1994-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-12#1)(2009-5#1)
A reduction of the##3##4##(2008-10#2)(2008-11#1)
A reduction of##7##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
A reduction##21##2##(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-5#1)
A reference##7##2##(1992-3#1)(2008-10#3)(2008-3#3)
A refined##2##2##(1994-12#1)(2008-3#1)
A refinement##2##2##(2007-11#1)(2008-3#1)
A reflection##2##2##(2008-2#1)(2008-3#1)
A region of##2##3##(2008-10#1)(2008-3#1)
A region##6##2##(1993-9#1)(1995-3#1)(2008-10#3)(2008-3#1)
A regional##2##2##(1993-12#1)(2008-2#1)
A regression##3##2##(2008-10#2)(2008-7#1)
A related##6##2##(1991-3#1)(1994-8#1)(1995-6#1)(1996-9#1)(2008-12#2)
A relation##2##2##(1993-2#1)(2011-1#1)
A relational database##3##3##(1996-2#1)(2008-7#2)
A relationship between the##3##4##(1994-5#1)(1995-9#1)(2008-10#1)
A relationship between##6##3##(1991-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(2008-10#1)(2010-9#1)
A relationship was found between##2##5##(2008-10#1)(2011-2#1)
A relationship##9##2##(1991-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(2008-10#2)(2010-9#1)(2011-2#2)
A relative standard deviation (R##2##5##(2008-10#2)
A relative standard deviation##4##4##(2008-10#4)
A relative##8##2##(2007-12#2)(2008-10#4)(2008-3#2)
A relatively high##3##3##(1997-2#1)(2008-10#2)
A relatively small##5##3##(1991-12#1)(1991-6#1)(1994-11#1)(2007-12#1)(2008-7#1)
A relatively##15##2##(1991-12#1)(1991-6#1)(1992-3#1)(1994-11#1)(1994-2#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#2)(2009-5#1)
A reliable and very sensitive procedure for the determination of##2##10##(2008-10#2)
A reliable diagnosis##2##3##(2007-7#1)(2008-7#1)
A reliable##8##2##(2007-7#1)(2008-10#4)(2008-7#1)(2010-4#1)(2011-2#1)
A remarkable##6##2##(2008-10#3)(2008-5#1)(2010-3#1)(2013-1#1)
A reminder##2##2##(2007-12#1)(2007-2#1)
A renal biopsy showed a##2##5##(2013-8#2)
A renal biopsy##3##3##(2008-7#1)(2013-8#2)
A renal##4##2##(2008-10#1)(2008-7#1)(2013-8#2)
A renewed##2##2##(1997-1#1)(2008-10#1)
A repeat##2##2##(2007-10#1)(2007-12#1)
A repeated dose##2##3##(2008-5#1)(2013-1#1)
A repeated measures##2##3##(2008-10#1)(2013-1#1)
A repeated##5##2##(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#2)
A reply to##2##3##(1993-3#1)(2008-2#1)
A reply##6##2##(1993-3#1)(2007-4#2)(2008-2#1)(2013-8#2)
A report from##2##3##(2008-11#2)
A report of an##2##4##(1992-5#1)(2012-12#1)
A report of four cases##2##5##(1990-12#1)(2011-2#1)
A report of the##3##4##(2007-7#1)(2008-11#1)(2008-3#1)
A report of three cases##3##5##(2010-10#1)(2011-1#1)(2013-1#1)
A report of two cases##3##5##(2012-12#1)(2012-3#1)(2013-1#1)
A report of two##4##4##(2012-12#1)(2012-3#1)(2013-1#2)
A report of##19##3##(1990-12#1)(1992-5#3)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
A report on##2##3##(1995-12#1)(1997-5#1)
A report was compiled##2##4##(1993-12#1)(2008-11#1)
A report##26##2##(1990-12#1)(1992-5#3)(1993-12#1)(1995-12#1)(1996-1#1)(1997-5#1)(2007-7#1)(2008-11#4)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
A representative sample of##3##4##(1996-6#1)(2007-2#1)(2008-1#1)
A representative##5##2##(1996-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2013-8#1)
A represents##2##2##(2009-10#1)(2012-12#1)
A reproducible and##5##3##(2008-10#4)(2008-5#1)
A reproducible##6##2##(2008-10#5)(2008-5#1)
A requirement for##2##3##(2011-2#1)(2013-1#1)
A requirement##3##2##(1991-6#1)(2011-2#1)(2013-1#1)
A research agenda##2##3##(1991-1#1)(2009-11#1)
A research##8##2##(1991-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-11#1)(2011-2#1)
A reservoir type of##2##4##(2008-10#2)
A resolution and##2##3##(1995-2#1)(1995-5#1)
A resolution##18##2##(1992-11#1)(1992-8#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-8#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#1)
A resource##2##2##(1990-11#1)(1996-2#1)
A response surface##2##3##(2008-10#1)(2013-1#1)
A response to##3##3##(2008-11#1)(2008-7#1)(2009-11#1)
A response##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
A retrospective analysis of##16##4##(1990-6#1)(1993-11#1)(1994-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
A retrospective analysis was##3##4##(1995-11#1)(2011-2#1)(2012-12#1)
A retrospective analysis##21##3##(1990-6#1)(1992-11#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)
A retrospective case##2##3##(2012-12#1)(2012-2#1)
A retrospective chart review was##2##5##(2010-8#1)(2011-2#1)
A retrospective chart review##5##4##(2007-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
A retrospective chart##6##3##(1994-3#1)(2007-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
A retrospective cohort study##2##4##(2010-3#1)(2013-1#1)
A retrospective cohort##3##3##(1996-11#1)(2010-3#1)(2013-1#1)
A retrospective review of##5##4##(1995-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
A retrospective review##7##3##(1995-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
A retrospective study of##6##4##(1990-3#1)(1991-4#1)(1995-1#1)(2007-8#2)(2012-3#1)
A retrospective study was##4##4##(1990-12#1)(1990-6#1)(1997-8#1)(2012-12#1)
A retrospective study##15##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-4#1)(1995-1#1)(1996-11#1)(1997-5#1)(1997-8#1)(2007-8#2)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)
A retrospective##64##2##(1990-12#1)(1990-3#1)(1990-6#2)(1991-4#1)(1992-11#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
A retrovirus##2##2##(2008-5#1)(2008-8#1)
A reusable##2##2##(2008-10#2)
A reverse##6##2##(1993-12#1)(2008-10#4)(2011-1#1)
A reversed phase C(18) column with gradient elution was utilized##2##10##(2008-10#2)
A reversed phase C(18) column##3##5##(2008-10#3)
A reversed##6##2##(1993-8#1)(2008-10#4)(2008-9#1)
A reversed-phase high-performance liquid chromatographic##2##5##(1991-5#1)(1995-6#1)
A reversed-phase high-performance liquid##3##4##(1991-5#1)(1995-6#1)(2008-10#1)
A reversed-phase##6##2##(1991-5#1)(1995-6#1)(2008-10#3)(2012-12#1)
A reversible##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
A review has been made of the literature##2##8##(2008-2#1)(2008-4#1)
A review of clinical##2##4##(1994-3#1)(1995-9#1)
A review of current##2##4##(2008-10#1)(2011-2#1)
A review of literature##2##4##(1993-9#1)(2012-12#1)
A review of the current##3##5##(2007-4#1)(2008-10#1)(2008-11#1)
A review of the literature found##2##6##(2008-10#2)
A review of the literature is##2##6##(1996-9#1)(2009-3#1)
A review of the literature revealed##2##6##(2006-10#1)(2008-12#1)
A review of the literature showed that##2##7##(1992-5#1)(2011-2#1)
A review of the literature showed##3##6##(1992-5#1)(2011-2#2)
A review of the literature shows that##2##7##(2008-10#1)(2011-3#1)
A review of the literature suggests that##2##7##(2008-11#2)
A review of the literature##29##5##(1992-5#1)(1993-1#1)(1993-3#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-7#2)(2008-9#1)(2009-3#2)(2011-2#4)(2011-3#1)(2012-2#1)(2013-7#1)
A review of the##55##4##(1992-5#2)(1993-1#1)(1993-3#2)(1993-6#1)(1993-8#1)(1995-1#1)(1996-12#1)(1996-9#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-7#3)(2008-9#1)(2009-11#3)(2009-3#2)(2009-4#1)(2009-5#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-7#1)
A review of##110##3##(1990-3#1)(1990-9#1)(1991-8#1)(1992-5#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#8)(2008-12#3)(2008-3#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-11#4)(2009-3#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#6)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
A review on the##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
A review on##6##3##(2008-10#2)(2008-12#1)(2009-12#1)(2010-12#1)(2012-2#1)
A review##143##2##(1990-3#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-5#2)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-3#2)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
A revised##2##2##(1991-9#1)(2011-2#1)
A revision##3##2##(1992-11#1)(2008-10#2)
A ribonuclease##2##2##(1990-7#1)(2008-10#1)
A rice##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
A right##4##2##(1993-9#1)(1995-2#1)(2009-1#1)(2013-8#1)
A rigorous##5##2##(2008-10#1)(2008-3#4)
A rise##2##2##(1996-7#1)(2007-8#1)
A risk##3##2##(1994-2#1)(2007-3#1)(2008-10#1)
A rms##3##2##(2008-2#1)(2008-3#2)
A robust##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
A role for the##2##4##(1992-6#1)(2012-2#1)
A role for##9##3##(1992-6#1)(1994-6#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
A role of##2##3##(2008-8#2)
A role##11##2##(1992-6#1)(1994-6#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-8#1)(2012-2#1)
A room-temperature##2##2##(2007-12#1)(2008-10#1)
A routine##6##2##(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#2)
A safe##3##2##(1993-12#1)(1995-2#1)(2007-10#1)
A sample of##14##3##(1991-2#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-1#2)(2012-2#1)(2013-8#1)
A sample preparation method based on##2##6##(2008-10#2)
A sample solution##4##3##(2008-10#4)
A sample throughput of 80 samples per hour and relative standard deviation##2##12##(2008-10#2)
A sample throughput of##7##4##(2008-10#7)
A sample##34##2##(1991-2#1)(1994-12#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-8#1)
A sampling frequency##2##3##(2008-10#2)
A sampling##6##2##(2008-10#5)(2008-11#1)
A sandwich enzyme-linked immunosorbent assay##2##5##(1995-11#2)
A sandwich##5##2##(1995-11#2)(2008-10#2)(2008-2#1)
A satisfactory result##2##3##(2008-10#2)
A satisfactory##3##2##(2008-10#3)
A scan##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
A scanning##4##2##(2007-12#1)(2008-3#2)(2008-4#1)
A scenario##3##2##(1992-9#1)(2008-9#1)(2010-8#1)
A scheme for##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
A score of##2##3##(2008-7#1)(2013-1#1)
A scoring and ranking system for persistent##3##7##(2008-11#3)
A screen-printed##2##2##(2008-10#2)
A screening##2##2##(1991-9#1)(1995-9#1)
A search for the##2##4##(2008-11#1)(2008-4#1)
A search for##4##3##(1991-9#1)(1994-5#1)(2008-11#1)(2008-4#1)
A search of the literature##2##5##(1992-12#1)(1995-5#1)
A search of the##3##4##(1992-12#1)(1995-5#1)(1995-6#1)
A search of##4##3##(1992-12#1)(1995-5#1)(1995-6#1)(2013-1#1)
A search##10##2##(1991-9#1)(1992-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
A seasonal##2##2##(2008-10#1)(2008-5#1)
A second round of##2##4##(1997-7#1)(2008-10#1)
A second set of##2##4##(2009-8#1)(2010-10#1)
A second study##2##3##(2008-5#1)(2011-2#1)
A second##51##2##(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-2#2)(1997-5#1)(1997-7#2)(2007-11#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
A second-order##2##2##(2007-12#1)(2008-10#1)
A secondary objective was to##2##5##(2011-1#1)(2013-1#1)
A secondary objective##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
A secondary##8##2##(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
A section on##2##3##(2008-4#1)(2011-2#1)
A section##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
A segregating##2##2##(2008-10#2)
A selection of the##3##4##(2008-10#2)(2008-2#1)
A selection of##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#1)
A selective and##3##3##(1990-8#1)(2008-10#1)(2009-12#1)
A selective method##2##3##(2008-10#2)
A selective##20##2##(1990-8#1)(1993-3#1)(1995-12#1)(1996-4#1)(2008-10#13)(2008-7#1)(2009-12#1)(2012-2#1)
A self-starting##2##2##(2007-12#2)
A semi-automated##2##2##(2008-10#2)
A semi-structured interview##2##3##(2008-4#1)(2012-3#1)
A semi-structured##5##2##(2006-10#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-8#1)
A semianalytical##3##2##(2008-2#2)(2008-3#1)
A semiconductor laser##2##3##(2007-12#1)(2008-3#1)
A sensitive and rapid method##2##5##(2008-10#2)
A sensitive and rapid##3##4##(2008-10#3)
A sensitive and selective flow injection##2##6##(2008-10#2)
A sensitive and selective method##4##5##(2008-10#4)
A sensitive and selective##13##4##(2008-10#13)
A sensitive and specific##3##4##(1990-2#1)(1992-6#1)(2008-10#1)
A sensitive and##24##3##(1990-2#1)(1992-6#1)(2008-10#20)(2010-5#2)
A sensitive flow-injection##2##3##(2008-10#2)
A sensitive method for the detection of catecholamine based on##2##10##(2008-10#2)
A sensitive method for the determination of##3##7##(1990-8#1)(2008-10#2)
A sensitive method for the##7##5##(1990-8#1)(2008-10#6)
A sensitive method for##8##4##(1990-8#1)(2008-10#7)
A sensitive method is described for the determination of##2##9##(2008-10#2)
A sensitive method is##4##4##(2008-10#3)(2008-4#1)
A sensitive method##14##3##(1990-8#1)(2008-10#12)(2008-4#1)
A sensitive spectrophotometric method for the determination of##2##8##(2008-10#2)
A sensitive spectrophotometric method for##3##5##(2008-10#3)
A sensitive spectrophotometric method##4##4##(2008-10#4)
A sensitive spectrophotometric##5##3##(2008-10#5)
A sensitive##78##2##(1990-2#1)(1990-8#1)(1991-2#4)(1992-3#1)(1992-6#1)(1994-6#1)(2008-10#64)(2008-4#1)(2008-7#1)(2009-6#1)(2010-5#2)
A sensitivity analysis of the##2##5##(2008-3#1)(2008-7#1)
A sensitivity analysis##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
A sensitivity##9##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)
A sensor array##2##3##(2008-10#1)(2008-7#1)
A sensor for##4##3##(2008-10#3)(2008-3#1)
A sensor##9##2##(2008-10#7)(2008-3#1)(2008-7#1)
A separate##5##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
A separation of##2##3##(1994-9#1)(2008-8#1)
A separation##4##2##(1994-9#1)(2008-10#2)(2008-8#1)
A sequence of##4##3##(1995-2#1)(1996-3#1)(2008-3#2)
A sequence##8##2##(1994-6#2)(1995-2#2)(1996-3#1)(1997-2#1)(2008-3#2)
A sequential extraction of##2##4##(2008-10#2)
A sequential extraction procedure for separating and##2##7##(2008-10#2)
A sequential extraction procedure for separating##3##6##(2008-10#3)
A sequential extraction##5##3##(2008-10#5)
A sequential injection analysis (SIA) system is##2##7##(2008-10#2)
A sequential injection analysis (SIA) system was developed##2##8##(2008-10#2)
A sequential injection analysis (SIA) system##4##6##(2008-10#4)
A sequential injection analysis (SIA)##7##5##(2008-10#7)
A sequential injection analysis system##2##5##(2008-10#2)
A sequential injection analysis##9##4##(2008-10#9)
A sequential injection spectrophotometric method for the##2##7##(2008-10#2)
A sequential injection spectrophotometric##3##4##(2008-10#3)
A sequential injection system##4##4##(2008-10#4)
A sequential injection##19##3##(2008-10#19)
A sequential##32##2##(1992-3#2)(2008-10#28)(2008-11#1)(2012-2#1)
A series of 30##2##4##(1990-3#1)(1990-8#1)
A series of analogs##2##4##(1990-5#1)(1995-3#1)
A series of experiments was##2##5##(1993-8#1)(1997-4#1)
A series of experiments##5##4##(1993-3#1)(1993-8#1)(1997-4#1)(2008-10#1)(2008-12#1)
A series of new##3##4##(2007-11#1)(2012-2#1)(2012-3#1)
A series of novel##3##4##(1992-3#1)(2007-11#1)(2011-3#1)
A series of plasmids##2##4##(1993-9#1)(1997-3#1)
A series of recommendations##2##4##(2008-12#1)(2008-3#1)
A series of samples##2##4##(2008-10#2)
A series of substrates##2##4##(1994-5#1)(2008-4#1)
A series of synthetic##3##4##(1994-9#1)(2008-10#2)
A series of##119##3##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#7)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-11#6)(2007-12#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)
A series##120##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#7)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-11#6)(2007-12#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)
A serologic##2##2##(1996-12#2)
A serum##3##2##(2008-11#1)(2011-1#1)(2013-8#1)
A serum-free medium formulation##2##4##(2008-11#2)
A serum-free medium##3##3##(2008-11#2)(2008-7#1)
A serum-free##6##2##(2008-11#5)(2008-7#1)
A set of##23##3##(1992-6#1)(1993-12#1)(1997-3#1)(2007-12#2)(2008-10#11)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#2)(2013-7#1)
A severe##3##2##(1993-3#1)(1993-6#1)(2011-2#1)
A sharp##2##2##(1991-12#1)(2008-12#1)
A shift##2##2##(2007-12#1)(2008-2#1)
A short exposure to##2##4##(2008-7#1)(2011-2#1)
A short review##2##3##(2008-10#1)(2008-11#1)
A short##15##2##(1993-3#1)(1994-11#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#1)
A shorter##2##2##(1994-2#1)(2008-10#1)
A showed##2##2##(1992-11#1)(1997-2#1)
A sideways glance##2##3##(2008-10#2)
A sideways##3##2##(1994-9#1)(2008-10#2)
A signal##3##2##(2008-4#1)(2009-8#1)(2012-12#1)
A significant advantage of##2##4##(2007-12#1)(2008-10#1)
A significant advantage##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
A significant association##2##3##(1996-12#1)(2011-2#1)
A significant correlation (r = 0##2##6##(2008-10#1)(2010-2#1)
A significant correlation was found between##3##6##(2008-10#1)(2008-3#1)(2013-1#1)
A significant correlation was##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
A significant correlation##8##3##(1992-12#1)(1993-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-2#1)(2013-1#1)
A significant decrease in##4##4##(1993-3#1)(1993-6#1)(1996-12#1)(2009-8#1)
A significant difference between the##2##5##(2008-10#2)
A significant difference between##3##4##(2008-10#2)(2013-7#1)
A significant difference in##3##4##(2008-10#2)(2013-1#1)
A significant difference was found between##2##6##(1990-8#1)(1993-2#1)
A significant difference was found##4##5##(1990-8#1)(1993-2#1)(1994-7#1)(2008-10#1)
A significant difference##13##3##(1990-8#1)(1993-2#1)(1994-7#1)(2007-10#1)(2008-10#6)(2008-5#1)(2013-1#1)(2013-7#1)
A significant effect of##3##4##(1996-12#1)(2008-9#1)(2009-8#1)
A significant effect##4##3##(1996-12#1)(2008-9#1)(2009-8#1)(2011-1#1)
A significant improvement in##2##4##(1991-3#1)(2008-7#1)
A significant increase in the##3##5##(1993-12#1)(1996-12#1)(2008-10#1)
A significant increase in##10##4##(1990-2#1)(1992-10#1)(1993-12#1)(1994-3#1)(1996-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
A significant increase##11##3##(1990-2#1)(1992-10#1)(1993-12#1)(1994-3#1)(1996-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
A significant interaction##3##3##(2008-10#2)(2009-2#1)
A significant level of##3##4##(1992-9#1)(2009-10#1)(2010-4#1)
A significant negative correlation##2##4##(2008-10#1)(2008-7#1)
A significant negative##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
A significant number of patients##3##5##(2008-7#1)(2008-8#1)(2012-12#1)
A significant number of##6##4##(1995-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
A significant number##7##3##(1995-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
A significant positive correlation was found between##2##7##(1992-10#1)(2008-6#1)
A significant positive correlation##3##4##(1992-10#1)(2008-6#1)(2011-1#1)
A significant positive##4##3##(1992-10#1)(2008-6#1)(2011-1#1)(2013-1#1)
A significant reduction in the##2##5##(1993-3#1)(2009-12#1)
A significant reduction in##5##4##(1993-10#1)(1993-3#1)(1995-5#1)(2008-10#1)(2009-12#1)
A significant reduction of##2##4##(1992-3#1)(2013-1#1)
A significant reduction##7##3##(1992-3#1)(1993-10#1)(1993-3#1)(1995-5#1)(2008-10#1)(2009-12#1)(2013-1#1)
A significant relationship between##2##4##(1991-8#1)(2008-8#1)
A significant relationship##3##3##(1991-8#1)(1996-12#1)(2008-8#1)
A significant##108##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#6)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#6)(2013-7#2)(2013-8#2)
A significantly greater##4##3##(1991-2#1)(1996-5#1)(2007-11#1)(2008-6#1)
A significantly higher incidence##2##4##(1993-8#1)(1996-8#1)
A significantly higher percentage of##2##5##(1994-6#2)
A significantly higher##6##3##(1993-8#1)(1994-6#2)(1996-8#1)(2008-12#1)(2011-2#1)
A significantly##14##2##(1991-11#1)(1991-2#1)(1993-8#1)(1994-6#2)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
A similar approach##2##3##(2008-3#1)(2009-8#1)
A similar effect was##2##4##(1994-5#1)(1995-2#1)
A similar effect##4##3##(1994-5#1)(1995-2#1)(2008-2#1)(2008-4#1)
A similar level of##2##4##(1994-5#1)(2008-10#1)
A similar pattern of##2##4##(1993-6#1)(1994-11#1)
A similar pattern was seen in the##2##7##(1993-6#1)(2008-4#1)
A similar pattern was##3##4##(1993-6#1)(2008-10#1)(2008-4#1)
A similar pattern##5##3##(1993-6#2)(1994-11#1)(2008-10#1)(2008-4#1)
A similar relationship##2##3##(2007-12#1)(2008-10#1)
A similar response##2##3##(1995-12#1)(2008-10#1)
A similar result##2##3##(2008-11#2)
A similar##54##2##(1991-12#2)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-5#4)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1996-2#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#1)(2013-1#2)
A simple analysis of the##2##5##(2007-12#1)(2008-10#1)
A simple analytical##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
A simple and effective##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
A simple and efficient method for the##3##7##(1995-6#1)(2007-11#1)(2010-3#1)
A simple and efficient##5##4##(1995-6#1)(2007-11#1)(2008-10#1)(2010-2#1)(2010-3#1)
A simple and fast method for##3##6##(2008-10#2)(2008-11#1)
A simple and fast method##4##5##(2008-10#3)(2008-11#1)
A simple and fast##7##4##(2008-10#6)(2008-11#1)
A simple and highly sensitive##2##5##(2008-10#1)(2008-3#1)
A simple and highly##3##4##(2008-10#2)(2008-3#1)
A simple and rapid method for##3##6##(2008-10#3)
A simple and rapid method##4##5##(2008-10#4)
A simple and rapid procedure for##2##6##(2008-10#2)
A simple and rapid procedure##3##5##(1994-8#1)(2008-10#2)
A simple and rapid##18##4##(1990-12#1)(1994-8#1)(2008-10#15)(2008-11#1)
A simple and reliable method for##2##6##(2008-10#2)
A simple and reliable method##3##5##(2008-10#3)
A simple and reliable##7##4##(2008-10#6)(2008-3#1)
A simple and robust##3##4##(2008-10#2)(2008-3#1)
A simple and selective method for rapid##2##7##(2008-10#2)
A simple and selective method##4##5##(2008-10#4)
A simple and selective##6##4##(2008-10#6)
A simple and sensitive capillary electrophoretic##2##6##(2008-10#2)
A simple and sensitive flow injection##2##6##(2008-10#2)
A simple and sensitive flow##3##5##(1990-12#1)(2008-10#2)
A simple and sensitive method for the determination of##3##9##(2008-10#3)
A simple and sensitive method for the##4##7##(2008-10#4)
A simple and sensitive method##7##5##(2008-10#6)(2011-1#1)
A simple and sensitive##27##4##(1990-12#1)(2008-10#23)(2008-3#1)(2011-1#1)(2011-2#1)
A simple and##96##3##(1990-12#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#71)(2008-11#2)(2008-2#1)(2008-3#9)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)
A simple but##3##3##(2008-10#2)(2008-3#1)
A simple device##2##3##(2007-11#1)(2008-10#1)
A simple fabrication technique##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
A simple flow injection system##2##5##(2008-10#2)
A simple flow injection##7##4##(2008-10#7)
A simple flow##8##3##(2008-10#8)
A simple mathematical model##2##4##(2007-12#1)(2008-9#1)
A simple method for improving the##3##6##(2007-11#1)(2008-3#2)
A simple method for measuring the##2##6##(2007-11#1)(2008-3#1)
A simple method for the rapid##2##6##(2008-10#2)
A simple method for the##6##5##(2008-10#6)
A simple method for##20##4##(1997-7#1)(2007-11#2)(2008-10#10)(2008-2#2)(2008-3#4)(2012-2#1)
A simple method has been developed for##2##7##(2008-10#2)
A simple method has been##3##5##(2008-10#2)(2010-8#1)
A simple method is##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
A simple method of measuring the##2##6##(2008-2#1)(2008-3#1)
A simple method of##7##4##(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)
A simple method to##3##4##(2008-6#1)(2008-8#1)(2011-2#1)
A simple method was##2##4##(2008-10#1)(2008-5#1)
A simple method##38##3##(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
A simple methodology##2##3##(1996-3#1)(2008-7#1)
A simple model for##3##4##(1990-8#1)(2008-3#1)(2012-12#1)
A simple model is presented##2##5##(2008-11#1)(2008-2#1)
A simple model of##2##4##(2008-3#1)(2013-8#1)
A simple model that##2##4##(2008-7#1)(2008-8#1)
A simple model was##2##4##(2008-10#1)(2008-7#1)
A simple model##15##3##(1990-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2012-12#1)(2013-8#1)
A simple pneumonia##2##3##(2008-11#2)
A simple procedure for the determination of##2##7##(2008-10#2)
A simple procedure for the##3##5##(2008-10#3)
A simple procedure##5##3##(2008-10#4)(2008-4#1)
A simple quantitative##2##3##(2008-10#2)
A simple reverse##2##3##(2008-10#2)
A simple spectrophotometric##2##3##(2008-10#2)
A simple strategy##2##3##(2007-8#1)(2008-10#1)
A simple technique for##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
A simple technique##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
A simple theoretical model##3##4##(1990-12#1)(2008-10#1)(2008-2#1)
A simple theoretical##5##3##(1990-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
A simple##346##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-11#9)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#204)(2008-11#6)(2008-12#3)(2008-2#13)(2008-3#42)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
A simpler##2##2##(2008-10#1)(2008-9#1)
A simplified approach##2##3##(2008-1#1)(2012-3#1)
A simplified method for##2##4##(1992-12#1)(2008-2#1)
A simplified model of##2##4##(2007-11#1)(2008-7#1)
A simplified model##4##3##(2007-11#1)(2008-2#1)(2008-7#1)(2009-8#1)
A simplified##13##2##(1990-12#1)(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-8#1)(2012-3#1)
A simulation model##2##3##(2007-12#2)
A simulation of##3##3##(2008-3#3)
A simulation study was##2##4##(2008-10#1)(2008-7#1)
A simulation study##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
A simulation##11##2##(1995-1#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-3#4)(2008-7#1)(2008-9#1)
A simultaneous##9##2##(2007-11#1)(2008-10#7)(2013-1#1)
A single administration of##2##4##(1990-7#1)(1997-7#1)
A single amino##2##3##(2008-10#2)
A single case##2##3##(1993-9#1)(2010-9#1)
A single cell##2##3##(2007-12#2)
A single dose of##2##4##(1994-2#1)(2010-1#1)
A single gene##2##3##(2008-10#2)
A single injection##2##3##(1992-10#1)(2008-8#1)
A single laser##2##3##(1990-12#1)(2008-2#1)
A single population of##2##4##(1990-8#1)(1996-2#1)
A single short##2##3##(2007-12#1)(2008-10#1)
A single##96##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
A single-centre##2##2##(2007-5#1)(2010-12#1)
A site##2##2##(1994-5#1)(2008-11#1)
A skin biopsy specimen##2##4##(2007-9#1)(2010-6#1)
A skin##5##2##(2007-9#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
A slab##2##2##(2008-10#1)(2008-3#1)
A slight but significant##3##4##(1991-4#1)(2008-5#1)(2012-3#1)
A slight loss of abduction and minimal loss of external rotation was found in patients but there was no recurrence of complete dislocations or subluxations##2##25##(2007-11#2)
A slight##9##2##(1991-4#1)(1991-5#1)(1993-12#1)(1996-9#1)(1997-2#1)(2007-11#2)(2008-5#1)(2012-3#1)
A slope efficiency of 0##2##5##(2007-11#2)
A slope efficiency of##3##4##(2007-11#2)(2008-2#1)
A slope##4##2##(2007-11#2)(2008-10#1)(2008-2#1)
A slow##2##2##(1995-12#1)(2008-6#1)
A small aliquot##2##3##(2008-10#2)
A small group of##2##4##(1995-12#1)(2008-7#1)
A small number of##3##4##(2008-7#1)(2008-9#1)(2009-3#1)
A small portion##2##3##(2008-10#2)
A small proportion of##2##4##(1994-9#1)(1996-5#1)
A small scale##2##3##(2010-8#1)(2011-2#1)
A small subset of##2##4##(1995-3#1)(1996-5#1)
A small##46##2##(1990-3#1)(1992-2#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-5#2)(1997-3#1)(2007-11#2)(2007-7#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-2#1)
A smaller##3##2##(1991-5#1)(1995-12#1)(2008-7#1)
A smooth##2##2##(2008-10#1)(2011-1#1)
A social##6##2##(1991-12#1)(1992-3#1)(1993-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
A sodium##2##2##(1990-8#1)(2008-10#1)
A software##5##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
A sol-gel##2##2##(2008-10#2)
A solid immersion lens##2##4##(2007-12#1)(2008-3#1)
A solid##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
A solid-liquid extraction##2##3##(2008-10#2)
A solid-phase extraction##2##3##(2008-10#2)
A solid-phase##3##2##(2008-10#3)
A solitary##2##2##(2007-7#1)(2008-9#1)
A soluble##4##2##(1990-5#1)(1993-8#1)(1994-2#1)(2008-10#1)
A solution of 0##3##4##(2008-10#3)
A solution of the##3##4##(2008-10#2)(2008-2#1)
A solution of##9##3##(2008-10#7)(2008-2#1)(2008-4#1)
A solution##13##2##(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#1)
A solutions##2##2##(1990-12#1)(1990-8#1)
A solvent extraction##3##3##(2008-10#3)
A spatial##6##2##(1992-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
A spatially##3##2##(2008-10#1)(2008-3#2)
A spatiotemporal##3##2##(2008-10#1)(2008-3#2)
A special feature of the##2##5##(1997-8#1)(2008-2#1)
A special##22##2##(1990-6#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)
A specially designed##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)
A specially##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
A speciation##3##2##(2008-10#2)(2013-1#1)
A specific##18##2##(1990-11#1)(1990-8#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
A specifically designed##2##3##(1990-3#1)(2008-3#1)
A specimen##2##2##(1995-3#1)(2008-5#1)
A spectral##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
A spectrofluorimetric method for the determination of##2##7##(2008-10#2)
A spectrofluorimetric method for the##3##5##(2008-10#3)
A spectrofluorimetric method has been developed for the determination of##2##10##(2008-10#2)
A spectrofluorimetric method to determine##2##5##(2008-10#2)
A spectrofluorimetric method##7##3##(2008-10#7)
A spectrometer##2##2##(2008-3#2)
A spectrometric##2##2##(2008-10#2)
A spectrophotometric method for the determination of##3##7##(2008-10#3)
A spectrophotometric method for##4##4##(2008-10#4)
A spectrophotometric method was##3##4##(2008-10#3)
A spectrophotometric method##8##3##(2008-10#8)
A spectrophotometric##13##2##(2008-10#12)(2009-8#1)
A spherical##2##2##(2007-12#2)
A split plot##2##3##(2007-11#1)(2008-12#1)
A split##3##2##(1992-10#1)(2007-11#1)(2008-12#1)
A spokesman for##2##3##(1995-6#2)
A spontaneously##2##2##(1992-9#1)(1995-8#1)
A spot##2##2##(2008-10#1)(2008-11#1)
A square wave##2##3##(2008-10#2)
A square-wave##2##2##(2008-10#2)
A stability##2##2##(2008-5#2)
A stabilized##2##2##(2007-12#1)(2011-2#1)
A stable##9##2##(1992-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
A staff##2##2##(1994-2#1)(2008-9#1)
A standard operational definition of CS would enable consistency as clinicians interpret research findings and facilitate translating research to practice##2##20##(2013-1#2)
A standard or sample solution was injected into the##2##9##(2008-10#2)
A standard or sample##3##4##(2008-10#3)
A standard##17##2##(2008-10#8)(2008-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#2)
A standardized##4##2##(1994-12#1)(1997-1#1)(2012-3#1)(2013-8#1)
A stapled side-to-side##2##3##(2013-1#2)
A statement of the##2##4##(2008-3#1)(2009-11#1)
A static##2##2##(1991-6#1)(2008-3#1)
A statistical analysis of the##4##5##(2008-10#1)(2008-11#2)(2008-3#1)
A statistical analysis of##5##4##(1993-9#1)(2008-10#1)(2008-11#2)(2008-3#1)
A statistical analysis##6##3##(1990-5#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-3#1)
A statistical model##3##3##(1992-2#1)(1995-12#1)(2008-2#1)
A statistical##14##2##(1990-5#1)(1992-2#1)(1993-9#1)(1995-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)
A statistically significant correlation was##2##5##(1995-5#1)(2008-5#1)
A statistically significant difference##2##4##(1993-2#1)(2009-11#1)
A statistically significant survival##2##4##(2013-1#1)(2013-8#1)
A statistically significant##14##3##(1990-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-5#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
A statistically##15##2##(1990-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-5#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-3#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
A status##2##2##(2007-11#1)(2007-12#1)
A steady state##2##3##(1993-12#1)(1995-3#1)
A steady-state##2##2##(2008-10#1)(2008-7#1)
A steep##2##2##(1992-6#1)(1995-12#1)
A step##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
A stepwise regression##2##3##(1996-3#1)(2008-9#1)
A stepwise##3##2##(1996-3#1)(2008-10#1)(2008-9#1)
A stereospecific##2##2##(2008-11#1)(2009-11#1)
A sterile##2##2##(2008-10#1)(2012-2#1)
A stimulation index##2##3##(2010-4#1)(2011-2#1)
A stimulation##4##2##(1993-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
A stimulus##2##2##(1997-2#1)(2008-9#1)
A stochastic##6##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)
A stoichiometric##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
A stopped-flow##5##2##(2008-10#4)(2008-4#1)
A story##2##2##(2011-1#1)(2013-8#1)
A straightforward##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
A strain of##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
A strain##6##2##(1991-7#1)(2008-10#3)(2008-8#1)(2011-2#1)
A strains##6##2##(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#1)
A strategic##3##2##(1992-12#1)(1995-3#1)(2012-2#1)
A strategy for the##3##4##(1992-9#1)(1995-3#1)(2008-11#1)
A strategy for##7##3##(1992-9#1)(1995-3#1)(1996-4#1)(1997-3#1)(2008-11#2)(2008-12#1)
A strategy that##2##3##(1995-6#1)(2008-10#1)
A strategy to##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
A strategy##15##2##(1992-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2010-10#1)(2012-3#1)
A stratified sample##2##3##(2010-1#1)(2011-1#1)
A streptococcal##5##2##(1991-8#1)(1995-6#1)(2007-12#2)(2008-10#1)
A stress##2##2##(2007-7#1)(2008-11#1)
A stretch of##2##3##(1995-8#2)
A strict##2##2##(1990-2#1)(1990-8#1)
A striking feature##2##3##(1994-5#1)(1996-6#1)
A striking##5##2##(1991-12#1)(1993-11#1)(1994-5#1)(1996-6#1)(2007-12#1)
A strong correlation##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
A strong relationship##2##3##(2007-10#1)(2012-2#1)
A strong##24##2##(1991-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
A strongly##3##2##(1993-8#1)(1994-5#1)(2008-10#1)
A structural##5##2##(1996-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
A structured interview##2##3##(2008-1#1)(2012-3#1)
A structured##4##2##(2007-7#1)(2008-1#1)(2012-3#1)(2013-1#1)
A structures##2##2##(1990-7#1)(1993-8#1)
A study from##2##3##(2009-10#1)(2012-12#1)
A study has been##2##4##(2007-12#1)(2008-10#1)
A study in##4##3##(1991-8#1)(1997-2#1)(2009-8#1)(2013-8#1)
A study is##2##3##(2008-10#2)
A study of a##2##4##(2008-10#1)(2012-3#1)
A study of the effect of##2##6##(2008-10#1)(2008-7#1)
A study of the effects of##2##6##(2008-1#1)(2008-9#1)
A study of the##27##4##(1990-2#1)(1990-3#1)(1990-7#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-8#1)
A study of##78##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-7#3)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-7#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-8#2)
A study on the interaction##2##5##(2008-10#2)
A study on the##8##4##(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#1)(2013-8#1)
A study on##18##3##(1995-6#1)(2006-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
A study to##3##3##(1991-3#1)(2008-11#1)(2011-1#1)
A study was conducted on##2##5##(1997-6#1)(2008-7#1)
A study was conducted to##5##5##(1993-1#1)(1994-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
A study was conducted##8##4##(1993-1#2)(1994-1#1)(1997-6#1)(2008-10#1)(2008-7#2)(2009-5#1)
A study was designed to##2##5##(1992-1#1)(2008-10#1)
A study was##15##3##(1990-11#1)(1991-1#1)(1992-1#1)(1993-1#2)(1994-1#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-5#1)(2012-3#1)
A study##134##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#5)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-5#4)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#4)(2009-5#2)(2009-7#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#1)(2013-8#4)
A sub-second##2##2##(2008-10#2)
A subcutaneous mass##2##3##(2008-10#1)(2012-1#1)
A subsequent##3##2##(1992-2#1)(2007-10#1)(2008-10#1)
A subset of these##3##4##(1995-5#1)(2008-10#2)
A subset of##12##3##(1991-5#1)(1995-5#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)
A substance##2##2##(1991-1#1)(2008-9#1)
A substantial increase in the##2##5##(1997-3#1)(2008-10#1)
A substantial increase in##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
A substantial proportion##2##3##(2006-8#1)(2008-12#1)
A substantial##9##2##(1994-2#1)(1997-3#1)(2006-8#1)(2008-10#2)(2008-11#3)(2008-12#1)
A substitution##2##2##(1990-8#1)(1991-2#1)
A subunit##8##2##(1995-2#1)(1995-6#7)
A subunits##2##2##(1993-11#1)(2009-2#1)
A success##2##2##(2008-10#1)(2008-11#1)
A successful pregnancy##2##3##(2010-8#1)(2012-3#1)
A successful##13##2##(1991-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
A succinct##2##2##(2008-10#1)(2008-3#1)
A suggested##2##2##(2010-4#1)(2013-1#1)
A suggestion is##2##3##(2008-10#1)(2010-8#1)
A suitable approach for##2##4##(2008-11#1)(2008-3#1)
A suitable##7##2##(2008-10#3)(2008-11#3)(2008-3#1)
A sulfate##2##2##(2008-10#1)(2013-1#1)
A summary of the##4##4##(2007-3#1)(2008-11#1)(2010-11#1)(2010-5#1)
A summary of##7##3##(1992-3#1)(2007-3#1)(2008-11#2)(2008-9#1)(2010-11#1)(2010-5#1)
A supplementation##4##2##(1991-8#1)(2007-11#2)(2010-5#1)
A support protocol describes a method for##2##7##(2008-2#1)(2008-4#1)
A support protocol describes a##3##5##(2008-2#1)(2008-4#2)
A support protocol describes the preparation of##2##7##(2008-4#2)
A support protocol describes the##5##5##(2008-4#5)
A support protocol describes##14##4##(2008-2#2)(2008-4#11)(2008-9#1)
A support protocol details##2##4##(2008-4#2)
A support protocol##19##3##(2008-2#2)(2008-4#16)(2008-9#1)
A supportive##2##2##(2008-11#1)(2009-7#1)
A surface plasmon resonance (SPR)##3##5##(2008-10#3)
A surface plasmon resonance##5##4##(2008-10#5)
A surface plasmon##6##3##(2007-11#1)(2008-10#5)
A surface##7##2##(2007-11#1)(2008-10#5)(2008-3#1)
A surgical##3##2##(1991-8#1)(2007-8#1)(2008-11#1)
A surprising##2##2##(2007-2#1)(2008-6#1)
A survey conducted##2##3##(1996-9#1)(2013-1#1)
A survey in##4##3##(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#1)
A survey of 45##2##4##(1993-10#1)(1995-1#1)
A survey of mycotic otitis externa of dogs in##2##9##(2008-5#2)
A survey of physicians'##2##4##(1991-3#1)(2011-2#1)
A survey of the##5##4##(1994-2#1)(1994-6#1)(1996-9#1)(2008-11#1)(2010-3#1)
A survey of##40##3##(1991-1#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-7#1)(1993-10#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-1#1)(1996-9#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
A survey was conducted in##2##5##(2011-2#1)(2012-12#1)
A survey was conducted to##3##5##(2008-10#1)(2013-1#2)
A survey was conducted##8##4##(1996-1#1)(1997-5#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#2)
A survey was mailed to##2##5##(1994-1#1)(2007-10#1)
A survey was##14##3##(1994-1#1)(1996-1#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
A survey##72##2##(1990-8#1)(1991-1#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-11#1)(1994-1#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-12#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
A susceptible##2##2##(2008-10#2)
A sustained##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
A symmetrical##2##2##(2008-3#1)(2011-2#1)
A synopsis of##2##3##(2008-11#1)(2010-12#1)
A synopsis##3##2##(1991-3#1)(2008-11#1)(2010-12#1)
A synthesis of##2##3##(1996-5#1)(2007-6#1)
A synthesized##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
A synthetic peptide##2##3##(1995-2#1)(2008-8#1)
A synthetic##12##2##(1990-11#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-3#1)
A system for##9##3##(1995-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-8#1)
A system of##5##3##(1992-3#1)(2008-12#1)(2008-2#1)(2008-3#2)
A system##19##2##(1992-3#1)(1995-9#1)(1997-2#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2010-8#1)
A systematic approach to the##2##5##(2008-3#1)(2009-9#1)
A systematic approach to##3##4##(2008-11#1)(2008-3#1)(2009-9#1)
A systematic approach##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)
A systematic investigation of the photophysics and photochemistry of purified##2##10##(2010-2#2)
A systematic investigation of##3##4##(2008-3#1)(2010-2#2)
A systematic investigation##4##3##(2008-3#1)(2010-2#2)(2011-2#1)
A systematic literature##2##3##(2011-2#1)(2012-12#1)
A systematic review of the literature##2##6##(2011-2#1)(2012-2#1)
A systematic review of the##4##5##(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
A systematic review of##9##4##(1995-9#1)(2008-11#1)(2008-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
A systematic review on##2##4##(2012-12#2)
A systematic review was conducted##2##5##(2007-11#1)(2011-2#1)
A systematic review was##3##4##(2007-11#1)(2011-2#1)(2012-12#1)
A systematic review##16##3##(1995-9#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#1)
A systematic search##2##3##(2012-2#1)(2013-8#1)
A systematic study of the##2##5##(2008-10#2)
A systematic study##4##3##(2008-10#3)(2009-5#1)
A systematic##51##2##(1991-6#1)(1995-9#1)(1997-9#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#2)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#3)(2013-1#2)(2013-8#1)
A systemic##3##2##(1996-6#1)(2009-10#1)(2013-1#1)
A systems approach to##2##4##(1992-2#1)(1997-2#1)
A systems approach##3##3##(1992-2#1)(1997-2#1)(2008-11#1)
A systems biology approach##2##4##(2010-5#1)(2010-9#1)
A systems##5##2##(1992-2#1)(1997-2#1)(2008-11#1)(2010-5#1)(2010-9#1)
A t##2##2##(1995-1#1)(2008-11#1)
A tail##8##2##(1992-9#1)(1994-11#1)(2011-2#6)
A tale of two##3##4##(1993-9#1)(2009-3#1)(2009-5#1)
A talon cusp is##2##4##(2012-2#2)
A tandem##2##2##(2008-10#1)(2011-3#1)
A target##2##2##(2008-10#1)(2008-3#1)
A team approach to##2##4##(1994-2#2)
A team approach##3##3##(1994-2#2)(2010-5#1)
A team##4##2##(1994-2#2)(2010-5#2)
A technical note##2##3##(2011-2#1)(2012-2#1)
A technique based on##2##4##(1996-2#1)(2008-10#1)
A technique based##3##3##(1996-2#1)(2008-10#2)
A technique for measuring##2##4##(1991-5#1)(2008-3#1)
A technique for the##2##4##(2008-10#1)(2008-3#1)
A technique for##12##3##(1991-5#1)(2007-12#1)(2008-10#2)(2008-3#7)(2009-2#1)
A technique in which##2##4##(2008-2#1)(2008-3#1)
A technique is described for##2##5##(2007-8#1)(2008-2#1)
A technique is presented##3##4##(2007-12#1)(2008-3#2)
A technique is proposed for##2##5##(2007-11#1)(2008-3#1)
A technique is proposed##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
A technique is##9##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#3)
A technique of##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
A technique to##3##3##(2008-2#1)(2008-3#2)
A technique##38##2##(1991-5#1)(1996-2#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#7)(2008-2#5)(2008-3#15)(2009-2#1)(2011-2#1)(2012-1#1)
A temperature##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
A temperature-based##2##2##(2008-10#2)
A temperature-sensitive##2##2##(1995-8#1)(2008-1#1)
A temporal##3##2##(1997-8#1)(2007-11#1)(2008-3#1)
A temporary##2##2##(2008-10#2)
A tendency to##2##3##(2008-10#1)(2013-1#1)
A tendency was##2##3##(1993-3#1)(2008-11#1)
A tendency##5##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
A tentative approach##2##3##(2008-10#2)
A tentative##5##2##(1996-5#1)(1997-3#1)(2008-10#3)
A test of##3##3##(1992-1#1)(1997-8#1)(2011-2#1)
A test##9##2##(1992-1#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
A testicular##3##2##(1995-6#1)(1997-3#1)(2009-11#1)
A that##5##2##(1992-11#1)(1993-6#1)(1994-5#1)(2011-2#1)(2012-1#1)
A the##2##2##(2008-1#1)(2011-1#1)
A theoretical analysis and##2##4##(2008-3#2)
A theoretical analysis of##4##4##(1993-9#1)(1997-3#1)(2008-2#1)(2008-3#1)
A theoretical analysis##10##3##(1993-9#1)(1997-3#1)(2007-12#1)(2008-2#3)(2008-3#4)
A theoretical and experimental study##2##5##(2008-3#2)
A theoretical description of##2##4##(2008-2#1)(2008-3#1)
A theoretical description##3##3##(2008-2#2)(2008-3#1)
A theoretical model for##2##4##(2007-11#1)(2008-3#1)
A theoretical model of the##2##5##(2008-3#2)
A theoretical model of##3##4##(2007-12#1)(2008-3#2)
A theoretical model##12##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2010-11#1)
A theoretical study has been##2##5##(2008-10#1)(2008-3#1)
A theoretical study##3##3##(2008-10#1)(2008-3#2)
A theoretical treatment##2##3##(2008-2#1)(2008-3#1)
A theoretical##44##2##(1991-1#1)(1991-2#1)(1992-3#1)(1993-9#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#10)(2008-3#16)(2008-7#2)(2010-11#1)
A theory of the##2##4##(2008-2#1)(2008-3#1)
A theory of##5##3##(2008-2#2)(2008-3#2)(2008-8#1)
A theory##10##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#1)(2009-10#1)
A therapeutic##4##2##(1991-2#1)(1992-12#1)(2010-6#1)(2013-1#1)
A thermal##2##2##(2008-3#2)
A thermodynamic study##2##3##(1990-8#1)(2008-10#1)
A thermodynamic##5##2##(1990-8#2)(1994-12#1)(1997-2#1)(2008-10#1)
A thick##2##2##(1995-11#1)(2012-12#1)
A thickness##2##2##(2008-10#1)(2008-3#1)
A thin##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2012-1#1)
A thioester##2##2##(1994-8#2)
A third##15##2##(1991-8#1)(1993-12#1)(1995-6#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
A thorough understanding of the##4##5##(1995-12#1)(2007-12#1)(2008-8#1)(2011-2#1)
A thorough understanding of##6##4##(1993-1#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-8#1)(2011-2#1)
A thorough##12##2##(1990-6#1)(1993-1#1)(1995-12#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
A three##7##2##(1991-5#1)(1991-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-7#1)
A three-day##2##2##(1997-8#1)(2008-8#1)
A three-dimensional (3-D)##2##3##(2008-3#2)
A three-dimensional##6##2##(1991-6#1)(2008-3#5)
A three-electrode##3##2##(2008-10#2)(2009-9#1)
A three-layered feed-forward artificial neural network (ANN)##2##7##(2008-10#2)
A three-mirror##2##2##(2007-11#1)(2008-3#1)
A three-year##2##2##(1996-6#1)(2008-12#1)
A threshold##5##2##(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
A throughput of##2##3##(2008-10#2)
A time##7##2##(1990-12#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
A time-domain##2##2##(2008-3#2)
A time-resolved##3##2##(1990-8#1)(2007-12#1)(2008-3#1)
A tissue##3##2##(2008-3#1)(2008-5#1)(2011-1#1)
A to E##2##3##(2006-10#1)(2010-2#1)
A to G##6##3##(1990-12#1)(1990-5#1)(1990-8#1)(2008-12#1)(2008-6#1)(2012-12#1)
A to the##2##3##(2008-10#1)(2008-3#1)
A to##18##2##(1990-12#2)(1990-5#1)(1990-8#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2010-2#1)(2012-12#1)
A tool to##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
A tool##6##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
A total of 1##13##4##(1990-9#2)(1991-6#1)(1994-11#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
A total of 10##4##4##(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#1)
A total of 100##2##4##(2008-7#1)(2008-9#1)
A total of 101##3##4##(2007-8#1)(2008-12#1)(2013-8#1)
A total of 103##2##4##(1995-11#1)(1996-1#1)
A total of 104##2##4##(2011-2#1)(2013-7#1)
A total of 105##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
A total of 108##2##4##(2008-10#1)(2008-8#1)
A total of 11##6##4##(2007-7#1)(2008-10#2)(2010-4#1)(2011-1#1)(2013-7#1)
A total of 111##2##4##(2007-7#1)(2013-1#1)
A total of 114##3##4##(1995-5#1)(2012-3#1)(2013-8#1)
A total of 117##2##4##(2008-10#1)(2008-3#1)
A total of 118##2##4##(2008-3#1)(2010-4#1)
A total of 119##2##4##(2008-7#1)(2013-7#1)
A total of 12##4##4##(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
A total of 122##3##4##(1995-6#1)(2007-7#1)(2008-8#1)
A total of 123##3##4##(1996-11#1)(2012-2#1)(2013-8#1)
A total of 124##3##4##(1997-8#1)(2012-2#1)(2013-3#1)
A total of 126##2##4##(2008-10#1)(2008-5#1)
A total of 13##2##4##(1997-8#1)(2007-10#1)
A total of 135##2##4##(2008-5#1)(2010-8#1)
A total of 14##4##4##(1993-12#1)(2008-10#1)(2013-1#1)(2013-7#1)
A total of 149##2##4##(2008-1#1)(2013-1#1)
A total of 15##5##4##(2008-10#1)(2008-11#2)(2013-7#2)
A total of 153##2##4##(2008-11#1)(2013-8#1)
A total of 155##2##4##(1994-3#1)(2013-7#1)
A total of 156##2##4##(2008-11#1)(2010-12#1)
A total of 159##2##4##(2011-2#1)(2012-2#1)
A total of 16##4##4##(1996-6#1)(2008-7#1)(2009-6#1)(2013-8#1)
A total of 161##2##4##(1994-12#1)(2008-12#1)
A total of 163##2##4##(2008-10#1)(2008-12#1)
A total of 168##2##4##(2010-2#1)(2012-2#1)
A total of 170##2##4##(2011-1#1)(2012-2#1)
A total of 171##2##4##(1995-8#1)(2008-7#1)
A total of 18 studies##2##5##(2007-12#1)(2008-8#1)
A total of 18##3##4##(1996-3#1)(2007-12#1)(2008-8#1)
A total of 19##8##4##(1996-6#1)(1997-8#1)(2008-5#1)(2010-4#1)(2010-9#1)(2013-1#2)(2013-8#1)
A total of 2##2##4##(1996-3#1)(2010-10#1)
A total of 20##5##4##(1997-6#1)(2008-10#2)(2008-3#1)(2011-1#1)
A total of 200##3##4##(2007-10#1)(2007-8#1)(2013-8#1)
A total of 21##4##4##(1990-8#1)(2008-10#2)(2008-5#1)
A total of 210##4##4##(2008-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
A total of 22##5##4##(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
A total of 223##2##4##(1994-3#1)(2010-3#1)
A total of 23##2##4##(2010-5#1)(2013-1#1)
A total of 237##2##4##(2008-10#1)(2012-3#1)
A total of 24##6##4##(1990-12#1)(1993-1#1)(1997-8#1)(2008-9#1)(2009-1#1)(2009-7#1)
A total of 240##2##4##(2007-7#1)(2008-5#1)
A total of 244##2##4##(2008-10#1)(2008-7#1)
A total of 25##4##4##(2008-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
A total of 258##2##4##(2008-7#1)(2010-5#1)
A total of 26##4##4##(1993-12#1)(2008-7#1)(2010-3#1)(2011-2#1)
A total of 27##3##4##(2010-6#1)(2012-2#1)(2013-1#1)
A total of 28##3##4##(1997-4#1)(2008-1#1)(2012-3#1)
A total of 3##4##4##(1991-9#1)(1993-1#1)(2012-6#1)(2013-1#1)
A total of 30 healthy##2##5##(2008-5#1)(2011-2#1)
A total of 30 patients with##2##6##(2008-3#1)(2013-1#1)
A total of 30 patients##4##5##(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
A total of 30##7##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
A total of 300##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
A total of 32##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
A total of 33##4##4##(2007-7#1)(2008-10#1)(2008-9#1)(2010-3#1)
A total of 34##4##4##(1993-3#1)(1995-4#1)(2008-7#1)(2010-5#1)
A total of 35##2##4##(2012-2#1)(2013-8#1)
A total of 360##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
A total of 40##6##4##(2008-10#1)(2009-8#1)(2012-3#1)(2013-1#3)
A total of 44##2##4##(1997-6#1)(2007-7#1)
A total of 45##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
A total of 46##2##4##(2008-6#1)(2013-7#1)
A total of 469##2##4##(1994-12#1)(2008-10#1)
A total of 5##2##4##(2010-5#1)(2013-1#1)
A total of 50##2##4##(2008-11#1)(2008-8#1)
A total of 52 patients were##2##6##(2008-4#1)(2008-7#1)
A total of 56##2##4##(2008-10#1)(2013-8#1)
A total of 57##3##4##(2007-7#1)(2011-2#1)(2012-3#1)
A total of 59##2##4##(2007-7#1)(2013-1#1)
A total of 60##4##4##(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
A total of 64##2##4##(2008-10#1)(2011-2#1)
A total of 65##2##4##(2008-1#1)(2011-2#1)
A total of 67##2##4##(2012-3#1)(2013-7#1)
A total of 69##2##4##(2009-5#1)(2011-1#1)
A total of 7##2##4##(2007-7#1)(2008-7#1)
A total of 71##2##4##(1994-1#1)(2013-7#1)
A total of 79##3##4##(1996-12#1)(2008-5#1)(2011-1#1)
A total of 80##6##4##(2008-10#3)(2008-7#1)(2011-1#1)(2013-1#1)
A total of 84##2##4##(2008-5#1)(2013-1#1)
A total of 9##4##4##(1993-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
A total of 96##2##4##(2008-5#1)(2010-2#1)
A total of 99 patients##3##5##(2007-8#1)(2008-1#1)(2008-5#1)
A total of five##2##4##(1993-2#1)(2008-10#1)
A total of nine##2##4##(1994-8#1)(1995-2#1)
A total of six##2##4##(1995-6#1)(2011-3#1)
A total of##424##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#3)(1996-6#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(2006-12#1)(2007-10#4)(2007-12#1)(2007-5#1)(2007-7#18)(2007-8#5)(2008-1#8)(2008-10#53)(2008-11#8)(2008-12#12)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#23)(2008-6#2)(2008-7#18)(2008-8#7)(2008-9#6)(2009-1#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#9)(2010-5#4)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#18)(2011-2#24)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#12)(2012-6#1)(2013-1#31)(2013-3#1)(2013-7#13)(2013-8#17)
A total##436##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-5#2)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#3)(1996-6#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(2006-12#1)(2007-10#4)(2007-12#2)(2007-5#1)(2007-7#18)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#54)(2008-11#10)(2008-12#12)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#23)(2008-6#2)(2008-7#18)(2008-8#7)(2008-9#6)(2009-1#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#9)(2010-5#4)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#20)(2011-2#24)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#13)(2012-6#1)(2013-1#31)(2013-3#1)(2013-7#13)(2013-8#17)
A toxic protein##2##3##(1992-3#2)
A toxin##2##2##(2008-10#1)(2008-2#1)
A traditional##3##2##(2008-3#1)(2012-2#1)(2012-3#1)
A training set##2##3##(2008-10#1)(2009-3#1)
A training##3##2##(1993-6#1)(2008-10#1)(2009-3#1)
A transcription##2##2##(1991-6#1)(1992-2#1)
A transesophageal echocardiography revealed an anterior displacement of the mitral valve anterior leaflet##2##13##(2013-1#2)
A transfer##2##2##(1990-2#1)(2008-2#1)
A transformation##2##2##(1993-12#1)(2008-2#1)
A transgenic##2##2##(1996-5#1)(2013-8#1)
A transition##4##2##(1993-3#2)(1994-12#1)(2008-10#1)
A transversion##2##2##(1992-8#1)(1994-11#1)
A traumatic##2##2##(2006-12#1)(2012-3#1)
A treatment in##2##3##(1997-7#1)(1997-8#1)
A treatment##5##2##(1991-1#1)(1991-2#1)(1997-7#1)(1997-8#1)(2008-5#1)
A trend##4##2##(1990-12#1)(1991-2#1)(1994-2#1)(2013-1#1)
A triad##2##2##(2007-12#1)(2013-8#1)
A trial was conducted to##2##5##(2008-12#1)(2011-2#1)
A trial##7##2##(1991-9#1)(2007-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)
A tribute to##2##3##(2008-11#1)(2008-3#1)
A tripartite##2##2##(1997-2#1)(2008-11#1)
A true##4##2##(1992-3#1)(1997-3#1)(2008-7#1)(2012-2#1)
A truly##2##2##(2008-10#1)(2012-3#1)
A tube##2##2##(1990-12#1)(2008-10#1)
A tumor##2##2##(1994-7#1)(2008-1#1)
A tunable##6##2##(2007-11#2)(2008-2#1)(2008-3#2)(2011-1#1)
A two##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
A two-channel##2##2##(2008-10#1)(2008-3#1)
A two-dimensional##7##2##(2007-12#1)(2008-2#2)(2008-3#3)(2009-7#1)
A two-level##2##2##(2008-10#2)
A two-locus##2##2##(2008-10#1)(2011-2#1)
A two-mirror##2##2##(2008-2#2)
A two-phase##2##2##(1992-12#1)(1996-5#1)
A two-stage process##2##3##(2008-11#1)(2008-6#1)
A two-stage##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
A two-step##7##2##(1995-6#1)(1996-5#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-8#1)
A two-wavelength##2##2##(2008-3#2)
A type##3##2##(1992-6#1)(2010-11#1)(2013-1#1)
A typical##18##2##(1990-8#1)(1994-8#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
A typology of##2##3##(2008-12#1)(2013-8#1)
A unified##7##2##(1994-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#2)
A uniform##2##2##(2010-3#1)(2010-4#1)
A unifying##2##2##(2008-4#1)(2008-8#1)
A unilateral##4##2##(1994-2#2)(1996-12#1)(2007-8#1)
A unique approach##2##3##(1995-2#1)(2008-7#1)
A unique case of##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
A unique feature of this##2##5##(2008-10#1)(2008-3#1)
A unique feature of##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
A unique##28##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2013-1#1)
A unit increase in RVUs was##2##6##(2013-1#2)
A universal##2##2##(1994-12#1)(2008-3#1)
A useful alternative##2##3##(2008-10#1)(2008-2#1)
A useful##11##2##(1995-8#1)(1996-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
A vaccine##5##2##(1994-8#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-7#1)
A validated##4##2##(2008-10#3)(2012-12#1)
A validation##4##2##(2008-1#1)(2008-10#2)(2010-8#1)
A valuable##2##2##(1995-1#1)(2008-9#1)
A value of##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
A value##4##2##(1996-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
A values of##2##3##(1996-7#1)(2011-1#1)
A variable##3##2##(2008-10#2)(2008-2#1)
A variant of##3##3##(1992-12#1)(1997-1#1)(2008-3#1)
A variant##6##2##(1992-12#1)(1995-6#1)(1997-1#1)(2008-3#1)(2010-12#1)(2012-2#1)
A variation in##2##3##(2008-12#1)(2008-5#1)
A variation of##2##3##(1994-12#1)(2008-5#1)
A variation##5##2##(1994-12#1)(2008-12#1)(2008-2#1)(2008-5#2)
A variety of methods##2##4##(2008-4#2)
A variety of molecular##2##4##(2008-10#1)(2010-10#1)
A variety of neuroprotective agents have been##2##7##(2007-9#1)(2008-7#1)
A variety of##33##3##(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-8#1)
A versatile##3##2##(2008-10#1)(2009-9#1)(2010-12#1)
A vertical incision##2##3##(1992-2#1)(2013-1#1)
A very large##2##3##(2007-12#1)(2008-1#1)
A very low##2##3##(2007-11#1)(2013-8#1)
A very sensitive flow##2##4##(2008-10#2)
A very sensitive##3##3##(2008-10#3)
A very significant##2##3##(2008-5#1)(2010-3#1)
A very simple and##3##4##(2008-10#3)
A very simple##11##3##(1992-8#1)(2008-10#9)(2009-6#1)
A very small##4##3##(1990-7#1)(1991-5#1)(2008-11#1)(2013-7#1)
A very stable chelating resin##2##5##(2008-10#2)
A very stable##3##3##(2008-10#2)(2008-5#1)
A very##40##2##(1990-7#1)(1991-5#1)(1992-8#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
A view from##2##3##(2008-11#1)(2009-11#1)
A view##3##2##(1993-5#1)(2008-11#1)(2009-11#1)
A viral##2##2##(2008-10#1)(2008-7#1)
A virtual##2##2##(2007-11#1)(2009-11#1)
A virus (HAV)##5##3##(2007-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-12#1)
A virus##20##2##(1992-9#2)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-7#2)(2009-4#1)(2009-5#1)(2011-2#4)(2012-12#3)(2013-1#1)(2013-8#1)
A viruses##13##2##(1992-9#3)(1994-8#3)(1996-6#2)(2007-12#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#1)
A vision##2##2##(1994-3#1)(2013-8#1)
A visual##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
A voltammetric##2##2##(2008-10#2)
A volume##2##2##(2008-10#1)(2008-3#1)
A vs##3##2##(2008-4#1)(2011-2#2)
A was found to##2##4##(1997-2#1)(2012-2#1)
A was found##4##3##(1997-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
A was the##3##3##(1990-8#1)(2013-8#2)
A was##37##2##(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
A water-soluble porphyrin##2##3##(2008-10#2)
A water-soluble##4##2##(1994-3#1)(2008-10#2)(2008-7#1)
A wavelength##2##2##(1991-3#1)(2008-10#1)
A way to improve##2##4##(1993-3#1)(1997-3#1)
A way to##4##3##(1990-6#1)(1991-12#1)(1993-3#1)(1997-3#1)
A way##5##2##(1990-6#1)(1991-12#1)(1993-3#1)(1997-3#1)(2009-9#1)
A weak##4##2##(2007-10#1)(2007-11#1)(2008-10#2)
A weakness##2##2##(2008-2#1)(2008-5#1)
A web-based##2##2##(2010-4#1)(2013-1#1)
A weighted##2##2##(2008-3#2)
A well##2##2##(2008-10#1)(2012-2#1)
A well-defined##3##2##(2008-10#3)
A well-developed##2##2##(2008-10#1)(2008-7#1)
A well-known##4##2##(2008-10#2)(2008-8#1)(2009-8#1)
A were isolated##2##3##(2008-5#1)(2012-2#1)
A were##15##2##(1992-6#1)(1992-8#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-3#2)(2008-5#3)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
A which##3##2##(1992-11#1)(1993-8#1)(1994-9#1)
A white##2##2##(1992-1#1)(2012-2#1)
A whole##2##2##(1995-2#1)(2011-2#1)
A wide linear##3##3##(2008-10#3)
A wide range of##14##4##(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
A wide variety of sequence analysis tools are available to biologists for this task##2##14##(2008-2#1)(2008-4#1)
A wide variety of##9##4##(1994-12#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#2)(2009-5#1)(2012-2#2)
A wide##32##2##(1994-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2009-5#1)(2009-7#1)(2010-3#1)(2012-2#3)(2013-1#1)
A widely##2##2##(2007-11#1)(2008-10#1)
A widespread##2##2##(2013-1#2)
A wild-type##3##2##(1995-3#1)(1995-8#1)(2008-10#1)
A with the##2##3##(1992-12#1)(2008-3#1)
A with##13##2##(1990-11#1)(1990-12#1)(1992-12#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2010-8#1)(2012-12#1)
A woman aged##2##3##(1997-8#1)(2011-2#1)
A woman##5##2##(1996-3#1)(1996-6#1)(1997-8#1)(2008-11#1)(2011-2#1)
A working##4##2##(1994-1#1)(1994-5#1)(2009-10#1)(2010-1#1)
A worldwide collection of##3##4##(2008-10#3)
A worldwide increase in##2##4##(1992-8#1)(1994-3#1)
A worldwide##5##2##(1992-8#1)(1994-3#1)(2008-10#3)
A written##2##2##(2008-8#1)(2012-1#1)
A young woman##2##3##(1990-2#1)(2009-5#1)
A young##8##2##(1990-2#1)(1992-6#1)(1996-3#1)(2007-7#1)(2007-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
A##16188##1##(1990-10#7)(1990-11#62)(1990-12#110)(1990-2#39)(1990-3#31)(1990-4#1)(1990-5#59)(1990-6#33)(1990-7#35)(1990-8#82)(1990-9#21)(1991-1#27)(1991-10#3)(1991-11#20)(1991-12#79)(1991-2#62)(1991-3#36)(1991-4#8)(1991-5#56)(1991-6#41)(1991-7#4)(1991-8#46)(1991-9#40)(1992-1#32)(1992-10#22)(1992-11#45)(1992-12#85)(1992-2#49)(1992-3#81)(1992-4#15)(1992-5#31)(1992-6#73)(1992-7#6)(1992-8#68)(1992-9#57)(1993-1#32)(1993-10#3)(1993-11#63)(1993-12#74)(1993-2#54)(1993-3#69)(1993-5#9)(1993-6#69)(1993-8#72)(1993-9#35)(1994-1#22)(1994-11#77)(1994-12#101)(1994-2#60)(1994-3#63)(1994-5#69)(1994-6#46)(1994-7#12)(1994-8#100)(1994-9#40)(1995-1#19)(1995-11#51)(1995-12#91)(1995-2#112)(1995-3#74)(1995-4#6)(1995-5#52)(1995-6#92)(1995-8#49)(1995-9#17)(1996-1#32)(1996-10#4)(1996-11#15)(1996-12#81)(1996-2#74)(1996-3#41)(1996-4#5)(1996-5#83)(1996-6#34)(1996-7#8)(1996-8#11)(1996-9#35)(1997-1#40)(1997-2#83)(1997-3#95)(1997-4#42)(1997-5#40)(1997-6#67)(1997-7#68)(1997-8#51)(1997-9#6)(2006-10#19)(2006-12#10)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#8)(2007-1#3)(2007-10#44)(2007-11#308)(2007-12#430)(2007-2#33)(2007-3#2)(2007-4#10)(2007-5#16)(2007-6#13)(2007-7#112)(2007-8#141)(2007-9#22)(2008-1#119)(2008-10#3838)(2008-11#491)(2008-12#214)(2008-2#493)(2008-3#1056)(2008-4#206)(2008-5#345)(2008-6#184)(2008-7#413)(2008-8#260)(2008-9#234)(2009-1#10)(2009-10#53)(2009-11#49)(2009-12#40)(2009-2#17)(2009-3#30)(2009-4#25)(2009-5#75)(2009-6#27)(2009-7#46)(2009-8#71)(2009-9#34)(2010-1#21)(2010-10#54)(2010-11#34)(2010-12#68)(2010-2#37)(2010-3#63)(2010-4#67)(2010-5#66)(2010-6#48)(2010-7#37)(2010-8#82)(2010-9#16)(2011-1#216)(2011-10#2)(2011-2#445)(2011-3#21)(2011-7#2)(2012-1#58)(2012-12#199)(2012-2#222)(2012-3#206)(2012-4#1)(2012-5#1)(2012-6#4)(2012-8#6)(2013-1#418)(2013-3#1)(2013-7#54)(2013-8#218)
A&amp##6##1##(2010-12#2)(2010-4#3)(2013-8#1)
A(1) and##3##2##(2008-10#2)(2008-4#1)
A(1) receptors##3##2##(2008-4#2)(2008-5#1)
A(1)##14##1##(2008-10#5)(2008-11#1)(2008-4#6)(2008-5#1)(2011-1#1)
A(1)R activation##3##2##(2008-4#3)
A(1)Rs##3##1##(2008-4#3)
A(2) and C##2##3##(2008-11#2)
A(2) and##4##2##(2008-11#4)
A(2) mating##2##2##(2008-10#2)
A(2)##15##1##(1997-7#1)(2008-10#3)(2008-11#7)(2008-2#2)(2009-12#1)(2011-2#1)
A(2A) receptor##2##2##(2008-10#1)(2008-4#1)
A(2A)##8##1##(2008-10#2)(2008-4#6)
A(2A)R antagonists##3##2##(2008-4#3)
A(2A)R##4##1##(2008-4#4)
A(2A)Rs##2##1##(2008-4#2)
A(2B)##3##1##(2008-4#3)
A(3) adenosine receptor##4##3##(2008-4#4)
A(3) adenosine##6##2##(2008-4#6)
A(3) receptor##5##2##(2008-4#5)
A(3) subtype##2##2##(2008-4#2)
A(3)##20##1##(2007-11#2)(2008-10#1)(2008-4#17)
A(4)-GAPDH##2##1##(2009-10#2)
A(490##2##1##(2008-11#2)
A(549) cell##2##2##(2008-9#2)
A(549) cells##2##2##(2008-9#2)
A(549)##5##1##(2008-9#5)
A(549)/DDP cells to##2##3##(2008-9#2)
A(549)/DDP cells##6##2##(2008-9#6)
A(H3N2) viruses##4##2##(1994-9#1)(2013-8#3)
A(H3N2)##6##1##(1994-9#2)(2013-8#4)
A(section)E((R))##4##1##(2008-9#4)
A(v' =0)##2##2##(2008-3#2)
A) and the##2##3##(1996-5#1)(2008-10#1)
A) and##15##2##(1990-6#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
A) in the##2##3##(1993-8#1)(2010-8#1)
A) in##5##2##(1993-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)
A) is##3##2##(1990-8#1)(2008-10#1)(2009-6#1)
A) or##4##2##(1994-5#1)(2008-10#3)
A) was##3##2##(1993-3#1)(1997-1#1)(2009-10#1)
A)##82##1##(1990-2#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-5#2)(1992-3#1)(1992-8#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-5#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)
A+##2##1##(1990-12#1)(1993-3#1)
A+T content##2##2##(2008-8#2)
A+T##3##1##(1997-4#1)(2008-8#2)
A+T-rich##5##1##(1993-2#1)(1997-4#1)(2008-10#3)
A- and B-type lamins##2##4##(2011-2#2)
A- and B-type##4##3##(1993-9#1)(2011-2#3)
A- and##11##2##(1990-2#4)(1991-12#1)(1993-9#1)(1994-11#1)(2008-10#1)(2011-2#3)
A-##17##1##(1990-2#4)(1991-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#4)(2008-10#1)(2011-2#3)(2013-1#1)
A--&gt##4##1##(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)
A-0##2##1##(2007-11#2)
A-25 gel##3##2##(2008-10#3)
A-25##5##1##(2008-10#5)
A-50##2##1##(2008-10#1)(2008-8#1)
A-F##2##1##(1997-2#1)(2013-1#1)
A-G##2##1##(2008-8#1)(2013-7#1)
A-H##2##1##(2010-6#1)(2010-7#1)
A-I##11##1##(1990-12#1)(1991-12#1)(1993-12#6)(1993-8#2)(2010-12#1)
A-II/DMPC complexes##3##2##(1990-12#3)
A-III##5##1##(1993-8#1)(1994-2#4)
A-IV apolipoproteins##2##2##(1990-8#2)
A-IV##6##1##(1990-8#3)(1991-8#2)(1993-8#1)
A-Sepharose and##2##2##(2006-6#1)(2008-11#1)
A-Sepharose##6##1##(1990-11#1)(1991-5#1)(1992-12#1)(2006-6#1)(2008-11#1)(2008-8#1)
A-T base pairs##2##3##(1994-5#1)(1995-3#1)
A-T##3##1##(1994-5#1)(1995-3#1)(1997-4#1)
A-T-rich##2##1##(1993-8#2)
A-Tishoo##2##1##(2007-2#2)
A-X (0##2##2##(2008-2#2)
A-X##3##1##(2008-2#2)(2008-3#1)
A-activated##4##1##(1992-12#1)(1994-8#3)
A-agarose and##2##2##(1993-6#1)(1994-8#1)
A-agarose##3##1##(1991-5#1)(1993-6#1)(1994-8#1)
A-band absorption correction##3##3##(2008-2#3)
A-band absorption##7##2##(2008-2#7)
A-based##2##1##(2008-10#2)
A-cells##2##1##(1994-11#1)(2008-1#1)
A-chain##3##1##(1990-11#1)(1992-3#2)
A-complex##5##1##(1995-6#5)
A-deficient##3##1##(1992-9#1)(2011-1#1)(2012-1#1)
A-dependent##3##1##(1992-12#1)(1995-2#1)(2012-1#1)
A-form backbone geometry##2##3##(1992-8#2)
A-form backbone##3##2##(1992-8#3)
A-form##5##1##(1992-8#4)(1993-11#1)
A-group isolates##4##2##(2008-10#4)
A-induced##8##1##(1991-12#1)(1992-6#1)(1995-12#3)(1997-6#1)(2010-12#2)
A-kinase anchoring proteins##2##3##(1995-11#2)
A-kinase##4##1##(1995-11#4)
A-like&quot##2##1##(2008-5#2)
A-mutants in##2##2##(2007-11#2)
A-mutants##5##1##(2007-11#5)
A-positive##2##1##(1991-8#1)(2008-9#1)
A-ring##4##1##(1990-11#3)(2008-10#1)
A-s##2##1##(2008-10#2)
A-side ALA##2##2##(1992-3#2)
A-side##3##1##(1992-3#2)(1994-11#1)
A-site##2##1##(1992-8#2)
A-stage process##2##2##(2013-1#2)
A-type lamins##7##2##(2008-8#1)(2011-2#6)
A-type##15##1##(1991-9#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-8#2)(2011-2#7)
A/A##4##1##(2011-1#4)
A/B and##2##2##(1991-9#1)(2013-1#1)
A/B ratio was##2##3##(1994-3#2)
A/B ratio##3##2##(1994-3#3)
A/B##6##1##(1991-9#2)(1994-3#3)(2013-1#1)
A/C polysaccharide##2##2##(2007-2#2)
A/G heterozygous and G/G homozygous##2##5##(2011-1#2)
A/G##4##1##(2008-10#1)(2011-1#2)(2012-12#1)
A/H1##8##1##(2011-2#8)
A/H1N1##8##1##(1996-6#1)(2011-2#5)(2011-9#1)(2012-2#1)
A/H3N2 and##3##2##(1996-6#2)(2011-2#1)
A/H3N2 virus##2##2##(2011-1#2)
A/H3N2 viruses##3##2##(1996-6#1)(2011-2#2)
A/H3N2##12##1##(1996-6#4)(2009-5#1)(2011-1#2)(2011-2#5)
A/J alleles##2##2##(2011-2#2)
A/J and SW##2##3##(1991-8#2)
A/J and##3##2##(1991-8#2)(2011-2#1)
A/J mice##6##2##(1991-8#2)(2012-1#3)(2013-1#1)
A/J##16##1##(1991-8#5)(1997-7#1)(2011-2#5)(2012-1#4)(2013-1#1)
A/S##2##1##(2012-2#1)(2012-3#1)
A/Sydney/5/97##4##1##(2011-1#4)
A/WSN/33##2##1##(1990-5#1)(2012-3#1)
A/Zhejiang/11/98 and A/Zhejiang/18/98##2##3##(2011-1#2)
A/Zhejiang/18/98##6##1##(2011-1#6)
A/s##2##1##(2009-7#2)
A0##3##1##(1990-8#3)
A1 allele##2##2##(2008-12#1)(2008-9#1)
A1 and A2 isolates##2##4##(2008-10#2)
A1 and A2 receptors##2##4##(1992-9#1)(1993-6#1)
A1 and A2##12##3##(1992-9#1)(1993-6#1)(1996-5#1)(2008-10#7)(2008-9#1)(2009-3#1)
A1 and A3##2##3##(2008-10#1)(2008-12#1)
A1 and B##2##3##(1991-12#1)(1997-8#1)
A1 and##24##2##(1991-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-3#3)(1996-5#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-9#1)(2009-3#1)(2013-7#2)
A1 in##3##2##(1991-5#1)(2008-10#1)(2013-7#1)
A1 isolate##2##2##(2008-10#2)
A1 mating type##2##3##(2008-10#2)
A1 pulley##5##2##(2008-9#5)
A1 receptor antagonism##3##3##(2007-8#3)
A1 receptor##11##2##(1993-5#1)(1993-6#1)(1995-12#1)(1995-5#2)(1997-1#2)(2007-8#4)
A1 receptors and##3##3##(1995-3#2)(1997-1#1)
A1 receptors##10##2##(1994-6#1)(1995-12#1)(1995-3#4)(1996-5#1)(1997-1#3)
A1 region##2##2##(1990-5#2)
A1 were##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
A1##114##1##(1990-5#5)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#4)(1994-11#2)(1994-5#1)(1994-6#4)(1995-12#4)(1995-3#8)(1995-5#2)(1996-2#1)(1996-5#2)(1997-1#6)(1997-8#1)(2007-8#4)(2008-10#24)(2008-11#2)(2008-12#3)(2008-9#11)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#4)(2013-1#1)(2013-7#5)(2013-8#5)
A1)##2##1##(1995-3#1)(2011-2#1)
A10 dopamine cells##3##3##(1994-2#1)(1995-12#2)
A10 dopamine##5##2##(1991-1#1)(1994-2#2)(1995-12#2)
A10##10##1##(1991-1#1)(1994-2#2)(1995-11#1)(1995-12#3)(1995-3#1)(2008-6#2)
A103C and A103C-MB##3##3##(1993-11#3)
A103C##4##1##(1993-11#4)
A10VSMC##3##1##(1995-11#3)
A12##3##1##(1994-8#1)(1995-12#1)(2010-10#1)
A12C4##2##1##(2008-10#2)
A17##2##1##(1992-8#2)
A172 cells##2##2##(2013-1#2)
A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China##2##12##(2013-1#2)
A18Fa##4##1##(1990-7#4)
A1AR##2##1##(1993-6#2)
A1C##2##1##(2008-10#1)(2012-2#1)
A1PCTS##3##1##(1990-11#3)
A1c levels##2##2##(2007-10#1)(2009-11#1)
A1c##13##1##(1990-8#1)(2007-10#1)(2008-1#3)(2008-3#1)(2009-11#1)(2012-3#1)(2012-5#5)
A2 (PLA2)##9##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-11#1)(1994-6#1)(1996-5#1)(2012-2#1)(2013-7#1)
A2 (all##2##2##(1992-4#2)
A2 activation##7##2##(1993-11#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-11#2)
A2 allele##3##2##(1992-8#1)(2008-12#2)
A2 and A4 pulleys##2##4##(2008-9#2)
A2 and A4##5##3##(2008-9#5)
A2 and one##2##3##(2008-10#2)
A2 and##21##2##(1991-6#2)(1991-8#1)(1992-3#2)(1992-6#1)(1994-11#1)(1996-2#4)(2008-10#4)(2008-12#1)(2008-9#5)
A2 gene##4##2##(1992-6#2)(1994-11#2)
A2 isolates##6##2##(2008-10#6)
A2 mating type##7##3##(2008-10#7)
A2 mating##8##2##(2008-10#8)
A2 or##2##2##(1992-3#1)(2008-9#1)
A2 population##3##2##(2008-10#3)
A2 receptor##6##2##(1990-12#3)(1991-12#1)(1992-9#1)(1993-6#1)
A2 receptors in##2##3##(1993-6#1)(1996-5#1)
A2 receptors##7##2##(1990-12#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-6#1)(1996-5#2)
A2 segment##4##2##(1996-3#4)
A2 synthesis##2##2##(1990-3#2)
A2 to##3##2##(1990-2#1)(1995-11#1)(2008-10#1)
A2 transferase##2##2##(1992-8#2)
A2 which##2##2##(1990-5#1)(1991-5#1)
A2##174##1##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#3)(1991-12#3)(1991-5#3)(1991-6#3)(1991-8#1)(1992-3#5)(1992-4#2)(1992-6#4)(1992-8#7)(1992-9#4)(1993-11#7)(1993-3#1)(1993-6#4)(1994-11#14)(1994-12#1)(1994-3#5)(1994-5#5)(1994-6#3)(1994-9#3)(1995-11#6)(1995-12#2)(1996-2#4)(1996-3#4)(1996-5#5)(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#35)(2008-12#3)(2008-7#1)(2008-8#3)(2008-9#9)(2009-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
A2) and##2##2##(1995-5#2)
A2)##6##1##(1995-5#4)(2008-10#1)(2008-9#1)
A2-1##3##1##(1995-11#3)
A2-receptor-mediated inhibition of phagocytosis##2##4##(1994-6#2)
A2-receptor-mediated##3##1##(1994-6#3)
A20##11##1##(1992-7#6)(1993-3#1)(2008-4#1)(2008-9#2)(2010-10#1)
A2058##3##1##(1990-5#1)(1995-11#2)
A211##2##1##(2008-10#2)
A23187 and##3##2##(1992-8#1)(1993-8#1)(1995-11#1)
A23187 or##2##2##(1995-11#1)(2008-10#1)
A23187 treatment##2##2##(1991-5#1)(1994-3#1)
A23187 was##2##2##(1991-5#1)(1992-6#1)
A23187##26##1##(1990-2#2)(1991-5#4)(1992-6#1)(1992-8#1)(1993-8#4)(1994-11#1)(1994-3#2)(1994-6#2)(1995-11#4)(2008-10#1)(2008-11#2)(2008-8#2)
A23187-stimulated##6##1##(1990-2#3)(1991-5#1)(1991-8#1)(1993-2#1)
A24##4##1##(2008-10#4)
A2A receptor##3##2##(1995-12#3)
A2A receptors##2##2##(1995-11#1)(1995-12#1)
A2A##6##1##(1995-11#1)(1995-12#4)(2008-4#1)
A2B5 and##2##2##(1996-5#1)(2013-1#1)
A2B5##3##1##(1996-5#2)(2013-1#1)
A2a receptors##5##2##(1995-3#3)(1996-5#2)
A2a##9##1##(1995-3#6)(1996-5#3)
A3 were##2##2##(1990-8#1)(1992-3#1)
A3##29##1##(1990-12#4)(1990-8#9)(1992-3#5)(1995-3#4)(2008-10#1)(2008-12#3)(2011-1#1)(2011-2#1)(2013-1#1)
A3)##2##1##(2007-12#1)(2008-12#1)
A375##3##1##(1990-11#1)(1993-9#1)(1994-6#1)
A375P##2##1##(1991-5#2)
A4 hydrolase##3##2##(1990-11#3)
A4 protein##3##2##(1990-7#1)(1992-8#1)(1992-9#1)
A4 pulley##2##2##(2008-9#2)
A4 were##2##2##(1991-6#1)(2012-1#1)
A4##29##1##(1990-11#5)(1990-7#1)(1991-1#1)(1991-5#2)(1991-6#4)(1992-8#2)(1992-9#4)(1994-5#1)(1995-12#1)(2008-10#1)(2008-9#6)(2012-1#1)
A4)##2##1##(1990-7#1)(1992-9#1)
A4-splitting enzyme##2##2##(1990-7#2)
A4-splitting##3##1##(1990-7#3)
A431 cells##13##2##(1990-11#3)(1992-3#3)(1992-7#3)(1992-9#3)(1993-3#1)
A431##16##1##(1990-11#3)(1992-2#1)(1992-3#3)(1992-7#3)(1992-8#1)(1992-9#4)(1993-3#1)
A46 cells into##2##3##(2013-1#2)
A4H is##2##2##(2010-2#2)
A4H##4##1##(2010-2#4)
A5##7##1##(1992-8#1)(1993-11#1)(1997-2#1)(2008-10#1)(2008-8#2)(2011-1#1)
A506 (pvd-inaZ)##5##2##(2008-10#5)
A506 and Pantoea agglomerans strains##2##5##(2008-10#2)
A506 and Pantoea agglomerans##3##4##(2008-10#3)
A506 and##5##2##(2008-10#5)
A506 in##2##2##(2008-10#2)
A506 is##3##2##(2008-10#3)
A506 on##3##2##(2008-10#3)
A506 was##2##2##(2008-10#2)
A506##45##1##(2008-10#45)
A506)##2##1##(2008-10#2)
A511##3##1##(2012-2#3)
A5314##3##1##(2008-10#3)
A5387##2##1##(2008-10#2)
A549 cell line##2##3##(2008-11#2)
A549 cell##3##2##(1992-9#1)(2008-11#2)
A549##17##1##(1992-9#1)(2008-10#1)(2008-11#12)(2008-9#1)(2011-3#1)(2013-1#1)
A5DC7##2##1##(2008-11#2)
A6##8##1##(1993-6#1)(1994-5#2)(2008-10#1)(2008-6#1)(2011-1#3)
A7 monoclonal antibody was##2##4##(2008-11#2)
A7 monoclonal antibody##4##3##(2008-11#4)
A7##7##1##(2008-11#7)
A9 allele##2##2##(2008-9#2)
A9 cells##2##2##(1996-6#2)
A9##8##1##(1995-12#3)(1995-3#1)(1996-6#2)(2008-9#2)
A</ForeName>##2##1##(1997-4#1)(2013-8#1)
A=0##3##1##(2008-10#3)
AA 231-1 in##2##3##(1992-12#2)
AA 231-1##3##2##(1992-12#3)
AA amyloidosis##2##2##(2006-10#1)(2007-7#1)
AA and DA in##2##4##(2008-10#2)
AA and DA##4##3##(2008-10#4)
AA and EPA##2##3##(1994-11#2)
AA and##9##2##(1993-3#1)(1994-11#2)(2008-10#5)(2008-5#1)
AA breast cancer survivors##2##4##(2008-4#2)
AA genotype##4##2##(2011-2#4)
AA in the##3##3##(2008-10#2)(2008-8#1)
AA in##10##2##(1992-12#2)(2008-10#5)(2008-8#1)(2011-1#2)
AA is##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
AA metabolites##2##2##(2010-9#2)
AA or its##2##3##(2008-5#2)
AA or##4##2##(1994-11#1)(2008-5#3)
AA protein##2##2##(2007-7#1)(2008-8#1)
AA was##6##2##(1995-5#1)(2008-10#5)
AA with##2##2##(2008-10#1)(2008-8#1)
AA##99##1##(1990-12#2)(1991-12#3)(1991-8#2)(1992-12#6)(1992-6#1)(1993-3#3)(1993-8#3)(1994-11#3)(1995-5#3)(1997-2#3)(2006-10#1)(2007-7#2)(2008-10#36)(2008-11#1)(2008-12#5)(2008-3#5)(2008-4#2)(2008-5#4)(2008-8#5)(2010-9#2)(2011-1#2)(2011-2#4)(2012-2#1)
AA)##2##1##(1990-5#1)(2008-10#1)
AA-I and AA-II##3##3##(2008-10#3)
AA560##7##1##(1990-11#7)
AA8##2##1##(1993-8#1)(1995-3#1)
AAA 99-2##3##2##(2008-10#3)
AAA and##2##2##(2008-8#1)(2010-12#1)
AAA##18##1##(1997-2#1)(2008-10#3)(2008-7#1)(2008-8#2)(2009-7#3)(2010-12#1)(2010-7#1)(2012-12#3)(2013-1#3)
AABB##6##1##(1995-6#6)
AABB's##2##1##(1995-6#2)
AAC in##2##2##(2008-10#2)
AAC##11##1##(2008-10#9)(2008-2#1)(2010-7#1)
AACOCF3 complex##3##2##(1993-11#3)
AACOCF3##6##1##(1993-11#6)
AAF modified##4##2##(1991-5#4)
AAF##6##1##(1991-5#5)(2008-10#1)
AAH##2##1##(2007-8#2)
AAI may be of particular interest to insurers dealing in the elderly market##2##13##(1993-12#2)
AAI will appear more common in attending physician's statements##2##9##(1993-12#2)
AAI##6##1##(1993-12#6)
AAL-TA##5##1##(2008-10#5)
AAL-TB##3##1##(2008-10#3)
AANAT##6##1##(2008-5#6)
AAP##6##1##(2008-10#6)
AAPCC (adjusted average per capita cost)##3##6##(1993-3#1)(1997-1#2)
AAPCC##13##1##(1991-3#2)(1993-3#9)(1997-1#2)
AAPH##6##1##(1991-1#1)(1995-6#5)
AAPH-induced##2##1##(1995-6#2)
AAPM##2##1##(2012-1#2)
AAPs##4##1##(2008-10#4)
AARE##2##1##(1996-2#2)
AARR syndrome##3##2##(2011-1#3)
AAS after##4##2##(1992-3#1)(2008-10#3)
AAS and GGS##3##3##(2010-4#3)
AAS and##9##2##(2008-10#5)(2010-4#4)
AAS determination of##3##3##(2008-10#3)
AAS for##2##2##(2008-10#2)
AAS method##3##2##(2008-10#3)
AAS signal##2##2##(2008-10#2)
AAS technique##2##2##(2008-10#2)
AAS using##3##2##(2008-10#3)
AAS was##4##2##(2008-10#4)
AAS##68##1##(1992-3#1)(2008-10#62)(2010-4#5)
AAS)##5##1##(2008-10#5)
AAS-found metal##3##2##(2008-10#3)
AAT protein##2##2##(2008-5#2)
AAT##6##1##(2008-4#1)(2008-5#4)(2010-7#1)
AAV vectors##3##2##(1997-4#1)(2008-9#1)(2011-3#1)
AAV##7##1##(1997-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-3#2)
AAV-2 genome##2##2##(2008-8#2)
AAV-2 rep and cap##2##4##(2008-8#2)
AAV-2##7##1##(2008-8#7)
AAV-mediated##3##1##(1997-4#1)(2008-8#2)
AB 136 and##2##3##(2008-10#2)
AB 136##4##2##(2008-10#4)
AB and##3##2##(1994-9#1)(2008-10#1)(2008-12#1)
AB is##2##2##(1996-7#2)
AB##34##1##(1990-12#1)(1992-8#2)(1994-9#3)(1995-3#1)(1996-7#5)(1997-2#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-11#1)(2012-12#1)
AB)##3##1##(2008-11#1)(2008-8#1)(2012-3#1)
AB- and B-responding cells##2##4##(1994-9#2)
AB- and##3##2##(1994-9#3)
AB-##5##1##(1994-9#4)(2013-1#1)
ABA accumulation is##2##3##(2008-8#2)
ABA accumulation##8##2##(2008-8#8)
ABA concentration in##3##3##(2008-8#3)
ABA production##3##2##(2009-6#3)
ABA##27##1##(1994-11#2)(2008-10#2)(2008-8#14)(2008-9#1)(2009-6#5)(2009-8#3)
ABA-binding##2##1##(2008-8#2)
ABATE##2##1##(2010-10#2)
ABB##3##1##(2009-12#3)
ABBP##5##1##(2008-8#5)
ABC and VED##3##3##(2011-1#3)
ABC and##4##2##(1994-9#1)(2011-1#3)
ABC is##2##2##(1993-12#1)(1994-3#1)
ABC neurotomy##2##2##(1994-3#2)
ABC of antenatal care##2##4##(1991-3#1)(1991-6#1)
ABC of major trauma##2##4##(1990-6#1)(1990-9#1)
ABC of mental health##2##4##(1997-5#1)(1997-8#1)
ABC of##13##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-2#1)(1995-9#1)(1996-8#1)(1997-5#1)(1997-8#1)(2012-3#1)
ABC transporter superfamily##2##3##(2008-11#2)
ABC transporter##4##2##(2008-11#2)(2011-2#1)(2012-3#1)
ABC transporters##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
ABC##44##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-12#3)(1993-2#1)(1994-3#4)(1994-9#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-3#6)(2013-8#1)
ABC-VED matrix analysis##2##3##(2011-1#2)
ABC155##2##1##(2008-10#2)
ABCD law for##2##3##(2007-11#2)
ABCD law##4##2##(2007-11#3)(2008-2#1)
ABCD matrix for reflection and refraction of Gaussian light beams at##2##11##(2008-2#2)
ABCD matrix for##4##3##(2008-2#3)(2008-3#1)
ABCD matrix##9##2##(2007-12#3)(2008-2#4)(2008-3#2)
ABCD##19##1##(2007-11#3)(2007-12#4)(2008-2#8)(2008-3#3)(2009-10#1)
ABE##2##1##(1990-7#2)
ABG##2##1##(2008-8#2)
ABI##8##1##(2007-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2013-1#1)
ABI-007##3##1##(2008-3#3)
ABI3 and ABI5 expression##2##4##(2009-8#2)
ABI3 and ABI5##3##3##(2009-8#3)
ABL height##2##2##(2008-2#2)
ABL##7##1##(2008-2#5)(2010-11#1)(2011-2#1)
ABLEDATA##2##1##(1992-3#2)
ABM##3##1##(2008-5#3)
ABO and D##3##3##(1994-6#3)
ABO and##4##2##(1993-12#1)(1994-6#3)
ABO blood group and##2##4##(1990-6#1)(2013-1#1)
ABO blood group##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
ABO blood##4##2##(1990-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
ABO incompatibility or positive##2##4##(2011-2#2)
ABO incompatibility##3##2##(1992-6#1)(2011-2#2)
ABO interpretation##2##2##(1994-6#2)
ABO##19##1##(1990-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-6#7)(2008-10#3)(2011-2#3)(2013-1#1)(2013-8#1)
ABPM in##2##2##(2009-11#2)
ABPM##5##1##(1992-8#1)(2008-11#1)(2009-11#3)
ABR##4##1##(2008-4#4)
ABSPI##3##1##(2011-2#3)
ABSTRACT A collection##2##3##(2008-10#2)
ABSTRACT A field experiment was##2##5##(2008-10#2)
ABSTRACT A field##3##3##(2008-10#3)
ABSTRACT A genetic##2##3##(2008-10#2)
ABSTRACT A leaf##2##3##(2008-10#2)
ABSTRACT A major##2##3##(2008-10#2)
ABSTRACT A multiplex##3##3##(2008-10#3)
ABSTRACT A new tospovirus##2##4##(2008-10#2)
ABSTRACT A new##10##3##(2008-10#10)
ABSTRACT A novel##3##3##(2008-10#3)
ABSTRACT A panel of##2##4##(2008-10#2)
ABSTRACT A polymerase chain reaction (PCR) assay##2##7##(2008-10#2)
ABSTRACT A polymerase chain reaction##4##5##(2008-10#4)
ABSTRACT A polymerase chain##6##4##(2008-10#6)
ABSTRACT A potential##2##3##(2008-10#2)
ABSTRACT A previously uncharacterized##2##4##(2008-10#2)
ABSTRACT A previously##4##3##(2008-10#4)
ABSTRACT A quantitative##3##3##(2008-10#3)
ABSTRACT A random##2##3##(2008-10#2)
ABSTRACT A series of##2##4##(2008-10#2)
ABSTRACT A set of##3##4##(2008-10#3)
ABSTRACT A survey was conducted##2##5##(2008-10#2)
ABSTRACT A survey##3##3##(2008-10#3)
ABSTRACT A technique was developed to##2##6##(2008-10#2)
ABSTRACT A technique##3##3##(2008-10#3)
ABSTRACT A total of##8##4##(2008-10#8)
ABSTRACT A worldwide collection of##2##5##(2008-10#2)
ABSTRACT A##150##2##(2008-10#150)
ABSTRACT Aflatoxins are carcinogens produced by Aspergillus flavus and A##2##10##(2008-10#2)
ABSTRACT Aflatoxins are carcinogens produced mainly by Aspergillus flavus during infection of susceptible crops such as maize##2##17##(2008-10#2)
ABSTRACT Aflatoxins are carcinogens produced##4##5##(2008-10#4)
ABSTRACT Aflatoxins are toxic##2##4##(2008-10#2)
ABSTRACT Aflatoxins are##6##3##(2008-10#6)
ABSTRACT After##2##2##(2008-10#2)
ABSTRACT Agrobacterium tumefaciens-mediated transformation##2##4##(2008-10#2)
ABSTRACT Agrobacterium##3##2##(2008-10#3)
ABSTRACT Alfalfa##2##2##(2008-10#2)
ABSTRACT Alternaria citri##2##3##(2008-10#2)
ABSTRACT Alternaria spp##2##3##(2008-10#2)
ABSTRACT Alternaria##8##2##(2008-10#8)
ABSTRACT Although##5##2##(2008-10#5)
ABSTRACT Amplified fragment length##2##4##(2008-10#2)
ABSTRACT An##19##2##(2008-10#19)
ABSTRACT Anthracnose##3##2##(2008-10#3)
ABSTRACT Antisera##2##2##(2008-10#2)
ABSTRACT Apple scab (Venturia inaequalis)##2##5##(2008-10#2)
ABSTRACT Apple##5##2##(2008-10#5)
ABSTRACT As a##2##3##(2008-10#2)
ABSTRACT Aspergillus flavus is##2##4##(2008-10#2)
ABSTRACT Aspergillus flavus##4##3##(2008-10#4)
ABSTRACT Aspergillus##5##2##(2008-10#5)
ABSTRACT Bacterial blight##2##3##(2008-10#2)
ABSTRACT Bacterial##5##2##(2008-10#5)
ABSTRACT Barley yellow dwarf virus##2##5##(2008-10#2)
ABSTRACT Barley yellow dwarf##3##4##(2008-10#3)
ABSTRACT Barley##6##2##(2008-10#6)
ABSTRACT Bayesian##2##2##(2008-10#2)
ABSTRACT Bean##2##2##(2008-10#2)
ABSTRACT Because##2##2##(2008-10#2)
ABSTRACT Biocontrol##2##2##(2008-10#2)
ABSTRACT Botrytis cinerea is##2##4##(2008-10#2)
ABSTRACT Botrytis cinerea##4##3##(2008-10#4)
ABSTRACT Botrytis##5##2##(2008-10#5)
ABSTRACT Breeding##2##2##(2008-10#2)
ABSTRACT Burkholderia##2##2##(2008-10#2)
ABSTRACT Cassava##2##2##(2008-10#2)
ABSTRACT Cephalosporium##2##2##(2008-10#2)
ABSTRACT Changes in##2##3##(2008-10#2)
ABSTRACT Chemical##3##2##(2008-10#3)
ABSTRACT Citrus exocortis viroid (CEVd)##2##5##(2008-10#2)
ABSTRACT Citrus tristeza virus (CTV)##2##5##(2008-10#2)
ABSTRACT Citrus##7##2##(2008-10#7)
ABSTRACT Colletotrichum gloeosporioides##3##3##(2008-10#3)
ABSTRACT Colletotrichum##8##2##(2008-10#8)
ABSTRACT Colonization of##2##3##(2008-10#2)
ABSTRACT Common bacterial blight (CBB)##2##5##(2008-10#2)
ABSTRACT Common##3##2##(2008-10#3)
ABSTRACT Compost##2##2##(2008-10#2)
ABSTRACT Controlled##2##2##(2008-10#2)
ABSTRACT Cranberry stem gall is characterized by tumors that girdle stems##2##11##(2008-10#2)
ABSTRACT Crown rust (Puccinia##2##4##(2008-10#2)
ABSTRACT Crown rust##4##3##(2008-10#4)
ABSTRACT Crown##6##2##(2008-10#6)
ABSTRACT Cucurbit##2##2##(2008-10#2)
ABSTRACT Culture##2##2##(2008-10#2)
ABSTRACT DNA##4##2##(2008-10#4)
ABSTRACT Data##3##2##(2008-10#3)
ABSTRACT Development of##2##3##(2008-10#2)
ABSTRACT Disease##3##2##(2008-10#3)
ABSTRACT Diverse##3##2##(2008-10#3)
ABSTRACT Dothistroma##2##2##(2008-10#2)
ABSTRACT Double-stranded##3##2##(2008-10#3)
ABSTRACT During##6##2##(2008-10#6)
ABSTRACT Effects of##2##3##(2008-10#2)
ABSTRACT Eight##3##2##(2008-10#3)
ABSTRACT Epidemics of##4##3##(2008-10#4)
ABSTRACT Epidemiological modeling##2##3##(2008-10#2)
ABSTRACT Epidemiological##3##2##(2008-10#3)
ABSTRACT Eutypa dieback is a##2##5##(2008-10#2)
ABSTRACT Experiments were conducted in##2##5##(2008-10#2)
ABSTRACT Experiments##4##2##(2008-10#4)
ABSTRACT Expression of##2##3##(2008-10#2)
ABSTRACT Eyespot of wheat is caused by##2##7##(2008-10#2)
ABSTRACT Field observations##2##3##(2008-10#2)
ABSTRACT Field##5##2##(2008-10#5)
ABSTRACT Fire blight##2##3##(2008-10#2)
ABSTRACT Five##4##2##(2008-10#4)
ABSTRACT Fluorescent Pseudomonas spp##2##4##(2008-10#2)
ABSTRACT For##3##2##(2008-10#3)
ABSTRACT Four##9##2##(2008-10#9)
ABSTRACT Fungi in##2##3##(2008-10#2)
ABSTRACT Fusarium graminearum##2##3##(2008-10#2)
ABSTRACT Fusarium head blight (FHB)##5##5##(2008-10#5)
ABSTRACT Fusarium head blight##6##4##(2008-10#6)
ABSTRACT Fusarium oxysporum f##5##4##(2008-10#5)
ABSTRACT Fusarium oxysporum##7##3##(2008-10#7)
ABSTRACT Fusarium species##2##3##(2008-10#2)
ABSTRACT Fusarium wilt of##3##4##(2008-10#3)
ABSTRACT Fusarium wilt##4##3##(2008-10#4)
ABSTRACT Fusarium##28##2##(2008-10#28)
ABSTRACT Genetic analysis##2##3##(2008-10#2)
ABSTRACT Genetic diversity was##2##4##(2008-10#2)
ABSTRACT Genetic diversity##3##3##(2008-10#3)
ABSTRACT Genetic resistance##2##3##(2008-10#2)
ABSTRACT Genetic variation##3##3##(2008-10#3)
ABSTRACT Genetic##15##2##(2008-10#15)
ABSTRACT Gibberella zeae##3##3##(2008-10#3)
ABSTRACT Grape berries##2##3##(2008-10#2)
ABSTRACT Grapevine##3##2##(2008-10#3)
ABSTRACT Gray leaf spot##5##4##(2008-10#5)
ABSTRACT Greasy spot##2##3##(2008-10#2)
ABSTRACT Host##2##2##(2008-10#2)
ABSTRACT In a##3##3##(2008-10#3)
ABSTRACT In an attempt to##3##5##(2008-10#3)
ABSTRACT In an##5##3##(2008-10#5)
ABSTRACT In order to##6##4##(2008-10#6)
ABSTRACT In the present##2##4##(2008-10#2)
ABSTRACT In the##11##3##(2008-10#11)
ABSTRACT In this study##2##4##(2008-10#2)
ABSTRACT In this##4##3##(2008-10#4)
ABSTRACT In##45##2##(2008-10#44)(2008-9#1)
ABSTRACT Infection of##5##3##(2008-10#5)
ABSTRACT Infection##6##2##(2008-10#6)
ABSTRACT Initial##2##2##(2008-10#2)
ABSTRACT Interactions between##2##3##(2008-10#2)
ABSTRACT Isolates of Colletotrichum spp##2##5##(2008-10#2)
ABSTRACT Isolates of Colletotrichum##4##4##(2008-10#4)
ABSTRACT Isolates of Puccinia triticina collected from##2##7##(2008-10#2)
ABSTRACT Isolates of Puccinia##3##4##(2008-10#3)
ABSTRACT Isolates of Rhizoctonia solani##2##5##(2008-10#2)
ABSTRACT Isolates of Rhizoctonia##3##4##(2008-10#3)
ABSTRACT Isolates of the##3##4##(2008-10#3)
ABSTRACT Isolates of##23##3##(2008-10#23)
ABSTRACT It##2##2##(2008-10#2)
ABSTRACT Karnal bunt of wheat##2##5##(2008-10#2)
ABSTRACT LATEBLIGHT##2##2##(2008-10#2)
ABSTRACT Late leaf spot##2##4##(2008-10#2)
ABSTRACT Late##3##2##(2008-10#3)
ABSTRACT Leaf rust##3##3##(2008-10#3)
ABSTRACT Leaf##7##2##(2008-10#7)
ABSTRACT Leptosphaeria maculans##3##3##(2008-10#3)
ABSTRACT Little cherry disease (LChD) is a##2##7##(2008-10#2)
ABSTRACT Little##3##2##(2008-10#3)
ABSTRACT Magnaporthe grisea##2##3##(2008-10#2)
ABSTRACT Modeling##2##2##(2008-10#2)
ABSTRACT Molecular##4##2##(2008-10#4)
ABSTRACT Monilinia fructicola##2##3##(2008-10#2)
ABSTRACT Monilinia##3##2##(2008-10#3)
ABSTRACT Most##3##2##(2008-10#3)
ABSTRACT Mycosphaerella##4##2##(2008-10#4)
ABSTRACT Natural##3##2##(2008-10#3)
ABSTRACT Naturally##2##2##(2008-10#2)
ABSTRACT Numerous##2##2##(2008-10#2)
ABSTRACT Observations##2##2##(2008-10#2)
ABSTRACT One hundred##3##3##(2008-10#3)
ABSTRACT One##6##2##(2008-10#6)
ABSTRACT Our##2##2##(2008-10#2)
ABSTRACT Panicle and shoot blight##2##5##(2008-10#2)
ABSTRACT Papaya ringspot virus (PRSV)##2##5##(2008-10#2)
ABSTRACT Partial resistance to##4##4##(2008-10#4)
ABSTRACT Partial##5##2##(2008-10#5)
ABSTRACT Pathogenic variation##2##3##(2008-10#2)
ABSTRACT Pathogenic##3##2##(2008-10#3)
ABSTRACT Pathogenicity##2##2##(2008-10#2)
ABSTRACT Pear##2##2##(2008-10#2)
ABSTRACT Penicillium##2##2##(2008-10#2)
ABSTRACT Pepper##2##2##(2008-10#2)
ABSTRACT Peronospora tabacina is an##2##5##(2008-10#2)
ABSTRACT Phytophthora capsici##3##3##(2008-10#3)
ABSTRACT Phytophthora infestans##3##3##(2008-10#3)
ABSTRACT Phytophthora nicotianae##3##3##(2008-10#3)
ABSTRACT Phytophthora ramorum##2##3##(2008-10#2)
ABSTRACT Phytophthora root##2##3##(2008-10#2)
ABSTRACT Phytophthora##14##2##(2008-10#14)
ABSTRACT Plant##8##2##(2008-10#8)
ABSTRACT Planting##2##2##(2008-10#2)
ABSTRACT Plasmopara viticola##2##3##(2008-10#2)
ABSTRACT Polymerase chain reaction##3##4##(2008-10#3)
ABSTRACT Population##3##2##(2008-10#3)
ABSTRACT Potato##3##2##(2008-10#3)
ABSTRACT Powdery mildew##3##3##(2008-10#3)
ABSTRACT Previous##2##2##(2008-10#2)
ABSTRACT Previously##2##2##(2008-10#2)
ABSTRACT Production of the##2##4##(2008-10#2)
ABSTRACT Production of##5##3##(2008-10#5)
ABSTRACT Pseudomonas fluorescens##3##3##(2008-10#3)
ABSTRACT Pseudomonas spp##2##3##(2008-10#2)
ABSTRACT Pseudomonas##8##2##(2008-10#8)
ABSTRACT Pyrenophora tritici-repentis##4##3##(2008-10#4)
ABSTRACT Pyrenophora##5##2##(2008-10#5)
ABSTRACT Pythium##3##2##(2008-10#3)
ABSTRACT Quantitative##2##2##(2008-10#2)
ABSTRACT Rain##2##2##(2008-10#2)
ABSTRACT Recent##2##2##(2008-10#2)
ABSTRACT Recombinant single-chain##2##3##(2008-10#2)
ABSTRACT Reliable##2##2##(2008-10#2)
ABSTRACT Resistance to##6##3##(2008-10#6)
ABSTRACT Resistance##8##2##(2008-10#8)
ABSTRACT Restriction fragment length polymorphism (RFLP) markers were used to##2##10##(2008-10#2)
ABSTRACT Restriction fragment length polymorphisms (RFLPs)##2##6##(2008-10#2)
ABSTRACT Restriction fragment length##4##4##(2008-10#4)
ABSTRACT Rhizoctonia solani##2##3##(2008-10#2)
ABSTRACT Rhizoctonia##3##2##(2008-10#3)
ABSTRACT Rice##4##2##(2008-10#4)
ABSTRACT Root and stem rot##2##5##(2008-10#2)
ABSTRACT Root and##3##3##(2008-10#3)
ABSTRACT Root-knot nematodes##2##3##(2008-10#2)
ABSTRACT Sclerotinia sclerotiorum##2##3##(2008-10#2)
ABSTRACT Sclerotinia##3##2##(2008-10#3)
ABSTRACT Seed treatment with##2##4##(2008-10#2)
ABSTRACT Seed##4##2##(2008-10#4)
ABSTRACT Selected isolates of##2##4##(2008-10#2)
ABSTRACT Selected##3##2##(2008-10#3)
ABSTRACT Septoria speckled leaf blotch (SSLB)##2##6##(2008-10#2)
ABSTRACT Septoria##3##2##(2008-10#3)
ABSTRACT Sequential##2##2##(2008-10#2)
ABSTRACT Seven##2##2##(2008-10#2)
ABSTRACT Several##4##2##(2008-10#4)
ABSTRACT Severe##3##2##(2008-10#3)
ABSTRACT Since the early 1990s##2##5##(2008-10#2)
ABSTRACT Since##4##2##(2008-10#4)
ABSTRACT Six##3##2##(2008-10#3)
ABSTRACT Sixty##2##2##(2008-10#2)
ABSTRACT Soil##4##2##(2008-10#4)
ABSTRACT Soilborne wheat mosaic virus (SBWMV)##2##6##(2008-10#2)
ABSTRACT Soybean rust##2##3##(2008-10#2)
ABSTRACT Soybean##3##2##(2008-10#3)
ABSTRACT Spatial and temporal##3##4##(2008-10#3)
ABSTRACT Spatial##4##2##(2008-10#4)
ABSTRACT Specific##4##2##(2008-10#4)
ABSTRACT Spiroplasma citri##2##3##(2008-10#2)
ABSTRACT Spot blotch##3##3##(2008-10#3)
ABSTRACT Spread of##2##3##(2008-10#2)
ABSTRACT Stagonospora nodorum##2##3##(2008-10#2)
ABSTRACT Stem##3##2##(2008-10#3)
ABSTRACT Stenotrophomonas maltophilia strain C3##2##5##(2008-10#2)
ABSTRACT Strains of Pseudomonas syringae##2##5##(2008-10#2)
ABSTRACT Strains of Pseudomonas##3##4##(2008-10#3)
ABSTRACT Strains of the##2##4##(2008-10#2)
ABSTRACT Strains of##11##3##(2008-10#11)
ABSTRACT Strawberry##2##2##(2008-10#2)
ABSTRACT Striga##3##2##(2008-10#3)
ABSTRACT Stripe rust##2##3##(2008-10#2)
ABSTRACT Structural##2##2##(2008-10#2)
ABSTRACT Studies##2##2##(2008-10#2)
ABSTRACT Sudden death syndrome##2##4##(2008-10#2)
ABSTRACT Sudden oak death##2##4##(2008-10#2)
ABSTRACT Sudden##4##2##(2008-10#4)
ABSTRACT Sugarcane mosaic##2##3##(2008-10#2)
ABSTRACT Sugarcane##3##2##(2008-10#3)
ABSTRACT Suppressive##2##2##(2008-10#2)
ABSTRACT Tan spot##2##3##(2008-10#2)
ABSTRACT Temperature##2##2##(2008-10#2)
ABSTRACT Tests##2##2##(2008-10#2)
ABSTRACT The ability of##6##4##(2008-10#6)
ABSTRACT The ability##7##3##(2008-10#7)
ABSTRACT The abundance##2##3##(2008-10#2)
ABSTRACT The aggressiveness of##3##4##(2008-10#3)
ABSTRACT The association##2##3##(2008-10#2)
ABSTRACT The biological and molecular properties of##2##7##(2008-10#2)
ABSTRACT The capacity of the##2##5##(2008-10#2)
ABSTRACT The causal##2##3##(2008-10#2)
ABSTRACT The complete nucleotide sequence of the##2##7##(2008-10#2)
ABSTRACT The complete nucleotide sequence of##3##6##(2008-10#3)
ABSTRACT The complete nucleotide##4##4##(2008-10#4)
ABSTRACT The complete##5##3##(2008-10#5)
ABSTRACT The course of##2##4##(2008-10#2)
ABSTRACT The development of##5##4##(2008-10#5)
ABSTRACT The development##6##3##(2008-10#6)
ABSTRACT The dispersal##2##3##(2008-10#2)
ABSTRACT The diversity of##2##4##(2008-10#2)
ABSTRACT The dynamics of the##2##5##(2008-10#2)
ABSTRACT The dynamics of##4##4##(2008-10#4)
ABSTRACT The effect of##17##4##(2008-10#17)
ABSTRACT The effect##18##3##(2008-10#18)
ABSTRACT The effects of temperature##2##5##(2008-10#2)
ABSTRACT The effects of##15##4##(2008-10#15)
ABSTRACT The effects##16##3##(2008-10#16)
ABSTRACT The efficacy of##2##4##(2008-10#2)
ABSTRACT The epidemiology##2##3##(2008-10#2)
ABSTRACT The first##2##3##(2008-10#2)
ABSTRACT The fungal##2##3##(2008-10#2)
ABSTRACT The fungus##4##3##(2008-10#4)
ABSTRACT The genetic diversity of##2##5##(2008-10#2)
ABSTRACT The genetic structure of field populations of##2##8##(2008-10#2)
ABSTRACT The genetic structure of populations of##2##7##(2008-10#2)
ABSTRACT The genetic structure of##5##5##(2008-10#5)
ABSTRACT The genetic##9##3##(2008-10#9)
ABSTRACT The genome of##2##4##(2008-10#2)
ABSTRACT The genus##2##3##(2008-10#2)
ABSTRACT The germination##2##3##(2008-10#2)
ABSTRACT The hypothesis that##2##4##(2008-10#2)
ABSTRACT The incidence of##2##4##(2008-10#2)
ABSTRACT The induction of##3##4##(2008-10#3)
ABSTRACT The infection of##2##4##(2008-10#2)
ABSTRACT The influence##2##3##(2008-10#2)
ABSTRACT The inheritance of resistance to##3##6##(2008-10#3)
ABSTRACT The inheritance of##4##4##(2008-10#4)
ABSTRACT The mechanism of##2##4##(2008-10#2)
ABSTRACT The nucleotide sequence of the##2##6##(2008-10#2)
ABSTRACT The population structure of##5##5##(2008-10#5)
ABSTRACT The population##7##3##(2008-10#7)
ABSTRACT The potential of the##2##5##(2008-10#2)
ABSTRACT The potential of##4##4##(2008-10#4)
ABSTRACT The potential##6##3##(2008-10#6)
ABSTRACT The presence of##2##4##(2008-10#2)
ABSTRACT The purpose of this##2##5##(2008-10#1)(2013-7#1)
ABSTRACT The recent##2##3##(2008-10#2)
ABSTRACT The relationship between##2##4##(2008-10#2)
ABSTRACT The relationship##3##3##(2008-10#3)
ABSTRACT The role of the##2##5##(2008-10#2)
ABSTRACT The role of##10##4##(2008-10#10)
ABSTRACT The roles of##2##4##(2008-10#2)
ABSTRACT The rust fungus Puccinia##2##5##(2008-10#2)
ABSTRACT The spatial pattern of##2##5##(2008-10#2)
ABSTRACT The spatial##3##3##(2008-10#3)
ABSTRACT The temporal and spatial##2##5##(2008-10#2)
ABSTRACT The use of##2##4##(2008-10#2)
ABSTRACT The virulence of##2##4##(2008-10#2)
ABSTRACT The##334##2##(2008-10#333)(2013-7#1)
ABSTRACT This paper##2##3##(2008-10#2)
ABSTRACT This study describes##2##4##(2008-10#2)
ABSTRACT This study examined##2##4##(2008-10#2)
ABSTRACT This study reports the##2##5##(2008-10#2)
ABSTRACT This study##12##3##(2008-10#12)
ABSTRACT This##15##2##(2008-10#15)
ABSTRACT Three hundred##2##3##(2008-10#2)
ABSTRACT Three isolates of##2##4##(2008-10#2)
ABSTRACT Three##13##2##(2008-10#13)
ABSTRACT To determine the##2##4##(2008-10#2)
ABSTRACT To determine##3##3##(2008-10#3)
ABSTRACT To elucidate##2##3##(2008-10#2)
ABSTRACT To investigate the##3##4##(2008-10#3)
ABSTRACT To investigate##5##3##(2008-10#5)
ABSTRACT To test the hypothesis that##2##6##(2008-10#2)
ABSTRACT To understand the##2##4##(2008-10#2)
ABSTRACT To##27##2##(2008-10#27)
ABSTRACT Tobacco##2##2##(2008-10#2)
ABSTRACT Tomato yellow leaf curl virus (TYLCV)##2##7##(2008-10#2)
ABSTRACT Tomato yellow leaf curl##3##5##(2008-10#3)
ABSTRACT Tomato##12##2##(2008-10#12)
ABSTRACT Transgenic##4##2##(2008-10#4)
ABSTRACT Transmission##2##2##(2008-10#2)
ABSTRACT Trichoderma##2##2##(2008-10#2)
ABSTRACT Two biocontrol agents##2##4##(2008-10#2)
ABSTRACT Two field experiments were conducted to study the##2##9##(2008-10#2)
ABSTRACT Two strains of##2##4##(2008-10#2)
ABSTRACT Two##31##2##(2008-10#31)
ABSTRACT Using a##2##3##(2008-10#2)
ABSTRACT Using##7##2##(2008-10#7)
ABSTRACT Ustilago hordei##2##3##(2008-10#2)
ABSTRACT Verticillium##2##2##(2008-10#2)
ABSTRACT We developed a##2##4##(2008-10#2)
ABSTRACT We developed##3##3##(2008-10#3)
ABSTRACT We evaluated##4##3##(2008-10#4)
ABSTRACT We examined the##2##4##(2008-10#2)
ABSTRACT We have developed a##3##5##(2008-10#3)
ABSTRACT We have##6##3##(2008-10#6)
ABSTRACT We investigated the##3##4##(2008-10#3)
ABSTRACT We used molecular markers to identify quantitative trait loci (QTL) that##2##12##(2008-10#2)
ABSTRACT We##37##2##(2008-10#37)
ABSTRACT Wheat (Triticum aestivum)##2##4##(2008-10#2)
ABSTRACT Wheat##4##2##(2008-10#4)
ABSTRACT When##5##2##(2008-10#5)
ABSTRACT While##2##2##(2008-10#2)
ABSTRACT Xanthomonas axonopodis pv##2##4##(2008-10#2)
ABSTRACT Xanthomonas campestris pv##2##4##(2008-10#2)
ABSTRACT Xanthomonas##7##2##(2008-10#7)
ABSTRACT Xylella fastidiosa is##2##4##(2008-10#2)
ABSTRACT Xylella fastidiosa##5##3##(2008-10#5)
ABSTRACT##1758##1##(2008-10#1693)(2008-5#29)(2008-9#1)(2011-2#7)(2012-12#1)(2012-2#9)(2012-3#15)(2013-1#2)(2013-7#1)
ABT-737 is##3##2##(2009-12#1)(2012-12#2)
ABT-737##11##1##(2009-12#2)(2012-12#9)
ABTM##2##1##(2008-10#2)
ABTS##6##1##(1997-2#1)(2008-10#5)
ABTS(+)##4##1##(2008-10#3)(2013-1#1)
ABU in the##2##3##(2008-12#2)
ABU was##2##2##(2008-12#2)
ABU##4##1##(2008-12#4)
ABZ1##2##1##(2012-3#2)
AC HEMIZYGOUS MICE Groups of##2##5##(2008-9#2)
AC HEMIZYGOUS MICE##13##3##(2008-8#1)(2008-9#12)
AC Hemizygous) mice (dermal##2##4##(2008-9#2)
AC Hemizygous) mice and carcinogenicity##2##5##(2008-9#2)
AC Hemizygous) mice##4##3##(2008-9#4)
AC Taber##4##2##(2008-10#4)
AC and##3##2##(1994-12#1)(2009-7#2)
AC hemizygous and p53 haploinsufficient mice were exposed to##2##9##(2008-9#2)
AC hemizygous and p53 haploinsufficient mice were##3##7##(2008-9#3)
AC hemizygous and p53 haploinsufficient mice##6##6##(2008-9#6)
AC hemizygous and##7##3##(2008-8#1)(2008-9#6)
AC hemizygous mice administered##3##4##(2008-9#3)
AC hemizygous mice dosed with##2##5##(2008-9#2)
AC hemizygous mice dosed##3##4##(2008-9#3)
AC hemizygous mice exposed to sodium bromate##2##7##(2008-9#2)
AC hemizygous mice exposed to##5##5##(2008-9#5)
AC hemizygous mice exposed##8##4##(2008-9#8)
AC hemizygous mice received dermal applications of 0##2##8##(2008-9#2)
AC hemizygous mice received##4##4##(2008-9#4)
AC hemizygous mice were administered 0##5##6##(2008-9#5)
AC hemizygous mice were administered technical grade##2##7##(2008-9#2)
AC hemizygous mice were administered##7##5##(2008-9#7)
AC hemizygous mice were dermally administered 0##2##7##(2008-9#2)
AC hemizygous mice were dermally administered the same doses##2##9##(2008-9#2)
AC hemizygous mice were dermally administered##4##6##(2008-9#4)
AC hemizygous mice were exposed to drinking water containing 0##5##10##(2008-9#5)
AC hemizygous mice were fed diets containing##2##7##(2008-8#1)(2008-9#1)
AC hemizygous mice were##20##4##(2008-8#1)(2008-9#19)
AC hemizygous mice##45##3##(2008-8#1)(2008-9#44)
AC hemizygous mouse peripheral blood erythrocytes##2##6##(2008-9#2)
AC hemizygous mouse##3##3##(2008-9#3)
AC hemizygous strain and the p53 haploinsufficient strain##2##8##(2008-8#1)(2008-9#1)
AC hemizygous##60##2##(2008-8#5)(2008-9#55)
AC hemizygous) mice (dermal studies)##2##5##(2008-9#2)
AC hemizygous) mice (dermal##3##4##(2008-9#3)
AC hemizygous) mice##4##3##(2008-9#4)
AC hemizygous)##5##2##(2008-8#1)(2008-9#4)
AC in##3##2##(2009-7#1)(2011-1#2)
AC was##3##2##(2008-10#2)(2009-7#1)
AC##125##1##(1990-5#3)(1991-8#1)(1994-12#2)(1994-9#7)(2008-10#15)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#75)(2009-10#1)(2009-11#2)(2009-7#6)(2011-1#2)(2012-12#1)(2013-1#1)
AC-##2##1##(2008-10#2)
AC1##2##1##(2008-10#2)
AC133(+) cells##2##2##(2013-1#2)
AC133(+)##3##1##(2013-1#3)
AC133(bright)##3##1##(2013-1#3)
AC2##4##1##(2008-10#1)(2008-9#3)
ACA and ANA##3##3##(2011-2#3)
ACA and##4##2##(2011-2#3)(2013-8#1)
ACA##14##1##(2011-2#10)(2013-7#1)(2013-8#3)
ACASS##2##1##(2012-12#2)
ACAT##4##1##(1990-8#2)(1995-3#2)
ACBP by##2##2##(1994-8#2)
ACBP concentrations##2##2##(1994-8#2)
ACBP was##2##2##(1994-8#2)
ACBP##8##1##(1994-8#8)
ACC content##2##2##(2011-2#2)
ACC in##3##2##(2008-10#2)(2011-10#1)
ACC of the##2##3##(2013-1#1)(2013-8#1)
ACC synthase##2##2##(1995-2#2)
ACC was##2##2##(1991-11#1)(2010-7#1)
ACC were##3##2##(2008-10#3)
ACC##34##1##(1991-11#4)(1991-6#2)(1992-10#2)(1993-6#2)(1995-2#2)(2008-10#9)(2008-3#1)(2009-6#2)(2010-7#1)(2011-10#1)(2011-2#2)(2013-1#1)(2013-8#5)
ACC-infected##2##1##(2008-10#2)
ACC/AHA##3##1##(2008-3#2)(2012-3#1)
ACCESSIBLE SUMMARY##6##2##(2011-2#6)
ACCH##3##1##(1991-3#1)(1992-3#2)
ACD##9##1##(2009-8#2)(2010-8#1)(2011-2#6)
ACDF##8##1##(2012-12#8)
ACE activity##3##2##(1993-12#3)
ACE and##3##2##(2008-9#2)(2010-2#1)
ACE cells##2##2##(1990-2#2)
ACE in##2##2##(1993-12#2)
ACE inhibitor##3##2##(1997-3#1)(2008-3#1)(2008-7#1)
ACE inhibitors have##2##3##(2008-7#2)
ACE inhibitors proved to be effective##2##6##(1994-7#1)(2008-7#1)
ACE inhibitors##15##2##(1990-2#1)(1993-2#1)(1994-7#3)(1996-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2011-2#1)
ACE inhibitory activities##2##3##(2010-2#2)
ACE inhibitory activity##3##3##(2010-2#3)
ACE inhibitory##5##2##(2010-2#5)
ACE was##2##2##(1993-12#1)(2008-9#1)
ACE##56##1##(1990-2#9)(1991-11#1)(1991-5#1)(1993-12#9)(1993-2#1)(1994-7#3)(1996-6#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-9#7)(2010-2#6)(2011-2#1)
ACE-R-Ch showed##2##2##(2013-1#2)
ACE-R-Ch##3##1##(2013-1#3)
ACE-inhibitors and##4##2##(1990-2#1)(1993-2#2)(2008-10#1)
ACE-inhibitors##10##1##(1990-2#4)(1990-3#1)(1992-6#2)(1993-2#2)(2008-10#1)
ACE1##3##1##(1991-7#2)(2011-2#1)
ACEHSA Fellowship##2##2##(1996-12#2)
ACEHSA##5##1##(1993-2#1)(1995-1#1)(1996-12#3)
ACFP##2##1##(1993-3#2)
ACG##3##1##(1995-2#1)(2010-2#1)(2010-7#1)
ACGMRF model##2##2##(2008-6#2)
ACGs##2##1##(1995-2#2)
ACIS##4##1##(2008-10#4)
ACL damage##2##2##(2007-8#1)(2013-1#1)
ACL graft##3##2##(1997-8#2)(2013-1#1)
ACL grafts##2##2##(1997-8#2)
ACL reconstruction with hamstrings##3##4##(2013-1#3)
ACL reconstruction##7##2##(2012-2#2)(2013-1#5)
ACL reconstructions using Achilles tendon allografts in patients##2##8##(2012-2#2)
ACL##32##1##(1997-8#8)(2007-11#2)(2007-8#1)(2012-2#4)(2013-1#17)
ACL-PCL##2##1##(2013-1#2)
ACLSV##7##1##(2008-10#7)
ACLU##2##1##(1996-5#2)
ACM##2##1##(2012-2#2)
ACM941 significantly##2##2##(2008-10#2)
ACM941##9##1##(2008-10#9)
ACMs##2##1##(2012-2#2)
ACN##9##1##(1994-9#3)(2008-10#6)
ACN-water mixtures##2##2##(2008-10#2)
ACN-water##3##1##(2008-10#3)
ACO##4##1##(2011-2#2)(2012-3#2)
ACOG guidelines##2##2##(2010-9#2)
ACOG##5##1##(2010-9#5)
ACP##9##1##(1991-11#2)(1992-4#2)(1993-12#1)(1995-6#1)(2013-1#1)(2013-8#2)
ACP1 gene product##4##3##(1992-12#4)
ACPA)##2##1##(2013-1#2)
ACPC##2##1##(1995-11#2)
ACPD (30 mu M)##2##4##(1995-12#2)
ACPD in the dentate gyrus##2##5##(1995-12#2)
ACPD in the##3##3##(1995-12#3)
ACPD in##4##2##(1995-12#4)
ACPD##13##1##(1995-12#13)
ACPT##2##1##(1996-5#2)
ACQUITY UPLC BEH##2##3##(2011-1#1)(2012-3#1)
ACR##14##1##(2007-4#3)(2008-10#9)(2008-5#1)(2013-1#1)
ACR-toxin##3##1##(2008-10#3)
ACS and##7##2##(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#3)
ACS were##2##2##(2011-2#1)(2012-2#1)
ACS##45##1##(1997-1#1)(2008-10#3)(2008-3#8)(2008-4#12)(2008-5#2)(2008-6#8)(2010-4#2)(2011-2#5)(2012-2#4)
ACT produced##2##2##(2008-10#2)
ACT##9##1##(2007-11#1)(2007-2#4)(2008-10#3)(2011-2#1)
ACT-toxin and##2##2##(2008-10#2)
ACT-toxin##8##1##(2008-10#8)
ACTH 1-24##2##2##(1994-2#1)(1995-12#1)
ACTH and corticosterone##3##3##(1995-12#1)(1996-12#2)
ACTH and cortisol##3##3##(1995-11#2)(2011-2#1)
ACTH and##8##2##(1994-2#1)(1995-11#2)(1995-12#2)(1996-12#2)(2011-2#1)
ACTH expression in##2##3##(1995-12#2)
ACTH receptor gene##2##3##(1993-11#2)
ACTH receptor##5##2##(1993-11#3)(2011-1#2)
ACTH release##2##2##(1992-12#2)
ACTH response to##2##3##(1992-8#1)(1994-2#1)
ACTH secretion##7##2##(1990-3#2)(1992-12#1)(2008-4#4)
ACTH stimulation##2##2##(1990-11#1)(2008-1#1)
ACTH##53##1##(1990-11#1)(1990-3#2)(1992-12#3)(1992-8#4)(1993-11#5)(1993-2#1)(1993-5#2)(1994-2#5)(1995-11#2)(1995-12#8)(1995-2#1)(1996-12#2)(2008-1#1)(2008-4#4)(2008-5#1)(2008-8#3)(2011-1#4)(2011-2#4)
ACTH-(4-10)##4##1##(1993-5#3)(1995-12#1)
ACTH-ir##5##1##(1995-12#5)
ACTH-stimulated##2##1##(1996-2#1)(2008-1#1)
ACTH4-9##2##1##(1993-5#2)
ACTIVITY##3##1##(1995-3#1)(2008-1#1)(2011-2#1)
ACh at##2##2##(2008-8#2)
ACh receptor##2##2##(2008-8#2)
ACh release reflected##2##3##(2008-4#2)
ACh release##3##2##(2008-4#3)
ACh##31##1##(1990-7#3)(1992-8#1)(1993-3#1)(1995-12#3)(1995-3#1)(1996-5#3)(1997-1#1)(2008-4#3)(2008-5#1)(2008-8#5)(2009-12#5)(2009-8#1)(2011-1#2)(2012-3#1)
ACh-mediated system##2##2##(2009-8#2)
ACh-mediated##3##1##(2009-8#3)
ACh-release##2##1##(2008-8#2)
AChCl##2##1##(2008-10#2)
AChE activity##3##2##(2008-11#3)
AChE and##2##2##(2009-8#2)
AChE layer##3##2##(2008-10#3)
AChE levels##2##2##(1995-12#2)
AChE was##2##2##(2008-10#2)
AChE##43##1##(1990-5#4)(1992-12#1)(1994-5#2)(1995-12#10)(1995-3#1)(2008-10#10)(2008-11#5)(2008-5#1)(2008-7#1)(2009-8#8)
AChEs##4##1##(2009-8#4)
AChR molecule##2##2##(2012-2#2)
AChR##11##1##(1997-5#3)(2009-8#3)(2012-2#5)
AD amygdala##2##2##(1993-12#2)
AD and PD##6##3##(1995-12#1)(2011-2#5)
AD and VaD##2##3##(2008-7#2)
AD and##18##2##(1990-11#1)(1993-12#2)(1995-12#1)(2007-8#1)(2008-10#1)(2008-7#5)(2009-10#1)(2011-2#6)
AD cases##5##2##(1991-1#4)(1996-5#1)
AD duration##5##2##(1992-12#3)(1994-2#2)
AD has been##2##3##(2008-7#1)(2011-1#1)
AD has##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
AD height gain##3##3##(2011-2#3)
AD in##3##2##(1994-5#1)(2008-4#1)(2009-12#1)
AD is a##2##3##(2008-5#1)(2012-2#1)
AD is##4##2##(2008-5#1)(2008-7#2)(2012-2#1)
AD pathogenesis##2##2##(2009-11#2)
AD pathology##3##2##(2009-12#2)(2013-1#1)
AD patients and##3##3##(2008-7#2)(2012-2#1)
AD patients was##2##3##(2008-7#1)(2012-1#1)
AD patients##17##2##(1993-12#1)(1995-12#1)(1996-5#2)(2008-5#3)(2008-7#4)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#3)
AD remains##2##2##(2008-7#1)(2012-2#1)
AD with##2##2##(1996-2#1)(2012-12#1)
AD##175##1##(1990-11#2)(1991-1#6)(1991-7#1)(1992-12#4)(1993-12#7)(1994-11#1)(1994-2#2)(1994-5#2)(1994-8#4)(1995-12#7)(1995-5#4)(1995-8#3)(1996-2#2)(1996-5#6)(1997-2#5)(2007-6#1)(2007-8#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#7)(2008-7#36)(2008-9#1)(2009-10#3)(2009-11#6)(2009-12#8)(2009-5#3)(2010-2#2)(2011-1#7)(2011-2#14)(2012-1#3)(2012-12#1)(2012-2#10)(2013-1#2)
AD-5423##4##1##(2008-5#4)
AD-related##2##1##(2008-7#2)
AD-type##2##1##(2008-10#1)(2009-11#1)
ADA and##2##2##(1995-12#1)(2013-1#1)
ADA is##2##2##(1996-1#1)(2008-10#1)
ADA##31##1##(1990-8#1)(1992-11#1)(1994-1#2)(1995-12#7)(1995-6#2)(1996-1#3)(1996-5#3)(1997-5#2)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
ADAM##6##1##(1990-9#1)(2008-11#1)(2008-8#2)(2008-9#2)
ADAM22 and 14-3-3beta##3##3##(2008-9#3)
ADAM22##7##1##(2008-9#7)
ADAM29##5##1##(2008-8#5)
ADAMTS13##12##1##(2009-7#12)
ADAMs##2##1##(2008-8#1)(2008-9#1)
ADAVS##3##1##(1996-9#3)
ADBI##5##1##(2008-10#5)
ADC##15##1##(1992-12#1)(1996-5#3)(2008-10#1)(2008-11#1)(2009-11#4)(2009-4#1)(2011-1#4)
ADCC##9##1##(1992-2#3)(1993-6#1)(2008-11#1)(2008-4#4)
ADCI is##2##2##(2008-5#2)
ADCI##7##1##(2008-5#7)
ADE##7##1##(2008-10#2)(2008-8#2)(2011-1#3)
ADEM##3##1##(2012-12#3)
ADEs##2##1##(2008-3#2)
ADG cell line##4##3##(2008-11#4)
ADG##6##1##(2008-11#4)(2008-12#1)(2010-2#1)
ADH activity and ADH CRM##2##5##(1997-8#2)
ADH activity and##3##3##(1997-8#3)
ADH activity##4##2##(1997-8#4)
ADH mRNA##3##2##(1993-3#1)(1997-8#2)
ADH promoter##3##2##(1993-3#3)
ADH##21##1##(1993-11#1)(1993-3#5)(1994-9#3)(1997-8#9)(2007-8#1)(2008-10#1)(2008-8#1)
ADH-I was##3##2##(2008-11#3)
ADH-I##8##1##(2008-11#8)
ADH1##8##1##(1990-5#7)(1997-3#1)
ADH1B##2##1##(2012-2#2)
ADH1C Ile350Val##2##2##(2012-2#2)
ADH1C##3##1##(2012-2#3)
ADHD Rating##2##2##(2006-10#2)
ADHD adults##2##2##(2008-2#2)
ADHD and ODD##2##3##(2012-2#2)
ADHD and##12##2##(2008-2#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)
ADHD group##2##2##(2010-8#1)(2013-8#1)
ADHD is##3##2##(2008-2#1)(2008-8#1)(2013-7#1)
ADHD symptoms##6##2##(2008-6#1)(2009-8#3)(2012-2#1)(2013-7#1)
ADHD treatment##2##2##(2008-11#1)(2009-9#1)
ADHD was##2##2##(1996-6#1)(2008-9#1)
ADHD were##4##2##(2011-2#1)(2013-7#1)(2013-8#2)
ADHD will##2##2##(1996-6#1)(2008-2#1)
ADHD##78##1##(1996-6#2)(2006-10#3)(2008-11#3)(2008-2#18)(2008-4#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-8#5)(2009-9#4)(2010-8#4)(2011-2#3)(2012-1#3)(2012-2#7)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#12)
ADHD)##2##1##(2009-8#2)
ADHD-Inattentive##2##1##(2010-8#2)
ADI 1015##2##2##(2008-11#2)
ADI-R is##2##2##(2012-12#2)
ADI-R##4##1##(2012-12#4)
ADK-expression from astrogliosis##2##3##(2009-8#2)
ADK-expression##3##1##(2009-8#3)
ADL dependence##2##2##(2008-7#2)
ADL##19##1##(1995-2#2)(1995-3#1)(2008-7#6)(2011-2#4)(2012-1#2)(2012-2#4)
ADLs was##2##2##(1995-2#1)(2008-7#1)
ADLs##4##1##(1995-2#1)(2007-10#1)(2008-7#2)
ADM##6##1##(1992-3#2)(2008-8#1)(2013-1#3)
ADMA##8##1##(2009-4#8)
ADP analogue##2##2##(2008-4#2)
ADP and AMP##4##3##(1990-8#1)(1997-7#1)(2008-10#2)
ADP and ATP in##3##4##(1990-8#1)(2008-7#1)(2013-1#1)
ADP and ATP##7##3##(1990-8#2)(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
ADP and GTP##2##3##(1990-7#2)
ADP and TxA(2)##3##3##(2006-6#3)
ADP and##25##2##(1990-7#2)(1990-8#3)(1991-12#1)(1991-8#1)(1993-6#1)(1997-7#1)(2006-6#4)(2007-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)
ADP beta S##3##3##(1995-11#3)
ADP in the regulation of respiration##2##6##(2008-7#2)
ADP in##4##2##(2006-6#2)(2008-7#2)
ADP is##3##2##(1992-3#2)(2008-4#1)
ADP or##3##2##(1990-7#1)(1992-3#2)
ADP receptor##2##2##(2006-6#1)(2008-4#1)
ADP receptors##2##2##(2008-4#2)
ADP to##2##2##(1991-9#1)(1992-3#1)
ADP was##2##2##(1995-2#1)(1997-7#1)
ADP##121##1##(1990-11#3)(1990-5#1)(1990-7#4)(1990-8#3)(1991-12#2)(1991-8#2)(1991-9#9)(1992-3#11)(1992-6#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#5)(1995-11#5)(1995-12#1)(1995-2#2)(1995-8#2)(1997-2#1)(1997-7#5)(2006-6#9)(2007-10#1)(2008-10#5)(2008-11#1)(2008-4#22)(2008-5#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2013-1#5)
ADP-induced platelet##2##2##(1990-5#1)(1991-8#1)
ADP-induced##3##1##(1990-5#1)(1991-8#1)(1996-7#1)
ADP-ribose (cADPR)##2##2##(1994-11#1)(1995-3#1)
ADP-ribose##6##1##(1991-12#1)(1994-11#1)(1995-3#2)(2008-1#1)(2008-12#1)
ADP-ribosyl##2##1##(1993-3#1)(1994-11#1)
ADP-ribosylarginine hydrolases##2##2##(1992-6#2)
ADP-ribosylated##3##1##(1990-3#1)(1993-3#1)(1995-6#1)
ADP-ribosylates##2##1##(1992-3#1)(1993-6#1)
ADP-ribosylation factor##2##2##(1991-12#1)(2011-2#1)
ADP-ribosylation of HMG 2##2##4##(1990-3#2)
ADP-ribosylation of HMG proteins##2##4##(1990-3#2)
ADP-ribosylation of HMG##6##3##(1990-3#6)
ADP-ribosylation of an##2##3##(1993-3#1)(1995-11#1)
ADP-ribosylation of small GTP-binding##2##4##(1992-3#1)(1993-6#1)
ADP-ribosylation of the rho/rac proteins##2##5##(1990-2#2)
ADP-ribosylation of the##4##3##(1990-2#2)(1992-9#1)(1993-3#1)
ADP-ribosylation of##25##2##(1990-2#2)(1990-3#9)(1992-3#1)(1992-9#4)(1993-3#6)(1993-6#1)(1995-11#1)(1995-3#1)
ADP-ribosylation##39##1##(1990-2#3)(1990-3#9)(1991-12#2)(1992-3#2)(1992-9#6)(1993-3#8)(1993-6#2)(1993-8#1)(1994-6#1)(1995-11#2)(1995-3#1)(1997-4#1)(2011-2#1)
ADP-ribosyltransferase activity##2##2##(1990-2#1)(1995-2#1)
ADP-ribosyltransferase##6##1##(1990-2#2)(1991-12#1)(1992-3#1)(1993-6#1)(1995-2#1)
ADP/ATP##2##1##(1994-6#1)(2008-4#1)
ADP/O ratio##3##2##(1994-8#3)
ADP/O##5##1##(1994-8#5)
ADPKD##10##1##(1997-1#1)(2010-6#2)(2013-1#7)
ADPssS##4##1##(2008-4#4)
ADR and##5##2##(1990-2#1)(1994-6#1)(1994-7#1)(1995-4#1)(2008-10#1)
ADR case##2##2##(1993-1#1)(2011-2#1)
ADR cases were##3##3##(2011-2#3)
ADR cases##8##2##(2011-2#8)
ADR monitoring##2##2##(2011-2#2)
ADR reporting##4##2##(2008-11#2)(2008-3#1)(2011-2#1)
ADR reports of##2##3##(2011-2#2)
ADR reports##5##2##(2011-2#5)
ADR risks##2##2##(1994-6#2)
ADR was##2##2##(1997-7#1)(2011-2#1)
ADR##60##1##(1990-2#4)(1993-1#3)(1993-12#2)(1994-6#6)(1994-7#7)(1995-4#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-3#2)(2011-2#26)(2011-3#2)
ADR-ONE with##2##2##(2008-10#2)
ADR-ONE##3##1##(2008-10#3)
ADR/AE in##2##2##(2011-2#2)
ADR/AE reporting##2##2##(2011-2#2)
ADR/AE##19##1##(2011-2#19)
ADRs include##2##2##(2011-2#2)
ADRs were##2##2##(2011-2#2)
ADRs##20##1##(1993-1#2)(1993-2#1)(2008-11#2)(2008-3#2)(2011-2#13)
ADS##3##1##(2008-10#2)(2009-10#1)
ADSC##2##1##(2012-12#1)(2012-2#1)
ADSCs##6##1##(2012-12#3)(2012-3#3)
ADT and##3##2##(2008-2#3)
ADT has##2##2##(2008-7#2)
ADT increases##2##2##(1994-2#2)
ADT procedure##4##2##(2012-2#4)
ADT##24##1##(1994-2#5)(1996-3#1)(2008-2#8)(2008-7#3)(2012-2#7)
ADULTS##2##1##(2008-10#1)(2008-5#1)
ADV##3##1##(2008-11#2)(2011-2#1)
ADX##3##1##(1990-12#3)
AE##3##1##(2008-10#1)(2013-8#2)
AE1/AE3##2##1##(2008-11#1)(2010-12#1)
AE6##2##1##(2008-11#2)
AE6F4 antibody was##2##3##(2008-11#2)
AE6F4 antibody##6##2##(2008-11#6)
AE6F4##9##1##(2008-11#9)
AEDs##3##1##(2008-8#2)(2013-1#1)
AEFB##3##1##(2011-1#3)
AER to##2##2##(2012-1#2)
AER##6##1##(2012-1#6)
AET treatment##2##2##(1994-6#2)
AET##8##1##(1992-9#1)(1994-12#1)(1994-5#4)(1994-6#2)
AEs##2##1##(2008-11#2)
AF and##5##2##(2007-8#3)(2011-2#2)
AF in##5##2##(2011-2#4)(2012-12#1)
AF initiation##2##2##(2011-2#2)
AF is##4##2##(2010-12#1)(2011-2#1)(2012-12#2)
AF patients##3##2##(2008-10#1)(2010-12#2)
AF tissue##3##2##(2012-2#3)
AF was not##2##3##(2011-2#2)
AF was##3##2##(2011-2#3)
AF##56##1##(1997-2#1)(2007-8#5)(2008-10#2)(2008-6#2)(2010-12#8)(2010-8#3)(2011-2#17)(2012-12#9)(2012-2#6)(2012-3#3)
AF-related stroke prevention##2##3##(2012-12#2)
AF36##2##1##(2008-10#2)
AF4Q alliance##2##2##(2013-1#2)
AF4Q alliances##2##2##(2013-1#2)
AF4Q initiative##11##2##(2013-1#11)
AF4Q##20##1##(2013-1#20)
AF508 mutation##2##2##(2007-6#1)(2013-1#1)
AF508##3##1##(2007-6#1)(2013-1#2)
AFB method##3##2##(2007-7#3)
AFB stain##3##2##(2007-8#3)
AFB##15##1##(2007-7#5)(2007-8#9)(2011-2#1)
AFB(1) aerosol##3##2##(2008-10#3)
AFB(1) on##2##2##(2008-10#2)
AFB(1)##15##1##(2008-10#12)(2010-5#3)
AFB1##6##1##(1992-9#1)(2008-10#4)(2008-12#1)
AFC and##2##2##(2008-10#1)(2011-2#1)
AFC assay is##2##3##(2008-10#2)
AFC assay##7##2##(2008-10#7)
AFC##16##1##(1993-8#1)(2008-10#9)(2011-2#6)
AFDC beneficiaries##2##2##(1992-2#1)(1996-3#1)
AFDC##9##1##(1992-2#4)(1996-1#1)(1996-12#2)(1996-3#2)
AFGPs##3##1##(1990-12#3)
AFLP analyses##6##2##(2008-10#6)
AFLP analysis##7##2##(2008-10#7)
AFLP and##4##2##(2008-10#4)
AFLP bands were##2##3##(2008-10#2)
AFLP data##9##2##(2008-10#8)(2008-9#1)
AFLP fingerprint##2##2##(2008-10#2)
AFLP groups##4##2##(2008-10#4)
AFLP haplotypes##2##2##(2008-10#2)
AFLP loci##3##2##(2008-10#3)
AFLP marker##3##2##(2008-10#3)
AFLP markers showed##2##3##(2008-10#2)
AFLP markers were##5##3##(2008-10#5)
AFLP markers##16##2##(2008-10#15)(2008-5#1)
AFLP patterns##3##2##(2008-10#3)
AFLP products##2##2##(2008-10#2)
AFLP profiles and##2##3##(2008-10#2)
AFLP profiles##4##2##(2008-10#4)
AFLP##98##1##(2008-10#94)(2008-5#2)(2008-9#1)(2011-2#1)
AFLP-based##2##1##(2008-10#1)(2008-2#1)
AFLPs##2##1##(2008-10#2)
AFM and##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
AFM images##4##2##(2008-10#2)(2009-11#1)(2013-8#1)
AFM imaging##2##2##(2008-10#1)(2008-3#1)
AFM in##2##2##(2008-10#2)
AFM measurements##2##2##(2008-10#1)(2008-3#1)
AFM on##2##2##(2008-4#2)
AFM scanning##2##2##(2008-3#1)(2012-2#1)
AFM tip##4##2##(2007-12#1)(2008-10#1)(2008-7#2)
AFM tips##2##2##(2008-10#2)
AFM were##2##2##(2008-10#2)
AFM##43##1##(2007-12#2)(2008-10#19)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-11#2)(2009-9#1)(2012-2#1)(2013-8#1)
AFM1##2##1##(2008-12#2)
AFP mRNA expression in blood##3##5##(2008-10#3)
AFP mRNA in HCC patients##2##5##(2008-10#2)
AFP mRNA in the##2##4##(2008-10#2)
AFP mRNA in##4##3##(2008-10#4)
AFP mRNA was##2##3##(2008-10#2)
AFP mRNA##17##2##(2008-10#17)
AFP positive hepatoma cells##3##4##(2008-8#3)
AFP values##2##2##(2008-10#1)(2013-1#1)
AFP##40##1##(1990-9#1)(1994-9#5)(2008-10#25)(2008-6#2)(2008-8#4)(2011-1#1)(2013-1#2)
AFP111##2##1##(2008-6#2)
AFPplus by a practitioner cooperating with a private laboratory thus reveals a detection rate comparable to that known from larger centers##2##21##(1997-4#2)
AFPplus##6##1##(1997-4#6)
AFS detection##4##2##(2008-10#4)
AFS##12##1##(1996-12#2)(2008-10#10)
AFTER group##2##2##(1996-2#2)
AG##34##1##(1990-8#1)(1991-8#1)(1995-2#5)(2007-8#2)(2008-10#14)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2012-4#1)(2013-8#5)
AG(37 kDa) and AG(9 kDa)##3##5##(1995-11#3)
AG(37 kDa)##6##2##(1995-11#6)
AG(37##7##1##(1995-11#7)
AG(9 kDa)##7##2##(1995-11#7)
AG)##6##1##(2007-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-2#1)(2012-4#1)
AG-1-IA##3##1##(2008-10#3)
AG-12 and##2##2##(2008-10#2)
AG-12##7##1##(2008-10#7)
AG-13##7##1##(2008-10#7)
AG-2 and##2##2##(2008-10#2)
AG-2##11##1##(2008-10#11)
AG-3##6##1##(2008-10#4)(2008-12#2)
AG-4##5##1##(2008-10#4)(2008-12#1)
AG-5##4##1##(2008-10#3)(2008-12#1)
AG-6 GV##3##2##(2008-10#3)
AG-6 HG##3##2##(2008-10#3)
AG-6##10##1##(2008-10#10)
AG-8##6##1##(2008-10#4)(2008-12#2)
AG-A##3##1##(2008-10#3)
AG-BI and the##2##3##(2008-10#2)
AG-BI and##3##2##(2008-10#3)
AG-BI##4##1##(2008-10#4)
AG-Ba##2##1##(2008-12#2)
AG-CUT##5##1##(2008-10#5)
AG-D##2##1##(2008-12#2)
AG-G##4##1##(2008-10#4)
AG-K##2##1##(2008-10#1)(2008-12#1)
AG-MIN##5##1##(2008-10#5)
AG-T and##2##2##(2008-10#2)
AG-U##2##1##(2008-10#2)
AG1##2##1##(2008-10#2)
AG1-IC##2##1##(2008-10#2)
AG490 inhibited##2##2##(2011-2#2)
AG490##6##1##(2011-2#6)
AGA and##2##2##(1993-12#1)(2011-1#1)
AGA##10##1##(1993-12#3)(2008-4#1)(2011-1#2)(2012-3#4)
AGC##2##1##(2008-8#1)(2010-7#1)
AGE##5##1##(2008-1#2)(2008-10#1)(2012-12#2)
AGE-beta 2M##4##2##(1994-6#4)
AGEs##5##1##(2008-1#1)(2011-1#4)
AGF2##4##1##(1993-3#4)
AGP##4##1##(1991-12#1)(1997-3#2)(2009-8#1)
AGPp##2##1##(1991-12#2)
AGR##7##1##(2008-10#4)(2012-2#3)
AGS and HEF cell lines##2##5##(2008-12#2)
AGS##5##1##(1992-8#1)(2008-12#4)
AGSF##3##1##(1992-9#3)
AGT activity in##2##3##(1992-6#1)(2008-5#1)
AGT activity##8##2##(1992-6#1)(1993-11#3)(1995-12#2)(1995-5#1)(2008-5#1)
AGT##21##1##(1992-6#2)(1993-11#4)(1995-12#6)(1995-5#6)(2008-5#2)(2010-7#1)
AGTa-20c and##2##2##(2008-10#2)
AGU patients##2##2##(1991-7#2)
AGabaA a(3)##3##2##(2012-12#3)
AGabaA##4##1##(2012-12#4)
AGabaAIG##2##1##(2012-12#2)
AGs of R##5##3##(2008-10#4)(2008-12#1)
AGs of binucleate Rhizoctonia spp##2##5##(2008-10#2)
AGs of##7##2##(2008-10#6)(2008-12#1)
AGs##12##1##(2008-10#11)(2008-12#1)
AH##14##1##(1993-8#4)(1995-1#2)(2008-7#1)(2009-7#4)(2010-3#2)(2011-2#1)
AH109A cells and##2##3##(2008-11#2)
AH109A cells were##2##3##(2008-11#2)
AH109A cells##21##2##(2008-11#21)
AH109A invasion##6##2##(2008-11#6)
AH109A##40##1##(1993-8#1)(2008-11#39)
AH66 cells were##2##3##(1992-3#2)
AH66 cells##6##2##(1992-3#4)(1993-8#2)
AH66##8##1##(1992-3#5)(1993-8#3)
AH66F cells##2##2##(1993-8#2)
AH66F##3##1##(1993-8#3)
AH8##4##1##(2010-5#4)
AHA##14##1##(1990-4#1)(1991-12#3)(1991-9#1)(1993-8#1)(1994-1#1)(1995-1#1)(1995-3#1)(1997-3#2)(2008-3#1)(2008-5#1)(2011-3#1)
AHA's new##2##2##(1992-3#1)(1993-12#1)
AHA's reform##2##2##(1993-2#1)(1993-3#1)
AHA's##8##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)
AHC##2##1##(2008-4#2)
AHCCCS##2##1##(1994-3#1)(1995-12#1)
AHCPR##2##1##(1995-1#1)(1996-12#1)
AHH##2##1##(1990-7#2)
AHL##2##1##(2008-10#2)
AHO##5##1##(2010-6#4)(2011-1#1)
AHP##13##1##(1991-5#3)(1992-3#2)(1993-3#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-3#1)(2008-10#1)
AHP's##3##1##(1992-3#2)(1993-1#1)
AHPs##3##1##(1994-3#3)
AHRA (American Healthcare Radiology Administrators)##2##5##(1995-12#1)(1996-1#1)
AHRA (American Healthcare Radiology##3##4##(1993-2#1)(1995-12#1)(1996-1#1)
AHRA Statistical Resource Committee##5##4##(1991-12#1)(1991-3#1)(1993-1#1)(1995-1#1)(1995-2#1)
AHRA Trends##2##2##(1991-1#1)(1996-1#1)
AHRA data##2##2##(1991-12#2)
AHRA members##2##2##(1991-2#1)(1994-3#1)
AHRA membership survey##3##3##(1994-1#1)(1994-2#1)(1994-3#1)
AHRA survey##7##2##(1991-12#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)
AHRA##33##1##(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#3)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#3)(1996-1#3)(1996-2#2)
AI and AII##3##3##(2008-10#3)
AI and B##3##3##(2008-10#2)(2008-4#1)
AI and##8##2##(2008-10#6)(2008-4#1)(2013-1#1)
AI assay##3##2##(2010-2#3)
AI group##4##2##(2013-1#4)
AI has##3##2##(2007-12#2)(2008-10#1)
AI in##3##2##(1993-12#1)(2008-7#2)
AI on##2##2##(2013-1#2)
AI protocol and##2##3##(2013-1#2)
AI##47##1##(1991-12#1)(1993-12#2)(1993-6#1)(1995-5#1)(2007-12#6)(2007-6#3)(2008-10#10)(2008-3#1)(2008-4#1)(2008-7#2)(2010-2#3)(2011-1#2)(2011-2#3)(2013-1#11)
AI-2##11##1##(2008-9#7)(2009-6#4)
AIBN##2##1##(2009-10#2)
AID is##2##2##(2011-2#2)
AID##10##1##(2008-10#1)(2011-2#9)
AIDS Confidentiality Act##2##3##(1992-9#2)
AIDS Foundation Houston##2##3##(1996-5#2)
AIDS among##2##2##(1991-12#2)
AIDS and HIV##3##3##(1995-6#1)(1997-6#1)(1997-8#1)
AIDS and cancer##2##3##(1997-3#2)
AIDS and other##4##3##(1993-6#1)(1993-9#1)(1994-3#1)(1995-5#1)
AIDS and the health care##2##5##(1992-12#1)(1994-3#1)
AIDS and the##5##3##(1992-12#1)(1994-3#1)(1995-5#1)(2008-9#1)(2009-1#1)
AIDS and##32##2##(1992-12#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-12#1)(1995-5#2)(1995-6#3)(1996-11#4)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-1#1)(2011-2#1)
AIDS are##6##2##(1992-9#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(2012-2#1)
AIDS as an##3##3##(1990-11#1)(1992-2#2)
AIDS as##4##2##(1990-11#1)(1992-2#2)(1997-6#1)
AIDS case##3##2##(1991-11#1)(1994-2#1)(1995-12#1)
AIDS cases in##4##3##(1993-6#1)(1993-8#1)(1995-12#1)(1997-5#1)
AIDS cases were##2##3##(1993-6#1)(1993-8#1)
AIDS cases##12##2##(1991-6#1)(1993-6#2)(1993-8#3)(1995-12#4)(1997-5#1)(2010-8#1)
AIDS clinical##3##2##(1997-4#2)(2009-5#1)
AIDS control##2##2##(1990-12#1)(1991-6#1)
AIDS crisis##4##2##(1990-3#1)(1992-12#2)(1993-1#1)
AIDS dementia##2##2##(1990-9#1)(2008-5#1)
AIDS diagnosis##6##2##(1991-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-5#1)
AIDS education##4##2##(1990-3#1)(1992-12#1)(1995-12#1)(2008-10#1)
AIDS epidemic and##2##3##(1990-12#2)
AIDS epidemic on the##2##4##(1995-1#1)(1996-5#1)
AIDS epidemic##16##2##(1990-12#4)(1990-3#3)(1994-9#1)(1995-1#2)(1996-5#2)(1996-6#1)(1997-6#1)(2008-4#1)(2008-5#1)
AIDS event and death in##2##5##(2010-8#2)
AIDS for##2##2##(1992-12#1)(1993-8#1)
AIDS in Africa##2##3##(1990-12#1)(1993-3#1)
AIDS in the##6##3##(1990-11#1)(1992-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2012-3#1)
AIDS in##19##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#3)(2010-3#1)(2012-3#2)
AIDS incidence in the##2##4##(1992-9#2)
AIDS incidence in##3##3##(1992-9#3)
AIDS incidence##10##2##(1992-9#4)(1994-9#2)(1995-12#1)(1997-3#2)(1997-6#1)
AIDS information##2##2##(1991-2#1)(1997-6#1)
AIDS is a##2##3##(1996-9#1)(2008-11#1)
AIDS is##7##2##(1995-12#1)(1996-11#1)(1996-9#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-2#1)
AIDS knowledge##2##2##(1996-9#1)(2010-7#1)
AIDS medication##2##2##(1995-6#2)
AIDS mortality##3##2##(1991-12#1)(1992-9#1)(1997-6#1)
AIDS pandemic##2##2##(1990-11#1)(1994-1#1)
AIDS patients and##3##3##(1996-9#1)(2008-5#2)
AIDS patients with##2##3##(1990-11#1)(2010-8#1)
AIDS patients##23##2##(1990-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#9)(2010-8#1)(2011-2#1)
AIDS policy##2##2##(1990-3#1)(1996-5#1)
AIDS prevention##10##2##(1990-3#1)(1995-1#3)(1995-12#1)(1995-6#1)(1996-9#1)(2008-10#2)(2008-4#1)
AIDS related##2##2##(1991-5#1)(2008-5#1)
AIDS research##4##2##(1990-5#1)(1993-6#1)(1995-12#1)(1997-4#1)
AIDS service organizations (ASOs)##2##4##(1996-3#1)(1997-2#1)
AIDS service organizations##4##3##(1995-12#1)(1996-3#2)(1997-2#1)
AIDS service##5##2##(1992-12#1)(1995-12#1)(1996-3#2)(1997-2#1)
AIDS strains##2##2##(2008-5#2)
AIDS surveillance##2##2##(1992-9#1)(1997-5#1)
AIDS to##4##2##(1997-6#3)(2009-7#1)
AIDS transmission##2##2##(1993-1#1)(1994-2#1)
AIDS treatment##3##2##(1994-8#1)(1996-1#1)(1996-5#1)
AIDS vaccine##4##2##(1993-3#1)(1994-2#1)(1996-8#1)(2007-7#1)
AIDS volunteers##5##2##(1993-12#2)(1994-3#3)
AIDS was reported##2##3##(1995-12#1)(2007-10#1)
AIDS was##7##2##(1990-3#1)(1993-8#1)(1995-12#2)(1997-6#1)(2007-10#1)(2008-10#1)
AIDS will##2##2##(1990-12#1)(1995-12#1)
AIDS##476##1##(1990-11#13)(1990-12#8)(1990-3#14)(1990-4#1)(1990-5#2)(1990-6#5)(1990-9#4)(1991-1#3)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#16)(1992-2#8)(1992-3#2)(1992-9#18)(1993-1#6)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#5)(1993-8#15)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#9)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#11)(1995-12#26)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#28)(1996-1#4)(1996-11#11)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#11)(1997-4#5)(1997-5#8)(1997-6#28)(1997-7#2)(1997-8#2)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#22)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#4)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#6)(2011-2#6)(2011-3#4)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#1)
AIDS-KS cells##3##2##(1992-3#3)
AIDS-KS##6##1##(1992-2#3)(1992-3#3)
AIDS-associated##4##1##(1992-3#1)(2008-5#1)(2009-8#2)
AIDS-related complications##3##2##(1995-6#2)(2012-2#1)
AIDS-related diffuse large B-cell##2##4##(2009-8#2)
AIDS-related organizations##2##2##(1991-2#1)(1995-3#1)
AIDS-related##22##1##(1991-12#1)(1991-2#2)(1993-1#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-3#1)(1997-6#2)(2007-12#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#2)(2010-8#1)(2012-2#1)
AIDS/HIV##4##1##(1992-12#1)(1995-1#2)(2011-2#1)
AII and##3##2##(1994-9#1)(1997-2#1)(2008-10#1)
AII antagonist##2##2##(1991-5#1)(1997-2#1)
AII binding##3##2##(1991-5#2)(1994-9#1)
AII or##3##2##(1994-8#1)(1995-12#1)(1997-2#1)
AII receptor##3##2##(1991-5#2)(1993-3#1)
AII was##2##2##(1994-8#1)(1997-2#1)
AII##31##1##(1991-5#5)(1993-3#1)(1993-6#1)(1994-12#3)(1994-8#2)(1994-9#3)(1995-12#2)(1995-5#1)(1997-2#6)(2008-10#7)
AII-induced contractions of##2##3##(1991-5#2)
AII-induced##3##1##(1991-5#3)
AIII##5##1##(1994-2#5)
AIM AND##2##2##(2010-9#1)(2011-2#1)
AIM of##2##2##(2008-12#1)(2008-7#1)
AIM##16##1##(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#3)(2010-11#3)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
AIM-1 was##2##2##(1995-2#2)
AIM-1##5##1##(1995-2#5)
AIM6##3##1##(2008-10#3)
AIMH##3##1##(2008-9#3)
AIMS##16##1##(1992-11#1)(1993-2#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
AIN/PIN##3##1##(2008-9#3)
AIP##5##1##(1990-2#2)(2013-1#3)
AIPP characterization##4##2##(2013-1#4)
AIPP##5##1##(2013-1#5)
AIRS##4##1##(1993-12#1)(2010-8#3)
AIS##6##1##(2007-11#1)(2008-10#4)(2010-7#1)
AIT-082 was##2##2##(2008-5#2)
AIT-082##10##1##(2008-5#10)
AIs in##2##2##(2011-1#2)
AJ##3##1##(2008-9#1)(2009-10#2)
AK##5##1##(1994-12#1)(2008-10#1)(2008-8#3)
AK-##2##1##(2008-10#2)
AK-toxin##3##1##(2008-10#3)
AKAP##3##1##(1995-11#3)
AKAP78 was##2##2##(1995-11#2)
AKAP78##4##1##(1995-11#4)
AKAPs##5##1##(1995-11#5)
AKBR decreased##2##2##(2007-8#2)
AKBR##11##1##(2007-8#11)
AKE##3##1##(2008-5#3)
AKG##4##1##(2007-8#4)
AKR lymphoma##2##2##(1990-6#2)
AKR##9##1##(1990-6#2)(1997-7#2)(2013-1#5)
AKT homologs##2##2##(2008-10#2)
AKT##5##1##(2008-10#4)(2013-1#1)
AKT1##2##1##(2008-10#1)(2012-3#1)
AL amyloidosis##3##2##(2010-4#2)(2011-2#1)
AL and##2##2##(2008-10#2)
AL formation in the resistant cactus##2##6##(2008-10#2)
AL formation##3##2##(2008-10#3)
AL##15##1##(1992-12#2)(1992-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2010-4#2)(2011-2#2)
AL-1##4##1##(2009-3#4)
AL-B##3##1##(1993-3#3)
AL-amyloidosis##2##1##(1992-3#2)
AL/SV##2##1##(1997-3#2)
ALA and##3##2##(1992-3#1)(1992-8#2)
ALA##19##1##(1992-3#3)(1992-8#6)(1992-9#3)(2008-1#2)(2008-6#1)(2009-8#2)(2012-1#1)(2012-3#1)
ALA)##2##1##(1992-3#2)
ALA-induced porphyrins##4##2##(1992-9#4)
ALAT##4##1##(1991-11#1)(1991-6#1)(1993-8#1)(2011-1#1)
ALB-RFLP##4##1##(2008-10#4)
ALC##3##1##(1997-2#2)(2008-10#1)
ALCL##6##1##(1997-3#2)(2011-2#3)(2013-1#1)
ALD##6##1##(1993-12#2)(1993-3#1)(1995-2#3)
ALDH##4##1##(1994-12#3)(1994-5#1)
ALDH2 activity##2##2##(2010-12#2)
ALDH2##5##1##(2010-12#5)
ALDH3c##5##1##(1992-8#5)
ALDH3m are##2##2##(1992-8#2)
ALDH3m##4##1##(1992-8#4)
ALDH7##3##1##(1994-12#3)
ALDP##2##1##(1995-2#2)
ALG-2##6##1##(2009-4#6)
ALGs were##2##2##(2008-11#2)
ALGs##4##1##(2008-11#4)
ALH(r)##4##1##(2008-10#4)
ALI due to##3##3##(2011-2#3)
ALI##12##1##(2008-8#4)(2010-12#4)(2011-2#4)
ALI1 gene product##2##3##(1993-12#2)
ALI1##4##1##(1991-9#2)(1993-12#2)
ALIAS-II##2##1##(2008-3#2)
ALK##3##1##(2008-9#3)
ALL IC-BFM-2002##2##2##(2011-2#2)
ALL and##5##2##(2011-2#5)
ALL cells##3##2##(2011-1#3)
ALL patients##3##2##(2011-2#1)(2012-12#2)
ALL##32##1##(1990-3#1)(1990-9#1)(1991-2#2)(1994-12#2)(1996-6#1)(2007-2#1)(2010-11#1)(2010-6#1)(2011-1#4)(2011-2#16)(2012-12#2)
ALL)##2##1##(2008-12#1)(2012-12#1)
ALL-1 and##2##2##(1997-7#2)
ALL-1##6##1##(1997-7#6)
ALM in situ##4##3##(2010-6#4)
ALM##8##1##(2010-6#8)
ALO##4##1##(1997-4#4)
ALP activity and cell proliferation##2##5##(2013-1#2)
ALP activity##5##2##(1991-5#1)(2008-11#2)(2013-1#2)
ALP in##2##2##(1991-5#1)(2008-10#1)
ALP levels were##3##3##(1991-5#2)(2013-1#1)
ALP levels##4##2##(1991-5#2)(2013-1#2)
ALP##34##1##(1991-5#8)(1994-5#2)(2007-12#1)(2008-10#4)(2008-11#9)(2011-1#3)(2012-3#2)(2013-1#5)
ALR##10##1##(1997-7#5)(2008-8#5)
ALS##10##1##(1996-5#2)(2008-10#1)(2008-4#2)(2008-7#2)(2009-9#3)
ALSD##2##1##(2008-10#2)
ALSV-CFP##4##1##(2008-10#4)
ALSV-YFP and ALSV-CFP##2##3##(2008-10#2)
ALSV-YFP and##3##2##(2008-10#3)
ALSV-YFP##7##1##(2008-10#7)
ALT and##2##2##(2008-11#1)(2010-11#1)
ALT levels##4##2##(2013-1#4)
ALT##16##1##(1996-12#1)(2008-10#6)(2008-11#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#4)(2013-8#1)
ALT/d-LDH##3##1##(2008-10#3)
ALTE##3##1##(2011-2#3)
ALV##3##1##(2008-3#1)(2009-8#2)
AM and##5##2##(1994-2#1)(1994-6#1)(2008-12#2)(2008-9#1)
AM frequencies##2##2##(2007-12#2)
AM fungal##2##2##(2008-11#2)
AM in a##2##3##(1994-6#1)(2008-5#1)
AM in##3##2##(1994-6#2)(2008-5#1)
AM may play##2##3##(1994-11#1)(1995-12#1)
AM transplantation##2##2##(2011-2#2)
AM we##2##2##(2008-10#1)(2011-2#1)
AM##47##1##(1992-3#1)(1992-6#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-6#7)(1995-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#6)
AM's##2##1##(2008-10#2)
AM-kindled seizures##2##2##(1994-2#2)
AM-plants##2##1##(2008-12#2)
AM-toxin##4##1##(2008-10#4)
AM1 and PM3##2##3##(2008-10#2)
AM1 level##2##2##(1996-5#2)
AM1##18##1##(1996-5#2)(1997-7#4)(2008-10#8)(2008-11#3)(2011-3#1)
AM19##2##1##(2008-10#2)
AMA##9##1##(1992-11#1)(1996-12#1)(1997-3#1)(2008-6#3)(2008-8#1)(2009-6#1)(2013-1#1)
AMA-1/RPB-1##2##1##(2012-3#2)
AMB##4##1##(1993-12#3)(1993-9#1)
AMBER##3##1##(1996-5#2)(2008-10#1)
AMCV-P19##2##1##(2011-2#2)
AMD development##2##2##(2011-2#2)
AMD##23##1##(2008-10#1)(2010-2#7)(2011-2#11)(2011-7#1)(2013-1#3)
AMD3100 at##2##2##(2008-7#2)
AMD3100##9##1##(2008-7#9)
AMF population biology##2##3##(2008-8#2)
AMF##5##1##(2008-8#5)
AMG 517##6##2##(2010-2#6)
AMH##2##1##(2008-4#2)
AMI and##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
AMI cases##2##2##(1995-2#2)
AMI in##5##2##(1993-10#1)(1995-2#1)(2006-8#1)(2008-12#1)(2008-3#1)
AMI patients##2##2##(1995-2#1)(2009-6#1)
AMI transformants##2##2##(2008-10#2)
AMI##35##1##(1990-12#4)(1992-3#4)(1993-10#1)(1995-12#2)(1995-2#4)(2006-8#3)(2008-10#5)(2008-12#1)(2008-3#4)(2008-5#1)(2009-6#4)(2010-12#2)
AML and##5##2##(1994-5#1)(2007-10#1)(2010-4#2)(2011-2#1)
AML axon##2##2##(2008-6#2)
AML axonal segment##2##3##(2008-6#2)
AML blast proliferation##2##3##(2006-6#2)
AML blast##3##2##(2006-6#3)
AML blasts##3##2##(2006-6#2)(2011-2#1)
AML cases##2##2##(2008-10#2)
AML cells##6##2##(2011-2#4)(2012-12#1)(2013-1#1)
AML has##2##2##(2008-6#1)(2013-1#1)
AML patients##4##2##(2007-10#2)(2007-2#1)(2013-1#1)
AML##56##1##(1992-10#2)(1994-5#1)(1997-4#1)(2006-6#5)(2007-10#3)(2007-2#1)(2008-10#7)(2008-5#1)(2008-6#8)(2010-1#2)(2010-4#5)(2011-2#15)(2012-12#1)(2013-1#4)
AML-2##5##1##(1997-4#5)
AML-BFM 2004 INTERIM protocol##2##4##(2011-2#2)
AML-BFM 2004##3##2##(2011-2#3)
AML-BFM##4##1##(2011-2#4)
AML1-ETO##2##1##(2007-4#1)(2011-2#1)
AML1/ETO fusion gene##4##3##(2008-10#4)
AML1/ETO fusion##5##2##(2008-10#5)
AML1/ETO positive##2##2##(2008-10#2)
AML1/ETO##8##1##(2008-10#8)
AMND is##2##2##(2008-10#2)
AMON-RA##2##1##(2008-3#2)
AMOVA and##2##2##(2008-10#1)(2010-8#1)
AMOVA##4##1##(2008-10#2)(2008-12#1)(2010-8#1)
AMP (N6##2##2##(1994-2#1)(1997-7#1)
AMP (cAMP)##3##2##(1997-2#1)(2008-10#2)
AMP N(1)-oxide##3##2##(2008-10#3)
AMP and adenosine and##2##4##(1993-12#1)(2008-4#1)
AMP and##9##2##(1991-9#1)(1993-12#1)(1993-6#1)(1995-11#1)(1996-5#1)(1997-7#1)(2008-4#1)(2008-9#2)
AMP deaminase##2##2##(1997-7#2)
AMP is##4##2##(1991-9#1)(1993-6#1)(2008-4#1)(2008-9#1)
AMP or##2##2##(2008-4#2)
AMP response element (CRE)##2##4##(1997-2#2)
AMP response element##3##3##(1991-2#1)(1997-2#2)
AMP response##4##2##(1991-2#1)(1995-8#1)(1997-2#2)
AMP was##2##2##(1996-5#1)(2008-4#1)
AMP##109##1##(1990-12#1)(1990-5#2)(1990-8#3)(1991-2#1)(1991-9#2)(1992-3#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#2)(1994-11#3)(1994-2#7)(1994-6#4)(1995-11#11)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-5#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#5)(2008-10#13)(2008-11#1)(2008-4#11)(2008-8#3)(2008-9#7)(2009-2#1)(2013-1#1)
AMP-activated protein kinase##3##3##(1994-11#1)(2010-10#1)(2011-2#1)
AMP-activated##4##1##(1994-11#1)(1997-2#1)(2010-10#1)(2011-2#1)
AMPA and NMDA receptors##2##4##(1995-11#2)
AMPA and##3##2##(1995-11#2)(1995-12#1)
AMPA receptor antagonist##3##3##(1994-2#2)(2008-8#1)
AMPA receptor subunit GluR-B##2##4##(1993-12#2)
AMPA receptor subunit##3##3##(1993-12#2)(2008-7#1)
AMPA receptor##15##2##(1993-12#2)(1994-2#2)(1995-11#1)(1996-5#4)(2008-7#3)(2008-8#2)(2009-8#1)
AMPA receptors were##4##3##(1996-2#4)
AMPA receptors##9##2##(1995-12#1)(1996-2#6)(2008-7#2)
AMPA type##2##2##(1995-5#2)
AMPA##42##1##(1993-12#2)(1994-2#2)(1995-11#3)(1995-12#3)(1995-5#2)(1996-2#6)(1996-5#4)(2008-7#6)(2008-8#7)(2009-8#1)(2011-1#6)
AMPA/kainate##2##1##(1995-5#1)(2008-7#1)
AMPA/kainate-like receptors##2##2##(2008-7#2)
AMPAR##2##1##(2012-2#1)(2012-3#1)
AMPH exposure##2##2##(2013-8#2)
AMPH##4##1##(2013-8#4)
AMPH-like nor DOM-like##2##3##(1991-1#2)
AMPH-like##5##1##(1991-1#5)
AMPK activation##2##2##(2010-11#2)
AMPK and##2##2##(2008-1#1)(2009-12#1)
AMPK##9##1##(2008-1#1)(2009-12#1)(2010-11#5)(2011-2#1)(2013-1#1)
AMPs##2##1##(2011-2#2)
AMT##5##1##(1991-3#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)
AMU##2##1##(2010-12#2)
AMV RNAs##2##2##(2008-10#2)
AMV isolates was##2##3##(2008-10#2)
AMV isolates##3##2##(2008-10#3)
AMV##12##1##(2008-10#11)(2008-7#1)
AN APPLICATION##2##2##(2009-11#1)(2009-9#1)
AN##21##1##(1991-11#2)(2007-7#8)(2008-10#1)(2008-5#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#3)
ANA##9##1##(1991-2#2)(2011-2#6)(2013-8#1)
ANALYSIS##2##1##(2009-11#1)(2010-12#1)
AND ASSOCIATED##2##2##(2008-9#1)(2013-8#1)
AND BACKGROUND##2##2##(2007-11#1)(2011-2#1)
AND METHOD##2##2##(2010-9#1)(2012-2#1)
AND METHODS##41##2##(1995-4#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-8#1)(2010-11#2)(2010-3#1)(2011-2#12)(2012-2#9)(2012-3#3)(2013-1#7)
AND RESULTS##10##2##(1997-7#1)(2008-11#2)(2008-12#3)(2012-2#3)(2013-1#1)
AND gate based on coupled gap-soliton formation in##2##8##(2007-12#2)
AND##129##1##(1993-12#1)(1993-2#1)(1995-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2008-11#5)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#12)(2009-1#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#16)(2011-7#1)(2012-12#5)(2012-2#28)(2012-3#4)(2013-1#10)(2013-8#4)
ANF prohormone##2##2##(1990-12#2)
ANF values were##2##3##(1990-9#2)
ANF##14##1##(1990-12#5)(1990-9#8)(2008-6#1)
ANG I##2##2##(1994-8#2)
ANG II by##2##3##(1994-11#1)(1994-8#1)
ANG II##11##2##(1991-5#4)(1994-11#5)(1994-8#2)
ANG##14##1##(1991-5#5)(1994-11#5)(1994-8#4)
ANGII and##2##2##(1992-8#2)
ANGII##5##1##(1992-8#5)
ANGIII##5##1##(1993-6#5)
ANKK1 gene##2##2##(2012-1#2)
ANKK1##5##1##(2012-1#5)
ANN classifier##2##2##(2008-10#1)(2010-8#1)
ANN model##4##2##(2008-10#4)
ANN models##3##2##(2008-10#3)
ANN structure##3##2##(2008-10#3)
ANN with##2##2##(2008-10#1)(2010-8#1)
ANN##43##1##(2008-10#35)(2009-3#3)(2010-8#5)
ANN/FTIR-ATR##2##1##(2008-10#2)
ANNs are##2##2##(2008-10#2)
ANNs##11##1##(2008-10#11)
ANOVA and Tukey##2##3##(2008-12#1)(2009-8#1)
ANOVA and Tukey's post-hoc test##2##5##(2008-11#1)(2008-12#1)
ANOVA and Tukey's test##3##4##(2008-12#2)(2013-1#1)
ANOVA and Tukey's##5##3##(2008-11#1)(2008-12#3)(2013-1#1)
ANOVA and##15##2##(1990-2#1)(2008-11#1)(2008-12#5)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#4)
ANOVA followed by##3##3##(2008-10#1)(2008-12#1)(2009-8#1)
ANOVA revealed significant##2##3##(1993-2#1)(2009-6#1)
ANOVA revealed##3##2##(1993-2#1)(2007-11#1)(2009-6#1)
ANOVA showed a significant##2##4##(2009-8#1)(2013-1#1)
ANOVA showed##3##2##(2009-8#1)(2010-9#1)(2013-1#1)
ANOVA were##2##2##(2008-10#1)(2012-12#1)
ANOVA with##3##2##(2008-9#1)(2010-3#1)(2013-8#1)
ANOVA##51##1##(1990-2#1)(1991-2#1)(1992-6#2)(1993-2#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#8)(2008-5#4)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#3)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
ANOVA)##4##1##(1994-8#2)(2013-1#1)(2013-7#1)
ANOVAs##2##1##(1996-2#1)(2008-9#1)
ANP and BNP##5##3##(1990-12#1)(1991-5#2)(2008-11#1)(2009-5#1)
ANP infusion##4##2##(2008-5#4)
ANP is a##2##3##(2008-5#2)
ANP is##3##2##(2008-5#2)(2009-5#1)
ANP##29##1##(1990-12#8)(1991-5#3)(1992-3#1)(1993-8#2)(2008-11#1)(2008-5#10)(2009-5#2)(2011-2#1)(2012-3#1)
ANP-(1-28)##4##1##(1992-3#4)
ANS activity##2##2##(2013-8#2)
ANS binding##3##2##(1990-2#1)(1993-11#1)(2008-4#1)
ANS dysfunction##5##2##(2009-11#3)(2011-1#2)
ANS##18##1##(1990-2#1)(1991-9#1)(1993-11#1)(2008-4#2)(2009-11#4)(2011-1#3)(2013-8#6)
ANSI##2##1##(1994-12#2)
ANTA##5##1##(2008-11#4)(2013-8#1)
ANTIBODY##2##1##(1997-5#1)(2007-2#1)
AO and BSA##2##3##(2008-10#2)
AO cells##2##2##(2008-2#2)
AO classification##2##2##(2007-11#1)(2012-2#1)
AO modulator##2##2##(2008-2#2)
AO plate##2##2##(2007-11#2)
AO system##8##2##(2008-2#1)(2008-3#7)
AO systems##2##2##(2008-2#1)(2008-3#1)
AO##28##1##(2007-11#4)(2008-10#4)(2008-2#10)(2008-3#9)(2012-2#1)
AOAC Official##2##2##(2008-10#2)
AOAC##6##1##(2008-10#5)(2013-7#1)
AOB##2##1##(1992-8#2)
AOBs system##2##2##(2011-2#2)
AOBs##4##1##(2011-2#4)
AOD at##2##2##(2008-2#2)
AOD##13##1##(2008-2#3)(2012-12#6)(2012-3#4)
AOFAS score##3##2##(2008-8#1)(2009-10#1)(2010-11#1)
AOFAS##4##1##(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)
AOM##5##1##(1990-6#1)(1992-3#1)(1993-11#2)(2011-2#1)
AOP##3##1##(2008-10#3)
AOR =##2##2##(2012-12#1)(2013-1#1)
AOS metabolism##2##2##(2008-10#2)
AOS##7##1##(2007-11#2)(2008-10#2)(2008-2#2)(2009-3#1)
AOSC-971##2##1##(2007-11#2)
AOT over##2##2##(1995-3#1)(2008-3#1)
AOT##5##1##(1995-3#1)(2008-3#4)
AOTF##8##1##(2007-12#1)(2008-10#6)(2008-2#1)
AOU##2##1##(2008-10#2)
AOX##10##1##(1994-6#3)(2008-9#5)(2009-8#2)
AP and##8##2##(1993-12#1)(1996-5#1)(2007-8#2)(2008-10#1)(2012-3#3)
AP neurons##2##2##(1997-3#2)
AP severity##2##2##(2013-1#2)
AP site##5##2##(1995-2#3)(2008-10#2)
AP structure##2##2##(2010-4#2)
AP was##4##2##(2008-5#1)(2009-8#1)(2012-3#2)
AP##75##1##(1991-10#3)(1992-3#1)(1993-12#1)(1993-9#1)(1995-2#6)(1996-12#5)(1996-5#2)(1997-3#2)(2007-11#1)(2007-8#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#6)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#3)(2010-4#4)(2012-2#1)(2012-3#9)(2013-1#12)
AP's cover)##3##2##(2012-3#3)
AP-1 and NF-kappa B##2##4##(1992-8#2)
AP-1 and NF-kappaB##3##3##(2008-9#3)
AP-1 and##7##2##(1992-8#3)(1994-11#1)(2008-9#3)
AP-1 binding##3##2##(1994-11#1)(1994-8#2)
AP-1##25##1##(1992-8#4)(1993-2#1)(1994-11#4)(1994-8#2)(1995-12#1)(1995-2#1)(1996-2#4)(1997-7#2)(2008-11#2)(2008-9#4)
AP-2##5##1##(1991-7#1)(1994-11#2)(1995-6#1)(2012-2#1)
AP-V##2##1##(2009-12#2)
AP1 and##2##2##(1995-11#1)(2008-9#1)
AP1##5##1##(1993-6#1)(1994-6#1)(1995-11#1)(1997-8#1)(2008-9#1)
AP2##5##1##(1994-6#1)(1997-8#2)(2008-8#1)(2008-9#1)
AP3/F7##2##1##(1991-9#2)
AP5##4##1##(1997-7#4)
APA beads##2##2##(2008-11#2)
APA##5##1##(1991-8#1)(1994-12#1)(2008-11#2)(2008-8#1)
APACHE II and Balthazar##2##4##(2013-1#2)
APACHE II score##3##3##(2010-10#1)(2013-1#2)
APACHE II##7##2##(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#4)
APACHE##8##1##(2009-5#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#4)
APB##2##1##(1993-8#2)
APBI##2##1##(2013-1#2)
APC and##2##2##(1997-2#1)(2011-2#1)
APC anticoagulant activity##2##3##(1993-11#2)
APC##22##1##(1993-11#6)(1994-11#1)(1997-2#2)(2007-12#1)(2007-3#2)(2008-10#2)(2008-4#3)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)
APC-PY##3##1##(2008-8#3)
APC-resistance##3##1##(1997-3#3)
APCI##2##1##(2008-10#1)(2008-5#1)
APCs between##2##2##(2012-3#2)
APCs##10##1##(1997-4#1)(2008-11#5)(2008-7#1)(2012-3#3)
APD##7##1##(2008-3#1)(2008-8#1)(2010-2#2)(2011-10#3)
APDC##10##1##(2008-10#10)
APDC-AC##2##1##(2008-10#2)
APDs and TBZ##2##3##(2011-10#2)
APDs##5##1##(2008-3#3)(2011-10#2)
APG##2##1##(1994-3#1)(2008-10#1)
APGWamide##2##1##(1990-2#1)(1991-5#1)
APGs##2##1##(1994-3#2)
API and##2##2##(2008-7#1)(2013-8#1)
API##9##1##(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-8#1)
APL muscle##2##2##(2008-7#2)
APL##4##1##(1991-9#1)(2008-7#3)
APLP2 mRNA levels##2##3##(1996-12#2)
APLP2 mRNA was##2##3##(1996-12#2)
APLP2 mRNA##13##2##(1996-12#13)
APLP2##14##1##(1996-12#14)
APM##2##1##(1997-5#1)(2008-3#1)
APN##4##1##(1995-8#2)(2012-2#2)
APOAC##2##1##(2008-11#2)
APOE knockout mice##2##3##(1996-6#2)
APOE transgenic##2##2##(1996-6#2)
APOE##7##1##(1995-12#1)(1996-12#1)(1996-6#5)
APP KPI##3##2##(1996-12#3)
APP and APLP2 mRNA in##2##5##(1996-12#2)
APP and APLP2 mRNA##5##4##(1996-12#5)
APP and APLP2##6##3##(1996-12#6)
APP and##10##2##(1991-9#1)(1992-12#1)(1995-12#1)(1996-12#6)(2008-11#1)
APP expression in##2##3##(1991-10#1)(1993-3#1)
APP expression##4##2##(1991-10#2)(1993-3#1)(1996-12#1)
APP fragments##3##2##(1992-12#2)(1992-8#1)
APP gene##2##2##(1993-3#1)(1996-12#1)
APP in##6##2##(1991-10#1)(1992-12#3)(1992-9#1)(1995-12#1)
APP is##5##2##(1991-9#1)(1992-12#2)(1992-6#1)(1996-12#1)
APP mRNA##10##2##(1993-3#3)(1996-12#7)
APP processing and##3##3##(1992-12#1)(1993-11#1)(2008-5#1)
APP processing##8##2##(1992-12#2)(1992-6#1)(1993-11#1)(1995-12#1)(1996-12#1)(2008-5#2)
APP secretase##2##2##(1992-12#2)
APP was##4##2##(1992-12#1)(1994-9#1)(1996-12#1)(2008-11#1)
APP##106##1##(1991-10#7)(1991-11#1)(1991-9#6)(1992-12#23)(1992-6#4)(1992-8#4)(1992-9#6)(1993-11#2)(1993-3#6)(1994-11#4)(1994-9#4)(1995-12#3)(1996-12#29)(2008-11#4)(2008-5#2)(2012-3#1)
APP)##5##1##(1991-10#1)(1991-11#1)(1992-8#1)(1992-9#1)(2008-5#1)
APP695##5##1##(1992-6#2)(1992-9#1)(1993-8#1)(1994-9#1)
APP751##2##1##(1992-9#1)(1994-9#1)
APP770##2##1##(1992-9#1)(1994-9#1)
APPI is##2##2##(1991-11#2)
APPI##6##1##(1991-11#4)(2008-10#2)
APPLICATION OF##2##2##(2009-5#1)(2009-9#1)
APPLICATION##3##1##(2009-11#1)(2009-5#1)(2009-9#1)
APPs##3##1##(1991-9#2)(1994-11#1)
APR##4##1##(2008-10#4)
APRN##2##1##(2012-3#2)
APRNs##4##1##(2012-3#4)
APS Abstracts Submitted for Presentation at the##9##7##(2008-11#9)
APS Annual Meeting##15##3##(2008-11#15)
APS stability##2##2##(2008-10#2)
APS##46##1##(1991-12#1)(1994-3#2)(2006-10#2)(2008-10#9)(2008-11#25)(2008-7#1)(2008-8#1)(2009-8#2)(2012-3#1)(2013-8#2)
APS1##3##1##(2008-7#3)
APS2##3##1##(2008-7#3)
APSs##2##1##(2008-8#1)(2012-3#1)
APT effect##2##2##(2012-12#2)
APT##5##1##(1991-11#1)(2012-12#4)
APTT##3##1##(1994-9#1)(2008-7#2)
APV and##2##2##(1994-11#1)(1997-6#1)
APV##6##1##(1994-11#1)(1997-6#4)(2008-1#1)
APW##2##1##(2012-2#2)
APXS##2##1##(2013-8#2)
APs##6##1##(2008-10#4)(2012-3#1)(2013-8#1)
AQ-based IIP particles##2##3##(2008-10#2)
AQM-TFL##2##1##(2008-7#2)
AQP1 and AVT-R##2##3##(2008-7#2)
AQP1 and OAT##2##3##(2009-12#2)
AQP1 and##5##2##(2007-12#1)(2008-7#2)(2009-12#2)
AQP1##9##1##(2007-12#2)(2008-7#4)(2009-12#3)
AQP2 expression levels##2##3##(2012-12#2)
AQP2 expression##3##2##(2012-12#3)
AQP2 is##2##2##(2012-12#2)
AQP2##13##1##(2012-12#13)
AR and##6##2##(1992-8#1)(1995-3#1)(2010-1#1)(2011-2#2)(2012-12#1)
AR cDNA##4##2##(1995-12#4)
AR coating##2##2##(2008-2#2)
AR coatings##4##2##(2008-2#4)
AR has##2##2##(1990-11#1)(2012-12#1)
AR in##7##2##(1990-11#3)(1992-8#1)(2008-4#1)(2010-1#1)(2012-12#1)
AR is##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
AR mRNA and protein##2##4##(1995-12#1)(2012-3#1)
AR mRNA down-regulation##2##3##(1995-12#2)
AR mRNA##9##2##(1995-12#7)(2012-3#2)
AR patients##4##2##(1991-9#4)
AR protein##3##2##(1995-12#3)
AR root powder##2##3##(2008-10#2)
AR root##6##2##(2008-10#6)
AR seasonal subtypes##2##3##(2012-2#2)
AR subtypes##2##2##(2012-2#2)
AR symptoms##2##2##(2008-3#1)(2013-8#1)
AR was##4##2##(2008-8#3)(2010-1#1)
AR were##3##2##(2008-8#1)(2012-2#2)
AR##111##1##(1990-11#9)(1991-9#4)(1992-3#1)(1992-8#3)(1995-12#16)(1995-3#5)(2007-8#3)(2008-10#9)(2008-2#6)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#5)(2010-1#3)(2010-12#1)(2011-2#7)(2012-12#10)(2012-2#11)(2012-3#2)(2013-8#7)
AR-JP##4##1##(2008-7#4)
AR-mediated cardiac hypertrophy##8##3##(2010-12#8)
AR-mediated##9##1##(2008-9#1)(2010-12#8)
AR4-2J##3##1##(1992-11#3)
ARA##3##1##(2012-1#2)(2013-1#1)
ARA/EPA ratio##2##2##(2012-2#2)
ARBs##4##1##(2008-8#4)
ARC and##2##2##(1991-5#2)
ARC derivatives##2##2##(2008-10#2)
ARC##14##1##(1991-5#4)(1992-1#1)(1994-8#2)(2007-12#2)(2008-10#2)(2012-3#3)
ARCs##2##1##(2007-11#2)
ARDS and ALI##3##3##(2008-8#3)
ARDS and##6##2##(1991-9#2)(1997-1#1)(2008-8#3)
ARDS patients##4##2##(1991-9#3)(1993-2#1)
ARDS##25##1##(1990-2#1)(1991-9#10)(1993-2#4)(1997-1#5)(2008-8#3)(2009-5#1)(2011-2#1)
ARE##6##1##(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-8#1)
ARF class##2##2##(1993-6#2)
ARF patients##3##2##(2008-4#3)
ARF protein##2##2##(1993-6#2)
ARF was##2##2##(2008-4#2)
ARF##29##1##(1993-6#9)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#11)(2009-8#1)(2012-3#1)
ARF-C isolates##4##2##(2008-10#4)
ARF-C##5##1##(2008-10#5)
ARF-L isolates parasitized##2##3##(2008-10#2)
ARF-L isolates##3##2##(2008-10#3)
ARF-L##6##1##(2008-10#6)
ARF18 and##2##2##(2008-10#2)
ARF18##6##1##(2008-10#6)
ARF18-C isolates##2##2##(2008-10#2)
ARF18-C##5##1##(2008-10#5)
ARF18-L isolates##2##2##(2008-10#2)
ARF18-L##4##1##(2008-10#4)
ARG##2##1##(2013-8#2)
ARG1(+/-) and##2##2##(2013-8#2)
ARG1(+/-)##4##1##(2013-8#4)
ARG2(-/-) mice##3##2##(2013-8#3)
ARG2(-/-)##4##1##(2013-8#4)
ARI values##2##2##(2008-10#2)
ARI##3##1##(2008-10#2)(2012-12#1)
ARIA##4##1##(2008-3#1)(2012-12#3)
ARIS##6##1##(1992-8#6)
ARK##3##1##(1992-3#2)(2013-1#1)
ARL67156##2##1##(2008-4#2)
ARM in##4##2##(1994-8#1)(2011-2#3)
ARM##16##1##(1994-8#4)(2011-2#12)
ARMD and hearing##2##3##(2011-2#2)
ARMD and##5##2##(2011-2#5)
ARMD group##3##2##(2011-1#3)
ARMD groups##2##2##(2011-1#2)
ARMD is##4##2##(2011-2#4)
ARMD##31##1##(2011-1#14)(2011-2#17)
ARMS2##4##1##(2013-1#4)
AROM in##2##2##(2008-12#2)
AROM##11##1##(2008-12#11)
ARP1##4##1##(2008-9#4)
ARP2/3 complex##2##2##(2009-10#2)
ARP2/3##4##1##(2009-10#4)
ARPE-19 cells##2##2##(2008-4#2)
ARPs##2##1##(2011-1#2)
ARS##13##1##(2008-10#8)(2008-3#1)(2008-6#3)(2013-7#1)
ART and##3##2##(1992-2#1)(2011-2#1)(2012-12#1)
ART roll-out##3##2##(2011-1#1)(2012-12#2)
ART services##2##2##(2010-8#2)
ART side##2##2##(2008-6#2)
ART to##3##2##(2010-4#1)(2011-2#1)(2012-12#1)
ART##38##1##(1992-2#3)(2008-6#3)(2009-10#1)(2010-4#1)(2010-8#8)(2011-1#7)(2011-2#3)(2012-12#10)(2012-2#1)(2013-1#1)
ARV treatment##2##2##(2009-7#2)
ARV##6##1##(2009-7#2)(2010-8#1)(2012-2#1)(2013-1#2)
ARVs##2##1##(2010-8#1)(2011-2#1)
AS 3##2##2##(2008-8#2)
AS and NAS mastectomies##3##4##(2011-2#3)
AS and##9##2##(2007-11#1)(2007-7#1)(2008-11#1)(2011-2#3)(2012-12#1)(2013-8#2)
AS in##2##2##(1994-6#1)(2007-11#1)
AS or##2##2##(2011-2#1)(2012-12#1)
AS subjects##4##2##(2011-2#4)
AS vs##2##2##(1994-6#2)
AS was##2##2##(2007-7#1)(2013-8#1)
AS##69##1##(1994-6#8)(2007-11#4)(2007-7#6)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#5)(2009-9#1)(2010-10#3)(2011-2#12)(2012-12#7)(2012-2#1)(2012-3#4)(2013-8#7)
AS) and##2##2##(2008-10#2)
AS)##3##1##(1994-6#1)(2008-10#2)
AS-OCT##4##1##(2010-9#4)
AS-alpha-Tm##2##1##(1997-7#2)
AS-alpha-tropomyosin##2##1##(1997-7#2)
AS4-12 and metalaxyl##2##3##(2008-10#2)
AS4-12##5##1##(2008-10#5)
ASA and CF##2##3##(2008-10#2)
ASA and##6##2##(2008-10#4)(2008-7#1)(2009-5#1)
ASA in##2##2##(2008-10#2)
ASA physical status##2##3##(1993-1#1)(2010-7#1)
ASA was##2##2##(1997-6#2)
ASA##27##1##(1993-1#1)(1994-3#1)(1997-3#1)(1997-6#6)(2007-8#1)(2008-10#10)(2008-7#1)(2009-5#1)(2010-5#1)(2010-7#4)
ASAD (n=26)##2##2##(2012-2#2)
ASAD individuals##2##2##(2012-2#2)
ASAD patients##2##2##(2012-2#2)
ASAD##10##1##(2012-2#10)
ASAH##4##1##(2007-10#4)
ASAT##4##1##(1991-11#1)(1991-6#1)(1993-8#1)(2011-1#1)
ASC and##2##2##(2008-11#1)(2012-4#1)
ASC mice##3##2##(2013-1#3)
ASC##10##1##(2008-11#2)(2008-7#1)(2009-3#1)(2012-4#1)(2013-1#5)
ASCO##3##1##(2010-9#1)(2012-3#1)(2013-1#1)
ASCs in the##2##3##(2012-4#2)
ASCs in##3##2##(2012-4#3)
ASCs##6##1##(1997-1#1)(2008-4#1)(2012-4#4)
ASD as##3##2##(2011-2#2)(2012-3#1)
ASD mouse models##4##3##(2010-7#4)
ASD of##2##2##(1996-6#1)(2012-3#1)
ASD patient##3##2##(2011-2#3)
ASD were##3##2##(2008-9#1)(2012-12#2)
ASD##40##1##(1996-6#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#2)(2010-7#4)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#1)
ASE ratio##2##2##(2008-2#2)
ASE##13##1##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)
ASGPR##2##1##(2008-9#2)
ASGT##3##1##(2008-5#3)
ASGV##2##1##(2008-10#2)
ASH##4##1##(1995-3#1)(2008-10#2)(2012-2#1)
ASI##3##1##(1991-1#1)(1995-3#1)(2011-1#1)
ASIA motor classification levels##2##4##(2012-2#2)
ASIA##3##1##(2012-2#3)
ASIC##2##1##(2010-8#2)
ASK1##2##1##(2008-9#2)
ASL CBF##2##2##(2011-1#2)
ASL##5##1##(2011-1#2)(2011-2#3)
ASLE##2##1##(2008-10#2)
ASM##22##1##(2007-11#11)(2008-10#8)(2012-1#3)
ASM-treated##3##1##(2008-10#3)
ASO##3##1##(1996-7#2)(1997-8#1)
ASOB2##5##1##(2008-5#5)
ASOs that##2##2##(1996-3#2)
ASOs##6##1##(1996-3#4)(1997-2#2)
ASP##11##1##(1994-2#1)(1997-5#1)(2008-3#1)(2013-1#8)
ASPD##11##1##(1994-2#11)
ASPV in##2##2##(2008-10#2)
ASPV##5##1##(2008-10#5)
ASPs##8##1##(2013-1#8)
ASRC##7##1##(1996-12#7)
ASSESSMENT##2##1##(2009-4#1)(2013-8#1)
AST and##2##2##(1996-12#1)(2008-10#1)
AST gene##2##2##(1993-12#1)(1996-10#1)
AST##16##1##(1993-12#1)(1994-5#2)(1996-10#3)(1996-12#1)(2007-6#1)(2008-10#3)(2011-2#1)(2011-3#3)(2013-1#1)
ASTIV##3##1##(1993-12#3)
ASTM##6##1##(2008-10#3)(2008-7#1)(2009-7#1)(2013-1#1)
ASTP protein##2##2##(1993-6#2)
ASTP##4##1##(1993-6#4)
ASTs##2##1##(1996-10#1)(2007-6#1)
ASV determination of##3##3##(2008-10#3)
ASV##8##1##(2008-10#7)(2008-7#1)
ASY and HAP##2##3##(2008-9#2)
ASY and##4##2##(2008-8#1)(2008-9#3)
ASY interacting protein##2##3##(2008-8#1)(2008-9#1)
ASY or HAP##2##3##(2008-9#2)
ASY##11##1##(2008-8#2)(2008-9#9)
ASYIP##3##1##(2008-8#3)
AT THE##3##2##(2008-7#1)(2012-3#2)
AT and##5##2##(1992-3#1)(1993-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
AT from baseline was##2##4##(2013-1#2)
AT has##2##2##(1993-6#1)(2010-11#1)
AT in##2##2##(2013-1#2)
AT revealed##2##2##(2008-10#2)
AT rich##3##2##(2008-12#1)(2008-8#2)
AT sequences##2##2##(1992-3#2)
AT to##2##2##(1993-6#1)(2008-5#1)
AT##252##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#17)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#9)(1993-12#8)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#5)(1993-8#16)(1993-9#4)(1994-1#1)(1994-12#4)(1994-2#11)(1994-3#4)(1994-5#19)(1994-8#4)(1994-9#1)(1995-2#14)(1995-3#4)(1995-5#17)(1995-6#8)(1996-1#1)(1996-2#4)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-9#1)(2010-11#3)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)
AT(1) receptor##3##2##(2008-9#3)
AT-DNA RFLP##2##2##(2008-10#2)
AT-DNA##3##1##(2008-10#3)
AT-cut quartz crystal##2##3##(2008-10#2)
AT-rich DNA##3##2##(2008-10#1)(2008-12#2)
AT-rich##11##1##(1995-2#1)(1995-6#2)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2012-3#2)
AT-step##2##1##(1993-11#2)
AT1 and AT2 receptors##4##4##(1991-9#1)(1995-12#2)(1996-5#1)
AT1 and AT2##5##3##(1991-9#1)(1995-12#3)(1996-5#1)
AT1 receptor subtype##4##3##(1992-3#2)(1994-8#1)(1994-9#1)
AT1 receptor##17##2##(1992-3#5)(1992-9#2)(1993-3#1)(1994-8#2)(1994-9#1)(1995-12#5)(1997-2#1)
AT1 receptors##4##2##(1991-5#1)(1991-9#1)(1996-5#1)(2008-8#1)
AT1##33##1##(1991-12#1)(1991-5#2)(1991-9#3)(1992-3#6)(1992-9#3)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#9)(1996-5#2)(1997-2#1)(2008-8#1)
AT1A and AT1B receptor mRNA##2##5##(1996-5#2)
AT1A and AT1B##3##3##(1996-5#3)
AT1A mRNA##2##2##(1992-3#2)
AT1A##6##1##(1992-3#3)(1996-5#3)
AT1B but not##2##3##(1992-3#1)(1996-5#1)
AT1B##5##1##(1992-3#2)(1996-5#3)
AT2 receptor##11##2##(1991-12#1)(1994-8#4)(1994-9#1)(1995-12#3)(1996-5#2)
AT2 receptors##11##2##(1991-12#2)(1991-9#3)(1995-12#4)(1996-5#1)(2008-8#1)
AT2##28##1##(1991-12#5)(1991-9#5)(1994-8#5)(1994-9#2)(1995-12#7)(1996-5#3)(2008-8#1)
AT2R##8##1##(1994-11#3)(1994-9#5)
ATA##5##1##(1993-12#4)(2008-8#1)
ATA)##2##1##(2011-3#2)
ATCC 14579##3##2##(2011-1#1)(2011-2#2)
ATCC##38##1##(1990-12#1)(1991-12#1)(1994-11#2)(1994-12#1)(1994-5#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#6)(2008-6#6)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
ATCO##3##1##(2008-10#3)
ATCase##7##1##(1997-2#7)
ATF5##3##1##(2011-2#3)
ATG##12##1##(1990-12#1)(1992-11#1)(1993-3#1)(1996-8#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#2)
ATG12##5##1##(2013-1#5)
ATIII##3##1##(1992-10#3)
ATL cells are##2##3##(2011-2#2)
ATL##8##1##(1991-11#1)(2008-11#1)(2008-5#3)(2011-2#3)
ATLD##2##1##(2008-10#2)
ATM##6##1##(2007-7#2)(2008-2#2)(2008-3#2)
ATMP##3##1##(2008-10#3)
ATMT protocol##2##2##(2008-10#2)
ATMT##5##1##(2008-10#3)(2008-5#2)
ATP &gt##5##2##(1993-8#1)(1995-11#1)(1995-12#2)(1995-8#1)
ATP (10(-4) M)##2##3##(1990-7#1)(2008-4#1)
ATP III##3##2##(2008-3#3)
ATP also##2##2##(1990-5#1)(1997-7#1)
ATP and ADP##9##3##(1991-9#6)(1993-12#1)(1994-6#1)(2008-7#1)
ATP and GTP##7##3##(1992-8#3)(2008-4#4)
ATP and UTP##5##3##(2008-4#5)
ATP and a##2##3##(1992-12#1)(1995-3#1)
ATP and capsaicin##2##3##(2008-4#2)
ATP and histamine##3##3##(1994-2#3)
ATP and its##2##3##(2008-4#2)
ATP and other nucleotides##3##4##(2008-4#3)
ATP and pH##2##3##(2008-8#2)
ATP and the##4##3##(1993-6#1)(1996-2#1)(2008-4#1)(2010-3#1)
ATP and##62##2##(1990-7#2)(1991-9#6)(1992-12#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#3)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-4#21)(2008-7#3)(2008-8#3)(2009-3#1)(2010-3#2)(2013-1#1)(2013-8#1)
ATP at##2##2##(1995-11#1)(1995-2#1)
ATP binding of##3##3##(1993-6#2)(1995-2#1)
ATP binding was##2##3##(1993-6#1)(1995-5#1)
ATP binding##12##2##(1993-6#4)(1995-2#3)(1995-5#1)(2008-11#2)(2008-4#1)(2011-2#1)
ATP bioluminescence##2##2##(2008-5#2)
ATP by##4##2##(2008-4#2)(2008-7#1)(2012-2#1)
ATP channel##4##2##(2008-11#1)(2011-1#3)
ATP concentration of##2##3##(1990-7#1)(2008-5#1)
ATP concentration##5##2##(1990-7#1)(2008-11#1)(2008-4#1)(2008-5#2)
ATP concentrations##2##2##(1991-9#1)(2008-11#1)
ATP content##2##2##(1994-6#1)(2008-11#1)
ATP deficit##2##2##(1994-5#2)
ATP depletion and##3##3##(1990-7#1)(1994-8#2)
ATP depletion##4##2##(1990-7#1)(1994-8#2)(1995-11#1)
ATP effect is##2##3##(1990-5#2)
ATP formation##2##2##(1994-5#1)(1994-8#1)
ATP gamma S##2##3##(1993-8#1)(1995-3#1)
ATP hydrolysis is a key reaction in living cells that drives many cellular processes##2##14##(2013-1#2)
ATP hydrolysis##17##2##(1990-7#1)(1992-3#1)(1992-6#1)(1994-5#2)(1994-6#1)(1996-6#1)(1997-8#1)(2008-4#1)(2013-1#8)
ATP in the regulation of##2##5##(2008-7#2)
ATP in the##5##3##(1994-2#1)(2008-4#1)(2008-7#2)(2009-7#1)
ATP in##14##2##(1990-7#1)(1990-8#1)(1993-6#1)(1994-2#1)(1995-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-7#1)(2013-1#1)
ATP induced a##2##3##(1994-2#1)(2008-4#1)
ATP induced##5##2##(1993-8#2)(1994-2#1)(2008-4#2)
ATP is##4##2##(2008-4#3)(2009-4#1)
ATP level of 500 nM##2##5##(1991-9#2)
ATP level##5##2##(1991-9#3)(2008-11#1)(2011-2#1)
ATP levels and##2##3##(2008-11#2)
ATP levels##10##2##(1990-7#1)(1991-9#3)(1992-11#1)(1994-8#1)(1997-1#1)(2008-11#2)(2011-2#1)
ATP monitoring##2##2##(2007-10#2)
ATP on##3##2##(1993-6#1)(2008-4#2)
ATP or##6##2##(1992-11#1)(1992-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#1)
ATP production##4##2##(1994-11#1)(1996-5#1)(2008-10#1)(2012-2#1)
ATP protects##2##2##(1997-7#2)
ATP receptor##4##2##(1993-8#3)(2008-4#1)
ATP receptors##6##2##(1995-12#1)(2008-4#5)
ATP recovery##3##2##(1991-5#1)(1994-8#2)
ATP release in##3##3##(2008-4#3)
ATP release##10##2##(1991-12#1)(1994-5#1)(2007-10#1)(2008-4#7)
ATP site##2##2##(2008-5#2)
ATP site-directed##2##2##(2008-5#2)
ATP sulfurylase##4##2##(2008-7#4)
ATP synthase subunits##2##3##(2008-8#2)
ATP synthase##6##2##(1994-8#1)(2008-8#4)(2010-4#1)
ATP to##7##2##(1990-7#1)(1991-9#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-4#2)
ATP was##9##2##(1993-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(2008-4#1)(2008-6#1)(2008-8#1)
ATP##428##1##(1990-11#6)(1990-5#10)(1990-7#12)(1990-8#3)(1991-12#6)(1991-5#4)(1991-6#1)(1991-9#18)(1992-11#2)(1992-12#5)(1992-3#1)(1992-6#7)(1992-8#3)(1993-11#3)(1993-12#1)(1993-6#19)(1993-8#20)(1994-11#1)(1994-12#1)(1994-2#8)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#13)(1995-11#12)(1995-12#12)(1995-2#14)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#6)(1997-8#1)(2006-10#1)(2007-10#6)(2008-10#11)(2008-11#18)(2008-2#1)(2008-3#3)(2008-4#93)(2008-5#13)(2008-6#1)(2008-7#15)(2008-8#11)(2009-3#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-4#2)(2011-1#3)(2011-2#4)(2012-2#3)(2013-1#15)(2013-8#1)
ATP)##3##1##(1994-3#1)(1995-6#1)(2013-1#1)
ATP- and##2##2##(1995-12#1)(2009-12#1)
ATP-binding cassette##2##2##(2008-11#1)(2011-2#1)
ATP-binding domain##2##2##(1991-2#1)(1995-6#1)
ATP-binding motifs##4##2##(1996-2#4)
ATP-binding proteins##2##2##(1993-9#1)(1995-9#1)
ATP-binding##15##1##(1990-8#2)(1991-2#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#4)(2008-11#1)(2008-4#1)(2011-2#1)
ATP-dependent nuclease##2##2##(1995-8#2)
ATP-dependent transport of##2##3##(1994-12#2)
ATP-dependent transport system for##2##4##(1994-12#1)(1995-12#1)
ATP-dependent transport##5##2##(1990-8#1)(1994-12#3)(1995-12#1)
ATP-dependent##19##1##(1990-8#1)(1991-6#1)(1994-12#6)(1995-12#1)(1995-6#1)(1995-8#3)(1997-4#1)(2008-11#2)(2008-2#1)(2008-8#1)(2011-9#1)
ATP-hydrolysis is##2##2##(1994-12#2)
ATP-hydrolysis##6##1##(1994-12#5)(1995-6#1)
ATP-induced currents in TG neurons##2##5##(2009-12#2)
ATP-induced currents in##4##3##(2009-12#4)
ATP-induced##15##1##(1990-11#1)(1993-3#1)(1995-11#3)(1995-12#1)(1995-2#4)(2009-12#5)
ATP-sensitive K(+)##3##2##(2008-8#3)
ATP-sensitive K+ channels##3##3##(1994-11#1)(1997-1#1)(1997-7#1)
ATP-sensitive K+##4##2##(1994-11#2)(1997-1#1)(1997-7#1)
ATP-sensitive potassium channels##3##3##(1994-6#1)(2008-5#2)
ATP-sensitive potassium##4##2##(1994-6#1)(2008-5#3)
ATP-sensitive##13##1##(1994-11#2)(1994-6#1)(1995-5#1)(1997-1#1)(1997-7#1)(2008-5#3)(2008-8#3)(2010-11#1)
ATP-stimulated##2##1##(1993-6#1)(1994-2#1)
ATP/ADP##2##1##(1994-6#1)(1994-8#1)
ATP4-##3##1##(1990-5#3)
ATP6##2##1##(1994-8#1)(2008-5#1)
ATP7A gene##4##2##(2011-1#4)
ATP7A##10##1##(2011-1#7)(2012-2#3)
ATP7B gene##2##2##(2008-9#2)
ATP7B##5##1##(2008-9#2)(2012-2#3)
ATPase 6##2##2##(1996-9#1)(2008-6#1)
ATPase activity and##5##3##(1990-11#1)(1992-6#1)(1992-9#1)(1995-6#1)(2008-9#1)
ATPase activity is##2##3##(1994-12#1)(2008-4#1)
ATPase activity of PKC##2##4##(1992-6#2)
ATPase activity of the##2##4##(1992-6#1)(1994-12#1)
ATPase activity of##10##3##(1992-6#4)(1993-12#1)(1994-12#1)(1996-2#3)(1997-2#1)
ATPase activity##30##2##(1990-11#1)(1990-12#1)(1992-6#5)(1992-9#3)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#2)(1996-2#4)(1997-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
ATPase and##4##2##(1992-6#2)(1994-12#1)(2008-11#1)
ATPase fraction##2##2##(1991-2#2)
ATPase in##2##2##(2008-8#1)(2012-1#1)
ATPase inhibitor##3##2##(1992-6#1)(2006-6#1)(2007-10#1)
ATPase on##2##2##(1995-8#1)(1997-8#1)
ATPase was##3##2##(1995-2#1)(1995-6#1)(1997-8#1)
ATPase##84##1##(1990-11#1)(1990-12#2)(1991-2#5)(1992-6#11)(1992-9#3)(1993-11#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#1)(1994-8#7)(1995-2#2)(1995-3#1)(1995-6#6)(1995-8#4)(1996-2#4)(1996-9#2)(1997-2#1)(1997-8#5)(2006-6#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
ATPases##11##1##(1990-12#1)(2008-7#7)(2010-10#1)(2011-2#2)
ATPgammaS##8##1##(1996-2#5)(2008-4#3)
ATR cell##2##2##(2008-10#2)
ATR spectra##3##2##(2007-12#2)(2008-10#1)
ATR system##4##2##(2008-2#3)(2008-3#1)
ATR##17##1##(2007-12#3)(2008-10#6)(2008-2#3)(2008-3#2)(2009-5#1)(2011-2#2)
ATR-FT-IR spectroscopy and multivariate control charts##2##6##(2008-10#2)
ATR-FTIR##6##1##(2008-10#5)(2008-5#1)
ATRA##7##1##(2007-4#1)(2008-4#4)(2011-2#1)(2013-1#1)
ATRP##2##1##(2008-12#1)(2010-4#1)
ATTITUDES##2##1##(2009-11#1)(2011-1#1)
ATryn##2##1##(2010-11#2)
ATs##3##1##(2010-5#3)
AU##7##1##(1992-3#2)(1992-8#1)(2008-9#1)(2011-2#3)
AU-rich##2##1##(1996-12#1)(2008-10#1)
AU/ml##4##1##(1993-9#4)
AUC (area under##2##3##(2008-11#1)(2010-8#1)
AUC for##4##2##(2008-5#1)(2008-7#2)(2013-1#1)
AUC of MS##2##3##(2011-1#2)
AUC of##7##2##(2008-11#2)(2008-8#1)(2011-1#3)(2011-2#1)
AUC##23##1##(1994-12#3)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-4#1)(2013-1#1)
AUC(0-12h)##3##1##(2008-10#2)(2011-3#1)
AUC(0-4)##3##1##(2008-6#3)
AUC/MIC &gt##2##2##(2011-2#2)
AUC/MIC##6##1##(2011-2#6)
AUD severity factor##3##3##(2013-8#3)
AUD severity##8##2##(2013-8#8)
AUDPC values##2##2##(2008-10#2)
AUDPC was reduced##2##3##(2008-10#2)
AUDPC##8##1##(2008-10#8)
AUDPC(S)##3##1##(2008-10#3)
AUDPCs of the##2##3##(2008-10#2)
AUDPCs##3##1##(2008-10#3)
AUG codon##3##2##(1990-8#1)(1991-12#1)(1992-6#1)
AUG##4##1##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)
AUGPC##2##1##(2008-10#2)
AULEC##2##1##(2008-10#2)
AUPHA##4##1##(1991-1#1)(1994-2#1)(1995-1#1)(2009-8#1)
AURIGA##2##1##(2008-3#2)
AURKAIP1##2##1##(2013-8#2)
AUS##2##1##(2008-10#2)
AUV and PUV##2##3##(2008-10#2)
AV fistulae##4##2##(1996-9#1)(2007-7#3)
AV fistulas##2##2##(2007-7#1)(2008-7#1)
AV##15##1##(1992-5#1)(1996-3#1)(1996-9#2)(2007-7#5)(2008-3#1)(2008-7#1)(2010-7#1)(2011-3#3)
AV-nodal reentrant tachycardia##2##3##(1993-2#2)
AV1##3##1##(2008-10#2)(2008-8#1)
AVA##2##1##(1994-3#1)(1996-12#1)
AVF and PTFE##2##3##(2007-7#2)
AVF and##3##2##(2007-7#2)(2008-7#1)
AVF create##2##2##(2007-7#2)
AVF has##2##2##(2008-7#2)
AVF were##2##2##(1996-9#1)(2007-7#1)
AVF##35##1##(1996-9#6)(2006-12#1)(2007-7#20)(2008-1#4)(2008-7#4)
AVFs are##2##2##(2007-7#2)
AVFs##7##1##(2007-7#6)(2008-1#1)
AVHRR data##2##2##(2008-3#2)
AVM (nine cases)##2##3##(2008-7#2)
AVM has##3##2##(1997-6#1)(2008-7#2)
AVM in the##3##3##(2008-7#3)
AVM is##2##2##(2008-7#2)
AVM nidus##2##2##(2008-7#1)(2012-3#1)
AVM rupture##5##2##(2008-7#1)(2012-3#4)
AVM surgery##4##2##(2008-9#3)(2012-2#1)
AVM was##2##2##(2008-7#1)(2012-3#1)
AVM were##2##2##(2008-7#2)
AVM##62##1##(1996-6#1)(1997-3#4)(1997-6#3)(2008-7#34)(2008-9#4)(2012-2#3)(2012-3#13)
AVM's##5##1##(1996-3#5)
AVM-ICH##5##1##(2012-3#5)
AVM-oICH##2##1##(2012-3#2)
AVMs in##4##2##(2008-7#4)
AVMs is##2##2##(2008-7#1)(2008-9#1)
AVMs with##3##2##(1997-3#3)
AVMs##38##1##(1993-9#1)(1997-3#7)(1997-6#1)(2008-7#21)(2008-9#3)(2012-2#2)(2012-3#3)
AVN##9##1##(2006-10#3)(2007-8#6)
AVP cell##2##2##(1990-5#2)
AVP cells##3##2##(1990-5#3)
AVP##12##1##(1990-5#5)(1992-8#2)(1993-12#1)(1995-12#2)(2008-11#1)(2008-8#1)
AVR gene cluster##2##3##(2008-10#2)
AVR gene##3##2##(2008-10#3)
AVR##6##1##(2007-8#2)(2008-10#4)
AVR-Pita##3##1##(2008-10#3)
AVS##3##1##(2008-10#3)
AVT##2##1##(2008-6#2)
AVT-R mRNA##2##2##(2008-7#2)
AVT-R##4##1##(2008-7#4)
AW##4##1##(1994-8#1)(2008-2#2)(2012-9#1)
AWI 31##4##2##(1997-2#4)
AWR##6##1##(2008-10#6)
AX3##4##1##(1992-12#4)
AX9##2##1##(1995-3#2)
AXAD-16-DMABA##2##1##(2008-10#2)
AY##2##1##(2008-10#2)
AY-BD2##2##1##(2008-10#2)
AY-BW##2##1##(2008-10#2)
AY-S##2##1##(2008-10#2)
AY-SG##2##1##(2008-10#2)
AY-SS##2##1##(2008-10#2)
AY-WB##4##1##(2008-10#4)
AYA patients##2##2##(2008-11#2)
AYP and S##2##3##(2008-10#2)
AYP##5##1##(2008-10#5)
AYP-infected shoots##3##2##(2008-10#3)
AYP-infected##4##1##(2008-10#4)
AYRSV##3##1##(2008-10#3)
AYVV-[Java]##4##1##(2008-10#4)
AZ##2##1##(1990-8#1)(2008-10#1)
AZA and##2##2##(1992-8#1)(2011-2#1)
AZA##6##1##(1992-8#4)(2010-12#1)(2011-2#1)
AZT##15##1##(1990-8#3)(1993-3#1)(1994-11#1)(1994-6#1)(1995-6#3)(1996-5#1)(2008-10#4)(2011-3#1)
AZT-resistant HIV-1##2##2##(1994-6#2)
AZT-resistant##7##1##(1992-8#1)(1994-6#6)
AZTTP and##3##2##(1993-3#3)
AZTTP##4##1##(1993-3#4)
A]##2##1##(1994-5#1)(1997-5#1)
Aa##3##1##(2011-1#3)
Ab Initio##2##2##(1996-2#1)(2012-2#1)
Ab and##3##2##(1993-12#1)(2011-1#2)
Ab initio##4##2##(1996-2#1)(1997-7#1)(2008-7#2)
Ab production##4##2##(2008-11#4)
Ab were##4##2##(1996-12#3)(1997-4#1)
Ab##25##1##(1993-12#1)(1994-12#1)(1996-12#5)(1996-2#2)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-7#2)(2011-1#3)(2012-2#1)
Ab-Sepharose##2##1##(2008-4#2)
Ab0##2##1##(2013-8#2)
Abbasabad station##2##2##(2008-12#2)
Abbe limit##2##2##(2007-12#1)(2012-1#1)
Abbe##4##1##(2007-12#1)(2008-3#2)(2012-1#1)
Abbe's limit of resolution##2##4##(2008-3#2)
Abbott Northwestern Hospital##2##3##(1993-3#1)(1994-1#1)
Abbott Northwestern##4##2##(1993-3#1)(1994-1#3)
Abbott##8##1##(1993-3#1)(1994-1#3)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)
Abbottabad##4##1##(2009-7#2)(2010-11#2)
Abbreviations used in this manual##2##5##(2008-9#2)
Abbreviations##3##1##(2008-7#1)(2008-9#2)
Abdominal CT##3##2##(2008-12#1)(2011-2#2)
Abdominal aortic##2##2##(1994-1#1)(2007-4#1)
Abdominal fat pad##2##3##(2008-12#2)
Abdominal paracentesis##2##2##(2007-12#1)(2013-1#1)
Abdominal tuberculosis##2##2##(1993-3#1)(2011-2#1)
Abdominal ultrasound##2##2##(2008-1#1)(2009-3#1)
Abdominal##30##1##(1993-3#1)(1994-1#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2013-1#2)
Abdomino-scrotal hydrocele##2##2##(2008-7#2)
Abductor##2##1##(2008-12#1)(2008-7#1)
Abel inversion of##2##3##(2008-3#2)
Abel##5##1##(1995-12#1)(2007-11#1)(2008-2#1)(2008-3#2)
Abeles##8##1##(1993-11#1)(2008-5#7)
Abelson##2##1##(2008-9#1)(2009-7#1)
Abelès##2##1##(2008-3#2)
Aberrant methylation##3##2##(1993-9#1)(2007-5#1)(2008-7#1)
Aberrant##9##1##(1993-9#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
Aberrantly##2##1##(2010-4#1)(2012-12#1)
Aberration##5##1##(2007-12#1)(2008-3#4)
Aberration-free##2##1##(2008-3#2)
Aberrations##5##1##(2008-3#4)(2008-4#1)
Abeta##5##1##(2008-10#1)(2008-7#4)
Abies guatemalensis##2##2##(2013-7#2)
Ability of bone mineral density to predict osteoporotic fractures##2##9##(1996-8#2)
Ability of##7##2##(1996-8#2)(2008-10#4)(2010-2#1)
Ability to##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
Ability##14##1##(1993-11#1)(1996-8#2)(2008-10#6)(2010-1#1)(2010-2#1)(2012-2#2)(2013-1#1)
Abiotic##3##1##(2008-10#3)
Abl and Arg##3##3##(2012-12#3)
Abl kinase activity##3##3##(2011-2#2)(2012-12#1)
Abl kinase##5##2##(2011-1#1)(2011-2#2)(2012-12#2)
Abl kinases##2##2##(2011-2#1)(2012-12#1)
Abl oncoproteins##2##2##(2012-12#2)
Abl regulation##2##2##(2012-12#2)
Abl##32##1##(1994-10#2)(2011-1#1)(2011-2#8)(2012-12#21)
Ablation of##2##2##(1993-1#1)(2013-1#1)
Ablation##6##1##(1993-1#1)(1995-12#1)(2010-6#1)(2010-8#1)(2013-1#2)
Abnormal iron##2##2##(2013-8#2)
Abnormal levels of##2##3##(2010-1#2)
Abnormal uterine bleeding##2##3##(1991-12#1)(1994-9#1)
Abnormal##29##1##(1991-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-9#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2010-1#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#2)
Abnormalities and##2##2##(2009-10#1)(2010-8#1)
Abnormalities of##2##2##(2008-9#1)(2011-3#1)
Abnormalities##7##1##(1994-11#1)(2008-2#1)(2008-9#2)(2009-10#1)(2010-8#1)(2011-3#1)
Abnormality##2##1##(1991-6#1)(2009-6#1)
Aboriginal Australian##2##2##(2008-12#2)
Aboriginal Health Workers##3##3##(2008-6#3)
Aboriginal health research##2##3##(2008-12#2)
Aboriginal nurses##2##2##(2008-12#2)
Aboriginal nursing students##2##3##(2008-12#2)
Aboriginal nursing##3##2##(2008-12#3)
Aboriginal##24##1##(1996-12#1)(2008-12#12)(2008-4#3)(2008-6#7)(2008-8#1)
Aboriginals##2##1##(2007-12#2)
Abortion##8##1##(1990-6#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-5#1)
About 0##3##2##(1990-2#1)(1992-12#1)(1994-9#1)
About 1/3 of##2##3##(2010-2#1)(2012-2#1)
About 1/4##2##2##(1993-6#1)(2007-11#1)
About 10%##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
About 15%##2##2##(2007-7#1)(2008-10#1)
About 2##2##2##(1993-12#1)(1996-8#1)
About 20##2##2##(1990-8#1)(2008-10#1)
About 3##2##2##(2008-8#1)(2010-8#1)
About 30% of all##2##4##(1990-6#1)(2013-1#1)
About 30%##3##2##(1990-6#1)(2007-12#1)(2013-1#1)
About 40##2##2##(1997-4#1)(2013-8#1)
About 50##2##2##(1990-9#1)(2008-10#1)
About 50% of the##3##4##(1997-6#1)(1997-8#1)(2008-7#1)
About 50% of##7##3##(1993-12#1)(1994-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
About 60% of all##2##4##(1993-8#1)(2011-2#1)
About 60% of##4##3##(1992-9#1)(1993-8#1)(1995-4#1)(2011-2#1)
About 70% of the##2##4##(1997-4#1)(2008-11#1)
About 70% of##4##3##(1997-4#1)(2007-12#1)(2008-11#1)(2013-1#1)
About 70%##5##2##(1997-4#1)(2007-12#1)(2008-11#1)(2013-1#2)
About 75% of##3##3##(1996-1#1)(2010-1#1)(2012-2#1)
About 80%##2##2##(1990-6#1)(2013-1#1)
About 90% of##2##3##(1992-3#1)(2011-1#1)
About 90%##3##2##(1992-3#1)(2011-1#2)
About half of the##3##4##(1996-5#1)(2008-10#1)(2010-11#1)
About half of##5##3##(1996-5#1)(2008-10#1)(2009-6#1)(2010-11#1)(2013-7#1)
About half##9##2##(1990-3#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-11#1)(2013-7#1)
About one half of the##2##5##(1993-12#1)(2008-9#1)
About one##4##2##(1993-12#1)(2007-2#1)(2008-1#1)(2008-9#1)
About one-third##2##2##(1997-2#1)(2011-1#1)
About the##7##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
About##123##1##(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
Above 0##2##2##(1991-11#1)(1991-8#1)
Above a##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
Above all##6##2##(2007-12#1)(2008-10#2)(2010-12#1)(2012-2#1)(2012-3#1)
Above the##2##2##(2008-10#1)(2008-3#1)
Above##21##1##(1991-11#1)(1991-12#1)(1991-8#1)(1992-6#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
Abraham##2##1##(1991-8#1)(1995-12#1)
Abs##7##1##(2008-11#1)(2011-2#6)
Abscess##2##1##(2012-3#2)
Abscisic acid##2##2##(2008-10#1)(2009-6#1)
Absence of the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
Absence of##30##2##(1990-9#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-8#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
Absidia corymbifera##4##2##(2008-5#4)
Absidia##7##1##(2008-11#1)(2008-12#1)(2008-5#4)(2010-4#1)
Absolute detection limits##2##3##(2008-10#2)
Absolute frequency measurement of the##2##5##(2007-12#2)
Absolute frequency##3##2##(2007-12#3)
Absolute testis weights##2##3##(2008-9#2)
Absolute##30##1##(1992-11#2)(1996-5#2)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#7)(2008-9#6)(2009-8#1)(2011-1#1)(2012-2#1)
Absorbance of##2##2##(2008-10#1)(2008-3#1)
Absorbance##13##1##(1991-12#1)(2008-1#1)(2008-10#9)(2008-3#2)
Absorbed##2##1##(2008-12#1)(2008-5#1)
Absorber##7##1##(2008-2#1)(2008-3#6)
Absorption Measurements of##2##3##(2008-2#1)(2008-3#1)
Absorption Spectrometry##3##2##(2008-10#3)
Absorption Spectroscopy of##2##3##(2008-2#1)(2010-2#1)
Absorption Spectroscopy##5##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
Absorption and##5##2##(1992-3#1)(1994-12#1)(1996-1#1)(1997-7#1)(2008-3#1)
Absorption by##3##2##(2007-12#1)(2008-11#2)
Absorption of energy as light by some molecules and emission of energy as fluorescence can occur only at certain wavelengths##2##20##(2008-1#1)(2008-4#1)
Absorption of the##2##3##(1992-8#1)(2007-12#1)
Absorption of##9##2##(1992-8#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
Absorption spectra of the##2##4##(2008-10#1)(2008-3#1)
Absorption spectra of##5##3##(2008-10#1)(2008-3#4)
Absorption spectra##6##2##(1996-2#1)(2008-10#1)(2008-3#4)
Absorption spectrum##3##2##(2007-11#1)(2008-2#2)
Absorption##61##1##(1992-3#1)(1992-8#2)(1994-12#1)(1996-1#1)(1996-2#3)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#10)(2008-3#20)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-12#1)
Abstainers##2##1##(2010-4#2)
Abstinence##2##1##(1991-12#1)(2009-9#1)
Abstract The##8##2##(2011-1#5)(2013-8#3)
Abstract This paper reports a##2##5##(2011-1#2)
Abstract This##3##2##(2011-1#2)(2013-8#1)
Abstract from acta neurochirurgica and surgery for cerebral stroke (Japan)##2##10##(1996-6#1)(1996-9#1)
Abstract##34##1##(1996-6#1)(1996-9#1)(2007-7#2)(2008-7#1)(2008-8#3)(2011-1#10)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#10)
Abstracts Submitted for Presentation at the 2001 APS/MSA/SON Joint Meeting##3##10##(2008-11#3)
Abstracts Submitted for Presentation at the##11##6##(2008-11#11)
Abstracts and##2##2##(2009-11#1)(2013-1#1)
Abstracts from the##2##3##(2007-6#1)(2007-7#1)
Abstracts of Special Session Presentations at the##7##7##(2008-11#7)
Abstracts of papers and posters presented at the 2001 Pittsburgh Conference##2##11##(2008-10#2)
Abstracts of papers presented at the 1999 Pittsburgh Conference##2##9##(2008-10#2)
Abstracts of papers presented at the 2002 Pittsburgh Conference##2##9##(2008-10#2)
Abstracts of papers presented at the ISLAR (International Symposium on Laboratory Automation and Robotics)##2##14##(2008-10#2)
Abstracts of papers presented at the ISLAR (International##3##8##(2008-10#3)
Abstracts of papers presented at the##9##6##(2008-10#8)(2010-3#1)
Abstracts of papers published in the##2##6##(2008-5#2)
Abstracts of papers##14##3##(2008-10#10)(2008-5#3)(2010-3#1)
Abstracts of presentations at the 1999##5##6##(2008-11#5)
Abstracts of presentations at the 2000##6##6##(2008-11#6)
Abstracts of presentations at the 2001##4##6##(2008-11#4)
Abstracts of presentations at the 2002##4##6##(2008-11#4)
Abstracts of presentations at the 2003##6##6##(2008-11#6)
Abstracts of presentations at the 2004##5##6##(2008-11#5)
Abstracts of presentations at the 2005##6##6##(2008-11#6)
Abstracts of presentations at the 2006##6##6##(2008-11#6)
Abstracts of presentations at the 2007##2##6##(2008-11#2)
Abstracts of presentations at the##45##5##(2008-11#45)
Abstracts of the 18th##2##4##(2008-1#1)(2008-7#1)
Abstracts of the 9th##2##4##(2008-8#1)(2009-2#1)
Abstracts of the##27##3##(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)
Abstracts of##97##2##(2008-1#1)(2008-10#12)(2008-11#56)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)
Abstracts##130##1##(1990-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-7#1)(1997-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#67)(2008-12#2)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Abstracts]##3##1##(1991-6#1)(2008-11#1)(2011-2#1)
Abu##3##1##(2008-4#1)(2013-1#1)(2013-7#1)
Abundance of##3##2##(1996-5#1)(2008-10#1)(2010-7#1)
Abundance##5##1##(1996-5#1)(2008-10#2)(2009-11#1)(2010-7#1)
Abundant##7##1##(1991-2#1)(1992-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#1)
Abuse and##3##2##(1991-12#1)(2009-9#1)(2012-12#1)
Abuse##13##1##(1991-12#1)(1995-12#2)(1996-10#1)(1996-4#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-6#1)(2012-12#2)
Abusers##2##1##(2012-2#1)(2013-8#1)
Abyssinian 14##3##2##(2008-10#3)
Ac element##2##2##(2012-3#2)
Ac elements##7##2##(2012-3#7)
Ac stocks##2##2##(2012-3#2)
Ac##21##1##(1991-3#6)(2012-3#15)
Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2##2##1##(1991-9#2)
Ac-LDL##2##1##(1990-8#2)
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2##2##1##(1991-9#2)
Ac61##2##1##(2008-10#2)
AcFL##2##1##(2008-10#2)
AcIGPD##2##1##(2008-10#2)
AcLDL##2##1##(1995-2#2)
AcNPV polh##2##2##(1997-4#2)
AcNPV##16##1##(1997-3#3)(1997-4#11)(2008-11#1)(2008-8#1)
AcNPV-bcl2 coinfection##2##2##(2008-7#2)
AcNPV-bcl2##3##1##(2008-7#3)
AcNPV-betagal alone##2##2##(2008-7#2)
AcNPV-betagal##3##1##(2008-7#3)
AcNPV-tPA##2##1##(2008-7#2)
AcOEC2##4##1##(2008-10#4)
AcOH##2##1##(1996-5#1)(2007-11#1)
AcP##2##1##(2008-10#2)
AcSer(P)-Ser(P)-Ser-Ser(P)##3##1##(1992-6#3)
AcSer(P)-Ser-Ser(P)##2##1##(1992-6#2)
Acacia##3##1##(2008-10#1)(2008-6#1)(2010-12#1)
Acad##32##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#2)(1997-2#1)(2006-4#1)(2008-3#1)(2008-4#1)
Academia##2##1##(1993-6#1)(2008-7#1)
Academic Medical##3##2##(1994-2#2)(1996-1#1)
Academic Press##4##2##(1990-8#1)(2008-12#1)(2008-4#2)
Academic buoyancy##2##2##(2008-12#2)
Academic medical centers and##2##4##(1994-3#1)(1997-2#1)
Academic medical centers##3##3##(1994-3#1)(1995-3#1)(1997-2#1)
Academic programs##3##2##(1993-1#2)(1995-1#1)
Academic##29##1##(1990-8#1)(1993-1#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
Academies##2##1##(1993-9#1)(2013-1#1)
Academy and##2##2##(2007-11#1)(2013-1#1)
Academy of Medical##2##3##(1996-11#1)(2012-3#1)
Academy of Medicine##5##3##(2007-11#2)(2007-8#2)(2012-2#1)
Academy of Sciences##6##3##(1990-3#2)(1994-12#1)(2008-7#1)(2010-12#2)
Academy of##32##2##(1990-3#2)(1994-12#2)(1995-2#1)(1996-11#1)(1996-6#2)(2007-11#5)(2007-6#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
Academy##39##1##(1990-3#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-11#1)(1996-6#2)(2007-11#6)(2007-6#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Acala NemX##5##2##(2008-10#5)
Acala SJ-2##3##2##(2008-10#3)
Acala##9##1##(2008-10#9)
Acamprosate##5##1##(1991-3#1)(2008-2#4)
Acanthamoeba##2##1##(1994-8#2)
Acanthocephala##3##1##(2008-7#2)(2011-2#1)
Acanthophora spicifera##3##2##(2008-11#2)(2008-5#1)
Acari##2##1##(2007-12#1)(2011-2#1)
Acb cell firing during##3##4##(2007-8#3)
Acb##7##1##(2007-8#7)
AccI##7##1##(1991-9#1)(1994-12#2)(2008-12#4)
Accelerated ventricular rhythm##3##3##(2008-11#3)
Accelerated##15##1##(1992-10#1)(1996-11#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#4)(2010-6#1)(2013-1#1)
Accelerating##4##1##(2008-10#1)(2008-12#1)(2009-6#1)(2011-1#1)
Acceleration of##3##2##(1997-2#1)(2010-11#2)
Accell Plus QMA##2##3##(2008-10#1)(2008-6#1)
Acceptability E-scale##3##2##(2010-10#3)
Acceptability of stem cell therapy by pregnant women##2##8##(2013-1#2)
Acceptability of##3##2##(2012-12#1)(2013-1#2)
Acceptability##8##1##(2008-7#1)(2010-10#3)(2012-12#1)(2013-1#3)
Acceptable results##2##2##(2007-11#1)(2008-10#1)
Acceptable##9##1##(2007-11#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-11#2)(2012-3#1)(2013-1#1)
Acceptance and##2##2##(2012-2#2)
Acceptance of##3##2##(2007-12#2)(2008-10#1)
Acceptance##7##1##(2007-12#2)(2008-10#1)(2011-1#1)(2012-2#2)(2012-3#1)
Accepted##2##1##(2012-2#2)
Access (R)##2##2##(2008-1#2)
Access Control##2##2##(2010-8#2)
Access and##4##2##(1994-2#1)(1994-3#2)(1995-12#1)
Access flow##2##2##(2007-7#2)
Access to care##3##3##(1995-12#1)(1996-3#1)(2011-2#1)
Access to health care##2##4##(1994-2#1)(1996-2#1)
Access to health##3##3##(1994-2#1)(1995-12#1)(1996-2#1)
Access to##32##2##(1992-2#1)(1994-2#2)(1995-1#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#1)
Access##60##1##(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#4)(1997-1#1)(2007-2#1)(2007-7#3)(2008-1#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-8#1)
Accessibility##5##1##(1997-1#1)(2009-5#1)(2012-1#1)(2012-2#2)
Accessing the##2##2##(2007-12#1)(2008-4#1)
Accessing##3##1##(2007-12#1)(2007-8#1)(2008-4#1)
Accessions##3##1##(2008-10#3)
Accessory##3##1##(1993-8#1)(2012-2#2)
Accident and Emergency##2##3##(1992-12#2)
Accident occurrence and functional health patterns##2##6##(2013-1#2)
Accident##7##1##(1992-12#2)(1994-2#1)(2009-10#2)(2013-1#2)
Accidental##4##1##(1991-8#1)(2009-4#1)(2011-2#1)(2012-12#1)
Accidents##2##1##(1990-6#1)(1996-12#1)
Acclimatization##2##1##(2009-12#1)(2011-2#1)
Accompanied by##3##2##(2008-5#1)(2012-12#1)(2013-7#1)
Accompanying the##5##2##(1990-5#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
Accompanying##8##1##(1990-5#1)(1993-12#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
According to Southern##2##3##(1994-11#1)(1997-7#1)
According to World Health Organization (WHO)##2##6##(2010-10#1)(2012-12#1)
According to a##4##3##(1990-5#1)(1990-6#1)(2009-6#1)(2012-12#1)
According to data##2##3##(2008-10#1)(2008-11#1)
According to one##2##3##(1994-2#1)(1997-7#1)
According to our experience##2##4##(2008-10#1)(2008-11#1)
According to our##9##3##(1994-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-2#1)(2013-1#1)
According to present##2##3##(1992-4#1)(2008-12#1)
According to previous##2##3##(2008-12#1)(2012-12#1)
According to recent##3##3##(1997-7#1)(2010-8#1)(2011-2#1)
According to the author##6##4##(1991-1#1)(1991-3#2)(1992-1#1)(1993-2#2)
According to the chromatographic data##2##5##(2008-10#2)
According to the current##2##4##(1991-9#1)(2012-3#1)
According to the experimental##2##4##(2008-11#1)(2008-2#1)
According to the literature##3##4##(1990-6#1)(1996-6#1)(2011-2#1)
According to the opinion of the authors##2##7##(1995-6#1)(1997-3#1)
According to the outcomes model##2##5##(2008-4#2)
According to the results of this study##2##7##(2008-12#2)
According to the results of##4##5##(2008-12#2)(2010-2#1)(2012-2#1)
According to the results##12##4##(2007-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
According to the traditional model##2##5##(2008-4#2)
According to the##117##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-1#1)(1993-2#4)(1993-3#1)(1993-6#1)(1995-12#1)(1995-6#3)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-3#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#7)
According to their##2##3##(1995-12#1)(2008-10#1)
According to these findings##4##4##(2008-5#1)(2008-7#1)(2009-1#1)(2013-1#1)
According to these results##2##4##(2008-10#1)(2008-5#1)
According to these##9##3##(1997-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-1#1)(2013-1#1)
According to this professional paper##2##5##(1994-3#2)
According to this study##2##4##(2007-7#1)(2011-2#1)
According to this##20##3##(1990-7#1)(1994-3#2)(1995-2#2)(1997-6#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
According to##240##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#2)(1995-2#2)(1995-6#4)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#10)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#8)
According##241##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#2)(1995-2#2)(1995-6#4)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#8)(2008-12#10)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#8)
Accordingly##85##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Accountability##5##1##(1995-1#1)(1995-3#1)(1997-2#1)(2007-12#2)
Accounting for##3##2##(2008-12#1)(2010-5#1)(2010-6#1)
Accounting##9##1##(1991-1#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-1#1)(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#1)
Accounts##3##1##(1991-2#1)(1997-1#1)(2010-5#1)
Accreditation Manual for Hospitals (AMH)##2##5##(1995-2#2)
Accreditation and##2##2##(1990-8#1)(2007-6#1)
Accreditation of Healthcare Organizations (JCAHO)##3##5##(1993-2#1)(1995-2#2)
Accreditation of Healthcare Organizations##4##4##(1993-2#1)(1995-2#2)(1995-3#1)
Accreditation of##7##2##(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#1)(2008-3#1)(2008-6#1)
Accreditation##17##1##(1990-8#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-2#4)(1995-3#1)(1996-3#1)(1997-2#1)(2007-4#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-6#1)
AccrualNet##3##1##(2012-3#3)
Acculturation##4##1##(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
Accumulated##3##1##(1994-12#1)(2007-12#1)(2013-1#1)
Accumulating evidence suggests that##3##4##(2008-8#1)(2011-1#1)(2012-2#1)
Accumulating evidence##6##2##(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Accumulation and##3##2##(2008-10#3)
Accumulation in##2##2##(2008-10#2)
Accumulation of flavonoids in##2##4##(2008-10#1)(2009-10#1)
Accumulation of flavonoids##3##3##(2008-10#1)(2009-10#2)
Accumulation of##26##2##(1990-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
Accumulation##41##1##(1990-2#1)(1990-5#1)(1993-6#1)(1994-6#1)(1995-12#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
Accuracy and precision of the##2##5##(2008-10#2)
Accuracy and##6##2##(1993-12#1)(2008-10#2)(2008-3#1)(2009-12#1)(2012-12#1)
Accuracy of a##3##3##(2008-3#2)(2008-7#1)
Accuracy of the proposed##2##4##(2008-10#2)
Accuracy of the##8##3##(2008-10#4)(2008-12#1)(2008-2#2)(2013-1#1)
Accuracy of##27##2##(1996-8#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-7#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Accuracy profiles##2##2##(2008-10#2)
Accuracy was assessed##2##3##(2008-10#2)
Accuracy was determined##2##3##(1990-6#1)(2008-10#1)
Accuracy was##7##2##(1990-6#1)(2008-10#6)
Accuracy##60##1##(1990-6#1)(1993-12#2)(1996-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#18)(2008-12#3)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#3)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
Accurate and##2##2##(2007-2#1)(2008-12#1)
Accurate determination of##3##3##(2008-10#1)(2008-2#2)
Accurate diagnosis and##2##3##(1995-5#1)(2007-8#1)
Accurate diagnosis##3##2##(1995-5#1)(2007-8#1)(2011-2#1)
Accurate measurement of##2##3##(2008-10#1)(2008-3#1)
Accurate measurements were possible for up to##2##7##(2008-10#2)
Accurate measurements##3##2##(2008-10#2)(2008-3#1)
Accurate results##2##2##(2008-10#2)
Accurate values##3##2##(2008-10#3)
Accurate##55##1##(1993-11#1)(1993-3#1)(1994-7#1)(1995-5#1)(1996-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-4#1)(2013-1#1)(2013-7#1)
Accurately##2##1##(2008-3#1)(2008-8#1)
Accutase and##2##2##(2008-11#2)
Acer##2##1##(2008-9#1)(2013-8#1)
Aceria##2##1##(2008-10#2)
Acervuli##2##1##(2008-10#2)
Acesulfame potassium##3##2##(2008-9#3)
Acetabular fractures in the elderly##2##5##(2008-8#2)
Acetal##2##1##(2009-10#1)(2009-11#1)
Acetaminophen##4##1##(1994-6#1)(2008-7#1)(2013-1#2)
Acetate kinase##2##2##(2008-6#2)
Acetate##6##1##(1995-4#1)(1997-7#1)(2008-10#1)(2008-6#2)(2013-1#1)
Acetic acid##4##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-6#1)
Acetic##8##1##(1996-5#1)(1997-4#1)(2008-10#5)(2008-6#1)
Acetohalobium arabaticum##2##2##(2011-2#2)
Acetone##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
Acetyl-L-carnitine##3##1##(1990-3#2)(1992-7#1)
Acetylated##2##1##(1996-2#1)(2009-8#1)
Acetylcholine##3##1##(1993-3#1)(2008-11#1)(2009-12#1)
Acetylcholinesterase##2##1##(1995-12#2)
Acetylene##5##1##(1992-3#5)
Acetylsalicylic acid##3##2##(1990-12#1)(1990-9#1)(2008-4#1)
Ach injection to##2##3##(2011-2#2)
Ach injection##3##2##(2011-2#3)
Ach##10##1##(1992-8#1)(2011-2#9)
Achatina achatina##3##2##(2008-12#3)
Achatina##6##1##(1991-5#3)(2008-12#3)
Acheilognathus##3##1##(2010-8#3)
Achieved##2##1##(2007-8#1)(2008-10#1)
Achievement in##2##2##(2007-8#1)(2009-12#1)
Achievement of##2##2##(2008-11#1)(2013-1#1)
Achievement##7##1##(2007-8#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
Achievements##2##1##(2007-8#2)
Achieving a##2##2##(2008-10#1)(2010-1#1)
Achieving health equity##2##3##(2011-1#1)(2012-3#1)
Achieving quality##2##2##(1993-12#1)(2008-1#1)
Achieving##22##1##(1993-12#2)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
Achilles heel##2##2##(1992-11#1)(2008-5#1)
Achilles tendinosis##8##2##(2009-10#4)(2010-3#4)
Achilles tendon rupture following##2##4##(2010-3#2)
Achilles tendon rupture##3##3##(2010-3#3)
Achilles tendon##14##2##(1993-9#1)(1996-6#1)(2007-12#2)(2008-9#1)(2009-10#2)(2010-3#4)(2012-1#1)(2012-2#2)
Achilles tendons##2##2##(1995-8#1)(1997-8#1)
Achilles##31##1##(1992-11#1)(1993-9#1)(1995-8#1)(1996-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#7)(2010-3#8)(2011-2#1)(2012-1#1)(2012-2#4)
Achilles' heel cleavage##2##3##(1990-5#2)
Achilles' heel##4##2##(1990-5#3)(2008-8#1)
Acholeplasma##3##1##(1993-12#2)(2008-10#1)
Achromatic##6##1##(2007-11#3)(2008-2#1)(2008-3#2)
Acid and##4##2##(1996-9#1)(2008-10#2)(2008-5#1)
Acid as##2##2##(2008-10#1)(2010-6#1)
Acid diffusion##2##2##(2008-10#2)
Acid from##2##2##(2008-10#1)(2013-1#1)
Acid in the##2##3##(2007-11#1)(2012-2#1)
Acid in##8##2##(2007-11#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
Acid on the##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
Acid on##7##2##(2008-11#1)(2008-5#1)(2009-12#1)(2010-5#1)(2012-12#1)(2013-1#2)
Acid pH##3##2##(1992-12#1)(2010-3#2)
Acid supplementation##2##2##(2008-5#1)(2010-1#1)
Acid##93##1##(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)
Acid-base equilibria of##2##3##(2008-10#2)
Acid-base equilibria##3##2##(2008-10#3)
Acid-base##5##1##(2008-10#5)
Acid-producing bacteria##3##2##(2008-10#2)(2009-5#1)
Acid-producing##4##1##(1995-6#1)(2008-10#2)(2009-5#1)
Acidaminococcus fermentans##3##2##(1994-12#1)(2011-2#2)
Acidaminococcus##4##1##(1994-12#1)(2011-2#3)
Acidic##4##1##(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
Acidification##2##1##(2008-10#1)(2008-11#1)
Acidity constants##2##2##(2008-10#2)
Acidity##4##1##(1997-7#1)(2008-10#3)
Acidothermus cellulolyticus##3##2##(2008-6#1)(2011-2#2)
Acidovorax avenae subsp##6##3##(2008-10#6)
Acids Res##4##2##(1991-9#2)(1993-12#1)(1997-6#1)
Acids from##2##2##(2008-10#1)(2009-8#1)
Acids in##2##2##(2008-10#2)
Acids on##2##2##(2009-3#1)(2012-2#1)
Acids##19##1##(1991-9#2)(1993-12#1)(1996-5#3)(1997-6#1)(2008-10#4)(2008-11#2)(2009-3#1)(2009-8#1)(2012-2#3)(2013-1#1)
Acinetobacter baumannii##3##2##(2009-5#1)(2012-2#1)(2013-8#1)
Acinetobacter sp##7##2##(1997-6#6)(2012-3#1)
Acinetobacter spp##3##2##(2007-7#1)(2012-2#1)(2013-8#1)
Acinetobacter##18##1##(1997-6#6)(2007-11#1)(2007-7#2)(2009-5#1)(2010-3#2)(2010-4#1)(2012-2#2)(2012-3#1)(2013-8#2)
Acini##2##1##(2007-12#2)
Acinic cell carcinoma of minor salivary gland of the base of tongue##2##12##(2013-1#2)
Acipenser##3##1##(2008-8#2)(2010-8#1)
Acipenseriformes##4##1##(2008-8#4)
Acivicin##3##1##(1990-7#2)(2008-7#1)
Ackermann [Appl##2##2##(2008-2#1)(2008-3#1)
Ackermann##3##1##(2008-2#1)(2008-3#1)(2013-1#1)
Ackers and H##2##3##(1990-8#1)(1997-2#1)
Ackers and##4##2##(1990-8#3)(1997-2#1)
Ackers##7##1##(1990-8#4)(1997-2#3)
Acknowledgement##2##1##(2008-11#1)(2010-12#1)
Acknowledgements##2##1##(2010-12#2)
Acknowledgment of reviewers##8##3##(2008-10#8)
Acknowledgment##10##1##(2008-10#8)(2008-8#1)(2010-11#1)
Acne vulgaris is the most common##2##6##(2008-5#1)(2010-8#1)
Acne##6##1##(1997-8#2)(2008-5#1)(2009-2#1)(2010-6#1)(2010-8#1)
Acomys##8##1##(2010-11#8)
Aconitum##3##1##(2008-10#3)
Acori graminei rhizoma##2##3##(2008-10#2)
Acoupa weakfish##2##2##(2013-7#2)
Acoustic##8##1##(1992-8#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2012-3#1)
Acousto-optic (AO)##2##2##(2007-11#1)(2008-2#1)
Acousto-optic##5##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
Acquired generalized lipodystrophy##2##3##(2011-1#2)
Acquired##15##1##(1992-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
Acquiring##2##1##(2007-4#1)(2008-10#1)
Acquisition and##4##2##(2008-10#3)(2008-7#1)
Acquisition of a##2##3##(1993-6#1)(2008-10#1)
Acquisition of##7##2##(1993-5#1)(1993-6#1)(2008-10#4)(2010-6#1)
Acquisition##15##1##(1993-5#1)(1993-6#1)(2008-10#8)(2008-7#1)(2009-9#1)(2010-6#1)(2011-1#2)
Acquity##2##1##(2008-10#1)(2011-1#1)
Acral Lentiginous Melanoma##2##3##(2010-6#2)
Acral##3##1##(2010-6#3)
Acremonium strictum##2##2##(2008-10#2)
Acremonium##6##1##(2008-10#2)(2008-9#2)(2011-1#2)
Acridine Orange##5##2##(2008-10#5)
Acridine##6##1##(1990-7#1)(2008-10#5)
Acridones##2##1##(1996-4#2)
Acro-LDL uptake by THP-1##2##4##(2013-1#2)
Acro-LDL uptake##5##2##(2013-1#5)
Acro-LDL were##3##2##(2013-1#3)
Acro-LDL##11##1##(2013-1#11)
Acrolein-conjugated##2##1##(2013-1#2)
Acropora digitifera##2##2##(2012-12#2)
Acropora spat recruited##2##3##(2007-5#2)
Acropora##9##1##(2007-5#4)(2008-6#2)(2012-12#2)(2012-2#1)
Acrosome##2##1##(1992-8#1)(2012-2#1)
Across a##2##2##(2008-10#1)(2008-12#1)
Across all##9##2##(2008-10#3)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
Across the##5##2##(2008-10#1)(2010-7#1)(2011-2#2)(2013-1#1)
Across trials##2##2##(2008-10#2)
Across two experiments##2##3##(2009-5#1)(2013-1#1)
Across##43##1##(1991-3#1)(2007-7#1)(2008-10#11)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#4)(2012-9#1)(2013-1#3)
Acrylic##3##1##(1997-3#1)(2008-10#1)(2009-10#1)
Act (Stark##2##2##(1996-3#2)
Act 1998##2##2##(2008-11#2)
Act and the##4##3##(1991-1#2)(1994-1#1)(1997-5#1)
Act and##7##2##(1991-1#2)(1994-1#1)(1995-12#2)(1996-5#1)(1997-5#1)
Act in Time to Heart Attack Signs&quot##2##7##(2008-3#2)
Act in##3##2##(1996-11#1)(2008-3#2)
Act of 1989##2##3##(1991-3#1)(1992-1#1)
Act of 1990##5##3##(1991-12#1)(1992-1#1)(1993-1#1)(1995-1#1)(1995-2#1)
Act of 1992##2##3##(1993-3#1)(1996-2#1)
Act of 1993##5##3##(1994-3#2)(1996-1#1)(1996-12#1)(1996-3#1)
Act of 1997##5##3##(1997-4#1)(2008-1#1)(2008-11#1)(2008-7#2)
Act of##33##2##(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-1#1)
Act was passed##2##3##(1991-1#1)(1993-1#1)
Act##150##1##(1990-6#1)(1991-1#7)(1991-12#6)(1991-2#1)(1991-3#4)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#3)(1992-5#1)(1992-9#2)(1993-1#3)(1993-12#2)(1993-3#7)(1994-1#11)(1994-2#3)(1994-3#4)(1995-1#2)(1995-12#11)(1995-2#3)(1995-3#2)(1995-6#4)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#4)(1996-8#2)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#3)(2007-10#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#2)(2008-7#4)(2008-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
Act's##2##1##(1993-3#2)
Act)##4##1##(1995-1#1)(1996-3#2)(1996-8#1)
Acta##18##1##(1990-2#1)(1991-5#1)(1992-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1995-11#1)(1996-2#1)(2008-10#7)(2008-11#1)
Actigard##2##1##(2008-10#2)
Actigraphy##2##1##(2012-12#2)
Actin Binding##2##2##(2008-6#1)(2011-2#1)
Actin filaments##3##2##(2009-10#2)(2009-12#1)
Actin organization##2##2##(2008-11#1)(2008-9#1)
Actin##13##1##(1994-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2011-2#3)(2012-2#1)
Actin-based##2##1##(2008-1#2)
Actin-binding##2##1##(1993-8#1)(2012-2#1)
Acting on##2##2##(1992-12#1)(2012-1#1)
Acting##3##1##(1992-12#1)(1994-8#1)(2012-1#1)
Actinic keratoses##2##2##(2010-8#2)
Actinic##4##1##(2008-3#1)(2010-8#3)
Actinobacillus actinomycetemcomitans##2##2##(2007-7#2)
Actinobacillus##7##1##(1994-2#1)(1996-12#3)(2007-7#2)(2008-5#1)
Actinobacteria##5##1##(2011-1#1)(2011-2#1)(2012-2#3)
Actinomyces spp##2##2##(2013-1#2)
Actinomyces##6##1##(1997-4#1)(2007-7#1)(2010-12#1)(2013-1#3)
Actinomycin##2##1##(1993-12#1)(2008-11#1)
Actinomycosis is##2##2##(2008-1#2)
Actinomycosis##5##1##(2008-1#4)(2010-12#1)
Action Plan##4##2##(2008-1#3)(2012-12#1)
Action Research##2##2##(2008-12#1)(2011-2#1)
Action and##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
Action learning groups##2##3##(2008-11#2)
Action of##2##2##(2008-10#1)(2011-2#1)
Action##43##1##(1991-5#1)(1993-3#2)(1994-2#2)(1997-2#1)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-10#3)(2011-1#2)(2011-2#3)(2012-12#2)
Actions of##3##2##(1992-5#1)(2008-11#1)(2008-4#1)
Actions##7##1##(1992-5#1)(1995-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
Activated protein C and pulmonary embolism##3##6##(1996-6#3)
Activated protein C and##4##4##(1996-6#3)(2011-2#1)
Activated protein C##5##3##(1993-11#1)(1996-6#3)(2011-2#1)
Activated##26##1##(1991-8#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1996-2#2)(1996-5#1)(1996-6#3)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
Activates##2##1##(2008-10#1)(2008-11#1)
Activating##6##1##(1991-5#1)(2008-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
Activation by IVC##2##3##(1990-2#2)
Activation by##5##2##(1990-2#2)(1992-11#1)(2011-2#1)(2013-8#1)
Activation energies##2##2##(2008-10#1)(2013-1#1)
Activation in##2##2##(2011-2#1)(2012-3#1)
Activation of both##3##3##(1994-6#1)(1994-8#1)(1996-2#1)
Activation of human T helper 1##2##6##(1994-12#2)
Activation of protein kinase C##2##5##(1992-12#1)(1993-8#1)
Activation of the glucocorticoid receptor##2##5##(1996-12#2)
Activation of the##16##3##(1992-8#1)(1993-12#2)(1993-9#2)(1994-12#1)(1994-6#1)(1995-8#1)(1996-12#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)
Activation of##69##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-12#4)(1996-2#3)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#2)(2010-3#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Activation##92##1##(1990-2#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-12#4)(1996-2#3)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#2)(2010-3#2)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
Activations##2##1##(2008-5#1)(2013-8#1)
Activator##3##1##(1995-8#1)(2012-3#1)(2013-8#1)
Active and##3##2##(2006-10#1)(2008-8#1)(2010-12#1)
Active coping##3##2##(2009-5#1)(2011-1#2)
Active ingredients##2##2##(2008-10#1)(2008-5#1)
Active laser##2##2##(2008-3#2)
Active packaging##2##2##(2010-7#2)
Active##65##1##(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#2)(2009-5#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#3)(2010-7#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#2)(2013-8#1)
Activin A is##2##3##(1995-8#2)
Activin A##7##2##(1992-6#2)(1992-8#2)(1995-8#3)
Activin##11##1##(1992-6#2)(1992-8#2)(1993-8#2)(1994-9#1)(1995-8#3)(2008-9#1)
Activin-A##2##1##(1994-11#2)
Activists##2##1##(1993-9#1)(1995-12#1)
Activities in##3##2##(2008-10#2)(2010-11#1)
Activities of Daily Living (ADL) and##2##6##(2008-7#2)
Activities of Daily Living##7##4##(2008-7#5)(2011-2#1)(2012-2#1)
Activities of daily living##2##4##(1992-12#1)(1995-2#1)
Activities of the Essential Oil##2##5##(2013-1#2)
Activities of the##4##3##(1997-3#1)(2008-11#1)(2013-1#2)
Activities of##22##2##(1990-12#1)(1992-12#1)(1992-6#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-7#6)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
Activities##31##1##(1990-12#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#7)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
Activity Toward##2##2##(2008-10#2)
Activity and Solar Ultraviolet Radiation##2##5##(2008-2#2)
Activity and distribution of protein kinase C##2##7##(1990-2#1)(1996-5#1)
Activity and##13##2##(1990-2#2)(1996-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2009-11#1)(2011-2#3)(2013-1#1)
Activity in the##2##3##(2008-10#1)(2011-2#1)
Activity in##9##2##(1990-11#1)(1993-11#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#2)
Activity of Leaves of##2##4##(2010-3#1)(2010-5#1)
Activity of a##3##3##(2008-10#2)(2008-11#1)
Activity of cathepsin##2##3##(1992-9#1)(2008-7#1)
Activity of the##11##3##(1990-5#1)(1991-12#1)(1993-12#1)(2008-10#5)(2008-5#1)(2010-11#1)(2012-2#1)
Activity of##50##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-12#1)(1995-9#1)(1996-2#1)(1997-7#1)(2008-10#19)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#3)(2010-5#5)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
Activity was##2##2##(1992-3#1)(1995-8#1)
Activity with##2##2##(1992-9#1)(2008-10#1)
Activity##119##1##(1990-11#1)(1990-2#2)(1990-5#1)(1991-12#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#39)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#1)
Activity-dependent##4##1##(1994-8#1)(1995-2#1)(2009-3#2)
Acts as a##2##3##(2008-3#1)(2012-12#1)
Acts of##2##2##(1995-3#1)(2010-1#1)
Acts##10##1##(1992-2#1)(1994-12#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-1#1)(2012-12#1)
Actual mortality##2##2##(2007-8#2)
Actual##8##1##(1990-11#1)(1992-12#1)(2007-8#2)(2008-3#3)(2013-1#1)
Actually##7##1##(1992-10#1)(1994-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2011-3#1)(2012-3#1)
Actuarial##5##1##(1990-6#1)(1991-12#1)(2007-8#1)(2008-6#1)(2011-2#1)
Acuity##3##1##(1991-2#1)(1996-1#1)(2013-1#1)
Acupuncture##10##1##(1997-6#1)(2006-10#1)(2008-10#4)(2008-8#1)(2012-3#1)(2013-1#2)
Acute Care Funding Project##2##4##(1993-3#2)
Acute Care Funding##3##3##(1993-3#2)(1996-1#1)
Acute Care##5##2##(1993-3#2)(1996-1#1)(2009-3#1)(2010-10#1)
Acute Coronary Syndrome##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
Acute Coronary##6##2##(2008-10#3)(2008-3#2)(2012-2#1)
Acute Lung Injury (ALI)##2##4##(2008-8#1)(2010-12#1)
Acute Lung Injury##4##3##(2008-8#2)(2010-12#2)
Acute Lymphoblastic##3##2##(2007-2#1)(2008-12#1)(2011-1#1)
Acute Myeloid Leukemia Cells##2##4##(2012-12#1)(2013-1#1)
Acute Myeloid Leukemia##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
Acute Myocardial Infarction##2##3##(2008-12#1)(2012-3#1)
Acute Pancreatitis##2##2##(2013-8#2)
Acute Renal Failure in##2##4##(2008-1#1)(2008-4#1)
Acute Renal Failure##7##3##(2007-7#1)(2008-1#3)(2008-4#3)
Acute Respiratory Distress Syndrome (ARDS)##2##5##(1997-1#1)(2008-8#1)
Acute Respiratory Distress Syndrome##3##4##(1997-1#1)(2008-8#2)
Acute Stroke##3##2##(2007-10#1)(2008-8#2)
Acute abdomen##2##2##(2011-2#1)(2012-2#1)
Acute and chronic##5##3##(1991-9#1)(2009-10#1)(2011-2#1)(2012-5#1)(2013-8#1)
Acute and##7##2##(1991-1#1)(1991-9#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-5#1)(2013-8#1)
Acute aortic dissection is##2##4##(2011-2#1)(2012-1#1)
Acute aortic dissection##3##3##(2011-2#1)(2012-1#1)(2013-1#1)
Acute aortic##4##2##(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
Acute care##3##2##(1993-1#1)(1995-2#1)(2013-8#1)
Acute compartment syndrome##2##3##(2009-3#2)
Acute coronary syndrome##3##3##(2008-11#1)(2008-3#1)(2010-4#1)
Acute effect of##2##3##(2008-3#1)(2010-3#1)
Acute effects of##5##3##(1990-5#1)(1991-1#1)(2008-7#1)(2010-7#1)(2012-2#1)
Acute haemorrhagic presentation of##2##4##(2008-7#2)
Acute heart failure##2##3##(2008-3#1)(2012-3#1)
Acute hepatitis##2##2##(1995-2#1)(2007-12#1)
Acute infection of##2##3##(1994-11#1)(2008-4#1)
Acute inflammatory demyelinating##2##3##(1995-5#1)(2008-7#1)
Acute lymphoblastic leukemia##2##3##(2008-11#1)(2011-2#1)
Acute mesenteric ischemia##2##3##(2008-10#1)(2010-11#1)
Acute myeloid leukemia (AML) is a##2##6##(2010-4#1)(2013-1#1)
Acute myeloid leukemia (AML)##3##4##(2010-4#1)(2011-2#1)(2013-1#1)
Acute myeloid##4##2##(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
Acute myocardial infarction##3##3##(1994-11#1)(1994-12#1)(2008-3#1)
Acute myocardial##4##2##(1994-11#1)(1994-12#1)(2007-8#1)(2008-3#1)
Acute pancreatitis (AP) is a##2##5##(2009-8#1)(2013-1#1)
Acute pancreatitis (AP)##3##3##(2009-8#2)(2013-1#1)
Acute pancreatitis is##2##3##(2012-12#1)(2013-1#1)
Acute pancreatitis##10##2##(2008-12#1)(2009-8#2)(2010-6#1)(2012-12#2)(2012-3#2)(2013-1#2)
Acute pulmonary##3##2##(1996-12#1)(2009-4#1)(2010-6#1)
Acute rejection##2##2##(1994-5#1)(2007-8#1)
Acute renal failure due to##2##5##(1997-5#1)(2008-4#1)
Acute renal failure in the##3##5##(2008-4#3)
Acute renal failure in##7##4##(2008-1#1)(2008-4#6)
Acute renal failure##13##3##(1996-6#1)(1997-5#1)(2008-1#2)(2008-3#1)(2008-4#8)
Acute renal##14##2##(1996-6#1)(1997-5#1)(2008-1#2)(2008-3#1)(2008-4#8)(2011-2#1)
Acute respiratory##2##2##(2007-8#1)(2011-2#1)
Acute severe asthma##2##3##(2007-8#2)
Acute severe##3##2##(1990-5#1)(2007-8#2)
Acute stress##3##2##(2006-9#1)(2011-2#1)(2013-1#1)
Acute tongue enlargement##2##3##(2012-12#2)
Acute toxicity##2##2##(1992-10#1)(2008-7#1)
Acute treatment with##2##3##(2007-5#1)(2008-7#1)
Acute urinary retention##2##3##(1993-9#1)(2008-10#1)
Acute##244##1##(1990-10#1)(1990-5#4)(1991-1#6)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-5#2)(2007-7#2)(2007-8#7)(2008-1#7)(2008-10#8)(2008-11#6)(2008-12#4)(2008-3#9)(2008-4#13)(2008-5#1)(2008-7#15)(2008-8#12)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#5)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#13)(2012-1#3)(2012-12#9)(2012-2#6)(2012-3#8)(2012-5#1)(2013-1#14)(2013-8#5)
Acyclovir triphosphate##2##2##(1995-2#2)
Acyclovir##4##1##(1995-2#2)(2012-2#2)
Acyl Radical##2##2##(1996-5#2)
Acyl##5##1##(1990-12#2)(1996-5#2)(2011-2#1)
Acyl-CoA##2##1##(1992-8#1)(1995-3#1)
Acylation of##3##2##(1994-8#1)(1996-2#1)(2009-2#1)
Acyrthosiphon pisum##4##2##(1996-12#1)(2007-12#1)(2008-10#2)
Ad Libitum group##2##3##(1990-3#2)
Ad and DA##4##3##(1997-7#4)
Ad hoc##2##2##(1990-8#1)(2008-10#1)
Ad libitum##2##2##(2013-8#2)
Ad##20##1##(1990-3#2)(1990-8#1)(1997-3#1)(1997-4#1)(1997-7#8)(2008-10#1)(2008-11#3)(2011-3#1)(2013-8#2)
Ad-GFP##3##1##(2008-9#3)
Ad-HGF##10##1##(2008-9#10)
Ad5##2##1##(1997-3#2)
Ad9##4##1##(1992-9#4)
AdGTi'IX was##2##2##(2008-9#2)
AdGTi'IX##5##1##(2008-9#5)
AdSPi'IX##4##1##(2008-9#4)
AdSV##3##1##(2008-10#3)
AdSV)##2##1##(2008-10#2)
Ada protein##2##2##(1991-9#2)
Adair constant##2##2##(1990-8#2)
Adair constants##3##2##(1990-8#3)
Adair equation##3##2##(1990-8#3)
Adair scheme##2##2##(1990-8#2)
Adair##13##1##(1990-8#13)
Adalat SL##3##2##(1990-8#3)
Adalimumab##3##1##(2012-2#3)
Adam Gruca##2##2##(2007-8#2)
Adam##3##1##(1997-1#1)(2007-8#2)
Adamantinoma is##2##2##(2010-11#1)(2010-3#1)
Adamantinoma of the##2##3##(2010-3#2)
Adamantinoma of##3##2##(2010-11#1)(2010-3#2)
Adamantinoma##6##1##(2010-11#2)(2010-3#4)
Adaptation and##2##2##(2008-10#1)(2009-7#1)
Adaptation of##6##2##(2007-8#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-1#1)
Adaptation to##5##2##(1993-12#1)(2008-10#2)(2008-8#1)(2012-3#1)
Adaptation##20##1##(1993-12#1)(1996-9#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
Adaptations##3##1##(2008-4#1)(2008-5#1)(2013-8#1)
Adapted##2##1##(2008-11#1)(2009-12#1)
Adapting to##3##2##(1992-3#1)(2009-8#1)(2012-2#1)
Adapting##7##1##(1992-3#1)(1994-12#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
Adaptive control of##2##3##(2007-11#1)(2007-12#1)
Adaptive mutation##2##2##(1994-9#2)
Adaptive optics systems##2##3##(2008-2#1)(2008-3#1)
Adaptive optics##5##2##(2008-2#2)(2008-3#3)
Adaptive##36##1##(1992-3#1)(1994-9#2)(1996-9#1)(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
Adaptive-optics##2##1##(2007-11#1)(2008-3#1)
Add-on devices##2##2##(1997-1#2)
AddAB complex##2##2##(1995-8#2)
AddAB##6##1##(1995-8#6)
Added to the##2##3##(2008-10#1)(2008-7#1)
Added##8##1##(1990-11#1)(1992-3#1)(1994-6#1)(1997-8#1)(2008-10#1)(2008-7#2)(2010-4#1)
Addenbrooke's Cognitive##3##2##(2013-1#3)
Addiction Severity Index##3##3##(2011-1#2)(2013-8#1)
Addiction to##2##2##(2011-2#1)(2012-2#1)
Addiction##10##1##(1992-12#1)(2008-1#1)(2008-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Adding a##2##2##(1996-3#1)(2007-12#1)
Adding to##2##2##(2010-3#1)(2011-2#1)
Adding##15##1##(1990-3#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2010-2#1)(2010-3#1)(2011-2#2)(2013-1#4)(2013-8#1)
Addison's disease##8##2##(1990-12#2)(1992-8#3)(1996-12#1)(2006-10#1)(2012-3#1)
Addition of 10%##2##3##(1990-2#1)(2008-10#1)
Addition of a##9##3##(1993-1#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
Addition of biotin plus Na+ to vesicle suspensions prior to treatment with##2##12##(1992-6#2)
Addition of exogenous##2##3##(1992-8#1)(1994-8#1)
Addition of increasing amounts of##2##5##(1992-5#1)(2008-10#1)
Addition of inhibitors of##2##4##(1991-5#1)(1993-11#1)
Addition of potassium##2##3##(1990-12#1)(2008-10#1)
Addition of the##4##3##(1992-9#1)(2008-10#1)(2009-3#1)(2010-6#1)
Addition of yeast##2##3##(2008-10#1)(2008-12#1)
Addition of##108##2##(1990-12#3)(1990-2#2)(1990-5#4)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-5#4)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#2)(1994-8#4)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#1)(1996-2#4)(1996-5#4)(1997-1#1)(1997-4#1)(1997-7#2)(2006-6#1)(2008-10#19)(2008-11#11)(2008-12#2)(2008-3#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)
Addition##112##1##(1990-12#3)(1990-2#2)(1990-5#4)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-5#4)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#2)(1994-8#4)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#1)(1996-2#4)(1996-5#5)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#2)(2006-6#1)(2008-10#19)(2008-11#11)(2008-12#3)(2008-3#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)
Additional analyses##4##2##(1997-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
Additional analysis##2##2##(1995-3#1)(2008-9#1)
Additional data##2##2##(2008-5#1)(2011-2#1)
Additional experiments with##2##3##(1993-6#1)(2007-12#1)
Additional experiments##6##2##(1993-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
Additional features##2##2##(1994-12#1)(1997-4#1)
Additional groups of 10 male and 10 female Tg##2##9##(2008-9#2)
Additional groups of 10 male and 10 female##3##8##(2008-9#3)
Additional groups of 15 male and 15 female mice maintained as positive controls received dermal applications of 1##2##18##(2008-9#2)
Additional groups of##5##3##(2008-9#5)
Additional groups##6##2##(1993-6#1)(2008-9#5)
Additional information is presented##2##4##(1994-2#1)(2008-1#1)
Additional information is provided regarding common side reactions and synthesizing modified residues##2##12##(2008-4#2)
Additional information is##4##3##(1994-2#1)(2008-1#1)(2008-4#2)
Additional information##7##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)
Additional investigations##2##2##(2008-9#1)(2012-2#1)
Additional isolates##2##2##(2008-10#2)
Additional microbiological tests##2##3##(2012-2#2)
Additional protocols describe##3##3##(2008-2#1)(2008-4#2)
Additional protocols##6##2##(2008-2#1)(2008-4#5)
Additional research is warranted##2##4##(2009-4#1)(2012-2#1)
Additional research is##3##3##(2009-4#1)(2012-2#1)(2013-1#1)
Additional research##7##2##(1996-9#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Additional results##2##2##(1991-12#1)(2011-2#1)
Additional strategies##2##2##(1994-5#1)(2010-3#1)
Additional studies are##2##3##(2007-10#1)(2008-5#1)
Additional studies have##2##3##(2008-11#1)(2012-2#1)
Additional studies##9##2##(1990-8#1)(1992-12#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
Additional study is##2##3##(2011-2#1)(2012-3#1)
Additional support protocols describe##2##4##(2008-4#2)
Additional support protocols##4##3##(2008-4#4)
Additional support##5##2##(1995-12#1)(2008-4#4)
Additional value of##3##3##(2008-11#1)(2009-10#1)(2010-10#1)
Additional work##2##2##(1997-8#1)(2008-11#1)
Additional##154##1##(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#14)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#12)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
Additionally##270##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#2)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#8)(2007-12#4)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#52)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#12)(2008-4#7)(2008-5#10)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#5)
Additions##3##1##(1995-2#1)(2008-11#1)(2008-9#1)
Additive and logistic EuroSCORE##2##4##(2007-8#1)(2013-8#1)
Additive##4##1##(1992-5#1)(2007-8#1)(2010-2#1)(2013-8#1)
Address##3##1##(1994-12#1)(2007-2#1)(2008-11#1)
Addressing social##2##2##(1996-1#1)(2008-12#1)
Addressing the##5##2##(2007-4#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
Addressing these##2##2##(2008-1#2)
Addressing##16##1##(1996-1#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Adduct##3##1##(1992-3#1)(1994-2#2)
Adducts##2##1##(2008-10#2)
Ade and##3##2##(1990-8#1)(1993-11#1)(2008-9#1)
Ade##8##1##(1990-8#2)(1993-11#4)(1995-6#1)(2008-9#1)
Adenine##2##1##(1990-8#1)(2008-5#1)
Adeno-associated virus##2##2##(1997-4#2)
Adeno-associated##3##1##(1997-4#2)(2008-3#1)
Adenocarcinoma of the Lung##2##4##(2010-8#1)(2013-1#1)
Adenocarcinoma of the##4##3##(2009-5#1)(2010-8#1)(2013-1#2)
Adenocarcinoma of##6##2##(1992-2#1)(2009-5#2)(2010-8#1)(2013-1#2)
Adenocarcinoma##11##1##(1992-2#1)(2006-8#1)(2009-5#2)(2010-8#2)(2013-1#4)(2013-8#1)
Adenoma##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
Adenomatoid##2##1##(2007-12#1)(2008-12#1)
Adenomatous polyps are##2##3##(1997-8#1)(2009-12#1)
Adenomatous##3##1##(1997-8#1)(2008-11#1)(2009-12#1)
Adenomyoepithelioma##3##1##(1990-12#3)
Adenosine and##2##2##(1995-8#1)(2008-5#1)
Adenosine is##2##2##(2008-4#1)(2008-7#1)
Adenosine receptor##2##2##(1996-9#1)(1997-2#1)
Adenosine##23##1##(1991-12#2)(1992-9#2)(1993-12#1)(1993-5#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-4#5)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#1)
Adenovirus vectors##2##2##(1994-5#2)
Adenovirus##8##1##(1990-12#1)(1992-5#1)(1992-6#1)(1994-5#2)(2008-8#2)(2011-2#1)
Adenovirus-mediated##3##1##(1994-5#1)(2008-8#1)(2010-1#1)
Adenoviruses##7##1##(2008-12#2)(2008-8#4)(2013-8#1)
Adequacy in##2##2##(2008-1#1)(2011-1#1)
Adequacy of##5##2##(1996-12#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-10#1)
Adequacy##8##1##(1996-12#1)(2008-1#3)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)
Adequate nutrition##2##2##(2011-2#1)(2012-2#1)
Adequate##22##1##(1993-1#1)(1997-3#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-7#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
Adequately##2##1##(1992-6#1)(2013-8#1)
Adh##3##1##(1997-8#3)
Adh(F) and Adh(S) strains##2##4##(1997-8#2)
Adh(F) and##3##2##(1997-8#3)
Adh(F)##4##1##(1997-8#4)
Adh(S)##3##1##(1997-8#3)
Adherence of##3##2##(1997-3#1)(2008-5#1)(2011-1#1)
Adherence to antiretroviral##2##3##(2009-7#1)(2010-11#1)
Adherence to##11##2##(1992-12#1)(1995-9#1)(2007-12#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
Adherence##20##1##(1992-12#1)(1994-3#1)(1995-9#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
Adherent cells were##2##3##(2012-4#1)(2013-1#1)
Adhesion and biofilm##2##3##(2008-7#2)
Adhesion molecules##2##2##(2008-5#2)
Adhesion of##5##2##(1992-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
Adhesion reformation##2##2##(1992-1#2)
Adhesion to##2##2##(2008-10#1)(2009-10#1)
Adhesion##19##1##(1992-1#2)(1992-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#3)(2009-10#1)(2011-1#1)(2013-1#1)
Adhesions##2##1##(1992-1#2)
Adhesive AH109A cells##2##3##(2008-11#2)
Adhesive##8##1##(1997-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)
Adiabatic##5##1##(1992-11#1)(1992-8#1)(2007-12#3)
Adipocyte##3##1##(1994-11#1)(2008-3#1)(2012-2#1)
Adipocytes##4##1##(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
Adipogenesis##3##1##(2008-11#1)(2008-3#1)(2012-2#1)
Adiponectin and##2##2##(2008-3#1)(2011-1#1)
Adiponectin##5##1##(2008-3#2)(2011-1#2)(2013-8#1)
Adipose Tissue##2##2##(2012-2#1)(2013-1#1)
Adipose tissue##3##2##(2010-6#1)(2012-8#1)(2013-8#1)
Adipose##8##1##(2008-10#1)(2010-6#1)(2012-2#2)(2012-8#1)(2013-1#2)(2013-8#1)
Adjacent segment disease##2##3##(2012-12#1)(2012-3#1)
Adjacent to the##2##3##(1991-6#1)(2010-12#1)
Adjacent##8##1##(1991-6#1)(1996-2#2)(1996-4#1)(2010-12#1)(2012-12#1)(2012-3#2)
Adjunct##2##1##(2011-2#1)(2013-1#1)
Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and##2##13##(2008-6#2)
Adjunctive##6##1##(2008-6#2)(2010-6#1)(2011-2#2)(2012-3#1)
Adjustable##2##1##(2007-12#1)(2008-10#1)
Adjusted##6##1##(1993-9#1)(1994-1#1)(1997-1#1)(2007-10#1)(2008-7#1)(2012-12#1)
Adjusting the##2##2##(1991-5#1)(2008-5#1)
Adjusting##6##1##(1991-5#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)
Adjustment##7##1##(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC)##2##7##(1994-7#1)(1997-7#1)
Adjuvant Chemoendocrine Therapy for Breast##3##5##(1994-7#1)(1997-7#2)
Adjuvant Therapy for##2##3##(1994-7#1)(1997-7#1)
Adjuvant chemotherapy in breast cancer##3##5##(1995-8#3)
Adjuvant chemotherapy in##5##3##(1991-8#1)(1995-8#3)(2010-3#1)
Adjuvant chemotherapy is##2##3##(1991-8#1)(2007-5#1)
Adjuvant chemotherapy of##2##3##(2007-5#1)(2008-6#1)
Adjuvant chemotherapy##11##2##(1991-8#2)(1992-8#1)(1995-8#3)(2007-5#2)(2008-6#2)(2010-3#1)
Adjuvant radiation##2##2##(2008-6#2)
Adjuvant therapy##3##2##(1992-12#1)(2010-7#2)
Adjuvant##30##1##(1991-8#2)(1992-12#2)(1992-8#1)(1994-11#1)(1994-7#2)(1995-11#1)(1995-8#3)(1997-4#1)(1997-7#3)(2007-5#2)(2008-10#1)(2008-6#7)(2010-3#1)(2010-7#2)(2013-1#1)
Adjuvants##2##1##(1995-5#1)(1996-6#1)
Adk-gene##2##1##(2009-8#2)
Adk-tg mice##2##2##(2009-8#2)
Adler##2##1##(2010-1#1)(2013-1#1)
Administered##4##1##(1991-12#1)(1991-2#1)(1995-12#1)(1996-12#1)
Administration and##7##2##(1994-1#1)(1994-3#1)(1995-2#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
Administration for##2##2##(1991-1#1)(2012-3#1)
Administration has##2##2##(1991-12#1)(1994-12#1)
Administration in##2##2##(2009-9#1)(2013-1#1)
Administration is##4##2##(1992-1#1)(1992-2#1)(1994-2#1)(1997-3#1)
Administration of 300##2##3##(1990-12#1)(1996-2#1)
Administration of a##3##3##(1993-9#1)(2008-4#1)(2011-1#1)
Administration of raclopride to rats pretreated with mianserin resulted in a large enhancement of DA output in the mPFC and##2##20##(2008-6#2)
Administration of the##5##3##(1990-5#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
Administration of##44##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-6#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
Administration to##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
Administration##161##1##(1990-12#1)(1990-5#2)(1991-1#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#4)(1992-2#2)(1992-3#1)(1993-3#2)(1993-9#1)(1994-1#5)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#4)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#9)(2012-2#5)(2012-3#5)(2013-1#6)
Administration's##10##1##(1991-12#1)(1993-1#1)(1993-2#1)(1994-12#2)(1995-1#1)(1996-1#1)(1996-2#2)(2008-11#1)
Administration)##2##1##(1993-2#1)(2008-8#1)
Administrative costs##2##2##(1993-2#1)(1996-3#1)
Administrative##11##1##(1993-2#2)(1994-12#1)(1995-1#1)(1996-3#2)(1997-2#1)(2007-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
Administrators are##2##2##(1992-3#1)(1997-2#1)
Administrators##14##1##(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(2012-12#1)
Administrators'##2##1##(1992-3#1)(2009-4#1)
Admission to##4##2##(1997-8#1)(2006-5#1)(2012-1#1)(2013-1#1)
Admission##6##1##(1997-2#1)(1997-8#1)(2006-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
Admissions##2##1##(1997-3#1)(1997-8#1)
Admitting##3##1##(1991-3#1)(1992-3#1)(1994-3#1)
Ado##3##1##(1990-8#3)
AdoMetDC by##2##2##(1992-8#2)
AdoMetDC##4##1##(1992-11#1)(1992-8#3)
Adobe Photoshop##2##2##(2007-10#1)(2008-2#1)
Adolescence##4##1##(2008-11#1)(2009-12#1)(2012-12#1)(2012-3#1)
Adolescent Girls##2##2##(2013-1#2)
Adolescent Sexuality##2##2##(1996-9#2)
Adolescent and##2##2##(1990-12#1)(2012-12#1)
Adolescent##44##1##(1990-12#1)(1994-2#1)(1995-1#1)(1996-9#2)(2006-10#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-3#1)(2010-7#2)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
Adolescents With##2##2##(2013-1#1)(2013-8#1)
Adolescents and young adults##2##4##(2008-11#2)
Adolescents and##6##2##(2008-11#3)(2008-9#1)(2009-11#1)(2009-5#1)
Adolescents in##3##2##(2009-8#2)(2013-1#1)
Adolescents who##3##2##(2008-11#1)(2010-1#1)(2013-8#1)
Adolescents with schizophrenia##3##3##(2011-2#3)
Adolescents with##6##2##(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
Adolescents##48##1##(2007-2#1)(2008-11#5)(2008-2#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-6#1)(2010-9#2)(2011-1#4)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#14)(2013-8#2)
Adolescents'##7##1##(2008-9#1)(2009-7#3)(2010-1#1)(2012-12#1)(2013-8#1)
Adopted##2##1##(2009-8#2)
Adopting##4##1##(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
Adoption and##2##2##(2009-11#1)(2009-8#1)
Adoption of##2##2##(1997-8#1)(2010-8#1)
Adoption##6##1##(1997-8#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#2)
Adoptive immunotherapy##2##2##(2008-11#1)(2012-2#1)
Adoptive transfer of##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
Adoptive##6##1##(2008-11#2)(2010-11#1)(2011-2#1)(2012-2#2)
Adr##2##1##(1993-8#2)
Adrenal gland##2##2##(1992-12#2)
Adrenal##9##1##(1990-12#1)(1992-12#2)(1995-12#1)(2007-10#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Adrenaline##2##1##(1992-5#1)(1996-5#1)
Adrenergic##3##1##(1990-5#1)(1996-2#1)(2013-8#1)
Adrenoleukodystrophy##3##1##(1993-3#2)(1995-2#1)
Adriamycin and##3##2##(2010-3#3)
Adriamycin##11##1##(1994-2#1)(1994-7#1)(1995-11#3)(2008-10#1)(2010-3#5)
AdsiRNA-survivin##3##1##(2010-1#3)
Adsorbed##3##1##(2008-10#3)
Adsorption and##2##2##(2008-10#2)
Adsorption of Pb(2+) ions on##2##5##(2008-10#2)
Adsorption of the##2##3##(1994-9#1)(2008-10#1)
Adsorption of##12##2##(1994-9#1)(2008-10#8)(2008-3#1)(2008-6#1)(2010-4#1)
Adsorption##25##1##(1994-12#1)(1994-9#1)(2008-10#18)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)
Adsorptive stripping voltammetric determination of##4##5##(2008-10#4)
Adsorptive stripping voltammetric##5##3##(2008-10#5)
Adsorptive##6##1##(2008-10#6)
Adult Branch##2##2##(2008-11#1)(2008-12#1)
Adult Separation Anxiety##2##3##(2012-2#2)
Adult Soft Tissue Sarcoma##2##4##(2008-6#2)
Adult T cell leukemia (ATL)##2##5##(2008-11#1)(2011-2#1)
Adult T-cell##2##2##(1991-8#1)(2012-12#1)
Adult Treatment Panel III (ATPIII) criteria##2##6##(2008-11#1)(2008-3#1)
Adult Treatment Panel III (ATPIII)##3##5##(2008-11#1)(2008-3#2)
Adult and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
Adult day##2##2##(1993-2#1)(1995-1#1)
Adult male##2##2##(1996-12#1)(2008-10#1)
Adult males##3##2##(2008-5#1)(2010-4#2)
Adult rat##2##2##(2008-11#1)(2008-7#1)
Adult rats were##2##3##(1996-12#1)(2007-10#1)
Adult rats##3##2##(1994-3#1)(1996-12#1)(2007-10#1)
Adult##84##1##(1991-1#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Adulthood##3##1##(2009-12#1)(2009-7#1)(2013-1#1)
Adults in the##2##3##(2008-10#1)(2013-1#1)
Adults in##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
Adults of##2##2##(2008-10#2)
Adults with##8##2##(1995-2#1)(1997-8#2)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#2)
Adults##40##1##(1991-1#1)(1991-12#1)(1995-2#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#4)(2008-8#4)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#2)
Advance care planning##2##3##(2012-12#1)(2012-3#1)
Advance directives##2##2##(1992-12#1)(1993-2#1)
Advance##16##1##(1992-12#2)(1993-2#1)(1994-2#1)(1996-2#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
Advanced Breast Cancer##2##3##(1994-7#1)(1997-7#1)
Advanced Earth Observing Satellite##3##4##(2008-2#3)
Advanced MR##2##2##(2008-7#1)(2012-2#1)
Advanced Non-small Cell Lung Cancer##3##5##(2010-8#3)
Advanced Oxidation Process##2##3##(2008-10#2)
Advanced Practice##2##2##(2008-11#1)(2012-2#1)
Advanced Research Projects Agency##2##4##(2008-3#2)
Advanced Satellite for Cosmology and##2##5##(2008-3#2)
Advanced Trail Making Test##2##4##(2008-5#2)
Advanced Very High Resolution Radiometer (AVHRR)##2##6##(2008-3#1)(2008-8#1)
Advanced Very High Resolution Radiometer##3##5##(2008-3#1)(2008-8#2)
Advanced age and##2##3##(1997-3#1)(2008-7#1)
Advanced age##3##2##(1997-3#1)(2008-7#1)(2013-7#1)
Advanced breeding lines##2##3##(2008-10#2)
Advanced glycation end products (AGEs)##2##5##(2008-1#1)(2011-1#1)
Advanced glycation end products##3##4##(2008-1#1)(2008-7#1)(2011-1#1)
Advanced laser-backlit Grazing-Incidence X-Ray Imaging Systems for Inertial Confinement Fusion Research##2##11##(2008-3#2)
Advanced practice##2##2##(2012-3#2)
Advanced trauma life support##2##4##(1992-5#2)
Advanced##91##1##(1990-11#1)(1992-5#2)(1994-12#2)(1994-2#1)(1994-7#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#3)
Advancement of##4##2##(2007-11#1)(2011-2#3)
Advancement##7##1##(1995-2#1)(1997-2#1)(2007-11#1)(2008-8#1)(2011-2#3)
Advancements in##2##2##(2007-10#1)(2009-3#1)
Advances and##2##2##(2009-12#1)(2011-2#1)
Advances in contemporary##2##3##(2011-1#2)
Advances in diagnosis and management of##2##6##(2007-12#1)(2013-8#1)
Advances in imaging##2##3##(2007-12#1)(2008-7#1)
Advances in medical##2##3##(2008-7#1)(2009-6#1)
Advances in pig##2##3##(2008-7#2)
Advances in technology have##3##4##(1996-2#1)(2008-7#1)(2010-6#1)
Advances in the treatment of##2##5##(2008-10#1)(2008-4#1)
Advances in the understanding of the##3##6##(2008-1#1)(2008-10#1)(2009-1#1)
Advances in the understanding of##4##5##(2008-1#1)(2008-10#1)(2009-1#1)(2012-2#1)
Advances in the##17##3##(2007-12#1)(2008-1#2)(2008-10#5)(2008-4#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
Advances in understanding##2##3##(2008-5#1)(2008-7#1)
Advances in##80##2##(1990-3#1)(1990-8#1)(1992-7#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#6)(2011-1#5)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Advances##85##1##(1990-3#1)(1990-8#1)(1992-7#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#6)(2010-8#1)(2011-1#5)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Advancing practice##2##2##(2013-8#2)
Advancing##8##1##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
Advantage##3##1##(2008-10#1)(2008-5#1)(2009-8#1)
Advantages and disadvantages of each##3##5##(2008-10#1)(2008-3#1)(2008-4#1)
Advantages and disadvantages of using##2##5##(1991-3#1)(1996-1#1)
Advantages and disadvantages of##7##4##(1991-11#1)(1991-3#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
Advantages and disadvantages##8##3##(1991-11#1)(1991-3#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-7#1)
Advantages and##12##2##(1991-11#1)(1991-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-7#1)
Advantages of the##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
Advantages of this technique include its##2##6##(2007-11#1)(2010-7#1)
Advantages of##14##2##(1992-3#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#2)(2010-7#1)
Advantages##31##1##(1991-11#1)(1991-3#1)(1992-3#1)(1993-3#1)(1996-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-9#1)(2010-7#1)(2011-7#1)
Adventist##3##1##(1996-1#2)(2011-2#1)
Adventitial reactions##2##2##(1997-8#2)
Adverse Drug Reactions##2##3##(2008-3#1)(2012-2#1)
Adverse Drug##4##2##(2008-3#2)(2010-5#1)(2012-2#1)
Adverse Event##2##2##(2010-8#1)(2013-1#1)
Adverse Events##2##2##(2008-3#1)(2013-1#1)
Adverse drug reaction##2##3##(1993-1#1)(2008-3#1)
Adverse drug reactions##4##3##(1997-8#1)(2008-3#1)(2011-2#2)
Adverse drug##8##2##(1991-11#1)(1993-1#1)(1993-12#1)(1997-8#1)(2008-3#2)(2011-2#2)
Adverse effects of##3##3##(1990-9#1)(2008-7#1)(2013-8#1)
Adverse effects were##4##3##(2007-11#1)(2007-7#1)(2008-7#2)
Adverse effects##11##2##(1990-9#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#3)(2011-2#1)(2013-8#1)
Adverse event##2##2##(2008-7#1)(2012-3#1)
Adverse events associated with##2##4##(2008-7#1)(2012-2#1)
Adverse events following##2##3##(2008-7#1)(2013-7#1)
Adverse events were##3##3##(1994-6#1)(2008-5#1)(2012-12#1)
Adverse events##12##2##(1992-1#1)(1994-6#1)(2008-11#1)(2008-5#2)(2008-7#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
Adverse health effects of##2##4##(1995-3#1)(1996-12#1)
Adverse reactions to##2##3##(2007-7#1)(2011-1#1)
Adverse reactions were##2##3##(1991-11#1)(2012-3#1)
Adverse reactions##4##2##(1991-11#1)(2007-7#1)(2011-1#1)(2012-3#1)
Adverse##56##1##(1990-9#1)(1991-11#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-3#5)(2008-5#2)(2008-7#6)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
Advice on##2##2##(2008-4#1)(2011-1#1)
Advice##4##1##(1996-3#1)(2007-2#1)(2008-4#1)(2011-1#1)
Advisor##2##1##(2010-1#1)(2013-1#1)
Advisory Committee on##6##3##(1994-11#2)(1994-9#1)(1995-11#2)(1995-6#1)
Advisory Committee##12##2##(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#2)(1995-6#1)(2007-5#1)(2008-10#1)(2008-5#1)(2012-3#2)
Advisory Council on HIV/AIDS##3##4##(1995-12#1)(1995-6#2)
Advisory Council##4##2##(1995-12#1)(1995-6#3)
Advisory Group##2##2##(1992-2#1)(2008-8#1)
Advisory##21##1##(1992-2#1)(1993-1#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#4)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#2)
Advocacy##2##1##(2010-3#1)(2012-12#1)
Advocates##2##1##(1992-11#1)(2012-12#1)
Advocating for##2##2##(2008-11#1)(2012-12#1)
Ae##13##1##(1992-8#2)(2008-8#3)(2013-1#8)
Aedes aegypti (Diptera##4##3##(2008-5#3)(2013-8#1)
Aedes aegypti mosquitoes from##2##4##(2007-10#2)
Aedes aegypti##16##2##(2007-10#6)(2008-5#7)(2011-2#2)(2013-8#1)
Aedes albopictus##5##2##(1992-8#2)(2007-7#3)
Aedes communis is a##2##4##(2011-2#2)
Aedes communis##3##2##(2011-2#3)
Aedes##25##1##(1992-8#2)(2007-10#6)(2007-7#3)(2008-5#7)(2008-7#1)(2011-2#5)(2013-8#1)
Aegean##3##1##(2008-10#2)(2008-2#1)
Aegilops speltoides##3##2##(2008-10#3)
Aegilops##7##1##(2008-10#5)(2008-5#1)(2008-8#1)
Aelia##3##1##(2013-8#3)
Aerial photography##2##2##(2008-10#2)
Aerial##6##1##(2007-12#1)(2007-5#1)(2008-10#4)
Aerobic and##2##2##(2008-5#1)(2013-1#1)
Aerobic##6##1##(1996-12#1)(2007-7#1)(2008-5#1)(2009-1#1)(2013-1#2)
Aerococcus##2##1##(2008-10#2)
Aerodynamic##2##1##(2008-2#1)(2008-3#1)
Aeromonas species##2##2##(2007-10#1)(2007-7#1)
Aeromonas spp##4##2##(2007-10#1)(2007-7#3)
Aeromonas strains isolated##2##3##(2008-10#2)
Aeromonas strains##4##2##(2008-10#4)
Aeromonas##15##1##(2007-10#5)(2007-7#5)(2008-10#4)(2008-11#1)
Aerosol Characterization Experiment##3##3##(2008-3#3)
Aerosol bolus dispersion##3##3##(1997-2#3)
Aerosol delivery##2##2##(1997-1#1)(2010-3#1)
Aerosol observations by lidar in the nocturnal boundary layer##2##9##(2008-3#2)
Aerosol##41##1##(1991-8#1)(1992-12#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-1#4)(1997-2#3)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#13)(2008-5#1)(2010-3#1)(2013-1#1)
Aerosol-OT##2##1##(2009-12#1)(2011-1#1)
Aerosolized##7##1##(1990-9#1)(1992-3#1)(1994-12#2)(1997-1#1)(2008-10#1)(2008-3#1)
Aerosols are##2##2##(2008-9#2)
Aerosols##8##1##(1995-3#1)(1996-2#1)(1997-1#1)(2008-2#1)(2008-3#2)(2008-9#2)
Aesthetic##7##1##(2007-11#1)(2007-12#1)(2010-8#5)
Aetiologically##2##1##(1997-4#1)(2013-1#1)
Aetiology and##4##2##(1995-10#1)(2007-11#2)(2011-2#1)
Aetiology##6##1##(1995-10#1)(2007-11#2)(2008-8#1)(2010-11#1)(2011-2#1)
Aetna and CIGNA settlements##2##4##(2008-4#2)
Affairs Committee##3##2##(2010-3#3)
Affairs##22##1##(1990-11#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1995-2#1)(1996-3#1)(2007-10#1)(2007-5#1)(2008-6#1)(2009-11#1)(2010-3#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Affect Balance Scale##2##3##(1991-6#2)
Affect##13##1##(1991-6#2)(2008-10#3)(2008-6#3)(2009-9#1)(2010-11#1)(2010-8#1)(2013-8#2)
Affected by##5##2##(2008-10#5)
Affected individuals##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
Affected##12##1##(1997-3#1)(2008-1#1)(2008-10#6)(2008-7#1)(2011-1#1)(2011-2#2)
Affecting##12##1##(2008-1#1)(2008-10#10)(2008-5#1)
Affective##3##1##(2008-11#1)(2009-9#1)(2012-1#1)
Affects the##4##2##(2008-10#3)(2012-3#1)
Affects##5##1##(2008-10#4)(2012-3#1)
Affibody molecule##3##2##(2009-9#3)
Affibody molecules##3##2##(2009-9#3)
Affibody##7##1##(2009-9#7)
Affinity cross-linking of##2##3##(1990-5#1)(1992-9#1)
Affinity cross-linking##3##2##(1990-5#1)(1992-9#1)(1994-6#1)
Affinity labeling of##2##3##(1990-7#1)(1992-8#1)
Affinity labeling##3##2##(1990-7#1)(1992-8#2)
Affinity purification of##2##3##(1990-8#1)(1995-8#1)
Affinity##16##1##(1990-5#1)(1990-7#1)(1990-8#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#2)(2009-11#1)(2012-2#2)
Affirming##2##1##(2008-5#1)(2013-1#1)
Affordable Care##2##2##(2010-9#1)(2011-1#1)
Affymetrix GeneChip(R) 100K Human Mapping##2##5##(2009-8#2)
Affymetrix##9##1##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#3)(2010-11#1)
Aflatoxin B(1) in##2##3##(2008-10#2)
Aflatoxin B(1)##4##2##(2008-10#4)
Aflatoxin Contamination##3##2##(2008-10#3)
Aflatoxin M1##3##2##(2008-12#1)(2013-1#2)
Aflatoxin Production##3##2##(2008-10#2)(2013-1#1)
Aflatoxin contamination##2##2##(2008-10#2)
Aflatoxin##18##1##(2008-10#14)(2008-12#1)(2013-1#3)
Aflatoxins##7##1##(2008-10#7)
Africa (SSA)##2##2##(2008-10#1)(2008-8#1)
Africa and in##3##3##(1993-3#1)(2011-1#2)
Africa and the##5##3##(1991-11#1)(1994-3#1)(2007-2#1)(2008-10#2)
Africa and##22##2##(1991-11#1)(1993-3#1)(1993-6#2)(1994-3#1)(1997-7#1)(2007-2#1)(2008-10#7)(2009-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-8#1)
Africa are##7##2##(1997-7#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Africa can##2##2##(2011-2#1)(2012-2#1)
Africa has##2##2##(2008-10#1)(2011-1#1)
Africa have##2##2##(2007-7#1)(2008-10#1)
Africa is##4##2##(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)
Africa to##2##2##(2008-1#1)(2008-12#1)
Africa was##4##2##(2009-5#1)(2011-1#3)
Africa were##3##2##(1997-8#1)(2007-2#1)(2008-10#1)
Africa with##2##2##(1995-9#1)(2013-8#1)
Africa##252##1##(1990-12#3)(1991-11#2)(1991-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#3)(1994-3#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-6#2)(1996-8#1)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#2)(2007-2#10)(2007-7#6)(2008-1#4)(2008-10#57)(2008-11#2)(2008-12#9)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#14)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-1#9)(2010-11#3)(2010-12#1)(2010-3#8)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#18)(2011-2#12)(2012-12#9)(2012-2#9)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#4)
Africa)##4##1##(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
Africa?##2##1##(1993-11#1)(1996-11#1)
Africa]##5##1##(1990-8#1)(1993-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
African American adolescent##2##3##(2009-7#1)(2012-12#1)
African American adolescents##3##3##(2009-5#1)(2009-7#1)(2012-3#1)
African American adolescents' identity##2##4##(2012-12#2)
African American adolescents'##3##3##(2012-12#3)
African American adults##2##3##(2009-7#2)
African American and Caribbean men##2##5##(2008-4#2)
African American and Caribbean##4##4##(2008-4#3)(2010-10#1)
African American and Latino##2##4##(1996-3#1)(2008-12#1)
African American and white##2##4##(2011-1#1)(2011-2#1)
African American and##10##3##(1996-3#1)(2008-12#1)(2008-4#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
African American blood##2##3##(1994-12#2)
African American breast cancer##2##4##(2008-4#2)
African American children##2##3##(2010-9#1)(2011-1#1)
African American male##5##3##(2008-12#1)(2009-5#4)
African American men aged##2##4##(2009-5#2)
African American men and##3##4##(2009-5#2)(2012-3#1)
African American men have##2##4##(2009-5#2)
African American men with prostate cancer##4##6##(2009-5#4)
African American men##25##3##(2008-4#1)(2009-5#22)(2010-7#1)(2012-3#1)
African American men's##2##3##(2009-5#2)
African American mothers##2##3##(2009-10#1)(2009-12#1)
African American nose##2##3##(2010-8#2)
African American smokers##2##3##(2008-12#1)(2012-3#1)
African American women##9##3##(2008-4#7)(2009-11#1)(2011-2#1)
African American youth##2##3##(2009-5#1)(2009-7#1)
African American##112##2##(1994-12#2)(1996-3#1)(2007-10#2)(2007-7#1)(2008-10#2)(2008-12#7)(2008-4#14)(2008-5#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-5#34)(2009-7#7)(2010-10#1)(2010-4#1)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#7)(2012-2#1)(2012-3#7)
African Americans and##8##3##(2008-4#1)(2009-11#1)(2012-2#2)(2012-3#1)(2013-1#3)
African Americans are##2##3##(2008-12#1)(2012-2#1)
African Americans than##2##3##(2008-4#1)(2011-2#1)
African Americans were more##2##4##(2010-10#1)(2013-1#1)
African Americans were##6##3##(2008-12#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#2)
African Americans with##4##3##(2010-4#4)
African Americans##53##2##(1995-12#1)(2007-10#1)(2008-1#1)(2008-12#4)(2008-4#7)(2008-5#1)(2008-8#1)(2009-11#2)(2009-8#1)(2010-10#5)(2010-4#6)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#1)
African Americans' perceptions of the##2##5##(2009-11#2)
African Americans'##3##2##(2009-11#2)(2009-5#1)
African and##4##2##(2008-1#2)(2008-10#2)
African catfish##5##2##(1992-8#5)
African clawed frogs (Xenopus laevis)##2##5##(1996-6#2)
African countries##4##2##(1993-6#1)(2007-2#1)(2007-7#1)(2008-11#1)
African cultivated rice##3##3##(2009-10#3)
African horse sickness##2##3##(2010-4#2)
African man##2##2##(1993-6#1)(2010-12#1)
African origin##5##2##(1994-3#2)(2008-8#2)(2012-12#1)
African population##2##2##(2007-7#1)(2010-5#1)
African populations##7##2##(2008-12#1)(2010-3#1)(2010-5#5)
African strain XcmN##2##3##(2008-10#2)
African strains of Xanthomonas##2##4##(2008-10#2)
African strains##9##2##(2008-10#9)
African swine fever##2##3##(2011-2#2)
African##303##1##(1991-11#1)(1991-5#1)(1992-8#5)(1993-6#5)(1994-12#2)(1994-3#3)(1994-9#1)(1995-12#2)(1995-2#3)(1995-9#1)(1996-3#1)(1996-6#3)(1997-6#1)(1997-8#1)(2007-10#3)(2007-2#3)(2007-7#3)(2008-1#3)(2008-10#25)(2008-11#1)(2008-12#15)(2008-3#1)(2008-4#22)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#5)(2009-11#8)(2009-12#1)(2009-5#35)(2009-7#7)(2009-8#1)(2010-1#5)(2010-10#7)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#9)(2010-5#7)(2010-7#5)(2010-8#9)(2010-9#3)(2011-1#15)(2011-2#15)(2012-12#8)(2012-2#9)(2012-3#10)(2013-1#12)(2013-7#1)(2013-8#4)
African-American and##3##2##(2007-2#1)(2008-4#1)(2008-5#1)
African-American boy##2##2##(1997-3#2)
African-American hair and##2##3##(2008-5#2)
African-American hair fibre##2##3##(2008-5#2)
African-American hair##6##2##(2008-5#6)
African-American##26##1##(1995-11#1)(1995-9#1)(1997-3#2)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#8)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-6#1)(2013-1#1)
African-American)##2##1##(2009-6#1)(2009-7#1)
African-Americans and##2##2##(2013-1#2)
African-Americans##14##1##(1994-1#1)(1997-3#2)(2006-10#1)(2007-7#3)(2008-1#1)(2010-6#3)(2013-1#2)(2013-8#1)
Africanized bees##2##2##(2008-6#2)
Africanized##3##1##(2008-6#3)
Africans from##2##2##(2008-12#1)(2010-5#1)
Africans##10##1##(1993-6#4)(2008-12#2)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#1)
Afro-American hair##2##2##(2008-5#2)
Afro-American##3##1##(2008-5#3)
Afro-Andean isolates##2##2##(2008-10#2)
Afro-Andean##8##1##(2008-10#8)
Afro-Caribbean##2##1##(1993-2#1)(2008-1#1)
After 1 hour##2##3##(1993-6#1)(2013-8#1)
After 1 year##2##3##(2008-9#1)(2013-1#1)
After 1##8##2##(1993-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
After 10##3##2##(2008-10#2)(2010-8#1)
After 11##2##2##(2008-10#1)(2011-2#1)
After 12 months##2##3##(2007-5#1)(2013-1#1)
After 12 weeks##3##3##(1991-2#1)(2007-8#1)(2008-3#1)
After 12##7##2##(1991-2#1)(1995-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
After 14 days##2##3##(2008-12#1)(2013-1#1)
After 14##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
After 15##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
After 18 months##2##3##(2011-2#1)(2013-1#1)
After 2 days##2##3##(2008-10#1)(2008-12#1)
After 2 h##3##3##(1994-3#1)(2007-8#1)(2008-10#1)
After 2 months##2##3##(2008-1#1)(2013-8#1)
After 2 weeks of treatment##2##5##(1996-2#1)(2008-1#1)
After 2 weeks##3##3##(1996-2#1)(1996-5#1)(2008-1#1)
After 2 years##2##3##(2008-6#1)(2008-7#1)
After 2##13##2##(1994-3#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-8#1)
After 20 days##2##3##(1994-6#1)(2008-10#1)
After 20##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
After 24 h##7##3##(2008-10#2)(2008-12#2)(2008-7#1)(2010-3#1)(2013-1#1)
After 24 hours##2##3##(1992-6#1)(2008-5#1)
After 24##9##2##(1992-6#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
After 2 years##2##2##(2011-1#2)
After 3 days##2##3##(1994-3#1)(2008-10#1)
After 3 months##2##3##(2007-12#1)(2011-2#1)
After 3 weeks of##2##4##(1993-8#1)(1994-8#1)
After 3 weeks##3##3##(1993-8#1)(1994-8#1)(2008-11#1)
After 3##8##2##(1993-8#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
After 30 min##2##3##(1995-12#1)(1995-3#1)
After 30##4##2##(1995-12#1)(1995-3#1)(2008-4#1)(2011-2#1)
After 4 days of##2##4##(1994-6#1)(2008-11#1)
After 4 months of##3##4##(2007-7#1)(2008-10#1)(2010-8#1)
After 4 months##6##3##(1991-8#1)(2007-7#1)(2008-10#2)(2010-8#1)(2013-1#1)
After 4 weeks in culture##2##5##(2008-11#2)
After 4 weeks##5##3##(1993-6#1)(2008-11#2)(2008-7#1)(2009-4#1)
After 4##16##2##(1991-8#1)(1993-6#1)(1994-6#1)(1995-9#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
After 48 h##2##3##(1992-6#1)(2008-10#1)
After 48##3##2##(1992-6#1)(2008-10#2)
After 5 days of##2##4##(1990-7#1)(2008-11#1)
After 5 days##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
After 5##6##2##(1990-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
After 56 days##2##3##(2008-10#1)(2010-5#1)
After 6 months##3##3##(2007-7#1)(2008-6#1)(2013-8#1)
After 6 weeks##4##3##(1990-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
After 6##8##2##(1990-12#1)(1992-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
After 60 min##2##3##(1994-11#1)(1995-3#1)
After 60##3##2##(1994-11#1)(1995-3#1)(2013-1#1)
After 7 days##2##3##(2008-5#2)
After 7 years##2##3##(2008-10#1)(2013-1#1)
After 7##7##2##(1991-5#1)(2008-10#3)(2008-5#2)(2013-1#1)
After 72 h##2##3##(1993-12#1)(2008-7#1)
After 8##2##2##(1991-8#1)(2008-10#1)
After 9##2##2##(2007-12#1)(2009-12#1)
After 90##2##2##(1992-12#1)(2008-6#1)
After Arteriovenous##2##2##(2012-3#2)
After DNA sequencing##2##3##(2008-8#2)
After DNA##3##2##(2008-8#3)
After Transposition of##2##3##(2008-10#2)
After Treatment##2##2##(2011-1#1)(2012-3#1)
After a brief##6##3##(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
After a complete##3##3##(2008-3#1)(2013-1#2)
After a comprehensive##2##3##(1997-1#1)(2012-2#1)
After a few##2##3##(2008-11#1)(2008-2#1)
After a long period of##2##5##(1990-8#1)(2007-11#1)
After a long##3##3##(1990-8#1)(2007-11#1)(2008-1#1)
After a mean follow-up of##2##5##(2008-6#1)(2012-2#1)
After a mean##5##3##(2007-8#1)(2008-6#2)(2011-2#1)(2012-2#1)
After a median follow-up of##2##5##(1992-12#1)(2010-3#1)
After a median follow-up period of##2##6##(1990-8#1)(2007-10#1)
After a median follow-up##4##4##(1990-8#1)(1992-12#1)(2007-10#1)(2010-3#1)
After a median##5##3##(1990-8#1)(1991-8#1)(1992-12#1)(2007-10#1)(2010-3#1)
After a review of the literature##2##6##(2010-8#1)(2011-2#1)
After a review of the##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
After a review of##4##4##(1993-6#1)(2008-10#1)(2010-8#1)(2011-2#1)
After a review##5##3##(1990-10#1)(1993-6#1)(2008-10#1)(2010-8#1)(2011-2#1)
After a single##2##3##(1997-2#1)(2008-2#1)
After a systematic##2##3##(2008-3#1)(2011-1#1)
After a##84##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
After about##2##2##(1994-12#1)(2010-5#1)
After addition of##2##3##(2008-10#1)(2008-4#1)
After adjusting for age##2##4##(2007-10#1)(2013-8#1)
After adjusting for##6##3##(2007-10#2)(2009-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
After adjustment for##7##3##(1991-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
After adjustment##8##2##(1991-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#2)
After admission##2##2##(2009-6#1)(2012-12#1)
After an initial evaluation of##2##5##(1992-1#1)(2008-5#1)
After an introduction##2##3##(1996-6#1)(2008-10#1)
After an overview of the##2##5##(1993-2#1)(2012-12#1)
After an##16##2##(1992-1#1)(1992-5#1)(1993-2#1)(1996-5#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#2)
After analyzing the##2##3##(2008-2#1)(2012-2#1)
After analyzing##3##2##(2008-2#1)(2008-8#1)(2012-2#1)
After application of##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
After applying these to three moral issues--marketing##2##7##(1994-1#2)
After being##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#3)
After careful##3##2##(1990-10#1)(1992-2#1)(2008-10#1)
After cells are##2##3##(2008-8#1)(2008-9#1)
After centrifugation##5##2##(1990-2#1)(2008-10#3)(2008-11#1)
After chromatography on##2##3##(1992-9#1)(1993-11#1)
After clinical##2##2##(2007-11#1)(2008-10#1)
After collecting the available instruments used by nurses and/or patients in the measurement of patients' problems or perceptions of those problems (actual and/or potential)##2##24##(2013-1#2)
After collecting the##3##3##(2008-10#1)(2013-1#2)
After comparing our##2##3##(2007-11#1)(2008-10#1)
After comparing##3##2##(1991-12#1)(2007-11#1)(2008-10#1)
After completing their##2##3##(1994-12#1)(2011-2#1)
After completing##4##2##(1994-12#1)(2009-6#1)(2010-10#1)(2011-2#1)
After completion of##4##3##(1991-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
After consideration of the##2##4##(2008-10#1)(2010-6#1)
After controlling for a variety of##2##6##(1995-2#1)(2008-11#1)
After controlling for##9##3##(1995-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#2)(2011-1#1)(2013-1#1)
After conventional##2##2##(2008-10#1)(2008-2#1)
After coronary##2##2##(1994-3#1)(2007-8#1)
After correction for##2##3##(1990-12#1)(1990-3#1)
After correction##3##2##(1990-12#1)(1990-3#1)(2008-10#1)
After day##2##2##(1995-2#1)(2008-7#1)
After decades of##2##3##(1992-5#1)(2008-8#1)
After deposition##2##2##(2008-10#1)(2008-3#1)
After derivatization##3##2##(2008-10#2)(2008-11#1)
After describing the##2##3##(1990-6#1)(2013-8#1)
After describing##3##2##(1990-10#1)(1990-6#1)(2013-8#1)
After developing a##2##3##(2008-11#1)(2010-12#1)
After discussing##4##2##(1991-2#1)(1993-12#1)(2008-10#1)(2010-8#1)
After each##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
After eight##2##2##(2013-1#1)(2013-7#1)
After elution with##2##3##(2008-10#2)
After elution##5##2##(1995-3#1)(2008-10#3)(2008-4#1)
After establishing the##2##3##(1995-3#1)(2008-2#1)
After examining the##2##3##(1990-2#1)(2007-12#1)
After exclusion of##2##3##(1991-8#1)(2008-9#1)
After exposure to##2##3##(1995-5#1)(2008-10#1)
After exposure##7##2##(1993-12#1)(1995-5#1)(2007-11#2)(2008-10#2)(2008-3#1)
After extracted by##2##3##(2011-1#2)
After filtration##5##2##(2008-10#5)
After five##2##2##(2008-2#1)(2008-5#1)
After four##2##2##(1996-9#1)(2008-10#1)
After freezing##2##2##(2008-10#1)(2008-9#1)
After further##2##2##(1997-3#1)(2012-1#1)
After having##2##2##(1990-12#1)(1990-9#1)
After identifying##2##2##(1995-2#1)(2012-3#1)
After incubation of##2##3##(1993-11#1)(2008-10#1)
After incubation with##2##3##(1994-6#1)(2008-4#1)
After incubation##7##2##(1993-11#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2013-1#1)
After induction chemotherapy##2##3##(2008-10#1)(2008-6#1)
After induction##4##2##(1995-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
After initial##6##2##(1997-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)
After injecting##3##2##(1994-8#1)(2008-10#2)
After injection of the##2##4##(1992-12#1)(2008-10#1)
After injection##4##2##(1992-12#1)(1994-9#1)(2008-10#2)
After inoculation of##3##3##(2008-10#2)(2008-11#1)
After inoculation##4##2##(2008-10#3)(2008-11#1)
After intravenous administration of##2##4##(2007-11#1)(2012-12#1)
After making##2##2##(2008-6#1)(2011-3#1)
After measurement##2##2##(2008-10#2)
After measuring##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
After multivariate analysis##2##3##(2007-10#1)(2013-1#1)
After nine months##2##3##(1993-1#1)(1993-3#1)
After nine##4##2##(1993-1#1)(1993-3#1)(1995-11#1)(2012-2#1)
After obtaining a##2##3##(1995-12#1)(2010-6#1)
After one year##3##3##(1994-12#1)(2011-2#1)(2013-1#1)
After one##7##2##(1994-12#1)(1995-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#2)
After only##2##2##(2008-9#1)(2012-1#1)
After operation##2##2##(1990-6#1)(2007-11#1)
After optimisation##3##2##(2008-10#2)(2008-11#1)
After optimization of the##4##4##(2008-10#3)(2011-2#1)
After optimization of##5##3##(2008-10#4)(2011-2#1)
After optimization##6##2##(2008-10#5)(2011-2#1)
After oral##2##2##(2008-11#1)(2011-2#1)
After overnight##2##2##(2008-10#1)(2008-4#1)
After pre-treatment with acids##2##4##(2008-10#2)
After preliminary##2##2##(2007-11#1)(2012-3#1)
After pretreatment##2##2##(2008-5#1)(2008-7#1)
After probing with the primary antibody##2##6##(2008-4#2)
After providing##2##2##(2009-4#1)(2011-1#1)
After purification##4##2##(1994-5#1)(1995-3#1)(2007-11#1)(2008-11#1)
After receiving##3##2##(1996-3#1)(2008-12#1)(2012-12#1)
After removal of the##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
After removal of##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
After removing##2##2##(2008-7#1)(2012-4#1)
After resection of the##2##4##(2008-5#1)(2008-7#1)
After resection##4##2##(2007-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
After reviewing the##4##3##(1995-3#1)(1996-12#1)(1997-3#1)(2008-2#1)
After reviewing##6##2##(1990-8#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-2#1)
After screening##2##2##(1992-9#1)(2008-9#1)
After selective##2##2##(2008-8#1)(2011-2#1)
After separation##4##2##(1992-6#1)(2008-10#2)(2011-2#1)
After several##5##2##(1990-5#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-5#1)
After signing##2##2##(2008-5#1)(2012-12#1)
After six months of##2##4##(2013-1#2)
After six months##3##3##(1990-5#1)(2013-1#2)
After six weeks##2##3##(2007-7#1)(2008-5#1)
After six##6##2##(1990-5#1)(1997-4#1)(2007-7#1)(2008-5#1)(2013-1#2)
After solubilization with Triton X-100##2##5##(1990-11#1)(2008-4#1)
After some##2##2##(1994-6#1)(2012-2#1)
After stimulation##2##2##(1990-7#1)(1995-12#1)
After storage##2##2##(2008-11#1)(2013-1#1)
After surgery##13##2##(1990-6#1)(1992-10#1)(1992-6#1)(1997-4#3)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#2)(2013-1#1)
After testing the##2##3##(2008-10#1)(2008-11#1)
After testing##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
After that the##2##3##(1990-6#1)(2008-10#1)
After that##9##2##(1990-6#1)(1995-9#1)(2006-12#1)(2008-10#4)(2008-6#2)
After the Second World War##2##5##(2008-11#1)(2011-4#1)
After the analysis##2##3##(1992-12#1)(2010-3#1)
After the application of##2##4##(2008-12#1)(2008-5#1)
After the competitive##2##3##(2008-10#2)
After the diagnosis##2##3##(2007-11#1)(2010-10#1)
After the enrichment##2##3##(2008-10#2)
After the exposure of the sample to microwave radiation##2##9##(2008-10#2)
After the first##6##3##(1994-12#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-8#1)(2013-8#1)
After the initial##2##3##(2008-10#1)(2008-8#1)
After the operation##3##3##(1993-1#1)(2007-10#1)(2010-8#1)
After the surgery##2##3##(2007-11#1)(2008-4#1)
After the treatment##2##3##(2008-10#1)(2008-5#1)
After the##118##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-4#1)(2008-10#30)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-4#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
After these##3##2##(2008-3#2)(2010-7#1)
After this##9##2##(1990-6#1)(1993-6#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
After thorough investigation##2##3##(2008-7#1)(2013-1#1)
After three##8##2##(1994-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
After training##2##2##(2008-7#1)(2013-1#1)
After transfection##3##2##(1993-11#1)(1995-2#1)(2008-9#1)
After treating##2##2##(2008-10#1)(2008-4#1)
After treatment of##2##3##(1994-8#1)(2007-11#1)
After treatment with either##2##4##(1990-5#1)(1996-6#1)
After treatment with##9##3##(1990-5#1)(1994-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-7#2)(2009-12#1)(2009-3#1)
After treatment##15##2##(1990-5#1)(1991-2#1)(1991-6#1)(1994-11#1)(1994-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-7#2)(2009-12#1)(2009-3#1)(2012-3#1)
After two years of##2##4##(1993-1#1)(2008-1#1)
After two##5##2##(1993-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
After using the##2##3##(1991-3#1)(1995-12#1)
After using##3##2##(1991-3#1)(1992-11#1)(1995-12#1)
After washing the column with##2##5##(2008-10#2)
After washing the##3##3##(2008-10#3)
After washing##5##2##(2008-10#5)
After years of##2##3##(2008-1#1)(2008-10#1)
After##1122##1##(1990-10#4)(1990-11#3)(1990-12#9)(1990-2#6)(1990-3#4)(1990-5#6)(1990-6#8)(1990-7#2)(1990-8#6)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#3)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#5)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#8)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#5)(1993-1#5)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#4)(1995-11#5)(1995-12#14)(1995-2#7)(1995-3#11)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#6)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#25)(2007-12#9)(2007-4#2)(2007-5#2)(2007-7#5)(2007-8#13)(2007-9#2)(2008-1#11)(2008-10#232)(2008-11#39)(2008-12#20)(2008-2#15)(2008-3#18)(2008-4#19)(2008-5#40)(2008-6#14)(2008-7#34)(2008-8#30)(2008-9#24)(2009-10#3)(2009-12#6)(2009-3#7)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#12)(2011-2#42)(2011-3#3)(2011-4#3)(2012-1#9)(2012-12#8)(2012-2#14)(2012-3#30)(2012-4#1)(2013-1#64)(2013-7#3)(2013-8#21)
After-School##2##1##(2012-12#1)(2013-1#1)
Afterward##2##1##(2011-2#1)(2013-1#1)
Afterwards##7##1##(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
Ag (I)##5##2##(2008-10#4)(2010-11#1)
Ag and Cu##2##3##(2008-10#2)
Ag and##12##2##(1991-5#1)(2007-12#1)(2008-10#8)(2008-3#2)
Ag electrode##5##2##(2007-12#1)(2008-10#1)(2013-1#3)
Ag films##2##2##(2007-12#1)(2008-3#1)
Ag in##3##2##(1993-3#1)(2008-10#1)(2009-7#1)
Ag islands##2##2##(1993-5#1)(2007-12#1)
Ag on TiO2 films##2##4##(2007-12#2)
Ag surface##3##2##(2013-1#3)
Ag vapor-deposited films##2##3##(2007-12#2)
Ag was immobilized##2##3##(2008-10#2)
Ag##88##1##(1990-8#1)(1991-2#1)(1991-5#2)(1993-1#1)(1993-3#2)(1993-5#1)(1996-2#1)(2007-11#2)(2007-12#14)(2007-7#1)(2008-10#37)(2008-11#1)(2008-3#9)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#9)(2013-8#1)
Ag(+) and Cu(2+) ions##2##4##(2008-10#2)
Ag(+) and Zn(2+)##3##3##(2008-10#3)
Ag(+) and##11##2##(2008-10#11)
Ag(+) ions##3##2##(2008-10#3)
Ag(+) to##2##2##(2008-10#1)(2010-11#1)
Ag(+)##28##1##(2008-10#25)(2010-11#3)
Ag(+)-ISEs##2##1##(2008-10#2)
Ag(110)##2##1##(1991-9#1)(1992-11#1)
Ag(2)S##7##1##(2008-10#3)(2008-3#4)
Ag(2+)##2##1##(2008-10#2)
Ag(CN)(2)(-)##2##1##(2008-10#2)
Ag(I) and Pd(II)##3##3##(2008-10#3)
Ag(I) and##5##2##(2008-10#5)
Ag(I) by##2##2##(2008-10#2)
Ag(I)##21##1##(1996-2#1)(2008-10#20)
Ag-NOR and##2##2##(2008-12#2)
Ag-NOR##4##1##(1994-7#2)(2008-12#2)
Ag-stimulated##3##1##(1991-2#3)
Ag-zeolite (silver-exchanged zeolite)##2##3##(2008-5#2)
Ag-zeolite##8##1##(2008-5#8)
Ag/AgCl (saturated KCl)##2##3##(2008-10#2)
Ag/AgCl and##2##2##(2008-10#2)
Ag/AgCl electrode##4##2##(2008-10#4)
Ag/AgCl electrodes##2##2##(2008-10#2)
Ag/AgCl in##6##2##(2008-10#6)
Ag/AgCl reference electrode##8##3##(1991-5#1)(2008-10#7)
Ag/AgCl reference##14##2##(1991-5#1)(2008-10#13)
Ag/AgCl to detect##2##3##(2008-10#2)
Ag/AgCl to##3##2##(2008-10#3)
Ag/AgCl was##3##2##(2008-10#3)
Ag/AgCl##71##1##(1990-8#1)(1991-5#1)(2008-10#68)(2008-6#1)
Ag/AgCl) for##3##2##(2008-10#3)
Ag/AgCl) in##2##2##(2008-10#2)
Ag/AgCl)##28##1##(2007-12#1)(2008-10#26)(2010-4#1)
Ag/AgCl/KCl(s))##2##1##(2008-10#2)
Ag/Au core-shell and pure gold##2##5##(2008-10#2)
Ag/Au core-shell nanoparticles##3##3##(2008-10#3)
Ag/Au core-shell##5##2##(2008-10#5)
AgBr##3##1##(2008-2#1)(2008-3#2)
AgCl precipitates##2##2##(2008-10#2)
AgCl##3##1##(2008-10#3)
AgGaS(2) as a nonlinear medium##2##5##(2008-3#2)
AgGaS(2) crystal##4##2##(2007-11#1)(2008-2#3)
AgGaS(2)##12##1##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#4)
AgGaS2##2##1##(2008-2#1)(2008-3#1)
AgL##4##1##(2008-10#4)
AgMNPV polyhedra##2##2##(2008-11#2)
AgMNPV##5##1##(2008-11#5)
AgNOR##3##1##(1995-4#1)(2009-5#1)(2010-3#1)
AgOTf##3##1##(1997-7#1)(2010-3#1)(2012-3#1)
Again at day##2##3##(2008-12#2)
Again##15##1##(1991-8#1)(1992-3#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-4#1)
Against Botrytis cinerea##4##3##(2008-10#4)
Against Cancer##2##2##(2011-2#2)
Against Fusarium##2##2##(2008-10#2)
Against Rhizoctonia##2##2##(2008-10#2)
Against Stroke##2##2##(2008-8#2)
Against the backdrop of a dramatic increase in the number of individuals living longer##2##14##(2013-1#2)
Against the background of the##2##5##(2008-5#1)(2009-7#1)
Against the##11##2##(1995-2#1)(2008-10#6)(2008-5#1)(2009-7#1)(2013-1#2)
Against##60##1##(1991-6#1)(1992-5#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#37)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#2)(2009-8#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#3)
Agar##6##1##(1997-6#1)(2008-12#1)(2008-7#2)(2012-2#1)(2013-1#1)
Agaricus bisporus##6##2##(1997-1#2)(2008-10#3)(2011-1#1)
Agaricus##9##1##(1997-1#2)(2008-10#5)(2010-5#1)(2011-1#1)
Agarose gel electrophoresis##2##3##(2008-1#1)(2008-2#1)
Agarose gel##5##2##(1997-1#1)(2008-1#2)(2008-2#2)
Agarose##7##1##(1991-5#1)(1997-1#1)(2008-1#2)(2008-2#2)(2011-1#1)
Agave spp##2##2##(2009-8#2)
Agave##4##1##(2009-8#4)
Age adjusted incidence##2##3##(1994-12#1)(2008-4#1)
Age and##11##2##(1991-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)
Age as##2##2##(1994-5#1)(1996-8#1)
Age at first##2##3##(1990-9#1)(2009-5#1)
Age at sexual debut##2##4##(2011-1#2)
Age at##5##2##(1990-9#1)(2009-5#1)(2011-1#2)(2013-1#1)
Age effects##2##2##(2008-7#1)(2011-2#1)
Age for##2##2##(2008-10#1)(2013-8#1)
Age had a##2##3##(2008-7#1)(2009-7#1)
Age of women##2##3##(2010-3#2)
Age of##11##2##(1993-12#1)(1996-5#1)(2008-12#3)(2010-3#2)(2011-2#1)(2012-1#2)(2013-1#1)
Age related##2##2##(1994-3#1)(1994-6#1)
Age##81##1##(1990-3#1)(1990-8#1)(1990-9#2)(1991-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-8#1)(2007-10#1)(2007-12#1)(2008-1#4)(2008-10#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#4)(2009-10#1)(2009-5#1)(2009-7#5)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Age-Related Macular Degeneration (AMD)##2##4##(2011-2#2)
Age-Related Macular Degeneration##3##3##(2011-2#3)
Age-Related##4##1##(2011-2#3)(2013-7#1)
Age-matched##2##1##(1993-12#1)(1993-3#1)
Age-related changes in plasma##2##4##(2008-7#2)
Age-related changes in the##2##4##(1990-3#1)(2008-8#1)
Age-related changes in##10##3##(1990-3#1)(1991-12#1)(1995-8#1)(1996-9#1)(2008-7#5)(2008-8#1)
Age-related changes of##2##3##(1997-2#1)(2008-3#1)
Age-related changes##12##2##(1990-3#1)(1991-12#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-3#1)(2008-7#5)(2008-8#1)
Age-related differences in##2##3##(2008-11#2)
Age-related macular degeneration##2##3##(2010-12#1)(2010-2#1)
Age-related##32##1##(1990-11#1)(1990-3#2)(1991-12#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-9#1)(1997-2#2)(2008-11#2)(2008-3#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Age-specific##2##1##(1993-12#1)(1995-8#1)
Aged rats##2##2##(1992-12#1)(1994-8#1)
Aged##6##1##(1992-1#1)(1992-12#1)(1994-8#1)(2008-5#1)(2009-11#1)(2011-1#1)
Ageing##6##1##(1992-3#1)(1996-3#1)(2008-11#1)(2008-5#2)(2009-12#1)
Agelenopsis aperta##3##2##(1990-5#2)(1993-11#1)
Agence de la biomédecine##2##4##(2011-3#2)
Agence de la##3##3##(2011-3#3)
Agencies##6##1##(1996-12#1)(1996-3#4)(2008-11#1)
Agency and the##2##3##(1991-3#1)(2008-9#1)
Agency and##5##2##(1991-3#1)(1994-6#1)(1997-3#1)(2008-9#1)(2012-12#1)
Agency for Health##3##3##(1992-8#1)(1993-12#1)(2007-6#1)
Agency for the##3##3##(2008-10#2)(2008-7#1)
Agency for##13##2##(1992-11#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-6#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
Agency in##2##2##(2008-3#1)(2013-1#1)
Agency of##5##2##(2008-11#1)(2008-3#2)(2011-1#1)(2013-8#1)
Agency##61##1##(1991-3#1)(1992-1#1)(1992-11#1)(1992-8#2)(1993-12#1)(1994-2#1)(1994-6#1)(1995-3#2)(1997-2#1)(1997-3#2)(2007-6#1)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#7)(2008-7#3)(2008-9#4)(2009-4#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
Agency's##2##1##(1992-8#1)(2008-11#1)
Agenda for##3##2##(1995-1#1)(1995-3#1)(2009-10#1)
Agent of Potato##2##3##(2008-10#2)
Agent of##19##2##(2008-10#19)
Agent##39##1##(2008-1#1)(2008-10#33)(2008-9#2)(2010-8#1)(2012-2#1)(2013-1#1)
Agent-Based Models##2##2##(2010-5#2)
Agent-based models##3##2##(2010-5#2)(2010-9#1)
Agent-based##4##1##(2008-5#1)(2010-5#2)(2010-9#1)
Agents Chemother##2##2##(2008-5#1)(2008-7#1)
Agents for##2##2##(2009-10#1)(2009-6#1)
Agents in##2##2##(1994-7#1)(2011-2#1)
Agents that##3##2##(1991-9#1)(2008-5#1)(2010-12#1)
Agents##22##1##(1990-8#1)(1991-9#1)(1993-8#1)(1994-7#1)(1996-11#2)(2007-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2013-8#1)
Ageratum yellow vein China virus##2##5##(2008-10#2)
Ageratum yellow vein virus##2##4##(2008-10#2)
Ageratum yellow vein##4##3##(2008-10#4)
Ageratum##5##1##(2008-10#5)
Ages##4##1##(1997-8#1)(2009-10#1)(2013-8#2)
Aggregated resources and timing were estimated to obtain vital implementation sponsorship##2##11##(2012-2#2)
Aggregated##3##1##(1991-11#1)(2012-2#2)
Aggregation of##7##2##(1994-10#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)
Aggregation was##3##2##(1994-11#1)(2008-10#2)
Aggregation##15##1##(1994-10#1)(1994-11#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-9#1)(2009-11#1)
Aggression##4##1##(1995-2#1)(2008-10#1)(2008-11#2)
Aggressive fibromatosis##2##2##(2008-6#2)
Aggressive treatment##2##2##(1995-11#1)(2008-1#1)
Aggressive##12##1##(1993-6#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-6#2)(2008-8#1)(2012-3#3)(2013-1#1)(2013-8#1)
Aggressiveness of##5##2##(2008-10#5)
Aggressiveness##8##1##(2008-10#8)
Agilent##5##1##(2008-7#1)(2011-1#2)(2011-3#1)(2013-1#1)
Aging and##4##2##(1994-6#1)(2008-4#1)(2008-7#1)(2012-3#1)
Aging is associated with##2##4##(2011-2#1)(2013-1#1)
Aging is characterized by a##2##5##(2008-7#1)(2012-2#1)
Aging is##5##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
Aging of the##2##3##(1990-3#1)(1994-5#1)
Aging##40##1##(1990-3#1)(1991-12#1)(1993-12#2)(1994-2#1)(1994-5#4)(1994-6#4)(1995-3#1)(1997-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)
Agonis##2##1##(2010-3#2)
Agonist##5##1##(1993-6#1)(2008-4#2)(2008-5#1)(2012-1#1)
Agonist-induced down-regulation of##2##3##(1993-9#1)(2008-4#1)
Agonist-induced##3##1##(1992-12#1)(1993-9#1)(2008-4#1)
Agonists##3##1##(2007-8#1)(2011-1#1)(2012-2#1)
Agouti paca (Rodentia##2##3##(2008-5#2)
Agouti paca##3##2##(2008-5#3)
Agouti##4##1##(2008-5#3)(2013-7#1)
Agoutidae)##2##1##(2008-5#2)
Agrammatism##2##1##(2008-10#2)
Agreement between the##2##3##(2008-10#1)(2008-3#1)
Agreement between##6##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
Agreement is##2##2##(2008-10#2)
Agreement on##2##2##(1995-1#1)(1996-2#1)
Agreement with##2##2##(2007-12#1)(2008-2#1)
Agreement##17##1##(1995-1#1)(1996-2#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
Agric##2##1##(1995-6#1)(2008-10#1)
Agricultural Production-Crops establishments##3##3##(2008-12#3)
Agricultural Production-Crops##5##2##(2008-12#5)
Agricultural Research##3##2##(2008-12#1)(2008-7#1)(2010-10#1)
Agricultural University##2##2##(2008-12#2)
Agricultural##26##1##(1995-3#1)(2008-10#9)(2008-11#2)(2008-12#9)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-3#1)
Agriculture##18##1##(1990-11#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#2)
Agrobacterium radiobacter strain K84##2##4##(2008-10#2)
Agrobacterium radiobacter##3##2##(2008-10#3)
Agrobacterium rhizogenes##3##2##(1991-7#2)(2008-8#1)
Agrobacterium sp##2##2##(2008-6#2)
Agrobacterium tumefaciens cells##4##3##(2008-10#4)
Agrobacterium tumefaciens##16##2##(1990-5#2)(1997-2#1)(2008-10#9)(2008-9#2)(2011-2#2)
Agrobacterium tumefacients##2##2##(2008-10#2)
Agrobacterium vitis##3##2##(2008-10#3)
Agrobacterium##41##1##(1990-5#2)(1991-7#2)(1997-2#1)(2006-12#1)(2008-1#1)(2008-10#22)(2008-6#3)(2008-8#3)(2008-9#4)(2011-2#2)
Agrobacterium- mediated##2##2##(2008-8#2)
Agrobacterium-Mediated##2##1##(2008-10#2)
Agrobacterium-mediated transformation##3##2##(1997-2#1)(2008-10#1)(2011-1#1)
Agrobacterium-mediated##9##1##(1997-2#1)(2006-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2011-1#1)
Agromyzidae)##2##1##(2011-2#2)
Agropyron##3##1##(2008-12#1)(2008-9#2)
Ag|AgCl)##2##1##(2008-10#2)
Ah receptor in##2##3##(1992-12#1)(1993-12#1)
Ah receptor##10##2##(1992-12#2)(1992-8#2)(1993-11#2)(1993-12#2)(1995-11#1)(2008-10#1)
Ah receptor-dependent##2##2##(1992-8#1)(1993-12#1)
Ah##14##1##(1992-12#2)(1992-8#3)(1993-11#2)(1993-12#4)(1993-6#1)(1995-11#1)(2008-10#1)
AhR agonist##2##2##(1993-11#1)(2008-10#1)
AhR ligands##5##2##(2008-10#5)
AhR##18##1##(1993-11#4)(1993-6#2)(2008-10#12)
Ahead##2##1##(1994-3#1)(2010-8#1)
Ahvaz##4##1##(2008-12#3)(2013-1#1)
Ahx-beta##2##1##(1997-3#2)
Aib-rich peptides##2##2##(1995-2#2)
Aicardi syndrome is characterized by agenesis of the corpus callosum##2##10##(2011-1#1)(2011-2#1)
Aicardi syndrome##6##2##(2011-1#4)(2011-2#2)
Aicardi##7##1##(2011-1#5)(2011-2#2)
Aid to Families with Dependent Children (AFDC)##2##7##(1996-1#1)(1996-12#1)
Aid to Families with Dependent Children##4##6##(1992-2#1)(1996-1#1)(1996-12#1)(1996-3#1)
Aid##8##1##(1992-2#1)(1994-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2012-12#1)(2013-1#1)
Aided##2##1##(2008-9#1)(2009-5#1)
Aim and##2##2##(2010-10#1)(2010-8#1)
Aim of the present investigation was to##2##7##(2008-4#2)
Aim of the present study##2##5##(2011-2#1)(2013-1#1)
Aim of the present##5##4##(2008-11#1)(2008-4#2)(2011-2#1)(2013-1#1)
Aim of the study was to##2##6##(2008-12#1)(2012-3#1)
Aim of the study##3##4##(2008-12#1)(2012-3#2)
Aim of the##8##3##(2008-11#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-3#2)(2013-1#1)
Aim of this article is to##2##6##(2011-2#1)(2012-3#1)
Aim of this study is to##2##6##(2008-12#1)(2011-2#1)
Aim of this study is##3##5##(2008-12#1)(2011-2#1)(2013-1#1)
Aim of this study was to evaluate the##2##8##(2008-7#1)(2011-2#1)
Aim of this study was to evaluate##3##7##(2008-7#1)(2011-2#1)(2013-1#1)
Aim of this study was to##8##6##(2008-4#1)(2008-7#1)(2011-2#3)(2011-7#1)(2012-7#1)(2013-1#1)
Aim of this study##11##4##(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#4)(2011-7#1)(2012-7#1)(2013-1#2)
Aim of this##16##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-3#1)(2012-7#1)(2013-1#2)
Aim of##26##2##(1991-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-3#4)(2012-7#1)(2013-1#3)
Aim##118##1##(1991-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#2)(2009-7#2)(2010-10#11)(2010-8#1)(2011-1#3)(2011-2#11)(2011-7#1)(2012-12#7)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#43)(2013-8#13)
Aiming at##5##2##(2007-8#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
Aiming to##3##2##(2008-10#3)
Aiming##8##1##(2007-8#1)(2008-10#3)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
Aims and objectives##2##3##(2010-10#2)
Aims##25##1##(2007-11#2)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#7)(2013-8#5)
Aim  To examine##2##3##(2012-3#2)
Aim  To##4##2##(2012-3#4)
Ain Shams University hospitals and##2##5##(2008-10#2)
Ain Shams University hospitals##3##4##(2008-10#3)
Aini minority##2##2##(2011-1#2)
Aini population##3##2##(2011-1#3)
Aini##9##1##(2008-10#1)(2011-1#8)
Air Force##4##2##(1995-5#1)(2008-3#2)(2012-3#1)
Air samples were##2##3##(2010-4#1)(2013-8#1)
Air travel and##3##3##(2008-10#1)(2008-11#2)
Air##26##1##(1992-9#1)(1995-5#1)(1996-12#1)(1997-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-6#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
Airborne Lidar LEANDRE II for Water-Vapor Profiling in the Troposphere##2##10##(2008-3#2)
Airborne Simulator (MAS)##2##3##(2008-3#2)
Airborne laser-induced##3##2##(2008-2#3)
Airborne##25##1##(2007-5#1)(2008-10#4)(2008-2#5)(2008-3#13)(2012-7#1)(2013-1#1)
Aircraft##2##1##(2008-3#1)(2009-9#1)
Aires##13##1##(2008-5#4)(2009-10#5)(2009-7#3)(2013-7#1)
Airway management##3##2##(1993-10#1)(2010-7#1)(2011-1#1)
Airway##6##1##(1993-10#1)(1997-2#1)(2007-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
Airy##14##1##(2007-11#4)(2008-2#7)(2008-3#3)
Aitaiyin 2##2##2##(2008-9#2)
Akaike Information Criterion##2##3##(2008-6#1)(2008-9#1)
Akaike##5##1##(1995-11#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)
Aker Hospital##2##2##(1992-9#1)(1995-6#1)
Aker##3##1##(1990-11#1)(1992-9#1)(1995-6#1)
Akin osteotomy##2##2##(2010-3#2)
Akt activation##2##2##(2008-1#1)(2009-9#1)
Akt and##3##2##(2010-1#2)(2011-1#1)
Akt##18##1##(2008-1#1)(2008-10#1)(2009-5#5)(2009-9#1)(2010-1#2)(2010-12#1)(2011-1#4)(2013-1#3)
Al (2)O (3)##2##3##(2007-12#2)
Al amendment##3##2##(2008-10#3)
Al and Fe##2##3##(2008-10#2)
Al and##6##2##(2007-11#1)(2008-10#5)
Al are##2##2##(1996-12#1)(2008-3#1)
Al by##2##2##(2008-10#2)
Al concentration##3##2##(1996-12#1)(2008-10#2)
Al concentrations were##2##3##(2007-12#1)(2008-10#1)
Al concentrations##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
Al for##3##2##(1995-6#2)(2008-10#1)
Al from##3##2##(2008-10#3)
Al g(-1) of medium##2##4##(2008-10#2)
Al g(-1)##3##2##(2008-10#2)(2009-8#1)
Al have been##2##3##(2008-10#2)
Al in hemodialysis solutions was##2##5##(2008-10#2)
Al in the##4##3##(1996-12#2)(2009-8#1)(2013-8#1)
Al in##16##2##(1996-12#2)(2008-10#12)(2009-8#1)(2013-8#1)
Al is##5##2##(2008-10#1)(2008-2#2)(2013-8#2)
Al levels##6##2##(1996-12#2)(2008-10#4)
Al species##7##2##(2008-10#7)
Al toxicity##2##2##(2008-10#1)(2012-2#1)
Al##175##1##(1995-6#4)(1996-12#11)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#120)(2008-2#4)(2008-3#5)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#5)(2010-3#1)(2010-5#1)(2012-2#4)(2013-8#10)
Al(2)(SO(4))(3) solution at##2##3##(2008-10#2)
Al(2)(SO(4))(3)##6##1##(2008-10#6)
Al(2)O(3) laser##5##2##(2007-11#4)(2007-12#1)
Al(2)O(3)##11##1##(2007-11#4)(2007-12#3)(2008-10#4)
Al(2)O(3))##2##1##(2007-12#1)(2008-10#1)
Al(2)O(3)-AChE biosensor##2##2##(2008-10#2)
Al(2)O(3)-CaSO(4)##4##1##(2008-10#4)
Al(3+) and##5##2##(2008-10#5)
Al(3+) ion##2##2##(2008-10#2)
Al(3+)##21##1##(2007-11#1)(2008-10#20)
Al(III) and Fe(III) were##2##4##(2008-10#2)
Al(III) and Fe(III)##8##3##(2008-10#8)
Al(III) and##15##2##(2008-10#15)
Al(III) in##3##2##(2008-10#3)
Al(III) ion##2##2##(2008-10#2)
Al(III)##39##1##(2008-10#39)
Al(OH)(4)(-)##3##1##(2008-10#3)
Al)##6##1##(1992-11#1)(2008-10#4)(2008-2#1)
Al-Hassa##2##1##(2008-12#2)
Al-Khadoud##2##1##(2008-12#2)
Al-citrate in##4##2##(2008-10#4)
Al-citrate##13##1##(2008-10#13)
Al-injured##2##1##(2012-2#2)
Al-mediated suppression of plant pathogens##2##5##(2008-10#2)
Al-tetrabromophthalate##2##1##(2008-10#2)
Al-treated cells##3##2##(2009-6#3)
Al-treated##4##1##(2009-6#4)
Al/MgF(2)/Mo multilayer coatings##2##3##(2008-3#2)
Al2O3##7##1##(2008-12#1)(2008-2#1)(2008-3#3)(2009-8#2)
AlCl(3) and##2##2##(2008-10#1)(2008-11#1)
AlCl(3) is##2##2##(2009-2#1)(2013-1#1)
AlCl(3)##11##1##(1996-2#1)(2008-10#1)(2008-11#1)(2009-2#2)(2013-1#6)
AlCl3##4##1##(1993-3#2)(2008-10#2)
AlF-A1##2##1##(1990-12#2)
AlGaAs laser diode##2##3##(2007-12#2)
AlGaAs laser##3##2##(2007-12#2)(2008-2#1)
AlGaAs waveguide##2##2##(2007-12#1)(2008-2#1)
AlGaAs##12##1##(2007-12#7)(2008-2#4)(2008-3#1)
AlGaAs-based air-bridge-type two-dimensional##2##3##(2007-11#2)
AlGaInP##2##1##(2007-12#2)
AlH(3)##3##1##(1996-2#3)
AlMV##2##1##(2008-10#2)
Ala at##2##2##(1991-6#1)(1995-2#1)
Ala enzyme##6##2##(1995-6#6)
Ala mutation##4##2##(1992-6#3)(1995-6#1)
Ala##44##1##(1990-11#2)(1990-5#2)(1990-7#2)(1991-6#1)(1992-3#4)(1992-4#2)(1992-6#6)(1992-8#3)(1993-11#1)(1993-3#1)(1994-5#2)(1995-2#3)(1995-3#1)(1995-6#9)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
Ala)##4##1##(1990-5#1)(1991-12#1)(1993-2#1)(1993-8#1)
Ala-##3##1##(1991-5#3)
Ala-161 in the E##2##4##(1993-6#2)
Ala-161--&gt##2##1##(1993-6#2)
Ala-Pro##2##1##(1992-6#1)(1994-11#1)
Ala147Thr SNP##3##2##(2012-2#3)
Ala147Thr##4##1##(2012-2#4)
Alabama##10##1##(1992-12#1)(1997-2#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)
Alain C##2##2##(1993-12#2)
Alain##3##1##(1993-12#2)(2007-12#1)
Alajuela##3##1##(2008-5#3)
Alamine 336##2##2##(2008-10#2)
Alan C##2##2##(1994-1#2)
Alan##3##1##(1994-1#2)(2008-7#1)
Alanine aminotransferase##2##2##(2008-10#1)(2012-3#1)
Alanine##4##1##(1993-11#1)(2008-10#2)(2012-3#1)
Alaska##6##1##(1996-12#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
Alaskan Native people infected with##2##5##(2013-1#2)
Alb method##3##2##(2008-7#3)
Albania##4##1##(1995-3#1)(2011-2#3)
Albanian immigration##2##2##(2008-10#2)
Albanian##8##1##(2008-10#5)(2008-12#1)(2011-2#2)
Albanians##2##1##(2008-10#2)
Albany##3##1##(1991-3#1)(2006-12#1)(2013-1#1)
Alberta Health and Wellness##2##4##(2012-12#2)
Alberta Health##5##2##(1996-2#2)(2012-12#2)(2012-2#1)
Alberta and British Columbia##2##4##(2008-10#1)(2010-8#1)
Alberta and Ontario##2##3##(1995-2#1)(2007-12#1)
Alberta and##7##2##(1995-12#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-8#1)
Alberta hospitals##4##2##(1995-1#2)(1995-12#1)(2012-12#1)
Alberta##51##1##(1992-12#5)(1992-3#1)(1993-12#5)(1993-3#2)(1994-1#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#2)(1996-1#4)(1996-2#2)(1996-3#1)(1997-2#2)(2007-12#2)(2008-10#3)(2008-11#3)(2008-12#1)(2010-8#1)(2012-12#7)(2012-2#2)
Alberta's##4##1##(1993-3#1)(1996-2#1)(2012-2#2)
Albicidin##2##1##(2008-10#2)
Albino##7##1##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)
Albitarsis##2##1##(2007-12#1)(2012-12#1)
Alboaggregin-B##2##1##(1993-3#2)
Albright hereditary osteodystrophy (AHO)##2##4##(2010-6#1)(2011-1#1)
Albugo candida##3##2##(2008-10#3)
Albumin##9##1##(1991-12#1)(1991-5#1)(1992-9#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
Albuminuria and neuropathy##2##3##(2012-2#2)
Albuminuria##3##1##(2012-2#3)
Alcaligenes eutrophus##6##2##(2008-6#4)(2008-7#2)
Alcaligenes##8##1##(2008-6#5)(2008-7#2)(2012-3#1)
Alcian##3##1##(1991-1#1)(2008-7#1)(2011-2#1)
Alcohol Dependence##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
Alcohol Screening##2##2##(2008-11#1)(2013-1#1)
Alcohol Use##3##2##(2010-9#1)(2012-12#1)(2013-8#1)
Alcohol abuse##2##2##(2011-2#1)(2012-12#1)
Alcohol addiction##2##2##(2013-7#1)(2013-8#1)
Alcohol and##7##2##(1992-5#1)(1993-7#1)(1994-2#1)(2008-6#1)(2009-9#2)(2012-12#1)
Alcohol consumption was##2##3##(2009-9#1)(2013-1#1)
Alcohol consumption##5##2##(1990-2#1)(1991-8#1)(1995-11#1)(2009-9#1)(2013-1#1)
Alcohol dependence is a complex##2##5##(2009-10#1)(2013-8#1)
Alcohol dependence is##3##3##(2009-10#1)(2012-2#1)(2013-8#1)
Alcohol is##4##2##(1990-8#1)(1995-8#1)(2008-4#1)(2009-7#1)
Alcohol oxidase##2##2##(1991-5#1)(2008-10#1)
Alcohol sensing##2##2##(2008-10#2)
Alcohol use disorders are##2##4##(2009-12#1)(2012-3#1)
Alcohol use disorders##3##3##(2008-11#1)(2009-12#1)(2012-3#1)
Alcohol use##5##2##(2008-11#2)(2008-7#1)(2009-12#1)(2012-3#1)
Alcohol##63##1##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-8#1)(2008-10#7)(2008-11#7)(2008-4#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#3)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#6)
Alcoholic##4##1##(2006-10#1)(2009-7#1)(2012-12#1)(2012-3#1)
Alcoholism is a complex##2##4##(2008-6#1)(2012-2#1)
Alcoholism##4##1##(1994-6#1)(2008-2#1)(2008-6#1)(2012-2#1)
Alcohols##4##1##(1996-5#1)(2008-8#1)(2009-6#1)(2009-8#1)
Aldehyde##4##1##(1994-12#1)(2009-12#1)(2010-12#1)(2010-7#1)
Aldehydes##2##1##(1992-5#1)(1996-5#1)
Aldol##4##1##(1996-5#4)
Aldolase##2##1##(1993-8#2)
Aldose reductase inhibitors##3##3##(1994-8#1)(2007-7#1)(2013-1#1)
Aldose reductase##5##2##(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
Aldosterone##5##1##(1995-12#1)(2008-4#2)(2008-8#1)(2010-12#1)
Alefacept##2##1##(2008-5#2)
Alendronate##3##1##(1995-11#1)(1997-6#1)(2008-8#1)
Aleochara curtula##2##2##(2007-12#2)
Aleochara##6##1##(2007-12#4)(2008-7#2)
Alert##8##1##(1991-12#2)(2008-11#3)(2008-3#1)(2008-6#1)(2008-8#1)
Alex##2##1##(2008-5#1)(2010-11#1)
Alexander##6##1##(1992-3#1)(1995-6#1)(2007-11#1)(2008-7#1)(2012-12#2)
Alexandria University##3##2##(2008-10#3)
Alexandria##5##1##(2008-10#4)(2013-8#1)
Alexis Boyer##2##2##(2007-5#2)
Alfalfa mosaic virus (AMV)##2##4##(2008-10#2)
Alfalfa mosaic virus in##4##4##(2008-10#4)
Alfalfa mosaic virus##9##3##(2008-10#9)
Alfalfa##14##1##(2008-10#14)
Alfred Taubman Medical Library##2##4##(1991-3#1)(1995-1#1)
Alfred##6##1##(1991-3#1)(1995-1#1)(2007-10#2)(2008-7#2)
Alfredson##2##1##(1993-1#1)(1993-3#1)
Algebraic##3##1##(2007-12#1)(2008-2#1)(2011-1#1)
Algeria##5##1##(1996-6#1)(2010-1#4)
Algerian##2##1##(2010-1#2)
Alginate pellets##2##2##(2008-10#2)
Alginate##4##1##(2008-10#2)(2008-7#1)(2008-8#1)
Algorithm for the##2##3##(2008-2#1)(2011-10#1)
Algorithm for##7##2##(2008-10#1)(2008-2#2)(2008-3#1)(2009-9#1)(2011-10#1)(2013-1#1)
Algorithm##18##1##(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#2)(2009-9#1)(2010-8#2)(2011-10#1)(2013-1#1)
Algorithms are##2##2##(2009-5#1)(2011-1#1)
Algorithms for##9##2##(1996-12#1)(2008-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Algorithms##16##1##(1996-12#2)(1996-3#1)(1997-1#1)(2008-2#1)(2008-3#4)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Alienation##2##1##(2009-7#1)(2011-2#1)
Aligned##3##1##(1996-1#1)(2008-7#1)(2009-9#1)
Aligning Forces for Quality (AF4Q) alliances##2##6##(2013-1#2)
Aligning Forces for Quality (AF4Q) initiative is the##2##8##(2013-1#2)
Aligning Forces for Quality (AF4Q) initiative##3##6##(2013-1#3)
Aligning Forces for Quality (AF4Q)##5##5##(2013-1#5)
Aligning Forces for Quality##7##4##(2013-1#7)
Aligning##8##1##(1993-2#1)(2013-1#7)
Alignment of the##3##3##(1990-11#1)(1994-12#1)(2007-12#1)
Alignment of##7##2##(1990-11#1)(1990-7#1)(1992-3#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-3#1)
Alignment##15##1##(1990-11#1)(1990-7#1)(1992-3#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-6#1)(2013-1#2)
Aliphatic##3##1##(1996-5#2)(2008-11#1)
Aliquots of##3##2##(2008-10#3)
Aliquots##4##1##(1994-3#1)(2008-10#3)
Alizarin Red S (ARS)##4##4##(2008-10#4)
Alizarin Red S in##2##4##(2008-10#2)
Alizarin Red S##12##3##(2008-10#10)(2008-11#2)
Alizarin Red##13##2##(2008-10#11)(2008-11#2)
Alizarin##14##1##(2008-10#12)(2008-11#2)
AlkB##3##1##(1994-12#3)
Alkali Blue 6B##2##3##(2008-10#2)
Alkali Blue 6B-attached##3##3##(2008-10#3)
Alkali Blue##5##2##(2008-10#5)
Alkaline phosphatase##3##2##(1990-12#1)(2008-10#2)
Alkaline##10##1##(1990-12#1)(1990-5#1)(1994-9#1)(2008-10#4)(2008-11#1)(2013-1#2)
Alkyl Radicals##3##2##(1996-5#2)(2009-5#1)
Alkyl##7##1##(1996-5#2)(2009-5#2)(2009-8#1)(2011-1#1)(2012-2#1)
Alkylation of##2##2##(1996-2#1)(2008-11#1)
Alkylation##4##1##(1996-2#2)(2008-1#1)(2008-11#1)
All 11 patients##2##3##(1992-11#1)(2008-10#1)
All 11##3##2##(1992-11#1)(1995-11#1)(2008-10#1)
All 13##2##2##(2008-7#2)
All 15##2##2##(2011-1#1)(2012-3#1)
All 3 patients##2##3##(2007-10#1)(2008-7#1)
All 3##5##2##(2007-10#1)(2008-11#2)(2008-7#2)
All 4##2##2##(2007-5#1)(2008-7#1)
All 5##3##2##(2008-2#1)(2010-8#1)(2011-2#1)
All 6 patients had##2##4##(2008-1#1)(2008-10#1)
All 62 patients##2##3##(2008-7#1)(2009-10#1)
All 7 patients##2##3##(2007-11#1)(2008-3#1)
All Kids Count##2##3##(1996-12#2)
All Nations Breath of Life##2##5##(2011-2#2)
All analyses were##2##3##(1994-8#1)(2012-2#1)
All analyses##4##2##(1994-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
All animals survived to the end of the study##2##9##(2008-9#2)
All animals were##3##3##(1996-12#1)(2008-7#1)(2009-4#1)
All animals##12##2##(1993-1#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-9#2)(2009-4#1)(2010-4#1)
All biopsies were##2##3##(2008-1#1)(2010-12#1)
All but four of the##2##5##(1994-12#1)(1994-6#1)
All but four##3##3##(1992-3#1)(1994-12#1)(1994-6#1)
All but one of the isolates##2##6##(2008-10#2)
All but one of the##7##5##(1992-3#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-11#1)
All but one of##8##4##(1990-2#1)(1992-3#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-11#1)
All but one patient##2##4##(2006-10#1)(2008-11#1)
All but one##16##3##(1990-2#1)(1991-2#1)(1992-3#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)
All but two##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
All but##23##2##(1990-2#1)(1991-2#1)(1992-3#2)(1992-8#1)(1994-12#1)(1994-6#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2012-12#1)
All cases of##2##3##(2011-2#1)(2013-8#1)
All cases were##2##3##(1991-8#1)(2008-11#1)
All cases##7##2##(1991-8#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
All chemical##2##2##(2008-10#2)
All children##5##2##(2007-8#1)(2008-12#1)(2008-6#1)(2009-8#1)(2013-7#1)
All clones##2##2##(2008-10#1)(2008-11#1)
All combinations of##2##3##(1993-11#1)(2008-10#1)
All complications were##2##3##(1991-3#1)(1994-3#1)
All components##2##2##(1992-8#1)(2008-10#1)
All compounds##7##2##(1990-7#1)(1991-3#1)(1992-12#1)(1995-11#2)(1997-4#1)(2011-2#1)
All data##2##2##(2008-10#1)(2011-2#1)
All determinations were done##2##4##(2008-10#1)(2008-5#1)
All devices##3##2##(1992-3#1)(2008-3#1)(2008-9#1)
All dogs were fed##2##4##(2008-10#2)
All eight##2##2##(2008-10#2)
All enrolled##2##2##(2008-3#1)(2008-5#1)
All except##4##2##(1993-8#1)(1997-8#1)(2008-10#2)
All experiments were##2##3##(2008-10#2)
All extracts##2##2##(2008-10#1)(2008-12#1)
All facilities##2##2##(1991-3#1)(2007-12#1)
All five patients##2##3##(2009-12#1)(2013-1#1)
All five##9##2##(1991-4#1)(1993-3#1)(1996-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#2)(2013-1#1)
All forms##2##2##(1990-5#1)(2009-10#1)
All four groups##2##3##(1993-3#1)(2008-10#1)
All four species##2##3##(2008-10#2)
All four##14##2##(1993-3#1)(1995-5#1)(1995-6#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)
All genotypes##2##2##(2008-10#2)
All grafts##2##2##(2007-7#1)(2007-8#1)
All groups##5##2##(1994-3#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-12#1)
All had##6##2##(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-1#1)(2012-3#1)
All have##3##2##(1990-2#1)(1995-2#2)
All in##2##2##(1990-9#1)(1994-2#1)
All information##2##2##(1994-8#1)(2008-5#1)
All inoculated##2##2##(2008-10#2)
All interviews were##2##3##(1993-9#1)(2011-1#1)
All investigated##2##2##(2008-10#1)(2008-5#1)
All isolates from##2##3##(2008-10#2)
All isolates in##2##3##(2008-10#2)
All isolates produced##4##3##(2008-10#4)
All isolates were##7##3##(2007-7#1)(2008-10#3)(2009-10#1)(2010-8#1)(2012-2#1)
All isolates##26##2##(2007-7#1)(2008-10#20)(2008-5#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#1)
All known##6##2##(1990-3#1)(1990-8#1)(1992-4#1)(2007-12#1)(2008-12#1)(2008-7#1)
All lines##2##2##(2008-10#2)
All loci##2##2##(2008-12#2)
All males and##2##3##(2008-9#1)(2012-2#1)
All measurements were##4##3##(2008-10#2)(2010-12#1)(2013-8#1)
All measurements##6##2##(2008-10#3)(2008-3#1)(2010-12#1)(2013-8#1)
All measures of##3##3##(2008-10#2)(2013-1#1)
All members##2##2##(1996-2#1)(2011-2#1)
All methods##3##2##(2008-10#2)(2008-3#1)
All mice survived to the end of the study##2##9##(2008-9#2)
All mutant##2##2##(1993-3#1)(1995-6#1)
All new##3##2##(2007-11#1)(2008-4#1)(2008-8#1)
All nine##2##2##(1992-12#1)(2008-10#1)
All of the isolates##2##4##(1997-4#1)(2008-10#1)
All of the patients##4##4##(1990-6#1)(2008-4#1)(2011-1#1)(2013-1#1)
All of the samples##2##4##(2008-11#1)(2008-12#1)
All of the three##2##4##(1996-5#1)(2011-2#1)
All of the variables have been optimized and the##2##9##(2008-10#2)
All of the##46##3##(1990-12#2)(1990-6#1)(1992-12#1)(1992-8#4)(1993-11#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-5#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
All of them had##3##4##(2007-2#1)(2007-7#1)(2011-1#1)
All of them underwent##2##4##(2008-1#1)(2008-3#1)
All of them were##4##4##(1990-2#1)(1997-3#1)(2011-2#1)(2013-1#1)
All of them##14##3##(1990-2#1)(1996-2#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
All of these cell##2##4##(1993-3#1)(2008-4#1)
All of these disorders##2##4##(2008-6#2)
All of these##26##3##(1993-1#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
All of##91##2##(1990-12#2)(1990-2#1)(1990-6#1)(1992-12#1)(1992-8#4)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
All other important analytical parameters were studied and practical applicability of the method has been verified by the analysis of some biological materials##2##23##(2008-10#2)
All other patients##3##3##(1991-11#1)(2011-2#1)(2012-2#1)
All other##10##2##(1991-11#1)(1993-8#1)(1996-3#1)(2007-6#1)(2008-10#2)(2009-9#1)(2011-2#2)(2012-2#1)
All participants completed##2##3##(2010-4#1)(2013-1#1)
All participants in the##2##4##(1991-8#1)(1997-8#1)
All participants underwent##2##3##(2011-2#1)(2012-3#1)
All participants were##2##3##(2010-11#1)(2012-2#1)
All participants##12##2##(1991-8#1)(1997-8#1)(2008-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
All pathology##2##2##(2006-8#2)
All patient##2##2##(2007-11#1)(2008-1#1)
All patients are alive and##2##5##(1992-5#1)(2007-8#1)
All patients are##4##3##(1992-4#1)(1992-5#2)(2007-8#1)
All patients had been##3##4##(2008-5#1)(2008-9#1)(2012-3#1)
All patients had##16##3##(1991-4#1)(1991-8#1)(1995-11#1)(2007-10#2)(2007-7#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-3#2)
All patients have##2##3##(2007-8#2)
All patients in##3##3##(1996-2#1)(2008-5#1)(2012-3#1)
All patients made##2##3##(1994-2#1)(2006-12#1)
All patients presented##2##3##(1992-4#1)(2008-9#1)
All patients received##4##3##(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)
All patients showed##4##3##(1990-3#1)(1993-3#1)(1994-11#1)(2008-3#1)
All patients survived##3##3##(1990-2#1)(1992-5#1)(2011-2#1)
All patients underwent##13##3##(1992-12#1)(1995-10#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
All patients were followed##3##4##(1996-1#1)(2008-11#1)(2013-1#1)
All patients were given##2##4##(1991-5#1)(2007-11#1)
All patients were prescribed##2##4##(2010-12#1)(2012-2#1)
All patients were treated with##7##5##(1995-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2011-1#1)
All patients were treated##11##4##(1991-8#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-3#1)
All patients were##49##3##(1991-5#1)(1991-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-7#4)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
All patients who##2##3##(1995-11#1)(2008-7#1)
All patients with##5##3##(1995-10#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
All patients##137##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-4#2)(1992-5#4)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#7)(2007-11#4)(2007-7#8)(2007-8#9)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#3)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#13)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#8)(2013-7#1)
All peptides##2##2##(1990-2#1)(1994-11#1)
All physicians##2##2##(1996-1#1)(2008-4#1)
All plants were##2##3##(2008-10#2)
All populations##2##2##(2008-10#2)
All rats survived to the end of the study##4##9##(2008-9#4)
All rats##9##2##(1993-12#1)(2007-10#1)(2008-10#2)(2008-9#4)(2011-2#1)
All reagents##2##2##(2008-10#2)
All received##2##2##(2007-8#1)(2011-2#1)
All reflectance measurements were carried out##2##6##(2008-10#2)
All relevant##2##2##(2007-11#1)(2008-3#1)
All reported cases had##2##4##(2008-1#1)(2011-1#1)
All residents aged 40-42 were invited##2##6##(1991-6#2)
All residents##3##2##(1991-6#2)(2012-1#1)
All respondents were##2##3##(2008-9#1)(2013-1#1)
All results obtained for##2##4##(2008-10#2)
All results obtained##3##3##(2008-10#3)
All results##7##2##(2008-10#4)(2008-3#1)(2011-2#1)(2013-8#1)
All samples collected##2##3##(2008-12#1)(2008-5#1)
All samples were##2##3##(1992-12#1)(2008-10#1)
All samples##8##2##(1992-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
All selected##2##2##(2007-10#1)(2011-2#1)
All seven##3##2##(1992-11#1)(2008-10#1)(2008-5#1)
All six isolates##2##3##(2008-10#1)(2008-5#1)
All six##8##2##(1992-3#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-5#1)
All species##3##2##(1996-1#1)(2012-2#1)(2012-5#1)
All specimens were##2##3##(2008-5#1)(2009-7#1)
All specimens##4##2##(2007-12#1)(2008-5#1)(2008-8#1)(2009-7#1)
All strains grew##2##3##(2008-10#1)(2010-4#1)
All strains produced##2##3##(2008-10#2)
All strains were##5##3##(2008-10#5)
All strains##17##2##(2008-10#13)(2008-5#2)(2009-5#1)(2010-4#1)
All studies##4##2##(2007-12#1)(2008-7#1)(2012-3#2)
All study patients were seen during each dialysis session by a physician and the occurrence of intra-dialytic symptoms were recorded##2##20##(2007-7#1)(2008-1#1)
All study subjects##2##3##(2006-8#1)(2011-2#1)
All study##4##2##(2006-8#1)(2007-7#1)(2008-1#1)(2011-2#1)
All subjects had##2##3##(1996-12#1)(1996-5#1)
All subjects underwent##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
All subjects were examined##2##4##(2012-3#1)(2013-1#1)
All subjects were males##2##4##(2007-7#1)(2011-2#1)
All subjects were##7##3##(1993-12#1)(2007-7#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
All subjects##22##2##(1990-12#1)(1991-12#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-8#2)(2011-2#3)(2012-3#2)(2013-1#2)
All systems##2##2##(2008-10#1)(2010-3#1)
All ten patients##2##3##(1990-10#1)(2007-7#1)
All ten##3##2##(1990-10#1)(2007-7#1)(2008-12#1)
All tested isolates##2##3##(2008-10#1)(2008-12#1)
All tested##9##2##(1992-9#1)(1995-12#2)(2008-10#3)(2008-12#1)(2009-9#1)(2010-1#1)
All tests##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
All the above##2##3##(2008-6#1)(2013-8#1)
All the children##2##3##(2008-9#2)
All the compounds##3##3##(1994-8#1)(2008-10#2)
All the cultivars##2##3##(2008-10#2)
All the experimental parameters were optimized for the determination of##2##10##(2008-10#2)
All the experimental##3##3##(2008-10#3)
All the extracts were##2##4##(2008-10#1)(2008-5#1)
All the films were found to be amorphous##2##8##(2008-10#2)
All the five##2##3##(2008-1#1)(2013-1#1)
All the formulations##2##3##(2008-5#2)
All the four##2##3##(2007-7#1)(2008-10#1)
All the images##2##3##(2008-3#1)(2012-3#1)
All the isolates were##5##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
All the isolates##8##3##(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2011-2#2)
All the parameters##2##3##(2008-10#2)
All the patients recovered##2##4##(1997-6#1)(2007-8#1)
All the patients underwent##2##4##(1997-8#1)(2008-4#1)
All the patients were followed up for##2##7##(2007-7#1)(2013-8#1)
All the patients were##9##4##(1990-12#1)(1990-9#1)(1993-1#1)(2007-7#1)(2008-4#2)(2012-2#1)(2013-7#1)(2013-8#1)
All the patients##19##3##(1990-12#1)(1990-9#1)(1992-5#1)(1993-1#1)(1995-11#1)(1997-6#1)(1997-8#1)(2007-7#3)(2007-8#1)(2008-4#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
All the procedures were##2##4##(1996-3#1)(2011-3#1)
All the procedures##4##3##(1996-3#1)(2008-7#1)(2009-8#1)(2011-3#1)
All the resources needed for these protocols are accessible via publicly available Web servers and databases and require little or no computational expertise##2##23##(2008-2#1)(2008-4#1)
All the results are##2##4##(2007-12#1)(2008-3#1)
All the results obtained##2##4##(2008-10#2)
All the results##8##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#3)(2012-3#1)
All the samples##2##3##(2007-7#1)(2008-5#1)
All the species##2##3##(2008-12#1)(2008-5#1)
All the strains were##2##4##(1996-12#1)(2007-10#1)
All the strains##3##3##(1996-12#1)(2007-10#1)(2008-5#1)
All the subjects##2##3##(2008-5#1)(2013-8#1)
All the synthesized compounds were tested for their##2##8##(2008-4#1)(2008-5#1)
All the synthesized compounds##3##4##(2007-11#1)(2008-4#1)(2008-5#1)
All the three##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
All the variables##2##3##(2008-10#2)
All the##193##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-9#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1993-1#1)(1993-12#4)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#7)(2007-8#2)(2008-1#1)(2008-10#39)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#7)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#7)
All these complexes##2##3##(2008-5#2)
All these effects##2##3##(1990-6#1)(2008-10#1)
All these features##2##3##(1991-9#1)(2008-10#1)
All these observations##2##3##(2008-10#1)(2009-10#1)
All these results##7##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)
All these were##2##3##(2008-2#1)(2012-2#1)
All these##51##2##(1990-6#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#2)
All this##4##2##(2007-12#1)(2008-9#1)(2009-3#1)(2011-2#1)
All those##2##2##(1995-2#1)(2008-10#1)
All three are##4##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
All three assessment##2##3##(2007-8#1)(2008-10#1)
All three had##2##3##(1991-12#1)(1997-5#1)
All three patients##4##3##(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)
All three species were##2##4##(2008-10#1)(2013-7#1)
All three species##3##3##(2007-12#1)(2008-10#1)(2013-7#1)
All three strains##2##3##(2008-10#2)
All three##45##2##(1990-7#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-2#2)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
All together now##2##3##(2010-11#1)(2010-8#1)
All together##3##2##(1990-8#1)(2010-11#1)(2010-8#1)
All treatment##2##2##(1991-2#1)(2008-6#1)
All treatments were##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
All treatments##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
All types of##3##3##(1996-6#1)(2008-7#1)(2013-1#1)
All variables were studied##2##4##(2008-10#2)
All variables were##3##3##(2008-10#3)
All variables##4##2##(2008-10#3)(2009-7#1)
All were##14##2##(1991-11#1)(1997-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
All##1291##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#8)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#8)(1992-4#3)(1992-5#10)(1992-6#3)(1992-8#7)(1992-9#7)(1993-1#3)(1993-11#7)(1993-12#9)(1993-2#2)(1993-3#7)(1993-6#4)(1993-8#3)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#12)(1995-12#10)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#6)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#8)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#6)(2006-10#3)(2006-12#2)(2006-6#1)(2006-8#3)(2007-10#19)(2007-11#16)(2007-12#18)(2007-2#3)(2007-5#2)(2007-6#3)(2007-7#29)(2007-8#26)(2007-9#5)(2008-1#11)(2008-10#270)(2008-11#26)(2008-12#24)(2008-2#7)(2008-3#28)(2008-4#19)(2008-5#49)(2008-6#12)(2008-7#44)(2008-8#17)(2008-9#44)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#7)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#8)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#18)(2011-10#1)(2011-2#67)(2011-3#3)(2012-1#2)(2012-12#11)(2012-2#24)(2012-3#26)(2012-5#1)(2013-1#45)(2013-7#8)(2013-8#19)
All-Solid-State##3##1##(2008-2#3)
All-fiber##6##1##(2007-11#2)(2007-12#3)(2008-2#1)
All-optical active mode locking##2##4##(2007-11#2)
All-optical switching##3##2##(2007-12#1)(2008-3#2)
All-optical##21##1##(2007-11#4)(2007-12#6)(2008-2#5)(2008-3#5)(2012-2#1)
All-solid-state##6##1##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
All-trans retinoic acid##2##3##(1996-5#1)(2008-5#1)
All-trans##3##1##(1996-5#2)(2008-5#1)
Allan variance##3##2##(2007-12#1)(2008-2#2)
Allan##5##1##(1996-5#1)(2007-12#1)(2008-2#2)(2008-3#1)
Allee effect##10##2##(2008-10#4)(2008-8#6)
Allee effects##5##2##(2008-8#1)(2008-9#4)
Allee##17##1##(2008-10#5)(2008-8#8)(2008-9#4)
Allele C gave higher C18##2##5##(2010-2#2)
Allele frequencies for##3##3##(2008-12#3)
Allele frequencies##6##2##(2008-10#1)(2008-12#5)
Allele frequency data and forensic efficiency parameters for 15 STR loci##2##11##(2008-12#2)
Allele##18##1##(1997-5#1)(2008-10#4)(2008-12#7)(2010-12#1)(2010-2#3)(2011-2#1)(2012-3#1)
Allele-specific##2##1##(1993-2#1)(2008-10#1)
Alleles at##2##2##(2008-10#1)(2008-5#1)
Alleles##9##1##(2008-10#5)(2008-5#1)(2009-5#1)(2011-2#1)(2012-3#1)
Allelic##8##1##(1995-12#1)(1997-9#1)(2008-10#4)(2008-12#1)(2008-7#1)
Allen test##2##2##(2008-9#1)(2011-2#1)
Allen##12##1##(1990-8#2)(1995-12#2)(1996-12#3)(1997-5#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)
Allen's test##4##2##(2007-8#4)
Allergen##3##1##(2008-11#1)(2012-2#1)(2013-8#1)
Allergens##3##1##(1994-9#1)(1996-5#1)(2013-1#1)
Allergic Rhinitis and##3##3##(2008-3#1)(2012-12#2)
Allergic Rhinitis##4##2##(2008-3#2)(2012-12#2)
Allergic diseases##2##2##(2008-3#1)(2010-5#1)
Allergic fungal##2##2##(2009-2#1)(2011-2#1)
Allergic reactions##2##2##(1991-11#1)(2011-1#1)
Allergic rhinitis (AR)##2##3##(2008-3#1)(2011-2#1)
Allergic rhinitis and##2##3##(2010-6#1)(2012-12#1)
Allergic rhinitis can##2##3##(2007-11#1)(2010-6#1)
Allergic rhinitis is a##2##4##(2012-12#2)
Allergic rhinitis is##3##3##(2012-1#1)(2012-12#2)
Allergic rhinitis##10##2##(2007-11#1)(2008-3#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#4)
Allergic##23##1##(1991-11#1)(2007-11#1)(2008-3#4)(2008-7#1)(2009-2#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#6)(2013-1#1)
Allergy and Infectious Diseases##4##4##(2008-5#3)(2011-2#1)
Allergy and##6##2##(2008-5#3)(2008-8#1)(2011-2#1)(2012-12#1)
Allergy to peanut##4##3##(1996-11#4)
Allergy to##9##2##(1990-6#1)(1991-6#1)(1996-11#4)(2007-12#1)(2011-1#1)(2011-2#1)
Allergy##22##1##(1990-6#1)(1991-6#1)(1996-11#4)(2007-12#1)(2008-5#4)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#2)
Alliance in##2##2##(1997-1#1)(2013-1#1)
Alliance##9##1##(1994-12#4)(1997-1#2)(2008-10#1)(2008-4#1)(2013-1#1)
Alliance)##2##1##(1994-12#1)(2008-4#1)
Alliances were##2##2##(2013-1#2)
Alliances##7##1##(1992-1#1)(2013-1#6)
Alliant Health System##4##3##(1994-2#2)(1995-12#2)
Alliant##8##1##(1994-2#5)(1995-12#3)
Allied Force&quot##2##2##(2008-11#2)
Allied Health Sciences##2##3##(2011-1#2)
Allied Health##5##2##(1996-2#1)(2011-1#2)(2013-1#2)
Allied Healthcare Products##2##3##(2011-1#2)
Allied##14##1##(1996-2#1)(1996-4#2)(2008-10#1)(2008-11#2)(2008-7#1)(2011-1#5)(2013-1#2)
Alligator##2##1##(2012-3#2)
Allison##2##1##(1992-1#1)(2008-7#1)
Allium cepa##2##2##(1993-12#2)
Allium spp##4##2##(2008-10#4)
Allium##11##1##(1993-12#2)(2008-10#9)
AlloMap molecular expression##2##3##(2008-10#2)
AlloMap test classifier##2##3##(2008-10#2)
AlloMap test##4##2##(2008-10#4)
AlloMap##6##1##(2008-10#6)
Allocating census data to general practice populations##2##7##(1995-9#2)
Allocating##5##1##(1992-3#1)(1994-1#1)(1995-9#2)(2008-10#1)
Allocation of##2##2##(1992-2#1)(2008-10#1)
Allocation##3##1##(1992-2#1)(2008-10#1)(2008-9#1)
Allodynia##2##1##(2008-9#1)(2011-2#1)
Allogeneic##6##1##(1991-5#1)(1992-9#1)(2008-11#1)(2012-3#1)(2013-1#2)
Allograft bone##2##2##(1996-3#1)(2009-10#1)
Allograft##6##1##(1996-3#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
Alloimmune neonatal neutropenia##3##3##(2012-3#3)
Alloimmunization##2##1##(1992-12#1)(2013-1#1)
Allometry and##2##2##(2007-12#1)(2011-2#1)
Allonemobius##2##1##(2008-8#2)
Allopurinol##2##1##(1995-12#1)(1996-9#1)
Allosteric regulation##2##2##(1990-8#2)
Allowable##2##1##(2008-2#1)(2008-3#1)
Allowance##2##1##(2008-7#1)(2008-8#1)
Alloy and colleagues'##2##3##(2010-7#2)
Alloy##6##1##(1996-9#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-7#2)
Alloy-ceramic oxide##2##2##(2007-12#2)
Allura red and Ponceau 4R##2##5##(2008-10#2)
Allura red##3##2##(2008-10#3)
Allura##4##1##(2008-10#4)
Allylic##4##1##(1996-5#2)(2006-10#1)(2007-11#1)
Almond##6##1##(2008-10#6)
Almost 40% of the##3##4##(1992-8#1)(1995-5#1)(2011-1#1)
Almost all of them##2##4##(2009-10#1)(2012-12#1)
Almost all of##7##3##(1997-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)(2012-12#1)
Almost all the##2##3##(1992-6#1)(2008-1#1)
Almost all##26##2##(1991-12#1)(1992-6#3)(1993-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
Almost half of##3##3##(2007-2#1)(2007-7#1)(2008-11#1)
Almost no##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
Almost one third of##2##4##(1997-2#1)(2013-1#1)
Almost##54##1##(1991-12#1)(1992-6#3)(1992-8#1)(1993-1#2)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
Alocasia##6##1##(2010-5#2)(2011-1#4)
Aloe##2##1##(2013-1#1)(2013-7#1)
Alone##3##1##(1995-4#1)(2008-8#1)(2009-6#1)
Along these##2##2##(1992-2#1)(2008-11#1)
Along with a##2##3##(1996-12#1)(2012-2#1)
Along with the##6##3##(1993-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
Along with##19##2##(1992-2#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Along##23##1##(1992-2#2)(1993-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#3)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Alongside##2##1##(1996-7#1)(2008-11#1)
Alopecia##3##1##(1991-3#1)(2010-6#1)(2012-3#1)
Alpha and##4##2##(1990-2#1)(1991-12#1)(1995-3#1)(2008-10#1)
Alpha##22##1##(1990-2#1)(1991-12#2)(1991-5#1)(1992-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#4)(2010-10#1)(2010-4#1)(2010-8#1)(2013-8#1)
Alpha-melanocyte-stimulating hormone##3##2##(1993-5#3)
AlphaSeal##2##1##(2013-1#2)
Alphaproteobacteria##2##1##(2011-1#2)
Alphavirus##2##1##(1997-4#2)
Alpine##3##1##(2008-10#2)(2012-6#1)
Alpinia katsumadai (IC50##2##3##(2008-5#2)
Alpinia##3##1##(2008-5#3)
Alport Syndrome##2##2##(2007-7#1)(2011-2#1)
Alport syndrome##9##2##(2011-2#9)
Alport##12##1##(2007-7#1)(2011-2#11)
Alport's##2##1##(2007-7#2)
Alps##6##1##(2008-10#1)(2008-11#3)(2010-8#1)(2012-6#1)
Already the##2##2##(2008-3#1)(2013-8#1)
Already##5##1##(1990-12#1)(1990-6#1)(1997-6#1)(2008-3#1)(2013-8#1)
Alsen and##2##2##(2008-10#2)
Alsen is##2##2##(2008-10#2)
Alsen##5##1##(2008-10#5)
Also adding##2##2##(2008-10#1)(2008-12#1)
Also described are##2##3##(2008-2#2)
Also described is a##2##4##(2008-4#2)
Also described##4##2##(2008-2#2)(2008-4#2)
Also discussed are the##4##4##(1994-1#2)(1994-2#1)(2008-3#1)
Also discussed are##5##3##(1992-12#1)(1994-1#2)(1994-2#1)(2008-3#1)
Also in##3##2##(2008-10#2)(2013-1#1)
Also included are two methods for monitoring cell growth using a spectrophotometer or a hemacytometer##2##15##(2008-2#1)(2008-9#1)
Also included are##5##3##(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)
Also included in the##2##4##(2008-10#1)(2008-3#1)
Also included in this##2##4##(2008-10#1)(2008-4#1)
Also included in##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
Also included is a discussion of##2##6##(2008-9#2)
Also included is an##2##4##(1992-1#1)(2008-4#1)
Also included is##4##3##(1992-1#1)(2008-4#1)(2008-9#2)
Also included##13##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-9#3)
Also it was##2##3##(1990-10#1)(2008-8#1)
Also known as##2##3##(2009-3#1)(2011-2#1)
Also of##2##2##(1997-4#1)(2007-12#1)
Also presented are methods for assaying free sulfhydryl content and for reducing disulfide bonds in synthetic peptides##2##17##(2008-4#2)
Also presented are##6##3##(2008-2#1)(2008-3#2)(2008-4#3)
Also presented is the##2##4##(2008-4#1)(2008-7#1)
Also presented is##3##3##(1990-8#1)(2008-4#1)(2008-7#1)
Also presented##9##2##(1990-8#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#1)
Also provided is a##2##4##(2008-4#2)
Also shown##2##2##(2008-10#1)(2008-3#1)
Also the degraded products were well##2##6##(2008-10#2)
Also the number##2##3##(2007-11#1)(2008-5#1)
Also the possible##2##3##(2007-12#1)(2008-10#1)
Also the stability of##2##4##(1994-12#1)(2008-10#1)
Also the##33##2##(1990-9#1)(1991-10#1)(1991-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-2#1)
Also they##2##2##(2008-2#1)(2010-7#1)
Also we##4##2##(2008-11#2)(2009-3#1)(2011-2#1)
Also##405##1##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#3)(2006-4#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#86)(2008-11#15)(2008-12#13)(2008-2#23)(2008-3#27)(2008-4#13)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#7)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#26)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#1)(2012-7#1)(2013-1#17)(2013-7#2)(2013-8#6)
Alsomitra macrocarpa##2##2##(2008-11#2)
Alström syndrome##2##2##(2011-1#2)
Alter the##2##2##(2008-10#2)
Alter##3##1##(2008-10#3)
Alteration in##2##2##(1991-9#1)(1993-12#1)
Alteration of the##2##3##(1993-3#1)(2010-9#1)
Alteration of##11##2##(1990-7#1)(1992-5#1)(1993-3#1)(1993-8#1)(1995-5#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-9#1)
Alteration##13##1##(1990-7#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-5#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-9#1)
Alterations in the##6##3##(1991-1#1)(1991-9#1)(1995-12#1)(1996-2#1)(2008-7#1)(2012-2#1)
Alterations in##16##2##(1990-2#1)(1991-1#1)(1991-5#1)(1991-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-2#2)(2012-3#2)
Alterations of the##2##3##(1991-12#1)(1992-8#1)
Alterations of##11##2##(1991-12#1)(1992-12#2)(1992-8#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)
Alterations that##2##2##(1994-8#1)(2008-2#1)
Alterations##32##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-8#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)
Altered expression of##5##3##(1991-12#1)(1992-8#1)(1996-12#1)(2011-2#1)(2013-7#1)
Altered##28##1##(1991-12#2)(1992-10#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
Altering the##2##2##(1992-11#1)(2012-2#1)
Alternanthera tenella##2##2##(2008-10#2)
Alternaria alternata##23##2##(2008-10#23)
Alternaria brown spot##3##3##(2008-10#3)
Alternaria citri##11##2##(2008-10#11)
Alternaria dauci##2##2##(2008-10#2)
Alternaria isolates were##2##3##(2008-10#2)
Alternaria isolates##4##2##(2008-10#4)
Alternaria leaf##2##2##(2008-10#2)
Alternaria solani##4##2##(1992-8#1)(2008-10#3)
Alternaria species##2##2##(2008-10#2)
Alternaria spp##16##2##(2008-10#13)(2010-4#1)(2013-1#2)
Alternaria##84##1##(1992-8#1)(1997-6#1)(2008-10#75)(2008-12#1)(2008-5#2)(2010-4#1)(2010-5#1)(2013-1#2)
Alternate Protocol 1##4##3##(2008-4#2)(2008-9#2)
Alternate Protocol 2##2##3##(2008-4#1)(2008-9#1)
Alternate Protocol describes a##4##4##(2008-4#3)(2008-9#1)
Alternate Protocol##13##2##(2008-4#9)(2008-9#4)
Alternate protocols describe##4##3##(2008-4#4)
Alternate protocols present##2##3##(2008-4#1)(2008-9#1)
Alternate protocols##10##2##(2008-2#1)(2008-4#8)(2008-9#1)
Alternate rapid staining procedures are provided for each method and a support protocol describes how to photograph stained gels##2##19##(2008-2#1)(2008-4#1)
Alternate##30##1##(1991-12#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#19)(2008-9#5)
Alternating##6##1##(1995-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-9#1)
Alternative geographic##2##2##(1991-1#1)(1993-1#1)
Alternative medicine##2##2##(1993-12#1)(2011-2#1)
Alternative model##2##2##(1993-11#1)(1993-12#1)
Alternative splicing of##3##3##(1994-12#1)(2008-4#2)
Alternative splicing##5##2##(1994-12#1)(2008-12#1)(2008-4#2)(2008-8#1)
Alternative strategies##2##2##(1994-12#1)(2010-11#1)
Alternative therapies##2##2##(1997-2#1)(1997-3#1)
Alternative##48##1##(1991-1#1)(1992-12#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
Alternatively the##2##2##(1992-12#1)(2008-1#1)
Alternatively##55##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1995-3#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2009-6#2)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
Alternatives for##2##2##(1991-1#1)(2008-12#1)
Alternatives to##4##2##(1991-3#1)(1996-12#1)(1997-7#1)(2010-5#1)
Alternatives##7##1##(1991-1#1)(1991-3#1)(1993-11#1)(1996-12#1)(1997-7#1)(2008-12#1)(2010-5#1)
Alters the##2##2##(2008-10#1)(2009-6#1)
Alters##5##1##(2008-10#4)(2009-6#1)
Although &quot##2##2##(1992-12#1)(1994-3#1)
Although 2##2##2##(2006-10#1)(2008-10#1)
Although Asian##2##2##(2007-12#1)(2008-10#1)
Although HIV##2##2##(1996-11#1)(1996-5#1)
Although HIV-1##2##2##(1997-3#1)(2008-2#1)
Although P##2##2##(2008-10#1)(2011-2#1)
Although UV##2##2##(2008-10#1)(2010-4#1)
Although a high##2##3##(1992-12#1)(1997-8#1)
Although a large##2##3##(1992-3#1)(2008-8#1)
Although a majority of##2##4##(1990-11#1)(1996-3#1)
Although a number of##4##4##(1990-2#1)(2008-1#1)(2009-9#1)(2010-10#1)
Although a rare##2##3##(2007-5#1)(2008-3#1)
Although a variety of##2##4##(2008-9#1)(2010-8#1)
Although a##35##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-8#1)(1996-3#2)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Although all of the##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
Although all three##2##3##(2008-10#1)(2011-2#1)
Although all##16##2##(1994-9#1)(1995-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-3#2)
Although almost##2##2##(2008-10#1)(2008-11#1)
Although an##11##2##(1993-3#1)(1995-12#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-12#2)
Although application of##2##3##(2008-10#2)
Although bats##2##2##(2013-1#2)
Although bisphosphonates have been##2##4##(2008-8#1)(2010-4#1)
Although both##12##2##(1992-6#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#1)
Although chemists have##2##3##(2010-12#2)
Although clinical##2##2##(1990-2#1)(2013-1#1)
Although commonly##2##2##(1991-7#1)(2008-10#1)
Although considerable##4##2##(1995-1#1)(2008-10#1)(2008-3#1)(2009-7#1)
Although controversial##2##2##(1991-9#1)(2008-12#1)
Although conventional##2##2##(2008-6#1)(2010-8#1)
Although different##2##2##(2009-9#1)(2010-10#1)
Although efforts##2##2##(2007-9#1)(2008-10#1)
Although evidence of##2##3##(2008-10#1)(2010-6#1)
Although evidence##4##2##(1993-3#1)(2008-10#1)(2010-6#1)(2012-12#1)
Although experimental##2##2##(1994-12#1)(2008-2#1)
Although females##2##2##(2008-10#1)(2008-8#1)
Although few##4##2##(1994-2#1)(2008-10#2)(2008-2#1)
Although for a##2##3##(2008-10#1)(2008-5#1)
Although future##2##2##(1994-1#1)(2008-7#1)
Although general##2##2##(1990-3#1)(1996-7#1)
Although heat##2##2##(1996-12#1)(2008-11#1)
Although highly##3##2##(1992-5#1)(2008-9#1)(2011-2#1)
Although imaging##2##2##(2008-7#1)(2011-7#1)
Although in recent years##2##4##(2008-9#1)(2013-1#1)
Although in situ##2##3##(2008-7#1)(2012-2#1)
Although in##9##2##(1993-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
Although incubation##2##2##(1995-11#1)(2008-10#1)
Although infection##2##2##(2007-12#1)(2008-5#1)
Although it has been suggested that##3##6##(2008-10#1)(2008-8#1)(2010-11#1)
Although it has been##6##4##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
Although it has##8##3##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)
Although it is rare##2##4##(2008-5#1)(2008-6#1)
Although it is recognized that##2##5##(2008-10#1)(2008-5#1)
Although it is##23##3##(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
Although it was##4##3##(1992-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
Although it##41##2##(1990-11#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Although its##4##2##(1990-11#1)(1993-11#1)(2008-4#2)
Although less##2##2##(2008-1#1)(2008-7#1)
Although malignant##2##2##(1992-11#1)(2010-6#1)
Although many authors##2##3##(1993-6#1)(2013-1#1)
Although many of the##2##4##(2008-10#1)(2009-9#1)
Although many of these##2##4##(2006-12#1)(2010-12#1)
Although many of##4##3##(2006-12#1)(2008-10#1)(2009-9#1)(2010-12#1)
Although many studies##2##3##(2008-5#1)(2008-8#1)
Although many##23##2##(1991-1#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-12#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
Although microscopic##2##2##(2008-10#1)(2011-2#1)
Although molecular##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
Although more##4##2##(1996-12#1)(2008-1#1)(2008-5#1)(2008-8#1)
Although morphological##2##2##(2008-10#1)(2011-2#1)
Although most of the##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
Although most of##5##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
Although most##10##2##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-6#1)(2012-1#1)(2013-1#1)
Although much##6##2##(1996-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
Although no significant change in##2##5##(1991-9#1)(2008-10#1)
Although no##22##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-10#1)(1994-2#1)(1994-3#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2010-9#1)(2011-1#1)(2012-3#1)
Although none of the##2##4##(1991-12#1)(1991-6#1)
Although none of##3##3##(1991-12#1)(1991-6#1)(2006-10#1)
Although not all##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
Although not specifically##2##3##(1996-4#1)(2008-8#1)
Although not##16##2##(1996-2#1)(1996-4#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2011-2#1)
Although novel##2##2##(1992-8#1)(2011-1#1)
Although numerous##6##2##(1991-2#1)(1995-1#1)(2007-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
Although nursing##3##2##(2007-10#1)(2008-11#1)(2008-12#1)
Although one##2##2##(1996-3#1)(2010-9#1)
Although only##3##2##(1991-12#1)(2008-10#1)(2010-5#1)
Although oral##2##2##(2008-11#1)(2011-2#1)
Although originally##2##2##(2008-10#1)(2012-12#1)
Although other##5##2##(1994-6#1)(2008-10#2)(2009-8#1)(2011-2#1)
Although our results do not##2##5##(1997-5#1)(2008-11#1)
Although our understanding of##2##4##(2008-10#1)(2009-3#1)
Although our##10##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-2#1)
Although patients with##2##3##(1992-12#1)(1996-2#1)
Although patients##4##2##(1992-12#1)(1996-2#1)(2007-8#1)(2013-1#1)
Although previous studies have##2##4##(2008-9#1)(2010-8#1)
Although primarily##2##2##(1995-2#1)(2008-10#1)
Although problems##2##2##(1991-2#1)(2007-11#1)
Although progress has been made##3##5##(2008-7#2)(2012-3#1)
Although rare##7##2##(2007-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2012-2#1)
Although recent studies have##2##4##(2007-8#1)(2013-1#1)
Although recombinant##2##2##(1995-2#1)(2008-10#1)
Although relatively##2##2##(2008-10#1)(2011-2#1)
Although researchers##3##2##(2008-12#1)(2009-9#1)(2010-8#1)
Although risk##2##2##(2006-10#1)(2008-7#1)
Although several##14##2##(1996-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#1)(2011-2#2)(2012-3#1)
Although short##2##2##(2008-1#1)(2010-5#1)
Although significant##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
Although similar##2##2##(1997-3#1)(2008-10#1)
Although some of these##3##4##(1997-7#1)(2010-4#1)(2012-2#1)
Although some protein databases are widely known##2##7##(2008-2#1)(2008-4#1)
Although some strains##2##3##(2008-10#1)(2012-3#1)
Although some##26##2##(1991-3#1)(1993-1#2)(1993-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#3)
Although specific##2##2##(1996-12#1)(2013-1#1)
Although spinal reconstruction##2##3##(2007-8#1)(2008-7#1)
Although statistical##2##2##(1994-1#1)(2008-7#1)
Although statistically significant##2##3##(2008-8#1)(2011-2#1)
Although still##2##2##(1991-1#1)(2011-7#1)
Although strain##2##2##(2008-10#2)
Although such##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
Although surgery##3##2##(1995-5#1)(2008-6#1)(2008-9#1)
Although surgical##2##2##(2008-6#2)
Although technical##2##2##(2008-7#1)(2010-8#1)
Although the achievement of##2##4##(1994-3#1)(2009-7#1)
Although the amino acid##2##4##(1992-10#1)(2008-10#1)
Although the analysis##2##3##(1994-2#1)(2008-3#1)
Although the apparent##2##3##(2010-2#1)(2012-2#1)
Although the basic##2##3##(2008-5#1)(2010-9#1)
Although the concept of##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2013-7#1)
Although the concept##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2013-7#1)
Although the current##4##3##(2008-7#2)(2010-8#1)(2011-2#1)
Although the data##6##3##(1996-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)
Although the derived##2##3##(2007-12#1)(2008-10#1)
Although the diagnosis of##2##4##(2008-11#1)(2011-2#1)
Although the effectiveness of##2##4##(2008-7#1)(2011-2#1)
Although the effects of##2##4##(2008-3#1)(2011-2#1)
Although the etiology of##2##4##(2011-2#1)(2012-1#1)
Although the evidence for##2##4##(1992-9#1)(2008-8#1)
Although the exact##6##3##(1991-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)(2012-3#1)
Although the findings##3##3##(1991-12#1)(2007-10#1)(2008-11#1)
Although the first##4##3##(1991-3#1)(1997-3#1)(2010-2#1)(2011-1#1)
Although the gene##3##3##(1992-8#1)(2008-4#1)(2009-6#1)
Although the growth##2##3##(2008-11#1)(2008-7#1)
Although the imaging##2##3##(2012-2#2)
Although the implementation##2##3##(2010-3#1)(2012-12#1)
Although the importance of##3##4##(2008-11#1)(2008-12#1)(2012-2#1)
Although the incidence of##2##4##(1990-10#1)(2008-4#1)
Although the incidence##3##3##(1990-10#1)(2008-4#1)(2010-9#1)
Although the influence of##2##4##(2008-9#2)
Although the majority of##6##4##(2008-10#2)(2010-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
Although the majority##7##3##(2008-10#2)(2008-12#1)(2010-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
Although the mean##3##3##(1994-2#1)(2008-1#1)(2011-1#1)
Although the mechanism of##2##4##(2008-10#1)(2008-11#1)
Although the mechanism##3##3##(2008-10#2)(2008-11#1)
Although the mechanisms by which##2##5##(2008-7#1)(2010-5#1)
Although the model##2##3##(2008-10#1)(2009-7#1)
Although the molecular##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
Although the most##2##3##(2008-12#1)(2011-2#1)
Although the pathogenesis of##2##4##(2008-10#1)(2009-3#1)
Although the pathophysiology##2##3##(2008-1#1)(2008-6#1)
Although the patient had##2##4##(1993-6#1)(2007-12#1)
Although the patient was##2##4##(1994-12#1)(2013-1#1)
Although the patient##5##3##(1992-3#1)(1993-6#1)(1994-12#1)(2007-12#1)(2013-1#1)
Although the physiological##2##3##(1994-5#1)(2008-10#1)
Although the precise##3##3##(1994-8#1)(2008-7#2)
Although the present##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
Although the prevalence of##4##4##(1994-6#1)(2008-1#1)(2008-9#1)(2009-5#1)
Although the primary##3##3##(1992-3#1)(2009-7#1)(2010-12#1)
Although the prognosis##2##3##(2007-10#1)(2007-4#1)
Although the pulmonary##2##3##(1997-8#1)(2013-8#1)
Although the results##4##3##(1993-6#1)(2008-10#1)(2009-12#1)(2010-3#1)
Although the risk##2##3##(2008-1#1)(2012-3#1)
Although the role of the##2##5##(2007-12#1)(2007-7#1)
Although the sexual##2##3##(1996-11#1)(2012-2#1)
Although the strength of the##2##5##(2008-7#1)(2009-7#1)
Although the study##2##3##(2007-8#1)(2012-2#1)
Although the two##2##3##(1992-3#1)(1995-1#1)
Although the underlying##2##3##(1994-8#1)(2008-7#1)
Although the use of##8##4##(1993-12#2)(1994-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
Although the##377##2##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-9#1)(1997-3#5)(1997-4#3)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#45)(2008-11#19)(2008-12#4)(2008-2#9)(2008-3#18)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#24)(2008-8#11)(2008-9#8)(2009-10#3)(2009-12#3)(2009-3#4)(2009-5#4)(2009-6#5)(2009-7#4)(2009-8#2)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#18)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#7)(2012-6#1)(2013-1#7)(2013-7#4)(2013-8#6)
Although their##5##2##(1995-12#1)(2008-7#2)(2008-8#1)(2012-2#1)
Although there are many##5##4##(2008-10#1)(2008-12#1)(2008-2#1)(2010-3#1)(2011-2#1)
Although there are several##5##4##(1995-1#1)(1996-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
Although there are some##2##4##(2008-7#1)(2010-8#1)
Although there are##17##3##(1995-1#1)(1996-2#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
Although there has been##6##4##(1992-1#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
Although there have been##2##4##(2007-12#1)(2008-7#1)
Although there is a considerable##2##5##(1997-8#1)(2010-9#1)
Although there is a##3##4##(1997-8#1)(2010-8#1)(2010-9#1)
Although there is evidence##2##4##(1994-9#1)(2008-10#1)
Although there is general agreement that##2##6##(1994-8#1)(2008-11#1)
Although there is no##3##4##(2008-7#1)(2008-8#2)
Although there is##21##3##(1990-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Although there was a##3##4##(1990-7#1)(2008-5#1)(2010-7#1)
Although there was no##4##4##(1997-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
Although there was some##2##4##(2011-1#1)(2011-2#1)
Although there was##12##3##(1990-7#1)(1993-8#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#2)
Although there were##2##3##(1994-12#1)(2011-2#1)
Although there##63##2##(1990-2#1)(1990-7#1)(1992-1#1)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Although these cells##2##3##(1994-8#1)(2008-9#1)
Although these findings##2##3##(2008-7#1)(2013-8#1)
Although these levels##2##3##(1997-4#1)(2008-10#1)
Although these observations##2##3##(1994-9#1)(2008-6#1)
Although these results##4##3##(1993-3#1)(1994-8#1)(2007-12#1)(2008-10#1)
Although these statistics##2##3##(1995-3#1)(1997-1#1)
Although these##38##2##(1990-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Although they are##2##3##(2008-3#1)(2012-3#1)
Although they##6##2##(1990-3#1)(1996-9#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-3#1)
Although this has been##2##4##(1994-2#1)(2012-12#1)
Although this has##3##3##(1994-2#1)(2008-8#1)(2012-12#1)
Although this information##2##3##(1996-1#1)(2008-7#1)
Although this is not a##2##5##(2008-2#1)(2011-2#1)
Although this is##5##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
Although this process##2##3##(1991-1#1)(2009-9#1)
Although this study was##2##4##(2007-7#1)(2011-2#1)
Although this study##5##3##(2007-7#1)(2008-12#1)(2011-2#2)(2013-1#1)
Although this##48##2##(1991-1#1)(1992-12#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)
Although traumatic##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
Although uncommon##2##2##(2010-12#1)(2011-2#1)
Although use of##3##3##(2008-3#1)(2008-7#1)(2012-1#1)
Although various##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
Although very##3##2##(1991-11#1)(1995-1#1)(2008-9#1)
Although viral##2##2##(2008-10#1)(2010-11#1)
Although vitamin##2##2##(1996-3#1)(2012-3#1)
Although we cannot exclude##2##4##(1990-10#1)(1991-2#1)
Although we have##2##3##(1991-12#1)(2008-12#1)
Although we##11##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-4#1)(1995-11#1)(1997-4#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
Although with##2##2##(1994-8#1)(2008-10#1)
Although##1558##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#8)(1990-3#5)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1991-1#4)(1991-11#2)(1991-12#9)(1991-2#9)(1991-3#6)(1991-6#2)(1991-7#1)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#6)(1992-3#11)(1992-4#2)(1992-5#3)(1992-6#5)(1992-8#10)(1992-9#3)(1993-1#6)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#6)(1993-3#7)(1993-6#4)(1993-8#4)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#9)(1994-2#11)(1994-3#9)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#9)(1994-9#7)(1995-1#10)(1995-11#4)(1995-12#5)(1995-2#12)(1995-3#7)(1995-5#4)(1995-6#8)(1995-8#3)(1996-1#4)(1996-11#3)(1996-12#8)(1996-2#12)(1996-3#10)(1996-4#5)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#14)(1997-4#6)(1997-5#4)(1997-6#3)(1997-7#7)(1997-8#6)(2006-10#14)(2006-12#1)(2007-10#7)(2007-11#11)(2007-12#27)(2007-2#3)(2007-4#2)(2007-5#4)(2007-7#8)(2007-8#10)(2007-9#2)(2008-1#26)(2008-10#197)(2008-11#57)(2008-12#22)(2008-2#32)(2008-3#53)(2008-4#18)(2008-5#32)(2008-6#17)(2008-7#83)(2008-8#56)(2008-9#37)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#11)(2009-4#4)(2009-5#13)(2009-6#7)(2009-7#8)(2009-8#12)(2009-9#9)(2010-1#6)(2010-10#6)(2010-11#4)(2010-12#12)(2010-2#2)(2010-3#12)(2010-4#8)(2010-5#10)(2010-6#8)(2010-7#3)(2010-8#17)(2010-9#5)(2011-1#19)(2011-2#82)(2011-7#2)(2012-1#8)(2012-12#19)(2012-2#50)(2012-3#33)(2012-6#1)(2012-9#1)(2013-1#48)(2013-7#5)(2013-8#19)
Althoughthe##2##1##(2008-11#2)
Altiplano##4##1##(2008-8#3)(2011-2#1)
Altitude##2##1##(2008-2#1)(2013-7#1)
Altitudinal##2##1##(2009-5#1)(2013-7#1)
Altman##10##1##(1994-12#3)(1994-3#1)(1997-1#1)(2008-11#3)(2008-12#2)
Altogether##38##1##(1991-3#1)(1993-5#1)(1995-2#2)(1995-6#1)(1996-2#1)(2007-8#11)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
Altruism##3##1##(2008-8#3)
Alu element##2##2##(1993-11#1)(1997-6#1)
Alu family##3##2##(1991-5#2)(1995-3#1)
Alu repeat sequences##2##3##(1991-2#1)(1994-12#1)
Alu repeat##4##2##(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#1)
Alu repeats##3##2##(1991-5#1)(1995-3#2)
Alu repetitive elements##2##3##(1991-6#1)(1991-9#1)
Alu sequence##3##2##(1993-11#1)(1993-2#1)(1997-2#1)
Alu sequences##2##2##(1991-5#2)
Alu subfamilies##3##2##(1995-3#3)
Alu##27##1##(1991-2#1)(1991-5#7)(1991-6#1)(1991-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1994-12#1)(1995-3#7)(1997-2#1)(1997-6#1)
AluI##8##1##(1994-12#1)(1995-12#1)(2008-10#5)(2010-4#1)
Alumina ceramic veneers##2##3##(2009-8#2)
Alumina##6##1##(2007-11#2)(2008-10#1)(2009-8#3)
Aluminium (Al)##2##2##(1996-12#1)(2013-8#1)
Aluminium##9##1##(1995-6#1)(1996-12#1)(2008-10#4)(2008-5#1)(2013-1#1)(2013-8#1)
Aluminum is##2##2##(1992-12#1)(2007-8#1)
Aluminum toxicity##2##2##(2009-6#1)(2012-2#1)
Aluminum##20##1##(1992-12#1)(1995-5#1)(1996-2#2)(2007-8#2)(2008-10#7)(2008-2#1)(2009-6#1)(2011-2#1)(2012-1#3)(2012-2#1)
Alumni Association##2##2##(2008-8#2)
Alveolar bone##2##2##(2007-12#1)(2011-2#1)
Alveolar distraction osteogenesis##2##3##(2007-12#2)
Alveolar macrophages##2##2##(1993-3#1)(2008-12#1)
Alveolar ridge##3##2##(2007-12#3)
Alveolar##14##1##(1990-2#1)(1993-3#1)(1994-3#1)(2007-12#6)(2007-8#2)(2008-12#1)(2009-12#1)(2011-2#1)
Alzheimer A beta amyloid peptide##2##5##(1994-8#2)
Alzheimer amyloid precursor protein##3##4##(1993-8#2)(1994-8#1)
Alzheimer amyloid protein precursor##5##4##(1991-9#1)(1992-8#1)(1992-9#1)(1994-11#2)
Alzheimer amyloid##9##2##(1991-9#1)(1992-8#1)(1992-9#2)(1993-8#2)(1994-11#2)(1994-8#1)
Alzheimer disease (AD)##4##3##(1994-8#1)(1997-2#1)(2008-7#1)(2009-5#1)
Alzheimer disease and Down syndrome##2##5##(1990-3#2)
Alzheimer disease and##5##3##(1990-3#2)(1994-8#1)(1997-2#1)(2008-4#1)
Alzheimer disease or Down syndrome##2##5##(1990-3#2)
Alzheimer disease##25##2##(1990-3#10)(1994-8#5)(1996-9#1)(1997-2#2)(2008-4#1)(2008-7#1)(2009-5#2)(2010-6#1)(2011-2#1)(2013-7#1)
Alzheimer patients##4##2##(1990-7#1)(1992-12#1)(2008-7#2)
Alzheimer##59##1##(1990-3#13)(1990-7#1)(1991-9#2)(1992-12#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#2)(1994-5#3)(1994-8#8)(1995-3#1)(1996-11#1)(1996-9#1)(1997-2#2)(2008-4#1)(2008-7#6)(2009-5#2)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
Alzheimer's Disease (AD)##2##3##(1993-12#1)(2011-3#1)
Alzheimer's Disease##14##2##(1992-12#2)(1993-11#1)(1993-12#2)(1995-11#3)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)
Alzheimer's and Parkinson's diseases##2##4##(1996-2#1)(2008-7#1)
Alzheimer's and##5##2##(1993-1#1)(1995-12#1)(1996-2#1)(2008-7#1)(2013-7#1)
Alzheimer's beta-amyloid##2##2##(1991-11#1)(1996-2#1)
Alzheimer's dementia##4##2##(1990-11#1)(1992-1#1)(1996-11#1)(2008-9#1)
Alzheimer's disease (AD) and##6##4##(1995-12#2)(1996-5#1)(2007-8#1)(2008-5#2)
Alzheimer's disease (AD) has##2##4##(2009-11#1)(2012-2#1)
Alzheimer's disease (AD) is a neurodegenerative disorder##2##7##(2008-7#1)(2013-1#1)
Alzheimer's disease (AD) is##6##4##(1992-12#1)(1992-9#1)(2008-7#2)(2011-2#1)(2013-1#1)
Alzheimer's disease (AD)##50##3##(1991-1#1)(1991-11#1)(1992-12#2)(1992-9#1)(1993-12#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#2)(1997-2#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#11)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
Alzheimer's disease -##2##3##(2012-2#2)
Alzheimer's disease amyloid##4##3##(1990-7#1)(1992-12#1)(1997-2#2)
Alzheimer's disease and other##2##4##(1995-12#1)(1996-6#1)
Alzheimer's disease and vascular dementia##2##5##(2008-7#2)
Alzheimer's disease and vascular##3##4##(1993-2#1)(2008-7#2)
Alzheimer's disease and##16##3##(1993-12#1)(1993-2#1)(1995-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-8#1)(2008-4#1)(2008-7#5)(2009-3#1)(2012-3#1)(2013-1#1)
Alzheimer's disease are discussed##2##4##(1995-6#1)(2013-8#1)
Alzheimer's disease in##4##3##(1992-12#1)(1995-8#1)(2008-6#1)(2008-7#1)
Alzheimer's disease is##6##3##(1991-9#1)(1992-12#1)(1996-12#1)(1996-5#1)(2009-11#1)(2013-1#1)
Alzheimer's disease may##2##3##(1991-7#1)(1995-12#1)
Alzheimer's disease post-mortem##2##3##(1996-12#2)
Alzheimer's disease##207##2##(1990-7#2)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#1)(1991-7#2)(1991-9#1)(1992-12#13)(1992-2#3)(1992-6#1)(1992-8#4)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-5#4)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#8)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#4)(1996-12#10)(1996-2#3)(1996-3#1)(1996-5#9)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#4)(1997-6#1)(2007-6#2)(2007-8#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#33)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#3)
Alzheimer's disease?##3##2##(2008-5#1)(2008-8#1)(2009-10#1)
Alzheimer's disease]##3##2##(1991-8#1)(1997-5#1)(2013-8#1)
Alzheimer's type##4##2##(1994-6#2)(2008-6#2)
Alzheimer's##255##1##(1990-11#1)(1990-7#2)(1991-1#2)(1991-10#2)(1991-11#7)(1991-12#1)(1991-3#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#18)(1992-2#5)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-5#4)(1994-6#5)(1994-9#1)(1995-11#4)(1995-12#9)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#4)(1996-11#2)(1996-12#11)(1996-2#5)(1996-3#1)(1996-5#9)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#4)(1997-5#1)(1997-6#1)(2007-6#2)(2007-8#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#11)(2008-6#6)(2008-7#36)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#3)(2011-1#2)(2011-2#4)(2011-3#3)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
Am J Phys Anthropol##8##4##(2011-2#8)
Am J##11##2##(2010-7#1)(2011-2#8)(2012-3#2)
Am and Cm##3##3##(2008-10#3)
Am and##4##2##(2008-10#4)
Am##38##1##(1992-4#1)(1992-8#1)(1995-2#3)(2007-12#1)(2008-10#10)(2008-12#1)(2008-2#4)(2008-3#5)(2010-1#1)(2010-7#1)(2011-2#8)(2012-3#2)
Am(III)##4##1##(2008-10#4)
AmB interacts with##2##3##(1997-2#2)
AmB is##3##2##(1997-2#3)
AmB##9##1##(1997-2#9)
Amadori adducts in glycated albumin##2##5##(1993-6#2)
Amadori adducts##4##2##(1993-6#4)
Amadori##5##1##(1990-12#1)(1993-6#4)
Amanita muscaria##2##2##(2008-10#1)(2011-2#1)
Amanita phalloides##2##2##(1991-11#2)
Amanita##5##1##(1991-11#2)(2008-10#1)(2011-2#2)
Amantadine##6##1##(1991-1#1)(1992-3#1)(1997-2#2)(2008-7#1)(2011-2#1)
Amaranth##2##1##(2008-10#1)(2008-11#1)
Amaranthaceae##5##1##(2008-10#5)
Amaranthus##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
Amaurosis##2##1##(2011-2#2)
Amavadin##4##1##(2008-10#4)
Amazilia amazilia##2##2##(2008-5#2)
Amazilia##3##1##(2008-5#3)
Amazon molly##3##2##(2009-2#3)
Amazon##12##1##(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#4)(2010-7#3)(2013-7#2)
Amazonia##2##1##(1991-12#1)(2013-7#1)
Amazonian species##2##2##(2008-5#1)(2013-7#1)
Amazonian##5##1##(1991-12#1)(2008-5#1)(2013-7#2)(2013-8#1)
Amazonians have##2##2##(1991-12#2)
Amazonians##5##1##(1991-12#5)
Ambae##5##1##(2008-1#5)
Amberlite IR 120##2##3##(2008-10#2)
Amberlite IRC 718##2##3##(2008-10#2)
Amberlite IRC 76 and##2##4##(2008-10#2)
Amberlite IRC##4##2##(2008-10#4)
Amberlite IRC-718##2##2##(2008-10#2)
Amberlite XAD-16 (AXAD-16)##2##3##(2008-10#2)
Amberlite XAD-16 resin##4##3##(2008-10#4)
Amberlite XAD-16##13##2##(2008-10#13)
Amberlite XAD-2 functionalized with##2##4##(2008-10#2)
Amberlite XAD-2 loaded with##2##4##(2008-10#2)
Amberlite XAD-2 resin loaded with PAN##2##6##(2008-10#2)
Amberlite XAD-2 resin loaded with##4##5##(2008-10#4)
Amberlite XAD-2 resin##8##3##(2008-10#8)
Amberlite XAD-2##22##2##(2008-10#22)
Amberlite XAD-4 as a##2##4##(2008-10#2)
Amberlite XAD-4 coated with##2##4##(2008-10#2)
Amberlite XAD-4 coated##3##3##(2008-10#3)
Amberlite XAD-4 functionalized##2##3##(2008-10#2)
Amberlite XAD-4 resin##6##3##(2008-10#6)
Amberlite XAD-4##20##2##(2008-10#20)
Amberlite XAD-7##5##2##(2008-10#5)
Amberlite##78##1##(1992-12#1)(2008-10#77)
Amberlyst 36##3##2##(2008-10#3)
Ambient##3##1##(1994-8#1)(2008-11#1)(2008-2#1)
Ambivalent Adhesives##2##2##(2013-1#2)
Amblyomma##4##1##(1996-12#1)(2008-5#3)
Ambrosia artemisiifolia##2##2##(2013-8#2)
Ambrosiella sp##2##2##(2008-10#2)
Ambulance##3##1##(1995-9#1)(2007-9#1)(2012-1#1)
Ambulatory Care Group (ACG)##2##4##(1995-2#1)(1997-1#1)
Ambulatory Care Group##3##3##(1995-2#2)(1997-1#1)
Ambulatory Care##4##2##(1995-2#2)(1996-1#1)(1997-1#1)
Ambulatory Peritoneal Dialysis##2##3##(2007-7#1)(2008-1#1)
Ambulatory##15##1##(1991-3#1)(1992-5#1)(1993-3#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-12#1)(1997-1#2)(2007-7#1)(2008-1#1)(2009-11#1)(2010-8#1)
Amebic##2##1##(2006-10#1)(2011-2#1)
Amelioration of##3##2##(1993-12#1)(1996-6#1)(2008-10#1)
Amended with##3##2##(2008-10#3)
Amended##4##1##(2008-10#4)
Amending##2##1##(2008-10#2)
Amendment##12##1##(1993-12#2)(1995-6#1)(2008-10#4)(2011-2#5)
Amendments of##4##2##(1993-1#2)(1995-3#1)(1997-2#1)
Amendments##8##1##(1993-1#2)(1994-2#1)(1995-3#1)(1997-2#2)(2008-10#1)(2013-1#1)
America and the##4##3##(1991-3#1)(2008-11#1)(2008-2#1)(2008-5#1)
America and##40##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#2)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
America are##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
America because of##2##3##(2008-10#1)(2008-11#1)
America for##2##2##(1992-5#1)(2008-10#1)
America has##2##2##(2008-11#1)(2011-2#1)
America have##5##2##(2008-11#2)(2008-8#1)(2009-12#1)(2012-2#1)
America in##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
America is##5##2##(1995-2#1)(2007-2#1)(2008-7#2)(2013-7#1)
America that##4##2##(2008-10#2)(2011-2#2)
America was##4##2##(1992-5#1)(2008-10#2)(2013-1#1)
America were##3##2##(2008-10#2)(2011-2#1)
America where##2##2##(1993-3#1)(2008-10#1)
America with##4##2##(1996-1#1)(2008-11#1)(2008-5#1)(2013-7#1)
America##257##1##(1990-6#2)(1991-11#2)(1991-3#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#3)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#3)(2008-1#2)(2008-10#91)(2008-11#14)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#13)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#16)(2011-9#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#9)(2013-7#3)(2013-8#2)
America's changing##2##2##(1995-3#1)(2007-3#1)
America's health##2##2##(1994-1#1)(1996-12#1)
America's##8##1##(1993-2#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-3#1)(2010-9#1)
America]##4##1##(1990-6#1)(1992-5#1)(2012-2#1)(2012-3#1)
American Academy of##9##3##(1995-2#1)(1996-6#2)(2007-11#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
American Adolescents##2##2##(2009-11#1)(2012-12#1)
American Association of Colleges of##2##5##(2010-3#1)(2012-2#1)
American Association of##5##3##(1995-6#1)(2008-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
American Association##8##2##(1991-1#2)(1995-6#1)(2008-1#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
American Blacks##2##2##(1993-3#2)
American Cancer Society##3##3##(2010-9#1)(2012-3#2)
American Civil##3##2##(1996-5#1)(2009-7#2)
American College of Cardiology (ACC)##2##5##(2009-6#1)(2012-3#1)
American College of Cardiology##4##4##(2008-3#1)(2009-6#1)(2010-5#1)(2012-3#1)
American College of Cardiology/American Heart Association guidelines for##2##8##(2008-3#2)
American College of Cardiology/American Heart Association guidelines##3##7##(2008-3#3)
American College of Cardiology/American Heart Association##5##6##(2008-3#5)
American College of Healthcare Executives and##2##6##(1991-1#1)(1994-12#1)
American College of Healthcare##3##4##(1991-1#1)(1994-12#1)(1996-12#1)
American College of Rheumatology##2##4##(2006-10#1)(2007-8#1)
American College of##25##3##(1991-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-3#7)(2008-4#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
American Diabetes Association##2##3##(2008-3#1)(2011-1#1)
American Dietetic Association##4##3##(1994-2#1)(1995-2#1)(1995-3#1)(2008-5#1)
American Health##5##2##(1992-5#1)(1994-1#1)(1994-9#1)(1995-2#1)(2013-1#1)
American Healthcare Radiology Administrators##2##4##(1991-2#1)(1996-2#1)
American Healthcare##4##2##(1990-4#1)(1991-2#1)(1992-12#1)(1996-2#1)
American Heart Association##11##3##(1996-6#2)(2008-11#1)(2008-3#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)(2012-3#1)
American Heart##13##2##(1996-6#2)(2008-11#1)(2008-3#4)(2009-11#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)(2012-3#1)
American Hospital Association (AHA)##2##4##(1991-12#1)(2008-11#1)
American Hospital Association##9##3##(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#1)(1994-2#1)(2008-11#3)
American Indian families##3##3##(1991-3#3)
American Indian##12##2##(1991-3#4)(1996-2#1)(1997-1#1)(2008-8#1)(2010-4#1)(2011-2#2)(2013-8#2)
American Indians##6##2##(2010-4#1)(2011-2#4)(2013-8#1)
American Institute of Chemical Engineers Biotechnol##22##6##(2011-2#22)
American Life##2##2##(1995-6#1)(2010-10#1)
American Medical Association##7##3##(1991-8#2)(1992-12#1)(1993-3#1)(1996-12#2)(1997-5#1)
American Medical##10##2##(1990-4#1)(1991-8#2)(1992-12#1)(1993-3#1)(1996-12#2)(1997-5#1)(2012-3#2)
American Orthopaedic Foot and Ankle Society (AOFAS)##2##7##(2008-8#1)(2009-10#1)
American Orthopaedic Foot and Ankle Society##5##6##(2008-8#1)(2009-10#3)(2012-2#1)
American Orthopaedic##6##2##(2008-8#2)(2009-10#3)(2012-2#1)
American Phytopathological Society##3##3##(2008-10#3)
American Psychiatric##3##2##(2009-6#1)(2013-8#2)
American Red Cross##2##3##(1992-12#1)(1995-6#1)
American Rhinologic Society##2##3##(2012-1#2)
American Samoa##3##2##(2008-1#1)(2013-8#2)
American Society for##6##3##(1992-3#1)(1997-7#1)(2010-10#1)(2011-1#1)(2011-2#2)
American Society of Anesthesiologists##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
American Society of Clinical Oncology (ASCO)##2##6##(2008-5#1)(2013-1#1)
American Society of Clinical Oncology##6##5##(2008-5#1)(2008-7#3)(2010-11#1)(2013-1#1)
American Society of Clinical##8##4##(2008-5#2)(2008-7#3)(2009-4#1)(2010-11#1)(2013-1#1)
American Society of Gene##3##4##(2008-5#3)
American Society of Hematology##3##4##(2008-7#1)(2009-4#1)(2010-11#1)
American Society of##20##3##(2008-5#5)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#2)(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#2)
American Society##26##2##(1992-3#1)(1997-7#1)(2008-5#5)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#2)
American Thoracic Society##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
American Thoracic##4##2##(2008-5#2)(2008-7#1)(2013-1#1)
American Type Culture Collection##2##4##(2008-12#1)(2008-5#1)
American Whites and##2##3##(1993-3#1)(1995-6#1)
American adolescents##6##2##(2008-4#1)(2009-11#1)(2009-5#1)(2009-7#2)(2012-3#1)
American adolescents'##4##2##(2009-7#1)(2012-12#3)
American adults##3##2##(2009-7#2)(2011-2#1)
American alligator##2##2##(2008-8#1)(2010-3#1)
American and European##4##3##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
American and##20##2##(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#3)(2008-6#1)(2008-7#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
American center of origin##2##4##(2008-10#1)(2011-2#1)
American children##7##2##(1995-3#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#2)
American college of##3##3##(1997-8#1)(2009-6#1)(2012-3#1)
American countries##10##2##(1992-5#2)(2008-10#1)(2008-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
American experts##2##2##(2007-12#1)(2011-2#1)
American families##2##2##(2008-10#1)(2009-7#1)
American ginseng##4##2##(1997-2#1)(2008-10#3)
American health care delivery##2##4##(1994-3#1)(1996-2#1)
American health care system##4##4##(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)
American health care##17##3##(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#2)(1997-3#1)(2012-3#1)
American health##21##2##(1992-12#3)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#2)(1997-3#1)(2012-3#1)
American healthcare##2##2##(1991-3#1)(1993-2#1)
American hospitals##2##2##(1991-1#1)(1994-3#1)
American industry##2##2##(1994-12#1)(1995-1#1)
American isolates##4##2##(2008-10#4)
American origin##2##2##(2008-10#1)(2010-2#1)
American parents##2##2##(2010-10#2)
American patients##3##2##(1991-2#1)(1992-8#1)(2010-8#1)
American physicians##2##2##(2008-11#1)(2010-8#1)
American population##8##2##(1993-12#1)(1997-5#2)(2008-10#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-3#1)
American populations##6##2##(2008-10#4)(2008-12#1)(2010-8#1)
American psychology##2##2##(1994-12#2)
American public##2##2##(1993-3#1)(1994-2#1)
American sample##2##2##(2007-12#1)(2008-12#1)
American society of##2##3##(2009-9#1)(2012-2#1)
American society##3##2##(2007-2#1)(2009-9#1)(2012-2#1)
American students##2##2##(2008-12#2)
American subject##2##2##(2008-7#2)
American university##2##2##(1992-1#1)(2007-12#1)
American women##14##2##(1997-3#1)(2007-12#3)(2008-4#7)(2008-9#1)(2009-11#1)(2011-2#1)
American youth##4##2##(2009-5#1)(2009-7#3)
American##608##1##(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#7)(1991-12#4)(1991-2#3)(1991-3#6)(1991-8#2)(1992-1#1)(1992-12#6)(1992-2#3)(1992-3#3)(1992-5#4)(1992-8#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#8)(1993-6#3)(1993-9#1)(1994-1#3)(1994-12#9)(1994-2#5)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#4)(1995-6#6)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#4)(1996-5#5)(1996-6#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#11)(2008-12#16)(2008-2#1)(2008-3#15)(2008-4#19)(2008-5#17)(2008-6#9)(2008-7#12)(2008-8#13)(2008-9#11)(2009-10#4)(2009-11#9)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#35)(2009-6#5)(2009-7#18)(2009-9#2)(2010-1#4)(2010-10#12)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#11)(2010-9#6)(2011-1#6)(2011-2#59)(2012-1#2)(2012-12#12)(2012-2#7)(2012-3#24)(2013-1#13)(2013-7#3)(2013-8#8)
American)##4##1##(2008-10#2)(2009-7#1)(2010-7#1)
Americans With Disabilities Act##5##4##(1991-12#2)(1994-1#2)(1995-1#1)
Americans and how##2##3##(1994-1#1)(2008-4#1)
Americans and##10##2##(1994-1#1)(2008-4#1)(2009-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
Americans are##5##2##(1992-9#1)(1996-3#1)(2008-12#1)(2010-8#1)(2012-2#1)
Americans have##2##2##(1996-3#1)(2008-1#1)
Americans in##4##2##(1993-1#1)(1994-9#1)(2011-2#2)
Americans who##2##2##(1996-5#1)(2011-2#1)
Americans with Disabilities Act##25##4##(1991-12#1)(1992-12#1)(1993-1#3)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)
Americans with Disabilities##26##3##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)
Americans with##32##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#3)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-1#1)(1997-5#3)(2010-4#4)
Americans##130##1##(1991-12#3)(1991-3#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-1#6)(1994-2#2)(1994-9#1)(1995-1#3)(1995-12#6)(1995-6#2)(1996-1#2)(1996-12#2)(1996-3#3)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#4)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-12#4)(2008-3#2)(2008-4#7)(2008-5#2)(2008-8#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-10#5)(2010-12#1)(2010-4#6)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#12)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#7)(2013-8#1)
Americans' competence##2##2##(2012-3#2)
Americans'##6##1##(1993-3#1)(2009-11#2)(2009-5#1)(2012-3#2)
Americas and##4##2##(1993-8#1)(1994-9#1)(2008-10#2)
Americas##16##1##(1993-8#1)(1994-9#2)(2006-10#2)(2007-2#1)(2008-10#7)(2008-5#1)(2011-2#2)
Amerindian##3##1##(1991-12#2)(2008-12#1)
Amerindians##6##1##(1991-12#3)(2008-12#1)(2008-5#1)(2012-3#1)
Amersham##2##1##(2008-5#2)
Ames##7##1##(1996-12#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
Amide##4##1##(1997-7#1)(2008-10#1)(2012-12#1)(2013-7#1)
Amides##3##1##(1996-5#1)(1997-7#1)(2010-8#1)
Amiloride##4##1##(1991-6#1)(2008-10#2)(2008-4#1)
Aminated##2##1##(2012-3#2)
Amine##3##1##(1996-2#1)(1997-7#1)(2010-4#1)
Amines##2##1##(1991-5#1)(1996-5#1)
Amino Acid Substitutions in the##2##5##(2008-10#1)(2012-3#1)
Amino Acid##6##2##(2008-10#2)(2008-12#1)(2010-6#1)(2012-12#1)(2012-3#1)
Amino Acids##4##2##(1996-5#1)(2008-11#2)(2009-3#1)
Amino acid analysis showed##2##4##(1990-11#1)(1992-8#1)
Amino acid analysis##8##3##(1990-11#2)(1990-2#2)(1992-8#1)(1994-6#1)(1994-8#1)(2008-10#1)
Amino acid composition##2##3##(1993-11#1)(1997-8#1)
Amino acid sequence analysis of##2##5##(1994-5#1)(1995-6#1)
Amino acid sequence analysis##3##4##(1994-11#1)(1994-5#1)(1995-6#1)
Amino acid sequence data##2##4##(1991-10#1)(1992-8#1)
Amino acid sequence##8##3##(1991-10#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-6#1)(2008-10#2)(2009-9#1)
Amino acid sequences of##2##4##(1995-6#1)(2008-10#1)
Amino acid sequences##4##3##(1991-5#1)(1995-6#1)(2008-10#1)(2008-11#1)
Amino acid substitutions##3##3##(1990-8#1)(1991-2#1)(2008-4#1)
Amino acid##34##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)
Amino acids in##2##3##(1994-11#1)(2012-12#1)
Amino acids##8##2##(1992-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(2008-11#2)(2008-4#1)(2012-12#1)
Amino##54##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#3)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)
Amino-terminal##2##1##(1991-12#1)(1991-8#1)
Aminoalkylindoles (AAIs)##2##2##(1991-1#2)
Aminobacterium colombiense##2##2##(2011-2#2)
Aminobacterium##4##1##(2011-2#4)
Aminoglycosides##4##1##(1995-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
Aminomonas paucivorans##2##2##(2011-2#2)
Aminomonas##4##1##(2011-2#4)
Amlodipine was##2##2##(2008-3#2)
Amlodipine##7##1##(1992-2#1)(2007-10#1)(2008-10#1)(2008-3#3)(2008-6#1)
Amman##2##1##(2007-10#1)(2007-7#1)
Ammonia and##3##2##(2008-10#2)(2008-7#1)
Ammonia##17##1##(1990-7#1)(1994-5#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#2)
Ammonia-forming cytochrome c nitrite reductase from Sulfurospirillum deleyianum##2##8##(1994-11#2)
Ammonium##16##1##(1990-11#1)(1996-5#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-9#1)
Amniocentesis##3##1##(1994-12#1)(2012-3#2)
Amniotic##2##1##(2011-2#1)(2012-3#1)
Amomum##2##1##(2012-3#1)(2013-1#1)
Among 1##2##2##(1993-9#1)(2008-10#1)
Among 120##2##2##(1992-5#1)(2007-8#1)
Among 14##2##2##(1994-2#1)(1995-2#1)
Among 2##2##2##(1993-9#1)(2011-1#1)
Among 5 patients with##2##4##(1990-3#1)(2011-2#1)
Among 60##2##2##(2012-12#1)(2012-3#1)
Among Adolescent##2##2##(2013-1#2)
Among African##2##2##(2011-1#1)(2012-3#1)
Among College##2##2##(2010-10#1)(2013-8#1)
Among HIV-Infected##3##2##(2008-6#1)(2011-2#2)
Among Isolates of##4##3##(2008-10#4)
Among Israeli##2##2##(2008-1#2)
Among Populations of##2##3##(2008-10#2)
Among Strains of##3##3##(2008-10#3)
Among a##6##2##(1993-6#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-5#1)(2012-12#1)
Among all the##4##3##(1991-12#1)(2011-2#1)(2012-2#2)
Among all##9##2##(1990-6#1)(1991-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#2)
Among cases##2##2##(2008-12#1)(2008-6#1)
Among children##2##2##(2008-9#1)(2013-7#1)
Among different##2##2##(2007-11#1)(2012-2#1)
Among four##3##2##(1994-2#1)(2008-7#1)(2008-8#1)
Among individuals with diabetes##2##4##(2013-1#2)
Among invasive##2##2##(1992-8#1)(1994-2#1)
Among its##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
Among males##2##2##(2009-5#1)(2009-8#1)
Among many##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
Among other##6##2##(1992-3#1)(1993-6#1)(1995-2#1)(1997-8#1)(2010-7#1)(2011-2#1)
Among others##5##2##(2008-10#1)(2010-12#1)(2011-2#2)(2013-8#1)
Among our specimens##2##3##(2013-1#2)
Among participants##2##2##(2012-12#1)(2013-1#1)
Among patients with##8##3##(1991-11#1)(1992-11#1)(1993-1#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
Among patients##12##2##(1990-12#1)(1991-11#1)(1992-11#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
Among primary##2##2##(1990-8#1)(2008-1#1)
Among six##2##2##(2008-7#1)(2008-8#1)
Among students##2##2##(1993-6#1)(2008-11#1)
Among subjects with##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
Among teens##2##2##(2013-1#2)
Among the 18##2##3##(2008-5#1)(2013-8#1)
Among the 32##3##3##(1993-9#1)(2008-3#1)(2011-2#1)
Among the 42##3##3##(1990-2#1)(1990-6#2)
Among the alternatives##2##3##(2008-10#1)(2008-9#1)
Among the causes of##3##4##(2007-11#1)(2007-7#1)(2008-4#1)
Among the compounds tested##2##4##(1995-5#1)(1995-6#1)
Among the different##4##3##(1991-9#1)(1997-3#1)(2008-10#2)
Among the eight##2##3##(2008-10#2)
Among the elderly##2##3##(2008-2#1)(2013-8#1)
Among the four##3##3##(1994-8#1)(2008-1#1)(2008-10#1)
Among the genes##3##3##(1996-2#1)(2009-4#1)(2012-3#1)
Among the investigated##2##3##(2007-8#1)(2008-10#1)
Among the isolates in VCG##2##5##(2008-10#2)
Among the known##2##3##(1996-10#1)(2008-4#1)
Among the many##5##3##(2008-10#1)(2008-2#1)(2009-10#1)(2009-12#1)(2010-12#1)
Among the most##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-3#1)
Among the new##2##3##(1992-8#1)(2008-3#1)
Among the newest##2##3##(2008-4#1)(2010-5#1)
Among the numerous##3##3##(1991-4#1)(2008-10#1)(2008-11#1)
Among the other##2##3##(1997-7#1)(2008-5#1)
Among the sequenced##2##3##(1996-10#1)(2008-10#1)
Among the several##2##3##(1991-5#1)(2008-12#1)
Among the three##5##3##(2008-10#3)(2010-3#1)(2013-1#1)
Among the top##2##3##(2012-3#1)(2013-7#1)
Among the various##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
Among the##211##2##(1990-2#3)(1990-6#3)(1990-7#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-10#2)(1996-2#3)(1996-3#2)(1996-6#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#36)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#12)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#6)
Among them the most##2##4##(2010-8#1)(2011-2#1)
Among them the##3##3##(2010-8#1)(2011-1#1)(2011-2#1)
Among them##48##2##(1990-12#1)(1990-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
Among these are##2##3##(2012-2#2)
Among these factors##3##3##(1995-11#1)(2008-6#1)(2012-2#1)
Among these isolates##2##3##(2008-10#2)
Among these##41##2##(1990-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-7#1)
Among those reporting##2##3##(2008-12#1)(2010-8#1)
Among those##9##2##(1990-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
Among various##5##2##(1990-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-3#1)
Among women aged##2##3##(1992-9#1)(2011-2#1)
Among women##8##2##(1990-6#1)(1992-9#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
Among##580##1##(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#1)(1990-6#7)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#3)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#2)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#2)(2006-6#1)(2007-11#5)(2007-7#7)(2007-8#7)(2007-9#2)(2008-1#12)(2008-10#105)(2008-11#17)(2008-12#9)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#19)(2008-6#4)(2008-7#23)(2008-8#13)(2008-9#10)(2009-10#8)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#8)(2011-2#26)(2011-3#2)(2012-1#2)(2012-12#11)(2012-2#10)(2012-3#13)(2012-5#1)(2013-1#41)(2013-7#4)(2013-8#15)
Amongst the##9##2##(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2013-1#1)
Amongst##17##1##(2007-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#3)(2010-2#1)(2010-5#1)(2013-1#2)
Amorphous##4##1##(1995-3#1)(1996-9#1)(2008-2#2)
Amount of##4##2##(2008-10#3)(2008-12#1)
Amounts of##5##2##(2008-10#3)(2008-6#1)(2009-8#1)
Amounts##7##1##(1997-2#1)(2008-10#3)(2008-6#1)(2009-5#1)(2009-8#1)
Amoxycillin##2##1##(1990-3#1)(1991-3#1)
AmpFlSTR##2##1##(2008-12#2)
Ampelomyces quisqualis##2##2##(2008-10#2)
Amperometric biosensors##2##2##(2008-10#2)
Amperometric detection of##3##3##(2008-10#3)
Amperometric detection##5##2##(2008-10#5)
Amperometric determination of##6##3##(2008-10#6)
Amperometric sensor for##2##3##(2008-10#2)
Amperometric##29##1##(1992-11#1)(2008-10#28)
Amperometry and cyclic voltammetry##2##4##(2008-4#2)
Amperometry##3##1##(2008-10#1)(2008-4#2)
Amphetamine##4##1##(1992-10#1)(1993-6#2)(2013-1#1)
Amphidinolide E##2##2##(2008-6#2)
Amphiphilic##2##1##(1996-2#1)(2008-5#1)
Amphiprion clarkii##2##2##(2010-8#2)
Amphiprion##3##1##(2010-8#3)
Amphotericin B and##2##3##(2011-2#2)
Amphotericin B##7##2##(1997-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#2)
Amphotericin##10##1##(1992-6#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#2)
Ampicillin##5##1##(2008-10#1)(2008-8#1)(2009-12#3)
Amplatzer##4##1##(1997-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
AmpliDet RNA system##3##3##(2008-10#3)
AmpliDet RNA##5##2##(2008-10#5)
Amplifiable##2##1##(2008-10#1)(2008-4#1)
Amplification and large-scale production of the vector can be done in both adherent and suspension cell culture systems##2##18##(2008-2#1)(2008-4#1)
Amplification and##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
Amplification by##2##2##(2008-10#1)(2008-3#1)
Amplification in##2##2##(2008-2#1)(2013-8#1)
Amplification of the##4##3##(1990-2#1)(1990-7#1)(1994-12#1)(2008-10#1)
Amplification of##17##2##(1990-2#1)(1990-7#1)(1994-12#2)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)
Amplification##32##1##(1990-2#1)(1990-7#1)(1992-6#1)(1994-12#2)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
Amplified Fragment Length Polymorphism Markers##2##5##(2008-10#2)
Amplified Fragment Length Polymorphism and##2##5##(2008-10#2)
Amplified Fragment Length Polymorphism##6##4##(2008-10#6)
Amplified Polymorphic##5##2##(2008-10#5)
Amplified Region##2##2##(2008-10#2)
Amplified fragment length polymorphism (AFLP)##3##5##(2008-10#3)
Amplified fragment length polymorphism analysis##2##5##(2008-10#2)
Amplified fragment length polymorphism markers##2##5##(2008-10#2)
Amplified fragment length polymorphism##7##4##(2008-10#7)
Amplified fragment length##8##3##(2008-10#8)
Amplified rDNA##2##2##(2008-10#1)(2008-9#1)
Amplified##30##1##(1990-2#1)(1997-8#1)(2007-12#1)(2008-10#25)(2008-9#1)(2013-1#1)
Amplifier##3##1##(2008-2#2)(2008-3#1)
Amplitude and phase##2##3##(2007-12#2)
Amplitude and##3##2##(2007-12#3)
Amplitude control##2##2##(2008-2#1)(2008-3#1)
Amplitude modulation##2##2##(1994-6#1)(2008-3#1)
Amplitude##7##1##(1994-6#1)(2007-12#3)(2008-2#1)(2008-3#2)
Amplivex##2##1##(1990-11#2)
Ampullary##2##1##(1990-6#1)(1995-12#1)
Amputation##3##1##(2007-7#1)(2008-9#1)(2010-3#1)
Amputee##2##1##(2010-3#1)(2013-1#1)
Amsterdam##7##1##(1990-3#2)(1990-6#3)(1991-6#1)(1996-12#1)
Amy##3##1##(1990-11#3)
Amy1 was##2##2##(2008-10#2)
Amy1##3##1##(2008-10#3)
Amy3##10##1##(1994-11#9)(2008-10#1)
Amycolatopsis sp##2##2##(2009-2#2)
Amygdala##2##1##(1993-12#1)(1994-8#1)
Amygdaloid##3##1##(1994-2#1)(2008-10#2)
Amylase##3##1##(2008-10#3)
Amylin is##2##2##(1991-12#2)
Amylin##3##1##(1991-12#2)(2008-9#1)
Amyloid beta (Abeta)##2##3##(2008-10#1)(2008-7#1)
Amyloid beta##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
Amyloid precursor protein (APP)##2##4##(1996-12#2)
Amyloid##11##1##(1992-12#1)(1995-12#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
Amyloidosis and##2##2##(1994-5#1)(2008-1#1)
Amyloidosis is a systemic disease##2##5##(2008-10#1)(2011-2#1)
Amyloidosis is a##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
Amyloidosis is##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
Amyloidosis##7##1##(1994-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2011-2#2)
Amyotrophic lateral sclerosis (ALS) is a progressive##2##7##(2008-4#1)(2009-9#1)
Amyotrophic lateral sclerosis##3##3##(1995-2#1)(2008-4#1)(2009-9#1)
Amyotrophic##4##1##(1995-2#1)(2008-4#1)(2008-5#1)(2009-9#1)
Amélia Queen Reformatory##2##3##(2009-7#2)
An &quot##4##2##(1991-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
An 11-year-old boy presented with##2##5##(2008-10#1)(2010-9#1)
An 11-year-old boy##3##3##(2008-10#1)(2010-9#1)(2011-1#1)
An 11-year-old##4##2##(2008-10#1)(2010-6#1)(2010-9#1)(2011-1#1)
An 18-year-old##3##2##(2008-9#1)(2010-12#1)(2013-1#1)
An 8-year-old male child##2##4##(2007-8#2)
An 80-year-old##3##2##(1994-12#1)(2008-12#1)(2009-1#1)
An Allee##2##2##(2008-10#2)
An Alternate Protocol describes a##2##5##(2008-4#1)(2008-9#1)
An Alternate Protocol##4##3##(2008-4#3)(2008-9#1)
An Alu##2##2##(1993-2#1)(1997-6#1)
An American##2##2##(1996-12#1)(1996-3#1)
An Approach to##2##3##(2008-11#1)(2009-5#1)
An Australian##3##2##(1991-2#1)(1992-1#1)(2008-7#1)
An Bord Altranais##3##3##(2008-11#3)
An E##3##2##(1993-9#1)(1997-4#1)(1997-6#1)
An ELISA procedure for the determination of##2##7##(1990-12#2)
An ELISA##6##2##(1990-12#4)(1992-11#1)(2010-4#1)
An Efficient##5##2##(1996-5#2)(2008-10#1)(2010-7#1)(2010-8#1)
An Enantioselective Synthesis of##2##4##(1996-5#1)(2009-9#1)
An Epidemiological##2##2##(2008-10#1)(2012-12#1)
An Evaluation of##5##3##(1995-4#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
An Examination of##2##3##(2008-1#1)(2008-10#1)
An HPLC method##2##3##(1995-2#1)(2008-10#1)
An HPLC##3##2##(1995-2#1)(2008-10#2)
An IR##2##2##(2007-12#1)(2008-3#1)
An Inexpensive##2##2##(2008-11#1)(2009-10#1)
An Innovative Treatment Approach for##2##5##(2008-7#1)(2009-6#1)
An Internet##2##2##(2010-4#1)(2013-1#1)
An M/# of##2##3##(2007-12#2)
An NMR##2##2##(1990-5#1)(1994-3#1)
An RNA##3##2##(1992-11#1)(1994-3#1)(2008-6#1)
An SV 40 DNA fraction##2##5##(1990-7#2)
An Update for Neurosurgeons##2##4##(2011-2#2)
An Update##4##2##(2008-1#1)(2011-2#2)(2012-12#1)
An X-ray structure##2##3##(1996-5#1)(2008-11#1)
An X-ray##5##2##(1993-11#1)(1996-5#1)(2008-11#3)
An abdominal computed tomography##2##4##(2010-1#1)(2011-2#1)
An abdominal##3##2##(2007-12#1)(2010-1#1)(2011-2#1)
An abnormal##2##2##(2007-10#1)(2008-6#1)
An absolute##2##2##(1994-6#1)(2008-10#1)
An accompanying##3##2##(2007-11#1)(2008-11#2)
An account of##2##3##(1990-10#1)(1995-11#1)
An account##3##2##(1990-10#1)(1995-11#1)(1997-7#1)
An accumulation##2##2##(2008-10#1)(2008-12#1)
An accuracy of##2##3##(2008-2#1)(2008-3#1)
An accurate history##2##3##(2008-7#1)(2008-9#1)
An accurate method##2##3##(2008-10#1)(2008-3#1)
An accurate##14##2##(1990-12#1)(1993-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)
An acid##2##2##(2008-10#2)
An acidic##2##2##(1991-12#1)(2008-10#1)
An acousto-optic##2##2##(2008-2#1)(2008-3#1)
An action research##2##3##(1991-2#1)(2008-12#1)
An activating##2##2##(2009-8#1)(2011-2#1)
An active##2##2##(2008-5#1)(2010-12#1)
An acute##10##2##(1991-8#1)(1992-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
An ad hoc##2##3##(2008-7#1)(2012-12#1)
An adaptive##9##2##(1997-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2012-3#1)
An added##2##2##(1992-2#1)(2008-9#1)
An addition of##2##3##(2008-10#2)
An additional advantage##2##3##(2008-10#1)(2008-3#1)
An additional benefit##4##3##(1991-12#1)(1994-3#1)(2008-10#1)(2008-3#1)
An additional four##2##3##(1990-2#1)(1997-3#1)
An additional protocol##3##3##(2008-4#2)(2008-9#1)
An additional##43##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-9#1)(2009-8#2)(2012-3#3)
An adequate##5##2##(2008-10#2)(2008-2#1)(2012-2#1)(2012-5#1)
An adsorption##2##2##(2008-10#1)(2013-1#1)
An advanced##7##2##(2008-10#1)(2008-12#1)(2008-3#2)(2009-5#1)(2011-3#1)(2013-1#1)
An advantage of the##2##4##(1990-8#1)(2008-8#1)
An advantage of this##3##4##(2008-10#1)(2008-2#2)
An advantage of##5##3##(1990-8#1)(2008-10#1)(2008-2#2)(2008-8#1)
An air##4##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
An algorithm for##8##3##(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2010-4#1)
An algorithm is presented for##2##5##(2008-2#1)(2008-3#1)
An algorithm is proposed##2##4##(2008-10#2)
An algorithm is##6##3##(2008-10#2)(2008-2#1)(2008-3#3)
An algorithm to##3##3##(2007-11#1)(2008-3#2)
An algorithm##22##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#12)(2008-8#1)(2010-4#1)
An alignment of the##2##4##(1993-12#1)(2008-4#1)
An aliquot of##3##3##(2008-10#3)
An all-optical implementation##2##3##(2008-3#2)
An all-optical##4##2##(2008-3#3)(2013-8#1)
An alternate protocol describes##2##4##(2008-4#2)
An alternate protocol is##2##4##(2008-4#2)
An alternate protocol##7##3##(2008-2#1)(2008-4#5)(2008-9#1)
An alternate##9##2##(1994-3#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-9#1)
An alternative and##2##3##(2008-6#1)(2008-8#1)
An alternative approach##5##3##(1994-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
An alternative method for the##2##5##(2008-10#2)
An alternative method for##3##4##(2008-10#2)(2008-3#1)
An alternative method of##2##4##(2008-10#1)(2008-4#1)
An alternative method##7##3##(2008-10#3)(2008-3#1)(2008-4#2)(2008-6#1)
An alternative strategy##3##3##(1993-1#1)(2008-6#1)(2008-7#1)
An alternative to##2##3##(1996-1#1)(2008-2#1)
An alternative##37##2##(1993-1#1)(1994-1#1)(1994-8#1)(1996-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
An amino acid##3##3##(1994-6#1)(1997-9#1)(2013-1#1)
An amino-terminal##2##2##(1990-12#1)(1995-6#1)
An amperometric biosensor was##2##4##(2008-10#2)
An amperometric biosensor##4##3##(2008-10#4)
An amperometric immunosensor##2##3##(2008-10#2)
An amperometric##12##2##(2008-10#12)
An amplified##2##2##(2008-11#1)(2008-7#1)
An analog of##4##3##(1996-4#1)(2008-11#2)(2008-4#1)
An analogous##3##2##(1997-6#1)(2008-3#1)(2009-8#1)
An analysis and##2##3##(1992-3#1)(2010-5#1)
An analysis based on##2##4##(1997-4#1)(2010-6#1)
An analysis is made of the##2##6##(2008-3#2)
An analysis is##5##3##(2008-3#3)(2008-5#1)(2009-5#1)
An analysis of the effect of##2##6##(2008-3#2)
An analysis of the##24##4##(1991-9#1)(1992-3#1)(1993-2#1)(1996-9#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
An analysis of variance##2##4##(2008-10#2)
An analysis of##55##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-12#2)(1996-1#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)
An analysis was made of the##3##6##(1991-1#1)(1994-1#1)(2013-1#1)
An analysis was##5##3##(1991-1#1)(1994-1#1)(1995-12#1)(1996-9#1)(2013-1#1)
An analysis##72##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#2)(1993-2#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#3)(1996-1#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#2)
An analytic solution##2##3##(2007-12#1)(2008-2#1)
An analytic##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-2#2)
An analytical approach##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
An analytical cross-sectional study##2##4##(2008-10#1)(2011-2#1)
An analytical expression for the##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
An analytical expression##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
An analytical method based on the##2##6##(2008-10#2)
An analytical method for the determination of##4##7##(2008-10#4)
An analytical method for##6##4##(1993-3#1)(2008-10#5)
An analytical method##10##3##(1993-3#1)(2008-10#8)(2008-3#1)
An analytical methodology##3##3##(2008-10#3)
An analytical model of##3##4##(2008-1#2)(2008-10#1)
An analytical model##4##3##(2007-12#1)(2008-1#2)(2008-10#1)
An analytical procedure was##2##4##(2008-10#2)
An analytical##42##2##(1993-3#1)(2007-11#4)(2007-12#4)(2008-1#2)(2008-10#22)(2008-2#3)(2008-3#5)(2011-2#1)
An animal model##2##3##(1993-12#1)(2008-7#1)
An anion-exchange fast protein liquid##2##5##(2008-10#2)
An anionic##2##2##(1994-12#1)(2008-10#1)
An annotated##2##2##(1992-12#1)(2011-1#1)
An annual##4##2##(1993-2#1)(1995-3#1)(2007-2#1)(2008-1#1)
An anomaly##2##2##(1993-9#1)(2008-7#1)
An anonymous##2##2##(1997-4#1)(2008-10#1)
An antibody##2##2##(1991-8#1)(1995-12#1)
An antisense##2##2##(1993-6#1)(1996-12#1)
An antiserum to##4##3##(1991-1#3)(2008-10#1)
An antiserum##5##2##(1991-1#3)(2008-10#2)
An apparent##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
An apparently##2##2##(1990-2#1)(1992-8#1)
An application of the##4##4##(1991-1#1)(2008-10#2)(2008-3#1)
An application of##8##3##(1991-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)
An application to the##2##4##(2008-10#2)
An application to##4##3##(2007-11#1)(2008-10#2)(2012-3#1)
An application##17##2##(1991-1#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2012-3#1)(2013-1#1)
An appraisal of##3##3##(1991-1#1)(2008-11#1)(2008-12#1)
An approach based on##2##4##(2008-10#1)(2008-2#1)
An approach for preparing##2##4##(2008-10#1)(2008-9#1)
An approach is##2##3##(1991-8#1)(2008-2#1)
An approach to the macrocyclic core##2##6##(2008-6#2)
An approach to the##4##4##(1991-3#1)(2008-6#2)(2012-4#1)
An approach to##15##3##(1991-3#1)(1993-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-8#1)(2012-4#1)
An approach##23##2##(1991-3#1)(1991-8#1)(1993-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)(2012-4#1)
An appropriate##9##2##(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
An approximate expression##2##3##(2008-3#2)
An approximate##8##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
An approximately##3##2##(1994-8#1)(1995-2#1)(2007-12#1)
An approximation##2##2##(2008-3#1)(2008-6#1)
An aqueous extract of##2##4##(2008-10#1)(2008-11#1)
An aqueous solution##2##3##(2008-10#1)(2011-2#1)
An aqueous two-phase system of##3##5##(2008-10#3)
An aqueous##9##2##(2008-10#7)(2008-11#1)(2011-2#1)
An area of##2##3##(1996-4#1)(2008-8#1)
An area##3##2##(1996-4#1)(2008-10#1)(2008-8#1)
An array of##7##3##(2008-2#2)(2008-3#3)(2010-8#1)(2013-1#1)
An artificial neural network (ANN) model##2##6##(2008-10#2)
An artificial neural network (ANN)##3##5##(2008-10#2)(2013-1#1)
An artificial neural network##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
An artificial##6##2##(1991-9#1)(1997-4#1)(2008-10#2)(2008-3#1)(2013-1#1)
An assay##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
An assessment of non-communicable diseases##10##5##(2013-8#10)
An assessment of the##7##4##(1992-6#1)(1993-12#1)(1997-3#2)(2008-5#1)(2010-9#1)(2012-2#1)
An assessment of##20##3##(1992-6#1)(1993-12#1)(1996-8#1)(1997-3#2)(2008-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#10)
An assessment##21##2##(1992-6#1)(1993-12#1)(1996-8#1)(1997-3#2)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#10)
An association between##9##3##(1991-12#1)(1993-9#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
An association of##2##3##(1990-3#1)(1997-8#1)
An association##14##2##(1990-3#1)(1991-12#1)(1993-9#1)(1996-3#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#2)(2011-2#1)(2012-12#1)
An asymmetric##2##2##(2008-10#2)
An asymmetry in the##2##4##(1992-3#1)(2008-3#1)
An asymptotic##2##2##(1996-3#1)(2008-3#1)
An atomic##2##2##(2008-10#1)(2008-2#1)
An attempt has been made to##2##6##(2008-10#1)(2013-1#1)
An attempt is made to##2##5##(1990-3#1)(2008-10#1)
An attempt to##8##3##(1995-11#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-3#2)
An attempt was made to##4##5##(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
An attempt was##5##3##(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#1)
An attempt##18##2##(1990-3#1)(1995-11#1)(1995-8#1)(1997-4#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#2)(2013-1#1)
An attenuated##3##2##(1997-6#1)(2007-6#1)(2008-10#1)
An attractive##3##2##(2007-5#1)(2008-10#1)(2009-2#1)
An atypical presentation of##2##4##(2007-10#1)(2007-7#1)
An atypical##3##2##(2007-10#1)(2007-7#1)(2008-10#1)
An audit of##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
An author##2##2##(2007-11#2)
An automatable microassay##2##3##(1996-12#2)
An automated analyser##2##3##(2008-10#2)
An automated system for##3##4##(2008-10#2)(2010-12#1)
An automated system##6##3##(2008-10#4)(2010-12#2)
An automated##23##2##(1990-12#1)(1990-2#1)(2008-10#13)(2008-3#2)(2008-7#2)(2010-12#2)(2010-8#1)(2011-1#1)
An automatic flow-injection##2##3##(2008-10#2)
An automatic method for the determination of##2##7##(2008-10#2)
An automatic method for##4##4##(2008-10#2)(2008-3#2)
An automatic photometric method##2##4##(2008-10#2)
An automatic##14##2##(2008-10#10)(2008-3#3)(2011-1#1)
An autopsy case of##2##4##(2011-2#2)
An autopsy##5##2##(2008-7#2)(2011-2#2)(2013-1#1)
An average density of the genes and/or gene##2##8##(1997-6#1)(1997-8#1)
An average of##4##3##(1996-9#1)(1997-2#1)(2007-10#1)(2012-12#1)
An average recovery of##2##4##(2008-10#2)
An average##17##2##(1990-11#1)(1990-12#1)(1993-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2012-12#1)
An awareness##2##2##(1992-2#1)(1997-1#1)
An early##12##2##(1990-6#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
An easily##2##2##(2007-8#1)(2008-2#1)
An ecological##4##2##(2008-1#1)(2008-10#1)(2008-9#1)(2012-12#1)
An economic##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
An educational and support intervention##2##5##(2011-2#2)
An educational##7##2##(1993-12#1)(1994-2#1)(2008-11#1)(2008-12#2)(2011-2#2)
An effective way of##2##4##(1991-2#1)(2008-7#1)
An effective way##3##3##(1991-2#1)(2008-12#1)(2008-7#1)
An effective##16##2##(1991-2#1)(1995-5#1)(2007-10#1)(2007-11#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#2)(2010-7#1)(2012-12#1)
An efficiency##2##2##(2008-11#1)(2008-2#1)
An efficient and##4##3##(2007-11#1)(2008-3#1)(2008-4#2)
An efficient method for##4##4##(1991-12#1)(1992-9#1)(2008-10#1)(2008-3#1)
An efficient method was##2##4##(2008-10#1)(2012-2#1)
An efficient method##8##3##(1991-12#1)(1992-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-2#1)
An efficient procedure for##2##4##(2008-3#1)(2008-5#1)
An efficient system for##2##4##(1990-5#1)(2008-2#1)
An efficient##37##2##(1990-5#1)(1991-12#1)(1992-9#1)(1996-3#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
An elderly##2##2##(2007-7#2)
An electrically##2##2##(2008-2#1)(2008-3#1)
An electro-optic##3##2##(2008-2#1)(2008-3#2)
An electroanalytical method##2##3##(2008-10#2)
An electrocatalytic##2##2##(2008-10#2)
An electrochemical method for##2##4##(2008-10#2)
An electrochemical##7##2##(2007-12#1)(2008-10#6)
An electron##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
An electronic nose##2##3##(2008-10#1)(2008-11#1)
An electronic questionnaire was##2##4##(2011-2#2)
An electronic search for##2##4##(2012-2#1)(2012-3#1)
An electronic sensor##2##3##(2008-10#1)(2013-1#1)
An electronic##13##2##(1994-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
An electrophoretic##2##2##(2008-11#1)(2008-5#1)
An elevated##2##2##(1995-3#1)(2008-10#1)
An emergency##5##2##(1992-4#1)(1995-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
An emerging##4##2##(2009-10#1)(2010-2#1)(2012-1#1)(2013-1#1)
An emphasis##2##2##(2008-7#1)(2013-8#1)
An empirical##5##2##(1992-2#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-2#1)
An encrypted optical memory system##2##5##(2007-12#1)(2008-3#1)
An encrypted##3##2##(2007-12#1)(2008-3#2)
An end-channel amperometric detector##2##4##(2008-10#2)
An endogenous##3##2##(1993-8#1)(2008-10#1)(2008-8#1)
An endoscopic##3##2##(1991-3#1)(2007-12#1)(2013-8#1)
An enhanced##3##2##(1991-2#1)(2008-2#1)(2008-3#1)
An enhancement factor of##2##4##(2008-10#1)(2008-3#1)
An enhancement of##2##3##(2007-11#1)(2008-10#1)
An enhancement##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2013-1#1)
An enrichment factor of##7##4##(2008-10#7)
An enrichment factor##8##3##(2008-10#8)
An environmentally friendly##2##3##(2008-10#2)
An enzymatic##5##2##(1993-12#1)(1994-9#1)(2008-10#3)
An enzyme linked immunosorbent assay (ELISA)##2##6##(1990-2#1)(2007-2#1)
An enzyme linked##3##3##(1990-2#1)(2007-2#1)(2011-1#1)
An enzyme##7##2##(1990-2#1)(1990-3#1)(1991-5#1)(1995-6#1)(2007-2#1)(2008-10#1)(2011-1#1)
An enzyme-linked immunosorbent assay (ELISA)##2##5##(2008-10#2)
An epidemic of##3##3##(1997-3#1)(2008-10#2)
An epidemiologic study##2##3##(1992-12#1)(2013-7#1)
An epidemiological model##2##3##(2008-10#2)
An epidemiological survey##2##3##(1990-3#1)(2008-5#1)
An epidemiological##11##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
An epigenetic approach##2##3##(1994-5#2)
An equation for##3##3##(1994-2#1)(2007-11#1)(2008-3#1)
An equation##5##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
An error analysis##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
An error##6##2##(1994-6#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
An essay##2##2##(2008-10#1)(2012-12#1)
An essential##5##2##(1994-9#1)(1995-2#1)(2007-8#1)(2008-11#1)(2012-12#1)
An established##2##2##(1997-4#1)(2008-5#1)
An estimate of##2##3##(2007-12#1)(2008-10#1)
An estimated 1##2##3##(2009-12#1)(2009-5#1)
An estimated##9##2##(1990-3#1)(1992-9#1)(1993-12#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-5#1)(2012-12#1)(2012-2#1)
An estimation of the##2##4##(1995-6#1)(2008-3#1)
An estimation##3##2##(1995-6#1)(2008-3#1)(2008-6#1)
An ethnically##2##2##(2010-1#1)(2010-8#1)
An evaluation of a##5##4##(1992-1#1)(1993-1#1)(1994-1#1)(2008-11#1)(2012-3#1)
An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for##4##16##(2008-7#4)
An evaluation of the effectiveness of##5##6##(2007-11#1)(2008-7#4)
An evaluation of the##21##4##(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#5)(2011-2#3)(2013-1#1)
An evaluation of##42##3##(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-7#5)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
An evaluation##44##2##(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#5)(2008-3#1)(2008-7#5)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)
An even##4##2##(1990-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
An evidence-based##6##2##(2007-12#1)(2008-10#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
An evolutionary perspective on the##2##5##(2008-8#1)(2012-3#1)
An evolutionary##4##2##(2008-8#2)(2010-5#1)(2012-3#1)
An exact analysis is presented##2##5##(2007-12#1)(2008-3#1)
An exact analysis##3##3##(2007-12#1)(2008-3#2)
An exact##5##2##(2007-12#2)(2008-3#2)(2008-6#1)
An examination of the##10##4##(1993-11#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)(2012-3#1)
An examination of##18##3##(1991-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-3#1)
An examination##20##2##(1991-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-3#1)
An example application is##2##4##(2008-2#1)(2008-3#1)
An example application##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
An example is given##3##4##(1997-3#1)(2008-11#1)(2008-3#1)
An example is##5##3##(1997-3#1)(2008-11#1)(2008-3#2)(2008-9#1)
An example of a practical##2##5##(2008-2#1)(2008-3#1)
An example of a##4##4##(2008-2#2)(2008-3#1)(2008-5#1)
An example of the##4##4##(1994-9#1)(2008-10#1)(2008-4#1)(2012-3#1)
An example of##14##3##(1990-12#1)(1994-12#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-3#1)
An example using##2##3##(2009-10#1)(2012-1#1)
An example##27##2##(1990-12#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
An exception is##2##3##(1994-9#1)(2007-12#1)
An exception##4##2##(1993-1#1)(1994-9#1)(1995-6#1)(2007-12#1)
An exceptional##2##2##(2008-10#1)(2008-8#1)
An excess of##2##3##(2008-10#1)(2008-5#1)
An expanded##2##2##(2008-12#1)(2008-7#1)
An expanding##2##2##(1992-3#1)(2010-6#1)
An experience##2##2##(1994-1#1)(2008-9#1)
An experiment is##3##3##(2007-11#2)(2008-3#1)
An experiment was conducted to investigate the##2##7##(1992-2#1)(2008-12#1)
An experiment was conducted to##3##5##(1992-2#1)(2008-12#2)
An experiment was conducted##6##4##(1992-2#1)(2008-12#3)(2008-5#1)(2011-1#1)
An experiment was##10##3##(1992-2#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#2)(2011-1#1)
An experiment##16##2##(1992-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#3)(2008-3#2)(2008-5#2)(2010-8#1)(2011-1#1)(2012-3#1)
An experimental demonstration of the##2##5##(2007-12#1)(2008-2#1)
An experimental demonstration of##4##4##(2007-12#2)(2008-2#2)
An experimental demonstration##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
An experimental design method##2##4##(2008-10#1)(2008-7#1)
An experimental design was used for the##2##7##(2008-10#2)
An experimental design was##3##4##(2008-10#3)
An experimental design##7##3##(2008-10#5)(2008-5#1)(2008-7#1)
An experimental investigation of the##2##5##(2007-12#2)
An experimental investigation##4##3##(2007-12#2)(2008-3#1)(2009-6#1)
An experimental method##3##3##(1990-2#1)(1992-9#1)(2008-3#1)
An experimental setup##2##3##(2007-11#1)(2008-6#1)
An experimental study of##2##4##(2008-2#1)(2008-3#1)
An experimental study was##2##4##(2008-11#1)(2010-8#1)
An experimental study##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)
An experimental system was##2##4##(2008-3#1)(2013-8#1)
An experimental system##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
An experimental##46##2##(1990-2#1)(1990-8#1)(1992-9#1)(1995-5#1)(2007-11#2)(2007-12#7)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
An experimentally##2##2##(2007-11#1)(2009-8#1)
An expert##2##2##(2008-10#1)(2008-11#1)
An explanation for##2##3##(1992-3#1)(2011-2#1)
An explanation##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
An explicit##2##2##(2008-10#1)(2008-6#1)
An exploration of##6##3##(2007-12#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-5#1)(2012-1#1)
An exploratory descriptive##3##3##(1992-1#1)(2010-3#2)
An exploratory study##3##3##(2008-11#1)(2010-10#1)(2011-2#1)
An exploratory##11##2##(1992-1#1)(1995-5#1)(2008-10#1)(2008-11#2)(2010-10#2)(2010-3#2)(2011-2#1)(2012-3#1)
An explosion of research has been done in discovering how human health is affected by environmental factors##2##17##(2013-1#2)
An expression for the##2##4##(2008-2#2)
An expression is derived for##3##5##(2007-11#2)(2008-3#1)
An expression is##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
An expression profile of active genes in##2##7##(1996-10#1)(1996-2#1)
An expression profile of##3##4##(1996-10#1)(1996-2#2)
An expression vector##2##3##(1992-8#1)(2008-8#1)
An expression##12##2##(1992-8#1)(1996-10#1)(1996-2#2)(2007-11#2)(2008-2#3)(2008-3#1)(2008-8#1)(2011-2#1)
An extended##4##2##(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
An extension of the##2##4##(2007-12#1)(2008-2#1)
An extension of##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
An extensive literature review##2##4##(2011-2#1)(2012-2#1)
An extensive literature##3##3##(2011-2#2)(2012-2#1)
An extensive##14##2##(1995-3#1)(1996-1#1)(1997-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#1)
An external##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
An extract of##3##3##(2008-5#1)(2009-6#1)(2011-2#1)
An extraction procedure##2##3##(2008-10#2)
An extraction##5##2##(2008-10#4)(2008-7#1)
An extreme-ultraviolet##2##2##(2008-3#2)
An extremely rare case of##2##5##(1990-5#1)(2008-8#1)
An extremely rare##3##3##(1990-5#1)(2008-8#1)(2012-12#1)
An extremely##5##2##(1990-5#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
An ideal##7##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-4#1)
An illustrative##2##2##(2008-2#1)(2011-2#1)
An image of a##2##4##(2008-2#1)(2008-3#1)
An image of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
An image##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
An imaging##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
An imbalance in##2##3##(1991-9#1)(2008-9#1)
An imbalance##3##2##(1991-9#1)(2008-7#1)(2008-9#1)
An immersion model is used with the assumption that each layer is embedded between two##2##15##(2008-3#2)
An immunohistochemical##3##2##(1995-2#1)(2007-12#1)(2008-10#1)
An implementation of the##2##4##(2008-3#2)
An implementation##3##2##(2008-3#2)(2012-3#1)
An important advantage of##2##4##(2008-10#1)(2013-8#1)
An important aspect of the##2##5##(1991-1#1)(2008-10#1)
An important aspect of##3##4##(1991-1#1)(2008-10#1)(2011-2#1)
An important issue in##2##4##(2008-8#1)(2009-9#1)
An important issue##3##3##(2008-8#1)(2008-9#1)(2009-9#1)
An important role##2##3##(1995-5#1)(1996-2#1)
An important step in##2##4##(1996-2#1)(2008-3#1)
An important step##3##3##(1994-8#1)(1996-2#1)(2008-3#1)
An important unresolved issue is whether the natural selection of geometric isomers of carotenoids in photosynthetic pigment-protein complexes is determined by the structure of the protein binding site or by the need for the organism to accomplish a specific physiological task##2##41##(2010-2#2)
An important##41##2##(1991-1#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-2#3)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-2#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
An improved method for the##2##5##(1995-11#1)(1996-5#1)
An improved method for##5##4##(1994-3#1)(1995-11#1)(1996-5#1)(2008-11#1)(2008-3#1)
An improved method##6##3##(1994-3#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
An improved##31##2##(1990-12#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-5#1)(2007-11#3)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2009-11#1)(2012-12#1)
An improvement of##3##3##(2007-11#1)(2007-12#1)(2009-6#1)
An improvement##6##2##(2007-11#1)(2007-12#2)(2008-10#2)(2009-6#1)
An in situ##3##3##(2008-10#2)(2008-4#1)
An in vitro study##6##4##(1990-5#1)(2012-3#1)(2013-1#4)
An in vitro##16##3##(1990-5#1)(1991-9#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-3#2)(2013-1#4)
An in vivo##6##3##(1991-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-5#1)
An in##25##2##(1990-5#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(2008-10#5)(2008-4#1)(2008-5#2)(2009-4#1)(2012-3#2)(2013-1#4)
An in-line##2##2##(2008-10#1)(2008-2#1)
An incident##2##2##(2008-2#1)(2009-10#1)
An increase in the concentration##2##5##(2008-10#1)(2011-2#1)
An increase in the number of##2##6##(1996-12#1)(2006-10#1)
An increase in the##15##4##(1992-11#1)(1994-6#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
An increase in##41##3##(1990-8#1)(1992-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#1)
An increase of##7##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
An increase##49##2##(1990-8#1)(1992-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#1)
An increased frequency of##2##4##(1996-2#1)(2008-5#1)
An increased##12##2##(1992-10#1)(1993-9#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)
An increasing number of patients are##2##6##(2011-2#2)
An increasing number of##7##4##(1991-9#1)(1992-1#1)(1993-2#1)(2008-4#1)(2008-7#1)(2011-2#2)
An increasing##10##2##(1991-9#1)(1992-1#1)(1993-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
An incubation##2##2##(2010-5#1)(2011-2#1)
An independent##4##2##(2008-10#2)(2008-5#1)(2011-1#1)
An index of##2##3##(2008-10#1)(2008-11#1)
An index##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
An indirect##7##2##(1990-12#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-7#1)
An individual##3##2##(1993-3#1)(1994-12#1)(2008-7#1)
An individual's improvement##2##3##(2012-1#2)
An individual's##3##2##(2010-4#1)(2012-1#2)
An inexpensive and##2##3##(2008-10#1)(2009-10#1)
An inexpensive##5##2##(2008-10#2)(2008-7#1)(2009-10#1)(2012-2#1)
An infrared##2##2##(2008-3#2)
An inhibition##2##2##(1995-6#1)(2013-7#1)
An inhibitor of##2##3##(1993-3#1)(2008-7#1)
An inhibitor##4##2##(1993-3#2)(2008-7#1)(2008-8#1)
An inhibitory##2##2##(1990-2#1)(1990-7#1)
An initial quality-by-design (QbD) framework was assembled##2##7##(2012-2#2)
An initial##17##2##(1990-7#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2012-12#1)(2012-2#2)(2013-1#1)
An injected##2##2##(2008-10#2)
An injection##4##2##(2008-10#4)
An innovative approach to##2##4##(2011-2#1)(2013-7#1)
An innovative approach##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
An innovative technique for##2##4##(2007-11#1)(2008-7#1)
An innovative##12##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
An insight into the##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
An insight into##4##3##(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
An insight##5##2##(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-2#1)
An instantaneous##2##2##(2008-3#2)
An instrument to measure##2##4##(2008-3#1)(2010-11#1)
An instrument to##3##3##(2008-3#1)(2008-9#1)(2010-11#1)
An instrument##5##2##(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)
An insufficient##3##2##(1990-3#1)(1993-11#1)(1997-8#1)
An integral equation that##2##4##(2007-11#1)(2008-3#1)
An integral##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
An integrated approach to##2##4##(2008-10#1)(2008-3#1)
An integrated approach##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
An integrated light emitting##2##4##(2008-10#2)
An integrated##24##2##(1992-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#2)(2011-2#1)(2013-1#2)
An integration##2##2##(1997-1#1)(2008-3#1)
An integrative functional model largely based upon##2##7##(2008-12#2)
An integrative##5##2##(1991-2#1)(1996-2#1)(2008-12#2)(2010-10#1)
An intelligent##3##2##(2008-10#3)
An intensity##2##2##(2008-2#1)(2008-3#1)
An intensity-modulated##2##2##(2007-11#1)(2008-3#1)
An intensive##3##2##(1994-12#1)(2008-3#1)(2011-2#1)
An inter-laboratory##2##2##(2008-10#2)
An interaction##2##2##(2007-12#1)(2010-2#1)
An interactive##2##2##(2008-10#1)(2012-2#1)
An interdisciplinary approach##2##3##(1992-2#1)(2012-3#1)
An interdisciplinary##5##2##(1992-1#1)(1992-2#1)(2009-9#1)(2012-3#1)(2013-1#1)
An interesting case of##4##4##(2008-10#2)(2013-1#1)(2013-8#1)
An interesting##10##2##(2008-10#5)(2008-2#1)(2008-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
An interference study##4##3##(2008-10#4)
An interference##6##2##(2008-10#4)(2008-3#2)
An interferogram regeneration procedure##2##4##(2008-3#2)
An interlaboratory##2##2##(2008-10#1)(2008-5#1)
An internal standard##3##3##(1992-12#1)(1993-6#1)(2008-10#1)
An internal##4##2##(1992-12#1)(1993-6#1)(1997-7#1)(2008-10#1)
An international##7##2##(1994-3#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-3#1)
An interpretation of the##2##4##(1991-12#1)(2008-10#1)
An interpretation of##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
An interview study##2##3##(2008-3#1)(2013-8#1)
An interview with the##2##4##(2008-5#1)(2011-2#1)
An interview with##7##3##(1994-1#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
An interview##11##2##(1992-3#1)(1994-1#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
An intestinal##2##2##(1991-12#1)(1994-8#1)
An intracavity##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
An intravenous##2##2##(2008-7#1)(2011-2#1)
An intriguing##2##2##(1994-5#1)(2008-8#1)
An introduction to the##2##4##(1995-3#1)(2008-7#1)
An introduction to##7##3##(1993-3#1)(1995-3#2)(2008-4#2)(2008-7#2)
An introduction##8##2##(1993-2#1)(1993-3#1)(1995-3#2)(2008-4#2)(2008-7#2)
An intron##2##2##(1993-8#1)(1997-2#1)
An inverse##6##2##(2008-11#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-7#1)(2012-1#1)
An investigation into the##4##4##(1997-7#1)(2008-10#1)(2008-9#1)(2009-6#1)
An investigation of the##7##4##(1995-9#1)(2008-3#3)(2009-4#1)(2012-2#1)(2013-1#1)
An investigation of##15##3##(1991-11#1)(1992-11#1)(1995-9#1)(2008-10#2)(2008-3#3)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
An investigation was conducted##2##4##(1991-5#1)(2012-3#1)
An investigation was##3##3##(1991-5#1)(2008-11#1)(2012-3#1)
An investigation##24##2##(1991-11#1)(1991-5#1)(1992-11#1)(1995-9#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
An ion chromatographic##2##3##(1994-9#1)(2008-10#1)
An ion##3##2##(1994-9#1)(2008-10#2)
An isocratic##5##2##(1996-5#1)(2008-10#3)(2011-1#1)
An isolate##2##2##(1995-3#1)(2008-10#1)
An isometric virus##2##3##(2008-10#2)
An iterative##2##2##(2008-3#1)(2010-2#1)
An mRNA##2##2##(1992-12#1)(2008-11#1)
An objective##5##2##(1991-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
An observational study##3##3##(2012-12#1)(2013-1#2)
An observational##7##2##(1995-9#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
An obvious##2##2##(1990-12#1)(2008-6#1)
An off-line##2##2##(2008-10#2)
An oligonucleotide##5##2##(1993-1#1)(1993-11#1)(2008-10#3)
An on-line automated flow injection system with microwave-assisted sample digestion##2##10##(2008-10#2)
An on-line automated##3##3##(2008-10#3)
An on-line flow injection (FI)##2##5##(2008-10#2)
An on-line flow##3##3##(2008-10#3)
An on-line method##2##3##(2008-10#1)(2008-3#1)
An on-line system for preconcentration and determination of##2##8##(2008-10#2)
An on-line system##3##3##(2008-10#3)
An on-line##24##2##(2008-10#21)(2008-11#1)(2008-3#2)
An online##2##2##(1991-11#1)(2008-12#1)
An open label##2##3##(2008-6#1)(2012-2#1)
An open letter##2##3##(1996-3#1)(2008-7#1)
An open reading frame of##2##5##(1993-11#1)(1993-6#1)
An open reading frame##4##4##(1990-11#1)(1992-4#1)(1993-11#1)(1993-6#1)
An open##18##2##(1990-11#1)(1990-9#1)(1991-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-5#1)(2012-2#1)(2013-8#1)
An operational##3##2##(1997-3#1)(2008-10#1)(2010-5#1)
An opposite##3##2##(1993-12#1)(2008-3#1)(2008-7#1)
An optical biosensor for##2##4##(2008-10#2)
An optical biosensor##3##3##(2008-10#3)
An optical chemical sensor##2##4##(2008-10#2)
An optical design##2##3##(2008-3#2)
An optical fiber##7##3##(2008-10#3)(2008-2#2)(2008-3#2)
An optical implementation##3##3##(2008-2#2)(2008-3#1)
An optical method##2##3##(2008-2#1)(2009-5#1)
An optical parametric##2##3##(2007-11#1)(2007-12#1)
An optical resonator##2##3##(2008-3#2)
An optical sensor for##2##4##(2008-10#1)(2008-3#1)
An optical sensor##4##3##(2008-10#1)(2008-3#2)(2010-5#1)
An optical setup##2##3##(2008-3#2)
An optical system##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
An optical##60##2##(2007-11#1)(2007-12#5)(2008-10#12)(2008-2#16)(2008-3#24)(2009-5#1)(2010-5#1)
An optimal strategy##2##3##(2008-2#1)(2008-7#1)
An optimal##7##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
An optimization procedure##2##3##(2008-1#1)(2008-10#1)
An optimization study of##2##4##(2008-10#2)
An optimization##5##2##(2008-1#1)(2008-10#3)(2008-6#1)
An optimized##12##2##(2008-10#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
An optimum##7##2##(2008-10#2)(2008-3#1)(2008-5#2)(2009-5#1)(2013-7#1)
An optoelectronic##4##2##(2008-3#3)(2008-7#1)
An ordinary##2##2##(1990-11#1)(2008-3#1)
An organic##3##2##(1993-11#1)(2007-12#1)(2008-2#1)
An original technique##2##3##(1995-9#1)(2008-4#1)
An original##9##2##(1990-8#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
An orthogonal##3##2##(2008-10#2)(2008-2#1)
An orthopedic group that recently moved to a new location needed to boost its image##2##15##(1994-3#2)
An orthophosphate##2##2##(2008-10#2)
An otherwise##2##2##(2007-2#1)(2008-5#1)
An outbreak investigation practicum##2##4##(1996-1#2)
An outbreak of anthrax##2##4##(1990-9#2)
An outbreak of peste des petits ruminants##2##7##(2011-2#2)
An outbreak of##9##3##(1990-9#2)(1992-5#1)(2007-12#2)(2007-7#1)(2009-5#1)(2011-2#2)
An outbreak##12##2##(1990-3#1)(1990-9#2)(1992-5#1)(1996-1#2)(2007-12#2)(2007-7#1)(2009-5#1)(2011-2#2)
An outcomes##2##2##(1994-2#1)(1997-1#1)
An output power of 1##2##5##(2007-11#1)(2008-2#1)
An output power of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
An output##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
An overall##9##2##(1994-5#1)(1997-7#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
An overlapping##2##2##(1996-12#1)(2009-8#1)
An overlay##2##2##(2007-11#1)(2008-3#1)
An overview is##2##3##(2008-10#1)(2008-2#1)
An overview of the##14##4##(1993-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)
An overview of##43##3##(1992-1#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)
An overview on##2##3##(2008-10#1)(2008-4#1)
An overview##55##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-12#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
An oxygen##2##2##(1997-7#1)(2008-10#1)
An ultrafast##2##2##(2008-3#1)(2012-8#1)
An ultrafiltration##2##2##(2008-10#1)(2008-7#1)
An ultrasonic scalpel##2##3##(2007-8#1)(2010-8#1)
An ultrasonic##5##2##(2007-8#1)(2008-10#2)(2008-3#1)(2010-8#1)
An ultrasound scan##2##3##(1997-3#1)(2008-10#1)
An ultrastructural investigation of##2##4##(2008-10#1)(2008-7#1)
An ultrastructural investigation##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
An ultrastructural##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)
An uncommon##4##2##(1992-9#1)(2008-10#1)(2011-2#1)(2012-3#1)
An underlying##4##2##(1997-8#1)(2008-3#1)(2009-11#1)(2009-8#1)
An understanding of the##8##4##(2007-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)
An understanding of these##2##4##(2007-8#1)(2008-2#1)
An understanding of##13##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
An understanding##14##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
An uneven##2##2##(2008-10#1)(2011-1#1)
An unexpected##7##2##(1990-2#1)(1992-12#1)(2008-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
An untapped##2##2##(1992-1#1)(2008-11#1)
An unusual case of a##2##5##(2007-7#1)(2009-7#1)
An unusual case of##7##4##(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)
An unusual case##8##3##(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-3#1)
An unusual cause of##2##4##(2009-10#1)(2013-1#1)
An unusual complication##2##3##(2007-7#1)(2013-8#1)
An unusual finding was##2##4##(2007-7#1)(2008-12#1)
An unusual presentation of##3##4##(2007-7#1)(2010-11#1)(2013-1#1)
An unusual##31##2##(1990-3#1)(1990-6#1)(1991-11#2)(1991-8#1)(1992-8#1)(1995-2#1)(2007-10#2)(2007-7#4)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
An unusually##2##2##(1992-4#1)(2011-1#1)
An unweighted pair-group method##2##4##(2008-10#2)
An update of##2##3##(1990-6#1)(2012-3#1)
An update on##4##3##(1994-1#1)(2007-12#1)(2008-1#1)(2008-11#1)
An update##9##2##(1990-6#1)(1994-1#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2012-3#1)(2013-1#1)
An upstream region##2##3##(1992-3#1)(1994-2#1)
An urban##2##2##(1997-1#1)(2008-11#1)
An urgent##2##2##(2007-2#1)(2009-4#1)
An x-ray##2##2##(1991-3#1)(2008-3#1)
An##2701##1##(1990-10#2)(1990-11#5)(1990-12#17)(1990-2#10)(1990-3#11)(1990-5#4)(1990-6#4)(1990-7#6)(1990-8#7)(1990-9#5)(1991-1#9)(1991-10#1)(1991-11#4)(1991-12#10)(1991-2#8)(1991-3#6)(1991-4#1)(1991-5#6)(1991-6#1)(1991-8#7)(1991-9#9)(1992-1#8)(1992-10#1)(1992-11#7)(1992-12#14)(1992-2#9)(1992-3#15)(1992-4#4)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#8)(1993-1#4)(1993-10#2)(1993-11#10)(1993-12#12)(1993-2#8)(1993-3#11)(1993-5#1)(1993-6#5)(1993-8#7)(1993-9#9)(1994-1#6)(1994-11#5)(1994-12#16)(1994-2#9)(1994-3#11)(1994-5#10)(1994-6#8)(1994-8#7)(1994-9#5)(1995-1#2)(1995-11#11)(1995-12#9)(1995-2#16)(1995-3#12)(1995-4#1)(1995-5#6)(1995-6#8)(1995-8#4)(1995-9#6)(1996-1#9)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#15)(1996-3#8)(1996-4#4)(1996-5#11)(1996-8#3)(1996-9#5)(1997-1#11)(1997-2#9)(1997-3#15)(1997-4#11)(1997-5#5)(1997-6#11)(1997-7#9)(1997-8#8)(1997-9#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-10#9)(2007-11#58)(2007-12#90)(2007-2#6)(2007-5#3)(2007-6#2)(2007-7#17)(2007-8#12)(2007-9#2)(2008-1#20)(2008-10#523)(2008-11#93)(2008-12#44)(2008-2#125)(2008-3#250)(2008-4#47)(2008-5#56)(2008-6#30)(2008-7#79)(2008-8#48)(2008-9#31)(2009-1#1)(2009-10#11)(2009-11#6)(2009-12#12)(2009-2#4)(2009-3#2)(2009-4#11)(2009-5#15)(2009-6#7)(2009-7#7)(2009-8#16)(2009-9#11)(2010-1#6)(2010-10#7)(2010-11#7)(2010-12#9)(2010-2#9)(2010-3#8)(2010-4#17)(2010-5#9)(2010-6#4)(2010-7#6)(2010-8#12)(2010-9#5)(2011-1#25)(2011-10#1)(2011-2#76)(2011-3#4)(2012-1#12)(2012-12#44)(2012-2#40)(2012-3#38)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#81)(2013-7#5)(2013-8#39)
An0##2##1##(2013-8#2)
An1 mRNA##2##2##(1993-6#2)
An1##5##1##(1993-6#5)
An1a and An1b##2##3##(1993-6#2)
AnFBV##4##1##(2008-10#4)
Anabaena sp##6##2##(1995-6#1)(2008-8#5)
Anabaena##9##1##(1992-12#2)(1995-6#1)(2008-11#1)(2008-8#5)
Anabaptist children##3##2##(2008-12#3)
Anabaptist##10##1##(2008-12#10)
Anabolic##2##1##(2008-10#1)(2010-11#1)
Anadara grandis##2##2##(2008-5#2)
Anaemia##3##1##(2008-1#2)(2013-8#1)
Anaerobic##2##1##(2007-7#1)(2008-5#1)
Anaesthesia for conjoined twins##2##4##(2010-7#2)
Anaesthesia for##5##2##(1993-7#1)(1995-10#1)(2006-10#1)(2010-7#2)
Anaesthesia##8##1##(1993-7#1)(1995-10#1)(1996-3#1)(2006-10#1)(2010-7#3)(2011-2#1)
Anaesthetic management of##4##3##(2010-7#3)(2012-2#1)
Anaesthetic##5##1##(2010-7#3)(2011-1#1)(2012-2#1)
Anal##25##1##(1991-10#1)(1991-6#1)(1995-2#1)(2007-11#1)(2008-10#16)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
Analgesia and##2##2##(1993-1#1)(2010-1#1)
Analgesia##9##1##(1993-1#1)(2007-2#1)(2008-7#3)(2009-5#1)(2010-1#1)(2012-1#1)(2012-12#1)
Analgesic##2##1##(2008-1#1)(2008-10#1)
Analog##7##1##(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2012-3#2)
Analogous##5##1##(1991-8#1)(1992-12#1)(1995-11#1)(2008-10#2)
Analogously##2##1##(1997-1#1)(2008-10#1)
Analogs of##5##2##(1990-2#2)(1992-8#1)(2007-11#1)(2008-7#1)
Analogue Scale (VAS)##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
Analogue Scale##5##2##(1991-2#1)(2007-11#1)(2007-8#1)(2012-1#1)(2013-1#1)
Analogue##7##1##(1991-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-11#1)(2012-1#1)(2013-1#1)
Analogues of##4##2##(1992-8#1)(1993-5#1)(1995-11#1)(2011-1#1)
Analogues##11##1##(1992-3#1)(1992-8#1)(1993-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(2007-12#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
Analyser##5##1##(2008-10#3)(2008-5#2)
Analyses are##2##2##(1993-12#1)(2008-10#1)
Analyses by##3##2##(1992-3#1)(1996-2#1)(1997-7#1)
Analyses focused on##2##3##(1994-6#1)(2013-1#1)
Analyses for##2##2##(2008-10#2)
Analyses of a##2##3##(2008-6#1)(2008-8#1)
Analyses of disease##2##3##(2008-10#2)
Analyses of the##13##3##(1991-2#1)(1992-3#1)(1994-5#1)(2008-10#4)(2008-6#1)(2008-8#2)(2009-8#1)(2012-2#1)(2013-8#1)
Analyses of these##2##3##(2008-10#1)(2010-10#1)
Analyses of##51##2##(1990-5#1)(1991-10#1)(1991-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
Analyses revealed##2##2##(2009-7#2)
Analyses were carried out##2##4##(2007-12#1)(2008-10#1)
Analyses were performed##4##3##(2008-10#3)(2009-7#1)
Analyses were##8##2##(2007-12#1)(2008-10#5)(2008-3#1)(2009-7#1)
Analyses##86##1##(1990-5#1)(1991-10#1)(1991-2#1)(1992-3#2)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#37)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#3)(2008-8#4)(2008-9#3)(2009-2#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Analysing the##5##2##(2008-5#1)(2011-2#1)(2012-12#3)
Analysing##7##1##(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#4)
Analysis (PCA)##3##2##(2007-5#1)(2008-10#1)(2010-8#1)
Analysis (SFA)##2##2##(2008-11#1)(2013-8#1)
Analysis Critical Control##3##3##(1997-3#1)(2009-3#2)
Analysis Identifies##2##2##(2008-10#1)(2012-3#1)
Analysis Methods##2##2##(2008-12#2)
Analysis allowed##2##2##(2008-10#1)(2008-4#1)
Analysis and design of##3##4##(2008-3#3)
Analysis and the##2##3##(2008-11#1)(2010-8#1)
Analysis and##24##2##(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-3#2)(2013-1#1)
Analysis by##9##2##(1990-6#1)(1993-6#1)(1993-8#1)(1994-9#1)(1996-9#1)(2008-10#2)(2008-9#1)(2010-2#1)
Analysis for##5##2##(2008-10#5)
Analysis in##4##2##(1990-8#1)(2009-10#1)(2010-7#1)(2012-1#1)
Analysis indicates that##2##3##(2007-11#1)(2010-10#1)
Analysis of DNA content and##3##5##(2008-9#3)
Analysis of DNA##5##3##(2008-9#5)
Analysis of Host Species Specificity of Magnaporthe grisea Toward##2##9##(2008-10#2)
Analysis of Host Species Specificity of Magnaporthe##3##7##(2008-10#3)
Analysis of Host##5##3##(2008-10#5)
Analysis of Isolates of##2##4##(2008-10#2)
Analysis of Leptosphaeria maculans##2##4##(2008-10#2)
Analysis of RNA by northern##2##5##(2008-4#2)
Analysis of SMV##2##3##(2008-10#2)
Analysis of a Global Collection of##2##6##(2008-10#2)
Analysis of a simple##2##4##(2008-11#1)(2008-2#1)
Analysis of a##26##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2009-10#1)(2009-4#1)(2013-1#2)
Analysis of amino##2##3##(2008-10#1)(2008-4#1)
Analysis of an##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
Analysis of both##2##3##(2008-10#1)(2008-11#1)
Analysis of cell##4##3##(1995-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
Analysis of clinical##3##3##(1992-5#1)(2010-5#1)(2012-3#1)
Analysis of covariance##2##3##(1992-9#1)(2012-1#1)
Analysis of data##4##3##(1991-2#1)(1995-3#1)(2008-9#1)(2010-2#1)
Analysis of drug utilization##2##4##(2008-11#2)
Analysis of drug##3##3##(1992-9#1)(2008-11#2)
Analysis of extracts of##2##4##(1997-6#1)(2008-10#1)
Analysis of extracts##3##3##(1997-6#1)(2008-10#2)
Analysis of factors##2##3##(2007-5#1)(2008-1#1)
Analysis of gene expression##4##4##(2008-10#2)(2008-4#1)(2010-10#1)
Analysis of gene##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2010-10#1)
Analysis of medical records##2##4##(2013-1#2)
Analysis of molecular variance (AMOVA)##2##5##(2008-10#1)(2008-12#1)
Analysis of molecular variance##6##4##(2008-10#5)(2008-12#1)
Analysis of molecular##7##3##(2008-10#6)(2008-12#1)
Analysis of one##2##3##(2013-1#2)
Analysis of other##3##3##(1995-6#1)(1997-2#1)(2008-10#1)
Analysis of protein##7##3##(1994-11#1)(2008-1#1)(2008-2#1)(2008-4#3)(2010-4#1)
Analysis of the data##4##4##(1994-2#1)(1997-7#1)(2008-10#1)(2008-3#1)
Analysis of the effect of##3##5##(2007-12#1)(2008-10#1)(2008-11#1)
Analysis of the expression of##2##5##(1992-8#1)(2012-1#1)
Analysis of the influence of##2##5##(2008-3#1)(2013-1#1)
Analysis of the mechanism of##2##5##(2008-11#1)(2008-5#1)
Analysis of the molecular##2##4##(1993-8#1)(2008-10#1)
Analysis of the nucleotide sequence of##3##6##(1990-11#1)(1995-6#1)(1995-8#1)
Analysis of the nucleotide sequence##4##5##(1990-11#1)(1994-12#1)(1995-6#1)(1995-8#1)
Analysis of the nucleotide##6##4##(1990-11#1)(1990-7#1)(1994-12#1)(1995-6#1)(1995-8#1)(2008-10#1)
Analysis of the predicted##2##4##(1993-12#1)(1995-8#1)
Analysis of the rate##2##4##(2008-4#1)(2013-7#1)
Analysis of the sequence revealed##2##5##(1996-12#1)(1996-3#1)
Analysis of the sequence##3##4##(1996-12#1)(1996-3#1)(2008-10#1)
Analysis of the spatial##2##4##(2008-10#1)(2008-8#1)
Analysis of the structure and##2##5##(1997-6#1)(2009-11#1)
Analysis of the structure##4##4##(1995-5#1)(1997-3#1)(1997-6#1)(2009-11#1)
Analysis of the use of##2##5##(1995-1#1)(2008-11#1)
Analysis of the##152##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-12#3)(1992-3#1)(1992-8#3)(1993-1#1)(1993-12#2)(1993-2#3)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#5)(1995-6#3)(1995-8#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#22)(2008-11#9)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#4)(2013-7#1)
Analysis of these##5##3##(1991-11#1)(1992-10#1)(2008-10#1)(2008-4#1)(2009-12#1)
Analysis of this##2##3##(1997-3#1)(2008-9#1)
Analysis of three##3##3##(1993-6#1)(1993-9#1)(1996-6#1)
Analysis of tissue##2##3##(1991-12#1)(2008-9#1)
Analysis of variance (ANOVA)##2##4##(1994-2#1)(2008-10#1)
Analysis of variance and##2##4##(2008-10#1)(2013-1#1)
Analysis of variance##11##3##(1994-2#1)(2008-10#4)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#3)
Analysis of volatiles##2##3##(2008-10#2)
Analysis of##603##2##(1990-11#3)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#6)(1995-8#5)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#8)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-5#2)(2007-9#1)(2008-1#8)(2008-10#171)(2008-11#25)(2008-12#5)(2008-2#18)(2008-3#28)(2008-4#13)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#19)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#2)(2010-10#4)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#12)(2012-5#1)(2013-1#21)(2013-7#2)(2013-8#3)
Analysis on the##2##3##(2011-1#1)(2013-7#1)
Analysis on##3##2##(2010-12#1)(2011-1#1)(2013-7#1)
Analysis revealed##3##2##(1996-7#1)(2008-10#1)(2009-3#1)
Analysis showed that##2##3##(1991-6#1)(2008-10#1)
Analysis shows that the##2##4##(2008-2#2)
Analysis shows that##3##3##(2008-2#2)(2010-3#1)
Analysis speed of the##2##4##(1993-8#2)
Analysis to##5##2##(1994-12#1)(2008-10#1)(2009-10#1)(2010-8#2)
Analysis using##2##2##(2008-10#1)(2010-4#1)
Analysis was performed by##2##4##(1995-12#1)(2008-10#1)
Analysis was performed##4##3##(1991-2#1)(1995-12#1)(2008-10#2)
Analysis was##13##2##(1991-2#1)(1995-12#2)(2008-10#5)(2010-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
Analysis with##4##2##(1995-4#1)(2008-7#1)(2009-3#1)(2012-3#1)
Analysis##791##1##(1990-11#3)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#2)(1990-8#3)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#3)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#6)(1995-8#5)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#8)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#3)(2007-10#1)(2007-11#7)(2007-12#8)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#8)(2008-10#214)(2008-11#30)(2008-12#7)(2008-2#23)(2008-3#38)(2008-4#19)(2008-5#11)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#21)(2009-1#2)(2009-10#10)(2009-11#2)(2009-12#2)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#5)(2011-2#8)(2012-1#5)(2012-12#3)(2012-2#11)(2012-3#31)(2012-5#1)(2013-1#26)(2013-7#4)(2013-8#9)
Analysts at Yamaichi estimate that##2##5##(2008-5#2)
Analysts##6##1##(2008-10#1)(2008-5#5)
Analyte##5##1##(2008-10#5)
Analytes were extracted##2##3##(2008-10#1)(2011-1#1)
Analytes were##6##2##(2008-10#4)(2011-1#1)(2011-3#1)
Analytes##8##1##(2008-10#6)(2011-1#1)(2011-3#1)
Analytic expressions##2##2##(2008-2#1)(2010-7#1)
Analytic##12##1##(2007-10#1)(2007-11#1)(2008-2#3)(2008-3#5)(2010-7#1)(2011-2#1)
Analytical Chemistry##3##2##(2008-10#2)(2010-11#1)
Analytical and numerical##2##3##(2008-3#1)(2008-7#1)
Analytical and##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
Analytical applications of##4##3##(2008-10#4)
Analytical chemistry of##2##3##(2008-10#1)(2010-7#1)
Analytical chemistry##4##2##(2008-10#1)(2010-7#3)
Analytical curves##2##2##(2008-10#2)
Analytical data##2##2##(2008-10#2)
Analytical evaluation of##2##3##(2008-10#2)
Analytical expressions for the wave-front aberration coefficients##2##7##(2008-2#2)
Analytical expressions for the##6##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
Analytical expressions for##7##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#1)
Analytical expressions##8##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#1)
Analytical formulas##2##2##(2007-11#1)(2008-2#1)
Analytical investigation of##2##3##(2008-10#2)
Analytical methods for##2##3##(2008-10#2)
Analytical parameters##2##2##(2008-10#1)(2009-8#1)
Analytical properties of##2##3##(2008-10#2)
Analytical recoveries##2##2##(2008-10#2)
Analytical recovery##2##2##(1993-9#1)(1997-2#1)
Analytical results for the##3##4##(2008-10#3)
Analytical results obtained by##3##4##(2008-10#3)
Analytical results obtained##4##3##(2008-10#4)
Analytical results of##3##3##(2007-11#1)(2008-10#2)
Analytical results##10##2##(2007-11#1)(2008-10#9)
Analytical studies##3##2##(1996-12#1)(2008-10#2)
Analytical study##2##2##(2008-10#2)
Analytical treatment##2##2##(2007-12#1)(2007-7#1)
Analytical##116##1##(1992-3#1)(1993-9#1)(1995-2#1)(1996-12#1)(1997-2#2)(2007-11#5)(2007-12#4)(2007-7#1)(2008-10#63)(2008-11#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#5)(2010-7#4)(2012-2#1)(2013-1#1)(2013-8#1)
Analytically##2##1##(1990-8#1)(2012-1#1)
Analyzed##2##1##(2008-10#1)(2008-7#1)
Analyzer##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
Analyzing and##2##2##(2008-10#1)(2008-4#1)
Analyzing the##6##2##(1991-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)
Analyzing##23##1##(1991-3#1)(1992-3#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#5)(2008-7#1)(2008-8#3)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
Anaphylactoid##2##1##(1991-9#1)(1996-11#1)
Anaphylaxis is##2##2##(2013-1#1)(2013-8#1)
Anaphylaxis##9##1##(1995-11#1)(1997-7#1)(2008-10#1)(2010-6#1)(2013-1#3)(2013-8#2)
Anaplasma phagocytophilum is##2##3##(2008-12#1)(2008-9#1)
Anaplasma phagocytophilum##4##2##(2008-12#2)(2008-9#2)
Anaplasma##9##1##(1996-12#2)(2008-12#3)(2008-9#2)(2013-1#2)
Anaplastic##3##1##(1993-11#1)(2013-1#2)
Anarrhichomenum##7##1##(2008-10#7)
Anastomosis Group##6##2##(2008-10#6)
Anastomosis Groups##2##2##(2008-10#1)(2008-12#1)
Anastomosis reactions##3##2##(2008-10#3)
Anastomosis##16##1##(2007-8#1)(2008-10#14)(2008-12#1)
Anastomotic##3##1##(1996-2#1)(2007-7#2)
Anastrepha ludens##2##2##(2011-2#2)
Anastrepha species##2##2##(2008-6#2)
Anastrepha suspensa##4##2##(2007-12#2)(2011-2#2)
Anastrepha##10##1##(2007-12#2)(2008-6#4)(2011-2#4)
Anatolia##4##1##(2008-12#2)(2012-9#1)(2013-8#1)
Anatomic and##2##2##(1996-3#1)(2010-7#1)
Anatomic##4##1##(1996-3#1)(1996-6#1)(2010-7#1)(2013-1#1)
Anatomical and##3##2##(2011-2#1)(2013-1#2)
Anatomical##19##1##(1990-8#1)(1991-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
Anatomy and##2##2##(1990-2#1)(2011-1#1)
Anatomy of##4##2##(2007-4#1)(2008-10#1)(2008-11#1)(2009-10#1)
Anatomy##11##1##(1990-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-1#2)(2011-1#1)(2012-2#1)
Ancestry##3##1##(2009-5#3)
Anchor##2##1##(1996-3#1)(2012-2#1)
Anchorage-independent growth of##3##3##(1991-12#3)
Anchorage-independent growth##4##2##(1991-12#3)(2012-12#1)
Anchoring##2##1##(2008-10#1)(2009-5#1)
Ancient Theory about Public Health through Physical Activity against Hyperlipidemia and Ischemic Heart Disease##2##14##(2013-1#2)
Ancient cystic##2##2##(2008-7#2)
Ancient##11##1##(1991-2#1)(2008-10#2)(2008-7#3)(2009-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
Ancillary##3##1##(1993-12#1)(1997-2#1)(2008-10#1)
Ancistrocladus korupensis##2##2##(1994-12#2)
Ancrod-formed fibrin##2##2##(1994-9#2)
Ancylostoma sp##2##2##(2011-1#2)
And a##2##2##(1994-3#1)(2008-8#1)
And also##3##2##(1990-12#1)(2008-10#2)
And finally##4##2##(1991-2#1)(1993-2#1)(2008-11#1)(2010-3#1)
And how##3##2##(1995-11#1)(2008-7#1)(2011-2#1)
And it is##2##3##(2008-7#1)(2010-8#1)
And it##5##2##(1991-3#1)(1996-1#1)(2008-7#1)(2010-8#1)(2013-8#1)
And less important ones were Changing##2##6##(1991-2#2)
And now##2##2##(1995-9#1)(2007-9#1)
And the##16##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
And then##4##2##(1991-2#1)(2008-11#1)(2010-9#1)(2013-8#1)
And while##4##2##(1992-11#1)(1993-12#1)(1993-2#1)(2012-12#1)
And you##2##2##(1994-3#2)
And##105##1##(1990-12#2)(1991-12#1)(1991-2#4)(1991-3#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-2#4)(1994-1#2)(1994-3#4)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#2)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
Andean and##3##2##(2008-10#3)
Andean forest##3##2##(2013-7#3)
Andean isolates from Africa##3##4##(2008-10#3)
Andean isolates from##4##3##(2008-10#4)
Andean isolates##5##2##(2008-10#5)
Andean species##2##2##(2009-2#2)
Andean##36##1##(1997-6#1)(2008-10#21)(2008-11#1)(2008-5#1)(2008-8#3)(2009-2#2)(2013-7#6)(2013-8#1)
Andersen syndrome##4##2##(2008-8#4)
Anderson Cancer Center##2##3##(2007-12#1)(2011-2#1)
Anderson Cancer##3##2##(2007-12#1)(2011-2#2)
Anderson and##2##2##(2008-6#1)(2010-4#1)
Anderson sampler technique##2##3##(2008-10#2)
Anderson##19##1##(1993-6#1)(1994-12#2)(1995-6#1)(1996-5#4)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#2)(2010-11#1)(2010-4#1)(2011-2#2)(2013-8#1)
Anderson's##2##1##(1991-3#1)(1996-5#1)
Andersson##2##1##(2008-5#2)
Andes of##2##2##(2008-10#1)(2013-7#1)
Andes##20##1##(1990-6#1)(2008-10#6)(2008-5#6)(2008-8#3)(2009-2#1)(2013-1#1)(2013-7#2)
Andre##2##1##(2008-10#1)(2009-1#1)
Andreas##7##1##(1990-11#1)(1996-4#4)(2009-7#2)
Andreev##3##1##(1992-3#1)(1996-9#1)(2008-7#1)
Andrew##8##1##(1992-3#1)(1992-8#1)(1993-8#1)(1996-12#1)(1996-2#1)(2007-2#1)(2010-8#1)(2011-2#1)
Andrews##7##1##(2008-10#5)(2008-4#1)(2012-2#1)
Androgen binding##2##2##(1990-11#2)
Androgen receptor##2##2##(1992-12#1)(1995-12#1)
Androgen##11##1##(1990-11#2)(1992-12#1)(1995-12#3)(2008-4#4)(2008-7#1)
Androgenic##3##1##(1995-12#1)(2012-3#2)
Androgens##3##1##(2008-4#2)(2009-4#1)
Andrographis paniculata##2##2##(2008-10#1)(2012-2#1)
Andross##5##1##(2008-10#5)
Anecdotal##2##1##(2007-10#1)(2012-12#1)
Anemia in##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
Anemia is common in##2##4##(2008-1#1)(2008-7#1)
Anemia is##3##2##(2008-1#1)(2008-7#2)
Anemia management in##2##3##(2008-1#1)(2013-1#1)
Anemia of##2##2##(2008-1#1)(2012-2#1)
Anemia##17##1##(1991-12#1)(1997-3#1)(2008-1#4)(2008-10#1)(2008-7#5)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
Anesthesia for##4##2##(2006-10#3)(2012-3#1)
Anesthesia##13##1##(1997-4#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
Anesthetic##4##1##(1993-1#1)(2012-12#1)(2013-1#2)
Aneuploidy##2##1##(1994-12#1)(1996-12#1)
Aneurysm Surgery##2##2##(2008-12#1)(2012-3#1)
Aneurysm##10##1##(1997-6#1)(2008-12#2)(2010-7#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#2)
Aneurysmal Subarachnoid Haemorrhage or ASAH##2##5##(2007-10#2)
Aneurysmal Subarachnoid Hemorrhage##2##3##(2011-2#1)(2012-3#1)
Aneurysmal Subarachnoid##4##2##(2007-10#2)(2011-2#1)(2012-3#1)
Aneurysmal##9##1##(1996-3#2)(2007-10#3)(2007-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
Aneurysms of##2##2##(1991-6#1)(2007-8#1)
Aneurysms##9##1##(1991-6#1)(1995-11#2)(1997-3#3)(2007-8#1)(2008-12#1)(2012-3#1)
Ang II##3##2##(1992-9#1)(2008-1#2)
Ang##4##1##(1992-9#2)(2008-1#2)
Ang-II##3##1##(2008-8#3)
AngCP##6##1##(2008-9#6)
AngI and AngII##2##3##(1990-12#2)
AngI##4##1##(1990-12#4)
AngII##7##1##(1990-12#5)(2008-4#2)
Angeles##17##1##(1991-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Angelica dahurica##3##2##(2008-10#2)(2012-3#1)
Angelica##6##1##(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#2)
Angelman##2##1##(1990-9#1)(2011-2#1)
Angelman's syndrome##3##2##(1990-9#3)
Angelman's##4##1##(1990-9#4)
Angelonia flower##2##2##(2008-10#2)
Angelonia##6##1##(2008-10#6)
Angina in##3##2##(2009-10#1)(2011-2#2)
Angina##5##1##(2008-3#2)(2009-10#1)(2011-2#2)
Angio##2##1##(2010-5#1)(2011-2#1)
AngioJet rheolytic thrombectomy##4##3##(2011-2#4)
AngioJet##5##1##(2011-2#5)
Angiogenesis is##3##2##(1990-4#1)(2008-11#1)(2012-2#1)
Angiogenesis##14##1##(1990-4#1)(1994-12#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Angiogenic##3##1##(1992-2#1)(2009-8#1)(2013-8#1)
Angiogenin is a##2##3##(1992-11#2)
Angiogenin is##3##2##(1992-11#2)(1994-9#1)
Angiogenin##6##1##(1992-11#3)(1994-9#1)(1996-10#1)(2012-2#1)
Angiographic assessment##2##2##(1996-3#1)(1997-8#1)
Angiographic findings##3##2##(1997-8#2)(2007-8#1)
Angiographic##12##1##(1990-5#1)(1996-3#1)(1997-3#2)(1997-8#3)(2007-8#2)(2008-11#2)(2011-2#1)
Angiography and##2##2##(2008-7#1)(2011-1#1)
Angiography demonstrated##2##2##(1997-6#1)(2008-12#1)
Angiography of the##2##3##(1992-6#1)(2011-2#1)
Angiography showed##3##2##(2008-7#3)
Angiography was##2##2##(1990-9#1)(2012-2#1)
Angiography##27##1##(1990-9#1)(1991-11#1)(1991-8#1)(1992-6#1)(1995-11#1)(1997-6#2)(2007-8#1)(2008-12#2)(2008-7#6)(2009-5#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#1)
Angiomyolipoma##2##1##(1992-2#2)
Angiomyxolipoma##2##1##(2010-6#2)
Angioplasty##3##1##(1990-2#1)(2008-11#1)(2012-3#1)
Angiosarcoma is a rare##2##4##(2008-6#1)(2013-7#1)
Angiosperm##2##1##(2008-10#1)(2009-12#1)
Angiotensin II receptor##2##3##(1995-11#1)(2008-8#1)
Angiotensin II##13##2##(1992-3#1)(1994-11#2)(1995-11#3)(1997-7#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#1)
Angiotensin converting enzyme##2##3##(2008-1#1)(2008-7#1)
Angiotensin##20##1##(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#2)(1995-11#3)(1997-7#1)(2008-1#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2012-1#1)
Angiotensin-converting enzyme inhibitors and beta-blockers##2##5##(2011-2#2)
Angiotensin-converting enzyme##3##2##(2008-1#1)(2011-2#2)
Angiotensin-converting##4##1##(2008-1#1)(2011-2#2)(2012-3#1)
Angle of##2##2##(2007-8#1)(2008-3#1)
Angle##10##1##(1997-2#1)(2007-8#1)(2008-2#1)(2008-3#2)(2012-3#5)
Angles##2##1##(2008-2#1)(2008-3#1)
Anglo youths reported more##2##4##(2008-9#2)
Anglo youths##3##2##(2008-9#3)
Anglo##10##1##(2007-12#1)(2008-9#5)(2011-2#1)(2012-2#2)(2012-3#1)
Anglophone##2##1##(1994-12#1)(2012-12#1)
Angola##3##1##(2007-7#1)(2008-12#1)(2011-1#1)
Angström##2##1##(2008-2#1)(2008-3#1)
Anguilla japonica##3##2##(2008-5#1)(2010-8#2)
Anguilla##4##1##(2008-5#1)(2009-5#1)(2010-8#2)
Angular Leaf Spot##2##3##(2008-10#2)
Angular and##2##2##(2008-2#1)(2008-3#1)
Angular dependence##2##2##(2008-1#1)(2008-2#1)
Angular dispersion of##2##3##(2007-11#2)
Angular displacement of##2##3##(2008-3#1)(2013-1#1)
Angular##17##1##(1996-12#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#7)(2013-1#1)
Anhui Province##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
Anhui##4##1##(2008-10#2)(2012-3#1)(2013-8#1)
Aniba perutilis##2##2##(2013-7#2)
Animal Cell##2##2##(2008-11#2)
Animal Farm##2##2##(2008-11#2)
Animal Health##10##2##(2011-2#9)(2013-8#1)
Animal and human studies##2##4##(2008-10#1)(2012-2#1)
Animal and##3##2##(2008-10#1)(2010-6#1)(2012-2#1)
Animal experiments##2##2##(2008-8#1)(2010-3#1)
Animal health assurance##2##3##(2008-4#2)
Animal model of##2##3##(2008-4#1)(2008-9#1)
Animal model##4##2##(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
Animal models for##2##3##(2008-4#1)(2010-6#1)
Animal models have##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
Animal models of##6##3##(2008-12#1)(2008-4#4)(2008-7#1)
Animal models##13##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#2)(2010-6#1)(2012-3#1)
Animal studies##5##2##(1996-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
Animal##77##1##(1991-1#2)(1991-11#1)(1991-8#1)(1992-10#1)(1993-11#1)(1994-3#1)(1996-3#1)(1996-7#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#11)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#12)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
Animals are##2##2##(2008-11#1)(2008-6#1)
Animals from##2##2##(2008-5#1)(2010-1#1)
Animals in##3##2##(1994-2#1)(2006-6#1)(2008-10#1)
Animals of##2##2##(2010-1#1)(2013-1#1)
Animals treated with##2##3##(1993-1#1)(2008-10#1)
Animals were assigned to##2##4##(2008-12#2)
Animals were slaughtered##2##3##(2008-9#1)(2010-4#1)
Animals were##17##2##(1992-11#1)(1992-2#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#3)
Animals with##2##2##(1993-12#1)(1993-5#1)
Animals##52##1##(1990-5#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#5)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#3)(2010-4#2)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
Anion binding##2##2##(1990-5#1)(2011-1#1)
Anion##14##1##(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-8#1)(2011-1#1)(2011-2#3)
Anionic##2##1##(1990-8#1)(2008-12#1)
Anions##2##1##(2008-10#2)
Anisakis##2##1##(1997-7#1)(2010-8#1)
Anisogramma anomala##5##2##(2008-10#5)
Anisotropic Self-Diffraction##2##2##(2008-2#1)(2008-3#1)
Anisotropic##11##1##(1992-8#1)(1996-9#1)(2007-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-9#1)
Anisotropy in the##2##3##(2008-2#2)
Anisotropy in##3##2##(2008-2#2)(2008-3#1)
Anisotropy##7##1##(1995-3#1)(1995-5#1)(2008-10#2)(2008-2#2)(2008-3#1)
Anita Schweiger]##4##2##(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)
Anita##5##1##(1994-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)
Ankara##10##1##(2008-10#2)(2008-11#1)(2008-12#6)(2008-2#1)
Anker##3##1##(1995-6#3)
Ankle impingement##3##2##(2011-2#3)
Ankle##16##1##(1996-6#1)(2008-12#2)(2008-8#1)(2009-10#3)(2009-7#1)(2010-11#1)(2011-2#5)(2012-2#1)(2012-3#1)
Ankle-Hindfoot Scale##2##2##(2009-10#2)
Ankle-Hindfoot scores##2##2##(2009-10#2)
Ankle-Hindfoot##5##1##(2009-10#5)
Ankle/arm blood pressure index##2##4##(1993-12#2)
Ann Arbor##4##2##(1990-8#1)(1992-2#1)(2008-3#1)(2013-7#1)
Ann##11##1##(1990-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(2007-8#1)(2008-11#1)(2008-3#2)(2013-1#1)(2013-7#1)
Annales de l'Institut Pasteur##2##4##(2008-11#2)
Annals of the##2##3##(1990-3#1)(2011-2#1)
Annals##3##1##(1990-3#1)(1994-2#1)(2011-2#1)
Anne##4##1##(2008-10#1)(2008-11#2)(2010-6#1)
Annealing##5##1##(1994-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
Annelida and Arthropoda##2##3##(2009-6#2)
Annelida##4##1##(1992-6#1)(2009-6#3)
Annetocin##2##1##(2008-5#2)
Annex II B of EU Directive 94/15/EC##2##7##(2008-11#2)
Annex II B##3##3##(2008-11#3)
Annex II##4##2##(2008-11#4)
Annex##6##1##(2008-11#5)(2008-5#1)
Annexin-V##2##1##(2009-4#1)(2010-11#1)
Annexin-V-FLUOS staining##2##2##(2008-8#2)
Annexin32##5##1##(2008-9#5)
Annexins are a family of##2##5##(1994-6#1)(1995-11#1)
Annexins##4##1##(1993-8#1)(1994-6#1)(1995-11#2)
Anniversary##2##1##(1995-3#1)(2008-10#1)
Annotating##3##1##(2008-4#1)(2010-12#1)(2013-1#1)
Annotation##3##1##(2008-7#1)(2011-2#2)
Announcement##3##1##(2008-10#3)
Announcements##2##1##(2007-2#1)(2008-10#1)
Annual Conference on##2##3##(2007-7#1)(2008-11#1)
Annual Conference##5##2##(2007-7#1)(2008-11#1)(2008-12#2)(2010-11#1)
Annual Future of Supportive Therapy in Oncology##2##7##(2008-7#2)
Annual International##2##2##(2008-11#1)(2010-4#1)
Annual Meeting of the American Society of Clinical Oncology##3##9##(2008-7#3)
Annual Meeting of the American Society of##5##7##(2008-5#1)(2008-7#4)
Annual Meeting of the American##6##5##(2008-5#1)(2008-7#4)(2009-6#1)
Annual Meeting of the Society##2##5##(2008-10#1)(2012-1#1)
Annual Meeting of the##15##4##(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-1#1)
Annual Meeting of##16##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-1#1)(2013-1#1)
Annual Meeting##37##2##(2007-6#1)(2008-10#3)(2008-11#16)(2008-5#4)(2008-7#4)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-1#1)(2013-1#1)
Annual PRIDE Institute##2##3##(1991-1#1)(1994-1#1)
Annual Report##2##2##(2008-10#1)(2011-7#1)
Annual Reports##5##2##(2008-8#1)(2012-12#4)
Annual Scientific Meeting of the##3##5##(2008-7#1)(2008-8#1)(2011-2#1)
Annual Scientific Meeting##4##3##(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
Annual Scientific##5##2##(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
Annual influenza vaccination##3##3##(2011-2#3)
Annual reports##2##2##(1990-3#1)(2012-12#1)
Annual##134##1##(1990-3#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-10#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#7)(2008-11#23)(2008-12#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#17)(2011-2#18)(2011-7#1)(2012-1#12)(2012-12#5)(2012-3#1)(2013-1#1)
Annular##2##1##(2008-2#2)
Annuloplasty##2##1##(2007-8#1)(2008-10#1)
Anocentor nitens##3##2##(2008-10#2)(2008-5#1)
Anode##2##1##(2008-10#1)(2013-1#1)
Anodic oxidation of##2##3##(2008-10#2)
Anodic stripping voltammetric determination of##2##5##(2008-10#2)
Anodic stripping voltammetry##2##3##(2008-10#2)
Anodic stripping##5##2##(2008-10#5)
Anodic voltammetric##2##2##(2008-10#2)
Anodic##11##1##(2008-10#11)
Anodonta anatina##2##2##(2008-12#2)
Anodonta##3##1##(2008-12#2)(2010-8#1)
Anogenital##2##1##(2011-1#2)
Anolis ventrimaculatus##2##2##(2013-7#2)
Anolis##6##1##(2010-3#1)(2011-2#2)(2013-7#3)
Anomalies in the##2##3##(1993-5#1)(2008-10#1)
Anomalies##3##1##(1993-5#1)(2008-10#1)(2012-12#1)
Anomalous dispersion techniques##2##3##(2006-4#2)
Anomalous scattering##2##2##(2006-4#1)(2007-11#1)
Anomalous##14##1##(1996-9#1)(2006-4#4)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-5#1)(2013-2#1)
Anopheles darlingi##2##2##(2012-12#2)
Anopheles gambiae##3##2##(2007-12#1)(2008-8#2)
Anopheles##16##1##(2007-12#3)(2008-7#1)(2008-8#2)(2010-1#6)(2012-12#4)
Anoplotettix fuscovenosus##2##2##(2008-10#2)
Anorexia Nervosa##2##2##(2008-11#1)(2013-1#1)
Anorexia nervosa is##2##3##(1992-11#1)(2012-3#1)
Anorexia##8##1##(1992-11#1)(1996-2#1)(2007-7#2)(2008-11#2)(2012-3#1)(2013-1#1)
Anostostomatidae)##2##1##(2007-12#2)
Anostraca)##2##1##(2007-12#2)
Another 35##2##2##(2007-10#1)(2012-2#1)
Another advantage of##2##3##(2008-10#1)(2010-8#1)
Another case##2##2##(1991-5#1)(2011-1#1)
Another characteristic##2##2##(1993-9#1)(2013-8#1)
Another control group##2##3##(2008-5#1)(2011-1#1)
Another factor##2##2##(2008-10#1)(2008-4#1)
Another group of##4##3##(1991-12#1)(1993-3#1)(1994-6#1)(2008-5#1)
Another group##5##2##(1991-12#1)(1993-3#1)(1994-6#1)(1997-8#1)(2008-5#1)
Another important##4##2##(1996-2#1)(2008-10#1)(2008-12#1)(2009-5#1)
Another interesting##2##2##(1994-5#1)(2008-10#1)
Another issue##4##2##(1995-6#1)(1996-7#1)(1997-1#1)(2008-1#1)
Another major##2##2##(1997-1#1)(2008-10#1)
Another physician##2##2##(1995-12#2)
Another plasmid##2##2##(1994-12#2)
Another possible explanation##2##3##(2008-1#1)(2011-2#1)
Another possible##4##2##(1996-11#1)(2008-1#1)(2008-7#1)(2011-2#1)
Another potential##2##2##(1991-3#1)(2008-9#1)
Another set of##2##3##(2008-8#1)(2009-5#1)
Another##139##1##(1990-2#1)(1990-3#1)(1991-1#2)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#3)(1995-4#1)(1995-6#2)(1996-1#1)(1996-11#2)(1996-2#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-12#1)(2008-1#4)(2008-10#24)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#4)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#2)(2013-8#2)
Anserine bursitis is##2##3##(2006-10#2)
Anserine##3##1##(2006-10#3)
Answer##4##1##(2007-5#3)(2011-1#1)
Answers to##2##2##(2008-1#1)(2009-12#1)
Ant##3##1##(2008-5#1)(2008-6#1)(2008-8#1)
Antagonism of the##2##3##(1992-6#1)(2008-10#1)
Antagonism of##5##2##(1992-6#1)(2008-10#3)(2008-4#1)
Antagonism##8##1##(1992-6#1)(2008-10#5)(2008-4#1)(2008-8#1)
Antagonist Ulocladium atrum##2##3##(2008-10#2)
Antagonist##10##1##(1997-7#1)(2008-10#6)(2008-7#1)(2009-10#1)(2011-2#1)
Antagonistic interactions##2##2##(2008-10#2)
Antagonistic##10##1##(2008-10#8)(2008-9#1)(2012-3#1)
Antagonists of##2##2##(1997-7#1)(2008-10#1)
Antagonists to##2##2##(1994-8#2)
Antagonists##7##1##(1994-8#2)(1997-7#1)(2008-10#4)
Antarctic##13##1##(1990-12#2)(1991-5#1)(1996-1#1)(2008-10#1)(2008-2#1)(2012-2#4)(2013-8#3)
Antarctica##3##1##(2008-10#2)(2008-5#1)
Antecedents of##4##2##(1992-3#1)(1993-3#1)(1994-9#1)(2007-12#1)
Antecedents##5##1##(1992-3#1)(1993-3#1)(1994-9#1)(2007-12#1)(2008-12#1)
Antega stem##4##2##(2013-1#4)
Antega##6##1##(2013-1#6)
Antegrade##3##1##(2007-8#1)(2007-9#1)(2008-11#1)
Antegren##4##1##(2008-5#4)
Antenatal diagnosis of##2##3##(1991-11#1)(2010-4#1)
Antenatal screening##2##2##(1990-9#1)(1996-11#1)
Antenatal##8##1##(1990-9#1)(1991-11#1)(1996-11#1)(2007-8#1)(2008-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
Anterior Cervical Discectomy and Fusion##2##5##(2012-3#1)(2013-8#1)
Anterior Cruciate Ligament##2##3##(2013-1#2)
Anterior cervical##2##2##(2008-7#2)
Anterior urethral##2##2##(2008-10#2)
Anterior##35##1##(1995-11#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-12#3)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Anterograde##3##1##(1996-2#1)(2008-4#1)(2008-7#1)
Anther##2##1##(2008-10#1)(2008-8#1)
Anthocyanin content in##2##3##(2008-10#2)
Anthocyanins##2##1##(2008-4#2)
Anthony##2##1##(1995-2#1)(1996-5#1)
Anthracnose in##2##2##(2008-10#2)
Anthracnose##11##1##(2008-10#11)
Anthrasteroids##2##1##(1990-11#2)
Anthrax edema toxin##2##3##(2010-1#2)
Anthrax##4##1##(2010-1#2)(2012-2#2)
Anthropogenic##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
Anthropological##2##1##(2008-8#1)(2009-4#1)
Anthropometric data##2##2##(1991-12#1)(2008-3#1)
Anthropometric measurements##2##2##(2011-1#1)(2011-2#1)
Anthropometric##8##1##(1991-12#1)(2008-1#1)(2008-3#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
Anti##6##1##(1991-11#1)(2008-11#2)(2009-7#1)(2012-3#1)(2013-7#1)
Anti-GABA immunohistochemistry##2##2##(2007-12#2)
Anti-HCV##5##1##(1990-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2013-8#1)
Anti-HIV agents##14##2##(2007-1#14)
Anti-HIV##15##1##(2007-1#14)(2011-3#1)
Anti-IgE##2##1##(1991-12#2)
Anti-Inflammatory Drugs##2##2##(2008-10#1)(2008-12#1)
Anti-Inflammatory##6##1##(2006-10#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
Anti-Stokes##5##1##(2007-1#1)(2007-11#1)(2008-2#1)(2008-3#2)
Anti-TNF-alpha##2##1##(1992-8#1)(2010-12#1)
Anti-TNFs##2##1##(2010-12#2)
Anti-angiogenic##2##1##(2013-1#2)
Anti-apoptotic##2##1##(2009-12#1)(2011-2#1)
Anti-inflammatory and##4##2##(1997-7#1)(2008-12#1)(2008-3#1)(2013-1#1)
Anti-inflammatory##10##1##(1997-7#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-1#2)(2013-1#1)
Anti-malware software##2##2##(2011-2#2)
Anti-oxidant##2##1##(2008-3#1)(2008-7#1)
Anti-oxidants##2##1##(2008-3#2)
Anti-tumor##3##1##(2008-11#1)(2008-8#1)(2011-2#1)
Antibacterial Activity of##2##3##(2010-3#2)
Antibacterial activity and##2##3##(2008-12#1)(2013-8#1)
Antibacterial activity of essential##2##4##(2010-3#1)(2012-3#1)
Antibacterial activity of##5##3##(2008-7#1)(2009-6#1)(2010-3#2)(2012-3#1)
Antibacterial activity##7##2##(2008-12#1)(2008-7#1)(2009-6#1)(2010-3#2)(2012-3#1)(2013-8#1)
Antibacterial##15##1##(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Antibiosis and##2##2##(2008-10#2)
Antibiosis##3##1##(2008-10#3)
Antibiotic lock##2##2##(2010-3#2)
Antibiotic prophylaxis in##2##3##(2007-12#1)(2009-5#1)
Antibiotic resistance##2##2##(2007-12#1)(2008-7#1)
Antibiotic resistant##2##2##(1993-2#1)(1996-6#1)
Antibiotic susceptibility testing##2##3##(2008-9#1)(2012-3#1)
Antibiotic susceptibility##4##2##(2008-12#1)(2008-9#1)(2010-8#1)(2012-3#1)
Antibiotic therapy##3##2##(1990-6#1)(1992-6#1)(1997-7#1)
Antibiotic##25##1##(1990-6#1)(1992-6#1)(1993-2#1)(1996-6#1)(1997-7#1)(2007-12#5)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Antibiotics##8##1##(1996-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#2)(2013-1#1)
Antiblastic treatment of##2##3##(2013-1#2)
Antiblastic treatment##3##2##(2013-1#3)
Antibodies Against##2##2##(2008-10#2)
Antibodies against##3##2##(1996-6#1)(2007-2#1)(2008-9#1)
Antibodies and##2##2##(2008-1#1)(2008-10#1)
Antibodies raised against the##2##4##(1991-5#1)(1994-12#1)
Antibodies specific for##2##3##(1995-11#1)(1995-6#1)
Antibodies specific##3##2##(1995-11#1)(1995-6#1)(2008-10#1)
Antibodies that recognize intact proteins can be produced through the use of synthetic peptides based on short stretches of the protein sequence##3##22##(2008-2#1)(2008-4#2)
Antibodies that##4##2##(1991-9#1)(2008-2#1)(2008-4#2)
Antibodies to##13##2##(1990-5#4)(1990-6#1)(1992-11#1)(1992-9#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
Antibodies were##3##2##(1991-7#1)(1996-12#1)(2008-10#1)
Antibodies##40##1##(1990-5#4)(1990-6#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-6#2)(1997-7#1)(2007-2#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#2)
Antibody Against##2##2##(2008-10#1)(2008-7#1)
Antibody against##2##2##(1991-5#1)(2008-9#1)
Antibody response##2##2##(1990-12#1)(2008-10#1)
Antibody responses##3##2##(1991-5#1)(2009-5#2)
Antibody titer##2##2##(2008-12#1)(2012-3#1)
Antibody titers##2##2##(2008-12#1)(2012-3#1)
Antibody##38##1##(1990-12#1)(1990-3#1)(1991-5#3)(1992-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-6#1)(2007-7#3)(2008-10#6)(2008-11#5)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2012-3#3)(2013-1#2)(2013-8#1)
Anticancer##3##1##(1994-12#1)(1995-4#1)(2012-2#1)
Anticardiolipin##2##1##(1990-9#1)(2010-4#1)
Anticarsia gemmatalis multicapsid nucleopolyhedrovirus##3##4##(2008-11#3)
Anticarsia gemmatalis##8##2##(2008-11#8)
Anticipated##2##1##(2008-4#1)(2010-8#1)
Anticipation was##2##2##(1997-5#2)
Anticipation##5##1##(1997-5#5)
Anticoagulant##2##1##(2010-12#1)(2012-12#1)
Anticoagulants##2##1##(2008-5#1)(2012-12#1)
Anticoagulation control##2##2##(2009-12#2)
Anticoagulation##4##1##(2008-3#1)(2008-5#1)(2009-12#2)
Anticoccidial##2##1##(1997-6#1)(2007-6#1)
Anticonvulsant##2##1##(1991-12#1)(2010-3#1)
Antidandruff##2##1##(2008-5#2)
Antidepressant##5##1##(2009-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Antidepressants##2##1##(1991-11#1)(2009-7#1)
Antidiuretic##2##1##(2008-5#1)(2011-2#1)
Antiepileptic##3##1##(2008-3#1)(2008-8#1)(2013-1#1)
Antiestrogen##2##1##(2008-11#2)
Antiestrogenic##2##1##(2008-11#2)
Antiferromagnetic Spin##2##2##(1996-9#1)(2008-10#1)
Antifungal Activity of##2##3##(2008-10#1)(2012-2#1)
Antifungal Activity##4##2##(2008-10#3)(2012-2#1)
Antifungal Peptide##2##2##(2008-10#2)
Antifungal activity##3##2##(2008-10#1)(2010-5#1)(2012-2#1)
Antifungal and##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
Antifungal##17##1##(2008-10#9)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#3)(2013-1#1)(2013-8#1)
Antigen in##2##2##(1994-7#1)(2012-2#1)
Antigen##12##1##(1994-11#1)(1994-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
Antigen-Specific##3##1##(2008-11#2)(2013-8#1)
Antigen-induced##2##1##(1991-2#1)(1991-5#1)
Antigen-specific##2##1##(2008-12#1)(2008-5#1)
Antigenic##6##1##(1991-1#1)(1996-12#1)(1997-6#1)(2007-6#1)(2008-5#1)(2012-3#1)
Antigens against one or other of##2##6##(1993-2#2)
Antigens from##2##2##(2008-10#2)
Antigens##9##1##(1993-2#2)(2008-1#1)(2008-10#2)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#1)
Antihepatotoxic##2##1##(2008-11#2)
Antihyperglycemic and antihyperlipidemic##2##3##(2012-2#1)(2013-1#1)
Antihyperglycemic##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
Antihypertensive therapy##2##2##(2008-1#2)
Antihypertensive##4##1##(1997-8#1)(2008-1#3)
Antiidiotypic antibodies##2##2##(1992-11#1)(1995-3#1)
Antiinflammatory##4##1##(1991-8#1)(2006-10#1)(2008-5#1)(2010-5#1)
Antilles##5##1##(1992-2#2)(1994-12#1)(2008-5#1)(2011-2#1)
Antimicrobial Activity of##3##3##(2008-10#1)(2010-5#1)(2011-1#1)
Antimicrobial Activity##4##2##(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)
Antimicrobial Resistance##2##2##(2008-10#1)(2013-8#1)
Antimicrobial evaluation##2##2##(2010-5#1)(2011-1#1)
Antimicrobial resistance in Canada##2##4##(2007-12#2)
Antimicrobial resistance in##3##3##(2007-12#3)
Antimicrobial resistance patterns of##2##4##(2007-7#1)(2013-8#1)
Antimicrobial resistance##8##2##(2007-12#4)(2007-7#1)(2012-2#1)(2013-8#2)
Antimicrobial stewardship in##3##3##(2009-5#1)(2013-1#2)
Antimicrobial stewardship programs (ASPs)##2##4##(2013-1#2)
Antimicrobial stewardship##6##2##(2009-5#1)(2013-1#5)
Antimicrobial susceptibility##2##2##(2008-7#1)(2012-3#1)
Antimicrobial##41##1##(1994-11#1)(2007-1#1)(2007-12#5)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#4)
Antimony(V)##2##1##(2008-10#2)
Antimutagenic##3##1##(1992-9#1)(2008-4#1)(2008-7#1)
Antineutrophil cytoplasmic antibody (ANCA) and antiphospholipid (APL) were positive in a few cases##2##13##(2013-1#2)
Antinociceptive##2##1##(1995-12#1)(2011-1#1)
Antioquia##8##1##(2009-7#1)(2012-12#7)
Antioxidant activity of##3##3##(2008-10#2)(2011-2#1)
Antioxidant activity##4##2##(1991-9#1)(2008-10#2)(2011-2#1)
Antioxidant and##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
Antioxidant capacity##2##2##(2008-10#2)
Antioxidant functions##2##2##(1992-9#2)
Antioxidant response##2##2##(1992-9#1)(2010-5#1)
Antioxidant##29##1##(1991-9#1)(1992-9#5)(1993-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#3)
Antioxidants and ischaemic heart disease##3##5##(1997-8#3)
Antioxidants##9##1##(1991-9#1)(1995-5#1)(1997-8#3)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)
Antiperspirant compositions##2##2##(2008-5#2)
Antiphospholipid syndrome##2##2##(2013-8#2)
Antiphospholipid##4##1##(2006-10#1)(2008-7#1)(2013-8#2)
Antiplatelet agents##2##2##(2006-7#1)(2007-8#1)
Antiplatelet therapy##2##2##(2007-7#1)(2011-2#1)
Antiplatelet##5##1##(1993-12#1)(2006-7#1)(2007-7#1)(2007-8#1)(2011-2#1)
Antiproliferative##4##1##(1990-11#1)(1990-6#1)(1991-12#1)(1992-5#1)
Antiretroviral Therapy##2##2##(2008-3#1)(2009-5#1)
Antiretroviral##7##1##(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)
Antirrhinum##4##1##(1996-2#2)(2008-8#1)(2009-5#1)
Antisense oligodeoxynucleotides##4##2##(1991-12#1)(1992-6#1)(1993-3#1)(1996-12#1)
Antisense oligonucleotide##2##2##(1995-12#1)(2008-11#1)
Antisense##18##1##(1991-12#1)(1991-2#1)(1992-6#2)(1993-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#5)(2008-8#1)(2008-9#1)(2011-2#1)
Antisera raised against##3##3##(1990-7#1)(1991-12#1)(2008-10#1)
Antisera to##2##2##(1990-5#1)(2008-10#1)
Antisera##10##1##(1990-5#1)(1990-7#1)(1991-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)
Antiserum##3##1##(1990-8#1)(1992-6#1)(1996-12#1)
Antithrombotic##2##1##(1993-5#1)(2006-6#1)
Antitrust issues##3##2##(1992-3#1)(1993-1#1)(1993-12#1)
Antitrust##5##1##(1992-3#1)(1993-1#2)(1993-12#2)
Antitumor activity of##2##3##(1992-2#1)(1992-5#1)
Antitumor##3##1##(1992-2#1)(1992-5#1)(1997-7#1)
Antiviral##7##1##(1996-8#1)(2008-10#2)(2009-7#1)(2013-1#2)(2013-8#1)
Antonio##10##1##(2008-1#1)(2008-7#2)(2009-11#1)(2009-4#1)(2011-2#1)(2012-12#4)
Ants##4##1##(2008-10#3)(2008-6#1)
Antwerp##3##1##(2008-10#3)
Anxiety Disorder##2##2##(2010-5#1)(2012-2#1)
Anxiety Disorders##2##2##(2009-6#1)(2010-7#1)
Anxiety Inventory##9##2##(1995-12#2)(2007-7#1)(2008-10#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
Anxiety Scale##2##2##(2007-12#1)(2008-1#1)
Anxiety and##10##2##(1994-2#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
Anxiety disorders##4##2##(2009-6#1)(2012-12#1)(2013-8#2)
Anxiety in Children##2##3##(2009-12#1)(2013-8#1)
Anxiety##36##1##(1994-2#2)(1994-6#1)(1995-12#2)(1996-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#4)
Anxiolytic##2##1##(1993-3#1)(2008-10#1)
Any additional##2##2##(1991-3#1)(2008-2#1)
Any of these##4##3##(1991-2#1)(1996-2#1)(2008-4#1)(2008-7#1)
Any of##5##2##(1991-2#1)(1996-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
Any##54##1##(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-2#3)(1995-5#1)(1996-2#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Anyang##2##1##(2008-10#2)
Anyone##3##1##(1997-4#1)(2008-9#1)(2010-7#1)
Anzali Lagoon##3##2##(2012-2#3)
Aorta##2##1##(2012-1#1)(2012-12#1)
Aortic Aneurysm##2##2##(2011-1#1)(2012-1#1)
Aortic Stenosis##2##2##(2012-1#1)(2012-2#1)
Aortic Valve Replacement##2##3##(2012-1#1)(2012-2#1)
Aortic arch##2##2##(2007-8#1)(2008-8#1)
Aortic dissection##5##2##(1991-2#2)(2007-7#1)(2008-11#2)
Aortic root##3##2##(1997-8#1)(2007-8#1)(2009-10#1)
Aortic stenosis##2##2##(2007-8#1)(2009-5#1)
Aortic##29##1##(1990-12#2)(1991-2#2)(1991-9#1)(1997-8#1)(2007-7#1)(2007-8#6)(2008-11#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#3)(2012-2#2)(2013-7#2)
Aortico-left ventricular tunnel##2##3##(2008-11#2)
Aortography##2##1##(1997-8#1)(2007-8#1)
Aotearoa##4##1##(2008-1#4)
Août##3##1##(2013-1#3)
Ap##3##1##(1993-9#1)(2008-12#2)
Ap(4)A hydrolase##2##2##(2009-2#2)
Ap(4)A hydrolases##2##2##(2009-2#2)
Ap(4)A##5##1##(2009-2#5)
Ap(n)As were##2##2##(1997-7#2)
Ap(n)As##5##1##(1997-7#5)
Ap4A and##2##2##(1997-7#2)
Ap4A##5##1##(1997-7#4)(2009-2#1)
ApMV isolates##2##2##(2008-10#2)
ApMV##3##1##(2008-10#3)
Apa I##2##2##(1990-12#2)
Apart from a##3##3##(1990-6#1)(2010-5#1)(2012-3#1)
Apart from genetically##2##3##(2008-10#1)(2008-5#1)
Apart from the fact that##2##5##(1993-6#1)(2012-2#1)
Apart from the##12##3##(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
Apart from this##2##3##(2007-5#1)(2012-3#1)
Apart from##43##2##(1990-12#1)(1990-6#1)(1992-3#1)(1992-6#1)(1993-6#1)(1996-4#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-2#4)(2012-3#4)(2013-8#1)
Apennine##4##1##(2008-8#4)
Apert##3##1##(2007-12#3)
Aperture##4##1##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
Apex##3##1##(2008-10#1)(2011-2#1)(2013-7#1)
Apgar score##3##2##(1995-6#1)(1996-6#1)(2008-4#1)
Apgar scores##2##2##(1990-8#1)(1994-3#1)
Apgar##7##1##(1990-8#1)(1994-3#1)(1995-6#1)(1996-6#2)(2008-4#1)(2012-12#1)
Aph1##4##1##(2008-10#4)
Aph2##3##1##(2008-10#3)
Aphaereta laeviuscula (Spinola)##2##3##(2008-6#2)
Aphanomyces euteiches##16##2##(2008-10#16)
Aphanomyces root rot##6##3##(2008-10#6)
Aphanomyces##26##1##(2008-10#26)
Apheresis##10##1##(2011-2#10)
Aphid Transmission##2##2##(2008-10#2)
Aphid Vector##2##2##(2008-10#2)
Aphid##11##1##(2008-10#11)
Aphididae)##4##1##(2008-6#1)(2008-9#1)(2011-2#2)
Aphidius ervi Haliday (Hymenoptera##2##4##(2007-12#2)
Aphidius##4##1##(2007-12#2)(2008-6#2)
Aphids##2##1##(2008-10#2)
Aphis craccivora##2##2##(2008-10#2)
Aphis fabae##4##2##(2008-10#1)(2009-8#3)
Aphis gossypii##7##2##(2008-10#5)(2008-6#2)
Aphis##15##1##(2008-10#10)(2008-6#2)(2009-8#3)
Aphrodes makarovi##2##2##(2008-10#2)
Aphytis##2##1##(2008-9#2)
Apical##7##1##(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)
Apidae)##6##1##(2008-6#5)(2008-7#1)
Apiosporina morbosa##2##2##(2008-10#2)
Apis mellifera L##3##3##(2008-6#3)
Apis mellifera##7##2##(2008-6#3)(2008-7#2)(2008-8#1)(2011-2#1)
Aplasia##2##1##(2011-2#1)(2013-1#1)
Aplastic anemia##2##2##(2010-11#2)
Aplastic##5##1##(2010-11#5)
Aplysia abdominal ganglion##2##3##(1990-7#1)(2008-4#1)
Aplysia californica##6##2##(1993-12#1)(1994-8#1)(1997-6#1)(2008-6#3)
Aplysia ganglia##2##2##(2008-10#2)
Aplysia gut##2##2##(2008-6#2)
Aplysia kurodai##2##2##(1990-7#1)(1997-6#1)
Aplysia##19##1##(1990-7#2)(1993-12#2)(1994-8#4)(1997-6#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#5)
Apnea##2##1##(2012-2#1)(2013-7#1)
Apo A1##4##2##(2013-1#1)(2013-7#3)
Apo B##14##2##(1990-3#2)(1990-8#2)(1993-12#1)(1994-3#6)(2013-1#1)(2013-7#2)
Apo B-100 and##2##3##(1990-8#2)
Apo##26##1##(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#5)(1993-12#1)(1994-3#6)(1994-6#1)(1995-8#1)(2008-7#1)(2013-1#2)(2013-7#5)
ApoAI##6##1##(1993-12#4)(2008-4#2)
ApoB mRNA editing##2##3##(1992-11#2)
ApoE##2##1##(1996-6#1)(2009-8#1)
ApoH##3##1##(1993-3#3)
Apocytochrome P450cam is##2##3##(1993-8#2)
Apodization##2##1##(2008-2#1)(2008-3#1)
Apodizing holographic gratings##2##3##(2008-2#2)
Apolipoprotein (apo)##2##2##(1990-8#1)(1992-11#1)
Apolipoprotein B is##2##3##(1995-2#2)
Apolipoprotein B##7##2##(1990-11#2)(1992-3#1)(1994-3#1)(1994-8#1)(1995-2#2)
Apolipoprotein E (apoE)##3##3##(1995-6#1)(1996-2#1)(1996-6#1)
Apolipoprotein E genotype##2##3##(1996-12#1)(2008-7#1)
Apolipoprotein E type epsilon 4##2##5##(1995-12#2)
Apolipoprotein E##11##2##(1990-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(2008-7#2)
Apolipoprotein L1##2##2##(2008-10#2)
Apolipoprotein##27##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-7#2)
Apomorphine##2##1##(1992-11#1)(1995-12#1)
Apoplexy##2##1##(2011-2#2)
Apoptosis and##6##2##(1991-12#1)(1994-8#1)(1995-2#1)(2007-10#1)(2008-11#1)(2008-8#1)
Apoptosis genes and DNA repairing genes) play a vital role in altering the normal cell division##2##16##(2013-1#2)
Apoptosis in the##2##3##(1994-10#1)(2013-1#1)
Apoptosis in##6##2##(1994-10#1)(1994-11#1)(2008-6#1)(2009-2#1)(2010-6#1)(2013-1#1)
Apoptosis is a##4##3##(1991-12#1)(2008-4#1)(2009-3#1)(2011-2#1)
Apoptosis is an active##2##4##(2008-11#1)(2011-2#1)
Apoptosis is##7##2##(1991-12#1)(1994-11#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#2)
Apoptosis of##7##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-2#1)
Apoptosis signaling pathways##2##3##(2008-4#1)(2008-9#1)
Apoptosis was##6##2##(1993-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
Apoptosis##51##1##(1991-12#2)(1993-2#1)(1994-10#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-10#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
Apoptotic Cell Death##3##3##(2008-10#1)(2011-2#2)
Apoptotic cell death##2##3##(1996-12#1)(2012-2#1)
Apoptotic cells##2##2##(1993-8#1)(2008-1#1)
Apoptotic##11##1##(1993-8#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
Apothecia##3##1##(2008-10#3)
App##3##1##(2007-3#3)
Apparent Km##2##2##(1992-3#1)(1995-8#1)
Apparent##18##1##(1991-4#1)(1992-2#1)(1992-3#2)(1995-8#2)(2008-10#3)(2008-2#2)(2008-5#1)(2008-9#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
Apparently##16##1##(1990-6#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-8#1)
Appeal##7##1##(1990-2#1)(1997-5#5)(2012-2#1)
Appeals##22##1##(1993-1#1)(1995-12#4)(1995-6#5)(1996-12#3)(1996-5#3)(1997-5#4)(1997-6#1)(2008-8#1)
Appearance of##2##2##(1994-11#1)(1997-6#1)
Appearance##8##1##(1992-6#1)(1994-11#1)(1997-6#1)(2007-12#3)(2010-9#1)(2012-2#1)
Appellate Division##3##2##(1993-1#1)(1995-6#1)(1996-5#1)
Appellate##4##1##(1992-12#1)(1993-1#1)(1995-6#1)(1996-5#1)
Appendicitis can##2##2##(1997-8#1)(2011-2#1)
Appendicitis##3##1##(1997-8#1)(2011-2#1)(2013-8#1)
Appendix##3##1##(1995-1#1)(2008-12#1)(2008-2#1)
Appetite##3##1##(2013-8#3)
Appin##2##1##(2008-5#2)
Appl##15##1##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2012-1#1)
Apple Fruit##3##2##(2008-10#3)
Apple Leaves##2##2##(2008-10#2)
Apple Scab##3##2##(2008-10#3)
Apple and##2##2##(2008-10#2)
Apple chlorotic leaf spot virus (ACLSV)##3##6##(2008-10#3)
Apple chlorotic leaf spot virus##6##5##(2008-10#6)
Apple stem pitting virus##3##4##(2008-10#3)
Apple stem##4##2##(2008-10#4)
Apple##49##1##(1991-12#2)(2008-10#45)(2012-12#2)
Apple-Leaves##2##1##(2008-10#2)
Apples##5##1##(2008-10#5)
Appleton##3##1##(1995-12#1)(2008-12#1)(2008-3#1)
Applicability of the##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
Applicability of##8##2##(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)
Applicability to##4##2##(2008-10#4)
Applicability##13##1##(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#1)
Application and comparison of##2##4##(2008-10#1)(2012-2#1)
Application and##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
Application for##3##2##(1990-12#1)(2008-10#2)
Application in##5##2##(1991-12#1)(1993-9#1)(2007-5#1)(2008-10#2)
Application of Candida##2##3##(2008-10#2)
Application of Doehlert##2##3##(2008-10#2)
Application of EMLA for##2##4##(1993-1#2)
Application of a flow##2##4##(2008-10#2)
Application of a##23##3##(1994-3#1)(1995-5#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2011-2#1)
Application of an##8##3##(1995-5#1)(1996-12#2)(2008-10#3)(2008-3#1)(2010-6#1)
Application of arthroscopy in##2##4##(2007-11#2)
Application of artificial neural networks##2##5##(2008-10#2)
Application of artificial neural##3##4##(2008-10#3)
Application of capillary electrophoresis to##2##5##(2008-10#2)
Application of capillary electrophoresis##3##4##(2008-10#3)
Application of capillary##4##3##(1994-9#1)(2008-10#3)
Application of factorial design in optimization of##2##7##(2008-10#2)
Application of flowing stream techniques to water analysis##2##8##(2008-10#2)
Application of high-performance liquid chromatography##2##5##(1990-8#1)(1991-5#1)
Application of molecular##2##3##(1997-4#1)(1997-7#1)
Application of multivariate data analysis##2##5##(2008-10#2)
Application of multivariate##3##3##(2008-10#3)
Application of neural##2##3##(2008-10#1)(2008-2#1)
Application of sequential##2##3##(2008-10#2)
Application of sodium##2##3##(2008-10#1)(2011-2#1)
Application of statistical##2##3##(2008-3#1)(2008-9#1)
Application of such##2##3##(1992-6#1)(2008-9#1)
Application of the extended boundary condition method to##2##8##(2008-3#2)
Application of the method to real samples##2##7##(2008-10#2)
Application of the method to the##3##6##(2008-10#3)
Application of the method to##7##5##(1996-3#1)(2008-10#6)
Application of the method##9##4##(1996-3#1)(2008-10#7)(2008-11#1)
Application of the##53##3##(1990-5#1)(1990-8#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#2)(2008-3#9)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
Application of these##3##3##(1996-12#1)(2007-11#1)(2008-11#1)
Application of this analysis to##2##5##(1992-3#1)(2008-10#1)
Application of this method##2##4##(2008-3#1)(2008-5#1)
Application of this technique##2##4##(2008-3#1)(2008-4#1)
Application of this##10##3##(1992-3#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#1)(2009-12#1)
Application of two##2##3##(2008-10#1)(2012-3#1)
Application of##265##2##(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-1#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-3#3)(1995-5#2)(1996-12#5)(1996-3#2)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-7#1)(2008-10#116)(2008-11#6)(2008-2#9)(2008-3#27)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-3#2)(2013-1#6)(2013-8#2)
Application on##2##2##(2008-10#2)
Application to the determination of##3##5##(1990-8#1)(2008-10#2)
Application to the##13##3##(1990-8#2)(1992-5#1)(2008-10#8)(2008-3#1)(2008-8#1)
Application to##37##2##(1990-8#2)(1992-5#1)(1997-2#1)(2006-4#1)(2008-10#21)(2008-3#5)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#1)
Application##325##1##(1990-12#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-3#3)(1995-5#2)(1996-12#5)(1996-3#2)(1996-5#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(2006-4#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#146)(2008-11#7)(2008-12#1)(2008-2#10)(2008-3#33)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
Applications and##2##2##(2008-10#1)(2008-12#1)
Applications are##2##2##(2008-10#1)(2008-4#1)
Applications in##7##2##(2007-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-6#1)
Applications include##2##2##(1995-2#1)(2007-11#1)
Applications of evolved gas analysis Part##2##6##(2008-10#2)
Applications of high-performance liquid##2##4##(1990-8#2)
Applications of the method to##4##5##(1997-6#1)(2008-10#3)
Applications of the##10##3##(1997-6#1)(2007-12#1)(2008-10#8)
Applications of this##2##3##(1994-9#1)(2008-10#1)
Applications of##36##2##(1990-8#2)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#3)(2008-10#18)(2008-12#2)(2008-7#1)(2010-1#1)(2010-7#3)(2010-8#1)
Applications on##2##2##(2008-10#2)
Applications such as##2##3##(2007-11#1)(2008-3#1)
Applications to the##2##3##(1990-8#1)(2008-10#1)
Applications to water##2##3##(2008-10#2)
Applications to##15##2##(1990-8#1)(1991-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-12#1)(2009-9#1)(2010-6#1)(2012-3#1)
Applications##81##1##(1990-8#3)(1991-12#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-5#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#2)(2010-7#3)(2010-8#3)(2011-2#1)(2012-3#1)
Applied to the##2##3##(2008-3#2)
Applied to##7##2##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-3#2)
Applied##34##1##(1994-10#1)(1994-12#1)(1996-12#2)(2006-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#3)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Applying a##2##2##(2011-9#1)(2013-1#1)
Applying the##12##2##(1991-2#2)(1994-1#1)(1995-3#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)
Applying this method##2##3##(2008-10#1)(2009-5#1)
Applying this##5##2##(1994-5#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
Applying##44##1##(1991-2#2)(1992-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-9#1)(2013-1#3)(2013-8#1)
Appraisal##2##1##(2006-10#1)(2008-11#1)
Appreciation of music##2##3##(2008-9#2)
Appreciation##4##1##(2007-12#2)(2008-9#2)
Appressoria of Colletotrichum acutatum##2##4##(2008-10#2)
Appressoria were##2##2##(2008-10#2)
Appressoria##8##1##(2008-10#8)
Appressorium Formation##2##2##(2008-10#2)
Approach curves##2##2##(2007-12#1)(2008-10#1)
Approach for##10##2##(2008-10#3)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
Approach in##4##2##(2006-12#3)(2008-12#1)
Approach to the##8##3##(1996-5#1)(1997-2#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-3#1)
Approach to##24##2##(1990-11#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
Approach##61##1##(1990-11#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-12#3)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#5)
Approaches for Functional##2##3##(2008-7#2)
Approaches for##9##2##(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-5#1)(2012-3#2)(2013-1#1)
Approaches in##2##2##(2009-5#1)(2013-1#1)
Approaches that##2##2##(2008-8#1)(2013-1#1)
Approaches to##16##2##(1991-1#1)(1992-3#1)(2006-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
Approaches##35##1##(1991-1#1)(1992-12#1)(1992-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#5)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#5)
Approaching##4##1##(1992-11#1)(1992-3#1)(1995-2#1)(2008-7#1)
Appropriate management##2##2##(2008-6#1)(2010-12#1)
Appropriate##32##1##(1992-3#1)(1994-2#1)(1995-12#2)(2006-10#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#3)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Appropriately##4##1##(2007-12#1)(2008-11#2)(2010-6#1)
Appropriateness Criteria##3##2##(2007-4#3)
Appropriateness of##3##2##(2010-12#3)
Appropriateness##8##1##(2007-4#3)(2010-12#5)
Approved##5##1##(1992-3#1)(2008-10#2)(2012-2#2)
Approximate Bayesian Bootstrap##2##3##(2009-12#2)
Approximate Bayesian##3##2##(2009-12#2)(2012-3#1)
Approximate##12##1##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-12#2)(2009-5#1)(2012-3#1)
Approximately 1##4##2##(1992-1#1)(1997-4#1)(2008-10#1)(2010-3#1)
Approximately 12##2##2##(2008-10#1)(2008-7#1)
Approximately 25%##2##2##(2012-2#1)(2012-3#1)
Approximately 40%##2##2##(1991-11#1)(2008-4#1)
Approximately 50% of##2##3##(2008-11#1)(2010-8#1)
Approximately 7%##2##2##(2009-4#1)(2010-11#1)
Approximately 75% of##2##3##(2008-11#1)(2008-7#1)
Approximately 80% of##2##3##(1991-2#1)(2008-12#1)
Approximately 90##3##2##(1992-6#1)(2007-2#1)(2008-10#1)
Approximately 90% of##2##3##(1997-2#1)(2008-6#1)
Approximately 90%##3##2##(1997-2#1)(2008-6#1)(2011-2#1)
Approximately 95##2##2##(2008-6#1)(2010-2#1)
Approximately 98%##2##2##(2008-10#1)(2008-6#1)
Approximately half of the##2##4##(2008-10#1)(2011-2#1)
Approximately half of##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
Approximately half##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
Approximately one##3##2##(2008-12#1)(2008-2#1)(2012-2#1)
Approximately one-fifth##2##2##(2008-3#1)(2012-1#1)
Approximately one-third of##2##3##(2007-12#1)(2012-2#1)
Approximately two-thirds of the##3##4##(2007-2#1)(2008-1#1)(2008-10#1)
Approximately two-thirds##4##2##(2007-2#1)(2008-1#1)(2008-10#1)(2009-4#1)
Approximately##99##1##(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#3)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#3)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
Approximation##4##1##(1996-9#1)(2008-3#1)(2010-12#1)(2012-1#1)
Approximations##2##1##(2008-3#2)
Apricot pseudo-chlorotic leaf spot virus##2##5##(2008-10#2)
Apricot##3##1##(2008-10#3)
April 1##3##2##(1993-2#1)(2013-1#1)(2013-7#1)
April 1989##2##2##(1990-6#1)(1991-1#1)
April 1990##2##2##(1992-6#1)(1993-1#1)
April 1992##3##2##(1992-5#1)(1993-12#1)(1994-6#1)
April 1993##3##2##(1994-6#1)(1995-11#1)(1997-3#1)
April 1994##3##2##(1995-2#1)(2007-8#1)(2008-2#1)
April 1995##2##2##(2008-10#1)(2008-3#1)
April 1996 to##2##3##(2007-8#1)(2008-3#1)
April 1996##4##2##(2007-8#1)(2008-3#1)(2008-5#1)(2012-3#1)
April 1997##2##2##(1997-5#1)(2007-7#1)
April 1998##7##2##(2007-12#1)(2008-5#5)(2008-6#1)
April 2##2##2##(2008-11#1)(2009-6#1)
April 2000##3##2##(2008-10#1)(2008-6#1)(2013-7#1)
April 2001##2##2##(2007-8#1)(2008-5#1)
April 2002##2##2##(2008-10#1)(2013-7#1)
April 2003##3##2##(2007-5#1)(2008-10#1)(2008-12#1)
April 2004##2##2##(2007-8#1)(2008-1#1)
April 2005 to##2##3##(2011-2#2)
April 2005##3##2##(2008-1#1)(2011-2#2)
April 2006##7##2##(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
April 2007##2##2##(2009-7#1)(2012-3#1)
April 2008##7##2##(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
April 2009##3##2##(2011-2#2)(2012-12#1)
April 2010##3##2##(2012-2#1)(2013-1#1)(2013-7#1)
April 2011 to##2##3##(2012-2#1)(2013-8#1)
April 2011##4##2##(2012-2#2)(2013-1#1)(2013-8#1)
April 29##11##2##(2011-2#5)(2012-1#5)(2013-8#1)
April and May##9##3##(2008-10#8)(2010-2#1)
April and##15##2##(2008-10#9)(2008-5#3)(2010-10#1)(2010-2#1)(2010-8#1)
April to June##2##3##(2008-10#1)(2010-2#1)
April to##7##2##(2008-10#3)(2008-12#1)(2008-3#1)(2010-2#1)(2012-3#1)
April##141##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-6#4)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#11)(2008-6#2)(2008-8#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#12)(2012-1#6)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#7)(2013-8#3)
Apropos of a case##2##4##(1990-6#1)(1997-3#1)
Apropos of a##3##3##(1990-3#1)(1990-6#1)(1997-3#1)
Apropos of##5##2##(1990-3#1)(1990-6#1)(1991-2#1)(1997-3#2)
Apropos##7##1##(1990-3#1)(1990-6#1)(1991-2#1)(1993-9#2)(1997-3#2)
Aprotinin##4##1##(1991-11#1)(1996-9#3)
Aptamers are##2##2##(2009-12#1)(2010-7#1)
Aptamers generated##2##2##(2008-4#1)(2010-5#1)
Aptamers##5##1##(2008-4#1)(2009-12#1)(2010-5#1)(2010-7#1)(2013-7#1)
Apteronotus leptorhynchus##4##2##(1995-12#2)(1996-5#2)
Aquatic##3##1##(2008-10#3)
Aqueous and##3##2##(2010-4#1)(2012-2#1)(2013-8#1)
Aqueous solutions of##3##3##(1997-7#1)(2008-10#2)
Aqueous solutions##4##2##(1997-7#1)(2008-10#3)
Aqueous suspensions of##2##3##(2008-10#2)
Aqueous##26##1##(1992-3#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
Aquilegia##5##1##(2008-8#5)
Ar as the##2##3##(2008-10#1)(2008-2#1)
Ar atoms##5##2##(2010-4#5)
Ar flow rate##2##3##(2008-10#2)
Ar flow##3##2##(2008-10#3)
Ar or##2##2##(2008-11#1)(2008-2#1)
Ar##35##1##(1992-11#1)(2007-11#1)(2007-12#4)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#3)(2010-4#7)(2010-5#1)
Ar'##2##1##(2008-11#2)
ArCl##4##1##(2008-10#4)
ArF excimer laser radiation in a mixture of##2##8##(2008-2#2)
ArF excimer laser radiation##3##4##(2008-2#3)
ArF excimer laser##10##3##(2007-12#3)(2008-2#4)(2008-3#3)
ArF excimer##12##2##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)
ArF##13##1##(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#4)
ArF-excimer laser light##4##3##(2008-3#4)
ArF-laser##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
Ara h1##3##2##(2008-11#3)
Ara##7##1##(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#2)
Ara-C and##2##2##(2007-4#2)
Ara-C##3##1##(2007-4#3)
AraC is##2##2##(1997-2#2)
Arab American##2##2##(2012-12#2)
Arab and##2##2##(2008-1#1)(2008-10#1)
Arab countries##9##2##(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#4)
Arab group##2##2##(2008-1#2)
Arab population in##2##3##(2008-1#1)(2008-6#1)
Arab population##4##2##(2007-12#1)(2008-1#1)(2008-6#2)
Arab##40##1##(2007-12#1)(2007-7#2)(2008-1#14)(2008-10#4)(2008-12#2)(2008-4#5)(2008-6#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
Arabia##69##1##(1994-2#1)(2007-12#1)(2007-2#4)(2007-7#5)(2008-1#38)(2008-10#4)(2008-12#2)(2008-4#7)(2010-11#2)(2013-1#2)(2013-7#1)(2013-8#2)
Arabian Sea##3##2##(2008-3#1)(2013-7#2)
Arabian crude oil residue##2##4##(2008-10#2)
Arabian##8##1##(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-7#2)
Arabic##7##1##(2008-1#2)(2008-10#1)(2013-8#4)
Arabic-speaking##2##1##(2013-1#2)
Arabidopsis ESTs##2##2##(1997-6#1)(1997-8#1)
Arabidopsis Information Resource (TAIR)##2##4##(2008-4#1)(2008-7#1)
Arabidopsis Information Resource##3##3##(2008-4#2)(2008-7#1)
Arabidopsis Thaliana##2##2##(2008-7#2)
Arabidopsis and tomato##2##3##(2008-10#2)
Arabidopsis and##11##2##(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-10#2)(2012-2#1)
Arabidopsis by##2##2##(2008-9#2)
Arabidopsis cell death mutation locus##2##5##(2008-8#2)
Arabidopsis genes##3##2##(1995-2#1)(2008-4#2)
Arabidopsis genome##6##2##(2007-12#2)(2008-7#1)(2009-10#3)
Arabidopsis is##2##2##(1996-10#1)(2007-12#1)
Arabidopsis mutants##3##2##(2009-10#2)(2009-8#1)
Arabidopsis plants grown in the compost##2##6##(2008-10#2)
Arabidopsis plants##10##2##(1996-10#1)(2008-10#5)(2009-8#2)(2011-1#2)
Arabidopsis roots##4##2##(2008-10#1)(2009-10#1)(2009-8#1)(2012-1#1)
Arabidopsis sp##2##2##(2008-10#2)
Arabidopsis thaliana and##8##3##(1996-10#1)(2008-10#2)(2008-7#1)(2008-9#2)(2012-1#1)(2013-8#1)
Arabidopsis thaliana by##2##3##(2008-10#1)(2009-3#1)
Arabidopsis thaliana ecotypes##2##3##(2008-10#1)(2012-3#1)
Arabidopsis thaliana genome##2##3##(1997-6#1)(2008-7#1)
Arabidopsis thaliana genomic##2##3##(1996-10#1)(2008-12#1)
Arabidopsis thaliana is##3##3##(1993-2#1)(2008-9#1)(2009-8#1)
Arabidopsis thaliana##83##2##(1991-6#2)(1992-3#1)(1993-2#1)(1994-12#1)(1996-10#4)(1997-2#3)(1997-6#2)(1997-8#3)(2008-1#1)(2008-10#24)(2008-12#1)(2008-4#1)(2008-7#5)(2008-9#10)(2009-10#4)(2009-3#1)(2009-5#1)(2009-8#3)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#2)(2012-1#2)(2012-3#4)(2013-8#2)
Arabidopsis##235##1##(1991-6#2)(1992-3#2)(1993-2#1)(1994-12#2)(1995-2#3)(1996-10#9)(1996-12#1)(1997-2#4)(1997-6#3)(1997-8#6)(2007-12#8)(2008-1#1)(2008-10#52)(2008-12#1)(2008-4#7)(2008-7#17)(2008-8#4)(2008-9#18)(2009-10#25)(2009-3#1)(2009-5#2)(2009-6#5)(2009-8#26)(2010-2#1)(2010-9#1)(2011-1#6)(2011-10#5)(2011-2#4)(2012-1#3)(2012-2#8)(2012-3#5)(2013-8#2)
Arabidopsis-thrips system##2##2##(2009-8#2)
Arabis mosaic virus##3##3##(2008-10#3)
Arabs##12##1##(1994-12#1)(1997-8#1)(2007-7#1)(2008-1#8)(2010-4#1)
Araceae##8##1##(2008-10#7)(2008-5#1)
Arachidonate-induced 45Ca efflux was##2##4##(1990-2#2)
Arachidonate-induced##3##1##(1990-2#3)
Arachidonic acid (AA)##2##3##(1990-2#1)(1995-5#1)
Arachidonic acid##6##2##(1990-2#1)(1991-9#1)(1992-6#1)(1994-3#1)(1995-5#1)(1996-7#1)
Arachnida##3##1##(2007-12#3)
Arachnida)##2##1##(2007-12#2)
Arago##2##1##(2008-2#2)
Araneae##3##1##(2007-12#2)(2008-6#1)
Aras dam##2##2##(2008-12#2)
Arbitrarily primed polymerase chain reaction and A+T-rich DNA analyses##2##9##(2008-10#2)
Arbitrarily primed polymerase chain reaction##3##5##(2008-10#3)
Arbitrarily##4##1##(2008-10#4)
Arbitrary##4##1##(2008-3#4)
Arbuscular mycorrhizal fungi##2##3##(2008-8#1)(2013-1#1)
Arbuscular mycorrhizal##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
Arc A-mutants##2##2##(2007-11#2)
Arc gene##2##2##(2008-11#1)(2013-1#1)
Arc repressor##2##2##(2007-11#2)
Arc##12##1##(2007-11#8)(2008-11#1)(2013-1#3)
Arcanobacterium haemolyticum##2##2##(2011-2#2)
Arcanobacterium hemolyticum##2##2##(2007-7#2)
Arcanobacterium##6##1##(2007-7#2)(2011-2#4)
Arceuthobium on##2##2##(2008-10#2)
Arceuthobium##3##1##(2008-10#3)
Arch##2##1##(1993-8#1)(2011-2#1)
Archaea project##40##2##(2011-2#40)
Archaeoglobus profundus##2##2##(2011-2#2)
Archaeology##2##1##(1990-8#1)(2012-9#1)
Archezoa are##2##2##(2008-8#2)
Archezoa##4##1##(2008-8#4)
Architectural##2##1##(1997-1#1)(2008-3#1)
Architecture##7##1##(1996-9#1)(1997-3#1)(2009-2#1)(2010-8#3)(2012-2#1)
Architectures##2##1##(1995-12#1)(2008-2#1)
Archival##2##1##(2008-1#1)(2009-9#1)
Archives and##2##2##(2009-10#2)
Archives of##2##2##(2008-12#1)(2009-4#1)
Archives##8##1##(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#3)(2009-4#1)(2010-1#1)
Arcjet##2##1##(2008-2#1)(2008-3#1)
Arcobacter nitrofigilis##2##2##(2011-2#2)
Arcobacter##5##1##(2011-2#5)
Arcs##2##1##(1991-8#1)(2008-2#1)
Arctic Sun Energy Transfer Pads##2##5##(2007-10#2)
Arctic Sun##3##2##(2007-10#3)
Arctic charr Salvelinus alpinus##2##4##(2010-8#2)
Arctic##11##1##(1990-12#1)(1991-5#2)(2007-10#3)(2008-10#1)(2008-11#1)(2010-8#2)(2013-1#1)
Are Associated with##2##3##(2012-12#1)(2013-7#1)
Are Associated##3##2##(2012-12#1)(2013-7#1)(2013-8#1)
Are Not##2##2##(2009-8#1)(2012-3#1)
Are There##2##2##(2012-3#1)(2013-1#1)
Are We##3##2##(2009-4#1)(2009-6#1)(2010-12#1)
Are all##3##2##(2008-4#1)(2009-11#1)(2010-4#1)
Are fiberoptic lasers better than CO 2 lasers for operative laparoscopy?##2##11##(1991-3#2)
Are first-time mothers who plan home birth more likely to receive evidence-based care? A comparative study of home and hospital care provided by the same midwives##2##26##(2013-1#2)
Are the##4##2##(2008-5#1)(2008-8#1)(2009-5#2)
Are there differences in##2##4##(2007-11#1)(2012-2#1)
Are there##9##2##(1991-8#1)(1992-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-2#1)
Are they##2##2##(2008-11#1)(2013-8#1)
Are we##12##2##(1992-1#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#2)(2012-1#1)(2012-3#1)
Are you##6##2##(1991-3#1)(1994-3#1)(1995-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
Are##100##1##(1990-6#1)(1991-12#1)(1991-3#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#3)
Area Medical Center##2##3##(1993-1#1)(1994-12#1)
Area Mental Health Service##2##4##(2008-11#2)
Area and##2##2##(1996-2#1)(2007-7#1)
Area of##8##2##(1993-6#1)(1994-6#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-5#2)
Area under the curve (AUC)##2##5##(2008-5#1)(2011-1#1)
Area under the disease progress curve##2##6##(2008-10#2)
Area under the disease progress##3##5##(2008-10#3)
Area under the##5##3##(2008-10#3)(2008-5#1)(2011-1#1)
Area##49##1##(1993-1#1)(1993-6#1)(1994-12#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#5)(2008-3#1)(2008-5#5)(2009-11#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
Areas of##5##2##(1991-2#1)(1993-11#1)(1994-2#1)(1995-12#1)(2010-7#1)
Areas##13##1##(1991-2#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
Areca catechu (IC50##3##3##(2008-5#3)
Areca catechu L##3##3##(2008-5#3)
Areca catechu##8##2##(2008-5#8)
ArfB##4##1##(2009-8#4)
Arg 303##5##2##(1995-5#5)
Arg 44##4##2##(1992-6#4)
Arg and##4##2##(1992-4#1)(1995-3#1)(1995-6#1)(1996-2#1)
Arg are##2##2##(2012-12#2)
Arg at position##3##3##(1991-9#1)(1992-8#1)(2008-10#1)
Arg in##2##2##(1995-8#1)(2012-12#1)
Arg mutation##2##2##(1993-2#1)(1997-7#1)
Arg or##2##2##(1990-5#1)(1995-5#1)
Arg residues##4##2##(1990-11#1)(1992-4#1)(1995-8#1)(2008-4#1)
Arg substitution##4##2##(1992-8#1)(1993-6#1)(1997-7#2)
Arg##51##1##(1990-11#1)(1990-5#1)(1991-9#2)(1992-4#4)(1992-6#5)(1992-8#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-5#6)(1995-6#1)(1995-8#2)(1996-2#1)(1997-7#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#4)(2012-12#5)(2012-2#1)
Arg)##2##1##(1993-6#1)(2006-12#1)
Arg- Phe- Tyr-##2##3##(1991-5#2)
Arg-125##3##1##(1994-6#3)
Arg39p to Pro6##2##3##(1995-3#2)
Argas persicus Oken##2##3##(2008-12#2)
Argentina and##5##2##(2008-10#2)(2008-5#2)(2013-8#1)
Argentina##51##1##(1996-12#1)(2006-10#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#15)(2008-8#1)(2009-10#2)(2009-7#2)(2013-1#3)(2013-7#4)(2013-8#1)
Argentina)##2##1##(2008-2#1)(2008-5#1)
Argentina]##3##1##(2009-10#1)(2009-7#1)(2013-7#1)
Argentine##5##1##(2008-5#3)(2009-11#1)(2013-1#1)
Argentinean isolates##2##2##(2008-10#2)
Argentinean serovar B strains##2##4##(1997-6#2)
Argentinean serovar B##3##3##(1997-6#3)
Argentinean##5##1##(1997-6#3)(2008-10#2)
Argentinian##2##1##(2008-3#1)(2009-7#1)
Arginine##4##1##(1990-12#1)(2007-9#1)(2008-5#2)
Argon laser laparoscopy##2##3##(1992-1#2)
Argon plasma coagulation (APC) is a##2##6##(2010-8#1)(2013-1#1)
Argon##6##1##(1992-1#2)(2010-8#2)(2012-1#1)(2013-1#1)
Argon-photocoagulator##2##1##(1991-9#2)
Argonne##4##1##(2008-11#2)(2008-3#1)(2008-6#1)
Argulus foliaceus##2##2##(2009-5#2)
Argus X-8##3##2##(2008-12#3)
Argus##4##1##(2008-12#3)(2010-3#1)
Argyle##2##1##(2008-10#2)
Argyranthemum##3##1##(1996-4#3)
Argyreia speciosa##5##2##(2010-3#5)
Ariana##2##1##(2007-8#2)
Arina and Riband##2##3##(2008-10#2)
Arina##9##1##(2008-10#9)
Arising from##2##2##(2007-7#1)(2013-8#1)
Arising##4##1##(1997-3#1)(2007-7#1)(2013-8#2)
Arizona and##2##2##(1990-8#1)(2011-2#1)
Arizona is##2##2##(1992-2#1)(2011-2#1)
Arizona##39##1##(1990-8#2)(1991-3#1)(1992-2#1)(1995-12#3)(1996-3#2)(1997-5#2)(1997-8#1)(2006-10#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#2)(2009-11#1)(2009-8#2)(2011-2#8)(2012-12#1)
Arkansas Medicaid##2##2##(1997-2#2)
Arkansas##9##1##(1997-2#3)(2008-10#5)(2013-8#1)
Arlington##3##1##(1993-12#1)(2008-3#1)(2010-11#1)
Arm##8##1##(1993-6#1)(2008-12#2)(2008-7#2)(2008-9#3)
Armed Forces Hospital##3##3##(2007-7#1)(2008-1#2)
Armed Forces##5##2##(2007-7#1)(2008-1#2)(2011-1#2)
Armed with##2##2##(1993-2#1)(2008-5#1)
Armed##10##1##(1993-2#1)(1995-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-1#3)
Armenia##3##1##(1995-12#1)(2008-10#1)(2008-12#1)
Armenian isolates##2##2##(1995-12#2)
Armenian##3##1##(1995-12#2)(2008-12#1)
Armillaria ostoyae##3##2##(2008-10#3)
Armillaria spp##3##2##(2008-10#3)
Armillaria##10##1##(2008-10#9)(2012-2#1)
Arms##2##1##(2007-2#2)
Arms's##2##1##(2007-2#2)
Army Corps##2##2##(1990-3#1)(2008-2#1)
Army Hospitals##2##2##(2012-2#2)
Army Medical Center##2##3##(1992-12#1)(2008-1#1)
Army hospitals in Iran##2##4##(2012-2#2)
Army hospitals##3##2##(2012-2#3)
Army##14##1##(1990-3#1)(1992-12#3)(2007-8#1)(2008-1#1)(2008-2#1)(2009-7#1)(2012-2#5)(2012-3#1)
Arnold##4##1##(2007-2#1)(2010-1#1)(2012-2#2)
Aroclor 1254##4##2##(1993-8#2)(1996-12#2)
Aroclor##6##1##(1993-8#2)(1996-12#2)(2008-10#2)
Arom-IR cells##2##2##(1994-2#2)
Arom-IR neurones were##3##3##(1994-2#3)
Arom-IR##5##1##(1994-2#5)
Aromatase activity##2##2##(1991-5#1)(1994-2#1)
Aromatase inhibitors##2##2##(2011-1#2)
Aromatase##6##1##(1991-5#1)(1993-8#1)(1994-2#1)(2010-2#1)(2011-1#2)
Aromatic amines##2##2##(2008-10#2)
Aromatic azo compounds##2##3##(2008-10#2)
Aromatic##13##1##(1994-11#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-5#1)(2012-3#1)
Aronia melanocarpa##2##2##(2008-4#2)
Around 1900##2##2##(2008-10#1)(2010-1#1)
Around##9##1##(1995-2#1)(2008-10#2)(2008-2#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
Arp3 (actin-related protein 3##2##4##(2012-2#2)
Arp3 to##2##2##(2012-2#2)
Arp3##6##1##(2012-2#6)
Array and##2##2##(1995-6#1)(2008-3#1)
Array##19##1##(1995-6#1)(2008-10#2)(2008-3#6)(2008-4#3)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#2)
Arrayed##2##1##(2007-5#1)(2008-3#1)
Arrays as##2##2##(2007-12#1)(2008-10#1)
Arrays of##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
Arrays with good##2##3##(2008-2#2)
Arrays##15##1##(2007-12#3)(2008-10#3)(2008-2#5)(2008-3#2)(2008-4#1)(2009-8#1)
Arrest##3##1##(2008-12#1)(2011-2#2)
Arrhenius activation##2##2##(1996-7#2)
Arrhenius equation##2##2##(2008-6#1)(2008-9#1)
Arrhenius plot##2##2##(1994-8#1)(2008-10#1)
Arrhenius plots##2##2##(1991-5#1)(1994-12#1)
Arrhenius##11##1##(1991-5#1)(1994-12#1)(1994-8#1)(1996-7#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)
Arrhenotokous##2##1##(2008-10#2)
Arrhythmia##4##1##(1995-11#1)(2008-8#1)(2010-11#1)(2010-8#1)
Arrhythmias##2##1##(2009-4#1)(2010-8#1)
ArsA protein##4##2##(1994-5#4)
Arsenazo III procedure was tested by##3##6##(2008-10#3)
Arsenazo III procedure##4##3##(2008-10#4)
Arsenazo III##9##2##(2008-10#9)
Arsenic compounds were##2##3##(2008-10#2)
Arsenic compounds##3##2##(2008-10#3)
Arsenic in##3##2##(2008-10#3)
Arsenic is##2##2##(2008-10#2)
Arsenic speciation in##4##3##(2008-10#4)
Arsenic speciation##7##2##(2008-10#6)(2010-5#1)
Arsenic##28##1##(2008-10#22)(2008-12#1)(2010-5#3)(2013-1#2)
Arsenic(V)##2##1##(2008-10#2)
Arsenite##3##1##(1994-11#1)(2008-10#2)
Arsine##4##1##(2008-10#4)
Art##8##1##(1991-6#2)(1995-1#2)(1995-3#1)(2007-11#1)(2008-2#1)(2010-7#1)
Artemia franciscana##4##2##(1994-8#1)(2008-5#1)(2013-1#2)
Artemia sp##3##2##(2008-9#2)(2010-8#1)
Artemia##14##1##(1994-8#2)(2007-12#2)(2008-5#5)(2008-9#2)(2010-8#1)(2013-1#2)
Artemisia annua##2##2##(2007-1#1)(2012-2#1)
Artemisia monosperma##2##2##(2008-10#1)(2013-1#1)
Artemisia##6##1##(2007-1#1)(2008-10#3)(2012-2#1)(2013-1#1)
Artemisinin##2##1##(1995-3#1)(2007-1#1)
Artemisinin-class##2##1##(2007-2#2)
Arterial blood##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
Arterial enhancement##2##2##(2008-7#2)
Arterial hypertension##2##2##(2008-1#1)(2011-2#1)
Arterial##21##1##(1991-3#1)(1993-1#1)(1995-3#1)(1997-8#1)(2007-8#2)(2008-1#2)(2008-7#4)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-3#1)(2013-8#1)
Arteries##4##1##(1995-8#1)(1996-9#1)(2009-8#1)(2011-2#1)
Arteriovenous Malformations##3##2##(1995-11#1)(1997-6#1)(2012-3#1)
Arteriovenous fistulae##3##2##(1992-2#1)(1995-11#1)(2007-7#1)
Arteriovenous malformation of the pregnant uterus##2##6##(2008-8#2)
Arteriovenous##14##1##(1992-2#1)(1995-11#2)(1996-3#1)(1996-9#1)(1997-6#2)(2007-7#1)(2008-1#1)(2008-8#2)(2012-3#3)
Artery Stenosis##2##2##(2008-11#1)(2012-3#1)
Artery##22##1##(2008-1#2)(2008-11#4)(2008-12#2)(2008-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)
Artery)##2##1##(2013-8#2)
Arthrex AR-6400 and AR-6475##2##4##(2011-2#2)
Arthrex##3##1##(2009-10#1)(2011-2#2)
Arthritis##9##1##(1993-1#2)(2006-10#1)(2008-10#1)(2008-9#1)(2010-12#2)(2012-2#1)(2013-1#1)
Arthrobacter sp##3##2##(1995-3#2)(2009-9#1)
Arthrobacter##5##1##(1994-11#1)(1995-3#2)(2008-10#1)(2009-9#1)
Arthrodesis of the##2##3##(2010-3#1)(2010-5#1)
Arthroplasty##10##1##(2008-8#1)(2012-12#1)(2012-3#2)(2013-1#6)
Arthropod##4##1##(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
Arthropoda and##2##2##(2007-12#1)(2009-6#1)
Arthropoda##5##1##(2007-12#2)(2009-6#3)
Arthropods##4##1##(2007-12#3)(2008-6#1)
Arthroscopic excision of##2##3##(2008-9#1)(2013-1#1)
Arthroscopic treatment of acute shoulder dislocations has been succesfull in 100%##2##11##(2007-11#2)
Arthroscopic treatment of##4##3##(2007-11#4)
Arthroscopic##12##1##(2007-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
Arthroscopy is undoubtly the most comprehensive procedure for shoulder lesions providing even better inspection of the interior of the joint than conventional open procedures##2##24##(2007-11#2)
Arthroscopy##6##1##(2007-11#4)(2008-9#1)(2013-1#1)
Arthur##3##1##(1993-3#1)(2008-10#2)
Arthus##3##1##(1992-12#1)(2008-7#2)
Artichoke isolates##2##2##(2008-10#2)
Artichoke yellow ringspot virus##2##4##(2008-10#2)
Artichoke##7##1##(2008-10#6)(2011-2#1)
Article##16##1##(1990-2#1)(1991-3#1)(1992-3#1)(1996-1#1)(1996-11#1)(2007-3#1)(2008-10#4)(2008-11#4)(2008-9#1)(2010-1#1)
Articles were excluded if they did not##2##7##(2012-12#2)
Articles were##3##2##(2011-1#1)(2012-12#2)
Articles##10##1##(1994-12#1)(1995-12#1)(1996-1#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#2)
Articular##2##1##(2008-8#1)(2011-2#1)
Articulating the Ineffable##2##3##(2013-1#2)
Artificial Neural Network (ANN)##2##4##(2008-10#1)(2010-8#1)
Artificial Neural Network##3##3##(2008-10#1)(2010-8#2)
Artificial Neural Networks##4##3##(2008-10#3)(2008-11#1)
Artificial Neural##7##2##(2008-10#4)(2008-11#1)(2010-8#2)
Artificial inoculation##3##2##(2008-10#3)
Artificial inoculations were performed with##2##5##(2008-10#2)
Artificial neural network##2##3##(2008-10#1)(2008-3#1)
Artificial neural networks (ANNs) are among the most popular techniques for nonlinear multivariate calibration in complicated mixtures using spectrophotometric data##2##20##(2008-10#2)
Artificial neural networks (ANNs) are##3##5##(2008-10#3)
Artificial neural networks (ANNs)##5##4##(2008-10#5)
Artificial neural networks##6##3##(2008-10#6)
Artificial neural##8##2##(2008-10#7)(2008-3#1)
Artificial sapphire contact probes##2##4##(1993-1#2)
Artificial##48##1##(1991-11#1)(1993-1#2)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#1)
Artificially damaged##2##2##(1990-11#1)(2008-5#1)
Artificially##6##1##(1990-11#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
Artocarpus lakoocha##2##2##(2008-5#2)
Artocarpus##3##1##(1994-12#1)(2008-5#2)
Artogeia rapae##2##2##(1997-8#2)
Aryl##3##1##(1996-5#1)(2010-8#1)(2013-8#1)
Arylsulfatase A##3##2##(1991-12#3)
Arylsulfatase##4##1##(1991-12#3)(2008-11#1)
As (III) and As (V)##2##5##(2008-10#2)
As a component of##2##4##(1995-3#1)(2008-9#1)
As a conclusion##2##3##(2008-10#1)(2013-1#1)
As a consequence of the##2##5##(1990-11#1)(2012-2#1)
As a consequence of their##2##5##(2008-3#1)(2010-3#1)
As a consequence of this##3##5##(1997-8#1)(2008-6#1)(2008-8#1)
As a consequence of##12##4##(1990-11#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
As a consequence##47##3##(1990-11#1)(1990-8#1)(1992-11#1)(1995-3#1)(1995-6#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
As a demonstration of the##2##5##(2008-3#1)(2011-2#1)
As a demonstration##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
As a direct##2##3##(1995-8#1)(2008-10#1)
As a first application##3##4##(2007-11#2)(2008-3#1)
As a first step in##3##5##(1992-6#1)(1996-10#1)(1996-6#1)
As a first step toward a##2##6##(1992-6#1)(2012-3#1)
As a first step toward##4##5##(1992-6#1)(2008-10#1)(2009-7#1)(2012-3#1)
As a first step towards##2##5##(1994-11#1)(1994-12#1)
As a first step##11##4##(1992-6#2)(1993-2#1)(1994-11#1)(1994-12#1)(1996-10#1)(1996-6#1)(2008-10#1)(2009-7#1)(2012-1#1)(2012-3#1)
As a first##18##3##(1992-6#2)(1993-2#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-10#1)(1996-6#1)(2007-11#2)(2008-10#2)(2008-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
As a general rule##2##4##(2007-11#1)(2008-8#1)
As a matter of fact##2##5##(1996-7#1)(2013-1#1)
As a matter of##3##4##(1996-7#1)(2008-8#1)(2013-1#1)
As a means of##2##4##(1990-8#1)(1991-11#1)
As a measure##2##3##(2008-6#1)(2012-5#1)
As a model system##4##4##(1990-12#1)(2008-10#2)(2008-11#1)
As a model##8##3##(1990-12#1)(1993-1#1)(1993-8#1)(2008-10#2)(2008-11#2)(2008-6#1)
As a new technique in##2##5##(2008-10#1)(2013-7#1)
As a new##7##3##(1993-12#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
As a part of##4##4##(1992-1#1)(1997-3#1)(2008-11#1)(2008-12#1)
As a potential##2##3##(2008-3#1)(2011-2#1)
As a practical##2##3##(2007-12#1)(2013-1#1)
As a preliminary##3##3##(2008-10#2)(2008-9#1)
As a reference##2##3##(2008-10#1)(2008-2#1)
As a result a##2##4##(2008-3#1)(2008-5#1)
As a result of field and##2##6##(2008-12#2)
As a result of the##16##5##(1991-3#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#1)(2010-10#1)(2011-1#1)(2013-1#1)
As a result of these##5##5##(1992-3#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-8#1)
As a result of this study##2##6##(2008-3#1)(2013-1#1)
As a result of this##9##5##(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
As a result of using the##2##6##(2007-11#1)(2008-3#1)
As a result of##51##4##(1991-3#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-11#5)(2007-8#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#3)(2013-8#1)
As a result the##6##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)
As a result we##3##4##(1997-7#1)(2008-3#1)(2008-9#1)
As a result##202##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#1)(2007-11#9)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#14)(2008-12#7)(2008-2#8)(2008-3#23)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-3#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
As a rule of thumb##2##5##(2008-2#1)(2008-3#1)
As a rule##5##3##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
As a simulation of the etiological factors known for Itai-Itai disease##2##11##(1997-4#2)
As a simulation of##3##4##(1997-4#3)
As a standard##3##3##(2007-11#1)(2008-10#1)(2008-12#1)
As a starting point##3##4##(1996-2#1)(1996-3#1)(2008-10#1)
As a step toward##2##4##(1997-2#1)(2007-12#1)
As a step towards developing##2##5##(2008-11#1)(2009-7#1)
As a step##4##3##(1997-2#1)(2007-12#1)(2008-11#1)(2009-7#1)
As a test of this##2##5##(1992-7#1)(2012-2#1)
As a test##5##3##(1992-7#1)(2007-12#1)(2008-12#1)(2008-8#1)(2012-2#1)
As a way of##2##4##(2007-8#1)(2008-10#1)
As a whole##4##3##(1990-8#1)(1993-2#1)(2007-8#1)(2008-1#1)
As a##420##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#18)(2007-12#10)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#59)(2008-11#24)(2008-12#16)(2008-2#15)(2008-3#32)(2008-4#4)(2008-5#5)(2008-6#6)(2008-7#13)(2008-8#9)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#2)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#4)
As above##2##2##(1997-7#1)(2008-10#1)
As administrators##2##2##(1994-3#2)
As an adjunct to##2##4##(2007-8#1)(2008-10#1)
As an aid##2##3##(1992-8#1)(1993-3#1)
As an alternative approach##2##4##(2012-12#1)(2012-3#1)
As an alternative to##2##4##(2008-10#1)(2011-1#1)
As an alternative##10##3##(1990-12#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
As an application##7##3##(2008-10#2)(2008-3#3)(2008-6#1)(2011-3#1)
As an approach to##2##4##(1993-8#1)(1994-8#1)
As an example of practical##2##5##(2008-10#1)(2008-2#1)
As an example of the use of the##2##8##(2007-11#1)(2008-10#1)
As an example of the##6##5##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
As an example of##11##4##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)
As an example we##2##4##(2008-5#1)(2009-3#1)
As an example##31##3##(1991-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#8)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-3#1)
As an illustration of##2##4##(2008-3#2)
As an illustration##3##3##(2008-3#2)(2012-3#1)
As an initial##2##3##(1994-5#1)(1997-2#1)
As an##75##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#3)
As analyzing##2##2##(1990-12#1)(2008-10#1)
As and 0##2##3##(2008-10#1)(2008-12#1)
As and Sb in##2##4##(2008-10#2)
As and Sb##10##3##(2008-10#10)
As and Se in##3##4##(2008-10#3)
As and Se speciation##2##4##(2008-10#2)
As and Se##18##3##(2008-10#18)
As and##37##2##(2008-10#36)(2008-12#1)
As anticipated##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
As at##8##2##(2008-10#6)(2008-12#1)(2012-12#1)
As background##2##2##(1991-2#1)(2008-9#1)
As blood##2##2##(2007-12#1)(2008-10#1)
As both##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2013-1#2)
As cancer##2##2##(1997-1#1)(2008-7#1)
As compared to the control##2##5##(1994-11#1)(1994-12#1)
As compared to the##8##4##(1993-2#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
As compared to##17##3##(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-10#2)(2010-12#1)(2011-2#1)(2013-8#1)
As compared with the##6##4##(1990-5#1)(1995-6#1)(1995-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
As compared with##12##3##(1990-5#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
As compared##29##2##(1990-5#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
As content##3##2##(2008-10#3)
As cord blood##2##3##(2008-11#1)(2008-9#1)
As could be##2##3##(2008-10#2)
As demonstrated by##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
As demonstrated##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
As described in##2##3##(1995-2#1)(2008-4#1)
As described##3##2##(1995-2#1)(2008-4#2)
As determination##2##2##(2008-10#2)
As determined by##2##3##(1997-2#1)(1997-6#1)
As discussed in this##2##4##(1994-3#1)(2008-4#1)
As discussed##3##2##(1992-12#1)(1994-3#1)(2008-4#1)
As each department##2##3##(1994-3#1)(1996-1#1)
As evidence##2##2##(2008-1#1)(2008-11#1)
As examples##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
As expected by##2##3##(2008-10#1)(2008-6#1)
As expected for a##2##4##(1993-11#1)(2008-10#1)
As expected from##2##3##(2008-10#1)(2008-5#1)
As expected##41##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-11#2)(2007-4#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-8#2)
As far as the authors##2##5##(1991-1#1)(2011-2#1)
As far as the##5##4##(1991-1#1)(2007-11#1)(2008-10#1)(2010-1#1)(2011-2#1)
As far as we know##4##5##(1997-4#1)(2006-10#1)(2008-10#1)(2008-2#1)
As far as we##5##4##(1993-6#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-2#1)
As far as##11##3##(1991-1#1)(1993-6#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-1#1)(2011-2#1)
As follows from##2##3##(2008-3#1)(2013-8#1)
As for the##13##3##(1990-5#1)(1993-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
As for##30##2##(1990-5#1)(1990-9#1)(1993-6#1)(1993-8#2)(1994-2#1)(1995-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#3)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
As forms##2##2##(2009-6#2)
As found in##2##3##(1995-8#1)(2008-10#1)
As from groundwater samples##2##4##(2013-1#2)
As from groundwater##3##3##(2013-1#3)
As from##6##2##(1990-11#1)(2008-10#1)(2013-1#4)
As has been##2##3##(1997-7#1)(2008-10#1)
As has##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
As high##2##2##(2008-7#2)
As home care##2##3##(1996-3#1)(1997-3#1)
As hospitals##2##2##(1994-2#1)(1997-3#1)
As hypothesized##2##2##(2008-10#1)(2009-8#1)
As illustrated in##2##3##(2006-10#1)(2008-4#1)
As illustrated##3##2##(2006-10#1)(2008-11#1)(2008-4#1)
As in a previous##2##4##(1995-1#1)(1995-11#1)
As in other##6##3##(1991-2#1)(1996-12#1)(2007-12#1)(2008-6#1)(2008-8#1)(2013-7#1)
As in previous##2##3##(2008-10#1)(2008-8#1)
As in the case of##3##5##(2008-10#1)(2008-4#1)(2010-7#1)
As in the case##4##4##(1994-3#1)(2008-10#1)(2008-4#1)(2010-7#1)
As in the first case##2##5##(1993-2#1)(2008-10#1)
As in the##12##3##(1993-2#1)(1994-3#1)(1996-11#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-7#1)(2012-3#1)
As in this##2##3##(2006-10#1)(2013-8#1)
As in##40##2##(1991-2#1)(1991-8#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
As increasing##2##2##(1996-5#1)(2008-10#1)
As indicated by the##2##4##(2007-11#1)(2008-8#1)
As indicated##3##2##(2007-11#1)(2008-8#1)(2010-6#1)
As is##4##2##(1991-9#1)(2006-10#1)(2008-10#2)
As it is##3##3##(1991-1#1)(2007-11#1)(2008-12#1)
As it##7##2##(1991-1#1)(1991-3#1)(1997-6#1)(2007-11#1)(2008-12#1)(2009-7#1)(2013-1#1)
As judged by##2##3##(1997-2#1)(2008-11#1)
As l(-1)##4##2##(2008-10#4)
As little as##2##3##(1994-2#1)(2008-10#1)
As little##3##2##(1994-2#1)(1995-11#1)(2008-10#1)
As long as##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
As low as##3##3##(2008-10#2)(2008-7#1)
As managed care##2##3##(1997-1#1)(1997-3#1)
As many as##2##3##(1996-11#1)(2010-8#1)
As many of the##2##4##(2008-2#2)
As many of these##2##4##(2006-12#1)(2008-8#1)
As many of##4##3##(2006-12#1)(2008-2#2)(2008-8#1)
As many##11##2##(1992-1#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
As measured by##2##3##(2008-1#1)(2009-10#1)
As measures of##2##3##(1991-11#1)(1994-12#1)
As medicine##2##2##(1993-12#1)(2008-11#1)
As molecular##2##2##(1997-4#1)(2012-12#1)
As more##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#1)
As most##2##2##(2007-7#1)(2008-10#1)
As much as 1##2##4##(1996-6#1)(2008-2#1)
As much as##8##3##(1996-6#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
As much##9##2##(1993-12#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
As new##7##2##(1992-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-9#1)(2008-7#1)(2013-8#1)
As no##6##2##(2008-10#5)(2008-9#1)
As observed in other##2##4##(2008-5#1)(2010-4#1)
As observed##3##2##(1991-9#1)(2008-5#1)(2010-4#1)
As of 2002##2##3##(2008-4#1)(2008-5#1)
As of June##2##3##(1995-6#1)(2007-7#1)
As of October##2##3##(2008-10#1)(2008-5#1)
As of today##2##3##(1992-6#1)(2012-2#1)
As of##11##2##(1991-1#1)(1992-6#1)(1995-6#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#3)(2012-2#1)
As one application##2##3##(1990-8#1)(2008-7#1)
As one of the##3##4##(1997-2#1)(2009-5#1)(2013-1#1)
As one##6##2##(1990-8#1)(1997-2#1)(2008-7#1)(2009-5#1)(2012-1#1)(2013-1#1)
As opposed to the##2##4##(2008-10#2)
As opposed to##5##3##(2007-11#2)(2008-10#2)(2011-2#1)
As our population ages##2##4##(1996-2#1)(2012-3#1)
As our##7##2##(1996-2#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-3#1)
As part of a U##2##5##(1991-2#1)(1992-1#1)
As part of a##12##4##(1991-2#1)(1992-1#1)(1992-5#1)(1995-1#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-8#1)
As part of an##4##4##(2008-10#2)(2008-5#1)(2011-2#1)
As part of our##2##4##(1996-2#1)(2009-7#1)
As part of the evaluation of new mouse cancer screening models##2##11##(2008-8#1)(2008-9#1)
As part of the##11##4##(1994-1#1)(1997-3#1)(1997-5#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
As part of##37##3##(1990-6#1)(1991-2#1)(1992-1#1)(1992-5#1)(1993-8#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-5#1)(2007-1#1)(2007-4#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
As per##3##2##(2013-1#1)(2013-7#1)(2013-8#1)
As predicted by the##2##4##(2008-10#1)(2008-3#1)
As predicted##9##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
As previously reported##3##3##(1996-5#1)(2008-10#1)(2008-7#1)
As previously##4##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
As recently##2##2##(2008-10#1)(2009-9#1)
As regards the##3##3##(2008-1#1)(2008-10#2)
As regards##8##2##(1990-2#1)(1991-8#1)(1992-10#2)(1995-6#1)(2008-1#1)(2008-10#2)
As reported in the##2##4##(1992-6#1)(2013-1#1)
As reported in##3##3##(1992-6#1)(2008-5#1)(2013-1#1)
As reported##6##2##(1992-6#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
As research##2##2##(2009-12#1)(2009-7#1)
As revealed by##3##3##(1992-8#1)(2007-12#1)(2008-9#1)
As risk##2##2##(1991-12#1)(2011-1#1)
As shown by##5##3##(1993-11#1)(1993-9#1)(1995-5#1)(1996-3#1)(2008-9#1)
As shown in this##2##4##(2008-10#1)(2008-7#1)
As shown in##4##3##(1995-2#1)(2008-10#1)(2008-7#2)
As shown##12##2##(1992-11#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)
As soon as the##2##4##(2008-10#2)
As soon as##3##3##(2008-10#2)(2008-7#1)
As speciation##2##2##(2008-10#2)
As species in##3##3##(2008-10#3)
As species##6##2##(2008-10#6)
As such##36##2##(1991-5#1)(1992-2#1)(1993-3#1)(1994-1#1)(1996-1#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
As suggested##2##2##(1992-6#1)(2008-1#1)
As the algorithm##2##3##(2008-3#1)(2008-6#1)
As the concentration of##2##4##(1997-4#1)(2009-11#1)
As the field of##2##4##(2008-10#1)(2010-5#1)
As the field##3##3##(2008-10#2)(2010-5#1)
As the final##3##3##(1995-2#1)(2008-10#1)(2011-1#1)
As the first step in##2##5##(1995-12#1)(2008-6#1)
As the first step of##3##5##(1997-5#1)(2008-10#1)(2013-8#1)
As the first step##6##4##(1993-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2013-8#1)
As the first##8##3##(1993-8#1)(1995-12#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
As the growth##2##3##(2008-11#1)(2011-1#1)
As the level of##2##4##(1991-5#1)(2009-12#1)
As the level##3##3##(1991-5#1)(2008-6#1)(2009-12#1)
As the major##2##3##(2008-7#1)(2012-2#1)
As the method could effectively separate the drug from its degradation products##2##12##(2008-10#2)
As the need for##2##4##(1996-3#1)(2008-3#1)
As the number of##5##4##(1995-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2010-3#1)
As the population of##2##4##(1990-6#1)(2008-1#1)
As the population##3##3##(1990-6#1)(2008-1#1)(2008-7#1)
As the protein##2##3##(1994-3#1)(2011-2#1)
As the result of a##2##5##(1991-2#1)(2012-2#1)
As the result of##3##4##(1991-2#1)(2008-7#1)(2012-2#1)
As the result##4##3##(1991-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
As the results##2##3##(1996-12#1)(2010-6#1)
As the second##2##3##(1996-12#1)(2008-10#1)
As the sensitivity##2##3##(2007-11#1)(2008-10#1)
As the use of##3##4##(1995-1#1)(1995-12#1)(2012-2#1)
As the##207##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#2)(1994-3#3)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-9#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#26)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#5)(2011-3#2)(2011-7#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#1)
As there have##2##3##(2008-7#1)(2013-1#1)
As there is##2##3##(1997-5#1)(2008-5#1)
As there##5##2##(1996-12#1)(1997-5#1)(2008-5#1)(2008-7#1)(2013-1#1)
As these##13##2##(1992-2#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#2)(2013-8#1)
As this article##3##3##(1992-3#1)(1993-3#1)(1994-1#1)
As this professional paper##2##4##(1993-1#1)(1997-1#1)
As this was##2##3##(2008-11#1)(2008-12#1)
As this##11##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2012-1#1)(2012-6#1)
As to the##4##3##(1995-8#1)(2008-7#1)(2011-2#2)
As to##5##2##(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#2)
As was##7##2##(2008-10#6)(2008-9#1)
As we have##2##3##(1994-2#1)(2008-10#1)
As we##11##2##(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-7#1)(2013-8#1)
As well as##11##3##(1995-5#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)
As well##26##2##(1992-3#1)(1993-11#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
As with all##2##3##(2009-10#1)(2010-6#1)
As with any##3##3##(1991-3#1)(1996-1#1)(1997-4#1)
As with many##2##3##(2012-3#1)(2013-1#1)
As with other##3##3##(1995-8#1)(2008-6#1)(2012-12#1)
As with the##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
As with##22##2##(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
As yet##5##2##(1996-8#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)
As##1679##1##(1990-11#5)(1990-12#4)(1990-2#3)(1990-5#3)(1990-6#3)(1990-8#5)(1990-9#1)(1991-1#5)(1991-11#4)(1991-12#4)(1991-2#8)(1991-3#7)(1991-5#7)(1991-8#3)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#11)(1992-5#2)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#6)(1993-11#4)(1993-12#11)(1993-2#10)(1993-3#7)(1993-5#1)(1993-6#4)(1993-8#10)(1993-9#2)(1994-1#6)(1994-11#3)(1994-12#6)(1994-2#7)(1994-3#14)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#8)(1995-11#5)(1995-12#8)(1995-2#12)(1995-3#9)(1995-4#1)(1995-5#5)(1995-6#8)(1995-8#9)(1995-9#1)(1996-1#10)(1996-10#1)(1996-11#2)(1996-12#13)(1996-2#8)(1996-3#17)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#9)(1997-2#13)(1997-3#14)(1997-4#10)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#2)(2006-10#5)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#34)(2007-12#27)(2007-2#2)(2007-4#3)(2007-5#2)(2007-7#5)(2007-8#9)(2008-1#16)(2008-10#376)(2008-11#76)(2008-12#33)(2008-2#37)(2008-3#79)(2008-4#24)(2008-5#39)(2008-6#17)(2008-7#53)(2008-8#34)(2008-9#36)(2009-1#1)(2009-10#11)(2009-11#7)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#13)(2009-6#9)(2009-7#12)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#10)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#7)(2010-4#3)(2010-5#12)(2010-6#6)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#23)(2011-2#35)(2011-3#4)(2011-4#1)(2011-7#1)(2012-1#8)(2012-12#11)(2012-2#27)(2012-3#24)(2012-5#2)(2012-6#1)(2013-1#44)(2013-7#10)(2013-8#22)
As(0##2##1##(2007-12#2)
As(2)##2##1##(2009-11#2)
As(2)O(3) induced##2##2##(2008-8#2)
As(2)O(3)##5##1##(2008-8#5)
As(2)S(3) film##2##2##(2007-12#2)
As(2)S(3)##3##1##(2007-12#3)
As(DDTP)(3)##2##1##(2008-10#2)
As(III) and As(V) in##9##4##(2008-10#9)
As(III) and As(V) were##2##4##(2008-10#2)
As(III) and As(V)##22##3##(2008-10#21)(2010-5#1)
As(III) and##27##2##(2008-10#26)(2010-5#1)
As(III) by silver diethyldithiocarbamate##2##4##(2008-10#2)
As(III) concentration##2##2##(2008-10#2)
As(III) determination##2##2##(2008-10#2)
As(III) in##7##2##(2008-10#7)
As(III) is##5##2##(2008-10#5)
As(III) to##3##2##(2008-10#3)
As(III) was 1##2##3##(2008-10#2)
As(III) was##7##2##(2008-10#6)(2010-5#1)
As(III)##99##1##(2008-10#95)(2010-5#4)
As(III+V)##5##1##(2008-10#5)
As(V) and##6##2##(2008-10#6)
As(V) at##2##2##(2008-10#2)
As(V) based##2##2##(2008-10#2)
As(V) in##11##2##(2008-10#11)
As(V) is##2##2##(2008-10#1)(2010-5#1)
As(V) species##2##2##(2008-10#2)
As(V) to As(III)##2##3##(2008-10#2)
As(V) with##2##2##(2008-10#2)
As(V)##73##1##(2008-10#67)(2010-5#6)
As)##4##1##(2008-10#4)
As-prepared##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
As51 satellite DNA##3##3##(2010-8#3)
As51##4##1##(2010-8#4)
AsA in##3##2##(2008-10#3)
AsA suppressed the##2##3##(2008-11#2)
AsA##16##1##(1992-3#2)(2008-10#8)(2008-11#6)
AsB and AsC##3##3##(2008-10#3)
AsB was##2##2##(2008-10#2)
AsB##5##1##(2008-10#5)
AsC##5##1##(2008-10#5)
AsH(3)##3##1##(2008-10#3)
Asahipak##2##1##(1990-8#2)
Asbestos Disease##2##2##(1991-12#2)
Asbestos disease##2##2##(1991-12#2)
Asbestos exposure and##2##3##(1991-12#2)
Asbestos exposure##3##2##(1991-12#3)
Asbestos fibers##2##2##(1991-12#2)
Asbestos in place##2##3##(1991-12#2)
Asbestos in##4##2##(1991-12#4)
Asbestos##17##1##(1991-12#15)(1992-2#1)(1995-2#1)
Asbestos-associated##2##1##(1991-12#2)
Asbestos-related disease in##2##3##(1991-12#2)
Asbestos-related disease##3##2##(1991-12#3)
Asbestos-related##5##1##(1991-12#5)
Asc I##2##2##(1996-2#1)(1997-2#1)
Ascaris suum##3##2##(1992-9#2)(1994-12#1)
Ascaris##4##1##(1992-9#2)(1994-12#1)(2012-3#1)
Ascension PIP##2##2##(2008-9#2)
Ascites and##2##2##(1993-9#1)(2013-1#1)
Ascites##11##1##(1991-12#1)(1993-9#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2013-1#1)
Ascocarps##2##1##(2008-10#2)
Ascochyta blight##3##2##(2008-10#3)
Ascochyta spp##2##2##(2008-10#2)
Ascochyta##7##1##(2008-10#7)
Ascomycetes##5##1##(2008-10#2)(2008-12#1)(2009-6#1)(2010-7#1)
Ascomycota and##2##2##(2009-6#1)(2010-6#1)
Ascomycota##5##1##(2008-10#1)(2009-6#1)(2010-6#3)
Ascorbate##2##1##(1993-8#1)(2008-10#1)
Ascorbic acid (AA)##2##3##(2008-10#2)
Ascorbic acid and##2##3##(1993-3#1)(2008-10#1)
Ascorbic acid is##2##3##(2008-10#1)(2008-5#1)
Ascorbic acid was also##2##4##(2008-10#2)
Ascorbic acid was##3##3##(2008-10#3)
Ascorbic acid##18##2##(1992-9#3)(1993-12#2)(1993-3#2)(2008-10#9)(2008-5#2)
Ascospore Production of##2##3##(2008-10#2)
Ascospore maturation##2##2##(2008-10#2)
Ascospore release##5##2##(2008-10#5)
Ascospore##15##1##(2008-10#15)
Ascospores in##4##2##(2008-10#4)
Ascospores of Monosporascus cannonballus##2##4##(2008-10#2)
Ascospores of Venturia inaequalis##2##4##(2008-10#2)
Ascospores of##8##2##(2008-10#8)
Ascospores##18##1##(2008-10#17)(2008-8#1)
Asellus aquaticus##3##2##(2008-12#3)
Aseptic##7##1##(1991-2#3)(1992-5#1)(2007-11#1)(2008-11#1)(2012-2#1)
Asexual Reproduction##2##2##(2008-10#1)(2008-5#1)
Asexual##5##1##(2008-10#3)(2008-5#1)(2008-8#1)
Ash##4##1##(1992-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
Ashkenazi Jews##2##2##(2008-12#2)
Ashkenazi##6##1##(2008-1#4)(2008-12#2)
AsiA##4##1##(1995-2#4)
Asia Pacific##4##2##(2008-8#1)(2010-10#1)(2012-12#2)
Asia and Australia##2##3##(2008-6#1)(2013-8#1)
Asia and Europe)##2##3##(2008-12#1)(2009-5#1)
Asia and North America##3##4##(2008-10#1)(2008-8#2)
Asia and the##8##3##(2008-1#2)(2008-10#4)(2010-8#1)(2012-12#1)
Asia and##24##2##(1994-3#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Asia##108##1##(1991-11#1)(1992-6#1)(1993-3#1)(1994-3#4)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#4)(2007-2#3)(2007-5#1)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#4)(2008-8#11)(2008-9#5)(2009-4#2)(2009-5#6)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
Asia-Pacific countries##2##2##(2008-8#1)(2009-8#1)
Asia-Pacific##9##1##(1995-12#1)(2008-10#5)(2008-8#2)(2009-8#1)
Asian American##3##2##(2008-12#1)(2009-7#1)(2010-10#1)
Asian Americans##2##2##(2008-5#1)(2010-8#1)
Asian Indians##9##2##(2008-3#7)(2010-4#1)(2010-5#1)
Asian PD patients##6##3##(2007-12#6)
Asian and Pacific Islander##2##4##(1997-2#2)
Asian and other##2##3##(2010-4#1)(2010-8#1)
Asian and##9##2##(1997-2#2)(2007-12#1)(2008-1#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
Asian blepharoplasty##2##2##(2010-8#2)
Asian countries##12##2##(1990-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)(2009-8#1)(2013-1#4)(2013-8#1)
Asian groups##2##2##(1997-4#1)(2008-12#1)
Asian or##2##2##(2007-7#1)(2009-7#1)
Asian patient##4##2##(2010-8#4)
Asian patients with##2##3##(2008-3#1)(2009-12#1)
Asian patients##5##2##(2007-12#2)(2008-3#1)(2008-8#1)(2009-12#1)
Asian population with##2##3##(2008-3#1)(2010-8#1)
Asian population##5##2##(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-3#1)
Asian populations##5##2##(2007-12#1)(2007-5#1)(2008-9#1)(2010-10#1)(2010-3#1)
Asian rhinoplasty##2##2##(2010-8#2)
Asian skin##2##2##(2008-5#2)
Asian##149##1##(1990-6#1)(1991-9#1)(1993-2#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#2)(2007-11#1)(2007-12#13)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-12#5)(2008-3#13)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#2)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#20)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-3#2)(2013-7#1)(2013-8#3)
Asian-African varanids##2##2##(2013-1#2)
Asian-African##4##1##(2013-1#4)
Asian-Pacific consensus statement on the management of chronic hepatitis##2##9##(2009-8#2)
Asian-Pacific##3##1##(2008-10#1)(2009-8#2)
Asians and##6##2##(2008-10#1)(2008-5#1)(2011-2#3)(2012-2#1)
Asians do not##2##3##(2008-5#1)(2010-8#1)
Asians in##3##2##(1990-6#1)(2011-2#2)
Asians with chronic##2##3##(2007-12#1)(2011-2#1)
Asians with##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
Asians##32##1##(1990-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#5)(2008-8#1)(2010-1#1)(2010-6#2)(2010-8#2)(2011-2#11)(2012-2#4)
Asiatic citrus canker (ACC)##3##4##(2008-10#3)
Asiatic##4##1##(2008-10#3)(2008-5#1)
Aside from##4##2##(1993-3#1)(1995-1#1)(2008-5#1)(2009-12#1)
Ask the doctors##5##3##(2007-2#3)(2013-7#2)
Ask##7##1##(1991-3#1)(2007-2#4)(2013-7#2)
Asking##3##1##(1994-12#1)(1996-7#1)(2013-8#1)
Asn at##2##2##(1993-8#1)(2008-8#1)
Asn substitution##2##2##(1995-5#2)
Asn##18##1##(1990-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-5#3)(1997-3#1)(2008-8#2)
Asn402 of##2##2##(1991-9#2)
Asn402##3##1##(1991-9#3)
Asn467##2##1##(1992-12#2)
Asp residues##2##2##(1991-5#1)(1993-11#1)
Asp##18##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#2)(1997-3#1)(2008-1#1)(2008-11#1)
Asp-##2##1##(1991-5#2)
Asp-100-Gly and Arg-269-Gly##2##3##(1990-8#2)
Asp-156##6##1##(1992-3#6)
Asp102##7##1##(1992-3#6)(1995-5#1)
Asp20##3##1##(1994-5#2)(2013-7#1)
Asp222##4##1##(1992-6#4)
Asp299Gly and Thr399Ile##3##3##(2008-3#2)(2012-3#1)
Asp299Gly##4##1##(2008-3#3)(2012-3#1)
Asp369##2##1##(1995-6#2)
Asp96##2##1##(1995-5#2)
Asp96--&gt##2##1##(1995-5#2)
Aspalathus linealis##2##2##(1994-2#2)
Asparagus##13##1##(1990-11#1)(2008-10#7)(2010-2#1)(2010-5#3)(2013-1#1)
Aspartame##3##1##(2008-8#2)(2010-9#1)
Aspartate transcarbamylase##2##2##(1990-8#1)(1997-2#1)
Aspartate##5##1##(1990-8#1)(1991-12#1)(1997-2#1)(2008-5#2)
Aspartic acid##3##2##(1990-10#1)(1991-2#1)(2008-5#1)
Aspects of the##4##3##(1991-12#1)(2008-10#3)
Aspects of##27##2##(1991-12#2)(1991-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1996-9#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
Aspects on##2##2##(2008-11#2)
Aspects##31##1##(1991-12#2)(1991-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1996-9#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
Asperger's disorder##3##2##(2007-8#3)
Aspergillosis##3##1##(2008-5#1)(2011-2#1)(2013-8#1)
Aspergillums can produce and secrete directly aflatoxin M1##2##8##(2013-1#2)
Aspergillus and##2##2##(1993-12#1)(2008-10#1)
Aspergillus awamori##3##2##(2008-6#2)(2008-7#1)
Aspergillus ear rot##7##3##(2008-10#7)
Aspergillus ear##12##2##(2008-10#12)
Aspergillus ficuum phytase##2##3##(1992-12#1)(1995-3#1)
Aspergillus flavipes##2##2##(2008-1#2)
Aspergillus flavus and A##4##4##(2008-10#4)
Aspergillus flavus and Fusarium##2##4##(2008-10#2)
Aspergillus flavus and##9##3##(2008-10#9)
Aspergillus flavus in##2##3##(2008-10#1)(2008-12#1)
Aspergillus flavus was studied##2##4##(2008-10#2)
Aspergillus flavus was##3##3##(2008-10#3)
Aspergillus flavus##36##2##(2008-10#32)(2008-12#2)(2012-3#1)(2013-1#1)
Aspergillus fumigatus##11##2##(1990-11#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
Aspergillus giganteus##5##2##(1993-2#2)(1997-4#1)(2008-10#2)
Aspergillus infections##2##2##(2008-10#1)(2011-2#1)
Aspergillus nidulans##21##2##(1996-6#1)(1997-2#1)(1997-4#5)(1997-7#2)(1997-8#2)(2008-10#1)(2008-5#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-7#2)(2011-1#1)
Aspergillus niger (ficuum)##2##3##(1993-8#2)
Aspergillus niger and##3##3##(1997-2#1)(2008-6#1)(2010-5#1)
Aspergillus niger glucoamylase##2##3##(2008-7#2)
Aspergillus niger##25##2##(1991-9#2)(1993-2#1)(1993-8#3)(1994-12#2)(1997-2#4)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2010-5#1)(2012-2#1)
Aspergillus sp##3##2##(1990-12#1)(2008-12#1)(2008-6#1)
Aspergillus species##5##2##(1997-2#1)(2008-1#1)(2009-2#1)(2011-2#1)(2012-3#1)
Aspergillus spp##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
Aspergillus terreus##3##2##(2008-5#2)(2012-2#1)
Aspergillus versicolor##2##2##(1994-3#1)(2008-5#1)
Aspergillus##164##1##(1990-11#3)(1990-12#1)(1990-3#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#4)(1993-8#3)(1994-12#2)(1994-3#3)(1995-3#1)(1996-6#2)(1997-2#6)(1997-3#2)(1997-4#6)(1997-7#2)(1997-8#2)(2008-1#4)(2008-10#57)(2008-11#1)(2008-12#3)(2008-5#12)(2008-6#7)(2008-7#6)(2008-9#2)(2009-2#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)
Aspergillus-like fungi##2##2##(2012-3#2)
Aspergillus/Penicillium##2##1##(2010-5#2)
Aspiration##8##1##(1993-10#2)(1994-7#1)(1996-9#1)(2006-10#1)(2008-10#1)(2012-2#1)(2013-8#1)
Aspirin is the##2##3##(2007-10#1)(2008-8#1)
Aspirin##16##1##(1991-11#2)(1991-8#1)(1995-10#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
Assay conditions##2##2##(1991-5#1)(2008-10#1)
Assay for the##2##3##(2008-10#2)
Assay for##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
Assay of##7##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-9#2)(1994-7#1)(1996-5#1)
Assay sensitivity##2##2##(1990-12#1)(2008-9#1)
Assay##46##1##(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-9#2)(1994-7#1)(1995-9#2)(1996-5#1)(1997-2#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-1#2)(2013-8#2)
Assay)##3##1##(1996-2#1)(2008-11#1)(2009-3#1)
Assaying##3##1##(2008-4#2)(2010-12#1)
Assays for B##2##3##(2008-4#2)
Assays for the##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
Assays for##10##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-4#4)(2008-9#2)(2012-2#1)
Assays of##3##2##(1990-7#1)(2008-10#1)(2008-9#1)
Assays performed##2##2##(1995-2#1)(2008-10#1)
Assays to##3##2##(2008-4#2)(2009-6#1)
Assays using##2##2##(1990-11#1)(1996-12#1)
Assays##29##1##(1990-11#1)(1990-12#1)(1990-7#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#6)(2008-5#1)(2008-9#3)(2009-12#1)(2009-6#1)(2012-12#1)(2012-2#3)
Assemblage A##2##2##(2012-3#2)
Assemblage E##2##2##(2012-3#2)
Assemblage##4##1##(2012-3#4)
Assembly and##2##2##(2008-1#1)(2010-5#1)
Assembly of##9##2##(1991-2#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-9#1)(2011-2#1)
Assembly##17##1##(1991-2#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)
Assertiveness is##2##2##(2008-11#2)
Assess##10##1##(1990-4#1)(1992-3#1)(1994-12#1)(2008-10#4)(2009-9#1)(2012-1#1)(2012-12#1)
Assessed##2##1##(2008-10#1)(2012-2#1)
Assessing health system performance##2##4##(2012-12#1)(2013-8#1)
Assessing health##3##2##(1997-1#1)(2012-12#1)(2013-8#1)
Assessing the effect of##2##4##(2008-3#1)(2008-9#1)
Assessing the effects of##3##4##(1994-3#1)(2009-8#1)(2011-2#1)
Assessing the needs of##2##4##(1994-2#1)(1994-3#1)
Assessing the quality of##4##4##(2011-2#1)(2012-12#2)(2013-1#1)
Assessing the##33##2##(1992-12#1)(1992-3#2)(1994-2#2)(1994-3#3)(1996-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#2)(2013-8#3)
Assessing##74##1##(1991-1#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
Assessment Protocol for Excellence in Public Health##2##7##(1996-2#1)(1997-2#1)
Assessment Protocol##3##2##(1996-2#1)(1997-2#1)(2009-9#1)
Assessment Scale##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
Assessment Tool##4##2##(2008-1#1)(2009-4#1)(2012-12#2)
Assessment Tools##2##2##(2008-11#1)(2008-12#1)
Assessment and##6##2##(1991-12#1)(1996-12#1)(1997-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
Assessment in##3##2##(1997-3#1)(2008-10#1)(2012-2#1)
Assessment is a##2##3##(1996-1#1)(2010-9#1)
Assessment is##4##2##(1996-1#1)(2008-6#1)(2010-9#1)(2012-1#1)
Assessment of Cancer##5##3##(2008-7#4)(2009-11#1)
Assessment of cell##2##3##(2008-9#2)
Assessment of exposure to##2##4##(1992-11#1)(2011-2#1)
Assessment of learning##2##3##(2008-11#1)(2008-4#1)
Assessment of the Effects of##2##5##(2008-10#2)
Assessment of the risk of##2##5##(2007-12#1)(2011-2#1)
Assessment of the risk##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
Assessment of the##17##3##(1990-2#1)(1990-8#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Assessment of##116##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-7#2)(1996-8#2)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-3#1)(2013-8#2)
Assessment strategies##2##2##(2008-11#1)(2009-9#1)
Assessment was done##2##3##(2007-7#1)(2008-10#1)
Assessment##189##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#3)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#23)(2008-11#15)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#11)(2008-9#8)(2009-10#1)(2009-11#2)(2009-4#2)(2009-9#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2011-8#1)(2012-1#5)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#10)(2013-3#1)(2013-8#5)
Assessments of##3##2##(2007-6#1)(2008-5#1)(2012-12#1)
Assessments##6##1##(2007-6#1)(2008-11#1)(2008-5#1)(2009-11#1)(2012-12#1)(2013-1#1)
Asset management##2##2##(2013-8#2)
Assignment of##5##2##(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#1)(2009-7#1)
Assimilation##3##1##(2008-12#1)(2008-5#1)(2012-1#1)
Assistance##10##1##(1991-1#1)(1992-1#1)(1993-2#1)(1995-1#1)(1997-3#1)(2008-11#1)(2011-7#1)(2012-12#2)(2013-1#1)
Assistant##4##1##(1992-12#1)(2010-10#2)(2010-5#1)
Assisted living and##2##3##(2008-12#2)
Assisted living##3##2##(2008-12#3)
Assisted##11##1##(1997-4#1)(2008-10#2)(2008-12#3)(2009-1#1)(2010-12#1)(2011-1#1)(2011-7#1)(2012-1#1)
Assisting##3##1##(2009-7#1)(2010-3#1)(2010-9#1)
Assoc##2##1##(2008-10#2)
Associated With##5##2##(2006-10#1)(2013-1#2)(2013-7#1)(2013-8#1)
Associated risk factors of##2##4##(1994-12#1)(2012-12#1)
Associated with a##4##3##(2008-10#4)
Associated with an##2##3##(2008-10#1)(2008-6#1)
Associated with the##2##3##(2008-10#1)(2012-12#1)
Associated with##56##2##(1991-9#1)(1994-12#1)(2008-1#1)(2008-10#34)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Associated##75##1##(1990-8#1)(1991-9#1)(1994-12#2)(2006-10#1)(2008-1#2)(2008-10#34)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
Associating##2##1##(2011-2#1)(2012-1#1)
Association (AHA)##4##2##(1991-12#1)(2008-11#1)(2008-3#1)(2012-3#1)
Association Between##2##2##(2007-12#1)(2011-1#1)
Association and American##2##3##(1996-6#1)(2008-5#1)
Association and the American##2##4##(1994-2#1)(1996-6#1)
Association and the##6##3##(1991-2#1)(1994-2#1)(1996-6#1)(2008-1#2)(2008-10#1)
Association and##14##2##(1991-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#2)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#1)(2010-9#1)
Association between##19##2##(1993-9#1)(1996-8#1)(1997-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Association constants of##2##3##(2008-10#2)
Association constants##3##2##(2008-10#3)
Association for European##2##3##(2011-2#1)(2013-8#1)
Association for Healthcare##4##3##(1991-12#1)(1992-12#1)(1992-2#1)(1993-3#1)
Association for Volunteer Administration##4##4##(1994-3#2)(1995-12#1)(1996-12#1)
Association for the##3##3##(1992-3#1)(1994-3#1)(1997-6#1)
Association for##23##2##(1991-1#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#3)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Association has##3##2##(1994-3#1)(2009-11#1)(2012-12#1)
Association have##2##2##(1995-6#1)(2010-1#1)
Association is##3##2##(1995-12#1)(1995-2#1)(2008-7#1)
Association of Blood Banks##2##4##(1994-9#1)(1995-6#1)
Association of Clinical##2##3##(1994-12#1)(2008-1#1)
Association of Medical##3##3##(1991-6#1)(2007-12#1)(2011-1#1)
Association of Private Psychiatric##5##4##(1991-1#2)(1992-2#2)(1992-3#1)
Association of University Programs in Health Administration##2##7##(1991-1#2)
Association of the##7##3##(1992-6#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
Association of urodynamic##2##3##(2008-7#1)(2012-12#1)
Association of##88##2##(1991-1#4)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#2)(1996-9#1)(1997-3#2)(1997-4#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-7#5)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#2)(2011-4#1)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
Association recently##2##2##(1994-2#1)(2007-10#1)
Association studies##2##2##(2008-7#1)(2008-9#1)
Association was founded##2##3##(2008-8#1)(2011-4#1)
Association was##6##2##(2008-8#1)(2009-6#1)(2011-4#3)(2012-3#1)
Association with##7##2##(2008-1#1)(2008-10#4)(2008-7#1)(2012-2#1)
Association##287##1##(1990-6#4)(1991-1#7)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#5)(1992-6#1)(1993-12#2)(1993-3#4)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#7)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#8)(1995-3#2)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#4)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#6)(2008-10#19)(2008-11#8)(2008-12#4)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#2)(2009-6#2)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#11)(2011-4#6)(2012-1#2)(2012-12#13)(2012-2#6)(2012-3#9)(2013-1#6)(2013-7#2)(2013-8#7)
Association's##3##1##(2007-2#1)(2008-4#1)(2012-12#1)
Association)##4##1##(1996-1#1)(2008-5#1)(2008-8#2)
Associations among##4##2##(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
Associations between##8##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
Associations have##2##2##(2008-11#1)(2013-8#1)
Associations of##3##2##(1997-2#1)(2012-1#1)(2012-12#1)
Associations with##3##2##(1991-8#1)(2009-8#1)(2010-12#1)
Associations##29##1##(1991-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
Assuming a##5##2##(1995-12#1)(1995-3#1)(2008-2#1)(2008-3#1)(2008-9#1)
Assuming that the##2##3##(2008-2#1)(2008-8#1)
Assuming that##8##2##(1991-5#1)(1992-3#1)(1994-3#1)(1995-5#1)(2008-2#1)(2008-3#1)(2008-8#2)
Assuming the##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
Assuming##23##1##(1991-1#1)(1991-5#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#2)(2009-6#1)(2011-1#1)
Assumptions##4##1##(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
Assurance##10##1##(1993-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
Astacus leptodactylus##4##2##(2008-12#2)(2008-7#2)
Astacus##5##1##(2008-12#3)(2008-7#2)
Astaxanthin##3##1##(2008-12#1)(2013-8#2)
Asteraceae##4##1##(2008-10#3)(2013-7#1)
Asterias rollestoni##4##2##(2011-1#4)
Asterina pectinifera##4##2##(1992-8#4)
Asthma Management##2##2##(2010-5#1)(2013-1#1)
Asthma and##4##2##(2012-3#3)(2013-1#1)
Asthma in##2##2##(2012-12#2)
Asthma is##4##2##(2008-3#2)(2010-9#1)(2011-1#1)
Asthma##48##1##(1990-8#1)(1990-9#1)(1992-1#2)(1993-1#1)(1993-2#1)(1995-12#1)(1997-1#1)(2007-2#2)(2007-6#1)(2008-3#5)(2008-7#1)(2009-6#5)(2010-1#1)(2010-5#5)(2010-9#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-3#4)(2013-1#3)(2013-8#1)
Astilbe rivularis##2##2##(2008-10#2)
Astrix##3##1##(2008-10#3)
Astro-E##6##1##(2008-3#6)
Astroblastoma##2##1##(2012-2#2)
Astroblepus ubidiai##2##2##(2008-5#2)
Astrocytes and microglia##2##3##(2008-7#1)(2013-7#1)
Astrocytes and##3##2##(1995-2#1)(2008-7#1)(2013-7#1)
Astrocytes were##2##2##(1994-2#1)(2009-3#1)
Astrocytes##14##1##(1994-2#1)(1995-2#1)(1996-2#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2009-3#3)(2013-7#1)
Astronomers##3##1##(1990-11#1)(1990-8#1)(1995-6#1)
Astronomical##4##1##(1995-6#1)(2007-12#1)(2008-3#2)
Astrophysics##2##1##(2008-3#2)
Astyanax bimaculatus lacustris##2##3##(2008-7#2)
Astyanax##7##1##(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#3)
Aswan##3##1##(1994-9#2)(2008-10#1)
Asymmetric logistic equations##2##3##(2008-11#2)
Asymmetric periflexural##2##2##(2007-7#2)
Asymmetric synthesis and##2##3##(2007-11#1)(2012-3#1)
Asymmetric##21##1##(1993-8#1)(1996-5#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
Asymmetrical##4##1##(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
Asymmetry of##3##2##(2008-3#1)(2008-5#1)(2010-3#1)
Asymmetry##6##1##(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-3#1)(2012-12#1)
Asymptomatic##16##1##(1994-11#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2012-12#1)(2012-3#2)(2013-8#1)
Asymptotic analysis of##3##3##(2007-11#2)(2007-12#1)
Asymptotic results##2##2##(1991-9#1)(2010-12#1)
Asymptotic##6##1##(1991-9#1)(2007-11#2)(2007-12#1)(2008-3#1)(2010-12#1)
Asynchronous##3##1##(2007-12#1)(2008-10#2)
At 0##4##2##(1991-5#1)(2008-10#1)(2008-5#2)
At 1##7##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
At 10 degrees C##2##4##(2008-10#2)
At 10##4##2##(1991-6#1)(2007-8#1)(2008-10#2)
At 100##3##2##(2008-11#1)(2008-2#1)(2010-4#1)
At 12##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
At 15##2##2##(2008-10#1)(2008-3#1)
At 16##2##2##(2008-10#2)
At 18##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
At 2 and##2##3##(2008-10#1)(2008-4#1)
At 2##6##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
At 20 degrees C##4##4##(2008-10#4)
At 20##7##2##(1996-5#1)(2008-10#5)(2008-5#1)
At 22##4##2##(1996-5#1)(2007-6#1)(2008-10#1)(2013-7#1)
At 23 degrees C##2##4##(2008-10#2)
At 25 degrees C##2##4##(2008-10#2)
At 25##3##2##(2008-10#3)
At 26 weeks##2##3##(2008-5#1)(2008-9#1)
At 266 nm##2##3##(2008-3#2)
At 3 years##3##3##(2007-8#1)(2008-9#1)(2010-3#1)
At 3##7##2##(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#2)
At 30 and##2##3##(2007-10#1)(2013-1#1)
At 30##3##2##(1993-1#1)(2007-10#1)(2013-1#1)
At 300##2##2##(2008-10#2)
At 35##2##2##(2008-10#1)(2012-3#1)
At 37 degrees C##3##4##(1990-11#1)(1992-3#1)(1996-5#1)
At 4##13##2##(1990-12#1)(1992-3#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#3)(2013-1#1)
At 45##2##2##(2008-10#1)(2012-12#1)
At 48 h##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
At 48##4##2##(1995-12#1)(2008-11#1)(2008-8#2)
At 5 years##2##3##(1991-4#1)(2008-6#1)
At 5##3##2##(1991-4#1)(1997-3#1)(2008-6#1)
At 500##2##2##(2008-11#2)
At 52##2##2##(1995-8#1)(1997-2#1)
At 6 months##6##3##(2007-8#3)(2008-5#1)(2008-9#2)
At 6 weeks##5##3##(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-7#1)
At 6##14##2##(1991-8#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-7#1)
At 7##5##2##(1992-3#1)(1994-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
At 8##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
At 96 h##2##3##(2007-6#1)(2008-8#1)
At Day 3##2##3##(2008-10#2)
At Day##3##2##(2008-10#3)
At a 2##2##3##(1990-11#1)(1990-2#1)
At a Fo47 to Foln3GUS inoculum ratio of##2##8##(2008-10#2)
At a concentration of##2##4##(1995-5#1)(2010-3#1)
At a concentration##3##3##(1994-6#1)(1995-5#1)(2010-3#1)
At a dose##2##3##(1996-5#1)(2008-5#1)
At a given##3##3##(2008-3#2)(2008-5#1)
At a higher concentration##2##4##(2008-10#1)(2008-11#1)
At a higher##3##3##(2008-10#2)(2008-11#1)
At a mean follow-up of##3##5##(1990-6#1)(2009-10#1)(2013-1#1)
At a sample frequency of##2##5##(2008-10#2)
At a time when##5##4##(1996-12#1)(1997-2#1)(2008-11#1)(2009-10#1)(2010-1#1)
At a##60##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#2)(2008-8#2)(2009-10#3)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#2)(2012-3#2)(2013-1#1)
At acidic pH##2##3##(1996-12#1)(2008-10#1)
At age 546 days (mid-R-12)##3##5##(1997-4#3)
At age 68 days##2##4##(1997-4#2)
At age 70 days##3##4##(1997-4#3)
At age##10##2##(1997-3#1)(1997-4#8)(2007-12#1)
At all##3##2##(1993-6#2)(1993-8#1)
At an average follow-up of##3##5##(1990-12#1)(1992-6#1)(2008-9#1)
At an average##4##3##(1990-12#1)(1992-6#1)(2008-9#1)(2010-8#1)
At an##14##2##(1990-12#1)(1992-6#1)(1993-3#1)(1995-8#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-9#1)(2010-8#1)(2013-8#1)
At baseline##10##2##(1990-9#1)(1993-12#1)(1996-5#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-3#3)
At best##2##2##(1996-12#1)(2011-2#1)
At birth##3##2##(2008-4#1)(2011-1#1)(2012-12#1)
At both##4##2##(1990-7#1)(2008-10#2)(2008-12#1)
At certain##2##2##(2007-11#1)(2007-12#1)
At concentrations of##6##3##(1992-3#1)(1992-8#1)(1994-2#1)(1995-11#1)(1997-4#2)
At concentrations##8##2##(1992-3#1)(1992-8#1)(1994-2#1)(1995-11#1)(1997-4#2)(2008-10#1)(2013-1#1)
At day##6##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-3#1)
At diagnosis##2##2##(2008-5#2)
At different##2##2##(2008-3#1)(2008-8#1)
At discharge##7##2##(1991-2#2)(2008-12#2)(2008-6#2)(2008-7#1)
At each location##2##3##(2008-10#1)(2008-5#1)
At each site##2##3##(2008-10#1)(2008-5#1)
At each##14##2##(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2011-1#1)
At early##3##2##(1992-12#1)(2007-11#1)(2010-8#1)
At elevated##3##2##(1990-8#1)(1995-11#1)(1995-3#1)
At end##2##2##(2008-5#1)(2011-1#1)
At entry##2##2##(1990-5#1)(2008-1#1)
At first glance##4##3##(1991-12#1)(2008-11#1)(2008-2#1)(2009-11#1)
At first##14##2##(1991-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)
At follow-up after##2##3##(1993-1#1)(2013-8#1)
At follow-up##8##2##(1990-2#1)(1991-6#1)(1993-1#1)(1994-11#1)(1997-6#1)(2008-7#2)(2013-8#1)
At frequencies##4##2##(2008-3#2)(2009-5#2)
At harvest##3##2##(2008-10#2)(2010-3#1)
At high##9##2##(1994-11#1)(1997-4#1)(2008-10#3)(2008-9#3)(2010-10#1)
At higher concentrations of##3##4##(1992-5#1)(1993-6#1)(2008-11#1)
At higher concentrations the##2##4##(1990-5#1)(2008-5#1)
At higher concentrations##9##3##(1990-5#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(1996-4#1)(2008-11#1)(2008-5#1)
At higher##23##2##(1990-5#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-6#1)
At initial##2##2##(1993-2#1)(2012-12#1)
At intermediate##5##2##(1990-8#1)(1992-12#1)(1993-8#1)(2008-8#1)(2009-7#1)
At its##2##2##(2008-7#1)(2010-11#1)
At laparotomy there was##2##4##(1993-9#2)
At laparotomy##4##2##(1993-9#2)(2008-7#1)(2011-2#1)
At larger##3##2##(1997-5#1)(2007-11#1)(2007-12#1)
At last##2##2##(2008-5#1)(2013-8#1)
At least four##2##3##(1993-2#1)(1995-6#1)
At least one##8##3##(1990-5#1)(1994-11#1)(1995-3#1)(2006-6#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
At least three##4##3##(1994-9#1)(2008-10#1)(2009-8#1)(2011-2#1)
At least two##7##3##(1990-6#1)(1995-8#1)(1996-5#1)(2008-10#2)(2010-6#1)(2013-1#1)
At least##41##2##(1990-5#1)(1990-6#1)(1991-7#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-6#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)
At locus##2##2##(2008-12#2)
At long-term follow-up##2##3##(2008-9#1)(2011-2#1)
At low concentrations of##2##4##(1996-4#1)(2008-2#1)
At low concentrations##3##3##(1996-4#1)(2008-10#1)(2008-2#1)
At low##19##2##(1994-5#1)(1996-2#1)(1996-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2008-9#2)
At lower concentrations##2##3##(1993-12#1)(2008-10#1)
At lower##4##2##(1992-6#1)(1993-12#1)(2008-10#2)
At most##3##2##(1996-11#1)(2008-10#1)(2008-9#1)
At my##2##2##(1992-3#1)(2010-9#1)
At necropsy##2##2##(2008-12#1)(2008-9#1)
At neutral pH##3##3##(1991-8#1)(1995-2#1)(1996-2#1)
At night##2##2##(1990-7#1)(2008-3#1)
At one##4##2##(1991-6#1)(1992-2#1)(2007-11#1)(2008-1#1)
At operation##3##2##(1993-6#1)(2007-8#1)(2008-10#1)
At optimized conditions##2##3##(2008-10#2)
At optimum##3##2##(2008-10#3)
At our institution##2##3##(2008-8#1)(2008-9#1)
At our##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
At pH 3##5##3##(1995-5#1)(1997-7#1)(2008-10#3)
At pH 4##4##3##(1992-3#1)(1994-11#1)(2008-10#2)
At pH 5##2##3##(2008-10#2)
At pH 6##5##3##(1991-8#1)(1992-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
At pH 7##6##3##(1993-8#1)(1994-5#1)(2008-10#4)
At pH 8##3##3##(2008-10#2)(2012-2#1)
At pH 9##2##3##(2008-10#2)
At pH##31##2##(1991-8#1)(1992-3#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-10#17)(2008-11#1)(2012-2#1)(2013-1#1)
At posttest##3##2##(2008-9#1)(2010-4#2)
At present the##3##3##(1993-6#1)(1997-6#1)(2008-11#1)
At present there##2##3##(2008-11#1)(2013-8#1)
At present##48##2##(1990-12#1)(1990-2#1)(1990-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-5#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-9#1)(2013-1#1)(2013-8#1)
At room temperature##5##3##(1993-11#1)(1995-2#1)(2007-12#2)(2008-2#1)
At shorter##2##2##(1990-5#1)(2008-3#1)
At sites of##2##3##(2008-11#2)
At sites##3##2##(2008-10#1)(2008-11#2)
At some##2##2##(1991-12#1)(2008-10#1)
At surgery the##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
At surgery##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)
At temperatures##3##2##(1995-2#1)(2008-10#2)
At that time##5##3##(1995-12#1)(2007-7#1)(2009-10#1)(2010-3#1)(2011-2#1)
At that##8##2##(1995-12#1)(2007-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#3)
At the 1-year follow-up##2##4##(2012-2#1)(2012-3#1)
At the University of##2##4##(1995-1#1)(2007-5#1)
At the age of##7##4##(1995-8#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-4#1)
At the amino acid level##2##5##(1991-9#1)(2008-7#1)
At the beginning of the second##2##6##(1995-5#1)(2008-7#1)
At the beginning of the##6##5##(1994-11#1)(1995-5#1)(1996-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
At the beginning of##8##4##(1994-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
At the beginning##9##3##(1994-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
At the cellular level##3##4##(2008-1#1)(2009-10#1)(2009-12#1)
At the concentration of##2##4##(1996-5#1)(2008-11#1)
At the concentration##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
At the conclusion of the 252-day reproductive period##2##8##(1997-4#2)
At the conclusion of##3##4##(1992-3#1)(1997-4#2)
At the core of the##2##5##(2008-5#1)(2009-12#1)
At the core of##3##4##(2008-5#1)(2009-12#1)(2010-12#1)
At the dawn of the##2##5##(2008-1#1)(2008-10#1)
At the early stage of##3##5##(2008-5#1)(2008-9#2)
At the end of the 19th century##2##7##(1991-6#1)(2009-7#1)
At the end of the analysis##2##6##(2008-10#2)
At the end of the experiment the##2##7##(2012-1#2)
At the end of the experiment##3##6##(1997-6#1)(2012-1#2)
At the end of the observation period##2##7##(2008-1#1)(2008-2#1)
At the end of the study##4##6##(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)
At the end of the trial##2##6##(1991-3#1)(2008-8#1)
At the end of the##27##5##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#2)(1994-6#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
At the end of this##4##5##(2008-10#1)(2008-12#1)(2011-3#1)(2012-12#1)
At the end of treatment##2##5##(2007-12#1)(2007-7#1)
At the end of##49##4##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#2)(1994-6#1)(1996-6#1)(1997-4#2)(1997-6#2)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)
At the end##52##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#2)(1994-6#1)(1996-6#1)(1997-4#2)(1997-6#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)
At the final##2##3##(2007-12#1)(2008-9#1)
At the first##2##3##(2008-12#1)(2009-5#1)
At the follow-up##2##3##(2013-1#2)
At the global level##2##4##(2007-12#1)(2008-10#1)
At the heart of##2##4##(1996-12#1)(2012-12#1)
At the higher##3##3##(1990-5#1)(2008-10#1)(2010-8#1)
At the highest dose##2##4##(1996-5#1)(2013-8#1)
At the highest##4##3##(1992-9#1)(1996-5#1)(2010-8#1)(2013-8#1)
At the last##2##3##(2008-1#1)(2008-10#1)
At the level of the##2##5##(2009-1#1)(2009-12#1)
At the level of##4##4##(2008-7#1)(2009-1#1)(2009-12#1)(2013-8#1)
At the low##3##3##(1995-2#1)(1997-2#1)(2007-8#1)
At the lowest##2##3##(2008-10#1)(2013-1#1)
At the molecular level##2##4##(1997-2#1)(2008-10#1)
At the moment##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
At the optimum##3##3##(2008-10#2)(2008-4#1)
At the population level##2##4##(1994-12#1)(2011-2#1)
At the present stage##2##4##(2007-11#1)(2007-5#1)
At the present time##9##4##(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
At the present##14##3##(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
At the receiver##2##3##(2007-11#1)(2008-3#1)
At the same time the##4##5##(1991-5#1)(2007-11#1)(2008-10#1)(2011-1#1)
At the same time##64##4##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-5#1)(2011-1#4)(2011-3#1)(2011-7#1)(2012-2#3)(2013-1#1)
At the same##65##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2010-5#1)(2011-1#4)(2011-3#1)(2011-7#1)(2012-2#3)(2013-1#1)
At the second##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
At the site of application##3##5##(2008-9#3)
At the third##2##3##(2008-10#1)(2009-5#1)
At the time of the##3##5##(1990-6#1)(1992-8#1)(2008-11#1)
At the time of##20##4##(1990-10#1)(1990-11#1)(1990-6#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
At the time##23##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
At the##351##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-8#3)(1992-9#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#1)(1997-2#4)(1997-3#3)(1997-4#6)(1997-6#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#44)(2008-11#14)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#10)(2008-6#6)(2008-7#16)(2008-8#9)(2008-9#20)(2009-1#1)(2009-10#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#2)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#5)(2011-1#8)(2011-2#11)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#2)(2013-1#11)(2013-8#2)
At these##5##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-3#1)
At this concentration##2##3##(1993-3#1)(2008-10#1)
At this level of##2##4##(1991-9#1)(2008-3#1)
At this level##3##3##(1991-9#1)(1992-5#1)(2008-3#1)
At this moment##2##3##(2008-7#1)(2010-10#1)
At this point##4##3##(1994-2#1)(1994-3#1)(2008-11#1)(2009-12#1)
At this stage##7##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
At this time##10##3##(1990-6#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-4#1)(2012-12#1)
At this##39##2##(1990-6#1)(1991-9#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-4#1)(2012-12#1)(2012-3#1)
At time##2##2##(2008-11#1)(2008-8#1)
At two##2##2##(2008-1#1)(2008-10#1)
At urethroscopy##2##2##(2008-10#2)
At variance with##3##3##(1990-8#1)(1995-6#1)(1996-6#1)
At various##2##2##(2011-2#1)(2012-12#1)
At week 24##2##3##(2008-5#1)(2011-2#1)
At week##5##2##(1992-11#1)(2008-5#2)(2011-2#2)
At year-end 2009##3##3##(2011-2#3)
At##1182##1##(1990-10#1)(1990-11#6)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#9)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#7)(1991-7#1)(1991-8#4)(1991-9#4)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#15)(1992-5#4)(1992-6#6)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#5)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#8)(1994-12#11)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#7)(1995-12#5)(1995-2#9)(1995-3#5)(1995-4#1)(1995-5#7)(1995-6#4)(1995-8#5)(1996-11#2)(1996-12#10)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#13)(1996-6#5)(1996-9#2)(1997-2#9)(1997-3#7)(1997-4#19)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#2)(2006-10#2)(2006-6#1)(2007-10#3)(2007-11#18)(2007-12#28)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#20)(2007-9#1)(2008-1#13)(2008-10#213)(2008-11#42)(2008-12#20)(2008-2#12)(2008-3#54)(2008-4#10)(2008-5#34)(2008-6#17)(2008-7#42)(2008-8#27)(2008-9#42)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#2)(2009-5#10)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#2)(2010-6#2)(2010-8#9)(2010-9#2)(2011-1#15)(2011-10#1)(2011-2#42)(2011-3#3)(2011-4#1)(2011-7#1)(2012-1#5)(2012-12#12)(2012-2#19)(2012-3#13)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#42)(2013-7#4)(2013-8#7)
AtSNX2b##7##1##(2009-10#7)
AtT-20 cells##5##2##(1990-12#4)(1994-11#1)
AtT-20##8##1##(1990-12#5)(1994-11#1)(1995-12#1)(1997-7#1)
AtT20##2##1##(1992-12#1)(1994-11#1)
Ataxia telangiectasia##3##2##(1995-6#2)(2008-7#1)
Ataxia##7##1##(1995-6#2)(2008-7#2)(2009-5#1)(2013-7#2)
Atencion Primaria]##2##2##(1995-5#1)(1996-3#1)
Athena Neurosciences##2##2##(2008-5#2)
Athens area##2##2##(1993-9#1)(2008-2#1)
Athens##16##1##(1993-9#6)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#1)
Atherosclerosis and##2##2##(1994-8#1)(2009-5#1)
Atherosclerosis is a##2##3##(2011-2#1)(2012-2#1)
Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction##2##25##(2008-4#2)
Atherosclerosis is##5##2##(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#1)
Atherosclerosis##19##1##(1991-8#2)(1994-8#1)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#1)(2009-5#1)(2010-12#2)(2011-2#2)(2012-2#3)
Atherosclerotic plaque##2##2##(2007-11#1)(2012-2#1)
Atherosclerotic##12##1##(1990-6#1)(1990-9#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
Athlete##4##1##(1993-3#1)(2010-7#1)(2013-1#2)
Athletes##3##1##(2008-5#1)(2012-3#2)
Athletic##2##1##(2010-12#1)(2013-1#1)
Atkins##7##1##(2008-3#7)
Atkins'##3##1##(2008-3#3)
Atlanta##3##1##(1997-2#1)(2008-11#1)(2012-12#1)
Atlantic Canada##2##2##(1991-8#1)(1993-1#1)
Atlantic Coast##2##2##(1992-8#1)(2012-12#1)
Atlantic Ocean##4##2##(1996-4#1)(2008-3#1)(2011-2#1)(2012-3#1)
Atlantic coast of##2##3##(2007-5#1)(2008-10#1)
Atlantic cod (Gadus morhua)##2##4##(2012-3#2)
Atlantic cod Gadus morhua in the##2##6##(2010-8#2)
Atlantic cod Gadus morhua##3##4##(2010-8#3)
Atlantic cod##6##2##(2010-8#3)(2012-3#3)
Atlantic salmon (Salmo salar L##2##5##(2008-7#1)(2013-1#1)
Atlantic salmon (Salmo salar)##4##4##(1992-9#1)(1994-7#1)(1995-11#1)(2008-7#1)
Atlantic salmon (Salmo##6##3##(1992-9#1)(1994-7#1)(1995-11#1)(2008-7#2)(2013-1#1)
Atlantic salmon##10##2##(1991-8#1)(1992-9#1)(1994-7#2)(1995-11#1)(2008-7#3)(2009-6#1)(2013-1#1)
Atlantic##54##1##(1991-8#3)(1992-8#1)(1992-9#1)(1993-1#1)(1994-7#2)(1995-11#1)(1996-4#2)(2007-12#1)(2007-5#3)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#4)(2009-6#1)(2010-3#2)(2010-8#7)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
Atlantoaxial##2##1##(2012-3#2)
Atlas##9##1##(1997-6#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
Atmosphere##7##1##(2008-2#4)(2008-3#3)
Atmospheric CO(2)##2##2##(2008-10#1)(2008-2#1)
Atmospheric Correction of##2##3##(2008-3#2)
Atmospheric Research##2##2##(2008-3#2)
Atmospheric Sounding##8##2##(2008-2#2)(2008-3#6)
Atmospheric aerosol##2##2##(2008-2#2)
Atmospheric correction of##3##3##(2008-2#1)(2008-3#2)
Atmospheric correction##5##2##(2008-2#2)(2008-3#3)
Atmospheric##41##1##(1992-2#1)(1995-3#1)(2008-10#2)(2008-2#10)(2008-3#26)(2013-8#1)
Atoll##5##1##(2010-8#2)(2013-8#3)
Atom##2##1##(1997-7#1)(2007-11#1)
Atomic Absorption Spectrometry##2##3##(2008-10#2)
Atomic Absorption##3##2##(2008-10#3)
Atomic absorption spectrometric determination of##2##5##(2008-10#2)
Atomic absorption spectrometry##2##3##(2008-10#2)
Atomic absorption##6##2##(1990-12#1)(1997-4#1)(2008-10#4)
Atomic fluorescence##2##2##(2008-10#2)
Atomic force microscope##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
Atomic force microscopy (AFM) and##2##5##(2009-11#2)
Atomic force microscopy (AFM)##7##4##(2008-10#3)(2008-7#2)(2009-11#2)
Atomic force microscopy##12##3##(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#2)(2010-12#1)(2010-4#1)
Atomic force##16##2##(1993-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#2)(2010-12#1)(2010-4#1)
Atomic structure of##2##3##(1991-5#1)(1991-9#1)
Atomic##40##1##(1990-12#1)(1991-5#1)(1991-9#1)(1993-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-11#3)(2008-10#16)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#2)(2009-12#1)(2010-12#1)(2010-4#1)(2012-2#1)
Atomization of##2##2##(2007-12#1)(2008-10#1)
Atomization##3##1##(2007-12#1)(2008-10#2)
Atoms##5##1##(1991-8#1)(1996-2#1)(1996-9#3)
Atopic Dermatitis##3##2##(2012-1#2)(2013-1#1)
Atopic dermatitis##4##2##(1991-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
Atopic##8##1##(1991-2#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
Atopy##2##1##(2007-7#1)(2012-3#1)
Atorvastatin##4##1##(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
Atoxigenic##2##1##(2008-10#2)
Atpk5##3##1##(1993-2#3)
Atr##3##1##(2008-10#2)(2008-8#1)
Atractaspis engaddensis##2##2##(1992-12#2)
Atrazine##5##1##(2008-10#4)(2013-1#1)
Atrial Septal##2##2##(2008-11#1)(2012-3#1)
Atrial fibrillation (AF)##2##3##(2007-8#1)(2010-12#1)
Atrial fibrillation is##2##3##(2008-7#1)(2013-1#1)
Atrial fibrillation##6##2##(2007-8#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#1)
Atrial flutter##2##2##(2010-11#1)(2011-2#1)
Atrial natriuretic peptide (ANP)##2##4##(1993-8#1)(2008-5#1)
Atrial natriuretic peptide##3##3##(1993-8#2)(2008-5#1)
Atrial##19##1##(1993-8#2)(1994-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Atrophy of the##2##3##(2008-9#2)
Atrophy##3##1##(2008-9#2)(2011-2#1)
Atropine##3##1##(1990-5#1)(1995-3#1)(2011-2#1)
Atta cephalotes##2##2##(2008-8#2)
Atta laevigata (Smith)##2##3##(2008-6#2)
Atta##5##1##(2008-6#2)(2008-8#3)
Attachment Style##2##2##(2010-8#1)(2012-2#1)
Attachment and##3##2##(2008-11#2)(2008-7#1)
Attachment of##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
Attachment##15##1##(1995-6#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2010-8#1)(2012-1#2)(2012-2#1)
Attack##5##1##(2007-1#1)(2007-9#1)(2008-3#3)
Attacks##4##1##(1990-6#1)(1991-9#1)(2008-10#1)(2009-7#1)
Attempt has also been made to##2##6##(2008-10#2)
Attempt##4##1##(2008-10#3)(2009-7#1)
Attempts of##2##2##(1990-5#1)(1995-5#1)
Attempts to identify##3##3##(2007-12#1)(2008-1#1)(2011-1#1)
Attempts to increase##2##3##(2008-11#1)(2008-3#1)
Attempts to use##2##3##(1993-5#1)(2007-11#1)
Attempts to##21##2##(1990-5#1)(1993-5#1)(1994-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-7#1)
Attempts were made to##2##4##(1993-2#1)(2008-10#1)
Attempts##28##1##(1990-5#2)(1993-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
Attendance at##3##2##(1991-6#1)(2008-6#1)(2012-3#1)
Attendance##7##1##(1991-6#3)(2008-12#2)(2008-6#1)(2012-3#1)
Attending##2##1##(2009-10#1)(2009-9#1)
Attention Deficit Hyperactivity Disorder##3##4##(2010-8#2)(2012-1#1)
Attention Deficit Hyperactivity##4##3##(2010-8#3)(2012-1#1)
Attention Deficit##6##2##(1990-2#1)(2008-6#1)(2010-8#3)(2012-1#1)
Attention and##3##2##(1996-5#1)(2010-6#1)(2012-12#1)
Attention deficit hyperactivity disorder (ADHD)##2##5##(1996-6#1)(2013-8#1)
Attention deficit hyperactivity disorder##3##4##(1996-6#1)(2008-7#1)(2013-8#1)
Attention deficit##4##2##(1996-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
Attention has been##2##3##(2008-10#2)
Attention has##4##2##(2008-10#3)(2008-9#1)
Attention is also##2##3##(2007-11#1)(2008-10#1)
Attention is drawn to the##2##5##(1996-8#1)(2008-5#1)
Attention is drawn to##3##4##(1994-3#1)(1996-8#1)(2008-5#1)
Attention is##8##2##(1994-3#1)(1996-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
Attention should be paid to##2##5##(1992-12#1)(1993-12#1)
Attention to these##2##3##(2008-11#1)(2013-1#1)
Attention to##3##2##(2008-11#1)(2008-2#1)(2013-1#1)
Attention##45##1##(1990-2#1)(1992-12#1)(1993-12#1)(1994-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#2)(2007-11#2)(2007-4#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-6#2)(2010-8#4)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Attention-Deficit/Hyperactivity Disorder##2##2##(2009-8#1)(2013-8#1)
Attention-deficit/hyperactivity disorder (ADHD) is a##2##5##(2008-2#2)
Attentional Bias##3##2##(2008-2#1)(2010-7#1)(2013-8#1)
Attentional##6##1##(1996-5#1)(2008-2#1)(2010-7#1)(2011-2#1)(2013-8#2)
Attenuated total reflection Fourier##2##4##(2008-10#2)
Attenuated total##3##2##(2008-10#3)
Attenuated##6##1##(2008-10#4)(2009-11#1)(2013-1#1)
Attenuation of isoproterenol-mediated vasodilatation in blacks##3##6##(1995-11#3)
Attenuation of##8##2##(1990-7#1)(1995-11#3)(2008-2#1)(2008-8#3)
Attenuation##9##1##(1990-7#1)(1995-11#3)(2008-2#1)(2008-3#1)(2008-8#3)
Atteva brucea##2##2##(2013-8#2)
Atteva##5##1##(2013-8#5)
Attitude of physicians##2##3##(2007-7#1)(2008-1#1)
Attitude of##5##2##(2007-7#1)(2008-1#1)(2008-7#1)(2009-7#1)(2011-1#1)
Attitude##9##1##(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-8#1)
Attitudes Toward##2##2##(2009-11#1)(2009-9#1)
Attitudes Towards##2##2##(2010-9#1)(2012-3#1)
Attitudes and##3##2##(2007-2#1)(2010-5#1)(2011-1#1)
Attitudes of##5##2##(2008-12#1)(2008-7#2)(2010-10#1)(2012-1#1)
Attitudes were##2##2##(1991-2#1)(1994-3#1)
Attitudes##19##1##(1991-2#1)(1994-3#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
Attractive##3##1##(2008-7#1)(2008-8#1)(2010-11#1)
Attractiveness##2##1##(2007-12#1)(2011-2#1)
Attributes##2##1##(2011-2#1)(2012-3#1)
Atypical##19##1##(1990-12#1)(1991-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)
Au and Pd##2##3##(2008-10#2)
Au and##7##2##(2008-10#4)(2008-3#2)(2011-1#1)
Au at SiO(2) nanoparticles##2##4##(2008-10#2)
Au at SiO(2)##3##3##(2008-10#3)
Au at##4##2##(2008-10#4)
Au by##2##2##(2008-10#1)(2008-6#1)
Au disk##2##2##(2008-10#2)
Au electrode##3##2##(2008-10#2)(2008-8#1)
Au electrodes##4##2##(2008-10#4)
Au nanocrystalline films##5##3##(2009-11#5)
Au nanoparticle##3##2##(2008-7#1)(2011-1#2)
Au nanoparticles##6##2##(2008-10#4)(2010-12#1)(2011-1#1)
Au surface##3##2##(2008-10#3)
Au##80##1##(1992-11#1)(1994-6#1)(2007-11#3)(2007-12#2)(2008-10#50)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#5)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#4)
Au(111)##6##1##(2008-10#3)(2010-12#2)(2012-1#1)
Au(79)Ag(21)##2##1##(2012-2#2)
Au(III)##15##1##(2008-10#15)
Au-NP/SAM-modified electrodes##3##2##(2008-10#3)
Au-electrode##2##1##(2008-10#2)
AuNPs self-assembly with 6MP##2##4##(2008-10#2)
AuNPs##4##1##(2008-10#4)
AuTM##12##1##(1994-5#6)(1995-3#6)
Auchenorrhyncha##5##1##(2007-12#3)(2011-2#2)
Auckland##6##1##(2007-2#1)(2008-1#3)(2008-12#1)(2012-12#1)
Audio##2##1##(2007-9#1)(2013-1#1)
Audiologists##2##1##(2008-9#2)
Audit of##3##2##(2011-1#2)(2013-1#1)
Audit##5##1##(1993-1#1)(1996-11#1)(2011-1#2)(2013-1#1)
Auditing the##2##2##(1994-12#1)(1994-3#1)
Auditing##4##1##(1991-11#1)(1994-12#1)(1994-3#1)(2012-3#1)
Auditory evoked##2##2##(1991-1#1)(1996-5#1)
Auditory neuropathy##2##2##(2008-9#2)
Auditory##16##1##(1991-1#1)(1996-5#2)(2007-7#1)(2008-2#3)(2008-8#2)(2008-9#4)(2010-9#1)(2011-1#2)
Auger electron##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
Auger##6##1##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)
Augmentation of the##2##3##(2007-12#1)(2008-11#1)
Augmentation of##3##2##(1992-8#1)(2007-12#1)(2008-11#1)
Augmentation##5##1##(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
Augmenting##2##1##(1996-12#1)(2008-11#1)
August 1##2##2##(1992-1#1)(2008-9#1)
August 1991##3##2##(1991-12#1)(1994-7#1)(1995-12#1)
August 1992##2##2##(1993-12#1)(2007-5#1)
August 1993##2##2##(1994-12#1)(1994-9#1)
August 1994##5##2##(1994-9#2)(1995-5#1)(2008-10#1)(2008-2#1)
August 1995##2##2##(1996-8#1)(2008-2#1)
August 1997##2##2##(2007-7#1)(2008-5#1)
August 1998##4##2##(2008-3#3)(2008-5#1)
August 2000##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
August 2001##3##2##(2008-10#2)(2008-5#1)
August 2004##6##2##(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
August 2006##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
August 2007##3##2##(2010-1#1)(2011-2#2)
August 2008##5##2##(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
August 2009##3##2##(2011-1#1)(2011-2#1)(2012-2#1)
August 2010##2##2##(2012-12#1)(2013-1#1)
August and September##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
August and##7##2##(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#1)
August of##2##2##(1995-12#1)(2012-2#1)
August were##2##2##(2008-10#1)(2008-5#1)
August with##2##2##(2008-10#1)(2012-3#1)
August##110##1##(1990-3#1)(1991-12#2)(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#3)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#9)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#4)(2011-2#8)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
August)##5##1##(2008-10#3)(2011-2#2)
Augustine##4##1##(1991-9#1)(2008-10#1)(2008-12#2)
Augustine's conversion to Christianity##3##4##(2008-12#3)
Augustine's conversion##4##2##(2008-12#4)
Augustine's##6##1##(2008-12#6)
Augustinegrass and##3##2##(2008-10#3)
Augustinegrass following M##2##3##(2008-10#2)
Augustinegrass##14##1##(2008-10#14)
Aujeszky's disease virus (ADV)##2##4##(2008-11#1)(2011-2#1)
Aujeszky's disease virus##4##3##(2008-11#2)(2011-2#2)
Aulacorthum solani##3##2##(2008-10#3)
AurSCOPE Ion##2##2##(2008-8#2)
Aureobasidium pullulans##4##2##(2007-11#1)(2008-10#3)
Aurora kinases##4##2##(2013-1#4)
Aurora##9##1##(2008-10#1)(2011-2#1)(2013-1#7)
Aurora-A##6##1##(2012-12#6)
Austin v##2##2##(1991-3#1)(1994-1#1)
Austin##5##1##(1991-3#1)(1991-9#1)(1994-1#1)(1996-1#1)(2007-8#1)
Australasia##5##1##(2007-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-8#1)
Australasian##3##1##(2008-10#1)(2008-6#1)(2013-7#1)
Australia and New Zealand##8##4##(1992-11#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-12#2)
Australia and the United States##2##5##(2012-12#2)
Australia and the United##3##4##(1992-1#1)(2012-12#2)
Australia and the##8##3##(1992-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#2)
Australia and##27##2##(1992-1#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-7#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#4)
Australia by##2##2##(2007-2#1)(2008-7#1)
Australia has a##2##3##(2007-2#1)(2008-10#1)
Australia has been##2##3##(2007-2#1)(2008-10#1)
Australia has##4##2##(2007-2#2)(2008-10#2)
Australia in##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
Australia to##2##2##(2007-10#1)(2008-12#1)
Australia were##2##2##(2008-10#2)
Australia with##2##2##(2008-7#1)(2008-8#1)
Australia##206##1##(1990-2#1)(1991-2#1)(1991-8#2)(1992-1#7)(1992-11#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-2#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-1#1)(1996-7#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#13)(2007-5#1)(2008-1#1)(2008-10#55)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#3)(2010-3#5)(2010-4#1)(2010-8#6)(2011-1#1)(2011-10#1)(2011-2#17)(2012-12#9)(2012-2#2)(2013-1#5)(2013-8#3)
Australia's##5##1##(2008-11#1)(2008-6#3)(2011-1#1)
Australia)##4##1##(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
Australian Aboriginal Community Controlled Health Services##2##6##(2008-6#2)
Australian Aboriginal##3##2##(1996-12#1)(2008-6#2)
Australian College of##3##3##(1992-1#2)(2011-2#1)
Australian Indigenous##2##2##(2011-1#2)
Australian Populations of##2##3##(2008-10#2)
Australian and Indian isolates##2##4##(2008-10#2)
Australian and New Zealand##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
Australian and##10##2##(2007-11#2)(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
Australian broiler##2##2##(2011-2#2)
Australian data##2##2##(2007-10#1)(2008-10#1)
Australian experience##2##2##(1996-2#1)(2008-7#1)
Australian families##2##2##(1997-5#2)
Australian health care##4##3##(1992-1#1)(1995-3#1)(1996-2#1)(2011-2#1)
Australian health##8##2##(1992-1#3)(1995-3#2)(1996-2#1)(2011-2#2)
Australian intensive care##3##3##(2007-11#3)
Australian isolates##2##2##(2008-10#2)
Australian nursing##3##2##(2008-11#2)(2008-12#1)
Australian perspective##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
Australian study##2##2##(2008-7#1)(2011-2#1)
Australian teaching##2##2##(2008-7#2)
Australian university##2##2##(2008-11#1)(2008-12#1)
Australian varanids##2##2##(2013-1#2)
Australian veterans##3##2##(2011-2#3)
Australian white wines##2##3##(2008-10#2)
Australian##155##1##(1990-2#3)(1991-11#1)(1991-2#2)(1992-1#7)(1994-12#2)(1994-2#2)(1995-3#4)(1996-1#1)(1996-12#1)(1996-2#3)(1997-5#3)(2007-10#1)(2007-11#13)(2007-12#4)(2007-2#2)(2007-6#2)(2008-10#30)(2008-11#12)(2008-12#9)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#1)(2009-2#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#17)(2012-12#5)(2013-1#10)
Australian-Caucasian males##2##2##(2008-10#2)
Australians##5##1##(2008-10#1)(2011-1#1)(2012-12#3)
Australopithecus afarensis##2##2##(1994-3#2)
Austria##14##1##(1990-2#1)(1993-3#1)(1994-12#1)(1997-3#1)(2007-1#1)(2007-10#2)(2008-10#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-7#1)
Austria)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
Austrian and##3##2##(1997-3#1)(2008-10#2)
Austrian##11##1##(1990-2#3)(1993-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2009-10#1)
Authentic##3##1##(1990-8#1)(1991-12#1)(2013-1#1)
Authenticity##2##1##(1990-2#1)(2009-9#1)
Authie##3##1##(2008-10#3)
Author index##17##2##(2008-11#16)(2008-4#1)
Author response##2##2##(2013-8#2)
Author##25##1##(1990-5#1)(1991-9#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-11#16)(2008-4#1)(2011-2#1)(2013-8#2)
Author's response##3##2##(2008-8#2)(2011-2#1)
Author's##6##1##(1991-3#1)(1991-5#1)(2008-8#2)(2011-2#1)(2013-1#1)
Authorities##4##1##(1992-3#1)(2008-10#2)(2010-3#1)
Authority##8##1##(1992-3#1)(1995-6#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)
Authorization##2##1##(1996-5#1)(2010-11#1)
Authors are presenting##2##3##(2011-2#1)(2013-8#1)
Authors conclude##3##2##(1990-5#1)(1990-9#1)(1992-9#1)
Authors describe a case##4##4##(1991-5#1)(1991-6#1)(1992-9#1)(2011-3#1)
Authors describe a##9##3##(1990-3#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#3)(2011-3#1)(2013-1#1)
Authors describe the##2##3##(1990-9#1)(1993-6#1)
Authors describe##14##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#3)(1993-3#1)(1993-6#1)(2007-11#1)(2011-3#1)(2013-1#1)
Authors discuss##4##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)
Authors emphasize##4##2##(1990-5#1)(1992-9#1)(1993-6#1)(2011-2#1)
Authors evaluate##2##2##(1991-3#1)(2011-3#1)
Authors have##2##2##(1992-6#1)(2013-1#1)
Authors pointed out##2##3##(2007-11#2)
Authors present the##2##3##(1990-3#1)(1990-5#1)
Authors present##8##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#1)(2007-11#2)(2012-12#1)
Authors report a##7##3##(1990-10#1)(1990-6#1)(1991-6#1)(1992-6#2)(1992-9#2)
Authors report on##2##3##(1990-5#2)
Authors report the case of##2##5##(1991-6#1)(2013-1#1)
Authors report the##4##3##(1990-5#1)(1991-6#1)(1992-9#1)(2013-1#1)
Authors report##19##2##(1990-10#1)(1990-5#4)(1990-6#1)(1990-9#2)(1991-5#1)(1991-6#2)(1992-6#4)(1992-9#3)(2013-1#1)
Authors suggest##2##2##(1991-3#1)(1992-5#1)
Authors underline##2##2##(1991-5#1)(1992-6#1)
Authors##101##1##(1990-10#6)(1990-2#2)(1990-3#7)(1990-5#9)(1990-6#3)(1990-9#7)(1991-3#7)(1991-5#5)(1991-6#6)(1992-5#2)(1992-6#8)(1992-9#10)(1993-3#1)(1993-6#2)(1994-12#1)(1994-7#1)(2007-11#10)(2007-8#2)(2011-2#2)(2011-3#2)(2012-12#1)(2013-1#5)(2013-8#2)
Authors'##5##1##(1991-5#1)(1992-6#1)(1997-5#1)(1997-8#1)(2008-12#1)
Autism Spectrum Disorders##2##3##(2010-7#1)(2013-8#1)
Autism and Williams syndrome##2##4##(2008-11#2)
Autism is a##4##3##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Autism is##5##2##(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
Autism##14##1##(2008-11#4)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Autistic spectrum disorder##2##3##(2008-10#1)(2008-11#1)
Autistic##3##1##(1995-5#1)(2008-10#1)(2008-11#1)
Autoantibodies##4##1##(1994-6#1)(1997-5#1)(2008-4#1)(2012-3#1)
Autochthonous##2##1##(2008-10#1)(2012-12#1)
Autoclaving##2##1##(2007-7#1)(2008-10#1)
Autocorrelation##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Autocrine##4##1##(1990-5#1)(1994-9#1)(2008-5#1)(2008-6#1)
Autofluorescence##2##1##(2007-8#1)(2008-3#1)
Autofocus##2##1##(2008-2#2)
Autograft##3##1##(2007-8#1)(2009-3#1)(2013-1#1)
Autographa californica NPV (AcNPV)##2##4##(1997-3#1)(1997-4#1)
Autographa californica multinucleocapsid nuclear polyhedrosis virus##2##6##(1993-12#2)
Autographa californica nuclear polyhedrosis virus (AcNPV)##5##6##(1994-11#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)
Autographa californica nuclear polyhedrosis virus##7##5##(1994-11#1)(1995-12#1)(1997-4#2)(2008-11#1)(2008-7#1)(2008-8#1)
Autographa californica##13##2##(1993-12#2)(1994-11#1)(1995-12#2)(1997-3#1)(1997-4#3)(2008-11#2)(2008-7#1)(2008-8#1)
Autoimmune channelopathies##2##2##(2012-3#2)
Autoimmune diseases##2##2##(2007-5#1)(2007-7#1)
Autoimmune neuromuscular disorders##2##3##(2012-3#2)
Autoimmune ovarian disease##2##3##(2008-4#2)
Autoimmune polyglandular syndrome##2##3##(2012-2#1)(2013-1#1)
Autoimmune polyglandular##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
Autoimmune thyroiditis##2##2##(1991-8#1)(2007-7#1)
Autoimmune##25##1##(1991-8#1)(1994-12#1)(1996-11#1)(2006-10#2)(2007-5#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#1)
Autologous chondrocyte##2##2##(2007-11#1)(2011-2#1)
Autologous##14##1##(2007-11#2)(2008-10#3)(2008-11#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#2)(2013-1#1)
Automated analyser for monitoring##2##4##(2008-10#2)
Automated and##2##2##(2008-10#2)
Automated determination of##2##3##(2008-10#2)
Automated system##2##2##(2008-10#1)(2010-12#1)
Automated##43##1##(1990-2#1)(1991-5#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
Automatic flow##2##2##(2008-10#2)
Automatic##22##1##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-8#3)(2013-1#1)(2013-8#1)
Automating##3##1##(1995-3#1)(1996-12#1)(1997-2#1)
Automation of a##2##3##(2008-10#2)
Automation of repetitive##2##3##(1996-3#1)(2008-10#1)
Automation of##8##2##(1996-3#1)(2007-4#1)(2008-10#6)
Automation##16##1##(1996-3#1)(2007-4#1)(2008-10#13)(2008-9#1)
Autonomic dysfunction##2##2##(2008-7#1)(2011-1#1)
Autonomic##10##1##(1991-12#1)(2007-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Autonomous Region##2##2##(2011-2#1)(2012-12#1)
Autonomous beam alignment for coherent Doppler lidar##2##7##(2008-3#2)
Autonomous##9##1##(1994-12#1)(1996-2#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
Autophagy in##2##2##(2008-7#1)(2013-1#1)
Autophagy is##3##2##(2008-7#2)(2012-1#1)
Autophagy##8##1##(2008-7#4)(2012-1#2)(2012-3#1)(2013-1#1)
Autopsy##8##1##(1995-11#2)(1997-8#1)(2007-10#1)(2008-4#1)(2008-7#1)(2013-1#2)
Autoradiograms##2##1##(1990-10#1)(2008-7#1)
Autoradiographic##2##1##(1994-3#1)(1995-12#1)
Autoradiography##4##1##(1991-12#1)(1992-5#1)(1993-12#1)(2008-4#1)
Autoregulation of androgen receptor##2##4##(1991-5#2)
Autoregulation of the##3##3##(1990-11#1)(1993-9#1)(1996-6#1)
Autoregulation of##6##2##(1990-11#1)(1991-5#2)(1993-9#1)(1996-6#1)(1997-1#1)
Autosomal Dominant Polycystic Kidney Disease##2##5##(2010-6#1)(2013-1#1)
Autosomal dominant##3##2##(2007-7#1)(2008-11#1)(2008-7#1)
Autosomal recessive##2##2##(2008-7#1)(2011-1#1)
Autosomal##7##1##(2007-7#1)(2008-11#1)(2008-7#2)(2010-6#1)(2011-1#1)(2013-1#1)
Autosuture##3##1##(1995-1#3)
Autumn##2##1##(2008-10#2)
Aux/IAA proteins##5##2##(2009-8#5)
Aux/IAA##6##1##(2009-8#6)
AuxRE##2##1##(2008-9#2)
Auxiliaries##3##1##(1991-3#1)(1993-1#1)(1994-1#1)
Auxiliary##9##1##(1991-3#1)(1992-3#1)(1994-2#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)
Auxin##5##1##(2008-10#1)(2008-9#2)(2009-6#1)(2011-1#1)
Availability of##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#2)
Available clinical##3##2##(2008-8#1)(2009-12#1)(2009-8#1)
Available data##2##2##(1994-9#1)(2011-2#1)
Available evidence indicates that##2##4##(1996-12#1)(2008-8#1)
Available evidence##5##2##(1990-6#1)(1996-12#1)(1997-3#1)(2008-8#1)(2010-11#1)
Available##20##1##(1990-6#1)(1991-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
Avascular necrosis of the femoral head##2##6##(2007-8#1)(2009-3#1)
Avascular necrosis of##3##3##(2006-10#1)(2007-8#1)(2009-3#1)
Avascular necrosis##4##2##(2006-10#1)(2007-8#2)(2009-3#1)
Avascular##5##1##(2006-10#2)(2007-8#2)(2009-3#1)
Ave##2##1##(2013-1#1)(2013-8#1)
Avena sativa L##2##3##(2008-9#1)(2011-2#1)
Avena sativa##5##2##(2008-10#1)(2008-9#3)(2011-2#1)
Avena##8##1##(2008-10#4)(2008-9#3)(2011-2#1)
Avenue in##2##2##(1992-2#1)(2008-8#1)
Avenue##8##1##(1992-2#1)(2008-8#5)(2013-8#2)
Avenues of##2##2##(2008-4#1)(2008-5#1)
Average age##2##2##(2011-2#1)(2012-12#1)
Average daily##2##2##(2008-11#1)(2010-2#1)
Average productivity##2##2##(2008-12#2)
Average recoveries of##2##3##(2008-10#2)
Average recoveries##7##2##(2008-10#7)
Average##76##1##(1991-12#1)(1991-2#1)(1992-2#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-7#1)(1995-3#5)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#4)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)
Averaged over all##2##3##(2008-10#1)(2012-6#1)
Averaged over##3##2##(2008-10#2)(2012-6#1)
Averaging##2##1##(2008-3#1)(2008-8#1)
Aversion to xenotransplantation##3##3##(1995-11#3)
Avian Adenoviruses##2##2##(2008-8#2)
Avian##12##1##(1991-5#1)(1997-7#1)(2007-12#1)(2008-5#2)(2008-8#3)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
Aviation##4##1##(1996-12#1)(2007-2#1)(2009-10#1)(2013-8#1)
Avicenna has##4##2##(2013-1#4)
Avicenna the first to describe diseases which may be prevented by exercise##2##12##(2013-1#2)
Avicenna##8##1##(2013-1#8)
Avicennia germinans##2##2##(2008-5#2)
Avirulence Gene of##2##3##(2008-10#2)
Avirulence Gene##4##2##(2008-10#4)
Avirulence Genes##3##2##(2008-10#3)
Avirulence on##2##2##(2008-10#2)
Avirulence to##2##2##(2008-10#2)
Avirulence##15##1##(2008-10#15)
Avirulent##2##1##(2008-10#2)
Avocado Fruits##2##2##(2008-10#2)
Avoid##3##1##(1993-3#1)(1997-2#1)(2008-11#1)
Avoidance of##2##2##(2008-8#1)(2012-12#1)
Avoiding the##4##2##(1991-3#1)(1993-12#1)(1995-1#1)(2008-11#1)
Avoiding##12##1##(1991-3#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-11#1)(2008-11#1)(2009-5#1)(2011-2#2)
Avr genes##2##2##(2008-10#2)
Avr loci##3##2##(2008-10#3)
Avr##9##1##(2008-10#9)
AvrLm1 and##2##2##(2008-10#2)
AvrLm1##7##1##(2008-10#7)
AvrLm2##2##1##(2008-10#2)
AvrLm3 and##2##2##(2008-10#2)
AvrLm3##3##1##(2008-10#3)
AvrLm4##2##1##(2008-10#2)
AvrLm7##2##1##(2008-10#2)
AvrLm8##2##1##(2008-10#2)
AvrLm9##2##1##(2008-10#2)
AvrPik hybridized##2##2##(2008-10#2)
AvrPik##6##1##(2008-10#6)
AvrPiz##3##1##(2008-10#3)
AvrPto in##2##2##(2009-8#2)
AvrPto is##2##2##(2009-8#2)
AvrPto##8##1##(2009-8#8)
AvrT10##2##1##(2008-10#2)
AvrT6##2##1##(2008-10#2)
AvrT8a##2##1##(2008-10#2)
AvrT9a##2##1##(2008-10#2)
Awaken##2##1##(1993-3#1)(2008-4#1)
Award in##4##2##(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)
Award##28##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#4)(1996-2#5)(1996-3#1)(1997-2#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-5#2)(2011-2#1)(2011-6#1)(2012-2#1)(2013-8#1)
Awards and honors##8##3##(2008-10#8)
Awards for##8##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-12#1)
Awards##24##1##(1991-1#2)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#3)(1996-2#2)(1997-4#1)(2007-5#1)(2008-10#8)(2008-12#1)(2013-1#1)
Awareness and knowledge about human papillomavirus among Latina immigrants##2##9##(2011-2#2)
Awareness and knowledge##3##3##(2011-2#2)(2013-1#1)
Awareness of the##7##3##(1992-12#1)(2009-3#1)(2011-2#2)(2012-2#3)
Awareness of this condition is##2##5##(2010-5#1)(2012-12#1)
Awareness of this##3##3##(2008-10#1)(2010-5#1)(2012-12#1)
Awareness of##16##2##(1992-12#1)(1993-1#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
Awareness##26##1##(1992-12#1)(1993-1#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#2)
Away##2##1##(1994-9#1)(2007-2#1)
Awwad had##3##2##(2008-10#3)
Awwad##10##1##(2008-10#10)
AxC##2##1##(2008-10#2)
AxeA##4##1##(2011-1#4)
Axial rotation angle in##2##4##(2007-8#2)
Axial rotation##3##2##(2007-11#1)(2007-8#2)
Axial##13##1##(1995-8#1)(1996-2#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-2#1)(2010-1#2)(2013-1#2)(2013-8#1)
Axillary##8##1##(1995-4#1)(2008-10#1)(2008-5#4)(2008-7#1)(2010-7#1)
Axillo-axillary bypass##2##2##(1993-3#2)
Axis I##7##2##(1993-12#3)(2009-9#1)(2012-12#2)(2013-1#1)
Axis II##3##2##(1993-12#1)(2008-11#1)(2009-9#1)
Axis and##2##2##(2010-8#1)(2012-3#1)
Axis##16##1##(1993-12#4)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#2)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
Axon##4##1##(1997-2#1)(1997-3#1)(2008-7#1)(2011-2#1)
Axonal##6##1##(1996-5#1)(1997-3#1)(2007-12#1)(2008-7#3)
Ayahuasca is a##2##3##(2008-7#1)(2013-8#1)
Ayurvedic system of medicine##2##4##(2008-10#2)
Ayurvedic##6##1##(1994-6#1)(2008-10#2)(2010-5#2)(2013-1#1)
AzT##2##1##(1994-8#2)
Azadirachta indica (neem)##2##3##(2007-7#1)(2012-3#1)
Azadirachta indica##7##2##(2007-7#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-3#1)(2012-3#1)
Azalomycine B##2##2##(2010-8#2)
Azar##2##1##(2008-12#2)
Azar2)##2##1##(2008-12#2)
Azarbaijan##4##1##(2008-12#3)(2013-1#1)
Azathioprine##3##1##(2008-1#1)(2010-12#1)(2011-2#1)
Azerbaijan##4##1##(2008-10#1)(2008-12#2)(2009-4#1)
Azithromycin##2##1##(2008-10#1)(2008-8#1)
Azobenzene##3##1##(1995-6#2)(2008-7#1)
Azorubin##3##1##(2008-10#3)
Azotobacter chroococcum##5##2##(2008-11#5)
Azotobacter vinelandii mannuronan C5-epimerase##2##4##(2009-7#2)
Azotobacter vinelandii##6##2##(1990-11#2)(1992-3#2)(2009-7#2)
Azotobacter##12##1##(1990-11#2)(1992-3#2)(2008-11#5)(2008-7#1)(2009-7#2)
Azul##2##1##(2008-5#2)
Azygos##2##1##(2012-12#1)(2013-8#1)
Aβ##4##1##(2011-1#1)(2012-2#1)(2013-1#2)
Aβ1-42 toxicity##2##2##(2013-1#2)
Aβ40 and Aβ42##2##3##(2010-8#2)
Aβ42##3##1##(2010-8#3)
B &amp##2##2##(2007-10#1)(2009-8#1)
B (2)Sigma-##2##2##(2008-2#2)
B (4)##3##2##(1992-8#3)
B (RB)##5##2##(2008-10#5)
B (apo B)##3##3##(1990-11#1)(1993-9#1)(1997-8#1)
B (apoB)##2##2##(1994-8#1)(1995-6#1)
B -##2##2##(2007-11#1)(2011-2#1)
B =##3##2##(1997-7#1)(2008-10#2)
B APV##2##2##(1997-6#2)
B X##2##2##(2008-10#1)(2009-3#1)
B activation##7##2##(1991-3#1)(1992-12#3)(1993-3#2)(2008-10#1)
B activity by##2##3##(1990-11#1)(1994-6#1)
B activity##5##2##(1990-11#1)(1994-6#3)(1995-6#1)
B allele##3##2##(1995-2#1)(2008-12#2)
B alleles##3##2##(2008-12#2)(2008-4#1)
B alpha##4##2##(1995-2#3)(1995-3#1)
B and C in##2##4##(2007-12#1)(2010-4#1)
B and C infection in##2##5##(1992-12#1)(2013-1#1)
B and C were##2##4##(1997-6#1)(2008-1#1)
B and C##37##3##(1991-5#1)(1992-12#1)(1992-8#1)(1994-7#2)(1997-2#1)(1997-6#2)(1997-7#2)(2006-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#3)(2010-12#5)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
B and C77##2##3##(2008-10#2)
B and D##11##3##(1995-6#6)(1997-1#4)(2013-1#1)
B and D3##2##3##(1997-6#2)
B and E##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
B and H##2##3##(1992-12#1)(1994-8#1)
B and T cell##2##4##(2008-11#1)(2008-4#1)
B and T lymphocytes##4##4##(1994-3#1)(1994-8#1)(2007-10#1)(2008-4#1)
B and T##8##3##(1990-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(2007-10#1)(2008-11#1)(2008-4#2)
B and the##3##3##(1994-12#1)(1995-8#1)(2008-7#1)
B and typhoid fever##2##4##(2007-2#2)
B and##124##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#6)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-7#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#6)(1995-8#1)(1995-9#1)(1997-1#4)(1997-2#1)(1997-6#5)(1997-7#2)(2006-10#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#2)(2010-12#6)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2013-1#3)(2013-7#2)(2013-8#1)
B antigens##2##2##(1992-12#1)(2008-10#1)
B are##8##2##(1994-5#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
B as a##4##3##(1990-11#1)(1992-12#1)(1994-3#1)(2008-10#1)
B as##7##2##(1990-11#1)(1990-5#1)(1992-12#1)(1994-3#2)(1997-5#1)(2008-10#1)
B at##4##2##(2008-10#3)(2011-1#1)
B biotype of##3##3##(2008-10#2)(2011-2#1)
B biotype##5##2##(2008-10#3)(2011-2#2)
B by##4##2##(1990-11#1)(1993-12#1)(2008-9#1)(2010-8#1)
B cell activation##2##3##(2008-4#2)
B cell and##2##3##(2008-4#2)
B cell clones##3##3##(1994-9#1)(2008-11#1)(2008-5#1)
B cell development in humans##2##5##(2008-4#2)
B cell development##4##3##(2008-4#4)
B cell differentiation##3##3##(2008-4#3)
B cell epitope##3##3##(1997-6#2)(2008-11#1)
B cell epitopes##5##3##(1995-5#4)(2008-4#1)
B cell growth factors##2##4##(1991-3#2)
B cell growth##4##3##(1991-3#4)
B cell hybridoma##3##3##(1990-12#1)(2008-11#1)(2008-4#1)
B cell line##7##3##(1994-3#2)(1995-2#1)(2008-11#1)(2008-8#3)
B cell lines##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
B cell lymphoma##5##3##(2007-7#2)(2009-8#3)
B cell lymphomas##4##3##(1993-9#1)(2008-7#1)(2008-9#1)(2013-1#1)
B cell mitogen##2##3##(2008-11#2)
B cell number##3##3##(2007-10#3)
B cell population##2##3##(2011-2#2)
B cell progenitors##3##3##(2008-4#3)
B cell proliferation##3##3##(1992-8#1)(2008-4#2)
B cell responses##2##3##(2008-11#1)(2008-4#1)
B cell##86##2##(1990-12#1)(1991-2#2)(1991-3#5)(1991-5#1)(1991-9#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-5#6)(1997-6#2)(2007-10#3)(2007-7#2)(2008-11#9)(2008-4#28)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-4#1)(2009-8#3)(2011-2#2)(2012-12#1)(2013-1#3)
B cells and T##2##4##(1995-2#1)(2006-10#1)
B cells and the##3##4##(1995-6#1)(1997-8#1)(2008-4#1)
B cells and##11##3##(1990-12#2)(1991-2#1)(1995-2#1)(1995-6#1)(1997-8#1)(2006-10#1)(2008-4#2)(2008-5#1)(2012-3#1)
B cells are##2##3##(2008-4#2)
B cells by##2##3##(2008-11#1)(2008-4#1)
B cells can##2##3##(2008-11#1)(2008-4#1)
B cells in##3##3##(1995-5#1)(2008-11#1)(2008-4#1)
B cells were##4##3##(1992-6#1)(1994-2#1)(2008-11#2)
B cells##84##2##(1990-12#2)(1991-1#2)(1991-2#2)(1991-3#3)(1991-9#3)(1992-12#3)(1992-6#1)(1993-11#6)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#6)(1997-8#1)(1997-9#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#10)(2008-4#22)(2008-5#1)(2008-7#1)(2010-11#1)(2010-5#3)(2012-3#2)(2013-1#3)
B cepacia##2##2##(2007-12#2)
B chain##7##2##(1992-3#1)(1993-11#3)(1997-4#1)(2008-6#1)(2008-9#1)
B chains##2##2##(1993-11#1)(1997-4#1)
B chromosome##4##2##(2008-12#3)(2008-5#1)
B chromosomes##11##2##(2008-12#4)(2008-5#7)
B coli##3##2##(2007-12#3)
B complex##2##2##(1991-7#1)(2008-5#1)
B component##2##2##(2008-10#2)
B concentrations##3##2##(1991-2#1)(1995-12#1)(2008-10#1)
B containing lipoproteins##3##3##(1994-12#2)(2008-7#1)
B contains##2##2##(1995-6#1)(2013-8#1)
B determined by##2##3##(1990-8#2)
B e antigen##2##3##(1995-2#1)(2013-1#1)
B e##3##2##(1995-2#1)(2013-1#2)
B followed by##3##3##(2007-12#1)(2010-10#1)(2010-12#1)
B for##3##2##(1994-12#1)(2008-10#1)(2012-1#1)
B from the gut##2##4##(2007-12#2)
B from the##3##3##(2007-12#2)(2008-10#1)
B from##8##2##(1990-5#2)(1994-12#1)(2007-12#2)(2008-10#2)(2009-2#1)
B gene in##3##3##(1990-3#1)(1997-8#2)
B gene##11##2##(1990-3#2)(1990-7#1)(1995-2#2)(1997-8#3)(2008-5#1)(2008-6#1)(2008-9#1)
B genome##5##2##(2008-10#5)
B had##3##2##(1997-6#1)(2007-9#1)(2008-10#1)
B has been##2##3##(2006-10#1)(2008-7#1)
B has##3##2##(1993-9#1)(2006-10#1)(2008-7#1)
B have##3##2##(1992-8#1)(1996-2#1)(2011-2#1)
B hydroxylamide##2##2##(2008-12#2)
B in a##2##3##(1990-8#1)(2008-5#1)
B in the##4##3##(1997-1#1)(2007-1#1)(2008-7#1)(2012-12#1)
B in##32##2##(1990-8#2)(1991-6#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-5#4)(2008-7#2)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
B infection##6##2##(1991-11#1)(1996-3#1)(2007-12#2)(2009-6#1)(2013-8#1)
B into##3##2##(1992-12#1)(1994-3#1)(2008-7#1)
B is a##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
B is##16##2##(1990-7#1)(1990-8#3)(1992-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
B isolates##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
B isothiocyanate##3##2##(2008-10#3)
B it##2##2##(1992-8#1)(2008-4#1)
B levels##4##2##(1990-3#1)(1992-8#1)(1995-2#1)(2009-12#1)
B ligand##5##2##(2008-11#1)(2010-10#1)(2011-1#2)(2013-1#1)
B lymphocyte activation##2##3##(2008-4#2)
B lymphocyte function##2##3##(2007-10#1)(2008-4#1)
B lymphocyte stimulator##2##3##(2007-7#1)(2012-3#1)
B lymphocyte##10##2##(1991-6#1)(1991-9#1)(2007-10#1)(2007-7#1)(2008-4#3)(2008-9#1)(2012-3#2)
B lymphocytes and##4##3##(1990-9#1)(1991-3#1)(1991-6#1)(2011-2#1)
B lymphocytes by##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
B lymphocytes in the##2##4##(1993-11#1)(2010-5#1)
B lymphocytes in##3##3##(1993-11#1)(2010-5#2)
B lymphocytes##28##2##(1990-12#1)(1990-9#1)(1991-2#2)(1991-3#2)(1991-6#2)(1992-8#2)(1993-11#3)(1994-10#1)(1994-3#2)(2008-1#1)(2008-10#2)(2008-4#3)(2008-9#1)(2010-5#3)(2011-2#1)(2013-8#1)
B lymphoid##2##2##(1991-5#1)(1992-3#1)
B mRNA editing##4##3##(1990-11#1)(1990-7#2)(1994-8#1)
B mRNA##8##2##(1990-11#3)(1990-7#3)(1992-11#1)(1994-8#1)
B may be##2##3##(1990-11#1)(2008-5#1)
B medium##4##2##(2008-10#4)
B of pyruvate kinase##2##4##(1990-5#2)
B of##8##2##(1990-5#4)(1991-12#1)(1994-7#1)(2008-11#2)
B on##7##2##(1990-8#1)(1991-5#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#2)
B or C##2##3##(2007-12#1)(2009-8#1)
B or D##3##3##(2010-7#3)
B or##6##2##(1997-4#1)(2007-12#1)(2009-8#1)(2010-7#3)
B patients##5##2##(2007-8#1)(2008-1#1)(2010-12#1)(2010-7#2)
B plays##2##2##(1995-2#2)
B production##4##2##(1994-8#4)
B reactions##2##2##(2008-8#2)
B receptor##3##2##(1994-2#2)(2011-2#1)
B respectively##2##2##(2008-10#1)(2012-3#1)
B showed significant##2##3##(1991-5#1)(2013-1#1)
B showed##4##2##(1991-5#1)(1997-3#1)(2007-8#1)(2013-1#1)
B site##4##2##(1993-9#1)(1994-5#2)(1996-2#1)
B solution##2##2##(2008-10#2)
B strains in##2##3##(2008-10#1)(2013-8#1)
B strains of##3##3##(1997-4#1)(1997-6#2)
B strains##13##2##(1997-4#1)(1997-6#4)(2008-10#6)(2008-5#1)(2013-8#1)
B subunit##11##2##(1995-3#2)(1995-6#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-2#2)
B subunits##2##2##(1993-11#1)(1995-2#1)
B surface antigen (HBsAg)##6##4##(1995-2#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
B surface antigen##17##3##(1994-5#1)(1995-2#1)(1996-11#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
B surface##22##2##(1994-11#1)(1994-5#1)(1995-2#2)(1996-11#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#2)(2012-3#1)(2013-1#1)(2013-8#2)
B than##2##2##(1995-11#1)(2008-1#1)
B that##3##2##(1991-9#1)(1992-12#1)(2008-5#1)
B to##4##2##(1992-6#1)(1994-3#1)(2007-9#1)(2009-2#1)
B type##4##2##(1991-2#1)(1994-11#1)(2008-5#1)(2012-3#1)
B vaccination in##2##3##(1995-2#1)(2009-12#1)
B vaccination##12##2##(1993-2#1)(1995-2#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-12#2)(2009-4#1)(2012-3#1)
B vaccine##15##2##(1990-6#1)(1991-8#2)(1995-3#1)(1995-5#1)(2007-11#1)(2008-9#3)(2009-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
B virus (HBV) and##3##4##(2008-1#1)(2008-10#1)(2013-8#1)
B virus (HBV) infection is##3##5##(2008-8#1)(2013-1#1)(2013-8#1)
B virus (HBV) infection##9##4##(1997-4#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
B virus (HBV)##38##3##(1990-8#1)(1991-11#1)(1993-8#1)(1995-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2012-12#2)(2013-1#6)(2013-8#3)
B virus X gene##2##4##(1996-8#1)(2012-12#1)
B virus and##4##3##(2007-7#2)(2011-3#1)(2013-1#1)
B virus is initiated by binding of##2##7##(2009-7#2)
B virus##102##2##(1990-8#2)(1991-11#1)(1991-6#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-7#2)(1994-8#2)(1995-2#6)(1996-12#2)(1996-2#1)(1996-3#2)(1996-8#1)(1997-4#4)(1997-5#1)(1997-6#4)(2006-10#4)(2007-12#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#4)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#10)(2013-8#4)
B viruses##8##2##(1994-9#2)(1996-6#4)(2008-9#1)(2011-2#1)
B vitamins##3##2##(1995-6#2)(2010-1#1)
B was also##2##3##(1997-1#1)(2007-8#1)
B was found##2##3##(2007-8#1)(2008-10#1)
B was##30##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-5#1)(1992-12#2)(1992-8#1)(1993-12#1)(1996-3#1)(1997-1#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#3)(2008-8#1)(2009-2#1)(2010-7#1)(2011-2#1)(2013-8#1)
B were found##3##3##(1994-6#1)(2007-8#1)(2008-10#1)
B were##21##2##(1992-2#1)(1992-6#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
B with##6##2##(1992-6#1)(1994-3#1)(1995-5#1)(1996-6#1)(2008-10#1)(2013-1#1)
B##2093##1##(1990-11#29)(1990-12#13)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#12)(1990-6#3)(1990-7#7)(1990-8#19)(1990-9#1)(1991-1#4)(1991-11#5)(1991-12#3)(1991-2#11)(1991-3#15)(1991-5#7)(1991-6#7)(1991-7#2)(1991-8#5)(1991-9#9)(1992-11#5)(1992-12#35)(1992-2#2)(1992-3#12)(1992-5#2)(1992-6#15)(1992-7#1)(1992-8#15)(1992-9#1)(1993-10#1)(1993-11#16)(1993-12#9)(1993-2#13)(1993-3#4)(1993-6#12)(1993-8#8)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#12)(1994-12#12)(1994-2#10)(1994-3#16)(1994-5#10)(1994-6#7)(1994-7#5)(1994-8#18)(1994-9#11)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#15)(1995-2#40)(1995-3#5)(1995-5#16)(1995-6#34)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#12)(1996-2#7)(1996-3#11)(1996-5#4)(1996-6#9)(1996-8#2)(1997-1#9)(1997-2#30)(1997-3#3)(1997-4#16)(1997-5#6)(1997-6#24)(1997-7#6)(1997-8#13)(1997-9#1)(2006-10#8)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#7)(2007-11#10)(2007-12#40)(2007-2#8)(2007-5#1)(2007-6#1)(2007-7#18)(2007-8#17)(2007-9#3)(2008-1#9)(2008-10#485)(2008-11#48)(2008-12#43)(2008-2#6)(2008-3#11)(2008-4#76)(2008-5#82)(2008-6#20)(2008-7#22)(2008-8#28)(2008-9#42)(2009-10#2)(2009-11#6)(2009-12#14)(2009-2#10)(2009-3#6)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#24)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#13)(2010-2#3)(2010-3#12)(2010-4#4)(2010-5#9)(2010-6#12)(2010-7#10)(2010-8#4)(2011-1#16)(2011-2#83)(2011-3#2)(2012-1#4)(2012-12#11)(2012-2#14)(2012-3#16)(2012-8#2)(2013-1#50)(2013-7#24)(2013-8#29)
B&quot##6##1##(1991-3#2)(1991-6#1)(2009-8#1)(2011-2#2)
B'##2##1##(1993-2#1)(1995-3#1)
B(1)##13##1##(2008-10#12)(2010-5#1)
B(12) and##3##2##(2008-10#1)(2008-3#2)
B(12)##29##1##(2007-10#1)(2008-10#11)(2008-11#5)(2008-3#3)(2008-7#5)(2011-1#4)
B(2) and##2##2##(2008-10#2)
B(2)##16##1##(2008-10#14)(2008-8#2)
B(4)##6##1##(2008-10#5)(2009-10#1)
B(4)-##2##1##(2009-10#2)
B(4)C in the spectral##2##4##(2008-2#1)(2008-3#1)
B(4)C##4##1##(2008-2#2)(2008-3#2)
B(5)##2##1##(2008-10#1)(2009-2#1)
B(6) and B(12)##2##3##(2008-10#2)
B(6) and##3##2##(2008-10#2)(2008-3#1)
B(6)##9##1##(2007-10#1)(2008-10#4)(2008-3#3)(2008-8#1)
B(6)C(3)F(1) mice##8##2##(2008-10#8)
B(6)C(3)F(1)##10##1##(2008-10#10)
B(8)-GAPDH##2##1##(2009-10#2)
B(A)P for##2##2##(1993-8#2)
B(A)P of##2##2##(1993-8#2)
B(A)P##13##1##(1993-8#13)
B(In)##4##1##(2008-10#4)
B(rd) and O(rd) distances##2##4##(2008-12#2)
B(rd) and O(rd)##3##3##(2008-12#3)
B(rd)##6##1##(2008-12#6)
B(with FT)yielded##2##2##(1997-7#2)
B) and the##2##3##(1993-9#1)(2013-7#1)
B) and##5##2##(1993-9#1)(1997-2#1)(2007-10#1)(2008-12#1)(2013-7#1)
B) as##2##2##(1997-8#1)(2008-8#1)
B) in##2##2##(2008-10#1)(2011-1#1)
B) of##2##2##(1997-3#1)(2009-2#1)
B) or the##2##3##(1994-12#1)(2008-10#1)
B) was##2##2##(1997-6#1)(2008-10#1)
B) were##4##2##(1992-8#1)(2008-10#2)(2012-12#1)
B)##51##1##(1990-11#1)(1990-6#1)(1991-5#1)(1992-12#2)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
B- and D-cell lines##2##4##(1995-8#2)
B- and T-cell epitope##3##4##(1995-2#2)(2008-10#1)
B- and T-cell epitopes##2##4##(1994-8#1)(1995-2#1)
B- and T-cell##5##3##(1994-8#1)(1995-2#3)(2008-10#1)
B- and##10##2##(1994-8#1)(1995-2#5)(1995-8#2)(2008-10#2)
B-##15##1##(1994-3#2)(1994-8#1)(1995-2#5)(1995-8#2)(2008-10#4)(2009-8#1)
B-100 and apo B-48##2##4##(1990-8#2)
B-100 and apo##3##3##(1990-8#2)(1993-12#1)
B-100 and##6##2##(1990-8#3)(1993-12#2)(1993-2#1)
B-100 mRNA##2##2##(1990-11#1)(1992-11#1)
B-100##12##1##(1990-11#1)(1990-8#4)(1992-11#2)(1993-12#3)(1993-2#1)(2009-8#1)
B-3##2##1##(2008-5#2)
B-48 determined by the##2##4##(1990-8#2)
B-48 in##2##2##(1990-8#2)
B-48##13##1##(1990-8#13)
B-CLL cells##3##2##(1995-2#2)(2008-5#1)
B-CLL##4##1##(1991-4#1)(1995-2#2)(2008-5#1)
B-DNA##4##1##(1993-8#3)(1997-3#1)
B-EIA##3##1##(1993-2#3)
B-GOx##6##1##(2008-10#6)
B-H(2)ats##3##1##(2008-10#3)
B-Lynch##3##1##(2011-2#3)
B-MYB##9##1##(2011-2#9)
B-PE##3##1##(2008-10#3)
B-Twin system##3##2##(2008-11#3)
B-Twin##5##1##(2008-11#5)
B-box domain##2##2##(2009-8#2)
B-box##4##1##(2009-8#4)
B-cell and##2##2##(1997-3#1)(2009-8#1)
B-cell chronic lymphocytic leukemia##2##4##(1991-4#1)(2008-10#1)
B-cell epitope identification##3##3##(2008-10#3)
B-cell epitope##5##2##(2008-10#5)
B-cell epitopes##4##2##(2008-10#3)(2012-2#1)
B-cell line##2##2##(1995-8#1)(2008-11#1)
B-cell lymphoma of##2##3##(2009-5#1)(2013-8#1)
B-cell lymphoma##14##2##(2008-1#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#4)(2012-2#1)(2013-1#3)(2013-8#1)
B-cell lymphomas##3##2##(1992-12#1)(1992-8#1)(1997-1#1)
B-cell##60##1##(1990-11#1)(1991-4#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-9#1)(2007-10#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#10)(2010-11#2)(2010-5#2)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#3)
B-cell-targeted therapy##2##2##(2010-5#2)
B-cells and##2##2##(2008-10#1)(2009-4#1)
B-cells##13##1##(1997-1#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#4)(2009-4#1)(2009-6#2)
B-chain##2##1##(1992-3#1)(1992-6#1)
B-complex##3##1##(2008-10#1)(2010-1#2)
B-containing LP##2##2##(1995-8#2)
B-containing lipoproteins##3##2##(1995-2#1)(1995-8#1)(2008-6#1)
B-containing##5##1##(1995-2#1)(1995-8#3)(2008-6#1)
B-form##4##1##(1991-5#1)(2008-8#1)(2008-9#2)
B-group isolates were pathogenic on##2##5##(2008-10#2)
B-group isolates##3##2##(2008-10#3)
B-like##3##1##(1991-7#2)(2008-10#1)
B-lymphocyte##6##1##(1991-6#2)(1993-6#1)(2008-10#2)(2010-5#1)
B-lymphocytes##6##1##(1991-6#1)(2008-10#5)
B-mode US##2##2##(2010-12#2)
B-mode ultrasonographic images of##2##4##(2007-10#2)
B-mode ultrasound##2##2##(2010-12#1)(2013-8#1)
B-mode##9##1##(2007-10#4)(2008-1#1)(2010-12#3)(2013-8#1)
B-phospholipid##2##1##(1992-6#2)
B-phycoerythrin##3##1##(2008-10#1)(2008-8#2)
B-responding cells##4##2##(1994-9#4)
B-spline##4##1##(2008-10#1)(2008-3#1)(2008-6#2)
B-type lamins##3##2##(2008-8#1)(2011-2#2)
B-type natriuretic peptide (BNP)##2##4##(2008-3#1)(2008-7#1)
B-type natriuretic peptide##7##3##(2007-5#1)(2008-3#3)(2008-7#2)(2013-1#1)
B-type natriuretic##8##2##(2007-5#1)(2008-11#1)(2008-3#3)(2008-7#2)(2013-1#1)
B-type##15##1##(1991-5#1)(1992-3#1)(1993-9#1)(2007-5#1)(2008-11#1)(2008-3#3)(2008-7#2)(2008-8#1)(2011-2#3)(2013-1#1)
B/C##2##1##(1991-12#1)(2013-8#1)
B/F##2##1##(1992-6#1)(2008-10#1)
B1 ADH##2##2##(1994-9#2)
B1 and B2##7##3##(2008-10#1)(2008-11#1)(2008-5#5)
B1 and##11##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#5)(2010-4#1)(2013-8#2)
B1 strains were##2##3##(2008-10#2)
B1##41##1##(1990-2#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-9#3)(1995-3#3)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#7)(2010-4#1)(2010-5#1)(2011-2#5)(2012-3#1)(2012-5#1)(2013-8#4)
B1)##4##1##(1994-5#1)(1994-6#2)(2008-1#1)
B10 and G16##2##3##(2011-2#2)
B10##9##1##(1990-12#1)(1990-3#3)(1991-1#1)(2008-12#2)(2011-2#2)
B104 and H411E##2##3##(1993-6#2)
B104 cells##4##2##(1993-8#4)
B104##8##1##(1993-6#2)(1993-8#4)(2008-10#2)
B12 and##3##2##(1993-12#1)(2008-8#1)(2010-1#1)
B12 deficiency##13##2##(1990-3#5)(1993-12#1)(1995-11#1)(2007-9#1)(2008-8#1)(2012-2#4)
B12 status##3##2##(1993-12#2)(2012-3#1)
B12##59##1##(1990-3#14)(1992-9#5)(1993-12#12)(1995-11#3)(2007-1#1)(2007-9#1)(2008-8#4)(2010-1#11)(2012-2#5)(2012-3#1)(2013-8#2)
B12-deficient##2##1##(1995-11#1)(2008-7#1)
B12FA##3##1##(1992-9#3)
B12FA-labelled##2##1##(1992-9#2)
B13##5##1##(2011-2#5)
B14##2##1##(2008-1#2)
B15##2##1##(1997-9#2)
B16 2F2 cells##2##3##(2008-11#2)
B16 2F2##4##2##(2008-11#4)
B16 cells##2##2##(2008-11#2)
B16 melanoma cells##2##3##(2008-5#2)
B16##11##1##(1993-5#2)(2008-11#7)(2008-5#2)
B16-C3##3##1##(1991-5#3)
B16-F10##3##1##(1997-7#2)(2013-1#1)
B16F10##4##1##(1992-8#1)(2008-9#2)(2013-1#1)
B18C6##7##1##(2008-10#7)
B19 erythrovirus##2##2##(2012-2#2)
B19##10##1##(1994-8#3)(1996-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
B2 and##4##2##(1991-8#1)(1995-12#1)(2008-11#2)
B2 is##2##2##(2007-12#1)(2008-5#1)
B2 production##2##2##(1992-12#1)(2008-5#1)
B2 protein##3##2##(1991-5#2)(2008-5#1)
B2 receptor##2##2##(1992-3#2)
B2##49##1##(1990-10#1)(1990-12#5)(1990-3#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-10#1)(1996-3#4)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#8)(2008-9#1)
B22##2##1##(1996-6#2)
B245/270D##2##1##(2008-11#2)
B27##5##1##(1990-11#4)(1997-5#1)
B3 and B4##2##3##(1995-3#2)
B3 and##3##2##(1995-3#2)(2008-12#1)
B3##7##1##(1991-5#1)(1994-5#2)(1995-3#2)(2008-11#1)(2008-12#1)
B3)##3##1##(2008-11#1)(2008-5#2)
B30 and##2##2##(1997-9#1)(2008-9#1)
B30##3##1##(1997-9#1)(2008-9#2)
B37##6##1##(1997-5#5)(2008-10#1)
B37HtN##3##1##(2008-10#3)
B39##4##1##(1997-8#4)
B3LYP method##2##2##(2010-7#1)(2011-2#1)
B3LYP##3##1##(2010-7#2)(2011-2#1)
B4 and##2##2##(1991-5#1)(1994-8#1)
B4##13##1##(1990-11#1)(1990-12#1)(1991-5#3)(1991-8#2)(1992-8#1)(1994-8#1)(1995-3#2)(1997-4#1)(2008-10#1)
B4)##3##1##(1990-7#1)(2008-12#2)
B5 were##2##2##(2008-10#1)(2008-12#1)
B5##15##1##(1997-8#2)(2008-10#9)(2008-12#4)
B5*-sat##2##1##(2008-10#2)
B6 metabolism##3##2##(2013-1#3)
B6 mice##3##2##(1994-5#2)(2011-2#1)
B6 than##2##2##(1996-12#2)
B6##29##1##(1991-2#1)(1991-5#2)(1992-9#7)(1994-5#2)(1996-12#3)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#7)
B6C3F 1 mice##3##3##(2008-9#3)
B6C3F 1##6##2##(2008-9#6)
B6C3F(1) mice treated with##2##4##(2008-9#2)
B6C3F(1) mice were administered##6##4##(2008-9#6)
B6C3F(1) mice##8##2##(2008-9#8)
B6C3F(1)##14##1##(2008-9#14)
B6C3F1 mice##5##2##(1995-11#1)(1995-3#1)(2008-9#3)
B7##8##1##(1997-9#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)
B7(+) macrophages##4##2##(2008-10#4)
B7-2##2##1##(1995-12#1)(2008-4#1)
B728a##3##1##(2008-10#3)
B73 (P(1))##2##2##(2008-10#2)
B73 and LB31##2##3##(2008-10#2)
B73 and##5##2##(2008-10#5)
B73 x Tex6##5##3##(2008-10#5)
B73##21##1##(2008-10#18)(2012-3#3)
B8##4##1##(1994-7#1)(2008-1#1)(2008-10#2)
B9 cells##3##2##(2008-4#3)
B9##5##1##(2008-4#5)
B92##2##1##(2008-2#2)
B971##2##1##(2010-7#2)
BA and##2##2##(2008-7#2)
BA at##2##2##(2008-10#2)
BA increased##2##2##(2008-11#2)
BA is##2##2##(2008-10#2)
BA was##2##2##(2008-7#1)(2012-2#1)
BA##24##1##(1995-11#2)(2008-10#7)(2008-11#4)(2008-7#7)(2011-2#1)(2012-12#1)(2012-2#2)
BA) and##2##2##(2008-12#2)
BA) or##2##2##(1997-3#2)
BA)##5##1##(1997-3#2)(2008-12#3)
BA-ELISA##2##1##(2008-10#2)
BAA##5##1##(2011-2#5)
BABA and##2##2##(2009-6#2)
BABA were##2##2##(2008-10#2)
BABA##16##1##(2008-10#12)(2009-6#4)
BABA-IR and##2##2##(2009-6#2)
BABA-IR##3##1##(2009-6#3)
BABA-treated##3##1##(2008-10#3)
BABO##6##1##(2008-9#6)
BAC DNA for##4##3##(2008-2#1)(2008-4#3)
BAC DNA suitable for##2##4##(2008-2#1)(2008-4#1)
BAC DNA##9##2##(2007-6#1)(2008-2#3)(2008-4#5)
BAC clone was##2##3##(2008-8#2)
BAC clone##6##2##(2008-10#1)(2008-4#1)(2008-8#4)
BAC clones mapped to##2##4##(2012-3#2)
BAC clones that##2##3##(2010-3#1)(2012-3#1)
BAC clones were##2##3##(2008-8#1)(2012-3#1)
BAC clones with##2##3##(2008-8#2)
BAC clones##15##2##(1997-8#1)(2008-10#2)(2008-4#1)(2008-8#3)(2010-3#2)(2012-3#6)
BAC contig##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
BAC library with##2##3##(2008-7#1)(2008-9#1)
BAC library##4##2##(2008-7#1)(2008-8#2)(2008-9#1)
BAC recombineering##3##2##(2012-2#3)
BAC transgenic mice##5##3##(2008-4#3)(2013-8#2)
BAC transgenic##8##2##(2008-4#6)(2013-8#2)
BAC##59##1##(1997-8#1)(2007-6#2)(2008-10#3)(2008-2#6)(2008-4#17)(2008-7#3)(2008-8#11)(2008-9#1)(2010-3#2)(2012-2#3)(2012-3#8)(2013-8#2)
BAC-end sequences##2##2##(2010-10#1)(2012-3#1)
BAC2##4##1##(2008-8#4)
BACKGROUND &amp##2##2##(2013-1#2)
BACKGROUND AND AIMS##3##3##(2011-2#1)(2012-2#2)
BACKGROUND AND OBJECTIVES##7##3##(2009-4#1)(2012-2#6)
BACKGROUND AND##11##2##(2009-4#1)(2010-10#1)(2011-2#1)(2012-2#8)
BACKGROUND##128##1##(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#2)(2009-1#4)(2009-11#3)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#13)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#25)(2012-3#20)(2013-1#15)
BACTEC 460 TB##2##3##(2007-7#2)
BACTEC##3##1##(2007-7#2)(2011-1#1)
BACs by homologous recombination in E##2##6##(2008-4#2)
BACs##9##1##(2007-6#1)(2008-2#1)(2008-4#4)(2008-7#1)(2010-10#1)(2010-3#1)
BAD##5##1##(1997-5#5)
BAE with##2##2##(2012-3#2)
BAE##4##1##(2010-12#2)(2012-3#2)
BAGI##2##1##(2008-3#2)
BAI##2##1##(2012-2#1)(2013-1#1)
BAK homologues by the##2##4##(1992-11#2)
BAK##3##1##(1992-11#3)
BAL fluid##3##2##(2008-10#3)
BAL##14##1##(1991-2#2)(1996-9#1)(2007-8#1)(2008-10#5)(2010-12#2)(2011-2#1)(2012-2#2)
BALB##4##1##(1994-5#4)
BALB/c and C57BL/6 mice##3##4##(2008-12#1)(2013-1#2)
BALB/c and##5##2##(1996-12#1)(2008-10#1)(2008-12#1)(2013-1#2)
BALB/c mice and##2##3##(2012-2#1)(2013-8#1)
BALB/c mice immunized##2##3##(1995-2#1)(2008-11#1)
BALB/c mice in##2##3##(1996-12#1)(2012-2#1)
BALB/c mice were##3##3##(1992-5#1)(2008-10#1)(2008-11#1)
BALB/c mice##35##2##(1992-5#2)(1992-8#1)(1993-5#3)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#4)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-9#3)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
BALB/c or##2##2##(1996-12#1)(2013-1#1)
BALB/c##49##1##(1991-1#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-5#3)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#8)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
BALB/cByJ##7##1##(1995-2#1)(2008-11#2)(2008-5#4)
BALB/cJ##4##1##(2008-5#4)
BALBc mice##3##2##(1995-12#2)(1996-5#1)
BAM##2##1##(2008-10#2)
BAMR##2##1##(2008-7#2)
BAN##2##1##(2010-8#2)
BAN215-6##2##1##(1997-2#2)
BAP (2##2##2##(2013-1#2)
BAP##9##1##(2008-12#6)(2013-1#3)
BAP2##5##1##(1995-11#5)
BAPEN##2##1##(2012-12#2)
BAPP##3##1##(2008-2#3)
BAPTA##7##1##(1992-6#1)(1994-11#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-4#1)(2008-8#1)
BAQABP##2##1##(2008-10#2)
BAR density was##2##3##(1992-12#2)
BAR density##3##2##(1992-12#3)
BARC##2##1##(2008-3#2)
BAS##3##1##(2007-12#3)
BASED##2##1##(2009-11#1)(2012-12#1)
BASIC REMARKS##2##2##(1992-11#1)(1993-3#1)
BASIC##6##1##(1992-11#1)(1992-9#1)(1993-3#1)(2008-10#3)
BASICS##2##1##(1992-11#1)(2008-8#1)
BAT##8##1##(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
BAW sensor##2##2##(2008-10#2)
BAX and##2##2##(2008-11#1)(2012-12#1)
BAX translocation to the mitochondria##2##5##(2008-11#2)
BAX##10##1##(2008-11#3)(2009-8#1)(2011-2#4)(2012-12#1)(2012-2#1)
BAb##3##1##(1993-9#3)
BB and was insignificantly##3##4##(2007-7#3)
BB and##5##2##(1990-12#1)(1996-5#1)(2007-7#3)
BB is##2##2##(1991-9#2)
BB pathotypes##2##2##(2008-10#2)
BB resistance##2##2##(2008-10#2)
BB##20##1##(1990-12#2)(1991-9#3)(1996-5#1)(2007-7#7)(2008-10#4)(2008-12#1)(2008-8#2)
BB) and##2##2##(1990-12#1)(1996-5#1)
BB-640##4##1##(2008-2#3)(2008-3#1)
BB170##4##1##(2008-9#3)(2009-6#1)
BB84##3##1##(2007-12#1)(2008-2#2)
BBA 2890##6##2##(2008-10#6)
BBA 809##3##2##(2008-10#3)
BBA##16##1##(2008-10#9)(2008-11#7)
BBB cotransporter##2##2##(2008-8#2)
BBB##18##1##(1990-5#2)(1996-5#3)(2007-11#1)(2008-7#5)(2008-8#5)(2012-2#2)
BBM##7##1##(1991-9#5)(1992-6#2)
BBMV##4##1##(1992-6#2)(2008-10#1)(2008-9#1)
BBN##2##1##(2010-6#2)
BBO crystal##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
BBO is##2##2##(2007-12#1)(2008-2#1)
BBO##13##1##(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#2)
BBOS##5##1##(2011-2#5)
BBP##2##1##(2008-10#1)(2008-5#1)
BBR##4##1##(2012-3#4)
BBS and TUG##3##3##(2010-3#3)
BBS##7##1##(2010-3#7)
BBSV##7##1##(1995-12#3)(2008-10#4)
BBSV-Co##3##1##(2008-10#3)
BBWV 2##3##2##(2008-10#3)
BBWV##5##1##(2008-10#5)
BBWV-1 and BBWV-2##2##3##(2008-10#2)
BBWV-1##3##1##(2008-10#3)
BBWV-2##3##1##(2008-10#3)
BBWV-K##3##1##(2008-10#3)
BBX##2##1##(2008-4#2)
BC (2)F(2)##2##2##(2008-9#2)
BC and##2##2##(2008-10#2)
BC in##2##2##(1993-3#2)
BC was##3##2##(1992-8#1)(2008-10#1)(2008-6#1)
BC##30##1##(1992-8#3)(1993-3#3)(2007-2#1)(2007-5#1)(2008-10#8)(2008-6#4)(2008-7#1)(2008-9#2)(2012-12#1)(2012-9#3)(2013-1#2)(2013-8#1)
BC(1)##3##1##(2008-10#3)
BC(1)F(1)##4##1##(2008-10#4)
BC(1)r##2##1##(2008-10#2)
BC(1)s##2##1##(2008-10#2)
BC) were##2##2##(2008-10#2)
BC)##5##1##(2008-10#2)(2010-4#1)(2012-9#2)
BC-1 RNA##6##2##(1992-11#6)
BC-R2##4##1##(1992-12#4)
BC1 progenies##3##2##(2008-5#3)
BC1 progeny##2##2##(2008-5#2)
BC1##5##1##(2008-5#5)
BC1F4##3##1##(2008-10#3)
BC3-5-1-OS2A##2##1##(2008-10#2)
BCA was##2##2##(2008-10#2)
BCA##5##1##(2008-10#5)
BCAs with##2##2##(2008-10#2)
BCAs##13##1##(2008-10#13)
BCC is itself##2##3##(2013-1#2)
BCC lesions##2##2##(2012-3#1)(2013-1#1)
BCC##11##1##(2007-5#1)(2008-9#1)(2012-3#3)(2013-1#6)
BCCAO##5##1##(2007-10#5)
BCCs##3##1##(1997-3#3)
BCE##2##1##(2008-11#1)(2008-12#1)
BCE-001##2##1##(1994-6#2)
BCEC##3##1##(2008-10#3)
BCECF##2##1##(1990-2#1)(2008-10#1)
BCEOC##5##1##(2008-10#5)
BCF##5##1##(2008-12#5)
BCF(2) families##4##2##(2008-10#4)
BCFAs with##2##2##(2008-6#2)
BCG and##2##2##(2008-7#1)(2011-2#1)
BCG as a##2##3##(2011-2#2)
BCG in##3##2##(2013-1#2)(2013-8#1)
BCG recombinant##2##2##(1995-5#2)
BCG vaccination##3##2##(1990-6#1)(2007-2#1)(2008-10#1)
BCG vaccine##2##2##(2009-7#1)(2011-2#1)
BCG##30##1##(1990-6#1)(1995-12#1)(1995-5#7)(1995-8#1)(1996-11#1)(1996-8#2)(1997-4#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
BCGC cocultures##3##2##(2008-11#3)
BCL-2##2##1##(2008-8#1)(2013-8#1)
BCL2 expression##2##2##(2008-9#1)(2010-11#1)
BCL2 gene rearrangements##2##3##(2009-8#2)
BCL2 gene##3##2##(2009-8#3)
BCL2##12##1##(2008-9#2)(2009-8#9)(2010-11#1)
BCL6##2##1##(2009-8#2)
BCM gene expression in the##2##5##(2009-6#2)
BCM gene expression##3##3##(2009-6#3)
BCM##4##1##(2008-10#1)(2009-6#3)
BCMNV##3##1##(2008-10#3)
BCMoV DNA-A##2##2##(2008-10#2)
BCMoV DNA-B##2##2##(2008-10#2)
BCMoV has a##2##3##(2008-10#2)
BCMoV##8##1##(2008-10#8)
BCN##2##1##(2008-10#1)(2010-12#1)
BCN-A##2##1##(2008-10#2)
BCN-like##2##1##(2008-10#2)
BCNU and prednisolone (FIB-P)##2##4##(1992-2#2)
BCNU and##3##2##(1991-6#1)(1992-2#2)
BCNU##7##1##(1991-6#2)(1992-2#2)(1992-9#3)
BCO##2##1##(2008-10#2)
BCP mutations##7##2##(2013-1#7)
BCP(1)##4##1##(2008-10#4)
BCP(1)-selfed##3##1##(2008-10#3)
BCP(1)S(1) families##2##2##(2008-10#2)
BCP(1)S(1)##4##1##(2008-10#4)
BCP(2)##4##1##(2008-10#4)
BCR CRM##2##2##(2008-10#2)
BCR procedure##4##2##(2008-10#4)
BCR protocol##2##2##(2008-10#2)
BCR sequential extraction procedure##2##4##(2008-10#1)(2011-2#1)
BCR sequential extraction##4##3##(2008-10#3)(2011-2#1)
BCR##24##1##(2008-10#22)(2011-2#2)
BCR-ABL kinase##2##2##(2011-2#1)(2012-12#1)
BCR-ABL##7##1##(2009-7#1)(2010-4#2)(2011-2#1)(2012-12#3)
BCR-CRM 277 and##2##3##(2008-10#2)
BCR-CRM 320##2##2##(2008-10#2)
BCR-CRM##4##1##(2008-10#4)
BCR/ABL##2##1##(2007-11#1)(2009-8#1)
BCS##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
BCT##8##1##(1994-12#1)(1995-4#4)(2008-6#3)
BCTV##4##1##(2008-10#4)
BCTV-resistant##2##1##(2008-10#2)
BCVA##4##1##(2011-2#4)
BCX-4208##5##1##(2010-4#5)
BCaMV##2##1##(2008-10#2)
BChl a##2##2##(1996-2#2)
BChl c --&gt##2##3##(1996-2#2)
BChl c##3##2##(1996-2#3)
BChl##8##1##(1996-2#5)(2010-2#3)
BCs were##2##2##(1992-8#2)
BCs##3##1##(1992-8#3)
BD Cell MAb medium##2##4##(2008-11#2)
BD##16##1##(2007-12#4)(2008-11#3)(2008-4#1)(2009-6#1)(2011-2#1)(2013-8#6)
BD1047##2##1##(2011-2#2)
BD737##2##1##(1995-12#2)
BD9##2##1##(2008-11#2)
BDD and##4##2##(2008-10#3)(2012-12#1)
BDD electrode exhibited##2##3##(2008-10#2)
BDD electrode##6##2##(2008-10#6)
BDD##15##1##(2008-10#12)(2012-12#3)
BDES##2##1##(2008-10#2)
BDI##2##1##(2008-4#1)(2012-2#1)
BDIS as the gold standard##2##5##(2012-12#2)
BDIS##5##1##(2012-12#5)
BDJ##2##1##(2013-1#2)
BDL cell cultures##2##3##(1995-11#2)
BDL##6##1##(1995-11#3)(2009-8#1)(2013-1#1)(2013-8#1)
BDM##2##1##(2008-11#2)
BDNF and##4##2##(1996-12#1)(1997-2#1)(2008-7#1)(2011-2#1)
BDNF did##2##2##(2008-11#1)(2013-1#1)
BDNF is##4##2##(1997-6#1)(2009-3#1)(2013-1#1)(2013-8#1)
BDNF levels in##2##3##(2011-2#1)(2013-8#1)
BDNF levels##7##2##(2011-2#2)(2013-8#5)
BDNF mRNA in the##2##4##(1997-2#1)(2012-2#1)
BDNF mRNA was##2##3##(1997-2#1)(2012-1#1)
BDNF mRNA##13##2##(1996-12#2)(1997-2#7)(1997-6#1)(2012-1#2)(2012-2#1)
BDNF protein levels in##2##4##(2013-8#2)
BDNF protein##5##2##(2012-2#2)(2013-8#3)
BDNF secretion##3##2##(2009-8#3)
BDNF##77##1##(1994-8#2)(1995-5#5)(1996-12#5)(1997-2#11)(1997-6#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#7)(2009-8#4)(2011-2#3)(2012-1#3)(2012-2#6)(2013-1#14)(2013-8#10)
BDS##4##1##(2008-10#1)(2010-8#3)
BDV p24##3##2##(2011-1#3)
BDV##6##1##(1990-11#2)(2011-1#4)
BDV-infected##4##1##(1990-11#4)
BDV-specific##4##1##(1990-11#4)
BE and##2##2##(2010-12#1)(2012-3#1)
BE are##2##2##(2008-10#2)
BE for the##2##3##(2008-10#2)
BE with HGD/IMCA##2##3##(2010-12#2)
BE with##4##2##(2010-12#3)(2012-3#1)
BE##16##1##(2008-10#5)(2010-11#1)(2010-12#6)(2011-2#1)(2012-3#3)
BEA##3##1##(2008-10#3)
BEF-1 homology##2##2##(1995-6#2)
BEF-1##13##1##(1995-6#13)
BEFV##3##1##(2008-10#3)
BEH##4##1##(2008-10#1)(2011-1#2)(2012-3#1)
BEHAVIOR##4##1##(1991-1#1)(2009-11#1)(2011-1#1)(2012-3#1)
BER is##2##2##(2008-3#2)
BER on the repeated cocaine-induced locomotor activity##2##7##(2008-10#2)
BER on the repeated cocaine-induced##3##5##(2008-10#3)
BER##13##1##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2011-2#1)
BES##2##1##(2010-10#1)(2013-8#1)
BEST##2##1##(2008-10#1)(2008-5#1)
BET inhibitor##3##2##(2012-12#3)
BET protein##2##2##(2012-12#2)
BET surface area##3##3##(2008-10#2)(2009-11#1)
BET##10##1##(2008-10#2)(2009-11#1)(2012-12#7)
BETWEEN##3##1##(2012-2#1)(2012-3#2)
BF astrocytes##3##2##(2009-3#3)
BF##10##1##(2008-10#4)(2009-3#4)(2013-1#2)
BF%##2##1##(2012-2#2)
BF(3)##2##1##(2008-10#2)
BF(3)/methanol esterification##3##2##(2008-10#3)
BF473324 and##2##2##(2008-10#2)
BFB##2##1##(2008-10#2)
BFD patients##2##2##(2008-10#2)
BFH##2##1##(2010-12#2)
BFHI##4##1##(2010-5#4)
BFNS##2##1##(2008-8#2)
BFP##4##1##(1991-8#4)
BG##11##1##(2008-10#2)(2008-5#2)(2009-11#1)(2009-9#5)(2012-4#1)
BGC-823##2##1##(2008-9#2)
BGD##2##1##(1994-5#2)
BGMV##2##1##(2008-10#2)
BGMV-BZ##4##1##(2008-10#4)
BGMV-GA##2##1##(2008-10#2)
BGQ60 is##2##2##(1995-6#2)
BGQ60##8##1##(1995-6#8)
BGSS##2##1##(2008-10#2)
BGYMV from##2##2##(2008-10#2)
BGYMV##8##1##(2008-10#8)
BGYMV-MX was##2##2##(2008-10#2)
BGYMV-MX##7##1##(2008-10#7)
BH##2##1##(1990-7#1)(2008-10#1)
BH(4)(-)##2##1##(2008-10#2)
BH3 domain##2##2##(2009-12#2)
BH3##4##1##(2008-10#1)(2009-12#2)(2012-12#1)
BH4##7##1##(1993-8#5)(1994-11#2)
BHA and##2##2##(2008-10#1)(2008-12#1)
BHA##5##1##(1996-2#1)(2008-10#3)(2008-12#1)
BHK 21 C13##3##3##(2008-11#3)
BHK 21##4##2##(2008-11#4)
BHK and CHO cell##2##4##(2008-11#2)
BHK and##3##2##(2008-11#3)
BHK cell##4##2##(1992-9#1)(2008-11#3)
BHK cells##10##2##(1992-5#1)(1992-9#2)(1994-9#2)(2008-11#5)
BHK##23##1##(1992-5#2)(1992-9#3)(1994-9#2)(1995-8#1)(2008-11#15)
BHK-21 cell##2##2##(2008-11#1)(2008-8#1)
BHK-21 cells with##2##3##(2008-11#1)(2008-9#1)
BHK-21 cells##7##2##(2008-11#5)(2008-4#1)(2008-9#1)
BHK-21##9##1##(2008-11#6)(2008-4#1)(2008-8#1)(2008-9#1)
BHK/SG2##2##1##(2008-9#2)
BHK21##4##1##(2008-11#4)
BHKBI147##2##1##(1994-9#2)
BHLF1##4##1##(1997-3#4)
BHP##2##1##(2008-10#2)
BHS##4##1##(2009-7#1)(2010-7#3)
BHSL##2##1##(1995-2#2)
BHT as##2##2##(2008-10#1)(2013-8#1)
BHT injection##3##2##(1994-5#2)(1995-3#1)
BHT was##3##2##(1994-5#1)(2008-5#1)(2011-2#1)
BHT##27##1##(1992-5#1)(1994-3#1)(1994-5#8)(1995-3#3)(1996-2#2)(2008-10#2)(2008-5#4)(2011-2#2)(2013-8#4)
BHT-induced##2##1##(1994-5#1)(1995-3#1)
BHU##4##1##(2011-2#4)
BHV-1##5##1##(1995-9#2)(2008-11#3)
BHmC-4##4##1##(2008-10#4)
BHmC-6##3##1##(2008-10#3)
BHmC-8##2##1##(2008-10#2)
BI was located in##2##4##(2012-3#2)
BI##22##1##(1994-9#4)(2007-12#6)(2008-10#3)(2008-7#2)(2011-2#1)(2012-3#6)
BI-BS-resistant isolates were##2##3##(2008-10#2)
BI-BS-resistant isolates##4##2##(2008-10#4)
BIA##2##1##(2008-10#1)(2011-2#1)
BIAcore technology##2##2##(1997-2#1)(2008-9#1)
BIAcore##4##1##(1997-2#1)(1997-4#1)(1997-7#1)(2008-9#1)
BIBO waveguides##2##2##(2007-12#2)
BIBO##3##1##(2007-12#3)
BIBP 3226 (10(-6) M)##2##4##(1995-12#2)
BIBP 3226##8##2##(1995-12#8)
BIBP##9##1##(1995-12#9)
BII phobia##4##2##(2012-2#4)
BII##6##1##(2012-2#4)(2013-1#2)
BIM 22015##2##2##(1993-5#2)
BIM administration##2##2##(2008-11#2)
BIM expression##7##2##(2008-8#7)
BIM##17##1##(1993-5#2)(2008-11#6)(2008-8#9)
BINPHT##2##1##(2008-10#2)
BIOLOG##2##1##(2008-10#2)
BIONJ##2##1##(2008-4#2)
BIRADS score##2##2##(2011-2#2)
BIRADS scores had##2##3##(2011-2#2)
BIRADS##4##1##(2011-2#4)
BIREME##2##1##(2012-3#1)(2013-1#1)
BIS scale##4##2##(2009-9#4)
BIS##7##1##(2009-9#5)(2012-3#2)
BIS95##2##1##(2008-10#2)
BISAP score##5##2##(2013-1#5)
BISAP##6##1##(2013-1#6)
BIs of##4##2##(2008-10#4)
BIs##5##1##(2008-10#5)
BK channel##5##2##(2008-8#1)(2009-2#4)
BK currents were##2##3##(2008-8#2)
BK##9##1##(2008-8#5)(2009-2#4)
BK(-/-) mice##2##2##(2009-2#2)
BK(-/-)##5##1##(2009-2#5)
BK-B2 receptor##2##2##(1990-5#2)
BK7 glass##4##2##(2007-12#1)(2008-3#3)
BK7##7##1##(2007-12#1)(2008-2#2)(2008-3#4)
BKbeta1##2##1##(2008-8#2)
BL and LL groups the levels were statistically decreased##2##9##(2007-7#2)
BL and##4##2##(2007-7#3)(2009-8#1)
BL cell lines##2##3##(1993-9#2)
BL##15##1##(1993-9#4)(2007-7#6)(2008-10#3)(2009-8#1)(2011-2#1)
BL)##2##1##(1990-7#1)(2011-2#1)
BL19##3##1##(1990-2#3)
BL21 (DE3)##4##2##(1994-5#2)(1995-12#1)(2009-3#1)
BL21##7##1##(1994-5#2)(1995-12#1)(1997-7#1)(2009-3#1)(2010-6#1)(2013-1#1)
BL70 cells##3##2##(1993-9#3)
BL70##4##1##(1993-9#4)
BLAST analysis##2##2##(2008-10#1)(2012-2#1)
BLAST search##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)
BLAST searches##4##2##(2008-4#1)(2008-9#1)(2009-5#1)(2010-4#1)
BLAST##23##1##(2008-10#2)(2008-12#3)(2008-4#7)(2008-7#1)(2008-9#3)(2009-5#3)(2010-4#2)(2012-2#1)(2013-1#1)
BLASTP on a##2##3##(2009-6#2)
BLASTP##8##1##(2008-10#1)(2009-6#7)
BLC##4##1##(1995-11#3)(2012-1#1)
BLCD##2##1##(2008-10#2)
BLM or##2##2##(1997-7#1)(2008-10#1)
BLM##9##1##(1990-12#2)(1990-6#1)(1997-7#4)(2008-10#2)
BLO##2##1##(2008-10#2)
BLOOD##2##1##(2008-11#1)(2012-3#1)
BLOSUM##2##1##(2008-9#2)
BLPC##3##1##(2010-4#3)
BLS severity##3##2##(2008-10#3)
BLS signals##2##2##(2008-10#2)
BLS##6##1##(2008-10#6)
BLSD##2##1##(2008-10#2)
BLSE strains##2##2##(2010-4#2)
BLSE##6##1##(2010-4#6)
BM MNCs in##2##3##(2008-9#2)
BM and##2##2##(1991-8#1)(2013-1#1)
BM aspirates with##2##3##(2008-11#2)
BM aspirates##3##2##(2008-11#3)
BM components##3##2##(2010-9#3)
BM for##2##2##(2013-1#2)
BM traveling waves##2##3##(2009-5#2)
BM traveling##3##2##(2009-5#3)
BM##22##1##(1991-8#3)(2008-11#5)(2008-5#2)(2008-9#2)(2009-5#3)(2010-9#3)(2011-2#1)(2013-1#3)
BM-HSC##2##1##(2010-11#2)
BM-derived fragments##2##2##(2010-9#2)
BM/Hitachi 917##3##2##(2008-10#3)
BM25##3##1##(2011-2#3)
BM35##2##1##(2011-2#2)
BMC of##2##2##(1991-11#2)
BMC##7##1##(1991-11#5)(2011-2#2)
BMCTV##4##1##(2008-10#4)
BMD and##5##2##(2008-8#1)(2010-3#2)(2011-2#2)
BMD at the##3##3##(2010-1#1)(2010-3#1)(2011-2#1)
BMD in the##2##3##(2010-1#1)(2011-2#1)
BMD in##4##2##(2010-1#1)(2010-3#1)(2011-2#2)
BMD is##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
BMD of##2##2##(1991-11#1)(2011-2#1)
BMD values##2##2##(1993-11#1)(2011-2#1)
BMD was estimated at##2##4##(2010-3#1)(2011-2#1)
BMD was estimated##3##3##(2010-3#2)(2011-2#1)
BMD was##6##2##(2010-3#3)(2011-2#3)
BMD were##2##2##(2010-3#1)(2011-2#1)
BMD##47##1##(1991-11#2)(1993-11#2)(2007-11#1)(2008-4#3)(2008-8#1)(2009-5#1)(2010-1#5)(2010-3#12)(2011-2#17)(2012-2#3)
BMDBM##2##1##(2008-5#2)
BMECs and##2##2##(2012-2#2)
BMI &gt##6##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
BMI =##2##2##(2008-3#1)(2010-8#1)
BMI and WHR##3##3##(2007-12#3)
BMI and##17##2##(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#2)(2013-1#3)
BMI at##3##2##(2008-3#2)(2008-5#1)
BMI cases##2##2##(2008-9#2)
BMI is##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
BMI of##4##2##(2006-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
BMI range##2##2##(2008-1#1)(2010-4#1)
BMI was found to be significantly##2##6##(2008-5#1)(2013-8#1)
BMI was##11##2##(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2013-1#1)(2013-8#1)
BMI were##3##2##(1994-12#1)(2008-3#1)(2012-5#1)
BMI z-scores showed significant positive correlations with insulin resistance and##2##10##(2011-1#2)
BMI##134##1##(1991-11#1)(1994-12#2)(1997-7#1)(2006-8#1)(2007-12#9)(2007-8#6)(2008-1#5)(2008-10#13)(2008-11#2)(2008-12#4)(2008-3#10)(2008-5#3)(2008-6#3)(2008-7#5)(2008-9#6)(2009-2#2)(2009-7#2)(2009-9#3)(2010-4#3)(2010-5#1)(2010-8#6)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#11)(2012-3#5)(2012-5#2)(2013-1#13)(2013-8#3)
BMI)##2##1##(2010-8#2)
BMIs##3##1##(2007-12#2)(2008-9#1)
BML is##2##2##(2012-3#2)
BML##7##1##(1996-11#2)(2012-3#5)
BMM##5##1##(1994-6#2)(2013-7#3)
BMP and##2##2##(2012-12#2)
BMP inhibitor##2##2##(2012-12#2)
BMP receptors and pSmad1/5/8 were##2##5##(2011-2#2)
BMP receptors and##3##3##(2011-2#3)
BMP##11##1##(1994-12#1)(2008-8#1)(2011-2#5)(2012-12#4)
BMP- 7##2##2##(2011-2#2)
BMP-2##7##1##(1994-12#2)(1994-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
BMP-4##4##1##(1994-12#2)(2008-6#2)
BMP-7 expression was##2##3##(2011-2#2)
BMP-7 expression##4##2##(2011-2#4)
BMP-7##10##1##(2011-2#10)
BMPR-IA##2##1##(2011-2#2)
BMPR-IB##2##1##(2011-2#2)
BMPR-II##3##1##(2011-2#3)
BMPs##10##1##(2008-8#3)(2011-2#6)(2012-12#1)
BMR and##2##2##(2008-8#1)(2013-1#1)
BMR by approximately##2##3##(2013-1#2)
BMR##11##1##(2008-8#2)(2008-9#3)(2013-1#6)
BMRF1##6##1##(1997-3#6)
BMRF1-induced activation of the##2##4##(1997-3#2)
BMRF1-responsiveness##2##1##(1997-3#2)
BMS1316 and##2##2##(2008-12#2)
BMS1316 locus##2##2##(2008-12#2)
BMS1316##5##1##(2008-12#5)
BMS2213##2##1##(2008-12#2)
BMS2361##3##1##(2008-12#3)
BMSC treated with##2##3##(2008-8#2)
BMSM##2##1##(2009-5#2)
BMT in##2##2##(2007-4#2)
BMT##8##1##(2007-4#4)(2008-1#4)
BMV##6##1##(2008-10#6)
BN rats##3##2##(2008-10#3)
BN whiskers##4##2##(2008-10#4)
BN##10##1##(2008-10#10)
BN/BiRijHsd rats##2##2##(2008-7#2)
BN11##2##1##(1991-12#2)
BNCT##8##1##(1994-3#6)(2013-1#2)
BNP and NT-proBNP##3##3##(2008-7#3)
BNP is##2##2##(1991-2#1)(2009-5#1)
BNP levels##2##2##(2008-3#1)(2009-10#1)
BNP was cleaved at the##3##5##(1991-2#3)
BNP was##5##2##(1991-2#3)(1991-5#2)
BNP##25##1##(1990-12#2)(1991-2#4)(1991-5#6)(2008-11#1)(2008-3#5)(2008-7#3)(2009-10#1)(2009-5#3)
BNP-45##3##1##(1991-5#3)
BNR hyphae##3##2##(2008-10#3)
BNR##19##1##(2008-10#16)(2008-12#3)
BNYVV##3##1##(2008-10#3)
BO (VBBO)##2##2##(2008-11#2)
BO##3##1##(2008-11#3)
BO-101##2##1##(1991-6#2)
BOA##2##1##(2008-10#2)
BOC##4##1##(2013-1#4)
BOD sensing film##3##3##(2008-10#3)
BOD sensing##4##2##(2008-10#4)
BOD standard##2##2##(2008-10#2)
BOD##10##1##(2008-10#10)
BODIPY##2##1##(2008-10#2)
BOLD signal##3##2##(2008-11#1)(2009-6#2)
BOLD##6##1##(1996-2#1)(2008-11#2)(2009-6#3)
BON cells display the intestinal pattern of##2##7##(1994-8#2)
BON cells##4##2##(1994-8#4)
BOP##3##1##(2013-1#3)
BOR##2##1##(2013-1#2)
BOS##6##1##(2007-8#1)(2012-2#5)
BOS-free##2##1##(2012-2#2)
BOX##3##1##(2008-10#3)
BOX-PCR##3##1##(2008-10#3)
BOX-polymerase chain reaction##3##3##(2008-10#3)
BP Koirala Institute of Health Sciences##2##6##(2008-7#1)(2012-3#1)
BP and HR##4##3##(1990-5#2)(2008-11#2)
BP and##6##2##(1990-5#3)(2008-10#1)(2008-11#2)
BP over##3##2##(1992-6#1)(2008-8#1)(2009-11#1)
BP quinones##2##2##(1994-8#2)
BP response##2##2##(2008-7#2)
BP to##2##2##(2008-10#1)(2012-3#1)
BP was##5##2##(2008-5#2)(2010-4#1)(2010-7#1)(2011-2#1)
BP were##2##2##(2008-5#1)(2012-2#1)
BP##90##1##(1990-5#4)(1991-3#3)(1992-5#1)(1992-6#7)(1994-8#4)(1995-3#1)(1997-5#2)(2008-10#13)(2008-11#10)(2008-3#5)(2008-5#4)(2008-7#6)(2008-8#1)(2009-11#1)(2009-4#8)(2010-4#5)(2010-7#6)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#2)
BP-10##3##1##(2008-8#3)
BP-3##3##1##(1994-8#3)
BP-induced##2##1##(2009-4#2)
BPA and other phenolic compounds##2##5##(2008-10#2)
BPA in##4##2##(2008-10#2)(2009-8#1)(2010-9#1)
BPA##17##1##(1997-7#1)(2008-10#7)(2008-4#4)(2009-8#2)(2010-9#3)
BPC 157##10##2##(1997-7#10)
BPC157##3##1##(1997-7#3)
BPD##12##1##(1997-5#2)(2008-4#1)(2009-8#5)(2009-9#1)(2010-5#1)(2011-1#2)
BPDE##7##1##(1992-2#5)(2008-10#2)
BPDE-DNA##4##1##(2008-10#4)
BPE##6##1##(1994-5#2)(1997-7#1)(2013-7#3)
BPG##3##1##(1997-7#2)(2010-10#1)
BPH##2##1##(2006-12#1)(2009-5#1)
BPHA##3##1##(2008-10#3)
BPI##12##1##(1997-5#2)(2008-5#7)(2008-7#3)
BPKIHS##2##1##(2008-7#2)
BPMV isolates tested##2##3##(2008-10#2)
BPMV isolates##3##2##(2008-10#3)
BPMV strains##2##2##(2008-10#2)
BPMV##14##1##(1992-8#2)(2008-10#12)
BPMV-pCP##4##1##(2008-10#4)
BPOF##3##1##(2007-12#1)(2008-3#2)
BPP spectra set##3##3##(2007-12#3)
BPP spectra##6##2##(2007-12#6)
BPP##16##1##(2007-12#16)
BPPV in##2##2##(2012-2#2)
BPPV##3##1##(2012-2#3)
BPRS-E##2##1##(2011-2#2)
BPSD risk##2##2##(2012-2#2)
BPSD##3##1##(2012-2#3)
BPTA-Tb(3+) labeled streptavidin##2##3##(2008-10#2)
BPTI##4##1##(1991-11#3)(1997-2#1)
BPW##2##1##(2008-10#2)
BPYV##3##1##(2008-10#3)
BPs##7##1##(1992-4#1)(2008-7#5)(2010-7#1)
BQ and MNQ##4##3##(2009-9#4)
BQ##6##1##(2009-9#6)
BQ-123##5##1##(1992-4#1)(1994-8#1)(1995-12#2)(2010-12#1)
BQ-788##11##1##(1994-11#9)(1995-12#2)
BR films##3##2##(2007-11#1)(2007-12#2)
BR has##2##2##(1993-11#1)(2007-11#1)
BR##26##1##(1990-5#2)(1993-11#8)(2007-11#3)(2007-12#8)(2008-9#3)(2009-8#2)
BRA-3##5##1##(1993-6#5)
BRAF and##2##2##(2009-12#1)(2009-4#1)
BRAF mutation status##2##3##(2009-4#2)
BRAF mutation##4##2##(2009-4#4)
BRAF mutational##2##2##(2009-4#1)(2013-8#1)
BRAF mutations##3##2##(2008-9#1)(2009-4#2)
BRAF##16##1##(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#11)(2013-8#1)
BRAF(V600E)##5##1##(2008-8#4)(2009-4#1)
BRAF--&gt##3##1##(2008-8#3)
BRAIN##2##1##(2008-9#1)(2009-9#1)
BRAV##2##1##(2008-10#2)
BRCA1##8##1##(1994-6#2)(1994-9#2)(1995-12#1)(2008-10#2)(2011-2#1)
BRCA1)##2##1##(2008-11#1)(2008-4#1)
BRCA2##5##1##(1994-9#3)(2008-10#1)(2011-2#1)
BRCs##2##1##(2010-2#2)
BRD2##4##1##(2008-9#1)(2012-12#3)
BRD4##2##1##(2012-12#2)
BRD7 coding protein were##2##4##(2008-9#2)
BRD7 gene##2##2##(2008-9#2)
BRD7##6##1##(2008-9#6)
BRDF for##2##2##(2008-3#2)
BRDF measurements of##2##3##(2008-3#2)
BRDF measurements##3##2##(2008-3#3)
BRDF of##2##2##(2008-3#2)
BRDF##12##1##(2008-2#2)(2008-3#10)
BREH##5##1##(2008-11#5)
BRET##3##1##(2008-4#2)(2013-8#1)
BRF1##2##1##(1997-3#2)
BRJ##3##1##(1994-6#3)
BRK1 and SCAR1 are##2##4##(2009-10#2)
BRK1##3##1##(2009-10#3)
BRL 24924 and##2##3##(1990-5#2)
BRL 24924##6##2##(1990-5#6)
BRL 46470A##5##2##(1993-12#4)(1994-2#1)
BRL##11##1##(1990-5#6)(1993-12#4)(1994-2#1)
BRNs##2##1##(1994-2#2)
BRP and DHA##2##3##(2013-1#2)
BRP##3##1##(2013-1#3)
BRS in##2##2##(2008-1#2)
BRS##11##1##(1991-10#1)(1992-3#3)(1994-1#1)(2008-1#6)
BRTO were##2##2##(2013-1#2)
BRTO##5##1##(2013-1#5)
BS and##2##2##(2008-10#1)(2013-1#1)
BS containing##2##2##(2008-10#2)
BS##7##1##(2008-10#4)(2012-2#1)(2013-1#2)
BSA also##2##2##(1991-5#1)(2008-3#1)
BSA and HSA##3##3##(2008-10#3)
BSA and##14##2##(1991-5#1)(1997-2#1)(2008-10#10)(2008-5#1)(2008-9#1)
BSA is##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
BSA or##2##2##(2008-10#2)
BSA protein##3##2##(2008-10#3)
BSA was##6##2##(1991-5#1)(1993-11#1)(2008-10#1)(2008-3#1)(2009-9#2)
BSA were##2##2##(1993-11#1)(2008-10#1)
BSA##82##1##(1990-2#1)(1991-5#9)(1993-11#2)(1995-12#3)(1995-6#1)(1997-2#1)(2008-10#43)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#3)(2011-2#8)(2011-3#1)
BSA)##2##1##(2008-10#2)
BSC's##5##1##(2008-2#2)(2008-3#3)
BSE risk##2##2##(2011-2#2)
BSE##16##1##(1990-11#1)(1990-6#2)(1991-3#1)(1996-11#2)(2007-10#4)(2008-11#1)(2011-2#5)
BSG##2##1##(2007-8#1)(2011-2#1)
BSK-II##2##1##(2008-9#2)
BSM##10##1##(1994-9#5)(2008-10#3)(2008-3#2)
BSO##3##1##(1995-3#1)(2007-12#1)(2012-2#1)
BSP##5##1##(1992-3#5)
BSR##2##1##(2008-3#2)
BSR101##2##1##(2008-10#2)
BSV isolates were##2##3##(2008-10#2)
BSV##4##1##(2008-10#4)
BSV-Cav##3##1##(2008-10#3)
BSV-Onne##3##1##(2008-10#3)
BSV-RD##2##1##(2008-10#2)
BSc##2##1##(2008-11#2)
BT and##4##2##(1992-11#1)(1992-8#1)(2007-7#1)(2011-2#1)
BT##20##1##(1992-11#3)(1992-8#1)(2007-7#8)(2008-10#2)(2008-2#2)(2011-2#4)
BT-20##2##1##(1992-9#2)
BT-549##2##1##(2011-1#2)
BT-B##2##1##(2008-2#2)
BT-PABA/PAS test##2##2##(1992-11#2)
BT474 cells##2##2##(2012-3#2)
BT474##3##1##(2009-4#1)(2012-3#2)
BTB also##2##2##(2012-2#2)
BTB dynamics##2##2##(2009-10#1)(2012-2#1)
BTB##28##1##(2009-10#10)(2012-12#2)(2012-2#16)
BTEX in water samples##3##4##(2008-10#3)
BTEX in##4##2##(2008-10#4)
BTEX##13##1##(2008-10#11)(2008-11#2)
BTH induced##2##2##(2008-10#2)
BTH treatment##2##2##(2008-10#2)
BTH##14##1##(2008-10#14)
BTH-treated##3##1##(2008-10#3)
BTI-Tn-5B1-4 cells##5##2##(1997-4#5)
BTI-Tn-5B1-4##9##1##(1997-4#5)(2008-7#4)
BTR and BPCR##2##3##(2008-7#2)
BTV is##2##2##(1997-4#2)
BTV##8##1##(1997-4#7)(2011-2#1)
BTX block##2##2##(2008-8#2)
BTX##11##1##(2008-10#2)(2008-8#9)
BTs##4##1##(2008-11#4)
BUA difference##2##2##(2008-7#2)
BUD21##2##1##(2012-3#2)
BUN##4##1##(1990-12#1)(1994-5#1)(2011-3#1)(2013-1#1)
BUS##2##1##(2010-12#2)
BV##5##1##(1997-4#3)(2008-11#2)
BV+##2##1##(1992-8#2)
BV-15##5##1##(2008-10#5)
BV2##2##1##(1994-8#2)
BVA policy on animal welfare##2##5##(1992-2#2)
BVDV vaccination##2##2##(2012-3#2)
BVDV-1-like virus##4##2##(2012-3#4)
BVI 2000##2##2##(1992-11#2)
BVS##4##1##(1997-7#3)(2010-8#1)
BW##15##1##(1994-8#1)(2008-10#5)(2008-12#3)(2008-7#1)(2012-3#2)(2013-1#1)(2013-8#2)
BW)##10##1##(2008-10#3)(2008-5#3)(2012-3#4)
BWYV##3##1##(2008-10#3)
BXSB and##2##2##(1994-8#2)
BXSB-Yaa +##3##2##(1996-5#3)
BXSB-Yaa and BXSB-Yaa +##2##4##(1996-5#2)
BXSB-Yaa##7##1##(1994-8#1)(1996-5#6)
BY##3##1##(1997-5#1)(2009-9#1)(2010-7#1)
BY-2 cells##3##2##(2008-1#1)(2008-11#2)
BY-2##5##1##(2008-1#2)(2008-11#3)
BYDV PAV isolates##2##3##(2008-10#2)
BYDV PAV##3##2##(2008-10#3)
BYDV and##3##2##(2008-10#3)
BYDV isolates##2##2##(2008-10#2)
BYDV resistance gene##2##3##(2008-8#2)
BYDV resistance##7##2##(2008-10#1)(2008-5#2)(2008-8#4)
BYDV tolerance##3##2##(2008-10#3)
BYDV were##2##2##(2008-10#1)(2008-8#1)
BYDV##34##1##(2008-10#26)(2008-5#2)(2008-8#6)
BYDV-PAV RNA##2##2##(2008-10#2)
BYDV-PAV and##2##2##(2008-10#2)
BYDV-PAV##5##1##(2008-10#5)
BYDV-RMV isolates##2##2##(2008-10#2)
BYDV-RMV##8##1##(2008-10#8)
BYMV##2##1##(2008-10#2)
BYSV CP##5##2##(2008-10#5)
BYSV##9##1##(2008-10#9)
BZ susceptible##2##2##(1996-12#2)
BZ##7##1##(1996-12#4)(2008-10#3)
BZD##10##1##(1991-12#10)
BZE-DADOO##2##1##(2008-10#2)
BZP##3##1##(2008-3#3)
BZPA##2##1##(2008-3#2)
B[a]P##2##1##(1995-5#1)(1997-4#1)
B]##3##1##(1993-6#1)(2011-2#2)
Ba and Pb##2##3##(2008-10#1)(2013-8#1)
Ba and##7##2##(2008-10#5)(2010-8#1)(2013-8#1)
Ba##38##1##(2008-10#28)(2008-12#1)(2008-3#1)(2009-11#1)(2010-5#2)(2010-8#4)(2013-8#1)
Ba(0##5##1##(2012-2#5)
Ba(1-x)Sr(x)TiO(3)##2##1##(2008-3#2)
Ba(2+) and##3##2##(2008-10#3)
Ba(2+) cations##2##2##(1997-7#2)
Ba(2+)##21##1##(1997-7#2)(2008-10#18)(2008-8#1)
Ba(2+)&gt##2##1##(2008-10#2)
Ba(2+)-and Ca(2+)-evoked release were##2##4##(1995-11#2)
Ba(II)##8##1##(2008-10#8)
Ba(SO(4))(x)(CrO(4))(1-x) solid solution##2##3##(2008-10#2)
Ba(VOPO(4))(2)##2##1##(1997-7#2)
Ba)##5##1##(2008-10#5)
Ba2+ (10mM)##2##2##(1993-3#2)
Ba2+ replaces Ca2+/calmodulin in the##2##5##(1995-11#2)
Ba2+##11##1##(1990-2#1)(1993-3#2)(1994-11#1)(1995-11#6)(1995-12#1)
BaCl(2)##3##1##(2008-10#3)
BaF and NbF##2##3##(1990-7#2)
BaF##3##1##(1990-7#3)
BaF(2)##5##1##(2007-12#2)(2008-2#3)
BaFCl##2##1##(2007-12#2)
BaMgF(4)##2##1##(2007-12#2)
BaP 7##7##2##(1992-2#7)
BaP##16##1##(1992-2#7)(2011-1#9)
BaP-7##2##1##(2011-1#2)
BaP-9##2##1##(2011-1#2)
BaP-dione##2##1##(2011-1#2)
BaSO(4)##2##1##(2008-10#2)
BaTiO(3) crystal##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
BaTiO(3)##18##1##(2007-11#1)(2007-12#4)(2008-2#7)(2008-3#6)
BaTiO3##4##1##(2008-2#1)(2008-3#3)
BaWO(4) crystal##3##2##(2007-11#3)
BaWO(4)##4##1##(2007-11#3)(2009-11#1)
Babies in##2##2##(1995-2#1)(2008-8#1)
Babies##5##1##(1991-12#2)(1995-2#1)(2007-10#1)(2008-8#1)
Babinet##2##1##(2008-2#2)
Baby##5##1##(2008-11#1)(2008-7#1)(2009-9#1)(2013-1#1)(2013-7#1)
Baby-Friendly Hospital Initiative##2##3##(2010-5#2)
Bac-BH##2##1##(2008-11#2)
Baca##4##1##(1996-5#4)
Baccalaureate##2##1##(1996-2#1)(2008-12#1)
Bachelor of Nursing degree##3##4##(2008-11#1)(2008-12#2)
Bachelor of Nursing##6##3##(2008-11#1)(2008-12#2)(2010-3#2)(2012-3#1)
Bacille Calmette##3##2##(2011-1#2)(2011-2#1)
Bacille##4##1##(2009-7#1)(2011-1#2)(2011-2#1)
Bacilli##5##1##(2008-10#1)(2011-2#4)
Bacillus amyloliquefaciens##8##2##(1990-11#2)(1991-6#2)(2008-10#2)(2013-1#2)
Bacillus and Paenibacillus spp##3##4##(2008-10#3)
Bacillus and##5##2##(2008-10#4)(2013-7#1)
Bacillus anthracis##10##2##(1992-12#1)(1992-3#1)(2007-12#1)(2008-10#2)(2010-1#1)(2011-2#2)(2012-2#2)
Bacillus cereus ATCC 14579##2##4##(2011-1#1)(2011-2#1)
Bacillus cereus and##2##3##(2011-1#1)(2011-2#1)
Bacillus cereus group##5##3##(2011-2#5)
Bacillus cereus##25##2##(1992-3#2)(1994-11#1)(2008-10#2)(2008-5#1)(2010-12#2)(2011-1#2)(2011-2#15)
Bacillus coagulans##3##2##(2011-2#1)(2013-1#2)
Bacillus licheniformis##9##2##(1990-11#1)(1997-4#4)(2008-10#2)(2011-2#2)
Bacillus megaterium##5##2##(1994-9#1)(2008-10#2)(2011-1#2)
Bacillus mycoides##5##2##(2008-10#5)
Bacillus pumilus##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
Bacillus sp##8##2##(1993-3#2)(2008-10#5)(2010-4#1)
Bacillus species##4##2##(1997-4#1)(2011-2#3)
Bacillus spore##4##2##(2008-3#3)(2011-2#1)
Bacillus spores##3##2##(2008-10#1)(2008-3#2)
Bacillus spp##16##2##(2008-10#15)(2011-1#1)
Bacillus stearothermophilus is##2##3##(1993-11#1)(1995-5#1)
Bacillus stearothermophilus##12##2##(1990-11#1)(1990-7#1)(1992-3#1)(1993-11#3)(1995-2#2)(1995-5#1)(2008-6#2)(2008-7#1)
Bacillus strain##2##2##(2008-10#2)
Bacillus strains##2##2##(2008-10#2)
Bacillus subtilis (Bs)##2##3##(1994-12#1)(1997-7#1)
Bacillus subtilis alkaline##2##3##(2008-6#2)
Bacillus subtilis and Lactococcus lactis##2##5##(1991-9#2)
Bacillus subtilis and##8##3##(1991-9#2)(1994-8#1)(1995-3#1)(1996-6#1)(1997-2#1)(2011-2#1)(2012-2#1)
Bacillus subtilis flagellar proteins##2##4##(1993-12#2)
Bacillus subtilis genome##5##3##(1995-12#2)(1996-8#2)(1997-7#1)
Bacillus subtilis is a##2##4##(2008-7#1)(2009-8#1)
Bacillus subtilis senS##2##3##(1993-6#2)
Bacillus subtilis spores##4##3##(1991-5#1)(2008-10#1)(2008-9#1)(2010-1#1)
Bacillus subtilis var##2##3##(2008-3#2)
Bacillus subtilis##70##2##(1990-11#2)(1990-12#2)(1991-5#1)(1991-6#2)(1991-9#4)(1992-3#1)(1993-12#3)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#2)(1997-7#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-2#1)
Bacillus thuringiensis (Bt)##5##3##(2008-10#1)(2008-5#1)(2011-2#3)
Bacillus thuringiensis subsp##5##3##(1993-12#2)(2013-1#3)
Bacillus thuringiensis##18##2##(1993-12#2)(1993-8#1)(1995-6#1)(2008-10#4)(2008-5#2)(2008-9#1)(2011-2#4)(2013-1#3)
Bacillus weihenstephanensis##3##2##(2011-2#3)
Bacillus##246##1##(1990-11#6)(1990-12#2)(1990-7#1)(1991-5#1)(1991-6#4)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#5)(1993-11#3)(1993-12#5)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#7)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#63)(2008-11#1)(2008-3#8)(2008-5#3)(2008-6#10)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#2)(2009-8#2)(2010-1#4)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#9)(2011-2#44)(2012-2#3)(2013-1#8)(2013-7#1)
Bacillus-based BCAs##3##2##(2008-10#3)
Bacillus-based##4##1##(2008-10#4)
Back Pain##2##2##(1997-3#1)(2007-11#1)
Back pain##2##2##(2007-11#1)(2007-12#1)
Back to##2##2##(2007-12#1)(2010-12#1)
Back##9##1##(1997-3#1)(2007-11#3)(2007-12#2)(2007-2#1)(2010-12#1)(2010-8#1)
Back-projection##2##1##(1994-9#2)
Backbone 1H##2##2##(2009-7#2)
Backbone NMR##2##2##(2009-7#2)
Backbone##9##1##(1993-11#1)(2008-11#1)(2009-7#7)
Background and Aims##2##3##(2013-1#2)
Background and Objective##2##3##(2008-5#1)(2013-1#1)
Background and Objectives##7##3##(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
Background and aims##3##3##(2009-8#2)(2012-3#1)
Background and##22##2##(1991-6#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-8#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
Background information about##2##3##(1994-2#1)(2008-9#1)
Background information##5##2##(1994-2#1)(1994-3#1)(2007-10#1)(2008-9#1)(2012-12#1)
Background##369##1##(1991-6#1)(1994-2#1)(1994-3#1)(1996-9#1)(2007-10#2)(2007-11#75)(2007-2#6)(2007-5#1)(2007-7#2)(2007-8#41)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#16)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#4)(2010-10#12)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#21)(2012-12#4)(2012-2#4)(2012-3#15)(2012-8#1)(2013-1#103)(2013-8#22)
Background  The##3##2##(2011-2#1)(2012-1#2)
Background ##16##1##(2011-2#7)(2012-1#5)(2012-3#4)
Backscatter##6##1##(2008-2#2)(2008-3#4)
Backscattered##2##1##(2008-3#2)
Backscattering##6##1##(2007-11#2)(2007-12#1)(2008-3#3)
Backward##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
Baclofen##2##1##(1990-5#1)(1992-3#1)
Bacteremia##3##1##(2011-1#1)(2011-2#1)(2012-12#1)
Bacteria and##40##2##(1994-9#1)(2011-2#39)
Bacteria have been##2##3##(2008-5#1)(2010-7#1)
Bacteria have##3##2##(1996-12#1)(2008-5#1)(2010-7#1)
Bacteria in##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
Bacteria of##2##2##(2008-10#1)(2011-2#1)
Bacteria were identified##2##3##(2008-5#1)(2011-2#1)
Bacteria were##6##2##(1994-3#1)(2008-10#2)(2008-5#2)(2011-2#1)
Bacteria##72##1##(1994-3#1)(1994-9#1)(1996-12#2)(2007-12#1)(2008-10#15)(2008-4#1)(2008-5#5)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#42)
Bacterial Artificial Chromosome (BAC)##2##4##(2008-4#1)(2010-3#1)
Bacterial Artificial Chromosome##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
Bacterial Blight Resistance##2##3##(2008-10#2)
Bacterial Blight of##2##3##(2008-10#2)
Bacterial Blight##5##2##(2008-10#5)
Bacterial adherence##2##2##(1991-3#1)(2013-8#1)
Bacterial blight##4##2##(2008-10#3)(2009-10#1)
Bacterial colonization##2##2##(2008-10#1)(2009-6#1)
Bacterial contamination of##2##3##(1991-12#1)(1991-3#1)
Bacterial contamination##3##2##(1991-12#2)(1991-3#1)
Bacterial expression of##2##3##(1995-6#1)(1995-8#1)
Bacterial expression##3##2##(1995-6#1)(1995-8#1)(2008-1#1)
Bacterial isolates##2##2##(2007-7#1)(2011-2#1)
Bacterial meningitis##2##2##(2007-7#1)(2010-12#1)
Bacterial pathogens##2##2##(2008-7#1)(2009-6#1)
Bacterial spore formers are##2##4##(2011-2#2)
Bacterial strains##2##2##(2008-10#1)(2013-8#1)
Bacterial##104##1##(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#38)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#3)
Bacteriocin was##2##2##(2010-2#2)
Bacteriocin##3##1##(2010-10#1)(2010-2#2)
Bacteriol##2##1##(1993-9#1)(1995-6#1)
Bacteriological##5##1##(2007-5#1)(2007-7#1)(2007-8#1)(2009-6#1)(2011-2#1)
Bacteriophage##4##1##(1994-5#1)(1995-2#1)(1995-8#1)(2012-2#1)
Bacteriophages##2##1##(2012-2#2)
Bacteriorhodopsin##7##1##(1991-12#2)(2007-11#1)(2007-12#2)(2008-1#2)
Bacterium##5##1##(2008-10#5)
Bacteriuria##2##1##(2008-12#1)(2012-3#1)
Bacteroides species##2##2##(1997-2#2)
Bacteroides spp##2##2##(2007-7#1)(2008-7#1)
Bacteroides##17##1##(1990-11#2)(1997-2#4)(2007-7#2)(2008-11#4)(2008-12#3)(2008-7#1)(2010-12#1)
Bacteroidetes##2##1##(2010-6#1)(2013-7#1)
Bactrocera cucurbitae (Coquillett)##2##3##(2011-2#1)(2013-8#1)
Bactrocera cucurbitae##3##2##(2011-2#2)(2013-8#1)
Bactrocera dorsalis (Hendel)##2##3##(2011-2#2)
Bactrocera species##3##2##(2011-2#3)
Bactrocera##19##1##(2011-2#17)(2013-8#2)
Baculovirus Expression Vector System##2##4##(2008-11#1)(2008-7#1)
Baculovirus##6##1##(1997-4#2)(2008-11#3)(2008-7#1)
Baculovirus/insect cell##2##2##(2008-11#2)
Bad##10##1##(1990-8#1)(1992-2#1)(1994-2#1)(1994-8#1)(1996-8#1)(2007-11#1)(2008-10#2)(2011-2#1)(2012-3#1)
Bader's##2##1##(2008-10#2)
Baena et al##2##3##(2011-2#2)
Baerum##2##1##(1991-9#1)(1992-5#1)
Baggiolini##2##1##(1994-5#2)
Bahia Magdalena##2##2##(2008-5#2)
Bahia State##3##2##(2008-10#2)(2009-10#1)
Bahia and other##2##3##(2008-10#1)(2009-10#1)
Bahia and##4##2##(1991-6#2)(2008-10#1)(2009-10#1)
Bahia in the latter half of the##2##7##(2009-10#2)
Bahia in the##4##3##(2009-10#4)
Bahia##36##1##(1991-6#3)(1991-9#2)(2008-10#6)(2008-5#5)(2008-8#6)(2009-10#12)(2010-10#1)(2010-8#1)
Bahia]##2##1##(2009-10#2)
Bahian##9##1##(2009-10#9)
Bahrain##2##1##(2007-7#1)(2008-10#1)
Bahía##2##1##(2008-5#1)(2010-8#1)
Bai of##2##2##(2008-9#2)
Bai##3##1##(1995-6#1)(2008-9#2)
Baill##5##1##(2008-11#1)(2008-8#4)
Baima and Gaoyou lakes in Jiangsu province##2##7##(2008-8#2)
Baja California Peninsula##2##3##(2010-8#1)(2013-7#1)
Baja California Sur##3##3##(2008-5#2)(2013-7#1)
Baja California##10##2##(2008-5#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2013-7#2)
Baja##13##1##(2008-5#3)(2008-8#2)(2008-9#2)(2009-2#2)(2009-9#1)(2010-8#1)(2013-7#2)
Baker's yeast##3##2##(2008-10#2)(2010-7#1)
Baker's yeast-mediated##2##2##(2008-5#2)
Baker's##6##1##(1990-3#1)(2008-10#2)(2008-5#2)(2010-7#1)
Bal31##2##1##(2008-8#2)
Balance Master and Equitest##2##4##(2010-12#2)
Balance Master##3##2##(1996-7#1)(2010-12#2)
Balance and##2##2##(2008-8#1)(2013-1#1)
Balance in##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
Balance##14##1##(1991-6#2)(1994-12#2)(1996-7#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#2)(2010-8#1)(2013-1#1)(2013-8#1)
Balanced Budget Act of 1997##4##5##(2008-1#1)(2008-11#1)(2008-7#2)
Balanced Budget Act##6##3##(2008-1#1)(2008-11#3)(2008-7#2)
Balanced Budget##7##2##(2008-1#1)(2008-11#4)(2008-7#2)
Balanced##11##1##(2008-1#1)(2008-11#6)(2008-3#1)(2008-7#2)(2008-9#1)
Balancing the##2##2##(1993-1#1)(2011-2#1)
Balancing##3##1##(1993-1#1)(2011-2#1)(2013-1#1)
Balantidium coli##3##2##(2007-12#2)(2008-5#1)
Balb/C mice##2##2##(1992-9#1)(2008-7#1)
Balb/c 3T3 cells##5##3##(1993-11#1)(1994-11#1)(2008-11#3)
Balb/c mice were##2##3##(2007-10#1)(2008-11#1)
Balb/c mice##5##2##(1995-11#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-8#1)
Balb/c##12##1##(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#1)(2007-10#1)(2007-2#1)(2008-11#4)(2008-12#1)(2008-8#1)
Baldrige Award##2##2##(1995-2#2)
Baldrige##7##1##(1994-3#1)(1995-12#1)(1995-2#4)(1995-3#1)
Bale highlands of##2##3##(2011-2#2)
Bali##5##1##(2008-10#2)(2009-8#1)(2011-2#2)
Balint's syndrome##3##2##(2008-4#3)
Balkan##5##1##(2008-7#1)(2011-1#3)(2011-2#1)
Ball##2##1##(1995-12#1)(2008-7#1)
Ballet##2##1##(2010-1#1)(2013-1#1)
Ballistic##2##1##(2007-11#1)(2008-3#1)
Balloon atrial septostomy was##2##4##(2007-8#2)
Balloon dilatation##2##2##(1991-3#1)(2013-1#1)
Balloon##12##1##(1991-3#1)(1997-3#1)(1997-6#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
Balloonborne##2##1##(2008-2#1)(2008-3#1)
Balouchi sheep population##2##3##(2008-12#2)
Balpha##3##1##(2008-11#3)
Balthazar score##2##2##(2013-1#2)
Balthazar##3##1##(2013-1#3)
Baltic amber##2##2##(2008-10#2)
Baltic##13##1##(1995-2#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-5#2)(2010-8#2)
Baltimore##9##1##(1992-2#1)(1997-6#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)
BamHI and##2##2##(1994-12#1)(2008-10#1)
BamHI fragment##2##2##(1990-11#1)(2008-5#1)
BamHI restriction##2##2##(1997-6#1)(2008-5#1)
BamHI##15##1##(1990-11#1)(1990-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#4)(2009-3#1)
Banana streak virus##2##3##(2008-10#2)
Banana##7##1##(2008-10#7)
Band 3##2##2##(2013-7#2)
Band depth##2##2##(2013-8#2)
Band##13##1##(1993-12#1)(1996-9#3)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
Bandar Abbas##2##2##(2008-12#2)
Bandgap##2##1##(2008-3#2)
Banding##2##1##(1996-3#1)(2008-12#1)
Bands##4##1##(2008-10#2)(2008-3#1)(2009-5#1)
Bandura's##2##1##(2008-9#1)(2012-2#1)
Bandwidth##4##1##(2007-11#1)(2008-3#3)
Banerjee##2##1##(1992-3#1)(1993-5#1)
Bang##3##1##(1997-8#1)(2008-4#1)(2013-1#1)
Bangalore##8##1##(2007-7#2)(2008-10#5)(2012-2#1)
Bangkok##2##1##(2007-2#1)(2008-6#1)
Bangladesh##29##1##(1991-8#3)(1994-3#1)(1994-9#1)(2007-12#1)(2007-7#2)(2008-10#14)(2010-11#1)(2010-2#1)(2011-2#4)(2013-8#1)
Bangladeshi##5##1##(1993-12#1)(2008-1#1)(2011-2#3)
Bank and##3##2##(1990-3#1)(1997-8#1)(2009-2#1)
Bank##35##1##(1990-3#1)(1991-3#1)(1992-1#2)(1992-3#2)(1992-5#1)(1994-1#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-12#1)(1997-8#3)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-9#1)(2009-2#2)(2011-2#2)(2011-3#2)(2012-12#1)(2013-1#1)(2013-7#3)
Banking##2##1##(1994-9#1)(2008-4#1)
Banks##3##1##(1992-5#1)(1994-9#1)(1995-6#1)
Banksia##3##1##(2008-10#1)(2010-3#2)
Bantu##4##1##(1991-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
Bap levels in##2##3##(2010-5#2)
Bar##3##1##(2008-1#1)(2008-10#1)(2012-3#1)
Barbados##8##1##(1992-6#1)(2008-10#3)(2011-2#4)
Barbara##5##1##(1994-2#1)(1995-5#1)(1996-2#1)(2007-8#1)(2008-4#1)
Barbour##2##1##(2008-2#2)
Barcellos##2##1##(2008-6#2)
Barcelona##16##1##(1990-9#2)(1993-2#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-5#1)(2008-10#6)(2008-3#1)(2008-5#1)(2013-1#1)
Barer-Stoddart##2##1##(2009-3#2)
Bari##2##1##(2013-1#1)(2013-8#1)
Barium##7##1##(1992-9#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-2#2)(2009-9#1)
Bark##5##1##(2008-10#3)(2008-8#1)(2011-1#1)
Barker##6##1##(2008-10#5)(2012-2#1)
Barley Yellow Dwarf Virus-PAV##2##4##(2008-10#2)
Barley Yellow Dwarf##3##3##(2008-10#3)
Barley yellow dwarf virus (BYDV) and##2##6##(2008-10#2)
Barley yellow dwarf virus (BYDV)##5##5##(2008-10#4)(2008-5#1)
Barley yellow dwarf virus##14##4##(2008-10#13)(2008-5#1)
Barley yellow dwarf##18##3##(2008-10#17)(2008-5#1)
Barley##47##1##(2008-10#46)(2008-5#1)
Barlow##5##1##(1995-12#4)(2013-8#1)
Barnard##2##1##(1990-12#1)(1995-11#1)
Barnes et al##2##3##(1993-8#1)(2008-11#1)
Barnes##4##1##(1993-8#1)(1996-2#1)(2008-11#1)(2008-5#1)
Baroreflex sensitivity##2##2##(2008-1#1)(2008-7#1)
Baroreflex##6##1##(2008-1#2)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)
Barr has##2##2##(2008-10#2)
Barr##6##1##(2007-2#1)(2008-10#4)(2008-11#1)
Barrage##3##1##(2008-10#3)
Barreirinhas##2##1##(2008-6#2)
Barrett's esophagus##14##2##(2008-12#2)(2010-12#1)(2012-3#1)(2013-1#4)(2013-8#6)
Barrett's oesophagus##4##2##(1996-8#1)(2009-4#3)
Barrett's##22##1##(1996-8#1)(2008-12#5)(2009-4#3)(2010-12#2)(2012-3#1)(2013-1#4)(2013-8#6)
Barrier cells in##2##3##(2008-7#2)
Barrier cells##3##2##(2008-7#3)
Barrier to##2##2##(2008-10#1)(2008-5#1)
Barrier##14##1##(2008-10#1)(2008-5#4)(2008-7#3)(2009-10#2)(2009-12#2)(2012-1#2)
Barriers and##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
Barriers to seeking##2##3##(2012-12#1)(2012-3#1)
Barriers to##10##2##(1995-12#1)(1995-9#1)(2008-1#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Barriers##18##1##(1995-12#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-11#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
Barriga##2##1##(1997-5#2)
Barry##4##1##(1990-3#2)(2008-7#2)
Barthakur##2##1##(1994-7#2)
Barthel Index##2##2##(2007-10#1)(2011-2#1)
Barthel##4##1##(2007-10#3)(2011-2#1)
Bartonella##6##1##(1995-8#2)(2012-3#1)(2013-1#3)
Bartter syndrome##4##2##(2007-7#3)(2008-10#1)
Bartter##5##1##(2007-7#4)(2008-10#1)
Basal bolus##2##2##(2008-1#2)
Basal cell carcinoma##6##3##(2007-12#1)(2007-5#1)(2007-7#1)(2012-3#1)(2013-1#2)
Basal cell##9##2##(2007-12#1)(2007-5#1)(2007-7#2)(2012-3#2)(2013-1#3)
Basal ganglia##3##2##(1997-3#1)(2008-7#1)(2013-1#1)
Basal glucose##2##2##(1990-8#1)(2010-2#1)
Basal##41##1##(1990-11#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-3#1)(1994-11#2)(1994-6#2)(1995-11#3)(1997-2#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#4)(2010-12#4)(2010-2#1)(2010-8#1)(2012-3#2)(2013-1#4)
Base##22##1##(1993-12#1)(1995-12#1)(2006-12#6)(2008-10#4)(2008-3#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)
Based in##2##2##(2008-5#2)
Based on a combination of##2##5##(2007-12#1)(2009-6#1)
Based on a literature review##2##5##(1991-6#1)(2008-7#1)
Based on a previous##2##4##(1990-5#1)(2008-10#1)
Based on a review of##2##5##(1994-1#1)(2008-12#1)
Based on a sample of##2##5##(2008-12#1)(2008-8#1)
Based on a simple##2##4##(2008-10#1)(2008-6#1)
Based on a##46##3##(1990-5#1)(1990-8#1)(1991-6#1)(1993-3#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
Based on all these##2##4##(2008-10#1)(2011-1#1)
Based on all##3##3##(2008-10#2)(2011-1#1)
Based on amino acid##2##4##(1990-12#1)(2008-10#1)
Based on an##6##3##(1990-3#1)(1991-3#1)(1995-5#1)(2007-12#1)(2008-9#1)(2013-8#1)
Based on analysis##2##3##(2008-10#1)(2009-10#1)
Based on case study interviews with##2##6##(1997-3#2)
Based on clinical##2##3##(2009-10#1)(2010-10#1)
Based on cluster analysis##2##4##(2008-10#2)
Based on colony morphology and##2##5##(2008-10#2)
Based on current##2##3##(2012-12#1)(2013-8#1)
Based on data from the##2##5##(2007-12#1)(2008-10#1)
Based on data from##4##4##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
Based on data##6##3##(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)
Based on empirical##2##3##(1992-1#1)(2008-3#1)
Based on gaseous compound introduction as##2##6##(2008-10#2)
Based on its##2##3##(2008-10#1)(2008-9#1)
Based on model##2##3##(2008-10#2)
Based on molecular phylogenetic##2##4##(2008-5#1)(2010-3#1)
Based on molecular##3##3##(1997-3#1)(2008-5#1)(2010-3#1)
Based on our data##2##4##(1996-11#1)(2007-12#1)
Based on our findings##3##4##(2008-8#1)(2008-9#1)(2011-1#1)
Based on our results##6##4##(1990-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
Based on our##17##3##(1990-12#1)(1993-12#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#1)(2011-2#2)
Based on pathogenicity to##2##4##(2008-10#2)
Based on previous##3##3##(1994-3#1)(2008-3#1)(2008-7#1)
Based on primary##2##3##(1992-3#1)(2013-1#1)
Based on recent##3##3##(2008-11#1)(2008-9#1)(2010-12#1)
Based on results from the##2##5##(1991-6#1)(2008-10#1)
Based on results from##3##4##(1991-6#1)(2007-12#1)(2008-10#1)
Based on results##4##3##(1991-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
Based on sequence##2##3##(1990-12#1)(2008-6#1)
Based on spectral##2##3##(2007-12#2)
Based on spore##2##3##(2008-10#2)
Based on the above findings##3##5##(1997-8#1)(2008-10#2)
Based on the above##4##4##(1997-8#1)(2007-11#1)(2008-10#2)
Based on the analysis of##5##5##(2007-11#1)(2008-10#3)(2010-9#1)
Based on the analysis##6##4##(2007-11#1)(2008-10#3)(2010-12#1)(2010-9#1)
Based on the assumption that##3##5##(1992-12#1)(1996-12#1)(2008-3#1)
Based on the biological##2##4##(1992-8#1)(2008-10#1)
Based on the data##2##4##(1991-5#1)(2008-10#1)
Based on the deduced amino acid sequence##2##7##(2008-10#2)
Based on the different##2##4##(2012-2#1)(2013-7#1)
Based on the enquiry committee report##3##6##(2008-10#3)
Based on the estimated##2##4##(2007-12#1)(2008-10#1)
Based on the experience of the##2##6##(1992-3#1)(2012-12#1)
Based on the experimental##4##4##(1990-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
Based on the findings of this##2##6##(2008-11#1)(2008-7#1)
Based on the findings of##3##5##(2008-11#1)(2008-7#1)(2012-2#1)
Based on the findings##7##4##(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#2)
Based on the in##2##4##(2010-3#1)(2012-2#1)
Based on the interaction between##2##5##(2008-10#2)
Based on the measurements of##2##5##(2008-10#2)
Based on the model##2##4##(2007-11#1)(2008-10#1)
Based on the morphological##2##4##(2007-12#1)(2008-5#1)
Based on the nucleotide##2##4##(1993-12#1)(2008-10#1)
Based on the observation that##2##5##(1994-5#1)(1997-6#1)
Based on the observation##4##4##(1994-3#1)(1994-5#1)(1997-6#1)(2008-10#1)
Based on the obtained results##3##5##(2008-10#2)(2013-8#1)
Based on the phylogenetic##2##4##(2008-10#1)(2008-9#1)
Based on the quenching##2##4##(2008-10#1)(2013-8#1)
Based on the research##2##4##(2008-2#1)(2010-8#1)
Based on the results of theoretical##2##6##(2011-1#1)(2013-7#1)
Based on the results of this study##4##7##(1990-6#1)(2008-10#2)(2008-5#1)
Based on the results of##11##5##(1990-6#1)(1994-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
Based on the results##14##4##(1990-6#1)(1994-2#1)(2008-10#6)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
Based on the selective reaction##2##5##(2008-10#2)
Based on the sequence##2##4##(1991-9#1)(2008-8#1)
Based on the structural##2##4##(2011-2#1)(2012-2#1)
Based on the##224##3##(1990-6#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-8#3)(2007-10#1)(2007-11#5)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#76)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#10)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-7#2)(2013-8#10)
Based on their##10##3##(1992-3#1)(1993-8#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
Based on theoretical considerations##2##4##(2008-10#1)(2010-12#1)
Based on these data##4##4##(1994-6#1)(2008-10#1)(2009-10#1)(2010-2#1)
Based on these findings we conclude##2##6##(1991-5#1)(2011-2#1)
Based on these findings##15##4##(1991-5#1)(1993-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#4)
Based on these genetic##2##4##(2008-10#2)
Based on these observations##4##4##(1995-5#1)(2008-7#1)(2009-10#1)(2009-12#1)
Based on these results the##3##5##(2008-12#1)(2008-5#2)
Based on these results##24##4##(1990-12#1)(1990-2#1)(1990-3#1)(1994-7#1)(1995-4#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)
Based on these##70##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#1)(1993-12#2)(1994-6#2)(1994-7#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#4)
Based on this fact##2##4##(2008-10#2)
Based on this method##2##4##(2008-10#1)(2012-3#1)
Based on this observation##2##4##(2007-12#1)(2008-10#1)
Based on this phenomenon##2##4##(2008-10#2)
Based on this result##2##4##(2008-3#1)(2008-8#1)
Based on this situation##2##4##(2011-2#1)(2013-1#1)
Based on this study##2##4##(2008-10#1)(2013-8#1)
Based on this##47##3##(1990-10#1)(1991-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Based on total##2##3##(2008-8#1)(2013-1#1)
Based on two##3##3##(1996-6#1)(2008-11#2)
Based on virulence##2##3##(2008-10#2)
Based on which##2##3##(2008-10#2)
Based on##642##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#6)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#3)(2007-10#5)(2007-11#10)(2007-12#15)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#197)(2008-11#21)(2008-12#7)(2008-2#15)(2008-3#24)(2008-4#3)(2008-5#22)(2008-6#4)(2008-7#21)(2008-8#19)(2008-9#16)(2009-10#8)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#4)(2010-3#6)(2010-5#3)(2010-6#5)(2010-8#6)(2010-9#2)(2011-1#11)(2011-2#22)(2012-1#3)(2012-12#4)(2012-2#17)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#27)
Based upon the##5##3##(1990-5#1)(1995-11#1)(2007-11#1)(2008-12#1)(2012-3#1)
Based upon this##3##3##(2008-10#2)(2012-3#1)
Based upon##13##2##(1990-5#1)(1991-12#1)(1995-11#1)(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-11#1)(2012-3#2)
Based##672##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#7)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#4)(2007-10#5)(2007-11#11)(2007-12#15)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#200)(2008-11#22)(2008-12#8)(2008-2#15)(2008-3#24)(2008-4#3)(2008-5#24)(2008-6#4)(2008-7#22)(2008-8#19)(2008-9#16)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#9)(2010-5#3)(2010-6#5)(2010-8#8)(2010-9#2)(2011-1#11)(2011-2#24)(2012-1#3)(2012-12#4)(2012-2#17)(2012-3#7)(2013-1#7)(2013-7#3)(2013-8#27)
Basel##4##1##(1996-6#1)(1996-8#1)(2008-1#1)(2008-4#1)
Baseline and##4##2##(2007-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
Baseline separation of the##2##4##(2008-10#2)
Baseline separation##3##2##(2008-10#3)
Baseline toxicity##3##2##(2011-2#3)
Baseline##32##1##(1995-5#1)(1996-5#1)(1997-4#2)(2007-10#2)(2007-2#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-6#2)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)
Basement Membrane##2##2##(2007-7#2)
Bases##3##1##(2009-12#1)(2010-4#1)(2011-2#1)
Basic Health Area of##2##4##(1993-6#1)(1994-6#1)
Basic Health##3##2##(1993-6#1)(1994-6#1)(1995-2#1)
Basic Local Alignment Search Tool (BLAST)##3##6##(2008-9#2)(2009-5#1)
Basic Local Alignment Search Tool##4##5##(2008-4#1)(2008-9#2)(2009-5#1)
Basic Protocol 1##2##3##(2008-4#2)
Basic Protocol 2 describes##2##4##(2008-4#2)
Basic Protocol 2##3##3##(2008-4#3)
Basic Protocol for##2##3##(2008-2#1)(2008-4#1)
Basic Protocol in this unit##2##5##(2008-4#2)
Basic Protocol##26##2##(2008-2#1)(2008-4#23)(2008-9#2)
Basic Protocols##2##2##(2008-2#1)(2008-4#1)
Basic Research##2##2##(1995-6#1)(2008-5#1)
Basic Rule of Environmental Hygiene##2##5##(2008-11#2)
Basic Science##2##2##(2006-10#1)(2010-10#1)
Basic and advanced life support units in Spain##2##8##(2013-1#2)
Basic and##3##2##(2008-4#1)(2013-1#2)
Basic features of##2##3##(2008-2#1)(2009-10#1)
Basic fibroblast growth factor (bFGF) is a##2##7##(1992-9#1)(1994-11#1)
Basic fibroblast growth factor (bFGF) is##3##6##(1992-9#1)(1994-11#1)(2008-5#1)
Basic fibroblast growth factor (bFGF)##4##5##(1992-9#1)(1994-11#1)(1995-12#1)(2008-5#1)
Basic fibroblast growth factor##10##4##(1992-9#1)(1994-11#2)(1994-6#1)(1995-12#5)(2008-5#1)
Basic information##2##2##(1995-1#1)(2008-9#1)
Basic issues##2##2##(1995-2#1)(2008-4#1)
Basic principles##2##2##(2008-9#1)(2010-8#1)
Basic protein sequence analysis##2##4##(2008-2#1)(2008-4#1)
Basic research##2##2##(2008-5#1)(2008-8#1)
Basic##111##1##(1990-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#7)(2008-4#31)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
Basically##2##1##(1994-1#1)(1996-5#1)
Basicities##2##1##(1996-2#2)
Basics of##2##2##(2008-9#1)(2010-2#1)
Basidiomycetes##3##1##(2008-10#2)(2008-12#1)
Basidiomycota##2##1##(2008-10#1)(2009-6#1)
Basilar##2##1##(1997-6#1)(2008-8#1)
Basin and the##2##3##(2008-6#2)
Basin and##6##2##(2008-10#2)(2008-6#2)(2010-8#1)(2011-2#1)
Basin from##2##2##(2008-10#1)(2010-8#1)
Basin of##4##2##(2008-10#3)(2010-8#1)
Basin##40##1##(2008-1#1)(2008-10#17)(2008-6#9)(2010-8#6)(2011-2#5)(2013-8#2)
Basis for##2##2##(2007-10#1)(2008-10#1)
Basis of##2##2##(2008-3#1)(2009-5#1)
Basis##5##1##(2007-10#1)(2008-10#2)(2008-3#1)(2009-5#1)
Basle##2##1##(2008-10#1)(2008-11#1)
Basolateral##2##1##(2008-11#1)(2008-8#1)
Basque valleys##3##2##(2009-5#3)
Basque##7##1##(2008-10#2)(2009-5#5)
Basques##2##1##(2009-5#2)
Bassini's##2##1##(1990-6#2)
Bastianelli and##2##2##(2010-1#2)
Batch cultivation##2##2##(2008-11#2)
Batch experiments##2##2##(2008-10#1)(2008-11#1)
Batch foam##2##2##(2008-6#2)
Batch##23##1##(2008-10#11)(2008-11#7)(2008-4#1)(2008-6#4)
Batesian mimicry##3##2##(2012-3#3)
Batesian##4##1##(2008-9#1)(2012-3#3)
Bathyaltum wareni##2##2##(2011-2#2)
Bathyergus suillus##2##2##(2011-2#2)
Bathypelta##2##1##(2011-2#2)
Bathysciadiidae##2##1##(2011-2#2)
Bathysciadium##2##1##(2011-2#2)
Batophora spp##2##2##(2008-5#2)
Batophora##3##1##(2008-5#3)
Battery##2##1##(1996-12#1)(2012-12#1)
Battista Grassi##4##2##(2010-1#4)
Bavaria##3##1##(1994-3#1)(2008-11#1)(2008-4#1)
Bavarian##3##1##(1996-8#1)(2008-4#1)(2012-6#1)
Bax and Caspase-3##4##3##(2013-8#4)
Bax and c-myc##3##3##(2008-5#3)
Bax and##8##2##(2008-5#4)(2013-8#4)
Bax in##3##2##(2008-9#1)(2010-12#1)(2010-8#1)
Bax proteins##2##2##(2008-5#1)(2013-7#1)
Bax was##3##2##(2008-9#2)(2009-4#1)
Bax##29##1##(1995-2#1)(2008-5#7)(2008-9#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#5)(2013-7#2)(2013-8#4)
Baxter Colleague##3##2##(2011-2#3)
Baxter Healthcare##2##2##(1994-1#1)(1996-5#1)
Baxter##13##1##(1991-12#1)(1992-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2011-2#5)
Baxter's##3##1##(1993-3#2)(1994-1#1)
Bay K 8644##2##3##(1993-3#1)(1996-2#1)
Bay K##3##2##(1993-3#1)(1996-2#2)
Bay and##8##2##(2007-5#2)(2008-5#1)(2010-8#5)
Bay##46##1##(1993-3#1)(1994-8#2)(1996-1#1)(1996-2#2)(1996-9#1)(2007-12#1)(2007-5#7)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#7)(2008-6#1)(2010-5#1)(2010-8#10)(2013-7#1)(2013-8#2)
Bayer##11##1##(1996-5#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#1)
Bayes##10##1##(1995-12#1)(1995-9#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-3#2)
Bayesian analysis##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2010-6#1)
Bayesian approach for##2##3##(1995-2#1)(2010-3#1)
Bayesian approach##7##2##(1995-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)
Bayesian approaches##4##2##(1994-9#1)(1995-12#1)(1997-8#1)(2010-6#1)
Bayesian computation##2##2##(2012-3#1)(2013-1#1)
Bayesian estimation theory##2##3##(2007-12#1)(2008-2#1)
Bayesian estimation##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
Bayesian geostatistical##2##2##(2008-8#2)
Bayesian hierarchical models##2##3##(1994-9#1)(2012-2#1)
Bayesian hierarchical##4##2##(1994-9#3)(2012-2#1)
Bayesian ideas##2##2##(1995-2#1)(2008-10#1)
Bayesian inference##6##2##(1995-2#1)(2008-10#4)(2008-8#1)
Bayesian method##3##2##(1994-9#2)(2010-5#1)
Bayesian methodology##4##2##(2008-10#4)
Bayesian methods##7##2##(2007-12#1)(2008-10#5)(2010-4#1)
Bayesian model selection##5##3##(2009-10#5)
Bayesian model##6##2##(2009-10#5)(2010-11#1)
Bayesian models##3##2##(1994-9#2)(2009-11#1)
Bayesian posterior##2##2##(1997-8#1)(2011-2#1)
Bayesian probability##2##2##(2008-3#1)(2008-7#1)
Bayesian statistics##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
Bayesian tree##2##2##(2011-2#2)
Bayesian##109##1##(1993-12#1)(1994-11#2)(1994-9#9)(1995-12#2)(1995-2#7)(1996-6#1)(1997-8#5)(2007-12#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#3)(2008-8#8)(2009-10#5)(2009-11#1)(2009-12#3)(2009-4#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#7)(2012-2#1)(2012-3#3)(2013-1#2)
Baz localization##3##2##(2008-9#3)
Baz##6##1##(2008-9#6)
Bazooka##2##1##(2008-9#2)
BazookaSPECT##3##1##(2009-6#3)
Bb 23S rDNA##2##3##(1995-8#2)
Bb 23S rRNA##2##3##(1995-8#2)
Bb 23S##4##2##(1995-8#4)
Bb increased##2##2##(1991-3#2)
Bb##11##1##(1991-3#5)(1995-8#6)
BcEST##3##1##(2011-1#3)
BcOS1p is##2##2##(2008-10#2)
BcOS1p##3##1##(2008-10#3)
Bcl-2 and##8##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2010-8#1)(2012-12#1)(2013-7#1)
Bcl-2 expression was##3##3##(2008-9#3)
Bcl-2 expression##11##2##(1994-3#1)(2007-8#1)(2008-11#2)(2008-8#1)(2008-9#3)(2009-4#2)(2011-2#1)
Bcl-2 family members##2##3##(2009-12#2)
Bcl-2 family proteins##4##3##(2011-2#2)(2013-7#1)(2013-8#1)
Bcl-2 family##14##2##(2008-11#2)(2009-12#4)(2011-2#5)(2012-12#1)(2013-7#1)(2013-8#1)
Bcl-2 into a##2##3##(2008-9#2)
Bcl-2 protein##2##2##(2008-10#1)(2009-4#1)
Bcl-2 was##2##2##(2008-11#1)(2013-8#1)
Bcl-2##70##1##(1993-3#1)(1994-3#1)(2007-8#1)(2008-10#3)(2008-11#12)(2008-6#1)(2008-8#5)(2008-9#7)(2009-12#6)(2009-4#6)(2010-12#1)(2010-8#1)(2011-2#6)(2012-12#5)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#6)
Bcl-2/Bax ratio##3##2##(2013-1#1)(2013-8#2)
Bcl-2/Bax##5##1##(2008-9#1)(2013-1#2)(2013-8#2)
Bcl-X(L)##3##1##(2011-2#1)(2012-12#2)
Bcl-xL##10##1##(2008-11#8)(2013-1#1)(2013-7#1)
Bcl-xLtriangle up 46-83##3##3##(2008-11#3)
Bcl2 and Bax##2##3##(2008-5#2)
Bcl2 and##5##2##(2008-5#3)(2013-1#2)
Bcl2 levels##2##2##(2008-5#2)
Bcl2##12##1##(2008-5#9)(2010-1#1)(2013-1#2)
BcpLH##3##1##(2008-8#3)
Bcr-Abl fusion##2##2##(1994-10#1)(2011-2#1)
Bcr-Abl##5##1##(1994-10#1)(2011-2#3)(2012-12#1)
Bct##4##1##(2008-10#4)
Be##12##1##(1994-2#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
Be(+2)##4##1##(2008-10#4)
Be(II) ion##2##2##(2008-10#2)
Be(II)##9##1##(2008-10#9)
Beach##10##1##(1994-2#1)(1996-5#1)(2007-5#4)(2008-10#3)(2010-1#1)
Bead-to-bead##2##1##(2008-11#2)
BeadCons##2##1##(2008-9#2)
Beads##5##1##(1996-12#2)(2008-10#1)(2008-5#1)(2008-6#1)
Beagle dog and##2##3##(2011-3#2)
Beagle##3##1##(1994-2#1)(2011-3#2)
Beam misalignments and##2##3##(2008-3#2)
Beam propagation##3##2##(2007-11#1)(2008-2#2)
Beam quality##2##2##(2008-2#1)(2008-3#1)
Beam splitter##2##2##(2008-2#2)
Beam##26##1##(1996-12#1)(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#10)(2008-5#1)(2009-10#1)(2012-3#1)(2013-1#2)
Beamlike twin-photon generation by use of type II##2##8##(2007-11#2)
Beams##4##1##(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#1)
Bean Plants##3##2##(2008-10#3)
Bean calico mosaic virus##2##4##(2008-10#2)
Bean common mosaic necrosis virus (BCMNV)##3##6##(2008-10#3)
Bean common mosaic necrosis virus##7##5##(2008-10#7)
Bean common mosaic virus##4##4##(2008-10#4)
Bean common mosaic##11##3##(2008-10#11)
Bean golden mosaic virus (BGMV)##2##5##(2008-10#2)
Bean golden mosaic##3##3##(2008-10#3)
Bean golden yellow mosaic virus (BGYMV)##2##6##(2008-10#2)
Bean golden yellow mosaic virus##4##5##(2008-10#4)
Bean golden##7##2##(2008-10#7)
Bean pod mottle virus##5##4##(2008-10#5)
Bean pod mottle##6##3##(2008-10#6)
Bean##46##1##(2008-10#46)
Beard##3##1##(2008-11#3)
Bearing in mind##2##3##(2008-11#1)(2012-2#1)
Bearing##3##1##(2008-11#1)(2012-2#1)(2013-1#1)
Beauvericin##2##1##(2008-10#2)
Because DNA##2##2##(1994-3#1)(2008-4#1)
Because a##9##2##(1991-2#1)(1993-12#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
Because all##2##2##(2008-10#1)(2008-7#1)
Because an##3##2##(2008-3#2)(2008-7#1)
Because changes##2##2##(2008-9#1)(2010-4#1)
Because child##2##2##(2008-11#2)
Because data##2##2##(2009-7#1)(2013-1#1)
Because each##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
Because flow##2##2##(2008-9#2)
Because it has##2##3##(2008-8#1)(2011-2#1)
Because it is##4##3##(1993-11#1)(2008-4#1)(2008-7#1)(2009-10#1)
Because it was##2##3##(1995-1#1)(2008-12#1)
Because it##13##2##(1991-12#1)(1993-11#1)(1995-1#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
Because many of the##2##4##(1992-2#1)(2008-9#1)
Because many##7##2##(1992-2#1)(1993-1#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-11#1)
Because most of the##2##4##(2007-10#1)(2008-3#1)
Because most of##3##3##(2007-10#1)(2008-3#1)(2010-8#1)
Because most##7##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)
Because no single##2##3##(1993-2#1)(2010-8#1)
Because no##4##2##(1993-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
Because of a##4##3##(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
Because of differences in##2##4##(2008-10#1)(2008-6#1)
Because of high##2##3##(2008-10#1)(2011-1#1)
Because of its high##2##4##(2007-11#1)(2008-3#1)
Because of its sensitivity##2##4##(2007-12#1)(2008-9#1)
Because of its##22##3##(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
Because of limitations##2##3##(2008-3#1)(2011-2#1)
Because of reports that##2##4##(1992-8#1)(2012-3#1)
Because of that##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
Because of the complex##2##4##(2009-6#1)(2010-6#1)
Because of the difficulty##2##4##(1990-12#1)(1992-12#1)
Because of the high##5##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
Because of the important##2##4##(1992-3#1)(2008-1#1)
Because of the lack of##2##5##(2007-10#1)(2008-7#1)
Because of the large##2##4##(2007-7#1)(2008-2#1)
Because of the multiple##2##4##(2008-4#1)(2012-12#1)
Because of the nature of the##2##6##(2008-10#1)(2012-2#1)
Because of the strong##2##4##(2008-10#1)(2013-1#1)
Because of the unique##3##4##(1996-1#1)(2006-12#1)(2012-3#1)
Because of the##97##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#3)(1993-12#1)(1993-2#1)(1994-2#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
Because of their##14##3##(1991-6#1)(1992-12#1)(1992-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2013-8#1)
Because of these##6##3##(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)
Because of this##16##3##(1992-6#1)(1993-11#1)(1994-2#1)(1995-1#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#1)(2013-1#1)
Because of##201##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#5)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-5#1)(1997-3#1)(2006-12#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#4)(2010-4#1)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#18)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
Because patients with##2##3##(1991-9#1)(1997-7#1)
Because some##2##2##(2007-5#1)(2008-10#1)
Because the absorption##2##3##(2008-2#2)
Because the fungus##2##3##(2008-10#2)
Because the incidence of##2##4##(1997-5#1)(2010-8#1)
Because the optical##2##3##(2008-2#1)(2008-3#1)
Because the patient was##2##4##(2008-1#1)(2008-4#1)
Because the physical##2##3##(2008-4#1)(2008-5#1)
Because the prevalence##2##3##(1992-2#1)(2009-11#1)
Because the ratio##2##3##(2008-10#1)(2008-3#1)
Because the two##2##3##(1995-12#1)(2008-3#1)
Because the##94##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-12#2)(2008-2#4)(2008-3#17)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
Because there is no##2##4##(2010-11#1)(2012-2#1)
Because there is##6##3##(1992-2#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-10#1)(2012-2#1)
Because there##8##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-10#1)(2012-2#1)
Because these excipients are not inert##2##6##(2012-2#2)
Because these##7##2##(2008-9#1)(2010-3#1)(2012-12#2)(2012-2#3)
Because they are##2##3##(1996-2#1)(2008-4#1)
Because they##5##2##(1990-8#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
Because this##13##2##(1993-8#1)(1994-1#1)(1994-2#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#1)
Because two##2##2##(2008-10#2)
Because we##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
Because##563##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#8)(1994-3#1)(1994-5#1)(1994-9#3)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2006-12#3)(2007-10#4)(2007-11#9)(2007-12#10)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#3)(2008-1#7)(2008-10#71)(2008-11#14)(2008-12#6)(2008-2#16)(2008-3#51)(2008-4#20)(2008-5#11)(2008-6#7)(2008-7#22)(2008-8#18)(2008-9#16)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#4)(2010-12#2)(2010-3#5)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#5)(2010-8#6)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#32)(2011-3#1)(2011-7#1)(2012-12#9)(2012-2#12)(2012-3#10)(2013-1#18)(2013-7#1)(2013-8#3)
Beck Depression Inventory (BDI)##2##4##(1991-2#1)(2008-4#1)
Beck Depression Inventory##7##3##(1991-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Beck Depression##8##2##(1991-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Beck##15##1##(1991-2#1)(1996-7#2)(2008-4#1)(2008-7#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
Beck's##4##1##(1992-1#1)(1992-2#2)(2007-7#1)
Becker##2##1##(1992-9#1)(1997-3#1)
Beckmann's##2##1##(2008-3#2)
Becoming a##2##2##(2008-4#1)(2008-7#1)
Becoming##5##1##(2008-12#2)(2008-4#1)(2008-7#1)(2012-12#1)
Bed##4##1##(1991-12#1)(1993-1#1)(2008-9#1)(2013-1#1)
Bedside##3##1##(2007-8#1)(2011-2#1)(2013-1#1)
Bee##4##1##(1994-3#1)(2008-8#1)(2012-3#1)(2013-1#1)
Beef patties were##2##3##(2010-4#2)
Beef##6##1##(1992-5#1)(1997-2#1)(2009-4#1)(2010-4#3)
Beer##2##1##(2011-2#1)(2013-1#1)
Beer's Law was obeyed over the range##2##7##(2008-10#2)
Beer's Law##7##2##(2008-10#6)(2008-2#1)
Beer's law holds##2##3##(2008-10#1)(2008-2#1)
Beer's law in the concentration range of 0##2##8##(2008-10#2)
Beer's law in the range 0##3##6##(2008-10#3)
Beer's law in the range of 0##3##7##(2008-10#3)
Beer's law in the range##6##5##(2008-10#6)
Beer's law in the##8##4##(2008-10#8)
Beer's law is followed in the range##2##7##(2008-10#2)
Beer's law is obeyed for##3##5##(2008-10#3)
Beer's law is obeyed in a concentration range of##2##9##(2008-10#2)
Beer's law is obeyed in the range 0##2##8##(2008-10#2)
Beer's law is obeyed in the range of 0##3##9##(2008-10#3)
Beer's law is obeyed in the range of##5##8##(2008-10#5)
Beer's law is obeyed in the range##8##7##(2008-10#8)
Beer's law is obeyed in the##9##6##(2008-10#9)
Beer's law is obeyed in##11##5##(2008-10#11)
Beer's law is obeyed over the concentration range of 0##3##10##(2008-10#3)
Beer's law is obeyed over the concentration range##6##8##(2008-10#6)
Beer's law is obeyed over the range from 0 to##2##10##(2008-10#2)
Beer's law is obeyed over the##9##6##(2008-10#9)
Beer's law is obeyed##26##4##(2008-10#26)
Beer's law is##31##3##(2008-10#31)
Beer's law over the range 0##2##6##(2008-10#2)
Beer's law was obeyed in the##2##6##(2008-10#2)
Beer's law was obeyed in##3##5##(2008-10#3)
Beer's law was obeyed over the concentration range of##2##9##(2008-10#2)
Beer's law was obeyed over the range##4##7##(2008-10#4)
Beer's law was obeyed over the##6##6##(2008-10#6)
Beer's law was obeyed##12##4##(2008-10#12)
Beer's law was##14##3##(2008-10#14)
Beer's law##69##2##(2008-10#67)(2008-2#2)
Beer's plots were obeyed in a general concentration range of##2##10##(2008-10#2)
Beer's##79##1##(2008-10#76)(2008-2#3)
Beer-Lambert law##5##2##(2008-10#2)(2008-3#1)(2008-4#2)
Beet curly top virus##3##4##(2008-10#3)
Beet curly top##4##3##(2008-10#4)
Beet mild curly top virus##3##5##(2008-10#3)
Beet necrotic yellow vein virus##3##5##(2008-10#3)
Beet western yellows virus##2##4##(2008-10#2)
Beet western yellows##3##3##(2008-10#3)
Beet##25##1##(2008-10#24)(2012-3#1)
Beetle##4##1##(2008-10#2)(2008-6#1)(2009-10#1)
Beetles were##2##2##(2008-5#1)(2011-2#1)
Beetles##3##1##(2007-12#1)(2008-5#1)(2011-2#1)
Before NACE determination##2##3##(2008-10#2)
Before and after##4##3##(2008-7#1)(2011-2#2)(2013-8#1)
Before attempting to##2##3##(1993-2#1)(2008-9#1)
Before each##2##2##(1992-12#1)(2008-5#1)
Before making##2##2##(2007-11#1)(2008-1#1)
Before the##16##2##(1991-3#1)(1992-5#1)(1997-2#1)(1997-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
Before transplantation##2##2##(2007-8#1)(2008-1#1)
Before treatment##4##2##(1996-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
Before##69##1##(1990-5#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#3)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-4#1)(2010-12#1)(2010-8#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
Begin##2##1##(1997-2#1)(2008-8#1)
Beginning at##3##2##(1992-3#1)(1994-8#1)(2008-10#1)
Beginning with the##2##3##(2008-6#1)(2012-12#1)
Beginning with##5##2##(1993-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)
Beginning##13##1##(1992-3#2)(1993-2#1)(1994-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2012-12#1)
Beginnings##9##1##(1995-3#8)(2011-1#1)
Begomovirus Species##4##2##(2008-10#4)
Begomovirus from##2##2##(2008-10#2)
Begomovirus##14##1##(2008-10#14)
Begomoviruses Associated with##2##3##(2008-10#2)
Begomoviruses and##2##2##(2008-10#2)
Begomoviruses##7##1##(2008-10#7)
Behavior Questionnaire##2##2##(2010-4#1)(2013-1#1)
Behavior Therapy##4##2##(2008-11#1)(2008-6#1)(2013-1#2)
Behavior and##3##2##(1996-4#1)(2009-10#1)(2011-2#1)
Behavior in##7##2##(2008-3#1)(2009-7#1)(2013-1#2)(2013-8#3)
Behavior of##6##2##(1997-7#1)(2008-10#3)(2008-5#1)(2008-6#1)
Behavior##44##1##(1990-11#1)(1992-3#1)(1993-1#1)(1996-4#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#7)(2013-8#4)
Behavioral Indicators of Conscientiousness##2##4##(2011-2#2)
Behavioral Responses##2##2##(2008-5#1)(2011-2#1)
Behavioral Risk Factor Surveillance System##5##5##(2008-12#2)(2009-5#1)(2011-1#1)(2011-2#1)
Behavioral and##5##2##(1991-1#2)(1995-9#1)(2009-10#1)(2009-7#1)
Behavioral couples therapy##2##3##(2008-6#2)
Behavioral methods##2##2##(2010-7#2)
Behavioral studies##3##2##(1993-12#1)(2007-8#1)(2012-3#1)
Behavioral tests##2##2##(1994-6#1)(2013-1#1)
Behavioral thermoregulation##2##2##(2011-2#2)
Behavioral##57##1##(1991-1#3)(1993-12#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-2#1)(2007-8#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Behaviors among##2##2##(2012-12#1)(2013-1#1)
Behaviors and##2##2##(2012-2#1)(2013-1#1)
Behaviors##18##1##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
Behaviour of##5##2##(1991-5#1)(2008-10#3)(2013-1#1)
Behaviour##17##1##(1991-2#1)(1991-5#2)(1991-9#1)(1996-12#1)(1996-4#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#3)
Behavioural and##2##2##(1996-4#1)(2012-2#1)
Behavioural##15##1##(1991-5#1)(1993-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(2008-11#1)(2010-3#1)(2010-4#1)(2012-2#3)(2013-1#1)(2013-7#1)
Behcet's disease##2##2##(2008-1#1)(2008-5#1)
Behind the##2##2##(2008-10#1)(2011-2#1)
Behind##4##1##(1993-12#1)(2008-10#1)(2011-2#2)
Behring##3##1##(2008-10#3)
Behçet's disease##3##2##(1990-6#1)(1992-5#1)(2006-10#1)
Beige mice##2##2##(1991-8#2)
Beijing Normal University##2##3##(2008-10#2)
Beijing and##2##2##(2008-10#1)(2013-8#1)
Beijing during the##2##3##(2008-2#1)(2011-1#1)
Beijing was##2##2##(2008-2#1)(2011-1#1)
Beijing##27##1##(1990-11#1)(1994-3#2)(2008-10#6)(2008-2#3)(2008-9#1)(2010-1#1)(2011-1#8)(2013-1#1)(2013-8#4)
Being a##2##2##(2008-11#1)(2012-3#1)
Being on##3##2##(2008-11#1)(2008-5#1)(2010-4#1)
Being##25##1##(1996-1#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
Belarus##6##1##(2008-10#2)(2011-2#2)(2012-3#2)
Belgian coastal waters##2##3##(2008-3#2)
Belgian##9##1##(1994-12#1)(2008-10#3)(2008-3#2)(2009-11#1)(2011-2#2)
Belgium##10##1##(2008-10#2)(2008-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-8#2)
Belgium)##2##1##(2009-7#1)(2013-1#1)
Belief##4##1##(2008-12#1)(2008-4#1)(2010-8#1)(2011-1#1)
Beliefs About##2##2##(2009-10#1)(2010-4#1)
Beliefs##5##1##(2007-12#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)
Belize##3##1##(2008-4#1)(2008-5#1)(2011-2#1)
Bell Pepper##2##2##(2008-10#2)
Bell pepper##2##2##(2008-10#2)
Bell##14##1##(1991-1#1)(1997-1#1)(2007-11#1)(2008-10#8)(2008-2#1)(2011-2#1)(2012-2#1)
Bell's##2##1##(1994-3#1)(2012-3#1)
Bellavere's criteria##3##2##(2012-2#3)
Bellevue Hospital##2##2##(1991-1#1)(2008-8#1)
BelloCell((R))##4##1##(2008-11#4)
Belonging to the##2##3##(2008-10#1)(2012-3#1)
Belonging to##4##2##(2008-10#2)(2010-9#1)(2012-3#1)
Belonging##6##1##(2008-10#2)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#1)
Belostoma##2##1##(2008-5#2)
Belostomatidae)##2##1##(2008-5#2)
Belousov-Zhabotinsky reaction##2##2##(2008-10#2)
Belousov-Zhabotinsky##3##1##(2008-10#3)
Below the##2##2##(2008-10#1)(2008-3#1)
Below##7##1##(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#3)
Belt from##2##2##(2008-10#2)
Belt##7##1##(2007-9#2)(2008-10#4)(2008-5#1)
Beltsville##3##1##(2008-10#3)
Bemisia tabaci in Pakistan##2##4##(2008-10#2)
Bemisia tabaci in##3##3##(2008-10#2)(2011-2#1)
Bemisia tabaci##19##2##(2008-10#15)(2008-12#2)(2011-2#2)
Ben##3##1##(2008-10#1)(2011-2#2)
Bence Jones protein (BJP-DIA)##3##4##(1992-3#3)
Bence Jones protein##4##3##(1992-3#3)(1993-8#1)
Bench##4##1##(1992-3#1)(1997-4#1)(2011-2#1)(2013-1#1)
BenchMate##3##1##(2008-10#3)
Benchmark##4##1##(1996-3#1)(2008-10#1)(2012-12#2)
Benchmarking in health##2##3##(1996-1#1)(1997-1#1)
Benchmarking in##3##2##(1995-12#1)(1996-1#1)(1997-1#1)
Benchmarking is##3##2##(1996-3#2)(1997-1#1)
Benchmarking reference services##2##3##(1996-3#1)(1997-1#1)
Benchmarking##16##1##(1995-12#3)(1995-3#4)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#3)(2008-6#1)
Benchmarks##4##1##(1995-12#1)(1996-1#3)
Bend##7##1##(1996-4#1)(2008-10#6)
Beneath the##2##2##(2007-9#1)(2008-10#1)
Beneath##3##1##(1990-6#1)(2007-9#1)(2008-10#1)
Benedictine monastery##2##2##(2011-2#2)
Benedictine##4##1##(2011-2#4)
Beneficial effect of##3##3##(2008-7#1)(2008-9#1)(2011-1#1)
Beneficial effects of##8##3##(1994-5#1)(1994-6#1)(2007-8#2)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
Beneficial effects##9##2##(1994-5#1)(1994-6#1)(2007-8#2)(2008-1#2)(2008-7#1)(2011-2#1)(2012-2#1)
Beneficial##15##1##(1994-5#1)(1994-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
Beneficiary Survey##14##2##(1993-1#1)(1994-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
Beneficiary##21##1##(1993-1#2)(1994-1#2)(1995-12#5)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)
Benefit##11##1##(1993-12#2)(1993-3#1)(1995-2#1)(2007-10#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
Benefits and##2##2##(1992-3#1)(1993-12#1)
Benefits of##13##2##(1991-11#1)(1991-9#1)(1995-5#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
Benefits to##2##2##(2008-10#1)(2008-12#1)
Benefits##23##1##(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#1)(1995-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
Benes network##3##2##(2008-2#3)
Benes##5##1##(2008-2#5)
Benesi-Hildebrand method##2##2##(2008-10#2)
Benesi-Hildebrand##3##1##(2008-10#3)
Benfotiamine##2##1##(2008-1#2)
Bengal##15##1##(1994-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-7#1)
Benign ovary##2##2##(2011-1#2)
Benign paroxysmal positional vertigo##2##4##(2012-2#2)
Benign##15##1##(1993-1#1)(1993-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-2#3)(2012-3#3)
Benin##5##1##(2007-7#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#1)
Benjamin##3##1##(1993-2#2)(1995-6#1)
Bentall and##3##2##(2012-2#3)
Bentall-De Bono##2##2##(2007-8#2)
Benth##3##1##(2008-10#2)(2008-12#1)
Benzene##4##1##(1990-9#1)(2007-11#1)(2008-10#2)
Benzeneacetaldehyde-4-hydroxy-alpha-oxo-aldoxime##2##1##(2008-10#2)
Benzimidazole and Dicarboximide Fungicides##2##4##(2008-10#2)
Benzimidazole resistance in##2##3##(1991-6#2)
Benzimidazole##5##1##(1991-6#2)(2008-10#2)(2012-2#1)
Benzo(a)pyrene##2##1##(2008-10#1)(2008-11#1)
Benzodiazepine##4##1##(1991-12#1)(1995-11#1)(1996-9#1)(2009-9#1)
Benzodiazepines##4##1##(1995-11#1)(2008-10#1)(2012-2#2)
Benzothiadiazole##2##1##(2008-10#2)
Berberine##4##1##(2008-10#1)(2008-12#1)(2012-3#2)
Bereavement##2##1##(2007-11#1)(2008-7#1)
Berg##2##1##(1991-5#1)(2010-3#1)
Bergen in##5##2##(1992-6#3)(1993-3#2)
Bergen##19##1##(1990-6#4)(1992-6#7)(1993-3#4)(1993-6#2)(1995-6#1)(1997-8#1)
Bergenia ciliata##2##2##(2008-10#2)
Berger-Parker##2##1##(2008-5#1)(2008-8#1)
Bergmann glia##3##2##(2008-7#3)
Bergmann##5##1##(1992-12#1)(2008-7#4)
Bering group##2##2##(2010-8#2)
Berlin##11##1##(1991-6#1)(1994-6#2)(1995-1#3)(2007-1#2)(2007-2#1)(2011-2#2)
Bermuda grass white leaf##2##4##(2008-10#2)
Bermuda grass##4##2##(2008-10#4)
Bernard##2##1##(2007-7#1)(2008-10#1)
Berne##3##1##(1993-8#1)(1995-6#1)(1996-11#1)
Berries##6##1##(2008-10#6)
Berry##4##1##(2007-12#1)(2008-10#3)
Berry's##4##1##(2008-2#2)(2008-8#2)
Berta Ruck##2##2##(2011-2#2)
Berthelot##2##1##(2008-10#2)
Berwick##2##1##(1994-3#1)(2013-8#1)
Beside the##4##2##(1990-2#1)(2007-12#1)(2008-7#1)(2010-12#1)
Beside##11##1##(1990-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-10#1)(2011-2#1)(2013-1#1)
Besides a##2##2##(1995-12#1)(2008-7#1)
Besides its##2##2##(2008-7#1)(2011-1#1)
Besides providing##2##2##(1993-3#1)(2012-12#1)
Besides the risk##2##3##(1994-12#1)(2013-1#1)
Besides the##13##2##(1994-12#1)(1995-6#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
Besides their##3##2##(2007-7#1)(2008-5#1)(2012-12#1)
Besides these##3##2##(1996-11#1)(2006-12#1)(2008-11#1)
Besides this##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
Besides##87##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#9)
Bessel beam##8##2##(2007-11#1)(2008-2#6)(2009-6#1)
Bessel function##6##2##(2008-3#6)
Bessel##17##1##(2007-11#1)(2008-2#7)(2008-3#6)(2009-6#3)
Bessel-Gauss beam##2##2##(2007-11#2)
Bessel-Gauss wave##2##2##(2007-11#2)
Bessel-Gauss##4##1##(2007-11#4)
Bessel-Gaussian beams##2##2##(2008-3#2)
Best practice##2##2##(2007-11#1)(2008-3#1)
Best practices for##2##3##(2009-4#1)(2011-2#1)
Best practices##3##2##(2008-5#1)(2009-4#1)(2011-2#1)
Best##16##1##(1993-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#1)
Best's disease##3##2##(2010-9#3)
Best's##4##1##(2010-9#4)
Bestatin##5##1##(1992-5#4)(1994-2#1)
Beta blockers##2##2##(2008-7#1)(2011-2#1)
Beta##12##1##(1991-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)
Beta-2 microglobulin##2##2##(1995-1#2)
Beta-2##3##1##(1995-1#2)(2013-1#1)
Beta-blockers##2##1##(2010-5#1)(2011-2#1)
Beta-cyclodextrin##3##1##(2008-10#2)(2008-6#1)
Beta-galactosidase##2##1##(1990-5#1)(2011-2#1)
Betahistine##2##1##(2008-2#2)
Betaine##2##1##(1991-12#1)(2008-3#1)
Beth Israel##2##2##(1996-2#1)(2008-4#1)
Bethesda##7##1##(1991-4#1)(1992-12#1)(1992-3#1)(1995-5#1)(2008-4#1)(2008-5#1)(2012-12#1)
Better Beginnings##8##2##(1995-3#8)
Better Futures initiative of the Government of Ontario##2##8##(1995-3#2)
Better Futures prevention project##2##4##(1995-3#2)
Better Futures##7##2##(1995-3#7)
Better adjustment##2##2##(2013-1#2)
Better intervention##2##2##(1991-1#1)(2009-11#1)
Better knowledge of##2##3##(2011-2#1)(2013-1#1)
Better outcomes##2##2##(2010-12#1)(2011-2#1)
Better patient##2##2##(1994-1#1)(2013-1#1)
Better results in##2##3##(2008-10#2)
Better results##5##2##(2008-10#4)(2008-11#1)
Better than##2##2##(2008-2#1)(2009-8#1)
Better understanding of the##5##4##(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
Better understanding of##6##3##(2007-5#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
Better##53##1##(1991-1#1)(1991-8#1)(1994-1#1)(1994-3#1)(1995-3#15)(1997-1#2)(2007-5#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#4)
Between 1977 and##2##3##(1991-11#1)(1992-9#1)
Between 1980 and##3##3##(1990-9#1)(2008-7#1)(2013-1#1)
Between 1983 and##2##3##(1991-6#1)(2011-2#1)
Between 1989 and##3##3##(1991-8#1)(1997-8#1)(2007-10#1)
Between 1990 and##3##3##(1996-11#1)(2007-7#1)(2007-8#1)
Between 1991 and##2##3##(1995-11#1)(2008-7#1)
Between 1997 and##2##3##(2008-10#1)(2008-7#1)
Between 1998 and##2##3##(2007-11#1)(2008-10#1)
Between 1999 and 2001##3##4##(2007-11#1)(2007-8#1)(2008-10#1)
Between 2000 and##3##3##(2008-1#1)(2009-4#1)(2010-12#1)
Between 2005 and##2##3##(2011-1#1)(2013-8#1)
Between 2007 and##2##3##(2011-2#1)(2013-1#1)
Between 4##2##2##(2008-10#2)
Between American##2##2##(2008-10#1)(2012-3#1)
Between April##2##2##(2007-8#1)(2013-1#1)
Between December##3##2##(1997-3#1)(2007-10#1)(2007-5#1)
Between February##2##2##(1994-9#1)(2012-2#1)
Between Host##2##2##(2008-10#2)
Between January 1999 and##2##4##(2007-7#1)(2007-8#1)
Between January##10##2##(1990-12#1)(1991-8#1)(1995-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-3#1)(2012-12#1)
Between March##2##2##(1990-12#2)
Between Meloidogyne##2##2##(2008-10#2)
Between November##3##2##(1994-12#1)(1996-2#1)(2007-7#1)
Between October##4##2##(2007-7#1)(2007-8#1)(2008-1#1)(2012-12#1)
Between Verticillium##2##2##(2008-10#2)
Between a##2##2##(2008-10#1)(2009-7#1)
Between and Within##2##3##(2008-10#2)
Between the years##2##3##(2007-2#1)(2011-1#1)
Between the##12##2##(1994-7#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-8#1)(2009-11#1)(2011-1#2)(2011-2#1)
Between##173##1##(1990-12#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-6#2)(1991-8#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#8)(2008-1#2)(2008-10#56)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#5)
Between-group##2##1##(2008-8#1)(2009-7#1)
Bevacizumab##5##1##(2008-7#1)(2011-2#4)
Beyond &quot##2##2##(1997-3#1)(2007-12#1)
Beyond the##11##2##(1991-1#1)(1993-12#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
Beyond their##2##2##(2008-7#1)(2012-1#1)
Beyond this##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
Beyond##44##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
Bhaktapur##2##1##(2008-7#1)(2010-4#1)
Bhutan and##2##2##(2008-10#1)(2008-7#1)
Bhutan##4##1##(1994-3#1)(2008-10#2)(2008-7#1)
Bhutanese refugee##2##2##(2008-7#1)(2010-5#1)
Bhutanese refugees##3##2##(2008-7#3)
Bhutanese##7##1##(2008-10#2)(2008-7#4)(2010-5#1)
Bi and Se were##2##4##(2008-10#2)
Bi and Se##4##3##(2008-10#4)
Bi and##6##2##(2008-10#6)
Bi in##7##2##(2008-10#7)
Bi##48##1##(1991-11#1)(2007-11#3)(2008-10#43)(2008-12#1)
Bi(3+)##2##1##(2008-10#2)
Bi(III) was##2##2##(2008-10#2)
Bi(III)##15##1##(2008-10#15)
Bi12TiO20##3##1##(2008-3#3)
Bi2WO6##8##1##(2013-8#8)
BiAS##2##1##(2008-10#2)
BiB(3)O(6)##2##1##(2007-12#2)
BiCONTACT and Antega##2##3##(2013-1#2)
BiCONTACT and##3##2##(2013-1#3)
BiCONTACT##4##1##(2013-1#4)
BiFE##6##1##(2008-10#6)
BiI(3)##4##1##(2009-11#4)
BiP is##2##2##(1994-11#2)
BiP##21##1##(1994-11#4)(1995-2#5)(2008-11#3)(2008-7#8)(2012-1#1)
Biapenem is##2##2##(2008-5#2)
Biapenem##3##1##(2008-5#3)
Biaryl##2##1##(2007-11#1)(2008-8#1)
Bias in##3##2##(1996-2#1)(2011-2#1)(2012-3#1)
Bias##10##1##(1991-12#1)(1996-2#2)(1997-3#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
Biases##4##1##(1997-3#1)(2007-12#1)(2008-3#1)(2010-4#1)
Białystok##2##1##(2007-11#1)(2008-7#1)
Bibliographic##2##1##(1995-3#1)(2010-12#1)
Bibliography of##3##2##(1993-6#1)(1995-1#1)(2012-3#1)
Bibliography##17##1##(1991-2#1)(1993-6#1)(1995-1#1)(2006-10#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#4)(2012-3#1)
Biceps femoris##5##2##(2010-4#5)
Bichromatic##2##1##(2007-12#2)
Bicycle##2##1##(1993-2#1)(2012-2#1)
Bicyclo[2##2##1##(1996-5#2)
Bicyclus anynana##2##2##(2008-9#2)
Bidens biternata##2##2##(2008-12#2)
Bidens##5##1##(2008-12#4)(2013-7#1)
Bidentate##2##1##(1996-2#2)
Bidimensional##2##1##(2007-12#1)(2008-8#1)
Bidirectional cavopulmonary shunt##2##3##(2007-8#2)
Bidirectional signaling##2##2##(2008-5#1)(2009-9#1)
Bidirectional##8##1##(2007-11#2)(2007-8#2)(2008-5#1)(2008-6#1)(2009-9#1)(2013-1#1)
Bielschowsky##3##1##(1991-1#1)(2011-2#1)(2013-1#1)
Bieth##2##1##(1995-2#1)(2011-1#1)
Bifidobacterium breve UCC2003##3##3##(2011-1#2)(2011-2#1)
Bifidobacterium components##3##2##(2008-11#3)
Bifidobacterium spp##4##2##(2008-5#4)
Bifidobacterium##17##1##(1997-4#1)(2008-11#5)(2008-5#5)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
Bifurcation to polarization self-modulation in vertical-cavity surface-emitting lasers##2##8##(2007-11#2)
Bifurcation##3##1##(2007-11#2)(2008-11#1)
Big##10##1##(1993-6#1)(1994-2#1)(1995-9#1)(1996-1#1)(1996-4#1)(2008-10#2)(2008-4#1)(2010-7#1)(2013-8#1)
Bight##5##1##(2008-2#2)(2008-3#3)
Bignami##2##1##(2010-1#2)
Bigo##3##1##(2008-10#3)
Bilateral anophthalmia##2##2##(2011-1#2)
Bilateral femoral neck fractures##2##4##(2009-3#2)
Bilateral lesions of the##2##4##(1993-12#1)(1994-3#1)
Bilateral orbital infarction##2##3##(2013-8#2)
Bilateral osteonecrosis of the femoral head##2##6##(2009-3#2)
Bilateral simultaneous##2##2##(2008-7#1)(2012-2#1)
Bilateral single ectopic ureters with hypoplastic bladder##2##7##(2008-10#2)
Bilateral spontaneous##2##2##(2008-10#1)(2008-7#1)
Bilateral thoracic ganglion##2##3##(2013-8#2)
Bilateral thoracoscopic##2##2##(2007-8#2)
Bilateral##59##1##(1992-2#1)(1993-12#2)(1994-12#1)(1994-3#2)(1995-3#1)(1997-8#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#5)(2009-5#1)(2010-3#2)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#4)
Bilaterally symmetrical##2##2##(2007-12#1)(2011-1#1)
Bilaterally##5##1##(2007-10#1)(2007-12#1)(2008-7#1)(2010-9#1)(2011-1#1)
Bilateria##2##1##(2009-5#1)(2011-2#1)
Bilberry##2##1##(2009-6#2)
Bile acid##2##2##(1993-8#1)(2008-4#1)
Bile duct ligation##2##3##(2008-8#1)(2013-8#1)
Bile duct##3##2##(2007-8#1)(2008-8#1)(2013-8#1)
Bile##8##1##(1992-9#1)(1993-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-8#1)
Biliary atresia is##2##3##(2013-1#2)
Biliary atresia##3##2##(2013-1#3)
Biliary##6##1##(2008-5#1)(2012-2#2)(2013-1#3)
Bilimoria##2##1##(2011-2#2)
Bilingual##2##1##(2008-4#1)(2008-9#1)
Bilirubin##3##1##(1993-12#2)(2008-10#1)
Biliverdins with##2##2##(1992-3#2)
Bill Clinton##2##2##(1995-12#1)(1995-6#1)
Bill##6##1##(1994-2#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-5#1)(2008-10#1)
Billroth I and Billroth II##2##5##(1991-6#1)(2013-1#1)
Billroth I and##3##3##(1991-6#1)(2013-1#2)
Billroth I##4##2##(1991-6#1)(2009-7#1)(2013-1#2)
Billroth II##5##2##(1991-6#3)(2009-7#1)(2013-1#1)
Billroth##17##1##(1991-6#4)(2007-4#2)(2009-7#2)(2013-1#9)
Billroth's##3##1##(2013-1#3)
Bim##4##1##(2013-1#4)
Binary and ternary##2##3##(2008-10#2)
Binary and##3##2##(2008-10#3)
Binary##12##1##(1994-3#1)(2008-10#5)(2008-2#1)(2008-3#4)(2010-5#1)
Binding activity##2##2##(1992-9#1)(1994-12#1)
Binding affinities##2##2##(1990-11#1)(1993-8#1)
Binding and##4##2##(1994-5#1)(1994-8#1)(1995-2#1)(2012-2#1)
Binding characteristics of##2##3##(1994-8#1)(2008-11#1)
Binding experiments##3##2##(1995-11#1)(1995-12#1)(1995-2#1)
Binding of a##2##3##(1994-8#1)(2011-2#1)
Binding of polyanions by biogenic amines##3##6##(2008-10#3)
Binding of the##3##3##(1990-11#1)(1993-11#1)(2008-5#1)
Binding of##46##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-2#4)(1995-3#1)(1995-5#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)
Binding properties of##2##3##(1995-11#1)(2008-10#1)
Binding sites##3##2##(1992-6#1)(1993-9#1)(1995-12#1)
Binding studies with##2##3##(1990-2#1)(1994-6#1)
Binding studies##4##2##(1990-2#1)(1994-6#1)(1994-8#1)(2008-4#1)
Binding to##5##2##(1993-6#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-5#1)
Binding was inhibited by##2##4##(1993-11#1)(1996-12#1)
Binding was##5##2##(1993-11#2)(1995-2#1)(1996-12#2)
Binding##102##1##(1990-11#4)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-8#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#4)(1993-6#4)(1993-8#3)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#1)(1996-12#4)(1997-2#1)(1997-7#1)(2008-10#14)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
Bing##2##1##(2008-9#1)(2013-1#1)
Binge Eating##3##2##(2012-2#2)(2013-8#1)
Binge eating in rats##2##4##(2008-4#2)
Binge##5##1##(2008-4#2)(2012-2#2)(2013-8#1)
Binocular OCT##2##2##(2011-7#2)
Binocular##6##1##(2007-11#1)(2007-9#1)(2008-9#1)(2011-7#3)
Bintje##5##1##(2008-10#5)
Binucleate Rhizoctonia spp##2##3##(2008-10#2)
Binucleate Rhizoctonia##5##2##(2008-10#5)
Bio-Gel P-60##3##2##(1990-5#1)(1992-3#1)(1992-9#1)
Bio-Gel##4##1##(1990-5#1)(1992-3#1)(1992-9#1)(1993-11#1)
Bio-Save 10 LP##2##3##(2008-10#2)
Bio-Save 11 LP##2##3##(2008-10#2)
Bio-Save##4##1##(2008-10#4)
Bio-metabolism of##2##2##(1993-8#2)
Bio-ontologies##2##1##(2008-7#2)
BioLector##2##1##(2011-2#2)
BioPAX##3##1##(2008-4#1)(2010-10#2)
BioPathways##3##1##(2008-7#3)
BioRID##2##1##(2013-8#2)
BioSTAR bioabsorbable implant##2##3##(2011-2#2)
BioTechniques##2##1##(2013-8#2)
BioTrap precolumn##2##2##(2008-10#2)
Bioaccumulation##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
Bioactive##5##1##(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#1)
Bioactivities##2##1##(2008-10#1)(2008-9#1)
Bioanalytical##3##1##(2009-8#1)(2010-11#2)
Bioassay and##2##2##(2008-10#2)
Bioassay##7##1##(2008-10#5)(2012-1#1)(2013-1#1)
Bioassays##2##1##(2008-10#2)
Bioavailability##2##1##(2008-10#1)(2012-2#1)
Biobanks##3##1##(2008-7#2)(2012-2#1)
Biocatalytic##2##1##(2008-6#2)
Biochar##2##1##(2008-6#2)
Biochem##35##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#3)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#2)(2010-4#1)
Biochemical analysis##3##2##(2008-11#2)(2012-2#1)
Biochemical and molecular##2##3##(1995-6#1)(2008-10#1)
Biochemical and##8##2##(1990-5#1)(1992-6#1)(1993-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2010-5#1)(2012-5#1)
Biochemical characterization of the##2##4##(1992-6#1)(2009-3#1)
Biochemical characterization of##3##3##(1992-6#1)(1993-3#1)(2009-3#1)
Biochemical characterization##5##2##(1992-6#1)(1993-3#1)(1995-6#1)(2008-2#1)(2009-3#1)
Biochemical evidence for the##2##4##(1994-11#1)(1995-2#1)
Biochemical markers of bone turnover##3##5##(1993-11#2)(1997-6#1)
Biochemical parameters##3##2##(2012-3#1)(2012-9#1)(2013-8#1)
Biochemical studies have##2##3##(1992-12#1)(1993-8#1)
Biochemical studies##3##2##(1990-8#1)(1992-12#1)(1993-8#1)
Biochemical tests##2##2##(2008-1#1)(2008-11#1)
Biochemical##44##1##(1990-5#1)(1990-6#1)(1990-8#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2010-7#1)(2012-2#2)(2012-3#1)(2012-5#1)(2012-9#1)(2013-8#1)
Biochemically##2##1##(1997-8#1)(2013-8#1)
Biochemistry 15 (1976)##2##3##(1990-8#2)
Biochemistry 26##4##2##(1990-8#1)(1992-3#1)(1993-11#1)(1995-6#1)
Biochemistry 27##3##2##(1990-8#1)(1993-11#1)(1994-5#1)
Biochemistry 31##7##2##(1993-11#2)(1993-8#1)(1994-5#2)(1995-2#1)(1995-6#1)
Biochemistry and Molecular Biology##2##4##(1997-7#2)
Biochemistry and Molecular##3##3##(1994-12#1)(1997-7#2)
Biochemistry of##2##2##(1997-8#1)(2008-7#1)
Biochemistry##59##1##(1990-5#1)(1990-8#4)(1991-8#2)(1992-3#3)(1992-4#2)(1992-6#3)(1992-8#1)(1993-11#6)(1993-3#1)(1993-8#3)(1994-12#2)(1994-5#4)(1995-2#6)(1995-5#5)(1995-6#3)(1997-2#5)(1997-7#2)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
Biochim##8##1##(1990-2#1)(1991-5#1)(1992-6#1)(1993-8#2)(1994-3#1)(1996-2#1)(2008-11#1)
Biocompatibility##2##1##(2008-5#1)(2010-4#1)
Biocompatible##4##1##(2008-10#2)(2009-7#1)(2011-2#1)
Biocontrol Activity##2##2##(2008-10#2)
Biocontrol Agent Candida##2##3##(2008-10#2)
Biocontrol Agent##12##2##(2008-10#11)(2013-1#1)
Biocontrol Fungus##3##2##(2008-10#3)
Biocontrol Potential of##2##3##(2008-10#2)
Biocontrol activity##2##2##(2008-10#2)
Biocontrol agents##2##2##(2008-10#2)
Biocontrol of Pythium ultimum##2##4##(2008-10#2)
Biocontrol of##4##2##(2008-10#4)
Biocontrol##40##1##(2008-10#39)(2013-1#1)
Bioconversion of##2##2##(2008-6#1)(2013-1#1)
Biocorrosion##2##1##(2012-12#2)
Biodegradable##9##1##(1996-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-12#2)(2010-6#1)(2010-7#1)(2012-2#1)
Biodegradation of##4##2##(1992-5#1)(2008-11#2)(2008-6#1)
Biodemography##2##1##(2009-7#2)
Biodiesel##2##1##(2008-6#1)(2013-1#1)
Biodiversity and##2##2##(1994-11#1)(2011-2#1)
Biodiversity of keratinophilic fungal flora in university campus##2##8##(2013-1#2)
Biodiversity of##4##2##(2011-2#1)(2013-1#2)(2013-7#1)
Biodiversity##6##1##(1994-11#1)(2011-2#2)(2013-1#2)(2013-7#1)
Bioeng##63##1##(2008-7#62)(2013-1#1)
Bioethics##3##1##(1992-2#1)(2007-11#1)(2008-11#1)
Biofilms are##2##2##(2008-7#1)(2013-8#1)
Biofilms##3##1##(2008-7#1)(2013-1#1)(2013-8#1)
Biogenic amines are##2##3##(2008-10#1)(2008-7#1)
Biogenic amines##4##2##(1991-5#1)(2008-10#1)(2008-7#2)
Biogenic##5##1##(1991-5#1)(2008-10#1)(2008-3#1)(2008-7#2)
Bioimaging of##2##2##(2010-11#1)(2010-12#1)
Bioinformatic analysis of expressed sequence tags from grass shrimp Palaemonetes pugio exposed to environmental stressors##2##15##(2010-4#2)
Bioinformatics analysis##2##2##(2008-4#1)(2008-9#1)
Bioinformatics and##5##2##(2008-7#3)(2013-8#2)
Bioinformatics is##2##2##(2010-11#1)(2010-2#1)
Bioinformatics##22##1##(2008-4#4)(2008-7#9)(2008-9#1)(2010-11#2)(2010-2#2)(2011-2#2)(2013-8#2)
Biol Chem##4##2##(1994-11#1)(1994-8#1)(2008-4#1)(2009-9#1)
Biol##90##1##(1990-11#2)(1990-2#1)(1990-5#4)(1990-7#2)(1990-8#6)(1991-12#3)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#4)(1994-11#3)(1994-12#2)(1994-5#7)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#4)(1995-8#1)(1996-5#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#8)(2009-9#1)(2010-7#1)(2010-9#1)
Biolog##3##1##(2008-10#3)
Biologic therapies##3##2##(2008-8#1)(2009-12#1)(2010-5#1)
Biologic##10##1##(1992-12#2)(2007-8#1)(2008-8#1)(2009-12#1)(2010-5#2)(2011-2#2)(2013-7#1)
Biological Control of Bipolaris sorokiniana##2##5##(2008-10#2)
Biological Control of Botrytis cinerea by##2##6##(2008-10#2)
Biological Control of Botrytis cinerea##4##5##(2008-10#4)
Biological Control of Fusarium Wilt of Tomato by Nonpathogenic Fusarium spp##2##11##(2008-10#2)
Biological Control of Fusarium Wilt##3##5##(2008-10#3)
Biological Control of the##2##4##(2008-10#2)
Biological Control of##23##3##(2008-10#23)
Biological Control##34##2##(2008-10#34)
Biological Reserve##2##2##(2008-5#1)(2008-6#1)
Biological Resource Centers##2##3##(2010-2#2)
Biological Sciences##2##2##(1994-12#1)(2008-4#1)
Biological Station##2##2##(2008-5#1)(2013-7#1)
Biological Suppression##2##2##(2008-10#2)
Biological activities##2##2##(1994-12#1)(2012-12#1)
Biological activity and##2##3##(1994-11#1)(2009-6#1)
Biological activity of##2##3##(1993-11#1)(2008-12#1)
Biological activity##4##2##(1993-11#1)(1994-11#1)(2008-12#1)(2009-6#1)
Biological and Molecular Characterization of##2##5##(2008-10#2)
Biological and Molecular##4##3##(2008-10#4)
Biological and molecular characterization of a##2##6##(2008-10#2)
Biological and##16##2##(1990-12#1)(1993-2#1)(1995-2#1)(2008-10#10)(2010-11#1)(2012-2#1)(2013-1#1)
Biological approaches##2##2##(2007-11#1)(2008-10#1)
Biological assay of##2##3##(1992-12#1)(2008-8#1)
Biological assay##3##2##(1992-12#1)(2008-8#2)
Biological characterization##2##2##(2011-2#1)(2013-1#1)
Biological control of fusarium##2##4##(2008-10#2)
Biological control of##5##3##(2008-10#4)(2008-8#1)
Biological control##7##2##(2008-10#5)(2008-5#1)(2008-8#1)
Biological function of##2##3##(2008-4#1)(2008-8#1)
Biological markers##4##2##(1993-11#1)(1995-3#1)(2007-10#1)(2010-8#1)
Biological materials##2##2##(2008-10#1)(2009-7#1)
Biological screening of 100 plant extracts for cosmetic use##2##9##(2008-5#2)
Biological warfare##2##2##(1992-12#2)
Biological##149##1##(1990-12#2)(1991-1#1)(1992-12#6)(1992-3#2)(1993-11#2)(1993-2#2)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-10#2)(2007-11#1)(2008-10#66)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#7)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-4#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#1)
Biologically active##2##2##(1991-9#1)(2008-5#1)
Biologically##5##1##(1991-9#1)(1995-9#1)(2008-10#1)(2008-5#2)
Biologicals##2##1##(2012-3#1)(2013-1#1)
Biologics##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
Biologists##2##1##(2008-7#1)(2013-1#1)
Biology 2002##2##2##(2008-7#2)
Biology and##8##2##(1991-9#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
Biology of the##3##3##(1996-9#1)(2008-10#2)
Biology of##4##2##(1996-9#1)(2006-6#1)(2008-10#2)
Biology##44##1##(1990-11#1)(1990-2#1)(1991-5#1)(1991-9#1)(1996-9#1)(1997-7#2)(2006-6#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#4)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2011-2#6)(2012-1#6)(2012-12#1)(2013-1#3)(2013-8#3)
Biology'##2##1##(1994-12#1)(2008-7#1)
Bioluminescence resonance energy transfer##2##4##(2008-4#1)(2013-8#1)
Bioluminescence##4##1##(2007-10#1)(2008-10#1)(2008-4#1)(2013-8#1)
Bioluminescent##2##1##(1990-8#1)(2011-1#1)
Biomarker discovery##2##2##(2010-5#1)(2010-7#1)
Biomarker measurements##2##2##(2010-11#1)(2012-1#1)
Biomarker##8##1##(2009-12#1)(2010-11#2)(2010-5#2)(2010-7#1)(2012-1#1)(2012-3#1)
Biomarkers of##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
Biomarkers##8##1##(2008-11#2)(2008-8#1)(2010-7#2)(2011-2#2)(2012-12#1)
Biomass and##2##2##(2007-5#2)
Biomass##8##1##(2007-5#3)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
Biomaterials##4##1##(2008-11#1)(2009-12#3)
Biomechanical analysis of the##2##4##(2009-7#1)(2011-2#1)
Biomechanical comparison##2##2##(2008-9#1)(2011-2#1)
Biomechanical##9##1##(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)
Biomedical Research##3##2##(2009-12#1)(2010-4#1)(2012-2#1)
Biomedical applications of##2##3##(2011-1#2)
Biomedical journals not dead yet##2##5##(1995-9#2)
Biomedical journals##3##2##(1993-12#1)(1995-9#2)
Biomedical##18##1##(1993-12#1)(1993-3#1)(1995-9#2)(1996-2#1)(1996-5#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
Biomimetic##5##1##(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#2)
Biomimetics##2##1##(2008-7#2)
Biomolecular##6##1##(2008-10#2)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)
Biomolecules##2##1##(1996-5#1)(2008-12#1)
Biomonitoring##2##1##(1996-3#1)(2008-11#1)
Biomphalaria##5##1##(1993-6#2)(2008-12#1)(2008-8#2)
Biophys##27##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-11#2)
Biophysical and##2##2##(1994-11#1)(2008-9#1)
Biophysical##6##1##(1994-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
Biophysics##6##1##(2011-2#1)(2012-1#4)(2013-1#1)
Biopolymers##3##1##(1992-3#1)(1992-4#1)(2007-11#1)
Bioprocess Development##2##2##(2013-1#2)
Bioprocess##5##1##(2008-11#2)(2012-2#1)(2013-1#2)
Biopsies##3##1##(2008-1#1)(2008-5#2)
Biopsy of the mass##2##4##(2009-4#1)(2010-5#1)
Biopsy of the##3##3##(2009-4#1)(2010-5#1)(2012-3#1)
Biopsy of##6##2##(1991-12#1)(2008-1#1)(2009-4#1)(2009-7#1)(2010-5#1)(2012-3#1)
Biopsy##16##1##(1991-12#1)(1991-2#1)(1992-5#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Biopsychosocial##2##1##(1994-2#1)(2012-2#1)
Bioreactor##7##1##(1994-11#1)(2008-11#4)(2008-3#1)(2008-7#1)
Bioremediation##3##1##(1995-3#1)(2008-6#1)(2012-12#1)
Biosafety Level 3##4##3##(2008-9#4)
Biosafety##8##1##(2008-4#2)(2008-9#6)
Biosciences##6##1##(1997-3#1)(2008-11#2)(2008-12#1)(2013-1#1)(2013-8#1)
Biosensing##3##1##(2007-11#1)(2008-10#1)(2010-5#1)
Biosensor##3##1##(2008-10#2)(2008-11#1)
Biosensors for##3##2##(2008-10#3)
Biosensors have##2##2##(2008-10#2)
Biosensors##8##1##(2008-10#8)
Biosorb##2##1##(1995-3#2)
Biosorption of##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
Biosphere Reserve##4##2##(2008-5#2)(2013-7#2)
Biosurfactants production by##2##3##(2008-6#2)
Biosynthesis in##2##2##(1991-3#1)(2008-10#1)
Biosynthesis of##6##2##(1992-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(2009-8#1)(2012-2#1)
Biosynthesis##13##1##(1990-5#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-10#4)(2009-8#1)(2011-2#1)(2012-2#1)
Biosynthetic labeling##2##2##(2008-4#2)
Biosynthetic##3##1##(2008-10#1)(2008-4#2)
Biotech##2##1##(2008-5#2)
Biotechnol Bioeng 55##12##3##(2008-7#12)
Biotechnol Bioeng 56##50##3##(2008-7#50)
Biotechnol Bioeng##62##2##(2008-7#62)
Biotechnol##86##1##(1995-6#1)(2008-11#1)(2008-7#62)(2011-2#22)
Biotechnological production of##2##3##(2008-6#2)
Biotechnological##3##1##(2008-6#2)(2011-2#1)
Biotechnology##15##1##(1991-2#2)(2008-10#2)(2008-11#5)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#1)
Bioterrorism in##2##2##(2007-12#2)
Biotic##3##1##(2008-10#3)
Biotinylated##4##1##(2008-10#1)(2008-11#2)(2010-2#1)
Biotinylation of##2##2##(1990-5#1)(1993-6#1)
Biotinylation##3##1##(1990-5#1)(1993-6#1)(2008-4#1)
Biotransformation of##3##2##(1994-11#1)(2008-6#1)(2008-7#1)
Biotype##3##1##(2008-10#1)(2012-3#2)
Biovar 2##3##2##(2008-10#3)
Biovar##5##1##(2008-10#5)
Bipartite##2##1##(2013-1#2)
Biphasic##4##1##(1992-6#1)(1997-2#1)(2008-11#1)(2011-2#1)
Bipolar Disorder##9##2##(1997-5#2)(2009-8#2)(2010-7#1)(2011-1#1)(2013-8#3)
Bipolar disorder##6##2##(2008-7#1)(2009-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
Bipolar##18##1##(1997-5#3)(2008-7#1)(2009-12#1)(2009-8#2)(2010-7#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#5)
Bipolaris maydis##3##2##(2008-10#3)
Bipolaris sorokiniana##16##2##(2008-10#16)
Bipolaris##24##1##(2008-10#24)
Bir Hospital##2##2##(2008-7#2)
Birch##2##1##(2008-10#1)(2008-7#1)
Bird##3##1##(2008-4#1)(2010-8#1)(2013-7#1)
Birds in##2##2##(2010-4#2)
Birds##6##1##(1990-11#1)(1997-3#1)(1997-6#1)(2009-2#1)(2010-4#2)
Birefringence (B(f))##2##2##(2008-2#2)
Birefringence and##2##2##(2008-2#1)(2008-3#1)
Birefringence control##2##2##(2008-2#1)(2008-3#1)
Birefringence measurements##2##2##(2008-3#2)
Birefringence of##2##2##(2008-2#2)
Birefringence##17##1##(2007-12#1)(2008-2#6)(2008-3#9)(2013-1#1)
Birmingham##5##1##(1991-2#1)(2007-12#1)(2008-12#2)(2008-9#1)
Birth Defects Information System##2##4##(2012-12#2)
Birth Defects##3##2##(2011-2#1)(2012-12#2)
Birth Weight##3##2##(2011-1#1)(2012-1#1)(2012-3#1)
Birth##24##1##(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-4#1)(1995-6#1)(1996-11#1)(1997-7#1)(2007-2#2)(2008-7#1)(2009-11#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)
Birthweight##2##1##(1991-11#1)(1992-2#1)
Bis(melaminium) terephthalate dihydrate##4##3##(2013-1#4)
Bis(tri-n-butyltin)oxide##2##1##(2008-10#2)
BisEMA and BisGMA##3##3##(2013-1#3)
BisEMA##6##1##(2013-1#6)
BisGMA##6##1##(2013-1#6)
Bisexual##2##1##(2009-12#1)(2010-8#1)
Bismuth##5##1##(2008-10#4)(2012-3#1)
Bisphenol A (BPA)##3##3##(2008-10#1)(2008-4#1)(2010-9#1)
Bisphenol A##4##2##(2008-10#2)(2008-4#1)(2010-9#1)
Bisphenol##5##1##(2008-10#2)(2008-4#1)(2010-9#2)
Bisphosphonate therapy##2##2##(1991-3#1)(2010-4#1)
Bisphosphonate##3##1##(1991-3#1)(2008-11#1)(2010-4#1)
Bisphosphonates are##4##2##(1993-11#2)(2007-11#1)(2012-12#1)
Bisphosphonates have##3##2##(2007-11#2)(2008-7#1)
Bisphosphonates in the##2##3##(1997-6#1)(2010-7#1)
Bisphosphonates in##3##2##(1997-6#1)(2007-11#1)(2010-7#1)
Bisphosphonates##15##1##(1993-11#3)(1997-6#1)(2007-11#5)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
Bisson##2##1##(2008-10#2)
Bistable nonspecular reflection at a nonlinear-linear local interface##2##8##(2007-12#2)
Bistable##5##1##(2007-12#5)
Bit-error##2##1##(2007-12#1)(2008-2#1)
Bite##2##1##(1993-2#1)(2007-7#1)
Bitter##2##1##(2008-10#2)
Bivalent##3##1##(1994-2#1)(2013-1#2)
Bivalve##2##1##(2011-2#2)
Bivariate analysis##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
Bivariate##8##1##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
Biz-2##8##1##(2010-1#8)
Bjerrum's method##2##2##(2008-10#2)
BlShV when##2##2##(2008-10#2)
BlShV##4##1##(2008-10#4)
BlaM##4##1##(1990-11#4)
Black Caribbeans##3##2##(2010-10#3)
Black Deaf and##2##3##(2011-2#2)
Black Deaf##4##2##(2011-2#4)
Black Death##3##2##(1990-6#3)
Black Hole##2##2##(2013-1#2)
Black Rot##2##2##(2008-10#2)
Black Sea##2##2##(2009-8#1)(2010-8#1)
Black and White##4##3##(2008-11#2)(2011-2#2)
Black and##10##2##(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)(2011-2#2)(2013-1#3)
Black faces##3##2##(2008-11#1)(2009-9#2)
Black men##5##2##(2009-12#1)(2009-5#1)(2009-9#3)
Black was##2##2##(2009-7#1)(2013-1#1)
Black women##2##2##(2011-2#1)(2013-1#1)
Black women's thoughts about##2##4##(2010-10#2)
Black##87##1##(1990-6#3)(1995-2#1)(1997-4#1)(2007-3#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#5)(2010-10#6)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#10)(2012-12#2)(2012-2#4)(2013-1#15)(2013-7#3)(2013-8#1)
Blackbody infrared radiative dissociation##2##4##(1996-7#2)
Blackeye##3##1##(2008-10#3)
Blackfoot disease##2##2##(2008-10#2)
Blackleg##4##1##(2008-10#4)
Blacks and Whites##2##3##(1993-3#1)(2010-2#1)
Blacks and##3##2##(1993-3#1)(2010-10#1)(2010-2#1)
Blacks were##3##2##(2010-10#1)(2011-2#2)
Blacks##19##1##(1993-3#2)(1995-6#1)(2010-10#3)(2010-12#1)(2010-2#4)(2010-3#1)(2011-2#5)(2012-12#1)(2013-8#1)
Blackwell##2##1##(2008-4#1)(2013-1#1)
Bladder cancer##2##2##(2008-10#1)(2013-8#1)
Bladder##21##1##(1992-12#1)(1994-8#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#5)(2008-12#1)(2009-5#1)(2010-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
Blanchard##3##1##(2010-1#3)
Bland and Altman plots##2##4##(2008-12#2)
Bland and Altman##5##3##(2008-11#3)(2008-12#2)
Bland##6##1##(2007-7#1)(2008-11#3)(2008-12#2)
Blantyre##3##1##(2009-6#3)
Blast Fungus##3##2##(2008-10#3)
Blast##7##1##(2008-10#6)(2008-7#1)
Blastomycosis##3##1##(2007-12#3)
Blattella germanica##2##2##(2011-2#1)(2012-2#1)
Blattellidae)##3##1##(2011-2#3)
Blazac##2##1##(1996-5#2)
Blazed gratings##2##2##(2007-12#1)(2008-3#1)
Bleaching##2##1##(2007-11#1)(2009-8#1)
Blechnum##3##1##(2013-7#3)
Bleeding complications##2##2##(2008-5#1)(2011-2#1)
Bleeding was##2##2##(2007-8#1)(2009-7#1)
Bleeding##13##1##(1993-3#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-2#3)(2013-8#1)
Blended##2##1##(1991-12#1)(2008-5#1)
Blending##2##1##(2008-6#1)(2012-3#1)
Blepharoptosis##2##1##(2011-2#1)(2012-3#1)
Bligh-Dyer method##2##2##(2008-10#1)(2008-11#1)
Bligh-Dyer##4##1##(2008-10#3)(2008-11#1)
Blight Pathogen##2##2##(2008-10#2)
Blight Resistance##3##2##(2008-10#3)
Blight in##3##2##(2008-10#3)
Blight of##9##2##(2008-10#9)
Blight on##2##2##(2008-10#2)
Blight##33##1##(2008-10#33)
BlightBan A506##5##2##(2008-10#5)
Blindness##2##1##(1992-2#1)(2009-4#1)
Blister##3##1##(2006-10#1)(2008-10#2)
Blk##4##1##(1995-6#4)
Bloch has##2##2##(2009-10#2)
Bloch##8##1##(1997-8#1)(2008-3#3)(2009-10#4)
Block Design##5##2##(1995-11#1)(2008-12#4)
Block##10##1##(1995-11#1)(2007-10#1)(2008-12#4)(2008-7#2)(2008-8#2)
Blockade of endothelin receptors##2##4##(1994-11#1)(1997-4#1)
Blockade of the##2##3##(1996-2#1)(2008-11#1)
Blockade of##10##2##(1990-5#1)(1994-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-11#1)
Blockade##11##1##(1990-5#1)(1994-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)
Blocking of##2##2##(1991-9#1)(1994-11#1)
Blocking the##2##2##(1990-12#1)(2008-4#1)
Blocking##11##1##(1990-12#1)(1991-9#1)(1994-11#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
Blocks##6##1##(1996-5#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)
Blood Bank##2##2##(2011-2#2)
Blood Pressure##2##2##(2008-1#1)(2012-2#1)
Blood and urine##2##3##(1993-11#1)(2007-12#1)
Blood and##3##2##(1993-11#1)(1997-5#1)(2007-12#1)
Blood conservation##2##2##(1990-2#1)(2007-9#1)
Blood cultures##2##2##(2007-7#1)(2008-5#1)
Blood flow##4##2##(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
Blood glucose and##2##3##(2008-3#1)(2009-11#1)
Blood glucose levels were##2##4##(2007-12#1)(2012-3#1)
Blood glucose monitoring in gestational diabetes mellitus##3##7##(1996-2#3)
Blood glucose##11##2##(1991-2#1)(1994-11#1)(1996-2#3)(2007-12#1)(2008-3#2)(2009-11#2)(2012-3#1)
Blood group##2##2##(1994-9#1)(2008-10#1)
Blood loss was minimal##2##4##(1991-2#1)(2011-2#1)
Blood loss was significantly##2##4##(1996-3#1)(2011-2#1)
Blood loss was##5##3##(1991-2#1)(1996-3#1)(1996-8#1)(2011-2#2)
Blood loss##7##2##(1991-2#1)(1996-3#1)(1996-8#1)(2010-3#1)(2011-2#2)(2013-1#1)
Blood plasma##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
Blood pressure and##3##3##(1991-12#1)(1991-8#1)(2007-10#1)
Blood pressure was##2##3##(1997-8#1)(2008-11#1)
Blood pressure##14##2##(1990-3#1)(1991-10#1)(1991-12#1)(1991-8#1)(1994-9#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-4#1)(2012-12#1)
Blood samples and##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
Blood samples for##2##3##(1995-11#1)(2008-7#1)
Blood samples from##5##3##(1994-12#1)(1995-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
Blood samples were collected before##3##5##(2007-8#1)(2011-2#1)(2012-12#1)
Blood samples were collected from##4##5##(2008-5#1)(2011-1#1)(2012-3#2)
Blood samples were collected##10##4##(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)
Blood samples were drawn at##2##5##(1994-9#1)(2013-8#1)
Blood samples were drawn##3##4##(1994-9#1)(2013-1#1)(2013-8#1)
Blood samples were obtained##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
Blood samples were taken##2##4##(1996-9#1)(2013-8#1)
Blood samples were##21##3##(1994-9#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Blood samples##32##2##(1993-2#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#3)(2009-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Blood was drawn##2##3##(2007-10#1)(2011-1#1)
Blood was taken##2##3##(2008-7#1)(2013-1#1)
Blood was##7##2##(2007-10#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Blood##158##1##(1990-2#3)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#5)(1995-11#1)(1995-12#2)(1995-6#3)(1996-11#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#2)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#5)(2009-12#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#17)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#5)
Bloom##4##1##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
Blossom Blight##2##2##(2008-10#2)
Blossom blight##2##2##(2008-10#2)
Blossom##4##1##(2008-10#4)
Blossoms in##2##2##(2008-10#2)
Blossoms##5##1##(2008-10#5)
Blotch in Wheat##2##3##(2008-10#2)
Blotch##8##1##(2008-10#8)
Blue A##2##2##(2008-10#1)(2013-1#1)
Blue B##2##2##(2012-3#2)
Blue Cross and Blue Shield of##2##6##(1992-2#1)(1996-1#1)
Blue Cross and Blue Shield##5##5##(1992-2#1)(1993-1#1)(1994-12#1)(1996-1#1)(2008-4#1)
Blue Cross##7##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-4#1)
Blue Mold of##3##3##(2008-10#3)
Blue Mold##4##2##(2008-10#4)
Blue Sepharose##6##2##(1990-12#3)(1992-11#1)(1997-1#2)
Blue Shield of California##2##4##(1995-2#2)
Blue Shield of##4##3##(1992-2#1)(1995-2#2)(1996-1#1)
Blue Shield##8##2##(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#3)(1996-1#1)(2008-4#1)
Blue and##7##2##(1993-8#1)(2008-10#6)
Blue##86##1##(1990-12#5)(1992-1#1)(1992-11#1)(1992-2#2)(1993-1#2)(1993-8#1)(1994-12#2)(1994-5#1)(1995-2#3)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-6#1)(2007-12#4)(2007-5#1)(2008-10#37)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
Blue-light##2##1##(1995-3#1)(2011-1#1)
Blueberry##7##1##(2008-10#5)(2013-1#2)
Bluemke##2##1##(1994-3#2)
Blueprint Committee on##2##3##(1996-1#2)
Blueprint##3##1##(1996-1#2)(1997-3#1)
Blues##5##1##(1993-5#1)(1993-8#2)(1994-2#1)(1997-6#1)
Bluetongue##2##1##(2011-2#2)
Bluetooth##2##1##(2008-10#1)(2012-3#1)
Blumenbach's##3##1##(2012-2#3)
Blumeria graminis f##5##3##(2008-10#5)
Blumeria graminis##6##2##(2008-10#5)(2008-7#1)
Blumeriella jaapii##2##2##(2008-10#2)
Blunt##4##1##(1993-2#1)(2008-4#1)(2008-6#1)(2010-1#1)
Bm-N cells##2##2##(2008-11#2)
Bm86 antigen##3##2##(1994-3#3)
Bm86##4##1##(1994-3#4)
BmK M4##3##2##(2008-9#3)
BmK##5##1##(2008-9#5)
BmN##6##1##(1997-3#2)(1997-4#2)(1997-8#2)
BmN-4 cells##4##2##(2008-11#4)
BmNPV dnahel##2##2##(1997-4#2)
BmNPV ie-1 promoter##2##3##(2008-11#2)
BmNPV lef##2##2##(1997-3#2)
BmNPV lefs##2##2##(1997-3#2)
BmNPV##29##1##(1997-3#11)(1997-4#8)(2008-11#10)
BmScH##2##1##(1997-4#2)
Bmax = 0##2##3##(1993-8#1)(1996-2#1)
Bmax = 1##2##3##(1990-7#1)(1996-2#1)
Bmax = 3##2##3##(1990-7#1)(1996-2#1)
Bmax =##7##2##(1990-7#2)(1993-8#1)(1996-2#4)
Bmax of##6##2##(1990-2#1)(1990-7#1)(1991-5#2)(1993-12#1)(1997-2#1)
Bmax values for##2##3##(1993-12#1)(1994-8#1)
Bmax values##7##2##(1993-12#2)(1994-8#1)(1995-8#1)(1996-7#1)(1997-2#2)
Bmax##26##1##(1990-2#1)(1990-7#3)(1991-12#1)(1991-5#2)(1991-6#1)(1993-12#4)(1993-8#1)(1994-8#1)(1995-8#3)(1996-2#5)(1996-7#1)(1997-2#3)
Bmg##2##1##(1995-12#2)
BmorPBP##2##1##(2008-10#2)
BmuG@S##3##1##(2008-7#3)
BmuG@Sbase##2##1##(2008-7#2)
BoHV-1 sequences were##2##3##(2011-2#2)
BoHV-1 sequences##3##2##(2011-2#3)
BoHV-1##7##1##(2011-2#7)
BoNTs##3##1##(2008-5#3)
Boa Vista##2##2##(1991-12#2)
Boal##2##1##(2008-10#2)
Board and the##2##3##(1996-7#1)(2008-11#1)
Board of Directors##2##3##(2008-11#1)(2008-6#1)
Board of Education##4##3##(1991-12#4)
Board of Health and##2##4##(1993-11#1)(1993-3#1)
Board of Health##8##3##(1990-12#1)(1993-11#1)(1993-3#3)(1996-6#1)(1996-9#1)(1997-8#1)
Board of Managers##3##3##(2008-8#3)
Board of##23##2##(1990-12#1)(1991-12#4)(1992-2#1)(1993-11#1)(1993-3#3)(1994-12#1)(1996-6#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#3)(2012-3#1)
Board##56##1##(1990-12#1)(1991-1#1)(1991-12#5)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#7)(1994-12#2)(1994-2#1)(1996-1#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
Boards of##2##2##(1993-3#1)(2010-3#1)
Boards##5##1##(1993-3#1)(2008-2#1)(2009-4#1)(2009-6#1)(2010-3#1)
Boari's##2##1##(2008-1#2)
Bob##3##1##(1995-6#1)(2008-10#1)(2008-8#1)
BocCCK-8(ns)##3##1##(1991-12#3)
BocCCK-8(s)##2##1##(1991-12#2)
Bocaripo##2##1##(2011-2#2)
Boceprevir is##2##2##(2012-12#2)
Boceprevir##6##1##(2012-12#5)(2013-1#1)
Bochdalek diaphragmatic hernia is##2##4##(2008-7#1)(2012-2#1)
Bochdalek diaphragmatic hernia##3##3##(2008-7#1)(2012-2#2)
Bochdalek hernia##2##2##(2008-7#1)(2012-2#1)
Bochdalek##5##1##(2008-7#2)(2012-2#3)
Bodian silver##2##2##(1991-1#1)(1992-8#1)
Bodies in motion##2##3##(2007-8#2)
Body Appreciation##2##2##(2007-12#2)
Body Image Disturbance##2##3##(2007-12#1)(2012-2#1)
Body Image##5##2##(2007-12#3)(2012-2#2)
Body Mass Index (BMI) and##2##5##(2007-8#2)
Body Mass Index (BMI)##5##4##(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)
Body Mass Index##9##3##(2007-8#2)(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Body composition and##2##3##(2011-2#2)
Body composition in##2##3##(2008-7#2)
Body composition##11##2##(2008-5#1)(2008-7#4)(2009-11#2)(2011-2#3)(2012-12#1)
Body dissatisfaction##2##2##(2007-12#2)
Body fat percentage##2##3##(2008-5#1)(2009-7#1)
Body fat##3##2##(2008-5#2)(2009-7#1)
Body image and##5##3##(2007-12#3)(2012-2#2)
Body image##10##2##(2007-12#7)(2012-2#3)
Body mass index (BMI)##3##4##(2006-8#1)(2012-3#2)
Body mass index##7##3##(2006-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#2)
Body mass was##2##3##(2008-9#1)(2013-8#1)
Body mass##10##2##(2006-8#1)(2008-2#1)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
Body perceptions##2##2##(2010-7#2)
Body rolling##2##2##(2008-5#2)
Body size##2##2##(2007-12#1)(2008-9#1)
Body surface##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
Body temperature##2##2##(2007-10#1)(2013-7#1)
Body weight and##2##3##(2008-12#1)(2008-7#1)
Body weight gain##2##3##(2011-2#1)(2013-1#1)
Body weight was##4##3##(1992-12#1)(1995-3#1)(2008-3#1)(2013-1#1)
Body weight##12##2##(1992-12#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
Body weights were##2##3##(2008-10#1)(2008-3#1)
Body weights##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
Body##106##1##(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-11#1)(1995-3#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-12#17)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#8)(2008-6#2)(2008-7#8)(2008-9#5)(2009-11#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#3)(2010-8#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
Bodyw##2##1##(2010-3#2)
Boehringer##2##1##(2008-10#1)(2008-8#1)
Boeing 757##2##2##(1996-12#2)
Boeing##4##1##(1996-12#3)(2008-11#1)
Bogota and Manizales##2##3##(2012-12#2)
Bogota##11##1##(2011-2#1)(2012-12#9)(2013-1#1)
Bogotá##11##1##(2011-2#2)(2012-12#6)(2013-1#3)
Bohr effect##6##2##(1990-8#5)(1992-3#1)
Bohr##7##1##(1990-8#5)(1992-3#1)(1997-2#1)
Boiss##4##1##(2008-11#2)(2008-12#2)
Boldo##2##1##(2007-1#2)
Bolivia and##2##2##(2008-10#1)(2010-3#1)
Bolivia are##2##2##(2008-8#1)(2012-12#1)
Bolivia##10##1##(1992-5#1)(2008-10#2)(2008-8#1)(2010-3#1)(2011-2#3)(2012-12#2)
Bollgard II##3##2##(2011-2#3)
Bologna##8##1##(1991-12#1)(1991-2#2)(2007-8#1)(2008-7#4)
Boltzmann##7##1##(2007-12#3)(2008-2#2)(2008-3#1)(2010-8#1)
Bombay##3##1##(1994-1#1)(1997-4#1)(2007-7#1)
Bombesin levels##2##2##(2008-5#2)
Bombesin##4##1##(1994-3#2)(2008-5#2)
Bombycidae)##2##1##(2007-12#1)(2008-5#1)
Bombyx bombyxin##3##2##(2008-6#3)
Bombyx mori nuclear polyhedrosis virus (BmNPV)##2##6##(1997-3#1)(1997-4#1)
Bombyx mori nuclear polyhedrosis virus##4##5##(1997-3#1)(1997-4#3)
Bombyx mori nucleopolyhedrovirus (BmNPV)##2##4##(2008-11#2)
Bombyx mori nucleopolyhedrovirus##4##3##(2008-11#4)
Bombyx mori##31##2##(1995-11#2)(1995-6#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#7)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
Bombyx##37##1##(1995-11#2)(1995-6#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#7)(2008-5#4)(2008-6#7)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
Bombyxin##4##1##(2008-6#4)
Bon Accord Lagoon##7##3##(2007-5#7)
Bon Secours##2##2##(2012-3#2)
Bon##9##1##(2007-5#7)(2012-3#2)
Bond Elut C18 extracted CS##2##5##(1990-12#2)
Bond Elut C18##3##3##(1990-12#3)
Bond Elut##4##2##(1990-12#3)(2008-10#1)
Bond##14##1##(1990-12#3)(1995-2#1)(1996-2#2)(1997-7#3)(2008-10#2)(2008-12#1)(2009-10#1)(2010-7#1)
Bondapak##2##1##(1997-2#1)(2008-10#1)
Bonded glucose##2##2##(2008-10#2)
Bonded##4##1##(2008-10#3)(2009-8#1)
Bonding##2##1##(1996-2#1)(2012-1#1)
Bonds##2##1##(1997-7#2)
Bone Marrow Transplantation##2##3##(1995-12#1)(2008-9#1)
Bone Marrow##9##2##(1995-12#1)(2008-11#4)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
Bone and##2##2##(1994-12#1)(2008-6#1)
Bone biopsy##2##2##(2008-4#1)(2012-12#1)
Bone density measurement##2##3##(2007-8#1)(2008-4#1)
Bone density##6##2##(1990-9#1)(2007-8#3)(2008-4#1)(2013-1#1)
Bone formation##2##2##(2008-11#1)(2011-2#1)
Bone fractures##2##2##(2007-8#2)
Bone marrow engraftment studies##2##4##(2008-4#2)
Bone marrow examination showed##2##4##(2012-2#1)(2013-1#1)
Bone marrow micrometastases##2##3##(2007-5#1)(2010-3#1)
Bone marrow necrosis##2##3##(2008-12#2)
Bone marrow transplantation##3##3##(2010-11#3)
Bone marrow##16##2##(1997-7#1)(2007-5#1)(2008-12#2)(2008-4#2)(2010-11#3)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2012-2#1)(2013-1#1)
Bone marrow-derived##3##2##(2008-9#1)(2009-6#1)(2012-12#1)
Bone mass##3##2##(1993-11#3)
Bone metastases are observed in##2##5##(2007-11#2)
Bone metastases are##3##3##(2007-11#2)(2008-7#1)
Bone metastases in##2##3##(2007-11#2)
Bone metastases##9##2##(2007-11#7)(2008-10#1)(2008-7#1)
Bone metastasis##3##2##(2008-7#1)(2009-10#1)(2010-10#1)
Bone mineral content##2##3##(1991-11#1)(1994-7#1)
Bone mineral density##9##3##(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#3)
Bone mineral##12##2##(1990-11#1)(1991-11#1)(1994-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#3)
Bone morphogenetic proteins (BMPs) are##2##5##(1994-12#1)(2011-2#1)
Bone morphogenetic proteins##4##3##(1994-12#1)(2007-12#1)(2011-2#2)
Bone morphogenetic##6##2##(1994-12#1)(2007-12#1)(2011-2#4)
Bone pain disappeared or was##2##5##(1991-5#1)(1993-3#1)
Bone pain##4##2##(1991-5#2)(1993-3#2)
Bone quality##2##2##(2008-12#1)(2011-2#1)
Bone quantity and##2##3##(2008-12#2)
Bone quantity##3##2##(2008-12#3)
Bone resorption##4##2##(1991-11#2)(1993-6#1)(2008-10#1)
Bone scan##2##2##(2007-11#2)
Bone scintigraphy##3##2##(2008-7#2)(2011-2#1)
Bone tumors##2##2##(2007-8#2)
Bone##129##1##(1990-11#1)(1990-9#1)(1991-11#3)(1991-5#2)(1992-12#1)(1992-3#1)(1993-11#3)(1993-3#2)(1993-6#1)(1994-12#3)(1994-7#1)(1995-12#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#9)(2007-12#2)(2007-5#1)(2007-8#10)(2008-10#2)(2008-11#5)(2008-12#7)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#4)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#15)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Bone-marrow-derived##2##1##(2010-6#2)
Bonferroni correction##2##2##(2008-12#1)(2010-2#1)
Bonferroni##3##1##(2008-12#1)(2010-2#1)(2010-9#1)
Bonghan Kim##2##2##(2010-7#2)
Bonghan ducts##2##2##(2010-7#2)
Bonghan system##2##2##(2010-7#2)
Bonghan##9##1##(2010-7#9)
Bonn##3##1##(1994-2#1)(2008-5#2)
Bono##4##1##(1995-1#1)(2007-8#2)(2012-2#1)
Bonus##3##1##(1995-1#3)
Bony##4##1##(2011-2#1)(2012-2#3)
Book review##11##2##(2008-10#2)(2008-5#8)(2008-7#1)
Book reviews##2##2##(1997-6#1)(2008-5#1)
Book##20##1##(1994-6#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-5#9)(2008-7#1)(2011-1#1)(2013-8#1)
Books received##4##2##(2008-4#4)
Boolean expressions##3##2##(1995-12#3)
Boolean##5##1##(1995-12#3)(2008-7#1)(2008-9#1)
Boost##2##1##(1994-12#1)(2008-1#1)
Bootstrap analysis##3##2##(2008-10#3)
Bootstrap##6##1##(2008-10#3)(2009-12#2)(2010-3#1)
Borate##2##1##(2008-2#2)
Bord Altranais##4##2##(2008-11#4)
Bordeaux##2##1##(2008-10#2)
Border crossing##2##2##(1994-3#2)
Border##6##1##(1994-3#2)(2008-10#3)(2011-2#1)
Borderline personality disorder##2##3##(1993-12#1)(2009-9#1)
Borderline personality##3##2##(1993-12#1)(2009-9#2)
Borderline##8##1##(1993-12#1)(2008-11#1)(2009-9#2)(2011-2#4)
Borders##2##1##(1996-8#1)(1997-6#1)
Bordetella pertussis##6##2##(1992-3#1)(2007-12#1)(2008-4#1)(2008-7#2)(2013-1#1)
Bordetella##8##1##(1992-3#1)(1994-2#1)(2007-12#1)(2008-4#1)(2008-7#2)(2013-1#1)(2013-8#1)
Boric acid##2##2##(2008-10#2)
Born approximation is##2##3##(2008-2#2)
Born approximation##8##2##(2007-11#1)(2007-12#2)(2008-2#5)
Born##16##1##(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-2#6)(2009-12#3)(2011-1#1)
Borna disease virus##3##3##(1990-11#1)(1994-6#1)(2011-1#1)
Borna disease##4##2##(1990-11#2)(1994-6#1)(2011-1#1)
Borno state##2##2##(1990-3#2)
Boron neutron capture therapy (BNCT)##3##5##(1994-3#2)(2013-1#1)
Boron neutron capture therapy##7##4##(1994-3#6)(2013-1#1)
Boron##13##1##(1994-3#7)(2008-10#3)(2008-7#1)(2012-2#1)(2013-1#1)
Borquez was##2##2##(1995-12#2)
Borquez##8##1##(1995-12#8)
Borquez's##4##1##(1995-12#4)
Borrelia and##2##2##(2012-2#1)(2013-8#1)
Borrelia burgdorferi in##3##3##(2008-9#2)(2010-6#1)
Borrelia burgdorferi infection in##2##4##(2011-2#2)
Borrelia burgdorferi infection##3##3##(2011-2#3)
Borrelia burgdorferi##19##2##(1990-2#2)(1991-11#1)(1992-3#2)(1995-5#1)(2008-9#5)(2010-6#2)(2011-2#6)
Borrelia garinii##2##2##(1997-4#1)(2008-7#1)
Borrelia##37##1##(1990-12#2)(1990-2#2)(1991-11#1)(1992-11#1)(1992-3#2)(1995-5#1)(1997-4#1)(2008-7#1)(2008-9#7)(2010-6#2)(2011-2#7)(2012-2#6)(2013-8#4)
Borrmann effect##2##2##(2007-11#2)
Bortezomib to##2##2##(2012-12#2)
Bortezomib##10##1##(2010-8#3)(2011-2#1)(2012-12#6)
Bos taurus##6##2##(1993-12#1)(1993-2#4)(2011-2#1)
Bos##8##1##(1991-5#1)(1993-12#1)(1993-2#4)(2007-11#1)(2011-2#1)
Boschniakia rossica##2##2##(2011-2#2)
Bose-Einstein##4##1##(1996-12#2)(2007-12#1)(2008-3#1)
Bosentan##3##1##(2009-10#3)
Bosnia and Herzegovina##3##3##(1996-6#1)(2009-11#1)(2011-1#1)
Boston and##2##2##(2007-7#1)(2013-8#1)
Boston##30##1##(1992-3#1)(1993-5#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
Bosutinib##2##1##(2010-11#2)
Boswell was##2##2##(1990-11#2)
Boswell##4##1##(1990-11#4)
Boswellia serrata##7##2##(2013-1#7)
Boswellia##8##1##(2008-10#1)(2013-1#7)
Botanical##2##1##(2008-10#1)(2010-2#1)
Both 2CA and betagamma mATP##2##5##(2008-2#2)
Both a##7##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
Both activities##2##2##(1991-9#1)(1992-6#1)
Both adult##2##2##(1991-12#1)(2010-8#1)
Both age##2##2##(1990-12#1)(1997-6#1)
Both agents##2##2##(1992-12#1)(2013-1#1)
Both algorithms##2##2##(2008-3#1)(2008-6#1)
Both alpha##2##2##(1994-5#1)(1994-6#1)
Both alpha- and beta-CGRP##2##4##(1992-6#2)
Both an##2##2##(1992-12#1)(1996-6#1)
Both analyses indicated##2##3##(2008-10#2)
Both aneurysms were##2##3##(2008-7#1)(2011-2#1)
Both applications##2##2##(2008-3#1)(2008-9#1)
Both approaches##5##2##(2008-2#2)(2009-11#2)(2011-2#1)
Both are##8##2##(1992-9#1)(1993-2#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)
Both assays could##2##3##(2008-10#1)(2012-3#1)
Both bacterial and clinical results indicate##2##6##(1990-2#1)(1991-3#1)
Both bacterial##5##2##(1990-2#1)(1991-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
Both basal and##4##3##(1990-8#1)(1992-12#1)(1992-8#1)(2011-2#1)
Both bpV(pic) and vanadate##2##4##(1997-1#2)
Both cases were##4##3##(1990-10#1)(1993-8#1)(2008-12#1)(2013-1#1)
Both cases##6##2##(1990-10#1)(1993-8#1)(2008-1#1)(2008-12#1)(2009-2#1)(2013-1#1)
Both cell lines##2##3##(2008-11#1)(2008-6#1)
Both cell types##3##3##(1992-6#1)(2007-12#1)(2008-7#1)
Both cell##7##2##(1990-5#1)(1992-6#1)(1995-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)
Both clones##2##2##(1992-8#1)(2008-11#1)
Both compounds were##2##3##(1990-2#1)(2008-10#1)
Both compounds##11##2##(1990-2#1)(1991-5#1)(1994-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-1#2)
Both conditions were##2##3##(2008-10#1)(2011-1#1)
Both conditions##6##2##(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#2)(2011-2#1)
Both conservative and surgical treatment##3##5##(1994-2#1)(2007-11#1)(2007-8#1)
Both conservative and surgical##4##4##(1994-2#1)(2007-11#2)(2007-8#1)
Both control and##2##3##(1990-7#1)(2010-9#1)
Both cortisol and##2##3##(1990-12#1)(1991-6#1)
Both cysts##2##2##(2008-7#1)(2011-2#1)
Both drugs caused##2##3##(1995-12#2)
Both drugs##6##2##(1990-5#1)(1994-11#1)(1994-5#1)(1995-12#3)
Both effects##4##2##(1992-5#1)(1996-2#1)(2007-12#1)(2008-4#1)
Both embryonic and##2##3##(2008-11#1)(2012-2#1)
Both environmental##2##2##(2008-11#1)(2008-7#1)
Both ethanol##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
Both experimental and##2##3##(1996-9#1)(2008-9#1)
Both experimental##3##2##(1996-9#1)(2008-7#1)(2008-9#1)
Both extracts##2##2##(2008-10#2)
Both factors##2##2##(2008-9#1)(2010-2#1)
Both fasting and##2##3##(1994-12#2)
Both forms##3##2##(1991-12#1)(1995-3#1)(2009-9#1)
Both free radicals##2##3##(2008-5#2)
Both fundamental and##2##3##(2007-12#1)(2008-2#1)
Both fungi##2##2##(2008-10#2)
Both genes##2##2##(1993-8#1)(1994-11#1)
Both genetic and##2##3##(1995-6#1)(2008-7#1)
Both genetic##3##2##(1995-6#1)(2008-7#2)
Both glycosylated and nonglycosylated forms of##2##6##(1991-9#1)(1992-8#1)
Both groups of vinca site agents##2##6##(1995-5#2)
Both groups of##6##3##(1995-1#1)(1995-5#2)(1997-3#1)(2007-8#1)(2008-12#1)
Both groups were found to##3##5##(1994-3#1)(2008-10#1)(2008-11#1)
Both groups were##9##3##(1991-2#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2013-1#1)
Both groups##27##2##(1991-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2013-1#1)
Both hardware and software##2##4##(2008-7#1)(2008-9#1)
Both have##3##2##(1993-11#1)(1997-3#1)(2008-11#1)
Both human##5##2##(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#1)
Both in the##3##3##(1994-11#1)(1997-1#1)(2012-3#1)
Both in##4##2##(1994-11#1)(1997-1#1)(2008-11#1)(2012-3#1)
Both instruments##6##2##(1991-1#1)(2008-10#2)(2008-3#2)(2013-1#1)
Both lesions##3##2##(1992-11#1)(2007-8#1)(2008-7#1)
Both ligands##2##2##(1995-5#1)(1996-5#1)
Both male and female##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
Both methods are##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
Both methods have##2##3##(2008-10#2)
Both methods showed##2##3##(2008-12#1)(2011-2#1)
Both methods were applied to##2##5##(2008-10#2)
Both methods were##7##3##(1993-9#1)(2008-10#6)
Both methods##23##2##(1991-2#1)(1993-9#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
Both models were##2##3##(2007-8#1)(2008-10#1)
Both models##8##2##(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)
Both native##2##2##(2008-9#1)(2013-8#1)
Both of the##2##3##(2008-10#1)(2008-11#1)
Both of them##2##3##(2008-9#2)
Both of these##14##3##(1992-9#1)(1993-11#1)(1995-2#1)(1995-6#2)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)
Both of##20##2##(1992-9#1)(1993-11#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)
Both pairs of##2##3##(2008-10#2)
Both patient groups##2##3##(1995-5#1)(1996-7#1)
Both patient##3##2##(1995-5#1)(1996-7#1)(2010-2#1)
Both patients are##2##3##(2008-10#1)(2013-1#1)
Both patients had##8##3##(1995-11#1)(2006-12#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
Both patients were##4##3##(1995-11#1)(2012-12#1)(2013-1#2)
Both patients who##2##3##(2008-10#1)(2012-12#1)
Both patients##25##2##(1993-6#1)(1995-11#2)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2010-11#1)(2011-1#1)(2012-12#5)(2012-3#1)(2013-1#5)
Both phenomena##2##2##(1992-12#1)(2010-11#1)
Both positive##2##2##(2008-10#1)(2008-7#1)
Both primary##2##2##(1991-5#1)(2008-6#1)
Both procedures##4##2##(1995-3#1)(2007-8#1)(2008-10#2)
Both processes are##2##3##(2007-11#1)(2013-8#1)
Both processes##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
Both proposed methods##2##3##(2008-10#2)
Both proteins##5##2##(1991-6#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-6#1)
Both protocols##2##2##(2008-2#1)(2008-4#1)
Both recombinant##3##2##(1992-8#1)(1995-12#1)(1997-3#1)
Both require##2##2##(1992-6#1)(1996-1#1)
Both scalar##2##2##(2008-2#1)(2008-3#1)
Both selective##2##2##(2008-12#1)(2013-1#1)
Both sets of##3##3##(1995-11#1)(2008-10#1)(2009-10#1)
Both sexes##3##2##(1990-8#1)(2008-1#1)(2011-2#1)
Both shampoos##3##2##(2008-5#3)
Both sides##3##2##(1997-6#1)(2008-1#1)(2008-10#1)
Both simulation and experimental results##2##5##(2008-2#1)(2008-3#1)
Both sites##2##2##(2012-12#1)(2013-8#1)
Both spatial##2##2##(2007-12#1)(2008-8#1)
Both species of##3##3##(1994-11#1)(2008-10#2)
Both species##7##2##(1994-11#1)(2008-10#3)(2009-10#1)(2013-1#1)(2013-7#1)
Both strains of##2##3##(2008-10#2)
Both strains##4##2##(2008-10#4)
Both studies##2##2##(2008-7#1)(2010-6#1)
Both subpopulations were##2##3##(2008-10#2)
Both systems were##2##3##(2007-8#1)(2008-3#1)
Both techniques were##2##3##(2008-10#1)(2013-1#1)
Both techniques##7##2##(2008-10#3)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
Both tests##3##2##(1994-3#1)(2007-5#1)(2008-10#1)
Both the mutant and the##2##5##(1994-11#1)(2008-10#1)
Both the original##2##3##(1994-2#1)(2008-10#1)
Both the proportion of##2##4##(1993-11#1)(2008-10#1)
Both the rates##2##3##(1990-5#2)
Both the real and the imaginary parts of the##2##9##(2007-11#1)(2008-3#1)
Both the right and left lobes##2##6##(2013-1#2)
Both the separation##2##3##(1990-8#1)(2008-10#1)
Both the theoretical##2##3##(2008-3#1)(2010-2#1)
Both the theory and the experiment are demonstrated##2##8##(2008-3#2)
Both the theory and the##3##5##(1990-12#1)(2008-3#2)
Both the theory and##4##4##(1990-12#1)(2008-3#3)
Both the##127##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1992-11#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-8#1)(1994-11#3)(1994-2#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#3)(2008-3#16)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#1)(2010-2#1)(2010-5#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Both theoretical and experimental results##2##5##(2008-3#2)
Both theoretical##3##2##(2008-10#1)(2008-3#2)
Both these##10##2##(1991-12#1)(1994-8#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
Both toxins##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
Both treatments were well tolerated##2##5##(2008-10#1)(2010-4#1)
Both treatments##3##2##(1991-3#1)(2008-10#1)(2010-4#1)
Both twins##3##2##(2010-1#2)(2011-1#1)
Both types of##6##3##(1994-5#1)(2008-10#2)(2008-3#2)(2010-8#1)
Both types##8##2##(1994-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2010-8#1)
Both vaccines##2##2##(1996-12#1)(2010-10#1)
Both versions##2##2##(1995-6#1)(2008-10#1)
Both viruses were##2##3##(2008-10#1)(2008-11#1)
Both were##6##2##(1990-6#1)(1995-11#1)(1995-6#1)(1996-8#1)(2008-2#1)(2012-2#1)
Both##1033##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#5)(1990-5#11)(1990-6#1)(1990-7#6)(1990-8#5)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#8)(1991-6#6)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#2)(1992-11#6)(1992-12#6)(1992-2#3)(1992-3#6)(1992-5#2)(1992-6#10)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#7)(1993-12#8)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#12)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#12)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#2)(1995-1#2)(1995-11#11)(1995-12#7)(1995-2#7)(1995-3#4)(1995-5#11)(1995-6#11)(1995-8#3)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#8)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#2)(1997-6#9)(1997-7#3)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#13)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#9)(2008-1#8)(2008-10#221)(2008-11#37)(2008-12#7)(2008-2#19)(2008-3#58)(2008-4#15)(2008-5#23)(2008-6#16)(2008-7#41)(2008-8#19)(2008-9#21)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#11)(2011-2#25)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#10)(2012-3#13)(2012-4#1)(2012-5#1)(2013-1#31)(2013-7#2)(2013-8#9)
Bothrops cotiara##2##2##(2008-5#2)
Bothrops jararaca##3##2##(1995-5#2)(2008-7#1)
Bothrops##9##1##(1995-5#2)(2008-5#6)(2008-7#1)
Botryoid odontogenic cyst##2##3##(2013-1#2)
Botryoid##4##1##(2007-10#1)(2007-7#1)(2013-1#2)
Botryoidal tissue##2##2##(2007-12#2)
Botryosphaeria dothidea##12##2##(2008-10#12)
Botryosphaeria##17##1##(2008-10#16)(2011-10#1)
Botryotinia fuckeliana (anamorph##2##3##(1997-2#1)(2008-10#1)
Botryotinia fuckeliana##7##2##(1997-2#2)(1997-4#3)(2008-10#2)
Botryotinia##8##1##(1997-2#2)(1997-4#3)(2008-10#3)
Botrytis blight##2##2##(2008-10#2)
Botrytis cinerea Infection##2##3##(2008-10#2)
Botrytis cinerea and the##2##4##(2008-10#2)
Botrytis cinerea and##9##3##(1991-5#1)(2008-10#7)(2008-5#1)
Botrytis cinerea conidia##3##3##(2008-10#3)
Botrytis cinerea in##6##3##(2008-10#6)
Botrytis cinerea on##9##3##(2008-10#9)
Botrytis cinerea was investigated##3##4##(2008-10#3)
Botrytis cinerea was##7##3##(2008-10#7)
Botrytis cinerea##91##2##(1991-5#1)(2008-10#87)(2008-5#1)(2009-6#1)(2011-10#1)
Botrytis cinerea)##2##2##(1997-2#1)(2008-10#1)
Botrytis spp##9##2##(2008-10#9)
Botrytis##112##1##(1991-5#1)(1997-2#1)(2008-10#106)(2008-5#1)(2009-6#1)(2010-5#1)(2011-10#1)
Botswana##9##1##(1993-11#1)(1997-6#1)(2008-10#3)(2010-4#1)(2013-1#3)
Bottlenecks##2##1##(1995-2#1)(2013-1#1)
Bottlinger's rings##2##2##(2008-3#2)
Bottom-up##2##1##(1990-8#1)(2011-2#1)
Botulin toxin##2##2##(2007-11#2)
Botulinum ADP-ribosyltransferase C3##2##3##(1990-2#1)(1993-6#1)
Botulinum toxin##6##2##(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
Botulinum##12##1##(1990-2#1)(1993-6#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-3#1)
Botulism##2##1##(2007-12#2)
Bouchard##4##1##(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)
Bouguer-Lambert-Beer law##2##2##(2008-3#2)
Bouin's##2##1##(2008-5#1)(2011-1#1)
Boulder##3##1##(1996-3#1)(2007-8#1)(2008-2#1)
Bound algorithms##2##2##(2008-6#2)
Bound##9##1##(1990-12#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#4)
Boundaries##3##1##(1995-1#1)(2008-12#1)(2013-1#1)
Boundary##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
Bouyei##2##1##(1995-6#1)(2008-9#1)
Bovicola ovis##2##2##(1996-12#2)
Bovine Herpesvirus##2##2##(2008-11#2)
Bovine Kidney##2##2##(2008-11#2)
Bovine Liver##2##2##(1995-6#1)(2008-10#1)
Bovine alpha s2-casein D##2##4##(1993-6#2)
Bovine heart##2##2##(1990-5#1)(1995-2#1)
Bovine liver##3##2##(1990-7#1)(1993-3#1)(2008-10#1)
Bovine milk##2##2##(2012-2#2)
Bovine neutrophil##2##2##(1991-2#1)(1992-6#1)
Bovine p23 and p7##2##4##(1992-6#2)
Bovine serum albumin (BSA) was##2##5##(1993-11#1)(1997-2#1)
Bovine serum albumin (BSA)##3##4##(1993-11#1)(1997-2#1)(2008-10#1)
Bovine serum albumin##7##3##(1990-11#1)(1993-11#1)(1994-8#1)(1997-2#1)(2008-10#3)
Bovine spongiform encephalopathy##2##3##(1990-3#1)(1992-5#1)
Bovine viral diarrhea virus##2##4##(2012-3#2)
Bovine##52##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-2#1)(2007-2#1)(2008-10#6)(2008-11#7)(2008-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
Bowel bacterial overgrowth##2##3##(2011-2#2)
Bowel##18##1##(1995-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
Bowen##2##1##(1993-1#1)(2011-1#1)
Bowen's disease##7##2##(2007-8#1)(2010-6#6)
Bowen's##8##1##(2007-8#1)(2010-6#7)
Bowenoid##2##1##(2011-1#1)(2012-12#1)
Bowling Green##2##2##(2008-4#2)
Bowling##3##1##(2008-4#2)(2012-12#1)
Bowman Gray School of Medicine##2##5##(1992-1#1)(2008-5#1)
Bowman##10##1##(1992-1#1)(2008-10#8)(2008-5#1)
Box##6##1##(1996-8#2)(2007-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
Box-Behnken design##2##2##(2013-1#2)
Box-Behnken##4##1##(2008-10#2)(2013-1#2)
Boy##2##1##(2008-12#1)(2013-8#1)
Boyacá##4##1##(2008-5#1)(2013-1#3)
Boyd##2##1##(1992-3#1)(2008-10#1)
Boyden chamber##3##2##(1990-12#1)(2013-8#2)
Boyden##4##1##(1990-12#1)(2008-10#1)(2013-8#2)
Boys and##2##2##(2008-12#1)(2009-5#1)
Boys##5##1##(2008-10#1)(2008-12#1)(2009-5#1)(2010-4#1)(2012-2#1)
Bp##5##1##(2008-11#5)
Bp-1 protein##6##2##(1992-11#6)
BqsS-BqsR##5##1##(2009-6#5)
Br##7##1##(1994-5#1)(2006-6#4)(2008-10#1)(2008-11#1)
Br(-) ion##2##2##(2008-10#2)
Br(-)##9##1##(2008-10#8)(2011-1#1)
Br(2)(NBu(4))(2)##3##1##(1996-2#3)
Br(a)/Br(b)##2##1##(2006-6#2)
Br)##2##1##(1997-7#1)(2008-10#1)
Br-##6##1##(1995-12#1)(1995-3#1)(1995-5#1)(2008-10#3)
BrCr##2##1##(2008-8#2)
BraMT##3##1##(1993-6#3)
Braak stage I-II##2##3##(2009-12#2)
Braak stage V-VI##2##3##(2009-12#2)
Braak stage##5##2##(2009-12#4)(2011-2#1)
Bracco Imaging##4##2##(2008-7#4)
Bracco##5##1##(2008-7#5)
Brachial plexus##4##2##(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
Brachial##6##1##(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)
Brachiocephalic##2##1##(2007-7#1)(2008-1#1)
Brachyspira murdochii##2##2##(2011-2#2)
Brachyspira##3##1##(2011-2#3)
Brachyspiraceae##4##1##(2011-2#3)(2013-8#1)
Bracket##2##1##(2009-7#2)
Braconidae##2##1##(2007-12#1)(2008-5#1)
Braconidae)##9##1##(1992-6#1)(2007-12#4)(2008-6#2)(2010-2#1)(2013-8#1)
Bradford method##2##2##(2008-10#2)
Bradford##10##1##(1990-3#1)(1991-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-9#1)(2013-8#3)
Bradycardia##2##1##(1991-5#1)(2006-10#1)
Bradykinin##3##1##(1990-5#2)(1992-3#1)
Bradyrhizobium japonicum##3##2##(1994-6#2)(1994-8#1)
Bragg angle##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
Bragg degeneracy##2##2##(2008-3#2)
Bragg diffraction##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
Bragg fibers##4##2##(2007-11#1)(2007-12#3)
Bragg grating and##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
Bragg grating in##2##3##(2008-2#1)(2008-3#1)
Bragg grating sensor##2##3##(2007-12#1)(2008-3#1)
Bragg grating sensors##4##3##(2008-3#4)
Bragg grating with##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
Bragg grating##62##2##(2007-11#19)(2007-12#16)(2008-2#7)(2008-3#20)
Bragg gratings by##2##3##(2008-2#1)(2008-3#1)
Bragg gratings have been written in##2##6##(2007-12#2)
Bragg gratings have been##3##4##(2007-12#2)(2008-3#1)
Bragg gratings in a##2##4##(2007-11#1)(2007-12#1)
Bragg gratings in##8##3##(2007-11#3)(2007-12#4)(2008-2#1)
Bragg gratings is presented##3##4##(2007-11#2)(2008-3#1)
Bragg gratings is##5##3##(2007-11#2)(2008-3#3)
Bragg gratings were fabricated by##2##5##(2007-11#1)(2013-8#1)
Bragg gratings with##3##3##(2007-11#2)(2008-3#1)
Bragg gratings written##3##3##(2007-12#1)(2008-3#2)
Bragg gratings##66##2##(2007-11#19)(2007-12#22)(2008-2#7)(2008-3#17)(2013-8#1)
Bragg mirror is##2##3##(2007-12#2)
Bragg mirror##4##2##(2007-12#4)
Bragg mirrors##2##2##(2007-12#2)
Bragg modulational instability##2##3##(2007-11#2)
Bragg multiple-quantum-well structures##3##3##(2007-11#1)(2007-12#2)
Bragg order near##2##3##(2008-3#2)
Bragg reflection##8##2##(2007-11#4)(2007-12#1)(2008-3#3)
Bragg reflector##14##2##(2007-11#7)(2007-12#1)(2008-3#6)
Bragg reflectors##2##2##(2008-3#2)
Bragg scattering from the dynamic grating within##2##7##(2007-12#2)
Bragg scattering from##3##3##(2007-12#2)(2008-3#1)
Bragg scattering##4##2##(2007-12#2)(2008-3#2)
Bragg selectivity##2##2##(2008-2#2)
Bragg wavelength of##2##3##(2007-12#1)(2013-8#1)
Bragg wavelength shift##2##3##(2007-11#1)(2008-3#1)
Bragg wavelength##14##2##(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#1)(2013-8#3)
Bragg##227##1##(1992-8#1)(2007-11#63)(2007-12#62)(2008-2#21)(2008-3#75)(2008-7#1)(2013-8#4)
Bragg-grating-based##2##1##(2008-3#2)
Brahman steers##2##2##(1996-12#2)
Brahman##4##1##(1996-12#3)(2013-1#1)
Brahmans##2##1##(1996-12#2)
Brahms##6##1##(2013-1#6)
Brain Derived Neurotrophic Factor##2##4##(2012-2#1)(2013-1#1)
Brain Injury##3##2##(2008-10#1)(2008-9#1)(2010-2#1)
Brain activation##2##2##(1996-2#1)(2008-5#1)
Brain biopsy##3##2##(1996-11#3)
Brain glucose metabolism##2##3##(1996-5#2)
Brain metastases##2##2##(1997-4#1)(2007-5#1)
Brain neuronal##2##2##(1994-12#1)(2013-1#1)
Brain slices##2##2##(2008-7#2)
Brain sonography##2##2##(2011-2#2)
Brain stem##2##2##(1995-12#1)(2008-7#1)
Brain substrates activated by electroacupuncture##2##5##(1996-12#2)
Brain tumours##2##2##(2008-7#1)(2009-4#1)
Brain##90##1##(1991-2#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#3)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#2)(2013-8#1)
Brain-Derived Neurotrophic Factor (BDNF)##2##4##(2013-8#2)
Brain-Derived##3##1##(2008-11#1)(2013-8#2)
Brain-derived neurotrophic factor (BDNF)##2##4##(1997-6#1)(2012-12#1)
Brains and##2##2##(2008-6#1)(2009-1#1)
Brains##4##1##(1995-12#1)(2007-10#1)(2008-6#1)(2009-1#1)
Branch &amp##4##2##(2008-6#4)
Branch of the##2##3##(1994-12#1)(2013-1#1)
Branch of##4##2##(1994-12#1)(1996-3#1)(2008-6#1)(2013-1#1)
Branch students##2##2##(2008-11#1)(2008-12#1)
Branch##17##1##(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-6#5)(2008-7#1)(2013-1#1)
Branched##2##1##(1992-3#1)(2008-4#1)
Branches##2##1##(2008-10#1)(2008-5#1)
Branching##2##1##(2008-10#1)(2008-11#1)
Brand##2##1##(1994-1#2)
Brandes##2##1##(2009-10#2)
Brasil##2##1##(2008-11#1)(2008-5#1)
Brassaia##4##1##(2008-10#4)
Brassaiopsis glomerulata##2##2##(2010-2#2)
Brassica juncea by##2##3##(1991-12#1)(2008-10#1)
Brassica juncea##7##2##(1991-12#2)(2008-10#4)(2011-1#1)
Brassica napus L##2##3##(2008-12#1)(2011-2#1)
Brassica napus cv##2##3##(2008-10#2)
Brassica napus##15##2##(2008-10#12)(2008-12#1)(2011-2#1)(2012-3#1)
Brassica napus-B##2##2##(2008-10#2)
Brassica oleracea (C genome)##2##4##(2008-10#2)
Brassica oleracea L##2##3##(2012-3#2)
Brassica oleracea##5##2##(2008-10#3)(2012-3#2)
Brassica spp##8##2##(2008-10#7)(2011-10#1)
Brassica##49##1##(1991-12#2)(2008-10#33)(2008-12#1)(2008-5#1)(2011-1#2)(2011-10#5)(2011-2#1)(2012-3#4)
Brassicaceae##4##1##(2008-10#3)(2009-8#1)
Brattleboro rats##3##2##(1992-3#3)
Braun##6##1##(2007-7#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-5#1)
Bravais lattices can be formed by##2##6##(2007-11#2)
Bravais##3##1##(2007-11#2)(2008-2#1)
Brave##2##1##(1993-5#1)(2008-11#1)
Bravo##2##1##(2008-10#1)(2009-8#1)
Brazil and China##2##3##(2008-12#1)(2013-8#1)
Brazil and China)##2##3##(2008-12#1)(2011-2#1)
Brazil and also##2##3##(1991-12#1)(2013-7#1)
Brazil and the##2##3##(2008-10#1)(2010-1#1)
Brazil and##19##2##(1991-12#1)(1991-6#1)(2008-10#5)(2008-12#3)(2008-5#1)(2008-6#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
Brazil during##4##2##(1991-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
Brazil has##2##2##(1991-6#1)(2013-8#1)
Brazil were##2##2##(2008-10#1)(2010-1#1)
Brazil##230##1##(1990-12#1)(1991-12#5)(1991-6#11)(1991-9#1)(1992-5#1)(1993-3#1)(1993-6#8)(1993-8#2)(1996-12#2)(2007-2#1)(2007-5#1)(2008-10#58)(2008-11#3)(2008-12#7)(2008-2#4)(2008-3#1)(2008-5#13)(2008-6#10)(2008-7#3)(2008-8#3)(2008-9#13)(2009-10#5)(2009-7#2)(2009-9#1)(2010-1#5)(2010-10#3)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#8)(2013-7#9)(2013-8#22)
Brazil)##2##1##(1991-12#1)(2010-8#1)
Brazil]##14##1##(1990-12#1)(1991-12#1)(1991-6#1)(1993-6#1)(2008-6#5)(2008-9#4)(2013-1#1)
Brazilian Cerrado##2##2##(2008-6#2)
Brazilian Congress of Epidemiology]##2##4##(1990-12#2)
Brazilian and##3##2##(1991-6#1)(2008-11#1)(2013-1#1)
Brazilian athletes and##2##3##(2012-12#2)
Brazilian isolates from##2##3##(2008-10#2)
Brazilian isolates##4##2##(2008-10#4)
Brazilian patient with##2##3##(2007-12#1)(2011-2#1)
Brazilian patients with##3##3##(2008-12#1)(2008-5#1)(2013-8#1)
Brazilian population##4##2##(1991-9#1)(2008-12#1)(2010-3#1)(2013-8#1)
Brazilian##100##1##(1990-12#2)(1991-12#2)(1991-6#2)(1991-9#2)(1992-5#1)(1993-6#2)(1994-8#2)(2007-12#1)(2007-2#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#8)(2008-9#4)(2009-10#4)(2009-11#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#3)(2011-2#7)(2012-1#3)(2012-12#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#12)
Brazilians##5##1##(2010-3#1)(2012-2#1)(2013-8#3)
BrdU immunohistochemistry##2##2##(2008-4#2)
BrdU incorporation##2##2##(2008-9#2)
BrdU labeling##5##2##(2007-12#1)(2008-11#1)(2008-9#3)
BrdU##23##1##(1993-11#1)(1993-3#1)(1996-5#2)(2007-12#2)(2008-11#1)(2008-4#4)(2008-9#12)
BrdU-labelled cells##2##2##(1996-5#2)
BrdUrd and urethan##2##3##(1992-5#2)
BrdUrd##4##1##(1992-5#4)
Break Repair##2##2##(2012-3#1)(2013-1#1)
Break through volume and limit of detection of the membrane disks modified by##2##13##(2008-10#2)
Break##4##1##(2008-10#2)(2012-3#1)(2013-1#1)
Breakdown of the##2##3##(1992-8#1)(2008-10#1)
Breakdown of##3##2##(1992-8#1)(2008-10#2)
Breakfast##2##1##(2012-1#2)
Breaking down barriers##2##3##(1994-3#1)(2012-12#1)
Breaking the##2##2##(2008-4#1)(2012-3#1)
Breaking with tradition##2##3##(1992-12#1)(1995-12#1)
Breaking##10##1##(1992-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-9#1)(2007-9#1)(2008-4#1)(2012-12#1)(2012-3#1)
Breakthrough##5##1##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Breast Cancer Cells##2##3##(1994-12#1)(2012-3#1)
Breast Cancer Patients##2##3##(1994-12#1)(1995-4#1)
Breast Cancer Screening##2##3##(1993-12#1)(2013-1#1)
Breast Cancer in##2##3##(1994-12#1)(1997-7#1)
Breast Cancer##49##2##(1993-11#2)(1993-12#2)(1994-12#9)(1994-7#9)(1995-11#1)(1995-4#4)(1995-9#1)(1997-7#8)(2007-2#1)(2007-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
Breast Cancers##2##2##(1994-12#1)(1995-4#1)
Breast Conserving Surgery##2##3##(1995-4#1)(2011-2#1)
Breast Conserving Treatment##2##3##(1994-12#1)(1995-4#1)
Breast Conserving##4##2##(1994-12#1)(1995-4#2)(2011-2#1)
Breast Reconstruction##2##2##(2013-1#2)
Breast and Cervical Cancer##3##4##(1997-1#3)
Breast and##5##2##(1990-2#1)(1995-11#1)(1997-1#3)
Breast cancer in##2##3##(1995-9#1)(2010-9#1)
Breast cancer is the##2##4##(2010-8#1)(2013-1#1)
Breast cancer is##3##3##(2010-8#1)(2013-1#2)
Breast cancer risk with cyst type in cystic disease of the breast##2##12##(1997-8#2)
Breast cancer screening##2##3##(1990-2#1)(1995-10#1)
Breast cancer was##2##3##(1995-4#1)(2010-8#1)
Breast cancer##21##2##(1990-2#1)(1991-12#2)(1995-10#1)(1995-4#1)(1995-9#1)(1996-8#1)(1997-8#2)(2008-5#1)(2008-9#1)(2010-8#5)(2010-9#1)(2011-2#1)(2013-1#3)
Breast carcinoma is##2##3##(2013-8#2)
Breast carcinoma##3##2##(1993-11#1)(2013-8#2)
Breast conservation##2##2##(1994-8#1)(2007-11#1)
Breast feeding##3##2##(1990-2#1)(1991-8#1)(2012-12#1)
Breast screening##2##2##(1991-8#1)(1996-8#1)
Breast##125##1##(1990-11#2)(1990-12#2)(1990-2#3)(1991-12#2)(1991-8#3)(1992-8#1)(1993-11#4)(1993-12#3)(1994-12#12)(1994-5#1)(1994-7#12)(1994-8#1)(1995-10#1)(1995-11#2)(1995-4#10)(1995-9#2)(1996-1#1)(1996-2#1)(1996-8#2)(1997-1#3)(1997-7#10)(1997-8#2)(2007-11#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#3)
Breastfeeding was##3##2##(2010-6#2)(2011-1#1)
Breastfeeding##12##1##(2007-2#1)(2007-9#2)(2008-10#4)(2010-6#3)(2011-1#1)(2012-2#1)
Breath hydrogen excretion##2##3##(1996-6#2)
Breath##6##1##(1996-6#2)(2011-2#3)(2013-8#1)
Breathing##5##1##(1996-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
Breed differences in the##2##4##(2011-2#2)
Breeding for##3##2##(2008-10#3)
Breeding##14##1##(1990-11#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)(2013-7#1)
Brefeldin A##2##2##(1997-7#2)
Bregmaceros##2##1##(2008-5#2)
Bremia lactucae##11##2##(2008-10#11)
Brenneria##3##1##(2008-10#3)
Brescia##2##1##(1990-2#2)
Breton##5##1##(1991-8#1)(1992-6#4)
Bretschneider's##3##1##(2007-8#3)
Brevibacterium##2##1##(1990-12#1)(2008-6#1)
Brewer##9##1##(2008-2#7)(2008-3#2)
Brewer's yeast##2##2##(2011-2#2)
Brewster angle##6##2##(2008-3#6)
Brewster plate##2##2##(2008-2#1)(2008-3#1)
Brewster##16##1##(1994-1#2)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#9)
Brewster's##4##1##(2008-2#4)
Brian##3##1##(2007-12#1)(2008-12#1)(2008-4#1)
Brianne##3##1##(1995-12#3)
Brianne's##3##1##(1995-12#3)
Bridging the gap between##2##4##(1994-12#1)(2010-3#1)
Bridging the##5##2##(1992-2#1)(1994-12#1)(2008-11#1)(2008-2#1)(2010-3#1)
Bridging##7##1##(1992-2#1)(1994-12#1)(1997-7#1)(2008-11#1)(2008-2#1)(2010-3#1)(2013-1#1)
Brief COPE Scale##3##3##(2011-1#3)
Brief Psychiatric Rating Scale##2##4##(1996-7#1)(2010-9#1)
Brief exposure to an enriched environment##2##6##(1992-11#2)
Brief homeopathic pathogenetic experimentation##2##4##(2008-10#2)
Brief interventions##3##2##(2008-11#3)
Brief report##5##2##(1992-11#1)(1992-12#1)(1995-8#1)(2008-3#1)(2009-4#1)
Brief##31##1##(1992-11#3)(1992-12#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-7#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-1#3)(2012-2#1)(2013-8#1)
Briefly##5##1##(1997-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)
Brigham and Women's Hospital##6##4##(1993-3#1)(1994-3#1)(2008-3#1)(2008-4#1)(2010-5#2)
Brigham##8##1##(1993-3#2)(1994-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-5#2)
Bright green##2##2##(2008-7#1)(2008-9#1)
Bright##8##1##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
Brij(R)-35##3##1##(2008-10#3)
Brij-35##2##1##(2008-10#2)
Brilliant Blue and Sunset Yellow##3##5##(2008-10#3)
Brilliant Blue and##4##3##(1993-8#1)(2008-10#3)
Brilliant Blue##8##2##(1993-8#1)(2008-10#6)(2009-8#1)
Brilliant##10##1##(1993-8#1)(2008-10#8)(2009-8#1)
Brillouin backscattered light##6##3##(2008-3#6)
Brillouin backscattered##7##2##(2007-12#1)(2008-3#6)
Brillouin lidar measurements of temperature and sound speed in the ocean##2##11##(2008-2#2)
Brillouin scattering and##2##3##(2007-11#1)(2007-12#1)
Brillouin scattering with##2##3##(2007-11#1)(2007-12#1)
Brillouin scattering##20##2##(2007-11#10)(2007-12#6)(2008-2#4)
Brillouin shift##2##2##(2008-2#2)
Brillouin##53##1##(1992-7#1)(1996-9#1)(2007-11#19)(2007-12#9)(2008-2#13)(2008-3#10)
Brillouin-based distributed##2##2##(2007-11#1)(2007-12#1)
Brillouin-based##4##1##(2007-11#1)(2007-12#3)
Brillouin-erbium fiber laser##2##3##(2007-12#2)
Brillouin-frequency##2##1##(2008-3#2)
Bringing the##2##2##(1993-12#1)(2012-2#1)
Bringing##11##1##(1993-12#1)(1996-1#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
Brisbane##4##1##(2008-7#4)
Bristol##8##1##(1991-11#2)(1994-9#1)(1996-2#1)(1997-8#1)(2007-9#1)(2008-4#2)
Bristol-Myers##2##1##(2008-10#1)(2008-9#1)
Britain and Malaysia##4##3##(2007-12#4)
Britain and##8##2##(1997-6#1)(2007-12#4)(2009-4#1)(2012-2#1)(2013-8#1)
Britain in##2##2##(1997-6#1)(2008-5#1)
Britain##41##1##(1990-11#1)(1990-6#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1995-1#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-6#4)(2007-12#4)(2008-10#2)(2008-11#1)(2008-5#5)(2008-8#1)(2009-4#1)(2010-1#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
Britain's National##2##2##(1990-3#1)(1996-12#1)
Britain's##6##1##(1990-3#1)(1991-3#1)(1991-8#1)(1996-12#1)(1997-5#2)
British American Tobacco##2##3##(2011-1#2)
British Columbia and##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
British Columbia##49##2##(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#2)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#2)(1995-9#1)(1997-2#1)(1997-8#1)(2007-12#6)(2008-10#6)(2008-11#7)(2008-12#1)(2008-3#1)(2009-3#1)(2009-5#1)(2010-8#3)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
British Thoracic Society##2##3##(1990-9#1)(2010-5#1)
British and American##2##3##(1991-1#1)(2011-2#1)
British and German##2##3##(2008-10#1)(2008-11#1)
British and##4##2##(1991-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
British beef##2##2##(1996-3#2)
British isolate##2##2##(2008-10#2)
British##119##1##(1990-6#1)(1990-9#1)(1991-1#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#4)(1992-4#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#2)(1995-8#1)(1995-9#3)(1996-3#2)(1996-8#2)(1997-2#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-12#7)(2007-2#2)(2007-4#1)(2008-10#17)(2008-11#13)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#2)(2010-2#1)(2010-5#3)(2010-8#3)(2011-1#6)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#5)
Britton Robinson buffer##2##3##(2008-10#2)
Britton Robinson##3##2##(2008-10#3)
Britton-Robinson (BR) buffer##4##3##(2008-10#4)
Britton-Robinson buffer (pH##4##3##(2008-10#4)
Britton-Robinson buffer at pH 2##2##5##(2008-10#2)
Britton-Robinson buffer solution##3##3##(2008-10#3)
Britton-Robinson buffer##18##2##(2008-10#18)
Britton-Robinson##25##1##(2008-10#25)
Brn-3 factors##4##2##(1996-12#4)
Brn-3##6##1##(1996-12#6)
Brn-3a and##2##2##(1995-6#1)(1996-12#1)
Brn-3a##7##1##(1995-6#5)(1996-12#2)
Broad bean mottle virus##2##4##(2008-10#2)
Broad bean wilt virus##4##4##(2008-10#4)
Broad bean##6##2##(2008-10#6)
Broad##15##1##(1997-6#1)(2008-10#8)(2008-11#1)(2008-6#1)(2009-11#1)(2012-2#2)(2013-1#1)
Broad-Spectrum Resistance##2##2##(2008-10#2)
Broad-Spectrum##3##1##(2008-10#3)
Broad-sense heritabilities##2##2##(2008-10#2)
Broad-sense heritability for##2##3##(2008-10#2)
Broad-sense heritability was##2##3##(2008-10#2)
Broad-sense heritability##5##2##(2008-10#5)
Broad-sense##7##1##(2008-10#7)
Broadband monolithic acousto-optic tunable##2##4##(2007-12#2)
Broadband##24##1##(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#7)(2009-11#1)(2010-5#1)
Broadcasting##2##1##(1996-8#1)(2008-3#1)
Broadening##3##1##(2006-9#1)(2010-3#1)(2011-1#1)
Broader##5##1##(2008-10#1)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)
Broadly speaking##2##2##(1991-6#1)(2006-10#1)
Broadly##5##1##(1991-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-3#1)
Broca's area aphasia##2##3##(2007-10#2)
Broca's##4##1##(2007-10#4)
Broccoli##2##1##(2008-10#2)
Brockman##2##1##(1993-3#1)(1993-6#1)
Brodie's abscess##5##2##(2007-11#2)(2012-2#3)
Brodie's##6##1##(2007-11#3)(2012-2#3)
Brodmann's area##2##2##(1994-8#1)(2008-11#1)
Brodmann's##3##1##(1990-11#1)(1994-8#1)(2008-11#1)
Broilers##2##1##(1997-3#1)(2008-8#1)
Broken##2##1##(2012-2#1)(2013-1#1)
Brome mosaic virus##4##3##(2008-10#4)
Bromelain is##2##2##(2013-1#2)
Bromelain##5##1##(2013-1#5)
Bromide##4##1##(1995-3#1)(2008-10#3)
Bromley##2##1##(1997-5#1)(2008-10#1)
Bromley's##3##1##(2008-10#3)
Bromocriptine treatment##2##2##(1994-6#2)
Bromodeoxyuridine incorporation##2##2##(2007-12#1)(2008-11#1)
Bromodichloromethane##2##1##(2008-9#2)
Bromus species hosts##2##3##(2008-10#2)
Bromus##3##1##(2008-10#2)(2008-9#1)
Bronchial artery embolization##3##3##(1992-9#2)(2012-3#1)
Bronchial artery##4##2##(1992-9#2)(2012-3#2)
Bronchial asthma##2##2##(1993-9#1)(1996-7#1)
Bronchial vessels##2##2##(1997-1#2)
Bronchial##15##1##(1990-9#1)(1992-9#2)(1993-9#1)(1996-7#1)(1997-1#3)(2008-1#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#2)
Broncho-Vaxom##4##1##(1997-2#4)
Bronchoalveolar lavage fluid##2##3##(2007-12#1)(2008-1#1)
Bronchoalveolar lavage##3##2##(2007-12#1)(2008-1#2)
Bronchogenic cysts##2##2##(2007-8#2)
Bronchogenic##3##1##(2007-8#2)(2012-1#1)
Bronchopulmonary##2##1##(2009-9#1)(2013-1#1)
Bronchoscopic##2##1##(2008-8#1)(2010-8#1)
Bronze Age##4##2##(1995-11#1)(2008-10#3)
Brood##2##1##(2008-6#1)(2008-9#1)
Brown Norway##5##2##(2008-10#4)(2008-7#1)
Brown Rot##3##2##(2008-10#3)
Brown Spot of##4##3##(2008-10#4)
Brown Spot##6##2##(2008-10#6)
Brown rot##2##2##(2008-10#2)
Brown##35##1##(1990-11#1)(1991-3#1)(1992-2#1)(1995-12#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#3)
Brownian dynamics simulations##2##3##(2008-12#1)(2008-3#1)
Brownian motion model of##2##4##(2008-8#2)
Brownian motion model##3##3##(2008-8#3)
Brownian motion of##2##3##(2008-3#1)(2010-12#1)
Brownian motion##10##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#4)(2010-12#1)(2012-2#1)
Brownian##15##1##(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#4)(2010-12#2)(2012-2#2)
Bruce protocol##2##2##(2008-7#2)
Bruce##4##1##(1995-6#1)(2008-7#2)(2011-6#1)
Brucella abortus strain 2308##2##4##(1996-12#2)
Brucella abortus strain##4##3##(1996-12#2)(2010-4#2)
Brucella abortus##7##2##(1996-12#2)(2008-9#2)(2010-4#2)(2011-2#1)
Brucella canis in##3##3##(2011-2#2)(2012-2#1)
Brucella melitensis##6##2##(1995-3#2)(1996-8#1)(1997-7#1)(2008-10#1)(2009-3#1)
Brucella spp##2##2##(2011-2#2)
Brucella##27##1##(1995-3#2)(1996-12#2)(1996-6#1)(1996-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-4#2)(2011-2#6)(2012-2#6)
Brucellosis in##2##2##(2007-7#1)(2011-2#1)
Brucellosis##5##1##(2007-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
Brugada syndrome and atrial fibrillation##2##5##(2011-2#2)
Brugada syndrome in a##2##4##(2008-12#1)(2011-2#1)
Brugada syndrome in##3##3##(2008-12#2)(2011-2#1)
Brugada syndrome##19##2##(2008-11#1)(2008-12#9)(2009-5#1)(2011-2#5)(2012-12#2)(2013-1#1)
Brugada##21##1##(2008-11#1)(2008-12#9)(2009-5#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#1)
Bruggeman##3##1##(2008-2#1)(2008-3#2)
Brugmansia##3##1##(2008-10#1)(2008-6#2)
Bruguiera##2##1##(2008-11#2)
Bruhat technique##4##2##(1991-12#4)
Bruhat##6##1##(1991-12#6)
Bruises in##2##2##(2010-7#2)
Bruker##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Brunner's gland hamartoma##2##3##(2013-8#2)
Brunner's gland##3##2##(2013-8#3)
Brunner's##4##1##(2013-8#4)
Bruno##2##1##(2008-11#1)(2009-10#1)
Brush##3##1##(1992-3#1)(2008-5#1)(2013-8#1)
Brussels sprouts and barley##2##4##(2008-10#2)
Brussels sprouts##3##2##(2008-10#3)
Brussels##7##1##(1994-3#1)(2008-10#4)(2008-7#1)(2010-5#1)
Bryonia dioica##3##2##(1990-11#1)(1992-3#2)
Brønsted##4##1##(2009-8#1)(2010-2#2)(2013-1#1)
Bs##10##1##(1994-12#3)(2008-12#2)(2008-5#4)(2010-3#1)
Bs1##8##1##(2008-10#8)
Bs2 + Bs3)##3##3##(2008-10#3)
Bs2##9##1##(2008-10#9)
Bs2)##4##1##(2008-10#4)
Bs3)##7##1##(2008-10#7)
BsPFK##3##1##(1995-2#1)(1995-5#2)
Bt cotton planting##2##3##(2011-2#2)
Bt cotton##4##2##(2011-2#4)
Bt toxin##2##2##(2010-10#2)
Bt toxins##3##2##(2008-9#1)(2011-2#2)
Bt##14##1##(2008-5#3)(2008-9#1)(2010-10#2)(2011-2#8)
Bt-maize##4##1##(2011-2#4)
Bu(4)NOH (MeOH)##2##2##(2008-10#2)
BuChE##5##1##(1992-12#3)(2008-10#2)
BuONa##3##1##(1993-8#3)
Bubble##2##1##(2008-10#1)(2009-11#1)
Bucaramanga##2##1##(2012-12#1)(2013-1#1)
Buccal##5##1##(2007-9#1)(2008-10#2)(2010-5#1)(2013-8#1)
Bucharest##3##1##(2010-4#2)(2012-3#1)
Buchnera aphidicola##2##2##(1996-12#2)
Buchnera##5##1##(1996-12#2)(2007-12#3)
Bud##3##1##(2008-10#1)(2009-8#2)
Budding##2##1##(2008-10#2)
Buddleja##2##1##(2012-3#1)(2012-8#1)
Budgam##2##1##(2013-8#2)
Budget##19##1##(1991-12#2)(1991-3#2)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#4)(2008-7#2)
Bueno##2##1##(2013-8#2)
Buenos Aires##12##2##(2008-5#3)(2009-10#5)(2009-7#3)(2013-7#1)
Buenos##14##1##(2008-5#3)(2009-10#5)(2009-7#4)(2013-7#1)(2013-8#1)
Buerger disease and##2##3##(1997-8#2)
Buerger disease##9##2##(1997-8#9)
Buerger's disease in##3##3##(1996-8#1)(1997-8#1)(2006-10#1)
Buerger's disease##8##2##(1996-8#1)(1997-8#5)(2006-10#1)(2008-10#1)
Buerger's##9##1##(1990-2#1)(1996-8#1)(1997-8#5)(2006-10#1)(2008-10#1)
Bufalin##3##1##(2013-1#3)
Buffalo rats##6##2##(1993-12#5)(2013-7#1)
Buffalo##13##1##(1992-8#1)(1993-12#6)(2008-10#1)(2008-5#1)(2012-3#2)(2013-1#1)(2013-7#1)
Buffer##4##1##(1994-9#1)(2008-10#2)(2008-11#1)
Buffon used##2##2##(2008-12#2)
Buffon was also a##2##4##(2008-12#2)
Buffon was##4##2##(2008-12#4)
Buffon##13##1##(2008-12#13)
Buffon's##5##1##(2008-12#5)
Bufo marinus##2##2##(1993-5#2)
Bufo viridis viridis##2##3##(2008-12#2)
Bufo##5##1##(1993-5#2)(2008-12#2)(2008-5#1)
Bugando Medical##2##2##(2010-8#2)
Build##4##1##(2007-10#1)(2008-7#2)(2012-12#1)
Building a##12##2##(1991-1#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#2)
Building an##5##2##(1992-12#1)(1993-2#1)(1996-1#1)(1997-1#1)(2008-7#1)
Building health##2##2##(1997-1#1)(2012-12#1)
Building on previous##2##3##(2008-7#1)(2010-8#1)
Building on##7##2##(1997-3#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-3#1)
Building the##6##2##(1994-2#1)(1996-1#1)(1996-12#1)(2008-1#1)(2010-8#1)(2012-12#1)
Building##56##1##(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#3)(1997-3#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)
Buildup##2##1##(2008-10#1)(2008-2#1)
Built##2##1##(1997-7#1)(2008-10#1)
Bulgaria##14##1##(2007-5#3)(2008-10#1)(2008-11#1)(2008-8#2)(2009-10#1)(2011-1#1)(2013-1#4)(2013-8#1)
Bulgarian##4##1##(2007-5#1)(2008-9#1)(2009-10#1)(2011-1#1)
Bulimia Nervosa##2##2##(2008-11#1)(2012-2#1)
Bulimia##4##1##(2007-7#1)(2008-11#2)(2012-2#1)
Bulk##3##1##(2008-10#2)(2010-5#1)
Bulked segregant analysis and##2##4##(2008-10#2)
Bulked segregant analysis was used to##2##6##(1995-6#1)(2008-10#1)
Bulked segregant analysis##8##3##(1995-6#1)(2008-10#6)(2008-5#1)
Bulked##9##1##(1995-6#1)(2008-10#7)(2008-5#1)
Bulky##2##1##(1996-5#1)(2008-10#1)
Bull##2##1##(2008-10#1)(2008-5#1)
Bulletin##3##1##(2012-2#1)(2013-1#2)
Bullying and##2##2##(2010-1#1)(2011-1#1)
Bullying##3##1##(2008-4#1)(2010-1#1)(2011-1#1)
Bungarus multicinctus##2##2##(1997-7#2)
Bunyaviridae##4##1##(2008-10#2)(2011-2#1)(2013-8#1)
Bupivacaine##3##1##(1993-1#2)(1995-3#1)
Buprenorphine is##2##2##(2008-11#1)(2008-6#1)
Buprenorphine##7##1##(1991-1#2)(1995-12#1)(2008-11#3)(2008-6#1)
Buprestidae)##3##1##(2007-12#2)(2008-12#1)
Burden of stroke in##3##4##(2008-8#3)
Burden of stroke##4##3##(2008-8#4)
Burden of##6##2##(2008-8#4)(2012-2#1)(2013-8#1)
Burden##11##1##(1991-12#1)(2008-8#4)(2011-2#1)(2011-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
Bureau of Labor Statistics##3##4##(1993-1#1)(1993-12#1)(1994-2#1)
Bureau of Reference (BCR)##2##4##(2008-10#2)
Bureau of Reference##3##3##(2008-10#3)
Bureau of the Census##2##4##(1992-3#1)(1997-2#1)
Bureau of##13##2##(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#5)(2010-8#1)(2012-12#1)
Bureau##20##1##(1992-3#1)(1993-1#1)(1993-12#3)(1994-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#6)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Burgos##2##1##(1995-12#1)(1997-3#1)
Burkholderia cenocepacia##2##2##(2008-10#2)
Burkholderia cepacia AMMDR1##2##3##(2008-10#2)
Burkholderia cepacia##6##2##(2007-12#1)(2008-10#5)
Burkholderia pseudomallei##4##2##(2007-2#1)(2007-7#2)(2008-7#1)
Burkholderia##15##1##(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#9)(2008-7#1)
Burkina Faso##10##2##(1990-6#1)(1996-8#1)(2008-10#1)(2008-12#2)(2009-10#1)(2009-4#1)(2010-6#3)
Burkina##11##1##(1990-6#1)(1996-8#1)(2008-10#1)(2008-12#2)(2009-10#2)(2009-4#1)(2010-6#3)
Burkitt lymphoma cells from apoptosis by##2##6##(1993-9#2)
Burkitt lymphoma##4##2##(1993-9#4)
Burkitt##6##1##(1993-9#4)(2009-8#2)
Burkitt's lymphoma of the jaws##2##5##(2008-1#2)
Burkitt's lymphoma##12##2##(1993-2#3)(1996-8#1)(2008-1#6)(2008-9#1)(2009-2#1)
Burlington##3##1##(1991-2#1)(1995-12#1)(1996-12#1)
Burnout Inventory and##3##3##(1996-2#1)(1997-1#1)(2009-9#1)
Burnout Inventory##7##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-7#1)(2011-2#1)
Burnout Syndrome##4##2##(2013-1#4)
Burnout and##2##2##(1992-1#1)(1996-2#1)
Burnout was measured by the Maslach Burnout Inventory and health care utilization by insurance company records regarding these employees' health care costs and number of times they accessed health care services over a##2##33##(1996-2#1)(1997-1#1)
Burnout##18##1##(1991-2#1)(1992-1#1)(1996-2#3)(1997-1#3)(2008-10#1)(2008-11#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#4)
Burns##2##1##(2008-1#1)(2008-12#1)
Burpee##2##1##(2012-12#2)
Bursaphelenchus xylophilus##4##2##(2008-10#4)
Burst##2##1##(2008-10#1)(2010-8#1)
Buruli ulcer##2##2##(2010-4#2)
Burundi##3##1##(1994-9#3)
Buschke-Löwenstein##2##1##(1991-2#1)(2011-1#1)
Bush signed the Americans##2##4##(1994-1#1)(1996-1#1)
Bush##7##1##(1991-12#1)(1991-8#1)(1994-1#1)(1996-1#1)(1996-2#1)(2010-1#1)(2011-2#1)
Business process reengineering##2##3##(1994-12#2)
Business process##3##2##(1993-3#1)(1994-12#2)
Business##19##1##(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#5)(1994-2#1)(1995-1#1)(1997-2#1)(2008-12#1)(2008-5#1)(2010-7#1)(2013-8#1)
Busto Arsizio##3##2##(1992-10#3)
But Congress##2##2##(1991-1#1)(2008-8#1)
But Not##3##2##(2008-10#1)(2013-7#1)(2013-8#1)
But a##3##2##(2008-7#2)(2013-8#1)
But also the##2##3##(1995-5#1)(2009-12#1)
But as##2##2##(1991-2#1)(1995-3#1)
But at##3##2##(1993-11#1)(2008-7#1)(2010-8#1)
But despite##2##2##(1993-2#1)(2009-10#1)
But for the##2##3##(2008-10#1)(2008-9#1)
But for##6##2##(1996-3#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)
But if##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
But in this##2##3##(1995-2#1)(2013-1#1)
But in##7##2##(1994-8#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
But it is##2##3##(2008-3#1)(2012-2#1)
But its##2##2##(2008-12#1)(2008-8#1)
But most##2##2##(1990-4#1)(1995-2#1)
But on##2##2##(2007-7#1)(2009-5#1)
But the##23##2##(1991-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
But there is##2##3##(2008-3#1)(2011-2#1)
But there##3##2##(1995-3#1)(2008-3#1)(2011-2#1)
But these##4##2##(1990-4#1)(1992-8#1)(1994-2#1)(2010-5#1)
But they##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
But this##6##2##(1990-6#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
But when##2##2##(2008-7#1)(2012-2#1)
But with the##2##3##(2008-10#1)(2009-5#1)
But with##3##2##(1995-3#1)(2008-10#1)(2009-5#1)
But##170##1##(1990-10#1)(1990-11#3)(1990-3#1)(1990-4#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#3)(1997-1#2)(1997-4#1)(1997-7#2)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
Butenafine##2##1##(2007-7#2)
Butorphanol##2##1##(2010-7#2)
Butterfly rash##2##2##(2013-1#2)
Butterfly##3##1##(2012-12#1)(2013-1#2)
Button Personal Inhalable##2##3##(2008-5#2)
Button Samplers##3##2##(2008-5#3)
Button##13##1##(2008-10#2)(2008-5#11)
Butyltin compounds##2##2##(2008-10#1)(2008-11#1)
Butyltin##3##1##(2008-10#2)(2008-11#1)
Butyrate##2##1##(1990-6#1)(2008-11#1)
Butyric acid##2##2##(1993-8#2)
Butyrivibrio fibrisolvens strain 49##2##4##(1995-11#2)
Butyrylcholinesterase##2##1##(1994-6#1)(2012-2#1)
Buy##2##1##(1993-3#1)(1996-2#1)
Buy-In##2##1##(1995-12#1)(2010-12#1)
Bv8##5##1##(2008-7#5)
By 1996##2##2##(1997-6#1)(2008-2#1)
By 2008##2##2##(2011-2#2)
By December##3##2##(1993-8#1)(1994-9#1)(2010-8#1)
By Northern blot analysis##3##4##(1993-11#2)(1994-8#1)
By Northern##4##2##(1991-6#1)(1993-11#2)(1994-8#1)
By a##5##2##(2007-1#1)(2008-10#2)(2012-2#1)(2012-3#1)
By adapting##2##2##(1995-12#1)(1997-3#1)
By adding##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
By adjusting the##5##3##(1996-2#1)(2007-11#1)(2008-2#1)(2008-7#2)
By all##2##2##(1992-2#1)(2007-9#1)
By allowing##2##2##(2008-10#2)
By altering##2##2##(2008-4#1)(2013-1#1)
By analogy to##2##3##(1995-6#1)(2008-3#1)
By analogy##4##2##(1991-11#1)(1995-6#1)(1996-5#1)(2008-3#1)
By analysing the##2##3##(1990-6#1)(1996-9#1)
By analysing##3##2##(1990-6#1)(1996-9#1)(2013-1#1)
By analysis of the##3##4##(1997-4#1)(2007-11#1)(2008-2#1)
By analysis of##4##3##(1997-3#1)(1997-4#1)(2007-11#1)(2008-2#1)
By analyzing the##7##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)
By analyzing##9##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)
By application of##2##3##(2007-11#1)(2008-1#1)
By applying an external magnetic field to the##2##8##(2008-3#2)
By applying an##3##3##(2008-3#2)(2008-6#1)
By applying multivariate##2##3##(2008-8#1)(2013-8#1)
By applying the##4##3##(2008-10#4)
By applying##15##2##(1995-12#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-8#1)(2013-8#1)
By assembling##2##2##(2008-9#2)
By assuming##2##2##(1995-5#1)(2008-10#1)
By careful##3##2##(2008-3#2)(2008-4#1)
By changing the##10##3##(1995-3#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#1)
By changing##11##2##(1994-5#1)(1995-3#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#1)
By choosing##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2009-2#1)
By collecting##3##2##(2007-12#1)(2008-11#1)(2008-6#1)
By combination of##4##3##(1991-5#1)(2007-12#2)(2008-8#1)
By combination##5##2##(1991-5#1)(2007-12#2)(2008-10#1)(2008-8#1)
By combining a##2##3##(2007-12#1)(2008-10#1)
By combining the##2##3##(2008-10#1)(2008-4#1)
By combining##14##2##(1990-3#1)(1990-7#1)(1994-2#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#1)(2013-1#1)
By comparing the results##2##4##(2007-11#1)(2007-12#1)
By comparing the##15##3##(1990-12#1)(1990-7#2)(1991-5#1)(1991-9#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#2)
By comparing this expression profile with##2##6##(1996-10#1)(1996-2#1)
By comparing##26##2##(1990-12#1)(1990-7#2)(1991-3#1)(1991-5#1)(1991-9#1)(1994-3#1)(1996-10#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2013-1#1)
By comparison of the##4##4##(1994-12#1)(1995-6#1)(1996-2#1)(1996-8#1)
By comparison of##6##3##(1994-11#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-8#1)(2007-12#1)
By comparison with##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
By comparison##19##2##(1990-6#1)(1994-11#1)(1994-12#1)(1995-6#2)(1996-2#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-8#1)(2010-8#1)
By confocal##2##2##(1992-11#1)(2008-5#1)
By considering##2##2##(2007-8#1)(2012-2#1)
By continuously##3##2##(2007-11#1)(2007-12#2)
By contrast to##3##3##(1990-5#1)(2008-5#1)(2013-1#1)
By contrast##93##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-8#2)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#2)(2010-1#1)(2010-11#3)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)
By controlling the##7##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)
By correlating the##2##3##(2010-12#1)(2010-5#1)
By correlating##3##2##(2007-11#1)(2010-12#1)(2010-5#1)
By coupling##2##2##(2008-10#1)(2008-5#1)
By day##4##2##(2006-6#1)(2007-12#1)(2009-6#1)(2011-2#1)
By developing a##2##3##(1995-12#1)(2010-12#1)
By developing##4##2##(1992-3#1)(1995-12#1)(2010-12#2)
By dividing##3##2##(1992-9#1)(2008-2#1)(2008-8#1)
By doing so##2##3##(2008-2#1)(2008-5#1)
By doing this##3##3##(1992-12#1)(2008-1#1)(2008-3#1)
By doing##5##2##(1992-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
By employing##4##2##(1994-3#1)(2007-7#1)(2008-10#2)
By examining the##2##3##(1991-2#1)(2008-1#1)
By examining##3##2##(1991-2#1)(2008-1#1)(2008-9#1)
By exploiting the##4##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
By exploiting##6##2##(1990-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)
By fitting the##2##3##(2008-2#1)(2008-5#1)
By fitting##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
By focusing##2##2##(1994-3#1)(2007-11#1)
By following##3##2##(1994-1#1)(2006-5#1)(2008-10#1)
By frequency##2##2##(2008-2#1)(2008-3#1)
By further##2##2##(2007-12#1)(2008-3#1)
By gel filtration##2##3##(1993-3#1)(1994-6#1)
By helping##2##2##(1993-1#1)(1993-2#1)
By identifying##4##2##(1993-12#1)(1993-3#1)(1996-2#1)(2008-1#1)
By immunofluorescence##2##2##(2008-8#1)(2012-12#1)
By in##2##2##(1996-12#1)(2007-10#1)
By incorporating##2##2##(2008-10#1)(2008-8#1)
By increasing the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
By increasing##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
By inserting##2##2##(2007-11#1)(2008-10#1)
By integrating the##2##3##(2008-3#1)(2008-6#1)
By integrating##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
By introduction of##2##3##(2007-12#1)(2008-2#1)
By linking##2##2##(2008-8#1)(2012-2#1)
By loading##2##2##(2008-10#2)
By looking##2##2##(1994-12#1)(2009-6#1)
By making use of##2##4##(2008-10#1)(2009-9#1)
By manipulating##2##2##(2008-10#1)(2011-1#1)
By mapping##4##2##(2008-10#2)(2008-5#1)(2010-3#1)
By matching##2##2##(2008-3#2)
By means of a##6##4##(1990-8#1)(1991-12#1)(1992-9#1)(2007-11#1)(2008-10#1)(2009-8#1)
By means of the##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
By means of this##3##4##(1994-6#1)(2008-10#2)
By means of##29##3##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)
By means##31##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)
By measurement of the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
By measurement of##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
By measuring the##4##3##(2007-12#1)(2008-10#3)
By measuring##8##2##(1997-1#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)
By modification of the##2##4##(2008-11#1)(2008-2#1)
By monitoring the change in absorbance of the oxidation product of##2##11##(2008-10#2)
By monitoring the##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
By monitoring##9##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
By multivariate analysis##2##3##(1995-4#1)(2012-12#1)
By multivariate##3##2##(1995-4#1)(2008-10#1)(2012-12#1)
By observing the##2##3##(1990-8#1)(2008-10#1)
By observing##3##2##(1990-8#1)(2008-10#2)
By optimizing the##2##3##(2008-10#1)(2009-6#1)
By optimizing##3##2##(2008-10#1)(2009-6#1)(2011-1#1)
By performing##2##2##(2008-2#1)(2008-3#1)
By placing##2##2##(2008-10#1)(2008-2#1)
By presenting##3##2##(2008-11#2)(2008-3#1)
By proper selection of the##2##5##(2008-3#2)
By providing##7##2##(1993-12#1)(2007-12#2)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
By putting the##2##3##(1997-3#1)(2008-2#1)
By reaction##2##2##(1996-2#1)(2008-10#1)
By reducing the##3##3##(1996-6#1)(2007-12#1)(2008-8#1)
By reducing##4##2##(1996-6#1)(2007-12#1)(2007-8#1)(2008-8#1)
By reviewing##2##2##(2008-12#1)(2010-5#1)
By screening##3##2##(1995-5#1)(2008-10#1)(2010-2#1)
By simple##2##2##(1992-11#1)(2008-10#1)
By simulation##2##2##(2008-2#1)(2008-3#1)
By solving##2##2##(2008-2#2)
By strategically##2##2##(1997-3#1)(2008-6#1)
By studying the##5##3##(1996-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
By studying##8##2##(1991-6#1)(1993-11#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
By subtracting##2##2##(1992-3#1)(2008-3#1)
By taking into account the##3##5##(2008-2#1)(2008-3#2)
By taking##6##2##(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#3)
By testing##2##2##(2008-10#1)(2008-11#1)
By the developed##2##3##(2008-10#1)(2013-1#1)
By the end of the##5##5##(1994-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)
By the end of##7##4##(1994-9#1)(1995-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
By the present method##2##4##(2008-10#2)
By the use of##5##4##(1990-5#1)(1990-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
By the way##4##3##(2008-10#1)(2010-9#3)
By the##45##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#1)(1993-3#2)(1994-9#1)(1995-11#2)(1995-2#1)(1996-1#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#3)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
By this method##3##3##(2008-2#1)(2008-5#1)(2008-8#1)
By this technique##3##3##(1991-11#1)(2008-10#2)
By this##11##2##(1990-5#1)(1991-11#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
By treatment with##2##3##(1991-12#1)(2008-10#1)
By tuning the##2##3##(2006-4#1)(2007-11#1)
By use of CRD##2##4##(2008-2#2)
By use of a##15##4##(1991-9#1)(1993-12#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#7)
By use of the##13##4##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)(2008-7#1)
By use of these relations##2##5##(2008-3#2)
By use of these##3##4##(2008-3#3)
By use of this##3##4##(2008-3#3)
By use of##56##3##(1990-12#1)(1990-7#1)(1991-9#1)(1993-12#1)(2007-11#7)(2007-12#8)(2008-10#2)(2008-2#9)(2008-3#25)(2008-7#1)
By using PCR##2##3##(1994-9#1)(2008-8#1)
By using a##21##3##(1991-5#1)(1994-2#1)(1994-9#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#1)
By using multivariate calibration methods##2##5##(2008-10#2)
By using the recommended procedure##2##5##(2008-10#2)
By using the##25##3##(1992-10#1)(1993-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#2)(2010-6#1)(2010-8#1)(2011-1#1)
By using these##5##3##(1990-5#1)(2008-2#1)(2008-3#1)(2008-9#2)
By using this##8##3##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
By using two##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
By using##119##2##(1990-5#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#12)(2008-5#1)(2008-7#3)(2008-8#10)(2008-9#9)(2009-10#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
By utilizing the##2##3##(2008-10#1)(2008-8#1)
By utilizing##5##2##(1992-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
By varying the##9##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)
By varying##11##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#2)(2009-11#1)(2009-6#1)(2009-8#1)
By##990##1##(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#8)(1990-8#3)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#5)(1991-4#1)(1991-5#7)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#6)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#6)(1992-6#6)(1992-8#3)(1992-9#8)(1993-1#2)(1993-11#5)(1993-12#9)(1993-2#2)(1993-3#5)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#5)(1994-8#8)(1994-9#6)(1995-1#1)(1995-11#5)(1995-12#5)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#9)(1995-9#4)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#7)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#8)(1997-4#8)(1997-6#3)(1997-7#5)(1997-8#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#35)(2007-12#57)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#153)(2008-11#38)(2008-12#5)(2008-2#51)(2008-3#96)(2008-4#8)(2008-5#26)(2008-6#7)(2008-7#26)(2008-8#32)(2008-9#29)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#7)(2011-2#11)(2012-12#5)(2012-2#13)(2012-3#11)(2013-1#14)(2013-8#5)
ByT-FAS instrumentation##3##2##(2008-10#3)
ByT-FAS system##2##2##(2008-10#2)
ByT-FAS##12##1##(2008-10#12)
Bydgoszcz##3##1##(2007-11#1)(2007-8#1)(2008-9#1)
Byham and##2##2##(1995-1#2)
Byocerulin##2##1##(2011-1#2)
Bypass Surgery##2##2##(2010-8#1)(2012-3#1)
Bypass trapped flow analysis system (ByT-FAS)##2##6##(2008-10#2)
Bypass##7##1##(2008-10#2)(2010-8#2)(2012-1#2)(2012-3#1)
Byrd##2##1##(1991-12#2)
Byssochlamys and##2##2##(2010-3#2)
Byssochlamys##5##1##(2010-3#5)
Bystander effects##3##2##(2008-7#3)
Bystander##4##1##(2008-7#3)(2011-2#1)
BzATP##7##1##(1993-8#1)(2008-4#6)
BzATP-induced##2##1##(2008-4#2)
C &lt##2##2##(2008-3#2)
C (0##2##2##(2007-11#1)(2008-4#1)
C (MC)##3##2##(1992-3#1)(1993-11#1)(1995-2#1)
C (MMC)##4##2##(1992-12#1)(1997-7#1)(2008-11#2)
C (PKC)##52##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-8#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#2)(2013-8#2)
C (PLC)##3##2##(1991-2#1)(1997-4#1)(2011-2#1)
C (VitC)##2##2##(1997-4#1)(2008-5#1)
C (max)##3##2##(2011-2#3)
C -points##3##2##(2007-11#3)
C = O stretching##2##4##(1990-2#1)(1994-3#1)
C = O##7##3##(1990-2#2)(1992-6#1)(1994-3#3)(1995-5#1)
C =##12##2##(1990-2#2)(1992-6#2)(1993-8#1)(1994-12#1)(1994-3#3)(1995-5#1)(2008-10#1)(2008-3#1)
C a##2##2##(2008-2#1)(2008-7#1)
C activation and##2##3##(1995-11#1)(2008-8#1)
C activation in##4##3##(1990-11#1)(1995-11#1)(1997-2#1)(2008-11#1)
C activation##24##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-6#3)(1992-8#1)(1993-3#2)(1994-11#1)(1994-3#1)(1995-11#2)(1995-2#2)(1995-8#2)(1997-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#2)
C activity in##6##3##(1990-11#1)(1990-8#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-11#1)
C activity##20##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#2)(1992-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1997-6#1)(2008-11#1)(2008-3#1)
C administration##5##2##(1996-12#1)(1997-3#1)(2011-1#3)
C after##7##2##(1995-3#1)(2008-10#5)(2013-8#1)
C allele##3##2##(2011-1#3)
C alpha is##2##3##(1993-6#1)(1994-8#1)
C alpha##9##2##(1993-6#4)(1994-5#2)(1994-8#2)(1995-11#1)
C also##4##2##(1991-2#1)(1991-8#1)(1993-8#1)(2008-4#1)
C and 22##2##3##(1996-5#1)(2006-8#1)
C and B##2##3##(2011-2#1)(2013-8#1)
C and D##12##3##(1991-5#2)(1993-11#2)(1993-2#1)(2008-10#1)(2008-12#1)(2008-6#3)(2011-2#1)(2013-1#1)
C and E supplementation##2##4##(2008-5#2)
C and E##12##3##(1992-9#2)(1996-5#1)(2007-7#1)(2008-10#2)(2008-5#3)(2010-11#1)(2011-2#2)
C and S##2##3##(1992-6#1)(2008-1#1)
C and a##10##3##(1994-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
C and between##2##3##(2008-6#1)(2008-7#1)
C and in##6##3##(2008-10#4)(2008-11#1)(2010-12#1)
C and its##2##3##(1994-5#1)(2008-5#1)
C and one##2##3##(1992-8#1)(2009-3#1)
C and protein kinase##5##4##(1995-6#1)(2008-11#3)(2008-3#1)
C and serum##2##3##(2009-8#1)(2010-7#1)
C and the##12##3##(1991-2#1)(1992-3#1)(1992-6#2)(1997-2#1)(2008-10#4)(2008-11#1)(2011-1#1)(2011-2#1)
C and##289##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-2#1)(1991-5#4)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#5)(1992-8#1)(1992-9#4)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#3)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#2)(2006-8#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#101)(2008-11#16)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#14)(2008-6#13)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#6)
C appears to##2##3##(1992-8#1)(2013-7#1)
C appears##3##2##(1992-8#1)(1992-9#1)(2013-7#1)
C are##10##2##(1992-6#1)(1993-8#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)
C as well as##2##4##(1992-9#1)(1997-6#1)
C as##7##2##(1990-5#1)(1992-9#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
C at the time##2##4##(2008-10#1)(2012-3#1)
C at the##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
C at##29##2##(1990-11#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-11#1)(1996-12#2)(1997-2#2)(2007-12#1)(2008-10#10)(2008-12#4)(2008-2#1)(2008-3#3)(2012-3#1)
C base##3##2##(1993-1#2)(1993-11#1)
C before##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
C botulinum type##2##3##(2007-12#2)
C botulinum##3##2##(2007-12#3)
C burnetii##2##2##(2007-12#1)(2008-4#1)
C but##14##2##(1991-2#3)(1992-6#1)(1992-9#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-9#1)
C by the##2##3##(1992-9#1)(2009-5#1)
C by##18##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-9#1)(1993-8#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-5#1)
C can##3##2##(1992-9#2)(1993-8#1)
C cell##3##2##(1990-2#1)(1992-6#1)(2012-1#1)
C concentration##6##2##(2008-10#2)(2010-4#4)
C conjugate vaccine##4##3##(2010-10#4)
C deficiency##6##2##(1991-8#1)(2008-12#4)(2013-1#1)
C derivatives##2##2##(2008-5#2)
C difficile toxin##2##3##(2007-12#2)
C difficile toxins A##2##4##(2007-12#2)
C difficile toxins##3##3##(2007-12#3)
C difficile##6##2##(2007-12#6)
C displays##2##2##(1993-11#1)(1994-5#1)
C fiber##2##2##(1990-7#1)(2009-12#1)
C for the##5##3##(1992-8#2)(2007-12#1)(2008-10#2)
C for##162##2##(1990-12#3)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-8#1)(1994-5#2)(1994-8#3)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#4)(1997-4#1)(2006-11#2)(2007-10#1)(2007-11#4)(2007-12#3)(2008-10#73)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-2#3)(2010-3#1)(2010-4#4)(2011-1#3)(2011-2#2)(2013-8#1)
C from the##2##3##(1993-8#1)(2008-10#1)
C from##5##2##(1992-6#1)(1993-8#1)(2008-10#3)
C gave##4##2##(1996-5#1)(2008-10#1)(2010-2#2)
C genes##2##2##(1997-4#1)(2008-8#1)
C glabrata##2##2##(2008-10#2)
C had a##2##3##(2008-10#1)(2008-6#1)
C had##8##2##(1995-6#2)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)
C has been##4##3##(1991-5#1)(2008-10#1)(2008-6#1)(2010-4#1)
C has##5##2##(1991-5#1)(1995-6#1)(2008-10#1)(2008-6#1)(2010-4#1)
C have been##3##3##(1990-11#1)(2008-10#1)(2008-3#1)
C in a##8##3##(1991-9#1)(1993-11#1)(2008-10#4)(2008-2#1)(2008-6#1)
C in both##2##3##(2008-11#1)(2010-4#1)
C in comparison##2##3##(2008-4#1)(2010-7#1)
C in dialysis##3##3##(2007-7#2)(2010-3#1)
C in the presence of##2##5##(1994-11#1)(1995-11#1)
C in the presence##3##4##(1990-5#1)(1994-11#1)(1995-11#1)
C in the##29##3##(1990-5#1)(1990-7#2)(1992-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2010-4#1)(2013-8#1)
C in vitro##2##3##(1991-9#1)(1997-6#1)
C in##97##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#4)(2010-7#1)(2011-2#1)(2013-8#1)
C infection##6##2##(1992-12#1)(2007-7#1)(2010-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
C infections##3##2##(2008-1#1)(2009-4#1)(2010-10#1)
C inhibitor##9##2##(1990-2#1)(1990-8#1)(1994-11#3)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)
C is a##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
C is not##2##3##(1992-8#1)(1995-2#1)
C is##32##2##(1990-8#1)(1991-3#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
C isolates##2##2##(2008-5#2)
C level in the##2##4##(1992-9#1)(2011-1#1)
C level##3##2##(1992-9#1)(2011-1#2)
C levels and Ts##2##4##(2008-9#2)
C levels in##5##3##(2011-1#5)
C levels##13##2##(1992-9#1)(2008-9#6)(2011-1#6)
C may##3##2##(2007-1#1)(2008-10#1)(2012-1#1)
C of 0##2##3##(2008-10#2)
C of##8##2##(1995-2#1)(1997-4#1)(2008-10#3)(2012-12#1)(2012-3#1)(2012-9#1)
C on##12##2##(1990-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(2006-10#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)
C only##2##2##(1990-11#1)(1992-12#1)
C or##22##2##(1990-12#1)(1992-9#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)
C over 24##2##3##(2008-10#1)(2008-8#1)
C over##5##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
C patients##6##2##(1991-9#1)(2009-8#1)(2012-12#3)(2013-7#1)
C plays a##2##3##(1990-12#1)(1993-6#1)
C points and daisy modes##2##5##(2007-11#2)
C points##4##2##(2007-11#4)
C production process with##2##4##(2008-6#2)
C production##5##2##(2008-6#5)
C protein##4##2##(1997-4#3)(2008-10#1)
C reactive protein##3##3##(2008-3#2)(2013-1#1)
C reduced##2##2##(1994-9#1)(2012-2#1)
C regions##2##2##(1992-10#1)(2008-4#1)
C resistance##2##2##(1993-9#1)(1997-3#1)
C resulted in an increase in##2##6##(1990-11#1)(2013-8#1)
C resulted in##5##3##(1990-11#1)(1995-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
C showed##4##2##(1992-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
C source##3##2##(2008-10#1)(2008-6#2)
C status##3##2##(1992-9#2)(2008-7#1)
C tablets##4##2##(2008-10#4)
C terminal##4##2##(2008-6#1)(2008-8#1)(2008-9#2)
C terminus of the catalytic subunit##2##6##(1995-2#2)
C terminus of the##8##4##(1991-6#1)(1994-12#3)(1994-8#1)(1995-2#2)(1995-6#1)
C terminus of##11##3##(1991-6#1)(1994-12#4)(1994-8#2)(1995-2#3)(1995-6#1)
C terminus##19##2##(1991-6#2)(1993-6#1)(1994-12#6)(1994-8#2)(1995-2#4)(1995-3#1)(1995-6#2)(1997-4#1)
C than##8##2##(1990-2#1)(1991-5#1)(1994-3#1)(1995-12#1)(2008-10#2)(2010-8#2)
C that##2##2##(1992-12#1)(2008-5#1)
C the##10##2##(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-4#1)
C to##16##2##(1991-12#1)(1994-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
C transition at##2##3##(1994-11#1)(2008-12#1)
C transition##4##2##(1992-8#1)(1993-6#1)(1994-11#1)(2008-12#1)
C treatment##3##2##(1996-5#1)(2008-10#1)(2009-7#1)
C under##11##2##(1991-2#1)(1992-9#1)(1994-8#1)(2007-12#1)(2008-10#5)(2008-11#2)
C underwent##2##2##(2010-7#1)(2013-1#1)
C virus (HCV) and##3##4##(2007-7#1)(2008-1#1)(2008-10#1)
C virus (HCV) infection##9##4##(2006-10#1)(2007-7#2)(2008-1#1)(2009-8#1)(2012-2#1)(2013-1#3)
C virus (HCV) is##3##4##(2007-7#1)(2008-10#1)(2012-1#1)
C virus (HCV)##32##3##(1990-3#1)(1994-8#1)(2006-10#1)(2007-7#5)(2008-1#3)(2008-10#2)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
C virus and##3##3##(1991-2#1)(2007-7#1)(2013-1#1)
C virus antibodies in##3##4##(1990-3#1)(1994-7#2)
C virus antibodies##4##3##(1990-3#1)(1994-7#3)
C virus infection##18##3##(2006-10#4)(2008-1#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
C virus##99##2##(1990-3#3)(1991-11#1)(1991-2#3)(1992-12#1)(1993-5#1)(1994-11#2)(1994-6#1)(1994-7#5)(1994-8#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#8)(2007-12#1)(2007-7#10)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#10)(2013-8#5)
C was activated by##2##4##(1990-11#1)(2008-11#1)
C was administered##2##3##(2010-7#1)(2011-1#1)
C was also##2##3##(2008-10#1)(2008-11#1)
C was found to##2##4##(1990-11#1)(2008-10#1)
C was found##3##3##(1990-11#1)(2008-10#2)
C was significantly##3##3##(2008-4#1)(2010-4#1)(2010-7#1)
C was##44##2##(1990-11#2)(1990-5#1)(1993-6#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#2)
C water##2##2##(1996-2#1)(2008-8#1)
C were##32##2##(1990-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#2)(1993-8#1)(1996-4#1)(1997-6#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2012-1#1)(2013-1#1)
C whereas##2##2##(1990-8#1)(2008-12#1)
C which##5##2##(1990-12#1)(1993-3#1)(2007-7#1)(2008-11#1)(2011-1#1)
C while##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
C with a##8##3##(1993-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-5#1)
C with##33##2##(1990-8#1)(1992-9#1)(1993-8#1)(1994-3#3)(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-3#1)
C yr(-2) for##2##3##(2012-2#2)
C##3837##1##(1990-10#2)(1990-11#28)(1990-12#15)(1990-2#22)(1990-3#5)(1990-5#26)(1990-6#8)(1990-7#12)(1990-8#21)(1990-9#2)(1991-11#2)(1991-12#13)(1991-2#19)(1991-3#1)(1991-5#17)(1991-6#5)(1991-7#1)(1991-8#26)(1991-9#14)(1992-1#2)(1992-10#1)(1992-11#12)(1992-12#19)(1992-2#1)(1992-3#26)(1992-4#1)(1992-5#2)(1992-6#33)(1992-7#3)(1992-8#23)(1992-9#45)(1993-1#3)(1993-11#26)(1993-12#11)(1993-2#3)(1993-3#17)(1993-5#1)(1993-6#20)(1993-8#39)(1993-9#16)(1994-1#3)(1994-11#35)(1994-12#26)(1994-2#1)(1994-3#29)(1994-5#22)(1994-6#8)(1994-7#6)(1994-8#23)(1994-9#3)(1995-11#18)(1995-12#14)(1995-2#39)(1995-3#9)(1995-5#30)(1995-6#27)(1995-8#19)(1996-1#2)(1996-12#19)(1996-2#17)(1996-3#4)(1996-4#2)(1996-5#25)(1996-6#12)(1996-9#4)(1997-1#9)(1997-2#36)(1997-3#8)(1997-4#21)(1997-5#2)(1997-6#13)(1997-7#18)(1997-8#10)(2006-10#13)(2006-11#2)(2006-8#1)(2007-1#1)(2007-10#9)(2007-11#43)(2007-12#70)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#3)(2007-7#20)(2007-8#2)(2008-1#22)(2008-10#1331)(2008-11#112)(2008-12#72)(2008-2#46)(2008-3#67)(2008-4#32)(2008-5#149)(2008-6#86)(2008-7#34)(2008-8#62)(2008-9#29)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#7)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#10)(2009-8#13)(2009-9#10)(2010-1#4)(2010-10#11)(2010-11#4)(2010-12#10)(2010-2#20)(2010-3#18)(2010-4#34)(2010-5#8)(2010-6#8)(2010-7#8)(2010-8#13)(2011-1#51)(2011-2#94)(2011-3#1)(2012-1#13)(2012-12#12)(2012-2#30)(2012-3#26)(2012-6#8)(2012-8#1)(2012-9#2)(2013-1#76)(2013-7#16)(2013-8#43)
C&quot##4##1##(1994-2#1)(2008-1#2)(2008-8#1)
C's##4##1##(1991-8#1)(1994-5#2)(2009-5#1)
C(10)##2##1##(2008-10#2)
C(10)H(8)##2##1##(2009-11#2)
C(11)##2##1##(1990-7#1)(2008-10#1)
C(12)##4##1##(1990-7#2)(2007-12#1)(2008-10#1)
C(13)##4##1##(1990-7#3)(2008-10#1)
C(14)##2##1##(1990-7#1)(2008-10#1)
C(16)##2##1##(1990-7#1)(2008-10#1)
C(16)-MCM-41##3##1##(2008-10#3)
C(17)##3##1##(1990-7#3)
C(17)PC##4##1##(1990-7#4)
C(18) SPE##2##2##(2008-10#2)
C(18) analytical column##2##3##(2008-10#2)
C(18) and##5##2##(2008-10#4)(2009-8#1)
C(18) bonded silica##2##3##(2008-10#2)
C(18) bonded##4##2##(2008-10#4)
C(18) cartridge and##2##3##(2008-10#2)
C(18) cartridge was##2##3##(2008-10#2)
C(18) cartridge##5##2##(2008-10#5)
C(18) column and##6##3##(2008-10#4)(2010-5#1)(2012-2#1)
C(18) column with##4##3##(2008-10#4)
C(18) column##23##2##(2008-10#19)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
C(18) disk##4##2##(2008-10#4)
C(18) material##2##2##(2008-10#2)
C(18) phase##3##2##(2008-10#3)
C(18) precolumn##3##2##(2008-10#3)
C(18) silica gel##2##3##(2008-10#2)
C(18)##83##1##(1990-7#1)(2008-10#76)(2008-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
C(18)-bonded silica##2##2##(2008-10#2)
C(18)-bonded##3##1##(2008-10#3)
C(18)PC##2##1##(1990-7#2)
C(19)PC##3##1##(1990-7#3)
C(2)##2##1##(1996-2#1)(1996-5#1)
C(2)H(2)##3##1##(2008-10#2)(2010-2#1)
C(2)H(5)OH##3##1##(2008-10#3)
C(3)##2##1##(2008-8#1)(2008-9#1)
C(36)-T(54) and##2##2##(2008-8#2)
C(4##3##1##(2008-5#3)
C(4) pathway enzymes in##2##4##(2008-9#2)
C(4) pathway##4##2##(2008-9#4)
C(4)##10##1##(1990-7#1)(1992-11#2)(2008-11#1)(2008-9#5)(2009-10#1)
C(6)H(5)OM (M =##2##3##(1997-7#2)
C(60) and C(70)##2##3##(2008-10#1)(2008-8#1)
C(60) and##5##2##(2008-10#3)(2008-2#1)(2008-8#1)
C(60) in##2##2##(2008-12#1)(2008-2#1)
C(60)##22##1##(1991-5#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-5#3)(2008-8#3)(2009-10#2)(2009-2#1)(2012-1#1)
C(60)(OH)(24)##3##1##(2008-8#3)
C(60)-SIMS##5##1##(2012-12#5)
C(60)-[dimethyl-(beta-cyclodextrin)](2)##2##1##(2008-10#2)
C(60)-gamma-cyclodextrin and Nafion chemically modified electrode##2##6##(2008-10#2)
C(60)-modified glassy carbon##2##3##(2008-10#2)
C(70)##6##1##(2008-10#3)(2008-2#1)(2008-8#2)
C(8) column##3##2##(2008-10#3)
C(8)##8##1##(1990-7#1)(2008-10#6)(2008-8#1)
C(DON)##4##1##(2008-10#4)
C(H(2)SO(4)##4##1##(2008-10#4)
C(IND) and C(DON)##2##3##(2008-10#2)
C(IND) and##3##2##(2008-10#3)
C(IND)##5##1##(2008-10#5)
C(L)##2##1##(2008-10#2)
C(S)##2##1##(2008-10#2)
C(T)##2##1##(2008-10#1)(2008-12#1)
C(X + 6)PC##2##3##(1990-7#2)
C(X +##4##2##(1990-7#4)
C(X)##4##1##(1990-7#4)
C(f) = 2##2##3##(2008-6#2)
C(f) =##3##2##(2008-6#3)
C(max)##3##1##(2008-10#1)(2008-12#1)(2011-1#1)
C(n)(2)##3##1##(2008-2#2)(2008-3#1)
C(n)E(m) surfactants##3##2##(2008-10#3)
C(n)E(m)##6##1##(2008-10#6)
C(s)##3##1##(1990-12#1)(1996-2#1)(2008-10#1)
C(up)##2##1##(2008-3#2)
C) and##32##2##(1990-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-2#2)(2008-10#12)(2008-12#3)(2008-5#4)(2008-7#1)(2009-11#1)(2009-5#1)(2010-8#1)(2013-1#1)
C) as well as##2##4##(1992-9#1)(2008-1#1)
C) at##3##2##(2008-10#2)(2010-2#1)
C) by##3##2##(2008-10#3)
C) has been##3##3##(2008-10#2)(2008-5#1)
C) in##5##2##(1993-8#1)(1997-7#1)(2008-10#2)(2008-4#1)
C) is##4##2##(1992-8#1)(2007-11#2)(2012-2#1)
C) on##2##2##(2008-10#1)(2008-8#1)
C) or##3##2##(2008-10#3)
C) was##5##2##(1991-9#2)(1995-3#1)(2008-10#1)(2008-4#1)
C) were##5##2##(1990-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
C)##227##1##(1990-12#2)(1990-7#2)(1991-2#1)(1991-5#2)(1991-9#3)(1992-11#1)(1992-3#4)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2007-10#4)(2007-11#5)(2007-9#1)(2008-1#1)(2008-10#86)(2008-11#7)(2008-12#12)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#10)(2008-8#5)(2009-10#1)(2009-11#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#3)(2013-7#1)
C*I##8##1##(1992-6#8)
C++##2##1##(2008-10#1)(2009-12#1)
C+1##2##1##(1995-6#2)
C+1/A+72##2##1##(1995-6#2)
C- and##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
C-##5##1##(1991-5#1)(2008-12#1)(2008-7#2)(2013-1#1)
C--&gt##6##1##(1992-11#1)(1994-8#1)(2008-8#4)
C-1 chain##2##2##(1995-3#2)
C-1##3##1##(1995-3#2)(1995-5#1)
C-10##5##1##(1992-3#4)(1994-5#1)
C-105 plants##2##2##(2008-10#2)
C-105##6##1##(2008-10#6)
C-18 and##2##2##(2008-10#1)(2008-5#1)
C-18 column##2##2##(2008-10#2)
C-18##15##1##(2008-10#12)(2008-5#3)
C-2##9##1##(1995-3#1)(1996-5#5)(2007-11#1)(2007-7#1)(2008-5#1)
C-3##4##1##(1993-11#1)(1996-5#2)(2008-11#1)
C-4##12##1##(1992-11#1)(1993-8#3)(1994-11#1)(1996-5#4)(2007-12#1)(2008-10#1)(2009-5#1)
C-4'##2##1##(1991-3#2)
C-5' of the##2##3##(1991-3#2)
C-6 formulation##2##2##(2008-10#2)
C-6##8##1##(1996-5#1)(2008-10#7)
C-8##3##1##(1991-5#1)(2008-10#2)
C-9a##3##1##(1995-5#3)
C-ADR and##3##2##(2012-12#3)
C-ADR compared with ACDF##2##4##(2012-12#2)
C-ADR compared with fusion##2##4##(2012-12#2)
C-ADR compared with##5##3##(2012-12#5)
C-ADR patients##2##2##(2012-12#2)
C-ADR use##2##2##(2012-12#2)
C-ADR with multilevel##3##3##(2012-12#3)
C-ADR with##6##2##(2012-12#6)
C-ADR##41##1##(2012-12#41)
C-C bond formation##2##3##(2009-9#1)(2010-5#1)
C-C bond##4##2##(1996-5#1)(2009-9#1)(2010-5#1)(2010-7#1)
C-C##13##1##(1992-6#1)(1994-11#1)(1996-5#3)(2007-1#2)(2009-9#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#1)
C-C-A-A-G-C-T-T-G-G##2##1##(1993-8#2)
C-Cl##2##1##(1996-5#2)
C-D method##3##2##(2007-11#3)
C-G method##2##2##(2008-7#2)
C-GF##3##1##(2008-5#3)
C-H activation##2##2##(2010-4#1)(2010-5#1)
C-H##7##1##(1997-7#1)(2008-3#1)(2010-10#1)(2010-4#1)(2010-5#3)
C-H2##2##1##(1990-2#2)
C-II deficiency##2##2##(1991-12#1)(1993-12#1)
C-II##4##1##(1991-12#1)(1993-12#3)
C-III##2##1##(1993-12#2)
C-Leg and##2##2##(2013-1#2)
C-Leg##4##1##(2013-1#4)
C-MEF##2##1##(1993-11#2)
C-N bond cleavage##2##3##(1996-5#1)(2010-4#1)
C-N bond##3##2##(1996-5#1)(1997-7#1)(2010-4#1)
C-N##5##1##(1996-5#1)(1997-7#2)(2008-4#1)(2010-4#1)
C-O##4##1##(1992-6#1)(1996-5#1)(2008-9#1)(2010-2#1)
C-RFa##3##1##(2008-6#3)
C-S##4##1##(1992-10#1)(2007-12#3)
C-S-C linkage##2##2##(2010-2#2)
C-arm##2##1##(2011-1#1)(2012-3#1)
C-aryl##2##1##(2008-8#2)
C-banding technique##2##2##(2008-12#1)(2008-5#1)
C-banding##17##1##(2008-12#7)(2008-4#1)(2008-5#9)
C-blocks##2##1##(2008-12#2)
C-cells##6##1##(1990-2#1)(1995-11#5)
C-erbB-2##3##1##(1990-9#1)(1993-1#1)(1994-7#1)
C-fiber##4##1##(1992-3#1)(1992-6#1)(1997-3#2)
C-fibre reflex##3##2##(1995-12#3)
C-fibre##4##1##(1995-12#3)(2008-7#1)
C-heterochromatin##3##1##(2008-12#3)
C-jun##2##1##(2008-11#1)(2008-4#1)
C-kinase##4##1##(1990-10#2)(1990-12#2)
C-less##2##1##(1993-11#2)
C-linked##3##1##(1992-5#2)(2008-9#1)
C-methylation##2##1##(2007-11#2)
C-nitroso compounds##3##2##(1993-11#2)(2008-10#1)
C-peptide in##3##2##(1990-11#1)(1994-12#1)(2012-3#1)
C-peptide values##5##2##(1994-12#5)
C-peptide##13##1##(1990-11#1)(1994-12#8)(2007-12#1)(2010-12#1)(2010-4#1)(2012-3#1)
C-proteinase enhancer is a##2##4##(1990-11#2)
C-proteinase enhancer##3##2##(1990-11#3)
C-reactive protein (CRP) in##3##4##(2007-10#1)(2007-8#1)(2012-2#1)
C-reactive protein (CRP)##15##3##(1990-12#1)(1994-12#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
C-reactive protein (hs-CRP)##4##3##(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
C-reactive protein in##3##3##(2007-10#1)(2010-4#1)(2013-1#1)
C-reactive protein levels##3##3##(1991-12#1)(2011-2#2)
C-reactive protein##45##2##(1990-12#1)(1991-12#2)(1992-5#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-7#1)(2007-10#2)(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-6#1)(2011-2#5)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#1)
C-ring cleavage##2##2##(2012-2#2)
C-shaped##3##1##(2011-2#2)(2012-12#1)
C-stem##2##1##(2013-1#2)
C-terminal amino acids##2##3##(1991-2#1)(1995-12#1)
C-terminal amino##3##2##(1991-2#1)(1992-6#1)(1995-12#1)
C-terminal binding##2##2##(2009-6#1)(2011-2#1)
C-terminal domain is##2##3##(1992-9#1)(1993-2#1)
C-terminal domain of##3##3##(1993-8#1)(2008-9#1)(2009-7#1)
C-terminal domain##13##2##(1992-9#2)(1993-2#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-4#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
C-terminal domains of the##2##4##(1992-9#1)(2008-10#1)
C-terminal domains of##4##3##(1992-9#1)(1995-2#1)(2008-10#1)(2011-2#1)
C-terminal domains##8##2##(1992-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#2)(2011-2#1)
C-terminal extension region##3##3##(1993-12#3)
C-terminal fragment of##2##3##(1994-5#1)(1995-5#1)
C-terminal fragment##6##2##(1990-12#1)(1991-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-4#1)
C-terminal fusion##3##2##(1996-6#1)(2008-7#2)
C-terminal half of OmpR##2##4##(1995-8#2)
C-terminal half of##7##3##(1990-11#1)(1993-11#1)(1994-5#1)(1995-8#2)(2008-10#1)(2010-5#1)
C-terminal half##8##2##(1990-11#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#2)(2008-10#1)(2010-5#1)
C-terminal hydrophobic##3##2##(1995-5#1)(2008-4#1)(2008-8#1)
C-terminal intracellular##3##2##(1991-12#1)(1992-9#2)
C-terminal motif##2##2##(1993-9#1)(2008-8#1)
C-terminal part##5##2##(1990-5#1)(1993-11#1)(1996-12#1)(1997-7#1)(2008-10#1)
C-terminal peptide##5##2##(1995-2#1)(2008-5#2)(2008-6#1)(2011-2#1)
C-terminal portion of the##3##4##(1993-2#1)(1994-8#1)(1996-5#1)
C-terminal portion of##4##3##(1990-12#1)(1993-2#1)(1994-8#1)(1996-5#1)
C-terminal propeptide of type I collagen##2##6##(1997-1#2)
C-terminal propeptide##4##2##(1997-1#2)(2008-7#1)(2009-10#1)
C-terminal region (residues##2##3##(1990-7#1)(1993-8#1)
C-terminal region of##8##3##(1992-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1997-7#1)(2008-4#1)(2012-12#1)(2012-2#1)
C-terminal region##23##2##(1990-7#1)(1992-6#1)(1993-8#3)(1994-12#3)(1994-5#2)(1995-2#1)(1997-2#4)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#1)(2009-10#1)(2012-12#1)(2012-2#1)
C-terminal regions of the##2##4##(1993-8#1)(2013-1#1)
C-terminal regions##3##2##(1991-10#1)(1993-8#1)(2013-1#1)
C-terminal residue##2##2##(1993-6#1)(1994-5#1)
C-terminal residues##2##2##(1992-12#1)(1993-3#1)
C-terminal sequence of##4##3##(1991-2#1)(1994-11#1)(1995-12#1)(2008-4#1)
C-terminal sequence##9##2##(1991-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-12#1)(2008-4#3)
C-terminal sequences##2##2##(1991-2#1)(1991-5#1)
C-terminal splice variant##2##3##(2008-8#2)
C-terminal third of##2##3##(1991-2#1)(1994-2#1)
C-terminal truncation of##2##3##(1995-11#1)(2008-6#1)
C-terminal truncation##5##2##(1993-3#1)(1995-11#1)(2008-11#1)(2008-6#2)
C-terminal##222##1##(1990-11#1)(1990-12#6)(1990-2#1)(1990-5#1)(1990-7#4)(1991-10#1)(1991-12#2)(1991-2#6)(1991-5#4)(1991-6#1)(1991-8#1)(1992-12#2)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#7)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#5)(1993-8#8)(1993-9#2)(1994-11#4)(1994-12#6)(1994-2#1)(1994-5#8)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#3)(1996-12#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#7)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2007-6#1)(2008-10#8)(2008-11#4)(2008-2#3)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#5)(2009-10#3)(2009-6#2)(2009-7#5)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
C-terminally##2##1##(1993-6#1)(1994-2#1)
C-terminals##2##1##(1993-8#2)
C-termini##9##1##(1991-2#1)(1993-3#1)(1994-12#1)(1997-4#1)(2009-7#1)(2010-7#2)(2011-2#1)(2013-8#1)
C-terminus of the##10##3##(1992-3#1)(1992-9#1)(1993-8#1)(1994-12#2)(1995-5#1)(2007-6#2)(2008-10#1)(2012-2#1)
C-terminus of##17##2##(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#3)(1995-5#1)(2007-6#2)(2008-10#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
C-terminus that catalyzes polymerase##2##4##(1997-6#1)(1997-8#1)
C-terminus that##3##2##(1997-6#1)(1997-8#1)(2008-8#1)
C-terminus was##2##2##(1990-7#1)(2011-2#1)
C-terminus##47##1##(1990-12#2)(1990-7#3)(1991-7#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#4)(2008-9#3)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
C-thiophenecalix[4]resorcinarene##2##1##(2008-10#2)
C-type lectins##2##2##(1993-3#1)(2013-7#1)
C-type natriuretic peptide (CNP)##2##4##(1993-11#1)(1994-8#1)
C-type natriuretic peptide##6##3##(1990-7#2)(1993-11#2)(1994-11#1)(1994-8#1)
C-type natriuretic##8##2##(1990-7#3)(1993-11#2)(1994-11#2)(1994-8#1)
C-type##16##1##(1990-7#3)(1992-6#1)(1993-11#2)(1993-3#2)(1994-11#2)(1994-8#1)(1996-2#1)(2010-4#3)(2013-7#1)
C/ Y-&gt##3##2##(2009-11#3)
C/##4##1##(2008-3#1)(2009-11#3)
C/+) and##2##2##(2009-11#2)
C/+)##3##1##(2009-11#3)
C/B##3##1##(1997-7#1)(2008-10#2)
C/C##6##1##(2011-1#3)(2012-12#2)(2013-1#1)
C/EBP alpha##2##2##(1994-12#1)(2012-2#1)
C/EBP binding site##3##3##(1990-5#2)(1993-3#1)
C/EBP##14##1##(1990-5#4)(1993-12#1)(1993-3#3)(1994-12#1)(1997-8#2)(2008-5#2)(2012-2#1)
C/EBPalpha##4##1##(2008-5#1)(2010-4#3)
C/Fe nanocomposite##2##2##(2008-10#2)
C/G##3##1##(2008-10#1)(2011-1#2)
C/N 30##4##2##(2008-10#4)
C/N ratio and heavy##2##4##(2008-12#2)
C/N ratio of##2##3##(2008-12#2)
C/N ratio##7##2##(2008-12#6)(2008-6#1)
C/N##17##1##(2008-10#9)(2008-12#6)(2008-6#1)(2012-9#1)
C0##2##1##(2008-6#2)
C01-A##2##1##(2008-10#2)
C1 and C2 averaged##2##4##(2008-10#2)
C1 and C2##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
C1 and##5##2##(1994-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
C1 column##2##2##(2008-10#2)
C1 esterase inhibitor deficiency##2##4##(1997-5#1)(2013-1#1)
C1 esterase inhibitor##3##3##(1997-5#2)(2013-1#1)
C1 to##2##2##(2008-10#2)
C1##27##1##(1990-8#2)(1991-12#1)(1994-5#1)(1997-5#2)(2008-10#9)(2008-12#2)(2008-7#1)(2012-12#3)(2012-3#1)(2013-1#5)
C1-2##4##1##(2012-3#4)
C1-C2##7##1##(1993-8#2)(2011-2#1)(2012-12#2)(2013-1#2)
C1-THF synthase##5##2##(1992-10#5)
C1-inhibitor##3##1##(2013-1#3)
C10 ester carbonyl of##2##4##(1993-11#2)
C10##4##1##(1990-8#1)(1993-11#3)
C1072##2##1##(1995-6#2)
C11##3##1##(1990-7#1)(1994-5#1)(2008-10#1)
C11-C12##3##1##(1994-3#1)(2009-8#2)
C12##2##1##(1990-7#1)(1995-6#1)
C14##10##1##(1990-7#1)(1992-3#1)(1995-6#8)
C146A##2##1##(1995-2#2)
C16##15##1##(1995-9#2)(2008-11#1)(2008-8#9)(2010-2#1)(2011-1#2)
C162A##2##1##(1995-2#2)
C17##2##1##(2011-1#2)
C18 cartridge##2##2##(2008-10#2)
C18 cartridges and##2##3##(1993-2#1)(2008-10#1)
C18 cartridges##4##2##(1992-11#1)(1993-2#1)(2008-10#2)
C18 column using##3##3##(1995-6#1)(2008-10#1)(2010-4#1)
C18 column with a##3##4##(1990-8#1)(2008-10#2)
C18 column with##6##3##(1990-8#1)(2008-10#4)(2011-1#1)
C18 column##22##2##(1990-8#1)(1993-9#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#10)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#3)(2012-3#1)
C18 columns##2##2##(1997-4#1)(2011-1#1)
C18 reversed-phase##2##2##(1993-11#1)(2008-10#1)
C18 stationary phase##2##3##(1996-5#1)(2008-10#1)
C18 stationary##3##2##(1996-5#1)(2008-10#2)
C18##67##1##(1990-12#4)(1990-8#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-5#4)(1997-2#1)(1997-4#1)(2008-10#27)(2008-5#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2011-1#8)(2011-3#1)(2012-3#1)
C19##4##1##(1990-11#1)(2008-6#2)(2013-8#1)
C190A##2##1##(1995-2#2)
C1YVV isolates##6##2##(2008-10#6)
C1YVV##7##1##(2008-10#7)
C1q-deficient SLE patient group##3##4##(2011-2#3)
C1q-deficient SLE patients##4##3##(2011-2#4)
C1q-deficient SLE##7##2##(2011-2#7)
C1q-deficient##8##1##(2011-2#8)
C2 acetyl##3##2##(1993-11#3)
C2 and C3##3##3##(2008-7#1)(2013-1#2)
C2 and C7##2##3##(2010-9#2)
C2 and##8##2##(2008-7#1)(2009-10#1)(2010-9#2)(2011-2#1)(2013-1#3)
C2 content##5##2##(2007-12#5)
C2 contents##2##2##(2007-12#2)
C2 myotubes##3##2##(1995-6#3)
C2 nerve##2##2##(2012-12#1)(2012-3#1)
C2 of##2##2##(1995-5#1)(1997-1#1)
C2##62##1##(1990-5#1)(1990-8#1)(1991-12#2)(1992-8#1)(1992-9#1)(1993-11#3)(1995-5#2)(1995-6#4)(1997-1#1)(2007-12#7)(2008-10#3)(2008-12#2)(2008-4#2)(2008-6#4)(2008-7#1)(2008-9#2)(2009-10#1)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#9)
C2'##3##1##(1991-3#1)(1995-3#1)(2008-4#1)
C2-C4##2##1##(1996-5#1)(2008-10#1)
C2-domain##3##1##(2009-10#3)
C2/c##4##1##(1996-2#3)(1997-7#1)
C20##5##1##(1990-7#1)(1992-3#1)(1997-1#3)
C2079 and C60213 were##2##4##(1996-10#2)
C2079##5##1##(1996-10#5)
C21##2##1##(1990-11#1)(2008-9#1)
C225SR1##2##1##(1993-11#2)
C24 and##3##2##(1993-8#1)(2012-3#2)
C24##7##1##(1993-11#1)(1993-8#1)(2012-3#5)
C24-C28##2##1##(2008-6#2)
C26##2##1##(1993-8#2)
C26-CBS/diC14-PC mixture had##2##3##(1993-8#2)
C26-CBS/diC14-PC mixture##3##2##(1993-8#3)
C282Y homozygous HFE##2##3##(2008-5#2)
C282Y homozygous##4##2##(2008-5#4)
C2C12 cells##3##2##(1991-11#1)(2008-11#1)(2009-6#1)
C2C12 myoblasts##2##2##(2008-4#2)
C2C12##11##1##(1991-11#2)(2008-11#4)(2008-4#4)(2009-6#1)
C2H2##6##1##(1992-3#4)(1993-2#1)(1996-6#1)
C3 activation##2##2##(1991-2#1)(1993-11#1)
C3 and C4##3##3##(2008-10#2)(2008-9#1)
C3 and##6##2##(1991-12#1)(1991-2#1)(1992-3#1)(2008-10#2)(2008-9#1)
C3 applied at##2##3##(2008-10#2)
C3 applied##3##2##(2008-10#3)
C3 cell##2##2##(2008-10#2)
C3 in##3##2##(2008-10#2)(2008-7#1)
C3 inhibited##2##2##(1993-6#1)(2008-10#1)
C3 level##2##2##(2007-2#1)(2008-1#1)
C3 population##2##2##(2008-10#2)
C3 was##4##2##(1993-6#1)(2008-10#2)(2013-1#1)
C3##78##1##(1990-2#2)(1990-8#2)(1991-12#1)(1991-2#6)(1992-3#2)(1993-11#1)(1993-6#8)(1996-5#1)(1997-1#4)(2007-2#2)(2008-1#1)(2008-10#36)(2008-11#2)(2008-6#2)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#3)
C3'##2##1##(1991-3#1)(1995-3#1)
C3/C4##2##1##(1994-3#2)
C32##2##1##(1991-5#2)
C3H##2##1##(1991-12#1)(1992-11#1)
C3H/10T1/2 cells##2##2##(1992-5#2)
C3H/10T1/2##4##1##(1992-5#4)
C3H/HeJ mice##4##2##(2008-10#4)
C3H/HeJ##7##1##(1991-12#1)(1997-8#1)(2008-10#5)
C3H10T1/2 cells##5##2##(1994-2#1)(2008-4#4)
C3H10T1/2##7##1##(1991-6#1)(1994-2#2)(2008-4#4)
C3II##3##1##(1994-3#3)
C4 and C5##2##3##(1990-5#1)(2008-6#1)
C4 and##5##2##(1990-5#1)(2008-4#1)(2008-6#1)(2013-1#1)(2013-8#1)
C4 gene##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
C4 genes are present in a diploid genome of a##2##10##(2008-4#2)
C4 genes##3##2##(2008-4#3)
C4 grasses##2##2##(2008-10#1)(2008-8#1)
C4 subgenotype##2##2##(2013-8#2)
C4 was##2##2##(2007-2#1)(2013-1#1)
C4##38##1##(1990-5#3)(1990-8#1)(1992-3#2)(1993-6#1)(1994-8#1)(1995-2#2)(2007-2#1)(2008-10#7)(2008-4#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#5)(2013-8#3)
C40/C40+##3##1##(2008-9#3)
C462SR1##2##1##(1993-11#2)
C47T##4##1##(2008-10#4)
C4A and C4B##3##3##(2008-4#3)
C4A##4##1##(2008-4#4)
C4B proteins##2##2##(2008-4#2)
C4B##4##1##(2008-4#4)
C4M##2##1##(2013-8#2)
C4RAHA##2##1##(2008-10#2)
C4a evolution branch##2##3##(2013-8#2)
C5 was##2##2##(1990-5#1)(2008-6#1)
C5##10##1##(1990-5#1)(1994-2#1)(2007-11#2)(2008-6#3)(2008-9#1)(2012-2#1)(2012-3#1)
C5-6##2##1##(2008-9#1)(2012-3#1)
C5-C6##4##1##(1997-8#1)(2011-2#2)(2012-3#1)
C5-epimerase##3##1##(2009-7#3)
C530W##2##1##(1995-11#2)
C57 BL/6J mice##3##3##(1995-11#3)
C57 mice##2##2##(1995-12#1)(2013-8#1)
C57##7##1##(1993-12#1)(1995-11#3)(1995-12#2)(2013-8#1)
C57B1/6 mice##2##2##(1995-3#1)(1997-8#1)
C57BL mice##2##2##(1993-5#2)
C57BL##4##1##(1991-12#1)(1993-5#3)
C57BL/10 mice infected with##2##4##(1996-12#2)
C57BL/10 mice##8##2##(1990-3#3)(1996-12#5)
C57BL/10##11##1##(1990-3#3)(1996-12#8)
C57BL/6 (B6)##2##2##(1996-12#1)(2008-4#1)
C57BL/6 and##2##2##(1991-1#1)(1993-12#1)
C57BL/6 mice were##5##3##(1992-8#1)(2008-10#2)(2009-12#1)(2012-3#1)
C57BL/6 mice##18##2##(1991-6#1)(1992-8#1)(1993-12#1)(1995-2#2)(1997-3#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#3)
C57BL/6##29##1##(1991-1#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1995-2#5)(1996-12#1)(1997-3#2)(1997-8#1)(2008-10#4)(2008-12#2)(2008-4#2)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#3)
C57BL/6J mice##3##2##(1992-3#1)(2010-10#1)(2010-7#1)
C57BL/6J##8##1##(1990-7#1)(1991-12#1)(1992-3#1)(1993-5#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)
C57BL/6N##2##1##(2008-10#2)
C57BL/KsJ##2##1##(2008-3#2)
C57BL/KsJ-db/db##2##1##(2008-3#1)(2008-7#1)
C57Bl/6 mice##2##2##(2008-10#2)
C5a##8##1##(1991-9#1)(1994-6#3)(2008-10#4)
C5lambda##3##1##(2008-11#3)
C6 and L##2##3##(1993-6#2)
C6 and##4##2##(1993-6#2)(1994-2#1)(2008-7#1)
C6 cells and##2##3##(1992-6#1)(2008-4#1)
C6 cells were##2##3##(1992-6#1)(1994-11#1)
C6 cells##6##2##(1992-6#3)(1994-11#1)(2008-4#2)
C6 glial cells##3##3##(1994-11#3)
C6 glioma cell line##2##4##(1994-11#2)
C6 glioma cell##3##3##(1992-6#1)(1994-11#2)
C6 glioma cells##4##3##(1992-6#1)(1995-12#1)(2008-4#1)(2012-2#1)
C6 glioma##7##2##(1992-6#2)(1994-11#2)(1995-12#1)(2008-4#1)(2012-2#1)
C6 to##2##2##(1995-2#1)(2009-3#1)
C6##35##1##(1992-6#5)(1993-6#3)(1994-11#6)(1994-2#2)(1995-12#1)(1995-2#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-3#1)(2012-2#2)(2012-3#2)(2013-1#2)
C6-ceramide##4##1##(1995-12#1)(1995-2#2)(2011-2#1)
C60##5##1##(1991-9#1)(1992-8#1)(2007-11#2)(2008-10#1)
C60213##4##1##(1996-10#4)
C677T##3##1##(2008-11#1)(2012-2#1)(2012-3#1)
C7 vertebral body##2##3##(2009-3#2)
C7##14##1##(1994-2#1)(1994-5#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#3)(2010-9#2)(2011-2#1)(2012-1#1)
C7-MDCK cells##2##2##(2008-8#2)
C77##5##1##(2008-10#5)
C8 and C18##3##3##(1990-8#1)(2008-10#2)
C8 and##5##2##(1990-7#1)(1990-8#1)(2008-10#2)(2008-8#1)
C8 column##3##2##(1995-3#2)(2008-10#1)
C8##18##1##(1990-7#1)(1990-8#1)(1994-2#1)(1994-8#1)(1995-3#2)(1997-2#1)(2007-11#1)(2008-10#6)(2008-4#2)(2008-8#1)(2012-3#1)
C9 keto##2##2##(1993-11#2)
C9##4##1##(1993-11#2)(1994-2#2)
C9-1 and##4##2##(2008-10#4)
C9-1##10##1##(2008-10#10)
C9-1S##8##1##(2008-10#8)
C923##3##1##(2008-10#3)
C</ForeName>##2##1##(2013-8#2)
C=0##7##1##(2008-10#7)
C=N##2##1##(2008-9#2)
C=O##2##1##(1996-2#1)(2007-11#1)
CA 1##5##2##(1995-3#5)
CA 125 levels##2##3##(1991-4#2)
CA 125 serum levels##2##4##(1991-4#2)
CA 125##8##2##(1991-4#7)(1996-11#1)
CA 19-9##3##2##(1990-6#2)(2013-1#1)
CA 2##3##2##(1995-3#3)
CA 3 and CA 4##3##5##(1995-3#3)
CA 336##2##2##(2008-10#2)
CA activity##2##2##(2008-7#2)
CA and OR collections##2##4##(2008-10#2)
CA and OR##4##3##(2008-10#4)
CA and##9##2##(1995-11#1)(2008-10#5)(2008-6#1)(2011-1#1)(2011-2#1)
CA cells##9##2##(1995-11#3)(1997-6#1)(2008-7#5)
CA group##3##2##(1994-2#1)(2011-1#2)
CA groups##2##2##(1994-2#2)
CA in##2##2##(1994-5#1)(2011-2#1)
CA index##2##2##(1995-3#2)
CA is##2##2##(2008-10#1)(2008-7#1)
CA lesions##3##2##(1994-12#3)
CA participants##3##2##(2008-11#3)
CA release##2##2##(1992-6#1)(1997-7#1)
CA repeat##2##2##(1997-3#1)(1997-5#1)
CA tissue##2##2##(2011-1#2)
CA to##3##2##(2008-10#2)(2011-1#1)
CA was##2##2##(2008-10#1)(2012-12#1)
CA were##2##2##(2008-10#1)(2013-1#1)
CA##134##1##(1990-11#1)(1990-6#2)(1990-8#1)(1991-4#7)(1991-8#1)(1992-6#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1995-11#7)(1995-3#18)(1996-11#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#4)(2007-8#3)(2008-10#24)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2009-3#1)(2009-7#3)(2011-1#9)(2011-2#7)(2012-1#1)(2012-12#3)(2013-1#3)(2013-8#2)
CA) in##2##2##(1996-9#1)(2012-12#1)
CA)##9##1##(1994-2#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-8#1)(2012-12#1)
CA-100##3##1##(2008-10#3)
CA-125##7##1##(2008-10#4)(2012-3#1)(2013-1#1)(2013-8#1)
CA-AI##2##1##(2008-8#2)
CA-CRC##4##1##(2011-2#4)
CA-EG##2##1##(2008-8#2)
CA-GTase##3##1##(1992-9#3)
CA-LA##2##1##(2008-8#2)
CA-PVD##4##1##(2009-7#4)
CA-clonal##4##1##(2008-10#4)
CA-variable##2##1##(2008-10#2)
CA1 and posterior parietal##2##4##(1997-2#2)
CA1 and the##2##3##(2008-11#1)(2008-9#1)
CA1 and##8##2##(1990-5#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-9#3)
CA1 area of the##2##4##(1995-5#1)(2009-12#1)
CA1 area##4##2##(1995-5#1)(2008-11#1)(2009-12#2)
CA1 hippocampal slices##2##3##(1996-5#1)(1997-2#1)
CA1 hippocampal##3##2##(1996-5#1)(1997-2#1)(2009-12#1)
CA1 neurons##5##2##(1990-12#1)(1991-12#2)(1995-12#1)(2009-12#1)
CA1 pyramidal cells##3##3##(1990-5#1)(1993-12#1)(1997-2#1)
CA1 pyramidal neurons##2##3##(1995-8#1)(2008-11#1)
CA1 pyramidal##7##2##(1990-5#1)(1993-12#1)(1995-8#1)(1997-2#2)(2008-11#1)(2008-7#1)
CA1 region of the hippocampus##3##5##(1994-8#1)(1996-12#1)(1997-2#1)
CA1 region of the##4##4##(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)
CA1 region of##6##3##(1992-12#1)(1994-8#1)(1995-12#2)(1996-12#1)(1997-2#1)
CA1 region##14##2##(1990-5#1)(1990-7#1)(1992-12#1)(1994-8#1)(1995-12#5)(1996-12#2)(1997-2#3)
CA1##76##1##(1990-12#1)(1990-5#5)(1990-7#3)(1991-10#1)(1991-12#2)(1992-12#1)(1993-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#11)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#6)(1996-2#1)(1996-5#6)(1997-2#11)(2008-11#5)(2008-12#1)(2008-7#2)(2008-9#7)(2009-12#4)
CA1-PCs and DG-GCs##2##3##(1997-2#2)
CA1-PCs##4##1##(1997-2#4)
CA125 levels##4##2##(1992-9#4)
CA125##7##1##(1992-9#5)(1994-9#1)(2013-8#1)
CA15##6##1##(1990-8#6)
CA2 and CA3##2##3##(2008-12#2)
CA2 and##4##2##(1994-2#1)(2008-12#3)
CA2##6##1##(1994-2#1)(1995-5#1)(1996-12#1)(2008-12#3)
CA3 and##3##2##(1995-12#1)(1996-12#1)(2008-11#1)
CA3 pyramidal cell##5##3##(2008-11#5)
CA3 pyramidal cells##3##3##(1990-5#2)(2008-11#1)
CA3 pyramidal##8##2##(1990-5#2)(2008-11#6)
CA3 region##2##2##(1996-12#1)(1997-2#1)
CA3##28##1##(1990-5#2)(1995-12#1)(1995-8#3)(1996-12#5)(1996-7#1)(1997-2#1)(2008-11#12)(2008-12#2)(2009-8#1)
CA3-CA1##3##1##(2008-11#1)(2009-8#2)
CA3-CA4##2##1##(1990-7#1)(1994-2#1)
CA4##4##1##(1994-6#1)(1995-12#1)(1996-12#2)
CAA concentrations##2##2##(1994-8#2)
CAA cytotoxicity##2##2##(1994-8#2)
CAA with##2##2##(2007-8#1)(2008-10#1)
CAA##21##1##(1992-11#1)(1994-8#11)(2007-2#1)(2007-8#4)(2008-10#4)
CAA-induced##2##1##(1994-8#2)
CAAT box##5##2##(1993-12#1)(1993-6#2)(1995-8#1)(2010-5#1)
CAAT boxes##2##2##(1993-2#1)(1994-12#1)
CAAT##9##1##(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-8#1)(1997-7#1)(2010-5#1)
CAAX##2##1##(1994-8#2)
CAAs##7##1##(2008-10#7)
CAB surgery patients enrolled##2##4##(2010-8#2)
CAB surgery patients##5##3##(2010-8#5)
CAB surgery##7##2##(2010-8#7)
CAB transcription##2##2##(1995-2#2)
CAB##9##1##(1995-2#2)(2010-8#7)
CAB2 expression##4##2##(1995-2#4)
CAB2 promoter##2##2##(1995-2#2)
CAB2##8##1##(1995-2#8)
CABG (group##2##2##(2007-8#2)
CABG patients##2##2##(2008-12#2)
CABG surgery##2##2##(2007-11#1)(2007-8#1)
CABG through##2##2##(2007-8#2)
CABG##21##1##(1992-11#1)(2006-8#1)(2007-11#1)(2007-8#13)(2008-11#1)(2008-12#2)(2008-4#1)(2013-1#1)
CABS and##2##2##(2008-10#2)
CABS was##3##2##(2008-10#3)
CABS##13##1##(2008-10#13)
CAC##2##1##(2008-3#1)(2013-8#1)
CACO##3##1##(2012-1#3)
CACY##5##1##(1994-5#5)
CAD and##5##2##(1993-12#1)(1997-8#1)(2008-7#1)(2009-10#1)(2010-8#1)
CAD mortality##2##2##(2008-7#2)
CAD patients##3##2##(1991-8#1)(1997-8#1)(2012-2#1)
CAD such as##2##3##(2011-1#2)
CAD with##2##2##(2011-2#1)(2012-2#1)
CAD##55##1##(1990-7#1)(1991-8#4)(1993-12#1)(1994-5#1)(1995-5#2)(1996-2#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-3#4)(2008-4#7)(2008-7#8)(2009-10#2)(2010-8#2)(2011-1#6)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#1)
CAD/CAM##6##1##(2008-7#6)
CAD1 -A##2##2##(2008-8#2)
CAD1##4##1##(2008-8#4)
CAD1-A and##2##2##(2008-8#2)
CADCA##2##1##(2008-6#2)
CADD-Solis##3##1##(2011-2#3)
CADO##2##1##(1995-5#2)
CADP)##2##1##(2011-1#2)
CADR##4##1##(2008-8#4)
CAF plus MPA therapy##3##4##(1995-4#3)
CAF plus##5##2##(1995-4#5)
CAF therapy and##2##3##(1994-7#1)(1995-4#1)
CAF therapy had significantly more toxicity than##2##7##(1994-7#1)(1995-4#1)
CAF therapy were##2##3##(1994-7#2)
CAF therapy##9##2##(1994-7#5)(1995-4#3)(1997-7#1)
CAF##19##1##(1994-7#7)(1995-4#10)(1997-7#2)
CAF+FT##8##1##(1997-7#8)
CAF+FT+ADR##3##1##(1997-7#3)
CAG insertion##2##2##(2008-12#2)
CAG repeat##4##2##(1997-5#3)(2008-6#1)
CAG repeats##3##2##(1997-5#3)
CAG##14##1##(1993-12#1)(1996-2#1)(1997-5#7)(2008-1#1)(2008-12#2)(2008-4#1)(2008-6#1)
CAH##11##1##(2008-1#1)(2008-4#4)(2008-8#1)(2010-2#4)(2012-3#1)
CAI##7##1##(1996-12#1)(2008-9#1)(2013-1#5)
CAK##4##1##(1997-1#4)
CAL##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
CAL-IR##4##1##(1996-5#4)
CALB##3##1##(1996-5#3)
CALUX and##2##2##(2008-10#2)
CALUX bioassay##9##2##(2008-10#9)
CALUX results obtained##2##3##(2008-10#2)
CALUX results##4##2##(2008-10#4)
CALUX##31##1##(2008-10#31)
CAM interventions##2##2##(2008-10#2)
CAM##10##1##(2008-1#1)(2008-10#7)(2009-5#2)
CAMR was##2##2##(2011-2#2)
CAMR##3##1##(2011-2#3)
CAN##14##1##(1990-9#2)(2009-11#1)(2009-7#4)(2012-2#7)
CAP##7##1##(1994-11#1)(1997-2#1)(2007-12#2)(2010-5#2)(2012-2#1)
CAP-5##2##1##(1991-8#2)
CAP/SRV2##2##1##(1995-9#2)
CAP102##3##1##(1991-5#3)
CAPB a##2##2##(2008-5#2)
CAPB##9##1##(2008-10#1)(2008-5#8)
CAPD fluid##2##2##(2008-10#2)
CAPD fluids##7##2##(2008-10#7)
CAPD in##3##2##(1992-5#1)(2007-12#1)(2008-1#1)
CAPD patients##11##2##(2007-12#4)(2007-7#3)(2008-10#2)(2011-2#2)
CAPD training program##2##3##(2007-12#2)
CAPD training##4##2##(2007-12#4)
CAPD##41##1##(1992-5#1)(2007-12#13)(2007-7#6)(2008-1#6)(2008-10#11)(2011-2#4)
CAPL##3##1##(1994-5#3)
CAPS##3##1##(1994-3#1)(2008-10#1)(2008-8#1)
CAPSNet collects##2##2##(2008-11#2)
CAR/PDMS##2##1##(2008-10#2)
CARDIAC##2##1##(2008-2#1)(2010-6#1)
CARE##5##1##(1995-12#1)(1996-5#1)(2008-8#1)(2009-11#1)(2012-12#1)
CARICOMP sites##4##2##(2011-2#4)
CARICOMP##6##1##(2008-5#1)(2011-2#5)
CARS measurements##2##2##(2008-3#2)
CARS signal##3##2##(2007-11#1)(2008-2#2)
CARS spectra of##2##3##(2008-2#1)(2008-3#1)
CARS spectra##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
CARS temperature##4##2##(2008-2#3)(2008-3#1)
CARS##26##1##(2007-11#2)(2007-12#4)(2008-2#10)(2008-3#10)
CART##6##1##(2008-10#3)(2010-11#1)(2013-1#2)
CAS are##2##2##(2008-2#1)(2011-2#1)
CAS proteins##2##2##(2012-12#2)
CAS was only##2##3##(2006-12#2)
CAS##25##1##(1992-2#1)(2006-12#5)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#2)(2011-2#8)(2012-12#6)
CASA concentrations##2##2##(1993-2#2)
CASA##4##1##(1993-2#4)
CASE DESCRIPTION##7##2##(2012-3#7)
CASE REPORT##7##2##(1993-9#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-5#1)(2013-1#2)
CASE##24##1##(1990-7#1)(1992-11#1)(1993-9#1)(1996-6#1)(1997-5#2)(2008-11#1)(2008-12#1)(2009-1#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#7)(2013-1#5)
CASES##2##1##(2009-1#2)
CASL##3##1##(2009-10#3)
CASP##2##1##(2008-7#1)(2013-8#1)
CASS-3##3##1##(2008-10#3)
CASV##2##1##(2008-10#2)
CAT activities##4##2##(1992-6#1)(1994-6#1)(1995-2#1)(2013-1#1)
CAT activity in##2##3##(1991-11#1)(1995-2#1)
CAT activity was##2##3##(1993-8#1)(2008-7#1)
CAT activity##9##2##(1991-11#3)(1993-8#2)(1995-2#1)(2008-4#1)(2008-7#2)
CAT and##4##2##(1990-8#1)(1997-4#1)(2008-7#1)(2009-5#1)
CAT assay##2##2##(1995-8#2)
CAT assays##2##2##(1992-6#1)(2008-9#1)
CAT expression##2##2##(1997-8#2)
CAT gene##2##2##(2008-11#1)(2008-9#1)
CAT mRNA##3##2##(1990-8#1)(2008-11#2)
CAT production##2##2##(2008-7#2)
CAT protein##2##2##(2008-11#2)
CAT reporter##3##2##(1992-12#1)(1993-8#1)(2008-4#1)
CAT##59##1##(1990-11#1)(1990-8#2)(1991-11#3)(1992-12#3)(1992-3#4)(1992-6#2)(1993-8#3)(1994-6#2)(1995-2#3)(1995-6#1)(1995-8#2)(1997-4#1)(1997-8#2)(2007-8#1)(2008-10#5)(2008-11#7)(2008-4#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#3)(2013-1#2)
CAT-like activity##2##2##(1990-11#2)
CAT-like##3##1##(1990-11#3)
CAUSAL##4##1##(1997-3#1)(2008-7#1)(2011-1#2)
CAV antigen##2##2##(2008-5#2)
CAV isolate##3##2##(2008-5#3)
CAV##12##1##(2007-6#1)(2008-5#10)(2012-3#1)
CA[4]##2##1##(2008-10#2)
CA[6]##2##1##(2008-10#2)
CA[8]##2##1##(2008-10#2)
CAdSV##7##1##(2008-10#7)
CArG box##5##2##(1993-8#4)(1994-11#1)
CArG boxes##4##2##(1993-8#2)(1994-11#2)
CArG motif and##2##3##(2009-8#1)(2010-5#1)
CArG##13##1##(1993-8#8)(1994-11#3)(2009-8#1)(2010-5#1)
CAs and MN##2##3##(2010-1#1)(2013-1#1)
CAs##4##1##(1995-3#1)(1996-2#1)(2010-1#1)(2013-1#1)
CAsp exchange##2##2##(1995-6#2)
CAsp##4##1##(1995-6#4)
CB CO##3##2##(1993-12#3)
CB agonists may##2##3##(2009-12#2)
CB agonists##5##2##(2009-12#5)
CB and EA##2##3##(2008-11#2)
CB electrodes##2##2##(2008-10#2)
CB integrity##2##2##(2010-6#2)
CB or##3##2##(1994-5#2)(2008-11#1)
CB receptor##2##2##(2009-12#2)
CB receptors##2##2##(2009-12#2)
CB##36##1##(1991-4#1)(1993-12#3)(1994-5#2)(1995-12#1)(1995-3#1)(2008-10#6)(2008-11#5)(2008-2#2)(2009-12#11)(2010-6#4)
CB(1) receptor##2##2##(2009-8#2)
CB(1)##3##1##(2009-8#3)
CB(2) receptor##4##2##(2009-8#4)
CB(2)##7##1##(2009-8#7)
CB1##3##1##(1990-5#2)(2009-12#1)
CB2##2##1##(1990-5#2)
CBA 2##3##2##(2008-10#3)
CBA strain##3##2##(2008-12#1)(2013-1#2)
CBA##11##1##(1995-12#2)(1996-5#1)(2008-10#3)(2008-12#3)(2013-1#2)
CBA/J##2##1##(1993-11#1)(1996-5#1)
CBB bacteria##3##2##(2008-10#3)
CBB##8##1##(2008-10#8)
CBC and##2##2##(2008-10#1)(2011-2#1)
CBC##4##1##(2008-10#2)(2011-2#2)
CBCT can be##2##3##(2013-1#2)
CBCT##7##1##(2012-3#2)(2013-1#5)
CBD##6##1##(2008-12#1)(2009-6#3)(2009-7#1)(2009-9#1)
CBDP##3##1##(2013-1#3)
CBDcex##2##1##(1995-5#2)
CBF and##3##2##(1996-7#1)(2008-7#2)
CBF is a##3##3##(1995-2#2)(2012-2#1)
CBF studies##2##2##(2008-7#2)
CBF values##2##2##(2008-7#1)(2011-1#1)
CBF was##4##2##(1991-5#1)(1996-7#1)(2007-8#1)(2008-7#1)
CBF##32##1##(1991-5#2)(1995-2#3)(1995-5#1)(1996-7#3)(2007-8#2)(2008-7#15)(2011-1#3)(2012-2#3)
CBF-A and CBF-B##3##3##(1995-2#3)
CBF-A and##4##2##(1995-2#4)
CBF-A##5##1##(1995-2#5)
CBF-A-CBF-C complex##2##2##(1995-2#2)
CBF-B##8##1##(1995-2#4)(2012-2#4)
CBF-C is##2##2##(1995-2#2)
CBF-C##8##1##(1995-2#8)
CBG- and RBG-banding##2##3##(2010-3#2)
CBH I##3##2##(1993-8#3)
CBL and BNM##2##3##(2008-10#2)
CBLVd##2##1##(2008-10#2)
CBO##2##1##(1995-3#1)(2008-2#1)
CBP 32##3##2##(1990-12#3)
CBP is##2##2##(2008-8#2)
CBP##9##1##(1990-12#3)(1995-11#1)(2008-4#1)(2008-8#3)(2013-1#1)
CBP2 gene##2##2##(1997-7#2)
CBPs##3##1##(1996-5#3)
CBS and##2##2##(1992-2#1)(1993-8#1)
CBS concentrations##5##2##(1993-8#5)
CBS##28##1##(1992-2#1)(1993-8#14)(1996-6#1)(2008-10#2)(2008-6#1)(2011-2#6)(2013-8#3)
CBT is##2##2##(2011-2#2)
CBT##9##1##(2007-12#3)(2008-11#1)(2011-2#4)(2012-2#1)
CBX1R##2##1##(2008-10#2)
CBZ ml(-1) and 0##2##4##(2008-10#2)
CBZ##6##1##(2008-10#6)
CBZ-E ml(-1)##2##2##(2008-10#2)
CBZ-E##4##1##(2008-10#4)
CBs##5##1##(2008-10#5)
CC chemokine##3##2##(2010-5#2)(2012-3#1)
CC genotype and C allele##2##5##(2011-1#2)
CC genotype##5##2##(2011-1#4)(2013-1#1)
CC in##2##2##(2008-11#1)(2011-1#1)
CC is##2##2##(1991-8#1)(2008-11#1)
CC##35##1##(1991-8#5)(2008-10#5)(2008-11#9)(2008-7#2)(2010-1#2)(2010-5#2)(2011-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
CC(4##2##1##(2008-5#2)
CC-516 showed##3##2##(2008-5#3)
CC-516##16##1##(2008-5#16)
CC-NBS-LRR subfamily##2##2##(2008-10#2)
CC-NBS-LRR##4##1##(2008-10#4)
CC9C10 hybridoma##2##2##(2008-11#2)
CCA and##2##2##(2008-7#1)(2011-1#1)
CCA nucleotidyltransferase##2##2##(1997-3#2)
CCA##17##1##(1997-3#2)(2007-12#2)(2008-7#1)(2009-12#3)(2010-1#4)(2011-1#1)(2011-2#4)
CCAAT binding##2##2##(1995-2#1)(2008-9#1)
CCAAT box##5##2##(1990-11#1)(1991-6#1)(1994-12#1)(1997-2#1)(2008-9#1)
CCAAT motifs in##2##3##(1995-2#2)
CCAAT##17##1##(1990-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-2#3)(1997-2#1)(2008-9#5)
CCAAT-binding##4##1##(2008-7#1)(2008-9#3)
CCBIP group##2##2##(2008-7#2)
CCBIP##6##1##(2008-7#6)
CCD (EMCCD)##2##2##(2008-11#1)(2011-1#1)
CCD array##8##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
CCD camera and a##2##4##(2007-11#1)(2011-1#1)
CCD camera and##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
CCD camera are##2##3##(2007-11#1)(2008-3#1)
CCD camera as##2##3##(2008-10#1)(2008-3#1)
CCD camera for the##2##4##(2008-3#1)(2010-12#1)
CCD camera for##3##3##(2008-3#2)(2010-12#1)
CCD camera is used to##3##5##(2008-2#1)(2008-3#2)
CCD camera is##4##3##(2008-2#2)(2008-3#2)
CCD camera to##2##3##(2008-11#1)(2008-3#1)
CCD camera with##2##3##(2007-12#1)(2008-3#1)
CCD camera##50##2##(2007-11#7)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#22)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#2)
CCD cameras and##2##3##(2007-11#1)(2008-3#1)
CCD cameras##9##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
CCD chip##4##2##(2007-12#2)(2008-2#2)
CCD detector##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
CCD detectors##2##2##(2008-2#1)(2008-3#1)
CCD for##2##2##(2007-12#1)(2008-3#1)
CCD has##2##2##(2007-11#1)(2008-3#1)
CCD image##2##2##(2008-2#1)(2008-3#1)
CCD images##5##2##(2008-2#1)(2008-3#3)(2013-8#1)
CCD imaging##2##2##(2008-3#2)
CCD is##3##2##(2008-3#1)(2011-1#2)
CCD size##2##2##(2008-3#2)
CCD spectrometer##3##2##(2008-10#3)
CCD##139##1##(1991-2#1)(2007-11#14)(2007-12#13)(2008-10#10)(2008-11#2)(2008-2#22)(2008-3#59)(2008-5#1)(2008-9#3)(2010-12#1)(2011-1#7)(2011-2#2)(2013-1#1)(2013-8#3)
CCD-based##4##1##(1997-6#1)(2008-3#1)(2009-6#1)(2010-12#1)
CCE##5##1##(2008-10#4)(2008-11#1)
CCE/CC128 cell line##2##3##(2008-11#2)
CCEs prepared##2##2##(2008-10#2)
CCEs##4##1##(2008-10#4)
CCF##2##1##(1996-6#1)(2008-10#1)
CCFC##2##1##(2008-10#2)
CCH##2##1##(2008-7#1)(2010-4#1)
CCH5##5##1##(2012-3#5)
CCHF##2##1##(2012-2#2)
CCI##7##1##(1996-5#2)(1997-2#1)(2008-11#2)(2008-9#2)
CCK and dopamine##2##3##(1993-6#2)
CCK and##3##2##(1993-12#1)(1993-6#2)
CCK mRNA##3##2##(1992-8#1)(1996-12#2)
CCK octapeptide##3##2##(1993-6#1)(1995-8#2)
CCK receptor##2##2##(1992-8#1)(1995-11#1)
CCK release##2##2##(1990-12#2)
CCK type B##2##3##(1994-2#2)
CCK type##3##2##(1994-2#3)
CCK##32##1##(1990-12#2)(1991-5#2)(1992-8#3)(1993-12#4)(1993-6#6)(1994-2#3)(1995-11#1)(1995-8#2)(1996-12#3)(1996-2#1)(2008-7#5)
CCK(B)/gastrin receptor antagonists##2##3##(1995-12#2)
CCK(B)/gastrin receptor##3##2##(1995-12#3)
CCK(B)/gastrin##4##1##(1995-12#4)
CCK-58##6##1##(1991-8#6)
CCK-8 and##2##2##(1994-2#1)(1995-12#1)
CCK-8 or ceruletide##2##3##(1994-2#2)
CCK-8 or##3##2##(1994-2#2)(1995-11#1)
CCK-8 was attenuated by a##2##5##(1994-2#2)
CCK-8 was##3##2##(1994-2#3)
CCK-8##24##1##(1991-8#2)(1994-2#9)(1995-11#7)(1995-12#4)(2008-7#2)
CCK-8)##2##1##(1992-8#1)(1995-12#1)
CCK-B receptor##3##2##(1995-12#3)
CCK-B##4##1##(1995-12#3)(1996-2#1)
CCK-JMV-180##4##1##(1993-6#4)
CCK/DA##2##1##(1993-12#2)
CCKA receptor antagonist##2##3##(1993-6#1)(1996-2#1)
CCKA receptor##3##2##(1993-6#1)(1996-2#2)
CCKA##4##1##(1993-6#1)(1996-2#3)
CCKB receptor##3##2##(1996-2#3)
CCL19##5##1##(2010-5#1)(2013-1#4)
CCL2##2##1##(2008-10#1)(2013-8#1)
CCM from##2##2##(1995-3#2)
CCM##4##1##(1995-3#3)(2008-7#1)
CCMV RNA1##2##2##(2008-10#2)
CCMV RNA3##3##2##(2008-10#3)
CCMV RdRp##2##2##(2008-10#2)
CCMV##13##1##(2008-10#13)
CCOMT were##2##2##(2008-11#2)
CCOMT##3##1##(2008-11#3)
CCOP##8##1##(1992-12#8)
CCOPs##2##1##(1992-12#2)
CCP and##3##2##(2009-8#3)
CCP11##4##1##(2008-7#4)
CCPA##3##1##(1995-12#3)
CCPE for##2##2##(2008-10#2)
CCPE##4##1##(2008-10#4)
CCR2-64I##3##1##(2008-9#3)
CCR5##2##1##(2008-4#1)(2011-2#1)
CCR7##2##1##(2012-2#1)(2013-1#1)
CCRC##3##1##(1991-2#1)(1994-2#2)
CCRCs##2##1##(1991-2#2)
CCRF-CEM##2##1##(1991-4#2)
CCRMP##2##1##(2008-10#2)
CCRT##7##1##(2008-10#7)
CCS and##2##2##(2008-10#2)
CCS##5##1##(2008-10#4)(2013-1#1)
CCSV NP##4##2##(2008-10#4)
CCSV S RNA##2##3##(2008-10#2)
CCSV##11##1##(2008-10#11)
CCSVI##10##1##(2012-3#10)
CCT and##2##2##(2008-3#1)(2013-1#1)
CCT ranges##2##2##(2008-3#2)
CCT##8##1##(1994-1#1)(2008-3#6)(2013-1#1)
CCTA##4##1##(2008-12#4)
CCTS-NMDG resin##2##2##(2008-10#2)
CCU##2##1##(2010-8#2)
CCVs from##4##2##(2008-1#4)
CCVs##5##1##(2008-1#4)(2009-6#1)
CCl(4)##7##1##(1996-5#2)(2008-10#4)(2009-8#1)
CCl4##17##1##(1990-2#3)(1992-6#1)(1993-3#5)(1994-5#6)(2008-10#1)(2013-1#1)
CCl4-induced##4##1##(1994-5#3)(2013-1#1)
CCs and MCCs##2##3##(2013-1#2)
CCs and##3##2##(2013-1#3)
CD 4/CD 8 ratio##2##4##(2008-1#2)
CD 9 monoclonal##2##3##(1990-8#2)
CD Plus MEDLINE##4##3##(1991-1#2)(1991-12#1)(1995-3#1)
CD Plus##10##2##(1991-1#5)(1991-12#3)(1992-2#1)(1995-3#1)
CD _ 2##4##3##(2008-5#4)
CD and##6##2##(1992-3#1)(1994-11#1)(1995-5#1)(1996-5#1)(2008-10#2)
CD in##3##2##(1994-5#1)(2008-2#1)(2008-7#1)
CD intensity at 293 nm##2##5##(1995-5#2)
CD intensity at##4##3##(1992-6#1)(1995-5#3)
CD is##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
CD isolates##2##2##(2008-10#2)
CD may##2##2##(1995-6#1)(2012-2#1)
CD measurements##3##2##(1992-6#1)(1995-6#1)(1996-5#1)
CD spectra of##2##3##(1992-8#1)(2008-7#1)
CD spectra##11##2##(1990-12#1)(1990-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
CD spectrum of##2##3##(1994-12#1)(1994-5#1)
CD spectrum##7##2##(1990-8#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-5#2)(2008-4#1)
CD study##2##2##(1990-8#1)(1992-6#1)
CD was##2##2##(1996-5#1)(2008-10#1)
CD were##2##2##(2008-7#1)(2010-12#1)
CD##133##1##(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#5)(1990-9#1)(1991-1#5)(1991-12#3)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#5)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#2)(1996-5#6)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2009-11#1)(2009-12#1)(2010-12#9)(2012-1#2)(2012-2#7)(2013-8#5)
CD(4)(+)##2##1##(2011-1#2)
CD)##5##1##(1995-11#3)(1996-5#1)(2008-10#1)
CD-1 mice were##2##3##(1990-6#1)(2008-10#1)
CD-1 mice##6##2##(1990-6#2)(1990-7#1)(1991-6#2)(2008-10#1)
CD-1##8##1##(1990-6#2)(1990-7#1)(1991-6#2)(2008-10#1)(2008-11#2)
CD-DCI##2##1##(2012-3#2)
CD-ROM MEDLINE##3##2##(1991-3#3)
CD-ROM database##2##2##(1991-12#1)(1993-1#1)
CD-ROM was##2##2##(1991-1#1)(1995-3#1)
CD-ROM##25##1##(1991-1#4)(1991-12#5)(1991-3#6)(1993-1#2)(1993-2#2)(1995-3#2)(2008-11#4)
CD-ROM-based##2##1##(1993-2#2)
CD-causing R##4##2##(2008-10#4)
CD1##2##1##(2008-10#1)(2008-4#1)
CD10##5##1##(2010-12#3)(2011-2#2)
CD105(+)##6##1##(2008-11#6)
CD117##4##1##(2008-6#1)(2009-7#1)(2012-12#1)(2013-1#1)
CD11a##3##1##(1994-6#1)(1995-3#1)(2011-2#1)
CD11a/CD18 and##2##2##(1996-12#2)
CD11a/CD18##4##1##(1996-12#4)
CD11b and CD11c##2##3##(1994-6#2)
CD11b and##3##2##(1994-6#2)(1996-2#1)
CD11b##10##1##(1991-2#2)(1992-3#1)(1994-6#3)(1996-2#1)(2006-6#2)(2008-11#1)
CD11b/CD18##2##1##(1996-12#2)
CD11c on leukocytes and fibrinogen##2##5##(2006-6#2)
CD11c surface##2##2##(1994-6#1)(2008-11#1)
CD11c##7##1##(1994-6#3)(2006-6#2)(2008-10#1)(2008-11#1)
CD11c(+)/B220(-) DCs##2##2##(2008-11#2)
CD11c+##4##1##(1996-12#3)(2008-11#1)
CD120a##3##1##(1995-2#3)
CD127 expression level##2##3##(2013-1#2)
CD127##4##1##(2013-1#4)
CD127(low) pentamer(+)##2##2##(2013-1#2)
CD127(low)##4##1##(2013-1#4)
CD133##6##1##(2008-9#1)(2009-11#1)(2009-9#2)(2011-2#1)(2013-1#1)
CD133-high cells##3##2##(2009-9#3)
CD138##2##1##(2008-9#1)(2009-3#1)
CD14 mRNA##2##2##(2012-3#2)
CD14##10##1##(1992-3#2)(2008-10#3)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#2)
CD14(+) cells##2##2##(2012-2#2)
CD14(+)##7##1##(2008-11#3)(2008-7#1)(2012-2#3)
CD14(-)##2##1##(2008-11#2)
CD161##3##1##(2012-2#3)
CD161+ T cell##2##3##(2012-2#2)
CD161+ T cells##4##3##(2012-2#4)
CD161+ T##6##2##(2012-2#6)
CD161+##7##1##(2012-2#7)
CD18##4##1##(1996-2#1)(2008-10#1)(2011-2#2)
CD19##3##1##(2008-9#2)(2011-2#1)
CD19(+)##4##1##(2008-10#4)
CD19+##2##1##(2008-11#1)(2010-11#1)
CD1a##4##1##(1996-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
CD1a+ cells in the dermis##2##5##(1996-12#2)
CD1a+##5##1##(1996-12#5)
CD20 expression on H-RS cells##2##5##(2008-7#2)
CD20 expression##3##2##(2008-7#3)
CD20##10##1##(1995-3#1)(2007-10#1)(2008-7#4)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
CD20+##2##1##(1992-6#1)(2010-11#1)
CD24##3##1##(2008-9#1)(2009-12#1)(2011-2#1)
CD25 and##2##2##(1995-8#1)(2011-2#1)
CD25##9##1##(1990-12#1)(1995-8#1)(2008-11#6)(2011-2#1)
CD25+CD4+ T cells##4##3##(2011-2#4)
CD25+CD4+ regulatory##3##2##(2011-2#3)
CD25+CD4+##8##1##(2011-2#8)
CD26##2##1##(2008-10#2)
CD28##8##1##(2008-10#2)(2008-7#4)(2011-1#1)(2011-2#1)
CD3 and##2##2##(2007-2#1)(2008-10#1)
CD3 x GD2 BAb##2##4##(1993-9#2)
CD3 x##3##2##(1993-9#3)
CD3##15##1##(1991-6#1)(1993-9#6)(1995-2#1)(1995-3#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-9#2)(2013-1#1)
CD3(+)##2##1##(2008-5#1)(2012-3#1)
CD3+ cells##2##2##(2008-11#2)
CD3+##8##1##(1992-6#1)(2007-8#1)(2008-11#2)(2009-8#1)(2013-1#1)(2013-8#2)
CD30##4##1##(1997-3#1)(2011-2#1)(2012-3#2)
CD30(Ki-1)##2##1##(1997-3#2)
CD30+ PCLCL##2##2##(2012-3#2)
CD31##2##1##(2010-12#1)(2011-2#1)
CD31(+) cells in the bone marrow##2##6##(2010-6#2)
CD34 and##5##2##(2007-2#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
CD34##13##1##(2007-2#1)(2007-8#1)(2008-11#1)(2008-9#3)(2009-11#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
CD34(+) cells were##2##3##(2008-8#2)
CD34(+) cells##12##2##(2008-8#8)(2008-9#3)(2012-2#1)
CD34(+)##18##1##(2008-5#1)(2008-8#8)(2008-9#7)(2012-2#1)(2012-3#1)
CD34(-) and weakly CD105(+)##2##4##(2008-11#2)
CD34(-)##4##1##(2008-11#4)
CD34+ cells##4##2##(2008-7#1)(2011-2#3)
CD34+ count in peripheral blood##2##5##(2011-2#2)
CD34+ hematopoietic##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
CD34+##15##1##(1993-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#6)(2012-2#2)
CD34+KSL cells##2##2##(2008-4#2)
CD34-KSL cells##3##2##(2008-4#3)
CD34-KSL##4##1##(2008-4#4)
CD36##9##1##(1991-2#2)(2008-11#1)(2008-5#1)(2010-2#4)(2013-1#1)
CD38##9##1##(1994-11#3)(2008-9#1)(2009-2#1)(2010-11#3)(2011-2#1)
CD38/ADPR-cyclase##2##1##(2010-11#2)
CD39 and##3##2##(2008-4#3)
CD39 are##2##2##(2008-4#2)
CD39##15##1##(2008-4#15)
CD4 +##3##2##(2008-8#2)(2013-8#1)
CD4 T cell##2##3##(2012-12#1)(2013-1#1)
CD4 T cells in##2##4##(2008-11#1)(2012-12#1)
CD4 T cells##12##3##(2008-11#6)(2012-12#5)(2013-8#1)
CD4 T##16##2##(2008-11#6)(2008-4#1)(2012-12#7)(2013-1#1)(2013-8#1)
CD4 and CD8##2##3##(2008-10#1)(2009-8#1)
CD4 and##5##2##(1995-2#1)(1995-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
CD4 antigen on the##2##4##(1991-2#2)
CD4 antigen##3##2##(1991-2#2)(1993-3#1)
CD4 binding##2##2##(1993-3#2)
CD4 cell count and##2##4##(2006-10#1)(2012-2#1)
CD4 cell count##5##3##(2006-10#1)(2007-12#1)(2008-5#1)(2009-8#1)(2012-2#1)
CD4 cell counts##3##3##(2006-10#1)(2009-8#1)(2013-8#1)
CD4 cell##10##2##(2006-10#2)(2007-12#1)(2008-5#3)(2009-8#2)(2012-2#1)(2013-8#1)
CD4 cells##7##2##(1994-8#1)(1995-3#1)(2006-10#2)(2012-2#3)
CD4 count was##2##3##(2007-2#1)(2007-7#1)
CD4 count##6##2##(2007-2#1)(2007-7#1)(2008-6#1)(2010-12#3)
CD4 counts##7##2##(1994-11#2)(2010-8#1)(2011-1#3)(2012-12#1)
CD4 lymphocytes in##2##3##(2012-2#2)
CD4 lymphocytes##5##2##(1990-12#1)(2012-2#4)
CD4 lymphopenia in elderly patients##2##5##(1996-3#2)
CD4##88##1##(1990-12#1)(1991-2#2)(1992-5#1)(1992-6#1)(1993-3#10)(1994-11#3)(1994-8#1)(1995-2#2)(1995-3#2)(1996-3#2)(1997-2#1)(1997-4#1)(2006-10#5)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#3)(2010-12#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#8)(2012-2#9)(2013-1#4)(2013-8#4)
CD4(+) CD8(-)##3##2##(2008-5#1)(2008-9#2)
CD4(+) T cell-rich population##3##4##(2008-11#3)
CD4(+) T cells and##2##4##(2008-11#1)(2013-8#1)
CD4(+) T cells from##2##4##(2008-11#2)
CD4(+) T cells to##3##4##(2008-11#3)
CD4(+) T cells with##2##4##(2008-9#1)(2010-1#1)
CD4(+) T cells##23##3##(2008-11#17)(2008-4#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-5#1)(2013-8#1)
CD4(+) T helper##2##3##(2008-11#1)(2012-3#1)
CD4(+) T##31##2##(2008-11#22)(2008-4#2)(2008-9#2)(2009-4#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-8#1)
CD4(+) T-cell-deficient chickens##2##3##(2008-5#2)
CD4(+) T-lymphocyte activation##2##3##(2008-10#2)
CD4(+) T-lymphocyte effects##2##3##(2008-10#2)
CD4(+) T-lymphocyte##4##2##(2008-10#4)
CD4(+) T-lymphocytes in##2##3##(2008-10#2)
CD4(+) T-lymphocytes##7##2##(2008-10#7)
CD4(+) and CD8(+)##2##3##(2008-10#1)(2013-8#1)
CD4(+) or CD8(+) T-cell-deficient##2##4##(2008-5#2)
CD4(+) or CD8(+) cells##2##4##(2008-10#1)(2008-9#1)
CD4(+) or CD8(+)##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
CD4(+)##70##1##(2008-10#17)(2008-11#26)(2008-4#3)(2008-5#6)(2008-9#7)(2009-4#1)(2010-1#5)(2010-5#2)(2012-3#1)(2013-8#2)
CD4(-)##2##1##(2008-5#2)
CD4+ T cell##3##3##(1993-8#1)(2007-7#1)(2012-12#1)
CD4+ T cells##7##3##(1994-12#2)(1995-2#1)(1996-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
CD4+ T##12##2##(1990-2#1)(1993-8#1)(1994-12#2)(1995-2#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
CD4+ and CD8+ T cells##5##5##(1995-12#2)(2011-1#1)(2011-2#1)(2013-8#1)
CD4+ and CD8+ T##6##4##(1995-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
CD4+ and CD8+##9##3##(1995-12#3)(1995-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
CD4+ cells##3##2##(1991-1#1)(1994-12#1)(2008-5#1)
CD4+ counts##4##2##(1992-8#1)(2010-8#3)
CD4+ helper##2##2##(1997-8#1)(2008-4#1)
CD4+ lymphocyte count##2##3##(1990-2#1)(1993-12#1)
CD4+##45##1##(1990-12#1)(1990-2#2)(1991-1#3)(1992-8#1)(1993-12#1)(1993-8#2)(1994-12#3)(1995-12#3)(1995-2#2)(1996-12#1)(1997-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-12#1)(2010-8#6)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#3)
CD4+/CD8+ ratio##3##2##(2010-8#3)
CD4+/CD8+##8##1##(2010-8#7)(2013-8#1)
CD4+FOXP3+##3##1##(2013-8#3)
CD4/CD8 ratio##5##2##(1990-2#3)(1991-6#2)
CD40 ligand (CD154)##2##3##(2008-9#2)
CD40 ligand##4##2##(2008-1#1)(2008-11#1)(2008-9#2)
CD40##13##1##(2008-1#1)(2008-10#5)(2008-11#2)(2008-9#2)(2012-2#3)
CD43##2##1##(1997-3#1)(2008-5#1)
CD44 expression##3##2##(1994-10#1)(1995-10#1)(2008-4#1)
CD44##12##1##(1994-10#5)(1994-9#1)(1995-10#1)(2008-4#3)(2009-4#1)(2011-2#1)
CD44(+) and CD34(-)##2##3##(2008-11#2)
CD44(+)##3##1##(2008-10#1)(2008-11#2)
CD44s expression##3##2##(1994-10#2)(2008-4#1)
CD44s##8##1##(1994-10#2)(2008-4#6)
CD44v##2##1##(2008-4#2)
CD45##11##1##(1993-11#5)(1994-6#3)(2009-11#1)(2011-2#1)(2012-2#1)
CD45(-)##5##1##(2008-11#4)(2012-4#1)
CD45RA positive##2##2##(1995-8#2)
CD45RB(high)##2##1##(2008-10#1)(2008-11#1)
CD45RO positive cells##2##3##(1995-8#2)
CD45RO##4##1##(1995-8#2)(2013-8#2)
CD49a(+)##2##1##(2008-11#2)
CD49f(+)##2##1##(2008-11#2)
CD5(+)B cells##3##2##(2011-2#3)
CD5(+)B##4##1##(2011-2#4)
CD54##6##1##(2008-10#6)
CD56##3##1##(2008-9#1)(2010-1#1)(2012-2#1)
CD59##2##1##(2008-8#2)
CD62 and CD63##2##3##(2006-6#2)
CD62P and CD11b##2##3##(2006-6#2)
CD63##6##1##(1997-3#1)(2006-6#2)(2009-4#1)(2009-8#1)(2012-3#1)
CD68##4##1##(2007-8#2)(2012-3#1)(2013-8#1)
CD68)##2##1##(2008-5#1)(2013-8#1)
CD74##2##1##(2012-2#2)
CD8 T cells##2##3##(2007-11#1)(2012-12#1)
CD8 and CD4##2##3##(1990-12#1)(2012-12#1)
CD8 cells##3##2##(1991-6#1)(1996-11#1)(2013-1#1)
CD8##18##1##(1990-12#1)(1991-6#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-11#1)(1997-9#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#2)(2013-1#1)
CD8(+) T cells##5##3##(2008-9#1)(2010-5#1)(2012-2#2)(2013-8#1)
CD8(+) T##8##2##(2008-9#1)(2010-5#3)(2012-2#2)(2013-8#2)
CD8(+) and CD19(+) cells##2##4##(2008-10#2)
CD8(+) and##3##2##(2008-10#2)(2008-9#1)
CD8(+)##23##1##(2008-10#7)(2008-11#2)(2008-5#2)(2008-9#3)(2010-1#1)(2010-5#3)(2012-2#2)(2013-1#1)(2013-8#2)
CD8(-)##4##1##(2008-5#2)(2008-9#2)
CD8+ T cells in the lung##2##6##(2013-8#2)
CD8+ T cells in the##3##5##(2013-8#3)
CD8+ T cells##9##3##(1995-12#2)(2011-1#2)(2011-2#1)(2013-8#4)
CD8+ T##11##2##(1995-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#5)
CD8+ T-cell levels##2##3##(2013-8#2)
CD8+ T-cell##5##2##(2013-8#5)
CD8+ T-cells##2##2##(2013-8#2)
CD8+ cells##2##2##(1991-1#1)(2008-11#1)
CD8+ lymphocytes##3##2##(1995-2#1)(2013-8#2)
CD8+##32##1##(1991-1#1)(1994-5#1)(1995-12#3)(1995-2#2)(1997-7#1)(2007-8#1)(2008-11#2)(2009-8#1)(2010-8#2)(2011-1#2)(2011-2#1)(2013-8#15)
CD8-##2##1##(1997-7#1)(2008-8#1)
CD8/CD3##2##1##(2008-11#2)
CD80##3##1##(2008-10#2)(2008-11#1)
CD86 expression in##2##3##(2008-10#2)
CD86 expression##6##2##(2008-10#6)
CD86##16##1##(2008-10#12)(2008-11#4)
CD8A##3##1##(1997-9#3)
CD8B##2##1##(1997-9#2)
CD8alpha immunoreactive lymphocytes##2##3##(2007-10#2)
CD8alpha##4##1##(1997-9#2)(2007-10#2)
CD9##7##1##(2009-8#7)
CD94##2##1##(2008-8#2)
CD95##2##1##(2008-10#1)(2012-1#1)
CD95/CD95L##3##1##(2012-1#3)
CD95/Ki-67##2##1##(2012-1#2)
CD95L##3##1##(2012-1#3)
CDA and##2##2##(1991-6#1)(1995-12#1)
CDA##12##1##(1991-6#1)(1992-2#1)(1995-1#3)(1995-12#1)(2008-3#2)(2010-8#4)
CDAI##2##1##(2013-8#2)
CDC INPHO##3##2##(1995-12#2)(1996-1#1)
CDC and##3##2##(1996-5#1)(1997-2#1)(1997-3#1)
CDC believes##2##2##(1996-12#1)(1997-3#1)
CDC##27##1##(1992-12#1)(1992-6#3)(1995-12#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#5)(1997-3#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
CDC's##4##1##(1995-12#1)(1997-2#1)(2008-7#2)
CDC2-related protein##2##2##(1993-2#2)
CDC25 and SOS1##2##3##(1994-8#2)
CDC25##4##1##(1994-12#1)(1994-8#3)
CDC28##3##1##(1991-5#3)
CDC43 gene product##2##3##(1990-5#2)
CDC43 gene##3##2##(1990-5#3)
CDC43##4##1##(1990-5#4)
CDC7##2##1##(2012-3#2)
CDCl(3)##4##1##(1996-5#2)(2008-10#2)
CDD/ANP-(99-126)##4##1##(1995-11#4)
CDDP and##2##2##(1993-9#1)(2013-1#1)
CDDP in##2##2##(2008-4#1)(2013-1#1)
CDDP sensitivity was##2##3##(1993-9#1)(2008-4#1)
CDDP sensitivity##6##2##(1993-9#5)(2008-4#1)
CDDP##23##1##(1990-6#2)(1993-9#9)(2008-4#6)(2013-1#6)
CDDP-resistant##2##1##(2008-4#2)
CDDP/DOX was##2##2##(2010-3#2)
CDDP/DOX##4##1##(2010-3#4)
CDER guidance##2##2##(2010-11#2)
CDER##4##1##(2010-11#4)
CDGP##12##1##(2011-1#5)(2011-2#7)
CDH1##2##1##(2008-7#1)(2011-2#1)
CDI process was##2##3##(2010-8#2)
CDI process##4##2##(2010-8#4)
CDI##9##1##(2010-8#9)
CDK##3##1##(2008-11#1)(2008-5#1)(2011-2#1)
CDK2 kinase##2##2##(1997-1#2)
CDK2 phosphorylation##2##2##(1997-1#2)
CDK2##14##1##(1993-11#5)(1993-6#1)(1994-12#1)(1997-1#5)(1997-6#1)(2008-5#1)
CDKN2A##14##1##(1997-7#4)(2008-11#1)(2008-12#4)(2008-7#4)(2011-2#1)
CDKs were##2##2##(1997-6#1)(2012-12#1)
CDKs##7##1##(1997-6#5)(2012-12#2)
CDM-PSS DGT##2##2##(2008-10#2)
CDOCT##3##1##(2007-12#3)
CDOM##3##1##(2008-2#3)
CDP infused into the medial septum##2##6##(1993-12#2)
CDP treatment##2##2##(1994-3#2)
CDP##14##1##(1992-8#1)(1993-12#8)(1994-3#2)(1997-2#3)
CDP-Choline##2##1##(1991-6#2)
CDP-choline##3##1##(1995-3#3)
CDR##2##1##(2012-12#1)(2013-1#1)
CDR3##3##1##(1997-9#3)
CDRs##2##1##(2008-4#1)(2012-2#1)
CDS and##2##2##(2008-3#2)
CDS##16##1##(1990-6#1)(2008-3#13)(2010-5#2)
CDSS##3##1##(2011-2#3)
CDSs##6##1##(1996-12#6)
CDT##9##1##(1993-8#3)(1997-2#5)(2011-2#1)
CDTR-PI##3##1##(2011-2#3)
CDV##7##1##(2008-12#4)(2009-8#1)(2012-3#2)
CDY##3##1##(2008-11#3)
CDs were##3##2##(1995-11#1)(2008-10#2)
CDs##12##1##(1995-11#1)(2008-10#11)
CDw 60##2##2##(1992-9#2)
CE and##7##2##(2008-10#6)(2011-1#1)
CE are##2##2##(2008-10#1)(2008-5#1)
CE for the##2##3##(2008-10#2)
CE for##4##2##(2008-10#4)
CE investigations used##2##3##(1996-5#2)
CE maturation##5##2##(2008-5#5)
CE maturity##2##2##(2008-5#2)
CE method##6##2##(1996-5#1)(1997-2#2)(2008-10#3)
CE modes##2##2##(2008-10#2)
CE offers a number of advantages over slab gel separations in terms of speed##2##14##(2008-2#1)(2008-4#1)
CE procedure developed##3##3##(2008-10#3)
CE separation of##4##3##(1996-5#3)(2008-10#1)
CE separations##3##2##(1994-9#1)(2008-10#2)
CE with##4##2##(1994-9#1)(2008-10#3)
CE##88##1##(1994-12#2)(1994-9#4)(1996-5#10)(1996-8#1)(1997-2#2)(2008-10#42)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#12)(2008-7#1)(2010-5#1)(2010-7#1)(2011-1#5)(2012-12#1)(2013-1#1)(2013-8#1)
CE-ICP-MS##2##1##(2008-10#2)
CE-MRA in paediatric patients##2##4##(2008-7#2)
CE-MRA is##2##2##(2008-7#2)
CE-MRA using##2##2##(2008-7#2)
CE-MRA##13##1##(2008-7#13)
CE-UV##4##1##(2008-10#4)
CEA AIA-PACK##2##2##(1994-2#2)
CEA and##4##2##(1990-6#1)(1992-11#2)(2008-11#1)
CEA in##3##2##(1994-2#2)(2008-10#1)
CEA levels##4##2##(1990-6#1)(1991-4#2)(1997-8#1)
CEA values##3##2##(1991-4#2)(1992-8#1)
CEA was##2##2##(2008-11#1)(2009-11#1)
CEA##42##1##(1990-5#2)(1990-6#3)(1991-4#6)(1991-6#1)(1991-8#1)(1992-11#4)(1992-2#1)(1992-8#1)(1994-12#1)(1994-2#7)(1994-5#1)(1994-7#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#7)(2009-11#1)(2012-12#1)
CEA-like##3##1##(1994-2#3)
CEA-related genes##2##2##(1992-6#2)
CEC and CEP##4##3##(2010-1#4)
CEC system##2##2##(2008-10#2)
CEC##9##1##(2008-10#4)(2010-1#5)
CECT 2413##2##2##(2008-10#2)
CECT##11##1##(2008-10#2)(2012-12#8)(2013-8#1)
CEE##6##1##(1995-3#1)(2013-1#5)
CEES##2##1##(2008-10#2)
CEF and##3##2##(1991-5#1)(2008-10#2)
CEF##8##1##(1991-5#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
CELISA##3##1##(1990-12#3)
CELL-ELISA##3##1##(1990-12#3)
CELLSNOW carriers##2##2##(1994-5#2)
CELLSNOW##3##1##(1994-5#3)
CEM##7##1##(1992-8#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#2)(2011-3#1)
CEN##3##1##(1996-2#1)(2010-8#1)(2012-3#1)
CENP-B box / pJalpha##2##4##(2008-7#2)
CENP-B box##3##2##(2008-7#3)
CENTRAL and##2##2##(2009-7#1)(2013-1#1)
CEO and##2##2##(1995-2#1)(2013-1#1)
CEO##8##1##(1990-4#1)(1995-2#3)(2008-1#3)(2013-1#1)
CEO's##2##1##(1991-3#1)(1992-2#1)
CEOP##2##1##(1990-12#2)
CEOs##6##1##(1993-2#1)(1994-2#1)(1995-3#2)(1996-2#1)(1996-3#1)
CEP##6##1##(1994-12#1)(2010-1#5)
CEPH##2##1##(1994-9#1)(2008-12#1)
CER cells##2##2##(2007-6#2)
CER##11##1##(1993-5#1)(2007-6#3)(2008-5#7)
CER3 and PA-d(31)##4##3##(2008-10#4)
CER3 and##5##2##(2008-10#5)
CER3##8##1##(2008-10#8)
CES that##2##2##(2012-3#2)
CES##9##1##(2009-9#2)(2012-3#7)
CES1##3##1##(2009-9#3)
CES5 genes##2##2##(2009-9#2)
CES5##8##1##(2009-9#8)
CETP##9##1##(1995-5#7)(2008-12#2)
CEUS has##3##2##(2010-12#3)
CEUS in the##2##3##(2010-12#2)
CEUS in##3##2##(2010-12#3)
CEUS is##5##2##(2008-7#1)(2010-12#2)(2012-2#2)
CEUS##23##1##(2008-7#3)(2010-12#15)(2012-2#5)
CEVd and CVd-IV##2##3##(2008-10#2)
CEVd and##3##2##(2008-10#3)
CEVd##15##1##(2008-10#15)
CEf and CEr##2##3##(2008-5#2)
CEf##4##1##(2008-5#4)
CEr##3##1##(2008-5#3)
CEs are##2##2##(2008-5#2)
CEs in the##2##3##(2008-5#2)
CEs in##3##2##(2008-5#3)
CEs##16##1##(2008-10#1)(2008-5#15)
CF alpha##2##2##(1995-11#2)
CF and##3##2##(1997-1#1)(1997-6#1)(2008-5#1)
CF concentration##2##2##(2008-10#2)
CF gene##2##2##(1990-3#1)(1990-8#1)
CF in##2##2##(2008-10#1)(2013-1#1)
CF is a##2##3##(2012-3#1)(2013-1#1)
CF patients##2##2##(1990-8#1)(2008-5#1)
CF preparations##2##2##(1997-6#2)
CF projections##2##2##(1994-2#2)
CF was##6##2##(2008-10#2)(2012-3#2)(2013-1#2)
CF##56##1##(1990-3#2)(1990-8#3)(1992-10#4)(1994-2#3)(1995-11#2)(1997-1#4)(1997-6#3)(2008-10#11)(2008-5#7)(2008-6#1)(2008-7#3)(2009-8#2)(2011-3#1)(2012-3#4)(2013-1#6)
CF(3)SO(3)H##3##1##(1996-2#1)(2008-10#1)(2012-3#1)
CF-mediated##2##1##(1994-2#1)(2009-8#1)
CF1/USP protein##2##2##(1993-6#2)
CF1/USP##4##1##(1993-6#4)
CF3CO-proteins##7##1##(1995-3#7)
CF600##3##1##(1991-7#1)(1994-12#2)
CFA and##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
CFA##16##1##(1995-3#2)(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#4)(2012-3#3)(2013-7#2)
CFAs##2##1##(2008-10#2)
CFC propellants##3##2##(1992-3#1)(1996-1#2)
CFC replacements##3##2##(1992-3#3)
CFC##14##1##(1991-12#1)(1992-3#5)(1996-1#4)(1996-2#2)(2008-8#2)
CFCPE##2##1##(2008-10#2)
CFCs and##2##2##(1992-3#2)
CFCs##20##1##(1992-3#6)(1996-1#12)(1996-2#2)
CFD##8##1##(2008-11#2)(2008-6#2)(2010-3#4)
CFF##4##1##(2008-10#3)(2012-2#1)
CFG##2##1##(2008-7#2)
CFH and##7##2##(2008-10#4)(2013-1#3)
CFH or Worland##2##3##(2008-10#2)
CFH##13##1##(2008-10#8)(2013-1#5)
CFI = 0##2##3##(2010-2#2)
CFK-43a##3##1##(1994-12#3)
CFLME##2##1##(2008-10#2)
CFMMV##2##1##(2008-10#2)
CFN##2##1##(2008-10#2)
CFNPE##2##1##(2008-10#2)
CFO##3##1##(1993-2#1)(2008-1#1)(2013-1#1)
CFP intensity##2##2##(2008-9#2)
CFP##4##1##(2008-10#2)(2008-9#2)
CFP- and YFP-tagged proteins##2##4##(2008-9#2)
CFS##6##1##(2009-10#1)(2010-1#5)
CFSE is##2##2##(2008-9#2)
CFSE##3##1##(2008-4#1)(2008-9#2)
CFTR cDNA##4##2##(1994-5#2)(1997-1#1)(2011-3#1)
CFTR gene##6##2##(1997-1#2)(1997-3#1)(2011-3#2)(2012-12#1)
CFTR protein##4##2##(1990-8#3)(2011-3#1)
CFTR##23##1##(1990-8#5)(1994-5#2)(1997-1#3)(1997-3#1)(2008-4#1)(2011-3#9)(2012-12#2)
CFU cm(-2)##2##2##(2008-10#2)
CFU counts##2##2##(2008-10#2)
CFU g(-1) of##3##3##(2008-10#3)
CFU in##2##2##(2008-10#2)
CFU ml(-1) on##2##3##(2008-10#2)
CFU ml(-1)##4##2##(2008-10#4)
CFU of##6##2##(1996-12#1)(2008-10#4)(2013-7#1)
CFU on##2##2##(1997-2#1)(2008-10#1)
CFU per gram of soil were##2##6##(2008-10#2)
CFU per kernel##2##3##(2008-10#2)
CFU per##6##2##(2008-10#6)
CFU##48##1##(1996-12#4)(1997-2#1)(2008-10#39)(2009-6#1)(2013-7#3)
CFU)##4##1##(1997-2#1)(2008-10#3)
CFU/100##2##1##(2012-2#2)
CFU/g of apple##2##3##(2008-10#2)
CFU/g of fresh##2##3##(2008-10#2)
CFU/g of root##2##3##(2008-10#2)
CFU/g of soil##2##3##(2008-10#2)
CFU/g of##11##2##(2008-10#11)
CFU/g##19##1##(2007-3#3)(2008-10#13)(2012-2#3)
CFU/m3 air##2##2##(1997-2#2)
CFU/m3)##2##1##(1997-2#2)
CFU/ml in##3##2##(2008-10#2)(2012-2#1)
CFU/ml of a P6 strain##2##5##(2008-10#2)
CFU/ml of##4##2##(2008-10#4)
CFU/ml##24##1##(2008-10#17)(2008-5#3)(2012-2#4)
CFU/ml) were applied at##2##4##(2008-10#2)
CFU/ml) were##3##2##(2008-10#3)
CFU/ml)##8##1##(2008-10#5)(2008-12#1)(2012-2#2)
CFVs##2##1##(1991-9#2)
CFZ##3##1##(2008-10#3)
CFs##2##1##(1994-2#2)
CG##9##1##(2008-1#3)(2008-4#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
CG15352##2##1##(2008-9#2)
CGA##8##1##(1992-9#5)(2013-8#3)
CGE cycle frequency##2##3##(2010-4#2)
CGE##8##1##(2010-4#8)
CGF##2##1##(2008-10#2)
CGF-1 binding##2##2##(1995-2#2)
CGF-1##4##1##(1995-2#4)
CGG repeat##3##2##(2009-5#3)
CGG##9##1##(1993-9#1)(2008-1#1)(2008-4#2)(2009-5#4)(2012-1#1)
CGH analysis of##2##3##(2008-4#1)(2008-9#1)
CGH is##2##2##(2008-9#1)(2012-3#1)
CGH##15##1##(2008-12#1)(2008-3#7)(2008-4#2)(2008-9#3)(2012-3#2)
CGHs are##2##2##(2008-3#2)
CGHs##4##1##(2008-3#4)
CGM##3##1##(2009-9#2)(2012-4#1)
CGP 42112A##2##2##(1991-12#2)
CGP##3##1##(1990-11#1)(1991-12#2)
CGPR##3##1##(2010-12#3)
CGRP (0##2##2##(1997-4#2)
CGRP (Ki =##2##3##(1993-11#2)
CGRP and##3##2##(1992-6#2)(1997-4#1)
CGRP immunoreactivity in the##2##4##(1990-7#1)(1992-6#1)
CGRP immunoreactivity##3##2##(1990-7#1)(1992-6#1)(1993-3#1)
CGRP in the amygdala##2##4##(1992-6#2)
CGRP in the##7##3##(1990-7#1)(1992-6#5)(1992-9#1)
CGRP in##11##2##(1990-7#1)(1992-6#9)(1992-9#1)
CGRP is released##2##3##(1992-6#2)
CGRP is##5##2##(1992-6#5)
CGRP produced##2##2##(1992-6#2)
CGRP release by##2##3##(1992-6#2)
CGRP release##3##2##(1992-6#3)
CGRP to##2##2##(1992-6#2)
CGRP was##3##2##(1992-6#1)(1997-3#1)(1997-4#1)
CGRP were##2##2##(1992-6#1)(1997-3#1)
CGRP##93##1##(1990-7#2)(1992-6#63)(1992-9#4)(1993-11#2)(1993-3#4)(1997-3#4)(1997-4#10)(2007-2#1)(2008-4#2)(2013-8#1)
CGRP(+) IENFs were##3##3##(2013-8#3)
CGRP(+) IENFs##5##2##(2013-8#5)
CGRP-LI content##2##2##(1994-8#2)
CGRP-LI##6##1##(1992-6#1)(1994-8#5)
CGRP-induced##2##1##(1992-6#2)
CGRP-like immunoreactive##3##2##(1992-6#1)(1997-3#2)
CGRP-like immunoreactivity##3##2##(1992-6#2)(1997-3#1)
CGRP-like##7##1##(1992-6#4)(1997-3#3)
CGRP1##2##1##(1997-4#2)
CGRP8-37##3##1##(1992-6#3)
CGS-9895 and CGS-9896##2##3##(1995-11#2)
CGTase of##2##2##(2008-6#2)
CGTase##4##1##(2008-6#4)
CH _ 2 rocking##3##4##(2008-5#3)
CH _ 2##5##3##(2008-5#5)
CH radical##2##2##(2007-12#1)(2008-2#1)
CH##22##1##(2007-12#2)(2008-10#11)(2008-2#2)(2008-5#5)(2011-2#2)
CH(2) and##2##2##(2008-10#1)(2008-8#1)
CH(2) scissoring##2##2##(2008-10#2)
CH(2)##13##1##(1997-2#1)(2006-12#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-9#1)
CH(2)Cl(2) and##2##2##(1996-2#1)(2008-10#1)
CH(2)Cl(2)##14##1##(1996-2#3)(1996-5#3)(2007-11#1)(2008-10#5)(2008-2#1)(2009-9#1)
CH(2)OCO##2##1##(2008-10#2)
CH(3) symmetric##3##2##(2008-10#3)
CH(3)##12##1##(1996-5#1)(1997-7#1)(2008-10#8)(2008-5#1)(2008-8#1)
CH(3)CN##4##1##(2008-10#4)
CH(3)Hg(+) and Hg(2+)##3##3##(2008-10#3)
CH(3)Hg(+) and##4##2##(2008-10#4)
CH(3)Hg(+)##12##1##(2008-10#12)
CH(3)OH-modified CO(2) supercritical fluid##2##4##(2008-10#2)
CH(3)OH…H(+)…OH(2)##2##1##(2012-12#2)
CH(3)SH##2##1##(2008-10#2)
CH(4) and##4##2##(2008-2#2)(2008-3#2)
CH(4) in##4##2##(2007-12#1)(2008-2#3)
CH(4)##29##1##(2007-12#3)(2008-2#11)(2008-3#12)(2010-7#1)(2012-2#2)
CH(4)-air flames##2##2##(2008-2#1)(2008-3#1)
CH(4)-air##4##1##(2008-2#2)(2008-3#2)
CH(dT)(15)##2##1##(2008-10#2)
CH-0356##2##1##(2008-10#2)
CH-B-15-C-5##2##1##(2008-10#2)
CH2 stretching##3##2##(1994-3#3)
CH2##4##1##(1994-3#3)(1997-2#1)
CH3CN##2##1##(1992-6#2)
CH4 and H2O##2##3##(2008-3#2)
CH4##5##1##(2008-3#5)
CHA##7##1##(1997-1#1)(1997-2#2)(2008-10#4)
CHA's accentuation##3##2##(1997-2#3)
CHA's##4##1##(1997-2#4)
CHA0 in##2##2##(2008-10#2)
CHA0 to##2##2##(2008-10#2)
CHA0##15##1##(2008-10#15)
CHA0r##4##1##(2008-10#4)
CHAC##4##1##(1991-3#2)(1992-3#2)
CHAID Decision##2##2##(2010-8#2)
CHAMPUS##2##1##(1996-12#2)
CHAP##3##1##(2009-6#3)
CHAPS and##3##2##(1990-11#2)(1990-2#1)
CHAPS##11##1##(1990-11#9)(1990-2#1)(2008-10#1)
CHAPS/dodecyl sulfate mixture gave epsilon 550 approximately##2##7##(1990-11#2)
CHARGE##3##1##(2008-9#3)
CHB##3##1##(2008-6#1)(2009-8#1)(2013-1#1)
CHC profiles##3##2##(2012-3#3)
CHC##8##1##(2008-1#1)(2012-3#7)
CHCl(3) and the##2##3##(2008-10#2)
CHCl(3) and##3##2##(2008-10#3)
CHCl(3)##9##1##(2008-10#8)(2008-11#1)
CHCs##8##1##(2011-2#4)(2012-3#4)
CHD events##2##2##(1990-3#1)(2008-3#1)
CHD patients in##2##3##(2009-4#1)(2011-2#1)
CHD patients##5##2##(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#2)
CHD risk##3##2##(2010-8#1)(2011-2#2)
CHD##23##1##(1990-3#5)(2007-10#3)(2008-3#2)(2008-4#1)(2009-4#2)(2010-10#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-2#2)
CHDF was##2##2##(2013-8#2)
CHEC##2##1##(2007-12#2)
CHEF and lambda clone grid##2##5##(1995-6#2)
CHF and##2##2##(2011-2#2)
CHF##17##1##(1995-12#3)(2008-3#3)(2008-5#1)(2009-10#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#2)
CHI and##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
CHI is##2##2##(2013-1#2)
CHI was##2##2##(2008-7#1)(2013-8#1)
CHI without ADHD##2##3##(2013-8#2)
CHI##11##1##(2008-7#3)(2013-1#4)(2013-8#4)
CHIK virus of Asian genotype##2##5##(2011-1#2)
CHIK virus of Central/East African genotype was##3##7##(2011-1#3)
CHIK virus of Central/East African genotype##4##6##(2011-1#4)
CHIK virus of##6##3##(2011-1#6)
CHIK##7##1##(2011-1#7)
CHIN (community health information network)##5##5##(1996-1#5)
CHIN##13##1##(1996-1#11)(1996-3#1)(1997-1#1)
CHINs##4##1##(1996-1#1)(1997-1#3)
CHM##5##1##(2008-10#5)
CHMS##2##1##(2008-12#2)
CHN analysis##2##2##(2008-10#2)
CHN elemental analysis##2##3##(2008-10#2)
CHN##6##1##(2008-10#6)
CHN1##3##1##(2008-10#3)
CHO (Chinese hamster ovary##2##4##(1995-12#1)(2008-11#1)
CHO 1-62 cells##2##3##(2008-11#2)
CHO and BHK cells##2##4##(2008-11#2)
CHO and BHK##3##3##(2008-11#3)
CHO and##6##2##(2008-11#5)(2008-4#1)
CHO cell culture##3##3##(2008-11#2)(2011-2#1)
CHO cell cultures##2##3##(2008-11#1)(2011-2#1)
CHO cell line producing##2##4##(2008-11#2)
CHO cell line were##2##4##(2008-11#2)
CHO cell line##20##3##(1990-8#1)(2008-11#17)(2008-8#1)(2011-2#1)
CHO cell lines##8##3##(2008-11#8)
CHO cell metabolism##2##3##(2011-2#1)(2012-3#1)
CHO cell tumors in nude mice##2##6##(1993-9#2)
CHO cell##43##2##(1990-8#1)(1992-12#1)(1993-9#2)(2008-10#1)(2008-11#30)(2008-2#1)(2008-8#1)(2011-2#5)(2012-3#1)
CHO cells and##4##3##(1994-11#1)(2008-11#2)(2011-2#1)
CHO cells expressing##4##3##(1995-2#2)(2008-11#1)(2010-12#1)
CHO cells in##6##3##(2008-11#5)(2008-7#1)
CHO cells overexpressing##4##3##(1994-11#1)(1995-6#2)(2008-11#1)
CHO cells stably expressing##2##4##(2008-11#1)(2010-12#1)
CHO cells transfected with##3##4##(1992-12#1)(1993-3#1)(1995-6#1)
CHO cells using##2##3##(2008-11#2)
CHO cells was##6##3##(2008-11#5)(2008-7#1)
CHO cells were##7##3##(2008-11#7)
CHO cells##107##2##(1990-12#1)(1990-8#1)(1992-10#2)(1992-12#2)(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#5)(1995-2#3)(1995-3#1)(1995-6#3)(1996-5#1)(1997-1#1)(2008-11#72)(2008-4#3)(2008-7#5)(2010-12#2)(2011-2#1)(2012-3#1)
CHO clones##3##2##(1993-9#2)(2008-11#1)
CHO culture##2##2##(2008-11#2)
CHO or##2##2##(1994-1#1)(2013-1#1)
CHO##202##1##(1990-12#1)(1990-8#2)(1991-6#2)(1992-10#2)(1992-12#4)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#5)(1994-1#3)(1994-11#5)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#133)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#5)(2008-8#1)(2010-12#2)(2011-2#6)(2012-3#2)(2013-1#2)(2013-8#2)
CHO-320 cells##3##2##(2008-11#3)
CHO-DG44 cells##2##2##(2008-11#2)
CHO-IR cells##3##2##(1994-11#3)
CHO-K1 and##2##2##(2008-11#2)
CHO-K1 cell line##2##3##(2008-11#2)
CHO-K1 cell##4##2##(1997-1#1)(2008-11#3)
CHO-K1 cells##13##2##(1993-6#2)(1994-11#1)(1996-5#1)(1997-1#1)(2008-11#8)
CHO-K1##23##1##(1993-6#2)(1994-11#1)(1996-5#1)(1997-1#2)(2008-11#17)
CHO-KI##2##1##(1997-4#1)(1997-7#1)
CHO-PRO##2##1##(2013-1#2)
CHO-S cells##2##2##(2008-11#2)
CHO-TAg##2##1##(2008-11#2)
CHOE1a##2##1##(2008-11#2)
CHOICE##5##1##(1997-5#1)(2012-12#4)
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits##2##14##(2008-12#2)
CHOP##5##1##(1992-12#1)(2008-12#2)(2008-7#1)(2012-2#1)
CHOcells##2##1##(2008-11#2)
CHP-126 neuroblastomas##2##2##(1995-12#2)
CHROMagar Candida##4##2##(2008-5#4)
CHT##3##1##(2008-10#3)
CHU##6##1##(2008-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
CHUP1##2##1##(2009-8#2)
CHV1##4##1##(2008-10#4)
CHV1-type dsRNAs##2##2##(2008-10#2)
CHV2-NB58##3##1##(2008-10#3)
CHV2-type dsRNAs##2##2##(2008-10#2)
CHV3-type dsRNAs##4##2##(2008-10#4)
CHX and NaOCl##3##3##(2013-1#3)
CHX##11##1##(2011-3#5)(2013-1#6)
CHr##2##1##(2011-1#2)
CI (1##3##2##(2007-7#1)(2008-6#2)
CI 0##31##2##(1992-2#1)(1993-9#4)(2007-10#1)(2008-12#1)(2008-8#1)(2009-9#3)(2010-3#2)(2011-1#5)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#5)
CI 1##38##2##(1993-12#1)(1993-9#2)(1995-6#1)(2007-2#4)(2008-11#2)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#14)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
CI 13227 and L-574-1##3##4##(2008-10#3)
CI 13227 and##6##3##(2008-10#6)
CI 13227##15##2##(2008-10#15)
CI 2##15##2##(1993-12#1)(1995-6#1)(2008-8#4)(2010-9#1)(2011-2#5)(2012-12#1)(2013-1#2)
CI 3##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
CI 6##2##2##(2010-9#1)(2011-2#1)
CI 95% 1##3##3##(2011-1#1)(2013-1#2)
CI 95%##6##2##(2008-10#1)(2011-1#1)(2013-1#4)
CI 988##4##2##(1996-2#4)
CI = 0##3##3##(2008-7#2)(2009-9#1)
CI = 1##2##3##(2010-10#1)(2011-2#1)
CI = 3##2##3##(2008-5#1)(2011-2#1)
CI =##13##2##(1996-1#3)(2008-5#2)(2008-7#2)(2009-7#2)(2009-9#1)(2010-10#1)(2011-2#2)
CI and##2##2##(2010-10#1)(2012-2#1)
CI can##2##2##(2008-8#2)
CI of##3##2##(2008-7#2)(2013-1#1)
CI strains##5##2##(2008-8#5)
CI was##2##2##(1993-10#1)(2007-10#1)
CI were##2##2##(2008-7#1)(2013-1#1)
CI##336##1##(1990-6#1)(1991-6#2)(1992-10#1)(1992-2#2)(1992-6#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-9#8)(1994-12#7)(1994-2#1)(1995-6#2)(1996-1#3)(1996-2#4)(2006-10#1)(2007-10#17)(2007-12#3)(2007-2#6)(2007-5#2)(2007-7#2)(2007-8#3)(2008-10#31)(2008-11#9)(2008-12#18)(2008-5#2)(2008-6#5)(2008-7#9)(2008-8#22)(2008-9#3)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#7)(2010-10#5)(2010-11#1)(2010-3#12)(2010-4#11)(2010-8#4)(2010-9#3)(2011-1#8)(2011-2#37)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#13)(2013-1#36)(2013-8#3)
CI(-)##2##1##(2008-10#2)
CI) was##2##2##(2007-10#1)(2012-12#1)
CI)##9##1##(2007-10#1)(2008-10#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#3)
CI-1##3##1##(1990-3#1)(1994-6#2)
CI-1a and CI-1b##2##3##(1994-6#2)
CI-1a##4##1##(1994-6#4)
CI-1b##4##1##(1994-6#4)
CI-2##3##1##(1994-6#3)
CI-mixture##2##1##(2008-5#2)
CI24##2##1##(2008-9#2)
CIA##5##1##(1990-12#1)(1990-6#2)(2008-11#2)
CIC level##2##2##(2007-11#2)
CIC##5##1##(1990-12#1)(2007-11#2)(2008-10#2)
CID##2##1##(2008-9#1)(2012-12#1)
CIDP##4##1##(2013-1#4)
CIDR##4##1##(2008-12#4)
CIE and##3##2##(1994-9#1)(2008-5#2)
CIE##11##1##(1994-9#2)(2008-2#3)(2008-3#2)(2008-5#2)(2010-2#1)(2010-4#1)
CII deficiency##2##2##(1993-6#2)
CII gene##2##2##(1993-6#2)
CII##12##1##(1993-6#6)(1996-12#1)(2008-9#5)
CIM##7##1##(2012-3#7)
CIMT##2##1##(2012-3#1)(2013-8#1)
CIN 612##2##2##(2008-4#2)
CIN I variant##2##3##(1994-1#2)
CIN I##3##2##(1994-1#3)
CIN II or more severe lesions##2##6##(1992-10#2)
CIN II or##3##3##(1992-10#2)(1994-2#1)
CIN III patients##2##3##(1992-8#2)
CIN III##3##2##(1992-10#1)(1992-8#2)
CIN and##3##2##(2011-1#1)(2012-3#2)
CIN were##3##2##(2011-1#2)(2011-2#1)
CIN##39##1##(1991-2#2)(1992-10#3)(1992-8#2)(1994-1#7)(1994-12#1)(1994-2#3)(1995-9#1)(1996-8#1)(2008-4#2)(2010-10#2)(2011-1#7)(2011-2#5)(2012-3#3)
CINAHL##8##1##(1992-12#1)(1994-3#4)(1996-3#1)(2013-1#2)
CINCA syndrome and##2##3##(2012-2#2)
CINCA syndrome##9##2##(2012-2#9)
CINV##6##1##(2008-7#6)
CIO##4##1##(1992-3#1)(1993-2#2)(2008-1#1)
CIOs##3##1##(1993-2#1)(1993-3#1)(1996-3#1)
CIP and CIM##2##3##(2012-3#2)
CIP and##5##2##(2008-10#2)(2012-3#3)
CIP##12##1##(2008-10#5)(2011-2#1)(2012-3#6)
CIP1##2##1##(1997-7#1)(2008-11#1)
CIPIC##2##1##(2008-10#2)
CIPIC-conjugated CCL##4##2##(2008-10#4)
CIPs of##4##2##(2008-10#4)
CIPs##7##1##(2008-10#7)
CIRC##2##1##(2013-8#2)
CIRCADIAN##2##1##(2008-11#2)
CIRP##3##1##(1997-7#3)
CIS##6##1##(1994-1#1)(1994-9#1)(2008-9#4)
CIT##2##1##(2007-10#2)
CITED1 expression is detected in##2##5##(2013-1#2)
CITED1 is##2##2##(2013-1#2)
CITED1##9##1##(2013-1#9)
CITP##2##1##(2008-10#2)
CIU##4##1##(2009-7#4)
CIho 4780##3##2##(2008-10#3)
CIho##8##1##(2008-10#8)
CIs in##3##2##(2012-2#3)
CIs##7##1##(2008-8#2)(2012-2#4)(2013-1#1)
CJC##4##1##(2008-7#4)
CJD##2##1##(1996-11#1)(1997-8#1)
CK activity##2##2##(1990-11#1)(1991-2#1)
CK and##2##2##(2008-11#1)(2013-8#1)
CK##20##1##(1990-11#1)(1990-2#2)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1993-6#1)(1994-12#1)(2008-11#5)(2011-2#1)(2011-3#3)(2013-8#1)
CK)##2##1##(1991-2#1)(1992-3#1)
CK-1##6##1##(1992-6#1)(1997-6#5)
CK-2##5##1##(1992-6#4)(1994-6#1)
CK-B gene##2##2##(1991-6#2)
CK-II##4##1##(1993-2#4)
CK-MB and TPI##2##3##(2011-2#2)
CK-MB isoform##2##2##(1992-3#2)
CK-MB mass and troponin I##2##5##(2008-10#2)
CK-MB##12##1##(1991-2#1)(1992-3#4)(2007-8#1)(2008-10#4)(2011-2#2)
CK-MM3 and##2##2##(1991-2#2)
CK-MM3 is##2##2##(1991-2#2)
CK-MM3##10##1##(1991-2#10)
CK8##5##1##(2008-11#4)(2011-2#1)
CKD and their##2##3##(2010-4#2)
CKD patients##7##2##(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#3)
CKD stage##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
CKD##28##1##(2009-1#5)(2010-10#2)(2010-4#3)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#4)
CKII##4##1##(1990-12#4)
CL and##2##2##(2008-10#1)(2008-3#1)
CL detection##12##2##(2008-10#12)
CL emission were investigated##2##4##(2008-10#1)(2010-4#1)
CL emission##11##2##(2008-10#10)(2010-4#1)
CL enhancement##3##2##(2008-10#3)
CL expressed##2##2##(2008-8#2)
CL flow##2##2##(2008-10#2)
CL generated##2##2##(1991-9#1)(2008-10#1)
CL inhibition##2##2##(2008-10#2)
CL intensity is linear with##2##5##(2008-10#2)
CL intensity is##3##3##(2008-10#3)
CL intensity was linear to the##3##6##(2008-10#3)
CL intensity was linear with##3##5##(2008-10#3)
CL intensity was linear##7##4##(2008-10#7)
CL intensity was##8##3##(2008-10#8)
CL intensity##23##2##(2008-10#22)(2010-4#1)
CL method##2##2##(1995-3#1)(2008-10#1)
CL methods##2##2##(1995-2#1)(2008-10#1)
CL occurred##2##2##(1991-9#1)(2008-10#1)
CL of##5##2##(2008-10#3)(2008-8#2)
CL reaction of##9##3##(2008-10#9)
CL reaction was studied##2##4##(2008-10#2)
CL reaction was##4##3##(2008-10#4)
CL reaction##20##2##(2008-10#19)(2010-4#1)
CL reagent##7##2##(2008-10#7)
CL reagents##2##2##(2008-10#2)
CL sensor##3##2##(2008-10#3)
CL signal##5##2##(1995-3#1)(2008-10#4)
CL spectra##2##2##(2008-10#1)(2010-4#1)
CL system##8##2##(2008-10#8)
CL systems##2##2##(2008-10#2)
CL was##6##2##(2008-10#5)(2008-9#1)
CL##193##1##(1991-2#2)(1991-9#12)(1994-3#1)(1995-2#2)(1995-3#4)(2007-11#1)(2007-7#2)(2008-10#134)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#14)(2008-9#8)(2010-4#4)(2013-8#1)
CL's##2##1##(2008-3#1)(2008-8#1)
CL)##2##1##(1997-5#1)(2008-12#1)
CL-1000##7##1##(2008-11#7)
CL-11G##2##1##(2008-11#2)
CL-6B##4##1##(1990-12#2)(1997-2#2)
CL-emission generated##2##2##(2008-10#2)
CL-emission##7##1##(2008-10#7)
CL218##3##1##(1995-11#3)
CLA supplementation##2##2##(2008-5#2)
CLA##11##1##(1993-8#3)(2008-5#7)(2012-2#1)
CLASSIFICATION##2##1##(2008-11#1)(2010-1#1)
CLB doses##4##2##(2007-10#4)
CLB##17##1##(2007-10#11)(2008-10#6)
CLBO crystal##2##2##(2008-3#2)
CLBO##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
CLCP##2##1##(2008-3#2)
CLCrV##7##1##(2008-10#7)
CLCuV##2##1##(2008-9#2)
CLD##2##1##(1992-2#2)
CLE genes##3##2##(2009-8#3)
CLEAN##2##1##(2008-3#2)
CLGC##3##1##(2009-11#3)
CLIA##2##1##(1993-3#1)(1994-2#1)
CLIMEX model##3##2##(2008-10#3)
CLIMEX##5##1##(2008-10#5)
CLINICAL ACTIVITIES AUDIT##2##3##(2007-11#2)
CLINICAL PRESENTATION##4##2##(2012-2#4)
CLINICAL##12##1##(1997-5#1)(2007-11#2)(2008-9#1)(2009-4#1)(2012-2#5)(2012-3#2)
CLIP##3##1##(1995-11#3)
CLL cell##2##2##(1995-2#2)
CLL cells##4##2##(1995-2#4)
CLL##18##1##(1991-4#1)(1995-2#7)(2008-11#1)(2008-4#1)(2008-9#4)(2009-12#2)(2009-2#1)(2011-2#1)
CLM is##2##2##(2007-2#1)(2012-3#1)
CLM##7##1##(2007-2#4)(2008-10#1)(2012-3#2)
CLMMG mucosa##3##2##(2009-3#3)
CLMMG##4##1##(2009-3#4)
CLN##2##1##(1991-5#2)
CLN1 and CLN2 mRNAs##2##4##(1991-5#2)
CLN1 and CLN2##5##3##(1991-5#5)
CLN1 and##6##2##(1991-5#5)(2009-5#1)
CLN1##8##1##(1991-5#6)(2009-5#2)
CLN2##8##1##(1991-5#6)(2009-5#2)
CLN3##5##1##(1991-5#2)(1994-11#1)(2009-5#2)
CLN5##2##1##(2009-5#2)
CLN6##2##1##(2009-5#2)
CLN7##2##1##(2009-5#2)
CLN8##2##1##(2009-5#2)
CLND and UV##2##3##(1997-2#2)
CLND##3##1##(1997-2#2)(2008-10#1)
CLO products##3##2##(2011-2#3)
CLOTBUST trial##2##2##(2008-8#2)
CLOTBUST##3##1##(2008-8#3)
CLP and SCLP##2##3##(2012-3#2)
CLP injury##3##2##(2012-3#3)
CLP##19##1##(2011-2#1)(2012-3#18)
CLPT##4##1##(2012-3#4)
CLS##12##1##(2008-10#8)(2012-3#4)
CLSA##3##1##(1995-12#2)(2008-10#1)
CLSM and MPLSM##2##3##(2008-9#2)
CLSM##4##1##(2008-4#1)(2008-5#1)(2008-9#2)
CLUSTERING##3##1##(2009-11#1)(2010-1#1)(2013-1#1)
CLcr=(1##2##1##(2008-7#2)
CM and##2##2##(2008-10#1)(2012-3#1)
CM group##3##2##(2012-3#3)
CM injection##2##2##(2011-2#2)
CM is##2##2##(2008-10#2)
CM layer is##2##3##(2008-10#2)
CM that##2##2##(2008-10#2)
CM##33##1##(1993-12#1)(1996-5#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#3)(2010-11#1)(2011-2#6)(2012-12#1)(2012-3#7)
CM-Cellulose##2##1##(2008-8#2)
CM-cellulose##2##1##(1990-7#1)(1997-6#1)
CM-dextran##7##1##(2008-10#7)
CM-glucan##4##1##(2008-5#4)
CM-hyaluronic acid##2##2##(2008-10#2)
CM334##4##1##(2008-10#4)
CMA3##5##1##(2008-12#5)
CMC and##2##2##(1993-6#2)
CMC was##3##2##(1993-6#1)(2008-10#2)
CMC##19##1##(1990-2#1)(1993-6#3)(1996-5#2)(2008-10#10)(2008-9#1)(2010-11#1)(2012-2#1)
CMCC##2##1##(2010-7#2)
CMD##4##1##(1991-9#2)(2007-11#1)(2008-10#1)
CMD1 gene##2##2##(1991-9#2)
CMD1##3##1##(1991-9#3)
CME surfaces##2##2##(2008-10#2)
CME was##2##2##(2008-10#2)
CME##13##1##(2008-1#1)(2008-10#9)(2010-11#1)(2010-12#1)(2012-3#1)
CME's##2##1##(2008-10#2)
CMF deposition##2##2##(2008-11#2)
CMF##10##1##(1992-12#2)(2008-11#3)(2009-1#5)
CMG groups were found to be##2##6##(1993-12#2)
CMG groups##4##2##(1993-12#4)
CMG##5##1##(1993-12#4)(1994-3#1)
CMGs##2##1##(1992-3#1)(1994-3#1)
CMH##2##1##(1992-2#1)(1994-3#1)
CMI films are##2##3##(2008-3#2)
CMI films can be##2##4##(2008-3#2)
CMI films##5##2##(2008-3#5)
CMI##15##1##(1995-5#2)(2007-2#1)(2007-7#2)(2008-12#1)(2008-3#5)(2011-1#2)(2011-2#2)
CMIV gene##2##2##(2008-8#2)
CMIV##5##1##(2008-8#5)
CML cell##2##2##(1991-4#1)(2010-11#1)
CML cells##2##2##(1990-2#1)(1991-4#1)
CML hydrogel##3##2##(2009-7#3)
CML patients##3##2##(2010-11#1)(2010-4#1)(2012-12#1)
CML stem cell##3##3##(2010-4#3)
CML stem##4##2##(2010-4#4)
CML##36##1##(1990-2#2)(1991-4#2)(1992-2#1)(1994-10#1)(1997-3#2)(2007-11#2)(2008-6#1)(2009-7#3)(2010-11#4)(2010-4#10)(2011-2#2)(2012-12#6)
CMLV##7##1##(2008-10#7)
CMM and##2##2##(2007-10#1)(2012-3#1)
CMM##10##1##(2007-10#4)(2008-7#4)(2012-3#2)
CMOS sensor##2##2##(2008-10#1)(2011-1#1)
CMOS##9##1##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-1#1)
CMP were##2##2##(1990-5#1)(2008-8#1)
CMP##10##1##(1990-11#5)(1990-5#1)(1992-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
CMPS-PAN##2##1##(2008-10#2)
CMR for##2##2##(2010-11#1)(2010-8#1)
CMR##4##1##(2010-11#3)(2010-8#1)
CMRI##2##1##(2013-3#2)
CMRglc##2##1##(1996-5#2)
CMS and##2##2##(2008-11#1)(2010-9#1)
CMS##16##1##(1995-2#2)(1996-7#3)(2008-10#4)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#3)(2012-3#1)
CMT is##2##2##(2009-10#2)
CMT##14##1##(2007-8#2)(2009-10#5)(2011-2#2)(2013-1#2)(2013-7#3)
CMT-3##2##1##(1992-9#2)
CMT-93##3##1##(2008-11#3)
CMT-U27##2##1##(2012-1#2)
CMT1A duplication##2##2##(1997-3#2)
CMT1A##8##1##(1997-3#7)(2013-1#1)
CMT4C##4##1##(2013-1#4)
CMV (-)##2##2##(2008-10#2)
CMV +##3##2##(2008-10#3)
CMV DNA##3##2##(2010-12#3)
CMV and##6##2##(2007-7#1)(2008-10#4)(2010-12#1)
CMV colitis##2##2##(2010-12#2)
CMV disease##2##2##(2007-7#1)(2008-10#1)
CMV in##3##2##(1992-6#1)(2008-10#1)(2010-12#1)
CMV incidence##2##2##(2008-10#2)
CMV infection was##2##3##(2007-7#1)(2011-2#1)
CMV infection##7##2##(2007-7#2)(2008-10#1)(2011-2#1)(2012-2#3)
CMV infections##2##2##(2008-10#1)(2010-12#1)
CMV is##2##2##(2008-10#1)(2010-12#1)
CMV isolates from##2##3##(2008-10#2)
CMV isolates##6##2##(2008-10#6)
CMV population##2##2##(2008-10#2)
CMV positive##2##2##(2008-11#1)(2010-12#1)
CMV promoter was##2##3##(2008-11#1)(2008-9#1)
CMV promoter##6##2##(1995-12#1)(1996-12#1)(2008-11#2)(2008-8#1)(2008-9#1)
CMV retinitis##2##2##(1996-8#1)(2007-12#1)
CMV strains##5##2##(2008-10#5)
CMV was detected in the##2##5##(2008-10#2)
CMV was detected##3##3##(2008-10#3)
CMV was##8##2##(2008-10#8)
CMV##104##1##(1992-6#6)(1994-11#1)(1995-12#1)(1996-12#1)(1996-8#1)(2007-12#1)(2007-7#7)(2008-10#61)(2008-11#3)(2008-8#3)(2008-9#1)(2010-12#12)(2011-2#2)(2012-2#4)
CMV-Y##3##1##(1997-6#3)
CMV-infected plants##2##2##(2008-10#1)(2012-2#1)
CMV-infected##3##1##(2008-10#2)(2012-2#1)
CMV-satRNA##3##1##(2008-10#3)
CMX##2##1##(1997-5#2)
CMoV##5##1##(2008-10#5)
CN IX##5##2##(2011-2#5)
CN and##2##2##(2008-9#2)
CN radical##2##2##(2008-10#2)
CN##28##1##(1995-9#1)(1996-5#2)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#7)(2011-1#1)(2011-2#6)
CN(-)##9##1##(2008-10#9)
CN-met##4##1##(1997-2#4)
CNAs##2##1##(2008-11#1)(2010-11#1)
CNBr peptides##2##2##(1996-5#2)
CNBr##7##1##(1990-5#1)(1991-12#1)(1992-12#1)(1993-8#1)(1995-5#1)(1996-5#2)
CNBr-Rev##2##1##(1993-8#2)
CNC##6##1##(2008-9#1)(2013-8#5)
CNDAC##5##1##(1992-5#5)
CNG channels##5##2##(2009-10#5)
CNICC##2##1##(2008-10#2)
CNL patients##4##2##(2008-7#4)
CNL##6##1##(2008-7#5)(2012-2#1)
CNMI##5##1##(2008-1#5)
CNP in##2##2##(1990-7#1)(1994-11#1)
CNP mRNA was##2##3##(1993-11#2)
CNP was##2##2##(1990-7#1)(1993-11#1)
CNP##13##1##(1990-12#1)(1990-7#2)(1993-11#4)(1994-11#3)(1994-8#2)(2011-2#1)
CNP-22##3##1##(1990-7#3)
CNP-53##2##1##(1990-7#1)(1993-11#1)
CNPHI##3##1##(2008-11#3)
CNQX##3##1##(1994-11#1)(1996-2#1)(2008-1#1)
CNR##4##1##(2008-2#3)(2008-3#1)
CNS and PNS##4##3##(1995-12#1)(2008-7#3)
CNS and##10##2##(1990-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-7#4)(2011-2#1)(2012-2#1)
CNS arousal##2##2##(2008-11#2)
CNS development##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
CNS disease##4##2##(2008-7#2)(2011-2#1)(2012-2#1)
CNS diseases##3##2##(1994-9#1)(2008-7#1)(2012-2#1)
CNS disorders##3##2##(2008-5#1)(2008-7#1)(2013-7#1)
CNS function##2##2##(1994-5#1)(2008-4#1)
CNS in##2##2##(1992-10#1)(2008-8#1)
CNS involvement by##2##3##(2012-3#2)
CNS involvement in##2##3##(1997-8#1)(2012-3#1)
CNS involvement##8##2##(1997-8#1)(2011-2#4)(2012-3#3)
CNS is located on the##2##5##(2008-5#2)
CNS is##3##2##(2008-5#2)(2008-8#1)
CNS myelination##4##2##(2008-7#3)(2009-6#1)
CNS neurons##2##2##(1991-12#2)
CNS of##4##2##(1994-2#1)(2008-7#2)(2009-8#1)
CNS or##2##2##(1997-3#1)(2008-7#1)
CNS tissue and##2##3##(2008-5#1)(2008-7#1)
CNS were##2##2##(1996-12#1)(2008-12#1)
CNS##166##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#4)(1991-12#6)(1991-2#1)(1992-10#3)(1992-8#1)(1993-5#2)(1993-6#2)(1994-2#2)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#4)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-11#4)(2008-12#4)(2008-2#2)(2008-4#5)(2008-5#14)(2008-7#39)(2008-8#9)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#11)(2012-1#1)(2012-2#4)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#1)
CNT Josephson junctions##2##3##(2008-7#2)
CNT content##2##2##(2009-11#2)
CNT sensor##2##2##(2013-8#2)
CNT##17##1##(2008-10#4)(2008-7#4)(2009-11#5)(2010-4#1)(2013-8#3)
CNT-metal##2##1##(2008-7#2)
CNTF##20##1##(1990-5#6)(1991-6#3)(1996-2#5)(1996-5#5)(2008-5#1)
CNTO 328##5##2##(2009-4#5)
CNTO 328/dex##3##2##(2009-4#3)
CNTO##8##1##(2009-4#8)
CNTs are##2##2##(2008-7#2)
CNTs on##2##2##(2008-7#2)
CNTs##14##1##(2008-10#2)(2008-7#7)(2009-11#1)(2010-4#1)(2011-2#3)
CNVM##3##1##(2010-10#3)
CO 2 laser##21##3##(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#9)(1993-1#1)
CO 2 lasers##3##3##(1991-3#2)(1992-12#1)
CO 2##26##2##(1991-2#3)(1991-3#4)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#10)(1993-1#1)
CO activity in##2##3##(1997-2#2)
CO activity##4##2##(1991-8#1)(1997-2#3)
CO and CH(4)##2##3##(2008-3#2)
CO and CO(2)##2##3##(2008-10#1)(2008-2#1)
CO and##11##2##(1991-5#1)(1993-12#1)(1996-12#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
CO binding##2##2##(1990-3#1)(1995-2#1)
CO concentration##4##2##(1990-5#1)(2008-2#1)(2008-3#2)
CO concentrations in##2##3##(2008-2#1)(2008-3#1)
CO concentrations##6##2##(1990-5#3)(2008-2#1)(2008-3#2)
CO exposure##3##2##(1990-5#3)
CO isolate##3##2##(2008-10#3)
CO laser##3##2##(2007-12#1)(2008-2#2)
CO molecules##3##2##(1990-3#2)(2008-2#1)
CO poisoning##2##2##(1990-5#1)(1997-6#1)
CO production##4##2##(1995-2#1)(1995-3#3)
CO recombination##2##2##(1994-11#2)
CO rotational##2##2##(2008-3#2)
CO stretching vibration##2##3##(2008-10#2)
CO stretching##5##2##(1996-2#2)(2008-10#2)(2008-8#1)
CO volume fractions##3##3##(2013-8#3)
CO was##2##2##(1991-8#1)(1997-2#1)
CO##162##1##(1990-3#7)(1990-4#1)(1990-5#9)(1990-8#2)(1991-2#3)(1991-3#4)(1991-5#3)(1991-8#3)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#10)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-11#3)(1994-6#3)(1995-12#1)(1995-2#7)(1995-3#5)(1996-12#3)(1996-2#5)(1997-2#4)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#18)(2008-2#16)(2008-3#24)(2008-4#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-12#3)(2013-1#1)(2013-8#3)
CO&gt##3##1##(2007-11#1)(2007-12#2)
CO(2) Doppler lidar##2##3##(2008-2#1)(2008-3#1)
CO(2) Laser##4##2##(2008-2#2)(2008-3#1)(2012-3#1)
CO(2) absorption##2##2##(2008-2#1)(2008-3#1)
CO(2) addition##3##2##(2008-11#3)
CO(2) amplifier##2##2##(2007-11#2)
CO(2) and H(2)O##3##3##(2008-2#3)
CO(2) and##15##2##(2007-12#1)(2008-10#5)(2008-2#5)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
CO(2) as##3##2##(2008-10#2)(2008-7#1)
CO(2) assimilation##4##2##(2008-10#3)(2008-9#1)
CO(2) band##3##2##(1991-5#1)(2008-10#1)(2008-2#1)
CO(2) by##2##2##(2008-10#1)(2008-3#1)
CO(2) concentration##9##2##(2008-10#6)(2008-11#1)(2008-3#1)(2012-12#1)
CO(2) concentrations in a##2##4##(2008-10#2)
CO(2) concentrations in##3##3##(2008-10#3)
CO(2) concentrations##11##2##(2008-10#9)(2008-11#1)(2008-3#1)
CO(2) condition##2##2##(2008-11#2)
CO(2) conditions##2##2##(2012-12#2)
CO(2) density##2##2##(2008-10#2)
CO(2) enrichment##2##2##(2008-10#2)
CO(2) exchange##3##2##(2008-10#2)(2008-8#1)
CO(2) in the##2##3##(2008-10#1)(2008-3#1)
CO(2) in##8##2##(2008-10#5)(2008-2#2)(2008-3#1)
CO(2) is##2##2##(2008-10#1)(2009-6#1)
CO(2) laser and##2##3##(2008-2#1)(2008-3#1)
CO(2) laser beam is##2##4##(2008-2#2)
CO(2) laser beam##5##3##(2008-2#4)(2008-3#1)
CO(2) laser lidar##2##3##(2008-2#1)(2008-3#1)
CO(2) laser light##4##3##(2008-2#3)(2008-3#1)
CO(2) laser pulses##3##3##(2007-11#2)(2008-2#1)
CO(2) laser windows##2##3##(2008-2#2)
CO(2) laser##40##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#16)(2008-3#15)(2012-1#1)(2012-3#2)
CO(2) laser-based##2##2##(2008-2#2)
CO(2) lasers##3##2##(2008-2#1)(2008-3#2)
CO(2) lidar##2##2##(2008-2#1)(2008-3#1)
CO(2) molecules##2##2##(2008-10#1)(2008-2#1)
CO(2) of##2##2##(2008-10#2)
CO(2) on the##2##3##(2008-10#1)(2011-2#1)
CO(2) on##4##2##(2008-10#3)(2011-2#1)
CO(2) photodissociation##2##2##(2008-2#2)
CO(2) sensor##3##2##(2008-10#3)
CO(2) supercritical fluid##3##3##(2008-10#3)
CO(2) supply##10##2##(2008-11#10)
CO(2) was##3##2##(2008-10#2)(2008-11#1)
CO(2) were made in##2##4##(2008-3#2)
CO(2) were##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)
CO(2)##269##1##(1991-5#2)(2007-11#7)(2007-12#5)(2008-10#97)(2008-11#25)(2008-2#56)(2008-3#43)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-6#5)(2009-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)
CO(2))##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
CO(2)-exchange##2##1##(2008-10#2)
CO(2)-laser radiation at a wavelength of 10##2##7##(2007-11#1)(2007-12#1)
CO(2)-laser##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
CO(3)(2-)##6##1##(2008-10#6)
CO) with##2##2##(2007-10#1)(2007-8#1)
CO)##4##1##(1993-12#1)(2006-12#1)(2007-10#1)(2007-8#1)
CO-diffusion capacity##3##2##(1992-6#3)
CO-sensing properties##2##2##(2008-10#2)
CO-sensing##3##1##(2008-10#3)
CO2 and##6##2##(1993-6#2)(1995-8#1)(1996-12#2)(2008-11#1)
CO2 from##2##2##(2008-3#1)(2013-8#1)
CO2 gas##2##2##(2007-12#2)
CO2 in the##3##3##(1991-3#1)(1994-8#1)(2008-6#1)
CO2 in##8##2##(1991-3#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
CO2 laser for##2##3##(1996-1#1)(2007-12#1)
CO2 laser in##3##3##(1991-6#1)(1994-12#1)(1996-1#1)
CO2 laser laparoscopy##3##3##(1995-2#3)
CO2 laser surgery##2##3##(1991-4#2)
CO2 laser##32##2##(1991-4#2)(1991-6#2)(1994-12#4)(1995-2#3)(1996-1#5)(1997-2#1)(2007-12#2)(2008-2#4)(2008-3#6)(2008-4#3)
CO2 lidar##5##2##(2008-2#2)(2008-3#3)
CO2##104##1##(1991-3#2)(1991-4#2)(1991-6#2)(1993-6#8)(1993-9#1)(1994-12#4)(1994-8#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-1#5)(1996-12#6)(1996-2#1)(1997-1#2)(1997-2#1)(1997-6#4)(2007-12#5)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#9)(2008-3#18)(2008-4#3)(2008-5#2)(2008-6#6)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#5)
CO2) and##2##2##(1996-12#1)(1997-4#1)
CO2)##4##1##(1996-12#3)(1997-4#1)
CO2-laser##4##1##(1993-8#1)(2008-3#3)
CO39##5##1##(2008-10#5)
COAD##2##1##(2008-7#2)
COBRA##4##1##(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)
COC and LIDO##2##3##(1996-12#2)
COC##5##1##(1996-12#5)
COCH-modified capillary##3##2##(2008-10#3)
COCs##2##1##(2013-1#2)
COD##14##1##(2008-10#11)(2008-12#1)(2013-1#2)
CODAM##2##1##(2008-11#2)
CODESSA##2##1##(2007-11#1)(2008-10#1)
COHb levels##2##2##(1996-12#2)
COHb##9##1##(1996-12#8)(1997-2#1)
COI##3##1##(2007-12#1)(2008-10#1)(2011-2#1)
COI1##3##1##(2008-9#3)
COIL##3##1##(2008-2#1)(2008-3#2)
COL1A(I) mRNA##3##2##(1992-6#3)
COL1A(I)##4##1##(1992-6#4)
COL1A2 gene##2##2##(1992-8#2)
COL1A2##3##1##(1992-8#3)
COL1OA1##2##1##(1992-8#2)
COLIPA##3##1##(2008-5#3)
COLO 320DM##2##2##(1992-9#2)
COLO##4##1##(1992-8#1)(1992-9#2)(2013-1#1)
COM acceleration feedback##2##3##(2013-1#2)
COM acceleration##4##2##(2013-1#4)
COM##6##1##(2012-3#2)(2013-1#4)
COMB##4##1##(1993-3#4)
COMFORT-B and FLACC scales##2##4##(2012-2#2)
COMFORT-B and##3##2##(2012-2#3)
COMFORT-B##8##1##(2012-2#8)
COMPLEX##2##1##(1997-3#1)(2012-3#1)
COMPONENTS##2##1##(2009-9#2)
COMT and CCOMT##2##3##(2008-11#2)
COMT##6##1##(2008-11#3)(2011-2#1)(2012-12#1)(2012-2#1)
CONCLUSION##142##1##(1992-11#1)(1993-9#1)(1994-11#1)(1995-4#1)(1996-11#1)(2007-10#1)(2007-12#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#3)(2010-3#2)(2010-4#1)(2011-1#25)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#32)(2012-3#11)(2013-1#11)
CONCLUSIONS Under the conditions of this##2##6##(2008-8#1)(2008-9#1)
CONCLUSIONS##172##1##(1992-11#1)(1993-2#1)(2006-10#1)(2007-12#4)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-11#3)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#13)(2011-2#26)(2011-7#1)(2012-12#4)(2012-2#13)(2012-3#32)(2013-1#38)
CONH group in##2##3##(1997-2#2)
CONH##4##1##(1992-8#1)(1997-2#3)
CONT##2##1##(2013-8#2)
CONTACT HYPERSENSITIVITY STUDIES##2##3##(2008-9#2)
CONTINUED TO##3##2##(2011-2#3)
CONTINUUM##4##1##(1995-3#4)
COOH terminus##2##2##(1992-9#1)(1993-3#1)
COOH##6##1##(1990-7#1)(1992-9#1)(1993-3#1)(1997-2#2)(2008-10#1)
COOH-terminal domain of the RNA polymerase##2##6##(1995-6#2)
COOH-terminal domain of the##4##4##(1992-3#1)(1995-6#3)
COOH-terminal domain of##5##3##(1992-3#1)(1995-6#4)
COOH-terminal domain##7##2##(1991-12#2)(1992-3#1)(1995-6#4)
COOH-terminal heptapeptide##2##2##(1992-9#2)
COOH-terminal##24##1##(1990-2#5)(1990-8#1)(1991-12#2)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#4)(1995-2#1)(1995-6#7)(1997-9#1)
COOP charts##4##2##(2008-7#4)
COOP decision support##2##3##(2010-8#2)
COOP score##2##2##(2008-7#2)
COOP##12##1##(2008-7#7)(2010-8#5)
COP layer##3##2##(2008-2#3)
COP procedure##3##2##(2012-12#3)
COP##14##1##(1994-1#2)(2008-2#4)(2009-7#1)(2010-9#3)(2012-12#4)
COPD and HF##3##3##(2011-2#3)
COPD and##10##2##(1995-12#1)(1997-1#1)(2008-7#2)(2010-5#2)(2011-2#3)(2013-7#1)
COPD in##4##2##(1991-4#1)(2008-12#1)(2009-1#1)(2012-12#1)
COPD is##3##2##(2011-2#1)(2013-7#1)(2013-8#1)
COPD patients##13##2##(1997-7#1)(2007-6#1)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#7)
COPD with##5##2##(2011-2#1)(2013-1#4)
COPD##85##1##(1991-4#3)(1995-12#4)(1997-1#1)(1997-7#3)(2007-6#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#5)(2009-1#1)(2010-1#2)(2010-10#4)(2010-5#9)(2011-2#15)(2012-12#2)(2013-1#6)(2013-7#6)(2013-8#19)
COPD]##2##1##(2008-1#1)(2013-7#1)
COPII##3##1##(2011-2#2)(2012-2#1)
COR treatment##2##2##(1994-6#2)
COR15##3##1##(1992-3#3)
CORD7##5##1##(2008-8#5)
COS 1 cells##6##3##(1995-12#2)(2008-11#4)
COS cell##5##2##(1991-9#2)(2008-11#1)(2008-2#2)
COS cells demonstrated##2##3##(1993-8#1)(1994-6#1)
COS cells##17##2##(1991-3#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-6#2)(1993-8#2)(1994-6#1)(1997-9#1)(2008-11#3)(2008-2#3)(2008-8#1)
COS##32##1##(1991-3#1)(1991-9#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#2)(1993-8#2)(1994-6#1)(1995-12#2)(1997-9#1)(2008-11#9)(2008-2#5)(2008-8#1)(2011-1#2)
COS-1 cells and##3##3##(1992-6#1)(1993-3#1)(2008-11#1)
COS-1 cells##21##2##(1990-8#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-3#1)(1994-11#1)(1995-2#2)(1995-6#1)(2008-11#1)(2008-8#6)
COS-1##23##1##(1990-8#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-3#1)(1994-11#1)(1995-2#2)(1995-6#1)(2008-11#2)(2008-8#7)
COS-7 cell##2##2##(1993-11#1)(1995-11#1)
COS-7 cells transfected with##2##4##(1994-11#1)(1994-9#1)
COS-7 cells with##2##3##(1993-12#1)(2008-4#1)
COS-7 cells##19##2##(1990-11#1)(1990-5#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-11#1)(1996-5#1)(2008-4#2)(2008-9#2)
COS-7##23##1##(1990-11#1)(1990-5#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-11#2)(1996-5#1)(2008-11#1)(2008-4#3)(2008-9#2)
COS1 cells##3##2##(1994-8#3)
COSS##4##1##(2010-3#4)
COST and QUAC##2##3##(2013-8#2)
COST##5##1##(2013-8#5)
COSY##6##1##(1994-3#1)(1996-2#1)(1996-5#1)(2007-1#1)(2007-11#1)(2008-10#1)
COUP##2##1##(1992-11#2)
COUP-TF I and COUP-TF II##2##5##(1996-5#2)
COUP-TF I and##3##3##(1992-11#1)(1996-5#2)
COUP-TF I##4##2##(1992-11#1)(1996-5#3)
COUP-TF II##4##2##(1996-5#4)
COUP-TF##11##1##(1991-5#1)(1992-11#3)(1996-5#7)
COVER##5##1##(1995-3#2)(2012-2#2)(2012-3#1)
COX inhibitors in##2##3##(2007-4#1)(2011-2#1)
COX inhibitors##3##2##(2007-4#1)(2011-2#2)
COX subunit VIb##4##3##(1991-6#4)
COX##11##1##(1991-6#4)(2007-4#1)(2010-2#1)(2011-2#4)(2012-2#1)
COX-1##4##1##(2008-7#1)(2010-2#3)
COX-2 Inhibitors on##2##3##(2008-10#2)
COX-2 and survivin positivity were significantly correlated##2##7##(2011-2#2)
COX-2 and survivin positivity##3##4##(2011-2#3)
COX-2 and survivin##5##3##(2011-2#5)
COX-2 expression in##2##3##(2010-12#1)(2013-7#1)
COX-2 expression##3##2##(2010-12#1)(2013-7#2)
COX-2 inhibitor##5##2##(2008-10#1)(2008-12#4)
COX-2 inhibitors are##2##3##(2006-10#1)(2008-8#1)
COX-2 inhibitors##10##2##(2006-10#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2010-2#1)
COX-2 selective and non-selective NSAIDs##3##5##(2011-2#3)
COX-2 selective inhibitors##2##3##(2006-10#1)(2007-4#1)
COX-2 selective##6##2##(2006-10#1)(2007-4#1)(2011-2#4)
COX-2##50##1##(2006-10#5)(2007-4#2)(2008-10#9)(2008-11#2)(2008-12#4)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#2)(2011-2#13)(2013-1#1)(2013-7#3)(2013-8#5)
COX10##3##1##(1994-8#3)
COX14##2##1##(1995-6#2)
COX5B##5##1##(2013-1#5)
COX6b##2##1##(1991-6#2)
COXI gene##3##2##(1993-2#1)(1995-6#2)
COXI of##2##2##(1993-2#2)
COXI##6##1##(1993-2#4)(1995-6#2)
COXIV##3##1##(2008-10#3)
CP 93129##2##2##(1995-12#2)
CP ORF##2##2##(2008-10#2)
CP amino acid sequence##2##4##(2008-10#2)
CP amino acid##4##3##(2008-10#4)
CP and MP##2##3##(2008-10#2)
CP and the##4##3##(2008-10#3)(2011-2#1)
CP and##13##2##(1995-6#1)(2008-10#8)(2008-12#1)(2008-9#1)(2011-2#2)
CP by##3##2##(2008-10#2)(2011-2#1)
CP children##4##2##(2007-11#3)(2009-4#1)
CP compared with##3##3##(2011-2#3)
CP gene and the 3' untranslated region##2##7##(1997-6#2)
CP gene of##4##3##(2008-10#3)(2012-3#1)
CP gene was##3##3##(2008-10#2)(2008-8#1)
CP gene##23##2##(1997-6#3)(2008-10#18)(2008-8#1)(2012-3#1)
CP genes and##2##3##(2008-10#2)
CP genes of##2##3##(2008-10#2)
CP genes##5##2##(2008-10#5)
CP in##3##2##(2008-10#1)(2011-2#2)
CP is most##2##3##(2008-10#1)(2008-12#1)
CP is probably##2##3##(2008-10#1)(2011-2#1)
CP is##5##2##(2008-10#2)(2008-12#1)(2011-2#2)
CP of##3##2##(2008-10#3)
CP region##2##2##(1997-6#1)(2008-10#1)
CP sequence##3##2##(2008-10#3)
CP sequences of##3##3##(2008-10#3)
CP under##3##2##(2008-10#2)(2011-2#1)
CP was detected##2##3##(2008-10#2)
CP was##7##2##(2008-10#4)(2008-7#1)(2011-2#1)(2012-2#1)
CP were##4##2##(2008-10#3)(2011-2#1)
CP##158##1##(1990-12#1)(1992-8#1)(1995-12#2)(1995-6#1)(1997-4#1)(1997-6#5)(2007-11#3)(2008-10#106)(2008-12#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-4#1)(2010-2#1)(2011-2#17)(2012-2#6)(2012-3#1)
CP-31398##2##1##(2009-4#1)(2011-2#1)
CP-870##10##1##(2008-10#10)
CP-Chirasil-Dex CB##3##2##(2008-10#3)
CP-mediated##3##1##(1997-6#1)(2008-10#1)(2008-8#1)
CP12##2##1##(2009-10#2)
CP7 mutant was##2##3##(2008-10#2)
CP7 mutant##3##2##(2008-10#3)
CP97##2##1##(1991-9#2)
CPA CM##2##2##(2012-3#2)
CPA##11##1##(1993-9#2)(1995-4#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-3#5)
CPA-1##5##1##(2008-10#5)
CPAP with##2##2##(2007-8#2)
CPAP##6##1##(2007-8#2)(2009-7#2)(2011-1#1)(2013-7#1)
CPB (group##2##2##(2007-8#2)
CPB and##2##2##(2007-8#1)(2008-11#1)
CPB compared with the value##2##5##(2007-8#2)
CPB##26##1##(2007-8#14)(2007-9#2)(2008-10#6)(2008-11#3)(2012-3#1)
CPBSQ and FCPBSQ##2##3##(2008-10#2)
CPC is##2##2##(2008-10#1)(2008-2#1)
CPC##22##1##(2008-10#11)(2008-2#2)(2008-3#7)(2008-9#1)(2013-8#1)
CPD located on the##2##4##(1994-8#2)
CPD##15##1##(1994-8#4)(1997-8#1)(2011-2#9)(2013-1#1)
CPE then##2##2##(1994-2#2)
CPE##24##1##(1994-2#6)(2008-10#10)(2008-11#6)(2008-6#2)
CPE-mediated diseases##2##2##(2011-2#2)
CPEs##2##1##(2008-10#1)(2008-6#1)
CPF##2##1##(2007-8#1)(2011-1#1)
CPG##2##1##(1995-3#1)(2008-10#1)
CPH##5##1##(1994-6#1)(1995-8#4)
CPI##3##1##(2008-10#3)
CPIB##9##1##(1990-2#4)(1991-4#5)
CPK##4##1##(2008-11#1)(2013-1#3)
CPL##7##1##(2008-10#3)(2010-12#4)
CPM to##2##2##(2007-8#1)(2008-11#1)
CPM##11##1##(2007-8#4)(2008-11#2)(2008-7#5)
CPMAS##3##1##(2008-10#3)
CPMV##3##1##(1995-2#3)
CPO-mediated reactions##2##2##(2008-6#2)
CPOE##4##1##(2010-3#1)(2010-8#3)
CPP (10##2##2##(1992-8#1)(2012-2#1)
CPP after##2##2##(1993-6#2)
CPP was##2##2##(1993-6#2)
CPP##19##1##(1991-1#1)(1992-8#2)(1993-6#7)(1994-2#1)(2008-12#5)(2008-7#1)(2009-8#1)(2012-2#1)
CPPs##5##1##(2009-8#2)(2010-10#1)(2011-3#2)
CPR decision aid##2##3##(2013-1#2)
CPR##8##1##(1993-12#1)(2011-1#1)(2013-1#6)
CPR5##5##1##(2009-8#5)
CPRO-1##2##1##(2008-10#2)
CPS 1##3##2##(2008-10#3)
CPS##7##1##(1990-7#2)(2008-10#3)(2008-4#2)
CPSA##2##1##(2008-10#2)
CPT measures##2##2##(2006-12#2)
CPT on##2##2##(1994-8#2)
CPT values##2##2##(2006-12#2)
CPT##20##1##(1992-11#1)(1994-2#1)(1994-8#6)(1995-5#3)(2006-12#4)(2007-11#2)(2007-12#1)(2008-6#1)(2013-7#1)
CPT-11##3##1##(1995-5#1)(2008-8#1)(2013-8#1)
CPTQ##5##1##(2008-12#5)
CPTs##3##1##(2006-12#2)(2008-11#1)
CPU implementation##2##2##(2012-2#2)
CPU is##3##2##(2008-3#3)
CPU time##3##2##(2008-3#3)
CPU##15##1##(2008-3#8)(2008-8#1)(2009-6#2)(2011-1#1)(2012-2#3)
CPV-2##2##1##(2012-3#2)
CPVR##2##1##(2012-3#2)
CPZ##2##1##(2008-10#2)
CPh##2##1##(1997-7#2)
CPs##7##1##(2009-5#5)(2013-1#2)
CQ##2##1##(2008-10#2)
CQI for imaging services##2##4##(1993-2#2)
CQI implementation##2##2##(1993-2#1)(1995-3#1)
CQI in##5##2##(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)
CQI process##2##2##(1993-3#1)(1994-3#1)
CQI team##3##2##(1994-2#1)(1994-3#1)(1996-1#1)
CQI teams##2##2##(1994-2#2)
CQI to##2##2##(1994-12#2)
CQI tools##2##2##(1994-3#1)(1996-1#1)
CQI##49##1##(1993-12#1)(1993-2#9)(1993-3#4)(1994-1#3)(1994-12#3)(1994-2#7)(1994-3#7)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#3)(1996-2#2)(1997-1#1)(2008-4#1)
CQI/TQM##3##1##(1993-12#1)(1993-2#1)(1994-3#1)
CR after##2##2##(2008-10#2)
CR and 3 PR##2##4##(1995-4#1)(2011-2#1)
CR and BER##2##3##(2008-10#2)
CR and multiple antioxidant agents##2##5##(2008-7#2)
CR and##8##2##(1990-12#1)(1995-4#1)(2008-10#3)(2008-7#2)(2011-2#1)
CR has##2##2##(2009-10#2)
CR improves##2##2##(2009-10#2)
CR in##2##2##(2008-10#1)(2009-10#1)
CR or##5##2##(1997-7#1)(2008-10#3)(2009-5#1)
CR rate##2##2##(2007-10#1)(2008-10#1)
CR sequences##3##2##(2008-10#2)(2010-8#1)
CR was##2##2##(2008-5#1)(2008-6#1)
CR##68##1##(1990-12#1)(1991-6#1)(1992-2#1)(1993-6#5)(1994-5#4)(1995-4#1)(1997-7#1)(2007-10#2)(2007-4#1)(2008-10#18)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#5)(2009-10#8)(2009-5#6)(2010-3#2)(2010-8#1)(2011-2#4)
CR-200)##2##1##(2008-5#2)
CR-induced life extension##2##3##(2008-7#2)
CR011-vcMMAE##5##1##(2009-4#5)
CR2##2##1##(2008-11#2)
CR3##2##1##(1997-3#1)(2008-11#1)
CRB assay##2##2##(2008-10#2)
CRB##5##1##(2008-10#3)(2010-3#2)
CRC and##4##2##(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
CRC disparities##2##2##(2013-1#2)
CRC incidence rates##2##3##(2012-2#2)
CRC incidence was##2##3##(2013-8#2)
CRC incidence##5##2##(2012-2#3)(2013-8#2)
CRC risk##2##2##(2010-6#1)(2012-2#1)
CRC tissues##4##2##(2010-12#4)
CRC were##2##2##(2012-2#2)
CRC##42##1##(1994-5#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#2)(2010-12#7)(2010-6#1)(2011-2#1)(2012-2#11)(2012-3#3)(2013-1#6)(2013-8#3)
CRD##6##1##(2008-2#5)(2013-8#1)
CRDI##2##1##(1995-3#2)
CRDS##7##1##(2008-2#4)(2010-7#3)
CRE and##2##2##(1993-6#1)(2013-1#1)
CRE##8##1##(1993-6#1)(1994-11#2)(1997-2#1)(2013-1#4)
CRE-binding proteins##2##2##(1996-2#2)
CREB activation in##2##3##(2008-11#2)
CREB activation##3##2##(2008-11#3)
CREB through##2##2##(2008-11#2)
CREB##16##1##(1996-12#4)(1997-8#1)(2008-11#10)(2010-11#1)
CREB-dependent##2##1##(2008-11#2)
CREM##3##1##(1995-12#2)(1996-2#1)
CRF in##2##2##(1994-9#1)(2008-1#1)
CRF is##2##2##(2007-7#1)(2011-2#1)
CRF levels##3##2##(2009-3#3)
CRF patients##3##2##(2008-1#3)
CRF##38##1##(1990-3#4)(1994-9#1)(1996-12#1)(1997-4#10)(2007-7#4)(2008-1#8)(2008-10#1)(2008-4#2)(2009-3#5)(2011-2#1)(2012-2#1)
CRF-R1##3##1##(2008-4#3)
CRF-R2##2##1##(2008-4#2)
CRF07_BC##5##1##(2013-8#5)
CRFGP##2##1##(2008-7#2)
CRH in the##2##3##(1993-5#1)(2008-4#1)
CRH##22##1##(1990-12#6)(1992-6#1)(1993-5#1)(1994-9#3)(1995-12#3)(1996-12#1)(2008-11#2)(2008-4#5)
CRH-LI##3##1##(1990-5#3)
CRI##2##1##(2007-7#2)
CRIB##5##1##(2008-5#5)
CRL##4##1##(1992-8#1)(2008-3#3)
CRLM##4##1##(2013-1#4)
CRLP and##2##2##(1995-6#2)
CRLV##3##1##(2008-10#3)
CRM No##5##2##(2008-10#5)
CRM model##2##2##(2008-6#1)(2012-3#1)
CRM##24##1##(1997-8#2)(2008-10#17)(2008-12#1)(2008-6#2)(2012-3#2)
CRM1##3##1##(1996-3#1)(2011-2#1)(2011-3#1)
CRMP2 functions##2##2##(2013-1#2)
CRMP2##8##1##(2013-1#8)
CRMs were##2##2##(2008-10#2)
CRMs##12##1##(1997-8#1)(2008-10#10)(2012-3#1)
CROM##4##1##(2008-12#4)
CRP and##5##2##(1995-11#1)(2007-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
CRP binding site##2##3##(1997-6#2)
CRP binding##5##2##(1997-6#5)
CRP levels##7##2##(1990-12#1)(2007-10#4)(2007-8#1)(2008-7#1)
CRP response##2##2##(1990-12#2)
CRP value of##2##3##(2011-1#1)(2012-2#1)
CRP was##2##2##(2008-10#2)
CRP were##2##2##(2007-11#2)
CRP##61##1##(1990-12#4)(1995-11#1)(1997-6#9)(1997-8#1)(2007-10#8)(2007-11#3)(2007-8#1)(2008-10#11)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#2)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#1)
CRPS I##3##2##(2008-12#3)
CRPS##6##1##(2008-12#3)(2009-2#3)
CRS##7##1##(1994-6#1)(2007-11#1)(2008-10#2)(2011-2#2)(2013-8#1)
CRT color##2##2##(2008-3#2)
CRT##13##1##(2007-12#1)(2008-10#3)(2008-3#4)(2008-6#1)(2011-2#4)
CRVO##3##1##(2011-2#1)(2013-1#2)
CRVS system##2##2##(2012-12#2)
CRVS##3##1##(2012-12#3)
CRs##2##1##(1991-6#1)(2010-3#1)
CS (but not a neutral CS) passed a summation test with a##2##12##(2008-5#2)
CS and PFF##2##3##(1990-12#2)
CS and##6##2##(1990-12#2)(2008-11#2)(2008-6#1)(2012-3#1)
CS for##3##2##(2012-12#1)(2013-1#2)
CS in##4##2##(2011-2#2)(2013-1#2)
CS is##3##2##(2010-8#1)(2013-1#2)
CS levels##2##2##(1995-3#1)(1997-2#1)
CS or##2##2##(1990-12#1)(1995-5#1)
CS was##4##2##(2008-10#1)(2008-5#2)(2013-1#1)
CS were##2##2##(2008-10#1)(2008-6#1)
CS when the CS was retrained as a##2##8##(2008-5#2)
CS##91##1##(1990-12#3)(1991-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-9#3)(1997-2#2)(1997-8#1)(2008-10#10)(2008-11#2)(2008-5#10)(2008-6#2)(2008-7#2)(2010-8#3)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#32)
CS(2) and##2##2##(2008-10#2)
CS(2)##9##1##(2007-12#2)(2008-10#7)
CS)##3##1##(2008-11#1)(2008-5#2)
CS-1 and CS-20##3##3##(2008-10#3)
CS-1 reduced disease##2##3##(2008-10#2)
CS-1##9##1##(2008-10#9)
CS-20 significantly##2##2##(2008-10#2)
CS-20##12##1##(2008-10#12)
CS-A##2##1##(1992-12#2)
CS-SM3-7ADS##4##1##(2008-10#4)
CS13*-1##2##1##(2008-11#2)
CS3 fimbriae##2##2##(2008-8#2)
CS3##7##1##(2008-8#7)
CS3/CTP3##2##1##(2008-8#2)
CSA##8##1##(2008-3#1)(2008-5#4)(2010-12#2)(2013-8#1)
CSAvein##4##1##(2013-8#4)
CSBV##4##1##(2008-8#4)
CSC##7##1##(1993-12#1)(1994-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#2)
CSCs than##2##2##(2012-12#2)
CSCs##15##1##(2009-9#1)(2011-2#6)(2012-12#8)
CSD##10##1##(1993-12#1)(2007-10#3)(2008-10#6)
CSDH##4##1##(2008-7#4)
CSDS##4##1##(2013-8#4)
CSE##7##1##(2008-12#1)(2008-7#1)(2012-2#2)(2013-8#3)
CSF GABA##3##2##(1995-11#3)
CSF and plasma##3##3##(1994-8#2)(1995-12#1)
CSF and##7##2##(1992-3#1)(1994-8#3)(1995-12#1)(1996-2#1)(2007-8#1)
CSF ascorbate##2##2##(1993-8#1)(1994-9#1)
CSF fistula##3##2##(2006-12#1)(2008-12#2)
CSF flow rate##2##3##(1993-8#2)
CSF flow##8##2##(1993-8#3)(2008-7#2)(2012-3#3)
CSF gusher in##2##3##(2008-9#2)
CSF gusher##3##2##(2008-9#3)
CSF in##5##2##(1993-1#2)(1996-2#1)(2008-7#1)(2012-3#1)
CSF is##2##2##(2008-3#1)(2011-2#1)
CSF leak##6##2##(2008-7#3)(2011-2#1)(2012-3#2)
CSF leakage##4##2##(2008-12#2)(2011-2#2)
CSF leaks##2##2##(2012-3#2)
CSF levels of##4##3##(1994-9#1)(1995-11#1)(2008-3#1)(2011-2#1)
CSF levels##5##2##(1994-9#1)(1995-11#2)(2008-3#1)(2011-2#1)
CSF of##2##2##(1993-1#1)(1995-12#1)
CSF protein##2##2##(1991-2#1)(2013-7#1)
CSF pulsatile##2##2##(2008-7#2)
CSF samples from##2##3##(1991-8#1)(1993-8#1)
CSF samples##3##2##(1991-8#1)(1993-8#1)(2007-8#1)
CSF was##6##2##(1990-5#1)(1993-1#1)(1995-8#1)(2007-8#1)(2008-12#1)(2011-2#1)
CSF were##2##2##(1991-5#1)(1994-9#1)
CSF##121##1##(1990-5#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1993-1#10)(1993-12#2)(1993-8#7)(1994-8#6)(1994-9#4)(1995-11#5)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#4)(2006-12#1)(2007-8#5)(2008-12#9)(2008-3#8)(2008-7#9)(2008-9#4)(2009-12#1)(2009-6#2)(2011-2#11)(2012-3#15)(2013-1#1)(2013-7#3)
CSF-1 expression##2##2##(1991-6#2)
CSF-1 gene##2##2##(1991-6#2)
CSF-1 promoter region##2##3##(1991-6#2)
CSF-1##11##1##(1991-6#8)(1997-7#3)
CSF-NSE##2##1##(1990-2#2)
CSF/serum##2##1##(1993-8#2)
CSF1PO##7##1##(2008-12#6)(2012-12#1)
CSFE##2##1##(2008-4#2)
CSFE-labeled##2##1##(2008-4#2)
CSI##7##1##(2008-8#4)(2009-7#1)(2012-1#2)
CSIs##4##1##(2013-8#4)
CSL##3##1##(1990-2#2)(2008-6#1)
CSM##5##1##(2008-8#4)(2010-3#1)
CSN3 gene##2##2##(2008-12#2)
CSN3##4##1##(2008-12#4)
CSOM following##2##2##(2008-9#2)
CSOM##5##1##(2008-9#5)
CSP##6##1##(1997-6#4)(2011-2#2)
CSP3##2##1##(2008-5#2)
CSPs##3##1##(1995-3#1)(2007-12#1)(2008-10#1)
CSQ##2##1##(1990-2#2)
CSS##6##1##(2008-10#3)(2008-3#2)(2010-6#1)
CSSM006##2##1##(2008-12#2)
CSSM018##2##1##(2008-12#2)
CSTR##2##1##(1992-11#2)
CSV##2##1##(2008-10#2)
CSW1##4##1##(2008-10#4)
CSW2##2##1##(2008-10#2)
CSW2-amended##3##1##(2008-10#3)
CSX##5##1##(2008-12#2)(2011-2#3)
CT (MDCT)##3##2##(2008-7#2)(2011-2#1)
CT activity##3##2##(1995-3#1)(2008-7#2)
CT after##2##2##(2013-1#2)
CT alone##4##2##(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
CT and MR imaging##5##4##(1997-8#2)(2008-7#1)(2011-2#1)(2012-2#1)
CT and MR##10##3##(1997-8#4)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
CT and MRI are##2##4##(2007-4#1)(2010-9#1)
CT and MRI evaluations in##2##5##(2007-11#2)
CT and MRI in##2##4##(2007-11#1)(2008-1#1)
CT and MRI##19##3##(1992-6#1)(2007-10#1)(2007-11#4)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#4)
CT and magnetic resonance##2##4##(2008-1#2)
CT and##47##2##(1990-5#1)(1992-12#1)(1992-6#1)(1997-8#4)(2007-10#2)(2007-11#4)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#6)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#7)(2013-1#2)
CT and/or##3##2##(1995-11#1)(2008-1#1)(2008-2#1)
CT angiograms##2##2##(2008-7#1)(2013-1#1)
CT angiography diagnosis##2##3##(2011-2#2)
CT angiography##14##2##(1997-8#3)(2008-7#6)(2011-2#3)(2012-2#2)
CT appearances##3##2##(2008-7#1)(2012-2#2)
CT are##3##2##(1997-8#1)(2007-11#1)(2012-2#1)
CT can##2##2##(2008-7#1)(2008-9#1)
CT characterisation of pancreatic##2##4##(2012-2#2)
CT colonography##2##2##(2008-1#2)
CT coronary angiography##4##3##(2007-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
CT coronary##5##2##(2007-8#2)(2009-11#1)(2011-2#1)(2012-2#1)
CT data##4##2##(1995-2#1)(2007-11#1)(2009-3#1)(2012-3#1)
CT energy##2##2##(1997-7#1)(2012-12#1)
CT evaluation of##2##3##(1990-3#1)(2008-8#1)
CT examination was##3##3##(2007-10#1)(2007-11#1)(2011-2#1)
CT examination##9##2##(2007-10#1)(2007-11#3)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
CT examinations and##2##3##(2012-2#2)
CT examinations of##3##3##(1996-6#1)(1997-8#2)
CT examinations##5##2##(1996-6#1)(1997-8#2)(2012-2#2)
CT features##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
CT findings and##2##3##(1990-3#1)(2012-2#1)
CT findings of a##2##4##(2012-12#2)
CT findings of##4##3##(2012-12#2)(2012-2#2)
CT findings##13##2##(1990-3#2)(1997-3#1)(1997-8#1)(2008-1#2)(2011-2#1)(2012-12#2)(2012-2#4)
CT for##4##2##(2012-12#1)(2012-2#2)(2013-1#1)
CT guided##3##2##(2008-1#2)(2008-7#1)
CT has##2##2##(2008-7#1)(2012-2#1)
CT images##9##2##(1997-8#2)(2008-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
CT imaging in the##2##4##(2007-8#1)(2012-2#1)
CT imaging of the##2##4##(2007-11#1)(2007-12#1)
CT imaging of##3##3##(2007-11#1)(2007-12#1)(2012-2#1)
CT imaging##14##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#3)(2008-7#1)(2012-1#1)(2012-2#5)(2012-3#1)
CT in the##4##3##(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
CT in##15##2##(1993-1#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
CT indices##3##2##(2007-11#3)
CT is useful##2##3##(2008-12#1)(2011-2#1)
CT is##13##2##(2007-8#2)(2008-12#1)(2008-7#5)(2008-8#1)(2010-6#2)(2011-2#1)(2012-2#1)
CT may##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
CT modified KNN based materials##2##5##(2009-5#2)
CT of the##2##3##(2007-8#1)(2008-7#1)
CT of##4##2##(1997-8#1)(2007-8#1)(2008-7#1)(2012-2#1)
CT only in##2##3##(2011-2#2)
CT only##3##2##(2011-2#3)
CT or MRI##5##3##(2007-11#2)(2008-1#2)(2008-7#1)
CT or##9##2##(1990-9#1)(1995-3#1)(2007-11#2)(2008-1#2)(2008-7#1)(2008-9#1)(2012-12#1)
CT performed##2##2##(2007-8#1)(2012-3#1)
CT perfusion imaging##2##3##(2008-7#2)
CT protocol##2##2##(2012-12#1)(2012-2#1)
CT reconstruction##2##2##(2007-11#1)(2008-2#1)
CT release##2##2##(1992-6#2)
CT revealed##5##2##(2008-10#1)(2008-9#1)(2013-1#3)
CT scan after##2##3##(1990-6#1)(2012-3#1)
CT scan and##4##3##(1990-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
CT scan at##2##3##(2008-7#1)(2013-1#1)
CT scan confirmed##2##3##(2010-3#1)(2013-1#1)
CT scan in##2##3##(1990-12#1)(2007-10#1)
CT scan of paranasal##2##4##(2008-7#1)(2011-1#1)
CT scan of the##3##4##(1995-11#1)(2007-8#1)(2010-3#1)
CT scan of##7##3##(1995-11#1)(2007-8#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)
CT scan performed##2##3##(2007-10#1)(2013-1#1)
CT scan revealed##5##3##(1992-11#1)(1992-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
CT scan showed a##2##4##(1990-6#1)(1993-12#1)
CT scan showed##6##3##(1990-6#1)(1993-12#1)(2011-2#1)(2013-1#3)
CT scan was##2##3##(2007-8#1)(2008-1#1)
CT scan were##2##3##(2007-8#1)(2008-7#1)
CT scan with##2##3##(2012-2#1)(2013-7#1)
CT scan##62##2##(1990-12#2)(1990-6#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-5#1)(1995-11#3)(2007-10#2)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#6)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
CT scanner##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)
CT scanning and##2##3##(2008-6#1)(2010-8#1)
CT scanning in##2##3##(1991-3#1)(1995-11#1)
CT scanning is##2##3##(1991-3#2)
CT scanning##10##2##(1991-3#4)(1992-9#1)(1995-11#1)(1996-6#1)(2008-6#1)(2010-8#1)(2012-12#1)
CT scans and##2##3##(2007-11#1)(2008-6#1)
CT scans were##3##3##(2008-11#1)(2009-11#1)(2012-2#1)
CT scans##27##2##(1990-12#1)(2006-12#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-11#1)(2010-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
CT showed##4##2##(1992-5#1)(2012-12#1)(2013-1#2)
CT studies##2##2##(1997-8#1)(2011-1#1)
CT systems and##2##3##(2008-7#1)(2012-2#1)
CT systems##5##2##(2008-7#2)(2010-9#1)(2012-1#1)(2012-2#1)
CT technique##4##2##(1997-8#1)(2012-1#3)
CT technology##2##2##(2008-7#1)(2011-2#1)
CT to##2##2##(1997-8#1)(2012-2#1)
CT treatment##3##2##(1994-2#3)
CT was##4##2##(1990-12#1)(1990-6#1)(2007-10#1)(2007-8#1)
CT with gastrografin enema##2##4##(2012-12#2)
CT with multiplanar reconstruction##2##4##(2011-2#2)
CT with##6##2##(2008-7#1)(2009-11#1)(2011-2#2)(2012-12#2)
CT##516##1##(1990-12#5)(1990-3#5)(1990-5#1)(1990-6#3)(1990-9#1)(1991-12#3)(1991-3#4)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#3)(1992-6#3)(1992-9#1)(1993-1#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#4)(1995-11#6)(1995-2#1)(1995-3#6)(1996-3#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#21)(2006-12#4)(2007-10#8)(2007-11#26)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#16)(2008-1#24)(2008-10#8)(2008-11#4)(2008-12#7)(2008-2#7)(2008-3#2)(2008-5#5)(2008-6#7)(2008-7#62)(2008-8#5)(2008-9#8)(2009-1#1)(2009-11#3)(2009-2#3)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#3)(2011-1#7)(2011-2#40)(2012-1#17)(2012-12#26)(2012-2#57)(2012-3#10)(2013-1#35)(2013-7#2)(2013-8#2)
CT(4##2##1##(2008-5#2)
CT)##4##1##(2007-11#1)(2011-3#1)(2012-2#2)
CT-guided infiltration##2##2##(1996-9#2)
CT-guided##6##1##(1996-9#3)(2008-6#1)(2011-1#1)(2011-2#1)
CT-scan is##2##2##(1992-6#2)
CT-scan##5##1##(1992-6#2)(1997-3#1)(2007-8#1)(2013-1#1)
CT-scans##2##1##(1994-5#1)(2007-8#1)
CT26##2##1##(2008-11#1)(2008-9#1)
CT60(∗)G##3##1##(2010-12#3)
CTA and##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
CTA in##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
CTA membrane##3##2##(2008-10#3)
CTA##23##1##(1991-9#1)(2008-10#8)(2008-12#3)(2008-3#1)(2008-7#4)(2009-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
CTA1##2##1##(1993-9#2)
CTAB to the##2##3##(2008-11#1)(2008-8#1)
CTAB was##2##2##(2008-10#1)(2008-11#1)
CTAB##24##1##(2008-10#14)(2008-11#7)(2008-2#2)(2008-8#1)
CTAB-capped gold##2##2##(2008-10#2)
CTAD##5##1##(2008-10#5)
CTC and##2##2##(2007-11#1)(2008-10#1)
CTC has a sensitivity of##2##5##(2008-1#2)
CTC is##2##2##(2008-1#2)
CTC##11##1##(2007-11#3)(2008-1#6)(2008-10#1)(2010-8#1)
CTEPH##21##1##(2010-10#1)(2010-6#20)
CTG##3##1##(2008-7#1)(2010-2#1)(2011-2#1)
CTGF##4##1##(2012-1#4)
CTL activity##3##2##(1995-3#3)
CTL clones##2##2##(1991-9#2)
CTL epitope minigene##2##3##(2008-8#2)
CTL epitope##3##2##(2008-8#3)
CTL epitopes##4##2##(2008-8#3)(2011-2#1)
CTL in##2##2##(1994-5#1)(2008-11#1)
CTL suppression in##2##3##(1995-3#2)
CTL suppression##5##2##(1995-3#5)
CTL##38##1##(1991-9#5)(1994-5#2)(1995-12#1)(1995-3#9)(1995-5#1)(2008-11#5)(2008-4#1)(2008-8#9)(2011-2#2)(2013-1#3)
CTLA-4##5##1##(2007-5#1)(2009-8#3)(2011-2#1)
CTLL##2##1##(1993-6#2)
CTLs against a##2##3##(2008-11#2)
CTLs against##4##2##(2008-11#4)
CTLs##17##1##(1994-5#1)(2008-11#10)(2011-2#2)(2013-1#4)
CTMA##4##1##(2008-10#4)
CTN##4##1##(1997-2#4)
CTP##16##1##(1991-11#3)(1992-11#3)(1992-6#3)(1995-3#2)(1997-2#2)(1997-7#1)(2008-11#2)
CTP3##2##1##(2008-8#2)
CTR1##2##1##(2012-2#2)
CTS##8##1##(2008-9#5)(2010-8#3)
CTSI##2##1##(2009-8#2)
CTSIM##3##1##(2009-8#3)
CTSR##3##1##(2013-1#3)
CTTH##4##1##(2010-9#4)
CTV isolates##7##2##(2008-10#7)
CTV sequences##2##2##(2008-10#2)
CTV spread##2##2##(2008-10#2)
CTV##36##1##(2008-10#32)(2008-2#4)
CTV-positive trees##3##2##(2008-10#3)
CTV1##2##1##(2008-10#2)
CTV2##2##1##(2008-10#2)
CTVpros and##2##2##(2012-12#2)
CTVpros##4##1##(2012-12#4)
CTVprosAPCT##2##1##(2012-12#2)
CTVprosAPMR##2##1##(2012-12#2)
CTVprosSZCT##2##1##(2012-12#2)
CTVprosSZMR##2##1##(2012-12#2)
CTVpvs##4##1##(2012-12#4)
CTVpvsAPCT##2##1##(2012-12#2)
CTVpvsAPMR##2##1##(2012-12#2)
CTVpvsSZCT##2##1##(2012-12#2)
CTVpvsSZMR##2##1##(2012-12#2)
CTW samples##2##2##(2008-12#2)
CTW##3##1##(2008-12#3)
CTX##5##1##(1992-6#1)(1993-3#4)
CTiVd##3##1##(2008-10#3)
CTrach##5##1##(2010-7#5)
CTscans##3##1##(2007-11#1)(2011-2#2)
CU1##2##1##(2008-10#2)
CUF-1##3##1##(1995-2#3)
CUL3##3##1##(2012-12#3)
CUL3-KLHL18 ligase regulates mitotic entry##2##5##(2012-12#2)
CUL3-KLHL18 ligase##3##2##(2012-12#3)
CUR##2##1##(2010-8#2)
CURRENT STATUS##2##2##(2008-7#1)(2009-5#1)
CUSUM##2##1##(2008-10#2)
CV 1##3##2##(1994-11#2)(2008-10#1)
CV and##6##2##(1993-12#2)(2008-10#4)
CV disease##3##2##(2010-5#3)
CV in##2##2##(2008-12#1)(2008-8#1)
CV was##3##2##(2008-10#3)
CV##33##1##(1993-12#2)(1994-11#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2010-5#3)(2010-7#1)
CV-1 cells##2##2##(2008-11#2)
CV-1##4##1##(2008-11#4)
CV-AAS##3##1##(2008-10#3)
CVA in the##2##3##(1992-2#2)
CVA in##3##2##(1992-2#2)(2008-1#1)
CVA##6##1##(1992-2#4)(2007-8#1)(2008-1#1)
CVA16##4##1##(2013-8#4)
CVAAS##3##1##(2008-10#3)
CVB1 M16560##2##2##(2013-8#2)
CVB1##7##1##(2013-8#7)
CVC occlusions##3##2##(2008-7#3)
CVC##6##1##(2007-7#3)(2008-7#3)
CVD and##4##2##(2008-1#1)(2010-12#1)(2011-1#1)(2012-3#1)
CVD in##3##2##(2008-3#1)(2010-5#1)(2012-12#1)
CVD is##4##2##(2011-1#2)(2012-2#1)(2013-8#1)
CVD prevention##4##2##(2009-4#4)
CVD risk factors##2##3##(2011-1#2)
CVD risk in##5##3##(2010-12#1)(2011-1#2)(2013-1#2)
CVD risk##13##2##(2010-12#4)(2010-8#1)(2011-1#4)(2012-12#1)(2013-1#3)
CVD##72##1##(1996-2#1)(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#8)(2009-4#8)(2009-9#2)(2010-12#12)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#14)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
CVI children##2##2##(2011-2#2)
CVI##10##1##(2009-12#2)(2011-2#5)(2011-3#2)(2012-12#1)
CVJ tuberculosis##2##2##(2008-12#2)
CVL beam##3##2##(2007-12#1)(2008-2#2)
CVL##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
CVR##2##1##(2012-3#2)
CVSMC##2##1##(1993-3#2)
CVd-III were##2##2##(2008-10#2)
CVd-III##4##1##(2008-10#4)
CVd-IIa##2##1##(2008-10#2)
CVd-IIb##2##1##(2008-10#2)
CVd-IIc##4##1##(2008-10#4)
CVs were##3##2##(1992-3#1)(2008-10#2)
CVs##7##1##(1992-3#2)(2008-10#3)(2008-9#2)
CW##4##1##(1991-6#1)(2007-9#1)(2008-2#1)(2011-1#1)
CW-SFS##2##1##(2008-10#2)
CW/TPR and PDMS/DVB fibers##2##4##(2008-10#2)
CW/TPR##4##1##(2008-10#4)
CW2 cells##3##2##(2008-11#3)
CWP treatment##2##2##(2008-10#2)
CWP##11##1##(2008-10#11)
CWT##4##1##(2008-10#3)(2008-3#1)
CWV##2##1##(2008-3#2)
CX##4##1##(1992-8#4)
CX(3)CR1##2##1##(2011-2#2)
CXB H mice##5##3##(1994-5#5)
CXB##7##1##(1994-5#5)(2008-10#2)
CXCL10##2##1##(2010-11#2)
CXCR4##4##1##(2008-4#1)(2008-7#2)(2013-1#1)
CXR##3##1##(1997-8#3)
CY##2##1##(1995-12#2)
CYC##6##1##(1993-9#2)(2010-12#4)
CYC1 is##2##2##(1993-9#2)
CYC1##7##1##(1993-9#5)(1997-3#1)(1997-4#1)
CYDV##8##1##(2008-10#8)
CYDV-RPV##2##1##(2008-10#2)
CYL1##2##1##(1992-10#2)
CYP 1A2 and CYP 2E1##2##5##(2007-11#2)
CYP 2C9##2##2##(2008-10#2)
CYP 2E1##3##2##(2007-11#3)
CYP##14##1##(2007-11#5)(2008-10#4)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#2)
CYP19a gene##4##2##(2009-7#4)
CYP19a##5##1##(2009-7#5)
CYP1A induction##4##2##(2008-10#4)
CYP1A was##2##2##(1996-12#1)(2008-10#1)
CYP1A##14##1##(1994-8#3)(1996-12#4)(2008-10#7)
CYP1A1 and CYP1A2##2##3##(1992-8#1)(1994-8#1)
CYP1A1 and CYP1B1 in##2##4##(1995-11#2)
CYP1A1 and CYP1B1##3##3##(1995-11#3)
CYP1A1 and CYP2B1##2##3##(1994-8#2)
CYP1A1 and P450 reductase##4##4##(1994-8#4)
CYP1A1 and##11##2##(1992-8#1)(1994-8#7)(1995-11#3)
CYP1A1 enzyme##2##2##(1992-8#1)(2011-1#1)
CYP1A1 gene##4##2##(1993-6#1)(1994-6#3)
CYP1A1 in##2##2##(1994-8#1)(2008-10#1)
CYP1A1 mRNA##5##2##(1992-8#1)(1994-6#2)(2008-11#2)
CYP1A1 or##2##2##(1992-8#1)(1994-6#1)
CYP1A1##41##1##(1992-8#5)(1993-6#1)(1994-6#10)(1994-8#10)(1995-11#6)(2008-10#4)(2008-11#4)(2011-1#1)
CYP1A1*##3##1##(1994-8#3)
CYP1A2 and##2##2##(1994-8#2)
CYP1A2##10##1##(1992-8#2)(1994-8#6)(2007-11#1)(2008-8#1)
CYP1B1 in##3##2##(1995-11#3)
CYP1B1 protein##5##2##(1995-11#5)
CYP1B1##14##1##(1995-11#14)
CYP26##3##1##(2008-8#2)(2012-1#1)
CYP26A1##2##1##(2008-8#2)
CYP2A6 genotypes##2##2##(2008-8#2)
CYP2A6##11##1##(1994-8#1)(2008-8#10)
CYP2B1 in##2##2##(1994-8#2)
CYP2B1##7##1##(1994-8#7)
CYP2C19 alleles##2##2##(2008-11#2)
CYP2C19##4##1##(2008-11#4)
CYP2C6##4##1##(1994-8#4)
CYP2C9 and VKORC1##2##3##(2011-1#2)
CYP2D6 and CYP2C19##2##3##(2008-11#2)
CYP2D6 extensive metabolizer genotype##2##4##(2008-4#2)
CYP2D6 gene##3##2##(2008-10#2)(2008-4#1)
CYP2D6 is##3##2##(1993-6#1)(2008-10#2)
CYP2D6##23##1##(1993-6#4)(2008-10#12)(2008-11#3)(2008-4#3)(2008-7#1)
CYP2E##3##1##(1996-12#3)
CYP2E1 and##2##2##(2008-8#2)
CYP2E1 in the##2##3##(1990-11#1)(1993-11#1)
CYP2E1 in##5##2##(1990-11#1)(1993-11#2)(2008-8#2)
CYP2E1 protein##5##2##(1990-11#2)(2008-8#3)
CYP2E1##20##1##(1990-11#5)(1993-11#3)(2006-10#1)(2008-8#11)
CYP3A enzymes##2##2##(1994-5#1)(2013-1#1)
CYP3A##15##1##(1994-5#2)(1994-8#1)(2011-2#4)(2011-3#6)(2013-1#2)
CYP3A4 activity in##2##3##(2008-8#1)(2012-3#1)
CYP3A4 activity##4##2##(2008-10#1)(2008-8#2)(2012-3#1)
CYP3A4 inactivation##2##2##(2008-3#2)
CYP3A4##24##1##(1994-5#2)(2007-11#1)(2008-10#2)(2008-3#7)(2008-8#4)(2010-8#1)(2011-2#4)(2012-3#3)
CYP3A4/5##2##1##(2012-12#2)
CYP3A5##2##1##(2011-2#2)
CYP450 2C9*3 + 1075C/A and VKORC1-1639A/G##2##6##(2011-1#2)
CYP450 2C9*3 + 1075C/A##3##4##(2011-1#3)
CYP450##6##1##(2008-8#1)(2011-1#5)
CYP51##3##1##(2008-10#2)(2009-9#1)
CYP51A1 gene was##2##3##(2008-10#2)
CYP51A1 gene##3##2##(2008-10#3)
CYP51A1##7##1##(2008-10#7)
CYP52A1##2##1##(1991-9#2)
CYP52A2 is##2##2##(1991-9#2)
CYP52A2##4##1##(1991-9#4)
CYP63##2##1##(2009-9#2)
CYP71##2##1##(2008-9#2)
CYPA##2##1##(2011-2#2)
CYS3 protein##3##2##(1992-3#3)
CYS3##5##1##(1992-3#5)
CYSDV CP gene##3##3##(2008-10#3)
CYSDV RNA##3##2##(2008-10#3)
CYSDV in##2##2##(2008-10#2)
CYSDV##20##1##(2008-10#20)
CYVD strains##7##2##(2008-10#7)
CYVD##8##1##(2008-10#8)
CZ and FZ##3##3##(1993-6#3)
CZE analysis##2##2##(1996-5#1)(2008-10#1)
CZE stage##2##2##(2008-10#2)
CZE##19##1##(1994-9#1)(1996-5#6)(2008-10#12)
CZE-DAD##2##1##(2008-10#2)
Ca (2+) release##2##3##(2010-11#2)
Ca (2+) signal##2##3##(2010-11#2)
Ca (2+)##5##2##(2010-11#5)
Ca and Fe##2##3##(2008-10#2)
Ca and Mg##6##3##(1991-5#2)(2008-10#4)
Ca and P##2##3##(2008-10#1)(2011-1#1)
Ca and##16##2##(1991-5#2)(2008-10#11)(2010-8#1)(2011-1#1)(2013-8#1)
Ca channel##2##2##(1993-11#2)
Ca concentrations##3##2##(2008-5#1)(2009-6#1)(2010-8#1)
Ca depletion##3##2##(2009-6#3)
Ca in##3##2##(1993-3#1)(2008-10#1)(2008-3#1)
Ca levels##2##2##(1995-8#1)(1997-4#1)
Ca ²⁺##2##2##(2013-1#2)
Ca##123##1##(1990-2#1)(1991-5#4)(1992-6#1)(1993-11#3)(1993-3#1)(1995-8#1)(1997-4#5)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#63)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#8)(2009-8#1)(2010-11#5)(2010-2#2)(2010-3#1)(2010-8#5)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
Ca(2 +)##4##2##(2008-10#2)(2009-8#2)
Ca(2##7##1##(2008-10#3)(2008-8#2)(2009-8#2)
Ca(2)Al(2)SiO(7)##3##1##(2008-2#2)(2008-3#1)
Ca(2)GeO(4) laser##2##2##(2008-3#2)
Ca(2)GeO(4)##3##1##(2008-3#3)
Ca(2+) and CaM##2##3##(2008-8#2)
Ca(2+) and Mg(2+) ions##2##4##(2008-10#2)
Ca(2+) and Mg(2+)##8##3##(2008-10#7)(2008-11#1)
Ca(2+) and##19##2##(2006-6#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-8#3)(2009-10#1)(2013-1#1)
Ca(2+) channel##4##2##(2008-8#3)(2012-2#1)
Ca(2+) channels##6##2##(2008-4#1)(2008-8#3)(2008-9#1)(2009-12#1)
Ca(2+) chelator##3##2##(2008-4#1)(2008-8#2)
Ca(2+) concentration ([Ca(2+)](i))##2##3##(2008-9#1)(2012-2#1)
Ca(2+) concentration##11##2##(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)
Ca(2+) current##2##2##(2009-12#1)(2009-2#1)
Ca(2+) homeostasis##2##2##(2008-4#2)
Ca(2+) imaging##3##2##(2008-4#1)(2009-12#1)(2011-2#1)
Ca(2+) increase##3##2##(2008-4#2)(2009-10#1)
Ca(2+) influx##2##2##(2008-7#1)(2008-8#1)
Ca(2+) ions##3##2##(2008-10#2)(2008-4#1)
Ca(2+) is##3##2##(1996-5#1)(2008-10#1)(2008-4#1)
Ca(2+) kinetics##2##2##(2008-11#2)
Ca(2+) levels##2##2##(2006-6#2)
Ca(2+) mobilization##8##2##(2008-4#6)(2009-6#2)
Ca(2+) or Mg(2+)##2##3##(2008-10#2)
Ca(2+) over Mg(2+)##2##3##(2008-4#1)(2009-7#1)
Ca(2+) receptor##2##2##(2008-11#1)(2008-4#1)
Ca(2+) release##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
Ca(2+) signal##2##2##(2007-11#1)(2008-4#1)
Ca(2+) signaling##8##2##(2008-11#6)(2008-4#1)(2009-8#1)
Ca(2+) wave##2##2##(2008-4#2)
Ca(2+) were##2##2##(2008-10#1)(2008-11#1)
Ca(2+)##181##1##(1996-5#3)(1997-7#1)(2006-6#5)(2007-11#3)(2007-12#1)(2008-10#45)(2008-11#22)(2008-4#33)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#27)(2008-9#4)(2009-10#2)(2009-12#5)(2009-2#2)(2009-6#3)(2009-7#3)(2009-8#3)(2010-4#2)(2011-2#1)(2012-2#6)(2013-1#2)(2013-8#1)
Ca(2+)&gt##4##1##(2008-10#4)
Ca(2+)- and phospholipid-dependent##2##3##(1992-6#1)(1993-8#1)
Ca(2+)- and##5##2##(1991-9#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-2#1)
Ca(2+)-##6##1##(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-2#1)
Ca(2+)-ATPase##8##1##(1992-11#1)(1992-5#2)(1993-8#1)(1995-11#1)(1995-2#2)(2008-8#1)
Ca(2+)-activated K(+) channel##2##3##(2008-6#1)(2008-8#1)
Ca(2+)-activated K+ channel##2##3##(1992-6#2)
Ca(2+)-activated K+ channels##4##3##(1994-11#2)(1996-2#2)
Ca(2+)-activated K+##8##2##(1992-6#2)(1994-11#2)(1994-3#1)(1996-2#2)(1996-5#1)
Ca(2+)-activated##16##1##(1992-6#3)(1994-11#2)(1994-3#2)(1995-11#1)(1996-2#2)(1996-5#1)(1997-2#1)(2008-6#1)(2008-8#3)
Ca(2+)-binding domain##2##2##(1994-12#2)
Ca(2+)-binding proteins##3##2##(1991-6#1)(1992-12#1)(1992-6#1)
Ca(2+)-binding sites##2##2##(1995-6#2)
Ca(2+)-binding##12##1##(1991-6#1)(1992-12#1)(1992-6#2)(1994-11#1)(1994-12#2)(1994-5#1)(1995-6#4)
Ca(2+)-chelation##4##1##(1994-6#4)
Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells##2##12##(1994-6#2)
Ca(2+)-dependent and##4##2##(1994-6#2)(1995-11#1)(2008-8#1)
Ca(2+)-dependent cell-cell junctions##2##3##(1991-12#2)
Ca(2+)-dependent exocytosis##2##2##(1992-6#1)(2008-5#1)
Ca(2+)-dependent inactivation##4##2##(1994-6#4)
Ca(2+)-dependent manner##4##2##(1991-12#1)(1992-6#1)(1995-6#1)(2008-4#1)
Ca(2+)-dependent##37##1##(1991-12#4)(1992-12#2)(1992-6#3)(1992-7#2)(1994-11#1)(1994-3#1)(1994-6#6)(1994-8#1)(1995-11#4)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2012-12#1)
Ca(2+)-free medium##5##2##(1993-12#3)(1995-11#1)(1996-2#1)
Ca(2+)-free##10##1##(1993-12#4)(1994-6#1)(1995-11#2)(1996-2#1)(1996-5#1)(2008-8#1)
Ca(2+)-independent kinase activity##2##3##(1992-12#2)
Ca(2+)-independent lipid-stimulated kinase##2##3##(1992-9#2)
Ca(2+)-independent##10##1##(1992-12#3)(1992-9#2)(1993-12#1)(1994-11#1)(1994-6#2)(2008-7#1)
Ca(2+)-induced##5##1##(1992-6#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-5#1)
Ca(2+)-permeable##2##1##(1996-2#1)(2011-2#1)
Ca(2+)-sensitive K+ channels##2##3##(1991-8#2)
Ca(2+)-sensitive##6##1##(1991-12#2)(1991-8#2)(1996-5#2)
Ca(2+)-sensitivity##2##1##(1991-12#1)(2008-8#1)
Ca(2+)-triggered##3##1##(1992-6#1)(2012-2#2)
Ca(2+)/Mg(2+) feeding##2##2##(2008-11#2)
Ca(4)GdO(BO(3))(3)##2##1##(2007-12#1)(2008-2#1)
Ca(II) and Ba(II)##6##3##(2008-10#6)
Ca(II) and##7##2##(2008-10#7)
Ca(II)##24##1##(2008-10#24)
Ca(V)2##2##1##(2008-8#2)
Ca(V)alpha(1)##2##1##(2008-8#2)
Ca(v)1##6##1##(2008-8#6)
Ca(v)2##2##1##(2008-8#2)
Ca(v)beta subunits##4##2##(2008-8#4)
Ca++ response##2##2##(1991-9#2)
Ca++##22##1##(1990-12#1)(1991-9#11)(1992-12#1)(1993-11#2)(1993-3#2)(1993-8#5)
Ca+2##2##1##(1992-3#1)(1996-9#1)
Ca-903##2##1##(2008-10#2)
Ca-depleted##2##1##(2009-6#2)
Ca-folinate##2##1##(2008-10#2)
Ca175##2##1##(2008-10#2)
Ca2(+)-ATPases##2##1##(1990-12#2)
Ca2(+)-activated##3##1##(1990-11#2)(1990-8#1)
Ca2(+)-induced Ca2+ release##3##3##(1990-2#3)
Ca2(+)-sensitive##2##1##(1990-8#2)
Ca2(+)-stimulated (10 microM)##2##3##(1990-12#2)
Ca2+ ([Ca2+]i)##2##2##(1992-3#1)(1994-11#1)
Ca2+ accumulation induced by Tg##2##5##(1991-6#2)
Ca2+ activated K+ channels##2##4##(1990-8#2)
Ca2+ and K+##3##3##(1996-2#1)(2008-10#2)
Ca2+ and Mg2+##5##3##(1990-5#1)(1990-7#1)(1995-11#2)(2008-5#1)
Ca2+ and Na+##4##3##(1992-7#1)(1994-6#1)(1995-5#2)
Ca2+ and##31##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#5)(1994-6#1)(1995-11#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-8#2)
Ca2+ as##2##2##(1994-6#1)(1995-6#1)
Ca2+ at##2##2##(1992-11#1)(1995-2#1)
Ca2+ binding sites##2##3##(1995-2#1)(1995-6#1)
Ca2+ binding to##2##3##(1990-7#1)(1995-6#1)
Ca2+ binding##15##2##(1990-11#4)(1990-7#3)(1993-8#1)(1994-5#1)(1995-2#2)(1995-6#3)(2008-11#1)
Ca2+ by##2##2##(1991-8#1)(1994-11#1)
Ca2+ channel blockade##2##3##(1997-7#2)
Ca2+ channel blocker##7##3##(1991-9#1)(1993-12#1)(1995-11#1)(1995-12#2)(1996-5#2)
Ca2+ channel blockers##7##3##(1990-12#1)(1990-7#2)(1995-11#2)(1996-2#1)(1996-5#1)
Ca2+ channel current##2##3##(1993-3#2)
Ca2+ channel##30##2##(1990-12#1)(1990-7#2)(1991-9#1)(1993-12#1)(1993-3#4)(1994-6#1)(1995-11#3)(1995-12#5)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#2)(1997-4#1)(1997-7#3)
Ca2+ channels and##3##3##(1990-8#1)(1993-12#1)(1994-5#1)
Ca2+ channels are##2##3##(1993-11#2)
Ca2+ channels can##2##3##(1993-12#1)(1993-3#1)
Ca2+ channels in the brain##2##5##(1993-11#1)(2009-7#1)
Ca2+ channels in the##4##4##(1993-11#1)(1993-12#1)(1996-5#1)(2009-7#1)
Ca2+ channels in##7##3##(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-5#1)(1997-2#1)(2009-7#1)
Ca2+ channels##31##2##(1990-7#1)(1990-8#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-3#3)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-2#1)(1996-5#5)(1997-2#2)(2008-8#2)(2009-7#1)(2009-8#1)(2010-11#1)
Ca2+ channels)##2##2##(1992-12#1)(1993-11#1)
Ca2+ chelator##3##2##(1994-3#1)(1996-2#1)(1997-1#1)
Ca2+ concentration ([Ca2+]i)##3##3##(1994-6#2)(1995-11#1)
Ca2+ concentration [(##2##3##(1990-7#1)(1991-6#1)
Ca2+ concentration in##3##3##(1990-2#1)(1994-8#1)(2009-3#1)
Ca2+ concentration induced by##2##4##(1992-8#1)(1995-8#1)
Ca2+ concentration was##2##3##(1990-7#1)(1995-6#1)
Ca2+ concentration##32##2##(1990-12#2)(1990-2#2)(1990-7#4)(1991-12#2)(1991-6#1)(1992-8#2)(1993-12#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#3)(2008-8#1)(2009-3#1)
Ca2+ concentrations##7##2##(1990-7#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-1#1)
Ca2+ current##3##2##(1992-8#2)(1995-12#1)
Ca2+ currents in##2##3##(1992-8#1)(1995-12#1)
Ca2+ currents of##2##3##(1994-9#2)
Ca2+ currents##7##2##(1992-8#2)(1994-9#2)(1995-12#1)(1996-2#2)
Ca2+ distribution##2##2##(1996-2#2)
Ca2+ does not affect##2##4##(1991-9#1)(1994-5#1)
Ca2+ does not##3##3##(1991-9#1)(1994-5#2)
Ca2+ entry##9##2##(1990-7#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-11#2)(1997-2#1)(1997-7#1)(2007-10#1)
Ca2+ fluxes##4##2##(1992-11#1)(1995-11#2)(1996-5#1)
Ca2+ for the##2##3##(1990-7#1)(1994-8#1)
Ca2+ for##3##2##(1990-2#1)(1990-7#1)(1994-8#1)
Ca2+ from##3##2##(1990-2#1)(1991-12#1)(1995-11#1)
Ca2+ had##3##2##(1990-5#1)(1990-8#1)(1995-12#1)
Ca2+ homeostasis##4##2##(1991-6#1)(1993-3#1)(1994-11#1)(2008-8#1)
Ca2+ in the presence of 2##2##6##(1990-8#1)(1993-8#1)
Ca2+ in the##6##3##(1990-8#1)(1991-12#1)(1993-3#1)(1993-8#1)(1995-6#1)(1997-1#1)
Ca2+ in##15##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#2)(1995-11#3)(1995-6#1)(1996-2#1)(1997-1#1)
Ca2+ indicator##2##2##(1990-2#1)(1990-8#1)
Ca2+ influx in##3##3##(1990-12#1)(1991-1#1)(1996-2#1)
Ca2+ influx is mediated##2##4##(1996-2#1)(1996-5#1)
Ca2+ influx is##4##3##(1992-6#1)(1994-2#1)(1996-2#1)(1996-5#1)
Ca2+ influx##23##2##(1990-12#7)(1990-7#2)(1991-1#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-2#2)(1996-5#2)
Ca2+ into##2##2##(1990-5#1)(1993-3#1)
Ca2+ ionophore ionomycin##2##3##(1997-1#1)(2008-8#1)
Ca2+ ionophore##6##2##(1994-3#1)(1994-6#2)(1995-11#1)(1997-1#1)(2008-8#1)
Ca2+ ions are##3##3##(1992-11#1)(1995-11#2)
Ca2+ ions##8##2##(1990-7#1)(1990-8#1)(1992-11#1)(1995-11#2)(1995-2#1)(1995-6#2)
Ca2+ is##5##2##(1990-7#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-2#1)
Ca2+ level##2##2##(1990-2#1)(1994-6#1)
Ca2+ levels in##2##3##(1994-6#1)(1996-2#1)
Ca2+ levels##6##2##(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-4#1)
Ca2+ medium##4##2##(1993-11#2)(1993-12#1)(1994-6#1)
Ca2+ mobilization and phosphoinositide hydrolysis##2##5##(1996-2#2)
Ca2+ mobilization and##4##3##(1990-2#1)(1995-3#1)(1996-2#2)
Ca2+ mobilization in##3##3##(1990-8#1)(1991-5#1)(2008-9#1)
Ca2+ mobilization##9##2##(1990-2#1)(1990-8#1)(1991-5#1)(1995-11#1)(1995-3#1)(1996-2#3)(2008-9#1)
Ca2+ mobilizing##3##2##(1994-11#1)(1994-6#1)(1995-3#1)
Ca2+ or##2##2##(1992-9#1)(1995-5#1)
Ca2+ oscillations##5##2##(1994-6#4)(1995-11#1)
Ca2+ per##2##2##(1990-7#1)(1994-5#1)
Ca2+ pools##3##2##(1991-6#2)(1992-11#1)
Ca2+ pump inhibitor##2##3##(1996-2#2)
Ca2+ pump##6##2##(1991-8#2)(1994-11#1)(1995-11#1)(1996-2#2)
Ca2+ release and##2##3##(1991-8#1)(1993-8#1)
Ca2+ release by##2##3##(1995-6#2)
Ca2+ release from sarcoplasmic reticulum##3##5##(1992-3#1)(1995-6#2)
Ca2+ release from the##2##4##(1995-12#1)(1995-6#1)
Ca2+ release from##10##3##(1990-2#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#4)
Ca2+ release in the##2##4##(1990-2#1)(1991-2#1)
Ca2+ release##29##2##(1990-2#4)(1991-2#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-12#1)(1995-3#2)(1995-6#10)(1997-4#2)
Ca2+ response to##2##3##(1990-2#1)(1993-8#1)
Ca2+ response##4##2##(1990-2#2)(1990-7#1)(1993-8#1)
Ca2+ reuptake##5##2##(1991-8#5)
Ca2+ rise##2##2##(1990-2#1)(2010-11#1)
Ca2+ signal##4##2##(1994-2#1)(2009-3#3)
Ca2+ signaling in hepatocytes##2##4##(1992-5#2)
Ca2+ signaling##4##2##(1992-5#2)(2007-12#1)(2010-11#1)
Ca2+ store and##2##3##(1991-8#1)(1993-8#1)
Ca2+ store##3##2##(1991-8#1)(1993-8#2)
Ca2+ stores##9##2##(1991-12#1)(1992-11#1)(1994-6#1)(1996-5#2)(1997-7#2)(2008-8#2)
Ca2+ to##2##2##(1990-2#1)(1997-7#1)
Ca2+ transport site of the##2##5##(1995-5#2)
Ca2+ transport##4##2##(1995-5#3)(1997-2#1)
Ca2+ uptake and##2##3##(1991-8#1)(1994-11#1)
Ca2+ uptake##5##2##(1991-8#2)(1994-11#2)(1996-5#1)
Ca2+ was required for##2##4##(1990-5#1)(1994-8#1)
Ca2+ was required##3##3##(1990-5#1)(1994-6#1)(1994-8#1)
Ca2+ was##10##2##(1990-5#1)(1990-7#2)(1991-8#3)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)
Ca2+ were##3##2##(1993-11#1)(1993-3#1)(1995-6#1)
Ca2+ which##2##2##(1991-6#1)(1993-5#1)
Ca2+ with##3##2##(1993-8#1)(1994-11#1)(1995-6#1)
Ca2+##563##1##(1990-10#2)(1990-11#5)(1990-12#13)(1990-2#19)(1990-5#10)(1990-7#34)(1990-8#17)(1991-1#2)(1991-11#1)(1991-12#8)(1991-2#2)(1991-5#6)(1991-6#9)(1991-8#17)(1991-9#3)(1992-11#6)(1992-12#6)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#9)(1992-7#1)(1992-8#7)(1992-9#4)(1993-11#10)(1993-12#9)(1993-3#17)(1993-5#2)(1993-8#13)(1993-9#1)(1994-11#18)(1994-12#6)(1994-2#8)(1994-3#3)(1994-5#9)(1994-6#32)(1994-8#9)(1994-9#3)(1995-11#30)(1995-12#21)(1995-2#8)(1995-3#4)(1995-5#12)(1995-6#36)(1995-8#7)(1996-12#2)(1996-2#36)(1996-5#14)(1997-1#4)(1997-2#7)(1997-4#4)(1997-7#9)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#15)(2008-9#2)(2009-10#1)(2009-3#6)(2009-7#2)(2009-8#1)(2010-11#4)(2013-1#1)(2013-7#1)
Ca2+)##3##1##(1990-12#1)(1990-5#1)(1993-6#1)
Ca2+-dependent##2##1##(1996-2#1)(2012-2#1)
Ca2+/CaM/CaN signal pathway##4##3##(2011-3#4)
Ca2+/calmodulin##7##1##(1995-11#3)(1996-2#1)(1997-2#2)(2013-7#1)
Ca2+/calmodulin-dependent protein kinase II##7##4##(1990-5#1)(1993-6#2)(1995-2#2)(1995-8#2)
Ca2+/calmodulin-dependent protein kinase V##2##4##(1994-6#2)
Ca2+/calmodulin-dependent protein kinase##9##3##(1990-5#1)(1993-6#2)(1994-6#2)(1995-2#2)(1995-8#2)
Ca2+/calmodulin-dependent##13##1##(1990-5#2)(1992-3#1)(1993-12#2)(1993-6#2)(1994-6#2)(1995-2#2)(1995-8#2)
Ca2+/calmodulin-independent##2##1##(1992-3#2)
Ca2+/calmodulin-regulated##2##1##(1991-12#1)(1992-3#1)
CaCO(3)##5##1##(2008-10#3)(2013-1#2)
CaCO3##9##1##(1995-3#2)(1997-4#1)(2007-12#1)(2008-12#1)(2008-6#4)
CaCO3)##2##1##(1995-3#2)
CaCV##4##1##(2008-10#4)
CaCl(2)##11##1##(2008-10#8)(2008-11#1)(2009-12#1)(2013-1#1)
CaCl2 and##4##2##(1993-6#1)(1994-3#1)(1995-3#1)(2008-12#1)
CaCl2##12##1##(1990-7#3)(1991-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(2008-12#1)
CaD gene##2##2##(1993-11#2)
CaD##4##1##(1993-11#4)
CaD*##5##1##(1994-5#5)
CaD*-actin-S1##2##1##(1994-5#2)
CaF(2) and BaF(2)##2##3##(2007-12#2)
CaF(2) and##5##2##(2007-12#2)(2008-10#2)(2008-3#1)
CaF(2)##11##1##(2007-12#2)(2008-10#4)(2008-3#4)(2008-7#1)
CaF(2)-TiO(2)##2##1##(2008-3#2)
CaF2##3##1##(1993-5#1)(2008-3#2)
CaHira##3##1##(2008-7#3)
CaLCV##3##1##(2008-10#3)
CaM and##3##2##(1990-8#1)(2008-8#1)(2011-3#1)
CaM cDNAs were##2##3##(1994-12#2)
CaM cDNAs##4##2##(1994-12#4)
CaM in##4##2##(1994-3#1)(2008-8#3)
CaM kinase I##3##3##(1994-6#3)
CaM kinase II exhibited##2##4##(1993-6#2)
CaM kinase II##13##3##(1990-5#4)(1993-6#9)
CaM kinase V##3##3##(1994-6#3)
CaM kinase##20##2##(1990-5#4)(1993-6#9)(1994-6#7)
CaM was found##2##3##(2008-8#2)
CaM##49##1##(1990-5#4)(1990-8#2)(1993-6#9)(1994-12#6)(1994-3#2)(1994-6#7)(1996-12#1)(2008-8#16)(2011-3#2)
CaM-BP68 in the##2##3##(1994-5#2)
CaM-BP68##4##1##(1994-5#4)
CaM-Sepharose affinity##2##2##(1990-8#1)(2008-9#1)
CaM-kinase II##4##2##(1995-2#4)
CaM-kinase III##2##2##(1994-2#2)
CaM-kinase##6##1##(1994-2#2)(1995-2#4)
CaMK II alpha##2##3##(1996-12#2)
CaMK II##8##2##(1995-8#6)(1996-12#2)
CaMKII##6##1##(1997-2#1)(2008-8#1)(2009-7#2)(2012-2#2)
CaMV 35S promoter##8##3##(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-8#1)(2008-9#2)(2011-10#1)
CaMV 35S##9##2##(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-8#1)(2008-9#3)(2011-10#1)
CaMV isolates##2##2##(2008-10#2)
CaMV##17##1##(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#8)(2008-8#1)(2008-9#3)(2011-10#1)
CaMV35S and rolC##2##3##(2008-9#2)
CaMV35S promoter and##2##3##(2008-9#2)
CaMV35S##6##1##(2008-9#6)
CaN was##2##2##(2011-3#2)
CaN##4##1##(2011-3#4)
CaO in##2##2##(2013-1#2)
CaO##10##1##(2008-10#3)(2008-5#1)(2013-1#6)
CaO)##2##1##(2008-10#1)(2013-1#1)
CaPKC1 gene##2##2##(1996-6#2)
CaSR mRNA expression in the##2##5##(2008-11#2)
CaSR mRNA was##2##3##(2008-11#2)
CaSR mRNA##9##2##(2008-11#9)
CaSR##11##1##(2008-11#11)
CaSTE7##3##1##(1997-4#3)
CaSki##2##1##(1994-12#2)
CaWO(4)##4##1##(2008-3#1)(2009-11#3)
Ca](otolith)##6##1##(2010-8#6)
Ca](water) and##2##2##(2010-8#2)
Caatinga##3##1##(2008-8#1)(2010-3#2)
Cab proteins##2##2##(2008-7#2)
Cabar##7##1##(2011-2#7)
Cabbage and##2##2##(1994-3#1)(2008-10#1)
Cabbage##8##1##(1994-3#1)(2008-10#6)(2013-1#1)
Cabernet Sauvignon##2##2##(2008-10#2)
Cabernet##3##1##(2008-10#3)
Cacao##2##1##(2008-10#2)
Cachexia##2##1##(1997-8#1)(2008-10#1)
Caco-2 and##2##2##(1994-6#1)(2008-11#1)
Caco-2 cell monolayer model##2##4##(2011-3#2)
Caco-2 cell monolayer##5##3##(2008-11#2)(2011-3#3)
Caco-2 cell monolayers##5##3##(2007-12#2)(2008-11#3)
Caco-2 cell##10##2##(2007-12#2)(2008-11#5)(2011-3#3)
Caco-2 cells and##3##3##(1994-6#2)(2011-2#1)
Caco-2 cells during##2##3##(2008-11#2)
Caco-2 cells##20##2##(1994-6#4)(2007-12#2)(2008-11#13)(2011-2#1)
Caco-2##38##1##(1994-6#5)(2007-12#4)(2008-11#25)(2011-2#1)(2011-3#3)
Cadherin##2##1##(1993-6#1)(2011-1#1)
Cadi ThermoSENSOR##2##2##(2010-5#2)
Cadmium and##2##2##(2008-10#2)
Cadmium was detected##2##3##(2008-10#1)(2008-12#1)
Cadmium was##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
Cadmium##20##1##(1991-12#1)(1993-12#1)(1996-7#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#1)
Cadmium-induced##2##1##(1996-12#1)(2008-10#1)
Cae##3##1##(1991-12#3)
Caenorhabditis elegans##37##2##(1990-5#3)(1993-12#2)(1994-11#2)(1994-12#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-6#2)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#8)(2008-9#1)(2012-12#1)(2012-3#2)(2013-1#1)
Caenorhabditis##38##1##(1990-5#3)(1993-12#2)(1994-11#2)(1994-12#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-6#2)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#9)(2008-9#1)(2012-12#1)(2012-3#2)(2013-1#1)
Caesarean section##8##2##(1990-9#1)(1991-9#3)(2006-10#1)(2008-7#3)
Caesarean sections##2##2##(1996-11#1)(2008-11#1)
Caesarean##12##1##(1990-9#1)(1991-9#3)(1996-11#1)(2006-10#1)(2008-11#1)(2008-7#3)(2011-1#1)(2011-2#1)
Caffeic acid##2##2##(2008-11#1)(2009-12#1)
Caffeic##3##1##(2008-11#1)(2009-12#2)
Caffeine##13##1##(1990-3#1)(1995-11#3)(1995-8#2)(2008-10#3)(2008-5#2)(2008-6#1)(2009-1#1)
Caféine##4##1##(2013-1#4)
CagA##6##1##(2011-2#2)(2012-12#4)
CagHira##2##1##(2008-7#2)
Cage##3##1##(1997-6#1)(1997-7#1)(2008-12#1)
Caged cADPR was##2##3##(1995-3#2)
Caged##5##1##(1995-2#1)(1995-3#3)(2008-4#1)
Cages##2##1##(2006-4#1)(2008-10#1)
Cagliari##3##1##(1991-2#1)(1992-5#1)(2012-3#1)
Cahuita National Park##3##3##(2008-5#3)
Cahuita##6##1##(2008-5#3)(2011-2#3)
Cairo University##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
Cairo##12##1##(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2010-10#2)
Cajal##5##1##(2008-6#1)(2009-12#2)(2009-5#1)(2012-12#1)
Caki-2 and##2##2##(2011-2#2)
Cal##3##1##(2008-3#3)
Cal/Logan##2##1##(2008-10#2)
Cal/OSHA##2##1##(1991-12#1)(1997-2#1)
CalB variants##2##2##(2011-2#2)
Calabar##6##1##(2008-10#2)(2008-5#2)(2013-1#2)
Calanus finmarchicus##3##2##(2009-6#1)(2013-1#2)
Calbindin D-28k and parvalbumin expression##2##5##(1995-5#2)
Calbindin##3##1##(1995-5#2)(1996-5#1)
Calcein##2##1##(2008-10#1)(2011-1#1)
Calcification##4##1##(1990-11#1)(2008-12#1)(2008-7#2)
Calcifying##4##1##(1991-4#1)(2007-12#2)(2012-3#1)
Calcipotriol##2##1##(1993-11#1)(1995-5#1)
Calcitonin gene-related peptide in the brain##2##6##(1992-6#2)
Calcitonin gene-related peptide in the regulation of##2##7##(1992-6#2)
Calcitonin gene-related peptide in the##4##5##(1992-6#4)
Calcitonin gene-related peptide in##5##4##(1992-6#5)
Calcitonin gene-related peptide is##3##4##(1992-6#3)
Calcitonin gene-related peptide##14##3##(1992-6#13)(1997-3#1)
Calcitonin gene-related##16##2##(1992-6#14)(1992-9#1)(1997-3#1)
Calcitonin##21##1##(1990-12#1)(1991-3#1)(1992-6#14)(1992-9#1)(1993-11#1)(1997-3#1)(1997-6#1)(2008-4#1)
Calcium and vitamin D##2##4##(1997-6#1)(2008-4#1)
Calcium and##4##2##(1997-6#1)(2008-10#2)(2008-4#1)
Calcium antagonists are##2##3##(2008-3#2)
Calcium channel blockers##2##3##(1992-8#1)(2008-10#1)
Calcium channel##5##2##(1991-12#1)(1992-8#1)(1993-6#1)(2008-10#1)(2008-7#1)
Calcium oxalate##2##2##(1995-8#1)(2008-10#1)
Calcium phosphate transfection##2##3##(2008-1#1)(2008-2#1)
Calcium##43##1##(1990-12#2)(1990-3#1)(1991-12#2)(1991-5#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
Calculated results are##2##3##(2008-2#1)(2008-3#1)
Calculated results##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Calculated##14##1##(1993-11#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2011-1#1)(2011-2#2)
Calculating##3##1##(2007-11#1)(2008-11#1)(2008-3#1)
Calculation of the##12##3##(1990-8#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#6)(2008-7#1)
Calculation of##16##2##(1990-8#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#8)(2008-7#1)
Calculation##17##1##(1990-8#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-7#1)
Calculations and##2##2##(1996-2#1)(2008-3#1)
Calculations are made for##2##4##(2008-2#1)(2008-3#1)
Calculations are##3##2##(2008-2#2)(2008-3#1)
Calculations based on##3##3##(1990-8#1)(2008-3#2)
Calculations of the##4##3##(2007-12#1)(2008-2#3)
Calculations of##9##2##(1994-3#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)
Calculations show that##2##3##(2008-2#1)(2013-1#1)
Calculations were performed##2##3##(1993-11#1)(2008-10#1)
Calculations were##3##2##(1993-11#1)(2008-10#2)
Calculations##32##1##(1990-8#1)(1993-11#1)(1994-3#2)(1995-6#1)(1996-2#1)(1996-5#3)(2007-12#1)(2008-10#3)(2008-2#7)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#2)
Calcutta##4##1##(2007-7#4)
Calcyclin and calvasculin##2##3##(1992-12#2)
Caldas##2##1##(2008-12#1)(2008-5#1)
Calendar##3##1##(2008-8#1)(2010-1#1)(2013-1#1)
Calf##3##1##(1995-6#1)(2008-10#1)(2008-11#1)
Calgary##3##1##(1992-3#1)(2011-2#1)(2012-2#1)
Cali##7##1##(2008-10#1)(2012-12#6)
Calibration and##4##2##(2007-8#1)(2008-10#2)(2008-2#1)
Calibration curves for##4##3##(2008-10#4)
Calibration curves were established for##2##5##(2008-10#2)
Calibration curves were linear##2##4##(2008-10#2)
Calibration curves were##6##3##(2008-10#6)
Calibration curves##15##2##(2008-10#15)
Calibration graph##4##2##(2008-10#4)
Calibration graphs are linear##2##4##(2008-10#2)
Calibration graphs are##3##3##(2008-10#3)
Calibration graphs for##2##3##(2008-10#2)
Calibration graphs were linear##3##4##(2008-10#3)
Calibration graphs were rectilinear over the uranium(VI) concentrations in the range 5-200mugl(-1)##2##12##(2008-10#2)
Calibration graphs were rectilinear over the##3##6##(2008-10#3)
Calibration graphs were##7##3##(2008-10#7)
Calibration graphs##14##2##(2008-10#14)
Calibration is carried out using aqueous standards##2##7##(2008-10#2)
Calibration is carried out##3##4##(2008-10#3)
Calibration matrices were##2##3##(2008-10#2)
Calibration models##2##2##(2008-10#2)
Calibration of SeaWiFS##2##3##(2008-3#2)
Calibration of a##2##3##(2008-3#2)
Calibration of the sensor was done##2##6##(2008-10#2)
Calibration of the##6##3##(2008-10#5)(2008-2#1)
Calibration of##13##2##(2008-10#5)(2008-2#1)(2008-3#7)
Calibration plot##2##2##(2008-10#2)
Calibration plots of the titrant end-point consumption##2##7##(2008-10#2)
Calibration plots of##3##3##(2008-10#3)
Calibration plots##7##2##(1996-5#1)(2008-10#6)
Calibration was##3##2##(2008-10#3)
Calibration with##2##2##(2008-10#1)(2008-3#1)
Calibration##84##1##(1996-5#1)(2007-8#1)(2008-10#65)(2008-2#4)(2008-3#11)(2008-9#1)(2010-3#1)
Calibrations##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Calicuchima-sib##2##1##(2008-10#2)
Calif##4##1##(1991-9#1)(2008-3#3)
Calif/09##3##1##(2011-2#3)
California Fair Employment and Housing##2##5##(1990-2#1)(1995-12#1)
California and Arizona##2##3##(2008-10#1)(2011-2#1)
California and Michigan##3##3##(1992-2#2)(1992-3#1)
California and Oregon##2##3##(2008-10#2)
California and the##3##3##(2008-10#2)(2008-8#1)
California and##17##2##(1992-2#2)(1992-3#1)(1994-3#1)(2008-10#9)(2008-8#2)(2008-9#1)(2011-2#1)
California are##2##2##(2008-10#1)(2010-6#1)
California counties##2##2##(1992-2#1)(2008-10#1)
California data##2##2##(1992-12#1)(2012-1#1)
California from##2##2##(1991-12#1)(2008-10#1)
California grunion Leuresthes##2##3##(2010-8#2)
California have##2##2##(2008-10#1)(2008-9#1)
California hospitals##2##2##(1993-2#1)(1994-12#1)
California in##6##2##(1992-2#1)(1997-3#1)(2008-10#4)
California isolates##3##2##(2008-10#3)
California or##2##2##(2008-5#1)(2008-8#1)
California pistachio##3##2##(2008-10#3)
California populations of##2##3##(2008-10#2)
California populations##3##2##(2008-10#2)(2008-9#1)
California sea lion populations in##2##5##(2009-2#2)
California sea##3##2##(2009-2#3)
California were##4##2##(2008-10#3)(2008-5#1)
California with##2##2##(2007-2#1)(2012-3#1)
California##265##1##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#7)(1992-3#2)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#3)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#9)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-4#7)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#6)(1997-6#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-10#119)(2008-11#4)(2008-2#2)(2008-3#4)(2008-5#8)(2008-6#2)(2008-8#8)(2008-9#6)(2009-11#1)(2009-2#6)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#3)(2010-8#6)(2011-1#1)(2011-2#13)(2012-1#5)(2012-3#2)(2013-1#1)(2013-7#2)
California's Medicaid##2##2##(1993-3#1)(1995-2#1)
California's##10##1##(1990-2#1)(1992-2#2)(1993-3#1)(1994-1#1)(1995-2#1)(1995-3#2)(2008-6#1)(2011-2#1)
California)##2##1##(1997-3#1)(2012-12#1)
California?##2##1##(1996-1#1)(2011-2#1)
Californian##4##1##(1995-12#1)(2008-10#2)(2008-2#1)
Calimyrna figs##3##2##(2008-10#3)
Calimyrna orchards##2##2##(2008-10#2)
Calimyrna##7##1##(2008-10#7)
Call for##4##2##(1995-11#1)(1996-8#1)(2011-2#1)(2012-12#1)
Call##9##1##(1994-12#1)(1995-11#1)(1995-6#1)(1996-8#1)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#1)
Calla lily chlorotic spot virus (CCSV)##2##6##(2008-10#2)
Calla lily chlorotic spot virus##3##5##(2008-10#3)
Callinectes sapidus##6##2##(1994-11#2)(2007-12#4)
Calling##2##1##(2007-4#1)(2010-1#1)
Calliphora vicina larvae##2##3##(1995-2#2)
Calliphora vicina##4##2##(1990-7#2)(1995-2#2)
Calmette Guerin##3##2##(2011-1#2)(2011-2#1)
Calmette##4##1##(2011-1#2)(2011-2#2)
Calmette-Guérin for##2##2##(1991-11#1)(2008-1#1)
Calmette-Guérin##5##1##(1991-11#1)(1997-2#1)(2008-1#1)(2009-7#1)(2010-5#1)
Calmodulin##6##1##(1991-12#1)(1993-6#2)(1994-12#2)(2012-2#1)
Calmodulin-binding proteins in##2##3##(1990-11#2)
Calophyllum lanigerum##2##2##(1992-8#2)
Calophyllum##3##1##(1992-8#2)(2008-5#1)
Calopteryx##5##1##(2008-8#5)
Caloric restriction (CR)##2##3##(1994-5#1)(2008-7#1)
Caloric restriction##3##2##(1994-5#1)(2008-3#1)(2008-7#1)
Caloric##4##1##(1994-5#1)(2008-3#2)(2008-7#1)
Calorie restriction##2##2##(2008-4#1)(2009-5#1)
Calorimetric##2##1##(1990-8#1)(2011-1#1)
Calothrix##3##1##(1992-12#3)
Calotropis##4##1##(2008-12#3)(2013-1#1)
Calpain##8##1##(1992-12#4)(1992-6#1)(1995-11#1)(1995-3#2)
Calphostin C##2##2##(1992-11#1)(1995-12#1)
Calu-6##3##1##(1992-9#3)
Calwonder##2##1##(2008-10#2)
Calycotome##4##1##(2007-11#4)
Calyculin A##3##2##(1992-12#1)(1993-8#2)
Cambisol)##2##1##(2008-11#2)
Cambodia##5##1##(1996-8#1)(2008-10#2)(2010-11#1)(2013-8#1)
Cambridge University Press##6##3##(1990-11#2)(1990-3#1)(1990-8#1)(2008-12#1)(2008-4#1)
Cambridge##25##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1992-4#1)(1994-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#4)(2008-5#2)(2008-9#2)(2009-7#1)(2011-1#1)(2013-1#1)
Cambrinus##2##1##(2008-10#2)
Camden##2##1##(1994-1#1)(2010-9#1)
Camel##3##1##(1990-12#1)(1996-11#1)(1996-12#1)
Camellia sinensis##3##2##(2008-7#3)
Camelot (carries##2##2##(2008-10#2)
Camelot##3##1##(2008-10#3)
Camera calibration##2##2##(2008-6#2)
Camera##8##1##(2008-2#3)(2008-3#2)(2008-6#2)(2011-1#1)
Camera-based##2##1##(2008-6#1)(2011-1#1)
Cameras##2##1##(2008-6#1)(2008-9#1)
Cameroon##11##1##(2007-7#2)(2008-10#2)(2009-10#1)(2010-9#1)(2012-12#1)(2013-1#4)
Camp##2##1##(1995-5#1)(2008-7#1)
Campaign 2000##2##2##(2008-11#2)
Campaign##8##1##(1990-9#1)(1995-12#1)(1996-8#1)(1997-5#1)(2008-11#2)(2009-10#1)(2012-2#1)
Campbell##5##1##(1992-3#1)(2008-10#3)(2010-4#1)
Campeche##10##1##(2008-5#7)(2013-7#3)
Campinas##6##1##(2008-10#1)(2008-6#1)(2008-9#2)(2013-8#2)
Campoletis sonorensis##2##2##(2010-2#2)
Camponotus##3##1##(2008-6#2)(2012-3#1)
Camptothecins##2##1##(1995-5#1)(1996-3#1)
Campus##5##1##(2008-6#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
Campylobacter fetus subsp##2##3##(2011-1#2)
Campylobacter fetus##7##2##(2011-1#7)
Campylobacter infections##3##2##(1991-3#1)(2008-10#2)
Campylobacter is##2##2##(2011-1#2)
Campylobacter jejuni and##2##3##(1990-3#1)(2008-10#1)
Campylobacter jejuni##6##2##(1990-3#2)(1993-9#1)(2008-10#1)(2010-12#1)(2011-1#1)
Campylobacter jejuni/coli##2##2##(2008-7#2)
Campylobacter species##3##2##(1996-3#1)(2007-12#1)(2011-2#1)
Campylobacter spp isolated from##2##4##(1990-3#1)(1991-11#1)
Campylobacter was found in##2##4##(2008-10#2)
Campylobacter##39##1##(1990-3#4)(1991-11#1)(1991-3#1)(1993-9#2)(1996-3#1)(2007-12#1)(2008-10#10)(2008-7#2)(2010-12#1)(2011-1#14)(2011-2#2)
Can hospitals##2##2##(1992-5#1)(1996-1#1)
Can physicians##2##2##(1992-2#1)(2010-9#1)
Can the##7##2##(1991-9#1)(1992-11#1)(1992-3#1)(2008-2#1)(2008-8#1)(2013-1#2)
Can urodynamic studies##2##3##(2008-10#2)
Can we##10##2##(1991-2#1)(1993-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-2#2)(2013-7#1)
Can you##6##2##(1993-3#1)(2008-1#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-7#1)
Can##83##1##(1991-2#2)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
Canada and the United States##10##5##(1991-3#1)(1993-3#3)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
Canada and the##12##3##(1991-3#1)(1993-3#3)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-2#1)
Canada and##26##2##(1991-3#2)(1993-2#1)(1993-3#3)(1994-9#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-5#1)(2009-6#1)(2012-2#1)
Canada as##2##2##(1991-3#1)(1996-3#1)
Canada between##2##2##(2008-3#1)(2009-5#1)
Canada in the face of the 2009 H1N1 pandemic##2##9##(2011-2#2)
Canada in the##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
Canada in##10##2##(1993-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#2)
Canada is##8##2##(1993-12#1)(1993-3#1)(1995-1#1)(2007-12#1)(2008-11#2)(2008-12#1)(2011-2#1)
Canada needs##2##2##(2008-11#2)
Canada remains##2##2##(2008-10#1)(2011-2#1)
Canada to determine##3##3##(2008-12#1)(2010-8#1)(2013-8#1)
Canada to##7##2##(1992-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-12#1)(2010-8#1)(2013-8#1)
Canada was##2##2##(1994-2#1)(2008-6#1)
Canada were##6##2##(2007-12#1)(2008-10#3)(2008-12#1)(2012-12#1)
Canada##365##1##(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#6)(1991-4#1)(1991-8#2)(1992-1#6)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#3)(1993-12#5)(1993-2#5)(1993-3#6)(1993-9#1)(1994-1#5)(1994-12#4)(1994-2#8)(1994-3#2)(1994-9#1)(1995-1#7)(1995-12#2)(1995-2#5)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#6)(1996-6#1)(1996-9#4)(1997-1#1)(1997-3#4)(2007-12#51)(2008-10#63)(2008-11#36)(2008-12#16)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#8)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#9)(2010-4#2)(2010-8#5)(2010-9#1)(2011-2#13)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#5)
Canada's Access to Medicines Regime##2##5##(2011-2#2)
Canada's Food##2##2##(1995-2#1)(2011-2#1)
Canada's response##2##2##(2007-12#1)(2011-2#1)
Canada's##23##1##(1995-2#1)(1996-2#1)(2007-12#2)(2008-11#8)(2008-12#2)(2008-4#1)(2009-4#1)(2011-2#7)
Canada)##4##1##(2007-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
Canadian AMV isolates##2##3##(2008-10#2)
Canadian Academy of##2##3##(1994-12#1)(2008-4#1)
Canadian Association of##2##3##(1995-2#1)(2008-11#1)
Canadian College of Health Service Executives##3##6##(1992-3#1)(1996-2#1)(1997-2#1)
Canadian Dietetic Association and##2##4##(1994-2#1)(1995-3#1)
Canadian Dietetic Association##6##3##(1994-2#3)(1995-1#1)(1995-2#1)(1995-3#1)
Canadian Drosophila##2##2##(2008-10#2)
Canadian Health Measures Survey##2##4##(2008-12#2)
Canadian Health##5##2##(1994-12#1)(2008-12#2)(2009-3#1)(2013-1#1)
Canadian Hospital Epidemiology Committee##2##4##(2007-12#2)
Canadian Hospital##4##2##(1992-1#2)(2007-12#2)
Canadian Infectious Disease Society##2##4##(2007-12#2)
Canadian Infectious##3##2##(2007-12#3)
Canadian Neonatal Network##2##3##(2008-11#2)
Canadian Paediatric##3##2##(1994-11#1)(2008-11#2)
Canadian Physiotherapy Association##3##3##(1993-3#2)(1995-2#1)
Canadian Physiotherapy##4##2##(1993-3#2)(1995-2#1)(1996-2#1)
Canadian Public Health Laboratory Network##2##5##(2008-10#2)
Canadian Public Health##3##3##(2008-10#2)(2008-12#1)
Canadian and##7##2##(1994-1#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
Canadian children##5##2##(2007-12#2)(2008-11#1)(2011-2#1)(2012-2#1)
Canadian children's##2##2##(2008-11#1)(2009-5#1)
Canadian clinical##2##2##(2007-12#1)(2011-2#1)
Canadian consensus##3##2##(2007-12#2)(2008-6#1)
Canadian culture##2##2##(2010-12#2)
Canadian experience##3##2##(1995-2#1)(2008-6#1)(2012-12#1)
Canadian families are##2##3##(2008-11#2)
Canadian families##3##2##(2008-11#3)
Canadian health care facilities##2##4##(2007-12#2)
Canadian health care organizations##2##4##(1993-1#1)(1997-2#1)
Canadian health care##17##3##(1991-1#1)(1992-1#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#2)(2011-2#1)
Canadian health##21##2##(1991-1#1)(1992-1#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-12#1)(2011-2#2)
Canadian hospital##3##2##(1992-1#1)(1992-12#1)(1995-3#1)
Canadian hospitals are##3##3##(1991-12#1)(1994-12#1)(1995-1#1)
Canadian hospitals##13##2##(1991-1#1)(1991-12#2)(1993-1#1)(1993-2#1)(1994-12#3)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#2)
Canadian medical##3##2##(1993-12#1)(1997-2#1)(2011-2#1)
Canadian obstetrical population##2##3##(2007-12#2)
Canadian organizations##5##2##(1993-1#3)(1994-2#2)
Canadian paediatric##3##2##(2008-11#3)
Canadian physicians##2##2##(2009-3#1)(2010-10#1)
Canadian physiotherapists' professional identity##2##4##(1993-3#2)
Canadian population##2##2##(2007-12#1)(2008-10#1)
Canadian populations of##2##3##(2008-10#2)
Canadian provinces##8##2##(1993-3#2)(2007-12#1)(2008-10#4)(2010-8#1)
Canadian public health nutritionists##4##4##(1993-1#2)(1993-2#2)
Canadian public health##5##3##(1993-1#2)(1993-2#2)(2008-10#1)
Canadian public##7##2##(1993-1#2)(1993-2#2)(2007-12#1)(2007-5#1)(2008-10#1)
Canadian schools of##2##3##(1994-2#1)(2008-12#1)
Canadian study##2##2##(2007-12#1)(2007-2#1)
Canadian teaching hospital##2##3##(1992-3#2)
Canadian wheat##3##2##(2008-10#3)
Canadian women##2##2##(1991-6#1)(2010-4#1)
Canadian##288##1##(1991-1#2)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#7)(1993-12#3)(1993-2#5)(1993-3#7)(1993-6#1)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#7)(1994-2#8)(1994-6#1)(1995-1#4)(1995-12#2)(1995-2#6)(1995-3#4)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#7)(2007-12#38)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#1)(2008-10#43)(2008-11#30)(2008-12#12)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#6)(2009-3#2)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#3)
Canadians are##3##2##(2007-12#2)(2010-12#1)
Canadians with##2##2##(2013-1#2)
Canadians##11##1##(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#2)(2013-1#3)
Canal##2##1##(2007-12#1)(2008-10#1)
Canary Islands##4##2##(1996-4#1)(2008-10#2)(2008-2#1)
Canary##6##1##(1996-4#1)(2008-10#4)(2008-2#1)
Canasí##2##1##(2008-5#2)
Cancellation of##2##2##(2007-12#1)(2008-3#1)
Cancer -##2##2##(2008-11#1)(2012-1#1)
Cancer 2011##2##2##(2012-3#2)
Cancer Care##5##2##(1991-12#1)(2008-7#2)(2010-9#1)(2012-3#1)
Cancer Cell##2##2##(1997-7#1)(2010-8#1)
Cancer Cells##6##2##(1994-12#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
Cancer Center between##3##3##(2008-10#2)(2013-1#1)
Cancer Center##11##2##(1991-12#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
Cancer Centre##2##2##(2008-7#1)(2012-12#1)
Cancer Hospital##2##2##(2012-2#2)
Cancer Information Service##2##3##(1991-3#1)(2013-1#1)
Cancer Institute of##2##3##(1990-8#1)(1993-6#1)
Cancer Institute##27##2##(1990-8#1)(1991-3#1)(1991-5#1)(1993-6#1)(1995-11#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#4)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
Cancer Patient##2##2##(2008-7#1)(2009-5#1)
Cancer Patients##6##2##(1994-12#2)(1995-4#2)(2010-2#1)(2010-8#1)
Cancer Prevention##2##2##(1995-9#2)
Cancer Program##2##2##(2011-2#1)(2012-3#1)
Cancer Registration##2##2##(1994-8#1)(2013-8#1)
Cancer Registry##11##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#1)(1995-2#2)(2006-8#1)(2008-6#1)(2009-8#1)(2012-3#1)
Cancer Risk##2##2##(2008-7#1)(2013-8#1)
Cancer Screening##3##2##(1993-12#1)(2013-1#2)
Cancer Society##4##2##(1994-12#1)(2010-9#1)(2012-3#2)
Cancer Therapy##4##2##(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
Cancer Treatment##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
Cancer Using##2##2##(1995-4#1)(2008-10#1)
Cancer and cancer treatments can##2##5##(2013-1#2)
Cancer and the##2##3##(2010-8#1)(2013-7#1)
Cancer and##9##2##(2008-10#1)(2010-10#2)(2010-7#1)(2010-8#1)(2013-1#3)(2013-7#1)
Cancer cells##7##2##(1990-11#1)(2008-11#2)(2008-12#1)(2009-3#1)(2009-9#1)(2010-8#1)
Cancer data##2##2##(1996-2#1)(2012-12#1)
Cancer has##2##2##(1997-7#1)(2008-7#1)
Cancer imaging -##2##3##(2008-1#2)
Cancer imaging##3##2##(2008-1#2)(2008-2#1)
Cancer in Japan##2##3##(1997-7#1)(2010-12#1)
Cancer in populations living##2##4##(1991-3#1)(2007-5#1)
Cancer in##11##2##(1991-3#1)(1994-12#1)(1997-7#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2013-1#1)(2013-8#2)
Cancer incidence in New Zealand born residents of New South Wales##2##11##(1990-2#2)
Cancer is a##2##3##(2008-2#1)(2008-7#1)
Cancer is##8##2##(1994-5#1)(2008-2#1)(2008-7#1)(2009-5#2)(2009-6#1)(2013-1#2)
Cancer mortality in Italy##3##4##(1991-2#1)(1994-12#1)(1994-2#1)
Cancer mortality in##5##3##(1991-12#1)(1991-2#1)(1994-12#1)(1994-2#2)
Cancer mortality##7##2##(1991-12#2)(1991-2#1)(1994-12#1)(1994-2#2)(2010-10#1)
Cancer of the##2##3##(1992-9#1)(2008-10#1)
Cancer patients##2##2##(1991-1#1)(2007-11#1)
Cancer research in the##2##4##(1993-2#1)(2009-4#1)
Cancer research##5##2##(1991-12#1)(1993-2#1)(2009-4#3)
Cancer##338##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#12)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#9)(1994-8#2)(1995-11#2)(1995-2#2)(1995-4#5)(1995-5#1)(1995-9#2)(1996-2#1)(1996-8#1)(1997-1#5)(1997-3#2)(1997-4#1)(1997-7#10)(1997-8#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#14)(2008-11#8)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#28)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#7)(2009-5#5)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#22)(2010-9#3)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#8)(2012-2#12)(2012-3#16)(2013-1#20)(2013-7#1)(2013-8#8)
Cancer)##4##1##(1990-12#2)(1992-2#1)(1992-8#1)
Cancers##7##1##(1994-12#1)(1995-4#2)(2006-8#1)(2009-4#1)(2010-11#1)(2012-2#1)
Candida albicans and Candida##2##4##(2008-11#1)(2008-5#1)
Candida albicans and##7##3##(2008-11#1)(2008-4#1)(2008-5#3)(2010-5#1)(2013-1#1)
Candida albicans by##2##3##(1997-4#1)(2007-7#1)
Candida albicans has been##2##4##(1990-5#1)(2012-3#1)
Candida albicans is a##2##4##(1991-9#1)(1996-12#1)
Candida albicans is##4##3##(1991-9#1)(1996-12#1)(2008-4#1)(2008-5#1)
Candida albicans strains##2##3##(2008-5#1)(2013-8#1)
Candida albicans was##2##3##(2008-5#1)(2012-2#1)
Candida albicans##69##2##(1990-5#2)(1991-12#3)(1991-9#2)(1992-6#1)(1992-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-4#3)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#27)(2009-8#2)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
Candida and##2##2##(2013-1#2)
Candida antarctica lipase B (CalB)##2##5##(2011-2#2)
Candida antarctica lipase B##4##4##(2008-4#1)(2011-2#2)(2013-1#1)
Candida boidinii##4##2##(1991-5#1)(1995-8#1)(2008-7#2)
Candida dubliniensis##4##2##(2008-5#4)
Candida glabrata##8##2##(2008-10#1)(2008-11#2)(2008-5#5)
Candida guillermondii##2##2##(2008-5#1)(2010-5#1)
Candida guilliermondii and##2##3##(2008-5#2)
Candida infections in##2##3##(1997-1#1)(2012-3#1)
Candida infections##4##2##(1997-1#1)(2008-5#1)(2011-2#1)(2012-3#1)
Candida isolates##2##2##(2008-5#1)(2011-2#1)
Candida kefyr##2##2##(2008-6#1)(2013-1#1)
Candida krusei##6##2##(2008-5#5)(2010-5#1)
Candida lesions##2##2##(2008-5#2)
Candida lusitaniae##2##2##(2007-7#2)
Candida magnoliae##2##2##(2008-6#2)
Candida maltosa was##2##3##(1993-12#1)(1996-3#1)
Candida maltosa##6##2##(1991-9#2)(1993-12#2)(1996-3#2)
Candida methylica##2##2##(1995-8#2)
Candida oleophila##6##2##(2008-10#6)
Candida parapsilosis##12##2##(1997-2#3)(2008-5#7)(2010-5#1)(2013-1#1)
Candida rugosa##3##2##(2008-5#1)(2008-7#2)
Candida saitoana and##2##3##(2008-10#2)
Candida saitoana##4##2##(2008-10#4)
Candida sake CPA-1##3##3##(2008-10#3)
Candida sake##6##2##(2008-10#6)
Candida sp##2##2##(1995-3#1)(2008-5#1)
Candida species have##3##3##(2011-2#1)(2012-3#2)
Candida species##11##2##(2008-5#3)(2008-7#1)(2011-2#3)(2012-3#2)(2013-1#2)
Candida spp and##2##3##(2009-9#1)(2011-2#1)
Candida spp##13##2##(2008-5#8)(2009-9#1)(2010-6#1)(2011-2#3)
Candida tropicalis##12##2##(1990-5#2)(1991-9#3)(1995-3#1)(2008-10#1)(2008-5#4)(2010-5#1)
Candida utilis##3##2##(1997-2#2)(2008-11#1)
Candida was##3##2##(2008-5#3)
Candida##229##1##(1990-5#4)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#7)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#2)(1995-3#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-3#4)(1996-6#2)(1997-1#1)(1997-2#5)(1997-4#3)(2006-6#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-4#3)(2008-5#90)(2008-6#3)(2008-7#5)(2009-8#2)(2009-9#1)(2010-5#9)(2010-6#1)(2011-2#13)(2012-2#2)(2012-3#6)(2013-1#15)(2013-8#3)
Candidate gene##2##2##(2008-7#1)(2010-11#1)
Candidate genes##2##2##(2008-6#1)(2012-3#1)
Candidate##8##1##(1996-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#2)(2012-3#2)
Candidates for##2##2##(1995-9#1)(2007-12#1)
Candidates##3##1##(1992-8#1)(1995-9#1)(2007-12#1)
Candidatus Liberibacter asiaticus##2##3##(2011-2#2)
Candidatus Phlomobacter##2##2##(2008-10#2)
Candidatus Phytoplasma australiense&quot##3##3##(2008-10#3)
Candidatus Phytoplasma##4##2##(2008-10#4)
Candidatus Ruthia magnifica##2##3##(2011-2#2)
Candidatus##11##1##(2008-10#6)(2011-2#4)(2012-3#1)
Candona neglecta Sars##2##3##(2008-5#2)
Canine rabies##2##2##(2011-2#2)
Canine##15##1##(1993-3#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#4)(2012-1#2)(2012-2#1)
Canker size##2##2##(2008-10#2)
Canker##3##1##(2008-10#3)
Cankers##2##1##(2008-10#2)
Canna and tansy leaves##2##4##(2008-10#2)
Canna##3##1##(2008-10#3)
Cannabinoid##2##1##(2008-7#1)(2009-12#1)
Cannabis is##2##2##(2008-12#2)
Cannabis sativa##4##2##(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
Cannabis##14##1##(1997-6#2)(2008-1#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-10#1)(2012-12#1)(2013-1#4)
Cannon's algorithms##2##2##(2009-12#2)
Cannon's##3##1##(2009-12#3)
Canola##5##1##(2008-10#4)(2011-2#1)
Canonical correspondence analysis##2##3##(2008-10#2)
Canonical##5##1##(2007-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
Canopies##2##1##(2008-10#2)
Canopy##3##1##(2008-10#2)(2008-6#1)
Cantaloupe##3##1##(2008-10#3)
Canton Zurich##2##2##(1996-11#2)
Canton of Vaud##3##3##(1990-6#1)(1993-9#2)
Canton of##6##2##(1990-6#1)(1993-9#2)(1996-11#3)
Canton##12##1##(1990-6#1)(1993-9#2)(1996-11#8)(2011-1#1)
Cantonese and##2##2##(2013-8#2)
Cantonese##7##1##(2008-2#1)(2008-9#2)(2013-8#4)
Cantoni##2##1##(1990-10#1)(2008-4#1)
Caohui Village##2##2##(2012-3#2)
Cap##3##1##(1992-12#1)(1993-12#1)(2008-9#1)
Capability of##2##2##(2012-3#1)(2013-1#1)
Capability##4##1##(2008-11#2)(2012-3#1)(2013-1#1)
Capable of##2##2##(2008-10#1)(2008-11#1)
Capacity Building##2##2##(1997-1#1)(2008-1#1)
Capacity of##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#2)(2011-2#1)
Capacity##21##1##(1993-1#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#3)(2011-2#3)(2012-3#1)
Cape Province of South Africa##3##5##(2010-3#1)(2011-1#2)
Cape Province##6##2##(2010-3#1)(2011-1#4)(2011-2#1)
Cape Town##7##2##(2007-2#1)(2007-7#1)(2008-8#3)(2010-3#2)
Cape fur seal##2##3##(1992-8#2)
Cape##21##1##(1992-8#2)(1997-4#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-8#3)(2010-11#1)(2010-3#4)(2011-1#4)(2011-2#3)
Caphorn##2##1##(2011-10#2)
Capillaria##4##1##(1996-12#1)(2011-1#3)
Capillary electrophoresis (CE) is an alternative to conventional slab gel electrophoresis for the separation of DNA fragments##2##17##(2008-2#1)(2008-4#1)
Capillary electrophoresis (CE) is##4##4##(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
Capillary electrophoresis (CE)##6##3##(1994-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
Capillary electrophoresis as##2##3##(2008-10#1)(2008-5#1)
Capillary electrophoresis of DNA##2##4##(2008-2#1)(2008-4#1)
Capillary electrophoresis##16##2##(1994-9#2)(2008-10#7)(2008-2#2)(2008-4#2)(2008-5#3)
Capillary electrophoretic##3##2##(2008-10#3)
Capillary isotachophoresis##2##2##(2008-10#2)
Capillary zone electrophoresis (CZE)##4##4##(2008-10#4)
Capillary zone electrophoresis##6##3##(1996-5#1)(2008-10#4)(2008-4#1)
Capillary zone##7##2##(1994-9#1)(1996-5#1)(2008-10#4)(2008-4#1)
Capillary##40##1##(1991-12#1)(1994-9#6)(1996-5#1)(1997-2#1)(2008-10#16)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#1)(2009-5#2)(2010-7#1)
Capital Territory##2##2##(2009-2#1)(2013-1#1)
Capital and##2##2##(1992-1#1)(2012-12#1)
Capital##8##1##(1992-1#2)(1994-2#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
Capitated##2##1##(1991-3#1)(1997-2#1)
Capitation is##2##2##(1995-12#2)
Capitation##7##1##(1995-12#4)(1996-12#1)(1996-3#1)(1997-1#1)
Capkc1p##2##1##(1996-6#2)
Capnor##2##1##(2011-10#2)
Caporale'##2##1##(2010-4#2)
Capparis decidua##2##2##(2013-7#2)
Capparis##3##1##(2008-10#1)(2013-7#2)
Capped##2##1##(2008-10#2)
Capra##2##1##(1991-9#1)(2013-1#1)
Capsaicin is the##2##3##(1993-11#1)(2012-3#1)
Capsaicin##3##1##(1993-11#2)(2012-3#1)
Capsaicin-enhanced Ribosomal Protein P2 Expression in Human Intestinal Caco-2 Cells##2##10##(2008-11#2)
Capsicum annuum##9##2##(2008-10#9)
Capsicum chlorosis virus (CaCV)##2##4##(2008-10#2)
Capsicum chlorosis virus##3##3##(2008-10#3)
Capsicum species##2##2##(2008-10#2)
Capsicum spp##3##2##(2008-10#3)
Capsicum##23##1##(1993-11#1)(2008-10#22)
Capsule endoscopy##3##2##(2011-2#3)
Capsule##5##1##(1990-10#1)(2011-2#4)
Captive##3##1##(1993-1#1)(2007-12#1)(2009-4#1)
Captopril and##2##2##(1990-9#1)(2008-10#1)
Captopril##9##1##(1990-9#1)(1994-5#1)(2008-10#7)
Capture of the##2##3##(2008-1#1)(2009-11#1)
Capture##7##1##(1994-3#1)(2008-1#1)(2009-11#1)(2010-6#2)(2010-8#1)(2011-2#1)
Caquetá##3##1##(2008-5#1)(2012-12#2)
CarMV##2##1##(2008-10#2)
Carabobo##2##1##(2008-9#1)(2011-2#1)
Caragana sinica##3##2##(2008-10#2)(2008-5#1)
Caragana##4##1##(2008-10#3)(2008-5#1)
Carassius auratus##7##2##(1994-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#2)
Carassius gibelio##3##2##(2008-12#3)
Carassius##14##1##(1994-11#1)(2008-1#1)(2008-12#3)(2008-5#3)(2008-6#2)(2008-7#1)(2010-8#3)
Carausius morosus##4##2##(1992-12#1)(2007-12#3)
Carazolol is##2##2##(1995-11#2)
Carazolol##3##1##(1995-11#3)
Carbachol##5##1##(1990-7#1)(1994-11#1)(1996-12#2)(1996-5#1)
Carbaryl##4##1##(1992-2#1)(2008-10#3)
Carbograph##2##1##(2008-10#2)
Carbohydrate deficient transferrin in alcoholism##2##5##(1993-12#2)
Carbohydrate deficient transferrin##3##3##(1993-12#2)(1993-8#1)
Carbohydrate##12##1##(1990-8#1)(1991-12#1)(1993-12#2)(1993-8#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-5#1)(2010-2#1)(2013-1#2)
Carbohydrate-restriction##2##1##(2008-3#2)
Carbohydrates were##3##2##(1991-7#1)(1994-5#1)(2008-10#1)
Carbohydrates##4##1##(1991-7#1)(1994-5#1)(2008-10#1)(2013-1#1)
Carbon Centers##2##2##(1996-5#2)
Carbon Monoxide##3##2##(1996-5#1)(2008-2#1)(2008-8#1)
Carbon Nanotubes##5##2##(2008-10#3)(2008-12#1)(2010-2#1)
Carbon dioxide laser##3##3##(1991-2#1)(1991-3#1)(2008-3#1)
Carbon dioxide##6##2##(1991-2#1)(1991-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
Carbon fiber##2##2##(1992-11#1)(2008-10#1)
Carbon film##2##2##(2008-10#2)
Carbon monoxide (CO)##2##3##(1995-2#1)(1996-12#1)
Carbon monoxide##4##2##(1995-2#1)(1995-3#1)(1996-12#1)(2009-11#1)
Carbon nanotube##5##2##(2008-10#2)(2008-7#3)
Carbon nanotubes##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)
Carbon##56##1##(1991-2#1)(1991-3#1)(1992-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#3)(2007-12#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-4#1)(2012-12#1)(2013-1#2)
Carbon-13 NMR##2##2##(1997-7#1)(2008-10#1)
Carbon-13##3##1##(1997-7#1)(2008-10#2)
Carboniferous##2##1##(2013-1#2)
Carbons of##2##2##(1995-11#2)
Carbonyl##5##1##(1996-2#2)(1996-5#2)(2008-10#1)
Carbopack##2##1##(2008-10#2)
Carboplatin##6##1##(1993-12#1)(1997-3#2)(2008-10#2)(2011-1#1)
Carboxin resistance was##2##3##(2008-10#2)
Carboxin##3##1##(2008-10#3)
Carboxylic##2##1##(2008-10#1)(2012-2#1)
Carboxypeptidase##2##1##(1995-6#1)(2008-4#1)
Carcinoembryonic antigen##3##2##(1990-5#1)(1997-8#1)(2009-11#1)
Carcinoembryonic##4##1##(1990-5#1)(1994-7#1)(1997-8#1)(2009-11#1)
Carcinogenesis in##2##2##(2008-12#1)(2012-1#1)
Carcinogenesis##9##1##(1992-8#2)(1995-6#1)(2008-12#1)(2009-11#1)(2012-1#3)(2013-1#1)
Carcinogenic and##2##2##(1992-2#1)(1997-2#1)
Carcinogenicity of##3##2##(1991-11#1)(1991-12#1)(1992-11#1)
Carcinogenicity##4##1##(1991-11#1)(1991-12#2)(1992-11#1)
Carcinoid##4##1##(1992-5#2)(2008-10#1)(2011-2#1)
Carcinoids##2##1##(2011-2#1)(2013-1#1)
Carcinoma and##2##2##(2010-8#2)
Carcinoma of the oesophagus##2##4##(2008-1#2)
Carcinoma of the##5##3##(1992-3#1)(1994-2#1)(1995-4#1)(2008-1#2)
Carcinoma of##6##2##(1992-3#1)(1994-2#1)(1995-4#1)(2007-10#1)(2008-1#2)
Carcinoma##27##1##(1992-3#1)(1993-9#1)(1994-2#1)(1994-7#2)(1995-4#1)(1996-9#3)(2007-10#1)(2008-1#2)(2008-10#2)(2008-5#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#5)(2013-8#1)
Carcinomas##5##1##(1994-12#1)(2007-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
Carcinosarcoma##4##1##(1991-8#1)(2007-8#2)(2012-1#1)
Carcinosinum##2##1##(2008-10#2)
Carcinus maenas##3##2##(1994-11#1)(1996-2#1)(2007-12#1)
Card##8##1##(1995-11#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-8#2)
Cardiac CT##2##2##(2008-7#2)
Cardiac Care Units##2##3##(2010-8#2)
Cardiac Care##4##2##(2010-6#2)(2010-8#2)
Cardiac Hypertrophy##2##2##(2011-2#1)(2012-12#1)
Cardiac Science##3##2##(2011-2#3)
Cardiac Surgery##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
Cardiac Troponin I in##3##4##(2008-12#3)
Cardiac Troponin I##5##3##(2008-12#5)
Cardiac amyloidosis##2##2##(2008-11#1)(2010-8#1)
Cardiac angiotensin##2##2##(1994-9#2)
Cardiac arrest##2##2##(1992-5#1)(1995-3#1)
Cardiac disease##2##2##(2007-10#1)(2011-2#1)
Cardiac function##2##2##(2007-8#1)(2007-9#1)
Cardiac herniation following##2##3##(2007-8#1)(2008-11#1)
Cardiac herniation##4##2##(2007-8#2)(2008-11#2)
Cardiac hypertrophy was##2##3##(1994-12#1)(2011-2#1)
Cardiac hypertrophy##3##2##(1994-12#1)(2011-2#1)(2012-12#1)
Cardiac magnetic resonance imaging##3##4##(2009-1#1)(2010-10#1)(2012-2#1)
Cardiac magnetic resonance##4##3##(2009-1#1)(2010-10#1)(2010-11#1)(2012-2#1)
Cardiac output##3##2##(1991-3#1)(1996-3#1)(2008-12#1)
Cardiac tamponade##2##2##(2007-8#1)(2008-1#1)
Cardiac##92##1##(1991-3#3)(1992-5#1)(1993-6#2)(1994-12#1)(1994-9#2)(1995-3#1)(1996-3#1)(1996-9#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#8)(2008-3#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#2)(2010-7#1)(2010-8#5)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
CardioVascular Clinical Trialists##2##3##(2013-1#2)
CardioVascular##3##1##(2013-1#3)
Cardiolipin##2##1##(2008-8#1)(2012-2#1)
Cardiological##2##1##(1991-11#1)(2008-12#1)
Cardiology##24##1##(1997-8#1)(2008-10#8)(2008-3#4)(2008-5#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-1#2)(2013-8#1)
Cardiomyopathies##2##1##(2010-11#1)(2013-1#1)
Cardiomyopathy##2##1##(2008-11#1)(2008-7#1)
Cardiopulmonary bypass (CPB)##2##3##(2008-10#1)(2008-7#1)
Cardiopulmonary resuscitation##2##2##(1993-3#1)(2009-4#1)
Cardiopulmonary##5##1##(1993-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-3#1)
Cardiorespiratory Fitness##3##2##(2008-3#1)(2008-5#1)(2009-3#1)
Cardiorespiratory##7##1##(1995-3#1)(1997-3#1)(2008-3#1)(2008-5#1)(2009-3#2)(2013-1#1)
Cardiothoracic Critical Care##2##3##(2013-1#2)
Cardiothoracic##3##1##(2011-2#1)(2013-1#2)
Cardiovascular Data Registry##2##3##(2008-3#2)
Cardiovascular Disease##5##2##(2009-10#1)(2011-1#2)(2012-2#1)(2012-3#1)
Cardiovascular Health##4##2##(2008-11#1)(2009-9#1)(2012-3#1)(2013-1#1)
Cardiovascular Hospitalization Atherosclerosis Management Program was implemented##2##7##(2008-3#2)
Cardiovascular Hospitalization Atherosclerosis Management Program##4##5##(2008-3#4)
Cardiovascular Research##2##2##(2009-12#1)(2011-2#1)
Cardiovascular Risk in##2##3##(2008-7#1)(2013-1#1)
Cardiovascular Study##2##2##(2008-3#2)
Cardiovascular and##2##2##(1991-10#1)(2007-8#1)
Cardiovascular disease (CVD) is the##2##5##(2012-2#1)(2013-7#1)
Cardiovascular disease (CVD)##3##3##(2012-2#1)(2013-7#1)(2013-8#1)
Cardiovascular disease and##2##3##(2008-1#1)(2011-1#1)
Cardiovascular disease is the leading##2##5##(2010-9#1)(2012-2#1)
Cardiovascular disease is the##4##4##(2008-3#1)(2010-9#1)(2012-2#1)(2013-8#1)
Cardiovascular disease is##5##3##(2008-3#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
Cardiovascular disease risk##2##3##(2008-1#1)(2008-7#1)
Cardiovascular disease##19##2##(2008-1#3)(2008-3#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
Cardiovascular diseases##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
Cardiovascular effects of##2##3##(1995-12#1)(1996-11#1)
Cardiovascular imaging##2##2##(2009-4#1)(2010-9#1)
Cardiovascular load##2##2##(2008-6#2)
Cardiovascular magnetic resonance##2##3##(2009-10#1)(2010-8#1)
Cardiovascular risk factor##2##3##(2008-7#1)(2011-2#1)
Cardiovascular risk factors##2##3##(2008-7#1)(2013-8#1)
Cardiovascular risk##4##2##(2008-7#2)(2011-2#1)(2013-8#1)
Cardiovascular##83##1##(1991-1#1)(1991-10#1)(1994-5#1)(1995-12#1)(1996-11#1)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#9)(2009-10#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
Care Act of##2##3##(1990-6#1)(2011-1#1)
Care Center##3##2##(1996-1#1)(1996-3#1)(2012-2#1)
Care Clinic##4##2##(1997-2#2)(2007-2#1)(2011-2#1)
Care Committee##2##2##(1994-1#1)(1995-12#1)
Care Funding##4##2##(1993-3#2)(1996-1#2)
Care Group##4##2##(1992-3#1)(1995-2#2)(1997-1#1)
Care Map##5##2##(1995-3#5)
Care Pairs&quot##2##2##(1994-2#2)
Care Policy##4##2##(1992-8#1)(1993-12#1)(1996-1#2)
Care Program##11##2##(1990-10#2)(1991-2#2)(1994-3#2)(1996-1#2)(1996-12#1)(2008-9#2)
Care Research##2##2##(1994-3#1)(2011-2#1)
Care System##6##2##(1993-12#1)(1994-1#2)(1994-12#1)(1997-3#1)(2013-8#1)
Care Unit##15##2##(1991-6#1)(1992-2#1)(1994-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-9#2)(2012-12#1)(2012-3#3)(2013-1#2)
Care Units##6##2##(2007-11#1)(2010-4#1)(2010-8#2)(2012-2#1)(2013-1#1)
Care and the##2##3##(2010-12#1)(2012-12#1)
Care and##13##2##(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#2)
Care for the##2##3##(1994-2#1)(1997-3#1)
Care for##5##2##(1994-2#1)(1994-3#1)(1997-3#1)(2010-10#1)(2011-1#1)
Care in##6##2##(1995-8#1)(1996-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
Care is##3##2##(1991-9#1)(1993-12#1)(1994-3#1)
Care must##2##2##(1994-2#1)(2008-8#1)
Care of My Child##2##4##(2010-7#2)
Care of the##2##3##(2007-12#1)(2012-12#1)
Care of##10##2##(1992-3#1)(1994-12#1)(1994-3#1)(1997-3#1)(2007-12#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#1)
Care program##6##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)
Care should be taken##2##4##(1994-3#1)(2009-12#1)
Care was##2##2##(1991-1#1)(2008-7#1)
Care##314##1##(1990-10#3)(1990-6#2)(1991-1#5)(1991-12#1)(1991-2#6)(1991-3#5)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#6)(1992-3#3)(1992-8#1)(1993-1#1)(1993-12#8)(1993-2#3)(1993-3#4)(1993-8#1)(1994-1#10)(1994-12#9)(1994-2#12)(1994-3#14)(1994-6#1)(1995-12#6)(1995-2#2)(1995-3#11)(1995-8#1)(1996-1#12)(1996-12#6)(1996-2#14)(1996-3#7)(1997-1#3)(1997-2#10)(1997-3#6)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2008-1#4)(2008-10#1)(2008-11#14)(2008-12#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#10)(2011-2#10)(2012-12#7)(2012-2#8)(2012-3#12)(2013-1#19)(2013-7#1)(2013-8#3)
CareFusion Alaris##2##2##(2011-2#2)
Career development##5##2##(1994-1#1)(2008-11#1)(2012-3#1)(2013-7#2)
Career professionals##2##2##(1991-12#2)
Career##14##1##(1991-12#2)(1992-2#1)(1994-1#1)(1994-3#1)(1997-2#1)(2008-11#2)(2012-2#3)(2012-3#1)(2013-7#2)
Careers in health care management##2##5##(1994-12#1)(1995-2#1)
Careers##4##1##(1994-12#1)(1995-2#1)(2007-12#1)(2009-4#1)
Careful analysis of the##2##4##(2007-11#1)(2008-7#1)
Careful attention to##2##3##(2008-3#1)(2008-9#1)
Careful attention##3##2##(1992-3#1)(2008-3#1)(2008-9#1)
Careful history and physical examination were undertaken from rheumatological stand points##2##11##(2013-1#2)
Careful history##3##2##(2006-10#1)(2013-1#2)
Careful##24##1##(1992-3#1)(1993-11#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
Caregiver##2##1##(2010-12#1)(2012-2#1)
Caregivers of##2##2##(1994-1#1)(2013-1#1)
Caregivers with##2##2##(2010-7#2)
Caregivers##10##1##(1994-1#2)(1995-3#1)(2008-10#1)(2008-6#2)(2008-9#1)(2010-7#2)(2013-1#1)
Caregiving##2##1##(2010-7#1)(2012-2#1)
Caremark##4##1##(1995-12#4)
Carers reported##2##2##(2011-1#2)
Carers##5##1##(1996-11#2)(2010-8#1)(2011-1#2)
Caribbean AIDS##2##2##(2008-4#1)(2009-7#1)
Caribbean Blacks##3##2##(2010-10#3)
Caribbean and##9##2##(1991-11#1)(2008-10#3)(2008-5#2)(2009-7#1)(2011-2#2)
Caribbean coast of Costa Rica##2##5##(2008-5#2)
Caribbean coast##5##2##(2008-5#4)(2011-2#1)
Caribbean division meeting##8##3##(2008-11#8)
Caribbean population##2##2##(2008-12#2)
Caribbean samples##2##2##(2011-2#2)
Caribbean spiny##2##2##(2007-12#2)
Caribbean##90##1##(1991-11#1)(1991-3#1)(1996-6#2)(2007-12#4)(2007-2#2)(2007-5#7)(2007-8#1)(2008-10#14)(2008-11#10)(2008-12#3)(2008-4#5)(2008-5#13)(2009-7#7)(2010-10#3)(2010-4#1)(2011-2#14)(2012-1#1)(2012-12#1)
Carilion##2##1##(1997-3#2)
Carinal##2##1##(2012-1#2)
Caring and##2##2##(2008-1#1)(2008-11#1)
Caring for children##2##3##(1997-2#1)(2010-3#1)
Caring for each other##2##4##(1991-12#1)(1996-1#1)
Caring for older people##4##4##(1996-11#4)
Caring for the##2##3##(1991-2#1)(1992-3#1)
Caring for##13##2##(1991-12#1)(1991-2#1)(1992-3#1)(1996-1#1)(1996-11#5)(1997-2#1)(2008-11#1)(2010-3#1)(2010-8#1)
Caring with##2##2##(1993-1#1)(1996-1#1)
Caring##26##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-1#2)(1996-11#5)(1997-1#1)(1997-2#1)(2007-10#1)(2008-1#3)(2008-11#2)(2008-8#1)(2009-11#1)(2010-3#1)(2010-8#1)
Carl##2##1##(1991-6#1)(2009-5#1)
Carlavirus##3##1##(2008-10#2)(2008-9#1)
Carlo##158##1##(1990-12#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#9)(2008-12#2)(2008-2#38)(2008-3#62)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-2#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#4)(2012-7#1)(2013-1#2)(2013-8#1)
Carlos##3##1##(1995-6#1)(2007-10#1)(2008-5#1)
Carlson##3##1##(1996-5#1)(2008-10#1)(2012-2#1)
Carmel##2##1##(2008-10#2)
Carnation##5##1##(2008-10#5)
Carnitine##2##1##(1991-12#1)(1991-2#1)
Carnival##3##1##(2008-10#1)(2009-10#2)
Carnobacterium##2##1##(1997-4#2)
Caroli's disease##2##2##(1993-5#1)(2010-12#1)
Carolina and##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
Carolina##61##1##(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#3)(1993-3#5)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-6#1)(2007-10#1)(2007-3#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#4)(2012-12#4)(2013-1#7)
Carolina's##4##1##(1995-12#1)(1997-2#3)
Carondelet##2##1##(1997-2#2)
Carotenoids##4##1##(1992-9#1)(2008-12#1)(2008-8#1)(2010-2#1)
Carotid Artery##2##2##(2011-1#1)(2013-1#1)
Carotid Endarterectomy##2##2##(2006-7#1)(2008-7#1)
Carotid angioplasty and##2##3##(2007-10#1)(2008-8#1)
Carotid artery stenting##2##3##(2008-11#1)(2009-10#1)
Carotid artery##8##2##(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-10#1)(2011-2#1)
Carotid atherosclerosis##2##2##(2008-11#1)(2008-7#1)
Carotid endarterectomy in symptomatic##2##4##(1991-11#1)(1993-1#1)
Carotid endarterectomy##5##2##(1991-11#1)(1993-1#1)(2008-7#1)(2009-7#1)(2010-9#1)
Carotid intima-media thickness##3##3##(2008-7#1)(2009-1#1)(2010-12#1)
Carotid##38##1##(1991-11#1)(1993-1#1)(1996-8#1)(1996-9#1)(2006-7#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-11#4)(2008-7#8)(2008-8#4)(2009-1#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
Carotid-subclavian bypass##2##2##(2008-7#2)
Carp##4##1##(1990-8#1)(2008-12#1)(2008-5#2)
Carpal tunnel syndrome##2##3##(2007-8#1)(2008-12#1)
Carpal##3##1##(2007-8#1)(2008-12#1)(2013-8#1)
Carpenter##2##1##(2007-12#1)(2012-2#1)
Carpinus##2##1##(2008-10#1)(2011-1#1)
Carpogenic Germination##2##2##(2008-10#2)
Carpogenic germination of##2##3##(2008-10#2)
Carpogenic##4##1##(2008-10#4)
Carposina niponensis##2##2##(2011-2#2)
Carposinadae)##2##1##(2011-2#2)
Carr application##2##2##(2011-10#2)
Carr##5##1##(2008-12#1)(2011-10#4)
Carraguard##2##1##(2007-7#2)
Carriacou##2##1##(2009-9#2)
Carrier##6##1##(1991-5#1)(2007-11#1)(2008-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
Carrion##2##1##(2012-2#1)(2013-1#1)
Carrot##4##1##(2008-10#4)
Carrying##2##1##(2008-10#1)(2010-7#1)
Cartagena##9##1##(2011-2#6)(2012-12#3)
Cartapip 97##3##2##(2008-10#3)
Cartesian coordinate##3##2##(2008-2#1)(2008-3#2)
Cartesian##4##1##(2008-2#1)(2008-3#2)(2009-11#1)
Cartilage##6##1##(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
Carvacrol##4##1##(2008-10#1)(2008-11#3)
Carvedilol##9##1##(1992-5#2)(1995-12#2)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#2)
Carver and White's (1994)##2##4##(2009-9#2)
Carver##3##1##(1992-3#1)(2009-9#2)
Caryodendron orinocense##2##2##(2008-5#2)
Caryodendron##3##1##(2008-5#3)
Cas and NEDD9##5##3##(2012-12#5)
Cas and##6##2##(2012-12#6)
Cas##7##1##(2012-12#7)
CasD##2##1##(1993-6#2)
Casa del Mitreo in Emerita Augusta##2##6##(2008-10#2)
Casa##6##1##(1991-12#2)(2008-10#2)(2009-10#2)
Cascade##9##1##(1992-2#1)(1992-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-7#1)
Cascaded##3##1##(2007-12#2)(2008-3#1)
Cascades##4##1##(2008-10#2)(2008-8#1)(2013-8#1)
Cascading##3##1##(2008-2#1)(2008-3#1)(2011-2#1)
Case 1##19##2##(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#10)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
Case 2##20##2##(1997-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#10)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Case 3##2##2##(2007-7#1)(2008-5#1)
Case 4##3##2##(1993-12#1)(2008-1#1)(2011-2#1)
Case Mix Groups (CMGs)##2##4##(1991-12#1)(1994-3#1)
Case Mix Groups##4##3##(1991-12#1)(1993-12#1)(1994-3#1)(1995-1#1)
Case Presentation##2##2##(2013-1#2)
Case Report and Literature Review##3##5##(2006-10#1)(2011-2#2)
Case Report and Review of the Literature##3##7##(2008-4#1)(2011-2#1)(2013-1#1)
Case Report and Review of##4##5##(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
Case Report and##7##3##(2006-10#1)(2008-1#1)(2008-4#1)(2011-2#3)(2013-1#1)
Case Report of##2##3##(2010-9#1)(2013-1#1)
Case Report##26##2##(1997-6#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#8)(2013-8#1)
Case Series##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
Case Study##4##2##(2009-12#1)(2010-12#1)(2011-1#1)(2012-12#1)
Case control study to##2##4##(2013-1#2)
Case management##11##2##(1991-12#3)(1994-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#3)(2008-1#1)
Case mix management##2##3##(1992-12#1)(1994-3#1)
Case mix##4##2##(1992-12#1)(1994-3#1)(1995-2#2)
Case of##15##2##(1991-11#1)(1994-7#1)(2007-10#2)(2008-1#1)(2008-2#1)(2008-6#1)(2010-6#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
Case records of the Massachusetts General Hospital##10##7##(1990-5#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)
Case report and review of the literature##2##7##(2007-12#1)(2007-5#1)
Case report and review of the literature]##2##7##(1992-9#1)(1993-6#1)
Case report and review of the##4##6##(1992-9#1)(1993-6#1)(2007-12#1)(2007-5#1)
Case report and review of##6##5##(1992-9#1)(1993-6#1)(2007-12#2)(2007-5#1)(2013-1#1)
Case report and review##7##4##(1992-9#1)(1993-6#1)(2007-12#2)(2007-5#1)(2009-5#1)(2013-1#1)
Case report and##9##3##(1992-9#1)(1993-6#1)(1993-8#1)(2007-12#2)(2007-5#1)(2009-5#1)(2013-1#2)
Case report of##3##3##(1993-8#1)(2009-10#1)(2012-12#1)
Case report##50##2##(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#3)(1994-12#2)(1994-7#1)(1996-10#1)(2006-10#2)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#4)(2009-10#1)(2009-4#4)(2009-5#1)(2009-9#7)(2012-1#1)(2012-12#1)(2012-8#1)(2013-1#4)
Case report]##4##2##(1992-6#2)(2008-7#1)(2012-1#1)
Case reports##3##2##(1994-3#1)(2007-11#1)(2011-2#1)
Case reports]##2##2##(1992-5#1)(1992-6#1)
Case series##3##2##(2009-9#2)(2011-2#1)
Case studies##3##2##(1995-1#1)(1996-3#1)(2008-2#1)
Case study design##2##3##(2007-10#1)(2008-11#1)
Case study##14##2##(1994-1#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#2)
Case##242##1##(1990-5#2)(1991-11#1)(1991-12#4)(1991-2#2)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#4)(1994-12#4)(1994-3#6)(1994-6#2)(1994-7#3)(1995-1#2)(1995-11#2)(1995-2#3)(1995-3#3)(1995-8#2)(1996-10#1)(1996-2#5)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-6#3)(1997-7#3)(2006-10#3)(2007-10#4)(2007-11#1)(2007-12#6)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#23)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#4)(2009-5#3)(2009-9#9)(2010-12#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#10)(2012-2#3)(2012-3#6)(2012-8#1)(2013-1#22)(2013-8#2)
Case-control study of##2##3##(1991-7#1)(2008-10#1)
Case-control study##4##2##(1991-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
Case-control##5##1##(1991-7#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-3#1)
Casein##2##1##(1990-12#1)(1992-6#1)
Cases and##2##2##(1991-7#1)(2008-6#1)
Cases of##11##2##(1997-2#1)(2007-10#1)(2007-12#1)(2008-3#1)(2009-1#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
Cases were##5##2##(1991-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
Cases with##4##2##(2007-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
Cases##38##1##(1991-2#2)(1991-7#1)(1993-1#1)(1995-2#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
Casey##3##1##(1993-2#1)(1993-3#1)(1994-2#1)
Cashmere##2##1##(2008-10#2)
Casina##2##1##(2008-10#2)
Casokefamide##2##1##(1993-3#2)
Caspase##2##1##(2008-11#2)
Caspase-3##12##1##(2008-4#1)(2008-9#2)(2010-11#1)(2013-1#1)(2013-8#7)
Caspases are##2##2##(2008-11#1)(2008-4#1)
Caspases##4##1##(2008-11#2)(2008-4#2)
Caspian Sea##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
Caspian##4##1##(2008-10#1)(2008-12#1)(2010-8#1)(2012-2#1)
Cassava##3##1##(2008-10#3)
Cassegrain##2##1##(2008-3#2)
Cassegrainian##3##1##(2007-12#1)(2008-2#2)
Cassette##2##1##(2008-7#1)(2008-8#1)
Cassia##2##1##(2010-2#1)(2010-3#1)
Cast (RIP) islets##2##3##(2010-11#2)
Cast (RIP)##4##2##(2010-11#4)
Cast##5##1##(2010-11#4)(2011-2#1)
Castleman disease##5##2##(2011-1#1)(2011-2#4)
Castleman's disease##5##2##(1992-5#2)(2009-7#1)(2012-12#2)
Casual##2##1##(2007-12#1)(2010-8#1)
Catabolism of##2##2##(1993-3#1)(2011-1#1)
Catabolism##4##1##(1993-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
Catalan##7##1##(2013-8#7)
Catalase##8##1##(1990-3#1)(1997-4#1)(2008-10#4)(2013-8#2)
Catalepsy##3##1##(1990-7#2)(2013-1#1)
Catalonia in##2##2##(1990-6#1)(2008-7#1)
Catalonia##7##1##(1990-6#2)(1997-3#1)(2008-3#1)(2008-7#1)(2011-2#2)
Catalyser-21(TM)##9##1##(2008-11#9)
Catalysis##2##1##(1993-8#1)(2010-2#1)
Catalytic activity##3##2##(1990-5#1)(2008-11#1)(2008-7#1)
Catalytic adsorptive stripping voltammetry##2##4##(2008-10#2)
Catalytic adsorptive stripping##3##3##(2008-10#3)
Catalytic determination of##2##3##(2008-10#2)
Catalytic spectrophotometric determination of##2##4##(2008-10#2)
Catalytic##23##1##(1990-11#1)(1990-5#1)(1993-8#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-7#2)(2009-2#1)(2010-4#1)(2010-6#1)
Catalyzed##3##1##(1997-7#1)(2009-12#1)(2010-7#1)
Catania##2##1##(2008-7#2)
Cataplexy##2##1##(1991-5#1)(1996-7#1)
Cataract##3##1##(2010-8#2)(2011-1#1)
Cataracts##2##1##(1990-6#1)(2008-11#1)
Catechins are##2##2##(2008-10#1)(2009-11#1)
Catechins##3##1##(2008-10#1)(2009-11#2)
Catecholamine##2##1##(1990-5#1)(1994-5#1)
Categories##4##1##(2008-11#1)(2008-9#3)
Category##6##1##(2009-5#1)(2012-2#4)(2013-1#1)
Catfish##3##1##(2008-5#1)(2008-7#2)
CathA##2##1##(1995-2#2)
Cathedral##2##1##(2008-2#1)(2008-3#1)
Cathepsin D##7##2##(1990-12#1)(1990-5#1)(1994-5#3)(1995-8#1)(2008-7#1)
Cathepsin##10##1##(1990-12#1)(1990-5#1)(1994-5#3)(1995-8#2)(2006-6#1)(2008-5#1)(2008-7#1)
Cathepsin-D expression##2##2##(1993-9#2)
Catheter ablation of##2##3##(2009-10#2)
Catheter##6##1##(1997-3#1)(1997-8#1)(2008-1#1)(2009-10#2)(2011-2#1)
Catheter-related##2##1##(2010-3#1)(2011-2#1)
Catheters##5##1##(1997-3#1)(2007-7#2)(2008-1#1)(2009-9#1)
Cathodic adsorptive stripping voltammetric determination of##2##6##(2008-10#2)
Cathodic adsorptive stripping voltammetric##3##4##(2008-10#3)
Cathodic stripping voltammetry of##4##4##(2008-10#4)
Cathodic stripping voltammetry##6##3##(2008-10#6)
Cathodic##10##1##(2008-10#10)
Catholic Health Association##2##3##(1995-2#1)(1997-3#1)
Catholic University##4##2##(1990-8#1)(2009-7#1)(2013-1#2)
Catholic health care##5##3##(1991-1#1)(1991-3#1)(1993-12#1)(1995-2#1)(1996-1#1)
Catholic health ministry##2##3##(1992-1#1)(1993-12#1)
Catholic health##7##2##(1991-1#1)(1991-3#1)(1992-1#1)(1993-12#2)(1995-2#1)(1996-1#1)
Catholic healthcare in##2##3##(1997-3#2)
Catholic healthcare##7##2##(1994-12#1)(1997-3#6)
Catholic##32##1##(1990-6#2)(1990-8#1)(1991-1#2)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#3)(1994-1#3)(1994-12#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-3#8)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
Cation##6##1##(1996-2#1)(1997-7#1)(2008-10#3)(2011-2#1)
Cationic lipid-mediated NGF##2##3##(1996-12#2)
Cationic liposomes##4##2##(1994-12#1)(1994-5#2)(2008-5#1)
Cationic##13##1##(1994-12#1)(1994-5#3)(1996-12#2)(1996-2#1)(2008-10#3)(2008-5#3)
Cations##2##1##(1996-5#2)
Catla catla##3##2##(2008-10#1)(2008-7#2)
Catla##4##1##(2008-10#2)(2008-7#2)
Catrachia is##2##2##(2008-5#2)
Catrachia##5##1##(2008-5#5)
Cats##3##1##(2012-3#1)(2013-8#2)
Cattle##4##1##(1991-8#1)(2012-2#2)(2013-8#1)
Cauca##4##1##(2012-12#4)
Caucasian and African American##2##4##(2008-5#1)(2012-2#1)
Caucasian and##4##2##(1990-8#1)(2008-5#2)(2012-2#1)
Caucasian facial##2##2##(2008-5#1)(2010-8#1)
Caucasian female subjects (n =##2##5##(2008-5#2)
Caucasian female##3##2##(2008-5#2)(2013-7#1)
Caucasian individuals##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
Caucasian man##4##2##(1990-8#1)(2006-10#1)(2010-12#1)(2011-2#1)
Caucasian or##2##2##(2008-12#1)(2008-5#1)
Caucasian patients##2##2##(2010-8#1)(2013-1#1)
Caucasian population##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
Caucasian populations##7##2##(2008-12#2)(2009-5#1)(2009-9#2)(2010-3#2)
Caucasian skin and##2##3##(2008-5#1)(2010-8#1)
Caucasian skin##3##2##(2008-5#1)(2010-8#2)
Caucasian subjects##2##2##(1994-12#1)(2013-1#1)
Caucasian woman##3##2##(1993-11#1)(1994-9#1)(2011-2#1)
Caucasian women##5##2##(2008-4#1)(2010-3#3)(2011-1#1)
Caucasian##68##1##(1990-8#2)(1992-2#1)(1993-11#1)(1994-12#2)(1994-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#2)(2009-5#3)(2009-7#2)(2009-9#2)(2010-12#1)(2010-3#5)(2010-5#2)(2010-8#8)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Caucasians and##4##2##(2008-1#2)(2008-4#1)(2012-2#1)
Caucasians may##2##2##(2008-10#2)
Caucasians with##3##2##(2011-2#2)(2012-2#1)
Caucasians##27##1##(1990-8#1)(2008-1#3)(2008-10#2)(2008-12#3)(2008-4#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#7)(2012-3#1)
Caucasus##9##1##(2008-10#8)(2008-11#1)
Caucus##4##1##(1996-5#4)
Cauliflower mosaic virus (CaMV)##3##4##(2008-10#3)
Cauliflower mosaic virus##5##3##(2008-10#5)
Cauliflower plants##2##2##(2008-10#2)
Cauliflower##11##1##(2008-10#11)
Causal Agent of##16##3##(2008-10#16)
Causal Agent##17##2##(2008-10#17)
Causal##23##1##(1997-3#1)(2008-10#18)(2008-11#1)(2011-1#2)(2012-3#1)
Cause a##2##2##(2008-10#2)
Cause of death##2##3##(2012-12#2)
Cause of##15##2##(1997-6#1)(2008-1#1)(2008-10#6)(2008-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
Cause##20##1##(1997-6#1)(2008-1#1)(2008-10#11)(2008-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
Caused by Colletotrichum##2##3##(2008-10#2)
Caused by Monilinia fructicola##2##4##(2008-10#2)
Caused by Monilinia##3##3##(2008-10#3)
Caused by Pseudomonas syringae##2##4##(2008-10#2)
Caused by Pseudomonas##3##3##(2008-10#3)
Caused by Pythium ultimum##3##4##(2008-10#3)
Caused by Pythium##4##3##(2008-10#4)
Caused by a##3##3##(1993-12#1)(2008-10#2)
Caused by##45##2##(1993-12#1)(2008-1#1)(2008-10#36)(2009-1#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
Causes and consequences##2##3##(1994-5#1)(2008-8#1)
Causes and##5##2##(1994-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-2#1)
Causes of new cases of major thalassemia in sistan and balouchistan province in South-East of iran##2##16##(2013-1#2)
Causes of##12##2##(1990-9#1)(1993-3#1)(1996-1#1)(2008-1#2)(2008-4#2)(2008-5#1)(2011-2#2)(2013-1#2)
Causes##26##1##(1990-11#1)(1990-9#1)(1993-3#1)(1994-5#1)(1996-1#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
Causing Anthracnose of##2##3##(2008-10#2)
Causing Bacterial Spot of##2##4##(2008-10#2)
Causing Brown Spot of##3##4##(2008-10#3)
Causing Root##2##2##(2008-10#2)
Causing##23##1##(2008-10#19)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
Caution is##2##2##(2009-5#1)(2011-2#1)
Caution must##2##2##(2008-11#2)
Caution##7##1##(2008-11#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
Cavalieri principle##2##2##(2008-12#1)(2011-2#1)
Cave##3##1##(2008-6#1)(2011-2#2)
Cavendish##2##1##(2008-10#2)
Caveolae are flask-shaped##2##3##(1995-2#1)(1995-6#1)
Caveolae##4##1##(1995-2#3)(1995-6#1)
Caveolin-1##2##1##(2011-2#1)(2012-3#1)
Caveolin-3##2##1##(2008-7#2)
Cavernous hemangioma##2##2##(2011-1#2)
Cavernous lymphangioma##2##2##(2013-1#2)
Cavernous##11##1##(1993-9#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
Cavities##2##1##(1990-2#1)(2008-10#1)
Cavitron Ultrasonic Surgical Aspirator##3##4##(1995-12#3)
Cavitron##4##1##(1995-12#4)
Cavity ringdown spectroscopy##2##3##(2007-12#1)(2008-2#1)
Cavity ringdown##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
Cavity##10##1##(2007-12#2)(2008-2#4)(2008-3#4)
Cavity-enhanced##2##1##(2007-11#2)
Cavity-linewidth narrowing##3##2##(2007-12#3)
Ca²⁺ release##2##2##(2013-1#2)
Ca²⁺##10##1##(2013-1#10)
Caño Negro National Wildlife Refuge##4##5##(2008-5#4)
Caño Negro##5##2##(2008-5#5)
Cb I##3##2##(1995-12#3)
Cb II##3##2##(1995-12#3)
Cb##10##1##(1994-12#3)(1995-12#7)
Cbl is##2##2##(2008-10#2)
Cbl may##3##2##(2008-10#3)
Cbl##11##1##(1990-11#2)(1991-12#2)(2008-10#7)
Cbz-Phe-Ala##2##1##(2006-6#2)
CcO##2##1##(1995-2#2)
Ccs3##2##1##(2011-2#2)
Ccs4##2##1##(2011-2#2)
Cd (II)##2##2##(2008-10#2)
Cd analysis##2##2##(2008-10#2)
Cd and Bi##2##3##(2008-10#2)
Cd and Cu were##2##4##(2008-10#1)(2008-11#1)
Cd and Pb in##9##4##(2008-10#8)(2013-8#1)
Cd and Pb were##3##4##(2008-10#3)
Cd and Pb##24##3##(2008-10#23)(2013-8#1)
Cd and Zn##9##3##(1997-4#1)(2008-10#8)
Cd and##57##2##(1990-5#4)(1997-4#1)(2008-10#49)(2008-11#1)(2013-1#1)(2013-8#1)
Cd by##4##2##(2008-10#4)
Cd concentration##6##2##(1997-4#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)
Cd concentrations in##2##3##(1997-4#2)
Cd concentrations##8##2##(1997-4#4)(2008-10#2)(2008-11#1)(2013-1#1)
Cd content##2##2##(2008-9#2)
Cd exposure##4##2##(1997-4#2)(2008-9#1)(2013-1#1)
Cd followed by##2##3##(1997-4#1)(2008-10#1)
Cd had##2##2##(1997-4#1)(2008-10#1)
Cd has been##2##3##(2008-10#2)
Cd hydride generation##2##3##(2008-10#2)
Cd in liver##2##3##(1995-3#1)(2008-10#1)
Cd in the##7##3##(1990-5#2)(1995-3#2)(2008-10#3)
Cd in##25##2##(1990-5#2)(1995-3#3)(1997-4#1)(2008-10#18)(2008-12#1)
Cd leads to##2##3##(2008-11#2)
Cd level##3##2##(1997-4#3)
Cd levels##3##2##(1997-4#2)(2008-7#1)
Cd or##3##2##(1990-5#1)(1997-4#1)(2008-10#1)
Cd stress##4##2##(2013-1#4)
Cd uptake##2##2##(1990-5#1)(1995-3#1)
Cd was##8##2##(1990-5#1)(1995-3#2)(2008-10#5)
Cd were##2##2##(1997-4#1)(2008-10#1)
Cd##311##1##(1990-5#12)(1993-12#1)(1995-3#11)(1997-4#32)(2008-10#214)(2008-11#6)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#7)(2008-9#9)(2010-5#1)(2011-2#2)(2013-1#7)(2013-8#2)
Cd(2+) and Pb(2+)##2##3##(2008-10#2)
Cd(2+) and Zn(2+)##2##3##(2008-10#2)
Cd(2+) and##7##2##(2008-10#7)
Cd(2+) from##2##2##(2008-10#2)
Cd(2+) in##3##2##(2008-10#3)
Cd(2+) inherent to MT##2##4##(2008-10#2)
Cd(2+) ions##5##2##(2008-10#5)
Cd(2+) is##4##2##(2008-10#4)
Cd(2+) with##2##2##(2008-10#2)
Cd(2+)##66##1##(2008-10#62)(2008-11#1)(2008-8#2)(2013-1#1)
Cd(II) and In(III) in##2##4##(2008-10#2)
Cd(II) and In(III)##3##3##(2008-10#3)
Cd(II) and Pb(II)##8##3##(2008-10#8)
Cd(II) and Zn(II)##3##3##(2008-10#3)
Cd(II) and##20##2##(2008-10#20)
Cd(II) ions##2##2##(2008-10#1)(2008-5#1)
Cd(II) was##2##2##(2008-10#2)
Cd(II)##88##1##(1995-5#1)(2008-10#85)(2008-5#2)
Cd(x)Hg(1-x)Ga(2)S(4)##2##1##(2007-11#2)
Cd)##8##1##(2008-10#7)(2013-8#1)
Cd-MT was##3##2##(1993-12#2)(1995-3#1)
Cd-MT##13##1##(1993-12#7)(1995-3#6)
Cd-exposed##3##1##(1990-5#1)(1997-4#2)
Cd-induced##2##1##(1997-4#1)(2008-7#1)
Cd-substituted horse liver alcohol dehydrogenase##2##5##(1995-5#2)
Cd1-x ZnxTe##2##2##(2013-8#2)
Cd1-x##4##1##(2013-8#4)
Cd2+ and Hg2+##2##3##(1991-9#2)
Cd2+##16##1##(1991-12#5)(1991-9#2)(1993-3#1)(1993-6#1)(1994-8#4)(1995-12#1)(1997-7#1)(2013-8#1)
CdCl(2)##5##1##(1997-4#2)(2008-10#3)
CdCl(2)-pretreated filter paper##2##3##(2008-10#2)
CdCl2##9##1##(1995-3#7)(1997-4#1)(2008-5#1)
CdH(2)L(2)##2##1##(2008-10#2)
CdIn(2)O(4)##2##1##(2008-3#2)
CdL##3##1##(2008-10#3)
CdL(2) and##2##2##(2008-10#2)
CdL(2)##4##1##(2008-10#4)
CdL(2+)##2##1##(2008-10#2)
CdL(OH)(+)##2##1##(2008-10#2)
CdMnTe##2##1##(2007-11#2)
CdS and CdTe qdots##2##4##(2008-10#2)
CdS and##4##2##(2008-10#4)
CdS nanocrystals##2##2##(2008-10#1)(2008-5#1)
CdS nanoparticles##3##2##(2008-10#2)(2008-5#1)
CdS sol##2##2##(2008-8#2)
CdS##23##1##(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-5#4)(2008-8#6)
CdSe and GaSe crystals##2##4##(2008-3#2)
CdSe and GaSe##3##3##(2008-3#3)
CdSe and##4##2##(2008-10#1)(2008-3#3)
CdSe laser##2##2##(2007-12#2)
CdSe nanocrystals##5##2##(2008-10#5)
CdSe quantum dots##2##3##(2008-10#2)
CdSe##19##1##(2007-11#1)(2007-12#3)(2008-10#11)(2008-3#4)
CdSe/CdS##2##1##(2007-11#2)
CdSe/ZnS nanocrystals##2##2##(2008-10#1)(2008-7#1)
CdTe nanoparticles##3##2##(2008-10#3)
CdTe quantum dots and##2##4##(2008-10#2)
CdTe quantum dots were##2##4##(2008-10#1)(2013-8#1)
CdTe quantum dots##9##3##(2008-10#7)(2013-8#2)
CdTe##19##1##(2007-12#1)(2008-10#13)(2008-2#2)(2008-3#1)(2013-8#2)
CdZnTe##3##1##(2007-11#2)(2008-2#1)
Cdc14##2##1##(2012-2#2)
Cdc14b##3##1##(2012-2#3)
Cdc25GEF##3##1##(1994-12#3)
Cdc42##3##1##(1996-2#1)(2011-2#2)
Cdc7##4##1##(2012-3#4)
Cdk1 mRNA##4##2##(2012-3#4)
Cdk1##5##1##(2012-3#5)
Cdk2##2##1##(1994-6#1)(2013-1#1)
Cdkn2a deficient mice were##2##4##(2008-8#2)
Cdkn2a deficient mice##4##3##(2008-8#4)
Cdkn2a deficient##5##2##(2008-8#5)
Cdkn2a##6##1##(2008-8#6)
Ce and##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
Ce crystals##2##2##(2007-12#2)
Ce##32##1##(2007-12#6)(2008-10#15)(2008-3#5)(2010-4#2)(2011-2#1)(2012-2#1)(2013-8#2)
Ce(0##2##1##(2010-4#2)
Ce(3+) and##3##2##(2008-10#3)
Ce(3+)##18##1##(2007-11#2)(2008-10#10)(2008-2#3)(2010-4#1)(2012-12#2)
Ce(III)-EDTA complex##4##2##(2008-10#4)
Ce(IV) in a nitric acid medium##2##6##(2008-10#2)
Ce(IV) in##3##2##(2008-10#3)
Ce(IV)##7##1##(2008-10#7)
Ce(IV)-quinine##2##1##(2008-10#2)
Ce-PbO(2) modified electrode##3##3##(2008-10#3)
Ce3+ emission##2##2##(2013-8#2)
Ce3+ phosphor##3##2##(2013-8#3)
Ce3+##10##1##(2013-8#10)
CeA fresh leaf juice##2##4##(2008-10#2)
CeA##5##1##(2008-10#5)
CeAX and control rats##2##4##(1993-12#2)
CeAX rats##5##2##(1993-12#5)
CeAX##10##1##(1993-12#10)
CeCu(2)Ge(2)##2##1##(2012-2#2)
CeMV##3##1##(2008-10#3)
CeO(2)/Chitosan##2##1##(2008-10#2)
Cea-2##3##1##(1992-6#3)
Ceará##2##1##(1991-9#1)(2013-8#1)
Cecal##3##1##(2008-11#1)(2012-3#2)
Cecidomyiidae)##4##1##(2011-2#4)
Cedex##2##1##(2008-11#2)
Cedrus libani and Cupressus arizonica##2##5##(2013-8#2)
Cedrus libani and##3##3##(2013-8#3)
Cefotetan therapy##2##2##(1994-6#2)
Ceftazidime in##2##2##(1991-3#2)
Ceftazidime##4##1##(1991-3#3)(2008-8#1)
Ceftriaxone was administered##2##3##(1990-5#1)(1990-6#1)
Ceftriaxone##3##1##(1990-5#1)(1990-6#1)(1997-7#1)
Cel48 was##2##2##(2009-3#2)
Cel48##5##1##(2009-3#5)
Cel9##4##1##(2009-3#4)
CelS##6##1##(1990-5#5)(1991-9#1)
Celgene##8##1##(2008-5#8)
Celiac artery stenting##2##3##(2013-1#2)
Celiac disease##3##2##(2011-2#1)(2013-8#2)
Celiac##5##1##(2011-2#1)(2013-1#2)(2013-8#2)
Celite##5##1##(1997-2#4)(2008-10#1)
Cell Biol##3##2##(1990-5#1)(1990-7#1)(1993-12#1)
Cell Carcinoma##8##2##(1996-9#3)(2007-10#1)(2008-10#1)(2013-1#3)
Cell Culture##4##2##(2008-11#4)
Cell Death of##2##3##(2008-10#2)
Cell Death##8##2##(2008-10#3)(2008-11#1)(2009-12#1)(2011-2#2)(2012-2#1)
Cell Invasion##2##2##(2008-11#1)(2013-1#1)
Cell Line##6##2##(1997-7#1)(2008-11#3)(2010-8#1)(2011-2#1)
Cell Lines##3##2##(2008-11#1)(2008-6#1)(2010-8#1)
Cell Lung Cancer##18##3##(2008-10#2)(2008-11#1)(2010-8#13)(2012-1#1)(2012-2#1)
Cell Method##2##2##(2009-7#2)
Cell Proliferation##3##2##(2010-6#1)(2012-2#1)(2013-7#1)
Cell SELEX##5##2##(2010-5#5)
Cell Wall##4##2##(2008-10#3)(2012-1#1)
Cell adhesion##2##2##(2008-4#1)(2010-4#1)
Cell biological##2##2##(2008-11#1)(2008-8#1)
Cell biology##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
Cell counting##2##2##(2008-9#2)
Cell counts##2##2##(2008-11#1)(2010-8#1)
Cell culture##7##2##(2008-11#4)(2008-5#1)(2008-9#1)(2012-2#1)
Cell cultures##4##2##(2008-11#2)(2008-5#1)(2013-1#1)
Cell cycle analysis of##2##4##(2008-9#2)
Cell cycle analysis##4##3##(1997-1#1)(2008-9#3)
Cell cycle arrest##2##3##(1997-7#1)(2008-11#1)
Cell cycle##16##2##(1991-5#1)(1993-12#1)(1997-1#1)(1997-3#1)(1997-7#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#3)(2012-3#1)(2013-1#1)
Cell death in##2##3##(1994-2#1)(1995-3#1)
Cell death was##2##3##(1994-2#1)(2008-7#1)
Cell death##8##2##(1994-2#2)(1995-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)
Cell density##2##2##(2008-11#1)(2012-1#1)
Cell division##2##2##(1994-11#1)(2008-11#1)
Cell fractionation##2##2##(1995-2#1)(2008-4#1)
Cell growth##9##2##(1991-5#1)(1994-8#1)(2008-11#6)(2013-1#1)
Cell line##4##2##(2008-11#2)(2008-5#1)(2012-3#1)
Cell lines expressing##2##3##(1992-12#1)(1994-2#1)
Cell lines##4##2##(1992-12#1)(1992-3#1)(1994-2#1)(2008-11#1)
Cell mortality##2##2##(2008-10#2)
Cell populations##2##2##(2008-4#1)(2008-9#1)
Cell proliferation was##2##3##(1995-2#1)(2010-3#1)
Cell proliferation##8##2##(1990-8#1)(1991-5#1)(1995-2#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-3#1)
Cell sorting##2##2##(1997-4#1)(2008-7#1)
Cell surface##3##2##(2008-11#1)(2012-2#2)
Cell swelling-induced##2##2##(2008-8#2)
Cell viability##4##2##(1994-5#1)(2007-11#1)(2008-9#1)(2013-1#1)
Cell volume##4##2##(2008-11#1)(2008-8#3)
Cell wall##3##2##(2008-10#2)(2008-5#1)
Cell walls##2##2##(2008-10#1)(2009-10#1)
Cell##283##1##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#4)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-3#2)(1997-4#1)(1997-7#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#22)(2008-11#66)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#10)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#18)(2011-1#2)(2011-2#6)(2012-1#5)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#2)
Cell-based##4##1##(2008-5#2)(2012-12#2)
Cell-cell interactions##3##2##(2007-12#2)(2008-7#1)
Cell-cell##6##1##(1995-2#1)(2007-12#2)(2008-7#2)(2010-7#1)
Cell-free filtrates from##2##3##(2008-10#2)
Cell-free##6##1##(1991-7#1)(1997-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
Cell-mediated##3##1##(1991-12#1)(2013-1#2)
Cell-penetrating peptides##2##2##(2009-8#1)(2010-10#1)
Cells In Vitro##2##3##(2008-10#1)(2009-12#1)
Cells Induced by##2##3##(2008-11#1)(2010-8#1)
Cells Through##2##2##(2008-11#1)(2012-3#1)
Cells and##6##2##(2008-11#3)(2008-8#1)(2012-12#1)(2013-1#1)
Cells are##7##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#1)
Cells by##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
Cells can##2##2##(2008-10#1)(2008-11#1)
Cells cultured##2##2##(2008-11#2)
Cells expressing##2##2##(1992-8#1)(1995-2#1)
Cells from##8##2##(1990-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2011-2#1)
Cells grown##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
Cells in a##2##3##(2008-11#1)(2012-3#1)
Cells in the##7##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)
Cells in##17##2##(1994-11#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#1)
Cells infected with##3##3##(1993-6#1)(2008-10#2)
Cells of the##7##3##(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)
Cells of##12##2##(1994-3#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2010-5#1)
Cells that##3##2##(1994-12#1)(1995-2#1)(2008-8#1)
Cells transfected with##3##3##(1995-2#1)(2008-11#1)(2008-8#1)
Cells transfected##4##2##(1995-2#1)(2008-11#2)(2008-8#1)
Cells were incubated for##2##4##(1994-6#1)(2009-6#1)
Cells were##13##2##(1990-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#1)(2009-6#2)
Cells with##5##2##(1992-6#1)(1995-11#1)(2008-9#1)(2009-11#1)(2009-5#1)
Cells##183##1##(1990-11#1)(1990-2#1)(1990-5#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#43)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#3)
Cellular Potts Model##2##3##(2008-11#2)
Cellular and humoral responses in coeliac disease##2##7##(1991-12#2)
Cellular and humoral##3##3##(1991-12#2)(1995-2#1)
Cellular and molecular mechanisms of##2##5##(1994-5#1)(2009-8#1)
Cellular and molecular##5##3##(1994-5#1)(1997-7#1)(2008-9#1)(2009-10#1)(2009-8#1)
Cellular and##10##2##(1991-12#2)(1994-5#1)(1995-2#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)
Cellular components##2##2##(1994-6#1)(2008-7#1)
Cellular##61##1##(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
Cellulase and laminarinase##2##3##(2008-10#2)
Cellulase##3##1##(2008-10#3)
Cellulite##6##1##(2008-5#6)
Cellulomonas fimi##5##2##(1992-11#2)(1995-5#2)(2008-7#1)
Cellulomonas flavigena##3##2##(2008-10#1)(2011-2#2)
Cellulomonas##12##1##(1991-9#1)(1992-11#2)(1995-5#2)(2008-10#1)(2008-7#1)(2011-2#5)
Cellulose acetate##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
Cellulose##5##1##(2007-12#1)(2008-10#3)(2008-3#1)
Celsius##4##1##(2008-10#1)(2008-8#2)(2008-9#1)
Cement##4##1##(1992-6#1)(2007-11#1)(2007-8#1)(2008-6#1)
Cementless acetabular components##2##3##(2008-11#2)
CenTrak##3##1##(2011-2#3)
Cenococcum geophilum##2##2##(2012-6#2)
Census##13##1##(1992-3#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-5#3)(2010-7#1)(2011-2#1)
Centella asiatica##3##2##(2008-10#2)(2008-5#1)
Centenarians##3##1##(2008-7#2)(2010-12#1)
Center Experience##3##2##(1995-11#1)(2008-1#1)(2012-3#1)
Center and##12##2##(1990-12#2)(1992-2#2)(1992-8#1)(1993-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-4#1)(2010-8#1)(2011-2#1)
Center at##6##2##(1990-11#1)(1993-3#1)(1996-1#1)(2008-7#1)(2009-6#1)(2011-2#1)
Center between##4##2##(2007-10#1)(2008-10#2)(2013-1#1)
Center for Clinical Evaluation Sciences##2##5##(1997-2#2)
Center for Clinical##3##3##(1997-2#2)(2008-5#1)
Center for Healthcare Industry Performance Studies##2##6##(1994-12#1)(1995-3#1)
Center for##47##2##(1990-11#2)(1991-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-3#1)(1995-5#2)(1997-2#3)(1997-3#3)(1997-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
Center from##2##2##(1990-9#1)(1997-8#1)
Center has##2##2##(1996-3#1)(2009-3#1)
Center in##20##2##(1991-12#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)(2012-2#1)
Center is##2##2##(2007-9#1)(2009-8#1)
Center of Diversity##3##3##(2008-10#3)
Center of the##2##3##(1990-11#1)(2010-3#1)
Center of##20##2##(1990-11#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
Center to##4##2##(1991-2#1)(1997-3#1)(2008-10#1)(2010-11#1)
Center were##2##2##(2008-12#1)(2010-8#1)
Center with##2##2##(2008-3#1)(2012-3#1)
Center##261##1##(1990-11#8)(1990-12#2)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#5)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#5)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#5)(1994-2#4)(1994-3#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#6)(1996-12#1)(1996-2#6)(1996-3#2)(1996-9#1)(1997-2#7)(1997-3#6)(1997-5#1)(1997-8#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#14)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#8)(2008-7#6)(2008-8#1)(2008-9#2)(2009-3#4)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#9)(2013-8#3)
Center's##5##1##(1992-1#1)(1996-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
Centers for Disease Control and Prevention (CDC)##12##7##(1995-12#3)(1995-6#3)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#1)(2008-10#1)
Centers for Disease Control and Prevention##19##6##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)
Centers for Disease Control and##23##5##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
Centers for Disease Control##26##4##(1992-2#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
Centers for Disease##27##3##(1992-2#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
Centers for##28##2##(1992-2#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
Centers in##5##2##(1990-2#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-9#1)
Centers of##3##2##(1992-1#1)(2007-9#1)(2008-10#1)
Centers##52##1##(1990-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#5)(1995-5#1)(1995-6#4)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#4)(2009-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
Central America##7##2##(1990-6#1)(2008-10#3)(2008-4#1)(2011-2#1)(2013-7#1)
Central American countries##3##3##(2008-10#1)(2011-2#2)
Central American##7##2##(2008-10#1)(2008-5#2)(2011-2#2)(2013-7#2)
Central Asia and the Caucasus##4##5##(2008-10#4)
Central Asia##5##2##(2008-10#5)
Central Cancer##4##2##(1990-2#1)(1992-8#1)(2008-11#1)(2008-7#1)
Central Europe##6##2##(1994-12#1)(1997-3#2)(2008-10#2)(2012-9#1)
Central European##3##2##(2007-5#1)(2008-10#1)(2012-9#1)
Central Florida##2##2##(1995-12#1)(2008-10#1)
Central Hospital##10##2##(1991-11#1)(1991-9#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-1#4)
Central Nervous System##6##3##(2007-11#1)(2008-2#2)(2011-2#1)(2012-3#1)(2013-1#1)
Central Venous##2##2##(2007-7#1)(2008-1#1)
Central Veterinary Laboratory##2##3##(2010-4#2)
Central and Eastern Europe##4##4##(1995-3#4)
Central and South##2##3##(1995-3#1)(2008-5#1)
Central and##7##2##(1995-3#5)(2008-10#1)(2008-5#1)
Central cannulation##2##2##(2007-8#2)
Central corneal##2##2##(2010-10#1)(2012-12#1)
Central nervous system##4##3##(2008-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
Central pontine myelinolysis##3##3##(1997-8#1)(2008-7#2)
Central to the##2##3##(2008-3#1)(2011-2#1)
Central to these##4##3##(1992-1#1)(1992-12#1)(2008-3#1)(2013-8#1)
Central to this##3##3##(1993-3#1)(2008-6#1)(2012-12#1)
Central to##11##2##(1992-1#1)(1992-12#1)(1993-3#1)(2008-10#2)(2008-3#2)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
Central venous access##2##3##(2009-4#1)(2011-2#1)
Central venous##7##2##(2007-7#1)(2008-1#2)(2008-7#1)(2009-4#1)(2011-2#2)
Central##159##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#6)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#9)(2008-10#29)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#15)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#2)(2012-9#2)(2013-1#4)(2013-7#3)(2013-8#2)
Centralized##4##1##(1992-1#1)(1994-2#1)(1996-12#1)(2011-2#1)
Centre for Disease##4##3##(1995-12#1)(2007-12#1)(2010-4#1)(2011-2#1)
Centre for Health##3##3##(1995-2#1)(1996-3#1)(1996-7#1)
Centre for Psychiatric Nursing Research and Practice (CPNRP)##2##8##(2008-11#2)
Centre for the##2##3##(2008-10#1)(2010-4#1)
Centre for##21##2##(1990-3#1)(1992-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-4#3)(2011-2#1)(2012-3#1)(2013-1#2)
Centre in##7##2##(1990-3#1)(1994-1#1)(1995-2#1)(1997-8#1)(2008-12#1)(2008-7#1)(2011-1#1)
Centre of the##2##3##(2008-11#1)(2011-2#1)
Centre of##6##2##(2008-11#1)(2008-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
Centre##82##1##(1990-3#2)(1990-9#1)(1991-11#1)(1992-1#1)(1992-2#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-4#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
Centre's##4##1##(1992-12#1)(1995-12#3)
Centres in##2##2##(2008-7#1)(2011-2#1)
Centres##8##1##(1993-2#1)(2008-7#1)(2011-2#5)(2012-2#1)
Centrifugation##2##1##(1990-2#1)(1997-6#1)
Centro Internacional de Agricultura Tropical##2##5##(2008-10#2)
Centro##4##1##(1993-3#1)(2008-10#2)(2008-9#1)
Centruroides noxius Hoffmann##3##3##(1993-6#2)(2008-7#1)
Centruroides##4##1##(1993-6#3)(2008-7#1)
Century##19##1##(1993-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
Cephalic##3##1##(2008-5#1)(2008-7#2)
Cephalosporins##2##1##(2006-10#1)(2012-3#1)
Cephalosporium acremonium ATCC 48272##2##4##(2008-6#2)
Cephalosporium gramineum##4##2##(2008-10#4)
Cephalosporium maydis##2##2##(2008-10#2)
Cephalosporium stripe##2##2##(2008-10#2)
Cephalosporium##11##1##(2008-10#9)(2008-6#2)
Cerambycidae) is a##2##3##(2013-8#2)
Cerambycidae)##4##1##(2007-12#2)(2013-8#2)
Ceramide##8##1##(1994-3#1)(1995-2#1)(1996-2#3)(2008-5#1)(2011-2#1)(2013-8#1)
Ceratitis capitata##7##2##(2007-12#4)(2008-6#2)(2009-9#1)
Ceratocystis fimbriata##7##2##(2008-10#7)
Ceratocystis resinifera##4##2##(2008-10#4)
Ceratocystis##12##1##(2008-10#12)
Ceratopogonidae)##2##1##(2008-5#1)(2008-8#1)
Ceratorhiza##2##1##(2008-10#2)
Ceratothripoides claratris##2##2##(2008-10#2)
Cercariae##2##1##(2013-1#2)
Cercon##2##1##(2009-8#2)
Cercopidae)##2##1##(2007-12#2)
Cercospora apii##2##2##(2008-10#2)
Cercospora cluster##2##2##(2008-10#2)
Cercospora kikuchii##4##2##(2008-10#4)
Cercospora leaf spot##3##3##(2008-10#2)(2012-3#1)
Cercospora leaf##5##2##(2008-10#4)(2012-3#1)
Cercospora sorghi##5##2##(2008-10#5)
Cercospora spp##3##2##(2008-10#3)
Cercospora zeae-maydis##9##2##(2008-10#9)
Cercospora##47##1##(2008-10#45)(2012-3#2)
Cereal yellow dwarf virus##3##4##(2008-10#3)
Cereal yellow dwarf##6##3##(2008-10#6)
Cereal##10##1##(1990-3#1)(2008-10#9)
Cereals##2##1##(2008-10#2)
Cerebellar##9##1##(1995-5#1)(1996-5#1)(2008-4#1)(2008-7#2)(2009-1#1)(2012-3#1)(2013-1#2)
Cerebellopontine Angle##2##2##(2012-3#2)
Cerebellopontine angle##2##2##(2008-8#1)(2011-2#1)
Cerebellopontine##4##1##(2008-8#1)(2011-2#1)(2012-3#2)
Cerebral Hyperperfusion##2##2##(2012-3#2)
Cerebral Vasospasm##2##2##(2008-8#1)(2011-2#1)
Cerebral and##2##2##(2008-11#2)
Cerebral angiography##3##2##(1996-3#1)(2007-10#1)(2008-7#1)
Cerebral arteriovenous malformations##2##3##(2008-9#1)(2012-3#1)
Cerebral aspergillosis##2##2##(2009-4#1)(2013-8#1)
Cerebral atherosclerosis##2##2##(2008-7#2)
Cerebral blood flow (CBF)##3##4##(2008-7#2)(2011-1#1)
Cerebral blood flow##7##3##(1995-5#1)(1996-12#1)(1996-5#1)(2007-10#1)(2008-7#2)(2011-1#1)
Cerebral microbleeds##2##2##(2008-8#2)
Cerebral palsy##3##2##(1991-6#1)(1995-6#1)(2009-4#1)
Cerebral perfusion##2##2##(1996-5#1)(2008-7#1)
Cerebral vasospasm##2##2##(2008-7#1)(2008-8#1)
Cerebral venous thrombosis##2##3##(2007-10#1)(2010-11#1)
Cerebral venous##3##2##(2007-10#2)(2010-11#1)
Cerebral##68##1##(1990-3#1)(1990-5#1)(1991-6#2)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2007-10#6)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#3)(2009-4#2)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#5)(2013-8#2)
Cerebratulus##2##1##(1994-2#2)
Cerebrospinal fluid (CSF)##3##3##(2009-11#1)(2009-6#1)(2012-3#1)
Cerebrospinal fluid leaks of##2##4##(2011-2#2)
Cerebrospinal fluid##10##2##(2007-5#1)(2009-11#1)(2009-6#1)(2011-2#2)(2012-3#4)(2013-8#1)
Cerebrovascular disease##2##2##(1993-3#1)(2008-7#1)
Cerebrovascular diseases##2##2##(1996-11#1)(2011-1#1)
Cerebrovascular##10##1##(1993-3#1)(1996-11#1)(1997-2#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#3)
Ceriodaphnia dubia##2##2##(2008-11#2)
Cerrado##7##1##(2008-6#4)(2008-8#1)(2010-3#2)
Cerrena unicolor##2##2##(2008-10#2)
Cerro##4##1##(2008-10#2)(2008-3#2)
Certain aspects of##3##3##(2008-10#1)(2008-7#1)(2009-2#1)
Certain isolates##2##2##(2008-10#2)
Certain morphological features##2##3##(1997-1#1)(2009-12#1)
Certain##35##1##(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-6#1)(1994-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Certainly##5##1##(1994-3#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)
Certhidea##3##1##(2008-8#3)
Certificate of##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
Certificate##5##1##(1993-12#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-2#1)
Certification##3##1##(1996-12#1)(2008-11#1)(2011-2#1)
Certified Reference Materials (CRMs)##2##4##(2008-10#2)
Certified Reference Materials##3##3##(2008-10#3)
Certified Reference##4##2##(2008-10#4)
Certified nurse##2##2##(1993-3#1)(2010-11#1)
Certified reference##2##2##(2008-10#2)
Certified##12##1##(1992-12#1)(1993-3#1)(2008-10#8)(2008-12#1)(2010-11#1)
Certifying##2##1##(1992-12#1)(2008-1#1)
Cervical Spine##2##2##(2008-12#1)(2012-3#1)
Cervical artery dissection##2##3##(2011-1#2)
Cervical artificial disc replacement versus fusion in the cervical spine##2##10##(2012-12#2)
Cervical artificial disc replacement##4##4##(2012-12#4)
Cervical artificial##5##2##(2008-12#1)(2012-12#4)
Cervical cancer##2##2##(2008-11#1)(2011-1#1)
Cervical carcinoma##2##2##(1994-5#1)(2007-4#1)
Cervical root##2##2##(2008-7#1)(2012-3#1)
Cervical##46##1##(1990-12#1)(1990-3#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-1#3)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#5)(2008-2#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#3)(2011-7#1)(2012-12#5)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#4)
Cervicogenic headache##2##2##(2008-12#2)
Ces##2##1##(2008-11#1)(2011-2#1)
Cesarean section##2##2##(2013-1#2)
Cesarean##4##1##(1993-12#1)(2013-1#3)
Cesium ion-selective##2##2##(2008-10#2)
Cesium##3##1##(2008-10#3)
Cessation of##2##2##(1992-12#1)(2008-7#1)
Cessation##5##1##(1991-5#1)(1992-12#1)(2008-7#1)(2010-4#1)(2011-2#1)
Cestrum parqui##2##2##(2008-12#2)
Cette##2##1##(2013-1#2)
Cetyltrimethylammonium##2##1##(2008-10#2)
Cex##5##1##(1992-11#2)(1995-5#1)(2008-7#2)
CfoI##3##1##(2008-10#3)
Cg##4##1##(1995-12#4)
Cg-14##3##1##(2008-10#3)
Cg-HTIF(I)##4##1##(2010-4#4)
Cg-M-1150 did not##3##3##(2008-10#3)
Cg-M-1150##7##1##(2008-10#7)
Cg-M-142 and Cg-M-1150##4##3##(2008-10#4)
Cg-M-142##8##1##(2008-10#8)
CgA##4##1##(2010-11#3)(2011-2#1)
Ch##2##1##(1991-12#1)(1992-3#1)
ChAT activity was##2##3##(1993-12#2)
ChAT activity##5##2##(1991-9#1)(1992-8#1)(1993-12#2)(1996-2#1)
ChAT##7##1##(1991-9#1)(1992-8#2)(1993-12#2)(1996-2#1)(2011-2#1)
ChEMBL##2##1##(2013-1#2)
ChIP##5##1##(2008-2#5)
ChL##7##1##(2008-10#7)
ChMV is related to##2##4##(2008-10#2)
ChMV is##3##2##(2008-10#3)
ChMV was##4##2##(2008-10#4)
ChMV##9##1##(2008-10#9)
ChOx##4##1##(2008-10#4)
ChOx/FNAB/ODT/Au##2##1##(2008-10#2)
Chacopata##2##1##(2007-5#1)(2008-5#1)
Chadoora##4##1##(2013-8#4)
Chaetomium globosum##3##2##(2008-5#1)(2013-1#2)
Chagas disease##3##2##(2008-8#1)(2012-12#2)
Chagas##4##1##(2008-8#1)(2012-12#2)(2013-7#1)
Chagas' disease##3##2##(1993-6#3)
Chagas'##4##1##(1993-6#3)(1996-3#1)
Chaguaramas Bay##2##2##(2007-5#2)
Chain Length##2##2##(1996-12#1)(2008-10#1)
Chain Reaction Detection##4##3##(2008-10#4)
Chain Reaction in##2##3##(2008-10#2)
Chain Reaction##46##2##(1990-12#1)(2007-10#1)(2008-10#38)(2008-12#5)(2013-8#1)
Chain##60##1##(1990-12#1)(1996-12#1)(1996-9#1)(2007-10#1)(2008-10#44)(2008-12#6)(2008-2#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-8#2)
Chains##2##1##(2008-10#2)
Chair of##5##2##(2008-5#1)(2010-1#1)(2012-12#1)(2012-3#2)
Chair##7##1##(2007-11#1)(2008-5#2)(2010-1#1)(2012-12#1)(2012-3#2)
Chairman##4##1##(1993-2#1)(1994-1#1)(2008-5#1)(2010-1#1)
Chairs##2##1##(2009-3#1)(2009-4#1)
Chaitophorus leucomelas##2##2##(2011-2#2)
Chalara elegans##3##2##(2008-10#3)
Chalcides##2##1##(2010-3#2)
Challenge testing##2##2##(2008-5#2)
Challenge tests##2##2##(1997-1#1)(2008-5#1)
Challenge##11##1##(1991-8#1)(1997-1#2)(2008-10#1)(2008-5#3)(2010-10#1)(2010-12#1)(2010-8#1)(2012-3#1)
Challenges and##9##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)
Challenges for##3##2##(2008-7#1)(2009-6#1)(2010-6#1)
Challenges in##10##2##(1993-2#1)(1994-3#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#1)
Challenges of##4##2##(1993-12#1)(2007-7#1)(2008-8#1)(2009-12#1)
Challenges to##4##2##(1991-3#1)(1993-2#1)(1996-3#1)(2008-12#1)
Challenges##37##1##(1991-3#1)(1993-12#1)(1993-2#2)(1994-3#2)(1996-3#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
Challenging##7##1##(1990-4#1)(1996-2#1)(1997-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
Chalupský##2##1##(2008-7#2)
Chamber##4##1##(2008-11#1)(2008-5#2)(2011-2#1)
Chamela##2##1##(2013-7#2)
Champion##2##1##(2008-10#1)(2008-4#1)
Chan##4##1##(1992-3#1)(2008-12#1)(2008-8#1)(2012-2#1)
Chances##2##1##(2013-1#1)(2013-8#1)
Chandigarh##3##1##(1994-3#1)(2007-7#1)(2011-1#1)
Chang##5##1##(1991-9#1)(1993-8#1)(1995-6#1)(2008-2#2)
Chang-X##2##1##(2012-12#2)
Changbai Mountain##3##2##(2008-9#3)
Change Strategies##2##2##(1994-3#1)(2012-2#1)
Change and##3##2##(1995-3#1)(2008-4#1)(2011-2#1)
Change blindness##2##2##(2008-9#2)
Change in the##2##3##(1994-2#1)(2008-10#1)
Change in##16##2##(1992-10#1)(1994-2#1)(1996-8#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
Change of##6##2##(1992-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
Change##56##1##(1992-10#1)(1992-3#1)(1994-1#1)(1994-2#2)(1994-3#2)(1995-3#1)(1996-8#1)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Changed participation##2##2##(2012-12#2)
Changed##3##1##(1995-12#1)(2012-12#2)
Changes During##2##2##(2008-10#2)
Changes in blood##2##3##(2007-11#1)(2008-10#1)
Changes in clinical##2##3##(1992-12#1)(1996-6#1)
Changes in expression of##2##4##(1991-9#1)(2008-12#1)
Changes in frequency and##2##4##(1990-3#1)(1991-9#1)
Changes in membrane##2##3##(1996-8#1)(2008-9#1)
Changes in mitochondrial##2##3##(2008-2#1)(2008-9#1)
Changes in renal##2##3##(2008-3#1)(2010-4#1)
Changes in skin##2##3##(2008-5#2)
Changes in the health care##2##5##(1996-2#1)(1997-2#1)
Changes in the structure##2##4##(2007-12#1)(2008-9#1)
Changes in the##51##3##(1990-5#1)(1991-1#2)(1991-11#1)(1991-5#1)(1992-6#1)(1994-2#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#4)(2008-9#1)(2009-6#1)(2009-8#1)(2012-1#2)(2012-2#2)(2013-1#1)
Changes in##154##2##(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#3)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#4)(2008-9#6)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#5)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
Changes of##10##2##(1993-8#1)(1995-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
Changes to##4##2##(1996-2#1)(2008-5#1)(2013-1#2)
Changes were##3##2##(1994-8#1)(2007-12#1)(2008-10#1)
Changes##190##1##(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#3)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#7)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#5)(2012-12#1)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#3)
Changeux##2##1##(1996-5#1)(1997-2#1)
Changing the social##2##3##(2008-4#1)(2012-2#1)
Changing the##10##2##(1991-10#1)(1994-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2012-2#2)
Changing##37##1##(1990-6#1)(1991-10#1)(1991-2#4)(1992-2#1)(1992-3#1)(1994-1#2)(1994-2#1)(1997-1#1)(1997-3#2)(2007-11#2)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
Changzhou##2##1##(2012-3#2)
Channel##16##1##(2007-8#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#2)
Channels in##2##2##(2011-2#1)(2013-1#1)
Channels##7##1##(2008-3#1)(2008-8#2)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
Chaos theory##2##2##(1996-2#1)(1997-2#1)
Chaos##7##1##(1996-2#1)(1996-9#2)(1997-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
Chaotic dynamics introduced in##2##4##(2008-11#2)
Chaotic dynamics##3##2##(2008-11#3)
Chaotic##11##1##(1990-4#1)(1994-2#1)(1996-12#1)(1996-9#2)(2007-11#2)(2008-11#3)(2012-2#1)
Chapter of##2##2##(1992-2#1)(2008-10#1)
Chapter##46##1##(1992-2#2)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#7)(2008-9#33)(2012-2#1)
Characidae)##4##1##(2008-5#1)(2008-7#1)(2008-8#1)(2013-7#1)
Characidium fishes##2##2##(2010-8#2)
Characidium##3##1##(2010-8#3)
Character##4##1##(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)
Characterisation of a##3##3##(1995-11#1)(2008-10#2)
Characterisation of the##5##3##(1990-12#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-12#1)
Characterisation of##15##2##(1990-12#1)(1993-2#1)(1994-8#1)(1995-11#2)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-12#1)
Characterisation##16##1##(1990-12#1)(1993-2#1)(1994-8#1)(1995-11#2)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-12#1)
Characteristic masses##2##2##(2008-10#2)
Characteristic##15##1##(1991-12#1)(1994-9#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
Characteristically##5##1##(1992-5#1)(1995-11#1)(1996-6#1)(1996-9#1)(2009-8#1)
Characteristics and##7##2##(1991-2#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
Characteristics of grating-assisted##2##3##(2008-3#2)
Characteristics of the##8##3##(1990-11#1)(1992-3#1)(1995-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
Characteristics of this##2##3##(2008-3#1)(2013-1#1)
Characteristics of##41##2##(1990-11#1)(1990-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Characteristics##55##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#3)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Characterization and Distribution of##2##4##(2008-10#2)
Characterization and mapping of##2##4##(1996-10#1)(2008-10#1)
Characterization and use##2##3##(2008-10#1)(2008-11#1)
Characterization and##21##2##(1991-9#1)(1993-3#1)(1996-10#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-2#2)(2009-12#1)(2009-7#1)
Characterization by##4##2##(2008-10#4)
Characterization of Colletotrichum acutatum##2##4##(2008-10#2)
Characterization of Phytophthora##2##3##(2008-10#2)
Characterization of Resistance##3##3##(2008-10#3)
Characterization of Two##4##3##(1997-7#1)(2008-10#3)
Characterization of a New##2##4##(2008-10#2)
Characterization of a Novel##2##4##(2008-10#2)
Characterization of a cDNA Encoding##2##5##(2008-5#1)(2008-6#1)
Characterization of a new##2##4##(1990-12#1)(1990-8#1)
Characterization of a novel##2##4##(1993-11#1)(2012-3#1)
Characterization of a second##2##4##(1991-9#2)
Characterization of a##38##3##(1990-12#1)(1990-8#1)(1991-9#3)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-3#1)
Characterization of an##10##3##(1990-8#1)(1991-12#1)(1991-7#1)(1992-8#1)(1997-7#1)(2008-10#4)(2008-11#1)
Characterization of monoclonal antibodies##2##4##(1995-12#1)(1996-12#1)
Characterization of murine##2##3##(1993-8#1)(1997-7#1)
Characterization of nanomaterials##2##3##(2010-7#2)
Characterization of rainbow trout##2##4##(1997-9#1)(2008-11#1)
Characterization of the electroactive process included an examination of the degree of reversibility##2##13##(2008-10#2)
Characterization of the gene##2##4##(1993-2#1)(1994-11#1)
Characterization of the murine##2##4##(1995-6#1)(1997-8#1)
Characterization of the##52##3##(1990-11#2)(1990-12#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2012-2#1)
Characterization of three##2##3##(2008-10#1)(2013-1#1)
Characterization of two##3##3##(1993-8#1)(1995-2#1)(1997-8#1)
Characterization of##274##2##(1990-11#3)(1990-12#3)(1990-2#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-8#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#5)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#5)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#6)(1997-8#5)(1997-9#1)(2007-11#4)(2007-12#5)(2007-7#1)(2008-10#94)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-11#2)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
Characterization##318##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-8#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#5)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#6)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#7)(1997-8#5)(1997-9#1)(2007-11#5)(2007-12#5)(2007-7#1)(2008-10#117)(2008-11#9)(2008-12#2)(2008-2#8)(2008-3#18)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-11#2)(2009-12#2)(2009-5#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
Characterized by##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
Characterized##8##1##(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
Characterizing the##2##2##(2008-10#2)
Characterizing##7##1##(2007-10#1)(2008-10#4)(2008-3#1)(2012-1#1)
Charcot arthropathy##2##2##(2008-12#2)
Charcot##3##1##(2008-12#2)(2011-2#1)
Charcot-Marie-Tooth (CMT) disease##2##3##(1997-3#1)(2013-7#1)
Charcot-Marie-Tooth disease##4##2##(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
Charcot-Marie-Tooth##6##1##(1997-3#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
Chardonnay and Riesling##2##3##(2008-10#2)
Chardonnay and##3##2##(2008-10#3)
Chardonnay##5##1##(2008-10#5)
Charge density##2##2##(1991-5#1)(2008-5#1)
Charge##11##1##(1991-5#1)(1992-8#2)(1996-2#1)(1996-9#2)(2006-4#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
Charge-based weights##2##2##(1993-1#2)
Charged##3##1##(1996-12#1)(2008-11#1)(2008-7#1)
Charitable##2##1##(2007-3#1)(2010-10#1)
Charity##3##1##(1990-5#1)(1991-3#1)(1992-8#1)
Charles Bonnet syndrome##4##3##(2011-2#2)(2013-8#2)
Charles Bonnet##6##2##(2011-2#4)(2013-8#2)
Charles Darwin##4##2##(2008-4#1)(2010-4#2)(2012-2#1)
Charles Tilly as##2##3##(2011-1#2)
Charles##23##1##(1994-2#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2010-1#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#2)
Charleston##2##1##(1993-1#1)(2012-3#1)
Charlotte Bay##2##2##(2010-8#2)
Charlotte##4##1##(1995-12#1)(2008-10#1)(2010-8#2)
Charlottetown##4##1##(2008-10#1)(2012-3#2)(2013-8#1)
Charolais cattle##2##2##(2010-4#2)
Charolais##3##1##(2010-4#3)
Chart review was performed##2##4##(2012-3#1)(2013-1#1)
Chart review was##3##3##(2012-3#1)(2013-1#2)
Chart##6##1##(1994-3#1)(1994-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
Charter Medical##2##2##(1992-12#2)
Charter##4##1##(1992-12#2)(1993-9#1)(1997-3#1)
Charting##3##1##(1996-1#1)(1997-3#1)(2008-1#1)
Charts##2##1##(1994-6#1)(2007-10#1)
Chase##3##1##(1991-12#1)(1993-12#2)
Chatoyant##2##1##(2008-2#2)
Chayote mosaic virus##2##3##(2008-10#2)
Chałasiński##2##1##(2008-12#2)
CheY##6##1##(1993-11#6)
Cheaper##2##1##(1995-2#1)(2011-3#1)
Chebyshev##3##1##(2008-3#3)
Check##3##1##(1990-11#1)(1994-3#1)(2007-11#1)
Checking##4##1##(1992-12#1)(1994-7#1)(2010-3#1)(2013-8#1)
Checklist (CBCL)##2##2##(1993-1#1)(2008-9#1)
Checklist were##2##2##(2006-10#1)(2012-1#1)
Checklist##15##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-1#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#2)(2012-5#1)(2013-1#1)
Chedoke##2##1##(1992-2#1)(2009-3#1)
Chelated##2##1##(2008-10#1)(2009-5#1)
Chelating agents##2##2##(1990-5#1)(2008-5#1)
Chelating##6##1##(1990-5#1)(1995-5#1)(2008-10#3)(2008-5#1)
Chelation of##2##2##(1990-12#1)(1994-11#1)
Chelation##4##1##(1990-12#1)(1994-11#1)(1997-7#1)(2011-2#1)
Chelex 100##2##2##(2008-10#2)
Chelex##3##1##(2008-10#3)
Chelex-100 resin##2##2##(2008-10#2)
Chelex-100##10##1##(2008-10#10)
Chelicerata##3##1##(2007-12#3)
Chelidonium majus L##2##3##(2008-10#2)
Chelsea Critical Care Physical Assessment Tool (CPAx)##2##7##(2012-12#2)
Chem 263##2##2##(1990-5#1)(1994-8#1)
Chem##91##1##(1990-11#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#5)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-8#3)(1993-3#3)(1993-6#2)(1993-8#3)(1994-11#3)(1994-12#2)(1994-5#5)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#4)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#17)(2008-4#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)
Chemerin##2##1##(2012-2#2)
Chemical Manganese Dioxide##2##3##(2007-11#2)
Chemical Society##2##2##(2008-5#1)(2011-2#1)
Chemical analyses of##2##3##(1995-12#1)(2008-10#1)
Chemical analysis of##4##3##(1993-11#1)(1997-3#1)(2008-10#2)
Chemical analysis##5##2##(1993-11#1)(1993-8#1)(1997-3#1)(2008-10#2)
Chemical and biological##2##3##(2010-7#2)
Chemical and flow variables as well as concomitant ions were studied in the developed procedure##2##15##(2008-10#2)
Chemical and flow variables as well as##3##7##(2008-10#3)
Chemical and##13##2##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-7#2)(2012-3#1)
Chemical biology##2##2##(2008-11#2)
Chemical cleavage##2##2##(1993-11#1)(2008-4#1)
Chemical composition and##2##3##(2008-11#1)(2008-12#1)
Chemical composition##3##2##(2008-11#2)(2008-12#1)
Chemical control##2##2##(2011-2#1)(2013-8#1)
Chemical cross-linking##2##2##(1995-2#1)(1995-6#1)
Chemical genomics##2##2##(2008-11#2)
Chemical imaging##3##2##(2008-10#2)(2008-5#1)
Chemical modification of the##2##4##(1990-2#1)(2008-7#1)
Chemical modification of##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
Chemical modification##7##2##(1990-2#2)(2008-10#1)(2008-4#3)(2008-7#1)
Chemical peeling##2##2##(2007-7#1)(2008-5#1)
Chemical shift##3##2##(1992-11#1)(2009-7#1)(2012-2#1)
Chemical speciation##2##2##(2008-10#2)
Chemical synthesis of##2##3##(1992-6#1)(2008-4#1)
Chemical synthesis##3##2##(1992-6#1)(2008-4#1)(2011-2#1)
Chemical treatment##2##2##(2007-12#1)(2008-6#1)
Chemical vapor##2##2##(2008-10#1)(2010-4#1)
Chemical##155##1##(1990-2#2)(1990-7#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#2)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#30)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#28)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
Chemically synthesized##2##2##(1993-11#1)(2008-4#1)
Chemically##10##1##(1991-2#1)(1993-11#1)(2007-12#1)(2008-10#3)(2008-4#2)(2009-8#1)(2011-2#1)
Chemicals and##2##2##(1997-7#1)(2008-8#1)
Chemicals##7##1##(1990-8#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-8#1)(2013-1#1)
Chemiluminescence determination of##5##3##(2008-10#5)
Chemiluminescence emission was monitored by means of a##2##8##(2008-10#2)
Chemiluminescence flow##2##2##(2008-10#2)
Chemiluminescence of##2##2##(2008-10#2)
Chemiluminescence##23##1##(2008-10#23)
Chemiluminescent detection of##2##3##(1995-3#1)(2008-10#1)
Chemiluminescent##6##1##(1995-3#1)(2008-10#4)(2010-11#1)
Chemistries##3##1##(1996-5#1)(2012-12#2)
Chemistry and##3##2##(1994-12#1)(2008-11#1)(2008-5#1)
Chemistry for the Environment (INCA)##2##5##(2008-11#2)
Chemistry for##4##2##(2008-10#1)(2008-11#2)(2010-12#1)
Chemistry in##2##2##(1990-5#1)(2010-7#1)
Chemistry of 1##2##3##(1996-5#2)
Chemistry of##7##2##(1993-5#1)(1996-5#2)(1997-7#1)(2008-12#1)(2008-4#2)
Chemistry##47##1##(1990-5#1)(1991-6#1)(1993-5#1)(1994-12#6)(1996-2#1)(1996-5#2)(1997-7#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#5)(2009-6#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2012-1#2)(2012-2#1)(2013-1#2)
Chemoendocrine##4##1##(1994-7#2)(1997-7#2)
Chemometric analysis of##2##3##(2008-10#1)(2008-3#1)
Chemometric##10##1##(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)
Chemometrical##2##1##(2008-10#1)(2008-11#1)
Chemoprevention of##5##2##(1991-9#1)(1995-9#2)(2008-6#1)(2013-1#1)
Chemoprevention##9##1##(1991-9#1)(1995-9#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-12#1)(2013-1#1)
Chemoradiation##2##1##(1995-8#1)(1995-9#1)
Chemoradiotherapy##2##1##(2008-10#1)(2012-3#1)
Chemotactic activity##3##2##(1992-6#2)(1993-11#1)
Chemotactic##4##1##(1991-2#1)(1992-6#2)(1993-11#1)
Chemotherapy as##2##2##(2008-10#1)(2008-11#1)
Chemotherapy for##4##2##(2008-6#1)(2010-12#2)(2010-8#1)
Chemotherapy in##3##2##(1990-10#1)(2007-11#1)(2010-8#1)
Chemotherapy is##2##2##(2009-1#1)(2012-2#1)
Chemotherapy of##4##2##(1990-9#1)(1997-7#1)(2007-5#1)(2008-7#1)
Chemotherapy was administered##2##3##(2008-6#1)(2011-1#1)
Chemotherapy was##3##2##(2007-7#1)(2008-6#1)(2011-1#1)
Chemotherapy with##4##2##(1992-10#1)(1993-8#1)(1997-3#1)(2008-6#1)
Chemotherapy##29##1##(1990-10#1)(1990-9#1)(1991-2#1)(1992-10#1)(1993-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#4)(2008-7#1)(2009-1#1)(2010-12#2)(2010-8#3)(2011-1#1)(2012-2#1)
Chemotherapy-Induced##2##1##(2008-7#2)
Chemotherapy-associated##2##1##(2012-3#1)(2013-1#1)
Chemotherapy-induced##2##1##(2008-7#2)
Chen##4##1##(1990-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
Chennai##4##1##(2007-7#2)(2007-8#1)(2009-4#1)
Chenopodiaceae##3##1##(2008-10#3)
Chenopodium quinoa and##2##3##(2008-10#2)
Chenopodium quinoa plants##3##3##(2008-10#3)
Chenopodium quinoa##7##2##(2008-10#7)
Chenopodium rubrum##2##2##(2008-11#2)
Chenopodium##13##1##(2007-2#1)(2008-10#8)(2008-11#2)(2008-8#1)(2013-1#1)
Chernobyl accident##2##2##(1995-11#1)(2008-10#1)
Chernobyl##15##1##(1991-11#1)(1994-9#2)(1995-11#1)(2008-10#2)(2008-4#3)(2008-7#1)(2010-4#3)(2011-1#2)
Chernoff criterion##3##2##(2008-6#3)
Chernoff##4##1##(2008-6#4)
Cherry leaf roll##2##3##(2008-10#2)
Cherry leaf##3##2##(2008-10#3)
Cherry##7##1##(2008-10#5)(2008-9#2)
Chest CT revealed##3##3##(2008-10#1)(2013-1#2)
Chest CT##4##2##(2008-1#1)(2008-10#1)(2013-1#2)
Chest Pain##3##2##(2008-3#3)
Chest X-ray revealed a##2##4##(2008-6#2)
Chest X-ray revealed##3##3##(2008-6#2)(2013-1#1)
Chest X-ray showed##2##3##(2007-8#1)(2010-11#1)
Chest X-ray##9##2##(1993-6#1)(2007-8#1)(2008-1#2)(2008-6#2)(2008-7#1)(2010-11#1)(2013-1#1)
Chest computed tomographic (CT) scans##2##5##(2008-1#2)
Chest computed##3##2##(2008-1#2)(2013-1#1)
Chest pain##3##2##(2007-5#1)(2008-3#1)(2012-2#1)
Chest radiograph and##2##3##(2007-8#1)(2011-2#1)
Chest radiograph##3##2##(2007-8#1)(2010-2#1)(2011-2#1)
Chest radiography##2##2##(2011-2#1)(2012-12#1)
Chest wall##6##2##(2007-12#1)(2007-8#1)(2008-6#1)(2012-2#3)
Chest##44##1##(1993-6#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#7)(2008-10#2)(2008-3#4)(2008-6#3)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#5)(2011-6#1)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#1)
Chesterman##2##1##(1994-5#2)
Chestnut##4##1##(1993-1#1)(2008-10#2)(2008-5#1)
Chetumal Bay##4##2##(2008-5#4)
Chevassu was##3##2##(2007-5#3)
Chevassu##4##1##(2007-5#4)
Chevron##4##1##(2008-10#4)
Chhattisgarh##2##1##(2009-5#1)(2012-2#1)
Chi square test was##2##4##(2007-7#1)(2013-8#1)
Chi square test##4##3##(2007-7#1)(2011-2#1)(2013-8#2)
Chi square##6##2##(1997-5#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-8#2)
Chi##9##1##(1991-3#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-7#2)(2011-2#1)(2013-8#2)
Chi-square test##4##2##(2007-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
Chi-square tests##2##2##(1996-12#1)(2013-1#1)
Chi-square##10##1##(1996-12#1)(1996-9#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Chi-squared test##2##2##(2008-10#1)(2013-1#1)
Chia5##2##1##(2008-10#2)
Chiapas##6##1##(1997-3#1)(2008-10#2)(2008-5#3)
Chiari I malformation##2##3##(2012-12#2)
Chiari##4##1##(2008-7#1)(2009-3#1)(2012-12#2)
Chiba##6##1##(2008-10#5)(2011-2#1)
Chicago##17##1##(1990-11#2)(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#3)(1996-5#1)(1997-3#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-6#1)(2013-1#1)
Chicano/Latino##2##1##(2010-10#2)
Chicken manure##2##2##(2008-10#2)
Chicken##11##1##(1991-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(2007-3#2)(2008-10#2)(2008-11#2)(2008-6#1)
Chickpea by##2##2##(2008-10#2)
Chickpea chlorotic stunt virus##2##4##(2008-10#2)
Chickpea##12##1##(2008-10#12)
Chicks may##2##2##(2008-6#2)
Chicks were##2##2##(2008-6#1)(2011-2#1)
Chicks##6##1##(2008-5#1)(2008-6#4)(2011-2#1)
Chicxulub basin##2##2##(1997-5#2)
Chicxulub##3##1##(1997-5#3)
Chief of the##2##3##(2008-10#2)
Chief##12##1##(1993-3#2)(1994-1#1)(1994-8#1)(1995-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2009-5#1)
Chikungunya Virus##2##2##(2013-8#2)
Chikungunya fever##6##2##(2013-8#6)
Chikungunya##17##1##(2013-8#17)
Chilblain lupus erythematosus##2##3##(2007-7#2)
Child A##2##2##(2008-9#1)(2013-1#1)
Child Health##12##2##(1991-3#1)(1992-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-11#5)(2012-12#2)
Child Life##2##2##(1992-12#2)
Child Oncology and##3##3##(2008-9#3)
Child Oncology##5##2##(2008-9#5)
Child Psychiatry##3##2##(1996-9#1)(1997-8#1)(2008-11#1)
Child and Adolescent##5##3##(2006-10#1)(2008-11#1)(2008-4#1)(2010-1#2)
Child and Family##2##3##(2009-9#1)(2012-12#1)
Child and##11##2##(1993-1#1)(1996-2#1)(2006-10#1)(2008-11#2)(2008-4#1)(2009-9#1)(2010-1#2)(2011-2#1)(2012-12#1)
Child communication##2##2##(1990-12#1)(2009-11#1)
Child health##4##2##(1992-2#1)(1995-1#2)(2009-4#1)
Child life##2##2##(1992-12#2)
Child poverty##4##2##(2008-11#4)
Child with##3##2##(1996-6#1)(2010-7#1)(2010-9#1)
Child##87##1##(1990-12#1)(1991-3#1)(1991-8#1)(1992-12#4)(1992-2#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-6#1)(1995-1#3)(1995-3#1)(1996-12#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#2)(2008-11#15)(2008-4#1)(2008-9#13)(2009-11#4)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#2)(2010-5#4)(2010-6#2)(2010-7#2)(2010-9#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
Child's##4##1##(2009-8#1)(2012-3#3)
Child-Pugh class B##2##3##(2011-2#2)
Child-Pugh class##3##2##(2011-2#3)
Child-Pugh score##2##2##(2008-10#1)(2013-1#1)
Child-Pugh##8##1##(1991-6#1)(2008-10#1)(2011-2#3)(2013-1#3)
Childbirth Education##2##2##(2007-2#2)
Childbirth Educators##2##2##(2007-2#2)
Childbirth##7##1##(1995-1#1)(2007-2#6)
Childcare##2##1##(1991-3#1)(2008-9#1)
Childhood and##3##2##(2008-12#1)(2009-12#1)(2009-6#1)
Childhood obesity is##2##3##(2010-6#1)(2011-1#1)
Childhood obesity##4##2##(2008-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
Childhood##29##1##(1991-11#1)(1991-3#1)(1991-8#1)(1992-6#2)(1993-8#1)(1995-3#1)(1996-3#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-8#2)
Children Hospital##2##2##(2007-11#1)(2008-3#1)
Children and Adolescents##7##3##(2008-11#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
Children and adolescents##2##3##(2010-11#1)(2013-1#1)
Children and their##2##3##(2008-3#1)(2010-12#1)
Children and##16##2##(1991-2#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
Children are##2##2##(1991-12#1)(2008-12#1)
Children at##2##2##(1994-6#1)(2009-5#1)
Children for##2##2##(1995-5#1)(2010-7#1)
Children from##3##2##(1992-3#1)(2008-11#2)
Children in the##3##3##(1995-5#1)(1996-2#1)(2007-12#1)
Children in##10##2##(1995-1#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-2#1)
Children were##3##2##(2007-12#1)(2013-8#2)
Children who##6##2##(1995-1#1)(2007-12#1)(2009-8#1)(2012-2#1)(2013-8#2)
Children whose parents were divorced or single##2##7##(1994-6#2)
Children whose##3##2##(1994-6#2)(2011-2#1)
Children with Special Health Care Needs##2##6##(1994-3#1)(2013-1#1)
Children with chronic##2##3##(1996-3#2)
Children with##29##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-3#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#3)
Children##155##1##(1990-6#1)(1991-12#1)(1991-2#2)(1992-2#2)(1992-3#4)(1993-1#2)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#6)(1996-2#1)(1996-3#5)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#6)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#8)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#10)(2012-3#3)(2013-1#15)(2013-8#10)
Children's Health Care##3##3##(1992-2#1)(1994-3#2)
Children's Health##5##2##(1992-2#1)(1992-3#1)(1994-3#3)
Children's Hospital of##2##3##(2008-11#1)(2013-8#1)
Children's Hospital##11##2##(1992-3#1)(1993-1#1)(1993-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
Children's Motivation Scale##2##3##(1996-7#2)
Children's Oncology Group##3##3##(2008-6#1)(2010-3#1)(2010-5#1)
Children's perceptions of##2##3##(2008-12#1)(2009-4#1)
Children's##55##1##(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#3)(1993-1#2)(1993-12#1)(1994-3#3)(1994-6#1)(1995-12#2)(1995-3#1)(1996-7#2)(2007-10#1)(2007-12#4)(2008-11#3)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#2)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#4)(2013-8#2)
Chile and##6##2##(1990-6#1)(2008-5#1)(2011-2#2)(2013-1#2)
Chile has##3##2##(2011-2#1)(2013-1#2)
Chile##67##1##(1990-6#1)(1991-9#1)(1992-5#1)(1993-12#1)(1997-6#2)(2007-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-2#1)(2010-12#1)(2011-2#6)(2012-2#2)(2013-1#31)(2013-8#9)
Chile]##8##1##(2012-2#1)(2013-1#5)(2013-8#2)
Chilean adolescents##3##2##(2013-1#3)
Chilean children aged 6 to 14 years##2##7##(2013-1#2)
Chilean children##3##2##(2013-1#3)
Chilean population##2##2##(2013-1#2)
Chilean school##2##2##(2012-2#1)(2013-1#1)
Chilean##30##1##(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#20)(2013-8#1)
Chili##3##1##(2008-10#3)
Chim##5##1##(2008-10#5)
Chimeric##10##1##(1995-2#1)(1997-4#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2013-1#1)(2013-7#1)
Chimpanzees##5##1##(2007-12#2)(2008-11#1)(2009-5#2)
China Rice Functional Genomics Program##2##5##(2008-7#2)
China Sea population##2##3##(2010-8#2)
China Sea##6##2##(2008-10#1)(2010-8#4)(2013-8#1)
China and India##2##3##(2008-10#1)(2008-7#1)
China and Japan##5##3##(2008-10#5)
China and##17##2##(1993-9#1)(1997-3#1)(2008-10#8)(2008-7#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)
China by##2##2##(1997-3#1)(2008-8#1)
China during##3##2##(2008-10#1)(2013-8#2)
China in 2010##2##3##(2012-3#1)(2013-1#1)
China in##5##2##(2007-7#1)(2008-7#1)(2012-3#2)(2013-1#1)
China is##4##2##(1995-6#1)(1997-4#1)(2010-10#1)(2010-8#1)
China strain SHZH98##2##3##(2008-8#2)
China strain##4##2##(2008-8#4)
China that##2##2##(2008-10#1)(2012-1#1)
China virus##3##2##(2008-10#3)
China was##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
China were##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
China with##2##2##(2008-10#1)(2013-8#1)
China##217##1##(1990-11#1)(1990-2#1)(1992-10#2)(1992-2#1)(1993-9#2)(1994-3#2)(1995-6#2)(1997-3#3)(1997-4#5)(1997-5#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#43)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#24)(2008-9#12)(2009-2#1)(2010-10#4)(2010-12#6)(2010-3#1)(2010-5#5)(2010-8#8)(2011-1#14)(2011-2#19)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#22)
China's##3##1##(1994-7#1)(1997-8#1)(2011-2#1)
China) had##2##2##(2008-10#2)
China)##7##1##(2008-10#5)(2008-12#1)(2011-2#1)
China]##3##1##(2012-3#2)(2013-8#1)
Chinese Academy of Sciences##2##4##(2008-7#1)(2010-12#1)
Chinese American##2##2##(2009-7#2)
Chinese Hamster Ovary (CHO) cell line##2##6##(2008-11#2)
Chinese Hamster Ovary (CHO) cell lines##2##6##(2008-10#1)(2008-11#1)
Chinese Hamster Ovary (CHO) cell##4##5##(2008-10#1)(2008-11#3)
Chinese Hamster Ovary (CHO) cells##3##5##(1993-3#1)(2008-11#2)
Chinese Hamster Ovary (CHO)##8##4##(1993-3#1)(2008-10#1)(2008-11#6)
Chinese Hamster Ovary cells##2##4##(1992-9#1)(2008-11#1)
Chinese Hamster Ovary##12##3##(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#9)
Chinese Hamster##13##2##(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#10)
Chinese Han population##7##3##(2011-1#2)(2011-2#3)(2013-1#2)
Chinese Han##9##2##(2010-12#1)(2011-1#3)(2011-2#3)(2013-1#2)
Chinese Herbal Medicine##2##3##(2008-10#1)(2013-1#1)
Chinese Sacbrood##2##2##(2008-8#2)
Chinese Science and##2##3##(2011-2#2)
Chinese Spring##6##2##(2008-10#6)
Chinese adults##2##2##(2007-12#1)(2011-2#1)
Chinese and Western medicine--a case report]##2##6##(2008-11#2)
Chinese and##10##2##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2012-1#1)(2013-8#1)
Chinese boy who##2##3##(2008-12#1)(2010-3#1)
Chinese boys##2##2##(2007-12#2)
Chinese cabbage and turnip hairy roots##2##6##(2008-10#2)
Chinese cabbage##15##2##(1997-2#2)(2008-10#8)(2008-8#3)(2011-3#1)(2012-3#1)
Chinese characters##3##2##(2008-11#1)(2008-8#2)
Chinese children##5##2##(2007-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
Chinese deaf##2##2##(2011-2#2)
Chinese donkey leukocyte attenuated equine infectious anemia virus##2##8##(2008-9#2)
Chinese elderly##3##2##(2008-7#2)(2012-12#1)
Chinese hamster V79##2##3##(1997-4#1)(2011-1#1)
Chinese hamster lung##2##3##(1997-3#1)(2008-10#1)
Chinese hamster ovary (CHO) and hybridoma cells##2##7##(2008-11#2)
Chinese hamster ovary (CHO) cell line##2##6##(2008-11#2)
Chinese hamster ovary (CHO) cell##6##5##(1997-2#1)(2008-11#3)(2008-7#2)
Chinese hamster ovary (CHO) cells and##2##6##(1990-12#1)(1992-6#1)
Chinese hamster ovary (CHO) cells stably##2##6##(1994-11#1)(1995-11#1)
Chinese hamster ovary (CHO) cells transfected with the##2##8##(1995-6#1)(2008-10#1)
Chinese hamster ovary (CHO) cells were##2##6##(2008-11#1)(2008-7#1)
Chinese hamster ovary (CHO) cells##26##5##(1990-12#1)(1992-10#1)(1992-12#2)(1992-6#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#11)(2008-4#1)(2008-7#5)
Chinese hamster ovary (CHO)##35##4##(1990-12#1)(1992-10#1)(1992-12#2)(1992-6#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#17)(2008-4#1)(2008-7#7)
Chinese hamster ovary cell culture##2##5##(2008-11#1)(2008-7#1)
Chinese hamster ovary cell line##3##5##(2008-11#3)
Chinese hamster ovary cell lines##2##5##(2008-11#2)
Chinese hamster ovary cell##10##4##(1991-9#1)(2008-11#8)(2008-7#1)
Chinese hamster ovary cells with##2##5##(1995-8#1)(2008-11#1)
Chinese hamster ovary cells##29##4##(1990-12#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(2008-11#10)(2008-7#1)(2008-8#1)
Chinese hamster ovary##80##3##(1990-12#2)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#3)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#40)(2008-4#1)(2008-7#9)(2008-8#1)
Chinese hamster##90##2##(1990-12#2)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#3)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-10#2)(2008-11#41)(2008-4#1)(2008-7#9)(2008-8#1)(2011-1#1)
Chinese herb##4##2##(2008-10#1)(2012-3#1)(2013-1#2)
Chinese herbal medicine##4##3##(2008-10#1)(2013-1#1)(2013-8#2)
Chinese herbal medicines##2##3##(1997-3#1)(2008-10#1)
Chinese herbal remedies##2##3##(2008-10#2)
Chinese herbal##17##2##(1997-3#1)(2008-10#8)(2008-8#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#3)
Chinese herbs##13##2##(1990-3#1)(2008-10#6)(2008-5#5)(2011-3#1)
Chinese immigrant youth##2##3##(2010-5#2)
Chinese isolate##4##2##(2008-10#3)(2008-9#1)
Chinese isolates##3##2##(2008-10#2)(2008-9#1)
Chinese materia medica##2##3##(2011-2#2)
Chinese materia##3##2##(2011-2#2)(2012-3#1)
Chinese medical##3##2##(2013-1#1)(2013-8#2)
Chinese medicament##2##2##(1997-2#2)
Chinese medicinal herbs##4##3##(1992-2#2)(2008-10#1)(2012-3#1)
Chinese medicinal##6##2##(1992-2#2)(2008-10#3)(2012-3#1)
Chinese medicine injections##5##3##(2011-2#4)(2011-3#1)
Chinese medicine theory##2##3##(2011-2#1)(2013-1#1)
Chinese medicine##25##2##(1992-2#1)(2008-10#4)(2011-2#7)(2011-3#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
Chinese men##4##2##(2009-9#3)(2010-6#1)
Chinese patients with##2##3##(2009-8#1)(2013-7#1)
Chinese patients##4##2##(2007-12#2)(2009-8#1)(2013-7#1)
Chinese physicians##2##2##(2011-2#2)
Chinese population##11##2##(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#3)(2011-2#3)(2013-7#1)
Chinese populations##5##2##(2008-8#4)(2008-9#1)
Chinese raccoon##2##2##(2008-12#2)
Chinese rice varieties through an##2##5##(2008-8#2)
Chinese species##2##2##(2008-12#1)(2008-8#1)
Chinese traditional##2##2##(1991-6#1)(2008-8#1)
Chinese with##2##2##(1993-3#1)(2007-5#1)
Chinese women##6##2##(2011-1#1)(2011-2#1)(2013-1#4)
Chinese##435##1##(1990-12#2)(1990-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#4)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#5)(1994-3#3)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#11)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#7)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#2)(2007-12#11)(2007-5#1)(2008-10#69)(2008-11#56)(2008-12#8)(2008-3#3)(2008-4#2)(2008-5#7)(2008-7#20)(2008-8#33)(2008-9#12)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#4)(2010-8#3)(2011-1#12)(2011-2#34)(2011-3#9)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#21)(2013-7#3)(2013-8#13)
Chingaza##2##1##(2013-7#2)
Chinook##3##1##(2008-11#1)(2010-8#2)
Chip for##2##2##(2008-10#1)(2010-8#1)
Chip##3##1##(2008-10#1)(2010-8#1)(2011-2#1)
Chiral polyamines##2##2##(2009-10#2)
Chiral separation of##2##3##(1990-8#1)(2008-10#1)
Chiral separations##2##2##(1995-3#1)(2008-10#1)
Chiral##15##1##(1990-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#5)(2008-10#3)(2008-7#1)(2009-10#2)
Chiralpak AD##2##2##(2008-10#2)
Chiralpak IA and Chiralpak IB columns##3##6##(2008-10#3)
Chiralpak IA and Chiralpak IB##4##5##(2008-10#4)
Chiralpak IA##7##2##(2008-10#7)
Chiralpak IB##5##2##(2008-10#5)
Chiralpak##15##1##(2008-10#15)
Chiranjeevi worked##3##2##(2008-10#3)
Chiranjeevi##12##1##(2008-10#12)
Chirasil-Val##2##1##(2008-10#2)
Chironomus##4##1##(2008-11#4)
Chiropractic##4##1##(2007-11#1)(2008-12#1)(2008-5#2)
Chirped##2##1##(2007-11#1)(2008-3#1)
Chirped-pulse amplification##3##2##(2007-11#2)(2008-3#1)
Chitin deacetylase##2##2##(1997-3#2)
Chitin##5##1##(1997-3#2)(2008-10#2)(2008-7#1)
Chitin-supplemented application of##2##3##(2008-10#2)
Chitinase activity##2##2##(2008-10#2)
Chitinase##10##1##(2008-10#8)(2013-1#2)
Chitinases##4##1##(2008-10#4)
Chitinophaga pinensis##2##2##(2011-2#2)
Chitinophaga##4##1##(2011-2#4)
Chitosan##5##1##(2008-10#3)(2012-2#2)
Chitosan/pGM-CSF##2##1##(2012-2#2)
Chl##5##1##(2008-3#4)(2008-4#1)
Chl)) may be##2##3##(2008-3#2)
Chl))##3##1##(2008-3#3)
Chl))]##3##1##(2008-3#3)
Chlamydia pneumoniae and##2##3##(2007-11#1)(2013-1#1)
Chlamydia pneumoniae##6##2##(2007-10#2)(2007-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
Chlamydia positive##3##2##(2008-5#3)
Chlamydia psittaci##5##2##(1990-5#1)(1992-5#1)(1993-2#2)(2013-1#1)
Chlamydia sp##4##2##(2008-5#4)
Chlamydia species##2##2##(2008-9#2)
Chlamydia trachomatis in##2##3##(1990-6#1)(1995-6#1)
Chlamydia trachomatis infection##2##3##(1997-3#1)(2013-1#1)
Chlamydia trachomatis##28##2##(1990-2#2)(1990-5#2)(1990-6#2)(1991-9#2)(1993-9#2)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#2)(2007-7#3)(2008-12#2)(2008-9#1)(2009-8#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
Chlamydia was detected in##2##4##(2008-5#2)
Chlamydia##66##1##(1990-2#2)(1990-5#3)(1990-6#3)(1991-9#2)(1992-5#1)(1993-2#2)(1993-9#2)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#3)(2007-10#3)(2007-11#1)(2007-7#3)(2008-12#5)(2008-5#13)(2008-7#1)(2008-9#5)(2009-8#3)(2010-12#2)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Chlamydomonas perigranulata##2##2##(2008-6#2)
Chlamydomonas reinhardtii##8##2##(1993-11#2)(1995-8#2)(2009-10#2)(2012-3#2)
Chlamydomonas##11##1##(1993-11#2)(1995-8#2)(2008-6#2)(2008-7#1)(2009-10#2)(2012-3#2)
Chlamydophila##2##1##(2012-12#1)(2013-8#1)
Chlamydospore##2##1##(2008-10#2)
Chlamydospores of##2##2##(2008-10#2)
Chlamydospores##3##1##(2008-10#3)
Chlorambucil##2##1##(1995-3#1)(2008-11#1)
Chloramphenicol acetyltransferase##2##2##(1995-2#2)
Chloramphenicol##4##1##(1994-6#1)(1995-2#2)(2008-7#1)
Chlorella fusca##2##2##(1991-12#2)
Chlorella vulgaris ESP6##2##3##(2013-1#2)
Chlorella vulgaris##10##2##(2008-10#5)(2008-12#1)(2013-1#4)
Chlorella##14##1##(1991-12#2)(2008-10#7)(2008-12#1)(2013-1#4)
Chloride##3##1##(2007-3#1)(2008-10#2)
Chlorides##2##1##(2010-12#1)(2010-8#1)
Chlorination##2##1##(1997-7#1)(2008-10#1)
Chlorofluorocarbons##2##1##(1992-3#1)(1996-1#1)
Chloroform##2##1##(1991-8#2)
Chlorogenic acid##2##2##(2008-10#1)(2008-11#1)
Chloroperlidae##2##1##(2007-12#2)
Chloroperoxidase##2##1##(1996-5#1)(2008-6#1)
Chlorophyll##4##1##(2008-10#2)(2008-12#1)(2008-2#1)
Chlorophyta and##2##2##(2008-5#2)
Chlorophyta##4##1##(2008-5#4)
Chloroplast##5##1##(1996-4#1)(2008-11#1)(2009-5#1)(2009-8#1)(2012-3#1)
Chloroplasts##2##1##(2008-1#1)(2008-7#1)
Chlorotoxin##4##1##(2013-1#4)
Chlorpheniramine##2##1##(2008-7#1)(2010-5#1)
Chlorpyrifos##6##1##(2008-10#5)(2011-2#1)
Choice and##2##2##(1997-2#1)(2010-3#1)
Choice of##6##2##(1990-11#1)(1991-6#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
Choice##12##1##(1990-11#1)(1991-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
Choices##4##1##(1995-11#1)(2006-10#1)(2013-1#2)
Cholangiocarcinoma##2##1##(2009-9#2)
Cholecystokinin##3##1##(1991-12#1)(1993-6#1)(1994-2#1)
Cholera Toxin##2##2##(2009-2#1)(2009-8#1)
Cholera in##2##2##(1990-6#1)(1991-6#1)
Cholera##11##1##(1990-6#1)(1991-6#3)(1994-2#2)(2007-2#2)(2009-2#1)(2009-8#1)(2012-3#1)
Cholesteatoma##2##1##(2008-9#2)
Cholesterol in##3##2##(1993-12#1)(2008-3#2)
Cholesterol side-chain cleavage and 11 beta-hydroxylation##2##6##(1990-11#2)
Cholesterol##36##1##(1990-11#2)(1990-12#1)(1990-2#3)(1991-11#1)(1991-4#1)(1991-8#1)(1993-12#2)(1994-8#1)(1995-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#5)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
Cholesteryl ester##3##2##(1990-8#1)(1992-11#1)(2008-12#1)
Cholesteryl##4##1##(1990-8#1)(1992-11#1)(2008-12#1)(2009-8#1)
Cholinergic##6##1##(1990-7#1)(1991-12#1)(2008-5#2)(2013-8#2)
Cholinesterases in##2##2##(1990-5#1)(1993-2#1)
Chondrocyte##2##1##(2009-12#1)(2011-2#1)
Chondrocytes##4##1##(2008-11#2)(2008-8#1)(2009-12#1)
Chondroprotection##2##1##(1991-3#1)(1991-8#1)
Chondrosarcoma is##2##2##(2008-1#1)(2008-5#1)
Chondrosarcoma##5##1##(1997-8#1)(2008-1#1)(2008-5#1)(2008-6#2)
Chondrosarcomas##2##1##(2008-1#1)(2008-7#1)
Choosing the right##2##3##(2008-11#1)(2011-2#1)
Choosing the##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
Choosing your##2##2##(1994-3#1)(1995-2#1)
Choosing##10##1##(1994-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-2#1)(2011-2#3)
Chorea##2##1##(2008-11#1)(2011-10#1)
Choroid plexus##2##2##(2008-10#1)(2008-12#1)
Chown et al##2##3##(2008-8#2)
Chr 3##3##2##(1994-12#3)
Chr##4##1##(1994-12#3)(2008-9#1)
Chr-3-specific DNA clones##2##3##(1994-12#2)
Chr-3-specific library##2##2##(1994-12#2)
Chr-3-specific##5##1##(1994-12#5)
Christ##3##1##(1993-12#1)(2008-12#1)(2008-9#1)
Christchurch##4##1##(1990-2#1)(2012-2#3)
Christian health care##2##3##(1991-2#1)(1993-12#1)
Christian##13##1##(1991-2#1)(1992-12#1)(1993-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-7#1)
Christianity##4##1##(1991-11#1)(2008-12#3)
Christians##3##1##(1991-2#1)(2008-10#1)(2008-12#1)
Christina##2##1##(2008-10#1)(2010-8#1)
Christine##3##1##(1994-12#1)(1996-5#1)(2012-3#1)
Christmas tree##2##2##(2008-10#1)(2011-2#1)
Christmas##5##1##(1990-5#1)(2008-10#3)(2011-2#1)
Christopher##2##1##(1996-5#1)(2010-6#1)
ChromID ESBL agar plates##3##4##(2010-6#3)
ChromID ESBL agar##5##3##(2010-6#5)
Chromaffin##2##1##(1990-11#1)(1996-5#1)
Chromatic##5##1##(2008-3#4)(2011-2#1)
Chromatid segregation##2##2##(2008-11#2)
Chromatid##4##1##(2008-11#2)(2008-4#1)(2012-2#1)
Chromatin Immunoprecipitation##2##2##(2008-2#1)(2008-7#1)
Chromatin immunoprecipitation##3##2##(2008-2#2)(2009-8#1)
Chromatin modifications##2##2##(2010-2#2)
Chromatin##14##1##(2007-12#1)(2008-2#4)(2008-4#2)(2008-7#2)(2009-8#1)(2010-2#2)(2012-12#1)(2012-2#1)
Chromatium vinosum##2##2##(1993-8#2)
Chromatium##3##1##(1993-8#3)
Chromatogr##9##1##(1990-8#1)(1991-5#1)(2008-10#7)
Chromatographic analysis of##2##3##(2008-11#1)(2008-4#1)
Chromatographic analysis##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
Chromatographic and##2##2##(2008-10#2)
Chromatographic behaviour##2##2##(1995-6#1)(1996-5#1)
Chromatographic conditions##2##2##(1990-8#1)(2012-1#1)
Chromatographic data##2##2##(1996-5#1)(2008-10#1)
Chromatographic separation was performed##2##4##(2011-3#1)(2013-1#1)
Chromatographic separation was##3##3##(2008-10#1)(2011-3#1)(2013-1#1)
Chromatographic separation##4##2##(2008-10#1)(2011-3#1)(2012-12#1)(2013-1#1)
Chromatographic##24##1##(1990-8#1)(1992-3#1)(1995-6#1)(1996-5#2)(2008-10#10)(2008-11#3)(2008-4#1)(2009-8#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
Chromatography and##2##2##(1996-5#1)(2010-11#1)
Chromatography##17##1##(1990-5#1)(1995-5#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-8#3)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)
Chromatography-Mass Spectrometry##2##2##(2008-12#1)(2008-5#1)
Chromazurol S##2##2##(2008-10#2)
Chrome Azurol S##2##3##(2008-10#1)(2013-1#1)
Chromic catgut suture should be abandoned for fascial closure of the anterior abdominal wall in favor of newer##2##18##(1991-1#2)
Chromic##3##1##(1991-1#2)(2010-2#1)
Chromium speciation using##2##3##(2008-10#2)
Chromium speciation##5##2##(2008-10#5)
Chromium##16##1##(1994-11#1)(1996-12#2)(2008-10#12)(2013-1#1)
Chromium(III)##4##1##(2008-10#4)
Chromium-doped##2##1##(2008-2#1)(2008-3#1)
Chromogenic##3##1##(1996-5#1)(2008-4#1)(2012-3#1)
Chromogranin##2##1##(1992-12#1)(1993-8#1)
Chromolith##3##1##(2008-10#2)(2013-1#1)
Chromolithtrade mark##2##2##(2008-10#2)
Chromophore##3##1##(1994-5#1)(2008-10#1)(2008-2#1)
Chromosomal integration of the##2##4##(1990-5#1)(1997-2#1)
Chromosomal localization##2##2##(1995-6#1)(1997-4#1)
Chromosomal location and##2##3##(2008-10#1)(2010-8#1)
Chromosomal translocations in##2##3##(1994-8#1)(1996-2#1)
Chromosomal##20##1##(1990-5#1)(1991-12#1)(1991-4#1)(1991-9#2)(1994-8#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#5)(2009-7#1)(2010-3#1)(2010-8#1)(2012-3#1)
Chromosome analysis##3##2##(1997-3#1)(2009-12#1)(2010-3#1)
Chromosome evolution##2##2##(2010-3#2)
Chromosome pairing and chiasma formation##2##5##(2008-5#2)
Chromosome sizes of##2##3##(2008-10#2)
Chromosome study of##2##3##(2008-12#2)
Chromosome##36##1##(1991-9#1)(1992-8#2)(1997-3#1)(2008-10#9)(2008-11#1)(2008-12#5)(2008-4#2)(2008-5#2)(2009-12#2)(2010-2#1)(2010-3#6)(2011-1#1)(2012-2#1)(2012-3#2)
Chromosomes of##2##2##(2008-12#1)(2010-3#1)
Chromosomes##4##1##(1994-8#1)(1997-2#1)(2008-12#1)(2010-3#1)
Chromosorb 105 and##2##3##(2008-10#2)
Chromosorb 105##4##2##(2008-10#4)
Chromosorb##5##1##(2008-10#4)(2008-7#1)
Chromosorb-107 filled in a syringe##2##5##(2008-10#2)
Chromosorb-107##3##1##(2008-10#3)
Chromotropic##2##1##(2008-10#2)
Chronic Disease##2##2##(2011-1#1)(2013-8#1)
Chronic Diseases##2##2##(2010-8#1)(2013-8#1)
Chronic Kidney Disease##2##3##(2008-1#1)(2013-1#1)
Chronic Renal Failure and##2##4##(2008-1#2)
Chronic Renal Failure##6##3##(2007-7#1)(2008-1#3)(2008-12#1)(2011-1#1)
Chronic Renal##7##2##(2007-7#1)(2008-1#4)(2008-12#1)(2011-1#1)
Chronic arterial##2##2##(1997-3#1)(2009-5#1)
Chronic benign pain##2##3##(2008-4#2)
Chronic cerebrospinal venous insufficiency (CCSVI) is a##2##7##(2012-3#2)
Chronic cerebrospinal venous insufficiency##3##4##(2012-3#3)
Chronic cocaine##2##2##(1991-1#1)(1996-12#1)
Chronic exposure to Al is##2##5##(2013-8#2)
Chronic exposure to##5##3##(1991-4#1)(1995-8#1)(2010-5#1)(2013-8#2)
Chronic exposure##6##2##(1991-4#1)(1995-8#1)(2010-5#1)(2013-1#1)(2013-8#2)
Chronic fatigue syndrome##2##3##(1993-7#1)(2010-1#1)
Chronic hepatitis B virus (HBV) infection##2##6##(2009-8#1)(2013-8#1)
Chronic hepatitis B##4##3##(2007-12#1)(2009-8#2)(2013-8#1)
Chronic hepatitis C##2##3##(1992-12#1)(2013-8#1)
Chronic hepatitis##6##2##(1992-12#1)(2007-12#1)(2009-8#2)(2013-8#2)
Chronic hyperglycemia##2##2##(2008-1#1)(2011-2#1)
Chronic inflammatory##3##2##(1997-1#1)(2011-2#1)(2013-1#1)
Chronic intravenous drug self-administration in##2##5##(2008-4#2)
Chronic kidney disease##2##3##(2009-12#1)(2012-2#1)
Chronic myelogenous leukemia##2##3##(2010-4#2)
Chronic myeloid leukemia (CML) is##3##5##(2007-11#1)(2011-2#1)(2012-12#1)
Chronic obstructive pulmonary disease (COPD) is##2##6##(2011-2#1)(2013-1#1)
Chronic obstructive pulmonary disease##4##4##(1992-1#1)(2011-2#2)(2013-1#1)
Chronic pain and parent-child relations in later life##2##8##(2013-1#2)
Chronic pain and##3##3##(2008-12#1)(2013-1#2)
Chronic pain is a debilitating and pervasive health problem##2##9##(2013-1#2)
Chronic pain is a##3##4##(2010-12#1)(2013-1#2)
Chronic pain##8##2##(2008-12#1)(2008-4#1)(2010-12#2)(2013-1#4)
Chronic pancreatitis##2##2##(1994-3#1)(2009-7#1)
Chronic reductions in cerebral blood flow (CBF) of between 25 and 50%##2##12##(2008-7#2)
Chronic renal failure##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
Chronic rhinitis##2##2##(1996-3#1)(2011-1#1)
Chronic rhinosinusitis##3##2##(2013-1#1)(2013-8#2)
Chronic schizophrenic##2##2##(1996-7#1)(2008-6#1)
Chronic subcutaneous infusion of##2##4##(2011-2#2)
Chronic suppurative otitis media following##2##5##(2008-9#2)
Chronic thromboembolic pulmonary hypertension (CTEPH) is##2##6##(2010-6#2)
Chronic thromboembolic pulmonary hypertension (CTEPH)##3##5##(2010-6#3)
Chronic thromboembolic pulmonary hypertension##4##4##(2010-10#1)(2010-6#3)
Chronic thromboembolic pulmonary##5##3##(2010-10#1)(2010-6#4)
Chronic tracheobronchial syndrome##2##3##(1992-5#2)
Chronic treatment with##3##3##(1994-6#1)(1997-2#1)(2010-6#1)
Chronic treatment##4##2##(1994-6#1)(1997-1#1)(1997-2#1)(2010-6#1)
Chronic venous insufficiency##2##3##(2011-3#1)(2013-1#1)
Chronic##182##1##(1990-3#1)(1991-1#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#11)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#8)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#13)
Chronoamperometric##3##1##(2008-10#2)(2009-9#1)
Chronobiology##3##1##(2008-11#1)(2008-5#1)(2008-8#1)
Chronopharmacology##2##1##(2008-8#2)
Chryseobacterium##2##1##(2008-10#2)
Chrysomelidae##2##1##(2008-5#2)
Chrysomelidae)##2##1##(2011-2#2)
Chrysoperla##3##1##(2008-6#2)(2008-7#1)
Chthamalus##3##1##(2008-9#1)(2013-7#2)
Chubu 32 and##2##3##(2008-10#2)
Chubu 32##5##2##(2008-10#5)
Church##4##1##(1990-6#1)(1990-8#1)(1992-2#1)(2012-12#1)
Churches##3##1##(1996-3#1)(2012-3#2)
Churchill Livingstone##2##2##(2007-2#1)(2008-11#1)
Churg-Strauss syndrome (CSS)##2##3##(2008-3#1)(2010-6#1)
Churg-Strauss syndrome##4##2##(2008-3#2)(2010-6#1)(2012-3#1)
Chuuk##3##1##(2008-1#1)(2013-8#2)
Chx##3##1##(1994-12#3)
Chylothorax##3##1##(2007-8#2)(2010-8#1)
Chyluria is##2##2##(2008-10#1)(2008-4#1)
Chyluria##5##1##(2008-1#1)(2008-10#1)(2008-4#3)
Chymotryptic##2##1##(1990-11#1)(1993-8#1)
Cibacron Blue F3G-A##2##3##(1997-2#2)
Cibacron Blue##5##2##(1990-12#2)(1997-2#2)(2008-10#1)
Cibacron##7##1##(1990-12#2)(1997-2#2)(2008-10#1)(2008-4#2)
Cicadellidae)##2##1##(2007-12#1)(2011-2#1)
Cichlidae)##4##1##(2008-5#1)(2008-7#1)(2013-7#2)
Ciclesonide##2##1##(2008-8#2)
Cigarette smoking was##2##3##(1992-10#1)(1997-2#1)
Cigarette smoking##6##2##(1991-12#1)(1992-10#1)(1997-2#1)(2008-12#1)(2013-1#2)
Cigarette##8##1##(1991-12#1)(1991-9#1)(1992-10#1)(1997-2#1)(2008-12#1)(2013-1#2)(2013-8#1)
Ciliary neurotrophic factor##2##3##(1990-5#1)(1991-6#1)
Ciliary##3##1##(1990-5#1)(1991-6#1)(2013-1#1)
Ciliates##2##1##(2008-12#1)(2012-3#1)
Cimento##2##1##(2007-12#1)(2010-1#1)
Cincinnati health care##2##3##(1994-12#2)
Cincinnati initiative##2##2##(1994-12#2)
Cincinnati##15##1##(1993-1#1)(1993-12#1)(1994-12#5)(1995-3#1)(2008-5#3)(2011-2#2)(2012-3#1)(2013-1#1)
Cine computed##2##2##(2013-1#2)
Cine##4##1##(2013-1#4)
Cinnulin PF(R)##4##2##(2008-5#4)
Ciprofloxacin##6##1##(2007-7#1)(2008-8#2)(2009-10#1)(2009-6#1)(2011-2#1)
Circadian rhythms##2##2##(2008-5#1)(2008-8#1)
Circadian##8##1##(1992-11#1)(1994-5#1)(2008-11#1)(2008-5#4)(2008-8#1)
Circles##2##1##(1991-8#1)(2008-2#1)
Circuit Court of Appeals##2##4##(1997-5#2)
Circuit Court##3##2##(1997-5#3)
Circuit issued##2##2##(1996-12#1)(1997-6#1)
Circuit##12##1##(1995-1#1)(1995-6#2)(1996-12#3)(1997-5#4)(1997-6#1)(2008-3#1)
Circuits##2##1##(1995-6#1)(2008-3#1)
Circular dichroism (CD)##4##3##(1992-6#1)(1994-5#1)(1997-4#1)(2008-4#1)
Circular dichroism showed that##2##4##(2012-2#2)
Circular dichroism##9##2##(1990-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-4#1)(2012-2#2)
Circular motion##2##2##(2008-6#2)
Circular##15##1##(1990-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2012-2#2)
Circulating AFP mRNA##3##3##(2008-10#3)
Circulating##25##1##(1992-12#1)(1992-8#1)(1993-2#2)(1996-3#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-3#3)
Circulation##6##1##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
Circulifer haematoceps##2##2##(2008-10#2)
Circulifer tenellus##4##2##(2008-10#4)
Circulifer##6##1##(2008-10#6)
Circumcision##4##1##(1993-2#1)(2008-11#3)
Circumference##2##1##(2008-12#1)(2012-2#1)
Cirrhosis and##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
Cirrhosis in##3##2##(2010-8#1)(2013-1#2)
Cirrhosis##10##1##(2006-10#1)(2008-9#2)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#1)
Cirrus##2##1##(2008-3#2)
Cirsium arvense##2##2##(2008-10#2)
Cisplatin was administered##2##3##(1990-2#1)(1991-2#1)
Cisplatin was##3##2##(1990-2#1)(1991-2#1)(2010-3#1)
Cisplatin##18##1##(1990-2#1)(1991-2#3)(1993-9#1)(2008-10#7)(2008-2#3)(2008-6#1)(2010-3#1)(2010-8#1)
Cisplatin-liposome##3##1##(2008-10#3)
Cistanche species and##3##3##(2011-2#3)
Cistanche species##6##2##(2011-2#6)
Cistanche##10##1##(2011-2#10)
Cit7##4##1##(2008-10#4)
Citation##6##1##(1991-3#1)(1992-3#1)(1996-2#1)(2010-12#2)(2013-1#1)
Citations##2##1##(2007-2#1)(2010-12#1)
Citicoline##2##1##(2007-10#1)(2009-6#1)
Cities##6##1##(1991-9#1)(1992-6#1)(1995-1#1)(1997-1#1)(2008-8#1)(2011-2#1)
Citing##3##1##(1992-1#1)(1993-2#1)(2008-10#1)
Citizen##3##1##(1997-2#1)(2010-3#1)(2012-3#1)
Citizens##3##1##(1996-3#1)(1997-4#1)(2008-1#1)
Citizens'##3##1##(1992-3#1)(2008-1#1)(2012-12#1)
Citrate##3##1##(1997-2#1)(2008-10#1)(2008-7#1)
Citric acid##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
Citrobacter freundii##5##2##(1993-11#1)(1994-9#2)(2010-6#1)(2011-2#1)
Citrobacter rodentium##2##2##(2011-1#2)
Citrobacter sp##3##2##(2008-7#2)(2010-4#1)
Citrobacter##12##1##(1993-11#1)(1994-9#2)(2008-7#4)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)
Citrus Black##2##2##(2008-10#2)
Citrus Brown##2##2##(2008-10#2)
Citrus Fruit##3##2##(2008-10#3)
Citrus aurantium var##2##3##(2008-10#2)
Citrus aurantium##3##2##(2008-10#2)(2008-5#1)
Citrus bacterial##2##2##(2008-10#2)
Citrus bent leaf viroid (CBLVd)##2##5##(2008-10#2)
Citrus exocortis viroid (CEVd)##3##4##(2008-10#3)
Citrus exocortis viroid##4##3##(2008-10#4)
Citrus tristeza virus (CTV)##7##4##(2008-10#7)
Citrus tristeza virus##11##3##(2008-10#11)
Citrus viroid III##2##3##(2008-10#2)
Citrus viroid IV##2##3##(2008-10#2)
Citrus viroid##6##2##(2008-10#6)
Citrus##65##1##(2008-10#60)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#2)
City Council##2##2##(1996-1#1)(2012-12#1)
City University##3##2##(1991-12#1)(2008-11#2)
City and##3##2##(2007-4#1)(2008-12#1)(2013-8#1)
City from 2005 to##2##4##(2012-3#2)
City from##8##2##(2012-3#8)
City of Hope##5##3##(2011-2#5)
City of##8##2##(1991-12#1)(2011-2#6)(2013-1#1)
City##119##1##(1990-11#2)(1990-12#1)(1991-1#3)(1991-12#5)(1992-3#1)(1993-5#1)(1994-2#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#1)(1996-3#6)(1996-5#1)(1997-1#1)(2006-8#1)(2007-10#4)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#5)(2009-7#2)(2011-1#3)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#18)(2013-1#4)(2013-8#6)
City]##4##1##(2009-7#1)(2012-3#3)
Ciudad##2##1##(2008-11#1)(2011-1#1)
Civil War##4##2##(2008-10#1)(2008-8#1)(2009-7#2)
Civil##10##1##(1993-3#1)(1994-1#1)(1994-9#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#2)
Civilian##3##1##(1992-12#1)(1994-12#1)(1996-12#1)
Ciwujia injection was##2##3##(2011-2#2)
Ciwujia injection##6##2##(2011-2#6)
Ciwujia##7##1##(2011-2#7)
Cixius wagneri##2##2##(2008-10#2)
Cl and Na##2##3##(2008-9#2)
Cl and##8##2##(1997-7#1)(2008-10#4)(2008-3#1)(2008-9#2)
Cl channel blocker##2##3##(2008-1#2)
Cl channel##3##2##(2008-1#3)
Cl ion##2##2##(2008-8#1)(2012-12#1)
Cl##45##1##(1991-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1996-9#1)(1997-7#4)(2008-1#4)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-5#2)(2011-1#5)(2012-12#1)(2013-1#1)
Cl(-) and##3##2##(2008-10#2)(2012-7#1)
Cl(-) in##2##2##(2008-10#2)
Cl(-)##29##1##(2008-10#25)(2008-5#1)(2009-8#1)(2011-1#1)(2012-7#1)
Cl(-))##3##1##(2008-10#2)(2008-9#1)
Cl(-)-channel##3##1##(1993-3#2)(1995-11#1)
Cl(2)##4##1##(2008-10#3)(2008-2#1)
Cl(2))##2##1##(2008-10#2)
Cl)##2##1##(2008-10#2)
Cl- and##2##2##(1990-8#2)
Cl- channel activity##2##3##(1990-2#2)
Cl- channel##4##2##(1990-2#3)(1995-12#1)
Cl- channels##3##2##(1990-2#2)(1995-2#1)
Cl- currents##2##2##(1995-12#1)(1995-5#1)
Cl-##26##1##(1990-2#8)(1990-8#4)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#2)(1997-2#1)(2008-10#1)(2008-8#2)
Cl-] cotransport system##4##3##(1991-8#4)
Cl-] cotransport##5##2##(1991-8#5)
ClO(-)/L##3##1##(2008-10#3)
ClO(3)(-) was##2##2##(2008-10#2)
ClO(3)(-)##7##1##(2008-10#7)
ClO(3)(-)-ClO(2)(-) and ClO(3)(-)-HClO##2##3##(2008-10#2)
ClO(3)(-)-ClO(2)(-)##3##1##(2008-10#3)
ClO(3)(-)-HClO##3##1##(2008-10#3)
ClO(4)(-)##2##1##(2008-10#2)
ClO4-##3##1##(1995-5#2)(2008-10#1)
ClYVV##4##1##(2008-10#4)
Clade##4##1##(2008-10#4)
Clades##3##1##(2008-10#1)(2008-8#1)(2010-3#1)
Cladosiphon novae-caledoniae kylin##3##3##(2008-11#3)
Cladosporium carpophilum##2##2##(2008-10#2)
Cladosporium caryigenum##2##2##(2008-10#2)
Cladosporium spp##4##2##(2008-10#1)(2010-4#1)(2013-1#2)
Cladosporium tenuissimum##5##2##(2008-10#5)
Cladosporium##21##1##(2008-10#11)(2008-12#1)(2008-5#3)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#2)
Claim##2##1##(1995-12#1)(2007-3#1)
Claims##4##1##(1994-12#1)(1997-1#1)(2008-11#1)(2008-7#1)
Claisen rearrangement of##2##3##(1996-5#2)
Claisen##4##1##(1996-5#3)(2008-11#1)
Clam##2##1##(2008-10#1)(2008-5#1)
Clara cell##2##2##(1993-12#1)(2013-1#1)
Clara cells##6##2##(1990-6#2)(1990-7#2)(2013-1#2)
Clara##11##1##(1990-6#2)(1990-7#2)(1993-12#1)(1995-12#1)(2008-5#1)(2010-8#1)(2013-1#3)
Clare Vaughan##3##2##(1996-8#3)
Clarias batrachus##2##2##(2008-5#2)
Clarias##3##1##(1992-8#1)(2008-5#2)
Clarification##5##1##(2008-10#1)(2012-2#3)(2012-3#1)
Clarifying the##2##2##(2007-12#1)(2008-9#1)
Clarifying##4##1##(1994-1#1)(2007-12#1)(2008-5#1)(2008-9#1)
Clarion CII##5##2##(2008-9#5)
Clarion##9##1##(2008-9#9)
Clarity of##2##2##(1993-12#1)(2012-3#1)
Clark I##2##2##(2008-11#2)
Clark##13##1##(1991-7#1)(1992-1#1)(1994-3#1)(2008-10#5)(2008-11#2)(2008-8#1)(2011-6#1)(2013-1#1)
Class 1 cells##2##3##(2007-12#2)
Class I##10##2##(1995-12#1)(1995-8#1)(2008-11#2)(2008-7#1)(2011-2#2)(2013-1#3)
Class II malocclusion##2##3##(2013-1#2)
Class II##10##2##(1991-2#1)(1995-8#1)(2008-11#3)(2008-8#1)(2013-1#4)
Class III malocclusion with##2##4##(2011-2#1)(2013-1#1)
Class III malocclusion##3##3##(2009-7#1)(2011-2#1)(2013-1#1)
Class III##9##2##(1995-8#1)(2009-7#3)(2011-2#3)(2013-1#2)
Class of##3##2##(1996-5#1)(2012-12#1)(2012-3#1)
Class##56##1##(1990-2#4)(1991-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-3#1)(1996-5#1)(2007-12#3)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#4)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#9)
Classes III and IV##2##4##(2008-1#1)(2008-10#1)
Classes##4##1##(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)
Classic##4##1##(1996-3#1)(2007-8#1)(2008-10#1)(2008-5#1)
Classical##18##1##(1992-12#1)(1995-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#2)
Classically##4##1##(2008-2#1)(2009-2#1)(2010-6#1)(2011-2#1)
Classification Criteria##2##2##(2011-2#1)(2012-2#1)
Classification System##2##2##(1993-12#1)(2011-2#1)
Classification and##2##2##(2008-10#1)(2010-10#1)
Classification of Diseases##5##3##(1990-12#1)(1991-9#1)(2008-12#1)(2008-3#1)(2012-12#1)
Classification of Functioning##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
Classification of Primary##3##3##(1991-9#2)(1994-6#1)
Classification of##24##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#3)(1992-11#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#2)
Classification##53##1##(1990-12#1)(1991-12#3)(1991-3#1)(1991-9#3)(1992-11#1)(1993-12#1)(1994-6#1)(1996-7#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-3#1)(2009-10#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#1)
Classifying##2##1##(1997-3#1)(2010-8#1)
Classroom##6##1##(2008-12#3)(2010-8#1)(2011-1#1)(2011-2#1)
Clause##2##1##(1993-9#1)(1995-6#1)
Clausthal-Zellerfeld##2##1##(2008-11#2)
Clavibacter michiganensis subsp##10##3##(2008-10#10)
Clavibacter michiganensis##12##2##(2008-10#12)
Clavibacter##13##1##(2008-10#13)
Claviceps africana##3##2##(2008-10#3)
Claviceps purpurea##4##2##(2008-10#4)
Claviceps spp##2##2##(2008-10#2)
Claviceps##10##1##(2008-10#10)
Claviradulomyces##3##1##(2010-10#3)
Clay##4##1##(1991-1#1)(1996-9#1)(2008-3#1)(2012-12#1)
Clayton##6##1##(2008-10#6)
Cld##2##1##(2009-2#2)
Clean Fe(111)##2##2##(2008-10#2)
Clean##7##1##(1997-3#1)(2008-10#3)(2008-5#1)(2012-12#2)
Clear cell chondrosarcoma##2##3##(2008-6#2)
Clear cell##3##2##(2008-6#2)(2013-1#1)
Clear differences were##2##3##(2008-10#1)(2008-5#1)
Clear evidence##2##2##(1991-2#1)(2007-12#1)
Clear##10##1##(1991-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-4#1)(2013-1#1)
Clearance##3##1##(1992-11#1)(2008-5#1)(2011-1#1)
Clearing##4##1##(1993-3#1)(2008-3#1)(2011-2#2)
Clearinghouse is##2##2##(1994-1#1)(1996-3#1)
Clearinghouse##17##1##(1994-1#5)(1995-12#1)(1996-3#8)(2012-12#3)
Clearly##21##1##(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#1)(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
Cleavable##2##1##(1995-5#1)(2008-10#1)
Cleavage of a##2##3##(1996-2#1)(1997-7#1)
Cleavage of the##4##3##(1993-2#1)(1994-8#1)(2008-10#1)(2008-4#1)
Cleavage of##13##2##(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
Cleavage##17##1##(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-7#2)(2008-10#1)(2008-4#2)(2008-8#1)
Clebsch-Zernike modes##2##2##(2008-3#2)
Clebsch-Zernike##3##1##(2008-3#3)
Cleft Lip and Palate##2##4##(2013-1#2)
Cleft Lip##3##2##(2013-1#3)
Cleft##11##1##(2008-12#1)(2009-6#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
Clefts##2##1##(2009-10#1)(2010-3#1)
Cleidocranial dysplasia (CCD) is##2##4##(2011-1#1)(2013-1#1)
Cleidocranial dysplasia##3##2##(2011-1#2)(2013-1#1)
Cleistogamous cultivars##2##2##(2008-10#2)
Clemens##5##1##(1994-2#1)(1996-3#1)(2010-5#2)(2011-2#1)
Clenbuterol treatment in##2##3##(2010-6#2)
Clenbuterol treatment##3##2##(2010-6#3)
Clenbuterol##7##1##(2008-10#1)(2010-6#6)
Cleome arabica##2##2##(2013-8#2)
Cleome##3##1##(2010-2#1)(2013-8#2)
Cleveland Clinic##7##2##(1994-3#1)(1995-12#1)(1995-3#1)(2008-7#1)(2011-2#3)
Cleveland Health Quality Choice##2##4##(1995-2#1)(1996-1#1)
Cleveland##11##1##(1992-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-7#1)(2011-2#3)
Client##3##1##(2007-10#1)(2009-10#1)(2009-9#1)
Client-centered##2##1##(2007-10#1)(2008-11#1)
Climate Change##2##2##(2008-11#1)(2011-2#1)
Climate change will##2##3##(2008-11#1)(2012-5#1)
Climate change##6##2##(2008-11#2)(2008-9#1)(2011-2#1)(2012-5#1)(2012-7#1)
Climate##12##1##(2008-10#1)(2008-11#3)(2008-9#1)(2011-2#3)(2012-12#1)(2012-5#1)(2012-7#2)
Climatic##2##1##(2008-10#1)(2011-2#1)
Clin Ter 2012##27##3##(2013-1#27)
Clin Trans Sci 2012##2##4##(2012-3#2)
Clin##46##1##(1991-12#1)(1992-6#1)(2010-8#5)(2011-2#8)(2012-2#1)(2012-3#3)(2013-1#27)
Clinic and##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
Clinic are##2##2##(1994-12#1)(2011-2#1)
Clinic as##2##2##(1993-12#1)(1997-2#1)
Clinic at the##2##3##(2007-11#2)
Clinic at##3##2##(2007-11#2)(2008-9#1)
Clinic for##5##2##(1994-12#2)(1995-5#1)(2007-11#1)(2011-2#1)
Clinic from##3##2##(1997-2#1)(2007-8#1)(2009-5#1)
Clinic in Warsaw##2##3##(2007-11#1)(2007-8#1)
Clinic in##9##2##(1991-3#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2009-10#1)(2011-1#1)
Clinic of Child##2##3##(2008-9#2)
Clinic of Children##2##3##(2008-9#2)
Clinic of Pediatrics##2##3##(2008-9#2)
Clinic of the##7##3##(2007-8#3)(2008-7#1)(2011-1#1)(2011-3#1)(2012-2#1)
Clinic of##27##2##(1996-11#1)(2007-11#4)(2007-8#4)(2008-11#1)(2008-7#1)(2008-9#8)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
Clinic##100##1##(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1993-12#7)(1993-2#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(2007-11#11)(2007-2#1)(2007-5#2)(2007-8#7)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#14)(2009-10#1)(2009-11#1)(2009-5#1)(2011-1#3)(2011-2#7)(2011-3#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
Clinica Chirurgica##2##2##(1992-9#1)(1993-5#1)
Clinical Applications##2##2##(2010-8#1)(2011-2#1)
Clinical Assessment-Geriatric##2##2##(1994-6#2)
Clinical Biochemistry##2##2##(1994-12#2)
Clinical Biochemists##2##2##(1994-12#2)
Clinical Centre##2##2##(2011-1#2)
Clinical Chemistry##6##2##(1994-12#5)(2008-10#1)
Clinical Data##4##2##(1993-2#3)(2012-2#1)
Clinical Evaluation##3##2##(1997-2#2)(2008-11#1)
Clinical Evidence##5##2##(2008-8#4)(2010-10#1)
Clinical Features##2##2##(2008-3#1)(2012-3#1)
Clinical Global##2##2##(2008-6#2)
Clinical Hospital##4##2##(2008-9#1)(2011-2#2)(2013-1#1)
Clinical Laboratory##5##2##(1994-12#1)(1994-2#1)(1994-3#1)(2008-5#1)(2010-8#1)
Clinical Oncology Group##2##3##(1994-8#1)(2010-12#1)
Clinical Oncology##11##2##(1991-6#1)(1992-12#1)(1994-8#1)(2008-5#1)(2008-7#3)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Clinical Outcome##2##2##(1992-12#1)(1995-11#1)
Clinical Outcomes##3##2##(2008-2#1)(2012-1#1)(2013-8#1)
Clinical Practice and##2##3##(1997-4#1)(2008-11#1)
Clinical Practice##6##2##(1997-2#1)(1997-4#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
Clinical Research##2##2##(1997-7#1)(2009-4#1)
Clinical School of Nursing##2##4##(2007-10#2)
Clinical Significance of##3##3##(2007-7#1)(2010-8#2)
Clinical Significance##6##2##(2007-7#1)(2008-10#1)(2010-8#3)(2012-12#1)
Clinical Trial##5##2##(1992-8#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
Clinical Trials##8##2##(2009-10#1)(2009-6#1)(2009-9#2)(2010-11#1)(2011-2#2)(2013-8#1)
Clinical Unit structure##2##3##(1992-12#2)
Clinical Unit##3##2##(1992-12#3)
Clinical Use##2##2##(2011-1#1)(2011-2#1)
Clinical Ward##2##2##(2012-12#2)
Clinical and Laboratory Standards Institute##2##5##(2013-1#1)(2013-8#1)
Clinical and experimental studies have##2##5##(2009-7#1)(2010-12#1)
Clinical and laboratory features##2##4##(2011-2#1)(2013-1#1)
Clinical and pathological features##2##4##(2010-6#1)(2013-1#1)
Clinical and pathological##4##3##(1992-5#1)(2010-6#1)(2013-1#2)
Clinical and radiologic##2##3##(2010-9#1)(2012-3#1)
Clinical and radiological##5##3##(1990-12#1)(2007-11#2)(2007-7#1)(2012-12#1)
Clinical and##50##2##(1990-12#2)(1990-9#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1995-4#1)(1995-9#1)(1996-12#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
Clinical applications for##2##3##(1993-2#1)(2010-8#1)
Clinical applications of##6##3##(1991-2#1)(2008-10#1)(2009-9#1)(2010-8#2)(2011-7#1)
Clinical applications##9##2##(1991-2#2)(1993-2#1)(2008-10#1)(2009-9#1)(2010-8#3)(2011-7#1)
Clinical approach##2##2##(1992-3#1)(1996-3#1)
Clinical aspects and##3##3##(1991-4#1)(1993-3#1)(1996-3#1)
Clinical aspects##4##2##(1991-4#1)(1993-3#1)(1996-3#1)(1997-5#1)
Clinical aspects]##2##2##(1990-5#1)(1990-6#1)
Clinical assessments##2##2##(1997-8#1)(2008-5#1)
Clinical biochemistry##5##2##(1994-12#5)
Clinical case##3##2##(1992-2#1)(2007-2#1)(2011-2#1)
Clinical case]##2##2##(1990-3#1)(1990-9#1)
Clinical characteristics of patients##2##4##(2007-10#1)(2012-12#1)
Clinical characteristics of##5##3##(1990-3#1)(2007-10#1)(2009-5#1)(2012-12#1)(2013-8#1)
Clinical characteristics##6##2##(1990-3#1)(2006-5#1)(2007-10#1)(2009-5#1)(2012-12#1)(2013-8#1)
Clinical chemistry##4##2##(1994-12#3)(2008-10#1)
Clinical commentary##4##2##(2008-11#3)(2009-5#1)
Clinical data were##3##3##(1996-11#1)(2008-3#1)(2013-1#1)
Clinical data##6##2##(1996-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
Clinical diagnosis##3##2##(1991-2#1)(1993-2#1)(2012-12#1)
Clinical effectiveness##3##2##(1993-2#1)(2007-11#1)(2012-8#1)
Clinical effects of##4##3##(2007-11#1)(2009-7#1)(2012-3#1)(2013-1#1)
Clinical efficacy and##2##3##(1990-3#1)(2008-8#1)
Clinical efficacy of a##2##4##(2011-2#1)(2013-7#1)
Clinical efficacy of##4##3##(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
Clinical efficacy##6##2##(1990-3#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
Clinical evaluation and##2##3##(2008-10#1)(2008-5#1)
Clinical evaluation of##8##3##(1991-5#1)(1993-6#1)(1996-1#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-12#1)
Clinical evaluation was performed##2##4##(1990-12#1)(2009-3#1)
Clinical evaluation##14##2##(1990-12#1)(1991-5#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-12#1)
Clinical examination and##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
Clinical examination demostrated positive labrum pathology in all cases##2##9##(2007-11#2)
Clinical examination revealed##4##3##(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
Clinical examination##11##2##(1994-9#1)(2007-11#3)(2007-12#1)(2008-7#2)(2008-9#1)(2010-7#1)(2013-1#2)
Clinical examinations and##2##3##(2008-5#1)(2012-12#1)
Clinical experience of a carbohydrate-restricted diet##2##6##(2008-3#2)
Clinical experience with##5##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
Clinical experience##10##2##(1992-8#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)
Clinical features and##2##3##(2008-7#1)(2009-3#1)
Clinical features of##5##3##(1991-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
Clinical features##14##2##(1991-1#1)(2008-1#1)(2008-11#1)(2008-7#4)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
Clinical findings##2##2##(1991-8#1)(2011-3#1)
Clinical guidelines##4##2##(2008-3#2)(2012-3#1)(2013-1#1)
Clinical implications of##2##3##(2008-3#1)(2010-4#1)
Clinical implications##5##2##(1993-11#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-4#1)
Clinical knowledge##2##2##(1990-2#1)(2013-8#1)
Clinical management of##3##3##(2008-11#1)(2008-2#1)(2013-7#1)
Clinical management##4##2##(2008-11#1)(2008-2#1)(2011-2#1)(2013-7#1)
Clinical manifestations are##2##3##(2009-7#1)(2013-1#1)
Clinical manifestations include##2##3##(2008-7#1)(2013-1#1)
Clinical manifestations of##3##3##(1990-9#1)(2009-7#1)(2010-1#1)
Clinical manifestations usually##2##3##(2007-5#1)(2010-1#1)
Clinical manifestations were##2##3##(2008-5#1)(2011-2#1)
Clinical manifestations##12##2##(1990-9#1)(1997-3#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-1#2)(2011-2#1)(2013-1#2)
Clinical observations##2##2##(1991-2#1)(2011-2#1)
Clinical onset is##2##3##(1996-9#1)(2008-4#1)
Clinical outcome of##3##3##(2008-1#1)(2008-7#2)
Clinical outcome##8##2##(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-12#1)
Clinical outcomes of##2##3##(2008-8#1)(2011-2#1)
Clinical outcomes##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
Clinical practice and##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
Clinical practice guidelines##4##3##(1997-2#1)(2008-7#1)(2009-6#1)(2009-7#1)
Clinical practice##9##2##(1997-2#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#2)(2012-12#1)
Clinical presentation##5##2##(2007-8#1)(2010-8#1)(2012-12#1)(2012-3#2)
Clinical problem-solving##3##2##(1992-5#1)(1994-3#2)
Clinical profile and##2##3##(2009-10#1)(2013-1#1)
Clinical profile of patients##2##4##(2010-5#1)(2012-3#1)
Clinical profile of##4##3##(2008-1#1)(2010-5#1)(2012-3#2)
Clinical profile##6##2##(2008-1#1)(2009-10#1)(2010-5#1)(2012-3#2)(2013-1#1)
Clinical question##3##2##(2012-12#3)
Clinical questions##4##2##(2012-12#4)
Clinical records##2##2##(2012-2#1)(2013-1#1)
Clinical resolution of##2##3##(2008-5#2)
Clinical results##5##2##(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
Clinical samples were##2##3##(2008-12#1)(2013-8#1)
Clinical samples##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
Clinical significance as it relates to evidence-based practice##2##8##(2013-1#2)
Clinical significance of##3##3##(2007-11#1)(2008-4#1)(2011-1#1)
Clinical significance##6##2##(1995-8#1)(2007-11#1)(2008-4#1)(2011-1#1)(2013-1#2)
Clinical signs of##2##3##(2012-3#1)(2013-1#1)
Clinical spectrum of##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
Clinical stage##3##2##(2013-1#3)
Clinical studies have shown that##2##5##(2010-12#1)(2011-2#1)
Clinical studies have shown##3##4##(1990-2#1)(2010-12#1)(2011-2#1)
Clinical studies have##7##3##(1990-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Clinical studies indicate that adjunctive treatment with the antidepressant drug mianserin##2##11##(2008-6#2)
Clinical studies##17##2##(1990-2#1)(1993-12#1)(1997-4#2)(2008-3#1)(2008-5#3)(2008-6#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
Clinical study of##2##3##(1990-3#1)(2007-10#1)
Clinical study##3##2##(1990-3#1)(2007-10#1)(2011-2#1)
Clinical supervision##2##2##(1997-7#2)
Clinical symptoms of##2##3##(1994-6#1)(2007-8#1)
Clinical symptoms##5##2##(1990-3#1)(1994-6#1)(2007-8#1)(2008-1#1)(2011-2#1)
Clinical translation of##2##3##(2011-2#1)(2012-12#1)
Clinical trial report##2##3##(2011-2#2)
Clinical trial##5##2##(2010-11#1)(2010-12#1)(2011-2#3)
Clinical trials have demonstrated that##2##5##(2007-11#1)(2008-7#1)
Clinical trials have##6##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
Clinical trials of##2##3##(1991-3#1)(2012-12#1)
Clinical trials##16##2##(1991-3#1)(1992-9#1)(1995-9#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Clinical use of##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2011-7#1)
Clinical usefulness of##2##3##(1992-10#1)(2013-8#1)
Clinical utility of##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
Clinical utility##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-7#1)
Clinical value of##4##3##(1997-5#1)(1997-8#1)(2007-11#1)(2008-7#1)
Clinical variables##2##2##(2008-11#1)(2010-11#1)
Clinical##623##1##(1990-10#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-5#3)(1990-6#3)(1990-9#3)(1991-1#3)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#7)(1992-2#3)(1992-3#3)(1992-5#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#6)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#23)(1994-2#1)(1994-3#6)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#7)(1997-4#4)(1997-5#2)(1997-7#3)(1997-8#3)(2006-5#2)(2007-10#6)(2007-11#18)(2007-12#5)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#8)(2008-10#12)(2008-11#22)(2008-12#12)(2008-2#2)(2008-3#12)(2008-4#6)(2008-5#21)(2008-6#5)(2008-7#26)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#7)(2009-8#2)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#7)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#15)(2010-9#5)(2011-1#10)(2011-2#43)(2011-3#1)(2011-7#2)(2012-1#3)(2012-12#32)(2012-2#11)(2012-3#13)(2012-8#1)(2013-1#46)(2013-7#6)(2013-8#17)
Clinically and##2##2##(1991-9#1)(1994-7#1)
Clinically relevant##4##2##(1991-6#1)(1993-9#1)(2010-11#1)(2011-2#1)
Clinically significant##2##2##(2008-10#1)(2013-1#1)
Clinically this##2##2##(2008-7#1)(2011-2#1)
Clinically##35##1##(1990-2#1)(1990-9#1)(1991-6#1)(1991-9#2)(1993-9#1)(1994-7#1)(2007-7#2)(2008-10#3)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
Clinician##2##1##(2006-10#1)(2008-11#1)
Clinicians can##2##2##(1992-12#1)(2008-11#1)
Clinicians should also##2##3##(2007-8#1)(2008-1#1)
Clinicians should be aware of##2##5##(2007-8#1)(2012-12#1)
Clinicians should be aware##3##4##(2007-8#1)(2010-9#1)(2012-12#1)
Clinicians should be##6##3##(1992-3#1)(2007-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
Clinicians should##15##2##(1992-3#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
Clinicians##30##1##(1992-12#2)(1992-3#1)(1994-5#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
Clinicians'##4##1##(2007-11#2)(2010-4#1)(2012-3#1)
Clinico-mycological evaluation of onychomycosis at Bangalore and Jorhat##2##8##(2007-7#2)
Clinico-mycological##3##1##(2007-7#3)
Clinico-pathologic##2##1##(1992-12#1)(1993-6#1)
Clinicopathologic##4##1##(2007-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
Clinicopathological##5##1##(1994-7#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
Clinics##5##1##(1996-1#1)(1996-11#1)(2007-8#2)(2013-1#1)
Clinton Administration##2##2##(1994-12#2)
Clinton Administration's##2##2##(1994-12#1)(1995-1#1)
Clinton has proposed##2##3##(1995-2#1)(1995-6#1)
Clinton has##3##2##(1995-2#1)(1995-6#2)
Clinton in##2##2##(1996-12#1)(2008-10#1)
Clinton plan##3##2##(1994-2#2)(1995-2#1)
Clinton##40##1##(1993-3#1)(1993-5#2)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#2)(1995-12#4)(1995-2#4)(1995-6#9)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#2)(2008-10#1)
Clinton's plan##2##2##(1993-5#1)(1995-6#1)
Clinton's##10##1##(1993-12#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#1)(2008-7#3)
Clipping of##2##2##(2008-12#1)(2009-7#1)
Clipping##4##1##(2008-12#1)(2009-7#1)(2011-2#1)(2012-3#1)
Clitocybe##2##1##(2011-2#2)
Clob with##2##2##(2008-10#2)
Clobazam##2##1##(2008-10#2)
Clonal Lineages of Phytophthora infestans##2##5##(2008-10#2)
Clonal Lineages of Phytophthora##3##4##(2008-10#3)
Clonal Lineages##4##2##(2008-10#4)
Clonal lineages##2##2##(2008-10#2)
Clonal##14##1##(1992-2#1)(1994-7#1)(2007-4#1)(2008-10#8)(2008-5#1)(2009-2#1)(2009-3#1)
Clonality##4##1##(2008-10#2)(2008-5#1)(2009-8#1)
Clone Y5 was##2##3##(1992-11#2)
Clone Y5##3##2##(1992-11#3)
Clone##6##1##(1992-11#5)(2008-10#1)
Cloned##12##1##(1990-5#1)(1994-12#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)
Clones of##4##2##(2008-10#2)(2008-11#2)
Clones##12##1##(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
Clonidine##3##1##(1997-4#1)(2010-7#2)
Cloning and Characterization of a##3##5##(2008-10#2)(2008-5#1)
Cloning and analysis of##2##4##(1994-12#1)(1997-4#1)
Cloning and characterization of a cDNA encoding##2##7##(1993-12#1)(2008-8#1)
Cloning and characterization of a novel##3##6##(1993-2#1)(2008-8#1)(2008-9#1)
Cloning and characterization of a##8##5##(1992-3#1)(1993-12#1)(1993-2#2)(1997-7#1)(2008-8#2)(2008-9#1)
Cloning and characterization of the gene encoding##2##7##(1993-2#1)(1994-12#1)
Cloning and characterization of the##11##5##(1990-5#1)(1991-6#1)(1993-2#1)(1994-12#2)(1995-11#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-8#1)
Cloning and characterization of##21##4##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-12#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#2)(2008-4#1)(2008-8#3)(2008-9#1)
Cloning and expression of a##3##5##(1990-11#1)(1997-6#1)(2013-1#1)
Cloning and expression of the##4##5##(1992-10#1)(1993-11#1)(1996-12#1)(2008-11#1)
Cloning and expression of##13##4##(1990-11#1)(1992-10#1)(1993-11#1)(1994-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
Cloning and expression##14##3##(1990-11#1)(1992-10#1)(1993-11#1)(1994-12#1)(1996-12#2)(1997-3#1)(1997-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
Cloning and functional##3##3##(1993-3#1)(1993-5#1)(1994-8#1)
Cloning and sequence analysis of##3##5##(1990-12#1)(1992-12#1)(2008-6#1)
Cloning and sequence analysis##4##4##(1990-12#1)(1992-12#1)(2008-10#1)(2008-6#1)
Cloning and sequence##5##3##(1990-12#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-6#1)
Cloning and sequencing of a##4##5##(1995-12#1)(1996-8#1)(1997-7#1)(2008-9#1)
Cloning and sequencing of the gene##2##6##(1994-9#1)(1996-8#1)
Cloning and sequencing of the##4##5##(1994-9#1)(1996-12#1)(1996-8#1)(2008-10#1)
Cloning and sequencing of##10##4##(1993-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-7#1)(2008-10#1)(2008-9#1)
Cloning and sequencing##12##3##(1993-2#1)(1993-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-7#2)(2008-10#1)(2008-9#1)
Cloning and tissue##2##3##(1991-9#1)(1993-11#1)
Cloning and##71##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#1)(1993-5#2)(1993-6#1)(1994-11#2)(1994-12#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#4)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#4)(2013-1#1)
Cloning of a cDNA encoding##2##5##(1994-12#2)
Cloning of a cDNA for##2##5##(1993-11#1)(1995-6#1)
Cloning of a cDNA##5##4##(1993-11#1)(1993-8#1)(1994-12#2)(1995-6#1)
Cloning of a##12##3##(1990-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#3)(1995-6#1)(1996-5#1)(1997-6#1)(2008-7#1)(2008-8#1)
Cloning of an##2##3##(1993-6#1)(1997-4#1)
Cloning of the human##2##4##(1991-12#1)(1993-6#1)
Cloning of the rat##2##4##(1993-3#1)(1994-12#1)
Cloning of the##9##3##(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#2)(1996-12#1)(1997-2#1)
Cloning of two##2##3##(1994-12#1)(2008-7#1)
Cloning of##35##2##(1990-12#2)(1990-5#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-12#6)(1994-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)
Cloning##127##1##(1990-11#2)(1990-12#3)(1990-5#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#3)(1993-5#2)(1993-6#4)(1993-8#1)(1994-11#2)(1994-12#13)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-12#4)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#5)(1997-9#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#8)(2010-12#1)(2010-5#2)(2012-2#1)(2013-1#1)
Cloninger##3##1##(2009-9#2)(2013-7#1)
Cloninger's##3##1##(1994-2#1)(2009-9#2)
Clonostachys rosea##4##2##(2008-10#4)
Clopidogrel##5##1##(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
Clos crossbar switch##2##3##(2008-2#2)
Clos switch##2##2##(2008-2#2)
Clos##5##1##(2008-2#5)
Close collaboration between##2##3##(1993-6#1)(2008-10#1)
Close##13##1##(1992-5#1)(1993-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-8#1)
Closed reduction##4##2##(2007-8#2)(2008-12#1)(2011-2#1)
Closed##9##1##(1993-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
Closed-form expressions##2##2##(2007-12#1)(2008-2#1)
Closely Related##3##2##(2008-10#2)(2013-8#1)
Closely related##3##2##(1995-5#1)(2008-10#1)(2012-5#1)
Closely##7##1##(1995-5#1)(2007-11#1)(2008-10#3)(2012-5#1)(2013-8#1)
Closer attention to##2##3##(2011-2#1)(2013-1#1)
Closer##4##1##(2011-2#2)(2012-12#1)(2013-1#1)
Closing the##3##2##(1993-1#1)(1994-12#1)(2009-6#1)
Closing##6##1##(1990-11#1)(1993-1#1)(1993-3#1)(1994-12#1)(1996-5#1)(2009-6#1)
Closteroviridae##2##1##(2008-10#2)
Closterovirus##5##1##(2008-10#5)
Clostridial myonecrosis##2##2##(2011-2#2)
Clostridial##4##1##(2009-7#1)(2011-2#3)
Clostridium beijerinckii##2##2##(2013-1#2)
Clostridium botulinum in##2##3##(2011-2#2)
Clostridium botulinum type##3##3##(1992-3#2)(1993-2#1)
Clostridium botulinum##15##2##(1992-3#3)(1993-2#1)(1997-4#2)(2007-12#2)(2011-2#7)
Clostridium butyricum##2##2##(2013-1#2)
Clostridium difficile##12##2##(2007-12#2)(2007-7#1)(2008-11#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-1#2)
Clostridium perfringens enterotoxin##2##3##(1994-2#2)
Clostridium perfringens growth##2##3##(2011-2#2)
Clostridium perfringens type A##2##4##(2007-6#1)(2011-2#1)
Clostridium perfringens type##3##3##(1997-8#1)(2007-6#1)(2011-2#1)
Clostridium perfringens##16##2##(1990-9#1)(1994-11#1)(1994-2#2)(1997-8#1)(2007-6#2)(2007-7#1)(2010-6#2)(2011-2#6)
Clostridium ramosum##2##2##(2007-8#2)
Clostridium spp##4##2##(2007-7#4)
Clostridium tetani##2##2##(2008-5#2)
Clostridium thermocellum##6##2##(1991-5#2)(2008-6#2)(2013-1#2)
Clostridium##72##1##(1990-9#1)(1991-5#2)(1991-8#2)(1992-3#4)(1993-2#1)(1994-11#1)(1994-2#2)(1997-4#3)(1997-8#1)(2007-12#5)(2007-6#2)(2007-7#6)(2007-8#2)(2008-11#2)(2008-5#2)(2008-6#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#18)(2013-1#9)
Closure of##4##2##(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)
Closure##8##1##(1996-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)(2013-1#1)
Clotting##2##1##(2008-7#1)(2012-2#1)
Cloud Detection##2##2##(2008-3#2)
Cloud and Radiation Testbed site##2##5##(2008-2#2)
Cloud point extraction (CPE)##2##4##(2008-10#2)
Cloud point extraction of##4##4##(2008-10#4)
Cloud point extraction was##2##4##(2008-10#2)
Cloud point extraction##10##3##(2008-10#10)
Cloud point##11##2##(2008-10#11)
Cloud##17##1##(2008-10#12)(2008-2#2)(2008-3#3)
Clouds##4##1##(2008-2#3)(2008-3#1)
Clover##3##1##(2008-10#2)(2011-2#1)
Club##8##1##(1996-5#1)(2008-4#1)(2009-8#1)(2012-12#5)
Clues##2##1##(1996-6#1)(2012-2#1)
Clumps of##2##2##(1993-2#1)(2008-10#1)
Clustal##2##1##(2008-9#2)
ClustalW##3##1##(2008-9#3)
ClustalX and##2##2##(2008-9#2)
ClustalX##5##1##(2008-9#5)
Cluster 2##2##2##(2008-10#1)(2011-2#1)
Cluster A##2##2##(1997-5#1)(2012-12#1)
Cluster analyses##2##2##(2008-10#1)(2011-1#1)
Cluster analysis based on##2##4##(2008-10#2)
Cluster analysis of multilocus genotypes##2##5##(2008-10#2)
Cluster analysis of the##3##4##(1997-3#1)(1997-6#1)(2008-10#1)
Cluster analysis of##10##3##(1994-2#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-8#1)(2013-1#1)
Cluster analysis revealed##3##3##(2008-10#3)
Cluster analysis showed that##2##4##(2008-10#1)(2008-8#1)
Cluster analysis showed##3##3##(2008-10#2)(2008-8#1)
Cluster analysis##29##2##(1994-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#19)(2008-12#1)(2008-8#2)(2010-12#1)(2010-4#1)(2013-1#1)
Cluster and##2##2##(2008-10#2)
Cluster of##2##2##(2008-10#2)
Cluster##49##1##(1994-2#1)(1996-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2008-10#30)(2008-12#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
Clustered##2##1##(2010-8#2)
Clustering Analysis##2##2##(2010-8#2)
Clustering of##3##2##(1997-8#1)(2008-10#2)
Clustering##11##1##(1997-8#2)(2008-10#3)(2009-10#1)(2009-6#1)(2010-1#1)(2010-8#2)(2011-2#1)
Clusters of##3##2##(2007-12#1)(2008-10#2)
Clusters##8##1##(1996-2#1)(2007-12#1)(2008-10#5)(2013-1#1)
Cm##6##1##(1991-9#1)(1995-8#2)(2008-10#3)
CmPGIP by##2##2##(2008-10#2)
CmPGIP##6##1##(2008-10#6)
CnH##4##1##(1993-6#4)
CnrN regulates##2##2##(2009-8#2)
CnrN##3##1##(2009-8#3)
Co and Cr##2##3##(2008-10#1)(2008-12#1)
Co and Fe in##2##4##(2008-10#2)
Co and##12##2##(2008-10#11)(2008-12#1)
Co as##2##2##(2008-10#2)
Co in##4##2##(2008-10#3)(2013-8#1)
Co##125##1##(1990-11#1)(1994-12#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#94)(2008-11#1)(2008-12#1)(2008-5#7)(2008-8#1)(2008-9#2)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#5)
Co(2+) -doped##2##2##(2007-11#2)
Co(2+) and Cu(2+)##4##3##(2008-10#4)
Co(2+) and##6##2##(2008-10#5)(2013-1#1)
Co(2+) in water##2##3##(2008-10#2)
Co(2+)##46##1##(2007-11#4)(2008-10#31)(2008-11#2)(2008-3#7)(2008-8#1)(2013-1#1)
Co(II) and Cu(II) in##3##4##(2008-10#3)
Co(II) and Cu(II)##7##3##(2008-10#7)
Co(II) and Ni(II)##3##3##(2008-10#3)
Co(II) and##23##2##(2008-10#23)
Co(II) determination by adsorptive stripping voltammetry##2##6##(2008-10#2)
Co(II) determination in##2##3##(2008-10#2)
Co(II) determination##5##2##(2008-10#5)
Co(II) in##4##2##(2008-10#4)
Co(II) or##2##2##(2008-10#2)
Co(II) was##4##2##(2008-10#4)
Co(II) with##5##2##(2008-10#5)
Co(II)##114##1##(1990-12#1)(2008-10#111)(2008-5#2)
Co(II))=0##2##1##(2008-10#2)
Co(III) complexes##2##2##(1993-3#1)(2008-10#1)
Co(III)##8##1##(1993-3#1)(1996-2#1)(2008-10#6)
Co(en)(3)(3+) and##2##2##(1997-7#2)
Co(en)(3)(3+)##7##1##(1997-7#7)
Co)##2##1##(2008-5#2)
Co-4##5##1##(2008-10#5)
Co-60##2##1##(1996-2#2)
Co-administration of nifedipine##2##3##(1995-12#1)(1997-7#1)
Co-administration of##3##2##(1995-12#1)(1997-7#1)(2008-7#1)
Co-expression of##7##2##(1990-9#1)(1991-9#1)(1995-5#1)(1995-8#1)(2008-1#2)(2008-11#1)
Co-infection of##2##2##(2008-10#1)(2012-2#1)
Co-infection with##4##2##(2007-7#1)(2011-2#3)
Co-infection##8##1##(2007-7#1)(2008-10#1)(2011-2#5)(2012-2#1)
Co-inheritance of sickle cell trait and thalassemia mutations in South central iran##2##12##(2013-1#2)
Co-injection of##4##2##(1991-12#2)(1993-6#1)(2010-4#1)
Co-localization##2##1##(1990-5#1)(2008-10#1)
Co-morbidity##2##1##(2012-12#1)(2013-1#1)
Co-occurrence of##2##2##(1994-11#1)(2009-6#1)
Co-occurring##3##1##(2010-3#1)(2012-12#1)(2012-3#1)
Co-operation##2##1##(1995-11#1)(2008-11#1)
Co-ordination##2##1##(2008-10#1)(2008-4#1)
Co-presence of##2##2##(2012-6#2)
Co-purification of##2##2##(1991-2#1)(1992-12#1)
Co-transfection of##3##2##(1990-8#1)(1995-6#1)(1997-4#1)
Co2+ and Zn2+##2##3##(1992-11#2)
Co2+ and##3##2##(1992-11#2)(2008-12#1)
Co2+##12##1##(1990-7#1)(1992-11#2)(1992-3#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-3#1)
CoA and pyruvate##2##3##(1993-11#1)(1995-2#1)
CoA mutase##2##2##(2008-10#2)
CoA##21##1##(1990-11#3)(1990-12#2)(1990-7#1)(1991-8#1)(1993-11#7)(1995-2#1)(1995-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
CoASH##3##1##(1990-2#3)
CoCl(2)##3##1##(2007-11#1)(2008-10#1)(2008-11#1)
CoCl2##3##1##(1996-5#3)
CoHCF nanowires could be##2##4##(2008-10#2)
CoHCF nanowires##3##2##(2008-10#3)
CoHCF##7##1##(2008-10#7)
CoMFA models##3##2##(2007-11#1)(2010-12#2)
CoMFA##11##1##(1995-3#7)(2007-11#1)(2010-12#3)
CoMSIA##2##1##(2011-2#2)
CoNS peritonitis reported##2##3##(2011-2#2)
CoNS##8##1##(2011-2#8)
CoPc##2##1##(2008-10#2)
CoPc-modified carbon paste##2##3##(2008-10#2)
CoPc-modified##3##1##(2008-10#3)
CoQ10 (200 mg daily)##2##4##(2013-1#2)
CoQ10 treatment##6##2##(2013-1#6)
CoQ10##22##1##(1991-5#7)(1993-3#4)(2013-1#11)
Coaching and counseling employees##2##4##(1993-1#1)(1993-2#1)
Coaching##5##1##(1993-1#1)(1993-2#1)(1996-1#1)(2010-9#2)
Coagulase-negative staphylococcal##2##2##(2008-11#1)(2011-2#1)
Coagulase-negative##3##1##(2008-11#1)(2011-2#2)
Coagulation abnormalities##2##2##(2007-10#2)
Coagulation parameters##2##2##(2013-8#2)
Coagulation##7##1##(1991-9#1)(2007-10#2)(2008-11#1)(2008-7#1)(2013-8#2)
Coal##3##1##(1990-3#1)(2008-1#1)(2008-10#1)
Coalescent##2##1##(2007-8#1)(2013-1#1)
Coalition for##2##2##(2008-3#1)(2009-11#1)
Coalition##8##1##(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-3#1)(2008-6#2)(2009-11#1)
Coarctation##2##1##(1991-8#1)(2012-1#1)
Coast and Islands##3##3##(2011-2#3)
Coast and##4##2##(2008-4#1)(2011-2#3)
Coast in##2##2##(2008-2#1)(2013-1#1)
Coast of##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-4#1)(2012-12#1)(2013-7#2)
Coast##40##1##(1992-8#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-1#5)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
Coastal Bend##4##2##(2008-10#4)
Coastal Zone Color Scanner##2##4##(2008-2#2)
Coastal##13##1##(2007-5#2)(2008-10#6)(2008-2#2)(2008-3#2)(2010-8#1)
Coat Protein Gene of##2##4##(2008-10#2)
Coat Protein Gene##5##3##(2008-10#5)
Coat Protein##6##2##(2008-10#6)
Coat protein##3##2##(1997-2#1)(2008-10#2)
Coat##10##1##(1997-2#1)(2008-10#9)
Coated with##2##2##(2008-10#1)(2008-11#1)
Coated##3##1##(2008-10#2)(2008-11#1)
Coating##8##1##(2008-10#6)(2008-2#1)(2008-3#1)
Coatings##3##1##(2008-2#1)(2008-3#2)
Coatomer##2##1##(1994-12#2)
Coaxial##2##1##(2007-11#1)(2013-8#1)
Cobalamin##2##1##(2008-10#1)(2011-1#1)
Cobalt##5##1##(2008-10#5)
Cobalt(II) Ion in##2##3##(1996-2#2)
Cobalt(II)##5##1##(1996-2#2)(2008-10#3)
Cobb angle decreased in##3##4##(2007-8#3)
Cobb angle##5##2##(2007-8#5)
Cobb##8##1##(1996-5#2)(2007-8#6)
Coblentz##2##1##(2006-12#1)(2008-2#1)
Cocaethylene##3##1##(1991-1#1)(1996-12#2)
Cocaine##15##1##(1991-1#4)(1991-2#1)(1992-12#1)(1996-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
Cocaine-induced##3##1##(1991-1#1)(2008-10#1)(2011-2#1)
Coccidae##2##1##(2007-12#2)
Coccinea)##2##1##(2007-12#2)
Cochlear Implant Centre##2##3##(2008-9#2)
Cochlear Implant Programme##2##3##(2008-9#2)
Cochlear Implant##7##2##(2008-9#5)(2011-1#1)(2012-2#1)
Cochlear implant##6##2##(2008-9#6)
Cochlear implantation after##2##3##(2008-9#2)
Cochlear implantation for##2##3##(2008-9#2)
Cochlear implantation has##2##3##(2008-9#2)
Cochlear implantation in a child with##2##6##(2008-9#1)(2012-2#1)
Cochlear implantation in a##5##4##(2008-9#4)(2012-2#1)
Cochlear implantation in children with##2##5##(2012-2#2)
Cochlear implantation in chronic##2##4##(2008-9#2)
Cochlear implantation in patients with##2##5##(2008-9#2)
Cochlear implantation in patients##3##4##(2008-9#3)
Cochlear implantation in##14##3##(2008-9#11)(2012-2#3)
Cochlear implantation is##4##3##(1996-3#1)(2008-9#3)
Cochlear implantation of##2##3##(2008-9#2)
Cochlear implantation##27##2##(1996-3#1)(2008-9#22)(2012-2#4)
Cochlear implants##4##2##(2008-9#4)
Cochlear nerve aplasia##2##3##(2008-9#2)
Cochlear reimplantation in##2##3##(2008-9#2)
Cochlear##54##1##(1996-3#1)(2008-9#43)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#6)
Cochlear™##2##1##(2012-2#2)
Cochliobolus carbonum##2##2##(2008-10#2)
Cochliobolus heterostrophus##5##2##(2008-10#5)
Cochliobolus miyabeanus##4##2##(2008-10#4)
Cochliobolus sativus and##3##3##(2008-10#3)
Cochliobolus sativus##8##2##(2008-10#8)
Cochliobolus sativus)##3##2##(2008-10#3)
Cochliobolus spp##3##2##(2008-10#3)
Cochliobolus##28##1##(2008-10#28)
Cochlospermum planchonii##3##2##(2008-12#3)
Cochlospermum##4##1##(2008-12#4)
Cochran##2##1##(1992-9#1)(2008-10#1)
Cochrane Central##2##2##(2007-8#1)(2013-8#1)
Cochrane Database of Systematic Reviews##4##5##(1993-12#1)(2011-2#1)(2013-1#2)
Cochrane Library and##2##3##(2011-2#2)
Cochrane Library##5##2##(2008-12#1)(2011-2#3)(2013-1#1)
Cochrane reviews - in their own words##3##7##(2011-2#3)
Cochrane##28##1##(1993-12#4)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-2#7)(2012-12#3)(2013-1#6)(2013-8#1)
Cockatiel##2##1##(2008-5#2)
Cockcroft-Gault##2##1##(2011-2#1)(2013-1#1)
Cocultures of Peronospora tabacina##2##4##(2008-10#2)
Code and##2##2##(1991-2#1)(1996-1#1)
Code of##7##2##(1994-1#1)(2008-10#3)(2010-5#1)(2012-1#1)(2012-2#1)
Code##20##1##(1991-2#2)(1993-9#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
Coding for##2##2##(2007-12#1)(2008-4#1)
Coding##9##1##(1995-8#1)(1997-7#1)(2007-12#2)(2008-4#2)(2009-3#1)(2009-5#1)(2009-8#1)
Codon##2##1##(1995-8#1)(1997-8#1)
Coefficient of variation##2##3##(1990-8#1)(2008-10#1)
Coefficient of##3##2##(1990-8#1)(2008-10#1)(2008-6#1)
Coefficient##7##1##(1990-8#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
Coefficients for##2##2##(2008-2#1)(2010-1#1)
Coefficients of variation of##2##4##(2008-10#2)
Coefficients of variation##3##3##(2008-10#3)
Coefficients of##6##2##(2008-10#3)(2008-2#2)(2008-3#1)
Coefficients##9##1##(2008-10#3)(2008-2#3)(2008-3#1)(2010-1#1)(2012-2#1)
Coeliac disease##2##2##(1991-11#1)(1991-8#1)
Coenzyme A##3##2##(1990-8#1)(1994-8#1)(2013-1#1)
Coenzyme Q10##3##2##(1991-5#2)(2009-8#1)
Coenzyme##8##1##(1990-8#1)(1991-5#2)(1992-11#1)(1994-8#1)(2009-8#1)(2013-1#2)
Coercion##2##1##(2008-11#1)(2009-4#1)
Coevolution##7##1##(2008-10#5)(2008-8#2)
Coexistence of##5##2##(1990-12#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
Coexistence times##2##2##(2008-9#2)
Coexistence##11##1##(1990-12#1)(2007-7#1)(2008-10#1)(2008-8#3)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
Coexistent##2##1##(2008-10#1)(2011-2#1)
Coexisting##3##1##(1994-2#1)(1994-7#1)(2007-8#1)
Coexpression of##4##2##(1993-9#1)(1995-11#1)(2008-8#1)(2008-9#1)
Cofermentation of##2##2##(2008-6#2)
Coffea canephora##2##2##(2008-10#1)(2008-6#1)
Coffea##3##1##(2008-10#1)(2008-5#1)(2008-6#1)
Coffee##6##1##(2007-2#1)(2008-10#5)
Cognition##3##1##(2007-12#1)(2008-2#1)(2012-2#1)
Cognitive Behavior Therapy##2##3##(2008-11#1)(2013-1#1)
Cognitive Behavioral##3##2##(2008-11#1)(2008-12#1)(2010-11#1)
Cognitive Changes##2##2##(2012-3#2)
Cognitive and##3##2##(1990-6#1)(2008-11#2)
Cognitive functions##2##2##(2008-9#1)(2013-8#1)
Cognitive rehabilitation##2##2##(2009-10#2)
Cognitive sciences explored in chicago##2##5##(1991-8#2)
Cognitive##56##1##(1990-6#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-8#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-3#1)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
Coh##3##1##(1994-3#3)
Cohen##4##1##(2008-1#2)(2010-11#1)(2010-8#1)
Cohen's kappa##4##2##(1997-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
Cohen's##5##1##(1997-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-1#1)
Coherence##10##1##(1996-9#1)(2007-11#2)(2007-9#1)(2008-7#1)(2011-1#4)(2013-8#1)
Coherent Anti-Stokes Raman Spectroscopy##2##4##(2008-2#1)(2008-3#1)
Coherent Anti-Stokes##3##2##(2008-2#1)(2008-3#2)
Coherent and incoherent##3##3##(2007-12#1)(2008-3#2)
Coherent artifacts##2##2##(2008-3#2)
Coherent population trapping resonances in thermal (85)Rb vapor##2##8##(2007-11#2)
Coherent population##3##2##(2007-11#3)
Coherent##26##1##(1990-5#1)(1996-12#2)(2007-11#6)(2007-12#2)(2008-2#3)(2008-3#11)(2012-2#1)
Cohesion##3##1##(2011-1#1)(2013-1#2)
Cohn##5##1##(1993-11#1)(2008-10#1)(2011-2#3)
Cohort Study##5##2##(2010-5#1)(2010-6#2)(2013-1#2)
Cohort of##2##2##(2013-1#1)(2013-8#1)
Cohort##14##1##(1994-2#1)(1994-6#1)(1996-8#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
Coiba Island##2##2##(2008-5#2)
Coiba National Park##3##3##(2008-5#3)
Coiba##5##1##(2008-5#5)
Coil-1##3##1##(2008-8#3)
Coiling##2##1##(2011-2#1)(2012-3#1)
Coils in##2##2##(1997-3#1)(2010-10#1)
Coincident##2##1##(2008-10#1)(2010-3#1)
Coinfection of##2##2##(2008-10#1)(2008-7#1)
Coinfection##4##1##(2007-7#1)(2008-10#1)(2008-7#2)
Col §##2##2##(2012-12#2)
Col##8##1##(1993-12#4)(2012-12#2)(2012-3#2)
Col-0##2##1##(2008-10#2)
Col1##3##1##(2008-10#3)
ColE1##2##1##(1993-8#1)(1994-8#1)
Colaizzi's##2##1##(2010-10#1)(2010-11#1)
Colchicine##3##1##(1997-6#3)
Cold Spring Harbor Laboratory and##2##5##(2008-4#1)(2008-7#1)
Cold Spring Harbor Laboratory##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
Cold pearl surfactant-based blends##2##4##(2008-5#2)
Cold##10##1##(1995-2#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)
Cold-active##2##1##(2008-7#1)(2008-9#1)
Cole et al##3##3##(1990-9#1)(2008-3#1)(2009-3#1)
Cole##4##1##(1990-9#1)(2008-3#1)(2008-6#1)(2009-3#1)
Colentina Hospital##3##2##(2008-10#3)
Coleoptera and##2##2##(2008-6#1)(2011-2#1)
Coleoptera##5##1##(2007-12#1)(2008-6#2)(2011-2#2)
Coleoptera)##2##1##(2007-12#1)(2008-12#1)
Colitis##4##1##(2010-11#1)(2010-12#2)(2012-12#1)
Collaborating Centres##4##2##(1993-2#1)(2011-2#3)
Collaborating##8##1##(1993-2#1)(2006-10#1)(2008-8#1)(2011-2#4)(2013-1#1)
Collaboration and##2##2##(1993-12#1)(1996-2#1)
Collaboration between##4##2##(1993-12#1)(2008-11#1)(2009-12#1)(2010-8#1)
Collaboration has##2##2##(1993-12#1)(2008-11#1)
Collaboration is a##2##3##(1995-1#1)(1995-2#1)
Collaboration is##5##2##(1995-1#2)(1995-2#1)(2007-10#1)(2007-7#1)
Collaboration with##3##2##(2008-8#1)(2013-1#2)
Collaboration##27##1##(1992-1#1)(1993-12#3)(1993-2#1)(1995-1#3)(1995-2#1)(1996-2#1)(1997-8#1)(2007-10#3)(2007-7#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-8#1)(2012-12#1)(2013-1#2)
Collaborative Group##8##2##(1991-11#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-6#1)(1997-5#1)(2007-5#1)
Collaborative Study Group##2##3##(1991-11#1)(1992-2#1)
Collaborative Study##3##2##(1991-11#1)(1992-2#1)(1997-7#1)
Collaborative##29##1##(1990-11#2)(1991-11#2)(1991-2#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-5#1)(1997-7#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-3#2)(2013-1#2)
Collagen##12##1##(1991-11#1)(1994-7#1)(1995-12#2)(1996-5#1)(1997-7#3)(2007-7#1)(2008-10#1)(2009-7#1)(2009-8#1)
Collagenase##3##1##(1992-5#1)(2008-11#1)(2008-8#1)
Collagenous hydrolysates from untraditional sources of proteins##2##7##(2008-5#2)
Collagenous sprue##2##2##(2010-6#2)
Collagenous##6##1##(2008-5#3)(2010-6#2)(2011-2#1)
Collateral##2##1##(1991-2#1)(2008-10#1)
Colleague##5##1##(1992-3#1)(1995-2#1)(2011-2#3)
Collected data were##2##3##(2008-1#1)(2011-2#1)
Collected data##3##2##(2008-1#1)(2008-2#1)(2011-2#1)
Collected##10##1##(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-2#3)(2012-12#1)
Collecting and using##2##3##(1997-2#1)(1997-3#1)
Collecting##5##1##(1991-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
Collection of Isolates##2##3##(2008-10#2)
Collection of##11##2##(2008-10#5)(2008-2#2)(2009-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
Collection##19##1##(1990-2#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-2#1)(2012-3#1)(2013-1#1)
Collections from##3##2##(2008-10#3)
Collections of##3##2##(2008-10#3)
Collections##7##1##(2007-5#1)(2008-10#6)
Collective memory##2##2##(2008-2#2)
Collective##5##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)
Collectively these##2##2##(1994-2#1)(2013-8#1)
Collectively##42##1##(1990-12#1)(1991-12#1)(1991-8#1)(1991-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
College Dublin##2##2##(2008-11#2)
College Hospital##2##2##(1993-12#1)(2011-2#1)
College Station##2##2##(2008-10#2)
College Students##2##2##(2010-10#1)(2010-7#1)
College and Hospital##2##3##(2008-3#1)(2013-1#1)
College and##3##2##(1994-1#1)(2008-3#1)(2013-1#1)
College of Cardiology##5##3##(2008-3#2)(2009-6#1)(2010-5#1)(2012-3#1)
College of Health##4##3##(1992-3#1)(1996-2#1)(1997-2#1)(2009-10#1)
College of Medicine##3##3##(1996-12#1)(2009-10#2)
College of Physicians and##2##4##(1994-12#1)(2010-8#1)
College of Physicians##7##3##(1990-9#1)(1993-12#2)(1994-12#1)(1996-8#2)(2010-8#1)
College of Rheumatology##4##3##(2006-10#2)(2007-8#1)(2011-2#1)
College of the##3##3##(1991-3#1)(1991-8#2)
College of##57##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-8#2)(1992-1#2)(1992-3#1)(1993-12#4)(1993-3#1)(1994-12#3)(1994-2#1)(1996-12#2)(1996-2#1)(1996-8#2)(1997-2#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#8)(2008-4#1)(2008-6#1)(2009-10#3)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
College public relations##3##3##(2008-6#3)
College##109##1##(1990-3#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-8#2)(1992-1#2)(1992-3#1)(1993-12#5)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-8#2)(1997-2#2)(1997-8#1)(2006-10#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#3)(2008-3#9)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#3)(2009-10#3)(2009-6#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-4#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#4)(2013-8#6)
Colleges of Nursing##2##3##(2008-11#1)(2012-2#1)
Colleges of##3##2##(2008-11#1)(2010-3#1)(2012-2#1)
Colleges##5##1##(1991-9#1)(2008-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
Collembola##2##1##(2008-6#1)(2008-7#1)
Colles fracture##2##2##(2009-3#2)
Colleters##2##1##(2008-5#2)
Colletotrichum acutatum and C##2##4##(2008-10#2)
Colletotrichum acutatum and##3##3##(2008-10#3)
Colletotrichum acutatum from##2##3##(2008-10#2)
Colletotrichum acutatum on Symptomless##3##4##(2008-10#3)
Colletotrichum acutatum on##6##3##(2008-10#6)
Colletotrichum acutatum##26##2##(2008-10#26)
Colletotrichum capsici##2##2##(2008-11#2)
Colletotrichum coccodes##8##2##(2008-10#8)
Colletotrichum crown rot of strawberry##2##5##(2008-10#2)
Colletotrichum dematium##3##2##(2008-10#3)
Colletotrichum gloeosporioides from##3##3##(2008-10#3)
Colletotrichum gloeosporioides were##2##3##(2008-10#2)
Colletotrichum gloeosporioides##23##2##(1997-6#1)(2008-10#22)
Colletotrichum graminicola##10##2##(2008-10#10)
Colletotrichum isolates from lupins##2##4##(2008-10#2)
Colletotrichum isolates from##4##3##(2008-10#4)
Colletotrichum isolates##7##2##(2008-10#7)
Colletotrichum lindemuthianum in Common Bean##2##5##(2008-10#2)
Colletotrichum lindemuthianum##9##2##(2008-10#9)
Colletotrichum orbiculare and##2##3##(2008-10#2)
Colletotrichum orbiculare##3##2##(2008-10#3)
Colletotrichum sp##2##2##(2008-10#2)
Colletotrichum species##4##2##(2008-10#4)
Colletotrichum spp##11##2##(2008-10#11)
Colletotrichum##126##1##(1997-4#1)(1997-6#3)(2008-10#120)(2008-11#2)
Colletotricum##2##1##(2012-2#2)
Collimated light sources in##2##4##(2008-3#2)
Collimators##2##1##(2008-2#1)(2009-8#1)
Collins and##2##2##(1994-8#1)(2011-2#1)
Collins##11##1##(1994-8#4)(2007-11#1)(2007-12#4)(2011-2#2)
Collision##3##1##(1992-8#1)(1993-3#1)(2013-8#1)
Collision-induced dissociation##2##2##(2010-4#1)(2012-12#1)
Collision-induced##3##1##(2007-11#1)(2010-4#1)(2012-12#1)
Collisions##3##1##(2007-12#2)(2008-8#1)
Colloidal##5##1##(1996-12#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-4#1)
Colloquium##2##1##(1995-3#1)(2008-10#1)
Colo201 cells##3##2##(2008-11#3)
Colocalization of##8##2##(1993-12#2)(1993-9#1)(1994-2#2)(1995-12#1)(1997-8#1)(2011-2#1)
Colocalization##9##1##(1993-12#2)(1993-9#1)(1994-2#2)(1995-12#1)(1997-8#1)(2011-2#2)
Colocasia esculenta in##2##3##(2008-10#2)
Colocasia esculenta##3##2##(2008-10#3)
Colocasia##6##1##(2008-10#6)
Cologne##4##1##(1995-3#2)(2008-5#1)(2012-3#1)
Colombia and##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
Colombia in##2##2##(2013-1#1)(2013-7#1)
Colombia is##2##2##(2012-12#2)
Colombia to##2##2##(2008-5#1)(2011-2#1)
Colombia with##2##2##(2008-10#1)(2012-12#1)
Colombia##111##1##(1992-5#1)(1997-8#1)(2008-10#12)(2008-12#3)(2008-5#11)(2008-8#1)(2011-2#10)(2012-12#58)(2013-1#7)(2013-7#7)
Colombia's##2##1##(2011-2#2)
Colombia)##6##1##(2008-10#1)(2008-5#1)(2012-12#4)
Colombia]##16##1##(2008-5#2)(2012-12#10)(2013-1#3)(2013-7#1)
Colombian Caribbean##2##2##(2008-12#1)(2008-5#1)
Colombian cities##2##2##(2012-12#1)(2013-1#1)
Colombian patients##2##2##(2012-12#2)
Colombian##41##1##(2008-10#1)(2008-12#4)(2008-5#4)(2011-2#4)(2012-12#16)(2013-1#10)(2013-7#2)
Colon 26-L5##2##2##(2008-4#2)
Colon cancer##3##2##(1993-12#1)(2008-1#1)(2008-9#1)
Colon##8##1##(1993-12#1)(2008-1#1)(2008-4#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)
Colonic lipomas##2##2##(1993-9#2)
Colonic##11##1##(1992-6#1)(1992-9#1)(1993-9#2)(2007-12#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
Colonies of##3##2##(2008-10#2)(2008-8#1)
Colonies were##2##2##(2008-10#2)
Colonies##8##1##(2008-10#7)(2008-8#1)
Colonization and##5##2##(2008-10#5)
Colonization by##5##2##(2008-10#5)
Colonization of Tomato##2##3##(2008-10#2)
Colonization of the##2##3##(2008-10#2)
Colonization of##20##2##(1997-6#1)(2008-10#19)
Colonization##32##1##(1997-6#1)(2008-10#31)
Colonized##2##1##(2008-10#1)(2011-2#1)
Colonoscopy is##3##2##(1997-8#1)(2010-12#1)(2011-2#1)
Colonoscopy revealed##2##2##(2011-2#2)
Colonoscopy was performed on##2##4##(2008-12#1)(2013-8#1)
Colonoscopy##11##1##(1996-8#1)(1997-8#1)(2008-11#1)(2008-12#1)(2009-1#1)(2010-12#1)(2011-2#4)(2013-8#1)
Colony forming units of##2##4##(2008-10#2)
Colony forming##3##2##(2008-10#2)(2008-11#1)
Colony morphology##3##2##(2008-10#3)
Colony of##2##2##(2007-12#1)(2009-10#1)
Colony##13##1##(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)
Color Doppler##3##2##(2007-12#1)(2011-2#1)(2012-12#1)
Color stability##2##2##(2010-4#1)(2013-1#1)
Color##22##1##(1993-5#1)(1995-3#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
Color-Doppler ultrasound##2##2##(1993-8#1)(2011-2#1)
Color-coded##2##1##(2008-3#2)
Colorado potato beetle (Leptinotarsa##2##4##(2008-10#1)(2008-9#1)
Colorado potato beetle##4##3##(2008-10#3)(2008-9#1)
Colorado##21##1##(1995-12#3)(1995-2#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-10#9)(2008-2#1)(2008-8#2)(2008-9#1)(2013-8#1)
Colorectal Cancer##6##2##(1990-6#1)(2008-10#2)(2008-12#1)(2012-3#1)(2013-1#1)
Colorectal cancer (CRC) is##2##4##(2008-5#1)(2013-1#1)
Colorectal cancer (CRC)##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
Colorectal cancer is a##2##4##(2009-12#1)(2009-9#1)
Colorectal cancer is##4##3##(2009-12#2)(2009-9#1)(2011-1#1)
Colorectal cancer##8##2##(2008-10#1)(2008-5#1)(2009-12#2)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
Colorectal##18##1##(1990-6#1)(1993-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-12#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#3)(2013-1#3)
Colorimetric##5##1##(2008-1#1)(2008-10#3)(2008-11#1)
Colors##2##1##(1995-5#1)(2008-2#1)
Colour##3##1##(2007-10#1)(2008-10#1)(2008-5#1)
Colovesical fistula##2##2##(2009-1#1)(2013-1#1)
Colposcopy##3##1##(1994-2#2)(1997-7#1)
Colpotomizer##2##1##(2011-2#2)
Columbia River##2##2##(2010-8#2)
Columbia University Assessment of Disability in Essential Tremor (CADET)##2##9##(2008-7#2)
Columbia and##6##2##(1994-2#1)(2008-10#3)(2011-2#1)(2013-1#1)
Columbia as a##2##3##(1992-12#1)(2008-10#1)
Columbia##87##1##(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#3)(1995-9#2)(1996-12#4)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-12#6)(2007-3#1)(2008-10#22)(2008-11#7)(2008-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#2)(2010-5#1)(2010-8#5)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
Columbian##2##1##(2008-8#1)(2009-5#1)
Columbicola columbae (Mallophaga)##2##3##(2007-12#2)
Columbus##4##1##(1991-9#1)(1995-2#1)(1996-3#1)(2008-10#1)
Column##11##1##(1990-5#1)(2008-10#5)(2008-12#1)(2008-2#2)(2013-1#2)
Column-switching high-performance liquid chromatographic##2##4##(2008-10#2)
Columnar##2##1##(2008-2#1)(2010-4#1)
Coma##8##1##(1990-2#1)(1991-8#1)(2007-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Combating##3##1##(1997-2#1)(2008-7#1)(2009-9#1)
Combi 40##2##2##(2008-9#2)
Combi 40+##2##2##(2008-9#2)
Combi##6##1##(2008-9#6)
Combination Chemotherapy##2##2##(1997-7#1)(2008-11#1)
Combination Therapy##2##2##(1997-7#1)(2007-2#1)
Combination chemotherapy##3##2##(1991-6#1)(1993-9#1)(2008-11#1)
Combination live##2##2##(1995-5#2)
Combination of the##3##3##(1992-1#1)(1993-8#1)(2008-4#1)
Combination of##22##2##(1992-1#1)(1992-2#1)(1993-8#2)(1996-5#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
Combination pharmacotherapy##2##2##(2008-2#2)
Combination therapy was##2##3##(2008-12#1)(2010-5#1)
Combination therapy with##2##3##(1992-11#1)(2008-8#1)
Combination therapy##7##2##(1992-11#1)(2008-12#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-5#1)
Combination treatment##2##2##(1991-6#1)(2008-12#1)
Combination vaccines##3##2##(1995-5#3)
Combination with##5##2##(2006-12#3)(2010-12#1)(2010-5#1)
Combination##60##1##(1991-6#2)(1992-1#1)(1992-11#1)(1992-2#1)(1993-8#2)(1993-9#1)(1995-5#5)(1996-5#1)(1997-7#2)(2006-12#3)(2007-2#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
Combinations of these##2##3##(2008-9#1)(2010-7#1)
Combinations of##10##2##(1990-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#2)
Combinations##11##1##(1990-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#2)
Combinatorial recombination##2##2##(2008-4#2)
Combinatorial##6##1##(1991-9#1)(1994-5#1)(1997-4#1)(2008-4#2)(2009-6#1)
Combined CTX plus nisoldipine##2##4##(1993-3#2)
Combined Treatment##2##2##(2012-3#1)(2013-1#1)
Combined and##2##2##(1995-5#1)(2010-8#1)
Combined autologous and allograft limbal cell##2##6##(2010-10#2)
Combined data##2##2##(2007-12#1)(2008-10#1)
Combined results##2##2##(2008-10#1)(2008-2#1)
Combined treatment with##4##3##(1991-9#1)(1992-2#1)(2008-12#1)(2008-5#1)
Combined use of##4##3##(1993-6#1)(1996-5#1)(1997-2#1)(2007-8#1)
Combined with the##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#2)
Combined with##16##2##(1991-12#1)(1994-6#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-9#1)(2013-1#1)
Combined##93##1##(1991-12#1)(1991-9#3)(1992-2#1)(1993-3#2)(1993-6#1)(1994-6#1)(1995-5#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#8)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#3)
Combining Biomimetic Cross-Linking With Antiadhesive Oligo(ethylene glycol)##2##7##(2013-1#2)
Combining both##2##2##(1992-3#1)(2008-10#1)
Combining results from different studies##2##5##(2008-10#2)
Combining the##5##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2012-1#1)
Combining these##5##2##(1991-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-10#1)
Combining this result with##2##4##(2007-11#1)(2008-10#1)
Combining this##5##2##(2007-11#1)(2008-10#2)(2012-2#1)(2013-8#1)
Combining##49##1##(1991-12#1)(1992-3#1)(1994-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
Combretodendron macrocarpum##2##2##(2008-12#2)
Combustion##3##1##(1996-12#1)(2008-3#2)
Come##3##1##(2008-6#1)(2009-9#1)(2012-12#1)
Comes of Age##2##3##(2008-2#1)(2009-7#1)
Comet##4##1##(1991-8#2)(1997-4#2)
Comfort##3##1##(2008-11#3)
Coming of age##2##3##(1992-12#1)(2011-2#1)
Coming to terms with the##2##5##(1994-1#1)(1997-2#1)
Coming to terms with##3##4##(1994-1#1)(1995-1#1)(1997-2#1)
Coming##7##1##(1992-12#1)(1994-1#1)(1995-1#1)(1996-6#1)(1997-2#1)(2010-9#1)(2011-2#1)
Comm##3##1##(1992-3#1)(1993-3#1)(2008-7#1)
Commandments##5##1##(2008-12#5)
Comment on &quot##24##3##(1990-12#1)(1990-4#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#1)(1996-12#1)(1996-9#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#7)
Comment on Radiative transfer over small distances from a heated metal##2##11##(2007-11#2)
Comment on##33##2##(1990-12#1)(1990-4#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#1)(1995-11#1)(1996-12#1)(1996-9#2)(2006-10#1)(2007-11#3)(2007-12#2)(2007-4#2)(2008-10#2)(2008-11#1)(2008-3#8)(2012-12#1)
Comment##36##1##(1990-12#1)(1990-4#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-5#2)(1994-2#2)(1995-11#1)(1996-12#1)(1996-9#2)(2006-10#1)(2007-11#3)(2007-12#2)(2007-4#2)(2008-10#2)(2008-11#2)(2008-3#9)(2012-12#1)
Commentaries on##2##2##(1996-2#1)(2012-2#1)
Commentaries##3##1##(1996-2#1)(2008-7#1)(2012-2#1)
Commentary - radiology in India##3##5##(2009-9#3)
Commentary on the##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
Commentary on##12##2##(1993-12#1)(1996-2#3)(2008-1#1)(2008-11#1)(2008-4#2)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
Commentary##43##1##(1993-12#1)(1995-1#1)(1996-2#3)(2006-10#1)(2006-12#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-8#7)(2008-9#2)(2009-9#4)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Comments on point##3##3##(2011-2#3)
Comments on the giant basal cell##2##6##(2013-7#2)
Comments on the##4##3##(1994-6#1)(1995-8#1)(2013-7#2)
Comments on##9##2##(1994-6#1)(1995-8#1)(2007-7#1)(2010-12#1)(2011-2#3)(2013-7#2)
Comments##12##1##(1991-5#1)(1994-6#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#3)(2013-7#2)
Commerce##6##1##(1994-7#1)(1995-6#2)(1996-12#1)(1997-2#1)(2008-11#1)
Commercial samples were##2##3##(2008-10#2)
Commercial samples##3##2##(2008-10#3)
Commercial##26##1##(1990-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-3#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-2#1)
Commercially available##5##2##(1993-9#1)(2007-11#1)(2008-10#2)(2008-5#1)
Commercially##7##1##(1993-9#1)(2007-11#1)(2008-10#3)(2008-5#1)(2011-2#1)
Commiphora myrrha##2##2##(2008-5#2)
Commiphora##3##1##(1996-5#1)(2008-5#2)
Commission for##6##2##(1997-3#1)(2008-11#2)(2008-4#1)(2008-7#2)
Commission has##2##2##(1993-2#1)(2008-10#1)
Commission of the##2##3##(2007-11#1)(2008-10#1)
Commission of##3##2##(1993-6#1)(2007-11#1)(2008-10#1)
Commission on Social Determinants of Health##2##6##(2011-1#2)
Commission on the##3##3##(1995-2#2)(2010-12#1)
Commission on##13##2##(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-12#1)(2012-2#1)
Commission##62##1##(1990-2#1)(1991-9#1)(1992-12#1)(1993-1#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#2)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#3)(2012-12#1)(2012-2#6)
Commissioning##3##1##(2013-8#3)
Commitment to##3##2##(2008-10#1)(2008-11#2)
Commitment##5##1##(1993-2#1)(2008-10#1)(2008-11#2)(2012-2#1)
Committee developed##2##2##(1993-1#1)(2011-2#1)
Committee for##10##2##(1993-11#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Committee is##2##2##(1994-2#1)(2012-2#1)
Committee of the##11##3##(1991-1#1)(1991-3#1)(1994-12#1)(1994-9#1)(1996-6#1)(1996-8#1)(2008-10#2)(2008-6#1)(2011-4#1)(2012-2#1)
Committee of##20##2##(1990-12#2)(1991-1#1)(1991-3#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-6#1)(2010-7#1)(2011-4#1)(2012-2#1)(2012-3#2)
Committee on Health##2##3##(1996-1#1)(2008-12#1)
Committee on Problems of Drug Dependence##2##6##(1991-1#2)
Committee on##26##2##(1991-1#2)(1991-3#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#2)(2007-11#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
Committee to Advise on Tropical Medicine and Travel (CATMAT)##4##9##(1995-2#1)(1995-8#2)(1996-8#1)
Committee##106##1##(1990-12#2)(1990-2#1)(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#3)(1995-8#2)(1996-1#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2010-3#4)(2010-7#1)(2010-8#1)(2011-2#3)(2011-4#1)(2012-1#1)(2012-2#4)(2012-3#8)(2013-1#3)
Committees##3##1##(1991-3#2)(2011-2#1)
Common Bean##9##2##(2008-10#9)
Common Foundation Programme##2##3##(2008-11#1)(2008-12#1)
Common Scab##2##2##(2008-10#2)
Common Standards for Exchanging Proteomics Data##2##6##(2008-7#2)
Common Toxicity Criteria##3##3##(2007-11#1)(2008-8#1)(2011-2#1)
Common and comet##2##3##(2010-8#2)
Common methods##2##2##(1997-5#1)(2008-1#1)
Common reasons for##2##3##(2008-1#1)(2008-10#1)
Common themes##2##2##(2008-11#1)(2009-5#1)
Common##90##1##(1993-11#1)(1993-6#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-5#1)(1997-5#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
Commonly used in##2##3##(1994-2#1)(2008-4#1)
Commonly used##8##2##(1994-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
Commonly##14##1##(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Commonwealth of the Northern Mariana Islands (CNMI)##3##7##(2008-1#1)(2013-8#2)
Commonwealth of the Northern Mariana Islands##7##6##(2008-1#5)(2013-8#2)
Commonwealth of the Northern##8##4##(2008-1#5)(2008-10#1)(2013-8#2)
Commonwealth##12##1##(2008-1#6)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-8#2)
Commun##14##1##(1990-5#1)(1990-7#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#3)
Communicate##2##1##(2008-11#1)(2010-4#1)
Communicating the##3##2##(1994-1#1)(1996-1#1)(1996-3#1)
Communicating with##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
Communicating##10##1##(1991-11#1)(1993-3#1)(1994-1#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-12#1)
Communication between##4##2##(1996-1#1)(2008-11#1)(2008-12#1)(2012-12#1)
Communication with##3##2##(1993-3#1)(2010-3#1)(2012-3#1)
Communication##34##1##(1990-12#3)(1992-3#1)(1993-3#2)(1994-1#1)(1996-1#2)(1996-2#2)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)
Communications##5##1##(1996-5#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
Communicative##2##1##(2008-11#1)(2008-7#1)
Communities##8##1##(1996-2#1)(1997-2#1)(2008-10#3)(2010-8#1)(2012-3#1)(2013-1#1)
Community Anti-Drug##2##2##(2008-6#2)
Community Blood##2##2##(1995-6#2)
Community Bureau of Reference##2##4##(2008-10#2)
Community Health##6##2##(1992-5#1)(1994-1#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-7#1)
Community Hospital##8##2##(1993-1#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(2011-2#1)(2012-3#1)
Community Medical Center in Toms River##2##6##(1992-1#1)(1995-2#1)
Community Medical Center##3##3##(1992-1#1)(1995-2#2)
Community Medical##5##2##(1992-1#1)(1995-2#2)(1997-1#2)
Community Service##2##2##(1992-1#1)(1997-2#1)
Community Services##2##2##(1996-1#1)(2008-12#1)
Community and##6##2##(1993-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-8#1)
Community based structure##2##3##(1993-12#2)
Community benefit##2##2##(1995-2#2)
Community care networks and##2##4##(1993-2#1)(1995-2#1)
Community care networks##3##3##(1993-2#1)(1994-1#1)(1995-2#1)
Community care##4##2##(1993-2#1)(1994-1#1)(1995-2#1)(1995-9#1)
Community health##3##2##(1996-1#1)(1997-2#1)(1997-3#1)
Community members##2##2##(1997-1#1)(2007-5#1)
Community service##2##2##(1996-3#1)(1997-2#1)
Community##126##1##(1991-1#3)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#7)(1995-3#1)(1995-6#2)(1995-9#2)(1996-1#4)(1996-12#1)(1996-3#2)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#3)(2007-12#1)(2007-5#1)(2008-1#5)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#6)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-3#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
Community-acquired methicillin-resistant Staphylococcus aureus##2##4##(2007-12#1)(2012-1#1)
Community-acquired pneumonia (CAP) is a##2##5##(2007-12#1)(2010-5#1)
Community-acquired pneumonia##3##2##(1997-3#1)(2007-12#1)(2010-5#1)
Community-acquired##9##1##(1997-3#1)(2007-12#3)(2008-4#1)(2008-5#1)(2009-5#1)(2010-5#1)(2012-1#1)
Community-associated methicillin-resistant Staphylococcus aureus##5##4##(2008-10#2)(2008-11#2)(2009-4#1)
Community-based##9##1##(1991-2#1)(1995-3#1)(1996-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#3)
Community-level##2##1##(2013-1#2)
Community-onset##2##1##(2011-2#2)
Commuting##3##1##(1997-8#1)(2010-5#1)(2013-1#1)
Comorbid##2##1##(1991-4#1)(2008-1#1)
Comorbidity##5##1##(1993-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
Comovirus##3##1##(2008-10#3)
Compact and##2##2##(2008-3#1)(2010-11#1)
Compact##16##1##(1991-9#1)(1993-9#1)(2007-11#3)(2007-12#2)(2008-3#8)(2010-11#1)
Companies##4##1##(1993-2#1)(2008-10#1)(2008-5#1)(2010-7#1)
Companion##3##1##(1997-2#1)(2013-1#1)(2013-8#1)
Company##23##1##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1997-4#1)(1997-5#2)(1997-6#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-1#2)(2013-8#1)
Company's##2##1##(1995-1#1)(2007-12#1)
Comparability of##2##2##(1991-12#1)(2012-2#1)
Comparable##7##1##(1990-12#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-2#1)(2013-1#2)
Comparative Analysis of##3##3##(2008-10#2)(2009-5#1)
Comparative Study of##6##3##(2008-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
Comparative Study##8##2##(2008-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
Comparative analyses between##3##3##(1991-12#1)(2008-12#1)(2010-3#1)
Comparative analyses of##2##3##(2008-7#1)(2009-10#1)
Comparative analyses##5##2##(1991-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-3#1)
Comparative analysis of the##5##4##(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
Comparative analysis of##13##3##(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-1#2)(2012-2#1)
Comparative analysis##16##2##(1995-3#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-1#2)(2012-2#1)
Comparative assessment of##2##3##(2008-10#1)(2008-5#1)
Comparative calibration##2##2##(1997-8#2)
Comparative data##3##2##(2008-10#2)(2012-12#1)
Comparative effects of##2##3##(1993-5#1)(1994-5#1)
Comparative efficacy of##2##3##(1996-12#1)(2008-10#1)
Comparative evaluation of a##2##4##(2012-3#2)
Comparative evaluation of tensile bond strength##2##6##(2013-1#2)
Comparative evaluation of##7##3##(1995-5#1)(1997-1#1)(2011-1#1)(2012-3#2)(2013-1#2)
Comparative evaluation##8##2##(1995-5#1)(1997-1#1)(2011-1#1)(2012-3#2)(2013-1#3)
Comparative spermatology in Plecoptera (Insecta)##2##5##(2007-12#2)
Comparative studies of##2##3##(2007-11#1)(2008-7#1)
Comparative studies on the##2##4##(1994-6#1)(1997-2#1)
Comparative studies on##3##3##(1990-5#1)(1994-6#1)(1997-2#1)
Comparative studies##10##2##(1990-5#2)(1994-6#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
Comparative study for the##2##4##(2008-10#1)(2011-2#1)
Comparative study for##4##3##(2008-10#3)(2011-2#1)
Comparative study of the##6##4##(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
Comparative study of##28##3##(1994-11#1)(1996-3#1)(1997-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
Comparative study on the##4##4##(1996-12#1)(2008-8#1)(2010-3#1)(2013-1#1)
Comparative study on##7##3##(1996-12#1)(2008-8#2)(2010-3#1)(2010-4#1)(2013-1#2)
Comparative study##40##2##(1994-11#1)(1996-12#1)(1996-3#1)(1997-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#4)
Comparative transcriptome analysis##2##3##(2009-8#2)
Comparative##169##1##(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)
Comparatively##4##1##(1990-12#1)(1993-11#1)(2007-8#2)
Compared to a##3##3##(1990-12#1)(2008-10#2)
Compared to controls##2##3##(1994-5#1)(2013-1#1)
Compared to conventional##3##3##(2007-12#1)(2008-10#2)
Compared to normal##2##3##(2008-11#1)(2008-5#1)
Compared to other##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
Compared to the##19##3##(1992-3#1)(1993-2#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#3)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)
Compared to those##2##3##(2008-10#1)(2013-8#1)
Compared to##77##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-1#2)(1996-2#2)(1996-5#3)(1997-1#1)(2007-12#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#2)(2011-6#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
Compared with a##2##3##(2009-10#1)(2011-2#1)
Compared with control##4##3##(2008-10#1)(2008-9#1)(2011-3#1)(2012-2#1)
Compared with conventional##4##3##(2008-10#2)(2008-3#1)(2012-1#1)
Compared with other##5##3##(1990-11#1)(1990-5#1)(2008-2#1)(2008-5#1)(2012-3#1)
Compared with previous##3##3##(2007-11#1)(2008-2#2)
Compared with previously reported##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
Compared with standard##2##3##(2008-10#2)
Compared with the conventional##8##4##(2007-12#1)(2008-10#5)(2011-2#1)(2013-8#1)
Compared with the previous##3##4##(2008-3#3)
Compared with the reported##2##4##(2008-10#2)
Compared with the results of the##2##6##(2008-10#1)(2008-3#1)
Compared with the results##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
Compared with the traditional##2##4##(1996-12#1)(2013-8#1)
Compared with the##55##3##(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-10#16)(2008-2#3)(2008-3#9)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#2)(2013-8#4)
Compared with##131##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-8#1)(2008-10#33)(2008-12#1)(2008-2#7)(2008-3#11)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#4)
Compared##211##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-5#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#3)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#1)(2008-10#48)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#12)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#7)(2011-3#1)(2011-6#1)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#7)
Comparing both##3##2##(1990-12#1)(2009-2#1)(2013-1#1)
Comparing physician##2##2##(1993-3#1)(1997-1#1)
Comparing the results##2##3##(1991-9#1)(1993-11#1)
Comparing the two##2##3##(2008-10#2)
Comparing the##20##2##(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
Comparing with the##2##3##(2011-1#1)(2012-12#1)
Comparing##54##1##(1990-12#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)
Comparison among##2##2##(1991-2#1)(1993-8#1)
Comparison and##3##2##(2008-10#2)(2012-3#1)
Comparison between experimental##2##3##(2008-4#1)(2008-6#1)
Comparison between proteins and between protein families in databases provides information about the relationship between proteins within a genome or across different species##2##23##(2008-2#1)(2008-4#1)
Comparison between the##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
Comparison between##21##2##(1990-12#1)(1990-9#1)(1991-11#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-10#2)(2009-5#1)(2011-2#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
Comparison experiments were carried out##2##5##(2008-10#2)
Comparison experiments were##3##3##(2008-10#3)
Comparison is made between the##2##5##(2008-11#1)(2008-2#1)
Comparison is made between##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
Comparison is made with##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
Comparison is made##7##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
Comparison of Clinical##2##3##(2008-11#1)(2010-7#1)
Comparison of DNA##2##3##(1993-8#1)(2008-5#1)
Comparison of a##5##3##(1993-8#1)(1997-4#1)(2007-10#1)(2008-10#1)(2013-8#1)
Comparison of adverse##2##3##(1996-8#1)(2011-2#1)
Comparison of amino acid sequences of##3##6##(1994-11#1)(1994-12#1)(1997-8#1)
Comparison of amino acid sequences##4##5##(1994-11#2)(1994-12#1)(1997-8#1)
Comparison of clinical##2##3##(2011-2#1)(2013-7#1)
Comparison of different methods for##2##5##(2007-6#1)(2009-8#1)
Comparison of different##7##3##(1991-8#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2011-2#1)
Comparison of direct##2##3##(2008-10#1)(2008-3#1)
Comparison of experimental##2##3##(2007-12#1)(2008-6#1)
Comparison of magnetic resonance imaging##2##5##(2007-4#1)(2012-3#1)
Comparison of oral##2##3##(1996-8#1)(2007-7#1)
Comparison of plasma##2##3##(1992-11#1)(2008-12#1)
Comparison of real-time##2##3##(2012-2#1)(2012-3#1)
Comparison of results with##2##4##(2008-10#1)(2008-7#1)
Comparison of results##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
Comparison of several##2##3##(1995-2#1)(2012-5#1)
Comparison of sun##2##3##(2008-2#1)(2008-5#1)
Comparison of the cDNA##2##4##(1991-11#1)(1991-9#1)
Comparison of the deduced##3##4##(1991-6#1)(1994-12#1)(2008-10#1)
Comparison of the effect of ELF on##2##7##(1992-3#2)
Comparison of the effects of##5##5##(1991-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(2012-3#1)
Comparison of the genomic##2##4##(1992-3#1)(1992-6#1)
Comparison of the in##2##4##(1993-3#1)(2008-5#1)
Comparison of the nucleotide sequence of##3##6##(1990-2#1)(1992-11#1)(2008-10#1)
Comparison of the predicted##3##4##(1993-2#1)(2008-10#1)(2008-3#1)
Comparison of the relative##2##4##(2008-10#1)(2010-12#1)
Comparison of the results obtained with##2##6##(1992-6#1)(2007-11#1)
Comparison of the results obtained##3##5##(1992-6#1)(2007-11#1)(2008-10#1)
Comparison of the results##7##4##(1992-6#1)(1994-2#1)(2007-11#1)(2008-10#3)(2012-1#1)
Comparison of the sequences of##2##5##(1995-11#1)(2010-4#1)
Comparison of the sequences##4##4##(1995-11#1)(1997-2#1)(2008-10#1)(2010-4#1)
Comparison of the two##2##4##(1991-11#1)(2008-6#1)
Comparison of the##99##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#3)
Comparison of these##4##3##(1993-11#1)(1995-6#1)(1997-7#1)(2008-10#1)
Comparison of three methods for##2##5##(1994-12#1)(2008-6#1)
Comparison of three##4##3##(1994-12#1)(2008-10#2)(2008-6#1)
Comparison of two##9##3##(1990-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-3#1)(2011-2#1)
Comparison of ultrasound-assisted extraction and##2##5##(2008-10#2)
Comparison of ultrasound-assisted extraction##3##4##(2008-10#2)(2013-1#1)
Comparison of various##3##3##(1997-8#1)(2008-3#1)(2010-4#1)
Comparison of##360##2##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#4)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#67)(2008-11#11)(2008-12#9)(2008-2#8)(2008-3#25)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#4)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#11)(2012-1#3)(2012-12#5)(2012-2#5)(2012-3#9)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#2)
Comparison to the##2##3##(1993-11#1)(1997-2#1)
Comparison to##5##2##(1992-9#1)(1993-11#1)(1997-2#1)(2008-10#1)(2013-8#1)
Comparison was made in some other properties between Epo produced by these astrocyte cell lines and that by CHO cells##2##20##(2008-11#2)
Comparison was made in##3##4##(2008-10#1)(2008-11#2)
Comparison was made##4##3##(2008-10#2)(2008-11#2)
Comparison with other##3##3##(1990-12#1)(1993-8#1)(2008-5#1)
Comparison with the##8##3##(1990-8#2)(1991-6#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-3#1)
Comparison with##35##2##(1990-12#1)(1990-8#3)(1991-3#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Comparison##450##1##(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#3)(1992-11#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#6)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-8#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-12#1)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#88)(2008-11#14)(2008-12#12)(2008-2#11)(2008-3#30)(2008-4#6)(2008-5#12)(2008-6#8)(2008-7#4)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#4)(2012-12#6)(2012-2#5)(2012-3#11)(2012-5#1)(2012-9#1)(2013-1#14)(2013-7#1)(2013-8#4)
Comparisons among##2##2##(1994-5#1)(2008-10#1)
Comparisons are drawn##2##3##(1995-1#1)(2008-2#1)
Comparisons are made between##2##4##(2008-10#1)(2008-3#1)
Comparisons are##5##2##(1991-12#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
Comparisons between the##2##3##(2008-10#1)(2008-3#1)
Comparisons between##11##2##(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-5#1)
Comparisons of experimental##2##3##(2007-12#1)(2009-2#1)
Comparisons of the##10##3##(1992-3#1)(1995-1#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-7#1)
Comparisons of##32##2##(1990-3#1)(1992-11#1)(1992-3#2)(1993-2#1)(1995-1#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-2#2)(2012-12#1)
Comparisons showed that##2##3##(2008-3#1)(2008-7#1)
Comparisons showed##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
Comparisons with other##4##3##(1992-12#1)(2008-10#2)(2010-10#1)
Comparisons with##17##2##(1991-9#1)(1992-12#1)(1993-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2010-10#1)
Comparisons##77##1##(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-6#1)(1994-5#1)(1995-1#2)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-5#1)
Compartment syndrome##2##2##(2008-12#1)(2009-3#1)
Compartment##4##1##(2008-12#1)(2009-3#1)(2012-12#1)(2013-8#1)
Compartmental analysis##2##2##(1990-11#1)(2008-7#1)
Compatibility Groups of##2##3##(2008-10#2)
Compatibility Groups##6##2##(2008-10#6)
Compatibility of##2##2##(2007-11#2)
Compatibility##16##1##(2007-11#2)(2008-10#11)(2011-2#1)(2013-8#2)
Compatible##3##1##(2008-10#2)(2011-2#1)
Compensating##2##1##(1992-1#1)(2009-6#1)
Compensation for##3##2##(2007-11#1)(2007-12#2)
Compensation in a##2##3##(1995-12#1)(1996-3#1)
Compensation in##3##2##(1995-12#1)(1996-3#1)(2008-9#1)
Compensation of##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
Compensation##16##1##(1991-12#3)(1995-12#1)(1996-3#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
Compensatory homeostasis##2##2##(2012-2#2)
Compensatory##6##1##(1993-5#1)(1994-5#1)(2009-10#1)(2012-2#3)
Competence of##2##2##(1997-4#1)(2008-10#1)
Competence##6##1##(1995-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
Competency Standards##2##2##(2007-11#2)
Competency and##2##2##(1994-2#1)(2008-4#1)
Competency##5##1##(1994-2#1)(1996-2#1)(2007-11#2)(2008-4#1)
Competency-based##3##1##(1995-1#1)(1995-3#1)(2008-11#1)
Competing##5##1##(1997-2#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
Competition among##2##2##(2008-10#1)(2008-9#1)
Competition between##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
Competition binding##2##2##(1991-8#1)(1994-6#1)
Competition experiments##4##2##(1993-6#1)(2006-6#1)(2008-10#2)
Competition for##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
Competition in##2##2##(1997-3#1)(2008-9#1)
Competition of##4##2##(1993-3#1)(1996-5#1)(2007-12#1)(2008-8#1)
Competition##37##1##(1990-11#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-8#5)(2008-9#4)(2009-10#1)
Competitive Fitness of Phytophthora infestans Isolates##2##6##(2008-10#2)
Competitive binding##2##2##(2010-11#1)(2013-1#1)
Competitive##17##1##(1992-6#2)(1993-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2010-11#1)(2013-1#1)
Compilation of##3##2##(1996-12#1)(2008-10#1)(2011-3#1)
Complaint##2##1##(1996-2#2)
Complaints##5##1##(1991-6#2)(2008-6#1)(2009-6#1)(2012-12#1)
Complement C3##2##2##(1990-8#1)(2008-6#1)
Complement activation##2##2##(1993-11#1)(1994-11#1)
Complement##7##1##(1990-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
Complementary DNA##3##2##(1993-6#1)(1997-8#1)(2008-10#1)
Complementary DNAs##2##2##(1994-3#1)(2008-6#1)
Complementary and Alternative Medicine##2##4##(2008-10#1)(2009-5#1)
Complementary and alternative##2##3##(2008-10#1)(2013-1#1)
Complementary and##4##2##(2008-10#2)(2009-5#1)(2013-1#1)
Complementary medicine##4##2##(1993-7#4)
Complementary##27##1##(1991-9#1)(1993-6#1)(1993-7#4)(1994-3#2)(1995-11#1)(1995-3#1)(1997-8#2)(2007-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-5#1)(2013-1#2)(2013-7#1)
Complementation of##2##2##(2008-10#2)
Complementation##3##1##(2008-10#2)(2008-9#1)
Complemented##2##1##(2008-10#2)
Complete Block Design with four replications##2##6##(2008-12#2)
Complete Block Design with##3##4##(2008-12#3)
Complete Nucleotide Sequence##2##3##(1994-12#1)(2008-10#1)
Complete clearance of##2##3##(1996-1#1)(2008-8#1)
Complete closure##2##2##(1997-8#1)(2008-3#1)
Complete data were##2##3##(1993-11#1)(2012-3#1)
Complete data##3##2##(1993-11#1)(2008-5#1)(2012-3#1)
Complete excision##2##2##(2008-6#1)(2010-3#1)
Complete genome sequence of Meiothermus##2##5##(2011-2#2)
Complete genome sequence of Rhizobium leguminosarum bv##2##7##(2011-2#2)
Complete genome sequence of##45##4##(2011-2#45)
Complete genome##46##2##(2008-10#1)(2011-2#45)
Complete nucleotide sequence##2##3##(1994-9#1)(2008-8#1)
Complete occlusion of the##2##4##(2006-12#1)(2007-8#1)
Complete occlusion of##3##3##(2006-12#1)(2007-8#2)
Complete protection##2##2##(1990-6#2)
Complete radiological##2##2##(2008-6#1)(2010-5#1)
Complete regression of##2##3##(1990-6#2)
Complete remission##3##2##(1995-5#1)(2007-4#1)(2011-2#1)
Complete resolution of##2##3##(2012-8#1)(2013-1#1)
Complete resolution##3##2##(2011-2#1)(2012-8#1)(2013-1#1)
Complete responses##2##2##(2008-5#2)
Complete separation of##3##3##(1996-5#1)(2008-10#2)
Complete tumor resection was##2##4##(2011-2#2)
Complete##154##1##(1990-3#1)(1990-6#4)(1991-11#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#1)(1994-9#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#10)(2008-11#2)(2008-12#7)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-2#50)(2012-1#2)(2012-3#1)(2012-8#1)(2013-1#5)(2013-8#2)
Completed##5##1##(1993-12#1)(1994-2#1)(1996-1#1)(2008-10#1)(2011-2#1)
Completely##3##1##(2008-12#1)(2008-5#1)(2008-6#1)
Completion of the##2##3##(2008-10#1)(2010-10#1)
Completion of##3##2##(1997-2#1)(2008-10#1)(2010-10#1)
Completion##9##1##(1990-11#1)(1997-2#1)(2007-10#1)(2008-10#1)(2010-10#1)(2011-2#4)
Complex 1##2##2##(2007-11#2)
Complex 2##3##2##(1996-2#1)(2007-11#1)(2013-1#1)
Complex 3##2##2##(1996-2#1)(1997-7#1)
Complex 5(b)##2##2##(2012-12#2)
Complex I##2##2##(1991-12#1)(1994-11#1)
Complex Regional Pain Syndrome##2##4##(2008-12#1)(2008-9#1)
Complex formation was##2##3##(2008-10#1)(2012-2#1)
Complex formation##5##2##(1995-2#1)(1995-6#1)(2008-10#2)(2012-2#1)
Complex in##2##2##(1997-7#1)(2008-10#1)
Complex of##4##2##(1996-2#1)(2008-5#1)(2013-1#2)
Complex##99##1##(1991-12#2)(1992-8#1)(1994-11#2)(1994-6#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#12)(1996-3#1)(1996-9#1)(1997-7#6)(2007-11#6)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#3)(2009-9#1)(2010-1#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#3)
Complexation and fluorescence behavior of##2##5##(2008-10#2)
Complexation and##3##2##(2008-10#3)
Complexation of##4##2##(2008-10#4)
Complexation##8##1##(2008-10#8)
Complexe hospitalier de la Sagamie##2##5##(2008-2#2)
Complexed##3##1##(2008-10#1)(2008-8#1)(2010-12#1)
Complexes (M =##2##3##(1996-2#2)
Complexes Containing##2##2##(1996-2#1)(1997-7#1)
Complexes of##8##2##(1990-5#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-5#1)(2009-9#1)(2010-11#1)
Complexes with##2##2##(1994-8#1)(1996-2#1)
Complexes##41##1##(1990-5#1)(1994-8#1)(1996-2#9)(1997-7#11)(2007-11#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
Complexities in##2##2##(2008-7#1)(2010-1#1)
Complexities of##2##2##(1997-2#1)(1997-6#1)
Complexities##4##1##(1997-2#1)(1997-6#1)(2008-7#1)(2010-1#1)
Complexity##3##1##(2009-8#2)(2011-2#1)
Compliance is##2##2##(1993-11#1)(2011-1#1)
Compliance to##2##2##(1991-8#1)(2013-8#1)
Compliance was##3##2##(1994-2#1)(1996-8#1)(2008-11#1)
Compliance##13##1##(1991-8#1)(1993-11#1)(1994-2#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#3)(2011-1#1)(2013-8#2)
Complicated urinary tract infection##2##4##(2007-12#2)
Complicated##6##1##(2007-12#2)(2008-3#1)(2008-9#1)(2010-3#1)(2010-8#1)
Complicating##3##1##(2008-1#1)(2010-1#1)(2013-8#1)
Complication of##3##2##(2007-11#1)(2012-1#1)(2013-1#1)
Complication rates##2##2##(2007-8#1)(2012-3#1)
Complication##9##1##(2007-11#1)(2007-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
Complications after##4##2##(2007-11#1)(2008-6#2)(2012-12#1)
Complications and##3##2##(2007-8#1)(2008-3#1)(2011-2#1)
Complications associated with##5##3##(2007-11#1)(2007-12#3)(2012-12#1)
Complications can be##2##3##(1996-11#1)(2007-11#1)
Complications in the treatment of##2##5##(2007-12#2)
Complications in##4##2##(2007-12#3)(2008-1#1)
Complications included 1 patient with##2##5##(1994-3#1)(2008-7#1)
Complications included##6##2##(1991-1#1)(1994-3#1)(2007-8#1)(2008-7#1)(2009-10#1)(2013-8#1)
Complications of intradural##2##3##(2012-3#2)
Complications of##12##2##(1992-5#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2009-8#1)(2012-3#2)(2013-1#1)
Complications such as##2##3##(2010-3#1)(2011-2#1)
Complications were##4##2##(1991-3#1)(2007-7#1)(2008-1#1)(2009-3#1)
Complications##65##1##(1991-1#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#11)(2007-7#2)(2007-8#3)(2008-1#4)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#1)
Component of##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
Component##12##1##(2008-10#4)(2008-2#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
Components Analysis (PCA)##2##3##(2007-5#1)(2008-10#1)
Components Analysis##4##2##(2007-5#1)(2008-10#1)(2010-7#1)(2012-2#1)
Components of a##3##3##(1991-12#1)(1996-1#1)(1997-1#1)
Components of the##2##3##(2008-4#1)(2012-3#1)
Components of##14##2##(1991-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1997-1#1)(2008-10#4)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
Components##30##1##(1991-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#1)
Composing##2##1##(1996-3#1)(2008-9#1)
Composite interval mapping##2##3##(2008-10#1)(2012-3#1)
Composite##14##1##(1995-2#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
Composition and##3##2##(2008-10#1)(2008-8#1)(2012-8#1)
Composition of##3##2##(1991-12#1)(2011-2#1)(2012-2#1)
Composition##17##1##(1991-12#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)
Compost tea##2##2##(2008-10#2)
Compost##8##1##(2008-10#8)
Composted Swine##2##2##(2008-10#2)
Composted##3##1##(2008-10#3)
Composting of##2##2##(2008-12#2)
Composting##3##1##(2008-12#3)
Composts##2##1##(2008-10#2)
Compound 1##5##2##(1990-7#5)
Compound 16##2##2##(1992-12#2)
Compound 2 was##3##3##(2007-11#3)
Compound 2##6##2##(1996-2#1)(2007-11#4)(2008-8#1)
Compound 3##2##2##(1996-2#1)(1996-5#1)
Compound 48/80##3##2##(1992-3#3)
Compound##38##1##(1990-7#5)(1991-11#1)(1992-12#2)(1992-3#4)(1994-6#1)(1994-8#2)(1995-3#3)(1996-2#2)(1996-5#1)(2007-11#6)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-8#2)
Compounds 1 and 2 showed##2##5##(2008-11#1)(2010-6#1)
Compounds 1 and 2##3##4##(2008-11#2)(2010-6#1)
Compounds 1##5##2##(2008-11#3)(2010-6#1)(2011-3#1)
Compounds 8##2##2##(2012-3#1)(2013-1#1)
Compounds containing##2##2##(1995-3#1)(1995-6#1)
Compounds in##3##2##(1992-8#2)(2009-8#1)
Compounds on##2##2##(2008-10#1)(2010-11#1)
Compounds with##2##2##(1995-3#1)(2013-1#1)
Compounds##41##1##(1990-2#1)(1992-5#1)(1992-8#2)(1994-8#1)(1995-3#3)(1995-6#1)(1996-2#3)(1996-5#7)(2008-10#3)(2008-11#4)(2008-3#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-3#2)(2012-3#3)(2013-1#3)
Comprehension of##2##2##(1997-3#1)(2008-11#1)
Comprehensive Health##3##2##(1994-1#1)(1995-2#1)(2008-1#1)
Comprehensive Stroke##2##2##(2013-8#2)
Comprehensive assessment of##2##3##(1990-3#1)(2010-9#1)
Comprehensive two-dimensional gas chromatography with##2##5##(2008-10#2)
Comprehensive two-dimensional gas chromatography##3##4##(2008-10#3)
Comprehensive##38##1##(1990-3#1)(1992-1#1)(1994-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Compression of the##2##3##(2008-12#1)(2008-9#1)
Compression of##7##2##(1994-2#1)(2008-12#1)(2008-2#2)(2008-9#1)(2011-2#1)(2013-1#1)
Compression with##2##2##(2008-3#1)(2009-3#1)
Compression##15##1##(1994-2#1)(2007-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#2)(2013-1#2)
Compromised##3##1##(2008-10#1)(2008-8#1)(2012-3#1)
Compulsory community treatment?##2##3##(1994-1#2)
Compulsory##4##1##(1994-1#2)(1997-8#1)(2011-2#1)
Computation of##2##2##(2008-2#1)(2008-3#1)
Computation##3##1##(2008-2#1)(2008-3#1)(2012-3#1)
Computational Biology##2##2##(2008-7#1)(2011-2#1)
Computational fluid dynamics##3##3##(2007-8#1)(2010-3#2)
Computational fluid##4##2##(2007-8#1)(2010-3#2)(2013-1#1)
Computational identification of##2##3##(2008-9#1)(2011-3#1)
Computational modeling##3##2##(2007-8#1)(2010-9#1)(2013-8#1)
Computational results##4##2##(2008-2#1)(2008-3#3)
Computational##35##1##(1993-8#1)(1995-5#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#3)
Computations with##2##2##(2007-12#1)(2008-3#1)
Computations##5##1##(2007-12#2)(2008-3#2)(2009-5#1)
Computed Tomography##7##2##(2007-8#1)(2008-12#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
Computed tomographic angiography##3##3##(2011-2#1)(2013-1#2)
Computed tomographic##8##2##(1991-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#2)
Computed tomography (CT) is##2##4##(2011-3#1)(2012-2#1)
Computed tomography (CT) scans##2##4##(2008-5#1)(2013-8#1)
Computed tomography (CT)##8##3##(1996-9#1)(2007-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
Computed tomography and magnetic resonance imaging of##2##7##(2007-10#1)(2011-2#1)
Computed tomography and magnetic resonance imaging##4##6##(2007-10#1)(2008-7#1)(2011-2#2)
Computed tomography and##6##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#2)
Computed tomography in##2##3##(2007-8#1)(2010-12#1)
Computed tomography of the##3##4##(1997-8#1)(2007-8#1)(2008-8#1)
Computed tomography scan##4##3##(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)
Computed tomography with##2##3##(1997-8#1)(2009-3#1)
Computed tomography##37##2##(1990-11#1)(1990-9#1)(1996-9#1)(1997-8#2)(2007-10#4)(2007-11#1)(2007-8#5)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Computed tomography-guided##2##2##(2009-3#2)
Computed##56##1##(1990-11#1)(1990-9#1)(1991-3#1)(1996-9#1)(1997-8#2)(2007-10#4)(2007-11#1)(2007-8#6)(2008-1#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
ComputedTomography Severity Index##2##3##(2009-8#2)
Computer alignment##2##2##(1993-6#1)(2008-8#1)
Computer analysis of the##2##4##(1995-8#1)(2008-8#1)
Computer analysis of##3##3##(1995-8#1)(1996-6#1)(2008-8#1)
Computer analysis##5##2##(1992-8#1)(1992-9#1)(1995-8#1)(1996-6#1)(2008-8#1)
Computer and##2##2##(2008-11#1)(2013-8#1)
Computer applications##2##2##(1993-1#1)(1997-2#1)
Computer literacy##2##2##(1996-1#1)(2008-11#1)
Computer modelling of##3##3##(1996-12#1)(2008-7#1)(2012-2#1)
Computer modelling##4##2##(1996-12#1)(2008-7#2)(2012-2#1)
Computer simulation shows that an array of##2##7##(2008-3#2)
Computer simulation shows##3##3##(2008-3#3)
Computer simulation##10##2##(1995-6#1)(2008-10#1)(2008-3#6)(2008-9#1)(2010-8#1)
Computer simulations and##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
Computer simulations are##2##3##(2008-2#1)(2008-3#1)
Computer simulations as well as##2##5##(2008-3#2)
Computer simulations indicate that the##2##5##(1994-2#1)(2008-4#1)
Computer simulations of the##4##4##(1992-7#1)(1995-6#1)(2008-2#1)(2008-3#1)
Computer simulations of##5##3##(1992-7#1)(1995-6#1)(2008-2#2)(2008-3#1)
Computer simulations show that##2##4##(2008-10#1)(2008-3#1)
Computer simulations##22##2##(1992-7#1)(1994-2#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#1)
Computer software##2##2##(1993-3#1)(1994-2#1)
Computer##69##1##(1990-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#5)(2008-2#6)(2008-3#16)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
Computer-aided##4##1##(1993-12#1)(2008-1#1)(2008-10#1)(2009-11#1)
Computer-assisted and frameless##2##3##(2008-7#2)
Computer-assisted decision support##2##3##(2011-2#2)
Computer-assisted sequence##2##2##(1994-6#1)(2008-10#1)
Computer-assisted##11##1##(1992-12#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-7#2)(2009-12#1)(2011-2#2)(2013-1#1)
Computer-based##5##1##(1993-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
Computer-generated holograms of##2##3##(2008-3#2)
Computer-generated holograms##3##2##(2008-3#3)
Computer-generated##5##1##(2008-3#5)
Computerization of##2##2##(1994-3#1)(1995-1#1)
Computerized tomography##7##2##(2007-10#1)(2007-11#3)(2008-11#2)(2008-6#1)
Computerized##26##1##(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#2)(2011-1#2)(2013-1#1)
Computers and##2##2##(1996-12#2)
Computers in##2##2##(1995-9#1)(1997-2#1)
Computers##5##1##(1992-12#1)(1995-9#1)(1996-12#2)(1997-2#1)
Computing##9##1##(1993-1#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-3#1)(2009-9#2)
Con A +##2##3##(1991-12#2)
Con A was##2##3##(1991-12#1)(2008-10#1)
Con A##17##2##(1991-12#4)(1992-8#1)(1994-11#1)(1995-2#1)(2008-10#8)(2008-9#2)
Con A-His##2##2##(1994-11#2)
Con A-stimulated##2##2##(2008-7#2)
Con##34##1##(1991-1#1)(1991-12#7)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#2)(1994-11#4)(1994-8#1)(1995-2#1)(2006-6#1)(2008-10#9)(2008-7#2)(2008-9#2)
ConA and LPS##2##3##(1995-12#2)
ConA and##3##2##(1995-12#3)
ConA##5##1##(1995-12#5)
ConA-stimulated##2##1##(1995-12#2)
Concanamycin A##2##2##(1994-6#2)
Concanavalin A (Con A)##2##4##(1994-8#1)(2012-3#1)
Concanavalin A (Con##3##3##(1991-12#1)(1994-8#1)(2012-3#1)
Concanavalin A##8##2##(1991-12#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-7#1)(2008-10#1)(2012-3#1)
Concanavalin##10##1##(1991-12#1)(1991-5#1)(1992-12#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-7#1)(2008-10#1)(2012-3#1)
Concentrated##2##1##(2008-10#1)(2008-7#1)
Concentration and##4##2##(1991-5#1)(2008-10#2)(2009-3#1)
Concentration dependent##2##2##(2008-10#1)(2008-7#1)
Concentration in##3##2##(1996-12#1)(1996-9#1)(2008-3#1)
Concentration measurements of##2##3##(2008-3#2)
Concentration of heavy##2##3##(2008-10#1)(2008-12#1)
Concentration of##17##2##(1994-6#1)(1994-7#1)(1994-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
Concentration polarization##3##2##(2008-7#2)(2008-9#1)
Concentration##41##1##(1991-5#1)(1991-9#2)(1993-8#1)(1994-6#1)(1994-7#1)(1994-9#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-7#5)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#1)
Concentration-dependent##2##1##(1997-2#1)(2009-6#1)
Concentrations for##2##2##(2008-10#1)(2011-2#1)
Concentrations in##3##2##(2008-10#2)(2008-3#1)
Concentrations of 0##3##3##(2008-10#2)(2008-5#1)
Concentrations of total##2##3##(2008-5#1)(2010-5#1)
Concentrations of##26##2##(1990-11#1)(1993-8#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-1#1)(2013-8#1)
Concentrations##36##1##(1990-11#1)(1993-8#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Concentric Tube Robots##2##3##(2012-1#1)(2012-2#1)
Concentric rings##2##2##(2008-10#2)
Concentric tube robots are a novel##2##6##(2012-1#1)(2012-2#1)
Concentric##8##1##(1994-3#1)(2008-10#2)(2012-1#3)(2012-2#2)
Concept of##3##2##(1994-2#1)(2008-10#1)(2010-8#1)
Concept##14##1##(1994-2#1)(1995-4#1)(1996-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2010-8#1)(2011-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
Conception##3##1##(2008-4#1)(2008-7#1)(2010-12#1)
Concepts and##2##2##(2009-6#1)(2011-2#1)
Concepts of##2##2##(2008-4#1)(2012-2#1)
Concepts such as##2##3##(1993-1#1)(2008-10#1)
Concepts##10##1##(1993-1#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
Conceptual##8##1##(1990-11#1)(1996-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#3)
Conceptualization##2##1##(2008-6#1)(2009-9#1)
Conceptually##8##1##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#2)
Concern about##3##2##(1991-12#1)(1994-9#1)(2007-12#1)
Concern##6##1##(1991-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2007-12#1)(2010-11#1)
Concerning the##14##2##(1995-2#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2013-1#2)
Concerning##20##1##(1995-2#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
Concerns about##7##2##(1993-3#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-3#1)
Concerns##16##1##(1993-3#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-7#1)
Concerted##2##1##(1996-2#1)(2009-8#1)
Concise review##5##2##(2012-12#5)
Concise##7##1##(2009-12#2)(2012-12#5)
Concluding##3##1##(2008-8#1)(2010-2#1)(2012-2#1)
Conclusion -##2##2##(2008-11#2)
Conclusion More##2##2##(2008-7#1)(2012-12#1)
Conclusion The above results##2##4##(2013-1#2)
Conclusion The##7##2##(2011-2#3)(2012-12#2)(2013-1#2)
Conclusion There was##2##3##(2012-12#1)(2013-8#1)
Conclusion There##3##2##(2012-12#2)(2013-8#1)
Conclusion##238##1##(1993-8#1)(1996-3#1)(1996-8#1)(2007-10#7)(2007-11#10)(2007-2#2)(2007-7#4)(2007-8#7)(2008-10#8)(2008-11#3)(2008-5#5)(2008-6#4)(2008-7#12)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#7)(2010-6#1)(2010-8#4)(2011-1#12)(2011-2#26)(2012-12#29)(2012-2#5)(2012-3#9)(2012-8#2)(2013-1#39)(2013-8#32)
Conclusions &amp##4##2##(2012-3#4)
Conclusions -##4##2##(2008-11#4)
Conclusions A##2##2##(2011-2#2)
Conclusions The prevalence of##2##4##(2011-2#1)(2012-12#1)
Conclusions The##18##2##(2008-8#1)(2011-2#6)(2012-12#8)(2013-1#2)(2013-8#1)
Conclusions This study##2##3##(2009-8#1)(2012-12#1)
Conclusions This##3##2##(2009-8#1)(2011-2#1)(2012-12#1)
Conclusions drawn from##2##3##(1996-6#1)(2010-3#1)
Conclusions##446##1##(1991-11#2)(1992-6#1)(1993-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(2006-10#2)(2006-8#2)(2007-10#1)(2007-11#69)(2007-2#10)(2007-7#3)(2007-8#31)(2008-11#4)(2008-3#13)(2008-5#1)(2008-6#11)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#6)(2010-12#1)(2010-3#1)(2010-8#4)(2011-1#9)(2011-2#32)(2012-1#7)(2012-12#50)(2012-2#5)(2012-3#20)(2013-1#117)(2013-7#1)(2013-8#24)
Conclusions-##3##1##(2008-11#3)
Conclusions  Our##2##2##(2011-2#2)
Conclusions  The##2##2##(2011-2#2)
Conclusions  This study##2##3##(2011-2#1)(2013-1#1)
Conclusions ##13##1##(2011-2#7)(2012-1#5)(2013-1#1)
Conclusion ##5##1##(2011-2#1)(2012-3#4)
Concomitant treatment##2##2##(1995-12#1)(2008-7#1)
Concomitant with this##2##3##(1990-10#1)(2008-12#1)
Concomitant with##4##2##(1990-10#1)(2008-10#2)(2008-12#1)
Concomitant##18##1##(1990-10#1)(1992-8#2)(1995-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-1#1)
Concomitantly##8##1##(1990-12#1)(1994-11#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
Concord grapes##2##2##(2008-10#2)
Concord##6##1##(2008-10#6)
Concordance between##3##2##(1992-3#1)(2012-3#2)
Concordance##5##1##(1992-3#1)(1992-8#1)(2008-7#1)(2012-3#2)
Concurrence of##2##2##(2012-2#2)
Concurrent validity##2##2##(1994-1#1)(2013-7#1)
Concurrent##20##1##(1991-1#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#3)(2012-3#2)(2013-7#1)
Concurrently##17##1##(1990-7#1)(1992-12#1)(1992-6#1)(1995-2#1)(1997-1#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#2)(2010-4#1)(2011-2#1)(2013-7#1)
Condensation##3##1##(1996-5#2)(2009-7#1)
Condition##4##1##(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)
Conditional##4##1##(2008-8#1)(2009-6#1)(2010-4#1)(2013-1#1)
Conditioned##4##1##(1991-2#1)(1992-9#1)(2008-4#2)
Conditioning##6##1##(2008-10#3)(2008-5#1)(2010-11#1)(2012-12#1)
Conditions and##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
Conditions for the##2##3##(1997-3#1)(2008-10#1)
Conditions for##10##2##(1990-12#1)(1992-6#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-2#1)
Conditions have been##2##3##(2008-10#1)(2008-11#1)
Conditions of##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
Conditions such as##2##3##(2008-10#1)(2008-5#1)
Conditions that promote##2##3##(2008-6#2)
Conditions that##4##2##(2008-6#2)(2010-3#1)(2013-8#1)
Conditions under which##2##3##(2007-11#1)(2008-8#1)
Conditions were##2##2##(1990-7#1)(2008-10#1)
Conditions##56##1##(1990-12#1)(1990-7#1)(1992-3#1)(1992-6#1)(1993-6#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#2)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Condoms##3##1##(1994-3#1)(2008-10#1)(2009-12#1)
Conduct##4##1##(2008-4#1)(2010-11#1)(2011-2#2)
Conducting polymer##4##2##(2008-10#4)
Conducting research in##2##3##(2008-9#1)(2010-3#1)
Conducting research##3##2##(2008-9#1)(2010-3#1)(2010-9#1)
Conducting##10##1##(1996-12#1)(2008-10#5)(2008-2#1)(2008-9#1)(2010-3#1)(2010-9#1)
Conduction disturbances##2##2##(1994-6#2)
Conduction velocities##2##2##(1993-3#1)(2009-5#1)
Conduction##8##1##(1993-3#1)(1994-6#2)(2006-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
Conductive##2##1##(2008-10#1)(2009-11#1)
Conductivity##4##1##(1996-9#1)(2008-10#2)(2008-12#1)
Conductometric##5##1##(2008-10#5)
Condyle##2##1##(2007-12#1)(2013-1#1)
Cone Beam CT##2##3##(2013-1#2)
Cone Beam##3##2##(2008-5#1)(2013-1#2)
Cone##6##1##(2007-5#1)(2008-3#2)(2008-5#1)(2013-1#2)
Conexibacter woesei##2##2##(2011-2#2)
Conexibacter##3##1##(2011-2#3)
Conexão##2##1##(2013-1#2)
Confederation##4##1##(1993-3#1)(2008-11#3)
Confer##2##1##(2008-10#2)
Conference Centre##2##2##(2008-7#2)
Conference attendees##2##2##(1990-4#1)(1995-12#1)
Conference in##7##2##(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)
Conference of the##3##3##(2008-12#1)(2008-7#2)
Conference of##7##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)
Conference on Osteoporosis##2##3##(1993-11#2)
Conference on##38##2##(1992-1#1)(1992-2#1)(1993-11#2)(1994-9#2)(1995-12#1)(1996-1#2)(1996-5#1)(1997-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)
Conference proceedings##2##2##(1995-3#1)(1995-5#1)
Conference##115##1##(1990-4#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-9#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-5#1)(1997-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#17)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#9)(2008-6#1)(2008-7#15)(2008-8#7)(2008-9#1)(2009-5#1)(2010-11#3)(2010-12#1)(2010-3#2)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
Conferences##3##1##(2008-5#1)(2008-7#2)
Conferring Resistance to##2##3##(2008-10#2)
Conferring##3##1##(2008-10#3)
Confers Resistance to##2##3##(2008-10#2)
Confers##6##1##(2008-10#4)(2010-12#1)(2012-3#1)
Confide##3##1##(1996-5#3)
Confidence##6##1##(1997-3#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-5#1)
Confidentiality and##2##2##(1995-3#1)(1997-1#1)
Confidentiality of health care information##2##5##(1992-12#1)(1996-2#1)
Confidentiality##10##1##(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-5#1)
Configuration of##2##2##(2008-10#1)(2013-1#1)
Configuration##3##1##(2008-10#1)(2008-2#1)(2013-1#1)
Confined##2##1##(2008-10#1)(2008-3#1)
Confinement##3##1##(1996-12#1)(2008-3#2)
Confirmation of the##2##3##(1990-11#1)(2008-10#1)
Confirmation of##8##2##(1990-11#1)(1991-11#1)(1996-12#1)(1996-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
Confirmation##11##1##(1990-11#1)(1991-11#1)(1996-12#1)(1996-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#2)
Confirmatory Factor Analysis##2##3##(2012-2#2)
Confirmatory factor analysis##2##3##(2008-12#1)(2011-2#1)
Confirmatory##5##1##(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#2)
Confirmed##7##1##(1991-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
Conflict of interest##37##3##(1992-8#1)(2008-8#1)(2011-1#34)(2013-1#1)
Conflict of##39##2##(1992-8#1)(2008-8#1)(2011-1#35)(2012-12#1)(2013-1#1)
Conflict##48##1##(1992-8#1)(1996-12#1)(2007-5#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-8#1)(2011-1#35)(2011-2#1)(2012-12#2)(2013-1#1)
Conflicting##4##1##(2007-3#1)(2008-5#1)(2012-1#1)(2012-12#1)
Conflicts##4##1##(1991-6#1)(1994-3#1)(1995-5#1)(1997-3#1)
Confluent##3##1##(1992-5#1)(1994-11#2)
Confocal imaging##2##2##(2008-3#2)
Confocal microscopy##7##2##(1992-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-3#1)
Confocal##21##1##(1992-11#1)(1997-6#3)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#2)(2011-3#1)(2012-2#2)(2013-1#1)
Conformal##3##1##(2008-10#1)(2008-11#1)(2008-6#1)
Conformation of##2##2##(1993-11#1)(2008-5#1)
Conformation##8##1##(1993-11#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)
Conformational Change##2##2##(2008-5#1)(2009-5#1)
Conformational changes in the##2##4##(1992-3#1)(1994-5#1)
Conformational changes in##3##3##(1992-3#1)(1992-5#1)(1994-5#1)
Conformational changes##6##2##(1990-7#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-5#1)(2010-10#1)
Conformational studies on##2##3##(1990-5#1)(2008-8#1)
Conformational##22##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-5#1)(1996-5#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#2)(2010-10#1)
Conformations of##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
Conformations##5##1##(1992-8#1)(1993-11#1)(1996-5#1)(2008-10#1)(2011-2#1)
Conformer##2##1##(1991-3#2)
Confounder##2##1##(2011-2#1)(2012-12#1)
Confounding##2##1##(2008-11#1)(2008-7#1)
Confronting##2##1##(1992-12#1)(1995-12#1)
Confucian##4##1##(2010-8#4)
Confusion##6##1##(1995-9#1)(1997-3#1)(2007-5#1)(2008-3#1)(2008-7#1)(2013-1#1)
Congenital absence of scaphoid##2##4##(2007-11#2)
Congenital absence of##4##3##(2007-11#2)(2008-9#1)(2011-1#1)
Congenital absence##5##2##(2007-11#2)(2008-9#1)(2011-1#2)
Congenital adrenal hyperplasia##3##3##(2007-7#1)(2008-1#1)(2010-2#1)
Congenital anomalies##2##2##(2008-10#1)(2010-8#1)
Congenital dislocation of the##2##4##(2007-11#1)(2010-3#1)
Congenital transmission##2##2##(2007-12#1)(2008-5#1)
Congenital##61##1##(1990-3#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
Congo##6##1##(1991-8#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)
Congress and the##2##3##(1994-2#1)(2008-7#1)
Congress and##4##2##(1992-1#1)(1994-2#1)(2008-6#1)(2008-7#1)
Congress appropriated##2##2##(1997-1#1)(2008-5#1)
Congress in##7##2##(1993-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-4#2)
Congress is##3##2##(1995-8#1)(2008-6#1)(2011-4#1)
Congress of the##8##3##(1991-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-3#1)(2010-6#1)(2011-2#2)
Congress of##20##2##(1990-12#2)(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
Congress on##12##2##(1991-1#1)(1993-3#1)(1996-2#1)(2008-7#1)(2008-8#2)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#2)
Congress passed##3##2##(1994-8#1)(1996-12#1)(2008-8#1)
Congress should##3##2##(1991-9#1)(1995-12#2)
Congress was##4##2##(1991-1#1)(2008-8#1)(2010-11#1)(2011-4#1)
Congress would##2##2##(1995-3#1)(2012-3#1)
Congress##99##1##(1990-12#2)(1990-2#1)(1990-8#2)(1991-1#8)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#6)(2009-2#1)(2009-5#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-4#4)(2012-3#2)(2013-1#3)
Congresses##3##1##(2008-7#2)(2011-4#1)
Congressional##5##1##(1995-12#1)(1995-3#1)(1995-6#1)(2009-6#1)(2012-3#1)
Congressman##2##1##(1995-3#1)(2011-2#1)
Conidia and##2##2##(2008-10#2)
Conidia from##2##2##(2008-10#2)
Conidia germinated on##2##3##(2008-10#2)
Conidia germinated##5##2##(2008-10#5)
Conidia of L##2##3##(2008-10#2)
Conidia of P##2##3##(2008-10#2)
Conidia of Trichoderma##2##3##(2008-10#2)
Conidia of##12##2##(2008-10#12)
Conidia##33##1##(2008-10#33)
Conidial germination##7##2##(2008-10#7)
Conidial production##2##2##(2008-10#2)
Conidial viability##3##2##(2008-10#3)
Conidial##23##1##(2008-10#23)
Conidiation##2##1##(2008-10#2)
Coniothyrium minitans##4##2##(2008-10#4)
Coniothyrium##5##1##(2008-10#4)(2010-3#1)
Conjoined##2##1##(2010-7#1)(2013-1#1)
Conjugated Polymer##2##2##(2009-2#1)(2009-8#1)
Conjugated linoleic##2##2##(2008-5#2)
Conjugated##8##1##(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-8#1)
Conjugates##2##1##(1997-1#1)(2008-10#1)
Conjugation of##5##2##(1990-12#1)(1992-12#1)(1994-9#1)(2008-4#1)(2008-9#1)
Conjugation##7##1##(1990-12#1)(1992-12#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)
Connect##2##1##(1993-1#1)(2013-1#1)
Connected with this##2##3##(2008-11#1)(2008-12#1)
Connected##4##1##(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#1)
Connecticut physicians##2##2##(1997-3#2)
Connecticut##15##1##(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#3)(2008-10#1)(2008-6#1)(2011-2#1)
Connecting##5##1##(1996-3#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
Connection##4##1##(1996-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
Connections##4##1##(2007-11#1)(2009-5#1)(2009-8#1)(2012-12#1)
Connective##2##1##(2008-6#1)(2013-1#1)
Connectivity##2##1##(2007-11#1)(2013-1#1)
Conoderus##6##1##(2011-2#6)
Conoscopic interferometry##2##2##(2008-3#2)
Conoscopic##3##1##(2008-3#3)
Conrad##2##1##(2008-10#2)
Conrad's##2##1##(2009-11#1)(2012-2#1)
Consanguinity##3##1##(2008-1#2)(2008-9#1)
Conscientiousness##5##1##(2010-12#2)(2011-2#2)(2012-1#1)
Conscious sedation##3##2##(1993-1#1)(1995-1#1)(2008-8#1)
Conscious##5##1##(1993-1#1)(1995-1#1)(1995-12#1)(2008-5#1)(2008-8#1)
Consecutive patients##2##2##(2012-12#1)(2012-2#1)
Consecutive transferring##2##2##(2008-10#2)
Consecutive##9##1##(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
Consed##6##1##(2008-4#6)
Consensus Conference on##4##3##(1993-11#1)(2008-8#3)
Consensus Conference##9##2##(1993-11#1)(2007-4#1)(2008-3#1)(2008-8#4)(2011-2#1)(2013-8#1)
Consensus Development Conference##4##3##(1991-3#1)(1991-8#1)(1993-11#1)(2008-2#1)
Consensus on Difficult-to-Control Asthma##2##4##(2009-6#2)
Consensus on##5##2##(1990-2#1)(1997-1#1)(2009-6#2)(2010-12#1)
Consensus statement on##2##3##(1997-5#1)(2008-10#1)
Consensus statement##4##2##(1995-12#1)(1996-8#1)(1997-5#1)(2008-10#1)
Consensus##36##1##(1990-2#1)(1990-7#1)(1991-3#2)(1991-4#1)(1991-8#1)(1993-11#2)(1995-12#1)(1996-8#1)(1997-1#1)(1997-5#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
Consent for##2##2##(1991-8#1)(2008-8#1)
Consent##6##1##(1990-2#1)(1991-8#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)
Consenting##2##1##(2009-10#1)(2012-3#1)
Consequence of##2##2##(1994-5#1)(1996-3#1)
Consequences for##4##2##(1990-11#1)(1991-6#1)(2008-10#1)(2008-2#1)
Consequences of##9##2##(1990-8#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-7#1)
Consequences##13##1##(1990-11#1)(1990-8#1)(1991-6#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2013-7#1)
Consequently the##3##2##(1996-1#1)(2008-10#2)
Consequently##155##1##(1990-8#1)(1991-1#1)(1991-3#1)(1992-3#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#6)(2012-6#1)(2013-1#8)(2013-8#2)
Conservation of##4##2##(1991-5#1)(1992-8#1)(1993-12#1)(2008-8#1)
Conservation##10##1##(1991-5#1)(1992-8#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
Conservative management of##2##3##(2008-10#1)(2009-5#1)
Conservative management##4##2##(2008-10#1)(2009-5#1)(2010-1#1)(2010-11#1)
Conservative surgery##2##2##(1993-11#1)(2008-4#1)
Conservative treatment of##4##3##(2007-8#1)(2008-4#1)(2010-11#1)(2011-2#1)
Conservative treatment##7##2##(1993-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)
Conservative##17##1##(1993-11#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Conserved N-terminal##2##2##(1990-2#1)(2012-2#1)
Conserved##8##1##(1990-2#1)(2008-10#1)(2008-4#1)(2012-2#3)(2012-3#1)(2013-8#1)
Consider the##2##2##(1991-2#1)(2008-4#1)
Consider##6##1##(1991-2#1)(1996-3#2)(2008-11#1)(2008-4#1)(2013-7#1)
Considerable concern was raised about the research purportedly conducted at Sri Venkateswara University##3##13##(2008-10#3)
Considerable data##2##2##(1991-1#1)(1993-2#1)
Considerable efforts are underway##2##4##(1997-3#1)(2008-8#1)
Considerable efforts are##3##3##(1997-3#1)(2008-8#1)(2012-2#1)
Considerable evidence##3##2##(1991-9#1)(2008-10#1)(2009-7#1)
Considerable progress has been##2##4##(1997-7#1)(2008-11#1)
Considerable variation in##3##3##(2008-10#3)
Considerable##35##1##(1991-1#1)(1991-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1996-1#1)(1997-3#2)(1997-7#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-2#1)
Consideration is given to the##2##5##(2008-3#1)(2010-6#1)
Consideration is##3##2##(2008-3#1)(2008-9#1)(2010-6#1)
Consideration of the##3##3##(2008-3#2)(2008-9#1)
Consideration of##8##2##(1992-8#1)(2008-3#4)(2008-7#2)(2008-9#1)
Consideration should be given to the##2##6##(1990-11#1)(2012-2#1)
Consideration##14##1##(1990-11#1)(1992-8#1)(2008-3#6)(2008-7#2)(2008-9#2)(2010-6#1)(2012-2#1)
Considerations for working with M##3##5##(2008-9#3)
Considerations for##7##2##(1997-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)
Considerations in##3##2##(1993-3#1)(2008-11#1)(2012-3#1)
Considerations of##2##2##(1992-3#1)(2008-5#1)
Considerations##14##1##(1992-3#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2012-3#1)
Considered a##2##2##(1996-8#1)(2012-3#1)
Considered##7##1##(1991-12#2)(1992-12#1)(1996-8#1)(2008-7#1)(2012-3#1)(2013-1#1)
Considering a##3##2##(2008-10#2)(2008-3#1)
Considering all##4##2##(2008-7#1)(2010-8#1)(2012-2#1)(2013-7#1)
Considering both##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
Considering that##8##2##(2008-11#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
Considering the fact that##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
Considering the high##3##3##(2008-10#1)(2011-2#2)
Considering the wide##2##3##(2007-12#1)(2013-1#1)
Considering the##42##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#1)(1993-9#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-7#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
Considering these results##2##3##(1994-8#1)(2013-7#1)
Considering these##3##2##(1994-8#1)(2013-1#1)(2013-7#1)
Considering##80##1##(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-1#1)(1996-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
Consistency and##2##2##(2010-7#1)(2013-1#1)
Consistency of##3##2##(1995-5#1)(1997-8#2)
Consistency##8##1##(1995-5#1)(1996-2#1)(1997-8#2)(2007-12#1)(2008-10#1)(2010-7#1)(2013-1#1)
Consistent differences in##2##3##(2008-10#2)
Consistent with a role##2##4##(1996-3#1)(2011-1#1)
Consistent with a##4##3##(1992-9#1)(1996-3#1)(2008-7#1)(2011-1#1)
Consistent with its##2##3##(1993-6#1)(2008-10#1)
Consistent with previous reports##2##4##(1991-5#1)(2008-11#1)
Consistent with previous studies##2##4##(2008-10#1)(2010-8#1)
Consistent with previous##7##3##(1991-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
Consistent with the##6##3##(1990-11#1)(1994-1#1)(2007-10#1)(2009-6#1)(2010-4#1)(2012-3#1)
Consistent with these##5##3##(1990-8#1)(1994-8#1)(2008-4#1)(2008-8#1)(2009-12#1)
Consistent with this hypothesis##3##4##(1994-3#1)(2008-4#1)(2010-11#1)
Consistent with this model##2##4##(1993-12#1)(2008-3#1)
Consistent with this notion##2##4##(1992-3#1)(2011-2#1)
Consistent with this observation##2##4##(1996-3#1)(2012-2#1)
Consistent with this##22##3##(1990-12#1)(1992-3#1)(1992-4#1)(1993-12#2)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
Consistent with##55##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
Consistent##65##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Consistently##2##1##(1993-5#1)(1995-6#1)
Consonant Harmony##3##2##(2010-1#3)
Consortium is##3##2##(2008-7#2)(2010-6#1)
Consortium##28##1##(1992-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-9#2)(2008-11#3)(2008-7#9)(2008-9#1)(2010-5#2)(2010-6#2)(2011-2#4)
Conspicuous##4##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
Constant##6##1##(1996-9#1)(2007-8#2)(2008-10#1)(2008-11#1)(2012-3#1)
Constants##2##1##(1996-5#1)(2008-2#1)
Constipation is##2##2##(2008-7#1)(2009-12#1)
Constipation##3##1##(2008-7#1)(2008-9#1)(2009-12#1)
Constitution and##2##2##(2008-10#1)(2012-12#1)
Constitution##6##1##(1995-6#1)(2008-10#1)(2011-2#2)(2012-12#2)
Constitutional##2##1##(1990-9#1)(2013-1#1)
Constitutive activation of##2##3##(2010-3#1)(2012-12#1)
Constitutive and inducible expression of##2##5##(1990-12#1)(1995-5#1)
Constitutive expression of##5##3##(1991-12#1)(1991-9#1)(1992-7#1)(2008-9#2)
Constitutive resistance##2##2##(2008-8#2)
Constitutive##23##1##(1990-12#1)(1991-12#2)(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1995-5#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-3#2)(2010-8#1)(2012-12#1)
Constrained##3##1##(1994-12#1)(2007-12#1)(2008-3#1)
Constraint##2##1##(2008-2#1)(2012-3#1)
Constraints are determined##2##3##(2008-3#2)
Constraints on the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
Constraints on##7##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
Constraints to##2##2##(2007-11#1)(2008-10#1)
Constraints##16##1##(1991-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
Construct validity##2##2##(2008-11#1)(2010-11#1)
Construct##5##1##(2008-11#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
Constructed##2##1##(1990-5#1)(2007-6#1)
Constructing##6##1##(1990-11#1)(1993-12#1)(1996-12#1)(2008-11#1)(2008-4#2)
Construction and characterization of a##2##5##(2008-10#1)(2008-8#1)
Construction and characterization of##6##4##(1993-12#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
Construction and evaluation of##2##4##(2008-10#2)
Construction and##11##2##(1993-12#1)(1994-12#1)(1994-6#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
Construction of YAC contigs##2##4##(1995-6#1)(1996-10#1)
Construction of YAC##3##3##(1995-6#1)(1996-10#1)(2008-4#1)
Construction of a##8##3##(1995-8#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
Construction of an##2##3##(2008-11#1)(2010-1#1)
Construction of human##2##3##(1994-12#1)(2010-12#1)
Construction of knowledge##2##3##(2013-1#2)
Construction of shuttle##2##3##(1997-4#1)(2008-8#1)
Construction of the##2##3##(1996-9#1)(2008-10#1)
Construction of##35##2##(1990-5#2)(1991-5#1)(1993-12#2)(1994-12#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(2008-10#3)(2008-11#3)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2013-1#2)
Construction##49##1##(1990-5#2)(1991-2#1)(1991-5#1)(1993-12#3)(1994-12#3)(1994-6#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-10#6)(2008-11#4)(2008-4#3)(2008-5#1)(2008-8#6)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2013-1#2)
Constructs##2##1##(1990-12#1)(2009-11#1)
Consultant Radiologist workload##3##3##(2012-2#3)
Consultant Radiologist##5##2##(2012-2#5)
Consultants##2##1##(1991-8#1)(1991-9#1)
Consultation due to pruritus##2##4##(2013-7#2)
Consultation##5##1##(1990-9#1)(1991-2#1)(2008-11#1)(2013-7#2)
Consulting##4##1##(1994-2#1)(1996-3#1)(2007-11#1)(2010-6#1)
Consumer participation in##2##3##(1997-8#1)(2008-11#1)
Consumer##21##1##(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-3#1)(1997-3#5)(1997-8#1)(2007-12#1)(2008-11#2)(2013-1#1)
Consumers of##2##2##(1997-3#1)(2013-1#1)
Consumers over age 50 currently comprise 40 percent of consumer demand##2##11##(1994-3#2)
Consumers who##2##2##(1993-3#1)(1996-2#1)
Consumers##14##1##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-1#2)(2011-1#1)(2013-1#1)
Consumption of##12##2##(1990-6#1)(1992-10#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-12#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-8#1)(2013-1#1)(2013-7#1)
Consumption##18##1##(1990-6#1)(1992-10#1)(1994-11#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-12#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Contact##13##1##(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-11#1)(2009-7#2)(2009-9#3)(2010-12#1)(2013-8#1)
Contacting##2##1##(2008-10#1)(2010-4#1)
Contacts##2##1##(1994-3#1)(2012-2#1)
Contained in this regular feature of the journal is a section on each of the following four topics##2##18##(1991-2#1)(1992-2#1)
Contained##3##1##(1991-2#1)(1992-2#1)(2008-10#1)
Container##2##1##(2008-10#2)
Containing an##2##2##(1996-5#1)(2009-10#1)
Containing the##2##2##(1997-7#1)(2008-10#1)
Containing##15##1##(1993-1#1)(1994-2#1)(1996-2#2)(1996-5#3)(1997-7#2)(2008-10#2)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#1)
Containment##3##1##(1995-12#1)(2008-10#1)(2013-8#1)
Contaminated##6##1##(1997-4#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
Contamination of##6##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
Contamination rate##2##2##(2011-2#2)
Contamination##16##1##(1993-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2011-2#2)(2013-1#2)
Contemporary management##2##2##(1994-1#1)(2007-12#1)
Contemporary##20##1##(1992-3#1)(1994-1#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Content analysis was used##2##4##(2008-4#1)(2011-1#1)
Content analysis##7##2##(1996-1#1)(2007-2#1)(2008-11#2)(2008-4#1)(2010-10#1)(2011-1#1)
Content and##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
Content of##2##2##(2008-10#1)(2013-8#1)
Content##26##1##(1996-1#1)(1997-3#1)(2007-1#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#2)(2008-4#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Contents of volume##4##3##(2008-11#3)(2008-4#1)
Contents of##7##2##(1993-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-5#1)
Contents volume##2##2##(2008-11#2)
Contents##11##1##(1993-11#1)(2008-10#2)(2008-11#5)(2008-4#1)(2010-5#1)(2011-2#1)
Context The##3##2##(2013-8#3)
Context of##2##2##(2011-2#1)(2012-2#1)
Context##21##1##(1992-12#1)(2007-10#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#14)
Context-Free Grammar##2##2##(2011-3#2)
Contextual##4##1##(1995-12#1)(2012-3#3)
Continence##3##1##(2007-7#1)(2012-12#1)(2013-8#1)
Continental##2##1##(2008-10#1)(2013-8#1)
Continents##2##1##(2008-10#2)
Contingency##4##1##(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
Continual##3##1##(1994-3#1)(2008-9#1)(2012-3#1)
Continued improvement##2##2##(2008-12#1)(2011-1#1)
Continued##18##1##(1994-9#1)(1995-2#1)(1997-1#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2011-9#1)(2013-1#2)(2013-8#1)
Continuing education is##2##3##(1994-12#1)(2008-11#1)
Continuing education##8##2##(1993-12#1)(1994-12#1)(1995-12#1)(1996-3#2)(2008-11#1)(2008-4#1)(2008-9#1)
Continuing professional development##2##3##(2009-10#1)(2013-1#1)
Continuing professional##3##2##(2007-11#1)(2009-10#1)(2013-1#1)
Continuing##21##1##(1993-12#2)(1994-12#2)(1995-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#2)(2013-1#2)
Continuity of##3##2##(1993-3#1)(2008-11#1)(2010-8#1)
Continuity##7##1##(1993-1#1)(1993-3#2)(1994-2#1)(2008-11#1)(2010-8#1)(2011-2#1)
Continuous Improvement##2##2##(1993-3#1)(1997-1#1)
Continuous Quality Improvement (CQI)##2##4##(1994-12#1)(1997-2#1)
Continuous Quality Improvement##4##3##(1994-12#2)(1997-2#1)(2011-1#1)
Continuous ambulatory peritoneal dialysis (CAPD)##2##5##(2007-12#1)(2007-7#1)
Continuous cultivation##2##2##(1994-5#1)(1997-2#1)
Continuous culture##2##2##(2008-11#1)(2008-6#1)
Continuous flow analysis of##2##4##(2008-10#2)
Continuous flow system for the determination of trace##2##8##(2008-10#2)
Continuous flow system for##3##4##(2008-10#3)
Continuous flow##7##2##(2008-10#7)
Continuous glucose##2##2##(2008-1#1)(2009-9#1)
Continuous monitoring of##3##3##(1995-6#1)(1997-8#1)(2008-10#1)
Continuous monitoring##4##2##(1995-6#1)(1997-8#1)(2008-10#2)
Continuous production##2##2##(2008-11#1)(2008-7#1)
Continuous quality improvement (CQI) is##2##5##(1993-3#1)(1995-3#1)
Continuous quality improvement (CQI)##3##4##(1993-2#1)(1993-3#1)(1995-3#1)
Continuous quality improvement and##3##4##(1993-12#1)(1993-3#2)
Continuous quality improvement in##3##4##(1993-3#1)(1994-1#1)(1995-12#1)
Continuous quality improvement##13##3##(1993-12#2)(1993-2#1)(1993-3#5)(1994-1#1)(1994-12#1)(1995-12#2)(1995-3#1)
Continuous quality##14##2##(1993-12#2)(1993-2#1)(1993-3#5)(1994-1#1)(1994-12#2)(1995-12#2)(1995-3#1)
Continuous treatment with##2##3##(1992-12#1)(1996-5#1)
Continuous tuning of##2##3##(2007-12#2)
Continuous tuning##3##2##(2007-12#3)
Continuous wave##2##2##(2008-2#2)
Continuous##94##1##(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-9#1)(1994-1#1)(1994-12#4)(1994-3#3)(1994-5#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#6)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-2#6)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#5)(2009-12#1)(2009-9#2)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
Continuous-Wave and##2##2##(2008-2#1)(2008-3#1)
Continuous-Wave##14##1##(2008-2#6)(2008-3#7)(2011-1#1)
Continuous-flow##4##1##(2008-10#3)(2008-7#1)
Continuous-wave and##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
Continuous-wave laser##2##2##(2008-2#2)
Continuous-wave##19##1##(2007-11#8)(2007-12#3)(2008-2#3)(2008-3#5)
Continuously##2##1##(2007-11#2)
Continuum##3##1##(1996-9#1)(2007-11#1)(2012-1#1)
Contour Advance implant##2##3##(2008-9#2)
Contour Advance##3##2##(2008-9#2)(2012-2#1)
Contour##9##1##(2008-10#2)(2008-6#1)(2008-9#4)(2009-5#1)(2012-2#1)
Contraception##3##1##(1997-6#1)(2008-11#1)(2008-4#1)
Contraceptive##7##1##(1993-2#1)(1994-9#1)(1996-11#1)(2012-12#2)(2013-1#2)
Contract##4##1##(1992-1#1)(1993-8#1)(1995-1#1)(1997-5#1)
Contractile fields##2##2##(2008-12#2)
Contraction##2##1##(1997-7#1)(2012-7#1)
Contracts##3##1##(1991-3#1)(2007-4#2)
Contracture of the##2##3##(2007-11#1)(2007-8#1)
Contracture##3##1##(2007-11#2)(2007-8#1)
Contralateral##4##1##(1990-12#1)(1992-8#1)(2008-7#1)(2009-10#1)
Contrary to current##2##3##(2008-8#1)(2010-8#1)
Contrary to expectation##5##3##(1996-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)
Contrary to expectations##2##3##(1993-2#1)(2008-10#1)
Contrary to popular belief##3##4##(1997-3#1)(2008-5#1)(2009-9#1)
Contrary to predictions##2##3##(2008-9#1)(2012-2#1)
Contrary to prior##2##3##(2008-9#1)(2011-2#1)
Contrary to the previous##2##4##(2008-5#2)
Contrary to the##9##3##(1990-6#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)
Contrary to this##2##3##(1994-11#1)(2009-8#1)
Contrary to what##2##3##(2008-10#1)(2012-3#1)
Contrary to##38##2##(1990-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-3#1)
Contrast between##2##2##(2008-3#1)(2010-12#1)
Contrast enhanced magnetic resonance##2##4##(2008-7#1)(2013-1#1)
Contrast enhanced##4##2##(2007-8#1)(2008-7#2)(2013-1#1)
Contrast enhancement##2##2##(2008-3#1)(2008-9#1)
Contrast##23##1##(2007-10#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
Contrast-enhanced MRA##2##2##(2008-7#2)
Contrast-enhanced harmonic##2##2##(2010-12#2)
Contrast-enhanced ultrasound (CEUS) is a##2##5##(2010-12#1)(2012-2#1)
Contrast-enhanced ultrasound (CEUS)##4##3##(2010-12#2)(2012-2#2)
Contrast-enhanced ultrasound##7##2##(2010-12#4)(2012-2#3)
Contrast-enhanced##12##1##(2008-7#2)(2010-12#7)(2012-2#3)
Contrasting effects of##3##3##(1993-9#1)(2008-8#1)(2013-7#1)
Contrasting with##2##2##(2007-12#1)(2013-1#1)
Contrasting##10##1##(1993-5#1)(1993-9#1)(1994-3#1)(2007-12#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Contribute to##2##2##(2008-10#1)(2012-12#1)
Contribute##4##1##(2008-10#1)(2012-12#1)(2013-1#2)
Contributes to##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
Contributing factors##2##2##(2008-5#1)(2011-2#1)
Contributing to##2##2##(2008-11#1)(2012-12#1)
Contributing##4##1##(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
Contribution of##17##2##(1990-3#1)(1990-6#1)(1993-8#1)(1994-5#1)(1996-9#1)(2006-12#3)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)
Contribution to##5##2##(2008-10#1)(2008-11#3)(2012-3#1)
Contribution##25##1##(1990-3#1)(1990-6#1)(1993-1#2)(1993-8#1)(1994-5#1)(1996-9#1)(2006-12#3)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
Contributions of the##4##3##(1992-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
Contributions of##7##2##(1991-12#1)(1992-12#1)(1992-6#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Contributions to the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
Contributions to##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2009-10#1)
Contributions##16##1##(1991-12#1)(1992-12#1)(1992-6#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
Contributors##2##1##(1993-12#1)(2011-2#1)
Control (ECDC)##2##2##(2010-4#2)
Control Program##7##2##(1996-12#1)(1997-6#2)(2011-2#2)(2013-1#2)
Control and Prevention##22##3##(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-6#2)(2012-12#1)
Control and##35##2##(1993-9#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-6#2)(2011-2#2)(2012-1#1)(2012-12#1)
Control animals were##2##3##(1993-3#1)(2013-7#1)
Control animals##3##2##(1991-12#1)(1993-3#1)(2013-7#1)
Control by##2##2##(2008-10#2)
Control efficacy values##2##3##(2008-10#2)
Control efficacy##3##2##(2008-10#3)
Control experiments##5##2##(1991-9#1)(1993-8#1)(1994-5#1)(2008-11#1)(2010-1#1)
Control group received##2##3##(2008-7#1)(2013-1#1)
Control group##8##2##(1994-3#1)(2008-7#1)(2011-1#1)(2011-2#4)(2013-1#1)
Control in##2##2##(2013-1#1)(2013-8#1)
Control of Botrytis cinerea on##3##5##(2008-10#3)
Control of Botrytis cinerea##6##4##(2008-10#6)
Control of Fire Blight##2##4##(2008-10#2)
Control of Fusarium Wilt of##3##5##(2008-10#3)
Control of Fusarium Wilt##4##4##(2008-10#4)
Control of Plant Diseases##2##4##(2008-10#2)
Control of Postharvest Decay of##2##5##(2008-10#2)
Control of the lesion was satisfactory in both cases##2##9##(2011-2#2)
Control of the##17##3##(1991-8#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-2#1)(2011-2#3)
Control of##92##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-8#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-6#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2007-11#4)(2007-12#3)(2008-10#44)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Control over the##2##3##(2008-10#1)(2008-7#1)
Control over##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
Control rats were##2##3##(1994-5#1)(2011-2#1)
Control studies##2##2##(1991-12#1)(1993-12#1)
Control to##2##2##(2007-7#1)(2008-10#1)
Control was##2##2##(2008-11#1)(2013-1#1)
Control with##2##2##(2008-10#1)(2008-3#1)
Control##254##1##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#2)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#70)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#4)(2011-2#15)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#3)
Control)##4##1##(1994-2#4)
Controllability of group-velocity dispersion##2##4##(2008-3#2)
Controlled Health##3##2##(2008-6#2)(2011-2#1)
Controlled Release##2##2##(2008-5#2)
Controlled by##3##2##(1996-5#1)(2008-10#2)
Controlled clinical##2##2##(1992-12#1)(2008-10#1)
Controlled growth##2##2##(2009-11#1)(2010-10#1)
Controlled vocabularies are##2##3##(2008-7#2)
Controlled##39##1##(1991-3#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-5#1)(1994-6#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-11#2)(2009-12#2)(2010-10#1)(2011-2#2)(2013-1#1)
Controlling costs##2##2##(1996-12#1)(1997-2#1)
Controlling for age##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
Controlling for##7##2##(1991-3#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-6#1)(2013-1#1)
Controlling risks##2##2##(1993-12#1)(1995-1#1)
Controlling the##2##2##(1995-1#1)(2008-7#1)
Controlling##34##1##(1991-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
Controls were##6##2##(1991-2#1)(1991-6#1)(1993-9#1)(1997-3#1)(2007-10#1)(2013-1#1)
Controls##16##1##(1990-2#2)(1991-2#1)(1991-6#1)(1993-12#1)(1993-9#1)(1995-3#1)(1997-3#1)(2007-10#1)(2008-10#1)(2011-2#2)(2013-1#4)
Controversial##4##1##(1997-7#1)(2010-12#1)(2011-2#2)
Controversies in the management of##2##5##(1991-8#1)(2007-5#1)
Controversies in the##4##3##(1991-8#1)(1994-12#1)(2007-5#1)(2010-7#1)
Controversies in##6##2##(1991-8#1)(1994-12#1)(1996-2#1)(2007-5#1)(2010-7#2)
Controversies##10##1##(1991-8#1)(1994-12#1)(1996-2#1)(2007-12#2)(2007-5#1)(2008-3#1)(2008-5#1)(2010-7#2)
Controversy exists##2##2##(2007-12#1)(2013-1#1)
Controversy surrounds##2##2##(1996-11#1)(2008-8#1)
Controversy##7##1##(1990-11#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
Conus parvatus##2##2##(2008-12#2)
Conus##6##1##(1993-11#2)(2008-12#2)(2008-8#2)
Convenience##2##1##(1992-12#1)(1995-1#1)
Convenient Route to##2##3##(1996-5#2)
Convenient Synthesis of##3##3##(1996-2#1)(1996-5#1)(2009-9#1)
Convenient##11##1##(1996-2#1)(1996-5#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-9#1)(2010-5#1)
Convention##9##1##(1990-2#3)(1992-12#4)(2011-2#1)(2012-2#1)
Conventional MRI##2##2##(2008-7#2)
Conventional Osteosarcoma##4##2##(2010-3#4)
Conventional and##2##2##(1997-8#1)(2013-1#1)
Conventional methods##3##2##(2008-10#2)(2008-9#1)
Conventional radiography##2##2##(2010-3#1)(2010-6#1)
Conventional therapies##2##2##(2008-3#1)(2013-1#1)
Conventional##68##1##(1990-2#1)(1990-8#1)(1994-3#1)(1994-5#1)(1994-7#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-7#1)
Conventionally##4##1##(1996-5#1)(1996-6#1)(2008-11#1)(2012-2#1)
Convergence##4##1##(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#1)
Convergent evolution of##2##3##(2009-8#2)
Convergent evolution##4##2##(2007-12#2)(2009-8#2)
Convergent##8##1##(2007-12#3)(2008-10#1)(2009-8#2)(2011-2#1)(2013-1#1)
Converging evidence suggests##2##3##(2009-12#1)(2009-6#1)
Converging##3##1##(2009-12#1)(2009-6#1)(2012-2#1)
Conversation##2##1##(2008-9#2)
Conversations##4##1##(1996-1#1)(1996-12#1)(2011-1#1)(2013-8#1)
Conversely##83##1##(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#2)(1993-1#1)(1993-11#2)(1993-5#1)(1994-2#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#1)
Conversion between##2##2##(2008-3#1)(2010-10#1)
Conversion efficiency##2##2##(2007-11#1)(2007-12#1)
Conversion of A into B was##2##6##(1997-1#2)
Conversion of a##2##3##(2008-10#1)(2008-3#1)
Conversion of porcine big endothelin##2##5##(1990-2#2)
Conversion of the##2##3##(1994-11#1)(2008-6#1)
Conversion of xanthine dehydrogenase to xanthine oxidase in endothelial cells##2##10##(1991-9#2)
Conversion of##26##2##(1990-2#2)(1991-9#2)(1992-3#1)(1992-8#1)(1994-11#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-12#1)(2009-5#1)(2010-5#1)(2013-1#1)
Conversion to##4##2##(1994-9#1)(2007-8#1)(2010-2#1)(2012-12#1)
Conversion##41##1##(1990-2#2)(1991-9#2)(1992-3#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#3)
Converter##2##1##(2008-2#1)(2008-3#1)
Converting##4##1##(1992-11#1)(2007-12#1)(2008-1#1)(2010-12#1)
Conway##2##1##(2008-10#1)(2008-7#1)
Cook Island women##2##3##(2008-1#2)
Cook Islands##3##2##(1992-6#1)(2008-1#1)(2012-12#1)
Cook##6##1##(1992-6#1)(2008-1#3)(2012-12#1)(2012-2#1)
Cooling##5##1##(2007-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
Coomassie Brilliant Blue##3##3##(1993-8#1)(2008-10#2)
Coomassie blue staining##2##3##(2008-2#1)(2008-4#1)
Coomassie blue##5##2##(1992-8#1)(2008-2#1)(2008-4#3)
Coomassie brilliant blue##4##3##(2008-1#1)(2008-10#2)(2008-4#1)
Coomassie##16##1##(1992-8#1)(1993-8#1)(1993-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#5)(2008-9#1)
Cooper##4##1##(1990-12#1)(1992-8#1)(1997-3#1)(2008-7#1)
Cooper's##2##1##(1992-2#1)(2009-6#1)
CooperSurgical##2##1##(2011-2#2)
Cooperation and##5##2##(1993-2#1)(1993-3#2)(1994-1#1)(1996-1#1)
Cooperation between##3##2##(1993-6#1)(1996-11#1)(1996-3#1)
Cooperation is##2##2##(1994-1#1)(2011-4#1)
Cooperation##13##1##(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1996-1#1)(1996-11#1)(1996-3#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-4#1)
Cooperative Group##4##2##(1991-4#1)(1993-11#1)(1994-8#1)(2011-2#1)
Cooperative Health Care Clinic##2##4##(1997-2#2)
Cooperative binding of##2##3##(1994-6#1)(1995-2#1)
Cooperative breeding##2##2##(2008-8#2)
Cooperative##32##1##(1990-11#1)(1991-4#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-2#1)(2010-3#3)(2011-1#1)(2011-2#3)(2013-7#1)
Cooperativity in the##2##3##(1993-11#2)
Cooperia oncophora##2##2##(1996-12#2)
Coopers &amp##2##2##(1990-4#1)(1993-3#1)
Coordinated##8##1##(1992-3#1)(1996-2#3)(1996-3#1)(2007-12#1)(2008-11#1)(2009-8#1)
Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer)##3##13##(1990-12#2)(1992-8#1)
Coordinating##6##1##(1990-12#2)(1992-8#1)(1996-12#1)(2008-10#1)(2008-6#1)
Coordination and##2##2##(1997-7#1)(2008-1#1)
Coordination of##2##2##(1990-10#1)(2010-11#1)
Coordination##10##1##(1990-10#1)(1995-3#1)(1996-2#1)(1997-7#4)(2008-1#1)(2008-10#1)(2010-11#1)
Coordinator##3##1##(1995-6#1)(2011-1#1)(2013-1#1)
Copenhagen##19##1##(1993-3#1)(1995-3#1)(1995-5#1)(1996-9#2)(1997-3#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-3#2)(2011-1#1)(2011-2#3)(2011-4#2)(2013-1#1)
Copepods##2##1##(2008-5#2)
Copies of##2##2##(2012-12#1)(2012-2#1)
Coping Orientations##2##2##(2008-11#1)(2013-1#1)
Coping Scale##3##2##(2008-11#1)(2010-10#1)(2010-5#1)
Coping Strategies##2##2##(2007-12#1)(2008-12#1)
Coping with a##2##3##(2008-8#1)(2013-1#1)
Coping with preoperative anxiety in cesarean section##2##7##(2013-1#2)
Coping with##9##2##(1991-3#1)(1992-3#1)(1997-3#2)(2008-8#1)(2010-5#1)(2013-1#3)
Coping##31##1##(1990-10#2)(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1997-3#2)(2007-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#3)(2013-1#7)
Copolymers##3##1##(1996-12#1)(2008-10#1)(2009-10#1)
Copper (II)##2##2##(2008-10#1)(2009-7#1)
Copper and##4##2##(2008-10#3)(2013-8#1)
Copper determination in##2##3##(2008-10#2)
Copper is##2##2##(2008-10#1)(2012-2#1)
Copper##31##1##(1992-12#1)(1995-11#1)(1995-3#1)(1997-7#1)(1997-8#1)(2008-10#20)(2009-7#1)(2012-2#2)(2013-8#3)
Copper(II) complexes##2##2##(2008-10#2)
Copper(II)##11##1##(1997-7#2)(2008-10#8)(2008-5#1)
Copper(II)-selective##2##1##(2008-10#2)
Coprecipitation of##2##2##(2008-10#1)(2008-4#1)
Coprecipitation parameters and matrix effects are discussed##2##7##(2008-10#2)
Coprecipitation parameters##3##2##(2008-10#3)
Coprecipitation with##2##2##(2008-10#2)
Coprecipitation##7##1##(2008-10#6)(2008-4#1)
Coprinus congregatus##2##2##(1991-9#2)
Coprinus##6##1##(1991-9#2)(2008-10#1)(2010-3#1)(2010-5#1)(2010-7#1)
Coptidis rhizoma##2##2##(2008-10#2)
Coptis##2##1##(2008-11#1)(2012-3#1)
Coptotermes formosanus##2##2##(2009-5#1)(2011-2#1)
Coptotermes##3##1##(2009-5#2)(2011-2#1)
Copyright (c) 2000 John Wiley &amp##36##6##(2008-11#36)
Copyright (c) 2005 John Wiley &amp##2##6##(2008-9#2)
Copyright (c)##38##2##(2008-11#36)(2008-9#2)
Copyright © 2010 European Peptide Society and John Wiley &amp##4##10##(2011-2#4)
Copyright © 2010 John Wiley &amp##10##6##(2011-1#1)(2011-2#7)(2012-2#2)
Copyright © 2010##14##3##(2011-1#1)(2011-2#11)(2012-2#2)
Copyright © 2011 John Wiley &amp##6##6##(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)
Copyright © 2012 John Wiley &amp##18##6##(2012-2#1)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Copyright © 2012##19##3##(2012-2#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Copyright ©##39##2##(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#6)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Copyright##77##1##(2008-11#36)(2008-9#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#6)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Coquillettidia arribalzagae##2##2##(2008-5#2)
Corah's##2##1##(2008-1#2)
Coral recruitment##2##2##(2007-5#2)
Coral##8##1##(2007-5#5)(2008-1#1)(2011-2#1)(2012-12#1)
Coraliomargarita akajimensis##2##2##(2011-2#2)
Coraliomargarita##3##1##(2011-2#3)
Cord Injury##6##2##(1992-6#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-2#1)(2013-8#1)
Cord blood##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
Cord##16##1##(1992-6#1)(1995-11#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)(2013-8#2)
Cordillera Occidental##2##2##(2008-5#2)
Cordoba##3##1##(2009-7#2)(2010-12#1)
Core Functions##2##2##(1995-12#2)
Core temperatures were##2##3##(1996-5#1)(2007-10#1)
Core##19##1##(1993-12#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#2)(2007-10#1)(2008-1#1)(2008-10#3)(2010-4#1)(2011-1#2)(2011-2#1)
CorePromoter##2##1##(2008-4#2)
Corfu##2##1##(2008-5#2)
Coriander##3##1##(2008-10#3)
Coriolus versicolor##2##2##(2008-11#1)(2011-2#1)
Corn Flea Beetle##2##3##(2008-10#2)
Corn##17##1##(1990-11#1)(2008-10#16)
Corneal##2##1##(2010-5#1)(2011-2#1)
Cornelia de Lange syndrome##5##4##(2007-7#2)(2013-1#3)
Cornelia de Lange##7##3##(2007-7#2)(2011-2#1)(2013-1#4)
Cornell##3##1##(2008-12#1)(2008-3#1)(2012-3#1)
Corneometer##3##1##(2008-5#2)(2012-2#1)
Corner##5##1##(1996-5#1)(2008-8#3)(2013-1#1)
Cornerstone is a##2##3##(1996-12#2)
Cornerstone##5##1##(1996-12#5)
Corning##2##1##(2007-11#1)(2008-10#1)
Coronal##3##1##(2008-3#2)(2009-12#1)
Coronary Artery Bypass##2##3##(2010-8#1)(2012-1#1)
Coronary Artery Disease##6##3##(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)
Coronary Artery##10##2##(2008-11#2)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#2)
Coronary angiography revealed normal##2##4##(2007-8#1)(2010-5#1)
Coronary angiography##4##2##(1991-3#1)(2007-8#1)(2010-5#1)(2013-1#1)
Coronary artery bypass##3##3##(1990-6#1)(2007-8#1)(2013-8#1)
Coronary artery disease##3##3##(1990-3#1)(2008-7#1)(2011-2#1)
Coronary artery##10##2##(1990-3#1)(1990-6#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#2)
Coronary computed tomography angiography##2##4##(2008-12#1)(2011-2#1)
Coronary computed tomography##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
Coronary heart disease is the##2##5##(2010-12#1)(2011-2#1)
Coronary heart disease##5##3##(1991-11#1)(1995-3#1)(2009-4#1)(2010-12#1)(2011-2#1)
Coronary heart##6##2##(1990-2#1)(1991-11#1)(1995-3#1)(2009-4#1)(2010-12#1)(2011-2#1)
Coronary risk##2##2##(2008-8#1)(2010-8#1)
Coronary vasospasm##2##2##(2007-8#1)(2008-7#1)
Coronary##64##1##(1990-2#1)(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#2)(1995-3#1)(1995-8#1)(2007-8#6)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
Coronas are##2##2##(2008-2#2)
Coronavirus##2##1##(2008-4#2)
Corp##11##1##(1991-9#1)(1995-6#2)(1996-5#3)(2008-5#3)(2008-8#1)(2012-12#1)
Corporate##3##1##(1991-3#2)(2008-12#1)
Corporation for##3##2##(1997-2#1)(1997-5#1)(2008-3#1)
Corporation of##2##2##(1997-3#1)(2009-12#1)
Corporation##25##1##(1991-1#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#2)(1995-2#1)(1996-12#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2011-2#1)
Corporation's##2##1##(1992-12#1)(2007-12#1)
Corps##7##1##(1990-3#1)(1991-5#2)(2008-10#2)(2008-2#1)(2012-3#1)
Corpus##2##1##(2008-10#1)(2010-3#1)
Correct classification##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
Correct##15##1##(1990-11#1)(1993-6#2)(1997-4#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
Corrected##5##1##(2008-10#2)(2008-2#1)(2011-1#1)(2013-1#1)
Correcting##4##1##(2008-10#2)(2008-2#1)(2010-7#1)
Correction of##19##2##(1997-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#2)
Correction##27##1##(1993-2#1)(1995-12#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#5)(2008-5#2)(2008-7#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#3)
Corrections Department##2##2##(1997-5#2)
Corrections to##2##2##(1992-6#1)(2008-11#1)
Corrections##7##1##(1992-6#1)(1995-3#1)(1996-9#1)(1997-5#3)(2008-11#1)
Corrective##2##1##(1996-11#1)(2008-9#1)
Correlated responses in behavioral isolation##2##5##(2008-9#2)
Correlated with##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
Correlated##10##1##(1996-9#1)(1997-4#1)(2008-10#2)(2008-9#3)(2009-9#1)(2012-2#1)(2013-8#1)
Correlates of Protective Viruses Damaging to HIV Infection##2##8##(1996-5#2)
Correlates of##6##2##(1996-5#2)(2007-12#1)(2009-5#2)(2013-7#1)
Correlates with##2##2##(2008-10#2)
Correlates##11##1##(1991-2#1)(1996-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-5#2)(2013-7#1)
Correlating the##2##2##(2008-8#1)(2009-7#1)
Correlating##5##1##(1993-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-1#1)
Correlation Coefficient (ICC)##2##3##(1995-3#1)(2011-1#1)
Correlation Coefficient##3##2##(1995-3#1)(2011-1#1)(2013-1#1)
Correlation Spectroscopy of##2##3##(1996-12#1)(2008-11#1)
Correlation analysis##2##2##(2008-1#1)(2008-10#1)
Correlation and##2##2##(2008-10#1)(2008-6#1)
Correlation between serum##2##3##(2006-6#1)(2011-2#1)
Correlation between the##4##3##(1994-7#2)(2008-10#1)(2009-7#1)
Correlation between##21##2##(1994-11#1)(1994-7#2)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
Correlation coefficients##2##2##(2008-10#1)(2010-12#1)
Correlation of the##3##3##(2008-2#1)(2011-1#1)(2013-8#1)
Correlation of##22##2##(1990-12#1)(1990-2#1)(1994-8#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#3)(2008-9#1)(2011-1#3)(2011-10#1)(2012-2#3)(2013-8#1)
Correlation with##4##2##(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
Correlation##76##1##(1990-12#1)(1990-2#1)(1991-9#1)(1994-11#1)(1994-7#2)(1994-8#1)(1995-3#1)(1995-4#1)(1996-12#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#2)(2012-2#6)(2013-1#3)(2013-8#1)
Correlational analyses##2##2##(2010-6#1)(2012-2#1)
Correlational##4##1##(2009-8#1)(2010-6#1)(2012-1#1)(2012-2#1)
Correlations and differences were analysed by means of the chi2-test##2##10##(1991-8#2)
Correlations between##13##2##(1993-2#1)(1994-7#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-1#1)
Correlations of##3##2##(1990-7#1)(1996-3#1)(2008-10#1)
Correlations##25##1##(1990-7#1)(1991-8#2)(1993-2#1)(1994-7#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Correlative##3##1##(1993-12#1)(2007-12#1)(2008-7#1)
Correspondence##2##1##(2008-11#1)(2010-4#1)
Corresponding to##2##2##(1991-5#1)(2008-10#1)
Corresponding values##2##2##(1993-1#1)(2008-10#1)
Corresponding##11##1##(1991-5#1)(1991-6#1)(1993-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
Correspondingly##6##1##(1990-7#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)
Corrientes##3##1##(2008-5#3)
Corrigan##3##1##(1995-2#3)
Cortecs##3##1##(2008-5#3)
Cortex##12##1##(2008-10#9)(2009-5#1)(2012-2#1)(2013-1#1)
Cortical activation##2##2##(1996-2#1)(2008-9#1)
Cortical##15##1##(1991-9#1)(1994-2#2)(1995-5#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-9#2)(2013-1#1)
Corticosteroid##2##1##(1994-6#1)(2008-1#1)
Corticosteroid-related psychiatric complications in the treatment of Hodgkin's lymphoma in an adolescent##2##12##(2008-4#2)
Corticosteroids##4##1##(1991-11#1)(2008-11#1)(2008-3#1)(2013-8#1)
Corticotropin releasing hormone##2##3##(2008-4#2)
Corticotropin releasing##3##2##(1992-12#1)(2008-4#2)
Cortisol##6##1##(2008-11#2)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
Cortés##3##1##(2008-5#3)
Coruña##2##1##(2008-10#2)
Corvallis##2##1##(2008-10#2)
Corylus##2##1##(2008-10#1)(2011-1#1)
Corynebacteria##3##1##(2008-5#3)
Corynebacterium diphtheriae##2##2##(1991-8#1)(1996-11#1)
Corynebacterium glutamicum was##2##3##(2008-7#2)
Corynebacterium glutamicum##6##2##(1994-6#2)(2008-7#4)
Corynebacterium##20##1##(1990-11#1)(1991-12#1)(1991-8#2)(1994-6#2)(1996-11#1)(2007-11#1)(2008-5#7)(2008-7#4)(2011-1#1)
Cos-P##2##1##(1994-8#2)
Cosgrove-Edwards annuloplasty ring##3##3##(2007-8#3)
Cosmetic Science##2##2##(2008-5#2)
Cosmetic Toiletry and Perfumery##2##4##(2008-5#2)
Cosmetic surgery##2##2##(2007-12#1)(2010-8#1)
Cosmetic##17##1##(2007-12#2)(2008-5#12)(2010-6#1)(2010-8#1)(2011-2#1)
Cosmetically##2##1##(2008-5#1)(2012-3#1)
Cosmic##2##1##(2008-2#1)(2008-3#1)
Cost and##6##2##(1991-12#1)(1991-2#1)(2008-11#2)(2008-7#1)(2009-4#1)
Cost containment##2##2##(1992-12#1)(2008-11#1)
Cost effectiveness of##2##3##(1991-6#1)(1997-7#1)
Cost of##7##2##(1990-8#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-9#1)
Cost per##2##2##(2007-8#1)(2013-7#1)
Cost reduction##2##2##(1994-3#1)(1996-1#1)
Cost##46##1##(1990-8#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-7#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
Cost-benefit analysis##2##2##(2008-7#1)(2009-12#1)
Cost-benefit##3##1##(2008-7#1)(2009-12#1)(2009-4#1)
Cost-effective##3##1##(2008-10#2)(2008-11#1)
Cost-effectiveness of##4##2##(2009-4#1)(2009-8#1)(2010-8#1)(2013-8#1)
Cost-effectiveness studies##2##2##(1996-9#1)(2008-2#1)
Cost-effectiveness##9##1##(1996-9#1)(2008-2#1)(2009-4#1)(2009-8#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
Costa Rica and the##2##4##(2008-10#2)
Costa Rica and##4##3##(2008-10#4)
Costa Rica using##2##3##(2008-10#1)(2008-5#1)
Costa Rica were##2##3##(2008-10#1)(2012-2#1)
Costa Rica##52##2##(1990-6#1)(2008-10#14)(2008-5#33)(2009-9#1)(2011-2#2)(2012-2#1)
Costa Rica)##3##2##(2008-5#3)
Costa Rica]##9##2##(2008-5#7)(2012-2#1)(2013-7#1)
Costa Rican##5##2##(2008-10#1)(2008-5#3)(2011-2#1)
Costa et al##2##3##(1990-5#2)
Costa##74##1##(1990-5#2)(1990-6#1)(2008-10#15)(2008-5#48)(2009-9#1)(2011-2#4)(2012-2#2)(2013-7#1)
Costs and benefits of##2##4##(1994-2#2)
Costs of##6##2##(1991-9#1)(1994-2#1)(1995-1#1)(2008-8#2)(2008-9#1)
Costs##14##1##(1991-9#1)(1993-12#1)(1994-2#3)(1995-1#1)(1996-11#1)(1997-2#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#1)
Costs&quot##2##1##(2010-8#2)
Cotard's syndrome##2##2##(2013-8#2)
Cotesia glomerata##2##2##(2010-4#2)
Cotesia rubecula##2##2##(2008-8#2)
Cotesia##6##1##(1990-11#1)(2008-8#2)(2010-4#3)
Cotransfection of the##2##3##(1993-3#1)(1994-8#1)
Cotransfection of##3##2##(1993-3#1)(1994-8#2)
Cotransfection##5##1##(1991-5#1)(1993-3#1)(1994-8#2)(2008-8#1)
Cotton leaf crumple virus##2##4##(2008-10#2)
Cotton leaf##3##2##(2008-10#2)(2008-9#1)
Cotton##19##1##(1994-3#1)(1995-2#1)(2008-10#14)(2008-9#1)(2011-2#1)(2013-8#1)
Cottonball##2##1##(2008-10#2)
Cougarblight and rain##2##3##(2008-10#2)
Cougarblight and##3##2##(2008-10#3)
Cougarblight##10##1##(2008-10#10)
Cough##2##1##(2007-8#1)(2013-1#1)
Could##7##1##(1992-3#1)(1993-3#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
Coulomb integral##2##2##(1996-2#2)
Coulomb interactions##2##2##(1992-6#2)
Coulomb##9##1##(1992-6#2)(1996-12#1)(1996-2#2)(1996-7#1)(2008-11#1)(2010-7#1)(2012-2#1)
Coulombic##3##1##(1994-5#1)(2007-12#1)(2010-4#1)
Coulometric determination of##2##3##(2008-10#2)
Coulometric##7##1##(2008-10#7)
Coulter counter##2##2##(2008-9#1)(2009-5#1)
Coulter##5##1##(2008-10#3)(2008-9#1)(2009-5#1)
Coumarin 460##2##2##(2008-3#2)
Coumarin##6##1##(1990-6#2)(1991-11#1)(2008-2#1)(2008-3#2)
Council and##2##2##(2008-8#1)(2012-1#1)
Council for##8##2##(1990-6#1)(1996-11#1)(2007-4#1)(2008-11#5)
Council of##16##2##(1992-2#1)(1994-12#1)(1995-6#1)(1996-3#4)(1996-4#2)(2008-10#1)(2008-11#2)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
Council on Medical Education##2##4##(1991-8#2)
Council on##14##2##(1991-2#1)(1991-8#2)(1992-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#2)(1997-3#1)(2010-1#1)
Council will##2##2##(1995-6#2)
Council##78##1##(1990-6#2)(1991-2#2)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-6#11)(1996-1#1)(1996-11#1)(1996-3#4)(1996-4#2)(1996-8#3)(1997-3#1)(1997-5#1)(1997-8#1)(2007-4#1)(2008-10#2)(2008-11#9)(2008-8#1)(2008-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
Counseling##8##1##(1991-8#1)(1993-12#1)(1997-3#1)(2008-5#2)(2010-12#1)(2013-1#2)
Counselling##2##1##(1992-1#1)(2008-7#1)
Counselors##3##1##(2010-11#3)
Count##7##1##(1996-12#3)(2008-12#3)(2008-8#1)
Counter##2##1##(2008-10#1)(2008-11#1)
Counterpoint##5##1##(2011-2#5)
Counties##5##1##(1992-12#1)(2008-10#3)(2008-12#1)
Counting blessings##2##2##(2008-12#2)
Counting cells##2##2##(2008-4#1)(2008-9#1)
Counting the##2##2##(2007-11#1)(2008-6#1)
Counting##11##1##(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-1#1)
Countries##12##1##(2008-1#1)(2008-10#2)(2008-8#1)(2010-3#1)(2011-2#3)(2012-12#3)(2012-2#1)
Country of birth##2##3##(2011-2#2)
Country##6##1##(1997-6#1)(2007-2#1)(2008-10#1)(2011-2#3)
Counts##2##1##(2012-12#1)(2013-8#1)
County Court##2##2##(1990-11#1)(1995-12#1)
County Hospital##3##2##(1991-11#1)(1996-3#1)(1996-9#1)
County has##2##2##(2011-2#2)
County in the##2##3##(2008-10#1)(2011-2#1)
County in##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
County of##3##2##(1991-9#1)(1997-3#1)(2008-10#1)
County##105##1##(1990-11#1)(1990-12#2)(1991-11#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#5)(1996-12#1)(1996-2#5)(1996-3#1)(1996-9#1)(1997-3#2)(1997-5#1)(2007-10#1)(2007-5#2)(2008-10#23)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-6#3)(2011-2#19)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Coup##2##1##(1991-2#1)(2008-7#1)
Couple##2##1##(1996-2#1)(2012-2#1)
Couple-based interventions for medical problems##2##5##(2012-2#2)
Coupled with a##2##3##(2007-12#1)(2008-10#1)
Coupled with microdialysis##2##3##(2008-10#2)
Coupled with##6##2##(2007-12#1)(2008-10#5)
Coupled##20##1##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
Couples##5##1##(2007-10#1)(2007-2#1)(2008-6#1)(2008-9#1)(2011-2#1)
Coupling between##4##2##(1997-7#1)(2007-12#1)(2009-5#1)(2012-2#1)
Coupling in a##3##3##(2008-3#3)
Coupling of a##2##3##(2008-3#1)(2008-4#1)
Coupling of##10##2##(2008-10#3)(2008-3#2)(2008-4#3)(2009-10#1)(2010-4#1)
Coupling##36##1##(1996-12#1)(1996-5#1)(1996-9#2)(1997-7#1)(2007-12#2)(2008-10#7)(2008-12#1)(2008-3#10)(2008-4#3)(2009-10#1)(2009-12#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-7#1)(2012-2#1)
Courage and Khazaka##2##3##(2008-5#2)
Courage##3##1##(1995-12#1)(2008-5#2)
Course for##2##2##(1997-4#1)(2008-1#1)
Course of##5##2##(1991-2#1)(2008-10#1)(2010-1#1)(2010-11#1)(2012-3#1)
Course##14##1##(1991-2#1)(1993-12#1)(1996-12#2)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-3#1)
Courses##2##1##(1991-6#1)(2013-1#1)
Court Judge##3##2##(1995-12#2)(1996-5#1)
Court for##5##2##(1995-2#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-7#1)
Court of Appeal##6##3##(1990-2#1)(1997-5#5)
Court of Appeals for the Fourth Circuit##2##7##(1995-6#1)(1997-6#1)
Court of Appeals for the##7##5##(1995-6#3)(1996-12#3)(1997-6#1)
Court of Appeals ruled that##2##5##(1995-12#1)(1997-5#1)
Court of Appeals##18##3##(1995-12#4)(1995-6#3)(1996-12#3)(1996-5#3)(1997-5#4)(1997-6#1)
Court of Common Pleas##2##4##(1995-12#2)
Court of Justice##2##3##(1996-3#1)(2008-9#1)
Court of##34##2##(1990-2#1)(1991-7#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#6)(1995-6#3)(1996-12#3)(1996-3#1)(1996-5#3)(1997-2#1)(1997-5#9)(1997-6#1)(2008-9#1)
Court rejects##2##2##(1995-6#1)(1996-5#1)
Court remanded the##2##3##(1996-12#1)(1997-5#1)
Court ruled that##2##3##(1997-5#2)
Court says##2##2##(1997-5#2)
Court upholds##4##2##(1990-2#1)(1992-11#1)(1995-6#2)
Court##87##1##(1990-11#2)(1990-2#2)(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#3)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#10)(1995-2#1)(1995-6#12)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-9#1)(1997-2#1)(1997-5#16)(1997-6#2)(1997-7#1)(2008-9#1)(2009-8#1)(2010-6#2)
Court's decision##2##2##(1991-12#2)
Court's##5##1##(1991-12#2)(1992-2#1)(1996-5#1)(2009-9#1)
Courts##4##1##(1993-3#1)(1995-6#1)(2010-10#1)(2012-12#1)
Courtship##2##1##(1990-11#1)(2013-8#1)
Covalent binding of##3##3##(1995-6#2)(2008-10#1)
Covalent modification##2##2##(1990-7#1)(1992-9#1)
Covalent##11##1##(1990-7#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-2#1)(1995-6#2)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#1)
Covalently##2##1##(1996-5#1)(2008-9#1)
Covariance##2##1##(1996-3#1)(1997-7#1)
Cover##3##1##(2008-10#1)(2009-4#1)(2013-8#1)
Coverage##2##1##(1996-12#1)(2008-2#1)
Cowdria ruminantium##2##2##(1996-12#2)
Cowpea aphid borne mosaic virus##2##5##(2008-12#2)
Cowpea##5##1##(2008-10#3)(2008-12#2)
Cows were##2##2##(2012-2#2)
Cows##4##1##(1996-8#1)(2012-2#3)
Cox analysis##2##2##(1996-9#1)(2011-2#1)
Cox model was##2##3##(2008-10#1)(2008-7#1)
Cox model##3##2##(1994-7#1)(2008-10#1)(2008-7#1)
Cox proportional hazard##2##3##(1997-3#1)(2011-1#1)
Cox proportional hazards models were used to##2##7##(2009-6#1)(2012-2#1)
Cox proportional hazards models##3##4##(2009-6#1)(2009-8#1)(2012-2#1)
Cox proportional hazards regression##2##4##(2011-2#1)(2013-1#1)
Cox proportional hazards##6##3##(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Cox proportional##8##2##(1997-3#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
Cox regression was used to##2##5##(2008-11#1)(2013-1#1)
Cox regression##6##2##(1992-9#1)(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
Cox##23##1##(1992-9#1)(1994-12#1)(1994-7#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)
Cox's##5##1##(1993-2#1)(1997-3#2)(1997-8#2)
Cox14p##3##1##(1995-6#3)
Coxiella burnetii plasmid QpH1##2##4##(1995-8#2)
Coxiella burnetii whole cells##2##4##(1995-12#2)
Coxiella burnetii##14##2##(1991-8#1)(1992-5#1)(1994-12#2)(1995-12#4)(1995-8#2)(2007-12#3)(2008-4#1)
Coxsackievirus B3##2##2##(1994-5#2)
Cp##10##1##(1993-8#1)(1996-2#1)(1997-2#3)(2012-12#5)
Cp'Ir(CO)(PR(3))##2##1##(1996-2#2)
Cp1##3##1##(2008-10#3)
Cp2##3##1##(2008-10#3)
CpG DNA##2##2##(2008-4#2)
CpG and##2##2##(2008-10#2)
CpG at position##2##3##(1995-2#2)
CpG dinucleotide##2##2##(1991-6#1)(2008-4#1)
CpG dinucleotides in##2##3##(1991-6#1)(2007-11#1)
CpG dinucleotides##9##2##(1990-8#2)(1991-6#1)(1993-2#2)(2007-11#2)(2008-4#1)(2013-8#1)
CpG features##4##2##(2007-11#4)
CpG island in the 5' region of the##2##8##(1991-6#2)
CpG island in the##3##4##(1991-6#2)(1997-4#1)
CpG island in##4##3##(1991-6#2)(1997-4#1)(2010-3#1)
CpG island##12##2##(1991-6#3)(1996-10#2)(1996-6#2)(1997-4#2)(2007-11#1)(2010-3#2)
CpG islands were##2##3##(1993-6#1)(1996-6#1)
CpG islands##12##2##(1993-6#1)(1995-12#2)(1995-8#2)(1996-10#1)(1996-6#2)(2007-11#2)(2008-7#1)(2012-2#1)
CpG islands)##2##2##(2007-11#2)
CpG methylase##2##2##(1993-6#2)
CpG methylation##3##2##(1992-3#1)(2007-11#1)(2011-1#1)
CpG motifs##3##2##(2008-10#1)(2008-4#2)
CpG sites in##2##3##(1996-10#1)(2013-8#1)
CpG##69##1##(1990-8#2)(1991-6#5)(1992-3#1)(1993-11#1)(1993-2#2)(1993-6#3)(1994-5#1)(1995-12#2)(1995-2#4)(1995-8#2)(1996-10#4)(1996-6#4)(1997-4#2)(2007-11#13)(2008-10#5)(2008-11#1)(2008-4#9)(2008-7#1)(2008-8#1)(2010-3#2)(2011-1#1)(2012-2#1)(2013-8#2)
CpGs in the##2##3##(1990-8#2)
CpGs##7##1##(1990-8#6)(1991-6#1)
CpIr(CO)(PMe(3))##2##1##(1996-2#2)
CpIr(CO)(PR(3))##3##1##(1996-2#3)
CpIr(CO)[P(p-C(6)H(4)CF(3))(3)] to##2##2##(1996-2#2)
Cq response in##2##3##(1994-12#2)
Cr (III) and Cr (VI)##2##5##(2008-10#2)
Cr (III)##5##2##(2008-10#5)
Cr (VI)##6##2##(2008-10#6)
Cr ZnSe##2##2##(2007-11#2)
Cr and Cd##2##3##(2008-10#2)
Cr and Co##2##3##(2008-10#2)
Cr and Cu##2##3##(2008-10#2)
Cr and Ni##2##3##(2008-10#1)(2008-11#1)
Cr and##11##2##(2008-10#10)(2008-11#1)
Cr concentration##3##2##(1993-8#2)(2008-10#1)
Cr for##2##2##(1993-8#1)(2008-10#1)
Cr had##2##2##(2008-10#2)
Cr in##6##2##(2008-10#5)(2009-12#1)
Cr l(-1)##2##2##(2008-10#2)
Cr species##3##2##(2008-10#3)
Cr with##3##2##(2008-10#3)
Cr##211##1##(1993-8#4)(1996-2#1)(1997-4#1)(2007-11#15)(2007-12#19)(2008-10#130)(2008-11#1)(2008-12#3)(2008-2#15)(2008-3#13)(2009-12#2)(2010-5#1)(2011-2#4)(2013-8#2)
Cr(2+) ZnS##3##2##(2007-11#3)
Cr(2+)##19##1##(2007-11#14)(2007-12#4)(2008-10#1)
Cr(3+) and##2##2##(2008-10#2)
Cr(3+)##15##1##(2007-11#2)(2008-10#10)(2008-2#3)
Cr(4)+##3##1##(2007-12#1)(2008-3#2)
Cr(4+)##40##1##(2007-11#5)(2007-12#8)(2008-2#9)(2008-3#18)
Cr(6+)##4##1##(2008-10#4)
Cr(III##2##1##(2008-10#2)
Cr(III) and Cr(VI) in##8##4##(2008-10#8)
Cr(III) and Cr(VI) ions##2##4##(2008-10#2)
Cr(III) and Cr(VI) species##2##4##(2008-10#2)
Cr(III) and Cr(VI) was##4##4##(2008-10#4)
Cr(III) and Cr(VI) were##2##4##(2008-10#2)
Cr(III) and Cr(VI)##23##3##(2008-10#23)
Cr(III) and Fe(III)##2##3##(2008-10#2)
Cr(III) and##32##2##(2008-10#31)(2013-1#1)
Cr(III) between##2##2##(2008-10#2)
Cr(III) by##3##2##(2008-10#3)
Cr(III) concentration##4##2##(2008-10#4)
Cr(III) determination##2##2##(2008-10#2)
Cr(III) ions from aqueous##2##4##(2008-10#2)
Cr(III) ions##8##2##(2008-10#7)(2011-2#1)
Cr(III) is##4##2##(2008-10#4)
Cr(III) selectively##2##2##(2008-10#2)
Cr(III) was##4##2##(2008-10#4)
Cr(III) were found to##2##4##(2008-10#2)
Cr(III) were##4##2##(2008-10#4)
Cr(III)##136##1##(2008-10#131)(2011-2#4)(2013-1#1)
Cr(III)&gt##2##1##(2008-10#2)
Cr(VI) and Cr(III) in##2##4##(2008-10#2)
Cr(VI) and Cr(III) were##2##4##(2008-10#2)
Cr(VI) and Cr(III)##11##3##(2008-10#11)
Cr(VI) and##26##2##(2008-10#26)
Cr(VI) at##2##2##(2008-10#2)
Cr(VI) by##3##2##(2008-10#2)(2011-2#1)
Cr(VI) can be##2##3##(2008-10#2)
Cr(VI) concentration##2##2##(2008-10#2)
Cr(VI) concentrations##5##2##(2008-10#5)
Cr(VI) determination##3##2##(2008-10#3)
Cr(VI) from solid samples##2##4##(2008-10#2)
Cr(VI) from##6##2##(2008-10#6)
Cr(VI) has been##2##3##(2008-10#2)
Cr(VI) in natural##2##3##(2008-10#2)
Cr(VI) in the##4##3##(2008-10#4)
Cr(VI) in##21##2##(2008-10#20)(2013-1#1)
Cr(VI) ion selectivity##2##3##(2008-10#2)
Cr(VI) ion##4##2##(2008-10#4)
Cr(VI) ions were##2##3##(2008-10#1)(2011-2#1)
Cr(VI) ions##3##2##(2008-10#2)(2011-2#1)
Cr(VI) is##7##2##(2008-10#7)
Cr(VI) on the##2##3##(2008-10#2)
Cr(VI) on##3##2##(2008-10#3)
Cr(VI) species##5##2##(2008-10#5)
Cr(VI) to Cr(III)##2##3##(2008-10#1)(2013-1#1)
Cr(VI) transformation##2##2##(2013-1#2)
Cr(VI) was determined##2##3##(2008-10#2)
Cr(VI) was found##2##3##(2008-10#2)
Cr(VI) was##14##2##(2008-10#14)
Cr(VI) were##4##2##(2008-10#3)(2011-2#1)
Cr(VI) with##5##2##(2008-10#5)
Cr(VI)##175##1##(2008-10#168)(2011-2#3)(2013-1#4)
Cr(VI)-PDC chelate##2##2##(2008-10#2)
Cr)##4##1##(2008-10#3)(2011-2#1)
Cr/Sc##2##1##(2008-2#1)(2008-3#1)
Cr1 and Cr2##2##3##(2008-10#2)
Cr1##7##1##(2008-10#7)
Cr2##24##1##(2008-10#24)
Cr2+##3##1##(2007-12#1)(2008-3#2)
Cr3##2##1##(2008-10#2)
Cr3+##5##1##(1993-6#1)(2008-2#2)(2008-3#1)(2013-8#1)
Cr4+##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
CrEL##3##1##(2008-10#3)
CrF(4)##3##1##(1996-2#3)
CrF(5)##4##1##(1996-2#4)
CrF(6)##4##1##(1996-2#4)
CrO(4)(2-)##4##1##(2008-10#4)
Crab apple##2##2##(2008-10#2)
Crack##4##1##(2008-10#2)(2008-3#1)(2012-2#1)
Cracow##3##1##(2007-8#2)(2008-10#1)
Crambidae) larvae##2##2##(2011-2#2)
Cranberry##3##1##(2008-10#3)
Cranial##12##1##(1994-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#3)(2012-3#2)
Craniofacial Surgery##2##2##(2007-12#1)(2012-3#1)
Craniofacial dysostosis syndromes##2##3##(2007-12#2)
Craniofacial surgery is##2##3##(2007-12#2)
Craniofacial##7##1##(2007-12#6)(2012-3#1)
Craniopharyngioma##2##1##(1993-9#1)(2008-7#1)
Craniotomy repair with##2##3##(2008-7#2)
Craniotomy##4##1##(2008-7#2)(2012-3#2)
Craniovertebral junction##3##2##(2008-12#2)(2008-7#1)
Crataegus##4##1##(1992-5#3)(2008-10#1)
Crater##3##1##(2008-10#2)(2013-1#1)
Cre recombinase##2##2##(2008-4#1)(2008-9#1)
Cre##4##1##(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)
Cre-LoxP system##2##2##(2008-8#1)(2008-9#1)
CreaT expression##2##2##(2008-5#2)
Creamide##4##1##(2013-1#4)
Created in##2##2##(1996-1#1)(1997-2#1)
Creatine kinase BB##2##3##(1991-9#2)
Creatine kinase##3##2##(1991-9#2)(1992-3#1)
Creatine##6##1##(1990-2#1)(1991-9#2)(1992-3#1)(2008-5#2)
Creating a##11##2##(1991-3#1)(1992-3#1)(1993-1#1)(1994-12#1)(1995-1#2)(1996-12#1)(1997-1#1)(2008-12#1)(2010-3#1)(2013-1#1)
Creating an integrated health care system##2##6##(1995-12#1)(1996-12#1)
Creating an##7##2##(1991-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-11#1)(2013-8#1)
Creating and##2##2##(2008-2#1)(2013-1#1)
Creating the##5##2##(1994-3#1)(1996-7#1)(2008-11#2)(2008-12#1)
Creating##32##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-1#3)(1995-12#1)(1995-2#2)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
Creatinine deiminase (EC 3##3##4##(1991-12#2)(2008-10#1)
Creatinine deiminase##4##2##(1991-12#3)(2008-10#1)
Creatinine was##2##2##(2008-10#2)
Creatinine##11##1##(1991-12#3)(2008-10#8)
Creation and##2##2##(2008-12#1)(2010-9#1)
Creation of a##3##3##(1996-3#1)(2010-8#1)(2010-9#1)
Creation of##8##2##(1991-12#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)
Creation##10##1##(1991-12#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#2)
Creative##8##1##(1990-11#1)(1991-1#1)(1992-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-11#1)(2012-3#1)
Creativity and##2##2##(1995-1#2)
Creek##5##1##(2009-10#1)(2010-8#3)(2011-2#1)
Creeping Bentgrass##2##2##(2008-10#2)
Cremophor EL##4##2##(2008-10#1)(2008-3#3)
Cremophor##5##1##(2008-10#1)(2008-3#3)(2008-7#1)
Cremophor-containing paclitaxel##4##2##(2008-3#4)
Crescent##4##1##(2008-10#3)(2008-9#1)
Cretaceous-Tertiary##2##1##(1997-5#2)
Crete and##2##2##(1997-6#1)(2008-10#1)
Crete##5##1##(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
Creutzfeldt-Jakob disease and##4##3##(1991-8#1)(1997-8#1)(2007-12#1)(2008-5#1)
Creutzfeldt-Jakob disease in##3##3##(1996-3#1)(1996-8#2)
Creutzfeldt-Jakob disease##12##2##(1991-8#1)(1996-3#3)(1996-8#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-5#3)
Creutzfeldt-Jakob##14##1##(1991-8#1)(1996-3#4)(1996-8#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-5#3)(2010-8#1)
Crikvenica##5##1##(2011-2#5)
Crime in hospitals##7##3##(1991-12#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)
Crime##10##1##(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2010-7#1)
Crimean-Congo##3##1##(1990-3#1)(2012-2#2)
Criminal##3##1##(1991-1#1)(1993-9#1)(1996-1#1)
Criminology##2##1##(2008-7#1)(2009-7#1)
Crinipellis perniciosa##4##2##(2008-10#4)
Crinivirus##2##1##(2008-10#2)
Crisis in##2##2##(1990-9#1)(2010-12#1)
Crisis##9##1##(1990-9#1)(1991-12#1)(1991-2#1)(1995-5#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Criteria are##2##2##(2007-4#1)(2009-11#1)
Criteria for##6##2##(1993-1#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-2#1)(2013-1#1)
Criteria to##3##2##(2008-2#2)(2012-2#1)
Criteria##19##1##(1993-1#1)(2007-11#1)(2007-4#3)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#1)
Criterion##7##1##(1996-9#1)(2008-6#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-1#1)
Critical Assessment of Functional Annotation Experiment (CAFAE) for bacterial genome annotation##2##11##(2011-2#2)
Critical Care Nurses##2##3##(2007-11#1)(2011-2#1)
Critical Care Unit##2##3##(2007-10#1)(2013-1#1)
Critical Care and##2##3##(2013-1#2)
Critical Care nurses##5##3##(2013-1#5)
Critical Care nurses' understanding of the##2##6##(2013-1#2)
Critical Care practice##2##3##(2013-1#2)
Critical Care##19##2##(2007-10#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#13)
Critical Control Points##3##3##(2009-3#2)(2013-1#1)
Critical Control##4##2##(1997-3#1)(2009-3#2)(2013-1#1)
Critical Incident Technique##2##3##(2012-3#1)(2013-1#1)
Critical Path##3##2##(1995-12#1)(1995-3#2)
Critical Pathways in Cardiology##2##4##(2008-3#2)
Critical Pathways##3##2##(2008-3#3)
Critical Thinking##3##2##(2008-11#3)
Critical appraisal##2##2##(2007-5#1)(2008-12#1)
Critical aspects##2##2##(1994-2#1)(2008-11#1)
Critical assessment of the##2##4##(1993-8#1)(2008-10#1)
Critical assessment of##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
Critical care##2##2##(2008-11#1)(2011-2#1)
Critical evaluation##3##2##(1993-11#1)(2008-3#1)(2008-9#1)
Critical foliations##2##2##(2007-11#2)
Critical issues in##3##3##(1991-1#1)(1993-2#1)(2007-12#1)
Critical paths##3##2##(1993-3#2)(1995-12#1)
Critical pathway for an aggressive diagnostic strategy for patients who present with chest pain##2##14##(2008-3#2)
Critical pathway for##5##3##(2008-3#5)
Critical pathways##3##2##(1996-3#1)(2008-3#2)
Critical review of##2##3##(1996-1#1)(2012-3#1)
Critical thinking is##2##3##(2008-11#1)(2008-12#1)
Critical to the##2##3##(1994-2#1)(2008-10#1)
Critical to##4##2##(1994-1#1)(1994-2#1)(2008-10#1)(2008-11#1)
Critical##110##1##(1991-1#1)(1991-12#1)(1992-2#3)(1993-11#2)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#2)(1995-12#3)(1995-3#2)(1996-1#1)(1996-3#3)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#12)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-11#2)(2010-9#1)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#16)(2013-8#1)
Critically##2##1##(2007-5#1)(2013-1#1)
Critics##4##1##(1992-12#1)(1996-5#2)(2012-12#1)
Critique of##3##2##(2008-12#1)(2009-9#1)(2012-12#1)
Crk and Abi1##2##3##(2012-12#2)
Crk and##4##2##(2012-12#4)
Crk proteins##5##2##(2012-12#5)
Crk##18##1##(2012-12#18)
Crl##2##1##(2012-1#2)
Croatia the##2##2##(2011-2#2)
Croatia##33##1##(2008-10#6)(2009-12#1)(2011-1#5)(2011-2#19)(2013-1#2)
Croatian anatomical and physiological terminology##2##5##(2013-1#2)
Croatian seafarers##2##2##(2011-2#2)
Croatian universities with medical##2##4##(2013-1#2)
Croatian##26##1##(2008-10#5)(2008-11#1)(2011-1#2)(2011-2#6)(2013-1#11)(2013-8#1)
Crohn disease]##2##2##(1990-3#1)(1997-5#1)
Crohn##5##1##(1990-3#1)(1993-2#1)(1997-5#1)(1997-8#2)
Crohn's disease (CD) and##2##4##(1996-2#1)(2011-2#1)
Crohn's disease (CD)##8##3##(1996-2#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#2)
Crohn's disease and ulcerative colitis##4##5##(2010-12#3)(2013-1#1)
Crohn's disease and ulcerative##5##4##(2010-12#4)(2013-1#1)
Crohn's disease and##11##3##(1990-3#1)(1992-5#1)(2007-12#1)(2008-10#1)(2010-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
Crohn's disease in##6##3##(1991-11#1)(2008-11#1)(2010-12#3)(2011-2#1)
Crohn's disease is##6##3##(2008-10#1)(2010-12#2)(2012-2#2)(2013-8#1)
Crohn's disease or##3##3##(1990-3#1)(2008-5#1)(2011-2#1)
Crohn's disease patients##2##3##(2010-12#1)(2013-8#1)
Crohn's disease presenting with##2##4##(2010-12#1)(2012-3#1)
Crohn's disease with##2##3##(1990-3#1)(1994-5#1)
Crohn's disease##112##2##(1990-3#3)(1990-6#1)(1991-11#1)(1991-8#1)(1992-5#2)(1994-2#2)(1994-5#1)(1994-6#3)(1995-8#2)(1996-2#3)(1996-3#1)(1997-5#2)(2007-12#3)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#45)(2011-2#6)(2012-1#2)(2012-2#12)(2012-3#1)(2013-1#3)(2013-8#8)
Crohn's##119##1##(1990-3#3)(1990-6#1)(1991-11#1)(1991-8#1)(1992-5#2)(1994-2#2)(1994-5#1)(1994-6#4)(1995-8#2)(1996-2#3)(1996-3#1)(1997-5#2)(2007-12#3)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#48)(2011-2#6)(2012-1#2)(2012-2#12)(2012-3#1)(2013-1#3)(2013-8#9)
Cromakalim and##2##2##(1990-8#2)
Cromakalim##4##1##(1990-8#3)(1992-9#1)
Cronartium flaccidum and Peridermium pini##2##5##(2008-10#2)
Cronartium ribicola in##3##3##(2008-10#3)
Cronartium ribicola##14##2##(2008-10#14)
Cronartium##18##1##(2008-10#18)
Cronbach##3##1##(2009-12#1)(2011-1#1)(2013-1#1)
Cronbach's Alpha was##2##3##(1996-3#1)(2010-10#1)
Cronbach's Alpha##3##2##(1996-3#1)(2009-12#1)(2010-10#1)
Cronbach's alpha coefficient was 0##2##5##(2008-10#1)(2013-1#1)
Cronbach's alpha coefficient was##3##4##(2008-10#1)(2013-1#2)
Cronbach's alpha coefficient##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
Cronbach's alpha##12##2##(1990-2#1)(2008-10#1)(2009-12#2)(2010-10#2)(2010-11#1)(2011-1#1)(2013-1#3)(2013-8#1)
Cronbach's##17##1##(1990-2#1)(1996-3#1)(2008-10#1)(2009-12#3)(2010-10#3)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
Crop Growth Rate (CGR)##3##4##(2008-12#3)
Crop Rotation##2##2##(2008-10#2)
Crop##19##1##(1991-8#1)(2008-10#10)(2008-12#6)(2012-1#1)(2012-2#1)
Cropping##2##1##(2008-10#2)
Crops and##2##2##(2008-10#2)
Crops##9##1##(2008-10#9)
Crosby##2##1##(1992-2#1)(1993-2#1)
Cross Between##3##2##(2008-10#3)
Cross Protection##3##2##(2008-10#3)
Cross sectional##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
Cross talk and##2##3##(2008-3#2)
Cross##41##1##(1991-11#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-1#2)(1994-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-5#1)(2008-10#12)(2008-2#1)(2008-3#4)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
Cross-Linked##2##1##(2009-12#1)(2010-8#1)
Cross-Linking##3##1##(2009-9#1)(2013-1#2)
Cross-cultural##2##1##(2007-12#1)(2012-2#1)
Cross-inoculation##2##1##(2008-10#1)(2008-8#1)
Cross-linking experiments revealed##2##3##(1991-2#1)(1994-3#1)
Cross-linking experiments##3##2##(1990-7#1)(1991-2#1)(1994-3#1)
Cross-linking of the##3##3##(1992-2#1)(1993-8#1)(2008-4#1)
Cross-linking of##4##2##(1992-2#1)(1993-8#1)(1995-6#1)(2008-4#1)
Cross-linking##9##1##(1990-7#1)(1991-2#2)(1992-2#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-4#1)
Cross-national##2##1##(1990-2#1)(1993-1#1)
Cross-phase modulation##2##2##(2007-12#2)
Cross-polarized##2##1##(2007-11#1)(2008-2#1)
Cross-protection between antigenically distinct H1N1 swine influenza viruses from Europe and North America##2##13##(2011-2#2)
Cross-protection##3##1##(1991-8#1)(2011-2#2)
Cross-reactivity##5##1##(1991-3#1)(2008-10#3)(2008-4#1)
Cross-sectional study##3##2##(2010-3#1)(2011-1#1)(2013-1#1)
Cross-sectional survey##2##2##(2011-2#2)
Cross-sectional##16##1##(2007-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#2)
Cross-species##2##1##(2009-5#1)(2012-2#1)
Cross-talk between##3##2##(1992-3#1)(2009-10#1)(2009-8#1)
Cross-talk##5##1##(1992-3#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-8#1)
Crossed##2##1##(2008-10#2)
Crosses between##2##2##(2008-10#2)
Crosses##4##1##(2008-10#3)(2008-8#1)
Crossflow##2##1##(2008-7#2)
Crossing##7##1##(1996-2#1)(1996-9#1)(2008-12#1)(2008-6#2)(2009-5#1)(2012-3#1)
Crosslink formation##2##2##(1993-3#1)(2008-10#1)
Crossover##5##1##(1992-6#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-3#1)
Crosstalk##2##1##(2008-8#1)(2010-10#1)
Crotalaria##2##1##(2008-11#2)
Crotalus atrox##4##2##(1992-8#2)(1994-6#1)(1994-8#1)
Crotalus##5##1##(1992-8#2)(1994-11#1)(1994-6#1)(1994-8#1)
Croup in the paediatric emergency department##3##6##(2008-11#3)
Croup##4##1##(2008-11#4)
Crouzon##3##1##(2007-12#3)
Crow##2##1##(1990-3#1)(1997-8#1)
Crowded##2##1##(2008-12#1)(2011-2#1)
Crown Gall in##2##3##(2008-10#2)
Crown and##4##2##(2008-10#4)
Crown dilaceration##2##2##(2013-1#2)
Crown##16##1##(2008-10#13)(2008-6#1)(2013-1#2)
Crucial##3##1##(2008-2#1)(2008-8#1)(2011-2#1)
Crucian Carp##2##2##(2008-5#2)
Cruciate Ligament##3##2##(2013-1#3)
Crucifers##3##1##(2008-10#3)
Crude oil##2##2##(2008-3#1)(2011-1#1)
Crude##12##1##(1992-12#1)(1994-12#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
Crudo Hamaca and Boscán crude oils and for the Orimulsión(R)-400##2##10##(2008-10#2)
Crush##2##1##(2013-8#2)
Crustacea##6##1##(2007-12#3)(2008-5#1)(2008-6#1)(2011-2#1)
Crustacean##2##1##(1991-8#1)(2008-5#1)
Cruz##12##1##(1993-6#2)(2007-12#4)(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#2)(2010-10#1)
Cruzan##2##1##(1991-12#2)
Cruzeiro do Sul##4##3##(2011-2#4)
Cry##5##1##(1993-6#2)(2008-10#1)(2011-2#2)
Cry1Aa##3##1##(2008-9#3)
Cry1Ac and Vip3Aa##2##3##(2011-2#2)
Cry1Ac and##4##2##(2011-2#4)
Cry1Ac cotton planting region##2##4##(2011-2#2)
Cry1Ac##7##1##(2011-2#7)
Cry2Ab in##2##2##(2011-2#2)
Cry2Ab##6##1##(2011-2#6)
CryIA(b) in##2##2##(2008-10#2)
CryIA(b)##4##1##(2008-10#4)
CrylAc##2##1##(2011-2#2)
CryoHex##2##1##(2008-11#2)
Cryopreservation of##6##2##(1996-8#1)(2008-10#1)(2008-9#1)(2012-3#2)(2013-1#1)
Cryopreservation##8##1##(1996-8#1)(2008-10#1)(2008-9#2)(2012-3#3)(2013-1#1)
Cryosurgery##2##1##(2007-7#1)(2009-11#1)
Cryphonectria cubensis##2##2##(2008-10#2)
Cryphonectria parasitica in##2##3##(2008-10#2)
Cryphonectria parasitica##11##2##(1995-6#1)(2008-10#9)(2008-9#1)
Cryphonectria##17##1##(1995-6#1)(2008-10#15)(2008-9#1)
Cryptic##5##1##(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
Cryptococcal meningitis in##2##3##(2007-7#1)(2007-8#1)
Cryptococcal meningitis is##2##3##(2007-8#1)(2011-2#1)
Cryptococcal meningitis##6##2##(2007-7#1)(2007-8#3)(2011-2#2)
Cryptococcus gattii##2##2##(2008-10#2)
Cryptococcus laurentii##4##2##(2008-10#3)(2008-5#1)
Cryptococcus neoformans strains##2##3##(2008-5#2)
Cryptococcus neoformans var##6##3##(2008-5#6)
Cryptococcus neoformans was isolated##2##4##(2007-8#2)
Cryptococcus neoformans##24##2##(2007-10#2)(2007-7#2)(2007-8#3)(2008-11#1)(2008-5#13)(2009-2#2)(2010-7#1)
Cryptococcus nodaensis OH 182##2##4##(2008-10#2)
Cryptococcus spp##3##2##(2008-5#2)(2009-9#1)
Cryptococcus##41##1##(1996-6#2)(1997-1#1)(2007-10#3)(2007-7#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-5#18)(2009-2#2)(2009-9#1)(2010-7#1)
Cryptogenic##2##1##(1997-8#1)(2007-10#1)
Cryptophlebia leucotreta##2##2##(2008-10#2)
Cryptophlebia##4##1##(2008-10#2)(2008-6#2)
Cryptorchidism##2##1##(2008-10#2)
Cryptosporidiosis##3##1##(2013-8#3)
Cryptosporidium DNA target##2##3##(2008-10#2)
Cryptosporidium DNA##3##2##(2008-10#3)
Cryptosporidium parvum##6##2##(1996-12#2)(1997-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
Cryptosporidium species in##2##3##(2007-8#1)(2012-2#1)
Cryptosporidium species##3##2##(2007-8#1)(2012-2#1)(2013-1#1)
Cryptosporidium spp##7##2##(2012-12#6)(2013-1#1)
Cryptosporidium was##2##2##(1996-12#1)(2013-1#1)
Cryptosporidium##36##1##(1996-12#5)(1997-4#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#6)(2012-12#7)(2012-2#1)(2013-1#11)(2013-8#1)
Crystal Structure of##2##3##(1996-2#1)(1997-7#1)
Crystal Structure##3##2##(1996-2#1)(1997-7#2)
Crystal data for##5##3##(1996-2#3)(1997-7#2)
Crystal structure determination##2##3##(1993-8#1)(2008-9#1)
Crystal structure of the##3##4##(1993-9#1)(1994-12#1)(1995-11#1)
Crystal structure of##9##3##(1992-12#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1997-4#1)(1997-6#1)(2008-8#2)
Crystal structure##13##2##(1992-12#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(2008-8#2)(2008-9#1)(2013-8#1)
Crystal structures##2##2##(1995-2#1)(1996-2#1)
Crystal##41##1##(1992-12#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#7)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#4)(2008-10#2)(2008-2#6)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
Crystalline##2##1##(2007-12#1)(2013-1#1)
Crystallization and preliminary##2##3##(1992-11#1)(1992-8#1)
Crystallization of##5##2##(1997-7#1)(2007-12#1)(2008-4#2)(2011-2#1)
Crystallization##10##1##(1992-11#1)(1992-8#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)
Crystallographic analysis of##2##3##(1992-11#1)(1993-8#1)
Crystallographic##6##1##(1992-11#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-11#1)
Crystallography##3##1##(2008-5#1)(2009-11#1)(2013-8#1)
Crystals of##10##2##(1992-12#1)(1996-2#7)(2008-8#2)
Crystals##16##1##(1992-12#1)(1996-12#1)(1996-2#8)(2008-2#1)(2008-3#2)(2008-8#2)(2009-12#1)
Crèching behavior##2##2##(2008-9#2)
Crèching##3##1##(2008-9#3)
Cs##15##1##(1993-12#1)(1997-7#1)(2007-12#3)(2008-10#6)(2009-11#4)
Cs(+) and##2##2##(2008-10#2)
Cs(+) or ZD7288##2##3##(2008-2#2)
Cs(+)##14##1##(2008-10#12)(2008-2#2)
Cs(+)&gt##2##1##(2008-10#2)
Cs(+)-selective##3##1##(2008-10#3)
Cs)##4##1##(1997-7#2)(2008-10#1)(2009-11#1)
Cs+##3##1##(1992-6#1)(1994-11#1)(2008-10#1)
Cs-137##3##1##(1994-9#3)
CsA can be##2##3##(1990-12#2)
CsA did not##2##3##(1994-8#2)
CsA was##2##2##(2007-7#1)(2013-1#1)
CsA##33##1##(1990-12#3)(1991-9#1)(1994-3#3)(1994-8#7)(1997-2#3)(2007-7#6)(2008-6#8)(2008-8#1)(2013-1#1)
CsCl##6##1##(1990-5#1)(1996-2#1)(2008-10#3)(2008-2#1)
CsI##2##1##(2011-1#2)
CsLiB(6)O(10) crystal##2##2##(2008-3#2)
CsLiB(6)O(10)##6##1##(2007-11#2)(2008-2#1)(2008-3#3)
CsLiB6O10##3##1##(2008-2#1)(2008-3#2)
CsO-2##2##1##(2009-2#2)
Csb mice##3##2##(1990-12#3)
Csb##5##1##(1990-12#5)
Csfm##5##1##(1990-5#5)
CsnSN##2##1##(1994-12#2)
Csp I fragments##2##3##(1992-6#2)
Csp##4##1##(1992-6#4)
CstF##2##1##(1995-6#1)(2007-12#1)
Ct##2##1##(1990-5#1)(2008-10#1)
Ct0##3##1##(2008-10#3)
CtoA protein was##2##3##(2009-2#2)
CtoA##4##1##(2009-2#4)
Ctr1##4##1##(2008-10#3)(2010-11#1)
CtxB##2##1##(2008-9#2)
Cu accumulates##2##2##(1995-3#2)
Cu and Cd##2##3##(2008-10#1)(2008-5#1)
Cu and Co##2##3##(2013-8#2)
Cu and Fe was##2##4##(2008-10#1)(2008-12#1)
Cu and Fe##7##3##(2008-10#6)(2008-12#1)
Cu and Mn was##2##4##(2008-10#2)
Cu and Mn##12##3##(2008-10#12)
Cu and Ni##3##3##(2008-10#3)
Cu and Pb##10##3##(2008-10#10)
Cu and SS##2##3##(2013-8#2)
Cu and Zn in##3##4##(2008-10#3)
Cu and Zn were found to##2##6##(2008-10#2)
Cu and Zn##12##3##(2008-10#12)
Cu and##63##2##(1995-3#1)(2008-10#55)(2008-12#1)(2008-5#2)(2013-8#4)
Cu concentration in the##3##4##(1995-3#2)(2008-10#1)
Cu concentration##7##2##(1995-3#4)(2008-10#1)(2008-12#2)
Cu coupons##2##2##(2013-8#2)
Cu electrode##5##2##(2008-10#5)
Cu exposure##2##2##(2008-12#2)
Cu for##5##2##(1997-4#2)(2008-10#3)
Cu in a##2##3##(2008-10#2)
Cu in the##2##3##(1995-3#1)(2008-10#1)
Cu in##10##2##(1995-3#1)(2008-10#8)(2012-2#1)
Cu level##2##2##(1995-3#1)(2008-10#1)
Cu on##4##2##(2008-10#3)(2008-12#1)
Cu thin##2##2##(2007-11#1)(2013-8#1)
Cu were##7##2##(1995-3#1)(1997-4#2)(2008-10#3)(2008-11#1)
Cu##355##1##(1990-12#2)(1991-12#1)(1993-11#1)(1995-3#15)(1995-6#3)(1996-2#1)(1997-2#6)(1997-4#13)(1997-8#9)(2007-11#2)(2007-12#4)(2008-10#251)(2008-11#5)(2008-12#8)(2008-3#2)(2008-5#4)(2010-11#1)(2010-5#3)(2011-2#3)(2012-2#8)(2013-1#2)(2013-8#11)
Cu(+)##4##1##(2008-10#3)(2008-3#1)
Cu(1)##3##1##(1997-7#3)
Cu(2)##5##1##(1997-7#5)
Cu(2)(ii)##2##1##(1997-7#2)
Cu(2)O##2##1##(2008-2#2)
Cu(2+) and Hg(2+)##3##3##(2008-10#3)
Cu(2+) and Ni(2+)##2##3##(1997-7#1)(2008-10#1)
Cu(2+) and##12##2##(1997-7#1)(2008-10#8)(2008-5#3)
Cu(2+) at##2##2##(2008-10#2)
Cu(2+) concentration##2##2##(2008-10#2)
Cu(2+) in the##2##3##(2008-10#1)(2008-12#1)
Cu(2+) in##7##2##(2008-10#6)(2008-12#1)
Cu(2+) ion##3##2##(2008-10#3)
Cu(2+) ions are##2##3##(2008-10#2)
Cu(2+) ions##11##2##(2008-10#9)(2009-8#2)
Cu(2+) is##4##2##(2008-10#3)(2008-12#1)
Cu(2+) levels##2##2##(2008-10#2)
Cu(2+) to##2##2##(2008-10#1)(2008-12#1)
Cu(2+) with a##3##3##(2008-10#3)
Cu(2+) with##7##2##(2008-10#7)
Cu(2+)##117##1##(1997-7#1)(2008-10#101)(2008-12#7)(2008-5#3)(2009-8#3)(2012-2#1)(2013-1#1)
Cu(2+)-selective##2##1##(2008-10#2)
Cu(A)##2##1##(1996-2#2)
Cu(B)##2##1##(1996-2#2)
Cu(I)##6##1##(2008-10#6)
Cu(II) and Ag(I)##3##3##(2008-10#3)
Cu(II) and Cd(II)##2##3##(2008-10#2)
Cu(II) and Co(II)##2##3##(2008-10#2)
Cu(II) and Hg(II)##2##3##(2008-10#2)
Cu(II) and Mn(II) beta-diketonates##2##4##(2008-10#2)
Cu(II) and Ni(II)##7##3##(2008-10#7)
Cu(II) and Pb(II)##3##3##(2008-10#1)(2013-1#2)
Cu(II) and Zn(II)##4##3##(2008-10#4)
Cu(II) and##37##2##(1995-5#1)(2008-10#33)(2008-5#1)(2013-1#2)
Cu(II) as the##2##3##(2008-10#2)
Cu(II) as##4##2##(1990-8#1)(2008-10#3)
Cu(II) at pH 5##2##4##(2008-10#2)
Cu(II) at pH##3##3##(2008-10#3)
Cu(II) by##4##2##(2008-10#4)
Cu(II) complex in##2##3##(2008-10#1)(2008-5#1)
Cu(II) extraction##3##2##(2008-10#3)
Cu(II) from the##3##3##(2008-10#3)
Cu(II) from##7##2##(2008-10#7)
Cu(II) in real samples##2##4##(2008-10#2)
Cu(II) in the##2##3##(1995-2#1)(2008-10#1)
Cu(II) in##15##2##(1995-2#1)(2008-10#14)
Cu(II) ions at##2##3##(2008-10#2)
Cu(II) ions##12##2##(2008-10#11)(2011-1#1)
Cu(II) on the##2##3##(2008-10#2)
Cu(II) or##3##2##(1995-2#1)(2008-10#2)
Cu(II) over a wide concentration range##2##6##(2008-10#2)
Cu(II) over a wide##3##4##(2008-10#3)
Cu(II) over##4##2##(2008-10#4)
Cu(II) was##6##2##(1995-2#1)(2008-10#5)
Cu(II) with##12##2##(2008-10#12)
Cu(II)##229##1##(1990-8#2)(1992-9#1)(1995-2#6)(1995-5#1)(2008-10#209)(2008-5#5)(2011-1#2)(2013-1#3)
Cu(II)(2)-TRH(2)##2##1##(2008-5#2)
Cu(II)-Nc##3##1##(2008-10#3)
Cu(II)-TRH##2##1##(2008-5#2)
Cu(II)/Ln(III)##2##1##(1997-7#2)
Cu(II)L(2)##3##1##(2008-10#3)
Cu(III)##2##1##(2008-10#2)
Cu(i) binding amino acids##2##4##(2011-2#2)
Cu(i) binding##3##2##(2011-2#3)
Cu(i)##6##1##(2011-2#6)
Cu) are##2##2##(2008-10#2)
Cu)##9##1##(2008-10#8)(2009-10#1)
Cu-EDTA(2-)##2##1##(2008-10#2)
Cu-rats##2##1##(2008-10#2)
Cu/Gd complexes##2##2##(1997-7#2)
Cu/Zn##5##1##(1994-6#2)(1996-5#1)(2008-10#1)(2013-8#1)
Cu2+##7##1##(1991-2#1)(1993-11#1)(1994-11#1)(1997-2#1)(1997-7#1)(2008-12#1)(2013-8#1)
CuBr##2##1##(2006-4#1)(2008-12#1)
CuCl(2)##2##1##(2008-10#2)
CuHCF##4##1##(2008-10#4)
CuII##2##1##(2007-11#2)
CuLCV##2##1##(2008-10#2)
CuLCV-AZ DNA A##2##3##(2008-10#2)
CuLCV-AZ and##3##2##(2008-10#3)
CuLCV-AZ##7##1##(2008-10#7)
CuN(6) units##4##2##(1996-2#4)
CuN(6)##6##1##(1996-2#6)
CuNb(py)(4)OF(5)##4##1##(1996-2#4)
CuO##2##1##(1996-2#1)(2013-1#1)
CuPb12##2##1##(2013-8#2)
CuSO(4)##7##1##(2008-10#4)(2008-11#3)
CuSO₄ and ZnSO₄ exhibited##2##4##(2010-11#2)
CuSO₄##7##1##(2010-11#7)
CuZn superoxide dismutase##2##3##(1992-12#1)(2008-7#1)
CuZn-superoxide dismutase RNA##2##3##(1990-3#2)
CuZn-superoxide dismutase##3##2##(1990-3#2)(2008-7#1)
Cuba and Chile##2##3##(2013-1#2)
Cuba and##4##2##(2007-10#2)(2013-1#2)
Cuba during the##2##3##(2007-10#1)(2008-5#1)
Cuba##41##1##(1993-8#1)(1996-11#2)(1997-5#1)(2007-10#12)(2007-12#2)(2008-10#1)(2008-5#7)(2008-6#1)(2008-7#2)(2013-1#12)
Cuba's##5##1##(1993-8#1)(1996-11#1)(1997-8#1)(2008-5#1)(2009-7#1)
Cuba]##2##1##(2007-10#2)
Cuban##10##1##(1996-11#1)(2008-5#5)(2008-6#1)(2012-12#3)
Cuc E##4##2##(2008-11#4)
Cucumber fruit mottle mosaic virus##2##5##(2008-10#2)
Cucumber green mottle mosaic virus##2##5##(2008-10#2)
Cucumber mosaic virus (CMV) and##2##5##(2008-10#2)
Cucumber mosaic virus (CMV) in##2##5##(2008-10#2)
Cucumber mosaic virus (CMV)##7##4##(2008-10#7)
Cucumber mosaic virus and##3##4##(2008-10#2)(2012-2#1)
Cucumber mosaic virus##20##3##(2008-10#19)(2012-2#1)
Cucumber necrosis virus##2##3##(2008-10#2)
Cucumber##33##1##(2008-10#30)(2008-5#2)(2012-2#1)
Cucumis melo##2##2##(2008-10#2)
Cucurbit Yellow Vine Disease##2##4##(2008-10#2)
Cucurbit leaf##2##2##(2008-10#2)
Cucurbit yellow stunting disorder virus##3##5##(2008-10#3)
Cucurbit##10##1##(2008-10#10)
Cucurbit-Infecting##2##1##(2008-10#2)
Cucurbitaceae##10##1##(2008-10#10)
Cucurbits##3##1##(2008-10#3)
Cues##2##1##(2010-9#1)(2013-8#1)
Culex coronator and Limatus durhamii##2##5##(2008-5#2)
Culex##8##1##(2007-12#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)
Culicidae)##12##1##(2007-12#1)(2008-5#5)(2008-8#1)(2012-12#1)(2013-1#3)(2013-8#1)
Culicoides and the##2##3##(2010-1#2)
Culicoides species##2##2##(2008-8#1)(2010-1#1)
Culicoides were##2##2##(2010-1#2)
Culicoides##10##1##(2008-8#3)(2010-1#7)
Cullin-5 E3##3##2##(2013-1#3)
Cullin-5##4##1##(2013-1#4)
Culprit##2##1##(2008-7#1)(2012-12#1)
Cultivar mixtures##2##2##(2008-10#2)
Cultivar##12##1##(2008-10#11)(2009-8#1)
Cultivars and##2##2##(2008-10#2)
Cultivars of##4##2##(2008-10#4)
Cultivars to##2##2##(2008-10#2)
Cultivars##24##1##(2008-10#24)
Cultivated##6##1##(2008-10#5)(2012-2#1)
Cultivation of##6##2##(2008-10#2)(2008-11#2)(2008-9#1)(2011-1#1)
Cultivation##9##1##(2008-10#3)(2008-11#3)(2008-9#2)(2011-1#1)
Cultural and##2##2##(1994-3#1)(2011-1#1)
Cultural characteristics##2##2##(2008-10#2)
Cultural diversity##2##2##(1994-12#1)(2008-1#1)
Cultural##19##1##(1990-8#1)(1992-3#1)(1994-12#1)(1994-3#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
Culturally competent##2##2##(2007-10#1)(2008-4#1)
Culturally##5##1##(1997-6#1)(2007-10#1)(2008-4#2)(2012-3#1)
Culture Collection##3##2##(2008-12#1)(2008-5#2)
Culture and##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
Culture filtrates of##2##3##(2008-10#2)
Culture of##8##2##(1991-3#1)(1993-6#1)(1993-9#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-11#2)
Culture##43##1##(1991-12#1)(1991-3#1)(1993-2#1)(1993-6#1)(1993-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#7)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Culture-bound##2##1##(2012-2#2)
Culture-negative##2##1##(2008-1#1)(2008-4#1)
Cultured hepatocytes##2##2##(1991-9#2)
Cultured human##3##2##(1995-12#1)(2008-4#1)(2013-1#1)
Cultured vascular##2##2##(1990-8#1)(1991-9#1)
Cultured##16##1##(1990-8#1)(1991-5#1)(1991-9#4)(1994-3#1)(1995-11#1)(1995-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
Cultures from##2##2##(1994-12#1)(2008-10#1)
Cultures of##7##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#2)
Cultures were incubated in alphaMEM containing fetal calf serum##2##9##(2008-11#2)
Cultures were incubated##3##3##(2008-10#1)(2008-11#2)
Cultures were##6##2##(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#1)
Cultures##18##1##(1994-12#1)(1996-6#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#3)(2012-2#1)
Culturing##3##1##(2008-11#1)(2010-2#1)(2011-1#1)
Cumulative data##2##2##(2008-7#1)(2012-12#1)
Cumulative##15##1##(1991-9#1)(1994-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Cunningham##2##1##(1995-2#2)
CupPrint##4##1##(2013-8#4)
Cupressus arizonica##3##2##(2013-8#3)
Cupriavidus basilensis HMF14##2##3##(2011-1#2)
Curative##4##1##(1996-12#1)(2007-11#1)(2008-10#1)(2010-12#1)
Curbside Consult##4##2##(2008-8#4)
Curculionidae)##5##1##(2008-7#2)(2011-2#2)(2013-8#1)
Curcuma longa (IC50##2##3##(2008-5#2)
Curcuma longa##5##2##(1992-9#1)(2008-5#3)(2011-2#1)
Curcuma##7##1##(1992-9#1)(1996-9#1)(2008-5#4)(2011-2#1)
Curcumin or turmeric##3##3##(1994-8#3)
Curcumin##14##1##(1992-9#1)(1994-8#3)(2008-11#3)(2010-3#2)(2011-2#1)(2012-3#4)
Cure##3##1##(2008-6#1)(2011-2#1)(2011-3#1)
Curie point##2##2##(2007-12#1)(2008-3#1)
Curie##5##1##(1993-5#1)(2007-11#1)(2007-12#1)(2008-3#2)
Curlin##3##1##(2010-9#1)(2011-2#2)
Current Beneficiary##15##2##(1994-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)
Current Developments in the##2##4##(2010-6#2)
Current Population##2##2##(1993-3#1)(2011-2#1)
Current Protocols##4##2##(2008-4#1)(2008-9#3)
Current Status##2##2##(2008-11#1)(2011-2#1)
Current Users##3##2##(2010-8#3)
Current Users'##2##2##(2010-8#2)
Current World Literature##3##3##(2008-7#1)(2008-8#2)
Current and##3##2##(1992-2#1)(1994-2#1)(2008-2#1)
Current applications##2##2##(2008-10#1)(2012-3#1)
Current approaches to##3##3##(1992-3#1)(2009-4#1)(2012-3#1)
Current awareness on yeast##2##4##(1995-6#1)(1995-9#1)
Current awareness on##3##3##(1995-6#1)(1995-9#1)(2008-7#1)
Current challenges for##2##3##(2008-8#1)(2012-3#1)
Current clinical##2##2##(2008-8#1)(2013-1#1)
Current concepts of##2##3##(2008-4#1)(2009-6#1)
Current concepts##4##2##(2007-12#1)(2008-4#1)(2009-6#1)(2010-3#1)
Current data##7##2##(1993-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-6#1)(2013-1#1)
Current evidence##8##2##(1991-9#1)(1995-3#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
Current guidelines for##3##3##(2008-7#1)(2010-7#1)(2011-2#1)
Current issues##2##2##(2008-11#1)(2010-2#1)
Current knowledge##2##2##(2008-10#2)
Current management of##3##3##(2007-11#1)(2007-12#1)(2010-8#1)
Current management##4##2##(2007-11#1)(2007-12#1)(2010-8#1)(2011-2#1)
Current medical##3##2##(2007-12#2)(2008-3#1)
Current methodologies##2##2##(2009-12#1)(2009-6#1)
Current methods for##3##3##(1995-12#1)(2007-8#1)(2008-4#1)
Current methods##8##2##(1995-12#2)(1997-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
Current models##2##2##(2008-8#2)
Current practice##2##2##(2009-4#1)(2010-10#1)
Current recommendations suggest##2##3##(2009-12#1)(2012-12#1)
Current research##6##2##(1995-6#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
Current response##2##2##(2008-10#2)
Current risk##2##2##(2008-10#1)(2013-8#1)
Current standards##2##2##(2008-11#1)(2009-4#1)
Current status and future##2##4##(1994-9#1)(2010-12#1)
Current status and##3##3##(1994-9#1)(2007-5#1)(2010-12#1)
Current status of##8##3##(1994-3#1)(1997-8#2)(2007-11#1)(2008-11#2)(2008-9#1)(2011-2#1)
Current status##13##2##(1994-3#1)(1994-9#1)(1997-8#2)(2007-11#1)(2007-5#1)(2008-11#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
Current studies##3##2##(2007-2#1)(2008-5#1)(2011-2#1)
Current technology##2##2##(1997-3#1)(2008-7#1)
Current therapeutic##2##2##(2008-1#1)(2008-7#1)
Current therapy for##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
Current therapy##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)
Current treatment of##2##3##(2006-10#1)(2011-2#1)
Current treatment##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
Current treatments##2##2##(2008-2#1)(2011-2#1)
Current trends in##2##3##(2008-6#1)(2009-9#1)
Current trends##4##2##(1994-2#1)(2008-5#1)(2008-6#1)(2009-9#1)
Current understandings##2##2##(2009-2#1)(2013-1#1)
Current views##2##2##(2007-8#1)(2008-9#1)
Current world literature##13##3##(2006-10#3)(2008-5#2)(2008-6#5)(2008-8#2)(2009-4#1)
Current##265##1##(1990-3#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-10#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#9)(2008-7#12)(2008-8#13)(2008-9#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#1)(2011-2#17)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#2)
Currently a variety##2##3##(2008-11#1)(2011-2#1)
Currently available##6##2##(1990-5#1)(1996-3#1)(2007-12#1)(2008-10#2)(2010-4#1)
Currently there are##2##3##(2009-12#1)(2012-2#1)
Currently there is##2##3##(1995-8#1)(2011-2#1)
Currently there##5##2##(1995-8#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
Currently used##2##2##(2008-10#1)(2011-2#1)
Currently##128##1##(1990-5#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1997-5#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#13)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#5)
Currents##5##1##(1995-12#3)(2009-12#1)(2012-12#1)
Curriculum##5##1##(1997-2#1)(2008-11#2)(2010-5#1)(2012-3#1)
Curtovirus##3##1##(2008-10#3)
Curvature##3##1##(2008-3#1)(2009-6#2)
Curve Analysis##2##2##(2008-10#1)(2009-11#1)
Curve##5##1##(2008-1#2)(2008-10#1)(2009-11#2)
Curves##3##1##(2008-3#1)(2008-7#1)(2009-12#1)
Curvularia##3##1##(2008-10#3)
Cusco##2##1##(2008-10#2)
Cushing syndrome##2##2##(2009-3#1)(2011-2#1)
Cushing##5##1##(1991-11#1)(2008-4#1)(2009-3#1)(2010-8#1)(2011-2#1)
Cushing's Syndrome##4##2##(2011-2#3)(2013-1#1)
Cushing's disease##7##2##(1990-3#2)(1991-11#1)(2009-4#1)(2011-2#3)
Cushing's syndrome (CS)##2##3##(2011-2#2)
Cushing's syndrome##15##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-11#1)(1992-10#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#4)(2013-1#1)
Cushing's##30##1##(1990-11#2)(1990-3#5)(1991-10#1)(1991-11#2)(1992-10#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#11)(2013-1#2)
Custom-made##2##1##(2007-11#1)(2008-10#1)
Customer service##2##2##(1991-1#1)(1995-1#1)
Customer##4##1##(1991-1#1)(1994-12#1)(1995-1#1)(2007-10#1)
Cut##6##1##(1997-2#1)(2008-9#3)(2009-5#1)(2012-3#1)
Cutaneous allodynia##2##2##(2008-9#2)
Cutaneous leishmaniasis is##2##3##(1991-11#1)(2012-12#1)
Cutaneous leishmaniasis##4##2##(1990-6#1)(1991-11#1)(2012-12#2)
Cutaneous lesions##2##2##(1997-6#1)(2012-3#1)
Cutaneous metastases from carcinoma of##2##5##(1990-8#1)(2010-11#1)
Cutaneous metastases from internal##2##4##(2010-11#1)(2010-6#1)
Cutaneous metastases from##4##3##(1990-8#1)(2010-11#2)(2010-6#1)
Cutaneous metastases##5##2##(1990-8#1)(2010-11#3)(2010-6#1)
Cutaneous pseudosarcomatous##2##2##(2008-11#2)
Cutaneous sarcoidosis##3##2##(2007-7#2)(2010-6#1)
Cutaneous##42##1##(1990-6#1)(1990-8#2)(1991-11#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-2#1)(2007-7#4)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-11#3)(2010-6#3)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#5)(2013-1#2)(2013-8#1)
Cutis laxa##2##2##(2008-7#2)
Cuttack##2##1##(2007-7#1)(2008-3#1)
Cutting the##2##2##(1992-2#1)(2008-5#1)
Cutting##5##1##(1990-6#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
Cvs##2##1##(2008-10#2)
Cx##6##1##(2013-1#4)(2013-7#2)
Cx40##2##1##(2012-12#2)
Cx43 transfection##4##2##(2008-11#4)
Cx43##12##1##(2008-11#6)(2008-6#3)(2008-8#3)
CxD##2##1##(2008-10#2)
Cy##2##1##(2008-10#2)
Cy3 or Cy3##4##3##(2008-10#4)
Cy3##13##1##(2008-10#9)(2008-4#1)(2008-9#1)(2010-12#2)
Cy3-AS1411##3##1##(2010-12#3)
Cy5##4##1##(2008-10#3)(2008-4#1)
Cy5-labeled anti-T3##2##2##(2008-10#2)
Cy5-labeled##3##1##(2008-10#3)
CyA and##4##2##(2008-10#4)
CyA##10##1##(2008-10#10)
CyDye DIGE fluor minimal dyes##2##5##(2008-2#2)
CyDyes##2##1##(2008-2#2)
CyP-CsA##2##1##(2008-9#2)
Cyanamid##2##1##(2008-5#2)
Cyanex 923##7##2##(2008-10#7)
Cyanex##11##1##(2008-10#11)
Cyanobacterium##2##1##(1997-2#2)
Cyanophora paradoxa##2##2##(1997-6#2)
Cyanothece 51142##2##2##(2009-7#2)
Cybex##2##1##(2008-12#1)(2011-2#1)
CycD5##2##1##(2009-8#2)
Cyclamen##2##1##(2008-10#2)
Cyclandelate##2##1##(1994-8#2)
Cycle##11##1##(1997-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-12#1)(2012-2#1)
Cycles of##2##2##(2009-10#1)(2012-3#1)
Cycles were repeated every##2##4##(1990-2#1)(2007-10#1)
Cycles##5##1##(1990-2#1)(1994-8#1)(2007-10#1)(2009-10#1)(2012-3#1)
Cyclic AMP##3##2##(1997-2#1)(2008-10#2)
Cyclic nucleotides##2##2##(2009-10#2)
Cyclic olefin##2##2##(2008-2#2)
Cyclic strain##3##2##(1993-3#2)(1994-11#1)
Cyclic voltammetric experiments##2##3##(2008-10#2)
Cyclic voltammetric##5##2##(2008-10#5)
Cyclic voltammetry (CV)##2##3##(2008-10#2)
Cyclic voltammetry of##2##3##(2008-10#2)
Cyclic voltammetry was employed to##2##5##(2008-10#2)
Cyclic voltammetry was used to characterize the interfacial and redox##2##10##(2008-10#2)
Cyclic voltammetry was used to##3##5##(2008-10#3)
Cyclic voltammetry was##5##3##(2008-10#5)
Cyclic voltammetry##14##2##(2008-10#14)
Cyclic voltammograms##5##2##(2008-10#5)
Cyclic##52##1##(1993-3#2)(1993-6#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#29)(2008-2#2)(2008-6#2)(2009-10#3)(2009-11#1)(2009-12#1)(2012-7#1)
Cyclin B1##2##2##(2008-5#2)
Cyclin##7##1##(1993-6#1)(1995-5#1)(1997-8#1)(2008-5#3)(2009-4#1)
Cyclin-dependent##2##1##(2013-1#2)
Cyclins##4##1##(1997-6#1)(2008-5#1)(2008-9#1)(2009-8#1)
Cyclization of##2##2##(1996-5#2)
Cyclization##3##1##(1996-5#3)
Cyclizations of##2##2##(1996-5#1)(2008-9#1)
Cycloaddition##3##1##(1996-5#2)(2012-3#1)
Cyclodextrin##2##1##(2008-10#2)
Cycloheximide##4##1##(1991-5#2)(1993-3#1)(2011-3#1)
Cyclooxygenase##6##1##(1993-8#2)(1994-5#1)(2006-10#1)(2007-4#1)(2008-12#1)
Cyclooxygenase-2##2##1##(2008-11#1)(2011-2#1)
Cyclophilins##2##1##(1993-9#1)(2011-2#1)
Cyclophosphamide##4##1##(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
Cyclopropanation of##2##2##(1996-5#1)(2009-6#1)
Cyclospora##4##1##(2007-12#1)(2007-7#3)
Cyclosporin A (CsA)##2##3##(1994-3#1)(1994-8#1)
Cyclosporin A##3##2##(1994-3#2)(1994-8#1)
Cyclosporin##5##1##(1994-3#2)(1994-8#1)(1997-6#1)(2008-6#1)
Cyclosporine A##2##2##(2008-10#2)
Cyclosporine##7##1##(1994-6#2)(2007-7#1)(2008-10#3)(2008-3#1)
Cycloxygenase-2 (COX-2)##2##2##(2013-8#2)
Cylindrical##5##1##(2007-12#1)(2008-12#1)(2008-3#3)
Cylindrocarpon destructans##6##2##(2008-10#6)
Cylindrocarpon root rot##4##3##(2008-10#4)
Cylindrocarpon spp##2##2##(2008-10#2)
Cylindrocarpon##12##1##(2008-10#12)
CymMV-K1##2##1##(1997-2#2)
CymMV-K2 and CymMV-S2##2##3##(1997-2#2)
CymMV-K2##5##1##(1997-2#5)
CymMV-S1 and##2##2##(1997-2#2)
CymMV-S1##3##1##(1997-2#3)
Cymadothea trifolii##2##2##(2010-3#2)
Cymadothea##3##1##(2010-3#3)
Cymbidium mosaic virus (CymMV) and Odontoglossum ringspot virus (ORSV)##2##9##(2008-10#2)
Cymbidium mosaic##3##2##(2008-10#3)
Cymbidium##5##1##(1997-2#1)(2008-10#4)
Cymoxanil##2##1##(2008-10#2)
Cynandra opis##2##2##(2008-3#2)
Cynodon dactylon##2##2##(2008-10#2)
Cynoglossus semilaevis##3##2##(2010-8#2)(2013-8#1)
Cynops pyrrhogaster##2##2##(2008-6#2)
Cynoscion acoupa##2##2##(2013-7#2)
Cynoscion##4##1##(2010-8#2)(2013-7#2)
Cyp1a-1 induction##3##2##(1992-8#3)
CypA is##3##2##(2011-2#3)
Cypermethrin and Chlorpyrifos##3##3##(2008-10#3)
Cypermethrin and##4##2##(2008-10#4)
Cyphertrade mark##2##2##(2008-11#2)
Cypress##3##1##(2008-10#3)
Cyprinidae)##3##1##(2008-12#1)(2008-5#1)(2010-8#1)
Cyprinus carpio##4##2##(2010-8#2)(2012-2#2)
Cyprus##4##1##(1990-6#1)(1991-12#1)(2008-10#1)(2008-5#1)
Cyps##3##1##(2011-2#3)
Cys &gt##2##2##(2011-2#2)
Cys and##3##2##(2008-10#3)
Cys at##2##2##(1993-3#1)(1995-6#1)
Cys in##2##2##(1992-9#1)(2008-10#1)
Cys residue##5##2##(1990-12#2)(1994-12#1)(1994-5#1)(2008-8#1)
Cys residues##6##2##(1991-6#1)(1993-11#1)(1993-2#1)(1994-5#1)(2008-8#2)
Cys was##2##2##(2008-10#2)
Cys##52##1##(1990-12#3)(1991-6#1)(1992-9#1)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-5#3)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#4)(2008-10#14)(2008-8#4)(2011-2#3)(2012-2#2)
Cys)##2##1##(1990-5#1)(2008-4#1)
Cys-138##3##1##(1993-8#3)
Cys-3##2##1##(1992-3#2)
Cys-33##2##1##(1994-5#2)
Cys163----Ser##3##1##(1991-7#3)
Cys2/His2 zinc##2##2##(1992-8#2)
Cys215##2##1##(1994-2#2)
Cys42Ala and Cys42Ser##2##3##(1995-5#2)
Cys4]deltorphin##2##1##(1996-2#2)
CysP##2##1##(1994-12#2)
Cyst Nematode##2##2##(2008-10#2)
Cyst##10##1##(1994-7#1)(2008-10#4)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Cystatin C##3##2##(2010-4#3)
Cysteine dioxygenase##2##2##(2009-11#2)
Cysteine##17##1##(1991-9#3)(1992-12#1)(1993-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-4#2)(2009-11#3)(2011-3#1)
Cystemustine##4##1##(2008-5#4)
Cystic fibrosis##2##2##(1997-1#1)(2012-12#1)
Cystic lymphangioma##3##2##(2007-8#3)
Cystic##7##1##(1994-7#1)(1997-1#1)(2007-8#3)(2012-12#2)
Cysticercosis of the CNS##2##4##(1995-12#2)
Cysticercosis of##3##2##(1995-12#2)(2008-1#1)
Cysticercosis##5##1##(1991-8#1)(1995-12#2)(2008-1#1)(2008-7#1)
Cystine##2##1##(2008-10#1)(2008-7#1)
Cystinosis and cystinuria##2##3##(2007-7#2)
Cystinosis##3##1##(2007-7#3)
Cystinuria in##2##2##(2007-7#2)
Cystinuria is a##2##3##(2007-7#2)
Cystinuria##5##1##(2007-7#5)
Cystoscopic##2##1##(2007-10#1)(2009-7#1)
Cysts of the jaws##2##4##(2007-12#2)
Cysts of##4##2##(2007-12#2)(2008-10#1)(2008-5#1)
Cysts##9##1##(2007-12#2)(2008-10#3)(2008-5#2)(2012-3#1)(2013-1#1)
Cyt c(6A)##3##2##(2009-10#3)
Cyt##10##1##(1993-11#2)(1995-6#1)(2008-10#4)(2009-10#3)
CytPTK activity##3##2##(1995-11#3)
CytPTK##6##1##(1995-11#6)
CytPTKs##7##1##(1995-11#7)
Cytisine##3##1##(2011-1#3)
CytoTherapeutics##2##1##(2008-5#2)
Cytochemical Investigation of##2##3##(2008-10#2)
Cytochemical investigations revealed that callose##2##5##(2008-10#2)
Cytochemical##10##1##(1995-12#1)(2008-10#9)
Cytochrome P450##6##2##(1993-8#1)(1994-8#1)(2008-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
Cytochrome b##4##2##(1991-12#1)(2008-10#2)(2008-5#1)
Cytochrome c oxidase subunit##2##4##(2008-10#1)(2010-4#1)
Cytochrome c oxidase##3##3##(1997-7#1)(2008-10#1)(2010-4#1)
Cytochrome c##7##2##(1993-3#1)(1997-7#1)(2008-10#2)(2009-9#1)(2010-4#1)(2013-1#1)
Cytochrome##22##1##(1990-7#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-7#1)(2008-10#6)(2008-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
Cytodex 1##2##2##(2008-11#2)
Cytodex-3##2##1##(2008-11#1)(2008-9#1)
Cytogenetic analysis of##4##3##(1993-9#2)(2008-4#1)(2008-5#1)
Cytogenetic analysis##5##2##(1992-12#1)(1993-9#2)(2008-4#1)(2008-5#1)
Cytogenetic and genetic##2##3##(2010-3#2)
Cytogenetic studies##3##2##(1992-8#1)(2008-12#2)
Cytogenetic##18##1##(1990-8#1)(1992-12#1)(1992-8#1)(1993-9#2)(2007-2#2)(2008-12#4)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#4)
Cytogenetics and##2##2##(1990-8#1)(2010-3#1)
Cytogenetics##3##1##(1990-8#1)(2008-4#1)(2010-3#1)
Cytohistological##2##1##(2011-2#2)
Cytokine##5##1##(1994-9#1)(1995-8#1)(1997-2#1)(2008-8#1)(2012-2#1)
Cytokines and##3##2##(1995-12#1)(1997-6#1)(2008-4#1)
Cytokines##10##1##(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
Cytoline 1 microcarriers##3##3##(2008-11#3)
Cytoline 1##4##2##(2008-11#4)
Cytoline##5##1##(2008-11#5)
Cytologic and##2##2##(1991-8#1)(1992-8#1)
Cytologic screening##2##2##(1990-6#2)
Cytologic##5##1##(1990-6#2)(1991-8#1)(1992-8#1)(2008-1#1)
Cytological Evidence##2##2##(2008-10#2)
Cytological and##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
Cytological aspects##2##2##(2008-10#1)(2013-1#1)
Cytological observations indicated that##2##4##(2008-10#2)
Cytological observations##3##2##(2008-10#3)
Cytological##24##1##(2008-10#17)(2008-7#1)(2008-9#1)(2011-10#1)(2013-1#3)(2013-8#1)
Cytology was##2##2##(2007-12#1)(2012-12#1)
Cytology##6##1##(2007-12#1)(2008-10#1)(2009-9#2)(2012-12#1)(2013-8#1)
Cytomegalovirus (CMV)##2##2##(2007-7#1)(2010-12#1)
Cytomegalovirus##6##1##(1992-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-12#2)
Cytometric##3##1##(1994-12#1)(2008-9#1)(2009-9#1)
Cytometry##7##1##(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#4)
Cytopathological##2##1##(2008-10#2)
Cytopilot Mini##4##2##(2008-11#4)
Cytoplasmic inhibition of##2##3##(1995-2#2)
Cytoplasmic##15##1##(1990-2#1)(1990-8#1)(1992-11#1)(1994-8#1)(1995-2#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2011-2#2)(2013-8#1)
Cytopore##3##1##(2008-11#3)
Cytosine arabinoside##2##2##(1997-2#2)
Cytosine##4##1##(1992-6#1)(1993-11#1)(1997-2#2)
Cytosol##2##1##(1990-8#1)(1991-5#1)
Cytosolic free##2##2##(1990-7#2)
Cytosolic##7##1##(1990-11#1)(1990-7#2)(1993-6#1)(1996-2#1)(1997-7#1)(2008-11#1)
Cytospin##2##1##(1993-8#1)(2008-1#1)
Cytotechnology 41##2##2##(2008-11#2)
Cytotoxic Effect of##2##3##(1997-7#1)(2010-2#1)
Cytotoxic T##2##2##(2008-3#1)(2010-12#1)
Cytotoxic activity of##2##3##(1994-2#1)(2008-11#1)
Cytotoxic##15##1##(1990-5#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
Cytotoxicity of##8##2##(1992-2#1)(1993-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2013-1#1)
Cytotoxicity was assessed by##2##4##(1990-5#1)(2013-1#1)
Cytotoxicity was evaluated##2##3##(2011-2#1)(2012-3#1)
Cytotoxicity was##5##2##(1990-5#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Cytotoxicity##14##1##(1990-5#1)(1992-2#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
Czech Republic and##2##3##(1994-12#2)
Czech Republic##11##2##(1990-11#1)(1994-12#2)(1996-5#1)(1996-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
Czech##18##1##(1990-11#3)(1994-12#2)(1996-5#1)(1996-7#4)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
Czerny-Turner monochromator##2##2##(2008-3#2)
Czerny-Turner##3##1##(2007-12#1)(2008-3#2)
Czochralski-grown BBO##2##2##(2008-2#2)
Czochralski-grown##3##1##(2008-2#3)
Córdoba##6##1##(2008-10#2)(2008-12#2)(2008-6#1)(2012-12#1)
Côte d'Ivoire##4##2##(2008-10#2)(2009-10#1)(2010-10#1)
Côte##5##1##(2008-10#2)(2009-10#2)(2010-10#1)
D &lt##2##2##(2008-10#1)(2008-3#1)
D (1##2##2##(2008-6#1)(2008-7#1)
D = 3##2##3##(2008-10#1)(2008-2#1)
D =##8##2##(1994-11#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-12#1)
D DNA##2##2##(2008-10#2)
D DNAs##2##2##(2008-10#2)
D activity in##3##3##(1993-3#1)(2008-7#2)
D activity was##3##3##(1993-3#1)(2008-7#2)
D activity##8##2##(1993-3#3)(2008-7#5)
D and E##4##3##(1993-11#1)(1997-6#1)(2008-10#1)(2009-3#1)
D and F##2##3##(2008-12#1)(2013-1#1)
D and L##2##3##(1992-12#1)(1993-8#1)
D and M##3##3##(2008-10#3)
D and psi##2##3##(1990-8#1)(2008-2#1)
D and the##2##3##(2008-10#1)(2008-11#1)
D and##40##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#3)(1993-8#1)(1994-9#2)(1996-9#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
D antigen expression##2##3##(1994-12#2)
D antigen##7##2##(1992-9#2)(1994-12#4)(2008-10#1)
D are##5##2##(1997-1#1)(2008-10#1)(2008-3#2)(2010-4#1)
D categories##3##2##(2008-10#3)
D category##3##2##(2008-10#2)(2011-1#1)
D concentrations##2##2##(2012-2#2)
D deficiency among##2##3##(2012-3#2)
D deficiency has been associated with##2##6##(2013-1#2)
D deficiency has been##4##4##(2011-2#1)(2013-1#3)
D deficiency has##6##3##(2011-2#1)(2012-2#2)(2013-1#3)
D deficiency in a##2##4##(2012-3#1)(2013-1#1)
D deficiency in##4##3##(2012-12#1)(2012-3#2)(2013-1#1)
D deficiency is##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
D deficiency##27##2##(2008-11#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#6)
D did not affect the mRNA##2##6##(1993-3#1)(2008-11#1)
D did not affect##3##4##(1990-8#1)(1993-3#1)(2008-11#1)
D exerts##2##2##(2008-7#1)(2013-1#1)
D expression##2##2##(1990-5#1)(1992-3#1)
D fiber##2##2##(2008-3#2)
D fusion##2##2##(1995-2#2)
D gene expression##2##3##(1990-5#1)(1992-8#1)
D gene##4##2##(1990-5#2)(1992-8#1)(2008-8#1)
D genotype##3##2##(2008-10#3)
D in the##4##3##(1992-3#1)(1993-3#1)(1997-6#1)(2008-7#1)
D in this##2##3##(2008-1#1)(2008-11#1)
D in##18##2##(1990-8#1)(1992-3#1)(1993-3#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
D is##13##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-6#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
D islets##6##2##(1995-8#6)
D levels and##2##3##(2011-2#1)(2012-12#1)
D levels were##2##3##(2011-1#1)(2012-12#1)
D levels##15##2##(2008-1#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#3)(2013-1#4)
D loop##3##2##(1993-11#2)(1993-3#1)
D metabolism##2##2##(2008-4#1)(2008-7#1)
D of the##2##3##(1991-5#1)(2008-3#1)
D of##4##2##(1991-5#1)(1992-6#1)(1994-5#1)(2008-3#1)
D on##2##2##(1992-1#1)(2010-7#1)
D or##4##2##(1990-8#1)(1992-8#1)(2008-10#1)(2009-8#1)
D plays##2##2##(2008-10#1)(2012-12#1)
D positive##2##2##(1994-12#2)
D possesses##2##2##(1994-5#2)
D protein##3##2##(1995-2#3)
D rats##3##2##(1994-6#3)
D receptor (VDR)##5##3##(1995-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)
D receptor##11##2##(1995-2#2)(1995-9#1)(2008-1#4)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
D status in##3##3##(2012-12#1)(2013-7#2)
D status##6##2##(2012-12#1)(2012-2#2)(2013-7#3)
D supplementation##2##2##(2008-11#1)(2008-8#1)
D synthetase##2##2##(1996-2#2)
D treatment##3##2##(1994-6#1)(2010-10#1)(2011-1#1)
D values##4##2##(2008-10#3)(2009-9#1)
D variant##2##2##(1997-4#1)(2013-1#1)
D was##10##2##(1991-11#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-3#2)
D were##9##2##(1992-1#1)(1994-5#1)(1995-6#1)(2008-2#1)(2008-8#1)(2013-1#4)
D with##2##2##(1993-2#1)(2008-1#1)
D##1307##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-5#6)(1990-7#2)(1990-8#9)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-5#12)(1991-6#3)(1991-8#6)(1991-9#1)(1992-1#6)(1992-11#2)(1992-12#5)(1992-3#16)(1992-6#10)(1992-7#1)(1992-8#8)(1992-9#3)(1993-11#16)(1993-12#11)(1993-2#7)(1993-3#13)(1993-6#2)(1993-8#8)(1993-9#2)(1994-1#5)(1994-11#3)(1994-12#11)(1994-2#2)(1994-3#11)(1994-5#19)(1994-6#10)(1994-7#1)(1994-8#4)(1994-9#7)(1995-1#2)(1995-12#2)(1995-2#21)(1995-3#3)(1995-5#4)(1995-6#12)(1995-8#19)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-4#1)(1996-5#6)(1996-6#1)(1996-9#2)(1997-1#5)(1997-2#8)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#1)(2007-8#4)(2008-1#15)(2008-10#553)(2008-11#24)(2008-12#16)(2008-2#7)(2008-3#18)(2008-4#13)(2008-5#25)(2008-6#8)(2008-7#37)(2008-8#12)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#4)(2009-8#6)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#4)(2010-9#1)(2011-1#14)(2011-2#29)(2012-12#19)(2012-2#24)(2012-3#30)(2012-9#1)(2013-1#37)(2013-7#5)(2013-8#12)
D&amp##5##1##(1993-3#4)(1995-3#1)
D(-)-ribose and 2-deoxy-D-ribose##2##3##(1994-6#2)
D(-)-ribose and##3##2##(1994-6#3)
D(1) versus D(2) line excitation##2##5##(2007-11#2)
D(1)##7##1##(2007-11#5)(2008-2#1)(2008-3#1)
D(2) line##6##2##(2007-11#4)(2008-3#2)
D(2)##34##1##(1997-7#1)(2007-11#5)(2007-12#2)(2008-10#13)(2008-2#5)(2008-3#3)(2008-6#2)(2008-7#1)(2010-12#1)(2010-4#1)
D(3) and FGF9##2##3##(2008-11#2)
D(3) and##8##2##(1997-3#1)(2008-10#5)(2008-11#2)
D(3)##19##1##(1997-3#3)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#2)(2012-12#2)
D(O)##2##1##(2008-10#2)
D(O2)##4##1##(2007-12#4)
D(R)##2##1##(2008-10#2)
D(Sr) was##2##2##(2008-10#2)
D(Sr)##3##1##(2008-10#3)
D(app)##2##1##(2008-10#2)
D(f)##3##1##(2008-3#3)
D(l)##2##1##(2008-7#2)
D(m) = 6##2##3##(2010-7#2)
D(m) =##3##2##(2010-7#3)
D) and##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
D) h##3##2##(2011-2#3)
D) programs##2##2##(1996-1#1)(2008-6#1)
D)##35##1##(1991-2#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-1#2)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
D* of##2##2##(2008-2#1)(2008-3#1)
D*##6##1##(2008-2#1)(2008-3#5)
D+##5##1##(1992-3#1)(1994-11#1)(1994-12#3)
D- (rr)##2##2##(1994-12#2)
D- RBCs##3##2##(1994-12#3)
D- and M-specific##2##3##(2008-10#2)
D- and##5##2##(1996-5#1)(2008-10#2)(2008-7#1)(2013-7#1)
D-##20##1##(1992-11#1)(1994-12#9)(1994-6#1)(1995-2#3)(1996-5#1)(2008-10#2)(2008-7#1)(2009-12#1)(2013-7#1)
D--##2##1##(1994-12#2)
D-2 receptor proliferation##2##3##(1993-12#2)
D-2 receptor##3##2##(1993-12#3)
D-2##6##1##(1993-12#5)(2011-3#1)
D-Ala-D-lactate##4##1##(1995-2#4)
D-Ala10] mGnRH (analog##2##3##(1994-8#2)
D-Amphetamine##2##1##(2013-8#2)
D-Arg6##2##1##(1994-8#2)
D-Cys##2##1##(1994-5#2)
D-MRI##4##1##(2011-2#4)
D-Pen2##2##1##(1992-3#2)
D-Pen5]enkephalin##4##1##(1992-3#3)(1996-2#1)
D-Pro4]morphiceptin##2##1##(1996-2#2)
D-Pyr##5##1##(1994-12#5)
D-R##4##1##(2008-10#4)
D-Sema II##2##2##(1993-12#2)
D-Sema##3##1##(1993-12#3)
D-Squame##5##1##(2008-5#5)
D-Trp3##3##1##(1994-8#3)
D-Tyr2##2##1##(1994-2#2)
D-[2-3H]mannose##2##1##(1992-12#2)
D-[3-(3)H]-glucose##2##1##(2008-8#2)
D-alanine##13##1##(1991-12#3)(1995-6#8)(1995-9#2)
D-amino acid##4##2##(1991-1#1)(1995-11#1)(1995-3#1)(2008-10#1)
D-amino acids##4##2##(1991-12#1)(1995-11#1)(2008-10#1)(2008-7#1)
D-amino##9##1##(1991-1#1)(1991-12#1)(1992-11#1)(1995-11#2)(1995-3#1)(2008-10#2)(2008-7#1)
D-amphetamine (2 mg/kg)##3##3##(1993-3#3)
D-amphetamine (2##4##2##(1993-12#1)(1993-3#3)
D-amphetamine##20##1##(1993-12#5)(1993-3#4)(1993-6#11)
D-amphetamine-induced##2##1##(1993-6#2)
D-aspartate##2##1##(1993-12#1)(2008-7#1)
D-cell##3##1##(1995-8#3)
D-dimer and##2##2##(2008-3#1)(2010-3#1)
D-dimer level##2##2##(2011-2#2)
D-dimer levels##2##2##(2011-2#2)
D-dimer##12##1##(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#8)
D-dipeptidase##3##1##(1995-2#3)
D-fiber antenna##2##2##(2008-3#2)
D-galactose##2##1##(1991-12#1)(1992-12#1)
D-galacturonic acid derivatives##2##3##(1992-12#2)
D-genotype##4##1##(2008-10#4)
D-glucopyranose##2##1##(1992-12#1)(1995-11#1)
D-glucosamine##4##1##(2008-10#1)(2011-2#3)
D-glucosaminic acid was produced##2##4##(2011-2#2)
D-glucosaminic acid was##3##3##(2011-2#3)
D-glucosaminic acid##6##2##(2011-2#6)
D-glucosaminic##7##1##(2011-2#7)
D-glucose transfer##2##2##(1991-5#2)
D-glucose##14##1##(1991-5#5)(1991-9#1)(1992-11#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2011-2#1)
D-glutamate##2##1##(1995-2#2)
D-glyceraldehyde-3-phosphate dehydrogenase##2##2##(2008-9#2)
D-hydantoinase by batch culture of##2##5##(2008-7#2)
D-hydantoinase##5##1##(2008-7#5)
D-isomerase##2##1##(1996-2#2)
D-lactate##3##1##(1991-12#1)(1994-3#1)(2008-7#1)
D-lactic acidosis##2##2##(1994-3#2)
D-like aspartyl protease activity##2##4##(1995-8#2)
D-loop and the##2##3##(1995-11#1)(1996-9#1)
D-loop region##3##2##(2007-10#1)(2008-5#1)(2011-2#1)
D-loop##10##1##(1990-5#1)(1995-11#1)(1996-9#1)(2007-10#1)(2008-5#3)(2008-8#2)(2011-2#1)
D-mannose##3##1##(1992-12#1)(1992-9#2)
D-methionine##3##1##(2008-2#3)
D-negative women##3##2##(1994-6#3)
D-negative##5##1##(1992-12#1)(1994-6#4)
D-optimal design criterion##2##3##(2008-7#2)
D-optimal design##3##2##(2008-7#2)(2013-1#1)
D-penicillamine-induced autoimmunity##4##2##(2008-10#4)
D-positive RBCs##2##2##(1994-6#2)
D-positive fetal cells##2##3##(1994-6#2)
D-positive fetal##3##2##(1994-6#3)
D-positive##8##1##(1992-12#1)(1992-6#1)(1994-6#6)
D-serine and glycine##2##3##(1996-5#2)
D-serine##9##1##(1995-11#1)(1996-5#4)(2008-5#1)(2012-2#3)
D/E##3##1##(1991-9#2)(2009-4#1)
D/P Cr##3##2##(2011-2#3)
D/P beta2MG##2##2##(2011-2#2)
D/P##8##1##(2008-10#2)(2011-2#6)
D/year##5##1##(2012-12#5)
D1 and D2 receptors##2##4##(1993-9#1)(2008-7#1)
D1 and D2##5##3##(1990-5#1)(1993-9#1)(1994-3#1)(1996-5#1)(2008-7#1)
D1 and##8##2##(1990-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1996-5#2)(2008-7#1)(2012-3#1)
D1 dopamine receptors in the##2##5##(1992-3#1)(1994-2#1)
D1 dopamine receptors##3##3##(1992-3#1)(1994-2#2)
D1 dopamine##5##2##(1992-3#1)(1993-5#1)(1994-2#2)(1994-8#1)
D1 receptor##9##2##(1992-3#2)(1993-3#3)(1995-12#1)(1996-2#3)
D1##37##1##(1990-5#1)(1992-3#4)(1993-3#3)(1993-5#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-2#3)(1996-5#3)(1997-6#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
D11S1819 and D11S1818##2##3##(1995-6#2)
D13 mice##2##2##(2013-1#2)
D13##3##1##(2013-1#3)
D13S317##5##1##(2008-12#5)
D16##2##1##(1992-12#2)
D16S539##5##1##(2008-12#5)
D186A and##3##2##(2012-2#3)
D18S51##7##1##(2008-12#7)
D19S433##5##1##(2008-12#5)
D1R- and D2R-expressing##2##3##(2013-8#2)
D1R- and##3##2##(2013-8#3)
D1S249 locus##4##2##(2008-9#4)
D2 and D3 receptors##2##4##(1993-9#1)(2008-5#1)
D2 and##4##2##(1992-3#1)(1993-9#1)(1995-11#1)(2008-5#1)
D2 dopamine receptors##2##3##(1994-3#1)(1995-2#1)
D2 dopamine##3##2##(1993-3#1)(1994-3#1)(1995-2#1)
D2 mice##2##2##(1996-12#2)
D2 receptor density##2##3##(1995-2#1)(1996-7#1)
D2 receptor##17##2##(1995-12#3)(1995-2#2)(1995-3#1)(1996-5#4)(1996-7#4)(1997-5#1)(2008-9#1)(2010-4#1)
D2 receptors and##4##3##(1992-12#1)(1995-12#2)(2008-7#1)
D2 receptors in##4##3##(1993-5#1)(1993-9#2)(1995-12#1)
D2 receptors were measured with##2##5##(1996-5#2)
D2 receptors##19##2##(1992-12#1)(1993-5#1)(1993-9#3)(1995-11#1)(1995-12#6)(1995-3#1)(1996-5#4)(2008-5#1)(2008-7#1)
D2 type dopamine##2##3##(2008-7#2)
D2##80##1##(1990-5#1)(1992-12#1)(1992-3#4)(1992-8#1)(1993-3#1)(1993-5#2)(1993-9#7)(1994-3#1)(1995-11#3)(1995-12#10)(1995-2#3)(1995-3#2)(1996-12#3)(1996-2#1)(1996-5#9)(1996-7#4)(1997-5#1)(1997-6#1)(1997-8#9)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#6)(2008-9#1)(2010-4#1)(2013-8#1)
D2-like receptors are##2##3##(1993-9#1)(1996-7#1)
D2-like##4##1##(1993-9#1)(1995-2#1)(1996-12#1)(1996-7#1)
D2-receptor##2##1##(1993-9#1)(1994-5#1)
D2/5-HT2 antagonists##2##2##(1995-3#2)
D21S11##5##1##(2008-12#5)
D21S1255##2##1##(1997-5#2)
D21S246##3##1##(1995-8#3)
D222N##3##1##(1992-6#3)
D24/D25 or E99/E100##2##3##(1995-2#2)
D24/D25##4##1##(1995-2#4)
D24A/D25A and E99A/E100A actins##2##4##(1995-2#2)
D29 cells##9##2##(2008-11#9)
D29##11##1##(2008-11#11)
D2O##2##1##(1992-3#1)(1992-8#1)
D2S123##3##1##(2008-4#3)
D2S1338##5##1##(2008-12#5)
D2S6##2##1##(2008-8#2)
D3 (1##8##2##(1991-5#2)(1992-1#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1997-1#1)
D3 and D4 receptors##3##4##(1993-9#1)(1997-5#1)(2008-5#1)
D3 and D4##4##3##(1993-9#1)(1997-5#2)(2008-5#1)
D3 and##6##2##(1993-11#1)(1993-9#2)(1997-5#2)(2008-5#1)
D3 is##2##2##(1992-12#1)(1994-3#1)
D3 on the##2##3##(1991-5#1)(1993-3#1)
D3 receptor density and mRNA##2##5##(1995-2#2)
D3 receptor gene##2##3##(1995-2#1)(2008-9#1)
D3 receptor in##3##3##(1992-12#2)(1995-2#1)
D3 receptor is##2##3##(1993-3#1)(1995-2#1)
D3 receptor mRNA##2##3##(1995-2#2)
D3 receptor##22##2##(1990-12#2)(1992-12#4)(1993-3#4)(1995-2#11)(2008-9#1)
D3 receptors##3##2##(1993-9#1)(1995-8#1)(2008-5#1)
D3##82##1##(1990-12#3)(1990-5#1)(1991-12#1)(1991-5#4)(1992-1#2)(1992-12#7)(1992-3#1)(1993-11#1)(1993-3#8)(1993-9#3)(1994-11#1)(1994-3#2)(1994-9#3)(1995-12#3)(1995-2#12)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#10)(1997-5#3)(1997-6#4)(1997-7#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#1)(2011-1#2)
D3-induced##2##1##(1995-6#1)(1997-1#1)
D308##2##1##(2008-10#2)
D3S1067##2##1##(2008-4#2)
D3S1358##5##1##(2008-12#5)
D4 receptor##8##2##(1993-6#5)(1993-9#1)(1997-5#1)(2008-9#1)
D4 receptors##5##2##(1993-9#3)(1997-5#1)(2008-5#1)
D4##19##1##(1991-8#1)(1993-6#8)(1993-9#6)(1997-5#2)(2008-5#1)(2008-9#1)
D4-specific binding to THP-1 cell membranes##2##6##(1993-6#2)
D4-specific binding##4##2##(1993-6#4)
D4T##10##1##(1991-3#4)(2008-7#6)
D5##2##1##(1990-11#2)
D5S1456##2##1##(1997-5#2)
D5S818 and##2##2##(2008-12#2)
D5S818##5##1##(2008-12#5)
D6-2 transgenic mice##2##3##(2008-4#2)
D6-2 transgenic##3##2##(2008-4#3)
D609##2##1##(1997-2#2)
D7S820##5##1##(2008-12#5)
D80/D81##3##1##(1995-2#3)
D8S1179##3##1##(2008-12#3)
D9S109 and##2##2##(1994-6#2)
D=1/3mu(s)(?)##2##1##(2007-11#2)
DA and 5-HT##2##3##(1994-2#2)
DA and NA release##2##4##(1997-7#2)
DA and NA##5##3##(1997-7#4)(2008-7#1)
DA and SA to learning##2##5##(2011-1#2)
DA and##16##2##(1993-12#2)(1994-2#2)(1994-8#1)(1996-12#1)(1997-7#5)(2008-10#1)(2008-7#2)(2011-1#2)
DA can be##2##3##(2008-10#2)
DA concentration##2##2##(2008-10#1)(2008-7#1)
DA in mPFC##2##3##(2008-7#2)
DA in the cerebral cortex##2##5##(2008-7#2)
DA in the mPFC##2##4##(2008-7#2)
DA in the##5##3##(2008-10#1)(2008-7#4)
DA in##11##2##(1993-12#1)(1996-12#1)(2008-10#3)(2008-7#6)
DA levels##4##2##(1996-12#3)(2008-7#1)
DA output in the##6##4##(2008-6#6)
DA rats##2##2##(1995-12#2)
DA receptor##3##2##(2008-5#1)(2013-1#2)
DA release##6##2##(1992-7#1)(1996-12#2)(1997-2#2)(1997-7#1)
DA released from##2##3##(1992-7#1)(1996-12#1)
DA released##3##2##(1992-7#1)(1996-12#2)
DA was measured by##2##4##(1993-12#1)(1997-2#1)
DA was##5##2##(1993-12#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#1)
DA##111##1##(1992-10#1)(1992-12#1)(1992-7#6)(1993-12#8)(1993-6#1)(1994-2#4)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#21)(1996-5#4)(1997-2#4)(1997-3#1)(1997-7#9)(2008-10#16)(2008-5#5)(2008-6#6)(2008-7#13)(2010-12#1)(2011-1#3)(2013-1#2)
DA)##2##1##(1995-5#1)(1997-7#1)
DA-9601##5##1##(2008-11#5)
DA-releasing##2##1##(1992-7#2)
DAB2IP##5##1##(2013-1#5)
DAB2IP-deficient PCa cells##2##3##(2013-1#2)
DAC##5##1##(2013-8#5)
DAD##5##1##(1993-12#1)(2008-10#1)(2011-2#3)
DAD1 gene is##2##3##(1997-9#2)
DAD1 gene##3##2##(1997-9#3)
DAD1##5##1##(1997-9#5)
DAE##2##1##(2008-10#2)
DAG by##2##2##(1991-12#2)
DAG##15##1##(1991-12#9)(1992-12#2)(1992-9#2)(1995-11#1)(2010-11#1)
DAGO##3##1##(1997-2#3)
DAH after BMT##2##3##(2008-1#2)
DAH##4##1##(2008-1#4)
DAI and##2##2##(2008-10#1)(2011-3#1)
DAI##6##1##(2008-10#3)(2011-3#3)
DALY##4##1##(2012-12#4)
DAMGE##2##1##(1991-1#2)
DAMGO##2##1##(1995-12#1)(1996-2#1)
DAML + OIL##3##3##(2008-7#3)
DAOM 175924##2##2##(2008-10#2)
DAP concentrations##2##2##(2010-5#2)
DAPI with##3##2##(1992-3#2)(2008-2#1)
DAPI##24##1##(1992-3#11)(2008-12#3)(2008-2#7)(2008-9#1)(2009-12#1)(2009-5#1)
DAPI-stained##3##1##(1995-6#1)(2008-10#1)(2008-2#1)
DAPs are##2##2##(2010-5#2)
DAPs in##4##2##(2010-5#4)
DAPs##11##1##(2010-5#11)
DARPP-32-IR##2##1##(1991-10#2)
DART##2##1##(2011-2#2)
DAS was##2##2##(1992-5#1)(2008-3#1)
DAS##7##1##(1992-5#3)(2008-1#3)(2008-3#1)
DAS-ELISA##2##1##(2008-10#2)
DASH##3##1##(2008-9#3)
DAST crystal##2##2##(2007-12#2)
DAST##11##1##(2007-12#11)
DAT mRNA level##2##3##(1996-12#2)
DAT mRNA##4##2##(1996-12#4)
DAT was##4##2##(1992-6#1)(1994-12#1)(1994-6#1)(1996-12#1)
DAT##15##1##(1992-6#2)(1994-12#3)(1994-6#1)(1996-12#6)(2008-6#2)(2013-7#1)
DAT-positive##2##1##(1994-3#2)
DATA SOURCES##4##2##(2013-1#4)
DATA SYNTHESIS##4##2##(2013-1#4)
DATA##15##1##(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#8)
DATA1 and DATA2##4##3##(2012-2#4)
DATA1##5##1##(2012-2#5)
DATAN##3##1##(2008-10#3)
DAV##3##1##(2008-8#3)
DAVM##3##1##(2006-12#3)
DAW##3##1##(2008-9#3)
DAX-1##3##1##(2008-4#3)
DAX-8 and XAD-8 resins from##2##5##(2008-10#2)
DAX-8 and XAD-8 resins##4##4##(2008-10#4)
DAX-8 resin##2##2##(2008-10#2)
DAX-8##7##1##(2008-10#7)
DAergic##7##1##(2013-7#7)
DArT##2##1##(2008-10#2)
DB exercise and a consistent##2##5##(2012-2#2)
DB exercise##5##2##(2012-2#5)
DB##8##1##(1990-12#1)(1997-9#1)(2008-10#1)(2012-2#5)
DB-PCR##2##1##(2008-10#2)
DB18C6##5##1##(2008-10#5)
DBA##12##1##(1990-7#3)(1994-11#1)(2008-10#1)(2013-1#7)
DBA/1 mice##3##2##(2008-10#1)(2008-11#2)
DBA/2 and##2##2##(1994-8#2)
DBA/2 mice and##2##3##(1993-12#2)
DBA/2 mice##5##2##(1993-12#2)(1995-12#2)(1996-12#1)
DBA/2##10##1##(1991-9#1)(1993-12#2)(1994-8#2)(1995-12#2)(1995-2#1)(1996-12#2)
DBA/2J and BALB/c mice##3##4##(1993-5#3)
DBB##3##1##(1995-12#3)
DBBP##2##1##(2008-10#2)
DBBT##3##1##(2008-10#3)
DBE were##2##2##(2012-2#2)
DBE##8##1##(2010-12#3)(2012-2#5)
DBF##2##1##(2008-10#2)
DBH activity##3##2##(1995-11#3)
DBH and##2##2##(1995-5#1)(1997-3#1)
DBH immunoreactivity##3##2##(1995-12#2)(1995-5#1)
DBH##13##1##(1995-11#4)(1995-12#3)(1995-5#3)(1997-3#1)(2008-5#1)(2013-1#1)
DBP and##4##2##(2008-10#2)(2008-5#1)(2011-1#1)
DBP were##2##2##(1990-3#1)(2013-8#1)
DBP##24##1##(1990-3#7)(1991-10#2)(1991-5#1)(1993-12#1)(2008-10#8)(2008-5#1)(2011-1#1)(2012-1#1)(2013-8#2)
DBP)##2##1##(1990-3#1)(2008-10#1)
DBPh##2##1##(2008-10#2)
DBQ##3##1##(2008-10#3)
DBR##2##1##(2008-3#2)
DBS in##4##2##(2008-1#1)(2010-12#1)(2012-3#2)
DBS is##2##2##(2009-8#1)(2010-12#1)
DBS##27##1##(2008-1#1)(2008-10#1)(2008-2#1)(2009-8#5)(2009-9#1)(2010-12#2)(2012-2#7)(2012-3#9)
DBS(-) and##2##2##(2008-10#2)
DBS(-)##8##1##(2008-10#8)
DBSQ ligand##3##2##(1996-2#3)
DBSQ##5##1##(1996-2#5)
DBT##3##1##(2008-10#1)(2008-11#2)
DBTC##3##1##(2008-10#3)
DBoxes##2##1##(2007-11#2)
DC and##3##2##(2008-11#1)(2009-7#1)(2013-1#1)
DC in##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
DC is##2##2##(2008-11#2)
DC populations##2##2##(2008-9#2)
DC##63##1##(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(2006-11#1)(2008-10#13)(2008-11#15)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#3)(2008-9#5)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
DC(tast)##2##1##(2008-10#2)
DC)##2##1##(2008-10#1)(2008-9#1)
DC-SIGNR is##2##2##(2013-7#2)
DC-SIGNR##8##1##(2013-7#8)
DC-based cancer immunotherapy##3##3##(2008-5#2)(2012-2#1)
DC-based##4##1##(2008-5#2)(2012-2#2)
DC3000##9##1##(2008-10#7)(2009-6#2)
DCA 2000##4##2##(2008-6#4)
DCA are##2##2##(2008-10#2)
DCA treatment##3##2##(2008-10#3)
DCA##18##1##(1995-3#2)(2008-10#12)(2008-6#4)
DCA-pretreatment did##2##2##(1995-3#2)
DCC and##2##2##(1992-10#1)(1994-12#1)
DCC components##2##2##(2007-12#2)
DCC##7##1##(1992-10#2)(1993-8#1)(1994-12#1)(2007-12#3)
DCCD##2##1##(1992-6#1)(1997-8#1)
DCD##3##1##(2008-11#3)
DCDHF##3##1##(2008-6#2)(2010-2#1)
DCE##6##1##(1996-5#1)(2008-10#2)(2010-11#2)(2010-12#1)
DCE-MRI##5##1##(2008-8#4)(2009-12#1)
DCF##2##1##(2008-10#2)
DCG##5##1##(2008-3#5)
DCI survey##2##2##(2013-8#2)
DCIS cases##2##2##(1990-12#2)
DCIS##7##1##(1990-12#5)(2013-1#2)
DCM patients##2##2##(2008-7#1)(2013-7#1)
DCM##10##1##(2008-10#2)(2008-7#2)(2011-2#3)(2013-7#3)
DCNQ##2##1##(1993-8#2)
DCP-1##4##1##(2008-3#4)
DCPC system##3##2##(2013-8#3)
DCPC##4##1##(2013-8#4)
DCQ##2##1##(2008-10#2)
DCR-10##3##1##(1997-8#3)
DCS and##2##2##(2011-1#1)(2013-1#1)
DCS##11##1##(2011-1#4)(2012-12#1)(2012-2#4)(2013-1#2)
DCT domain##4##2##(2008-2#1)(2010-8#3)
DCT##6##1##(2008-2#1)(2010-8#5)
DCT1 is##2##2##(1997-7#2)
DCT1##4##1##(1997-7#4)
DCs and##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
DCs are##3##2##(2008-11#1)(2008-4#2)
DCs from OVA-fed mice##2##4##(2008-11#2)
DCs from OVA-fed##3##3##(2008-11#3)
DCs from##6##2##(2008-11#6)
DCs had##2##2##(2011-2#1)(2012-2#1)
DCs in##4##2##(2008-11#1)(2010-5#2)(2012-2#1)
DCs into the##2##3##(2011-2#2)
DCs stimulated##2##2##(2008-11#1)(2011-2#1)
DCs were##2##2##(2008-11#2)
DCs##56##1##(2008-10#3)(2008-11#24)(2008-4#4)(2010-12#2)(2010-5#5)(2011-2#9)(2012-2#5)(2012-3#4)
DD and CDD groups##2##4##(2013-7#2)
DD and PD##7##3##(2008-12#7)
DD and##9##2##(2008-12#7)(2013-7#2)
DD of chitosan##2##3##(2008-10#2)
DD##28##1##(2008-10#5)(2008-12#9)(2008-5#3)(2008-9#4)(2011-2#3)(2012-2#2)(2013-7#2)
DD-FD-OCT##5##1##(2011-1#5)
DD/Tbr mice##2##2##(1994-7#2)
DD/Tbr##3##1##(1994-7#3)
DDB##2##1##(2008-10#2)
DDC##5##1##(1990-12#4)(1997-2#1)
DDD##8##1##(1995-11#2)(2011-2#4)(2012-12#1)(2012-2#1)
DDDs##2##1##(2008-11#2)
DDH is##2##2##(2007-8#1)(2013-8#1)
DDH using##2##2##(2007-8#2)
DDH##16##1##(2007-11#3)(2007-8#11)(2008-10#1)(2013-8#1)
DDI##2##1##(1992-12#2)
DDK##7##1##(2012-3#7)
DDK's##2##1##(2012-3#2)
DDLC1##2##1##(2012-2#2)
DDP alone##2##2##(1992-2#1)(1992-5#1)
DDP dose##2##2##(1992-5#2)
DDP##9##1##(1990-6#1)(1992-2#4)(1992-5#4)
DDQ##5##1##(1997-4#2)(2008-10#3)
DDR2 kinase##3##2##(2012-2#3)
DDR2##8##1##(2012-2#8)
DDSP is able to##2##4##(2008-3#2)
DDSP is##3##2##(2008-3#3)
DDSP##8##1##(2008-3#5)(2011-1#3)
DDT and##2##2##(2008-10#1)(2012-12#1)
DDT##5##1##(1991-9#1)(1994-3#1)(2008-10#2)(2012-12#1)
DDT-binding peptide##3##2##(1991-9#3)
DDT-binding##5##1##(1991-9#5)
DDT1 MF-2 smooth muscle cells##2##5##(1990-7#2)
DDTC##5##1##(2008-10#5)
DDTs##6##1##(2008-10#2)(2008-7#4)
DDVP##4##1##(2008-10#4)
DDX13 and##2##2##(1997-6#2)
DDX13 gene##4##2##(1997-6#4)
DDX13##8##1##(1997-6#8)
DE##8##1##(1990-11#1)(1991-8#1)(2008-10#1)(2008-6#5)
DEA (data envelopment analysis)##3##4##(1992-2#3)
DEA (data envelopment##4##3##(1992-2#4)
DEA for##2##2##(1996-12#2)
DEA published##2##2##(1996-12#2)
DEA##17##1##(1992-2#7)(1996-12#6)(2008-10#1)(2008-5#2)(2010-8#1)
DEAE cellulose##4##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
DEAE##14##1##(1992-12#1)(1993-11#1)(1996-5#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-11#1)(2013-1#4)
DEAE-Dx##3##1##(2008-7#3)
DEAE-Sephacel##2##1##(1990-5#1)(2006-6#1)
DEAE-Sepharose and##4##2##(1991-12#1)(1996-6#1)(2008-4#1)(2009-9#1)
DEAE-Sepharose##6##1##(1991-12#2)(1993-11#1)(1996-6#1)(2008-4#1)(2009-9#1)
DEAE-cellulose##4##1##(1992-3#1)(1994-9#2)(2008-10#1)
DEAE-dextran##4##1##(2008-1#3)(2008-11#1)
DEB treatment##2##2##(2008-7#2)
DEB##8##1##(2008-4#4)(2008-7#3)(2010-4#1)
DEET and##2##2##(2008-5#2)
DEET##12##1##(1991-9#1)(2008-5#11)
DEH##2##1##(2008-10#2)
DEHP##4##1##(2008-10#3)(2008-5#1)
DEJ width estimates##3##3##(2010-10#3)
DEJ width##4##2##(2010-10#4)
DEJ##15##1##(2008-5#5)(2010-10#10)
DELLA proteins##2##2##(2009-8#2)
DEM##2##1##(2013-1#2)
DENV infection##2##2##(2012-2#2)
DEP domain##2##2##(2012-12#2)
DEP extracts##5##2##(2008-10#5)
DEP##16##1##(1990-12#1)(2008-10#11)(2008-5#1)(2010-5#1)(2012-12#2)
DEP-modified amylase##2##2##(1990-12#2)
DEPC##5##1##(1990-11#1)(1992-6#4)
DEPE##2##1##(2008-8#2)
DES exposure##3##2##(1990-7#1)(2008-10#2)
DES in##3##2##(2008-10#3)
DES##14##1##(1990-7#1)(2008-10#13)
DES-exposed mice##2##2##(2008-10#2)
DES-exposed##4##1##(1990-7#2)(2008-10#2)
DESCRIPTION##8##1##(2009-6#1)(2012-3#7)
DESIGN AND METHODS##6##3##(2007-12#1)(2011-2#1)(2013-1#4)
DESIGN##23##1##(2007-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#5)(2012-12#5)(2013-1#5)
DET##4##1##(2008-10#3)(2009-10#1)
DETA##5##1##(2008-10#5)
DEVELOPMENT##3##1##(2008-12#1)(2009-11#1)(2012-3#1)
DEX exposure##5##2##(1995-12#5)
DEX treatment##5##2##(1994-9#2)(1995-12#3)
DEX##16##1##(1994-9#3)(1995-12#11)(2008-10#2)
DEXA##3##1##(2007-8#1)(2008-7#1)(2009-4#1)
DEs##2##1##(2008-10#2)
DFA test##2##2##(2007-7#2)
DFA##3##1##(2007-7#3)
DFB laser is##2##3##(2008-3#2)
DFB laser##3##2##(2008-3#3)
DFB lasers##3##2##(2008-3#3)
DFB##7##1##(2008-3#7)
DFC##2##1##(2008-8#2)
DFG##6##1##(2008-2#1)(2008-3#2)(2012-12#1)(2012-2#2)
DFHT##5##1##(2008-3#5)
DFNB7/11 family##2##2##(2011-1#2)
DFNB7/11##3##1##(2011-1#3)
DFO##5##1##(1992-11#4)(2008-10#1)
DFP-inhibited mature subtilisin E##2##4##(2009-7#2)
DFS in##2##2##(2007-10#1)(2011-2#1)
DFS##10##1##(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
DFT calculations##2##2##(2010-5#1)(2012-12#1)
DFT##6##1##(2008-2#1)(2010-5#2)(2012-12#1)(2013-1#2)
DFWM##2##1##(2008-3#2)
DG and##2##2##(1996-12#1)(2012-12#1)
DG extract##3##2##(2011-1#3)
DG was##2##2##(2007-7#1)(2012-12#1)
DG##25##1##(1991-5#2)(1993-8#1)(1994-3#1)(1996-12#3)(2007-7#3)(2009-4#3)(2009-8#1)(2011-1#5)(2012-12#6)
DG-GCs##4##1##(1997-2#4)
DGD is##2##2##(2007-12#2)
DGD##5##1##(2007-11#1)(2007-12#3)(2008-8#1)
DGE##3##1##(2010-4#2)(2012-2#1)
DGGE gels##2##2##(2008-10#1)(2008-9#1)
DGGE##5##1##(2008-10#1)(2008-9#3)(2010-6#1)
DGN##7##1##(2012-2#7)
DGPS##5##1##(2009-10#5)
DGS##4##1##(1996-7#4)
DGT device##2##2##(2008-10#2)
DGT##9##1##(2008-10#9)
DH for m =##2##4##(1991-8#2)
DH gene##3##2##(2008-8#3)
DH lines were##2##3##(2008-10#2)
DH lines##6##2##(2008-10#3)(2008-5#1)(2008-8#2)
DH population were##2##3##(2008-10#1)(2008-4#1)
DH population##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
DH##22##1##(1991-8#3)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#11)(2010-8#1)
DH(w)##3##1##(2008-10#3)
DH5 alpha##3##2##(1992-9#1)(1994-8#1)(1995-2#1)
DHA from##2##2##(2012-1#2)
DHA in##2##2##(2012-1#1)(2013-1#1)
DHA is##2##2##(2012-1#2)
DHA##18##1##(1994-8#1)(2008-11#2)(2010-1#1)(2010-2#1)(2012-1#9)(2013-1#4)
DHAA and AA were##2##4##(1997-2#2)
DHAA and##3##2##(1997-2#3)
DHAA##9##1##(1993-3#5)(1997-2#4)
DHAD##5##1##(1991-6#5)
DHC##3##1##(2012-3#3)
DHC+S##3##1##(2012-3#3)
DHD##3##1##(1994-3#3)
DHEA and##4##2##(1994-5#1)(2007-11#1)(2008-4#1)(2012-3#1)
DHEA are##2##2##(1994-6#2)
DHEA is##3##2##(1994-6#1)(2008-4#2)
DHEA##27##1##(1994-5#1)(1994-6#11)(2007-11#2)(2008-10#3)(2008-4#6)(2012-3#3)(2013-1#1)
DHEA-S##3##1##(1990-11#2)(2012-3#1)
DHEAS and##2##2##(1994-5#2)
DHEAS is##2##2##(1994-5#2)
DHEAS levels were##2##3##(1994-5#2)
DHEAS levels##4##2##(1994-5#4)
DHEAS##13##1##(1994-5#13)
DHF##2##1##(1992-5#2)
DHFR##10##1##(1992-6#1)(1994-12#1)(1995-2#3)(2008-11#2)(2008-2#2)(2012-2#1)
DHH children##3##2##(2011-2#3)
DHHS programs##2##2##(1996-5#2)
DHHS##3##1##(1996-5#3)
DHN##2##1##(2008-10#2)
DHN1##3##1##(2008-9#3)
DHN1-mGFP4 was##2##2##(2008-9#2)
DHN1-mGFP4##3##1##(2008-9#3)
DHOase##3##1##(1995-5#3)
DHOdehase##2##1##(1993-2#2)
DHP binding sites##2##3##(1991-2#2)
DHP binding##3##2##(1991-2#3)
DHP##6##1##(1991-2#5)(1995-3#1)
DHP-receptor binding##2##2##(1995-3#2)
DHP-receptor##3##1##(1995-3#3)
DHPI##2##1##(2008-4#2)
DHPLC##3##1##(2008-4#3)
DHPM##2##1##(2013-8#2)
DHPs##2##1##(1991-2#2)
DHR measurements of Energy Science##2##5##(2008-3#2)
DHR measurements##3##2##(2008-3#3)
DHR values##2##2##(2008-3#2)
DHR##10##1##(2008-3#10)
DHS##8##1##(1997-1#2)(2007-8#3)(2008-10#2)(2013-1#1)
DHT##9##1##(1990-11#4)(1991-5#2)(2008-5#2)(2010-1#1)
DHZS##3##1##(2008-10#3)
DI RNA containing the MHV-RI spike gene##2##7##(1997-3#2)
DI RNA species##2##3##(2008-10#2)
DI RNA##10##2##(1997-3#3)(2008-10#7)
DI RNAs in##2##3##(2008-10#2)
DI RNAs##8##2##(2008-10#8)
DI and##3##2##(1997-8#3)
DI##40##1##(1993-8#1)(1995-11#1)(1997-3#5)(1997-8#10)(2007-10#2)(2008-10#19)(2008-3#1)(2012-12#1)
DIA##2##1##(2008-10#1)(2013-8#1)
DIAL analysis##2##2##(2008-2#2)
DIAL calculations##2##2##(2008-3#2)
DIAL measurements##2##2##(2008-3#2)
DIAL system in##2##3##(2008-2#1)(2008-3#1)
DIAL system##7##2##(2008-2#2)(2008-3#5)
DIAL technique##3##2##(2008-2#1)(2008-3#2)
DIAL##27##1##(2008-2#10)(2008-3#17)
DIAM##2##1##(2013-8#2)
DIANA##2##1##(2008-8#1)(2013-8#1)
DIBAL-H##2##1##(2008-10#2)
DIBELS##3##1##(2008-12#3)
DIBOA##4##1##(2008-10#4)
DIBS##3##1##(2008-2#3)
DIC and##2##2##(2008-9#1)(2011-1#1)
DIC patients##3##2##(2010-3#3)
DIC##18##1##(2008-4#1)(2008-9#1)(2010-3#9)(2011-1#6)(2012-3#1)
DICOM##5##1##(1996-2#1)(2009-12#1)(2009-3#3)
DIDS and by##2##3##(1990-2#1)(1992-3#1)
DIDS and##3##2##(1990-2#1)(1992-3#1)(2008-6#1)
DIDS##11##1##(1990-2#2)(1992-12#6)(1992-3#1)(1995-12#1)(2008-6#1)
DIFFERENCE##2##1##(2008-10#2)
DIGE##8##1##(2008-2#4)(2008-4#1)(2010-12#3)
DII progress curve##3##3##(2008-10#3)
DII progress curves and##2##4##(2008-10#2)
DII progress##5##2##(2008-10#5)
DII##8##1##(2008-10#8)
DILI##4##1##(2008-8#4)
DIMBOA##2##1##(2008-10#2)
DIN 6800-2##6##2##(2012-1#6)
DIP##5##1##(1994-8#5)
DIPD##5##1##(2008-10#5)
DIR##2##1##(2007-2#1)(2009-12#1)
DIS##4##1##(1991-12#4)
DISCUSSION##21##1##(1993-9#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#6)(2013-1#4)
DISEASE##5##1##(1997-3#1)(1997-5#2)(2007-12#1)(2013-8#1)
DIV is##2##2##(2011-2#2)
DIV##5##1##(2008-10#3)(2011-2#2)
DIV112##2##1##(2008-11#2)
DIV56##2##1##(2008-11#2)
DIVs##2##1##(2008-10#2)
DJ scores##2##2##(2009-1#2)
DJ##4##1##(2009-1#3)(2009-10#1)
DJ-1##2##1##(2010-3#2)
DK##3##1##(2007-8#3)
DKA##5##1##(1994-12#3)(2008-5#1)(2011-1#1)
DKD##3##1##(2012-1#3)
DKT##5##1##(2011-2#5)
DL##13##1##(2008-10#7)(2008-3#3)(2008-4#1)(2011-2#2)
DL(50)##2##1##(2008-11#2)
DL-PCBs##3##1##(2008-10#3)
DL-beta-amino-butyric acid##2##2##(2009-6#2)
DL-propranolol##4##1##(2008-9#4)
DLA-EIAV and EIAV L##3##4##(2008-9#3)
DLA-EIAV and##4##2##(2008-9#4)
DLA-EIAV##8##1##(2008-9#8)
DLBCL##2##1##(2009-8#1)(2013-1#1)
DLF##3##1##(1994-2#3)
DLIF activity##2##2##(1991-8#2)
DLIF in##2##2##(1991-8#2)
DLIF per g of##2##4##(1991-8#2)
DLIF to chromatographic homogeneity##2##4##(1991-8#2)
DLIF##13##1##(1991-8#13)
DLL1##2##1##(2010-3#2)
DLPFC and ACC were##2##4##(2008-10#2)
DLPFC and##3##2##(2008-10#3)
DLQI##4##1##(2012-1#3)(2013-1#1)
DLS measurements##2##2##(2008-2#1)(2008-3#1)
DLS##5##1##(2008-2#2)(2008-3#2)(2013-1#1)
DLVO##2##1##(2013-1#2)
DM =##2##2##(1991-8#1)(2008-10#1)
DM and OM digestibility##2##4##(2010-2#2)
DM and psoriasis##2##3##(2012-2#2)
DM and##8##2##(2007-7#1)(2008-3#1)(2008-7#1)(2010-2#2)(2012-2#3)
DM in##2##2##(2008-7#1)(2011-1#1)
DM is##2##2##(2012-2#2)
DM of##2##2##(2008-3#1)(2012-2#1)
DM rats' skin##2##3##(2011-3#2)
DM##64##1##(1991-8#2)(1995-11#1)(1995-3#2)(1996-11#1)(1997-4#3)(2007-11#1)(2007-7#2)(2008-10#2)(2008-3#6)(2008-5#1)(2008-7#4)(2010-2#4)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#4)(2012-2#11)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#2)
DM-Allo group had##2##3##(2011-2#2)
DM-Allo group##3##2##(2011-2#3)
DM-Allo##4##1##(2011-2#4)
DM-nitrophen##2##1##(1994-6#2)
DM2 patients##3##2##(1994-12#1)(2008-7#2)
DM2##9##1##(1994-12#2)(2008-3#2)(2008-7#4)(2012-3#1)
DMA at##2##2##(2008-10#2)
DMA in##5##2##(2008-10#5)
DMA##22##1##(2008-10#22)
DMA)##2##1##(2008-10#2)
DMAA##5##1##(1993-3#4)(2008-10#1)
DMABTS##3##1##(2008-10#3)
DMARDs##4##1##(2010-5#3)(2012-3#1)
DMBA and##2##2##(2013-1#2)
DMBA##6##1##(1992-2#1)(1996-12#1)(2013-1#4)
DMBA-induced##2##1##(1993-1#1)(2008-10#1)
DMBA-initiated##2##1##(1992-2#2)
DMC##3##1##(2008-12#1)(2008-2#1)(2008-9#1)
DMCM##3##1##(1995-11#2)(2008-11#1)
DMD patients##4##2##(1995-12#3)(2011-2#1)
DMD##14##1##(1990-7#2)(1992-12#3)(1995-12#4)(2007-8#4)(2011-2#1)
DMD-based##2##1##(2008-2#1)(2013-8#1)
DMDTPA##3##1##(2008-10#3)
DMDTPA)##3##1##(2008-10#3)
DME##12##1##(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#2)(2011-7#5)(2012-12#1)
DMEM medium containing 10%##2##4##(2008-11#2)
DMEM##7##1##(2008-11#5)(2008-7#1)(2008-9#1)
DMF solution##4##2##(2008-10#4)
DMF##16##1##(2008-1#1)(2008-10#12)(2009-11#1)(2009-9#1)(2011-2#1)
DMF-water##3##1##(2008-10#3)
DMFT was##3##2##(2008-9#3)
DMFT##6##1##(1990-12#1)(2008-9#5)
DMH-treatment##3##1##(1992-8#3)
DMI fungicides##4##2##(2008-10#4)
DMI treatments##2##2##(2008-10#2)
DMI use##2##2##(2008-10#2)
DMI##20##1##(2008-10#18)(2012-2#2)
DMI(R)##4##1##(2008-10#4)
DMIs##4##1##(2008-10#4)
DMM or IPRO##2##3##(2008-10#2)
DMM##3##1##(2008-10#3)
DMN##6##1##(2012-3#1)(2013-8#5)
DMNQ##5##1##(2009-9#5)
DMP##2##1##(2008-5#1)(2010-5#1)
DMPA##2##1##(1997-6#1)(2011-2#1)
DMPC liposomes##2##2##(1990-12#1)(1994-3#1)
DMPC##6##1##(1990-12#1)(1992-6#1)(1994-12#1)(1994-3#2)(1997-6#1)
DMPC/sphingosine liposomes##4##2##(1994-3#4)
DMPC/sphingosine##5##1##(1994-3#5)
DMPG vesicles##2##2##(2008-10#2)
DMPG##3##1##(1992-6#1)(2008-10#2)
DMPM##4##1##(2010-12#4)
DMPO##4##1##(1990-12#1)(1991-2#2)(2008-5#1)
DMPS and bucillamine##3##3##(1995-3#3)
DMPS are##2##2##(1995-3#2)
DMPS##7##1##(1994-5#1)(1995-3#6)
DMR##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
DMRLSR-W##3##1##(2008-10#3)
DMRT1##4##1##(2010-5#4)
DMS##4##1##(2008-10#2)(2013-8#2)
DMSA is##2##2##(1995-3#1)(2008-10#1)
DMSA lowered the brain lead##2##5##(1992-12#2)
DMSA lowered the##3##3##(1992-12#3)
DMSA##11##1##(1992-12#7)(1995-3#2)(2008-10#1)(2008-4#1)
DMSO and DMF##3##3##(2008-10#2)(2009-9#1)
DMSO and##8##2##(1995-2#2)(2008-10#5)(2009-9#1)
DMSO or##2##2##(1991-5#1)(1991-9#1)
DMSO solutions of##4##3##(2008-10#4)
DMSO with##2##2##(2007-11#1)(2009-5#1)
DMSO##45##1##(1991-12#1)(1991-5#1)(1991-9#1)(1995-2#5)(1995-8#2)(2007-11#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
DMSO-Triton X-100##2##2##(2008-10#2)
DMSO-water mixtures##2##2##(2008-10#2)
DMSO-water##3##1##(2008-10#3)
DMSP##5##1##(2008-10#5)
DMT##4##1##(1992-3#1)(2007-10#1)(2008-10#2)
DMTS performance##2##2##(1995-5#2)
DMTS##3##1##(1995-5#3)
DMV##4##1##(1993-12#4)
DMY##2##1##(2008-10#2)
DMe for m =##2##4##(1991-8#2)
DMe##3##1##(1991-8#3)
DN##4##1##(2008-1#3)(2013-1#1)
DN-MSTN TG13 mice##3##3##(2012-12#3)
DN-MSTN TG13##4##2##(2012-12#4)
DNA (RAPD) analysis##8##3##(2008-10#8)
DNA (RAPD)##48##2##(1995-6#1)(1996-10#1)(2008-10#43)(2008-5#2)(2013-7#1)
DNA (RAPD)-PCR##2##2##(2008-10#2)
DNA (aDNA)##2##2##(2009-8#1)(2012-2#1)
DNA (cDNA) clones##2##3##(1990-12#1)(1993-6#1)
DNA (cDNA)##6##2##(1990-12#1)(1993-6#1)(2008-10#2)(2008-7#1)(2008-9#1)
DNA (ctDNA)##5##2##(2008-10#4)(2008-8#1)
DNA (dsDNA)##4##2##(1995-2#1)(2008-10#3)
DNA (rDNA)##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
DNA (ssDNA)##6##2##(1995-2#1)(2008-10#3)(2008-7#1)(2012-3#1)
DNA Analysis##2##2##(2008-10#1)(2008-12#1)
DNA DSB##3##2##(1995-2#1)(2010-2#1)(2013-1#1)
DNA Damage##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
DNA Fingerprint##2##2##(2008-10#2)
DNA Fingerprinting##2##2##(2008-10#2)
DNA IQ System##3##3##(2008-12#3)
DNA ISC was##2##3##(2008-11#2)
DNA ISC##7##2##(2008-11#7)
DNA Markers##6##2##(2008-10#5)(2008-5#1)
DNA PCR##2##2##(2008-10#2)
DNA accumulation in##2##3##(2008-10#2)
DNA accumulation##3##2##(2008-10#3)
DNA adduct formation##4##3##(1993-8#3)(1995-9#1)
DNA adduct##5##2##(1993-8#3)(1994-2#1)(1995-9#1)
DNA adducts##10##2##(1990-7#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-8#3)(2008-10#1)(2008-11#1)(2008-12#1)
DNA adenine##2##2##(1990-5#2)
DNA affinity##3##2##(1994-11#1)(1995-6#1)(2008-4#1)
DNA after##3##2##(2008-8#1)(2010-5#1)(2012-2#1)
DNA alkylation##3##2##(1992-11#2)(2007-11#1)
DNA alterations##4##2##(2008-7#4)
DNA amplification##11##2##(1990-12#1)(1993-3#2)(1995-11#1)(2008-10#3)(2008-5#2)(2013-8#2)
DNA amplified by a polymerase chain reaction##2##7##(2008-2#2)
DNA amplified##4##2##(2008-10#2)(2008-2#2)
DNA analyses##9##2##(1994-12#1)(2008-10#6)(2008-9#1)(2010-3#1)
DNA analysis showed##3##3##(1993-6#1)(1995-8#1)(2008-10#1)
DNA analysis##19##2##(1992-11#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-8#1)(2008-10#4)(2008-12#4)(2008-4#1)(2008-9#3)(2011-1#1)
DNA and RNA probes##2##4##(1994-2#1)(2008-9#1)
DNA and RNA##24##3##(1991-12#1)(1991-4#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(2008-10#3)(2008-4#3)(2008-9#6)(2009-10#2)(2009-5#2)(2011-3#1)
DNA and are##2##3##(1993-12#1)(1995-12#1)
DNA and chemicals into##2##4##(2008-7#2)
DNA and for##3##3##(1992-3#2)(2008-4#1)
DNA and is##3##3##(1990-7#1)(1994-12#1)(1995-2#1)
DNA and its##4##3##(2008-10#1)(2008-4#2)(2011-10#1)
DNA and mimic biomembrane##2##4##(2008-10#2)
DNA and protein##6##3##(1994-11#1)(1994-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
DNA and proteins in##2##4##(1991-6#1)(2008-12#1)
DNA and proteins##9##3##(1991-6#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)
DNA and that##4##3##(1992-12#1)(1992-3#1)(1994-8#1)(1996-2#1)
DNA and the##6##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
DNA and to##3##3##(1991-5#1)(1995-2#2)
DNA and##143##2##(1990-5#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-12#1)(1992-3#5)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#3)(1995-12#1)(1995-2#5)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#32)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#16)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#3)(2009-3#1)(2009-5#2)(2011-1#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
DNA aneuploidy##2##2##(1994-12#1)(1995-9#1)
DNA aptamers##7##2##(2007-11#4)(2008-9#3)
DNA are##9##2##(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#3)
DNA array technology##2##3##(2007-12#1)(2008-10#1)
DNA array##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
DNA arrays##3##2##(2008-10#1)(2008-7#2)
DNA as a##6##3##(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-5#1)(2008-8#1)
DNA as the##2##3##(1992-6#1)(2008-11#1)
DNA as##14##2##(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2010-11#1)(2013-8#1)
DNA assay##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
DNA at the##7##3##(1992-6#1)(1994-3#1)(1994-9#1)(1995-6#1)(2008-10#2)(2010-4#1)
DNA at##16##2##(1992-6#1)(1993-11#2)(1994-3#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2010-4#1)(2013-1#1)
DNA band##2##2##(2008-10#2)
DNA bands##4##2##(1995-12#1)(2008-10#3)
DNA barcode##4##2##(2008-9#3)(2012-2#1)
DNA barcoding##6##2##(2008-9#5)(2012-2#1)
DNA base modification##2##3##(1994-6#2)
DNA base pairs##2##3##(2009-6#1)(2013-1#1)
DNA base##6##2##(1994-6#2)(1995-5#1)(1997-6#1)(2009-6#1)(2013-1#1)
DNA based on##3##3##(2008-10#2)(2013-1#1)
DNA bases##2##2##(1994-2#1)(2008-10#1)
DNA bend sites##2##3##(1996-2#2)
DNA bending is##2##3##(1992-6#1)(1997-6#1)
DNA bending##7##2##(1992-6#2)(1995-8#1)(1997-6#2)(2008-7#2)
DNA binding activity of##2##4##(1990-12#1)(2008-9#1)
DNA binding activity##6##3##(1990-12#1)(1995-5#1)(1997-3#1)(2008-1#1)(2008-7#1)(2008-9#1)
DNA binding affinity##4##3##(1990-11#1)(1991-2#1)(1995-8#1)(2008-9#1)
DNA binding and##7##3##(1990-11#1)(1992-2#1)(1992-3#1)(1995-5#1)(1995-8#1)(2008-8#1)(2013-1#1)
DNA binding by##3##3##(1995-2#1)(1995-5#1)(1995-8#1)
DNA binding domain of##3##4##(1990-11#1)(1991-5#1)(1995-6#1)
DNA binding domain##5##3##(1990-11#1)(1991-5#1)(1995-5#1)(1995-6#1)(2012-12#1)
DNA binding is##2##3##(2008-4#1)(2012-2#1)
DNA binding of##2##3##(1991-2#1)(1992-2#1)
DNA binding properties of the##3##5##(1991-3#1)(1995-5#1)(2008-9#1)
DNA binding properties of##6##4##(1991-3#2)(1995-5#2)(1996-3#1)(2008-9#1)
DNA binding protein##16##3##(1990-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#2)(2008-2#2)(2008-9#2)
DNA binding proteins in SR##3##5##(2008-8#3)
DNA binding proteins in##6##4##(1991-5#1)(2008-8#5)
DNA binding proteins##12##3##(1991-5#1)(1992-6#1)(1994-11#1)(2008-2#1)(2008-8#6)(2008-9#1)(2010-5#1)
DNA binding site##6##3##(1990-11#2)(1991-5#2)(1992-8#1)(1995-5#1)
DNA binding sites##3##3##(1992-11#1)(1995-11#1)(1995-6#1)
DNA binding specificity##4##3##(1995-5#3)(2008-6#1)
DNA binding##103##2##(1990-11#6)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#5)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#4)(1995-5#10)(1995-6#4)(1995-8#5)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#9)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
DNA biosensor and##4##3##(2008-10#2)(2008-9#2)
DNA biosensor for the detection of##2##6##(2008-10#2)
DNA biosensor for the detection##3##5##(2008-10#3)
DNA biosensor for##4##3##(2008-10#4)
DNA biosensor is##4##3##(2008-10#4)
DNA biosensor##21##2##(2008-10#18)(2008-9#3)
DNA biosensors##4##2##(2008-10#2)(2008-9#2)
DNA bonding##4##2##(1995-5#4)
DNA breakage##7##2##(1991-12#1)(1995-6#2)(1997-4#2)(2011-2#1)(2013-1#1)
DNA breaking activity##2##3##(1996-2#2)
DNA breaking##3##2##(1996-2#3)
DNA breaks##7##2##(2008-11#2)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
DNA by PCR##3##3##(2008-2#2)(2008-9#1)
DNA by a##2##3##(1995-5#1)(2008-10#1)
DNA by an##2##3##(1991-12#1)(1995-5#1)
DNA by the polymerase chain reaction##2##6##(1994-12#2)
DNA by the##9##3##(1991-12#1)(1991-8#1)(1994-11#1)(1994-12#2)(1995-3#1)(2008-10#2)(2008-11#1)
DNA by##39##2##(1990-5#1)(1991-12#2)(1991-7#1)(1991-8#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
DNA can be used##2##4##(1994-8#1)(2007-6#1)
DNA can be##9##3##(1993-9#1)(1994-8#1)(2007-6#1)(2008-10#1)(2008-8#3)(2008-9#1)(2012-2#1)
DNA can##11##2##(1990-8#1)(1993-9#1)(1994-8#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)
DNA catalysts##2##2##(2012-12#2)
DNA cellulose##2##2##(1992-7#1)(2008-9#1)
DNA chip was##2##3##(2008-12#2)
DNA chip##7##2##(2008-10#2)(2008-12#5)
DNA chips##4##2##(2008-10#2)(2008-4#1)(2010-12#1)
DNA cleavage##5##2##(1993-8#1)(1995-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
DNA clones to##2##3##(1996-8#1)(2008-10#1)
DNA clones##10##2##(1992-11#1)(1994-12#2)(1996-8#1)(2008-10#5)(2008-8#1)
DNA comparisons##2##2##(2008-4#2)
DNA complex##2##2##(1995-6#1)(2009-11#1)
DNA components##3##2##(1991-5#1)(2008-10#2)
DNA concentration##10##2##(1991-5#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-12#1)
DNA concentrations##2##2##(2008-11#1)(2008-2#1)
DNA conformation##3##2##(1993-11#2)(2008-3#1)
DNA conformations##2##2##(2008-3#1)(2008-7#1)
DNA constituents##3##2##(2008-10#3)
DNA construct##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
DNA containing the##2##3##(2008-10#1)(2010-5#1)
DNA containing##8##2##(1993-11#1)(1993-9#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-12#1)
DNA contains##3##2##(1992-11#1)(1992-12#1)(2008-6#1)
DNA content analysis##8##3##(2008-11#2)(2008-6#1)(2008-9#4)(2010-8#1)
DNA content and expression of##2##5##(2008-11#1)(2008-9#1)
DNA content and##18##3##(1992-9#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#10)
DNA content in the##2##4##(2008-11#2)
DNA content in##6##3##(1991-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
DNA content is##3##3##(2008-9#3)
DNA content measurement##2##3##(2008-9#2)
DNA content of cancer cells##2##5##(1991-6#2)
DNA content of##6##3##(1991-6#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-5#1)
DNA content was##2##3##(1997-4#1)(2008-11#1)
DNA content were##2##3##(1996-12#1)(1996-5#1)
DNA content##72##2##(1991-6#3)(1992-9#2)(1994-12#4)(1994-3#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-4#3)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-5#5)(2008-6#1)(2008-9#28)(2009-8#1)(2010-8#1)
DNA contents##3##2##(1993-12#1)(1997-3#1)(2008-9#1)
DNA control region##6##3##(1996-6#1)(2008-12#3)(2009-2#1)(2010-8#1)
DNA control##7##2##(1992-5#1)(1996-6#1)(2008-12#3)(2009-2#1)(2010-8#1)
DNA copies##7##2##(1990-2#1)(1995-11#4)(2012-3#1)(2013-8#1)
DNA copy number##2##3##(1995-11#1)(2008-9#1)
DNA could##2##2##(1993-8#1)(2008-10#1)
DNA damage and the##2##4##(1994-8#1)(2008-11#1)
DNA damage and##12##3##(1994-8#2)(1995-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2012-2#1)(2013-7#1)
DNA damage as a##2##4##(1995-5#1)(2010-5#1)
DNA damage as##5##3##(1993-12#2)(1994-2#1)(1995-5#1)(2010-5#1)
DNA damage at##2##3##(1997-4#1)(2008-7#1)
DNA damage by##4##3##(1992-3#1)(1994-11#1)(1997-4#1)(2008-7#1)
DNA damage can be##2##4##(2008-11#1)(2008-4#1)
DNA damage checkpoint pathway##2##4##(2009-6#1)(2011-2#1)
DNA damage checkpoint##5##3##(2008-11#1)(2009-6#2)(2011-2#1)(2013-1#1)
DNA damage formation##2##3##(2008-11#2)
DNA damage in cells##2##4##(1995-2#1)(2011-2#1)
DNA damage in human##2##4##(1997-4#2)
DNA damage in rat##2##4##(1997-4#2)
DNA damage in tumor cells##2##5##(2010-2#2)
DNA damage in##29##3##(1991-9#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-6#1)(1997-4#10)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-5#2)(2010-2#3)(2010-5#1)(2011-2#1)(2013-1#1)
DNA damage induced by##5##4##(1993-3#1)(1994-11#1)(1994-5#1)(2008-9#1)(2013-1#1)
DNA damage induced##7##3##(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1997-4#1)(2008-9#1)(2013-1#1)
DNA damage is##3##3##(1997-4#1)(2008-5#1)(2011-2#1)
DNA damage leading to##2##4##(2008-5#1)(2012-12#1)
DNA damage may##2##3##(2008-1#1)(2008-7#1)
DNA damage response (DDR)##3##4##(2011-2#2)(2013-1#1)
DNA damage response##9##3##(2009-5#3)(2011-2#2)(2012-12#1)(2013-1#3)
DNA damage resulting##2##3##(2008-5#1)(2010-2#1)
DNA damage to##2##3##(1992-3#1)(1997-4#1)
DNA damage using the##2##4##(1997-4#2)
DNA damage was##5##3##(1994-8#2)(1997-4#2)(2010-5#1)
DNA damage##162##2##(1991-5#1)(1991-9#3)(1992-3#4)(1992-9#1)(1993-12#4)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#4)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-4#28)(2008-1#1)(2008-10#8)(2008-11#8)(2008-3#1)(2008-4#6)(2008-5#5)(2008-7#9)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#9)(2009-6#2)(2009-7#1)(2010-2#4)(2010-3#1)(2010-5#4)(2011-1#1)(2011-2#11)(2012-12#4)(2012-2#1)(2013-1#13)(2013-7#1)
DNA damage-control##2##2##(2008-7#2)
DNA damages##4##2##(1990-6#1)(1995-6#1)(1997-4#2)
DNA damaging agents##6##3##(1994-10#1)(1994-5#1)(2008-7#4)
DNA damaging##10##2##(1994-10#1)(1994-5#1)(2008-7#5)(2010-10#1)(2010-2#1)(2011-1#1)
DNA data##3##2##(1997-6#2)(2010-6#1)
DNA database##3##2##(2008-12#1)(2008-5#1)(2009-2#1)
DNA degradation and##2##3##(2008-12#2)
DNA degradation##5##2##(1991-12#2)(1994-10#1)(2008-12#2)
DNA delivery##5##2##(2008-11#2)(2010-8#1)(2011-1#1)(2011-2#1)
DNA demethylation##3##2##(1995-2#3)
DNA demonstrated that##2##3##(1991-5#1)(2008-10#1)
DNA denaturation##3##2##(2008-9#3)
DNA derived from##2##3##(2008-2#1)(2012-3#1)
DNA derived##4##2##(1991-2#1)(2008-2#1)(2008-7#1)(2012-3#1)
DNA detected##2##2##(1993-8#1)(2012-3#1)
DNA detection and##2##3##(1997-4#1)(2008-10#1)
DNA detection by##2##3##(1997-4#1)(2013-1#1)
DNA detection methods##3##3##(1997-4#3)
DNA detection##12##2##(1997-4#5)(2008-10#4)(2008-9#1)(2013-1#2)
DNA determined by##2##3##(1991-8#1)(2008-8#1)
DNA determined##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
DNA diagnostic procedures##2##3##(1991-11#2)
DNA did not##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
DNA digested with##2##3##(1993-2#1)(2008-4#1)
DNA digestion##2##2##(2008-10#1)(2008-4#1)
DNA directly from##2##3##(2008-10#2)
DNA directly##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
DNA double strand break##2##4##(1996-2#2)
DNA double strand breaks##2##4##(1994-11#2)
DNA double strand##4##3##(1994-11#2)(1996-2#2)
DNA double##6##2##(1994-11#2)(1996-2#2)(2008-10#1)(2008-11#1)
DNA double-strand break repair##5##4##(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)
DNA double-strand break##6##3##(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
DNA double-strand breaks (DSBs)##4##4##(1995-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
DNA double-strand breaks##8##3##(1995-2#1)(1995-8#1)(1997-7#1)(2008-9#2)(2010-2#1)(2011-2#1)(2013-1#1)
DNA double-strand##14##2##(1995-2#1)(1995-8#1)(1997-7#2)(2008-7#1)(2008-9#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
DNA duplexes##5##2##(1995-5#1)(2008-4#1)(2008-7#1)(2009-6#1)(2013-7#1)
DNA during the##3##3##(1997-4#1)(1997-6#1)(2008-4#1)
DNA during##7##2##(1994-10#1)(1995-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-4#1)(2011-2#1)
DNA dye permits##2##3##(2008-9#2)
DNA either##3##2##(1994-8#1)(2006-10#1)(2008-10#1)
DNA element##3##2##(1994-12#1)(2008-10#1)(2010-8#1)
DNA elements##6##2##(1991-9#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
DNA elimination##2##2##(2012-3#2)
DNA encapsulation##2##2##(2008-7#2)
DNA encoding a##2##3##(1996-12#1)(2008-2#1)
DNA encoding human##2##3##(1990-5#1)(1991-5#1)
DNA encoding the##2##3##(1993-9#1)(1994-12#1)
DNA encoding##9##2##(1990-5#1)(1991-5#1)(1993-9#1)(1994-12#2)(1996-12#1)(1997-4#2)(2008-2#1)
DNA end joining##3##3##(1993-2#2)(1997-7#1)
DNA end##5##2##(1993-2#2)(1997-7#2)(2013-1#1)
DNA endoreduplication##2##2##(2008-5#2)
DNA ends##7##2##(1993-2#1)(1996-2#1)(1997-7#2)(2008-4#2)(2009-11#1)
DNA expression##2##2##(1990-11#1)(2012-12#1)
DNA extracted from naturally infected##2##5##(2008-10#2)
DNA extracted from##17##3##(1990-7#1)(2008-10#10)(2008-12#3)(2008-4#1)(2012-2#2)
DNA extraction and##2##3##(2008-10#2)
DNA extraction from##3##3##(2008-10#1)(2008-12#1)(2010-2#1)
DNA extraction method##2##3##(2012-3#2)
DNA extraction##22##2##(1991-2#1)(1996-12#1)(2008-10#7)(2008-12#3)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#3)(2012-3#4)
DNA extracts##2##2##(2008-10#1)(2008-5#1)
DNA fingerprint for##2##3##(2008-10#2)
DNA fingerprint pattern##2##3##(2008-10#2)
DNA fingerprint patterns were##2##4##(2008-10#2)
DNA fingerprint patterns##4##3##(2008-10#4)
DNA fingerprint probe##3##3##(2008-10#3)
DNA fingerprint##21##2##(2008-10#21)
DNA fingerprinting analysis##2##3##(2008-10#2)
DNA fingerprinting and##2##3##(2008-10#2)
DNA fingerprinting of##2##3##(1996-12#1)(2008-10#1)
DNA fingerprinting with##4##3##(2008-10#4)
DNA fingerprinting##22##2##(1995-6#1)(1996-12#1)(2008-10#18)(2008-11#1)(2008-5#1)
DNA fingerprints of##3##3##(2008-10#2)(2008-5#1)
DNA fingerprints were used to##3##5##(2008-10#3)
DNA fingerprints were##5##3##(2008-10#5)
DNA fingerprints##23##2##(2008-10#21)(2008-5#2)
DNA flow cytometry##2##3##(1994-12#1)(1995-4#1)
DNA flow##3##2##(1994-12#1)(1995-4#1)(2008-6#1)
DNA for##14##2##(1990-12#1)(1994-11#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#4)(2011-1#1)(2011-2#1)
DNA forms##3##2##(1993-11#1)(2008-10#2)
DNA fragment and##2##3##(1990-12#1)(1993-12#1)
DNA fragment containing the##4##4##(1993-6#2)(1994-6#1)(1995-2#1)
DNA fragment containing##6##3##(1990-5#1)(1993-6#2)(1994-6#1)(1995-2#1)(2008-8#1)
DNA fragment contains##2##3##(2008-8#2)
DNA fragment from a##2##4##(1991-2#1)(1994-12#1)
DNA fragment from the left arm of##2##7##(1995-6#1)(1996-3#1)
DNA fragment from the##4##4##(1993-9#1)(1995-6#1)(1996-3#1)(1997-3#1)
DNA fragment from##7##3##(1991-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-8#1)
DNA fragment in##2##3##(2008-10#1)(2008-11#1)
DNA fragment including##2##3##(1990-12#1)(2008-8#1)
DNA fragment is##2##3##(1992-12#1)(1995-8#1)
DNA fragment obtained##2##3##(1992-3#1)(1993-8#1)
DNA fragment of the##3##4##(1996-6#1)(1997-3#1)(2008-10#1)
DNA fragment of##5##3##(1996-6#1)(1997-3#1)(2008-10#3)
DNA fragment revealed##2##3##(1990-12#1)(1991-9#1)
DNA fragment sizing##2##3##(2008-3#2)
DNA fragment that##2##3##(1991-5#1)(1997-2#1)
DNA fragment was cloned##2##4##(2008-8#2)
DNA fragment was##8##3##(1990-11#1)(1992-8#1)(1997-8#1)(2008-10#2)(2008-8#3)
DNA fragment within the ITS2 region of##2##7##(2008-10#2)
DNA fragment within the##3##4##(2008-10#3)
DNA fragment##71##2##(1990-11#1)(1990-12#4)(1990-5#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#14)(2008-9#2)
DNA fragmentation and activation of caspase-3-like##2##6##(2008-11#2)
DNA fragmentation and##8##3##(1992-9#1)(1993-8#1)(1995-12#1)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)
DNA fragmentation assays##2##3##(2008-1#1)(2013-1#1)
DNA fragmentation by agarose gel electrophoresis##2##6##(1994-6#1)(2008-1#1)
DNA fragmentation by##3##3##(1994-6#1)(2008-1#2)
DNA fragmentation in##4##3##(1993-8#1)(2008-4#1)(2008-8#1)(2008-9#1)
DNA fragmentation##47##2##(1991-12#1)(1992-3#1)(1992-9#4)(1993-3#1)(1993-8#6)(1994-10#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-12#2)(1997-4#2)(2008-1#6)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2013-1#2)
DNA fragments are##4##3##(1991-7#1)(1995-8#3)
DNA fragments containing the##2##4##(1992-3#1)(1995-5#1)
DNA fragments from##3##3##(1991-9#1)(2008-10#1)(2008-7#1)
DNA fragments in##6##3##(1992-2#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-8#1)
DNA fragments obtained##2##3##(1990-5#1)(2008-10#1)
DNA fragments of##6##3##(1994-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2011-1#2)
DNA fragments that##3##3##(1991-5#1)(2008-10#1)(2008-2#1)
DNA fragments unique to the##2##5##(2008-10#1)(2008-2#1)
DNA fragments were##5##3##(1991-5#1)(1995-2#1)(2008-10#1)(2008-8#2)
DNA fragments with a##2##4##(2008-8#1)(2008-9#1)
DNA fragments##74##2##(1990-12#1)(1990-5#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1997-2#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2011-1#2)(2012-3#1)
DNA from a collection of##2##5##(2008-10#2)
DNA from a human##2##4##(2008-6#2)
DNA from a single##2##4##(2008-10#1)(2008-4#1)
DNA from a##14##3##(1990-12#1)(1993-2#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-6#2)
DNA from both##2##3##(1994-2#1)(2008-9#1)
DNA from envelope flaps##2##4##(2008-12#2)
DNA from human##2##3##(1991-5#1)(1991-9#1)
DNA from isolates##2##3##(2008-10#2)
DNA from purified##2##3##(2008-10#1)(2013-1#1)
DNA from the##10##3##(1994-5#1)(1996-6#1)(1996-9#1)(2008-10#5)(2008-9#1)(2013-1#1)
DNA from various##3##3##(1993-8#1)(1993-9#1)(2008-4#1)
DNA from##105##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#37)(2008-11#2)(2008-12#3)(2008-2#5)(2008-4#6)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#3)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#1)(2013-1#2)
DNA gel electrophoresis##2##3##(1994-11#1)(2008-8#1)
DNA gene##3##2##(1991-4#1)(1991-5#2)
DNA genome##2##2##(2008-10#1)(2008-4#1)
DNA genomes##2##2##(1995-2#1)(2013-1#1)
DNA guanine##2##2##(2008-10#2)
DNA gyrase##4##2##(1994-12#1)(1995-6#1)(1995-8#2)
DNA had been##2##3##(1995-2#1)(2008-10#1)
DNA had##3##2##(1995-2#2)(2008-10#1)
DNA hairpin##5##2##(1992-3#1)(2008-4#1)(2010-5#2)(2012-2#1)
DNA hairpins##4##2##(1992-3#2)(2008-10#2)
DNA haplotype##5##2##(1992-9#2)(2008-10#3)
DNA has been##5##3##(1995-2#1)(1995-8#1)(2008-10#3)
DNA has##8##2##(1990-5#1)(1993-6#1)(1995-2#1)(1995-8#1)(2008-10#3)(2010-8#1)
DNA have been##2##3##(2008-10#1)(2008-2#1)
DNA have##3##2##(2008-10#2)(2008-2#1)
DNA helix##4##2##(1990-5#1)(1994-5#1)(1996-2#1)(2008-11#1)
DNA homology group 9##2##4##(2008-10#2)
DNA homology##3##2##(2008-10#3)
DNA hybridisation##3##2##(2008-10#3)
DNA hybridization analysis##2##3##(2008-10#2)
DNA hybridization and##2##3##(2008-10#2)
DNA hybridization kinetics##2##3##(1995-12#1)(2008-7#1)
DNA hybridization sensors##2##3##(2008-10#2)
DNA hybridization##20##2##(1995-12#2)(2008-10#16)(2008-4#1)(2008-7#1)
DNA identifications##2##2##(2012-2#2)
DNA immobilization##2##2##(2008-10#2)
DNA immunization##3##2##(1997-8#2)(2008-8#1)
DNA in a##8##3##(1990-11#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2013-1#1)
DNA in all##2##3##(1994-11#1)(2012-3#1)
DNA in ancient##2##3##(2008-12#1)(2012-2#1)
DNA in blood##2##3##(1991-5#1)(2008-5#1)
DNA in cell##3##3##(1991-9#1)(2008-11#1)(2008-9#1)
DNA in the presence of##3##5##(1994-8#1)(2008-10#1)(2008-4#1)
DNA in the##21##3##(1990-11#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
DNA in vitro##2##3##(1994-3#1)(1995-3#1)
DNA in##103##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#7)(2008-9#4)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)
DNA including the##2##3##(2008-10#1)(2008-8#1)
DNA indicated that the##3##4##(1990-12#1)(1992-11#1)(2008-10#1)
DNA injection##2##2##(1996-5#1)(2008-4#1)
DNA insert##3##2##(1993-9#1)(2008-6#1)(2008-8#1)
DNA instability##2##2##(2009-2#1)(2011-2#1)
DNA integration##3##2##(2008-4#2)(2013-1#1)
DNA integrity as##2##3##(2008-5#1)(2008-9#1)
DNA integrity##6##2##(1995-8#1)(2008-5#1)(2008-9#3)(2013-1#1)
DNA interaction with##2##3##(2008-10#1)(2013-1#1)
DNA interaction##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
DNA internal##6##2##(2008-10#5)(2008-12#1)
DNA into cells##3##3##(2008-11#2)(2008-4#1)
DNA into the##6##3##(1995-2#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-5#1)
DNA into yeast##2##3##(2008-4#2)
DNA into##25##2##(1993-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-11#4)(2008-2#4)(2008-4#8)(2008-5#1)(2008-8#1)
DNA is a##3##3##(1993-6#1)(1995-5#1)(2008-12#1)
DNA is an##2##3##(1992-3#1)(1997-8#1)
DNA is detected##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)
DNA is extracted##2##3##(2008-10#1)(2008-12#1)
DNA is not##2##3##(2008-4#1)(2008-9#1)
DNA is the##2##3##(1997-6#1)(2008-8#1)
DNA is##52##2##(1991-5#2)(1991-9#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-6#2)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-2#4)(2008-4#6)(2008-7#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-7#1)(2010-8#1)(2013-1#1)
DNA isolated from##9##3##(1991-9#1)(1993-12#1)(1994-12#3)(1995-12#1)(1996-12#1)(1997-4#1)(2008-10#1)
DNA isolated##11##2##(1991-9#1)(1993-12#1)(1994-12#3)(1995-12#1)(1996-12#2)(1997-4#1)(2008-10#1)(2008-2#1)
DNA ladder was##2##3##(2008-8#2)
DNA ladder##9##2##(1994-10#2)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)
DNA laddering##2##2##(2008-10#1)(2008-11#1)
DNA leads to##2##3##(1995-2#1)(2008-10#1)
DNA lesion##2##2##(1994-8#2)
DNA lesions##10##2##(1993-11#2)(1994-5#1)(1994-8#1)(1995-5#2)(2008-11#1)(2008-4#2)(2010-2#1)
DNA level##6##2##(1991-6#1)(1992-3#1)(1993-8#1)(2008-8#2)(2009-8#1)
DNA levels were##2##3##(2008-10#2)
DNA levels##8##2##(1992-8#1)(2008-10#4)(2009-8#2)(2010-12#1)
DNA library of Streptomyces ansochromogenes##2##5##(2008-8#2)
DNA library of##5##3##(1993-2#1)(1994-9#1)(1997-2#1)(2008-8#2)
DNA library was##2##3##(1990-12#1)(2008-9#1)
DNA library##17##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)
DNA ligase I##5##3##(1993-3#3)(1997-7#2)
DNA ligase IV##7##3##(1997-7#7)
DNA ligase##21##2##(1990-7#1)(1993-2#1)(1993-3#5)(1994-12#2)(1997-7#10)(2008-4#1)(2009-8#1)
DNA ligases are very sensitive to mismatches at the DNA ends to be joined through ligation##2##16##(2008-4#2)
DNA ligases##7##2##(1994-12#2)(1997-7#2)(2008-4#2)(2010-7#1)
DNA ligation##3##2##(1993-2#1)(2008-7#1)(2010-7#1)
DNA located between##2##3##(2008-11#1)(2008-2#1)
DNA loci##4##2##(1995-2#1)(2008-10#3)
DNA marker##5##2##(1997-2#1)(2008-10#4)
DNA markers and##3##3##(2008-10#2)(2008-9#1)
DNA markers for##2##3##(2008-10#2)
DNA markers from##2##3##(1996-12#1)(2008-10#1)
DNA markers identified##2##3##(1996-10#1)(2008-10#1)
DNA markers in##2##3##(1996-10#1)(2008-5#1)
DNA markers linked to##4##4##(2008-10#3)(2008-5#1)
DNA markers were##2##3##(2008-10#2)
DNA markers##43##2##(1995-6#1)(1996-10#7)(1996-12#2)(1997-2#2)(2008-10#23)(2008-5#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
DNA may be##2##3##(1993-3#1)(2008-2#1)
DNA may##7##2##(1993-3#1)(1993-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)
DNA metabolism##3##2##(1994-12#1)(2008-11#1)(2010-2#1)
DNA methylation and histone##2##4##(2008-5#1)(2009-4#1)
DNA methylation and##4##3##(2007-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
DNA methylation in##3##3##(1993-6#1)(2007-11#1)(2013-8#1)
DNA methylation patterns##2##3##(1997-4#1)(2011-2#1)
DNA methylation##26##2##(1993-6#1)(1994-11#1)(1995-12#2)(1997-4#1)(2007-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-2#3)(2011-9#1)(2012-12#5)(2013-8#3)
DNA methyltransferase inhibitors##4##3##(2007-11#3)(2008-5#1)
DNA methyltransferase##5##2##(1992-3#1)(2007-11#3)(2008-5#1)
DNA methyltransferases##2##2##(2008-5#1)(2011-2#1)
DNA microarray analysis##5##3##(2008-4#2)(2008-7#3)
DNA microarray experiments##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
DNA microarray method##2##3##(2012-3#2)
DNA microarray technology has##2##4##(2008-7#2)
DNA microarray technology##6##3##(2008-10#1)(2008-7#4)(2012-2#1)
DNA microarray##25##2##(2007-12#1)(2008-10#2)(2008-4#4)(2008-7#9)(2011-2#1)(2012-2#2)(2012-3#5)(2013-8#1)
DNA microarrays##13##2##(2008-4#5)(2008-7#5)(2010-4#1)(2012-3#2)
DNA migration##2##2##(1996-2#1)(2008-10#1)
DNA model##2##2##(1991-5#2)
DNA molecule##8##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#2)
DNA molecules and##3##3##(2008-10#3)
DNA molecules are##2##3##(2008-9#2)
DNA molecules by##2##3##(2008-10#1)(2008-11#1)
DNA molecules in##2##3##(1997-6#1)(2012-2#1)
DNA molecules##29##2##(1990-11#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-6#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-2#1)
DNA motifs##2##2##(2008-4#2)
DNA mutation##6##2##(1992-9#2)(2008-10#2)(2008-4#1)(2010-11#1)
DNA mutations and##2##3##(1996-2#1)(2008-12#1)
DNA mutations were##2##3##(1996-9#2)
DNA mutations##9##2##(1992-9#1)(1996-2#2)(1996-9#3)(2008-12#1)(2008-2#1)(2008-4#1)
DNA nanochannels##3##2##(2008-7#3)
DNA nanomachines##2##2##(2008-7#2)
DNA nanotechnology##6##2##(2008-4#4)(2008-7#1)(2009-5#1)
DNA network##2##2##(2008-10#2)
DNA obtained from##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
DNA obtained##4##2##(1990-5#1)(1991-2#1)(2008-10#1)(2012-2#1)
DNA of M##2##3##(2008-10#2)
DNA of S##2##3##(2008-10#1)(2008-8#1)
DNA of a##2##3##(1991-2#1)(2008-10#1)
DNA of agents of##3##4##(2013-1#3)
DNA of all##2##3##(2008-10#2)
DNA of bacteriophage##2##3##(1991-5#1)(1993-9#1)
DNA of rat##2##3##(1991-12#1)(2008-8#1)
DNA of the##9##3##(1991-11#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
DNA of##63##2##(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#2)(1992-11#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-7#1)(1996-3#1)(1997-3#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-6#1)(2010-2#1)(2010-7#1)(2013-1#7)
DNA oligonucleotide##2##2##(1995-5#1)(2008-4#1)
DNA oligonucleotides##5##2##(2007-11#1)(2008-10#1)(2008-4#3)
DNA on the##2##3##(1997-4#1)(2008-10#1)
DNA on##8##2##(1995-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#1)
DNA onto the##2##3##(2008-10#2)
DNA onto##3##2##(2008-10#3)
DNA or RNA##5##3##(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)
DNA or##11##2##(1991-2#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
DNA packaging system##2##3##(1996-2#2)
DNA packaging##6##2##(1991-5#1)(1996-2#2)(2008-7#1)(2010-5#2)
DNA particles##2##2##(1995-2#2)
DNA phosphate##2##2##(1991-8#1)(2008-11#1)
DNA photolesions##2##2##(1993-8#2)
DNA ploidy was found to be##2##6##(2008-6#2)
DNA ploidy##11##2##(1994-11#1)(2008-6#5)(2008-9#5)
DNA polymerase I##5##3##(1990-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-4#1)
DNA polymerase III holoenzyme##3##4##(1992-3#2)(1994-12#1)
DNA polymerase III##5##3##(1992-3#3)(1994-12#1)(1995-6#1)
DNA polymerase accessory protein##2##4##(1997-3#2)
DNA polymerase alpha and##2##4##(1995-4#2)
DNA polymerase alpha##7##3##(1990-7#1)(1995-4#5)(1995-6#1)
DNA polymerase alpha-primase##4##3##(1990-7#2)(1994-8#2)
DNA polymerase by##2##3##(1995-2#1)(1997-6#1)
DNA polymerase delta##2##3##(1994-12#1)(1995-2#1)
DNA polymerase from##3##3##(1997-6#2)(1997-8#1)
DNA polymerase gamma##2##3##(1990-7#2)
DNA polymerase gene##3##3##(1997-4#2)(2013-1#1)
DNA polymerase has##3##3##(1995-8#1)(1997-6#1)(1997-8#1)
DNA polymerase is##3##3##(1994-12#1)(1997-6#1)(1997-8#1)
DNA polymerase that##2##3##(1995-2#1)(1995-8#1)
DNA polymerase transactivates##2##3##(1993-8#2)
DNA polymerase was cloned into##2##5##(1993-12#1)(1997-4#1)
DNA polymerase was##5##3##(1993-12#1)(1993-8#1)(1997-4#2)(1997-6#1)
DNA polymerase##81##2##(1990-5#4)(1990-7#5)(1992-3#3)(1993-12#1)(1993-8#3)(1994-12#5)(1994-8#3)(1995-2#4)(1995-4#5)(1995-6#2)(1995-8#2)(1997-3#3)(1997-4#10)(1997-6#13)(1997-8#5)(1997-9#1)(2008-11#1)(2008-4#2)(2008-5#3)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
DNA polymerases alpha##4##3##(1992-6#1)(1995-2#2)(1995-6#1)
DNA polymerases that##2##3##(1990-7#2)
DNA polymerases##19##2##(1990-7#4)(1992-6#2)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-4#1)(1997-6#2)(1997-8#1)(2008-2#1)(2008-9#1)(2010-2#1)(2012-2#1)
DNA polymorphism and##2##3##(2008-10#1)(2008-7#1)
DNA polymorphism##8##2##(1991-8#1)(1994-12#1)(2008-10#5)(2008-7#1)
DNA polymorphisms##4##2##(2008-10#4)
DNA pool##2##2##(2008-4#1)(2008-8#1)
DNA preparation##2##2##(1990-11#1)(1994-12#1)
DNA preparations##5##2##(1990-12#2)(2008-10#2)(2008-11#1)
DNA present in##4##3##(2008-10#4)
DNA preservation##2##2##(2008-12#2)
DNA primase##3##2##(1994-12#1)(1995-2#2)
DNA prime-protein boost##2##3##(2013-1#2)
DNA primers##2##2##(2008-10#2)
DNA probe is##2##3##(1991-2#1)(2008-10#1)
DNA probe##19##2##(1990-5#1)(1991-2#2)(1992-6#1)(1993-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)
DNA probes are##2##3##(2008-10#1)(2010-5#1)
DNA probes by##2##3##(2008-4#2)
DNA probes for##3##3##(1990-12#1)(2010-5#2)
DNA probes##30##2##(1990-12#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-4#5)(2008-5#1)(2010-5#5)
DNA products##3##2##(2008-10#3)
DNA profile##3##2##(2008-11#1)(2008-12#1)(2010-5#1)
DNA profiles##9##2##(2008-10#3)(2008-11#1)(2008-12#3)(2010-5#2)
DNA profiling##5##2##(2008-11#1)(2008-12#4)
DNA purification##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
DNA purified##2##2##(2008-2#1)(2009-6#1)
DNA rearrangements##4##2##(1993-6#1)(1994-11#1)(1997-3#1)(2012-3#1)
DNA recognition by the##2##4##(1992-4#1)(1995-8#1)
DNA recognition##13##2##(1990-11#1)(1991-2#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1995-8#2)(2008-10#2)(2012-2#1)
DNA recombination##5##2##(1993-9#2)(1994-8#1)(2008-9#2)
DNA recovered from##2##3##(2008-10#1)(2008-12#1)
DNA region##8##2##(1991-9#1)(1993-2#2)(1997-8#1)(2008-10#3)(2008-8#1)
DNA regions from the##2##4##(2008-10#1)(2010-6#1)
DNA regions##4##2##(1995-6#1)(2008-10#1)(2009-10#1)(2010-6#1)
DNA repair and##5##3##(1993-8#1)(1996-2#1)(2008-7#3)
DNA repair enzyme endonuclease III##2##5##(1995-2#2)
DNA repair genes##2##3##(2010-6#1)(2011-2#1)
DNA repair is an##2##4##(2008-11#2)
DNA repair is##4##3##(1994-8#1)(2008-11#2)(2008-7#1)
DNA repair may##2##3##(1993-8#1)(2008-7#1)
DNA repair pathways##2##3##(2008-11#2)
DNA repair protein##3##3##(1993-12#1)(1994-8#1)(1995-5#1)
DNA repair##51##2##(1990-5#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#3)(1993-9#1)(1994-8#2)(1995-2#2)(1995-5#2)(1996-2#1)(2007-7#1)(2008-11#14)(2008-5#1)(2008-7#7)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-6#2)(2010-8#2)(2011-2#2)(2013-1#1)
DNA repair/apoptosis and##2##3##(2008-7#2)
DNA repair/apoptosis##4##2##(2008-7#4)
DNA repeat##2##2##(1997-6#1)(2008-10#1)
DNA replication after##2##3##(1990-5#1)(2006-10#1)
DNA replication and growth of##2##5##(1997-3#2)
DNA replication and##9##3##(1993-3#1)(1994-8#1)(1997-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2012-2#1)
DNA replication at##3##3##(1990-11#1)(2008-2#1)(2009-8#1)
DNA replication in##4##3##(1994-5#1)(2010-2#1)(2012-2#2)
DNA replication is##2##3##(1997-3#1)(2009-2#1)
DNA replication##62##2##(1990-11#3)(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#5)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-9#1)(1997-3#7)(1997-6#4)(2006-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-2#5)(2009-3#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#3)(2012-3#1)
DNA response##2##2##(1993-3#1)(1996-2#1)
DNA restriction fragment length polymorphisms##3##5##(2008-10#3)
DNA restriction fragment length##4##4##(2008-10#4)
DNA restriction fragment##5##3##(1993-12#1)(2008-10#4)
DNA restriction fragments from agarose gels##2##6##(2008-2#2)
DNA restriction##9##2##(1993-12#1)(2008-10#4)(2008-11#1)(2008-2#3)
DNA results in##2##3##(1990-11#1)(2007-12#1)
DNA revealed a##2##3##(2008-10#2)
DNA revealed##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
DNA sample##9##2##(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
DNA samples from##2##3##(2008-10#1)(2008-9#1)
DNA samples##16##2##(1996-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
DNA screening##2##2##(1991-8#1)(2008-12#1)
DNA segment##6##2##(1990-11#1)(1990-5#1)(1995-8#1)(1996-8#1)(1997-3#1)(2008-11#1)
DNA segments##3##2##(1993-9#1)(2008-10#1)(2008-11#1)
DNA sensor##3##2##(2008-10#1)(2013-7#2)
DNA sensors##2##2##(2008-10#2)
DNA separation##4##2##(2008-10#2)(2011-1#2)
DNA sequence analyses and##2##4##(1996-6#1)(2013-1#1)
DNA sequence analyses##6##3##(1991-9#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
DNA sequence analysis of the LPL gene from the patient revealed a homozygous nucleotide change##2##15##(1993-3#1)(1994-11#1)
DNA sequence analysis of the internal transcribed spacer##2##8##(2008-10#2)
DNA sequence analysis of the##8##5##(1993-3#1)(1993-6#1)(1994-11#1)(2008-10#5)
DNA sequence analysis of##10##4##(1993-3#1)(1993-6#1)(1994-11#1)(1997-3#1)(2008-10#6)
DNA sequence analysis revealed that##3##5##(1991-12#1)(1992-6#1)(1997-4#1)
DNA sequence analysis revealed##4##4##(1991-12#1)(1992-6#1)(1995-8#1)(1997-4#1)
DNA sequence analysis##24##3##(1991-12#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1995-8#1)(1997-3#1)(1997-4#2)(2008-10#6)(2008-4#3)(2008-9#1)(2009-2#1)(2012-2#1)
DNA sequence and##3##3##(1990-7#1)(1996-8#1)(2008-2#1)
DNA sequence are##2##3##(1992-3#1)(2011-2#1)
DNA sequence comparisons##2##3##(2008-10#2)
DNA sequence data from##2##4##(2008-10#1)(2009-2#1)
DNA sequence data##6##3##(2008-10#2)(2008-4#1)(2008-7#2)(2009-2#1)
DNA sequence in##2##3##(1991-11#1)(2008-8#1)
DNA sequence of the Escherichia coli K-12 genome corresponding to the##6##11##(1996-12#4)(1996-6#2)
DNA sequence of the##12##4##(1993-8#1)(1994-2#1)(1996-12#4)(1996-6#2)(1997-1#1)(2008-10#2)(2008-8#1)
DNA sequence of##19##3##(1993-8#1)(1994-2#1)(1995-6#3)(1996-12#4)(1996-6#2)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-8#2)
DNA sequence was##3##3##(1993-12#1)(2008-10#1)(2008-8#1)
DNA sequence which##3##3##(1997-2#1)(2008-8#2)
DNA sequence with##2##3##(2008-10#1)(2008-9#1)
DNA sequence##118##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-6#3)(1995-8#1)(1996-12#4)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#27)(2008-12#1)(2008-2#2)(2008-4#6)(2008-5#1)(2008-7#6)(2008-8#16)(2008-9#2)(2009-2#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
DNA sequences analysis##2##3##(1996-6#1)(2008-8#1)
DNA sequences and##2##3##(1996-3#1)(2013-8#1)
DNA sequences are##2##3##(1992-2#1)(1995-11#1)
DNA sequences from the##3##4##(2008-10#3)
DNA sequences from##8##3##(2008-10#5)(2008-4#1)(2008-9#1)(2011-2#1)
DNA sequences in Kaposi's sarcoma##2##5##(1992-2#2)
DNA sequences in situ##3##4##(2008-4#1)(2008-9#2)
DNA sequences in the##6##4##(1991-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
DNA sequences in##12##3##(1991-2#1)(1992-2#2)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2012-3#1)
DNA sequences into##2##3##(2008-4#1)(2013-8#1)
DNA sequences of the##4##4##(2008-10#2)(2008-12#1)(2008-8#1)
DNA sequences of##15##3##(1991-2#1)(1991-5#1)(1993-8#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)
DNA sequences present##2##3##(1997-4#1)(1997-6#1)
DNA sequences that##4##3##(1995-8#1)(2008-10#1)(2008-2#1)(2009-12#1)
DNA sequences to##2##3##(2008-5#1)(2010-7#1)
DNA sequences were##3##3##(1992-2#1)(2008-10#1)(2008-12#1)
DNA sequences within##2##3##(1990-5#1)(2008-4#1)
DNA sequences##113##2##(1990-3#1)(1990-5#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-2#4)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#16)(2008-5#2)(2008-8#5)(2008-9#8)(2009-12#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#5)
DNA sequencing and##4##3##(1994-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
DNA sequencing is##2##3##(1995-8#1)(2008-7#1)
DNA sequencing method##2##3##(1995-6#1)(2008-7#1)
DNA sequencing of##6##3##(2008-10#3)(2008-2#1)(2008-8#1)(2009-2#1)
DNA sequencing or##2##3##(2008-11#1)(2008-4#1)
DNA sequencing revealed##3##3##(1992-3#1)(1997-3#1)(2008-7#1)
DNA sequencing##50##2##(1990-11#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#2)(1995-8#2)(1997-3#1)(1997-7#1)(2006-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-2#1)(2009-7#1)(2010-6#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
DNA showed##2##2##(1990-11#1)(1991-6#1)
DNA single-strand breaks##12##3##(1993-3#2)(1993-8#1)(1994-8#4)(1996-2#1)(1997-4#3)(2008-3#1)
DNA size standards##2##3##(1991-9#1)(2008-4#1)
DNA sizing##2##2##(2008-2#2)
DNA so that##2##3##(1991-8#1)(2008-11#1)
DNA solution##2##2##(2008-2#1)(2008-9#1)
DNA solutions##2##2##(2008-10#1)(2008-2#1)
DNA strand breaks and##3##4##(1994-11#1)(1996-2#1)(2011-2#1)
DNA strand breaks in##2##4##(1993-9#1)(2008-4#1)
DNA strand breaks##14##3##(1991-12#2)(1993-9#1)(1994-11#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-2#1)
DNA strand##25##2##(1990-5#1)(1991-12#2)(1993-11#1)(1993-9#1)(1994-11#1)(1995-6#2)(1996-2#1)(1997-4#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#4)(2009-10#1)(2011-2#2)
DNA strands are##2##3##(1993-11#1)(2010-7#1)
DNA strands##10##2##(1993-11#1)(1993-8#1)(2008-4#2)(2009-6#1)(2010-5#1)(2010-7#1)(2012-2#3)
DNA structure##8##2##(1992-11#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-4#3)(2008-7#1)
DNA structures##5##2##(1995-8#1)(2007-11#1)(2008-4#2)(2008-7#1)
DNA studies##2##2##(2008-12#1)(2008-9#1)
DNA substrate##3##2##(1991-9#1)(1997-3#1)(2008-11#1)
DNA substrates##6##2##(1992-3#1)(1995-2#3)(1995-5#1)(1997-3#1)
DNA suggests that##2##3##(1991-2#1)(1992-8#1)
DNA suggests##3##2##(1991-2#1)(1991-9#1)(1992-8#1)
DNA supercoiling factor##2##3##(1995-6#2)
DNA supercoiling##6##2##(1994-5#1)(1995-6#2)(1995-8#1)(2008-8#1)(2008-9#1)
DNA synthesis and cell proliferation in##3##6##(1995-11#2)(2008-4#1)
DNA synthesis and cell proliferation##5##5##(1990-12#1)(1990-2#1)(1995-11#2)(2008-4#1)
DNA synthesis and cell##9##4##(1990-12#1)(1990-2#1)(1991-2#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-11#2)(2008-4#1)
DNA synthesis and mitosis in##2##5##(1993-6#1)(1995-11#1)
DNA synthesis and mitosis##3##4##(1993-6#1)(1995-11#1)(2008-7#1)
DNA synthesis and##26##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-11#3)(1995-6#1)(1997-1#1)(1997-4#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
DNA synthesis at##4##3##(1990-11#1)(1990-5#1)(1994-11#1)(1995-2#1)
DNA synthesis by##10##3##(1990-11#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-6#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-7#1)
DNA synthesis in AH66 cells##2##5##(1992-3#2)
DNA synthesis in AH66##3##4##(1992-3#3)
DNA synthesis in the##2##4##(1992-9#1)(1995-11#1)
DNA synthesis in vascular smooth muscle cells##2##7##(1994-9#1)(1995-11#1)
DNA synthesis in##27##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-3#5)(1992-9#2)(1993-3#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-7#2)
DNA synthesis of##4##3##(1995-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
DNA synthesis that was##2##4##(1992-3#1)(1997-7#1)
DNA synthesis was##7##3##(1990-7#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#2)(1995-12#1)
DNA synthesis with##2##3##(1991-5#1)(1993-9#1)
DNA synthesis without base protection##4##5##(2008-4#4)
DNA synthesis##144##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-5#3)(1990-7#3)(1991-12#1)(1991-2#2)(1991-5#1)(1992-10#2)(1992-11#1)(1992-3#11)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-3#3)(1993-6#8)(1993-8#4)(1993-9#5)(1994-11#3)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-11#13)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#4)(1997-7#8)(2008-11#3)(2008-3#3)(2008-4#8)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#2)(2012-2#1)
DNA synthesis)##3##2##(1990-12#1)(1997-4#1)(2012-4#1)
DNA target in##2##3##(2008-10#2)
DNA target##8##2##(1994-3#1)(2008-1#1)(2008-10#5)(2008-4#1)
DNA targets from##2##3##(1995-6#1)(2008-10#1)
DNA targets##6##2##(1995-6#1)(2008-10#3)(2008-2#1)(2008-9#1)
DNA technique##2##2##(2007-10#1)(2008-8#1)
DNA technology##4##2##(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
DNA template##15##2##(1990-11#1)(1992-3#1)(1994-8#2)(1995-2#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-7#3)(2009-6#1)
DNA templates##4##2##(1990-11#3)(1994-8#1)
DNA tests##2##2##(1991-8#1)(2012-2#1)
DNA that##10##2##(1990-5#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
DNA through the##2##3##(1995-3#1)(1996-6#1)
DNA through##4##2##(1995-3#1)(1996-6#1)(2008-2#1)(2008-4#1)
DNA to be##2##3##(1991-8#1)(1997-2#1)
DNA to##17##2##(1990-12#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-10#2)(1994-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#3)(2010-1#1)(2011-2#2)
DNA topoisomerase 1##2##3##(2009-8#2)
DNA topoisomerase I##3##3##(1995-5#2)(2008-11#1)
DNA topoisomerase II##6##3##(1993-8#1)(1995-6#3)(2008-11#2)
DNA topoisomerase##12##2##(1993-8#1)(1995-5#2)(1995-6#3)(2008-11#3)(2008-9#1)(2009-8#2)
DNA transfection and protein introduction techniques##2##6##(2008-11#2)
DNA transfection##6##2##(1991-5#1)(2008-1#1)(2008-11#3)(2008-8#1)
DNA transfer##4##2##(1991-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
DNA transformation##2##2##(1994-12#1)(1995-8#1)
DNA typing in##2##3##(1997-8#1)(2008-12#1)
DNA typing of##2##3##(1997-8#1)(2008-12#1)
DNA typing system##2##3##(1995-11#1)(2008-12#1)
DNA typing##13##2##(1993-9#2)(1995-11#1)(1995-3#2)(1997-8#5)(2008-12#3)
DNA under##2##2##(2008-8#1)(2008-9#1)
DNA unwinding##5##2##(1990-11#1)(1995-3#3)(1997-4#1)
DNA upstream##2##2##(1991-6#1)(2008-11#1)
DNA uptake##2##2##(2008-11#1)(2010-2#1)
DNA using the##3##3##(1996-6#1)(2008-10#1)(2013-7#1)
DNA using##12##2##(1990-5#1)(1996-6#1)(2008-10#7)(2008-2#1)(2012-3#1)(2013-7#1)
DNA vaccination##4##2##(2008-3#2)(2008-4#1)(2010-8#1)
DNA vaccine in##2##3##(2008-3#1)(2013-1#1)
DNA vaccine##7##2##(2008-3#2)(2008-4#1)(2010-8#1)(2013-1#3)
DNA vaccines##6##2##(2008-4#1)(2008-5#3)(2009-5#1)(2013-1#1)
DNA variation##2##2##(2008-7#1)(2013-8#1)
DNA vector##2##2##(1997-8#1)(2008-5#1)
DNA via##2##2##(1995-3#1)(1995-8#1)
DNA virus##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
DNA viruses that cause##2##4##(2008-10#1)(2013-8#1)
DNA viruses##7##2##(1994-11#1)(1995-2#1)(2008-10#1)(2008-9#1)(2011-3#1)(2013-1#1)(2013-8#1)
DNA was also##3##3##(1994-3#1)(1997-8#1)(2008-10#1)
DNA was amplified from##2##4##(2008-10#2)
DNA was amplified##3##3##(2008-10#2)(2008-12#1)
DNA was constructed##2##3##(2008-10#1)(2008-8#1)
DNA was detected by polymerase chain reaction##2##7##(2008-10#1)(2008-4#1)
DNA was detected by##3##4##(2008-10#2)(2008-4#1)
DNA was detected in##7##4##(1990-2#1)(1990-8#1)(1991-9#1)(2008-10#2)(2013-1#2)
DNA was detected##12##3##(1990-2#1)(1990-8#1)(1991-9#1)(2008-10#4)(2008-4#2)(2010-5#1)(2013-1#2)
DNA was determined##2##3##(1997-4#1)(2008-10#1)
DNA was extracted from the##5##5##(1994-2#1)(2008-10#2)(2009-4#1)(2013-1#1)
DNA was extracted from##15##4##(1991-4#1)(1994-2#1)(2006-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2013-1#1)
DNA was extracted##21##3##(1991-4#1)(1994-2#1)(1996-9#1)(2006-8#1)(2008-10#8)(2008-12#4)(2008-2#1)(2008-9#1)(2009-4#1)(2013-1#2)
DNA was incubated with##2##4##(1996-2#1)(2008-4#1)
DNA was investigated##2##3##(1994-6#1)(2008-10#1)
DNA was measured##2##3##(1991-5#1)(1996-12#1)
DNA was not##2##3##(1993-9#1)(1994-6#1)
DNA was purified and##2##4##(2008-10#1)(2008-12#1)
DNA was spiked##2##3##(2008-10#2)
DNA was used as a template##2##6##(1993-12#1)(2008-11#1)
DNA was used as a##4##5##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
DNA was##105##2##(1990-2#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-8#4)(1993-9#3)(1994-1#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#2)(1995-12#1)(1995-2#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-10#33)(2008-11#4)(2008-12#7)(2008-2#1)(2008-4#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#4)
DNA were detected##2##3##(2008-10#2)
DNA were introduced into##2##4##(2008-11#1)(2008-8#1)
DNA were##23##2##(1990-8#1)(1991-5#1)(1994-11#1)(1994-12#1)(1995-2#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
DNA when##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
DNA which##2##2##(1990-7#1)(2008-10#1)
DNA while##2##2##(1992-2#1)(2012-2#1)
DNA whose##2##2##(2008-11#2)
DNA will##2##2##(2008-11#1)(2008-9#1)
DNA with high affinity##3##4##(1990-11#1)(1996-3#1)(2008-10#1)
DNA with high##4##3##(1990-11#1)(1996-3#1)(2008-10#1)(2008-9#1)
DNA with the##4##3##(1990-5#1)(1990-8#1)(1995-3#1)(2008-5#1)
DNA with##23##2##(1990-11#1)(1990-5#2)(1990-8#1)(1992-11#1)(1992-6#2)(1993-2#1)(1993-8#2)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)
DNA within##3##2##(1994-2#1)(1994-9#1)(2008-10#1)
DNA without##2##2##(1995-3#1)(2013-1#1)
DNA##4415##1##(1990-11#39)(1990-12#23)(1990-2#11)(1990-3#1)(1990-5#44)(1990-6#2)(1990-7#23)(1990-8#8)(1991-10#1)(1991-11#6)(1991-12#23)(1991-2#25)(1991-3#6)(1991-4#4)(1991-5#39)(1991-6#17)(1991-7#4)(1991-8#14)(1991-9#30)(1992-10#3)(1992-11#25)(1992-12#7)(1992-2#9)(1992-3#64)(1992-4#2)(1992-5#1)(1992-6#26)(1992-7#1)(1992-8#17)(1992-9#20)(1993-1#1)(1993-11#29)(1993-12#28)(1993-2#18)(1993-3#36)(1993-6#36)(1993-8#58)(1993-9#33)(1994-1#4)(1994-10#9)(1994-11#45)(1994-12#65)(1994-2#14)(1994-3#25)(1994-5#22)(1994-6#15)(1994-7#1)(1994-8#52)(1994-9#12)(1995-11#32)(1995-12#21)(1995-2#78)(1995-3#22)(1995-4#7)(1995-5#46)(1995-6#49)(1995-8#48)(1995-9#5)(1996-10#9)(1996-12#27)(1996-2#32)(1996-3#12)(1996-4#2)(1996-5#5)(1996-6#14)(1996-8#4)(1996-9#8)(1997-1#6)(1997-2#23)(1997-3#38)(1997-4#103)(1997-6#51)(1997-7#39)(1997-8#23)(1997-9#1)(2006-10#2)(2006-8#2)(2007-10#5)(2007-11#17)(2007-12#7)(2007-2#1)(2007-6#2)(2007-7#3)(2008-1#25)(2008-10#945)(2008-11#163)(2008-12#112)(2008-2#92)(2008-3#20)(2008-4#234)(2008-5#76)(2008-6#16)(2008-7#137)(2008-8#150)(2008-9#182)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#5)(2009-2#14)(2009-3#4)(2009-4#6)(2009-5#19)(2009-6#11)(2009-7#9)(2009-8#19)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#24)(2010-3#3)(2010-4#8)(2010-5#28)(2010-6#8)(2010-7#10)(2010-8#17)(2011-1#24)(2011-10#1)(2011-2#54)(2011-3#2)(2011-9#1)(2012-1#1)(2012-12#18)(2012-2#51)(2012-3#46)(2012-4#1)(2013-1#83)(2013-7#7)(2013-8#20)
DNA) and##3##2##(2008-10#3)
DNA) are##2##2##(1990-11#1)(2008-8#1)
DNA)##13##1##(1990-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)
DNA-2NiTMpyP##2##1##(2008-10#2)
DNA-A and -B##3##3##(2008-10#3)
DNA-A and DNA-B components##4##4##(2008-10#4)
DNA-A and DNA-B of##4##4##(2008-10#4)
DNA-A and DNA-B##11##3##(2008-10#11)
DNA-A and##16##2##(2008-10#16)
DNA-A nt##2##2##(2008-10#2)
DNA-A of##2##2##(2008-10#2)
DNA-A##30##1##(2008-10#30)
DNA-B component##2##2##(2008-10#2)
DNA-B components##5##2##(2008-10#5)
DNA-B of ToLCGV-[Var]##2##3##(2008-10#2)
DNA-B of##7##2##(2008-10#7)
DNA-B##27##1##(2008-10#27)
DNA-Based##2##1##(2008-10#2)
DNA-DNA hybridization##4##2##(2008-10#4)
DNA-DNA interactions##5##2##(1995-12#3)(2009-6#2)
DNA-DNA##13##1##(1995-12#3)(2008-10#7)(2008-4#1)(2009-6#2)
DNA-Os##2##1##(2008-10#2)
DNA-PK in##2##2##(1994-8#1)(1996-2#1)
DNA-PK##8##1##(1994-8#3)(1996-2#5)
DNA-PKcs##5##1##(1996-2#2)(2013-1#3)
DNA-RNA##2##1##(2008-10#1)(2008-4#1)
DNA-associated##2##1##(2008-2#1)(2013-1#1)
DNA-based stable isotope##2##3##(2012-3#2)
DNA-based##16##1##(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#2)
DNA-binding ability##2##2##(1990-11#1)(1995-8#1)
DNA-binding activity in##2##3##(1992-3#1)(2008-9#1)
DNA-binding activity##10##2##(1990-11#2)(1991-7#1)(1992-3#2)(1992-6#1)(1994-8#1)(2008-9#2)(2012-2#1)
DNA-binding assay##2##2##(1993-11#1)(2008-8#1)
DNA-binding domain from##2##3##(1994-12#1)(2009-7#1)
DNA-binding domain of##4##3##(1991-12#1)(1992-3#1)(1995-8#1)(1996-3#1)
DNA-binding domain##15##2##(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-12#3)(1995-8#1)(1996-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)
DNA-binding domains##3##2##(1994-12#2)(2008-8#1)
DNA-binding properties of the yeast##2##5##(1996-2#1)(1996-3#1)
DNA-binding properties##4##2##(1990-5#1)(1996-2#2)(1996-3#1)
DNA-binding property##2##2##(1992-8#2)
DNA-binding protein##11##2##(1990-11#1)(1992-8#1)(1993-11#1)(1993-2#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)
DNA-binding proteins and##3##3##(1990-5#1)(1991-5#1)(2008-8#1)
DNA-binding proteins that##2##3##(1991-9#1)(1995-8#1)
DNA-binding proteins##14##2##(1990-5#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-8#1)(1997-4#1)(2008-2#3)(2008-8#2)
DNA-binding site##2##2##(1995-2#1)(2008-8#1)
DNA-binding##89##1##(1990-11#4)(1990-12#1)(1990-5#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#3)(1993-11#5)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#7)(1994-8#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#5)(1996-2#4)(1996-3#3)(1997-4#1)(1997-7#2)(2008-10#1)(2008-2#5)(2008-4#2)(2008-7#1)(2008-8#8)(2008-9#6)(2009-7#1)(2010-10#2)(2012-2#1)
DNA-bound##2##1##(1992-6#1)(1994-12#1)
DNA-damaging agent##2##2##(1996-3#1)(2013-1#1)
DNA-damaging agents in##4##3##(1992-12#1)(1997-4#1)(2008-10#2)
DNA-damaging agents##9##2##(1992-12#3)(1995-8#2)(1997-4#2)(2008-10#2)
DNA-damaging##12##1##(1992-12#3)(1995-8#2)(1996-3#1)(1997-4#3)(2008-10#2)(2013-1#1)
DNA-dependent RNA##2##2##(1995-2#1)(1997-4#1)
DNA-dependent protein kinase##4##3##(1994-8#1)(1996-2#2)(2013-1#1)
DNA-dependent##10##1##(1991-9#2)(1993-12#1)(1994-8#2)(1995-2#1)(1996-2#2)(1997-4#1)(2013-1#1)
DNA-directed RNA polymerase from##2##4##(1990-7#2)
DNA-directed##4##1##(1990-7#2)(1992-11#1)(2008-10#1)
DNA-hydrolyzing deoxyribozymes##2##2##(2012-12#2)
DNA-hydrolyzing##3##1##(1995-3#1)(2012-12#2)
DNA-lipids##3##1##(2008-10#3)
DNA-mediated transformation##2##2##(1997-2#1)(2008-10#1)
DNA-mediated##3##1##(1991-5#1)(1997-2#1)(2008-10#1)
DNA-microarray reading##2##2##(2007-12#2)
DNA-modified##5##1##(2008-10#5)
DNA-nicking domains##3##2##(2008-10#3)
DNA-nicking##4##1##(1990-7#1)(2008-10#3)
DNA-pairing##3##1##(1995-2#3)
DNA-protein crosslinks##2##2##(1993-3#1)(2008-10#1)
DNA-protein##10##1##(1990-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
DNA-synthesizing cells##2##2##(2008-6#1)(2008-9#1)
DNA-transposing##2##1##(1995-8#2)
DNA-unwinding time##5##2##(1997-4#5)
DNA-unwinding##6##1##(1997-4#6)
DNA/RNA FISH##2##2##(2008-9#2)
DNA/RNA##5##1##(2008-4#1)(2008-9#4)
DNA/protein complex##3##2##(1994-5#1)(1994-9#2)
DNA/protein complexes##2##2##(1994-9#2)
DNA/protein##5##1##(1994-5#1)(1994-9#4)
DNAase##3##1##(1994-12#2)(1994-6#1)
DNAbeta molecules##3##2##(2008-10#3)
DNAbeta##23##1##(2008-10#23)
DNAbeta01##2##1##(2008-10#2)
DNAbeta02##2##1##(2008-10#2)
DNAs and##2##2##(1994-12#1)(1994-8#1)
DNAs by##3##2##(1995-2#1)(2008-12#1)(2008-2#1)
DNAs from##6##2##(1992-3#1)(1993-12#1)(1996-6#1)(1997-5#1)(2008-10#1)(2012-12#1)
DNAs in##4##2##(1992-8#1)(1993-11#1)(2008-10#2)
DNAs is##2##2##(2008-10#2)
DNAs of##3##2##(1994-9#1)(1997-2#1)(2008-10#1)
DNAs preparation##2##2##(1994-8#2)
DNAs that are##2##3##(2008-10#1)(2008-11#1)
DNAs were##4##2##(1994-12#1)(1994-8#1)(2008-10#1)(2008-12#1)
DNAs with##2##2##(1995-2#1)(2009-6#1)
DNAs##68##1##(1990-12#1)(1990-5#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#9)(1994-9#1)(1995-2#4)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-12#1)
DNAse##3##1##(1994-11#1)(1994-9#1)(2008-11#1)
DNAzyme##4##1##(2008-10#4)
DNB and NBM lesions##2##4##(1993-3#2)
DNB and NBM##3##3##(1993-3#3)
DNB and##4##2##(1993-3#4)
DNB##10##1##(1993-3#6)(2008-3#4)
DNC diets##3##2##(2010-2#3)
DNC##7##1##(2010-2#7)
DNCB##2##1##(2008-10#2)
DNL##3##1##(2008-3#3)
DNL4##2##1##(1997-7#2)
DNM##3##1##(2007-8#2)(2008-12#1)
DNP##9##1##(1990-12#1)(2007-9#3)(2012-2#5)
DNP-lysine##2##1##(1990-12#2)
DNP-uncoupled##2##1##(1994-8#2)
DNR orders##6##2##(1992-12#2)(1992-3#3)(1996-3#1)
DNR statute##2##2##(1992-12#2)
DNR##17##1##(1992-12#8)(1992-3#8)(1996-3#1)
DNS##6##1##(2008-6#3)(2013-8#3)
DNT and##2##2##(2008-10#2)
DNT##3##1##(2008-10#2)(2008-7#1)
DNTs##2##1##(2008-7#2)
DNX##3##1##(2008-10#3)
DNase I footprinting##4##3##(1995-5#1)(2008-8#1)(2008-9#2)
DNase I##10##2##(1992-4#2)(1993-11#1)(1995-2#1)(1995-5#3)(2008-8#1)(2008-9#2)
DNase##21##1##(1991-9#1)(1992-4#3)(1993-11#1)(1994-11#2)(1994-8#4)(1995-2#1)(1995-5#3)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#2)
DNaseI hypersensitive site##4##3##(1992-6#2)(2008-8#2)
DNaseI##6##1##(1990-5#1)(1992-6#2)(2008-8#3)
DO NOT##2##2##(2009-12#1)(2012-3#1)
DO and TO##2##3##(1994-3#2)
DO and##4##2##(1994-3#2)(2008-11#1)(2013-1#1)
DO in##2##2##(2008-10#2)
DO##24##1##(1994-3#3)(2008-10#12)(2008-11#2)(2008-12#1)(2009-12#2)(2010-4#1)(2012-3#1)(2013-1#2)
DOC upon PKC##2##3##(1992-9#2)
DOC##10##1##(1992-9#8)(2008-11#1)(2008-4#1)
DOCA-salt treatment##2##2##(2013-8#2)
DOCA-salt##6##1##(2009-11#1)(2013-8#5)
DOCA-salt-induced##2##1##(2013-8#2)
DOD##3##1##(1991-8#1)(1996-5#2)
DODA-Suc-NHS-lipids##2##1##(1994-12#2)
DOE that is designed to##2##5##(2008-3#2)
DOE was##2##2##(2008-3#2)
DOE##14##1##(1994-12#1)(2008-3#11)(2008-7#2)
DOE's are##2##2##(2007-12#1)(2008-2#1)
DOE's##9##1##(2007-12#2)(2008-2#2)(2008-3#5)
DOEHLOPT##3##1##(2008-10#3)
DOEs##2##1##(2008-3#2)
DOF##6##1##(2008-3#2)(2010-8#4)
DOG##5##1##(2008-8#5)
DOH##2##1##(2008-11#2)
DOHH##2##1##(1994-3#2)
DOI 10##3##2##(2011-2#3)
DOI##12##1##(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#5)
DOM##7##1##(2008-10#6)(2008-11#1)
DOM-bound herbicides##2##2##(2008-11#2)
DOM-bound moieties##2##2##(2008-11#2)
DOM-bound##7##1##(2008-11#7)
DOM-flocculation##4##1##(2008-11#4)
DOM-like effects##2##2##(1991-1#2)
DOM-like##5##1##(1991-1#5)
DOM-solutions##2##1##(2008-11#2)
DON accumulation##4##2##(2008-10#4)
DON and IND##3##3##(2008-10#3)
DON and##6##2##(2008-10#6)
DON concentration##2##2##(2008-10#2)
DON content##3##2##(2008-10#3)
DON contents##2##2##(2008-10#2)
DON in##3##2##(2008-10#3)
DON##39##1##(2008-10#39)
DON-fed mice##2##2##(2008-10#2)
DON-fed##3##1##(2008-10#3)
DOP##12##1##(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)
DOPA auto-oxidation activity##2##3##(2008-5#2)
DOPA auto-oxidation##3##2##(2008-5#3)
DOPA derivative##2##2##(2009-9#1)(2010-2#1)
DOPA##9##1##(1992-6#1)(2008-5#3)(2009-9#2)(2010-2#3)
DOPA-containing##2##1##(1992-6#1)(2009-9#1)
DOPAC and HVA##2##3##(1992-7#1)(1995-3#1)
DOPAC and##3##2##(1992-7#1)(1995-3#1)(2008-10#1)
DOPAC##7##1##(1992-7#1)(1994-2#2)(1995-3#1)(2008-10#2)(2008-7#1)
DOPC##2##1##(1990-2#1)(1997-2#1)
DOPE##2##1##(2008-8#2)
DOPT##3##1##(1997-2#3)
DOR364##2##1##(2013-8#2)
DORM-1 and##2##2##(2008-10#2)
DORM-1##3##1##(2008-10#3)
DORM-2 and##3##2##(2008-10#3)
DORM-2##5##1##(2008-10#5)
DOS##7##1##(2008-10#5)(2012-2#2)
DOT in NYC##2##3##(1996-3#2)
DOT##20##1##(1996-3#14)(2011-1#5)(2013-8#1)
DOTAP##2##1##(2009-12#2)
DOX##8##1##(2009-11#8)
DOX-ADH-GAMNP##3##1##(2009-11#3)
DOs##5##1##(2013-1#5)
DP IV##4##2##(1993-8#4)
DP method##4##2##(2008-2#4)
DP##18##1##(1993-8#4)(2008-10#2)(2008-2#4)(2008-7#1)(2009-10#1)(2010-1#3)(2010-4#2)(2013-1#1)
DPA##3##1##(2008-10#2)(2008-9#1)
DPASV##3##1##(2008-10#3)
DPB##2##1##(1995-12#1)(1995-8#1)
DPB-induced##2##1##(1995-12#2)
DPCSV##6##1##(2008-10#6)
DPD was##2##2##(2008-10#2)
DPD##7##1##(2008-10#7)
DPDB##2##1##(2008-9#2)
DPDPE##3##1##(1991-1#1)(1992-3#1)(1996-2#1)
DPE##5##1##(1997-2#1)(2013-1#4)
DPE's is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
DPE's##7##1##(2007-12#2)(2008-2#2)(2008-3#3)
DPH##8##1##(1990-2#2)(1991-5#1)(1994-3#1)(1995-8#1)(2008-10#1)(2008-9#2)
DPH2##9##1##(1993-9#9)
DPI was##2##2##(2007-12#1)(2008-10#1)
DPI##9##1##(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-5#1)
DPI's##4##1##(1992-3#4)
DPKSH adsorption onto silica gel was##2##6##(2008-10#2)
DPKSH##5##1##(2008-10#5)
DPLL##4##1##(2008-3#3)(2013-8#1)
DPM##13##1##(2008-5#5)(2008-7#8)
DPM1##3##1##(1996-6#3)
DPN##2##1##(2008-7#1)(2008-9#1)
DPOAEs##3##1##(2008-4#3)
DPP and##2##2##(2008-10#2)
DPP was##2##2##(2008-10#2)
DPP##10##1##(2008-10#10)
DPP-IV inhibitors have##2##3##(2012-2#1)(2012-3#1)
DPP-IV inhibitors##3##2##(2012-2#2)(2012-3#1)
DPP-IV##6##1##(2012-2#4)(2012-3#2)
DPPAH##2##1##(2008-10#2)
DPPC SUV##2##2##(1992-3#2)
DPPC and DPPC-Chol liposomes##2##4##(1991-5#2)
DPPC and##5##2##(1990-2#1)(1991-5#3)(1992-6#1)
DPPC liposomes##9##2##(1991-5#1)(2008-10#5)(2008-8#3)
DPPC##26##1##(1990-2#1)(1991-3#1)(1991-5#4)(1992-3#2)(1992-6#3)(2008-10#7)(2008-8#8)
DPPC-Chol##3##1##(1991-5#3)
DPPC/ELA-COOH##2##1##(1994-12#2)
DPPH (2##2##2##(2008-5#1)(2012-1#1)
DPPH assay##4##2##(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
DPPH free radical scavenging assay##2##5##(2008-10#1)(2013-1#1)
DPPH free radical scavenging##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
DPPH free##4##2##(2008-10#1)(2008-12#1)(2009-3#1)(2013-1#1)
DPPH radical##4##2##(2008-10#3)(2008-11#1)
DPPH##24##1##(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#3)(2009-3#1)(2009-6#1)(2012-1#2)(2012-2#2)(2013-1#2)
DPPS##3##1##(1991-3#1)(2008-8#2)
DPR1##4##1##(1995-2#4)
DPRIS RNA##2##2##(1997-3#2)
DPRIS##3##1##(1997-3#3)
DPSCs##3##1##(2012-12#3)
DPTH-gel##2##1##(2008-10#2)
DPV and SWV##2##3##(2008-10#2)
DPV and##3##2##(2008-10#3)
DPV##9##1##(2008-10#9)
DQ and RES##3##3##(1992-3#3)
DQ##5##1##(1992-3#4)(1997-9#1)
DQ-2556##2##1##(1990-8#2)
DQA1##2##1##(1996-6#1)(1997-8#1)
DQB1(*)0602##3##1##(1997-9#3)
DR and the##2##3##(2008-1#1)(2008-10#1)
DR and##7##2##(1997-3#3)(2008-1#2)(2008-10#1)(2008-7#1)
DR is##2##2##(2008-1#2)
DR##27##1##(1991-2#2)(1996-12#1)(1997-3#3)(1997-4#1)(1997-8#1)(2008-1#8)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#3)(2011-2#4)
DR-CALUX((R)) measured concentrations were##2##4##(2008-10#2)
DR-CALUX((R)) measured##3##2##(2008-10#3)
DR-CALUX((R))##5##1##(2008-10#5)
DR-CALUX((R))-REP##2##1##(2008-10#2)
DR-CALUX((R))-TEQ contents##2##2##(2008-10#2)
DR3##6##1##(1991-11#1)(1995-11#1)(1995-8#1)(2012-2#3)
DR3-positive##2##1##(2010-5#2)
DR4##4##1##(1995-8#1)(1997-4#1)(1997-8#1)(2008-1#1)
DR9##2##1##(1997-8#2)
DRA of the locust##2##4##(2007-12#2)
DRA##3##1##(2007-12#3)
DRAGON View##2##2##(2008-4#2)
DRAGON##5##1##(2008-4#5)
DRAQ5##3##1##(2008-9#3)
DRB##2##1##(2008-4#2)
DRB1 * 1502 and DPB1 * 0901##2##7##(1997-8#2)
DRD2 gene##2##2##(1997-5#1)(2012-1#1)
DRD2##4##1##(1997-5#2)(2012-1#2)
DRD3 and DRD4 genes##2##4##(1997-5#2)
DRD3 and##3##2##(1997-5#3)
DRD4 genes##3##2##(1997-5#3)
DRD4##4##1##(1997-5#3)(2012-1#1)
DRE##14##1##(1993-11#4)(1993-6#2)(1994-12#1)(1995-6#4)(2008-7#1)(2010-11#2)
DRE-containing##2##1##(1993-6#2)
DREB/CBF##2##1##(2011-2#2)
DREF##3##1##(1995-6#3)
DRG and##5##2##(1993-12#1)(1994-12#1)(1997-2#1)(2008-9#2)
DRG following peripheral##2##3##(1997-2#1)(2008-9#1)
DRG neurons in##2##3##(1996-12#2)
DRG neurons transfected with##2##4##(2013-1#2)
DRG neurons##19##2##(1991-12#1)(1993-12#1)(1996-12#11)(1996-5#3)(2008-8#1)(2013-1#2)
DRG weights##2##2##(1992-12#1)(1992-2#1)
DRG##57##1##(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#6)(1993-1#1)(1993-12#2)(1994-12#7)(1994-3#1)(1995-3#1)(1995-8#2)(1996-12#13)(1996-5#3)(1997-2#3)(2007-10#1)(2008-4#1)(2008-8#3)(2008-9#3)(2010-12#1)(2013-1#4)
DRGs on##3##2##(1991-2#1)(1992-12#1)(1992-3#1)
DRGs to##2##2##(1991-12#1)(1992-2#1)
DRGs##22##1##(1991-12#2)(1991-2#2)(1991-3#1)(1992-12#2)(1992-2#3)(1992-3#1)(1993-12#1)(1994-12#4)(1994-3#2)(1995-2#1)(1995-3#1)(1997-1#1)(2008-7#1)
DRIFTS##2##1##(2008-10#2)
DRINKING WATER STUDIES IN Tg##2##5##(2008-9#2)
DRINKING WATER STUDIES IN p53##2##5##(2008-9#2)
DRINKING WATER STUDIES IN##6##4##(2008-9#6)
DRINKING##7##1##(1991-1#1)(2008-9#6)
DRL##2##1##(2010-4#2)
DRL-GRE##2##1##(2010-4#2)
DRM proteins can be analyzed##2##5##(2008-4#2)
DRM##3##1##(1992-6#1)(2008-4#2)
DRP determination##2##2##(2008-10#2)
DRP##5##1##(2008-10#5)
DRP+DOP##2##1##(2008-10#2)
DRP3A##2##1##(2009-10#2)
DRP3B##2##1##(2009-10#2)
DRR206 promoter##5##2##(2008-10#5)
DRR206##7##1##(2008-10#7)
DRUGS##2##1##(1997-3#1)(2012-1#1)
DRUJ##6##1##(2008-9#6)
DS and MRV##2##3##(2012-3#2)
DS and in##2##3##(1991-1#2)
DS and##7##2##(1991-1#3)(2008-3#1)(2012-2#1)(2012-3#2)
DS at Time##2##3##(2010-4#2)
DS cases##4##2##(1991-1#4)
DS in##2##2##(2010-4#1)(2011-2#1)
DS is##2##2##(1993-12#1)(2008-7#1)
DS on##2##2##(2008-10#2)
DS salt and##2##3##(2008-5#2)
DS salt##14##2##(2008-5#14)
DS##73##1##(1990-11#1)(1991-1#8)(1991-11#2)(1993-12#2)(1996-2#4)(2008-10#8)(2008-3#3)(2008-5#14)(2008-7#3)(2010-10#1)(2010-4#3)(2011-2#11)(2012-12#6)(2012-2#5)(2012-3#2)
DS(-)##2##1##(2008-10#2)
DSA for the evaluation of##2##5##(2008-7#2)
DSA is##2##2##(2008-7#1)(2012-2#1)
DSA##12##1##(1993-8#4)(2008-7#4)(2012-2#4)
DSB induction by##2##3##(1995-2#2)
DSB induction##4##2##(1995-2#3)(1995-8#1)
DSB repair and V(D)J recombination##2##5##(2013-1#2)
DSB repair and##4##3##(2011-2#1)(2013-1#3)
DSB repair in##2##3##(1995-6#2)
DSB repair##10##2##(1995-6#2)(2011-1#2)(2011-2#2)(2013-1#4)
DSB##23##1##(1995-2#9)(1995-6#2)(1995-8#2)(2008-11#1)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#4)
DSBs and##3##2##(1995-8#2)(2010-2#1)
DSBs were##2##2##(1995-8#1)(2010-2#1)
DSBs##10##1##(1995-8#6)(2010-2#2)(2011-2#1)(2013-1#1)
DSC and##2##2##(1997-7#1)(2010-5#1)
DSC measurements##2##2##(1992-10#1)(2009-7#1)
DSC##18##1##(1990-7#2)(1990-8#1)(1992-10#1)(1993-8#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-5#1)(2011-3#1)(2012-2#2)
DSCM##3##1##(2008-3#3)
DSCT axons##2##2##(1996-5#2)
DSCT##3##1##(1996-5#3)
DSE##2##1##(2008-10#2)
DSE-treated##2##1##(2008-10#2)
DSF##2##1##(2007-11#1)(2013-1#1)
DSG is transported into##2##4##(1993-8#2)
DSG##6##1##(1993-8#6)
DSI##3##1##(2008-3#2)(2012-3#1)
DSIP##4##1##(1990-5#4)
DSIP-like glycopeptide##2##2##(1990-5#2)
DSIP-related##2##1##(1990-5#2)
DSKNPH and##2##2##(2008-10#2)
DSKNPH in DMSO##3##3##(2008-10#3)
DSKNPH in##4##2##(2008-10#4)
DSKNPH##10##1##(2008-10#10)
DSM 7330##2##2##(1995-3#2)
DSM involving the##2##3##(1996-9#2)
DSM##17##1##(1992-11#1)(1992-5#1)(1995-3#2)(1996-9#5)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-10#3)
DSM's##2##1##(2012-12#2)
DSM-5##2##1##(2011-2#1)(2013-8#1)
DSM-III criteria for##2##3##(1995-11#1)(2008-7#1)
DSM-III criteria##3##2##(1995-11#1)(2008-7#2)
DSM-III##6##1##(1991-1#2)(1995-11#2)(2008-7#2)
DSM-III-R criteria##3##2##(1994-2#1)(2008-7#2)
DSM-III-R##7##1##(1991-1#1)(1991-2#1)(1993-6#1)(1994-2#1)(1996-7#1)(2008-7#2)
DSM-IV and ICD-10##2##3##(2008-11#1)(2013-7#1)
DSM-IV and##3##2##(2008-11#1)(2008-6#1)(2013-7#1)
DSM-IV criteria for major depressive##2##5##(2010-2#1)(2012-3#1)
DSM-IV criteria for##4##3##(2007-7#1)(2008-6#1)(2010-2#1)(2012-3#1)
DSM-IV criteria##10##2##(2007-10#2)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#1)
DSM-IV##29##1##(1997-8#4)(2007-10#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-6#3)(2008-7#1)(2010-2#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
DSM-IV-TR##6##1##(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)
DSM-V##2##1##(2009-2#1)(2011-2#1)
DSP is##2##2##(2010-6#2)
DSP result##2##2##(2008-3#2)
DSP##15##1##(1997-4#1)(2008-1#4)(2008-10#1)(2008-3#4)(2010-6#5)
DSPI phase maps##2##3##(2008-2#2)
DSPI##5##1##(2008-2#3)(2008-3#1)(2008-8#1)
DSS##3##1##(2011-2#3)
DST##3##1##(1990-11#1)(2011-2#2)
DSTD is##3##2##(2008-10#3)
DSTD##7##1##(2008-10#7)
DSU##4##1##(2008-5#4)
DSi##4##1##(2012-2#4)
DT and##2##2##(2007-2#1)(2011-1#1)
DT cells were##2##3##(1995-11#2)
DT cells##6##2##(1995-11#6)
DT patients##2##2##(2011-1#2)
DT##24##1##(1993-3#1)(1994-8#1)(1995-11#6)(1996-12#1)(2007-2#1)(2008-10#1)(2008-3#5)(2008-6#1)(2011-1#4)(2013-1#3)
DT-diaphorase##6##1##(1995-8#5)(2008-11#1)
DTC participants##2##2##(2010-6#2)
DTC television##3##2##(2008-12#3)
DTC##8##1##(1996-1#1)(2008-12#3)(2010-6#3)(2013-1#1)
DTG##2##1##(1995-12#1)(2008-10#1)
DTH response##2##2##(2008-10#2)
DTH responses##2##2##(2008-10#2)
DTH##5##1##(2008-10#5)
DTI##4##1##(2008-11#4)
DTNB##2##1##(1990-12#1)(2009-9#1)
DTP and##2##2##(1995-5#2)
DTP##8##1##(1995-5#3)(2010-4#5)
DTPA##11##1##(1990-5#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#5)
DTPP##6##1##(2008-10#6)
DTT as##2##2##(1992-3#1)(2011-2#1)
DTT treatment of##2##3##(1994-12#1)(1994-6#1)
DTT was##2##2##(1992-3#1)(1994-6#1)
DTT##15##1##(1992-3#5)(1994-12#1)(1994-6#2)(1995-12#1)(2008-9#1)(2009-9#1)(2011-2#4)
DTZ##2##1##(2008-10#2)
DTs##2##1##(2012-2#2)
DU-145##2##1##(2011-2#2)
DU145##2##1##(2010-1#1)(2011-2#1)
DUB##2##1##(1994-9#1)(2008-10#1)
DUF1089 homologs##2##2##(2010-10#2)
DUF1089##3##1##(2010-10#3)
DUF2063 domain##3##2##(2010-10#3)
DUM heart-1##3##2##(1994-2#3)
DUM##4##1##(1994-2#4)
DV prevention##2##2##(2012-12#2)
DV##5##1##(1991-9#2)(2008-2#1)(2012-12#2)
DVA in the##2##3##(2012-3#2)
DVA in##3##2##(2012-3#3)
DVA##7##1##(2012-3#7)
DVD##5##1##(2007-12#1)(2008-3#4)
DVD-R disc##2##2##(2008-3#2)
DVS (director of volunteer##2##4##(1992-3#2)
DVT and##4##2##(2007-2#2)(2007-8#1)(2011-2#1)
DVT in##3##2##(1993-5#1)(2007-2#1)(2012-2#1)
DVT##20##1##(1992-9#1)(1993-5#1)(1997-8#1)(2007-11#1)(2007-2#4)(2007-8#2)(2011-2#3)(2012-2#7)
DW##8##1##(1996-5#1)(1997-4#1)(2008-10#2)(2008-12#3)(2009-8#1)
DWI abnormalities in##2##3##(2007-10#2)
DWI abnormalities were detected in##2##5##(2007-10#2)
DWI abnormalities were##4##3##(2007-10#4)
DWI abnormalities##7##2##(2007-10#7)
DWI and PWI##2##3##(2007-9#2)
DWI and##3##2##(2007-10#1)(2007-9#2)
DWI volume##3##2##(2007-10#3)
DWI##20##1##(2007-10#14)(2007-9#4)(2009-11#1)(2010-12#1)
DWI-negative##2##1##(2007-10#2)
DWI-positive patients##2##2##(2007-10#2)
DWI-positive##3##1##(2007-10#3)
DWNT##2##1##(2008-7#2)
DX##8##1##(1990-2#6)(2008-10#2)
DXA##3##1##(1997-8#1)(2008-4#1)(2010-3#1)
DXB11-CHO cells##2##2##(2008-11#2)
DXB11-CHO##3##1##(2008-11#3)
DXR biosynthesis##2##2##(1994-12#2)
DXR##5##1##(1994-12#5)
DXS10134 and DXS10147##2##3##(2008-12#2)
DXS10134##5##1##(2008-12#5)
DXS10146##4##1##(2008-12#4)
DXS10147##3##1##(2008-12#3)
DYKDDDDK##2##1##(1997-3#2)
DYNAMIC##2##1##(2011-2#1)(2012-2#1)
DYS19 duplicated Y chromosomes##2##4##(2008-12#2)
DYS19##6##1##(2008-12#6)
DYS385##2##1##(2008-12#2)
DYS393##2##1##(2008-12#2)
DZ##10##1##(1997-4#4)(2008-2#2)(2009-7#2)(2012-2#2)
DZ's##2##1##(2008-2#2)
DZA##2##1##(2011-2#2)
DZA-induced##2##1##(2011-2#2)
DZHQ was found to cross-link##2##5##(1993-11#2)
DZHQ was##3##2##(1993-11#3)
DZHQ##4##1##(1993-11#4)
DZSAM##4##1##(2008-10#4)
Da and a pI of##2##5##(1992-8#1)(1995-6#1)
Da and a##3##3##(1992-8#1)(1993-6#1)(1995-6#1)
Da and the##2##3##(1990-5#2)
Da and##5##2##(1990-5#2)(1992-8#1)(1993-6#1)(1995-6#1)
Da which##2##2##(1995-5#1)(1997-4#1)
Da##34##1##(1990-11#2)(1990-5#3)(1990-7#2)(1991-5#1)(1992-12#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1997-4#2)(1997-7#1)(1997-8#1)(2008-10#4)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)
Da) were studied##2##3##(2008-10#1)(2008-5#1)
Da) with##2##2##(1991-9#1)(1995-2#1)
Da)##14##1##(1990-11#2)(1990-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-10#1)(2008-10#4)(2008-5#1)
Dabigatran##5##1##(2012-12#2)(2013-1#3)
Dacron graft##2##2##(2008-7#1)(2012-2#1)
Dacron grafts##2##2##(2010-8#2)
Dacron##6##1##(2007-8#1)(2008-11#1)(2008-7#1)(2010-8#2)(2012-2#1)
Dactylella oviparasitica and Fusarium oxysporum in##2##6##(2008-10#2)
Dactylella oviparasitica and Fusarium oxysporum##3##5##(2008-10#3)
Dactylella oviparasitica##5##2##(2008-10#5)
Dactylellina candidum##2##2##(2008-10#2)
Dactylellina##3##1##(2008-10#3)
Dactylobiotus dispar##3##2##(2008-12#3)
Dagua##4##1##(2008-5#3)(2012-12#1)
Dahlia##3##1##(2008-10#1)(2008-12#2)
Dai and Aini##2##3##(2011-1#2)
Dai and##3##2##(1995-6#1)(2011-1#2)
Dai##7##1##(1995-6#2)(2008-9#1)(2011-1#4)
Daidzein##2##1##(1992-12#1)(2008-10#1)
Daidzin##2##1##(2010-12#2)
Daily Life##2##2##(2008-7#1)(2009-5#1)
Daily Point of Light##2##4##(1996-2#2)
Daily administration of##3##3##(1992-8#1)(1994-2#1)(1994-6#1)
Daily pain##2##2##(2008-7#2)
Daily##38##1##(1990-2#1)(1992-8#1)(1994-2#1)(1994-6#1)(1996-2#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#8)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
Dainippon##2##1##(2008-5#2)
Dakota##10##1##(2008-10#8)(2010-5#1)(2012-3#1)
Dallas##6##1##(1990-11#3)(1991-3#1)(1992-8#1)(2007-6#1)
Dalton##2##1##(1992-12#1)(1992-9#1)
Dalton's lymphoma (DL)##2##3##(2008-4#1)(2008-5#1)
Dalton's lymphoma##3##2##(1992-3#1)(2008-4#1)(2008-5#1)
Dalton's##5##1##(1992-3#2)(2008-10#1)(2008-4#1)(2008-5#1)
Dam##5##1##(1990-5#3)(1994-12#1)(2008-7#1)
Damage can##2##2##(2008-11#1)(2011-2#1)
Damage control##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
Damage in the##2##3##(2009-12#1)(2013-1#1)
Damage in##4##2##(2009-12#1)(2012-3#1)(2013-1#2)
Damage of##2##2##(2008-3#1)(2012-12#1)
Damage to the##3##3##(1994-11#1)(2008-9#2)
Damage to##4##2##(1994-11#1)(2008-9#2)(2011-2#1)
Damage##24##1##(1994-11#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-3#3)(2008-9#2)(2009-12#1)(2009-5#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Damaged##3##1##(2008-8#1)(2008-9#1)(2011-1#1)
Damages##2##1##(2009-12#1)(2011-2#1)
Damascus##2##1##(1996-1#1)(2008-1#1)
Dame##2##1##(2009-10#1)(2012-12#1)
Dammam Central Hospital##3##3##(2008-1#3)
Dammam##5##1##(2008-1#5)
Dammann gratings##2##2##(2008-2#1)(2008-3#1)
Dammann##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Damping-Off##6##1##(2008-10#6)
Dan##4##1##(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
Danaea##2##1##(2008-5#2)
Dandruff is a common##2##4##(2008-5#2)
Dandruff is##3##2##(2008-5#3)
Dandruff##7##1##(2008-5#7)
Dandy Walker malformation##2##3##(2010-11#2)
Dandy-Walker malformation##2##2##(2011-1#2)
Dang##2##1##(2012-3#2)
Danger##2##1##(1991-1#1)(2010-7#1)
Dangerous##3##1##(1990-6#1)(1991-12#1)(1996-2#1)
Danida##4##1##(1990-12#4)
Daniel##3##1##(1997-2#1)(2008-4#1)(2013-1#1)
Danio##2##1##(2008-11#1)(2012-3#1)
Danish counties##3##2##(1997-3#2)(2010-10#1)
Danish hospitals##2##2##(1995-3#2)
Danish physicians##2##2##(1997-3#2)
Danish population##2##2##(2008-7#1)(2010-10#1)
Danish studies##2##2##(1996-9#1)(1997-5#1)
Danish##32##1##(1990-12#5)(1990-6#1)(1991-9#1)(1992-11#1)(1992-5#2)(1993-10#2)(1995-3#2)(1996-9#1)(1997-3#5)(1997-5#2)(2007-8#1)(2008-7#1)(2010-10#2)(2010-2#1)(2011-2#3)(2012-2#2)
Dans le##2##2##(2013-1#2)
Dans##4##1##(2011-2#1)(2013-1#3)
Danshen##2##1##(2008-10#2)
Danthonia##2##1##(2008-9#2)
Danube##4##1##(2008-10#3)(2010-8#1)
Daphnia magna##2##2##(2008-10#1)(2008-9#1)
Daphnia##5##1##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)
Darbepoetin##2##1##(2008-7#2)
Darfield##2##1##(2012-2#2)
Darjeeling##2##1##(2012-2#2)
Dark self-enhancement in##2##3##(2008-3#2)
Dark##9##1##(1992-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2013-7#1)
Darmor##2##1##(2008-10#2)
Dartmouth##2##1##(1993-12#1)(2008-11#1)
Darwin##14##1##(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#2)(2010-5#5)(2012-12#1)(2012-2#2)
Darwin's finches##3##2##(2008-8#3)
Darwin's##10##1##(1990-9#1)(2008-8#4)(2010-4#1)(2010-5#3)(2013-1#1)
Darwinian concept##2##2##(1995-2#2)
Darwinian##8##1##(1990-11#1)(1995-2#2)(1995-6#1)(2008-10#1)(2010-3#1)(2010-5#1)(2012-2#1)
Dasatinib##2##1##(2013-1#2)
Dastarcus helophoroides##2##2##(2013-8#2)
Dasypus novemcinctus##2##2##(2008-5#2)
Dasypus##3##1##(2008-5#3)
Data Analysis to##2##3##(2009-10#1)(2010-8#1)
Data Analysis##4##2##(2008-12#1)(2009-10#1)(2010-12#1)(2010-8#1)
Data Bank##16##2##(1991-3#1)(1992-1#2)(1992-3#2)(1994-1#1)(1994-2#2)(1995-11#1)(1996-12#1)(2008-4#3)(2011-3#2)(2013-1#1)
Data Envelopment Analysis##3##3##(2008-11#1)(2010-8#1)(2013-8#1)
Data Information##3##2##(1996-3#1)(1997-3#1)(2008-10#1)
Data Protection Act##3##3##(1996-8#2)(1997-5#1)
Data Set and##2##3##(1993-2#2)
Data Set##9##2##(1993-2#4)(1995-2#1)(1996-2#1)(2008-11#2)(2008-7#1)
Data about the##2##3##(2011-2#1)(2013-1#1)
Data also##4##2##(2008-10#2)(2010-10#1)(2010-8#1)
Data analyses##3##2##(1991-12#1)(1993-1#1)(2008-10#1)
Data analysis revealed##2##3##(2007-2#1)(2008-12#1)
Data analysis##9##2##(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-5#1)(2013-1#1)
Data and##4##2##(1995-2#1)(1997-2#1)(2008-11#1)(2008-9#1)
Data are available##2##3##(2008-5#1)(2011-2#1)
Data are from##4##3##(2010-9#1)(2013-1#2)(2013-8#1)
Data are presented that##3##4##(1993-12#1)(2008-2#1)(2008-7#1)
Data are presented to show##2##5##(1992-1#1)(2008-3#1)
Data are presented which##2##4##(1991-5#1)(2009-3#1)
Data are presented##12##3##(1991-5#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1997-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)
Data are##30##2##(1991-5#1)(1992-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1996-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-8#1)
Data collected##4##2##(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
Data collection for##2##3##(2008-11#2)
Data collection strategies##2##3##(1995-2#1)(2007-10#1)
Data collection was##6##3##(1993-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-7#1)
Data collection##15##2##(1993-12#1)(1995-2#1)(1996-3#1)(2007-10#2)(2007-6#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-5#1)(2009-6#1)(2013-7#1)
Data concerning the##2##3##(1994-7#1)(2012-3#1)
Data for the##2##3##(2010-6#1)(2011-2#1)
Data for##9##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
Data from Western##2##3##(1994-8#1)(2009-3#1)
Data from a large##2##4##(1995-9#1)(2009-7#1)
Data from a##12##3##(1992-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-9#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)
Data from other##2##3##(1990-8#1)(2010-4#1)
Data from several##2##3##(1992-11#1)(2008-10#1)
Data from the##23##3##(1990-10#1)(1990-8#1)(1991-2#1)(1993-1#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#3)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)
Data from this study##3##4##(2008-10#2)(2010-4#1)
Data from three##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
Data from two##3##3##(1991-6#1)(1993-1#1)(2011-1#1)
Data from##87##2##(1990-10#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#2)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-2#1)(2010-4#2)(2011-1#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Data gathered through##2##3##(1992-9#1)(2008-11#1)
Data gathered##4##2##(1992-9#1)(1997-5#1)(2008-11#1)(2012-2#1)
Data generated by##2##3##(2008-10#1)(2008-3#1)
Data have##2##2##(1992-3#1)(1993-9#1)
Data in##2##2##(2008-4#1)(2010-12#1)
Data mining##2##2##(2008-9#1)(2012-2#1)
Data obtained by##3##3##(2007-12#1)(2008-10#2)
Data obtained from##4##3##(1994-2#1)(1995-5#1)(2008-11#1)(2012-12#1)
Data obtained##11##2##(1993-6#1)(1994-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
Data of the##2##3##(2008-3#1)(2010-8#1)
Data of##8##2##(1990-3#1)(1991-2#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
Data on the##9##3##(1990-8#1)(1991-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
Data on##35##2##(1990-8#2)(1991-4#1)(1991-5#1)(1993-12#2)(1995-11#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-8#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
Data pages##2##2##(2007-11#1)(2008-3#1)
Data presented here##2##3##(1994-2#1)(1996-2#1)
Data protection##2##2##(1996-8#2)
Data recorded##2##2##(2008-10#1)(2008-5#1)
Data reduction##2##2##(2008-10#2)
Data related to##2##3##(1995-3#1)(2013-8#1)
Data show##2##2##(1991-1#1)(1996-3#1)
Data showed that the##2##4##(2008-9#1)(2011-1#1)
Data showed that##4##3##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
Data sources##4##2##(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
Data suggest that##9##3##(1990-12#1)(1992-3#1)(1993-1#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-9#1)
Data suggest##10##2##(1990-12#1)(1992-3#1)(1993-1#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-9#1)
Data to##3##2##(2008-10#1)(2011-9#1)(2013-1#1)
Data was collected##5##3##(1993-6#1)(1995-3#1)(2010-3#2)(2012-12#1)
Data was##9##2##(1993-6#1)(1995-3#1)(2006-10#1)(2008-11#1)(2010-3#2)(2012-12#1)(2013-7#1)(2013-8#1)
Data were analysed by##2##4##(2007-8#1)(2008-11#1)
Data were analysed using a##2##5##(2008-11#1)(2013-8#1)
Data were analysed using##6##4##(2008-11#1)(2010-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
Data were analysed##11##3##(1994-3#1)(2007-8#1)(2008-11#2)(2008-12#1)(2009-6#1)(2010-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
Data were analyzed by repeated measures ANOVA##2##7##(2008-5#2)
Data were analyzed by##5##4##(2008-12#1)(2008-5#3)(2010-9#1)
Data were analyzed statistically by##2##5##(2008-12#1)(2013-1#1)
Data were analyzed statistically##3##4##(2008-12#1)(2013-1#2)
Data were analyzed using a##2##5##(2008-10#1)(2013-1#1)
Data were analyzed using##6##4##(1993-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
Data were analyzed##20##3##(1993-9#1)(1994-1#1)(1995-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#4)(2009-7#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#5)
Data were collected as part of the##2##7##(1996-3#1)(2008-11#1)
Data were collected at##4##4##(1995-2#1)(2008-12#1)(2008-9#1)(2013-1#1)
Data were collected between##2##4##(2010-10#1)(2011-2#1)
Data were collected by means of##2##6##(1992-5#1)(2010-3#1)
Data were collected by##6##4##(1992-5#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#2)
Data were collected for a##2##5##(2008-2#1)(2011-2#1)
Data were collected for##3##4##(2008-11#1)(2008-2#1)(2011-2#1)
Data were collected from a##2##5##(2010-3#1)(2012-12#1)
Data were collected from##8##4##(2008-12#2)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
Data were collected in##5##4##(2008-12#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
Data were collected on##2##4##(1996-3#1)(2012-3#1)
Data were collected through semi-structured interviews##2##6##(2013-7#1)(2013-8#1)
Data were collected through##7##4##(1994-2#1)(1996-1#1)(2010-10#1)(2012-3#1)(2013-7#1)(2013-8#2)
Data were collected via##2##4##(1991-8#2)
Data were collected##49##3##(1991-8#2)(1992-5#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-3#2)(2007-6#1)(2008-11#4)(2008-12#4)(2008-2#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#4)(2010-3#2)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
Data were compared with those##2##5##(2008-10#1)(2008-3#1)
Data were compared with##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
Data were drawn from a##2##5##(2009-7#1)(2013-7#1)
Data were extracted from##2##4##(2008-10#1)(2008-8#1)
Data were extracted##5##3##(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
Data were from##2##3##(2011-1#1)(2012-3#1)
Data were gathered from##2##4##(2008-7#1)(2010-9#1)
Data were gathered##4##3##(1995-2#1)(2008-12#1)(2008-7#1)(2010-9#1)
Data were obtained from##8##4##(1995-1#1)(2007-10#1)(2009-11#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
Data were obtained##10##3##(1995-1#1)(2007-10#1)(2009-11#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#4)
Data were recorded##2##3##(2008-11#1)(2013-1#1)
Data were submitted to##2##4##(2008-12#1)(2013-1#1)
Data were used##3##3##(1995-1#1)(2008-10#1)(2009-7#1)
Data were##125##2##(1991-8#2)(1992-5#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#2)(1996-1#1)(1996-3#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#20)(2013-7#2)(2013-8#5)
Data with##3##2##(2009-12#1)(2009-8#1)(2011-2#1)
Data##542##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#3)(1992-1#4)(1992-11#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#5)(1993-12#5)(1993-2#8)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-11#1)(1994-2#8)(1994-3#5)(1994-7#1)(1994-8#1)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#8)(1996-3#7)(1996-6#2)(1996-8#5)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#4)(2006-10#3)(2007-10#3)(2007-11#6)(2007-12#3)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#52)(2008-11#27)(2008-12#20)(2008-2#8)(2008-3#18)(2008-4#8)(2008-5#13)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#13)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#3)(2010-10#10)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#6)(2010-9#4)(2011-1#14)(2011-2#19)(2011-3#3)(2011-9#1)(2012-1#2)(2012-12#9)(2012-2#10)(2012-3#10)(2013-1#36)(2013-7#4)(2013-8#15)
Data-based##2##1##(1997-1#1)(2008-1#1)
Data-dependent##2##1##(1997-7#1)(2008-3#1)
Database searching indicated that##2##4##(1994-12#1)(2008-9#1)
Database##33##1##(1993-12#1)(1993-6#1)(1994-12#1)(1997-1#2)(2007-12#2)(2008-11#2)(2008-12#1)(2008-4#6)(2008-7#1)(2008-9#4)(2009-10#2)(2010-5#1)(2011-2#3)(2013-1#5)(2013-8#1)
Databases##12##1##(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#3)
Datasets##2##1##(2008-12#1)(2010-5#1)
Date Palm##3##2##(2008-10#2)(2013-1#1)
Date of##2##2##(1991-2#1)(2008-10#1)
Date##7##1##(1991-2#1)(2008-10#4)(2013-1#2)
Dates##3##1##(2007-10#1)(2008-10#2)
Datta##2##1##(1992-8#1)(1997-4#1)
Datura metel##2##2##(2008-10#1)(2013-1#1)
Datura stramonium##7##2##(2008-10#5)(2008-7#1)(2013-8#1)
Datura wrightii##2##2##(2009-8#2)
Datura##12##1##(2008-10#6)(2008-7#1)(2009-8#3)(2013-1#1)(2013-8#1)
Daubechie##3##1##(2010-4#3)
Daubenton's bat##2##2##(2011-2#2)
Daucus##3##1##(2008-11#3)
Daudi and##3##2##(1994-3#1)(2008-8#2)
Daudi##5##1##(1994-3#1)(2008-10#2)(2008-8#2)
Daughter##2##1##(2008-7#1)(2009-3#1)
David##27##1##(1990-11#1)(1990-3#1)(1990-8#1)(1996-11#2)(1996-3#1)(1996-5#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Davidson##4##1##(1990-7#1)(1993-3#1)(2008-10#1)(2008-5#1)
Davies##3##1##(2008-4#1)(2011-2#2)
Davis##7##1##(1990-3#1)(1992-2#1)(1994-12#1)(1994-3#1)(1997-8#1)(2008-10#1)(2010-5#1)
Dax-1##6##1##(2008-4#6)
Day 10##2##2##(1993-12#1)(1994-8#1)
Day 14##3##2##(2008-10#1)(2008-9#2)
Day 15##2##2##(2008-10#1)(2008-11#1)
Day 2##2##2##(2008-9#1)(2011-2#1)
Day 3##3##2##(1995-11#1)(2008-10#2)
Day Hospital##2##2##(1994-12#1)(2008-7#1)
Day of##2##2##(1994-12#1)(2008-11#1)
Day##52##1##(1990-11#2)(1991-1#1)(1991-2#1)(1991-5#2)(1993-12#1)(1994-1#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#3)(1996-2#1)(1997-1#4)(2007-2#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
Days 6##2##2##(2008-10#2)
Days to##2##2##(2008-10#2)
Days##11##1##(1992-3#1)(1995-3#1)(2008-10#7)(2008-12#1)(2011-2#1)
Daytime##4##1##(1994-6#1)(2008-2#1)(2010-7#1)(2013-1#1)
Dbf4##2##1##(2012-3#2)
Dc##6##1##(1996-4#5)(2008-10#1)
DdTBP2 and 10##2##3##(1993-6#2)
De novo##4##2##(2007-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
De##20##1##(1992-1#1)(1993-2#1)(1994-8#1)(2007-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)
Deactivation##2##1##(1991-12#2)
Dead Sea (DS)##2##3##(2008-5#2)
Dead Sea##3##2##(2008-5#3)
Dead spot##2##2##(2008-10#2)
Dead##10##1##(1990-12#1)(1993-3#1)(2008-10#4)(2008-5#4)
Deaf and##3##2##(2011-2#3)
Deaf education and the Deaf community##2##6##(2011-2#2)
Deaf individuals##4##2##(2011-2#4)
Deaf##18##1##(2008-11#1)(2011-2#16)(2012-2#1)
Deaffrication##2##1##(2010-1#2)
Deafness##3##1##(1992-2#1)(2011-2#1)(2013-8#1)
Dealing with the##2##3##(2007-12#1)(2008-10#1)
Dealing with##8##2##(1991-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
Dealing##9##1##(1991-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)
Dean##2##1##(1991-8#1)(1996-1#1)
Deans##2##1##(2007-4#1)(2012-12#1)
Dearth##2##1##(1992-8#1)(2008-11#1)
Death Syndrome##5##2##(2007-10#1)(2008-1#2)(2008-10#2)
Death and##3##2##(1993-3#1)(1994-1#1)(2008-12#1)
Death by##2##2##(1994-2#1)(2008-11#1)
Death in##5##2##(1995-3#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
Death is##2##2##(2008-7#1)(2008-8#1)
Death occurs##2##2##(1993-2#1)(2009-9#1)
Death of##3##2##(2008-10#2)(2008-2#1)
Death rates##3##2##(1991-12#1)(2010-3#1)(2013-1#1)
Death##51##1##(1990-11#1)(1990-6#3)(1991-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-3#1)(2007-10#3)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#2)(2010-3#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Deaths in##3##2##(1990-6#1)(2010-1#1)(2011-2#1)
Deaths##8##1##(1990-6#1)(1991-3#1)(1995-11#1)(1997-6#1)(2008-11#1)(2010-1#2)(2011-2#1)
Debates about##2##2##(1996-1#1)(1996-11#1)
Debilitating##2##1##(2008-11#1)(2010-8#1)
Debris##2##1##(2008-10#2)
Debye length##3##2##(1997-6#2)(2008-10#1)
Debye##10##1##(1997-6#5)(2007-12#4)(2008-10#1)
Debye-Hückel equation##3##2##(2008-10#3)
Dec##2##1##(1996-11#1)(2008-11#1)
Decapoda##2##1##(2007-12#2)
Decay of##5##2##(1994-2#1)(2008-10#4)
Decay##8##1##(1994-2#1)(2008-10#5)(2008-2#1)(2013-8#1)
Deceased-donor kidney transplantation in Iran##2##5##(2008-7#2)
December 1848##3##2##(1992-6#1)(1993-3#2)
December 1985##2##2##(2008-6#1)(2013-1#1)
December 1988##6##2##(1990-12#2)(1990-9#1)(1991-2#1)(1992-10#1)(2008-3#1)
December 1989##6##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-5#1)(1992-6#2)
December 1990##6##2##(1991-12#2)(1991-8#1)(1993-5#1)(1994-1#1)(1995-3#1)
December 1991##2##2##(1992-5#1)(1993-12#1)
December 1992##3##2##(1994-12#1)(1997-3#1)(2008-2#1)
December 1993-January 1994##2##3##(1994-9#2)
December 1994##7##2##(1994-9#1)(1995-3#1)(1996-2#2)(2007-10#1)(2008-11#1)(2008-3#1)
December 1995##4##2##(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
December 1996##3##2##(1997-6#1)(2008-7#1)(2012-12#1)
December 1997 and##3##3##(2007-10#1)(2008-3#1)(2011-1#1)
December 1997##7##2##(2007-10#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
December 1998##2##2##(2008-10#1)(2008-4#1)
December 1999##2##2##(2007-8#1)(2008-3#1)
December 2000##6##2##(2007-7#3)(2008-10#1)(2008-11#1)(2008-6#1)
December 2001 and##2##3##(2007-5#1)(2008-1#1)
December 2001##6##2##(2007-10#2)(2007-12#1)(2007-5#1)(2008-1#1)(2013-1#1)
December 2002##5##2##(2007-11#1)(2007-8#2)(2008-7#1)(2013-1#1)
December 2003##5##2##(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-4#1)
December 2004##5##2##(2008-1#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
December 2005##4##2##(2008-8#2)(2010-3#1)(2011-1#1)
December 2006##9##2##(2008-8#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
December 2007##7##2##(2009-4#2)(2010-11#1)(2010-12#1)(2010-8#1)(2013-7#1)(2013-8#1)
December 2008##8##2##(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
December 2009##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
December 2010##8##2##(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
December 2011##4##2##(2012-12#1)(2013-1#1)(2013-8#2)
December 31##11##2##(1993-9#1)(2007-8#1)(2009-6#1)(2010-12#2)(2010-6#1)(2011-2#4)(2013-7#1)
December 31st 2001##2##3##(2008-1#1)(2011-2#1)
December 6##2##2##(1995-12#1)(2008-5#1)
December and January##2##3##(1996-6#1)(1997-3#1)
December of##3##2##(1993-1#1)(1996-5#1)(2008-6#1)
December##192##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#4)(1992-10#1)(1992-12#1)(1992-5#2)(1992-6#3)(1993-1#3)(1993-12#1)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#5)(1995-12#2)(1995-3#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-8#2)(2007-10#4)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#4)(2007-8#5)(2008-1#5)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#7)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#4)(2011-2#14)(2011-7#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#5)(2013-8#5)
Decentralization##2##1##(2008-7#1)(2012-12#1)
Decentralized##2##1##(1992-1#1)(2013-1#1)
Deciphering the##3##2##(2009-8#1)(2012-3#2)
Deciphering##4##1##(2009-8#1)(2012-12#1)(2012-3#2)
Decision Support System##2##3##(1995-12#1)(2010-8#1)
Decision Trees##2##2##(2008-6#1)(2010-8#1)
Decision about##2##2##(2008-10#1)(2013-1#1)
Decision latitude in##2##3##(2007-2#2)
Decision making##2##2##(1990-5#1)(2013-7#1)
Decision##21##1##(1990-5#1)(1992-2#1)(1993-2#2)(1995-12#1)(1995-9#1)(2007-2#2)(2008-10#3)(2008-6#1)(2009-10#1)(2009-5#1)(2010-8#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Decision-Making##4##1##(2008-11#1)(2009-3#1)(2013-1#2)
Decisions##9##1##(1991-1#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2011-1#1)
Decisive##2##1##(2008-10#1)(2012-3#1)
Declaration of Helsinki##2##3##(2007-7#1)(2012-2#1)
Declaration of##3##2##(2007-7#1)(2008-9#1)(2012-2#1)
Declaration##9##1##(2007-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2012-2#1)
Decline in##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-7#1)
Decline##8##1##(1993-6#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
Declining##2##1##(1992-12#1)(2008-11#1)
Decomposition of##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-5#1)
Decomposition##10##1##(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-8#1)(2010-5#1)(2013-1#1)
Decompressive##4##1##(1992-12#1)(2006-7#1)(2011-2#1)(2012-3#1)
Deconvolution of##2##2##(2008-10#1)(2008-3#1)
Deconvolution##4##1##(1994-5#1)(2008-10#1)(2008-3#2)
Decrease in the##3##3##(2007-10#1)(2009-7#1)(2012-1#1)
Decrease in##9##2##(1995-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
Decrease of##7##2##(1990-12#1)(1995-12#1)(1995-5#1)(2008-12#3)(2013-1#1)
Decrease##17##1##(1990-12#1)(1995-12#1)(1995-5#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-12#5)(2008-3#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
Decreased Sensitivity##2##2##(2008-10#1)(2013-7#1)
Decreased activity of##2##3##(2008-11#1)(2009-7#1)
Decreased levels of##2##3##(1995-2#1)(2008-1#1)
Decreased##36##1##(1990-5#1)(1991-10#1)(1992-5#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-5#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#3)
Decreases in##9##2##(1991-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-1#1)(2013-8#1)
Decreases##10##1##(1990-12#1)(1991-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-1#1)(2013-8#1)
Decreasing the##4##2##(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#1)
Decreasing##11##1##(1995-9#1)(1996-1#2)(1997-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-1#1)(2013-1#1)
Dedicated##4##1##(2008-11#1)(2008-3#2)(2013-8#1)
Dedication##3##1##(2007-12#1)(2008-11#2)
Dee##2##1##(2013-1#2)
Deeds##2##1##(2008-10#1)(2008-12#1)
Deep brain stimulation##3##3##(2008-11#1)(2009-9#1)(2010-12#1)
Deep##18##1##(1992-2#1)(1992-9#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
Deeply infiltrating endometriosis##2##3##(1994-9#2)
Deer##3##1##(2008-5#2)(2013-7#1)
Defeated##2##1##(2008-10#2)
Defect##6##1##(1991-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-1#1)(2012-2#1)
Defective Movement##2##2##(2008-10#2)
Defective RNAs##2##2##(2008-10#2)
Defective##13##1##(1990-3#1)(1993-9#1)(1994-8#1)(1995-8#1)(2008-10#6)(2008-3#1)(2008-6#1)(2011-1#1)
Defects in##7##2##(1994-12#1)(1995-5#1)(1996-9#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-8#1)
Defects##13##1##(1994-12#1)(1995-5#1)(1996-9#2)(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
Defence Research Establishment Valcartier##2##4##(2008-2#1)(2008-3#1)
Defense Mechanisms Against##2##3##(2008-10#2)
Defense Reactions in##2##3##(2008-10#2)
Defense Responses##3##2##(2008-10#3)
Defense##24##1##(1992-12#1)(1995-6#3)(1996-12#1)(1996-5#3)(1997-5#1)(2008-10#11)(2008-2#1)(2008-6#2)(2012-3#1)
Defense-Related##3##1##(2008-10#3)
Defenses by##2##2##(2008-10#2)
Defensive responses##2##2##(2008-4#2)
Defensive##3##1##(2008-4#2)(2011-2#1)
Deferiprone in iron overload##3##4##(1995-8#3)
Deferribacteres##2##1##(2011-2#2)
Deficiencies in the##2##3##(1990-8#1)(2012-12#1)
Deficiencies of##3##2##(2008-9#2)(2009-10#1)
Deficiencies##6##1##(1990-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2012-12#1)
Deficiency and##2##2##(2008-4#1)(2008-9#1)
Deficiency in a##2##3##(1991-9#1)(2013-1#1)
Deficiency in##5##2##(1991-9#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
Deficiency##12##1##(1991-9#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-1#1)(2013-7#1)
Deficient##3##1##(1994-8#1)(2013-1#2)
Deficit##10##1##(1990-2#1)(1993-8#1)(2008-6#1)(2010-8#3)(2012-1#1)(2012-3#1)(2013-1#2)
Deficits##2##1##(2008-2#1)(2013-1#1)
Define##5##1##(1994-3#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
Defined##7##1##(1990-3#1)(2008-10#1)(2008-11#1)(2008-9#3)(2012-3#1)
Defining and evolving the &quot##2##5##(1994-2#2)
Defining and##3##2##(1994-2#2)(1995-3#1)
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy##2##11##(1995-5#2)
Defining the##8##2##(1991-12#1)(1994-2#1)(1996-7#1)(1997-2#1)(2008-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Defining##25##1##(1991-12#1)(1992-2#1)(1994-12#1)(1994-2#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-7#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
Definite##2##1##(1990-6#1)(2011-2#1)
Definition and##3##2##(1995-5#1)(2008-12#1)(2008-5#1)
Definition of##4##2##(1990-12#1)(1991-1#1)(1993-11#1)(1996-3#1)
Definition##9##1##(1990-12#1)(1991-1#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-3#1)(2008-12#1)(2008-5#1)(2010-3#1)
Definitions and##2##2##(1991-11#1)(2011-1#1)
Definitions are provided for##2##4##(1995-3#1)(2008-9#1)
Definitions of##6##2##(1992-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
Definitions##12##1##(1991-11#1)(1992-12#1)(1995-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
Definitive diagnosis##2##2##(2011-2#1)(2013-1#1)
Definitive##8##1##(1991-8#1)(1995-8#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
Deflux injection##3##2##(2008-10#2)(2008-7#1)
Deflux##10##1##(2008-10#4)(2008-6#2)(2008-7#4)
Deformable##3##1##(2007-11#1)(2008-6#1)(2010-4#1)
Deformation of##2##2##(2008-10#1)(2011-2#1)
Deformation##6##1##(2008-10#3)(2008-2#1)(2009-7#1)(2011-2#1)
Deformations##3##1##(2008-3#2)(2009-7#1)
Deformed##3##1##(1995-9#1)(2007-12#1)(2008-3#1)
Dega and Salter pelvic osteotomies##2##5##(2007-8#2)
Dega and Salter##4##3##(2007-8#4)
Dega##9##1##(2007-8#6)(2013-1#3)
Degenerate oligodeoxyribonucleotides##2##2##(1994-12#1)(1995-8#1)
Degenerate primers##2##2##(2008-10#2)
Degenerate##11##1##(1993-9#1)(1994-12#1)(1995-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2013-1#1)
Degeneration of the##3##3##(2008-9#1)(2012-12#1)(2012-2#1)
Degeneration of##4##2##(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
Degeneration##7##1##(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
Degenerative disc disease of the lumbar spine##2##7##(2011-2#2)
Degenerative##7##1##(1997-6#1)(2007-11#1)(2007-8#1)(2011-2#3)(2012-3#1)
Degradation by##2##2##(2008-10#1)(2013-8#1)
Degradation of the##5##3##(1990-2#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-9#1)
Degradation of##19##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-12#1)(1994-8#1)(1995-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)
Degradation processes of##2##3##(2008-10#2)
Degradation##29##1##(1990-2#1)(1991-2#1)(1991-6#1)(1992-12#1)(1994-8#1)(1995-8#2)(2007-11#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
Degree of##6##2##(1991-9#1)(1996-8#1)(2008-11#2)(2008-3#1)(2008-6#1)
Degree##9##1##(1991-9#1)(1996-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2012-2#1)
Dehalococcoides spp##2##2##(2011-1#2)
Dehydroabietic acid##2##2##(1997-2#1)(2008-11#1)
Dehydroepiandrosterone (DHEA)##3##2##(1994-5#1)(1994-6#1)(2007-11#1)
Dehydroepiandrosterone (DHEA)--the##2##2##(1994-5#2)
Dehydroepiandrosterone##6##1##(1994-5#4)(1994-6#1)(2007-11#1)
Dehydrogenase##3##1##(2010-12#1)(2011-2#1)(2012-2#1)
Deir Alla 105##2##3##(2008-10#2)
Deiters cells##2##2##(1994-6#2)
Del 78 was more##2##4##(1995-2#2)
Del allele##2##2##(2008-9#2)
Del##17##1##(1995-2#6)(2008-10#6)(2008-3#2)(2008-9#2)(2010-1#1)
Del1##2##1##(2008-10#2)
DelPhi##2##1##(2008-4#2)
Delaware court decision##2##3##(2008-11#2)
Delaware##8##1##(1994-12#1)(2008-10#1)(2008-11#2)(2010-5#1)(2010-8#1)(2013-1#2)
Delay in##3##2##(2007-11#1)(2008-12#1)(2013-1#1)
Delay of##2##2##(1993-1#1)(1997-6#1)
Delay##8##1##(1993-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-12#1)(2013-1#2)(2013-8#1)
Delayed Vaccination and Related Predictors among Infants##2##7##(2013-1#2)
Delayed diagnosis of##4##3##(2007-8#1)(2008-12#1)(2009-11#1)(2009-3#1)
Delayed diagnosis##6##2##(2007-8#2)(2008-12#1)(2009-11#1)(2009-3#2)
Delayed presentation##3##2##(2008-7#1)(2009-3#1)(2011-2#1)
Delayed recovery##2##2##(1990-11#1)(2012-12#1)
Delayed##41##1##(1990-11#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#4)(2009-7#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
Delayed-type hypersensitivity (DTH)##2##3##(2008-10#2)
Delaying##2##1##(1997-5#1)(2011-1#1)
Delays in##3##2##(2008-10#1)(2009-8#1)(2010-3#1)
Delegates##2##1##(1994-3#1)(1995-1#1)
Deleteagene##3##1##(2008-7#3)
Deletion analyses##2##2##(1992-12#1)(1997-8#1)
Deletion analysis of the##2##4##(1997-2#1)(1997-6#1)
Deletion analysis of##3##3##(1997-2#1)(1997-3#1)(1997-6#1)
Deletion analysis##4##2##(1994-12#1)(1997-2#1)(1997-3#1)(1997-6#1)
Deletion of a##2##3##(1997-4#2)
Deletion of either##2##3##(1992-6#1)(2009-6#1)
Deletion of the##8##3##(1992-9#1)(1993-12#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-3#1)(2008-7#1)(2008-8#1)
Deletion of##21##2##(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-4#2)(2008-7#1)(2008-8#2)(2009-6#1)(2012-2#1)
Deletion##33##1##(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-7#1)(2008-8#3)(2009-6#1)(2012-2#1)
Delflex Neutral pH##3##3##(2011-2#3)
Delflex##5##1##(2011-2#5)
Delhi and##2##2##(2007-7#2)
Delhi##27##1##(1994-8#1)(1994-9#6)(1995-12#1)(1996-4#1)(1997-8#1)(2007-7#7)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-5#1)
Deliberate##2##1##(2010-3#1)(2012-2#1)
Delicious apple##2##2##(2008-10#2)
Delicious##5##1##(2008-10#5)
Delineation of##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
Delirious patients##2##2##(2008-7#1)(2010-10#1)
Delirium in##3##2##(2007-7#1)(2008-7#1)(2011-2#1)
Delirium is##2##2##(2008-7#1)(2013-1#1)
Delirium##10##1##(2007-7#1)(2008-7#3)(2011-2#2)(2013-1#4)
Delivering##3##1##(2008-11#1)(2008-12#1)(2013-1#1)
Delivery and##3##2##(1996-3#2)(2008-9#1)
Delivery of##11##2##(1992-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-3#1)(2011-1#1)(2013-1#2)
Delivery##26##1##(1992-3#1)(1993-1#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-12#2)(2013-1#2)
Delphi##8##1##(1991-3#1)(1996-3#1)(1997-7#1)(2010-8#1)(2010-9#1)(2013-1#3)
Delta 1-RM##2##2##(2008-5#2)
Delta Dental Plan of##2##4##(1993-3#2)
Delta Dental Plan##3##3##(1993-1#1)(1993-3#2)
Delta Dental##4##2##(1993-1#1)(1993-3#3)
Delta and##5##2##(2008-10#3)(2013-1#2)
Delta said##2##2##(1997-5#2)
Delta##40##1##(1991-10#1)(1991-9#1)(1993-1#1)(1993-3#3)(1996-3#1)(1997-5#7)(2008-10#15)(2008-11#2)(2008-3#2)(2008-5#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Delta(7)-PGA(1) methyl ester##3##3##(2008-11#3)
Delta(R##2##1##(2008-10#2)
Delta5 steroid abnormality in##2##4##(2008-4#2)
Delta5 steroid abnormality##3##3##(2008-4#3)
DeltaE##2##1##(2008-10#1)(2009-8#1)
DeltaFerrin(TM)##5##1##(2008-11#5)
DeltaFosB##2##1##(2008-6#2)
DeltaG##2##1##(2007-11#1)(2008-10#1)
DeltaG(0) and TDeltaS(0)##3##3##(2008-10#3)
DeltaG(0)##5##1##(2008-10#5)
DeltaH degrees and DeltaS degrees ) for##2##7##(2008-10#2)
DeltaH degrees##4##2##(1996-2#1)(2008-10#3)
DeltaH##5##1##(1996-2#1)(2008-10#4)
DeltaH() =##2##2##(1996-2#2)
DeltaH(0)##2##1##(2008-10#2)
DeltaH(cal)##2##1##(1997-2#2)
DeltaH(f)##3##1##(2008-11#3)
DeltaH(vH)##3##1##(1997-2#3)
DeltaL(1)##2##1##(2008-10#2)
DeltaPsi(m)##3##1##(2008-9#3)
DeltaR(1)##2##1##(2008-10#2)
DeltaRI##2##1##(2008-10#2)
DeltaS and##2##2##(2008-10#2)
DeltaS degrees =##2##3##(1996-2#2)
DeltaS degrees##4##2##(1996-2#2)(2008-10#2)
DeltaS##6##1##(1996-2#2)(2008-10#4)
DeltaS() =##2##2##(1996-2#2)
Deltabeta##2##1##(2008-3#2)
Deltaf##2##1##(2008-3#2)
Deltaf(0)##2##1##(2008-10#2)
Deltah##2##1##(2008-10#2)
Deltalambda parameter##3##2##(2008-10#3)
Deltalambda##6##1##(2008-10#6)
DeltalogK##2##1##(2008-10#1)(2008-5#1)
Deltam(s) =##3##2##(1997-7#3)
Deltamethrin induced##2##2##(2013-1#2)
Deltamethrin##4##1##(2013-1#4)
Deltan##2##1##(2008-3#2)
Demand##3##1##(2008-11#1)(2008-12#1)(2008-9#1)
Demands##2##1##(1991-2#1)(2011-2#1)
Demarketing##2##1##(1994-12#1)(1996-2#1)
Demented patients##2##2##(2008-7#2)
Dementia and the##2##3##(1991-1#1)(2008-2#1)
Dementia and##4##2##(1991-1#1)(2008-12#1)(2008-2#1)(2008-7#1)
Dementia was determined##2##3##(1991-9#1)(2008-7#1)
Dementia was##3##2##(1991-9#1)(2008-7#2)
Dementia##14##1##(1991-1#1)(1991-9#1)(1993-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#4)(2009-10#1)(2012-3#1)
Demethylation Inhibitor Fungicides##2##3##(2008-10#2)
Demethylation##3##1##(2008-10#3)
Demineralized##3##1##(2008-8#1)(2013-1#2)
Deming##5##1##(1992-2#1)(1993-12#1)(1993-2#1)(1996-1#1)(2013-1#1)
Deming's theory of##2##3##(1996-1#2)
Deming's##4##1##(1993-2#2)(1996-1#2)
Democratic Republic of##2##3##(2007-7#1)(2008-10#1)
Democratic Republic##6##2##(1992-1#1)(1995-1#1)(2007-7#1)(2008-10#1)(2010-4#1)(2013-8#1)
Democratic##10##1##(1990-12#1)(1992-1#1)(1995-1#1)(2007-7#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
Democrats##3##1##(1997-5#1)(2008-7#1)(2009-9#1)
Demodulation of intensity##2##3##(2008-3#2)
Demodulation of##3##2##(2008-3#3)
Demodulation##4##1##(2008-2#1)(2008-3#3)
Demographic Transition##2##2##(2009-10#1)(2010-5#1)
Demographic and Health Survey##3##4##(2009-7#1)(2010-6#1)(2012-12#1)
Demographic and##8##2##(1993-2#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Demographic characteristics and##2##3##(1994-1#1)(2011-1#1)
Demographic characteristics##4##2##(1992-8#1)(1994-1#1)(2007-10#1)(2011-1#1)
Demographic data##5##2##(1992-8#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
Demographic factors such as##2##4##(1994-3#1)(2011-1#1)
Demographic##41##1##(1992-8#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Demographics and the charitable estate planning marketplace##2##7##(1994-1#1)(1994-3#1)
Demographics of##2##2##(1996-3#1)(2009-8#1)
Demographics##9##1##(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-12#1)(2008-3#1)(2009-8#1)(2012-3#1)
Demography and##2##2##(2008-6#1)(2010-8#1)
Demography##3##1##(2008-6#1)(2008-8#1)(2010-8#1)
Demonstrate##2##1##(2008-3#1)(2013-1#1)
Demonstrated##2##1##(2007-11#1)(2008-10#1)
Demonstrating the##2##2##(2012-2#1)(2012-3#1)
Demonstrating##4##1##(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
Demonstration of a##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2012-12#1)
Demonstration of an##3##3##(2008-3#3)
Demonstration of highly efficient##2##4##(2007-12#2)
Demonstration of the##2##3##(2008-3#1)(2012-2#1)
Demonstration of##26##2##(1992-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(2006-12#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#2)(2008-3#8)(2010-7#1)(2012-12#1)(2012-2#1)
Demonstration##28##1##(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(2006-12#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#2)(2008-3#9)(2010-7#1)(2012-12#1)(2012-2#1)
Denaturation##2##1##(1995-2#1)(2008-11#1)
Denaturing##2##1##(1993-11#1)(2008-10#1)
Dendrimer##2##1##(1991-5#1)(2007-12#1)
Dendrimers##3##1##(1996-5#1)(2010-8#2)
Dendritic Cells from##2##3##(2008-11#2)
Dendritic Cells##4##2##(2008-10#1)(2008-11#2)(2012-3#1)
Dendritic cell##3##2##(2008-5#1)(2008-8#1)(2010-5#1)
Dendritic cells (DC)##2##3##(2008-5#1)(2010-12#1)
Dendritic cells (DCs) are##2##4##(2008-4#1)(2010-5#1)
Dendritic cells (DCs)##5##3##(2008-11#1)(2008-4#2)(2010-5#1)(2012-2#1)
Dendritic cells are##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
Dendritic cells##12##2##(2006-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#2)(2012-2#1)
Dendritic##27##1##(1994-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#4)(2012-2#2)(2012-3#1)(2013-7#1)
Dendronized##2##1##(2008-10#2)
Dendryphion penicillatum and Pleospora papaveracea##3##5##(2008-10#3)
Dendryphion penicillatum##4##2##(2008-10#4)
Deng-Fan##2##1##(2010-7#2)
Dengue fever is a##2##4##(2008-5#1)(2011-1#1)
Dengue fever##6##2##(2007-2#1)(2008-5#4)(2011-1#1)
Dengue is an##2##3##(2007-2#1)(2011-2#1)
Dengue virus##2##2##(2007-10#1)(2011-2#1)
Dengue##17##1##(2007-10#1)(2007-2#5)(2008-5#4)(2011-1#1)(2011-2#5)(2013-1#1)
Dengue-III virus D9964 strain##2##4##(2013-8#2)
Denial of##2##2##(1995-9#1)(1996-5#1)
Denitrovibrio acetiphilus##2##2##(2011-2#2)
Denitrovibrio##3##1##(2011-2#3)
Denmark in the##2##3##(1995-3#1)(1996-9#1)
Denmark is##2##2##(1992-11#1)(2013-1#1)
Denmark##31##1##(1990-11#3)(1990-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-3#2)(1996-6#1)(1996-9#2)(1997-3#3)(1997-6#1)(2008-7#6)(2011-2#3)(2011-4#1)(2013-1#1)
Denmark)##6##1##(2007-8#1)(2008-5#1)(2008-6#2)(2012-3#1)(2013-1#1)
Dennis##4##1##(1991-8#2)(1997-5#1)(2011-2#1)
Dense##5##1##(2007-12#3)(2008-2#2)
Densities##3##1##(1996-9#1)(2007-5#1)(2008-5#1)
Densitometric analysis of##2##3##(2008-10#2)
Densitometric##3##1##(2007-11#1)(2008-10#2)
Density Functional Theory##2##3##(2008-10#2)
Density Functional##3##2##(1996-2#1)(2008-10#2)
Density Lipoprotein##3##2##(1992-12#2)(2008-10#1)
Density of##9##2##(1991-9#1)(1995-6#1)(1996-9#1)(2007-5#1)(2008-10#3)(2010-11#1)(2013-8#1)
Density##25##1##(1991-9#1)(1992-12#2)(1992-3#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-9#2)(2007-5#1)(2008-10#9)(2008-11#1)(2008-2#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
Dental Assistants##2##2##(2013-1#2)
Dental Association##2##2##(1995-6#1)(2008-1#1)
Dental College##3##2##(2013-1#3)
Dental and##2##2##(1990-12#1)(2007-12#1)
Dental anxiety##2##2##(2008-1#2)
Dental caries is##2##3##(2012-2#1)(2013-8#1)
Dental caries##5##2##(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
Dental considerations for##2##3##(2008-1#1)(2008-10#1)
Dental implants##3##2##(2007-12#1)(2009-7#1)(2011-2#1)
Dental##60##1##(1990-12#2)(1990-9#1)(1993-1#2)(1993-3#3)(1995-12#1)(1995-6#1)(1996-9#1)(2007-12#3)(2008-1#8)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#3)(2010-3#2)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#14)(2013-7#1)(2013-8#2)
Dentigerous cysts##2##2##(2013-1#2)
Dentigerous##3##1##(2013-1#3)
Dentin hypersensitivity##2##2##(2011-2#2)
Dentistry##9##1##(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#2)(2013-1#4)
Dentsply##2##1##(2013-1#2)
Dentsply)##2##1##(2009-8#1)(2013-1#1)
Denver##5##1##(1995-12#3)(1997-2#1)(2008-10#1)
Deoxygenation at C-4##2##3##(1996-5#2)
Deoxynivalenol##3##1##(1997-6#2)(2008-10#1)
Deoxyribonucleic acid##2##2##(1996-12#1)(2011-1#1)
Departamento de##2##2##(1993-3#1)(2008-6#1)
Departing from##2##2##(2008-3#1)(2009-6#1)
Department Medical University##2##3##(2011-2#2)
Department Medical##3##2##(2007-11#1)(2011-2#2)
Department at the##5##3##(1996-9#1)(1997-2#1)(2007-8#1)(2008-9#1)(2013-8#1)
Department at##6##2##(1996-3#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-9#1)(2013-8#1)
Department for##4##2##(2007-11#1)(2007-2#1)(2008-10#1)(2012-3#1)
Department from##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
Department in##3##2##(2007-11#1)(2007-8#1)(2012-2#1)
Department of Agriculture##5##3##(1996-3#1)(2008-10#2)(2008-2#1)(2012-2#1)
Department of Agriculture-Agricultural Research Service##2##5##(2008-10#2)
Department of Clinical##2##3##(1991-5#1)(1997-8#1)
Department of Energy (DOE)##4##4##(2008-10#2)(2008-5#1)(2011-2#1)
Department of Energy##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
Department of General Surgery##2##4##(2008-7#1)(2011-2#1)
Department of Health Policy##2##4##(1997-2#1)(2009-5#1)
Department of Health Statistics and Information##2##6##(2011-2#1)(2013-1#1)
Department of Health and Human Services (DHHS)##2##7##(1993-12#1)(1996-5#1)
Department of Health and Human Services##9##6##(1992-3#1)(1993-12#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(2008-7#1)(2012-2#1)
Department of Health and Human##10##5##(1992-3#1)(1993-12#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Department of Health and##12##4##(1992-3#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Department of Health in##2##4##(2008-6#1)(2008-9#1)
Department of Health##43##3##(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-2#1)(2008-11#7)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
Department of Health's##3##3##(2008-11#1)(2012-12#2)
Department of Justice##3##3##(1991-1#1)(1995-12#1)(1995-6#1)
Department of Labor's##2##3##(1991-12#1)(1993-12#1)
Department of Neurosurgery##2##3##(1995-11#1)(2013-8#1)
Department of Obstetrics and Gynecology at##2##6##(1990-10#1)(1996-9#1)
Department of Obstetrics and Gynecology##3##5##(1990-10#2)(1996-9#1)
Department of Obstetrics and##5##4##(1990-10#2)(1996-1#1)(1996-9#1)(2008-3#1)
Department of Obstetrics##6##3##(1990-10#2)(1996-1#1)(1996-9#1)(2008-3#1)(2013-1#1)
Department of Oral##2##3##(2008-8#1)(2013-1#1)
Department of Orthopedic##2##3##(2007-11#1)(2007-8#1)
Department of Orthopedics and Traumatology##2##5##(2007-11#2)
Department of Pediatric##2##3##(2008-2#1)(2011-2#1)
Department of Public Health##4##4##(1995-11#1)(1996-12#1)(1996-2#1)(2008-7#1)
Department of Public##5##3##(1995-11#1)(1996-12#1)(1996-2#2)(2008-7#1)
Department of Surgery##4##3##(1991-9#1)(1992-3#1)(1992-6#1)(1995-12#1)
Department of Veterans Affairs (VA)##3##5##(1993-12#1)(2009-11#1)(2013-1#1)
Department of Veterans Affairs Medical Center##2##6##(1992-2#1)(1995-2#1)
Department of Veterans Affairs##8##4##(1992-12#1)(1992-2#1)(1993-12#1)(1995-2#1)(1996-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
Department of the University of##2##5##(1990-9#1)(1997-6#1)
Department of the University##3##4##(1990-9#1)(1996-11#1)(1997-6#1)
Department of the##8##3##(1990-10#1)(1990-9#1)(1992-12#1)(1996-11#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-9#1)
Department of##200##2##(1990-10#6)(1990-2#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#1)(1993-12#4)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#6)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-10#14)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#3)(2010-1#1)(2010-3#1)(2010-6#2)(2011-2#14)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#7)
Department##271##1##(1990-10#6)(1990-2#2)(1990-9#2)(1991-1#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#4)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#4)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#8)(1996-5#4)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#9)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#8)(2008-10#20)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-11#1)(2009-5#3)(2009-7#1)(2010-1#1)(2010-3#1)(2010-6#2)(2011-2#20)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#13)
Department's##2##1##(1992-2#1)(1995-1#1)
Departmental##4##1##(1993-1#2)(1994-3#1)(2008-12#1)
Departments of##6##2##(1991-9#1)(1992-8#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-8#1)
Departments##8##1##(1991-9#2)(1992-8#1)(1994-12#2)(1996-1#1)(1996-12#1)(1997-8#1)
Departures from##2##2##(2008-3#2)
Depend on the##2##3##(1997-7#1)(2010-1#1)
Dependence in##2##2##(2008-7#1)(2013-8#1)
Dependence of the##5##3##(1993-5#1)(2008-2#2)(2008-3#2)
Dependence of##16##2##(1993-5#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#5)(2009-12#1)(2009-6#1)(2011-2#1)
Dependence on##2##2##(2008-10#1)(2008-3#1)
Dependence##27##1##(1991-1#3)(1993-5#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#6)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Dependencies of##2##2##(2008-2#1)(2008-3#1)
Dependent##10##1##(1992-2#1)(1992-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(2010-7#1)(2010-9#1)(2011-2#1)
Depending on the nature of the##2##6##(2008-10#1)(2008-3#1)
Depending on the solvent polarity##2##5##(2008-10#2)
Depending on the type of##2##5##(1995-5#1)(2008-3#1)
Depending on the##35##3##(1990-9#1)(1993-11#1)(1994-5#2)(1995-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
Depending on their##3##3##(1992-8#1)(2008-10#1)(2009-12#1)
Depending on##47##2##(1990-9#1)(1992-8#1)(1993-11#1)(1994-5#2)(1995-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
Depending upon the##3##3##(1995-3#1)(2008-4#1)(2011-1#1)
Depending##50##1##(1990-9#1)(1992-8#1)(1993-11#1)(1994-5#2)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
Depixol injections##2##2##(2007-10#2)
Depletion of##8##2##(1991-5#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
Deployment of##3##2##(1994-11#1)(2008-10#2)
Deployment##5##1##(1994-11#1)(1994-12#1)(2008-10#2)(2008-7#1)
Depolarization##4##1##(1992-8#1)(2007-12#1)(2008-3#2)
Depolarizing##2##1##(1990-7#1)(2008-5#1)
Deposition in the##3##3##(1996-3#1)(2008-11#2)
Deposition of##6##2##(1992-3#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
Deposition probabilities are##2##3##(1994-12#2)
Deposition##16##1##(1992-3#1)(1994-12#2)(1996-3#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2010-5#1)(2011-2#1)(2013-1#1)
Depressed##3##1##(2011-2#2)(2013-1#1)
Depression Inventory##9##2##(1991-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Depression Scale##11##2##(2006-10#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#2)(2013-1#1)(2013-8#1)
Depression and Anxiety##2##3##(1994-6#1)(2010-8#1)
Depression and##9##2##(1994-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-1#1)
Depression in##5##2##(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
Depression is a##5##3##(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#2)
Depression is##7##2##(2008-1#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
Depression was##2##2##(1993-12#1)(2013-1#1)
Depression##68##1##(1991-2#2)(1993-12#1)(1994-6#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#5)
Depressive illnesses are##2##3##(2010-12#2)
Depressive symptoms and##3##3##(2007-7#1)(2009-9#1)(2010-9#1)
Depressive symptoms were##3##3##(1992-2#1)(2009-11#1)(2013-8#1)
Depressive symptoms##7##2##(1992-2#1)(2007-7#1)(2009-11#2)(2009-9#1)(2010-9#1)(2013-8#1)
Depressive##16##1##(1992-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-11#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
Depressor responses##2##2##(1991-12#1)(1996-5#1)
Deprivation of##4##2##(1990-12#2)(1991-5#1)(1996-6#1)
Deprivation##7##1##(1990-12#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-2#1)(1996-6#1)
Deprotection##2##1##(2007-11#1)(2009-9#1)
Deprotonation of##2##2##(1994-5#1)(1997-7#1)
Deprotonation##3##1##(1990-5#1)(1994-5#1)(1997-7#1)
Dept##2##1##(1992-8#1)(2012-2#1)
Depth is##2##2##(2008-3#2)
Depth of##3##2##(2009-12#1)(2009-5#1)(2013-8#1)
Depth profiles##3##2##(1992-8#1)(2008-10#1)(2008-2#1)
Depth##18##1##(1992-8#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-8#1)
Depth-resolved##2##1##(2008-3#1)(2011-1#1)
Der p 1##2##3##(2010-5#2)
Der p 2##5##3##(2010-5#5)
Der p##7##2##(2010-5#7)
Dera Ismail Khan##2##3##(2008-12#2)
Derakhshan##2##1##(2008-12#2)
Derby##4##1##(2008-9#1)(2011-2#1)(2013-8#2)
Derek for Windows##2##3##(2008-10#2)
Derivation of dimensional and material requirements for propagation and processing of temporal optical solitons in planar geometry channel waveguides##2##19##(2008-2#2)
Derivation of##7##2##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#1)
Derivation##8##1##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#2)
Derivative spectrophotometric determination of##3##4##(2008-10#3)
Derivative spectrophotometric##4##2##(2008-10#4)
Derivative spectrophotometry##2##2##(2008-10#2)
Derivative##15##1##(1990-5#1)(1996-2#1)(1997-7#1)(2007-1#1)(2008-10#9)(2009-8#1)(2010-1#1)
Derivatives are##2##2##(2008-10#2)
Derivatives of the##2##3##(1996-2#1)(2012-2#1)
Derivatives of##7##2##(1996-2#3)(1997-7#1)(2008-10#2)(2012-2#1)
Derivatives with##2##2##(1996-2#1)(2013-1#1)
Derivatives##20##1##(1996-2#5)(1996-5#2)(1997-7#2)(2008-10#5)(2008-5#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
Derivatization of##2##2##(1995-2#1)(2008-4#1)
Derivatization##6##1##(1990-8#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
Derived from##6##2##(1996-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
Derived##12##1##(1996-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
Deriving##3##1##(2008-3#1)(2008-8#1)(2009-3#1)
Dermacentor marginatus##3##2##(1995-12#2)(2008-8#1)
Dermacentor##5##1##(1995-12#2)(2008-5#2)(2008-8#1)
Dermal##6##1##(2008-1#1)(2008-5#4)(2008-9#1)
Dermatol##6##1##(2008-5#1)(2010-8#5)
Dermatologic##2##1##(2007-12#1)(2011-2#1)
Dermatological##2##1##(1997-8#1)(2011-1#1)
Dermatologists##2##1##(2010-3#1)(2013-8#1)
Dermatology##8##1##(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
Dermatomyositis##2##1##(1994-7#1)(2006-10#1)
Dermatophagoides##2##1##(2010-5#1)(2011-2#1)
Dermatophilus congolensis##2##2##(1991-8#2)
Dermoid##2##1##(2011-2#2)
Des##2##1##(2008-11#1)(2008-5#1)
Desacetyl-alpha-MSH##2##1##(2008-6#2)
Desault plaster cast##2##3##(2007-8#2)
Descartes##3##1##(2008-2#2)(2008-3#1)
Described are##3##2##(1994-1#1)(2008-4#1)(2011-2#1)
Described here##2##2##(2008-4#1)(2012-2#1)
Described in this unit are##4##5##(2008-4#1)(2008-9#1)(2010-7#1)(2012-3#1)
Described in this##5##3##(1996-1#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-3#1)
Described##20##1##(1994-1#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
Describing##5##1##(2008-10#1)(2012-12#2)(2013-1#2)
Description and##3##2##(2008-3#2)(2011-2#1)
Description of a case]##3##4##(1990-6#1)(1990-9#1)(1991-5#1)
Description of a##5##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-6#1)
Description of the##4##3##(1990-2#1)(2007-11#1)(2008-10#1)(2008-9#1)
Description of##14##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-6#1)(1997-9#1)(2007-11#2)(2008-10#2)(2008-9#1)(2011-2#1)
Description##22##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-6#1)(1997-9#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#1)(2011-2#2)(2012-2#1)
Descriptions of##4##2##(1997-1#1)(2008-10#2)(2013-8#1)
Descriptions##7##1##(1995-11#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-8#1)
Descriptive analyses##2##2##(1992-3#1)(2008-11#1)
Descriptive and##2##2##(1995-12#1)(2011-1#1)
Descriptive data##2##2##(1992-3#1)(2010-7#1)
Descriptive epidemiology of##2##3##(1992-12#1)(2013-8#1)
Descriptive statistics were calculated##2##4##(2008-11#1)(2012-12#1)
Descriptive statistics were used##3##4##(2010-3#1)(2012-12#1)(2013-1#1)
Descriptive statistics were##6##3##(2008-11#2)(2010-3#1)(2012-12#2)(2013-1#1)
Descriptive statistics##10##2##(2008-11#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
Descriptive study##4##2##(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Descriptive##31##1##(1992-12#1)(1992-3#2)(1995-1#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#3)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#4)
Desensitization##3##1##(1992-3#1)(1997-1#1)(2008-8#1)
Desert##12##1##(1991-3#1)(2008-10#5)(2008-12#1)(2008-8#2)(2009-8#1)(2013-7#2)
Desiccation resistance##2##2##(2008-10#2)
Desiccation##3##1##(2008-10#2)(2013-7#1)
Desiccations##2##1##(1992-12#2)
Design and analysis of##2##4##(2008-2#1)(2008-3#1)
Design and analysis##3##3##(1994-2#1)(2008-2#1)(2008-3#1)
Design and characterization of##2##4##(1990-7#1)(2011-2#1)
Design and development of a##2##5##(2008-10#2)
Design and fabrication of a##2##5##(2008-10#1)(2008-2#1)
Design and manufacture of##2##4##(2008-2#1)(2008-3#1)
Design and operation of a##2##5##(2008-2#1)(2008-3#1)
Design and optimization of a##3##5##(2008-2#1)(2008-3#1)(2012-2#1)
Design and optimization of##4##4##(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
Design and performance of a##2##5##(2008-2#1)(2008-3#1)
Design and synthesis of##5##4##(1990-2#1)(1994-3#1)(1995-3#2)(2009-12#1)
Design and##43##2##(1990-2#1)(1990-7#1)(1994-2#1)(1994-3#1)(1995-3#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#9)(2009-12#1)(2010-10#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
Design considerations##2##2##(1996-2#1)(2008-2#1)
Design modifications##2##2##(2008-3#1)(2008-6#1)
Design of a##16##3##(1994-3#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2010-8#2)
Design of an##5##3##(2008-2#1)(2008-3#3)(2008-7#1)
Design of novel##2##3##(1995-3#1)(2008-5#1)
Design of##46##2##(1994-12#1)(1994-3#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#10)(2008-3#13)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-8#3)(2012-1#1)
Design##168##1##(1990-2#1)(1990-7#1)(1991-12#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-3#5)(1996-2#2)(1997-4#1)(2007-11#1)(2007-12#3)(2007-2#3)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#4)(2008-2#24)(2008-3#27)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#8)(2010-2#1)(2010-8#7)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#14)(2013-8#3)
Designed##5##1##(1997-3#1)(2008-10#2)(2008-3#1)(2010-12#1)
Designer drinks and drunkenness among schoolchildren##2##6##(1996-11#2)
Designer##4##1##(1993-5#1)(1996-11#2)(2007-6#1)
Designing a##5##2##(1992-3#1)(1993-3#1)(1996-12#1)(1997-3#1)(2012-3#1)
Designing and##2##2##(1995-2#1)(2009-12#1)
Designing the##2##2##(1994-3#1)(1995-2#1)
Designing##20##1##(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#2)(1997-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
Designs of##2##2##(1995-11#1)(2008-2#1)
Designs##4##1##(1995-11#1)(2008-2#1)(2009-10#1)(2010-2#1)
Desire##2##1##(2007-7#1)(2013-8#1)
Desk##3##1##(1994-3#1)(2008-11#1)(2010-3#1)
Desmodium gangeticum##2##2##(2011-1#2)
Desmodium##3##1##(2008-10#1)(2011-1#2)
Desmoplastic##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
Desorption of##4##2##(2008-10#4)
Desorption##7##1##(2008-10#6)(2010-4#1)
Despite a lack of##2##4##(1996-8#1)(2008-10#1)
Despite a number of##2##4##(2008-10#1)(2012-12#1)
Despite a relatively##2##3##(1997-3#1)(2011-2#1)
Despite a##25##2##(1992-3#1)(1992-6#1)(1995-10#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#1)
Despite advances in##10##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)
Despite advances##11##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)
Despite aggressive therapy##2##3##(2008-1#1)(2009-8#1)
Despite all##2##2##(2009-10#1)(2011-1#1)
Despite an##5##2##(2007-8#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
Despite being the##2##3##(2008-10#1)(2013-1#1)
Despite being##5##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
Despite clinical##2##2##(2007-10#1)(2008-3#1)
Despite considerable##3##2##(1996-7#1)(2010-4#1)(2010-5#1)
Despite continuous##2##2##(1993-6#1)(2011-2#1)
Despite decades of research##2##4##(2008-9#1)(2012-2#1)
Despite extensive##5##2##(1997-1#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
Despite fundamental##2##2##(2007-12#1)(2009-8#1)
Despite having##2##2##(2008-7#1)(2011-2#1)
Despite higher##2##2##(2008-10#1)(2011-2#1)
Despite improvements in##3##3##(2007-7#1)(2011-3#1)(2012-2#1)
Despite increased awareness of##2##4##(1997-1#1)(2009-5#1)
Despite increased##4##2##(1997-1#2)(2009-5#1)(2009-8#1)
Despite its potential##2##3##(2010-7#1)(2010-8#1)
Despite its##17##2##(1993-11#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-7#2)(2009-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Despite limitations##2##2##(2008-12#1)(2012-12#1)
Despite low levels of##2##4##(2010-8#1)(2013-1#1)
Despite many##2##2##(1995-6#1)(2008-10#1)
Despite new##2##2##(2011-1#1)(2012-1#1)
Despite of##5##2##(2008-10#1)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
Despite ongoing##2##2##(2011-2#2)
Despite progress in##2##3##(2009-10#1)(2013-8#1)
Despite progressive##2##2##(1996-9#1)(2013-1#1)
Despite recent progress in##2##4##(1991-2#1)(2009-7#1)
Despite recent progress##3##3##(1991-2#1)(2009-7#1)(2012-2#1)
Despite recent##4##2##(1991-2#1)(2008-10#1)(2009-7#1)(2012-2#1)
Despite several##3##2##(1996-3#1)(2007-5#1)(2009-2#1)
Despite significant advances in##2##4##(2008-6#1)(2008-7#1)
Despite significant##6##2##(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)
Despite similar##2##2##(2009-3#1)(2013-1#1)
Despite some##5##2##(2008-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2013-1#1)
Despite successful##2##2##(1996-6#1)(2012-2#1)
Despite that##2##2##(2008-10#1)(2009-3#1)
Despite the challenges##2##3##(1997-2#1)(2008-1#1)
Despite the clinical##2##3##(2007-5#1)(2008-11#1)
Despite the considerable##2##3##(1995-1#1)(2011-2#1)
Despite the fact that the##3##5##(2007-6#1)(2008-3#1)(2008-9#1)
Despite the fact that##13##4##(1994-2#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
Despite the high##4##3##(1992-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
Despite the importance of##2##4##(1993-1#1)(2008-10#1)
Despite the increased##2##3##(1995-1#1)(2012-5#1)
Despite the increasing##3##3##(2008-9#1)(2013-1#2)
Despite the lack of##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
Despite the large##3##3##(2006-10#1)(2008-11#1)(2008-12#1)
Despite the many##3##3##(2008-5#2)(2010-3#1)
Despite the potential##2##3##(2009-2#1)(2011-1#1)
Despite the presence of##3##4##(1995-6#1)(1997-8#1)(2008-10#1)
Despite the rarity of##2##4##(1992-8#1)(2008-8#1)
Despite the recent##2##3##(2008-10#1)(2008-7#1)
Despite the relatively##2##3##(2007-11#1)(2011-2#1)
Despite the similarities between##2##4##(2008-2#1)(2008-7#1)
Despite the widespread##3##3##(1996-5#1)(2008-11#1)(2012-12#1)
Despite the##158##2##(1990-8#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#11)(2013-8#2)
Despite their##10##2##(1992-3#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-7#1)(2012-2#2)(2013-1#1)
Despite these advances##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
Despite these findings##2##3##(1997-4#1)(2007-6#1)
Despite these structural elucidations##2##4##(2010-2#2)
Despite these##21##2##(1992-11#1)(1994-5#1)(1994-9#1)(1996-6#1)(1997-4#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-6#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
Despite this##27##2##(1993-2#1)(1993-6#2)(1994-6#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-8#2)
Despite##446##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#3)(2006-8#1)(2007-10#3)(2007-11#7)(2007-12#9)(2007-2#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#13)(2008-10#37)(2008-11#15)(2008-12#8)(2008-2#4)(2008-3#13)(2008-4#3)(2008-5#6)(2008-6#7)(2008-7#22)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#5)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#5)(2010-11#4)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#9)(2011-2#30)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#14)(2012-3#6)(2012-5#1)(2012-7#1)(2013-1#27)(2013-7#1)(2013-8#10)
Desquamation##2##1##(2008-5#2)
Desquamative##2##1##(2008-5#1)(2011-2#1)
Destabilization of##2##2##(1993-5#1)(2007-11#1)
Destabilization##3##1##(1993-5#1)(2007-11#1)(2008-5#1)
Destruction of the##2##3##(1993-11#1)(1997-1#1)
Destruction of##5##2##(1993-11#1)(1996-3#1)(1997-1#1)(2008-11#2)
Destructive##2##1##(1992-11#1)(2008-10#1)
Desulfarculus baarsii##2##2##(2011-2#2)
Desulfarculus##3##1##(2011-2#3)
Desulfovibrio vulgaris##5##2##(1990-8#2)(1991-12#2)(1994-5#1)
Desulfovibrio##8##1##(1990-8#2)(1991-12#2)(1994-5#4)
Detachable##3##1##(1995-11#1)(1996-9#1)(1997-3#1)
Detached##4##1##(2008-10#4)
Detachment##2##1##(1996-12#1)(2008-11#1)
Detail on##2##2##(1994-3#2)
Detailed analyses of##2##3##(2008-6#1)(2010-7#1)
Detailed analyses##3##2##(1997-8#1)(2008-6#1)(2010-7#1)
Detailed analysis of the##3##4##(1995-5#1)(2009-11#2)
Detailed analysis of##4##3##(1995-5#1)(2008-6#1)(2009-11#2)
Detailed analysis##7##2##(1994-5#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#2)
Detailed descriptions##2##2##(1996-3#1)(2008-4#1)
Detailed examination##2##2##(2008-6#1)(2009-11#1)
Detailed information##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
Detailed protocols are provided for titering and isolating bacterial colonies by serial dilutions##2##13##(2008-2#1)(2008-9#1)
Detailed protocols are##3##3##(2008-2#1)(2008-9#2)
Detailed##54##1##(1990-8#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#3)(2008-9#3)(2009-11#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
Details of the##5##3##(2008-1#1)(2008-10#2)(2008-3#2)
Details of##9##2##(1994-12#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-9#1)
Details on##2##2##(2008-10#1)(2008-4#1)
Details##14##1##(1994-12#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-4#2)(2008-9#1)(2010-3#1)
Detect##3##1##(2008-10#3)
Detectability##3##1##(1990-2#1)(2008-6#1)(2010-9#1)
Detected by##2##2##(1994-7#1)(2008-6#1)
Detected##3##1##(1994-7#1)(2008-6#1)(2011-2#1)
Detecting and##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
Detecting patients with acute coronary syndrome in the chest pain center of the emergency department with cardiac magnetic resonance##2##19##(2008-3#2)
Detecting##22##1##(1995-2#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Detection and Quantification##2##3##(2008-10#2)
Detection and analysis of proteins modified by O-linked N-acetylglucosamine##2##9##(2008-2#1)(2008-4#1)
Detection and analysis of##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
Detection and cloning of LINE-1 elements in CHO cells##2##9##(2008-11#2)
Detection and determination##2##3##(2008-10#2)
Detection and identification of##4##4##(2008-10#2)(2008-7#1)(2012-3#1)
Detection and quantification of##2##4##(2008-11#1)(2008-5#1)
Detection and##31##2##(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
Detection by##2##2##(2008-3#1)(2011-2#1)
Detection limit is##4##3##(2008-10#4)
Detection limit of##4##3##(2008-10#4)
Detection limit##14##2##(2008-10#14)
Detection limits (DLs)##2##3##(2008-10#2)
Detection limits achieved##2##3##(2008-10#2)
Detection limits as low as##2##5##(2008-10#2)
Detection limits for##8##3##(2008-10#8)
Detection limits in the##2##4##(2008-10#2)
Detection limits in##3##3##(2008-10#2)(2008-2#1)
Detection limits obtained##2##3##(2008-10#2)
Detection limits of the##2##4##(2008-10#2)
Detection limits of##13##3##(1995-6#1)(2008-10#11)(2008-2#1)
Detection limits using##3##3##(2008-10#3)
Detection limits were calculated##2##4##(2008-10#2)
Detection limits were determined##2##4##(2008-10#2)
Detection limits were estimated as##2##5##(2008-10#2)
Detection limits were##9##3##(1994-9#1)(2008-10#8)
Detection limits##59##2##(1994-9#1)(1995-6#1)(2008-10#55)(2008-2#2)
Detection of Fusarium oxysporum f##2##5##(2008-10#2)
Detection of Grapevine##2##3##(2008-10#2)
Detection of Phytophthora ramorum##4##4##(2008-10#4)
Detection of Phytophthora##6##3##(2008-10#6)
Detection of a##5##3##(1992-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-6#1)
Detection of an##2##3##(1992-6#1)(2007-11#1)
Detection of borreliacidal antibodies##2##4##(2008-9#2)
Detection of phenolic compounds##2##4##(2008-10#2)
Detection of the##9##3##(1990-12#1)(1992-8#1)(1997-7#1)(2008-10#4)(2010-4#1)(2013-1#1)
Detection of##164##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-12#4)(1997-4#1)(1997-7#1)(1997-9#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#75)(2008-11#1)(2008-12#4)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#2)(2008-9#8)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-6#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
Detection was based on##2##4##(1997-2#1)(2008-10#1)
Detection was carried out using an##2##6##(2008-10#2)
Detection was carried out using##3##5##(2008-10#3)
Detection was carried out##5##4##(2008-10#5)
Detection was##8##2##(1997-2#1)(2008-10#7)
Detection##305##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#5)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-9#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#166)(2008-11#6)(2008-12#5)(2008-2#14)(2008-3#14)(2008-4#11)(2008-5#3)(2008-7#2)(2008-9#11)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-6#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
Detector##8##1##(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-12#1)
Detectors##2##1##(2008-3#2)
Detergents##2##1##(1994-8#1)(2010-6#1)
Determinant##2##1##(1995-5#1)(2008-10#1)
Determinants of##19##2##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#1)(2013-1#3)
Determinants##22##1##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#5)(2011-2#1)(2012-1#1)(2013-1#3)
Determination and##4##2##(1997-7#1)(2007-12#1)(2008-10#2)
Determination in##2##2##(2008-10#2)
Determination is based on the##2##5##(2008-10#2)
Determination of Aflatoxin M1 Contamination and Integrity as well as Credibility##2##11##(2013-1#2)
Determination of Cd and##2##4##(2008-10#2)
Determination of Cd in##2##4##(2008-10#2)
Determination of Cd##4##3##(2008-10#4)
Determination of Mo##2##3##(2008-10#2)
Determination of aliphatic##2##3##(2008-10#2)
Determination of aluminium##2##3##(1995-6#1)(2008-10#1)
Determination of ammonia##3##3##(2008-10#3)
Determination of arsenate##2##3##(2008-10#2)
Determination of arsenic compounds in##2##5##(2008-10#2)
Determination of arsenic in##3##4##(2008-10#3)
Determination of arsenic##8##3##(2008-10#8)
Determination of atrazine##2##3##(2008-10#2)
Determination of blood acetyl cholinesterase and butyryl cholinesterase activities remains a mainstay for the rapid initial screening of OP pesticides##2##20##(2013-1#2)
Determination of cadmium and lead in##3##6##(2008-10#3)
Determination of cadmium in urine##2##5##(2008-10#2)
Determination of cadmium in##6##4##(2008-10#6)
Determination of cadmium##13##3##(2008-10#13)
Determination of calcium##2##3##(2008-10#2)
Determination of chemical warfare agents##2##5##(2008-11#2)
Determination of chemical##3##3##(2008-10#1)(2008-11#2)
Determination of chloride##2##3##(2008-10#2)
Determination of chromium in##2##4##(2008-10#2)
Determination of chromium##4##3##(2008-10#4)
Determination of clenbuterol##2##3##(2008-10#2)
Determination of copper##2##3##(2008-10#2)
Determination of diclofenac in pharmaceutical preparations##2##6##(2008-10#2)
Determination of ethanol in##2##4##(2008-10#2)
Determination of formaldehyde in##2##4##(2008-10#2)
Determination of free##2##3##(1990-8#1)(2008-10#1)
Determination of inorganic##5##3##(2008-10#5)
Determination of iron(III)##2##3##(2008-10#2)
Determination of lead and##3##4##(2008-10#3)
Determination of lead in##5##4##(2008-10#5)
Determination of lead##10##3##(2008-10#10)
Determination of low##2##3##(2008-10#2)
Determination of manganese in##2##4##(2008-10#2)
Determination of manganese##3##3##(2008-10#3)
Determination of mercury##2##3##(2008-10#2)
Determination of metal##2##3##(2008-10#2)
Determination of metals in##2##4##(2008-10#2)
Determination of metals##4##3##(2008-10#4)
Determination of methanol##2##3##(2008-10#2)
Determination of mono- and##2##4##(2008-10#2)
Determination of nickel in##2##4##(2008-10#2)
Determination of nickel##4##3##(2008-10#4)
Determination of nitrite##2##3##(2008-10#2)
Determination of optical##2##3##(2008-3#2)
Determination of paracetamol in##2##4##(2008-10#2)
Determination of phosphate in##2##4##(2008-10#2)
Determination of phthalate##2##3##(2008-10#1)(2008-5#1)
Determination of platinum and##2##4##(2008-10#2)
Determination of polybrominated diphenyl ethers in soil##2##7##(2008-10#2)
Determination of polybrominated##3##3##(2008-10#3)
Determination of polycyclic aromatic hydrocarbons##2##5##(2008-10#1)(2008-11#1)
Determination of protein##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
Determination of proteins##2##3##(2008-10#2)
Determination of rare earth elements in##2##6##(2008-10#2)
Determination of rare earth##3##4##(2008-10#3)
Determination of residual##2##3##(2008-10#2)
Determination of rhodium##3##3##(2008-10#3)
Determination of selenium in##2##4##(2008-10#2)
Determination of selenium species in##2##5##(2008-10#2)
Determination of selenium##4##3##(2008-10#4)
Determination of some##2##3##(2008-10#2)
Determination of stability constants for##2##5##(2008-10#2)
Determination of stability constants of##2##5##(2008-10#2)
Determination of stability constants##4##4##(2008-10#4)
Determination of sulphur##2##3##(2008-10#2)
Determination of the antioxidant##2##4##(2008-10#2)
Determination of the number##2##4##(1994-9#2)
Determination of the parameters of##2##5##(2008-3#2)
Determination of the total##3##4##(2008-10#3)
Determination of the##46##3##(1990-5#1)(1991-5#1)(1991-9#1)(1993-1#1)(1994-11#1)(1994-9#2)(1995-3#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#19)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
Determination of tin##2##3##(2008-10#2)
Determination of total chromium##2##4##(2008-10#2)
Determination of total mercury in##2##5##(2008-10#2)
Determination of total##17##3##(2008-10#16)(2012-2#1)
Determination of trace amounts of##4##5##(2008-10#4)
Determination of trace elements in##2##5##(2008-10#2)
Determination of trace mercury by solid##2##6##(2008-10#2)
Determination of trace metal ions##2##5##(2008-10#2)
Determination of trace metals##2##4##(2008-10#1)(2012-2#1)
Determination of trace##26##3##(2008-10#25)(2012-2#1)
Determination of traces of Ni##2##5##(2008-10#2)
Determination of traces of##3##4##(2008-10#3)
Determination of traces##4##3##(2008-10#4)
Determination of urinary##4##3##(1990-8#1)(2008-10#3)
Determination of volatile##2##3##(2008-10#2)
Determination of zinc in##2##4##(2008-10#2)
Determination of zinc##3##3##(2008-10#3)
Determination of##537##2##(1990-5#1)(1990-8#7)(1991-12#1)(1991-2#1)(1991-5#6)(1991-7#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-10#425)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#5)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
Determination##551##1##(1990-5#1)(1990-8#7)(1991-12#1)(1991-2#1)(1991-5#6)(1991-7#1)(1991-9#1)(1992-11#3)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2008-10#434)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#5)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
Determinations in##2##2##(2008-10#1)(2010-11#1)
Determinations of##4##2##(2008-10#4)
Determinations were made##3##3##(1991-4#1)(2008-10#2)
Determinations were##4##2##(1991-4#1)(2008-10#3)
Determinations##11##1##(1991-4#1)(2008-10#9)(2010-11#1)
Determine##3##1##(2008-10#1)(2008-11#1)(2010-2#1)
Determined by##5##2##(1990-11#1)(1997-7#1)(2008-10#2)(2008-2#1)
Determined##6##1##(1990-11#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-8#1)
Determining how##2##2##(2009-5#2)
Determining the##16##2##(1994-11#2)(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#2)
Determining##37##1##(1991-12#1)(1994-11#2)(1995-1#1)(1996-1#2)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)
Deterministic##4##1##(2007-11#1)(2008-11#1)(2008-8#1)(2012-2#1)
Dethiosulfovibrio peptidovorans##2##2##(2011-2#2)
Dethiosulfovibrio##3##1##(2011-2#3)
Detroit##3##1##(1991-1#1)(1993-12#1)(2008-5#1)
Deukhury##2##1##(2012-3#2)
Deuterium##2##1##(1990-7#1)(1992-4#1)
Develop##5##1##(1997-2#1)(2008-10#3)(2008-11#1)
Developed for##2##2##(2008-10#1)(2008-3#1)
Developed##12##1##(1991-1#1)(1996-1#1)(1996-12#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-3#2)(2012-2#2)(2013-1#1)
Developing a##17##2##(1991-1#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
Developing an##5##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-9#1)(2009-2#1)
Developing and##3##2##(1991-12#1)(1994-3#1)(2008-11#1)
Developing clinical##2##2##(2008-12#1)(2008-8#1)
Developing nursing practice##2##3##(2008-11#2)
Developing the##3##2##(2008-11#2)(2008-6#1)
Developing##64##1##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-11#9)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Development Group in##2##3##(2008-11#2)
Development Report##2##2##(1997-6#2)
Development and Evaluation##2##3##(2008-10#1)(2012-12#1)
Development and evaluation of a##2##5##(1995-12#1)(2008-11#1)
Development and evaluation of##6##4##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)
Development and implementation of a##2##5##(1992-2#1)(2013-1#1)
Development and implementation of##3##4##(1992-2#1)(2008-10#1)(2013-1#1)
Development and validation of a##5##5##(1992-9#1)(2008-10#2)(2009-12#1)(2011-1#1)
Development and validation of an##3##5##(1990-2#1)(1996-12#1)(2008-10#1)
Development and validation of##11##4##(1990-2#1)(1992-9#1)(1996-12#1)(2008-10#4)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
Development and validation##12##3##(1990-2#1)(1992-9#1)(1996-12#1)(2008-10#5)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
Development and##50##2##(1990-2#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
Development in the United States##2##5##(1990-3#1)(2009-5#1)
Development in##10##2##(1990-3#1)(2008-10#5)(2008-11#1)(2009-5#1)(2010-4#1)(2011-2#1)
Development is##4##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-9#1)
Development of Colletotrichum##2##3##(2008-10#2)
Development of Root##2##3##(2008-10#2)
Development of a differential##2##4##(2008-2#1)(2008-3#1)
Development of a flow##2##4##(1994-6#1)(2008-10#1)
Development of a new##3##4##(2008-10#1)(2009-7#1)(2011-1#1)
Development of a novel##4##4##(1991-9#1)(2008-10#2)(2008-6#1)
Development of a sensitive fluorescent derivatization reagent 1##2##8##(2008-10#2)
Development of a simple##2##4##(1990-12#1)(2008-10#1)
Development of a##97##3##(1990-12#1)(1991-9#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#40)(2008-11#3)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Development of an in vivo##2##5##(1996-2#1)(2008-7#1)
Development of an in##3##4##(1996-2#1)(2008-5#1)(2008-7#1)
Development of an##15##3##(1996-2#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
Development of efficient##2##3##(1997-2#1)(2008-4#1)
Development of new##4##3##(2008-10#2)(2008-7#1)(2010-5#1)
Development of the##16##3##(1992-3#1)(1994-9#1)(1995-5#1)(1997-3#1)(1997-6#1)(2007-12#4)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)
Development of##245##2##(1990-12#1)(1991-9#1)(1992-3#4)(1992-8#1)(1993-1#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#100)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#5)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
Development on##3##2##(2008-10#2)(2009-5#1)
Development organization##2##2##(2008-10#2)
Development##393##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#3)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#10)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#131)(2008-11#19)(2008-12#5)(2008-2#12)(2008-3#10)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#6)(2010-8#2)(2011-1#4)(2011-2#13)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#1)
Developmental Stages of##2##3##(2008-10#2)
Developmental and Reproductive##2##3##(2010-1#1)(2011-2#1)
Developmental and##4##2##(1990-11#1)(2008-8#1)(2010-1#1)(2011-2#1)
Developmental change##2##2##(1992-11#1)(1993-6#1)
Developmental changes in##5##3##(1996-2#1)(1996-5#2)(2008-11#1)(2009-7#1)
Developmental dysplasia of the hip##2##5##(2007-8#1)(2013-8#1)
Developmental expression##3##2##(1995-6#1)(1996-5#1)(1997-2#1)
Developmental##52##1##(1990-11#1)(1992-11#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#3)(1997-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Developmentally##2##1##(2010-7#2)
Developments in health care##2##4##(1996-12#1)(1997-2#1)
Developments in the##4##3##(1991-12#1)(1997-4#1)(2010-6#2)
Developments in##17##2##(1991-12#1)(1991-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-6#2)(2011-7#1)(2012-3#1)
Developments##19##1##(1991-12#1)(1991-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-6#2)(2011-7#1)(2012-3#1)
Deviance##2##1##(1994-9#1)(2011-1#1)
Deviations from##2##2##(2008-10#1)(2010-4#1)
Deviations##4##1##(2008-10#2)(2008-3#1)(2010-4#1)
Device physics##2##2##(2008-7#2)
Device##21##1##(1997-2#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#2)
Devices based on##2##3##(1995-3#1)(2007-11#1)
Devices##16##1##(1991-2#1)(1993-3#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
Dew##2##1##(2008-10#2)
Dewar valence isomer##2##3##(1992-8#2)
Dewar##3##1##(1992-8#2)(1995-11#1)
Dewars##2##1##(2008-3#2)
Dex##4##1##(2008-11#4)
Dexamethasone (1##2##2##(1995-12#1)(2011-2#1)
Dexamethasone Suppression Test##2##3##(2008-11#1)(2011-2#1)
Dexamethasone##20##1##(1990-3#1)(1991-12#1)(1994-3#1)(1994-6#3)(1995-12#3)(1995-8#1)(1996-5#1)(2007-5#1)(2007-7#1)(2008-11#3)(2011-2#2)(2012-2#2)
Dexamethasone-dependent modulation of##2##3##(1994-3#2)
Dexmedetomidine##2##1##(2008-7#1)(2011-2#1)
Dexrazoxane##2##1##(2008-11#2)
Dextran##2##1##(1991-9#1)(2008-7#1)
Dextromethorphan##3##1##(1991-1#1)(1996-2#2)
Dextrose##2##1##(2009-11#1)(2013-1#1)
Dezful##3##1##(2008-12#3)
Dharan##2##1##(2008-7#1)(2012-3#1)
Dhol Kochuri##2##2##(2008-12#2)
Di##4##1##(1990-8#1)(2008-11#2)(2008-3#1)
DiGeorge syndrome##2##2##(1991-11#1)(2009-5#1)
DiGeorge##3##1##(1991-11#1)(1997-3#1)(2009-5#1)
DiSTRIBuTE##4##1##(2011-9#4)
DiYMV##4##1##(2008-10#4)
Diabesity##2##1##(2013-8#2)
Diabetes Association##4##2##(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)
Diabetes Mellitus in##2##3##(2008-1#1)(2008-3#1)
Diabetes Mellitus is a##2##4##(2008-1#2)
Diabetes Mellitus##10##2##(1994-12#1)(2008-1#5)(2008-3#3)(2013-1#1)
Diabetes Research##3##2##(1990-11#2)(2013-1#1)
Diabetes and breast feeding##2##4##(1995-9#2)
Diabetes and hyperlipidemia##2##3##(2007-7#2)
Diabetes and##14##2##(1991-12#1)(1995-9#2)(1996-12#1)(2007-7#2)(2008-1#3)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
Diabetes in##3##2##(1995-11#1)(2008-10#1)(2009-5#1)
Diabetes insipidus##2##2##(2007-10#1)(2011-1#1)
Diabetes is a##4##3##(2008-1#2)(2010-11#1)(2012-12#1)
Diabetes is##9##2##(2008-1#5)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)
Diabetes mellitus (DM) is a##2##5##(2010-8#1)(2012-3#1)
Diabetes mellitus (DM) is##3##4##(2010-8#1)(2012-2#1)(2012-3#1)
Diabetes mellitus (DM)##6##3##(2010-8#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
Diabetes mellitus and##4##3##(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
Diabetes mellitus in##2##3##(2013-1#1)(2013-8#1)
Diabetes mellitus is a##3##4##(2006-10#1)(2008-7#1)(2011-1#1)
Diabetes mellitus is##8##3##(1992-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
Diabetes mellitus was the##2##4##(2007-7#1)(2008-1#1)
Diabetes mellitus##27##2##(1992-8#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
Diabetes was induced in Wistar##2##5##(2012-2#1)(2012-3#1)
Diabetes was the commonest cause##2##5##(2007-7#1)(2008-1#1)
Diabetes was the commonest##3##4##(2007-7#2)(2008-1#1)
Diabetes was the##4##3##(2007-10#1)(2007-7#2)(2008-1#1)
Diabetes was##6##2##(2007-10#1)(2007-7#2)(2008-1#1)(2012-2#1)(2012-3#1)
Diabetes##112##1##(1990-11#2)(1991-12#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-9#2)(1996-12#1)(1996-8#1)(2006-10#1)(2007-10#2)(2007-7#5)(2008-1#22)(2008-10#2)(2008-11#1)(2008-3#6)(2008-7#5)(2008-8#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#6)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#5)
Diabetic Patients##2##2##(2007-7#1)(2012-3#1)
Diabetic Retinopathy##3##2##(1995-9#1)(2010-10#1)(2010-8#1)
Diabetic foot ulcer##2##3##(2010-10#1)(2013-1#1)
Diabetic nephropathy is##3##3##(2008-1#2)(2012-3#1)
Diabetic nephropathy##6##2##(2007-7#2)(2008-1#3)(2012-3#1)
Diabetic retinopathy (DR) is##2##4##(2008-1#1)(2011-2#1)
Diabetic retinopathy (DR)##3##3##(2008-1#2)(2011-2#1)
Diabetic retinopathy is##3##3##(2008-8#1)(2010-10#1)(2012-2#1)
Diabetic retinopathy##6##2##(2008-1#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
Diabetic##44##1##(1994-12#2)(1995-9#1)(2007-7#3)(2008-1#10)(2008-8#2)(2010-10#4)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)
Diabrotica virgifera virgifera LeConte##2##4##(2011-2#2)
Diabrotica##5##1##(2008-10#1)(2008-5#2)(2011-2#2)
Diabrotica-resistant Bt-maize##2##2##(2011-2#2)
Diacetyl production##2##2##(2008-6#2)
Diacylglycerol##4##1##(1990-12#1)(1990-5#1)(1992-9#1)(1995-2#1)
Diadema antillarum##5##2##(2008-5#3)(2011-2#2)
Diaeretiella rapae##2##2##(2009-8#2)
Diagn##2##1##(1996-12#1)(2012-2#1)
Diagnosed##3##1##(2008-3#1)(2008-6#1)(2008-7#1)
Diagnoses were##2##2##(1991-8#1)(2012-12#1)
Diagnoses##8##1##(1991-8#2)(1992-9#1)(2008-10#1)(2008-11#3)(2012-12#1)
Diagnosing and managing polymyalgia rheumatica and temporal arteritis##5##8##(1997-8#5)
Diagnosing and managing##6##3##(1997-8#5)(2013-8#1)
Diagnosing##17##1##(1991-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1994-7#1)(1995-12#1)(1996-6#1)(1997-8#5)(2011-2#1)(2012-2#1)(2013-8#2)
Diagnosis and management of##4##4##(2007-12#1)(2008-1#1)(2008-3#2)
Diagnosis and therapy of##2##4##(1996-11#1)(2008-10#1)
Diagnosis and therapy##3##3##(1996-11#2)(2008-10#1)
Diagnosis and treatment of##12##4##(1996-3#1)(1996-6#1)(2007-10#1)(2007-12#6)(2008-6#2)(2012-3#1)
Diagnosis and treatment##14##3##(1996-3#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#6)(2008-12#1)(2008-6#2)(2012-3#1)
Diagnosis and##37##2##(1991-2#1)(1991-6#2)(1993-2#1)(1993-3#1)(1993-5#1)(1996-11#2)(1996-3#1)(1996-6#2)(1997-3#1)(2007-10#2)(2007-12#8)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2012-12#1)(2012-3#1)(2013-1#1)
Diagnosis in##3##2##(1995-11#1)(1997-2#1)(2008-10#1)
Diagnosis is based on##2##4##(2007-8#1)(2013-1#1)
Diagnosis is based##3##3##(1996-3#1)(2007-8#1)(2013-1#1)
Diagnosis is difficult##2##3##(2009-1#1)(2012-2#1)
Diagnosis is made##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
Diagnosis is usually made##3##4##(2012-1#1)(2012-2#1)(2013-1#1)
Diagnosis is##15##2##(1991-11#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-1#1)(2009-8#1)(2012-1#1)(2012-2#5)(2013-1#2)
Diagnosis may be##2##3##(1992-2#1)(2012-3#1)
Diagnosis of a##2##3##(2012-2#1)(2013-1#1)
Diagnosis of intracranial injury##2##4##(1997-5#2)
Diagnosis of primary##2##3##(2007-12#1)(2011-1#1)
Diagnosis of the##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
Diagnosis of##70##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-8#1)(1993-2#1)(1995-10#1)(1995-3#2)(1996-12#2)(1997-3#1)(1997-5#2)(1997-8#4)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#5)(2009-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)
Diagnosis was based on##3##4##(1993-9#1)(2008-11#1)(2008-6#1)
Diagnosis was confirmed by##2##4##(2011-1#1)(2012-12#1)
Diagnosis was established##2##3##(2008-7#1)(2011-2#1)
Diagnosis was histological##2##3##(1991-11#1)(2007-8#1)
Diagnosis was##12##2##(1990-5#1)(1991-11#1)(1993-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Diagnosis##162##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-6#2)(1991-8#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-3#2)(1996-11#2)(1996-12#3)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#2)(1997-8#4)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#4)(2013-1#13)
Diagnoskin##2##1##(2008-5#2)
Diagnostic Criteria##2##2##(2008-6#1)(2009-9#1)
Diagnostic Imaging##2##2##(1994-2#1)(1995-3#1)
Diagnostic Interview##3##2##(2006-10#1)(2008-11#1)(2012-12#1)
Diagnostic Oncology##2##2##(1991-12#1)(2008-6#1)
Diagnostic Related##2##2##(1993-3#1)(1994-3#1)
Diagnostic Test##2##2##(2008-10#2)
Diagnostic and Statistical Manual of Mental Disorders##12##7##(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#6)(2013-1#1)
Diagnostic and Statistical Manual##13##4##(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#7)(2013-1#1)
Diagnostic and therapeutic##2##3##(2008-7#1)(2009-5#1)
Diagnostic and##18##2##(1991-2#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-11#1)(2011-1#2)(2011-2#7)(2013-1#1)
Diagnostic criteria for##3##3##(1997-8#1)(2009-3#1)(2012-12#1)
Diagnostic criteria##6##2##(1992-11#1)(1997-8#2)(2009-3#1)(2012-12#1)(2012-3#1)
Diagnostic delay in##2##3##(1990-12#2)
Diagnostic delay##3##2##(1990-12#3)
Diagnostic imaging of##2##3##(2007-11#1)(2007-12#1)
Diagnostic imaging##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2009-4#1)(2011-2#1)
Diagnostic problems##4##2##(1993-6#1)(1995-6#1)(2007-11#1)(2008-7#1)
Diagnostic procedures##2##2##(1990-9#1)(1993-6#1)
Diagnostic role##2##2##(2008-7#2)
Diagnostic value of##4##3##(1997-8#1)(2008-7#1)(2011-2#1)(2012-1#1)
Diagnostic yield##2##2##(2009-7#1)(2011-2#1)
Diagnostic##121##1##(1990-10#1)(1990-12#3)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#10)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#14)(2012-1#2)(2012-12#5)(2012-3#3)(2013-1#6)(2013-7#1)
Diagnostics and##2##2##(2007-11#1)(2010-6#1)
Diagnostics##11##1##(1994-12#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-6#1)
Diagonal gel electrophoresis##2##3##(2008-4#2)
Diaion HP-2MG resin##2##3##(2008-10#2)
Diaion HP-2MG##4##2##(2008-10#4)
Diaion##5##1##(2008-10#5)
Dialipon##2##1##(2011-1#2)
Dialogues##2##1##(2008-11#1)(2012-3#1)
Dialysate##2##1##(2008-1#1)(2011-2#1)
Dialysis Patient##2##2##(2007-7#1)(2011-1#1)
Dialysis of##2##2##(1992-12#1)(2008-10#1)
Dialysis##19##1##(1992-12#1)(1994-2#1)(2006-10#1)(2007-12#4)(2007-7#3)(2008-1#4)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)
Diameter##2##1##(2008-5#1)(2009-2#1)
Diamine oxidase##2##2##(1992-8#1)(2008-10#1)
Diamond and##3##2##(1990-8#1)(1996-9#1)(2007-5#1)
Diamond##6##1##(1990-8#1)(1996-9#1)(2007-10#1)(2007-5#1)(2008-10#2)
Diapause##3##1##(2008-5#1)(2013-1#2)
Diaporthe and Phomopsis##2##3##(2008-10#2)
Diaporthe phaseolorum and Phomopsis longicolla##4##5##(2008-10#4)
Diaporthe phaseolorum##6##2##(2008-10#6)
Diaporthe##9##1##(2008-10#9)
Diaporthe/Phomopsis helianthi##2##2##(2008-10#2)
Diaporthe/Phomopsis##4##1##(2008-10#4)
Diapterus##3##1##(2008-5#2)(2013-7#1)
Diarrhea in##2##2##(2011-2#2)
Diarrhea##4##1##(1992-12#1)(1996-3#1)(2011-2#2)
Diastat##3##1##(2007-7#3)
Diastereoselective Synthesis of a##2##4##(2008-10#1)(2009-7#1)
Diastereoselective Synthesis of##3##3##(1996-5#1)(2008-10#1)(2009-7#1)
Diastereoselective##8##1##(1996-5#6)(2008-10#1)(2009-7#1)
Diazepam##2##1##(1991-1#1)(1991-12#1)
Dibutyryl##2##1##(1993-8#1)(1995-8#1)
Dicarboximide Resistance##2##2##(2008-10#2)
Dicarboximide##5##1##(2008-10#5)
Dice Task##2##2##(2009-10#2)
Dice##5##1##(2008-10#2)(2009-10#2)(2013-8#1)
Dichelobacter nodosus##3##2##(1993-12#2)(2011-2#1)
Dichloroacetic acid is##2##3##(2008-10#1)(2008-9#1)
Dichloroacetic acid was##4##3##(2008-9#4)
Dichloroacetic acid##7##2##(2008-10#2)(2008-9#5)
Dicistronic RNA transfections##2##3##(2008-9#2)
Dicistronic##5##1##(1993-6#2)(1997-8#1)(2008-9#2)
Dickeya spp##2##2##(2008-10#2)
Dickeya##4##1##(2008-10#4)
Dickinson##3##1##(2008-4#2)(2011-2#1)
Dickson##2##1##(1992-1#1)(2012-3#1)
Dicliptera sexangularis##2##2##(2008-10#2)
Dicliptera##3##1##(2008-10#3)
Diclofenac##2##1##(2008-10#1)(2010-8#1)
Dictyostelium discoideum homologues##2##3##(1993-6#2)
Dictyostelium discoideum##13##2##(1991-2#2)(1991-9#1)(1993-6#2)(1994-12#1)(1995-6#2)(1995-8#1)(1997-3#2)(2008-9#1)(2009-8#1)
Dictyostelium##22##1##(1991-2#2)(1991-9#3)(1993-6#3)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#2)(1997-3#2)(2008-9#2)(2009-8#2)(2010-9#1)
Dicyclohexylcarbodiimide was##2##2##(2008-9#2)
Dicyclohexylcarbodiimide##3##1##(2008-9#3)
Did the##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
Did##5##1##(1992-1#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-8#1)
Didactics Applied to Care##2##4##(2012-3#2)
Didelphis virginiana##2##2##(1996-5#2)
Didelphis##3##1##(1996-5#2)(2008-5#1)
Didymella bryoniae##2##2##(2008-10#2)
Didymella rabiei in Chickpea##2##4##(2008-10#2)
Didymella rabiei##7##2##(2008-10#7)
Didymella##11##1##(2008-10#11)
Dieback of##2##2##(2008-10#2)
Dieffenbachia##2##1##(2008-10#1)(2008-5#1)
Dielectric##2##1##(2008-5#1)(2012-1#1)
Diels-Alder cycloaddition##6##2##(1996-5#4)(2008-4#2)
Diels-Alder cycloadduct##2##2##(1996-5#2)
Diels-Alder reaction of##3##3##(1996-5#2)(2007-11#1)
Diels-Alder reaction##6##2##(1996-5#2)(2007-11#2)(2008-6#2)
Diels-Alder reactions##2##2##(1996-5#1)(2008-8#1)
Diels-Alder##22##1##(1996-5#12)(2007-11#2)(2008-4#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-12#1)(2011-3#1)
Diesel engine##3##2##(2008-3#2)(2013-1#1)
Diesel fuel##3##2##(2008-2#1)(2008-3#2)
Diesel spray##3##2##(2008-3#3)
Diesel##15##1##(2008-10#2)(2008-2#1)(2008-3#10)(2009-8#1)(2013-1#1)
Diessenhofen##2##1##(1996-11#2)
Diet and exercise are##2##4##(2008-5#1)(2009-3#1)
Diet and##9##2##(1990-8#2)(1991-12#1)(1993-9#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-4#1)(2013-1#1)
Diet can##2##2##(1990-8#1)(2008-3#1)
Diet in dermatology##2##3##(2007-7#2)
Diet in##6##2##(1994-3#1)(2007-7#2)(2010-4#1)(2011-2#1)(2013-1#1)
Diet is##2##2##(1997-8#1)(2011-2#1)
Diet quality of##2##3##(2011-2#2)
Diet was##2##2##(2008-3#1)(2008-5#1)
Diet##31##1##(1990-8#3)(1991-12#1)(1993-9#1)(1994-3#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-3#8)(2008-5#2)(2009-3#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
Diet)##2##1##(2008-3#2)
Dietary Guidelines for Americans##2##4##(2012-2#2)
Dietary Guidelines##5##2##(2010-1#2)(2012-2#3)
Dietary antioxidants##2##2##(1992-9#1)(2008-10#1)
Dietary ellagic acid##2##3##(1994-6#2)
Dietary factors##2##2##(2008-10#1)(2009-8#1)
Dietary fat##3##2##(2008-1#1)(2008-4#1)(2010-4#1)
Dietary fiber##2##2##(2010-10#1)(2012-2#1)
Dietary habits##3##2##(1990-8#1)(1992-8#1)(1997-8#1)
Dietary intake##2##2##(1991-2#1)(2013-1#1)
Dietary modification##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
Dietary proteins##2##2##(2012-1#2)
Dietary supplements and sports performance##5##5##(2008-5#5)
Dietary##64##1##(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-8#1)(1992-9#2)(1994-11#1)(1994-2#1)(1994-6#2)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-4#3)(2008-5#6)(2008-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-6#1)(2012-1#2)(2012-2#9)(2012-3#1)(2013-1#3)(2013-7#1)
Dietetic Association##12##2##(1994-2#4)(1995-1#1)(1995-2#2)(1995-3#2)(1996-1#1)(2008-5#1)(2012-12#1)
Dietetic##13##1##(1994-2#4)(1995-1#1)(1995-2#2)(1995-3#2)(1996-1#2)(2008-5#1)(2012-12#1)
Dietitians##2##1##(1994-2#1)(1995-2#1)
Diets##2##1##(1993-11#1)(2012-2#1)
Differ in##2##2##(2008-10#2)
Difference Frequency Generation##2##3##(2008-2#1)(2008-3#1)
Difference between##2##2##(2007-10#1)(2007-8#1)
Difference frequency generation##2##3##(2007-11#1)(2007-12#1)
Difference gel electrophoresis (DIGE)##2##4##(2008-2#2)
Difference in##3##2##(1997-6#1)(2008-10#1)(2008-2#1)
Difference##27##1##(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#9)(2008-2#4)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Differences among##2##2##(2008-10#2)
Differences and##3##2##(1993-12#1)(2008-10#1)(2010-12#1)
Differences between the two##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
Differences between the##5##3##(1992-1#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-3#1)
Differences between##18##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)
Differences by##2##2##(1995-2#1)(2012-12#1)
Differences in the##25##3##(1990-12#1)(1992-12#1)(1992-4#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
Differences in##82##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-4#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#4)(2009-2#1)(2009-5#1)(2010-10#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#3)
Differences of##2##2##(2008-5#1)(2012-3#1)
Differences were considered##2##3##(2011-2#1)(2013-1#1)
Differences were##6##2##(1991-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Differences with##2##2##(2008-1#1)(2008-2#1)
Differences##133##1##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#3)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)
Different Prunus spp##2##3##(2008-10#2)
Different analytical##3##2##(2008-10#3)
Different aspects of record-keeping##2##4##(1994-12#1)(1995-1#1)
Different aspects of##4##3##(1994-12#1)(1995-1#1)(2008-7#1)(2013-7#1)
Different aspects##5##2##(1994-12#1)(1995-1#1)(2008-10#1)(2008-7#1)(2013-7#1)
Different batches were prepared##2##4##(2010-3#1)(2011-1#1)
Different concentrations of##2##3##(2008-3#1)(2010-3#1)
Different evaluation methods##2##3##(2008-10#2)
Different experimental variables##2##3##(2008-10#2)
Different experimental##4##2##(2007-10#1)(2008-10#2)(2011-1#1)
Different factors including pH of sample solution##2##7##(2008-10#2)
Different factors##8##2##(2008-1#1)(2008-10#6)(2012-3#1)
Different forms of##2##3##(2008-10#1)(2011-2#1)
Different from the##2##3##(1997-8#1)(2006-10#1)
Different from##3##2##(1997-8#1)(2006-10#1)(2008-1#1)
Different groups##3##2##(2008-10#1)(2010-10#1)(2012-2#1)
Different individual##2##2##(2008-11#1)(2008-9#1)
Different isoforms##2##2##(1993-8#1)(2009-9#1)
Different kinds of##2##3##(2008-10#1)(2008-4#1)
Different magnifications##2##2##(2008-3#1)(2011-1#1)
Different methods were used##2##4##(2008-10#1)(2008-12#1)
Different methods##6##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
Different parameters were tested to optimize the conditions for the determination of##2##12##(2008-10#2)
Different parameters were##3##3##(2008-10#3)
Different parameters##6##2##(2008-1#1)(2008-10#3)(2012-2#1)(2013-1#1)
Different possible##2##2##(1994-3#1)(2008-3#1)
Different procedures have been##2##4##(2008-10#1)(2011-7#1)
Different solvents##2##2##(1994-3#1)(2012-2#1)
Different species of##2##3##(2008-11#1)(2008-8#1)
Different techniques##3##2##(2008-10#3)
Different types of##9##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
Different variables and parameters affecting the reactions were studied and optimized##2##11##(2008-10#2)
Different variables##4##2##(2008-10#4)
Different##240##1##(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-8#3)(2008-1#3)(2008-10#98)(2008-11#9)(2008-12#4)(2008-2#9)(2008-3#12)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#8)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#7)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#1)
Differential Absorption Lidar##2##3##(2008-3#2)
Differential Expression of##2##3##(2008-5#1)(2008-6#1)
Differential Expression##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
Differential diagnoses##2##2##(2013-1#2)
Differential diagnosis and management of##2##5##(2006-12#1)(2008-3#1)
Differential diagnosis and therapy##2##4##(1992-5#1)(1997-8#1)
Differential diagnosis and##5##3##(1992-5#1)(1997-8#1)(2006-12#1)(2008-3#1)(2011-2#1)
Differential diagnosis of##3##3##(2007-11#1)(2010-7#1)(2011-2#1)
Differential diagnosis##10##2##(1992-5#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2010-7#1)(2011-2#3)
Differential diagnostic##2##2##(2009-8#1)(2011-2#1)
Differential effect of##4##3##(1994-5#1)(1997-7#1)(2008-11#1)(2008-4#1)
Differential effects of##11##3##(1991-1#1)(1992-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
Differential electrolytic potentiometry##2##3##(2008-10#2)
Differential electrolytic##3##2##(2008-10#3)
Differential expression of mRNAs##2##4##(1995-2#1)(2008-11#1)
Differential expression of##11##3##(1992-12#1)(1992-3#1)(1993-6#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-11#1)(2012-1#1)
Differential expression##13##2##(1992-12#1)(1992-3#1)(1993-6#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-1#1)
Differential gene##3##2##(1995-11#1)(2008-7#1)(2012-3#1)
Differential modulation##2##2##(1995-12#1)(2008-8#1)
Differential pulse anodic stripping voltammetry##2##5##(2008-10#2)
Differential pulse anodic stripping##3##4##(2008-10#3)
Differential pulse polarographic determination of trace##2##6##(2008-10#2)
Differential pulse polarographic determination of##7##5##(2008-10#7)
Differential pulse polarographic##8##3##(2008-10#8)
Differential pulse polarography##2##3##(2008-10#2)
Differential pulse voltammetry##2##3##(2008-10#2)
Differential pulse##17##2##(2008-10#17)
Differential regulation of##2##3##(1996-12#1)(2010-12#1)
Differential regulation##3##2##(1991-12#1)(1996-12#1)(2010-12#1)
Differential scanning calorimetric##3##3##(1990-7#1)(1990-8#2)
Differential scanning calorimetry (DSC)##2##4##(2008-8#2)
Differential scanning calorimetry study##2##4##(1990-7#1)(1994-3#1)
Differential scanning calorimetry##8##3##(1990-7#1)(1992-3#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-8#2)(2011-1#1)
Differential scanning potentiometry##2##3##(2008-10#2)
Differential scanning##13##2##(1990-7#2)(1990-8#2)(1992-3#1)(1994-3#1)(1995-11#1)(2008-10#3)(2008-8#2)(2011-1#1)
Differential staining of##2##3##(1990-7#1)(2008-9#1)
Differential##161##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#4)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
Differentially##5##1##(2008-10#3)(2010-8#1)(2011-2#1)
Differentiated##2##1##(1990-11#1)(2013-1#1)
Differentiating##2##1##(2008-10#1)(2008-11#1)
Differentiation and characterization of##2##4##(2008-4#2)
Differentiation and##8##2##(1993-3#1)(2008-10#4)(2008-4#2)(2013-1#1)
Differentiation in##2##2##(2008-10#1)(2008-5#1)
Differentiation of Tilletia##2##3##(2008-10#2)
Differentiation of human##2##3##(2008-4#1)(2008-9#1)
Differentiation of plant##2##3##(2008-7#2)
Differentiation of##33##2##(1990-4#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-6#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Differentiation was##2##2##(1992-12#1)(2008-10#1)
Differentiation##57##1##(1990-4#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#22)(2008-11#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Differently##3##1##(2008-10#1)(2008-6#1)(2010-8#1)
Differing##4##1##(1993-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
Difficult##5##1##(1993-10#1)(1993-7#1)(1994-2#1)(2007-12#1)(2010-11#1)
Difficult-to-control asthma##2##2##(2009-6#2)
Difficulties encountered##2##2##(2008-11#1)(2008-7#1)
Difficulties in the##2##3##(2007-11#1)(2008-11#1)
Difficulties in##5##2##(2007-11#1)(2008-11#1)(2008-7#2)(2011-2#1)
Difficulties##13##1##(1992-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
Difficulty in##2##2##(2010-12#1)(2010-7#1)
Difficulty##3##1##(1993-1#1)(2010-12#1)(2010-7#1)
Diffracted##2##1##(2007-12#1)(2008-3#1)
Diffraction and##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
Diffraction efficiencies##3##2##(2008-2#1)(2008-3#2)
Diffraction efficiency of##2##3##(2007-12#1)(2008-2#1)
Diffraction efficiency##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Diffraction gratings were##2##3##(2007-11#1)(2008-3#1)
Diffraction gratings##3##2##(2007-11#1)(2008-3#2)
Diffraction of##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Diffraction properties of##2##3##(2007-12#1)(2008-3#1)
Diffraction tomography##3##2##(2007-11#1)(2008-3#2)
Diffraction##37##1##(1996-2#1)(1997-7#2)(2007-11#2)(2007-12#3)(2008-11#2)(2008-2#7)(2008-3#17)(2008-7#3)
Diffraction-limited imaging##2##2##(2008-3#2)
Diffraction-limited##7##1##(2007-11#3)(2007-12#2)(2008-3#2)
Diffractive optical element##2##3##(2008-3#2)
Diffractive optical elements##3##3##(2008-2#1)(2008-3#2)
Diffractive optical##5##2##(2008-2#1)(2008-3#4)
Diffractive optics and micro-optics##2##4##(2008-3#2)
Diffractive optics##3##2##(2008-3#3)
Diffractive##13##1##(2007-12#1)(2008-2#2)(2008-3#10)
Diffuse alveolar##2##2##(2006-10#1)(2008-1#1)
Diffuse pulmonary##2##2##(2008-11#1)(2011-2#1)
Diffuse reflectance spectroscopy##2##3##(2008-10#1)(2008-3#1)
Diffuse reflectance##5##2##(2008-10#3)(2008-3#2)
Diffuse##30##1##(1990-5#1)(1991-11#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Diffuse-reflectance spectroscopy##2##2##(2007-11#2)
Diffusing##3##1##(2007-12#1)(2008-8#1)(2010-10#1)
Diffusion Tensor##3##2##(2010-6#2)(2010-7#1)
Diffusion coefficient##2##2##(2007-11#1)(2008-10#1)
Diffusion of##8##2##(1993-2#1)(1993-6#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-10#1)
Diffusion##26##1##(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-9#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-6#2)(2010-7#1)(2013-1#1)(2013-8#2)
Diffusion-limited aggregation##2##2##(1990-4#1)(2008-3#1)
Diffusion-weighted and perfusion-weighted magnetic resonance imaging##2##6##(2007-9#2)
Diffusion-weighted##5##1##(2007-10#2)(2007-9#2)(2008-11#1)
Digestion of the##2##3##(2008-10#2)
Digestion of##6##2##(1990-12#1)(2008-10#4)(2008-11#1)
Digestion##10##1##(1990-12#1)(1990-5#1)(1992-12#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-7#1)
Digestive##5##1##(1992-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#1)
Digging##2##1##(2008-4#1)(2012-3#1)
DigiTag2 assay##2##2##(2012-1#2)
Digit##2##1##(1992-6#1)(2012-12#1)
Digital Image##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
Digital images of##2##3##(2008-3#1)(2008-4#1)
Digital microscopy##3##2##(2008-9#1)(2011-2#2)
Digital recording##2##2##(2008-1#1)(2008-3#1)
Digital speckle##3##2##(2008-3#2)(2008-8#1)
Digital##44##1##(1995-11#1)(1997-3#1)(2007-11#6)(2007-5#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-8#1)
Digitaria##2##1##(2008-10#2)
Digitized##3##1##(1990-7#1)(1996-6#1)(2008-10#1)
Dignity##2##1##(2010-10#2)
Dihydrogen##3##1##(1996-2#1)(1997-7#1)(2009-10#1)
Dil##2##1##(1996-6#1)(2008-11#1)
Dilatation##4##1##(1990-12#2)(2008-11#1)(2012-2#1)
Dilated cardiomyopathy##3##2##(1997-8#1)(2008-7#1)(2013-7#1)
Dilated##5##1##(1997-8#1)(2008-7#2)(2008-8#1)(2013-7#1)
Dilemma##2##1##(2008-8#1)(2013-1#1)
Diltiazem##2##1##(1992-8#1)(2007-7#1)
Dilute##3##1##(1996-9#1)(2008-10#1)(2009-5#1)
Dilution##2##1##(1995-11#1)(1995-12#1)
Dimension##9##1##(2008-10#9)
Dimensional changes in##2##3##(2007-12#1)(2012-2#1)
Dimensional changes##3##2##(2007-12#1)(2012-2#2)
Dimensional##8##1##(1992-11#1)(2007-12#1)(2008-11#1)(2008-8#2)(2011-2#1)(2012-2#2)
Dimensionless##2##1##(1995-2#1)(2008-2#1)
Dimensions of##2##2##(1993-1#1)(2013-1#1)
Dimensions##8##1##(1993-1#1)(1996-9#2)(2006-12#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
Dimeric##8##1##(1993-11#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-2#2)(2008-11#1)(2010-2#1)
Dimerization##3##1##(1993-8#1)(1994-8#1)(2008-9#1)
Dimers##3##1##(1996-2#1)(1997-7#1)(2009-9#1)
Dimethylglyoxime##2##1##(2008-10#2)
Diminished##5##1##(1991-2#1)(1994-5#1)(2008-2#1)(2008-3#1)(2010-8#1)
Diminution of##2##2##(2008-11#1)(2009-8#1)
Dinitrogen##2##1##(1997-7#1)(2010-12#1)
Dinners##2##1##(2011-2#1)(2013-1#1)
Dinuclear##4##1##(1996-2#1)(1997-7#3)
Dinucleoside polyphosphates##2##2##(2008-4#1)(2009-2#1)
Diode Laser at##2##3##(2008-2#2)
Diode Laser##4##2##(2008-2#4)
Diode Lasers##2##2##(2008-2#1)(2008-3#1)
Diode laser##3##2##(2007-12#2)(2008-2#1)
Diode lasers##2##2##(2008-10#1)(2008-3#1)
Diode##14##1##(2007-12#2)(2008-10#1)(2008-2#9)(2008-3#2)
Diode-Laser Absorption##3##2##(2008-2#1)(2008-3#2)
Diode-Laser##6##1##(2008-2#1)(2008-3#5)
Diode-Pumped Nd##4##2##(2008-2#3)(2008-3#1)
Diode-Pumped##15##1##(2008-2#8)(2008-3#7)
Diode-laser##3##1##(2007-11#1)(2008-3#2)
Diode-laser-pumped##2##1##(2008-2#2)
Diode-pumped 1-W##2##2##(2007-12#2)
Diode-pumped##14##1##(2007-11#6)(2007-12#6)(2008-2#1)(2008-3#1)
Diol##3##1##(1996-5#1)(2013-1#2)
Dioscorea##10##1##(2008-5#10)
Dioxide##6##1##(1992-7#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)
Dioxin and##2##2##(2008-11#1)(2008-7#1)
Dioxin##5##1##(2008-10#1)(2008-11#2)(2008-7#2)
Dioxins##2##1##(2008-10#1)(2008-11#1)
Diphtheria##3##1##(1995-3#1)(1996-6#1)(1996-8#1)
Dipicolinic acid (DPA)##2##3##(2008-10#1)(2011-2#1)
Diploid##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
Diploma in Nursing##3##3##(2008-11#3)
Diploma in##7##2##(2008-1#1)(2008-11#5)(2013-1#1)
Diploma##9##1##(2008-1#2)(2008-11#6)(2013-1#1)
Diplopia##2##1##(1996-9#1)(2012-2#1)
Diploptera punctata##5##2##(1995-11#3)(2008-7#2)
Dipping##3##1##(2007-3#1)(2010-1#2)
Dipstick tests##2##2##(2007-2#2)
Dipstick##3##1##(2007-2#2)(2012-2#1)
Diptera##5##1##(2007-12#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)
Dipterocarpaceae)##2##1##(2013-8#2)
Dipyridamole##3##1##(2008-4#1)(2008-7#2)
Direct Access Diagnostics##2##3##(1996-5#2)
Direct Observation##2##2##(1996-12#1)(2010-8#1)
Direct access magnetic resonance imaging of the knee for GPs##3##10##(1996-3#3)
Direct analysis##2##2##(1995-6#1)(2008-10#1)
Direct and indirect##2##3##(2008-9#2)
Direct and##6##2##(1996-5#1)(2008-1#1)(2008-10#2)(2008-9#2)
Direct binding##2##2##(1991-9#1)(1995-2#1)
Direct detection of##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
Direct determination of cadmium in##2##5##(2008-10#2)
Direct determination of cadmium##4##4##(2008-10#4)
Direct determination of the##2##4##(1990-8#1)(2008-2#1)
Direct determination of trace##2##4##(2008-10#2)
Direct determination of##25##3##(1990-8#1)(2008-10#22)(2008-2#1)(2008-3#1)
Direct electrochemistry and##2##3##(2008-10#2)
Direct electrochemistry##3##2##(2008-10#3)
Direct electron transfer##2##3##(2008-10#2)
Direct evidence for##3##3##(1993-11#1)(2008-7#1)(2012-12#1)
Direct gene transfer##2##3##(1994-5#2)
Direct in##2##2##(1991-5#1)(2008-10#1)
Direct injection of##2##3##(1990-8#1)(2008-9#1)
Direct injection##4##2##(1990-8#1)(1991-5#1)(2008-7#1)(2008-9#1)
Direct interaction of##2##3##(2008-11#1)(2011-2#1)
Direct interaction##4##2##(1995-2#1)(2008-11#1)(2011-2#2)
Direct measurement of the##3##4##(2007-12#1)(2008-3#1)(2008-9#1)
Direct measurement of##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2011-1#1)
Direct observation of##2##3##(1991-9#1)(2008-10#1)
Direct sequencing of##2##3##(2008-10#1)(2008-12#1)
Direct stenting##2##2##(2008-11#1)(2009-5#1)
Direct visualization of##2##3##(2010-6#2)
Direct##166##1##(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-5#3)(1994-8#2)(1995-2#3)(1995-3#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#3)(1996-9#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#47)(2008-11#7)(2008-12#2)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)
Directed evolution##2##2##(2010-4#1)(2011-1#1)
Directed##9##1##(1997-2#1)(2008-11#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)
Directional##8##1##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
Directions for future research##2##4##(2009-11#1)(2013-1#1)
Directions for##3##2##(1991-1#1)(2009-11#1)(2013-1#1)
Directions in##5##2##(1990-8#1)(1991-3#1)(2010-11#1)(2010-2#1)(2011-1#1)
Directions##10##1##(1990-8#1)(1991-1#1)(1991-3#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
Directive##11##1##(2008-10#6)(2008-11#4)(2008-5#1)
Directly diode-pumped##2##2##(2007-11#1)(2007-12#1)
Directly observed therapy (DOT)##2##4##(1996-3#2)
Directly observed therapy##5##3##(1996-3#3)(1997-8#1)(2008-10#1)
Directly##17##1##(1994-12#1)(1994-2#1)(1996-3#3)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2013-1#1)
Director of the Institute##2##4##(1996-4#1)(2008-5#1)
Director of the##4##3##(1995-1#1)(1996-4#1)(2008-11#1)(2008-5#1)
Director of##5##2##(1994-2#1)(1995-1#1)(1996-4#1)(2008-11#1)(2008-5#1)
Director##9##1##(1991-12#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
Directors of##3##2##(1992-1#1)(1992-12#1)(1993-2#1)
Directors##5##1##(1992-1#1)(1992-12#1)(1993-2#1)(2008-11#1)(2008-6#1)
Directory of##4##2##(1996-3#1)(2007-2#2)(2012-2#1)
Disabilities Act (ADA)##13##3##(1994-1#2)(1995-12#4)(1995-6#2)(1996-1#1)(1996-5#1)(1997-5#3)
Disabilities Act of 1990##2##4##(1993-1#1)(1995-1#1)
Disabilities Act##30##2##(1991-12#3)(1992-12#1)(1993-1#3)(1993-3#2)(1994-1#5)(1994-2#1)(1995-1#2)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)
Disabilities of the Arm##3##4##(2008-9#3)
Disabilities##37##1##(1991-12#3)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#5)(1994-2#1)(1995-1#2)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)(2008-12#1)(2008-9#3)(2010-10#1)(2012-2#1)
Disability Index##10##2##(2008-12#3)(2009-3#1)(2012-12#4)(2012-3#2)
Disability Status##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
Disability and Health (ICF)##3##4##(2007-12#1)(2011-2#1)(2012-12#1)
Disability and Health##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
Disability and##5##2##(1992-3#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
Disability##29##1##(1991-1#1)(1992-12#1)(1992-3#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#3)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#1)
Disabled##4##1##(1995-2#1)(1996-2#1)(2008-11#1)(2010-7#1)
Disadvantage##2##1##(2008-5#1)(2013-1#1)
Disadvantages##3##1##(1995-2#1)(2008-1#1)(2012-12#1)
Disagreements were resolved by consensus##2##5##(2009-9#1)(2010-2#1)
Disagreements##3##1##(2007-12#1)(2009-9#1)(2010-2#1)
Disappearance of##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
Disappearance##4##1##(1992-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
Disaster Research Training##2##3##(2012-12#2)
Disaster Research##3##2##(2012-12#3)
Disaster##8##1##(2008-11#3)(2008-2#1)(2012-12#3)(2013-1#1)
Disc diffusion##2##2##(2008-7#1)(2010-5#1)
Disc##5##1##(2007-11#1)(2008-7#1)(2010-5#1)(2011-2#2)
Discharge of Ascospores##2##3##(2008-10#2)
Discharge of##3##2##(2008-10#2)(2008-11#1)
Discharge##7##1##(2008-10#3)(2008-11#1)(2008-3#1)(2010-11#1)(2012-1#1)
Discharged patients##3##2##(2007-1#3)
Disclosure of HIV##2##3##(2009-4#1)(2010-4#1)
Disclosure of##4##2##(2008-11#1)(2009-4#1)(2010-4#1)(2012-2#1)
Disclosure##6##1##(2008-10#1)(2008-11#1)(2009-4#2)(2010-4#1)(2012-2#1)
Discoid##2##1##(2013-1#2)
Discontinuation of##2##2##(2009-6#1)(2012-12#1)
Discontinuers##3##1##(2008-11#1)(2011-1#2)
Discontinuous##2##1##(2008-10#1)(2008-7#1)
Discopathy##2##1##(2007-8#2)
Discordant##2##1##(2008-9#1)(2011-1#1)
Discourse##3##1##(2008-10#1)(2012-3#1)(2013-1#1)
Discover Health Services Near##2##4##(2010-5#2)
Discovering##8##1##(1995-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
Discovery of a##3##3##(1990-5#1)(1993-5#1)(2013-1#1)
Discovery of##11##2##(1990-5#1)(1993-5#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
Discovery##18##1##(1990-5#1)(1993-5#1)(1997-4#1)(2007-10#1)(2007-5#2)(2008-10#4)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
Discrepancies between the##2##3##(2008-7#1)(2011-2#1)
Discrepancies between##5##2##(1995-8#1)(1997-2#1)(2008-7#2)(2011-2#1)
Discrepancies##6##1##(1995-8#1)(1997-2#1)(2008-12#1)(2008-7#2)(2011-2#1)
Discrepancy between##2##2##(1992-12#1)(2008-10#1)
Discrepant##2##1##(1996-8#1)(2011-2#1)
Discrete Data##2##2##(2008-10#1)(2009-9#1)
Discrete thin-film##2##2##(2008-2#1)(2008-3#1)
Discrete##17##1##(1991-9#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-9#1)(2010-10#1)(2010-8#1)(2013-8#1)
Discrete-Event##2##1##(2008-8#2)
Discriminant analysis and##2##3##(2008-10#1)(2008-8#1)
Discriminant analysis##3##2##(2008-10#2)(2008-8#1)
Discriminant function analysis##2##3##(1991-1#1)(1994-3#1)
Discriminant function##3##2##(1991-1#1)(1994-3#1)(1995-6#1)
Discriminant##10##1##(1991-1#1)(1994-3#1)(1995-6#1)(2008-10#6)(2008-8#1)
Discriminating##2##1##(2008-1#1)(2013-8#1)
Discrimination between##6##2##(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)
Discrimination in##2##2##(2008-10#1)(2013-1#1)
Discrimination of individual neuronal potentials is based on action potential##2##10##(2008-4#2)
Discrimination of##8##2##(1994-7#1)(2008-10#2)(2008-2#2)(2008-4#2)(2009-6#1)
Discrimination##20##1##(1994-7#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#2)(2008-8#3)(2009-6#1)(2013-1#1)
Discriminative##2##1##(2008-3#1)(2008-5#1)
Discs##4##1##(2008-5#1)(2008-7#1)(2012-3#2)
Discussed##2##1##(1991-1#1)(2007-11#1)
Discussing##3##1##(2009-7#1)(2011-2#1)(2012-12#1)
Discussion and conclusions##3##3##(2007-11#2)(2011-2#1)
Discussion and##4##2##(2007-11#2)(2011-2#1)(2013-1#1)
Discussion centres on the##2##4##(1994-3#1)(2008-11#1)
Discussion focuses on##4##3##(2008-3#1)(2009-11#2)(2010-8#1)
Discussion of##4##2##(2008-7#1)(2010-12#1)(2010-7#1)(2012-12#1)
Discussion##98##1##(1994-1#1)(1994-3#1)(1994-6#1)(2006-8#1)(2007-11#6)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#51)(2008-7#2)(2009-11#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#9)
Discussions of CS should receive greater emphasis in research journals##2##10##(2013-1#2)
Discussions of##4##2##(1996-2#1)(2008-9#1)(2013-1#2)
Discussions were##2##2##(2008-12#1)(2013-1#1)
Discussions##9##1##(1996-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-5#1)(2013-1#3)(2013-8#1)
Disease (AD)##3##2##(1993-12#1)(2008-7#1)(2011-3#1)
Disease Caused by##6##3##(2008-10#6)
Disease Development and##2##3##(2008-10#2)
Disease Development##3##2##(2008-10#3)
Disease Incidence##2##2##(2008-10#1)(2008-8#1)
Disease Prevention##3##2##(1994-3#1)(2010-4#1)(2011-1#1)
Disease Progress##3##2##(2008-10#3)
Disease Rating Scale##4##3##(2008-7#3)(2013-8#1)
Disease Spread##2##2##(2008-10#2)
Disease Study##2##2##(1994-3#1)(2008-1#1)
Disease Surveillance##2##2##(2008-11#1)(2011-9#1)
Disease activity correlated##2##3##(2006-10#1)(2012-1#1)
Disease and##5##2##(2006-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
Disease assessments##3##2##(2008-10#3)
Disease control##2##2##(2008-10#2)
Disease development over##2##3##(2008-10#2)
Disease development was##2##3##(2008-10#2)
Disease development##6##2##(2008-10#6)
Disease diversity measured by##2##4##(2008-10#2)
Disease free survival##2##3##(2008-6#1)(2010-3#1)
Disease in Children##2##3##(2008-1#1)(2011-2#1)
Disease in##12##2##(1990-9#1)(2008-1#1)(2008-10#7)(2010-9#1)(2011-1#1)(2011-2#1)
Disease incidence and severity were##2##5##(2008-10#2)
Disease incidence and severity##7##4##(2008-10#7)
Disease incidence and##9##3##(2008-10#8)(2008-6#1)
Disease incidence was##3##3##(2008-10#3)
Disease incidence##21##2##(1991-12#1)(1997-6#1)(2008-10#18)(2008-6#1)
Disease management##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
Disease of##6##2##(2008-10#6)
Disease on##3##2##(2008-10#3)
Disease onset was##2##3##(2008-10#2)
Disease progress curves##2##3##(2008-10#2)
Disease progress##5##2##(2008-10#5)
Disease progression##5##2##(2008-10#3)(2010-4#1)(2011-2#1)
Disease reactions##3##2##(2008-10#3)
Disease severity and##2##3##(2008-10#2)
Disease severity was##8##3##(1997-5#1)(2008-10#7)
Disease severity##18##2##(1997-5#2)(2008-10#15)(2012-1#1)
Disease suppression was##2##3##(2008-10#2)
Disease suppression##3##2##(2008-10#3)
Disease suppressiveness##2##2##(2008-10#2)
Disease to##2##2##(2008-11#1)(2012-12#1)
Disease was##2##2##(2008-10#1)(2013-7#1)
Disease##337##1##(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1993-11#1)(1993-12#4)(1993-2#1)(1994-3#2)(1995-11#3)(1995-12#6)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#2)(2006-10#2)(2007-12#5)(2007-2#1)(2007-7#4)(2008-1#8)(2008-10#147)(2008-11#9)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#14)(2008-8#8)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#14)(2011-3#1)(2011-8#2)(2011-9#1)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#6)
Disease)##3##1##(2007-10#1)(2008-3#1)(2012-12#1)
Disease-free survival##2##2##(2011-2#1)(2012-2#1)
Disease-free##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
Disease?##3##1##(2008-1#1)(2010-8#1)(2011-2#1)
Diseased##6##1##(2008-10#5)(2011-2#1)
Diseases and##5##2##(1991-6#1)(1997-6#1)(2008-1#1)(2008-12#1)(2009-2#1)
Diseases caused by##2##3##(2007-12#1)(2009-10#1)
Diseases in##4##2##(2008-10#2)(2011-1#1)(2013-8#1)
Diseases of the##2##3##(1997-5#1)(2012-2#1)
Diseases of##6##2##(1997-5#1)(1997-6#1)(2008-10#2)(2008-9#1)(2012-2#1)
Diseases##64##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-5#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-3#2)(1997-5#1)(1997-6#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#4)
Diseases)##2##1##(2008-4#1)(2013-1#1)
Disengagement##3##1##(2008-2#1)(2009-9#2)
Disgust##3##1##(2010-7#2)(2012-2#1)
Dishevelled##2##1##(2012-12#2)
Disinfection and sterilization##2##3##(1992-12#1)(2012-12#1)
Disinfection and##3##2##(1992-12#1)(2008-7#1)(2012-12#1)
Disk##4##1##(2008-10#1)(2008-12#1)(2008-3#2)
Diskhaler##2##1##(1992-3#1)(1996-2#1)
Disks##3##1##(2008-2#1)(2008-8#1)(2013-1#1)
Diskus is##2##2##(1996-2#2)
Diskus##8##1##(1996-2#8)
Dislocation of temporo-mandibular joint##2##4##(2011-2#2)
Dislocation of##4##2##(1995-10#1)(2007-11#1)(2011-2#2)
Dislocation##6##1##(1995-10#1)(2007-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
Disney##2##1##(1992-11#1)(2008-6#1)
Disorder (ADHD)##2##2##(2012-1#1)(2013-8#1)
Disorder##39##1##(1994-2#1)(1997-5#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2009-8#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#5)
Disordered##4##1##(1996-2#1)(1996-9#2)(2012-2#1)
Disorders and##5##2##(2007-10#1)(2008-7#2)(2009-6#1)(2012-12#1)
Disorders in##2##2##(2007-11#1)(2008-10#1)
Disorders of the##4##3##(1990-3#1)(2007-7#1)(2011-1#2)
Disorders of##9##2##(1990-3#1)(2007-7#1)(2008-10#2)(2008-9#1)(2010-1#1)(2011-1#3)
Disorders##49##1##(1990-2#1)(1990-3#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Disorganization##3##1##(2008-10#3)
Disparities##3##1##(2008-8#1)(2010-3#1)(2011-1#1)
Dispelling myths about##2##3##(1992-1#1)(1997-6#1)
Dispensing##3##1##(1990-3#1)(2010-3#1)(2010-9#1)
Dispersal of##15##2##(2008-10#15)
Dispersal##23##1##(2008-10#18)(2008-8#2)(2008-9#3)
Disperse Red 1##2##3##(2007-12#2)
Disperse Red 1-doped##2##3##(2007-11#1)(2008-2#1)
Disperse Red##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
Dispersed##2##1##(2008-10#1)(2010-11#1)
Dispersible##3##1##(2008-7#3)
Dispersion and##2##2##(1995-3#1)(2008-11#1)
Dispersion compensation##2##2##(2007-11#2)
Dispersion effects in##2##3##(2007-11#1)(2008-3#1)
Dispersion of the##2##3##(2007-12#1)(2008-3#1)
Dispersion of##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
Dispersion relations##2##2##(2008-3#2)
Dispersion##21##1##(1995-3#1)(2007-11#4)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#7)
Dispersion-free##2##1##(2007-12#1)(2008-3#1)
Dispersion-managed##2##1##(2007-12#2)
Dispersive##3##1##(2008-11#1)(2008-12#1)(2008-2#1)
Displaced##2##1##(2012-2#2)
Displacement of##2##2##(2008-10#1)(2008-9#1)
Displacement##7##1##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-9#1)(2010-7#1)
Display##9##1##(1995-11#1)(1995-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-1#2)(2012-2#1)
Disposable##2##1##(2008-10#1)(2008-11#1)
Disposition##2##1##(2008-11#1)(2008-3#1)
Disrupted##4##1##(1994-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
Disrupting##2##1##(2008-2#1)(2010-5#1)
Disruption of the fimA and fimF##2##6##(2008-10#2)
Disruption of the##4##3##(1997-3#1)(2008-10#2)(2008-9#1)
Disruption of##11##2##(1990-5#1)(1990-8#1)(1993-9#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#2)
Disruptions of##2##2##(1997-3#1)(2009-6#1)
Disruptive##2##1##(2009-12#1)(2011-2#1)
Disrupts##2##1##(2008-10#1)(2012-3#1)
Dissatisfaction##2##1##(2010-12#1)(2012-2#1)
Dissecting##2##1##(2008-7#2)
Dissection of the##4##3##(1991-8#1)(2007-8#1)(2008-7#1)(2013-1#1)
Dissection of##9##2##(1991-8#1)(1994-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2013-1#1)
Dissection##13##1##(1991-8#1)(1994-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2013-1#1)
Disseminated superficial porokeratosis##2##3##(2007-7#1)(2010-6#1)
Disseminated##8##1##(2006-10#1)(2007-7#2)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
Dissemination of##2##2##(1993-12#1)(2008-7#1)
Dissemination##4##1##(1993-12#1)(2008-10#1)(2008-7#1)(2010-8#1)
Dissertations##9##1##(2008-3#9)
Dissociation of##4##2##(1994-8#1)(1995-6#2)(1997-4#1)
Dissociation##9##1##(1993-1#1)(1994-8#1)(1995-6#2)(1996-6#1)(1997-4#1)(2008-10#1)(2008-9#1)(2009-12#1)
Dissolution of##4##2##(2007-12#1)(2008-10#1)(2010-3#1)(2010-5#1)
Dissolution##10##1##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-3#1)(2010-5#2)(2012-2#2)
Dissolved##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
Dissolving##2##1##(2008-10#1)(2010-3#1)
Distal radius##2##2##(2008-9#2)
Distal urethral##2##2##(1992-1#2)
Distal##12##1##(1991-12#2)(1992-1#2)(2008-12#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#2)(2013-8#1)
Distal-less##2##1##(2008-9#2)
Distance##5##1##(1991-6#1)(2008-10#2)(2008-11#1)(2013-8#1)
Distances between##3##2##(2006-12#1)(2008-10#2)
Distances##5##1##(2006-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
Distant##3##1##(1994-12#1)(2009-11#1)(2012-3#1)
Distilled water##2##2##(2008-10#1)(2010-3#1)
Distinct Species##2##2##(2008-10#2)
Distinct and##2##2##(1992-8#1)(2008-10#1)
Distinct from##2##2##(2008-10#1)(2011-2#1)
Distinct##37##1##(1991-2#1)(1992-6#1)(1992-8#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
Distinction##2##1##(2009-9#2)
Distinctions in##2##2##(2006-12#1)(2010-6#1)
Distinctive##3##1##(1991-2#1)(2008-10#1)(2008-3#1)
Distinguish##2##1##(2008-10#2)
Distinguishing between##3##2##(2007-12#1)(2009-8#1)(2010-5#1)
Distinguishing##9##1##(1994-1#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-9#1)
Distorted growth of the##2##4##(1995-9#2)
Distorted##3##1##(1995-9#2)(2008-5#1)
Distortion##3##1##(2008-10#1)(2008-3#1)(2013-1#1)
Distraction osteogenesis is##2##3##(2007-12#2)
Distraction osteogenesis##5##2##(2007-12#4)(2011-2#1)
Distraction##8##1##(2007-12#5)(2008-12#1)(2011-2#1)(2013-8#1)
Distress##9##1##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
Distributed##4##1##(2008-10#1)(2008-3#1)(2010-8#1)(2011-9#1)
Distributed-Feedback##3##1##(2008-3#3)
Distributed-feedback##2##1##(2008-3#2)
Distribution and##11##2##(1992-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-5#1)
Distribution in##2##2##(2008-10#1)(2012-12#1)
Distribution of the##9##3##(1990-7#1)(1991-12#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
Distribution of##50##2##(1990-7#2)(1991-1#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-2#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
Distribution##75##1##(1990-7#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-4#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#2)(2013-1#1)
Distributions of##4##2##(1993-11#1)(1995-3#1)(2008-10#1)(2008-2#1)
Distributions##13##1##(1992-2#1)(1993-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
District Court Judge##2##3##(1995-12#2)
District Court for##3##3##(1996-12#1)(1996-9#1)(1997-7#1)
District Court##8##2##(1990-2#1)(1992-9#1)(1995-12#2)(1996-12#2)(1996-9#1)(1997-7#1)
District Health##4##2##(1991-2#2)(1991-3#1)(2008-12#1)
District Hospital##2##2##(1996-12#1)(2012-3#1)
District Judge##5##2##(1995-12#2)(1996-5#1)(1997-5#2)
District of##15##2##(1990-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1996-12#4)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2009-10#1)(2010-5#1)
District##63##1##(1990-2#2)(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-9#2)(1995-12#6)(1995-6#1)(1996-1#3)(1996-12#7)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#4)(1997-7#2)(2007-5#1)(2008-12#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#3)(2012-3#5)(2013-1#2)(2013-8#1)
Districts##3##1##(2008-9#2)(2013-8#1)
Disturbance regimes##2##2##(2008-8#2)
Disturbance##7##1##(2007-12#1)(2008-2#1)(2008-8#4)(2012-2#1)
Disturbances in the##3##3##(1990-9#1)(1992-9#1)(2013-8#1)
Disturbances in##5##2##(1990-9#1)(1992-9#1)(1996-12#1)(2008-5#1)(2013-8#1)
Disturbances of##2##2##(2007-8#1)(2009-10#1)
Disturbances##8##1##(1990-9#1)(1992-9#1)(1996-12#1)(2007-8#1)(2008-5#1)(2009-10#1)(2013-7#1)(2013-8#1)
Disturbed##2##1##(1990-5#1)(1992-12#1)
Disulfide bond##2##2##(1993-8#1)(1995-12#1)
Disulfide##6##1##(1993-8#1)(1995-12#1)(1996-5#1)(2008-4#2)(2012-1#1)
Disulfides##3##1##(2008-6#1)(2012-1#2)
Dither##2##1##(2007-12#1)(2008-3#1)
Dithiothreitol##2##1##(1994-6#2)
Dithizone##6##1##(2008-10#6)
Ditylenchus dipsaci##5##2##(2008-10#5)
Ditylenchus##9##1##(1994-12#1)(2008-10#8)
Diuretic therapy##2##2##(1994-6#2)
Diuretic##4##1##(1994-6#2)(2009-9#1)(2012-2#1)
Diuretics and##2##2##(1992-6#1)(2008-3#1)
Diuretics are##2##2##(1996-3#1)(1996-6#1)
Diuretics##4##1##(1992-6#1)(1996-3#1)(1996-6#1)(2008-3#1)
Diurnal##2##1##(2008-10#1)(2008-6#1)
Divalent cations##4##2##(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)
Divergence##6##1##(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#2)
Divergent##4##1##(1992-6#1)(1994-8#1)(1996-9#1)(2008-10#1)
Diverse##16##1##(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Diversification of##2##2##(2008-4#1)(2008-6#1)
Diversification##3##1##(2008-11#1)(2008-4#1)(2008-6#1)
Diversion##4##1##(1996-12#1)(2008-7#1)(2012-1#1)(2012-3#1)
Diversity Among Strains of##2##4##(2008-10#2)
Diversity Among##6##2##(2008-10#6)
Diversity Panel##2##2##(2008-12#1)(2012-3#1)
Diversity Within##2##2##(2008-10#2)
Diversity and challenges in the management of maternity care for migrant women##2##12##(2012-3#2)
Diversity and##9##2##(2008-10#6)(2011-2#1)(2012-3#2)
Diversity in Colletotrichum##2##3##(2008-10#2)
Diversity in the##2##3##(1993-9#1)(1994-11#1)
Diversity in##16##2##(1993-9#1)(1994-11#1)(2008-10#14)
Diversity management##2##2##(1994-12#2)
Diversity of##30##2##(2008-10#27)(2009-12#1)(2012-2#1)(2012-3#1)
Diversity##84##1##(1993-9#1)(1994-11#1)(1994-12#3)(1997-8#1)(2008-10#63)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-8#1)
Diverticular disease##4##2##(1992-5#1)(2008-9#1)(2010-8#2)
Diverticular##5##1##(1992-5#1)(2008-9#1)(2010-8#3)
Divided##3##1##(1991-1#1)(2008-7#1)(2011-2#1)
Division I##2##2##(2013-1#2)
Division of Environmental##3##3##(1991-12#1)(2008-1#2)
Division of Human Rights##2##4##(1995-6#2)
Division of the##4##3##(1991-5#1)(2007-7#1)(2008-5#1)(2008-7#1)
Division of##19##2##(1991-12#2)(1991-5#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-3#2)(1997-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)
Division##40##1##(1991-12#2)(1991-5#1)(1992-1#1)(1993-1#1)(1993-5#1)(1993-9#1)(1994-3#2)(1995-6#3)(1996-1#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-7#1)(2010-6#1)(2012-12#2)(2012-3#3)(2013-1#3)
Divorce##2##1##(2008-12#1)(2011-2#1)
Dixon test##3##2##(1991-4#2)(2008-10#1)
Dixon##6##1##(1991-4#3)(1997-8#1)(2008-10#1)(2008-5#1)
Dixon's##3##1##(2008-10#3)
Djourno and##2##2##(2008-9#2)
Djourno##4##1##(2008-9#4)
Dk4[7/9]##4##1##(1995-2#4)
Dkk1##3##1##(2013-1#3)
DlEPV and##2##2##(2007-12#2)
DlEPV virions##2##2##(2007-12#2)
DlEPV##5##1##(2007-12#5)
Dm##3##1##(1994-12#2)(2010-4#1)
Dn(eff)##3##1##(2008-2#3)
DnaA##2##1##(1990-11#1)(1997-4#1)
DnaB at the##2##3##(1991-12#2)
DnaB helicase##3##2##(1991-12#3)
DnaB##10##1##(1991-12#8)(1997-2#1)(2011-3#1)
DnaC protein##2##2##(1991-12#2)
DnaC##10##1##(1991-12#10)
DnaG##2##1##(1994-12#2)
DnaJ##6##1##(1993-11#3)(1995-6#1)(2011-2#2)
DnaK protein##2##2##(1995-6#2)
DnaK##6##1##(1995-6#3)(2011-2#3)
Do Not##2##2##(2008-10#1)(2010-1#1)
Do People##2##2##(2009-3#2)
Do hospital##2##2##(1991-12#1)(1996-3#1)
Do not resuscitate&quot##2##3##(1992-12#1)(1992-3#1)
Do not##3##2##(1992-12#1)(1992-3#1)(1997-5#1)
Do patients##2##2##(2008-10#2)
Do plant##2##2##(2008-9#2)
Do the##2##2##(2010-10#1)(2012-2#1)
Do we know how##2##4##(2011-1#1)(2012-12#1)
Do we really##2##3##(2007-4#1)(2012-12#1)
Do we##8##2##(1992-1#1)(1993-1#1)(1996-3#1)(2007-4#1)(2008-7#1)(2011-1#1)(2012-12#2)
Do you##6##2##(1991-3#2)(2008-10#1)(2008-4#1)(2009-6#1)(2012-3#1)
Do##79##1##(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-3#2)(1995-3#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-5#1)(2007-12#1)(2007-4#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#1)(2010-1#1)(2010-10#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
Dobson and Brewer##2##3##(2008-3#2)
Dobson##7##1##(2008-2#2)(2008-3#4)(2008-9#1)
Dobutamine##4##1##(1994-11#1)(2011-2#1)(2013-1#2)
Doc##3##1##(1997-3#1)(2008-10#1)(2008-9#1)
Docetaxel and Cisplatin##2##3##(2008-10#2)
Docetaxel##9##1##(2008-10#5)(2008-6#3)(2010-3#1)
Docking of puppies' tails##4##4##(1995-9#4)
Docking of##5##2##(1995-9#4)(2013-8#1)
Docking##10##1##(1995-9#4)(2008-4#2)(2012-2#1)(2013-7#1)(2013-8#2)
Docosahexaenoic##2##1##(1996-7#1)(2012-1#1)
Docs##2##1##(1995-1#1)(1997-3#1)
Doctor of Nursing Practice##2##4##(2012-2#1)(2013-8#1)
Doctor of##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
Doctor##4##1##(2012-2#2)(2013-1#1)(2013-8#1)
Doctor-patient##2##1##(1991-11#1)(1996-6#1)
Doctors and patients##2##3##(1996-11#1)(1997-5#1)
Doctors and##4##2##(1996-11#1)(1996-6#1)(1997-5#1)(2011-2#1)
Doctors have##2##2##(1993-3#2)
Doctors##24##1##(1990-3#1)(1991-11#1)(1993-11#1)(1993-3#2)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#2)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#2)
Document##5##1##(2007-9#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-7#1)
Documentation and##2##2##(2011-2#1)(2012-3#1)
Documentation of red flags##2##4##(2008-12#2)
Documentation of##3##2##(2008-12#2)(2013-1#1)
Documentation##6##1##(2008-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Documenting##2##1##(2008-7#1)(2012-12#1)
Dodecyl##2##1##(2008-10#1)(2012-2#1)
Doe##6##1##(1992-9#1)(1993-3#1)(1995-6#1)(1997-5#3)
Doe's##2##1##(1995-6#2)
Doehlert design##2##2##(2008-10#2)
Doehlert designs##6##2##(2008-10#6)
Doehlert matrices##2##2##(2008-10#2)
Doehlert matrix##7##2##(2008-10#7)
Doehlert shells##2##2##(2008-10#2)
Doehlert##20##1##(2008-10#19)(2008-5#1)
Does Not##4##2##(1996-2#1)(2008-10#3)
Does a##2##2##(1993-3#1)(2012-2#1)
Does any##2##2##(1994-6#1)(2013-1#1)
Does cranberry juice##2##3##(1997-4#2)
Does cranberry##3##2##(1997-4#3)
Does it matter##2##3##(2010-10#1)(2011-2#1)
Does it##5##2##(1992-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
Does regular##2##2##(2008-8#1)(2009-5#1)
Does the##18##2##(1993-6#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
Does this mean##2##3##(2012-3#1)(2013-7#1)
Does this##4##2##(1992-5#1)(2009-5#1)(2012-3#1)(2013-7#1)
Does##84##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-5#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#10)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#4)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#2)
Dog owner/dog walkers##2##3##(2013-1#2)
Dog##6##1##(2007-12#1)(2013-1#5)
Dogs##5##1##(2008-12#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
Doha##2##1##(2009-5#1)(2010-11#1)
Doing more with##2##3##(1995-12#1)(2008-12#1)
Doing more##3##2##(1993-12#1)(1995-12#1)(2008-12#1)
Doing##12##1##(1993-12#2)(1995-12#1)(1996-1#1)(1996-8#1)(2008-12#1)(2010-12#1)(2012-12#2)(2012-2#2)(2013-8#1)
DoloTest##6##1##(2013-1#6)
Dolt-2##2##1##(2008-10#2)
Domain I helix 4##2##4##(2008-9#2)
Domain I##3##2##(2008-9#3)
Domain##16##1##(1992-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)
Domains##5##1##(2008-11#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#1)
Domega##2##1##(2007-12#1)(2008-3#1)
Domestic##9##1##(1996-2#1)(1997-3#1)(2008-12#1)(2011-2#2)(2012-12#3)(2013-1#1)
Dominance##3##1##(2008-10#2)(2009-11#1)
Dominant##14##1##(1995-8#1)(1996-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-3#3)(2013-1#1)
Dominantly inherited ataxias##2##3##(2008-7#2)
Dominating##2##1##(2006-10#1)(2008-10#1)
Dominican Republic##17##2##(2008-10#10)(2008-11#2)(2008-5#2)(2011-2#2)(2013-1#1)
Dominican##18##1##(2008-10#10)(2008-11#2)(2008-5#3)(2011-2#2)(2013-1#1)
Domperidone is##2##2##(2008-10#1)(2008-7#1)
Domperidone##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
Don##2##1##(1990-4#1)(1991-3#1)
Don't let##2##2##(1992-3#1)(2009-5#1)
Don't##11##1##(1992-3#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(2007-8#1)(2009-11#1)(2009-5#1)(2013-8#1)
Dona##2##1##(2008-10#1)(2009-7#1)
Donaghey##2##1##(1995-12#2)
Donald##3##1##(1994-3#1)(2008-10#1)(2008-8#1)
Doncaster##2##1##(2011-1#1)(2013-1#1)
Dong##2##1##(1995-6#2)
Donna##2##1##(1995-6#1)(2008-4#1)
Donnan dialysis is##3##3##(2008-10#3)
Donnan dialysis##7##2##(2008-10#7)
Donnan effect##5##2##(2011-2#5)
Donnan##15##1##(2008-10#8)(2011-2#7)
Donohue##3##1##(1997-5#3)
Donor##13##1##(1992-12#1)(1993-12#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Donors were##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
Donors##11##1##(1994-9#1)(1996-2#2)(1996-5#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-3#1)
Donovan##2##1##(2007-2#1)(2007-7#1)
Dopamine (DA) and##2##3##(1992-1#1)(2008-7#1)
Dopamine (DA)##3##2##(1992-1#1)(2008-5#1)(2008-7#1)
Dopamine D2##2##2##(1996-5#1)(2010-4#1)
Dopamine and serotonin##2##3##(2008-7#2)
Dopamine and##3##2##(2008-4#1)(2008-7#2)
Dopamine receptors##2##2##(1993-9#1)(1995-2#1)
Dopamine##20##1##(1992-1#1)(1993-12#1)(1993-3#1)(1993-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-5#1)(2008-4#1)(2008-5#3)(2008-7#3)(2010-12#1)(2010-4#1)
Dopaminergic##4##1##(2008-7#1)(2012-12#1)(2013-8#2)
Doping##4##1##(1993-3#1)(1996-12#2)(2007-12#1)
Doppler US##2##2##(2008-7#1)(2010-12#1)
Doppler USS##3##2##(2008-1#3)
Doppler Ultrasound and##2##3##(2008-12#1)(2012-12#1)
Doppler analyzer##3##2##(2008-2#1)(2008-3#2)
Doppler and##4##2##(2007-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
Doppler anemometry##5##2##(1994-12#1)(2008-2#1)(2008-3#3)
Doppler bandwidth##5##2##(2007-11#4)(2008-3#1)
Doppler catheter##2##2##(2007-12#2)
Doppler confirmed##2##2##(2007-8#1)(2013-1#1)
Doppler cw##2##2##(1993-9#2)
Doppler echocardiography##3##2##(2010-10#2)(2011-1#1)
Doppler flow measurements##2##3##(1996-6#2)
Doppler flow##7##2##(1995-3#1)(1996-6#2)(2007-11#1)(2008-7#1)(2011-2#2)
Doppler flowmetry and##2##3##(1991-12#1)(2008-5#1)
Doppler flowmetry##4##2##(1991-12#1)(1996-5#1)(2007-7#1)(2008-5#1)
Doppler guide##2##2##(1996-6#2)
Doppler imaging without##2##3##(2007-11#1)(2011-1#1)
Doppler imaging##9##2##(2007-11#1)(2007-12#2)(2008-3#2)(2011-1#4)
Doppler lidar at 9##2##4##(2008-2#1)(2008-3#1)
Doppler lidar at##3##3##(2008-2#1)(2008-3#2)
Doppler lidar signal##2##3##(2008-3#2)
Doppler lidar velocity##2##3##(2008-2#1)(2008-3#1)
Doppler lidar##32##2##(2007-11#1)(2008-2#9)(2008-3#22)
Doppler measurement##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
Doppler monitoring##3##2##(2007-10#3)
Doppler optical coherence tomography##6##4##(2007-11#2)(2007-12#4)
Doppler perfusion##2##2##(2007-11#2)
Doppler shift and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
Doppler shift##16##2##(2007-12#1)(2008-2#7)(2008-3#8)
Doppler shifted##2##2##(2007-12#1)(2008-3#1)
Doppler shifts##4##2##(2008-2#1)(2008-3#3)
Doppler signal##3##2##(1991-12#2)(2008-2#1)
Doppler sonography of the##2##4##(1991-6#1)(1995-6#1)
Doppler sonography##11##2##(1991-6#1)(1992-5#2)(1995-6#2)(1996-6#1)(2012-1#3)(2012-3#1)(2013-1#1)
Doppler studies##3##2##(1990-7#1)(2007-10#1)(2008-1#1)
Doppler technique##2##2##(1994-9#1)(2007-11#1)
Doppler ultrasonography in##2##3##(1992-5#1)(2013-1#1)
Doppler ultrasonography##9##2##(1990-5#1)(1992-5#1)(1996-2#1)(1996-3#2)(2007-8#1)(2008-7#1)(2010-11#1)(2013-1#1)
Doppler ultrasound in##2##3##(1992-6#1)(2009-7#1)
Doppler ultrasound or##2##3##(2007-8#2)
Doppler ultrasound##12##2##(1992-6#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-12#3)(2009-7#1)(2011-2#1)(2012-3#1)
Doppler velocimeter##3##2##(2008-2#1)(2008-3#2)
Doppler velocimetry##9##2##(1994-11#1)(1994-3#3)(2008-2#1)(2008-3#3)(2011-2#1)
Doppler wind lidar##5##3##(2008-2#1)(2008-3#4)
Doppler wind##11##2##(2008-2#4)(2008-3#7)
Doppler##253##1##(1990-5#2)(1990-6#1)(1990-7#2)(1991-12#3)(1991-6#1)(1992-5#4)(1992-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-9#1)(1995-3#6)(1995-6#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#6)(2007-10#9)(2007-11#16)(2007-12#17)(2007-7#1)(2007-8#6)(2008-1#9)(2008-10#1)(2008-12#4)(2008-2#28)(2008-3#73)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2011-1#7)(2011-2#8)(2011-5#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
Doppler-broadened medium##2##2##(2007-12#2)
Doppler-broadened##8##1##(2007-11#1)(2007-12#2)(2008-2#5)
Doppler-free two-photon##2##2##(2008-2#1)(2008-3#1)
Doppler-free##11##1##(2007-12#3)(2008-2#1)(2008-3#7)
Doppler-limited##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
Doppler-shift##2##1##(2008-2#1)(2008-3#1)
Doppler-shifted##4##1##(2008-2#3)(2008-3#1)
Dor##4##1##(1992-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
Dornan##2##1##(1995-6#1)(1996-5#1)
Dorothea##2##1##(1996-5#1)(2008-10#1)
Dorper ewes##2##2##(2011-1#2)
Dorsal##7##1##(1993-12#1)(2008-6#1)(2009-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
Dosage##3##1##(1990-9#1)(1992-2#1)(2008-5#1)
Dose and##2##2##(2008-1#1)(2008-8#1)
Dose heterogeneity##2##2##(2008-10#1)(2008-11#1)
Dose inhomogeneities were##2##3##(2007-10#2)
Dose intensification##2##2##(1993-9#1)(1994-8#1)
Dose intensity##2##2##(1992-2#1)(1993-11#1)
Dose response##3##2##(1994-11#1)(1995-2#1)(2008-5#1)
Dose##41##1##(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#4)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2010-8#1)(2012-2#1)(2012-3#2)
Dose-dependent##4##1##(1994-10#1)(1994-9#1)(2008-4#1)(2008-8#1)
Dose-response relationships##2##2##(2008-10#1)(2008-7#1)
Dose-response##10##1##(1995-5#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-7#3)(2008-9#1)
Dosed##2##1##(2008-9#2)
Doses to##2##2##(1993-9#2)
Doses##8##1##(1991-8#1)(1993-9#2)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
Dosimetry##4##1##(1992-3#1)(2008-7#2)(2012-1#1)
Dosing of##3##2##(1995-1#1)(2006-10#1)(2008-9#1)
Dosing##4##1##(1995-1#1)(1997-4#1)(2006-10#1)(2008-9#1)
Dot blot##2##2##(1990-12#1)(1990-5#1)
Dot##6##1##(1990-12#1)(1990-5#1)(1994-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
Dot-blot##2##1##(2008-10#1)(2008-9#1)
Dothistroma needle blight is##2##4##(2008-10#2)
Dothistroma needle blight##5##3##(2008-10#5)
Dothistroma##7##1##(2008-10#7)
Double presence##2##2##(2011-2#2)
Double##29##1##(1991-1#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Double-Stranded RNA##2##2##(2008-10#2)
Double-Stranded RNAs##2##2##(2008-10#2)
Double-Stranded##4##1##(2008-10#4)
Double-blind##2##1##(1992-9#1)(2007-12#1)
Double-labeling##2##1##(1994-2#1)(2008-4#1)
Double-strand##3##1##(2008-9#2)(2013-1#1)
Double-stranded (ds)##2##2##(2008-10#2)
Double-stranded RNA##2##2##(2008-10#2)
Double-stranded##7##1##(1994-5#1)(2008-10#5)(2008-11#1)
Doubling##3##1##(2008-2#1)(2008-3#1)(2012-3#1)
Doubly Resonant##2##2##(2008-2#2)
Doubly##3##1##(2008-2#2)(2013-8#1)
Douglas Carnall##2##2##(1996-8#2)
Douglas##11##1##(1991-3#1)(1994-9#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-6#2)(2008-9#1)(2010-11#1)
Douglas-Fir##2##1##(2008-10#2)
Douglas-fir foliage##2##2##(2008-10#2)
Douglas-fir##8##1##(2008-10#8)
Dow Jones##2##2##(2008-12#1)(2012-12#1)
Dowex 1##2##2##(2008-10#2)
Dowex 50W X8##3##3##(2008-10#3)
Dowex 50W x##2##3##(2008-10#2)
Dowex 50W##5##2##(2008-10#5)
Dowex CM-15 and Dowex C650##2##5##(2008-10#2)
Dowex##13##1##(1992-12#1)(2008-10#12)
Dowex-1##2##1##(2008-10#2)
Down regulation of the##2##4##(1994-8#1)(1995-2#1)
Down regulation of##4##3##(1990-3#1)(1993-12#1)(1994-8#1)(1995-2#1)
Down syndrome (DS)##2##3##(1996-2#1)(2012-2#1)
Down syndrome and##2##3##(2008-8#1)(2012-12#1)
Down syndrome patients and##2##4##(2008-11#2)
Down syndrome patients##3##3##(2008-11#3)
Down syndrome##43##2##(1990-3#9)(1992-5#1)(1996-12#2)(1996-2#3)(1996-6#2)(1997-2#3)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2010-4#3)(2012-12#3)(2012-2#2)(2013-1#7)
Down to##3##2##(2008-10#2)(2008-3#1)
Down##55##1##(1990-3#10)(1992-5#1)(1993-12#2)(1994-8#1)(1995-2#1)(1996-12#2)(1996-2#3)(1996-6#2)(1997-2#3)(2007-10#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#4)(2012-12#3)(2012-2#2)(2013-1#8)
Down's cases##2##2##(1996-12#2)
Down's syndrome and##6##3##(1991-11#1)(1992-2#1)(1993-12#1)(1996-12#1)(1996-5#2)
Down's syndrome in##3##3##(1990-2#2)(1996-12#1)
Down's syndrome pregnancies##2##3##(1996-12#2)
Down's syndrome screening in the UK##2##6##(1996-3#2)
Down's syndrome screening##4##3##(1996-12#2)(1996-3#2)
Down's syndrome##38##2##(1990-2#5)(1991-1#2)(1991-11#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-12#1)(1996-12#14)(1996-3#3)(1996-5#3)(2008-7#4)
Down's syndrome]##3##2##(1990-2#1)(1991-8#1)(1993-11#1)
Down's##46##1##(1990-2#6)(1991-1#2)(1991-11#1)(1991-8#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1996-12#17)(1996-3#3)(1996-5#3)(2008-10#1)(2008-7#4)
Down-regulation of##4##2##(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)
Downregulation and##2##2##(2012-3#1)(2013-1#1)
Downregulation of##4##2##(1994-9#1)(2009-9#1)(2011-2#1)(2012-12#1)
Downregulation##6##1##(1994-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Downsizing##4##1##(1991-3#1)(1994-3#1)(1995-6#1)(1996-12#1)
Downstream of##2##2##(1990-11#1)(2008-9#1)
Downstream targets of##2##3##(2008-10#1)(2009-9#1)
Downstream##8##1##(1990-11#1)(1990-5#1)(2008-10#2)(2008-6#2)(2008-9#1)(2009-9#1)
Downy Mildew##5##2##(2008-10#4)(2012-3#1)
Downy mildew##3##2##(2008-10#3)
Downy##8##1##(2008-10#7)(2012-3#1)
Doxazosin##2##1##(1993-2#1)(1995-12#1)
Doxorubicin and##2##2##(1992-10#1)(1997-7#1)
Doxorubicin is##2##2##(2011-2#1)(2013-1#1)
Doxorubicin##13##1##(1992-10#1)(1994-8#1)(1997-7#1)(2008-11#1)(2008-6#2)(2011-2#2)(2013-1#5)
Doxorubicin-based chemotherapy##2##2##(2008-6#2)
Doxycycline##2##1##(2008-10#1)(2012-3#1)
Doyle##2##1##(1990-8#1)(1993-3#1)
DpnI digestion##2##2##(1994-12#1)(2008-9#1)
DpnI##4##1##(1994-12#3)(2008-9#1)
Dr Beard said##2##3##(2008-11#2)
Dr J##2##2##(2007-11#1)(2008-5#1)
Dr Naranjan S Dhalla##2##4##(2008-7#2)
Dr##107##1##(1990-10#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-6#2)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-7#2)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#4)(2007-11#1)(2008-10#1)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Drainage##5##1##(2006-10#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
Dramatic changes in##2##3##(1993-12#1)(2008-11#1)
Dramatic changes##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
Dramatic##6##1##(1991-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
Draper-Lin small composite##2##3##(2008-10#2)
Drastic##2##1##(1990-4#1)(2007-11#1)
Drawing from##2##2##(2008-12#1)(2012-3#1)
Drawing on an##2##3##(2008-1#1)(2008-11#1)
Drawing on data##2##3##(1993-1#1)(2009-9#1)
Drawing on the##2##3##(1997-3#1)(2008-11#1)
Drawing on##16##2##(1992-1#1)(1993-1#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Drawing##21##1##(1992-1#1)(1992-3#1)(1993-1#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Drebrin E##2##2##(2012-2#2)
Drechslera teres##2##2##(2008-10#2)
Drechslera##3##1##(2008-10#3)
Dresden##3##1##(2008-10#3)
Drew &amp##2##2##(2011-2#2)
Drew##4##1##(1995-6#1)(2008-10#1)(2011-2#2)
Dried##5##1##(2008-10#3)(2008-5#1)(2013-7#1)
Drilling##2##1##(2008-12#1)(2013-8#1)
Drink##2##1##(2008-5#1)(2013-7#1)
Drinking##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
Drip##3##1##(2008-10#2)(2013-8#1)
Drive##3##1##(2007-12#1)(2008-2#1)(2012-3#1)
Driven by##2##2##(2010-8#1)(2013-1#1)
Drivers##2##1##(1992-6#1)(2012-3#1)
Driving##2##1##(1994-2#1)(2008-12#1)
Dromia personata##2##2##(2007-12#2)
Dromia wilsoni##2##2##(2007-12#2)
Dromia##4##1##(2007-12#4)
Drop##6##1##(2008-10#5)(2008-12#1)
Droplet##3##1##(1995-3#1)(2008-2#1)(2011-2#1)
Droplets##6##1##(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#2)(2012-1#1)
Drosophila HSF##3##2##(1990-11#3)
Drosophila RecQ5##2##2##(2011-1#2)
Drosophila Research Conference##2##3##(2008-10#2)
Drosophila Schneider##2##2##(1993-9#1)(2008-11#1)
Drosophila ananassae##2##2##(2008-5#2)
Drosophila and mammalian##2##3##(2008-7#1)(2011-2#1)
Drosophila and##10##2##(1990-3#2)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)
Drosophila are##2##2##(1994-8#1)(2008-2#1)
Drosophila as##2##2##(1995-8#1)(2012-2#1)
Drosophila auditory##2##2##(2008-9#2)
Drosophila cell culture##3##3##(2008-2#2)(2012-2#1)
Drosophila cell cultures##2##3##(2008-2#2)
Drosophila cell lines##2##3##(2008-2#1)(2012-2#1)
Drosophila cell##7##2##(2008-2#5)(2012-2#2)
Drosophila cells##3##2##(1994-8#1)(2008-2#1)(2012-2#1)
Drosophila egg##2##2##(1994-12#1)(2008-9#1)
Drosophila embryo##2##2##(1991-5#1)(1993-12#1)
Drosophila embryos##4##2##(1991-5#1)(1993-12#1)(2008-9#1)(2009-8#1)
Drosophila eye##4##2##(2008-9#4)
Drosophila genome##2##2##(2008-10#1)(2008-8#1)
Drosophila germ line##2##3##(2009-3#2)
Drosophila handedness##2##2##(2008-10#2)
Drosophila have##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
Drosophila heat shock##2##3##(1990-11#1)(1995-2#1)
Drosophila homolog of##2##3##(2008-9#2)
Drosophila is##2##2##(2008-1#1)(2008-9#1)
Drosophila koepferae##2##2##(1995-8#2)
Drosophila larvae##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
Drosophila lethal giant larvae##2##4##(2009-5#2)
Drosophila meetings##2##2##(2008-10#2)
Drosophila melanogaster (hsp70-lacZ) Bg(9)##2##4##(2013-1#2)
Drosophila melanogaster S2 cells##2##4##(2008-11#2)
Drosophila melanogaster and##8##3##(1991-5#1)(1993-2#1)(2008-10#1)(2008-7#2)(2012-2#1)(2012-3#2)
Drosophila melanogaster##83##2##(1990-12#2)(1991-12#2)(1991-5#1)(1991-6#1)(1993-12#1)(1993-2#8)(1993-6#3)(1993-9#1)(1994-12#3)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#3)(1996-2#2)(1997-6#2)(1997-7#6)(1997-8#4)(2007-12#3)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#8)(2009-5#1)(2009-7#2)(2010-1#1)(2010-9#1)(2012-2#1)(2012-3#4)(2013-1#2)
Drosophila mojavensis##4##2##(2008-8#2)(2008-9#2)
Drosophila serrata and Drosophila birchii##2##5##(2008-9#2)
Drosophila simulans##3##2##(2012-3#3)
Drosophila species##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
Drosophila subobscura##2##2##(2013-1#2)
Drosophila that##2##2##(2008-7#1)(2008-8#1)
Drosophila to##2##2##(2008-10#1)(2011-1#1)
Drosophila trithorax##3##2##(1995-11#1)(1997-7#2)
Drosophila##339##1##(1990-11#5)(1990-12#3)(1990-3#3)(1991-12#2)(1991-5#4)(1991-6#1)(1993-12#11)(1993-2#9)(1993-6#4)(1993-8#2)(1993-9#4)(1994-12#5)(1994-8#5)(1994-9#1)(1995-11#1)(1995-2#6)(1995-6#12)(1995-8#7)(1996-12#1)(1996-2#3)(1996-6#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#10)(1997-8#6)(2007-11#1)(2007-12#10)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#7)(2008-2#10)(2008-5#4)(2008-7#10)(2008-8#20)(2008-9#68)(2009-3#7)(2009-5#5)(2009-7#3)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#12)(2012-3#18)(2013-1#4)
Drought stress##2##2##(2008-12#1)(2011-2#1)
Drought##7##1##(2008-12#1)(2011-2#1)(2012-5#1)(2012-6#1)(2012-7#2)(2012-8#1)
Drs##3##1##(2008-5#1)(2013-1#2)
Drude##3##1##(2008-3#3)
Drug Administration##51##2##(1994-1#2)(1995-8#1)(1996-5#3)(1997-4#1)(1997-5#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-7#2)(2009-9#2)(2010-4#1)(2010-6#2)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#2)
Drug Delivery##4##2##(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)
Drug Therapy##4##2##(2006-10#1)(2009-6#1)(2013-1#2)
Drug Use##4##2##(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#1)
Drug Utilization Review Network##2##4##(1997-2#2)
Drug Utilization##4##2##(1997-2#2)(2008-11#2)
Drug abuse##2##2##(1993-11#1)(2008-12#1)
Drug and##3##2##(2008-6#1)(2010-5#1)(2010-8#1)
Drug delivery to the##2##4##(1996-3#1)(2008-9#1)
Drug delivery##4##2##(1992-3#1)(1995-3#1)(1996-3#1)(2008-9#1)
Drug discovery today##2##3##(2008-10#2)
Drug discovery##3##2##(2008-10#3)
Drug resistance##3##2##(2007-2#1)(2007-7#1)(2008-11#1)
Drug self-administration in primates has several characteristics that resemble drug-taking behavior in humans##2##13##(2008-4#1)(2012-3#1)
Drug self-administration is a procedure in which a subject performs a##2##11##(2008-4#1)(2012-3#1)
Drug self-administration##5##2##(2008-4#3)(2012-3#2)
Drug treatment of##2##3##(1992-11#1)(2008-8#1)
Drug treatment##4##2##(1992-11#1)(2008-6#1)(2008-8#1)(2010-6#1)
Drug use##5##2##(1991-1#2)(2009-7#1)(2013-1#1)(2013-8#1)
Drug##169##1##(1991-1#4)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-1#3)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-5#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-9#2)(2008-10#8)(2008-11#11)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-6#1)(2009-7#3)(2009-9#2)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#6)(2010-6#6)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#1)
Drug-eluting stents have##2##3##(2008-11#2)
Drug-eluting##5##1##(2008-11#2)(2009-12#1)(2009-5#1)(2011-2#1)
Drug-induced hair##2##2##(2008-8#2)
Drug-induced##12##1##(1993-12#1)(1993-6#1)(2006-10#2)(2008-10#2)(2008-7#2)(2008-8#2)(2011-2#2)
Drug-resistant##2##1##(2007-12#1)(2011-2#1)
Drugs (NSAIDs)##2##2##(2006-10#1)(2008-12#1)
Drugs and##2##2##(2008-10#1)(2008-11#1)
Drugs for Treatment of##2##4##(2010-8#1)(2011-1#1)
Drugs for##5##2##(2008-10#2)(2008-5#1)(2010-8#1)(2011-1#1)
Drugs in##3##2##(2006-10#1)(2012-2#1)(2013-1#1)
Drugs of##3##2##(1995-3#1)(1996-10#1)(2013-8#1)
Drugs that##3##2##(2008-5#1)(2008-7#1)(2012-1#1)
Drugs##49##1##(1992-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(2006-10#3)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Dry matter##3##2##(2008-10#2)(2008-12#1)
Dry powder inhalers##2##3##(1992-3#2)
Dry powder##4##2##(1992-3#3)(1997-1#1)
Dry skin##2##2##(2008-5#2)
Dry##23##1##(1992-3#4)(1997-1#1)(2006-10#2)(2008-10#6)(2008-12#5)(2008-5#4)(2008-7#1)
Drying##2##1##(2008-10#1)(2008-12#1)
Dryopteris##2##1##(2008-5#2)
Ds##3##1##(1990-4#1)(2008-10#1)(2012-3#1)
DsRed##2##1##(2009-4#2)
DsbA##6##1##(1993-9#5)(2011-2#1)
Dsk2p##4##1##(2009-7#4)
Dsquame(R) instant##2##2##(2008-5#2)
Dsquame(R)##4##1##(2008-5#4)
Du##3##1##(2008-10#1)(2011-3#2)
DuP 532 is a##2##4##(1991-5#2)
DuP 532 was##2##3##(1991-5#2)
DuP 532##10##2##(1991-5#10)
DuP 714##7##2##(1991-9#7)
DuP 753##5##2##(1990-11#1)(1991-5#4)
DuP##22##1##(1990-11#1)(1991-5#14)(1991-9#7)
DuPont Merck##2##2##(2008-5#2)
DuPont Pharmaceuticals##2##2##(2008-5#2)
DuPont##9##1##(2007-2#1)(2008-2#3)(2008-5#5)
Dual antiplatelet therapy after drug-eluting stents should##2##7##(2009-12#2)
Dual phase##2##2##(2009-7#2)
Dual##24##1##(1990-11#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-12#2)(2009-7#2)(2009-8#1)(2012-12#1)(2013-1#2)
Dual-wavelength##9##1##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)
Dubai##2##1##(2008-12#2)
Dubinin-Radushkevich (D-R)##3##2##(2008-10#3)
Dublanchet##2##1##(2007-12#2)
Dublin##7##1##(1991-12#1)(2007-2#1)(2008-11#2)(2009-7#2)(2011-2#1)
Duchenne Muscular Dystrophy##2##3##(2007-8#2)
Duchenne muscular dystrophy (DMD)##3##4##(1990-7#1)(1995-12#1)(2011-2#1)
Duchenne muscular dystrophy##10##3##(1990-7#2)(1991-3#1)(1994-8#1)(1995-12#3)(2008-7#1)(2011-2#2)
Duchenne##12##1##(1990-7#2)(1991-3#1)(1994-8#1)(1995-12#3)(2007-8#2)(2008-7#1)(2011-2#2)
Duck##5##1##(1997-6#1)(2009-7#4)
Duct##3##1##(1994-7#1)(1995-2#1)(2012-12#1)
Ductal##2##1##(1994-7#1)(2013-1#1)
Due diligence##2##2##(2007-9#1)(2008-10#1)
Due to a##4##3##(1996-8#1)(1997-3#1)(2008-5#1)(2011-2#1)
Due to an##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
Due to both##2##3##(2007-10#1)(2009-9#1)
Due to high sensitivity##2##4##(2008-10#2)
Due to high##5##3##(1990-8#1)(1995-11#1)(2008-10#2)(2012-2#1)
Due to increased##2##3##(2008-7#1)(2008-9#1)
Due to its simplicity##2##4##(2010-7#1)(2013-1#1)
Due to its##17##3##(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
Due to low##2##3##(1992-12#1)(2010-8#1)
Due to multiple##2##3##(2008-10#2)
Due to new##2##3##(2008-10#1)(2011-2#1)
Due to poor##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
Due to the fact that the##3##6##(2007-12#1)(2008-11#1)(2012-3#1)
Due to the fact that##6##5##(2007-12#1)(2008-10#3)(2008-11#1)(2012-3#1)
Due to the fundamental##2##4##(1992-6#1)(2011-2#1)
Due to the great##2##4##(2008-10#1)(2008-5#1)
Due to the high##6##4##(2008-10#4)(2008-7#1)(2008-8#1)
Due to the importance##3##4##(1991-9#1)(2008-1#1)(2008-9#1)
Due to the increasing##2##4##(1996-6#1)(2011-2#1)
Due to the lack of available##2##6##(1990-9#1)(2011-2#1)
Due to the lack of##9##5##(1990-9#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#2)
Due to the large##4##4##(1994-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
Due to the low##5##4##(2008-10#3)(2012-2#1)(2013-1#1)
Due to the presence of##2##5##(2008-10#1)(2010-11#1)
Due to the rapid development of colours at ambient temperature##2##10##(2008-10#2)
Due to the rarity of##3##5##(2010-12#1)(2012-12#1)(2012-3#1)
Due to the recent##2##4##(2008-4#1)(2010-7#1)
Due to the special##2##4##(2010-12#1)(2012-3#1)
Due to the strong##2##4##(2008-10#1)(2009-6#1)
Due to the##118##3##(1990-9#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#34)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#1)
Due to their##11##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#2)(2012-3#2)(2013-1#1)
Due to these##2##3##(1994-8#1)(2007-6#1)
Due to this##5##3##(1991-3#1)(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
Due to##218##2##(1990-10#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-12#2)(1993-2#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#60)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#2)
Due##221##1##(1990-10#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-12#2)(1993-2#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#61)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#2)
Duke University##2##2##(2009-5#2)
Duke##5##1##(2009-5#2)(2011-2#1)(2012-3#2)
Dukes stage##2##2##(1992-5#1)(2006-8#1)
Dukes##7##1##(1992-5#1)(2006-8#6)
Dukes' stage##2##2##(1992-8#1)(2008-10#1)
Dukes'##4##1##(1992-8#3)(2008-10#1)
Dulbecco's Modified Eagle's Medium##2##4##(2008-11#2)
Dulbecco's Modified##3##2##(2008-11#2)(2013-1#1)
Duloxetine##3##1##(2008-3#2)(2008-9#1)
Dunajec##2##1##(2008-10#2)
Dunaliella salina 1650##2##3##(2008-6#2)
Duncan grapefruit##2##2##(2008-10#2)
Dunedin##5##1##(1990-2#3)(2008-7#2)
Duodenal ulcer##2##2##(1991-8#1)(2010-4#1)
Duodenal##5##1##(1991-8#2)(2008-12#1)(2010-4#1)(2011-2#1)
Duplex sonography##2##2##(1993-6#2)
Duplex##7##1##(1990-11#1)(1991-8#1)(1993-6#2)(2008-10#1)(2008-12#1)(2011-2#1)
Duplicate bladder exstrophy##2##3##(2008-10#2)
Duplicate##4##1##(1995-2#1)(2008-10#2)(2008-3#1)
Duplication of##2##2##(2011-2#1)(2012-3#1)
Duplication##5##1##(2008-12#1)(2011-2#1)(2012-3#3)
Dupont##2##1##(1992-6#1)(2008-10#1)
Dupuytren's disease in the modern U##2##6##(2008-9#2)
Dupuytren's disease in the##3##4##(2008-9#3)
Dupuytren's disease##8##2##(2008-9#8)
Dupuytren's##9##1##(2008-9#9)
DuraHeart##2##1##(2010-8#2)
Durability of##2##2##(2008-10#2)
Dural Sealant##3##2##(2012-3#3)
Dural##10##1##(1996-9#2)(2008-7#2)(2012-3#6)
Durapore5 was##2##2##(2008-10#2)
Durapore5##5##1##(2008-10#5)
Duration and##2##2##(1996-6#1)(2008-12#1)
Duration of##8##2##(1990-6#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
Duration##14##1##(1990-6#1)(1993-2#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2012-3#1)
Durations##2##1##(1993-3#1)(1994-1#1)
Durban and Coast##2##3##(2011-1#2)
Durban and##3##2##(2011-1#2)(2013-8#1)
Durban##6##1##(1997-4#2)(2010-4#1)(2011-1#2)(2013-8#1)
Durham##3##1##(2008-11#2)(2013-1#1)
During 1983 to##2##3##(2008-10#2)
During 1990##2##2##(1992-3#1)(1993-3#1)
During 1998##2##2##(2008-10#2)
During 2001##2##2##(2008-10#1)(2008-5#1)
During 5##2##2##(1996-5#1)(2012-6#1)
During Infection of##3##3##(2008-10#3)
During January##2##2##(2008-12#1)(2008-5#1)
During July##2##2##(2007-2#1)(2008-10#1)
During October##2##2##(1994-3#1)(2008-11#1)
During a four##2##3##(1991-5#1)(1995-5#1)
During a period of##4##4##(1990-12#1)(1992-11#1)(1995-11#1)(1997-8#1)
During a single##2##3##(1990-12#1)(2012-12#1)
During a##38##2##(1990-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1997-8#3)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
During an##2##2##(2008-11#1)(2013-1#1)
During both##2##2##(1993-12#1)(2013-8#1)
During copulation##2##2##(2007-12#1)(2008-8#1)
During development of the##2##4##(1993-3#1)(1994-12#1)
During development##5##2##(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
During each sampling##2##3##(2007-5#1)(2008-12#1)
During each##5##2##(2007-5#1)(2008-12#1)(2008-5#2)(2010-3#1)
During embryogenesis##3##2##(1994-12#1)(1997-6#1)(1997-7#1)
During embryonic development##2##3##(1995-12#1)(2010-5#1)
During embryonic##3##2##(1995-12#1)(1996-2#1)(2010-5#1)
During exercise##3##2##(2011-1#1)(2013-8#2)
During field##2##2##(2008-10#2)
During flower development##2##3##(1997-2#1)(1997-8#1)
During follow-up##5##2##(1990-5#1)(1992-5#1)(1994-12#1)(1996-6#1)(2007-11#1)
During his##2##2##(1996-2#1)(2011-1#1)
During in##2##2##(2008-10#1)(2008-5#1)
During intraoperative##2##2##(2007-8#1)(2009-1#1)
During its##2##2##(1996-9#1)(2008-12#1)
During long-term##2##2##(2008-11#1)(2008-7#1)
During our##2##2##(1994-11#1)(2008-5#1)
During phase II##2##3##(1991-3#1)(1995-12#1)
During pregnancy##4##2##(1991-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
During recent##2##2##(1991-9#1)(2008-7#1)
During recovery under##2##3##(2013-8#2)
During recovery##3##2##(1993-12#1)(2013-8#2)
During storage##2##2##(2007-3#1)(2011-2#1)
During subsequent##2##2##(1997-2#1)(2007-5#1)
During surgery##2##2##(2008-9#1)(2012-12#1)
During that period##3##3##(2008-5#1)(2010-1#1)(2011-2#1)
During that time##3##3##(1996-12#1)(1997-2#1)(2008-9#1)
During that##7##2##(1996-12#1)(1997-2#1)(2008-5#2)(2008-9#1)(2010-1#1)(2011-2#1)
During the 11##2##3##(1993-11#1)(2007-8#1)
During the 1980s##4##3##(1992-2#1)(1994-2#1)(1997-4#1)(1997-6#1)
During the 1989-90##2##3##(1992-6#1)(1994-3#1)
During the 1990s##2##3##(1994-2#1)(1997-2#1)
During the 1995##2##3##(1996-6#1)(2008-10#1)
During the 4-year period##2##4##(2008-10#2)
During the 5 days##2##4##(1993-6#1)(1996-5#1)
During the 5 years##2##4##(1992-8#1)(2011-2#1)
During the 5##4##3##(1992-8#1)(1993-6#1)(1996-5#1)(2011-2#1)
During the First Year of##2##5##(2008-2#1)(2008-4#1)
During the aging process##3##4##(1994-2#1)(1997-2#2)
During the course of##8##4##(1991-6#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
During the early##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
During the enzymatic reaction##2##4##(2008-10#2)
During the exercise##2##3##(2008-10#2)
During the final##2##3##(1993-12#1)(2008-5#1)
During the first and##2##4##(2008-11#1)(2008-4#1)
During the first half of##3##5##(1992-3#1)(2008-1#1)(2009-7#1)
During the first phase##2##4##(1993-9#1)(2008-12#1)
During the first stage##2##4##(2008-5#1)(2009-5#1)
During the first##19##3##(1992-3#1)(1992-6#1)(1993-9#1)(1996-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
During the follow up##2##4##(2008-1#1)(2013-1#1)
During the follow-up##2##3##(2007-7#1)(2011-3#1)
During the following##3##3##(1993-3#1)(1996-3#1)(2008-4#1)
During the growth##2##3##(2008-11#2)
During the initial##2##3##(2008-1#1)(2013-8#1)
During the insertion of##2##4##(2008-9#1)(2011-2#1)
During the last 15 years##2##5##(2010-12#2)
During the last decade the##2##5##(1991-11#1)(1996-3#1)
During the last decade##10##4##(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1996-3#1)(2008-11#2)(2008-4#1)(2009-8#1)(2010-8#1)
During the last ten years##2##5##(1990-11#1)(1996-3#1)
During the last two##2##4##(1997-8#1)(2010-5#1)
During the last year the##2##5##(1993-8#1)(1997-3#1)
During the last##31##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-8#1)(1994-6#1)(1996-3#2)(1997-3#2)(1997-4#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
During the late##2##3##(2010-1#1)(2011-3#1)
During the month##2##3##(2008-4#1)(2013-1#1)
During the observation period##3##4##(1992-5#1)(1997-3#1)(2008-2#1)
During the operation##3##3##(1992-6#1)(2008-11#1)(2012-12#1)
During the past decade##7##4##(1991-3#1)(1997-3#1)(2008-10#3)(2011-1#1)(2012-3#1)
During the past few years##2##5##(2008-9#1)(2013-1#1)
During the past several years##2##5##(2008-7#1)(2009-3#1)
During the past several##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
During the past three decades##2##5##(2008-11#1)(2008-7#1)
During the past two decades##4##5##(1992-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
During the past##21##3##(1991-3#1)(1992-11#1)(1992-8#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-7#3)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
During the period of##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
During the period##15##3##(1991-8#1)(1993-2#1)(1995-9#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)
During the present##2##3##(2008-10#1)(2013-1#1)
During the previous decade several papers pertaining to aflatoxin M1 have been published in different journals##2##16##(2013-1#2)
During the previous##3##3##(1991-5#1)(2013-1#2)
During the procedure##2##3##(2010-12#1)(2011-2#1)
During the process of##2##4##(2007-11#1)(2008-2#1)
During the same period##3##4##(1990-11#1)(2008-5#1)(2010-7#1)
During the same##4##3##(1990-11#1)(2008-5#1)(2010-12#1)(2010-7#1)
During the second##6##3##(1993-9#1)(1995-5#1)(1997-6#1)(2008-1#2)(2009-5#1)
During the shift from##2##4##(1994-11#1)(1995-11#1)
During the study period##4##4##(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
During the study##6##3##(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)
During the year##2##3##(1990-5#1)(1994-6#1)
During the years##3##3##(1990-6#1)(1993-3#1)(2008-12#1)
During the##279##2##(1990-11#2)(1990-3#2)(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#2)(1996-11#1)(1996-3#6)(1996-5#2)(1996-6#3)(1997-2#6)(1997-3#4)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#4)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#8)(2008-10#31)(2008-11#14)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#14)(2011-3#2)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#2)
During therapy##2##2##(2008-1#1)(2011-2#1)
During these##2##2##(2007-10#1)(2008-7#1)
During this period##6##3##(1994-6#1)(1995-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-9#1)
During this phase##2##3##(2008-3#1)(2008-4#1)
During this time##7##3##(1990-11#1)(1995-8#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
During this##25##2##(1990-11#1)(1990-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-7#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-8#1)
During treatment##3##2##(1994-11#1)(2009-11#1)(2013-1#1)
During tumor##2##2##(2008-1#1)(2008-5#1)
During##608##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#6)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#7)(1994-3#4)(1994-6#5)(1994-8#1)(1995-11#3)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#6)(1996-5#4)(1996-6#5)(1996-7#1)(1996-9#1)(1997-2#9)(1997-3#5)(1997-4#4)(1997-6#6)(1997-7#2)(1997-8#9)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2007-3#1)(2007-5#6)(2007-7#4)(2007-8#6)(2008-1#13)(2008-10#73)(2008-11#29)(2008-12#7)(2008-2#7)(2008-3#8)(2008-4#11)(2008-5#26)(2008-6#8)(2008-7#19)(2008-8#4)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#29)(2011-3#4)(2011-9#2)(2012-1#2)(2012-12#10)(2012-2#12)(2012-3#11)(2012-6#1)(2012-8#1)(2013-1#24)(2013-7#3)(2013-8#13)
Durum##4##1##(2008-10#4)
Dust##4##1##(2008-10#3)(2013-8#1)
Dutch Belted rabbits##2##3##(1994-3#2)
Dutch Society of Family Physicians]##2##5##(1996-8#1)(1997-8#1)
Dutch TAD soils##5##3##(2008-10#5)
Dutch adolescents##2##2##(2009-7#2)
Dutch and##2##2##(2008-10#1)(2008-5#1)
Dutch cohorts born##2##3##(2011-2#2)
Dutch elm disease##4##3##(2008-10#4)
Dutch isolates##2##2##(2008-10#2)
Dutch respondents##2##2##(1992-5#2)
Dutch women##2##2##(1990-9#2)
Dutch##71##1##(1990-6#1)(1990-9#2)(1991-6#1)(1992-5#3)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#3)(1994-5#1)(1995-12#2)(1996-11#2)(1996-3#2)(1996-8#2)(1997-8#2)(2007-12#1)(2007-6#3)(2008-10#18)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2009-12#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
Duty to##2##2##(1997-5#1)(2012-12#1)
Duty##4##1##(1997-5#1)(2008-3#1)(2012-12#1)(2013-8#1)
Dv42 was##2##2##(2008-10#2)
Dvl2##4##1##(2012-12#4)
Dwarf Essex seed meal amendments##2##5##(2008-10#2)
Dwarf mistletoe incidence##2##3##(2008-10#2)
Dwarf##10##1##(2008-10#10)
Dwelling##2##1##(2013-1#2)
Dx##2##1##(2008-7#2)
Dy and Eu##4##3##(2008-10#4)
Dy##6##1##(2008-10#6)
Dy3+ ions##2##2##(1990-11#2)
Dy3+##4##1##(1990-11#4)
Dye##9##1##(2008-10#2)(2008-2#3)(2008-3#2)(2009-8#1)(2012-3#1)
Dye-doped##2##1##(2008-3#2)
Dye-stained gelatin microcarriers##2##3##(1990-2#2)
Dyer##4##1##(2008-10#1)(2009-7#2)(2013-8#1)
Dying in##2##2##(2010-10#1)(2010-8#1)
Dying##5##1##(1993-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
Dynabeads##3##1##(1990-12#2)(2008-10#1)
Dynalign##5##1##(2008-4#5)
Dynamic CT##2##2##(2008-1#1)(2012-1#1)
Dynamic changes##2##2##(1996-2#1)(2008-9#1)
Dynamic compliance##2##2##(2008-5#1)(2013-7#1)
Dynamic contrast-enhanced magnetic resonance imaging##2##5##(2008-8#1)(2010-3#1)
Dynamic contrast-enhanced##4##2##(2008-1#1)(2008-8#2)(2010-3#1)
Dynamic development of##2##3##(2007-8#1)(2012-2#1)
Dynamic hyperinflation##2##2##(2013-7#2)
Dynamic light scattering in##2##4##(2007-11#1)(2008-3#1)
Dynamic light scattering##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
Dynamic light-scattering##3##2##(2008-3#3)
Dynamic properties of##2##3##(2007-12#1)(2011-2#1)
Dynamic simulation of##2##3##(2007-12#1)(2008-11#1)
Dynamic studies of##2##3##(2007-12#1)(2008-11#1)
Dynamic surface tension##2##3##(2008-10#2)
Dynamic##95##1##(1991-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(2007-11#3)(2007-12#5)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#4)(2013-8#2)
Dynamical features of higher-order correlation events##2##6##(2008-11#2)
Dynamical##6##1##(1996-9#1)(2007-12#1)(2008-11#3)(2008-3#1)
Dynamics and##2##2##(1996-9#1)(2008-10#1)
Dynamics in##2##2##(1996-12#1)(1996-9#1)
Dynamics of light-induced reflectivity switching in gallium films deposited on silica by pulsed laser ablation##2##15##(2007-11#2)
Dynamics of the##3##3##(2008-10#1)(2009-6#1)(2009-8#1)
Dynamics of##37##2##(1992-11#1)(1993-11#1)(1994-3#1)(1996-12#1)(2007-11#3)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-8#1)(2009-5#1)(2009-6#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
Dynamics##53##1##(1992-11#1)(1993-11#1)(1994-3#1)(1996-12#2)(1996-9#2)(2007-11#3)(2007-12#1)(2008-10#22)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
Dynamization##2##1##(2013-1#1)(2013-8#1)
Dynastab DK##2##2##(2007-8#2)
Dynastab S##3##2##(2007-8#3)
Dynastab stabilizers##3##2##(2007-8#3)
Dynastab##10##1##(2007-8#10)
Dynein##2##1##(2012-2#2)
Dyract AP##4##2##(2008-5#4)
Dys##2##1##(2012-2#2)
Dysautonomia##2##1##(2008-10#2)
Dysembryoplastic neuroepithelial tumour##2##3##(2008-7#2)
Dysfunction in##2##2##(2012-2#1)(2012-3#1)
Dysfunction of the##2##3##(2010-3#1)(2012-2#1)
Dysfunction of##7##2##(1993-6#1)(2008-1#2)(2008-2#1)(2010-12#1)(2010-3#1)(2012-2#1)
Dysfunction##12##1##(1993-6#1)(2007-2#1)(2008-1#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)
Dysfunctional##6##1##(1994-9#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-1#1)
Dysglycaemia and risk of cardiovascular disease##3##6##(1996-6#3)
Dyslexia##2##1##(2008-11#2)
Dyspepsia##3##1##(1990-3#1)(1995-10#1)(2008-10#1)
Dysphagia##3##1##(2007-10#1)(2007-8#1)(2013-8#1)
Dysphonia##2##1##(2007-8#2)
Dysplasia##4##1##(2007-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
Dyspnea##7##1##(2008-3#3)(2012-3#3)(2013-8#1)
Dysregulation of##3##2##(2008-6#1)(2010-2#1)(2011-2#1)
Dysregulation##5##1##(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
Dystonia##2##1##(2008-7#1)(2013-1#1)
Dystrophin##3##1##(1991-12#1)(2012-2#2)
Désirée##3##1##(2008-10#3)
E (P=0##3##2##(2008-10#3)
E (apoE) and##2##3##(1996-6#1)(2009-8#1)
E (apoE)##4##2##(1995-6#1)(1996-2#1)(1996-6#1)(2009-8#1)
E -##2##2##(1990-5#1)(2007-11#1)
E =##3##2##(2008-10#1)(2008-3#2)
E and C##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
E and F##5##3##(1990-8#1)(2008-6#4)
E and the##2##3##(1996-2#1)(2007-2#1)
E and##39##2##(1990-8#1)(1991-2#2)(1992-9#4)(1993-11#1)(1994-5#1)(1995-11#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-6#5)(2010-12#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
E are##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2009-3#1)
E at##2##2##(2012-2#1)(2013-1#1)
E by##5##2##(1992-11#1)(2007-7#1)(2008-5#1)(2010-12#1)(2012-2#1)
E can be##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
E coli##5##2##(1993-2#1)(1995-9#1)(1996-8#1)(2006-5#1)(2008-10#1)
E coli/100 mL##3##3##(2008-10#3)
E concentrations##2##2##(1991-12#1)(1993-12#1)
E deficiency##4##2##(1991-12#1)(1994-5#3)
E deficient##4##2##(1994-5#3)(2008-6#1)
E degrees '##3##3##(2008-10#3)
E degrees##6##2##(2008-10#6)
E destruxin##2##2##(1991-5#2)
E for##2##2##(2007-11#1)(2010-12#1)
E from##2##2##(1994-3#1)(2008-5#1)
E gene##5##2##(1992-9#2)(1995-6#1)(2008-4#1)(2009-12#1)
E genotype##3##2##(1996-12#1)(2008-7#2)
E genotypes##2##2##(2008-10#1)(2008-7#1)
E genotyping##3##2##(1990-2#1)(2008-7#2)
E in Nepal##2##3##(2008-7#2)
E in the##3##3##(1994-6#1)(1995-5#1)(1995-6#1)
E in vitro##2##3##(1995-12#1)(1996-2#1)
E in##18##2##(1992-9#3)(1993-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)
E increases##2##2##(1993-6#1)(2008-5#1)
E is an##3##3##(2008-7#1)(2009-8#1)(2012-2#1)
E is##13##2##(1992-12#2)(1992-9#1)(1995-5#1)(1996-3#1)(2007-11#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#3)
E levels##3##2##(1993-2#1)(1994-9#1)(2008-7#1)
E mu-myc transgenic mice##4##4##(1991-5#4)
E mu-myc##5##2##(1991-5#5)
E of##3##2##(1993-11#1)(2008-5#1)(2009-7#1)
E or##2##2##(1995-11#1)(1997-2#1)
E prevent##2##2##(1994-8#1)(1996-3#1)
E receptor##2##2##(1995-11#1)(2009-8#1)
E rhusiopathiae##4##2##(2007-12#4)
E showed##2##2##(1991-2#1)(2013-1#1)
E to##5##2##(1991-12#1)(1991-2#3)(1993-6#1)
E via##3##2##(2008-1#1)(2008-11#2)
E virus (HEV)##2##3##(1997-4#1)(2007-7#1)
E virus##10##2##(1997-4#2)(2007-12#1)(2007-2#2)(2007-7#2)(2008-7#1)(2009-8#1)(2013-7#1)
E was##10##2##(1990-8#2)(1991-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#4)
E were##6##2##(1993-11#1)(1997-6#1)(2008-10#2)(2011-2#1)(2012-3#1)
E z##2##2##(1992-12#2)
E##1010##1##(1990-10#1)(1990-11#11)(1990-12#6)(1990-2#4)(1990-5#12)(1990-7#2)(1990-8#11)(1991-12#14)(1991-2#13)(1991-3#5)(1991-5#12)(1991-6#1)(1991-8#6)(1991-9#4)(1992-11#1)(1992-12#4)(1992-3#4)(1992-6#5)(1992-8#8)(1992-9#25)(1993-11#7)(1993-12#9)(1993-2#3)(1993-3#1)(1993-6#12)(1993-8#4)(1993-9#6)(1994-1#2)(1994-11#7)(1994-12#15)(1994-2#3)(1994-3#6)(1994-5#19)(1994-6#8)(1994-7#3)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#6)(1995-12#8)(1995-2#16)(1995-3#2)(1995-5#7)(1995-6#16)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#7)(1996-5#6)(1996-6#2)(1996-8#1)(1997-2#9)(1997-3#3)(1997-4#13)(1997-5#2)(1997-6#16)(1997-7#9)(1997-8#3)(2006-10#1)(2006-11#7)(2006-5#1)(2007-11#9)(2007-12#10)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#15)(2008-1#5)(2008-10#184)(2008-11#22)(2008-12#24)(2008-2#4)(2008-3#3)(2008-4#15)(2008-5#29)(2008-6#18)(2008-7#28)(2008-8#14)(2008-9#26)(2009-10#5)(2009-11#1)(2009-12#8)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#8)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#9)(2010-4#9)(2010-5#1)(2010-6#6)(2010-8#4)(2011-1#14)(2011-2#26)(2012-12#1)(2012-2#29)(2012-3#13)(2013-1#16)(2013-7#3)(2013-8#5)
E&amp##2##1##(2008-10#1)(2008-6#1)
E(1)##3##1##(1996-5#2)(2008-2#1)
E(1/2)##3##1##(1996-2#1)(2008-10#2)
E(2) level##2##2##(2009-7#2)
E(2)##9##1##(1996-5#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-7#2)(2010-9#1)
E(3)##4##1##(2008-10#4)
E(A)##2##1##(2008-5#2)
E(CT) and##2##2##(1997-7#2)
E(a) of##2##2##(1996-7#2)
E(i)##2##1##(2008-10#2)
E(n)##2##1##(2007-11#1)(2008-11#1)
E(pa) and I(pa)##2##3##(2008-10#2)
E(pa)##4##1##(2008-10#4)
E(u)(z) and E(d)(z)##2##3##(2008-2#2)
E) and##3##2##(1992-9#1)(2010-12#1)(2011-2#1)
E)##14##1##(1991-5#1)(1992-9#1)(1994-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
E)-9##2##1##(2008-10#2)
E- and P-selectin##2##3##(1993-8#1)(2006-6#1)
E- and##5##2##(1991-5#1)(1993-8#1)(1995-11#1)(2006-6#1)(2007-11#1)
E-##8##1##(1991-5#1)(1993-8#1)(1994-9#2)(1995-11#1)(2006-6#1)(2007-11#2)
E-1-26##3##1##(1991-5#3)
E-5##2##1##(1995-3#1)(2007-11#1)
E-64##7##1##(1990-2#1)(1990-7#1)(1992-9#3)(1995-6#2)
E-8##2##1##(2007-11#1)(2011-2#1)
E-ACT/M-CAA-170##2##1##(2008-10#2)
E-box##7##1##(1995-6#2)(1997-7#3)(2008-11#1)(2012-12#1)
E-cadherin and##2##2##(2010-8#1)(2012-2#1)
E-cadherin##18##1##(1991-12#3)(1991-5#3)(2008-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#6)
E-deficient mice##6##2##(1994-6#4)(2008-1#1)(2009-10#1)
E-deficient##7##1##(1994-6#4)(1995-6#1)(2008-1#1)(2009-10#1)
E-diol destruxin##3##2##(1991-5#3)
E-dominant##2##1##(1995-11#2)
E-field components##2##2##(2008-3#2)
E-field##6##1##(2008-10#1)(2008-3#5)
E-health readiness assessment framework in iran##2##6##(2013-1#2)
E-rich##2##1##(1993-12#1)(2008-1#1)
E-selectin has##2##2##(1992-12#1)(1993-8#1)
E-selectin##15##1##(1992-12#2)(1992-8#1)(1993-8#7)(1995-12#1)(2006-6#1)(2008-11#3)
E-selectin-IgG protein##2##2##(2008-11#2)
E-selectin-IgG##5##1##(2008-11#5)
E-state descriptors in##2##3##(2007-11#2)
E-state descriptors##3##2##(2007-11#3)
E-states##2##1##(2007-11#2)
E-trait and##2##2##(2008-10#2)
E/E35 and K/K35##3##3##(1993-11#3)
E/E35##4##1##(1993-11#4)
E/K42##5##1##(1993-11#5)
E1 and E2##3##3##(2008-11#2)(2008-9#1)
E1 and##7##2##(2008-10#4)(2008-11#2)(2008-9#1)
E1 or E2##2##3##(1994-8#1)(2008-9#1)
E1##43##1##(1990-11#1)(1991-12#2)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#8)(1995-5#4)(1997-4#1)(1997-7#1)(2007-8#3)(2008-10#6)(2008-11#5)(2008-8#1)(2008-9#7)
E1-deleted##2##1##(2008-11#2)
E11##2##1##(1996-5#1)(2008-9#1)
E13##3##1##(1996-5#1)(2008-8#2)
E14##2##1##(1992-6#1)(1997-2#1)
E15##3##1##(1991-12#1)(2008-8#2)
E15NL) and high-flux (F60##2##4##(2007-7#1)(2008-1#1)
E18##3##1##(1991-9#1)(2008-10#2)
E1A and ras##2##3##(2008-11#2)
E1A and##3##2##(1993-2#1)(2008-11#2)
E1A##7##1##(1993-2#2)(2008-11#4)(2008-8#1)
E1B 175R##3##2##(1993-2#3)
E1B##4##1##(1993-2#4)
E1B-19K cells##2##2##(2008-11#2)
E1B-19K myelomas##2##2##(2008-11#2)
E1B-19K##8##1##(2008-11#8)
E1a-cooperative transformation##2##2##(1993-2#2)
E2 (PGE2)##9##2##(1990-2#1)(1991-8#1)(1993-11#1)(1993-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2013-8#1)
E2 + MPA##2##3##(1994-9#2)
E2 alone##3##2##(1994-9#1)(1995-12#1)(2012-3#1)
E2 and BE##2##3##(2008-10#2)
E2 and##6##2##(1991-12#1)(1993-8#1)(1996-2#1)(2008-10#3)
E2 at##2##2##(1997-1#1)(2008-10#1)
E2 by##2##2##(1990-11#1)(1997-1#1)
E2 chlorohydrin##3##2##(2008-9#3)
E2 in##3##2##(1990-2#1)(1995-12#1)(1997-2#1)
E2 of##2##2##(2008-10#1)(2008-5#1)
E2 on##3##2##(1995-12#2)(1995-9#1)
E2 protein of##2##3##(1990-5#1)(2008-10#1)
E2 protein##3##2##(1990-5#2)(2008-10#1)
E2 proteins##3##2##(2008-8#1)(2008-9#2)
E2 receptors##2##2##(1990-11#1)(2008-7#1)
E2 treatment##2##2##(1990-11#1)(1993-1#1)
E2 was##3##2##(2008-10#2)(2008-8#1)
E2 were##2##2##(2008-10#1)(2008-5#1)
E2##133##1##(1990-11#13)(1990-12#1)(1990-2#2)(1990-5#4)(1991-12#2)(1991-5#1)(1991-8#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-8#1)(1994-8#2)(1994-9#5)(1995-12#8)(1995-3#3)(1995-6#2)(1995-9#7)(1996-2#2)(1996-6#1)(1997-1#8)(1997-2#2)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#6)(2009-7#2)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
E2)##3##1##(2008-10#2)(2008-11#1)
E2-ER##2##1##(1995-2#2)
E2-induced growth##2##2##(2011-2#2)
E2-induced##3##1##(2011-2#3)
E22Q##2##1##(2009-2#2)
E278Ar##3##1##(2008-10#3)
E2F and GATA-a motifs##2##4##(2012-2#2)
E2F and##4##2##(1992-8#1)(2012-2#3)
E2F family##2##2##(1995-2#2)
E2F motif##4##2##(2012-2#4)
E2F transcription##2##2##(1995-2#1)(2011-2#1)
E2F##20##1##(1992-8#4)(1995-2#5)(2011-2#1)(2012-12#3)(2012-2#7)
E2F-1##4##1##(1995-2#2)(2012-12#2)
E2F-binding##2##1##(1994-12#1)(2012-12#1)
E2F1##2##1##(2008-9#1)(2012-2#1)
E2F4 expression##4##2##(2011-2#4)
E2F4 overexpression##2##2##(2011-2#2)
E2F4##13##1##(2011-2#12)(2013-8#1)
E2H##2##1##(1991-12#2)
E2L##2##1##(1991-12#2)
E3 and##2##2##(2008-10#1)(2008-8#1)
E3 ligase##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
E3 ubiquitin ligases##4##3##(2009-10#1)(2013-1#3)
E3 ubiquitin##5##2##(2009-10#2)(2013-1#3)
E3##27##1##(1991-12#2)(1996-6#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#3)(2012-2#1)(2013-1#5)
E375--&gt##2##1##(1994-5#2)
E4 region##4##2##(1992-9#4)
E4##10##1##(1992-8#1)(1992-9#4)(1993-6#1)(1993-9#1)(1996-2#1)(1996-6#1)(2008-8#1)
E44##2##1##(2009-12#2)
E464##2##1##(1994-6#2)
E5##2##1##(2008-8#2)
E5-1##4##1##(1995-8#4)
E5050##7##1##(1990-7#7)
E6 and E7##4##3##(1995-2#4)
E6##6##1##(1992-2#1)(1995-2#4)(2008-9#1)
E7 fusion protein##2##3##(2011-1#2)
E7##14##1##(1995-2#4)(2007-11#1)(2007-12#1)(2008-9#1)(2011-1#7)
E8##4##1##(1997-4#3)(2009-2#1)
E83/K84 were##2##2##(1995-2#2)
E83/K84##3##1##(1995-2#3)
E98A enzyme##2##2##(1995-6#2)
E99/E100##4##1##(1995-2#4)
EA and CoQ(10)##2##3##(2008-10#2)
EA children##2##2##(2008-11#2)
EA had been##2##3##(2008-5#2)
EA is thought to##2##4##(2008-5#2)
EA of##2##2##(1996-12#2)
EA on##3##2##(1996-12#1)(2012-3#2)
EA stimulation##2##2##(1996-12#2)
EA treatment##2##2##(2008-10#2)
EA was##2##2##(1995-12#1)(2008-5#1)
EA##40##1##(1995-12#3)(1995-2#3)(1996-12#9)(2008-10#7)(2008-11#3)(2008-5#8)(2010-2#1)(2011-2#2)(2012-3#2)(2013-7#2)
EA-induced##3##1##(1996-12#3)
EAA##5##1##(1994-11#3)(2008-11#2)
EABR and##2##2##(2008-9#2)
EABR##4##1##(2008-9#4)
EAC##2##1##(1992-3#1)(2008-4#1)
EADmin was##2##2##(1996-2#2)
EADs##3##1##(1996-2#3)
EAE and##2##2##(2007-11#1)(2010-12#1)
EAE##11##1##(1995-12#2)(2007-11#4)(2010-12#2)(2011-2#3)
EAG activity##2##2##(2008-10#2)
EAG##5##1##(2008-10#5)
EAP##10##1##(1992-10#2)(1995-6#5)(2008-9#1)(2012-12#2)
EAS and ENA is##2##4##(2008-8#2)
EAS and ENA##6##3##(2008-8#6)
EAS and##9##2##(2008-8#9)
EAS##16##1##(2008-3#2)(2008-8#11)(2012-2#3)
EASE##6##1##(2008-11#6)
EAST##4##1##(2009-11#1)(2010-9#3)
EAT##7##1##(1992-3#2)(2007-7#1)(2009-1#2)(2013-1#1)(2013-8#1)
EATL##2##1##(2008-12#2)
EAU##3##1##(2008-4#3)
EB formation##2##2##(2008-11#1)(2008-8#1)
EB was##3##2##(2008-11#2)(2008-9#1)
EB##17##1##(2008-10#6)(2008-11#5)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
EB-PVD##5##1##(2009-7#5)
EBA##2##1##(2008-4#1)(2012-3#1)
EBC##2##1##(2010-5#2)
EBCM##3##1##(2008-2#1)(2008-3#2)
EBER-I##2##1##(1993-9#2)
EBID##3##1##(2009-11#3)
EBL##7##1##(2008-11#1)(2008-12#4)(2008-3#2)
EBM and HTA are##2##4##(2012-12#2)
EBM and HTA##5##3##(2012-12#5)
EBM and##6##2##(2009-7#1)(2012-12#5)
EBM##7##1##(2008-4#1)(2009-7#1)(2012-12#5)
EBNA-TgG##2##1##(2007-2#2)
EBP##4##1##(2008-11#2)(2013-1#2)
EBPs##4##1##(2013-1#4)
EBUS using##2##2##(2010-8#2)
EBUS##3##1##(2010-8#3)
EBV DNA polymerase##2##3##(1993-8#1)(1997-3#1)
EBV DNA##6##2##(1993-8#1)(1994-8#3)(1997-3#1)(2008-10#1)
EBV gene expression##2##3##(1993-9#2)
EBV in##2##2##(1993-9#1)(2011-2#1)
EBV infection##8##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-6#2)(2011-2#1)
EBV involvement in renal tissue##2##5##(2011-2#2)
EBV is##4##2##(1993-9#1)(2007-2#1)(2008-4#1)(2008-5#1)
EBV polymerase##2##2##(1993-8#2)
EBV##50##1##(1992-12#2)(1993-8#5)(1993-9#5)(1994-2#1)(1994-8#5)(1995-2#2)(1997-3#3)(2007-2#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#5)(2008-8#1)(2008-9#3)(2010-6#2)(2011-2#6)
EBV-1##2##1##(2008-12#2)
EBV-DNA##2##1##(2011-2#2)
EBV-associated##2##1##(2008-9#1)(2010-6#1)
EBV-based##2##1##(2008-11#1)(2008-8#1)
EBV-negative##2##1##(1993-9#2)
EBV-positive##3##1##(1993-9#3)
EBs##8##1##(2008-10#1)(2008-11#6)(2008-9#1)
EC 1##11##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#2)(2008-11#1)(2008-4#1)
EC 2##15##2##(1990-5#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-8#2)(1996-10#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#2)
EC 3##14##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-5#1)(1993-8#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#2)
EC 4##6##2##(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(2008-10#1)
EC 6##2##2##(1994-8#2)
EC Standards##3##2##(2008-10#3)
EC and HRP were##2##4##(2012-4#2)
EC and HRP##3##3##(2012-4#3)
EC and##6##2##(2008-1#1)(2009-10#1)(2012-2#1)(2012-4#3)
EC at 0##3##3##(2011-2#3)
EC cell biology and##2##4##(2012-12#2)
EC cell##4##2##(1990-11#1)(2012-12#3)
EC cells##5##2##(1994-9#4)(2013-1#1)
EC deprived of L-arginine##3##4##(1990-12#3)
EC deprived of##5##3##(1990-12#5)
EC in##3##2##(1994-2#1)(2012-4#1)(2013-8#1)
EC or##2##2##(2011-2#1)(2013-8#1)
EC were##3##2##(2008-10#1)(2008-12#1)(2012-4#1)
EC##123##1##(1990-11#2)(1990-12#5)(1990-2#3)(1990-5#4)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#7)(1994-5#1)(1994-8#7)(1994-9#4)(1995-2#4)(1995-5#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#2)(2009-11#2)(2009-2#2)(2010-5#2)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)(2012-4#7)(2013-1#1)(2013-8#9)
EC(50) and Emax##2##3##(2010-3#2)
EC(50) and##3##2##(2008-10#1)(2010-3#2)
EC(50) values for free##2##4##(1997-7#2)
EC(50) values for##3##3##(1997-7#3)
EC(50) values were compared with those obtained by##2##8##(2008-10#2)
EC(50) values were##3##3##(2008-10#3)
EC(50) values##10##2##(1997-7#3)(2008-10#5)(2008-11#1)(2012-2#1)
EC(50)##21##1##(1997-7#3)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#2)(2012-2#2)(2013-1#2)
EC(80)##2##1##(2008-10#2)
EC-1##6##1##(2008-10#5)(2011-2#1)
EC-2##4##1##(2008-10#4)
EC-3 and##2##2##(2008-10#2)
EC-3##3##1##(2008-10#3)
EC-IC bypass##3##2##(2008-12#1)(2012-2#2)
EC-SOD in Group I##2##4##(1992-11#2)
EC-SOD in Group II##2##4##(1992-11#2)
EC-SOD in Group##4##3##(1992-11#4)
EC-SOD is##2##2##(1992-11#2)
EC-SOD level##2##2##(1992-11#2)
EC-SOD##11##1##(1992-11#11)
EC/HRP and##2##2##(2012-4#2)
EC/HRP##4##1##(2012-4#4)
EC3 value##3##2##(2008-10#2)(2008-5#1)
EC3 values##2##2##(2008-10#1)(2008-5#1)
EC3##8##1##(2008-10#5)(2008-5#2)(2012-2#1)
EC50 and##2##2##(1995-11#1)(2008-11#1)
EC50 for##4##2##(1995-12#1)(1995-2#2)(1995-6#1)
EC50 of##7##2##(1993-11#2)(1994-11#1)(1994-9#1)(1997-2#1)(2008-11#1)(2011-3#1)
EC50 value of##2##3##(1991-5#1)(1995-12#1)
EC50 value##4##2##(1990-8#1)(1991-5#1)(1995-12#1)(1995-6#1)
EC50 values for##2##3##(1995-2#1)(2008-11#1)
EC50 values##6##2##(1995-12#2)(1995-2#1)(2008-11#3)
EC50##31##1##(1990-8#1)(1991-5#1)(1993-11#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#7)(2011-3#2)
EC50/IC50 estimates##2##2##(2012-2#2)
EC50/IC50 is the##2##3##(2012-2#2)
EC50/IC50 should only be used if there are at least two assay concentrations##2##13##(2012-2#2)
EC50/IC50##12##1##(2012-2#12)
ECAO##3##1##(1995-5#3)
ECAP##2##1##(2008-9#2)
ECB larvae fed##2##3##(2008-7#2)
ECB##6##1##(2008-10#4)(2008-7#2)
ECC##3##1##(2007-8#1)(2008-2#2)
ECD applications##2##2##(2010-1#2)
ECD detector##2##2##(2008-10#1)(2009-8#1)
ECD##11##1##(1995-11#2)(1995-12#1)(2008-10#4)(2009-8#1)(2010-1#3)
ECDs##5##1##(2010-1#5)
ECF##3##1##(2008-6#2)(2008-8#1)
ECG abnormalities##2##2##(2010-1#1)(2010-8#1)
ECG and##4##2##(1991-10#1)(1993-2#1)(1996-3#1)(2008-10#1)
ECG based##2##2##(2010-8#2)
ECG changes##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
ECG in##2##2##(1991-3#1)(1993-10#1)
ECG is##4##2##(1995-8#3)(2009-3#1)
ECG monitoring##4##2##(1996-3#3)(2008-7#1)
ECG recordings##2##2##(2009-3#1)(2010-8#1)
ECG signals##5##2##(2010-8#5)
ECG##65##1##(1991-10#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-8#5)(1996-1#1)(1996-3#6)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-7#3)(2009-10#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-5#1)(2010-8#16)(2011-1#2)(2012-12#1)(2012-3#1)
ECGs from##3##2##(2009-3#3)
ECGs##10##1##(2008-3#1)(2008-8#1)(2009-3#7)(2010-5#1)
ECH in water samples at the concentration##2##7##(2008-10#2)
ECH in##3##2##(2008-10#3)
ECH##6##1##(2008-10#6)
ECHL players##2##2##(2010-1#2)
ECII##6##1##(2008-11#6)
ECL catalytic activity##2##3##(2008-10#2)
ECL efficiency##2##2##(2008-10#2)
ECL intensity was linear with the##2##6##(2008-10#2)
ECL intensity##7##2##(2008-10#7)
ECL of Ru(bpy)(3)(2+)##3##3##(2008-10#3)
ECL of##6##2##(2008-10#6)
ECL##34##1##(1997-1#2)(2008-10#32)
ECL-generating##2##1##(2010-7#2)
ECM accumulation in##2##3##(2011-2#2)
ECM accumulation##3##2##(2011-2#3)
ECM molecules##2##2##(1994-5#1)(2009-12#1)
ECM##38##1##(1993-3#4)(1994-5#1)(1994-9#2)(2008-11#5)(2008-3#4)(2009-10#3)(2009-12#3)(2009-7#1)(2009-8#1)(2011-2#4)(2012-1#3)(2012-2#3)(2013-8#4)
ECMO##7##1##(2007-8#3)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)
ECOD##4##1##(1990-7#2)(2008-11#2)
ECOG##3##1##(2007-11#2)(2008-7#1)
ECONOMIC##2##1##(2009-11#1)(2011-2#1)
ECOPD##2##1##(2011-2#2)
ECP##6##1##(1996-12#6)
ECRI Institute##8##2##(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#2)
ECRI institute##2##2##(2010-9#1)(2011-2#1)
ECRI##11##1##(2010-9#2)(2011-1#1)(2011-2#6)(2013-1#2)
ECS##5##1##(1996-12#5)
ECT and##2##2##(2008-12#1)(2011-1#1)
ECT in##3##2##(2008-12#1)(2010-7#1)(2012-12#1)
ECT was##2##2##(2008-12#1)(2012-2#1)
ECT##21##1##(2008-12#6)(2010-7#1)(2011-1#2)(2012-12#11)(2012-2#1)
ECTO-NOX##3##1##(2008-7#2)(2009-9#1)
ECVAM##4##1##(2008-10#4)
ECW##4##1##(2008-10#4)
ECW-10R##2##1##(2008-10#2)
ECW-20R##2##1##(2008-10#2)
ECW123##5##1##(2008-10#5)
ECW12346##5##1##(2008-10#5)
ECZs##3##1##(2008-10#3)
ECoG##2##1##(1992-8#1)(2008-11#1)
ECs##7##1##(1994-6#4)(2008-11#2)(2012-12#1)
ED and##3##2##(2008-11#1)(2009-6#1)(2010-8#1)
ED by##2##2##(1997-2#1)(2011-2#1)
ED management##3##2##(2010-10#1)(2011-2#2)
ED nurses##4##2##(2008-7#3)(2009-9#1)
ED overcrowding is##3##3##(2008-11#3)
ED overcrowding##4##2##(2008-11#4)
ED patients##2##2##(2009-11#1)(2011-1#1)
ED risk behaviors##2##3##(2013-8#2)
ED risk##3##2##(1996-3#1)(2013-8#2)
ED setting##2##2##(2008-11#1)(2013-1#1)
ED symptoms##2##2##(2012-2#2)
ED was##2##2##(2011-2#1)(2013-8#1)
ED##90##1##(1993-3#4)(1996-12#1)(1996-3#1)(1997-2#3)(1997-8#1)(2007-11#1)(2007-3#1)(2007-5#6)(2008-10#1)(2008-11#12)(2008-3#1)(2008-7#3)(2009-11#1)(2009-5#5)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2011-9#2)(2012-2#6)(2013-1#11)(2013-8#6)
ED's##2##1##(1997-2#1)(2011-2#1)
ED(50) of##2##2##(2008-10#1)(2008-11#1)
ED(50)##10##1##(2008-10#7)(2008-11#3)
ED-ETAAS##2##1##(2008-10#2)
ED50 =##5##2##(1992-3#1)(1994-8#1)(1995-3#3)
ED50 of##3##2##(1991-5#1)(1992-3#1)(1994-8#1)
ED50 value of##2##3##(1990-12#1)(1996-2#1)
ED50 values##2##2##(1991-8#1)(1995-12#1)
ED50##15##1##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#2)(1994-8#2)(1995-12#2)(1995-3#3)(1996-2#1)
EDF##4##1##(1991-12#4)
EDFA's##2##1##(2008-2#2)
EDHB##3##1##(1992-9#3)
EDI##4##1##(1993-2#1)(2008-11#2)(2010-3#1)
EDI-OCT was##2##2##(2011-7#2)
EDI-OCT##5##1##(2011-7#5)
EDIN##5##1##(1990-11#5)
EDM process##3##2##(2012-2#3)
EDM##5##1##(2012-2#5)
EDMD and##2##2##(2008-7#2)
EDMD patients##4##2##(2008-7#4)
EDMD##9##1##(2008-7#9)
EDN3 gene##2##2##(1994-12#2)
EDN3 with##2##2##(1994-12#2)
EDN3##6##1##(1994-12#6)
EDNAP##2##1##(2008-12#2)
EDNRB gene##2##2##(1994-12#2)
EDNRB##7##1##(1994-12#7)
EDP##8##1##(1994-6#3)(2008-7#5)
EDRF inhibitors like##2##3##(1991-9#2)
EDRF inhibitors##3##2##(1991-9#3)
EDRF##11##1##(1990-12#2)(1991-9#6)(1993-3#1)(1994-11#2)
EDRF1 and EDRF2 might##2##4##(2008-9#2)
EDRF1 gene##2##2##(2008-9#2)
EDRF1##17##1##(2008-8#7)(2008-9#10)
EDS microanalysis detector##2##3##(2008-10#2)
EDS of deposits produced by these cells demonstrated a calcium/phosphate ratio parallel to hydroxyapatite##2##14##(2008-11#2)
EDS##7##1##(1990-2#1)(2008-10#3)(2008-11#2)(2013-8#1)
EDS-76##3##1##(1997-7#3)
EDTA and McIlvaine buffer at pH 7##2##7##(2008-10#2)
EDTA and citric acid##2##4##(2013-1#2)
EDTA and##14##2##(1996-12#1)(2008-10#11)(2013-1#2)
EDTA as a##2##3##(2008-10#2)
EDTA as the##2##3##(1995-2#1)(2008-10#1)
EDTA as##10##2##(1995-2#1)(2008-10#9)
EDTA at 33 mug of##2##5##(2008-10#2)
EDTA at##3##2##(2008-10#3)
EDTA complexes##2##2##(2008-10#2)
EDTA derived radicals##2##3##(1993-3#2)
EDTA exchange##3##2##(2008-10#3)
EDTA for##3##2##(1997-4#1)(2008-10#1)(2013-1#1)
EDTA in the##2##3##(2008-10#1)(2008-11#1)
EDTA in##6##2##(2008-10#5)(2008-11#1)
EDTA inhibition##2##2##(1992-3#1)(2010-3#1)
EDTA or##3##2##(1991-2#1)(1995-2#1)(2008-10#1)
EDTA was added to##2##4##(2008-10#2)
EDTA was added##3##3##(2008-10#3)
EDTA was##4##2##(2008-10#4)
EDTA with##3##2##(2008-10#3)
EDTA##149##1##(1990-12#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-9#2)(1992-3#3)(1992-8#1)(1993-12#4)(1993-3#5)(1993-6#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#6)(1996-12#1)(1996-5#1)(1997-4#1)(2006-6#1)(2008-10#94)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-3#1)(2013-1#5)
EDTA-Fe##2##1##(1993-11#2)
EDTA-bound Fe(III) is##3##3##(2008-10#3)
EDTA-treated and##2##2##(1997-7#2)
EDTA-treated##3##1##(1994-9#1)(1997-7#2)
EDV##3##1##(2008-1#1)(2013-8#2)
EDX##4##1##(1992-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
EDXRF spectrometry##4##2##(2008-10#4)
EDXRF##8##1##(2008-10#8)
EDs##4##1##(2008-11#4)
EE and##3##2##(2013-1#1)(2013-8#2)
EE has##2##2##(2009-11#2)
EE##16##1##(1990-11#1)(2008-10#1)(2009-11#5)(2013-1#3)(2013-8#6)
EE15NL) membrane dialyzers##2##3##(2007-7#1)(2008-1#1)
EE2 concentrations##2##2##(2013-1#2)
EEC##6##1##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(2009-6#1)
EEDQ into the##2##3##(1995-2#2)
EEE##2##1##(1992-8#2)
EEG abnormalities##2##2##(1990-3#1)(2008-4#1)
EEG activity##5##2##(1991-12#1)(1991-5#1)(1991-9#1)(2010-8#2)
EEG analysis##3##2##(1991-12#1)(2009-8#2)
EEG and##6##2##(1991-9#1)(1993-12#1)(2011-1#3)(2013-8#1)
EEG changes##5##2##(1990-9#1)(1991-9#3)(2013-8#1)
EEG characteristics##4##2##(1991-12#1)(2008-7#3)
EEG data##6##2##(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#2)(2013-8#1)
EEG is##2##2##(2008-4#1)(2008-7#1)
EEG of##2##2##(2008-7#1)(2009-8#1)
EEG patterns##3##2##(2010-11#3)
EEG recordings##2##2##(1992-8#1)(2010-8#1)
EEG segment##2##2##(2010-8#2)
EEG slow##2##2##(1991-9#2)
EEG spectral##2##2##(1991-1#1)(2008-7#1)
EEG was recorded##2##3##(2008-11#1)(2008-7#1)
EEG was##3##2##(2008-11#1)(2008-7#2)
EEG##110##1##(1990-3#1)(1990-5#1)(1990-9#10)(1991-1#3)(1991-11#1)(1991-12#5)(1991-5#2)(1991-9#7)(1992-8#2)(1993-12#1)(1993-9#1)(1994-3#2)(1994-8#1)(1996-7#1)(2007-9#1)(2008-11#4)(2008-4#3)(2008-6#1)(2008-7#17)(2009-8#9)(2010-11#6)(2010-7#5)(2010-8#17)(2011-1#4)(2012-12#1)(2013-8#4)
EEGs##4##1##(1994-3#1)(2008-7#2)(2010-8#1)
EEMR##2##1##(2011-2#2)
EEMRs##2##1##(2011-2#2)
EEOC##2##1##(1995-12#1)(1995-6#1)
EF &gt##2##2##(2008-4#1)(2013-1#1)
EF for##2##2##(2008-10#2)
EF group##5##2##(2011-2#5)
EF##20##1##(1991-8#1)(1993-9#4)(2007-8#1)(2008-10#4)(2008-4#2)(2009-10#1)(2011-2#5)(2012-12#1)(2013-1#1)
EF&quot##2##1##(2011-2#2)
EF-1 beta isoforms##2##3##(1993-11#2)
EF-1 beta##6##2##(1993-11#6)
EF-1alpha and mtSSU rDNA##2##4##(2008-10#2)
EF-1alpha and##4##2##(2008-10#4)
EF-1alpha##6##1##(2008-10#6)
EF-2 by##2##2##(1993-3#2)
EF-2##6##1##(1993-3#6)
EF-35##3##1##(2008-10#3)
EF-hand##4##1##(1992-12#1)(1995-6#3)
EFA processing##2##2##(1994-11#2)
EFA##5##1##(1992-3#1)(1994-11#2)(2008-10#1)(2012-3#1)
EFAs##5##1##(1994-11#5)
EFFECTS OF##3##2##(2009-11#1)(2009-4#1)(2010-8#1)
EFFECTS##5##1##(1997-3#1)(2009-11#1)(2009-4#1)(2010-8#2)
EFIA cDNA##4##2##(1993-2#4)
EFIA##8##1##(1993-2#8)
EFIA#1##7##1##(1993-2#7)
EFISH##2##1##(2007-11#2)
EFM##3##1##(2008-2#1)(2008-5#2)
EFR##4##1##(2008-3#2)(2009-8#2)
EFS for##3##2##(2008-10#1)(2011-2#2)
EFS in the presence of##2##5##(1997-4#2)
EFS##14##1##(1996-5#1)(1997-4#4)(2008-10#1)(2010-3#3)(2011-2#5)
EFT##3##1##(2008-6#3)
EFs##6##1##(2008-10#6)
EG III##3##2##(2008-9#3)
EG in##2##2##(2008-10#2)
EG material##3##2##(2008-10#3)
EG##15##1##(2008-10#11)(2008-9#3)(2013-8#1)
EG&amp##2##1##(2008-2#1)(2008-3#1)
EG-AI##2##1##(2008-8#2)
EGA by##2##2##(2008-10#2)
EGA##3##1##(2008-10#3)
EGC##6##1##(2008-10#6)
EGCG##11##1##(1995-9#1)(2008-10#4)(2008-11#6)
EGCG3''Me was##2##2##(2008-11#2)
EGCG3''Me##4##1##(2008-11#4)
EGF and TGF beta##2##4##(1991-12#2)
EGF and TGF##3##3##(1991-12#2)(1991-7#1)
EGF and##12##2##(1991-12#2)(1991-7#2)(1992-2#1)(1993-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-3#1)
EGF binding##2##2##(1990-12#1)(1993-9#1)
EGF increased##3##2##(1991-12#2)(1995-8#1)
EGF induced##2##2##(1993-6#1)(2008-4#1)
EGF mRNA##2##2##(1991-12#1)(2008-6#1)
EGF more##2##2##(1991-12#1)(2008-11#1)
EGF on##8##2##(1991-12#3)(1994-6#4)(2008-6#1)
EGF or##4##2##(1990-8#1)(1992-9#1)(1993-9#2)
EGF promotes##2##2##(1994-6#1)(2007-12#1)
EGF receptor tyrosine kinase##2##4##(1990-12#1)(1992-7#1)
EGF receptor##16##2##(1990-12#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-8#3)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-7#2)
EGF receptors are##2##3##(1991-7#1)(2008-6#1)
EGF receptors##4##2##(1990-8#1)(1991-7#1)(2008-6#1)(2010-5#1)
EGF stimulated##3##2##(1993-3#2)(2008-4#1)
EGF stimulation##2##2##(1994-8#1)(1995-6#1)
EGF than##2##2##(1991-12#1)(2008-11#1)
EGF treatment of##2##3##(1992-8#1)(1995-6#1)
EGF treatment##3##2##(1992-3#1)(1992-8#1)(1995-6#1)
EGF was##4##2##(1991-12#1)(1991-7#1)(1992-3#1)(1994-6#1)
EGF##123##1##(1990-11#1)(1990-12#3)(1990-8#2)(1991-12#21)(1991-2#1)(1991-7#5)(1992-2#1)(1992-3#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-3#9)(1993-6#2)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#12)(1994-8#3)(1995-2#1)(1995-6#4)(1995-8#1)(1997-1#1)(2007-12#3)(2008-11#5)(2008-4#4)(2008-6#11)(2008-8#4)(2010-5#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#2)
EGF's##2##1##(1992-7#1)(1994-6#1)
EGF-R and##2##2##(1993-9#1)(1994-8#1)
EGF-R immunostaining##2##2##(1994-9#2)
EGF-R was##3##2##(1991-7#2)(1994-9#1)
EGF-R##18##1##(1991-7#3)(1992-9#1)(1993-9#1)(1994-8#1)(1994-9#5)(1995-6#7)
EGF-dependent##2##1##(1992-8#1)(1994-11#1)
EGF-induced##5##1##(1990-11#1)(1993-3#2)(2008-6#1)(2008-7#1)
EGF-like RNA (##2##3##(1991-12#2)
EGF-like growth factor (HB-EGF)##2##4##(1997-1#1)(2013-8#1)
EGF-like growth factor##4##3##(1997-1#2)(2013-8#2)
EGF-like##8##1##(1991-12#2)(1991-2#1)(1995-2#1)(1997-1#2)(2013-8#2)
EGF-receptor and##2##2##(1994-7#1)(2007-12#1)
EGF-receptor signaling##2##2##(2007-12#2)
EGF-receptor##4##1##(1994-7#1)(2007-12#3)
EGF-stimulated tyrosine kinase##2##3##(1992-7#2)
EGF-stimulated##4##1##(1992-7#3)(1994-8#1)
EGFP expressing cells##3##3##(2008-11#3)
EGFP expression##3##2##(2008-11#3)
EGFP##10##1##(2008-11#9)(2008-9#1)
EGFP-tagged##2##1##(2008-11#2)
EGFR gene##8##2##(1993-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#2)(2012-1#2)
EGFR inhibitors##3##2##(2008-4#1)(2008-5#1)(2012-1#1)
EGFR kinase inhibitors##2##3##(2010-8#2)
EGFR kinase##5##2##(2008-4#3)(2010-8#2)
EGFR signaling##3##2##(2008-7#2)(2012-3#1)
EGFR##49##1##(1993-3#6)(1993-8#2)(1993-9#1)(2008-11#4)(2008-4#5)(2008-5#7)(2008-7#5)(2009-5#1)(2010-5#1)(2010-8#7)(2011-2#2)(2012-1#5)(2012-2#1)(2012-3#1)(2013-1#1)
EGFR(+) mice##2##2##(2008-7#2)
EGFR(+)##3##1##(2008-7#3)
EGFR-IC was##2##2##(1993-8#2)
EGFR-IC##4##1##(1993-8#4)
EGFr##3##1##(1992-8#3)
EGFs##3##1##(1990-12#3)
EGG##3##1##(1997-6#1)(2008-11#2)
EGH was##2##2##(1990-8#2)
EGH##4##1##(1990-8#4)
EGR-1##6##1##(1990-11#1)(1991-10#4)(2012-2#1)
EGT##6##1##(2009-6#6)
EGTA addition##2##2##(1994-6#2)
EGTA and##4##2##(1990-2#1)(1996-2#1)(2008-10#1)(2008-8#1)
EGTA or Ca(2+)##2##3##(2008-8#1)(2008-9#1)
EGTA or NaN3##2##3##(1994-12#2)
EGTA or##5##2##(1994-12#2)(2008-8#2)(2008-9#1)
EGTA was##2##2##(1994-6#1)(2008-10#1)
EGTA##32##1##(1990-10#2)(1990-2#2)(1990-8#2)(1991-9#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#9)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-8#5)(2008-9#1)
EGVGE##4##1##(2012-12#4)
EH and##3##2##(1996-5#1)(2008-9#2)
EH##12##1##(1996-5#2)(2008-9#4)(2009-7#2)(2011-2#4)
EHCO##4##1##(2008-10#4)
EHEC##4##1##(2008-9#4)
EHMC##8##1##(2008-10#7)(2008-5#1)
EHR##13##1##(2007-12#1)(2008-4#2)(2008-7#1)(2010-8#6)(2012-12#1)(2012-2#1)(2013-7#1)
EI and EII##5##3##(2008-6#5)
EI and##7##2##(2008-6#5)(2013-1#2)
EI mode##2##2##(2011-1#2)
EI##25##1##(1990-5#2)(2008-6#6)(2011-1#3)(2013-1#14)
EIA and##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
EIA tests##3##2##(1990-9#1)(2008-5#2)
EIA##17##1##(1990-12#1)(1990-9#1)(1995-12#4)(1995-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2010-5#1)(2012-3#1)
EIAV L##6##2##(2008-9#6)
EIAV##8##1##(2008-9#8)
EIB##6##1##(2010-1#5)(2010-5#1)
EID##3##1##(1995-2#3)
EII##6##1##(2008-6#6)
EIN##4##1##(2011-2#4)
EIS##4##1##(1993-2#1)(2008-10#2)(2008-11#1)
EIT##6##1##(2007-11#1)(2007-12#2)(2011-2#3)
EITB-positive##2##1##(1991-8#2)
EIV##2##1##(2013-1#2)
EKF approach enables one to##2##5##(2008-3#2)
EKF approach##3##2##(2008-2#1)(2008-3#2)
EKF##4##1##(2008-2#2)(2008-3#2)
EKG##3##1##(1992-11#1)(2007-8#1)(2008-3#1)
EL##10##1##(1996-5#2)(2008-10#2)(2008-3#3)(2012-3#1)(2013-1#2)
ELA##2##1##(1994-12#2)
ELBW teenagers are##2##3##(2008-11#2)
ELBW teenagers##6##2##(2008-11#6)
ELBW##7##1##(2008-11#7)
ELECTRONIC SUPPLEMENTARY MATERIAL##17##3##(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
ELF##3##1##(1992-3#2)(2008-12#1)
ELF-97 beta-D-glucuronide##4##2##(1996-12#4)
ELI##6##1##(1990-2#5)(2008-8#1)
ELISA (enzyme-linked immunosorbent assay)##2##4##(1993-2#1)(2008-8#1)
ELISA analysis##3##2##(2008-10#2)(2008-8#1)
ELISA and Western blot##2##4##(1996-12#1)(2008-8#1)
ELISA and by##2##3##(1990-12#1)(1997-6#1)
ELISA and immunoblot##2##3##(1997-6#1)(2008-10#1)
ELISA and##28##2##(1990-12#1)(1991-12#2)(1992-5#4)(1992-6#1)(1996-12#1)(1997-6#3)(2007-7#2)(2008-10#7)(2008-11#3)(2008-5#2)(2008-8#1)(2011-2#1)
ELISA assay of amyloid##2##4##(2008-4#2)
ELISA assay##7##2##(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-4#2)
ELISA assays##4##2##(1991-12#1)(1994-6#1)(2007-2#1)(2013-1#1)
ELISA at##3##2##(1997-3#1)(2008-10#2)
ELISA based##2##2##(2008-1#1)(2008-10#1)
ELISA employing##2##2##(1990-12#2)
ELISA for the detection of##2##5##(1990-12#1)(2008-10#1)
ELISA for the##4##3##(1990-12#1)(2008-10#2)(2010-4#1)
ELISA for##14##2##(1990-12#1)(1990-8#1)(1992-12#1)(2008-10#7)(2008-4#1)(2010-12#1)(2010-4#1)(2012-12#1)
ELISA format##5##2##(1995-2#1)(2008-10#3)(2008-9#1)
ELISA in both##2##3##(2008-10#2)
ELISA in##9##2##(1995-12#1)(2008-10#4)(2008-9#2)(2010-3#1)(2010-4#1)
ELISA is##3##2##(2008-10#2)(2008-11#1)
ELISA kit##3##2##(1997-4#1)(2008-12#1)(2008-8#1)
ELISA kits##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
ELISA method for##2##3##(1991-2#1)(1992-11#1)
ELISA method##9##2##(1991-2#1)(1992-11#1)(2008-10#5)(2008-11#1)(2011-1#1)
ELISA of##2##2##(1993-9#1)(1997-3#1)
ELISA on##2##2##(2007-2#1)(2010-12#1)
ELISA results##4##2##(1990-12#1)(2007-7#2)(2013-8#1)
ELISA showed that##2##3##(2008-9#1)(2011-1#1)
ELISA system##3##2##(2008-10#2)(2008-11#1)
ELISA technique##5##2##(1993-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
ELISA test##6##2##(1995-6#1)(1996-9#1)(2007-7#1)(2008-11#1)(2008-12#1)(2012-12#1)
ELISA to detect##2##3##(2008-10#1)(2011-1#1)
ELISA used##2##2##(1990-12#1)(2011-1#1)
ELISA using##5##2##(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#2)
ELISA was applied##2##3##(2008-10#2)
ELISA was developed##2##3##(1992-12#1)(1995-2#1)
ELISA was specific for##2##4##(1990-12#1)(1995-11#1)
ELISA was##14##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-12#1)(1992-5#1)(1995-11#1)(1995-2#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-8#1)
ELISA were##2##2##(2008-10#1)(2011-2#1)
ELISA which##3##2##(2007-2#1)(2008-4#1)(2013-8#1)
ELISA with##5##2##(1992-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(2008-10#1)
ELISA##280##1##(1990-12#18)(1990-2#1)(1990-3#1)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#3)(1992-12#6)(1992-3#1)(1992-5#7)(1992-6#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-5#2)(1995-6#1)(1996-12#3)(1996-9#1)(1997-2#1)(1997-3#8)(1997-4#2)(1997-6#6)(2007-10#1)(2007-2#5)(2007-7#6)(2008-1#3)(2008-10#75)(2008-11#14)(2008-12#2)(2008-4#15)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#6)(2009-3#1)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#1)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#5)
ELISA) for##2##2##(1990-12#1)(1990-3#1)
ELISA)##3##1##(1990-12#1)(1990-3#1)(2012-12#1)
ELISA-based assays##7##2##(2008-10#7)
ELISA-based##8##1##(2008-10#8)
ELISAs for##2##2##(1993-2#1)(2008-4#1)
ELISAs in##2##2##(1993-8#1)(2013-8#1)
ELISAs showed##2##2##(1997-3#1)(2008-10#1)
ELISAs##13##1##(1993-2#2)(1993-8#1)(1997-3#3)(2008-10#4)(2008-4#1)(2008-9#1)(2013-8#1)
ELISPOT assay##4##2##(2008-4#3)(2013-8#1)
ELISPOT##7##1##(2008-4#5)(2011-2#1)(2013-8#1)
ELKD##3##1##(2013-8#3)
EM algorithm##6##2##(1997-3#1)(2008-2#4)(2008-8#1)
EM of the##2##3##(1992-6#1)(2008-8#1)
EM panel##2##2##(2008-2#2)
EM sputum##3##2##(2013-1#3)
EM tracking##2##2##(2013-1#2)
EM##28##1##(1992-6#2)(1997-3#1)(2007-10#1)(2008-10#2)(2008-2#8)(2008-4#1)(2008-5#1)(2008-8#3)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
EMA treatment##2##2##(2009-6#2)
EMA##10##1##(1994-12#1)(2009-6#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
EMA-CO##3##1##(1994-3#3)
EMAF##4##1##(2010-11#4)
EMBASE##12##1##(1992-12#1)(1994-3#4)(2009-2#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#2)
EMBL database and##2##3##(2008-8#1)(2010-7#1)
EMBL database##4##2##(1991-9#1)(1996-8#1)(2008-8#1)(2010-7#1)
EMBL##5##1##(1991-9#1)(1996-8#1)(2008-4#1)(2008-8#1)(2010-7#1)
EMBL3##3##1##(1992-3#1)(1993-8#1)(1994-11#1)
EMBO J##3##2##(1990-7#1)(1995-2#2)
EMBO##4##1##(1990-7#1)(1995-2#2)(1997-7#1)
EMC##4##1##(2010-7#1)(2012-3#3)
EMC-B and EMC-DV##2##3##(1997-4#2)
EMC-B and##3##2##(1997-4#3)
EMC-B##4##1##(1997-4#4)
EMC-D##5##1##(1997-4#5)
EMD 51921##9##2##(1994-12#9)
EMD##11##1##(1994-12#9)(2006-8#2)
EMF (60 Hz##2##3##(2011-2#2)
EMF and##2##2##(1991-8#1)(2008-12#1)
EMF measurements##2##2##(2008-10#2)
EMF##13##1##(1991-8#1)(2008-10#4)(2008-12#4)(2011-2#4)
EMG activity in the##2##4##(2010-9#2)
EMG activity##7##2##(1990-9#1)(1997-7#1)(2010-8#1)(2010-9#2)(2013-1#2)
EMG and EOG##2##3##(2010-8#2)
EMG and##3##2##(2009-3#1)(2010-8#2)
EMG in##2##2##(2008-9#1)(2011-2#1)
EMG index##2##2##(1993-9#2)
EMG of the##2##3##(2012-2#2)
EMG of##3##2##(2012-2#3)
EMG recording##5##2##(2011-2#5)
EMG signal##2##2##(2012-2#1)(2013-1#1)
EMG signals were##2##3##(2010-8#1)(2012-2#1)
EMG signals##5##2##(2010-8#2)(2012-2#3)
EMG##57##1##(1990-6#1)(1990-9#3)(1993-12#4)(1993-9#4)(1996-5#1)(1997-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-5#1)(2010-8#8)(2010-9#2)(2011-2#6)(2012-12#7)(2012-2#8)(2013-1#4)
EMI events##2##2##(2011-2#2)
EMIT##2##1##(2008-10#2)
EMLA##5##1##(1993-1#4)(2009-5#1)
EMM##3##1##(2007-8#1)(2013-7#2)
EMPIRE##3##1##(2008-11#3)
EMR##13##1##(2008-12#6)(2008-4#1)(2010-8#4)(2012-12#1)(2012-3#1)
EMR-A##4##1##(2008-12#4)
EMR-F##4##1##(2008-12#4)
EMS systems##2##2##(2008-3#2)
EMS##9##1##(1996-3#2)(2008-3#5)(2008-4#1)(2008-9#1)
EMS-induced mutant frequency and##2##4##(2008-4#2)
EMS-induced##4##1##(2008-4#4)
EMSA showed that##2##3##(1997-7#1)(2008-8#1)
EMSA##5##1##(1995-8#1)(1997-7#1)(2008-11#1)(2008-8#2)
EMT6##2##1##(1995-2#1)(2008-11#1)
EMT6-R##3##1##(2008-11#3)
EMT6-S and EMT6-R##2##3##(2008-11#2)
EMT6-S##4##1##(2008-11#4)
EMTALA##2##1##(1995-12#1)(2008-4#1)
EN##12##1##(2007-10#1)(2008-10#5)(2008-11#4)(2013-1#2)
EN-4 wild type##2##3##(2008-10#2)
EN-4 with construct pPB-FO11-45##2##4##(2008-10#2)
EN-4##7##1##(2008-10#7)
EN5 stimulations##2##2##(1996-5#2)
ENA and WNA##4##3##(2008-8#4)
ENA and##6##2##(2008-8#6)
ENA##12##1##(2008-8#12)
ENA-78 gene##3##2##(1994-11#3)
ENA-78 has##2##2##(1994-11#1)(1994-12#1)
ENA-78##7##1##(1994-11#4)(1994-12#3)
ENBD tubes##2##2##(2013-1#2)
ENBD##5##1##(2013-1#5)
ENETS grading##3##2##(2011-2#3)
ENETS##5##1##(2011-2#5)
ENFET##2##1##(2008-10#2)
ENHANCE##2##1##(2009-6#2)
ENK-ir fibers##4##2##(1992-3#4)
ENK-ir terminals##3##2##(1992-3#3)
ENK-ir##9##1##(1992-3#9)
ENO##6##1##(2008-10#6)
ENOX proteins##3##2##(2009-9#3)
ENOX##5##1##(2009-9#5)
ENOX2##11##1##(2009-9#11)
ENS##7##1##(2008-7#2)(2008-8#5)
ENT##10##1##(1990-5#1)(1991-6#1)(2008-4#2)(2008-8#1)(2009-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
ENU##5##1##(1992-9#1)(2008-4#1)(2010-8#3)
ENX and##3##2##(2008-10#2)(2010-4#1)
ENX##6##1##(2008-10#2)(2010-4#4)
ENaC##5##1##(2008-8#1)(2009-9#4)
ENs used##2##2##(2007-10#2)
ENs##9##1##(2007-10#9)
EO and EGVGE##2##3##(2012-12#2)
EO and##3##2##(2012-12#3)
EO was##2##2##(2013-1#1)(2013-8#1)
EO##26##1##(2007-11#2)(2008-2#7)(2008-3#2)(2012-12#4)(2013-1#6)(2013-8#5)
EOC##7##1##(2007-7#2)(2010-7#4)(2011-1#1)
EODs##4##1##(2009-8#4)
EOF modifier is##2##3##(1996-5#1)(1997-2#1)
EOF modifier##3##2##(1996-5#2)(1997-2#1)
EOF##7##1##(1996-5#2)(1997-2#1)(2008-10#4)
EOFL exerted##2##2##(2008-12#2)
EOFL##3##1##(2008-12#3)
EOG ratios##2##2##(1995-11#2)
EOG##8##1##(1995-11#3)(2008-5#2)(2008-6#1)(2010-8#2)
EOG)##2##1##(2008-5#1)(2008-6#1)
EOP##3##1##(1994-9#1)(2008-10#2)
EORTC trial##2##2##(1992-10#2)
EORTC##8##1##(1992-10#3)(1994-3#1)(2008-6#4)
EOS system##2##2##(2008-3#1)(2012-2#1)
EOS##6##1##(1990-8#1)(2008-3#1)(2008-5#1)(2012-2#3)
EP in##2##2##(1994-9#1)(2008-10#1)
EP lesions and CA lesions##2##5##(1994-12#2)
EP lesions##3##2##(1994-12#3)
EP was sensed again##2##4##(2008-10#2)
EP##21##1##(1990-11#2)(1993-12#1)(1994-12#3)(1994-9#1)(2007-5#1)(2008-10#12)(2012-2#1)
EP-IPV alone##2##2##(1995-5#2)
EP-IPV followed by OPV##3##4##(1995-5#3)
EP-IPV##9##1##(1995-5#9)
EP1##2##1##(1993-11#1)(1993-12#1)
EP2 and##2##2##(1993-11#1)(2008-7#1)
EP2 receptor##2##2##(1993-11#2)
EP2##7##1##(1993-11#5)(1993-12#1)(2008-7#1)
EP3 subtype##3##2##(1993-12#1)(1994-9#2)
EP3##6##1##(1993-11#1)(1993-12#3)(1994-9#2)
EP4##2##1##(2008-7#2)
EPA and DHA##2##3##(2010-1#1)(2012-1#1)
EPA and##3##2##(1991-2#1)(2010-1#1)(2012-1#1)
EPA are##2##2##(1994-11#2)
EPA guidelines##2##2##(2008-10#2)
EPA priority##2##2##(2008-10#2)
EPA##25##1##(1991-12#1)(1991-2#3)(1994-11#3)(1995-3#1)(2008-10#9)(2008-2#2)(2010-1#1)(2012-1#3)(2013-1#2)
EPACT II##3##2##(2010-12#3)
EPC colony##3##2##(2012-12#3)
EPC number is##2##3##(2009-11#2)
EPC number##5##2##(2009-11#5)
EPC##15##1##(2008-1#3)(2009-11#5)(2010-10#1)(2010-6#1)(2012-12#5)
EPCs##9##1##(2008-1#2)(2012-12#7)
EPD-Fe##2##1##(1993-11#2)
EPD-Fe-mediated##2##1##(1993-11#2)
EPDS scores##3##2##(2013-1#3)
EPDS##4##1##(2013-1#4)
EPE##3##1##(2008-3#3)
EPEC infection##3##2##(1992-2#1)(2011-2#2)
EPEC##8##1##(1992-2#2)(1995-2#2)(2011-2#4)
EPF##2##1##(2008-10#2)
EPFN##2##1##(2012-2#2)
EPG##4##1##(2008-10#4)
EPI##5##1##(2008-9#4)(2011-2#1)
EPIC##3##1##(1991-12#3)
EPIYA motif##3##2##(2012-12#3)
EPO at##2##2##(2007-7#1)(2008-11#1)
EPO by##2##2##(2008-11#2)
EPO dose##2##2##(2008-1#2)
EPO is##2##2##(1992-12#1)(2008-8#1)
EPO production and glycosylation##2##4##(2008-11#2)
EPO production##3##2##(2008-11#3)
EPO quality##2##2##(2008-11#2)
EPO treatment##2##2##(2008-5#1)(2008-7#1)
EPO was##2##2##(2007-7#1)(2008-5#1)
EPO##50##1##(1992-12#3)(1996-12#1)(2007-7#7)(2008-1#5)(2008-11#21)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)
EPOF##8##1##(1993-12#8)
EPPs to adenosine##2##3##(2008-4#2)
EPPs##3##1##(2008-4#3)
EPR spectra of the##3##4##(1994-11#1)(1997-7#2)
EPR spectra##6##2##(1990-12#1)(1993-11#1)(1994-11#1)(1996-2#1)(1997-7#2)
EPR spectroscopy##4##2##(1993-11#1)(1997-7#1)(2008-10#2)
EPR spectrum of##2##3##(1993-11#1)(1997-7#1)
EPR spectrum##4##2##(1991-5#1)(1993-11#1)(1993-8#1)(1997-7#1)
EPR spin##2##2##(2008-10#1)(2008-5#1)
EPR##36##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#6)(1993-8#3)(1994-11#1)(1996-2#3)(1997-7#6)(2008-10#8)(2008-5#1)(2008-8#1)(2009-5#2)(2012-12#1)
EPR/ENDOR##2##1##(1996-2#2)
EPS I and EG##2##4##(2008-10#2)
EPS I##9##2##(2008-10#9)
EPS patients##3##2##(2011-2#3)
EPS was##3##2##(2008-10#1)(2011-2#2)
EPS##36##1##(2007-12#3)(2008-10#11)(2011-2#22)
EPS-minus strains##2##2##(2008-10#2)
EPS-minus##3##1##(2008-10#3)
EPSCs##7##1##(1996-2#3)(2009-12#4)
EPSP synthase##3##2##(2008-9#3)
EPSP was##2##2##(1996-5#1)(2008-9#1)
EPSP##10##1##(1991-12#1)(1993-12#2)(1995-12#1)(1995-5#1)(1996-5#1)(2008-9#4)
EPSP-spike##2##1##(1991-12#1)(1997-2#1)
EPSPs and##3##2##(1993-12#2)(2012-2#1)
EPSPs##4##1##(1993-12#3)(2012-2#1)
EPSR disks##2##2##(2008-2#2)
EPSR##3##1##(2008-2#3)
EPT##2##1##(2013-1#2)
EPV100 emergency portable ventilators##2##4##(2011-1#2)
EPV100##3##1##(2011-1#3)
EPs##4##1##(2007-5#3)(2012-2#1)
EQCM##2##1##(2008-10#2)
ER CALUX(®)##2##2##(2013-1#2)
ER and PR##4##3##(1997-7#2)(2013-8#2)
ER and##13##2##(1991-12#1)(1993-9#1)(1995-4#1)(1996-5#1)(1997-7#2)(2008-10#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
ER content##2##2##(1993-1#2)
ER cytidylyltransferase##2##2##(1991-11#2)
ER distribution##2##2##(2013-1#2)
ER gene##4##2##(1993-6#2)(1997-7#2)
ER is##5##2##(1990-5#1)(1995-9#1)(2008-11#1)(2009-8#1)(2012-2#1)
ER levels##3##2##(1991-12#1)(1993-6#2)
ER mRNA##2##2##(2008-6#2)
ER negative##2##2##(1990-5#1)(2007-10#1)
ER resident protein##2##3##(1996-9#2)
ER retention##3##2##(2008-8#3)
ER services##2##2##(2008-8#2)
ER status##4##2##(1991-12#1)(1993-1#1)(1993-9#1)(1994-12#1)
ER stress##3##2##(2009-8#1)(2012-2#2)
ER structure##2##2##(2009-8#1)(2011-2#1)
ER utilization##4##2##(2008-8#4)
ER was##2##2##(1993-1#1)(1995-2#1)
ER##133##1##(1990-5#4)(1991-11#3)(1991-12#4)(1991-2#3)(1992-10#1)(1992-3#1)(1992-6#1)(1993-1#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#5)(1993-9#2)(1994-11#1)(1994-12#3)(1994-9#2)(1995-2#5)(1995-4#3)(1995-9#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-7#6)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#9)(2008-12#1)(2008-6#4)(2008-7#4)(2008-8#13)(2008-9#1)(2009-2#4)(2009-8#13)(2010-11#1)(2011-2#5)(2012-2#7)(2013-1#6)(2013-8#3)
ER(2) =##4##2##(2009-9#4)
ER)##2##1##(1991-11#1)(2012-2#1)
ER+##3##1##(1990-12#1)(1991-12#2)
ER- breast cancer cell##2##4##(2011-1#2)
ER-##5##1##(1991-12#1)(1992-4#2)(2011-1#2)
ER-2 aircraft##2##2##(2008-3#2)
ER-ICA status##2##2##(1992-10#2)
ER-ICA##5##1##(1992-10#5)
ER-L##9##1##(2010-12#9)
ER-ir neurons in the##2##4##(1992-3#2)
ER-ir neurons##5##2##(1992-3#5)
ER-mediated##2##1##(2009-8#1)(2013-1#1)
ER-negative##3##1##(1990-5#1)(1993-9#1)(1997-7#1)
ER-poor##3##1##(1993-1#3)
ER-positive and##2##2##(1993-9#1)(1994-7#1)
ER-positive breast cancer##2##3##(1990-5#1)(2011-2#1)
ER-positive##7##1##(1990-5#1)(1993-9#3)(1994-7#1)(1997-7#1)(2011-2#1)
ER/LA opioid REMS##2##3##(2013-1#2)
ER/LA##3##1##(2013-1#3)
ERAP1##3##1##(2012-2#3)
ERAS##2##1##(2013-1#1)(2013-8#1)
ERCP and conservative management##2##4##(2013-1#2)
ERCP and##4##2##(1990-9#1)(2013-1#3)
ERCP in##3##2##(1991-5#1)(1991-9#1)(2013-1#1)
ERCP was done within 72 hours##2##6##(2013-1#2)
ERCP##18##1##(1990-9#2)(1991-5#1)(1991-9#2)(2008-2#1)(2013-1#12)
ERD##3##1##(2013-8#3)
ERE##5##1##(1991-2#1)(1995-2#4)
ERE-mediated transcription##2##2##(2011-2#2)
EREs##3##1##(1995-2#3)
ERG is##2##2##(2009-12#1)(2012-12#1)
ERG##6##1##(2009-12#5)(2012-12#1)
ERIC##4##1##(2008-10#2)(2009-7#1)(2013-1#1)
ERISA##3##1##(1993-12#2)(1997-2#1)
ERK and##4##2##(2008-3#1)(2008-4#2)(2010-10#1)
ERK in##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
ERK nuclear translocation##4##3##(2010-10#4)
ERK pathway##2##2##(2010-10#1)(2013-7#1)
ERK phosphorylation##10##2##(2008-11#1)(2008-4#8)(2013-8#1)
ERK signaling pathway##2##3##(2013-1#2)
ERK signaling##6##2##(2008-8#3)(2009-8#1)(2013-1#2)
ERK##49##1##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#16)(2008-8#3)(2008-9#1)(2009-8#2)(2010-10#8)(2010-12#1)(2011-2#2)(2013-1#5)(2013-7#1)(2013-8#6)
ERK-dependent##3##1##(2008-4#1)(2009-8#1)(2013-1#1)
ERK1 and ERK2##2##3##(2010-10#1)(2012-12#1)
ERK1##3##1##(2010-10#2)(2012-12#1)
ERK1-4##3##1##(2010-10#3)
ERK1/2 in##2##2##(2010-1#1)(2011-2#1)
ERK1/2##6##1##(2008-11#1)(2008-4#2)(2010-1#2)(2011-2#1)
ERK2##3##1##(2008-4#1)(2010-10#1)(2012-12#1)
ERKpp output is##2##3##(2009-8#2)
ERKpp output##4##2##(2009-8#4)
ERM##6##1##(2008-1#1)(2011-2#4)(2013-8#1)
ERMs##3##1##(2008-1#3)
EROD activity and##2##3##(1995-3#2)
EROD activity##3##2##(1993-12#1)(1995-3#2)
EROD##7##1##(1990-7#1)(1992-8#2)(1993-12#1)(1995-3#2)(2008-7#1)
ERP data##2##2##(2008-11#2)
ERP##10##1##(1996-5#1)(2008-11#4)(2008-8#2)(2013-8#3)
ERPs of##2##2##(2008-8#2)
ERPs##6##1##(1995-2#2)(2008-11#1)(2008-8#2)(2012-2#1)
ERR##2##1##(2013-1#2)
ERRATUM##2##1##(2011-2#1)(2012-2#1)
ERT costs##2##2##(2012-12#2)
ERT##7##1##(1994-9#1)(2012-12#6)
ERVs##2##1##(2008-7#2)
ERW supplemented with Pt nps suppressed##2##6##(2008-11#2)
ERW supplemented with Pt nps##4##5##(2008-11#4)
ERW supplemented with synthesized Pt nps##2##6##(2008-11#2)
ERW supplemented with##6##3##(2008-11#6)
ERW##9##1##(2008-11#9)
ERalpha and ERbeta##2##3##(2008-4#2)
ERalpha mRNA##3##2##(2008-12#3)
ERalpha##8##1##(2008-11#2)(2008-12#4)(2008-4#2)
ERbeta##4##1##(2008-11#1)(2008-4#3)
ERs in##2##2##(2008-10#1)(2008-8#1)
ERs##10##1##(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#6)
ERα positive breast##2##3##(2011-2#2)
ERα##5##1##(2011-2#4)(2013-7#1)
ES (2##2##2##(2013-1#2)
ES cell clones##2##3##(2008-11#1)(2008-9#1)
ES cell culture##2##3##(2008-11#1)(2008-9#1)
ES cell differentiation##2##3##(2008-11#1)(2012-2#1)
ES cell lines##3##3##(1995-2#1)(2012-2#2)
ES cell technology##2##3##(2008-9#2)
ES cell##19##2##(1995-2#1)(2008-11#10)(2008-9#5)(2012-2#3)
ES cell-derived##4##2##(2008-11#1)(2008-8#2)(2008-9#1)
ES cells and the##2##4##(2008-11#1)(2008-8#1)
ES cells and##6##3##(1992-12#1)(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#2)
ES cells by##2##3##(1997-8#1)(2008-8#1)
ES cells using##3##3##(2008-8#2)(2011-2#1)
ES cells were##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
ES cells with##2##3##(2008-11#1)(2008-8#1)
ES cells##54##2##(1992-12#1)(1994-9#2)(1995-2#2)(1997-8#1)(2008-11#13)(2008-8#14)(2008-9#15)(2009-12#1)(2011-2#1)(2012-12#4)
ES in the##2##3##(2012-2#2)
ES in##3##2##(2012-2#2)(2013-1#1)
ES is a##2##3##(2012-2#1)(2013-1#1)
ES is##4##2##(2012-2#1)(2013-1#3)
ES##118##1##(1992-12#1)(1994-9#2)(1995-2#4)(1997-8#1)(2008-10#1)(2008-11#24)(2008-8#19)(2008-9#21)(2009-10#2)(2009-12#1)(2010-5#4)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#21)(2013-1#11)
ES)##5##1##(2009-10#3)(2012-2#2)
ES-MS detection##2##2##(2008-10#2)
ES/MS##2##1##(2008-10#2)
ESA##11##1##(2008-11#8)(2008-3#2)(2010-11#1)
ESAS##2##1##(2008-7#2)
ESAs##3##1##(2010-11#3)
ESBL producers##2##2##(2010-6#1)(2013-8#1)
ESBL producing##2##2##(2007-7#1)(2012-2#1)
ESBL##12##1##(2007-7#2)(2008-10#1)(2010-6#7)(2012-2#1)(2013-8#1)
ESBL-producing##2##1##(2008-10#1)(2010-6#1)
ESBLs are##2##2##(2007-7#1)(2013-8#1)
ESBLs##3##1##(2007-7#2)(2013-8#1)
ESC##12##1##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#2)(2010-11#1)(2012-3#1)(2013-1#1)
ESCS##3##1##(2013-1#3)
ESCs##3##1##(2008-9#3)
ESD##6##1##(2012-2#4)(2013-8#2)
ESEM##2##1##(2008-9#2)
ESF Programme on 'Integrated Approaches##2##5##(2008-7#2)
ESF Programme on##4##3##(2008-7#4)
ESF##6##1##(2008-7#5)(2010-3#1)
ESGAR##2##1##(2008-7#2)
ESI##6##1##(1997-8#1)(2008-10#1)(2011-1#1)(2011-2#2)(2011-3#1)
ESI-IMS##2##1##(2008-10#2)
ESI-MS and##3##2##(2008-10#1)(2011-1#1)(2011-3#1)
ESI-MS##13##1##(2007-11#1)(2008-10#8)(2008-9#2)(2011-1#1)(2011-3#1)
ESI/MS##2##1##(1995-2#1)(2010-6#1)
ESIMA##2##1##(2008-11#2)
ESIMS##2##1##(2010-6#1)(2011-2#1)
ESLI appliqué exhibited the lowest DHR##2##6##(2008-3#2)
ESLI appliqué##3##2##(2008-3#3)
ESLI##4##1##(2008-3#4)
ESM drive conditions##2##3##(2008-2#2)
ESM##10##1##(2008-2#3)(2008-6#7)
ESP##4##1##(1994-12#2)(2008-1#1)(2008-7#1)
ESPE##3##1##(2008-12#2)(2009-8#1)
ESPE)##3##1##(2009-8#2)(2013-1#1)
ESPI system##2##2##(2008-2#1)(2008-3#1)
ESPI##6##1##(2008-2#2)(2008-3#3)(2009-7#1)
ESPRIT##2##1##(2008-8#1)(2009-12#1)
ESPU meeting in##2##3##(2008-10#2)
ESPU##4##1##(2008-10#4)
ESPs##3##1##(2008-7#3)
ESR and##4##2##(2007-11#1)(2007-7#2)(2008-9#1)
ESR signal##2##2##(1995-2#1)(2008-10#1)
ESR spectra of##3##3##(1990-2#1)(1990-5#1)(1994-3#1)
ESR spectra##4##2##(1990-2#1)(1990-5#1)(1994-3#1)(2008-10#1)
ESR spectrum of##2##3##(1990-5#1)(2008-10#1)
ESR was##3##2##(2007-7#3)
ESR##43##1##(1990-2#1)(1990-5#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-6#4)(2007-11#2)(2007-7#10)(2008-10#7)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)
ESR1##2##1##(2011-2#2)
ESRD HCQIP##2##2##(1996-2#2)
ESRD due to##2##3##(2007-7#1)(2008-8#1)
ESRD in##5##2##(2007-7#1)(2008-1#3)(2008-4#1)
ESRD patients on##2##3##(2007-7#2)
ESRD patients##17##2##(1995-12#4)(1996-2#2)(2007-12#2)(2007-7#5)(2008-1#3)(2008-7#1)
ESRD##56##1##(1991-3#4)(1995-1#2)(1995-12#7)(1996-2#5)(2007-12#2)(2007-7#17)(2008-1#13)(2008-4#3)(2008-7#2)(2008-8#1)
ESRT and##2##2##(2008-9#2)
ESRT##4##1##(2008-9#4)
ESS is##2##2##(2008-9#2)
ESS model##2##2##(2008-8#2)
ESS##14##1##(2008-8#4)(2008-9#6)(2009-5#3)(2012-3#1)
EST databases were##2##3##(2008-7#2)
EST databases##4##2##(1997-6#1)(1997-8#1)(2008-7#2)
EST evidence##2##2##(2008-4#1)(2008-9#1)
EST sequences##3##2##(2008-5#1)(2008-7#2)
EST##26##1##(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#7)(2008-9#6)
ESTIMATION##2##1##(2007-2#1)(2010-5#1)
ESTs from##2##2##(1997-6#1)(1997-8#1)
ESTs were##3##2##(1997-6#1)(1997-8#1)(2010-4#1)
ESTs##19##1##(1995-8#1)(1997-6#3)(1997-8#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#2)(2010-4#2)(2012-3#1)
ESUs##2##1##(2008-8#2)
ESWL monotherapy is##2##3##(2007-7#2)
ESWL##9##1##(1994-5#1)(2007-7#5)(2009-5#2)(2013-1#1)
ET AAS##7##2##(2008-10#7)
ET and dystonia##2##3##(2013-1#2)
ET and##6##2##(1990-2#1)(1994-9#2)(2012-3#1)(2013-1#2)
ET cases than##2##3##(2008-7#1)(2013-1#1)
ET cases##5##2##(2008-7#1)(2013-1#4)
ET in##6##2##(1990-2#1)(2008-10#2)(2008-7#2)(2012-3#1)
ET intubation was##2##3##(2010-7#2)
ET patients##2##2##(2008-7#2)
ET receptor##2##2##(1990-2#1)(1995-11#1)
ET was##4##2##(1990-2#1)(1994-9#2)(1996-2#1)
ET##62##1##(1990-12#3)(1990-2#7)(1994-9#4)(1995-11#1)(1995-3#2)(1996-2#5)(2008-10#11)(2008-7#9)(2008-9#1)(2010-5#1)(2010-7#2)(2012-3#9)(2013-1#7)
ET(A)##2##1##(1995-12#1)(2008-4#1)
ET-1 and##4##2##(1991-11#1)(1994-11#1)(2008-4#2)
ET-1 in the##3##3##(1991-2#1)(1993-3#1)(1995-11#1)
ET-1 increased##2##2##(1992-3#1)(1993-3#1)
ET-1 induced bronchoconstriction##2##3##(1992-3#2)
ET-1 induced##4##2##(1991-5#1)(1992-3#3)
ET-1 is##2##2##(1991-2#2)
ET-1 mRNA##2##2##(1993-3#2)
ET-1 to the##2##3##(1993-3#1)(1995-11#1)
ET-1 was##2##2##(1993-3#1)(1994-8#1)
ET-1##62##1##(1990-12#1)(1990-2#3)(1991-11#1)(1991-2#5)(1991-5#4)(1992-3#5)(1992-9#2)(1993-3#22)(1994-11#6)(1994-8#6)(1995-11#5)(2008-4#2)
ET-1-activated migration##3##2##(1994-8#3)
ET-1-induced activation of##2##3##(1993-8#2)
ET-1-induced##3##1##(1993-8#3)
ET-18-OCH3##4##1##(1995-3#4)
ET-2 and ET-3##2##3##(1990-2#2)
ET-2##5##1##(1990-2#2)(1993-6#3)
ET-3##4##1##(1990-2#2)(1994-11#2)
ET-AAS determination##2##2##(2008-10#2)
ET-AAS##4##1##(2008-10#4)
ET-LP##3##1##(1990-2#3)
ET1 in##2##2##(1990-2#1)(2013-1#1)
ET1##3##1##(1990-2#2)(2013-1#1)
ET1-21##2##1##(1990-2#2)
ET1-21LI release##2##2##(1990-2#2)
ET1-21LI##5##1##(1990-2#5)
ET1-39##3##1##(1990-2#3)
ETA and ETB mRNA##2##4##(1993-3#2)
ETA and ETB##4##3##(1991-11#1)(1993-3#3)
ETA receptor##6##2##(1992-9#5)(1994-8#1)
ETA receptors##4##2##(1992-9#2)(1995-12#2)
ETA##16##1##(1991-11#2)(1992-9#7)(1993-3#3)(1994-8#1)(1995-12#2)(2012-2#1)
ETA1##3##1##(1994-11#3)
ETAAS determination of##2##3##(2008-10#2)
ETAAS determination##5##2##(2008-10#5)
ETAAS method##3##2##(2008-10#3)
ETAAS using##4##2##(2008-10#4)
ETAAS with##2##2##(2008-10#2)
ETAAS##47##1##(2008-10#47)
ETAAS)##2##1##(2008-10#2)
ETB mRNA##3##2##(1993-3#3)
ETB receptor##2##2##(1993-3#1)(1995-12#1)
ETB##8##1##(1991-11#3)(1993-3#4)(1995-12#1)
ETB1 and ETB2 agonist)##2##4##(1994-11#2)
ETB1 and ETB2 receptors##5##4##(1994-11#5)
ETB1 and ETB2##7##3##(1994-11#7)
ETB1##8##1##(1994-11#8)
ETBE##2##1##(2009-8#2)
ETDRS##3##1##(2011-2#1)(2013-1#2)
ETH 9009##2##2##(2008-10#2)
ETH##13##1##(2008-10#12)(2011-2#1)
ETHICAL##2##1##(2009-4#2)
ETOH concentration##2##2##(1990-5#2)
ETOH##9##1##(1990-5#9)
ETR##6##1##(2011-2#6)
ETS protein##2##2##(1994-6#2)
ETS proteins##2##2##(1994-6#2)
ETS##11##1##(1994-6#5)(1997-5#3)(2008-6#3)
ETT stabilisation##4##2##(2007-11#4)
ETT##9##1##(2007-11#5)(2008-8#2)(2010-7#2)
ETU##2##1##(2008-3#2)
ETV##5##1##(2008-10#5)
ETV-ICP-MS after##2##2##(2008-10#2)
ETV-ICP-MS##4##1##(2008-10#4)
ETeB##2##1##(2008-11#2)
ETs##4##1##(1994-9#1)(2010-5#3)
EU Directive##4##2##(2008-10#1)(2008-11#3)
EU and##2##2##(2008-8#1)(2013-8#1)
EU countries##2##2##(2008-7#1)(2009-8#1)
EU directive##2##2##(1997-8#1)(2008-10#1)
EU##33##1##(1997-8#1)(2008-10#13)(2008-11#5)(2008-7#3)(2008-8#2)(2009-8#2)(2011-1#3)(2011-2#1)(2013-1#2)(2013-8#1)
EUK-134##3##1##(2008-5#3)
EUL##4##1##(2010-2#4)
EURACHEM Guide##3##2##(2008-10#3)
EURACHEM##5##1##(2008-10#5)
EURAMOS##3##1##(2010-3#3)
EUS has a##2##3##(2008-2#2)
EUS may be##2##3##(2008-2#1)(2013-1#1)
EUS##19##1##(1990-9#2)(2008-2#6)(2011-2#2)(2013-1#9)
EUS-guided##2##1##(2008-2#1)(2013-1#1)
EUSES##8##1##(2008-11#8)
EUV lithographic##2##2##(2008-3#2)
EUV##24##1##(2007-11#1)(2008-2#3)(2008-3#20)
EV##3##1##(1991-6#1)(2008-4#1)(2013-8#1)
EV71 RdRp (3D(pol))##3##3##(2011-1#3)
EV71 strains MS##2##3##(2008-8#2)
EV71 strains isolated in##2##4##(2008-12#2)
EV71 strains isolated##3##3##(2008-12#3)
EV71 strains of##2##3##(2008-12#2)
EV71 strains##11##2##(2008-12#8)(2008-8#3)
EV71##26##1##(2008-12#10)(2008-8#7)(2011-1#6)(2013-8#3)
EVA##6##1##(2008-10#1)(2008-11#3)(2008-7#2)
EVALUATION##3##1##(2008-12#1)(2011-2#2)
EVAR##6##1##(2010-12#2)(2012-2#4)
EVAR-1 trial criteria##3##3##(2012-2#3)
EVIDENCE FROM THE FIRST YEAR##2##5##(2013-1#2)
EVIDENCE##4##1##(2009-3#1)(2012-3#1)(2013-1#2)
EVOLUTIONARY##2##1##(2012-3#2)
EWR##4##1##(2009-3#4)
EWS##4##1##(2008-6#4)
EWS-ETS##2##1##(2008-6#2)
EX##4##1##(1994-5#2)(1995-6#2)
EX4##2##1##(1993-8#2)
EXAFS data##2##2##(2008-10#1)(2012-12#1)
EXAFS##8##1##(1996-2#1)(2008-10#5)(2012-12#2)
EXODUS##3##1##(1996-12#3)
EXPERIENCE##2##1##(2012-12#1)(2013-8#1)
EXPRESSION##2##1##(2009-9#1)(2010-1#1)
EY##4##1##(2008-10#2)(2011-1#1)(2012-2#1)
EYE2##2##1##(2012-3#2)
EZE + Statin patients##2##4##(2013-1#2)
Ea and Eb##2##3##(1994-2#2)
Ea##6##1##(1994-2#3)(2008-11#3)
Ea)##2##1##(2008-11#2)
Ea153)##2##1##(2008-10#2)
Ea153N##5##1##(2008-10#5)
Each analysis##2##2##(2008-10#2)
Each article was subject to quality rating and was analyzed by two independent reviewers##2##14##(2012-12#2)
Each article was##3##3##(2012-12#3)
Each cell##2##2##(1996-2#1)(2010-10#1)
Each day##2##2##(2008-10#1)(2008-7#1)
Each department##2##2##(1992-6#1)(1994-3#1)
Each element's detailed design was evaluated against internal and external established best practices##2##13##(2012-2#2)
Each experiment##2##2##(2008-3#1)(2008-5#1)
Each fiber##2##2##(2008-2#1)(2013-1#1)
Each group was##2##3##(2011-2#1)(2013-1#1)
Each group##4##2##(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#1)
Each has##2##2##(1992-8#1)(2008-10#1)
Each individual##2##2##(2008-1#1)(2008-10#1)
Each is##3##2##(2008-12#1)(2008-9#1)(2009-8#1)
Each isolate##3##2##(1997-8#1)(2008-10#2)
Each laser##2##2##(2008-2#1)(2008-3#1)
Each limb was##2##3##(2012-3#2)
Each material##2##2##(2011-1#1)(2013-1#1)
Each method has its##2##4##(1992-3#1)(2008-9#1)
Each method has##4##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-11#1)
Each method##8##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-3#1)
Each model##2##2##(2008-9#1)(2009-8#1)
Each month##2##2##(1996-12#1)(2008-10#1)
Each neuron##2##2##(1994-2#1)(2008-11#1)
Each of the three##6##4##(1991-9#1)(1993-11#1)(1994-8#1)(1996-1#1)(2008-10#1)(2009-10#1)
Each of the##18##3##(1991-9#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-2#2)(1996-1#2)(2007-11#1)(2007-12#1)(2008-10#3)(2009-10#1)(2009-11#1)(2010-4#1)(2013-8#1)
Each of these components##2##4##(2009-8#1)(2010-1#1)
Each of these##19##3##(1990-7#1)(1992-6#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#1)(2013-8#1)
Each of##40##2##(1990-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-2#2)(1996-1#2)(1997-4#1)(1997-5#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2013-8#2)
Each one##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
Each participant received a##2##4##(2007-11#1)(2012-3#1)
Each participant##5##2##(2007-11#1)(2007-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
Each patient had##2##3##(1996-5#1)(2011-2#1)
Each patient received##2##3##(2007-11#1)(2013-1#1)
Each patient underwent##2##3##(1991-11#1)(2013-8#1)
Each patient was##4##3##(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
Each patient##11##2##(1991-11#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Each patient's##2##2##(1995-2#1)(2007-10#1)
Each population##2##2##(2008-10#1)(2008-9#1)
Each region##3##2##(1997-2#1)(2007-11#1)(2008-11#1)
Each section##2##2##(2007-7#2)
Each sensillum##2##2##(2010-11#2)
Each session##2##2##(1991-11#1)(2013-1#1)
Each species was##2##3##(2008-10#2)
Each specimen##2##2##(2008-5#1)(2008-9#1)
Each step##2##2##(1992-2#1)(2008-9#1)
Each strain##4##2##(1991-8#1)(1995-8#1)(1996-5#1)(2008-9#1)
Each subject performed##2##3##(1991-3#1)(2008-5#1)
Each subject was##2##3##(1990-3#1)(1995-11#1)
Each subject##7##2##(1990-3#1)(1991-3#1)(1995-11#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
Each test##2##2##(1997-4#1)(2008-10#1)
Each theme##2##2##(2012-3#1)(2013-1#1)
Each type of##3##3##(2008-11#1)(2008-5#2)
Each type##4##2##(2008-11#1)(2008-5#3)
Each valve was##2##3##(1991-3#2)
Each vector contains##2##3##(1990-5#2)
Each was##2##2##(1995-3#1)(2012-12#1)
Each year##4##2##(2009-5#1)(2012-2#1)(2012-6#1)(2013-1#1)
Each##314##1##(1990-11#1)(1990-3#2)(1990-5#3)(1990-7#1)(1991-11#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#6)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#4)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#7)(2007-12#10)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#47)(2008-11#9)(2008-12#8)(2008-2#10)(2008-3#17)(2008-4#4)(2008-5#10)(2008-7#10)(2008-8#4)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#7)(2012-6#1)(2013-1#13)(2013-8#5)
Eadie-Hofstee plots##2##2##(1993-11#1)(2008-10#1)
Eagle's##3##1##(2008-11#2)(2008-12#1)
Ear##9##1##(1990-3#1)(1991-11#1)(1997-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)
Earlier reports##2##2##(1997-6#1)(2007-10#1)
Earlier research##2##2##(2010-3#1)(2011-3#1)
Earlier studies have##2##3##(1994-3#1)(2012-2#1)
Earlier work##2##2##(1993-12#1)(2008-10#1)
Earlier##24##1##(1990-11#1)(1990-9#1)(1991-4#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-3#1)(2012-2#1)(2013-8#2)
Early American##2##2##(2011-2#2)
Early Breast Cancer Trialists' Collaborative Group##4##6##(1993-11#1)(1993-12#1)(1995-11#1)(2007-5#1)
Early Breast Cancer##5##3##(1993-11#2)(1993-12#1)(1995-11#1)(2007-5#1)
Early Breast##6##2##(1993-11#2)(1993-12#1)(1995-11#1)(1995-4#1)(2007-5#1)
Early Career Investigators##3##3##(2012-2#3)
Early Detection##4##2##(1997-1#2)(2008-1#1)(2008-12#1)
Early Intervention in Bipolar Disorder##2##5##(2009-8#2)
Early Intervention##3##2##(2009-8#2)(2011-1#1)
Early Permian##2##2##(2013-1#2)
Early and##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-3#1)
Early attempts to##2##3##(2008-8#1)(2013-1#1)
Early bilateral##2##2##(2008-9#1)(2012-3#1)
Early changes##2##2##(1991-12#1)(2009-11#1)
Early clinical##3##2##(1995-1#1)(1997-3#1)(2010-11#1)
Early detection of##6##3##(2008-1#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
Early detection##8##2##(2008-1#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
Early development of##2##3##(2007-12#1)(2008-9#1)
Early diagnosis and management##2##4##(2007-12#1)(2012-3#1)
Early diagnosis and proper##2##4##(2010-11#1)(2013-8#1)
Early diagnosis and treatment is##2##5##(2008-12#1)(2011-1#1)
Early diagnosis and treatment##4##4##(1992-4#1)(2008-12#1)(2011-1#1)(2013-8#1)
Early diagnosis and##11##3##(1992-4#1)(1997-3#1)(2007-12#1)(2008-12#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
Early diagnosis is essential for##2##5##(2008-8#1)(2010-5#1)
Early diagnosis is very important##2##5##(1992-11#1)(2012-1#1)
Early diagnosis is##5##3##(1992-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#1)
Early diagnosis of##6##3##(1992-11#1)(1997-8#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)
Early diagnosis##24##2##(1992-11#2)(1992-4#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Early events of##2##3##(2008-1#1)(2008-7#1)
Early events##3##2##(2008-1#1)(2008-4#1)(2008-7#1)
Early failure##2##2##(2007-7#1)(2011-1#1)
Early in##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
Early initiation of##2##3##(2008-7#1)(2013-1#1)
Early intervention##3##2##(1994-1#2)(2010-9#1)
Early life##3##2##(1995-9#1)(2010-10#1)(2012-2#1)
Early postoperative##4##2##(1990-3#1)(1993-12#2)(2010-8#1)
Early recognition and##6##3##(1993-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)
Early recognition of this##2##4##(2013-1#1)(2013-7#1)
Early recognition of##5##3##(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
Early recognition##12##2##(1993-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
Early recurrence##2##2##(1990-11#1)(2008-6#1)
Early response##2##2##(1994-8#1)(2010-12#1)
Early results##2##2##(2007-7#1)(2011-2#1)
Early stages of##2##3##(2008-10#1)(2008-12#1)
Early studies were##2##3##(2008-11#1)(2008-9#1)
Early studies##5##2##(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
Early surgical##2##2##(2007-11#1)(2012-12#1)
Early treatment##2##2##(2008-9#1)(2012-2#1)
Early##248##1##(1990-11#1)(1990-2#1)(1990-3#2)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-5#1)(1993-9#1)(1994-1#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#4)(2007-8#7)(2008-1#9)(2008-10#16)(2008-11#13)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#18)(2011-3#1)(2011-8#1)(2012-1#4)(2012-12#5)(2012-2#11)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#4)
Earth Observing System##3##3##(2008-3#3)
Earth Observing##6##2##(2008-2#3)(2008-3#3)
Earth and##4##2##(1997-5#1)(2008-10#1)(2008-3#2)
Earth orbit##2##2##(2008-3#2)
Earth##47##1##(1995-11#2)(1996-4#2)(1997-5#6)(1997-6#2)(2008-10#3)(2008-12#2)(2008-2#5)(2008-3#18)(2009-9#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
Earth's##20##1##(1991-8#1)(1995-3#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2009-7#1)
Earth-looking imaging spectrometers##2##3##(2008-2#2)
Earth-looking##3##1##(2008-2#2)(2008-3#1)
Earth-surface##2##1##(2008-2#2)
Earthquake in##2##2##(2012-1#1)(2013-1#1)
Earthquake prediction##2##2##(1996-4#2)
Earthquake##9##1##(1996-4#4)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Earthworm##3##1##(2008-5#2)(2008-9#1)
Ease of##2##2##(2012-2#1)(2012-3#1)
Easing##2##1##(1996-2#1)(2009-12#1)
East Africa##4##2##(2007-2#1)(2008-10#3)
East African and New World##2##5##(2008-10#2)
East African strains##4##3##(2008-10#4)
East African##9##2##(1996-6#1)(2008-10#8)
East Asia##14##2##(1992-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)(2011-2#1)(2013-1#4)
East Asian##17##2##(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-3#2)(2010-8#5)(2011-2#2)(2012-12#1)(2012-2#1)
East Asians did##2##3##(2008-5#2)
East Asians##6##2##(2008-5#5)(2008-8#1)
East Azarbaijan province of Iran##2##5##(2008-12#2)
East Azarbaijan province##3##3##(2008-12#3)
East Chapman##5##2##(2008-10#5)
East Coast Hockey League##2##4##(2010-1#2)
East Coast fever##3##3##(2010-1#3)
East Coast##6##2##(2008-2#1)(2010-1#5)
East Germany##2##2##(2008-10#1)(2008-11#1)
East and Southeast Asia##3##4##(2009-5#3)
East and##14##2##(1997-8#3)(2008-10#2)(2008-6#1)(2009-2#1)(2009-5#4)(2010-9#1)(2011-2#2)
East##130##1##(1991-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1995-1#2)(1995-3#3)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#30)(2008-11#3)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#1)(2008-8#8)(2008-9#1)(2009-2#3)(2009-5#4)(2009-7#1)(2010-1#6)(2010-3#3)(2010-8#9)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#4)(2013-8#2)
Eastern Arabian Sea##2##3##(2013-7#2)
Eastern Canada##2##2##(2008-10#2)
Eastern Cooperative Oncology Group (ECOG) performance status##2##7##(2008-6#1)(2008-7#1)
Eastern Cooperative Oncology Group##4##4##(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)
Eastern Europe##6##2##(1995-3#4)(1996-8#1)(2011-2#1)
Eastern Himalayan range##2##3##(2013-7#2)
Eastern Nepal##2##2##(2008-7#2)
Eastern North Carolina##2##3##(2008-10#1)(2013-1#1)
Eastern North##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
Eastern and Western##2##3##(2008-10#1)(2009-10#1)
Eastern and##4##2##(1992-6#1)(2008-10#2)(2009-10#1)
Eastern##59##1##(1990-6#1)(1991-12#2)(1992-6#1)(1994-12#1)(1994-2#1)(1995-3#5)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#8)
Eastman Kodak##2##2##(1995-1#2)
Easy##4##1##(1996-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
Eating Attitude Test##2##3##(2007-7#1)(2013-8#1)
Eating Behaviors##2##2##(2012-2#1)(2013-1#1)
Eating Disorder Examination Questionnaire##2##4##(2007-12#1)(2012-5#1)
Eating Disorder##3##2##(2007-12#1)(2012-2#1)(2012-5#1)
Eating behavior##3##2##(2011-1#1)(2012-5#2)
Eating disorders##4##2##(1997-7#1)(2008-11#1)(2008-9#1)(2012-2#1)
Eating##20##1##(1997-7#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-5#3)(2013-1#1)(2013-8#2)
Eb IGF-I mRNA##2##3##(1994-2#2)
Eb##4##1##(1992-9#1)(1994-2#3)
Ebastine##2##1##(2007-11#1)(2008-3#1)
Ebeye##2##1##(2013-8#2)
Ebola##5##1##(1995-6#3)(1995-9#1)(1996-11#1)
Ebro river##4##2##(2008-10#4)
Ebro##5##1##(2008-10#5)
Ebstein's anomaly##2##2##(1992-2#2)
Ec##5##1##(1991-12#1)(1995-8#4)
EcPFK##4##1##(1995-5#4)
EcR/USP##2##1##(1995-8#2)
EcV may##2##2##(2009-8#2)
EcV##6##1##(2009-8#6)
Eccrine##2##1##(2008-5#1)(2013-8#1)
Echinococcosis##2##1##(2008-7#1)(2011-2#1)
Echinococcus granulosus##3##2##(1996-12#1)(2010-11#1)(2011-2#1)
Echinococcus multilocularis##4##2##(1996-12#2)(2008-7#1)(2010-11#1)
Echinococcus##8##1##(1996-12#3)(2008-7#1)(2010-11#2)(2011-2#2)
Echinoidea larvae##2##2##(2011-2#2)
Echinoidea##4##1##(2011-2#4)
Echinometra viridis decreased significantly##2##4##(2008-5#1)(2011-2#1)
Echiochilon fruticosum##2##2##(2007-11#2)
Echocardiogram##2##1##(2007-12#1)(2012-1#1)
Echocardiographic profile of##2##3##(2008-11#1)(2011-2#1)
Echocardiographic##7##1##(1997-5#1)(2008-11#2)(2011-2#1)(2012-12#2)(2012-3#1)
Echocardiography and##2##2##(2007-8#1)(2011-2#1)
Echocardiography demonstrated##2##2##(1990-11#1)(2007-8#1)
Echocardiography has##2##2##(2011-2#2)
Echocardiography is##2##2##(2008-10#1)(2010-4#1)
Echocardiography revealed a##2##3##(2007-8#1)(2008-11#1)
Echocardiography revealed##4##2##(2007-8#2)(2008-11#1)(2010-5#1)
Echocardiography showed##2##2##(2007-8#1)(2013-1#1)
Echocardiography##25##1##(1990-11#1)(2007-8#5)(2008-10#2)(2008-11#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#6)(2013-1#1)(2013-7#1)
Ecitoninae ants##2##2##(2008-5#2)
Eckhaus and zigzag##2##3##(2007-11#2)
Eclipse XDB-C18 column with the##2##5##(2011-1#1)(2011-3#1)
Eclipse XDB-C18 column##3##3##(2011-1#2)(2011-3#1)
Eclipse##4##1##(2008-10#1)(2011-1#2)(2011-3#1)
EcoRI DNA##2##2##(1992-3#2)
EcoRI and MseI##2##3##(2008-10#2)
EcoRI and XbaI##2##3##(1992-3#2)
EcoRI and##6##2##(1992-3#2)(1994-12#1)(2008-10#3)
EcoRI fragment of##2##3##(1992-3#1)(1995-8#1)
EcoRI fragment##4##2##(1992-3#1)(1995-8#2)(2008-10#1)
EcoRI restriction##2##2##(1991-9#1)(2008-4#1)
EcoRI##28##1##(1990-7#2)(1991-9#4)(1992-3#6)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-8#2)(1997-2#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-5#2)
EcoRV##4##1##(1990-5#1)(1993-8#1)(1994-12#1)(2008-5#1)
Ecol##2##1##(2008-10#2)
Ecological biogeography of southern ocean islands##2##6##(2008-8#1)(2008-9#1)
Ecological studies have shown that##2##5##(2007-5#1)(2008-10#1)
Ecological studies##4##2##(2007-5#1)(2008-10#1)(2008-12#1)(2009-8#1)
Ecological##26##1##(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#7)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
Ecology and evolution of##2##4##(2008-8#2)
Ecology and##4##2##(1990-11#1)(2008-8#2)(2013-1#1)
Ecology of##5##2##(2007-7#1)(2008-10#3)(2009-10#1)
Ecology##16##1##(1990-11#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#2)(2009-10#1)(2013-1#6)
Economic Change##2##2##(1994-3#2)
Economic Stabilization##4##2##(1994-12#2)(2008-9#2)
Economic and##4##2##(1991-2#1)(2008-10#1)(2009-10#1)(2013-1#1)
Economic credentialing##2##2##(1993-3#1)(1995-2#1)
Economic evaluation of##2##3##(2008-10#1)(2009-5#1)
Economic evaluation##4##2##(2008-10#1)(2009-5#1)(2013-8#2)
Economic impact of##2##3##(1994-5#1)(2011-2#1)
Economic##47##1##(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
Economical use of rabies vaccine##2##5##(1996-8#2)
Economics##3##1##(1990-8#1)(1993-12#1)(2008-12#1)
Economists##3##1##(1997-2#1)(2008-11#2)
Ecotoxicological##2##1##(2008-11#2)
Ecstasy and LSD##2##3##(2012-1#2)
Ectoparasite##2##1##(2008-5#1)(2013-1#1)
Ectopic expression of##2##3##(1994-12#1)(2008-8#1)
Ectopic opening of the vas deferens into##2##7##(2008-10#2)
Ectopic pregnancy##2##2##(1997-2#1)(2011-2#1)
Ectopic##12##1##(1994-12#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#2)
Ecuador and Peru##2##3##(2008-10#1)(2008-7#1)
Ecuador and##3##2##(2008-10#2)(2008-7#1)
Ecuador of##2##2##(2008-10#2)
Ecuador##27##1##(1992-5#1)(2006-10#1)(2008-10#16)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
Ecuadorian##6##1##(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
Eczema##2##1##(2007-7#1)(2013-1#1)
Ed##6##1##(1990-11#1)(1990-3#1)(1991-1#1)(2007-2#2)(2011-1#1)
Eddy##2##1##(1991-1#1)(1996-3#1)
Edema##3##1##(2008-5#2)(2011-2#1)
Eden##2##1##(2008-1#2)
Edge Hill railway accident##2##4##(2009-10#2)
Edge Hill##3##2##(2009-10#3)
Edge effects##2##2##(2008-6#1)(2008-9#1)
Edge##14##1##(1990-8#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#1)(2009-10#3)(2010-8#2)(2011-2#1)
Edinburgh##9##1##(1995-11#1)(1997-5#1)(1997-8#1)(2006-9#1)(2008-10#1)(2009-9#1)(2010-12#1)(2013-1#2)
Edinger-Westphal nucleus##3##2##(1992-8#2)(1993-12#1)
Edison##3##1##(1995-12#2)(2008-5#1)
Edited by##12##2##(2008-4#11)(2008-5#1)
Edition##11##1##(2008-12#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#6)(2012-2#1)
Editor of##2##2##(2008-10#1)(2008-4#1)
Editor##9##1##(2008-10#2)(2008-4#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#2)
Editor's Note##2##2##(1996-1#1)(2010-7#1)
Editor's Pick##6##2##(2008-8#6)
Editor's pick##2##2##(2008-8#2)
Editor's preface##2##2##(2009-11#1)(2010-5#1)
Editor's##13##1##(1996-1#1)(2008-8#8)(2009-11#1)(2010-5#1)(2010-7#1)(2011-1#1)
Editor-in-Chief##2##1##(2008-5#1)(2012-3#1)
Editorial Board has now been established and consists of##3##9##(2010-12#3)
Editorial board##3##2##(1997-3#1)(2007-2#2)
Editorial comment##13##2##(2008-11#12)(2008-9#1)
Editorial comments--&quot##2##2##(2008-9#2)
Editorial for##2##2##(2009-9#1)(2011-2#1)
Editorial foreword##3##2##(2008-3#3)
Editorial from the##2##3##(2008-5#2)
Editorial##84##1##(1995-11#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#2)(2006-5#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#7)(2008-11#18)(2008-12#1)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#6)(2009-4#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Editors and peer reviewers should encourage authors to include a discussion of CS##2##13##(2013-1#2)
Editors and##3##2##(2013-1#3)
Editors##6##1##(2008-8#1)(2011-1#1)(2013-1#4)
Editors-in-Chief##7##1##(2008-10#7)
Edman degradation and##2##3##(1991-12#1)(1996-12#1)
Edman degradation of##3##3##(1990-5#1)(1993-6#1)(2008-4#1)
Edman degradation##9##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1996-12#1)(2008-4#1)(2010-4#1)
Edman##11##1##(1990-5#1)(1991-12#1)(1992-3#2)(1992-8#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-12#1)(2008-4#1)(2010-4#1)
Edmonton##10##1##(1991-2#1)(1992-1#1)(1992-2#1)(1992-5#1)(1994-1#2)(2008-10#1)(2008-7#2)(2010-11#1)
Eds##8##1##(1990-11#3)(1990-3#2)(1990-8#3)
Educating for##3##2##(1995-12#1)(1997-2#1)(2008-11#1)
Educating the##3##2##(1991-1#1)(1992-12#1)(1997-8#1)
Educating##12##1##(1991-1#1)(1992-12#1)(1995-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2008-11#2)(2011-1#1)
Education Center##3##2##(2008-1#2)(2008-4#1)
Education Units##2##2##(2008-11#2)
Education and Communication##2##3##(2011-2#2)
Education and training##4##3##(1992-1#1)(1993-1#1)(1994-1#1)(2008-11#1)
Education and##15##2##(1992-1#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-12#1)(1995-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)
Education for##8##2##(1992-1#1)(1996-1#1)(1997-3#1)(2007-2#1)(2008-11#2)(2012-3#1)(2013-1#1)
Education in Practice##2##3##(2008-11#1)(2008-12#1)
Education in clinical chemistry in##2##5##(1994-12#2)
Education in clinical chemistry##4##4##(1994-12#4)
Education in clinical##5##3##(1994-12#5)
Education in##13##2##(1993-3#1)(1994-12#5)(1997-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-4#1)
Education of##6##2##(1991-8#1)(1994-12#1)(1995-11#1)(2008-1#1)(2008-8#1)(2010-3#1)
Education programs##3##2##(1992-12#2)(1994-12#1)
Education##126##1##(1991-12#6)(1991-3#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#9)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#1)(1997-2#1)(1997-3#3)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-11#24)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#3)
Educational and##4##2##(1993-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
Educational interventions##2##2##(2008-8#1)(2011-2#1)
Educational##27##1##(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1997-5#1)(2007-2#1)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Educators must##2##2##(2009-8#1)(2012-1#1)
Educators##7##1##(1996-3#1)(2007-2#2)(2008-1#1)(2008-11#1)(2009-8#1)(2012-1#1)
Edward Island##10##2##(1991-8#1)(2008-10#1)(2010-8#1)(2012-3#5)(2013-8#2)
Edward##19##1##(1991-8#1)(1995-1#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-3#5)(2013-8#2)
Edwards Deming's##2##2##(1993-2#1)(1996-1#1)
Edwards MIRA##2##2##(2007-8#2)
Edwards##8##1##(1993-12#1)(1993-2#1)(1995-12#1)(1996-1#1)(2007-8#2)(2008-11#1)(2012-3#1)
Eel##3##1##(1995-3#1)(2008-5#2)
Efalizumab##2##1##(2008-5#2)
Efamol##2##1##(2008-5#2)
Efavirenz is##2##2##(2008-5#2)
Efavirenz##3##1##(2008-5#3)
Efe Pygmy##2##2##(1993-6#2)
Effect Size##2##2##(2009-11#1)(2011-1#1)
Effect and##2##2##(2008-3#1)(2013-1#1)
Effect in##3##2##(1996-9#1)(2008-10#1)(2008-11#1)
Effect of DNA##2##3##(2008-8#1)(2008-9#1)
Effect of L-ascorbic##2##3##(1993-12#1)(2013-1#1)
Effect of Relative Humidity##2##4##(2008-10#2)
Effect of Water##2##3##(2008-10#2)
Effect of a##10##3##(1992-3#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
Effect of acute##2##3##(1994-11#1)(2010-8#1)
Effect of age and##2##4##(2008-3#1)(2010-4#1)
Effect of age on##4##4##(1990-3#2)(2008-1#1)(2008-7#1)
Effect of age##6##3##(1990-3#2)(2008-1#1)(2008-3#1)(2008-7#1)(2010-4#1)
Effect of an##4##3##(1992-3#1)(2007-12#1)(2008-11#1)(2013-1#1)
Effect of cold##2##3##(2011-2#1)(2012-12#1)
Effect of dietary##3##3##(1990-7#1)(2008-7#1)(2012-2#1)
Effect of different parameters##2##4##(2008-10#1)(2012-1#1)
Effect of different##8##3##(2008-10#1)(2008-12#3)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
Effect of extraction##2##3##(2008-10#1)(2008-6#1)
Effect of feeding##2##3##(2008-12#1)(2012-2#1)
Effect of fluoride##2##3##(2013-1#2)
Effect of hormone replacement therapy on cancer detection by mammography##2##10##(1997-5#2)
Effect of hormone replacement therapy on##3##6##(1997-5#2)(2008-5#1)
Effect of local##2##3##(2008-3#1)(2012-3#1)
Effect of low##2##3##(2010-9#1)(2013-1#1)
Effect of new##2##3##(1991-11#1)(2008-11#1)
Effect of oral carbohydrate intake on labor progress##2##8##(2013-1#2)
Effect of oral##3##3##(1995-11#1)(2013-1#2)
Effect of pH on##2##4##(1994-6#1)(2008-10#1)
Effect of pH##3##3##(1994-6#1)(2008-10#2)
Effect of protein##2##3##(2008-5#1)(2011-2#1)
Effect of ramadan fasting on body##2##6##(2012-3#2)
Effect of recombinant##2##3##(1991-2#1)(2008-9#1)
Effect of retinoic acid on##2##5##(1993-3#1)(1994-11#1)
Effect of retinoic acid##3##4##(1993-3#1)(1994-11#1)(1995-9#1)
Effect of serum##2##3##(1995-12#1)(2008-11#1)
Effect of short-term##2##3##(1992-9#1)(2012-3#1)
Effect of smoking on##2##4##(2007-10#1)(2012-3#1)
Effect of smoking##3##3##(1995-3#1)(2007-10#1)(2012-3#1)
Effect of sodium##3##3##(1995-5#1)(2008-12#1)(2010-3#1)
Effect of substrate##2##3##(2008-3#1)(2008-7#1)
Effect of temperature on the##2##5##(2008-10#1)(2008-3#1)
Effect of temperature on##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
Effect of temperature##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)
Effect of the##22##3##(1994-3#1)(1996-12#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)(2010-4#1)(2013-8#1)
Effect of thyrotropin##2##3##(1994-11#1)(1994-6#1)
Effect of various plasticizers viz##2##5##(2008-10#2)
Effect of vitamin C##3##4##(1992-9#1)(1996-12#1)(2008-5#1)
Effect of vitamin##5##3##(1990-3#1)(1992-9#1)(1993-12#1)(1996-12#1)(2008-5#1)
Effect of##453##2##(1990-10#1)(1990-12#2)(1990-3#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#7)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-5#4)(1993-6#1)(1993-9#1)(1994-11#7)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#4)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1995-9#2)(1996-12#4)(1996-2#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-7#3)(2008-1#5)(2008-10#80)(2008-11#18)(2008-12#19)(2008-2#7)(2008-3#22)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#9)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#18)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#11)(2012-3#11)(2013-1#22)(2013-7#1)(2013-8#8)
Effect on##12##2##(1990-5#1)(1992-8#1)(1997-2#1)(2008-10#5)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
Effect sizes##4##2##(2008-10#2)(2009-9#1)(2013-8#1)
Effect##488##1##(1990-10#1)(1990-12#2)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#8)(1992-6#3)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-5#4)(1993-6#1)(1993-9#1)(1994-11#7)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#4)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1995-9#2)(1996-12#4)(1996-2#2)(1996-5#3)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-7#4)(2008-1#5)(2008-10#90)(2008-11#21)(2008-12#19)(2008-2#7)(2008-3#23)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#9)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#11)(2012-3#12)(2013-1#24)(2013-7#1)(2013-8#9)
Effective and##3##2##(2011-2#2)(2013-1#1)
Effective communication##2##2##(1991-12#1)(2011-1#1)
Effective leadership##2##2##(1991-1#1)(2010-1#1)
Effective##57##1##(1990-12#1)(1991-1#1)(1991-12#2)(1992-12#2)(1993-1#2)(1993-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-5#3)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
Effectively##4##1##(1993-2#1)(1994-2#1)(1996-2#1)(2008-12#1)
Effectiveness and safety of##2##4##(2009-7#1)(2012-3#1)
Effectiveness of a##3##3##(2007-10#1)(2008-11#1)(2008-5#1)
Effectiveness of##30##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-5#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Effectiveness##34##1##(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-5#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
Effects and##2##2##(1992-3#1)(1996-3#1)
Effects for##2##2##(2008-10#1)(2008-12#1)
Effects in##4##2##(1996-12#1)(1996-5#1)(1997-7#1)(2008-3#1)
Effects of DNA##2##3##(2008-11#1)(2012-3#1)
Effects of HIV-1##2##3##(2008-11#1)(2008-2#1)
Effects of Irrigation and##2##4##(2008-10#2)
Effects of NaCl on##2##4##(1997-2#1)(2008-10#1)
Effects of Temperature and##3##4##(2008-10#3)
Effects of a Small Inclination Misalignment in Talbot Interferometry by##2##10##(2008-3#2)
Effects of a##15##3##(1993-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Effects of aerobic exercise##2##4##(2012-12#1)(2012-3#1)
Effects of an intervention##2##4##(1991-2#1)(2010-4#1)
Effects of an##10##3##(1991-2#1)(1993-12#1)(2008-10#1)(2008-3#2)(2008-8#2)(2010-4#1)(2011-2#1)(2012-1#1)
Effects of capsaicin on##2##4##(1993-11#1)(2008-11#1)
Effects of chronic##3##3##(1991-1#1)(1996-12#1)(2013-1#1)
Effects of dietary##3##3##(2008-7#1)(2010-2#1)(2012-2#1)
Effects of different concentrations of##2##5##(2008-12#2)
Effects of different##8##3##(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2013-1#1)
Effects of drugs##2##3##(1991-12#1)(1992-9#1)
Effects of ethanol##3##3##(1990-5#1)(1991-1#1)(2008-10#1)
Effects of feeding##2##3##(2008-5#1)(2010-2#1)
Effects of flow rate##2##4##(2008-10#1)(2010-4#1)
Effects of gender##3##3##(2008-12#1)(2013-1#2)
Effects of host##2##3##(2008-10#2)
Effects of intracranial##2##3##(1993-12#1)(1994-8#1)
Effects of leucine and related compounds on protein synthesis were studied in##2##12##(2008-11#2)
Effects of membrane##2##3##(1997-1#1)(2008-10#1)
Effects of organic##2##3##(2008-10#2)
Effects of pH##3##3##(2008-10#3)
Effects of plasticizers##2##3##(2008-10#2)
Effects of reaction##2##3##(2008-10#1)(2008-7#1)
Effects of repeated##2##3##(1993-6#1)(1995-12#1)
Effects of selected##2##3##(1994-1#1)(2012-3#1)
Effects of several##2##3##(2008-10#1)(2008-11#1)
Effects of swainsonine##2##3##(2008-11#2)
Effects of systematic##2##3##(1993-12#1)(1997-8#1)
Effects of temperature##2##3##(2008-10#1)(2011-2#1)
Effects of the##10##3##(1995-2#2)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2009-9#1)
Effects of time##2##3##(2008-3#1)(2008-9#1)
Effects of vitamin##2##3##(2011-1#2)
Effects of water##2##3##(2008-12#1)(2012-2#1)
Effects of##452##2##(1990-11#1)(1990-2#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#7)(1991-12#4)(1991-2#2)(1992-11#2)(1992-12#1)(1992-3#5)(1992-6#1)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#6)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#7)(1995-11#7)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#1)(2008-10#83)(2008-11#24)(2008-12#18)(2008-2#11)(2008-3#18)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#13)(2009-10#2)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-2#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#9)(2011-10#2)(2011-2#12)(2012-1#5)(2012-12#4)(2012-2#13)(2012-3#8)(2012-4#1)(2012-6#1)(2013-1#20)(2013-8#4)
Effects on other##2##3##(1995-6#1)(2008-11#1)
Effects on the##4##3##(1994-5#1)(2008-10#1)(2009-2#1)(2011-2#1)
Effects on##29##2##(1991-1#2)(1993-12#3)(1994-5#1)(1995-6#1)(1996-5#1)(2008-10#11)(2008-11#2)(2008-2#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Effects##507##1##(1990-11#1)(1990-2#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#9)(1991-12#4)(1991-2#2)(1992-11#2)(1992-12#1)(1992-3#6)(1992-6#1)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#9)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#4)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#7)(1995-11#7)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#5)(1996-2#5)(1996-3#2)(1996-5#5)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-4#1)(2008-10#98)(2008-11#27)(2008-12#19)(2008-2#13)(2008-3#20)(2008-4#2)(2008-5#16)(2008-6#4)(2008-7#10)(2008-8#13)(2008-9#13)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#2)(2010-2#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#9)(2011-10#2)(2011-2#13)(2012-1#5)(2012-12#5)(2012-2#15)(2012-3#9)(2012-4#1)(2012-6#1)(2013-1#20)(2013-8#5)
Efficacy and Safety##2##3##(2011-2#1)(2012-12#1)
Efficacy and Tolerability##2##3##(2008-3#2)
Efficacy and safety of##8##4##(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)
Efficacy and##15##2##(1991-2#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
Efficacy of a##2##3##(1990-6#1)(2008-5#1)
Efficacy of##38##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#2)
Efficacy was##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
Efficacy##64##1##(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
Efficiency in##4##2##(1996-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
Efficiency of the##2##3##(2008-10#1)(2008-3#1)
Efficiency of##15##2##(1991-6#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
Efficiency##30##1##(1991-6#1)(1994-1#1)(1996-12#2)(2008-1#1)(2008-10#12)(2008-12#2)(2008-3#3)(2008-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
Efficient Synthesis of##2##3##(1996-5#1)(2010-2#1)
Efficient continuous-wave##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
Efficient conversion##2##2##(2007-11#1)(2008-4#1)
Efficient cw##2##2##(2007-12#1)(2008-2#1)
Efficient diode pumping##2##3##(2007-11#1)(2008-3#1)
Efficient expression##2##2##(1990-5#1)(2008-11#1)
Efficient femtosecond##2##2##(2007-11#1)(2007-12#1)
Efficient frequency doubling of##3##4##(2007-11#1)(2007-12#2)
Efficient frequency doubling##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
Efficient generation of##2##3##(2007-11#1)(2008-3#1)
Efficient operation of a##3##4##(2008-3#3)
Efficient production of##2##3##(2008-6#1)(2011-2#1)
Efficient pulsed##2##2##(2008-2#2)
Efficient second-harmonic generation at##2##4##(2007-12#2)
Efficient second-harmonic generation##4##3##(2007-11#1)(2007-12#3)
Efficient secretion of##2##3##(1993-6#1)(1995-6#1)
Efficient transfection of##2##3##(2008-11#2)
Efficient##100##1##(1990-5#2)(1992-1#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#2)(2007-11#17)(2007-12#15)(2008-10#2)(2008-11#5)(2008-2#15)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
Efflux of##2##2##(1990-2#1)(1992-6#1)
Efflux##3##1##(1990-2#1)(1992-6#1)(1994-3#1)
Efforts are##2##2##(1995-5#1)(2008-4#1)
Efforts should be##3##3##(2008-1#1)(2010-8#1)(2013-8#1)
Efforts to improve##4##3##(1993-6#1)(1996-2#1)(2012-3#1)(2013-1#1)
Efforts to reduce##2##3##(2008-3#1)(2009-5#1)
Efforts to##22##2##(1990-11#1)(1991-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-3#1)(2009-5#2)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
Efforts##32##1##(1990-11#1)(1991-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#3)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Egg deposition##2##2##(2013-1#2)
Egg number##2##2##(2008-5#1)(2010-8#1)
Egg##17##1##(1992-8#1)(1996-12#1)(2008-10#1)(2008-12#3)(2008-5#1)(2009-4#2)(2010-8#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Eggs are##2##2##(2007-12#2)
Eggs of##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)
Eggs were##2##2##(2009-5#1)(2010-8#1)
Eggs##14##1##(1991-5#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-5#3)(2008-8#1)(2009-5#1)(2010-8#2)
Egr-1 DZs##2##2##(2012-2#2)
Egr-1 and##2##2##(1994-11#1)(2012-2#1)
Egr-1##8##1##(1994-11#1)(1994-8#1)(2012-2#6)
Egypt in 2006##2##3##(2011-2#2)
Egypt in##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#2)
Egypt##45##1##(1994-11#1)(1994-9#1)(1996-2#1)(1997-8#1)(2007-7#5)(2008-1#4)(2008-10#15)(2008-11#1)(2008-12#3)(2010-10#2)(2010-4#3)(2011-2#3)(2013-1#5)
Egyptian blue##2##2##(2008-10#2)
Egyptian cultivars of Vicia faba##2##5##(2008-12#2)
Egyptian mummy##2##2##(1991-2#1)(2008-8#1)
Egyptian##22##1##(1991-2#1)(1994-11#2)(2008-1#1)(2008-10#8)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#2)(2011-2#1)(2012-12#2)
Egyptians##4##1##(2008-4#1)(2011-2#1)(2012-12#2)
Eh252 and 10##2##3##(2008-10#2)
Eh252 and##5##2##(2008-10#5)
Eh252##15##1##(2008-10#15)
Ehlers-Danlos syndrome##6##2##(1990-2#2)(2008-5#1)(2013-8#3)
Ehrlich ascites carcinoma (EAC)##2##4##(1992-3#1)(2008-4#1)
Ehrlich ascites carcinoma##3##3##(1992-3#2)(2008-4#1)
Ehrlich ascites##7##2##(1990-5#2)(1992-3#4)(2008-4#1)
Ehrlich##10##1##(1990-5#2)(1992-3#4)(1993-8#1)(2008-4#1)(2008-7#1)(2012-3#1)
Eichrom##2##1##(2008-10#2)
Eidolon##2##1##(2007-5#2)
Eigen's##2##1##(1997-6#2)
Eigenvalue##2##1##(1996-9#1)(2008-3#1)
Eight (50##2##2##(2008-4#1)(2013-8#1)
Eight different##4##2##(2008-10#3)(2008-5#1)
Eight hundred##2##2##(2008-11#1)(2012-3#1)
Eight new##3##2##(1992-8#1)(1997-9#1)(2010-6#1)
Eight of the##5##3##(1994-11#1)(1996-6#1)(2007-2#1)(2009-6#1)(2010-4#1)
Eight of these patients##2##4##(1994-9#1)(2008-1#1)
Eight of these##6##3##(1990-11#1)(1992-6#1)(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)
Eight of##16##2##(1990-11#1)(1992-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-2#1)(2010-4#1)(2012-2#1)
Eight patients underwent##2##3##(1991-2#1)(2012-3#1)
Eight patients were##2##3##(2008-10#1)(2008-7#1)
Eight patients with##2##3##(2007-8#1)(2009-11#1)
Eight patients##11##2##(1990-9#1)(1991-2#1)(1991-4#1)(1992-11#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-3#1)
Eight pesticides##2##2##(1991-6#1)(2008-10#1)
Eight public hospitals were included##2##5##(2013-1#2)
Eight replicate##3##2##(2008-10#2)(2008-5#1)
Eight studies##3##2##(2010-12#1)(2013-1#1)(2013-8#1)
Eight subjects##2##2##(1994-3#1)(2011-2#1)
Eight weeks##2##2##(1991-3#1)(2009-10#1)
Eight##115##1##(1990-11#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-9#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#3)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#6)
Eighteen consecutive##2##2##(2008-1#1)(2013-1#1)
Eighteen female##2##2##(1992-3#1)(2008-11#1)
Eighteen participants##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
Eighteen patients##6##2##(1990-12#2)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
Eighteen percent of##2##3##(1990-2#1)(1994-3#1)
Eighteen##34##1##(1990-12#2)(1990-2#1)(1990-5#1)(1992-3#1)(1994-3#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
Eighth International##2##2##(1991-5#1)(2008-9#1)
Eighth##4##1##(1991-1#1)(1991-5#1)(2008-9#1)(2010-6#1)
Eighty patients with##2##3##(2011-2#1)(2013-1#1)
Eighty patients##3##2##(1994-7#1)(2011-2#1)(2013-1#1)
Eighty percent of the##2##4##(1996-9#1)(2008-4#1)
Eighty percent of##4##3##(1996-9#1)(1997-3#1)(2008-4#1)(2012-2#1)
Eighty percent##5##2##(1992-5#1)(1996-9#1)(1997-3#1)(2008-4#1)(2012-2#1)
Eighty##24##1##(1990-3#1)(1992-5#1)(1994-7#1)(1995-3#1)(1996-9#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)
Eighty-eight patients with##2##3##(1991-2#1)(1997-8#1)
Eighty-eight percent of##3##3##(1991-8#1)(1995-2#1)(2008-8#1)
Eighty-eight##8##1##(1991-2#1)(1991-8#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-8#1)
Eighty-five##4##1##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
Eighty-four percent##2##2##(1991-12#1)(1992-1#1)
Eighty-four##7##1##(1991-12#1)(1992-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
Eighty-nine##4##1##(1991-12#1)(2007-8#1)(2008-10#1)(2008-9#1)
Eighty-one percent##2##2##(2010-8#1)(2012-12#1)
Eighty-one##5##1##(1992-10#1)(1997-5#1)(2008-10#1)(2010-8#1)(2012-12#1)
Eighty-seven##2##1##(2007-8#1)(2012-3#1)
Eighty-six##10##1##(1990-8#1)(1991-3#1)(1996-1#1)(1997-9#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)
Eighty-three patients (80##2##3##(2007-8#2)
Eighty-three percent of##2##3##(1995-3#1)(2007-2#1)
Eighty-three##7##1##(1991-12#1)(1995-3#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)
Eighty-two##3##1##(2008-10#1)(2008-3#1)(2010-11#1)
Eikenella corrodens##4##2##(1997-8#1)(2007-7#2)(2013-8#1)
Eimeria spp##2##2##(2007-6#2)
Eimeria##7##1##(1997-6#2)(2007-6#3)(2008-5#2)
Eisenia fetida##3##2##(2008-12#1)(2008-9#2)
Eisenia foetida##2##2##(2008-5#2)
Eisenia##5##1##(2008-12#1)(2008-5#2)(2008-9#2)
Either a##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
Either the##4##2##(1992-9#1)(2008-3#1)(2008-7#1)(2008-8#1)
Either##21##1##(1992-6#1)(1992-9#1)(1995-12#1)(1995-3#1)(2006-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
Ejaculatory##3##1##(1997-8#1)(2009-5#1)(2010-11#1)
Ejection##2##1##(2008-10#1)(2013-8#1)
Ejp556##2##1##(2008-10#2)
El Hierro##2##2##(2008-10#2)
El Rosal##3##2##(2012-12#3)
El Salvador##4##2##(1992-5#1)(1994-2#1)(2011-2#2)
El Tor##4##2##(1992-5#2)(2007-7#1)(2012-3#1)
El and E2##2##3##(2008-8#2)
El and##4##2##(2008-8#4)
El##28##1##(1992-5#3)(1994-2#2)(1994-9#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-7#1)
Elan##2##1##(2008-10#1)(2008-5#1)
Elastase##3##1##(2008-5#1)(2008-7#2)
Elastic vesicles##3##2##(2008-5#3)
Elastic##8##1##(2007-11#1)(2008-3#1)(2008-5#3)(2009-3#1)(2009-4#1)(2012-2#1)
Elasticity of##2##2##(1992-7#1)(1995-3#1)
Elasticity##4##1##(1992-7#1)(1995-3#1)(2009-5#1)(2013-8#1)
Elastography##2##1##(2010-8#2)
Elastomeric pain pumps##2##3##(2011-2#2)
Elastomeric##3##1##(2008-12#1)(2011-2#2)
Elateridae) abundance in the coastal plain of North Carolina##2##9##(2011-2#2)
Elateridae)##3##1##(2007-12#1)(2011-2#2)
Elbow##2##1##(2008-9#1)(2011-2#1)
Elder Abuse Resource##2##3##(1995-12#2)
Elder abuse##6##2##(1991-1#2)(1991-2#1)(1995-12#1)(1996-8#2)
Elder##11##1##(1991-1#2)(1991-2#1)(1994-12#1)(1995-12#3)(1996-8#2)(2007-10#1)(2008-5#1)
Elderly Patients##2##2##(2010-8#1)(2012-3#1)
Elderly Welfare##2##2##(2011-2#2)
Elderly patients with##2##3##(2011-2#2)
Elderly patients##6##2##(1992-9#1)(2008-8#1)(2011-2#2)(2012-3#2)
Elderly##28##1##(1992-1#1)(1992-4#1)(1992-9#1)(1994-2#1)(1995-1#1)(1997-3#2)(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#2)
Elders##2##1##(2008-9#1)(2010-10#1)
Elect##2##1##(1997-4#1)(2008-5#1)
Elective##5##1##(1990-2#1)(1996-8#1)(2008-3#1)(2010-7#1)(2012-3#1)
Electri-Cord Manufacturing##2##2##(2011-1#1)(2011-2#1)
Electri-Cord##3##1##(2011-1#2)(2011-2#1)
Electric field##2##2##(2007-12#1)(2008-3#1)
Electric stimulation of the##2##4##(2008-9#2)
Electric stimulation##3##2##(2008-10#1)(2008-9#2)
Electric##12##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2009-9#1)(2012-12#1)
Electric-field multiplexing##2##2##(2008-2#2)
Electric-field-induced second-harmonic generation##2##3##(2007-11#2)
Electrical and##2##2##(2007-12#1)(2008-10#1)
Electrical field depolarization##2##3##(1993-12#2)
Electrical field##3##2##(1990-5#1)(1993-12#2)
Electrical stimulation of the brain for psychiatric disorders##2##8##(2008-1#2)
Electrical stimulation of the##6##4##(1991-5#1)(1995-12#1)(2008-1#2)(2008-7#1)(2010-6#1)
Electrical stimulation##9##2##(1990-7#1)(1991-5#1)(1993-12#2)(1995-12#1)(2008-1#2)(2008-7#1)(2010-6#1)
Electrical##32##1##(1990-5#1)(1990-7#1)(1991-5#1)(1992-8#1)(1993-12#4)(1994-5#2)(1995-12#2)(2007-12#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)
Electrically controlled##2##2##(2007-12#1)(2008-3#1)
Electrically evoked##2##2##(2008-9#2)
Electrically##4##1##(2007-12#1)(2008-3#1)(2008-9#2)
Electro-Optic##2##1##(2008-2#1)(2008-3#1)
Electro-Optically##2##1##(2008-3#2)
Electro-optic##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
Electroabsorption spectra of##2##3##(2010-5#2)
Electroabsorption##3##1##(2008-2#1)(2010-5#2)
Electroacupuncture##2##1##(2008-10#1)(2013-1#1)
Electroanalysis of##2##2##(2008-10#2)
Electroanalysis##5##1##(2008-10#5)
Electroanalytical##3##1##(2008-10#3)
Electrocardiogram##2##1##(2010-8#1)(2013-1#1)
Electrocardiographic##3##1##(2008-11#1)(2008-3#1)(2008-7#1)
Electrocatalysis of##3##2##(2008-10#3)
Electrocatalytic oxidation and detection of hydrazine##2##6##(2008-10#2)
Electrocatalytic oxidation of##2##3##(2008-10#2)
Electrocatalytic oxidation##4##2##(2008-10#4)
Electrocatalytic##12##1##(2008-10#11)(2010-6#1)
Electrochemical DNA biosensor##2##3##(2008-10#2)
Electrochemical analysis of##3##3##(2008-10#3)
Electrochemical and##3##2##(2008-10#2)(2010-2#1)
Electrochemical behavior of##4##3##(2008-10#4)
Electrochemical behavior##5##2##(2008-10#5)
Electrochemical behaviour of##4##3##(2008-10#4)
Electrochemical characteristics##2##2##(2008-10#1)(2010-2#1)
Electrochemical detection of##6##3##(1990-8#1)(2008-10#5)
Electrochemical detection##8##2##(1990-8#1)(2008-10#7)
Electrochemical determination of##4##3##(2008-10#4)
Electrochemical identification of##2##3##(2008-10#2)
Electrochemical impedance spectroscopy##6##3##(2008-10#5)(2012-2#1)
Electrochemical impedance##7##2##(2008-10#6)(2012-2#1)
Electrochemical oxidation of##4##3##(2008-10#3)(2008-3#1)
Electrochemical oxidation##5##2##(2008-10#4)(2008-3#1)
Electrochemical polymerization of##2##3##(2008-10#2)
Electrochemical properties of##2##3##(1991-8#1)(2008-10#1)
Electrochemical reduction##2##2##(2008-10#2)
Electrochemical sensing of##2##3##(2008-10#2)
Electrochemical sensor for##2##3##(2008-10#2)
Electrochemical studies of##3##3##(2008-10#3)
Electrochemical studies##5##2##(2008-10#5)
Electrochemical study of##3##3##(2008-10#3)
Electrochemical study##4##2##(2008-10#4)
Electrochemical##87##1##(1990-8#1)(1991-8#1)(1992-11#1)(1996-2#1)(2008-10#77)(2008-3#1)(2009-5#1)(2009-9#1)(2010-2#2)(2012-2#1)
Electrochemically##3##1##(2008-10#2)(2010-4#1)
Electrochemiluminescent behavior of##2##3##(2008-10#2)
Electrochemiluminescent##3##1##(2008-10#3)
Electrochemistry and electrocatalysis of binuclear cobalt##2##6##(2008-10#2)
Electrochemistry and electrocatalysis##3##3##(2008-10#3)
Electrochemistry and##6##2##(2008-10#6)
Electrochemistry of##4##2##(1996-2#2)(2008-10#1)(2008-5#1)
Electrochemistry##11##1##(1996-2#2)(2008-10#8)(2008-5#1)
Electroconvulsive therapy##2##2##(2010-7#1)(2011-1#1)
Electroconvulsive##3##1##(2010-7#1)(2011-1#1)(2012-2#1)
Electrode impedance##2##2##(2008-9#2)
Electrode insertion##2##2##(2008-9#1)(2010-12#1)
Electrode##11##1##(2008-10#5)(2008-9#4)(2010-12#1)(2010-8#1)
Electrodes containing##2##2##(2008-10#2)
Electrodes have##2##2##(2008-10#1)(2009-12#1)
Electrodes modified##2##2##(2008-10#2)
Electrodes were##2##2##(2008-10#2)
Electrodes##14##1##(2008-10#10)(2008-6#1)(2009-12#1)(2010-8#1)(2011-1#1)
Electrogenerated##3##1##(1995-6#1)(2008-10#1)(2010-7#1)
Electrolysis##2##1##(2008-10#1)(2013-1#1)
Electrolyte compositions##2##2##(2008-10#2)
Electrolytic##2##1##(1992-11#1)(1993-6#1)
Electrolyzed##3##1##(2008-10#1)(2008-11#2)
Electromagnetic Fields (EMF)##2##3##(2008-12#1)(2011-2#1)
Electromagnetic Fields##3##2##(2008-12#2)(2011-2#1)
Electromagnetic scattering by an aggregate of spheres##3##7##(2008-2#2)(2008-3#1)
Electromagnetic scattering##4##2##(2008-2#2)(2008-3#2)
Electromagnetic theory##2##2##(2008-3#2)
Electromagnetic##15##1##(1992-8#1)(2008-12#3)(2008-2#4)(2008-3#4)(2010-7#1)(2011-2#2)
Electromagnetically induced transparency##2##3##(2008-3#2)
Electromagnetically##3##1##(1996-12#1)(2008-3#2)
Electromechanical##2##1##(2008-7#1)(2009-9#1)
Electromyographic##2##1##(2008-5#1)(2012-12#1)
Electromyography (EMG)##2##2##(2011-2#1)(2012-2#1)
Electromyography##3##1##(2009-3#1)(2011-2#1)(2012-2#1)
Electron Microscopy##4##2##(2008-12#1)(2008-5#1)(2009-9#1)(2010-11#1)
Electron Transfer##2##2##(1996-9#1)(1997-7#1)
Electron beam computed tomography##2##4##(2008-3#2)
Electron beam##3##2##(2008-3#2)(2009-9#1)
Electron micrographs of##4##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-4#1)
Electron micrographs##5##2##(1995-6#2)(1997-3#1)(2008-10#1)(2008-4#1)
Electron microscope##3##2##(1990-2#1)(2008-10#1)(2008-2#1)
Electron microscopic examination of##3##4##(1996-5#1)(1997-3#1)(2008-7#1)
Electron microscopic examination##5##3##(1995-12#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Electron microscopic##8##2##(1995-12#1)(1996-5#1)(1997-3#2)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
Electron microscopy and##2##3##(2008-10#1)(2008-4#1)
Electron microscopy of##3##3##(1997-2#1)(1997-3#1)(1997-6#1)
Electron microscopy revealed that##5##4##(1991-2#1)(1996-12#1)(2008-11#2)(2008-5#1)
Electron microscopy revealed##6##3##(1991-2#1)(1996-12#1)(2008-11#3)(2008-5#1)
Electron microscopy showed that##2##4##(1996-1#1)(2011-2#1)
Electron microscopy showed##3##3##(1994-8#1)(1996-1#1)(2011-2#1)
Electron microscopy##19##2##(1991-2#1)(1992-2#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
Electron paramagnetic resonance (EPR)##2##4##(1993-11#1)(2008-10#1)
Electron paramagnetic resonance##4##3##(1993-11#1)(1996-2#1)(2008-10#1)(2009-2#1)
Electron spin resonance##2##3##(2008-10#2)
Electron transfer##2##2##(1990-5#1)(2008-10#1)
Electron##68##1##(1990-2#1)(1990-5#1)(1991-2#1)(1992-2#1)(1993-11#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#2)(2009-2#1)(2009-9#3)(2010-11#1)(2011-2#1)(2012-2#2)
Electron-beam##2##1##(2008-2#1)(2008-3#1)
Electron-transfer##2##1##(1990-5#1)(1995-2#1)
Electronic Health Record (EHR)##2##4##(2008-7#1)(2010-8#1)
Electronic Health Record##5##3##(2008-11#1)(2008-7#2)(2010-8#2)
Electronic Health Records##4##3##(2010-8#4)
Electronic Health##10##2##(2008-11#1)(2008-7#2)(2010-8#7)
Electronic and##2##2##(2008-3#1)(2009-6#1)
Electronic data##2##2##(1991-5#1)(2008-8#1)
Electronic databases and reference lists of key articles were searched to identify##3##12##(2012-12#3)
Electronic databases##5##2##(2008-6#1)(2011-2#1)(2012-12#3)
Electronic imaging##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
Electronic mail##2##2##(1992-2#1)(1992-3#1)
Electronic medical records##2##3##(2006-10#1)(2008-6#1)
Electronic patient records##2##3##(1997-1#2)
Electronic patient##3##2##(1997-1#2)(2010-4#1)
Electronic technology##2##2##(1995-2#1)(1997-3#1)
Electronic tools for infectious diseases and##2##6##(2008-11#2)
Electronic tools##3##2##(2008-11#3)
Electronic##62##1##(1991-5#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#2)(2008-10#4)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-8#9)(2011-2#1)(2012-12#5)(2012-2#2)
Electronically##2##1##(1996-5#1)(2007-12#1)
Electrophoresis and##2##2##(2008-10#2)
Electrophoresis in##2##2##(1992-2#1)(2008-12#1)
Electrophoresis##11##1##(1992-2#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)
Electrophoretic analysis of the##2##4##(2008-7#2)
Electrophoretic analysis of##3##3##(2007-12#1)(2008-7#2)
Electrophoretic analysis##4##2##(2007-12#1)(2008-7#2)(2010-8#1)
Electrophoretic mobility shift assay showed##2##5##(2008-11#1)(2008-9#1)
Electrophoretic mobility shift assay##3##4##(2008-11#1)(2008-9#2)
Electrophoretic mobility shift assays##2##4##(1995-6#1)(1997-7#1)
Electrophoretic mobility shift##5##3##(1995-6#1)(1997-7#1)(2008-11#1)(2008-9#2)
Electrophoretic separations of##2##3##(2008-10#2)
Electrophoretic##13##1##(1994-11#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#2)(2010-8#1)
Electrophysiological studies of##2##3##(1992-3#1)(1993-8#1)
Electrophysiological##10##1##(1990-8#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#2)
Electroporation##5##1##(2008-11#3)(2008-9#1)(2009-11#1)
Electrosensory##2##1##(1995-12#2)
Electrospinning##3##1##(2008-5#1)(2009-12#1)(2010-10#1)
Electrospun##3##1##(2008-5#1)(2009-12#1)(2009-9#1)
Electrostatic##6##1##(1990-8#1)(1992-3#1)(2008-10#2)(2008-5#1)(2009-5#1)
Electrotherapy##2##1##(1995-12#2)
Electrothermal atomic absorption spectrometric determination of##4##6##(2007-12#1)(2008-10#3)
Electrothermal atomic absorption##6##3##(2007-12#1)(2008-10#5)
Electrothermal##9##1##(2007-12#1)(2008-10#8)
Element Model##2##2##(2009-11#1)(2013-8#1)
Element in##2##2##(1994-6#1)(2008-10#1)
Element##13##1##(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-8#1)
Elemental analysis##3##2##(2008-10#3)
Elemental##5##1##(1995-3#1)(2008-10#4)
Elements in##11##2##(2008-10#10)(2008-11#1)
Elements of the##2##3##(1994-1#1)(2008-10#1)
Elements of##5##2##(1990-11#1)(1994-1#1)(1994-12#1)(2008-10#1)(2008-11#1)
Elements##22##1##(1990-11#1)(1994-1#1)(1994-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2011-1#1)(2012-3#1)
Elephant Trunk technique##2##3##(2012-2#2)
Elevated levels of##4##3##(1990-5#1)(2008-5#1)(2009-10#1)(2010-10#1)
Elevated plasma##3##2##(1992-9#1)(2008-1#1)(2009-10#1)
Elevated##32##1##(1990-5#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#3)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-7#1)(2013-1#1)(2013-7#1)
Elevating the##2##2##(2008-11#1)(2010-10#1)
Elevation of##2##2##(1990-2#1)(2011-2#1)
Elevation##4##1##(1990-2#1)(2007-5#1)(2008-11#1)(2011-2#1)
Elevations of##2##2##(1996-5#1)(2008-6#1)
Eleven AFLP markers##2##3##(2008-10#2)
Eleven elements##2##2##(2008-10#2)
Eleven focus groups##2##3##(2009-3#1)(2011-2#1)
Eleven of the##5##3##(1992-11#1)(1994-2#1)(1994-3#1)(2008-6#1)(2010-8#1)
Eleven of these##2##3##(2007-2#1)(2008-7#1)
Eleven of##10##2##(1992-11#1)(1994-2#1)(1994-3#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)
Eleven patients were##3##3##(1991-6#1)(1997-8#1)(2008-6#1)
Eleven patients with##2##3##(1992-10#1)(2008-7#1)
Eleven patients##11##2##(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1994-3#1)(1996-7#1)(1997-8#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-4#1)
Eleven sites##2##2##(1994-3#1)(1995-3#1)
Eleven##73##1##(1990-12#2)(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#3)(1995-3#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#1)
Eleventh##3##1##(1994-1#1)(1995-6#2)
Elgg##2##1##(1996-11#2)
Elicitation of##2##2##(2008-10#2)
Elicitin##3##1##(2008-10#3)
Eliciting##2##1##(2010-7#1)(2012-3#1)
Elicitins##2##1##(2008-10#2)
Elicitor##3##1##(2008-10#3)
Elicitors##2##1##(2008-10#2)
Eligibility for##2##2##(1990-12#1)(2012-2#1)
Eligible patients were##2##3##(2008-10#1)(2008-7#1)
Eligible patients##3##2##(2008-10#1)(2008-7#2)
Eliminate##2##1##(1996-3#1)(1997-3#1)
Eliminating poverty among First Nations children##2##6##(2008-11#2)
Eliminating##5##1##(1996-3#1)(2008-1#1)(2008-11#2)(2012-12#1)
Elimination of the##2##3##(1994-3#1)(2008-2#1)
Elimination of##10##2##(1994-3#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)
Elimination##14##1##(1994-3#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-3#1)
Elip family##3##2##(2008-7#3)
Elip##4##1##(2008-7#4)
Elisabeth##4##1##(1991-6#1)(1996-3#1)(1996-8#1)(1997-2#1)
Elite##4##1##(2008-10#2)(2011-2#1)(2012-3#1)
Elizabeth##7##1##(1990-2#1)(1993-12#1)(1994-3#3)(2007-3#1)(2008-11#1)
Ellagic acid##2##2##(2008-10#1)(2011-2#1)
Elle##2##1##(2013-1#2)
Elles sont##2##2##(2011-2#2)
Ellipsometric measurements##2##2##(2007-12#2)
Ellipsometric studies##2##2##(2008-10#1)(2008-2#1)
Ellipsometric##5##1##(2007-12#2)(2008-10#1)(2008-2#2)
Elliptic##2##1##(2007-11#1)(2007-12#1)
Ellis##5##1##(1990-11#1)(1990-3#1)(1995-12#2)(2009-8#1)
Ellman's##2##1##(2008-10#1)(2009-9#1)
Ellwood##3##1##(1994-1#3)
Elman recurrent neural networks have been defined by using##2##9##(2010-8#2)
Elman recurrent neural networks##3##4##(2010-8#3)
Elo##3##1##(1991-9#3)
Elongated##3##1##(1997-7#1)(2008-11#1)(2008-6#1)
Elsevier Policy on Article Withdrawal (http##6##6##(2008-10#4)(2008-11#2)
Elsevier Policy on Article Withdrawal##8##5##(2008-10#4)(2008-11#4)
Elsevier Science Inc##4##3##(2008-4#4)
Elsevier##13##1##(2008-10#4)(2008-11#4)(2008-4#4)(2008-5#1)
Elucidating the##4##2##(1996-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
Elucidating##5##1##(1996-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
Elucidation of fundamental equilibria which##2##5##(2008-10#2)
Elucidation of fundamental equilibria##3##4##(2008-10#3)
Elucidation of the role of##2##5##(1990-11#1)(2008-10#1)
Elucidation of the##11##3##(1990-11#1)(1990-9#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2012-2#2)(2012-3#1)
Elucidation of##16##2##(1990-11#1)(1990-9#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#7)(2008-11#1)(2012-2#2)(2012-3#1)
Elucidation##17##1##(1990-11#1)(1990-9#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#8)(2008-11#1)(2012-2#2)(2012-3#1)
Elution of##2##2##(2008-10#2)
Elution##7##1##(1995-3#1)(2008-10#6)
Elymus is##2##2##(2008-5#2)
Elymus species##3##2##(2008-5#3)
Elymus##6##1##(2008-5#6)
Em = +10 mV##2##4##(1993-8#2)
Em =##5##2##(1993-8#5)
EmD##2##1##(2013-1#2)
Emanuel Edward Klein##2##3##(2011-1#2)
Emax##5##1##(1991-5#1)(1995-12#1)(1997-2#1)(2010-3#2)
Embase and##2##2##(2009-2#1)(2011-2#1)
Embase##4##1##(2009-2#1)(2011-2#3)
Embelia tsjeriam-cottam##2##2##(2012-2#2)
Embelia##5##1##(2012-2#5)
Embelin##2##1##(2012-2#2)
Embolisation of##3##2##(1997-3#2)(1997-6#1)
Embolisation was##2##2##(1995-11#1)(1996-3#1)
Embolisation##10##1##(1995-11#1)(1996-3#2)(1997-3#3)(1997-6#4)
Embolization of##2##2##(2008-7#1)(2012-3#1)
Embolization##4##1##(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
Embracing##3##1##(2008-1#1)(2010-3#1)(2011-2#1)
Embryo##2##1##(1991-11#1)(1991-3#1)
Embryogenesis##2##1##(2011-2#1)(2012-1#1)
Embryogenic##2##1##(2006-12#1)(2008-8#1)
Embryonic Stem##2##2##(2008-11#1)(2012-12#1)
Embryonic development of the sensory innervation of the##2##8##(2007-12#2)
Embryonic development##3##2##(2007-12#2)(2010-8#1)
Embryonic stem (ES) cells have##3##5##(2008-11#2)(2008-9#1)
Embryonic stem (ES) cells##4##4##(2008-11#2)(2008-9#2)
Embryonic stem cells (ESC)##2##4##(2008-10#1)(2008-11#1)
Embryonic stem cells##6##3##(2008-10#1)(2008-11#5)
Embryonic stem##11##2##(2008-10#1)(2008-11#8)(2008-9#2)
Embryonic##22##1##(1994-7#1)(1994-9#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#10)(2008-8#1)(2008-9#2)(2010-8#2)(2012-12#1)
Embryos##6##1##(2008-5#1)(2008-6#2)(2009-12#1)(2010-8#1)(2013-1#1)
Emergence of a##2##3##(2008-10#1)(2013-1#1)
Emergence of##11##2##(2007-7#2)(2008-10#2)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Emergence##15##1##(2007-7#2)(2008-10#3)(2009-12#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
Emergency Department##10##2##(1991-12#1)(1997-2#1)(2008-11#1)(2008-3#4)(2012-12#1)(2013-8#2)
Emergency Hospital of##2##3##(2007-10#1)(2012-3#1)
Emergency Medical Services##2##3##(2007-9#1)(2010-3#1)
Emergency Medical##3##2##(2007-9#1)(2010-3#1)(2012-3#1)
Emergency Medicine##2##2##(2009-4#1)(2009-6#1)
Emergency Planning##2##2##(1991-1#1)(2009-3#1)
Emergency department##3##2##(2008-11#2)(2008-3#1)
Emergency laparotomy##2##2##(2008-12#2)
Emergency management of##2##3##(2010-8#1)(2012-2#1)
Emergency medicine##6##2##(2007-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2013-1#1)
Emergency operations and delayed operations for acute disease were encumbered with##2##11##(1997-8#2)
Emergency room##4##2##(1993-12#1)(1993-2#1)(2008-6#1)(2011-2#1)
Emergency##70##1##(1991-1#2)(1991-11#1)(1991-12#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-8#2)(2007-10#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#6)(2008-12#2)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
Emergent##2##1##(1996-8#1)(2008-10#1)
Emerging data##2##2##(2008-8#1)(2009-8#1)
Emerging evidence suggests that##2##4##(1994-9#1)(2011-2#1)
Emerging evidence suggests##3##3##(1994-9#1)(2007-11#1)(2011-2#1)
Emerging evidence##5##2##(1994-9#1)(2007-11#1)(2010-10#1)(2010-5#1)(2011-2#1)
Emerging roles##2##2##(2009-3#1)(2010-5#1)
Emerging technologies##3##2##(1996-3#1)(2008-6#1)(2013-8#1)
Emerging trends##2##2##(1991-1#1)(2007-9#1)
Emerging##33##1##(1991-1#1)(1991-3#1)(1992-3#1)(1994-1#1)(1994-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
Emerson-Trinder reaction##3##2##(2008-10#3)
Emery-Dreifuss muscular dystrophy##2##3##(2008-7#1)(2011-2#1)
Emery-Dreifuss##3##1##(2008-7#2)(2011-2#1)
Emile Roubaud##2##2##(2010-1#2)
Emile##4##1##(2010-1#4)
Emilia##3##1##(1992-2#1)(2008-10#1)(2012-7#1)
Emir##2##1##(2008-10#2)
Emission Tomography##2##2##(2008-2#1)(2012-12#1)
Emission characteristics of##2##3##(2008-2#2)
Emission from##2##2##(1993-11#1)(1996-9#1)
Emission intensities of nonalternant PAHs##2##5##(2008-10#2)
Emission intensities of##3##3##(2008-10#3)
Emission of##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
Emission##21##1##(1993-11#1)(1996-9#1)(2007-11#1)(2008-10#7)(2008-2#6)(2008-3#3)(2009-12#1)(2012-12#1)
Emissions##4##1##(2008-2#3)(2008-3#1)
Emitted##4##1##(2008-10#1)(2008-3#3)
Emory University##5##2##(1993-12#1)(1997-2#2)(2007-4#1)(2010-5#1)
Emotion regulation##2##2##(2011-2#2)
Emotion##5##1##(2008-11#1)(2011-2#3)(2012-12#1)
Emotion-oriented coping##2##2##(2010-5#2)
Emotional intelligence##2##2##(2013-1#2)
Emotional##20##1##(1992-2#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#2)(2008-9#1)(2010-12#2)(2013-1#5)(2013-8#1)
Emotions##5##1##(1992-3#1)(2008-1#1)(2008-6#1)(2012-12#1)(2013-1#1)
Empathy and##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
Empathy##4##1##(1993-12#1)(1997-3#1)(2008-11#1)(2013-1#1)
Emphasis is given to##2##4##(2008-10#2)
Emphasis is given##3##3##(2008-10#3)
Emphasis is made on##2##4##(1991-3#1)(2012-3#1)
Emphasis is placed on##4##4##(1992-12#1)(2008-4#1)(2009-12#1)(2010-3#1)
Emphasis is##9##2##(1991-3#1)(1992-12#1)(2008-10#3)(2008-4#1)(2009-12#1)(2010-3#1)(2012-3#1)
Emphasis on##5##2##(1993-3#1)(2008-1#1)(2009-8#1)(2012-12#1)(2012-3#1)
Emphasis##16##1##(1991-3#1)(1992-12#1)(1993-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-12#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
Emphysematous pyelonephritis##2##2##(2008-8#2)
Emphysematous##3##1##(2008-8#2)(2012-3#1)
Empididae)##2##1##(2007-12#2)
Empire in##2##2##(2008-10#1)(2009-10#1)
Empire##6##1##(1990-11#1)(2008-10#1)(2008-11#2)(2009-10#2)
Empirical Likelihood##2##2##(2010-2#1)(2013-1#1)
Empirical data##2##2##(2008-6#1)(2012-1#1)
Empirical research##2##2##(1991-1#1)(2008-11#1)
Empirical studies##2##2##(2008-9#2)
Empirical testing of##2##3##(2008-12#1)(2009-5#1)
Empirical##25##1##(1991-1#1)(1992-1#1)(1992-3#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
Employed##3##1##(2008-10#2)(2011-2#1)
Employee##9##1##(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1997-3#1)(2012-3#1)
Employees##6##1##(1993-2#2)(1995-12#1)(2010-5#1)(2011-2#2)
Employer Data Information Set##2##4##(1996-3#1)(1997-3#1)
Employer Data##4##2##(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
Employer##11##1##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(1997-5#2)
Employers Health Care##2##3##(1994-12#2)
Employers##5##1##(1994-12#2)(1994-2#1)(2008-11#1)(2012-3#1)
Employing a##2##2##(1994-2#1)(1996-12#1)
Employing an##2##2##(2008-10#1)(2008-2#1)
Employing the##6##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)
Employing##19##1##(1994-2#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
Employment and##4##2##(1990-2#1)(1995-12#1)(1997-5#1)(2009-10#1)
Employment in##2##2##(1994-3#2)
Employment of##4##2##(1991-1#2)(2008-10#1)(2011-2#1)
Employment##18##1##(1990-2#1)(1991-1#2)(1992-1#1)(1994-3#2)(1995-12#2)(1995-6#2)(1996-2#2)(1997-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2011-2#1)
Empowerment##3##1##(1994-12#1)(1995-1#1)(2008-10#1)
Empty##6##1##(1994-8#2)(1995-2#1)(2008-11#1)(2013-1#2)
Emulsion##3##1##(2008-10#2)(2008-5#1)
Emulsions##2##1##(2008-5#2)
En bloc##2##2##(2008-7#1)(2012-2#1)
En##6##1##(2007-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
En(a-)##3##1##(1993-12#3)
Enabling##6##1##(1996-5#1)(1997-2#1)(2008-11#1)(2009-12#1)(2010-12#2)
Enalapril##4##1##(2008-4#4)
Enamel##2##1##(2012-2#1)(2013-1#1)
Enantiomeric##2##1##(1995-2#1)(1995-6#1)
Enantiomerically pure##2##2##(1996-5#1)(2011-1#1)
Enantiomerically##4##1##(1996-5#2)(2009-11#1)(2011-1#1)
Enantioselective##14##1##(1994-3#1)(1996-5#2)(2008-10#7)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
Enantioseparation of##2##2##(2008-10#1)(2010-4#1)
Encapsulating peritoneal sclerosis (EPS) is##2##5##(2007-12#1)(2011-2#1)
Encapsulation of##2##2##(2008-10#1)(2008-5#1)
Encapsulation##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
Encephalomyelitis##2##1##(2008-7#1)(2013-7#1)
Encephalopathy##3##1##(1990-9#1)(2007-7#1)(2012-12#1)
Encoded##3##1##(2008-10#1)(2008-9#1)(2010-1#1)
Encoding an##2##2##(2008-10#1)(2008-6#1)
Encoding the##2##2##(1995-5#1)(2008-5#1)
Encoding##11##1##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-3#1)(2013-1#1)(2013-8#1)
Encouraged by##2##2##(1993-12#1)(2008-5#1)
Encouraging##6##1##(1994-12#1)(1995-3#1)(2006-5#1)(2008-10#1)(2012-12#1)(2012-3#1)
Encrypted optical storage with##2##4##(2008-3#2)
Encrypted optical##3##2##(2007-12#1)(2008-3#2)
Encyclopedia of##42##2##(2008-4#1)(2009-11#1)(2011-2#40)
End of the##2##3##(1995-8#1)(2008-11#1)
End of##5##2##(1993-3#1)(1995-8#1)(1996-12#1)(2008-11#1)(2012-12#1)
End points included##2##3##(2008-6#1)(2012-3#1)
End points##3##2##(1991-11#1)(2008-6#1)(2012-3#1)
End##19##1##(1991-11#1)(1992-12#1)(1993-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2010-11#1)(2012-12#1)(2012-3#3)
End-Ex##3##1##(2013-1#3)
End-Stage Renal Disease##2##3##(2007-7#1)(2009-3#1)
End-Stage##5##1##(2007-7#2)(2009-3#1)(2010-6#1)(2010-8#1)
End-of-Life##3##1##(2011-1#1)(2011-2#1)(2012-3#1)
End-stage Renal##2##2##(2007-7#1)(2008-1#1)
End-stage renal disease (ESRD)##2##4##(2007-12#1)(2007-7#1)
End-stage renal disease##3##3##(2007-12#1)(2007-7#2)
End-stage##6##1##(2007-12#1)(2007-7#3)(2008-1#1)(2013-8#1)
End-user##2##1##(1991-3#1)(1993-3#1)
Endangered##2##1##(1991-5#1)(2007-5#1)
Endcaps may be##2##3##(2008-4#2)
Endemic##4##1##(1991-12#1)(1996-3#1)(2011-2#1)(2012-2#1)
Ender nailing##3##2##(2007-11#2)(2007-8#1)
Ender technique##2##2##(2007-11#2)
Ender##8##1##(2007-11#5)(2007-8#3)
Ender's##3##1##(2012-2#3)
Endo F1##4##2##(1992-3#4)
Endo H##2##2##(1992-3#2)
Endo##6##1##(1992-3#6)
Endobronchial##6##1##(1990-12#1)(1992-8#1)(2008-7#1)(2010-8#2)(2013-1#1)
Endocarditis with##2##2##(2008-12#1)(2008-4#1)
Endocervical##2##1##(1992-2#1)(1994-9#1)
Endochitinase##2##1##(2008-10#2)
Endocrine Society##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
Endocrine cells##2##2##(2008-7#2)
Endocrine therapy##2##2##(1990-11#1)(1993-11#1)
Endocrine##19##1##(1990-11#2)(1991-2#1)(1993-11#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#3)
Endocrinol##6##1##(1992-12#1)(1995-12#1)(2008-4#4)
Endocrinologic##2##1##(1991-11#1)(2008-5#1)
Endocrinologists##2##1##(2008-1#1)(2011-2#1)
Endocrinology and##3##2##(1996-8#1)(2008-4#2)
Endocrinology of##2##2##(2008-4#1)(2008-7#1)
Endocrinology##18##1##(1995-8#1)(1996-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
Endocytosis##2##1##(2013-1#1)(2013-8#1)
Endodontic management of##2##3##(2013-1#2)
Endodontic##5##1##(2008-12#1)(2012-12#1)(2013-1#3)
Endogenous retroviruses##2##2##(2008-7#2)
Endogenous##26##1##(1991-8#1)(1992-11#1)(1993-6#1)(1994-2#2)(1995-12#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#2)(2009-12#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Endoglycosidase H##2##2##(1992-12#1)(2008-4#1)
Endoglycosidase##3##1##(1992-12#1)(2008-4#2)
Endoleaks##2##1##(2007-8#1)(2011-3#1)
Endoluminal##3##1##(1990-9#1)(2008-10#1)(2011-2#1)
Endometrial ablation vs laparoscopic hysterectomy##2##5##(1996-1#2)
Endometrial carcinomas with ambiguous features##2##5##(2011-2#2)
Endometrial carcinomas##3##2##(2011-2#3)
Endometrial hyperplasia##2##2##(2011-2#2)
Endometrial intraepithelial neoplasia##2##3##(2011-2#2)
Endometrial osseous metaplasia##2##3##(2011-1#2)
Endometrial##23##1##(1994-9#5)(1996-1#2)(1996-2#3)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#7)(2012-2#1)
Endometrioid carcinoma of the endometrium##2##5##(2011-2#2)
Endometriosis##3##1##(2008-8#1)(2009-8#1)(2013-1#1)
Endometrium##2##1##(1994-3#1)(2008-8#1)
Endonasal##2##1##(2006-12#1)(2012-3#1)
Endonuclease III interactions with DNA substrates##2##6##(1995-2#2)
Endonuclease III##3##2##(1995-2#3)
Endonuclease##4##1##(1995-2#3)(1997-3#1)
Endophyte##2##1##(2008-10#1)(2008-8#1)
Endophytic Fungus##2##2##(2008-10#2)
Endophytic##5##1##(2008-10#5)
Endoplasmic reticulum##2##2##(2009-8#1)(2012-2#1)
Endoplasmic##3##1##(2008-7#1)(2009-8#1)(2012-2#1)
Endopolygalacturonase##3##1##(2008-10#3)
Endoscopic Resection##2##2##(2010-12#1)(2013-8#1)
Endoscopic diagnosis of##2##3##(2007-10#1)(2008-5#1)
Endoscopic fenestration of##2##3##(2008-5#2)
Endoscopic resection of##2##3##(2007-10#1)(2008-5#1)
Endoscopic resection##4##2##(2007-10#1)(2008-5#1)(2009-12#1)(2010-12#1)
Endoscopic transnasal##4##2##(2008-8#1)(2011-2#3)
Endoscopic treatment of##5##3##(1993-2#1)(1993-6#1)(1994-9#1)(2008-6#1)(2008-7#1)
Endoscopic treatment##7##2##(1993-2#1)(1993-6#1)(1994-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
Endoscopic ultrasonography##3##2##(2008-2#1)(2008-5#1)(2009-5#1)
Endoscopic ultrasound##2##2##(2008-2#1)(2013-1#1)
Endoscopic ultrasound-guided##2##2##(2013-7#2)
Endoscopic##63##1##(1990-9#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-9#1)(1996-8#1)(2007-10#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-12#3)(2010-8#2)(2011-2#10)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
Endoscopic-assisted##2##1##(2012-12#2)
Endoscopy and##2##2##(1990-3#1)(2011-2#1)
Endoscopy showed##2##2##(2008-11#1)(2009-10#1)
Endoscopy##9##1##(1990-3#1)(1991-2#1)(1993-6#1)(1996-6#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-1#1)
Endospores##2##1##(2008-3#1)(2011-2#1)
Endothelial Cells##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
Endothelial Dysfunction##2##2##(2010-5#1)(2012-3#1)
Endothelial Progenitor##2##2##(2008-1#1)(2009-11#1)
Endothelial cells##5##2##(1992-9#1)(1994-6#1)(2008-11#1)(2010-11#2)
Endothelial dysfunction in##2##3##(2008-1#1)(2013-1#1)
Endothelial dysfunction##6##2##(2008-1#2)(2008-3#1)(2008-7#1)(2010-5#1)(2013-1#1)
Endothelial function was##2##3##(2007-8#1)(2009-5#1)
Endothelial function##3##2##(2007-8#2)(2009-5#1)
Endothelial progenitor cells##3##3##(2008-1#1)(2012-12#2)
Endothelial##29##1##(1992-9#1)(1994-6#1)(1995-12#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-5#1)(2010-11#2)(2010-5#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
Endothelin 1##2##2##(1993-3#1)(2008-4#1)
Endothelin##9##1##(1990-12#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(2008-10#2)(2008-4#1)(2013-1#1)
Endothelin-1 (ET-1) is a potent##2##5##(1993-3#2)
Endothelin-1 (ET-1)##4##2##(1993-3#2)(1994-11#1)(1995-11#1)
Endothelin-1 induces##3##2##(1991-5#1)(1993-3#2)
Endothelin-1 is##2##2##(1993-3#1)(2009-10#1)
Endothelin-1##13##1##(1990-8#1)(1991-5#1)(1992-3#2)(1993-3#6)(1994-11#1)(1995-11#1)(2009-10#1)
Endothelins##2##1##(1994-12#1)(2008-4#1)
Endothelium##3##1##(2008-3#1)(2009-10#1)(2009-6#1)
Endothermic##2##1##(2008-5#1)(2009-8#1)
Endotoxin is##2##2##(2008-4#1)(2008-5#1)
Endotoxin##6##1##(1994-11#1)(1994-7#1)(1997-8#1)(2006-10#1)(2008-4#1)(2008-5#1)
Endovascular Embolization##2##2##(2012-1#1)(2012-3#1)
Endovascular Treatment##2##2##(1997-6#1)(2008-1#1)
Endovascular approach to##2##3##(1997-6#1)(2010-12#1)
Endovascular embolization##2##2##(2008-7#2)
Endovascular stent graft repair of abdominal aortic##2##7##(2010-12#2)
Endovascular stent##3##2##(2008-11#1)(2010-12#2)
Endovascular treatment of##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
Endovascular treatment##5##2##(2006-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2011-3#1)
Endovascular##27##1##(1995-11#2)(1996-9#1)(1997-6#2)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#4)(2010-12#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-8#1)
Endpoint##2##1##(1990-8#1)(2008-8#1)
Endpoints##2##1##(2008-3#1)(2008-7#1)
Enduring Freedom##2##2##(2013-1#2)
Energies##4##1##(2007-11#1)(2008-2#1)(2012-12#2)
Energy Dispersive##2##2##(2008-11#1)(2008-12#1)
Energy Transfer##7##2##(2007-10#2)(2008-4#2)(2009-2#1)(2009-8#1)(2009-9#1)
Energy and##3##2##(1996-9#1)(2008-8#1)(2010-6#1)
Energy expenditure##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
Energy is##2##2##(1994-8#1)(2008-2#1)
Energy transfer##4##2##(2007-11#1)(2007-12#2)(2008-8#1)
Energy##67##1##(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#3)(2007-10#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Enforcement##3##1##(1991-12#1)(1994-1#1)(1996-3#1)
Eng##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Engagement in##2##2##(2011-1#1)(2011-2#1)
Engagement##5##1##(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Engaging##4##1##(2008-11#1)(2009-3#1)(2010-9#1)(2013-8#1)
Engine##2##1##(2008-2#1)(2012-2#1)
Engineered##7##1##(1994-5#1)(2008-10#3)(2008-11#1)(2013-1#1)(2013-8#1)
Engineering and laboratory notes##4##4##(2008-2#4)
Engineering of##2##2##(2008-3#1)(2009-11#1)
Engineering##28##1##(1992-11#1)(1995-3#1)(1996-12#2)(1997-7#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-11#2)(2011-2#1)(2012-3#2)(2013-8#1)
Engineers##23##1##(2007-12#1)(2011-2#22)
Engineers'##2##1##(2008-2#1)(2009-10#1)
Engl J Med##2##3##(1997-3#1)(2008-4#1)
Engl##4##1##(1997-3#1)(2008-11#1)(2008-4#1)(2010-5#1)
England and U##2##3##(2010-8#2)
England and Wales in##3##4##(1991-11#1)(2008-11#1)(2011-2#1)
England and Wales##18##3##(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1995-3#3)(1995-6#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#3)
England and##27##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-8#1)(1995-3#3)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-8#2)(2011-2#3)(2012-12#4)
England were##2##2##(2008-10#1)(2008-9#1)
England##69##1##(1990-6#3)(1990-9#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#7)(2008-11#11)(2008-12#3)(2008-3#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#2)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#4)(2013-8#2)
English Channel##2##2##(2011-1#1)(2011-2#1)
English National Board for Nursing##2##5##(2008-11#2)
English National Board##3##3##(2008-11#3)
English University##3##2##(2008-11#1)(2008-12#2)
English and Mandarin##2##3##(2008-9#2)
English and Spanish##5##3##(2008-12#2)(2008-2#2)(2012-12#1)
English and##12##2##(1996-9#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#1)(2008-9#2)(2012-1#1)(2012-12#1)
English as an additional language##5##5##(2008-2#5)
English as##6##2##(2008-2#5)(2010-1#1)
English dialects##2##2##(2013-8#2)
English language articles##2##3##(2009-5#1)(2013-1#1)
English language##10##2##(2007-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-3#1)(2013-1#2)
English literature##16##2##(2006-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
English to##3##2##(2006-10#1)(2008-5#1)(2011-2#1)
English version of the##2##4##(2008-10#1)(2009-11#1)
English##133##1##(1990-8#1)(1992-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#7)(2008-11#12)(2008-12#9)(2008-2#15)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#9)
English-language articles##2##2##(2010-12#1)(2012-3#1)
English-language literature##4##2##(2007-10#1)(2012-12#2)(2012-2#1)
English-language##8##1##(1993-1#1)(2007-10#1)(2008-8#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
English-speaking##2##1##(2012-12#1)(2013-8#1)
Engraftment was##2##2##(2011-2#1)(2012-12#1)
Engraftment##4##1##(2008-4#1)(2011-2#1)(2012-12#2)
Engrailed expression##3##2##(2007-12#3)
Engraulis##3##1##(2008-5#1)(2010-8#2)
Enhance##2##1##(2008-11#1)(2009-12#1)
Enhanced Resistance##2##2##(2008-10#2)
Enhanced backscattering##2##2##(2007-11#1)(2008-3#1)
Enhanced fluorescence##2##2##(2007-11#1)(2009-12#1)
Enhanced optical##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
Enhanced recovery##2##2##(2013-1#2)
Enhanced sensitivity##2##2##(1996-12#1)(2008-10#1)
Enhanced surveillance of##2##3##(2007-12#2)
Enhanced##98##1##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#6)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#8)(2008-6#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#4)
Enhancement by##2##2##(1996-5#1)(2008-10#1)
Enhancement factors##2##2##(2008-5#2)
Enhancement of cisplatin##2##3##(1993-9#1)(2008-4#1)
Enhancement of the##9##3##(1991-9#1)(1992-11#1)(1994-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-4#1)
Enhancement of this MoAb production was due to the improved survival of the cells and was##2##16##(2008-11#2)
Enhancement of##40##2##(1990-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-6#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)
Enhancement##49##1##(1990-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#2)
Enhances##8##1##(2008-10#3)(2008-6#1)(2009-12#1)(2012-2#1)(2013-1#2)
Enhancing factor##3##2##(1993-11#1)(1993-9#2)
Enhancing the##7##2##(1995-1#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-10#1)(2013-1#1)
Enhancing##27##1##(1993-11#1)(1993-12#2)(1993-9#2)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#2)(2010-10#2)(2012-12#1)(2012-2#2)(2013-1#1)
Enlightenment##4##1##(2008-12#3)(2009-10#1)
Enneking test##3##2##(2007-11#3)
Enneking##9##1##(2007-11#7)(2008-6#2)
Ennis##2##1##(2008-10#2)
Enough##3##1##(1994-2#1)(2008-10#1)(2008-5#1)
Enriched##5##1##(1992-8#2)(2008-10#2)(2009-11#1)
Enrichment of##2##2##(2008-10#1)(2008-9#1)
Enrichment##12##1##(2008-10#4)(2008-2#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
Enrolled Nurses##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
Enrolled##8##1##(1997-7#1)(2007-10#3)(2008-11#1)(2008-12#1)(2010-4#1)(2011-1#1)
Ensembles of##2##2##(1995-3#1)(2008-11#1)
Ensenada##2##1##(2008-3#1)(2008-5#1)
Enshi##2##1##(2012-3#2)
Ensuring that##2##2##(1997-1#1)(2008-11#1)
Ensuring##9##1##(1992-1#1)(1992-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#2)
Entamoeba histolytica (EhCaM)##2##3##(2009-7#2)
Entamoeba histolytica##9##2##(1991-7#1)(2007-12#1)(2009-10#2)(2009-7#2)(2009-8#2)(2012-3#1)
Entamoeba spp##2##2##(2013-1#2)
Entamoeba##12##1##(1991-7#1)(2007-12#1)(2009-10#2)(2009-7#2)(2009-8#2)(2010-12#1)(2012-3#1)(2013-1#2)
Entecavir##4##1##(2013-1#4)
Enteric fever##2##2##(2008-7#1)(2013-8#1)
Enteric##5##1##(1992-6#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
Entering the##3##2##(1992-2#1)(2007-12#1)(2011-2#1)
Enteritidis and the##2##3##(1997-3#1)(2011-2#1)
Enteritidis and##3##2##(1997-3#1)(2010-4#1)(2011-2#1)
Enteritidis was##2##2##(1997-3#1)(2010-4#1)
Enteritidis##10##1##(1997-3#5)(2010-4#4)(2011-2#1)
Enterobacter aerogenes##2##2##(2010-3#2)
Enterobacter cloacae##12##2##(1992-6#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#3)(2010-6#3)(2011-2#1)
Enterobacter##16##1##(1992-6#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-3#2)(2010-4#1)(2010-6#3)(2011-2#1)
Enterobacteriaceae##19##1##(1997-4#1)(1997-5#2)(2007-3#2)(2008-10#3)(2008-5#1)(2010-4#1)(2010-6#3)(2011-1#2)(2011-2#1)(2013-8#3)
Enterococcus faecalis##5##2##(1995-5#1)(2007-11#1)(2010-3#1)(2010-4#1)(2013-1#1)
Enterococcus faecium##6##2##(1995-2#2)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
Enterococcus hirae##3##2##(1997-3#3)
Enterococcus spp##4##2##(2008-12#1)(2010-8#1)(2011-2#2)
Enterococcus##27##1##(1993-12#1)(1995-2#2)(1995-5#1)(1997-3#3)(1997-4#3)(2007-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
Enterocolitis##2##1##(2012-2#2)
Enteropathogenic Escherichia coli (EPEC)##2##4##(1995-2#1)(2011-2#1)
Enterovirus 71##3##2##(2008-8#2)(2011-1#1)
Enterovirus detection##2##2##(2012-2#2)
Enterovirus##7##1##(2008-8#2)(2011-1#2)(2012-2#3)
Enteroviruses in stool specimens##2##4##(2012-2#2)
Enteroviruses in##3##2##(2012-2#3)
Enteroviruses##5##1##(2012-2#5)
Enterprise##2##1##(2007-10#1)(2008-7#1)
Enterprises##3##1##(1990-4#1)(1994-12#1)(2008-5#1)
Enthalpy changes##3##2##(1990-7#1)(1990-8#1)(2008-10#1)
Enthoven##3##1##(1993-12#3)
Entomology in##2##2##(2010-1#2)
Entomology##4##1##(2010-1#4)
Entomopathogenic##2##1##(2008-6#1)(2011-2#1)
Entostat powder##3##2##(2011-2#3)
Entostat##5##1##(2011-2#5)
Entostat-exposed##2##1##(2011-2#2)
Entrance##3##1##(1993-9#1)(1994-12#1)(2008-10#1)
Entrapment of##2##2##(2008-10#1)(2008-5#1)
Entrepreneurship##2##1##(2009-12#2)
Entrez system##3##2##(2008-4#3)
Entrez##5##1##(2008-4#5)
Entropy##4##1##(1996-9#1)(2009-8#1)(2009-9#1)(2010-12#1)
Entry to##3##2##(1996-5#1)(2008-8#1)(2013-7#1)
Entry##13##1##(1996-5#1)(2008-10#4)(2008-5#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-7#1)
Enucleation##3##1##(1992-10#1)(2008-5#1)(2011-2#1)
Enugu##8##1##(2010-8#3)(2011-2#1)(2013-1#4)
Enumeration of##7##2##(2008-7#1)(2008-9#4)(2011-2#1)(2012-2#1)
Enumeration##9##1##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-2#1)
Enuresis is##2##2##(2007-7#1)(2013-8#1)
Enuresis##5##1##(1994-8#1)(2007-7#3)(2013-8#1)
Environ##3##1##(2008-10#1)(2008-3#1)(2012-1#1)
Environment and##3##2##(2008-1#1)(2008-5#1)(2008-9#1)
Environment for##3##2##(1996-9#1)(2008-2#1)(2013-8#1)
Environment of##2##2##(1996-12#1)(2007-6#1)
Environment##21##1##(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-5#1)(2008-9#1)(2010-4#1)(2011-7#1)(2013-1#1)(2013-8#1)
Environmental Conditions on##3##3##(2008-10#3)
Environmental Conditions##4##2##(2008-10#4)
Environmental Factors Affecting##3##3##(2008-10#3)
Environmental Factors on##2##3##(2008-10#2)
Environmental Factors##9##2##(2008-10#6)(2008-11#1)(2011-2#1)(2012-12#1)
Environmental Health##10##2##(2008-1#7)(2008-9#2)(2012-1#1)
Environmental Protection Agency (EPA)##7##4##(1992-1#1)(2008-10#4)(2008-7#1)(2008-9#1)
Environmental Protection Agency for##2##4##(2008-10#1)(2008-9#1)
Environmental Protection Agency##13##3##(1992-1#1)(2008-10#6)(2008-7#1)(2008-9#3)(2010-5#1)(2013-1#1)
Environmental Protection##14##2##(1992-1#1)(1992-11#1)(2008-10#6)(2008-7#1)(2008-9#3)(2010-5#1)(2013-1#1)
Environmental Satellite##6##2##(2008-2#1)(2008-3#5)
Environmental Studies##2##2##(2008-10#2)
Environmental and##5##2##(1991-12#1)(2008-10#1)(2008-11#2)(2012-2#1)
Environmental conditions##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
Environmental education##2##2##(2007-5#2)
Environmental factors inducing human cancers##2##5##(2013-1#2)
Environmental factors##8##2##(1995-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#2)
Environmental health impact assessment##2##4##(2012-1#2)
Environmental health##3##2##(2008-1#1)(2012-1#2)
Environmental risk assessment of##2##4##(2008-10#1)(2008-9#1)
Environmental risk##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
Environmental sensitivity##2##2##(2008-10#2)
Environmental water samples were analyzed##2##5##(2008-10#2)
Environmental water##3##2##(2008-10#3)
Environmental##124##1##(1990-6#1)(1991-12#1)(1992-1#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-5#2)(2007-7#1)(2008-1#10)(2008-10#36)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#8)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#3)(2011-1#4)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#3)
Environmentally##2##1##(2008-5#1)(2010-2#1)
Environments##8##1##(2008-10#2)(2008-9#1)(2010-10#1)(2011-2#3)(2012-2#1)
Enzymatic activity was##2##3##(1991-5#1)(1993-12#1)
Enzymatic activity##3##2##(1991-5#1)(1993-12#1)(2008-11#1)
Enzymatic amplification of DNA by PCR##2##6##(2008-2#1)(2008-9#1)
Enzymatic amplification of##3##3##(2008-2#2)(2008-9#1)
Enzymatic amplification staining##2##3##(2008-9#2)
Enzymatic amplification##5##2##(2008-2#2)(2008-9#3)
Enzymatic and##5##2##(1992-11#1)(1996-9#1)(2008-10#1)(2008-4#1)(2010-12#1)
Enzymatic determination of##2##3##(2008-10#2)
Enzymatic determination##3##2##(2008-10#3)
Enzymatic determinations##2##2##(1990-11#1)(1993-2#1)
Enzymatic digestion of proteins##2##4##(2008-4#2)
Enzymatic digestion##3##2##(2008-10#1)(2008-4#2)
Enzymatic hydrolysis##3##2##(2008-10#2)(2013-1#1)
Enzymatic production of##2##3##(1995-3#1)(2008-5#1)
Enzymatic rotating biosensor for##2##4##(2008-10#2)
Enzymatic synthesis of##2##3##(1995-3#2)
Enzymatic##52##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1995-3#4)(1996-9#1)(2007-11#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
Enzymatically active##2##2##(1994-6#1)(1995-8#1)
Enzymatically##5##1##(1993-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2008-10#1)
Enzyme Engineering##2##2##(1992-11#1)(1995-3#1)
Enzyme Linked Immuno Sorbent Assay (ELISA)##2##6##(2008-12#1)(2013-8#1)
Enzyme activities were##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
Enzyme activities##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
Enzyme activity was##3##3##(1991-12#1)(1994-11#1)(2010-11#1)
Enzyme activity##6##2##(1991-12#1)(1991-5#1)(1993-8#1)(1994-11#1)(2008-5#1)(2010-11#1)
Enzyme electrode##2##2##(2008-10#2)
Enzyme immunoassay of##2##3##(1990-11#1)(2012-1#1)
Enzyme immunoassay##3##2##(1990-11#1)(1992-6#1)(2012-1#1)
Enzyme##46##1##(1990-11#1)(1990-2#2)(1990-5#4)(1991-10#1)(1991-12#1)(1991-5#2)(1992-11#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
Enzyme-Linked Immunosorbent##2##2##(2008-10#2)
Enzyme-linked immunosorbent assay##2##3##(1995-8#1)(1997-4#1)
Enzyme-linked immunosorbent##3##2##(1995-8#1)(1997-4#1)(2011-2#1)
Enzyme-linked##4##1##(1995-8#1)(1997-4#1)(2008-11#1)(2011-2#1)
Enzymes##6##1##(1995-3#1)(1996-2#1)(2008-10#2)(2008-3#1)(2010-3#1)
Eosin##2##1##(2008-10#1)(2008-5#1)
Eosinophil##3##1##(1992-6#1)(1996-12#1)(2012-3#1)
Eosinophilic gastroenteritis##2##2##(2013-8#2)
Eosinophilic##4##1##(2008-10#1)(2008-5#1)(2013-8#2)
Eotaxin##3##1##(1994-11#3)
Epac2##3##1##(2010-11#3)
Eph receptors##2##2##(2008-7#1)(2009-9#1)
Eph-ephrin##2##1##(2008-7#2)
EphB receptors##2##2##(2008-7#2)
Ephedra sinica##2##2##(2008-10#2)
Ephedra##3##1##(2007-2#1)(2008-10#2)
Ephraim##2##1##(1994-12#1)(2013-8#1)
Epi-rich cocoa##4##2##(2012-3#4)
Epicatechin##2##1##(2008-10#2)
Epicuticular##2##1##(2008-10#2)
Epidemic Development##2##2##(2008-10#2)
Epidemic##11##1##(1990-11#1)(1995-3#1)(2008-10#7)(2011-2#2)
Epidemics in##4##2##(2008-10#4)
Epidemics of##6##2##(2008-10#5)(2011-2#1)
Epidemics##16##1##(2007-12#1)(2008-10#14)(2011-2#1)
Epidemiologic data##2##2##(2008-7#1)(2011-2#1)
Epidemiologic evidence##2##2##(1992-9#1)(2008-3#1)
Epidemiologic monitoring is a##2##4##(1996-12#2)
Epidemiologic studies##3##2##(1993-2#1)(1997-2#1)(2011-2#1)
Epidemiologic##18##1##(1991-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-9#1)(1996-12#2)(1997-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-3#1)(2013-8#1)
Epidemiological and##3##2##(2007-12#1)(2010-1#1)(2013-7#1)
Epidemiological aspects of##3##3##(2012-2#2)(2013-8#1)
Epidemiological data##3##2##(1997-3#1)(2008-9#1)(2009-7#1)
Epidemiological evidence on the##2##4##(1990-8#1)(2008-11#1)
Epidemiological research##2##2##(1992-11#1)(2011-2#1)
Epidemiological studies and##2##3##(2010-8#1)(2013-8#1)
Epidemiological studies on##2##3##(2011-2#1)(2012-2#1)
Epidemiological studies##10##2##(1994-2#1)(1994-6#1)(1996-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
Epidemiological study##2##2##(1992-5#1)(2011-2#1)
Epidemiological surveillance of##2##3##(1995-2#1)(2008-10#1)
Epidemiological##49##1##(1990-8#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#2)
Epidemiology and quality##2##3##(2009-7#1)(2011-2#1)
Epidemiology and##9##2##(1994-11#1)(1994-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
Epidemiology in##2##2##(2008-10#1)(2008-11#1)
Epidemiology of##23##2##(1991-11#1)(1993-2#2)(1994-5#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Epidemiology##51##1##(1990-12#2)(1990-5#1)(1991-11#1)(1991-3#1)(1993-2#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-8#1)(2011-2#5)(2011-4#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
Epidermal Growth Factor##2##3##(1992-7#1)(2012-3#1)
Epidermal cells##2##2##(2007-12#1)(2008-10#1)
Epidermal growth factor (EGF) is##2##5##(1991-12#1)(2008-6#1)
Epidermal growth factor (EGF)##4##4##(1991-12#1)(1992-8#1)(2008-4#1)(2008-6#1)
Epidermal growth factor receptor##5##4##(1994-2#1)(1994-9#2)(1995-9#1)(2012-1#1)
Epidermal growth factor##14##3##(1991-12#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-9#1)(2008-4#1)(2008-6#2)(2012-1#1)
Epidermal hyperplasia##2##2##(2008-9#2)
Epidermal##24##1##(1991-12#1)(1991-7#1)(1992-7#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-9#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-6#2)(2008-9#3)(2012-1#1)(2012-3#1)
Epidermoid cyst##2##2##(2007-8#2)
Epidermoid##3##1##(2007-8#2)(2012-2#1)
Epidermolysis Bullosa##2##2##(2008-5#2)
Epidermolysis bullosa simplex##2##3##(1991-12#2)
Epidermolysis bullosa##4##2##(1991-11#1)(1991-12#2)(2008-10#1)
Epidermolysis##6##1##(1991-11#1)(1991-12#2)(2008-10#1)(2008-5#2)
Epidural pressure was##2##3##(1993-10#2)
Epidural pressure##4##2##(1993-10#4)
Epidural##10##1##(1991-1#1)(1993-10#4)(2007-2#1)(2007-8#1)(2008-8#1)(2012-1#1)(2012-3#1)
Epigenetic mechanisms##2##2##(2011-2#1)(2012-12#1)
Epigenetic##9##1##(2008-5#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-8#3)
Epigenetics in Development and Disease##3##5##(2008-7#3)
Epigenetics in##4##2##(2008-7#3)(2012-12#1)
Epigenetics##6##1##(2008-7#3)(2009-4#1)(2010-12#1)(2012-12#1)
Epilachna vigintioctopunctata##2##2##(2008-6#2)
Epilepsy and##2##2##(1993-3#1)(2009-8#1)
Epilepsy is a##2##3##(2008-11#1)(2008-2#1)
Epilepsy##7##1##(1993-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
Epinephelus coioides##4##2##(2008-12#2)(2010-5#2)
Epinephelus##5##1##(2008-12#2)(2009-5#1)(2010-5#2)
Epinephrine in digital blocks##2##4##(2007-5#2)
Epinephrine was##2##2##(2008-10#1)(2013-1#1)
Epinephrine##5##1##(2007-5#2)(2008-10#2)(2013-1#1)
Epipericardial fat necrosis##2##3##(2012-2#2)
Epiphytic##5##1##(2008-10#3)(2008-5#2)
Epirubicin##2##1##(1991-2#1)(2008-6#1)
Episode of Care Program##2##4##(1996-1#1)(1996-12#1)
Episode of Care##3##3##(1996-1#1)(1996-12#2)
Episode##5##1##(1996-1#1)(1996-12#2)(2007-2#1)(2008-6#1)
Episodic##6##1##(2008-11#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
Epistylis##4##1##(2008-9#4)
Epithelial Cells##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2013-7#1)
Epithelial and##2##2##(1990-11#1)(1991-5#1)
Epithelial cells##5##2##(1990-11#1)(1997-1#1)(2008-1#2)(2009-12#1)
Epithelial##22##1##(1990-11#2)(1991-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1997-1#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-6#1)(2009-12#2)(2009-9#1)(2010-7#2)(2011-2#1)(2013-1#1)(2013-7#1)
Epithelioid##2##1##(2007-10#1)(2013-7#1)
Epitheloid hemangioendothelioma##2##2##(2009-5#2)
Epitope analysis##2##2##(2008-11#2)
Epitope mapping of##2##3##(1995-3#1)(2008-11#1)
Epitope##7##1##(1993-1#1)(1995-3#1)(2008-11#3)(2008-7#1)(2012-2#1)
Epitopes##2##1##(2008-10#1)(2011-2#1)
Epo partially purified from the culture medium showed a neuroprotective effect similar to that of rat Epo produced by Chinese hamster ovary (CHO) cells##2##24##(2008-11#2)
Epo produced by##5##3##(2008-11#5)
Epo##21##1##(1991-12#1)(2008-11#20)
Epo-induced##2##1##(1991-12#2)
EpoR##2##1##(2008-11#1)(2008-8#1)
EpoR-gp130##2##1##(2008-11#2)
Epoetin alfa was##2##3##(2008-7#2)
Epoetin alfa##5##2##(2008-7#5)
Epoetin##6##1##(2008-7#6)
Eponemycin##4##1##(1991-12#4)
Epopeptide AB##4##2##(2008-11#4)
Epoxidation of##4##2##(1996-5#3)(2008-11#1)
Epoxidation##7##1##(1996-5#4)(2007-11#1)(2008-11#1)(2009-9#1)
Eprex##2##1##(2008-10#2)
Epristeride is##2##2##(2008-5#2)
Epristeride##3##1##(2008-5#3)
Eps15##2##1##(2009-7#1)(2012-2#1)
Eps8 (epidermal growth factor receptor pathway substrate 8##2##8##(2012-2#2)
Eps8##3##1##(2012-2#3)
Epstein Barr nuclear##2##3##(2007-2#1)(2008-11#1)
Epstein##3##1##(2007-2#2)(2008-11#1)
Epstein-Barr Virus##4##2##(1993-9#1)(2008-4#1)(2008-9#1)(2011-2#1)
Epstein-Barr virus (EBV) DNA polymerase##2##5##(1993-8#1)(1997-3#1)
Epstein-Barr virus (EBV) DNA##3##4##(1993-8#1)(1994-8#1)(1997-3#1)
Epstein-Barr virus (EBV) and##2##4##(1992-2#1)(2008-11#1)
Epstein-Barr virus (EBV) was##2##4##(1992-12#1)(2008-9#1)
Epstein-Barr virus (EBV)##16##3##(1992-12#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2010-6#1)(2011-2#1)
Epstein-Barr virus and##2##3##(1993-9#1)(1994-8#1)
Epstein-Barr virus infection in##2##4##(2007-12#1)(2011-2#1)
Epstein-Barr virus infection##4##3##(2007-12#1)(2008-4#1)(2011-2#2)
Epstein-Barr virus transformed##2##3##(1994-3#2)
Epstein-Barr virus##40##2##(1990-12#1)(1991-8#1)(1992-12#2)(1992-2#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#2)(1994-8#2)(1995-2#2)(1997-3#1)(2007-12#4)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-9#2)(2009-1#1)(2010-6#1)(2011-2#3)(2013-8#1)
Epstein-Barr##46##1##(1990-12#1)(1991-8#1)(1992-12#2)(1992-2#1)(1993-8#2)(1993-9#3)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#2)(1997-3#1)(2007-12#4)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#4)(2008-9#3)(2009-1#1)(2010-6#2)(2011-2#4)(2013-8#1)
Equal Employment Opportunity Commission##3##4##(1995-12#1)(1995-6#2)
Equal##7##1##(1995-12#1)(1995-6#2)(1996-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
Equally##7##1##(1991-5#1)(1997-7#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
Equation for##2##2##(2008-2#1)(2012-1#1)
Equation##9##1##(2008-10#1)(2008-2#3)(2008-3#1)(2009-2#1)(2010-3#1)(2012-1#1)(2012-2#1)
Equations are##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
Equations for##2##2##(2008-2#1)(2008-3#1)
Equations##12##1##(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2011-1#1)(2012-1#1)
Equilibrium studies of##2##3##(2008-10#2)
Equilibrium studies##4##2##(2008-10#4)
Equilibrium##15##1##(1990-7#2)(1990-8#1)(1996-2#1)(2008-10#9)(2008-9#1)(2013-8#1)
Equine##2##1##(2009-1#1)(2013-1#1)
Equipment design##2##2##(2008-11#2)
Equipment##10##1##(1992-3#1)(1993-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-6#1)(2012-3#1)
Equity##6##1##(1993-12#1)(1994-3#1)(1996-1#2)(1997-1#1)(2011-1#1)
Equivalence of##3##2##(1996-9#1)(2008-2#1)(2008-5#1)
Equivalent results##2##2##(2008-10#1)(2008-7#1)
Equivalent##7##1##(2008-10#3)(2008-3#1)(2008-7#1)(2010-8#1)(2012-12#1)
Equivalents##2##1##(1996-5#1)(2009-9#1)
Er ions##2##2##(2008-3#2)
Er##46##1##(1990-5#2)(1991-2#2)(1991-9#5)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#9)(2008-3#12)(2008-7#5)(2010-6#1)(2011-1#3)
Er(3+) -doped##3##2##(2007-11#1)(2007-12#2)
Er(3+)##16##1##(2007-11#3)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#3)
Er(3+)-doped fiber##2##2##(2008-2#1)(2008-3#1)
Er(3+)-doped##4##1##(2008-2#2)(2008-3#2)
Er-Al-codoped##2##1##(2007-12#2)
Er-Yb##7##1##(2007-11#4)(2007-12#1)(2008-3#2)
Er-doped fiber lasers##2##3##(2007-12#2)
Er-doped fiber##5##2##(2007-12#5)
Er-doped##10##1##(2007-12#8)(2008-3#2)
Er-fiber laser##2##2##(2007-11#2)
Er-fiber soliton##2##2##(2007-12#2)
Er-fiber##4##1##(2007-11#2)(2007-12#2)
Era##3##1##(2008-10#2)(2011-2#1)
Eradication of##5##2##(1996-8#1)(1997-1#1)(2008-10#1)(2010-3#1)(2012-2#1)
Eradication##11##1##(1993-12#3)(1996-8#1)(1997-1#1)(2008-10#3)(2010-12#1)(2010-3#1)(2012-2#1)
Eragrostis tef##2##2##(2008-5#2)
Erasmus##3##1##(1991-3#1)(1993-12#1)(2008-12#1)
ErbB2##3##1##(1995-6#2)(2009-2#1)
ErbBs and Ephs##2##3##(2009-9#2)
Erbium##3##1##(1991-2#2)(2007-11#1)
Erectile dysfunction##4##2##(2007-10#2)(2008-1#1)(2009-5#1)
Eremophilus mutisii##2##2##(2008-5#2)
Eremothecium##4##1##(2012-3#4)
Eretz Israel##4##2##(2011-2#4)
Ergonomic##2##1##(1996-9#1)(2008-6#1)
Ergonomics##2##1##(1994-3#2)
Eric##3##1##(2008-4#1)(2010-11#1)(2010-12#1)
Erie County##3##2##(1996-1#3)
Erik H##2##2##(2008-12#2)
Erik##5##1##(2008-10#3)(2008-12#2)
Erikson's##5##1##(2008-12#4)(2012-12#1)
Eriochrome Blue Black R##2##4##(2008-10#2)
Eriochrome black-T##2##2##(2008-10#2)
Eriochrome##6##1##(2008-10#6)
Erosion##4##1##(2008-12#1)(2010-4#1)(2010-5#1)(2012-12#1)
Erosive##2##1##(2013-1#2)
Errata##6##1##(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#1)(2013-8#2)
Erratum to##4##2##(2007-2#1)(2011-2#2)(2012-2#1)
Erratum##28##1##(1990-11#1)(2007-2#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#6)(2009-5#2)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-8#1)
Erroneous##5##1##(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2011-3#1)
Error analysis for##2##3##(2008-3#2)
Error analysis of##5##3##(2008-11#1)(2008-2#1)(2008-3#3)
Error analysis##8##2##(1992-5#1)(2008-11#1)(2008-2#1)(2008-3#5)
Error reduction through team leadership##3##5##(2008-6#3)
Error reduction##4##2##(2008-2#1)(2008-6#3)
Error##16##1##(1992-5#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#3)(2009-10#1)(2010-2#1)
Errors in##2##2##(1996-8#1)(2008-3#1)
Errors of##2##2##(2008-3#2)
Errors##10##1##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#6)(2009-9#1)
Erwinia amylovora and##6##3##(2008-10#5)(2008-8#1)
Erwinia amylovora on##3##3##(2008-10#3)
Erwinia amylovora##30##2##(2008-10#29)(2008-8#1)
Erwinia and##2##2##(2010-3#2)
Erwinia carotovora subsp##3##3##(1990-5#2)(2008-10#1)
Erwinia carotovora##6##2##(1990-5#2)(2008-10#2)(2010-11#2)
Erwinia chrysanthemi##2##2##(1991-9#2)
Erwinia herbicola##2##2##(1993-8#1)(2008-10#1)
Erwinia herbicola)##2##2##(2008-10#2)
Erwinia sp##2##2##(2008-10#2)
Erwinia spp##4##2##(2008-10#4)
Erwinia##58##1##(1990-5#2)(1991-9#2)(1993-8#1)(2008-10#48)(2008-8#1)(2010-11#2)(2010-3#2)
Ery+##4##1##(1990-5#4)
EryA##4##1##(1990-5#4)
Erysipelothrix rhusiopathiae##2##2##(2007-12#2)
Erysiphe graminis f##2##3##(2008-10#2)
Erysiphe graminis##3##2##(2008-10#3)
Erysiphe necator##4##2##(2008-10#4)
Erysiphe##10##1##(2008-10#10)
Erythema##3##1##(1996-3#1)(2008-5#1)(2011-2#1)
Erythrocyte##7##1##(1995-8#2)(1997-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
Erythrocytes##5##1##(2008-8#1)(2008-9#1)(2009-8#2)(2010-2#1)
Erythroid##3##1##(2008-10#2)(2008-8#1)
Erythromycin##2##1##(2008-10#1)(2009-6#1)
Erythropoietin##8##1##(1991-11#3)(2008-1#1)(2008-11#1)(2008-8#2)(2012-12#1)
Erythroxylum coca##2##2##(2008-10#2)
Erythroxylum##3##1##(2008-10#2)(2010-10#1)
Erytropoietin administration##2##2##(2008-7#2)
Escape from the##2##3##(1993-2#1)(1993-9#1)
Escape##4##1##(1993-2#1)(1993-9#1)(2008-10#2)
Escherichia Coli##2##2##(2008-11#1)(2013-8#1)
Escherichia coli (EHEC)##2##3##(2008-9#2)
Escherichia coli (EPEC)##4##3##(1992-2#1)(1995-2#1)(2011-2#2)
Escherichia coli (Ec)##2##3##(1995-8#2)
Escherichia coli 0119##2##3##(1992-12#2)
Escherichia coli DNA polymerase III##2##5##(1992-3#1)(1995-6#1)
Escherichia coli DNA##3##3##(1992-3#2)(1995-6#1)
Escherichia coli K-12##16##3##(1990-11#1)(1990-5#1)(1991-11#2)(1996-12#6)(1996-6#3)(2008-10#1)(2008-7#1)(2009-6#1)
Escherichia coli K12##6##3##(1990-5#1)(2008-7#2)(2008-9#1)(2013-1#2)
Escherichia coli O157##6##3##(1996-3#1)(1997-3#1)(2008-10#3)(2012-2#1)
Escherichia coli RNA polymerase##2##4##(1995-2#1)(1995-6#1)
Escherichia coli acetyl-CoA carboxylase##2##4##(1992-9#2)
Escherichia coli adenylosuccinate synthetase##2##4##(1995-6#2)
Escherichia coli and Saccharomyces cerevisiae##3##5##(1990-5#2)(2012-2#1)
Escherichia coli and Salmonella##4##4##(1994-8#2)(2007-12#1)(2011-1#1)
Escherichia coli and Staphylococcus aureus##2##5##(1997-3#1)(2008-5#1)
Escherichia coli and a##2##4##(2009-5#1)(2011-1#1)
Escherichia coli and##36##3##(1990-11#1)(1990-5#3)(1990-6#1)(1991-3#2)(1992-8#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-8#3)(1995-2#2)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-5#2)(2011-1#3)(2011-2#2)(2012-2#1)(2013-8#1)
Escherichia coli are##3##3##(1997-2#1)(2008-10#1)(2010-8#1)
Escherichia coli as##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
Escherichia coli beta-galactosidase##2##3##(1995-12#1)(2008-7#1)
Escherichia coli by##5##3##(1993-11#1)(1993-9#1)(1995-5#1)(2008-11#1)(2009-6#1)
Escherichia coli can##2##3##(2011-2#1)(2013-1#1)
Escherichia coli cells##5##3##(1990-11#1)(1992-3#1)(1993-8#1)(1995-8#1)(2013-1#1)
Escherichia coli containing##3##3##(1993-6#1)(1994-8#1)(2008-7#1)
Escherichia coli glutaminyl-tRNA synthetase##2##4##(1993-8#2)
Escherichia coli had##2##3##(1993-11#1)(2011-3#1)
Escherichia coli has been##2##4##(1994-5#1)(2008-8#1)
Escherichia coli heat-labile##2##3##(1995-2#2)
Escherichia coli hemolysin (HlyA)##2##4##(1994-2#2)
Escherichia coli host strain BL21 (DE3)##2##6##(1995-12#1)(2009-3#1)
Escherichia coli host##5##3##(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
Escherichia coli immobilized on sepiolite##2##5##(2008-10#2)
Escherichia coli in##6##3##(1993-11#1)(2007-12#1)(2007-7#2)(2009-5#1)(2010-4#1)
Escherichia coli is##9##3##(1990-8#2)(1991-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-2#1)(2011-1#1)
Escherichia coli isolates##2##3##(1991-8#1)(2008-12#1)
Escherichia coli lacZ##3##3##(1993-12#1)(1994-6#1)(1997-4#1)
Escherichia coli or##2##3##(1990-5#1)(2008-10#1)
Escherichia coli strain##6##3##(1993-8#1)(1994-12#1)(1995-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
Escherichia coli strains##6##3##(1993-9#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
Escherichia coli to##7##3##(1990-5#1)(1993-12#1)(1994-6#1)(1995-2#1)(1997-3#1)(2009-3#1)(2010-8#1)
Escherichia coli tryptophan##2##3##(2008-7#2)
Escherichia coli urinary##2##3##(1996-3#1)(2008-10#1)
Escherichia coli using the##4##4##(1992-8#1)(1993-8#1)(1997-4#2)
Escherichia coli using##5##3##(1991-3#1)(1992-8#1)(1993-8#1)(1997-4#2)
Escherichia coli vector##2##3##(1990-5#2)
Escherichia coli was isolated from##2##5##(1990-5#1)(2009-3#1)
Escherichia coli was isolated##3##4##(1990-5#1)(1995-8#1)(2009-3#1)
Escherichia coli was studied##2##4##(1991-5#1)(1994-11#1)
Escherichia coli was##14##3##(1990-5#2)(1991-5#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
Escherichia coli were##6##3##(1990-7#1)(1990-8#1)(1994-12#1)(1995-11#1)(1996-12#1)(2011-2#1)
Escherichia coli with a##3##4##(1991-9#1)(1994-6#1)(2008-7#1)
Escherichia coli with##5##3##(1990-11#2)(1991-9#1)(1994-6#1)(2008-7#1)
Escherichia coli##492##2##(1990-11#18)(1990-5#17)(1990-6#1)(1990-7#5)(1990-8#4)(1991-10#2)(1991-11#2)(1991-12#5)(1991-3#3)(1991-5#8)(1991-7#4)(1991-8#2)(1991-9#11)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#2)(1992-6#10)(1992-8#4)(1992-9#3)(1993-11#13)(1993-12#7)(1993-2#1)(1993-6#6)(1993-8#8)(1993-9#10)(1994-11#4)(1994-12#20)(1994-2#2)(1994-3#1)(1994-5#7)(1994-6#3)(1994-8#10)(1995-11#3)(1995-12#3)(1995-2#22)(1995-3#2)(1995-5#5)(1995-6#12)(1995-8#9)(1996-12#10)(1996-3#3)(1996-6#6)(1996-8#1)(1997-2#6)(1997-3#5)(1997-4#14)(1997-6#7)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#5)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#4)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#25)(2008-8#7)(2008-9#8)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#3)(2010-12#1)(2010-3#2)(2010-4#5)(2010-6#5)(2010-8#3)(2011-1#12)(2011-2#12)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#1)
Escherichia##500##1##(1990-11#18)(1990-5#17)(1990-6#1)(1990-7#5)(1990-8#4)(1991-10#2)(1991-11#2)(1991-12#5)(1991-3#3)(1991-5#8)(1991-7#4)(1991-8#2)(1991-9#11)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#2)(1992-6#10)(1992-8#4)(1992-9#3)(1993-11#13)(1993-12#7)(1993-2#1)(1993-6#6)(1993-8#8)(1993-9#11)(1994-11#4)(1994-12#20)(1994-2#2)(1994-3#1)(1994-5#7)(1994-6#3)(1994-8#10)(1995-11#3)(1995-12#3)(1995-2#22)(1995-3#2)(1995-5#5)(1995-6#12)(1995-8#9)(1996-12#10)(1996-3#3)(1996-6#6)(1996-8#1)(1997-2#7)(1997-3#5)(1997-4#14)(1997-6#7)(1997-7#2)(1997-8#3)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#5)(2008-1#1)(2008-10#29)(2008-11#7)(2008-12#4)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#25)(2008-8#7)(2008-9#8)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#3)(2010-12#1)(2010-3#2)(2010-4#5)(2010-6#5)(2010-8#3)(2011-1#12)(2011-2#12)(2011-3#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#2)
Escovopsis##2##1##(2012-2#2)
Esophageal cancer is##2##3##(2010-6#1)(2012-12#1)
Esophageal cancer##3##2##(2007-8#1)(2010-6#1)(2012-12#1)
Esophageal carcinoma##2##2##(2007-2#1)(2011-2#1)
Esophageal foreign bodies##2##3##(2007-8#2)
Esophageal perforations##2##2##(2010-12#1)(2013-1#1)
Esophageal##20##1##(1997-8#1)(2007-2#1)(2007-8#4)(2008-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#2)
Esophagomyotomy##3##1##(1992-6#3)
Esophagus##2##1##(2008-9#1)(2010-12#1)
EspC and Pet##4##3##(2011-1#4)
Especially for##2##2##(2008-7#1)(2012-2#1)
Especially in##2##2##(1990-11#1)(2008-1#1)
Especially the##3##2##(2010-8#1)(2011-3#1)(2012-2#1)
Especially##27##1##(1990-11#1)(1992-3#1)(1993-8#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
Essential Amino Acids##2##3##(2008-11#2)
Essential Hypertension in##2##3##(2008-3#1)(2011-2#1)
Essential Oil##6##2##(2007-1#1)(2010-5#1)(2012-2#1)(2013-1#3)
Essential Tremor##4##2##(2008-7#2)(2012-3#1)(2013-1#1)
Essential fatty acids##2##3##(1990-3#1)(1994-11#1)
Essential hypertension##2##2##(1992-1#1)(2008-9#1)
Essential in support of these practices is a diagnostic laboratory capable of testing for rodent and rabbit pathogens##2##18##(2008-4#2)
Essential oil##2##2##(2008-11#1)(2010-3#1)
Essential oils##2##2##(2008-10#1)(2010-3#1)
Essential role of##2##3##(1992-9#1)(2012-2#1)
Essential role##3##2##(1992-9#1)(1995-8#1)(2012-2#1)
Essential tremor (ET) is##2##4##(2008-7#2)
Essential##39##1##(1990-3#1)(1992-1#1)(1992-9#1)(1994-11#1)(1995-8#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#1)(2009-5#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)
Essentially similar##3##2##(1992-3#1)(1995-11#1)(2009-7#1)
Essentially##11##1##(1992-3#1)(1992-6#1)(1995-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
Essex County##3##2##(2008-10#3)
Essex##6##1##(2008-10#6)
Establish##3##1##(1997-2#1)(2011-2#1)(2013-1#1)
Established##13##1##(1990-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-5#1)(2009-4#1)
Establishes##2##1##(2008-10#1)(2012-2#1)
Establishing a##4##2##(1991-3#1)(1993-1#1)(1997-2#1)(2008-1#1)
Establishing the prevalence of##2##4##(2012-12#2)
Establishing the##8##2##(1994-11#1)(1995-2#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)
Establishing##22##1##(1991-3#1)(1992-1#1)(1993-1#1)(1994-11#1)(1995-1#1)(1995-2#2)(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-1#1)
Establishment and characterization of##2##4##(1991-2#1)(2008-11#1)
Establishment and##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
Establishment of a##2##3##(1991-6#1)(2008-5#1)
Establishment of human T cell clones exhibiting natural killer-like activity##2##10##(2008-11#2)
Establishment of##15##2##(1991-5#1)(1991-6#1)(1995-9#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-8#1)(2008-9#2)(2012-2#1)
Establishment##24##1##(1991-2#1)(1991-5#1)(1991-6#1)(1995-9#1)(2008-10#3)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2012-2#2)
Estadual##2##1##(2008-6#2)
Estate##2##1##(1993-3#1)(2008-10#1)
Ester##6##1##(1996-5#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)
Esters##3##1##(1996-5#1)(2009-11#1)(2009-8#1)
Esthesioneuroblastoma##2##1##(2011-1#2)
Esthetic##2##1##(2008-7#1)(2013-1#1)
Estimate of##2##2##(1991-6#1)(1997-5#1)
Estimate optimization parameters for incoherent backscatter heterodyne lidar##2##8##(2008-2#1)(2008-3#1)
Estimate the##2##2##(2008-10#1)(2009-10#1)
Estimate##6##1##(1991-6#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
Estimated##18##1##(1990-8#2)(1992-2#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Estimates are##2##2##(1994-2#1)(2008-3#1)
Estimates from##2##2##(1991-5#1)(2012-12#1)
Estimates in##2##2##(2009-9#1)(2010-11#1)
Estimates of CFU##2##3##(2008-10#2)
Estimates of the##8##3##(1992-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)
Estimates of##33##2##(1991-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-9#2)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-3#1)(2012-2#1)(2012-3#1)
Estimates##50##1##(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Estimating the cost of##3##4##(1993-1#1)(1995-1#1)(1995-12#1)
Estimating the frequency and rate of first 50 common types of invasive procedures in iran healthcare system##2##17##(2013-1#2)
Estimating the##12##2##(1993-1#1)(1995-1#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
Estimating##22##1##(1992-3#1)(1992-9#1)(1993-1#1)(1995-1#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
Estimation and##2##2##(2008-10#1)(2008-6#1)
Estimation in##2##2##(2008-3#1)(2012-3#1)
Estimation of rates of recombination and migration in populations of plant##2##11##(2008-10#2)
Estimation of rates of##3##4##(2008-10#2)(2008-11#1)
Estimation of the##10##3##(1996-8#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-2#1)(2010-8#1)
Estimation of##47##2##(1994-5#1)(1995-9#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#7)(2008-7#1)(2008-9#4)(2009-7#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#4)(2013-1#1)
Estimation##57##1##(1994-5#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#8)(2008-6#1)(2008-7#1)(2008-9#4)(2009-7#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-8#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)
Estonian##3##1##(2008-10#1)(2012-12#1)(2013-1#1)
Estradiol##3##1##(1991-3#1)(1994-3#1)(2008-4#1)
Estrogen Receptor##3##2##(1997-7#1)(2008-6#1)(2013-1#1)
Estrogen and##5##2##(1992-3#1)(1993-11#1)(1994-9#1)(1997-6#1)(2008-7#1)
Estrogen receptors##2##2##(1994-9#1)(2008-4#1)
Estrogen treatment##2##2##(1992-3#1)(1992-9#1)
Estrogen##25##1##(1992-3#4)(1992-6#1)(1992-9#2)(1993-11#2)(1994-8#1)(1994-9#2)(1995-9#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
Estrogenic##3##1##(1994-8#1)(2008-11#1)(2013-1#1)
Estrogens##4##1##(2008-4#1)(2009-10#1)(2010-6#1)(2012-2#1)
Estrous##2##1##(1993-11#1)(2008-12#1)
Estuaries##2##1##(1992-8#1)(2013-1#1)
Estuary##2##1##(2008-10#2)
Et##5##1##(1996-2#1)(1997-7#1)(2008-7#1)(2009-11#1)(2009-9#1)
EtOH administration##3##2##(2008-10#3)
EtOH and NO##2##3##(2008-8#2)
EtOH and##3##2##(2008-10#1)(2008-8#2)
EtOH exposure##5##2##(2008-10#3)(2008-8#2)
EtOH treatment##5##2##(2008-10#5)
EtOH##37##1##(1996-5#2)(2008-10#20)(2008-8#14)(2010-6#1)
EtX##3##1##(2008-10#3)
Etching##3##1##(1996-9#1)(2008-10#1)(2008-3#1)
Eternal##2##1##(2012-3#2)
Etest##4##1##(2008-7#3)(2011-2#1)
Eth##2##1##(2008-1#1)(2008-10#1)
Ethanol extract of##4##3##(2010-3#2)(2010-5#2)
Ethanol extract##5##2##(2008-10#1)(2010-3#2)(2010-5#2)
Ethanol extracts of##2##3##(2008-10#1)(2010-3#1)
Ethanol metabolism##2##2##(2008-8#1)(2009-8#1)
Ethanol production from##2##3##(2008-6#1)(2013-1#1)
Ethanol##33##1##(1990-12#1)(1990-8#1)(1992-7#1)(1994-3#1)(1994-6#1)(2008-10#8)(2008-6#3)(2008-8#2)(2009-7#1)(2009-8#4)(2010-3#3)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Ethanolic extract##2##2##(2008-5#1)(2012-2#1)
Ethanolic##5##1##(2008-10#2)(2008-5#1)(2011-1#1)(2012-2#1)
Ethephon##3##1##(2006-11#3)
Ethical Committee##2##2##(1991-3#2)
Ethical Committees##2##2##(1991-3#2)
Ethical and##3##2##(1991-12#1)(2008-12#1)(2008-9#1)
Ethical aspects of##2##3##(1996-12#1)(2010-11#1)
Ethical considerations##3##2##(1992-1#1)(1993-6#1)(1996-6#1)
Ethical decision making##2##3##(1992-3#1)(2008-1#1)
Ethical dilemmas are##2##3##(1995-5#1)(2010-4#1)
Ethical dilemmas in##2##3##(1995-3#1)(2008-12#1)
Ethical dilemmas##7##2##(1995-12#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-1#1)
Ethical issues in health care institutions##5##6##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)
Ethical issues in##10##3##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1997-1#1)(2008-11#1)(2008-7#1)(2012-2#1)
Ethical issues##12##2##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#1)
Ethical principles##2##2##(1996-2#1)(2012-3#1)
Ethical##43##1##(1991-12#2)(1991-3#4)(1992-1#2)(1992-2#3)(1992-3#3)(1993-2#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
Ethicists##2##1##(1994-1#1)(2012-2#1)
Ethics Committee##4##2##(2012-2#2)(2012-3#1)(2013-1#1)
Ethics and##5##2##(1991-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-12#1)
Ethics committee##2##2##(2007-7#1)(2009-4#1)
Ethics for medical group managers##2##5##(1994-1#2)
Ethics for##3##2##(1994-1#2)(2010-8#1)
Ethics in clinical research##2##4##(2012-2#2)
Ethics in##7##2##(1991-1#1)(1991-8#1)(1996-3#1)(2007-12#1)(2008-7#1)(2012-2#2)
Ethics of##2##2##(1992-5#1)(2013-1#1)
Ethics##30##1##(1991-1#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#2)(1993-1#1)(1993-3#1)(1994-1#2)(1994-12#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
Ethidium bromide##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
Ethiodol/ethanol mixture##2##2##(1997-8#2)
Ethiopia##31##1##(1994-3#2)(1995-9#2)(2008-10#10)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-2#5)(2012-12#2)(2012-3#1)
Ethmoidal##2##1##(2006-12#1)(2011-2#1)
Ethnic Groups##3##2##(2008-5#1)(2009-10#1)(2012-12#1)
Ethnic differences in the BMI-%BF##2##5##(2008-10#2)
Ethnic differences in##3##3##(2008-10#2)(2012-2#1)
Ethnic##13##1##(2008-10#2)(2008-5#2)(2009-10#1)(2009-7#1)(2010-10#2)(2010-8#2)(2012-12#2)(2012-2#1)
Ethnicity##2##1##(2008-1#1)(2012-12#1)
Ethyl##5##1##(1994-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
Ethylene##6##1##(1993-12#1)(1995-2#1)(2008-10#2)(2008-5#1)(2009-6#1)
Etienne Sergent##2##2##(2010-1#2)
Etilefrine##2##1##(2007-8#2)
Etiologic factors##3##2##(1991-8#1)(2006-10#1)(2013-1#1)
Etiologic##4##1##(1991-8#1)(2006-10#1)(2012-12#1)(2013-1#1)
Etiology and##3##2##(2007-12#1)(2008-10#2)
Etiology of##5##2##(2008-10#2)(2008-7#1)(2010-7#1)(2013-1#1)
Etiology##11##1##(1996-3#1)(2007-12#1)(2008-10#5)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#1)
Etoposide##3##1##(1997-7#1)(2007-10#1)(2008-10#1)
Etravirine##2##1##(2009-9#1)(2011-3#1)
Ets family##2##2##(1994-12#1)(2012-12#1)
Ets##5##1##(1994-12#1)(2008-11#1)(2012-12#3)
Etude##4##1##(2008-2#3)(2013-1#1)
Eu and Gd)##2##3##(2008-10#2)
Eu and##6##2##(2008-10#6)
Eu were##2##2##(2008-10#2)
Eu##24##1##(1997-7#1)(2008-10#21)(2008-11#1)(2010-4#1)
Eu(2+) ions##2##2##(2007-12#2)
Eu(2+)##5##1##(2007-12#5)
Eu(3+) -doped##2##2##(2007-12#2)
Eu(3+) and##3##2##(2008-10#3)
Eu(3+) ions##4##2##(2007-12#3)(2008-3#1)
Eu(3+) to Eu(2+)##3##3##(2007-12#3)
Eu(3+)##32##1##(2007-11#1)(2007-12#11)(2008-10#11)(2008-2#1)(2008-3#2)(2010-4#3)(2012-12#3)
Eu(III) and##3##2##(2008-10#3)
Eu(III) ions##2##2##(2008-10#2)
Eu(III)##16##1##(2008-10#16)
Eu(fod)(3)##4##1##(2008-10#4)
Eu3+##6##1##(1990-8#1)(2007-12#2)(2008-3#2)(2008-4#1)
Euborellia plebeja##2##2##(2008-6#2)
Eucalyptus camaldulensis##2##2##(2008-5#2)
Eucalyptus globulus and##2##3##(2008-10#1)(2008-5#1)
Eucalyptus globulus##6##2##(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#2)
Eucalyptus spp##3##2##(2008-10#2)(2011-2#1)
Eucalyptus##21##1##(2008-10#9)(2008-5#4)(2008-8#1)(2009-12#2)(2010-3#4)(2011-2#1)
Eucheuma serra agglutinin (ESA)##2##4##(2008-11#2)
Eucheuma serra##3##2##(2008-11#3)
Euclidean distance##5##2##(2008-10#1)(2008-3#1)(2010-7#1)(2013-8#2)
Euclidean distances##2##2##(2008-12#1)(2008-6#1)
Euclidean##13##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#3)(2010-7#1)(2011-2#2)(2013-8#2)
Eucoleus##2##1##(2011-1#2)
Eucommia ulmodies Oliv##2##3##(2008-10#2)
Eucommia##4##1##(2008-10#2)(2010-2#2)
Eudragit RSPO alone##2##3##(2012-2#2)
Eudragit##5##1##(2010-5#2)(2012-2#3)
Eugene##3##1##(1990-11#1)(2007-9#1)(2008-3#1)
Eugenia uniflora L##2##3##(2008-10#2)
Eugenia##6##1##(2008-10#2)(2008-5#1)(2010-2#2)(2010-8#1)
Eugenol inhibited##2##2##(2009-12#2)
Eugenol##4##1##(2009-12#4)
Euglena gracilis##2##2##(1996-2#2)
Euglossa##2##1##(2008-5#1)(2008-6#1)
Eukaryotic##6##1##(2008-1#1)(2008-4#2)(2009-2#2)(2012-3#1)
Eulaema##3##1##(2008-6#3)
Eulemur collaris##2##2##(2011-2#2)
Eulemur##3##1##(2009-8#1)(2011-2#2)
Euler##2##1##(2008-3#1)(2008-6#1)
Euler's method##2##2##(2008-6#2)
Euphorbia heterophylla##5##2##(2008-10#2)(2013-1#3)
Euphorbia macroclada##2##2##(2008-10#2)
Euphorbia##14##1##(2008-10#5)(2011-1#5)(2013-1#4)
Euphorbiaceae)##2##1##(2013-8#2)
Euplectes##3##1##(2008-8#2)(2013-1#1)
Euplectrus separatae##2##2##(2007-12#2)
Euplotes crassus##2##2##(1994-12#2)
Eur##10##1##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-3#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-6#1)
Eurasia##4##1##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
Eurasian group##4##2##(2010-8#4)
Eurasian##13##1##(2008-12#4)(2008-6#1)(2008-9#1)(2010-10#1)(2010-8#5)(2011-2#1)
Euro-FISH programme##2##2##(2009-8#2)
EuroQol##2##1##(2008-10#1)(2011-2#1)
EuroQol-VAS##2##1##(2011-2#2)
EuroSCORE##14##1##(2007-8#12)(2010-8#1)(2013-8#1)
Europe and North America##10##4##(2008-10#3)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
Europe and North##11##3##(2008-10#3)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)
Europe and elsewhere##2##3##(2008-10#1)(2013-8#1)
Europe and the United States##2##5##(2008-1#1)(2008-8#1)
Europe and the##8##3##(2008-1#2)(2008-10#1)(2008-12#1)(2008-8#2)(2010-11#1)(2011-2#1)
Europe and##37##2##(1991-11#1)(1991-12#1)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
Europe in the##2##3##(2008-10#1)(2012-2#1)
Europe in##4##2##(1995-3#1)(2007-7#1)(2008-10#1)(2012-2#1)
Europe is##5##2##(1994-12#1)(1996-7#1)(1996-8#1)(2009-4#1)(2012-12#1)
Europe or##3##2##(1997-6#1)(2008-10#2)
Europe the##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
Europe was##2##2##(2009-2#1)(2010-1#1)
Europe were##7##2##(2007-2#1)(2008-10#4)(2008-8#1)(2011-2#1)
Europe with##2##2##(2008-5#1)(2010-8#1)
Europe##245##1##(1991-11#5)(1991-12#3)(1991-3#1)(1991-4#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#7)(1996-12#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#4)(2006-10#1)(2007-2#6)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#65)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#9)(2008-8#13)(2008-9#2)(2009-11#3)(2009-2#2)(2009-4#7)(2009-5#1)(2009-7#1)(2010-1#4)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#24)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#4)(2012-5#1)(2012-9#1)(2013-1#3)(2013-8#6)
Europe)##4##1##(1995-3#1)(2008-11#1)(2008-12#1)(2009-5#1)
European American##10##2##(2008-12#1)(2008-9#1)(2009-11#3)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-3#1)
European Centre for##3##3##(2008-10#1)(2010-4#2)
European Commission##8##2##(1996-1#1)(2008-10#6)(2012-2#1)
European Community##6##2##(1992-6#1)(1993-2#1)(1994-5#1)(2008-10#3)
European Conference on##2##3##(2008-5#1)(2008-7#1)
European Conference##4##2##(2008-5#1)(2008-7#3)
European Congress##2##2##(2008-5#1)(2010-5#1)
European Cosmetic##2##2##(2008-5#2)
European Journal of##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
European Medicines Agency##5##3##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
European Organisation for Research and Treatment of Cancer (EORTC)##2##9##(2008-1#1)(2010-11#1)
European Organization for Research and Treatment of Cancer##2##8##(1994-3#1)(2008-7#1)
European Organization for Research and Treatment of##3##7##(1994-3#1)(2008-7#1)(2011-2#1)
European Osteosarcoma Intergroup (EOI)##3##4##(2010-3#3)
European Panel on the Appropriateness of Crohn's##2##7##(2010-12#2)
European Stroke##3##2##(2008-8#3)
European Union (EU)##3##3##(1996-1#1)(2011-2#1)(2013-8#1)
European Union##22##2##(1996-1#1)(1996-3#1)(1997-6#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
European VCG 0094##2##3##(2008-10#2)
European and American##2##3##(1996-9#1)(2012-3#1)
European and East Asian##2##4##(2008-12#1)(2011-2#1)
European and##11##2##(1996-9#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2011-2#1)(2012-3#1)
European avian-like##2##2##(2011-2#2)
European children##2##2##(2008-1#2)
European corn borer##7##3##(1995-6#1)(2008-10#2)(2008-7#2)(2011-2#2)
European countries and Australia##2##4##(1993-2#1)(2008-10#1)
European countries and##3##3##(1993-2#1)(2008-10#1)(2008-2#1)
European countries##31##2##(1991-3#1)(1991-4#1)(1992-11#1)(1993-2#1)(1993-3#1)(1996-2#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
European descent##2##2##(2008-12#1)(2012-2#1)
European expert panel##3##3##(2010-12#3)
European flint maize##2##3##(2008-10#2)
European hazelnut##3##2##(2008-10#3)
European health##3##2##(1991-11#1)(1995-3#1)(2008-7#1)
European isolates##4##2##(2008-10#3)(2008-8#1)
European laboratories##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
European legislation##4##2##(2008-10#3)(2008-7#1)
European medicine##2##2##(2009-7#1)(2010-3#1)
European oak bark beetle (Scolytus intricatus) extracts##2##7##(2008-10#2)
European oak species##3##3##(2012-5#1)(2012-7#1)(2012-9#1)
European oak##5##2##(2008-10#2)(2012-5#1)(2012-7#1)(2012-9#1)
European oaks to##2##3##(2012-7#1)(2012-9#1)
European oaks##3##2##(2012-7#2)(2012-9#1)
European or##3##2##(1991-12#1)(2008-10#2)
European pear##3##2##(2008-10#3)
European population##2##2##(1997-6#1)(2008-10#1)
European populations##3##2##(1991-12#2)(2008-10#1)
European requirements##2##2##(2008-11#1)(2013-1#1)
European samples##2##2##(2008-10#1)(2010-4#1)
European species##3##2##(2008-12#1)(2008-8#2)
European starlings Sturnus vulgaris to##2##5##(2008-8#1)(2008-9#1)
European study##2##2##(2008-7#1)(2009-4#1)
European treatment protocols##2##3##(2011-2#2)
European women##2##2##(1991-11#1)(2008-1#1)
European##388##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-4#3)(1992-1#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-12#4)(1994-3#2)(1994-5#2)(1994-9#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#2)(2007-10#1)(2007-2#8)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#92)(2008-11#9)(2008-12#12)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#28)(2008-8#16)(2008-9#5)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-3#6)(2010-4#6)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#29)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#8)(2012-5#1)(2012-7#3)(2012-9#2)(2013-1#15)(2013-8#5)
European-American##2##1##(2009-11#1)(2009-7#1)
Europeans##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
Eurygaster##3##1##(2013-8#3)
Euscelidius variegatus##2##2##(2008-10#2)
Euseius victoriensis##2##2##(2011-2#2)
Euthanasia and##2##2##(1996-2#1)(1996-6#1)
Euthanasia##6##1##(1991-11#1)(1996-2#1)(1996-6#1)(2008-4#2)(2012-12#1)
Eutypa dieback##7##2##(2008-10#7)
Eutypa lata and Eutypella vitis##3##5##(2008-10#3)
Eutypa lata and##4##3##(2008-10#4)
Eutypa lata##7##2##(2008-10#7)
Eutypa##22##1##(2008-10#22)
Eutypella vitis##5##2##(2008-10#5)
Euzophera##2##1##(2008-10#2)
Evacuation of##2##2##(2008-7#2)
Evacuation##3##1##(2008-7#2)(2013-1#1)
Evaheart##2##1##(2010-8#2)
Evaluate the##2##2##(2012-3#1)(2013-8#1)
Evaluate##7##1##(2008-11#1)(2011-2#4)(2012-3#1)(2013-8#1)
Evaluating a##2##2##(2008-11#1)(2013-1#1)
Evaluating changes in##2##3##(2007-8#1)(2011-2#1)
Evaluating the impact of##2##4##(2007-7#1)(2008-12#1)
Evaluating the##27##2##(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-8#1)(2011-2#3)(2012-2#3)
Evaluating##63##1##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
Evaluation and Management of##3##4##(2008-4#1)(2010-9#1)(2011-2#1)
Evaluation and Review##2##3##(1995-12#2)
Evaluation and##15##2##(1990-9#1)(1995-12#2)(1996-6#1)(2007-12#2)(2008-10#2)(2008-4#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#2)(2013-1#1)
Evaluation in##4##2##(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
Evaluation of DNA##2##3##(1995-4#1)(1997-4#1)
Evaluation of Maize##2##3##(2008-10#2)
Evaluation of PCR##2##3##(2007-2#1)(2011-1#1)
Evaluation of Pain and Accuracy Diagnostic in Hospitalized Children##2##9##(2013-1#2)
Evaluation of Tomato##2##3##(2008-10#2)
Evaluation of a new##3##4##(2007-7#1)(2008-10#1)(2008-12#1)
Evaluation of a##27##3##(1992-5#1)(1993-2#1)(1996-1#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Evaluation of acute##2##3##(2013-1#2)
Evaluation of an on-line##2##4##(1997-2#1)(2008-10#1)
Evaluation of an##10##3##(1997-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
Evaluation of chemical##2##3##(2011-2#1)(2013-1#1)
Evaluation of different##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
Evaluation of energy##2##3##(2008-2#2)
Evaluation of in vitro##2##4##(2007-7#1)(2008-5#1)
Evaluation of measurement uncertainty in##2##5##(2008-10#2)
Evaluation of the Contribution of CAS in Combination with the Subcranial/Subfrontal Approach in Anterior Skull Base Surgery&quot##2##17##(2006-12#2)
Evaluation of the Contribution of CAS in Combination with the Subcranial/Subfrontal Approach in Anterior Skull Base##3##16##(2006-12#3)
Evaluation of the data##2##4##(2008-10#1)(2012-3#1)
Evaluation of the grant program for rural health care transition##2##10##(1992-12#1)(1996-2#1)
Evaluation of the##56##3##(1990-12#1)(1991-1#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Evaluation of two commercial##2##4##(2008-10#2)
Evaluation of two##4##3##(2008-10#3)(2013-7#1)
Evaluation of urinary##2##3##(2007-10#1)(2008-10#1)
Evaluation of##297##2##(1990-12#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(2006-12#3)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#77)(2008-11#13)(2008-12#9)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#6)(2010-8#2)(2011-1#9)(2011-2#5)(2012-1#3)(2012-12#9)(2012-2#6)(2012-3#11)(2013-1#17)(2013-7#5)(2013-8#7)
Evaluation was##2##2##(2007-11#1)(2007-8#1)
Evaluation##350##1##(1990-12#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(2006-12#3)(2006-7#1)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-10#82)(2008-11#15)(2008-12#9)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#6)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#8)(2011-9#1)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#11)(2013-1#19)(2013-7#5)(2013-8#8)
Evaluations of##2##2##(2008-11#1)(2008-12#1)
Evaluations were##2##2##(2010-4#1)(2012-2#1)
Evaluations##10##1##(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
Evans blue dye##2##3##(1992-3#1)(1994-12#1)
Evans blue##7##2##(1992-3#1)(1994-12#1)(2008-7#1)(2009-6#1)(2012-2#3)
Evans syndrome##2##2##(2010-5#2)
Evans##16##1##(1990-7#1)(1992-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-5#2)(2012-2#4)
Evaporation of##3##2##(1995-3#1)(2008-5#2)
Evaporation rates##2##2##(2008-5#2)
Evaporation##10##1##(1995-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)
Eve##2##1##(1991-6#1)(2008-8#1)
Evechinus chloroticus##2##2##(2008-8#2)
Even after being##2##3##(2007-10#1)(2008-10#1)
Even after two##2##3##(1994-2#1)(2010-12#1)
Even after##9##2##(1990-7#1)(1994-2#2)(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)
Even at the##2##3##(1992-11#1)(2007-11#1)
Even at##6##2##(1992-11#1)(1993-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2012-3#1)
Even before the##2##3##(2008-1#1)(2011-2#1)
Even during##2##2##(1993-6#1)(2008-3#1)
Even fewer##2##2##(1996-2#1)(2011-2#1)
Even for##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
Even if the##3##3##(1991-12#1)(1997-6#1)(2012-1#1)
Even if##9##2##(1991-12#1)(1991-2#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-6#1)(2008-8#1)(2009-7#1)(2012-1#1)
Even in the absence of##4##5##(1991-12#1)(1992-6#1)(1993-5#1)(2009-5#1)
Even in the presence of##2##5##(2008-10#1)(2008-3#1)
Even in the##9##3##(1991-12#1)(1992-6#1)(1993-11#1)(1993-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)
Even in##13##2##(1991-12#1)(1992-6#1)(1993-11#1)(1993-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-3#1)
Even minor##2##2##(1994-9#1)(2008-7#1)
Even more##6##2##(1991-6#1)(1997-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-1#1)
Even now##2##2##(2008-10#2)
Even so##7##2##(1992-3#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)
Even the##3##2##(1995-12#1)(1997-3#1)(2013-8#1)
Even this is##2##3##(1990-6#1)(2009-7#1)
Even though a##2##3##(1994-3#1)(2013-1#1)
Even though all##2##3##(1997-8#1)(2008-10#1)
Even though many##2##3##(1992-9#1)(1995-1#1)
Even though the##11##3##(1991-6#1)(1992-5#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-5#1)(2012-12#1)(2013-1#1)
Even though##44##2##(1990-3#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-5#2)(2009-8#1)(2009-9#1)(2012-12#1)(2012-2#2)(2013-1#2)
Even when a##4##3##(1996-9#1)(1997-3#1)(2010-8#1)(2012-12#1)
Even when the##2##3##(2008-3#2)
Even when##14##2##(1991-6#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-12#1)
Even with these##2##3##(1992-3#1)(1997-5#1)
Even with##12##2##(1992-3#1)(1994-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
Even##165##1##(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-6#3)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-2#4)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#3)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
Even-type##2##1##(2008-3#2)
Event##9##1##(2008-1#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Event-related potentials (ERPs)##2##3##(2008-11#1)(2008-8#1)
Event-related potentials##4##2##(2008-11#1)(2008-8#3)
Events and##3##2##(1996-6#1)(2008-10#1)(2013-1#1)
Events##18##1##(1991-2#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#1)(2013-1#2)
Eventually##8##1##(1992-10#1)(1993-6#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
Ever since##3##2##(2009-3#1)(2011-1#1)(2011-2#1)
Ever##5##1##(1990-12#1)(2009-3#1)(2011-1#2)(2011-2#1)
Everest##2##1##(2007-2#1)(2010-6#1)
Everett Koop##2##2##(1993-3#1)(1996-5#1)
Evergreen##2##1##(1995-1#1)(2008-10#1)
Evernia prunastri##2##2##(2008-10#1)(2008-5#1)
Evers##2##1##(2008-11#1)(2013-7#1)
Every 2##2##2##(1993-1#1)(1996-12#1)
Every batch of samples was composed by three real samples and three standard solutions##2##14##(2008-10#2)
Every patient##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
Every year##6##2##(1991-2#1)(1992-6#1)(2008-10#1)(2010-11#1)(2010-7#1)(2012-12#1)
Every##40##1##(1990-11#1)(1990-9#1)(1991-2#1)(1992-6#1)(1993-1#1)(1994-12#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
Everyday##8##1##(2007-12#2)(2008-12#1)(2010-3#2)(2010-4#1)(2012-3#1)(2013-8#1)
Everyone##2##1##(1993-2#1)(1995-2#1)
Evidence based##3##2##(1996-12#1)(2008-7#1)(2009-7#1)
Evidence exists demonstrating##2##3##(2008-12#1)(2008-4#1)
Evidence exists for##2##3##(1996-5#1)(2008-5#1)
Evidence exists##5##2##(1996-5#1)(1997-8#1)(2008-12#1)(2008-4#1)(2008-5#1)
Evidence for a##11##3##(1990-5#1)(1990-8#1)(1991-5#1)(1992-3#2)(1993-3#1)(1994-5#1)(1995-6#1)(2008-10#2)(2012-12#1)
Evidence for an##3##3##(1990-3#1)(1990-7#1)(1994-6#1)
Evidence for high##2##3##(1991-1#1)(2008-7#1)
Evidence for rapid##2##3##(1994-12#1)(1994-2#1)
Evidence for specific##2##3##(1993-5#1)(1993-6#1)
Evidence for the involvement of##5##5##(1990-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(2008-1#1)
Evidence for the presence##2##4##(1992-12#1)(2008-5#1)
Evidence for the##19##3##(1990-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-11#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-5#2)
Evidence for##81##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-8#4)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-5#3)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-2#1)(2012-1#2)(2012-12#2)(2012-2#1)
Evidence from a##3##3##(2007-12#1)(2009-6#1)(2013-8#1)
Evidence from the##5##3##(1991-12#1)(1991-8#1)(2009-3#1)(2013-1#2)
Evidence from##25##2##(1990-7#1)(1991-12#1)(1991-8#1)(1993-11#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Evidence has##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
Evidence indicates that##2##3##(1994-5#1)(2008-11#1)
Evidence is also presented that##2##5##(1993-6#1)(1995-6#1)
Evidence is also presented##3##4##(1993-6#1)(1995-6#1)(2008-10#1)
Evidence is also provided##2##4##(2008-10#1)(2008-7#1)
Evidence is also##6##3##(1993-6#1)(1995-6#1)(2008-10#2)(2008-7#1)(2010-5#1)
Evidence is presented in support of the hypothesis that##2##9##(1995-2#1)(2009-2#1)
Evidence is presented in##3##4##(1995-11#1)(1995-2#1)(2009-2#1)
Evidence is presented that##2##4##(1990-2#1)(2008-4#1)
Evidence is presented to##2##4##(1990-12#1)(1996-5#1)
Evidence is presented##9##3##(1990-12#1)(1990-2#1)(1992-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-4#1)(2009-2#1)
Evidence is provided in this study##2##6##(2008-10#2)
Evidence is provided that##2##4##(2010-8#1)(2012-2#1)
Evidence is provided##6##3##(1994-3#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-2#1)
Evidence is##28##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-5#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
Evidence of a##2##3##(2008-10#1)(2008-4#1)
Evidence of the##3##3##(1995-9#1)(1996-2#1)(2008-10#1)
Evidence of##47##2##(1990-5#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-3#1)(2012-12#3)(2012-2#2)
Evidence shows that##2##3##(1991-9#1)(1993-2#1)
Evidence suggests that the##4##4##(2007-12#1)(2009-6#1)(2011-2#1)(2013-7#1)
Evidence suggests that##12##3##(2007-12#2)(2008-11#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Evidence suggests##15##2##(2007-12#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
Evidence supporting##2##2##(2011-2#1)(2013-1#1)
Evidence that the##5##3##(1990-5#1)(1992-9#1)(1994-5#1)(1997-2#1)(1997-7#1)
Evidence that##18##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#1)
Evidence was##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
Evidence##259##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#5)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#3)(1993-2#1)(1993-3#3)(1993-5#3)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#6)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#35)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#2)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
Evidence-Based##5##1##(2006-10#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
Evidence-based answer and summary##4##4##(2008-11#3)(2009-5#1)
Evidence-based approach##2##2##(2008-10#1)(2009-3#1)
Evidence-based medicine and##2##3##(1996-6#1)(2008-11#1)
Evidence-based medicine##4##2##(1996-12#1)(1996-6#1)(2008-11#1)(2010-9#1)
Evidence-based practice##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
Evidence-based##21##1##(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2009-3#2)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Evo-Devo##2##1##(2009-2#2)
Evoked##3##1##(1990-9#1)(1996-5#1)(2011-2#1)
Evolution and##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)
Evolution in the##2##3##(2008-9#1)(2012-2#1)
Evolution in##6##2##(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Evolution of a##3##3##(1997-2#1)(2008-7#1)(2008-9#1)
Evolution of the arthropod neuromuscular system##2##6##(2007-12#2)
Evolution of the arthropod##3##4##(2007-12#3)
Evolution of the##12##3##(1992-8#1)(1994-8#1)(1995-1#1)(2007-12#4)(2008-10#1)(2008-2#2)(2009-10#1)(2013-8#1)
Evolution of##40##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-6#1)(2007-12#5)(2008-1#1)(2008-10#6)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Evolution##61##1##(1990-3#2)(1991-1#1)(1991-5#1)(1992-11#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-6#2)(2007-12#5)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-2#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
Evolutionary Biology##2##2##(2013-1#2)
Evolutionary Relationships##2##2##(2008-10#1)(2011-2#1)
Evolutionary conservation and##2##3##(1994-11#1)(2008-9#1)
Evolutionary conservation##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
Evolutionary dynamics of##2##3##(2008-8#2)
Evolutionary##33##1##(1990-11#1)(1994-11#1)(1995-11#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-7#1)(2008-8#7)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
Evolved##5##1##(2008-10#2)(2008-8#1)(2009-12#1)(2012-3#1)
Evolving##9##1##(1991-12#1)(1996-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-7#1)(2013-8#1)
Ewald##4##1##(1992-6#2)(2007-11#1)(2012-2#1)
Ewan Birney##2##2##(2008-7#2)
Ewing sarcoma##2##2##(2008-6#1)(2010-3#1)
Ewing##4##1##(1993-6#1)(2008-6#2)(2010-3#1)
Ewing's Sarcoma of the##2##4##(2008-6#1)(2011-2#1)
Ewing's Sarcoma of##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
Ewing's Sarcoma##5##2##(2008-6#2)(2011-2#1)(2012-12#1)(2012-3#1)
Ewing's sarcoma in the##2##4##(2008-6#1)(2011-2#1)
Ewing's sarcoma in##4##3##(2008-6#3)(2011-2#1)
Ewing's sarcoma of##2##3##(2009-5#1)(2011-2#1)
Ewing's sarcoma##12##2##(2008-6#7)(2009-5#1)(2010-3#1)(2011-2#3)
Ewing's##21##1##(2008-6#11)(2009-5#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
Ex vivo##5##2##(2008-11#1)(2008-4#1)(2008-5#1)(2011-3#1)(2013-1#1)
Ex##6##1##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-3#1)(2013-1#1)
Ex-IDU##4##1##(2012-1#4)
Ex1a IRES##2##2##(2008-9#2)
Ex2##4##1##(2008-9#4)
Exacerbation of##2##2##(2008-7#1)(2012-2#1)
Exact results for##2##3##(2008-2#1)(2009-9#1)
Exact test##2##2##(2013-1#1)(2013-8#1)
Exact##16##1##(2007-12#1)(2008-2#2)(2008-3#4)(2008-9#3)(2009-8#1)(2009-9#1)(2010-12#1)(2013-1#2)(2013-8#1)
Exactly##3##1##(1994-12#1)(1995-11#1)(2007-12#1)
Exaggerated##3##1##(2007-7#1)(2008-4#1)(2008-8#1)
Exam##4##1##(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)
Examination (MMSE)##6##2##(2008-6#1)(2008-7#3)(2010-12#1)(2013-1#1)
Examination Survey##4##2##(2008-1#1)(2008-12#1)(2009-7#1)(2010-12#1)
Examination in##2##2##(2008-10#1)(2012-2#1)
Examination of a##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
Examination of the##21##3##(1990-12#2)(1990-8#1)(1991-5#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
Examination of these##2##3##(1992-9#1)(2008-2#1)
Examination of##51##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Examination revealed a##2##3##(2006-10#1)(2010-3#1)
Examination revealed##3##2##(2006-10#1)(2010-3#1)(2013-1#1)
Examination##88##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#7)(2013-8#1)
Examinations of##3##2##(1996-4#1)(2008-12#1)(2009-8#1)
Examine the##5##2##(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
Examine##6##1##(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
Examining the relationship between##2##4##(2008-12#1)(2009-4#1)
Examining the##7##2##(1992-12#1)(2008-12#2)(2009-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
Examining##17##1##(1992-12#1)(1992-2#1)(1995-12#1)(2007-2#1)(2008-12#2)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
Example of##3##2##(1996-2#1)(2008-7#1)(2008-9#1)
Example systems from##2##3##(2008-3#2)
Example with##2##2##(2008-10#1)(2009-8#1)
Example##11##1##(1996-2#1)(2008-10#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-2#1)
Examples are given##6##3##(2007-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)
Examples are provided of##3##4##(1997-7#1)(2010-11#1)(2013-8#1)
Examples are provided##4##3##(1997-7#1)(2008-2#1)(2010-11#1)(2013-8#1)
Examples are##18##2##(1991-8#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-10#1)(2010-11#1)(2013-8#1)
Examples for##2##2##(2007-7#1)(2008-2#1)
Examples from the##2##3##(1991-8#1)(1994-3#1)
Examples from##6##2##(1991-8#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-4#1)
Examples include##3##2##(1992-3#1)(1997-3#1)(2006-12#1)
Examples of applications to the##2##5##(2008-10#1)(2008-2#1)
Examples of applications##3##3##(1990-8#1)(2008-10#1)(2008-2#1)
Examples of the##5##3##(1997-6#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)
Examples of##48##2##(1990-8#1)(1992-2#1)(1992-3#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#2)
Examples showing the##2##3##(2008-10#1)(2013-1#1)
Examples with##2##2##(1994-12#1)(2008-3#1)
Examples##88##1##(1990-8#2)(1991-8#2)(1992-2#1)(1992-3#2)(1994-12#2)(1994-3#1)(1995-2#1)(1996-11#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#5)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Excel##8##1##(1994-2#1)(1994-3#2)(2008-10#2)(2008-12#1)(2013-1#2)
Excellence in##3##2##(1992-3#1)(1996-2#1)(1997-2#1)
Excellence##8##1##(1992-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
Excellent agreement between the##2##4##(2008-10#1)(2008-2#1)
Excellent agreement between##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
Excellent agreement is obtained##2##4##(2008-2#1)(2008-3#1)
Excellent agreement is##4##3##(2008-2#2)(2008-3#2)
Excellent agreement was##2##3##(2007-11#1)(2008-2#1)
Excellent agreement##12##2##(2007-11#3)(2008-10#1)(2008-2#4)(2008-3#4)
Excellent linear responses were observed##2##5##(2008-10#2)
Excellent linearity##2##2##(1991-5#1)(2008-10#1)
Excellent outcomes##2##2##(2008-8#1)(2011-1#1)
Excellent results##2##2##(2008-10#2)
Excellent##31##1##(1991-5#1)(1997-2#1)(2007-11#6)(2007-8#2)(2008-10#10)(2008-2#5)(2008-3#4)(2008-8#1)(2011-1#1)
Except for the##8##3##(1991-6#2)(1992-6#1)(1992-8#1)(2008-7#3)(2009-9#1)
Except for##26##2##(1991-6#2)(1992-6#2)(1992-8#1)(1994-6#1)(1995-5#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#5)(2009-9#1)(2013-8#2)
Except in##2##2##(2008-10#1)(2010-11#1)
Except##34##1##(1991-6#2)(1992-6#2)(1992-8#1)(1994-6#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-7#1)(2009-9#1)(2010-11#1)(2013-8#2)
Exceptional##2##1##(1991-5#1)(2008-2#1)
Exceptionally##2##1##(2007-12#1)(2009-5#1)
Excerpts from &quot##2##3##(1995-1#1)(1995-2#1)
Excerpts from##4##2##(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)
Excess mortality##2##2##(1990-5#1)(2008-7#1)
Excess zinc##2##2##(1996-3#2)
Excess##13##1##(1990-5#1)(1994-8#1)(1995-2#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)
Excessive##15##1##(1990-8#1)(1994-11#1)(1995-8#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
Exchange in##2##2##(2008-10#1)(2012-12#1)
Exchange of##5##2##(1991-12#1)(1996-2#2)(1997-7#1)(2008-10#1)
Exchange##14##1##(1990-3#1)(1991-12#1)(1996-2#2)(1997-7#2)(2008-10#6)(2008-12#1)(2012-12#1)
Exchanges##2##1##(2008-11#1)(2008-4#1)
Excipients##2##1##(2012-2#2)
Excised##3##1##(2008-10#2)(2009-4#1)
Excision of the##3##3##(2007-12#1)(2007-7#1)(2009-4#1)
Excision of##4##2##(2007-12#1)(2007-7#1)(2009-4#1)(2013-1#1)
Excision##8##1##(2007-12#1)(2007-7#1)(2009-4#1)(2010-6#1)(2012-3#1)(2013-1#3)
Excisional##2##1##(2013-8#2)
Excitation is##2##2##(2008-3#2)
Excitation of the##2##3##(1997-6#1)(2007-11#1)
Excitation of##7##2##(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
Excitation##16##1##(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#6)(2008-9#1)
Exciting new##2##2##(2008-4#1)(2010-4#1)
Exciting##4##1##(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
Excluded from##2##2##(1995-12#1)(2013-1#1)
Excluded##6##1##(1992-12#1)(1993-12#1)(1995-12#1)(2008-10#1)(2013-1#2)
Excluding##8##1##(1994-2#1)(1997-3#1)(1997-4#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#2)
Exclusion criteria included##2##3##(2006-10#1)(2009-8#1)
Exclusion criteria##4##2##(2006-10#1)(2008-7#1)(2009-8#1)(2010-11#1)
Exclusion of##6##2##(1996-12#1)(1997-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-9#1)
Exclusion##10##1##(1996-12#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)
Exclusive##4##1##(1990-4#1)(1995-3#1)(1996-5#1)(2008-10#1)
Excretion of both##2##3##(1990-3#2)
Excretion of##4##2##(1990-3#2)(1993-6#1)(1994-12#1)
Executive Summary##2##2##(2008-3#1)(2011-2#1)
Executive##26##1##(1991-12#1)(1992-1#2)(1992-2#2)(1994-1#1)(1995-12#1)(1995-6#2)(1996-9#1)(1997-7#1)(2007-11#2)(2008-1#2)(2008-11#5)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
Executives and##4##2##(1991-1#1)(1994-12#1)(1996-2#1)(1997-2#1)
Executives##6##1##(1991-1#1)(1992-3#1)(1994-12#2)(1996-2#1)(1997-2#1)
Exenatide##2##1##(2012-3#2)
Exercise Training##3##2##(2012-3#2)(2013-1#1)
Exercise and##3##2##(2010-5#1)(2010-9#1)(2012-3#1)
Exercise on##2##2##(2008-10#1)(2012-3#1)
Exercise performance##2##2##(2008-12#1)(2011-3#1)
Exercise training is##2##3##(2008-5#1)(2013-8#1)
Exercise training##5##2##(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
Exercise##48##1##(1991-3#1)(1991-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#2)(2010-6#3)(2010-9#1)(2011-3#1)(2012-12#1)(2012-3#9)(2013-1#10)(2013-8#4)
Exercise-induced anaphylaxis##2##2##(2010-1#2)
Exercise-induced##7##1##(2010-1#3)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
Exhaled breath##2##2##(2010-10#2)
Exhaled##3##1##(2010-10#2)(2012-1#1)
Exist##2##1##(2008-10#1)(2009-9#1)
Existence of##4##2##(1995-2#1)(2007-12#1)(2008-10#1)(2010-10#1)
Existence##5##1##(1995-2#1)(2007-12#1)(2008-10#1)(2010-10#1)(2013-8#1)
Existing techniques##2##2##(2007-11#1)(2012-12#1)
Existing##18##1##(1992-1#1)(1994-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-4#1)
Exo-beta-1##2##1##(2008-10#2)
Exocytosis##3##1##(1993-11#1)(1995-11#1)(2008-10#1)
Exogenous addition of##3##3##(1993-6#1)(2008-10#1)(2009-6#1)
Exogenous administration of ghrelin##2##4##(2008-3#1)(2011-2#1)
Exogenous surfactant##2##2##(1997-1#1)(2008-8#1)
Exogenous##21##1##(1991-9#1)(1992-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#2)(1995-6#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
Exoglc1##2##1##(2008-10#2)
Exome##3##1##(2013-1#3)
Exon##8##1##(1993-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)
Exons##2##1##(1993-11#1)(1994-12#1)
Exonuclease##2##1##(1991-9#1)(2008-8#1)
Exophiala##2##1##(2008-5#2)
Exotic##3##1##(2007-12#1)(2010-4#1)(2012-2#1)
Exp##2##1##(1990-5#1)(1991-3#1)
Expanded Disability Status Scale (EDSS)##2##5##(2008-11#1)(2010-12#1)
Expanded programme on immunization##2##4##(1990-8#1)(1995-3#1)
Expanded##11##1##(1990-8#1)(1992-5#1)(1995-3#1)(2007-10#1)(2008-11#2)(2008-6#1)(2009-8#1)(2010-12#2)(2013-7#1)
Expanded-bed adsorption##3##2##(2008-4#2)(2008-6#1)
Expanding adult day care##2##4##(1994-3#2)
Expanding the##7##2##(1995-1#1)(1997-1#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
Expanding##19##1##(1991-1#1)(1991-8#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)
Expansion of a hospital-based service systems to support a satellite clinic network##2##12##(1994-1#2)
Expansion of a##3##3##(1994-1#2)(1997-3#1)
Expansion of the##2##3##(2008-8#1)(2013-1#1)
Expansion of##9##2##(1994-1#2)(1995-12#1)(1997-3#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
Expansion##14##1##(1994-1#2)(1995-12#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
Expectant management##2##2##(2011-1#2)
Expected final online publication date for the Annual Review of Biochemistry Volume 80 is June##2##15##(2011-2#2)
Expected final online publication date for the Annual Review of Biophysics Volume 41 is May 04##3##16##(2012-1#3)
Expected final online publication date for the Annual Review of Biophysics Volume##4##12##(2011-2#1)(2012-1#3)
Expected final online publication date for the Annual Review of Clinical Psychology Volume 7 is March 27##2##17##(2011-2#2)
Expected final online publication date for the Annual Review of Physical Chemistry Volume 63 is March 31##2##17##(2012-1#2)
Expected final online publication date for the Annual Review of Plant Biology Volume 62 is April 29##5##17##(2011-2#5)
Expected final online publication date for the Annual Review of Plant Biology Volume 63 is April 29##5##17##(2012-1#5)
Expected final online publication date for the Annual Review of Plant Biology Volume##10##13##(2011-2#5)(2012-1#5)
Expected final online publication date for the Annual Review of Public Health Volume 32 is March 17##15##17##(2011-1#15)
Expected final online publication date for the Annual Review of##35##10##(2011-1#15)(2011-2#10)(2012-1#10)
Expected##38##1##(1991-12#1)(2007-8#1)(2008-12#1)(2011-1#15)(2011-2#10)(2012-1#10)
Expecting##3##1##(1993-6#2)(2010-6#1)
Expenditure##3##1##(2008-5#1)(2010-3#1)(2013-1#1)
Expenditures for##2##2##(1996-1#1)(1997-1#1)
Expenditures##5##1##(1993-3#1)(1996-1#1)(1997-1#1)(2008-7#1)(2013-1#1)
Experience Survey##2##2##(1992-1#1)(1996-1#1)
Experience and##2##2##(2008-2#1)(2012-1#1)
Experience at##3##2##(1996-3#1)(2007-10#1)(2013-7#1)
Experience from the##2##3##(1994-11#1)(1996-11#1)
Experience from##8##2##(1992-6#1)(1993-12#1)(1994-11#1)(1996-11#1)(2008-1#1)(2008-12#1)(2012-12#1)(2013-8#1)
Experience in##9##2##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
Experience of the##2##3##(1997-6#1)(2008-6#1)
Experience of##5##2##(1997-6#1)(2007-12#1)(2008-1#1)(2008-6#1)(2013-1#1)
Experience with##12##2##(1990-8#1)(1991-2#1)(1991-6#1)(1993-11#1)(1996-6#1)(2008-1#2)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-3#1)
Experience##61##1##(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
Experienced and entry-level groups##2##4##(1995-3#2)
Experienced and##3##2##(1995-3#2)(2013-8#1)
Experienced##8##1##(1992-12#1)(1993-11#1)(1995-3#3)(2008-11#1)(2008-9#1)(2013-8#1)
Experiences Scale##3##2##(2009-11#1)(2010-6#2)
Experiences and##5##2##(1995-11#1)(1997-2#1)(2008-11#1)(2011-1#1)(2012-3#1)
Experiences from a##2##3##(1995-2#1)(2008-11#1)
Experiences from##5##2##(1990-6#1)(1992-6#1)(1994-6#1)(1995-2#1)(2008-11#1)
Experiences in##6##2##(1995-3#1)(1997-2#1)(2008-11#1)(2012-12#1)(2013-1#2)
Experiences of children treating functional bladder disturbances on##2##8##(2008-10#2)
Experiences of##11##2##(1993-6#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#2)(2010-4#1)(2011-1#1)(2013-1#1)
Experiences with##5##2##(1991-6#1)(1991-9#1)(1992-11#1)(1995-5#1)(1996-3#1)
Experiences##42##1##(1990-6#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-3#1)(1997-2#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-4#1)(2010-6#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#6)
Experiential learning is##2##3##(2008-11#1)(2009-8#1)
Experiment 1##17##2##(2007-6#2)(2008-11#2)(2008-2#2)(2008-5#3)(2008-6#2)(2009-2#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
Experiment 2##17##2##(2007-6#1)(2008-11#1)(2008-2#2)(2008-5#3)(2008-6#3)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
Experiment 3##9##2##(1994-2#1)(2008-2#1)(2008-5#4)(2008-6#1)(2009-5#1)(2011-2#1)
Experiment 4##2##2##(2008-5#1)(2009-10#1)
Experiment and##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
Experiment##79##1##(1990-3#1)(1994-2#2)(1996-12#1)(2007-6#3)(2008-11#8)(2008-2#13)(2008-3#12)(2008-5#12)(2008-6#6)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-8#1)(2011-1#2)(2011-2#5)(2013-8#4)
Experimental Group 1##2##3##(2007-6#2)
Experimental Group 2##2##3##(2007-6#2)
Experimental Group##4##2##(2007-6#4)
Experimental Lidar in Space Equipment##2##5##(2008-3#2)
Experimental Lidar##3##2##(2008-3#3)
Experimental Study##2##2##(1996-5#1)(2012-12#1)
Experimental Verification##2##2##(2008-3#2)
Experimental and clinical studies have##3##5##(1992-2#1)(2010-10#1)(2012-3#1)
Experimental and clinical##4##3##(1992-2#1)(2008-7#1)(2010-10#1)(2012-3#1)
Experimental and theoretical##6##3##(2008-11#1)(2008-2#1)(2008-3#3)(2012-2#1)
Experimental and##16##2##(1991-6#1)(1992-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-10#1)(2012-2#2)(2012-3#1)
Experimental animal##2##2##(2008-10#1)(2010-4#1)
Experimental approaches##2##2##(2008-11#1)(2010-11#1)
Experimental autoimmune uveoretinitis##2##3##(2008-4#2)
Experimental autoimmune##3##2##(1995-12#1)(2008-4#2)
Experimental conditions such as pH##2##5##(2008-10#2)
Experimental conditions were##4##3##(2008-10#3)(2008-11#1)
Experimental conditions##8##2##(2008-10#7)(2008-11#1)
Experimental confirmation of the##2##4##(2008-3#2)
Experimental confirmation of##4##3##(2008-3#4)
Experimental confirmation##6##2##(2008-3#5)(2008-8#1)
Experimental data are presented##2##4##(2008-10#1)(2008-2#1)
Experimental data are##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
Experimental data obtained##2##3##(2007-11#1)(2008-10#1)
Experimental data were##2##3##(2008-10#1)(2008-3#1)
Experimental data##18##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
Experimental demonstration of##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
Experimental demonstration##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
Experimental design for the##2##4##(2008-10#1)(2008-7#1)
Experimental design methodologies to##2##4##(2008-10#2)
Experimental design##8##2##(1994-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)
Experimental determination of the##3##4##(1993-5#1)(2008-2#1)(2008-3#1)
Experimental determination of##6##3##(1993-5#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)
Experimental evaluation of a##2##4##(2008-7#1)(2011-1#1)
Experimental evaluation of##4##3##(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
Experimental evidence for the##3##4##(1993-3#1)(1993-6#1)(2008-7#1)
Experimental evidence for##4##3##(1990-12#1)(1993-3#1)(1993-6#1)(2008-7#1)
Experimental evidence of##2##3##(2007-12#1)(2008-3#1)
Experimental evidence##10##2##(1990-12#1)(1993-3#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)
Experimental group submitted to##2##4##(2013-1#2)
Experimental group##3##2##(2013-1#3)
Experimental images##2##2##(2007-12#1)(2008-3#1)
Experimental implementation##2##2##(2007-11#1)(2008-3#1)
Experimental infections##2##2##(2007-6#2)
Experimental investigation of saturated##2##4##(2008-3#2)
Experimental investigation of##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
Experimental investigation##7##2##(2007-11#2)(2008-2#1)(2008-3#3)(2008-7#1)
Experimental measurement of##2##3##(1997-2#1)(2008-3#1)
Experimental measurements of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
Experimental measurements##8##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
Experimental metastasis assays##2##3##(2008-1#2)
Experimental model##2##2##(2008-11#1)(2012-3#1)
Experimental observation of##5##3##(1993-5#1)(2007-11#1)(2007-12#1)(2008-3#2)
Experimental observations##2##2##(2007-11#1)(2008-3#1)
Experimental parameters such as the##2##5##(2008-10#1)(2009-8#1)
Experimental parameters##6##2##(2008-10#4)(2009-8#1)(2010-5#1)
Experimental realization of##3##3##(2008-2#1)(2008-7#1)(2010-4#1)
Experimental results also##2##3##(2007-11#1)(2008-10#1)
Experimental results are compared with##5##5##(2007-11#2)(2008-3#2)(2009-11#1)
Experimental results are given##2##4##(2008-2#1)(2008-3#1)
Experimental results are in##2##4##(2008-3#2)
Experimental results are presented for the##2##6##(2008-3#2)
Experimental results are presented that demonstrate the validity of the principle##2##11##(2008-3#2)
Experimental results are presented that##3##5##(2007-11#1)(2008-3#2)
Experimental results are presented to##2##5##(2008-3#1)(2008-7#1)
Experimental results are presented##17##4##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#10)(2008-7#1)
Experimental results are provided##2##4##(2008-3#2)
Experimental results are reported that show##2##6##(2007-11#1)(2007-12#1)
Experimental results are##35##3##(2007-11#7)(2007-12#2)(2008-2#4)(2008-3#20)(2008-7#1)(2009-11#1)
Experimental results demonstrate the##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
Experimental results demonstrate##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2012-1#1)
Experimental results for a##3##4##(2007-11#2)(2008-3#1)
Experimental results for##8##3##(1992-6#1)(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#2)
Experimental results from a pixel-matched##2##5##(2007-11#2)
Experimental results from the##2##4##(2008-2#1)(2008-3#1)
Experimental results from##7##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)
Experimental results indicate that##2##4##(1996-12#1)(2007-11#1)
Experimental results obtained from##2##4##(2007-12#1)(2008-10#1)
Experimental results obtained with a##2##5##(2008-2#1)(2008-3#1)
Experimental results obtained with##5##4##(2008-2#3)(2008-3#2)
Experimental results obtained##8##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
Experimental results of measurements##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
Experimental results of the##3##4##(2008-2#1)(2008-3#2)
Experimental results of##12##3##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#3)
Experimental results on##2##3##(2008-3#1)(2008-6#1)
Experimental results prove that this method##2##6##(2007-12#1)(2008-2#1)
Experimental results prove that##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
Experimental results show that the##10##5##(1991-5#1)(2008-10#3)(2008-2#2)(2008-3#2)(2013-8#2)
Experimental results show that##14##4##(1991-5#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#3)(2013-8#3)
Experimental results show the##3##4##(2007-11#1)(2008-3#2)
Experimental results show##20##3##(1991-5#1)(2007-11#6)(2008-10#3)(2008-2#2)(2008-3#5)(2013-8#3)
Experimental results showed that##2##4##(2008-10#2)
Experimental results showed the##2##4##(2008-10#2)
Experimental results showed##7##3##(2008-10#6)(2008-11#1)
Experimental results verify##2##3##(2008-3#2)
Experimental results were##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
Experimental results with##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
Experimental results##138##2##(1991-12#1)(1991-5#1)(1992-6#1)(1996-12#1)(2007-11#24)(2007-12#14)(2008-10#14)(2008-11#1)(2008-2#18)(2008-3#55)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-1#1)(2013-8#3)
Experimental short-term##2##2##(2008-10#2)
Experimental studies on##2##3##(1995-11#1)(2008-9#1)
Experimental studies##7##2##(1992-4#1)(1992-9#1)(1995-11#1)(1997-6#1)(2008-9#1)(2011-1#1)(2012-3#1)
Experimental study of##5##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
Experimental study on##2##3##(2008-3#1)(2008-6#1)
Experimental study##7##2##(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)
Experimental synchronization of chaotic oscillations in##2##6##(2007-12#2)
Experimental test of##2##3##(2007-10#1)(2008-2#1)
Experimental tests of##2##3##(2008-3#1)(2008-9#1)
Experimental tests##3##2##(2008-3#2)(2008-9#1)
Experimental verification of##2##3##(2007-12#1)(2008-3#1)
Experimental verification##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Experimental##383##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-12#2)(1991-5#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#38)(2007-12#25)(2007-6#7)(2008-1#3)(2008-10#52)(2008-11#5)(2008-12#3)(2008-2#33)(2008-3#106)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
Experimentally##15##1##(1995-3#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
Experimentation##2##1##(2008-2#1)(2010-4#1)
Experiments 1 and 2##2##4##(2008-5#1)(2011-1#1)
Experiments 1##4##2##(2008-5#2)(2008-6#1)(2011-1#1)
Experiments are carried out to##2##5##(2007-12#1)(2008-3#1)
Experiments are carried out##3##4##(2007-12#1)(2008-3#1)(2012-12#1)
Experiments are performed with an##2##5##(2007-12#1)(2008-2#1)
Experiments are performed with##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
Experiments are performed##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
Experiments are presented to##2##4##(2008-3#2)
Experiments are##12##2##(2007-12#2)(2008-2#1)(2008-3#8)(2012-12#1)
Experiments based on##4##3##(2007-12#2)(2008-10#1)(2010-10#1)
Experiments demonstrate##2##2##(2007-12#1)(2008-2#1)
Experiments have been##2##3##(1990-8#1)(2008-10#1)
Experiments have shown that##2##4##(2008-2#1)(2009-4#1)
Experiments have##6##2##(1990-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-4#1)
Experiments in##5##2##(1993-11#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
Experiments of##3##2##(2008-10#2)(2008-7#1)
Experiments on the##2##3##(1992-3#1)(2007-11#1)
Experiments on##8##2##(1991-6#1)(1992-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
Experiments performed##2##2##(2008-10#1)(2011-2#1)
Experiments show that##2##3##(2007-11#1)(2007-12#1)
Experiments show##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Experiments showed that##2##3##(2008-2#1)(2008-9#1)
Experiments that##2##2##(2008-10#1)(2008-3#1)
Experiments to##4##2##(2008-10#2)(2008-11#1)(2010-5#1)
Experiments using##4##2##(1992-1#1)(2008-10#2)(2008-8#1)
Experiments were carried out in##2##5##(2008-10#1)(2012-1#1)
Experiments were carried out on##2##5##(2007-12#1)(2008-4#1)
Experiments were carried out to determine##2##6##(1991-8#1)(2008-12#1)
Experiments were carried out to##3##5##(1991-8#1)(2008-10#1)(2008-12#1)
Experiments were carried out##9##4##(1991-8#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2012-1#1)
Experiments were conducted in three##2##5##(2008-10#1)(2013-8#1)
Experiments were conducted in##3##4##(2008-10#2)(2013-8#1)
Experiments were conducted to##4##4##(1991-5#1)(2008-10#2)(2008-12#1)
Experiments were conducted##7##3##(1991-5#1)(2008-10#4)(2008-12#1)(2013-8#1)
Experiments were performed by##2##4##(1993-3#1)(2008-2#1)
Experiments were performed in the##2##5##(1996-5#1)(2008-6#1)
Experiments were performed to determine##2##5##(1990-12#1)(2008-10#1)
Experiments were performed to##5##4##(1990-12#1)(2007-10#1)(2008-10#1)(2008-3#2)
Experiments were performed with the##2##5##(1997-7#1)(2008-11#1)
Experiments were performed##14##3##(1990-12#1)(1993-3#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)
Experiments were##33##2##(1990-12#1)(1991-5#1)(1991-8#1)(1993-3#1)(1994-5#1)(1995-5#2)(1996-5#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
Experiments with a##3##3##(2008-2#1)(2008-3#2)
Experiments with##15##2##(1990-11#1)(1991-5#1)(1992-11#1)(1992-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
Experiments##138##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-5#2)(1996-5#1)(1997-7#1)(2007-10#2)(2007-11#6)(2007-12#9)(2007-9#1)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#11)(2008-3#23)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#2)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#2)
Expert Group on the Immunization Programme##3##6##(2009-5#3)
Expert Group##4##2##(2009-5#4)
Expert Panel##5##2##(2008-1#1)(2008-3#2)(2009-6#1)(2013-1#1)
Expert##18##1##(1990-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-5#4)(2009-6#1)(2009-9#1)(2012-3#1)(2013-1#1)
Expertise##2##1##(2009-8#1)(2013-1#1)
Experts##9##1##(1996-4#1)(2007-12#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-10#2)(2012-12#1)
Expiratory loading##2##2##(1996-5#2)
Expiratory##3##1##(1996-5#2)(2008-8#1)
Explaining##4##1##(1991-12#1)(1996-1#1)(2008-8#1)(2009-5#1)
Explanation##4##1##(1990-4#1)(1991-8#1)(2008-10#1)(2013-1#1)
Explant##3##1##(2008-11#2)(2010-9#1)
Explants##4##1##(1990-11#1)(1996-5#1)(2008-11#1)(2008-12#1)
Explicit expressions are##2##3##(2008-3#2)
Explicit expressions for##2##3##(2008-3#2)
Explicit expressions##4##2##(2008-3#4)
Explicit##14##1##(1995-3#1)(2007-12#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)
Exploitation of the##2##3##(2007-12#1)(2008-10#1)
Exploitation of##7##2##(1990-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2012-3#1)
Exploitation##8##1##(1990-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-3#1)
Exploiting a##2##2##(2008-2#1)(2008-3#1)
Exploiting the##2##2##(2008-10#1)(2008-2#1)
Exploiting##12##1##(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)
Exploration of the##4##3##(1996-9#1)(1997-7#1)(2008-9#1)(2013-1#1)
Exploration of##9##2##(1996-9#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Exploration##12##1##(1996-9#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
Explorations into the Spiritual Lives of Old Women##2##8##(2013-1#2)
Exploratory factor analysis##2##3##(2010-6#2)
Exploratory factor##3##2##(2010-6#2)(2012-2#1)
Exploratory laparotomy revealed##2##3##(2007-8#1)(2009-5#1)
Exploratory laparotomy was##2##3##(1990-2#1)(2013-8#1)
Exploratory laparotomy##4##2##(1990-2#1)(2007-8#1)(2009-5#1)(2013-8#1)
Exploratory##11##1##(1990-2#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#2)
Exploring and##2##2##(2008-8#1)(2012-2#1)
Exploring how##2##2##(2008-11#1)(2008-7#1)
Exploring the##16##2##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
Exploring##38##1##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#2)(2007-2#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
Explosive pleuritis##2##2##(2007-12#2)
Exposed to##4##2##(2008-10#3)(2008-12#1)
Exposed##7##1##(2008-10#3)(2008-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
Exposing the##3##2##(2007-8#1)(2008-11#2)
Exposing##7##1##(1993-3#1)(2007-8#1)(2008-10#2)(2008-11#3)
Exposure Alters##2##2##(2008-10#2)
Exposure and##2##2##(1997-3#1)(2009-4#1)
Exposure of acutely compensated animals to##2##6##(1991-2#2)
Exposure of cells to##4##4##(1995-3#1)(1995-8#1)(1997-4#1)(2008-4#1)
Exposure of cells##5##3##(1995-3#1)(1995-8#1)(1997-4#1)(2008-4#1)(2008-7#1)
Exposure of human##4##3##(1992-12#1)(1992-9#1)(1995-3#1)(2008-5#1)
Exposure of mouse##2##3##(1995-2#1)(1995-8#1)
Exposure of the##4##3##(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
Exposure of##38##2##(1990-2#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#2)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-7#1)
Exposure to TDCPP##2##3##(2013-1#2)
Exposure to a##2##3##(2008-10#2)
Exposure to acesulfame potassium had no effect on survival or mean body weights##2##13##(2008-9#2)
Exposure to aspartame had no effect on survival##2##8##(2008-8#2)
Exposure to high##2##3##(2008-10#1)(2009-8#1)
Exposure to the##2##3##(1993-12#1)(2012-12#1)
Exposure to ultraviolet##2##3##(2008-10#1)(2013-8#1)
Exposure to##51##2##(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-3#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
Exposure##108##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#21)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
Express Five SFM##4##3##(2008-7#4)
Express##5##1##(1996-3#1)(2008-7#4)
Expressed Sequence##2##2##(2008-4#1)(2009-8#1)
Expressed emotion##2##2##(2009-11#1)(2012-2#1)
Expressed in##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
Expressed##9##1##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-2#1)
Expressing the##3##2##(2008-10#2)(2008-3#1)
Expressing##7##1##(2008-10#5)(2008-3#1)(2008-9#1)
Expression Analysis of##4##3##(2008-10#3)(2008-7#1)
Expression Analysis##5##2##(2008-10#3)(2008-7#1)(2012-1#1)
Expression Data##2##2##(2008-7#1)(2011-2#1)
Expression and characterization of##3##4##(1994-3#1)(1997-4#2)
Expression and function of##2##4##(2008-5#1)(2010-11#1)
Expression and purification of##2##4##(2008-2#2)
Expression and regulation of mRNAs for insulin-like growth##2##8##(2008-8#2)
Expression and regulation of##4##4##(2008-8#3)(2010-11#1)
Expression and##22##2##(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-4#2)(2007-7#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#4)(2010-11#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
Expression cloning of a##2##4##(1992-8#1)(1994-8#1)
Expression cloning of##3##3##(1992-8#1)(1994-8#1)(1995-2#1)
Expression in Human##3##3##(2008-10#1)(2008-11#2)
Expression in the##2##3##(2008-10#1)(2008-6#1)
Expression in##14##2##(1996-3#1)(2008-10#4)(2008-11#2)(2008-6#2)(2008-8#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
Expression levels of##4##3##(2008-11#2)(2012-12#1)(2012-3#1)
Expression of a human##2##4##(1995-2#1)(1996-12#1)
Expression of a##6##3##(1990-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#2)
Expression of an##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
Expression of both##3##3##(1994-2#1)(1995-6#1)(2013-1#1)
Expression of epidermal growth factor##2##5##(1992-8#1)(1995-11#1)
Expression of estrogen##2##3##(2008-12#1)(2013-8#1)
Expression of exogenous##2##3##(1996-5#1)(1997-7#1)
Expression of genes##3##3##(1994-8#1)(2008-4#1)(2011-1#1)
Expression of human##6##3##(1991-12#1)(1991-5#1)(1993-8#1)(1995-6#1)(2008-11#1)(2008-8#1)
Expression of listeriolysin O##2##4##(1996-12#2)
Expression of mRNAs##2##3##(2008-11#1)(2008-8#1)
Expression of recombinant##5##3##(1992-10#1)(1994-6#1)(2008-8#1)(2010-5#1)(2013-8#1)
Expression of several##2##3##(2008-8#1)(2011-2#1)
Expression of the Arabidopsis##2##4##(2008-10#2)
Expression of the gene encoding the##2##6##(1991-9#1)(1993-3#1)
Expression of the gene encoding##3##5##(1991-6#1)(1991-9#1)(1993-3#1)
Expression of the human##5##4##(1991-12#1)(1992-11#1)(1993-3#1)(2008-11#1)(2008-7#1)
Expression of the transgene##2##4##(1990-8#1)(1994-8#1)
Expression of the##53##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
Expression of two##3##3##(1990-12#1)(1992-8#2)
Expression of vascular endothelial growth factor##2##6##(2008-7#1)(2008-9#1)
Expression of##225##2##(1990-12#5)(1990-5#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#6)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#9)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#6)(1997-9#1)(2006-7#1)(2007-8#1)(2008-10#30)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#7)(2008-7#6)(2008-8#13)(2008-9#5)(2009-12#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#5)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#5)(2013-8#2)
Expression pattern##2##2##(2008-8#1)(2009-7#1)
Expression studies of##2##3##(1994-11#1)(2008-5#1)
Expression studies##5##2##(1991-7#1)(1993-2#1)(1994-11#1)(2008-5#1)(2013-1#1)
Expression was##2##2##(2008-10#1)(2008-11#1)
Expression##323##1##(1990-12#5)(1990-5#4)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#7)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#6)(1995-8#5)(1995-9#1)(1996-12#9)(1996-3#1)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#6)(1997-9#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#43)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#10)(2008-7#9)(2008-8#19)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#8)(2011-1#2)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#3)
Expressions are##2##2##(2008-2#1)(2008-3#1)
Expressions for##3##2##(2008-10#2)(2008-3#1)
Expressions##7##1##(2008-10#2)(2008-2#1)(2008-3#3)(2012-3#1)
Expressive##3##1##(2010-11#1)(2010-4#1)(2011-2#1)
Expresso##6##1##(2008-7#6)
Expt##10##1##(1992-12#4)(1993-3#2)(1993-6#4)
Exserohilum rostratum in a child##2##5##(2008-10#2)
Exserohilum rostratum##6##2##(2007-7#3)(2008-10#3)
Exserohilum##10##1##(2007-7#3)(2008-10#7)
Extended ageing of the##2##4##(2008-10#2)
Extended spectrum -lactamases##2##3##(2007-7#2)
Extended spectrum##3##2##(2007-7#3)
Extended##26##1##(1990-5#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Extended-Release##2##1##(2010-4#1)(2013-1#1)
Extended-spectrum##2##1##(2011-2#2)
Extending our##2##2##(1992-3#1)(1997-4#1)
Extending prior##2##2##(2009-11#1)(2013-8#1)
Extending the##6##2##(1992-11#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
Extending##11##1##(1992-11#1)(1992-3#1)(1995-12#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2013-8#1)
Extensible##3##1##(1992-2#1)(2008-2#1)(2010-8#1)
Extension in##2##2##(1994-7#1)(2007-12#1)
Extension of the##6##3##(1997-6#1)(2008-11#2)(2008-2#2)(2008-3#1)
Extension of##9##2##(1991-7#1)(1992-3#1)(1997-6#1)(2008-11#2)(2008-2#2)(2008-3#1)(2012-3#1)
Extension to##2##2##(2007-12#1)(2008-2#1)
Extension##21##1##(1991-2#1)(1991-7#1)(1992-3#1)(1994-7#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-7#2)(2010-11#1)(2012-3#1)(2013-7#1)
Extensive experimental##2##2##(1995-3#1)(2007-12#1)
Extensive numerical##2##2##(2008-3#1)(2012-12#1)
Extensive studies##3##2##(1992-3#1)(1997-4#1)(2007-8#1)
Extensive##43##1##(1990-3#1)(1992-3#1)(1992-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#2)(2007-8#3)(2008-10#7)(2008-3#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-8#1)
Extent of##4##2##(1990-11#1)(1992-9#1)(1994-8#1)(2008-4#1)
Extent##5##1##(1990-11#1)(1992-9#1)(1994-8#1)(2008-4#1)(2009-5#1)
External and internal##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
External fixation##3##2##(2007-8#1)(2008-8#1)(2010-12#1)
External radiotherapy##2##2##(1990-6#1)(1995-9#1)
External rotation##2##2##(2007-11#1)(2007-8#1)
External##30##1##(1990-6#1)(1991-6#1)(1994-8#1)(1995-9#1)(1996-9#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#2)
Extinction##6##1##(2008-3#1)(2008-8#2)(2008-9#2)(2013-8#1)
Extra##5##1##(2008-6#1)(2008-9#1)(2011-2#2)(2013-7#1)
Extra-adrenal non-functioning##2##2##(1990-6#2)
Extra-anatomic##2##1##(2007-8#1)(2012-1#1)
Extraarticular##2##1##(1990-6#1)(1995-11#1)
Extracellular ATP##6##2##(1990-5#1)(1993-8#1)(2008-4#4)
Extracellular Ca2+ was required##2##4##(1994-6#1)(1994-8#1)
Extracellular Ca2+##3##2##(1994-6#1)(1994-8#1)(1996-2#1)
Extracellular matrix proteins##2##3##(2010-11#2)
Extracellular matrix##4##2##(2008-11#1)(2009-10#1)(2010-11#2)
Extracellular nucleotides that are released from a variety of arterial and blood cells##2##13##(2008-4#2)
Extracellular nucleotides##3##2##(2008-4#3)
Extracellular##41##1##(1990-12#1)(1990-5#3)(1990-7#1)(1992-3#1)(1993-12#3)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-9#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#10)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#2)(2013-1#1)(2013-8#3)
Extrachromosomal##2##1##(1990-11#1)(2007-12#1)
Extracolonic manifestations##2##2##(2009-12#2)
Extracontractual referrals##2##2##(1991-8#2)
Extracorporeal##4##1##(2007-7#1)(2008-10#1)(2010-8#1)(2012-1#1)
Extracranial orbital decompression##2##3##(2008-7#2)
Extracranial##4##1##(2008-11#1)(2008-2#1)(2008-7#2)
Extract of##9##2##(2008-10#4)(2011-1#2)(2012-2#3)
Extract on##2##2##(2012-2#1)(2013-1#1)
Extract##26##1##(1992-2#1)(1996-8#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-11#1)(2009-12#1)(2011-1#3)(2012-2#4)(2013-1#3)(2013-7#1)
Extractable##3##1##(2008-2#1)(2008-5#1)(2010-5#1)
Extracted##5##1##(1990-2#1)(1991-2#1)(1996-9#1)(2009-2#1)(2013-1#1)
Extracting##3##1##(2008-2#1)(2008-9#1)(2012-2#1)
Extraction and separation##2##3##(2008-10#2)
Extraction and spectrophotometric determination of##2##5##(2008-10#2)
Extraction and##8##2##(2008-10#8)
Extraction by##2##2##(2008-10#1)(2008-2#1)
Extraction chromatographic##2##2##(2008-10#2)
Extraction conditions##2##2##(2008-10#2)
Extraction constants##2##2##(2008-10#2)
Extraction efficiencies &gt##2##3##(2008-10#2)
Extraction efficiencies##5##2##(2008-10#5)
Extraction efficiency and the influence of##2##6##(2008-10#2)
Extraction efficiency and##3##3##(2008-10#3)
Extraction efficiency##4##2##(2008-10#4)
Extraction of arsenic##2##3##(2008-10#2)
Extraction of cationic surfactant templates from##2##6##(2008-10#2)
Extraction of proteins from##2##4##(2008-4#1)(2010-4#1)
Extraction of sodium and potassium picrates with##2##7##(2008-10#2)
Extraction of sodium and potassium##3##5##(2008-10#3)
Extraction of the##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
Extraction of##35##2##(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#24)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2010-4#1)
Extraction recovery of##2##3##(2008-10#2)
Extraction recovery##3##2##(2008-10#3)
Extraction spectrophotometric determination of##2##4##(2008-10#2)
Extraction studies##2##2##(2008-10#2)
Extraction with##2##2##(2008-10#1)(2008-7#1)
Extraction##87##1##(1991-6#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#73)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#3)(2010-4#1)
Extraction-spectrophotometric##2##1##(2008-10#2)
Extractions were##2##2##(2008-10#2)
Extractions##4##1##(2008-10#4)
Extractive spectrophotometric##3##2##(2008-10#3)
Extractive##4##1##(2008-10#3)(2011-2#1)
Extracts from##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
Extracts obtained from the##2##4##(2008-10#1)(2011-1#1)
Extracts of Inula viscosa##2##4##(2008-10#2)
Extracts of the##3##3##(2008-10#1)(2010-2#1)(2013-8#1)
Extracts of##10##2##(1991-12#1)(1992-9#1)(2008-10#5)(2008-11#1)(2010-2#1)(2013-8#1)
Extracts on##2##2##(2008-5#1)(2010-2#1)
Extracts##26##1##(1990-12#1)(1991-12#1)(1992-9#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-5#3)(2010-2#3)(2011-1#1)(2013-8#1)
Extradenticle##2##1##(2008-9#2)
Extradural##3##1##(2008-7#1)(2011-2#2)
Extragonadal##2##1##(2007-10#1)(2008-6#1)
Extraintestinal##3##1##(1990-6#1)(1994-6#1)(2007-12#1)
Extramedullary##2##1##(2008-10#1)(2011-2#1)
Extranodal##2##1##(2009-8#1)(2012-3#1)
Extraordinarily##3##1##(1996-9#1)(2008-12#1)(2012-2#1)
Extraordinary##6##1##(1992-11#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#1)
Extrapolation of##2##2##(2008-11#1)(2008-4#1)
Extrapolation##4##1##(1990-7#1)(2008-11#1)(2008-4#1)(2008-7#1)
Extrapulmonary##2##1##(2007-7#1)(2010-3#1)
Extraskeletal osteosarcoma##5##2##(2008-6#4)(2012-1#1)
Extraskeletal##6##1##(1993-8#1)(2008-6#4)(2012-1#1)
Extraversion##2##1##(2010-12#2)
Extreme##3##1##(2008-10#1)(2008-3#1)(2013-1#1)
Extreme-ultraviolet##3##1##(2007-12#1)(2008-3#2)
Extremely high##2##2##(1993-12#1)(2008-10#1)
Extremely##10##1##(1990-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#1)
Extremity##7##1##(1996-3#1)(2008-6#4)(2009-8#1)(2010-7#1)
Extrinsic##2##1##(2009-9#1)(2011-2#1)
Exudates##2##1##(2008-10#2)
Eye Hospital##2##2##(2010-10#1)(2010-4#1)
Eye gaze##2##2##(2008-11#1)(2008-6#1)
Eye##13##1##(1991-6#1)(1991-9#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
Eye-target synchronization##2##2##(2009-8#2)
Eye-tracking##2##1##(2013-1#2)
Eyebrow##2##1##(2010-3#1)(2012-12#1)
Eyeglass##3##1##(2008-3#3)
Eyes##2##1##(2008-10#1)(2008-12#1)
Eyespot##5##1##(2008-10#2)(2012-2#1)(2012-3#2)
Eyriès##2##1##(2008-9#2)
Ezetimibe and##2##2##(2009-6#1)(2012-2#1)
Ezetimibe in##2##2##(2012-2#1)(2013-1#1)
Ezetimibe##6##1##(2009-6#1)(2012-2#4)(2013-1#1)
Eα (1)##2##2##(2008-9#2)
F &gt##2##2##(1995-6#1)(1997-6#1)
F (2)##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
F 105561 [2-(4- methylthiophenyl)-3-(4-pyridyl)-6##2##4##(1991-8#2)
F 105561 inhibited##2##3##(1991-8#2)
F 105561 nor SK&amp##2##4##(1991-8#2)
F 105561##10##2##(1991-8#10)
F 105809##11##2##(1991-8#11)
F 105809--I##2##2##(1991-8#2)
F 2##2##2##(2009-8#2)
F = 200##2##3##(1995-6#2)
F =##10##2##(1993-2#1)(1995-6#2)(2007-11#4)(2008-3#2)(2012-3#1)
F AAS##3##2##(2008-10#3)
F and G and##2##4##(2008-12#2)
F and G##6##3##(2008-10#1)(2008-12#2)(2008-6#1)(2008-9#1)(2011-2#1)
F and R islets##2##4##(1995-8#2)
F and##13##2##(1991-7#2)(1995-5#1)(1995-8#2)(2008-10#1)(2008-12#3)(2008-6#2)(2008-9#1)(2011-2#1)
F islets##3##2##(1995-8#3)
F of##2##2##(1995-5#1)(1997-8#1)
F ratio##3##2##(2007-7#2)(2008-3#1)
F statistics##2##2##(2008-10#2)
F test##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
F was##2##2##(1995-5#1)(2007-6#1)
F wave##2##2##(2011-2#2)
F were##2##2##(2007-6#1)(2008-10#1)
F##585##1##(1990-11#4)(1990-6#1)(1990-7#1)(1990-8#4)(1991-12#1)(1991-5#1)(1991-7#4)(1991-8#25)(1992-3#7)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#5)(1995-5#3)(1995-6#7)(1995-8#6)(1996-12#2)(1996-2#2)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#4)(2007-2#1)(2007-6#5)(2007-7#2)(2008-10#372)(2008-11#4)(2008-12#11)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#8)(2009-5#6)(2009-8#5)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-10#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#4)
F(-) ion##2##2##(2008-10#2)
F(-)##9##1##(2008-10#9)
F(0) was##4##2##(2008-8#4)
F(0)##13##1##(2008-10#1)(2008-8#12)
F(1) (Japanese Black##2##3##(2013-1#2)
F(1) and F(2) generations##2##4##(2008-10#2)
F(1) and F(2) populations of hybrids of group##2##8##(2008-10#2)
F(1) and F(2)##5##3##(2008-10#4)(2008-8#1)
F(1) hybrid between##2##3##(2008-10#1)(2008-9#1)
F(1) hybrid##7##2##(2008-10#6)(2008-9#1)
F(1) hybrids were##3##3##(2008-10#3)
F(1) hybrids##10##2##(2008-10#9)(2008-8#1)
F(1) or Holstein##2##3##(2013-1#2)
F(1) plants were##2##3##(2008-10#2)
F(1) plants##4##2##(2008-10#4)
F(1) progenies were##2##3##(2008-10#2)
F(1) progenies##3##2##(2008-10#3)
F(1) progeny were##4##3##(2008-10#4)
F(1) progeny##9##2##(2008-10#8)(2009-9#1)
F(1)##83##1##(2008-10#71)(2008-8#4)(2008-9#2)(2009-12#1)(2009-9#1)(2013-1#4)
F(10)##2##1##(2008-10#2)
F(2##11##1##(2008-10#10)(2008-4#1)
F(2) and F(2##2##3##(2008-10#2)
F(2) and F(3)##2##3##(2008-10#2)
F(2) and##9##2##(2007-11#2)(2008-10#7)
F(2) individuals were##2##3##(2008-10#2)
F(2) individuals##3##2##(2008-10#3)
F(2) laser##2##2##(2007-11#2)
F(2) plants##7##2##(2008-10#7)
F(2) population derived from a cross between##2##7##(2008-10#2)
F(2) population derived from##3##4##(2008-10#2)(2009-10#1)
F(2) population of##5##3##(2008-10#5)
F(2) population segregating##2##3##(2008-10#2)
F(2) population was##2##3##(2008-10#1)(2008-8#1)
F(2) population##22##2##(2008-10#16)(2008-8#4)(2008-9#1)(2009-10#1)
F(2) populations##9##2##(2008-10#9)
F(2) progeny from##2##3##(2008-10#2)
F(2) progeny##8##2##(2008-10#8)
F(2)##96##1##(2007-11#6)(2007-12#1)(2008-10#78)(2008-8#8)(2008-9#2)(2009-10#1)
F(2)(+) laser##3##2##(2008-3#3)
F(2)(+)##6##1##(2008-3#6)
F(2)(-) laser##3##2##(2007-12#1)(2008-2#2)
F(2)(-)##8##1##(2007-12#2)(2008-2#6)
F(2)H(2)Dz-foam##2##1##(2008-10#2)
F(23)##2##1##(2008-10#2)
F(3) and F(4)##2##3##(2008-10#2)
F(3) and F(5)##2##3##(2008-10#2)
F(3) and##5##2##(2008-10#5)
F(3) families were##2##3##(2008-10#2)
F(3) families##5##2##(2008-10#5)
F(3) families)##2##2##(2008-10#2)
F(3) lines##4##2##(2008-10#4)
F(3) progeny##4##2##(2008-10#4)
F(3)##33##1##(2008-10#33)
F(4) lines##2##2##(2008-10#2)
F(4)##8##1##(2008-10#5)(2008-8#3)
F(5##2##1##(2008-10#2)
F(5) lines##2##2##(2008-10#2)
F(5)##5##1##(2008-10#5)
F(6) lines##5##2##(2008-10#5)
F(6)##8##1##(2008-10#8)
F(7)##2##1##(2008-10#2)
F(8)##3##1##(2008-10#3)
F(B) was##2##2##(2008-10#2)
F(B)##4##1##(2008-10#4)
F(L)##2##1##(2008-2#2)
F(ST)##6##1##(2008-10#2)(2011-2#3)(2013-1#1)
F(ab')(2)##2##1##(2008-1#2)
F(ab')2 anti-C3 ELISA##3##3##(1990-12#3)
F(ab')2 fragments##2##2##(1990-5#1)(1991-2#1)
F(ab')2##8##1##(1990-12#3)(1990-5#2)(1991-2#1)(1997-2#2)
F(c)##3##1##(2008-1#2)(2008-8#1)
F(st)##3##1##(2008-10#1)(2008-8#1)(2012-1#1)
F)##10##1##(1995-5#1)(1995-8#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#2)(2013-1#1)(2013-8#1)
F+ are##2##2##(1991-11#2)
F+##6##1##(1991-11#5)(1992-7#1)
F- and G-actin in##2##4##(1992-3#2)
F- and##3##2##(1992-3#2)(2010-4#1)
F-##7##1##(1991-11#1)(1992-3#2)(1995-12#1)(1995-8#1)(2008-10#1)(2010-4#1)
F-18##3##1##(1990-12#2)(2009-9#1)
F-344 rats##2##2##(1992-11#1)(1994-5#1)
F-344##3##1##(1992-11#1)(1994-5#1)(1995-9#1)
F-68##3##1##(2008-11#1)(2011-2#2)
F-DOPA uptake##3##2##(2008-7#3)
F-DOPA##7##1##(2008-7#7)
F-MEL cells##2##2##(2008-11#2)
F-MEL-SEAP##2##1##(2008-11#2)
F-SKI249380##2##1##(2013-1#2)
F-actin and##2##2##(2009-8#1)(2011-2#1)
F-actin depolymerization##3##2##(2012-12#3)
F-actin in##2##2##(2008-7#1)(2011-2#1)
F-actin is##3##2##(1993-8#1)(2007-12#1)(2008-11#1)
F-actin organization##2##2##(2008-10#2)
F-actin was observed##2##3##(2012-12#2)
F-actin was##4##2##(2007-12#1)(2012-12#3)
F-actin##45##1##(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#6)(1994-6#3)(1997-6#1)(2007-12#5)(2008-10#6)(2008-11#3)(2008-7#1)(2009-10#3)(2009-8#1)(2011-2#5)(2012-12#7)(2012-2#1)
F-d analysis##2##2##(2008-5#2)
F-d##5##1##(2008-5#5)
F-ddI##4##1##(1995-3#4)
F-statistic##2##1##(2012-3#2)
F-test and##2##2##(1992-6#1)(2008-10#1)
F-test##7##1##(1992-6#2)(2008-10#5)
F-tests##2##1##(2008-10#2)
F0 peak##3##2##(2013-8#3)
F0##9##1##(1995-6#1)(1997-4#2)(2013-8#6)
F1 and F2 populations##3##4##(2008-10#3)
F1 and F2##8##3##(2008-10#4)(2008-12#2)(2013-8#2)
F1 and##9##2##(2008-10#4)(2008-12#2)(2009-2#1)(2013-8#2)
F1 plants##2##2##(1997-6#1)(2008-10#1)
F1 progeny##2##2##(2008-5#1)(2011-2#1)
F1 was##3##2##(1991-7#1)(2008-11#2)
F1##47##1##(1991-7#2)(1992-3#5)(1992-6#3)(1993-8#1)(1994-8#1)(1997-6#1)(2008-10#7)(2008-11#8)(2008-12#4)(2008-5#6)(2009-2#1)(2010-2#1)(2011-2#3)(2011-3#1)(2013-8#3)
F1-27 was##2##2##(2008-10#2)
F1-27##6##1##(2008-10#6)
F1-ATPase##3##1##(1990-2#2)(1992-6#1)
F10##3##1##(1997-7#2)(2008-10#1)
F1009##3##1##(1997-7#3)
F1009/F1021##4##1##(1997-7#4)
F1021 and F1009/F1021 infectants##2##4##(1997-7#2)
F1021 and F1009/F1021##3##3##(1997-7#3)
F1021##4##1##(1997-7#4)
F105W##3##1##(1995-5#3)
F113##5##1##(2008-10#5)
F12##6##1##(2008-11#6)
F129L##2##1##(2008-10#2)
F156L mutation##2##2##(1995-2#2)
F18 FDG PET/CT##3##3##(2012-12#3)
F18-FDG##2##1##(2012-12#2)
F1F0 ATPase##4##2##(1997-8#4)
F1Fo-ATPsynthase##3##1##(2012-2#3)
F1s##2##1##(1994-8#2)
F2 alpha##4##2##(1990-8#3)(1992-8#1)
F2 and backcross##2##3##(1996-12#2)
F2 and##4##2##(1996-12#2)(2008-12#1)(2008-5#1)
F2 individuals##2##2##(1995-6#1)(2008-5#1)
F2 population##4##2##(2008-10#1)(2008-8#3)
F2 progeny##2##2##(2008-10#2)
F2##33##1##(1990-8#3)(1992-8#1)(1993-2#1)(1995-6#1)(1996-12#2)(2007-6#1)(2008-10#8)(2008-12#3)(2008-4#1)(2008-5#4)(2008-8#3)(2011-2#2)(2013-8#3)
F2/5##6##1##(2008-10#6)
F29W and F105W##2##3##(1995-5#2)
F29W and##3##2##(1995-5#3)
F2alpha##2##1##(1997-1#1)(1997-7#1)
F3##13##1##(2008-10#3)(2008-11#1)(2008-12#5)(2008-5#2)(2009-2#2)
F344 rat##3##2##(2011-2#3)
F344 rats##11##2##(1990-3#2)(1992-3#3)(1992-9#3)(1995-11#1)(2008-7#1)(2011-2#1)
F344##16##1##(1990-3#2)(1992-3#3)(1992-9#3)(1995-11#1)(2008-7#1)(2011-2#5)(2012-1#1)
F344/N rats##14##2##(1994-2#2)(2008-8#1)(2008-9#11)
F344/N##18##1##(1994-2#3)(2008-8#1)(2008-9#14)
F3TdR##5##1##(1994-8#5)
F6##3##1##(2008-10#1)(2008-11#2)
F62##3##1##(1993-9#3)
F751##2##1##(1997-7#2)
F8##2##1##(1994-5#1)(2008-5#1)
F8Fa and A18Fa##2##3##(1990-7#2)
F8Fa##5##1##(1990-7#5)
F9 EC cells##2##3##(1994-9#2)
F9 cells##6##2##(1992-9#6)
F9 teratocarcinoma cells##2##3##(1992-9#2)
F9##12##1##(1992-9#9)(1994-9#2)(2008-12#1)
F966##3##1##(1997-7#3)
F970 and F1009 infectants##2##4##(1997-7#2)
F970##3##1##(1997-7#3)
FA (200##2##2##(1992-2#1)(1992-8#1)
FA and##2##2##(1992-2#1)(2013-8#1)
FA can##2##2##(2008-10#2)
FA content##5##2##(2012-1#5)
FA could phosphorylate##2##3##(1993-6#2)
FA could##4##2##(1993-6#4)
FA is##2##2##(2008-10#1)(2013-8#1)
FA using##2##2##(2008-10#1)(2008-4#1)
FA were##2##2##(2008-10#1)(2008-11#1)
FA##59##1##(1992-2#2)(1992-8#4)(1993-6#5)(1997-3#2)(2008-10#19)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#5)(2010-6#1)(2012-1#5)(2013-1#5)(2013-8#2)
FA)##2##1##(1993-6#1)(2008-10#1)
FA-APGD-MS##2##1##(2010-5#2)
FA-GNPs##2##1##(2013-8#2)
FAA##2##1##(1996-12#1)(2008-10#1)
FAAS after##4##2##(2008-10#4)
FAAS in##3##2##(2008-10#3)
FAAS##37##1##(2008-10#37)
FAAS)##3##1##(2008-10#3)
FAB classification##3##2##(1991-2#1)(1992-10#1)(2007-2#1)
FAB##8##1##(1990-7#1)(1991-2#3)(1992-10#1)(2007-2#2)(2008-10#1)
FABP##3##1##(1994-8#2)(2013-1#1)
FABPs##2##1##(2013-1#2)
FAC/FEC##2##1##(2009-4#2)
FACE##4##1##(1995-6#4)
FACS Calibur##4##2##(2008-4#4)
FACS analysis##5##2##(1994-5#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
FACS##18##1##(1994-5#1)(2008-11#4)(2008-4#7)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
FACT-Fatigue##2##1##(2008-7#2)
FACTORS##2##1##(2013-8#2)
FAD and NADP binding##2##4##(1990-7#2)
FAD and the##2##3##(1996-8#1)(2008-10#1)
FAD and##5##2##(1990-7#2)(1996-8#1)(2008-10#2)
FAD##26##1##(1990-12#2)(1990-7#3)(1990-8#1)(1992-1#2)(1992-3#1)(1994-8#1)(1996-5#3)(1996-8#3)(2008-10#3)(2008-4#1)(2009-10#1)(2010-2#5)
FAD-dependent component##2##2##(1992-12#2)
FAD/NADPH##2##1##(1994-8#2)
FAE activity##2##2##(2011-1#1)(2013-1#1)
FAE##6##1##(2011-1#2)(2013-1#4)
FAEES##2##1##(1992-6#2)
FAH##3##1##(1992-8#3)
FALS##3##1##(1996-5#3)
FAM##3##1##(1990-2#1)(2008-10#2)
FAME analysis##2##2##(2008-10#2)
FAME profiles##3##2##(2008-10#3)
FAME was##2##2##(2008-10#1)(2009-3#1)
FAME##14##1##(2008-10#12)(2009-3#1)(2009-8#1)
FAMEs##2##1##(2008-10#2)
FAMS##4##1##(2008-4#4)
FAP##5##1##(2008-11#1)(2008-2#2)(2008-4#1)(2009-12#1)
FAQs##2##1##(1994-12#1)(2008-5#1)
FAS and CTLA-4##3##3##(2009-8#3)
FAS signaling##2##2##(2009-9#2)
FAS##6##1##(2009-8#4)(2009-9#2)
FASEB##3##1##(1990-11#1)(2007-5#2)
FAST##6##1##(2012-12#6)
FASTA programs##4##2##(2008-4#4)
FASTA provides very accurate statistical significance estimates##2##7##(2008-4#2)
FASTA##11##1##(2008-4#11)
FAT##2##1##(2007-11#1)(2012-3#1)
FATS##2##1##(1991-8#2)
FAs by##3##2##(2008-10#3)
FAs increased##2##2##(2012-1#2)
FAs##12##1##(2008-10#6)(2012-1#3)(2013-1#3)
FB##12##1##(1995-3#1)(2007-8#3)(2008-11#2)(2012-2#6)
FB(1) was##2##2##(2008-10#2)
FB(1)##9##1##(2008-10#9)
FBA/NE-ISG##6##1##(2011-3#6)
FBB##3##1##(2008-11#3)
FBCA##3##1##(2008-10#3)
FBG and##2##2##(2007-12#1)(2008-5#1)
FBG##9##1##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#3)
FBI##2##1##(1993-2#1)(1993-8#1)
FBL-3 cells##5##2##(2008-4#5)
FBL3##2##1##(2008-9#2)
FBP in biological##2##3##(1992-3#2)
FBP in##3##2##(1992-3#2)(2012-1#1)
FBP##14##1##(1992-3#6)(1995-3#5)(2008-2#2)(2012-1#1)
FBR was##2##2##(2008-6#2)
FBR##4##1##(2008-6#2)(2009-11#2)
FBS and##3##2##(2007-11#1)(2008-11#2)
FBS for##2##2##(2008-11#1)(2008-9#1)
FBS supplemented##2##2##(2007-11#1)(2008-11#1)
FBS##37##1##(1992-11#2)(1994-2#4)(1994-3#1)(1997-8#3)(2007-11#7)(2008-10#1)(2008-11#16)(2008-9#2)(2012-2#1)
FBs were##2##2##(1991-12#1)(2007-8#1)
FBs##6##1##(1991-12#2)(2007-8#4)
FC##10##1##(2008-11#3)(2008-3#5)(2008-8#1)(2013-1#1)
FCAT-SSS##2##1##(2008-12#2)
FCC in##2##2##(1991-1#1)(1991-12#1)
FCC##6##1##(1991-1#3)(1991-12#2)(2008-7#1)
FCF##5##1##(1990-6#2)(2008-10#3)
FCFP##3##1##(2011-2#3)
FCHL##2##1##(1993-12#2)
FCM clustered PNN##2##3##(2010-8#2)
FCM clustered##4##2##(2010-8#4)
FCM##11##1##(2009-6#4)(2010-1#2)(2010-8#5)
FCModeler##3##1##(2008-7#3)
FCPAQ##2##1##(2008-10#2)
FCPBSQ##4##1##(2008-10#4)
FCRR development##2##2##(2008-10#2)
FCRR infection##2##2##(2008-10#2)
FCRR##8##1##(2008-10#8)
FCS 3##2##2##(2008-9#2)
FCS concentration##4##2##(1993-9#3)(2013-1#1)
FCS concentrations and##2##3##(2013-1#2)
FCS##13##1##(1993-9#3)(2008-11#4)(2008-9#3)(2013-1#3)
FCU##4##1##(2009-5#1)(2013-7#3)
FD data##3##2##(2008-3#3)
FD patients##4##2##(2008-10#4)
FD reflectance##2##2##(2008-3#2)
FD uptake##2##2##(2008-7#2)
FD##16##1##(2007-7#2)(2008-10#5)(2008-2#1)(2008-3#6)(2008-7#2)
FDA and##2##2##(2011-2#2)
FDA approved##8##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-3#3)(2013-1#1)
FDA data##2##2##(2012-12#2)
FDA for the treatment of##2##5##(2008-5#2)
FDA for the##3##3##(2008-5#3)
FDA for##6##2##(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#1)
FDA guidelines##2##2##(2008-11#1)(2008-8#1)
FDA issued a##2##3##(2008-5#1)(2013-8#1)
FDA issued##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
FDA trials reporting outcomes##2##4##(2012-12#2)
FDA trials##4##2##(2012-12#4)
FDA##72##1##(1992-3#2)(1992-9#1)(1994-2#1)(1995-5#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#9)(2008-7#1)(2008-8#6)(2008-9#2)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-9#1)(2011-2#7)(2011-3#2)(2012-12#9)(2012-3#6)(2013-1#3)(2013-8#1)
FDA's##6##1##(1997-5#1)(2008-5#1)(2010-6#2)(2013-8#2)
FDA-approved##5##1##(2008-12#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
FDC polypharmacotherapy##2##2##(2009-4#2)
FDC##4##1##(2009-4#3)(2011-1#1)
FDC-P1 cells##4##2##(1994-5#4)
FDC-P2##4##1##(1997-7#4)
FDCD##3##1##(2008-10#3)
FDG##7##1##(1991-1#1)(2008-1#2)(2011-2#1)(2012-12#3)
FDH##6##1##(1995-8#4)(2008-7#1)(2011-2#1)
FDH-N##4##1##(1992-6#4)
FDH-Z##4##1##(1992-6#4)
FDOT##2##1##(2007-12#1)(2012-12#1)
FDP DNA##2##2##(2008-10#2)
FDP##11##1##(1990-5#1)(2008-10#7)(2008-7#3)
FDPM data##4##2##(2008-3#4)
FDPM##9##1##(2008-3#9)
FDTD and##2##2##(2008-3#2)
FDTD program##3##2##(2008-3#3)
FDTD##16##1##(2007-11#1)(2008-3#15)
FE analysis##2##2##(2008-6#1)(2013-1#1)
FE model##3##2##(2008-7#1)(2013-1#2)
FE models##2##2##(2008-7#1)(2013-1#1)
FE##12##1##(1994-11#1)(2008-6#2)(2008-7#3)(2009-7#1)(2012-2#1)(2013-1#4)
FE's##4##1##(1994-11#4)
FE(NO)##3##1##(2010-5#3)
FEATURES##2##1##(2009-4#1)(2009-9#1)
FEBS Lett##12##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-12#1)(1995-11#1)(1997-8#1)
FEBS##13##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-12#1)(1995-11#1)(1997-8#1)
FECG##2##1##(1994-5#2)
FED##4##1##(1996-12#4)
FEF25-75%##2##1##(1996-3#1)(2011-2#1)
FEL##5##1##(2008-3#5)
FEOET device##2##2##(2009-5#2)
FEOET##4##1##(2009-5#4)
FEP Teflon and PMMA##3##4##(2010-4#3)
FEP Teflon##5##2##(2010-4#5)
FEP##6##1##(2010-4#5)(2011-1#1)
FER gene product##2##3##(1992-3#2)
FES slope##3##2##(2008-2#3)
FET##11##1##(1992-2#1)(2008-10#3)(2008-7#6)(2009-6#1)
FETV-ICP-MS##2##1##(2008-10#2)
FETs##2##1##(2008-10#1)(2008-7#1)
FEV(1)##3##1##(2010-8#3)
FEV1 and##3##2##(2007-2#1)(2008-7#1)(2008-8#1)
FEV1 was##2##2##(2007-8#1)(2011-2#1)
FEV1##20##1##(1996-3#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-7#4)(2008-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#1)
FEV1%##4##1##(2011-2#2)(2012-2#2)
FEV1/FVC ratio##2##2##(2008-7#2)
FEV1/FVC##4##1##(1991-4#1)(2008-7#2)(2013-8#1)
FF and##3##2##(2008-12#1)(2008-8#1)(2010-2#1)
FF transection##2##2##(1996-12#2)
FF##26##1##(1996-12#2)(2008-10#4)(2008-12#6)(2008-8#1)(2010-1#2)(2010-2#9)(2013-8#2)
FF9 = 6##2##3##(2010-2#2)
FF9##3##1##(2010-2#3)
FFA content##2##2##(2008-10#2)
FFA##8##1##(2007-8#1)(2008-10#3)(2008-12#2)(2008-6#1)(2013-8#1)
FFE##3##1##(2008-4#2)(2008-5#1)
FFF##4##1##(2008-10#4)
FFM##3##1##(2008-5#2)(2011-2#1)
FFMCT##4##1##(2012-1#4)
FFP##4##1##(2008-11#1)(2008-3#3)
FFPI##4##1##(2007-11#3)(2008-2#1)
FFS##7##1##(1993-12#1)(1994-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)
FFT##3##1##(2008-10#1)(2008-3#1)(2009-12#1)
FFT-based##4##1##(2008-3#3)(2009-12#1)
FG##4##1##(2011-2#2)(2012-2#2)
FG-labeled perikarya in the##2##4##(1992-12#2)
FGA were##2##2##(2008-12#2)
FGA##10##1##(2008-12#10)
FGD type 1##2##3##(2011-1#2)
FGD type 2##3##3##(2011-1#3)
FGD type##5##2##(2011-1#5)
FGD##7##1##(2011-1#7)
FGF receptor##3##2##(1997-1#2)(1997-7#1)
FGF signaling##4##2##(2012-12#3)(2013-1#1)
FGF##21##1##(1991-12#2)(1991-2#4)(1994-11#1)(1995-12#1)(1997-1#4)(1997-7#3)(2008-11#1)(2012-12#3)(2013-1#2)
FGF-1##5##1##(1993-6#1)(1997-1#2)(1997-4#2)
FGF-2 and##2##2##(1996-12#1)(1997-4#1)
FGF-2 mRNA##3##2##(1996-12#2)(1997-4#1)
FGF-2##22##1##(1993-6#1)(1996-12#6)(1997-4#7)(2008-11#8)
FGF2 and##2##2##(2008-4#2)
FGF2##4##1##(2008-4#4)
FGF2-induced mitogenesis##2##2##(2008-4#2)
FGF2-induced##3##1##(2008-4#3)
FGF3##2##1##(2012-12#2)
FGFR##7##1##(1997-1#2)(2007-12#3)(2013-1#2)
FGFR1##4##1##(1997-1#4)
FGFR3 expression##4##2##(2008-3#4)
FGFR3##9##1##(2008-3#9)
FGFR4 and##2##2##(1997-1#2)
FGFs##5##1##(2008-7#4)(2012-12#1)
FGR and PDT##5##3##(2009-4#5)
FGR and##6##2##(2009-4#6)
FGR##9##1##(2009-4#9)
FGS##12##1##(1996-12#11)(2008-10#1)
FGT placement##2##2##(2007-10#2)
FGT##7##1##(2007-10#7)
FH is##2##2##(2007-10#1)(2008-6#1)
FH##4##1##(2007-10#2)(2008-6#2)
FHB and##4##2##(2008-10#4)
FHB epidemics in##2##3##(2008-10#2)
FHB epidemics##3##2##(2008-10#3)
FHB in##2##2##(2008-10#2)
FHB incidence##2##2##(2008-10#2)
FHB infection and##2##3##(2008-10#2)
FHB resistance in##3##3##(2008-10#3)
FHB resistance##15##2##(2008-10#15)
FHB severity and DON##2##4##(2008-10#2)
FHB severity##4##2##(2008-10#4)
FHB symptoms##2##2##(2008-10#1)(2011-10#1)
FHB was##3##2##(2008-10#3)
FHB##51##1##(2008-10#47)(2011-10#4)
FHB-resistance##2##1##(2008-10#2)
FHF##2##1##(2007-7#2)
FHIT##2##1##(2010-8#1)(2011-2#1)
FHL3##6##1##(2012-3#6)
FHP##3##1##(2010-9#3)
FHR monitoring##2##2##(1994-3#2)
FHR##5##1##(1994-3#4)(1994-5#1)
FHT##2##1##(2008-3#2)
FI analysis##2##2##(2008-10#2)
FI determination of##2##3##(2008-10#2)
FI manifold##2##2##(2008-10#2)
FI method for the accurate and precise##2##7##(2008-10#2)
FI method is##3##3##(2008-10#3)
FI method##12##2##(2008-10#12)
FI methods##2##2##(2008-10#2)
FI procedure##3##2##(2008-10#3)
FI system and##2##3##(2008-10#2)
FI system##14##2##(2008-10#14)
FI##54##1##(2008-10#54)
FI-BI##3##1##(2008-10#3)
FI-CV-AAS##4##1##(2008-10#4)
FI-ECL##3##1##(2008-10#3)
FI-ETAAS##2##1##(2008-10#2)
FI-FAAS and FI-BI##2##3##(2008-10#2)
FI-FAAS##5##1##(2008-10#5)
FI-FT-IR##2##1##(2008-10#2)
FI-in-valve##2##1##(2008-10#2)
FI-spectrophotometric##2##1##(2008-10#2)
FIA (MCFIA)##2##2##(2008-10#2)
FIA and##6##2##(2008-10#6)
FIA conditions##4##2##(2008-10#4)
FIA manifold##2##2##(2008-10#2)
FIA method was developed##2##4##(2008-10#2)
FIA method were##2##3##(2008-10#2)
FIA method##5##2##(2008-10#5)
FIA peaks##2##2##(2008-10#2)
FIA set up##2##3##(2008-10#2)
FIA system and##5##3##(2008-10#5)
FIA system developed in this##2##5##(2008-10#2)
FIA system for##3##3##(2008-10#3)
FIA system is##2##3##(2008-10#2)
FIA system offers##2##3##(1995-3#1)(2008-10#1)
FIA system to##2##3##(2008-10#2)
FIA system using##3##3##(2008-10#3)
FIA system##38##2##(1995-3#1)(2008-10#37)
FIA systems##3##2##(2008-10#3)
FIA to##2##2##(2008-10#2)
FIA##113##1##(1995-3#2)(2008-10#111)
FIA-potentiometric system##2##2##(2008-10#2)
FIA/DSTD##2##1##(2008-10#2)
FIB##2##1##(2008-10#1)(2008-3#1)
FID detection##2##2##(2008-10#2)
FID##5##1##(2008-10#5)
FIGO staging system##2##3##(2007-4#2)
FIGO##4##1##(2007-4#2)(2011-1#1)(2012-3#1)
FINDINGS##18##1##(2008-11#1)(2008-9#1)(2009-10#1)(2009-11#2)(2011-2#2)(2012-3#2)(2013-1#9)
FIP##4##1##(2008-10#4)
FIPA##2##1##(2013-1#2)
FIQ##3##1##(1996-3#3)
FIS1##2##1##(2009-10#2)
FIS1A and FIS1B##3##3##(2009-10#3)
FIS1A##5##1##(2009-10#5)
FIS1B##5##1##(2009-10#5)
FISH analysis for##2##3##(1997-3#1)(2008-4#1)
FISH analysis##13##2##(1996-6#1)(1996-8#1)(1997-3#2)(2008-1#1)(2008-11#1)(2008-4#5)(2008-9#1)(2009-8#1)
FISH and C-banding##2##3##(2008-5#2)
FISH and##4##2##(1997-2#1)(2008-5#2)(2008-9#1)
FISH mapping##2##2##(2008-4#2)
FISH method##2##2##(1996-8#1)(2012-3#1)
FISH probes##3##2##(2008-4#1)(2010-3#1)(2012-3#1)
FISH study##2##2##(2007-11#1)(2011-2#1)
FISH technique##3##2##(1994-12#1)(2008-11#1)(2010-12#1)
FISH techniques##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
FISH with##3##2##(2008-4#1)(2008-9#1)(2010-3#1)
FISH##66##1##(1994-12#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#9)(2007-11#1)(2008-1#3)(2008-11#4)(2008-4#11)(2008-5#5)(2008-9#10)(2009-2#1)(2009-5#1)(2009-8#3)(2010-12#3)(2010-3#2)(2011-2#1)(2012-3#5)(2013-8#2)
FISO Neb##5##2##(1993-2#5)
FITC##5##1##(1995-5#1)(2008-10#1)(2008-4#2)(2008-8#1)
FITC-conjugated##5##1##(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)
FITC-labeled##7##1##(2008-10#5)(2008-9#1)(2012-1#1)
FITCH##2##1##(2008-4#2)
FIV integrase##2##2##(1997-3#2)
FIX protein##4##2##(1995-2#4)
FIX##5##1##(1995-2#4)(2008-9#1)
FJHN##3##1##(2007-7#3)
FK-228##2##1##(2008-6#2)
FK506 and rapamycin##5##3##(1991-9#1)(1993-11#1)(1993-8#3)
FK506 and##6##2##(1991-9#1)(1992-11#1)(1993-11#1)(1993-8#3)
FK506 binding protein##3##3##(1993-11#2)(1993-8#1)
FK506##13##1##(1990-9#1)(1991-9#3)(1992-11#1)(1993-11#3)(1993-8#4)(2008-9#1)
FK506-binding protein##3##2##(1990-9#2)(1992-11#1)
FKB1/FPR1/RBP1##2##1##(1995-9#2)
FKBP##3##1##(1991-9#2)(1993-11#1)
FKBP-12 gene##3##2##(1991-9#3)
FKBP-12##4##1##(1991-9#4)
FKRP##4##1##(2008-7#4)
FL and##2##2##(2008-8#1)(2010-11#1)
FL##20##1##(1992-2#3)(2008-10#6)(2008-12#1)(2008-7#1)(2008-8#2)(2010-11#6)(2011-1#1)
FL)##4##1##(2008-10#2)(2011-1#1)(2013-1#1)
FLA653##2##1##(2008-10#2)
FLAASH##4##1##(2013-8#4)
FLACC and COMFORT-B##2##3##(2012-2#2)
FLACC##9##1##(2012-2#9)
FLAG peptides##3##2##(1997-3#3)
FLAG##4##1##(1997-3#3)(2012-3#1)
FLAIR model##3##2##(2008-10#3)
FLC##10##1##(2008-2#4)(2008-3#1)(2012-3#5)
FLHCC tissue##2##2##(2010-3#2)
FLHCC##8##1##(2010-3#8)
FLI was present in the##2##5##(1993-12#2)
FLI was##3##2##(1993-12#3)
FLI##4##1##(1993-12#4)
FLIM##6##1##(2007-11#2)(2008-1#2)(2011-1#2)
FLIP regulation of HO-1##2##4##(2011-2#2)
FLIP##10##1##(2008-1#1)(2008-9#1)(2009-9#4)(2011-2#4)
FLIPL knock-down##2##2##(2011-2#2)
FLIPL##4##1##(2011-2#4)
FLIPR##4##1##(2008-10#4)
FLK##2##1##(1995-8#1)(2008-11#1)
FLLs##3##1##(2010-12#3)
FLO1##4##1##(1995-6#4)
FLO11 expression##3##2##(2008-11#3)
FLO11##4##1##(2008-11#4)
FLO5 and FLO8##4##3##(1995-6#4)
FLO5##8##1##(1995-6#8)
FLO8##7##1##(1995-6#7)
FLOW##2##1##(2010-1#1)(2012-3#1)
FLOWERING LOCUS T##2##3##(2009-8#1)(2012-2#1)
FLOWERING LOCUS##3##2##(2009-8#1)(2012-2#1)(2012-3#1)
FLP/FRT##2##1##(2008-8#1)(2008-9#1)
FLS2 and EFR##2##3##(2009-8#2)
FLS2##3##1##(2009-8#3)
FLT##5##1##(2009-12#5)
FLT3##3##1##(2008-11#1)(2011-2#2)
FM and##2##2##(2010-12#1)(2013-1#1)
FM dye##2##2##(2008-8#2)
FM laser operation##2##3##(2008-3#2)
FM laser##3##2##(2008-3#3)
FM noise##2##2##(2007-12#2)
FM patients##5##2##(2009-11#2)(2010-12#3)
FM spectroscopy##2##2##(2008-2#1)(2008-3#1)
FM##37##1##(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#7)(2008-8#4)(2009-11#5)(2010-12#7)(2013-1#2)
FM3A and##2##2##(1995-11#2)
FM3A cells##2##2##(1995-11#2)
FM3A##4##1##(1995-11#4)
FM4-64##3##1##(2008-8#1)(2009-10#2)
FMD outbreaks reported in Israel and Palestine##2##7##(2009-2#2)
FMD##7##1##(2009-2#5)(2011-2#1)(2013-1#1)
FMDV##4##1##(2013-1#4)
FMF##3##1##(2007-7#3)
FMH was##2##2##(1994-6#1)(2011-2#1)
FMH##10##1##(1994-6#3)(2011-2#7)
FMI##2##1##(2012-2#2)
FMLP##7##1##(1993-1#3)(1993-6#4)
FMME044##2##1##(2013-1#2)
FMN and##2##2##(1994-8#2)
FMN domain##2##2##(1994-8#2)
FMN phosphatase activity was##2##4##(1992-12#2)
FMN phosphatase##4##2##(1992-12#4)
FMN##13##1##(1991-5#1)(1992-12#5)(1992-3#1)(1994-8#4)(1994-9#2)
FMOC##6##1##(2008-10#6)
FMR1 gene##3##2##(2009-5#2)(2012-1#1)
FMR1##5##1##(2009-5#4)(2012-1#1)
FMRF-NH2##3##1##(1991-1#3)
FMRFamide (Phe-Met-Arg-Phe-NH2)##2##2##(1991-1#2)
FMRFamide or##3##2##(1991-1#2)(1991-2#1)
FMRFamide related peptide in##2##4##(1994-2#2)
FMRFamide related peptide##3##3##(1994-2#3)
FMRFamide##17##1##(1990-7#2)(1991-1#5)(1991-2#7)(1994-2#3)
FMRFamide-like##4##1##(1991-1#2)(1994-2#2)
FMRFamide-related peptides (FaRPs)##2##3##(1991-1#2)
FMRFamide-related peptides##4##2##(1990-7#1)(1991-1#3)
FMRFamide-related##5##1##(1990-7#1)(1991-1#3)(1993-6#1)
FMRI##2##1##(2008-10#1)(2010-2#1)
FMS##9##1##(1990-6#1)(2011-2#8)
FN and##2##2##(1993-9#1)(1994-11#1)
FN expression in##2##3##(1994-9#2)
FN expression##4##2##(1994-9#4)
FN fragments##3##2##(1994-11#3)
FN##36##1##(1990-8#1)(1993-12#1)(1993-9#2)(1994-11#5)(1994-9#7)(2008-12#2)(2008-7#7)(2010-4#3)(2012-2#8)
FNA##6##1##(2007-5#1)(2008-6#4)(2008-7#1)
FNAB##15##1##(1997-2#3)(2008-10#3)(2008-6#2)(2011-1#5)(2011-2#1)(2012-2#1)
FNAC is##2##2##(1990-6#1)(2013-8#1)
FNAC##6##1##(1990-6#1)(2012-12#1)(2013-8#4)
FNP##2##1##(2008-12#2)
FNR antibodies##2##2##(1992-3#2)
FNR##9##1##(1992-3#9)
FNs or Cs##3##3##(2009-11#3)
FNs##5##1##(1994-9#1)(2009-11#4)
FO-1##2##1##(1997-9#2)
FOCOIVA##2##1##(2008-3#2)
FOD##3##1##(2007-11#3)
FOG and KW co-digestions##2##4##(2013-1#2)
FOG co-digestion##3##2##(2013-1#3)
FOG##5##1##(2013-1#5)
FOM1##2##1##(2008-10#2)
FOR##25##1##(1997-5#1)(2007-11#2)(2007-2#1)(2008-12#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
FOUR##3##1##(2007-12#1)(2007-2#1)(2012-3#1)
FOV##3##1##(2008-2#1)(2008-3#2)
FOXO1a##3##1##(2010-11#3)
FP cavity##2##2##(2008-3#2)
FP method##4##2##(2008-10#4)
FP##18##1##(1996-1#2)(1996-2#1)(2008-10#5)(2008-3#3)(2008-4#2)(2009-2#2)(2010-4#3)
FP-IX##5##1##(1994-8#5)
FP-SPA##2##1##(2008-2#2)
FPA##2##1##(1991-3#1)(2008-2#1)
FPB##2##1##(2008-10#2)
FPCA##3##1##(2008-10#2)(2010-7#1)
FPD##4##1##(2008-7#2)(2011-1#2)
FPDF##4##1##(2008-2#4)
FPG##8##1##(1994-12#6)(2011-1#1)(2011-2#1)
FPGA##6##1##(2008-12#2)(2009-5#1)(2009-6#1)(2012-3#2)
FPGA-accelerated##2##1##(2009-6#2)
FPGAs##2##1##(2008-12#1)(2009-6#1)
FPI##7##1##(2008-2#3)(2008-3#4)
FPL##2##1##(1997-6#1)(2008-9#1)
FPLC##10##1##(1990-5#1)(1991-12#1)(1993-8#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-9#1)
FPLC-ICP-AES##2##1##(2008-10#2)
FPP##2##1##(1990-2#2)
FPU)##2##1##(2011-2#2)
FPs##4##1##(2008-10#1)(2008-6#3)
FQ##4##1##(1996-12#1)(1996-5#1)(2008-3#1)(2012-3#1)
FQ/nociceptin-ir##2##1##(1996-5#2)
FQs##2##1##(2008-10#1)(2012-3#1)
FR units##2##2##(2013-8#2)
FR##14##1##(1993-12#3)(1996-12#2)(2008-1#2)(2008-12#1)(2008-6#2)(2011-1#2)(2013-8#2)
FR1064##3##1##(2008-10#3)
FR1141 x##2##2##(2008-10#2)
FR1141##4##1##(2008-10#4)
FR5 schedule##4##2##(1993-6#3)(2008-11#1)
FRA16E##2##1##(1994-11#2)
FRAP##8##1##(2008-1#1)(2008-10#1)(2008-9#3)(2013-1#3)
FRAX##2##1##(2012-12#1)(2013-8#1)
FRDA patients##2##2##(2013-7#2)
FRDA##3##1##(2013-7#3)
FRDS##4##1##(1996-8#4)
FRE exhibited##2##2##(2008-10#2)
FRE##7##1##(2008-10#7)
FRET and##3##2##(2008-4#2)(2010-5#1)
FRET as##3##2##(2008-1#1)(2008-9#2)
FRET between##2##2##(2009-8#2)
FRET in##2##2##(2008-10#1)(2008-9#1)
FRET is a##2##3##(2008-4#1)(2008-9#1)
FRET is##5##2##(2008-4#2)(2008-9#3)
FRET was##2##2##(2008-10#1)(2010-12#1)
FRET##43##1##(2008-1#1)(2008-10#2)(2008-4#8)(2008-9#20)(2009-8#5)(2009-9#1)(2010-12#5)(2010-5#1)
FRI and FLC##3##3##(2012-3#3)
FRM2##3##1##(1996-3#3)
FROG trace##2##2##(2007-12#1)(2008-3#1)
FROG##10##1##(2007-12#5)(2008-3#5)
FROM##4##1##(2010-2#1)(2011-2#1)(2013-1#2)
FRS##8##1##(2011-1#6)(2013-8#2)
FRT##7##1##(1993-8#2)(2007-11#3)(2008-2#2)
FRTL-5 cells##2##2##(1992-12#2)
FRTL5##2##1##(1994-11#2)
FS GPU implementation##3##3##(2012-2#3)
FS workers##2##2##(1991-12#2)
FS##17##1##(1991-12#6)(2008-10#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
FSA##6##1##(1995-12#3)(2012-1#3)
FSGS was##4##2##(2008-1#4)
FSGS##9##1##(2008-1#8)(2012-2#1)
FSH and LH##4##3##(1990-6#1)(1995-11#1)(2008-7#1)(2011-2#1)
FSH and##6##2##(1990-6#1)(1993-11#1)(1995-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
FSH in##2##2##(1993-11#1)(2012-12#1)
FSH receptor##3##2##(1995-11#1)(2010-5#1)(2010-8#1)
FSH##36##1##(1990-6#1)(1991-6#2)(1993-11#6)(1993-2#1)(1995-11#4)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#3)(2010-8#1)(2011-2#4)(2012-12#7)(2012-3#2)
FSHbeta##3##1##(2008-8#3)
FSM##4##1##(1994-1#1)(2008-1#3)
FSR##3##1##(2007-12#1)(2008-3#1)(2013-8#1)
FSTRAP protein##2##2##(2008-8#2)
FSTRAP was transcribed in##2##4##(2008-8#2)
FSTRAP##5##1##(2008-8#5)
FSW01##3##1##(2008-9#3)
FSWs from##2##2##(2010-8#2)
FSWs##5##1##(2010-8#5)
FT mRNA##4##2##(2012-2#4)
FT##17##1##(1991-11#2)(1994-7#2)(2008-2#2)(2008-5#1)(2008-7#1)(2012-2#5)(2013-1#4)
FT's##2##1##(2007-12#2)
FT(3) concentrations##2##2##(2008-7#2)
FT-IR and##6##2##(2008-10#3)(2008-7#1)(2008-9#1)(2011-3#1)
FT-IR method##2##2##(2008-10#2)
FT-IR of##2##2##(2008-7#1)(2012-2#1)
FT-IR spectra of pure##2##4##(2008-10#2)
FT-IR spectra of##3##3##(2007-12#1)(2008-10#2)
FT-IR spectra were##2##3##(2008-10#2)
FT-IR spectra##9##2##(2007-12#1)(2008-10#7)(2008-5#1)
FT-IR spectrometry##2##2##(2008-10#2)
FT-IR spectroscopic##3##2##(2008-10#3)
FT-IR spectroscopy and##3##3##(2008-10#3)
FT-IR spectroscopy##14##2##(1994-6#2)(2007-12#1)(2008-10#10)(2013-8#1)
FT-IR##55##1##(1994-6#4)(2007-12#3)(2008-10#38)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
FT-Raman and##3##2##(1996-2#1)(2008-10#2)
FT-Raman spectra##3##2##(2008-10#2)(2013-1#1)
FT-Raman spectrometry##3##2##(2008-10#3)
FT-Raman spectroscopy##6##2##(2008-10#6)
FT-Raman##19##1##(1996-2#1)(2008-10#16)(2013-1#2)
FT3##4##1##(2008-7#1)(2012-12#1)(2012-3#2)
FT4##2##1##(2007-8#1)(2008-7#1)
FTC##3##1##(1991-9#1)(1993-1#2)
FTD in##2##2##(2008-6#1)(2008-9#1)
FTD##13##1##(2008-4#3)(2008-6#1)(2008-9#9)
FTEs##6##1##(1991-2#1)(1994-2#1)(1994-3#1)(1996-3#3)
FTICR##2##1##(2008-7#2)
FTIR analyses##2##2##(2008-10#1)(2013-1#1)
FTIR and FT-Raman##2##3##(2013-1#2)
FTIR and##8##2##(2008-10#5)(2013-1#2)(2013-8#1)
FTIR data##2##2##(2008-10#2)
FTIR is##2##2##(2008-10#1)(2008-3#1)
FTIR spectra of the##2##4##(1995-5#1)(2013-8#1)
FTIR spectra of##3##3##(1995-5#1)(2013-8#2)
FTIR spectra were##2##3##(2008-10#2)
FTIR spectra##14##2##(1995-5#1)(2008-10#9)(2008-5#2)(2013-8#2)
FTIR spectroelectrochemical##2##2##(2008-10#2)
FTIR spectroscopic##2##2##(2008-10#2)
FTIR spectroscopy coupled to##2##4##(2008-10#2)
FTIR spectroscopy coupled##3##3##(2008-10#3)
FTIR spectroscopy to##2##3##(1997-7#1)(2008-10#1)
FTIR spectroscopy##13##2##(1997-7#3)(2008-10#9)(2008-5#1)
FTIR spectrum##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
FTIR studies##2##2##(1992-6#1)(2008-7#1)
FTIR study of##2##3##(2008-10#2)
FTIR study##4##2##(2008-10#4)
FTIR techniques##2##2##(2008-10#2)
FTIR##87##1##(1992-6#2)(1994-11#1)(1995-5#1)(1997-7#3)(2007-12#1)(2008-10#58)(2008-3#3)(2008-5#4)(2008-7#3)(2009-7#1)(2011-3#1)(2013-1#5)(2013-8#4)
FTIR-ATR and FTNIR spectroscopies##2##4##(2008-10#2)
FTND##2##1##(2013-1#2)
FTNIR##3##1##(2008-10#3)
FTP has##2##2##(2007-11#1)(2008-3#1)
FTP##7##1##(1996-3#1)(2007-11#1)(2008-3#4)(2008-4#1)
FTS##7##1##(2008-2#3)(2008-3#2)(2013-8#2)
FU +##2##2##(1992-8#2)
FU##6##1##(1992-8#2)(1995-3#2)(1997-6#2)
FUNDS##3##1##(2011-2#3)
FURA##2##1##(1993-12#1)(1993-3#1)
FUTHAN##3##1##(1990-5#3)
FV##2##1##(2008-10#1)(2012-12#1)
FVB/N##2##1##(1995-2#2)
FVC##10##1##(1996-3#1)(2008-1#1)(2008-7#4)(2011-2#3)(2012-2#1)
FVIII##2##1##(2012-12#2)
FW##6##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)
FWER##3##1##(2009-9#2)(2012-3#1)
FWHM and##2##2##(1994-5#1)(2008-3#1)
FWHM cut##2##2##(2007-11#2)
FWHM of the##3##3##(2008-2#2)(2008-3#1)
FWHM of##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
FWHM pulse##2##2##(2007-12#1)(2008-3#1)
FWHM##29##1##(1994-5#1)(2007-11#6)(2007-12#2)(2008-2#6)(2008-3#10)(2012-12#2)(2012-2#1)(2013-8#1)
FWHM)##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
FWL01##2##1##(2008-9#2)
FXIIIa##3##1##(1995-12#3)
FXS##4##1##(2009-5#1)(2010-4#3)
FY##3##1##(1992-12#1)(1994-1#1)(2012-2#1)
FZ in##3##2##(1993-6#1)(2008-10#2)
FZ##8##1##(1993-6#3)(2006-4#2)(2008-10#3)
FaO cells##2##2##(1991-12#2)
FaRP##2##1##(1991-1#1)(1993-6#1)
FaRPs##3##1##(1991-1#2)(1993-6#1)
Fab and##4##2##(1993-6#1)(1995-5#3)
Fab fragment##4##2##(1993-6#2)(2011-2#2)
Fab fragments in##2##3##(2008-2#1)(2011-2#1)
Fab fragments##12##2##(1992-3#2)(1992-6#2)(1992-7#1)(1993-6#4)(1996-2#1)(2008-2#1)(2011-2#1)
Fab##37##1##(1990-12#1)(1991-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-6#9)(1993-8#1)(1995-5#8)(1996-2#1)(2008-1#1)(2008-2#1)(2011-2#4)(2012-2#5)
Fab' fragment of##2##3##(1991-2#2)
Fab' fragments##3##2##(1990-5#1)(1995-2#2)
Fab'##6##1##(1990-5#1)(1991-2#2)(1995-2#2)(1997-2#1)
Fabaceae##4##1##(2008-10#4)
Fabaceae)##2##1##(2013-8#2)
Fabavirus##4##1##(2008-10#4)
Fabricated##3##1##(2008-10#1)(2008-12#1)(2008-3#1)
Fabrication and characterization of a##2##5##(2008-3#2)
Fabrication and characterization of##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
Fabrication and##15##2##(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#6)(2009-11#1)
Fabrication of a##4##3##(2008-10#2)(2008-3#2)
Fabrication of an##2##3##(2008-10#1)(2010-5#1)
Fabrication of##28##2##(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#10)(2008-7#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
Fabrication tolerances##2##2##(2008-2#2)
Fabrication##49##1##(2007-11#3)(2007-12#5)(2008-10#9)(2008-2#8)(2008-3#17)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
Fabricius##6##1##(1997-3#1)(2007-12#1)(2008-5#1)(2008-6#2)(2008-9#1)
Fabry disease##3##2##(2007-10#1)(2007-7#1)(2010-4#1)
Fabry##5##1##(2007-10#1)(2007-7#2)(2008-3#1)(2010-4#1)
Fabry-Perot Michelson interferometer##2##3##(2008-3#2)
Fabry-Perot cavities with##2##3##(2008-2#1)(2008-3#1)
Fabry-Perot cavities##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Fabry-Perot cavity as a function of##2##6##(2008-2#1)(2008-3#1)
Fabry-Perot cavity is##4##3##(2008-2#1)(2008-3#3)
Fabry-Perot cavity##23##2##(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#12)(2013-8#1)
Fabry-Perot etalon used in##2##4##(2007-11#1)(2008-3#1)
Fabry-Perot etalon##12##2##(2007-11#5)(2008-2#2)(2008-3#5)
Fabry-Perot etalons as solar background filters##2##6##(2008-3#2)
Fabry-Perot etalons##4##2##(2008-3#4)
Fabry-Perot filter##2##2##(2008-3#2)
Fabry-Perot interferometer (FPI)##3##3##(2008-2#2)(2008-3#1)
Fabry-Perot interferometer and a##2##4##(2008-3#2)
Fabry-Perot interferometer and##4##3##(2008-2#1)(2008-3#3)
Fabry-Perot interferometer dielectric stack##2##4##(2008-2#2)
Fabry-Perot interferometer with##2##3##(2008-3#2)
Fabry-Perot interferometer##27##2##(2007-11#2)(2008-10#1)(2008-2#11)(2008-3#13)
Fabry-Perot interferometers##2##2##(2008-2#1)(2008-3#1)
Fabry-Perot laser##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
Fabry-Perot mirror##2##2##(2007-11#2)
Fabry-Perot resonator##5##2##(2007-11#2)(2008-3#3)
Fabry-Perot saturable absorber##2##3##(2007-12#2)
Fabry-Perot semiconductor##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Fabry-Perot sensor with##2##3##(2008-3#2)
Fabry-Perot##120##1##(2007-11#18)(2007-12#10)(2008-10#1)(2008-2#29)(2008-3#59)(2013-8#3)
Fabry-Pérot##2##1##(2008-3#1)(2008-7#1)
Face##10##1##(1994-9#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-1#2)(2010-4#1)(2012-12#1)
Faced with##5##2##(1993-1#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)
Faced##6##1##(1993-1#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(2013-8#1)
Faces##2##1##(2008-11#1)(2008-2#1)
Facial Nerve Monitoring##2##3##(2012-3#2)
Facial nerve##3##2##(2008-9#2)(2011-2#1)
Facial##18##1##(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)
Facile##5##1##(2007-11#1)(2008-12#1)(2010-10#1)(2010-5#1)(2013-8#1)
Facilitating##8##1##(1993-2#1)(2008-11#3)(2008-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
Facilitation##2##1##(1991-2#1)(1994-3#1)
Facilitators##3##1##(2008-11#1)(2013-1#2)
Facilities should##2##2##(2010-9#1)(2011-1#1)
Facilities##7##1##(1995-2#1)(2007-12#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
Facility##11##1##(1992-2#1)(1994-12#1)(2008-2#1)(2008-3#7)(2010-8#1)
Facing##3##1##(1995-3#1)(2008-11#1)(2008-7#1)
Factitious disorder##2##2##(2010-12#2)
Factitious##3##1##(2010-12#3)
Factor (BDNF)##3##2##(2008-11#1)(2013-8#2)
Factor 1##2##2##(1997-8#1)(2008-10#1)
Factor 2##2##2##(1995-2#1)(2008-10#1)
Factor Analysis##4##2##(2008-10#2)(2012-2#2)
Factor B##2##2##(1991-3#2)
Factor V##2##2##(2012-12#2)
Factor VIIa##2##2##(1995-6#1)(2008-8#1)
Factor Xa##3##2##(1994-8#1)(2008-11#1)(2008-5#1)
Factor analysis revealed##2##3##(2008-10#1)(2011-1#1)
Factor analysis##5##2##(1996-7#1)(2008-10#1)(2008-11#2)(2011-1#1)
Factor and##4##2##(1990-5#1)(1994-11#1)(2012-3#1)(2013-1#1)
Factor b##2##2##(1993-12#2)
Factor in##2##2##(1994-6#1)(2012-2#1)
Factor##80##1##(1990-12#1)(1990-5#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-7#1)(1992-9#1)(1993-12#2)(1994-11#2)(1994-6#6)(1994-8#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-8#1)(2008-10#7)(2008-11#8)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
Factor)##2##1##(2008-5#1)(2009-6#1)
Factorial design for##2##3##(2008-10#2)
Factorial design##6##2##(2008-10#5)(2010-5#1)
Factorial designs##2##2##(2008-10#2)
Factorial##9##1##(2008-10#8)(2010-5#1)
Factors Affecting the Release##2##4##(2008-10#2)
Factors Affecting the##4##3##(2008-10#4)
Factors Affecting##11##2##(2008-1#1)(2008-10#10)
Factors Associated with##2##3##(1994-12#1)(2011-2#1)
Factors Influencing##3##2##(2008-10#3)
Factors affecting survival in##2##4##(2007-10#1)(2010-11#1)
Factors affecting the##6##3##(1991-12#1)(1994-7#1)(2008-10#3)(2011-1#1)
Factors affecting##15##2##(1991-12#1)(1992-11#1)(1994-7#1)(1997-1#1)(2007-10#1)(2008-10#5)(2008-5#1)(2010-11#2)(2011-1#1)(2011-2#1)
Factors and##3##2##(2008-6#1)(2009-6#1)(2011-2#1)
Factors as##2##2##(2011-1#2)
Factors associated with##13##3##(1991-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
Factors contributing to##2##3##(2008-11#1)(2008-9#1)
Factors in##8##2##(1995-4#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-9#1)(2012-3#1)(2013-1#1)
Factors influencing the separation and detection processes were examined and optimized##2##11##(2008-10#2)
Factors influencing the separation and detection##3##6##(2008-10#3)
Factors influencing the##11##3##(1994-12#1)(1994-3#2)(2008-10#8)
Factors influencing##23##2##(1991-1#2)(1993-10#1)(1993-2#1)(1994-12#1)(1994-3#2)(1996-1#1)(2008-10#9)(2008-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
Factors on##3##2##(2008-10#2)(2013-1#1)
Factors related to##5##3##(1994-12#1)(2010-3#1)(2010-9#1)(2011-2#2)
Factors responsible for the##2##4##(1990-3#1)(1994-8#1)
Factors studied##2##2##(2008-1#1)(2008-10#1)
Factors such as##6##3##(2007-7#2)(2008-10#3)(2010-8#1)
Factors that affect the##2##4##(1991-9#1)(2008-6#1)
Factors that may##2##3##(1995-2#1)(2008-10#1)
Factors that##14##2##(1991-9#1)(1992-3#1)(1995-2#1)(2007-12#2)(2008-10#4)(2008-6#1)(2008-7#2)(2009-12#1)(2013-1#1)
Factors were##2##2##(2008-12#1)(2011-2#1)
Factors which##4##2##(1995-1#1)(2008-1#1)(2008-7#1)(2011-1#1)
Factors##146##1##(1990-3#1)(1991-1#3)(1991-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-10#1)(1993-2#1)(1994-12#3)(1994-3#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-1#5)(2008-10#44)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#3)(2009-12#2)(2009-6#2)(2009-9#2)(2010-10#1)(2010-11#6)(2010-12#1)(2010-3#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
Facts for Action to Stroke##2##5##(2010-10#2)
Facts##3##1##(2007-2#1)(2010-10#2)
Faculties##2##1##(1994-12#1)(2011-1#1)
Faculty development##2##2##(2008-11#1)(2013-8#1)
Faculty of Agriculture##3##3##(2008-12#3)
Faculty of Medicine##10##3##(1994-2#1)(2008-1#1)(2008-10#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)
Faculty of Veterinary##3##3##(1996-12#1)(1997-8#1)(2013-8#1)
Faculty of##24##2##(1994-2#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-12#4)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
Faculty##38##1##(1993-6#1)(1994-2#1)(1996-12#2)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2013-1#2)(2013-8#2)
Faculté de médecine##2##3##(2010-1#2)
FadR##2##1##(1992-8#2)
FadR-DNA##2##1##(1992-8#2)
Fading of artificial hair colour##2##5##(2008-5#2)
Fading##3##1##(2008-2#1)(2008-5#2)
Faecal consistency was##2##3##(1996-12#2)
Faecal examination##2##2##(1996-12#2)
Faecal##10##1##(1993-8#1)(1996-12#6)(2007-7#1)(2008-8#1)(2011-1#1)
Faeces were##2##2##(1996-12#1)(2008-10#1)
Failed##2##1##(2008-7#1)(2012-3#1)
Failing to##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
Failure of the##3##3##(1996-11#1)(1997-6#1)(2008-3#1)
Failure of##13##2##(1991-12#1)(1993-10#1)(1996-11#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#2)(2012-3#1)
Failure to##17##2##(1991-10#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1997-1#2)(1997-7#1)(2007-2#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
Failure##51##1##(1991-10#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-11#1)(1997-1#2)(1997-6#1)(1997-7#1)(2007-2#1)(2007-7#3)(2008-1#10)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
Fair Employment and Housing Act##2##5##(1995-12#1)(1997-5#1)
Fair Employment and Housing##3##4##(1990-2#1)(1995-12#1)(1997-5#1)
Fair##8##1##(1990-2#1)(1991-11#1)(1991-3#1)(1995-12#2)(1997-5#1)(1997-8#1)(2008-11#1)
Faith##4##1##(2008-12#3)(2011-1#1)
Falanga##2##1##(1996-3#2)
Falciparum malaria##3##2##(2007-2#2)(2012-3#1)
Falciparum##5##1##(2007-2#2)(2012-3#3)
Fall in##2##2##(1991-11#1)(1995-9#1)
Fall##8##1##(1991-11#1)(1994-1#1)(1995-1#1)(1995-9#1)(2008-10#2)(2010-10#1)(2011-2#1)
Falling##2##1##(2008-3#1)(2008-6#1)
Fallopian tube##3##2##(2011-1#2)(2012-12#1)
Fallopian##4##1##(1991-11#1)(2011-1#2)(2012-12#1)
Falls and Balance Clinic for the elderly##2##7##(1994-12#2)
Falls##6##1##(1994-12#2)(1995-2#2)(1997-3#1)(2008-7#1)
False Claims Act##2##3##(1997-1#1)(2008-11#1)
False positive##5##2##(1990-12#1)(1992-1#1)(2008-7#1)(2009-3#1)(2011-2#1)
False##15##1##(1990-12#1)(1992-1#1)(1994-9#1)(1997-1#1)(2007-7#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-3#1)
False-negative##2##1##(1991-2#1)(2008-10#1)
Familial Mediterranean##2##2##(1996-6#1)(2007-7#1)
Familial adenomatous polyposis##2##3##(2008-4#1)(2009-12#1)
Familial colorectal##2##2##(1993-7#1)(2009-12#1)
Familial glucocorticoid deficiency##2##3##(2011-1#2)
Familial hypercholesterolaemia##2##2##(2008-6#2)
Familial restrictive cardiomyopathy##2##3##(2008-7#2)
Familial##33##1##(1990-12#1)(1991-8#1)(1993-7#1)(1994-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-7#1)(2007-10#2)(2007-5#1)(2007-7#5)(2008-4#2)(2008-6#2)(2008-7#4)(2009-12#2)(2009-6#1)(2010-4#1)(2011-1#2)(2013-1#2)
Familiar##3##1##(2008-4#1)(2008-9#1)(2011-1#1)
Familiarity##2##1##(2008-7#1)(2012-2#1)
Families Program##2##2##(2013-1#2)
Families and##3##2##(2008-12#1)(2008-2#1)(2012-12#1)
Families in##3##2##(1995-3#1)(2008-6#1)(2012-12#1)
Families of children with##2##4##(1995-1#1)(1995-3#1)
Families with##5##2##(1992-2#1)(1994-11#1)(1996-1#1)(1996-12#1)(1996-3#1)
Families##25##1##(1990-6#1)(1992-2#1)(1994-11#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#2)(2010-10#1)(2010-12#1)(2012-12#2)(2012-2#2)(2013-1#3)
Family Asthma##2##2##(1992-1#2)
Family Check-Up##2##2##(2013-7#2)
Family Functioning##2##2##(2008-9#1)(2013-1#1)
Family Health Teams and##2##4##(2008-9#2)
Family Health Teams##3##3##(2008-9#3)
Family Health##10##2##(1994-3#1)(2008-11#1)(2008-9#4)(2010-10#1)(2011-2#2)(2012-3#1)
Family Physicians##2##2##(1993-12#1)(2013-1#1)
Family Planning##4##2##(1991-1#1)(1996-3#1)(2008-11#1)(2013-8#1)
Family Practice##2##2##(1992-1#1)(2008-7#1)
Family Proteins##3##2##(2010-8#1)(2012-3#1)(2013-1#1)
Family Welfare##3##2##(1994-7#1)(1996-4#2)
Family and Community Medicine##2##4##(1994-2#1)(1997-3#1)
Family and Community##4##3##(1993-5#1)(1994-2#1)(1997-3#1)(2010-10#1)
Family and Medical Leave Act##2##5##(1994-2#1)(1994-3#1)
Family and##11##2##(1993-3#1)(1993-5#1)(1994-2#2)(1994-3#1)(1997-3#1)(2008-1#1)(2008-8#2)(2010-10#1)(2013-1#1)
Family factors##2##2##(2013-8#2)
Family history of##3##3##(1994-2#1)(1995-9#1)(2008-7#1)
Family history##5##2##(1994-2#1)(1995-9#1)(2008-4#1)(2008-7#2)
Family planning##2##2##(1992-4#1)(1994-8#1)
Family##115##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-12#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#6)(2009-12#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-4#2)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#5)
Family-centered care##3##2##(1991-1#2)(1992-3#1)
Family-centered##4##1##(1991-1#2)(1992-3#1)(2010-9#1)
Fan##4##1##(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
Fanconi anemia (FA) is an autosomal recessive syndrome characterized by progressive pancytopenia and a high risk of##2##17##(2008-4#2)
Fanconi anemia (FA)##3##3##(1997-3#1)(2008-4#2)
Fanconi anemia##4##2##(1997-3#2)(2008-4#2)
Fanconi##8##1##(1997-3#3)(2008-1#2)(2008-4#3)
Fantastic questionnaire##3##2##(2012-12#3)
Fantastic##5##1##(2012-12#5)
Fanti-Brown##2##1##(1997-4#2)
Fanti-White##2##1##(1997-4#2)
Fao cells##5##2##(1992-10#2)(1994-11#1)(2008-4#2)
Fao hepatoma cells##2##3##(1992-10#1)(1993-6#1)
Fao##9##1##(1992-10#4)(1993-6#1)(1994-11#1)(2008-4#3)
Far Ultraviolet Spectroscopic##2##3##(2008-3#2)
Far##9##1##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)
Far-UV circular dichroism##2##3##(1992-8#1)(1993-8#1)
Far-UV##4##1##(1992-8#3)(1993-8#1)
Far-field radiation##2##2##(2007-12#2)
Far-field scattering##2##2##(2008-2#2)
Far-field##9##1##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)
Far-infrared##3##1##(2007-12#2)(2008-3#1)
Far-ultraviolet##2##1##(1992-8#1)(2008-2#1)
Faraday effect##4##2##(2007-12#2)(2008-3#2)
Faraday rotation##4##2##(2007-11#1)(2008-3#3)
Faraday rotator##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
Faraday##21##1##(1993-5#1)(2007-11#2)(2007-12#6)(2008-2#3)(2008-3#8)(2008-7#1)
Farewell##2##1##(2006-12#2)
Farm##14##1##(1990-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-9#1)(2012-3#1)(2013-1#1)
Farmers##3##1##(1995-8#1)(2008-12#2)
Farming##3##1##(2007-10#1)(2008-10#1)(2008-12#1)
Fas expression##8##2##(2008-8#2)(2010-3#5)(2011-2#1)
Fas pathway##2##2##(2010-3#2)
Fas##22##1##(2008-11#1)(2008-8#7)(2008-9#1)(2010-3#11)(2011-2#1)(2012-3#1)
Fas+ cells##2##2##(2010-3#2)
Fas+ tumor cells##2##3##(2010-3#2)
Fas+##4##1##(2010-3#4)
Fas-##3##1##(2010-3#3)
Fas-mediated apoptosis##3##2##(1997-8#3)
Fas/FasL##4##1##(2008-9#2)(2010-3#2)
FasL##5##1##(2008-10#1)(2008-9#1)(2010-3#3)
Fasciitis##4##1##(2006-10#4)
Fasciola eggs##5##2##(1996-12#5)
Fasciola hepatica##7##2##(1992-6#1)(1995-5#1)(2007-10#2)(2008-8#1)(2009-8#2)
Fasciola##14##1##(1992-6#1)(1995-5#1)(1996-12#6)(2007-10#2)(2008-8#1)(2009-8#2)(2012-2#1)
Fast Blue##2##2##(1996-5#1)(2012-3#1)
Fast Fourier##2##2##(2008-7#1)(2009-12#1)
Fast Track##3##2##(2007-9#3)
Fast algorithm for##2##3##(2008-2#2)
Fast and##3##2##(2008-10#2)(2008-3#1)
Fast atom bombardment mass spectrometry##2##5##(1993-11#1)(1994-3#1)
Fast atom##3##2##(1993-11#1)(1994-3#1)(1996-5#1)
Fast determination of##3##3##(2008-10#3)
Fast green FCF##2##3##(1990-6#2)
Fast photorefractive response in##2##4##(2007-11#1)(2007-12#1)
Fast repair of##2##3##(2008-8#1)(2008-9#1)
Fast simultaneous##2##2##(2008-10#2)
Fast##77##1##(1990-2#1)(1990-6#2)(1993-11#1)(1994-3#1)(1994-9#1)(1996-5#2)(1997-8#1)(2007-11#5)(2007-12#2)(2007-9#4)(2008-10#17)(2008-2#5)(2008-3#10)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2012-8#1)(2013-1#1)
FastME is##2##2##(2008-4#2)
FastME##5##1##(2008-4#5)
Faster##5##1##(1995-2#1)(1996-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
Fasting blood##2##2##(2008-5#1)(2013-1#1)
Fasting serum glucose##2##3##(2011-1#1)(2013-1#1)
Fasting##12##1##(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#5)(2013-1#2)
Fat Mass##2##2##(2012-2#2)
Fat and##4##2##(1997-7#1)(2008-5#1)(2010-4#2)
Fat grafting##2##2##(2013-1#2)
Fat is##2##2##(2006-12#1)(2008-11#1)
Fat mass##2##2##(2008-7#1)(2013-1#1)
Fat##22##1##(1997-7#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-4#4)(2012-2#3)(2013-1#5)
FatB##3##1##(2011-2#3)
Fatal##16##1##(1992-2#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(2007-8#2)(2008-11#1)(2009-4#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
Fatality##2##1##(2010-1#1)(2011-2#1)
Fatebenefratelli Hospital##2##2##(1992-6#1)(2011-7#1)
Father of##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
Father##4##1##(1997-3#1)(2008-10#1)(2010-8#1)(2013-8#1)
Fathers'##2##1##(2008-2#1)(2009-5#1)
Fatibello-Filho##2##1##(2008-10#2)
Fatigue and##2##2##(2008-7#1)(2013-8#1)
Fatigue in##2##2##(2009-10#1)(2010-7#1)
Fatigue##14##1##(2008-6#1)(2008-7#5)(2009-10#1)(2009-7#1)(2010-4#1)(2010-7#1)(2013-1#2)(2013-8#2)
Fatty Acid##3##2##(2008-10#2)(2010-1#1)
Fatty Acids##6##2##(2008-10#2)(2009-8#1)(2012-2#2)(2013-1#1)
Fatty acid composition of the##2##5##(2008-7#1)(2010-4#1)
Fatty acid composition of##4##4##(1991-12#1)(2008-7#1)(2010-4#2)
Fatty acid composition##5##3##(1991-12#1)(2008-7#1)(2010-4#2)(2013-1#1)
Fatty acid profiles of##2##4##(2008-10#2)
Fatty acid profiles##3##3##(2008-10#3)
Fatty acid##16##2##(1990-7#1)(1991-12#1)(1992-3#2)(1993-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-3#1)(2010-4#2)(2013-1#1)(2013-8#1)
Fatty acid-binding protein##2##3##(2013-1#2)
Fatty acids and##2##3##(2012-2#2)
Fatty acids##9##2##(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#2)
Fatty liver deposition##2##3##(2012-2#2)
Fatty liver##4##2##(1997-3#1)(2012-2#2)(2013-1#1)
Fatty##46##1##(1990-7#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-8#1)(1997-2#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-2#6)(2013-1#7)(2013-8#1)
Fault##3##1##(1996-4#2)(2009-10#1)
Favorable##5##1##(1992-10#1)(2008-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
Favourable##3##1##(1991-11#1)(1992-9#1)(1997-3#1)
Fc portion of IgG##2##4##(1990-12#1)(2008-10#1)
Fc portion of##4##3##(1990-12#1)(2008-10#1)(2008-4#2)
Fc receptor##5##2##(1991-2#1)(1994-6#1)(1994-8#2)(1996-3#1)
Fc receptors and##2##3##(1990-12#1)(2008-10#1)
Fc receptors##3##2##(1990-12#1)(1991-2#1)(2008-10#1)
Fc region##4##2##(2008-11#3)(2009-2#1)
Fc##29##1##(1990-12#4)(1991-2#2)(1993-6#1)(1994-6#2)(1994-8#2)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-11#5)(2008-4#3)(2009-2#1)(2009-9#2)
Fc-fusion protein##2##2##(2011-2#2)
Fc-fusion proteins##2##2##(2011-2#1)(2012-2#1)
Fc-fusion##8##1##(2011-2#3)(2012-2#5)
FcepsilonRI expression##6##2##(2008-11#6)
FcepsilonRI on##3##2##(2008-11#3)
FcepsilonRI##14##1##(2008-11#14)
FcepsilonRI-mediated##2##1##(2009-6#2)
Fcgamma##3##1##(2008-10#1)(2008-8#2)
FcgammaR##5##1##(2008-10#3)(2008-4#2)
Fd chain##2##2##(1993-6#2)
Fd##4##1##(1992-12#1)(1993-6#3)
Fe Boltzmann##2##2##(2008-2#2)
Fe XIV 211##2##3##(2008-3#2)
Fe XIV##3##2##(2008-3#3)
Fe and Al##3##3##(2008-10#3)
Fe and Cu##3##3##(2008-10#3)
Fe and Mn##3##3##(2008-10#3)
Fe and Ni were##3##4##(2008-10#3)
Fe and Ni##7##3##(2008-10#7)
Fe and Ti contents in##2##5##(2013-8#2)
Fe and V##3##3##(2008-10#3)
Fe and Zn in##2##4##(2008-10#2)
Fe and Zn##9##3##(1995-3#2)(2008-10#6)(2013-1#1)
Fe and##43##2##(1995-3#2)(1996-2#1)(2008-10#34)(2008-5#2)(2009-10#1)(2013-1#1)(2013-8#2)
Fe at 56##3##3##(2008-10#3)
Fe at##4##2##(2008-10#4)
Fe binding##2##2##(1996-2#2)
Fe content##2##2##(2008-10#2)
Fe crystal##3##2##(2007-12#1)(2008-3#2)
Fe deficient##2##2##(1995-3#2)
Fe from##3##2##(1996-2#1)(2008-10#2)
Fe in the##2##3##(2008-10#2)
Fe in##12##2##(2008-10#11)(2008-12#1)
Fe levels##2##2##(2008-10#2)
Fe minus##3##2##(2008-10#1)(2013-1#2)
Fe per##2##2##(1992-8#1)(2010-11#1)
Fe photorefractive crystal##2##3##(2007-12#1)(2008-3#1)
Fe were##4##2##(2008-10#4)
Fe##246##1##(1992-8#1)(1993-5#1)(1995-3#4)(1996-2#5)(1997-4#1)(2007-11#3)(2007-12#6)(2008-10#173)(2008-12#4)(2008-2#8)(2008-3#12)(2008-5#7)(2008-7#2)(2009-10#1)(2009-11#3)(2010-11#3)(2010-4#1)(2010-5#1)(2010-6#1)(2013-1#4)(2013-8#5)
Fe(111)##6##1##(2008-10#6)
Fe(2)O(3)##6##1##(2008-10#5)(2008-2#1)
Fe(2+) and##6##2##(2008-10#5)(2008-8#1)
Fe(2+)##22##1##(1997-7#1)(2008-10#19)(2008-11#1)(2008-8#1)
Fe(2+)-chelating ability##2##2##(2008-10#2)
Fe(2+)/Fe(3+)##2##1##(2008-10#2)
Fe(3)O(4)##2##1##(2009-11#2)
Fe(3+) (0##2##2##(2008-10#2)
Fe(3+) and Zn(2+)##2##3##(2008-10#1)(2010-11#1)
Fe(3+) and##5##2##(2008-10#3)(2008-8#1)(2010-11#1)
Fe(3+) into##2##2##(2008-10#1)(2010-11#1)
Fe(3+) of##2##2##(2008-9#2)
Fe(3+) to##2##2##(2008-10#2)
Fe(3+)##45##1##(2008-10#38)(2008-8#1)(2008-9#3)(2010-11#3)
Fe(3+))##3##1##(2008-10#3)
Fe(II) and Fe(III) can be determined##2##6##(2008-10#2)
Fe(II) and Fe(III) can be##3##5##(2008-10#3)
Fe(II) and Fe(III)##17##3##(2008-10#16)(2010-4#1)
Fe(II) and##26##2##(2008-10#25)(2010-4#1)
Fe(II) by##3##2##(2008-10#3)
Fe(II) concentrations##2##2##(2008-10#2)
Fe(II) in##5##2##(2008-10#5)
Fe(II) ions##3##2##(2008-10#3)
Fe(II) levels##2##2##(2008-10#2)
Fe(II) molar##2##2##(2010-4#2)
Fe(II) or##4##2##(2008-10#3)(2011-1#1)
Fe(II) plus##2##2##(2008-10#1)(2011-1#1)
Fe(II) to Fe(III)##2##3##(2008-10#2)
Fe(II) to##5##2##(2008-10#5)
Fe(II) uptake and##2##3##(1996-2#2)
Fe(II) uptake##5##2##(1996-2#5)
Fe(II) was##3##2##(1996-2#1)(2008-10#2)
Fe(II) which##2##2##(2008-10#2)
Fe(II) with##4##2##(2008-10#4)
Fe(II)##118##1##(1990-8#2)(1991-8#1)(1995-6#1)(1996-2#9)(2008-10#99)(2008-5#1)(2010-4#3)(2011-1#2)
Fe(II)-EDTA##2##1##(1995-2#2)
Fe(III) and Co(II)##4##3##(2008-10#4)
Fe(III) and Fe(II) ions##2##4##(2008-10#2)
Fe(III) and Fe(II)##9##3##(2008-10#9)
Fe(III) and Pb(II)##3##3##(2008-10#3)
Fe(III) and total##2##3##(2008-10#2)
Fe(III) and##24##2##(2008-10#24)
Fe(III) by##3##2##(2008-10#3)
Fe(III) can be determined in the range of 0##2##9##(2008-10#2)
Fe(III) can be determined in the##3##6##(2008-10#3)
Fe(III) can be determined##4##4##(2008-10#4)
Fe(III) can be##5##3##(2008-10#5)
Fe(III) can##6##2##(2008-10#6)
Fe(III) concentration from##2##3##(2008-10#2)
Fe(III) concentration##3##2##(2008-10#3)
Fe(III) in HCl##2##3##(2008-10#2)
Fe(III) in the presence of##4##5##(2008-10#4)
Fe(III) in the##6##3##(2008-10#6)
Fe(III) in##16##2##(2008-10#16)
Fe(III) ion##2##2##(2008-10#2)
Fe(III) ions##5##2##(2008-10#5)
Fe(III) is##6##2##(2008-10#6)
Fe(III) to Fe(II)##6##3##(1995-6#1)(2008-10#5)
Fe(III) was##4##2##(2008-10#4)
Fe(III) were##5##2##(2008-10#5)
Fe(III) with##4##2##(2008-10#4)
Fe(III)##159##1##(1993-6#1)(1995-6#2)(1997-7#2)(2008-10#152)(2008-5#1)(2010-4#1)
Fe(III)(hydr)oxide##2##1##(2008-10#2)
Fe(III))##2##1##(2008-10#2)
Fe(III)-1##2##1##(2008-10#2)
Fe(III)-Fe(II) potential buffer##2##3##(2008-10#2)
Fe(III)-anthracycline complex##2##2##(1993-6#2)
Fe(III)-reducing conditions##2##2##(2008-10#2)
Fe(III)/Fe(II) redox couple##3##3##(2008-10#3)
Fe(III)/Fe(II)##4##1##(2008-10#4)
Fe(NO(3))(3)##2##1##(2008-10#2)
Fe(OH)(3) precipitation##2##2##(2008-10#2)
Fe(OH)(3)##3##1##(2008-10#3)
Fe) in sera from patients with dilated cardiomyopathy##2##8##(1993-2#2)
Fe)##6##1##(1993-2#2)(1996-2#1)(2008-10#3)
Fe- and Mn-TCPP(g)s##2##3##(2008-10#2)
Fe- and##4##2##(2008-10#4)
Fe-##5##1##(2008-10#5)
Fe-BPANS complex##3##2##(2008-10#3)
Fe-Fe##3##1##(1995-6#2)(2009-11#1)
Fe-Mn##3##1##(2008-10#3)
Fe-S##2##1##(1993-11#2)
Fe-SOD##3##1##(1990-11#2)(2008-10#1)
Fe-containing##2##1##(1992-3#1)(1994-8#1)
Fe/V alloys##2##2##(2008-10#2)
Fe/ferritin##2##1##(1996-2#2)
Fe0##5##1##(1994-5#5)
Fe0-treated##2##1##(1994-5#2)
Fe2+##4##1##(1992-9#2)(1997-4#1)(1997-7#1)
Fe2O3##2##1##(2008-10#1)(2008-12#1)
Fe2S2##2##1##(1994-5#2)
Fe2S2Cys4 ferredoxins##2##2##(1994-5#2)
Fe3+##6##1##(1991-5#4)(2008-3#1)(2013-8#1)
FeCl(3) to##2##2##(2008-10#2)
FeCl(3)##8##1##(2008-10#7)(2013-1#1)
FeCl3##2##1##(1995-6#1)(2008-10#1)
FeEDDHA##3##1##(2008-10#3)
FeLV-p27##2##1##(2008-11#2)
FeMnCuO(x) and##2##2##(2008-3#2)
FeMnCuO(x)##3##1##(2008-3#3)
FeNO level##3##2##(2012-1#3)
FeNO levels remained associated with##2##5##(2012-1#2)
FeNO levels##3##2##(2012-1#3)
FeNO##10##1##(2012-1#10)
FePd##2##1##(2006-4#2)
FePt nanoparticles are##2##3##(2008-10#2)
FePt nanoparticles##3##2##(2008-10#3)
FePt##4##1##(2008-10#4)
FeS##6##1##(1995-6#5)(2008-10#1)
FeSO(4) were##2##2##(2008-11#2)
FeSO(4)##14##1##(2008-10#3)(2008-11#9)(2008-7#2)
FeSO(4)·7H(2)O##2##1##(2013-1#2)
FeTSPc##3##1##(2008-10#3)
Fear of##2##2##(1990-3#1)(2012-1#1)
Fear##3##1##(1990-3#1)(2010-7#1)(2012-1#1)
Fear-potentiation##2##1##(2008-11#2)
Fearful-avoidant##2##1##(2012-1#2)
Fears##3##1##(1996-11#1)(2007-2#1)(2008-11#1)
Feasibility of the##3##3##(1993-12#1)(2008-3#1)(2011-2#1)
Feasibility of##9##2##(1993-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
Feasibility study##2##2##(2008-3#1)(2012-3#1)
Feasibility##18##1##(1993-12#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Feasible##2##1##(2008-5#1)(2013-8#1)
Feather##2##1##(1997-6#1)(2008-6#1)
Feature##6##1##(2008-2#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
Features and##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
Features of the##5##3##(1995-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
Features of##14##2##(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#2)
Features##25##1##(1995-12#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
Feb##3##1##(1990-10#1)(2008-12#1)(2008-7#1)
Febrile neutropenia is##2##3##(2008-11#1)(2008-7#1)
Febrile neutropenia##4##2##(2008-11#1)(2008-7#3)
Febrile seizures##3##2##(2006-5#1)(2010-11#1)(2013-1#1)
Febrile##11##1##(1991-11#1)(1994-12#1)(2006-5#1)(2008-11#2)(2008-7#3)(2010-11#1)(2011-2#1)(2013-1#1)
February 13##2##2##(1994-12#1)(1997-2#1)
February 1991##3##2##(1992-8#1)(1993-1#1)(1994-2#1)
February 1992 to##3##3##(2008-2#2)(2008-5#1)
February 1992##6##2##(1993-3#1)(2008-2#3)(2008-5#2)
February 1994##3##2##(1996-3#1)(1997-2#1)(2008-7#1)
February 1996##2##2##(2008-7#2)
February 1997##5##2##(1997-8#1)(2008-2#1)(2008-3#1)(2008-5#2)
February 1998##5##2##(2007-5#2)(2008-11#1)(2008-5#1)(2008-6#1)
February 2000##3##2##(2008-3#1)(2008-5#1)(2008-6#1)
February 2002##5##2##(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)
February 2003##4##2##(2007-7#1)(2008-5#1)(2008-7#2)
February 2004##3##2##(2008-1#1)(2008-5#1)(2010-8#1)
February 2006##3##2##(2008-4#1)(2008-7#1)(2010-2#1)
February 2008##5##2##(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)
February 2009##7##2##(2010-3#1)(2011-2#4)(2013-1#1)(2013-7#1)
February 2011##3##2##(2012-12#1)(2012-2#2)
February and April##2##3##(2008-3#1)(2013-7#1)
February and March##3##3##(1996-6#1)(2008-10#1)(2013-8#1)
February and##11##2##(1996-6#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#2)(2013-7#2)(2013-8#2)
February##121##1##(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#4)(1994-2#1)(1994-9#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2007-5#5)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#7)(2009-2#2)(2009-9#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#14)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#6)(2013-8#3)
February)##2##1##(2008-5#1)(2008-7#1)
February-March##2##1##(1996-9#1)(2013-7#1)
Fecal samples##3##2##(2009-4#1)(2011-2#1)(2012-3#1)
Fecal##8##1##(1991-12#1)(2009-4#5)(2011-2#1)(2012-3#1)
Fed-batch culture##3##2##(2008-11#1)(2008-7#2)
Fed-batch##6##1##(2008-11#2)(2008-7#3)(2011-2#1)
Federal Agency for the Safety of the Food##2##8##(2008-10#2)
Federal Government##8##2##(1995-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2008-11#1)(2008-6#2)
Federal Republic of Germany##7##4##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#3)(1995-1#1)
Federal Republic of##8##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#3)(1995-1#1)
Federal Republic##9##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#4)(1995-1#1)
Federal University##5##2##(1993-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
Federal agencies##2##2##(1995-3#1)(1996-2#1)
Federal and State##3##3##(1994-1#1)(1996-1#1)(2008-6#1)
Federal and state##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
Federal and##6##2##(1994-1#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-6#1)(2012-3#1)
Federal budget##3##2##(1995-6#1)(1996-3#1)(1996-5#1)
Federal government##3##2##(1995-12#1)(1997-5#1)(2008-7#1)
Federal grants##2##2##(1996-3#1)(1997-2#1)
Federal health care##2##3##(1996-1#1)(1997-5#1)
Federal health##3##2##(1995-3#1)(1996-1#1)(1997-5#1)
Federal judge##5##2##(1995-12#2)(1995-6#1)(1996-5#1)(1997-5#1)
Federal##91##1##(1990-12#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#6)(1992-12#1)(1993-1#2)(1993-2#1)(1993-6#1)(1994-1#3)(1994-2#1)(1995-1#2)(1995-12#6)(1995-3#4)(1995-6#2)(1996-1#11)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#5)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
Federated States of Micronesia##8##4##(2008-1#2)(2008-10#1)(2013-8#5)
Federation and##3##2##(1995-3#2)(2012-12#1)
Federation for##2##2##(1994-3#1)(2010-5#1)
Federation of##9##2##(1990-2#1)(1994-7#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
Federation##20##1##(1990-2#1)(1994-3#1)(1994-7#1)(1995-3#3)(1995-6#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Feed consumption by the exposed groups was similar to that by the control groups throughout the study##4##17##(2008-8#2)(2008-9#2)
Feed intake##2##2##(2008-12#1)(2010-2#1)
Feed##9##1##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-8#1)
Feed-forward##2##1##(2008-10#2)
Feedback control of##2##3##(2008-3#1)(2009-8#1)
Feedback from the##2##3##(1993-2#1)(2008-11#1)
Feedback from##5##2##(1993-2#2)(2008-11#1)(2008-12#1)(2010-2#1)
Feedback was##2##2##(1992-12#1)(2013-8#1)
Feedback##19##1##(1992-12#1)(1993-2#2)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#2)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
Feeding and##2##2##(2013-8#2)
Feeding in##2##2##(2008-8#1)(2012-2#1)
Feeding##21##1##(1990-12#1)(1993-12#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
Feeling##6##1##(1997-1#1)(2007-12#1)(2008-12#2)(2008-9#1)(2010-10#1)
Feingold##2##1##(1997-3#2)
Feldenkrais method##3##2##(2010-6#3)
Feldenkrais##4##1##(2010-6#4)
Feline##4##1##(1992-5#1)(2008-11#1)(2008-3#1)(2009-4#1)
Fellow##4##1##(1994-12#1)(1996-12#3)
Fellows and##2##2##(2009-4#2)
Fellows##5##1##(1996-12#1)(2008-4#1)(2008-6#1)(2009-4#2)
Fellowship experience##3##2##(1996-12#3)
Fellowship in Quality Management##2##4##(1997-3#2)
Fellowship training##2##2##(1996-3#1)(2012-1#1)
Fellowship##17##1##(1994-12#1)(1996-1#5)(1996-12#4)(1996-3#1)(1997-3#2)(2007-3#1)(2008-4#1)(2012-1#2)
Felty's syndrome##3##2##(2006-10#3)
Felty's##4##1##(2006-10#4)
Female Tg##3##2##(2008-9#3)
Female Wistar##2##2##(2008-12#1)(2012-1#1)
Female athlete triad##2##3##(2010-1#2)
Female genital schistosomiasis (FGS)##2##4##(1996-12#2)
Female genital schistosomiasis##3##3##(1996-12#3)
Female patients##2##2##(2008-10#1)(2013-8#1)
Female security officers##2##3##(1993-2#2)
Female sexual problems##2##3##(2008-8#2)
Female##52##1##(1991-6#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-12#3)(2007-12#4)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-1#1)(2009-11#1)(2009-9#1)(2010-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2013-8#1)
Females are more##2##3##(2008-5#1)(2008-8#1)
Females did##2##2##(2009-1#1)(2009-9#1)
Females fed##2##2##(2008-6#2)
Females in##2##2##(2008-5#1)(2008-9#1)
Females may##2##2##(2008-8#1)(2008-9#1)
Females of##3##2##(1990-11#1)(2008-6#1)(2009-9#1)
Females were##3##2##(1996-12#1)(2008-8#1)(2009-8#1)
Females##32##1##(1990-11#1)(1992-1#1)(1993-2#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#5)(2009-1#1)(2009-8#1)(2009-9#3)(2010-4#1)(2011-2#1)(2013-1#1)
Femoral nerve##2##2##(2008-10#1)(2009-3#1)
Femoral##10##1##(1995-12#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-2#2)(2013-1#2)
Femtosecond laser-assisted##2##2##(2007-11#1)(2009-2#1)
Femtosecond##27##1##(1990-4#1)(2007-11#7)(2007-12#10)(2008-2#1)(2008-3#6)(2009-2#1)(2011-1#1)
Femur##2##1##(2007-11#1)(2013-1#1)
Fenn##3##1##(2010-7#3)
Fenn's##2##1##(2010-7#2)
Fenton reaction##8##2##(2008-10#3)(2008-4#1)(2008-5#1)(2010-4#3)
Fenton##13##1##(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2010-4#4)
Fenton's##2##1##(2008-10#1)(2008-5#1)
Fenton-like##2##1##(1997-8#1)(2008-10#1)
Fermentation##3##1##(2012-2#1)(2012-3#2)
Fermi GPU##2##2##(2011-1#2)
Fermi level##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
Fermi##13##1##(1990-12#1)(1993-5#1)(1996-9#2)(2008-10#3)(2008-3#1)(2008-7#3)(2011-1#2)
Ferric##2##1##(2008-10#2)
Ferrimonas balearica##2##2##(2011-2#2)
Ferrimonas##4##1##(2011-2#4)
Ferritin##3##1##(1990-5#1)(2009-3#1)(2013-8#1)
Fertile##6##1##(1994-8#1)(2008-10#4)(2013-7#1)
Fertility##9##1##(1993-2#1)(1996-8#1)(1997-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)
Fertilization##3##1##(2008-9#2)(2011-1#1)
Fetal Alcohol Spectrum##2##3##(2008-11#1)(2013-1#1)
Fetal Alcohol##3##2##(2008-11#2)(2013-1#1)
Fetal Alert Network##3##3##(2008-11#3)
Fetal and##2##2##(1990-3#1)(1994-3#1)
Fetal##38##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-6#2)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-11#7)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Fever and a##2##3##(2007-12#1)(2012-2#1)
Fever and##4##2##(2006-10#1)(2007-12#1)(2007-7#1)(2012-2#1)
Fever in##5##2##(1994-12#1)(2009-5#1)(2009-6#1)(2013-1#2)
Fever is one of the most##2##6##(2011-2#2)
Fever is##4##2##(2006-5#1)(2007-7#1)(2011-2#2)
Fever with##3##2##(2007-7#1)(2008-11#1)(2013-7#1)
Fever##29##1##(1994-12#1)(1997-3#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#5)(2008-11#2)(2008-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)
Few cases##2##2##(2008-6#1)(2009-4#1)
Few data are available from the##2##6##(2008-3#1)(2011-2#1)
Few data##4##2##(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
Few patients##2##2##(2008-8#1)(2013-1#1)
Few reports have##2##3##(2008-9#1)(2010-8#1)
Few reports##3##2##(2007-10#1)(2008-9#1)(2010-8#1)
Few studies have compared##2##4##(1991-3#1)(2011-1#1)
Few studies have examined##4##4##(2009-7#1)(2010-4#1)(2011-1#1)(2013-1#1)
Few studies have##9##3##(1991-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2013-1#1)
Few studies to date have##2##5##(2008-11#1)(2012-1#1)
Few studies##16##2##(1991-3#1)(1992-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2013-1#1)
Few##67##1##(1991-3#2)(1992-2#1)(1992-3#1)(1993-12#2)(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#6)
Fewer patients needed##2##3##(1992-6#1)(2007-8#1)
Fewer studies have##2##3##(2008-3#1)(2009-5#1)
Fewer than##3##2##(2008-10#1)(2010-1#1)(2013-1#1)
Fewer##15##1##(1992-12#1)(1992-5#1)(1992-6#1)(1996-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-5#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
FgDNA content##2##2##(2008-10#2)
Fhl1##2##1##(2008-11#2)
Fib-H##2##1##(2008-9#2)
Fib75##5##1##(1990-12#5)
Fiber Bragg grating##2##3##(2007-12#1)(2008-3#1)
Fiber Bragg##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Fiber optic##3##2##(2008-10#2)(2008-3#1)
Fiber##28##1##(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#7)(2008-3#7)(2008-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
Fiber-based##2##1##(2008-3#2)
Fiber-optic chemical sensing##2##3##(2008-3#2)
Fiber-optic voltage sensor##2##3##(2008-3#2)
Fiber-optic##17##1##(2007-12#3)(2008-2#4)(2008-3#9)(2011-1#1)
Fibers##4##1##(2008-2#3)(2009-9#1)
Fibre##2##1##(2008-5#2)
Fibres from the##2##3##(2009-7#2)
Fibres##3##1##(2009-7#3)
Fibrillary##2##1##(1993-2#1)(2011-2#1)
Fibrillation##3##1##(2009-9#1)(2011-1#1)(2012-12#1)
Fibrin##2##1##(1995-6#1)(2011-2#1)
Fibrinogen##3##1##(1991-6#1)(2008-7#1)(2011-2#1)
Fibrinolysis##2##1##(1994-5#1)(1996-6#1)
FibroTest##2##1##(2013-1#2)
Fibroblast Growth Factor##3##3##(2008-11#1)(2013-1#2)
Fibroblast Growth##4##2##(1994-11#1)(2008-11#1)(2013-1#2)
Fibroblast growth##2##2##(1991-12#1)(2008-7#1)
Fibroblast##7##1##(1990-11#1)(1991-12#1)(1994-11#1)(2008-11#1)(2008-7#1)(2013-1#2)
Fibroblasts and##2##2##(1990-2#1)(1997-4#1)
Fibroblasts##9##1##(1990-2#1)(1992-9#1)(1997-4#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
Fibrodysplasia##2##1##(1997-6#1)(2007-2#1)
Fibromatosis##2##1##(1997-7#2)
Fibromyalgia (FM) is##2##3##(2009-11#1)(2010-12#1)
Fibromyalgia##3##1##(2009-11#1)(2010-12#1)(2011-2#1)
Fibronectin is a ubiquitous extracellular matrix##2##6##(1994-9#1)(2008-1#1)
Fibronectin is##3##2##(1994-9#1)(2008-1#2)
Fibronectin##5##1##(1991-5#1)(1992-12#1)(1994-9#1)(2008-1#2)
Fibrosarcoma of the##2##3##(1991-8#2)
Fibrosis##2##1##(1991-8#1)(2008-9#1)
Fibrous dysplasia is a##2##4##(2008-8#1)(2013-1#1)
Fibrous dysplasia##5##2##(2006-10#1)(2008-8#3)(2013-1#1)
Fibrous##7##1##(2006-10#1)(2008-10#1)(2008-8#3)(2011-2#1)(2013-1#1)
Fick's##2##1##(1993-6#1)(2008-10#1)
Fickian##2##1##(2008-5#1)(2012-2#1)
Ficoll gradient##2##2##(1992-2#1)(2011-2#1)
Ficoll##3##1##(1992-2#1)(2008-1#1)(2011-2#1)
Ficoll-Hypaque##2##1##(2008-4#2)
Ficoll-Hypaque-purified mononuclear cells##2##3##(2008-4#2)
Ficoll-Paque density gradient##2##3##(2008-9#2)
Ficoll-Paque##6##1##(2008-11#2)(2008-9#4)
Ficus insipida##2##2##(2008-5#2)
Ficus racemosa##2##2##(2008-10#2)
Ficus##7##1##(2008-10#3)(2008-5#2)(2011-1#2)
Fidelity and##2##2##(2007-3#1)(2010-4#1)
Field Conditions##4##2##(2008-10#4)
Field Isolates##2##2##(2008-10#2)
Field Populations of##7##3##(2008-10#7)
Field Resistance##2##2##(2008-10#2)
Field and##2##2##(2008-10#2)
Field data##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
Field experiments were conducted##2##4##(2008-10#2)
Field experiments##4##2##(2008-10#3)(2008-8#1)
Field isolates of##2##3##(2008-10#2)
Field observations##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
Field studies of##2##3##(1994-2#1)(2008-9#1)
Field studies##4##2##(1994-2#1)(2008-10#1)(2008-9#2)
Field testing##2##2##(2008-10#1)(2008-12#1)
Field trials were conducted in##2##5##(2008-10#1)(2011-2#1)
Field trials##3##2##(2008-10#2)(2011-2#1)
Field##90##1##(1994-2#1)(1995-3#2)(1996-9#1)(2007-12#1)(2007-2#1)(2008-10#61)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Field-of-view##9##1##(2008-10#1)(2008-2#2)(2008-3#6)
Field-programmable##2##1##(2008-2#1)(2008-3#1)
Fields and##3##2##(1996-9#1)(2008-10#1)(2008-5#1)
Fields in##5##2##(2008-10#5)
Fields of##3##2##(2008-12#1)(2008-3#2)
Fields##25##1##(1990-11#1)(1996-9#1)(2008-10#15)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
Fifteen days after##2##3##(1990-9#1)(2008-10#1)
Fifteen of the##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
Fifteen of##5##2##(1993-11#1)(1997-8#1)(2008-11#1)(2008-5#2)
Fifteen patients received only##2##4##(1993-1#1)(2007-8#1)
Fifteen patients##6##2##(1993-1#1)(1994-1#1)(2007-8#2)(2011-2#1)(2013-1#1)
Fifteen percent of the##2##4##(1995-12#1)(1995-2#1)
Fifteen##52##1##(1990-9#2)(1991-4#1)(1991-5#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-2#1)(2013-1#6)
Fifth Edition##2##2##(2011-2#2)
Fifth##7##1##(1992-9#1)(1995-5#1)(2008-1#1)(2008-2#1)(2010-12#1)(2011-2#2)
Fifty eight percent##2##3##(2012-3#1)(2013-1#1)
Fifty eight##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
Fifty one percent##2##3##(2013-1#2)
Fifty one##4##2##(1990-6#1)(2013-1#2)(2013-8#1)
Fifty patients undergoing##2##3##(2011-2#1)(2012-3#1)
Fifty patients were##2##3##(2007-7#1)(2008-6#1)
Fifty patients##7##2##(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Fifty percent of##4##3##(2009-11#1)(2012-2#1)(2013-1#2)
Fifty percent##7##2##(1993-8#1)(2008-10#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
Fifty seven percent of patients##2##5##(2013-1#2)
Fifty three##2##2##(2008-10#1)(2010-7#1)
Fifty years of##2##3##(2008-7#1)(2012-2#1)
Fifty years##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
Fifty##54##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-8#1)(1995-12#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#3)
Fifty-eight patients##2##2##(2007-8#1)(2008-3#1)
Fifty-eight percent of##2##3##(1995-3#1)(2012-2#1)
Fifty-eight##6##1##(1995-3#1)(2007-8#2)(2008-3#1)(2008-5#1)(2012-2#1)
Fifty-five percent of the##2##4##(2010-8#1)(2013-1#1)
Fifty-five##4##1##(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
Fifty-four##9##1##(1990-12#1)(1991-2#1)(1993-2#1)(1996-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)
Fifty-nine##7##1##(1991-2#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-12#2)
Fifty-one isolates##2##2##(2008-10#2)
Fifty-one patients##3##2##(2008-6#1)(2008-7#2)
Fifty-one##12##1##(1993-2#1)(1997-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-11#1)
Fifty-six##3##1##(1992-11#1)(2008-10#2)
Fifty-three patients##2##2##(1991-3#1)(1993-12#1)
Fifty-three per cent##2##3##(1991-3#1)(2010-4#1)
Fifty-three##7##1##(1991-3#2)(1993-12#1)(1994-9#1)(2008-9#1)(2010-4#1)(2011-2#1)
Fifty-two##5##1##(1990-6#1)(1991-6#1)(2008-1#1)(2008-5#1)(2008-7#1)
Fight##3##1##(2010-10#1)(2011-2#1)(2012-12#1)
Fighting##6##1##(1992-1#1)(1992-2#1)(1997-2#1)(2007-11#1)(2008-5#1)(2008-8#1)
Figure 8&quot##2##2##(2013-1#2)
Figure Rating Scale##3##3##(2007-12#1)(2008-9#1)(2013-8#1)
Figure##9##1##(2007-12#2)(2008-2#1)(2008-7#2)(2008-9#1)(2013-1#2)(2013-8#1)
Figures of merit##2##3##(2008-10#2)
Fiji Islands##3##2##(2008-1#3)
Fiji School of Medicine##2##4##(2008-1#2)
Fiji School of##3##3##(2008-1#3)
Fiji and##3##2##(2008-1#3)
Fiji as well as##2##4##(2008-1#2)
Fiji population##2##2##(2008-1#2)
Fiji##45##1##(2008-1#36)(2008-10#1)(2008-6#5)(2012-12#2)(2013-8#1)
Fijian##3##1##(2008-1#3)
Fijians##3##1##(2008-1#3)
Filamentous bacteriophage##2##2##(1991-5#2)
Filamentous##3##1##(1991-5#2)(2008-10#1)
Filariasis##2##1##(2008-1#2)
File##3##1##(2008-11#2)(2010-11#1)
Filipino##8##1##(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#5)
Filling the##3##2##(1993-3#1)(2007-11#1)(2013-1#1)
Filling##8##1##(1991-6#1)(1993-3#1)(1997-2#1)(2007-11#3)(2008-3#1)(2013-1#1)
Film##3##1##(1994-1#1)(2008-10#1)(2008-4#1)
Films by##3##2##(2008-2#3)
Films of##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
Films##19##1##(1996-9#2)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#3)(2009-11#1)(2009-12#1)(2010-4#1)(2012-2#2)(2013-8#1)
Filtek P90 and Z250##2##4##(2013-1#2)
Filtek##4##1##(2008-12#2)(2013-1#2)
Filter##5##1##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#2)
Filtered##2##1##(1996-12#1)(2008-3#1)
Filtering Method##2##2##(2008-3#1)(2010-8#1)
Filtering##5##1##(2008-2#3)(2008-3#1)(2010-8#1)
Filters##2##1##(1990-5#1)(2007-12#1)
Filtration and clearance rates##2##4##(2008-5#2)
Filtration##5##1##(2008-10#1)(2008-5#3)(2013-1#1)
FimA and##2##2##(2008-10#2)
FimA or FimF mutants of X##2##6##(2008-10#2)
FimA or FimF##3##3##(2008-10#3)
FimA##6##1##(2008-10#6)
FimA- or FimF-##2##3##(2008-10#2)
FimA-##3##1##(2008-10#3)
FimF##5##1##(2008-10#5)
FimF-##3##1##(2008-10#3)
Fimbrial and##2##2##(2008-10#2)
Fimbrial##3##1##(2008-10#3)
Final Rule##3##2##(1996-12#1)(2009-4#2)
Final analysis of##2##3##(2008-10#1)(2008-5#1)
Final class of evidence-prognosisStudy designProspective CohortRetrospective Cohort•Case controlCase seriesMethodsPatients at similar point in course of treatment•F/U ≥##2##17##(2012-12#2)
Final class of evidence-prognosisStudy##3##4##(2012-12#3)
Final germination##2##2##(2008-12#2)
Final mean body weights of##2##5##(2008-9#2)
Final mean body##3##3##(2008-9#3)
Final results of a##2##4##(1993-9#1)(2008-7#1)
Final results##6##2##(1993-9#1)(1997-3#1)(2008-5#1)(2008-7#2)(2011-2#1)
Final solutions obtained##2##3##(2008-10#2)
Final##46##1##(1992-12#1)(1993-3#1)(1993-9#1)(1994-5#2)(1995-10#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#9)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#4)(2008-9#4)(2009-4#2)(2009-7#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
Finally the speciation was tested on##2##6##(2008-10#2)
Finally the##16##2##(1990-11#1)(1991-12#1)(1994-9#1)(2006-8#1)(2007-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
Finally we##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)
Finally##628##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#2)(1993-11#5)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#6)(1995-2#5)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#2)(1996-2#4)(1996-3#3)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#1)(1997-9#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#99)(2008-11#19)(2008-12#5)(2008-2#22)(2008-3#44)(2008-4#24)(2008-5#16)(2008-6#10)(2008-7#17)(2008-8#27)(2008-9#16)(2009-10#5)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#5)(2009-9#8)(2010-10#3)(2010-11#4)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#9)(2011-2#25)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#17)(2012-3#9)(2013-1#14)(2013-7#2)(2013-8#12)
Finance##6##1##(1992-8#1)(2008-11#1)(2008-6#1)(2010-8#1)(2012-12#1)(2013-8#1)
Financial##18##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#2)(1994-12#1)(1994-2#1)(1996-2#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)
Financing##42##1##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#1)(1995-12#1)(1996-1#3)(1996-2#6)(1996-3#3)(1997-2#5)(1997-3#3)
Finasteride##2##1##(1994-11#1)(2011-2#1)
Find out which##2##3##(2011-2#2)
Find out##3##2##(2011-2#3)
Find##4##1##(1996-3#1)(2011-2#3)
Finding a##5##2##(1996-3#1)(2008-12#2)(2009-5#1)(2009-8#1)
Finding homologs to##2##3##(2008-9#2)
Finding homologs##3##2##(2008-4#1)(2008-9#2)
Finding protein##2##2##(2008-4#2)
Finding the##4##2##(1993-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
Finding##25##1##(1991-5#1)(1993-1#1)(1996-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#3)(2008-9#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
Findings also##5##2##(2007-12#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
Findings are##4##2##(2007-12#1)(2008-1#1)(2008-9#1)(2013-8#1)
Findings demonstrate that##2##3##(2007-10#1)(2013-1#1)
Findings demonstrated that##2##3##(1996-7#1)(2008-11#1)
Findings demonstrated##3##2##(1996-7#1)(2008-11#1)(2011-2#1)
Findings from a##3##3##(1994-12#1)(1996-1#1)(2008-12#1)
Findings from an##2##3##(1992-3#1)(2012-12#1)
Findings from the##5##3##(1991-2#2)(2007-4#1)(2010-10#1)(2012-12#1)
Findings from this study##3##4##(2009-5#1)(2013-1#1)(2013-8#1)
Findings from this##4##3##(1995-2#1)(2009-5#1)(2013-1#1)(2013-8#1)
Findings from##20##2##(1991-2#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-1#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#2)(2010-10#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
Findings highlight the##2##3##(2009-7#1)(2011-2#1)
Findings in##3##2##(1994-2#1)(1997-3#1)(1997-7#1)
Findings include##2##2##(1994-12#1)(1996-3#1)
Findings indicate that##10##3##(1991-3#1)(1996-1#1)(1996-3#1)(2008-12#1)(2009-5#2)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#1)
Findings indicated that##5##3##(1994-12#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
Findings indicated##6##2##(1994-1#1)(1994-12#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
Findings may##2##2##(2010-10#1)(2010-2#1)
Findings of medical and health data reveal that##2##8##(2013-8#2)
Findings of the##2##3##(2009-7#1)(2013-1#1)
Findings of this##2##3##(1995-11#1)(2008-11#1)
Findings of##7##2##(1995-11#1)(1996-5#1)(2008-11#1)(2009-7#1)(2013-1#1)(2013-8#2)
Findings on magnetic resonance imaging##2##5##(2008-7#1)(2009-11#1)
Findings reveal that the risk factors of poor diet##7##9##(2013-8#7)
Findings reveal that##10##3##(1995-2#1)(2008-4#1)(2013-8#8)
Findings reveal##12##2##(1995-2#1)(2008-4#1)(2008-6#1)(2013-8#9)
Findings revealed that##3##3##(2007-10#1)(2008-12#2)
Findings revealed##6##2##(2007-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)
Findings show that##3##3##(1997-3#2)(2008-11#1)
Findings suggest that the##6##4##(1991-1#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
Findings suggest that##21##3##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#4)(2008-12#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Findings suggest the##2##3##(2011-1#2)
Findings suggest##26##2##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#5)(2008-12#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Findings suggested that##3##3##(1996-5#1)(2007-12#1)(2011-1#1)
Findings support the##3##3##(1995-12#1)(2007-12#1)(2010-4#1)
Findings support##4##2##(1995-12#1)(2007-12#1)(2009-12#1)(2010-4#1)
Findings supported the##3##3##(2007-10#1)(2012-12#1)(2012-2#1)
Findings were discussed##2##3##(2008-12#1)(2009-7#1)
Findings were##4##2##(2008-10#1)(2008-12#1)(2009-7#1)(2011-1#1)
Findings##163##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-3#3)(1997-7#1)(2007-10#3)(2007-12#7)(2007-4#2)(2008-1#2)(2008-10#4)(2008-11#9)(2008-12#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#9)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#16)
Fine Needle##2##2##(1994-7#1)(2013-8#1)
Fine needle aspiration cytology (FNAC)##2##5##(2008-7#1)(2009-7#1)
Fine needle aspiration cytology##3##4##(2008-7#1)(2009-7#1)(2010-11#1)
Fine needle aspiration##5##3##(1994-7#1)(2008-7#2)(2009-7#1)(2010-11#1)
Fine structure of the##2##4##(2008-5#1)(2010-11#1)
Fine structure of##3##3##(2007-12#1)(2008-5#1)(2010-11#1)
Fine structure##5##2##(1994-2#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-11#1)
Fine##24##1##(1991-12#1)(1994-2#1)(1994-7#2)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#2)(2012-6#1)(2013-8#1)
Fine-needle aspiration biopsy##2##3##(2011-1#1)(2012-2#1)
Fine-needle aspiration cytology of##2##4##(2008-6#1)(2012-2#1)
Fine-needle aspiration cytology##3##3##(2007-5#1)(2008-6#1)(2012-2#1)
Fine-needle aspiration##6##2##(2007-5#2)(2008-6#1)(2011-1#1)(2012-2#2)
Finger mark##2##2##(2012-2#2)
Finger##4##1##(2008-9#1)(2012-2#2)(2013-1#1)
Fingerprint##3##1##(2008-10#3)
Fingerprinting with##2##2##(2008-10#2)
Fingerprinting##9##1##(2008-10#8)(2010-6#1)
Fingerprints##2##1##(2008-10#1)(2012-12#1)
Finite Element##2##2##(2009-4#1)(2013-8#1)
Finite element approximation of a population spatial adaptation model##2##9##(2013-8#2)
Finite element##5##2##(2008-7#1)(2009-6#1)(2009-7#1)(2013-8#2)
Finite##11##1##(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#3)
Finite-difference time-domain calculations##2##3##(2007-11#1)(2009-12#1)
Finite-difference time-domain solution of light scattering by dielectric particles with##2##10##(2008-3#2)
Finite-difference time-domain##5##2##(2007-11#2)(2008-3#2)(2009-12#1)
Finland##20##1##(1990-11#2)(1991-2#1)(1991-4#1)(1992-3#1)(1993-2#1)(1996-8#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-4#1)
Finnish health care##2##3##(1996-3#2)
Finnish hospitals##2##2##(1996-3#1)(2009-12#1)
Finnish patients##4##2##(1991-11#1)(1991-7#2)(1994-12#1)
Finnish strains##4##2##(2008-10#4)
Finnish##21##1##(1991-11#1)(1991-7#3)(1991-8#1)(1994-12#1)(1996-3#3)(2007-7#1)(2008-10#5)(2008-7#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-10#1)(2013-1#1)
Finnmark county##2##2##(1993-3#1)(1993-6#1)
Finnmark##8##1##(1993-11#2)(1993-3#1)(1993-6#5)
Fire Blight##4##2##(2008-10#4)
Fire##10##1##(1990-8#1)(1993-12#1)(1997-5#1)(2008-10#6)(2008-8#1)
Firework##2##1##(2012-2#2)
Firm##2##1##(1993-8#1)(2012-3#1)
Firmicutes##2##1##(2011-2#1)(2013-7#1)
Firms##2##1##(1993-1#1)(1994-2#1)
First Dental Home##3##3##(2011-2#3)
First Detection of##2##3##(2012-2#2)
First Nations##4##2##(2007-12#1)(2008-11#3)
First Observation of the##2##4##(1996-9#2)
First a##2##2##(2008-2#1)(2008-3#1)
First aid##3##2##(2007-2#1)(2008-11#1)(2010-8#1)
First and second dissociation constants##2##5##(2008-10#2)
First and second##3##3##(2008-10#3)
First and##5##2##(1995-9#1)(2008-10#3)(2013-8#1)
First case##2##2##(2008-12#1)(2008-7#1)
First efforts##2##2##(1996-12#1)(2009-11#1)
First joint Italian-German##2##3##(2008-4#2)
First method##2##2##(2008-8#1)(2010-5#1)
First of all##2##3##(2008-11#1)(2009-10#1)
First record of##3##3##(2008-12#1)(2008-6#1)(2010-8#1)
First results of a##3##4##(1993-2#1)(2007-6#1)(2008-1#1)
First results of##4##3##(1993-2#1)(2007-6#1)(2008-1#1)(2008-9#1)
First results##8##2##(1993-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
First the##5##2##(1993-8#1)(2007-11#1)(2008-10#2)(2008-3#1)
First time##2##2##(1990-2#2)
First we discuss##2##3##(2007-12#1)(2008-3#1)
First we show##2##3##(2008-3#1)(2008-7#1)
First we##8##2##(1992-12#1)(1993-1#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)
First##292##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#36)(2008-11#15)(2008-12#10)(2008-2#10)(2008-3#21)(2008-4#9)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#18)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#4)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#6)(2010-9#2)(2011-1#1)(2011-2#10)(2011-4#1)(2012-12#2)(2012-2#6)(2013-1#8)(2013-7#1)(2013-8#5)
First-Line##2##1##(2010-12#1)(2013-1#1)
First-Year##2##1##(2010-3#1)(2012-12#1)
First-line nurse leaders' health-care change management initiatives##2##7##(2012-3#2)
First-line nurse##3##2##(2012-3#3)
First-line##8##1##(1997-2#1)(2008-11#1)(2011-2#2)(2012-3#3)(2013-1#1)
First-order quasi-phase-matched##2##2##(2007-11#1)(2007-12#1)
First-order##4##1##(2007-11#1)(2007-12#1)(2008-1#1)(2010-10#1)
FirstEF##3##1##(2008-4#3)
Firstly##29##1##(1990-9#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#4)
Fis expression##2##2##(2008-7#2)
Fis##8##1##(2008-7#8)
Fiscal##5##1##(1993-12#1)(1994-3#1)(1997-1#2)(1997-2#1)
Fischer 344 rat##2##3##(1994-3#1)(1994-5#1)
Fischer 344 rats##15##3##(1990-3#1)(1990-6#3)(1992-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1996-9#1)(2008-3#3)(2008-7#1)
Fischer 344##17##2##(1990-3#1)(1990-6#3)(1992-12#2)(1994-3#3)(1994-5#2)(1994-6#1)(1996-9#1)(2008-3#3)(2008-7#1)
Fischer##40##1##(1990-3#3)(1990-6#3)(1992-1#1)(1992-12#2)(1993-12#2)(1994-3#3)(1994-5#2)(1994-6#2)(1995-6#1)(1996-9#1)(2006-12#1)(2008-10#11)(2008-3#3)(2008-6#1)(2008-7#1)(2009-10#2)(2012-2#1)
Fischer-344 rats##2##2##(1993-11#1)(1994-6#1)
Fish in##2##2##(2013-7#2)
Fish with##2##2##(2008-7#1)(2008-8#1)
Fish##14##1##(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#2)(2013-7#2)
Fishbein##2##1##(1993-12#1)(1993-3#1)
Fisher Exact##2##2##(2009-8#1)(2013-1#1)
Fisher exact##2##2##(1997-5#1)(2013-1#1)
Fisher##15##1##(1993-12#1)(1995-2#1)(1995-6#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
Fisher's equation##2##2##(2009-8#2)
Fisher's exact test##3##3##(1995-12#1)(2008-12#1)(2012-3#1)
Fisher's exact##6##2##(1995-12#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
Fisher's##14##1##(1995-12#1)(2007-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Fisheries##4##1##(2007-5#1)(2008-12#1)(2008-8#1)(2010-4#1)
Fishery##2##1##(2008-7#1)(2009-5#1)
Fishing##6##1##(2008-12#1)(2008-5#2)(2008-7#1)(2013-7#2)
Fisoneb and##2##2##(1996-12#2)
Fisoneb##3##1##(1996-12#3)
Fission yeast##5##2##(1990-2#2)(1991-2#1)(2008-2#2)
Fissure##2##1##(2008-12#1)(2011-2#1)
Fistula##6##1##(1996-9#1)(1997-3#1)(2007-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Fistula</DescriptorName> <QualifierName MajorTopicYN="Y">prevention &amp##2##4##(1996-12#2)
Fit##4##1##(2007-2#1)(2008-10#1)(2009-5#1)(2009-6#1)
Fitmore® hip stem##2##3##(2011-2#2)
Fitness and##4##2##(2008-12#1)(2008-3#2)(2010-1#1)
Fitness components##2##2##(2008-10#1)(2008-8#1)
Fitness for Practice##5##3##(2008-11#5)
Fitness for Practice'##2##3##(2008-11#2)
Fitness for##8##2##(2008-11#8)
Fitness of##4##2##(2008-10#4)
Fitness on##2##2##(2008-10#1)(2009-3#1)
Fitness##28##1##(2007-12#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-1#1)(2012-3#1)(2013-8#1)
Fitting of##2##2##(2008-2#2)
Fitting the##7##2##(1996-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
Fitting##14##1##(1996-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
Fitzpatrick##2##1##(2008-5#2)
Five Factor##3##2##(2011-1#3)
Five QTL##2##2##(2008-10#2)
Five candidate##2##2##(1996-8#1)(2010-8#1)
Five cases of##2##3##(1990-9#1)(1991-8#1)
Five cases##5##2##(1990-9#1)(1991-8#1)(2008-7#1)(2010-3#1)(2012-2#1)
Five classes of##2##3##(2007-11#1)(2008-5#1)
Five different##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
Five dimensions of##2##3##(2009-11#1)(2012-12#1)
Five focus groups##2##3##(2008-12#1)(2013-1#1)
Five hundred and##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
Five hundred##9##2##(1995-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
Five key##2##2##(1997-3#1)(2013-1#1)
Five new##2##2##(1997-9#1)(2007-12#1)
Five of the##10##3##(1990-2#1)(1995-12#1)(1996-11#1)(2008-1#1)(2008-10#5)(2010-2#1)
Five of these##4##3##(1992-11#1)(2008-10#2)(2008-6#1)
Five of##15##2##(1990-2#1)(1992-11#1)(1995-12#1)(1996-11#1)(2008-1#1)(2008-10#8)(2008-6#1)(2010-2#1)
Five overlapping##2##2##(2008-2#1)(2008-8#1)
Five patients had##2##3##(1990-6#1)(2007-7#1)
Five patients underwent##2##3##(2008-6#1)(2011-2#1)
Five patients with##5##3##(1990-9#1)(1991-11#1)(2007-8#1)(2011-2#1)(2012-3#1)
Five patients##17##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-6#3)(2011-2#4)(2012-3#1)(2013-1#1)
Five percent of##2##3##(2008-10#1)(2008-4#1)
Five rats##2##2##(2008-12#1)(2008-7#1)
Five replicate determinations of 25mug of##2##6##(2008-10#2)
Five replicate determinations of##5##4##(2008-10#5)
Five samples##2##2##(2008-10#1)(2008-12#1)
Five soil##2##2##(2008-10#1)(2008-12#1)
Five strategies##2##2##(1992-2#1)(1997-2#1)
Five subjects##2##2##(2008-7#1)(2013-1#1)
Five themes emerged from the##2##5##(2010-7#1)(2013-1#1)
Five themes emerged##3##3##(2009-5#1)(2010-7#1)(2013-1#1)
Five times##2##2##(1993-8#1)(1997-3#1)
Five types of narratives that emerged from data are discussed##2##10##(2013-1#2)
Five types of##3##3##(2008-5#1)(2013-1#2)
Five were classified as##2##4##(1995-11#1)(2009-3#1)
Five were##4##2##(1995-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
Five year survival rate##2##4##(2008-6#2)
Five years later##2##3##(2008-9#1)(2012-12#1)
Five years of##2##3##(1990-3#1)(2007-8#1)
Five years##5##2##(1990-3#2)(2007-8#1)(2008-9#1)(2012-12#1)
Five##230##1##(1990-10#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-8#2)(1994-12#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-8#2)(1997-9#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#53)(2008-11#6)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#18)(2008-8#5)(2008-9#2)(2009-11#4)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#12)(2013-8#2)
Five)##2##1##(2008-11#1)(2008-7#1)
Five-year survival##3##2##(1991-6#1)(1994-9#1)(2007-8#1)
Five-year##8##1##(1991-6#1)(1994-3#1)(1994-9#1)(2007-8#1)(2008-1#1)(2011-2#3)
Fivetrade mark##5##2##(2008-11#1)(2008-7#4)
Fivetrade##7##1##(2008-11#2)(2008-7#5)
Fixation of an##2##3##(2010-3#1)(2013-1#1)
Fixation of##4##2##(2007-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
Fixation##14##1##(2007-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#4)
Fixing##4##1##(1991-11#1)(2008-2#2)(2009-5#1)
Fixion##2##1##(2009-3#2)
Fizeau fringes##2##2##(2008-3#2)
Fizeau interferometer##7##2##(2008-2#3)(2008-3#4)
Fizeau interferometry##2##2##(2008-3#2)
Fizeau wedge with unequal mirrors##2##5##(2008-3#2)
Fizeau##15##1##(2007-12#1)(2008-2#3)(2008-3#11)
Fla##6##1##(1991-9#3)(1992-8#1)(1993-8#1)(1994-2#1)
Flag##4##1##(2008-10#3)(2008-12#1)
Flame atomic absorption and emission spectrometry##2##6##(2008-10#2)
Flame atomic absorption determination of##2##5##(2008-10#2)
Flame atomic absorption spectrometric determination of##2##6##(2008-10#2)
Flame atomic absorption##9##3##(2008-10#8)(2013-8#1)
Flame atomic##10##2##(2008-10#9)(2013-8#1)
Flame ionization##2##2##(2008-10#2)
Flame##26##1##(2008-10#20)(2008-2#3)(2008-3#2)(2013-8#1)
Flap##5##1##(2007-12#2)(2007-9#1)(2011-2#1)(2013-1#1)
Flash RP-18e##2##2##(2008-10#2)
Flash##3##1##(2008-10#3)
Flat##3##1##(2008-12#1)(2009-8#1)(2010-3#1)
Flaviviridae##2##1##(2011-2#1)(2013-8#1)
Flavobacterium columnare##2##2##(2008-9#1)(2013-1#1)
Flavobacterium meningosepticum##3##2##(1992-3#2)(1993-11#1)
Flavobacterium psychrophilum and##2##3##(2008-9#2)
Flavobacterium psychrophilum heat shock proteins##2##5##(2009-5#2)
Flavobacterium psychrophilum##4##2##(2008-9#2)(2009-5#2)
Flavobacterium##12##1##(1992-3#2)(1993-11#2)(2008-10#1)(2008-9#4)(2009-5#2)(2013-1#1)
Flavone##2##1##(2007-11#1)(2008-10#1)
Flavonoid##3##1##(1994-11#1)(2008-10#1)(2010-6#1)
Flavonoids are##2##2##(2008-10#1)(2011-2#1)
Flavonoids##4##1##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
Flavopiridol##3##1##(2008-5#3)
FlbB##2##1##(2010-2#2)
FlbD##2##1##(2010-2#2)
Fleming##5##1##(1995-6#3)(2008-10#1)(2013-8#1)
Fletcher Allen Health Care##3##4##(1995-12#2)(1996-12#1)
Fletcher Allen Health##4##3##(1995-12#2)(1996-12#2)
Fletcher Allen##5##2##(1995-12#2)(1996-12#3)
Flevoland##2##1##(2008-10#2)
Flex##3##1##(1992-2#1)(2008-9#1)(2010-3#1)
FlexPen##3##1##(2009-11#3)
Flexibility##3##1##(2007-12#1)(2008-4#1)(2010-8#1)
Flexible##6##1##(2007-12#3)(2008-11#3)
Flexner's##2##1##(1991-8#2)
Flexor##5##1##(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)
Flexural strength##2##2##(2008-12#1)(2009-7#1)
Flexural##3##1##(2008-12#1)(2008-5#1)(2009-7#1)
Fli-2##3##1##(1994-8#3)
FliA##2##1##(2009-8#2)
FliP##2##1##(1993-12#2)
FliQ##2##1##(1993-12#2)
FliR and FlhB##2##3##(1993-12#2)
Flies##5##1##(2008-10#1)(2008-9#2)(2012-3#1)(2013-1#1)
Flight##9##1##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#4)(2009-12#1)(2012-12#1)
Flo##4##1##(2011-2#3)(2013-8#1)
Flo-Lab##3##1##(2011-2#3)
Floating knee##2##2##(2012-12#2)
Floating##5##1##(2008-11#1)(2009-5#1)(2012-12#2)(2012-2#1)
Flocculation##2##1##(2008-11#1)(2008-7#1)
Floor##2##1##(1996-5#1)(2013-1#1)
Florence (Italy)##2##2##(1992-8#1)(1994-9#1)
Florence Nightingale##3##2##(2011-2#3)
Florence Nightingale's##2##2##(2008-1#1)(2011-2#1)
Florence##19##1##(1991-5#1)(1991-6#2)(1992-10#2)(1992-2#2)(1992-8#1)(1994-9#1)(2008-1#1)(2008-5#2)(2009-4#1)(2010-1#1)(2011-2#4)(2013-8#1)
Florida CTV isolates##2##3##(2008-10#2)
Florida and the##6##3##(2008-10#1)(2011-2#5)
Florida and##19##2##(1992-8#1)(2008-10#9)(2011-2#7)(2012-3#1)(2013-8#1)
Florida citrus##2##2##(2008-10#1)(2011-2#1)
Florida counties##2##2##(1994-1#2)
Florida to##4##2##(1993-3#1)(2008-10#2)(2011-2#1)
Florida was##2##2##(1997-5#1)(2008-10#1)
Florida were##2##2##(2008-10#2)
Florida##128##1##(1991-2#2)(1991-3#1)(1992-1#2)(1992-3#1)(1992-8#3)(1993-3#2)(1994-1#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#3)(1997-6#1)(2007-10#1)(2007-5#8)(2008-10#56)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-3#3)(2013-7#1)(2013-8#2)
Florida's##4##1##(1993-3#1)(1996-2#1)(1997-5#1)(2008-12#1)
Floridian##2##1##(2008-10#2)
Florisil##3##1##(2008-10#3)
Floristic##3##1##(2008-8#3)
Florunner##2##1##(2008-10#2)
Flow Analysis##2##2##(1997-6#1)(2008-11#1)
Flow Cytometric Analysis##2##3##(1994-12#1)(2008-9#1)
Flow Cytometry##4##2##(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#1)
Flow Injection##3##2##(2008-10#2)(2010-5#1)
Flow analysis##4##2##(2008-10#3)(2008-9#1)
Flow analysis-hydride##2##2##(2008-10#2)
Flow and##2##2##(2008-10#2)
Flow cytometers collect data in an attempt to understand some aspect of a biological system##2##15##(2008-9#2)
Flow cytometers##3##2##(2008-9#3)
Flow cytometric analysis of##8##4##(2008-9#8)
Flow cytometric analysis##9##3##(2008-11#1)(2008-9#8)
Flow cytometric assessment of##2##4##(2008-9#2)
Flow cytometric detection of##2##4##(2008-9#1)(2010-1#1)
Flow cytometric measurement of##2##4##(2008-9#2)
Flow cytometric##21##2##(2008-11#1)(2008-6#1)(2008-9#17)(2010-1#1)(2011-2#1)
Flow cytometry analysis using##2##4##(1992-12#1)(2008-4#1)
Flow cytometry analysis##4##3##(1992-12#1)(1997-3#1)(2008-4#1)(2012-2#1)
Flow cytometry and##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
Flow cytometry can##3##3##(2008-9#3)
Flow cytometry is##2##3##(1994-6#1)(2008-4#1)
Flow cytometry of apoptosis##2##4##(2008-1#1)(2008-9#1)
Flow cytometry of##3##3##(2008-1#1)(2008-9#2)
Flow cytometry provides##2##3##(2008-9#2)
Flow cytometry##26##2##(1992-12#1)(1994-6#1)(1994-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#12)(2009-6#1)(2010-2#1)(2012-2#1)(2012-3#1)
Flow in##2##2##(1996-12#1)(2008-11#1)
Flow injection (FI)##3##3##(2008-10#3)
Flow injection analysis for##2##4##(2008-10#1)(2008-11#1)
Flow injection analysis of##9##4##(2008-10#9)
Flow injection analysis##12##3##(2008-10#11)(2008-11#1)
Flow injection chemiluminescence determination of##5##5##(2008-10#5)
Flow injection determination of##7##4##(2008-10#7)
Flow injection determination##8##3##(2008-10#8)
Flow injection dialysis##2##3##(2008-10#2)
Flow injection hydride generation electrothermal atomic absorption##2##7##(2008-10#2)
Flow injection hydride generation##3##4##(2008-10#3)
Flow injection kinetic spectrophotometric determination of##2##6##(2008-10#2)
Flow injection on-line##3##3##(2008-10#3)
Flow injection potentiometric determination of##2##5##(2008-10#2)
Flow injection potentiometry##5##3##(2008-10#5)
Flow injection spectrophotometric determination of##9##5##(2008-10#9)
Flow injection spectrophotometric##12##3##(2008-10#12)
Flow injection##76##2##(2008-10#75)(2008-11#1)
Flow systems##2##2##(2008-10#2)
Flow was##2##2##(1997-3#1)(2007-7#1)
Flow##186##1##(1992-1#1)(1992-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-3#2)(1997-6#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#105)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#36)(2009-10#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
Flow-FISH##2##1##(2008-9#2)
Flow-cytometric analysis of##3##3##(1993-9#1)(2008-11#1)(2010-3#1)
Flow-injection analysis##2##2##(2008-10#2)
Flow-injection chemiluminescence determination of##6##4##(2008-10#6)
Flow-injection chemiluminescence##7##2##(2008-10#7)
Flow-injection chemiluminescent determination of##2##4##(2008-10#2)
Flow-injection determination of##4##3##(2008-10#4)
Flow-injection fluorimetric determination of##2##4##(2008-10#2)
Flow-injection simultaneous determination of##2##4##(2008-10#2)
Flow-injection spectrophotometric determination of##3##4##(2008-10#3)
Flow-injection spectrophotometry of##2##3##(2008-10#2)
Flow-injection##38##1##(2008-10#38)
Flow-through##5##1##(2008-10#5)
Flowcytometric##2##1##(2008-11#1)(2010-11#1)
Flower Age##2##2##(2008-10#2)
Flower##7##1##(2008-10#6)(2008-5#1)
Flowering##3##1##(1996-2#1)(2008-7#1)(2012-1#1)
Flowers by##3##2##(2008-10#3)
Flowers##10##1##(2008-10#10)
Flowing##2##1##(2008-5#1)(2010-5#1)
Flt-1##3##1##(2008-8#3)
Flt4##4##1##(1997-7#4)
Flt4-L##4##1##(1997-7#4)
Flu-6plx PCR##3##2##(2011-2#3)
Flu-6plx assay##3##2##(2011-2#3)
Flu-6plx##6##1##(2011-2#6)
Fluconazole##2##1##(2008-5#2)
Fluctuating##3##1##(2008-7#1)(2008-8#1)(2012-2#1)
Fluctuation##2##1##(1996-9#1)(2008-10#1)
Fluctuations in the##3##3##(1990-8#1)(2008-12#1)(2008-3#1)
Fluctuations in tremor at rest and##2##6##(2008-7#2)
Fluctuations in##10##2##(1990-8#1)(1992-5#1)(1996-12#1)(1996-6#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2013-1#1)
Fluctuations of the##2##3##(2008-2#2)
Fluctuations of##5##2##(1996-12#1)(2008-2#3)(2011-1#1)
Fluctuations##16##1##(1990-8#1)(1991-9#1)(1992-5#1)(1996-12#2)(1996-6#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#1)
Fluence##2##1##(2008-3#1)(2012-1#1)
Fluency##4##1##(1995-11#1)(1996-7#1)(2008-2#1)(2008-4#1)
Fluid Flow##2##2##(1996-12#1)(2007-5#1)
Fluid##19##1##(1990-12#1)(1990-8#1)(1991-12#2)(1992-3#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-7#3)(2008-9#1)(2009-11#1)(2011-1#1)
Fluids##2##1##(2009-2#1)(2012-12#1)
Flunitrazepam##2##1##(2008-10#2)
Fluo-3##3##1##(1990-2#1)(1994-6#1)(2008-4#1)
Fluorescein##4##1##(1994-9#1)(2008-10#1)(2010-10#1)(2011-2#1)
Fluorescence Resonance Energy Transfer (FRET)##2##5##(2008-4#2)
Fluorescence Spectrometry##2##2##(2008-10#1)(2013-8#1)
Fluorescence and terbium-sensitised luminescence##2##4##(2008-10#2)
Fluorescence behavior of##2##3##(2008-10#2)
Fluorescence behavior##3##2##(2008-10#3)
Fluorescence correlation spectroscopy##3##3##(2008-3#2)(2010-9#1)
Fluorescence correlation##4##2##(2008-3#2)(2010-9#1)(2012-2#1)
Fluorescence detection of##2##3##(2008-1#1)(2008-10#1)
Fluorescence detection##4##2##(2008-1#1)(2008-10#3)
Fluorescence from##4##2##(2007-12#1)(2008-3#2)(2009-12#1)
Fluorescence in situ hybridization##4##4##(1997-8#1)(2008-4#1)(2010-3#2)
Fluorescence in situ##5##3##(1997-8#1)(2008-4#1)(2008-8#1)(2010-3#2)
Fluorescence intensities##2##2##(2006-6#1)(2008-10#1)
Fluorescence lidar##2##2##(2008-2#1)(2008-3#1)
Fluorescence lifetime imaging##2##3##(2007-12#1)(2008-1#1)
Fluorescence lifetime##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-12#1)
Fluorescence lifetimes##3##2##(1991-5#1)(2008-2#1)(2008-3#1)
Fluorescence localization after photobleaching##2##4##(2008-1#2)
Fluorescence measurements are##2##3##(2008-10#2)
Fluorescence microscopes are equipped to observe the fluorescence of one or more specific fluorophores to localize specific molecules and analyzed cellular structures##2##22##(2008-1#1)(2008-4#1)
Fluorescence microscopy##6##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)
Fluorescence of##2##2##(1991-12#1)(2008-2#1)
Fluorescence polarization##2##2##(1995-5#1)(2008-4#1)
Fluorescence postlabeling assay##2##3##(1991-5#2)
Fluorescence quenching of##2##3##(2008-10#2)
Fluorescence quenching##3##2##(1995-2#1)(2008-10#2)
Fluorescence resonance energy transfer##2##4##(2008-10#1)(2008-4#1)
Fluorescence spectra of##3##3##(1992-3#1)(1992-6#1)(1995-5#1)
Fluorescence spectra##6##2##(1992-3#1)(1992-6#2)(1995-5#1)(2008-10#2)
Fluorescence studies of##2##3##(2007-11#1)(2008-10#1)
Fluorescence studies##3##2##(1994-6#1)(2007-11#1)(2008-10#1)
Fluorescence##108##1##(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#4)(1992-3#1)(1992-6#2)(1993-11#1)(1994-6#1)(1995-2#1)(1995-5#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#2)(2008-1#6)(2008-10#34)(2008-12#1)(2008-2#4)(2008-3#15)(2008-4#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
Fluorescence-based##2##1##(1993-9#1)(2008-4#1)
Fluorescent Polymerase Chain Reaction##2##4##(2008-10#2)
Fluorescent Pseudomonas spp##5##3##(2008-10#5)
Fluorescent proteins##2##2##(2009-10#1)(2009-4#1)
Fluorescent speckle microscopy (FSM)##2##4##(2008-1#2)
Fluorescent staining##2##2##(2008-2#1)(2008-4#1)
Fluorescent##42##1##(1990-2#1)(1991-5#1)(1991-9#1)(2007-2#1)(2007-7#2)(2008-1#4)(2008-10#18)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)
Fluoride was##2##2##(1990-2#1)(2013-1#1)
Fluoride##13##1##(1990-2#1)(1991-2#1)(1993-11#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2012-2#1)(2013-1#1)
Fluorimetric determination of##10##3##(2008-10#10)
Fluorimetric##15##1##(2008-10#15)
Fluorinated##4##1##(2009-9#4)
Fluoro-Gold##2##1##(1995-12#1)(1996-5#1)
Fluoro-Gold-labelled##2##1##(1995-12#2)
Fluoro-Jade##2##1##(2007-10#1)(2010-2#1)
Fluoro-substituted ketones##2##2##(2012-3#2)
Fluoro-substituted##3##1##(2012-3#3)
Fluorogenic##3##1##(1996-12#1)(2008-10#1)(2008-4#1)
Fluorometric determination of##3##3##(2008-10#3)
Fluorometric##9##1##(1996-12#1)(2008-10#7)(2008-9#1)
Fluoroquinolone resistance in##2##3##(1990-3#1)(2008-8#1)
Fluoroquinolones are##2##2##(2007-7#1)(2010-12#1)
Fluoroquinolones##4##1##(1993-8#1)(2007-7#1)(2008-10#1)(2010-12#1)
Fluoroscopy##2##1##(2010-7#1)(2013-1#1)
Fluorous##3##1##(2008-10#2)(2010-4#1)
Fluoxetine##7##1##(1991-1#1)(1991-10#1)(2007-7#4)(2013-1#1)
Flupirtine##4##1##(1991-2#2)(1995-12#2)
Fluquinconazole##3##1##(2008-10#3)
Flurbiprofen##2##1##(2008-10#2)
Fluvoxamine is##2##2##(2008-6#2)
Fluvoxamine##5##1##(2008-6#5)
Flux##6##1##(2008-10#1)(2008-11#1)(2008-3#2)(2009-11#1)(2013-1#1)
Fly ash SRM##2##3##(2008-10#2)
Fly ash##3##2##(2008-10#2)(2008-3#1)
Fly##5##1##(2007-12#1)(2008-10#2)(2008-3#2)
FlyBase##2##1##(2008-10#1)(2008-9#1)
Flynn##2##1##(1991-9#1)(2008-5#1)
Fmoc##3##1##(2008-2#1)(2009-9#2)
Fmoc-DOPA(acetonide)-OH##2##1##(2009-9#2)
Fn##3##1##(1995-5#1)(2012-12#2)
FnR##3##1##(1993-9#3)
Fny-CMV##3##1##(2008-10#3)
Fo magnitude##2##2##(1995-3#2)
Fo##5##1##(1993-8#1)(1995-3#2)(2008-10#2)
Fo-B2##7##1##(2008-10#7)
Fo47 and##4##2##(2008-10#4)
Fo47 is##2##2##(2008-10#2)
Fo47 to Foln3GUS##3##3##(2008-10#3)
Fo47##26##1##(2008-10#26)
Fo47)##2##1##(2008-10#2)
Fo47-inoculated roots##2##2##(2008-10#2)
Foc-0##3##1##(2008-10#3)
Foc-5##5##1##(2008-10#5)
Focal and segmental glomerulosclerosis##3##4##(2007-7#1)(2008-1#2)
Focal cerebral##2##2##(1996-5#1)(2013-1#1)
Focal##18##1##(1991-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
Foci of##6##2##(1996-5#1)(2007-7#1)(2008-10#4)
Foci##7##1##(1996-5#1)(2007-7#1)(2008-10#5)
Focus group discussions##2##3##(2010-3#2)
Focus group interviews were##3##4##(2007-10#1)(2008-11#2)
Focus group interviews##4##3##(2007-10#1)(2008-11#2)(2010-10#1)
Focus group participants##2##3##(2008-11#1)(2008-12#1)
Focus group##13##2##(1992-2#1)(2007-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2010-10#1)(2010-3#2)(2010-5#1)(2011-2#1)
Focus groups were used to##2##5##(1997-3#1)(2008-11#1)
Focus groups were##4##3##(1996-1#1)(1997-3#1)(2008-11#2)
Focus groups##5##2##(1996-1#1)(1997-3#1)(2008-11#2)(2010-10#1)
Focus is placed on##2##4##(2008-4#1)(2009-10#1)
Focus on the##3##3##(2008-8#1)(2009-9#1)(2013-8#1)
Focus on##8##2##(2007-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-3#1)(2013-8#1)
Focus was##2##2##(2008-12#1)(2013-8#1)
Focus##38##1##(1992-2#1)(1994-2#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#7)(2008-12#2)(2008-3#4)(2008-4#3)(2008-8#1)(2009-10#2)(2009-9#2)(2010-10#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
Focused educational##2##2##(1994-1#1)(1996-3#1)
Focused microwave-assisted##2##2##(2008-10#2)
Focused##46##1##(1993-1#1)(1993-12#8)(1993-3#2)(1994-1#9)(1994-2#14)(1994-3#2)(1995-5#1)(1996-3#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Focusing on the##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
Focusing on##7##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)
Focusing properties of##2##3##(2007-11#1)(2008-2#1)
Focusing properties##3##2##(2007-11#1)(2008-2#2)
Focusing##23##1##(1992-1#1)(1993-5#1)(1994-12#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)
Foeniculum vulgare##2##2##(2008-10#2)
Foetal##2##1##(1997-4#1)(2007-8#1)
Fol007##4##1##(2008-10#4)
Folate deficiency##2##2##(1992-10#1)(1993-6#1)
Folate receptor##2##2##(2011-1#1)(2013-8#1)
Folate##9##1##(1992-10#1)(1992-3#1)(1992-9#1)(1993-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Folding##6##1##(1990-7#1)(1991-6#1)(1995-3#1)(1995-5#1)(1996-12#2)
Foley##2##1##(1995-12#1)(2013-1#1)
Foliage##4##1##(2008-10#3)(2012-9#1)
Foliar spray of##2##3##(2008-10#2)
Foliar symptoms##2##2##(2008-10#2)
Foliar##10##1##(2008-10#6)(2008-12#3)(2011-10#1)
Folic Acid##2##2##(2009-8#1)(2012-1#1)
Folic acid and prevention of neural-tube defects##3##7##(1997-8#3)
Folic acid##4##2##(1997-8#3)(2010-1#1)
Folic##6##1##(1997-8#3)(2009-8#1)(2010-1#1)(2012-1#1)
Folimycin (concanamycin A)##2##3##(1993-6#2)
Folin-Ciocalteu reagent##2##2##(2008-10#1)(2012-2#1)
Folkman##2##1##(1990-10#1)(1994-12#1)
Follicle##2##1##(2008-7#1)(2012-2#1)
Follicle-stimulating hormone##2##2##(1995-11#1)(2007-7#1)
Follicular##3##1##(2008-5#1)(2008-7#1)(2010-11#1)
Follow up of##2##3##(2010-8#1)(2012-2#1)
Follow up was##2##3##(2011-2#1)(2012-2#1)
Follow up##6##2##(2007-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
Follow##8##1##(1996-2#1)(2007-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
Follow-Up of a##3##3##(2008-6#1)(2011-1#2)
Follow-Up##5##1##(2008-6#1)(2011-1#2)(2011-2#1)(2013-1#1)
Follow-up MR##2##2##(1996-6#1)(1997-8#1)
Follow-up at##2##2##(2008-1#1)(2008-7#1)
Follow-up in##2##2##(1995-11#1)(1997-3#1)
Follow-up of the##3##3##(1991-11#1)(2008-11#1)(2008-12#1)
Follow-up of##7##2##(1991-11#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)
Follow-up was##2##2##(1994-2#1)(2013-1#1)
Follow-up##42##1##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-2#1)(1995-11#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-10#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
Followed by the##2##3##(1995-6#1)(2009-6#1)
Followed by##5##2##(1995-6#1)(2008-10#3)(2009-6#1)
Following Spine Surgery##2##3##(2012-2#2)
Following a review of the literature##2##6##(1990-3#1)(1992-5#1)
Following a review of the##3##5##(1990-3#1)(1992-5#1)(1996-1#1)
Following a review of##4##4##(1990-3#1)(1990-9#1)(1992-5#1)(1996-1#1)
Following a##29##2##(1990-3#1)(1990-5#1)(1990-9#2)(1991-5#1)(1992-11#2)(1992-5#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#1)
Following an initial##3##3##(1990-12#1)(1995-5#1)(2008-11#1)
Following an##8##2##(1990-12#1)(1992-8#1)(1994-12#2)(1995-5#1)(1997-8#1)(2008-11#1)(2010-8#1)
Following are summaries of the Medicare##2##6##(1991-12#1)(1994-3#1)
Following data##2##2##(1995-3#1)(2008-10#1)
Following each##2##2##(1992-5#1)(2008-11#1)
Following incubation of##2##3##(2008-11#1)(2008-5#1)
Following incubation##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
Following infection##2##2##(1997-6#1)(2008-10#1)
Following initial##3##2##(1990-7#1)(2008-5#1)(2008-6#1)
Following our##2##2##(2007-12#1)(2009-3#1)
Following publication of##2##3##(1996-12#1)(2008-2#1)
Following removal of##3##3##(1994-6#1)(2009-9#1)(2013-8#1)
Following several##2##2##(1997-8#1)(2008-3#1)
Following subcutaneous##2##2##(1996-2#1)(2013-1#1)
Following surgical##2##2##(2007-8#1)(2010-5#1)
Following the introduction of##2##4##(2008-1#1)(2010-12#1)
Following the##48##2##(1991-1#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Following these##2##2##(2008-10#1)(2008-11#1)
Following this##7##2##(1993-12#1)(1995-1#1)(2008-10#2)(2008-9#1)(2010-5#1)(2013-1#1)
Following treatment with##2##3##(1997-4#1)(2008-10#1)
Following treatment##3##2##(1997-4#1)(2008-10#1)(2013-1#1)
Following up##2##2##(1994-1#1)(2012-1#1)
Following##271##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#3)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#45)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#8)(2008-7#9)(2008-8#4)(2008-9#4)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#3)(2011-1#6)(2011-2#10)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#16)(2013-8#4)
Foln3GUS on##2##2##(2008-10#2)
Foln3GUS##6##1##(2008-10#6)
Fomitiporia punctata##3##2##(2008-10#3)
Fontan operation##4##2##(2007-8#2)(2010-5#2)
Fontan procedure##3##2##(2007-8#3)
Fontan##10##1##(1992-3#1)(2007-8#6)(2008-10#1)(2010-5#2)
Food Chem##2##2##(1992-8#1)(2008-10#1)
Food Guide Pyramid##4##3##(2008-3#4)
Food Guide##6##2##(1995-2#1)(2008-11#1)(2008-3#4)
Food Safety##4##2##(2008-4#1)(2008-5#1)(2010-4#2)
Food allergies##2##2##(1990-8#2)
Food and Drug Administration (FDA)##19##5##(1996-5#3)(1997-4#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
Food and Drug Administration and the##4##6##(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
Food and Drug Administration and##5##5##(1994-1#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
Food and Drug Administration of##2##5##(2008-4#1)(2011-2#1)
Food and Drug Administration##50##4##(1994-1#2)(1995-8#1)(1996-5#3)(1997-4#1)(1997-5#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-7#2)(2009-9#2)(2010-4#1)(2010-6#2)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#2)
Food and Drug Administration-approved##3##4##(2006-7#2)(2011-2#1)
Food and Drug##56##3##(1994-1#2)(1995-8#1)(1996-5#3)(1997-4#1)(1997-5#2)(2006-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-7#2)(2009-9#2)(2010-4#1)(2010-6#2)(2011-2#5)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#2)
Food and##57##2##(1994-1#2)(1995-8#1)(1996-5#3)(1997-4#1)(1997-5#2)(2006-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-7#2)(2009-9#2)(2010-4#2)(2010-6#2)(2011-2#5)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#2)
Food consumption##4##2##(1995-5#1)(1997-4#2)(2008-1#1)
Food for thought##4##3##(1991-2#1)(2007-12#1)(2007-8#1)(2008-11#1)
Food for##5##2##(1991-2#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#1)
Food is##2##2##(2008-1#1)(2008-10#1)
Food safety is##2##3##(1994-3#1)(2007-12#1)
Food safety##8##2##(1991-3#1)(1994-3#1)(1996-3#1)(1997-1#1)(2007-12#2)(2012-12#1)(2012-2#1)
Food security##2##2##(1994-12#1)(2010-9#1)
Food web##2##2##(2008-8#1)(2008-9#1)
Food##128##1##(1990-3#2)(1990-8#2)(1991-2#2)(1991-3#1)(1992-8#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#2)(2006-7#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#4)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#3)(2011-2#6)(2012-12#8)(2012-2#7)(2012-3#5)(2013-1#2)(2013-8#1)
Food-deprived rats##2##2##(1992-11#1)(1993-12#1)
Foodborne##4##1##(1990-3#2)(2007-12#1)(2011-2#1)
Foods##2##1##(2008-11#1)(2011-2#1)
Foot and Ankle##6##3##(2008-8#1)(2009-10#3)(2011-2#1)(2012-2#1)
Foot and##8##2##(2008-8#1)(2009-10#3)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
Foot##17##1##(2007-11#2)(2008-10#1)(2008-8#1)(2009-10#3)(2009-11#1)(2009-4#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Football##3##1##(2007-11#1)(2013-1#2)
Foothills##2##1##(1992-3#1)(2012-2#1)
For 1##2##2##(1994-11#1)(2008-10#1)
For 10##3##2##(1991-12#1)(2008-10#2)
For 20##2##2##(1997-6#1)(1997-8#1)
For 4##2##2##(1990-3#1)(1995-3#1)
For 5##2##2##(2008-10#1)(2008-2#1)
For 90 s preconcentration##2##4##(2008-10#2)
For 90 s##3##3##(2008-10#3)
For B##2##2##(1996-12#1)(2013-7#1)
For GC##2##2##(1995-2#1)(1996-12#1)
For ICD 850##2##3##(1990-12#2)
For LC##2##2##(2008-10#2)
For M##2##2##(2008-9#2)
For Readers&quot##6##2##(2012-3#6)
For a fixed##3##3##(1996-3#1)(2008-2#1)(2008-8#1)
For a given##9##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)
For a laser##2##3##(2008-2#1)(2008-3#1)
For a long##2##3##(1993-2#1)(2009-7#1)
For a particular##2##3##(2008-2#1)(2008-3#1)
For a period of##2##4##(1991-2#1)(2008-11#1)
For a preconcentration time of##2##5##(2008-10#2)
For a specific##2##3##(2008-10#1)(2008-3#1)
For a typical##2##3##(2008-3#1)(2009-5#1)
For a variety of##2##4##(1993-6#1)(2008-2#1)
For a##100##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-11#6)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#15)(2008-3#17)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)
For academic##3##2##(1991-2#1)(1996-1#1)(2008-2#1)
For additional##2##2##(2008-6#1)(2013-7#1)
For adolescent##2##2##(2013-1#2)
For all four##2##3##(1995-5#1)(2008-10#1)
For all other##2##3##(2007-8#1)(2008-10#1)
For all species##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
For all the##5##3##(1992-2#1)(2007-7#1)(2008-10#2)(2012-12#1)
For all these##2##3##(1990-8#1)(2008-8#1)
For all three##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
For all##47##2##(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
For an inhomogeneous##2##3##(2008-2#1)(2008-3#1)
For an integrated##2##3##(2008-10#1)(2008-3#1)
For an ion-selective electrode##2##4##(2008-10#2)
For an##26##2##(1997-6#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
For analysis of##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
For analysis##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)
For analytical purposes##2##3##(2008-10#1)(2008-3#1)
For analytical##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
For and against Eusol##2##4##(1992-5#2)
For assessment of therapy effectivness##2##5##(2007-11#2)
For better##3##2##(1991-11#1)(1991-8#1)(2011-2#1)
For black##2##2##(2011-2#1)(2013-1#1)
For both compounds##3##3##(2008-10#3)
For both groups##4##3##(1991-12#1)(1994-2#1)(2011-2#1)(2013-8#1)
For both sexes##3##3##(1990-2#1)(1991-12#1)(1991-6#1)
For both techniques##2##3##(2008-10#1)(2011-1#1)
For both##51##2##(1990-2#1)(1991-12#2)(1991-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
For cadmium##4##2##(2008-10#4)
For cancers##2##2##(1991-12#1)(1997-3#1)
For cells that##2##3##(1994-5#1)(2008-1#1)
For cells##3##2##(1994-5#1)(2008-1#1)(2008-11#1)
For chemical##2##2##(2008-10#2)
For children##2##2##(2009-5#1)(2012-3#1)
For chromium in##2##3##(2008-10#2)
For chromium##4##2##(2008-10#4)
For comparison purposes##2##3##(1994-2#1)(2009-11#1)
For comparison##17##2##(1990-12#1)(1994-2#1)(1994-5#1)(1995-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2009-11#1)(2013-1#1)
For complex##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
For concepts that are##2##4##(2008-7#2)
For continuous##2##2##(2008-10#1)(2012-12#1)
For control##3##2##(1994-2#1)(2007-8#1)(2008-11#1)
For convenience##3##2##(1995-6#1)(2010-3#1)(2012-3#1)
For decades##2##2##(2012-12#1)(2012-3#1)
For demonstration purposes##2##3##(2007-11#1)(2011-1#1)
For demonstration##4##2##(2007-11#1)(2008-3#2)(2011-1#1)
For detection of##2##3##(2008-1#1)(2011-2#1)
For determination of the##2##4##(2008-11#1)(2008-3#1)
For determination of##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
For determination##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
For differentiation diagnosis between##4##4##(2010-12#4)
For direct##4##2##(2008-10#3)(2008-4#1)
For each case##2##3##(2008-8#1)(2011-2#1)
For each field##2##3##(2008-10#2)
For each of the##5##4##(1991-8#1)(1995-3#1)(2008-7#1)(2009-7#1)(2012-3#1)
For each of##8##3##(1991-8#1)(1995-3#1)(2008-10#3)(2008-7#1)(2009-7#1)(2012-3#1)
For each patient##2##3##(2012-1#1)(2013-1#1)
For each pixel##2##3##(2008-3#2)
For each sample##2##3##(2008-10#2)
For each species##2##3##(2008-8#1)(2009-4#1)
For each subject##2##3##(2008-7#1)(2011-2#1)
For each##54##2##(1991-8#1)(1992-6#1)(1994-2#1)(1995-2#2)(1995-3#1)(1997-4#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#2)(2009-7#1)(2010-11#2)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)
For effective##2##2##(2008-5#1)(2008-8#1)
For efficient##2##2##(2007-11#1)(2008-9#1)
For eight##3##2##(2008-10#3)
For enrollees##2##2##(1995-1#2)
For epoetin beta##2##3##(2008-7#2)
For evaluation##2##2##(2012-2#2)
For every diluent##2##3##(2008-10#2)
For every##7##2##(1992-6#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-3#1)(2013-7#1)
For example##120##2##(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#2)(1995-5#2)(1995-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#5)(2008-10#15)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-9#2)(2010-3#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
For experiment##2##2##(2008-10#2)
For fast##2##2##(2008-10#1)(2008-7#1)
For field##2##2##(2008-10#1)(2008-3#1)
For five##2##2##(1991-12#1)(2008-5#1)
For four of the##2##4##(1997-8#1)(2008-8#1)
For four##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
For free-space##2##2##(2008-2#1)(2008-3#1)
For further characterization of##2##4##(2008-10#2)
For further##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
For health##2##2##(1992-12#1)(1997-1#1)
For high##2##2##(1994-5#1)(2008-3#1)
For high-resolution##2##2##(2008-2#1)(2008-3#1)
For higher concentrations##2##3##(1994-11#1)(2008-10#1)
For higher##6##2##(1990-3#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-6#1)
For highly##2##2##(2008-10#1)(2008-3#1)
For identification##2##2##(1995-6#1)(2010-11#1)
For illustration##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
For image##2##2##(2008-10#1)(2008-3#1)
For in vitro##3##3##(1995-12#1)(2013-1#2)
For in vivo##2##3##(1995-12#1)(2008-10#1)
For in##5##2##(1995-12#2)(2008-10#1)(2013-1#2)
For input##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
For instance##23##2##(1992-12#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
For large spheres##2##3##(2007-11#1)(2008-3#1)
For large##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
For larger##5##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
For lead##3##2##(2008-10#3)
For long-term##2##2##(1990-11#1)(2008-10#1)
For low pump##2##3##(2008-3#2)
For low##5##2##(1996-6#1)(2007-12#1)(2008-3#2)(2009-7#1)
For males##2##2##(2012-3#1)(2013-1#1)
For many of the##2##4##(1994-2#1)(2008-10#1)
For many of##3##3##(1994-2#1)(1994-3#1)(2008-10#1)
For many years##8##3##(1994-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-1#1)(2010-7#1)(2012-12#1)
For many##24##2##(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-9#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#3)(2009-1#1)(2010-7#1)(2011-2#2)(2012-12#2)
For maximum##2##2##(2007-11#1)(2008-3#1)
For measurement of##2##3##(2009-7#2)
For measurements in the##2##4##(2008-3#2)
For measurements##3##2##(2008-3#3)
For men##4##2##(1991-6#1)(2007-12#1)(2008-10#1)(2009-7#1)
For more than 100 years##2##5##(2008-10#1)(2010-5#1)
For more than 25 years##2##5##(2008-10#1)(2008-5#1)
For more than a##2##4##(1996-2#1)(2009-8#1)
For more than##7##3##(1996-2#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-5#1)(2013-1#1)
For more##9##2##(1996-2#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
For most of the##4##4##(1992-2#1)(1995-6#1)(2007-8#1)(2008-10#1)
For most##14##2##(1991-12#1)(1991-3#1)(1992-2#1)(1995-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2012-2#1)
For natural##2##2##(2008-2#1)(2008-9#1)
For naturally contaminated raisins##2##4##(2008-10#2)
For naturally##3##2##(2008-10#3)
For observation##2##2##(2008-3#1)(2008-5#1)
For obtaining##2##2##(2008-3#1)(2011-3#1)
For older##2##2##(2010-12#1)(2013-1#1)
For one##5##2##(1991-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
For optical##3##2##(2008-2#1)(2008-3#2)
For other##3##2##(1994-2#1)(2008-10#1)(2011-1#1)
For our study##2##3##(2010-12#1)(2012-3#1)
For our##4##2##(2010-12#1)(2012-12#2)(2012-3#1)
For over a decade##2##4##(1995-1#1)(1996-1#1)
For over##3##2##(1995-1#1)(1996-1#1)(1996-11#1)
For overcoming##2##2##(2008-10#1)(2008-2#1)
For patients with mild TBI##2##5##(2013-8#2)
For patients with##13##3##(1992-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
For patients##17##2##(1992-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
For planar##2##2##(2008-2#1)(2008-3#1)
For populations##2##2##(2008-8#2)
For post-crash fires##2##3##(1996-12#2)
For practical##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
For primary##2##2##(1997-3#1)(2012-2#1)
For proteins##2##2##(1997-2#1)(2008-10#1)
For purposes of##2##3##(1991-12#1)(2011-2#1)
For reducing##2##2##(2008-10#1)(2008-3#1)
For routine##2##2##(2008-10#2)
For samples spiked with both##3##5##(2008-10#3)
For samples##5##2##(2008-10#4)(2008-5#1)
For selected##3##2##(2008-3#1)(2008-4#1)(2008-6#1)
For sequential##2##2##(2008-10#2)
For several years##2##3##(2008-9#1)(2010-3#1)
For several##5##2##(1991-8#1)(1997-8#1)(2008-3#1)(2008-9#1)(2010-3#1)
For six##2##2##(2007-12#1)(2008-3#1)
For small##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
For some cells##2##3##(2008-1#1)(2008-2#1)
For some patients##2##3##(1991-1#1)(2011-2#1)
For some##23##2##(1990-7#1)(1991-1#1)(1991-3#1)(1994-1#1)(1994-3#1)(1997-1#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-4#1)(2008-8#2)(2009-3#1)(2011-2#2)(2013-7#2)
For spheres##2##2##(2008-2#1)(2008-3#1)
For study##2##2##(2008-3#2)
For such##7##2##(2006-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-8#1)
For surface##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
For ten##2##2##(2008-10#1)(2012-3#1)
For test##2##2##(1994-3#2)
For that purpose we##2##4##(1996-12#1)(2008-2#1)
For that purpose##6##3##(1996-12#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
For that reason##9##3##(2007-12#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
For that##15##2##(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
For the 0##2##3##(2012-1#2)
For the Super-RENS in which##2##5##(2008-3#2)
For the age range##3##4##(2008-7#3)
For the analysis of##2##4##(2008-10#2)
For the case of the##3##5##(2008-10#1)(2008-5#1)(2009-11#1)
For the case of##6##4##(1995-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)
For the comparison of the##2##5##(2008-10#1)(2011-1#1)
For the detection of##4##4##(1992-11#1)(2008-3#3)
For the determination of##6##4##(2008-10#5)(2008-5#1)
For the development of##2##4##(2008-10#1)(2008-11#1)
For the efficient##2##3##(2008-2#2)
For the elution##2##3##(2008-10#2)
For the entire##2##3##(2008-7#1)(2012-2#1)
For the equilibrium##2##3##(2008-10#2)
For the evaluation of##4##4##(2008-10#2)(2011-2#1)(2013-7#1)
For the first time a##2##5##(2008-10#2)
For the first time in##2##5##(2008-8#1)(2013-1#1)
For the first time to our knowledge##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
For the first time to the authors' knowledge##2##8##(2007-12#1)(2008-2#1)
For the first time to the##3##6##(2007-12#2)(2008-2#1)
For the first time to##6##5##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
For the first time##33##4##(1991-12#1)(2007-11#1)(2007-12#3)(2008-10#15)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#1)(2012-8#1)(2013-1#1)
For the first##39##3##(1991-12#1)(1995-12#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-2#4)(2008-3#3)(2008-5#2)(2008-8#1)(2009-1#1)(2009-11#1)(2010-8#1)(2012-2#1)(2012-8#1)(2013-1#1)
For the fundamental##2##3##(2008-10#1)(2008-3#1)
For the in##2##3##(2008-5#1)(2008-9#1)
For the investigation of##2##4##(2008-10#1)(2010-12#1)
For the majority of##3##4##(2007-7#1)(2009-5#1)(2010-3#1)
For the management of##2##4##(2008-7#1)(2013-1#1)
For the measurement of##2##4##(2008-10#1)(2010-2#1)
For the measurement##4##3##(2008-10#3)(2010-2#1)
For the method to##2##4##(2008-1#1)(2008-3#1)
For the more##2##3##(1996-2#1)(2008-10#1)
For the most part##5##4##(1992-5#1)(1994-11#1)(2007-12#1)(2008-1#1)(2012-3#1)
For the optimization of##2##4##(2008-2#1)(2011-1#1)
For the other##2##3##(2008-10#2)
For the overall##2##3##(2008-10#2)
For the past several##2##4##(1995-12#1)(2011-2#1)
For the past##7##3##(1992-1#1)(1992-12#1)(1993-3#1)(1995-12#2)(1995-2#1)(2011-2#1)
For the patient##6##3##(2011-2#6)
For the purpose of this study##3##6##(2008-10#1)(2008-11#1)(2013-1#1)
For the purpose of##11##4##(1990-8#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-3#1)(2013-1#1)
For the purposes of this##2##5##(2008-4#1)(2013-1#1)
For the quality control of##2##5##(2008-10#2)
For the quantitative##2##3##(2008-10#2)
For the regenerated gratings from group##2##6##(2013-8#2)
For the sake of##3##4##(1994-12#1)(2008-10#1)(2013-8#1)
For the same number of##2##5##(1990-11#1)(2008-10#1)
For the same##9##3##(1990-11#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-2#1)
For the second##3##3##(1991-8#1)(2008-10#1)(2008-3#1)
For the subsequent##2##3##(2008-7#1)(2011-3#1)
For the system##2##3##(2008-10#1)(2008-2#1)
For the whole##3##3##(2008-10#2)(2008-4#1)
For the##358##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#114)(2008-11#11)(2008-12#5)(2008-2#16)(2008-3#34)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#5)(2011-1#6)(2011-2#12)(2011-3#2)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#6)(2013-7#3)(2013-8#8)
For therapeutic##2##2##(2011-2#1)(2013-1#1)
For these patients##3##3##(1995-8#1)(2009-12#1)(2010-5#1)
For these reasons##14##3##(1997-3#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
For these studies##2##3##(1994-11#1)(2008-10#1)
For these##42##2##(1990-8#1)(1991-3#1)(1992-2#2)(1992-3#1)(1994-11#1)(1994-2#2)(1995-8#1)(1997-3#1)(2006-7#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
For thin##2##2##(2008-3#1)(2008-5#1)
For this assay##2##3##(1990-12#1)(2008-10#1)
For this experiment##2##3##(2008-3#1)(2009-4#1)
For this group##2##3##(2008-12#1)(2012-3#1)
For this purpose a##2##4##(2008-10#1)(2008-3#1)
For this purpose the##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
For this purpose we have##3##5##(2007-11#1)(2008-10#1)(2008-11#1)
For this purpose##64##3##(1990-2#1)(1991-9#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-12#1)(2007-11#2)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#3)(2013-8#2)
For this reason we believe that##2##6##(1992-2#1)(2008-1#1)
For this reason we##4##4##(1992-2#1)(1997-6#1)(2008-1#1)(2010-5#1)
For this reason##42##3##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-6#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
For this study##8##3##(2008-10#2)(2008-12#1)(2009-7#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
For this to##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
For this##163##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-6#2)(2008-1#5)(2008-10#34)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#4)(2012-9#1)(2013-1#7)(2013-7#8)(2013-8#4)
For those groups##2##3##(1993-12#2)
For those who##2##3##(1992-12#1)(2007-2#1)
For those##12##2##(1992-12#1)(1993-12#2)(2007-2#2)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)(2012-2#2)
For three##2##2##(1994-6#1)(2008-2#1)
For tin##2##2##(2008-10#2)
For total##2##2##(2008-10#1)(2008-5#1)
For transmission electron microscopy##2##4##(2008-5#1)(2008-7#1)
For two years##2##3##(1994-3#1)(2012-12#1)
For two##4##2##(1994-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
For typical parameters##2##3##(2007-11#1)(2008-3#1)
For typical##3##2##(2007-11#1)(2008-3#2)
For validation##4##2##(2008-10#3)(2008-7#1)
For very##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
For what is believed to be the first time##2##9##(2007-11#2)
For what is##3##3##(2007-11#2)(2007-12#1)
For women##7##2##(1991-5#1)(1992-2#1)(1994-2#1)(2007-12#1)(2008-10#1)(2009-7#1)(2011-1#1)
For years##2##2##(1995-6#1)(2008-11#1)
For##2005##1##(1990-11#8)(1990-12#6)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#1)(1991-1#5)(1991-11#2)(1991-12#13)(1991-2#5)(1991-3#9)(1991-5#4)(1991-6#3)(1991-8#7)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#7)(1992-5#6)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#4)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-5#3)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#5)(1994-12#4)(1994-2#16)(1994-3#9)(1994-5#8)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-11#7)(1995-12#6)(1995-2#7)(1995-3#4)(1995-4#2)(1995-5#6)(1995-6#9)(1995-8#2)(1995-9#5)(1996-1#3)(1996-11#2)(1996-12#17)(1996-2#9)(1996-3#5)(1996-4#6)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#1)(1997-1#5)(1997-2#9)(1997-3#8)(1997-4#8)(1997-5#4)(1997-6#4)(1997-7#3)(1997-8#5)(2006-10#2)(2006-4#2)(2006-7#1)(2007-10#6)(2007-11#40)(2007-12#37)(2007-2#6)(2007-4#2)(2007-6#3)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#22)(2008-10#479)(2008-11#75)(2008-12#23)(2008-2#98)(2008-3#197)(2008-4#23)(2008-5#50)(2008-6#11)(2008-7#52)(2008-8#46)(2008-9#39)(2009-1#4)(2009-10#4)(2009-11#10)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#7)(2009-6#7)(2009-7#12)(2009-8#6)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#12)(2010-2#2)(2010-3#8)(2010-4#6)(2010-5#8)(2010-6#3)(2010-7#7)(2010-8#15)(2011-1#20)(2011-2#63)(2011-3#7)(2011-7#1)(2012-1#6)(2012-12#18)(2012-2#29)(2012-3#33)(2012-5#2)(2012-8#2)(2012-9#1)(2013-1#45)(2013-7#19)(2013-8#28)
Foraging##6##1##(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2013-7#1)
Forbidden gaps in##3##3##(2008-3#3)
Force Microscopy##2##2##(2009-12#1)(2010-10#1)
Force spectroscopy##2##2##(2010-4#1)(2012-2#1)
Force to##2##2##(1991-2#1)(2013-8#1)
Force##42##1##(1990-12#2)(1990-6#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Forced##5##1##(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)
Forces of##2##2##(2011-1#1)(2012-3#1)
Forces##18##1##(1990-4#1)(1992-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#7)
Forcing##3##1##(1994-1#1)(1997-3#1)(2012-8#1)
Ford##7##1##(1991-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-7#1)
Forecasting##4##1##(1994-12#1)(2008-10#3)
Foreign bodies##2##2##(2007-8#1)(2008-7#1)
Foreign body aspiration##2##3##(1993-2#1)(2010-4#1)
Foreign body##4##2##(1993-2#1)(2007-8#1)(2010-4#1)(2012-12#1)
Foreign##10##1##(1993-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#2)(2013-1#1)
Foremost##3##1##(2008-10#1)(2011-2#1)(2012-12#1)
Forensic Science##2##2##(2008-12#1)(2012-12#1)
Forensic chemistry##3##2##(2010-7#3)
Forensic psychiatry##2##2##(2011-2#1)(2013-7#1)
Forensic##25##1##(1991-8#1)(1992-11#1)(1995-3#2)(1995-6#1)(1997-8#2)(2008-10#2)(2008-12#4)(2010-7#3)(2010-8#2)(2011-2#3)(2012-12#3)(2013-7#1)
Forest in##4##2##(2008-10#1)(2008-5#1)(2008-6#2)
Forest##35##1##(1992-1#1)(1994-6#2)(1995-3#1)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2012-2#1)(2013-7#3)
Forestier's disease##6##2##(2007-8#4)(2008-12#2)
Forestier's##7##1##(2007-8#4)(2008-12#3)
Forestry##3##1##(2008-10#1)(2008-12#1)(2010-4#1)
Forests##3##1##(2008-10#3)
Foreword##13##1##(1995-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
Form##22##1##(1994-2#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-8#2)(2010-10#2)(2010-5#1)(2010-8#1)(2012-12#3)
Form-12##2##1##(2009-10#1)(2012-3#1)
Formae Speciales##2##2##(2008-10#2)
Formal##12##1##(1992-1#2)(1993-12#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-7#1)(2012-2#1)
Formaldehyde##6##1##(2008-10#3)(2008-7#3)
Formalin-fixed##2##1##(1991-8#1)(2010-3#1)
Formation Between##3##2##(2008-10#1)(2009-11#1)(2009-7#1)
Formation and stability of protonated putrescine and cadaverine complexes with##2##10##(2008-10#2)
Formation and stability of protonated##3##5##(2008-10#3)
Formation and##10##2##(1995-8#1)(2007-12#1)(2008-10#6)(2010-4#1)(2012-2#1)
Formation by##3##2##(1996-9#1)(2008-10#1)(2013-1#1)
Formation constants of##2##3##(2008-10#2)
Formation constants##4##2##(2008-10#4)
Formation in##5##2##(1994-3#1)(2008-10#2)(2008-5#1)(2008-6#1)
Formation of a##2##3##(1997-7#1)(2007-12#1)
Formation of the complex##3##4##(1993-9#1)(2008-10#2)
Formation of the##11##3##(1991-6#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-7#1)
Formation of this##3##3##(1990-12#1)(1996-2#1)(2009-11#1)
Formation of##56##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#18)(2008-11#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-2#1)
Formation##93##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#35)(2008-11#6)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
Formed##2##1##(2008-12#1)(2008-2#1)
Former##2##1##(2008-11#1)(2008-5#1)
Formerly##3##1##(2007-12#1)(2008-2#1)(2013-1#1)
Formica japonica##2##2##(2008-5#2)
Formicidae##3##1##(2008-5#1)(2008-6#2)
Formicidae) in##2##2##(2008-6#2)
Formicidae)##11##1##(2007-12#2)(2008-5#3)(2008-6#4)(2008-8#2)
Forming##3##1##(1996-12#1)(2008-10#1)(2010-7#1)
Formosa##3##1##(2013-1#3)
Formosan subterranean##3##2##(2009-5#2)(2011-2#1)
Forms of##2##2##(1996-2#1)(2009-1#1)
Forms##5##1##(1995-1#1)(1996-2#1)(2009-1#1)(2009-4#1)(2009-5#1)
Formulas are##2##2##(2008-2#1)(2008-3#1)
Formulas that##2##2##(2008-2#1)(2008-3#1)
Formulas##6##1##(2008-10#1)(2008-2#3)(2008-3#2)
Formulating##3##1##(2008-5#3)
Formulation and evaluation of##3##4##(2010-5#1)(2011-1#1)(2012-2#1)
Formulation and##6##2##(2008-5#2)(2010-5#2)(2011-1#1)(2012-2#1)
Formulation of Bacillus spp##2##4##(2008-10#2)
Formulation of##7##2##(2008-10#3)(2008-5#2)(2009-12#1)(2011-2#1)
Formulation##14##1##(2008-10#3)(2008-12#1)(2008-5#4)(2009-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)
Formulations based on##2##3##(2008-10#1)(2008-5#1)
Formulations were##2##2##(2008-10#1)(2008-5#1)
Formulations##11##1##(2008-10#5)(2008-5#4)(2010-5#2)
Formylation of##2##2##(1990-9#1)(1995-3#1)
Fornix lesions##2##2##(1993-6#2)
Forno##3##1##(2008-10#3)
Forrest##3##1##(2007-8#2)(2008-10#1)
Forsch Komplementmed 2009##2##3##(2010-3#2)
Forskolin##8##1##(1991-9#1)(1993-3#1)(1993-6#2)(1995-8#1)(2008-11#1)(2009-12#2)
Forsus##3##1##(2013-1#3)
Fort##6##1##(2007-12#2)(2008-10#2)(2011-2#1)(2013-1#1)
Fortaleza##5##1##(1991-9#2)(2007-2#1)(2008-11#1)(2013-8#1)
Fortified##4##1##(2008-10#3)(2009-8#1)
Fortunately##14##1##(1991-6#1)(1992-1#1)(1993-1#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-1#1)
Forty patients were##3##3##(2012-2#1)(2013-1#2)
Forty patients##10##2##(1990-6#1)(1993-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
Forty percent of##4##3##(1992-6#1)(2009-10#1)(2011-2#1)(2013-1#1)
Forty percent##5##2##(1992-6#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
Forty six##2##2##(1990-2#1)(2008-5#1)
Forty subjects##2##2##(2008-12#1)(2011-2#1)
Forty two##5##2##(1996-3#1)(2007-9#1)(2008-2#1)(2008-7#1)(2013-8#1)
Forty##54##1##(1990-2#1)(1990-6#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-11#2)(1996-1#1)(1996-3#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#3)
Forty-eight hours after##2##3##(1991-11#1)(1997-2#1)
Forty-eight patients##3##2##(1991-6#1)(2009-6#1)(2013-8#1)
Forty-eight##11##1##(1991-11#1)(1991-6#1)(1996-10#1)(1997-2#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
Forty-five patients##2##2##(2008-9#1)(2012-12#1)
Forty-five##11##1##(1994-2#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-3#1)(2012-12#2)(2013-1#1)
Forty-four dogs with##2##3##(2008-10#1)(2012-3#1)
Forty-four patients with##2##3##(1990-2#1)(2013-1#1)
Forty-four percent##2##2##(1996-7#1)(2013-1#1)
Forty-four##12##1##(1990-2#1)(1994-5#2)(1996-7#1)(2008-10#3)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
Forty-nine##9##1##(1990-10#1)(1991-12#1)(1993-1#1)(1993-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
Forty-one patients with##2##3##(2007-8#1)(2008-6#1)
Forty-one patients##4##2##(1990-8#1)(2006-10#1)(2007-8#1)(2008-6#1)
Forty-one percent of##2##3##(1990-6#1)(2013-1#1)
Forty-one##11##1##(1990-6#1)(1990-8#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-6#1)(2009-10#1)(2013-1#2)
Forty-seven patients with##2##3##(2008-7#1)(2011-2#1)
Forty-seven patients##4##2##(2006-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
Forty-seven##10##1##(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
Forty-six patients with##2##3##(1992-10#1)(2008-7#1)
Forty-six patients##3##2##(1990-6#1)(1992-10#1)(2008-7#1)
Forty-six##7##1##(1990-6#1)(1992-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
Forty-three patients##3##2##(2010-3#1)(2011-2#1)(2012-2#1)
Forty-three percent of##2##3##(2008-12#1)(2013-1#1)
Forty-three##14##1##(1997-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#1)
Forty-two patients##3##2##(1991-6#1)(2008-7#1)(2011-2#1)
Forty-two##9##1##(1991-6#1)(1993-2#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
Forum##15##1##(1995-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-11#5)(2011-2#1)(2012-12#1)(2013-8#1)
Forward selection##2##2##(2008-10#2)
Forward##10##1##(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-12#1)
Fos and Jun proteins##2##4##(1996-12#2)
Fos and Jun##3##3##(1995-11#1)(1996-12#2)
Fos and##4##2##(1995-11#1)(1996-12#3)
Fos protein##2##2##(1994-2#1)(1994-8#1)
Fos##13##1##(1993-12#3)(1994-2#1)(1994-8#1)(1995-11#3)(1996-12#4)(1996-2#1)
Fos-LI##4##1##(1994-2#4)
Fos-immunoreactive##2##1##(1993-12#2)
Fos-ir neurons##3##2##(1993-12#3)
Fos-ir##4##1##(1993-12#4)
Fos-like immunoreactivity (FLI)##2##3##(1993-12#1)(1996-12#1)
Fos-like immunoreactivity in the##2##4##(1997-2#2)
Fos-like immunoreactivity##5##2##(1993-12#1)(1994-2#1)(1996-12#1)(1997-2#2)
Fos-like##7##1##(1993-12#1)(1994-2#1)(1996-12#1)(1997-2#4)
Fossa##2##1##(2012-3#2)
Foster##13##1##(1990-2#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#5)(2008-10#1)(2008-12#2)
Foster/CIho 10644##2##2##(2008-10#2)
Foster/CIho##5##1##(2008-10#5)
Fostering##2##1##(2008-12#1)(2013-1#1)
Fot1 and##2##2##(2008-10#2)
Fot1##6##1##(2008-10#6)
Foucault's knife-edge##2##2##(2008-3#2)
Fouling##2##1##(2008-6#1)(2008-7#1)
Found##2##1##(2008-10#1)(2012-2#1)
Foundation Programme##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
Foundation and##3##2##(2008-11#1)(2012-1#1)(2013-8#1)
Foundation of##3##2##(1992-3#1)(2008-8#1)(2013-8#1)
Foundation##44##1##(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#2)(1994-1#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#2)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
Foundation's##11##1##(1993-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2010-10#1)(2010-12#2)(2013-1#2)
Foundations##5##1##(1990-11#1)(1995-12#1)(1997-2#1)(2008-7#1)(2012-2#1)
Founder##2##1##(2008-10#1)(2008-9#1)
Fountain##2##1##(1992-12#1)(2011-2#1)
Four and a half##2##4##(1990-9#1)(2012-3#1)
Four and##3##2##(1990-9#1)(2012-3#1)(2013-1#1)
Four cases of##2##3##(2007-8#1)(2012-2#1)
Four cases##3##2##(1997-3#1)(2007-8#1)(2012-2#1)
Four categories of##2##3##(1993-9#1)(2008-10#1)
Four chelating##2##2##(1995-3#1)(2008-10#1)
Four cycles of##2##3##(2008-10#2)
Four days after##3##3##(1992-3#1)(1997-3#1)(2013-1#1)
Four days##4##2##(1992-3#1)(1993-6#1)(1997-3#1)(2013-1#1)
Four decades of##2##3##(2008-1#1)(2013-8#1)
Four developmental##2##2##(1993-12#1)(2008-7#1)
Four different##13##2##(1993-3#1)(1994-2#1)(1997-5#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2012-12#1)(2013-1#1)
Four examples##2##2##(2010-6#1)(2012-2#1)
Four experimental##2##2##(2008-12#1)(2012-2#1)
Four groups##2##2##(2008-4#1)(2008-9#1)
Four hours after##2##3##(1995-3#1)(2008-11#1)
Four hours##3##2##(1995-3#1)(2008-11#1)(2008-12#1)
Four hundred and##4##3##(1991-12#1)(2008-10#3)
Four hundred##11##2##(1991-12#1)(1991-2#1)(1997-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2013-1#2)
Four independent##2##2##(2008-10#1)(2011-2#1)
Four isolates##3##2##(2007-6#1)(2008-10#2)
Four kinds of##2##3##(1990-8#1)(1991-2#1)
Four lesions##2##2##(2012-3#2)
Four linear##2##2##(2008-10#2)
Four main##6##2##(2008-10#2)(2008-5#4)
Four major##5##2##(1994-9#1)(1996-9#1)(2008-10#1)(2009-8#1)(2011-1#1)
Four months later##2##3##(1994-12#1)(2007-8#1)
Four months##4##2##(1990-6#1)(1994-12#1)(2007-8#1)(2011-2#1)
Four new##2##2##(2009-3#1)(2011-1#1)
Four of eight##2##3##(2008-10#1)(2010-1#1)
Four of the 5##2##4##(1991-8#1)(2007-10#1)
Four of the patients##2##4##(1996-7#1)(2011-1#1)
Four of the##19##3##(1991-8#1)(1992-6#1)(1993-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
Four of these##5##3##(1991-12#1)(1993-8#1)(2007-10#1)(2010-11#1)(2012-2#1)
Four of##32##2##(1991-12#1)(1991-8#1)(1992-6#2)(1993-6#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-10#2)(2008-10#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Four pairs of##2##3##(2007-12#1)(2008-10#1)
Four parameters were assessed##2##4##(2008-10#2)
Four parameters were##3##3##(2008-10#2)(2008-3#1)
Four parameters##4##2##(2008-10#3)(2008-3#1)
Four patients are##2##3##(2008-7#1)(2011-2#1)
Four patients died of##2##4##(1990-12#1)(2008-6#1)
Four patients died##3##3##(1990-12#1)(1993-2#1)(2008-6#1)
Four patients had##4##3##(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Four patients presented persistent##2##4##(1994-3#1)(2007-11#1)
Four patients received##2##3##(1993-2#1)(2008-7#1)
Four patients underwent##4##3##(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
Four patients were##3##3##(1993-5#1)(2008-4#1)(2008-5#1)
Four patients with##4##3##(1990-12#1)(2008-6#2)(2008-7#1)
Four patients##37##2##(1990-12#3)(1992-10#1)(1992-11#1)(1993-10#1)(1993-2#2)(1993-5#1)(1994-3#1)(1994-8#1)(1997-6#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#5)(2008-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#2)
Four populations##2##2##(2008-10#2)
Four potential##2##2##(2008-11#1)(2011-2#1)
Four separate##2##2##(2008-7#1)(2011-2#1)
Four sets of##2##3##(1997-1#1)(2008-11#1)
Four simple and sensitive##2##4##(2008-10#2)
Four species##3##2##(2008-10#2)(2013-8#1)
Four studies were##2##3##(2008-11#1)(2012-3#1)
Four studies##5##2##(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
Four themes emerged from##2##4##(2008-11#1)(2013-1#1)
Four themes##5##2##(2007-2#1)(2008-11#2)(2012-3#1)(2013-1#1)
Four tomato##2##2##(2008-10#2)
Four treatments##2##2##(2008-10#2)
Four types of##9##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#2)
Four units of##2##3##(1994-9#2)
Four variables##2##2##(2008-10#2)
Four volunteers were##2##3##(1992-8#1)(2008-12#1)
Four weeks after surgery##2##4##(1992-3#2)
Four weeks after##3##3##(1992-3#2)(2008-10#1)
Four weeks later##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
Four weeks##7##2##(1992-3#2)(2007-8#1)(2008-10#3)(2011-1#1)
Four women##2##2##(1990-9#1)(2011-2#1)
Four years after##2##3##(1991-1#1)(1995-11#1)
Four years later##4##3##(1996-3#1)(2006-10#1)(2008-6#1)(2008-8#1)
Four years##8##2##(1991-1#1)(1995-11#1)(1996-3#1)(1997-8#1)(2006-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
Four young##2##2##(1991-2#1)(1995-6#1)
Four##398##1##(1990-12#3)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#4)(1997-6#5)(1997-7#2)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#3)(2008-10#114)(2008-11#12)(2008-12#5)(2008-3#5)(2008-4#5)(2008-5#14)(2008-6#9)(2008-7#9)(2008-8#8)(2008-9#8)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#17)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#12)(2013-8#6)
Four-dimensional##3##1##(2008-3#2)(2011-2#1)
Four-wave mixing in##2##3##(2007-12#2)
Four-wave mixing##4##2##(2007-12#4)
Fourier Transform Infrared Spectroscopy##2##4##(2008-10#1)(2011-2#1)
Fourier Transform Infrared##4##3##(2008-10#3)(2011-2#1)
Fourier Transform infrared##2##3##(2008-10#1)(2008-3#1)
Fourier Transform##10##2##(2008-10#5)(2008-2#2)(2008-3#1)(2009-12#1)(2011-2#1)
Fourier analysis of##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
Fourier analysis##10##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)(2008-8#1)
Fourier and##2##2##(2007-11#1)(2008-3#1)
Fourier coefficients##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
Fourier domain low coherence interferometry##2##5##(2011-1#2)
Fourier domain##14##2##(2007-11#4)(2007-12#2)(2008-3#6)(2011-1#2)
Fourier filtering##4##2##(2007-11#1)(2007-12#2)(2011-1#1)
Fourier frequencies##2##2##(2007-12#2)
Fourier frequency##2##2##(2007-11#1)(2007-12#1)
Fourier holography##2##2##(2008-3#2)
Fourier methods##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
Fourier modulus##3##2##(2008-3#3)
Fourier optics is##2##3##(2008-3#2)
Fourier optics##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
Fourier plane is##2##3##(2008-3#1)(2011-1#1)
Fourier plane##13##2##(2007-11#2)(2008-2#5)(2008-3#5)(2011-1#1)
Fourier polarimetry##2##2##(2008-3#2)
Fourier processor and##2##3##(2008-3#2)
Fourier processor is##2##3##(2008-3#2)
Fourier processor##4##2##(2008-3#4)
Fourier self-deconvolution##2##2##(2008-10#2)
Fourier series##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Fourier space##3##2##(2007-12#1)(2008-2#1)(2010-6#1)
Fourier spectrum of##3##3##(2007-12#1)(2008-3#2)
Fourier spectrum##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
Fourier synthesis of##2##3##(2007-11#2)
Fourier transform IR##5##3##(2008-2#3)(2008-3#1)(2010-4#1)
Fourier transform Raman spectroscopy (FT-Raman)##2##5##(2008-10#2)
Fourier transform Raman spectroscopy##3##4##(2008-10#3)
Fourier transform algorithm##4##3##(2008-2#1)(2008-3#3)
Fourier transform and##3##3##(2008-2#2)(2008-3#1)
Fourier transform approach##2##3##(2008-2#2)
Fourier transform infrared (ATR FT-IR)##2##5##(2007-12#1)(2008-10#1)
Fourier transform infrared (FT-IR) spectroscopy##2##5##(2007-12#1)(2008-10#1)
Fourier transform infrared (FT-IR)##7##4##(2007-12#4)(2008-10#2)(2013-1#1)
Fourier transform infrared (FTIR) spectroscopic##2##5##(2008-10#2)
Fourier transform infrared (FTIR) spectroscopy and##2##6##(1994-11#1)(2008-10#1)
Fourier transform infrared (FTIR) spectroscopy##6##5##(1994-11#1)(2008-10#3)(2008-5#1)(2008-8#1)
Fourier transform infrared (FTIR)##13##4##(1994-11#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-8#1)
Fourier transform infrared determination of##2##5##(2008-10#2)
Fourier transform infrared imaging##2##4##(2007-12#1)(2008-8#1)
Fourier transform infrared spectra##2##4##(1991-5#1)(1995-5#1)
Fourier transform infrared spectrometer##3##4##(2008-10#2)(2008-3#1)
Fourier transform infrared spectrometric detection##2##5##(2008-10#2)
Fourier transform infrared spectrometric##3##4##(2008-10#3)
Fourier transform infrared spectrometry (FT-IR)##2##5##(1997-2#1)(2008-10#1)
Fourier transform infrared spectrometry##12##4##(1992-8#1)(1997-2#1)(2008-10#9)(2008-5#1)
Fourier transform infrared spectroscopic##2##4##(2007-12#1)(2008-10#1)
Fourier transform infrared spectroscopy (FT-IR)##6##5##(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#1)
Fourier transform infrared spectroscopy (FTIR)##7##5##(2008-10#5)(2008-5#1)(2013-8#1)
Fourier transform infrared spectroscopy and##3##5##(2007-12#1)(2008-10#1)(2010-5#1)
Fourier transform infrared spectroscopy##21##4##(2007-12#2)(2008-10#12)(2008-5#2)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
Fourier transform infrared##80##3##(1991-5#3)(1992-8#1)(1994-11#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#9)(2008-10#45)(2008-3#3)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
Fourier transform ion cyclotron resonance##2##5##(2008-7#2)
Fourier transform is##3##3##(2008-2#1)(2008-3#2)
Fourier transform of an##2##4##(2008-3#2)
Fourier transform of the##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
Fourier transform of##9##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
Fourier transform profilometry##2##3##(2008-2#1)(2008-3#1)
Fourier transform spectrometer##8##3##(2008-2#2)(2008-3#6)
Fourier transform spectrometers##2##3##(2008-2#1)(2008-3#1)
Fourier transform spectrometry##3##3##(2007-11#1)(2008-3#2)
Fourier transform spectroscopy##10##3##(2008-10#2)(2008-2#7)(2008-3#1)
Fourier transform##188##2##(1991-5#3)(1992-8#1)(1993-11#1)(1994-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#5)(2007-12#19)(2008-1#1)(2008-10#55)(2008-2#37)(2008-3#40)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-8#1)
Fourier transformation of##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
Fourier transformation##16##2##(1993-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#2)(2013-1#1)
Fourier transformed infrared spectroscopy##2##4##(2008-10#1)(2013-8#1)
Fourier transformed infrared##4##3##(2008-10#3)(2013-8#1)
Fourier transformed##8##2##(2008-1#1)(2008-10#3)(2008-3#3)(2013-8#1)
Fourier transformer##2##2##(2007-11#1)(2008-3#1)
Fourier transforms##6##2##(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#2)
Fourier##355##1##(1991-3#1)(1991-5#3)(1992-8#1)(1993-11#2)(1993-3#1)(1994-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#26)(2007-12#35)(2008-1#4)(2008-10#76)(2008-11#2)(2008-2#64)(2008-3#98)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#3)
Fourier-Transform Spectrometer##2##2##(2008-3#2)
Fourier-Transform##3##1##(2008-3#3)
Fourier-modal##2##1##(2007-12#2)
Fourier-optics##2##1##(2008-2#2)
Fourier-plane##2##1##(2007-12#1)(2008-3#1)
Fourier-transform algorithm##2##2##(2007-11#1)(2008-3#1)
Fourier-transform emission##2##2##(2008-3#2)
Fourier-transform infrared (FTIR)##4##3##(1992-6#1)(2007-12#1)(2008-3#1)(2008-7#1)
Fourier-transform infrared analysis##2##3##(2008-10#2)
Fourier-transform infrared imaging##2##3##(2007-12#1)(2008-8#1)
Fourier-transform infrared spectroscopy was used to##2##6##(1994-11#1)(1994-6#1)
Fourier-transform infrared spectroscopy##5##3##(1994-11#2)(1994-6#1)(2008-3#1)(2008-6#1)
Fourier-transform infrared##22##2##(1990-2#1)(1992-6#1)(1994-11#2)(1994-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)
Fourier-transform method to##2##3##(2008-3#2)
Fourier-transform method##6##2##(2008-2#1)(2008-3#5)
Fourier-transform profilometry (FTP) and data-dependent##2##5##(2008-3#2)
Fourier-transform profilometry (FTP)##3##3##(2007-11#1)(2008-3#2)
Fourier-transform spectrometer (FTS)##2##3##(2008-2#1)(2008-3#1)
Fourier-transform spectrometer##11##2##(2008-2#3)(2008-3#8)
Fourier-transform spectrometers##2##2##(2008-3#2)
Fourier-transform spectroscopy##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2011-1#2)
Fourier-transform##79##1##(1990-2#1)(1992-6#1)(1994-11#2)(1994-6#1)(1996-7#1)(2007-11#5)(2007-12#8)(2008-10#4)(2008-2#14)(2008-3#37)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)
Fourier-transform-limited##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Fourier-transformed##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Fournier's gangrene complicating##2##3##(2010-12#2)
Fournier's gangrene##5##2##(2010-12#3)(2013-1#2)
Fournier's##6##1##(2010-12#3)(2013-1#3)
Fourteen of 16 studies (88%) implemented##2##6##(2009-6#2)
Fourteen of 16 studies##3##4##(2008-2#1)(2009-6#2)
Fourteen of the##2##3##(2008-1#1)(2008-12#1)
Fourteen of##8##2##(1994-12#1)(1994-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-6#2)
Fourteen patients underwent##2##3##(2007-8#1)(2008-7#1)
Fourteen patients were##4##3##(1990-12#1)(1992-8#1)(1997-8#1)(2010-3#1)
Fourteen patients with##3##3##(1991-5#1)(1993-12#1)(2013-1#1)
Fourteen patients##12##2##(1990-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1997-8#1)(2007-8#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
Fourteen##55##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
Fourth Edition criteria for##2##4##(2011-2#2)
Fourth Edition##7##2##(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#4)
Fourth Paradigm##3##2##(1994-11#3)
Fourth ventricular administration of##2##4##(1995-12#2)
Fourth##28##1##(1990-2#1)(1992-9#1)(1993-2#3)(1994-11#3)(1995-12#2)(1995-5#1)(1995-6#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#2)(2011-2#4)
Fov1##2##1##(2008-10#2)
Foveal##2##1##(2008-2#1)(2013-8#1)
Foveavirus##2##1##(2008-10#2)
Fowler's##2##1##(2011-1#2)
FowlerStephens##2##1##(2011-2#2)
Fox##4##1##(1991-12#1)(1993-11#1)(2007-7#1)(2008-8#1)
Foxd3 locus##2##2##(2012-2#2)
Foxd3##3##1##(2012-2#3)
Foxp3 and##2##2##(2007-5#1)(2011-2#1)
Foxtail Millet##3##2##(2008-10#3)
Fr##3##1##(2010-8#1)(2012-12#2)
Fr11##2##1##(1993-3#2)
Fraction##3##1##(2008-10#1)(2008-11#1)(2012-1#1)
Fractional##10##1##(1996-12#2)(2007-11#2)(2008-2#2)(2008-3#2)(2009-4#1)(2010-6#1)
Fractionated RNA is transferred from an agarose gel to a membrane support (northern blotting)##2##14##(2008-4#2)
Fractionated##5##1##(1995-9#1)(2008-10#1)(2008-4#2)(2012-3#1)
Fractionation of the##3##3##(1991-2#1)(1995-11#1)(2010-2#1)
Fractionation of##13##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-4#1)(2010-2#1)
Fractionation##14##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-4#1)(2010-2#1)
Fractions were##3##2##(1992-10#1)(1997-2#1)(2008-11#1)
Fractions##8##1##(1990-5#1)(1992-10#1)(1997-2#1)(2008-10#2)(2008-11#2)(2009-8#1)
Fracture characteristics predictive of##2##4##(2008-8#2)
Fracture##13##1##(2007-11#1)(2008-12#1)(2008-8#2)(2009-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
Fractures of##3##2##(2007-11#1)(2008-12#1)(2013-8#1)
Fractures##11##1##(1996-12#1)(2007-11#1)(2007-8#1)(2008-12#2)(2009-3#1)(2009-8#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
Fragaria x ananassa##2##3##(2008-10#2)
Fragaria##5##1##(2008-10#4)(2008-8#1)
Fragile X Syndrome##2##3##(2009-5#1)(2010-4#1)
Fragile X syndrome##2##3##(2010-4#1)(2012-1#1)
Fragile X##6##2##(2009-5#3)(2010-4#2)(2012-1#1)
Fragile##7##1##(2009-5#3)(2010-4#2)(2011-2#1)(2012-1#1)
Fragment Length Polymorphism##11##3##(2008-10#11)
Fragment Length##13##2##(2008-10#13)
Fragment##16##1##(2008-10#13)(2008-3#1)(2008-8#1)(2013-1#1)
Fragmentation of##5##2##(1992-2#1)(1992-3#1)(1996-5#1)(1997-8#1)(2008-1#1)
Fragmentation##7##1##(1992-2#1)(1992-3#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)
Fragmented##3##1##(2008-9#1)(2009-10#1)(2012-3#1)
Fragments of the##3##3##(1995-6#1)(2008-10#1)(2008-9#1)
Fragments of##9##2##(1993-2#1)(1994-12#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
Fragments##16##1##(1990-5#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
Frailty##2##1##(1997-7#1)(2012-12#1)
Framesearch##4##1##(2008-9#4)
Framework for##6##2##(1990-3#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#1)
Framework##20##1##(1990-3#1)(1996-2#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)
Framingham Study cohort##2##3##(1993-3#1)(2007-10#1)
Framingham##9##1##(1993-3#1)(2007-10#2)(2008-1#2)(2009-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
France and##12##2##(2008-10#8)(2008-2#1)(2010-4#1)(2012-2#1)(2013-8#1)
France are##2##2##(1990-8#1)(2008-10#1)
France during##2##2##(2008-10#2)
France in##2##2##(2011-2#1)(2012-12#1)
France##105##1##(1990-8#3)(1991-11#2)(1991-2#1)(1992-2#1)(1994-12#2)(1995-1#2)(1995-3#1)(1997-5#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#47)(2008-11#1)(2008-2#1)(2008-5#6)(2008-7#4)(2008-8#1)(2009-4#2)(2009-7#1)(2010-1#4)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
France) and##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
France)##11##1##(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#4)(2011-2#1)
Francesco##2##1##(2010-1#2)
Francis##5##1##(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
Francisco##20##1##(1990-11#1)(1990-9#1)(1991-11#1)(1991-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#4)(2011-2#1)(2013-7#1)
Francisella novicida##2##2##(2012-2#2)
Francisella tularensis##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
Francisella##8##1##(2008-10#1)(2008-7#1)(2012-2#6)
Francois##2##1##(2008-7#2)
Frank and##2##2##(2008-5#1)(2008-8#1)
Frank##7##1##(1993-11#1)(1996-3#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
Frankel grade B##2##3##(2008-7#2)
Frankel grade##3##2##(2007-11#1)(2008-7#2)
Frankel##6##1##(1992-3#1)(2007-11#3)(2008-7#2)
Frankfort##3##1##(2008-10#1)(2012-3#2)
Franklin##3##1##(2008-10#1)(2008-4#1)(2012-2#1)
Frankliniella fusca##3##2##(2008-10#3)
Frankliniella occidentalis##6##2##(2008-10#5)(2011-2#1)
Frankliniella##10##1##(2008-10#9)(2011-2#1)
Franz cell##3##2##(2008-10#2)(2008-5#1)
Franz diffusion cells##2##3##(2008-5#1)(2011-3#1)
Franz##5##1##(2008-10#2)(2008-5#2)(2011-3#1)
Franz-Keldysh effect in##2##3##(2008-2#1)(2008-3#1)
Franz-Keldysh effect##3##2##(2008-2#2)(2008-3#1)
François##2##1##(2009-7#1)(2011-1#1)
Fraser fir##3##2##(2008-10#1)(2011-2#2)
Fraser##5##1##(2008-10#1)(2008-9#1)(2011-2#2)(2013-8#1)
Frauenfeld/Aadorf##2##1##(1996-11#2)
Fraunhofer and##2##2##(2008-2#1)(2008-3#1)
Fraunhofer diffraction pattern##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
Fraunhofer diffraction##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Fraunhofer##12##1##(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#3)
Fraxinus##2##1##(2008-8#1)(2013-8#1)
Frederick III##2##2##(2007-10#2)
Frederiksborg County##2##2##(1990-12#2)
Fredholm integral equation of the##2##5##(2008-3#1)(2009-10#1)
Fredholm##3##1##(2008-3#1)(2009-10#2)
Free Radical##2##2##(2009-9#1)(2010-5#1)
Free State province##3##3##(2012-12#3)
Free State##4##2##(2012-12#4)
Free and##3##2##(1993-2#2)(1996-2#1)
Free radical scavengers##2##3##(2008-11#1)(2008-5#1)
Free radical##3##2##(1990-12#1)(2008-11#1)(2008-5#1)
Free radicals and##2##3##(1996-9#1)(2009-6#1)
Free radicals play##2##3##(1992-9#1)(2011-2#1)
Free radicals##6##2##(1990-12#1)(1992-9#1)(1993-6#1)(1996-9#1)(2009-6#1)(2011-2#1)
Free##58##1##(1990-12#3)(1990-8#1)(1991-12#1)(1991-6#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#1)
Free-Space Optical Interconnections##2##3##(2008-2#2)
Free-Space Optical##3##2##(2008-2#3)
Free-Space##4##1##(2008-2#3)(2008-3#1)
Free-flow##2##1##(2008-1#1)(2008-4#1)
Free-space optical##4##2##(2008-2#2)(2008-3#2)
Free-space##7##1##(2007-12#1)(2008-2#2)(2008-3#4)
Freedom##10##1##(1991-12#1)(1995-6#1)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#2)(2013-1#2)
Freely##2##1##(1995-5#1)(2008-2#1)
Freeman##3##1##(2008-10#1)(2012-2#1)(2012-3#1)
Freestanding##3##1##(2008-2#3)
Freeze##2##1##(1991-5#1)(2008-10#1)
Freeze-fracture##2##1##(1992-6#1)(1997-2#1)
Freezing resistance##2##2##(2009-2#2)
Freezing##6##1##(2008-10#1)(2008-8#1)(2009-2#2)(2011-2#1)(2013-1#1)
Frejka pillow and##3##3##(2007-8#3)
Frejka pillow##9##2##(2007-8#9)
Fremont##2##1##(1996-9#1)(1997-3#1)
French and##4##2##(2008-10#3)(2008-11#1)
French beans in##2##3##(2008-10#2)
French beans##5##2##(2008-10#5)
French children##3##2##(2009-7#3)
French urologist resident and chief resident's##2##6##(2011-2#2)
French wheat##2##2##(2008-10#1)(2011-10#1)
French##91##1##(1990-8#5)(1991-11#1)(1991-9#1)(1992-5#1)(1994-12#1)(1995-2#1)(1996-11#2)(1996-8#1)(1997-5#3)(1997-8#1)(2007-2#1)(2007-6#2)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2008-9#2)(2009-5#1)(2009-7#4)(2010-1#5)(2010-3#1)(2010-6#1)(2010-9#3)(2011-1#1)(2011-10#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
French-language health care services##2##4##(1995-2#2)
French-language health##3##2##(1991-3#1)(1995-2#2)
French-language##5##1##(1991-3#2)(1995-2#3)
French-speaking##4##1##(1991-3#1)(2009-10#1)(2010-1#1)(2010-3#1)
Frequencies and##3##2##(2008-10#3)
Frequencies of the##2##3##(1996-2#1)(2008-7#1)
Frequencies of virulence were##2##4##(2008-10#2)
Frequencies of##10##2##(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
Frequencies##13##1##(1995-8#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
Frequency Domain##2##2##(2011-1#2)
Frequency Doubling##2##2##(2008-2#1)(2008-3#1)
Frequency Generation##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
Frequency Modulation##2##2##(2008-2#2)
Frequency Shift##2##2##(1996-12#1)(1997-7#1)
Frequency Stabilization of a##2##4##(2008-2#1)(2008-3#1)
Frequency and risk factors for##2##5##(2007-10#1)(2011-2#1)
Frequency and##4##2##(2007-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
Frequency doubling of##2##3##(2007-12#1)(2008-3#1)
Frequency doubling##3##2##(2007-12#2)(2008-3#1)
Frequency modulation##2##2##(2007-11#1)(2008-3#1)
Frequency of factors##2##3##(2007-12#1)(2012-2#1)
Frequency of##28##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1995-11#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-11#2)(2010-12#2)(2011-1#1)(2012-12#2)(2012-2#4)
Frequency stabilization of##3##3##(2007-11#1)(2007-12#2)
Frequency##79##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#8)(2008-10#8)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#3)(2010-11#2)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#4)
Frequency-Doubled##2##1##(2008-2#1)(2008-3#1)
Frequency-agile##2##1##(2007-12#1)(2008-2#1)
Frequency-dependent##3##1##(2008-3#2)(2008-9#1)
Frequency-derived distributed optical-fiber sensing technique##2##5##(2008-3#2)
Frequency-derived distributed optical-fiber sensing##3##4##(2008-3#3)
Frequency-domain##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Frequency-modulation spectroscopy##2##2##(2008-3#2)
Frequency-modulation##3##1##(2008-3#3)
Frequency-resolved optical gating is used to characterize##2##7##(2007-11#1)(2007-12#1)
Frequency-resolved optical gating##4##3##(2007-11#2)(2007-12#2)
Frequency-resolved##5##1##(2007-11#3)(2007-12#2)
Frequent light pulses##2##3##(2008-5#2)
Frequent##15##1##(1992-12#1)(1993-11#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
Frequently asked##2##2##(2008-4#1)(2013-1#1)
Frequently##13##1##(1993-9#1)(1994-12#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
Fresh##13##1##(1993-9#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-6#1)(2009-3#1)(2009-4#1)(2013-1#1)(2013-7#1)
Freshly harvested##3##2##(2008-10#3)
Freshly isolated##4##2##(1990-2#1)(1995-2#1)(2008-1#1)(2008-11#1)
Freshly##11##1##(1990-2#1)(1993-9#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-12#1)
Fresnaye##2##1##(2008-10#2)
Fresnel Zone##2##2##(2008-2#1)(2008-3#1)
Fresnel approximation##6##2##(2008-2#2)(2008-3#4)
Fresnel diffraction by##2##3##(2007-12#1)(2008-3#1)
Fresnel diffraction theory##2##3##(2008-2#1)(2008-3#1)
Fresnel diffraction##13##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#6)
Fresnel null correctors are##2##4##(2008-3#2)
Fresnel null correctors##4##3##(2008-3#4)
Fresnel number##6##2##(2007-12#2)(2008-3#4)
Fresnel numbers in##2##3##(2008-3#2)
Fresnel numbers##4##2##(2008-3#4)
Fresnel propagation##2##2##(2007-12#1)(2008-3#1)
Fresnel rhombs##2##2##(2008-2#2)
Fresnel zone plates##5##3##(2007-11#2)(2008-3#1)(2012-2#2)
Fresnel zone##8##2##(2007-11#2)(2008-2#2)(2008-3#2)(2012-2#2)
Fresnel##81##1##(2007-11#11)(2007-12#13)(2008-2#14)(2008-3#41)(2012-2#2)
Fresnel's equations##2##2##(2008-3#2)
Fresnel's##3##1##(2008-3#3)
Fresnel-Kirchhoff##7##1##(2007-12#1)(2008-2#3)(2008-3#3)
Freund's adjuvant##8##2##(1995-12#4)(1996-12#1)(1997-2#2)(2008-4#1)
Freund's##9##1##(1995-12#4)(1996-12#2)(1997-2#2)(2008-4#1)
Freundlich adsorption##2##2##(2008-10#2)
Freundlich and Dubinin-Radushkevich (D-R) isotherms##2##5##(2008-10#2)
Freundlich and Langmuir##3##3##(2008-10#2)(2008-6#1)
Freundlich and##5##2##(2008-10#4)(2008-6#1)
Freundlich sorption##3##2##(2008-10#2)(2008-12#1)
Freundlich##20##1##(1997-2#1)(2008-10#13)(2008-12#1)(2008-6#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
Friction##6##1##(1996-4#1)(2008-5#2)(2010-10#2)(2012-2#1)
Friday##4##1##(2008-11#1)(2008-12#1)(2013-1#2)
Friedel-Crafts##3##1##(2009-2#3)
Friedlander##3##1##(1990-4#1)(1995-3#2)
Friedman test##2##2##(2010-6#1)(2013-1#1)
Friedman##5##1##(1990-4#1)(2008-4#1)(2009-8#1)(2010-6#1)(2013-1#1)
Friedreich's##2##1##(2008-7#1)(2013-7#1)
Friend leukemia##2##2##(1990-11#1)(2012-12#1)
Friend##9##1##(1990-11#1)(1993-8#1)(1994-8#4)(2008-11#1)(2012-12#1)(2013-1#1)
Friendly Hills HealthCare Network##3##4##(1997-3#3)
Friendly Hills##4##2##(1997-3#4)
Friendly##5##1##(1997-3#4)(2008-2#1)
Friends of##3##2##(1995-3#1)(2010-4#1)(2013-7#1)
Friends##5##1##(1995-3#1)(2010-4#1)(2012-2#2)(2013-7#1)
Friendship##2##1##(2010-5#1)(2013-8#1)
Fringe patterns##3##2##(2007-12#1)(2008-3#2)
Fringe visibility##2##2##(2008-2#2)
Fringe##10##1##(2007-12#1)(2008-2#5)(2008-3#4)
Fritillaria-type embryo sac##2##3##(2009-12#2)
Fritz's method##2##2##(2008-3#2)
From &quot##2##2##(1994-12#1)(2008-8#1)
From 1##3##2##(1992-5#1)(1992-9#1)(2007-12#1)
From 100##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
From 14##2##2##(2007-8#1)(2008-5#1)
From 1974##2##2##(1995-12#1)(1996-1#1)
From 1978 to##2##3##(1991-2#1)(1993-6#1)
From 1978##3##2##(1991-2#1)(1991-4#1)(1993-6#1)
From 1980##2##2##(1990-5#1)(2008-10#1)
From 1982##2##2##(1992-5#1)(1997-2#1)
From 1986 to##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
From 1987 to##3##3##(1992-11#1)(1995-3#1)(1996-6#1)
From 1993##2##2##(2008-5#1)(2012-3#1)
From 1996 to##3##3##(2007-11#1)(2008-10#1)(2011-7#1)
From 1997 to##2##3##(2011-2#2)
From 200##2##2##(2007-12#1)(2008-8#1)
From 8##2##2##(1991-8#1)(2008-5#1)
From April##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
From February##3##2##(1991-5#1)(1992-8#1)(2008-2#1)
From January##8##2##(1991-6#1)(1992-5#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
From July##2##2##(2007-2#1)(2007-5#1)
From March##4##2##(1991-2#2)(1996-9#1)(2011-1#1)
From May##2##2##(1991-2#1)(2011-2#1)
From November##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
From October##7##2##(1991-3#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
From September 1986 to##2##4##(1991-2#1)(1992-6#1)
From September##6##2##(1991-2#1)(1992-6#1)(1994-9#1)(2008-5#2)(2008-6#1)
From a collection of##2##4##(2008-10#2)
From a comparison of the##2##5##(1995-6#1)(2008-3#1)
From a theoretical point of view##2##6##(2008-3#1)(2008-8#1)
From a theoretical##3##3##(2008-3#1)(2008-8#2)
From a total of##2##4##(2008-10#1)(2008-5#1)
From a##49##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2009-11#1)(2009-7#2)(2010-10#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-8#3)
From an##11##2##(1990-9#1)(1994-11#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-8#1)(2012-2#1)(2013-1#1)
From analysis of##2##3##(2007-12#1)(2008-3#1)
From being##2##2##(2009-9#1)(2013-7#1)
From data##2##2##(2008-10#1)(2011-2#1)
From day##2##2##(1993-6#1)(2008-7#1)
From each##5##2##(1991-5#1)(1992-3#1)(1997-3#1)(2008-10#1)(2009-5#1)
From my perspective##11##3##(2008-4#7)(2008-6#4)
From one##3##2##(1994-9#1)(1995-2#1)(2008-10#1)
From our analysis of##2##4##(2007-12#1)(2012-3#1)
From our analysis##3##3##(1991-8#1)(2007-12#1)(2012-3#1)
From our data##2##3##(1990-8#1)(1996-3#1)
From our results it##2##4##(1994-8#1)(2007-12#1)
From our results##5##3##(1990-5#1)(1992-9#1)(1994-8#1)(2007-12#1)(2011-2#1)
From our##15##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-9#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
From such##2##2##(1994-12#1)(2008-10#1)
From the above##2##3##(2008-12#1)(2012-2#1)
From the analysis of the##4##5##(1990-7#1)(2008-10#2)(2010-2#1)
From the analysis of##6##4##(1990-7#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-2#1)
From the analysis##8##3##(1990-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-6#1)(2010-2#1)
From the aspect of the##2##5##(1990-11#1)(1996-9#1)
From the aspect of##3##4##(1990-11#1)(1995-5#1)(1996-9#1)
From the beginning##2##3##(1995-3#1)(1996-6#1)
From the calculated##2##3##(2008-10#1)(2009-1#1)
From the computational##2##3##(2008-2#1)(2013-8#1)
From the computer-simulation results##2##4##(2008-2#2)
From the data##4##3##(1997-4#1)(2008-10#1)(2008-2#2)
From the day of##2##4##(1992-6#1)(2007-12#1)
From the experimental results##3##4##(2008-2#1)(2008-3#1)(2009-7#1)
From the experimental##4##3##(2008-2#1)(2008-3#1)(2009-7#1)(2010-4#1)
From the four##2##3##(2007-11#1)(2008-5#1)
From the initial##2##3##(1995-2#1)(2008-10#1)
From the literature reviewed##2##4##(1993-2#1)(2012-1#1)
From the literature##3##3##(1993-2#1)(2009-10#1)(2012-1#1)
From the obtained data##2##4##(2008-5#2)
From the obtained results##2##4##(2008-10#1)(2008-5#1)
From the obtained##4##3##(2008-10#1)(2008-5#3)
From the onset of##2##4##(1997-4#1)(2012-2#1)
From the perspective of##2##4##(1992-3#1)(2012-12#1)
From the present study##2##4##(1994-11#1)(2012-2#1)
From the present##3##3##(1990-7#1)(1994-11#1)(2012-2#1)
From the result of##2##4##(1993-3#1)(2011-1#1)
From the results it##2##4##(1990-12#1)(2008-12#1)
From the results obtained##2##4##(2008-10#2)
From the results of##5##4##(1993-2#1)(2008-11#1)(2008-3#1)(2008-5#2)
From the results##12##3##(1990-12#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2011-1#1)
From the review##2##3##(2008-10#1)(2009-5#1)
From the start##2##3##(1991-3#1)(2008-12#1)
From the study of##2##4##(1995-2#1)(2008-1#1)
From the study##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
From the temperature##2##3##(2007-12#1)(2008-3#1)
From the total##3##3##(1997-6#1)(2012-3#1)(2013-7#1)
From the two##3##3##(2008-10#1)(2008-11#2)
From the very##2##3##(2008-12#1)(2010-3#1)
From the viewpoint of##3##4##(2008-1#1)(2008-12#1)(2013-8#1)
From the##205##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#4)(1991-3#2)(1992-3#2)(1992-6#2)(1992-8#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#3)(1997-6#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#38)(2008-11#8)(2008-12#8)(2008-2#10)(2008-3#14)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#4)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#3)(2013-7#3)(2013-8#5)
From them##3##2##(1993-9#1)(2008-2#1)(2013-1#1)
From these data##9##3##(1990-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
From these findings##4##3##(2008-10#1)(2010-6#2)(2013-1#1)
From these measurements##2##3##(2008-10#1)(2008-3#1)
From these results it was##2##5##(1994-2#1)(2008-3#1)
From these results it##3##4##(1993-8#1)(1994-2#1)(2008-3#1)
From these results we##2##4##(2008-10#1)(2008-5#1)
From these results##26##3##(1990-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-2#1)(1995-3#2)(1996-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2011-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
From these studies##5##3##(1992-12#1)(2008-10#3)(2011-2#1)
From these##60##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#4)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)
From this analysis##2##3##(1995-2#1)(2007-11#1)
From this it##2##3##(1995-6#1)(2008-10#1)
From this perspective##4##3##(1992-3#1)(2008-10#1)(2012-2#2)
From this point of view##2##5##(2008-10#1)(2010-3#1)
From this result##2##3##(1990-11#1)(1990-8#1)
From this review##2##3##(2008-4#1)(2013-1#1)
From this study##5##3##(2008-10#2)(2008-5#1)(2013-1#1)(2013-8#1)
From this##38##2##(1990-11#1)(1990-8#1)(1992-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(2007-11#2)(2008-10#11)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-1#2)(2010-3#1)(2012-2#3)(2013-1#2)(2013-8#2)
From##655##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#6)(1992-5#3)(1992-6#3)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#4)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#6)(1995-5#2)(1995-6#8)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#9)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#14)(2007-12#18)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#11)(2008-1#4)(2008-10#101)(2008-11#20)(2008-12#13)(2008-2#22)(2008-3#33)(2008-4#9)(2008-5#26)(2008-6#11)(2008-7#16)(2008-8#14)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#21)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#14)(2012-5#1)(2012-9#1)(2013-1#19)(2013-7#4)(2013-8#15)
Frontal analysis of aqueous phenol solutions in##2##7##(2008-10#2)
Frontal sinus##2##2##(2013-1#2)
Frontal##9##1##(1995-2#1)(2008-10#2)(2008-4#1)(2010-8#1)(2013-1#2)(2013-8#2)
Frontotemporal dementia (FTD) is##2##4##(2008-6#1)(2008-9#1)
Frontotemporal dementia##3##2##(2008-6#2)(2008-9#1)
Frozen tail or limber tail in working dogs##2##8##(1997-5#2)
Frozen##8##1##(1990-12#1)(1995-4#1)(1997-5#2)(2007-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
Fru 2##6##2##(1994-3#6)
Fru##7##1##(1994-3#7)
Fru-2##2##1##(1992-3#2)
Fru-6-P##2##1##(1995-2#2)
Fructose also##2##2##(1994-8#1)(2012-2#1)
Fructose##3##1##(1994-8#1)(1995-11#1)(2012-2#1)
Fruit Rot##2##2##(2008-10#2)
Fruit and##2##2##(2008-10#1)(2009-5#1)
Fruit by##2##2##(2008-10#2)
Fruit of##4##2##(2008-10#3)(2009-10#1)
Fruit weight##2##2##(2008-12#2)
Fruit were##3##2##(2008-10#2)(2011-2#1)
Fruit with##2##2##(2008-10#2)
Fruit##46##1##(2007-12#1)(2008-10#35)(2008-12#3)(2008-5#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
Fruiting bodies were##2##3##(2008-10#2)
Fruiting bodies##3##2##(2008-10#3)
Fruiting##4##1##(2008-10#4)
Fruits and##2##2##(2008-10#2)
Fruits##8##1##(2008-10#4)(2008-12#1)(2008-5#1)(2010-3#1)(2012-2#1)
Fry##7##1##(1991-9#1)(1994-11#1)(2007-2#1)(2008-3#3)(2011-1#1)
FsphDNase##4##1##(2008-10#4)
Ft##2##1##(2012-12#2)
FtsZ-ring##3##1##(2009-2#3)
Fu's##2##1##(2011-2#1)(2013-8#1)
FucT-VI##4##1##(1992-8#4)
Fuchs##2##1##(1990-7#1)(1993-2#1)
Fucoidan##2##1##(2008-11#2)
Fucus##2##1##(2013-1#2)
Fuego##3##1##(2008-2#1)(2008-3#2)
Fuel##3##1##(1990-3#1)(2008-2#1)(2012-3#1)
Fuerte##7##1##(2008-10#7)
Fugu rubripes##2##2##(1995-2#2)
Fugu##6##1##(1995-2#5)(2008-7#1)
Fuhrmann (1913)##2##2##(2011-2#2)
Fuhrmann##4##1##(2011-2#4)
Fuji IX##4##2##(2008-5#3)(2010-3#1)
Fuji and resistant cv##2##4##(2008-10#2)
Fuji##12##1##(1991-2#1)(2008-10#5)(2008-5#4)(2010-3#2)
Fujimoto##2##1##(1995-6#1)(2007-12#1)
Fukuho-komugi x##2##2##(2008-10#2)
Fukuho-komugi##3##1##(2008-10#3)
Fukushima NPS##2##2##(2012-2#2)
Fukushima##8##1##(2012-2#5)(2013-1#3)
Fukuyo##2##1##(2008-5#2)
Full Text##3##2##(2008-12#1)(2013-1#2)
Full##31##1##(1990-3#1)(1991-1#1)(1991-5#1)(1996-12#2)(1997-2#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-5#1)(2013-1#3)
Full- and##2##2##(2008-10#1)(2008-3#1)
Full-Text##2##1##(1996-3#1)(2010-12#1)
Full-length cDNA##2##2##(2008-10#1)(2008-9#1)
Full-length##5##1##(1991-3#1)(1992-11#1)(2008-10#2)(2008-9#1)
Full-thickness sclerotomy without##2##3##(2013-8#2)
Full-thickness##3##1##(2013-8#3)
Fully automated##2##2##(2008-10#1)(2008-11#1)
Fully##17##1##(1993-11#1)(1994-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-2#1)(2012-2#1)(2013-8#1)
Fulminant##2##1##(1994-2#1)(2012-2#1)
Fulton##2##1##(1993-3#1)(2008-10#1)
Fumonisin B(1)##2##2##(2008-10#2)
Fumonisin levels##2##2##(2008-10#2)
Fumonisin##7##1##(2008-10#7)
Funambulus pennanti##2##2##(2008-5#2)
Funct##3##1##(1992-3#1)(1993-11#1)(2012-1#1)
Function Test##2##2##(2008-8#1)(2012-2#1)
Function and##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
Function in##4##2##(2008-10#1)(2008-5#1)(2013-1#2)
Function of the##3##3##(1994-8#1)(2008-9#1)(2013-1#1)
Function of##10##2##(1994-8#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-1#1)
Function##45##1##(1994-12#1)(1994-8#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
Functional Assessment of Cancer##4##4##(2008-7#3)(2009-11#1)
Functional Genomics and##2##3##(2008-7#2)
Functional Genomics##10##2##(2008-4#1)(2008-7#9)
Functional Genomics'##3##2##(2008-7#3)
Functional analyses of##2##3##(1993-8#1)(1994-2#1)
Functional analysis of##7##3##(1994-12#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
Functional analysis##9##2##(1994-12#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#2)
Functional and##6##2##(1992-12#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-12#1)(2010-5#1)
Functional assays##2##2##(2008-9#1)(2009-8#1)
Functional assessment##2##2##(2007-7#1)(2013-1#1)
Functional bracing of##2##3##(2007-11#2)
Functional brain imaging##3##3##(1995-2#1)(2008-11#1)(2008-8#1)
Functional capillary##2##2##(2009-5#2)
Functional characterization of the##2##4##(1993-11#1)(1994-2#1)
Functional characterization of##5##3##(1993-11#1)(1994-2#1)(1997-7#1)(2008-1#1)(2008-4#1)
Functional classification##2##2##(2008-8#1)(2010-12#1)
Functional connectivity##2##2##(2009-12#1)(2012-2#1)
Functional dissection of##2##3##(1995-2#1)(1995-6#1)
Functional evaluation of##2##3##(2007-8#1)(2008-6#1)
Functional expression of##4##3##(1990-5#1)(1991-12#1)(1992-9#1)(1994-8#1)
Functional expression##5##2##(1990-5#1)(1991-12#1)(1992-9#1)(1994-8#1)(2009-9#1)
Functional genomics##3##2##(2008-7#2)(2011-2#1)
Functional identification of the##2##4##(1995-2#1)(2008-9#1)
Functional imaging##4##2##(2008-1#1)(2008-8#2)(2012-2#1)
Functional improvement##2##2##(1993-6#1)(2012-12#1)
Functional magnetic resonance imaging##3##4##(1994-8#1)(1996-2#2)
Functional magnetic resonance##4##3##(1994-8#1)(1996-2#2)(2011-1#1)
Functional magnetic##5##2##(1994-8#1)(1996-2#2)(2008-10#1)(2011-1#1)
Functional outcome##3##2##(2007-8#1)(2008-6#1)(2011-2#1)
Functional outcomes##2##2##(2011-2#1)(2012-3#1)
Functional properties##2##2##(1995-8#1)(2008-7#1)
Functional studies##3##2##(1991-6#1)(1993-3#1)(2008-4#1)
Functional study##2##2##(1991-6#1)(1993-6#1)
Functional##180##1##(1990-5#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#4)(1997-3#1)(1997-7#3)(1997-8#1)(2007-11#8)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#5)(2008-6#4)(2008-7#25)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#12)(2011-3#1)(2011-8#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#3)
Functionality##3##1##(1995-2#1)(2008-10#1)(2009-9#1)
Functionalized##3##1##(2009-5#1)(2010-4#1)(2010-6#1)
Functionally##8##1##(1990-5#1)(1991-3#1)(1993-1#1)(1993-6#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)
Functioning Scale##3##2##(1996-7#1)(2011-1#1)(2011-2#1)
Functioning of##2##2##(1997-2#1)(2012-3#1)
Functioning##19##1##(1991-2#1)(1996-7#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
Functions and##2##2##(1997-4#1)(2007-11#1)
Functions of##5##2##(1991-11#1)(1992-2#1)(1997-5#1)(2008-3#1)(2008-9#1)
Functions##11##1##(1991-11#1)(1992-2#1)(1995-12#2)(1997-4#1)(1997-5#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-9#1)
Fund for##3##2##(1997-3#1)(2007-2#1)(2008-11#1)
Fund raising in##3##3##(1991-3#1)(1992-3#1)(1993-3#1)
Fund raising##5##2##(1991-3#1)(1992-3#1)(1993-3#3)
Fund##19##1##(1990-9#1)(1991-3#1)(1992-3#2)(1993-3#3)(1995-12#1)(1995-6#2)(1997-3#1)(2007-2#1)(2007-5#1)(2008-11#1)(2009-4#1)(2010-12#3)(2013-8#1)
Fundamental information-density limits##2##3##(2007-12#2)
Fundamental issues##2##2##(2011-2#2)
Fundamental limits##2##2##(2007-12#2)
Fundamental to##2##2##(2008-2#1)(2013-1#1)
Fundamental##21##1##(1992-1#1)(1993-12#1)(2007-11#2)(2007-12#6)(2008-12#1)(2008-2#2)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
Fundamentals of##3##2##(2008-10#2)(2008-6#1)
Fundamentals##4##1##(2008-10#3)(2008-6#1)
Funded##2##1##(2008-11#2)
Funding for##2##2##(1994-12#1)(2009-4#1)
Funding system##2##2##(1994-1#1)(1996-1#1)
Funding##14##1##(1991-12#1)(1992-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1997-4#1)(2009-10#1)(2009-4#2)
Funds##3##1##(2008-7#1)(2009-5#2)
Funeral##2##1##(1997-5#2)
Fungal Pathogen##3##2##(2008-10#2)(2011-2#1)
Fungal culture filtrates##2##3##(2008-10#2)
Fungal isolates from##2##3##(2008-10#2)
Fungal isolates##3##2##(2008-10#3)
Fungal populations##3##2##(2008-10#3)
Fungal##37##1##(1992-11#2)(2007-7#1)(2008-10#25)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#4)(2013-8#1)
Fungi are##3##2##(2008-5#1)(2009-9#1)(2010-2#1)
Fungi in##3##2##(2008-10#3)
Fungi were##2##2##(2008-10#2)
Fungi##26##1##(2008-10#15)(2008-5#2)(2008-9#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-6#2)(2011-2#2)
Fungicide##10##1##(1996-3#1)(2008-10#9)
Fungicides applied##2##2##(2008-10#2)
Fungicides in##4##2##(2008-10#4)
Fungicides##16##1##(2008-10#16)
Fungus Bipolaris sorokiniana##2##3##(2008-10#2)
Fungus Fusarium##2##2##(2008-10#2)
Fungus##31##1##(2008-10#30)(2008-5#1)
Fur##3##1##(1997-7#1)(2009-6#2)
Fura-2##4##1##(1990-12#1)(1991-9#1)(1992-3#1)(1995-8#1)
Furin and##2##2##(2008-11#1)(2013-1#1)
Furin##6##1##(2008-11#5)(2013-1#1)
Furnace##2##1##(2008-10#2)
Further addition of##3##3##(1994-6#1)(2008-5#2)
Further analyses of these data##2##5##(1992-12#1)(2008-6#1)
Further analyses##7##2##(1992-12#1)(1993-12#1)(1996-10#1)(2008-2#1)(2008-3#1)(2008-6#2)
Further analysis of the##7##4##(1992-3#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-6#1)(2013-8#1)
Further analysis of##10##3##(1992-3#1)(1992-9#1)(1995-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2013-8#1)
Further analysis showed that##2##4##(1997-3#1)(2012-3#1)
Further analysis using##2##3##(1991-8#1)(2010-4#1)
Further analysis##20##2##(1991-8#1)(1992-3#1)(1992-9#1)(1995-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
Further characterization of the##4##4##(1991-3#1)(1992-8#1)(2008-10#1)(2008-8#1)
Further characterization of##6##3##(1990-12#1)(1991-3#1)(1992-8#1)(1994-6#1)(2008-10#1)(2008-8#1)
Further clinical studies##2##3##(2010-11#1)(2011-2#1)
Further clinical##3##2##(2007-12#1)(2010-11#1)(2011-2#1)
Further development of##7##3##(2008-10#1)(2008-3#1)(2009-11#1)(2009-7#1)(2010-6#1)(2010-8#1)(2012-2#1)
Further development##8##2##(2008-10#2)(2008-3#1)(2009-11#1)(2009-7#1)(2010-6#1)(2010-8#1)(2012-2#1)
Further developments##2##2##(2008-5#1)(2008-7#1)
Further evidence for acquired undescended testicle in the UK and its incompatibility with current recommendations in the Hall Report##2##19##(2008-10#2)
Further evidence for##4##3##(1996-12#1)(1997-7#1)(2008-10#2)
Further evidence on the##2##4##(1997-7#1)(2009-2#1)
Further evidence##7##2##(1996-12#1)(1997-7#2)(2008-10#3)(2009-2#1)
Further examination of##3##3##(2008-10#2)(2008-9#1)
Further examination##4##2##(2008-10#3)(2008-9#1)
Further experimentation will be##2##4##(1997-6#1)(2008-10#1)
Further experiments are##2##3##(1994-10#1)(1997-2#1)
Further experiments##6##2##(1992-5#1)(1994-10#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-2#1)
Further follow-up##4##2##(1992-2#1)(1997-8#1)(2006-10#1)(2009-3#1)
Further functional##2##2##(1995-6#1)(2010-12#1)
Further identification##2##2##(1997-1#1)(2008-10#1)
Further imaging##2##2##(2013-1#1)(2013-7#1)
Further improvements##5##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
Further in##2##2##(2007-8#1)(2008-5#1)
Further increase in##2##3##(1994-3#1)(2008-5#1)
Further information##3##2##(2007-2#1)(2008-10#1)(2011-2#1)
Further investigation is necessary to##2##5##(1991-8#1)(2008-10#1)
Further investigation is##3##3##(1991-8#1)(2008-10#1)(2012-1#1)
Further investigation of##2##3##(2008-6#1)(2008-7#1)
Further investigation revealed that##4##4##(1990-5#1)(1994-6#1)(2006-10#1)(2010-2#1)
Further investigation##16##2##(1990-5#1)(1991-8#1)(1994-6#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-6#2)(2008-7#2)(2009-3#1)(2010-2#1)(2011-2#2)(2012-1#1)
Further investigations are needed to determine##2##6##(1992-8#1)(2013-8#1)
Further investigations are needed to##4##5##(1992-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
Further investigations are##8##3##(1992-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)(2013-8#1)
Further investigations of##2##3##(1996-12#1)(2008-10#1)
Further investigations##15##2##(1992-8#1)(1996-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-7#1)(2013-8#1)
Further mutations##2##2##(2008-1#1)(2008-8#1)
Further on in##2##3##(2008-12#1)(2008-5#1)
Further phase##2##2##(2008-5#2)
Further prospective studies##2##3##(2007-10#2)
Further prospective##3##2##(1991-2#1)(2007-10#2)
Further research in this##2##4##(1992-9#1)(2012-12#1)
Further research is needed on##2##5##(1995-11#1)(2012-2#1)
Further research is needed to determine the##3##7##(2008-12#1)(2008-5#1)(2012-2#1)
Further research is needed to determine##4##6##(1994-12#1)(2008-12#1)(2008-5#1)(2012-2#1)
Further research is needed to##8##5##(1994-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
Further research is needed##11##4##(1994-12#1)(1995-11#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#2)
Further research is required to##3##5##(2007-11#1)(2011-2#1)(2013-1#1)
Further research is##18##3##(1994-12#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#1)
Further research on##2##3##(1990-6#1)(2008-10#1)
Further research##31##2##(1990-6#2)(1992-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-5#2)(2010-10#2)(2010-3#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
Further studies are necessary to determine##2##6##(2011-2#1)(2013-8#1)
Further studies are necessary to##3##5##(2011-2#1)(2012-12#1)(2013-8#1)
Further studies are necessary##4##4##(2007-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Further studies are needed to confirm##2##6##(2008-10#1)(2011-2#1)
Further studies are needed to determine##2##6##(1993-8#1)(2008-12#1)
Further studies are needed to elucidate the##2##7##(1995-6#1)(2012-12#1)
Further studies are needed to establish the##2##7##(2007-10#1)(2012-2#1)
Further studies are needed to establish##3##6##(2007-10#1)(2008-5#1)(2012-2#1)
Further studies are needed to##14##5##(1991-6#1)(1993-8#1)(1995-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#2)
Further studies are needed##15##4##(1991-6#1)(1993-8#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#2)
Further studies are required to evaluate the##2##7##(1993-11#1)(2011-2#1)
Further studies are required to##4##5##(1993-11#1)(1993-2#1)(2008-6#1)(2011-2#1)
Further studies are required##5##4##(1993-11#1)(1993-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
Further studies are warranted to determine the##2##7##(2008-10#1)(2008-7#1)
Further studies are warranted to##3##5##(2008-10#1)(2008-7#2)
Further studies are##27##3##(1991-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-6#1)(2007-10#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-8#1)
Further studies indicated that##2##4##(1990-11#1)(2008-8#1)
Further studies may be needed on##2##6##(1992-9#1)(2007-2#1)
Further studies may be##3##4##(1992-9#1)(2007-2#1)(2008-1#1)
Further studies of the##2##4##(2009-8#1)(2011-3#1)
Further studies of##3##3##(1993-12#1)(2009-8#1)(2011-3#1)
Further studies on##5##3##(1992-6#1)(1994-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
Further studies should##3##3##(1990-3#1)(1991-12#1)(1993-6#1)
Further studies show that the##3##5##(2008-3#1)(2008-8#2)
Further studies show that##4##4##(2008-3#1)(2008-8#3)
Further studies using##2##3##(2008-10#2)
Further studies were##4##3##(1991-11#1)(1993-11#1)(1997-1#1)(2008-10#1)
Further studies with##6##3##(1990-10#1)(1995-5#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)
Further studies##72##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Further study is needed##2##4##(2008-2#1)(2008-9#1)
Further study is##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
Further study of##2##3##(2008-7#2)
Further study##8##2##(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#1)
Further suggestions##2##2##(2008-3#1)(2008-4#1)
Further support for##2##3##(1993-11#1)(1994-9#1)
Further support##3##2##(1993-11#1)(1994-9#1)(1997-2#1)
Further testing##2##2##(1996-3#1)(2009-3#1)
Further tests##2##2##(1995-2#1)(2008-10#1)
Further work is needed to identify##2##6##(1994-9#1)(2012-2#1)
Further work is##3##3##(1994-9#1)(2006-6#1)(2012-2#1)
Further work to##2##3##(2008-10#1)(2010-3#1)
Further work##9##2##(1994-2#1)(1994-9#1)(1995-3#1)(2006-10#1)(2006-6#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
Further##504##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#5)(1993-2#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#5)(1994-2#2)(1994-3#4)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#4)(2006-6#1)(2006-8#1)(2007-10#6)(2007-11#7)(2007-12#8)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#76)(2008-11#18)(2008-12#15)(2008-2#9)(2008-3#10)(2008-4#6)(2008-5#18)(2008-6#8)(2008-7#16)(2008-8#21)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#21)(2011-3#2)(2012-1#5)(2012-12#6)(2012-2#18)(2012-3#3)(2013-1#14)(2013-7#4)(2013-8#10)
Furthermore it is##2##3##(2008-11#1)(2008-3#1)
Furthermore it##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
Furthermore the##17##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-5#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)
Furthermore this##2##2##(2012-12#1)(2012-2#1)
Furthermore we##3##2##(1992-12#1)(2008-11#1)(2011-2#1)
Furthermore##1008##1##(1990-10#1)(1990-12#3)(1990-2#4)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#9)(1990-9#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#3)(1994-11#9)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#6)(1994-6#4)(1994-8#15)(1994-9#3)(1995-11#9)(1995-12#8)(1995-2#11)(1995-3#4)(1995-5#5)(1995-6#7)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#13)(2007-12#13)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#17)(2008-10#157)(2008-11#71)(2008-12#11)(2008-2#27)(2008-3#43)(2008-4#14)(2008-5#31)(2008-6#13)(2008-7#28)(2008-8#32)(2008-9#25)(2009-1#1)(2009-10#6)(2009-11#10)(2009-12#2)(2009-2#2)(2009-3#8)(2009-4#1)(2009-5#6)(2009-6#7)(2009-7#4)(2009-8#11)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#6)(2010-12#4)(2010-2#2)(2010-3#8)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#8)(2010-9#3)(2011-1#15)(2011-2#28)(2012-1#3)(2012-12#19)(2012-2#23)(2012-3#18)(2012-6#1)(2012-7#2)(2012-9#1)(2013-1#36)(2013-7#2)(2013-8#14)
Fusaric acid##2##2##(2008-10#2)
Fusarium Crown and Root Rot of##2##6##(2008-10#2)
Fusarium Wilt of Tomato##4##4##(2008-10#4)
Fusarium Wilt of##9##3##(2008-10#9)
Fusarium Wilt##14##2##(2008-10#14)
Fusarium and Aspergillus ear rots##2##5##(2008-10#2)
Fusarium and##4##2##(2008-10#2)(2008-5#1)(2010-5#1)
Fusarium crown and root rot##4##5##(2008-10#4)
Fusarium culmorum in##2##3##(2008-10#2)
Fusarium culmorum##6##2##(2008-10#6)
Fusarium disease##2##2##(2008-10#2)
Fusarium ear and kernel rot##2##5##(2008-10#2)
Fusarium ear rot and##3##4##(2008-10#3)
Fusarium ear##5##2##(2008-10#5)
Fusarium fujikuroi culture material containing##2##5##(2008-5#2)
Fusarium fujikuroi##3##2##(2008-5#3)
Fusarium graminearum and##2##3##(2008-10#1)(2009-6#1)
Fusarium graminearum is##2##3##(2008-10#2)
Fusarium graminearum##30##2##(2008-10#25)(2008-8#1)(2009-6#1)(2010-7#1)(2011-10#2)
Fusarium graminearum)##2##2##(2008-10#2)
Fusarium head blight (FHB) caused by Fusarium graminearum##2##8##(2008-10#2)
Fusarium head blight (FHB) of wheat and barley and##2##9##(2008-10#2)
Fusarium head blight (FHB) of##3##5##(2008-10#3)
Fusarium head blight (FHB)##15##4##(2008-10#14)(2011-10#1)
Fusarium head blight and##2##4##(2008-10#2)
Fusarium head blight index (IND##2##5##(2008-10#2)
Fusarium head blight of wheat and##2##6##(2008-10#2)
Fusarium head blight of wheat##4##5##(2008-10#4)
Fusarium head blight were##2##4##(2008-10#2)
Fusarium head blight##31##3##(2008-10#30)(2011-10#1)
Fusarium isolates##6##2##(2008-10#6)
Fusarium moniliforme and##2##3##(2008-10#2)
Fusarium moniliforme##9##2##(1995-3#1)(2008-10#7)(2008-5#1)
Fusarium oxysporum Fo-B2##2##3##(2008-10#2)
Fusarium oxysporum Fo47 and Pseudomonas putida WCS358##2##7##(2008-10#2)
Fusarium oxysporum Fo47##4##3##(2008-10#4)
Fusarium oxysporum and F##2##4##(2008-10#2)
Fusarium oxysporum and##5##3##(2008-10#5)
Fusarium oxysporum f##84##3##(2008-10#84)
Fusarium oxysporum in##4##3##(1997-4#1)(2008-10#3)
Fusarium oxysporum##121##2##(1997-4#1)(2008-10#120)
Fusarium proliferatum##2##2##(2008-10#2)
Fusarium sambucinum##2##2##(2008-10#2)
Fusarium solani f##13##3##(2008-10#13)
Fusarium solani pisi##2##3##(1995-3#1)(2008-7#1)
Fusarium solani##16##2##(1995-3#1)(2008-10#13)(2008-7#2)
Fusarium sp##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
Fusarium species was##2##3##(2008-10#2)
Fusarium species##13##2##(1997-6#1)(2008-10#12)
Fusarium sporotrichioides##2##2##(1995-2#1)(2008-10#1)
Fusarium spp##37##2##(1997-6#3)(2008-10#31)(2010-4#1)(2011-2#1)(2013-1#1)
Fusarium subglutinans##2##2##(2008-10#2)
Fusarium symptoms and infection##2##4##(2008-10#2)
Fusarium symptoms##3##2##(2008-10#3)
Fusarium verticillioides in##3##3##(2008-10#2)(2008-12#1)
Fusarium verticillioides##12##2##(2008-10#10)(2008-12#2)
Fusarium wilt and##2##3##(2008-10#2)
Fusarium wilt disease##3##3##(2008-10#3)
Fusarium wilt in##3##3##(2008-10#3)
Fusarium wilt of chickpea##3##4##(2008-10#3)
Fusarium wilt of cucumber##2##4##(2008-10#2)
Fusarium wilt of tomato by##2##5##(2008-10#2)
Fusarium wilt of tomato##4##4##(2008-10#4)
Fusarium wilt of##19##3##(2008-10#19)
Fusarium wilt suppression##2##3##(2008-10#2)
Fusarium wilt symptoms##2##3##(2008-10#2)
Fusarium wilt was##4##3##(2008-10#4)
Fusarium wilt##60##2##(2008-10#60)
Fusarium##427##1##(1995-2#1)(1995-3#2)(1997-4#1)(1997-6#6)(2008-10#390)(2008-12#3)(2008-5#9)(2008-7#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-10#4)(2011-2#1)(2013-1#1)
Fusarium-selective##2##1##(2008-10#2)
Fused##4##1##(1996-5#1)(2008-10#1)(2013-1#1)(2013-7#1)
Fusicoccum sp##4##2##(2008-10#4)
Fusiform##2##1##(2008-10#1)(2008-7#1)
Fusion Gene##2##2##(2008-10#1)(2012-12#1)
Fusion of##2##2##(2008-7#1)(2012-12#1)
Fusion##23##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#2)(2012-3#6)(2013-1#2)(2013-8#1)
Fusions of##2##2##(1995-2#1)(2008-11#1)
Fusions##4##1##(1990-5#1)(1995-2#1)(2008-11#1)(2012-3#1)
Fusobacterium necrophorum##3##2##(1990-3#3)
Fusobacterium nucleatum and##2##3##(2007-7#1)(2008-5#1)
Fusobacterium nucleatum strain Fev1##2##4##(1993-9#2)
Fusobacterium nucleatum##4##2##(1993-9#2)(2007-7#1)(2008-5#1)
Fusobacterium##8##1##(1990-3#3)(1993-9#2)(2007-7#2)(2008-5#1)
Futraful vs##2##2##(1997-7#2)
Future Search approach##2##3##(1996-3#2)
Future Search##4##2##(1996-3#4)
Future Thinking Studies##2##3##(2013-1#2)
Future applications of##2##3##(2007-12#1)(2008-10#1)
Future applications##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
Future developments##2##2##(2008-7#1)(2008-9#1)
Future directions##5##2##(1994-5#1)(1995-1#1)(2008-11#1)(2009-2#1)(2009-3#1)
Future immunization##2##2##(1996-1#1)(1996-3#1)
Future issues in##2##3##(1991-3#1)(1997-3#1)
Future of##10##2##(1996-1#2)(1996-2#1)(2008-10#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#1)(2013-7#1)
Future orientation##2##2##(2007-12#2)
Future prospects##2##2##(2008-10#1)(2008-3#1)
Future research is##2##3##(2010-3#1)(2013-8#1)
Future research needs##2##3##(2008-10#1)(2013-1#1)
Future research should focus on##2##5##(2008-3#1)(2010-11#1)
Future research should##7##3##(1995-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-8#1)
Future research will##2##3##(2008-3#2)
Future research##20##2##(1991-12#1)(1992-9#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#2)
Future studies are necessary##2##4##(2009-12#1)(2012-12#1)
Future studies are##4##3##(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#1)
Future studies of##2##3##(2010-5#1)(2012-3#1)
Future studies should##3##3##(2008-1#1)(2008-8#1)(2012-3#1)
Future studies will##3##3##(1994-9#1)(2008-10#1)(2013-1#1)
Future studies##17##2##(1994-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
Future trends in##3##3##(1993-2#1)(2008-10#2)
Future trends##4##2##(1993-2#1)(2008-10#2)(2008-12#1)
Future work will##2##3##(1991-1#1)(1995-5#1)
Future work##4##2##(1991-1#1)(1995-5#1)(2008-11#1)(2010-6#1)
Future##143##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#3)(1996-2#1)(1996-3#6)(1997-2#1)(1997-3#3)(1997-4#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#3)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
Fuzi##2##1##(2013-1#2)
Fuzzy##12##1##(2008-10#3)(2008-2#1)(2008-8#1)(2009-10#1)(2010-8#5)(2011-2#1)
Fv fragment##4##2##(1993-8#3)(2008-10#1)
Fv##13##1##(1993-8#7)(2008-10#1)(2008-8#3)(2010-12#2)
Fy(a-)##4##1##(1992-6#1)(1994-12#3)
Fya typing##2##2##(1992-6#2)
Fya##3##1##(1992-6#2)(1994-12#1)
Fyb##2##1##(1993-12#1)(1994-12#1)
Fyn##6##1##(1995-11#1)(1995-6#3)(2009-6#2)
Fz stimulation##3##2##(2011-2#3)
Fz##5##1##(2011-2#5)
Förster resonance energy transfer (FRET)##4##5##(2008-1#1)(2009-8#1)(2009-9#1)(2012-2#1)
Förster##7##1##(2008-1#1)(2009-2#1)(2009-8#2)(2009-9#2)(2012-2#1)
F = 0##2##1##(2011-2#2)
G + C##2##3##(1991-6#2)
G + C-rich##2##3##(1993-6#1)(1994-12#1)
G +##5##2##(1991-6#2)(1991-9#1)(1993-6#1)(1994-12#1)
G 2M arrest##2##3##(2013-1#2)
G =##3##2##(1993-8#1)(2008-10#1)(2008-2#1)
G acylase##2##2##(2008-8#2)
G allele frequencies were##3##4##(2011-1#3)
G allele##4##2##(2011-1#4)
G alpha 2 is##2##4##(1991-2#2)
G alpha 2##6##3##(1991-2#6)
G alpha subunit##2##3##(1993-9#2)
G alpha##11##2##(1991-2#6)(1993-3#1)(1993-9#2)(1995-6#2)
G alpha12##2##2##(1997-7#2)
G and C##2##3##(2008-11#1)(2008-7#1)
G and P##2##3##(2013-1#2)
G and the##2##3##(2008-10#1)(2008-9#1)
G and##26##2##(1990-12#2)(1992-5#3)(1993-1#1)(1993-3#1)(1994-5#2)(1996-4#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
G are##3##2##(1996-4#2)(2008-7#1)
G at position##2##3##(1994-12#1)(2008-12#1)
G at##5##2##(1990-12#2)(1994-12#1)(1994-8#1)(2008-12#1)
G beta gamma##3##3##(1993-9#2)(1995-8#1)
G beta gamma-mediated MAP kinase activation##3##6##(1995-8#3)
G beta gamma-mediated##4##3##(1995-8#4)
G beta##8##2##(1993-9#2)(1994-2#1)(1995-8#5)
G class##2##2##(2012-2#2)
G domain##3##2##(1997-4#3)
G for##4##2##(1992-9#1)(2008-10#2)(2008-3#1)
G ialpha2 deficiency##3##3##(1996-2#3)
G ialpha2##7##2##(1996-2#7)
G in the##3##3##(1990-12#1)(2008-10#2)
G in##7##2##(1990-12#1)(2007-11#1)(2008-10#2)(2009-5#1)(2011-1#1)(2013-1#1)
G is##4##2##(1992-9#1)(1995-6#1)(2008-10#1)(2013-1#1)
G lines of both composites##2##5##(2008-10#2)
G mutation##3##2##(1994-8#2)(2013-8#1)
G or##3##2##(1990-12#1)(1992-12#1)(2008-10#1)
G protein activation##2##3##(2008-8#1)(2009-12#1)
G protein alpha subunits##2##4##(1995-11#1)(1995-6#1)
G protein alpha##3##3##(1995-11#1)(1995-6#1)(1997-7#1)
G protein and##3##3##(1995-8#1)(2008-4#2)
G protein coupled##2##3##(1997-2#1)(2008-4#1)
G protein is##2##3##(1993-6#1)(2008-1#1)
G protein to##2##3##(1993-6#1)(2008-3#1)
G protein##43##2##(1990-2#1)(1990-7#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#3)(2008-1#1)(2008-3#2)(2008-4#9)(2008-8#1)(2008-9#3)(2009-12#2)
G protein(s)##2##2##(1992-11#1)(1995-11#1)
G protein-coupled receptor genes##2##4##(1994-12#2)
G protein-coupled receptor##6##3##(1990-12#1)(1994-12#3)(2008-4#1)(2008-7#1)
G protein-coupled receptors and##3##4##(1991-2#1)(1991-9#1)(2008-4#1)
G protein-coupled receptors are##2##4##(2008-4#2)
G protein-coupled receptors##12##3##(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(2008-4#4)(2008-5#1)(2010-3#1)
G protein-coupled##22##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#4)(1995-6#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)
G protein-dependent##2##2##(2008-4#1)(2008-8#1)
G proteins and##4##3##(1991-9#1)(1993-1#1)(1993-9#1)(1995-6#1)
G proteins in the##2##4##(1993-3#1)(2008-7#1)
G proteins in##9##3##(1991-9#2)(1993-3#1)(1993-6#1)(1994-6#1)(1995-6#1)(2008-7#2)(2008-9#1)
G proteins to##2##3##(2008-4#1)(2008-9#1)
G proteins##32##2##(1991-9#3)(1992-11#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-6#1)(1995-11#3)(1995-6#7)(1995-8#1)(1997-1#1)(2008-4#4)(2008-7#4)(2008-9#2)
G response##2##2##(2008-10#1)(2013-1#1)
G to A##2##3##(1990-8#1)(1997-4#1)
G to I##2##3##(2008-6#2)
G to##7##2##(1990-8#1)(1992-3#1)(1992-8#1)(1997-4#1)(2008-12#1)(2008-6#2)
G virus with##2##3##(2008-10#2)
G virus##6##2##(1996-3#1)(1997-2#1)(2008-10#4)
G was not##2##3##(2010-7#1)(2011-1#1)
G was##5##2##(1991-8#1)(2008-10#1)(2010-7#1)(2011-1#1)(2013-8#1)
G were##2##2##(2008-10#1)(2011-1#1)
G with##4##2##(1993-8#2)(2008-10#1)(2011-3#1)
G x A mismatches##3##4##(1993-11#3)
G x A##5##3##(1993-11#5)
G x C##2##3##(1993-11#2)
G x##7##2##(1993-11#7)
G##596##1##(1990-10#2)(1990-12#11)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#7)(1991-5#2)(1991-6#2)(1991-8#10)(1991-9#6)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#10)(1992-4#1)(1992-5#6)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#5)(1993-11#11)(1993-12#1)(1993-3#4)(1993-6#8)(1993-8#13)(1993-9#7)(1994-11#2)(1994-12#10)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#7)(1995-2#4)(1995-3#1)(1995-5#9)(1995-6#20)(1995-8#9)(1996-11#1)(1996-12#1)(1996-2#9)(1996-3#1)(1996-4#5)(1996-5#2)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#3)(1997-7#7)(2007-11#5)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#130)(2008-11#7)(2008-12#9)(2008-2#3)(2008-3#6)(2008-4#30)(2008-5#4)(2008-6#8)(2008-7#11)(2008-8#7)(2008-9#17)(2009-10#4)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#19)(2010-4#5)(2010-6#1)(2010-7#4)(2010-8#7)(2011-1#14)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#17)(2013-7#2)(2013-8#12)
G(0)##2##1##(2008-3#1)(2008-9#1)
G(1) arrest##2##2##(2008-9#2)
G(1) cells##2##2##(2008-11#1)(2008-9#1)
G(1)##7##1##(2008-11#4)(2008-9#3)
G(1)/S##2##1##(2008-11#1)(2009-8#1)
G(2)##4##1##(2008-10#1)(2008-9#2)(2009-6#1)
G(2)/M##6##1##(2008-11#4)(2010-2#1)(2013-1#1)
G(5) ranged from 0##2##4##(2010-8#2)
G(5)##4##1##(2010-8#4)
G(ST) values##2##2##(2008-10#2)
G(ST)##6##1##(2008-10#6)
G(o alpha)##6##2##(1992-9#6)
G(o)##2##1##(1992-9#1)(2008-9#1)
G(o)alpha GDP##3##2##(2008-9#3)
G(o)alpha and##2##2##(2008-9#2)
G(o)alpha##9##1##(2008-9#9)
G)##11##1##(1991-12#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
G+C content##5##2##(1997-4#3)(2008-9#2)
G+C##7##1##(1993-2#1)(1997-4#3)(2008-8#1)(2008-9#2)
G--&gt##3##1##(1993-3#1)(1993-6#1)(1994-12#1)
G-1##6##1##(1996-9#6)
G-2 and##2##2##(1996-9#2)
G-2##8##1##(1996-9#6)(2008-10#1)(2008-5#1)
G-26 and##3##2##(1994-11#3)
G-26##7##1##(1994-11#7)
G-A##4##1##(2012-12#4)
G-CSF in##3##2##(2008-10#1)(2008-7#2)
G-CSF##17##1##(1992-2#1)(1994-3#1)(1997-7#1)(2006-10#2)(2008-10#2)(2008-6#1)(2008-7#7)(2011-2#1)(2012-3#1)
G-CSFR##7##1##(1994-11#7)
G-II##2##1##(2012-2#2)
G-LDL exposed to Fe3+##2##4##(1991-5#2)
G-LDL##5##1##(1991-5#5)
G-actin in##3##2##(1992-3#2)(1992-4#1)
G-actin##15##1##(1992-3#2)(1992-4#10)(2008-1#2)(2011-2#1)
G-actins##2##1##(1990-5#2)
G-band patterns##2##2##(1994-11#2)
G-band##3##1##(1994-11#2)(2010-3#1)
G-liposomal nanovesicles##9##2##(2008-10#9)
G-protein alpha-subunit##2##2##(1991-9#1)(2012-2#1)
G-protein alpha-subunits##5##2##(1991-9#4)(1994-6#1)
G-protein beta##2##2##(1993-9#1)(1996-2#1)
G-protein coupled membrane##2##3##(1993-6#1)(2008-11#1)
G-protein coupled receptors##6##3##(1992-12#1)(1997-1#1)(2008-11#1)(2008-7#2)(2009-3#1)
G-protein coupled##13##2##(1992-12#1)(1992-3#1)(1993-6#1)(1996-2#2)(1997-1#1)(2008-11#2)(2008-7#2)(2009-3#1)(2010-11#1)(2012-2#1)
G-protein signaling##2##2##(2009-8#1)(2012-2#1)
G-protein##38##1##(1990-12#1)(1991-5#1)(1991-9#5)(1992-12#1)(1992-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-2#6)(1997-1#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-8#1)(2010-11#1)(2012-2#3)(2013-8#1)
G-protein-coupled receptor##2##2##(1995-6#1)(1996-2#1)
G-protein-coupled receptors##4##2##(1995-8#1)(1996-2#1)(2008-4#2)
G-protein-coupled##9##1##(1994-11#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#2)(2008-4#2)(2012-12#1)
G-protein-linked receptors##2##2##(1993-5#1)(1997-7#1)
G-protein-linked##3##1##(1993-5#1)(1993-6#1)(1997-7#1)
G-proteins was##2##2##(1993-8#1)(1997-2#1)
G-proteins##14##1##(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#2)(1993-8#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-7#1)(2008-8#1)(2013-1#1)
G-rich##2##1##(1994-8#1)(1997-9#1)
G/A polymorphism##4##2##(2008-10#1)(2011-2#3)
G/A##7##1##(2008-10#3)(2011-1#1)(2011-2#3)
G/G genotypes##2##2##(2011-1#2)
G/G##6##1##(2011-1#6)
G/l)##2##1##(2007-8#2)
G0 + G1##4##3##(1990-11#4)
G0 to##2##2##(1992-8#1)(1995-2#1)
G0##9##1##(1990-11#4)(1990-9#1)(1992-8#1)(1995-2#1)(2008-3#2)
G0/G1 cell cycle##2##3##(1995-2#1)(2008-11#1)
G0/G1##5##1##(1992-8#1)(1993-8#1)(1993-9#1)(1995-2#1)(2008-11#1)
G069##2##1##(2008-9#2)
G1 (at##2##2##(1994-6#2)
G1 and G2##3##3##(1994-6#1)(1997-3#1)(2012-3#1)
G1 and##8##2##(1994-6#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2012-3#2)
G1 arrest and##2##3##(1991-9#1)(1997-7#1)
G1 arrest##10##2##(1991-9#5)(1996-3#1)(1997-7#1)(2008-11#2)(2009-9#1)
G1 cell cycle##3##3##(2008-11#2)(2011-2#1)
G1 cyclin##3##2##(1992-10#1)(1994-11#2)
G1 extract##5##2##(1994-8#5)
G1 of the cell cycle##2##5##(1993-9#1)(1997-8#1)
G1 phase in##3##3##(1993-8#1)(2008-11#1)(2010-6#1)
G1 phase##15##2##(1991-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1997-1#1)(2008-11#4)(2008-8#1)(2009-8#1)(2010-6#2)
G1 to S##6##3##(1990-11#2)(1994-5#1)(1997-7#1)(2008-11#1)(2011-2#1)
G1 to##7##2##(1990-11#2)(1994-5#1)(1997-7#1)(2008-11#2)(2011-2#1)
G1##83##1##(1990-11#4)(1991-5#1)(1991-9#6)(1992-10#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#7)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#4)(1997-8#2)(2008-10#6)(2008-11#11)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-6#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
G1-phase##5##1##(1997-1#1)(2008-11#1)(2008-7#2)(2012-3#1)
G1/G2 ORF##2##2##(2008-10#2)
G1/G2##5##1##(2008-10#5)
G1/S progression##2##2##(1993-6#2)
G1/S##12##1##(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(1997-1#4)(1997-7#3)
G1181C##2##1##(2013-1#2)
G12 coupled thrombin receptor##2##4##(1997-7#2)
G12##10##1##(1994-5#1)(1997-7#7)(2008-10#2)
G12(pGT-trp)##3##1##(2008-10#3)
G123##2##1##(2008-10#2)
G19833##2##1##(2013-8#2)
G2 Tenderometer##3##2##(2013-1#3)
G2 and##2##2##(2013-1#2)
G2 phase##3##2##(1996-3#1)(2008-8#2)
G2##35##1##(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-3#2)(1997-3#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#8)
G2)##2##1##(1997-1#1)(2008-10#1)
G2/M =##2##2##(1994-3#2)
G2/M##11##1##(1990-2#1)(1994-3#2)(2008-11#4)(2008-8#2)(2012-2#1)(2012-3#1)
G2M##2##1##(1990-11#1)(2012-1#1)
G3 and##2##2##(2013-1#1)(2013-8#1)
G3##11##1##(1994-9#2)(1995-6#1)(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
G3BP##2##1##(2012-12#2)
G3OH##4##1##(1990-9#4)
G4 isoform##2##2##(1995-12#2)
G4##16##1##(1991-7#3)(1995-12#5)(2008-10#2)(2008-12#2)(2013-1#4)
G418 resistance##2##2##(2008-11#1)(2012-2#1)
G418##13##1##(1994-9#1)(1995-2#2)(2008-11#9)(2012-2#1)
G418-resistance##2##1##(1997-8#1)(2008-11#1)
G418-resistant clones##2##2##(1995-2#1)(1996-6#1)
G418-resistant##3##1##(1995-2#1)(1996-6#1)(1997-8#1)
G4T4##2##1##(1991-7#2)
G5##2##1##(2008-12#2)
G5-##2##1##(1995-11#2)
G6 and##2##2##(2008-10#2)
G6##6##1##(2008-10#4)(2008-12#2)
G6A N52I##2##2##(1995-5#2)
G6A##3##1##(1995-5#3)
G6PD deficiency##5##2##(1991-2#1)(2007-12#3)(2013-8#1)
G6PD gene##2##2##(1991-6#2)
G6PD##7##1##(1991-2#1)(1991-6#2)(2007-12#3)(2013-8#1)
G6PDH##2##1##(1990-3#1)(1993-3#1)
G7##3##1##(2008-10#1)(2008-12#2)
G8-OH##2##1##(1990-7#2)
G832##2##1##(2008-7#2)
G9170##2##1##(1997-3#2)
G93##2##1##(1995-6#2)
GA 20-oxidase##3##2##(1994-8#3)
GA and##3##2##(1991-8#1)(2008-10#1)(2013-1#1)
GA was##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
GA were##2##2##(2008-10#1)(2010-7#1)
GA##33##1##(1991-8#2)(1992-11#1)(1993-12#5)(1993-3#1)(1994-8#3)(2008-10#8)(2008-3#1)(2008-5#3)(2008-9#2)(2009-8#2)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
GA(3)##2##1##(2008-8#2)
GA1##2##1##(1994-12#1)(1994-8#1)
GA12 20-oxidase activity##2##3##(1994-8#2)
GA12##3##1##(1994-8#3)
GAAATA##2##1##(2008-9#2)
GABA (gamma-aminobutyric acid)##2##3##(1992-3#1)(1993-3#1)
GABA and##3##2##(1995-12#1)(2008-7#1)(2008-8#1)
GABA as##2##2##(1996-7#1)(1997-2#1)
GABA efflux increases##2##3##(1993-12#2)
GABA efflux is##2##3##(1993-12#2)
GABA efflux##9##2##(1993-12#9)
GABA improved##2##2##(2012-2#2)
GABA in##4##2##(1995-11#1)(1995-2#1)(1996-7#1)(2008-7#1)
GABA levels on##2##3##(1995-11#2)
GABA levels##7##2##(1992-3#1)(1995-11#4)(1995-12#1)(1996-7#1)
GABA metabolism##3##2##(1992-11#1)(2008-11#2)
GABA receptors##2##2##(1996-12#1)(2008-7#1)
GABA release in the##2##4##(1992-7#2)
GABA release in##5##3##(1992-12#1)(1992-7#3)(2010-12#1)
GABA release##6##2##(1992-12#1)(1992-7#3)(1995-12#1)(2010-12#1)
GABA rho 1 receptors##4##4##(1995-5#4)
GABA rho 1##5##3##(1995-11#1)(1995-5#4)
GABA##87##1##(1990-5#1)(1992-11#1)(1992-12#2)(1992-3#7)(1992-7#3)(1993-12#14)(1993-3#1)(1994-2#2)(1995-11#11)(1995-12#3)(1995-2#1)(1995-5#6)(1996-12#2)(1996-7#3)(1997-2#6)(2008-11#2)(2008-7#7)(2008-8#7)(2008-9#3)(2009-6#1)(2010-12#1)(2012-2#3)
GABA(A) antagonist##2##2##(2008-7#1)(2008-8#1)
GABA(A) receptor##2##2##(2008-9#1)(2012-2#1)
GABA(A) receptor-mediated inhibition##2##3##(2011-2#2)
GABA(A) receptors##4##2##(2008-8#4)
GABA(A)##13##1##(1997-2#1)(1997-7#1)(2008-7#1)(2008-8#5)(2008-9#2)(2011-2#2)(2012-2#1)
GABA(B) receptor##2##2##(1997-7#1)(2008-4#1)
GABA(B)##4##1##(1997-7#1)(2008-4#1)(2008-8#2)
GABA(C)##2##1##(2008-9#2)
GABA-immunoreactive boutons##2##2##(1997-2#2)
GABA-immunoreactive##4##1##(1994-2#1)(1997-2#3)
GABAA and GABAB receptors##2##4##(1995-5#1)(2008-7#1)
GABAA receptor gamma 2 subunit subtype##2##6##(1995-11#2)
GABAA receptor gamma 2 subunit##3##5##(1995-11#2)(1995-12#1)
GABAA receptor subunit##2##3##(1996-12#2)
GABAA receptor##10##2##(1995-11#6)(1995-12#1)(1996-12#2)(1997-2#1)
GABAA receptors##8##2##(1992-3#1)(1993-12#1)(1995-11#3)(1995-12#2)(1997-2#1)
GABAA##24##1##(1990-5#1)(1992-3#2)(1993-12#1)(1995-11#11)(1995-12#3)(1995-5#1)(1996-12#2)(1997-2#2)(2008-7#1)
GABAB agonist##2##2##(1992-3#1)(1993-12#1)
GABAB antagonist##3##2##(1992-3#2)(1993-12#1)
GABAB receptor##2##2##(1990-5#1)(2013-8#1)
GABAB receptors in the##2##4##(1992-3#1)(1993-12#1)
GABAB receptors##5##2##(1992-3#1)(1993-12#1)(1995-5#1)(2008-7#1)(2013-8#1)
GABAB##14##1##(1990-5#1)(1992-3#5)(1993-12#3)(1995-11#1)(1995-5#1)(2008-7#1)(2013-8#2)
GABABR##2##1##(2013-8#2)
GABAergic and dopaminergic##2##3##(1994-2#2)
GABAergic fibers##2##2##(1993-12#2)
GABAergic inhibition##4##2##(2009-8#1)(2011-2#1)(2013-8#2)
GABAergic interneurons##4##2##(2008-1#1)(2008-7#1)(2009-8#1)(2013-8#1)
GABAergic neurons in the##2##4##(1994-2#1)(1996-12#1)
GABAergic neurons##5##2##(1992-3#1)(1994-2#1)(1996-12#1)(2009-8#1)(2013-8#1)
GABAergic synaptic inhibition##2##3##(2008-7#2)
GABAergic synaptic##3##2##(1995-2#1)(2008-7#2)
GABAergic transmission##3##2##(1990-5#1)(1993-12#2)
GABAergic##30##1##(1990-5#1)(1992-3#1)(1993-12#6)(1994-2#3)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-7#4)(2009-10#1)(2009-8#3)(2011-2#1)(2013-8#4)
GABR beta1##2##2##(1997-5#2)
GAC##5##1##(2008-10#5)
GAD##3##1##(1996-5#2)(2013-1#1)
GAD65 Ab were##3##3##(1996-12#3)
GAD65 Ab##5##2##(1996-12#5)
GAD65##8##1##(1996-12#8)
GAD67 mRNA levels in the##2##5##(1996-12#2)
GAD67 mRNA##3##2##(1996-12#3)
GAD67##6##1##(1996-12#4)(2013-8#2)
GADD34 and##2##2##(2012-2#2)
GAF##2##1##(1991-2#1)(1995-12#1)
GAG##4##1##(1992-3#1)(1992-9#1)(1997-2#1)(2012-3#1)
GAI into GAII is##2##4##(2008-6#2)
GAI##8##1##(2008-10#1)(2008-6#6)(2010-6#1)
GAII##3##1##(2008-6#3)
GAL gene expression in##2##4##(1996-12#2)
GAL gene##4##2##(1990-5#2)(1996-12#2)
GAL##9##1##(1990-5#2)(1995-2#2)(1996-12#3)(1997-3#1)(2013-8#1)
GAL-based##2##1##(1993-12#2)
GAL10 promoter##2##2##(1993-12#1)(1996-3#1)
GAL10##3##1##(1993-12#1)(1993-9#1)(1996-3#1)
GAL4##3##1##(1994-12#1)(1997-4#1)(2008-8#1)
GALA##2##1##(1994-5#2)
GAM estimator is##2##3##(1997-7#2)
GAM##3##1##(1997-7#3)
GAMNP and##3##2##(2009-11#3)
GAMNP##4##1##(2009-11#4)
GAP activities##4##2##(1992-8#4)
GAP activity was##2##3##(1991-5#2)
GAP activity##4##2##(1991-5#3)(1992-11#1)
GAP and##2##2##(1992-12#1)(2013-1#1)
GAP information##3##2##(2013-1#3)
GAP##29##1##(1991-12#1)(1991-5#5)(1992-11#1)(1992-12#4)(1992-8#5)(1993-8#1)(2008-6#1)(2009-3#1)(2013-1#10)
GAP-43 in the##2##3##(1995-5#2)
GAP-43 in##4##2##(1995-12#1)(1995-5#2)(2008-7#1)
GAP-43 is##3##2##(1994-2#1)(2008-7#2)
GAP-43 mRNA##4##2##(1995-12#4)
GAP-43##44##1##(1993-12#1)(1994-2#7)(1995-12#7)(1995-5#6)(2008-11#1)(2008-7#13)(2008-9#9)
GAP1##8##1##(1990-5#7)(1995-6#1)
GAP2##3##1##(1995-6#3)
GAP3##3##1##(1993-12#1)(1995-6#2)
GAPDH and##3##2##(1991-9#1)(1994-5#1)(2009-10#1)
GAPDH is##2##2##(1993-6#2)
GAPDH##17##1##(1990-7#2)(1991-9#2)(1993-6#4)(1994-5#5)(1995-6#1)(2009-10#3)
GAPs##2##1##(1992-8#1)(1995-11#1)
GARS##6##1##(1993-12#5)(2008-1#1)
GART##3##1##(1993-12#2)(1997-8#1)
GAS##3##1##(2007-8#1)(2008-11#1)(2008-8#1)
GASPIDs##6##1##(2008-6#6)
GASTRIC##2##1##(2012-2#1)(2013-8#1)
GATA##5##1##(1995-2#1)(2008-9#1)(2012-2#2)(2012-3#1)
GATA-1##6##1##(1997-8#1)(2008-9#4)(2012-3#1)
GATA-a##4##1##(2012-2#4)
GATACT##2##1##(2008-9#2)
GAW17 data##3##2##(2012-3#3)
GAmyb##4##1##(2008-8#4)
GB stone##3##2##(2013-8#3)
GB stones##5##2##(2013-8#5)
GB virus C##2##3##(2008-10#2)
GB virus##4##2##(2008-10#4)
GB##19##1##(1993-2#1)(2008-10#6)(2009-12#2)(2013-1#2)(2013-8#8)
GB03 (Bacillus subtilis)##2##3##(2008-10#2)
GB03 and##2##2##(2008-10#2)
GB03##7##1##(2008-10#7)
GBC##5##1##(2008-10#3)(2010-12#2)
GBM cells##6##2##(2011-2#6)
GBM##14##1##(2009-4#4)(2011-2#8)(2012-2#2)
GBMT##3##1##(1994-8#3)
GBP##5##1##(1992-6#3)(2008-10#2)
GBS##8##1##(2008-6#1)(2008-7#2)(2012-3#5)
GBW 07401##2##2##(2008-10#2)
GBW##9##1##(2008-10#9)
GBW07401##3##1##(2008-10#3)
GC COHb concentrations##2##3##(1996-12#2)
GC COHb##3##2##(1996-12#3)
GC analysis of acidic##2##4##(2008-10#2)
GC analysis##3##2##(2008-10#3)
GC and GC/MS##4##3##(2008-11#2)(2008-12#2)
GC and SHMT##2##3##(1997-1#2)
GC and##10##2##(1997-1#2)(2008-11#2)(2008-12#2)(2012-2#1)(2013-1#3)
GC boxes##2##2##(1993-2#1)(1996-10#1)
GC column##3##2##(2008-10#3)
GC conditions##2##2##(1994-9#1)(2008-10#1)
GC content of##2##3##(1996-10#1)(1997-2#1)
GC content##7##2##(1995-2#1)(1996-10#1)(1997-2#1)(2008-5#1)(2012-2#1)(2012-3#2)
GC coupled to##2##3##(2008-10#1)(2013-8#1)
GC electrode##7##2##(2008-10#7)
GC excess##2##2##(2008-7#2)
GC injection port##2##3##(2008-10#2)
GC injector##2##2##(2008-10#2)
GC neurons##4##2##(2008-11#4)
GC retention##2##2##(1996-5#1)(2008-10#1)
GC rich##3##2##(1993-3#2)(2008-12#1)
GC stationary phases##2##3##(2011-1#2)
GC stationary##3##2##(2008-10#1)(2011-1#2)
GC was##2##2##(2008-10#1)(2012-2#1)
GC x GC separation##2##4##(2008-10#2)
GC x GC##4##3##(2008-10#4)
GC x GC/TOFMS##2##3##(2008-10#2)
GC x##7##2##(2008-10#7)
GC##122##1##(1991-9#2)(1993-2#1)(1993-3#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-5#2)(1997-1#2)(1997-2#1)(2008-10#57)(2008-11#6)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-4#2)(2009-8#2)(2010-3#2)(2011-1#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#1)
GC)##3##1##(1992-8#1)(2008-7#1)(2011-1#1)
GC-EAD responses##2##2##(2008-10#2)
GC-EAD##5##1##(2008-10#5)
GC-ECD and##2##2##(2008-10#2)
GC-ECD for##2##2##(2008-10#2)
GC-ECD method##3##2##(2008-10#3)
GC-ECD##9##1##(2008-10#9)
GC-EI-MS##2##1##(2008-10#1)(2008-5#1)
GC-FID##10##1##(2008-10#8)(2008-5#1)(2012-1#1)
GC-HRMS##17##1##(2008-10#17)
GC-IDTOFMS##2##1##(2008-10#2)
GC-LRMS/MS##2##1##(2008-10#2)
GC-MS analysis##7##2##(2008-10#5)(2008-5#1)(2012-3#1)
GC-MS and##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
GC-MS as##2##2##(2008-10#2)
GC-MS data##2##2##(2008-10#1)(2008-11#1)
GC-MS or##2##2##(1997-6#1)(2008-10#1)
GC-MS system##2##2##(2008-10#2)
GC-MS##60##1##(1990-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(1994-11#1)(1997-1#1)(1997-6#1)(2007-11#2)(2008-10#36)(2008-11#4)(2008-5#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)
GC-TEA##2##1##(2008-5#2)
GC-derived lymphomas##2##2##(2009-4#2)
GC-mass spectrometry##2##2##(1994-6#1)(2008-10#1)
GC-rich and##2##2##(1997-6#1)(2008-12#1)
GC-rich##13##1##(1990-11#1)(1991-7#1)(1996-5#1)(1997-6#1)(2008-12#3)(2008-7#2)(2012-3#4)
GC/ECD and##2##2##(2008-10#1)(2008-11#1)
GC/ECD##7##1##(2008-10#5)(2008-11#2)
GC/EI-MS/ICP-MS##2##1##(2010-11#2)
GC/FID##5##1##(2008-10#4)(2008-11#1)
GC/MS and##5##2##(2008-10#4)(2008-12#1)
GC/MS data##3##2##(2008-10#3)
GC/MS in##2##2##(2008-10#1)(2008-11#1)
GC/MS method##4##2##(2008-10#4)
GC/MS methods##2##2##(2008-10#2)
GC/MS with##2##2##(2008-10#2)
GC/MS##44##1##(1995-2#1)(2008-1#1)(2008-10#34)(2008-11#5)(2008-12#3)
GC/MS/MS##3##1##(2008-10#3)
GC/PCI/MS##3##1##(2008-10#3)
GC/PCI/MS/MS##4##1##(2008-10#4)
GC7##8##1##(1997-1#8)
GCAP mutants##3##2##(1992-3#3)
GCAP##10##1##(1992-3#10)
GCC##6##1##(2009-9#6)
GCE and##2##2##(2008-10#2)
GCE##13##1##(2008-10#11)(2013-1#2)
GCG##7##1##(1991-2#1)(1997-2#1)(2008-4#3)(2013-1#2)
GCM##6##1##(1996-1#6)
GCN4 motif in##2##3##(2008-9#2)
GCN4 motif##4##2##(2008-9#4)
GCN4##6##1##(1991-5#1)(2008-9#5)
GCN5##3##1##(1997-3#3)
GCP##4##1##(1991-3#3)(2010-3#1)
GCS and##2##2##(2008-7#1)(2011-2#1)
GCS score##3##2##(2011-2#1)(2013-8#2)
GCS##11##1##(2008-7#4)(2009-5#1)(2011-2#3)(2013-1#1)(2013-8#2)
GCSF##2##1##(2008-7#1)(2010-3#1)
GCTs##2##1##(2007-10#2)
GCV##3##1##(1992-10#1)(2013-2#2)
GCX##2##1##(2011-2#2)
GCY##6##1##(1990-5#6)
GCs on##3##2##(2008-11#2)(2008-7#1)
GCs##8##1##(2008-11#5)(2008-7#3)
GCxGC/TOFMS##2##1##(2008-10#2)
GD and##4##2##(2010-2#1)(2013-8#3)
GD##11##1##(2007-8#1)(2008-10#1)(2010-2#1)(2013-1#2)(2013-8#6)
GD12 and##2##2##(2013-8#2)
GD12##9##1##(2013-8#9)
GD1a##5##1##(1991-2#1)(1993-11#1)(1994-12#1)(1996-5#2)
GD1b and##2##2##(1991-2#1)(1994-3#1)
GD1b##6##1##(1991-2#1)(1993-11#1)(1994-12#1)(1994-3#2)(1996-5#1)
GD2 were##2##2##(1993-9#1)(2008-10#1)
GD2##15##1##(1993-9#6)(1996-5#3)(2008-10#4)(2011-2#2)
GD3##10##1##(1990-8#2)(1992-9#2)(1994-3#1)(1994-9#1)(1996-5#4)
GDC treatment##2##2##(1997-3#2)
GDC##9##1##(1997-3#2)(1997-6#4)(2006-12#1)(2008-7#2)
GDCs##5##1##(1996-9#4)(1997-6#1)
GDD##4##1##(2008-10#1)(2008-3#3)
GDD-WB##2##1##(2008-8#2)
GDH activity##2##2##(1995-5#1)(2008-4#1)
GDH##11##1##(1993-9#4)(1995-5#1)(2008-10#1)(2008-4#1)(2008-8#4)
GDI and##3##2##(1991-2#1)(2013-1#2)
GDI was##5##2##(1991-2#2)(1994-9#2)(2013-1#1)
GDI##15##1##(1991-2#4)(1994-11#4)(1994-9#3)(2013-1#4)
GDM and##2##2##(2008-1#1)(2009-3#1)
GDM is##3##2##(2008-1#2)(2009-3#1)
GDM##21##1##(2008-1#9)(2009-3#7)(2011-2#5)
GDME##3##1##(2008-10#3)
GDNF in##2##2##(1995-12#1)(2012-2#1)
GDNF##5##1##(1995-12#4)(2012-2#1)
GDP activation##2##2##(1995-5#2)
GDP as##2##2##(1994-11#1)(2013-1#1)
GDP beta S##2##3##(1992-11#1)(1993-8#1)
GDP dissociation inhibitor##3##3##(1995-6#1)(1996-10#2)
GDP for GTP##2##3##(1991-12#1)(1995-8#1)
GDP from##2##2##(1991-2#1)(1995-2#1)
GDP in the##2##3##(1994-11#2)
GDP in##3##2##(1994-11#2)(2013-8#1)
GDP or##2##2##(1992-3#1)(1993-8#1)
GDP reduction##2##2##(2011-2#2)
GDP to eIF-2##3##3##(1991-12#3)
GDP##46##1##(1991-12#6)(1991-2#2)(1991-5#2)(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#2)(1994-11#5)(1994-12#1)(1995-2#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(2008-11#1)(2008-6#2)(2008-9#4)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
GDP-ribosyl cyclase activity##2##3##(1994-11#2)
GDP/GTP exchange protein for##2##4##(1991-2#1)(1994-9#1)
GDP/GTP exchange protein##3##3##(1991-2#2)(1994-9#1)
GDP/GTP exchange##6##2##(1991-2#2)(1994-9#1)(1995-6#2)(2008-9#1)
GDP/GTP##10##1##(1991-2#2)(1993-11#1)(1994-9#1)(1995-2#3)(1995-6#2)(2008-9#1)
GDPs##3##1##(2011-2#3)
GDQE)##2##1##(2011-1#2)
GDS is a##2##3##(2006-10#2)
GDS is##3##2##(2006-10#3)
GDS was##2##2##(2006-10#2)
GDS##9##1##(1994-6#1)(2006-10#8)
GDx VCC##4##2##(2010-8#4)
GE activity##4##2##(1990-2#4)
GE##7##1##(1990-2#5)(2013-1#2)
GE-0208##3##1##(2008-10#3)
GE7 gene delivery system##2##4##(2008-8#2)
GE7##6##1##(2008-8#6)
GEC##2##1##(1991-6#2)
GEF##3##1##(1995-8#2)(2008-10#1)
GEN##4##1##(2010-10#4)
GENE##2##1##(2010-1#1)(2012-3#1)
GENES##2##1##(2012-3#1)(2013-1#1)
GENETIC TOXICOLOGY##8##2##(2008-8#1)(2008-9#7)
GENETIC##12##1##(1997-5#1)(2008-8#1)(2008-9#7)(2009-9#1)(2011-1#1)(2012-3#1)
GENETICS##2##1##(2011-1#1)(2012-3#1)
GEO##2##1##(1992-2#1)(2010-5#1)
GEO600##2##1##(2008-2#2)
GEP data##2##2##(2008-7#2)
GEP##8##1##(2008-10#2)(2008-7#2)(2009-8#1)(2010-1#1)(2011-2#2)
GEP-ISFG##2##1##(2008-12#2)
GEPR##5##1##(1996-12#5)
GEPR-3 and GEPR-9##3##3##(1996-12#3)
GEPR-3 compared to SD rats and GEPR-9##3##7##(1996-12#3)
GEPR-3 compared to##4##3##(1996-12#4)
GEPR-3##11##1##(1996-12#11)
GEPR-9##10##1##(1996-12#10)
GER##5##1##(2008-10#3)(2009-3#2)
GERD##6##1##(2010-12#3)(2010-6#1)(2011-2#2)
GF##3##1##(1997-7#1)(2008-10#1)(2013-1#1)
GF-AAS##5##1##(2008-10#5)
GFAAS determination of##2##3##(2008-10#2)
GFAAS determination##6##2##(2008-10#6)
GFAAS through the##2##3##(2008-10#2)
GFAAS##25##1##(2008-10#25)
GFAP and##4##2##(2008-11#1)(2008-7#3)
GFAP expression in##2##3##(1995-12#1)(1997-3#1)
GFAP mRNA expression was##2##4##(1995-12#2)
GFAP mRNA in##2##3##(1995-12#1)(1997-3#1)
GFAP mRNA levels##2##3##(1997-3#2)
GFAP mRNA##6##2##(1995-12#3)(1997-3#3)
GFAP##24##1##(1990-7#5)(1995-12#5)(1997-2#2)(1997-3#5)(2008-11#2)(2008-7#3)(2011-2#2)
GFAP+ astrocytes##4##2##(1996-5#4)
GFD##4##1##(2011-2#4)
GFJ##7##1##(2008-8#7)
GFJ-drug interaction##3##2##(2008-8#3)
GFJ-drug##4##1##(2008-8#4)
GFLV RNA-2##3##2##(2008-10#3)
GFLV isolates##2##2##(2008-10#2)
GFLV##11##1##(2008-10#11)
GFOR##2##1##(2008-6#2)
GFP and##2##2##(2008-11#1)(2008-7#1)
GFP as a reporter##2##4##(2008-4#1)(2008-9#1)
GFP as a##4##3##(1996-6#1)(2008-1#1)(2008-4#1)(2008-9#1)
GFP chimeras##2##2##(2008-1#2)
GFP could be##2##3##(2008-11#1)(2008-8#1)
GFP expression##4##2##(1996-6#1)(2008-11#1)(2008-9#2)
GFP fluorescence and##3##3##(2008-11#1)(2008-9#2)
GFP fluorescence##6##2##(2008-11#1)(2008-7#1)(2008-9#4)
GFP fusion proteins##2##3##(2008-11#1)(2008-7#1)
GFP has been##2##3##(2008-1#1)(2009-6#1)
GFP mutants##2##2##(2008-9#1)(2009-6#1)
GFP was an##2##3##(2008-10#1)(2008-7#1)
GFP was##5##2##(1996-6#1)(2008-10#1)(2008-7#1)(2008-8#2)
GFP##71##1##(1996-6#5)(1997-4#1)(2008-1#6)(2008-10#6)(2008-11#14)(2008-2#1)(2008-4#4)(2008-7#8)(2008-8#4)(2008-9#15)(2009-4#1)(2009-6#2)(2011-2#2)(2011-3#1)(2012-2#1)
GFP-AtSNX2b##2##1##(2009-10#2)
GFP-labeled##2##1##(2009-10#1)(2013-8#1)
GFP-tagged##2##1##(2009-10#2)
GFR##7##1##(1992-2#1)(2008-1#3)(2010-4#1)(2011-2#1)(2012-3#1)
GFW##6##1##(2013-1#6)
GG##9##1##(1991-8#1)(2008-10#1)(2008-7#1)(2009-12#2)(2011-1#4)
GG12##2##1##(2008-10#2)
GGA##4##1##(1993-3#3)(2008-10#1)
GGG##2##1##(1991-2#2)
GGGTCAT##2##1##(1993-12#2)
GGMs##2##1##(2013-1#2)
GGO##2##1##(1997-6#2)
GGPP##2##1##(2008-8#2)
GGR rates##2##2##(2008-11#2)
GGR##3##1##(2008-11#3)
GGS##5##1##(2010-4#5)
GGT is##2##2##(1995-12#1)(2009-8#1)
GGT##10##1##(1993-8#1)(1995-12#4)(2006-6#1)(2009-6#2)(2009-8#1)(2010-11#1)
GH and IGF-I##5##3##(2010-5#3)(2012-3#2)
GH and##17##2##(1990-12#2)(1991-12#3)(2008-1#1)(2010-5#5)(2010-8#1)(2012-1#1)(2012-3#3)(2013-1#1)
GH concentrations##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
GH deficiency##3##2##(1996-11#1)(1997-8#1)(2008-4#1)
GH gene polymorphism##2##3##(2010-2#2)
GH gene##3##2##(2010-2#2)(2011-1#1)
GH hypersecretion##2##2##(2007-7#2)
GH in circulation)##2##3##(2011-1#2)
GH in mineral oil##2##4##(2013-7#2)
GH in##7##2##(1993-3#1)(1997-8#1)(2008-1#1)(2011-1#2)(2013-7#2)
GH injection##4##2##(1995-12#3)(2013-7#1)
GH pulse frequency##2##3##(2013-1#2)
GH pulse##3##2##(2013-1#3)
GH pulses##2##2##(1997-2#1)(2013-1#1)
GH receptor (GHR)##2##3##(1995-8#1)(2012-1#1)
GH receptor and##3##3##(1996-2#3)
GH receptor mRNA##2##3##(1996-2#2)
GH receptor##11##2##(1995-8#1)(1996-2#5)(2008-1#4)(2012-1#1)
GH release##5##2##(1994-8#5)
GH replacement therapy##3##3##(1996-11#1)(2008-4#2)
GH replacement##7##2##(1996-11#2)(1997-8#3)(2008-4#2)
GH resistance##3##2##(1993-6#1)(2007-7#1)(2010-8#1)
GH secretion in##2##3##(2007-11#1)(2008-3#1)
GH secretion##11##2##(1991-12#1)(1991-9#2)(1997-2#2)(2007-11#1)(2007-7#4)(2008-3#1)
GH showed##2##2##(1991-12#1)(2013-7#1)
GH therapy##4##2##(1997-8#1)(2008-1#1)(2008-4#1)(2013-1#1)
GH treatment of##2##3##(1995-8#1)(2008-3#1)
GH treatment##8##2##(1995-12#1)(1995-8#2)(1997-8#1)(2007-11#1)(2008-3#3)
GH was##2##2##(1990-12#1)(2013-7#1)
GH##172##1##(1990-12#14)(1991-12#6)(1991-6#2)(1991-9#2)(1993-2#1)(1993-3#3)(1993-6#5)(1994-8#6)(1995-11#1)(1995-12#5)(1995-8#6)(1996-11#6)(1996-2#7)(1997-2#4)(1997-8#8)(2007-11#2)(2007-7#10)(2008-1#10)(2008-3#9)(2008-4#6)(2008-7#3)(2008-9#1)(2010-2#4)(2010-5#15)(2010-8#6)(2011-1#3)(2011-2#1)(2012-1#2)(2012-3#5)(2013-1#10)(2013-7#9)
GH-deficiency##2##1##(1996-11#1)(1997-8#1)
GH-deficient##4##1##(1996-11#1)(1997-8#2)(2008-4#1)
GH-transgenic##2##1##(2010-5#2)
GH-treated##2##1##(2008-4#2)
GH/IGF-1 axis##2##2##(2010-8#2)
GH/IGF-1##5##1##(2008-3#1)(2010-8#3)(2011-2#1)
GH/IGF-I axis in##2##3##(2007-7#2)
GH/IGF-I##3##1##(2007-7#2)(2012-3#1)
GH1 gene deletions##4##3##(2008-1#4)
GH1 gene##6##2##(2008-1#6)
GH1##9##1##(1994-11#1)(2008-1#8)
GH3 cells##5##2##(1992-8#3)(1994-12#1)(1996-2#1)
GH3##9##1##(1992-8#4)(1993-8#2)(1994-12#2)(1996-2#1)
GH4##2##1##(1994-8#2)
GH4C1##5##1##(1990-7#2)(1991-6#3)
GHB##2##1##(1997-2#2)
GHD##8##1##(2008-1#1)(2011-1#3)(2012-3#4)
GHF##5##1##(2011-2#5)
GHG##6##1##(2012-2#6)
GHPSAM is##2##2##(2008-10#2)
GHPSAM##4##1##(2008-10#4)
GHQ-12##3##1##(2008-11#2)(2011-1#1)
GHR and IGF-I gene expression##2##5##(2008-9#2)
GHR and IGF-I##3##3##(2008-9#3)
GHR reduction##2##2##(2012-1#2)
GHR##14##1##(2008-1#2)(2008-4#2)(2008-9#4)(2010-5#3)(2012-1#3)
GHR1 and GHR2##2##3##(2010-5#2)
GHR1 expression##2##2##(1995-8#2)
GHR1 mRNA##3##2##(1995-8#3)
GHR1##9##1##(1995-8#7)(2010-5#2)
GHRH##4##1##(1994-9#3)(2012-3#1)
GHz and 1##2##3##(2007-9#1)(2008-3#1)
GHz and##8##2##(2007-11#3)(2007-12#2)(2007-9#1)(2008-3#2)
GHz are##2##2##(2008-10#1)(2008-3#1)
GHz by##2##2##(2007-11#1)(2008-2#1)
GHz is##6##2##(2007-11#2)(2007-12#1)(2008-3#2)(2013-8#1)
GHz was##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
GHz with a##2##3##(2007-12#2)
GHz with##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
GHz##71##1##(2007-11#21)(2007-12#13)(2007-9#1)(2008-10#3)(2008-2#4)(2008-3#24)(2008-6#1)(2009-5#1)(2011-1#1)(2013-8#2)
GHz)##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
GI Disorders##2##2##(2010-6#1)(2012-12#1)
GI and GII norovirus##3##4##(2013-8#3)
GI diagnoses##2##2##(2008-11#2)
GI disorders##3##2##(2011-2#1)(2012-12#2)
GI drug##2##2##(2008-11#2)
GI endoscopy##2##2##(2008-5#1)(2011-2#1)
GI is##3##2##(2008-1#3)
GI malabsorption and maldigestion##2##4##(2011-2#2)
GI manifestations of SLE##2##4##(2011-2#2)
GI motility##2##2##(2013-1#2)
GI tract##8##2##(1991-1#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-1#3)(2013-1#1)
GI##52##1##(1991-1#2)(1991-2#1)(2008-1#6)(2008-10#2)(2008-11#7)(2008-5#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#6)(2012-3#3)(2013-1#3)(2013-8#4)
GIB Laboratories##2##2##(1997-2#2)
GIB##3##1##(1997-2#3)
GIC##3##1##(2011-1#2)(2012-2#1)
GIFT is##2##2##(1991-11#2)
GIFT##5##1##(1991-11#4)(2009-6#1)
GINA guidelines##2##2##(2010-5#2)
GINA##8##1##(2009-6#2)(2010-5#6)
GINV could##2##2##(2008-10#2)
GINV##9##1##(2008-10#9)
GIP gene##4##2##(1995-11#4)
GIP mRNA##2##2##(1995-11#2)
GIP transcripts##2##2##(1995-11#2)
GIP##17##1##(1995-11#12)(1997-4#5)
GIP(1-42)##3##1##(1997-4#3)
GIP(10-30)##2##1##(1997-4#2)
GIP(6-30amide)##5##1##(1997-4#5)
GIQE##5##1##(2008-2#4)(2008-3#1)
GIS and RS##2##3##(2008-8#2)
GIS and##3##2##(2008-12#1)(2008-8#2)
GIS projects##3##2##(2008-8#3)
GIS##13##1##(2007-5#3)(2008-11#1)(2008-12#2)(2008-8#6)(2010-2#1)
GISH##5##1##(2008-5#1)(2008-8#3)(2008-9#1)
GIST was##3##2##(2009-7#2)(2012-12#1)
GIST with##2##2##(2008-6#1)(2009-7#1)
GIST##15##1##(2008-6#2)(2009-7#3)(2012-12#2)(2012-3#6)(2013-1#2)
GISTs have been##2##3##(2008-6#1)(2012-3#1)
GISTs##7##1##(2008-6#2)(2012-12#1)(2012-3#3)(2013-1#1)
GIT##4##1##(2008-12#2)(2012-2#1)(2013-1#1)
GJB2##3##1##(2008-4#3)
GJIC and##2##2##(2008-11#1)(2008-8#1)
GJIC##6##1##(2008-11#1)(2008-8#4)(2010-9#1)
GL##4##1##(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)
GLA##8##1##(1997-2#1)(2008-5#3)(2008-7#4)
GLB##3##1##(2008-12#3)
GLC and##2##2##(2008-10#1)(2008-11#1)
GLC##3##1##(1997-2#1)(2008-10#1)(2008-11#1)
GLDH##2##1##(1993-2#1)(1995-3#1)
GLE and GLG##2##3##(1997-2#2)
GLE##4##1##(1997-2#4)
GLF scores##4##2##(1996-7#4)
GLF##7##1##(1996-7#6)(2008-10#1)
GLG6##4##1##(1990-12#4)
GLH##2##1##(1997-2#1)(2006-12#1)
GLI2##2##1##(2013-1#2)
GLM and the##2##3##(2008-10#1)(2009-6#1)
GLM and##3##2##(2008-10#1)(2009-6#2)
GLM##7##1##(2008-10#4)(2008-12#1)(2009-6#2)
GLN##2##1##(1990-7#2)
GLORY##5##1##(2011-2#5)
GLP##4##1##(1995-8#4)
GLP-1 and##2##2##(1994-8#1)(2011-2#1)
GLP-1 concentrations##2##2##(2012-3#2)
GLP-1 could##2##2##(1995-8#2)
GLP-1 protects β-cells against apoptosis by##2##6##(2010-11#2)
GLP-1##27##1##(1994-8#1)(1995-8#6)(1996-2#6)(2009-10#1)(2010-11#7)(2011-2#4)(2012-3#2)
GLRaV-3##2##1##(2008-10#2)
GLRaV-4##2##1##(2008-10#2)
GLRaV-5##7##1##(2008-10#7)
GLS resistance##3##2##(2008-10#3)
GLS severity##3##2##(2008-10#3)
GLS##15##1##(1992-6#1)(2008-10#13)(2013-7#1)
GLS×LVtw##4##1##(2013-7#4)
GLT-1##4##1##(1996-2#2)(2008-7#2)
GLUD1 gene##2##2##(2008-1#1)(2013-8#1)
GLUD1##4##1##(2008-1#3)(2013-8#1)
GLUT 2 in##2##3##(1994-2#2)
GLUT 2##4##2##(1994-2#4)
GLUT family##2##2##(2008-7#2)
GLUT##9##1##(1991-9#1)(1994-2#5)(2008-5#1)(2008-7#2)
GLUT-1 was expressed##2##3##(1993-6#2)
GLUT-1 was##3##2##(1993-6#3)
GLUT-1##4##1##(1993-6#4)
GLUT-2 and##2##2##(1993-6#2)
GLUT-2 was##2##2##(1993-6#2)
GLUT-2##7##1##(1993-6#7)
GLUT-5##4##1##(1993-6#4)
GLUT1 and GLUT4 mRNA##2##4##(1991-9#2)
GLUT1 protein##2##2##(1993-6#2)
GLUT1##8##1##(1991-9#2)(1993-6#5)(1994-12#1)
GLUT2##3##1##(1991-12#1)(1993-6#2)
GLUT4 translocation is##2##3##(1994-11#2)
GLUT4 translocation##4##2##(1994-11#4)
GLUT4##12##1##(1991-9#2)(1993-6#2)(1994-11#4)(1994-12#1)(1994-8#2)(2008-11#1)
GLX-I##3##1##(2008-10#3)
GLY and AMPA were##3##4##(2011-1#3)
GLY and AMPA##6##3##(2011-1#6)
GM Prunus species##3##3##(2011-2#3)
GM and##4##2##(2011-2#3)(2012-4#1)
GM modified PLGA particles##3##4##(2009-7#3)
GM##20##1##(2008-11#1)(2008-8#2)(2009-7#3)(2011-2#11)(2012-4#2)(2013-1#1)
GM-CSF and##4##2##(1992-8#1)(1994-11#1)(2006-6#1)(2008-11#1)
GM-CSF gene-modified and tumor antigen-pulsed macrophages##2##6##(2008-8#2)
GM-CSF gene-modified##3##2##(2008-8#3)
GM-CSF versus placebo##3##3##(2008-7#3)
GM-CSF versus##5##2##(2008-7#5)
GM-CSF was##2##2##(1992-3#1)(2008-7#1)
GM-CSF##40##1##(1991-12#1)(1991-8#4)(1992-3#4)(1992-8#2)(1993-6#2)(1994-11#1)(1995-6#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#11)(2008-8#6)(2008-9#1)(2010-3#1)(2012-2#1)
GM1 (30 mg/kg)##2##3##(1993-3#2)
GM1 and##2##2##(1994-12#1)(1996-5#1)
GM1 antibody##2##2##(2008-10#2)
GM1 effects##2##2##(1993-3#2)
GM1 ganglioside##4##2##(1993-3#1)(1993-5#2)(2012-3#1)
GM1 gangliosidosis##6##2##(2010-8#1)(2012-3#5)
GM1 in##2##2##(1995-5#1)(2012-3#1)
GM1 induces internalisation and##2##4##(1993-3#2)
GM1##36##1##(1990-5#2)(1993-3#7)(1993-5#4)(1994-12#1)(1995-12#1)(1995-5#1)(1996-5#3)(2008-10#2)(2008-7#1)(2010-8#1)(2012-3#13)
GM1a##2##1##(1991-2#1)(1993-11#1)
GM2 and##2##2##(1996-5#2)
GM2 ganglioside and dendrite growth##2##5##(1996-5#2)
GM2 ganglioside and##3##3##(1996-5#3)
GM2 ganglioside is##2##3##(1996-5#2)
GM2 ganglioside##5##2##(1996-5#5)
GM2##17##1##(1994-2#4)(1996-5#13)
GM3##16##1##(1990-5#4)(1990-8#2)(1991-2#1)(1991-5#2)(1994-12#1)(1996-5#4)(2012-3#2)
GM4##7##1##(1996-5#4)(2008-10#3)
GM6001##2##1##(2008-10#2)
GMC##4##1##(1993-2#1)(1997-5#1)(2008-1#2)
GME##2##1##(1994-2#1)(2008-11#1)
GMI1000##3##1##(2008-10#3)
GMM##6##1##(2012-3#6)
GMMs##2##1##(2013-1#2)
GMP levels##2##2##(2007-10#2)
GMP##21##1##(1990-12#1)(1992-12#4)(1992-3#1)(1992-8#2)(1994-11#1)(1994-12#1)(1995-11#3)(2007-10#2)(2008-11#4)(2008-4#1)(2012-2#1)
GMP-140 (CD62##2##2##(1991-12#2)
GMP-140##9##1##(1991-12#5)(1992-3#4)
GMP-PNP##4##1##(1993-6#2)(2008-6#2)
GMR##5##1##(2008-10#1)(2012-3#4)
GMRF##2##1##(2008-3#1)(2008-6#1)
GMS##2##1##(2008-1#1)(2008-8#1)
GMYC##2##1##(2010-6#2)
GN and##3##2##(1997-8#1)(2008-1#2)
GN in##6##2##(2008-1#6)
GN registry##3##2##(2008-1#3)
GN were##2##2##(2008-1#2)
GN##30##1##(1997-8#2)(2007-7#3)(2008-1#23)(2008-10#1)(2011-1#1)
GNAS mutations in##2##3##(2012-2#2)
GNAS mutations##4##2##(2012-2#4)
GNAS##7##1##(2011-1#1)(2012-2#6)
GNNPS and##2##2##(2011-1#2)
GNP films##2##2##(2013-1#2)
GNP##4##1##(1991-3#1)(2007-7#1)(2013-1#2)
GNPs##4##1##(1991-1#3)(2013-8#1)
GNR##2##1##(2010-1#2)
GNRs##6##1##(2010-1#2)(2012-12#4)
GO consists of##2##3##(2013-1#2)
GO terms##4##2##(2010-4#2)(2011-2#2)
GO##27##1##(1997-7#1)(2008-7#8)(2008-9#3)(2010-1#1)(2010-4#3)(2011-2#2)(2012-2#6)(2013-1#3)
GOD##2##1##(2008-10#1)(2011-1#1)
GOES##2##1##(2008-2#2)
GOO##2##1##(2012-2#2)
GOT and##2##2##(1994-5#2)
GOT##4##1##(1994-5#2)(2008-7#1)(2013-1#1)
GOTO##3##1##(1991-9#2)(1993-9#1)
GOX##4##1##(2008-10#4)
GOx##6##1##(2008-10#6)
GP 34##3##2##(2008-10#3)
GP IIb/IIIa##2##2##(2008-3#1)(2008-8#1)
GP Ia##3##2##(2006-6#3)
GP and##2##2##(2010-3#1)(2011-2#1)
GP code##2##2##(1990-9#2)
GP in##2##2##(1993-6#1)(2011-2#1)
GP sensilla##4##2##(2007-12#4)
GP##33##1##(1990-6#1)(1990-9#2)(1993-12#1)(1993-6#4)(1994-12#1)(1997-4#1)(2006-6#3)(2007-12#6)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
GP's##4##1##(1995-11#1)(1997-4#2)(2011-1#1)
GP1##2##1##(1990-2#1)(2008-10#1)
GPA and##2##2##(1993-12#2)
GPA##4##1##(1993-12#3)(2008-12#1)
GPC system##2##2##(2007-11#2)
GPC##3##1##(2007-11#2)(2010-2#1)
GPC5##3##1##(2012-3#3)
GPCR##2##1##(2008-7#1)(2012-2#1)
GPCRs##2##1##(1995-8#1)(2012-2#1)
GPDCM##3##1##(2008-2#3)
GPDH##3##1##(2008-11#3)
GPI##13##1##(1990-8#2)(1994-3#1)(1995-2#4)(1996-3#2)(1997-6#3)(2008-4#1)
GPI-anchored ALP derived from##2##4##(2008-11#2)
GPI-anchored ALP##3##2##(2008-11#3)
GPI-anchored##4##1##(2008-11#4)
GPIIIa##7##1##(1997-7#2)(2006-6#5)
GPIIb alpha##2##2##(1991-8#2)
GPIIb##7##1##(1991-8#3)(1994-12#4)
GPIIb-16##2##1##(1994-12#2)
GPIIb-3##3##1##(1994-12#3)
GPIIb-IIIa and fibrinogen##2##3##(2006-6#2)
GPIIb-IIIa and##3##2##(1997-7#1)(2006-6#2)
GPIIb-IIIa##6##1##(1997-7#2)(2006-6#4)
GPIIb/IIIa##3##1##(1993-3#1)(1997-7#1)(2008-5#1)
GPIb/IX/V complex##2##2##(2008-11#2)
GPIb/IX/V##4##1##(2008-11#4)
GPIs##3##1##(2013-8#3)
GPL##4##1##(1992-12#1)(1992-3#3)
GPNMB##5##1##(2009-4#5)
GPO##4##1##(2007-9#2)(2008-10#2)
GPR1##4##1##(1994-12#4)
GPR54##2##1##(2009-6#2)
GPR6##2##1##(1994-12#2)
GPR80 is a##2##3##(2008-4#2)
GPR80 is not##2##3##(2008-4#2)
GPR80 is##4##2##(2008-4#4)
GPR80##8##1##(2008-4#8)
GPR80-expressing##2##1##(2008-4#2)
GPR80/99 and GPR91 are##2##4##(2008-4#2)
GPR80/99##6##1##(2008-4#6)
GPR91##3##1##(2008-4#3)
GPS 5##7##2##(2008-10#7)
GPS measurements##2##2##(2012-2#2)
GPS units##2##2##(2008-8#2)
GPS##17##1##(2008-10#7)(2008-8#4)(2011-2#1)(2012-2#5)
GPT##3##1##(2008-11#1)(2008-7#1)(2013-1#1)
GPU cards##2##2##(2012-2#2)
GPU has##2##2##(2011-1#1)(2012-2#1)
GPU implementation is##2##3##(2012-2#2)
GPU implementation##4##2##(2012-2#4)
GPU##18##1##(2011-1#7)(2012-2#10)(2013-8#1)
GPUs##3##1##(2011-1#3)
GPX##5##1##(1990-3#2)(2008-10#3)
GPa##14##1##(1994-2#1)(2007-12#4)(2008-3#1)(2009-7#3)(2010-12#2)(2012-2#3)
GPa)##2##1##(2008-10#2)
GPs and##2##2##(2008-3#1)(2008-7#1)
GPs as##3##2##(1997-4#1)(2008-10#2)
GPs in##2##2##(2007-2#1)(2011-1#1)
GPs reported##2##2##(2007-2#2)
GPs were##3##2##(2007-2#1)(2008-3#2)
GPs with##2##2##(2007-2#1)(2008-7#1)
GPs##44##1##(1994-12#2)(1996-3#3)(1997-4#1)(2007-2#21)(2008-10#2)(2008-11#1)(2008-3#6)(2008-7#3)(2011-1#2)(2011-2#2)(2013-8#1)
GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants##3##12##(1997-8#3)
GPs'##4##1##(1997-8#3)(2007-2#1)
GPx##2##1##(2008-7#1)(2013-1#1)
GR had##2##2##(2010-2#1)(2011-2#1)
GR in##2##2##(1994-2#2)
GR##28##1##(1994-2#6)(1995-12#2)(1997-4#1)(2008-11#2)(2008-8#2)(2009-8#3)(2010-2#1)(2010-4#2)(2011-2#7)(2013-1#1)(2013-7#1)
GR-205171##6##1##(2008-5#6)
GRACE##2##1##(2012-2#1)(2013-8#1)
GRAIL##2##1##(1997-2#1)(2008-4#1)
GRAV##7##1##(2008-10#7)
GRB##2##1##(2012-2#2)
GRE##5##1##(1993-6#1)(1994-6#1)(1997-8#3)
GRF##2##1##(1991-9#2)
GRF-antagonist##4##1##(1991-9#4)
GRGDS##2##1##(2008-5#2)
GRH##3##1##(1992-6#3)
GRIN rod##4##2##(2008-3#4)
GRIN##6##1##(2007-12#1)(2008-3#5)
GRNN##4##1##(2008-10#4)
GRO protein##2##2##(1994-12#2)
GRO##8##1##(1994-12#8)
GRO-alpha##2##1##(1994-12#1)(2011-2#1)
GROUPWISE REGISTRATION##2##2##(2011-2#2)
GRP##10##1##(1992-6#6)(1995-3#1)(1997-7#1)(2008-9#2)
GRP1 PH domain##2##3##(2009-7#2)
GRP1##3##1##(2009-7#3)
GRPR##7##1##(1996-12#2)(2010-6#5)
GRS 243 and##3##3##(2008-10#3)
GRSV##2##1##(2008-10#2)
GRV isolates##3##2##(2008-10#3)
GRV##6##1##(2008-10#6)
GS 58##2##2##(2008-10#2)
GS is##2##2##(2008-8#1)(2011-2#1)
GS##22##1##(1993-12#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-8#2)(2010-8#1)(2011-2#3)(2012-2#3)
GS-4104##8##1##(2008-5#8)
GS-NS0##2##1##(2008-11#2)
GS-X pump##3##2##(2008-11#3)
GSA##3##1##(1990-7#2)(2012-3#1)
GSAAE and NCySAAE##2##3##(1996-12#2)
GSAAE and##3##2##(1996-12#3)
GSC##4##1##(2008-10#1)(2011-2#3)
GSCbl can##2##2##(2008-10#2)
GSCbl##3##1##(2008-10#3)
GSFUR design##2##2##(2008-2#1)(2008-3#1)
GSFUR##3##1##(2008-2#1)(2008-3#2)
GSG1##6##1##(1995-9#6)
GSGG##2##1##(2008-2#1)(2008-3#1)
GSH and##3##2##(2008-10#3)
GSH as##2##2##(1990-12#1)(2012-3#1)
GSH concentration in##2##3##(2008-10#1)(2010-5#1)
GSH concentrations##2##2##(1990-2#1)(2008-7#1)
GSH content##4##2##(1994-2#1)(2008-10#1)(2008-7#2)
GSH depletion##5##2##(1994-8#1)(2008-7#3)(2011-1#1)
GSH in the##4##3##(1990-2#2)(2008-10#1)(2013-1#1)
GSH in##10##2##(1990-2#2)(1991-9#2)(2008-10#4)(2008-7#1)(2013-1#1)
GSH level of normal##2##4##(1990-2#2)
GSH level##3##2##(1990-2#2)(2011-1#1)
GSH levels in the##2##4##(2013-1#2)
GSH levels in##3##3##(2010-5#1)(2013-1#2)
GSH levels of##2##3##(1990-2#1)(2012-3#1)
GSH levels##8##2##(1990-2#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#4)
GSH metabolism##2##2##(2008-11#1)(2008-7#1)
GSH peroxidase activity##2##3##(1994-2#1)(2008-2#1)
GSH peroxidase##4##2##(1994-2#3)(2008-2#1)
GSH plays##2##2##(1990-2#1)(1991-8#1)
GSH transporter##4##2##(1995-2#4)
GSH values##2##2##(1990-2#2)
GSH was##3##2##(1990-2#1)(2008-10#2)
GSH were##2##2##(2008-10#2)
GSH##95##1##(1990-12#2)(1990-2#14)(1991-5#1)(1991-8#1)(1991-9#4)(1992-12#2)(1992-8#1)(1993-8#2)(1994-2#6)(1994-8#1)(1994-9#1)(1995-2#6)(1995-6#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-7#11)(2009-6#1)(2010-11#1)(2010-5#4)(2011-1#2)(2011-3#1)(2012-3#2)(2013-1#8)
GSH) and##2##2##(2010-11#1)(2011-2#1)
GSH+insulin##2##1##(2012-2#2)
GSH-dependent##2##1##(1991-5#1)(1994-2#1)
GSI##5##1##(1994-3#2)(2008-3#2)(2008-7#1)
GSIS##3##1##(2010-11#1)(2012-2#2)
GSK3β activity##2##2##(2012-2#2)
GSM##12##1##(2007-11#3)(2008-12#1)(2008-3#2)(2008-9#4)(2009-6#2)
GSNO and##2##2##(1997-4#2)
GSNO##4##1##(1995-5#1)(1997-4#3)
GSP##2##1##(2010-2#2)
GSP13##2##1##(2009-7#2)
GSR##5##1##(2012-2#5)
GSRS scores##2##2##(2013-1#2)
GSSG##3##1##(2008-10#2)(2011-2#1)
GSSG/GSH##2##1##(2008-10#1)(2009-12#1)
GST P subunit##2##3##(1990-2#2)
GST P##5##2##(1990-2#5)
GST activity##9##2##(1992-6#1)(1995-6#1)(1997-7#2)(2008-7#1)(2011-10#2)(2011-2#1)(2013-7#1)
GST alpha##2##2##(1997-7#1)(2010-5#1)
GST inhibition##2##2##(2013-7#2)
GST nanoparticle arrays##3##3##(2009-11#3)
GST pi##5##2##(1990-2#2)(1994-2#2)(1997-7#1)
GST was##3##2##(1991-12#1)(1995-6#1)(2010-5#1)
GST##59##1##(1990-2#8)(1991-12#3)(1992-6#1)(1993-2#1)(1994-12#1)(1994-2#5)(1995-6#4)(1997-7#10)(2007-10#1)(2008-12#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#5)(2010-5#2)(2011-10#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#4)
GST-P positive foci##2##3##(1992-3#2)
GST-P positive##3##2##(1992-3#3)
GST-P##5##1##(1992-3#3)(1992-6#2)
GST-lambdaN##2##1##(2008-9#2)
GST-mu##3##1##(1995-6#3)
GSTM1 and GSTT1##4##3##(1995-8#1)(2008-12#3)
GSTM1 null genotype##2##3##(2008-12#2)
GSTM1##9##1##(1995-8#1)(2008-12#8)
GSTT (100##3##2##(2011-3#3)
GSTT##5##1##(2011-3#5)
GSTT1 and GSTM1 genotypes##2##4##(2008-12#2)
GSTT1##8##1##(1995-8#1)(2008-12#7)
GSTs##4##1##(1990-2#2)(2008-11#2)
GT and##2##2##(2009-5#1)(2011-2#1)
GT families##3##2##(2006-6#1)(2009-10#2)
GT genes##2##2##(2009-10#2)
GT##22##1##(1990-11#3)(1991-11#1)(2006-6#4)(2008-5#2)(2008-9#2)(2009-10#7)(2009-5#1)(2011-2#1)(2013-1#1)
GT1b or##2##2##(1996-5#2)
GT1b##7##1##(1991-2#1)(1994-12#1)(1994-9#2)(1996-5#3)
GTG##2##1##(1994-12#1)(1996-8#1)
GTH-II and GH release##4##4##(1994-8#4)
GTH-II and GH##5##3##(1994-8#5)
GTH-II and##6##2##(1994-8#5)(2008-5#1)
GTH-II levels in##2##3##(2008-5#2)
GTH-II levels##3##2##(2008-5#3)
GTH-II release##3##2##(1994-8#3)
GTH-II##20##1##(1994-8#8)(2008-5#12)
GTN reduced peripheral##2##3##(2007-10#2)
GTN##16##1##(1995-11#3)(2007-10#9)(2008-8#3)(2009-5#1)
GTP analog##2##2##(1993-12#2)
GTP analogue##4##2##(1991-6#1)(1992-8#1)(1995-11#1)(1996-5#1)
GTP analogues##2##2##(1992-8#1)(2008-6#1)
GTP and##8##2##(1991-12#1)(1991-5#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-4#1)
GTP are##2##2##(1994-12#1)(2008-4#1)
GTP as##2##2##(1991-12#1)(2008-6#1)
GTP avoidance in Tetrahymena##2##4##(2008-3#2)
GTP avoidance##4##2##(2008-3#4)
GTP binding proteins##3##3##(1996-5#1)(1997-4#2)
GTP binding##8##2##(1996-5#1)(1997-4#6)(2008-4#1)
GTP bound to##2##3##(1992-8#1)(2008-4#1)
GTP cyclohydrolase I##5##3##(1992-8#3)(1993-8#2)
GTP gamma S and##2##4##(1991-2#1)(1992-11#1)
GTP gamma S binding##2##4##(1993-8#2)
GTP gamma S stimulated##2##4##(1992-11#1)(1995-8#1)
GTP gamma S was##2##4##(1992-11#1)(1995-8#1)
GTP gamma S##21##3##(1991-2#2)(1991-6#2)(1991-9#1)(1992-11#5)(1992-8#2)(1993-6#1)(1993-8#4)(1995-8#4)
GTP gamma##25##2##(1991-2#2)(1991-6#3)(1991-9#1)(1992-11#5)(1992-12#1)(1992-8#2)(1993-6#1)(1993-8#5)(1994-3#1)(1995-8#4)
GTP hydrolysis##3##2##(1990-7#2)(1995-5#1)
GTP in##3##2##(1995-2#1)(1995-6#1)(1995-8#1)
GTP inhibition##2##2##(1992-8#2)
GTP or##3##2##(1991-12#1)(2008-6#1)(2011-1#1)
GTP signals##2##2##(2008-3#1)(2008-4#1)
GTP##125##1##(1990-7#13)(1991-12#8)(1991-2#3)(1991-5#2)(1991-6#4)(1991-9#1)(1992-11#5)(1992-12#1)(1992-6#1)(1992-8#13)(1993-12#2)(1993-6#3)(1993-8#7)(1994-11#1)(1994-12#2)(1994-3#2)(1995-11#2)(1995-2#3)(1995-5#3)(1995-6#4)(1995-8#6)(1996-2#1)(1996-5#3)(1997-1#1)(1997-4#6)(1997-7#2)(2008-11#2)(2008-3#7)(2008-4#11)(2008-6#5)(2011-1#1)
GTP-binding protein in pea##2##4##(1993-6#2)
GTP-binding protein##17##2##(1991-12#1)(1991-5#2)(1992-11#1)(1992-6#1)(1992-8#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-8#1)
GTP-binding proteins in the##2##4##(1991-9#1)(1993-6#1)
GTP-binding proteins in##4##3##(1991-9#1)(1992-3#1)(1993-6#1)(1994-9#1)
GTP-binding proteins##19##2##(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-6#1)
GTP-binding##40##1##(1991-12#2)(1991-5#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-8#2)(1996-2#1)(1997-1#1)(2008-6#1)(2008-7#1)
GTP-bound##2##1##(1993-8#1)(1994-8#1)
GTP-dependent##2##1##(1990-7#1)(1992-6#1)
GTP-gamma-S##2##1##(1991-12#1)(1991-2#1)
GTP-gammaS and##2##2##(2008-6#2)
GTP-induced##2##1##(1995-3#1)(2008-4#1)
GTPCH mRNA of##2##3##(1993-8#2)
GTPCH mRNA##9##2##(1993-8#9)
GTPCH##12##1##(1993-8#12)
GTP[S]##3##1##(1991-5#3)
GTPase activating protein (GAP)##3##4##(1991-12#1)(1991-5#1)(1993-8#1)
GTPase activating protein toward ras p21##2##6##(1991-5#2)
GTPase activating protein##7##3##(1991-12#1)(1991-5#3)(1992-8#1)(1993-8#2)
GTPase activating##8##2##(1991-12#1)(1991-5#3)(1992-8#2)(1993-8#2)
GTPase activity of##8##3##(1992-11#6)(1993-8#1)(1994-12#1)
GTPase activity##19##2##(1992-11#7)(1992-3#1)(1992-8#1)(1993-8#2)(1994-12#1)(1995-11#5)(1995-2#1)(2012-7#1)
GTPase##44##1##(1991-12#1)(1991-5#3)(1992-11#7)(1992-3#1)(1992-8#3)(1993-8#4)(1994-12#1)(1995-11#5)(1995-2#2)(1996-2#1)(1996-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#5)(2012-12#4)(2012-7#1)
GTPase-activating protein##4##2##(1992-12#2)(1993-12#1)(1994-12#1)
GTPases and##3##2##(1997-7#1)(2008-11#1)(2008-4#1)
GTPases are##2##2##(1995-8#1)(2009-10#1)
GTPases##15##1##(1995-8#2)(1996-2#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-8#1)
GTPgammaS binding##3##2##(2008-11#1)(2008-9#2)
GTPgammaS##5##1##(1996-2#1)(2008-11#1)(2008-9#3)
GTR##3##1##(2012-3#3)
GTV##5##1##(2008-2#4)(2009-2#1)
GTaS##2##1##(2013-8#2)
GTs are##2##2##(2009-10#2)
GTs##7##1##(2008-10#2)(2009-10#5)
GUARANTEE##2##1##(2008-3#2)
GUB quails##2##2##(1997-3#2)
GUB##3##1##(1997-3#3)
GUS activity in##3##3##(1996-12#1)(2008-9#2)
GUS activity of the##2##4##(2008-8#1)(2008-9#1)
GUS activity of transgenic plants##2##5##(2008-8#1)(2008-9#1)
GUS activity of##6##3##(2008-8#2)(2008-9#4)
GUS activity was##3##3##(2008-10#3)
GUS activity##20##2##(1996-12#2)(2008-10#7)(2008-5#1)(2008-8#2)(2008-9#8)
GUS assay showed that##2##4##(2008-8#1)(2008-9#1)
GUS expression##4##2##(1997-2#1)(2008-10#3)
GUS gene##6##2##(1997-2#3)(2008-10#1)(2008-9#2)
GUS histochemical##2##2##(2008-9#2)
GUS with##2##2##(2008-11#1)(2008-9#1)
GUS##46##1##(1996-12#2)(1997-2#4)(2008-10#18)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#17)
GUS-expressing transformants 398D97 and 8036E27##2##5##(2008-10#2)
GUS-expressing transformants##3##2##(2008-10#3)
GUT6##3##1##(2008-10#3)
GV than to##2##3##(2008-10#2)
GV##6##1##(2008-10#4)(2008-9#1)(2013-1#1)
GVBD##5##1##(1992-11#2)(1995-2#3)
GVG##3##1##(1991-12#3)
GVHD##8##1##(2006-10#2)(2009-10#6)
GVI##6##1##(2013-7#6)
GVIA and##2##2##(1992-7#1)(1996-5#1)
GVIA##8##1##(1992-7#1)(1993-11#1)(1993-12#1)(1993-9#2)(1996-5#3)
GW scale##2##2##(2009-11#2)
GW##8##1##(2007-11#1)(2008-3#1)(2008-9#2)(2009-11#3)(2011-2#1)
GW/cm(2)##2##1##(2008-2#1)(2008-3#1)
GWG##7##1##(2013-1#7)
GWSS##2##1##(2008-10#2)
GXM##4##1##(2007-10#4)
GY##2##1##(2008-12#1)(2008-5#1)
GYD##2##1##(2008-8#2)
GYKI 52466 in##2##3##(1994-6#1)(1995-12#1)
GYKI 52466##7##2##(1994-6#1)(1995-12#6)
GYKI##8##1##(1994-6#1)(1995-12#6)(2008-8#1)
Ga and##3##2##(2008-10#2)(2008-3#1)
Ga kenkey##2##2##(1997-4#2)
Ga##21##1##(1997-3#1)(1997-4#4)(2007-11#2)(2008-10#10)(2008-3#3)(2009-11#1)
Ga(0##4##1##(2007-12#3)(2008-2#1)
Ga(3+)##6##1##(2008-10#6)
Ga(III) and Ti(IV) ions##2##4##(2008-10#2)
Ga(III) and Ti(IV)##3##3##(2008-10#3)
Ga(III) and##4##2##(2008-10#4)
Ga(III)##8##1##(2008-10#8)
Ga2##2##1##(1990-5#2)
GaAlAs diode laser##2##3##(2008-2#2)
GaAlAs##3##1##(2008-2#3)
GaAs (001)##2##2##(2009-11#2)
GaAs JFETs##2##2##(2009-6#2)
GaAs and semi-insulating##2##3##(2008-2#2)
GaAs and##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-7#1)
GaAs for##3##2##(2007-11#1)(2008-3#2)
GaAs photomultiplier tube##2##3##(2007-11#2)
GaAs quantum##2##2##(1994-2#1)(2008-3#1)
GaAs single##3##2##(2008-2#2)(2008-3#1)
GaAs##66##1##(1990-12#1)(1994-2#1)(1996-12#2)(1996-9#1)(2007-11#16)(2007-12#9)(2008-2#16)(2008-3#11)(2008-7#1)(2009-11#3)(2009-6#5)
GaAs-based##2##1##(2007-11#2)
GaAs/AlGaAs microring resonator##2##3##(2007-11#2)
GaAs/AlGaAs multiple-quantum-well waveguide##2##3##(2007-12#2)
GaAs/AlGaAs quantum-cascade lasers##2##3##(2008-3#2)
GaAs/AlGaAs##8##1##(1992-11#1)(2007-11#2)(2007-12#3)(2008-3#2)
GaInAsP waveguide##2##2##(2008-3#2)
GaInAsP##4##1##(2007-11#1)(2008-3#3)
GaN##7##1##(2007-11#3)(2008-3#3)(2010-7#1)
GaP##5##1##(2007-11#4)(2008-3#1)
GaSe crystal##2##2##(2007-11#2)
GaSe##7##1##(2007-11#2)(2008-2#1)(2008-3#4)
Gabon##2##1##(1996-6#1)(2009-10#1)
Gabor filters##2##2##(2008-7#1)(2011-1#1)
Gabor##5##1##(1996-2#1)(2007-11#1)(2008-7#1)(2011-1#2)
Gadd45 alpha##3##2##(2009-7#3)
Gadd45##11##1##(1994-12#4)(2008-9#4)(2009-7#3)
Gadd45(as)/MCF-7##3##1##(2008-9#3)
Gadd45-β can##2##2##(2011-2#2)
Gadd45-β##7##1##(2011-2#7)
Gaeumannomyces graminis var##7##3##(2008-10#7)
Gag and##4##2##(2011-3#4)
Gag##8##1##(1997-3#1)(2009-7#1)(2011-3#5)(2012-12#1)
Gag-Pol##2##1##(2011-3#2)
Gail and Claus models##2##4##(1995-9#2)
Gail##3##1##(1993-12#1)(1995-9#2)
Gain and saturation irradiance##2##4##(2008-2#2)
Gain and##4##2##(2008-10#1)(2008-2#3)
Gain##14##1##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-5#1)(2009-9#1)(2013-1#2)
Gain-of-function##3##1##(2008-4#1)(2009-8#1)(2013-1#1)
Gaining##4##1##(1996-1#1)(1997-3#1)(2009-11#1)(2012-2#1)
Gainsharing##2##1##(1996-3#2)
Gait Variability Index##2##3##(2013-7#2)
Gait and##3##2##(2007-10#1)(2008-7#1)(2013-1#1)
Gait##13##1##(1993-12#1)(2007-10#2)(2008-12#1)(2008-7#2)(2010-3#1)(2013-1#3)(2013-7#3)
Gal##10##1##(1990-5#3)(1990-7#1)(1992-12#1)(1993-9#2)(1997-4#3)
Gal(beta1-4)GlcNAc-R##2##1##(2008-11#2)
Gal4##5##1##(1995-6#1)(2008-10#2)(2008-9#1)(2010-1#1)
GalC+ oligodendrocytes##6##2##(1996-5#6)
GalCer##3##1##(2008-11#3)
GalN##3##1##(1994-6#3)
GalN/LPS-treated##2##1##(1994-8#2)
GalNAc linked alpha##3##3##(1990-7#3)
GalNAc residues##2##2##(1990-7#2)
GalNAc##12##1##(1990-7#8)(1992-10#2)(1992-8#2)
GalNAc-transferase##2##1##(1992-10#2)
Gala##2##1##(2008-10#2)
Galactose##3##1##(1990-11#1)(1995-5#1)(2013-8#1)
Galaxias brevipinnis##2##2##(2010-8#2)
Galaxias maculatus and##2##3##(2010-8#2)
Galaxias##4##1##(2010-8#4)
Galectin-3 is a##2##3##(2009-3#2)
Galerkin##2##1##(2008-7#1)(2011-1#1)
Galicia (Spain)##2##2##(2008-10#2)
Galicia##4##1##(2008-10#4)
Galician##5##1##(2008-10#5)
Galilean##2##1##(1993-3#1)(2008-3#1)
Gall##3##1##(2008-10#2)(2009-8#1)
Gallbladder sludge##2##2##(2012-3#2)
Gallbladder##4##1##(1995-11#1)(2012-3#2)(2013-8#1)
Galleria##2##1##(2008-10#1)(2008-5#1)
Gallic acid (GA)##2##3##(2008-10#2)
Gallium##5##1##(2008-10#5)
Gallstone##3##1##(1990-9#1)(2008-12#2)
Gallup##2##1##(1992-2#1)(2009-5#1)
Galpha subunit##2##2##(2008-7#2)
Galpha subunits##8##2##(2008-7#7)(2009-7#1)
Galpha##11##1##(2008-7#9)(2009-7#2)
Galter##2##1##(1996-12#2)
Galveston technique##2##2##(2008-12#2)
Galveston##4##1##(2008-12#4)
Gambia##2##1##(1996-11#1)(1997-7#1)
Gamble##3##1##(2008-5#2)(2012-12#1)
Gambling##3##1##(2008-10#1)(2008-11#1)(2013-8#1)
Gambro Engström Edith##3##3##(1992-2#3)
Gambro Prismaflex continuous renal replacement therapy##2##6##(2011-2#2)
Gambro##8##1##(1990-11#1)(1992-2#3)(2007-12#1)(2011-2#3)
Game theory##2##2##(2012-3#2)
Game##8##1##(2009-10#1)(2010-1#1)(2012-3#3)(2013-1#3)
Games##6##1##(1993-3#1)(1996-2#1)(1996-3#1)(2007-2#1)(2012-2#2)
Gamma Knife##4##2##(1997-4#3)(2012-3#1)
Gamma irradiation##2##2##(2007-12#1)(2008-10#1)
Gamma knife##2##2##(1996-3#1)(2011-2#1)
Gamma nail in##2##3##(2007-8#2)
Gamma nail##6##2##(2007-11#2)(2007-8#4)
Gamma##24##1##(1996-3#1)(1997-4#3)(2007-11#2)(2007-12#1)(2007-8#5)(2008-10#1)(2008-3#4)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Gamma-aminobutyric acid##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
Gammamed plus vaginal cylinders##2##4##(2009-2#2)
Gammaproteobacteria##3##1##(2011-1#1)(2011-2#2)
Gandalf copies##2##2##(1995-8#2)
Gandalf##7##1##(1995-8#7)
Gandoca##2##1##(2011-2#2)
Ganglion##3##1##(2009-12#1)(2011-2#1)(2013-8#1)
Ganglioside##4##1##(1990-5#1)(1991-5#1)(1994-2#1)(2012-3#1)
Gangliosides of##2##2##(1993-11#2)
Gangliosides##5##1##(1990-5#1)(1993-11#2)(1994-12#2)
Ganoderma lucidum##3##2##(1997-2#2)(2013-8#1)
Ganoderma##4##1##(1997-2#2)(2010-5#1)(2013-8#1)
Ganz##3##1##(2007-8#2)(2010-8#1)
Gao##3##1##(1994-8#1)(2008-10#2)
Gap##7##1##(1996-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-7#2)
Gap'##2##1##(2011-1#1)(2012-12#1)
Gaps were identified and risks mitigated to assure robustness of the proposed framework##2##13##(2012-2#2)
Gaps##4##1##(1996-9#1)(2012-12#1)(2012-2#2)
Garcinia intermedia (Clusiaceae)##2##3##(2008-5#2)
Garcinia##5##1##(2008-5#2)(2012-2#3)
Garden##6##1##(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#1)
Gardenswartz and##2##2##(1994-12#2)
Gardner##2##1##(1995-1#1)(2012-3#1)
Gardner's syndrome##3##2##(1990-6#2)(1994-5#1)
Gardner's##4##1##(1990-6#3)(1994-5#1)
Gardner-Diamond syndrome##2##2##(2008-11#2)
Gardos##2##1##(1992-6#1)(2008-8#1)
Garlic##2##1##(2008-9#1)(2012-2#1)
Garlicki##2##1##(2007-8#2)
Garnet##2##1##(2008-2#1)(2008-3#1)
Gartland and Werley##2##3##(2008-9#2)
Gartland##3##1##(2008-9#2)(2013-1#1)
Gartner's duct##2##2##(2008-7#2)
Gas Temperature##2##2##(2008-3#2)
Gas chromatographic analysis##2##3##(2008-10#1)(2008-11#1)
Gas chromatographic##7##2##(2008-10#5)(2008-11#1)(2012-2#1)
Gas chromatography##6##2##(1991-12#1)(2008-10#4)(2008-5#1)
Gas chromatography-mass spectrometry analysis##2##4##(2008-5#1)(2013-1#1)
Gas chromatography-mass##3##2##(1997-1#1)(2008-5#1)(2013-1#1)
Gas chromatography-olfactometry##2##2##(2008-10#2)
Gas chromatography/mass spectrometry##2##3##(1992-8#1)(2008-10#1)
Gas##48##1##(1991-12#1)(1992-8#1)(1996-12#1)(1997-1#2)(2007-12#1)(2007-7#1)(2008-10#18)(2008-11#2)(2008-2#7)(2008-3#7)(2008-5#3)(2012-1#1)(2012-2#2)(2013-1#1)
Gas-phase##2##1##(2008-2#1)(2009-2#1)
Gaseous##5##1##(1996-2#1)(2008-10#4)
Gases##9##1##(1996-9#2)(2008-2#2)(2008-3#3)(2013-1#2)
Gasterosteus aculeatus##2##2##(2010-8#2)
Gastric Cancer##2##2##(2008-5#1)(2010-12#1)
Gastric acid secretion in##2##4##(1993-12#2)
Gastric acid secretion##3##3##(1993-12#2)(1997-1#1)
Gastric cancer##4##2##(1990-9#1)(2010-12#1)(2012-12#2)
Gastric emptying##2##2##(1993-10#1)(2013-1#1)
Gastric teratoma##2##2##(2007-5#2)
Gastric##29##1##(1990-9#1)(1992-2#1)(1993-10#1)(1993-12#2)(1995-11#1)(1995-6#1)(1996-6#1)(1997-1#4)(2007-5#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#2)(2010-8#1)(2012-12#2)(2013-1#2)(2013-8#2)
Gastro-hep news##3##2##(2010-6#1)(2013-1#2)
Gastrobronchial##2##1##(2007-8#2)
Gastrodia##2##1##(2008-5#1)(2012-3#1)
Gastroenterology##8##1##(1995-12#1)(2008-11#1)(2008-9#5)(2013-1#1)
Gastroesophageal reflux disease##2##3##(2010-12#2)
Gastroesophageal##4##1##(2006-10#1)(2009-7#1)(2010-12#2)
Gastrointestinal Disease##2##2##(2008-1#1)(2010-10#1)
Gastrointestinal bleeding##6##2##(1993-8#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-1#2)
Gastrointestinal stromal tumor##2##3##(2009-7#2)
Gastrointestinal stromal tumors (GISTs)##2##4##(2012-12#1)(2013-1#1)
Gastrointestinal stromal tumors##5##3##(1992-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
Gastrointestinal stromal##9##2##(1992-9#1)(2008-6#2)(2009-7#2)(2012-12#1)(2012-3#1)(2013-1#2)
Gastrointestinal##39##1##(1991-11#1)(1992-9#1)(1993-8#1)(1997-8#2)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
Gastropod##2##1##(2008-6#1)(2011-2#1)
Gastroprotective##3##1##(2006-10#2)(2008-11#1)
Gastrula##2##1##(2008-5#1)(2008-6#1)
Gated##2##1##(2008-2#1)(2008-3#1)
Gateway cloning##3##2##(2008-4#3)
Gateway##9##1##(2007-12#4)(2008-4#4)(2008-7#1)
Gating##3##1##(2008-9#1)(2010-12#1)(2011-1#1)
Gaucher disease##9##2##(1994-11#1)(1994-5#1)(1997-7#1)(2006-10#1)(2008-10#5)
Gaucher##12##1##(1991-9#1)(1994-11#1)(1994-5#1)(1997-7#1)(2006-10#1)(2008-10#7)
Gaucher's disease##3##2##(1991-9#3)
Gauge##2##1##(1996-9#1)(2006-12#1)
Gaussian MRF##2##2##(2008-6#2)
Gaussian Schell-model beams##2##3##(2007-11#1)(2007-12#1)
Gaussian Schell-model source and##2##4##(2007-12#1)(2008-3#1)
Gaussian Schell-model##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Gaussian and##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
Gaussian approximation##3##2##(2007-11#1)(2008-3#2)
Gaussian beam TL##3##3##(2008-3#3)
Gaussian beam in##3##3##(2007-11#1)(2008-3#2)
Gaussian beam into a##2##4##(2007-11#1)(2008-3#1)
Gaussian beam to a##2##4##(2008-3#2)
Gaussian beam with##3##3##(2007-11#1)(2008-2#2)
Gaussian beam##41##2##(2007-11#7)(2007-12#7)(2008-2#11)(2008-3#16)
Gaussian beams as##2##3##(2007-11#1)(2008-3#1)
Gaussian beams have been##2##4##(2007-12#1)(2008-3#1)
Gaussian beams in##3##3##(2007-12#1)(2008-3#2)
Gaussian beams is##2##3##(2008-3#2)
Gaussian beams##21##2##(2007-11#2)(2007-12#7)(2008-2#2)(2008-3#10)
Gaussian distribution with##2##3##(2008-10#1)(2008-2#1)
Gaussian distribution##7##2##(2008-10#2)(2008-2#3)(2008-3#2)
Gaussian distributions##2##2##(2012-1#1)(2013-1#1)
Gaussian function##4##2##(2008-2#2)(2008-3#2)
Gaussian functions##3##2##(2008-10#2)(2008-2#1)
Gaussian gradient filter and##2##4##(2008-2#2)
Gaussian incident##2##2##(2008-2#1)(2008-3#1)
Gaussian intensity##3##2##(2008-3#3)
Gaussian laser beam##8##3##(2007-11#3)(2008-2#2)(2008-3#2)(2009-6#1)
Gaussian laser##10##2##(2007-11#4)(2008-2#3)(2008-3#2)(2009-6#1)
Gaussian model##4##2##(2008-10#3)(2008-2#1)
Gaussian noise##8##2##(2008-2#2)(2008-3#5)(2008-7#1)
Gaussian or##2##2##(2007-11#1)(2008-10#1)
Gaussian probability distribution##3##3##(2008-3#1)(2009-9#1)(2010-5#1)
Gaussian pulse##3##2##(2007-12#2)(2008-2#1)
Gaussian pulses##3##2##(2007-11#3)
Gaussian quadrature##2##2##(2008-3#1)(2012-1#1)
Gaussian random##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
Gaussian statistics##3##2##(2008-2#1)(2008-3#2)
Gaussian##224##1##(1996-12#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#23)(2007-12#25)(2007-9#1)(2008-10#13)(2008-2#62)(2008-3#79)(2008-6#3)(2008-7#2)(2009-6#1)(2009-9#2)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
Gaussian-Schell model beams##2##3##(2007-11#2)
Gaussian-Schell model##4##2##(2007-11#4)
Gaussian-beam##4##1##(2007-12#1)(2008-3#3)
Gaussian-beam-induced##2##1##(2007-11#2)
Gaussian-like beam##2##2##(2007-12#1)(2011-1#1)
Gaussian-like##5##1##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#2)
Gaussian-shaped##2##1##(2007-12#1)(2008-3#1)
Gaussianlike##2##1##(2007-12#2)
Gaustad##3##1##(1993-6#3)
Gavarni##3##1##(2012-2#3)
Gay##5##1##(1991-2#1)(2008-10#1)(2009-12#1)(2010-8#2)
Gaza##4##1##(2008-1#2)(2008-9#1)(2009-2#1)
Gazeta Medica da Bahia##2##4##(2009-10#2)
Gazeta Medica da##3##3##(2009-10#3)
Gazeta##5##1##(2009-10#5)
Gb3 and##2##2##(2011-1#1)(2013-1#1)
Gb3##6##1##(2007-7#1)(2011-1#3)(2013-1#2)
GbCLH was##2##2##(2008-11#2)
GbCLH##4##1##(2008-11#4)
Gbeta(1)gamma(2) was##2##2##(2008-9#2)
Gbeta(1)gamma(2)##6##1##(2008-9#6)
Gbetagamma##3##1##(2008-8#2)(2009-7#1)
Gbit/s##3##1##(2008-2#1)(2008-3#2)
Gbogbe##3##1##(2008-10#3)
Gc##6##1##(1990-8#4)(1993-12#2)
Gcr1p binds##2##2##(1996-3#2)
Gcr1p##6##1##(1996-3#6)
Gd and Yb##2##3##(1997-8#2)
Gd and##5##2##(1997-8#2)(2008-10#3)
Gd##17##1##(1997-7#1)(1997-8#8)(2007-12#1)(2008-10#7)
Gd(2)O(3)##5##1##(2008-10#4)(2008-11#1)
Gd(3+)##9##1##(2008-10#8)(2008-11#1)
Gd(3+))##2##1##(2008-10#2)
Gd(III) and Nd(III)##2##3##(2008-10#2)
Gd(III) and Yb(III)##2##3##(2008-10#2)
Gd(III) and##4##2##(2008-10#4)
Gd(III)##10##1##(2008-10#10)
Gd(x)Y(1-x)Ca(4)O(BO(3))(3)##3##1##(2007-12#3)
Gd-BOPTA##8##1##(2008-7#8)
Gd-DTPA##10##1##(1990-2#3)(1995-4#1)(2007-11#3)(2008-10#1)(2008-7#1)(2009-6#1)
Gd-Trp-SDBS##2##1##(2008-10#2)
GdAl(3)(BO(3))(4)##2##1##(2007-11#2)
GdCOB##3##1##(2007-11#2)(2008-2#1)
GdCOB)##2##1##(2007-12#1)(2008-2#1)
GdYCOB##3##1##(2007-12#3)
Gdansk##2##1##(2008-9#1)(2012-12#1)
Gdańsk##4##1##(2007-8#1)(2008-11#3)
GdmCl##2##1##(2008-9#2)
Gdn##4##1##(1993-6#4)
Ge and##2##2##(2007-12#1)(2009-9#1)
Ge##23##1##(1992-6#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-3#6)(2009-9#2)
Ge(2)Sb(2##3##1##(2008-3#3)
Ge(IV)##2##1##(2008-10#2)
Ge-coated Ag hollow waveguides##2##4##(2008-3#2)
Ge-coated##4##1##(2008-3#4)
Ge-doped silica##4##2##(2007-11#1)(2007-12#3)
Ge-doped##8##1##(2007-11#3)(2007-12#5)
Ge/Si##2##1##(2008-7#2)
GeMe(2)##2##1##(2009-9#2)
GeO(2)##3##1##(2008-2#3)
GeO(2)-SiO(2)##2##1##(2007-12#1)(2008-2#1)
GeXP assay##2##2##(2013-8#2)
GeXP##7##1##(2013-8#7)
Gekko##3##1##(2010-3#3)
Gel electrophoresis##3##2##(1994-8#1)(2008-10#1)(2008-4#1)
Gel filtration chromatography##2##3##(1994-5#1)(2008-10#1)
Gel filtration##4##2##(1993-3#1)(1994-5#1)(1995-11#1)(2008-10#1)
Gel mobility shift assays using##2##5##(1995-6#1)(2011-1#1)
Gel mobility shift assays##3##4##(1994-6#1)(1995-6#1)(2011-1#1)
Gel mobility shift##4##3##(1994-6#1)(1995-6#1)(1995-8#1)(2011-1#1)
Gel retardation##2##2##(1992-8#1)(2008-8#1)
Gel shift##2##2##(1992-12#1)(2008-10#1)
Gel##34##1##(1990-10#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)
Gel'fand and##2##2##(2008-2#1)(2012-1#1)
Gel'fand-Graev inversion formula##2##3##(2012-1#2)
Gel'fand-Graev##3##1##(2012-1#3)
Gelastocoridae##2##1##(2008-5#2)
Gels##2##1##(2008-5#1)(2008-8#1)
Gemcitabine and##2##2##(2008-10#2)
Gemcitabine##7##1##(2008-10#3)(2008-6#1)(2010-3#3)
Gemella haemolysans##2##2##(2012-12#2)
Gemella##6##1##(2007-12#4)(2012-12#2)
Gemini##2##1##(2008-10#1)(2008-3#1)
Geminiviridae)##5##1##(2008-10#5)
Geminivirus##5##1##(2008-10#5)
Geminiviruses##3##1##(2008-10#3)
Gen##6##1##(1990-11#2)(1990-5#2)(2008-10#1)(2008-9#1)
GenBank and##2##2##(2008-7#1)(2008-9#1)
GenBank##25##1##(1990-11#1)(1991-5#2)(1994-12#1)(1994-8#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#1)(2011-1#2)(2013-1#1)
GenMark##6##1##(1995-12#6)
Genbank accession number##2##3##(2008-8#2)
Genbank##3##1##(2008-11#1)(2008-8#2)
Gender also##2##2##(2008-4#1)(2009-7#1)
Gender and##7##2##(2007-7#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Gender did not##2##3##(1994-12#1)(2011-2#1)
Gender differences in##7##3##(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)
Gender differences##10##2##(2008-10#1)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
Gender nonconformity##2##2##(2008-12#2)
Gender was not##2##3##(2011-2#1)(2012-12#1)
Gender##44##1##(1994-12#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#5)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
Gene Diversity##2##2##(2008-10#1)(2012-2#1)
Gene Expression Analysis##2##3##(2008-10#1)(2012-1#1)
Gene Expression in##4##3##(2008-10#3)(2012-12#1)
Gene Expression##11##2##(2008-10#5)(2008-7#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Gene Flow##3##2##(2008-10#3)
Gene Index##2##2##(2008-4#2)
Gene Ontology (GO)##5##3##(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)
Gene Ontology##17##2##(2008-4#2)(2008-7#7)(2008-9#3)(2010-1#1)(2010-4#1)(2011-2#2)(2013-1#1)
Gene Polymorphisms##2##2##(2008-8#1)(2010-8#1)
Gene Sequences##2##2##(2008-10#1)(2008-5#1)
Gene Silencing##2##2##(2008-10#1)(2013-1#1)
Gene Therapy##5##2##(1990-8#1)(1994-5#1)(2008-5#3)
Gene Transfer##2##2##(2008-10#2)
Gene activation##2##2##(1995-8#1)(2009-5#1)
Gene and##4##2##(2008-10#2)(2008-11#1)(2010-8#1)
Gene delivery##2##2##(2008-4#2)
Gene discovery##3##2##(1994-9#1)(2008-10#1)(2008-2#1)
Gene disruption studies indicate that##2##5##(1993-9#1)(1995-8#1)
Gene disruption##4##2##(1990-5#1)(1993-9#1)(1995-8#1)(2008-9#1)
Gene diversity##2##2##(2008-10#2)
Gene duplications##2##2##(2007-11#2)
Gene expression analysis of a single or few cells##2##9##(2008-2#1)(2008-4#1)
Gene expression analysis of##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
Gene expression analysis##5##3##(2008-2#1)(2008-4#3)(2008-9#1)
Gene expression of##6##3##(1992-12#1)(1992-6#1)(1993-3#1)(1995-12#1)(1996-5#1)(2011-2#1)
Gene expression profiling of##5##4##(2008-10#3)(2008-8#1)(2010-11#1)
Gene expression profiling##7##3##(2008-10#3)(2008-7#2)(2008-8#1)(2010-11#1)
Gene expression was##3##3##(2008-10#2)(2012-3#1)
Gene expression##36##2##(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-12#1)(1996-5#2)(2008-10#9)(2008-2#1)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
Gene flow##6##2##(2008-10#4)(2008-8#1)(2011-2#1)
Gene for Resistance to##4##4##(2008-10#4)
Gene for##5##2##(2008-10#5)
Gene in##6##2##(1994-12#1)(1997-7#1)(2008-10#4)
Gene of##5##2##(2008-10#5)
Gene polymorphisms of##2##3##(2010-8#1)(2011-1#1)
Gene polymorphisms##3##2##(2008-12#1)(2010-8#1)(2011-1#1)
Gene probes##2##2##(1996-6#1)(2008-10#1)
Gene structure##2##2##(1990-5#1)(1992-11#1)
Gene therapy for##4##3##(1994-5#1)(2008-8#1)(2008-9#2)
Gene therapy in##4##3##(2008-5#1)(2010-10#1)(2011-1#1)(2013-8#1)
Gene therapy is##2##3##(2008-11#1)(2013-8#1)
Gene therapy##21##2##(1990-8#1)(1994-5#3)(1997-3#1)(2007-7#1)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#2)(2010-10#2)(2011-1#1)(2012-10#1)(2013-8#3)
Gene transcription is the most important regulatory mechanism by which a phenotype and functional state of a cell is determined##2##20##(2008-2#1)(2008-4#1)
Gene transfer into##4##3##(1994-5#1)(2008-11#1)(2008-9#1)(2009-3#1)
Gene transfer is##2##3##(2008-11#1)(2008-8#1)
Gene transfer of##2##3##(1994-5#1)(2012-2#1)
Gene transfer##13##2##(1994-5#3)(1994-9#1)(1995-12#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
Gene##278##1##(1990-11#2)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#1)(1993-12#5)(1993-3#2)(1993-9#3)(1994-12#5)(1994-5#8)(1994-9#2)(1995-12#2)(1995-8#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-10#100)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#19)(2008-5#9)(2008-7#16)(2008-8#7)(2008-9#9)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#5)(2012-1#1)(2012-10#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#4)
Gene-Mediated##2##1##(2008-10#2)
Gene-for-Gene##5##1##(2008-10#5)
GeneChip##4##1##(2008-10#1)(2008-5#1)(2009-10#1)(2010-11#1)
GeneHacker##5##1##(1996-12#5)
GeneHackerTL for##2##2##(1997-6#2)
GeneHackerTL##4##1##(1997-6#4)
GeneMark and GeneMark##2##3##(2008-4#2)
GeneMark##17##1##(1995-12#6)(1996-12#1)(1996-6#1)(2008-4#9)
GenePattern##2##1##(2010-12#2)
Genealogies##2##1##(2008-10#2)
Genebank##2##1##(2008-10#1)(2008-9#1)
General Accounting Office##2##3##(1991-1#1)(1993-12#1)
General Cross Validation##2##3##(2008-10#2)
General Health##6##2##(1994-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2013-1#1)
General Hospital in##4##3##(1992-2#1)(1992-3#1)(1995-1#1)(2012-2#1)
General Hospital##31##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
General Image-Quality Equation##2##3##(2008-2#2)
General Practice##5##2##(2008-1#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
General Practitioners##5##2##(1993-2#1)(1994-6#2)(2008-11#1)(2011-1#1)
General Surgery##4##2##(1990-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
General and##4##2##(1991-1#1)(1992-9#1)(2008-3#1)(2008-7#1)
General anesthesia##2##2##(2009-5#1)(2012-12#1)
General equations##3##2##(2008-10#1)(2008-3#2)
General features##2##2##(2007-11#2)
General management##2##2##(1993-1#1)(2008-10#1)
General observations##2##2##(1992-12#1)(2008-2#1)
General practice##6##2##(1990-3#1)(1991-8#1)(1997-4#1)(2011-1#1)(2011-2#2)
General practitioners##10##2##(1992-2#1)(1993-2#2)(1995-11#1)(1995-9#1)(1996-9#3)(2007-2#1)(2008-8#1)
General practitioners' workload in primary care led NHS##3##8##(1997-8#3)
General problems##2##2##(1997-8#1)(2008-10#1)
General results##2##2##(2008-10#1)(2008-2#1)
General solutions for##2##3##(2008-2#2)
General##164##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-8#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-9#1)(1994-1#2)(1994-2#2)(1994-3#5)(1994-6#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-9#4)(1997-4#1)(1997-7#2)(1997-8#4)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#5)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#8)(2008-4#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#3)(2010-1#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#1)
General's##3##1##(1993-12#1)(2008-1#1)(2009-7#1)
Generalization of##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
Generalized linear models##2##3##(2010-12#1)(2010-8#1)
Generalized linear##3##2##(2010-12#1)(2010-8#1)(2012-2#1)
Generalized##24##1##(1991-2#1)(1992-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
Generally it is##2##3##(2007-11#1)(2008-12#1)
Generally speaking the##2##3##(2008-10#1)(2011-2#1)
Generally speaking##4##2##(1996-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
Generally##49##1##(1990-8#1)(1991-3#2)(1994-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2007-10#2)(2007-11#2)(2008-1#2)(2008-10#13)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
Generated##3##1##(2008-10#1)(2010-10#1)(2013-1#1)
Generating##2##1##(1993-9#1)(2007-12#1)
Generation and characterization of##3##4##(2007-12#2)(2008-10#1)
Generation and##14##2##(1991-9#1)(1992-11#1)(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-4#1)(2011-1#1)
Generation in AgGaS(2)##2##3##(2008-2#1)(2008-3#1)
Generation mean analysis##2##3##(2008-10#2)
Generation of a##2##3##(2007-11#1)(2007-12#1)
Generation of high-power##2##3##(2007-11#1)(2007-12#1)
Generation of milliwatt narrow-bandwidth vacuum ultraviolet radiation by##2##8##(2007-11#2)
Generation of the##2##3##(1991-9#1)(1996-5#1)
Generation of tunable narrow-band##2##4##(2007-11#2)
Generation of tunable##4##3##(2007-11#3)(2007-12#1)
Generation of##61##2##(1991-9#1)(1993-5#1)(1996-5#1)(1997-4#1)(2007-11#18)(2007-12#15)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
Generation##91##1##(1990-11#1)(1991-9#2)(1992-11#1)(1993-5#1)(1995-2#1)(1996-5#1)(1997-4#1)(2007-11#19)(2007-12#19)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
Generation)##2##1##(1990-11#1)(2008-3#1)
Generator##2##1##(1990-5#1)(2009-6#1)
Generic##5##1##(2009-10#2)(2010-11#1)(2011-1#1)(2011-2#1)
Genes and##7##2##(2008-10#2)(2008-4#2)(2009-11#1)(2009-5#2)
Genes for##7##2##(1997-5#1)(2007-7#1)(2008-10#5)
Genes from##2##2##(2008-10#1)(2008-8#1)
Genes in the##2##3##(2008-10#2)
Genes in##10##2##(2008-10#8)(2009-10#1)(2012-2#1)
Genes involved in##2##3##(2008-10#2)
Genes of##4##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)
Genes that##3##2##(2011-2#1)(2012-3#2)
Genes to##2##2##(2008-10#2)
Genes##65##1##(1990-5#1)(1993-9#1)(1994-12#1)(1995-6#1)(1997-5#1)(2007-7#1)(2008-10#32)(2008-11#1)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-8#1)
Genet##7##1##(1990-11#2)(1990-5#2)(1992-3#1)(1993-11#1)(1997-6#1)
Genetic Algorithm Rule-Set Prediction (GARP)##2##5##(2008-8#2)
Genetic Algorithm##3##2##(2008-8#2)(2010-8#1)
Genetic Analysis Workshop 17##10##4##(2012-3#10)
Genetic Analysis of a##3##4##(2008-10#3)
Genetic Analysis of##8##3##(2008-10#8)
Genetic Analysis##20##2##(2008-10#10)(2012-3#10)
Genetic Characterization of##2##3##(2008-10#2)
Genetic Characterization##4##2##(2008-10#4)
Genetic Control of##2##3##(2008-10#1)(2009-5#1)
Genetic Control##4##2##(2008-10#2)(2009-5#1)(2012-3#1)
Genetic Differentiation of##2##3##(2008-10#1)(2008-6#1)
Genetic Differentiation##6##2##(2008-10#5)(2008-6#1)
Genetic Diversity Among##2##3##(2008-10#2)
Genetic Diversity and Structure##2##4##(2008-10#2)
Genetic Diversity and##4##3##(2008-10#4)
Genetic Diversity in##5##3##(2008-10#5)
Genetic Diversity of Xanthomonas##3##4##(2008-10#3)
Genetic Diversity of Xylella fastidiosa##2##5##(2008-10#2)
Genetic Diversity of##11##3##(2008-10#11)
Genetic Diversity##25##2##(2008-10#23)(2008-8#1)(2012-3#1)
Genetic Epidemiology##3##2##(1990-12#2)(2012-3#1)
Genetic Exchange##2##2##(2008-10#2)
Genetic Factors##3##2##(2008-10#2)(2009-6#1)
Genetic Mapping##2##2##(2008-10#2)
Genetic Markers##3##2##(2008-10#3)
Genetic Regulation of##2##3##(2008-10#1)(2011-2#1)
Genetic Structure and##3##3##(2008-10#3)
Genetic Structure of Field Populations of##2##6##(2008-10#2)
Genetic Structure of Phytophthora##3##4##(2008-10#3)
Genetic Structure of##20##3##(2008-10#20)
Genetic Structure##24##2##(2008-10#24)
Genetic Variability and##2##3##(2008-10#2)
Genetic Variability in##3##3##(2008-10#2)(2008-5#1)
Genetic Variability##7##2##(2008-10#6)(2008-5#1)
Genetic Variation Among##2##3##(2008-10#2)
Genetic Variation##5##2##(2007-1#1)(2008-10#4)
Genetic Variations in##2##3##(2011-1#1)(2013-8#1)
Genetic Variations##3##2##(2008-5#1)(2011-1#1)(2013-8#1)
Genetic admixture##2##2##(2008-12#2)
Genetic analyses and##2##3##(2008-10#2)
Genetic analyses##6##2##(2008-10#4)(2008-8#1)(2012-2#1)
Genetic analysis and##3##3##(2008-10#1)(2008-9#2)
Genetic analysis in##2##3##(1993-12#1)(2008-9#1)
Genetic analysis indicated that##3##4##(2008-10#2)(2008-4#1)
Genetic analysis of the##4##4##(2008-1#1)(2008-10#2)(2008-7#1)
Genetic analysis of##12##3##(1995-6#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
Genetic analysis revealed##2##3##(2008-10#1)(2012-3#1)
Genetic analysis##27##2##(1990-11#1)(1993-12#1)(1995-6#1)(2008-1#1)(2008-10#11)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Genetic and Molecular##2##3##(2008-10#1)(2009-5#1)
Genetic and Morphological##2##3##(2008-10#2)
Genetic and Phenotypic##2##3##(2008-10#2)
Genetic and Virulence Diversity##2##4##(2008-10#2)
Genetic and environmental determinants##2##4##(2008-1#1)(2013-1#1)
Genetic and environmental factors##2##4##(1992-2#1)(2011-1#1)
Genetic and environmental##5##3##(1992-2#1)(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
Genetic and molecular studies have##2##5##(2007-12#1)(2011-2#1)
Genetic and molecular##5##3##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
Genetic and##26##2##(1992-2#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-6#1)(2008-8#2)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
Genetic basis of##2##3##(2008-4#1)(2013-8#1)
Genetic characteristics of##2##3##(2008-10#1)(2012-12#1)
Genetic characteristics##3##2##(2008-10#1)(2009-12#1)(2012-12#1)
Genetic characterization##2##2##(1992-5#1)(2008-10#1)
Genetic control of##2##3##(1997-7#1)(2008-10#1)
Genetic data##4##2##(1990-11#1)(2008-12#1)(2008-9#1)(2010-12#1)
Genetic determinants of##2##3##(2010-5#1)(2013-8#1)
Genetic differences##2##2##(1991-1#1)(2008-10#1)
Genetic differentiation##3##2##(2008-10#3)
Genetic dissection of##2##3##(1994-9#1)(2011-2#1)
Genetic distances among the##2##4##(2008-10#1)(2008-5#1)
Genetic distances were##3##3##(2008-10#2)(2008-8#1)
Genetic distances##6##2##(2008-10#3)(2008-5#1)(2008-8#2)
Genetic diversity among X##2##4##(2008-10#2)
Genetic diversity among##3##3##(2008-10#3)
Genetic diversity and##2##3##(2008-10#1)(2011-2#1)
Genetic diversity of##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
Genetic diversity was##5##3##(2008-10#4)(2011-2#1)
Genetic diversity##14##2##(2008-10#10)(2008-12#1)(2011-2#2)(2013-1#1)
Genetic engineering##2##2##(1990-5#1)(1997-2#1)
Genetic evidence##2##2##(1994-12#1)(2010-8#1)
Genetic factors are##2##3##(2007-10#1)(2008-11#1)
Genetic factors##4##2##(2007-10#1)(2008-11#1)(2013-1#2)
Genetic influences in##2##3##(1991-4#1)(2008-6#1)
Genetic influences on cellular reactions to##2##6##(1997-3#2)
Genetic influences on##4##3##(1994-2#1)(1997-3#2)(2008-8#1)
Genetic influences##6##2##(1991-4#1)(1994-2#1)(1997-3#2)(2008-6#1)(2008-8#1)
Genetic information and life insurance##2##5##(1994-12#1)(1996-2#1)
Genetic information##4##2##(1994-12#1)(1996-2#1)(1997-6#1)(2008-8#1)
Genetic instability##2##2##(1994-6#1)(2013-1#1)
Genetic linkage analysis##2##3##(2008-4#2)
Genetic linkage##6##2##(1997-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2013-8#1)
Genetic manipulation of##4##3##(1993-9#1)(2008-9#3)
Genetic mapping##2##2##(2008-8#1)(2008-9#1)
Genetic modification##2##2##(2008-10#1)(2009-10#1)
Genetic mutations in four groups of genes##2##7##(2013-1#2)
Genetic mutations##4##2##(1992-12#1)(2008-5#1)(2013-1#2)
Genetic polymorphism of##2##3##(2008-12#2)
Genetic polymorphisms##2##2##(2008-6#1)(2012-12#1)
Genetic predisposition##2##2##(1996-10#1)(2008-7#1)
Genetic relationships##3##2##(2008-10#1)(2008-5#1)(2012-1#1)
Genetic resistance in##2##3##(2008-10#1)(2011-2#1)
Genetic resistance##4##2##(2008-10#3)(2011-2#1)
Genetic structure of##2##3##(2008-10#1)(2013-8#1)
Genetic structure##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
Genetic studies have##3##3##(2008-2#1)(2011-2#1)(2012-2#1)
Genetic studies of this pathogen have been hampered##2##8##(2008-10#2)
Genetic studies of##3##3##(2007-10#1)(2008-10#2)
Genetic studies##10##2##(1997-7#1)(2007-10#2)(2008-10#2)(2008-2#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
Genetic susceptibility##2##2##(2008-7#1)(2013-1#1)
Genetic testing and##2##3##(2011-2#2)
Genetic testing##7##2##(2008-4#1)(2010-3#1)(2011-2#4)(2013-1#1)
Genetic toxicology studies were conducted in Salmonella typhimurium##3##8##(2008-8#1)(2008-9#2)
Genetic toxicology studies were conducted in mouse peripheral blood erythrocytes##3##10##(2008-9#3)
Genetic toxicology studies were conducted in##7##6##(2008-8#1)(2008-9#6)
Genetic toxicology##8##2##(2008-8#1)(2008-9#7)
Genetic tumours##2##2##(2008-7#2)
Genetic variability##2##2##(2008-10#1)(2010-9#1)
Genetic variation among##2##3##(2008-10#1)(2008-12#1)
Genetic variation and##2##3##(2008-10#1)(2012-2#1)
Genetic variation in##4##3##(1993-11#1)(2008-10#1)(2009-9#1)(2012-3#1)
Genetic variation of##2##3##(1997-8#1)(2011-2#1)
Genetic variation was##3##3##(2008-10#3)
Genetic variation##17##2##(1993-11#1)(1994-3#1)(1997-8#1)(2007-10#1)(2008-10#7)(2008-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
Genetic##403##1##(1990-11#3)(1990-12#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-1#1)(2007-10#6)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#178)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#18)(2008-9#19)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#5)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#20)(2013-1#14)(2013-8#5)
Genetically##16##1##(1995-2#1)(2008-1#4)(2008-10#5)(2008-2#1)(2008-4#1)(2010-10#1)(2010-11#1)(2012-3#2)
Genetics Initiative##5##2##(1997-5#5)
Genetics and##3##2##(1997-3#1)(2007-6#1)(2008-5#1)
Genetics of##17##2##(1996-8#1)(2007-10#3)(2008-1#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-3#1)
Genetics##42##1##(1994-12#1)(1994-9#1)(1996-8#1)(1997-3#2)(1997-5#5)(1997-6#1)(2007-10#3)(2007-6#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Geneva##11##1##(1990-11#2)(1990-2#2)(1991-6#1)(1996-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-5#2)
Genevestigator##3##1##(2009-10#3)
Genghis##5##1##(2008-10#5)
Gengoroubuna and Nagabuna populations##2##4##(2008-5#2)
Gengoroubuna##7##1##(2008-5#7)
Genistein and##2##2##(2008-11#1)(2010-3#1)
Genistein was##2##2##(2012-2#2)
Genistein##7##1##(2008-11#1)(2010-10#1)(2010-3#2)(2012-2#3)
Genital self mutilation##2##3##(2012-2#2)
Genital self-mutilation##2##2##(2009-10#2)
Genital##10##1##(1991-2#1)(2008-10#1)(2008-8#1)(2009-10#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
Genitourinary##2##1##(1991-11#1)(2008-10#1)
Genoa syndrome##4##2##(2011-1#4)
Genoa##5##1##(2011-1#4)(2013-8#1)
Genome Analysis Pipeline##3##3##(2008-4#3)
Genome Organization##2##2##(2008-10#2)
Genome Project##9##2##(1994-9#2)(1995-6#1)(1997-3#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-1#1)
Genome analysis of##2##3##(1997-2#1)(2009-5#1)
Genome analysis##3##2##(1997-2#1)(2008-10#1)(2009-5#1)
Genome mining and##2##3##(2011-1#1)(2011-2#1)
Genome to Life'##2##3##(2008-7#2)
Genome##62##1##(1991-5#1)(1994-5#1)(1994-9#4)(1995-6#1)(1995-9#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-3#1)(2007-7#1)(2008-10#11)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#10)(2008-9#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#5)
Genome-Wide##2##1##(2008-7#1)(2012-3#1)
Genome-wide analysis of the##2##4##(2008-7#2)
Genome-wide analysis of##3##3##(2008-7#2)(2010-7#1)
Genome-wide association analysis of##2##4##(2012-3#2)
Genome-wide association studies##4##3##(2010-12#1)(2012-3#3)
Genome-wide association##7##2##(2010-12#1)(2011-2#1)(2012-3#5)
Genome-wide##16##1##(2008-7#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#6)
Genomes##6##1##(2008-10#3)(2008-4#1)(2009-11#1)(2012-3#1)
Genomic DNA from##3##3##(1997-3#1)(2008-10#2)
Genomic DNA was extracted from the parents and 150##2##9##(2008-10#2)
Genomic DNA was extracted from##5##5##(2006-8#1)(2008-10#4)
Genomic DNA##11##2##(1997-3#1)(2006-8#1)(2008-10#7)(2008-5#1)(2010-5#1)
Genomic DNAs##2##2##(1996-6#1)(2008-10#1)
Genomic Sequence##2##2##(2008-10#2)
Genomic Southern##2##2##(1991-6#1)(1995-8#1)
Genomic Standards Consortium##4##3##(2011-2#4)
Genomic and##5##2##(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
Genomic clones##3##2##(1991-5#1)(1993-2#1)(1995-8#1)
Genomic organization of the##2##4##(1991-6#1)(1997-6#1)
Genomic organization of##3##3##(1991-6#1)(1997-6#1)(2012-2#1)
Genomic organization##4##2##(1991-6#1)(1993-6#1)(1997-6#1)(2012-2#1)
Genomic structure##3##2##(1993-12#1)(1993-6#1)(2010-3#1)
Genomic##104##1##(1990-11#1)(1991-5#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#2)(1995-12#1)(1995-8#2)(1996-10#1)(1996-6#3)(1997-3#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-3#2)(2010-5#1)(2011-10#1)(2011-2#45)(2012-2#1)(2013-1#1)
Genomics and##7##2##(2008-2#1)(2008-7#4)(2008-8#1)(2013-1#1)
Genomics##23##1##(1997-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#14)(2008-8#1)(2010-4#2)(2013-1#1)
Genomics'##4##1##(2008-7#4)
Genotoxic##3##1##(1992-5#1)(2007-5#1)(2013-1#1)
Genotype analysis of##2##3##(1990-4#1)(1994-12#1)
Genotype and##2##2##(2008-10#1)(2013-8#1)
Genotype distribution##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
Genotype imputation##2##2##(2012-3#2)
Genotype##21##1##(1990-4#1)(1994-12#1)(2008-10#12)(2008-12#1)(2009-3#1)(2011-1#1)(2012-3#3)(2013-8#1)
Genotype-specific##2##1##(2008-10#2)
Genotypes and##3##2##(2008-10#3)
Genotypes as##2##2##(2008-10#1)(2009-8#1)
Genotypes of##3##2##(2008-10#3)
Genotypes were##3##2##(2008-12#1)(2012-3#2)
Genotypes with##2##2##(1997-6#1)(2008-10#1)
Genotypes##25##1##(1997-6#1)(2008-10#18)(2008-12#1)(2009-8#1)(2012-3#3)(2012-5#1)
Genotypic and##4##2##(2008-10#3)(2012-2#1)
Genotypic diversity##3##2##(2008-10#3)
Genotypic variation##2##2##(2008-10#2)
Genotypic##15##1##(1997-5#1)(2008-10#12)(2008-4#1)(2012-2#1)
Genotyping of apolipoprotein E##2##4##(2008-4#2)
Genotyping of##7##2##(2008-10#2)(2008-4#3)(2012-2#1)(2013-1#1)
Genotyping was performed##3##3##(1997-5#1)(2011-2#2)
Genotyping was##4##2##(1997-5#1)(2008-9#1)(2011-2#2)
Genotyping##18##1##(1997-5#1)(2008-10#4)(2008-4#3)(2008-9#2)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#2)
Genova##5##1##(2008-4#5)
Genovesa##2##1##(2008-8#2)
Gentamicin##2##1##(2012-2#1)(2013-8#1)
Gentamicin-induced##2##1##(2009-12#2)
Gentian mosaic virus##2##3##(2008-10#2)
Genus##7##1##(2008-10#4)(2010-2#1)(2012-2#1)(2013-8#1)
Geobacillus##5##1##(2011-2#5)
Geobacter sulfurreducens and Desulfococcus multivorans##2##5##(2011-1#2)
Geobacter##4##1##(2008-10#2)(2011-1#2)
Geodermatophilus obscurus##2##2##(2011-2#2)
Geographic Information System (GIS)##2##4##(2007-5#1)(2011-2#1)
Geographic Information System##3##3##(2007-5#1)(2009-7#1)(2011-2#1)
Geographic Information Systems##3##3##(2008-10#1)(2010-2#1)(2010-5#1)
Geographic Information##6##2##(2007-5#1)(2008-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
Geographic distribution##3##2##(2008-10#2)(2012-12#1)
Geographic variation in##2##3##(2008-10#1)(2008-9#1)
Geographic##22##1##(1991-1#1)(1992-12#1)(1992-2#1)(2007-5#1)(2008-10#7)(2008-8#3)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
Geographical information systems##2##3##(2008-8#2)
Geographical##8##1##(1995-5#1)(2008-10#2)(2008-4#1)(2008-8#3)(2010-8#1)
Geological##4##1##(1990-11#1)(1991-8#1)(2008-10#1)(2008-3#1)
Geometric mean##2##2##(1992-8#1)(1993-8#1)
Geometric##8##1##(1992-8#1)(1993-8#1)(1994-3#1)(1996-4#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-2#1)
Geometrical optics##2##2##(2008-2#1)(2008-3#1)
Geometrical##4##1##(1993-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
Geometrical-transformation approach to optical two-dimensional beam shaping##2##7##(2008-2#2)
Geometry##2##1##(1996-9#1)(2008-11#1)
Geophys##3##1##(2008-3#3)
George Bush##2##2##(1996-1#1)(1996-2#1)
George Orwell's##2##2##(2008-11#2)
George Washington##2##2##(1992-12#1)(2012-2#1)
George##22##1##(1992-12#1)(1992-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-5#4)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
George's Hospital##2##2##(2008-5#1)(2008-7#1)
Georgia##35##1##(1990-11#1)(1991-1#1)(1991-11#1)(1993-12#1)(1995-12#2)(1996-1#4)(1996-12#6)(1996-9#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-6#1)(2009-4#1)(2010-12#1)
Georgia's##3##1##(1993-12#1)(1996-12#1)(1996-9#1)
Geospatial##4##1##(2008-8#2)(2010-5#1)(2011-2#1)
Geostationary Operational Environmental##2##3##(2008-2#2)
Geostationary Operational##3##2##(2008-2#3)
Geostatistical analyses##4##2##(2008-10#4)
Geostatistical##5##1##(2008-10#4)(2008-11#1)
Geostatistics##4##1##(2008-10#4)
Geotrichum##2##1##(2008-12#1)(2008-5#1)
Geranium##2##1##(2008-10#2)
Geranylgeranyl pyrophosphate##2##2##(2008-8#2)
Gerbich##3##1##(1992-6#3)
Gerbillus##2##1##(2008-8#2)
Gerbils##3##1##(2010-11#3)
Geriatric Depression Scale (GDS)##3##4##(2006-10#2)(2008-7#1)
Geriatric Depression Scale##6##3##(2006-10#2)(2007-10#2)(2008-7#2)
Geriatric##19##1##(1990-3#1)(1991-2#1)(1992-12#1)(1996-3#3)(2006-10#2)(2007-10#2)(2008-4#1)(2008-7#4)(2009-10#2)(2011-2#2)
Geriforte##4##1##(1994-6#4)
Geriforte-treated rat brain##2##3##(1994-6#2)
Germ Plasm##3##2##(2008-10#3)
Germ line p53 mutations##2##4##(1990-12#2)
Germ tubes##4##2##(2008-10#4)
Germ##16##1##(1990-12#2)(1994-12#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-2#1)
German and English##4##3##(2007-10#1)(2008-2#2)(2011-2#1)
German and##5##2##(2007-10#1)(2007-5#1)(2008-2#2)(2011-2#1)
German language##3##2##(2008-10#2)(2011-2#1)
German life##2##2##(2012-2#2)
German occupation##2##2##(1990-6#2)
German population##4##2##(1997-8#1)(2008-12#3)
German reunification##2##2##(1992-1#1)(1995-1#1)
German scientists##2##2##(2008-11#2)
German##84##1##(1990-11#1)(1990-6#2)(1991-11#1)(1992-1#2)(1992-10#1)(1992-6#1)(1994-6#1)(1995-1#2)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-5#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#6)(2008-7#2)(2008-8#2)(2009-7#4)(2010-4#1)(2011-2#9)(2012-1#5)(2012-12#6)(2012-2#7)(2013-1#2)(2013-8#2)
Germany and Italy##3##3##(2011-2#3)
Germany and Poland##2##3##(2013-1#2)
Germany and the##5##3##(1992-12#2)(1996-1#1)(2008-10#1)(2008-11#1)
Germany and##15##2##(1992-1#1)(1992-12#2)(1996-1#1)(2008-10#4)(2008-11#1)(2011-2#4)(2013-1#2)
Germany in the##2##3##(1997-8#1)(2008-11#1)
Germany in##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
Germany is##2##2##(1992-1#1)(1995-11#1)
Germany that##2##2##(2008-11#1)(2013-1#1)
Germany was##2##2##(2008-11#2)
Germany##122##1##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#2)(1992-1#7)(1992-12#3)(1994-11#1)(1994-12#2)(1994-3#2)(1995-1#4)(1995-11#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#3)(1997-8#2)(2007-2#1)(2008-10#19)(2008-11#19)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#5)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Germany) and a FIAlab((R)) 3000 system (USA) with a six-port selection valve and##2##13##(2008-10#2)
Germany) was##2##2##(2008-10#2)
Germany) were##2##2##(2008-10#1)(2008-11#1)
Germany)##17##1##(1991-11#1)(1995-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2011-2#1)
Germany]##4##1##(1991-5#1)(1995-11#1)(2008-2#1)(2010-12#1)
Germinal##3##1##(2009-4#2)(2011-2#1)
Germination and##5##2##(2008-10#4)(2011-2#1)
Germination in##2##2##(2008-10#2)
Germination of Puccinia##2##3##(2008-10#2)
Germination of Sclerotinia##2##3##(2008-10#2)
Germination of conidia##2##3##(2008-10#1)(2008-5#1)
Germination of sporangia##2##3##(2008-10#2)
Germination of##18##2##(2006-11#1)(2008-10#14)(2008-5#1)(2011-2#2)
Germination percentage##3##2##(2008-10#1)(2008-12#2)
Germination##38##1##(2006-11#1)(2008-10#27)(2008-12#4)(2008-5#2)(2011-2#3)(2013-7#1)
Germline##2##1##(1993-2#1)(2008-9#1)
Germán##2##1##(2012-12#1)(2013-1#1)
Gernika##2##1##(2009-5#2)
Gerry##2##1##(1991-2#1)(2008-9#1)
Gestalt concept and humanistic psychology##2##5##(2010-6#2)
Gestalt##5##1##(1993-1#1)(2008-9#1)(2010-6#3)
Gestational Diabetes##2##2##(2008-1#1)(2010-8#1)
Gestational cocaine exposure##3##3##(1991-5#3)
Gestational diabetes mellitus (GDM) is##3##5##(2008-1#2)(2009-3#1)
Gestational diabetes mellitus##7##3##(1993-2#3)(2008-1#3)(2009-3#1)
Gestational diabetes##8##2##(1993-2#3)(2008-1#3)(2009-3#2)
Gestational##16##1##(1991-5#3)(1993-2#3)(1994-5#1)(1995-6#1)(2008-1#4)(2009-3#2)(2010-8#1)(2013-1#1)
Gestrinone in cyclical breast pain##2##5##(1992-2#2)
Get the##2##2##(2010-9#1)(2013-7#1)
Get##8##1##(1995-3#1)(1996-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-8#1)(2010-9#1)(2013-7#1)
Getting a##3##2##(1995-6#1)(1996-2#1)(2008-4#1)
Getting the##4##2##(1994-1#1)(1994-3#1)(2012-2#1)(2013-1#1)
Getting##22##1##(1991-2#1)(1991-3#1)(1992-1#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-6#1)(1996-2#1)(1997-6#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Gg##2##1##(2012-2#2)
GhTub1##6##1##(2008-9#6)
Ghaem Hospital##2##2##(2007-7#1)(2011-2#1)
Ghana##15##1##(1997-4#4)(2008-12#2)(2009-12#2)(2010-10#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
Ghanaian##2##1##(2009-12#2)
Ghanima score##2##2##(2011-2#2)
Ghanima##3##1##(2011-2#3)
Ghedini##2##1##(1993-6#1)(2007-7#1)
Ghrelin and##2##2##(2011-2#2)
Ghrelin levels##3##2##(2011-1#2)(2013-8#1)
Ghrelin##10##1##(2008-3#2)(2011-1#3)(2011-2#3)(2013-8#2)
Gi##6##1##(1994-2#1)(1997-1#1)(1997-2#1)(2008-4#3)
Gi-dependent##2##1##(1994-11#1)(2008-4#1)
Gi2 alpha gene via##2##4##(1994-9#2)
Gi2 alpha##4##2##(1994-9#4)
Gi2##5##1##(1992-3#1)(1994-9#4)
Giannina##2##1##(2008-4#1)(2013-8#1)
Giant cavernous##2##2##(2008-10#1)(2009-1#1)
Giant cell glioblastoma##2##3##(2013-1#2)
Giant cell hepatitis##2##3##(2008-5#2)
Giant cell##5##2##(2008-5#2)(2009-3#1)(2013-1#2)
Giant coronary artery aneurysm##2##4##(2007-2#1)(2007-8#1)
Giant coronary##3##2##(2007-2#1)(2007-8#1)(2012-2#1)
Giant gastric##2##2##(2008-12#1)(2013-1#1)
Giant##41##1##(1990-4#1)(1993-1#1)(1997-8#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
Giardia and##2##2##(2008-8#1)(2010-12#1)
Giardia duodenalis##5##2##(1997-3#1)(2012-3#4)
Giardia intestinalis##4##2##(2009-10#2)(2011-1#2)
Giardia lamblia##2##2##(2007-12#1)(2008-8#1)
Giardia spp##8##2##(2012-12#8)
Giardia##21##1##(1997-3#1)(2007-12#1)(2008-8#2)(2009-10#2)(2010-12#1)(2011-1#2)(2012-12#8)(2012-3#4)
Gibberella zeae (anamorph##2##3##(2008-10#2)
Gibberella zeae##15##2##(2008-10#14)(2008-8#1)
Gibberella zeae)##2##2##(2008-10#1)(2008-8#1)
Gibberella##23##1##(1995-2#1)(2008-10#20)(2008-8#2)
Gibbs conference##3##2##(1997-2#3)
Gibbs energy##2##2##(1997-2#1)(2011-1#1)
Gibbs free energy##2##3##(1997-2#1)(2008-10#1)
Gibbs sampling##3##2##(1997-7#1)(1997-8#1)(2011-2#1)
Gibbs##18##1##(1994-9#1)(1997-2#5)(1997-7#2)(1997-8#1)(2008-10#2)(2008-4#3)(2008-5#1)(2011-1#1)(2011-2#2)
Gibbs-Donnan model##3##2##(2008-10#3)
Gibney as##2##2##(2008-8#2)
Gibney##9##1##(1992-9#1)(2008-8#8)
Giemsa staining##2##2##(2008-12#1)(2008-5#1)
Giemsa##10##1##(1991-11#1)(2008-12#3)(2008-5#4)(2008-9#1)(2013-1#1)
Giemsa's staining##2##2##(2008-8#2)
Gift shop##2##2##(1992-2#1)(1994-1#1)
Gift##5##1##(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1994-1#1)
Gil##2##1##(2009-7#2)
Gilbertiodendron##3##1##(2008-8#3)
Gilead##2##1##(2008-5#2)
Gill##4##1##(1990-8#2)(1995-2#1)(2008-7#1)
Ginbuna##2##1##(2008-5#2)
Gingival enlargement##2##2##(2010-4#1)(2012-12#1)
Gingival##8##1##(1991-2#1)(2010-4#1)(2012-12#1)(2012-3#3)(2013-1#2)
Gingrich##2##1##(1993-12#1)(1995-12#1)
Ginkgo biloba extracts##2##3##(1990-3#1)(2008-10#1)
Ginkgo biloba##9##2##(1990-3#1)(1990-6#3)(2008-10#1)(2008-11#3)(2008-8#1)
Ginseng##4##1##(2008-10#2)(2008-11#2)
Giovanni##2##1##(2010-1#2)
Girard##2##1##(2008-5#1)(2013-1#1)
Girardinichthys multiradiatus##2##2##(2008-5#2)
Gires-Tournois##2##1##(2007-12#2)
Girls also##2##2##(2009-7#1)(2012-2#1)
Girls with##2##2##(1994-12#1)(2008-11#1)
Girls##11##1##(1990-2#1)(1994-12#2)(2008-11#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
Girls'##2##1##(2010-7#1)(2013-1#1)
Gitelman's syndrome##4##2##(1996-6#2)(1997-8#2)
Gitelman's##5##1##(1996-6#2)(1997-8#2)(2007-7#1)
Giuseppe##3##1##(1991-6#1)(2010-1#2)
Given a##7##2##(2008-2#2)(2008-3#2)(2010-2#1)(2011-2#1)(2012-1#1)
Given its##4##2##(1992-8#1)(1994-3#1)(2009-11#1)(2010-3#1)
Given such##2##2##(2008-8#1)(2009-6#1)
Given that the##4##3##(1997-7#1)(2008-11#1)(2009-6#1)(2009-8#1)
Given that##25##2##(1992-12#1)(1993-12#1)(1997-7#1)(2007-8#1)(2008-11#3)(2008-12#4)(2008-3#1)(2008-7#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
Given the complexity of##2##4##(2009-12#1)(2011-2#1)
Given the differences##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
Given the high##3##3##(2008-7#1)(2010-11#1)(2010-6#1)
Given the highly##2##3##(1995-3#1)(2008-1#1)
Given the importance##2##3##(2010-3#1)(2012-3#1)
Given the increasing##2##3##(2008-10#1)(2012-2#1)
Given the large number of##2##5##(2008-10#1)(2008-11#1)
Given the low##2##3##(1996-11#1)(2012-12#1)
Given the potential##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
Given the prevalence of##2##4##(2009-9#1)(2012-2#1)
Given the rapidly##2##3##(2013-1#2)
Given the small##2##3##(2008-11#1)(2008-6#1)
Given the substantial##2##3##(2007-11#1)(2008-8#1)
Given the##93##2##(1990-3#1)(1990-9#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#4)
Given their##3##2##(1995-2#1)(2007-12#1)(2010-10#1)
Given these findings##2##3##(2008-7#1)(2009-10#1)
Given these##6##2##(1990-2#1)(1991-3#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#1)
Given this##5##2##(1991-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)
Given##159##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#11)(2013-8#4)
Giving bed baths(3##2##3##(1991-2#2)
Giving##9##1##(1991-2#4)(1993-1#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-4#1)
Gl-As-14(S)##2##1##(1990-6#2)
Gla residues 6##2##3##(1995-2#2)
Gla residues##6##2##(1995-2#6)
Gla##18##1##(1991-12#9)(1995-2#7)(1995-6#1)(2009-11#1)
Gla1##2##1##(2008-5#2)
Glad you asked##2##3##(1995-12#1)(1996-2#1)
Gland##6##1##(2013-1#3)(2013-8#3)
Glands##3##1##(2008-10#1)(2008-4#1)(2008-6#1)
Glanville fritillary butterfly##2##3##(2008-8#2)
Glanzmann's thrombasthenia##3##2##(1997-7#1)(2006-6#2)
Glare##2##1##(2008-2#1)(2008-3#1)
Glasgow Coma Scale (GCS)##2##4##(2011-2#1)(2013-8#1)
Glasgow Coma Scale##6##3##(2007-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Glasgow Outcome Scale##2##3##(1997-3#1)(2012-3#1)
Glasgow coma scale##2##3##(1991-11#1)(2008-11#1)
Glasgow coma##3##2##(1991-11#1)(2008-11#1)(2008-7#1)
Glasgow##18##1##(1991-11#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Glass##19##1##(1990-4#1)(1996-5#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-7#2)(2012-2#1)
Glasses##4##1##(1995-3#2)(2008-3#2)
Glasshouse##2##1##(2008-10#2)
Glaucoma##6##1##(1991-9#1)(1996-6#1)(2008-8#1)(2010-8#1)(2011-1#2)
Glaxo Wellcome##2##2##(2008-10#1)(2008-5#1)
Glaxo and##2##2##(1990-3#1)(2008-10#1)
Glaxo##8##1##(1990-3#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-5#2)
GlaxoSmithKline##2##1##(2008-8#1)(2013-1#1)
GlcA(beta##2##1##(1990-7#2)
GlcNAc of##2##2##(1992-10#1)(2008-11#1)
GlcNAc residue##2##2##(1994-5#2)
GlcNAc##8##1##(1992-10#2)(1992-11#1)(1994-5#3)(2008-11#1)(2008-4#1)
Gleason score##4##2##(2010-11#1)(2011-2#2)(2013-1#1)
Gleason##8##1##(2007-10#1)(2008-10#1)(2010-11#3)(2011-2#2)(2013-1#1)
Glenn##4##1##(2008-10#4)
Glia##3##1##(2008-5#1)(2008-7#1)(2009-11#1)
Glial cells##2##2##(2008-7#2)
Glial##11##1##(1992-8#1)(2008-7#7)(2009-11#1)(2011-2#1)(2013-1#1)
Glibenclamide uptake was##2##3##(1992-3#2)
Glibenclamide uptake##3##2##(1992-3#3)
Glibenclamide##6##1##(1992-3#3)(1994-8#1)(2012-2#1)(2012-3#1)
Gliclazide##4##1##(1994-8#1)(2008-10#1)(2011-1#2)
Glide##3##1##(2012-2#3)
GlimmerM##3##1##(2008-9#3)
Glioblastoma multiforme##2##2##(2011-3#1)(2013-1#1)
Glioblastoma##9##1##(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
Gliocladium roseum on##2##3##(2008-10#1)(2008-5#1)
Gliocladium roseum##4##2##(2008-10#3)(2008-5#1)
Gliocladium##8##1##(2008-10#6)(2008-5#2)
Glioma##6##1##(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#3)
Gliomas##3##1##(2008-7#1)(2011-2#1)(2013-1#1)
Gliosis##2##1##(2008-7#2)
Glisoxepide uptake##2##2##(1992-3#2)
Glisoxepide##3##1##(1992-3#3)
Gln##15##1##(1991-3#1)(1992-3#1)(1992-6#1)(1992-9#2)(1994-5#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#5)
Gln-218 and Gln-292##2##3##(2008-8#2)
Gln-292##4##1##(2008-8#4)
Gln-tRNA(Gln)##2##1##(1994-8#2)
Gln281--&gt##3##1##(1997-7#3)
GlnRS##6##1##(1994-8#6)
Global Assessment##4##2##(2008-11#1)(2011-1#1)(2012-1#2)
Global Budgets##2##2##(1994-12#1)(2010-8#1)
Global Imager##2##2##(2008-2#2)
Global Impact##2##2##(2011-2#1)(2013-1#1)
Global Initiative for Asthma (GINA)##2##5##(2010-5#2)
Global Initiative for Asthma##3##4##(2009-6#1)(2010-5#2)
Global Orthopaedic Registry (GLORY)##6##4##(2011-2#6)
Global Ozone Monitoring Experiment##2##4##(2008-2#1)(2008-3#1)
Global Ozone Monitoring by Occultation of Stars##3##7##(2008-3#3)
Global Ozone Monitoring##5##3##(2008-2#1)(2008-3#4)
Global Partnership##2##2##(2008-7#1)(2012-12#1)
Global Rating of Change (GROC)##2##5##(2008-12#2)
Global Strategy for##2##3##(2010-5#2)
Global climate change##2##3##(2008-9#1)(2012-6#1)
Global warming and##2##3##(1996-8#1)(2012-5#1)
Global warming##4##2##(1996-8#1)(2007-12#1)(2009-8#1)(2012-5#1)
Global##98##1##(1991-2#1)(1991-6#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#1)(2012-5#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
Globalization##3##1##(2008-7#1)(2011-1#1)(2012-12#1)
Globally##3##1##(2008-10#2)(2012-12#1)
Globin transcripts with##2##3##(2008-11#2)
Globodera pallida##2##2##(2008-10#2)
Globodera##3##1##(2008-10#3)
Glomerella cingulata##5##2##(2008-10#5)
Glomerella##9##1##(2008-10#8)(2013-1#1)
Glomeromycota##3##1##(2013-1#3)
Glomerulonephritis in##2##2##(2008-1#2)
Glomerulonephritis##5##1##(2008-1#4)(2008-7#1)
Glomus intraradices##2##2##(2008-10#1)(2008-12#1)
Glomus##6##1##(2008-10#1)(2008-12#3)(2010-10#1)(2012-12#1)
Glossina morsitans morsitans##2##3##(1997-4#1)(2010-4#1)
Glossina##5##1##(1997-4#1)(2010-1#3)(2010-4#1)
Glove integrity testing##2##3##(2012-2#2)
Glove##3##1##(1995-3#1)(2012-2#2)
Gloves##2##1##(2012-2#2)
Glu 177##3##2##(1992-3#3)
Glu and##5##2##(1991-5#1)(1992-3#1)(1997-8#1)(2008-10#2)
Glu residue##2##2##(1992-11#2)
Glu residues in the##2##4##(1992-12#1)(1993-12#1)
Glu##29##1##(1990-5#2)(1990-7#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#7)(1992-6#3)(1992-8#1)(1993-12#1)(1994-6#1)(1994-8#2)(1995-5#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-8#1)
Glu-##2##1##(1991-11#1)(1991-5#1)
Glu-1 and Glu-2##2##3##(2008-10#2)
Glu-1 was##2##2##(2008-10#2)
Glu-1##5##1##(2008-10#5)
Glu-2##4##1##(1995-3#1)(2008-10#3)
Glu-239----Glu##2##1##(1990-8#2)
Glu-50##2##1##(1995-6#2)
Glu-50--&gt##8##1##(1995-6#8)
Glu-86-Gln##3##1##(1990-8#3)
Glu-98##8##1##(1995-6#8)
Glu-C##2##1##(1990-7#2)
Glu-plasminogen##3##1##(1997-2#3)
Glu1-plasminogen conformation##2##2##(1995-6#2)
Glu1-plasminogen##3##1##(1995-6#3)
GluR-B##5##1##(1993-12#5)
GluR1 in##2##2##(2008-7#2)
GluR1##6##1##(1990-8#1)(1995-2#1)(2008-7#4)
GluR2/3##2##1##(1995-5#1)(1997-2#1)
GluR4-positive##2##1##(1996-5#2)
GluR5 and GluR6##3##3##(1993-9#3)
GluR5-1d##2##1##(1993-9#2)
GluR6-2##2##1##(1993-9#2)
GluRS and GlnRS##2##3##(1994-8#2)
GluRs##2##1##(1995-5#1)(2012-12#1)
GluT-1 and GLT-1 mRNAs##2##4##(1996-2#2)
Glucagon (via the second messenger cAMP) and glucocorticoids stimulate##2##9##(1995-6#1)(1996-2#1)
Glucagon and##2##2##(1994-6#1)(2011-2#1)
Glucagon##17##1##(1991-3#1)(1994-6#1)(1994-8#1)(1995-6#2)(1995-8#2)(1996-2#3)(2010-11#2)(2011-1#3)(2011-2#1)(2012-3#1)
Glucagon-37##2##1##(1997-6#2)
Glucan##2##1##(2008-5#2)
Glucocorticoids##3##1##(1992-12#1)(1994-9#1)(2012-3#1)
Glucolevel##6##1##(2008-10#6)
Glucometer##2##1##(1993-9#1)(2007-12#1)
Gluconacetobacter diazotrophicus PAl 5##2##4##(2011-2#2)
Gluconacetobacter sp##4##2##(2008-6#4)
Gluconacetobacter##6##1##(2008-6#4)(2011-2#2)
Glucose Oxidase##2##2##(2008-10#2)
Glucose and##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
Glucose biosensors based on##2##4##(2008-10#2)
Glucose is##2##2##(2008-6#1)(2008-7#1)
Glucose oxidase (GOD)##2##3##(2008-10#2)
Glucose oxidase was##2##3##(2008-10#2)
Glucose oxidase##6##2##(2008-10#5)(2012-2#1)
Glucose transporter##2##2##(1993-6#1)(1994-2#1)
Glucose variability##2##2##(2012-4#2)
Glucose was##2##2##(2008-10#1)(2008-11#1)
Glucose##49##1##(1990-7#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#2)
Glucose-6-phosphatase##3##1##(1994-11#2)(2008-7#1)
Glucose-6-phosphate dehydrogenase##2##2##(1991-2#1)(1993-3#1)
Glucose-6-phosphate##3##1##(1991-2#1)(1993-3#1)(2008-10#1)
Glucose-dependent##2##1##(1995-11#1)(2010-11#1)
Glucose-stimulated insulin secretion##2##3##(1990-12#1)(1995-8#1)
Glucosinolate##2##1##(2008-10#2)
Glue##2##1##(1997-3#1)(1997-6#1)
Glutamate levels##2##2##(1990-11#1)(1995-12#1)
Glutamate##17##1##(1990-11#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#4)(2009-3#1)(2012-3#1)
Glutamatergic##2##1##(2008-7#1)(2009-8#1)
Glutamic acid##2##2##(1996-12#1)(2008-11#1)
Glutamic##3##1##(1996-12#1)(2008-11#1)(2008-8#1)
Glutamine and glucose##2##3##(2008-11#2)
Glutamine##6##1##(1993-9#1)(2008-11#5)
Glutathione is##4##2##(2008-11#1)(2008-5#2)(2012-2#1)
Glutathione peroxidase (GPX)##2##3##(2008-10#1)(2013-8#1)
Glutathione peroxidase##3##2##(1994-9#1)(2008-10#1)(2013-8#1)
Glutathione transferases##2##2##(2008-11#2)
Glutathione##14##1##(1992-6#1)(1994-9#1)(2008-10#2)(2008-11#3)(2008-5#4)(2009-8#1)(2012-2#1)(2013-8#1)
Gluten sensitivity and neurological dysfunction##2##5##(1996-3#2)
Glx/Cre##2##1##(2008-7#2)
Gly and beta-Ala##3##3##(1995-5#3)
Gly and##4##2##(1995-5#3)(2008-11#1)
Gly to Arg##2##3##(1992-8#2)
Gly to##4##2##(1992-2#1)(1992-8#2)(2008-10#1)
Gly##33##1##(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#2)(1992-8#7)(1993-11#2)(1993-2#1)(1994-12#1)(1994-5#1)(1995-5#3)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#5)(2008-8#1)(2012-2#1)
Gly)##3##1##(2008-10#3)
Gly- Leu- Met- NH2 (ranatachykinin##3##5##(1991-5#3)
Gly- Leu- Met- NH2##4##4##(1991-5#4)
Gly-1##2##1##(1992-6#2)
Gly-Met-Gly##2##1##(2008-10#2)
Gly-Xaa-Yaa##2##1##(1993-12#1)(1993-3#1)
Gly5-ol]enkephalin (DAMGO)##2##2##(1995-12#1)(1996-2#1)
GlyT-1 inhibitors##2##2##(2011-1#2)
GlyT-1##3##1##(2011-1#3)
Glycation##2##1##(1992-12#1)(2012-3#1)
Glycemic variability##2##2##(2009-11#2)
Glycemic##7##1##(2008-1#2)(2008-10#1)(2009-11#2)(2010-12#1)(2012-2#1)
Glycerol gradient analysis of##2##4##(1990-11#2)
Glycerol##3##1##(1990-11#2)(2008-11#1)
Glycine max##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
Glycine##8##1##(1990-7#1)(1991-5#2)(2008-10#2)(2011-1#1)(2011-2#2)
Glycine-EDTA treatment to prepare Ko##2##5##(1994-6#2)
Glycinergic##2##1##(1992-11#1)(1995-2#1)
Glycogen synthesis##2##2##(1995-8#2)
Glycogen##5##1##(1995-5#1)(1995-8#2)(2008-10#1)(2008-7#1)
Glycopeptides##3##1##(1990-5#1)(1992-6#1)(1993-6#1)
Glycoprotein##7##1##(1992-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
Glycoproteins##2##1##(2008-10#2)
Glycoproteomics##2##1##(2010-12#2)
Glycosides##2##1##(2008-12#1)(2009-8#1)
Glycosphingolipids##2##1##(1990-7#1)(1993-9#1)
Glycosylated##3##1##(1994-11#1)(2008-11#1)(2008-8#1)
Glycosylation is##2##2##(1991-9#1)(2010-12#1)
Glycosylation of the##3##3##(1990-11#1)(1994-11#1)(1997-4#1)
Glycosylation of##4##2##(1990-11#1)(1994-11#1)(1997-4#1)(2008-1#1)
Glycosylation##7##1##(1990-11#1)(1991-9#1)(1994-11#1)(1997-4#1)(2008-1#1)(2008-11#1)(2010-12#1)
Glycyrrhetinic acid##2##2##(2012-3#2)
Glycyrrhiza##3##1##(2008-11#2)(2008-5#1)
Glycyrrhizae radix et rhizoma and its extracts##3##7##(2011-1#3)
Glycyrrhizae radix et rhizoma##6##4##(2011-1#6)
Glycyrrhizae radix##7##2##(2011-1#6)(2011-2#1)
Glycyrrhizae##8##1##(2011-1#6)(2011-2#2)
Glyphosate##4##1##(2008-10#2)(2010-1#2)
Glyptosternoids##2##1##(2008-9#2)
Glyptothorax-like##2##1##(2008-9#2)
Gm##2##1##(1992-6#2)
GmbH##5##1##(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
GmsPLA₂-XIA-1##3##1##(2013-1#3)
Gn-RH##2##1##(1990-2#1)(1994-9#1)
GnRH II##2##2##(1992-8#2)
GnRH agonist in##2##3##(2008-5#2)
GnRH agonist##7##2##(1996-2#2)(2008-5#5)
GnRH antagonist##3##2##(1994-8#1)(2008-5#1)(2012-3#1)
GnRH gene##2##2##(1995-11#2)
GnRH receptor##2##2##(1993-3#2)
GnRH receptors##2##2##(1993-3#1)(1994-8#1)
GnRH##45##1##(1992-6#1)(1992-8#5)(1993-11#2)(1993-3#5)(1994-8#5)(1994-9#2)(1995-11#6)(1996-2#6)(1997-2#3)(2008-5#7)(2008-6#1)(2009-6#1)(2012-3#1)
GnRH)##4##1##(1992-6#1)(1996-2#1)(2008-7#1)(2008-8#1)
GnRH-a is##2##2##(1996-2#2)
GnRH-a##5##1##(1996-2#5)
GnRH-induced##2##1##(1993-11#1)(1996-2#1)
Gna-1##3##1##(2008-8#3)
Gna4##3##1##(1990-5#3)
Gnotobiotic##2##1##(2008-10#1)(2008-12#1)
Go Local##4##2##(2010-5#4)
Go alpha##2##2##(1994-2#1)(1995-2#1)
Go for##2##2##(1994-12#1)(1995-2#1)
Go##17##1##(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-5#1)(2010-11#1)(2010-5#4)(2012-3#1)
Goal of this study was##2##5##(2007-8#1)(2010-7#1)
Goal of##4##2##(2007-8#2)(2010-12#1)(2010-7#1)
Goal##10##1##(2007-8#2)(2008-7#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
Goals and methods of audit should be reappraised##2##8##(1996-11#2)
Goals and##3##2##(1993-8#1)(1996-11#2)
Goals of##2##2##(2011-2#1)(2013-1#1)
Goals##15##1##(1991-2#2)(1993-8#1)(1996-11#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Goat Mb##2##2##(2010-4#2)
Goat##3##1##(2008-10#1)(2010-4#2)
Gobiodon##3##1##(2010-8#3)
Goblet cell carcinoid##2##3##(2013-1#2)
God is##2##2##(2008-4#1)(2013-1#1)
God##17##1##(1991-2#1)(2008-12#2)(2008-4#4)(2009-10#1)(2010-12#1)(2013-1#8)
God's##3##1##(2008-12#2)(2009-11#1)
Going##3##1##(2011-2#1)(2013-1#1)(2013-7#1)
Goiás##5##1##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#2)
Goiânia##2##1##(2008-10#1)(2008-9#1)
Gold Nanorods##2##2##(2008-11#1)(2010-1#1)
Gold colloids##2##2##(2008-10#1)(2008-3#1)
Gold electrodes##2##2##(2008-10#2)
Gold nanoparticles##2##2##(2008-10#1)(2010-5#1)
Gold##33##1##(1991-12#1)(1991-2#1)(1991-8#1)(1996-2#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2010-1#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#1)
Gold(I)-catalyzed##2##1##(2010-2#1)(2013-7#1)
Golden Delicious##3##2##(2008-10#3)
Golden##9##1##(1992-10#1)(2008-10#5)(2009-6#1)(2011-2#1)(2012-2#1)
Goldfinger##3##1##(2008-10#3)
Goldfish exposed to##2##3##(2008-6#2)
Goldfish##4##1##(2008-6#4)
Goldman##3##1##(2007-8#2)(2008-8#1)
Goldmann##3##1##(2008-7#2)(2013-1#1)
Goldner##2##1##(2011-2#2)
Goldstein and##2##2##(2013-1#2)
Goldstein##5##1##(1992-2#1)(2008-10#1)(2013-1#3)
Goldstein's##2##1##(2007-8#1)(2008-2#1)
Golgi and plasma##2##3##(1996-5#1)(2009-10#1)
Golgi and##5##2##(1993-6#1)(1996-5#2)(2008-11#1)(2009-10#1)
Golgi apparatus and##2##3##(1992-12#1)(2009-10#1)
Golgi apparatus in##2##3##(2008-11#1)(2008-8#1)
Golgi apparatus is##3##3##(2008-8#1)(2009-2#1)(2012-2#1)
Golgi apparatus##22##2##(1990-5#2)(1990-7#4)(1992-12#1)(1993-12#1)(1995-5#1)(1997-7#2)(2008-11#3)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2011-1#1)(2012-2#1)
Golgi cells##5##2##(1995-2#4)(2012-2#1)
Golgi complex##4##2##(2008-7#3)(2009-8#1)
Golgi complexes##2##2##(2008-7#2)
Golgi membranes##3##2##(1992-12#1)(1994-11#1)(2009-10#1)
Golgi method##2##2##(1995-8#2)
Golgi network##2##2##(1992-12#1)(1995-2#1)
Golgi stacks##2##2##(2008-7#2)
Golgi##82##1##(1990-5#2)(1990-7#4)(1992-12#5)(1993-12#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#9)(1995-5#1)(1995-8#3)(1996-5#2)(1997-1#1)(1997-7#2)(2008-11#9)(2008-5#1)(2008-7#7)(2008-8#5)(2009-10#4)(2009-2#9)(2009-8#3)(2010-1#1)(2010-12#1)(2011-1#1)(2012-2#5)
Golgi-derived##2##1##(1995-2#1)(1997-3#1)
Golgi-specific##2##1##(1995-2#2)
Gombe##2##1##(2009-10#2)
Gomez##3##1##(1995-12#3)
Gomori##3##1##(1990-3#2)(2012-3#1)
Gomori's##2##1##(2008-7#2)
Gompertz law##2##2##(2008-1#2)
Gompertz model##10##2##(2008-10#7)(2008-9#1)(2013-8#2)
Gompertz relative rate of disease progress##2##6##(2008-10#2)
Gompertz##20##1##(1993-12#1)(2008-1#3)(2008-10#11)(2008-9#1)(2010-8#2)(2013-8#2)
Gompertzian##6##1##(1991-6#4)(1993-12#1)(2013-8#1)
Gomti##2##1##(2008-7#2)
Gonadal##3##1##(2008-1#1)(2008-10#1)(2008-5#1)
Gonadotrophin-releasing hormone##2##2##(2007-7#1)(2008-6#1)
Goniopsis cruentata##3##2##(2013-7#3)
Gonyleptidae)##2##1##(2007-12#2)
Good Manufacturing##2##2##(2012-2#1)(2013-1#1)
Good Practices of Livestock##4##4##(2012-12#4)
Good Scientific Practice##3##3##(2007-5#3)
Good agreement between the certified##2##5##(2008-10#2)
Good agreement between the##5##4##(2007-12#2)(2008-10#2)(2008-3#1)
Good agreement between##10##3##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)
Good agreement is found##2##4##(2008-10#1)(2008-3#1)
Good agreement is obtained##2##4##(2008-10#1)(2008-3#1)
Good agreement is##4##3##(2008-10#2)(2008-3#2)
Good agreement was also found##2##5##(2008-10#1)(2008-3#1)
Good agreement was found between the##3##6##(2008-10#2)(2008-3#1)
Good agreement was found between##4##5##(2008-10#3)(2008-3#1)
Good agreement was found##5##4##(2007-11#1)(2008-10#3)(2008-3#1)
Good agreement was obtained##2##4##(2008-10#1)(2008-2#1)
Good agreement was##10##3##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#2)
Good agreement with certified values##2##5##(2008-10#2)
Good agreement with##7##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
Good agreement##32##2##(2007-11#1)(2007-12#3)(2008-10#15)(2008-2#5)(2008-3#8)
Good communication between##2##3##(1992-4#1)(2008-11#1)
Good correlation between##2##3##(2008-10#2)
Good correlation was##2##3##(2008-1#1)(2008-10#1)
Good correlation##4##2##(2008-1#1)(2008-10#3)
Good linear##2##2##(2008-10#2)
Good linearity##4##2##(1990-8#1)(1994-9#1)(2008-10#2)
Good quality##4##2##(1993-1#1)(1993-6#1)(2007-12#1)(2008-5#1)
Good recoveries were obtained##2##4##(2008-10#2)
Good recoveries were##3##3##(2008-10#3)
Good recoveries##7##2##(2008-10#7)
Good results were obtained for##3##5##(2008-10#3)
Good results were obtained##4##4##(2008-10#4)
Good results##7##2##(1995-5#1)(2008-10#5)(2008-6#1)
Good separation##2##2##(2008-10#2)
Good stability and##2##3##(2007-11#1)(2008-10#1)
Good##137##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-4#1)(1993-1#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-5#3)(2008-1#1)(2008-10#55)(2008-11#1)(2008-2#9)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)
Good's##2##1##(2012-2#1)(2013-1#1)
Goodman##3##1##(2008-10#2)(2009-12#1)
Google Earth##2##2##(2010-2#2)
Google##7##1##(2008-7#1)(2010-2#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Goos-Hänchen shift##3##2##(2007-11#3)
Goos-Hänchen##5##1##(2007-11#5)
Gopher##2##1##(1996-2#1)(1996-3#1)
Gordon James Mogenson (1931-1991)##2##4##(1993-6#2)
Gordon##7##1##(1990-11#1)(1993-6#3)(2008-1#1)(2008-2#2)
Gordon-Haus timing jitter is##2##4##(2007-11#1)(2007-12#1)
Gore-tex##2##1##(1993-3#1)(2007-7#1)
Gorski Kotar and Islands (chi2 = 4##2##7##(2011-2#2)
Gorski Kotar##6##2##(2011-2#6)
Gorski kotar##2##2##(2011-2#2)
Gorski##8##1##(2011-2#8)
Gorsuch##2##1##(1995-12#1)(2010-6#1)
Gossypium hirsutum L##4##3##(2011-2#4)
Gossypium##6##1##(2008-10#1)(2008-9#1)(2011-2#4)
Got##2##1##(1995-2#1)(2008-4#1)
Gothenburg##2##1##(1991-2#1)(2008-7#1)
Gould##2##1##(1990-5#1)(1995-6#1)
Gouy phase shift##3##3##(2007-11#3)
Gouy phase##4##2##(2007-11#4)
Gouy shift##2##2##(2007-12#2)
Gouy##6##1##(2007-11#4)(2007-12#2)
Governance for##2##2##(1991-1#1)(1996-3#1)
Governance in##2##2##(1996-1#1)(2013-7#1)
Governance##8##1##(1991-1#1)(1994-2#1)(1996-1#1)(1996-3#2)(2009-5#1)(2012-3#1)(2013-7#1)
Governing##4##1##(1991-1#1)(2008-10#2)(2010-9#1)
Government and##2##2##(1992-3#1)(2009-4#1)
Government has##3##2##(1992-11#1)(1992-5#1)(2008-7#1)
Government of##5##2##(1995-3#2)(1996-4#1)(2008-11#1)(2012-1#1)
Government##41##1##(1991-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-7#1)(1995-3#3)(1996-1#2)(1996-11#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
Government's##4##1##(1994-2#1)(1994-3#1)(1996-1#1)(2008-6#1)
Governmental##8##1##(1993-11#1)(1994-12#1)(1996-3#4)(2008-10#1)(2008-11#1)
Governments##7##1##(1994-1#1)(1994-2#1)(1995-3#1)(2008-11#1)(2009-7#1)(2011-1#1)(2013-1#1)
Governor##5##1##(1995-1#1)(1996-5#2)(1997-5#2)
Governorate of##2##2##(1994-3#1)(2010-4#1)
Governorate##8##1##(1994-3#2)(1994-9#2)(2008-10#2)(2008-12#1)(2010-4#1)
Governors'##2##1##(2007-3#1)(2008-4#1)
Govt##2##1##(2007-7#1)(2013-1#1)
Gp90##2##1##(2008-9#2)
GpIIb-IIIa on platelets##2##3##(2006-6#2)
GpIIb-IIIa##3##1##(2006-6#3)
GpIIb/IIIa complex##3##2##(1993-8#2)(2008-4#1)
GpgP##3##1##(2012-2#3)
Gpi##2##1##(2008-10#2)
Gpp(NH)p##4##1##(1990-8#1)(1992-11#1)(2008-3#2)
Gpp(NH)p-sensitive high affinity binding##3##4##(2008-3#3)
Gpp(NH)p-sensitive high affinity##4##3##(2008-3#4)
Gq alpha subunit##2##3##(1995-2#2)
Gq alpha##5##2##(1995-2#5)
Gq##6##1##(1995-2#5)(2008-7#1)
Gq-coupled receptor##4##2##(2008-4#1)(2008-8#3)
Gq-coupled##5##1##(2008-4#1)(2008-8#4)
Gr##3##1##(2008-10#3)
Graber##2##1##(2008-2#2)
Grace and##2##2##(1990-8#1)(2008-9#1)
Grace##4##1##(1990-8#1)(1995-2#1)(2008-9#1)(2010-10#1)
Grace's medium with##3##3##(2008-11#3)
Grace's medium##6##2##(2008-11#6)
Grace's##8##1##(2008-11#8)
Gracilariopsis##2##1##(2007-5#2)
Grade 3##2##2##(1996-3#1)(2008-9#1)
Grade 4##2##2##(1990-6#1)(2008-9#1)
Grade 5##2##2##(1996-3#1)(2008-9#1)
Grade I##4##2##(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
Grade II##2##2##(2008-12#1)(2008-7#1)
Grade III##3##2##(1991-2#1)(2008-6#1)(2008-7#1)
Grade IV##2##2##(2008-12#1)(2008-7#1)
Grade##27##1##(1990-6#1)(1991-2#1)(1992-12#1)(1994-12#1)(1996-3#2)(2007-10#1)(2007-8#2)(2008-12#2)(2008-6#1)(2008-7#5)(2008-9#5)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Graded##2##1##(1995-12#1)(2012-2#1)
Grades##2##1##(2010-5#1)(2012-12#1)
Gradient elution##2##2##(2008-10#2)
Gradient##6##1##(2008-10#4)(2008-3#1)(2013-1#1)
Gradient-index##2##1##(2008-3#2)
Gradients##3##1##(1993-8#1)(2008-10#1)(2010-3#1)
Grading##2##1##(1996-3#1)(2008-2#1)
Gradual##4##1##(1996-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
Graduate Medical Education##2##3##(2007-4#1)(2010-12#1)
Graduate programs in health administration##2##5##(1996-1#2)
Graduate programs in health##3##4##(1996-1#2)(1996-2#1)
Graduate##13##1##(1993-1#1)(1993-12#2)(1996-1#3)(1996-2#1)(2007-11#1)(2007-4#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)
Graduates of##2##2##(2007-11#1)(2009-11#1)
Graduates##5##1##(1994-12#1)(2007-11#1)(2009-11#1)(2012-3#2)
Graf##4##1##(2007-11#4)
Graft and##2##2##(2007-9#1)(2013-1#1)
Graft##15##1##(1991-11#1)(2007-10#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-5#1)(2012-1#1)(2013-1#1)
Grafting##2##1##(2008-10#1)(2012-1#1)
Grafts##2##1##(2008-1#1)(2008-7#1)
Graham##5##1##(1995-12#1)(1995-2#1)(1997-3#1)(2007-2#1)(2008-9#1)
GrailEXP and Genome Analysis Pipeline for genome annotation##2##8##(2008-4#2)
GrailEXP##5##1##(2008-4#5)
Grain##8##1##(2008-10#4)(2008-11#1)(2008-12#2)(2010-1#1)
Gram +##2##2##(1991-9#2)
Gram negative bacteria##5##3##(1994-11#1)(1995-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
Gram negative##9##2##(1990-6#1)(1994-11#1)(1995-11#1)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
Gram positive and Gram negative##3##5##(1994-11#1)(2010-10#1)(2012-3#1)
Gram positive bacteria##4##3##(2007-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
Gram positive##11##2##(1990-6#1)(1994-11#1)(2007-7#2)(2007-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#2)
Gram stain##4##2##(2007-7#2)(2008-9#2)
Gram staining and##2##3##(2010-6#2)
Gram staining##6##2##(2007-7#1)(2008-9#1)(2010-12#1)(2010-6#3)
Gram##33##1##(1990-6#2)(1991-9#2)(1994-11#2)(1995-11#1)(2007-7#5)(2007-8#1)(2008-9#4)(2010-10#2)(2010-12#2)(2010-5#2)(2010-6#3)(2012-2#2)(2012-3#4)(2013-1#1)
Gram+##3##1##(1991-3#1)(1994-12#1)(2011-2#1)
Gram-##4##1##(1990-11#1)(1993-12#1)(1993-9#1)(2011-2#1)
Gram-Charlier matched filter for Shack-Hartmann sensing##2##6##(2007-12#2)
Gram-Positive##2##1##(2008-10#1)(2009-6#1)
Gram-negative bacilli and##2##3##(2007-12#1)(2008-7#1)
Gram-negative bacilli isolated from patients##2##5##(2012-2#2)
Gram-negative bacilli##6##2##(2007-12#1)(2008-7#1)(2010-4#1)(2012-2#3)
Gram-negative bacteria##11##2##(1991-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
Gram-negative bacterial pathogens##2##3##(2008-9#1)(2011-2#1)
Gram-negative bacterial##5##2##(1995-2#1)(1997-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
Gram-negative organisms##6##2##(1994-2#1)(1996-11#1)(1996-12#1)(2007-7#3)
Gram-negative rod##2##2##(2011-2#2)
Gram-negative rods##3##2##(2007-12#1)(2011-2#2)
Gram-negative##49##1##(1991-3#2)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-8#1)(2007-12#3)(2007-7#3)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#11)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
Gram-positive and -negative##2##3##(2008-5#1)(2009-6#1)
Gram-positive and Gram-negative bacteria##2##4##(2008-5#1)(2008-9#1)
Gram-positive and##6##2##(1991-3#1)(2008-5#2)(2008-9#1)(2009-6#1)(2012-3#1)
Gram-positive bacteria##6##2##(2007-12#1)(2008-5#1)(2008-6#2)(2011-1#1)(2012-2#1)
Gram-positive bacterium that##2##3##(2008-7#1)(2011-2#1)
Gram-positive bacterium##4##2##(2008-7#1)(2009-5#1)(2011-2#2)
Gram-positive organisms##3##2##(2007-12#1)(2008-6#1)(2008-9#1)
Gram-positive##30##1##(1991-3#1)(2006-10#1)(2007-12#4)(2008-5#4)(2008-6#3)(2008-7#1)(2008-9#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)
Gramene##5##1##(2008-7#5)
Gramicidin S##2##2##(2011-2#2)
Gramineae##2##1##(1995-8#1)(2008-10#1)
Grammar##3##1##(2011-3#2)(2012-12#1)
Gran I method##3##3##(2008-10#3)
Gran##5##1##(2008-10#5)
Gran's##2##1##(2008-10#2)
Granada##6##1##(2008-2#1)(2008-5#4)(2009-10#1)
Grande Riviere Beach##3##3##(2007-5#3)
Grande##14##1##(1993-6#3)(2007-5#3)(2008-10#5)(2008-5#1)(2009-7#1)(2013-7#1)
Grandin##2##1##(2008-10#2)
Granger causality##2##2##(2008-11#1)(2012-2#1)
Grannelose Zweizeilige##3##2##(2008-10#3)
Grano##2##1##(2008-10#2)
Grant##4##1##(1996-3#1)(2007-12#1)(2008-5#1)(2008-7#1)
Granting##2##1##(1992-1#1)(1997-2#1)
Granular##2##1##(1994-6#1)(2008-7#1)
Granule-Associated Serine Peptidases of Immune Defense##2##6##(2008-6#2)
Granulocyte##6##1##(1990-2#1)(1991-2#1)(1991-9#1)(2007-10#1)(2008-7#1)(2012-2#1)
Granulomatosis##2##1##(2008-1#1)(2012-12#1)
Granulomatous angiitis##2##2##(2008-7#2)
Granulomatous##6##1##(2008-7#3)(2011-1#3)
Grape Berries##4##2##(2008-10#4)
Grape Flowers##2##2##(2008-10#2)
Grape##15##1##(2008-10#14)(2013-1#1)
Grapefruit juice##4##2##(2007-7#1)(2008-10#2)(2008-8#1)
Grapefruit##8##1##(2007-7#1)(2008-10#5)(2008-8#1)(2011-2#1)
Grapes##3##1##(2008-10#3)
Grapevine Downy Mildew##2##3##(2008-10#2)
Grapevine berry inner necrosis virus (GINV)##2##6##(2008-10#2)
Grapevine berry inner necrosis virus##4##5##(2008-10#4)
Grapevine fanleaf virus (GFLV)##2##4##(2008-10#2)
Grapevine fanleaf virus##6##3##(2008-10#6)
Grapevine leafroll-associated virus-1##2##3##(2008-10#2)
Grapevine leafroll-associated##5##2##(2008-10#5)
Grapevine virus A##2##3##(2008-10#2)
Grapevine virus##3##2##(2008-10#3)
Grapevine##31##1##(2008-10#31)
Graphic evidence##4##2##(2008-6#4)
Graphical##4##1##(2010-8#1)(2011-2#1)(2012-2#2)
Graphite##5##1##(2008-10#5)
Graphs##4##1##(1994-12#1)(1996-12#1)(1997-6#1)(2007-11#1)
Grass##3##1##(2008-5#1)(2008-8#1)(2012-2#1)
Grassi##7##1##(2010-1#7)
Grassi's##2##1##(2010-1#2)
Grateful Med##2##2##(1995-3#2)
Grateful##3##1##(1995-3#3)
Grating##11##1##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#3)(2013-8#1)
Gratings with##4##2##(2008-3#4)
Gratings##7##1##(2008-3#7)
Grave's disease##2##2##(2007-8#2)
Grave's##3##1##(2007-8#3)
Graves' disease and##4##3##(1993-9#1)(2008-4#1)(2012-3#1)(2013-8#1)
Graves' disease##16##2##(1990-6#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#2)(1996-12#1)(2008-4#2)(2011-1#1)(2012-3#3)(2013-8#1)
Graves' eye disease##4##3##(2008-7#4)
Graves' patient thyroid##2##3##(1990-7#2)
Graves' thyroid##3##2##(1990-7#1)(1995-12#2)
Graves'##29##1##(1990-6#1)(1990-7#4)(1991-12#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#2)(1995-12#3)(1996-12#1)(2008-4#2)(2008-7#5)(2011-1#1)(2012-3#3)(2013-1#1)(2013-8#2)
Gravimetric determination of##2##3##(1993-2#1)(2008-10#1)
Gravitational Wave##4##2##(1996-9#1)(2007-11#1)(2008-3#2)
Gravitational##9##1##(1994-2#1)(1996-9#3)(2007-11#1)(2008-10#1)(2008-3#3)
Gravity##4##1##(1990-11#1)(1995-12#1)(2007-11#1)(2008-10#1)
Gray et al##2##3##(2010-4#1)(2013-8#1)
Gray leaf spot is a serious disease##2##7##(2008-10#2)
Gray leaf spot##7##3##(2008-10#7)
Gray matter heterotopias##2##3##(1995-5#2)
Gray##22##1##(1990-4#1)(1992-1#1)(1995-5#2)(1996-3#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
Gray's##3##1##(2008-8#1)(2009-9#1)(2010-1#1)
Graz##2##1##(2007-10#2)
Grazing-incidence##2##1##(2008-2#1)(2008-3#1)
Grb2 and Sos##2##3##(1995-8#2)
Grb2 and##3##2##(1995-8#2)(1997-6#1)
Grb2##5##1##(1995-8#2)(1997-6#2)(2008-6#1)
Greasy##4##1##(2008-10#4)
Great Britain and##3##3##(2009-4#1)(2012-2#1)(2013-8#1)
Great Britain##11##2##(1991-2#1)(1992-11#1)(1995-1#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-5#2)(2009-4#1)(2012-2#1)(2013-8#1)
Great Lakes##5##2##(2008-10#1)(2008-11#4)
Great Ormond Street##2##3##(2012-2#2)
Great Plains of the United States##2##6##(2008-10#2)
Great Plains of##3##3##(2008-10#3)
Great Plains##15##2##(2008-10#13)(2008-2#1)(2008-3#1)
Great War##2##2##(2008-4#1)(2011-2#1)
Great##53##1##(1991-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-3#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-4#1)(2009-7#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
Greater Athens##3##2##(1993-9#3)
Greater Manchester##2##2##(2008-11#1)(2013-1#1)
Greater Victoria Hospital Society##2##4##(1994-1#1)(1996-3#1)
Greater than##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
Greater understanding of the##2##4##(2008-4#1)(2008-7#1)
Greater##42##1##(1991-12#1)(1991-2#1)(1991-5#1)(1993-9#3)(1994-1#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
Greatest##3##1##(1995-5#1)(2008-10#1)(2008-11#1)
Greece and##4##2##(1991-4#1)(1993-9#1)(2008-11#1)(2008-8#1)
Greece during##3##2##(2008-2#1)(2013-1#2)
Greece to##2##2##(2010-8#1)(2013-8#1)
Greece with##2##2##(2008-10#1)(2009-10#1)
Greece##28##1##(1991-4#1)(1993-9#2)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
Greece)##2##1##(2008-10#1)(2009-9#1)
Greek Island##2##2##(2008-10#1)(2011-2#1)
Greek traditional dances and##2##4##(2010-6#2)
Greek traditional dances##4##3##(2010-6#4)
Greek##18##1##(2008-10#2)(2008-11#1)(2009-1#1)(2009-2#1)(2009-7#2)(2010-2#1)(2010-4#3)(2010-6#4)(2011-2#3)
Greeks##2##1##(2010-9#1)(2011-2#1)
Green Fluorescent Protein##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
Green Fluorescent Protein-Tagged##2##3##(2008-10#2)
Green Fluorescent##7##2##(2008-10#5)(2008-11#1)(2009-6#1)
Green Mold##4##2##(2008-10#4)
Green S and Indigo##2##4##(1993-8#2)
Green S##4##2##(1993-8#4)
Green and##4##2##(2008-10#2)(2008-9#1)(2009-12#1)
Green by##2##2##(2008-10#1)(2008-3#1)
Green fluorescence##3##2##(2008-10#2)(2008-9#1)
Green fluorescent protein##2##3##(1996-6#1)(2008-9#1)
Green fluorescent##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
Green manures##2##2##(2008-10#2)
Green##68##1##(1993-8#4)(1996-6#1)(1997-5#1)(1997-6#1)(2008-10#27)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#8)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-8#1)
Green's function is##2##3##(2007-12#1)(2008-3#1)
Green's function##9##2##(2007-12#1)(2008-3#6)(2009-7#1)(2011-1#1)
Green's##14##1##(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#9)(2009-7#1)(2011-1#1)
Green-Beam Generation by##2##3##(2008-2#1)(2008-3#1)
Greenhouse and##2##2##(2008-10#2)
Greenhouse inoculations##2##2##(2008-10#2)
Greenhouse##11##1##(1992-3#1)(2008-10#9)(2008-2#1)
Greenhouse-grown##2##1##(2008-10#2)
Greenland##4##1##(2008-3#3)(2011-4#1)
Greenwald##2##1##(1994-12#2)
Gregoire##2##1##(2007-5#1)(2008-1#1)
Gregory##3##1##(1994-9#1)(1997-5#1)(2008-10#1)
Gremmeniella abietina##5##2##(2008-10#5)
Grenada##2##1##(2009-9#2)
Grey College##2##2##(2008-11#2)
Grey##5##1##(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)
Grief##3##1##(1990-10#2)(2010-2#1)
Griess reaction##2##2##(2008-10#1)(2008-5#1)
Griess##4##1##(2008-10#3)(2008-5#1)
Grieving##2##1##(2007-2#1)(2008-12#1)
Griffith##2##1##(2008-11#1)(2011-2#1)
Griffiths' method##2##2##(1990-2#2)
Griffonia simplicifolia##2##2##(1990-7#1)(1997-2#1)
Grignard##2##1##(1996-5#2)
Grimelius stain##2##2##(1992-2#2)
Grinding##2##1##(2008-3#1)(2009-4#1)
Grip##4##1##(2007-12#1)(2008-9#2)(2013-8#1)
Griswold##2##1##(1991-8#1)(1996-9#1)
GroE##11##1##(1992-3#11)
GroEL##4##1##(1994-5#2)(1996-12#1)(1997-2#1)
GroEL14 oligomer##2##2##(1994-5#2)
GroEL14##6##1##(1994-5#6)
GroEL7 heptameric##2##2##(1994-5#2)
GroEL7##3##1##(1994-5#3)
GroPIns4P as##2##2##(2013-8#2)
GroPIns4P##3##1##(2013-8#3)
Grodsky##2##1##(2008-10#2)
Grojean et al##2##3##(2008-2#2)
Groningen##3##1##(1996-6#1)(2008-1#1)(2008-10#1)
Groove##4##1##(1993-8#1)(2007-12#1)(2008-2#1)(2008-7#1)
Gross and microscopic##2##3##(2008-5#2)
Gross cystic breast disease is##2##5##(2008-12#1)(2008-4#1)
Gross lesions##4##2##(1997-3#1)(1997-6#1)(2008-5#2)
Gross##16##1##(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
Grossly##4##1##(1992-2#1)(1992-8#1)(1997-3#1)(1997-6#1)
Ground##6##1##(1991-2#1)(1996-9#1)(1997-2#1)(2010-12#1)(2012-2#2)
Ground-Based##2##1##(2008-3#2)
Ground-based differential absorption lidar for water-vapor and temperature profiling##2##9##(2008-2#2)
Ground-based differential absorption lidar for water-vapor##3##6##(2008-2#3)
Ground-based##6##1##(2008-2#3)(2008-3#1)(2013-8#2)
Grounded Theory##2##2##(2008-1#1)(2013-1#1)
Grounded theory##2##2##(2013-1#2)
Grounded##5##1##(2008-1#1)(2013-1#3)(2013-8#1)
Groundnut ringspot##2##2##(2008-10#2)
Groundnut##5##1##(2008-10#5)
Groundwater##2##1##(2008-10#1)(2013-1#1)
Group 1 was##2##3##(2011-1#2)
Group 1##29##2##(1990-5#2)(1991-3#1)(1992-9#1)(1995-12#1)(1996-12#1)(2007-6#2)(2008-10#3)(2008-12#1)(2008-3#6)(2010-3#2)(2011-1#4)(2011-2#4)(2012-2#1)
Group 2##18##2##(1990-5#1)(1991-3#1)(1992-9#1)(1995-12#1)(2007-6#2)(2008-10#2)(2008-3#3)(2008-7#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-2#1)
Group 3##9##2##(1990-5#1)(1992-9#1)(2008-10#3)(2011-2#3)(2012-2#1)
Group 4##5##2##(1992-9#1)(1997-7#1)(2008-10#3)
Group A and B strains##2##5##(2008-10#2)
Group A was##3##3##(2007-7#1)(2010-7#1)(2011-2#1)
Group A##21##2##(1991-12#1)(1992-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-2#2)(2012-2#2)
Group B patients##3##3##(2007-8#1)(2010-7#2)
Group B was##2##3##(2007-7#1)(2010-7#1)
Group B##11##2##(2007-7#1)(2007-8#2)(2008-10#2)(2010-4#1)(2010-7#3)(2011-2#1)(2012-2#1)
Group C##5##2##(2007-7#1)(2008-11#1)(2010-4#1)(2010-7#1)(2011-2#1)
Group Cohesiveness Scale (GCS)##2##4##(2013-1#2)
Group I (P &lt##2##4##(2013-1#2)
Group I -##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
Group I and Group##2##4##(1993-2#1)(1995-12#1)
Group I and##3##3##(1993-2#1)(1995-12#1)(2008-10#1)
Group I is##2##3##(1992-11#1)(2008-10#1)
Group I was##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2010-7#1)
Group I##37##2##(1992-11#3)(1993-2#2)(1995-12#2)(2007-11#1)(2007-8#9)(2008-10#9)(2008-11#1)(2008-8#1)(2009-3#1)(2010-7#5)(2013-1#3)
Group II -##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
Group II##30##2##(1992-11#2)(1993-2#1)(1995-12#2)(1996-12#1)(2007-11#1)(2007-8#8)(2008-10#9)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#3)
Group III##6##2##(2007-8#3)(2008-10#1)(2012-2#1)(2013-1#1)
Group N##2##2##(2010-7#1)(2013-1#1)
Group P##5##2##(2010-7#5)
Group and the##3##3##(1996-12#1)(2008-7#1)(2011-2#1)
Group and##4##2##(1996-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
Group at##2##2##(2008-7#1)(2010-11#1)
Group for the Study of##2##5##(1992-2#1)(1995-11#1)
Group for##7##2##(1991-12#1)(1992-2#1)(1993-11#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-1#1)
Group from##2##2##(2011-2#2)
Group in##8##2##(1990-3#1)(1991-4#1)(1991-8#1)(1994-1#1)(2008-11#2)(2011-2#1)(2012-3#1)
Group of the##4##3##(1991-8#1)(2008-10#1)(2008-2#1)(2010-5#1)
Group of##13##2##(1991-8#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-5#2)(2008-10#2)(2008-2#1)(2009-11#1)(2010-5#1)(2012-2#1)
Group on the##5##3##(1993-5#1)(1996-6#1)(2009-5#3)
Group on##16##2##(1991-11#1)(1993-5#1)(1994-12#3)(1996-6#1)(2007-9#1)(2008-12#1)(2008-6#2)(2009-5#3)(2011-2#1)(2013-1#2)
Group sequential##3##2##(1994-9#1)(1995-2#1)(1997-3#1)
Group therapy##2##2##(2008-11#1)(2013-1#1)
Group to##2##2##(1994-1#1)(2010-5#1)
Group two##2##2##(2008-7#1)(2013-8#1)
Group was##3##2##(2008-10#1)(2009-12#1)(2010-2#1)
Group work##2##2##(1995-6#2)
Group##400##1##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#6)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#5)(1992-12#1)(1992-2#4)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#2)(1993-2#8)(1993-3#1)(1993-5#1)(1993-9#3)(1994-1#2)(1994-12#5)(1994-3#5)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#7)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#4)(1997-7#5)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#24)(2007-9#1)(2008-1#1)(2008-10#50)(2008-11#11)(2008-12#7)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#8)(2008-8#5)(2008-9#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-5#5)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#10)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#22)(2010-8#2)(2011-1#6)(2011-2#26)(2012-2#10)(2012-3#1)(2013-1#19)(2013-8#3)
Group's##2##1##(2008-11#1)(2010-5#1)
Group)##5##1##(2008-3#2)(2009-11#2)(2011-2#1)
Group-I##3##1##(2007-8#2)(2008-10#1)
Group-II##2##1##(2007-8#1)(2008-10#1)
Group]##4##1##(1994-3#1)(1996-6#1)(1997-8#1)(2011-2#1)
Groupe##2##1##(1996-11#1)(1997-5#1)
Grouping##4##1##(1994-6#2)(2008-10#2)
Groups 2##2##2##(1990-5#1)(2011-1#1)
Groups A and##2##3##(2007-8#1)(2013-1#1)
Groups B and C##2##4##(2010-12#2)
Groups P and G##2##4##(2010-7#2)
Groups in the##2##3##(2008-10#1)(2012-3#1)
Groups in##5##2##(2008-10#4)(2012-3#1)
Groups of 10 female Tg##2##5##(2008-9#2)
Groups of 10 male and 10 female B6C3F(1) mice were administered 0##2##12##(2008-9#2)
Groups of 10 male and 10 female F344/N rats were administered 0##2##12##(2008-9#2)
Groups of 10 male and 10 female Tg##2##8##(2008-9#2)
Groups of 10 male and 10 female p53 haploinsufficient mice were##2##11##(2008-9#2)
Groups of 10 male and 10 female##10##7##(2008-9#10)
Groups of 10##14##3##(1992-5#1)(1997-3#1)(2008-9#12)
Groups of 15 female##2##4##(2008-9#2)
Groups of 15 male and 15 female Tg##11##8##(2008-8#1)(2008-9#10)
Groups of 15 male and 15 female p53 haploinsufficient mice were exposed to drinking water containing 0##3##17##(2008-9#3)
Groups of 15 male and 15 female p53 haploinsufficient mice were fed diets containing##2##14##(2008-8#1)(2008-9#1)
Groups of 15 male and 15 female p53 haploinsufficient mice were##6##11##(2008-8#1)(2008-9#5)
Groups of 15 male and 15 female##18##7##(2008-8#3)(2008-9#15)
Groups of 15##20##3##(2008-8#3)(2008-9#17)
Groups of Expecting##2##3##(1993-6#2)
Groups of eight##2##3##(1995-5#1)(1997-3#1)
Groups of five male and five female B6C3F(1) mice were administered 0##2##12##(2008-9#2)
Groups of five male and five female F344/N rats were administered 0##2##12##(2008-9#2)
Groups of five male and five female##6##7##(2008-9#6)
Groups of rats received##2##4##(1993-3#1)(2008-6#1)
Groups of rats##3##3##(1993-3#1)(2008-5#1)(2008-6#1)
Groups of##60##2##(1992-5#1)(1993-3#1)(1993-6#3)(1994-7#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#36)(2009-10#1)(2009-12#1)
Groups with the highest prevalence of##3##6##(2013-8#3)
Groups##114##1##(1990-5#1)(1991-1#1)(1991-12#1)(1992-5#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#5)(1994-12#3)(1994-3#2)(1994-7#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#37)(2009-10#2)(2009-12#1)(2009-3#1)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
Growing and analyzing##2##3##(2008-9#2)
Growing bacteria##2##2##(2008-9#2)
Growing evidence suggests that##2##4##(2009-10#1)(2012-12#1)
Growing evidence##4##2##(2009-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
Growing interest in##2##3##(1996-2#1)(2008-9#1)
Growing interest##3##2##(1996-2#1)(2008-9#1)(2010-8#1)
Growing##25##1##(1996-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Grown in##4##2##(2008-10#3)(2008-11#1)
Grown##7##1##(2008-10#6)(2008-11#1)
Growth Factor##11##2##(1990-12#1)(1992-7#1)(2008-11#2)(2009-12#1)(2011-1#1)(2012-3#2)(2013-1#3)
Growth Hormone##5##2##(1990-12#1)(2008-1#1)(2008-4#1)(2013-1#2)
Growth Rate##6##2##(2008-10#1)(2008-12#4)(2013-8#1)
Growth and Biocontrol##2##3##(2008-10#2)
Growth and##20##2##(1993-6#1)(1994-12#1)(1995-3#1)(1996-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#3)
Growth curve##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
Growth dynamics##2##2##(2007-11#1)(2010-11#1)
Growth factor##2##2##(1994-5#1)(2008-12#1)
Growth factors such as##2##4##(1995-11#1)(2008-7#1)
Growth factors##7##2##(1993-11#1)(1995-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
Growth hormone (GH)##4##3##(1991-9#1)(1993-3#1)(1996-11#1)(2011-2#1)
Growth hormone and##2##3##(2010-5#2)
Growth hormone deficiency##2##3##(2012-3#2)
Growth hormone##12##2##(1991-9#1)(1993-3#1)(1995-12#1)(1996-11#1)(2010-5#3)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
Growth in medium consisting of##2##5##(2008-11#2)
Growth in the##2##3##(2008-10#1)(2011-2#1)
Growth in##6##2##(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)
Growth indices##2##2##(2008-12#1)(2012-12#1)
Growth inhibition of##5##3##(1992-6#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-11#1)
Growth inhibition##6##2##(1992-6#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-9#1)
Growth media##2##2##(2008-10#1)(2013-1#1)
Growth of the##7##3##(1993-9#1)(2008-10#5)(2008-7#1)
Growth of##22##2##(1990-7#1)(1991-4#1)(1993-9#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-7#2)(2011-1#2)
Growth parameters##2##2##(2008-12#1)(2008-6#1)
Growth rates##4##2##(2007-12#1)(2008-11#3)
Growth trajectories##2##2##(2010-8#2)
Growth under##2##2##(2008-11#1)(2012-2#1)
Growth##173##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#18)(2008-12#8)(2008-2#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#2)
Growth-regulatory##2##1##(1993-9#1)(1994-8#1)
Grubbs##3##1##(2007-11#2)(2008-10#1)
Gruber##2##1##(2008-7#1)(2012-3#1)
Gruca##4##1##(2007-8#4)
Grundy and Schmitt##2##3##(2008-3#2)
Grunwald-Winstein##3##1##(2011-1#3)
Grx5 and##3##2##(2008-7#3)
Grx5##5##1##(2008-7#5)
Gryllus assimilis##2##2##(2008-9#2)
Gryllus bimaculatus##6##2##(2008-5#4)(2008-6#2)
Gryllus##10##1##(2008-5#4)(2008-6#2)(2008-9#4)
Grynfeltt's##3##1##(1993-9#3)
Gs alpha##8##2##(1992-3#1)(1994-2#4)(1994-9#1)(1995-6#1)(1996-5#1)
Gs##11##1##(1992-3#3)(1994-2#4)(1994-9#1)(1995-6#1)(1996-5#1)(1997-7#1)
Gu##4##1##(1992-6#2)(2008-9#2)
Guadeloupe##9##1##(2008-10#9)
Guadiana##2##1##(2008-10#1)(2008-12#1)
Guajira##5##1##(2008-12#1)(2008-5#4)
Guam and##4##2##(2008-10#3)(2013-8#1)
Guam##13##1##(2008-1#5)(2008-10#5)(2008-7#1)(2013-8#2)
Guangdong##2##1##(2007-7#1)(2013-8#1)
Guangzhou##9##1##(2011-1#4)(2011-2#1)(2013-8#4)
Guangzhou09##2##1##(2013-8#2)
Guanidine hydrochloride##2##2##(1992-6#1)(1993-3#1)
Guanidine##3##1##(1992-6#1)(1993-3#1)(1995-5#1)
Guanine##4##1##(1991-9#1)(1995-5#1)(1996-2#2)
Guanosine 5'-triphosphate (GTP)##2##3##(1995-5#1)(2008-3#1)
Guanosine##5##1##(1992-6#1)(1995-5#1)(2008-3#1)(2008-4#2)
Guaraní-Kaiwá##2##1##(1991-12#2)
Guard##3##1##(1994-2#1)(1996-2#1)(2012-3#1)
Guardado##2##1##(1995-12#2)
Guatemala as##2##2##(2008-10#1)(2008-8#1)
Guatemala##15##1##(1992-5#1)(2008-10#4)(2008-8#3)(2010-1#1)(2011-1#3)(2013-1#1)(2013-7#2)
Guelph##9##1##(1992-2#1)(2008-10#1)(2013-8#7)
Guest editorial##2##2##(2008-3#2)
Guest##4##1##(1992-1#1)(2008-3#2)(2013-8#1)
Guglielmi detachable coils##3##3##(1995-11#1)(2006-12#1)(2008-7#1)
Guglielmi detachable##5##2##(1995-11#1)(1997-6#1)(2006-12#1)(2008-7#2)
Guglielmi##6##1##(1995-11#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-7#2)
Guha##2##1##(1994-8#2)
Guidance for Industry##2##3##(2008-10#1)(2010-11#1)
Guidance for##6##2##(1995-2#1)(2008-10#1)(2010-11#1)(2010-2#1)(2013-1#2)
Guidance on##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
Guidance##14##1##(1991-12#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-11#2)(2010-2#1)(2010-5#1)(2013-1#2)
Guide for##5##2##(2008-10#1)(2008-4#1)(2009-8#1)(2012-3#1)(2013-1#1)
Guide to##5##2##(2007-2#2)(2008-10#1)(2008-2#1)(2012-2#1)
Guide##21##1##(1995-2#1)(2007-2#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
Guidebook##2##1##(1994-1#1)(2008-3#1)
Guided by theory and empirical research on these topics##2##9##(2013-1#2)
Guided by##7##2##(2009-5#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
Guided tissue regeneration##2##3##(2009-5#1)(2012-3#1)
Guided##12##1##(2007-12#1)(2008-1#1)(2009-5#2)(2009-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
Guided-wave##2##1##(2007-12#1)(2008-3#1)
Guideline##8##1##(2008-5#1)(2008-6#1)(2010-11#1)(2011-1#2)(2012-12#3)
Guidelines and##3##2##(1996-12#1)(2007-4#1)(2012-2#1)
Guidelines are also##2##3##(2007-9#1)(2008-4#1)
Guidelines are provided##2##3##(2007-9#1)(2012-2#1)
Guidelines are##4##2##(2007-9#2)(2008-4#1)(2012-2#1)
Guidelines for detection##2##3##(2008-11#2)
Guidelines for the##8##3##(1996-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
Guidelines for treatment of##2##4##(1995-11#1)(2012-12#1)
Guidelines for##31##2##(1990-9#1)(1992-1#1)(1995-11#1)(1996-2#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
Guidelines from the##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
Guidelines of##2##2##(1991-5#1)(2011-2#1)
Guidelines on the##3##3##(2008-12#1)(2008-3#1)(2013-1#1)
Guidelines on##6##2##(1993-2#1)(1996-6#2)(2008-12#1)(2008-3#1)(2013-1#1)
Guidelines##66##1##(1990-9#1)(1991-5#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#1)
Guides##2##1##(2008-10#1)(2008-2#1)
Guiding##4##1##(1991-3#1)(2008-11#1)(2008-3#1)(2008-8#1)
Guignardia citricarpa##2##2##(2008-10#2)
Guignardia##4##1##(2008-10#4)
Guilan##3##1##(2008-12#3)
Guillain-Barre syndrome##2##2##(2010-11#2)
Guillain-Barre##3##1##(2007-8#1)(2010-11#2)
Guillain-Barré syndrome (GBS)##2##3##(2008-6#1)(2008-7#1)
Guillain-Barré syndrome and##2##3##(1990-2#1)(2012-3#1)
Guillain-Barré syndrome##11##2##(1990-2#1)(1991-11#1)(1991-3#1)(1996-11#2)(2008-6#2)(2008-7#1)(2012-2#1)(2012-3#2)
Guillaume##2##1##(2008-10#1)(2009-7#1)
Guinea pig meat##2##3##(2013-1#2)
Guinea pig##6##2##(1991-2#1)(1993-11#1)(2008-12#1)(2013-1#3)
Guinea pigs##2##2##(2008-12#1)(2011-1#1)
Guinea##19##1##(1991-12#1)(1991-2#1)(1993-11#1)(1994-9#1)(2008-1#2)(2008-12#4)(2008-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
Guinea-Bissau##5##1##(1990-8#1)(1996-6#1)(1997-6#1)(2011-1#2)
Guinea-pigs were##2##2##(1995-11#1)(2008-5#1)
Guizhi-Fuling-Wan##2##1##(2013-1#2)
Gujarat##7##1##(2008-10#6)(2013-8#1)
Gujarati Indian adolescents##3##3##(2012-2#3)
Gujarati Indian##4##2##(2012-2#4)
Gulf War exposure##2##3##(2011-2#2)
Gulf War oil spill##2##4##(1997-4#2)
Gulf War##8##2##(1992-12#1)(1997-4#2)(2008-5#1)(2011-2#4)
Gulf of California##6##3##(2008-5#4)(2009-2#2)
Gulf of Cariaco##2##3##(2011-2#2)
Gulf of Mexico##6##3##(2008-3#1)(2008-5#4)(2013-7#1)
Gulf of Mexico]##3##3##(2008-5#3)
Gulf of Paria##4##3##(2007-5#4)
Gulf of##31##2##(2007-5#4)(2008-11#2)(2008-3#1)(2008-5#13)(2009-2#2)(2011-2#4)(2013-1#1)(2013-7#4)
Gulf##51##1##(1992-12#1)(1997-4#3)(2007-5#4)(2008-10#1)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#15)(2009-2#2)(2010-11#1)(2011-2#9)(2012-2#2)(2013-1#1)(2013-7#4)
Gum##2##1##(1991-12#1)(2012-2#1)
Gumseb##5##1##(2008-8#5)
Gun##2##1##(1993-2#1)(2008-4#1)
Guo##3##1##(1990-11#1)(1994-8#1)(2012-2#1)
Gupta##2##1##(2008-10#1)(2012-3#1)
Gurleya sp##2##2##(2011-2#2)
Gurung community##4##2##(2008-7#4)
Gurung##5##1##(2008-7#5)
Gus Mayer's##2##2##(1996-5#2)
Gus mRNA##3##2##(1993-8#3)
Gus##11##1##(1993-8#7)(1996-5#3)(2008-9#1)
Gustatory##2##1##(1993-12#1)(1996-5#1)
Gut in##3##2##(2008-8#3)
Gut##8##1##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#5)
Gutenberg-Richter##4##1##(1996-4#4)
Guthrie cards##2##2##(1991-8#2)
Guthrie##3##1##(1991-8#2)(2008-9#1)
Guttmacher Institute##3##2##(2013-1#3)
Guyana##3##1##(1992-5#1)(2009-7#1)(2012-1#1)
Guérette##3##1##(2008-2#3)
Gwent##4##1##(2008-10#4)
Gy and##4##2##(1992-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
Gy for##4##2##(2009-2#2)(2011-2#1)(2013-1#1)
Gy in##7##2##(1991-2#1)(1991-8#2)(2008-6#1)(2011-2#2)(2013-8#1)
Gy or more##3##3##(1991-4#1)(2008-11#1)(2011-2#1)
Gy or##4##2##(1991-4#1)(2007-10#1)(2008-11#1)(2011-2#1)
Gy to the##3##3##(1990-8#2)(2008-6#1)
Gy was delivered##2##3##(1990-12#1)(1994-12#1)
Gy was##6##2##(1990-12#1)(1992-11#1)(1994-12#1)(1996-2#1)(2008-6#1)(2011-2#1)
Gy##72##1##(1990-12#1)(1990-8#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#3)(1992-11#2)(1994-12#1)(1996-2#1)(1997-4#2)(2007-10#1)(2008-10#3)(2008-11#4)(2008-6#13)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#5)(2010-3#2)(2011-2#8)(2013-1#5)(2013-8#3)
Gy) and##3##2##(1990-10#1)(1997-4#1)(2007-11#1)
Gy) of##2##2##(2008-6#2)
Gy)##13##1##(1990-10#1)(1990-6#1)(1992-12#1)(1993-8#1)(1997-4#2)(2007-11#2)(2008-6#2)(2008-7#2)(2011-2#1)
Gy/T in##2##2##(2007-11#2)
Gy/T##5##1##(2007-11#5)
Gymnodactylus##4##1##(2010-3#4)
Gynaecology##8##1##(1991-9#1)(1996-1#1)(2007-4#1)(2007-7#1)(2008-12#2)(2008-3#1)(2011-1#1)
Gynecologic and##2##2##(2008-12#1)(2012-3#1)
Gynecologic##3##1##(2007-7#1)(2008-12#1)(2012-3#1)
Gynecological##3##1##(1990-10#1)(2011-2#1)(2012-3#1)
Gynecology and Obstetrics##4##3##(1994-5#1)(1995-3#1)(2011-2#1)(2012-3#1)
Gynecology and##6##2##(1990-10#1)(1994-5#1)(1995-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
Gynecology##12##1##(1990-10#2)(1991-3#2)(1994-5#2)(1995-3#2)(1996-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
Gypsies##4##1##(2011-2#4)
Gypsophila paniculata##2##2##(2008-10#2)
GyrA##5##1##(1994-12#5)
Gyrodactylus salaris##2##2##(2013-1#2)
Gyrotron##2##1##(2007-9#1)(2011-1#1)
Gys causes the##2##3##(2013-8#2)
Gérard##2##1##(1993-12#1)(1995-2#1)
G→T##3##1##(2013-1#3)
H 7998##3##2##(2008-10#3)
H = 1##2##3##(2008-5#2)
H =##7##2##(1990-8#2)(1997-7#2)(2008-10#1)(2008-5#2)
H _ 2O _ 2##2##5##(2008-5#2)
H and E##2##3##(2008-12#1)(2012-3#1)
H and L##2##3##(1990-2#1)(2008-3#1)
H and a##2##3##(1990-8#1)(2008-10#1)
H and##13##2##(1990-2#1)(1990-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
H are##3##2##(2009-2#3)
H beta##2##2##(1992-4#2)
H channel##2##2##(1992-6#1)(2008-2#1)
H current##7##2##(2008-2#7)
H in the##2##3##(1992-3#1)(1995-8#1)
H in##3##2##(1992-3#1)(1995-8#1)(2009-6#1)
H is##3##2##(1990-12#1)(2008-3#2)
H synthase##10##2##(1992-8#2)(1994-5#5)(1995-5#1)(2008-4#2)
H synthase-1##4##2##(1995-5#1)(2008-4#3)
H were##2##2##(1994-5#1)(2009-6#1)
H x##3##2##(2008-3#3)
H##556##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#4)(1990-4#1)(1990-5#6)(1990-7#3)(1990-8#6)(1991-10#1)(1991-12#1)(1991-5#3)(1991-6#3)(1991-8#6)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#7)(1993-8#7)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#15)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#6)(1995-5#6)(1995-6#5)(1995-8#3)(1996-12#4)(1996-5#2)(1997-1#18)(1997-2#3)(1997-3#12)(1997-6#4)(1997-7#4)(1997-8#5)(1997-9#3)(2006-5#1)(2007-12#5)(2007-2#5)(2007-8#1)(2008-1#20)(2008-10#108)(2008-11#11)(2008-12#17)(2008-2#12)(2008-3#13)(2008-4#14)(2008-5#27)(2008-6#11)(2008-7#6)(2008-8#10)(2008-9#1)(2009-10#1)(2009-2#7)(2009-3#1)(2009-5#3)(2009-6#12)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#3)(2010-4#1)(2011-1#7)(2011-10#1)(2011-2#23)(2012-12#13)(2012-2#7)(2012-3#2)(2012-8#2)(2013-1#7)(2013-7#6)(2013-8#1)
H&amp##4##1##(2009-11#1)(2012-3#1)(2013-8#2)
H' was##2##2##(2008-8#1)(2013-7#1)
H'##4##1##(2008-10#1)(2008-8#2)(2013-7#1)
H'n=1##2##1##(2013-7#2)
H(+)##20##1##(2008-10#14)(2008-4#1)(2008-8#5)
H(+)-ATPase activity and##2##3##(2008-10#2)
H(+)-ATPase from Neurospora crassa reconstituted##2##5##(1995-2#2)
H(+)-ATPase from Neurospora crassa##3##4##(1995-2#3)
H(+)-ATPase from##4##2##(1995-2#4)
H(+)-ATPase##12##1##(1992-6#2)(1993-11#1)(1993-6#1)(1995-2#6)(2008-10#2)
H(+)-chromoionophore##2##1##(2008-10#2)
H(+)-pumping ATPase##2##2##(1994-8#2)
H(+)-selective chromoionophore and##2##3##(2008-10#2)
H(+)-selective chromoionophore##3##2##(2008-10#3)
H(+)-selective##5##1##(2008-10#5)
H(1) receptor antagonists##2##3##(2007-11#2)
H(1) receptor##3##2##(2007-11#3)
H(1)##5##1##(2007-11#3)(2008-10#1)(2008-3#1)
H(2) O(2) concentration##2##3##(2011-2#2)
H(2) O(2)##4##2##(2011-2#4)
H(2) and CO(2)##3##3##(2008-7#3)
H(2) and D(2)##3##3##(2008-2#2)(2010-12#1)
H(2) and##7##2##(2008-10#1)(2008-2#2)(2008-7#3)(2010-12#1)
H(2) concentration##2##2##(2007-12#1)(2008-7#1)
H(2) with##3##2##(2007-11#2)(2007-12#1)
H(2)##45##1##(1996-2#3)(2007-11#3)(2007-12#3)(2008-10#6)(2008-2#10)(2008-3#1)(2008-7#4)(2009-9#1)(2010-12#2)(2010-4#4)(2011-2#6)(2012-2#1)(2012-7#1)
H(2)(18)O##2##1##(1997-7#1)(2008-2#1)
H(2)- CH(4) gas mixtures##2##4##(2007-12#2)
H(2)-##3##1##(2007-12#3)
H(2)-receptor##2##1##(1993-10#1)(2008-11#1)
H(2)/O(2)##2##1##(2009-2#2)
H(2)O absorption features##2##3##(2008-2#1)(2008-3#1)
H(2)O absorption##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
H(2)O and (16)O(3)##2##3##(2008-2#2)
H(2)O and##8##2##(2008-10#2)(2008-2#4)(2008-3#2)
H(2)O in##2##2##(2008-3#2)
H(2)O lines##3##2##(2008-2#2)(2008-3#1)
H(2)O molecule##2##2##(2008-10#1)(2008-8#1)
H(2)O##62##1##(1993-10#5)(1996-2#2)(1997-7#2)(2007-8#3)(2008-10#13)(2008-11#2)(2008-2#15)(2008-3#14)(2008-8#4)(2009-11#1)(2012-3#1)
H(2)O(2) and 0##2##3##(2008-10#2)
H(2)O(2) and NADH detection##2##4##(2013-1#2)
H(2)O(2) and NADH##3##3##(2013-1#3)
H(2)O(2) and##25##2##(2008-10#20)(2009-12#1)(2012-2#1)(2013-1#3)
H(2)O(2) as##2##2##(2008-10#2)
H(2)O(2) at##2##2##(2008-10#2)
H(2)O(2) concentration##4##2##(2008-10#4)
H(2)O(2) detection##4##2##(2008-10#3)(2013-1#1)
H(2)O(2) for##2##2##(2008-10#2)
H(2)O(2) from##2##2##(2008-10#1)(2008-11#1)
H(2)O(2) in a##2##3##(2008-10#2)
H(2)O(2) in real samples##2##4##(2008-10#2)
H(2)O(2) in the presence of##2##5##(2008-10#2)
H(2)O(2) in the##7##3##(2008-10#7)
H(2)O(2) in##17##2##(2008-10#15)(2008-11#1)(2008-2#1)
H(2)O(2) occurred##2##2##(2008-10#2)
H(2)O(2) produced##2##2##(2008-10#2)
H(2)O(2) production by##3##3##(2008-10#1)(2008-11#2)
H(2)O(2) production was##2##3##(2008-11#2)
H(2)O(2) production##9##2##(2008-10#1)(2008-11#8)
H(2)O(2) system containing Cu(2+) or Zn(2+)##2##6##(2008-10#2)
H(2)O(2) system containing Cu(2+)##4##4##(2008-10#4)
H(2)O(2) to##3##2##(1996-2#1)(2008-10#2)
H(2)O(2) was##6##2##(2008-10#6)
H(2)O(2) were##2##2##(2008-10#2)
H(2)O(2) with##3##2##(2008-10#3)
H(2)O(2)##173##1##(1996-2#2)(2008-10#134)(2008-11#11)(2008-2#7)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-4#4)(2010-7#1)(2012-2#5)(2013-1#4)
H(2)O) nanowires##2##2##(2009-11#2)
H(2)O)##10##1##(1993-10#3)(2008-10#1)(2008-2#1)(2009-11#2)(2009-8#1)(2010-7#2)
H(2)PO(4)(-)##4##1##(2008-10#4)
H(2)S and##4##2##(2008-10#4)
H(2)S for##2##2##(2008-10#1)(2008-3#1)
H(2)S is high in##2##4##(2011-1#2)
H(2)S##22##1##(2008-10#12)(2008-3#1)(2008-7#1)(2011-1#8)
H(2)SO(4) and 0##3##3##(2008-10#3)
H(2)SO(4) and H(2)O are##2##4##(2008-10#2)
H(2)SO(4) and H(2)O(2)##2##3##(2008-10#2)
H(2)SO(4) and HNO(3)##2##3##(2008-10#1)(2008-3#1)
H(2)SO(4) and##10##2##(2008-10#9)(2008-3#1)
H(2)SO(4) at##2##2##(2008-10#1)(2013-1#1)
H(2)SO(4) concentration##2##2##(2008-10#2)
H(2)SO(4) in##2##2##(2008-10#2)
H(2)SO(4) is##3##2##(2008-10#3)
H(2)SO(4) medium##2##2##(2008-10#2)
H(2)SO(4) solution##3##2##(2008-10#2)(2009-10#1)
H(2)SO(4) was##2##2##(2008-10#2)
H(2)SO(4)##55##1##(1991-5#1)(2008-10#50)(2008-3#2)(2009-10#1)(2013-1#1)
H(2)SO(4))##4##1##(2008-10#3)(2013-1#1)
H(2)SO(4)-H(2)O##2##1##(2008-3#2)
H(2)SO(4)-HNO(3)-H(2)O##2##1##(2008-3#2)
H(3)##2##1##(2008-8#1)(2009-9#1)
H(3)(tpfc)##2##1##(2008-10#2)
H(3)AsO(3)##2##1##(2008-10#2)
H(3)BO(3)##2##1##(2008-10#2)
H(5)O(2) (+)##2##2##(2012-12#2)
H(79)Br##2##1##(2007-11#1)(2007-12#1)
H(VNTR) values##2##2##(2008-10#2)
H) and##2##2##(1990-7#1)(2008-3#1)
H)##14##1##(1990-12#1)(1990-7#1)(1993-8#1)(1994-5#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#1)(2010-2#1)(2010-4#1)
H)=-7##2##1##(2008-10#2)
H+ concentration##2##2##(1990-11#2)
H+ ejection##2##2##(1994-11#2)
H+ electrochemical potential generated by F1F0 ATPase##2##7##(1997-8#2)
H+ electrochemical potential##4##3##(1997-8#4)
H+ flux##2##2##(1990-11#1)(1991-5#1)
H+ gradient##4##2##(1990-11#1)(1994-6#3)
H+ on the##2##3##(1991-5#1)(2013-8#1)
H+ pumping by##2##3##(1995-2#2)
H+##38##1##(1990-11#7)(1990-8#2)(1991-12#1)(1991-5#2)(1994-11#3)(1994-3#1)(1994-6#5)(1994-8#2)(1995-2#2)(1995-6#6)(1997-8#5)(2013-8#2)
H+/K(+)-ATPase beta subunit -1035 to##2##5##(1995-6#2)
H+/K(+)-ATPase beta subunit##3##3##(1995-6#3)
H+/K(+)-ATPase##5##1##(1995-6#3)(1997-1#2)
H-##3##1##(1993-11#1)(1996-9#1)(2009-8#1)
H-2##3##1##(1990-3#1)(1992-8#1)(2008-5#1)
H-2(d) restricted antigen-specific##2##3##(2008-8#2)
H-2(d) restricted##4##2##(2008-8#4)
H-2(d)##6##1##(2008-8#6)
H-2Dd expression##2##2##(1995-2#2)
H-2Dd##4##1##(1995-2#4)
H-7##13##1##(1990-11#1)(1990-2#5)(1991-2#2)(1994-11#1)(1995-8#2)(1996-12#1)(1997-2#1)
H-B scale##2##2##(2008-10#2)
H-D and H-H##2##3##(2008-12#2)
H-D##6##1##(2008-12#6)
H-FABP##2##1##(2008-10#2)
H-H##10##1##(1996-2#1)(1997-7#2)(2008-12#5)(2010-4#2)
H-NS K57N##4##2##(2011-1#4)
H-NS##13##1##(2011-1#13)
H-Ras in vitro##2##3##(1994-12#2)
H-Wave(R) device##11##2##(2010-1#11)
H-aggregation of NBS##2##3##(2008-10#2)
H-bond##7##1##(1992-10#1)(1993-11#3)(2008-10#1)(2013-7#2)
H-bonding interactions##2##2##(1993-11#1)(2009-6#1)
H-bonding##12##1##(1992-4#1)(1993-11#3)(1995-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-6#1)(2009-9#1)
H-bonds##7##1##(1992-10#4)(1992-4#1)(2008-8#1)(2008-9#1)
H-channel structure was##2##3##(2008-10#2)
H-phosphonate monoester##2##2##(2008-4#2)
H-phosphonate##8##1##(2008-4#8)
H-point and##3##2##(2008-10#3)
H-point curve isolation##2##3##(2008-10#2)
H-point standard addition method (HPSAM) for##2##6##(2008-10#2)
H-point standard addition method (HPSAM) is##2##6##(2008-10#2)
H-point standard addition method (HPSAM) was applied to##2##8##(2008-10#2)
H-point standard addition method (HPSAM)##9##5##(2008-10#9)
H-point standard addition method##25##4##(2008-10#25)
H-point standard addition##27##3##(2008-10#27)
H-point standard additions method##2##4##(2008-10#2)
H-point standard additions methods##2##4##(2008-10#2)
H-point standard additions##4##3##(2008-10#4)
H-point standard##31##2##(2008-10#31)
H-point##36##1##(2008-10#36)
H-ras##5##1##(1993-11#3)(1994-5#1)(2012-2#1)
H-reflex amplitude##2##2##(1993-12#2)
H-reflex recruitment curve##2##3##(2013-1#2)
H-reflex recruitment##3##2##(2013-1#3)
H-reflex##16##1##(1993-12#9)(2013-1#7)
H-reflexes##3##1##(1993-12#2)(2013-1#1)
H-strand##2##1##(2008-11#2)
H-type intramolecular##2##2##(2008-10#2)
H-type##6##1##(2008-10#6)
H/M##2##1##(2008-7#2)
H1 and##5##2##(1992-9#3)(2009-2#2)
H1 receptor##7##2##(1992-11#6)(1994-2#1)
H1##33##1##(1990-2#1)(1990-5#1)(1992-11#6)(1992-8#2)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#3)(2008-4#1)(2009-2#4)(2011-2#3)
H1(0) mRNA##2##2##(1993-6#2)
H1(0)##8##1##(1993-6#8)
H1-##2##1##(1995-12#2)
H1-H2##3##1##(2013-1#3)
H10##3##1##(1990-12#3)
H111##2##1##(2008-10#2)
H12##3##1##(2010-4#2)(2011-2#1)
H120##3##1##(1997-3#1)(2010-4#2)
H125 cells##2##2##(2008-9#2)
H1N1 SIV##2##2##(2011-2#2)
H1N1 SIVs##2##2##(2011-2#2)
H1N1 and##3##2##(2013-1#3)
H1N1 exposure##2##2##(2012-12#2)
H1N1 infection and##2##3##(2012-12#2)
H1N1 infection##3##2##(2012-12#3)
H1N1 influenza##5##2##(1997-6#1)(2010-4#1)(2011-2#2)(2013-8#1)
H1N1 pandemic##5##2##(2011-2#5)
H1N1 swine influenza##3##3##(2011-2#3)
H1N1 vaccination##2##2##(2010-9#1)(2012-2#1)
H1N1 vaccine##4##2##(2011-2#1)(2012-12#2)(2012-2#1)
H1N1 virus##2##2##(2012-3#1)(2013-1#1)
H1N1##41##1##(1997-6#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-2#16)(2012-12#10)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
H1N2##3##1##(2009-5#1)(2013-1#1)(2013-8#1)
H1aV##3##1##(2008-11#3)
H2 and##3##2##(1992-9#1)(2008-10#1)(2008-2#1)
H2 is##2##2##(2009-2#1)(2011-2#1)
H2 receptor antagonists##4##3##(1991-5#1)(1992-11#1)(1995-10#2)
H2 receptor##12##2##(1991-5#1)(1991-9#4)(1992-11#1)(1994-2#1)(1995-10#2)(1995-12#1)(1996-3#1)(2008-9#1)
H2##40##1##(1990-12#3)(1991-5#1)(1991-9#5)(1992-11#1)(1992-3#3)(1992-9#1)(1993-3#2)(1994-2#1)(1995-10#2)(1995-12#1)(1995-5#2)(1996-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#3)(2010-5#2)(2011-2#1)
H2-##2##1##(1995-12#2)
H2-antagonist##3##1##(1990-5#1)(1991-5#1)(1992-8#1)
H2-antagonists##4##1##(1991-5#3)(1995-12#1)
H2-oxidizing##2##1##(2008-6#2)
H2-receptor antagonists##2##2##(1992-11#1)(2012-2#1)
H2-receptor##4##1##(1991-9#1)(1992-11#1)(2012-2#2)
H24##3##1##(2010-4#1)(2011-2#2)
H28##2##1##(1990-7#2)
H295R##4##1##(1995-12#2)(2013-1#2)
H2A and##2##2##(1990-5#1)(2008-8#1)
H2A histone##2##2##(1997-6#1)(2009-5#1)
H2A##11##1##(1990-5#1)(1994-9#1)(1997-6#1)(2008-7#6)(2008-8#1)(2009-5#1)
H2AX in astrocytes##2##3##(2009-5#2)
H2AX##8##1##(2008-9#3)(2009-5#5)
H2B##3##1##(1990-5#1)(1994-9#1)(2008-8#1)
H2O and##2##2##(1992-8#1)(2008-2#1)
H2O in##2##2##(2008-2#1)(2008-3#1)
H2O##18##1##(1992-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#8)(2008-4#1)
H2O2 alone##2##2##(1995-8#2)
H2O2 and ascorbate##2##3##(1995-2#1)(1995-6#1)
H2O2 and##7##2##(1992-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#1)(2013-8#2)
H2O2 as a##2##3##(1994-8#1)(1997-2#1)
H2O2 generated by##2##3##(1993-11#1)(1995-8#1)
H2O2 in##4##2##(1995-8#2)(1997-8#1)(2008-10#1)
H2O2 on##2##2##(1991-9#1)(1996-2#1)
H2O2 or##2##2##(1991-9#1)(1995-3#1)
H2O2 was found to be##2##5##(1995-2#1)(1997-4#1)
H2O2 was used##2##3##(1992-12#1)(2013-8#1)
H2O2 was##7##2##(1992-12#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-12#1)(2008-6#1)(2013-8#1)
H2O2##71##1##(1990-2#1)(1990-5#2)(1991-9#6)(1992-11#1)(1992-12#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#11)(1996-2#2)(1997-2#2)(1997-4#7)(1997-7#1)(1997-8#5)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-9#1)(2012-3#1)(2013-8#4)
H2O2-L-histidine##3##1##(1995-8#3)
H2S##5##1##(2008-3#1)(2008-6#1)(2011-1#1)(2013-8#2)
H2SO4##4##1##(1991-7#3)(2007-11#1)
H3 and H4##4##3##(1994-9#1)(2009-12#1)(2011-2#2)
H3 and##7##2##(1992-8#2)(1994-9#1)(2009-12#1)(2011-2#2)(2012-12#1)
H3##30##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#3)(1991-6#3)(1992-8#4)(1992-9#3)(1994-9#1)(1997-2#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#2)(2013-1#5)
H3K4##2##1##(2009-10#2)
H3K9 di- and tri-methylation##2##4##(2009-10#2)
H3K9##3##1##(2009-10#3)
H3N2 influenza##2##2##(2009-5#1)(2011-1#1)
H3N2 virus##2##2##(2011-1#1)(2013-1#1)
H3N2##8##1##(2009-5#2)(2011-1#3)(2013-1#2)(2013-8#1)
H4##9##1##(1990-2#1)(1993-6#1)(1994-6#2)(1994-9#1)(2008-3#1)(2009-12#1)(2011-2#2)
H46A##4##1##(1991-9#1)(2012-2#3)
H48##2##1##(2010-4#2)
H4B##2##1##(1990-7#2)
H5##3##1##(1994-9#1)(2008-9#1)(2013-8#1)
H5N1##3##1##(2007-12#1)(2011-2#1)(2013-8#1)
H6 and C1##2##3##(2008-10#2)
H6##3##1##(2008-10#2)(2010-4#1)
H668##2##1##(2009-10#2)
H7 and##2##2##(1994-9#1)(1995-2#1)
H7 in##3##2##(2008-9#1)(2010-4#1)(2012-2#1)
H7 subtype avian influenza##2##4##(2013-8#2)
H7 subtype##3##2##(2013-8#3)
H7##27##1##(1990-12#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-2#2)(1997-1#1)(1997-9#1)(2007-12#1)(2008-10#6)(2008-9#2)(2010-4#2)(2011-2#1)(2012-2#1)(2013-8#5)
H7N1##2##1##(2011-3#2)
H8##5##1##(1990-12#2)(1994-11#1)(1994-9#1)(1997-6#1)
H9 cells##8##2##(1990-8#1)(1991-5#2)(1991-9#1)(1992-6#1)(1994-11#1)(1997-1#1)(1997-3#1)
H9##12##1##(1990-10#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-6#2)(1994-11#1)(1997-1#1)(1997-3#1)(2011-3#1)(2013-8#1)
H93G Mb##3##2##(1994-5#3)
HA + AR##3##3##(2007-8#3)
HA alone##2##2##(2008-10#1)(2009-7#1)
HA and FA##5##3##(2008-10#5)
HA and HA##2##3##(2007-8#1)(2008-10#1)
HA and WEC bioassays##2##4##(1993-12#2)
HA and the##2##3##(2008-5#1)(2009-7#1)
HA and to##2##3##(2011-2#1)(2013-8#1)
HA and##26##2##(1993-12#2)(1997-4#1)(2007-8#1)(2008-10#10)(2008-5#1)(2009-7#4)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#3)
HA as##2##2##(2008-10#2)
HA concentration##3##2##(1996-12#3)
HA concentrations##3##2##(2008-10#1)(2013-8#2)
HA did not##2##3##(2010-10#1)(2010-8#1)
HA in solution##2##3##(2008-10#2)
HA in##6##2##(2008-10#4)(2013-8#2)
HA is##2##2##(2011-2#1)(2013-8#1)
HA of##2##2##(1990-5#1)(2008-5#1)
HA polymers##2##2##(2010-8#2)
HA samples##6##2##(2008-10#4)(2013-8#2)
HA titer##3##2##(2008-10#1)(2008-11#2)
HA was##5##2##(2008-5#3)(2013-8#2)
HA were##3##2##(2008-10#2)(2013-8#1)
HA with carbon-13 of natural abundance##2##6##(2008-10#2)
HA with##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
HA##134##1##(1990-5#2)(1992-9#1)(1993-12#3)(1996-12#3)(1997-4#1)(2007-8#5)(2008-10#49)(2008-11#5)(2008-5#9)(2008-8#1)(2009-7#6)(2010-10#3)(2010-8#9)(2011-1#2)(2011-2#9)(2012-2#1)(2012-3#1)(2013-8#24)
HA) and##2##2##(2008-10#1)(2009-7#1)
HA)##3##1##(2008-10#1)(2009-7#1)(2010-8#1)
HA-CdS and HB-CdS##2##3##(2008-8#2)
HA-based PEO##2##2##(2008-5#2)
HA-based##4##1##(2008-5#4)
HA-coated##2##1##(2008-8#2)
HA-metal ion##2##2##(2008-10#2)
HA/PLLA##2##1##(2009-7#2)
HA1##8##1##(1994-8#3)(1997-6#2)(2011-1#1)(2011-2#2)
HA1004##3##1##(1993-3#2)(1994-9#1)
HA5-1##2##1##(2008-10#2)
HAA##7##1##(1994-6#2)(2008-10#2)(2009-10#3)
HAART initiation##2##2##(2010-5#2)
HAART##23##1##(2007-1#2)(2007-12#1)(2007-7#1)(2008-3#4)(2009-4#1)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#3)(2010-9#1)(2011-2#1)(2013-8#5)
HAAs##2##1##(2008-10#2)
HABP##3##1##(1997-4#3)
HAC##3##1##(2008-11#3)
HACCP##2##1##(1996-3#1)(1997-3#1)
HACEK group##2##2##(2007-7#2)
HAD##6##1##(2008-1#1)(2008-10#2)(2008-2#1)(2009-10#1)(2011-1#1)
HAE##5##1##(1996-12#3)(2013-1#2)
HAG1##4##1##(2008-8#4)
HAI test##2##2##(2011-1#2)
HAI##3##1##(2011-1#3)
HAM's F12##2##2##(2008-11#2)
HAM/TSP##4##1##(2012-12#4)
HAMMER##4##1##(2011-2#4)
HAP complex##2##2##(2008-7#2)
HAP is##2##2##(1994-8#1)(2008-9#1)
HAP##18##1##(1994-8#4)(2008-7#6)(2008-9#7)(2012-2#1)
HAP1##3##1##(2012-2#3)
HAP2##6##1##(1995-2#3)(2008-9#3)
HAP3##3##1##(1995-2#3)
HAPC sheet bed##2##3##(2008-11#2)
HAPC sheet##3##2##(2008-11#3)
HAPC##4##1##(2008-11#4)
HAPLOINSUFFICIENT MICE##7##2##(2008-8#1)(2008-9#6)
HARTOB##3##1##(2008-10#3)
HARV cultivation##2##2##(2008-11#2)
HARV##3##1##(2008-11#3)
HAT-sensitive mouse myeloma cell line##2##5##(2008-11#2)
HAT-sensitive mouse myeloma##3##3##(2008-11#3)
HAV and HBV##3##3##(2009-4#2)(2009-5#1)
HAV and##5##2##(2007-12#1)(2009-4#2)(2009-5#2)
HAV is##2##2##(2007-12#1)(2010-8#1)
HAV vaccine##3##2##(2009-4#3)
HAV##13##1##(2007-12#4)(2009-4#5)(2009-5#2)(2010-8#1)(2011-1#1)
HAVE (Hospital Awards for Volunteer Excellence) winners announced##2##8##(1995-12#1)(1995-3#1)
HAVE (Hospital Awards for Volunteer Excellence) winners describe##2##8##(1991-3#1)(1992-3#1)
HAVE (Hospital Awards for Volunteer Excellence) winners##5##7##(1991-3#1)(1992-3#1)(1993-3#1)(1995-12#1)(1995-3#1)
HAVE (Hospital Awards for Volunteer Excellence)##7##6##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)
HAVE##8##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(2009-12#1)
HAc-NaAc buffer solution##2##3##(2008-10#2)
HAc-NaAc buffer##4##2##(2008-10#4)
HAc-NaAc##5##1##(2008-10#5)
HAs in##2##2##(2008-10#1)(2008-5#1)
HAs##5##1##(2008-10#4)(2008-5#1)
HB and##2##2##(2008-1#1)(2011-2#1)
HB##11##1##(2008-1#1)(2008-10#1)(2008-8#3)(2011-2#5)(2013-8#1)
HB)##2##1##(2008-8#1)(2013-8#1)
HB-EGF gene transcription##3##3##(1997-1#3)
HB-EGF gene##4##2##(1993-11#1)(1997-1#3)
HB-EGF mRNA levels in##2##4##(1993-11#2)
HB-EGF mRNA##6##2##(1993-11#2)(1997-1#4)
HB-EGF protein##2##2##(1997-1#1)(2013-8#1)
HB-EGF##21##1##(1993-11#4)(1997-1#11)(2013-8#6)
HB1##2##1##(2011-2#2)
HB4C5 cells##7##2##(2008-11#7)
HB4C5##9##1##(2008-11#9)
HBA1c##2##1##(1994-12#2)
HBB##2##1##(2009-4#1)(2011-2#1)
HBCs##4##1##(1994-6#4)
HBI##3##1##(2007-11#3)
HBK-51##4##1##(2013-1#4)
HBM##2##1##(2008-4#1)(2011-1#1)
HBO##6##1##(1993-12#5)(2007-8#1)
HBP##2##1##(1991-12#1)(2009-5#1)
HBV DNA decline##3##3##(2013-1#3)
HBV DNA integration##2##3##(2008-4#2)
HBV DNA was##2##3##(1990-8#2)
HBV DNA##25##2##(1990-8#4)(1995-2#1)(1997-4#6)(2006-10#1)(2008-4#5)(2009-8#4)(2013-1#4)
HBV Subgenotype C2 Infection##2##4##(2013-1#2)
HBV and HCV##3##3##(2007-7#2)(2008-8#1)
HBV and HDV##2##3##(2009-8#2)
HBV and##13##2##(1995-5#1)(2007-7#3)(2008-10#1)(2008-8#1)(2009-8#3)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
HBV construct##2##2##(1995-2#2)
HBV core region##2##3##(1997-4#1)(2008-8#1)
HBV core##3##2##(1997-4#1)(2008-8#2)
HBV genome integration##3##3##(2008-4#3)
HBV genome##4##2##(1997-4#1)(2008-4#3)
HBV genotype##3##2##(2009-3#1)(2013-1#2)
HBV genotypes##3##2##(2009-3#1)(2013-1#2)
HBV in##5##2##(1995-2#1)(2008-4#1)(2009-3#1)(2012-12#1)(2013-1#1)
HBV induction##2##2##(2012-12#2)
HBV infection and##3##3##(2011-1#3)
HBV infection in##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
HBV infection##23##2##(1995-2#2)(1997-4#1)(2006-10#1)(2007-12#4)(2008-1#1)(2008-10#4)(2009-12#1)(2009-8#2)(2010-8#1)(2011-1#4)(2011-2#1)(2013-1#1)
HBV knowledge##2##2##(2012-1#2)
HBV or HDV##2##3##(2009-8#2)
HBV reactivation##3##2##(1991-3#1)(2009-12#1)(2012-12#1)
HBV replication##4##2##(2013-1#3)(2013-8#1)
HBV stigma instrument##2##3##(2012-1#2)
HBV stigma##4##2##(2012-1#4)
HBV surface antigen##2##3##(1997-4#1)(2006-10#1)
HBV transmission##4##2##(2008-7#3)(2012-1#1)
HBV up-regulation##2##2##(2012-12#2)
HBV vaccination##2##2##(2009-5#2)
HBV vaccine response##2##3##(2009-4#2)
HBV vaccine##8##2##(2008-9#2)(2009-4#6)
HBV virions##2##2##(1995-2#2)
HBV was##2##2##(2007-7#1)(2012-3#1)
HBV with##3##2##(1991-8#1)(2012-1#1)(2012-12#1)
HBV##193##1##(1990-8#5)(1991-3#1)(1991-8#1)(1993-8#6)(1995-2#11)(1995-5#1)(1997-4#10)(2006-10#4)(2007-12#8)(2007-4#1)(2007-7#5)(2008-1#2)(2008-10#9)(2008-12#1)(2008-4#9)(2008-7#3)(2008-8#5)(2008-9#3)(2009-12#3)(2009-3#6)(2009-4#7)(2009-5#3)(2009-7#4)(2009-8#17)(2010-8#2)(2011-1#8)(2011-2#1)(2012-1#10)(2012-12#11)(2012-3#3)(2013-1#24)(2013-8#9)
HBV- and HCV-endemic##3##3##(2013-8#3)
HBV- and##5##2##(2008-8#1)(2013-8#4)
HBV-DNA load##3##2##(2011-1#3)
HBV-DNA##17##1##(2011-1#15)(2013-8#2)
HBV-infected individuals##2##2##(2007-12#2)
HBV-infected patients##2##2##(1991-11#1)(2010-8#1)
HBV-infected##5##1##(1991-11#1)(1997-4#1)(2007-12#2)(2010-8#1)
HBV-related##3##1##(2013-1#1)(2013-8#2)
HBV/B6##2##1##(2013-1#2)
HBV/D##2##1##(2013-1#2)
HBV/F##3##1##(2013-1#3)
HBX degradation##2##2##(2008-8#2)
HBX protein stability##2##3##(2008-8#2)
HBX protein##6##2##(2008-8#6)
HBX##10##1##(2008-8#10)
HBc##4##1##(1996-12#1)(2008-8#3)
HBc3-144-HCMV##2##1##(1996-12#2)
HBcAg and##2##2##(1996-12#2)
HBcAg particles##3##2##(1995-5#3)
HBcAg##13##1##(1991-8#1)(1995-5#9)(1996-12#3)
HBe-Ag positive##2##2##(1990-8#2)
HBeAg negative##2##2##(2013-1#2)
HBeAg##6##1##(2008-8#1)(2009-8#1)(2011-1#2)(2013-1#2)
HBeAg-negative patients##3##2##(2009-8#1)(2013-1#2)
HBr##9##1##(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-3#1)
HBr)##2##1##(1995-3#1)(2008-10#1)
HBs antigen##2##2##(1990-8#1)(2013-1#1)
HBs##7##1##(1990-8#1)(1994-5#1)(2007-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
HBs-MAb production in##2##3##(1994-5#2)
HBsAg (-)##2##2##(2011-2#2)
HBsAg and HBV-DNA##2##3##(2011-1#2)
HBsAg and anti-HCV##2##3##(2007-7#1)(2013-8#1)
HBsAg and##5##2##(2007-7#1)(2008-8#1)(2011-1#2)(2013-8#1)
HBsAg carriage in##2##3##(2013-1#2)
HBsAg carrier rate##2##3##(2008-7#2)
HBsAg carrier##6##2##(1996-3#1)(2008-7#2)(2011-1#3)
HBsAg loss##2##2##(2013-1#2)
HBsAg positivity##2##2##(1996-3#2)
HBsAg was##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
HBsAg##41##1##(1993-2#1)(1995-2#3)(1996-3#3)(1997-4#1)(1997-6#1)(2007-7#2)(2008-10#1)(2008-12#3)(2008-7#5)(2008-8#1)(2011-1#6)(2011-2#2)(2013-1#7)(2013-8#5)
HBsAg(+) group##3##2##(2011-1#3)
HBsAg(-) group##2##2##(2011-1#2)
HBsAg+##3##1##(1993-2#3)
HBsAg-negative and anti-HCV-positive HCC##3##4##(2008-4#3)
HBsAg-negative and anti-HCV-positive##4##3##(2008-4#4)
HBsAg-negative##6##1##(1991-8#1)(2008-4#4)(2011-2#1)
HBsAg-positive father to infant##4##4##(2011-1#4)
HBsAg-positive##5##1##(2011-1#5)
HBsAg-specific##3##1##(1995-2#2)(2012-3#1)
HBx##6##1##(2008-8#1)(2012-12#5)
HC and SNP treated KU812 cells##2##6##(2008-11#2)
HC and##6##2##(2008-10#2)(2008-11#2)(2011-1#1)(2012-3#1)
HC for##3##2##(1991-12#1)(2008-11#2)
HC is##2##2##(2008-10#1)(2012-3#1)
HC treated##2##2##(2008-11#2)
HC was##2##2##(2008-10#1)(2008-8#1)
HC##41##1##(1991-12#3)(2008-10#19)(2008-11#7)(2008-8#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-3#6)(2013-8#2)
HC(3##2##1##(1996-2#2)
HC-Pro mRNA##2##2##(2008-10#2)
HC-Pro of##2##2##(2008-10#2)
HC-Pro was##3##2##(2008-10#3)
HC-Pro##27##1##(2008-10#26)(2008-9#1)
HC-toxin##5##1##(2008-10#5)
HC-transcomplementation##3##1##(2008-10#3)
HC/HU patients##2##2##(2008-10#2)
HC/HU##5##1##(2008-10#5)
HCA cases##2##2##(2009-8#2)
HCA##7##1##(2009-8#5)(2013-1#1)(2013-8#1)
HCAs are observed in##2##4##(2009-8#2)
HCAs are##3##2##(2009-8#3)
HCAs##8##1##(2008-10#3)(2009-8#5)
HCB and##2##2##(2008-10#2)
HCB##17##1##(1993-5#3)(2008-10#11)(2008-11#3)
HCB-induced skin lesions##2##3##(2008-10#2)
HCB-induced##4##1##(2008-10#4)
HCC and##4##2##(1990-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
HCC cells##7##2##(2008-10#3)(2008-8#3)(2012-5#1)
HCC development in##2##3##(2013-8#2)
HCC development##3##2##(2013-8#3)
HCC in##8##2##(1993-2#1)(2006-10#2)(2008-11#3)(2008-7#1)(2011-2#1)
HCC is##4##2##(1991-11#1)(2006-10#1)(2013-1#1)(2013-7#1)
HCC patients##9##2##(1992-3#1)(2008-10#8)
HCC were##2##2##(1993-2#1)(2013-8#1)
HCC with##2##2##(1993-2#1)(2011-2#1)
HCC##92##1##(1990-8#2)(1991-11#4)(1992-3#3)(1993-2#6)(2006-10#5)(2008-10#22)(2008-11#5)(2008-4#4)(2008-7#2)(2008-8#5)(2009-8#2)(2010-12#9)(2011-2#9)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#9)
HCCs##3##1##(1991-11#1)(2006-10#1)(2011-2#1)
HCD##3##1##(2008-10#3)
HCFA and##2##2##(1997-3#2)
HCFA could##2##2##(1997-2#2)
HCFA##11##1##(1992-3#1)(1994-12#2)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#3)
HCFA's##4##1##(1992-2#1)(1995-1#1)(1997-3#2)
HCFC-22##2##1##(1992-3#2)
HCFCs and HFCs##2##3##(1992-3#2)
HCFCs##3##1##(1992-3#3)
HCG##2##1##(1991-1#1)(1997-3#1)
HCHO##5##1##(1992-8#1)(2008-10#3)(2008-2#1)
HCHs and DDTs##4##3##(2008-7#4)
HCM subjects##2##2##(2008-7#2)
HCM##9##1##(2008-10#1)(2008-7#7)(2012-2#1)
HCMV infection##2##2##(1997-3#2)
HCMV strains##2##2##(1997-3#2)
HCMV##16##1##(1993-8#2)(1996-12#2)(1997-3#10)(2008-9#1)(2011-3#1)
HCMV-induced TGr##3##2##(1997-3#3)
HCMV-specific##3##1##(1993-8#1)(1997-3#2)
HCN generation##2##2##(1996-12#2)
HCN##12##1##(1996-12#4)(2008-10#4)(2008-2#2)(2008-3#2)
HCO(3)(-)##3##1##(2008-10#2)(2013-1#1)
HCO3-##5##1##(1993-6#3)(1994-6#1)(1995-8#1)
HCPS##2##1##(2008-10#2)
HCQIP##4##1##(1996-2#4)
HCT##3##1##(1990-7#1)(2010-11#2)
HCT-116 cells##4##2##(2008-9#2)(2013-1#2)
HCT-116##5##1##(2008-9#2)(2013-1#3)
HCT-8 and##2##2##(2011-3#1)(2013-1#1)
HCT-8##4##1##(1994-6#1)(1994-8#1)(2011-3#1)(2013-1#1)
HCT116##6##1##(1992-2#1)(1994-8#2)(2011-2#3)
HCTZ##3##1##(2009-9#3)
HCV +ve patients##2##3##(2008-1#2)
HCV +ve##4##2##(2008-1#4)
HCV RNA##11##2##(1994-8#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)
HCV and##4##2##(2008-1#1)(2008-8#1)(2009-4#1)(2012-2#1)
HCV antibodies##3##2##(2007-7#2)(2008-1#1)
HCV antibody##3##2##(2007-7#3)
HCV cirrhosis##2##2##(2013-1#2)
HCV clearance##5##2##(2009-8#1)(2012-2#4)
HCV core genes##2##3##(2008-8#2)
HCV core protein##2##3##(2008-8#2)
HCV core##7##2##(1994-8#2)(2008-8#5)
HCV genotype##5##2##(2009-4#1)(2010-11#1)(2012-12#3)
HCV in##2##2##(1991-8#1)(2012-2#1)
HCV infection among##2##3##(2007-7#1)(2011-2#1)
HCV infection and##4##3##(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
HCV infection in##6##3##(2007-7#2)(2008-10#2)(2009-8#1)(2012-2#1)
HCV infection##30##2##(2007-7#6)(2008-1#4)(2008-10#3)(2009-4#2)(2009-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
HCV infections##3##2##(1991-8#1)(1994-8#1)(2009-4#1)
HCV is##4##2##(2008-1#2)(2009-8#1)(2013-1#1)
HCV may##2##2##(2006-10#1)(2008-11#1)
HCV patients##2##2##(2008-8#1)(2013-1#1)
HCV positive##3##2##(2008-1#3)
HCV prevalence of##4##3##(2007-7#3)(2008-1#1)
HCV prevalence##6##2##(2007-7#5)(2008-1#1)
HCV replication by targeting the##2##5##(2013-1#2)
HCV replication##6##2##(2008-11#1)(2012-2#1)(2013-1#4)
HCV structural genes##2##3##(2008-8#2)
HCV to##2##2##(2007-7#1)(2012-2#1)
HCV treatment##4##2##(2008-10#1)(2012-1#2)(2013-1#1)
HCV who##2##2##(2006-10#1)(2012-12#1)
HCV##163##1##(1991-8#2)(1994-8#6)(1995-10#1)(2006-10#3)(2007-4#1)(2007-7#24)(2008-1#17)(2008-10#15)(2008-11#4)(2008-12#2)(2008-4#2)(2008-8#14)(2009-3#1)(2009-4#7)(2009-5#1)(2009-8#7)(2010-11#1)(2011-2#6)(2012-1#5)(2012-12#7)(2012-2#16)(2012-3#1)(2013-1#17)(2013-8#3)
HCV-induced##2##1##(2013-1#2)
HCV-infected##3##1##(2009-7#1)(2012-2#1)(2013-1#1)
HCV-positive##2##1##(2008-1#1)(2013-1#1)
HCV-specific CTL##2##2##(2013-1#2)
HCV-specific CTLs were##2##3##(2013-1#2)
HCV-specific CTLs##4##2##(2013-1#4)
HCV-specific cytotoxic T##2##3##(2013-1#2)
HCV-specific##8##1##(2013-1#8)
HCV-treatment##2##1##(2009-7#2)
HCWA and##3##2##(2008-10#3)
HCWA##8##1##(2008-10#8)
HCWs##2##1##(2007-7#1)(2011-2#1)
HCb in##2##2##(1993-3#2)
HCc##3##1##(2008-8#3)
HCl 0##2##2##(2008-10#2)
HCl acid-iodine##2##2##(2008-10#2)
HCl and CCl##2##3##(2008-2#2)
HCl and H(2)O(2)##3##3##(2008-10#3)
HCl and HNO(3)##4##3##(2008-10#4)
HCl and determined##2##3##(2008-10#2)
HCl and the##3##3##(1992-6#1)(2008-10#1)(2009-10#1)
HCl and##34##2##(1992-6#1)(2008-10#28)(2008-2#2)(2008-3#1)(2009-10#2)
HCl as##3##2##(2008-10#2)(2008-4#1)
HCl concentration in the##3##4##(2008-10#3)
HCl concentration##6##2##(2008-10#6)
HCl directly to the##2##4##(2008-10#2)
HCl for CH(3)Hg(+) and##2##4##(2008-10#2)
HCl for##6##2##(2008-10#6)
HCl in##5##2##(1992-5#1)(2008-10#2)(2009-10#1)(2013-8#1)
HCl into##2##2##(1997-1#1)(2008-10#1)
HCl medium##7##2##(2008-10#7)
HCl of##2##2##(1993-6#1)(2008-10#1)
HCl or HNO(3)##4##3##(2008-10#4)
HCl or##9##2##(1997-2#1)(2008-10#8)
HCl solution##7##2##(2008-10#7)
HCl to the##2##3##(2008-10#2)
HCl to##9##2##(2008-10#7)(2010-8#2)
HCl was added to the##2##5##(2008-10#2)
HCl was added##4##3##(2008-10#2)(2010-2#2)
HCl was##7##2##(1993-12#1)(2008-10#4)(2010-2#2)
HCl were##3##2##(2008-10#2)(2010-3#1)
HCl which##2##2##(2008-10#2)
HCl with carboxylate groups of##2##5##(1993-6#2)
HCl##203##1##(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#1)(1993-12#1)(1993-6#4)(1993-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#161)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2009-10#3)(2009-5#1)(2009-9#1)(2010-2#2)(2010-3#2)(2010-8#2)(2012-1#1)(2013-1#1)(2013-8#1)
HCl) and##3##2##(2008-10#3)
HCl) were##2##2##(1996-2#1)(2008-10#1)
HCl)##17##1##(1992-5#1)(1993-12#1)(1996-2#1)(2008-10#13)(2008-5#1)
HCl+0##2##1##(2008-10#2)
HCl+HNO(3)##2##1##(2008-10#2)
HCl-0##2##1##(2008-10#2)
HCl/HNO(3)##3##1##(2008-10#3)
HClO and ClO(2)(-)##3##3##(2008-10#3)
HClO##4##1##(2008-10#4)
HClO(4) and##3##2##(2008-10#3)
HClO(4) digestion##4##2##(2008-10#4)
HClO(4)##12##1##(2008-10#12)
HCl]1/2 ranges from##2##3##(1992-6#2)
HCs##3##1##(2008-10#1)(2012-3#2)
HD and place##3##3##(2007-8#3)
HD and##8##2##(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-9#1)(2012-12#1)
HD are##2##2##(1993-9#1)(1995-12#1)
HD individuals##3##2##(2011-8#3)
HD is##3##2##(1992-8#1)(1993-9#1)(2008-1#1)
HD may##2##2##(2011-2#1)(2013-1#1)
HD patients##9##2##(2007-7#2)(2008-1#7)
HD session##6##2##(2007-12#2)(2007-7#1)(2008-1#2)(2011-2#1)
HD sessions##7##2##(2007-12#1)(2007-7#1)(2008-1#5)
HD than##2##2##(2007-7#1)(2008-3#1)
HD treatments##2##2##(2007-12#1)(2008-1#1)
HD units##4##2##(2007-7#1)(2008-1#3)
HD was##7##2##(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
HD were##6##2##(2007-7#1)(2008-1#3)(2011-2#2)
HD with##2##2##(2007-7#1)(2008-10#1)
HD##119##1##(1992-8#2)(1993-9#5)(1995-12#1)(1996-8#4)(1997-7#1)(2007-12#8)(2007-7#24)(2007-8#8)(2008-1#32)(2008-10#4)(2008-3#2)(2008-7#2)(2008-9#3)(2011-10#2)(2011-2#13)(2011-8#4)(2012-12#3)(2013-1#1)
HD-Mtx##3##1##(2011-2#3)
HD-affected##2##1##(1995-12#2)
HDAC inhibitors##4##2##(2010-3#1)(2010-6#1)(2012-12#1)(2013-1#1)
HDAC##8##1##(2008-6#1)(2008-7#1)(2010-3#2)(2010-6#1)(2012-12#2)(2013-1#1)
HDAC-1 and##2##2##(2012-12#2)
HDAC-1##6##1##(2012-12#6)
HDAd##4##1##(2008-2#2)(2008-4#2)
HDC and##2##2##(1990-12#2)
HDC gene##2##2##(1997-1#2)
HDC##14##1##(1990-12#6)(1997-1#6)(2008-10#2)
HDI-M##2##1##(2008-9#2)
HDL acts to reduce##2##4##(2008-6#2)
HDL and LDL##2##3##(1995-5#1)(2008-5#1)
HDL and##6##2##(1994-8#1)(1995-5#1)(1997-7#1)(1997-8#1)(2008-5#1)(2011-1#1)
HDL cholesterol and##2##3##(2009-4#1)(2013-1#1)
HDL cholesterol concentrations##2##3##(1991-2#1)(2008-3#1)
HDL cholesterol##21##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(2007-7#1)(2008-10#1)(2008-3#8)(2008-4#1)(2008-6#1)(2009-4#1)(2012-3#1)(2013-1#2)
HDL in GS##2##3##(2012-2#2)
HDL in##3##2##(2012-2#3)
HDL of##2##2##(2008-3#1)(2012-2#1)
HDL particles##2##2##(1995-5#1)(2008-6#1)
HDL##67##1##(1990-2#1)(1991-12#4)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#2)(1993-12#2)(1993-6#1)(1994-8#1)(1995-5#5)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#9)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#4)
HDL-C level##2##2##(2008-3#1)(2013-1#1)
HDL-C levels##2##2##(2013-1#2)
HDL-C##16##1##(1990-2#1)(2008-10#1)(2008-12#1)(2008-3#3)(2011-1#3)(2012-6#2)(2013-1#5)
HDL-cholesterol and##3##2##(1992-11#1)(2008-5#1)(2013-1#1)
HDL-cholesterol in##2##2##(2008-5#1)(2008-6#1)
HDL-cholesterol levels##2##2##(2007-11#1)(2008-6#1)
HDL-cholesterol##26##1##(1992-11#1)(1993-12#3)(1993-2#1)(1994-11#2)(1994-12#2)(1995-11#1)(2007-11#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
HDL3##4##1##(1990-12#2)(1990-8#1)(1994-8#1)
HDL3-induced##3##1##(1994-11#3)
HDR##7##1##(2007-11#1)(2009-11#1)(2009-2#3)(2013-1#2)
HDS##3##1##(2007-12#3)
HDV##4##1##(2009-8#4)
HDVC##2##1##(2010-8#2)
HE##4##1##(1992-3#1)(2008-10#2)(2011-3#1)
HEALTH##14##1##(1991-12#2)(1991-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#6)(2013-1#2)
HEART score##3##2##(2012-2#3)
HEC 1A##2##2##(1995-12#2)
HEC gel##3##2##(2008-5#3)
HEC##16##1##(1994-2#8)(1995-12#2)(2008-3#2)(2008-5#4)
HEDIS 2##2##2##(1995-2#1)(1996-12#1)
HEDIS##7##1##(1995-2#3)(1996-12#1)(1997-2#1)(1997-3#2)
HEDP and ATMP##2##3##(2008-10#2)
HEDP##3##1##(2008-10#3)
HEG##5##1##(2008-10#5)
HEI score##6##2##(2011-2#6)
HEI##9##1##(2008-11#1)(2011-2#8)
HEK 293 cells##5##3##(2008-11#4)(2008-8#1)
HEK 293##10##2##(2008-11#8)(2008-8#1)(2011-2#1)
HEK##11##1##(2008-11#9)(2008-8#1)(2011-2#1)
HEK-293 cells##2##2##(2008-11#2)
HEK-293##3##1##(2008-11#3)
HEK293 and COS-1 cells##4##4##(2008-8#4)
HEK293 and##6##2##(2008-11#2)(2008-8#4)
HEK293 cells expressing##2##3##(2008-4#1)(2008-8#1)
HEK293 cells##21##2##(2008-11#4)(2008-4#5)(2008-8#5)(2009-12#2)(2010-1#2)(2011-2#1)(2013-1#2)
HEK293##30##1##(2008-11#6)(2008-4#6)(2008-8#10)(2009-12#2)(2010-1#2)(2011-1#1)(2011-2#1)(2013-1#2)
HEL 299##2##2##(2008-11#2)
HEL cells##4##2##(1990-2#3)(1995-3#1)
HEL##12##1##(1990-2#3)(1994-8#3)(1995-3#1)(2008-10#1)(2008-11#4)
HEL117##5##1##(1995-6#5)
HELLP Syndrome##2##2##(2008-1#1)(2008-4#1)
HELLP syndrome##4##2##(2008-4#3)(2008-8#1)
HELLP##9##1##(1993-3#1)(2008-1#1)(2008-4#6)(2008-8#1)
HEMA BIO 1000##2##3##(1996-5#2)
HEMA##3##1##(1996-5#2)(2008-10#1)
HEPES buffer##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
HEPES##5##1##(1995-11#1)(2008-10#2)(2008-11#1)(2011-1#1)
HER-2/neu overexpression##3##2##(1997-7#3)
HER-2/neu##9##1##(1993-9#1)(1997-7#6)(2009-7#1)(2011-2#1)
HER-2/neu-overexpressing xenografts##2##2##(1997-7#2)
HER-2/neu-overexpressing##4##1##(1997-7#4)
HER-2neu##2##1##(2008-5#2)
HER2 amplified breast##2##3##(1993-1#2)
HER2##14##1##(1993-1#4)(1995-2#1)(2008-10#1)(2008-11#4)(2009-9#4)
HER2+ breast cancer##3##3##(2010-12#1)(2010-7#2)
HER2+##5##1##(2010-12#3)(2010-7#2)
HER2-positive##3##1##(2012-12#2)(2013-1#1)
HERG##10##1##(1996-2#4)(2008-8#5)(2010-8#1)
HERV-H sequences##2##2##(1996-12#2)
HERV-H##5##1##(1996-12#5)
HES##5##1##(2007-12#1)(2007-7#1)(2012-1#3)
HET##8##1##(2008-10#5)(2008-12#3)
HEV group##2##2##(2007-7#2)
HEV##6##1##(2007-7#6)
HEV-B##2##1##(2011-1#2)
HEV71 and CVA16##2##3##(2013-8#2)
HEV71 and##3##2##(2013-8#3)
HEV71 isolates were##2##3##(2013-8#2)
HEV71 strains in##2##3##(2013-8#2)
HEV71 strains were##2##3##(2013-8#2)
HEV71 strains##13##2##(2013-8#13)
HEV71##20##1##(2013-8#20)
HEp-2 cells##3##2##(2008-10#2)(2009-8#1)
HEp-2##6##1##(2008-10#2)(2008-11#2)(2009-8#2)
HF + HClO(4) digestion##3##4##(2008-10#3)
HF and##7##2##(2008-10#6)(2010-5#1)
HF is##2##2##(2011-2#2)
HF treatment##3##2##(1993-1#1)(2008-3#1)(2013-8#1)
HF with an effective area of##2##6##(2007-11#2)
HF with##5##2##(1992-10#1)(2007-11#2)(2008-10#2)
HF##61##1##(1992-10#3)(1993-1#1)(2007-11#4)(2007-8#1)(2008-10#31)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-3#3)(2013-8#4)
HF-HR-IMS##3##1##(2008-10#3)
HF-SCs##2##1##(2012-2#2)
HFA propellants##2##2##(1996-1#2)
HFA##3##1##(1992-3#1)(1996-1#2)
HFA-134a and HFA-227##3##3##(1992-3#3)
HFA134a and##2##2##(1996-1#1)(1996-2#1)
HFA134a is a##2##3##(1996-1#1)(1996-2#1)
HFA134a was devoid of##2##4##(1996-1#2)
HFA134a was##4##2##(1996-1#4)
HFA134a##22##1##(1996-1#19)(1996-2#3)
HFAs##2##1##(1996-1#2)
HFD test##4##2##(2008-7#4)
HFD##7##1##(2008-7#7)
HFE haemochromatosis##2##2##(2008-5#2)
HFE##3##1##(2008-5#3)
HFHS##3##1##(1992-2#1)(1994-2#2)
HFMD patients in##2##3##(2013-8#2)
HFMD##3##1##(2013-8#3)
HFS##4##1##(2008-12#2)(2008-7#2)
HFpEF##4##1##(2011-2#4)
HG 3 cultivars##2##3##(2008-10#2)
HG 3##4##2##(2008-10#4)
HG and##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
HG have##2##2##(1992-8#1)(2008-7#1)
HG##36##1##(1992-8#5)(2008-1#3)(2008-10#19)(2008-11#2)(2008-7#6)(2011-2#1)
HG-AAS##3##1##(2008-10#3)
HG-AFS##2##1##(2008-10#2)
HG-I##2##1##(2008-10#2)
HG-II##4##1##(2008-10#4)
HG-III##3##1##(2008-10#3)
HGC-27##2##1##(1993-9#2)
HGD/IMCA##3##1##(2010-12#3)
HGDSC##2##1##(1994-3#2)
HGF and EGF##6##3##(1991-12#6)
HGF and##8##2##(1991-12#6)(2008-11#1)(2011-2#1)
HGF gene is##2##3##(1991-6#2)
HGF gene##3##2##(1991-6#2)(2008-11#1)
HGF on##2##2##(1990-12#1)(1991-12#1)
HGF was##11##2##(1990-12#1)(1992-12#1)(1993-3#1)(2008-1#1)(2008-11#4)(2008-9#2)(2011-2#1)
HGF were##2##2##(1992-12#1)(2008-8#1)
HGF##49##1##(1990-12#3)(1991-12#10)(1991-6#2)(1992-12#7)(1993-3#3)(2008-1#1)(2008-11#13)(2008-8#3)(2008-9#5)(2011-2#2)
HGF-bound ECM##2##2##(1993-3#2)
HGIN##2##1##(2012-2#2)
HGP##5##1##(1994-8#4)(1995-6#1)
HGSCs##4##1##(2012-12#4)
HHBIM-NTf2 and HOBIM-NTf2##3##3##(2011-1#3)
HHBIM-NTf2##5##1##(2011-1#5)
HHE in##2##2##(2011-1#2)
HHE##6##1##(2011-1#6)
HHE-related hypothyroidism##2##2##(2011-1#2)
HHR##4##1##(2011-2#3)(2012-2#1)
HHS##6##1##(1991-9#2)(1993-1#1)(1994-2#1)(2012-3#1)(2013-1#1)
HHT patients##2##2##(2008-1#2)
HHT##6##1##(2008-1#5)(2010-10#1)
HHcy induced##2##2##(2010-5#2)
HHcy-induced ED##2##2##(2010-5#2)
HI 6 in blood and brain##2##6##(1997-7#2)
HI 6 in##4##3##(1997-7#4)
HI 6##9##2##(1997-7#9)
HI activity##4##2##(1992-9#4)
HI did not affect the##2##5##(1996-5#2)
HI has##2##2##(1996-5#1)(2008-1#1)
HI to##2##2##(2008-3#2)
HI##45##1##(1992-9#5)(1996-12#4)(1996-5#11)(1997-3#3)(1997-6#5)(1997-7#9)(2008-1#3)(2008-10#1)(2008-3#3)(2010-8#1)
HIA##6##1##(2007-11#1)(2013-1#5)
HIC##6##1##(2008-10#3)(2011-1#1)(2013-1#2)
HIC1##6##1##(2009-8#6)
HIF-1 activation##3##2##(2010-7#3)
HIF-1 inhibitors##3##2##(2010-7#3)
HIF-1##10##1##(2009-4#2)(2010-7#8)
HIF-1α##3##1##(2011-1#2)(2013-1#1)
HIGH##3##1##(1993-8#1)(2010-6#1)(2012-3#1)
HII phase##7##2##(1990-12#3)(1990-2#4)
HII##10##1##(1990-12#5)(1990-2#4)(2009-2#1)
HIIE (p &lt##2##3##(2013-8#2)
HIIE (p##3##2##(2013-8#3)
HIIE##8##1##(2013-8#8)
HIK and TES##3##3##(2009-10#3)
HIK##4##1##(2009-10#4)
HILP##4##1##(2008-6#4)
HIM professionals##6##2##(2007-12#6)
HIM##10##1##(2007-12#10)
HIMA##3##1##(1993-8#3)
HINKEL##2##1##(2009-10#2)
HIP##3##1##(1995-12#2)(1997-3#1)
HIPAA compliance##3##2##(2007-12#1)(2007-9#1)(2008-9#1)
HIPAA privacy##2##2##(2007-12#2)
HIPAA security##2##2##(2007-12#1)(2008-9#1)
HIPAA##12##1##(2007-12#6)(2007-3#1)(2007-9#2)(2008-4#1)(2008-9#2)
HIPVs##3##1##(2009-8#3)
HIR-B##2##1##(1991-12#2)
HIRA##2##1##(2008-7#2)
HIS in the region##2##4##(2012-12#2)
HIS in##3##2##(2012-12#3)
HIS##19##1##(1993-12#5)(1996-1#1)(2007-10#1)(2012-12#12)
HIS3 3'##2##2##(1997-4#2)
HIS3 mRNA##4##2##(1997-4#4)
HIS3##8##1##(1994-12#1)(1997-4#7)
HIS5##3##1##(1995-6#1)(1995-9#2)
HISS release##4##2##(2008-3#4)
HISS##6##1##(2008-3#6)
HIT##14##1##(2010-3#6)(2013-1#8)
HIT-Elisa-positive##2##1##(2010-3#2)
HIT-T15 cells##2##2##(1997-4#1)(2008-11#1)
HIT-T15##4##1##(1997-4#2)(2008-11#2)
HITRAN##6##1##(2008-2#3)(2008-3#3)
HIV -##2##2##(2012-12#1)(2013-1#1)
HIV / AIDS##3##3##(1997-6#3)
HIV Care and Treatment Plan##2##5##(2010-8#2)
HIV Infection##5##2##(1996-5#2)(2008-1#1)(2008-5#1)(2010-12#1)
HIV LTR-CAT##3##2##(1993-8#3)
HIV Reverse Transcriptase##2##3##(2008-10#2)
HIV Sequence Database##2##3##(2013-1#2)
HIV Vaccine Trials Network##2##4##(2012-12#2)
HIV among##6##2##(1991-1#2)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
HIV and AIDS##4##3##(1995-12#1)(2009-7#1)(2010-8#1)(2011-3#1)
HIV and HCV##2##3##(2007-7#1)(2012-3#1)
HIV and STI prevention programs##2##5##(2008-12#1)(2011-2#1)
HIV and STI##3##3##(2008-12#1)(2011-2#2)
HIV and TB##3##3##(1993-5#1)(2010-4#2)
HIV and hepatitis C virus##3##5##(2007-12#1)(2008-10#2)
HIV and hepatitis##6##3##(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-6#1)
HIV and other sexually transmitted##2##5##(1997-6#1)(2011-2#1)
HIV and other##3##3##(1997-6#1)(2007-7#1)(2011-2#1)
HIV and the##2##3##(2008-2#2)
HIV and##49##2##(1990-6#1)(1991-3#1)(1991-6#1)(1993-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#6)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)
HIV antibodies##6##2##(1995-12#1)(1996-5#4)(2007-7#1)
HIV antibody testing##2##3##(1995-1#2)
HIV antibody##6##2##(1993-6#1)(1995-1#3)(2007-7#1)(2008-5#1)
HIV are##2##2##(2008-10#1)(2010-5#1)
HIV as##4##2##(1992-2#1)(2007-7#1)(2012-2#1)(2013-1#1)
HIV can be transmitted##2##4##(1996-5#1)(2008-10#1)
HIV can##3##2##(1996-5#1)(2008-10#1)(2009-7#1)
HIV care and treatment services in Tanzania##2##7##(2010-8#2)
HIV care and##3##3##(2010-8#2)(2013-1#1)
HIV care##14##2##(1997-5#1)(2009-10#1)(2010-4#1)(2010-8#2)(2012-12#5)(2013-1#4)
HIV cases##3##2##(1997-6#3)
HIV controllers##5##2##(2012-2#5)
HIV disclosure##2##2##(1995-6#1)(1996-5#1)
HIV discrimination##2##2##(1997-5#2)
HIV disease##22##2##(1992-1#1)(1992-4#1)(1995-3#1)(1995-6#3)(1996-3#2)(1997-4#1)(2008-4#2)(2008-6#1)(2009-5#1)(2009-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#3)
HIV dynamics##2##2##(2009-5#2)
HIV envelope##2##2##(2008-4#2)
HIV epidemic in the##2##4##(1995-1#1)(2009-7#1)
HIV epidemic in##4##3##(1990-12#1)(1995-1#1)(1996-11#1)(2009-7#1)
HIV epidemic##16##2##(1990-12#1)(1990-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#2)(1997-3#1)(2009-7#2)(2010-5#3)(2011-2#1)
HIV epidemics in##2##3##(2007-7#2)
HIV epidemics##4##2##(2007-7#2)(2010-4#1)(2010-5#1)
HIV from##8##2##(1995-12#1)(1996-5#1)(1997-5#2)(2010-10#1)(2012-12#3)
HIV glycoproteins##2##2##(1991-5#2)
HIV gp120##2##2##(1992-5#1)(1997-4#1)
HIV heterosexually##3##2##(1996-11#2)(1997-6#1)
HIV in the##3##3##(1995-3#1)(1996-9#1)(2008-4#1)
HIV in##17##2##(1991-6#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-5#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-4#1)(2011-2#2)(2013-1#1)
HIV infected children##2##3##(2010-3#1)(2010-9#1)
HIV infected in##2##3##(1991-7#1)(1993-8#1)
HIV infected patients and##2##4##(2007-8#1)(2013-8#1)
HIV infected patients##10##3##(1990-2#1)(1992-2#1)(2007-7#3)(2007-8#2)(2008-8#1)(2010-5#1)(2013-8#1)
HIV infected##26##2##(1990-2#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-8#2)(1995-12#2)(1996-11#1)(1997-5#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
HIV infection among##9##3##(1991-12#1)(2007-7#2)(2008-12#1)(2011-2#5)
HIV infection and sexually transmitted##2##5##(2009-5#1)(2011-1#1)
HIV infection and##16##3##(1991-6#1)(1996-11#2)(1996-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#3)(2013-1#1)(2013-8#2)
HIV infection are##4##3##(1995-12#1)(1995-3#1)(1996-11#1)(2011-1#1)
HIV infection has##2##3##(1990-3#1)(1996-11#1)
HIV infection in Norway (population 4##2##6##(1996-11#2)
HIV infection in intravenous drug##2##5##(1991-1#1)(1991-5#1)
HIV infection in the##3##4##(1993-11#1)(1996-11#1)(2008-8#1)
HIV infection in##21##3##(1990-3#1)(1991-1#2)(1991-3#1)(1991-5#1)(1993-11#2)(1995-6#1)(1995-9#1)(1996-11#3)(1996-8#1)(2007-7#2)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
HIV infection intensities##2##3##(1994-9#2)
HIV infection is##5##3##(1992-4#1)(1993-6#1)(2007-7#1)(2008-12#1)(2013-1#1)
HIV infection of##2##3##(1996-11#1)(2008-4#1)
HIV infection on##3##3##(1992-9#2)(2013-8#1)
HIV infection to the##2##4##(1993-3#1)(2011-2#1)
HIV infection was##4##3##(1997-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
HIV infection were##2##3##(2008-5#1)(2011-2#1)
HIV infection##154##2##(1990-2#2)(1990-3#2)(1990-6#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-4#2)(1992-9#3)(1993-11#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-3#1)(1995-6#3)(1995-9#2)(1996-11#10)(1996-3#1)(1996-5#3)(1996-8#4)(1996-9#1)(1997-3#1)(1997-5#4)(1997-6#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#10)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-5#3)(2009-7#2)(2010-12#4)(2010-3#1)(2010-5#1)(2011-1#7)(2011-2#11)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#11)
HIV infection]##5##2##(1990-6#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)
HIV infections among##2##3##(2007-7#1)(2013-1#1)
HIV infections have##2##3##(1997-3#1)(1997-6#1)
HIV infections##14##2##(1990-3#1)(1992-9#1)(1993-3#1)(1996-9#1)(1997-3#2)(1997-6#4)(2007-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
HIV is##6##2##(1996-5#1)(1996-8#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
HIV latency##3##2##(2012-12#3)
HIV may##2##2##(1993-8#1)(2010-12#1)
HIV negative patients with##2##4##(1993-11#1)(2007-10#1)
HIV negative patients##3##3##(1993-11#1)(2007-10#1)(2008-5#1)
HIV negative##5##2##(1993-11#1)(2007-10#1)(2007-7#1)(2008-5#1)(2012-12#1)
HIV on##3##2##(1995-12#1)(2012-2#1)(2013-1#1)
HIV or AIDS##2##3##(1995-6#2)
HIV or hepatitis B##2##4##(1991-6#1)(2007-2#1)
HIV or hepatitis##3##3##(1991-6#1)(2007-2#1)(2008-6#1)
HIV or##10##2##(1991-6#1)(1993-1#1)(1995-6#3)(1996-1#1)(1996-8#1)(2007-2#1)(2008-6#1)(2012-12#1)
HIV organizations##2##2##(2009-5#2)
HIV patient##2##2##(2008-1#1)(2013-8#1)
HIV patients##8##2##(1996-12#1)(2007-10#1)(2008-1#1)(2010-12#1)(2012-12#2)(2013-1#2)
HIV population##2##2##(1996-1#2)
HIV positive cases##3##3##(2007-10#2)(2007-8#1)
HIV positive patient##4##3##(2007-7#2)(2010-12#2)
HIV positive patients##11##3##(1993-11#1)(2007-7#1)(2008-1#2)(2008-5#6)(2010-12#1)
HIV positive##31##2##(1993-11#4)(1993-8#2)(1997-6#1)(2007-10#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-5#6)(2008-7#1)(2010-12#5)(2011-2#1)(2013-1#2)
HIV positivity##2##2##(1991-1#1)(2008-10#1)
HIV prevalence among##2##3##(1990-6#1)(2008-5#1)
HIV prevalence and its##2##4##(2009-4#2)
HIV prevalence and##4##3##(1992-9#2)(2009-4#2)
HIV prevalence##20##2##(1990-6#1)(1992-9#2)(2007-7#4)(2008-10#1)(2008-5#1)(2009-4#3)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
HIV prevention and transmission##2##4##(2011-2#1)(2012-12#1)
HIV prevention and##4##3##(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
HIV prevention community planning##4##4##(1997-2#4)
HIV prevention education##2##3##(2009-5#2)
HIV prevention in##4##3##(1996-11#1)(1996-4#2)(2008-4#1)
HIV prevention##31##2##(1990-6#1)(1995-12#1)(1996-11#1)(1996-4#2)(1996-5#1)(1997-2#4)(1997-5#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-4#3)(2008-7#1)(2009-5#8)(2009-7#1)(2011-2#2)(2012-12#1)
HIV protease##2##2##(1995-3#1)(1996-5#1)
HIV proteinase##2##2##(1990-5#1)(1993-3#1)
HIV rates##3##2##(2009-7#3)
HIV replication##6##2##(1990-8#1)(1995-2#1)(2007-7#1)(2008-4#1)(2012-2#2)
HIV risk behavior##3##3##(2008-12#1)(2008-4#1)(2009-8#1)
HIV risk##10##2##(1996-6#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-8#1)(2010-7#1)(2011-2#2)
HIV screening##2##2##(2008-1#1)(2008-5#1)
HIV seroconversion##2##2##(1990-3#1)(2009-12#1)
HIV seropositive individuals and##2##4##(2013-8#2)
HIV seropositive patients##2##3##(2007-7#1)(2013-8#1)
HIV seropositive##9##2##(1995-1#1)(2007-7#1)(2009-11#1)(2010-7#1)(2013-8#5)
HIV seropositivity in##2##3##(1991-1#1)(1992-2#1)
HIV seropositivity##7##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-11#1)(2007-7#2)(2008-5#1)
HIV serostatus##2##2##(2009-4#2)
HIV sexual risk behavior##3##4##(2008-12#3)
HIV spread##2##2##(1996-11#2)
HIV status from##2##3##(1996-5#1)(2010-4#1)
HIV status##20##2##(1991-7#1)(1995-12#1)(1995-6#1)(1996-5#5)(1997-5#2)(2008-10#1)(2009-7#2)(2010-4#4)(2011-2#1)(2012-1#1)(2012-12#1)
HIV stigma##4##2##(1996-5#1)(2009-7#2)(2012-1#1)
HIV symptoms##2##2##(2010-7#1)(2012-12#1)
HIV test and##4##3##(2009-5#1)(2011-1#3)
HIV test in##2##3##(1997-5#1)(2011-1#1)
HIV test##11##2##(1994-3#1)(1995-12#1)(1996-5#1)(1997-5#1)(2009-5#2)(2011-1#5)
HIV testing among##2##3##(2009-5#2)
HIV testing and##3##3##(1997-5#1)(2009-5#2)
HIV testing in##2##3##(1996-8#1)(2009-5#1)
HIV testing of##4##3##(1990-3#1)(1995-1#1)(1995-12#1)(1997-5#1)
HIV testing##18##2##(1990-3#1)(1992-4#1)(1993-8#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-5#4)(2008-8#1)(2009-5#6)
HIV tests##4##2##(1992-12#1)(1997-5#2)(2011-2#1)
HIV through##3##2##(1996-5#1)(1997-5#2)
HIV to##2##2##(1990-6#1)(1996-5#1)
HIV transcription##5##2##(1992-12#1)(1995-2#1)(2008-4#1)(2012-12#2)
HIV transmission and prevention##4##4##(2011-2#2)(2012-12#2)
HIV transmission and##8##3##(1997-6#1)(2009-7#1)(2011-2#2)(2012-12#3)(2012-2#1)
HIV transmission to##2##3##(1992-12#1)(1995-6#1)
HIV transmission##30##2##(1991-1#2)(1992-12#1)(1993-1#1)(1995-6#1)(1996-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#2)(2013-8#4)
HIV treatment##10##2##(2008-10#2)(2008-6#1)(2009-4#1)(2010-11#1)(2010-4#3)(2011-1#1)(2013-8#1)
HIV type 1##2##3##(2008-2#1)(2008-5#1)
HIV vaccine##4##2##(1996-2#1)(2007-7#2)(2013-1#1)
HIV viral load##2##3##(2006-10#1)(2013-1#1)
HIV viral##3##2##(2006-10#1)(2009-12#1)(2013-1#1)
HIV was##2##2##(1996-5#1)(2012-12#1)
HIV western blot and##2##4##(2008-12#2)
HIV##934##1##(1990-12#1)(1990-2#4)(1990-3#6)(1990-5#1)(1990-6#10)(1990-8#1)(1990-9#1)(1991-1#8)(1991-11#5)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#4)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#7)(1992-2#3)(1992-4#4)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#9)(1993-1#2)(1993-11#8)(1993-12#4)(1993-3#6)(1993-5#1)(1993-6#4)(1993-8#10)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#6)(1995-1#9)(1995-12#21)(1995-2#3)(1995-3#4)(1995-5#4)(1995-6#20)(1995-9#2)(1996-1#6)(1996-11#25)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#3)(1996-5#40)(1996-6#3)(1996-8#7)(1996-9#4)(1997-2#6)(1997-3#9)(1997-4#4)(1997-5#30)(1997-6#18)(1997-7#1)(1997-8#1)(2006-10#4)(2007-10#5)(2007-11#1)(2007-12#8)(2007-2#8)(2007-4#1)(2007-7#48)(2007-8#5)(2008-1#13)(2008-10#27)(2008-11#6)(2008-12#15)(2008-2#3)(2008-4#22)(2008-5#28)(2008-6#7)(2008-7#10)(2008-8#11)(2008-9#1)(2009-10#5)(2009-11#1)(2009-12#5)(2009-4#13)(2009-5#31)(2009-7#26)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#15)(2010-3#3)(2010-4#12)(2010-5#13)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#15)(2011-2#45)(2011-3#6)(2012-1#3)(2012-12#46)(2012-2#23)(2012-3#3)(2013-1#34)(2013-8#29)
HIV+##9##1##(1996-3#1)(2008-1#1)(2008-10#2)(2008-4#3)(2009-7#1)(2010-8#1)
HIV-1 CRF07_BC##2##2##(2013-8#2)
HIV-1 DNA was##2##3##(1990-2#2)
HIV-1 DNA##3##2##(1990-2#3)
HIV-1 Infection##8##2##(2008-2#7)(2009-9#1)
HIV-1 Integrase##2##2##(2009-11#1)(2010-5#1)
HIV-1 PR were##2##3##(1991-9#2)
HIV-1 PR##5##2##(1991-9#3)(2011-3#2)
HIV-1 Rev##3##2##(1993-8#2)(2011-3#1)
HIV-1 Tat##5##2##(1993-2#2)(1994-11#1)(2009-8#2)
HIV-1 Vpr has##2##3##(1997-3#2)
HIV-1 Vpr##3##2##(1997-3#3)
HIV-1 activity in vitro##2##4##(1996-5#2)
HIV-1 and HIV-2 proteinases##3##4##(1990-5#1)(1990-8#2)
HIV-1 and HIV-2##6##3##(1990-5#1)(1990-8#3)(1992-6#1)(2011-2#1)
HIV-1 and##11##2##(1990-5#1)(1990-8#3)(1990-9#1)(1992-6#1)(1996-9#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-8#1)
HIV-1 disease##2##2##(2008-2#2)
HIV-1 drug##2##2##(2011-2#1)(2013-1#1)
HIV-1 envelope##2##2##(1994-8#1)(2011-2#1)
HIV-1 fusion inhibitors##2##3##(2011-3#2)
HIV-1 fusion##3##2##(2011-3#3)
HIV-1 group N##3##3##(2013-1#3)
HIV-1 group##4##2##(1996-3#1)(2013-1#3)
HIV-1 have##2##2##(1992-6#1)(2008-4#1)
HIV-1 in##9##2##(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#2)(1994-11#1)(1994-6#1)(2008-12#1)(2008-4#1)
HIV-1 infected individuals##6##3##(1990-2#1)(2007-7#1)(2008-11#3)(2010-8#1)
HIV-1 infected women##2##3##(1994-11#1)(2011-1#1)
HIV-1 infected##16##2##(1990-2#1)(1994-11#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-11#5)(2010-8#2)(2011-1#2)(2011-2#1)(2011-3#1)
HIV-1 infection in##2##3##(1997-2#1)(2007-7#1)
HIV-1 infection##28##2##(1990-2#2)(1991-1#1)(1991-9#1)(1994-6#2)(1995-9#3)(1996-11#1)(1997-2#1)(2007-7#1)(2008-11#4)(2008-2#7)(2010-11#2)(2013-1#2)(2013-8#1)
HIV-1 integrase##9##2##(1992-6#2)(2010-5#3)(2011-3#4)
HIV-1 is##2##2##(1992-6#1)(2008-2#1)
HIV-1 long terminal repeat##2##4##(1992-12#1)(1994-5#1)
HIV-1 matrix##2##2##(2013-1#2)
HIV-1 particles are##2##3##(1997-3#2)
HIV-1 positive##3##2##(2009-8#2)(2010-8#1)
HIV-1 preparations##2##2##(1997-3#2)
HIV-1 prevalence##2##2##(1995-9#2)
HIV-1 production##3##2##(1992-12#1)(1994-11#2)
HIV-1 protease activity##2##3##(1991-12#2)
HIV-1 protease##18##2##(1990-8#1)(1991-12#4)(1991-9#3)(1992-11#4)(1992-6#1)(1992-8#3)(2011-3#2)
HIV-1 protein##3##2##(2013-1#3)
HIV-1 replication and##2##3##(1992-8#1)(2011-3#1)
HIV-1 replication##10##2##(1992-8#1)(1994-6#3)(2011-3#5)(2013-1#1)
HIV-1 replicative enzymes##3##3##(2011-3#3)
HIV-1 reverse transcriptase##9##3##(1991-9#1)(1992-3#2)(1993-3#3)(2011-2#1)(2011-3#2)
HIV-1 seronegative##2##2##(1990-2#1)(2007-12#1)
HIV-1 seropositive##3##2##(1990-2#1)(1997-4#1)(2013-8#1)
HIV-1 seroprevalence in##2##3##(1995-9#2)
HIV-1 specific##2##2##(1992-8#2)
HIV-1 strain##3##2##(2011-2#1)(2011-3#2)
HIV-1 subtypes##5##2##(2013-1#5)
HIV-1 transmission##4##2##(1992-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
HIV-1 with##2##2##(2008-12#1)(2011-3#1)
HIV-1##314##1##(1990-2#8)(1990-5#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#12)(1992-11#4)(1992-12#5)(1992-3#2)(1992-6#8)(1992-8#10)(1992-9#9)(1993-2#2)(1993-3#6)(1993-8#2)(1994-11#8)(1994-2#5)(1994-5#1)(1994-6#14)(1994-8#2)(1995-9#7)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#14)(1997-4#2)(1997-6#1)(2007-12#2)(2007-7#4)(2008-11#16)(2008-12#4)(2008-2#22)(2008-4#4)(2008-5#1)(2008-9#1)(2009-11#1)(2009-4#4)(2009-5#1)(2009-8#5)(2009-9#1)(2010-11#2)(2010-5#4)(2010-8#3)(2011-1#5)(2011-2#9)(2011-3#48)(2012-12#1)(2013-1#22)(2013-7#1)(2013-8#7)
HIV-1-Associated##2##1##(2008-1#1)(2008-2#1)
HIV-1-associated dementia##2##2##(2008-1#1)(2008-2#1)
HIV-1-associated##4##1##(2008-1#1)(2008-2#3)
HIV-1-infected individuals##3##2##(1994-6#1)(2008-5#1)(2013-8#1)
HIV-1-infected##8##1##(1994-11#1)(1994-6#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-8#1)(2013-8#1)
HIV-1-related##2##1##(1997-5#1)(2011-3#1)
HIV-1/AIDS##8##1##(2009-11#1)(2009-4#7)
HIV-1IIIB##2##1##(1992-6#2)
HIV-2 and##2##2##(1997-3#1)(2011-2#1)
HIV-2 protease from##2##3##(1990-8#2)
HIV-2 protease##3##2##(1990-8#3)
HIV-2##18##1##(1990-3#1)(1990-5#1)(1990-8#7)(1992-6#1)(1992-8#1)(1994-11#1)(1997-3#4)(2011-2#1)(2013-7#1)
HIV-Infected Individuals##2##2##(2008-6#1)(2012-12#1)
HIV-Infected Patient##2##2##(2011-2#2)
HIV-Infected##7##1##(2008-3#1)(2008-6#1)(2011-2#4)(2012-12#1)
HIV-Positive##2##1##(2007-2#1)(2013-1#1)
HIV-RNA##4##1##(2008-5#4)
HIV-TB-coinfected patients##2##2##(2010-5#2)
HIV-antibody home test##2##3##(1996-5#2)
HIV-antibody home##3##2##(1996-5#3)
HIV-antibody testing##5##2##(1996-5#5)
HIV-antibody##10##1##(1996-5#10)
HIV-associated nephropathy##2##2##(2008-1#1)(2012-2#1)
HIV-associated neurocognitive##2##2##(2011-2#2)
HIV-associated##6##1##(2008-1#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
HIV-epidemic in##2##2##(1996-11#2)
HIV-epidemic##4##1##(1996-11#4)
HIV-induced##2##1##(2008-11#1)(2011-2#1)
HIV-infected Africans##3##2##(1993-6#3)
HIV-infected and -exposed children##2##4##(2012-12#2)
HIV-infected and##5##2##(2009-7#1)(2010-5#1)(2012-12#2)(2013-1#1)
HIV-infected cells##2##2##(1991-5#1)(1992-8#1)
HIV-infected hemophiliacs##2##2##(1996-5#2)
HIV-infected individuals##7##2##(1996-8#1)(2007-2#1)(2008-5#2)(2009-7#1)(2010-5#1)(2012-12#1)
HIV-infected or AIDS patients##2##4##(2008-5#2)
HIV-infected out of##2##3##(1993-6#2)
HIV-infected patients in##2##3##(2008-3#1)(2010-5#1)
HIV-infected patients with##4##3##(1997-8#1)(2008-5#2)(2011-2#1)
HIV-infected patients##27##2##(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-3#2)(2008-5#6)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-2#1)
HIV-infected people##2##2##(1993-6#1)(2008-10#1)
HIV-infected persons##8##2##(1990-3#1)(1993-1#2)(1997-6#2)(2010-5#3)
HIV-infected subjects##4##2##(1997-4#1)(2008-12#1)(2009-12#2)
HIV-infected travellers##2##2##(2007-2#2)
HIV-infected##94##1##(1990-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#4)(1993-1#2)(1993-3#2)(1993-6#7)(1993-9#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-12#6)(2007-2#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#7)(2010-5#7)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#1)(2013-1#1)
HIV-infection##10##1##(1990-6#1)(1992-2#1)(1992-4#2)(1992-8#2)(1996-9#1)(2007-12#1)(2008-1#1)(2008-12#1)
HIV-negative men##2##2##(2009-12#1)(2009-5#1)
HIV-negative##7##1##(1996-5#1)(2008-5#1)(2009-12#2)(2009-5#1)(2009-7#1)(2012-3#1)
HIV-positive individuals##4##2##(1992-12#1)(1994-1#1)(2008-1#1)(2013-1#1)
HIV-positive man who##2##3##(1996-5#1)(1997-5#1)
HIV-positive patient##3##2##(1993-6#1)(1994-3#1)(1997-5#1)
HIV-positive patients in##2##3##(2008-5#1)(2009-8#1)
HIV-positive patients##6##2##(1995-6#1)(2008-5#2)(2009-8#1)(2013-1#2)
HIV-positive pregnant women##2##3##(2007-2#1)(2013-1#1)
HIV-positive service members##2##3##(1995-6#2)
HIV-positive women at an##2##4##(2011-1#2)
HIV-positive women##7##2##(2007-2#2)(2008-12#1)(2009-4#1)(2011-1#3)
HIV-positive##59##1##(1990-3#2)(1991-7#2)(1992-12#3)(1993-6#3)(1994-1#1)(1994-3#1)(1995-12#2)(1995-6#7)(1996-3#1)(1996-5#5)(1997-5#5)(1997-6#1)(2006-5#1)(2007-2#3)(2008-1#4)(2008-11#1)(2008-12#1)(2008-5#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-1#4)
HIV-related knowledge##2##2##(1992-12#1)(2013-1#1)
HIV-related##17##1##(1990-9#1)(1991-1#1)(1992-12#1)(1992-6#1)(1995-1#1)(1995-12#2)(1996-11#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-7#1)(2013-1#1)
HIV-risk reduction##2##2##(2008-6#2)
HIV-risk##3##1##(1991-1#1)(2008-6#2)
HIV-seropositive##2##1##(1997-8#1)(2008-12#1)
HIV-specific responses##2##2##(2013-8#2)
HIV/ AIDS##2##2##(2008-10#1)(2010-5#1)
HIV/AIDS and STI##2##3##(2008-10#1)(2008-12#1)
HIV/AIDS and##10##2##(1995-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
HIV/AIDS conspiracy theories##3##3##(2013-1#3)
HIV/AIDS epidemic##2##2##(2007-7#1)(2012-3#1)
HIV/AIDS have##2##2##(1995-12#1)(2011-3#1)
HIV/AIDS high risk##2##3##(2011-1#2)
HIV/AIDS in Jamaica##5##3##(2009-7#5)
HIV/AIDS in##13##2##(1995-3#1)(2007-7#1)(2008-1#1)(2009-4#1)(2009-7#6)(2010-8#1)(2011-1#2)
HIV/AIDS patients##5##2##(1995-6#1)(2007-7#1)(2008-1#1)(2010-9#1)(2012-12#1)
HIV/AIDS prevention education##2##3##(2008-10#1)(2009-5#1)
HIV/AIDS prevention##4##2##(2008-10#2)(2009-5#1)(2009-6#1)
HIV/AIDS surveillance##2##2##(1997-3#2)
HIV/AIDS that##2##2##(1997-3#1)(1997-6#1)
HIV/AIDS to##2##2##(1995-3#1)(1995-6#1)
HIV/AIDS transmission##2##2##(2008-10#1)(2010-8#1)
HIV/AIDS was##2##2##(1995-12#1)(2011-1#1)
HIV/AIDS were##2##2##(2010-8#1)(2011-1#1)
HIV/AIDS##144##1##(1990-2#1)(1992-12#3)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-6#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#5)(1997-3#4)(1997-5#2)(1997-6#5)(2007-1#1)(2007-12#1)(2007-7#12)(2008-1#6)(2008-10#9)(2008-12#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#11)(2010-10#1)(2010-3#2)(2010-8#11)(2010-9#1)(2011-1#11)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#1)
HIV/acquired immunodeficiency syndrome##2##3##(1996-9#1)(2012-2#1)
HIV1 Rev##3##2##(1997-4#3)
HIV1##4##1##(1993-6#1)(1997-4#3)
HIV?##2##1##(1991-1#1)(2010-5#1)
HIVAN##2##1##(2008-1#2)
HIVmn##3##1##(1991-9#3)
HJ-1A/1B CCD##2##2##(2013-8#2)
HJ-1A/1B##3##1##(2013-8#3)
HK were##2##2##(1992-2#2)
HK##9##1##(1992-2#5)(1996-8#1)(2011-2#3)
HKD animals##2##2##(1991-5#2)
HKD rats##2##2##(1991-5#2)
HKD##5##1##(1991-5#5)
HKII gene##2##2##(1993-11#1)(1994-11#1)
HKT##3##1##(2008-10#3)
HL activity##2##2##(1994-8#1)(2008-7#1)
HL patients##3##2##(1992-12#3)
HL##15##1##(1990-12#1)(1991-2#4)(1992-12#3)(1994-8#4)(2007-8#1)(2008-7#1)(2012-2#1)
HL-1 cells##2##2##(2008-7#2)
HL-1 cells)##2##2##(2008-7#2)
HL-1##4##1##(2008-7#4)
HL-60 Cells##2##2##(2011-2#2)
HL-60 and##2##2##(1995-3#1)(1995-8#1)
HL-60 cell line##2##3##(1993-8#2)
HL-60 cell nuclei##2##3##(2008-8#2)
HL-60 cell##8##2##(1991-12#1)(1993-8#2)(1994-9#1)(2008-8#3)(2008-9#1)
HL-60 cells and##3##3##(1994-8#1)(1995-6#1)(2008-11#1)
HL-60 cells by##3##3##(1993-8#2)(1994-11#1)
HL-60 cells induced by##2##4##(1994-8#1)(2008-8#1)
HL-60 cells to##2##3##(1994-6#1)(2008-11#1)
HL-60 cells was##2##3##(1993-6#1)(2008-8#1)
HL-60 cells were##2##3##(1993-8#1)(1994-9#1)
HL-60 cells##40##2##(1992-11#2)(1993-6#2)(1993-8#5)(1994-11#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-3#1)(1995-6#3)(1996-2#2)(2008-11#6)(2008-8#9)(2011-2#2)
HL-60 promyelocytic leukemia##2##3##(1991-9#1)(2008-11#1)
HL-60##71##1##(1990-2#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#2)(1993-6#3)(1993-8#7)(1994-11#3)(1994-12#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-3#5)(1995-6#4)(1995-8#1)(1996-2#2)(2008-11#9)(2008-4#1)(2008-8#13)(2008-9#1)(2011-2#5)
HL-60/R-CP cells##3##2##(2008-11#3)
HL60 cells##6##2##(1992-8#1)(1993-8#2)(1994-8#1)(2012-12#2)
HL60##10##1##(1992-8#1)(1993-3#1)(1993-8#2)(1994-8#1)(2008-9#2)(2012-12#3)
HLA Class I##2##3##(2011-2#2)
HLA Class##3##2##(2008-8#1)(2011-2#2)
HLA DR and beta 2-M##2##5##(1997-3#2)
HLA DR and beta##3##4##(1997-3#3)
HLA allele##2##2##(2007-6#2)
HLA alleles##2##2##(2007-6#1)(2012-12#1)
HLA antibodies##3##2##(1994-12#1)(2008-9#2)
HLA antibody##2##2##(1990-11#1)(2008-9#1)
HLA antigens and##2##3##(1990-11#1)(2008-1#1)
HLA class I and II##3##5##(2011-2#1)(2012-12#2)
HLA class I and##4##4##(2008-4#1)(2011-2#1)(2012-12#2)
HLA class I##13##3##(1994-5#1)(1997-8#1)(1997-9#6)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#2)
HLA class II##6##3##(1995-12#1)(1997-8#4)(1997-9#1)
HLA class##20##2##(1994-5#1)(1995-12#1)(1997-8#5)(1997-9#8)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#2)
HLA genes##4##2##(1991-11#1)(1991-2#1)(1997-8#2)
HLA heavy##2##2##(1991-2#1)(1997-9#1)
HLA matched##2##2##(2011-2#2)
HLA matching##2##2##(2011-2#2)
HLA molecules##4##2##(2008-4#1)(2008-9#2)(2011-2#1)
HLA typing##3##2##(1997-8#1)(2008-11#1)(2011-2#1)
HLA##80##1##(1990-11#2)(1991-11#2)(1991-2#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-3#3)(1997-5#2)(1997-8#9)(1997-9#11)(2006-10#1)(2007-6#3)(2008-1#4)(2008-10#4)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#7)(2009-8#1)(2011-2#15)(2012-12#4)
HLA-A*0201-restricted##3##1##(2011-2#3)
HLA-A11##3##1##(2008-7#2)(2011-2#1)
HLA-A2##2##1##(2008-8#2)
HLA-B##5##1##(1997-8#4)(2008-9#1)
HLA-B27 and##2##2##(1990-11#1)(2012-12#1)
HLA-B27 is##2##2##(2008-9#2)
HLA-B27##14##1##(1990-11#2)(2008-9#7)(2012-12#5)
HLA-B52 and B39##3##3##(1997-8#3)
HLA-B52##5##1##(1997-8#5)
HLA-B7##2##1##(2008-1#1)(2011-2#1)
HLA-DQ##2##1##(1997-3#1)(1997-9#1)
HLA-DR and##4##2##(1991-2#2)(1994-9#1)(1997-9#1)
HLA-DR##14##1##(1990-6#2)(1991-2#3)(1994-9#3)(1997-3#2)(1997-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
HLA-DR-containing##2##1##(1997-3#2)
HLA-DR3 and##2##2##(1995-11#1)(2008-1#1)
HLA-DR3##4##1##(1995-11#2)(2008-1#1)(2010-5#1)
HLA-DR4##2##1##(1997-4#1)(1997-8#1)
HLA-DRB4*01##2##1##(2012-12#2)
HLA-Dr##3##1##(1990-12#3)
HLA-G##2##1##(1994-9#1)(2013-1#1)
HLA-class I##3##2##(1991-3#1)(1997-8#1)(2007-7#1)
HLA-identical##3##1##(1991-5#1)(2010-5#1)(2011-2#1)
HLA-linked##2##1##(1997-8#2)
HLA-matched##3##1##(2006-10#1)(2010-11#1)(2012-12#1)
HLA-peptide binding prediction##2##3##(2007-6#2)
HLA-peptide binding##3##2##(2007-6#3)
HLA-peptide##4##1##(2007-6#4)
HLA/GO##2##1##(2008-10#2)
HLB##9##1##(2008-10#7)(2011-1#2)
HLE##7##1##(1992-12#3)(1993-8#3)(2008-5#1)
HLH can##2##2##(2011-2#2)
HLH is##2##2##(2011-2#2)
HLH##17##1##(2008-8#1)(2011-2#14)(2012-3#2)
HLH-29##5##1##(2012-12#5)
HM and##5##2##(1990-7#1)(2008-10#1)(2008-9#3)
HM##16##1##(1990-7#1)(1991-8#1)(2008-10#6)(2008-9#8)
HM-heart##2##1##(2008-9#2)
HMA##8##1##(1994-8#1)(2008-10#7)
HMB##2##1##(2007-5#1)(2008-10#1)
HMBC##3##1##(1992-8#1)(2007-11#1)(2008-11#1)
HMC##3##1##(1992-11#3)
HMC-1 cells##2##2##(2011-2#2)
HMC-1##4##1##(2011-2#4)
HMCL##2##1##(1993-9#1)(2009-4#1)
HMCLs##2##1##(1993-9#1)(2009-4#1)
HMDE and a##2##3##(2008-10#2)
HMDE and##3##2##(2008-10#3)
HMDE##7##1##(2008-10#7)
HMDSO##2##1##(2008-3#2)
HMEC##3##1##(1990-12#3)
HMEs##6##1##(1992-2#6)
HMF was found##2##3##(1996-2#2)
HMF was##5##2##(1996-2#5)
HMF##13##1##(1996-2#5)(2008-10#2)(2008-11#3)(2011-1#3)
HMG 1 was##2##3##(1990-3#2)
HMG 14##2##2##(1990-3#2)
HMG 17##2##2##(1990-3#2)
HMG 2 in young##2##4##(1990-3#2)
HMG 2 in##3##3##(1990-3#3)
HMG 2##5##2##(1990-3#5)
HMG box##2##2##(2008-8#1)(2010-5#1)
HMG domain##2##2##(1995-8#2)
HMG proteins and##3##3##(1990-3#1)(2008-8#2)
HMG proteins may##2##3##(1990-3#1)(2008-8#1)
HMG proteins##8##2##(1990-3#2)(2008-8#6)
HMG##26##1##(1990-3#13)(1993-2#1)(1995-8#3)(2008-8#7)(2010-5#1)(2013-1#1)
HMG-14##2##1##(1993-2#2)
HMG-14a is##2##2##(1993-2#2)
HMG-14a##5##1##(1993-2#5)
HMG-CoA reductase activity##2##3##(1993-6#1)(2008-10#1)
HMG-CoA reductase inhibitors##2##3##(2008-1#1)(2008-11#1)
HMG-CoA reductase##7##2##(1991-12#2)(1993-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
HMG-CoA##9##1##(1990-8#2)(1991-12#2)(1993-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
HMG1##6##1##(1994-9#5)(1997-3#1)
HMG1-induced##2##1##(1997-6#2)
HMG1/2##3##1##(1994-9#1)(2008-8#2)
HMG14/17##2##1##(2008-8#2)
HMG2 gene##7##2##(1995-2#7)
HMG2##10##1##(1995-2#9)(1997-3#1)
HMG2TF##2##1##(1995-2#2)
HMGA2 by downregulating##2##3##(2012-12#2)
HMGA2 expression##2##2##(2012-12#2)
HMGA2##7##1##(2012-12#7)
HMGCoA reductase inhibitors##2##3##(1991-6#2)
HMGCoA reductase##4##2##(1991-6#4)
HMGI proteins##2##2##(1995-8#2)
HMH##4##1##(1992-12#1)(2008-9#3)
HMHs##2##1##(1992-12#2)
HMK and HSK##3##3##(1993-12#3)
HMK##6##1##(1993-12#6)
HML and HMR##3##3##(2008-8#3)
HMM##9##1##(1996-12#1)(1997-2#3)(2008-7#3)(2009-3#1)(2009-7#1)
HMMs##3##1##(2008-6#1)(2008-7#1)(2009-7#1)
HMO and PPO##2##3##(1996-2#1)(1997-3#1)
HMO and##5##2##(1994-12#2)(1996-2#1)(1997-3#1)(2008-11#1)
HMO enrollees##5##2##(1994-3#2)(1996-2#1)(1997-2#2)
HMO industry##3##2##(1991-3#2)(1992-1#1)
HMO payments##2##2##(1993-3#1)(1997-2#1)
HMO penetration##3##2##(2008-11#3)
HMO performance##4##2##(1991-3#1)(1993-12#2)(1996-2#1)
HMO perturbation##2##2##(1996-2#2)
HMO respondents##2##2##(1997-2#2)
HMO to make##2##3##(1994-12#2)
HMO to##3##2##(1994-12#3)
HMO was##2##2##(1993-3#1)(1994-12#1)
HMO##78##1##(1991-1#3)(1991-3#7)(1991-9#2)(1992-1#3)(1993-1#1)(1993-12#10)(1993-2#1)(1993-3#3)(1994-12#6)(1994-3#4)(1995-1#2)(1996-12#1)(1996-2#11)(1996-3#3)(1996-8#1)(1997-1#7)(1997-2#6)(1997-3#2)(2008-11#5)
HMO's##4##1##(1991-12#2)(1996-3#1)(2008-6#1)
HMO(4)Q##4##1##(2008-10#4)
HMOs and##3##2##(1991-3#1)(1997-2#2)
HMOs are##3##2##(1991-3#1)(1993-1#1)(1997-3#1)
HMOs have##2##2##(1994-1#1)(1997-3#1)
HMOs in local markets##2##4##(1997-1#2)
HMOs in the##2##3##(1997-1#2)
HMOs in##5##2##(1993-12#1)(1997-1#4)
HMOs offer Medicare##2##3##(1996-3#2)
HMOs that##4##2##(1991-3#1)(1994-3#1)(1995-12#1)(1997-2#1)
HMOs to##6##2##(1993-12#2)(1993-3#1)(1996-3#2)(1997-2#1)
HMOs##60##1##(1991-1#1)(1991-3#7)(1993-1#1)(1993-12#3)(1993-3#3)(1994-1#3)(1994-2#1)(1994-3#4)(1995-12#4)(1996-3#5)(1997-1#9)(1997-2#9)(1997-3#4)(1997-6#1)(2008-11#2)(2008-6#3)
HMPD##2##1##(2008-3#2)
HMPG##2##1##(2008-3#2)
HMQ##10##1##(2008-10#10)
HMQ)##2##1##(2008-10#2)
HMQC##4##1##(1992-8#1)(2007-1#1)(2007-11#1)(2008-11#1)
HMRI##2##1##(1993-12#1)(1994-3#1)
HMTA aqueous solutions##2##3##(2013-1#2)
HMTA##4##1##(2008-10#1)(2013-1#3)
HMV-1 cells##4##2##(2008-11#4)
HMV-1##5##1##(2008-11#5)
HMW HA##2##2##(2010-8#2)
HMW PAH biodegradation##3##3##(2011-1#3)
HMW##9##1##(1990-12#3)(2008-10#1)(2010-8#2)(2011-1#3)
HMW-BCGF and Bb##2##3##(1991-3#2)
HMW-BCGF and##3##2##(1991-3#3)
HMW-BCGF but not Bb##2##4##(1991-3#2)
HMW-BCGF receptor##2##2##(1991-3#2)
HMW-BCGF##10##1##(1991-3#10)
HMW-pp185##3##1##(1992-10#3)
HMX and TNT##2##3##(2008-10#2)
HMX##10##1##(2008-10#10)
HMX)##2##1##(2008-10#1)(2008-11#1)
HN gene##4##2##(2007-6#1)(2008-11#1)(2008-9#2)
HN mRNA##2##2##(2008-9#2)
HN##13##1##(2007-6#3)(2008-11#1)(2008-7#3)(2008-9#6)
HN30##2##1##(2011-2#2)
HNDB##4##1##(1994-3#4)
HNE##7##1##(1996-12#4)(2008-5#3)
HNG##5##1##(2012-12#5)
HNO##2##1##(1992-9#2)
HNO(3) and 0##6##3##(2008-10#6)
HNO(3) and H(2)O(2)##5##3##(2008-10#5)
HNO(3) and HF##2##3##(2008-10#2)
HNO(3) and##26##2##(2008-10#26)
HNO(3) as##2##2##(2008-10#2)
HNO(3) at a flow rate of##2##6##(2008-10#2)
HNO(3) at##3##2##(2008-10#3)
HNO(3) concentration##2##2##(2008-10#2)
HNO(3) in##6##2##(2008-10#5)(2008-3#1)
HNO(3) medium##2##2##(2008-10#2)
HNO(3) solution and##2##3##(2008-10#2)
HNO(3) solution##4##2##(2008-10#4)
HNO(3) was##2##2##(2008-10#2)
HNO(3)##114##1##(1991-5#1)(2008-10#110)(2008-3#3)
HNO(3)) and##3##2##(2008-10#3)
HNO(3))##4##1##(2008-10#4)
HNO(3)-H(2)O##2##1##(2008-3#2)
HNO(3)-HF##2##1##(2008-10#2)
HNO3 +##2##2##(2013-8#2)
HNO3##3##1##(2008-3#1)(2013-8#2)
HNPP##3##1##(1997-3#3)
HNR##2##1##(2008-10#2)
HNSCC##6##1##(1997-7#4)(2013-1#2)
HO is##2##2##(2007-11#2)
HO sensitivity##3##2##(1991-6#3)
HO##23##1##(1991-6#3)(1994-5#1)(1995-2#4)(2007-11#5)(2008-10#2)(2008-4#1)(2012-2#7)
HO-1##11##1##(1995-2#3)(2008-4#2)(2011-2#6)
HOBIM-NTf2##4##1##(2011-1#4)
HOBs exposed to gp120##2##4##(2013-1#2)
HOBs##3##1##(2013-1#3)
HOCM##2##1##(1992-9#2)
HOCl and cathepsin G##2##4##(1992-5#2)
HOCl##8##1##(1991-9#1)(1992-5#7)
HOE##4##1##(2008-2#1)(2008-3#3)
HOE's##5##1##(2008-2#3)(2008-3#2)
HOLF##3##1##(2013-1#3)
HOLMES##2##1##(2008-10#2)
HOMA &gt##2##2##(2012-5#2)
HOMA##5##1##(2008-3#1)(2012-5#4)
HOMA-IR index##2##2##(2008-3#1)(2010-4#1)
HOMA-IR was##2##2##(2008-3#1)(2010-4#1)
HOMA-IR##14##1##(2008-3#4)(2010-4#3)(2011-1#4)(2013-1#1)(2013-8#2)
HOOK-domain##6##1##(2008-8#6)
HOPD##2##1##(1992-12#2)
HOR type##2##2##(2008-7#2)
HOR##4##1##(2008-7#4)
HORs in##2##2##(2008-7#2)
HORs##5##1##(2008-7#5)
HOS##3##1##(1994-6#1)(2008-3#2)
HOX 1 genes##3##3##(1992-3#3)
HOX 1##5##2##(1992-3#5)
HOX 60##2##2##(1993-9#2)
HOX##9##1##(1992-3#6)(1993-9#2)(2007-12#1)
HOXB13##2##1##(2008-7#1)(2010-5#1)
HP##18##1##(1990-5#1)(1991-12#1)(1991-5#4)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
HP-beta-CD##5##1##(2008-10#5)
HP1 paralogs##2##2##(2013-1#2)
HP1 proteins##3##2##(2013-1#3)
HP1##5##1##(2013-1#5)
HP1α and β##2##3##(2013-1#2)
HP2##3##1##(1990-7#3)
HP3##3##1##(1990-7#2)(1994-6#1)
HPA axis function##3##3##(2013-1#3)
HPA axis##12##2##(1990-3#1)(1994-2#2)(1995-12#1)(2008-11#2)(2008-4#2)(2013-1#4)
HPA##17##1##(1990-3#1)(1990-7#2)(1994-2#2)(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2011-2#1)(2013-1#4)
HPA-1 platelet##2##2##(1991-11#2)
HPA-1a##3##1##(1991-11#3)
HPAEC-PAD was##3##2##(1991-7#3)
HPAEC-PAD##5##1##(1991-7#3)(1995-2#2)
HPB##9##1##(2008-10#2)(2011-2#2)(2013-1#5)
HPC-CS preparations##2##2##(1997-6#2)
HPC-CS##3##1##(1997-6#3)
HPCE##6##1##(1996-12#1)(2008-10#5)
HPCM##2##1##(1994-3#2)
HPD##4##1##(2008-3#1)(2013-1#3)
HPE##5##1##(2011-1#4)(2013-1#1)
HPF##2##1##(1991-8#1)(1994-6#1)
HPI##5##1##(1992-12#2)(1996-2#3)
HPI1 is##2##2##(1990-7#2)
HPI1##4##1##(1990-7#4)
HPLC after##2##2##(1990-12#1)(2008-10#1)
HPLC analysis of##3##3##(1993-8#1)(1995-8#1)(2008-11#1)
HPLC analysis##11##2##(1993-11#1)(1993-8#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-8#1)
HPLC and CE##2##3##(1996-5#1)(2008-10#1)
HPLC and GC-MS##2##3##(2008-10#2)
HPLC and HPCE##2##3##(2008-10#2)
HPLC and Raman spectroscopy##2##4##(2008-10#2)
HPLC and UV spectrophotometric techniques##2##5##(2011-1#2)
HPLC and UV##3##3##(2008-10#1)(2011-1#2)
HPLC and##38##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-5#2)(1997-4#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)(2011-2#1)
HPLC as##3##2##(1993-11#1)(2008-10#2)
HPLC assay was##3##3##(2008-10#3)
HPLC assay##13##2##(1992-9#1)(1996-5#2)(1997-2#1)(1997-4#1)(2008-10#7)(2011-1#1)
HPLC assays##2##2##(2008-10#1)(2010-3#1)
HPLC based##2##2##(2008-10#2)
HPLC column##10##2##(1991-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-10#4)(2009-8#1)
HPLC columns##6##2##(1997-2#2)(2008-10#2)(2008-4#2)
HPLC coupled to##2##3##(2008-10#1)(2008-7#1)
HPLC determination of##9##3##(1996-5#1)(2008-10#7)(2008-5#1)
HPLC equipment##3##2##(2008-10#3)
HPLC fingerprint of##2##3##(2012-3#1)(2013-8#1)
HPLC for the##3##3##(2008-10#3)
HPLC for##5##2##(1991-5#1)(2008-10#4)
HPLC gave a##2##3##(1994-5#1)(2008-10#1)
HPLC has##2##2##(1991-5#1)(1997-2#1)
HPLC in##4##2##(1994-11#1)(1997-7#1)(2008-10#2)
HPLC is##4##2##(1990-8#1)(1991-5#1)(2008-10#1)(2008-8#1)
HPLC measurements##2##2##(2008-10#1)(2008-4#1)
HPLC method can##2##3##(2008-10#2)
HPLC method for simultaneous determination of##2##6##(2008-10#1)(2008-5#1)
HPLC method for the##4##4##(2008-10#3)(2011-1#1)
HPLC method for##11##3##(1995-2#2)(2008-10#6)(2008-5#1)(2010-5#1)(2011-1#1)
HPLC method has been developed and validated for the##2##9##(2010-5#1)(2011-2#1)
HPLC method has been developed for the##2##7##(2008-10#1)(2008-11#1)
HPLC method has been developed for##3##6##(2008-10#1)(2008-11#1)(2010-5#1)
HPLC method has been developed##5##5##(2008-10#1)(2008-11#1)(2010-5#2)(2011-2#1)
HPLC method has been##6##4##(2008-10#2)(2008-11#1)(2010-5#2)(2011-2#1)
HPLC method in##2##3##(2008-10#2)
HPLC method is##2##3##(1990-8#1)(2010-5#1)
HPLC method was##5##3##(1990-8#1)(2008-10#4)
HPLC method with##7##3##(2008-10#6)(2011-1#1)
HPLC method##58##2##(1990-5#1)(1990-8#3)(1994-8#1)(1995-2#2)(1997-2#1)(2008-10#36)(2008-11#1)(2008-5#2)(2009-8#2)(2010-5#4)(2011-1#4)(2011-2#1)
HPLC methods for the##3##4##(1991-5#1)(2008-10#2)
HPLC methods##9##2##(1991-5#1)(1994-8#1)(2008-10#5)(2008-9#1)(2011-2#1)
HPLC of##3##2##(1990-8#1)(2008-10#1)(2009-8#1)
HPLC on##4##2##(1992-12#1)(1992-8#1)(1996-12#1)(1996-5#1)
HPLC post-column flow injection system for##2##6##(2008-10#2)
HPLC procedure##4##2##(1995-2#1)(2008-10#3)
HPLC profiles##3##2##(1990-8#1)(1992-3#1)(1994-9#1)
HPLC purification of##2##3##(1995-3#1)(2013-1#1)
HPLC purification##3##2##(1995-3#2)(2013-1#1)
HPLC retention##2##2##(1996-5#1)(2008-10#1)
HPLC separation and##3##3##(2008-10#3)
HPLC separation of the##2##4##(1992-3#1)(2008-10#1)
HPLC separation of##5##3##(1992-3#1)(2008-10#4)
HPLC separation was carried out on an##2##7##(2011-1#2)
HPLC separation was##3##3##(1996-5#1)(2011-1#2)
HPLC separation##17##2##(1992-3#1)(1993-12#1)(1996-5#1)(2008-10#12)(2011-1#2)
HPLC separations##2##2##(1996-5#1)(2008-10#1)
HPLC so##2##2##(1990-7#1)(2008-10#1)
HPLC stationary phase##2##3##(2008-10#2)
HPLC system for##2##3##(2008-10#2)
HPLC system with a##2##4##(1996-5#1)(2011-1#1)
HPLC system with##3##3##(1996-5#1)(2008-10#1)(2011-1#1)
HPLC system##12##2##(1990-8#2)(1996-5#1)(2008-10#7)(2008-4#1)(2011-1#1)
HPLC systems##2##2##(1990-11#1)(2008-11#1)
HPLC technique##3##2##(1992-9#1)(1997-4#1)(2008-10#1)
HPLC to##5##2##(1990-8#1)(1991-5#1)(2008-10#2)(2012-2#1)
HPLC using a##3##3##(1993-11#1)(2008-10#2)
HPLC using##11##2##(1993-11#1)(1995-3#1)(2008-10#8)(2008-11#1)
HPLC versus##2##2##(2008-10#2)
HPLC with UV detection##3##4##(2008-10#3)
HPLC with a photodiode array detector##2##6##(2008-10#2)
HPLC with a##3##3##(2008-10#3)
HPLC with##20##2##(1990-5#1)(1991-5#1)(1996-5#1)(1997-2#1)(2008-10#16)
HPLC##434##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#6)(1990-7#1)(1990-8#15)(1991-2#1)(1991-5#7)(1991-8#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#5)(1992-8#3)(1992-9#2)(1993-11#7)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#1)(1995-11#2)(1995-2#3)(1995-3#4)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#13)(1997-2#10)(1997-4#4)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#230)(2008-11#10)(2008-12#1)(2008-4#10)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#1)(2009-6#1)(2009-8#7)(2010-2#1)(2010-3#2)(2010-5#4)(2011-1#11)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
HPLC)##4##1##(1994-12#1)(2008-10#2)(2008-7#1)
HPLC-(UV)-HG-AFS##3##1##(2008-10#3)
HPLC-DAD##3##1##(2008-10#3)
HPLC-EC##3##1##(2008-10#3)
HPLC-ECD method is##2##3##(2008-10#2)
HPLC-ECD method##3##2##(2008-10#3)
HPLC-ECD##6##1##(1991-3#2)(2008-10#4)
HPLC-ELSD fingerprints and biological##2##4##(2011-3#2)
HPLC-ELSD fingerprints##4##2##(2011-3#4)
HPLC-ESI-MS##2##1##(2008-10#1)(2011-1#1)
HPLC-ICP-MS##6##1##(2008-10#6)
HPLC-ICPMS and##2##2##(2010-11#2)
HPLC-ICPMS##5##1##(2008-10#3)(2010-11#2)
HPLC-MS##4##1##(1995-5#1)(2008-10#2)(2009-9#1)
HPLC-TLS##3##1##(2008-10#3)
HPLC-UV method##4##2##(2008-10#3)(2013-1#1)
HPLC-UV##11##1##(2008-10#9)(2013-1#1)(2013-8#1)
HPLC-UV-HG-AFS##2##1##(2008-10#2)
HPLC-fluorescence method##2##2##(2008-10#2)
HPLC-fluorescence##3##1##(2008-10#3)
HPLC-reference method##2##2##(2008-10#2)
HPLC/UV##3##1##(2008-5#3)
HPLC/fluorescence derivatization##2##2##(2008-10#2)
HPMC K4M##2##2##(2012-2#2)
HPMC##4##1##(2008-10#1)(2012-2#3)
HPO(4)(2-)##5##1##(2008-10#5)
HPP##5##1##(2010-4#5)
HPRG bound##2##2##(1995-2#1)(1997-2#1)
HPRG has##2##2##(1995-2#2)
HPRG##23##1##(1995-2#9)(1997-2#14)
HPSAM and##3##2##(2008-10#3)
HPSAM is##2##2##(2008-10#2)
HPSAM##8##1##(2008-10#8)
HPSE and HB-EGF##2##3##(2013-8#2)
HPSE##8##1##(2013-8#8)
HPTLC method##2##2##(2008-10#2)
HPTLC##9##1##(2008-10#7)(2008-11#1)(2008-5#1)
HPTP treatment##3##2##(1996-12#3)
HPTP##4##1##(1996-12#4)
HPTP-treated##2##1##(1996-12#2)
HPV 13##2##2##(1991-2#2)
HPV 6##2##2##(1991-2#1)(1994-1#1)
HPV 6/11##3##2##(1994-1#3)
HPV 6b E7 gene##2##4##(2011-1#2)
HPV 6b E7##5##3##(2011-1#5)
HPV 6b E7-specific##2##3##(2011-1#2)
HPV 6b infection##3##3##(2011-1#3)
HPV 6b##11##2##(2011-1#11)
HPV DNA sequences##3##3##(1992-2#2)(1994-1#1)
HPV DNA was found in##2##5##(1993-9#1)(1994-1#1)
HPV DNA was found##4##4##(1993-9#2)(1994-1#2)
HPV DNA was##6##3##(1993-9#3)(1994-1#2)(2013-1#1)
HPV DNA##15##2##(1992-2#2)(1993-9#4)(1994-1#4)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
HPV infection in the oral cavity##2##6##(2013-1#2)
HPV infection in the##4##4##(1991-2#1)(2013-1#3)
HPV infection in##6##3##(1991-2#3)(2013-1#3)
HPV infection##14##2##(1991-2#6)(1992-3#1)(2008-11#1)(2011-2#1)(2011-3#1)(2013-1#4)
HPV is##2##2##(1995-9#1)(2011-1#1)
HPV testing##3##2##(1994-1#1)(2008-11#1)(2008-8#1)
HPV types 6##2##3##(1993-9#2)
HPV types##9##2##(1993-9#2)(1994-1#3)(2007-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
HPV vaccination##2##2##(2011-1#1)(2013-1#1)
HPV vaccine for##2##3##(2010-8#1)(2011-1#1)
HPV vaccine##4##2##(2008-11#2)(2010-8#1)(2011-1#1)
HPV was##2##2##(1996-12#1)(2013-7#1)
HPV were##2##2##(1991-2#1)(2012-3#1)
HPV##112##1##(1991-2#16)(1992-10#1)(1992-2#2)(1992-3#7)(1993-9#9)(1994-1#14)(1994-5#1)(1995-9#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#6)(2008-8#5)(2010-8#1)(2011-1#16)(2011-2#4)(2011-3#1)(2012-12#3)(2012-3#5)(2013-1#13)(2013-7#4)
HPV-16 homologous##2##2##(1992-2#2)
HPV-16 infection and##2##3##(2011-3#2)
HPV-16 infection##4##2##(2011-3#4)
HPV-16##11##1##(1992-2#4)(1995-2#2)(2011-3#5)
HPV-16-related DNA sequences##2##3##(1992-2#2)
HPV-6/11/16/18##3##1##(2013-1#3)
HPV-DNA in##2##2##(1991-2#1)(2013-7#1)
HPV-DNA##3##1##(1991-2#1)(2011-2#1)(2013-7#1)
HPV-associated##4##1##(1991-2#1)(2011-1#2)(2012-3#1)
HPV-negative##4##1##(2013-1#4)
HPV-positive##4##1##(1994-1#1)(2013-1#3)
HPV-related##4##1##(1994-1#2)(2008-11#1)(2013-7#1)
HPVs##2##1##(2008-11#1)(2013-1#1)
HPX rats##3##2##(2008-5#3)
HPg##4##1##(1993-8#4)
HPlg or##2##2##(1993-8#2)
HPlg##3##1##(1993-8#3)
HPlm##2##1##(1993-8#2)
HQ anchored polymeric resin##2##4##(2008-10#2)
HQ anchored resin##2##3##(2008-10#2)
HQ anchored##4##2##(2008-10#4)
HQ and CAT##3##3##(1992-3#3)
HQ and##4##2##(1992-3#3)(2008-10#1)
HQ##13##1##(1992-3#4)(2008-10#9)
HQ-##2##1##(2008-10#2)
HR and##10##2##(2008-1#1)(2008-10#2)(2008-5#2)(2012-2#1)(2013-1#1)(2013-8#3)
HR at rest and##2##4##(2008-3#2)
HR at##3##2##(2008-10#1)(2008-3#2)
HR deceleration##3##2##(2013-8#3)
HR induction##3##2##(2008-10#3)
HR that were##2##3##(1990-5#1)(2008-10#1)
HR was##6##2##(2008-10#3)(2010-7#1)(2012-2#1)(2013-8#1)
HR were##2##2##(2008-10#1)(2008-5#1)
HR##80##1##(1990-5#2)(1991-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-3#5)(2008-5#4)(2009-6#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-2#9)(2012-3#2)(2013-1#3)(2013-8#16)
HR-15 and HR-30##3##3##(1990-2#3)
HR-HPV and CIN##2##3##(2011-1#2)
HR-HPV infection##2##2##(2011-1#2)
HR-HPV##7##1##(2011-1#7)
HR-QoL##2##1##(2012-12#2)
HRANAFINA--Croatian##2##1##(2013-1#2)
HRC##2##1##(2009-7#1)(2011-1#1)
HRCT findings##2##2##(2011-2#1)(2012-2#1)
HRCT##10##1##(2011-2#6)(2012-12#1)(2012-2#3)
HRG##2##1##(1995-2#2)
HRH##2##1##(2011-2#1)(2012-12#1)
HRMS##4##1##(2008-10#4)
HRP and##5##2##(2008-10#4)(2012-4#1)
HRP as##3##2##(1995-12#1)(2008-10#2)
HRP catalyzes##2##2##(2008-10#2)
HRP immobilized##2##2##(2008-10#2)
HRP is##4##2##(2008-10#4)
HRP was##3##2##(2008-10#3)
HRP with##3##2##(2008-10#3)
HRP##56##1##(1990-9#1)(1995-12#1)(2008-10#46)(2012-2#1)(2012-4#7)
HRP-SjAb##5##1##(2008-10#5)
HRP-labeled##6##1##(2008-10#6)
HRP-labelled protein A##3##3##(2008-10#3)
HRQOL##2##1##(2008-7#1)(2011-2#1)
HRS cells##4##2##(1993-9#4)
HRT in##2##2##(1997-6#1)(2010-12#1)
HRT of##2##2##(2013-1#2)
HRT##16##1##(1997-6#1)(2008-3#3)(2008-5#5)(2010-12#1)(2013-1#5)(2013-8#1)
HRV and##2##2##(2010-12#1)(2013-8#1)
HRV in##2##2##(2008-6#1)(2011-2#1)
HRV measures##2##2##(2013-8#2)
HRV##25##1##(2008-6#1)(2009-11#3)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#13)
HRV-positive samples##2##2##(2013-8#2)
HRV-positive##3##1##(2013-8#3)
HRdown subjects##3##2##(2013-1#3)
HReO(4)##2##1##(1996-2#2)
HRup and##2##2##(2013-1#2)
HRup##3##1##(2013-1#3)
HS and##2##2##(1990-7#1)(2011-2#1)
HS fractions##3##2##(2008-10#3)
HS in##3##2##(2008-5#1)(2011-2#2)
HS was found to##2##4##(1990-7#1)(1991-9#1)
HS was##5##2##(1990-7#2)(1991-9#1)(2008-10#1)(2011-2#1)
HS were##3##2##(2008-10#2)(2008-5#1)
HS##55##1##(1990-7#4)(1991-12#2)(1991-9#6)(1994-11#2)(1996-2#1)(2008-10#25)(2008-5#3)(2008-9#2)(2011-2#8)(2013-8#2)
HS)##2##1##(1990-7#1)(2013-8#1)
HS-2##2##1##(1995-1#1)(1995-3#1)
HS-LPME##2##1##(2008-10#2)
HS-SPME method##2##2##(2008-10#2)
HS-SPME##8##1##(2008-10#8)
HS-SPME-GC-MS##2##1##(2008-10#2)
HS-SPME-GC/ECD##2##1##(2009-8#2)
HS-metal species##2##2##(2008-10#2)
HS-metal##3##1##(2008-10#3)
HS191R##2##1##(2008-10#2)
HS2##2##1##(2008-9#2)
HS2core DNA sequence##4##3##(2008-8#4)
HSA and##5##2##(1994-9#2)(1997-2#1)(2008-10#2)
HSA binding##3##2##(2008-10#3)
HSA in##2##2##(2008-10#2)
HSA was##2##2##(2008-10#2)
HSA##39##1##(1994-9#4)(1996-1#1)(1997-2#1)(1997-6#2)(2008-10#27)(2008-4#1)(2011-2#3)
HSAD system##5##2##(2008-6#5)
HSAG-1##4##1##(1991-6#4)
HSAs##3##1##(2007-10#1)(2008-4#2)
HSC##10##1##(1991-2#1)(2008-10#4)(2008-11#2)(2009-12#1)(2010-11#2)
HSC-T6##4##1##(2008-11#4)
HSC1##2##1##(1993-6#2)
HSC3##2##1##(1993-6#2)
HSC5##2##1##(1993-6#2)
HSCCC##6##1##(2008-10#3)(2011-1#3)
HSCR##3##1##(1994-12#3)
HSCT##8##1##(2010-11#2)(2010-5#4)(2011-2#1)(2013-1#1)
HSCs in##2##2##(2009-12#2)
HSCs##9##1##(1993-8#1)(2008-4#2)(2009-12#3)(2009-7#2)(2010-11#1)
HSD test##2##2##(2008-12#1)(2009-8#1)
HSD##8##1##(1994-2#2)(1994-6#4)(2008-12#1)(2009-8#1)
HSE sequence##2##2##(1991-9#2)
HSE##9##1##(1991-9#3)(1994-6#1)(1994-8#1)(1995-5#4)
HSF in##2##2##(1995-11#1)(2008-5#1)
HSF was activated##2##3##(1995-11#2)
HSF was##3##2##(1995-11#2)(2008-5#1)
HSF##22##1##(1990-11#7)(1993-6#1)(1994-8#1)(1995-11#7)(2008-5#4)(2010-2#2)
HSG cells##5##2##(2011-2#5)
HSG##13##1##(1993-1#1)(2011-2#12)
HSI model##2##2##(2008-5#2)
HSI##4##1##(2008-10#1)(2008-5#3)
HSK##4##1##(1993-12#4)
HSO(3)(-)##5##1##(2008-10#5)
HSO(3)F##2##1##(1996-2#2)
HSOT polymer##2##2##(2008-3#2)
HSP 70##3##2##(1996-9#2)(2008-10#1)
HSP and##2##2##(1994-11#2)
HSP expression##3##2##(1994-11#2)(2008-7#1)
HSP##23##1##(1990-7#1)(1993-8#1)(1994-11#15)(1994-8#1)(1996-9#2)(2008-10#1)(2008-7#1)(2010-12#1)
HSP-70##2##1##(1995-12#1)(2009-8#1)
HSP27##2##1##(2008-11#1)(2008-7#1)
HSP28 gene expression##2##3##(1994-8#2)
HSP28 gene##3##2##(1994-8#3)
HSP28##7##1##(1994-8#7)
HSP60 mRNA expression was##2##4##(2008-4#2)
HSP60 mRNA expression##4##3##(2008-4#4)
HSP60##5##1##(2008-4#5)
HSP70 and HSP28##2##3##(1994-8#2)
HSP70 and##4##2##(1993-8#1)(1994-8#2)(2008-9#1)
HSP70 expression in##2##3##(2008-10#1)(2010-5#1)
HSP70 expression was observed in##2##5##(2008-10#2)
HSP70 expression##5##2##(2008-10#4)(2010-5#1)
HSP70 gene expression##2##3##(1994-8#2)
HSP70 gene##5##2##(1993-6#1)(1994-8#3)(2010-2#1)
HSP70 mRNA and cortisol##2##4##(2008-6#2)
HSP70 mRNA and##3##3##(1995-11#1)(2008-6#2)
HSP70 mRNA expression##4##3##(2008-6#4)
HSP70 mRNA in##2##3##(1995-11#1)(2008-6#1)
HSP70 mRNA##11##2##(1994-8#1)(1995-11#3)(2008-6#7)
HSP70 sequences##3##2##(2008-10#3)
HSP70 synthesis##5##2##(1994-8#1)(1995-11#4)
HSP70 to##2##2##(2008-10#1)(2008-9#1)
HSP70##52##1##(1993-6#1)(1993-8#2)(1993-9#2)(1994-8#9)(1995-11#9)(2008-10#13)(2008-6#7)(2008-9#2)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#4)
HSP72 expression in##2##3##(1995-5#2)
HSP72 expression##3##2##(1995-5#3)
HSP72 is##2##2##(1994-11#1)(1995-5#1)
HSP72 was##3##2##(1991-9#1)(1995-5#2)
HSP72##12##1##(1991-9#3)(1994-11#1)(1995-5#8)
HSP73##3##1##(1994-11#2)(1995-11#1)
HSP90 levels##2##2##(1993-8#2)
HSP90##6##1##(1993-8#5)(2009-6#1)
HSPs and##2##2##(2008-12#1)(2008-4#1)
HSPs##9##1##(2008-12#1)(2008-4#5)(2008-7#3)
HSR##6##1##(1992-3#1)(2010-2#5)
HSRV weights##2##2##(1992-12#2)
HSS and IKDC##4##3##(2013-1#4)
HSS##7##1##(2008-8#2)(2013-1#5)
HSSB##4##1##(1994-8#4)
HSSPME##4##1##(2008-10#4)
HST##2##1##(2008-10#2)
HSTAT##2##1##(1996-3#2)
HSTs produced by##2##3##(2008-10#2)
HSTs##3##1##(2008-10#3)
HSV from##2##2##(2008-11#2)
HSV oesophagitis in##2##3##(1996-6#2)
HSV oesophagitis##3##2##(1996-6#3)
HSV type##2##2##(2008-10#2)
HSV##20##1##(1993-8#1)(1996-6#3)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-9#6)(2011-3#1)
HSV-1 amplicon##4##2##(2008-4#1)(2008-8#3)
HSV-1 genome##2##2##(2008-4#2)
HSV-1##23##1##(1994-11#1)(2007-12#6)(2008-10#1)(2008-4#7)(2008-8#8)
HSV-2 TSS is##2##3##(2008-10#2)
HSV-2 TSS##3##2##(2008-10#3)
HSV-2##10##1##(2007-12#2)(2008-10#3)(2008-11#2)(2013-8#3)
HSV-II##3##1##(2007-7#3)
HSV1-rc/DeltaUL2##2##1##(2008-9#2)
HSVd and CVd-IV##2##3##(2008-10#2)
HSVd sequences##2##2##(2008-10#2)
HSVd##4##1##(2008-10#4)
HSiW/ZrO(2)##3##1##(2013-1#3)
HT plan##3##2##(2008-11#3)
HT##14##1##(1996-3#4)(2008-11#4)(2008-8#3)(2011-2#3)
HT-1080##2##1##(1992-5#2)
HT-2 toxin##2##2##(1997-6#2)
HT-29 cells##3##2##(1994-3#2)(1994-8#1)
HT-29##6##1##(1994-3#2)(1994-8#1)(1995-3#2)(2010-1#1)
HT-induced apoptosis##3##2##(2008-8#3)
HT-induced##4##1##(2008-8#4)
HT1080 cells##2##2##(2008-11#2)
HT1080##4##1##(2008-11#4)
HT29 cells##3##2##(1992-9#3)
HT29##9##1##(1992-8#2)(1992-9#7)
HT29-19A##4##1##(1994-3#4)
HTA is##2##2##(2011-2#1)(2012-12#1)
HTA##7##1##(2009-3#1)(2011-2#1)(2012-12#5)
HTB 17##2##2##(1993-3#2)
HTC cells##2##2##(1997-4#2)
HTC##3##1##(1997-4#2)(2008-8#1)
HTC-TSHr cells##3##2##(1993-3#3)
HTC-TSHr##4##1##(1993-3#4)
HTH as well as WTH slices##2##6##(1996-5#2)
HTH##7##1##(1992-4#1)(1996-5#3)(2008-7#2)(2012-2#1)
HTIFs##2##1##(2010-4#2)
HTLV-1 infection##3##2##(1990-3#1)(2012-12#2)
HTLV-1##11##1##(1990-3#1)(1994-11#1)(2011-2#2)(2012-12#7)
HTLV-I LTR transcriptional activation##2##4##(1994-11#2)
HTLV-I LTR##4##2##(1994-11#3)(2008-8#1)
HTLV-I protease##3##2##(1991-12#3)
HTLV-I seropositive women##2##3##(1994-6#2)
HTLV-I seropositive##4##2##(1994-6#4)
HTLV-I tax##3##2##(2008-8#3)
HTLV-I##23##1##(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1994-11#4)(1994-6#5)(2008-4#1)(2008-8#5)
HTLV-I/II##4##1##(1991-11#3)(1991-12#1)
HTN##8##1##(2008-7#2)(2010-4#6)
HTR was##3##2##(1990-12#3)
HTR##7##1##(1990-12#5)(1993-2#2)
HTS##6##1##(2008-10#4)(2008-9#1)(2012-2#1)
HU protein##4##2##(1994-11#1)(1997-6#3)
HU##14##1##(1994-11#3)(1997-6#3)(1997-8#4)(2008-10#2)(2012-3#2)
HU-1##3##1##(1990-11#3)
HU-mediated inhibition##2##2##(1994-11#2)
HUC2-13##4##1##(2008-11#4)
HUH7-ins##7##1##(2010-11#7)
HUI2##2##1##(2007-10#2)
HUI2/3##3##1##(2007-10#3)
HUI3 scores##2##2##(2007-10#1)(2008-7#1)
HUI3##5##1##(2007-10#1)(2008-7#4)
HUMAN##2##1##(1997-3#1)(2012-12#1)
HUPO Proteomics Standards Initiative##2##4##(2008-7#2)
HUT-78##2##1##(1991-9#1)(1993-6#1)
HUVEC for##3##2##(2008-11#1)(2008-9#2)
HUVEC in##2##2##(2008-11#1)(2012-2#1)
HUVEC is##3##2##(1993-11#1)(2008-8#2)
HUVEC were##2##2##(2013-8#2)
HUVEC##29##1##(1993-11#2)(1994-8#1)(1997-1#2)(2008-11#6)(2008-8#4)(2008-9#4)(2010-3#1)(2012-2#2)(2013-8#7)
HUVECs##2##1##(2008-10#1)(2008-11#1)
HV##7##1##(1992-6#1)(2008-10#1)(2010-3#1)(2010-6#2)(2011-2#2)
HVA##4##1##(1992-7#1)(1993-1#1)(1995-3#1)(2008-3#1)
HVC##2##1##(1997-2#1)(2008-9#1)
HVD##5##1##(2008-7#5)
HVDRR##4##1##(2008-1#4)
HVLA##2##1##(2007-11#2)
HVS activity##2##2##(1991-12#2)
HVS##3##1##(1991-12#3)
HVTN##3##1##(2012-12#3)
HW##2##1##(2008-12#1)(2010-7#1)
HWDS##2##1##(2010-1#2)
HX##4##1##(1990-5#1)(2008-10#2)(2008-11#1)
HX-MS##2##1##(2008-4#2)
HXC-26##4##1##(1996-10#4)
HY5##3##1##(2009-8#3)
HYDRA-POINT##2##1##(2008-10#2)
HYPP in##2##2##(1991-12#2)
HYPP##3##1##(1991-12#3)
Ha-ras##3##1##(1992-2#3)
Ha-ras-transformed epithelial cells##2##3##(1992-12#2)
HaCaT cell line##2##3##(2008-11#2)
HaCaT cells##4##2##(2008-11#2)(2010-2#2)
HaCaT keratinocytes##3##2##(1997-1#1)(2009-6#2)
HaCaT##12##1##(1997-1#2)(2008-11#4)(2009-6#3)(2010-2#3)
HaCat cells##4##2##(2011-3#4)
HaCat##5##1##(2011-3#5)
Habib##2##1##(2009-1#1)(2013-1#1)
Habitat characteristics##2##2##(2009-10#2)
Habitat loss##2##2##(2008-9#1)(2009-8#1)
Habitat##13##1##(1996-5#1)(2008-5#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-8#1)(2013-1#1)
Hacinas##7##1##(2009-10#7)
Hadamard matrix##2##2##(2008-3#2)
Hadamard transform spectral imager##3##4##(2013-8#3)
Hadamard##7##1##(2008-10#1)(2008-3#2)(2013-8#4)
Hadar##3##1##(1994-3#3)
HaeIII##8##1##(1993-9#1)(1997-2#1)(1997-3#3)(2008-10#3)
Haemato-biochemical##2##1##(2008-10#1)(2010-4#1)
Haematococcus pluvialis##2##2##(2010-10#2)
Haematological and clinical biochemistry##2##4##(2008-5#2)
Haematological##5##1##(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)
Haematology and Transfusion Medicine##2##4##(2013-1#2)
Haematology##4##1##(1996-8#1)(2013-1#3)
Haematopinus suis (Anoplura) and##2##4##(2007-12#2)
Haemodynamic##2##1##(1993-10#1)(2006-10#1)
Haemogamasus##2##1##(2013-1#2)
Haemoglobin##7##1##(1991-6#1)(1992-6#1)(2007-9#1)(2008-12#3)(2011-1#1)
Haemonchus contortus##5##2##(1991-8#2)(1994-12#1)(1996-12#1)(2012-2#1)
Haemonetics##2##1##(2011-2#2)
Haemophilia A##2##2##(2011-2#2)
Haemophilia##3##1##(1990-5#1)(2011-2#2)
Haemophilus b##3##2##(1990-12#1)(1995-5#2)
Haemophilus influenzae type B##3##4##(1993-6#1)(1994-9#1)(2008-11#1)
Haemophilus influenzae type b (Hib)##2##5##(1997-3#1)(2008-1#1)
Haemophilus influenzae type b##14##4##(1990-12#2)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2009-5#1)(2012-12#1)
Haemophilus influenzae type##18##3##(1990-12#2)(1992-9#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#1)(2009-5#1)(2012-12#1)
Haemophilus influenzae##29##2##(1990-12#2)(1992-11#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-7#2)(2009-5#4)(2011-1#1)(2011-2#1)(2012-12#1)
Haemophilus##41##1##(1990-12#3)(1992-11#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#7)(1997-3#3)(1997-6#2)(2007-11#1)(2007-7#2)(2008-1#2)(2008-11#2)(2008-5#3)(2008-7#2)(2009-5#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
Haemorrhage##5##1##(1997-6#1)(2007-10#2)(2008-10#1)(2011-2#1)
Haemorrhagic##2##1##(1991-3#1)(1996-6#1)
Hage##10##1##(1991-3#1)(1992-1#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-2#1)
Hagen's glands are##2##3##(2007-12#2)
Hagen's glands of##2##3##(2007-12#2)
Hagen's glands##5##2##(2007-12#5)
Hagen's##6##1##(2007-12#6)
Hagfish##2##1##(2008-5#1)(2012-2#1)
Haglund's syndrome is##2##3##(2008-8#2)
Haglund's syndrome##4##2##(2008-8#4)
Haglund's##5##1##(2008-8#5)
Hahnemann##2##1##(1997-3#1)(2008-10#1)
Hair is a##2##3##(2012-2#1)(2012-3#1)
Hair is##3##2##(2008-5#1)(2012-2#1)(2012-3#1)
Hair shedding##2##2##(2008-5#2)
Hair##16##1##(1993-9#1)(1996-3#1)(2008-10#1)(2008-5#6)(2012-2#2)(2012-3#5)
Hairs were##2##2##(2008-5#2)
Hairy##2##1##(2008-10#1)(2008-6#1)
Haiti and##2##2##(2009-7#1)(2011-2#1)
Haiti##6##1##(2008-4#3)(2009-7#1)(2011-2#2)
Haitian youths##2##2##(2008-4#2)
Haitian##5##1##(1997-2#1)(2008-4#4)
Hajjah##2##1##(2008-1#2)
Half of the##13##3##(1990-9#1)(1991-12#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-6#2)(1997-3#1)(2008-10#2)(2008-11#1)(2011-10#1)(2011-2#1)
Half of##18##2##(1990-6#1)(1990-9#1)(1991-12#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-6#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-10#1)(2011-2#1)
Half the patients had##2##4##(1991-6#1)(2008-6#1)
Half the patients##3##3##(1990-9#1)(1991-6#1)(2008-6#1)
Half the##4##2##(1990-9#1)(1991-6#1)(2007-12#1)(2008-6#1)
Half##28##1##(1990-6#1)(1990-9#2)(1991-12#1)(1991-6#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-6#2)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-1#2)(2011-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
Half-maximal binding##2##2##(1991-12#1)(1992-6#1)
Halide##2##1##(1996-2#1)(2008-10#1)
Halides##2##1##(2009-11#2)
Halifax Bay and Upstart Bay##2##5##(2010-8#2)
Halifax Bay and Upstart##3##4##(2010-8#3)
Halifax##5##1##(2007-12#1)(2008-11#1)(2010-8#3)
Hall of##2##2##(2008-10#1)(2013-8#1)
Hall technique##4##2##(2013-1#4)
Hall##20##1##(1990-4#1)(1992-11#2)(1993-5#1)(1994-12#2)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-2#2)(2013-1#4)(2013-8#1)
Halo nevi##3##2##(2011-2#3)
Halo##11##1##(2008-10#1)(2008-2#4)(2008-3#2)(2011-2#4)
Halobacteriaceae##3##1##(2011-2#3)
Halobacterium halobium##6##2##(1990-11#2)(1990-2#1)(1990-5#2)(1993-11#1)
Halocyanin##2##1##(1993-11#2)
Halocynthia roretzi##3##2##(1993-6#1)(2008-6#2)
Haloferax volcanii##2##2##(2011-2#2)
Halogenated##5##1##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)
Haloperidol##7##1##(1995-12#4)(1996-12#1)(2012-2#1)(2013-1#1)
Halophilic##2##1##(2011-2#1)(2013-1#1)
Haloterrigena turkmenica##2##2##(2011-2#2)
Haloterrigena##5##1##(2011-2#5)
Halothane##2##1##(1991-2#1)(1995-3#1)
Halotherapy##2##1##(1996-3#2)
Halsted##2##1##(1990-12#1)(2012-3#1)
Halvorson##2##1##(1990-8#1)(1997-2#1)
Hamburg##2##1##(1991-12#1)(2008-5#1)
Hamilton Health Sciences Laboratory Program##2##5##(1994-3#2)
Hamilton PRP-X100##2##2##(2008-10#2)
Hamilton and Beck depression##2##4##(1996-7#2)
Hamilton##19##1##(1994-3#3)(1994-6#1)(1995-12#1)(1996-7#2)(2007-2#1)(2008-10#4)(2008-12#5)(2008-6#1)(2009-3#1)
Hamilton's rule##2##2##(2008-10#2)
Hamilton-Zuk hypothesis##3##2##(2008-8#3)
Hamiltonian##6##1##(1996-12#1)(1996-9#1)(2007-11#1)(2008-11#1)(2009-5#1)(2012-3#1)
Hampshire##5##1##(1993-1#1)(1994-12#1)(2008-10#1)(2012-12#2)
Hampton##3##1##(2008-2#1)(2008-3#1)(2008-4#1)
Hamster Ovary##13##2##(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#10)
Hamster##17##1##(1992-10#1)(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#11)(2008-9#1)(2011-1#1)
Hamstring##2##1##(2009-7#1)(2012-2#1)
Hamza##2##1##(2008-10#2)
Han Chinese populations##3##3##(2008-8#3)
Han Chinese##5##2##(2008-8#3)(2008-9#2)
Han and##2##2##(1995-6#1)(2008-8#1)
Han population from the Northern parts of##3##7##(2011-1#3)
Han population from##4##3##(2011-1#4)
Han population##12##2##(2011-1#7)(2011-2#3)(2013-1#2)
Han subpopulations in different##2##4##(2008-8#2)
Han##30##1##(1995-6#3)(2008-8#8)(2008-9#4)(2010-12#1)(2011-1#8)(2011-2#3)(2012-2#1)(2013-1#2)
Hanau##2##1##(2008-10#1)(2008-11#1)
Hancock##2##1##(2011-2#2)
Hand##18##1##(2007-12#2)(2007-8#1)(2008-9#10)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
Hand-assisted laparoscopic##2##2##(2011-2#1)(2012-12#1)
Handbook of##2##2##(1996-2#1)(2012-2#1)
Handbook##5##1##(1993-3#2)(1995-3#1)(1996-2#1)(2012-2#1)
Handedness##3##1##(1995-11#2)(2007-12#1)
Handling and##2##2##(2008-9#1)(2011-2#1)
Handling of##2##2##(2008-10#1)(2008-9#1)
Handling##7##1##(2008-10#1)(2008-9#4)(2011-2#1)(2012-3#1)
Hangekobokuto##2##1##(2008-10#2)
Hankel transform##5##2##(2007-12#3)(2008-3#2)
Hankel##6##1##(2007-12#3)(2008-3#3)
Hanlester Network##2##2##(1992-3#1)(1993-1#1)
Hanlester##5##1##(1992-3#1)(1993-1#4)
Hannover##4##1##(2008-3#1)(2012-1#3)
Hansen's disease##3##2##(2007-7#2)(2013-1#1)
Hansen's##4##1##(2007-7#2)(2011-2#1)(2013-1#1)
Hansenula mrakii##2##2##(1993-12#2)
Hansenula polymorpha and##2##3##(1997-4#2)
Hansenula polymorpha##6##2##(1995-8#1)(1995-9#1)(1997-4#2)(2008-11#1)(2013-1#1)
Hansenula##9##1##(1993-12#2)(1995-8#1)(1995-9#2)(1997-4#2)(2008-11#1)(2013-1#1)
Hantavirus pulmonary syndrome##2##3##(2011-2#2)
Hantavirus##5##1##(2008-10#1)(2011-2#2)(2013-1#2)
Hap4-GC haplotype##2##2##(2011-1#2)
HapMap##2##1##(2011-1#1)(2012-3#1)
Hapalosiphon##2##1##(2013-7#2)
Haplotype diversity##2##2##(2008-10#1)(2010-8#1)
Haplotype relative risk approaches##2##4##(1997-5#2)
Haplotype##8##1##(1997-5#2)(2008-10#1)(2008-12#2)(2010-8#2)(2011-2#1)
Haplotypes in##2##2##(2008-10#1)(2009-5#1)
Haplotypes##3##1##(1997-9#1)(2008-10#1)(2009-5#1)
Hapten##2##1##(1993-8#1)(2008-10#1)
Harbor and##2##2##(2008-10#1)(2010-5#1)
Harbor##8##1##(1992-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#3)
Hard##5##1##(1990-11#1)(1996-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
Hardcover##2##1##(2007-2#2)
Hardness of##2##2##(2007-12#1)(2011-2#1)
Hardness was##2##2##(2009-7#1)(2010-4#1)
Hardness##6##1##(2007-12#1)(2009-7#1)(2010-4#1)(2011-2#3)
Hardy's understanding of##2##3##(2012-2#2)
Hardy's##5##1##(2012-2#5)
Hardy-Weinberg equilibrium##4##2##(2008-10#1)(2008-12#2)(2008-5#1)
Hardy-Weinberg##8##1##(2008-10#2)(2008-12#3)(2008-5#1)(2012-3#1)(2013-8#1)
Hargal##5##1##(2008-12#5)
Harlem##3##1##(1990-5#1)(1996-3#2)
Harm minimisation for drug misusers##2##5##(1992-5#2)
Harm##3##1##(1992-5#2)(2007-8#1)
Harmal##5##1##(2008-12#5)
Harmonic##2##1##(2008-2#1)(2009-7#1)
Harmonization of##2##2##(2008-10#1)(2011-1#1)
Harmonization##3##1##(2008-10#1)(2010-11#1)(2011-1#1)
Harmony##4##1##(2010-1#3)(2012-12#1)
Harnessing the##4##2##(1995-9#1)(2008-11#1)(2009-11#1)(2009-3#1)
Harnessing##6##1##(1995-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-3#1)
Harran mounds##2##2##(2008-12#2)
Harran##7##1##(2008-12#7)
Harrington classification##2##2##(2007-11#2)
Harrington method##2##2##(2007-11#1)(2007-8#1)
Harrington##5##1##(2007-11#3)(2007-8#1)(2008-10#1)
Harris##5##1##(1997-3#1)(2007-11#1)(2009-3#1)(2013-1#2)
Harrisburg##2##1##(1993-1#1)(1993-12#1)
Harry ernest##2##2##(2008-10#2)
Harry##6##1##(1990-11#1)(1990-4#1)(1996-1#1)(2008-10#2)(2009-5#1)
Harsh issues in##3##3##(1993-1#3)
Harsh##4##1##(1993-1#3)(2008-9#1)
Harstad Hospital and##2##3##(1991-9#2)
Harstad Hospital##3##2##(1991-9#3)
Hartmann procedure##2##2##(2008-10#2)
Hartmann sensor##2##2##(2008-3#2)
Hartmann test is##3##3##(2008-3#3)
Hartmann test##6##2##(2008-3#6)
Hartmann##15##1##(2008-10#3)(2008-3#12)
Hartmann's procedure##3##2##(2008-10#1)(2009-1#1)(2010-8#1)
Hartmann's##5##1##(1993-9#2)(2008-10#1)(2009-1#1)(2010-8#1)
Hartmanngrams##5##1##(2008-3#5)
Harvard Medical School##6##3##(1993-3#1)(2008-4#2)(2010-5#2)(2011-2#1)
Harvard Medical##7##2##(1992-1#1)(1993-3#1)(2008-4#2)(2010-5#2)(2011-2#1)
Harvard##20##1##(1990-11#2)(1992-1#1)(1992-3#1)(1993-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2010-5#3)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
Harvest##3##1##(2008-10#1)(2008-12#2)
Harvested##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
Harvesting the##2##2##(2007-9#1)(2008-7#1)
Harvesting##4##1##(2007-7#1)(2007-9#1)(2008-7#1)(2012-2#1)
Harvey Cushing##2##2##(2008-4#1)(2010-8#1)
Harvey##3##1##(1995-6#1)(2008-4#1)(2010-8#1)
Harvey-ras transfected C3H10T1/2 cells##4##4##(2008-4#4)
Haryana##2##1##(1997-8#1)(2010-8#1)
Has##5##1##(1995-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
Hashimoto thyroiditis##2##2##(2009-3#1)(2011-2#1)
Hashimoto's thyroiditis and vitiligo##2##4##(2007-5#2)
Hashimoto's thyroiditis and##3##3##(1990-6#1)(2007-5#2)
Hashimoto's thyroiditis##8##2##(1990-5#2)(1990-6#2)(1996-12#1)(2007-5#2)(2013-1#1)
Hashimoto's##11##1##(1990-5#2)(1990-6#2)(1996-12#1)(2007-5#2)(2011-2#2)(2013-1#2)
Hass avocados and##2##3##(2011-2#2)
Hass avocados exposed##2##3##(2011-2#2)
Hass avocados##5##2##(2011-2#5)
Hass##6##1##(2011-2#6)
Hassan K##2##2##(2008-10#2)
Hassan##3##1##(2008-10#2)(2011-2#1)
Hatching##2##1##(2008-10#1)(2009-4#1)
Hatm##2##1##(2008-10#2)
Hats##2##1##(2008-10#2)
Hattan 3##2##2##(2008-10#2)
Hauenstein's Nursing Practice Paradigm for Depressed Rural Women##2##8##(2011-2#2)
Hauenstein's##3##1##(2011-2#3)
Haukeland Hospital##3##2##(1990-2#1)(1991-11#1)(1996-3#1)
Haukeland##6##1##(1990-2#2)(1991-11#1)(1996-3#1)(1997-4#1)(1997-8#1)
Hausa/Fulani##2##1##(2009-10#2)
Hausman test##2##2##(1992-6#2)
Haustorial##2##1##(2008-10#2)
Havana City##4##2##(2007-10#4)
Havana##7##1##(1997-8#1)(2007-10#4)(2008-5#2)
Have you##2##2##(1994-2#1)(2013-1#1)
Have##9##1##(1994-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-10#1)(2012-3#2)(2013-1#1)
Haven##6##1##(1995-12#2)(1996-2#1)(1997-1#1)(2011-2#1)(2013-8#1)
Haversian canals##4##2##(1995-6#3)(2013-1#1)
Haversian##7##1##(1995-6#3)(2013-1#4)
Having a##4##2##(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Having an##2##2##(1991-12#1)(2008-11#1)
Having been##2##2##(2008-10#2)
Having reviewed the##2##3##(1990-6#1)(1992-5#1)
Having##34##1##(1990-6#1)(1990-9#2)(1991-12#1)(1991-6#1)(1992-5#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#2)
Hawai'i##3##1##(2008-1#3)
Hawaii 7998##2##2##(2008-10#2)
Hawaii and##4##2##(2007-10#1)(2007-5#1)(2008-10#1)(2012-2#1)
Hawaii##38##1##(1992-2#2)(1994-2#1)(1995-1#1)(1996-1#2)(1996-6#1)(2007-10#3)(2007-5#2)(2008-1#2)(2008-10#18)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)
Hawaiian proprietary selections##2##3##(2008-10#2)
Hawaiian##17##1##(1996-6#1)(2008-1#9)(2008-10#3)(2008-3#2)(2008-8#1)(2009-12#1)
Hawaiians##2##1##(1992-2#1)(2008-1#1)
Hawk##2##1##(2008-2#1)(2008-3#1)
Haymana##3##1##(2008-12#3)
Hazafon##3##1##(2009-2#3)
Hazara##2##1##(2009-7#1)(2010-11#1)
Hazard Analysis Critical Control Points##2##5##(2009-3#2)
Hazard Analysis##3##2##(2009-3#2)(2013-1#1)
Hazard Report##3##2##(2011-2#3)
Hazard ratios##2##2##(2011-2#2)
Hazard report##34##2##(2010-9#6)(2011-1#3)(2011-2#25)
Hazard##48##1##(1993-3#1)(1995-11#1)(1996-12#2)(2008-10#1)(2008-11#1)(2009-3#2)(2010-9#6)(2011-1#3)(2011-2#30)(2013-1#1)
Hazardous Substances Data Bank##2##4##(1995-11#1)(1996-12#1)
Hazardous##7##1##(1992-2#1)(1995-11#2)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
Hb &gt##3##2##(1996-12#2)(2008-7#1)
Hb A##7##2##(1990-7#3)(1990-8#1)(1992-3#3)
Hb CH##2##2##(2011-2#2)
Hb Phe-37 beta##4##3##(1992-3#4)
Hb S##2##2##(2011-2#2)
Hb and##3##2##(1990-8#1)(1991-2#1)(2008-10#1)
Hb can be##2##3##(2008-10#2)
Hb can##3##2##(2008-10#3)
Hb concentration##3##2##(1990-8#1)(1994-12#1)(1997-2#1)
Hb in##4##2##(1994-12#1)(2008-10#2)(2008-12#1)
Hb increase##2##2##(2008-7#2)
Hb level##5##2##(2008-7#5)
Hb levels##2##2##(2008-7#2)
Hb solutions prepared in##2##4##(1992-11#2)
Hb solutions prepared##3##3##(1992-11#3)
Hb solutions##4##2##(1992-11#4)
Hb with##2##2##(2007-7#1)(2008-10#1)
Hb##86##1##(1990-7#5)(1990-8#7)(1991-2#1)(1992-11#4)(1992-3#9)(1993-3#1)(1994-12#4)(1996-12#5)(1997-2#3)(2007-7#3)(2008-10#18)(2008-12#3)(2008-5#1)(2008-7#16)(2011-2#6)
HbA##2##1##(1993-11#1)(2008-1#1)
HbA(1c) testing on the##2##4##(2008-6#2)
HbA(1c) testing##5##2##(2008-6#5)
HbA(1c)##7##1##(2008-6#6)(2011-1#1)
HbA1##11##1##(1991-5#7)(1992-9#3)(2007-10#1)
HbA1C##5##1##(1990-6#3)(2012-3#1)(2013-1#1)
HbA1c levels and##2##3##(2012-4#2)
HbA1c levels##12##2##(2007-10#1)(2012-3#2)(2012-4#5)(2012-5#3)(2013-8#1)
HbA1c was positively correlated with##2##5##(1994-6#2)
HbA1c was##4##2##(1994-6#4)
HbA1c##35##1##(1990-8#1)(1994-6#6)(2007-10#2)(2008-6#1)(2010-10#1)(2011-1#1)(2011-2#6)(2012-3#2)(2012-4#9)(2012-5#5)(2013-8#1)
HbF levels##2##2##(2008-10#1)(2009-4#1)
HbF##8##1##(1990-8#2)(2008-10#1)(2009-3#1)(2009-4#4)
HbF0##4##1##(1992-3#4)
HbFGF##3##1##(1991-2#3)
HbO-HA ELISA can##2##3##(1990-12#2)
HbO-HA ELISA##6##2##(1990-12#6)
HbO-HA##7##1##(1990-12#7)
HbPs##2##1##(1990-12#2)
HbS##4##1##(2009-4#2)(2012-12#2)
Hbd##3##1##(2008-4#3)
HbsAg##2##1##(2008-1#2)
Hc2##3##1##(1993-9#3)
HcNPV attachment##3##2##(2008-11#3)
HcNPV binding##2##2##(2008-11#2)
HcNPV##6##1##(2008-11#6)
Hca-F cells##5##2##(2012-3#5)
Hca-F##6##1##(2012-3#6)
Hct was##3##2##(1994-12#1)(1997-6#1)(2011-3#1)
Hct##14##1##(1994-12#1)(1994-6#1)(1997-6#1)(2008-1#1)(2011-3#10)
Hcy##2##1##(2013-8#2)
Hcy/Au##2##1##(2008-10#2)
Hdacs and Polr3##2##3##(2012-12#2)
He also##14##2##(1991-12#1)(1991-6#1)(1993-2#2)(1993-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-6#2)(2010-1#2)
He and##2##2##(2007-12#1)(2008-9#1)
He became##3##2##(1993-3#1)(2007-5#1)(2012-3#1)
He believes##2##2##(1990-11#1)(1993-12#1)
He completed##2##2##(2010-5#1)(2011-1#1)
He concludes that the##2##4##(1996-2#1)(1997-2#1)
He concludes##3##2##(1993-2#1)(1996-2#1)(1997-2#1)
He developed an acute##2##4##(2007-10#1)(2010-3#1)
He developed##5##2##(2007-10#1)(2010-3#1)(2010-7#1)(2011-2#2)
He did not##3##3##(1990-6#1)(2007-8#1)(2009-11#1)
He did##4##2##(1990-6#1)(2007-8#1)(2009-11#1)(2011-1#1)
He died##2##2##(1997-3#1)(2007-5#1)
He discusses why##2##3##(1992-2#1)(1996-2#1)
He discusses##4##2##(1992-2#1)(1995-2#1)(1996-2#2)
He experienced##2##2##(2008-1#2)
He had a history of##2##5##(2008-1#1)(2013-1#1)
He had a##9##3##(1993-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
He had been##2##3##(2007-12#1)(2012-3#1)
He had no##6##3##(1990-11#1)(1992-2#1)(2007-10#1)(2007-12#2)(2008-6#1)
He had suffered##2##3##(2007-10#1)(2012-3#1)
He had##39##2##(1990-11#1)(1992-2#1)(1993-9#2)(1996-6#1)(1997-3#3)(2007-10#2)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-6#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
He has been##3##3##(1994-1#1)(2010-6#1)(2013-1#1)
He has no##2##3##(2011-2#1)(2013-1#1)
He has##8##2##(1994-1#1)(2008-5#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
He i 584 A##2##4##(2008-3#2)
He i##4##2##(2008-3#4)
He is##4##2##(1994-1#1)(1994-12#1)(2008-12#1)(2013-1#1)
He made##3##2##(2008-7#1)(2008-8#1)(2009-7#1)
He presented with##3##3##(2007-7#1)(2008-12#1)(2008-7#1)
He presented##4##2##(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)
He provides##4##2##(1991-1#1)(1993-12#1)(1994-2#1)(1995-2#1)
He received##4##2##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
He recovered##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
He should know##3##3##(1996-11#3)
He subsequently developed##2##3##(2008-7#2)
He subsequently##5##2##(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#1)
He then##6##2##(1993-2#1)(1995-1#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
He underwent##10##2##(2008-10#1)(2008-12#3)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#2)
He was admitted to the##2##5##(1993-8#1)(2013-1#1)
He was admitted to##3##4##(1993-8#1)(2007-2#1)(2013-1#1)
He was admitted##4##3##(1993-8#1)(2007-2#1)(2009-6#1)(2013-1#1)
He was diagnosed to have##2##5##(2012-2#2)
He was diagnosed##4##3##(2010-11#1)(2011-2#1)(2012-2#2)
He was discharged##2##3##(1997-8#1)(2010-12#1)
He was given a##2##4##(2008-1#1)(2009-6#1)
He was given##3##3##(2007-7#1)(2008-1#1)(2009-6#1)
He was on##2##3##(2007-11#1)(2008-1#1)
He was started on##3##4##(2008-12#1)(2012-2#1)(2013-8#1)
He was successfully treated with##3##5##(2009-5#1)(2010-6#2)
He was treated with oral##2##5##(1996-6#1)(2008-10#1)
He was treated with##10##4##(1996-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#3)(2013-1#2)
He was treated##11##3##(1996-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#3)(2013-1#2)
He was weaned from ventilator and extubated##2##7##(2012-2#2)
He was##60##2##(1992-6#1)(1993-8#1)(1995-3#1)(1996-2#1)(1996-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#5)(2008-8#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#2)
He##281##1##(1990-11#4)(1990-6#2)(1991-1#1)(1991-12#1)(1991-6#4)(1992-11#3)(1992-2#2)(1992-3#3)(1992-6#1)(1993-11#3)(1993-12#6)(1993-2#6)(1993-3#4)(1993-8#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#7)(1996-5#1)(1996-6#3)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#5)(2007-11#2)(2007-12#12)(2007-2#2)(2007-4#1)(2007-5#5)(2007-7#6)(2007-8#2)(2008-1#8)(2008-10#22)(2008-11#1)(2008-12#10)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#11)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#6)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#4)(2011-1#6)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#12)(2013-8#6)
He(+)-ion##2##1##(2007-12#2)
He-Cd laser##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
He-Ne laser and##2##3##(2007-12#1)(2008-3#1)
He-Ne laser as the##2##4##(2007-11#1)(2008-3#1)
He-Ne laser as##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
He-Ne laser beam##3##3##(2008-3#3)
He-Ne laser##29##2##(1996-5#1)(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#17)
He-Ne ring laser##2##3##(2008-2#1)(2008-3#1)
He-Ne ring##3##2##(2008-2#2)(2008-3#1)
He-Ne##33##1##(1996-5#1)(2007-11#2)(2007-12#4)(2008-2#7)(2008-3#19)
He/H(2)/CH(4)/N(2)##2##1##(2008-10#2)
HeLa MR##2##2##(1992-3#2)
HeLa S3##2##2##(1992-3#1)(2010-3#1)
HeLa and##4##2##(1991-6#1)(1992-11#1)(1994-3#1)(2008-11#1)
HeLa cell nuclear extracts##2##4##(1993-6#2)
HeLa cell##8##2##(1993-6#2)(1995-6#1)(2008-11#2)(2008-8#2)(2010-12#1)
HeLa cells and##6##3##(1997-1#1)(2007-11#1)(2008-11#1)(2008-8#3)
HeLa cells by##2##3##(2008-9#2)
HeLa cells overexpressing Bcl-2##3##4##(2008-8#3)
HeLa cells were##5##3##(1996-5#1)(2008-11#2)(2008-8#1)(2010-2#1)
HeLa cells##59##2##(1990-11#1)(1990-5#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-10#2)(1994-11#3)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#3)(1997-1#1)(1997-7#1)(2007-11#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-8#11)(2008-9#6)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2012-2#2)
HeLa nuclear##3##2##(1993-8#2)(1995-6#1)
HeLa##94##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-3#7)(1992-6#4)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-10#2)(1994-11#3)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#4)(1996-5#3)(1997-1#1)(1997-7#2)(2006-12#1)(2007-11#1)(2008-11#16)(2008-12#1)(2008-2#1)(2008-8#14)(2008-9#6)(2009-4#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2012-2#2)
HeNe laser##3##2##(2007-12#3)
HeNe##4##1##(2007-12#4)
Head Blight##2##2##(2008-10#2)
Head Start##2##2##(2009-4#1)(2012-2#1)
Head and Neck Surgery##2##4##(1990-9#1)(2013-1#1)
Head and Neck##5##3##(1990-9#1)(2008-1#1)(2011-2#1)(2013-1#2)
Head and neck##7##3##(1995-9#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
Head and##12##2##(1990-9#1)(1995-9#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
Head##31##1##(1990-6#1)(1990-9#1)(1991-5#1)(1993-12#1)(1995-5#1)(1995-9#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Head-to-head comparison##2##2##(2009-5#1)(2011-2#1)
Head-to-head##3##1##(2008-7#1)(2009-5#1)(2011-2#1)
Headache##4##1##(2008-4#1)(2008-5#2)(2012-3#1)
Heads##2##1##(1992-1#1)(2009-7#1)
Headspace##7##1##(2008-10#6)(2009-8#1)
Healers##3##1##(2008-12#3)
Healing in##2##2##(2009-12#1)(2010-1#1)
Healing of##4##2##(1991-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
Healing was##2##2##(1996-1#1)(2008-10#1)
Healing##13##1##(1991-8#1)(1995-3#1)(1996-1#1)(2007-11#1)(2008-10#2)(2009-12#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
Health Act##5##2##(1993-12#1)(2007-10#1)(2008-7#1)(2010-1#1)(2013-1#1)
Health Administration##13##2##(1991-1#2)(1991-12#1)(1992-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(2008-7#3)
Health Agencies##5##2##(1996-3#4)(2008-11#1)
Health Agency of##2##3##(2008-11#1)(2013-8#1)
Health Agency##4##2##(1994-2#1)(2008-11#1)(2009-9#1)(2013-8#1)
Health Area##3##2##(1993-6#1)(1994-6#1)(1996-2#1)
Health Association of Canada##2##4##(1991-3#1)(1997-3#1)
Health Association##7##2##(1991-2#1)(1991-3#1)(1995-2#1)(1996-5#1)(1997-3#1)(2007-2#1)(2008-12#1)
Health Authorities##2##2##(1992-3#1)(2008-10#1)
Health Behaviors##2##2##(2008-11#1)(2013-1#1)
Health Behaviour##2##2##(1991-9#1)(2013-1#1)
Health Board##2##2##(2008-12#1)(2012-3#1)
Health Care Financing Administration (HCFA) has##4##6##(1992-2#1)(1992-3#1)(1994-3#1)(1996-2#1)
Health Care Financing Administration (HCFA)##18##5##(1992-2#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#5)(1997-3#1)
Health Care Financing Administration is##3##5##(1992-2#1)(1994-2#1)(1997-3#1)
Health Care Financing Administration##28##4##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#3)(1996-3#1)(1997-2#5)(1997-3#2)
Health Care Financing Administration's (HCFA)##2##5##(1996-2#2)
Health Care Financing Administration's##4##4##(1993-2#1)(1996-1#1)(1996-2#2)
Health Care Financing##38##3##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-2#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#1)(1996-1#3)(1996-2#6)(1996-3#2)(1997-2#5)(1997-3#3)
Health Care Quality Improvement Program (HCQIP)##2##6##(1996-2#2)
Health Care Quality Improvement Program##3##5##(1996-2#3)
Health Care Quality Improvement##9##4##(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#3)
Health Care Quality Team Award##2##5##(1996-2#1)(1997-2#1)
Health Care Quality##11##3##(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#4)(1997-2#1)
Health Care Reform##2##3##(1992-1#1)(1995-12#1)
Health Care Services in##2##4##(1996-3#1)(2009-10#1)
Health Care System is##2##4##(1994-1#1)(1994-12#1)
Health Care System##5##3##(1994-1#2)(1994-12#1)(1997-3#1)(2013-8#1)
Health Care##109##2##(1990-6#1)(1991-1#3)(1991-2#3)(1991-3#2)(1992-1#2)(1992-2#5)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#2)(1994-1#7)(1994-12#8)(1994-2#2)(1994-3#5)(1995-12#5)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#13)(1996-3#6)(1997-2#10)(1997-3#4)(2008-1#2)(2008-11#8)(2009-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Health Center##5##2##(1990-2#1)(1994-2#1)(2008-1#2)(2011-2#1)
Health Centers in##2##3##(1990-2#1)(2008-9#1)
Health Centers##5##2##(1990-2#1)(2008-9#3)(2011-2#1)
Health Centre##9##2##(1993-12#2)(1994-1#1)(1995-1#1)(1997-6#1)(2008-1#1)(2010-5#1)(2013-7#1)(2013-8#1)
Health Council has##2##3##(1991-2#1)(1996-8#1)
Health Council##5##2##(1991-2#1)(1991-3#1)(1996-8#2)(1997-8#1)
Health Day##3##2##(1995-3#2)(1996-2#1)
Health Department##2##2##(1996-5#1)(1997-5#1)
Health Devices##2##2##(1991-2#1)(2011-2#1)
Health District##4##2##(1990-2#1)(1996-1#3)
Health Education##4##2##(2008-1#2)(2012-3#2)
Health Emergency##2##2##(2010-8#1)(2011-2#1)
Health Evaluation##2##2##(2007-12#1)(2010-10#1)
Health Impact Assessment##2##3##(2012-1#1)(2013-1#1)
Health Impact##4##2##(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
Health Improvement##6##2##(1995-12#1)(1996-2#1)(2008-7#1)(2009-6#3)
Health Index Plus##2##3##(1993-1#2)
Health Index##3##2##(1993-1#2)(2008-10#1)
Health Information System##2##3##(1996-3#1)(2011-2#1)
Health Information##8##2##(1996-3#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#3)
Health Initiative##3##2##(1995-3#1)(2008-1#1)(2013-8#1)
Health Insurance Portability and Accountability Act (HIPAA)##2##7##(2007-12#2)
Health Insurance##9##2##(1994-2#1)(1996-1#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-8#1)
Health Interview##7##2##(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#2)(2009-7#1)(2010-11#1)
Health Maintenance##3##2##(1993-3#1)(2010-8#2)
Health Management##2##2##(2010-8#1)(2013-8#1)
Health Ministry##2##2##(1994-7#1)(1997-6#1)
Health Network##3##2##(1997-2#1)(2007-2#1)(2008-3#1)
Health Nursing##3##2##(2008-11#3)
Health Office##2##2##(1994-6#1)(2013-8#1)
Health Officials##6##2##(1995-12#3)(1996-1#3)
Health Organisation##7##2##(2008-1#1)(2008-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Health Organization at##2##3##(1994-9#1)(1997-6#1)
Health Organization##72##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-5#1)(1993-11#2)(1993-6#1)(1994-3#1)(1994-9#4)(1995-3#1)(1996-9#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#6)
Health Outcomes Institute##2##3##(1994-1#2)
Health Outcomes##4##2##(1994-1#2)(2008-11#1)(2012-12#1)
Health Plan Employer Data and Information Set##2##7##(1995-2#1)(1997-2#1)
Health Plan Employer Data##3##4##(1995-2#1)(1996-3#1)(1997-2#1)
Health Plan##7##2##(1995-1#2)(1995-2#1)(1996-3#2)(1997-1#1)(1997-2#1)
Health Planning and##2##3##(1991-12#1)(2008-1#1)
Health Policy##7##2##(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2009-5#1)(2010-4#1)(2012-3#1)
Health Professional##2##2##(2012-2#1)(2013-1#1)
Health Profile##3##2##(1991-6#1)(1997-1#2)
Health Program##4##2##(1994-2#1)(1997-1#2)(2008-9#1)
Health Promotion##4##2##(1994-3#1)(1997-5#1)(2008-11#1)(2011-1#1)
Health Protective Behaviors##2##3##(2013-1#2)
Health Questionnaire##5##2##(2008-1#2)(2008-11#1)(2008-3#1)(2013-1#1)
Health Record##6##2##(2008-11#1)(2008-7#2)(2010-8#2)(2011-2#1)
Health Reform##2##2##(1996-1#1)(1997-2#1)
Health Regulations##3##2##(2009-10#2)(2010-5#1)
Health Research##4##2##(1997-3#1)(2009-9#1)(2012-1#1)(2012-12#1)
Health Science##11##2##(1992-1#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)(2008-11#1)(2008-12#1)(2011-2#1)
Health Sciences Centre##3##3##(2008-11#2)(2008-7#1)
Health Sciences Library##4##3##(1992-12#1)(1995-2#1)(1996-12#1)(1997-3#1)
Health Sciences##24##2##(1992-12#1)(1992-2#1)(1994-3#3)(1995-2#2)(1996-12#1)(1997-3#1)(2008-1#2)(2008-11#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)(2011-1#2)(2012-3#2)
Health Sector##2##2##(1997-8#1)(2012-12#1)
Health Security##2##2##(1995-1#1)(1995-2#1)
Health Service in##2##3##(1992-5#1)(2012-2#1)
Health Service##35##2##(1991-1#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-2#1)(1997-6#1)(2007-4#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Health Services Act##2##3##(1996-1#2)
Health Services Administration##2##3##(1997-2#1)(2012-12#1)
Health Services Research##10##3##(1994-12#1)(2009-3#1)(2010-3#1)(2012-2#7)
Health Services Technology Assessment Research (HSTAR)##2##6##(1994-12#2)
Health Services Technology/Assessment Text (HSTAT)##2##5##(1996-3#2)
Health Services##33##2##(1991-2#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-2#1)(2008-6#3)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#2)(2012-12#1)(2012-2#8)
Health Services</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##5##(1996-12#2)
Health Start has been##2##4##(1995-12#2)
Health Start has##3##3##(1995-12#3)
Health Statistics##6##2##(1992-12#1)(1997-3#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Health Strategy##2##2##(1991-2#1)(2011-2#1)
Health Study##7##2##(2008-12#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-6#3)
Health Survey##7##2##(1994-6#1)(2009-7#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
Health System Reform##3##3##(1991-9#1)(1996-1#1)(2007-5#1)
Health System and##2##3##(1992-1#1)(2012-12#1)
Health System has##2##3##(1993-3#1)(1996-12#1)
Health System in##2##3##(1991-9#1)(2012-3#1)
Health System is##2##3##(1996-12#1)(1997-3#1)
Health System##30##2##(1991-9#2)(1992-1#1)(1992-2#1)(1993-3#2)(1994-1#1)(1994-2#4)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#3)(1996-2#1)(1997-2#2)(1997-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2012-12#2)(2012-3#3)
Health System's##2##2##(1993-3#1)(1996-12#1)
Health Systems##3##2##(1991-12#1)(1996-1#1)(2011-1#1)
Health Technologies##2##2##(2009-5#1)(2011-1#1)
Health Training##3##2##(1991-2#1)(2009-4#1)(2010-11#1)
Health Unit##2##2##(1991-2#1)(2010-10#1)
Health Utilities Index Mark 2##2##5##(2007-10#2)
Health Utilities Index Mark##3##4##(2007-10#2)(2008-7#1)
Health Utilities##4##2##(2007-10#3)(2008-7#1)
Health administration education##3##3##(1992-3#1)(1993-2#1)(1996-3#1)
Health administration in##2##3##(1992-1#2)
Health administration##5##2##(1992-1#2)(1992-3#1)(1993-2#1)(1996-3#1)
Health and Community##2##3##(1996-1#2)
Health and Family##2##3##(1996-3#1)(1996-4#1)
Health and Health##4##3##(1997-2#1)(2008-11#2)(2011-1#1)
Health and Hospital##2##3##(1996-3#1)(2008-1#1)
Health and Human Services##12##4##(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-7#1)(2012-2#1)
Health and Human##16##3##(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
Health and Nutrition##4##3##(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
Health and Safety##3##3##(1995-12#1)(2007-2#1)(2011-2#1)
Health and Social##5##3##(1993-6#2)(1994-1#1)(1994-2#1)(2013-1#1)
Health and Welfare Canada##3##4##(1991-3#2)(1996-3#1)
Health and Welfare##7##3##(1991-1#1)(1991-3#2)(1996-3#1)(1997-8#1)(2008-5#1)(2013-8#1)
Health and the environment##2##4##(1991-11#1)(1992-2#1)
Health and the##6##3##(1991-11#1)(1992-2#1)(1993-1#1)(1995-6#1)(2007-5#1)(2013-1#1)
Health and##91##2##(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-2#2)(1992-3#3)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#4)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#4)
Health announced that##2##3##(1995-1#1)(1996-2#1)
Health as a##2##3##(1996-12#1)(2013-8#1)
Health aspects of organophosphorous pesticides in asian countries##2##8##(2013-1#2)
Health behaviors##2##2##(2010-5#1)(2011-2#1)
Health care administrators##2##3##(1995-1#1)(1996-3#1)
Health care and##2##3##(1991-12#1)(2007-12#1)
Health care delivery is##2##4##(1996-2#1)(2012-1#1)
Health care facilities##2##3##(1993-12#1)(2008-3#1)
Health care financing##2##3##(1991-3#1)(1993-1#1)
Health care fraud##4##3##(1993-12#2)(1993-2#1)(1996-12#1)
Health care in##2##3##(1993-12#1)(1996-12#1)
Health care indicators##14##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)
Health care is##2##3##(1995-2#1)(2013-8#1)
Health care leaders##2##3##(1993-1#1)(1994-2#1)
Health care leadership##2##3##(1993-1#1)(1993-12#1)
Health care litigation##4##3##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)
Health care managers in British Columbia##2##6##(1994-1#1)(1994-2#1)
Health care managers##4##3##(1994-1#1)(1994-2#1)(1995-3#1)(2008-12#1)
Health care marketers need to##2##5##(1995-2#1)(1997-1#1)
Health care organizations##3##3##(1994-12#1)(1997-2#1)(2008-6#1)
Health care professionals##4##3##(1991-3#1)(1992-3#1)(2011-1#1)(2012-3#1)
Health care providers need to##2##5##(2007-10#1)(2008-10#1)
Health care providers who##2##4##(1992-12#1)(2008-1#1)
Health care providers##8##3##(1991-2#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#1)
Health care reform and the##4##5##(1991-12#1)(1993-12#1)(1995-12#1)(1995-3#1)
Health care reform and##6##4##(1991-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-3#1)
Health care reform has##2##4##(1995-2#1)(2011-1#1)
Health care reform in the United States##2##7##(1993-12#1)(1995-12#1)
Health care reform in the##3##5##(1993-12#1)(1995-12#1)(1997-3#1)
Health care reform is##2##4##(1996-1#2)
Health care reform##20##3##(1991-12#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#2)(1997-3#1)(2011-1#1)
Health care systems##2##3##(1993-2#1)(2010-11#1)
Health care workers##2##3##(2007-7#1)(2011-1#1)
Health care##132##2##(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#4)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#3)(1993-1#5)(1993-12#8)(1993-2#3)(1993-3#1)(1994-1#2)(1994-12#8)(1994-2#4)(1994-3#2)(1995-1#3)(1995-12#6)(1995-2#6)(1995-3#5)(1996-1#4)(1996-12#6)(1996-2#5)(1996-3#4)(1997-1#2)(1997-2#3)(1997-3#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#4)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#2)(2011-1#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
Health conducted##2##2##(1995-11#1)(2011-2#1)
Health courts##2##2##(2008-6#2)
Health education##5##2##(1990-11#1)(1993-11#2)(1994-3#1)(2008-12#1)
Health effects of##2##3##(1991-12#1)(2013-8#1)
Health for##3##2##(1992-1#1)(1995-1#1)(2008-1#1)
Health fraud##2##2##(1991-2#2)
Health from##2##2##(2008-1#1)(2008-10#1)
Health has##6##2##(1990-3#1)(1997-1#1)(1997-2#2)(2008-1#1)(2010-8#1)
Health in Nepal##2##3##(2008-7#2)
Health in the##3##3##(2008-9#1)(2009-9#1)(2012-3#1)
Health in##14##2##(1991-2#1)(1991-3#1)(1994-1#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#2)
Health information##5##2##(2008-7#2)(2012-12#3)
Health insurance and##2##3##(1994-1#1)(1995-2#1)
Health insurance##4##2##(1992-2#1)(1992-3#1)(1994-1#1)(1995-2#1)
Health is##4##2##(1991-6#1)(1996-1#1)(2008-10#1)(2012-12#1)
Health maintenance organizations##2##3##(1996-2#1)(1997-2#1)
Health maintenance##3##2##(1991-3#1)(1996-2#1)(1997-2#1)
Health objectives##2##2##(1994-3#1)(1996-12#1)
Health of the##4##3##(1991-11#1)(1997-5#1)(2008-1#1)(2008-11#1)
Health of##12##2##(1991-11#1)(1993-1#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
Health plan##2##2##(1994-3#1)(2008-6#1)
Health policy##3##2##(1990-2#1)(1994-2#1)(2012-12#1)
Health professionals need to##3##4##(1994-3#1)(1996-3#1)(2008-9#1)
Health professionals working##2##3##(1991-2#1)(2007-12#1)
Health professionals##9##2##(1991-2#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-3#1)
Health profile of##2##3##(2008-7#1)(2009-10#1)
Health promotion##2##2##(1991-1#1)(1995-12#1)
Health reform##6##2##(1994-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(2012-3#2)
Health risk##2##2##(1992-12#1)(2008-7#1)
Health risks associated with##2##4##(1991-3#1)(1992-2#1)
Health risks##3##2##(1991-3#1)(1992-2#1)(2008-1#1)
Health services administration##3##3##(1991-12#1)(1997-2#2)
Health services management##3##3##(1994-2#1)(1995-3#2)
Health services##12##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-3#2)(1997-2#2)(2009-5#1)(2009-6#1)(2012-12#2)
Health status of##4##3##(1994-9#1)(1995-12#1)(1997-2#1)(2011-2#1)
Health study##3##2##(2008-7#1)(2009-5#1)(2012-3#1)
Health system reform##3##3##(1993-12#2)(1995-12#1)
Health system##4##2##(1993-12#2)(1995-12#1)(2012-1#1)
Health systems##2##2##(1997-1#1)(2012-12#1)
Health technology assessment##2##3##(1996-12#1)(2008-2#1)
Health technology##4##2##(1996-12#2)(2008-2#1)(2009-3#1)
Health to##6##2##(1995-1#1)(2008-1#2)(2008-10#1)(2010-7#1)(2011-2#1)
Health was##2##2##(1993-3#1)(1997-2#1)
Health were##3##2##(1996-9#1)(2008-11#1)(2012-12#1)
Health workers and the baby food industry##2##7##(1996-11#2)
Health workers##3##2##(1996-11#2)(2010-8#1)
Health##1363##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#11)(1991-11#2)(1991-12#15)(1991-2#30)(1991-3#14)(1991-6#4)(1991-9#5)(1992-1#14)(1992-12#6)(1992-2#17)(1992-3#15)(1992-5#3)(1992-8#2)(1993-1#10)(1993-11#6)(1993-12#17)(1993-2#7)(1993-3#11)(1993-6#4)(1994-1#21)(1994-11#3)(1994-12#27)(1994-2#24)(1994-3#23)(1994-6#3)(1994-7#1)(1994-9#5)(1995-1#15)(1995-11#2)(1995-12#33)(1995-2#21)(1995-3#19)(1995-6#4)(1996-1#30)(1996-11#2)(1996-12#25)(1996-2#40)(1996-3#32)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#14)(1997-2#33)(1997-3#22)(1997-5#8)(1997-6#8)(1997-8#7)(2006-10#2)(2007-10#8)(2007-12#9)(2007-2#10)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-9#3)(2008-1#46)(2008-10#36)(2008-11#73)(2008-12#27)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#16)(2008-7#35)(2008-8#5)(2008-9#14)(2009-10#6)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#10)(2009-6#6)(2009-7#7)(2009-8#2)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#6)(2010-4#5)(2010-5#12)(2010-6#7)(2010-7#2)(2010-8#21)(2010-9#1)(2011-1#42)(2011-2#62)(2011-7#1)(2011-9#1)(2012-1#5)(2012-12#45)(2012-2#24)(2012-3#26)(2013-1#44)(2013-7#2)(2013-8#34)
Health'##2##1##(2010-4#1)(2013-1#1)
Health's##7##1##(1995-2#1)(2008-11#1)(2010-10#1)(2010-8#1)(2012-12#3)
Health)##2##1##(2008-1#1)(2011-2#1)
Health-related quality of life and##2##5##(2007-12#1)(2013-7#1)
Health-related quality of life##3##4##(2007-12#1)(2008-7#1)(2013-7#1)
Health-related##7##1##(1994-6#1)(2007-12#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
HealthCare##6##1##(1991-9#1)(1993-5#1)(1996-12#1)(1997-3#3)
HealthSystem##2##1##(1997-2#2)
Healthcare (USHC)##2##2##(1996-3#1)(1997-1#1)
Healthcare Management##3##2##(1990-4#1)(1996-12#1)(2009-8#1)
Healthcare Radiology##5##2##(1991-2#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-2#1)
Healthcare Reform##2##2##(2011-2#1)(2012-2#1)
Healthcare System##4##2##(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
Healthcare Units##4##2##(2008-9#4)
Healthcare access##2##2##(1993-2#1)(1995-2#1)
Healthcare combinations##3##2##(1996-2#1)(1996-3#1)(1997-1#1)
Healthcare providers##2##2##(2008-3#2)
Healthcare reform##2##2##(1995-1#1)(1996-1#1)
Healthcare security##2##2##(1992-12#1)(1996-2#1)
Healthcare##91##1##(1990-4#4)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#3)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#2)(1996-1#4)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#2)(2008-9#6)(2009-8#1)(2010-1#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Healthcare's##3##1##(1995-12#1)(1996-2#1)(1997-1#1)
Healthier##5##1##(1995-2#3)(1996-1#1)(2012-2#1)
Healthiest Babies Possible Program##2##4##(1991-12#2)
Healthy Environments Project##2##3##(2011-2#2)
Healthy Kids##2##2##(2008-12#2)
Healthy People 2000##4##3##(1994-3#2)(1996-12#1)(1996-2#1)
Healthy People 2010##3##3##(2008-7#1)(2010-9#1)(2011-1#1)
Healthy People##9##2##(1994-3#2)(1996-12#1)(1996-2#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-1#2)
Healthy subjects##2##2##(1993-9#1)(2011-2#1)
Healthy volunteers##2##2##(2008-3#1)(2010-9#1)
Healthy##45##1##(1992-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-12#2)(1996-2#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
Hearing preservation##2##2##(2010-4#2)
Hearing##11##1##(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#2)(2011-2#3)(2012-3#1)
Hearings##2##1##(1995-12#1)(2008-1#1)
Heart Association##20##2##(1996-6#2)(2007-8#1)(2008-11#1)(2008-3#8)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
Heart Attack##3##2##(2008-3#3)
Heart J##2##2##(2008-4#1)(2010-1#1)
Heart Study##6##2##(1991-8#1)(2008-1#1)(2009-12#1)(2011-2#2)(2013-8#1)
Heart and##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
Heart disease##2##2##(2009-6#1)(2011-2#1)
Heart failure has##2##3##(1994-7#1)(2008-3#1)
Heart failure in##2##3##(2008-7#1)(2010-3#1)
Heart failure is one of the##2##6##(2010-8#1)(2011-2#1)
Heart failure is##4##3##(1996-6#1)(2008-3#1)(2010-8#1)(2011-2#1)
Heart failure##14##2##(1994-7#1)(1996-6#1)(1997-8#1)(2008-3#3)(2008-7#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-2#2)
Heart of##2##2##(2007-2#1)(2008-5#1)
Heart rate (HR) and##2##4##(2013-8#2)
Heart rate (HR)##3##3##(2013-1#1)(2013-8#2)
Heart rate variability (HRV)##2##4##(2009-11#1)(2010-5#1)
Heart rate variability##4##3##(2009-11#2)(2010-5#2)
Heart rate##12##2##(1991-10#1)(1992-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2010-5#2)(2013-1#2)(2013-8#2)
Heart valves are fragile connective tissues which are vulnerable to any systemic autoimmune diseases##2##14##(2013-1#2)
Heart##99##1##(1991-10#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-7#1)(1995-5#1)(1996-6#3)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#18)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#3)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#10)(2013-8#3)
HeartMate VE##2##2##(2010-8#2)
HeartMate##3##1##(2010-8#3)
Heartland##3##1##(2008-10#3)
Hearts##2##1##(2008-7#1)(2012-3#1)
Heat Treatment##2##2##(2008-10#1)(2008-3#1)
Heat shock protein##4##3##(1992-11#1)(1993-8#1)(1995-12#1)(2008-4#1)
Heat shock proteins in##2##4##(1994-11#1)(2008-5#1)
Heat shock proteins##4##3##(1994-11#2)(2008-5#2)
Heat shock##12##2##(1992-11#1)(1993-8#1)(1994-11#3)(1995-12#1)(1997-7#2)(2008-4#1)(2008-5#2)(2008-7#1)
Heat treatment##3##2##(1993-11#1)(2008-10#1)(2013-8#1)
Heat##32##1##(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#3)(1995-12#1)(1997-2#1)(1997-7#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2011-2#3)(2013-8#2)
Heat-resistant flexible-film optical waveguides##2##4##(2008-2#2)
Heat-shock proteins##2##2##(2008-4#2)
Heat-treated##2##1##(2012-2#2)
Heath##2##1##(2009-8#1)(2013-1#1)
Heather##2##1##(2008-10#1)(2008-6#1)
Heating at 40 degrees C##2##5##(2008-4#2)
Heating of##3##2##(1992-12#1)(2007-10#1)(2008-10#1)
Heating the##2##2##(2008-10#2)
Heating##9##1##(1992-12#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-4#2)
Heavy metal##5##2##(2008-10#2)(2008-12#1)(2009-12#1)(2010-11#1)
Heavy metals and##2##3##(1995-3#1)(2008-10#1)
Heavy metals##7##2##(1995-3#2)(1997-4#1)(2008-10#2)(2008-12#1)(2010-11#1)
Heavy##18##1##(1995-3#2)(1995-8#1)(1996-9#2)(1997-4#1)(2007-12#1)(2008-10#4)(2008-12#2)(2009-12#1)(2010-11#2)(2011-1#1)(2012-2#1)
Hebb##3##1##(2008-11#2)(2008-7#1)
Hebbian##3##1##(2008-8#1)(2009-8#1)(2013-8#1)
Hebei province##2##2##(1997-3#1)(2011-1#1)
Hebei##4##1##(1997-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
Hebrew University of Jerusalem##2##4##(2011-2#1)(2013-8#1)
Hebrew letters##2##2##(2008-4#2)
Hebrew##5##1##(2008-4#2)(2009-11#1)(2011-2#1)(2013-8#1)
Hedrick (2011)##2##2##(2012-3#2)
Heg RNA and Cdk1 mRNA##2##5##(2012-3#2)
Heg RNA##4##2##(2012-3#4)
Heg##5##1##(2012-3#5)
Height and##2##2##(2011-1#2)
Height##9##1##(2008-3#1)(2011-1#4)(2011-2#3)(2013-8#1)
Heils Franken##2##2##(2008-10#2)
Heinz##2##1##(1995-3#1)(2007-11#1)
Hel-N1##4##1##(1994-12#4)
Hel-N2##2##1##(1994-12#2)
Hela cells and##2##3##(1990-5#1)(2011-1#1)
Hela cells##10##2##(1990-5#3)(1997-7#1)(2008-10#3)(2011-1#3)
Helen##2##1##(1995-12#1)(2009-12#1)
Helferich##2##1##(1992-12#1)(2009-8#1)
Helianthus annuus##4##2##(2008-10#1)(2008-8#1)(2009-6#2)
Helianthus##8##1##(1991-5#1)(2008-10#2)(2008-8#3)(2009-6#2)
Heliao lead-zinc polymetallic ore district##2##5##(2013-8#2)
Helical##6##1##(1995-2#1)(2008-11#1)(2009-11#2)(2009-2#1)(2010-12#1)
Helichrysum##3##1##(2008-11#3)
Helicobacter pylori (H##2##3##(2008-5#1)(2011-2#1)
Helicobacter pylori and##6##3##(1991-2#1)(1996-6#1)(1997-1#3)(2008-12#1)
Helicobacter pylori has been##2##4##(1997-1#2)
Helicobacter pylori in##2##3##(1997-8#1)(2012-12#1)
Helicobacter pylori infection in##3##4##(1992-5#1)(2011-2#1)(2012-12#1)
Helicobacter pylori infection##18##3##(1992-5#2)(1995-2#1)(1996-11#1)(1997-1#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
Helicobacter pylori is##3##3##(1995-2#1)(2008-12#1)(2012-12#1)
Helicobacter pylori##73##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-5#3)(1995-2#2)(1996-11#3)(1996-12#5)(1996-6#1)(1996-8#1)(1997-1#11)(1997-7#2)(1997-8#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#5)(2008-5#3)(2008-7#3)(2008-8#1)(2009-6#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#1)(2013-1#1)(2013-8#2)
Helicobacter##81##1##(1990-11#1)(1990-2#1)(1991-2#2)(1991-8#1)(1992-5#3)(1995-2#2)(1996-11#3)(1996-12#5)(1996-6#1)(1996-8#1)(1997-1#13)(1997-7#2)(1997-8#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#5)(2008-5#3)(2008-7#3)(2008-8#2)(2009-6#2)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#8)(2012-2#1)(2013-1#1)(2013-8#2)
Heliconius##5##1##(2013-1#5)
Helicoverpa armigera (Hübner)##3##3##(2008-12#1)(2011-2#2)
Helicoverpa armigera##6##2##(2008-11#1)(2008-12#2)(2011-2#3)
Helicoverpa punctigera##2##2##(2011-2#2)
Helicoverpa zea cell line##2##4##(2008-11#2)
Helicoverpa zea##3##2##(2008-11#3)
Helicoverpa##11##1##(2008-11#4)(2008-12#2)(2011-2#5)
Heliosperma##5##1##(2010-6#5)
Heliothis virescens##2##2##(2008-11#1)(2010-2#1)
Heliothis##3##1##(2008-11#1)(2010-2#1)(2012-2#1)
Helix aspersa maxima##4##3##(2008-12#4)
Helix aspersa##5##2##(2008-12#4)(2008-7#1)
Helix pomatia##2##2##(1990-7#1)(1991-8#1)
Helix##12##1##(1990-7#1)(1991-8#1)(2008-10#1)(2008-12#5)(2008-7#1)(2013-1#3)
Helleborus##2##1##(1990-9#1)(2008-10#1)
Hellenic##2##1##(1991-6#1)(2008-5#1)
Heller##2##1##(2011-1#1)(2011-2#1)
Helmholtz equation##3##2##(2007-11#1)(2008-3#2)
Helmholtz reciprocity##2##2##(2008-2#2)
Helmholtz##5##1##(2007-11#1)(2008-2#2)(2008-3#2)
Helminthosporium victoriae##4##2##(2008-10#4)
Helminthosporium##7##1##(2008-10#7)
Helminths##2##1##(2012-12#1)(2012-2#1)
Help##4##1##(1991-11#1)(1994-2#1)(2008-2#1)(2010-8#1)
Helper Component-Protease##2##2##(2008-10#2)
Helper Component-Proteinase##3##2##(2008-10#3)
Helper##8##1##(1994-11#1)(2008-10#7)
Helper-dependent adenoviral vectors##2##3##(2008-2#1)(2008-4#1)
Helpers##2##1##(2008-8#1)(2008-9#1)
Helping hospitals spread the word about their patient focused care programs##3##11##(1993-1#1)(1993-2#1)(1993-3#1)
Helping sick doctors##2##3##(1996-6#2)
Helping##18##1##(1992-5#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-6#2)(1997-3#2)(2008-11#1)(2012-12#1)(2013-8#2)
Helsingborg Consensus Conference on European Stroke Strategies##2##7##(2008-8#2)
Helsingborg Declaration##5##2##(2008-8#5)
Helsingborg##7##1##(2008-8#7)
Helsinki (1##2##2##(1992-3#2)
Helsinki##12##1##(1991-8#1)(1992-3#5)(1993-2#1)(2007-7#1)(2008-1#1)(2008-7#2)(2012-2#1)
Hemangioblastomas##2##1##(2012-3#2)
Hemangioma##2##1##(1990-9#1)(2008-8#1)
Hemangiomas are##3##2##(1993-1#1)(2007-8#1)(2011-2#1)
Hemangiomas##4##1##(1993-1#1)(2007-8#1)(2011-2#2)
Hemangiopericytoma##2##1##(1993-6#1)(2011-2#1)
Hematocrit##2##1##(2008-1#1)(2013-8#1)
Hematogenous##3##1##(2008-10#1)(2009-12#1)(2010-3#1)
Hematologic toxicity##2##2##(1990-10#1)(1990-2#1)
Hematologic##6##1##(1990-10#1)(1990-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-2#1)
Hematological##4##1##(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
Hematology and Oncology at##2##4##(2008-9#2)
Hematology and Oncology##7##3##(2008-9#7)
Hematology and##10##2##(2008-11#1)(2008-9#9)
Hematology results indicated that trimethylolpropane triacrylate##2##6##(2008-9#2)
Hematology results indicated that##3##4##(2008-9#3)
Hematology results indicated##4##3##(2008-9#4)
Hematology##21##1##(2008-11#1)(2008-7#1)(2008-9#14)(2009-4#1)(2010-11#2)(2011-2#2)
Hematopoiesis##2##1##(1996-2#1)(2008-11#1)
Hematopoietic Stem Cell##2##3##(2008-11#1)(2012-12#1)
Hematopoietic Stem##3##2##(2008-11#1)(2010-11#1)(2012-12#1)
Hematopoietic cytokines##2##2##(1993-6#1)(2008-7#1)
Hematopoietic stem cell transplantation##2##4##(2009-10#1)(2010-11#1)
Hematopoietic stem##3##2##(2009-10#1)(2009-12#1)(2010-11#1)
Hematopoietic##11##1##(1993-6#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-11#2)(2011-2#1)(2012-12#1)
Hematoxylin and##2##2##(2007-10#1)(2008-5#1)
Heme##4##1##(1992-12#1)(2008-10#1)(2012-1#1)(2013-7#1)
Hemiballismus##2##1##(2008-7#1)(2009-5#1)
Hemibiotrophic##2##1##(2008-10#2)
Hemifacial spasm##2##2##(2008-12#2)
Hemiptera and##2##2##(2007-12#2)
Hemiptera##3##1##(2007-12#2)(2008-6#1)
Hemisphere##12##1##(1990-8#1)(2008-10#9)(2013-7#1)(2013-8#1)
Hemoccult##3##1##(1991-6#2)(1993-3#1)
Hemocyanin##2##1##(1996-2#1)(2010-4#1)
Hemodialysis Patients##3##2##(2007-10#1)(2008-1#2)
Hemodialysis##21##1##(1996-2#1)(2007-10#1)(2007-7#4)(2008-1#11)(2008-4#2)(2011-2#1)(2013-8#1)
Hemodynamic effects##2##2##(1991-6#1)(2009-8#1)
Hemodynamic factors##2##2##(2007-7#1)(2013-1#1)
Hemodynamic##10##1##(1991-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-1#1)
Hemoglobin (Hb) was##2##3##(1991-2#1)(1995-11#1)
Hemoglobin levels##2##2##(1993-2#1)(2008-7#1)
Hemoglobin##14##1##(1990-8#1)(1991-2#2)(1993-2#2)(1995-11#1)(2007-2#1)(2008-7#2)(2009-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
Hemolymph##2##1##(1997-8#1)(2008-10#1)
Hemolytic disease of the newborn##2##5##(1993-12#1)(2012-2#1)
Hemolytic disease of the##3##4##(1993-12#1)(2010-11#1)(2012-2#1)
Hemolytic##5##1##(1993-12#1)(1994-12#1)(2008-4#1)(2010-11#1)(2012-2#1)
Hemophagocytic##3##1##(2011-2#3)
Hemophilia A##4##2##(2008-11#1)(2008-12#1)(2012-12#2)
Hemopoietic##3##1##(1992-5#1)(2008-5#1)(2013-1#1)
Hemorheological##2##1##(2008-7#1)(2009-11#1)
Hemorrhage##10##1##(1995-11#3)(2007-7#1)(2011-2#1)(2012-3#4)(2013-8#1)
Hemorrhagic##6##1##(2006-10#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Hemorrhoidal##2##1##(2009-2#1)(2013-1#1)
Hemostasis impairment##2##2##(2011-1#2)
Hemosuccus pancreaticus##2##2##(2011-2#2)
Hence it##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
Hence the##11##2##(1990-5#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-3#1)(2013-8#1)
Hence we conclude that##2##4##(1992-9#1)(2008-7#1)
Hence we##4##2##(1992-9#1)(2007-12#1)(2008-7#2)
Hence##161##1##(1990-5#2)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#12)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#2)
Henderson General Division##2##3##(1994-3#2)
Henderson##4##1##(1994-3#2)(1995-12#1)(2008-10#1)
Henie##3##1##(1991-6#3)
Hennepin and Ramsey counties##2##4##(2012-12#2)
Hennepin##3##1##(1994-2#1)(2012-12#2)
Henoch-Schonlein purpura##2##2##(2008-1#2)
Henri##2##1##(2008-10#1)(2009-7#1)
Henry Ford Health System##2##4##(1992-2#1)(1994-2#1)
Henry Ford##3##2##(1992-2#1)(1993-12#1)(1994-2#1)
Henry##8##1##(1990-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(2007-10#2)(2008-10#1)(2008-6#1)
Henry's##3##1##(2008-10#1)(2008-5#1)(2008-7#1)
Hep G2##4##2##(2008-11#4)
Hep-1##2##1##(2008-11#2)
Hep-2 cells##3##2##(2008-10#1)(2011-2#2)
Hep-2##5##1##(2008-10#1)(2011-2#3)(2012-2#1)
HepG2 and Vero##2##3##(2007-10#2)
HepG2 and##3##2##(2007-10#2)(2010-1#1)
HepG2 cell line##6##3##(1990-12#1)(1992-3#3)(1995-6#1)(2007-10#1)
HepG2 cell##9##2##(1990-12#1)(1992-3#4)(1995-6#2)(2007-10#2)
HepG2 cells##16##2##(1990-5#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(2008-11#3)(2008-8#1)(2010-11#2)(2012-12#1)
HepG2 human##2##2##(2013-1#2)
HepG2##38##1##(1990-12#1)(1990-5#2)(1992-3#4)(1993-6#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-6#4)(1997-1#1)(1997-7#1)(2007-10#5)(2008-11#6)(2008-8#1)(2010-1#1)(2010-11#2)(2012-12#1)(2013-1#3)
HepSS-1##2##1##(1995-12#2)
HepZ##2##1##(2008-11#2)
Hepa##2##1##(1993-6#1)(2008-11#1)
Heparanase##2##1##(2010-8#2)
Heparin induced thrombocytopenia##2##3##(2007-8#1)(2013-1#1)
Heparin is##2##2##(1995-2#2)
Heparin was##2##2##(2008-11#2)
Heparin##15##1##(1994-9#1)(1995-2#4)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2013-1#2)(2013-8#1)
Heparin-binding##2##1##(1993-11#1)(1997-1#1)
Heparin-induced thrombocytopenia (HIT) is##2##4##(2008-10#1)(2010-3#1)
Heparin-induced thrombocytopenia##3##2##(1997-2#1)(2008-10#1)(2010-3#1)
Hepatic CYP1A##2##2##(2008-10#2)
Hepatic artery pseudoaneurysm##2##3##(2012-2#2)
Hepatic mesenchymal hamartoma##2##3##(2008-9#2)
Hepatic##26##1##(1990-6#1)(1991-6#1)(1993-12#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Hepatitis A and##2##3##(2009-4#1)(2013-1#1)
Hepatitis A virus##2##3##(2006-10#1)(2007-12#1)
Hepatitis A##7##2##(1996-12#1)(2006-10#1)(2007-12#2)(2009-4#1)(2011-1#1)(2013-1#1)
Hepatitis B Virus##2##3##(2008-10#1)(2008-11#1)
Hepatitis B and C##4##4##(1992-12#1)(1994-7#1)(2008-1#1)(2013-7#1)
Hepatitis B e##2##3##(2013-1#2)
Hepatitis B surface antigen (HBsAg)##2##5##(2008-10#1)(2012-3#1)
Hepatitis B vaccination##4##3##(2008-10#1)(2008-4#1)(2009-12#1)(2012-3#1)
Hepatitis B virus (HBV)##5##4##(2007-7#1)(2008-10#1)(2008-12#1)(2013-1#2)
Hepatitis B virus core##2##4##(1994-7#1)(1996-12#1)
Hepatitis B virus##12##3##(1994-7#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#3)
Hepatitis B##31##2##(1992-12#1)(1994-7#2)(1996-12#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#6)(2013-7#1)
Hepatitis C Virus##3##3##(2008-1#2)(2011-2#1)
Hepatitis C virus (HCV) and##2##5##(2007-7#1)(2008-10#1)
Hepatitis C virus (HCV) is##2##5##(2007-7#1)(2012-1#1)
Hepatitis C virus (HCV)##7##4##(2007-7#3)(2008-1#1)(2008-10#1)(2012-1#1)(2013-1#1)
Hepatitis C virus infection##4##4##(2006-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
Hepatitis C virus##16##3##(1990-3#1)(1994-11#1)(1995-6#1)(2006-10#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
Hepatitis C##23##2##(1990-3#1)(1994-11#1)(1995-6#1)(2006-10#1)(2007-7#4)(2008-1#3)(2008-10#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#3)
Hepatitis E is an##2##4##(2008-7#1)(2009-8#1)
Hepatitis E virus is##3##4##(2007-12#1)(2007-2#1)(2007-7#1)
Hepatitis E virus##4##3##(2007-12#1)(2007-2#1)(2007-7#2)
Hepatitis E##11##2##(2007-12#1)(2007-2#2)(2007-7#4)(2008-7#2)(2009-8#2)
Hepatitis and##2##2##(2008-9#1)(2012-2#1)
Hepatitis##84##1##(1990-3#1)(1992-12#2)(1994-11#1)(1994-7#2)(1995-6#1)(1996-12#2)(1996-3#1)(2006-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#9)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
Hepatoblastoma##3##1##(2011-1#1)(2013-1#2)
Hepatocellular carcinoma (HCC)##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
Hepatocellular carcinoma##5##2##(1990-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
Hepatocellular##8##1##(1990-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-2#1)(2013-1#2)
Hepatocyte growth factor (HGF)##2##4##(1992-12#1)(1993-3#1)
Hepatocyte growth factor is##2##4##(1992-12#1)(1993-8#1)
Hepatocyte growth factor##4##3##(1992-12#2)(1993-3#1)(1993-8#1)
Hepatocyte##11##1##(1990-12#2)(1992-12#2)(1993-3#1)(1993-8#1)(1994-8#1)(2008-11#1)(2008-6#1)(2009-8#1)(2013-1#1)
Hepatocytes##9##1##(1990-2#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#1)(2008-11#2)
Hepatoma Cell##2##2##(2008-11#2)
Hepatoma cells previously cultured with##2##5##(2008-11#2)
Hepatoma##5##1##(2008-11#4)(2012-3#1)
Hepatoprotective activity of##2##3##(2010-2#1)(2013-1#1)
Hepatoprotective##3##1##(2008-10#1)(2010-2#1)(2013-1#1)
Hepatorenal##2##1##(2006-10#1)(2011-2#1)
Hepatotoxicity was##2##2##(1994-5#1)(2012-2#1)
Hepes buffer##3##2##(2008-10#3)
Hepes##4##1##(1990-8#1)(2008-10#3)
Hepoxilin A3##3##2##(1990-12#3)
Her past##2##2##(2007-7#1)(2009-3#1)
Her symptoms##2##2##(2008-1#1)(2013-8#1)
Her##29##1##(1993-10#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#1)(1997-3#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
Her-2/neu##2##1##(2008-10#2)
Herb##2##1##(2008-10#2)
Herba Houttuyniae injection##2##3##(2011-2#2)
Herba##5##1##(2008-11#2)(2011-2#2)(2012-2#1)
Herbal medicines##2##2##(2008-11#1)(2013-1#1)
Herbal##8##1##(2008-1#1)(2008-10#1)(2008-11#2)(2013-1#3)(2013-8#1)
Herbert##3##1##(2007-2#2)(2012-2#1)
Herbicide##3##1##(1996-3#1)(2008-10#1)(2008-11#1)
Herbicides##2##1##(2008-10#2)
Herbimycin A##2##2##(1993-8#1)(1994-8#1)
Herbs##2##1##(2007-12#1)(2013-1#1)
Here I present an##2##4##(2008-3#1)(2012-2#1)
Here I show##2##3##(2012-2#1)(2012-3#1)
Here I##10##2##(1996-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2012-2#2)(2012-3#1)
Here a case of##2##4##(2011-2#1)(2012-2#1)
Here a new##2##3##(2008-3#2)
Here a simple##2##3##(2008-10#1)(2008-3#1)
Here a##14##2##(1994-5#1)(1997-1#1)(2008-10#1)(2008-3#8)(2011-2#1)(2012-12#1)(2012-2#1)
Here an##6##2##(2008-3#6)
Here are the##3##3##(1992-2#1)(1992-3#1)(1993-1#1)
Here are##7##2##(1992-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1997-2#1)(2008-10#1)(2011-2#1)
Here is##2##2##(2008-9#2)
Here it is##2##3##(1995-11#1)(2007-8#1)
Here it##3##2##(1993-11#1)(1995-11#1)(2007-8#1)
Here the authors##3##3##(2008-9#2)(2012-1#1)
Here the##21##2##(1993-11#2)(1996-2#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-9#2)(2010-1#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#1)
Here we analyze##2##3##(2008-2#1)(2008-8#1)
Here we attempt to##2##4##(2008-7#1)(2012-2#1)
Here we characterize##2##3##(2009-12#1)(2011-2#1)
Here we compare##2##3##(2008-11#1)(2008-9#1)
Here we conduct##2##3##(2008-8#1)(2008-9#1)
Here we demonstrate how our lab##2##6##(2008-8#2)
Here we demonstrate how##3##4##(2008-10#1)(2008-8#2)
Here we demonstrate that the##2##5##(1992-12#1)(2012-12#1)
Here we demonstrate that##14##4##(1991-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-5#1)(1995-8#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#2)
Here we demonstrate the##3##4##(2008-1#1)(2012-2#2)
Here we demonstrate##24##3##(1991-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-5#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#3)(2010-12#1)(2012-12#1)(2012-2#5)
Here we describe a new##2##5##(1992-8#1)(2013-8#1)
Here we describe a simple##3##5##(1990-12#1)(2008-11#1)(2012-2#1)
Here we describe a##16##4##(1990-12#2)(1992-8#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#2)(2010-5#1)(2012-2#3)(2013-8#1)
Here we describe an##3##4##(2008-10#1)(2008-3#1)(2009-5#1)
Here we describe the basic features of##2##7##(2011-2#2)
Here we describe the development of##2##6##(1997-4#1)(2009-5#1)
Here we describe the features of the organism##3##8##(2011-2#3)
Here we describe the features of this organism##16##8##(2011-2#16)
Here we describe the features of this##17##7##(2011-2#17)
Here we describe the features of##22##6##(2011-2#22)
Here we describe the molecular cloning##2##6##(1992-8#1)(1994-12#1)
Here we describe the##48##4##(1992-8#1)(1993-12#1)(1994-12#2)(1995-5#1)(1997-4#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#28)(2012-3#1)(2013-1#1)
Here we describe##78##3##(1990-12#2)(1992-8#2)(1993-12#1)(1993-9#1)(1994-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#29)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
Here we develop##2##3##(2008-3#1)(2008-8#1)
Here we discuss the possible##2##5##(2009-8#2)
Here we discuss the##7##4##(2008-10#1)(2008-11#2)(2009-8#3)(2011-2#1)
Here we discuss##11##3##(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#4)(2011-2#2)
Here we estimate##2##3##(2008-11#1)(2008-3#1)
Here we examine the##2##4##(1991-2#1)(2008-8#1)
Here we examined##2##3##(2008-11#1)(2008-8#1)
Here we expand##2##3##(2008-8#1)(2011-2#1)
Here we extend those##2##4##(1996-12#1)(2007-11#1)
Here we extend##4##3##(1996-12#1)(2007-11#1)(2008-11#1)(2008-8#1)
Here we focus on the##2##5##(2010-12#1)(2012-1#1)
Here we focus on##4##4##(2008-3#1)(2008-9#1)(2010-12#1)(2012-1#1)
Here we have examined the##2##5##(1997-7#1)(2008-7#1)
Here we have explored##2##4##(2008-10#1)(2008-3#1)
Here we have##12##3##(1993-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)
Here we identify##3##3##(1994-6#1)(2009-8#1)(2013-1#1)
Here we investigate the##2##4##(2008-12#1)(2009-9#1)
Here we investigate##3##3##(2008-12#1)(2009-9#1)(2010-3#1)
Here we investigated the##2##4##(2009-12#1)(2012-12#1)
Here we investigated##3##3##(2008-11#1)(2009-12#1)(2012-12#1)
Here we present a case of##3##6##(2010-11#1)(2012-3#1)(2013-1#1)
Here we present a case report of a##2##8##(2011-2#1)(2012-2#1)
Here we present a case##6##5##(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Here we present a detailed##2##5##(2008-3#1)(2010-3#1)
Here we present a method##2##5##(2008-3#1)(2008-7#1)
Here we present a new##3##5##(2008-3#1)(2010-8#1)(2012-2#1)
Here we present a##24##4##(2008-10#1)(2008-12#1)(2008-3#6)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
Here we present an##3##4##(2008-10#1)(2008-3#2)
Here we present data##2##4##(2008-8#1)(2013-8#1)
Here we present evidence##2##4##(1994-3#1)(2008-2#1)
Here we present experimental##2##4##(2008-2#1)(2008-9#1)
Here we present our##3##4##(2008-7#1)(2012-1#1)(2012-3#1)
Here we present the first##2##5##(2008-7#1)(2013-8#1)
Here we present the##5##4##(1994-12#1)(1994-3#1)(2008-3#1)(2008-7#1)(2013-8#1)
Here we present##50##3##(1990-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#9)(2008-7#5)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
Here we propose a new##2##5##(1993-9#1)(2008-3#1)
Here we propose a##4##4##(1993-9#1)(1994-9#1)(2008-3#2)
Here we propose##7##3##(1993-9#1)(1994-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
Here we provide a##2##4##(2008-11#1)(2008-9#1)
Here we provide##6##3##(1993-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2012-12#1)
Here we report a case of##3##6##(2008-11#1)(2010-4#1)(2010-6#1)
Here we report a new##2##5##(2008-7#1)(2012-2#1)
Here we report a novel##2##5##(2008-8#1)(2012-2#1)
Here we report a##25##4##(1991-2#1)(1993-11#1)(2007-7#1)(2008-11#2)(2008-7#5)(2008-8#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#1)
Here we report an##4##4##(1996-12#1)(2008-11#1)(2008-7#2)
Here we report for the first time the##2##8##(1995-6#1)(2008-7#1)
Here we report four##2##4##(2007-7#1)(2011-1#1)
Here we report on a##2##5##(2008-11#1)(2012-2#1)
Here we report on the##3##5##(1991-5#1)(2008-7#1)(2009-4#1)
Here we report on##9##4##(1991-5#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
Here we report that a##2##5##(1990-5#1)(1992-9#1)
Here we report that the##3##5##(1994-8#1)(1995-8#1)(2012-2#1)
Here we report that##23##4##(1990-11#1)(1990-5#2)(1991-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-8#2)(1996-2#1)(1996-5#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#2)
Here we report the backbone##2##5##(2009-7#2)
Here we report the case of##2##6##(2008-9#1)(2010-5#1)
Here we report the case##3##5##(2008-9#1)(2010-5#1)(2013-1#1)
Here we report the cloning of the##2##7##(1994-12#1)(1995-11#1)
Here we report the cloning of##3##6##(1994-12#1)(1995-11#1)(2008-7#1)
Here we report the cloning##4##5##(1992-3#1)(1994-12#1)(1995-11#1)(2008-7#1)
Here we report the crystal##2##5##(1993-9#1)(2011-1#1)
Here we report the discovery of##2##6##(2010-4#1)(2012-2#1)
Here we report the first##3##5##(2008-7#1)(2009-7#1)(2011-1#1)
Here we report the identification of a##2##7##(1990-11#1)(2009-6#1)
Here we report the identification of##4##6##(1990-11#1)(1994-11#1)(2008-10#1)(2009-6#1)
Here we report the identification##5##5##(1990-11#1)(1994-11#1)(2008-10#1)(2009-6#1)(2013-8#1)
Here we report the isolation of##2##6##(1995-2#1)(1997-3#1)
Here we report the isolation##3##5##(1993-6#1)(1995-2#1)(1997-3#1)
Here we report the resonance assignment of##2##7##(2009-7#2)
Here we report the results of a##2##7##(2008-11#1)(2013-1#1)
Here we report the results of##3##6##(2008-11#1)(2008-5#1)(2013-1#1)
Here we report the synthesis of##2##6##(1995-11#1)(2009-6#1)
Here we report the##50##4##(1990-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-2#1)(1995-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-6#2)(2009-7#10)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#5)(2013-1#2)(2013-8#1)
Here we report two cases of##2##6##(2008-7#1)(2010-2#1)
Here we report##132##3##(1990-11#2)(1990-5#2)(1991-2#3)(1991-5#1)(1992-11#1)(1992-3#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#15)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#13)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#6)(2011-2#2)(2012-12#2)(2012-2#15)(2013-1#3)(2013-7#1)(2013-8#1)
Here we review recent##4##4##(2008-11#3)(2013-1#1)
Here we review the results##2##5##(2008-4#1)(2009-8#1)
Here we review the##12##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#1)
Here we review##25##3##(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Here we show a##3##4##(1995-11#1)(2008-7#1)(2010-12#1)
Here we show for the first time##2##7##(2011-2#1)(2012-2#1)
Here we show that DNA##2##5##(1997-7#1)(2008-7#1)
Here we show that an##4##5##(1990-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
Here we show that in##3##5##(2008-9#2)(2012-12#1)
Here we show that the##16##5##(1992-6#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#2)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Here we show that##66##4##(1990-5#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-7#3)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
Here we show##78##3##(1990-5#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-7#3)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#8)(2008-8#3)(2008-9#4)(2009-4#1)(2009-8#1)(2009-9#3)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#2)
Here we study the##2##4##(2008-3#1)(2008-8#1)
Here we study##3##3##(2008-3#1)(2008-8#2)
Here we suggest##2##3##(2008-2#1)(2009-8#1)
Here we summarize##2##3##(2008-9#1)(2009-8#1)
Here we test the##3##4##(2008-9#1)(2011-1#1)(2011-2#1)
Here we test##5##3##(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
Here we use a simple##2##5##(2008-10#2)
Here we use the##6##4##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
Here we use##16##3##(1994-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
Here we used##6##3##(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)
Here we will##4##3##(2008-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
Here we##553##2##(1990-11#3)(1990-12#2)(1990-5#3)(1991-2#5)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#5)(1994-11#3)(1994-12#5)(1994-3#3)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#6)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#7)(1996-12#2)(1996-2#4)(1996-5#1)(1997-2#2)(1997-3#5)(1997-4#3)(1997-6#1)(1997-7#7)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#33)(2008-12#5)(2008-2#11)(2008-3#31)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#46)(2008-8#26)(2008-9#18)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#4)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#13)(2009-8#15)(2009-9#5)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#13)(2011-2#45)(2012-1#2)(2012-12#13)(2012-2#45)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#10)
Here##1095##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#7)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-6#2)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#3)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#5)(1994-11#8)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-11#8)(1995-12#3)(1995-2#9)(1995-3#1)(1995-5#3)(1995-6#7)(1995-8#7)(1996-12#2)(1996-2#7)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#5)(1997-6#1)(1997-7#10)(1997-8#1)(2007-11#4)(2007-12#5)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#70)(2008-11#60)(2008-12#12)(2008-2#16)(2008-3#61)(2008-4#12)(2008-5#9)(2008-6#6)(2008-7#77)(2008-8#61)(2008-9#37)(2009-10#11)(2009-11#2)(2009-12#7)(2009-2#8)(2009-3#2)(2009-4#2)(2009-5#9)(2009-6#10)(2009-7#21)(2009-8#27)(2009-9#10)(2010-1#2)(2010-10#4)(2010-11#11)(2010-12#11)(2010-2#3)(2010-3#9)(2010-4#11)(2010-5#4)(2010-6#6)(2010-7#3)(2010-8#4)(2011-1#21)(2011-2#75)(2012-1#4)(2012-12#25)(2012-2#75)(2012-3#38)(2012-5#2)(2013-1#32)(2013-7#5)(2013-8#22)
Here's how##2##2##(1991-1#1)(1993-3#1)
Here's##4##1##(1991-1#1)(1993-3#1)(1995-1#1)(2011-2#1)
Hereby##2##1##(1991-8#1)(2013-1#1)
Hereditary##18##1##(1993-1#1)(1994-9#1)(1995-5#1)(1996-6#2)(2007-10#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-3#1)(2010-6#2)(2011-2#1)(2012-3#2)(2013-1#1)
Herein I##2##2##(1997-3#1)(2008-3#1)
Herein a##2##2##(2010-10#1)(2012-12#1)
Herein lies##2##2##(1996-11#1)(1997-7#1)
Herein we describe##2##3##(1990-10#1)(2011-2#1)
Herein we present##2##3##(2008-7#1)(2010-12#1)
Herein we report a case of##3##6##(2010-6#2)(2012-3#1)
Herein we report a##6##4##(2007-8#1)(2010-5#1)(2010-6#2)(2012-12#1)(2012-3#1)
Herein we report that##2##4##(1995-5#1)(2011-1#1)
Herein we report##9##3##(1995-5#1)(2007-8#1)(2010-5#1)(2010-6#2)(2011-1#2)(2012-12#1)(2012-3#1)
Herein we##17##2##(1990-10#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
Herein##83##1##(1990-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#5)(2013-8#4)
Hereward##4##1##(2008-10#4)
Heritabilities##3##1##(2008-10#2)(2008-8#1)
Heritability estimates of##2##3##(2008-10#2)
Heritability estimates##4##2##(1994-2#1)(2008-10#3)
Heritability of##4##2##(2008-10#4)
Heritability##10##1##(1994-2#1)(2008-10#9)
Herlitz##2##1##(1991-11#2)
Hermann##3##1##(1995-2#1)(2008-5#1)(2012-2#1)
Hermeneutic##2##1##(2008-12#1)(2012-3#1)
Hermite##3##1##(2009-12#3)
Hermite-Gaussian beams##2##2##(2008-2#1)(2008-3#1)
Hermite-Gaussian modes##5##2##(2007-12#2)(2008-3#3)
Hermite-Gaussian##13##1##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#6)
Hernia##2##1##(2012-2#1)(2012-3#1)
Hernias##3##1##(2011-2#1)(2012-12#1)(2012-2#1)
Heroin##2##1##(2008-10#1)(2008-11#1)
Herpes simplex virus (HSV)##2##4##(2008-11#1)(2008-9#1)
Herpes simplex virus type 1##2##5##(2008-10#1)(2008-4#1)
Herpes simplex virus type##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
Herpes simplex virus##10##3##(1996-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2013-1#1)
Herpes simplex##11##2##(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2013-1#1)
Herpes zoster##4##2##(1994-3#2)(2008-7#1)(2009-12#1)
Herpes##16##1##(1994-3#2)(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2013-1#1)(2013-8#1)
Herpesviridae##2##1##(1995-3#1)(2008-9#1)
Herpesvirus saimiri##3##2##(1991-6#1)(2008-4#2)
Herpesvirus##6##1##(1991-6#1)(2008-11#2)(2008-4#2)(2009-5#1)
Herpetomonas sp##4##2##(2008-10#4)
Herpetosiphon giganteus strain Hpa2##2##4##(1991-9#2)
Herrera de Pisuerga##2##3##(2008-10#2)
Herrera##3##1##(2008-10#2)(2011-1#1)
Herring##3##1##(2008-10#3)
Hershey Medical Center##2##3##(1995-12#2)
Hertfordshire##5##1##(2008-11#2)(2008-12#1)(2010-7#1)(2012-12#1)
Hes1 expression##2##2##(2010-3#2)
Hes1##4##1##(2010-3#4)
Hessian fly in##2##3##(2011-2#2)
Hessian fly##8##2##(2011-2#8)
Hessian##12##1##(2008-3#3)(2011-2#9)
Het##2##1##(2012-12#2)
Heterakis gallinarum##2##2##(2011-1#2)
Heteranthelium piliferum##2##2##(2008-12#2)
Heterobasidion annosum##5##2##(2008-10#4)(2010-10#1)
Heterobasidion irregulare##2##2##(2010-10#2)
Heterobasidion occidentale##2##2##(2010-10#2)
Heterobasidion species##2##2##(2008-10#2)
Heterobasidion##14##1##(2008-10#6)(2010-10#8)
Heterochromatin##3##1##(2008-9#2)(2013-1#1)
Heterocyclic##2##1##(1996-5#1)(2012-2#1)
Heterodera avenae##3##2##(2008-10#3)
Heterodera glycines##16##2##(2008-10#16)
Heterodera schachtii Using##2##3##(2008-10#2)
Heterodera schachtii##13##2##(2008-10#10)(2008-12#3)
Heterodera##35##1##(2008-10#32)(2008-12#3)
Heterodyne##5##1##(2007-12#2)(2008-3#3)
Heterogeneity and##2##2##(1992-2#1)(1994-9#1)
Heterogeneity in##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
Heterogeneity of the##2##3##(1992-5#1)(2008-11#1)
Heterogeneity of##7##2##(1991-2#1)(1992-5#1)(1994-11#1)(1994-2#1)(2008-10#2)(2008-11#1)
Heterogeneity##12##1##(1991-2#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(2008-10#3)(2008-11#1)(2012-2#1)
Heterogeneous expressions of hepcidin isoforms in##2##6##(2010-12#2)
Heterogeneous##8##1##(2008-10#2)(2008-11#1)(2009-3#1)(2010-12#3)(2013-1#1)
Heterologous expression##2##2##(1996-12#1)(2008-7#1)
Heterologous##7##1##(1996-12#1)(1997-4#1)(2008-10#2)(2008-7#3)
Heteronuclear##2##1##(1997-2#1)(2009-2#1)
Heteroplexis micocephala##2##2##(2011-2#2)
Heteroptera##3##1##(2007-12#1)(2011-2#2)
Heterosexual##4##1##(1992-9#1)(1993-6#1)(2007-7#1)(2013-1#1)
Heterosis##2##1##(2009-10#1)(2012-3#1)
Heterotopic bone##2##2##(2012-2#2)
Heterotopic pancreas##2##2##(1997-8#1)(2013-7#1)
Heterotopic##6##1##(1997-8#1)(2007-11#1)(2011-1#1)(2012-2#2)(2013-7#1)
Heterozygous##3##1##(1995-2#1)(1997-4#1)(2009-6#1)
Heuer##2##1##(2012-3#2)
Hewlett##2##1##(1994-11#1)(2008-10#1)
Hexaene H-85 and##2##3##(2010-8#2)
Hexagonal##2##1##(2008-3#1)(2008-7#1)
Hexapoda and##3##2##(2007-12#3)
Hexapoda##4##1##(2007-12#4)
Hexavalent chromium##2##2##(2008-12#1)(2011-2#1)
Heyde's##2##1##(2012-2#2)
Heyssel##2##1##(1993-3#2)
Hf and##2##2##(2008-10#2)
Hf##14##1##(1997-7#1)(2008-10#13)
Hf(IV) and Zr(IV)##3##3##(2010-6#3)
Hf(IV) and##4##2##(2008-10#1)(2010-6#3)
Hf(IV) ions##2##2##(2008-10#2)
Hf(IV)##15##1##(2008-10#12)(2010-6#3)
Hf(Por) and Zr(Por)##2##3##(2010-6#2)
Hg after##3##2##(1992-6#2)(1995-12#1)
Hg and Se##2##3##(2008-10#2)
Hg and##12##2##(1995-12#1)(2007-9#2)(2008-10#7)(2008-11#1)(2010-4#1)
Hg exposure##2##2##(1990-5#1)(1995-3#1)
Hg in the##2##3##(2008-10#2)
Hg in##13##2##(1990-5#2)(2008-10#11)
Hg was achieved##2##3##(2008-10#2)
Hg was##7##2##(1990-5#3)(2008-10#4)
Hg were##2##2##(1990-3#1)(2008-10#1)
Hg##136##1##(1990-11#1)(1990-3#1)(1990-5#10)(1991-5#1)(1992-11#1)(1992-5#2)(1992-6#2)(1993-8#5)(1994-11#2)(1994-6#1)(1995-12#2)(1995-3#3)(1996-3#1)(1996-6#1)(1997-5#2)(2006-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#2)(2008-10#65)(2008-11#7)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#2)(2010-4#5)(2011-1#1)(2013-1#1)(2013-8#2)
Hg(0)##4##1##(2008-10#4)
Hg(2)(2+)##2##1##(2008-10#2)
Hg(2+) and CH(3)Hg(+)##5##3##(2008-10#5)
Hg(2+) and##15##2##(2008-10#15)
Hg(2+) in##3##2##(2008-10#3)
Hg(2+) interference on##2##3##(2008-10#2)
Hg(2+) interference##3##2##(2008-10#3)
Hg(2+) ion in##2##3##(2008-10#2)
Hg(2+) ion##4##2##(2008-10#4)
Hg(2+) ions in##2##3##(2008-10#2)
Hg(2+) ions##7##2##(2008-10#7)
Hg(2+) were##2##2##(2008-10#2)
Hg(2+)##60##1##(2008-10#59)(2013-1#1)
Hg(I)##4##1##(2008-10#4)
Hg(II) and Pb(II)##3##3##(2008-10#3)
Hg(II) and Zn(II)##2##3##(2008-10#2)
Hg(II) and##9##2##(2008-10#9)
Hg(II) by##2##2##(2008-10#2)
Hg(II) concentration##2##2##(2008-10#2)
Hg(II) from##2##2##(2008-10#2)
Hg(II) in the presence of##2##5##(2008-10#2)
Hg(II) in the##4##3##(2008-10#4)
Hg(II) in##14##2##(2008-10#14)
Hg(II) ions##6##2##(2008-10#6)
Hg(II) is##5##2##(2008-10#5)
Hg(II) reduction##2##2##(2008-10#2)
Hg(II) solution##2##2##(2008-10#2)
Hg(II) was##5##2##(2008-10#5)
Hg(II)##85##1##(2008-10#85)
Hg(II)-imprinted##2##1##(2008-10#2)
Hg(II)-imprinting thiol-functionalized mesoporous sorbent##2##4##(2008-10#2)
Hg(SCN)(2) immobilized in##2##3##(2008-10#2)
Hg) and##3##2##(2007-10#1)(2008-10#2)
Hg) were##2##2##(1994-11#1)(2008-10#1)
Hg)##15##1##(1990-3#1)(1991-5#1)(1994-11#1)(1995-12#1)(2007-10#2)(2008-10#5)(2008-3#1)(2009-5#1)(2010-4#1)(2013-8#1)
Hg+##2##1##(2008-2#1)(2013-8#1)
Hg- and##2##2##(2008-10#1)(2008-7#1)
Hg-based superconductors##2##2##(2008-10#2)
Hg/g Cr##2##2##(1993-8#2)
Hg/g##4##1##(1993-8#3)(2008-10#1)
Hg/l and##2##2##(1993-8#2)
Hg/l##3##1##(1993-8#3)
Hg2+ concentrations##2##2##(1993-12#2)
Hg2+ in##2##2##(1992-11#1)(1993-12#1)
Hg2+ toxicity##2##2##(1992-11#2)
Hg2+##18##1##(1991-9#2)(1992-11#9)(1993-12#7)
HgCdTe detector##4##2##(2008-2#3)(2008-3#1)
HgCdTe##6##1##(2008-2#5)(2008-3#1)
HgI(2) surface##2##2##(2008-2#1)(2008-3#1)
HgI(2)##8##1##(1996-2#1)(2008-2#2)(2008-3#5)
Hgb##10##1##(2008-7#10)
HhaI##6##1##(1990-5#1)(2008-10#5)
Hhe and##2##2##(2008-3#2)
Hhe##3##1##(2008-3#3)
Hi to##2##2##(2008-5#2)
Hi##3##1##(2008-5#3)
Hi40##3##1##(2008-10#3)
HiB5 cells##2##2##(1997-6#2)
HiB5##3##1##(1997-6#3)
HiPIP I##2##2##(1993-11#2)
HiPIP##3##1##(1993-11#3)
HiPIPs##2##1##(1993-11#2)
HiPco##8##1##(2008-10#8)
HiRes##2##1##(2008-11#2)
Hib disease##3##2##(1995-5#2)(2008-1#1)
Hib meningitis##4##2##(2008-1#4)
Hib##15##1##(1995-5#3)(1997-3#1)(2007-12#1)(2008-1#8)(2009-5#2)
Hicks##2##1##(1991-12#2)
Hidden Markov model##2##3##(1997-6#1)(2008-4#1)
Hidden Markov models##3##3##(2008-4#1)(2009-7#2)
Hidden Markov##7##2##(1997-6#2)(2008-4#2)(2009-3#1)(2009-7#2)
Hidden##12##1##(1995-5#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-3#1)(2009-7#2)(2011-2#1)
Hienerwadel##2##1##(1992-6#2)
Hierarchical Linear##2##2##(2008-12#2)
Hierarchical clustering##2##2##(2008-10#1)(2008-2#1)
Hierarchical linear modeling##2##3##(2008-12#1)(2009-7#1)
Hierarchical linear##3##2##(2008-12#1)(2009-7#1)(2011-2#1)
Hierarchical regression analyses##2##3##(1996-2#1)(2010-11#1)
Hierarchical regression##3##2##(1996-2#1)(1996-3#1)(2010-11#1)
Hierarchical##22##1##(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-10#5)(2008-12#3)(2008-2#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
Hierro##3##1##(2008-10#3)
High Court##4##2##(1992-6#1)(1995-6#2)(1997-2#1)
High Dose##2##2##(1997-3#1)(2007-11#1)
High Five cell##4##3##(2008-7#4)
High Five cells##2##3##(2008-7#2)
High Five##6##2##(2008-7#6)
High Fivetrade mark cells##4##4##(2008-11#1)(2008-7#3)
High Genetic##3##2##(2008-10#3)
High K+##2##2##(1993-11#1)(1997-1#1)
High Performance Liquid##2##3##(1997-2#1)(2008-10#1)
High Performance##5##2##(1994-9#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
High Pressure##2##2##(1995-6#1)(2008-10#1)
High Protein##2##2##(2008-3#2)
High Resolution Dynamics Limb Sounder##2##5##(2008-3#2)
High Resolution##7##2##(2007-8#1)(2008-3#3)(2008-8#2)(2011-1#1)
High Risk##4##2##(1995-9#1)(2006-9#1)(2007-4#1)(2011-2#1)
High School##2##2##(2009-8#1)(2013-1#1)
High Throughput Screening##3##3##(2009-6#2)(2013-8#1)
High affinity##2##2##(1995-6#2)
High and##2##2##(1996-7#1)(2008-8#1)
High blood pressure in acute stroke##2##6##(2007-10#1)(2008-8#1)
High blood pressure##3##3##(2007-10#1)(2008-8#2)
High blood##4##2##(2007-10#1)(2008-3#1)(2008-8#2)
High capacity##2##2##(2008-3#1)(2008-7#1)
High competition with low similarity##2##5##(2008-9#2)
High concentration of##2##3##(1990-5#1)(2008-10#1)
High concentration##3##2##(1990-5#1)(2008-10#2)
High concentrations of##7##3##(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-5#1)
High correlation##2##2##(1993-12#1)(2013-1#1)
High density##3##2##(1994-5#1)(2008-11#1)(2011-2#1)
High dose of##2##3##(1993-8#1)(2009-8#1)
High dose##8##2##(1992-2#1)(1993-11#1)(1993-8#1)(1995-8#1)(1997-3#1)(2008-1#1)(2009-8#1)(2010-3#1)
High doses of##2##3##(1997-5#1)(2011-2#1)
High efficiency##4##2##(1990-11#1)(1997-2#1)(2007-12#1)(2008-10#1)
High energy##2##2##(2007-8#1)(2011-2#1)
High enrichment factors##2##3##(2008-10#2)
High expression of##4##3##(2008-8#1)(2010-3#1)(2011-2#2)
High frequency##2##2##(2009-5#1)(2012-2#1)
High genetic diversity##2##3##(2008-10#1)(2013-8#1)
High infection##2##2##(2008-10#1)(2009-5#1)
High internal##2##2##(1993-5#1)(1996-3#1)
High level expression of##2##4##(1994-3#1)(1994-8#1)
High level expression##3##3##(1994-3#1)(1994-6#1)(1994-8#1)
High level##4##2##(1994-3#1)(1994-6#1)(1994-8#1)(2008-5#1)
High levels of polyamines were detected in freshly collected##2##9##(2008-10#2)
High levels of##18##3##(1990-12#1)(1993-9#1)(1997-7#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
High molecular weight##3##3##(1991-3#1)(2008-5#1)(2009-11#1)
High nucleotide##2##2##(1997-2#1)(2010-8#1)
High patient##2##2##(2012-1#1)(2012-3#1)
High performance liquid chromatographic determination of##2##6##(1993-2#1)(2008-10#1)
High performance liquid chromatographic##3##4##(1993-2#1)(1994-8#1)(2008-10#1)
High performance liquid chromatography (HPLC)##2##5##(2008-10#2)
High performance liquid chromatography of##2##5##(1994-6#1)(2008-10#1)
High performance liquid chromatography##6##4##(1994-6#1)(2008-10#5)
High performance liquid##9##3##(1993-2#1)(1994-6#1)(1994-8#1)(2008-10#6)
High performance##11##2##(1993-2#1)(1994-6#1)(1994-8#1)(2008-10#7)(2008-7#1)
High prevalence of##6##3##(1990-6#1)(1992-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-2#1)
High prevalence##7##2##(1990-6#1)(1992-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
High quality##2##2##(1993-11#1)(1997-2#1)
High rate of##2##3##(2008-11#1)(2012-2#1)
High rates of##2##3##(2006-10#1)(2013-8#1)
High resistance##2##2##(2007-7#2)
High resolution spectrophotometry##2##3##(2008-10#2)
High resolution##10##2##(1994-3#1)(1994-6#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-2#1)
High sensitivity for##2##3##(1995-5#1)(2008-10#1)
High sensitivity of##2##3##(1995-8#1)(2007-12#1)
High sensitivity##10##2##(1995-5#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
High speed##2##2##(1995-11#1)(2008-7#1)
High stability##3##2##(2008-10#2)(2008-9#1)
High strength bonding was found with a subset of the polymers containing appreciable OEG content##2##15##(2013-1#2)
High technology##2##2##(1993-2#1)(2013-8#1)
High throughput screening##3##3##(2007-11#1)(2008-10#2)
High throughput##9##2##(2007-11#1)(2008-10#6)(2008-11#1)(2009-4#1)
High yields##2##2##(2008-6#1)(2008-7#1)
High##340##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#3)(1992-8#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#71)(2008-11#13)(2008-12#1)(2008-2#4)(2008-3#22)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#21)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#5)
High- and low-copy-number##2##3##(1993-12#2)
High- and##3##2##(1993-12#2)(2008-10#1)
High-##4##1##(1993-12#2)(2008-10#1)(2008-3#1)
High-Density##2##1##(2008-3#1)(2013-1#1)
High-Dose##2##1##(2009-6#1)(2009-8#1)
High-Fivetrade mark##3##2##(2008-11#3)
High-Intensity Focused Ultrasound##2##3##(2013-1#2)
High-Performance Liquid Chromatography##3##3##(2008-12#1)(2009-8#2)
High-Power##2##1##(2008-3#2)
High-Pressure##2##1##(1995-3#1)(2008-10#1)
High-Q##3##1##(2007-11#2)(2007-12#1)
High-Repetition-Rate##3##1##(2008-2#2)(2008-3#1)
High-Resolution##7##1##(2008-3#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
High-Throughput##2##1##(2008-10#1)(2010-12#1)
High-affinity binding of##2##3##(1995-2#1)(1996-5#1)
High-affinity##3##1##(1995-2#1)(1995-5#1)(1996-5#1)
High-average-power##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
High-density optical data storage##2##4##(2008-3#2)
High-density##8##1##(2007-12#2)(2008-11#3)(2008-3#2)(2012-2#1)
High-dose chemotherapy##2##2##(1996-3#1)(2012-12#1)
High-dose##14##1##(1990-9#1)(1991-2#1)(1991-6#1)(1992-8#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-3#1)(1997-7#1)(2007-1#2)(2010-12#1)(2012-12#1)(2013-1#1)
High-dynamic-range##2##1##(2007-11#1)(2007-12#1)
High-efficiency diffractive##2##2##(2008-2#2)
High-efficiency##13##1##(1991-9#1)(1994-5#1)(2007-11#4)(2008-2#3)(2008-3#4)
High-energy femtosecond##2##2##(2007-11#1)(2007-12#1)
High-energy##9##1##(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#1)(2010-3#1)(2011-2#1)
High-fidelity##2##1##(2008-11#1)(2008-3#1)
High-frequency##8##1##(1994-6#1)(2007-12#3)(2008-2#1)(2008-3#3)
High-grade##6##1##(1997-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
High-intensity##2##1##(2008-10#1)(2013-8#1)
High-level expression of##2##3##(2008-11#1)(2008-4#1)
High-level expression##3##2##(2008-11#1)(2008-4#1)(2009-3#1)
High-level##8##1##(1993-6#1)(1993-9#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-7#1)
High-numerical-aperture##2##1##(2008-3#2)
High-performance capillary electrophoresis##2##3##(1994-9#1)(1996-5#1)
High-performance liquid chromatographic assay of##2##5##(1991-5#1)(2008-10#1)
High-performance liquid chromatographic assay##3##4##(1991-5#1)(1996-5#1)(2008-10#1)
High-performance liquid chromatographic determination of##3##5##(1991-5#1)(1996-5#1)(1997-2#1)
High-performance liquid chromatographic method for the simultaneous##2##7##(2008-10#2)
High-performance liquid chromatographic method for##3##5##(2008-10#3)
High-performance liquid chromatographic microassay for##2##5##(1992-6#1)(1993-9#1)
High-performance liquid chromatographic##14##3##(1991-5#4)(1992-6#1)(1993-9#1)(1996-5#3)(1997-2#1)(2008-10#4)
High-performance liquid chromatography analysis##2##4##(2008-10#2)
High-performance liquid chromatography of##2##4##(1990-8#1)(2008-10#1)
High-performance liquid chromatography with##2##4##(1991-5#1)(2008-10#1)
High-performance liquid chromatography##8##3##(1990-8#1)(1991-5#3)(2008-10#4)
High-performance liquid##22##2##(1990-8#1)(1991-5#7)(1992-6#1)(1993-9#1)(1996-5#3)(1997-2#1)(2008-10#8)
High-performance##30##1##(1990-8#1)(1991-5#7)(1991-7#1)(1992-6#1)(1993-9#1)(1994-9#1)(1996-5#4)(1997-2#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#1)
High-power diode-pumped##2##2##(2007-12#1)(2008-3#1)
High-power##16##1##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#6)
High-precision##2##1##(2008-3#2)
High-quality##6##1##(2007-12#1)(2008-3#2)(2010-12#1)(2010-5#1)(2012-2#1)
High-resolution images of##2##3##(2008-2#2)
High-resolution optical##2##2##(2007-11#1)(2007-12#1)
High-resolution##38##1##(1990-8#1)(1991-9#1)(1994-5#1)(2007-11#3)(2007-12#7)(2008-10#4)(2008-2#6)(2008-3#7)(2008-4#1)(2009-8#1)(2010-10#1)(2012-2#4)(2012-3#1)
High-risk human##2##2##(2011-2#1)(2013-7#1)
High-risk##9##1##(1991-6#1)(1994-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)
High-salt##2##1##(1993-6#2)
High-sensitivity##6##1##(1992-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-9#1)
High-spatial-resolution##2##1##(2008-2#2)
High-speed myocardial perfusion imaging##2##4##(2009-4#1)(2009-5#1)
High-speed##17##1##(1991-2#1)(1994-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)
High-throughput screening##2##2##(2008-4#1)(2012-2#1)
High-throughput##16##1##(2008-11#2)(2008-4#3)(2008-7#5)(2008-9#2)(2010-6#1)(2012-2#3)
High-titer##3##1##(1994-5#1)(2008-5#1)(2008-8#1)
Higher Education Institutions (HEI)##2##4##(2008-11#1)(2012-3#1)
Higher Education Institutions (HEIs)##2##4##(2008-11#2)
Higher Education Institutions##5##3##(2008-11#4)(2012-3#1)
Higher Education##12##2##(1995-3#1)(2008-11#7)(2008-12#1)(2012-3#2)(2013-8#1)
Higher concentrations##3##2##(1990-7#1)(1993-12#1)(1994-8#1)
Higher expression of##2##3##(1993-8#1)(2013-8#1)
Higher incidence##2##2##(1991-6#1)(2008-1#1)
Higher levels of##5##3##(1994-2#1)(1995-6#1)(2008-8#1)(2009-5#1)(2012-3#1)
Higher rates of##2##3##(2007-7#1)(2008-10#1)
Higher scores##2##2##(2008-6#1)(2009-11#1)
Higher sensitivity##2##2##(2007-6#1)(2008-10#1)
Higher values##2##2##(2008-10#1)(2012-1#1)
Higher##75##1##(1990-6#1)(1990-7#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-4#2)(2009-5#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#3)
Higher-order##7##1##(1992-2#1)(1994-8#1)(2007-11#4)(2008-6#1)
Highest levels of##3##3##(2008-6#2)(2010-5#1)
Highest solubility was obtained in##2##5##(2012-2#2)
Highest##16##1##(1995-5#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2010-5#1)(2012-2#2)
Highlighted##2##1##(2008-7#1)(2012-2#1)
Highlighting##2##1##(1991-3#1)(2012-3#1)
Highlights from##8##2##(2008-5#2)(2008-7#6)
Highlights of the##2##3##(1994-2#1)(2007-5#1)
Highlights of##3##2##(1992-1#1)(1994-2#1)(2007-5#1)
Highlights##14##1##(1992-1#1)(1994-2#1)(2007-5#1)(2008-3#1)(2008-5#2)(2008-7#6)(2012-3#1)(2013-8#1)
Highly accurate##2##2##(2008-10#1)(2008-3#1)
Highly active antiretroviral therapy (HAART)##2##5##(2008-11#1)(2011-3#1)
Highly active##3##2##(2008-11#1)(2008-7#1)(2011-3#1)
Highly efficient optical##2##3##(2007-12#1)(2008-2#1)
Highly efficient second-harmonic##2##3##(2007-11#1)(2007-12#1)
Highly efficient##17##2##(2007-11#3)(2007-12#7)(2008-2#3)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#1)
Highly linear response is obtained for##2##6##(2008-10#2)
Highly parallel##2##2##(1990-11#2)
Highly purified##4##2##(1990-7#1)(1994-2#1)(2008-10#1)(2008-4#1)
Highly resistant##3##2##(2008-10#3)
Highly selective##2##2##(2008-10#2)
Highly sensitive detection of##3##4##(2008-10#3)
Highly sensitive##10##2##(2007-12#2)(2008-10#7)(2009-7#1)
Highly significant##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
Highly virulent##2##2##(2008-10#2)
Highly##89##1##(1990-11#2)(1990-7#1)(1991-11#1)(1992-3#1)(1992-9#1)(1994-2#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-7#2)(2007-11#5)(2007-12#11)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-3#3)(2013-1#3)(2013-8#1)
Higuchi##2##1##(1992-12#1)(2012-2#1)
Higuchi's##2##1##(2010-5#2)
Hilarini (Diptera##2##2##(2007-12#2)
Hilarini##3##1##(2007-12#3)
Hilbert transform was##2##3##(2008-2#2)
Hilbert transform##12##2##(2008-2#8)(2008-3#3)(2012-1#1)
Hilbert##13##1##(2007-11#1)(2008-2#8)(2008-3#3)(2012-1#1)
Hill coefficient##7##2##(1990-11#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-5#1)(1997-2#1)
Hill##22##1##(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-6#1)(1995-5#1)(1997-2#3)(2008-10#1)(2009-10#3)(2012-2#1)(2013-8#3)
Hill-Sachs##2##1##(2008-8#2)
Hillel##2##1##(2010-1#1)(2011-2#1)
Hills##9##1##(1997-3#4)(2008-10#2)(2012-2#1)(2013-1#2)
Himachal Pradesh (India)##2##3##(2007-7#2)
Himalaya##2##1##(2012-2#1)(2013-7#1)
Himalayan##7##1##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-7#2)
Himalayas##3##1##(2008-8#2)(2008-9#1)
HindIII##9##1##(1991-9#2)(1993-8#1)(1997-2#1)(1997-3#3)(1997-7#1)(2008-10#1)
Hindle spheres##2##2##(2008-3#2)
Hindle##3##1##(2008-3#3)
Hindus##3##1##(1996-8#1)(2011-2#2)
Hinnavin I##3##2##(1997-8#3)
Hip Score##2##2##(2011-2#1)(2013-1#1)
Hip##14##1##(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-3#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
Hippocampal cell death##3##3##(1996-5#3)
Hippocampal##6##1##(1994-2#1)(1996-5#4)(1996-9#1)
Hippocampus erectus Perry##2##3##(2012-12#2)
Hippocampus##3##1##(2009-12#1)(2012-12#2)
Hippocratic ethic##2##2##(1992-3#2)
Hippophae rhamnoides and its medicinal preparation##2##6##(2008-10#2)
Hippophae rhamnoides##3##2##(2008-10#2)(2012-8#1)
Hiproly##3##1##(2008-10#3)
Hira mRNA##2##2##(2008-7#2)
Hira##9##1##(2008-7#9)
Hiroshima##2##1##(1996-8#1)(2008-10#1)
Hirsch##2##1##(2011-2#1)(2012-2#1)
Hirschsprung's disease##9##2##(1994-12#4)(1995-12#4)(2011-2#1)
Hirst##2##1##(2008-11#1)(2012-7#1)
Hirsutella rhossiliensis was##2##3##(2008-10#2)
Hirsutella rhossiliensis##4##2##(2008-10#4)
Hirudin##3##1##(2008-10#2)(2008-5#1)
Hirulog-1##3##1##(1990-7#3)
His 10##3##2##(1995-5#3)
His 57##2##2##(1991-3#2)
His and##2##2##(1991-5#1)(2008-8#1)
His clinical##2##2##(2008-12#1)(2012-2#1)
His first##2##2##(2008-12#1)(2010-1#1)
His postoperative course was uneventful##2##5##(2007-8#1)(2008-12#1)
His residues##3##2##(1990-2#1)(1994-8#1)(2008-8#1)
His serum##3##2##(1993-12#1)(1994-12#1)(2013-8#1)
His symptoms##3##2##(2008-1#2)(2008-7#1)
His tag##2##2##(1997-4#1)(2010-5#1)
His##84##1##(1990-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#3)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
His-127##3##1##(1994-8#3)
His-132##2##1##(2008-4#2)
His-tagged##2##1##(2008-4#2)
His6##3##1##(1991-5#1)(1993-8#1)(1997-4#1)
His85##4##1##(2008-9#4)
Hishimonoides sellatiformis##4##2##(2008-10#4)
Hishimonus sellatus##2##2##(2008-10#2)
Hispanic and Anglo##3##3##(2008-9#2)(2012-2#1)
Hispanic and##4##2##(2008-9#2)(2012-12#1)(2012-2#1)
Hispanic children##2##2##(2009-9#1)(2012-12#1)
Hispanic families##3##2##(2012-12#3)
Hispanic homicides##2##2##(2012-2#2)
Hispanic patients##5##2##(2008-3#2)(2010-8#2)(2012-3#1)
Hispanic smokers##2##2##(2012-3#2)
Hispanic women##3##2##(1994-9#2)(2011-2#1)
Hispanic youths##2##2##(2008-9#2)
Hispanic##63##1##(1991-1#1)(1994-1#1)(1994-9#2)(1995-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#11)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#7)(2011-2#6)(2012-12#11)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
Hispanic&quot##3##1##(2011-2#3)
Hispanic-American gravidas##2##2##(2007-2#2)
Hispanic-American##3##1##(2007-2#2)(2008-5#1)
Hispanic/Latino##2##1##(2013-1#2)
Hispanics and##5##2##(2008-1#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
Hispanics are##2##2##(2010-8#1)(2012-12#1)
Hispanics##22##1##(1995-12#2)(2008-1#1)(2008-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#7)(2012-12#7)
Histamine is##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
Histamine##8##1##(1994-2#2)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)
Histidine Kinase##2##2##(2008-10#2)
Histiocytic##2##1##(1991-9#1)(2008-5#1)
Histochemical and##4##2##(1990-8#1)(2007-5#1)(2008-10#1)(2008-6#1)
Histochemical##12##1##(1990-2#1)(1990-8#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#2)
Histocompatibility##2##1##(1994-11#1)(2012-3#1)
Histograms##4##1##(2008-10#1)(2008-6#1)(2008-9#1)(2009-9#1)
Histologic examination of##4##3##(1992-6#1)(1997-2#1)(2008-1#1)(2008-10#1)
Histologic examination revealed##2##3##(2008-11#2)
Histologic examination##7##2##(1992-6#1)(1993-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)
Histologic findings##2##2##(2009-1#1)(2011-2#1)
Histologic##21##1##(1990-9#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-1#2)(2010-3#2)(2011-2#1)(2012-3#3)(2013-1#1)
Histological Characterization of Resistance to##2##5##(2008-10#2)
Histological and ultrastructural##3##3##(1992-9#1)(2008-10#1)(2008-7#1)
Histological and##9##2##(1992-9#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#1)(2012-12#1)
Histological changes##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
Histological diagnosis of##2##3##(2008-5#2)
Histological evaluation of##2##3##(2007-12#1)(2008-5#1)
Histological evaluation##3##2##(2007-12#1)(2008-5#1)(2012-3#1)
Histological examination of the resected##2##5##(1997-3#1)(2008-10#1)
Histological examination of the##6##4##(1990-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-10#1)
Histological examination of##9##3##(1990-3#1)(1991-11#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-10#1)(2013-1#1)
Histological examination revealed that##2##4##(1994-12#1)(1996-5#1)
Histological examination revealed##8##3##(1993-12#1)(1994-12#1)(1996-5#1)(2007-8#2)(2008-5#1)(2008-8#1)(2011-2#1)
Histological examination showed##2##3##(1995-2#1)(1995-3#1)
Histological examination##23##2##(1990-3#1)(1991-11#1)(1993-12#2)(1994-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
Histological grading##2##2##(2008-6#1)(2008-7#1)
Histological investigations##2##2##(2008-10#2)
Histological observations##3##2##(2008-10#3)
Histological studies##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
Histological##71##1##(1990-3#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#16)(2008-11#3)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#2)(2009-12#2)(2010-10#1)(2010-11#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
Histologically##26##1##(1990-2#1)(1990-6#1)(1991-6#1)(1991-8#1)(1993-11#1)(1994-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
Histology and##3##2##(2007-12#1)(2008-11#1)(2013-1#1)
Histology confirmed a##2##3##(2007-8#1)(2011-2#1)
Histology confirmed##3##2##(2007-8#1)(2011-2#2)
Histology revealed a##3##3##(2008-6#1)(2010-3#1)(2011-2#1)
Histology revealed##4##2##(1997-8#1)(2008-6#1)(2010-3#1)(2011-2#1)
Histology showed a##3##3##(1992-12#1)(2007-7#2)
Histology showed##5##2##(1992-12#1)(1993-9#1)(1997-3#1)(2007-7#2)
Histology##23##1##(1990-2#1)(1992-12#1)(1993-9#1)(1995-4#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#2)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
Histomorphological##2##1##(2011-2#1)(2013-8#1)
Histone Deacetylase Inhibitor##2##3##(2008-6#1)(2010-6#1)
Histone Deacetylase##3##2##(2008-10#1)(2008-6#1)(2010-6#1)
Histone modifications##2##2##(2009-8#1)(2011-2#1)
Histone##11##1##(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#2)
Histopathologic evaluation of##2##3##(2008-10#2)
Histopathologic examination of the excised##2##5##(2009-5#1)(2012-12#1)
Histopathologic examination of##5##3##(2008-9#2)(2009-5#1)(2010-6#1)(2012-12#1)
Histopathologic examination revealed##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
Histopathologic examination##10##2##(2006-12#1)(2008-11#1)(2008-9#3)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
Histopathologic##18##1##(1990-8#1)(1992-8#1)(1994-1#1)(1994-2#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-9#3)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Histopathological diagnosis may##2##3##(2008-6#1)(2009-8#1)
Histopathological evaluation##2##2##(2007-10#1)(2013-8#1)
Histopathological examination of the##2##4##(2008-7#1)(2013-8#1)
Histopathological examination of##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
Histopathological examination revealed##2##3##(2008-7#1)(2011-1#1)
Histopathological examination##9##2##(1995-12#1)(2008-7#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Histopathological findings##2##2##(2007-7#1)(2008-7#1)
Histopathological##27##1##(1992-6#1)(1995-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
Histopathologically##8##1##(1997-3#1)(2007-10#1)(2009-7#1)(2010-6#1)(2012-1#2)(2013-1#1)(2013-8#1)
Histopathology and##2##2##(2008-5#1)(2011-1#1)
Histopathology confirmed##4##2##(2008-7#1)(2009-5#1)(2010-12#1)(2013-8#1)
Histopathology of##4##2##(2008-10#3)(2013-8#1)
Histopathology revealed a##2##3##(2009-8#1)(2012-1#1)
Histopathology revealed that the##2##4##(2012-2#1)(2012-3#1)
Histopathology revealed##9##2##(1990-6#1)(1997-6#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
Histopathology showed##3##2##(1993-2#1)(2007-7#1)(2013-1#1)
Histopathology##28##1##(1990-6#1)(1993-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Histoplasma capsulatum##7##2##(2006-10#1)(2007-7#1)(2008-5#5)
Histoplasmosis##2##1##(2006-10#1)(2008-1#1)
Historical data##2##2##(2008-10#2)
Historical##16##1##(1991-12#1)(1994-12#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
Historically##33##1##(1990-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#4)(2009-12#1)(2009-2#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#4)
History and##4##2##(1997-3#1)(2007-12#1)(2010-1#1)(2013-8#1)
History of the##4##3##(2010-1#1)(2011-4#1)(2012-12#2)
History of##22##2##(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-3#1)(2011-2#1)(2011-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
History##38##1##(1991-2#1)(1992-12#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-1#2)(2010-3#1)(2011-1#2)(2011-2#2)(2011-4#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
Hit##2##1##(2010-11#1)(2012-2#1)
Hitachi##6##1##(1990-8#3)(2008-10#3)
Hitherto##2##1##(2008-10#1)(2008-4#1)
Hitting the##2##2##(1994-3#1)(2011-2#1)
Hizikia##2##1##(2008-10#2)
Hl-Tbr##2##1##(2008-5#2)
Hlips##2##1##(2008-7#2)
HlyA##3##1##(1994-2#3)
Hm##2##1##(1995-5#1)(2008-5#1)
Hmgi family##2##2##(1995-8#2)
Hmgi-c##2##1##(1995-8#2)
Hmong##6##1##(2008-12#6)
Hn2 and Hn2-19##2##3##(2008-10#2)
Hn2 and##3##2##(2008-10#3)
Hn2##5##1##(2008-10#5)
Ho##27##1##(2007-12#4)(2008-10#1)(2008-2#7)(2008-3#8)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#3)
Hoagland's solution##3##2##(2008-10#3)
Hochuekkito##2##1##(2008-10#2)
Hockey##3##1##(2010-1#3)
Hodges-Lehmann##2##1##(1992-6#1)(1997-3#1)
Hodgkin and Reed-Sternberg##2##3##(1993-9#1)(2008-7#1)
Hodgkin and##3##2##(1990-11#1)(1993-9#1)(2008-7#1)
Hodgkin lymphoma##2##2##(2009-8#1)(2013-1#1)
Hodgkin##8##1##(1990-11#1)(1993-9#2)(2008-7#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
Hodgkin's disease (HD)##3##3##(1993-9#1)(2011-2#2)
Hodgkin's disease after##2##3##(1992-6#1)(2008-10#1)
Hodgkin's disease in##3##3##(1990-9#1)(1992-8#1)(2009-7#1)
Hodgkin's disease##29##2##(1990-9#1)(1992-12#1)(1992-6#2)(1992-8#4)(1993-9#2)(1994-12#2)(1995-8#1)(1995-9#3)(1996-3#1)(2007-7#3)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#4)
Hodgkin's lymphoma##7##2##(2007-10#2)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
Hodgkin's##39##1##(1990-9#2)(1992-12#1)(1992-6#2)(1992-8#4)(1993-9#2)(1994-12#2)(1995-8#1)(1995-9#3)(1996-3#1)(2007-10#2)(2007-7#4)(2008-10#2)(2008-4#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#4)(2013-7#1)
Hodgkins lymphoma##2##2##(2012-2#1)(2013-1#1)
Hodgkinson##2##1##(1995-6#2)
Hoe 140##5##2##(1992-3#5)
Hoechst 33342 dye##2##3##(2008-11#2)
Hoechst 33342 fluorescent##2##3##(1991-6#1)(2008-11#1)
Hoechst 33342##11##2##(1991-6#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#4)(2012-2#1)
Hoechst is##2##2##(2008-5#1)(2008-9#1)
Hoechst##21##1##(1991-6#1)(1992-11#1)(2008-1#1)(2008-11#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#7)(2012-2#1)
Hoehn &amp##3##2##(2008-7#2)(2013-8#1)
Hoehn and Yahr stage##3##4##(2008-11#1)(2008-7#2)
Hoehn and Yahr##5##3##(2008-11#1)(2008-7#4)
Hoehn##9##1##(2008-11#1)(2008-7#7)(2013-8#1)
Hoepfl was##2##2##(1995-12#2)
Hoepfl##7##1##(1995-12#7)
Hoerl##2##1##(2007-10#2)
Hoff and##4##2##(1997-2#3)(2008-11#1)
Hoff enthalpy##2##2##(1992-10#1)(1997-2#1)
Hoff plots##6##2##(1997-2#3)(2008-10#3)
Hoff##15##1##(1992-10#1)(1997-2#8)(2008-10#5)(2008-11#1)
Hoffa fracture##2##2##(2013-1#2)
Hoffa##3##1##(2013-1#3)
Hofmeister effects##2##2##(2009-10#1)(2012-2#1)
Hofmeister series##2##2##(2008-10#1)(2009-2#1)
Hofmeister##7##1##(2008-10#1)(2009-10#3)(2009-2#1)(2009-8#1)(2012-2#1)
Hokkaido##2##1##(1997-3#1)(2012-2#1)
Holding##3##1##(2008-10#1)(2011-2#1)(2012-3#1)
Hole##6##1##(1993-12#1)(1994-1#2)(1997-3#1)(2013-1#2)
Holey fibers##2##2##(2007-12#2)
Holistic##2##1##(2008-10#1)(2008-4#1)
Holland##5##1##(1991-8#3)(1995-1#1)(2008-10#1)
Holliday##4##1##(1995-3#2)(2012-3#2)
Hollow cylindrical##2##2##(2008-2#2)
Hollow##5##1##(2008-2#3)(2008-3#1)(2009-9#1)
Holm procedure##2##2##(2009-9#2)
Hologic NovaSure endometrial ablation system##2##5##(2010-9#2)
Hologic##4##1##(2008-8#2)(2010-9#2)
Hologram##3##1##(2008-2#2)(2008-3#1)
Holograms##3##1##(2007-12#1)(2008-2#2)
Holographic Recording##2##2##(2008-2#1)(2008-3#1)
Holographic gratings were##2##3##(2007-11#1)(2008-2#1)
Holographic gratings##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Holographic optical##2##2##(2008-3#2)
Holographic reconstruction with a 10-##2##5##(2007-11#2)
Holographic recording with orthogonally polarized beams in a cesium-doped##2##9##(2008-3#2)
Holographic recording##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
Holographic solitons are##2##3##(2007-11#2)
Holographic solitons##3##2##(2007-11#3)
Holographic##35##1##(2007-11#12)(2007-12#4)(2008-2#6)(2008-3#12)(2011-1#1)
Holography with##2##2##(2008-3#2)
Holography##6##1##(2008-2#3)(2008-3#3)
Holotrichia diomphalia larvae##2##3##(1997-2#2)
Holstein and Charolais##2##3##(2010-4#2)
Holstein cows were##2##3##(2012-2#1)(2013-1#1)
Holstein##13##1##(2010-4#3)(2012-2#3)(2013-1#7)
Holstein) and Holstein##2##3##(2013-1#2)
Holt-Oram syndrome##2##2##(1994-3#1)(1997-3#1)
Holter ECG monitoring##3##3##(1996-3#3)
Holter ECG##4##2##(1996-3#4)
Holter##5##1##(1996-3#5)
Homalodisca coagulata##3##2##(2007-12#2)(2008-10#1)
Home Care Program##7##3##(1990-10#2)(1991-2#2)(1996-1#1)(2008-9#2)
Home Care##11##2##(1990-10#3)(1991-2#2)(1993-3#1)(1996-1#1)(2008-9#2)(2011-2#2)
Home Health##3##2##(1994-2#1)(1995-3#1)(2012-2#1)
Home Office##4##2##(2008-11#3)(2011-2#1)
Home care##9##2##(1991-12#1)(1991-2#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(2011-2#2)
Home for the Aged##2##4##(2009-11#1)(2011-1#1)
Home health care##4##3##(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)
Home health##5##2##(1995-3#2)(1996-2#1)(1996-3#1)(1997-2#1)
Home is##3##2##(1995-3#1)(2009-11#1)(2011-2#1)
Home testing##2##2##(1994-9#1)(1996-5#1)
Home##70##1##(1990-10#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#5)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-2#2)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-11#2)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#2)(2013-7#1)
Homeless##3##1##(2008-6#1)(2012-3#1)(2013-1#1)
Homelessness##3##1##(1993-3#1)(2013-1#2)
Homeopathy##3##1##(1997-6#1)(2008-10#1)(2008-11#1)
Homeostatic##2##1##(2008-11#1)(2010-10#1)
Homer##3##1##(2008-11#3)
Homer1a##3##1##(2008-11#3)
Homeward##2##1##(1993-1#2)
Homicide##2##1##(1995-3#1)(2012-2#1)
Homo sapiens##7##2##(1991-5#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#1)
Homocysteine and##3##2##(2006-10#1)(2008-8#1)(2013-8#1)
Homocysteine##8##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2013-8#1)
Homodyne##2##1##(2007-12#1)(2008-3#1)
Homoeopathy##2##1##(1990-6#1)(1997-6#1)
Homogenates##2##1##(2008-10#2)
Homogeneity##2##1##(2007-8#1)(2008-11#1)
Homogeneous immunoassay##2##2##(2008-10#2)
Homogeneous time-resolved fluoroimmunoassay of##2##4##(2008-10#2)
Homogeneous##12##1##(1992-3#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)
Homogenised tissue was incubated for##2##5##(1992-6#1)(1993-9#1)
Homolog##2##1##(2008-10#1)(2008-5#1)
Homologous pairing##2##2##(1990-5#1)(1995-2#1)
Homologous##9##1##(1990-5#1)(1991-12#1)(1991-8#1)(1995-2#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
Homology##3##1##(1991-2#1)(1994-6#1)(2008-4#1)
Homomeric##2##1##(1995-11#1)(1995-5#1)
Homoptera##2##1##(2011-2#2)
Homothorax##3##1##(2008-9#2)(2012-2#1)
Homozygous##5##1##(1992-3#1)(1995-2#1)(2008-10#2)(2008-12#1)
Honduras##8##1##(1992-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#2)
Honey##6##1##(1991-3#1)(2008-10#3)(2008-7#1)(2013-1#1)
Hong Kong and New York in##2##6##(2011-1#2)
Hong Kong and##3##3##(2008-7#1)(2011-1#2)
Hong Kong nurses working in an acute surgical unit##2##9##(2010-10#2)
Hong Kong surgical nurses##2##4##(2010-10#2)
Hong Kong were##2##3##(1994-3#1)(2008-7#1)
Hong Kong##41##2##(1993-11#1)(1994-3#1)(1996-1#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-5#2)(2010-10#4)(2010-11#4)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-6#2)(2013-8#1)
Hong##42##1##(1993-11#1)(1994-3#1)(1996-1#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-5#2)(2010-10#4)(2010-11#4)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-6#2)(2013-8#1)
Hongze##2##1##(2008-8#2)
Honolulu##2##1##(1992-2#1)(2010-8#1)
Honorary Member of the Polish Society of Pediatric Oncology and Hematology]##2##11##(2008-9#2)
Honours##2##1##(2008-11#1)(2008-12#1)
Hoogsteen base##2##2##(1993-11#2)
Hoogsteen##6##1##(1993-11#5)(1995-5#1)
Hook##4##1##(2008-10#1)(2008-11#1)(2008-12#2)
Hop stunt viroid##2##3##(2008-10#2)
Hop##3##1##(2008-10#3)
Hope##8##1##(2010-10#2)(2010-2#1)(2011-2#5)
Hopefully##5##1##(1997-8#1)(2008-1#1)(2008-5#1)(2010-6#1)(2012-12#1)
Hopf bifurcation##6##2##(2007-11#2)(2007-12#1)(2010-10#1)(2013-8#2)
Hopf##7##1##(2007-11#2)(2007-12#1)(2010-10#2)(2013-8#2)
Hopkins##25##1##(1992-3#1)(1993-1#1)(1993-3#5)(1994-12#1)(1994-3#1)(1995-2#2)(1996-9#1)(1997-1#1)(1997-5#1)(2008-1#2)(2008-3#1)(2008-5#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#1)
Hopland##2##1##(2008-10#2)
Hor 2596 and Triumph##2##4##(2008-10#2)
Hor 2596##3##2##(2008-10#3)
Hor2596##6##1##(2008-10#6)
Hordaland county##2##2##(1996-6#1)(1996-9#1)
Hordaland##4##1##(1994-11#2)(1996-6#1)(1996-9#1)
Hordeum vulgare##2##2##(2008-10#1)(2008-8#1)
Hordeum##4##1##(2008-10#2)(2008-12#1)(2008-8#1)
Horizons##2##1##(2008-11#2)
Horizontal transfer##2##2##(2008-10#1)(2009-6#1)
Horizontal##6##1##(1990-5#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#1)
Hormesis##4##1##(2008-7#4)
Hormonal contraception##2##2##(1994-9#2)
Hormonal control of##2##3##(1994-9#1)(2008-6#1)
Hormonal regulation of##5##3##(1993-5#1)(1995-8#2)(2008-3#1)(2012-3#1)
Hormonal##14##1##(1993-5#1)(1994-9#4)(1995-8#2)(1996-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
Hormone replacement and cardiovascular risk factors##4##6##(1993-9#4)
Hormone replacement therapy##6##3##(1991-3#2)(1991-6#1)(1993-11#1)(2008-3#1)(2010-12#1)
Hormone replacement##10##2##(1991-3#2)(1991-6#1)(1993-11#1)(1993-9#4)(2008-3#1)(2010-12#1)
Hormone therapy##2##2##(2008-6#1)(2008-7#1)
Hormone##33##1##(1990-12#1)(1991-3#2)(1991-6#1)(1993-11#1)(1993-9#4)(1994-9#1)(2008-1#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#2)
Hormones and##2##2##(2008-4#1)(2008-5#1)
Hormones##5##1##(1990-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)
Hormozgan province##2##2##(2008-12#2)
Horner's syndrome##3##2##(2011-2#1)(2013-1#2)
Horner's##4##1##(2008-8#1)(2011-2#1)(2013-1#2)
Horro beef muscles in Ethiopia##2##5##(2010-4#2)
Horse heart##2##2##(1990-8#1)(1995-2#1)
Horse##7##1##(1990-12#1)(1990-8#1)(1995-2#1)(2008-5#1)(2008-6#1)(2012-12#2)
Horseradish peroxidase (HRP)##3##3##(2008-10#3)
Horseradish peroxidase##8##2##(2008-10#8)
Horseradish##9##1##(2008-10#9)
Horses##3##1##(2012-12#2)(2012-2#1)
Horticultural##2##1##(2008-10#2)
Hoshin planning system##2##3##(1996-1#2)
Hoshin planning##3##2##(1994-2#1)(1996-1#2)
Hoshin##4##1##(1994-2#1)(1996-1#3)
Hospice Benefit##2##2##(1993-12#2)
Hospice##13##1##(1990-10#3)(1993-12#2)(1994-12#3)(2009-7#2)(2010-2#2)(2012-12#1)
Hospital Anxiety and Depression Scale (HADS)##3##6##(2007-11#1)(2007-7#1)(2008-10#1)
Hospital Association##14##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(2008-11#3)
Hospital Center##3##2##(1996-3#1)(2011-2#1)(2013-1#1)
Hospital Complex of Navarre##2##4##(2013-1#2)
Hospital Literature Index##2##3##(1991-12#2)
Hospital Medical Records Institute##3##4##(1993-12#1)(1994-3#2)
Hospital Medical##4##2##(1993-12#1)(1994-3#2)(2008-7#1)
Hospital Medicine in Chile##2##4##(2013-8#2)
Hospital Performance Index (HPI)##2##4##(1992-12#1)(1996-2#1)
Hospital San##2##2##(1997-1#1)(2013-1#1)
Hospital Security##2##2##(1992-12#1)(1992-2#1)
Hospital Universiti Kebangsaan Malaysia##2##4##(2008-12#1)(2008-8#1)
Hospital administration primarily determined which instruments were to be used (67##2##11##(2013-1#2)
Hospital administrators are##3##3##(1991-2#1)(1994-3#1)(1995-2#1)
Hospital admission##2##2##(2008-11#1)(2008-3#1)
Hospital and##11##2##(1991-3#1)(1991-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(2010-10#1)(2010-5#1)(2011-2#1)
Hospital between##5##2##(1997-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
Hospital case##2##2##(1991-6#1)(1993-12#1)
Hospital diversification##2##2##(2008-11#2)
Hospital during the##2##3##(1991-11#1)(1995-6#1)
Hospital during##3##2##(1991-11#1)(1995-6#1)(2013-8#1)
Hospital executives##3##2##(1990-4#1)(1991-12#1)(1994-12#1)
Hospital experience##2##2##(1995-2#2)
Hospital for Special Surgery (HSS)##2##5##(2008-8#2)
Hospital for Special Surgery##9##4##(2008-8#8)(2009-3#1)
Hospital for the Ruptured and Crippled##5##6##(2008-8#5)
Hospital for##23##2##(1991-2#1)(1992-1#1)(1992-3#1)(1992-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#13)(2009-3#1)(2012-2#1)(2013-8#1)
Hospital from##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
Hospital governance##2##2##(1992-3#1)(1993-12#1)
Hospital has##2##2##(1990-3#1)(1993-1#1)
Hospital have been##2##3##(1992-1#1)(1993-6#1)
Hospital have##3##2##(1992-1#1)(1993-6#1)(1996-3#1)
Hospital in the##3##3##(2008-1#1)(2008-9#1)(2009-7#1)
Hospital in##34##2##(1990-3#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Hospital is##5##2##(1991-9#1)(1992-2#1)(1994-3#1)(1995-3#1)(2010-3#1)
Hospital mortality was##3##3##(2007-8#3)
Hospital of the##8##3##(2011-2#6)(2013-1#1)(2013-8#1)
Hospital of##31##2##(1991-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-5#1)(1996-11#2)(1996-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#7)(2012-3#1)(2013-1#1)(2013-8#3)
Hospital outpatient##2##2##(1991-2#2)
Hospital security##4##2##(1992-2#3)(1995-2#1)
Hospital stay##2##2##(1995-3#1)(2012-2#1)
Hospital was##6##2##(1993-1#2)(1995-2#1)(1995-3#1)(1996-2#1)(2008-3#1)
Hospital with a##2##3##(1996-3#1)(2008-12#1)
Hospital with##3##2##(1992-2#1)(1996-3#1)(2008-12#1)
Hospital##542##1##(1990-10#1)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#8)(1991-11#3)(1991-12#5)(1991-2#12)(1991-3#10)(1991-5#1)(1991-6#2)(1991-9#9)(1992-1#5)(1992-11#1)(1992-12#8)(1992-2#15)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#9)(1993-12#14)(1993-2#3)(1993-3#12)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#6)(1994-11#1)(1994-12#5)(1994-2#7)(1994-3#15)(1994-6#1)(1995-1#5)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#6)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#6)(1996-11#2)(1996-12#1)(1996-2#11)(1996-3#15)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#7)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#16)(2008-10#9)(2008-11#17)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#17)(2008-8#19)(2008-9#4)(2009-1#1)(2009-10#5)(2009-3#2)(2009-5#3)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#7)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#37)(2011-7#1)(2012-12#3)(2012-2#9)(2012-3#6)(2012-6#1)(2013-1#19)(2013-8#13)
Hospital's##6##1##(1992-2#1)(1995-3#1)(1996-2#2)(2008-11#1)(2008-12#1)
Hospital)##2##1##(2008-10#1)(2011-3#1)
Hospital-based##4##1##(1991-2#1)(1993-2#1)(2008-11#1)(2008-3#1)
Hospital-physician##3##1##(1992-3#1)(1993-1#1)(1994-1#1)
Hospital]##3##1##(1990-2#1)(1991-11#1)(2010-6#1)
Hospitalization##8##1##(1991-1#2)(1997-3#1)(2008-3#4)(2012-3#1)
Hospitalization&quot##2##1##(2013-1#2)
Hospitalizations for##2##2##(2007-12#1)(2008-8#1)
Hospitalizations##3##1##(2007-12#1)(2008-8#1)(2013-1#1)
Hospitalized##3##1##(2007-7#1)(2013-1#2)
Hospitals and health systems##2##4##(2008-11#2)
Hospitals and the##2##3##(1991-1#1)(1993-2#1)
Hospitals and##7##2##(1991-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-11#2)
Hospitals are##3##2##(1994-1#1)(1995-1#1)(2013-1#1)
Hospitals can reduce##2##3##(2010-9#1)(2011-2#1)
Hospitals can##3##2##(1995-2#1)(2010-9#1)(2011-2#1)
Hospitals in##7##2##(1991-3#1)(1992-8#1)(1995-2#1)(1996-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
Hospitals of##2##2##(1995-2#1)(1997-3#1)
Hospitals should begin removing certain##2##5##(2011-1#1)(2011-2#1)
Hospitals should##5##2##(1997-2#1)(2011-1#1)(2011-2#3)
Hospitals that##3##2##(1991-11#1)(1993-3#1)(2008-11#1)
Hospitals with##2##2##(1992-12#2)
Hospitals##81##1##(1990-4#4)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#3)(1992-1#4)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-11#3)(2008-12#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#1)
Hospitals'##4##1##(1994-2#1)(1995-1#1)(2011-2#1)(2012-2#1)
Host Adaptation##2##2##(2008-10#2)
Host Defense##2##2##(2008-10#2)
Host Plant##2##2##(2008-10#2)
Host Plants##4##2##(2008-10#4)
Host Range##4##2##(2008-10#4)
Host Specialization in the##2##4##(2008-10#2)
Host Specificity of##3##3##(2008-10#3)
Host Specificity##5##2##(2008-10#5)
Host and Nonhost##2##3##(2008-10#2)
Host and##3##2##(2008-10#3)
Host cell##2##2##(1995-6#1)(2008-10#1)
Host defense##2##2##(2008-10#1)(2008-5#1)
Host penetration was not##2##4##(2008-10#2)
Host plant##2##2##(2008-10#2)
Host range and##2##3##(2008-10#2)
Host range##6##2##(2008-10#5)(2010-10#1)
Host response##2##2##(1995-5#1)(2008-10#1)
Host specificity##2##2##(2008-10#2)
Host##83##1##(1995-5#1)(1995-6#1)(2008-10#71)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-10#1)(2012-3#1)(2013-1#1)
Host-Dependent##2##1##(2008-10#2)
Host-Pathogen Interactions##2##2##(2008-10#2)
Host-Pathogen##3##1##(2008-10#3)
Host-Selective##2##1##(2008-10#2)
Host-Specific##3##1##(2008-10#3)
Host-specific##2##1##(2008-10#2)
Hostility##2##1##(2008-4#2)
Hosts in California##2##3##(2008-10#2)
Hosts##11##1##(2008-10#10)(2011-2#1)
Hot flashes##2##2##(2008-7#1)(2009-5#1)
Hot##5##1##(1996-9#1)(2008-7#2)(2009-12#1)(2009-5#1)
Hotel##6##1##(1992-8#1)(1994-2#2)(1994-3#2)(2008-5#1)
House Conference on Library and Information##2##6##(1996-1#2)
House Conference on##3##3##(1995-12#1)(1996-1#2)
House of Representatives##4##3##(1995-6#1)(1996-5#2)(1997-5#1)
House of##7##2##(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-5#1)(2008-11#1)
House on##2##2##(1997-2#1)(2007-12#1)
House##39##1##(1991-12#1)(1991-3#1)(1993-1#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#12)(1996-1#2)(1996-5#7)(1997-2#1)(1997-5#2)(2007-12#1)(2008-11#1)(2008-8#1)(2013-1#1)
Household Food Security##2##3##(2010-9#1)(2012-2#1)
Household density##2##2##(2011-2#2)
Household##9##1##(1997-4#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
Households##4##1##(1991-12#1)(1994-1#1)(2008-2#1)(2009-12#1)
Housing Act##3##2##(1995-12#2)(1997-5#1)
Housing First##2##2##(2013-1#2)
Housing##10##1##(1990-2#1)(1992-8#1)(1995-12#2)(1995-6#1)(1997-5#1)(2013-1#4)
Houston##6##1##(1991-1#1)(1994-3#1)(1996-5#2)(2008-10#1)(2010-3#1)
Houttuynia cordata##4##2##(2008-10#4)
Hove##2##1##(2007-11#1)(2011-1#1)
How Does##2##2##(2008-5#1)(2012-2#1)
How a##4##2##(1995-3#1)(1997-2#1)(2008-11#1)(2008-7#1)
How are our##2##3##(2006-10#1)(2012-12#1)
How are##6##2##(1991-3#1)(1996-1#1)(2006-10#1)(2008-4#1)(2012-12#1)(2013-8#1)
How big##2##2##(1995-3#1)(2008-2#1)
How can it##2##3##(2012-1#2)
How can we##6##3##(1991-11#1)(1992-1#1)(2008-7#1)(2010-12#2)(2012-2#1)
How can##17##2##(1991-11#1)(1992-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#3)(2012-1#2)(2012-12#1)(2012-2#1)
How do I##2##3##(1997-1#1)(2013-1#1)
How do patients##2##3##(1991-11#1)(2012-12#1)
How do the##3##3##(1996-3#1)(2008-4#1)(2008-7#1)
How do these##2##3##(1996-9#1)(2012-12#1)
How do we##3##3##(1994-1#1)(1996-12#1)(2010-9#1)
How do you get##2##4##(1994-3#1)(1996-3#1)
How do you##5##3##(1994-3#1)(1996-3#1)(1997-3#1)(2008-4#1)(2008-9#1)
How do##29##2##(1990-2#1)(1991-11#1)(1994-1#2)(1994-12#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
How does a##3##3##(2008-1#1)(2008-4#1)(2010-3#1)
How does the brain##2##4##(2007-8#1)(2010-5#1)
How does the##3##3##(2007-8#2)(2010-5#1)
How does##9##2##(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#2)(2010-3#1)(2010-5#1)(2013-1#1)
How far should##2##3##(1990-3#1)(2008-1#1)
How far##3##2##(1990-3#1)(2008-1#1)(2013-1#1)
How fast##2##2##(1993-5#1)(2008-7#1)
How important is##2##3##(2008-11#1)(2011-3#1)
How is the##3##3##(1991-1#1)(1997-6#1)(2010-9#1)
How is##6##2##(1991-1#1)(1992-8#1)(1997-6#1)(2010-5#1)(2010-9#1)(2011-2#1)
How little##2##2##(2008-1#1)(2009-8#1)
How long should##2##3##(2008-4#1)(2008-7#1)
How long##4##2##(2007-1#1)(2008-4#1)(2008-7#1)(2013-7#1)
How many##3##2##(1991-3#1)(2008-7#1)(2008-8#1)
How medical reviewers can avoid bad faith claims and ERISA violations##2##11##(1993-12#2)
How might##2##2##(1997-4#1)(2009-5#1)
How much insurance##2##3##(1992-12#2)
How much##7##2##(1992-12#2)(1993-7#1)(1994-2#1)(1994-9#1)(2008-5#1)(2008-8#1)
How parents##2##2##(1991-5#1)(1994-12#1)
How the##14##2##(1991-3#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-7#1)(2010-3#1)(2013-7#1)
How this##2##2##(2009-8#1)(2013-8#1)
How to apply##2##3##(1994-12#1)(2011-2#1)
How to get##2##3##(2008-11#1)(2008-4#1)
How to keep##2##3##(1992-3#1)(2008-4#1)
How to manage##2##3##(1994-2#1)(2011-2#1)
How to read a##2##4##(1997-8#1)(2007-11#1)
How to write##2##3##(2009-4#1)(2010-7#1)
How to##58##2##(1991-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-8#1)
How we do it##8##4##(2008-9#8)
How we##9##2##(2007-9#1)(2008-9#8)
How well is##2##3##(1994-2#1)(1996-2#1)
How well##5##2##(1994-2#1)(1996-2#2)(1997-3#1)(2008-10#1)
How will##4##2##(1995-1#1)(1995-3#1)(1996-3#1)(2008-4#1)
How you##2##2##(1994-3#1)(1997-1#1)
How##292##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1994-1#3)(1994-12#7)(1994-2#4)(1994-3#5)(1994-9#2)(1995-1#6)(1995-12#2)(1995-2#2)(1995-3#5)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#5)(1996-3#6)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#11)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#7)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-9#4)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#6)
Howard##6##1##(1994-12#2)(1996-5#1)(2008-9#1)(2013-1#2)
Howardula aoronymphium##2##2##(2008-8#1)(2008-9#1)
Howardula##3##1##(2008-8#1)(2008-9#2)
Howell##3##1##(1996-5#1)(2008-2#2)
However a##6##2##(1993-6#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-5#1)(2013-1#1)
However by##2##2##(1997-4#1)(2013-1#1)
However for##2##2##(2008-10#1)(2008-12#1)
However in##2##2##(2011-1#1)(2012-2#1)
However it is##3##3##(1995-3#1)(2011-2#1)(2013-1#1)
However it##7##2##(1995-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
However its##4##2##(1990-2#1)(1996-1#1)(2008-11#1)(2011-1#1)
However no##3##2##(1990-6#1)(1996-2#1)(2013-1#1)
However the very lack of interactions with other molecules that prevents toxicity and fouling also makes adhesion elusive##2##18##(2013-1#2)
However the##25##2##(1990-12#1)(1991-12#1)(1992-11#1)(1992-8#1)(1994-8#2)(1995-6#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-1#2)(2013-8#1)
However there are no##2##4##(2008-12#1)(2010-12#1)
However there is##2##3##(2008-11#1)(2010-6#1)
However there##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2012-3#1)
However treatment with##2##3##(2008-5#1)(2013-1#1)
However when##3##2##(1997-2#1)(2008-11#1)(2013-8#1)
However##3499##1##(1990-10#2)(1990-11#17)(1990-12#14)(1990-2#13)(1990-3#5)(1990-5#9)(1990-6#6)(1990-7#7)(1990-8#7)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#23)(1991-2#11)(1991-3#12)(1991-4#1)(1991-5#10)(1991-6#8)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#2)(1992-10#4)(1992-11#11)(1992-12#27)(1992-2#13)(1992-3#16)(1992-4#1)(1992-5#5)(1992-6#5)(1992-8#14)(1992-9#8)(1993-1#4)(1993-10#1)(1993-11#12)(1993-12#23)(1993-2#12)(1993-3#12)(1993-5#4)(1993-6#15)(1993-8#18)(1993-9#2)(1994-1#3)(1994-11#12)(1994-12#15)(1994-2#8)(1994-3#16)(1994-5#17)(1994-6#18)(1994-7#3)(1994-8#19)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#15)(1995-12#29)(1995-2#13)(1995-3#13)(1995-4#1)(1995-5#11)(1995-6#20)(1995-8#10)(1995-9#2)(1996-1#9)(1996-10#1)(1996-11#8)(1996-12#17)(1996-2#17)(1996-3#11)(1996-4#1)(1996-5#11)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#11)(1997-2#25)(1997-3#14)(1997-4#20)(1997-5#6)(1997-6#11)(1997-7#11)(1997-8#11)(1997-9#1)(2006-10#6)(2006-6#4)(2007-10#7)(2007-11#28)(2007-12#39)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#21)(2007-8#24)(2007-9#1)(2008-1#41)(2008-10#516)(2008-11#196)(2008-12#56)(2008-2#47)(2008-3#103)(2008-4#47)(2008-5#97)(2008-6#45)(2008-7#158)(2008-8#133)(2008-9#75)(2009-1#3)(2009-10#17)(2009-11#13)(2009-12#16)(2009-2#9)(2009-3#13)(2009-4#11)(2009-5#20)(2009-6#14)(2009-7#17)(2009-8#34)(2009-9#10)(2010-1#8)(2010-10#15)(2010-11#26)(2010-12#24)(2010-2#17)(2010-3#18)(2010-4#12)(2010-5#23)(2010-6#13)(2010-7#9)(2010-8#25)(2010-9#5)(2011-1#44)(2011-10#5)(2011-2#169)(2011-3#6)(2011-7#1)(2012-1#13)(2012-12#46)(2012-2#90)(2012-3#72)(2012-5#5)(2012-6#1)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#153)(2013-7#10)(2013-8#43)
Hox clusters##2##2##(2008-1#2)
Hox gene clusters##2##3##(2008-1#2)
Hox gene##6##2##(1995-11#1)(2007-12#1)(2008-1#4)
Hox genes and##2##3##(2007-12#1)(2008-1#1)
Hox genes are##2##3##(1997-4#1)(2008-1#1)
Hox genes##10##2##(1993-12#1)(1997-4#1)(2007-12#2)(2008-1#3)(2008-9#2)(2013-8#1)
Hox proteins##2##2##(2012-2#2)
Hox##26##1##(1993-12#1)(1995-11#2)(1997-4#1)(2007-12#4)(2008-1#9)(2008-9#3)(2012-2#5)(2013-8#1)
HoxA3##4##1##(1995-5#4)
Hoxa-7##5##1##(1995-11#1)(1997-4#4)
Hoxb-4##2##1##(1995-2#2)
Hp##3##1##(1990-6#1)(2008-8#2)
HpD##5##1##(1990-6#1)(2008-7#2)(2008-9#2)
HpaG(Xooc)##7##1##(2008-10#7)
HpaII and##2##2##(1997-3#2)
HpaII##5##1##(1997-3#3)(2008-10#2)
Hprt sequences##3##2##(1997-4#3)
Hprt##5##1##(1997-4#5)
Hr##5##1##(1991-10#5)
Hrabeiella##3##1##(2008-7#3)
Hrr1##2##1##(2012-3#2)
Hrs##4##1##(1991-10#4)
Hsc70##6##1##(1993-9#1)(1995-6#5)
Hsp are##2##2##(2008-5#2)
Hsp##3##1##(2008-5#2)(2013-1#1)
Hsp22##2##1##(2013-1#2)
Hsp25##3##1##(1993-6#3)
Hsp60##2##1##(1996-12#1)(2009-5#1)
Hsp70 and##2##2##(1994-11#1)(2012-12#1)
Hsp70 in##6##2##(1991-9#3)(1994-11#3)
Hsp70 isoforms##2##2##(2009-5#2)
Hsp70 proteins##3##2##(1994-11#2)(2009-5#1)
Hsp70##21##1##(1990-12#1)(1991-9#7)(1994-11#6)(2009-5#6)(2012-12#1)
Hsp70s and##3##2##(1994-11#1)(2009-5#2)
Hsp70s##8##1##(1994-11#1)(1995-6#1)(2009-5#6)
Hsp90 can##2##2##(2010-4#2)
Hsp90 is##3##2##(1997-4#1)(2010-4#2)
Hsp90 might##2##2##(1997-4#1)(2010-4#1)
Hsp90 on the##2##3##(1997-4#2)
Hsp90##20##1##(1997-4#8)(2008-4#2)(2010-4#9)(2012-12#1)
Hsps##2##1##(2009-5#2)
Htt##4##1##(2012-2#4)
HuES culture plate is##2##4##(2008-8#2)
HuES human embryonic stem cell lines##2##6##(2008-8#2)
HuES human embryonic stem cell##4##5##(2008-8#4)
HuES human embryonic stem##6##4##(2008-8#6)
HuES media##7##2##(2008-8#7)
HuES##16##1##(2008-8#16)
Huallaga Valley##2##2##(2008-10#2)
Huang et al##2##3##(1997-2#1)(2009-5#1)
Huang##5##1##(1990-5#1)(1997-2#1)(2008-11#1)(2009-10#1)(2009-5#1)
Huanglongbing##2##1##(2011-2#1)(2013-8#1)
Huangshan City##2##2##(2012-3#2)
Hubbard##2##1##(1991-9#1)(2010-4#1)
Hubble##5##1##(1990-11#1)(1995-3#1)(2008-2#2)(2008-3#1)
Hubei##3##1##(2010-8#1)(2012-3#1)(2013-8#1)
Huber##4##1##(1993-8#1)(2008-10#1)(2011-2#2)
Hudson's##2##1##(2007-12#1)(2013-8#1)
Huge amounts of data for protein structures##2##7##(2008-2#1)(2008-4#1)
Huge amounts of##3##3##(2008-2#1)(2008-4#1)(2013-1#1)
Huge##8##1##(2007-10#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-1#1)
Hughes##2##1##(2008-9#1)(2011-2#1)
Huh 7 cells##4##3##(2008-11#4)
Huh 7##6##2##(2008-11#6)
Hui##2##1##(1995-6#1)(2008-9#1)
Huit cas de##2##3##(2013-1#2)
Human Breast##2##2##(1994-12#2)
Human Development##6##2##(1992-8#1)(1996-2#1)(1997-6#1)(2008-9#3)
Human Gene##2##2##(2008-4#1)(2008-5#1)
Human Genome Project##8##3##(1994-9#2)(1995-6#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-1#1)
Human Genome##11##2##(1994-9#3)(1995-6#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
Human Growth Hormone##2##3##(2008-1#1)(2013-1#1)
Human Immunodeficiency Virus (HIV) infection##2##5##(2007-7#1)(2008-8#1)
Human Immunodeficiency Virus (HIV)##5##4##(1990-2#1)(2007-7#2)(2008-12#1)(2008-8#1)
Human Immunodeficiency Virus##7##3##(1990-2#1)(2007-7#2)(2008-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
Human Immunodeficiency##8##2##(1990-2#1)(2007-7#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
Human Intestinal##4##2##(2008-11#3)(2009-12#1)
Human Leukocyte##2##2##(2008-4#1)(2010-12#1)
Human Papillomavirus##2##2##(2010-8#1)(2013-1#1)
Human Resources##3##2##(1994-1#1)(2008-11#1)(2008-9#1)
Human Rights Act##2##3##(2008-11#2)
Human Rights Campaign##2##3##(1995-12#1)(1997-5#1)
Human Rights##9##2##(1995-12#1)(1995-6#2)(1996-11#1)(1996-5#1)(1997-5#1)(2008-11#2)(2008-9#1)
Human T cell##2##3##(2008-4#1)(2011-2#1)
Human T-cell leukemia virus##2##4##(1991-12#1)(2012-12#1)
Human Umbilical##2##2##(2010-8#1)(2013-8#1)
Human acid beta-glucosidase##2##3##(1990-5#2)
Human adult dental pulp stem cells##2##6##(2012-12#2)
Human and murine##2##3##(1993-8#1)(2008-11#1)
Human and##5##2##(1992-5#1)(1993-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
Human apolipoprotein (apo) A-IV is a##2##6##(1990-8#1)(1991-8#1)
Human apolipoprotein##3##2##(1990-8#1)(1991-8#1)(1996-6#1)
Human astrocytoma cells##2##3##(1995-12#2)
Human brain##2##2##(1990-3#1)(1991-5#1)
Human breast cancer##2##3##(1992-5#1)(1993-9#1)
Human breast##3##2##(1992-5#1)(1993-9#1)(2008-11#1)
Human chorionic##2##2##(1995-8#1)(2007-7#1)
Human embryonic stem cells##2##4##(2008-8#1)(2008-9#1)
Human embryonic stem##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
Human exposure to these compounds##2##5##(1992-8#1)(2008-10#1)
Human health##2##2##(1996-12#1)(2012-1#1)
Human hematopoietic##2##2##(2008-8#1)(2009-12#1)
Human immunodeficiency virus (HIV)##4##4##(1991-5#1)(1994-11#1)(2007-7#1)(2008-10#1)
Human immunodeficiency virus type 1 (HIV-1)##2##6##(1994-6#1)(2011-2#1)
Human immunodeficiency virus type-1##2##4##(1994-11#1)(1997-4#1)
Human immunodeficiency virus##10##3##(1991-5#1)(1994-11#2)(1994-6#1)(1997-4#1)(2007-7#2)(2008-10#1)(2008-4#1)(2011-2#1)
Human immunodeficiency virus-1 protease##2##4##(1991-9#2)
Human immunodeficiency virus-1##3##3##(1991-9#2)(1994-5#1)
Human immunodeficiency##14##2##(1991-5#1)(1991-9#2)(1994-11#2)(1994-5#1)(1994-6#1)(1997-4#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
Human insulin##2##2##(1991-8#1)(2011-1#1)
Human leukemia##2##2##(1992-11#1)(2008-11#1)
Human lysosomal##2##2##(1995-2#2)
Human melanocytes##2##2##(1993-5#1)(2008-5#1)
Human milk##3##2##(1993-11#1)(2012-2#2)
Human mutation databases##2##3##(2008-4#2)
Human natural killer##2##3##(1994-2#1)(2008-4#1)
Human papillomavirus (HPV)##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
Human papillomavirus testing in the clinical laboratory##2##7##(1994-1#2)
Human papillomavirus##9##2##(1993-9#1)(1994-1#2)(2008-11#2)(2011-1#1)(2012-12#2)(2013-1#1)
Human plague##2##2##(1991-11#1)(2010-2#1)
Human plasma##5##2##(1990-8#1)(1991-5#1)(1996-3#1)(2008-10#2)
Human platelet##2##2##(1992-8#1)(2006-6#1)
Human resources##4##2##(2008-11#4)
Human rights##2##2##(1992-2#1)(2011-2#1)
Human serum and##2##3##(2008-10#1)(2008-4#1)
Human serum##6##2##(2008-10#4)(2008-4#1)(2008-7#1)
Human somatic cell gene targeting##3##5##(2008-2#3)
Human tissues##2##2##(1991-8#1)(2008-7#1)
Human type I interferons##2##4##(1995-12#2)
Human type##4##2##(1994-11#1)(1994-9#1)(1995-12#2)
Human type-alpha transforming growth factor##2##5##(1995-2#2)
Human##373##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#3)(1991-5#5)(1991-6#2)(1991-8#3)(1991-9#4)(1992-11#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#6)(1992-9#1)(1993-11#6)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#4)(1994-11#7)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#9)(1995-12#6)(1995-2#6)(1995-6#5)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#7)(2008-1#6)(2008-10#18)(2008-11#33)(2008-12#3)(2008-2#4)(2008-4#18)(2008-5#8)(2008-7#14)(2008-8#9)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#2)(2009-4#4)(2009-5#3)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#4)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#3)(2012-4#1)(2013-1#9)(2013-8#2)
Humana##5##1##(1991-3#1)(1992-1#1)(2008-4#3)
Humanities and##2##2##(2009-4#1)(2012-12#1)
Humanities##5##1##(2009-4#1)(2011-2#3)(2012-12#1)
Humans are##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
Humans produce##2##2##(1993-8#1)(2008-11#1)
Humans##15##1##(1990-11#1)(1993-8#1)(1995-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#2)
Humber##2##1##(2008-10#1)(2008-5#1)
Humboldt penguins (Spheniscus humboldti)##2##4##(2008-5#2)
Humboldt penguins##3##2##(2008-5#3)
Hume##3##1##(2008-10#2)(2012-12#1)
Humic Cambisol-DOM##4##2##(2008-11#4)
Humic acid##3##2##(2008-10#2)(2013-8#1)
Humic acids##2##2##(2008-10#2)
Humic##10##1##(2008-10#5)(2008-11#4)(2013-8#1)
Humicola insolens Y1##2##3##(2013-1#2)
Humicola##3##1##(2008-10#1)(2013-1#2)
Humidity##10##1##(2008-10#8)(2008-2#1)(2008-3#1)
Hummingbird##5##1##(2008-9#4)(2012-12#1)
Humor##3##1##(1994-1#1)(2008-8#1)(2011-2#1)
Humoral##4##1##(2007-7#1)(2008-11#1)(2008-6#1)(2008-9#1)
Humphrey##2##1##(1992-6#1)(2008-5#1)
Hunan province##2##2##(2011-1#2)
Hunan##5##1##(2008-9#2)(2011-1#3)
Hundred##3##1##(2007-7#1)(2011-2#1)(2013-8#1)
Hundreds of##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
Hungarian##6##1##(1995-3#1)(1996-6#2)(2008-10#1)(2008-7#1)(2008-8#1)
Hungary between##2##2##(1997-8#1)(2008-10#1)
Hungary##23##1##(1991-3#6)(1994-12#2)(1996-6#1)(1997-8#2)(2008-10#7)(2008-12#2)(2008-7#2)(2013-8#1)
Hunt and Hess grade at time of##2##7##(1995-11#1)(2008-7#1)
Hunt and Hess grade##3##4##(1995-11#2)(2008-7#1)
Hunt##4##1##(1995-11#2)(2008-11#1)(2008-7#1)
Hunter##5##1##(2007-10#4)(2009-10#1)
Hunterian ligation##3##2##(2008-7#1)(2012-2#2)
Huntington disease (HD)##2##3##(1995-5#1)(2011-8#1)
Huntington disease##3##2##(1995-5#2)(2011-8#1)
Huntington##6##1##(1995-5#2)(2008-11#1)(2010-1#1)(2011-8#2)
Huntington's disease (HD)##3##3##(1996-8#1)(2008-7#1)(2011-10#1)
Huntington's disease##17##2##(1995-12#1)(1995-5#1)(1996-8#2)(2008-5#2)(2008-7#2)(2011-10#1)(2011-2#6)(2012-2#1)(2013-8#1)
Huntington's##20##1##(1995-12#1)(1995-5#1)(1995-9#1)(1996-8#2)(2008-5#3)(2008-7#2)(2011-10#2)(2011-2#6)(2012-2#1)(2013-8#1)
HupBA1##2##1##(1990-11#2)
HupBF3 and HupBR45##2##3##(1990-11#2)
HupBF3##3##1##(1990-11#3)
HupBK2##2##1##(1990-11#2)
HupBR45##3##1##(1990-11#3)
Huron##2##1##(1997-3#1)(2008-10#1)
Hurricane Katrina##7##2##(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
Hurricane##8##1##(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#3)
Husbands##4##1##(1996-12#1)(2008-9#1)(2009-5#2)
Hut-102##2##1##(1991-12#2)
Hutchinson-Gilford progeria syndrome##2##3##(2009-12#2)
Hutchinson-Gilford progeria##3##2##(2009-12#3)
Hutchinson-Gilford##4##1##(2009-12#3)(2011-2#1)
Huygens-Fresnel##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
Hv-p68 gene##3##2##(2008-10#3)
Hv-p68 genomic DNA##2##3##(2008-10#2)
Hv-p68##14##1##(2008-10#14)
Hwaseong##4##1##(2008-10#4)
Hx was##2##2##(1994-8#1)(2008-10#1)
Hx##11##1##(1994-8#5)(2008-10#6)
HxR and Hx are##2##4##(2008-10#2)
HxR and Hx##3##3##(2008-10#3)
HxfB-##2##1##(2008-10#2)
Hyacinthus##3##1##(2008-10#1)(2008-8#2)
Hyalomma##3##1##(1996-12#1)(2008-8#1)(2011-1#1)
Hyaluronan##3##1##(1993-6#1)(2010-8#2)
Hyaluronic Acid##2##2##(2010-10#1)(2010-8#1)
Hyamine 1622 (HM)##2##3##(2008-10#2)
Hybrid glass substrates##2##3##(2007-11#2)
Hybrid holographic microscopy##2##3##(2008-3#2)
Hybrid zones##2##2##(2008-8#1)(2013-1#1)
Hybrid##38##1##(1995-11#1)(1996-9#1)(2007-11#3)(2007-12#2)(2008-10#11)(2008-3#8)(2008-8#3)(2009-2#1)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Hybridization and##3##2##(1994-12#1)(2008-10#1)(2009-2#1)
Hybridization between##2##2##(2008-10#1)(2008-5#1)
Hybridization histochemistry##2##2##(2008-4#2)
Hybridization of amplicons##2##3##(2008-10#2)
Hybridization of##11##2##(1992-8#1)(1993-2#1)(1997-7#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
Hybridization results##2##2##(2008-10#1)(2008-2#1)
Hybridization##29##1##(1991-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
Hybridoma cell##2##2##(2008-11#2)
Hybridoma cells were##2##3##(1994-5#1)(2008-11#1)
Hybridoma cells##4##2##(1994-2#1)(1994-5#1)(2008-11#2)
Hybridoma##10##1##(1991-12#1)(1994-2#1)(1994-5#1)(2008-11#7)
Hybridomas##2##1##(2008-11#2)
Hybrids of##3##2##(2008-10#3)
Hybrids were##2##2##(2008-10#1)(2008-5#1)
Hybrids with##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
Hybrids##11##1##(2008-10#7)(2008-5#1)(2010-4#2)(2012-3#1)
Hydathodes##2##1##(2008-10#2)
Hydatid cyst of the##2##4##(2007-7#1)(2008-7#1)
Hydatid cyst of##4##3##(2007-7#1)(2008-7#1)(2010-11#1)(2013-1#1)
Hydatid cyst##7##2##(2007-7#2)(2008-7#2)(2010-11#1)(2010-12#1)(2013-1#1)
Hydatid disease is##2##3##(2011-2#1)(2013-1#1)
Hydatid disease of the##3##4##(2007-7#3)
Hydatid disease of##4##3##(2007-7#3)(2008-7#1)
Hydatid disease##8##2##(2007-7#3)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
Hydatid##18##1##(1991-5#1)(2007-7#5)(2007-8#1)(2008-7#3)(2010-11#1)(2010-12#2)(2011-2#2)(2013-1#3)
Hyderabad##8##1##(2007-7#2)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-11#1)
Hydra attenuata##2##2##(1993-12#2)
Hydra##3##1##(1993-12#3)
Hydractinia##3##1##(2012-3#3)
Hydration of alpha-maltose and amylose##2##5##(1995-11#2)
Hydration##3##1##(1995-11#2)(2008-5#1)
Hydrazine and##2##2##(2008-10#2)
Hydrazine##4##1##(2008-10#3)(2009-8#1)
Hydrazones##2##1##(2008-9#1)(2010-7#1)
Hydride generation##3##2##(2008-10#3)
Hydride##7##1##(1997-7#1)(2007-11#1)(2008-10#5)
Hydroa##2##1##(2010-6#2)
Hydrocarbon##3##1##(2008-8#1)(2011-1#1)(2013-8#1)
Hydrocarbons##3##1##(1992-3#1)(1997-7#1)(2008-10#1)
Hydrocephalus in##2##2##(1993-2#1)(2012-12#1)
Hydrocephalus##3##1##(1993-2#1)(2011-2#1)(2012-12#1)
Hydrochlorothiazide##3##1##(2010-5#1)(2011-2#1)(2012-2#1)
Hydrocortisone was##2##2##(2008-11#1)(2012-3#1)
Hydrocortisone##4##1##(1992-5#1)(2008-11#2)(2012-3#1)
Hydrodynamic##2##1##(2010-11#1)(2011-1#1)
Hydrofluoric acid##2##2##(2008-10#2)
Hydrogel##3##1##(2010-5#1)(2011-1#1)(2012-3#1)
Hydrogels##4##1##(2009-7#1)(2009-9#1)(2010-10#2)
Hydrogen cyanide gas##3##3##(2008-10#3)
Hydrogen cyanide##4##2##(2008-10#4)
Hydrogen exchange##3##2##(1995-2#1)(2008-4#1)(2012-1#1)
Hydrogen ion-selective##2##2##(2008-10#2)
Hydrogen peroxide and##2##3##(1996-2#1)(2009-5#1)
Hydrogen peroxide was##2##3##(2008-3#1)(2011-2#1)
Hydrogen peroxide##9##2##(1996-2#1)(2008-10#4)(2008-3#1)(2009-5#1)(2011-2#1)(2012-8#1)
Hydrogen##35##1##(1991-8#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#15)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-8#1)(2013-8#1)
Hydrogen-Bonded##2##1##(2008-10#1)(2008-11#1)
Hydrolight##10##1##(2008-2#4)(2008-3#6)
Hydrolysis of cellulose##2##3##(2008-6#2)
Hydrolysis of##10##2##(1990-8#1)(1991-3#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(2008-6#2)(2010-7#1)(2010-8#1)
Hydrolysis##11##1##(1990-8#1)(1991-3#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-6#2)(2010-7#1)(2010-8#1)
Hydrophilic##3##1##(1993-12#1)(2009-7#1)(2010-10#1)
Hydrophobic interaction chromatography coupled##2##4##(2008-10#2)
Hydrophobic interaction##3##2##(2008-10#3)
Hydrophobic##9##1##(1990-5#1)(1996-5#1)(2008-10#5)(2008-7#1)(2010-10#1)
Hydrothermal##2##1##(2008-6#1)(2009-11#1)
Hydrotropism##2##1##(2009-8#2)
Hydroxoundecahydro-closo-dodecaborate(2-)##2##1##(1996-2#2)
Hydroxyproline##2##1##(1995-2#2)
Hydroxyurea##4##1##(1996-3#1)(2008-10#2)(2009-4#1)
Hygiene##5##1##(1997-6#1)(2007-10#1)(2008-11#2)(2009-4#1)
Hygienic##2##1##(1990-6#1)(1997-4#1)
Hygienists##2##1##(1993-1#1)(2008-10#1)
Hylobius abietis##3##2##(2008-7#1)(2011-10#2)
Hymenaea stigonocarpa##2##2##(2008-5#2)
Hymenaea##3##1##(2008-5#3)
Hymenolepis microsoma sensu Cohn##2##4##(2011-2#2)
Hymenolepis microsoma##3##2##(2011-2#3)
Hymenolepis##5##1##(2008-12#1)(2011-2#3)(2012-2#1)
Hymenoptera##13##1##(2007-12#5)(2008-6#2)(2008-8#5)(2008-9#1)
Hymenoptera)##3##1##(2007-12#1)(2010-4#1)(2011-2#1)
Hyp group##2##2##(2011-2#2)
HypSc##2##1##(2011-2#2)
Hyper-IgE##2##1##(2013-1#2)
Hyper-fractionated radiotherapy for##2##3##(2008-6#2)
Hyperactivity##6##1##(1993-12#1)(2010-8#3)(2012-1#1)(2012-2#1)
Hyperbaric##2##1##(1997-2#1)(2009-11#1)
Hypercapnic respiratory failure##2##3##(2006-10#2)
Hypercapnic##3##1##(1992-2#1)(2006-10#2)
Hypercholesterolemia##5##1##(1991-8#1)(2008-1#2)(2008-5#1)(2012-2#1)
Hypercoagulability##2##1##(2008-7#2)
Hypercoagulable states##2##2##(1991-3#1)(2007-10#1)
Hypereosinophilic syndrome##2##2##(2007-7#2)
Hyperglycemic##2##1##(2008-5#1)(2013-1#1)
Hyperhomocysteinemia and##4##2##(2008-1#1)(2008-3#2)(2010-5#1)
Hyperhomocysteinemia is an##2##3##(2008-3#1)(2008-8#1)
Hyperhomocysteinemia is##3##2##(2008-3#2)(2008-8#1)
Hyperhomocysteinemia##10##1##(2008-1#1)(2008-3#5)(2008-8#1)(2010-5#3)
Hypericin##4##1##(2008-8#3)(2009-3#1)
Hypericum perforatum##2##2##(2008-10#1)(2008-8#1)
Hypericum##4##1##(1997-8#1)(2008-10#1)(2008-8#1)(2013-7#1)
Hyperinsulinism in##2##2##(2008-1#2)
Hyperlipidaemia##2##1##(2008-3#1)(2008-7#1)
Hyperlipidemia is##2##2##(1996-11#2)
Hyperlipidemia##6##1##(1996-11#2)(2009-12#1)(2010-8#1)(2013-1#2)
Hypermagnesaemia##2##1##(2008-6#2)
Hypermethylated in Cancer 1 (HIC1)##2##5##(2009-8#2)
Hypermethylation##2##1##(2007-11#1)(2013-8#1)
Hyperparathyroidism##4##1##(1991-11#1)(2008-10#1)(2009-7#1)(2012-12#1)
Hyperplasia##3##1##(2008-10#1)(2012-3#1)(2013-1#1)
Hypersecretion of##2##2##(1995-2#1)(2008-7#1)
Hypersensitive Response in##3##3##(2008-10#3)
Hypersensitive Response##6##2##(2008-10#6)
Hypersensitive##7##1##(2008-10#6)(2008-8#1)
Hypersensitivity reactions##2##2##(1996-3#1)(2011-1#1)
Hypersensitivity to##3##2##(1992-2#1)(1993-2#1)(2012-12#1)
Hypersensitivity##8##1##(1992-2#1)(1993-2#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-12#1)
Hypersil##3##1##(1991-5#1)(2008-10#2)
Hyperspectral remote sensing for shallow waters##2##6##(2008-2#1)(2008-3#1)
Hyperspectral##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
Hypertension and##4##2##(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
Hypertension has##2##2##(1996-6#1)(2010-4#1)
Hypertension in a##2##3##(2008-11#1)(2011-1#1)
Hypertension in children##2##3##(2007-7#1)(2008-1#1)
Hypertension in pregnancy##2##3##(2008-1#1)(2008-4#1)
Hypertension in renal##2##3##(2008-1#2)
Hypertension in the##6##3##(1997-3#3)(2008-1#2)(2011-2#1)
Hypertension in##22##2##(1997-3#3)(2007-7#1)(2008-1#10)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
Hypertension is a##2##3##(1996-6#1)(2008-1#1)
Hypertension is the##2##3##(2008-1#1)(2008-8#1)
Hypertension is##8##2##(1996-6#1)(1997-5#1)(2008-1#3)(2008-11#1)(2008-8#1)(2012-12#1)
Hypertension was the most common##2##5##(2007-10#1)(2007-7#1)
Hypertension was the most##3##4##(2007-10#2)(2007-7#1)
Hypertension was the##5##3##(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#1)
Hypertension was##10##2##(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#4)(2012-12#1)(2013-8#1)
Hypertension##64##1##(1991-2#1)(1993-2#1)(1995-10#1)(1996-6#2)(1996-9#1)(1997-3#3)(1997-5#1)(1997-8#1)(2007-10#3)(2007-7#2)(2008-1#19)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
Hypertensive Patients##2##2##(2008-8#1)(2009-9#1)
Hypertensive patients should##2##3##(1993-2#1)(1993-8#1)
Hypertensive patients##3##2##(1993-2#1)(1993-8#1)(2010-4#1)
Hypertensive##6##1##(1992-8#1)(1993-2#1)(1993-8#1)(2008-8#1)(2009-9#1)(2010-4#1)
Hyperthermia##4##1##(1992-11#1)(1992-8#1)(2011-2#1)(2013-8#1)
Hyperthermic seizures##2##2##(2012-2#2)
Hyperthermic##6##1##(1991-8#1)(1993-8#1)(2008-6#1)(2012-2#3)
Hypertriglyceridemia during##2##2##(1992-10#2)
Hypertriglyceridemia##4##1##(1992-10#3)(1996-11#1)
Hypertrophic scar##2##2##(2008-9#2)
Hypertrophic##6##1##(1992-9#1)(2008-9#3)(2011-2#1)(2012-1#1)
Hyphae of the##2##3##(2008-10#2)
Hyphae of##6##2##(2008-10#6)
Hyphae were##2##2##(2008-10#2)
Hyphae##12##1##(2008-10#11)(2008-7#1)
Hyphal##4##1##(2008-10#4)
Hyphenated techniques##2##2##(2008-10#2)
Hyphenated##3##1##(2008-10#3)
Hyphessobrycon chocoensis##3##2##(2013-7#3)
Hyphessobrycon##7##1##(2013-7#7)
Hypocalcemia##4##1##(1990-9#2)(1991-8#1)(2011-2#1)
Hypocrea##6##1##(2008-10#5)(2013-1#1)
Hypocrellin##2##1##(2008-8#2)
Hypogastric##2##1##(1994-1#1)(1997-7#1)
Hypoglossal##2##1##(2008-2#1)(2011-2#1)
Hypoglycemia##4##1##(1997-2#1)(2007-12#1)(2007-5#1)(2010-2#1)
Hypogonadism##2##1##(2008-3#1)(2013-8#1)
Hypokalemic##3##1##(2007-5#2)(2007-7#1)
Hypolobocera##4##1##(2008-5#4)
Hyponatremia##2##1##(2009-5#1)(2010-1#1)
Hypoparathyroidism##2##1##(2012-2#1)(2013-8#1)
Hypophosphatemia##2##1##(1991-8#1)(2009-12#1)
Hypophysectomy##2##1##(1991-1#1)(2012-1#1)
Hypospadias is##2##2##(2008-10#1)(2009-5#1)
Hypospadias##5##1##(2008-10#3)(2009-5#2)
Hypotension##2##1##(1991-3#1)(1994-11#1)
Hypothalamic##5##1##(1995-12#1)(2008-4#1)(2008-9#3)
Hypothermia is a##2##3##(1993-3#1)(2010-7#1)
Hypothermia is##4##2##(1991-3#1)(1993-3#1)(2008-8#1)(2010-7#1)
Hypothermia##10##1##(1991-3#1)(1993-3#1)(1995-12#1)(1995-3#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#2)
Hypotheses are##2##2##(1995-12#1)(2008-11#1)
Hypotheses##4##1##(1995-12#1)(1996-4#1)(2008-11#1)(2009-9#1)
Hypothesis##10##1##(1994-9#1)(1996-4#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#4)(2012-2#1)
Hypothetical##5##1##(1992-12#1)(2008-10#2)(2008-8#2)
Hypothyroidism##6##1##(1994-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
Hypovirulence##5##1##(2008-10#4)(2008-9#1)
Hypovirulent Isolates of Sclerotinia homoeocarpa##2##5##(2008-10#2)
Hypovirulent##4##1##(2008-10#4)
Hypovirus##3##1##(2008-10#3)
Hypoxanthine##2##1##(2008-10#2)
Hypoxia is##2##2##(2009-11#1)(2009-4#1)
Hypoxia##12##1##(1994-5#1)(1995-2#1)(1996-12#2)(1996-3#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#3)
Hypoxia-inducible factors##2##2##(2011-2#2)
Hys##3##1##(2008-8#3)
Hysteroscopic metroplasty##2##2##(1994-9#2)
Hysteroscopic##7##1##(1991-2#1)(1991-3#1)(1992-1#1)(1994-9#4)
Hysteroscopy and endometrial##2##3##(1991-12#2)
Hysteroscopy##5##1##(1991-12#3)(1991-2#1)(1996-1#1)
Hz EA induced a##2##4##(1996-12#2)
Hz EA##5##2##(1996-12#5)
Hz and 0##2##3##(1997-6#1)(2008-3#1)
Hz and a##2##3##(2008-2#1)(2008-3#1)
Hz and an##2##3##(2008-2#1)(2011-2#1)
Hz and##14##2##(1996-12#2)(1997-6#1)(1997-7#1)(2006-12#2)(2007-11#2)(2008-2#2)(2008-3#2)(2011-2#2)
Hz band##3##2##(2008-7#2)(2013-8#1)
Hz during##2##2##(2008-2#2)
Hz for##2##2##(1996-4#1)(2008-3#1)
Hz frequency##4##2##(1991-10#1)(2008-11#2)(2010-8#1)
Hz in##2##2##(2007-12#1)(2008-12#1)
Hz induced##2##2##(2008-3#1)(2013-1#1)
Hz rTMS##2##2##(2011-2#1)(2013-1#1)
Hz sine wave stimuli activate small##2##6##(2006-12#2)
Hz sine wave stimuli activate##3##5##(2006-12#3)
Hz to##3##2##(2008-12#1)(2008-2#1)(2009-11#1)
Hz was##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Hz were##2##2##(2008-3#2)
Hz with a##2##3##(2007-12#1)(2008-3#1)
Hz with##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
Hz##120##1##(1991-10#2)(1991-12#4)(1992-11#1)(1993-12#1)(1994-8#1)(1996-12#7)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#2)(2006-12#11)(2007-11#7)(2007-12#7)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#23)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#2)(2009-1#1)(2009-11#1)(2010-1#1)(2010-8#2)(2011-2#9)(2013-1#3)(2013-8#2)
Hz(-1/2) was achieved##2##3##(2007-12#1)(2013-8#1)
Hz(-1/2)##5##1##(2007-12#1)(2008-3#3)(2013-8#1)
Hz) in##3##2##(1994-8#1)(2008-11#1)(2008-2#1)
Hz)##25##1##(1991-5#1)(1994-8#1)(1996-12#2)(1996-2#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#2)(2010-1#3)(2010-7#1)(2012-2#1)(2013-8#1)
Hz-1##2##1##(2007-11#1)(2012-2#1)
HzNV-1##2##1##(2012-2#2)
Häggström (Biology and Philosophy 22##2##5##(2010-3#2)
Häggström##3##1##(2008-11#1)(2010-3#2)
Hélène##2##1##(2013-1#1)(2013-8#1)
Hôpital##2##1##(2008-2#1)(2010-6#1)
Hückel##3##1##(1996-2#1)(2008-10#2)
I &amp##2##2##(2010-7#2)
I &gt##5##2##(1996-2#2)(1997-6#1)(1997-7#2)
I (p &lt##3##3##(2010-1#1)(2013-8#2)
I (p##4##2##(2010-1#1)(2010-7#1)(2013-8#2)
I -##7##2##(2007-11#2)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
I = 0##4##3##(1990-5#1)(1992-9#1)(1996-2#1)(2008-10#1)
I =##5##2##(1990-5#1)(1992-9#1)(1996-2#1)(2008-10#1)(2008-3#1)
I DNA fragment##3##3##(1996-6#1)(2008-8#2)
I DNA##4##2##(1993-8#1)(1996-6#1)(2008-8#2)
I IFNs##5##2##(1995-12#4)(2007-11#1)
I R##2##2##(2008-8#2)
I activity##3##2##(1994-8#1)(2008-7#2)
I address the##2##3##(2008-11#1)(2008-2#1)
I allele##3##2##(2008-10#2)(2008-8#1)
I also discuss the##2##4##(2008-2#1)(2010-7#1)
I also examined##2##3##(2008-8#2)
I also##16##2##(1996-11#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2010-7#1)(2012-3#1)
I am a##2##3##(2007-5#1)(2010-9#1)
I am##10##2##(1992-3#1)(1996-4#1)(2007-5#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-7#1)
I analyze##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
I and COUP-TF II##3##4##(1996-5#3)
I and Cb##2##3##(1995-12#2)
I and Hinf##2##3##(2008-12#1)(2008-9#1)
I and II and##5##4##(1992-11#1)(1997-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
I and II clinical##3##4##(2008-5#2)(2012-3#1)
I and II in the##2##5##(1995-12#1)(2008-10#1)
I and II in##5##4##(1995-12#1)(2007-11#1)(2008-10#2)(2012-12#1)
I and II metal ions##2##5##(2008-10#2)
I and II of the##5##5##(1991-2#1)(1995-12#2)(1997-2#1)(2008-10#1)
I and II of##7##4##(1991-2#1)(1993-9#1)(1995-12#2)(1997-2#1)(2008-10#1)(2010-3#1)
I and II strains##2##4##(2008-10#2)
I and II were##2##4##(1991-12#1)(1997-2#1)
I and II##81##3##(1991-12#3)(1991-2#2)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-12#6)(1995-5#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-5#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
I and II) and##2##4##(1996-5#1)(2008-11#1)
I and II)##4##3##(1991-11#1)(1996-5#1)(2008-10#1)(2008-11#1)
I and III##11##3##(1990-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-3#1)
I and II]##2##3##(1997-4#1)(2013-8#1)
I and IV##4##3##(1990-12#1)(1994-12#1)(2008-1#1)(2008-12#1)
I and Type##3##3##(1994-2#1)(2008-8#1)(2008-9#1)
I and V##2##3##(1990-2#1)(1992-12#1)
I and bc-1(2)##3##3##(2008-10#3)
I and class II##5##4##(1995-5#1)(1997-8#1)(2008-4#2)(2008-9#1)
I and in##2##3##(1995-12#1)(2007-8#1)
I and the##7##3##(1990-3#1)(2008-11#2)(2008-2#2)(2011-2#1)(2012-3#1)
I and type##10##3##(1994-2#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-11#1)(2011-2#1)
I and##225##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#19)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#6)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#6)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#48)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#8)(2008-7#6)(2008-8#2)(2008-9#8)(2009-12#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#3)
I antigens##5##2##(1991-3#1)(1992-7#1)(1994-5#2)(2008-8#1)
I applied the##2##3##(1997-3#1)(2008-8#1)
I applied##3##2##(1992-6#1)(1997-3#1)(2008-8#1)
I apply the##2##3##(1997-3#1)(2008-8#1)
I apply##3##2##(1997-3#1)(2008-8#1)(2013-1#1)
I argue that the##3##4##(2010-3#1)(2012-2#2)
I argue that this##2##4##(1997-3#1)(2010-7#1)
I argue that##12##3##(1997-3#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#2)(2013-1#1)
I argue##15##2##(1997-3#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-4#1)(2010-7#1)(2012-2#3)(2013-1#1)
I as a##2##3##(1995-8#1)(2008-11#1)
I as##5##2##(1995-8#1)(2008-10#2)(2008-11#1)(2010-6#1)
I at##4##2##(2008-8#2)(2009-3#2)
I based##2##2##(1991-5#1)(2012-3#1)
I believe it##2##3##(1994-2#1)(2009-6#1)
I believe##4##2##(1994-2#1)(1994-3#1)(2008-6#1)(2009-6#1)
I binding to immobilized##2##4##(2008-10#2)
I binding##3##2##(1997-9#1)(2008-10#2)
I by##8##2##(1993-6#1)(1993-8#1)(1994-8#1)(1996-6#1)(2007-5#1)(2008-10#2)(2008-8#1)
I can't##2##2##(1994-2#1)(2008-4#1)
I cases##2##2##(2008-7#1)(2013-8#1)
I cells##3##2##(2007-12#2)(2008-7#1)
I cleavage##2##2##(1990-7#1)(1993-8#1)
I clinical trial##2##3##(2008-5#1)(2010-6#1)
I clinical##10##2##(1994-8#1)(2008-11#1)(2008-5#5)(2010-6#1)(2011-2#1)(2012-3#1)
I coherent##2##2##(2008-11#1)(2013-1#1)
I collagen##17##2##(1991-5#1)(1994-12#1)(1994-5#1)(1995-5#1)(1997-1#2)(1997-7#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-8#1)(2013-8#1)
I compare the##3##3##(1992-6#1)(1994-12#1)(2013-8#1)
I conclude that##4##3##(1991-1#1)(1997-3#1)(2008-10#1)(2008-7#1)
I conclude##5##2##(1991-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2012-1#1)
I conducted a##2##3##(2008-8#2)
I consider a##2##3##(2008-3#1)(2008-8#1)
I consider##7##2##(1996-4#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
I constructed a##2##3##(2008-8#1)(2008-9#1)
I contained##3##2##(2008-10#3)
I data##2##2##(2011-2#1)(2012-3#1)
I deliberately##2##2##(2008-9#1)(2010-3#1)
I demonstrate##2##2##(2008-10#1)(2008-8#1)
I describe a##2##3##(1997-3#1)(2013-1#1)
I describe the##3##3##(2008-2#1)(2008-8#1)(2010-12#1)
I describe##8##2##(1992-6#1)(1994-9#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
I develop a##2##3##(2007-12#1)(2012-3#1)
I digestion of the##2##4##(1990-12#1)(1995-5#1)
I digestion##3##2##(1990-12#1)(1992-6#1)(1995-5#1)
I discuss the##7##3##(2008-11#1)(2008-7#3)(2010-3#1)(2010-4#2)
I discuss##11##2##(1992-6#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2010-3#1)(2010-4#2)
I do##4##2##(1997-1#1)(2008-3#1)(2008-9#1)(2013-1#1)
I don't have a##2##4##(2008-1#1)(2008-4#1)
I don't##4##2##(2007-2#1)(2008-1#1)(2008-4#2)
I element##7##2##(1995-8#7)
I elements introduced##2##3##(1995-8#2)
I elements##5##2##(1995-8#5)
I employ##3##2##(1997-3#1)(2008-10#2)
I enzyme##4##2##(1994-8#1)(1995-3#3)
I error rate is##3##4##(2012-2#2)(2012-3#1)
I error rate##8##3##(2012-1#1)(2012-2#5)(2012-3#2)
I error rates for##2##4##(2013-1#2)
I error rates##5##3##(2011-2#1)(2013-1#4)
I error##21##2##(1994-9#1)(1995-2#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#4)
I examine the##2##3##(2008-3#2)
I examine##3##2##(2008-2#1)(2008-3#2)
I experimentally##2##2##(2008-8#1)(2008-9#1)
I explore the##3##3##(2009-8#1)(2012-12#1)(2012-2#1)
I explore using in-depth interviews experiences of spirituality over the lifecourse##2##11##(2013-1#2)
I explore##5##2##(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
I explored##2##2##(2008-12#1)(2008-9#1)
I expression##5##2##(1993-8#1)(1997-9#3)(2008-4#1)
I factors can##2##3##(1995-8#2)
I factors##5##2##(1995-8#5)
I family##3##2##(1997-8#2)(2008-1#1)
I feel##3##2##(1992-3#1)(2008-10#1)(2013-7#1)
I find##5##2##(2008-3#1)(2008-8#2)(2012-2#2)
I first##3##2##(2008-9#1)(2010-8#1)(2012-3#1)
I focus on##3##3##(2008-12#1)(2008-3#1)(2012-2#1)
I footprinting and##2##3##(1994-9#1)(2008-9#1)
I footprinting##6##2##(1994-6#1)(1994-9#1)(1995-5#1)(2008-8#1)(2008-9#2)
I form##2##2##(1994-8#1)(1997-1#1)
I found that##3##3##(1993-3#1)(2008-6#1)(2008-9#1)
I found##6##2##(1993-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)
I fragment##2##2##(1997-2#1)(2008-9#1)
I fragments##4##2##(1992-6#3)(2008-10#1)
I from rat##2##3##(1991-5#1)(1992-3#1)
I from##9##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)
I gene expression##2##3##(1995-12#1)(2012-3#1)
I gene##10##2##(1993-8#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-6#1)(2011-2#2)(2012-3#1)
I get##3##2##(1996-12#1)(2007-2#1)(2010-9#1)
I had a##2##3##(2007-2#1)(2013-7#1)
I had##7##2##(2007-2#1)(2008-2#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-7#2)
I have a##2##3##(2008-11#1)(2010-12#1)
I have been##2##3##(1992-3#1)(2006-9#1)
I have not##2##3##(2007-11#1)(2008-11#1)
I have##18##2##(1991-1#1)(1992-2#1)(1992-3#2)(1994-2#1)(1995-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2011-1#1)
I hope##3##2##(1991-12#1)(2008-11#1)(2012-3#1)
I identify##3##2##(1992-6#1)(1997-1#1)(2010-3#1)
I in the##6##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)
I in##23##2##(1992-6#2)(1993-6#2)(1994-8#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#3)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
I inhibitors and##2##3##(2008-11#1)(2008-5#1)
I inhibitors##4##2##(1994-11#1)(2008-11#2)(2008-5#1)
I inhibitory##2##2##(1995-3#1)(1995-5#1)
I investigate a##2##3##(2008-8#1)(2013-1#1)
I investigate##4##2##(1997-8#1)(2008-8#2)(2013-1#1)
I investigated the##3##3##(2008-8#2)(2008-9#1)
I investigated##4##2##(2008-8#3)(2008-9#1)
I iodothyronine deiodinase##2##3##(1992-12#2)
I iodothyronine##5##2##(1990-12#3)(1992-12#2)
I is a##4##3##(1991-5#1)(1993-12#1)(1994-9#1)(2008-11#1)
I is##21##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
I isolates were##3##3##(2008-10#3)
I isolates##9##2##(2008-10#9)
I kappa B alpha inhibited##2##5##(1995-2#2)
I kappa B alpha##3##4##(1995-2#3)
I kappa B##4##3##(1995-2#4)
I kappa B-like##2##3##(1991-7#2)
I kappa##7##2##(1991-7#2)(1995-2#4)(1995-6#1)
I know that##2##3##(1992-3#1)(2010-9#1)
I know##4##2##(1992-3#1)(2010-9#2)(2013-8#1)
I mRNA##3##2##(1993-8#1)(1995-12#1)(1996-5#1)
I malformation##4##2##(1992-2#1)(2008-7#1)(2012-12#2)
I may form a family of isoforms##2##7##(1994-6#2)
I may##3##2##(1994-6#2)(2010-5#1)
I measured##2##2##(2008-8#1)(2008-9#1)
I metabotropic glutamate##5##3##(1995-12#1)(1996-12#2)(2008-4#1)(2009-3#1)
I metabotropic##6##2##(1995-12#1)(1996-12#2)(2008-4#1)(2009-3#2)
I method##4##2##(2008-10#3)(2012-2#1)
I molecules of##3##3##(1990-5#1)(2008-8#2)
I molecules##13##2##(1990-5#2)(1992-8#1)(1995-2#1)(1995-5#1)(1997-9#1)(2008-11#1)(2008-4#1)(2008-8#5)
I mutations##2##2##(1991-12#1)(2008-7#1)
I need##3##2##(2010-12#1)(2013-7#2)
I of cytochrome##4##3##(1993-2#1)(1994-6#1)(1997-7#2)
I of the##7##3##(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-7#1)
I of##24##2##(1991-2#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#3)(1994-2#1)(1994-6#3)(1995-2#1)(1997-1#1)(1997-7#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
I or II##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
I or##13##2##(1992-12#1)(1993-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#4)(2012-3#1)(2013-1#1)
I patient##2##2##(1993-11#1)(2011-1#1)
I peptides##2##2##(1995-5#1)(2008-10#1)
I phosphatidylinositol##2##2##(2008-7#1)(2013-1#1)
I present a new##2##4##(2008-9#1)(2012-3#1)
I present a##4##3##(1992-6#1)(2008-3#1)(2008-9#1)(2012-3#1)
I present results##2##3##(1996-3#1)(2008-2#1)
I present##12##2##(1992-6#1)(1992-9#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-9#2)(2012-2#1)(2012-3#1)
I propose a##6##3##(1992-9#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
I propose##11##2##(1992-9#2)(1995-2#1)(1995-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
I proteins##3##2##(1997-7#1)(2008-1#2)
I pulmonary##2##2##(2007-8#1)(2009-10#1)
I quantitatively##2##2##(2008-8#2)
I really##2##2##(1992-3#1)(2012-2#1)
I recently had a##2##4##(2010-12#1)(2013-7#1)
I receptors##2##2##(1995-12#1)(2011-2#1)
I region##3##2##(1997-2#1)(1997-8#1)(2008-10#1)
I remains##2##2##(2008-12#1)(2008-9#1)
I report on a##2##4##(2008-2#1)(2008-9#1)
I report on##4##3##(2008-2#1)(2008-3#1)(2008-9#2)
I report##8##2##(1992-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-9#1)
I restriction enzyme##2##3##(1997-5#1)(1997-7#1)
I restriction##5##2##(1990-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-9#1)
I review the evidence##2##4##(2007-12#1)(2008-7#1)
I review the##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)
I review##9##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#2)(2010-10#1)(2010-3#1)(2010-7#1)
I say##3##2##(1993-8#1)(2006-10#1)(2011-2#1)
I should##2##2##(2008-10#1)(2010-12#1)
I show that the##5##4##(1992-6#1)(1995-9#2)(2008-2#1)(2012-3#1)
I show that##11##3##(1992-6#1)(1995-9#2)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2012-3#2)(2013-1#1)
I show##13##2##(1992-6#1)(1995-9#2)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2012-2#2)(2012-3#2)(2013-1#1)
I showed##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
I studied##2##2##(2008-5#1)(2008-9#1)
I studies##5##2##(1995-8#1)(2006-6#1)(2008-5#1)(2008-8#1)(2010-12#1)
I study of##4##3##(1992-10#2)(1996-10#1)(2008-5#1)
I study##9##2##(1991-1#1)(1992-10#2)(1996-10#1)(2008-5#4)(2008-7#1)
I suggest that##5##3##(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
I suggest##8##2##(1997-4#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
I summarize##2##2##(1994-9#1)(2012-2#1)
I tested the hypothesis that##2##5##(2008-10#1)(2009-5#1)
I tested the##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
I tested##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2009-5#1)
I then##5##2##(1992-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)
I to II##2##3##(2008-5#1)(2011-2#1)
I to the##2##3##(1994-11#1)(2008-3#1)
I to##11##2##(1990-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(2007-2#1)(2007-8#1)(2008-3#2)(2008-5#1)(2009-2#1)(2011-2#1)
I trials##5##2##(1997-1#1)(2008-5#3)(2011-2#1)
I use##3##2##(2008-9#2)(2012-3#1)
I used##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
I using##2##2##(2008-10#2)
I versus##2##2##(1995-5#1)(2009-7#1)
I was able to##2##4##(2008-1#1)(2011-1#1)
I was##26##2##(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#2)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#2)(2010-7#1)(2010-8#2)(2011-1#1)(2013-7#1)
I were##6##2##(1992-11#1)(2008-10#3)(2008-8#1)(2013-1#1)
I will discuss the impacts of environmental cancer causing factors and how they continue to cause multiple disruptions in cellular networking##2##21##(2013-1#2)
I will discuss the##5##4##(2009-12#1)(2009-5#2)(2013-1#2)
I will discuss##7##3##(2007-5#1)(2009-12#1)(2009-5#2)(2010-3#1)(2013-1#2)
I will review##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
I will##21##2##(1992-3#2)(1994-11#1)(1996-11#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-5#3)(2010-1#1)(2010-3#2)(2011-2#2)(2012-12#1)(2013-1#2)
I with##6##2##(1993-6#1)(1997-7#2)(2008-10#3)
I would like to see##3##5##(1992-3#3)
I would##5##2##(1992-3#3)(2008-10#1)(2008-7#1)
I##2030##1##(1990-10#1)(1990-11#4)(1990-12#11)(1990-2#11)(1990-3#9)(1990-5#9)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#18)(1991-2#10)(1991-3#2)(1991-5#16)(1991-6#3)(1991-7#4)(1991-8#2)(1992-10#2)(1992-11#8)(1992-12#11)(1992-2#4)(1992-3#24)(1992-4#2)(1992-5#2)(1992-6#36)(1992-7#1)(1992-8#17)(1992-9#7)(1993-1#2)(1993-11#13)(1993-12#17)(1993-2#11)(1993-3#9)(1993-6#7)(1993-8#28)(1993-9#1)(1994-1#13)(1994-11#6)(1994-12#15)(1994-2#8)(1994-3#4)(1994-5#11)(1994-6#11)(1994-7#1)(1994-8#17)(1994-9#15)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#52)(1995-2#19)(1995-3#13)(1995-5#19)(1995-6#16)(1995-8#24)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#7)(1996-2#14)(1996-3#6)(1996-4#2)(1996-5#14)(1996-6#3)(1997-1#10)(1997-2#15)(1997-3#11)(1997-4#7)(1997-5#6)(1997-6#5)(1997-7#22)(1997-8#20)(1997-9#10)(2006-10#1)(2006-12#1)(2006-6#3)(2006-9#1)(2007-11#24)(2007-12#23)(2007-2#6)(2007-5#5)(2007-7#9)(2007-8#33)(2007-9#2)(2008-1#24)(2008-10#259)(2008-11#66)(2008-12#25)(2008-2#36)(2008-3#57)(2008-4#34)(2008-5#54)(2008-6#17)(2008-7#57)(2008-8#89)(2008-9#68)(2009-10#7)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#10)(2009-6#2)(2009-7#7)(2009-8#4)(2009-9#2)(2010-1#7)(2010-10#1)(2010-11#2)(2010-12#14)(2010-2#2)(2010-3#15)(2010-4#9)(2010-5#11)(2010-6#4)(2010-7#12)(2010-8#8)(2010-9#9)(2011-1#13)(2011-2#67)(2011-3#2)(2012-1#3)(2012-12#18)(2012-2#29)(2012-3#45)(2013-1#46)(2013-7#11)(2013-8#26)
I&quot##3##1##(2008-1#1)(2011-2#1)(2012-2#1)
I'm a##4##2##(1996-3#1)(2007-8#1)(2008-1#1)(2010-5#1)
I'm##9##1##(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-12#2)(2010-5#1)(2011-2#1)(2013-7#1)
I've been##3##2##(1995-5#1)(2008-2#1)(2010-9#1)
I've##9##1##(1995-5#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)
I(-) and##2##2##(2008-10#2)
I(-) ion##2##2##(2008-10#2)
I(-) to form##3##3##(2008-10#3)
I(-) to##4##2##(2008-10#4)
I(-)##17##1##(2008-10#17)
I(0)/I(100)##2##1##(2008-10#2)
I(2) and##2##2##(2008-10#1)(2008-2#1)
I(2)##6##1##(2008-10#3)(2008-2#1)(2012-2#2)
I(2)/Ag(2)O##2##1##(1996-5#2)
I(2)Li(2)##3##1##(1996-2#3)
I(2)Li(2))##2##1##(1996-2#2)
I(276##2##1##(2008-10#2)
I(3)(-) and I(5)(-)##2##3##(2008-10#2)
I(3)(-)##9##1##(2008-10#9)
I(300##2##1##(2008-10#2)
I(50)##2##1##(2008-10#2)
I(GAba)##2##1##(2008-8#2)
I(K##3##1##(2008-8#3)
I(Kr)##2##1##(2008-8#2)
I(Kv11##3##1##(2008-8#3)
I(a) and##3##2##(2008-10#3)
I(b)##2##1##(2008-3#2)
I(delta)##3##1##(2008-8#3)
I(genE)##2##1##(2008-10#2)
I(m)##3##1##(2008-10#3)
I(pa)##3##1##(2008-10#3)
I(th)##2##1##(2008-3#2)
I) activity##2##2##(1993-6#1)(1994-8#1)
I) and##11##2##(1991-3#1)(1992-8#1)(1994-2#1)(2007-8#1)(2008-10#4)(2010-8#1)(2011-2#1)(2013-1#1)
I) in##4##2##(1994-8#1)(1996-3#1)(2007-9#1)(2008-10#1)
I) is##2##2##(1992-12#1)(2008-10#1)
I) of##3##2##(1992-12#1)(1996-12#1)(2008-10#1)
I) were##2##2##(1992-6#1)(2011-2#1)
I) with##2##2##(2008-10#1)(2008-11#1)
I)##75##1##(1991-3#2)(1991-5#1)(1992-12#2)(1992-2#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-5#1)(1996-12#1)(1996-3#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
I+II##4##1##(2013-7#4)
I- and##2##2##(2008-11#1)(2013-1#1)
I-##3##1##(1995-12#1)(2008-11#1)(2013-1#1)
I-1##10##1##(2008-10#10)
I-2##3##1##(2008-10#3)
I-A beta##2##2##(1993-3#2)
I-A k on##2##3##(1990-12#2)
I-A k##9##2##(1990-12#9)
I-A##11##1##(1990-12#9)(1993-3#2)
I-B4##3##1##(1997-2#3)
I-CZE##4##1##(2008-10#4)
I-Ceu I##4##2##(1997-2#4)
I-FABP##2##1##(2013-1#2)
I-HII##3##1##(1994-3#3)
I-II##8##1##(1990-12#1)(1991-3#1)(1993-2#1)(1993-8#1)(2007-8#1)(2009-12#2)(2011-2#1)
I-II)##2##1##(1992-10#1)(2009-12#1)
I-III##4##1##(1997-2#1)(2007-8#1)(2008-11#1)(2008-7#1)
I-III)##2##1##(1990-9#1)(1992-4#1)
I-MOVE##2##1##(2010-4#2)
I-R hybrid dysgenesis##2##3##(1995-8#2)
I-R##5##1##(1995-8#4)(2007-8#1)
I-SceIII##2##1##(1995-6#2)
I-V##3##1##(1991-9#1)(1993-12#1)(1995-12#1)
I-compound levels##2##2##(1992-11#2)
I-compounds and##2##2##(1992-11#2)
I-compounds##5##1##(1992-11#5)
I-gel##2##1##(2010-7#2)
I-high##2##1##(1996-12#2)
I-low##3##1##(1996-12#3)
I-medium and##3##2##(1996-12#3)
I-sharing##4##1##(2009-11#4)
I-specific##2##1##(1997-9#1)(2008-10#1)
I-waves##2##1##(2008-7#2)
I/II##10##1##(1993-1#1)(1997-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-7#1)
I/II)##2##1##(2008-11#1)(2011-2#1)
I/O##6##1##(2008-3#6)
I/R injury##5##2##(2008-10#1)(2010-1#1)(2010-8#3)
I/R##17##1##(2008-10#3)(2008-12#2)(2010-1#1)(2010-5#3)(2010-8#4)(2013-7#4)
I1 and I2##2##3##(2008-12#1)(2008-5#1)
I1 and##3##2##(2008-12#2)(2008-5#1)
I1##6##1##(1992-3#3)(2008-12#2)(2008-5#1)
I1-imidazoline receptor##2##2##(1997-2#2)
I1-imidazoline##3##1##(1997-2#3)
I13##3##1##(2008-11#3)
I175A##3##1##(2012-2#3)
I179S was##2##2##(1997-3#2)
I179S##3##1##(1997-3#3)
I184Y##3##1##(1992-1#3)
I2 to##3##2##(1992-3#1)(2008-12#2)
I2##12##1##(1990-3#3)(1992-3#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)
I2-imidazoline receptors##4##2##(1996-5#4)
I2-imidazoline##5##1##(1996-5#5)
I201A##2##1##(2012-2#2)
I228M##4##1##(2013-1#4)
I3##3##1##(2008-10#1)(2008-12#2)
I5##3##1##(2008-10#3)
I50##2##1##(1990-11#1)(1992-8#1)
I=0##6##1##(2008-10#6)
IA and Chiralpak##5##3##(2008-10#5)
IA and##8##2##(1996-5#1)(2008-10#5)(2010-8#2)
IA in##2##2##(2008-10#1)(2008-6#1)
IA therapy##3##2##(2008-8#1)(2011-2#2)
IA using##2##2##(2011-2#2)
IA##35##1##(1992-8#1)(1996-3#1)(1996-5#2)(2007-10#2)(2007-11#2)(2008-1#1)(2008-10#11)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#3)(2011-2#9)
IA)##4##1##(2008-10#3)(2010-8#1)
IA-1##6##1##(1997-7#6)
IA-DSA##3##1##(2008-7#3)
IA1##5##1##(1990-5#4)(1992-8#1)
IA2##7##1##(1990-5#7)
IAA in##3##2##(2008-10#3)
IAA than##3##2##(1994-12#1)(2008-10#2)
IAA with 2##2##3##(2008-12#2)
IAA##24##1##(1994-12#3)(2008-10#13)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#2)
IAA-producing bacteria were##2##3##(2008-10#2)
IAA-producing bacteria##5##2##(2008-10#5)
IAA20 and IAA30##2##3##(2009-8#2)
IABP##4##1##(2010-8#4)
IAC clean-up##2##2##(2008-10#2)
IAC##5##1##(2006-12#1)(2008-10#4)
IAD##5##1##(1996-5#1)(2013-8#4)
IADL##3##1##(2007-7#1)(2008-7#1)(2013-1#1)
IAEA##6##1##(2007-11#1)(2008-10#3)(2012-1#2)
IAEA-Soil##2##1##(2008-10#2)
IAHSS (International Association for Healthcare Security &amp##3##7##(1991-12#1)(1992-12#1)(1992-2#1)
IAHSS survey##5##2##(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#2)
IAHSS surveys##3##2##(1992-2#1)(1994-2#2)
IAHSS##19##1##(1991-12#1)(1992-12#2)(1992-2#4)(1993-2#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#2)(1996-12#3)(1997-2#2)
IAI duration##2##2##(2008-12#2)
IAI##6##1##(2008-12#6)
IAL##2##1##(2008-10#2)
IAM##2##1##(2008-10#2)
IAN##3##1##(2012-12#3)
IAPP secretion and##2##3##(1994-8#2)
IAPP##11##1##(1992-6#4)(1994-8#6)(2010-11#1)
IAR excursion was##2##3##(2012-2#2)
IAR translates##4##2##(2012-2#4)
IAR##8##1##(2012-2#8)
IAR3##6##1##(2008-7#6)
IAS##2##1##(2008-8#2)
IAT##6##1##(1994-12#1)(1994-9#5)
IAVs##2##1##(2013-1#2)
IAd##2##1##(1991-2#2)
IB II##2##2##(2008-8#2)
IB and##2##2##(2008-12#1)(2010-10#1)
IB##17##1##(1997-3#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#2)(2013-8#1)
IB)##2##1##(2008-10#1)(2013-7#1)
IB-49 and IC-17##2##3##(2008-10#2)
IB-49##5##1##(2008-10#5)
IB-DCTFM##3##1##(2010-8#3)
IBA##6##1##(2008-10#2)(2008-12#4)
IBD in##2##2##(2008-9#1)(2011-1#1)
IBD is##3##2##(2008-9#1)(2009-12#1)(2010-12#1)
IBD slopes##3##2##(2008-9#2)(2013-1#1)
IBD virus##2##2##(1997-6#2)
IBD##32##1##(1997-5#2)(1997-6#2)(2008-10#2)(2008-12#2)(2008-9#7)(2009-12#5)(2010-12#6)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
IBDV + IBV-inoculated##2##3##(2008-5#2)
IBG System##6##2##(1994-6#6)
IBGE##4##1##(1991-9#3)(2008-9#1)
IBM compatible##2##2##(2008-10#2)
IBM##8##1##(1996-12#1)(2008-10#2)(2008-8#2)(2010-8#1)(2012-3#2)
IBM's##2##1##(1993-2#1)(1996-12#1)
IBO##2##1##(1997-2#2)
IBP##6##1##(1991-2#6)
IBS patients##2##2##(2010-6#1)(2013-1#1)
IBS##15##1##(1997-6#3)(2010-6#3)(2013-1#9)
IBTR##5##1##(2013-1#5)
IBV strain M41##2##3##(1997-6#2)
IBV strain##3##2##(1997-3#1)(1997-6#2)
IBV strains isolated between 1961 and 1994 from##2##8##(2008-5#2)
IBV strains isolated between##3##4##(2008-5#3)
IBV strains##10##2##(1997-6#2)(2008-5#8)
IBV##35##1##(1997-3#4)(1997-6#13)(2008-5#18)
IBV-infected##2##1##(1997-6#1)(2007-6#1)
IBV-inoculated ones##2##2##(2008-5#2)
IBV-inoculated##5##1##(2008-5#5)
IBW)##4##1##(2008-12#4)
IBZM##3##1##(1996-12#3)
IBa##4##1##(1995-12#4)
IC _ 50##2##3##(2008-5#2)
IC and##4##2##(2008-10#3)(2008-11#1)
IC at##2##2##(2008-10#2)
IC##34##1##(1994-9#1)(2008-10#26)(2008-11#1)(2008-5#2)(2012-2#1)(2012-3#2)(2013-1#1)
IC(50) of 0##2##3##(2008-10#2)
IC(50) of##7##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#1)
IC(50) value of##3##3##(2007-11#1)(2010-5#1)(2013-1#1)
IC(50) value##4##2##(2007-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
IC(50) values for ifosfamide and doxorubicin were##2##7##(2008-6#2)
IC(50) values for##4##3##(2008-6#3)(2008-7#1)
IC(50) values of##6##3##(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
IC(50) values##17##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#4)
IC(50)##34##1##(2007-11#1)(2008-10#7)(2008-11#6)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
IC(50)=0##2##1##(2008-8#2)
IC(50)=1##2##1##(2008-8#2)
IC(50)s##2##1##(2008-8#1)(2008-9#1)
IC-17##6##1##(2008-10#6)
IC-PCR##4##1##(2008-10#4)
IC50 = 4##2##3##(1995-3#2)
IC50 = 5 mg/kg)##2##4##(1992-8#2)
IC50 =##8##2##(1992-3#1)(1992-8#3)(1995-3#4)
IC50 for##5##2##(1991-5#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-12#1)
IC50 of 0##2##3##(1991-9#1)(1992-8#1)
IC50 of##17##2##(1990-5#1)(1991-11#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-12#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-8#1)(1996-2#2)(1997-4#1)(2010-11#1)
IC50 value of 0##2##4##(1995-8#1)(2008-5#1)
IC50 value of##5##3##(1991-9#2)(1993-9#1)(1995-8#1)(2008-5#1)
IC50 value##7##2##(1990-2#1)(1991-9#2)(1993-9#1)(1995-8#1)(1996-2#1)(2008-5#1)
IC50 values of compounds##2##4##(1995-3#1)(2008-11#1)
IC50 values of##14##3##(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(2008-11#1)
IC50 values were##3##3##(1995-8#2)(1997-7#1)
IC50 values##22##2##(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1997-7#1)(2008-11#1)
IC50##67##1##(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-5#1)(1991-8#4)(1991-9#3)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#6)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#6)(1995-5#1)(1995-8#4)(1996-12#1)(1996-2#3)(1997-4#1)(1997-7#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-11#1)(2011-3#3)
IC50s of##2##2##(1995-3#1)(1996-12#1)
IC50s##6##1##(1991-5#1)(1995-3#2)(1995-5#1)(1996-12#1)(2009-6#1)
IC95% -##2##2##(2008-11#2)
IC95%##3##1##(2008-11#2)(2008-6#1)
ICA and##3##2##(2010-8#1)(2012-3#2)
ICA aneurysms##2##2##(2012-3#2)
ICA in##2##2##(2008-7#1)(2013-1#1)
ICA may##2##2##(2008-10#1)(2009-6#1)
ICA programs##2##2##(1997-3#2)
ICA##32##1##(1994-12#5)(1996-12#1)(1997-3#3)(2008-10#2)(2008-12#1)(2008-7#6)(2009-6#2)(2010-8#2)(2011-2#2)(2012-3#4)(2013-1#4)
ICAM-1 mRNA expression and PMNL and MPhi infiltration in##2##9##(2010-1#2)
ICAM-1 mRNA expression##3##3##(2010-1#3)
ICAM-1 mRNA##6##2##(2010-1#6)
ICAM-1##16##1##(1995-2#2)(1995-6#1)(1996-2#1)(2008-10#4)(2010-1#6)(2012-2#1)(2013-1#1)
ICB process##2##2##(2013-1#2)
ICBI##3##1##(2007-11#3)
ICC 14216 K##4##3##(2008-10#4)
ICC##10##1##(1995-3#1)(2008-10#4)(2009-12#1)(2010-12#3)(2011-2#1)
ICC-MY##4##1##(2009-12#4)
ICCD##2##1##(2008-10#2)
ICD 850##4##2##(1990-12#4)
ICD##10##1##(1990-12#7)(1991-9#1)(2007-10#1)(2012-3#1)
ICD-10 CA##2##2##(2012-12#2)
ICD-10 RCPCH##2##2##(2012-12#2)
ICD-10##22##1##(1991-1#1)(1994-6#2)(1995-6#1)(1997-8#2)(2006-10#2)(2008-11#1)(2011-2#1)(2012-12#9)(2012-2#1)(2013-7#2)
ICD-9 and##2##2##(1995-8#1)(2007-12#1)
ICD-9 codes##2##2##(1994-3#1)(2012-2#1)
ICD-9##9##1##(1991-12#1)(1991-8#1)(1993-12#1)(1994-3#1)(1995-8#1)(2007-12#1)(2012-12#2)(2012-2#1)
ICD-9-CM##3##1##(1996-1#1)(2007-10#1)(2007-12#1)
ICD10##2##1##(1995-6#2)
ICDs##2##1##(2010-12#2)
ICE##3##1##(1995-6#2)(2008-5#1)
ICER##3##1##(1996-2#1)(2012-12#2)
ICEUs##4##1##(2008-7#4)
ICErel-II and ICErel-III##4##3##(1995-6#4)
ICErel-II##5##1##(1995-6#5)
ICErel-III##5##1##(1995-6#5)
ICF in##2##2##(2007-12#1)(2011-2#1)
ICF##17##1##(2007-12#5)(2008-10#1)(2008-3#4)(2011-2#5)(2012-12#2)
ICFIA##2##1##(2008-10#2)
ICG VA##4##2##(2012-2#4)
ICG##5##1##(2012-2#5)
ICH S8##3##2##(2008-10#3)
ICH Score##3##2##(2012-3#3)
ICH drainage##2##2##(2008-7#2)
ICH guidelines##5##2##(2008-10#2)(2011-1#2)(2012-12#1)
ICH volume##8##2##(2007-10#4)(2012-3#4)
ICH##42##1##(2007-10#12)(2008-10#7)(2008-11#1)(2008-7#4)(2008-8#3)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#9)
ICI 182##3##2##(2007-10#2)(2013-1#1)
ICI 198615##2##2##(1992-3#2)
ICI D1694##7##2##(1994-8#7)
ICI##13##1##(1992-3#2)(1993-6#1)(1994-8#7)(2007-10#2)(2013-1#1)
ICL and ICDH##2##3##(2008-10#2)
ICLLM##2##1##(2010-11#2)
ICP MS and MC ICP MS##2##6##(2008-10#2)
ICP MS and##4##3##(2008-10#4)
ICP MS##10##2##(2008-10#10)
ICP OES##3##2##(2008-10#3)
ICP and##5##2##(1996-9#1)(2006-7#1)(2008-10#2)(2008-7#1)
ICP atomic emission##2##3##(2008-10#2)
ICP is##2##2##(2008-7#1)(2010-5#1)
ICP management##2##2##(2008-7#2)
ICP spectrometer##2##2##(1992-3#2)
ICP##56##1##(1992-3#2)(1995-11#1)(1996-9#1)(2006-7#1)(2008-10#28)(2008-12#4)(2008-7#11)(2010-5#7)(2013-8#1)
ICP-AES analysis##3##2##(2008-10#3)
ICP-AES and##4##2##(2008-10#4)
ICP-AES determination of##5##3##(2008-10#5)
ICP-AES determination##6##2##(2008-10#6)
ICP-AES for##2##2##(2008-10#2)
ICP-AES measurement##3##2##(2008-10#3)
ICP-AES method##4##2##(2008-10#4)
ICP-AES was##2##2##(2008-10#2)
ICP-AES##61##1##(2008-10#61)
ICP-MS after##2##2##(2008-10#2)
ICP-MS analysis##3##2##(2008-10#3)
ICP-MS and ICP-AES##2##3##(2008-10#2)
ICP-MS and ICP-OES techniques##2##4##(2008-10#2)
ICP-MS and ICP-OES##3##3##(2008-10#3)
ICP-MS and##11##2##(2008-10#10)(2008-9#1)
ICP-MS as##2##2##(2008-10#2)
ICP-MS detection##7##2##(2008-10#7)
ICP-MS determination of##2##3##(2008-10#2)
ICP-MS determination##4##2##(2008-10#4)
ICP-MS for##3##2##(2008-10#3)
ICP-MS instrument##4##2##(2008-10#4)
ICP-MS or##2##2##(2008-10#2)
ICP-MS techniques##2##2##(2008-10#2)
ICP-MS was##5##2##(2008-10#5)
ICP-MS##96##1##(2008-10#95)(2008-9#1)
ICP-OES Vista-MPX##2##2##(2008-10#2)
ICP-OES elemental analysis of the##2##5##(2008-10#2)
ICP-OES for the##2##3##(2008-10#2)
ICP-OES using##2##2##(2008-10#2)
ICP-OES with##2##2##(2008-10#2)
ICP-OES##25##1##(2008-10#24)(2010-5#1)
ICP-QMS##3##1##(2008-10#3)
ICP/AES##2##1##(2008-10#2)
ICPD##7##1##(1994-9#7)
ICPMS##3##1##(2008-10#3)
ICR mice##3##2##(1992-3#1)(1996-2#1)(2008-11#1)
ICR##9##1##(1992-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#2)
ICRF-187 had no effect##2##4##(1995-3#2)
ICRF-187##3##1##(1995-3#3)
ICRF-193 does not##2##3##(1994-6#2)
ICRF-193##3##1##(1994-6#3)
ICRP##5##1##(1995-12#1)(1996-6#1)(1997-8#1)(2008-7#1)(2013-1#1)
ICS 205-930##6##2##(1990-12#6)
ICS##10##1##(1990-12#6)(2008-8#4)
ICSA##3##1##(1994-12#3)
ICSI##2##1##(1996-9#1)(2011-1#1)
ICSI's##2##1##(1997-2#2)
ICSS##9##1##(1991-2#6)(1996-2#3)
ICT Malaria P##3##3##(2007-2#3)
ICT##10##1##(2007-2#3)(2009-9#1)(2010-8#1)(2012-12#5)
ICU admission##2##2##(1992-2#1)(2012-3#1)
ICU and##2##2##(2008-4#1)(2008-5#1)
ICU nurses##2##2##(2007-11#2)
ICU patients##7##2##(2008-5#1)(2010-11#1)(2011-2#3)(2013-1#2)
ICU stay##3##2##(2007-11#1)(2011-2#2)
ICU were interviewed using##2##4##(1992-2#1)(1995-12#1)
ICU were##3##2##(1992-2#1)(1995-12#1)(2008-8#1)
ICU##56##1##(1991-2#3)(1992-2#7)(1995-12#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#4)(2007-8#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#5)(2010-12#1)(2010-5#2)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#6)(2013-8#1)
ICUs##12##1##(1991-2#1)(2007-11#4)(2008-8#1)(2010-11#1)(2012-2#4)(2013-8#1)
ICs and##3##2##(2008-8#3)
ICs bar##2##2##(2008-8#2)
ICs sensitive cells##2##3##(2008-8#2)
ICs##12##1##(2008-10#1)(2008-8#11)
ID and##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
ID##28##1##(1991-3#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-5#4)(2011-1#1)(2012-12#3)(2012-2#3)(2013-7#1)
ID(50) values##2##2##(2008-10#2)
ID-I##3##1##(1992-12#3)
ID1 activity and ID1 mRNA levels in##2##7##(1995-12#2)
ID1 activity and ID1 mRNA levels##3##6##(1995-12#3)
ID1 activity##5##2##(1995-12#5)
ID1 mRNA levels in female rats##2##6##(1995-12#2)
ID1 mRNA levels in##5##4##(1995-12#5)
ID1 mRNA levels##8##3##(1995-12#8)
ID1##13##1##(1995-12#13)
ID50 =##2##2##(1994-6#2)
ID50 of##2##2##(1992-2#1)(1996-2#1)
ID50##7##1##(1991-12#1)(1992-2#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-2#1)
IDA##5##1##(1990-8#1)(2008-10#3)(2008-2#1)
IDAVS##3##1##(1996-9#3)
IDB##2##1##(2013-8#2)
IDC##4##1##(1997-3#3)(2012-12#1)
IDDM patients and##2##3##(1990-5#1)(1996-12#1)
IDDM patients##3##2##(1990-5#1)(1996-12#2)
IDDM##12##1##(1990-11#1)(1990-5#1)(1992-5#1)(1994-12#2)(1995-3#3)(1996-12#3)(2007-5#1)
IDDS##6##1##(2008-7#6)
IDET##2##1##(2008-8#2)
IDH has##2##2##(2008-9#1)(2012-5#1)
IDH##8##1##(2008-9#5)(2012-5#3)
IDHR research##4##2##(2008-10#4)
IDHR##8##1##(2008-10#8)
IDL##2##1##(1994-8#1)(2008-10#1)
IDO induction by IFN-gamma at the transcriptional level##2##8##(2008-11#2)
IDO mRNA##2##2##(1992-11#1)(2008-11#1)
IDO##11##1##(1992-11#4)(2008-11#7)
IDP##3##1##(2008-7#3)
IDU##6##1##(2008-1#1)(2008-5#1)(2012-1#4)
IDUs were##2##2##(2007-7#2)
IDUs##3##1##(2007-7#3)
IDs##3##1##(1991-5#1)(2008-11#1)(2012-12#1)
IE and SSE##2##3##(2013-1#2)
IE and##4##2##(1993-1#1)(2011-2#1)(2013-1#2)
IE##18##1##(1993-1#1)(1995-12#1)(2006-6#2)(2008-4#1)(2008-6#3)(2011-2#4)(2013-1#6)
IE/I for##2##2##(1997-2#2)
IE1##5##1##(1993-8#5)
IE11##2##1##(2008-10#2)
IE86 protein##5##2##(2008-9#5)
IE86##7##1##(2008-9#7)
IEC##5##1##(1994-5#2)(2008-10#2)(2008-9#1)
IECs directly to enhance the secretion of##2##7##(2008-11#2)
IECs##11##1##(2008-11#11)
IED##3##1##(2011-2#3)
IED-IR criteria##3##2##(2011-2#3)
IED-IR##5##1##(2011-2#5)
IEEE##3##1##(2008-2#1)(2008-6#1)(2011-1#1)
IEF SSP 9502##2##3##(1994-12#2)
IEF##7##1##(1993-8#1)(1994-12#2)(2008-11#1)(2008-4#3)
IEGs##2##1##(1995-12#1)(1996-12#1)
IEM##5##1##(2008-11#5)
IENFs were##5##2##(2013-8#5)
IENFs##9##1##(2013-8#9)
IEP##2##1##(1992-12#1)(2008-7#1)
IES##5##1##(2008-1#2)(2012-3#3)
IES-R-Gr##2##1##(2010-2#2)
IF##7##1##(1990-11#5)(2008-8#2)
IF-Cbl##2##1##(1990-11#2)
IF-RT was##2##2##(2011-2#2)
IF-RT##4##1##(2011-2#4)
IF1 binding##2##2##(1991-5#2)
IF1##4##1##(1991-5#4)
IF2 alpha##2##2##(1991-12#2)
IF2 beta and##2##3##(1991-12#2)
IF2 beta was##2##3##(1991-12#2)
IF2 beta##8##2##(1991-12#8)
IF2 beta'##2##2##(1991-12#2)
IF2##14##1##(1991-12#13)(1991-5#1)
IFA##3##1##(2007-2#1)(2008-9#1)(2013-8#1)
IFADIC##3##1##(2008-6#3)
IFAT##2##1##(1991-5#1)(1996-8#1)
IFETS##2##1##(1996-12#2)
IFM##2##1##(2008-9#2)
IFN activity was##2##3##(1993-2#2)
IFN alpha##2##2##(1992-2#2)
IFN and##2##2##(1995-12#1)(2008-11#1)
IFN gamma##9##2##(1992-2#1)(1993-3#5)(1994-12#1)(1995-5#1)(1996-2#1)
IFN molecule##2##2##(1995-12#2)
IFN was##3##2##(1992-2#1)(2008-11#1)(2008-5#1)
IFN##45##1##(1992-2#7)(1993-2#3)(1993-3#5)(1994-12#1)(1995-12#3)(1995-5#1)(1996-2#3)(2007-11#4)(2008-11#7)(2008-4#2)(2008-5#1)(2009-8#7)(2013-7#1)
IFN-alpha activity##3##2##(1993-2#3)
IFN-alpha associated side effects##2##4##(2009-7#2)
IFN-alpha associated##3##2##(2009-7#3)
IFN-alpha subtypes##2##2##(1995-12#2)
IFN-alpha##12##1##(1990-5#1)(1993-2#4)(1995-12#2)(1996-2#1)(2009-5#1)(2009-7#3)
IFN-beta##9##1##(1990-5#2)(1995-12#2)(2007-11#2)(2008-11#3)
IFN-gamma and##2##2##(2008-11#1)(2010-12#1)
IFN-gamma at##3##2##(1993-9#1)(2008-11#2)
IFN-gamma glycosylation efficiency##2##3##(2008-7#2)
IFN-gamma in##3##2##(1994-8#1)(1994-9#1)(2008-11#1)
IFN-gamma on##3##2##(1993-12#1)(1993-9#1)(2008-8#1)
IFN-gamma production from##2##3##(2008-11#1)(2008-4#1)
IFN-gamma production##9##2##(1996-12#1)(2008-11#6)(2008-4#2)
IFN-gamma secretion by##2##3##(2008-11#2)
IFN-gamma secretion from##2##3##(2008-10#1)(2008-11#1)
IFN-gamma secretion##5##2##(2008-10#2)(2008-11#3)
IFN-gamma than##3##2##(1993-12#1)(1994-6#1)(1996-12#1)
IFN-gamma was##2##2##(2008-7#1)(2010-12#1)
IFN-gamma##83##1##(1992-12#5)(1993-12#5)(1993-9#6)(1994-6#1)(1994-8#1)(1994-9#3)(1996-12#9)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#26)(2008-3#1)(2008-4#3)(2008-7#5)(2008-8#4)(2009-12#2)(2010-12#5)(2013-8#1)
IFN-gamma-based tests appear##2##3##(2010-5#2)
IFN-gamma-based tests##4##2##(2010-5#4)
IFN-gamma/LPS##5##1##(2008-8#5)
IFN-induced antiviral activity##2##3##(2008-4#2)
IFN-omega##2##1##(1995-12#2)
IFN-tau has##2##2##(2007-11#2)
IFN-tau##9##1##(2007-11#9)
IFN-β##7##1##(2011-1#7)
IFN-γ gene##2##2##(2011-1#2)
IFN-γ pathway##2##2##(2012-2#2)
IFN-γ production##4##2##(2011-2#2)(2012-2#1)(2013-1#1)
IFN-γ##20##1##(2010-11#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-2#4)(2013-1#3)
IFNalpha lozenges##2##2##(2007-11#2)
IFNalpha treatment##2##2##(2007-11#2)
IFNalpha##18##1##(2007-11#18)
IFNgamma and##3##2##(2008-10#2)(2010-12#1)
IFNgamma##10##1##(2008-10#8)(2008-9#1)(2010-12#1)
IFNgamma-producing CD4(+) T-lymphocytes##2##3##(2008-10#2)
IFNgamma-producing##3##1##(2008-10#3)
IFNγ signaling and##2##3##(2011-2#2)
IFNγ##5##1##(2011-2#5)
IFNγ-induced##2##1##(2011-2#2)
IFNγ-inducible genes##3##2##(2011-2#3)
IFO##5##1##(1993-12#2)(2008-6#3)
IFPU/g glucan##2##2##(2008-6#2)
IFS 120M##2##2##(2008-2#1)(2008-3#1)
IFS##3##1##(2008-2#2)(2008-3#1)
IFSCC##3##1##(2008-5#3)
IFSP process##3##2##(1991-12#3)
IFX##5##1##(2010-12#5)
IG##2##1##(1991-9#1)(2010-4#1)
IGBP##4##1##(1996-12#3)(2013-8#1)
IGEs##4##1##(2008-8#4)
IGF I##3##2##(1996-5#1)(2008-8#1)(2010-3#1)
IGF II##2##2##(2008-8#2)
IGF action##2##2##(2008-4#2)
IGF actions##2##2##(2008-5#1)(2011-1#1)
IGF activity##2##2##(2008-4#1)(2008-5#1)
IGF and##2##2##(2008-4#1)(2008-5#1)
IGF binding proteins##2##3##(2008-11#1)(2008-5#1)
IGF binding##5##2##(1992-4#1)(2008-11#3)(2008-5#1)
IGF bioavailability##2##2##(2008-4#2)
IGF receptors##3##2##(2008-4#1)(2008-6#2)
IGF system##2##2##(1994-6#1)(2008-5#1)
IGF##34##1##(1992-4#1)(1993-9#1)(1994-6#1)(1996-5#1)(2008-11#5)(2008-4#8)(2008-5#6)(2008-6#3)(2008-8#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)
IGF-1 receptor##3##2##(1994-11#1)(1995-11#1)(2010-11#1)
IGF-1 serum levels##2##3##(2009-2#2)
IGF-1 stimulated##2##2##(1992-12#1)(1994-11#1)
IGF-1##28##1##(1990-12#1)(1992-12#2)(1994-11#10)(1995-11#1)(1996-2#1)(2008-3#1)(2008-9#5)(2009-2#4)(2010-11#1)(2011-1#1)(2012-2#1)
IGF-1-stimulation##2##1##(2009-2#2)
IGF-1R expression and##2##3##(2010-11#2)
IGF-1R expression##3##2##(2010-11#3)
IGF-1R##5##1##(2010-11#4)(2012-2#1)
IGF-2##3##1##(2010-11#3)
IGF-I a##2##2##(2010-5#2)
IGF-I action##2##2##(1991-5#1)(1993-8#1)
IGF-I and IGF-I receptor##2##4##(1996-2#2)
IGF-I and IGFBP-3##4##3##(2008-5#1)(2011-1#2)(2013-1#1)
IGF-I and TGF-alpha##3##3##(1992-9#3)
IGF-I and##15##2##(1992-9#3)(1993-9#1)(1996-2#3)(1997-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-1#2)(2013-1#1)
IGF-I binding##2##2##(1993-6#1)(2008-11#1)
IGF-I gene expression##5##3##(1992-9#1)(2008-9#2)(2010-8#2)
IGF-I gene##9##2##(1992-9#4)(2008-11#1)(2008-9#2)(2010-8#2)
IGF-I has been##2##3##(2008-11#1)(2013-1#1)
IGF-I in the##2##3##(1995-12#1)(2010-5#1)
IGF-I in##3##2##(1994-2#1)(1995-12#1)(2010-5#1)
IGF-I is##2##2##(1991-5#1)(1993-9#1)
IGF-I levels with##2##3##(2008-5#2)
IGF-I levels##6##2##(2007-7#1)(2008-5#2)(2012-3#1)(2013-1#2)
IGF-I mRNA expression##2##3##(1996-2#1)(2008-8#1)
IGF-I mRNA level##2##3##(2010-5#1)(2010-8#1)
IGF-I mRNA transcripts##2##3##(1994-2#2)
IGF-I mRNA##13##2##(1994-2#3)(1995-12#1)(1996-2#2)(2008-8#1)(2008-9#3)(2010-5#2)(2010-8#1)
IGF-I may be involved in##2##5##(2008-8#2)
IGF-I or##2##2##(1993-6#1)(2008-11#1)
IGF-I receptor and##3##3##(1993-9#1)(1996-2#1)(2008-11#1)
IGF-I receptor mRNA and##2##4##(1996-2#2)
IGF-I receptor##15##2##(1991-5#2)(1993-6#1)(1993-9#2)(1996-2#5)(1997-1#1)(2008-11#2)(2008-4#1)(2008-5#1)
IGF-I receptors##4##2##(1991-5#2)(1996-2#2)
IGF-I stimulated LHR##2##3##(2008-8#2)
IGF-I stimulated##3##2##(1997-1#1)(2008-8#2)
IGF-I was##2##2##(2008-6#1)(2008-8#1)
IGF-I with##2##2##(1991-5#1)(1993-8#1)
IGF-I##150##1##(1990-12#1)(1991-12#1)(1991-5#9)(1992-3#3)(1992-4#1)(1992-9#11)(1993-6#8)(1993-8#3)(1993-9#4)(1994-2#6)(1995-12#3)(1996-2#15)(1997-1#6)(1997-7#1)(2007-7#3)(2008-11#15)(2008-4#1)(2008-5#6)(2008-6#4)(2008-8#8)(2008-9#6)(2010-5#11)(2010-8#5)(2011-1#6)(2012-3#6)(2013-1#7)
IGF-I-induced##2##1##(1993-9#1)(2008-6#1)
IGF-II and insulin##2##3##(1991-5#2)
IGF-II and##7##2##(1991-5#2)(2008-5#1)(2011-1#1)(2013-1#3)
IGF-II gene##4##2##(1990-11#2)(1992-9#2)
IGF-II in##2##2##(1992-9#1)(2008-11#1)
IGF-II levels##2##2##(1992-9#2)
IGF-II mRNA##2##2##(1990-11#1)(1992-9#1)
IGF-II##35##1##(1990-11#3)(1990-5#3)(1991-12#1)(1991-5#2)(1992-3#2)(1992-9#11)(2008-11#1)(2008-5#1)(2008-6#3)(2011-1#1)(2013-1#7)
IGF-II/M6P receptor mRNA##2##3##(1996-2#2)
IGF-II/M6P receptor##4##2##(1996-2#4)
IGF-II/M6P receptors and GH receptors##2##5##(1996-2#2)
IGF-II/M6P##6##1##(1996-2#6)
IGF-IR##7##1##(1993-9#1)(2008-8#6)
IGF-binding protein-2##2##2##(2008-8#2)
IGF-binding##5##1##(1993-8#1)(2008-8#2)(2011-1#1)(2013-1#1)
IGF/GH ratio and##2##3##(2012-3#2)
IGF2##2##1##(2010-4#2)
IGFBP##6##1##(1991-12#1)(2008-4#4)(2008-5#1)
IGFBP-2##3##1##(1993-2#2)(2008-8#1)
IGFBP-3 and##2##2##(1991-12#1)(2013-1#1)
IGFBP-3 levels were##2##3##(2013-1#2)
IGFBP-3 levels##3##2##(2011-1#1)(2013-1#2)
IGFBP-3##13##1##(1991-12#2)(2008-4#1)(2008-5#1)(2011-1#5)(2013-1#4)
IGFBP-4 in##2##2##(2011-1#2)
IGFBP-4 levels did not change##2##5##(2011-1#2)
IGFBP-4 levels##3##2##(2011-1#3)
IGFBP-4##8##1##(1992-4#1)(2011-1#7)
IGFBP-5##12##1##(1992-4#4)(1993-8#8)
IGFBP-6 gene##3##2##(1993-3#3)
IGFBP-6##5##1##(1992-4#2)(1993-3#3)
IGFBPs inhibit IGF##2##3##(2008-4#1)(2008-5#1)
IGFBPs##10##1##(1991-12#2)(2008-4#6)(2008-5#2)
IGFD##2##1##(2011-1#2)
IGFs are##2##2##(1993-9#1)(2008-6#1)
IGFs##7##1##(1993-9#1)(2008-4#4)(2008-5#1)(2008-6#1)
IGHD 1A##4##2##(2008-1#4)
IGHD##8##1##(2008-1#8)
IGS and##2##2##(2008-10#2)
IGS region##2##2##(2008-10#2)
IGS type##2##2##(2008-10#2)
IGS types and##2##3##(2008-10#2)
IGS types##3##2##(2008-10#3)
IGS##13##1##(2008-10#12)(2008-12#1)
IGSTK##4##1##(2009-12#4)
IGs##5##1##(2010-4#5)
IH##6##1##(1990-7#2)(1994-9#1)(2008-6#2)(2012-2#1)
IH901##7##1##(2008-11#7)
IHA##8##1##(1992-5#7)(1994-6#1)
IHC for##2##2##(2011-2#1)(2013-8#1)
IHC##9##1##(2008-4#2)(2009-8#1)(2011-2#2)(2013-8#4)
IHCO will##3##2##(1997-2#3)
IHCO##4##1##(1997-2#4)
IHCOs will##3##2##(1997-2#3)
IHCOs##4##1##(1997-2#4)
IHD and##3##2##(1995-12#3)
IHD cases##3##2##(2008-3#3)
IHD##18##1##(1995-12#3)(2008-3#13)(2012-3#2)
IHDA##4##1##(1992-10#4)
IHI##4##1##(1994-3#3)(2008-7#1)
IHM##4##1##(1997-3#2)(2013-8#2)
IHPM##3##1##(2010-12#3)
IHs##3##1##(2013-8#3)
II (12 isolates)##2##3##(2008-10#2)
II (ANG II)##2##3##(1991-5#1)(1994-11#1)
II (RUG-II)##2##2##(1991-2#1)(1994-12#1)
II (p &lt##5##3##(1997-7#1)(2010-1#2)(2013-8#2)
II -##6##2##(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
II B##4##2##(2008-11#3)(2009-10#1)
II DM##2##2##(2008-7#2)
II DNA##2##2##(1992-3#1)(1997-8#1)
II MHC molecules##3##3##(1991-2#1)(1993-3#1)(1993-6#1)
II MHC##9##2##(1991-2#1)(1993-3#6)(1993-6#1)(1995-11#1)
II Strains##2##2##(2008-10#2)
II alcoholism##2##2##(1994-2#2)
II alleles##4##2##(1997-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
II alpha and beta##2##4##(1993-6#1)(1995-6#1)
II alpha and##3##3##(1993-6#1)(1995-6#1)(1996-12#1)
II alpha##5##2##(1993-6#1)(1995-6#2)(1996-12#2)
II also##2##2##(1995-11#1)(1995-5#1)
II and III are##2##4##(2008-10#1)(2008-9#1)
II and III##21##3##(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#2)
II and III)##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
II and IV of##2##4##(1990-8#1)(1996-6#1)
II and IV##7##3##(1990-8#1)(1994-2#1)(1996-6#2)(1997-7#1)(2008-10#1)(2011-2#1)
II and##89##2##(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-7#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-6#3)(1997-5#1)(1997-7#3)(2006-6#2)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#3)
II antigen##5##2##(1993-6#4)(1995-12#1)
II antigens##6##2##(1991-8#1)(1993-6#1)(1995-12#1)(1997-8#2)(2008-4#1)
II are##8##2##(1991-12#1)(1992-11#1)(1993-12#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-7#1)
II as##2##2##(2008-10#1)(2008-11#1)
II binding in##2##3##(1990-11#1)(1995-12#1)
II binding to##3##3##(1991-9#1)(1995-12#2)
II binding##8##2##(1990-11#1)(1991-6#1)(1991-9#1)(1995-12#3)(1996-5#1)(2008-10#1)
II but##3##2##(1993-11#1)(1995-2#1)(2006-6#1)
II by##3##2##(1994-11#1)(1994-8#2)
II can##2##2##(1991-2#1)(2008-11#1)
II cancer##2##2##(1994-12#1)(1997-8#1)
II clinical##14##2##(1990-12#1)(1997-8#1)(2008-12#1)(2008-5#9)(2012-3#1)(2013-1#1)
II collagen##5##2##(1991-5#1)(1992-2#1)(2008-11#3)
II contained##2##2##(2008-10#2)
II could##2##2##(1993-11#1)(2008-11#1)
II crystal##2##2##(2008-2#1)(2008-8#1)
II data##3##2##(2008-2#2)(2008-5#1)
II diabetes mellitus and##2##4##(2008-7#2)
II diabetes mellitus##8##3##(1991-7#1)(1993-12#2)(1996-11#1)(2008-1#1)(2008-7#3)
II diabetes##15##2##(1990-5#1)(1991-7#1)(1993-12#2)(1994-2#1)(1995-8#1)(1996-11#2)(2008-1#1)(2008-4#1)(2008-7#4)(2010-11#1)
II diabetic##3##2##(1993-12#1)(2008-5#1)(2008-7#1)
II did not##3##3##(1994-11#1)(1995-11#1)(2011-2#1)
II disorders##2##2##(1993-12#1)(2012-3#1)
II exhibited##3##2##(1993-6#2)(1993-9#1)
II expression##3##2##(1996-5#1)(2008-5#1)(2008-9#1)
II for##5##2##(1993-6#2)(2008-3#2)(2012-3#1)
II from the##2##3##(1991-2#1)(2008-7#1)
II from##3##2##(1991-2#1)(1993-11#1)(2008-7#1)
II functional##2##2##(2008-8#1)(2010-8#1)
II gene##8##2##(1991-11#1)(1994-11#1)(1996-10#2)(1997-7#1)(2008-10#2)(2008-8#1)
II genes##7##2##(1996-5#1)(1997-2#1)(1997-8#3)(2008-10#2)
II has been##2##3##(1996-10#1)(1996-5#1)
II has##3##2##(1996-10#1)(1996-5#1)(2008-11#1)
II have been##2##3##(1991-2#1)(2008-2#1)
II hypertension##3##2##(2013-8#3)
II in the##7##3##(1994-3#1)(1995-12#3)(1996-5#1)(1997-2#1)(2008-10#1)
II in vivo##2##3##(1993-8#1)(1997-2#1)
II in##26##2##(1992-9#3)(1993-8#3)(1994-3#1)(1994-8#1)(1995-12#3)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#2)(2007-11#1)(2008-10#3)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
II included##3##2##(2007-8#2)(2008-10#1)
II inhibitor##5##2##(1994-6#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-5#1)
II is mainly##2##3##(1992-11#1)(1994-9#1)
II is the##2##3##(1991-5#1)(1996-6#1)
II is##19##2##(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-2#1)(2012-3#2)
II isolates were##2##3##(2008-10#2)
II isolates##6##2##(2008-10#6)
II levels##2##2##(1995-3#1)(2013-1#1)
II mRNA in##2##3##(1993-8#1)(1994-5#1)
II mRNA##4##2##(1991-12#1)(1993-8#1)(1994-5#1)(1996-5#1)
II malocclusion##3##2##(2013-1#3)
II may##2##2##(1990-12#1)(1994-3#1)
II mediated##2##2##(1992-9#1)(2008-1#1)
II molecules##11##2##(1990-5#1)(1991-2#1)(1994-11#2)(1995-12#1)(1995-5#2)(2008-4#2)(2008-5#1)(2008-8#1)
II of the##9##3##(1991-2#1)(1991-3#1)(1995-12#3)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
II of this article##3##4##(1996-1#1)(2010-3#1)(2012-3#1)
II of this##6##3##(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2010-3#1)(2012-3#1)
II of##22##2##(1990-5#1)(1991-2#1)(1991-3#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-12#3)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
II on##2##2##(1992-9#1)(1996-12#1)
II or##9##2##(1992-10#2)(1993-11#2)(1994-2#1)(1995-5#1)(2008-5#1)(2008-7#1)(2008-9#1)
II patients##2##2##(1991-4#1)(2009-10#1)
II phospholipase A2##2##3##(1994-11#1)(1995-12#1)
II plays a##2##3##(1990-5#1)(1992-9#1)
II received##2##2##(2006-6#1)(2007-8#1)
II receptor antagonists##4##3##(1991-5#1)(1995-11#1)(1995-12#1)(2008-10#1)
II receptor blockers##5##3##(1996-6#2)(2008-11#2)(2008-8#1)
II receptor##33##2##(1990-11#1)(1991-5#4)(1992-3#2)(1992-9#1)(1993-3#4)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#4)(1996-5#1)(1996-6#2)(1997-2#2)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)
II receptors##7##2##(1990-11#1)(1992-3#1)(1993-3#1)(1995-12#3)(2011-2#1)
II regulatory phosphorylation site##2##4##(1995-2#2)
II sIL-1R##3##2##(1995-2#3)
II showed##2##2##(1997-8#1)(2008-7#1)
II strains##6##2##(2008-10#6)
II studies##6##2##(1990-9#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-1#1)
II study of##5##3##(1993-2#1)(1995-10#1)(1995-9#1)(2008-7#1)(2013-1#1)
II study with##2##3##(1990-10#1)(2008-6#1)
II study##22##2##(1990-10#1)(1991-2#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-9#1)(2007-4#2)(2008-10#4)(2008-6#3)(2008-7#1)(2011-2#1)(2013-1#1)
II the##4##2##(1993-2#1)(1995-3#1)(2008-10#1)(2008-7#1)
II to##9##2##(1992-9#1)(1994-2#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
II trial of##3##3##(1990-2#1)(1992-10#1)(2008-5#1)
II trial##10##2##(1990-2#1)(1992-10#1)(2007-7#2)(2008-5#5)(2010-12#1)
II trials have##2##3##(2008-5#1)(2013-1#1)
II trials in##3##3##(2007-7#1)(2008-5#2)
II trials##11##2##(1990-10#1)(2007-7#2)(2008-5#7)(2013-1#1)
II was##15##2##(1991-12#2)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-8#2)(1994-1#1)(1994-11#1)(1995-8#1)(2008-10#1)(2012-12#1)(2013-1#1)
II were##7##2##(1991-12#1)(1992-12#1)(1997-2#1)(2011-2#2)(2013-1#2)
II which##7##2##(1991-12#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(2009-8#2)
II will##3##2##(1995-1#1)(1996-1#1)(1996-3#1)
II with##12##2##(1990-2#1)(1992-9#2)(1993-6#2)(1994-5#2)(1995-11#1)(1995-6#1)(2008-11#2)(2010-7#1)
II##1365##1##(1990-10#2)(1990-11#8)(1990-12#8)(1990-2#5)(1990-3#2)(1990-5#9)(1990-6#4)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#3)(1991-11#5)(1991-12#16)(1991-2#20)(1991-3#6)(1991-4#2)(1991-5#13)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#4)(1992-12#10)(1992-2#4)(1992-3#15)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#10)(1992-9#20)(1993-1#1)(1993-11#13)(1993-12#12)(1993-2#13)(1993-3#16)(1993-5#1)(1993-6#20)(1993-8#15)(1993-9#6)(1994-1#6)(1994-11#24)(1994-12#4)(1994-2#19)(1994-3#8)(1994-5#13)(1994-6#3)(1994-7#3)(1994-8#17)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#16)(1995-12#39)(1995-2#24)(1995-3#13)(1995-5#6)(1995-6#12)(1995-8#13)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#14)(1996-2#13)(1996-3#6)(1996-4#1)(1996-5#10)(1996-6#9)(1996-9#3)(1997-1#2)(1997-2#13)(1997-3#7)(1997-4#6)(1997-5#4)(1997-6#1)(1997-7#16)(1997-8#16)(1997-9#1)(2006-10#5)(2006-12#1)(2006-6#5)(2006-8#1)(2007-11#15)(2007-12#11)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#10)(2007-8#24)(2007-9#2)(2008-1#9)(2008-10#150)(2008-11#37)(2008-12#5)(2008-2#26)(2008-3#40)(2008-4#23)(2008-5#49)(2008-6#8)(2008-7#38)(2008-8#38)(2008-9#17)(2009-1#1)(2009-10#5)(2009-2#2)(2009-3#6)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#6)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#4)(2011-1#4)(2011-2#33)(2011-3#1)(2012-12#7)(2012-2#11)(2012-3#18)(2013-1#42)(2013-7#2)(2013-8#17)
II'##2##1##(1991-5#1)(2011-2#1)
II's##4##1##(1990-6#1)(1991-12#1)(1993-2#2)
II) and##10##2##(1992-8#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
II) in the##2##3##(1990-5#1)(2008-10#1)
II) in##4##2##(1990-5#1)(1996-5#1)(2008-10#2)
II) of##3##2##(2008-10#3)
II) was##4##2##(1991-5#1)(1995-6#1)(2008-7#1)(2011-2#1)
II) were##2##2##(1992-8#1)(2007-8#1)
II)##95##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-8#2)(1992-9#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#2)(2013-8#2)
II-III##2##1##(1991-5#1)(1995-2#1)
II-V##4##1##(1990-11#1)(2007-12#1)(2008-10#2)
II-induced##6##1##(1994-2#1)(1995-11#3)(1995-12#1)(2008-1#1)
II-stimulated##2##1##(1992-9#2)
II-transcribed genes##2##2##(1997-2#2)
II/III##13##1##(1992-3#2)(1997-2#1)(2007-10#1)(2007-2#1)(2008-5#4)(2012-2#1)(2012-3#2)(2013-1#1)
IIA fibres##2##2##(2011-2#2)
IIA##11##1##(1991-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#3)(2012-2#2)(2013-1#2)
IIB and IIC##2##3##(2012-2#2)
IIB promoter constructs##2##3##(1995-6#2)
IIB promoter##4##2##(1995-6#4)
IIB##14##1##(1995-6#5)(1997-6#1)(2008-6#1)(2008-8#2)(2010-4#2)(2011-1#1)(2012-2#2)
IIEF5 score##2##2##(2011-2#2)
IIEF5##3##1##(2011-2#3)
IIH##2##1##(2011-2#2)
III -##5##2##(2007-11#1)(2007-8#1)(2008-10#1)(2010-3#1)(2013-8#1)
III A and##2##3##(2009-10#2)
III A##3##2##(2009-10#2)(2013-8#1)
III B##6##2##(1991-11#1)(2007-12#1)(2009-10#1)(2010-3#1)(2012-3#1)(2013-8#1)
III and I##2##3##(2008-10#2)
III and IV##18##3##(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-10#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
III and V##2##3##(1993-12#1)(2011-2#1)
III and VI##2##3##(1993-12#2)
III and the##3##3##(1992-3#1)(1995-5#1)(2008-10#1)
III and##45##2##(1990-5#1)(1990-6#1)(1992-3#1)(1993-12#4)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#8)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2011-2#6)(2012-3#1)(2013-1#3)(2013-8#4)
III are##7##2##(1990-5#1)(1993-12#1)(2008-10#3)(2008-9#1)(2013-1#1)
III by##2##2##(1991-5#1)(2008-10#1)
III cases##2##2##(1997-8#1)(2008-7#1)
III clinical trials##4##3##(1994-11#1)(2008-11#1)(2008-4#1)(2008-5#1)
III clinical##7##2##(1994-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-11#1)(2011-3#1)
III compared to group I at 8 weeks (P&lt##2##9##(2009-3#2)
III compared to##3##3##(2009-3#2)(2012-2#1)
III contained##2##2##(2008-10#2)
III core##6##2##(1992-3#6)
III criteria##4##2##(1992-5#1)(2008-3#1)(2013-1#2)
III from##3##2##(1994-2#1)(1995-2#1)(2008-9#1)
III gene expression##3##3##(1995-12#3)
III in##9##2##(1994-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#2)
III is the##3##3##(1994-3#1)(1994-9#1)(1996-6#1)
III is##7##2##(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-6#1)(2008-10#2)
III isolates##3##2##(2007-12#2)(2008-10#1)
III of the##5##3##(1991-12#1)(1992-12#1)(1995-1#1)(1995-6#1)(1997-5#1)
III of##8##2##(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1995-1#1)(1995-6#1)(1997-5#1)(2008-10#1)
III on##2##2##(1994-12#1)(2008-7#1)
III or##2##2##(1992-9#1)(1995-2#1)
III patients##3##2##(1991-4#1)(1992-8#2)
III produced##2##2##(2008-10#1)(2008-7#1)
III region##4##2##(1997-6#1)(2008-4#3)
III stage##2##2##(2008-10#1)(2011-1#1)
III studies##5##2##(2008-5#3)(2008-8#1)(2012-2#1)
III to##6##2##(1991-5#1)(1991-8#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
III trial##15##2##(2007-12#1)(2008-5#7)(2008-8#3)(2010-12#2)(2012-12#1)(2013-1#1)
III trials for##2##3##(2008-5#2)
III trials##10##2##(2007-7#1)(2008-5#6)(2010-12#2)(2012-3#1)
III was##8##2##(1995-2#2)(1997-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
III which##2##2##(2008-8#1)(2009-8#1)
III with##4##2##(1994-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
III##538##1##(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#6)(1991-8#2)(1992-10#3)(1992-12#3)(1992-3#15)(1992-5#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#9)(1994-2#8)(1994-3#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#8)(1995-2#20)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#3)(1996-12#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#4)(1997-8#4)(2006-10#1)(2006-6#2)(2007-10#2)(2007-11#9)(2007-12#12)(2007-7#7)(2007-8#9)(2008-1#7)(2008-10#73)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#27)(2008-6#5)(2008-7#21)(2008-8#19)(2008-9#15)(2009-10#4)(2009-3#6)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#5)(2010-3#6)(2010-8#2)(2011-1#5)(2011-2#26)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#15)(2013-1#15)(2013-8#14)
III) and##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
III) are##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
III) were##2##2##(2008-10#1)(2008-7#1)
III)##31##1##(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-5#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2011-2#2)
III-IV##8##1##(1990-6#2)(1991-4#1)(1992-3#2)(2007-8#1)(2008-10#1)(2011-2#1)
III-V##4##1##(1996-12#1)(1996-9#1)(2008-2#1)(2011-2#1)
III/IV##3##1##(1993-1#1)(2008-4#1)(2011-2#1)
IIIA and##2##2##(1992-12#1)(2008-10#1)
IIIA##9##1##(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#2)(2008-10#2)(2013-8#1)
IIIB##7##1##(2008-10#3)(2008-12#1)(2010-6#1)(2013-8#2)
IIIC##9##1##(1995-12#1)(2011-2#5)(2013-8#3)
IIIa##10##1##(1991-11#1)(1991-2#1)(1993-11#2)(1994-7#1)(1997-7#2)(2007-11#1)(2011-3#2)
IIP particles and##3##3##(2008-10#3)
IIP particles##10##2##(2008-10#10)
IIP##12##1##(2008-10#10)(2009-11#2)
IIP-MF##3##1##(1993-5#3)
IIPs##4##1##(2008-10#4)
IIR and adaptive##2##3##(2010-8#2)
II]##9##1##(1991-11#1)(1993-2#1)(1993-9#1)(1994-9#1)(1997-4#1)(2008-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
IIa and IIb##2##3##(2008-8#2)
IIa and##3##2##(2008-8#2)(2013-1#1)
IIa##12##1##(1990-3#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-8#3)(2013-1#3)(2013-8#2)
IIb patients##2##2##(2008-8#2)
IIb##9##1##(1991-2#1)(1991-8#1)(2007-11#1)(2007-12#1)(2008-8#4)(2009-1#1)
IIb-IIIa##7##1##(1990-5#6)(2006-6#1)
IIb/IIIa inhibitors##4##2##(2008-3#3)(2008-5#1)
IIb/IIIa##8##1##(2008-3#5)(2008-5#1)(2008-8#1)(2009-12#1)
IIc##2##1##(2007-11#2)
IId##3##1##(2013-1#3)
IIdA20G1##2##1##(2013-1#2)
IJPs were##3##2##(1996-5#3)
IJPs##6##1##(1996-5#6)
IK(Ca) induced by##2##3##(1996-5#2)
IK(Ca)##4##1##(1996-5#4)
IK726##6##1##(2008-10#6)
IKDC 2000##2##2##(2013-1#2)
IKDC##9##1##(2012-2#1)(2013-1#8)
IKK##2##1##(2012-3#2)
IKV##2##1##(1996-5#2)
IL##16##1##(1995-11#1)(1996-2#1)(1996-5#2)(2008-10#9)(2008-11#2)(2008-5#1)
IL-1 alpha and cisplatin##2##4##(1993-8#2)
IL-1 alpha and##3##3##(1993-8#2)(1995-2#1)
IL-1 alpha##9##2##(1990-11#1)(1993-8#5)(1995-2#1)(1996-12#2)
IL-1 and TNF##2##3##(1994-3#1)(1995-5#1)
IL-1 and##6##2##(1994-3#2)(1994-6#2)(1995-5#1)(2008-8#1)
IL-1 beta Thr9Gly##2##3##(1993-8#2)
IL-1 beta and IL-6##2##4##(1995-12#2)
IL-1 beta and##4##3##(1994-11#1)(1995-12#3)
IL-1 beta mRNA##3##3##(1996-12#3)
IL-1 beta precursor##4##3##(1995-2#4)
IL-1 beta production by##2##4##(2007-2#2)
IL-1 beta production##3##3##(2007-2#3)
IL-1 beta system##3##3##(1996-12#3)
IL-1 beta##47##2##(1993-3#3)(1993-8#3)(1994-11#3)(1994-9#4)(1995-12#3)(1995-2#12)(1995-5#1)(1996-12#13)(2007-2#3)(2008-4#2)
IL-1 in##3##2##(1990-12#3)
IL-1 production##4##2##(1991-8#1)(1993-6#1)(1995-6#1)(2007-2#1)
IL-1 ra##2##2##(1995-12#2)
IL-1 receptor antagonist##3##3##(1995-2#2)(1996-12#1)
IL-1 receptor##8##2##(1995-2#6)(1996-12#2)
IL-1 receptors##3##2##(1995-2#3)
IL-1 was##2##2##(1990-12#2)
IL-1##118##1##(1990-11#5)(1990-12#17)(1990-5#4)(1991-12#3)(1991-8#1)(1992-2#1)(1992-3#1)(1993-3#3)(1993-6#1)(1993-8#9)(1994-11#3)(1994-3#2)(1994-6#2)(1994-9#4)(1995-12#5)(1995-2#22)(1995-5#2)(1995-6#2)(1996-12#20)(2007-11#1)(2007-2#5)(2008-4#2)(2008-5#1)(2008-8#1)(2010-6#1)
IL-10 (p &lt##2##3##(2010-12#1)(2012-2#1)
IL-10 and##6##2##(1993-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-3#2)
IL-10 effects##2##2##(1994-8#2)
IL-10 gene##4##2##(2008-11#1)(2011-1#1)(2012-12#2)
IL-10 have##3##2##(1993-8#1)(1996-12#1)(2012-12#1)
IL-10 in##6##2##(1996-12#3)(2008-11#1)(2011-1#1)(2012-12#1)
IL-10 is##2##2##(1993-8#1)(2011-3#1)
IL-10 production##4##2##(2008-11#4)
IL-10 was##3##2##(1993-8#1)(2008-10#1)(2010-12#1)
IL-10##58##1##(1993-8#7)(1994-8#4)(1995-12#1)(1995-5#1)(1996-12#7)(2008-10#5)(2008-11#7)(2008-12#1)(2008-9#2)(2010-12#4)(2011-1#5)(2011-2#1)(2011-3#5)(2012-12#6)(2012-2#1)(2013-1#1)
IL-11##2##1##(1996-2#2)
IL-12 and IFN-γ##2##3##(2011-2#2)
IL-12 and##3##2##(2008-11#1)(2011-2#2)
IL-12 for##2##2##(2008-4#2)
IL-12 in##3##2##(2008-10#1)(2011-2#2)
IL-12 p40 and p35 mRNA##4##5##(2008-8#4)
IL-12 p40##5##2##(2008-8#4)(2008-9#1)
IL-12 p40/p35 mRNA##3##3##(2008-8#3)
IL-12 secretion##2##2##(2008-11#2)
IL-12 to##3##2##(2008-11#2)(2008-4#1)
IL-12 was##2##2##(2008-11#1)(2008-4#1)
IL-12##45##1##(2008-10#5)(2008-11#14)(2008-4#6)(2008-8#13)(2008-9#1)(2011-2#6)
IL-12B##2##1##(2012-2#2)
IL-12p40##2##1##(2008-11#1)(2008-9#1)
IL-13##8##1##(1996-2#1)(2008-4#4)(2009-5#3)
IL-17 is##2##2##(2007-11#2)
IL-17##11##1##(2007-11#8)(2009-12#1)(2012-2#2)
IL-18 is##2##2##(2008-4#2)
IL-18 levels between cancer patients and controls##2##7##(2013-1#2)
IL-18 levels in##2##3##(2012-12#1)(2013-1#1)
IL-18 levels##5##2##(2012-12#1)(2013-1#4)
IL-18##15##1##(2008-4#9)(2012-12#1)(2013-1#5)
IL-1RI and IL-1Ra mRNAs##2##4##(1996-12#2)
IL-1RI##3##1##(1996-12#3)
IL-1alpha was##3##2##(2008-10#3)
IL-1alpha##5##1##(2008-10#4)(2008-5#1)
IL-1beta and IL-6##2##3##(2008-6#2)
IL-1beta##17##1##(1997-7#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2013-8#1)
IL-1ra (30 mg/kg i##4##4##(1992-3#4)
IL-1ra in##3##2##(2008-5#1)(2008-8#2)
IL-1ra##15##1##(1992-3#6)(1995-2#3)(2007-11#1)(2008-5#1)(2008-8#4)
IL-1β and##2##2##(2011-2#1)(2013-1#1)
IL-1β##5##1##(2010-11#1)(2011-2#1)(2013-1#3)
IL-2 and IL-1beta levels##2##4##(1997-7#2)
IL-2 and IL-4##7##3##(1992-5#1)(2008-11#6)
IL-2 and##14##2##(1990-2#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-12#1)(1997-7#2)(2008-11#6)(2008-8#1)
IL-2 dependent##2##2##(1991-12#1)(1993-6#1)
IL-2 immunotherapy##2##2##(1990-12#2)
IL-2 in##3##2##(1990-12#1)(1991-12#1)(2008-7#1)
IL-2 plasma levels##2##3##(2008-7#2)
IL-2 production in##2##3##(1990-2#2)
IL-2 production##6##2##(1990-2#3)(1991-12#1)(1994-5#1)(2008-5#1)
IL-2 protein##2##2##(1992-8#2)
IL-2 receptor##3##2##(1991-2#2)(1994-5#1)
IL-2 was##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
IL-2 were##2##2##(1990-2#1)(2008-7#1)
IL-2##103##1##(1990-12#6)(1990-2#9)(1991-12#8)(1991-2#2)(1991-6#8)(1992-12#3)(1992-5#3)(1992-8#6)(1993-6#3)(1993-8#2)(1994-11#5)(1994-12#1)(1994-5#6)(1995-12#2)(1995-5#1)(1997-4#1)(1997-7#2)(2008-10#3)(2008-11#12)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#6)(2008-9#2)
IL-23##3##1##(2012-12#1)(2012-2#2)
IL-28B##2##1##(2013-1#2)
IL-29##2##1##(2012-2#2)
IL-2R alpha mRNA##3##3##(1991-2#3)
IL-2SA##4##1##(2008-11#4)
IL-3 and##5##2##(1994-11#3)(1995-6#1)(2008-4#1)
IL-3 or##2##2##(1995-6#1)(2008-4#1)
IL-3 receptor##3##2##(1990-12#1)(1993-12#1)(1994-11#1)
IL-3##16##1##(1990-12#3)(1993-12#1)(1994-10#1)(1994-11#6)(1995-6#2)(2008-4#2)(2008-5#1)
IL-3R alpha##3##2##(1993-12#3)
IL-3R beta IL-3 and IL-3R beta c##2##7##(1994-11#2)
IL-3R beta IL-3##3##3##(1994-11#3)
IL-3R beta##6##2##(1994-11#6)
IL-3R##9##1##(1993-12#3)(1994-11#6)
IL-4 and IFN-gamma from##2##4##(2008-11#2)
IL-4 and IL-10##2##3##(2008-10#1)(2008-9#1)
IL-4 and##6##2##(1992-8#1)(2008-10#1)(2008-11#3)(2008-9#1)
IL-4 secretion from##2##3##(2008-10#1)(2008-11#1)
IL-4 to##2##2##(1992-8#1)(2008-11#1)
IL-4 was##2##2##(2008-10#1)(2008-7#1)
IL-4##53##1##(1992-5#3)(1992-8#2)(1995-12#1)(1995-5#1)(1996-12#6)(1996-2#1)(2007-2#1)(2008-10#5)(2008-11#13)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#6)(2009-5#3)(2010-12#5)(2012-1#1)(2013-8#1)
IL-5 (p##2##2##(2010-12#1)(2012-2#1)
IL-5 and IL-10##2##3##(2010-12#2)
IL-5 and##3##2##(1995-6#1)(2010-12#2)
IL-5 levels##2##2##(2008-1#1)(2010-12#1)
IL-5 receptor##4##2##(1990-12#2)(1995-6#1)(2012-3#1)
IL-5 to##2##2##(2008-4#2)
IL-5##34##1##(1990-12#5)(1994-11#1)(1995-5#1)(1995-6#5)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#6)(2009-12#1)(2010-12#5)(2010-5#2)(2012-2#2)(2012-3#1)
IL-6 and IL-10##3##3##(2008-11#1)(2011-3#2)
IL-6 and IL-8 levels##2##4##(1996-12#2)
IL-6 and##14##2##(1990-5#1)(1996-12#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#2)(2011-3#2)
IL-6 antisense oligonucleotides##3##3##(1995-2#3)
IL-6 are##2##2##(1995-12#1)(2008-4#1)
IL-6 gene expression in##2##4##(1995-12#2)
IL-6 gene##4##2##(1995-12#3)(1995-2#1)
IL-6 in##4##2##(1994-6#1)(2008-10#1)(2008-6#1)(2013-1#1)
IL-6 is##3##2##(1990-5#2)(2008-11#1)
IL-6 levels were##2##3##(1997-7#1)(2008-6#1)
IL-6 levels##6##2##(1997-7#1)(2008-6#1)(2011-2#3)(2013-1#1)
IL-6 mRNA##4##2##(1995-12#3)(2013-1#1)
IL-6 modulation##2##2##(2009-6#2)
IL-6 production##7##2##(2008-10#6)(2009-6#1)
IL-6 receptor (IL-6sR)##2##3##(2008-4#2)
IL-6 receptor##10##2##(1990-5#1)(1994-2#2)(1997-7#2)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
IL-6 subfamily##3##2##(1996-2#3)
IL-6 was##3##2##(1990-5#1)(1994-2#1)(2008-11#1)
IL-6 were##2##2##(1995-2#1)(2008-10#1)
IL-6##121##1##(1990-5#8)(1993-8#1)(1994-2#5)(1994-6#3)(1995-12#10)(1995-2#6)(1996-12#6)(1996-2#4)(1997-7#10)(2008-10#12)(2008-11#8)(2008-3#2)(2008-4#8)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#2)(2009-6#3)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#7)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)
IL-6) and##4##2##(2009-12#1)(2011-3#2)(2013-1#1)
IL-6-containing##2##1##(1990-5#1)(2008-4#1)
IL-6-dependent##4##1##(2008-11#2)(2008-4#1)(2009-4#1)
IL-7 gene expression##4##3##(1995-2#4)
IL-7 gene regulation and apoptosis induction##2##6##(1995-2#2)
IL-7 gene regulation##3##3##(1995-2#3)
IL-7 gene##10##2##(1995-2#10)
IL-7 mRNA expression##2##3##(1995-2#2)
IL-7##15##1##(1995-2#12)(2008-11#2)(2008-4#1)
IL-8 and##6##2##(1990-5#1)(2008-5#2)(2009-8#1)(2011-2#2)
IL-8 levels##4##2##(1996-12#3)(2008-10#1)
IL-8 production##2##2##(2008-10#2)
IL-8 receptors in##2##3##(1993-6#2)
IL-8##33##1##(1990-5#5)(1993-6#4)(1994-11#2)(1994-5#1)(1996-12#3)(2008-10#8)(2008-5#2)(2009-10#1)(2009-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
IL-8-mediated neutrophil chemotaxis##2##3##(1994-11#2)
IL-8-mediated##4##1##(1994-11#3)(2009-10#1)
IL-8/CXCL-8##2##1##(2012-1#2)
IL-9 and##2##2##(2008-4#1)(2011-2#1)
IL-9 receptor##2##2##(2008-4#1)(2011-2#1)
IL-9##11##1##(1996-2#1)(2008-4#5)(2011-2#5)
IL-beta##2##1##(2008-12#1)(2010-12#1)
IL10##2##1##(1997-9#1)(2012-12#1)
IL12##2##1##(2008-4#1)(2012-2#1)
IL13##2##1##(2009-5#2)
IL2 neurons##2##2##(1995-3#2)
IL2##7##1##(1990-8#2)(1991-5#1)(1995-3#2)(1996-2#1)(2012-2#1)
IL2-RS##2##1##(1991-5#2)
IL28B genetic variants and##2##4##(2012-2#2)
IL28B genotypes##2##2##(2012-2#2)
IL28B polymorphisms##4##2##(2012-12#4)
IL28B##13##1##(2012-12#5)(2012-2#8)
IL4 and IL5 genes##2##4##(2008-7#2)
IL4##10##1##(1993-2#4)(2008-7#5)(2008-9#1)
IL5##4##1##(2008-7#4)
IL6##4##1##(1996-2#1)(2006-6#1)(2008-11#1)(2009-10#1)
ILI##10##1##(2008-10#5)(2010-4#3)(2011-2#1)(2011-9#1)
ILITC##3##1##(2008-10#3)
ILL##5##1##(1992-2#2)(2008-3#3)
ILL1 and ILR1##2##3##(2008-7#2)
ILL1 and##3##2##(2008-7#3)
ILL1##4##1##(2008-7#4)
ILL3##2##1##(2008-7#2)
ILL6##2##1##(2008-7#2)
ILP##2##1##(2009-11#2)
ILR1##3##1##(2008-7#3)
ILR1-like family of##2##3##(2008-7#2)
ILR1-like family##3##2##(2008-7#3)
ILS##14##1##(2008-10#7)(2008-2#2)(2008-3#4)(2008-4#1)
ILSs##4##1##(2008-10#1)(2008-7#3)
ILUMAE##3##1##(2012-1#3)
ILV3##2##1##(1993-12#2)
ILs and##2##2##(2010-7#2)
ILs##6##1##(2008-10#2)(2010-7#4)
IM fields were treated with Co60##3##6##(2007-10#3)
IM fields were##4##3##(2007-10#4)
IM fields##8##2##(2007-10#8)
IM strain##2##2##(2012-3#2)
IM##20##1##(1995-1#1)(1995-2#2)(2007-10#8)(2007-2#1)(2008-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2012-3#3)
IM-9 cells##3##2##(1996-2#3)
IM-9 lymphoblasts##3##2##(1996-2#3)
IM-9##6##1##(1996-2#6)
IMA between##2##2##(2007-8#2)
IMA grafting##2##2##(2007-8#2)
IMA##10##1##(2007-8#7)(2009-10#3)
IMAC would be##2##3##(2012-3#2)
IMAC##5##1##(2012-3#5)
IMAC's##2##1##(2012-3#2)
IMAGE##3##1##(1992-3#1)(2009-5#1)(2010-5#1)
IMC##4##1##(2008-10#1)(2008-3#3)
IMC-3 and IMC-3-DDP cells##3##4##(2008-4#3)
IMC-3##4##1##(2008-4#4)
IMC-3-DDP##4##1##(2008-4#4)
IMCT##4##1##(2010-2#4)
IMD risk##2##2##(2007-12#2)
IMD##7##1##(2007-12#7)
IMD-C##3##1##(2008-11#3)
IMDM (1##2##2##(2008-11#2)
IMEPGA was##2##2##(2008-8#2)
IMEPGA##3##1##(2008-8#3)
IMG##3##1##(2008-3#3)
IMID##9##1##(2011-2#9)
IMMP methodology##2##2##(2008-8#2)
IMMP##10##1##(2008-11#3)(2008-8#7)
IMP dehydrogenase##4##2##(1990-10#1)(1992-8#1)(1993-8#1)(1994-11#1)
IMP##13##1##(1990-10#3)(1992-8#1)(1993-8#1)(1994-11#1)(1995-6#3)(1996-7#1)(2008-10#2)(2008-11#1)
IMPACT##4##1##(2008-10#2)(2008-11#1)(2009-9#1)
IMPLICATIONS FOR NURSING PRACTICE##2##4##(2013-1#2)
IMPLICATIONS##15##1##(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#10)
IMPORTANT##2##1##(2009-6#1)(2011-2#1)
IMR##2##1##(1990-12#1)(2013-1#1)
IMR-90 cells##2##2##(1997-1#2)
IMR-90 human fibroblasts##2##3##(1995-12#2)
IMR-90##5##1##(1995-12#3)(1997-1#2)
IMRT for##2##2##(2011-2#2)
IMRT##10##1##(2008-11#1)(2008-2#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
IMS are##2##2##(2008-10#2)
IMS instruments##2##2##(2008-10#1)(2010-9#1)
IMS peaks##2##2##(2008-10#2)
IMS response##3##2##(2008-10#3)
IMS was##2##2##(2008-10#2)
IMS##33##1##(1995-5#1)(2008-10#27)(2008-5#1)(2008-8#1)(2010-9#3)
IMT and##2##2##(2008-1#1)(2008-8#1)
IMT are##2##2##(2008-8#1)(2012-3#1)
IMT as surrogate endpoint##2##4##(2012-3#2)
IMT is##4##2##(2008-8#2)(2012-3#2)
IMT of##3##2##(2011-1#3)
IMT##33##1##(2008-1#1)(2008-3#4)(2008-8#8)(2011-1#4)(2011-2#3)(2012-3#10)(2013-1#3)
IMV##3##1##(1992-8#3)
IMx ELISA##2##2##(1992-6#2)
IMx##3##1##(1992-6#3)
IN A##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
IN BURNED PATIENTS##2##3##(1997-3#2)
IN THE##5##2##(2009-11#1)(2009-6#1)(2009-9#1)(2012-3#2)
IN THIS COLUMN##2##3##(2007-2#2)
IN Tg##10##2##(2008-8#1)(2008-9#9)
IN inhibitors##2##2##(2011-3#1)(2013-1#1)
IN isolate induced##2##3##(2008-10#2)
IN isolate##3##2##(2008-10#3)
IN p53 HAPLOINSUFFICIENT MICE##4##4##(2008-8#1)(2008-9#3)
IN p53##5##2##(2008-8#1)(2008-9#4)
IN##84##1##(1995-12#2)(1997-3#2)(2007-1#1)(2007-11#1)(2007-2#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-5#1)(2008-8#3)(2008-9#31)(2009-11#3)(2009-4#1)(2009-6#2)(2009-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#3)(2012-3#4)(2013-1#2)(2013-8#1)
IN937a##2##1##(2008-10#2)
IN937b##2##1##(2008-10#2)
INA##4##1##(2008-10#3)(2011-2#1)
INC##2##1##(2008-10#2)
IND and DON##2##3##(2008-10#2)
IND and##5##2##(2008-10#5)
IND for##2##2##(2008-10#1)(2008-5#1)
IND##16##1##(2008-10#14)(2008-5#2)
INDICATORS##2##1##(2008-9#2)
INF-gamma##2##1##(1993-12#1)(2007-2#1)
INF1##5##1##(2008-10#5)
INF1-nonproducing isolates##2##2##(2008-10#2)
INFLUENCES##2##1##(2010-4#1)(2012-12#1)
INH##10##1##(1996-11#1)(2008-1#1)(2008-10#5)(2008-7#3)
INH-resistant M##2##2##(2012-3#2)
INO1##2##1##(1996-6#2)
INR##4##1##(2008-8#1)(2010-8#1)(2013-8#2)
INR7##3##1##(2008-10#3)
INS##2##1##(2007-8#2)
INSERM##2##1##(2008-5#2)
INSURANCE##3##1##(2009-11#1)(2013-1#2)
INSV##5##1##(2008-10#5)
INTERSTITIAL##2##1##(1997-3#2)
INTERVENTION##3##1##(2008-5#1)(2012-2#2)
INTERVENTIONS##3##1##(2012-12#3)
INTRODUCTION##24##1##(2007-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-10#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-2#5)(2013-1#4)
IO##2##1##(2008-10#2)
IOFB were##2##2##(2009-12#2)
IOFB##5##1##(2009-12#5)
IOL##2##1##(2011-2#2)
IOM##3##1##(1990-11#1)(2007-12#1)(2010-3#1)
IOM's##2##1##(2008-1#1)(2011-2#1)
IOP and##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
IOP is##2##2##(2011-2#2)
IOP was##3##2##(2011-2#1)(2013-1#2)
IOP##20##1##(2008-2#2)(2008-3#2)(2009-7#1)(2011-2#8)(2013-1#7)
IOP's##2##1##(2008-2#2)
IOR##3##1##(2008-2#3)
IORT and WBI were##2##4##(2011-2#2)
IORT and WBI##3##3##(2011-2#3)
IORT##10##1##(2008-6#1)(2011-2#9)
IP##21##1##(1992-7#1)(2008-10#4)(2008-7#14)(2008-9#1)(2012-3#1)
IP(3)##5##1##(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#2)
IP-10/CXCL10##3##1##(2012-1#3)
IP-RPHPLC was##2##2##(2008-10#2)
IP-RPHPLC##3##1##(2008-10#3)
IP3 and##2##2##(2009-3#1)(2010-11#1)
IP3 formation was##2##3##(1990-12#1)(1993-1#1)
IP3 formation##5##2##(1990-12#2)(1993-1#2)(1993-6#1)
IP3 or##2##2##(1991-6#1)(1992-12#1)
IP3 production##2##2##(1991-12#1)(2008-8#1)
IP3 receptor##5##2##(1991-2#1)(1991-6#1)(1997-4#1)(2008-8#2)
IP3 receptor-operated##2##2##(2008-8#2)
IP3 was##2##2##(1991-12#1)(1992-9#1)
IP3##45##1##(1990-12#5)(1991-12#3)(1991-2#2)(1991-6#4)(1992-12#2)(1992-9#2)(1993-1#2)(1993-3#1)(1993-6#1)(1993-8#6)(1995-11#5)(1997-4#2)(2008-8#6)(2009-3#1)(2010-11#3)
IP3- and##3##2##(1991-6#1)(1996-5#2)
IP3-induced##2##1##(1993-8#1)(2010-11#1)
IP3R##5##1##(1997-4#5)
IP3ROC##2##1##(2008-8#2)
IP5 was##2##2##(1992-11#2)
IP5##10##1##(1992-11#10)
IP6##3##1##(2008-10#3)
IPA were##2##2##(2013-1#2)
IPA##14##1##(1994-3#1)(1997-3#4)(2011-2#5)(2013-1#4)
IPAs##5##1##(1994-3#3)(1997-3#2)
IPB##3##1##(2008-10#3)
IPC and##2##2##(2010-1#2)
IPC on##2##2##(2010-1#2)
IPC##11##1##(2008-12#1)(2010-1#5)(2013-7#4)(2013-8#1)
IPD CL##2##2##(2008-10#2)
IPD##7##1##(2008-10#3)(2008-7#4)
IPE as##2##2##(2008-11#2)
IPE experience##2##2##(2008-12#2)
IPE##9##1##(2008-11#5)(2008-12#4)
IPFF##2##1##(2013-1#2)
IPL-41 medium##3##2##(2008-11#3)
IPL-41##4##1##(2008-11#4)
IPM has##2##2##(2008-10#2)
IPM##10##1##(2007-12#1)(2008-10#9)
IPMCs cut from films oriented##2##5##(2010-4#2)
IPMCs##4##1##(2010-4#4)
IPMN##5##1##(2012-2#5)
IPO323##9##1##(2008-10#8)(2011-10#1)
IPO94269##3##1##(2008-10#3)
IPOPO##2##1##(2008-3#2)
IPS##4##1##(2006-5#1)(2008-10#1)(2013-1#2)
IPS4334##5##1##(2011-2#5)
IPSB##7##1##(1996-1#7)
IPSF activity at##2##3##(2008-11#2)
IPSF activity of ADH-I##2##4##(2008-11#2)
IPSF activity##5##2##(2008-11#5)
IPSF##8##1##(2008-11#8)
IPSP##2##1##(2007-12#1)(2011-2#1)
IPT##4##1##(2011-2#4)
IPTG##10##1##(1990-5#1)(1993-8#2)(1993-9#2)(1994-8#1)(1995-12#1)(1995-2#1)(2013-1#2)
IPTG-inducible promoter##2##2##(1994-12#1)(2009-3#1)
IPTS was##2##2##(2008-2#2)
IPTS##3##1##(2008-2#3)
IPV and##2##2##(2008-12#1)(2010-11#1)
IPV perpetration##3##2##(2009-5#2)(2010-11#1)
IPV vaccine##2##2##(1995-5#1)(2008-4#1)
IPV##21##1##(1995-5#4)(2008-12#5)(2008-4#1)(2009-5#2)(2010-11#5)(2011-2#2)(2012-12#1)(2013-1#1)
IPoC##4##1##(2013-7#4)
IQ and MeIQ##2##3##(2008-10#2)
IQ and##3##2##(2008-10#2)(2008-9#1)
IQ heritability##3##2##(1997-7#3)
IQ scores##2##2##(2007-8#1)(2010-9#1)
IQ##22##1##(1992-6#1)(1994-3#1)(1997-2#1)(1997-4#1)(1997-7#6)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
IQ)##2##1##(1997-4#1)(2009-12#1)
IQs##2##1##(1997-7#1)(2007-8#1)
IR absorbing area##2##3##(2007-12#2)
IR absorption spectroscopy##2##3##(2008-3#1)(2010-4#1)
IR absorption with##2##3##(2008-3#2)
IR absorption##6##2##(2007-11#1)(2008-3#4)(2010-4#1)
IR and##14##2##(1990-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
IR bands of##2##3##(1994-11#1)(2008-10#1)
IR camera##2##2##(2008-3#1)(2008-7#1)
IR development##2##2##(2013-1#1)(2013-8#1)
IR femtosecond laser##2##3##(2007-11#1)(2007-12#1)
IR gas cell##4##3##(2008-10#4)
IR has##2##2##(2008-2#1)(2013-1#1)
IR imagery##2##2##(2008-3#2)
IR images##4##2##(2007-11#1)(2008-7#3)
IR in##3##2##(1995-8#1)(2010-4#1)(2012-2#1)
IR laser beam##2##3##(2007-12#1)(2008-3#1)
IR laser##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
IR light##3##2##(2007-12#3)
IR pulses##2##2##(2007-11#2)
IR radiation##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
IR receptor##2##2##(2007-12#2)
IR receptors##5##2##(2007-12#5)
IR region##3##2##(2008-10#1)(2008-2#2)
IR signals##3##2##(1992-6#2)(2008-10#1)
IR source##2##2##(2008-2#2)
IR spectra##10##2##(1996-2#1)(2007-11#3)(2008-10#3)(2008-2#1)(2013-8#2)
IR spectral data##2##3##(2008-10#1)(2008-2#1)
IR spectral region##2##3##(2008-3#2)
IR spectral##6##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
IR spectroscopy##10##2##(1996-2#2)(2008-10#7)(2010-5#1)
IR spectrum##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
IR study##2##2##(1992-6#1)(2008-10#1)
IR systems##2##2##(2008-2#1)(2008-3#1)
IR was##3##2##(1992-9#1)(1995-8#1)(2013-8#1)
IR##218##1##(1990-5#4)(1991-12#1)(1992-6#4)(1992-9#2)(1994-11#1)(1995-8#5)(1996-2#5)(1996-5#1)(2007-11#18)(2007-12#23)(2008-10#48)(2008-11#2)(2008-2#19)(2008-3#36)(2008-5#4)(2008-6#1)(2008-7#7)(2010-2#1)(2010-4#3)(2010-5#2)(2011-1#1)(2011-2#4)(2012-2#5)(2012-5#1)(2013-1#7)(2013-8#13)
IR)##2##1##(2008-2#1)(2013-8#1)
IR- and##2##2##(2008-10#2)
IR-36)##2##1##(1997-4#2)
IR-ET##2##1##(1990-2#2)
IR-I##4##1##(2008-10#4)
IR-II##2##1##(2008-10#2)
IR64/Azucena and##2##2##(2008-10#2)
IR64/Azucena##3##1##(2008-10#3)
IRB is##2##2##(1992-3#1)(2009-4#1)
IRB members and##4##3##(2009-4#4)
IRB members##7##2##(2009-4#7)
IRB##18##1##(1992-3#1)(2009-4#17)
IRBP promoter activity is##2##4##(1994-9#2)
IRBs##3##1##(2009-4#3)
IRC-3##3##1##(2008-8#3)
IRC-8 GDH(+) strain##2##3##(2008-8#2)
IRCCS Policlinico##2##2##(1993-5#1)(1993-6#1)
IRE1##2##1##(2012-2#2)
IRE1A and IRE1B##2##3##(2012-2#2)
IRES activity##2##2##(2008-9#2)
IRES is##3##2##(2008-9#3)
IRES##9##1##(2008-10#1)(2008-11#1)(2008-9#7)
IRF-1##5##1##(1997-7#1)(2008-11#4)
IRF-2##3##1##(1995-12#3)
IRF-8 expression in melanoma cells##2##5##(2013-1#2)
IRF-8 expression##4##2##(2013-1#4)
IRF-8##7##1##(2013-1#7)
IRF-8(-/-)##2##1##(2013-1#2)
IRI concentrations##2##2##(1994-12#2)
IRI##8##1##(1991-2#1)(1994-12#6)(2012-3#1)
IRIS##11##1##(1992-2#1)(2009-7#1)(2010-5#7)(2012-2#2)
IRL 1620##2##2##(1995-12#2)
IRMs##3##1##(2008-10#3)
IRS and##2##2##(2008-12#1)(2008-3#1)
IRS##13##1##(1991-2#1)(1992-8#1)(1994-1#1)(1995-2#1)(1996-2#1)(2008-12#4)(2008-3#2)(2013-8#2)
IRS-1 and##4##2##(1992-10#2)(2008-6#2)
IRS-1 in##8##2##(1992-10#1)(1995-8#7)
IRS-1 was##4##2##(1992-10#2)(1997-6#1)(2008-6#1)
IRS-1##24##1##(1992-10#8)(1994-11#3)(1995-8#7)(1997-6#2)(2008-6#4)
IRS-2 were##2##2##(2008-6#2)
IRS-2##7##1##(1996-2#1)(2008-3#1)(2008-6#5)
IRS-I tyrosine phosphorylation##4##3##(1997-1#4)
IRS-I##15##1##(1997-1#15)
IRS-proteins provide##2##2##(1996-2#2)
IRS-proteins##5##1##(1996-2#5)
IRS-signalling##2##1##(1996-2#2)
IRS1 degradation##2##2##(2013-1#2)
IRS1##8##1##(2013-1#8)
IRSs##3##1##(2008-12#2)(2008-6#1)
IRT##2##1##(2009-12#1)(2013-8#1)
IRs##2##1##(2008-10#2)
IS and##2##2##(2008-10#1)(2008-7#1)
IS applications##3##2##(1996-1#3)
IS curricula##2##2##(1993-12#2)
IS development##2##2##(1993-12#1)(2008-10#1)
IS in##3##2##(2008-10#1)(2013-7#2)
IS susceptibility##2##2##(2012-3#2)
IS to##2##2##(2012-3#1)(2013-1#1)
IS was##2##2##(1990-6#2)
IS##43##1##(1990-6#4)(1993-12#4)(1993-3#1)(1994-12#1)(1995-8#2)(1996-1#6)(2008-10#8)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-6#1)(2012-3#7)(2012-5#1)(2013-1#2)(2013-7#2)
IS)##2##1##(2008-10#1)(2013-7#1)
IS-like elements##2##2##(1995-12#1)(1995-8#1)
IS10##3##1##(1990-5#3)
IS1112##4##1##(2008-10#4)
IS1356##2##1##(2008-10#2)
IS256 arm##2##2##(1993-12#2)
IS4##3##1##(1990-11#3)
IS50 elements##3##2##(1995-8#3)
IS50##4##1##(1995-8#4)
ISA##2##1##(2008-10#1)(2009-6#1)
ISAAC Phase##2##2##(2012-3#2)
ISAAC##3##1##(2011-1#1)(2012-3#2)
ISAV##4##1##(2009-6#4)
ISBN 0 19 854292##2##4##(1997-6#2)
ISBN 0##5##2##(1997-6#4)(2008-5#1)
ISBN##26##1##(1997-6#5)(2007-2#7)(2008-4#12)(2008-5#2)
ISC machinery##2##2##(2008-7#2)
ISC##11##1##(2008-10#1)(2008-11#7)(2008-7#3)
ISCN##2##1##(2008-9#2)
ISE in##2##2##(2008-10#2)
ISE is##2##2##(2008-10#1)(2010-5#1)
ISE membrane##2##2##(2008-10#2)
ISE membranes##2##2##(2008-10#2)
ISE##27##1##(2008-10#24)(2010-5#3)
ISEL##2##1##(1994-10#1)(2008-1#1)
ISEs and one##2##3##(2008-10#2)
ISEs based on##4##3##(2008-10#4)
ISEs for##2##2##(2008-10#2)
ISEs is##3##2##(2008-10#3)
ISEs were##2##2##(2008-10#2)
ISEs with##5##2##(2008-10#5)
ISEs##32##1##(2008-10#32)
ISFET sensors##2##2##(2008-10#2)
ISFET##5##1##(2008-10#5)
ISFETs with##2##2##(2008-10#2)
ISFETs##9##1##(2008-10#9)
ISFG##3##1##(2008-12#3)
ISG with Heterobasidion##2##3##(2010-10#2)
ISG##4##1##(2010-10#3)(2013-1#1)
ISG-75 gene##3##2##(2013-1#3)
ISG-75##4##1##(2013-1#4)
ISGs##7##1##(2010-10#7)
ISH signal##3##2##(2012-3#3)
ISH signals##2##2##(2008-9#1)(2012-3#1)
ISH##10##1##(1992-12#2)(1996-12#1)(2008-9#1)(2012-3#6)
ISI Web of Knowledge##2##4##(2013-1#2)
ISI##3##1##(2013-1#2)(2013-8#1)
ISIS 12449 or ISIS 2302##2##5##(2008-10#2)
ISIS 12449##3##2##(2008-10#3)
ISIS 2302##7##2##(2008-10#7)
ISIS 3082##2##2##(2008-10#2)
ISIS##13##1##(2008-10#13)
ISL3##5##1##(1995-8#5)
ISM1499##2##1##(1993-12#2)
ISMB 2003##3##2##(2008-7#3)
ISMB##4##1##(2008-7#4)
ISNT##2##1##(2008-4#2)
ISO 9001##2##2##(2010-9#2)
ISO gene##4##2##(1990-11#4)
ISO standards##2##2##(2011-2#1)(2013-1#1)
ISO##20##1##(1990-11#4)(2008-10#5)(2008-12#1)(2008-2#1)(2009-12#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#2)
ISO/IEC##2##1##(2008-11#1)(2011-2#1)
ISP sensor##2##2##(2008-10#2)
ISP##3##1##(2008-10#2)(2012-1#1)
ISPR##3##1##(2008-7#3)
ISR by Bacillus spp##3##4##(2008-10#3)
ISR by##5##2##(2008-10#5)
ISR elicited by Bacillus spp##2##5##(2008-10#2)
ISR elicited by##4##3##(2008-10#4)
ISR in##2##2##(2008-10#2)
ISR##21##1##(2008-10#18)(2008-3#1)(2010-11#2)
ISR398##2##1##(2008-10#2)
ISR8036##2##1##(2008-10#2)
ISS##2##1##(2007-7#1)(2012-2#1)
ISSCR##2##1##(2008-9#2)
ISSN is##2##2##(2008-5#2)
ISSN##6##1##(2008-5#6)
IT (information technology)##2##3##(1993-2#2)
IT and##3##2##(1995-2#2)(2008-11#1)
IT##24##1##(1993-2#4)(1995-2#5)(1996-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#4)(2010-8#1)(2011-2#1)(2012-3#1)
IT15 mRNA levels##2##3##(1995-5#2)
IT15##5##1##(1995-5#4)(1996-8#1)
ITA##11##1##(2007-8#9)(2008-5#1)(2010-8#1)
ITA1 and ITA3##3##3##(2008-10#3)
ITAs##3##1##(2007-8#1)(2010-8#2)
ITBN##3##1##(1997-4#3)
ITCZ for##2##2##(2008-1#2)
ITCZ was##2##2##(2008-1#2)
ITCZ##7##1##(2008-1#7)
ITFDE##5##1##(1993-12#5)
ITIES##3##1##(2008-10#3)
ITNF##3##1##(1990-7#3)
ITO nanoparticles##3##2##(2009-11#3)
ITO overlayers##2##2##(2008-2#2)
ITO##13##1##(2008-10#2)(2008-12#3)(2008-2#3)(2009-11#4)(2010-6#1)
ITO-TEOS-BSA-ChOx/HRP biosensor was##2##3##(2008-10#2)
ITO-TEOS-BSA-ChOx/HRP##4##1##(2008-10#4)
ITO-coated##2##1##(2008-10#1)(2009-11#1)
ITP##8##1##(1992-6#2)(1993-9#1)(2006-6#4)(2008-10#1)
ITPA variants##2##2##(2013-1#2)
ITS and LSU sequences##2##4##(2010-3#2)
ITS and##8##2##(2008-10#4)(2008-11#1)(2010-3#3)
ITS rDNA sequence analysis##2##4##(2008-10#1)(2008-11#1)
ITS region of##2##3##(2008-5#1)(2009-2#1)
ITS region with##2##3##(2008-10#2)
ITS region##17##2##(2008-10#14)(2008-5#1)(2009-2#1)(2010-3#1)
ITS regions##4##2##(2008-10#4)
ITS sequence data##2##3##(2008-10#2)
ITS sequence##6##2##(2008-10#6)
ITS sequences of##2##3##(2008-10#2)
ITS sequences##8##2##(2008-10#8)
ITS##65##1##(1991-2#1)(2008-10#54)(2008-11#3)(2008-5#1)(2009-2#1)(2010-3#5)
ITS-1 region##2##2##(2008-9#2)
ITS-1##3##1##(2008-10#1)(2008-9#2)
ITS1 alleles##2##2##(2008-10#2)
ITS1##12##1##(2008-10#9)(2008-12#1)(2010-10#1)(2012-2#1)
ITS1-5##2##1##(2008-10#2)
ITS2 and D2##2##3##(2007-12#2)
ITS2 and##4##2##(2007-12#2)(2008-10#1)(2008-12#1)
ITS2 regions##3##2##(2008-10#2)(2010-10#1)
ITS2 sequence analysis##2##3##(2008-10#2)
ITS2 sequence##3##2##(2008-10#3)
ITS2##15##1##(2007-12#2)(2008-10#11)(2008-12#1)(2010-10#1)
ITS2)##8##1##(2008-10#6)(2008-12#1)(2012-2#1)
ITT##2##1##(1993-12#1)(2012-3#1)
ITs were##2##2##(2008-10#2)
IU /day##2##2##(2011-1#2)
IU##18##1##(1990-12#1)(1991-11#1)(1992-2#1)(1993-2#2)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#4)(2013-7#2)
IU/L##2##1##(2011-2#2)
IU/d for##2##2##(2012-2#2)
IU/day##5##1##(1992-12#1)(1993-11#1)(2008-6#1)(2011-1#2)
IU/l##4##1##(1994-12#1)(2008-7#3)
IU/mL##7##1##(1993-1#1)(2008-6#2)(2011-1#1)(2012-3#1)(2013-1#2)
IU/ml##4##1##(1997-4#1)(2011-2#1)(2013-8#2)
IUBMB##4##1##(2012-3#4)
IUC adoption##2##2##(2013-1#2)
IUC use##2##2##(2013-1#2)
IUC##8##1##(2008-10#1)(2013-1#7)
IUD##4##1##(1993-12#3)(2013-1#1)
IUDs##7##1##(1991-2#1)(1993-12#4)(1994-9#1)(2011-2#1)
IUGR##3##1##(1995-8#1)(2011-2#1)(2012-2#1)
IUPAC detection##2##2##(2008-10#2)
IUPAC##7##1##(2008-10#6)(2008-11#1)
IUPHAR Congress in Munich##2##4##(2008-5#2)
IUPHAR##3##1##(2008-5#3)
IV -##2##2##(2007-11#2)
IV V compared to stage I and##2##7##(2011-2#2)
IV according to Graf classification) was##2##6##(2007-11#2)
IV administration of##2##3##(1997-8#1)(2012-2#1)
IV and V##3##3##(1996-5#1)(2008-10#1)(2011-3#1)
IV and V)##2##3##(2008-10#1)(2011-2#1)
IV and VII##3##3##(2008-5#3)
IV and the##3##3##(1990-2#1)(1993-8#1)(2008-1#1)
IV and##29##2##(1990-2#2)(1991-8#1)(1992-6#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
IV collagen##9##2##(1993-12#1)(1994-7#4)(1997-3#1)(2010-11#1)(2013-8#2)
IV contained##2##2##(2008-10#2)
IV cyclophosphamide##3##2##(2006-10#3)
IV drug use and##2##4##(1997-6#1)(2007-7#1)
IV drug use##3##3##(1995-12#1)(1997-6#1)(2007-7#1)
IV drug users##2##3##(1997-6#2)
IV drug##6##2##(1995-12#1)(1997-6#3)(2007-7#1)(2009-6#1)
IV has##2##2##(1995-1#1)(2008-8#1)
IV in##4##2##(1994-12#1)(1997-7#1)(2007-11#1)(2008-8#1)
IV inferior hip joint##2##4##(2008-12#2)
IV inhibitors in the treatment of##2##6##(2008-5#2)
IV inhibitors##6##2##(2008-5#5)(2012-3#1)
IV iron saccharate##3##3##(2008-1#3)
IV is##2##2##(1990-5#1)(1997-7#1)
IV of S##3##3##(1996-6#3)
IV of the##7##3##(1990-8#1)(1997-3#1)(2007-1#1)(2008-1#1)(2008-5#1)(2011-2#2)
IV of##13##2##(1990-8#1)(1995-2#1)(1996-3#1)(1996-6#3)(1997-3#1)(2007-1#1)(2008-1#2)(2008-5#1)(2011-2#2)
IV on##2##2##(1997-7#1)(2008-12#1)
IV or##3##2##(2007-12#1)(2008-5#1)(2012-3#1)
IV ovarian cancer##4##3##(1990-6#1)(2011-2#3)
IV ovarian##6##2##(1990-6#3)(2011-2#3)
IV was##6##2##(1990-12#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-5#1)(2008-8#1)
IV were##4##2##(1996-6#1)(2007-11#1)(2008-12#1)(2013-1#1)
IV##283##1##(1990-12#2)(1990-2#4)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-12#5)(1993-8#6)(1994-11#2)(1994-12#1)(1994-2#2)(1994-7#6)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-5#3)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#7)(1996-9#1)(1997-2#2)(1997-3#7)(1997-6#3)(1997-7#11)(1997-8#3)(2006-10#6)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-5#2)(2007-7#5)(2007-8#2)(2008-1#12)(2008-10#34)(2008-11#5)(2008-12#6)(2008-3#3)(2008-5#15)(2008-7#4)(2008-8#14)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#2)(2010-1#2)(2010-11#3)(2010-7#1)(2011-1#2)(2011-2#21)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#4)
IV) and##4##2##(2006-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
IV)##20##1##(1991-3#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-6#1)(2006-10#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
IV-V)##2##1##(1990-9#1)(2011-2#1)
IVA##4##1##(1996-5#1)(2009-6#3)
IVB and##5##2##(2011-2#5)
IVB##8##1##(2011-2#8)
IVB/IVT groups##4##2##(2011-2#4)
IVB/IVT##6##1##(2011-2#6)
IVC is##3##2##(1990-2#1)(2008-7#1)(2013-1#1)
IVC##22##1##(1990-10#2)(1990-2#4)(2007-7#1)(2008-7#4)(2011-2#8)(2013-1#3)
IVCP##5##1##(2007-7#5)
IVDUs and##2##2##(1992-9#2)
IVDUs##8##1##(1991-1#2)(1992-9#6)
IVF patients with##2##3##(1990-2#1)(2012-3#1)
IVF patients##4##2##(1990-2#3)(2012-3#1)
IVF##19##1##(1990-10#2)(1990-2#6)(1991-11#2)(1994-12#1)(1994-9#1)(2008-11#3)(2011-1#1)(2012-3#2)(2013-1#1)
IVF-ET##3##1##(1994-9#1)(2012-3#2)
IVF/ICSI##2##1##(2007-10#1)(2012-3#1)
IVH in##2##2##(2008-7#1)(2011-2#1)
IVH##12##1##(2007-10#2)(2008-7#6)(2011-2#4)
IVI method##2##2##(2008-11#2)
IVI##7##1##(2008-11#6)(2013-1#1)
IVIG has##3##2##(2007-12#3)
IVIG##7##1##(1991-3#1)(1996-3#2)(2007-12#4)
IVS1 -27AA##2##2##(2011-2#2)
IVS1##3##1##(2011-2#3)
IVT##2##1##(2011-2#2)
IVUS##2##1##(2007-8#2)
IW32 erythroleukemia##2##2##(1991-9#2)
IW32##4##1##(1991-9#4)
IWGH's##4##1##(2008-3#4)
IX alpha##3##2##(1990-8#2)(1994-5#1)
IX and X##4##3##(1995-2#1)(2008-7#3)
IX and the##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
IX and##11##2##(1993-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(2008-5#2)(2008-7#3)(2011-2#1)
IX in##6##2##(1993-8#2)(1995-6#1)(2008-9#2)(2012-3#1)
IX to##3##2##(1992-12#1)(1994-8#1)(2011-2#1)
IX was##2##2##(1991-5#1)(2011-2#1)
IX##94##1##(1990-5#5)(1990-8#3)(1991-12#1)(1991-5#4)(1992-12#4)(1992-8#1)(1993-8#7)(1994-5#1)(1994-8#1)(1995-12#5)(1995-2#4)(1995-6#4)(1995-8#1)(1995-9#1)(1996-3#3)(1996-5#1)(1996-8#1)(2007-11#2)(2008-10#1)(2008-11#4)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#12)(2009-2#2)(2010-3#1)(2011-2#8)(2012-2#1)(2012-3#2)
IX)##4##1##(2008-10#1)(2011-2#2)(2012-3#1)
IYCN##2##1##(2010-5#2)
IYSV##2##1##(2008-10#2)
IZS A&amp##2##2##(2010-4#2)
Ia mitochondrial##2##2##(2008-10#2)
Ia##13##1##(1991-2#1)(2006-6#3)(2007-8#1)(2008-10#6)(2008-4#1)(2011-1#1)
Ia)##2##1##(1995-5#1)(2011-1#1)
Ian##2##1##(2008-4#1)(2009-3#1)
Iatrogenic##5##1##(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)
Ib##10##1##(1991-2#1)(1993-3#1)(1994-11#2)(2008-10#2)(2008-3#1)(2008-4#1)(2011-3#2)
Ibacus##6##1##(2007-12#6)
Ibadan##6##1##(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#2)(2013-7#1)
Iball's indices##2##2##(1992-9#2)
Ibandronic acid##2##2##(2011-2#2)
Iberian##6##1##(2008-10#3)(2009-10#1)(2013-8#2)
Ibiá##2##1##(2008-5#2)
Ibogaine##3##1##(1991-1#1)(1996-10#1)(1997-2#1)
Ibsen##2##1##(1993-3#2)
Ibuprofen suppositories##2##2##(2012-12#2)
Ibuprofen##7##1##(1992-6#1)(2008-10#2)(2010-5#1)(2012-12#3)
Ice Age##2##2##(2008-1#1)(2008-8#1)
Ice##7##1##(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
Iceland##11##1##(1991-2#1)(1993-3#1)(2006-10#1)(2006-8#5)(2011-2#1)(2011-4#1)(2013-1#1)
Icelandic children##2##2##(2006-8#2)
Icelandic##12##1##(1990-6#1)(1993-3#1)(2006-10#3)(2006-8#3)(2007-10#1)(2010-8#2)(2011-2#1)
Ichneumonidae##2##1##(2007-12#1)(2008-5#1)
Ichneumonoidea)##2##1##(2008-5#2)
Ichthyophthirius multifiliis##2##2##(2010-4#2)
Ichthyosiform##2##1##(2007-7#1)(2010-6#1)
Id proteins##2##2##(2011-2#2)
Id##7##1##(1994-12#2)(1994-2#2)(2008-4#1)(2011-2#2)
Id-1 expression##2##2##(2008-8#2)
Id-1 was##2##2##(2008-8#2)
Id-1##14##1##(2008-8#14)
Id1##6##1##(1994-12#1)(2013-1#5)
Id3##2##1##(1994-12#2)
Id4##6##1##(2011-2#6)
Idaho##8##1##(1990-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-2#2)(2008-10#1)(2013-1#1)
Ideal##9##1##(1991-1#1)(1993-2#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)
Idealized##3##1##(1995-6#1)(2007-12#2)
Ideally##9##1##(1993-3#1)(1995-1#1)(1995-5#1)(1997-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)
Ideas and##3##2##(1991-1#1)(1994-3#1)(1995-3#1)
Ideas for##2##2##(2008-11#1)(2008-2#1)
Ideas##5##1##(1991-1#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-2#1)
Identical##9##1##(1991-6#1)(1993-12#1)(1994-11#1)(2008-10#2)(2008-7#2)(2009-3#2)
Identification System##2##2##(1995-2#1)(2008-10#1)
Identification and Characterization of##3##4##(2008-10#3)
Identification and Differentiation of##2##4##(2008-10#1)(2012-2#1)
Identification and Molecular Mapping of a Gene##2##7##(2008-10#2)
Identification and characterization of a novel##2##6##(1997-8#1)(2008-10#1)
Identification and characterization of a##4##5##(1992-3#1)(1997-8#1)(2008-10#2)
Identification and characterization of##9##4##(1990-11#1)(1992-3#1)(1993-12#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
Identification and classification##2##3##(2009-10#2)
Identification and cloning of##3##4##(1993-8#1)(1996-10#1)(2008-8#1)
Identification and initial characterization of##2##5##(1990-11#1)(1990-7#1)
Identification and partial characterization of##3##5##(1990-12#1)(1992-6#1)(1993-3#1)
Identification and partial##4##3##(1990-12#1)(1990-8#1)(1992-6#1)(1993-3#1)
Identification and quantification##2##3##(2008-10#1)(2009-7#1)
Identification and quantitation of##2##4##(1997-3#1)(2008-10#1)
Identification and structural##2##3##(1994-5#1)(2008-10#1)
Identification and##62##2##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-10#3)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
Identification of Molecular##2##3##(2008-10#2)
Identification of Two##2##3##(2008-10#1)(2011-2#1)
Identification of a new##3##4##(1997-7#1)(2008-10#2)
Identification of a novel##5##4##(1996-2#1)(2008-12#1)(2008-8#1)(2010-11#1)(2012-12#1)
Identification of a##34##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(1994-9#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
Identification of active##2##3##(1995-2#1)(2010-12#1)
Identification of an##7##3##(1992-8#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-10#1)(2012-12#1)(2012-3#1)
Identification of gene##2##3##(1997-3#1)(2010-10#1)
Identification of genes##2##3##(1995-6#1)(2008-10#1)
Identification of human##4##3##(1994-6#1)(1995-2#1)(2008-4#1)(2008-9#1)
Identification of material flow systems##2##5##(1997-6#1)(2008-11#1)
Identification of new##3##3##(1997-3#1)(2010-12#1)(2010-6#1)
Identification of novel##7##3##(1992-12#1)(1992-8#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-7#1)
Identification of patients##2##3##(2007-7#1)(2013-1#1)
Identification of proteins##2##3##(1997-2#1)(2008-1#1)
Identification of quantitative##2##3##(2008-10#2)
Identification of residues involved in##2##5##(1992-12#1)(2012-2#1)
Identification of some##2##3##(2008-10#2)
Identification of the DNA##2##4##(1991-5#1)(1997-7#1)
Identification of the genes##2##4##(2008-11#1)(2008-9#1)
Identification of the major##2##4##(1993-6#1)(2008-10#1)
Identification of the site of##2##5##(1994-5#2)
Identification of the##30##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-6#2)(1994-5#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#1)
Identification of three##3##3##(1991-6#1)(2008-11#1)(2010-4#1)
Identification of two##3##3##(1992-6#1)(1993-8#1)(1994-9#1)
Identification of##235##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1992-12#3)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-12#2)(1993-3#2)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#2)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#3)(2007-11#2)(2007-7#1)(2008-1#4)(2008-10#68)(2008-11#9)(2008-12#7)(2008-2#2)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#6)(2009-2#1)(2009-4#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#3)(2010-6#1)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Identified in##2##2##(2009-12#1)(2010-5#1)
Identified risk factors include##2##4##(2007-7#1)(2008-7#1)
Identified##12##1##(1994-3#1)(1995-2#1)(1996-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-12#1)(2010-11#1)(2010-5#1)
Identifier##2##1##(1992-11#1)(2011-2#1)
Identifies Genes##2##2##(2008-10#1)(2012-3#1)
Identifies##5##1##(2008-10#3)(2012-3#2)
Identifiler##3##1##(2008-12#3)
Identify##6##1##(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
Identifying and##9##2##(1995-12#1)(1996-12#1)(1997-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#1)
Identifying new##2##2##(1997-1#1)(2010-3#1)
Identifying protein##2##2##(2008-4#2)
Identifying the##8##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
Identifying##46##1##(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#2)(1996-12#1)(1997-1#2)(1997-2#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
Identities##2##1##(1991-12#1)(2010-7#1)
Identity##8##1##(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
Idiopathic granulomatous##2##2##(1997-8#1)(2008-7#1)
Idiopathic hypertrophic cranial pachymenigitis##2##4##(2012-2#2)
Idiopathic hypertrophic##3##2##(2010-12#1)(2012-2#2)
Idiopathic pulmonary fibrosis##2##3##(2010-5#2)
Idiopathic##21##1##(1992-5#1)(1996-6#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-7#5)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
Idiosyncratic reactions can be##2##4##(1990-3#1)(2008-8#1)
Ieaf curl##2##2##(2008-8#2)
If EDTA-bound Fe(III) is##2##4##(2008-10#2)
If a country were##2##4##(1992-12#2)
If a##21##2##(1992-12#2)(1992-6#1)(1993-12#1)(1994-2#2)(1996-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
If an##4##2##(1996-2#1)(2007-6#1)(2007-8#1)(2010-8#1)
If both##2##2##(1992-2#1)(2008-5#1)
If current##2##2##(1993-3#1)(2013-8#1)
If either##2##2##(1994-2#1)(1995-4#1)
If it were##2##3##(1993-2#1)(2013-1#1)
If it##5##2##(1993-2#1)(1995-1#1)(1997-3#1)(2009-6#1)(2013-1#1)
If left untreated##2##3##(2012-3#1)(2013-8#1)
If no##3##2##(1997-3#1)(2008-5#1)(2008-6#1)
If not##3##2##(2008-11#1)(2010-8#1)(2012-2#1)
If our##2##2##(1993-11#1)(1997-6#1)
If quality##2##2##(1993-12#1)(1995-3#1)
If so##4##2##(1990-5#1)(2008-3#1)(2009-4#1)(2009-8#1)
If the concentration of##2##4##(1992-4#1)(2008-10#1)
If the frequency of encounters##2##5##(2008-8#2)
If the patient##3##3##(1995-5#1)(2007-8#1)(2008-1#1)
If the sample##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
If the samples##2##3##(2008-10#1)(2008-2#1)
If the two##4##3##(1991-9#1)(2008-10#2)(2008-4#1)
If the##121##2##(1990-11#2)(1990-2#1)(1990-6#5)(1990-8#1)(1991-12#1)(1991-3#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-2#7)(2008-3#5)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-1#1)(2009-3#2)(2009-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#6)(2013-1#3)
If there is a##5##4##(1991-7#1)(1994-1#1)(1996-2#1)(2008-10#1)(2008-7#1)
If there is no##2##4##(1990-6#1)(2008-9#1)
If there is##10##3##(1990-6#1)(1991-7#1)(1994-1#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
If there##12##2##(1990-6#1)(1991-7#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
If these##9##2##(1990-7#1)(1993-12#1)(1994-1#1)(1996-1#1)(2008-3#1)(2008-9#2)(2011-2#1)(2013-8#1)
If they##2##2##(1996-3#1)(2008-7#1)
If this is the case##3##5##(1997-5#1)(2008-1#1)(2008-10#1)
If this is##8##3##(1996-4#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-1#1)
If this##14##2##(1994-6#1)(1996-4#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
If used##2##2##(1993-12#1)(1995-12#1)
If we wish to##2##4##(1994-1#1)(1997-8#1)
If we##10##2##(1992-3#1)(1993-12#1)(1994-1#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
If you are##2##3##(1995-2#1)(2008-2#1)
If you##5##2##(1991-3#1)(1995-2#2)(2008-11#1)(2008-2#1)
If your facility##2##3##(2011-2#2)
If your##3##2##(1996-1#1)(2011-2#2)
If##393##1##(1990-11#2)(1990-2#3)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#5)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#8)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#4)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#5)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#2)(2006-12#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#30)(2008-11#9)(2008-12#2)(2008-2#14)(2008-3#15)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#20)(2008-9#19)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#4)(2009-4#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-6#3)(2010-8#6)(2010-9#2)(2011-1#4)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#9)(2013-8#4)
Ifosfamide##3##1##(2008-6#3)
Ifosfamide-based##2##1##(2008-6#2)
Ifremeria nautilei##2##2##(2008-6#2)
Ig production##2##2##(1994-2#2)
Ig##17##1##(1990-12#7)(1994-11#1)(1994-2#2)(1994-9#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#2)
Ig-CAMs##2##1##(2009-8#2)
Ig3 domain##2##2##(2009-7#2)
IgA and IgM##2##3##(1990-12#1)(2007-10#1)
IgA and##4##2##(1990-12#1)(1995-6#1)(2007-10#1)(2012-2#1)
IgA antibodies in##2##3##(2008-7#1)(2011-2#1)
IgA antibodies##6##2##(1990-2#2)(1994-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
IgA antibody##4##2##(1991-9#1)(2007-10#2)(2008-10#1)
IgA concentration##3##2##(1991-2#1)(2008-11#2)
IgA deficiency and##2##3##(1991-11#1)(2007-2#1)
IgA deficiency##3##2##(1991-11#1)(1996-11#1)(2007-2#1)
IgA hybridoma cell##2##3##(1994-2#2)
IgA hybridoma##3##2##(1994-2#3)
IgA hybridomas##2##2##(1994-2#2)
IgA immune response##3##3##(2008-10#2)(2011-2#1)
IgA in##6##2##(1990-12#1)(1993-2#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-7#1)
IgA levels##2##2##(1991-12#1)(2013-1#1)
IgA nephropathy (IgAN)##4##3##(2008-1#3)(2009-6#1)
IgA nephropathy was##3##3##(2007-7#1)(2008-1#2)
IgA nephropathy##13##2##(2007-7#3)(2008-1#6)(2008-4#1)(2009-6#2)(2013-8#1)
IgA production##8##2##(1994-2#1)(2008-11#6)(2013-1#1)
IgA response##3##2##(2008-11#3)
IgA secretion##3##2##(2008-11#2)(2013-8#1)
IgA##110##1##(1990-12#6)(1990-2#3)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-9#1)(1992-8#2)(1993-2#1)(1994-2#7)(1994-8#7)(1995-6#1)(1996-11#2)(1996-12#5)(2007-10#5)(2007-2#1)(2007-7#3)(2008-1#9)(2008-10#9)(2008-11#17)(2008-4#2)(2008-7#2)(2009-6#2)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#5)(2013-8#4)
IgA)##2##1##(2008-4#1)(2013-8#1)
IgAN##8##1##(2008-1#1)(2008-8#6)(2009-6#1)
IgD##4##1##(1993-8#1)(1993-9#3)
IgE and##9##2##(2008-11#4)(2009-5#3)(2010-5#1)(2012-3#1)
IgE antibodies##2##2##(2010-5#1)(2013-1#1)
IgE antibody in##2##3##(2008-10#2)
IgE antibody##7##2##(2008-10#5)(2013-1#2)
IgE detection##2##2##(2008-10#2)
IgE in##5##2##(1990-12#2)(2008-10#2)(2008-11#1)
IgE is##2##2##(2007-11#2)
IgE levels##2##2##(1990-12#1)(2008-10#1)
IgE production in##2##3##(2008-11#2)
IgE production##8##2##(2008-10#1)(2008-11#6)(2008-4#1)
IgE receptor##4##2##(1991-9#1)(2008-11#2)(2009-6#1)
IgE receptor-mediated##2##2##(1993-3#1)(2008-4#1)
IgE sensitization##2##2##(2013-1#2)
IgE to##2##2##(1990-3#1)(2010-5#1)
IgE##85##1##(1990-10#1)(1990-12#6)(1990-3#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-3#1)(1995-11#3)(2007-11#2)(2007-6#2)(2008-10#23)(2008-11#18)(2008-4#2)(2009-5#3)(2009-6#1)(2010-5#6)(2012-2#1)(2012-3#3)(2013-1#8)
IgE-mediated##9##1##(1990-12#1)(1991-11#1)(1993-3#1)(1996-3#2)(2009-6#1)(2011-2#1)(2013-1#2)
IgE-related conditions##2##2##(2010-5#2)
IgE-sensitized##2##1##(2013-1#2)
IgE/HC-##2##1##(2008-11#2)
IgE/SNP-treated KU812 cells##2##3##(2008-11#2)
IgG Langmuir-Blodgett##2##2##(2008-10#2)
IgG against##2##2##(1991-11#1)(2012-12#1)
IgG and HRP-labelled protein A##2##5##(2008-10#2)
IgG and IgA antibodies##3##4##(1990-2#1)(1994-2#1)(2008-4#1)
IgG and IgA##4##3##(1990-2#1)(1994-2#1)(2008-10#1)(2008-4#1)
IgG and IgM##5##3##(1992-9#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
IgG and its##3##3##(1994-11#1)(1994-12#1)(2008-10#1)
IgG and##28##2##(1990-2#1)(1990-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(2006-10#1)(2006-6#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-7#2)(2011-1#2)(2011-2#1)
IgG anti-Toxoplasma##6##2##(2007-10#6)
IgG anti-beta2-GPI##2##2##(2008-7#2)
IgG antibodies in##2##3##(1995-2#1)(2008-10#1)
IgG antibodies to##2##3##(1991-11#1)(2010-12#1)
IgG antibodies##14##2##(1990-2#2)(1991-11#2)(1994-9#2)(1995-2#2)(2007-10#1)(2007-7#2)(2008-10#2)(2010-12#1)
IgG antibody##12##2##(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(2008-10#5)(2008-4#1)(2011-1#1)(2012-12#1)
IgG as##3##2##(1992-8#1)(2008-10#2)
IgG at##2##2##(2008-10#1)(2008-11#1)
IgG binding##3##2##(1994-6#1)(1996-12#1)(2008-10#1)
IgG blots##2##2##(1992-8#2)
IgG class##3##2##(1990-12#2)(1995-12#1)
IgG concentration was##2##3##(2008-10#1)(2008-12#1)
IgG concentration##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
IgG concentrations##2##2##(1990-3#1)(1997-8#1)
IgG endpoint titers##2##3##(2008-10#2)
IgG for##2##2##(2010-3#1)(2012-2#1)
IgG from patients with##3##4##(2009-8#3)
IgG from##4##2##(2009-8#3)(2011-1#1)
IgG hybridoma##2##2##(1994-2#2)
IgG in##5##2##(1990-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
IgG kappa##2##2##(1991-5#1)(2012-12#1)
IgG labeled with##2##3##(2008-10#1)(2008-12#1)
IgG levels##2##2##(1993-12#1)(2012-12#1)
IgG molecules##2##2##(1990-12#2)
IgG on##2##2##(1990-12#2)
IgG or##5##2##(1990-2#1)(1991-11#1)(1996-2#1)(2008-10#1)(2011-2#1)
IgG production##5##2##(2008-11#3)(2008-7#2)
IgG response was##2##3##(1993-12#1)(2008-10#1)
IgG response##6##2##(1990-12#1)(1993-12#1)(1995-2#1)(2008-10#2)(2012-3#1)
IgG responses##6##2##(1995-2#2)(2008-10#3)(2008-9#1)
IgG serum levels were significantly##2##5##(2008-10#2)
IgG to NeutrAvidin##2##3##(2008-10#2)
IgG to##3##2##(1991-2#1)(2008-10#2)
IgG using##2##2##(2008-10#2)
IgG was significantly##2##3##(1995-11#1)(1995-2#1)
IgG was##7##2##(1995-11#1)(1995-2#1)(2008-10#5)
IgG with##2##2##(1991-5#1)(2008-10#1)
IgG##256##1##(1990-12#17)(1990-2#5)(1990-3#3)(1990-5#2)(1991-11#5)(1991-12#2)(1991-2#2)(1991-5#4)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#4)(1994-12#2)(1994-2#8)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#5)(1995-11#3)(1995-12#1)(1995-2#8)(1996-12#5)(1996-2#4)(1996-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#7)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#77)(2008-11#14)(2008-12#4)(2008-4#2)(2008-7#18)(2008-8#2)(2008-9#2)(2009-6#2)(2009-8#4)(2010-12#1)(2010-3#1)(2011-1#5)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#1)
IgG(2a)##3##1##(2008-10#3)
IgG(3)##2##1##(2008-10#2)
IgG)##4##1##(1994-9#1)(2008-10#1)(2008-4#2)
IgG-Fcs##3##1##(2013-1#3)
IgG-Sepharose##4##1##(1990-8#1)(1996-12#2)(1996-6#1)
IgG-binding domains of##2##3##(1994-12#2)
IgG-binding domains##3##2##(1994-12#3)
IgG-binding phages##2##2##(1994-12#2)
IgG-binding##9##1##(1990-8#1)(1994-12#5)(1995-5#1)(1996-12#1)(1996-6#1)
IgG-opsonized##2##1##(1994-6#1)(2008-4#1)
IgG1 and IgG3##3##3##(1993-6#1)(1994-11#1)(1994-9#1)
IgG1 and##7##2##(1993-6#2)(1994-11#1)(1994-9#1)(1995-11#1)(1997-8#1)(2008-11#1)
IgG1##29##1##(1993-6#5)(1994-11#1)(1994-12#3)(1994-9#1)(1995-11#2)(1996-12#2)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-11#4)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#1)
IgG2##4##1##(1994-12#1)(1995-11#2)(2013-8#1)
IgG2-ELISA##3##1##(1994-11#3)
IgG2a and IgG2b##2##3##(2008-11#1)(2009-6#1)
IgG2a##5##1##(1996-12#1)(1997-8#1)(2008-11#2)(2009-6#1)
IgG2b##5##1##(1996-12#1)(2008-11#2)(2009-6#1)(2012-2#1)
IgG3 subclass##2##2##(1993-6#1)(2011-2#1)
IgG3##15##1##(1993-6#5)(1994-11#1)(1994-12#3)(1994-2#1)(1994-9#1)(1996-12#2)(2009-6#1)(2011-2#1)
IgG4##5##1##(2009-5#1)(2011-2#3)(2012-3#1)
IgG4-ELISA##3##1##(1994-11#3)
IgM ELISA##2##2##(2007-7#1)(2008-10#1)
IgM and IgA concentrations##2##4##(2007-10#2)
IgM and IgG antibodies##2##4##(1994-9#1)(2007-7#1)
IgM and IgG production##2##4##(2008-11#2)
IgM and IgG##12##3##(1992-8#1)(1994-9#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)
IgM and##17##2##(1992-8#1)(1994-9#3)(2007-10#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#2)
IgM anti-beta2-GPI##2##2##(2008-7#2)
IgM antibodies##11##2##(1990-12#4)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)
IgM antibody##5##2##(1992-9#2)(2008-11#1)(2013-8#2)
IgM antibody-forming cell##2##3##(2008-10#2)
IgM on##2##2##(1994-2#1)(2011-2#1)
IgM production by human-human hybridoma##2##5##(2008-11#2)
IgM production##6##2##(2008-10#1)(2008-11#5)
IgM response to KLH##2##4##(2008-10#2)
IgM response##3##2##(1990-12#1)(2008-10#2)
IgM was##4##2##(1991-11#1)(1992-12#2)(2008-10#1)
IgM##101##1##(1990-12#7)(1991-11#1)(1991-9#2)(1992-12#2)(1992-8#3)(1992-9#2)(1993-12#1)(1994-2#5)(1994-3#2)(1994-9#3)(1995-6#1)(1996-12#2)(1997-7#1)(2006-10#1)(2007-10#4)(2007-7#4)(2008-10#19)(2008-11#14)(2008-4#3)(2008-7#11)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#7)(2013-8#2)
IgV(H)##5##1##(2008-9#5)
Igbo/Bini/Urhobo##2##1##(2009-10#2)
Igf2##6##1##(1996-10#6)
Igh##2##1##(1997-9#2)
Ignacio##9##1##(2008-10#3)(2008-5#1)(2010-8#1)(2013-7#4)
Ignisphaera aggregans##2##2##(2011-2#2)
Ignisphaera##4##1##(2011-2#4)
Ignoring##2##1##(2008-3#1)(2012-1#1)
Igs##4##1##(2007-10#4)
Il##5##1##(2009-4#2)(2010-1#1)(2013-1#2)
Ile##5##1##(1990-8#1)(1992-3#2)(1992-8#2)
Ile-81##2##1##(1994-5#2)
Ile-Val##2##1##(1990-8#2)
Ile184##2##1##(1992-1#2)
Ile8Glu##3##1##(2008-9#3)
Ile8]angiotensin II binding to angiotensin AT1 receptor##2##7##(1995-12#2)
Ile8]angiotensin II binding##3##3##(1995-12#3)
Ileal##2##1##(1996-3#1)(2009-2#1)
Ilha##3##1##(1991-9#1)(2008-5#2)
Iliac##4##1##(2006-10#1)(2008-12#2)(2012-3#1)
Ilizarov device##2##2##(2007-8#1)(2008-12#1)
Ilizarov limb##2##2##(2013-1#2)
Ilizarov method##6##2##(2007-11#1)(2007-8#1)(2008-8#3)(2013-1#1)
Ilizarov technique##4##2##(2007-11#1)(2009-3#3)
Ilizarov##23##1##(1997-5#1)(2007-11#4)(2007-8#6)(2008-12#1)(2008-8#3)(2009-3#3)(2009-4#1)(2013-1#4)
Ill##2##1##(2008-12#1)(2011-1#1)
Illegal##2##1##(1995-9#1)(2013-1#1)
Illicit drug##2##2##(1991-1#1)(2010-4#1)
Illicit drugs##2##2##(1991-12#1)(2007-12#1)
Illicit##6##1##(1991-1#1)(1991-12#1)(1996-12#1)(2007-12#1)(2010-4#2)
Illinois Department of Public Health##2##5##(1995-11#1)(1996-12#1)
Illinois University##2##2##(2010-1#1)(2013-8#1)
Illinois local health departments##2##4##(1996-2#2)
Illinois##34##1##(1992-12#1)(1992-8#1)(1992-9#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2013-8#1)
Illness##8##1##(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#2)(2011-2#1)
Illumina##2##1##(2012-2#2)
Illumination System##2##2##(2011-2#2)
Illumination of##2##2##(1993-3#1)(2008-2#1)
Illumination##8##1##(1993-3#1)(2008-2#1)(2008-3#2)(2011-2#4)
Illustration##3##1##(1996-5#1)(2012-3#1)(2013-1#1)
Illustrations are##2##2##(2008-2#2)
Illustrations##3##1##(2008-2#2)(2008-6#1)
Ilse##2##1##(2007-7#2)
ImTe##3##1##(2008-9#3)
Image Analysis##3##2##(2008-10#3)
Image Intensifier (SSXII)##3##3##(2011-1#3)
Image Quality##2##2##(2007-12#1)(2008-3#1)
Image Segmentation and##2##3##(2009-10#1)(2010-1#1)
Image analysis of##3##3##(2008-5#3)
Image analysis was##2##3##(2008-10#1)(2012-12#1)
Image analysis##8##2##(2008-10#2)(2008-4#1)(2008-5#3)(2008-9#1)(2012-12#1)
Image compression##2##2##(2008-3#2)
Image contrast enhancement##2##3##(2008-2#2)
Image edge##2##2##(2008-2#2)
Image formation##2##2##(2008-3#2)
Image processing##2##2##(2008-9#2)
Image quality##3##2##(2008-6#1)(2012-1#2)
Image reconstruction##3##2##(2008-3#3)
Image##81##1##(1991-8#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#20)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2012-1#2)(2012-12#1)(2012-2#5)
Image-Guided Surgery##2##2##(2009-12#2)
Image-guided##4##1##(2008-2#1)(2008-9#2)(2010-7#1)
Image-plane##2##1##(2008-3#2)
Imager##4##1##(2008-2#2)(2008-3#2)
Imagery##7##1##(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)
Images are##4##2##(2008-3#3)(2008-9#1)
Images in clinical medicine##9##4##(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)
Images in emergency medicine##4##4##(2009-6#4)
Images in surgery##2##3##(2009-9#2)
Images in##17##2##(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)(2009-6#5)(2009-9#2)(2011-2#1)
Images obtained##2##2##(2008-5#1)(2008-7#1)
Images of a##2##3##(2008-3#2)
Images of the##6##3##(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
Images of##16##2##(1990-11#1)(1995-12#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#6)(2012-1#2)(2012-3#1)
Images were##2##2##(1997-8#1)(2008-2#1)
Images##51##1##(1990-11#1)(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-9#2)(2010-8#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
Imaging Spectrometer##4##2##(2008-3#4)
Imaging Spectroradiometer##6##2##(2008-2#2)(2008-3#3)(2008-8#1)
Imaging System for##2##3##(2008-2#1)(2010-8#1)
Imaging System##4##2##(2008-2#1)(2010-11#1)(2010-8#1)(2013-8#1)
Imaging Using##3##2##(1996-9#1)(2008-5#1)(2009-12#1)
Imaging and##5##2##(1992-3#1)(1995-4#1)(2007-11#2)(2010-2#1)
Imaging at##3##2##(1994-2#1)(2012-3#1)(2013-8#1)
Imaging by##2##2##(2011-2#2)
Imaging interferometric lithography##2##3##(2007-12#2)
Imaging of the##4##3##(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
Imaging of##30##2##(1991-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#6)(2008-6#2)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#7)(2012-2#3)
Imaging plays a##3##3##(2008-1#1)(2008-2#1)(2009-11#1)
Imaging studies##7##2##(2007-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)
Imaging techniques in##2##3##(2007-7#1)(2011-2#1)
Imaging techniques##4##2##(2007-11#1)(2007-7#1)(2009-4#1)(2011-2#1)
Imaging the##5##2##(2008-1#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-7#1)
Imaging through scattering media##2##4##(2007-12#1)(2008-2#1)
Imaging through##3##2##(2007-12#2)(2008-2#1)
Imaging was##2##2##(2007-11#1)(2012-12#1)
Imaging with##4##2##(2008-2#1)(2008-3#3)
Imaging##152##1##(1991-2#1)(1992-3#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#7)(2007-12#6)(2007-5#1)(2007-7#2)(2008-1#6)(2008-2#14)(2008-3#25)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#2)(2010-8#3)(2011-2#16)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#4)(2013-8#4)
Imatinib and its##3##3##(2008-10#3)
Imatinib##9##1##(2008-10#7)(2009-7#1)(2013-1#1)
Imbrie##2##1##(2008-10#2)
Immanuel Kant##2##2##(2012-12#1)(2012-2#1)
Immature##7##1##(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-1#1)
Immediate and##2##2##(1990-6#1)(2012-7#1)
Immediate effects##2##2##(2008-12#1)(2012-2#1)
Immediate postoperative extubation##2##3##(2007-8#2)
Immediate versus delayed##3##3##(2010-7#1)(2012-3#1)(2013-1#1)
Immediate##27##1##(1990-6#1)(2007-8#6)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#2)(2013-1#5)
Immediately after the##4##3##(1991-3#1)(1994-6#1)(2007-8#1)(2013-8#1)
Immediately after##11##2##(1991-3#1)(1992-6#1)(1994-6#1)(1995-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#2)
Immediately following##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
Immediately##18##1##(1991-3#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-2#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#2)
Immersion in##2##2##(2008-3#1)(2013-1#1)
Immigrant##3##1##(2008-12#1)(2008-7#1)(2010-11#1)
Immigrants##4##1##(1992-5#1)(1993-2#1)(2008-11#1)(2010-12#1)
Immigration and##2##2##(2008-10#1)(2012-12#1)
Immigration##4##1##(1992-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
Immobilization and##2##2##(2008-10#1)(2012-1#1)
Immobilization of##12##2##(1991-5#2)(2008-10#6)(2008-5#1)(2008-7#2)(2010-11#1)
Immobilization##18##1##(1991-5#2)(2008-10#10)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-1#1)
Immobilized##5##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
Immortalized##3##1##(1995-2#1)(2008-11#2)
Immune Recognition System##2##3##(2010-8#2)
Immune Response##5##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Immune defense and host##2##4##(2008-8#2)
Immune defense##3##2##(2008-8#3)
Immune hemolytic anemia##3##3##(1992-6#2)(1994-6#1)
Immune response##4##2##(1990-5#1)(1990-9#1)(2012-3#2)
Immune responses##3##2##(1995-5#2)(2008-10#1)
Immune##41##1##(1990-5#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-2#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#2)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#4)(2009-4#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#4)(2013-1#2)
Immune-Mediated##2##1##(2008-10#1)(2011-2#1)
Immune-mediated inflammatory diseases (IMID)##2##4##(2011-2#2)
Immune-mediated##3##1##(2008-10#1)(2011-2#2)
Immunisation of##2##2##(1991-8#1)(1992-5#1)
Immunity##6##1##(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2013-8#1)
Immunization Initiative (CII)##2##3##(1995-3#1)(1996-12#1)
Immunization for##2##2##(2007-12#1)(2012-2#1)
Immunization of adults##3##3##(1993-9#3)
Immunization of##4##2##(1993-9#3)(2007-12#1)
Immunization with##2##2##(2008-8#1)(2009-6#1)
Immunization##26##1##(1993-9#3)(1994-11#1)(1994-9#1)(1995-11#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#4)(2009-6#1)(2011-2#1)(2012-2#1)
Immuno-cross-reactivity##2##1##(1990-12#2)
Immuno-histochemistry of##2##2##(2008-10#1)(2011-1#1)
Immunoaffinity chromatography##2##2##(2008-10#1)(2008-4#1)
Immunoaffinity column##2##2##(2008-11#2)
Immunoaffinity##5##1##(1990-11#1)(2008-10#1)(2008-11#2)(2008-4#1)
Immunoassay##2##1##(1994-2#1)(2008-10#1)
Immunoblot analyses revealed##2##3##(2008-10#1)(2008-11#1)
Immunoblot analyses##5##2##(1993-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
Immunoblot analysis##4##2##(1992-3#1)(1992-9#1)(1993-11#1)(1995-2#1)
Immunoblot##12##1##(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2012-12#1)
Immunoblots##4##1##(1993-11#1)(1993-2#1)(1995-3#1)(2008-10#1)
Immunoblotting analysis##2##2##(1991-5#1)(1995-11#1)
Immunoblotting and immunodetection##2##3##(2008-4#2)
Immunoblotting and##3##2##(2008-4#2)(2009-12#1)
Immunoblotting studies##2##2##(1993-6#2)
Immunoblotting##13##1##(1991-5#1)(1992-3#1)(1993-6#3)(1994-6#1)(1995-11#1)(2008-4#4)(2009-12#1)(2012-2#1)
Immunochemical##8##1##(1990-8#1)(1992-12#1)(1996-12#1)(2008-10#3)(2008-11#2)
Immunocytochemical staining##2##2##(1993-9#1)(2007-12#1)
Immunocytochemical techniques##3##2##(1993-12#2)(1994-2#1)
Immunocytochemical##12##1##(1992-11#1)(1993-12#2)(1993-9#1)(1994-2#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-9#1)(2009-8#1)
Immunocytochemistry##6##1##(1992-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
Immunodiagnostics##2##1##(2008-10#2)
Immunoendocrine##2##1##(1993-8#1)(2013-1#1)
Immunoenzyme assay##2##2##(2008-10#2)
Immunofluorescence microscopy##2##2##(2008-10#2)
Immunofluorescence studies##2##2##(1993-6#1)(1994-10#1)
Immunofluorescence##12##1##(1991-5#1)(1993-6#1)(1994-10#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)
Immunofluorescent##2##1##(1990-8#1)(2008-10#1)
Immunogenic##3##1##(1992-9#1)(2008-5#1)(2013-1#1)
Immunogenicity for##2##2##(2008-10#2)
Immunogenicity of##5##2##(1992-2#1)(1995-12#1)(1997-6#1)(2008-10#1)(2009-5#1)
Immunogenicity##13##1##(1992-2#1)(1995-12#1)(1995-5#1)(1997-6#1)(2008-10#6)(2008-3#1)(2009-5#1)(2012-12#1)
Immunoglobulin##9##1##(1991-6#1)(1992-8#1)(1994-2#1)(2008-1#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-7#1)
Immunogold electron microscopy##2##3##(1997-3#1)(2008-10#1)
Immunogold##5##1##(1997-3#3)(2008-10#2)
Immunohistochemical Localization of##2##3##(2008-5#1)(2008-6#1)
Immunohistochemical analysis of the##2##4##(2011-2#1)(2012-1#1)
Immunohistochemical analysis of##5##3##(2007-4#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
Immunohistochemical analysis revealed##2##3##(1995-12#1)(2010-8#1)
Immunohistochemical analysis##12##2##(1993-12#1)(1994-12#1)(1995-12#1)(1997-6#1)(2007-4#1)(2008-10#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
Immunohistochemical and##4##2##(1992-2#1)(2009-8#2)(2011-2#1)
Immunohistochemical detection of##2##3##(1992-2#1)(1995-12#1)
Immunohistochemical evidence for the##2##4##(1990-7#1)(1991-6#1)
Immunohistochemical localization of##3##3##(1992-6#1)(1995-12#1)(2008-4#1)
Immunohistochemical staining of##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
Immunohistochemical staining##10##2##(1992-3#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
Immunohistochemical studies were performed on##2##5##(1997-7#1)(2008-12#1)
Immunohistochemical studies##5##2##(1990-5#1)(1993-6#1)(1994-9#1)(1997-7#1)(2008-12#1)
Immunohistochemical study##4##2##(1997-3#1)(2011-2#1)(2012-1#2)
Immunohistochemical##57##1##(1990-5#1)(1990-7#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#4)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-8#2)(2010-8#1)(2011-2#4)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#3)
Immunohistochemically##8##1##(1991-2#1)(1994-12#1)(2007-5#1)(2008-11#2)(2009-8#1)(2012-1#2)
Immunohistochemistry was performed on##2##4##(1996-5#1)(2013-1#1)
Immunohistochemistry was performed##3##3##(1996-5#1)(2013-1#1)(2013-8#1)
Immunohistochemistry was##4##2##(1996-5#1)(1997-3#1)(2013-1#1)(2013-8#1)
Immunohistochemistry##16##1##(1991-8#1)(1995-12#1)(1996-5#1)(1997-3#2)(2008-12#1)(2008-4#1)(2009-8#1)(2010-8#2)(2012-12#1)(2013-1#2)(2013-8#3)
Immunohistological##2##1##(2008-5#1)(2009-4#1)
Immunolocalization of##2##2##(2008-10#1)(2008-11#1)
Immunologic##6##1##(1992-12#1)(1992-5#1)(1994-5#1)(1995-5#1)(2008-10#1)(2010-5#1)
Immunological analysis##2##2##(2008-9#1)(2013-1#1)
Immunological##15##1##(1990-12#1)(1990-7#1)(1991-1#1)(1992-9#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
Immunology##4##1##(1995-6#1)(2008-5#1)(2012-12#1)(2013-7#1)
Immunomagnetic##4##1##(2008-10#1)(2008-4#1)(2008-9#2)
Immunomodulatory activity##2##2##(1991-1#2)
Immunomodulatory##7##1##(1991-1#2)(1993-12#1)(2007-11#1)(2010-6#1)(2012-2#1)(2013-8#1)
Immunopathogenesis of##2##2##(2008-5#1)(2012-12#1)
Immunoperoxidase##2##1##(1992-2#1)(2008-4#1)
Immunophenotypic analysis of##4##3##(2008-9#4)
Immunophenotypic##5##1##(2008-9#5)
Immunophenotyping of##2##2##(2008-4#1)(2008-9#1)
Immunophenotyping##6##1##(2007-2#2)(2008-4#1)(2008-9#3)
Immunoprecipitation analysis##3##2##(1992-3#1)(1994-11#1)(2012-2#1)
Immunoprecipitation is##2##2##(1994-2#1)(2008-4#1)
Immunoprecipitation##12##1##(1992-3#1)(1993-11#1)(1994-11#1)(1994-2#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2012-2#1)
Immunoreactive##8##1##(1990-7#1)(1991-1#1)(1993-12#2)(1997-2#2)(2008-4#1)(2011-1#1)
Immunoreactivity for##3##2##(1991-12#1)(2008-6#1)(2008-7#1)
Immunoreactivity was##2##2##(1994-8#1)(2007-12#1)
Immunoreactivity##7##1##(1991-12#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-12#1)
Immunosorbent##3##1##(2008-10#2)(2008-11#1)
Immunostaining for##3##2##(1991-7#1)(1994-8#1)(2011-2#1)
Immunostaining of ginsenosides##2##3##(2008-11#2)
Immunostaining of##4##2##(2008-11#2)(2010-11#1)(2011-1#1)
Immunostaining##13##1##(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#2)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-1#1)(2011-2#1)
Immunosuppression##3##1##(1993-8#1)(2008-1#1)(2008-3#1)
Immunosuppressive therapy##2##2##(1996-11#1)(2008-1#1)
Immunosuppressive##7##1##(1990-5#1)(1991-1#1)(1993-12#1)(1996-11#2)(2008-1#2)
Immunotherapy##4##1##(2007-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
Immunotoxic##3##1##(2008-10#3)
Immunotoxicity##5##1##(2008-10#5)
Immunotoxicity&quot##2##1##(2008-10#2)
Imp##2##1##(2008-10#1)(2008-8#1)
Impact Assessment##3##2##(2008-11#1)(2012-1#1)(2013-1#1)
Impact Profile##2##2##(2011-2#1)(2013-1#1)
Impact and##3##2##(1990-10#1)(2008-2#1)(2013-8#1)
Impact of a##3##3##(1991-2#1)(2010-12#1)(2012-12#1)
Impact of new technologies##2##4##(1992-2#1)(1994-5#1)
Impact of new##3##3##(1992-2#1)(1994-5#1)(1997-3#1)
Impact of the##6##3##(1991-1#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
Impact of##87##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#2)(1992-9#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
Impact on Asthma##3##3##(2008-3#1)(2012-12#2)
Impact on##7##2##(2008-10#1)(2008-3#1)(2010-3#1)(2012-12#3)(2012-3#1)
Impact##116##1##(1990-10#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#2)(1992-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-8#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#6)
Impaction of##2##2##(2008-12#2)
Impacts of##2##2##(1995-4#1)(1996-2#1)
Impacts##3##1##(1995-4#1)(1996-2#1)(2013-8#1)
Impaired insulin##2##2##(2008-10#1)(2010-11#1)
Impaired##31##1##(1992-9#1)(1994-6#1)(1995-8#1)(1996-6#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-11#1)(2012-12#3)(2012-3#7)(2013-8#1)
Impairment of the##2##3##(1996-7#1)(2008-7#1)
Impairment of##13##2##(1990-3#1)(1992-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-5#2)(1996-7#1)(1997-2#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
Impairment##19##1##(1990-3#1)(1992-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-5#2)(1996-7#1)(1997-2#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#2)
Impairments in##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
Impairments##5##1##(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
Impairs##3##1##(2008-10#2)(2013-1#1)
Impala##3##1##(2008-10#3)
Impatiens necrotic spot virus##4##4##(2008-10#4)
Impatiens##6##1##(2008-10#5)(2008-5#1)
Impedance measurements##2##2##(2008-10#1)(2012-2#1)
Impedance##13##1##(2008-10#4)(2008-11#5)(2008-2#1)(2009-9#1)(2012-2#1)(2012-3#1)
Impedances were##2##2##(2008-9#2)
Impedances##4##1##(2008-9#4)
Impediments to##3##2##(1992-2#1)(1997-3#1)(2009-8#1)
Impella 2##2##2##(2010-6#2)
Imperforate##2##1##(2009-5#1)(2013-1#1)
Imperial##4##1##(2008-10#1)(2008-5#2)(2012-2#1)
Implant rehabilitation##2##2##(2013-1#2)
Implant##16##1##(2007-12#1)(2008-6#1)(2008-9#6)(2011-1#1)(2012-2#2)(2013-1#5)
Implant-supported##2##1##(2013-1#2)
Implantable cardiac defibrillators##2##3##(2010-8#2)
Implantable medical device##2##3##(2012-3#2)
Implantable##9##1##(1994-9#1)(2008-9#1)(2010-10#1)(2010-6#1)(2010-8#3)(2012-3#2)
Implantation of##4##2##(2007-8#1)(2008-12#2)(2012-3#1)
Implantation##8##1##(2007-8#1)(2008-11#1)(2008-12#2)(2011-2#2)(2012-3#1)(2013-1#1)
Implanting##2##1##(1991-12#1)(1993-12#1)
Implants##2##1##(2007-12#1)(2011-2#1)
Implement##3##1##(1996-3#1)(2008-11#1)(2008-3#1)
Implementation and##4##2##(2008-3#2)(2010-8#2)
Implementation issues##3##2##(1997-2#1)(2008-2#1)(2010-8#1)
Implementation of a##9##3##(1991-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#2)
Implementation of an##2##3##(2012-3#1)(2013-7#1)
Implementation of the Water Framework Directive##2##6##(2008-10#2)
Implementation of the##4##3##(1991-1#1)(2008-10#2)(2008-2#1)
Implementation of##32##2##(1991-1#1)(1991-2#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#5)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Implementation strategies of measurement instruments and their validity as adopted in italian hospital nursing practice##2##15##(2013-1#2)
Implementation##49##1##(1991-1#1)(1991-2#1)(1991-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#2)(1997-2#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#7)(2008-9#1)(2010-3#1)(2010-8#5)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
Implemented in##2##2##(2007-12#1)(2008-7#1)
Implementing TQM##2##2##(1996-2#1)(1997-3#1)
Implementing a##4##2##(1995-3#1)(1995-9#1)(1996-3#1)(2013-1#1)
Implementing and##2##2##(2008-12#1)(2010-5#1)
Implementing the##8##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-12#1)(2013-7#1)
Implementing##29##1##(1991-12#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#2)(2010-3#1)(2010-5#1)(2013-1#1)(2013-7#1)
Implicated in##2##2##(2008-10#2)
Implication for##2##2##(2008-11#1)(2013-1#1)
Implication of##3##2##(1995-11#1)(1996-9#1)(2013-1#1)
Implication##6##1##(1995-11#1)(1996-9#1)(2008-11#1)(2009-9#1)(2013-1#2)
Implications and recommendations##2##3##(1993-12#1)(1997-3#1)
Implications and##6##2##(1993-12#1)(1994-3#1)(1997-3#2)(2011-2#1)(2012-12#1)
Implications are discussed##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
Implications are##4##2##(1993-12#1)(1997-3#1)(2008-11#1)(2010-8#1)
Implications for Protein##2##3##(1996-12#1)(2008-10#1)
Implications for cancer therapy##2##4##(1994-5#2)
Implications for cancer##3##3##(1994-5#3)
Implications for clinical##2##3##(1994-3#1)(1995-2#1)
Implications for future research and##2##5##(1994-12#1)(2008-9#1)
Implications for future research##4##4##(1994-12#1)(2008-12#1)(2008-9#1)(2010-7#1)
Implications for future##5##3##(1994-12#1)(2008-12#1)(2008-9#1)(2010-7#1)(2012-12#1)
Implications for health care##3##4##(1993-3#1)(1995-1#1)(2011-2#1)
Implications for health##4##3##(1991-12#1)(1993-3#1)(1995-1#1)(2011-2#1)
Implications for human##2##3##(1995-2#1)(2011-2#1)
Implications for intervention##2##3##(1991-2#1)(2012-3#1)
Implications for nursing management ##2##4##(2012-3#2)
Implications for nursing##4##3##(2008-12#1)(2012-3#3)
Implications for practice##3##3##(2010-10#1)(2010-4#1)(2012-2#1)
Implications for the care of children##2##6##(2008-10#1)(2008-11#1)
Implications for the##12##3##(1993-12#1)(1994-1#1)(1995-12#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-7#1)
Implications for theory##2##3##(2008-11#1)(2009-8#1)
Implications for understanding spirituality and the role it plays in the lives of older adults are considered##2##17##(2013-1#2)
Implications for##88##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1995-1#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-1#1)(1996-12#2)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#6)(2013-8#1)
Implications in##2##2##(2009-7#1)(2012-2#1)
Implications include the need for##2##5##(2009-5#1)(2010-10#1)
Implications include##3##2##(2009-5#1)(2010-10#2)
Implications of genetic##2##3##(1996-6#1)(2008-10#1)
Implications of our results##2##4##(2008-2#1)(2011-2#1)
Implications of the findings are discussed##2##6##(2007-12#1)(2012-2#1)
Implications of the findings for##2##5##(1994-2#1)(1997-1#1)
Implications of the findings##5##4##(1994-2#1)(1997-1#1)(2007-12#2)(2012-2#1)
Implications of the model for##2##5##(1992-1#1)(2008-2#1)
Implications of the##14##3##(1992-1#1)(1994-2#1)(1995-1#1)(1997-1#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
Implications of these findings are discussed##2##6##(2008-12#1)(2009-7#1)
Implications of these findings are##3##5##(2008-12#1)(2009-7#1)(2013-1#1)
Implications of these findings for##2##5##(2009-4#1)(2009-5#1)
Implications of these findings##5##4##(2008-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2013-1#1)
Implications of these##9##3##(1991-3#1)(2008-12#1)(2008-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2013-1#1)
Implications of##43##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
Implications on##2##2##(2008-10#1)(2011-1#1)
Implications##156##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#5)(1995-1#2)(1995-12#2)(1995-2#4)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#3)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-10#11)(2008-11#6)(2008-12#8)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#1)(2009-9#4)(2010-10#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#11)(2013-1#7)(2013-8#1)
Implicit and##2##2##(2007-12#1)(2009-9#1)
Implicit##5##1##(2007-12#1)(2008-3#1)(2009-9#1)(2010-2#1)(2012-12#1)
Importance of##19##2##(1991-1#1)(1992-3#1)(1995-5#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
Important aspects of##2##3##(2012-2#1)(2013-7#1)
Important parameters##3##2##(2008-11#1)(2008-9#1)(2010-8#1)
Important questions##2##2##(1992-9#1)(2008-5#1)
Important##48##1##(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#4)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)
Importantly##47##1##(1990-2#1)(1992-8#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-12#1)(2013-1#11)(2013-8#1)
Imported##5##1##(2007-12#1)(2007-2#1)(2012-3#2)(2013-8#1)
Imposing##2##1##(2008-7#1)(2009-2#1)
Imprecision##2##1##(1993-2#1)(2008-10#1)
Impregnated##2##1##(2008-10#2)
Impression examination##2##2##(2008-12#2)
Improper##2##1##(2008-10#2)
Improve##8##1##(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
Improved Control of##2##3##(2008-10#2)
Improved awareness##2##2##(2008-7#1)(2009-10#1)
Improved care##2##2##(1994-1#1)(2010-2#1)
Improved design##2##2##(2008-3#2)
Improved detection of##2##3##(1991-12#1)(2011-2#1)
Improved detection##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
Improved methods##2##2##(2007-11#1)(2008-5#1)
Improved models##2##2##(2008-10#1)(2008-8#1)
Improved performance##2##2##(2007-11#1)(2008-10#1)
Improved quality##3##2##(1992-12#1)(1994-3#1)(2013-1#1)
Improved resolution##2##2##(1996-12#1)(2007-8#1)
Improved results with##2##3##(1990-9#1)(2007-8#1)
Improved results##3##2##(1990-9#1)(2007-8#1)(2008-10#1)
Improved sensitivity##2##2##(2008-10#1)(2008-11#1)
Improved##102##1##(1990-9#1)(1991-12#3)(1991-3#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-9#1)(1994-1#4)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-7#1)(2007-8#5)(2008-10#14)(2008-11#3)(2008-2#8)(2008-3#13)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
Improvement Act of##2##3##(1991-1#1)(2008-12#1)
Improvement Act##6##2##(1991-1#2)(1991-3#1)(1992-2#1)(1994-1#1)(2008-12#1)
Improvement Program##6##2##(1992-12#1)(1992-3#1)(1996-2#3)(2013-1#1)
Improvement in hearing was##2##4##(1995-6#1)(2008-4#1)
Improvement in the##4##3##(2007-8#1)(2008-3#2)(2011-2#1)
Improvement in##14##2##(1992-10#1)(1995-6#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-9#2)(2011-2#1)
Improvement of a##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
Improvement of pain##3##3##(2008-9#3)
Improvement of the##4##3##(1997-6#1)(2008-3#2)(2009-4#1)
Improvement of##35##2##(1990-6#1)(1991-2#1)(1992-11#1)(1994-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#3)(2008-9#4)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
Improvement was seen##2##3##(2007-8#1)(2012-2#1)
Improvement was##5##2##(1990-9#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
Improvement##90##1##(1990-6#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-6#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#6)(2009-4#1)(2009-6#3)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
Improvements have##2##2##(2007-11#1)(2008-6#1)
Improvements in the##4##3##(2007-12#1)(2008-3#3)
Improvements in##19##2##(1994-12#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-7#3)(2009-9#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Improvements of##2##2##(2008-11#1)(2013-8#1)
Improvements to##2##2##(2008-3#1)(2008-5#1)
Improvements##32##1##(1991-3#1)(1994-12#1)(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#4)(2009-9#1)(2011-1#2)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
Improves##6##1##(2008-10#2)(2010-7#1)(2012-3#1)(2013-1#2)
Improving access to##2##3##(2008-11#2)
Improving customer satisfaction##2##3##(1996-1#1)(1996-2#1)
Improving health##4##2##(1993-1#1)(2008-12#1)(2008-7#1)(2013-8#1)
Improving our understanding of##2##4##(1991-3#1)(2008-3#1)
Improving outcomes##2##2##(1997-1#2)
Improving physician##2##2##(2007-5#1)(2008-6#1)
Improving quality of care##2##4##(1994-3#1)(1997-3#1)
Improving quality##3##2##(1994-3#1)(1997-3#1)(2012-3#1)
Improving student##2##2##(2008-12#1)(2009-8#1)
Improving the accuracy of##2##4##(2008-2#1)(2011-3#1)
Improving the efficiency of##2##4##(2010-8#2)
Improving the quality and use of health information systems##2##9##(2012-12#2)
Improving the quality of##4##4##(1993-3#1)(1996-3#1)(2009-9#1)(2012-12#1)
Improving the quality##6##3##(1993-3#1)(1996-3#1)(2009-9#1)(2012-12#3)
Improving the##28##2##(1992-3#1)(1993-3#2)(1994-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#6)
Improving##91##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-2#3)(1994-3#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#3)(1997-3#3)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-8#3)(2011-2#3)(2011-3#1)(2012-12#10)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
Impulsive##2##1##(2012-12#1)(2013-1#1)
Impulsiveness##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
Impulsivity##3##1##(1991-1#1)(2010-6#1)(2013-7#1)
Impurities##2##1##(2010-2#1)(2012-2#1)
Imputation##2##1##(2009-8#1)(2012-3#1)
In &quot##2##2##(1993-6#1)(2008-10#1)
In 0##6##2##(1994-11#1)(2008-10#5)
In 1 case##2##3##(1993-9#1)(2011-2#1)
In 1 patient##4##3##(2007-11#2)(2007-9#1)(2011-2#1)
In 1##9##2##(1993-9#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#2)
In 10 patients##3##3##(1990-6#1)(2007-11#2)
In 10##5##2##(1990-6#1)(1991-3#1)(2007-11#2)(2008-11#1)
In 11 patients##3##3##(1990-6#1)(1991-11#1)(2011-2#1)
In 12 of##4##3##(1991-5#1)(1997-8#1)(2008-10#1)(2008-11#1)
In 12 patients##4##3##(1990-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
In 12##9##2##(1990-2#1)(1991-5#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
In 13 patients##2##3##(2008-11#1)(2011-2#1)
In 13##5##2##(1996-3#1)(2008-11#1)(2011-2#3)
In 14 patients##2##3##(1996-11#1)(2007-11#1)
In 14##4##2##(1990-12#1)(1996-11#1)(2007-11#1)(2008-5#1)
In 15 of the##3##4##(1997-7#1)(1997-8#1)(2007-11#1)
In 15 of##5##3##(1991-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-12#1)
In 15 patients##2##3##(1990-3#1)(2007-11#1)
In 15##9##2##(1990-3#1)(1990-8#1)(1991-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-12#1)
In 16 cases##2##3##(2007-11#2)
In 16 patients the##2##4##(1990-2#1)(1993-8#1)
In 16 patients##4##3##(1990-2#1)(1993-8#1)(2008-6#1)(2009-10#1)
In 16##9##2##(1990-2#1)(1993-8#1)(1997-5#1)(2007-11#2)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)
In 17##4##2##(1990-8#1)(1991-12#1)(2007-8#1)(2008-12#1)
In 18##2##2##(2007-11#1)(2007-8#1)
In 18%##2##2##(1992-5#1)(2012-3#1)
In 1895##2##2##(2008-7#1)(2010-1#1)
In 19 patients##2##3##(1994-11#1)(2007-8#1)
In 1966##2##2##(1995-1#1)(2008-8#1)
In 1974##2##2##(1996-12#1)(2007-8#1)
In 1979##2##2##(1993-12#1)(1994-5#1)
In 1980##3##2##(1991-3#1)(1995-6#1)(2008-10#1)
In 1982##3##2##(1991-3#1)(1993-2#1)(1993-3#1)
In 1983##2##2##(1990-9#1)(1995-6#1)
In 1986 the##2##3##(1990-2#1)(1991-6#1)
In 1986##4##2##(1990-2#1)(1991-12#1)(1991-6#1)(1996-3#1)
In 1987##4##2##(1991-2#2)(1992-2#1)(2008-2#1)
In 1988##7##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-2#1)(1993-1#1)(1995-6#1)
In 1989##14##2##(1991-12#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-10#1)
In 1990##8##2##(1991-11#1)(1991-9#1)(1992-5#1)(1992-6#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
In 1991##11##2##(1992-5#1)(1993-3#1)(1993-6#2)(1995-1#1)(1996-1#1)(1997-5#1)(1997-6#1)(2007-10#1)(2008-10#2)
In 1992##7##2##(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-3#1)(2008-10#1)
In 1993##9##2##(1993-6#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-9#1)(2008-10#4)
In 1994##11##2##(1996-11#1)(1996-3#3)(1996-7#1)(1997-2#1)(2008-10#3)(2008-8#1)(2011-2#1)
In 1995 the##3##3##(1996-11#1)(1996-9#1)(2008-7#1)
In 1995##9##2##(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-7#1)
In 1996##8##2##(2008-10#5)(2008-5#1)(2010-8#1)(2011-2#1)
In 1997##13##2##(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
In 1998 and##2##3##(2008-10#2)
In 1998##13##2##(2008-10#11)(2008-8#1)(2010-8#1)
In 1999##7##2##(2007-6#3)(2008-10#2)(2008-11#1)(2012-2#1)
In 2 cases##5##3##(1991-2#1)(2007-11#3)(2011-2#1)
In 2 of##2##3##(2008-7#1)(2011-2#1)
In 2 years of##2##4##(2008-10#2)
In 2##14##2##(1991-2#1)(1991-3#1)(1991-8#2)(1993-12#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#2)
In 20##4##2##(1992-12#1)(1997-5#1)(2007-11#2)
In 2000##7##2##(2007-2#1)(2008-10#3)(2008-9#1)(2011-2#2)
In 2001##8##2##(2007-12#1)(2008-10#3)(2008-12#2)(2009-8#1)(2011-1#1)
In 2002##4##2##(2007-12#1)(2008-10#3)
In 2003##4##2##(2008-10#3)(2010-8#1)
In 2004##2##2##(2008-10#1)(2008-5#1)
In 2005 and##2##3##(2011-2#2)
In 2005##7##2##(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
In 2006##5##2##(2010-8#1)(2011-2#3)(2013-1#1)
In 2007##6##2##(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
In 2008##5##2##(2010-9#1)(2012-2#1)(2013-1#3)
In 2009##3##2##(2010-6#1)(2011-2#1)(2012-12#1)
In 2011##3##2##(2012-12#3)
In 21 patients##2##3##(1990-12#1)(2007-8#1)
In 21##4##2##(1990-12#1)(2007-11#1)(2007-8#1)(2011-2#1)
In 26##2##2##(1994-12#1)(2007-11#1)
In 27##2##2##(1990-9#1)(1995-11#1)
In 28 patients##2##3##(1990-2#1)(1994-3#1)
In 3 cases##3##3##(1990-6#1)(2011-2#2)
In 3 patients##4##3##(1991-2#1)(2007-11#1)(2011-2#1)(2013-1#1)
In 3##11##2##(1990-6#1)(1991-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#3)(2013-1#1)
In 30##3##2##(1993-12#1)(2007-8#1)(2008-10#1)
In 32 cases##3##3##(2007-11#1)(2007-8#1)(2008-12#1)
In 32 patients##2##3##(1994-3#1)(2007-11#1)
In 32##5##2##(1994-3#1)(2007-11#2)(2007-8#1)(2008-12#1)
In 34 cases##2##3##(1997-3#1)(2007-11#1)
In 34##4##2##(1990-8#1)(1997-3#1)(1997-8#1)(2007-11#1)
In 35##3##2##(1991-2#1)(1991-8#1)(1995-6#1)
In 36##2##2##(2007-7#1)(2008-10#1)
In 37##2##2##(1996-3#1)(2007-11#1)
In 37th Hbd##2##3##(2008-4#2)
In 39 patients##2##3##(1990-9#1)(2007-8#1)
In 4 cases the##2##4##(2007-11#2)
In 4 cases##5##3##(1991-2#2)(2007-11#2)(2007-8#1)
In 4 of##2##3##(1996-11#1)(1997-5#1)
In 4 patients##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
In 4 tumors##2##3##(1991-8#1)(1995-4#1)
In 4##15##2##(1990-5#1)(1991-2#2)(1991-8#1)(1992-3#1)(1995-4#1)(1996-11#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#2)
In 40##2##2##(1991-2#1)(2013-8#1)
In 41##2##2##(1993-8#1)(2010-3#1)
In 45 patients the##2##4##(1990-3#1)(1996-6#1)
In 45 patients##3##3##(1990-3#1)(1996-6#1)(2011-2#1)
In 45##4##2##(1990-3#1)(1996-6#1)(2007-11#1)(2011-2#1)
In 48##2##2##(2007-11#1)(2008-6#1)
In 5 cases##3##3##(1992-8#1)(2007-11#1)(2011-1#1)
In 5 of##3##3##(2007-10#1)(2011-1#1)(2013-1#1)
In 5 patients with##2##4##(1993-10#1)(2007-10#1)
In 5 patients##7##3##(1993-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-3#1)(2011-2#2)
In 5##13##2##(1992-8#1)(1993-10#1)(2007-10#2)(2007-11#2)(2008-5#1)(2009-3#1)(2011-1#2)(2011-2#2)(2013-1#1)
In 51##2##2##(1993-9#1)(1996-12#1)
In 58##3##2##(2007-11#1)(2009-3#1)(2011-2#1)
In 6 cases##2##3##(1997-8#1)(2009-10#1)
In 6##4##2##(1997-8#1)(2008-10#1)(2009-10#1)(2010-11#1)
In 68##2##2##(2008-3#1)(2011-2#1)
In 7##3##2##(1991-8#1)(1993-5#1)(2009-7#1)
In 75##3##2##(1990-11#1)(1994-12#1)(2011-2#1)
In 75% of##3##3##(1992-11#1)(1992-12#1)(2007-11#1)
In 8 cases##2##3##(1996-11#1)(2011-2#1)
In 8##6##2##(1994-5#1)(1996-11#1)(2007-11#2)(2008-7#1)(2011-2#1)
In 80%##2##2##(1990-9#1)(1991-2#1)
In 82##2##2##(2007-11#1)(2013-8#1)
In 9##5##2##(1996-11#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
In A##4##2##(1991-5#1)(2008-10#1)(2008-12#1)(2008-2#1)
In AD##5##2##(1993-12#2)(1997-2#2)(2007-8#1)
In AML##2##2##(2007-10#1)(2011-2#1)
In Alzheimer's disease (AD)##2##4##(2008-4#1)(2011-2#1)
In Alzheimer's disease##4##3##(1993-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
In Anzali Lagoon##2##3##(2012-2#2)
In April##6##2##(1992-5#1)(1996-5#1)(2008-1#1)(2008-5#2)(2013-1#1)
In Arabidopsis##8##2##(2008-10#1)(2008-7#2)(2009-10#1)(2009-8#3)(2012-2#1)
In Auchenorrhyncha##2##2##(2007-12#2)
In August##4##2##(1994-9#1)(1995-12#1)(2008-5#1)(2010-1#1)
In Australia##4##2##(2007-2#1)(2008-11#1)(2008-3#1)(2010-10#1)
In Barbados##2##2##(2008-10#1)(2011-2#1)
In Brazil and##2##3##(1991-12#1)(2008-10#1)
In Brazil##5##2##(1991-12#1)(1991-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
In C##5##2##(2007-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
In CA1##2##2##(1994-2#1)(1994-8#1)
In CHO cells##2##3##(1992-12#1)(1993-3#1)
In California##3##2##(2008-10#1)(2011-2#2)
In Canada##3##2##(1991-4#1)(2008-11#1)(2011-2#1)
In Colombia##2##2##(2012-12#1)(2013-1#1)
In DMSO and DMF##2##4##(2008-10#2)
In December 1848##2##3##(1992-6#1)(1993-3#1)
In December 2004##2##3##(2008-1#1)(2013-1#1)
In December##9##2##(1992-5#1)(1992-6#1)(1993-3#1)(2007-10#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#2)
In Drosophila melanogaster##3##3##(1993-9#1)(1995-8#1)(2012-3#1)
In Drosophila##7##2##(1993-9#1)(1995-8#1)(2008-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
In E##4##2##(1993-6#1)(1994-12#1)(2008-10#1)(2008-8#1)
In Escherichia coli##2##3##(1995-2#1)(1996-6#1)
In Europe##6##2##(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#2)
In European##2##2##(2008-10#1)(2011-3#1)
In Experiment 1##10##3##(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2009-5#1)(2009-8#1)(2011-1#1)
In Experiment 2##10##3##(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2011-1#1)(2013-8#2)
In Experiment 3##4##3##(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#1)
In Experiment##25##2##(2007-6#2)(2008-11#3)(2008-2#3)(2008-5#5)(2008-6#3)(2009-5#3)(2009-8#2)(2011-1#2)(2013-8#2)
In Experiments##2##2##(2008-11#1)(2011-1#1)
In Expt##7##2##(1992-12#2)(1993-3#2)(1993-6#3)
In F##2##2##(1995-8#1)(2008-5#1)
In F(1)##2##2##(2008-10#2)
In February 2009##2##3##(2011-2#1)(2013-1#1)
In February##7##2##(1993-1#1)(1993-3#1)(1995-6#1)(2008-5#2)(2011-2#1)(2013-1#1)
In France##4##2##(1994-12#1)(2008-10#2)(2011-3#1)
In Germany##2##2##(1995-11#1)(1996-9#1)
In Group I##3##3##(2007-8#2)(2009-3#1)
In Group##7##2##(1990-5#3)(2007-8#3)(2009-3#1)
In H##3##2##(2007-12#1)(2008-5#1)(2012-8#1)
In HIV##2##2##(2008-5#1)(2010-5#1)
In Hungary##3##2##(1991-3#2)(1994-12#1)
In India##6##2##(1994-9#2)(1996-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
In January 1993##2##3##(1995-12#1)(1995-6#1)
In January 2004##2##3##(2007-12#1)(2010-8#1)
In January##8##2##(1995-12#1)(1995-6#1)(2007-10#1)(2007-12#1)(2009-5#1)(2010-8#1)(2011-2#2)
In Japan##10##2##(1992-9#1)(1993-12#1)(1994-12#1)(2008-1#1)(2010-12#1)(2010-4#1)(2010-8#4)
In July 1996##2##3##(2008-2#1)(2008-5#1)
In July 1998##3##3##(2008-5#3)
In July##10##2##(1991-2#1)(1996-1#1)(2008-2#1)(2008-4#1)(2008-5#4)(2011-3#1)(2013-1#1)
In June 1998##2##3##(2008-5#2)
In June##7##2##(1994-9#1)(1996-2#1)(2008-5#3)(2009-7#1)(2013-7#1)
In Lutzomyia##2##2##(2007-12#2)
In Manduca sexta##2##3##(1995-11#2)
In March 1998##3##3##(2008-5#3)
In March##9##2##(1990-3#1)(1994-3#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-5#3)(2008-7#1)
In May 1998##2##3##(2008-5#2)
In May##7##2##(1994-3#1)(1996-3#1)(2008-5#2)(2011-2#2)(2012-3#1)
In Mediterranean##2##2##(2012-5#1)(2012-7#1)
In Nd##2##2##(2008-3#2)
In Nepal##2##2##(2008-7#2)
In New York##2##3##(1996-12#1)(2008-10#1)
In New##6##2##(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2011-2#1)
In North##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
In Northern##2##2##(1993-9#1)(2008-10#1)
In Norway the##2##3##(1992-4#1)(1995-6#1)
In Norway##10##2##(1990-2#1)(1991-6#1)(1992-4#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-8#1)
In November##2##2##(2008-5#1)(2011-2#1)
In October 1997##2##3##(2008-5#2)
In October 2004##2##3##(2010-6#1)(2012-2#1)
In October##10##2##(1991-7#1)(1992-2#1)(1995-3#1)(1996-1#2)(1996-5#1)(2008-5#2)(2010-6#1)(2012-2#1)
In P##5##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
In PC12 cells##2##3##(1992-12#1)(1996-12#1)
In PD##2##2##(2008-7#1)(2011-2#1)
In PI##2##2##(2008-10#2)
In Part I##2##3##(1994-1#1)(2008-2#1)
In Part II##3##3##(1993-2#1)(1994-1#1)(1997-3#1)
In Part##5##2##(1993-2#1)(1994-1#2)(1997-3#1)(2008-2#1)
In Planta##5##2##(2008-10#5)
In Russia##2##2##(1994-12#1)(1997-1#1)
In S##5##2##(1990-7#1)(1991-5#1)(1994-12#1)(2008-10#2)
In SD##2##2##(1996-5#2)
In SLE##2##2##(2010-5#1)(2013-1#1)
In Saccharomyces cerevisiae##3##3##(1990-5#1)(1992-11#1)(1996-3#1)
In September##4##2##(1992-2#1)(1995-12#1)(2008-5#2)
In Silico##2##2##(2012-3#1)(2013-8#1)
In Situ##5##2##(2008-1#1)(2008-10#2)(2008-3#1)(2012-2#1)
In South##2##2##(2010-3#1)(2012-3#1)
In Southeast##2##2##(1997-5#1)(2012-12#1)
In Stage##2##2##(2007-8#2)
In Study 1##7##3##(2007-12#1)(2007-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)
In Study 2##4##3##(2007-8#1)(2009-9#1)(2010-10#1)(2010-8#1)
In Study##13##2##(2007-12#3)(2007-8#2)(2009-5#1)(2009-9#2)(2010-10#2)(2010-4#1)(2010-8#2)
In Switzerland##3##2##(1996-6#1)(1997-3#1)(1997-8#1)
In T47D cells that contained low levels of estrogen receptor (0##2##11##(2008-11#2)
In The##2##2##(2012-3#1)(2013-8#1)
In Vitro Transcripts##2##3##(2008-10#2)
In Vitro and In Vivo##3##5##(2008-10#2)(2012-2#1)
In Vitro and In##4##4##(2008-10#3)(2012-2#1)
In Vitro and##5##3##(2008-10#3)(2009-12#1)(2012-2#1)
In Vitro##19##2##(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#1)
In Vivo##8##2##(2008-10#2)(2009-2#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
In Western blot##2##3##(1992-11#1)(1993-12#1)
In Western##5##2##(1992-11#1)(1993-12#1)(1995-11#1)(2008-1#1)(2011-1#1)
In a binary##2##3##(2008-3#1)(2008-7#1)
In a case##2##3##(2006-10#1)(2011-2#1)
In a clinical##2##3##(1993-11#1)(2010-1#1)
In a companion paper##2##4##(2008-2#1)(2009-8#1)
In a companion##3##3##(1991-2#1)(2008-2#1)(2009-8#1)
In a comparison of the##2##5##(2008-3#1)(2010-8#1)
In a comparison of##4##4##(1991-2#1)(1997-5#1)(2008-3#1)(2010-8#1)
In a comparison##5##3##(1991-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
In a continuing##2##3##(1997-2#1)(2013-1#1)
In a cross-sectional study##3##4##(2009-12#1)(2011-2#2)
In a cross-sectional##4##3##(2007-1#1)(2009-12#1)(2011-2#2)
In a direct##2##3##(2008-10#1)(2008-9#1)
In a double blind##2##4##(2008-5#1)(2008-7#1)
In a few cases##2##4##(2008-10#2)
In a few##4##3##(2008-10#4)
In a field experiment##3##4##(2008-10#2)(2008-8#1)
In a field trial##2##4##(2008-10#2)
In a field##7##3##(2008-10#6)(2008-8#1)
In a first step##8##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#1)
In a greenhouse##2##3##(2008-10#2)
In a group of##5##4##(1990-11#1)(1993-2#1)(1994-6#1)(1996-3#1)(2007-8#1)
In a group##6##3##(1990-11#1)(1993-2#1)(1994-6#1)(1996-3#1)(2007-8#1)(2012-3#1)
In a hospital-based case-control study of##2##6##(1993-9#2)
In a hospital-based##3##3##(1993-9#2)(2007-10#1)
In a large number of##2##5##(1993-11#1)(2008-8#1)
In a multicenter##3##3##(1990-6#1)(1992-11#1)(2013-1#1)
In a multiple regression##2##4##(2010-11#1)(2012-12#1)
In a multivariate analysis##2##4##(1993-1#1)(1995-4#1)
In a multivariate##3##3##(1993-1#1)(1995-4#1)(1996-9#1)
In a novel##2##3##(1994-11#1)(2010-3#1)
In a patient with##2##4##(1992-6#1)(2011-2#1)
In a patient##3##3##(1992-6#1)(1994-11#1)(2011-2#1)
In a phase##2##3##(2008-3#1)(2008-5#1)
In a pilot study##2##4##(1990-8#1)(1994-12#1)
In a population of##2##4##(1992-6#1)(1996-6#1)
In a preliminary##5##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
In a previous article##2##4##(1992-3#1)(2008-11#1)
In a previous paper##5##4##(1991-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
In a previous report we##2##5##(1990-4#1)(1990-7#1)
In a previous report##4##4##(1990-4#1)(1990-7#1)(1995-2#2)
In a previous study##9##4##(1995-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
In a previous##27##3##(1990-4#1)(1990-7#1)(1991-12#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
In a prospective randomised##2##4##(1995-6#1)(2012-2#1)
In a prospective study of##3##5##(1990-2#2)(1990-5#1)
In a prospective study##8##4##(1990-11#1)(1990-2#2)(1990-5#1)(1996-2#1)(2007-10#1)(2007-2#1)(2011-2#1)
In a prospective##14##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(2007-10#1)(2007-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
In a random##2##3##(1990-6#1)(1992-1#1)
In a randomized##4##3##(1990-6#1)(1994-11#1)(1995-1#1)(2008-10#1)
In a recent Letter##2##4##(2007-12#1)(2008-10#1)
In a recent paper in Planta##2##6##(2009-8#2)
In a recent paper##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#2)
In a recent study##9##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-3#1)
In a recent##23##3##(1991-9#1)(1992-12#1)(1992-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#4)(2010-11#2)(2010-4#1)(2011-2#2)(2012-3#1)
In a related##2##3##(2007-11#1)(2008-10#1)
In a research##2##3##(2008-1#1)(2008-10#1)
In a retrospective study the##2##5##(1993-8#1)(1996-6#1)
In a retrospective study##5##4##(1990-10#1)(1993-8#1)(1995-5#1)(1996-11#1)(1996-6#1)
In a retrospective##10##3##(1990-10#1)(1993-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-12#1)
In a review##2##3##(1995-8#1)(2008-7#1)
In a sample of##5##4##(2007-12#1)(2009-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
In a screen for##2##4##(2008-10#1)(2008-9#1)
In a screen##3##3##(2008-10#1)(2008-9#2)
In a second experiment##3##4##(1996-12#1)(2008-10#2)
In a second field##2##4##(2008-10#2)
In a second step##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
In a second study##3##4##(1994-2#1)(2008-10#1)(2008-2#1)
In a second##24##3##(1991-12#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)
In a separate##2##3##(1990-3#1)(2008-8#1)
In a series of experiments##2##5##(2008-3#1)(2008-8#1)
In a series of##5##4##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
In a significant##2##3##(1992-4#1)(2011-2#1)
In a similar manner##2##4##(1995-3#1)(2008-11#1)
In a simple##4##3##(1992-12#1)(2008-3#1)(2008-8#2)
In a single##3##3##(1992-11#1)(1997-6#1)(2008-10#1)
In a small##2##3##(2008-5#1)(2009-12#1)
In a special##2##3##(1997-3#1)(2011-2#1)
In a study of##4##4##(1991-6#1)(1991-9#1)(1995-1#1)(2007-2#1)
In a study##6##3##(1991-6#1)(1991-9#1)(1994-11#1)(1995-1#1)(2007-11#1)(2007-2#1)
In a subsequent experiment##2##4##(1990-5#1)(2008-10#1)
In a subsequent##5##3##(1990-5#1)(1996-2#1)(2008-10#2)(2008-12#1)
In a survey##2##3##(1991-5#1)(1993-6#1)
In a third##3##3##(2008-10#2)(2011-2#1)
In a total of##3##4##(1991-8#1)(1994-2#1)(2008-12#1)
In a total##4##3##(1991-12#1)(1991-8#1)(1994-2#1)(2008-12#1)
In a typical##2##3##(2008-10#1)(2008-4#1)
In a word##2##3##(2008-8#1)(2011-3#1)
In a##441##2##(1990-10#2)(1990-11#4)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#6)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-6#2)(1994-8#3)(1995-1#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(2006-10#2)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#9)(2007-2#4)(2007-8#1)(2008-1#3)(2008-10#75)(2008-11#8)(2008-12#2)(2008-2#11)(2008-3#28)(2008-4#4)(2008-5#13)(2008-6#5)(2008-7#16)(2008-8#13)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#2)
In about##4##2##(1991-8#2)(2008-5#1)(2009-3#1)
In absence of##2##3##(2008-10#1)(2008-11#1)
In accordance with the##4##4##(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)
In accordance with##9##3##(1990-3#1)(1995-6#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
In accordance##11##2##(1990-3#1)(1995-6#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
In acidic conditions##2##3##(2008-10#2)
In acidic media##2##3##(1995-8#1)(2008-10#1)
In acidic##5##2##(1995-8#1)(2008-10#4)
In acute##3##2##(1995-12#1)(1995-5#1)(1996-1#1)
In addition a##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
In addition all##2##3##(2008-9#1)(2012-3#1)
In addition the##7##3##(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-2#1)(2010-6#1)
In addition there is##2##4##(2007-8#1)(2008-9#1)
In addition there##6##3##(1990-11#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)
In addition they##2##3##(1990-6#1)(2008-10#1)
In addition to a##8##4##(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-1#1)
In addition to being##5##4##(1990-11#1)(1991-11#1)(1992-8#1)(1993-3#1)(2008-10#1)
In addition to binding##2##4##(1990-11#1)(2008-11#1)
In addition to clinical##3##4##(1995-5#1)(2007-11#1)(2008-2#1)
In addition to demonstrating the##2##5##(1996-8#1)(2012-2#1)
In addition to examining change in appraisals##2##7##(2013-1#2)
In addition to examining##3##4##(2008-3#1)(2013-1#2)
In addition to its##8##4##(1990-6#1)(1991-5#1)(1993-12#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-2#1)(2010-7#1)
In addition to providing##7##4##(1993-3#1)(1995-3#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-4#1)
In addition to reducing##2##4##(1995-5#1)(2008-7#1)
In addition to simple##2##4##(2008-3#1)(2008-4#1)
In addition to the above##2##5##(1994-3#1)(2008-11#1)
In addition to the expected##3##5##(1991-6#1)(2008-3#1)(2008-5#1)
In addition to the usual##2##5##(1997-2#1)(2008-10#1)
In addition to the##66##4##(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
In addition to their##7##4##(1993-5#1)(1994-8#1)(1995-3#1)(2008-10#3)(2011-1#1)
In addition to these##8##4##(1993-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
In addition to this##9##4##(1990-8#1)(1991-3#1)(1992-2#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
In addition to##242##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#33)(2008-11#11)(2008-12#3)(2008-2#7)(2008-3#12)(2008-4#7)(2008-5#8)(2008-7#11)(2008-8#3)(2008-9#4)(2009-10#2)(2009-2#1)(2009-4#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#2)
In addition we##5##3##(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
In addition##1606##2##(1990-11#7)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#7)(1990-6#5)(1990-7#4)(1990-8#9)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#6)(1991-6#3)(1991-8#5)(1991-9#7)(1992-1#2)(1992-11#4)(1992-12#12)(1992-2#7)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#7)(1992-9#4)(1993-11#6)(1993-12#11)(1993-2#5)(1993-3#7)(1993-5#1)(1993-6#5)(1993-8#6)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#12)(1994-2#8)(1994-3#6)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#8)(1994-9#3)(1995-11#10)(1995-12#12)(1995-2#22)(1995-3#7)(1995-5#7)(1995-6#13)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#12)(1996-2#15)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#9)(1997-2#8)(1997-3#9)(1997-4#6)(1997-5#3)(1997-6#8)(1997-7#7)(1997-8#5)(1997-9#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#6)(2007-11#18)(2007-12#27)(2007-2#3)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#19)(2008-10#250)(2008-11#68)(2008-12#19)(2008-2#46)(2008-3#72)(2008-4#44)(2008-5#54)(2008-6#10)(2008-7#68)(2008-8#40)(2008-9#50)(2009-1#2)(2009-10#8)(2009-12#6)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#9)(2009-6#5)(2009-7#12)(2009-8#8)(2009-9#11)(2010-1#4)(2010-10#8)(2010-11#4)(2010-12#12)(2010-2#2)(2010-3#4)(2010-4#7)(2010-5#7)(2010-6#5)(2010-7#5)(2010-8#12)(2010-9#2)(2011-1#16)(2011-10#2)(2011-2#67)(2012-1#8)(2012-12#22)(2012-2#32)(2012-3#19)(2012-4#1)(2012-7#1)(2013-1#41)(2013-7#4)(2013-8#21)
In adult tissues##2##3##(1992-12#1)(2009-12#1)
In adult##8##2##(1992-12#1)(1992-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-3#1)(2012-2#1)
In adults the##2##3##(1996-7#1)(2008-1#1)
In adults##11##2##(1991-4#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
In aerobic conditions##2##3##(1993-8#1)(1997-4#1)
In agreement with the##3##4##(1994-6#1)(2008-10#2)
In agreement with##7##3##(1990-10#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)
In alcoholic##2##2##(2009-7#1)(2011-1#1)
In alkaline media##2##3##(1995-8#1)(2008-10#1)
In alkaline##4##2##(1995-8#1)(2008-10#3)
In all 10 patients with##2##5##(1991-5#2)
In all 3##2##3##(1996-6#1)(2008-10#1)
In all but one case##2##5##(2008-10#1)(2008-6#1)
In all but one##4##4##(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#1)
In all but##5##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
In all cases but one the##2##6##(1990-9#1)(1996-9#1)
In all cases but one##3##5##(1990-9#1)(1996-9#1)(2007-11#1)
In all cases the##9##4##(1993-8#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
In all cases##51##3##(1990-9#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-11#7)(2007-8#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
In all four cases##2##4##(1990-5#1)(2007-11#1)
In all four##3##3##(1990-5#1)(1995-6#1)(2007-11#1)
In all instances##4##3##(1990-11#1)(1991-12#1)(1995-5#1)(1996-2#1)
In all models##2##3##(2007-10#1)(2008-10#1)
In all of them##2##4##(1993-9#1)(1997-7#1)
In all of these##5##4##(1991-9#1)(1994-12#1)(1997-3#1)(2008-1#1)(2009-8#1)
In all of##9##3##(1991-9#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-7#1)(2009-8#1)
In all other##2##3##(1993-3#1)(2008-11#1)
In all patients the##5##4##(1991-3#1)(1996-6#1)(2007-11#1)(2013-1#2)
In all patients treated##2##4##(2007-8#1)(2008-6#1)
In all patients##18##3##(1990-3#1)(1991-3#1)(1996-6#1)(1997-8#2)(2007-11#2)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-1#3)
In all the cases##6##4##(1990-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2012-2#1)
In all the##8##3##(1990-7#1)(1993-6#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-9#1)(2012-2#1)
In all these cases##2##4##(2008-10#2)
In all these##4##3##(1990-12#1)(2008-10#2)(2012-3#1)
In all three cases##2##4##(1993-11#1)(2008-7#1)
In all three##6##3##(1993-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
In all trials##2##3##(2008-10#1)(2010-3#1)
In all##189##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#11)(2007-12#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#45)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#6)(2011-3#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#1)
In almost##3##2##(1991-3#1)(1992-11#1)(2010-3#1)
In an additional##4##3##(1991-2#1)(1996-3#1)(2008-10#1)(2013-8#1)
In an alternative##2##3##(1995-2#1)(2008-11#1)
In an analysis of##2##4##(1991-12#1)(2008-10#1)
In an attempt to achieve##2##5##(2008-3#1)(2009-12#1)
In an attempt to better understand the##2##7##(2008-10#2)
In an attempt to develop##4##5##(1992-11#1)(2008-10#2)(2011-2#1)
In an attempt to identify##2##5##(2008-8#1)(2013-8#1)
In an attempt to##32##4##(1990-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#2)(2011-2#1)(2013-8#2)
In an earlier paper##2##4##(2008-10#2)
In an earlier##4##3##(2008-10#3)(2008-12#1)
In an early##3##3##(2007-7#1)(2008-10#2)
In an effort to better understand the##2##7##(1993-1#1)(2008-7#1)
In an effort to better understand##3##6##(1993-1#1)(2008-10#1)(2008-7#1)
In an effort to develop##2##5##(2008-10#2)
In an effort to gain control of the market##2##9##(1994-3#2)
In an effort to identify##2##5##(1993-2#1)(2013-1#1)
In an effort to increase##2##5##(1997-3#1)(2010-8#1)
In an effort to##22##4##(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#2)(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
In an experiment##4##3##(1994-11#1)(2007-11#1)(2008-3#2)
In an experimental##2##3##(1996-2#1)(2007-12#1)
In an ideal##2##3##(1993-12#1)(2008-3#1)
In an in vitro test##2##5##(2008-10#1)(2008-5#1)
In an in vitro##6##4##(1991-8#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
In an in##7##3##(1991-8#1)(1993-12#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
In an irritancy study in which##2##6##(2008-9#2)
In an open-label##2##3##(2008-10#1)(2008-5#1)
In an##129##2##(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#33)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#10)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2013-1#2)(2013-8#4)
In analogy##2##2##(1993-11#1)(2009-6#1)
In analysis of##2##3##(2008-12#1)(2013-8#1)
In and Pb##2##3##(2008-10#2)
In anesthetized##2##2##(1997-1#1)(2008-5#1)
In animal cells##3##3##(2008-11#1)(2008-8#2)
In animal models of##2##4##(1996-9#1)(1997-7#1)
In animal models##4##3##(1996-9#1)(1997-7#1)(2008-5#1)(2013-1#1)
In animal##9##2##(1996-9#1)(1997-7#2)(2008-11#1)(2008-5#2)(2008-8#2)(2013-1#1)
In animals lesioned between##2##4##(1996-5#2)
In animals##5##2##(1996-5#3)(1997-2#1)(2008-7#1)
In another experiment##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
In another##15##2##(1990-11#1)(1991-11#1)(1991-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
In anticipation of##2##3##(1993-2#1)(1995-1#1)
In any case##8##3##(1990-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
In any##13##2##(1990-6#1)(1993-3#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
In approximately 40-50% of the patients##2##6##(2008-9#2)
In aqueous solution##2##3##(2008-10#1)(2008-9#1)
In areas of##2##3##(1994-11#2)
In areas where##2##3##(1991-6#1)(2008-10#1)
In areas##5##2##(1991-6#1)(1994-11#2)(2008-10#2)
In assays##2##2##(1991-9#1)(2008-4#1)
In attempts to##2##3##(2008-11#1)(2013-8#1)
In autumn 1991##2##3##(1992-6#2)
In autumn##3##2##(1992-6#2)(2008-2#1)
In batch cultures##3##3##(2008-11#2)(2008-7#1)
In batch fermentations with##2##4##(2008-6#1)(2008-7#1)
In batch##7##2##(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#2)
In benign##2##2##(2011-2#1)(2013-1#1)
In bioassays##2##2##(2008-10#2)
In blood##2##2##(1997-7#1)(2008-10#1)
In bone##2##2##(2008-7#1)(2011-2#1)
In both RES and ELI MOs##2##6##(1990-2#2)
In both cases the##8##4##(1993-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-2#1)
In both cases##36##3##(1993-11#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)
In both complexes the##2##4##(1995-3#1)(1996-2#1)
In both experiments##2##3##(2008-10#2)
In both groups##12##3##(1990-5#1)(1991-11#1)(1993-12#1)(1994-2#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
In both human and##2##4##(2008-4#1)(2012-12#1)
In both men and women##2##5##(2011-1#1)(2013-1#1)
In both patients the##2##4##(1991-3#1)(2008-7#1)
In both patients##3##3##(1990-10#1)(1991-3#1)(2008-7#1)
In both procedures##2##3##(2008-4#1)(2008-9#1)
In both sexes##2##3##(2008-11#1)(2008-7#1)
In both species##3##3##(2008-5#1)(2008-7#1)(2009-9#1)
In both studies##3##3##(2008-9#2)(2012-12#1)
In both systems##3##3##(1992-12#1)(2008-10#1)(2009-12#1)
In both the##7##3##(1990-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
In both tissues##2##3##(1996-2#1)(2008-10#1)
In both types of##2##4##(2008-11#1)(2010-9#1)
In both types##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
In both years##4##3##(2008-10#4)
In both##158##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#29)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#3)(2009-12#3)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#1)
In brain##2##2##(1996-2#2)
In breast cancer##2##3##(2011-1#1)(2011-2#1)
In building##2##2##(2008-10#1)(2008-7#1)
In cancer##2##2##(2008-10#1)(2008-11#1)
In carefully##2##2##(1990-6#1)(1991-12#1)
In case 1##2##3##(2006-12#2)
In case of the##2##4##(1994-8#1)(2008-10#1)
In case of##17##3##(1990-3#1)(1994-8#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
In case the##2##3##(2007-8#1)(2008-11#1)
In case##25##2##(1990-3#1)(1994-8#1)(1996-11#1)(1996-12#1)(2006-12#3)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#3)(2013-1#3)(2013-8#1)
In cases of##8##3##(1991-8#2)(1995-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-2#1)
In cases where these##2##4##(2008-11#1)(2011-2#1)
In cases where##11##3##(1990-5#1)(1991-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
In cases with##5##3##(1996-8#1)(1997-1#1)(2007-11#1)(2007-8#1)(2011-2#1)
In cases##28##2##(1990-5#1)(1991-8#2)(1991-9#1)(1994-3#1)(1995-11#1)(1996-8#1)(1997-1#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#3)(2012-2#1)(2013-8#1)
In cell lines##2##3##(1993-9#1)(2008-10#1)
In cell##3##2##(1990-2#1)(1993-9#1)(2008-10#1)
In cells##5##2##(1990-8#1)(1992-12#1)(2008-11#2)(2008-7#1)
In certain cases##3##3##(1997-7#1)(2008-10#2)
In certain##6##2##(1997-7#1)(2008-10#3)(2008-3#1)(2010-3#1)
In children with vomiting related to acute gastroenteritis##2##8##(2009-5#2)
In children with##4##3##(2007-8#1)(2008-11#1)(2009-5#2)
In children##9##2##(2007-8#1)(2008-11#1)(2009-5#2)(2011-2#3)(2013-1#2)
In choosing##2##2##(1992-8#1)(2007-12#1)
In chronic##4##2##(1993-11#1)(1995-3#1)(2007-12#1)(2009-8#1)
In clinical practice##5##3##(1992-12#1)(1997-8#1)(2009-3#1)(2012-12#1)(2013-8#1)
In clinical studies##2##3##(1996-2#1)(2008-3#1)
In clinical trials##4##3##(1997-4#1)(2007-10#1)(2008-3#2)
In clinical##14##2##(1990-5#1)(1992-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-3#3)(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
In clinically##2##2##(1991-6#1)(2013-8#1)
In co-cultures of##2##3##(2008-7#2)
In cold##2##2##(2008-10#1)(2008-7#1)
In colorectal cancer##2##3##(2013-1#2)
In column operation##2##3##(2008-10#2)
In column##3##2##(2008-10#2)(2008-6#1)
In combination with##9##3##(1994-2#1)(1995-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
In combination##11##2##(1994-2#1)(1994-9#1)(1995-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)
In common with##3##3##(1993-11#1)(1993-12#1)(2008-6#1)
In common##4##2##(1993-11#1)(1993-12#1)(2008-6#1)(2008-8#1)
In comparing##4##2##(1994-12#1)(2008-8#2)(2012-3#1)
In comparison of##2##3##(1990-10#1)(2008-8#1)
In comparison to a##2##4##(2008-10#1)(2008-7#1)
In comparison to the##7##4##(1990-2#1)(1991-6#1)(1993-2#1)(1996-1#1)(2008-10#2)(2012-3#1)
In comparison to##17##3##(1990-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-3#1)(1996-1#1)(2008-10#5)(2008-12#2)(2008-7#1)(2010-3#1)(2010-5#1)(2012-3#1)
In comparison with most##2##4##(2008-10#2)
In comparison with other##4##4##(1990-3#1)(1994-11#1)(1996-5#1)(2008-10#1)
In comparison with the control group##2##6##(2007-10#1)(2008-10#1)
In comparison with the##9##4##(1995-9#1)(1996-11#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-8#2)
In comparison with##33##3##(1990-11#1)(1990-3#1)(1991-8#1)(1994-11#1)(1995-9#1)(1996-11#1)(1996-5#2)(2007-10#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#4)(2009-8#1)(2010-5#1)(2013-1#1)
In comparison##65##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-5#2)(2007-10#2)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2009-8#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-3#1)(2013-1#1)
In comparisons##2##2##(1992-10#1)(2008-10#1)
In compliance##7##2##(2007-3#1)(2008-4#5)(2008-6#1)
In conclusion it is##2##4##(1992-3#1)(1995-2#1)
In conclusion it##3##3##(1992-3#1)(1995-2#1)(2008-12#1)
In conclusion our##3##3##(2008-7#2)(2011-2#1)
In conclusion the##2##3##(1990-12#1)(2008-1#1)
In conclusion we##2##3##(1995-12#1)(2011-2#1)
In conclusion##329##2##(1990-11#1)(1990-12#3)(1990-8#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#4)(2007-8#8)(2008-1#15)(2008-10#18)(2008-11#14)(2008-12#8)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#17)(2008-6#1)(2008-7#17)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#3)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#5)(2010-4#3)(2010-6#3)(2010-8#5)(2011-1#5)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#8)(2012-7#1)(2013-1#23)(2013-7#5)(2013-8#9)
In conjunction with a##2##4##(2007-12#1)(2008-10#1)
In conjunction with the##3##4##(2010-10#1)(2012-2#1)(2013-1#1)
In conjunction with##8##3##(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-2#1)(2013-1#1)
In consequence##4##2##(1992-11#1)(1995-3#1)(2008-10#1)(2008-11#1)
In considering the##2##3##(2008-10#1)(2010-12#1)
In considering##3##2##(2008-1#1)(2008-10#1)(2010-12#1)
In contact with##2##3##(2007-12#1)(2008-10#1)
In continuous##2##2##(1993-2#1)(2008-11#1)
In contrast the##5##3##(1996-12#2)(2008-11#1)(2012-2#1)(2013-8#1)
In contrast to a##2##4##(1990-10#1)(1992-12#1)
In contrast to all other##2##5##(1990-7#1)(2007-12#1)
In contrast to conventional##3##4##(2008-3#2)(2008-5#1)
In contrast to earlier##2##4##(1993-6#1)(2008-5#1)
In contrast to existing##3##4##(2008-2#1)(2008-6#1)(2012-12#1)
In contrast to expectations##2##4##(2008-10#1)(2010-8#1)
In contrast to other##6##4##(1996-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-9#1)(2013-1#1)
In contrast to previous##5##4##(1993-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
In contrast to results with##2##5##(1993-11#1)(2008-10#1)
In contrast to the predominance of##2##6##(1992-6#1)(2008-6#1)
In contrast to the##48##4##(1990-10#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2013-2#1)
In contrast to their##4##4##(1991-2#1)(1993-6#1)(2010-10#1)(2013-1#1)
In contrast to these##4##4##(1997-7#1)(2008-8#2)(2012-12#1)
In contrast to this##6##4##(1990-12#1)(1992-4#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-3#1)
In contrast to what##2##4##(2008-12#1)(2008-3#1)
In contrast to##162##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-6#5)(1993-8#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#4)(2009-11#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-2#1)(2013-8#1)
In contrast with previous##2##4##(2008-2#1)(2009-12#1)
In contrast with the##2##4##(2007-11#1)(2007-12#1)
In contrast with##11##3##(1991-11#1)(1991-8#1)(1994-11#1)(1995-6#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
In contrast##764##2##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#4)(1990-7#5)(1990-8#2)(1991-11#3)(1991-12#9)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#4)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#8)(1993-8#7)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#8)(1994-3#1)(1994-5#8)(1994-6#3)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#10)(1995-12#13)(1995-2#20)(1995-3#5)(1995-5#6)(1995-6#6)(1995-8#5)(1996-11#1)(1996-12#13)(1996-2#8)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#7)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#146)(2008-11#38)(2008-12#3)(2008-2#9)(2008-3#13)(2008-4#8)(2008-5#17)(2008-6#7)(2008-7#23)(2008-8#18)(2008-9#16)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#6)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#4)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#9)(2012-7#1)(2013-1#12)(2013-2#1)(2013-7#2)(2013-8#5)
In control rats##2##3##(1994-11#1)(2008-7#1)
In control##14##2##(1990-12#1)(1994-11#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2013-1#1)(2013-8#1)
In controlled##3##2##(2008-10#2)(2010-4#1)
In controls##4##2##(1993-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
In conventional##2##2##(2011-1#1)(2013-8#1)
In countries like##2##3##(2012-12#1)(2013-8#1)
In countries##4##2##(1996-8#1)(2007-11#1)(2012-12#1)(2013-8#1)
In crown##2##2##(2008-10#2)
In crystals##2##2##(2008-3#2)
In cultured rat##3##3##(1990-12#1)(1993-12#1)(1993-8#1)
In cultured vascular smooth muscle cells##2##6##(1992-9#1)(1993-3#1)
In cultured##6##2##(1990-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#1)
In cultures##2##2##(1993-12#1)(2008-11#1)
In cw##2##2##(2007-11#1)(2007-12#1)
In deciding##3##2##(1991-3#1)(1992-12#1)(1996-1#1)
In decisions under##2##3##(2009-10#2)
In dermatitis seborrhoeica##2##3##(2008-5#2)
In developed countries##5##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
In developing countries##5##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
In developing##7##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
In different##2##2##(1997-3#1)(2013-8#1)
In difficult##2##2##(1994-3#1)(1995-5#1)
In discussion##2##2##(2008-10#1)(2008-11#1)
In doing so##4##3##(1991-9#1)(2007-11#1)(2008-2#1)(2010-8#1)
In doing##5##2##(1991-9#1)(2007-11#1)(2008-2#1)(2010-8#1)(2012-2#1)
In drinking water##2##3##(2007-6#1)(2008-9#1)
In each case##13##3##(1990-12#1)(1990-8#1)(1995-3#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
In each experiment##7##3##(1993-9#1)(2008-10#5)(2011-1#1)
In each group##2##3##(2008-5#2)
In each of 2 years##2##5##(2008-10#2)
In each of the##2##4##(1992-9#1)(2008-10#1)
In each of##7##3##(1992-9#1)(1993-3#1)(2008-10#5)
In each orchard##2##3##(2008-10#2)
In each##58##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-7#2)
In earlier studies##3##3##(2008-3#1)(2008-7#1)(2010-7#1)
In earlier##6##2##(1990-7#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-7#1)
In early##9##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2013-1#1)
In eight patients##2##3##(1994-9#1)(2008-9#1)
In eight##6##2##(1992-11#1)(1994-9#1)(1995-12#1)(1996-9#1)(2007-8#1)(2008-9#1)
In either case##4##3##(1995-5#1)(2008-10#2)(2008-7#1)
In either##7##2##(1995-2#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-7#1)(2010-4#1)
In elderly patients##3##3##(1996-2#1)(2007-8#1)(2008-7#1)
In elderly##4##2##(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
In empirical##2##2##(2008-7#1)(2009-9#1)
In endoscopic##2##2##(2008-3#1)(2013-1#1)
In essence##6##2##(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)
In ethanol##2##2##(2007-11#1)(2008-6#1)
In eukaryotes##4##2##(1993-12#1)(1996-2#1)(2008-7#1)(2009-6#1)
In every case##5##3##(1992-3#1)(1993-12#1)(1993-6#1)(2007-11#1)(2008-5#1)
In every##6##2##(1992-3#1)(1993-12#1)(1993-6#1)(1996-6#1)(2007-11#1)(2008-5#1)
In excised##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
In experienced hands##2##3##(1994-2#1)(2008-10#1)
In experiment 1##6##3##(1994-8#1)(2007-12#1)(2008-10#1)(2010-2#2)(2010-8#1)
In experiment 2##5##3##(1994-8#1)(2007-12#1)(2008-10#1)(2010-2#2)
In experiment##13##2##(1994-8#2)(2007-12#2)(2008-10#4)(2010-2#4)(2010-8#1)
In experimental##5##2##(1992-9#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)
In experiments on##2##3##(2008-10#1)(2013-1#1)
In experiments using##3##3##(1990-12#1)(2008-11#2)
In experiments with a race##2##5##(2008-10#2)
In experiments##11##2##(1990-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2009-12#1)(2013-1#1)
In exposed males##2##3##(2008-9#2)
In extracellular##2##2##(1994-2#1)(2010-4#1)
In extreme cases##2##3##(2008-10#2)
In fact the##2##3##(1996-12#1)(1996-4#1)
In fact##82##2##(1990-8#2)(1991-12#1)(1991-2#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-2#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
In fair##2##2##(2008-10#1)(2008-7#1)
In female##5##2##(1994-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
In females##5##2##(1992-3#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
In fetal##2##2##(1996-12#1)(2012-2#1)
In fibers with##2##3##(2008-2#1)(2008-3#1)
In field experiments##4##3##(2008-10#3)(2008-8#1)
In field studies##3##3##(2008-10#3)
In field##10##2##(1997-6#1)(2008-10#8)(2008-8#1)
In finding##2##2##(2009-7#2)
In first##2##2##(2010-8#1)(2012-3#1)
In five of these##2##4##(2008-9#1)(2013-1#1)
In five of##3##3##(1992-5#1)(2008-9#1)(2013-1#1)
In five patients##2##3##(1996-9#1)(1997-3#1)
In five##14##2##(1992-5#1)(1993-2#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-1#1)
In food##2##2##(2008-10#1)(2012-2#1)
In four cases##2##3##(1990-9#1)(2008-9#1)
In four of##2##3##(2008-10#1)(2013-8#1)
In four##6##2##(1990-9#1)(1993-12#1)(1994-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
In free water##2##3##(2008-10#2)
In fresh apples##2##3##(2008-10#2)
In further studies##2##3##(1990-12#1)(2008-11#1)
In further##5##2##(1990-12#1)(2007-12#1)(2008-11#2)(2008-4#1)
In future studies##2##3##(1992-3#1)(2012-2#1)
In future##7##2##(1992-3#1)(1994-1#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-2#2)
In general the##2##3##(2008-11#1)(2008-2#1)
In general##121##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-6#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#7)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
In genetically normal##2##3##(2008-7#2)
In genotypes with##2##3##(2008-10#2)
In glands##2##2##(1997-6#1)(2007-12#1)
In grapevine leaves##2##3##(2008-10#2)
In grapevine##3##2##(2008-10#3)
In greenhouse experiments##4##3##(2008-10#4)
In greenhouse studies with##2##4##(2008-10#2)
In greenhouse studies##5##3##(2008-10#5)
In greenhouse tests##2##3##(2008-10#2)
In greenhouse##13##2##(2008-10#13)
In group 1##4##3##(1992-6#1)(2009-10#1)(2011-2#2)
In group 2##2##3##(2009-10#1)(2011-2#1)
In group A##2##3##(2007-8#1)(2008-1#1)
In group B##3##3##(1990-6#1)(2007-8#1)(2008-5#1)
In group I##2##3##(2006-12#1)(2007-11#1)
In group with##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
In group##18##2##(1990-6#1)(1992-6#1)(2006-12#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-5#1)(2009-10#2)(2011-2#5)(2012-3#1)
In growth chamber experiments##4##4##(2008-10#4)
In growth chamber##5##3##(2008-10#5)
In growth##6##2##(2008-10#5)(2008-5#1)
In growth-chamber##2##2##(2008-10#2)
In health care##5##3##(1993-1#1)(1993-12#1)(1995-2#1)(1996-3#1)(2008-12#1)
In healthy individuals##2##3##(1993-9#1)(1996-5#1)
In healthy skin##2##3##(2008-5#2)
In healthy subjects##3##3##(2008-7#1)(2009-8#1)(2011-1#1)
In healthy##9##2##(1993-9#1)(1996-12#1)(1996-5#1)(2008-5#3)(2008-7#1)(2009-8#1)(2011-1#1)
In hematology##2##2##(1997-5#1)(2010-2#1)
In hematopoietic##2##2##(2008-11#1)(2008-5#1)
In her##2##2##(1993-2#1)(1994-1#1)
In high risk##2##3##(1996-11#1)(2007-12#1)
In high##3##2##(1996-11#1)(2007-12#1)(2008-8#1)
In higher##3##2##(1990-6#1)(2008-8#1)(2009-10#1)
In highly##4##2##(1996-4#1)(2008-12#1)(2011-2#1)(2013-8#1)
In his##8##2##(1995-1#1)(1995-6#1)(1996-1#1)(1996-6#1)(2007-5#1)(2008-8#1)(2009-10#1)(2010-5#1)
In human breast cancer##2##4##(1993-1#1)(2011-2#1)
In human##15##2##(1990-12#1)(1991-12#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-4#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
In humans##11##2##(1992-11#1)(2008-4#1)(2009-10#1)(2009-5#2)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
In hypertension##2##2##(2009-1#1)(2010-4#1)
In immunofluorescence##2##2##(1992-11#1)(1994-2#1)
In in vitro##3##3##(1991-12#1)(2008-10#1)(2011-1#1)
In in##9##2##(1991-12#1)(2008-10#6)(2011-1#2)
In individuals##2##2##(2008-3#1)(2011-2#1)
In infants##3##2##(1992-2#1)(2008-10#1)(2013-1#1)
In infected##2##2##(2008-10#2)
In inflamed##2##2##(1993-2#1)(2012-3#1)
In initial experiments##2##3##(2008-3#1)(2008-5#1)
In initial##6##2##(1992-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-3#1)
In inoculated##3##2##(2008-10#3)
In insects##4##2##(2007-12#4)
In intact##6##2##(1990-12#1)(1993-12#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-5#1)
In isolated rat##2##3##(1994-6#1)(1996-2#1)
In isolated##6##2##(1992-6#2)(1994-11#1)(1994-6#1)(1996-2#1)(2007-8#1)
In its##11##2##(1990-11#1)(1991-12#1)(1993-6#1)(1996-1#1)(2007-12#2)(2008-10#3)(2009-2#1)(2012-1#1)
In keeping with other##2##4##(1990-6#1)(2008-12#1)
In keeping with the##2##4##(2008-7#1)(2010-4#1)
In keeping with this##2##4##(1995-6#1)(1997-4#1)
In keeping with##7##3##(1990-6#1)(1995-6#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
In laboratory studies##2##3##(2008-10#2)
In laboratory##6##2##(2008-10#3)(2009-8#1)(2010-8#1)(2011-2#1)
In large##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
In larvae##2##2##(2007-12#1)(2010-8#1)
In late##7##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-2#1)(2011-1#1)(2011-2#1)
In later stages##2##3##(2011-2#1)(2013-1#1)
In later##3##2##(2011-2#2)(2013-1#1)
In leaf##2##2##(2008-10#1)(2009-6#1)
In leaves##2##2##(2008-10#2)
In less than##2##3##(2009-3#1)(2010-11#1)
In less##3##2##(2008-11#1)(2009-3#1)(2010-11#1)
In leucine-depleted##2##2##(2008-11#2)
In light of the##10##4##(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-5#1)(2011-2#2)
In light of these findings##3##5##(2010-2#1)(2010-8#1)(2013-8#1)
In light of##23##3##(1994-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2009-2#2)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
In line with the##5##4##(1996-7#1)(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
In line with##9##3##(1995-3#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)(2012-2#2)
In liver and##2##3##(1991-2#1)(2013-1#1)
In liver##5##2##(1990-3#1)(1991-2#1)(1992-11#1)(1996-2#1)(2013-1#1)
In long-term follow-up##2##3##(2007-11#1)(2007-8#1)
In long-term##4##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)
In low##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
In lower##2##2##(1991-12#1)(2008-11#1)
In magneto-optical##2##2##(2008-2#2)
In major##2##2##(1992-9#1)(2009-8#1)
In majority of##2##3##(2010-11#1)(2013-8#1)
In making comparisons to national norms##2##6##(1994-3#2)
In making##4##2##(1994-3#2)(2008-11#1)(2008-3#1)
In male rats##2##3##(1990-11#1)(1995-12#1)
In male##4##2##(1990-11#1)(1995-12#1)(2008-8#1)(2011-2#1)
In males##6##2##(1992-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
In mammals##7##2##(1994-5#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-9#1)
In man##2##2##(1990-6#1)(1993-9#1)
In many cases it##2##4##(2008-3#1)(2008-4#1)
In many cases##12##3##(1990-9#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#1)(2008-3#1)(2008-4#2)(2010-7#1)(2012-3#1)
In many clinical##3##3##(1997-3#1)(2007-11#1)(2011-2#1)
In many countries##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
In many instances##3##3##(1990-8#1)(1992-5#1)(2013-1#1)
In many of the##2##4##(1993-11#1)(1994-8#1)
In many regions##2##3##(2007-12#1)(2011-3#1)
In many ways##6##3##(1991-12#1)(1994-12#1)(1995-3#1)(1996-8#1)(2008-9#1)(2010-5#1)
In many##53##2##(1990-8#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
In mature##2##2##(2008-10#1)(2008-5#1)
In membrane##3##2##(1992-5#1)(1996-2#1)(1996-5#1)
In membranes##2##2##(1991-5#1)(1993-1#1)
In memoriam##2##2##(1991-1#1)(2012-12#1)
In memory of##3##3##(1991-8#1)(2010-11#1)(2011-1#1)
In men aged##3##3##(2008-7#3)
In men##11##2##(1994-5#1)(1995-9#1)(2007-12#1)(2008-6#1)(2008-7#5)(2009-4#1)(2011-1#1)
In mice##7##2##(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2013-1#2)
In mixed##2##2##(2008-10#2)
In monkeys##2##2##(1992-11#1)(1995-3#1)
In more than##3##3##(1992-11#1)(2010-8#1)(2012-12#1)
In most animals##2##3##(2008-6#1)(2008-8#1)
In most cases it is##2##5##(1990-8#1)(2011-2#1)
In most cases the##3##4##(1995-11#1)(2008-3#1)(2011-2#1)
In most cases##33##3##(1990-12#1)(1990-8#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
In most countries##2##3##(1990-8#1)(2013-8#1)
In most instances##5##3##(1992-1#1)(1997-5#1)(2007-6#1)(2008-10#2)
In most of the cases##3##5##(1990-8#1)(2008-10#1)(2008-12#1)
In most of the##8##4##(1990-8#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)
In most of these##2##4##(1995-5#1)(2010-11#1)
In most of##11##3##(1990-8#1)(1995-12#1)(1995-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)
In most patients##3##3##(1990-11#1)(1990-9#1)(2012-3#1)
In most studies##2##3##(1992-9#1)(2008-10#1)
In most##81##2##(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#1)(1997-5#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
In mouse##3##2##(1993-8#1)(1994-8#1)(2008-7#1)
In multiple##3##2##(2008-6#1)(2008-8#1)(2012-3#1)
In multivariable##2##2##(2012-1#2)
In multivariate analyses##2##3##(2008-5#1)(2013-1#1)
In multivariate analysis##3##3##(2008-3#1)(2010-4#1)(2013-1#1)
In multivariate##6##2##(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#3)
In muscle##2##2##(1990-8#1)(1993-9#1)
In mutant##2##2##(1997-7#1)(2008-10#1)
In my opinion##2##3##(2008-6#1)(2013-1#1)
In my##4##2##(2007-11#1)(2008-6#1)(2009-10#1)(2013-1#1)
In natural##2##2##(2008-9#1)(2010-2#1)
In nature##5##2##(2008-10#2)(2008-12#1)(2008-9#2)
In near future##2##3##(2010-8#1)(2011-3#1)
In near##3##2##(2008-10#1)(2010-8#1)(2011-3#1)
In negative##2##2##(1992-12#1)(2008-9#1)
In neurons##2##2##(1993-12#1)(2013-8#1)
In new##2##2##(1993-12#1)(1994-9#1)
In no case##2##3##(2008-11#1)(2012-2#1)
In no##4##2##(1990-11#1)(1994-6#1)(2008-11#1)(2012-2#1)
In none of the##3##4##(1993-9#1)(2008-1#1)(2008-4#1)
In none of##4##3##(1993-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
In normal##9##2##(1990-5#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-11#1)(1997-2#1)(2008-7#1)(2010-3#1)(2010-5#1)
In nuclear fractions isolated##2##4##(1994-11#2)
In nuclear##3##2##(1994-11#2)(1995-2#1)
In numerous##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
In obese##2##2##(2008-3#1)(2013-1#1)
In older##5##2##(1990-9#1)(2008-10#2)(2008-8#1)(2011-2#1)
In one approach##2##3##(1996-1#1)(2008-3#1)
In one case of##3##4##(1997-3#2)(2007-11#1)
In one case the##4##4##(1991-2#1)(1992-8#1)(2007-6#1)(2007-8#1)
In one case##15##3##(1990-3#1)(1991-2#1)(1992-8#1)(1993-9#1)(1994-6#1)(1996-11#1)(1997-3#2)(2007-11#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-7#1)
In one family##2##3##(1991-12#1)(1994-8#1)
In one field##2##3##(2008-10#2)
In one group##3##3##(1993-12#1)(1994-8#1)(2013-1#1)
In one mode##2##3##(2008-3#1)(2009-6#1)
In one of the##2##4##(1991-6#1)(2008-10#1)
In one of these##2##4##(2008-5#1)(2008-9#1)
In one of##6##3##(1991-3#1)(1991-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
In one patient##7##3##(1991-5#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-7#1)(2011-3#1)(2012-3#1)
In one study##3##3##(2006-4#1)(2008-5#1)(2013-8#1)
In one##69##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#5)(1995-2#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1997-3#3)(1997-8#1)(2006-4#1)(2007-11#4)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
In only one case##3##4##(1997-8#1)(2008-10#1)(2008-9#1)
In only one##4##3##(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#1)
In only##6##2##(1993-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-3#1)
In optical##5##2##(2007-11#1)(2008-3#4)
In optimized conditions##2##3##(2008-10#2)
In order for##4##3##(1993-1#1)(2008-9#1)(2010-11#1)(2012-12#1)
In order to accommodate##2##4##(2010-10#1)(2011-1#1)
In order to achieve a##3##5##(1993-12#1)(2010-4#1)(2011-2#1)
In order to achieve the##2##5##(2008-10#1)(2008-11#1)
In order to achieve##7##4##(1990-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
In order to address##3##4##(1992-6#1)(2008-1#1)(2008-11#1)
In order to analyze the##3##5##(1997-7#1)(2008-10#1)(2008-6#1)
In order to analyze##4##4##(1992-5#1)(1997-7#1)(2008-10#1)(2008-6#1)
In order to assess the quality of##2##7##(1996-9#1)(2008-10#1)
In order to assess the##7##5##(1990-5#1)(1991-8#1)(1992-9#1)(1995-5#1)(1996-9#1)(2008-10#1)(2008-12#1)
In order to assess##14##4##(1990-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-7#3)(2012-2#1)
In order to avoid the##3##5##(1994-11#1)(2008-10#1)(2013-1#1)
In order to avoid##6##4##(1994-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-7#1)
In order to be able to##2##6##(1991-3#1)(1993-12#1)
In order to be##6##4##(1991-3#1)(1992-3#1)(1993-12#1)(1997-1#1)(2008-5#1)(2008-9#1)
In order to better understand the##2##6##(1993-8#1)(2008-10#1)
In order to better understand##3##5##(1993-8#1)(2008-10#1)(2013-1#1)
In order to calculate the##2##5##(2009-4#1)(2011-2#1)
In order to calculate##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
In order to characterize the##3##5##(2008-10#2)(2008-11#1)
In order to characterize##5##4##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)
In order to check the##2##5##(2008-12#1)(2008-5#1)
In order to check whether##2##5##(1992-5#1)(1997-4#1)
In order to check##4##4##(1992-5#1)(1997-4#1)(2008-12#1)(2008-5#1)
In order to clarify the##3##5##(1991-12#1)(1991-2#1)(1992-3#1)
In order to clarify whether##2##5##(2008-11#1)(2008-5#1)
In order to clarify##5##4##(1991-12#1)(1991-2#1)(1992-3#1)(2008-11#1)(2008-5#1)
In order to compare the##2##5##(1994-3#1)(2011-2#1)
In order to compare##4##4##(1994-3#1)(1994-5#1)(2008-5#1)(2011-2#1)
In order to confirm##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
In order to control##2##4##(2008-10#1)(2008-11#1)
In order to define##3##4##(2008-11#1)(2010-2#1)(2013-1#1)
In order to demonstrate the##2##5##(2008-10#1)(2008-7#1)
In order to demonstrate##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
In order to derive a##2##5##(1992-3#1)(2008-10#1)
In order to describe##2##4##(2008-6#1)(2009-4#1)
In order to determine the enantiopurity of##2##7##(2008-10#2)
In order to determine the function of##2##7##(2008-8#1)(2008-9#1)
In order to determine the##10##5##(1990-3#1)(1993-3#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)
In order to determine whether##5##5##(1991-12#1)(1993-12#1)(1994-12#1)(1996-12#1)(1997-3#1)
In order to determine which##2##5##(1994-2#1)(2008-10#1)
In order to determine##27##4##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)
In order to develop a##5##5##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
In order to develop##7##4##(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-5#1)
In order to distinguish##2##4##(1997-3#1)(2008-10#1)
In order to eliminate the##2##5##(1997-4#1)(2010-11#1)
In order to elucidate the##7##5##(1992-6#1)(1992-8#1)(1995-12#1)(2008-10#1)(2008-5#1)(2011-3#1)(2012-2#1)
In order to elucidate##9##4##(1992-6#1)(1992-8#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-2#1)
In order to enhance##4##4##(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
In order to ensure##4##4##(1997-8#1)(2008-10#1)(2012-3#2)
In order to eradicate##2##4##(1994-9#2)
In order to establish##5##4##(1995-5#1)(2007-4#1)(2008-11#3)
In order to estimate the##2##5##(2008-10#1)(2008-11#1)
In order to evaluate the effect of##2##7##(1995-11#1)(2008-7#1)
In order to evaluate the##12##5##(1992-3#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-11#1)(1995-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-7#1)
In order to evaluate##16##4##(1990-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-7#1)
In order to examine the##6##5##(1990-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)
In order to explore the##5##5##(1995-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-9#1)
In order to explore##7##4##(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-9#1)
In order to facilitate##2##4##(1990-12#1)(2008-10#1)
In order to find the##3##5##(2008-11#1)(2008-12#1)(2011-1#1)
In order to find##5##4##(1997-6#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-3#1)
In order to further verify the accuracy of the developed method##2##11##(2008-10#2)
In order to further##3##4##(2008-10#3)
In order to gain insight into##3##6##(1992-6#1)(1993-6#1)(2008-7#1)
In order to gain##7##4##(1992-6#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
In order to get a##3##5##(2008-10#2)(2013-8#1)
In order to get an insight into##2##7##(2008-11#1)(2009-12#1)
In order to get##6##4##(2008-10#3)(2008-11#1)(2009-12#1)(2013-8#1)
In order to help##5##4##(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-12#1)
In order to identify and##2##5##(2008-10#1)(2012-2#1)
In order to identify genes that##2##6##(1992-9#1)(2008-7#1)
In order to identify genes##3##5##(1992-9#1)(1995-11#1)(2008-7#1)
In order to identify the##4##5##(1993-12#1)(1994-6#1)(1994-9#1)(2008-10#1)
In order to identify##15##4##(1991-12#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2010-3#1)(2012-2#2)(2013-8#1)
In order to illustrate the##2##5##(2007-11#1)(2008-10#1)
In order to illustrate##3##4##(2007-11#1)(2008-10#2)
In order to improve the chromatographic##2##6##(2008-10#1)(2012-1#1)
In order to improve the##9##5##(2008-10#3)(2008-11#3)(2010-11#1)(2012-1#1)(2013-1#1)
In order to improve##14##4##(2008-10#5)(2008-11#4)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
In order to increase the##4##5##(1997-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
In order to increase##7##4##(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
In order to investigate the mechanism##2##6##(1991-11#1)(1994-8#1)
In order to investigate the relationship between the##3##8##(2008-10#1)(2008-9#1)(2011-2#1)
In order to investigate the role of##3##7##(1993-11#1)(2008-10#1)(2008-9#1)
In order to investigate the##21##5##(1991-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#2)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#3)(2010-5#1)(2011-2#1)(2012-2#1)
In order to investigate whether##2##5##(1994-12#1)(2012-5#1)
In order to investigate##29##4##(1991-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-8#2)(1996-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-5#1)(2011-2#1)(2012-2#1)(2012-5#1)
In order to make##4##4##(1997-8#1)(2008-10#2)(2009-10#1)
In order to maximize the##2##5##(2008-10#1)(2008-5#1)
In order to maximize##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
In order to minimize the##3##5##(2007-8#2)(2008-10#1)
In order to minimize##5##4##(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)
In order to monitor the##2##5##(1991-12#1)(1993-6#1)
In order to observe##2##4##(2008-11#1)(2008-5#1)
In order to obtain a##4##5##(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
In order to obtain good##2##5##(2008-10#1)(2008-9#1)
In order to obtain more##2##5##(1995-5#1)(2010-1#1)
In order to obtain the better##2##6##(2008-10#2)
In order to obtain the##4##5##(1994-12#1)(2008-10#3)
In order to obtain##17##4##(1994-12#1)(1995-5#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-1#1)
In order to optimize the##3##5##(1996-5#1)(1997-4#1)(2008-10#1)
In order to optimize##4##4##(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#1)
In order to overcome the##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
In order to overcome these##3##5##(2008-1#1)(2008-5#1)(2010-6#1)
In order to overcome this##3##5##(2008-5#1)(2010-11#1)(2012-2#1)
In order to overcome##12##4##(1990-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
In order to perform##3##4##(2008-10#3)
In order to predict the##2##5##(2008-10#1)(2008-8#1)
In order to predict##3##4##(2007-11#1)(2008-10#1)(2008-8#1)
In order to prevent the##2##5##(1994-9#1)(2008-10#1)
In order to prevent##7##4##(1992-3#1)(1994-9#1)(2008-10#1)(2010-1#1)(2010-4#1)(2012-12#1)(2013-1#1)
In order to probe##2##4##(1995-5#1)(2008-8#1)
In order to produce##3##4##(1991-12#1)(1994-9#1)(2008-12#1)
In order to provide##4##4##(1990-2#1)(1992-2#1)(1992-6#1)(2008-7#1)
In order to quantify the##2##5##(1997-6#1)(2013-1#1)
In order to quantify##3##4##(1997-6#1)(2012-2#1)(2013-1#1)
In order to realize this##2##5##(2008-10#1)(2010-8#1)
In order to realize##3##4##(2008-10#1)(2010-8#1)(2012-3#1)
In order to reduce the##2##5##(2008-10#1)(2008-11#1)
In order to reduce##5##4##(2008-1#2)(2008-10#1)(2008-11#1)(2013-1#1)
In order to show##2##4##(2008-10#2)
In order to study the effect of##2##7##(1991-6#1)(2008-12#1)
In order to study the influence of##2##7##(1994-8#1)(2013-8#1)
In order to study the role of##2##7##(1990-5#1)(1992-9#1)
In order to study the##17##5##(1990-5#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-6#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2013-8#1)
In order to study this##4##5##(1991-12#1)(1993-12#1)(1993-3#1)(1997-4#1)
In order to study##23##4##(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2013-8#1)
In order to support##2##4##(2008-12#1)(2008-7#1)
In order to test the##4##5##(1990-12#1)(1991-5#1)(2008-10#1)(2008-5#1)
In order to test these##2##5##(1991-5#1)(1994-12#1)
In order to test this hypothesis##2##6##(1995-5#1)(2008-7#1)
In order to test##9##4##(1990-12#1)(1991-5#2)(1994-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
In order to understand the molecular##2##6##(1995-5#1)(2008-10#1)
In order to understand the role of##2##7##(1997-2#1)(2012-3#1)
In order to understand the##12##5##(1994-5#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
In order to understand##14##4##(1994-5#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)
In order to utilize##2##4##(2008-11#2)
In order to validate the##4##5##(1997-2#1)(2008-10#2)(2011-2#1)
In order to validate##5##4##(1997-2#1)(2008-10#3)(2011-2#1)
In order to verify the##3##5##(1997-2#1)(2008-10#1)(2008-9#1)
In order to##501##3##(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#6)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#2)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#3)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#7)(1995-6#1)(1996-12#4)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#8)(1997-6#4)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#109)(2008-11#37)(2008-12#13)(2008-2#3)(2008-4#2)(2008-5#19)(2008-6#4)(2008-7#28)(2008-8#11)(2008-9#13)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#3)(2010-10#1)(2010-11#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#6)
In order##507##2##(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#6)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#2)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#3)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#7)(1995-6#1)(1996-12#4)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#8)(1997-6#4)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#109)(2008-11#38)(2008-12#13)(2008-2#3)(2008-4#2)(2008-5#19)(2008-6#4)(2008-7#28)(2008-8#11)(2008-9#14)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#3)(2010-10#1)(2010-11#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#6)
In organ##2##2##(1993-8#1)(1997-4#1)
In other experiments##4##3##(2006-6#1)(2008-10#3)
In other words##11##3##(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
In other##28##2##(1991-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(2006-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
In others##2##2##(2007-2#1)(2008-10#1)
In our Department##2##3##(2007-8#1)(2013-1#1)
In our analysis##2##3##(2007-8#2)
In our approach##2##3##(2008-3#1)(2008-7#1)
In our case##6##3##(1993-9#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
In our experience##12##3##(1991-12#1)(1991-2#2)(1991-3#1)(1992-8#1)(1994-9#1)(1997-3#2)(2008-1#2)(2008-10#1)(2011-2#1)
In our experiment##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
In our experiments##4##3##(1995-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
In our first##2##3##(2008-6#1)(2013-8#1)
In our laboratory##2##3##(1995-3#1)(2008-8#1)
In our method##2##3##(2008-2#2)
In our model##5##3##(1996-2#1)(2008-3#1)(2008-6#1)(2008-9#2)
In our opinion the##3##4##(1996-11#1)(2007-8#1)(2009-12#1)
In our opinion##8##3##(1990-11#1)(1991-5#1)(1991-6#1)(1996-11#1)(1997-8#1)(2007-8#1)(2008-5#1)(2009-12#1)
In our patient##4##3##(1995-8#1)(2008-6#1)(2009-3#1)(2011-2#1)
In our population##2##3##(2008-3#1)(2011-2#1)
In our present##2##3##(1990-8#1)(2008-10#1)
In our previous report##2##4##(2008-10#1)(2012-12#1)
In our previous study##5##4##(1991-2#1)(1993-12#1)(1994-8#1)(2008-11#1)(2012-2#1)
In our previous##8##3##(1991-2#1)(1993-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)
In our recent paper in##2##5##(2009-8#2)
In our recent paper##3##4##(2009-6#1)(2009-8#2)
In our recent study##2##4##(2009-8#1)(2011-2#1)
In our recent##9##3##(2007-11#1)(2007-8#1)(2008-5#1)(2009-6#1)(2009-8#4)(2011-2#1)
In our second##2##3##(2008-6#1)(2008-8#1)
In our series##4##3##(1990-12#1)(1990-6#1)(1991-8#1)(2007-10#1)
In our study we wanted to##2##6##(2008-10#1)(2011-2#1)
In our study we##6##4##(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
In our study##17##3##(1991-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)
In our system##2##3##(2007-11#1)(2008-10#1)
In our work##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
In our##138##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-10#2)(2007-11#6)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#5)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
In pH##4##2##(2008-10#4)
In pancreatic acini##2##3##(1994-8#1)(1995-11#1)
In parallel experiments##2##3##(1997-2#1)(2008-7#1)
In parallel to##2##3##(2008-5#1)(2012-3#1)
In parallel with the##2##4##(1994-2#1)(2010-9#1)
In parallel with##4##3##(1990-10#1)(1994-2#1)(2009-10#1)(2010-9#1)
In parallel##21##2##(1990-10#1)(1993-3#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
In part I of##2##4##(2008-3#1)(2008-7#1)
In part I##3##3##(2008-3#1)(2008-7#2)
In part II##2##3##(2008-7#2)
In part##6##2##(1991-12#1)(2008-3#1)(2008-7#4)
In particular it##2##3##(1990-9#1)(1993-1#1)
In particular the##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
In particular##233##2##(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-11#9)(2007-12#10)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#13)(2008-12#2)(2008-2#10)(2008-3#28)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
In pathogenicity tests##7##3##(2008-10#6)(2008-12#1)
In patients suffering from##2##4##(2008-1#1)(2011-2#1)
In patients who##4##3##(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)
In patients with a##2##4##(2008-1#1)(2010-12#1)
In patients with acute##2##4##(2007-10#1)(2008-11#1)
In patients with suspected##2##4##(2011-2#1)(2012-2#1)
In patients with the##2##4##(2008-1#1)(2011-1#1)
In patients with type 2 diabetes##2##6##(2008-1#1)(2008-3#1)
In patients with type##4##4##(1993-12#1)(2008-1#1)(2008-3#1)(2008-8#1)
In patients with##62##3##(1990-2#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#4)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
In patients##79##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-10#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-8#5)(2008-1#5)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#3)(2009-8#2)(2010-12#3)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
In period##3##2##(2010-8#2)(2011-2#1)
In persons with##2##3##(2008-4#1)(2009-4#1)
In phase I##2##3##(2008-5#2)
In phase##8##2##(2007-10#2)(2008-5#3)(2010-8#3)
In pilot##2##2##(1995-5#1)(2008-11#1)
In planning##2##2##(1995-1#1)(2007-11#1)
In plant cells##2##3##(2008-10#1)(2009-8#1)
In planta##3##2##(2008-10#3)
In plants##7##2##(2008-10#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
In plots##2##2##(2008-10#2)
In population##2##2##(2008-10#1)(2008-12#1)
In populations##5##2##(1994-5#1)(2008-8#2)(2008-9#1)(2012-12#1)
In postoperative##2##2##(1990-11#1)(2007-11#1)
In pot##2##2##(2008-10#2)
In practical##2##2##(2008-10#1)(2009-12#1)
In practice##16##2##(1992-6#1)(1995-2#1)(1995-9#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
In preliminary experiments##2##3##(2008-10#1)(2008-11#1)
In preliminary##4##2##(2008-10#3)(2008-11#1)
In preparation for the##2##4##(1997-2#1)(2009-4#1)
In preparation for##4##3##(1994-12#1)(1997-2#1)(2008-9#1)(2009-4#1)
In presence of##2##3##(2008-10#1)(2008-5#1)
In presence##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
In present study we have##2##5##(1994-11#1)(2011-1#1)
In present study##5##3##(1994-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-1#1)
In present##7##2##(1994-11#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2011-1#1)
In previous studies##5##3##(1993-12#1)(1994-2#1)(1996-12#1)(2008-11#1)(2009-6#1)
In previous##8##2##(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-11#1)(2009-6#1)
In primary cultures of##2##4##(1996-2#1)(2012-3#1)
In primary##5##2##(1990-2#1)(1992-11#1)(1996-2#1)(2011-2#1)(2012-3#1)
In principle##9##2##(1996-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
In prokaryotes##3##2##(1997-7#1)(2009-2#1)(2012-1#1)
In prospective analysis of OFDI##2##5##(2011-1#2)
In prospective##3##2##(2011-1#2)(2012-3#1)
In pursuit of##2##3##(1996-1#1)(2010-11#1)
In rabbit##3##2##(1995-12#2)(1996-2#1)
In rare cases##6##3##(1993-6#1)(1993-8#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)
In rare instances##3##3##(2008-10#2)(2011-2#1)
In rare##9##2##(1993-6#1)(1993-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-2#1)
In rat##8##2##(1991-12#1)(1991-2#1)(1993-11#1)(1993-6#1)(1996-5#1)(1997-7#2)(2008-10#1)
In rats subjected to porta-caval anastomosis##2##6##(1993-3#2)
In rats##9##2##(1992-3#1)(1992-9#1)(1993-3#2)(1994-3#1)(1995-3#1)(1997-7#1)(2012-2#1)(2013-1#1)
In re##6##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#1)
In reality##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
In recent decades##4##3##(2008-11#1)(2010-10#1)(2011-1#2)
In recent years it has been##2##6##(1990-11#1)(2008-12#1)
In recent years it has##3##5##(1990-11#1)(2008-12#1)(2008-7#1)
In recent years the##4##4##(1991-6#1)(2007-5#1)(2008-11#1)(2009-6#1)
In recent years there has been increasing interest in the##2##10##(2008-3#1)(2008-7#1)
In recent years there has been##4##6##(2007-11#1)(2008-3#1)(2008-7#2)
In recent years there##5##4##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#2)
In recent years##88##3##(1990-11#2)(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#8)(2008-9#2)(2009-11#1)(2009-6#3)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#3)(2013-8#2)
In recent##94##2##(1990-11#2)(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#9)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#3)(2013-8#2)
In recognition of this##2##4##(2008-12#1)(2010-12#1)
In recognition of##3##3##(2008-12#1)(2010-12#1)(2010-5#1)
In reflection##2##2##(2008-11#1)(2008-3#1)
In regard to##2##3##(1990-10#1)(2011-2#1)
In relation to##4##3##(1991-6#1)(2008-10#2)(2009-3#1)
In reply##2##2##(1990-11#2)
In research##2##2##(2008-10#1)(2008-5#1)
In resistant##2##2##(2008-10#2)
In response to a##3##4##(2007-12#1)(2008-7#1)(2010-4#1)
In response to standing##2##4##(2008-7#2)
In response to the##7##4##(1991-12#1)(1991-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#1)
In response to##31##3##(1991-12#1)(1991-2#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-8#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#6)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
In response##39##2##(1991-12#1)(1991-2#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-8#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#6)(2008-8#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)
In reviewing##2##2##(1995-12#1)(2008-11#1)
In rice##2##2##(2008-10#1)(2009-8#1)
In rodents##2##2##(2008-10#1)(2008-7#1)
In roots##3##2##(2008-10#2)(2008-12#1)
In samples of##3##3##(2008-11#1)(2008-6#1)(2013-8#1)
In samples##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
In schizophrenia##4##2##(1996-7#1)(2007-8#1)(2008-1#1)(2008-6#1)
In screening for##2##3##(2008-7#2)
In search of the##3##4##(2008-11#2)(2008-8#1)
In search of##11##3##(1990-11#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-2#1)
In search##12##2##(1990-11#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-2#1)
In select##2##2##(2011-2#1)(2013-1#1)
In selected areas##2##3##(1997-3#1)(2008-10#1)
In selected cases##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
In selected##9##2##(1994-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
In selecting##2##2##(1992-12#1)(1997-4#1)
In sensory evaluation##2##3##(2010-2#2)
In separate experiments##6##3##(1995-11#1)(1997-3#1)(2008-10#4)
In separate##9##2##(1995-11#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-4#1)
In seven patients##2##3##(1993-5#1)(1996-6#1)
In seven##9##2##(1993-2#1)(1993-5#1)(1995-12#1)(1996-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
In several cases##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
In several species##2##3##(1996-9#1)(2008-7#1)
In several##19##2##(1990-6#1)(1992-11#1)(1994-5#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#5)(2009-10#1)(2011-2#1)
In severe cases##3##3##(2008-10#1)(2013-1#2)
In severe##6##2##(1992-11#1)(2008-10#1)(2008-7#1)(2013-1#3)
In sharp contrast to the##2##5##(2008-7#1)(2009-8#1)
In sharp contrast##3##3##(2007-11#1)(2008-7#1)(2009-8#1)
In short##12##2##(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#2)
In short-term##2##2##(1995-5#1)(1996-5#1)
In silico##5##2##(2008-4#1)(2008-7#1)(2009-9#1)(2013-1#2)
In similar##2##2##(2008-5#1)(2010-6#1)
In simulation##2##2##(2008-10#1)(2010-8#1)
In single##2##2##(2007-8#1)(2011-3#1)
In situ determination of the##2##5##(2008-11#1)(2008-3#1)
In situ forming polymeric##2##4##(2010-5#2)
In situ forming##3##3##(2007-12#1)(2010-5#2)
In situ generated##2##3##(2008-10#1)(2010-2#1)
In situ hybridization analysis##3##4##(1992-9#1)(1996-12#1)(2008-5#1)
In situ hybridization and##2##4##(1997-3#1)(1997-7#1)
In situ hybridization of##2##4##(1995-11#1)(2008-10#1)
In situ hybridization to##2##4##(1991-2#1)(2008-4#1)
In situ hybridization using##2##4##(1990-12#1)(1991-5#1)
In situ hybridization was##2##4##(1996-5#1)(1997-6#1)
In situ hybridization##19##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)
In situ localization of##2##4##(1997-6#1)(2008-10#1)
In situ measurements of##4##4##(2008-2#1)(2008-3#3)
In situ##61##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2010-2#1)(2010-5#3)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
In six cases##2##3##(1995-3#1)(2008-10#1)
In six##10##2##(1993-6#1)(1995-3#1)(1996-9#2)(1997-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-3#1)
In slices of rats pretreated with##2##6##(1995-12#2)
In slices##3##2##(1995-12#3)
In so doing##4##3##(1991-2#1)(2008-12#2)(2008-3#1)
In so##5##2##(1991-2#1)(2008-12#2)(2008-3#1)(2009-10#1)
In sodium dodecyl sulfate-polyacrylamide gel electrophoresis of dissociated purified virus preparations##2##11##(2008-10#2)
In soil##2##2##(2008-10#1)(2011-2#1)
In solution##4##2##(1990-12#1)(1996-2#2)(2012-2#1)
In some cases it##2##4##(1994-11#1)(2009-6#1)
In some cases the##3##4##(1991-8#1)(1994-11#1)(2008-10#1)
In some cases##33##3##(1990-6#1)(1991-8#1)(1992-6#1)(1994-11#2)(1995-12#1)(1995-3#2)(1996-11#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)
In some instances##3##3##(1995-3#1)(2008-7#1)(2008-9#1)
In some of the##3##4##(1990-12#1)(2008-11#1)(2008-2#1)
In some patients with##2##4##(1994-3#1)(2011-2#1)
In some patients##5##3##(1992-8#1)(1994-3#1)(1997-4#1)(2011-2#1)(2013-8#1)
In some situations##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
In some studies##2##3##(2008-7#1)(2012-2#1)
In some##71##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#3)(1996-11#1)(1996-2#1)(1997-4#1)(2006-4#1)(2007-11#3)(2007-2#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
In southern##2##2##(2008-10#1)(2009-8#1)
In spatial##2##2##(1997-2#1)(2008-8#1)
In species##4##2##(1994-8#1)(2008-12#2)(2008-8#1)
In spite of a##5##4##(1991-8#1)(2008-10#2)(2010-10#1)(2012-12#1)
In spite of high##2##4##(1996-12#1)(2008-10#1)
In spite of its rarity##2##5##(2008-12#1)(2010-7#1)
In spite of its##6##4##(1995-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-7#1)(2013-1#1)
In spite of the fact that##5##6##(2007-8#1)(2008-11#2)(2009-8#1)(2011-1#1)
In spite of the large##2##5##(1991-8#1)(2008-6#1)
In spite of the##25##4##(1991-8#1)(1992-12#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-8#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
In spite of these##2##4##(2008-7#2)
In spite of this##5##4##(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2009-12#1)
In spite of##64##3##(1991-8#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#2)(2007-11#2)(2007-8#3)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#2)
In spring##3##2##(2008-10#3)
In standard##2##2##(1992-3#1)(2011-2#1)
In strain##2##2##(1994-3#1)(1994-6#1)
In strong##2##2##(2008-10#2)
In studies of##4##3##(1997-3#1)(2007-12#2)(2012-9#1)
In studies##8##2##(1997-3#1)(2007-12#2)(2008-10#2)(2008-7#1)(2012-9#1)(2013-7#1)
In subjects with##2##3##(2008-1#1)(2012-2#1)
In subsequent##2##2##(2009-4#1)(2011-2#1)
In such a situation##4##4##(1992-4#1)(2008-3#1)(2008-5#1)(2011-1#1)
In such a##9##3##(1992-4#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
In such cases##10##3##(1990-9#1)(1995-11#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-3#1)(2009-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
In such experimental##2##3##(2008-10#1)(2013-8#1)
In such terms##2##3##(2013-1#2)
In such##32##2##(1990-9#1)(1992-4#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
In sum##2##2##(1994-3#1)(2008-7#1)
In summary##94##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
In summer##5##2##(2008-10#1)(2008-12#1)(2008-2#1)(2013-7#1)(2013-8#1)
In support of our##3##4##(1996-5#1)(2010-11#1)(2010-4#1)
In support of the##5##4##(1991-5#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
In support of this##10##4##(1990-11#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-2#1)(2009-6#1)
In support of##18##3##(1990-11#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-4#1)
In susceptible##6##2##(2008-10#5)(2013-8#1)
In symptomatic##2##2##(2008-10#1)(2013-1#1)
In systems##2##2##(2008-11#1)(2008-9#1)
In ten patients##2##3##(1993-2#1)(1996-11#1)
In ten##3##2##(1993-2#1)(1996-11#1)(2008-2#1)
In terms of food##2##4##(2011-2#1)(2012-1#1)
In terms of the##2##4##(1997-7#1)(2008-3#1)
In terms of##31##3##(1995-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-3#1)(2011-2#3)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)
In tests with##5##3##(2008-10#4)(2008-11#1)
In tests##6##2##(2008-10#5)(2008-11#1)
In that case##3##3##(1994-2#1)(2008-7#1)(2008-9#1)
In that context##3##3##(1993-3#1)(2009-7#1)(2010-2#1)
In that##11##2##(1993-3#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)
In the &quot##3##3##(2010-3#1)(2011-2#2)
In the 16##3##3##(1992-2#1)(2008-6#1)(2008-8#1)
In the 1970s##2##3##(1991-2#1)(2008-7#1)
In the 1990s##4##3##(1996-2#1)(1996-3#1)(2007-12#1)(2008-12#1)
In the Etude d'un LaSer Accordable##2##6##(2008-2#2)
In the European##2##3##(1990-12#1)(2007-6#1)
In the FCO##2##3##(2008-7#2)
In the Netherlands##2##3##(2008-10#1)(2009-12#1)
In the Orthopedic##2##3##(2007-11#2)
In the TLH group##2##4##(2010-3#2)
In the TUG test##2##4##(2010-3#2)
In the UK##4##3##(1992-2#1)(2008-11#1)(2013-8#2)
In the US##2##3##(2013-1#1)(2013-8#1)
In the United States##10##4##(1994-12#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-8#1)(2011-2#3)(2013-1#1)
In the United##11##3##(1994-12#2)(2008-1#1)(2008-10#2)(2009-12#1)(2010-8#1)(2011-2#3)(2013-1#1)
In the Western##2##3##(1992-11#1)(2008-11#1)
In the abnormal##2##3##(1993-9#1)(2011-2#1)
In the absence of ATP##2##5##(1993-8#1)(1995-2#1)
In the absence of a##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
In the absence of acetic acid##2##6##(2008-6#2)
In the absence of an##5##5##(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)
In the absence of any##3##5##(1995-12#1)(2007-12#1)(2007-7#1)
In the absence of light##2##5##(1993-8#1)(1994-8#1)
In the absence of nitrate##2##5##(2008-11#2)
In the absence of noise##2##5##(2008-3#2)
In the absence of selection bias##2##6##(1997-5#2)
In the absence of testosterone##2##5##(1990-11#1)(2012-2#1)
In the absence of the##5##5##(1995-2#1)(1995-3#1)(2008-10#2)(2012-2#1)
In the absence of##78##4##(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
In the absence##79##3##(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)
In the accompanying paper##2##4##(1990-11#1)(1994-12#1)
In the accompanying##3##3##(1990-11#1)(1994-12#1)(2008-10#1)
In the acidic##2##3##(2008-10#2)
In the acute##2##3##(1991-11#1)(2013-1#1)
In the adult##3##3##(1993-6#1)(1994-8#1)(2010-7#1)
In the affected##2##3##(1990-11#1)(2013-8#1)
In the age group##3##4##(1990-2#1)(1995-9#1)(2008-7#1)
In the age##4##3##(1990-2#1)(1995-9#1)(2008-7#2)
In the alternate high-efficiency method##2##5##(2008-1#1)(2008-2#1)
In the alternate##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
In the analysis of##5##4##(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-11#1)
In the analysis##6##3##(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
In the animals##2##3##(2008-7#2)
In the anterior##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
In the apical##2##3##(2007-12#1)(2008-4#1)
In the arcuate nucleus##2##4##(1993-5#2)
In the area of##3##4##(1996-12#1)(1997-8#1)(2011-2#1)
In the article##2##3##(1994-1#1)(2013-1#1)
In the author's##3##3##(1991-3#1)(1994-2#1)(2008-6#1)
In the autumn##2##3##(1991-11#1)(2008-10#1)
In the basic##3##3##(2008-2#1)(2008-4#1)(2008-6#1)
In the beginning##2##3##(2008-10#1)(2008-7#1)
In the brain##7##3##(1991-9#1)(1994-2#1)(1997-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
In the business##2##3##(1994-1#1)(1995-2#1)
In the calculations##2##3##(2008-2#2)
In the calibration range 0##2##5##(2008-10#2)
In the case of a##6##5##(1991-3#1)(1997-7#1)(2008-2#1)(2008-3#3)
In the case of geriatric##2##5##(1990-11#1)(2008-4#1)
In the case of the Fe(III)-adriamycin##2##6##(1993-6#2)
In the case of the##19##5##(1990-11#1)(1992-3#1)(1993-6#2)(1997-4#1)(1997-7#1)(2008-10#7)(2008-3#2)(2008-5#2)(2009-12#1)(2010-4#1)
In the case of##97##4##(1990-11#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
In the case##101##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
In the cases of##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
In the cases##6##3##(1993-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
In the central nervous system##3##5##(2008-11#2)(2008-7#1)
In the ceramide##2##3##(2008-5#2)
In the combined##2##3##(1995-12#1)(2008-10#1)
In the competitive assay##2##4##(2008-10#2)
In the competitive##3##3##(2008-10#3)
In the complex##3##3##(1994-5#1)(2008-10#1)(2009-10#1)
In the context of a##3##5##(1996-2#1)(2007-12#1)(2008-11#1)
In the context of the##2##5##(1994-1#1)(2011-2#1)
In the context of##10##4##(1994-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
In the control group##13##4##(1993-8#1)(1995-8#1)(1997-6#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#2)(2012-3#1)
In the control##15##3##(1993-8#1)(1995-8#1)(1997-6#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
In the conventional##3##3##(2008-11#1)(2008-3#1)(2012-12#1)
In the cosmetics industry##2##4##(2008-5#2)
In the course of screening##2##5##(2008-11#2)
In the course of the##3##5##(1990-11#1)(1992-8#1)(2008-9#1)
In the course of these##2##5##(2007-12#1)(2008-6#1)
In the course of two##2##5##(1995-11#1)(1995-5#1)
In the course of##23##4##(1990-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-6#2)(2008-9#1)(2012-2#2)(2013-1#2)
In the current investigation##2##4##(1991-12#1)(1997-6#1)
In the current paper##2##4##(2008-8#1)(2010-3#1)
In the current review we##2##5##(2010-8#1)(2013-8#1)
In the current review##3##4##(2008-3#1)(2010-8#1)(2013-8#1)
In the current study we have##2##6##(1994-6#1)(2008-11#1)
In the current study we##3##5##(1994-6#1)(2008-11#1)(2012-3#1)
In the current study##28##4##(1994-6#1)(1995-2#3)(2008-10#8)(2008-11#6)(2008-2#1)(2008-4#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
In the current work##4##4##(1995-12#1)(2008-5#1)(2010-5#1)(2010-8#1)
In the current##47##3##(1991-12#1)(1992-3#1)(1994-6#1)(1995-12#1)(1995-2#3)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
In the cytoplasm##2##3##(1994-8#1)(2008-7#1)
In the dermal##2##3##(2008-5#1)(2008-7#1)
In the detection of##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
In the determination of##3##4##(2008-10#3)
In the developing##2##3##(2008-1#1)(2008-7#1)
In the development of##6##4##(1991-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)
In the diploid##2##3##(2008-5#2)
In the dorsal##2##3##(1995-5#1)(1996-12#1)
In the early 1970s##3##4##(1994-3#2)(2008-11#1)
In the early##10##3##(1994-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2010-8#1)(2011-2#1)
In the eastern United States##2##5##(2008-10#2)
In the eastern##3##3##(2008-10#2)(2011-2#1)
In the emergency department (ED)##2##5##(2007-5#1)(2009-6#1)
In the end of##2##4##(1992-5#1)(2008-12#1)
In the end##3##3##(1992-5#1)(1994-12#1)(2008-12#1)
In the entire##2##3##(2008-3#1)(2011-2#1)
In the era of##2##4##(2008-1#1)(2008-10#1)
In the evaluation of##3##4##(1997-8#1)(2008-7#1)(2013-1#1)
In the event of a##2##5##(1990-9#1)(2008-7#1)
In the event of##6##4##(1990-3#1)(1990-9#1)(1997-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
In the event##8##3##(1990-3#1)(1990-9#1)(1997-2#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)
In the example##2##3##(2008-2#1)(2008-3#1)
In the experiment the##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
In the experiment##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
In the experimental group##4##4##(2008-10#1)(2008-12#1)(2013-1#2)
In the experimental##7##3##(1994-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#2)(2013-8#1)
In the experiments##5##3##(2007-11#1)(2008-3#3)(2008-5#1)
In the extracts##2##3##(1990-11#1)(2008-10#1)
In the face of##3##4##(1991-3#1)(2011-2#2)
In the fall of##3##4##(1991-2#1)(2008-3#1)(2011-9#1)
In the fed-batch##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
In the female##2##3##(1990-5#1)(2011-1#1)
In the few##2##3##(2008-10#1)(2008-2#1)
In the field of##5##4##(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
In the field##17##3##(2008-10#10)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-8#1)
In the fifth##2##3##(1995-5#1)(2008-11#1)
In the final##5##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
In the first and##2##4##(1990-3#1)(1996-3#1)
In the first approach##2##4##(2008-10#1)(2008-3#1)
In the first case##7##4##(1991-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)(2011-2#1)
In the first experiment##5##4##(1996-12#1)(2008-10#3)(2013-1#1)
In the first group##4##4##(2009-7#1)(2011-2#1)(2013-1#2)
In the first part of the survey##2##7##(1990-3#2)
In the first part of this review##2##7##(2008-10#1)(2012-2#1)
In the first part of this##4##6##(2008-10#2)(2008-2#1)(2012-2#1)
In the first part of##6##5##(1990-3#2)(2008-10#2)(2008-2#1)(2012-2#1)
In the first part##7##4##(1990-3#2)(2008-10#2)(2008-2#1)(2012-2#1)(2013-8#1)
In the first place##2##4##(2008-11#1)(2009-7#1)
In the first section##2##4##(1992-6#1)(2008-4#1)
In the first series##2##4##(2008-5#1)(2011-2#1)
In the first stage##2##4##(1990-12#1)(2008-9#1)
In the first step##8##4##(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2009-10#1)(2011-1#1)
In the first study##3##4##(2008-5#1)(2008-6#2)
In the first system##2##4##(2008-10#1)(2008-11#1)
In the first two##2##4##(2007-11#1)(2008-10#1)
In the first type##2##4##(2008-10#2)
In the first##88##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#2)(1992-6#2)(1993-12#1)(1993-2#2)(1995-2#1)(1996-12#2)(1996-3#1)(2007-11#1)(2007-8#2)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
In the flow##2##3##(2008-10#2)
In the fluid phase with##2##5##(2010-5#2)
In the follow-up period##2##4##(2008-2#1)(2008-7#1)
In the follow-up##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
In the following article##4##4##(1991-3#2)(1997-4#1)(2012-2#1)
In the following##10##3##(1991-3#2)(1997-3#2)(1997-4#1)(2008-1#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
In the former##8##3##(1990-6#1)(1995-5#1)(2008-10#2)(2010-4#1)(2012-2#3)
In the fourth##5##3##(1994-12#1)(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
In the framework of a##3##5##(1994-5#1)(1997-3#1)(2008-2#1)
In the framework of the##2##5##(1997-7#1)(2008-3#1)
In the framework of##6##4##(1994-5#1)(1997-3#1)(1997-7#1)(2008-2#2)(2008-3#1)
In the future##16##3##(1991-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
In the gas##2##3##(2008-10#1)(2008-3#1)
In the greenhouse##3##3##(2008-10#3)
In the group of patients##3##5##(1990-3#1)(1992-11#1)(2013-1#1)
In the group of##5##4##(1990-3#1)(1992-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
In the group with##6##4##(1992-1#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-8#1)(2008-6#1)
In the group without##2##4##(1993-8#1)(2007-8#1)
In the group##16##3##(1990-3#1)(1992-1#1)(1992-11#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-6#1)(2011-2#3)(2013-1#1)
In the groups##2##3##(1995-8#1)(2012-1#1)
In the growth chamber##2##4##(2008-10#2)
In the growth##3##3##(1990-12#1)(2008-10#2)
In the guinea pig##2##4##(1992-12#1)(1994-11#1)
In the healthy##2##3##(2008-7#1)(2013-7#1)
In the heart##2##3##(2013-1#2)
In the high##3##3##(1992-6#1)(2009-3#1)(2011-2#1)
In the holographic##2##3##(2008-3#2)
In the hot plate test##2##5##(1992-3#1)(1996-2#1)
In the immediate##2##3##(2008-3#1)(2008-7#1)
In the in vitro##2##4##(1994-5#1)(2008-6#1)
In the in##3##3##(1994-5#2)(2008-6#1)
In the initial evaluation##2##4##(2013-1#2)
In the initial##5##3##(1990-7#1)(2008-12#1)(2010-2#1)(2013-1#2)
In the interim##2##3##(2008-11#1)(2012-2#1)
In the investigated species##2##4##(2007-12#2)
In the investigated##3##3##(1990-2#1)(2007-12#2)
In the laboratory##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
In the larger##2##3##(2007-8#1)(2013-1#1)
In the last 10 years##5##5##(1992-5#1)(1995-9#1)(2008-5#1)(2009-5#1)(2011-1#1)
In the last 5 years##2##5##(2008-4#1)(2012-3#1)
In the last case##2##4##(2008-3#1)(2008-7#1)
In the last decade##15##4##(1991-6#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#3)
In the last decades##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
In the last few decades##2##5##(2008-10#1)(2012-2#1)
In the last few years##8##5##(1990-11#1)(1991-3#2)(1994-9#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#1)
In the last few##10##4##(1990-11#1)(1991-3#2)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#1)(2012-2#1)
In the last part of the##2##6##(1994-8#1)(2011-2#1)
In the last three##2##4##(2009-4#1)(2011-2#1)
In the last two decades##3##5##(2008-8#1)(2011-2#1)(2013-7#1)
In the last two##4##4##(1992-3#1)(2008-8#1)(2011-2#1)(2013-7#1)
In the last years##3##4##(2009-10#1)(2011-2#2)
In the last##59##3##(1990-11#1)(1990-7#1)(1991-3#3)(1991-6#1)(1992-3#1)(1992-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
In the late 1970s##2##4##(2008-12#1)(2010-3#1)
In the late##5##3##(1997-2#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-12#1)
In the later##2##3##(2008-6#1)(2008-8#1)
In the latter case the##3##5##(1995-6#1)(2007-12#1)(2013-8#1)
In the latter case##15##4##(1991-2#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-8#1)
In the latter group##2##4##(1996-9#1)(2007-1#1)
In the latter part##2##4##(2008-10#1)(2008-5#1)
In the latter##32##3##(1991-2#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-6#1)(1996-9#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
In the light of the##5##5##(1993-9#1)(1995-12#1)(1997-4#1)(2010-7#1)(2012-2#1)
In the light of these##2##5##(2008-11#1)(2011-1#1)
In the light of this##2##5##(2007-12#1)(2011-1#1)
In the light of##12##4##(1992-12#1)(1993-9#1)(1994-1#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#2)(2012-2#1)
In the limit of##2##4##(2007-12#1)(2008-2#1)
In the lipid peroxidation assay##2##5##(2008-11#1)(2008-5#1)
In the literature##8##3##(1990-5#1)(1990-6#1)(1996-12#1)(2007-8#1)(2008-10#2)(2010-3#1)(2013-1#1)
In the liver##4##3##(1993-3#1)(1996-2#1)(2008-10#1)(2011-1#1)
In the long term##3##4##(1993-2#1)(2009-11#1)(2009-9#1)
In the long##4##3##(1993-2#1)(1996-1#1)(2009-11#1)(2009-9#1)
In the majority of cases the##2##6##(1997-4#1)(2008-9#1)
In the majority of cases##8##5##(1991-11#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
In the majority of##16##4##(1991-11#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
In the male##3##3##(2008-7#1)(2010-5#1)(2011-1#1)
In the meantime##6##3##(1992-3#1)(1995-12#1)(1996-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
In the medium of##2##4##(1991-5#1)(2008-10#1)
In the medium##3##3##(1991-5#1)(1992-6#1)(2008-10#1)
In the method##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2013-8#1)
In the model##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
In the modern medical era it has been known as well that physical activity and exercise are important factors to prevent from different chronic diseases##2##25##(2013-1#2)
In the modern##3##3##(2008-10#1)(2013-1#2)
In the most##2##3##(2008-10#1)(2008-8#1)
In the mouse##3##3##(1997-2#1)(2008-8#1)(2012-12#1)
In the natural##2##3##(2008-10#1)(2011-1#1)
In the near##2##3##(1994-3#1)(1997-4#1)
In the new##3##3##(1995-9#1)(2008-1#1)(2008-10#1)
In the next few##2##4##(1996-3#1)(2008-7#1)
In the next stage##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
In the next step we##2##5##(2008-10#1)(2008-7#1)
In the next##12##3##(1996-2#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-9#1)(2013-1#1)
In the non-treated specimen of the##2##6##(2008-10#2)
In the normal##3##3##(1991-9#1)(1992-10#1)(1994-5#1)
In the northern##3##3##(1997-6#1)(2008-10#1)(2010-8#1)
In the only##2##3##(2008-5#1)(2010-10#1)
In the optimization studies of the biosensor##2##7##(2008-10#2)
In the optimization studies##3##4##(2008-10#3)
In the optimization##5##3##(2008-10#5)
In the optimized##2##3##(2008-10#2)
In the optimum conditions##3##4##(2008-10#3)
In the orchard##2##3##(2008-10#2)
In the other group##2##4##(2008-10#1)(2009-11#1)
In the other three##2##4##(1994-8#1)(2008-5#1)
In the other two##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
In the other##19##3##(1990-8#3)(1991-5#1)(1991-6#1)(1992-2#1)(1994-6#1)(1994-8#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2013-1#2)
In the ovary##2##3##(1995-12#1)(2008-6#1)
In the pH range##2##4##(2008-10#1)(2013-8#1)
In the paper we##2##4##(2007-11#1)(2013-8#1)
In the paper##8##3##(2007-11#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
In the past decade##15##4##(1991-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
In the past few years##5##5##(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
In the past few##6##4##(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)
In the past##42##3##(1990-12#1)(1991-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1997-3#1)(2006-10#3)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
In the patients##2##3##(2008-1#1)(2008-7#1)
In the period##7##3##(1990-3#1)(1993-5#1)(2007-11#3)(2011-1#1)(2013-8#1)
In the pharmaceutical##2##3##(2010-5#1)(2010-9#1)
In the plant##3##3##(2008-10#1)(2009-10#1)(2010-10#1)
In the population##2##3##(2008-10#1)(2008-2#1)
In the postnatal##3##3##(1990-5#1)(1994-11#1)(2009-8#1)
In the prepubertal##2##3##(2011-1#1)(2012-2#1)
In the presence of 0##5##5##(1990-11#1)(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
In the presence of 2##2##5##(1995-8#1)(1996-2#1)
In the presence of DNA##3##5##(1994-3#1)(1995-2#1)(2008-10#1)
In the presence of a##9##5##(1990-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)
In the presence of an##3##5##(2007-12#1)(2008-10#1)(2010-12#1)
In the presence of appropriate standards##2##6##(2008-2#1)(2008-4#1)
In the presence of high##2##5##(1990-2#1)(2008-4#1)
In the presence of low##2##5##(1995-3#1)(2008-5#1)
In the presence of sodium##2##5##(2008-10#2)
In the presence of the##5##5##(1993-8#1)(1995-5#1)(1995-6#1)(1997-4#1)(2008-12#1)
In the presence of##97##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#4)(1996-2#2)(1997-4#2)(2007-12#2)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#2)
In the present article##8##4##(1995-8#1)(2008-10#1)(2008-11#3)(2009-12#1)(2010-1#1)(2010-10#1)
In the present case##4##4##(1994-7#1)(2008-5#1)(2010-6#1)(2011-2#1)
In the present experiment##3##4##(1993-11#1)(1994-3#1)(1997-2#1)
In the present experiments##2##4##(1993-3#1)(2008-5#1)
In the present investigation##10##4##(1990-12#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-5#1)(2013-1#1)
In the present method##2##4##(2008-10#2)
In the present paper the##4##5##(1990-12#1)(1990-2#1)(1990-6#1)(2012-3#1)
In the present paper we##7##5##(1991-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
In the present paper##38##4##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
In the present report##4##4##(2007-10#1)(2008-11#1)(2011-2#2)
In the present research we##2##5##(2008-12#1)(2008-2#1)
In the present review##12##4##(1994-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
In the present studies we##2##5##(1991-2#1)(2013-1#1)
In the present studies##4##4##(1991-2#1)(1992-4#1)(1993-12#1)(2013-1#1)
In the present study a##5##5##(2008-10#2)(2008-12#1)(2010-3#1)(2013-1#1)
In the present study an##2##5##(1990-6#1)(2008-11#1)
In the present study it##2##5##(1990-12#1)(2012-2#1)
In the present study the##7##5##(1991-6#1)(1991-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-6#2)
In the present study we compared##2##6##(1995-11#1)(1995-12#1)
In the present study we describe##2##6##(1994-6#1)(2007-8#1)
In the present study we evaluated the##3##7##(1992-12#1)(1997-2#1)(2008-4#1)
In the present study we examined##2##6##(1996-12#1)(2012-1#1)
In the present study we have evaluated##2##7##(1992-12#1)(2012-3#1)
In the present study we have investigated##2##7##(1994-2#1)(1995-12#1)
In the present study we have##10##6##(1991-2#1)(1992-12#1)(1994-2#1)(1995-12#2)(1996-12#1)(2007-7#1)(2009-7#1)(2010-7#1)(2012-3#1)
In the present study we investigated the effect of##2##9##(1996-2#1)(2008-7#1)
In the present study we investigated the##6##7##(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)(2009-2#1)(2013-8#1)
In the present study we investigated whether##2##7##(1995-8#1)(1997-7#1)
In the present study we investigated##8##6##(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-7#1)(2009-2#1)(2013-8#1)
In the present study we show that##2##7##(1994-9#1)(2008-7#1)
In the present study we##42##5##(1991-2#1)(1992-12#2)(1993-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#2)
In the present study##258##4##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#2)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#1)(1992-12#3)(1992-6#1)(1992-8#1)(1993-12#4)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-6#2)(1994-8#5)(1994-9#3)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#2)(1995-8#2)(1996-12#4)(1996-2#6)(1996-5#6)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#5)(1997-6#2)(1997-7#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#18)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-6#6)(2008-7#5)(2008-8#3)(2008-9#6)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#5)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#5)
In the present work a##2##5##(2008-10#1)(2009-10#1)
In the present work the##2##5##(2008-10#2)
In the present work we study the##2##7##(2008-10#2)
In the present work we##7##5##(1992-11#1)(1994-12#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#1)
In the present work##52##4##(1990-11#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#30)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
In the present##413##3##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#3)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#2)(1995-8#3)(1996-12#5)(1996-2#8)(1996-5#6)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#5)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#76)(2008-11#29)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#13)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#14)(2012-1#5)(2012-12#3)(2012-2#11)(2012-3#7)(2013-1#14)(2013-7#4)(2013-8#7)
In the presentstudy##3##3##(2008-11#3)
In the primary visual cortex##2##5##(1993-12#1)(2012-2#1)
In the primary##3##3##(1993-12#1)(2012-2#2)
In the process of##6##4##(1993-3#1)(1997-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
In the process##10##3##(1993-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2013-8#1)
In the proposed approach##2##4##(2008-10#1)(2012-1#1)
In the proposed##8##3##(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#1)(2012-1#1)(2013-8#1)
In the rabbit##2##3##(1994-11#1)(2008-10#1)
In the range of##4##4##(1994-11#1)(1994-12#1)(1997-6#1)(2008-11#1)
In the range##5##3##(1994-11#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-11#1)
In the rat aorta##3##4##(1991-9#1)(1994-11#2)
In the rat##8##3##(1990-5#1)(1991-9#1)(1992-9#1)(1994-11#2)(1995-11#1)(2008-4#2)
In the real##2##3##(2007-8#1)(2008-10#1)
In the recent past##2##4##(2008-10#1)(2008-11#1)
In the recent years##5##4##(1994-11#1)(1995-4#1)(2008-12#1)(2012-2#1)(2012-3#1)
In the recent##8##3##(1991-12#1)(1994-11#1)(1995-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
In the reciprocal##2##3##(1990-11#1)(2008-10#1)
In the region##3##3##(1997-2#1)(2008-10#2)
In the regression model##2##4##(2008-10#1)(2010-4#1)
In the remaining 52 wards##2##5##(2013-1#2)
In the remaining##13##3##(1991-8#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#2)
In the rest of the##2##5##(1992-10#1)(2008-8#1)
In the review##4##3##(1997-7#1)(2009-5#1)(2012-3#2)
In the rice##2##3##(2008-10#2)
In the same way##2##4##(2008-11#1)(2008-12#1)
In the same##14##3##(1991-8#1)(1993-3#1)(1993-6#1)(1995-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
In the search for new##2##5##(2008-8#1)(2013-1#1)
In the search for##4##4##(2008-11#1)(2008-8#2)(2013-1#1)
In the search##5##3##(2008-11#1)(2008-7#1)(2008-8#2)(2013-1#1)
In the second approach##2##4##(1995-2#1)(2008-3#1)
In the second case##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
In the second experiment##7##4##(1993-12#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
In the second method##2##4##(2008-10#2)
In the second part of the survey##2##7##(1990-3#2)
In the second part of the##3##6##(1990-3#2)(2008-11#1)
In the second part of##4##5##(1990-3#2)(1997-4#1)(2008-11#1)
In the second part##9##4##(1990-3#2)(1997-4#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-11#1)(2013-8#1)
In the second period##3##4##(2011-2#3)
In the second phase##2##4##(2008-4#1)(2008-6#1)
In the second section##5##4##(1991-1#1)(1992-6#1)(2008-4#1)(2012-2#2)
In the second step##3##4##(2008-3#1)(2009-8#1)(2011-1#1)
In the second study##5##4##(2008-5#1)(2008-6#2)(2012-3#1)(2013-1#1)
In the second##75##3##(1990-12#1)(1990-3#2)(1991-1#1)(1991-6#1)(1992-6#2)(1993-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
In the section##2##3##(1990-5#1)(1997-2#1)
In the selected conditions##2##4##(2008-10#2)
In the selected##4##3##(2008-10#3)(2012-3#1)
In the series of##3##4##(1992-11#1)(1995-3#1)(2008-7#1)
In the serum-free##2##3##(2008-11#1)(2008-4#1)
In the simulations##3##3##(2008-10#1)(2008-3#2)
In the skin##3##3##(2008-5#2)(2012-2#1)
In the special case##2##4##(1992-6#1)(2008-10#1)
In the special##4##3##(1992-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
In the spinal cord##3##4##(1990-7#1)(1991-5#1)(1993-12#1)
In the spinal##4##3##(1990-7#1)(1991-5#1)(1993-12#1)(2007-11#1)
In the spring of 2000##2##5##(2008-10#2)
In the spring of##5##4##(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
In the spring##6##3##(1996-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
In the standard##2##3##(1996-2#1)(2008-8#1)
In the studied##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
In the studies##4##3##(1994-8#1)(1997-5#1)(2008-10#2)
In the study group##2##4##(2008-1#1)(2008-6#1)
In the study of##3##4##(1991-9#1)(2007-7#1)(2011-2#1)
In the study period##2##4##(2013-1#1)(2013-8#1)
In the study reported here##2##5##(1992-3#1)(2013-8#1)
In the study the##2##4##(2007-8#1)(2008-12#1)
In the study##15##3##(1990-2#1)(1991-9#1)(1992-3#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#2)
In the subfamily##2##3##(2008-5#2)
In the subjects##2##3##(1991-2#1)(2008-5#1)
In the summer of##2##4##(1997-1#1)(2008-11#1)
In the system##3##3##(1990-8#1)(1993-8#1)(2008-10#1)
In the third and##2##4##(2008-10#1)(2012-2#1)
In the third case##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
In the third experiment##2##4##(2008-10#2)
In the third year##2##4##(2008-10#2)
In the third##14##3##(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
In the three##3##3##(1992-5#1)(2008-9#1)(2012-2#1)
In the total##2##3##(1994-3#1)(2008-7#1)
In the traditional##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
In the treatment of##7##4##(1990-9#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-2#1)(1997-3#1)(2007-8#1)
In the treatment##8##3##(1990-9#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-2#1)(1997-3#1)(2007-11#1)(2007-8#1)
In the tropical##2##3##(2007-5#1)(2008-9#1)
In the two##6##3##(1995-12#1)(1996-9#1)(2008-10#1)(2008-2#1)(2011-2#1)(2011-3#1)
In the view of##2##4##(2007-8#1)(2008-6#1)
In the volunteer##2##3##(1993-2#1)(2008-5#1)
In the wheat rhizosphere##2##4##(2008-10#2)
In the whole##4##3##(1991-9#1)(2008-3#1)(2008-8#1)(2011-2#1)
In the winter##2##3##(2007-6#1)(2008-10#1)
In the work reported here##2##5##(1995-8#1)(2011-2#1)
In the work##5##3##(1995-8#1)(2008-10#3)(2011-2#1)
In the year after random assignment##2##6##(2013-1#2)
In the year##5##3##(2007-6#1)(2010-3#1)(2011-1#1)(2013-1#2)
In the years##6##3##(1990-8#1)(1995-1#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-5#1)
In the yeast Saccharomyces cerevisiae##2##5##(1995-6#1)(2008-10#1)
In the##2495##2##(1990-10#2)(1990-11#20)(1990-12#11)(1990-2#10)(1990-3#11)(1990-5#17)(1990-6#7)(1990-7#6)(1990-8#12)(1990-9#5)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#11)(1991-2#17)(1991-3#11)(1991-5#4)(1991-6#7)(1991-7#2)(1991-8#6)(1991-9#11)(1992-1#1)(1992-10#4)(1992-11#7)(1992-12#9)(1992-2#6)(1992-3#13)(1992-4#1)(1992-5#7)(1992-6#11)(1992-8#4)(1992-9#8)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#22)(1993-2#8)(1993-3#6)(1993-5#3)(1993-6#10)(1993-8#16)(1993-9#7)(1994-1#4)(1994-10#1)(1994-11#15)(1994-12#11)(1994-2#11)(1994-3#8)(1994-5#11)(1994-6#9)(1994-7#1)(1994-8#19)(1994-9#6)(1995-1#3)(1995-11#8)(1995-12#26)(1995-2#20)(1995-3#9)(1995-4#1)(1995-5#13)(1995-6#11)(1995-8#13)(1995-9#5)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#17)(1996-2#24)(1996-3#7)(1996-5#13)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#6)(1997-2#16)(1997-3#16)(1997-4#21)(1997-5#4)(1997-6#14)(1997-7#12)(1997-8#7)(2006-10#7)(2006-12#2)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#7)(2007-11#35)(2007-12#35)(2007-2#2)(2007-5#5)(2007-6#4)(2007-7#11)(2007-8#25)(2008-1#18)(2008-10#415)(2008-11#120)(2008-12#44)(2008-2#55)(2008-3#92)(2008-4#38)(2008-5#79)(2008-6#44)(2008-7#88)(2008-8#59)(2008-9#43)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#10)(2009-2#7)(2009-3#7)(2009-4#4)(2009-5#7)(2009-6#7)(2009-7#8)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#8)(2010-12#10)(2010-2#1)(2010-3#21)(2010-4#9)(2010-5#13)(2010-6#6)(2010-7#6)(2010-8#15)(2010-9#2)(2011-1#21)(2011-2#95)(2011-3#3)(2011-9#1)(2012-1#15)(2012-12#21)(2012-2#55)(2012-3#30)(2012-4#3)(2012-7#2)(2013-1#86)(2013-7#9)(2013-8#36)
In their own words##2##4##(2008-4#1)(2008-6#1)
In their##9##2##(1990-9#1)(1991-3#1)(1992-11#1)(1994-12#1)(1994-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
In these animals##2##3##(1995-3#1)(1996-12#1)
In these cases the##3##4##(1997-6#1)(2008-10#1)(2008-9#1)
In these cases##12##3##(1990-6#1)(1994-11#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
In these cells the##2##4##(1993-6#1)(1997-6#1)
In these cells##9##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-6#1)(1994-11#1)(1997-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
In these circumstances##3##3##(1993-12#1)(1994-8#1)(2008-11#1)
In these conditions a##2##4##(2008-10#2)
In these conditions##9##3##(1995-2#1)(2008-10#5)(2008-7#2)(2011-1#1)
In these data##2##3##(1997-7#1)(2008-7#1)
In these experiments##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
In these patients##13##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-12#1)(2006-7#1)(2007-8#2)(2008-1#2)(2008-8#1)(2011-2#2)(2013-1#1)
In these plants##2##3##(2008-10#2)
In these protocols##2##3##(2008-1#1)(2008-2#1)
In these studies##9##3##(1993-3#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-6#1)(2012-1#1)
In these two##3##3##(1993-12#1)(1997-8#1)(2008-10#1)
In these##119##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-8#2)(1995-11#2)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-7#1)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
In this addendum we propose##2##5##(2009-8#2)
In this addendum we##5##4##(2009-8#4)(2013-1#1)
In this addendum##8##3##(2009-8#7)(2013-1#1)
In this analysis##4##3##(1992-12#1)(2008-9#1)(2010-5#1)(2012-3#1)
In this appendix##2##3##(2008-4#1)(2008-9#1)
In this approach##7##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-1#1)
In this article I##2##4##(1992-2#1)(2009-6#1)
In this article a##3##4##(2007-11#1)(2008-11#1)(2013-8#1)
In this article the##6##4##(1990-3#2)(1992-3#1)(1993-1#1)(2008-1#1)(2008-11#1)
In this article we briefly##2##5##(2008-7#1)(2012-2#1)
In this article we demonstrate##2##5##(2008-7#1)(2008-8#1)
In this article we describe the##2##6##(1997-6#1)(2012-12#1)
In this article we describe##5##5##(1994-1#1)(1997-6#1)(2008-7#1)(2010-7#1)(2012-12#1)
In this article we discuss the##4##6##(1991-12#1)(1992-11#1)(2007-12#1)(2011-2#1)
In this article we discuss##5##5##(1991-12#1)(1992-11#1)(1992-12#1)(2007-12#1)(2011-2#1)
In this article we have##2##5##(2008-5#1)(2012-2#1)
In this article we present a##2##6##(1990-9#1)(2008-11#1)
In this article we present results##2##6##(1995-6#1)(2008-11#1)
In this article we present##7##5##(1990-9#1)(1995-6#1)(2008-11#2)(2009-1#1)(2010-12#1)(2012-2#1)
In this article we review the##5##6##(2007-10#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)
In this article we##39##4##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1994-1#1)(1995-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)
In this article##308##3##(1990-11#1)(1990-3#2)(1990-9#1)(1991-1#6)(1991-12#4)(1991-2#5)(1991-3#6)(1991-9#1)(1992-1#6)(1992-11#1)(1992-12#7)(1992-2#8)(1992-3#4)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#3)(1994-1#7)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-6#1)(1996-1#3)(1996-2#2)(1996-3#4)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#3)(2008-1#5)(2008-10#12)(2008-11#20)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#16)(2008-9#11)(2009-1#2)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#5)(2011-1#4)(2011-2#14)(2011-3#1)(2012-12#5)(2012-2#13)(2012-3#4)(2013-1#6)(2013-8#3)
In this assay##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
In this brief review we##2##5##(1992-2#1)(2008-7#1)
In this brief review##3##4##(1992-2#1)(2008-5#1)(2008-7#1)
In this brief##5##3##(1992-2#1)(1996-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
In this case report the##2##5##(1997-3#1)(2010-10#1)
In this case report we describe##2##6##(2008-4#1)(2008-6#1)
In this case report we present a##2##7##(2007-10#1)(2007-8#1)
In this case report we present##3##6##(2007-10#1)(2007-8#1)(2012-12#1)
In this case report we##5##5##(2007-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-12#1)
In this case report##12##4##(1996-8#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
In this case study##2##4##(1993-1#1)(1996-1#1)
In this case the##8##4##(1995-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#4)
In this case there##2##4##(1995-5#1)(2008-7#1)
In this case##74##3##(1991-2#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-3#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
In this chapter##8##3##(2008-7#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-5#2)(2013-1#1)
In this column##9##3##(2007-2#9)
In this communication we report##2##5##(1990-2#1)(2007-8#1)
In this communication##8##3##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#1)(1996-3#1)(1997-2#1)(2007-8#1)(2012-8#1)
In this comprehensive article##2##4##(1995-1#1)(2010-8#1)
In this comprehensive##3##3##(1995-1#1)(2010-2#1)(2010-8#1)
In this condition##2##3##(1997-1#1)(2008-11#1)
In this configuration##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
In this context the##2##4##(2008-10#1)(2012-3#1)
In this context we##2##4##(2008-3#1)(2009-2#1)
In this context##33##3##(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#1)
In this contribution##4##3##(2008-1#2)(2008-10#1)(2008-3#1)
In this cross##2##3##(2008-10#1)(2013-8#1)
In this cross-sectional study##5##4##(2008-1#1)(2010-4#1)(2011-2#2)(2013-1#1)
In this cross-sectional##6##3##(2008-1#1)(2008-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
In this design##2##3##(2008-2#1)(2010-5#1)
In this domain##2##3##(2008-2#1)(2008-3#1)
In this essay##2##3##(1995-1#1)(2012-2#1)
In this evaluation##3##3##(2008-10#2)(2012-2#1)
In this exercise##2##3##(2008-10#2)
In this experiment##4##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-8#1)
In this experimental##2##3##(2008-7#1)(2008-9#1)
In this exploratory##2##3##(2010-5#1)(2010-6#1)
In this extra view##2##4##(2008-9#1)(2011-2#1)
In this first##3##3##(1991-12#1)(2011-1#1)(2012-2#1)
In this form##2##3##(1994-8#1)(2008-4#1)
In this group##10##3##(1991-6#1)(1993-11#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2009-8#1)(2013-1#1)
In this investigation##15##3##(1990-3#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2012-12#1)
In this issue of##2##4##(2009-9#1)(2013-1#1)
In this issue##3##3##(2009-9#1)(2013-1#2)
In this kind of##2##4##(2008-10#1)(2008-3#1)
In this latter##2##3##(1993-8#1)(2008-5#1)
In this letter##2##3##(2008-10#1)(2008-3#1)
In this manner##3##3##(2007-12#1)(2009-11#1)(2011-1#1)
In this manuscript the##2##4##(2008-5#1)(2013-8#1)
In this manuscript we##3##4##(2008-7#1)(2009-12#1)(2012-3#1)
In this manuscript##9##3##(2008-5#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
In this method the##8##4##(2007-11#1)(2008-10#1)(2008-3#6)
In this method we##2##4##(2008-3#2)
In this method##31##3##(2007-11#2)(2008-10#16)(2008-2#1)(2008-3#11)(2008-4#1)
In this mini-review##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
In this minireview##2##3##(1994-12#1)(2009-2#1)
In this model the##3##4##(2008-2#1)(2008-3#2)
In this model##13##3##(1991-9#1)(1994-2#1)(1994-9#1)(1996-4#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2012-2#1)
In this new##7##3##(1993-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-8#2)
In this overview##2##3##(2008-11#1)(2011-1#1)
In this paper I##4##4##(1995-12#1)(1995-9#1)(2008-7#1)(2013-1#1)
In this paper a method##2##5##(2008-10#2)
In this paper a##7##4##(2008-10#6)(2008-11#1)
In this paper an##2##4##(2008-10#2)
In this paper are##3##4##(2007-11#1)(2008-5#1)(2013-7#1)
In this paper the authors##2##5##(1993-3#1)(2007-10#1)
In this paper the##12##4##(1990-3#1)(1992-9#2)(1993-3#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-3#1)
In this paper we are going to have a bird's eye view on some articles published on this topic##2##19##(2013-1#2)
In this paper we describe a new##2##7##(2008-10#1)(2008-7#1)
In this paper we describe a##4##6##(1990-12#1)(1990-8#1)(2008-10#1)(2008-7#1)
In this paper we describe our##2##6##(1994-11#1)(2012-12#1)
In this paper we describe the application of the dual grid##2##11##(2013-1#2)
In this paper we describe the application##3##7##(2007-11#1)(2013-1#2)
In this paper we describe##13##5##(1990-12#1)(1990-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
In this paper we develop a##2##6##(2008-11#1)(2011-1#1)
In this paper we discuss the##2##6##(2008-10#1)(2008-5#1)
In this paper we discuss##5##5##(1995-9#1)(2008-10#2)(2008-5#1)(2008-7#1)
In this paper we focus##2##5##(2008-11#1)(2010-10#1)
In this paper we have##3##5##(1994-2#1)(1997-4#1)(2012-3#1)
In this paper we introduce##3##5##(2007-6#1)(2010-10#1)(2013-8#1)
In this paper we investigate##2##5##(2008-10#1)(2012-3#1)
In this paper we present a##3##6##(2008-3#1)(2012-12#1)(2013-1#1)
In this paper we present our experience##2##7##(2007-5#1)(2013-1#1)
In this paper we present##12##5##(1995-8#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-12#1)(2013-1#2)(2013-8#1)
In this paper we propose a##2##6##(2009-5#1)(2013-8#1)
In this paper we propose##4##5##(2008-5#1)(2009-5#1)(2013-8#2)
In this paper we report that##2##6##(1990-11#1)(2008-11#1)
In this paper we report the synthesis of##2##8##(2007-11#1)(2012-2#1)
In this paper we report the##3##6##(2007-11#1)(2012-2#1)(2013-1#1)
In this paper we report##5##5##(1990-11#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
In this paper we review the##5##6##(1996-2#1)(2008-11#1)(2009-7#1)(2012-2#2)
In this paper we review##7##5##(1994-11#1)(1996-2#1)(2008-11#1)(2009-7#1)(2012-2#3)
In this paper we show that##2##6##(1995-2#1)(2009-7#1)
In this paper we use##2##5##(1995-9#1)(2007-12#1)
In this paper we will##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
In this paper we##86##4##(1990-11#1)(1990-12#1)(1990-8#2)(1993-12#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-8#1)(1995-9#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#6)
In this paper##404##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#5)(1997-8#4)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#8)(2008-10#99)(2008-11#24)(2008-12#10)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#13)(2008-7#13)(2008-8#1)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#4)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#12)(2011-2#9)(2011-3#3)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#12)
In this paradigm##3##3##(1992-3#1)(2008-11#1)(2008-4#1)
In this patient##4##3##(2007-10#1)(2010-5#1)(2012-12#1)(2013-2#1)
In this period##2##3##(1994-12#1)(2011-2#1)
In this perspective##3##3##(2008-2#1)(2009-10#1)(2011-2#1)
In this phase##2##3##(2008-7#1)(2012-2#1)
In this pilot study##5##4##(1996-3#1)(2008-10#1)(2008-9#1)(2009-1#1)(2009-5#1)
In this population##2##3##(2008-12#2)
In this preliminary investigation##3##4##(2008-9#2)(2011-2#1)
In this preliminary##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
In this present##2##3##(2008-10#1)(2008-8#1)
In this presentation##2##3##(2010-3#1)(2011-2#1)
In this procedure##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
In this process##6##3##(1991-6#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-9#1)(2011-2#1)
In this project##2##3##(2008-12#1)(2013-1#1)
In this prospective cohort study##2##5##(2008-12#1)(2008-3#1)
In this prospective study##4##4##(1997-3#1)(2008-12#1)(2012-3#1)(2013-1#1)
In this prospective##9##3##(1997-3#1)(2008-12#2)(2008-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
In this protocol##3##3##(2008-10#1)(2008-4#2)
In this publication##4##3##(2008-10#1)(2008-11#2)(2013-1#1)
In this qualitative study of 16 women aged 82 and older##2##11##(2013-1#2)
In this reaction##2##3##(2008-10#2)
In this regard##19##3##(1991-12#1)(1991-6#1)(1992-5#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-3#1)(2012-2#1)
In this region##3##3##(1993-8#1)(1996-6#1)(1997-5#1)
In this report a##2##4##(1992-8#1)(2011-1#1)
In this report the##4##4##(1994-11#1)(2008-5#1)(2009-10#1)(2009-5#1)
In this report we demonstrate that##4##6##(1992-7#1)(1993-11#1)(1993-8#1)(2011-1#1)
In this report we describe a##2##6##(1992-11#1)(2012-3#1)
In this report we describe##6##5##(1990-8#1)(1992-11#1)(1997-9#1)(2007-7#1)(2012-3#2)
In this report we have##4##5##(1990-5#1)(1992-9#1)(1996-3#1)(2008-4#1)
In this report we present a##2##6##(2008-7#2)
In this report we present##4##5##(2008-4#1)(2008-7#2)(2012-2#1)
In this report we show that##2##6##(1990-2#1)(1995-2#1)
In this report we##24##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-9#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#3)
In this report##77##3##(1990-2#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#3)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
In this research we##2##4##(2008-12#1)(2010-1#1)
In this research##12##3##(2008-10#2)(2008-12#5)(2008-3#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#1)
In this respect##17##3##(1991-6#1)(1993-12#1)(1994-5#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
In this retrospective study##9##4##(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2011-2#2)(2013-1#1)
In this retrospective##12##3##(1996-11#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2011-1#1)(2011-2#3)(2013-1#1)
In this review article we##2##5##(2008-11#1)(2012-3#1)
In this review article##8##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
In this review the##7##4##(1992-5#1)(2007-12#1)(2008-11#2)(2008-6#1)(2009-12#1)(2011-2#1)
In this review we aim to##2##6##(2008-7#1)(2013-1#1)
In this review we analyze##2##5##(2008-11#1)(2008-7#1)
In this review we describe the##3##6##(2009-7#1)(2010-9#1)(2013-1#1)
In this review we describe##5##5##(2007-7#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
In this review we discuss the##3##6##(2007-5#1)(2011-2#1)(2013-8#1)
In this review we discuss##6##5##(2007-12#1)(2007-5#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
In this review we explore##2##5##(2008-1#1)(2012-2#1)
In this review we focus on##3##6##(2008-1#1)(2010-10#1)(2012-2#1)
In this review we will discuss the##3##7##(2009-3#1)(2010-10#1)(2012-1#1)
In this review we will discuss##4##6##(2008-7#1)(2009-3#1)(2010-10#1)(2012-1#1)
In this review we will##7##5##(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-1#2)
In this review we##43##4##(1996-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#7)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
In this review##191##3##(1992-5#1)(1994-11#1)(1996-11#1)(1996-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#7)(2008-10#14)(2008-11#13)(2008-12#2)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#25)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#5)(2013-8#8)
In this scheme##3##3##(1994-12#1)(2007-11#1)(2009-7#1)
In this second##3##3##(1992-1#1)(1994-1#1)(1994-3#1)
In this section##2##3##(1993-3#1)(2008-2#1)
In this sense##3##3##(2007-11#1)(2008-10#2)
In this series of projects##2##5##(1995-8#1)(1996-10#1)
In this series of##3##4##(1990-7#1)(1995-8#1)(1996-10#1)
In this series##6##3##(1990-7#1)(1994-12#1)(1995-8#1)(1996-10#1)(2011-2#1)(2012-2#1)
In this setting##6##3##(1995-5#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2012-2#1)
In this short##5##3##(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
In this situation the##2##4##(2008-10#1)(2008-3#1)
In this situation##3##3##(2008-10#1)(2008-3#2)
In this small##2##3##(1996-9#1)(2008-11#1)
In this species##4##3##(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)
In this spectral##2##3##(2008-3#2)
In this study a##6##4##(1993-2#1)(2008-10#3)(2008-3#1)(2010-4#1)
In this study it was shown that##2##7##(1994-11#1)(1996-12#1)
In this study it##3##4##(1994-11#1)(1996-12#1)(2008-2#1)
In this study of##4##4##(1996-1#1)(1997-1#1)(2009-6#1)(2009-9#1)
In this study the##21##4##(1990-5#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#2)(2012-3#1)
In this study two##2##4##(2008-10#1)(2008-5#1)
In this study we aimed to##2##6##(2007-8#1)(2012-3#1)
In this study we analyzed##3##5##(1990-11#1)(1995-12#1)(2007-7#1)
In this study we compared the##3##6##(1993-11#1)(1994-2#1)(2007-8#1)
In this study we evaluated##2##5##(2009-6#1)(2013-1#1)
In this study we examine##3##5##(2009-12#1)(2012-5#1)(2013-1#1)
In this study we examined the effects of##2##8##(1995-8#1)(2009-7#1)
In this study we examined##3##5##(1995-8#1)(2009-7#1)(2010-7#1)
In this study we have investigated##2##6##(1995-6#1)(2008-12#1)
In this study we have used##3##6##(1996-12#1)(2008-7#1)(2011-2#1)
In this study we have##12##5##(1991-2#1)(1992-10#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-3#1)(2011-2#2)(2013-1#1)
In this study we identified##3##5##(2007-2#1)(2008-10#1)(2008-6#1)
In this study we investigated##5##5##(1991-2#1)(1993-3#1)(2008-11#1)(2010-6#1)(2012-7#1)
In this study we present##2##5##(1991-9#1)(1997-3#1)
In this study we show that the##3##7##(1994-11#1)(1995-9#1)(1997-2#1)
In this study we show that##7##6##(1990-5#1)(1993-8#2)(1994-11#1)(1995-9#1)(1997-2#1)(2012-2#1)
In this study we sought to##2##6##(1995-2#1)(2008-10#1)
In this study we use a##2##6##(2008-10#1)(2008-7#1)
In this study we use##3##5##(1995-12#1)(2008-10#1)(2008-7#1)
In this study we used##3##5##(2008-12#1)(2009-9#1)(2012-2#1)
In this study we##82##4##(1990-11#2)(1990-5#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#5)(2013-7#1)
In this study##631##3##(1990-11#3)(1990-12#4)(1990-5#4)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#7)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#6)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#2)(1996-12#9)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#5)(1997-7#1)(1997-8#4)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#3)(2007-7#9)(2007-8#4)(2008-1#2)(2008-10#115)(2008-11#40)(2008-12#22)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#16)(2008-6#12)(2008-7#12)(2008-8#9)(2008-9#12)(2009-10#3)(2009-11#6)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#7)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#31)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#25)(2012-3#16)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#24)(2013-7#5)(2013-8#2)
In this survey 225 students##2##5##(1992-6#2)
In this survey##7##3##(1992-6#2)(1993-2#1)(1995-8#1)(2008-10#1)(2009-3#1)(2011-1#1)
In this system##17##3##(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-7#1)
In this technique##6##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
In this trial##2##3##(1995-4#1)(2008-7#1)
In this tutorial##3##3##(1993-12#1)(1993-3#1)(1994-12#1)
In this unit##52##3##(2008-1#4)(2008-2#7)(2008-4#32)(2008-9#9)
In this view##2##3##(2008-11#2)
In this way a##3##4##(1990-9#1)(1992-6#1)(2008-8#1)
In this way the##5##4##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
In this way we##5##4##(2007-8#2)(2008-11#1)(2008-3#2)
In this way##50##3##(1990-9#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-4#1)(2013-1#1)(2013-8#1)
In this work a new##2##5##(2008-10#2)
In this work a##7##4##(2008-10#5)(2011-2#1)(2012-2#1)
In this work the##9##4##(1990-3#1)(1993-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-1#1)
In this work we demonstrate##2##5##(1991-12#1)(2011-2#1)
In this work we have investigated the##2##7##(1991-5#1)(1992-8#1)
In this work we have studied##2##6##(1990-5#1)(2008-11#1)
In this work we have##4##5##(1990-5#1)(1991-5#1)(1992-8#1)(2008-11#1)
In this work we present a comparative study of the spectroscopy and excited state dynamics of cis and trans isomers of three different open-chain carotenoids in solution##2##27##(2010-2#2)
In this work we present##4##5##(1991-5#1)(2008-10#1)(2010-2#2)
In this work we studied the##2##6##(2008-10#1)(2013-7#1)
In this work we##25##4##(1990-5#1)(1991-12#1)(1991-5#2)(1992-8#1)(1997-2#1)(2008-10#6)(2008-11#4)(2009-8#1)(2010-2#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
In this work##185##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-4#1)(1997-2#3)(1997-7#1)(2007-12#1)(2008-10#98)(2008-11#9)(2008-5#3)(2008-6#6)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-8#4)(2011-1#1)(2011-2#4)(2011-3#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#2)
In this world##2##3##(2008-10#1)(2013-1#1)
In this##2540##2##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#2)(1990-3#6)(1990-5#7)(1990-7#3)(1990-8#7)(1990-9#2)(1991-1#9)(1991-11#2)(1991-12#16)(1991-2#10)(1991-3#10)(1991-4#1)(1991-5#4)(1991-6#6)(1991-8#2)(1991-9#3)(1992-1#8)(1992-10#1)(1992-11#5)(1992-12#14)(1992-2#12)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#6)(1993-12#12)(1993-2#7)(1993-3#15)(1993-6#4)(1993-8#13)(1993-9#2)(1994-1#8)(1994-11#9)(1994-12#15)(1994-2#12)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#8)(1994-9#4)(1995-1#6)(1995-11#4)(1995-12#10)(1995-2#17)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#7)(1995-8#7)(1995-9#4)(1996-1#7)(1996-10#1)(1996-11#4)(1996-12#14)(1996-2#7)(1996-3#8)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#8)(1997-2#10)(1997-3#8)(1997-4#9)(1997-5#2)(1997-6#7)(1997-7#9)(1997-8#10)(1997-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#12)(2007-11#17)(2007-12#29)(2007-2#16)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#16)(2007-8#19)(2008-1#43)(2008-10#454)(2008-11#134)(2008-12#53)(2008-2#38)(2008-3#67)(2008-4#61)(2008-5#42)(2008-6#43)(2008-7#92)(2008-8#44)(2008-9#60)(2009-1#4)(2009-10#13)(2009-11#13)(2009-12#9)(2009-2#8)(2009-3#17)(2009-4#3)(2009-5#18)(2009-6#10)(2009-7#18)(2009-8#19)(2009-9#21)(2010-1#9)(2010-10#14)(2010-11#13)(2010-12#18)(2010-2#10)(2010-3#14)(2010-4#15)(2010-5#23)(2010-6#14)(2010-7#11)(2010-8#31)(2010-9#11)(2011-1#43)(2011-10#1)(2011-2#106)(2011-3#8)(2011-7#1)(2012-1#11)(2012-12#31)(2012-2#76)(2012-3#52)(2012-5#2)(2012-6#1)(2012-7#3)(2012-8#1)(2013-1#90)(2013-2#1)(2013-7#12)(2013-8#36)
In those patients who##2##4##(2012-3#2)
In those patients##3##3##(2011-2#1)(2012-3#2)
In those undergoing##2##3##(2008-7#2)
In those##8##2##(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#2)
In three cases##2##3##(1994-12#1)(2007-8#1)
In three experiments##2##3##(2008-10#1)(2011-1#1)
In three of four##2##4##(2008-10#2)
In three of##6##3##(1991-2#1)(2007-8#1)(2008-10#4)
In three patients##4##3##(1993-2#1)(1996-11#1)(1997-5#1)(2013-1#1)
In three##22##2##(1991-2#1)(1991-3#1)(1992-6#1)(1993-2#1)(1994-12#2)(1996-11#1)(1996-5#1)(1997-5#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
In thus##2##2##(1990-11#1)(2012-4#1)
In today's##6##2##(1991-3#1)(1992-2#2)(1993-1#1)(1994-3#1)(2008-12#1)
In total##31##2##(1993-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#3)(2013-7#1)
In tumors from##2##3##(1993-9#2)
In tumors##3##2##(1993-9#2)(2010-3#1)
In tumours##2##2##(1994-10#1)(2013-1#1)
In turn##14##2##(1993-12#1)(1994-1#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
In twelve##2##2##(1991-6#1)(2008-8#1)
In two cases##6##3##(1995-3#1)(1996-4#1)(2007-11#2)(2008-6#1)(2011-2#1)
In two experiments##5##3##(2008-10#2)(2008-5#1)(2009-5#1)(2013-1#1)
In two field trials##2##4##(2008-10#2)
In two field##3##3##(2008-10#3)
In two of##2##3##(2008-10#1)(2013-1#1)
In two out of three##2##5##(1991-12#1)(2008-1#1)
In two patients with##2##4##(1996-9#1)(2011-2#1)
In two patients##4##3##(1990-3#1)(1996-9#1)(2007-8#1)(2011-2#1)
In two separate##3##3##(2007-2#1)(2008-10#1)(2008-5#1)
In two studies##3##3##(2008-6#1)(2010-8#1)(2012-3#1)
In two##56##2##(1990-3#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-7#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
In type##4##2##(2008-8#2)(2011-2#1)(2012-12#1)
In uncomplicated##3##2##(1990-9#1)(2010-12#1)(2011-3#1)
In univariate##2##2##(2008-6#1)(2013-1#1)
In untreated##4##2##(1991-11#1)(1995-12#1)(2008-10#2)
In urban##2##2##(2007-12#1)(2008-11#1)
In utero##2##2##(2008-5#1)(2011-1#1)
In very##2##2##(2007-2#1)(2008-5#1)
In view of the high##2##5##(2008-7#1)(2008-9#1)
In view of the increasing##2##5##(1990-11#1)(2010-5#1)
In view of the##24##4##(1990-11#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-3#1)(1994-1#1)(1994-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
In view of these findings##2##5##(1994-3#1)(2007-12#1)
In view of these##4##4##(1994-3#1)(1995-11#1)(2007-12#1)(2008-10#1)
In view of this##6##4##(2007-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
In view of##44##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-3#2)(1995-11#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
In view##45##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-3#2)(1995-11#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
In vitro Evaluation of##2##4##(2008-10#1)(2012-2#1)
In vitro activity of##3##4##(1994-11#1)(2007-7#1)(2008-7#1)
In vitro analysis of##5##4##(1995-2#1)(2008-1#3)(2010-7#1)
In vitro and in vivo evaluation of##2##7##(2008-5#1)(2011-2#1)
In vitro and in vivo studies##3##6##(1993-5#1)(2008-7#1)(2013-1#1)
In vitro and in vivo##18##5##(1993-5#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-2#3)(2011-2#2)(2012-12#1)(2013-1#2)
In vitro andin vivo##2##4##(2008-11#1)(2008-8#1)
In vitro antifungal susceptibility to amphotericin B##2##7##(2008-5#2)
In vitro antifungal susceptibility##3##4##(2008-5#3)
In vitro antioxidant activity##2##4##(1994-9#1)(2008-5#1)
In vitro cell##2##3##(2008-11#1)(2008-7#1)
In vitro culture##2##3##(2008-11#2)
In vitro cytotoxic##2##3##(1992-3#1)(2008-10#1)
In vitro degradation of##2##4##(1993-8#1)(2008-6#1)
In vitro effects of##3##4##(1993-9#1)(1995-9#1)(2013-1#1)
In vitro experiments using##2##4##(1994-12#1)(1997-4#1)
In vitro experiments##7##3##(1991-5#1)(1991-9#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
In vitro expression##2##3##(1995-8#1)(2008-10#1)
In vitro immunization##4##3##(2008-11#4)
In vitro incubation of##2##4##(1990-2#1)(1991-2#1)
In vitro incubation##3##3##(1990-2#1)(1991-2#1)(2008-10#1)
In vitro metabolism##2##3##(1990-11#1)(1990-6#1)
In vitro models##2##3##(2008-11#1)(2008-4#1)
In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells##2##24##(2008-11#2)
In vitro protein##3##3##(1993-12#1)(1995-12#1)(1995-3#1)
In vitro selection##2##3##(2008-4#2)
In vitro stimulation##2##3##(2008-5#1)(2011-2#1)
In vitro studies demonstrated that the##2##6##(2008-11#1)(2011-2#1)
In vitro studies demonstrated that##4##5##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
In vitro studies demonstrated##5##4##(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
In vitro studies have shown that##3##6##(1992-12#1)(1997-1#1)(2008-5#1)
In vitro studies have shown##4##5##(1992-12#1)(1997-1#1)(2008-5#2)
In vitro studies have##5##4##(1992-12#1)(1997-1#1)(2008-5#3)
In vitro studies using##2##4##(2007-12#1)(2011-1#1)
In vitro studies##15##3##(1992-12#2)(1994-2#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2011-1#1)(2011-2#1)(2013-1#1)
In vitro susceptibility##2##3##(1991-8#1)(2007-7#1)
In vitro tests##2##3##(1992-9#1)(2008-5#1)
In vitro transcription and translation of the##2##7##(1990-11#1)(1990-12#1)
In vitro transcription##4##3##(1990-11#1)(1990-12#1)(1991-11#1)(1993-9#1)
In vitro translated##2##3##(1991-7#1)(1995-2#1)
In vitro##193##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#4)(1995-2#3)(1995-3#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-4#2)(1997-7#4)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#23)(2008-11#20)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#19)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#4)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#8)
In vivo administration of##2##4##(1990-12#1)(1994-6#1)
In vivo and in vitro##3##5##(1994-5#1)(2008-5#1)(2013-1#1)
In vivo and##4##3##(1994-5#1)(2008-5#1)(2011-1#1)(2013-1#1)
In vivo imaging##2##3##(1994-11#1)(2009-11#1)
In vivo measurement of##2##4##(2008-4#1)(2009-10#1)
In vivo microdialysis was used to##2##6##(1995-12#1)(1997-2#1)
In vivo response##2##3##(1994-8#1)(2008-11#1)
In vivo studies were##2##4##(2008-11#1)(2012-2#1)
In vivo studies##5##3##(1992-11#1)(2007-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
In vivo##90##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#7)(1995-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-2#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)
In washed##2##2##(1994-9#1)(2008-10#1)
In weakly acidic##2##3##(2008-10#2)
In western##2##2##(2008-10#1)(2009-10#1)
In whole##2##2##(2008-10#1)(2008-3#1)
In wild-type##2##2##(1996-10#1)(2008-5#1)
In women with##2##3##(2008-3#1)(2013-8#1)
In women##11##2##(1991-8#1)(1994-2#1)(1994-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2013-8#1)
In work described here the cross-linking chemistry of marine mussel adhesive is combined with OEG to make a family of terpolymers##2##21##(2013-1#2)
In yeast##3##2##(1990-5#1)(2008-11#1)(2012-1#1)
In young patients##2##3##(2007-10#1)(2013-1#1)
In young##8##2##(1993-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-10#1)(2009-3#1)(2013-1#1)(2013-7#1)
In##14645##1##(1990-10#13)(1990-11#72)(1990-12#66)(1990-2#43)(1990-3#42)(1990-4#1)(1990-5#64)(1990-6#42)(1990-7#27)(1990-8#56)(1990-9#33)(1991-1#20)(1991-10#5)(1991-11#27)(1991-12#85)(1991-2#77)(1991-3#49)(1991-4#7)(1991-5#53)(1991-6#44)(1991-7#4)(1991-8#44)(1991-9#47)(1992-1#17)(1992-10#8)(1992-11#44)(1992-12#74)(1992-2#40)(1992-3#69)(1992-4#11)(1992-5#36)(1992-6#65)(1992-7#3)(1992-8#36)(1992-9#47)(1993-1#30)(1993-10#2)(1993-11#50)(1993-12#129)(1993-2#49)(1993-3#63)(1993-5#8)(1993-6#55)(1993-8#66)(1993-9#46)(1994-1#26)(1994-10#7)(1994-11#74)(1994-12#88)(1994-2#76)(1994-3#50)(1994-5#49)(1994-6#48)(1994-7#5)(1994-8#79)(1994-9#46)(1995-1#27)(1995-10#1)(1995-11#66)(1995-12#129)(1995-2#117)(1995-3#75)(1995-4#5)(1995-5#58)(1995-6#69)(1995-8#48)(1995-9#16)(1996-1#37)(1996-10#5)(1996-11#33)(1996-12#108)(1996-2#96)(1996-3#47)(1996-4#9)(1996-5#62)(1996-6#25)(1996-7#10)(1996-8#15)(1996-9#29)(1997-1#46)(1997-2#85)(1997-3#80)(1997-4#74)(1997-5#21)(1997-6#62)(1997-7#75)(1997-8#48)(1997-9#3)(2006-10#21)(2006-12#11)(2006-4#4)(2006-6#5)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#62)(2007-11#225)(2007-12#217)(2007-2#36)(2007-3#1)(2007-4#9)(2007-5#17)(2007-6#16)(2007-7#60)(2007-8#145)(2007-9#5)(2008-1#161)(2008-10#2398)(2008-11#636)(2008-12#246)(2008-2#240)(2008-3#465)(2008-4#247)(2008-5#450)(2008-6#178)(2008-7#559)(2008-8#334)(2008-9#317)(2009-1#10)(2009-10#64)(2009-11#36)(2009-12#52)(2009-2#39)(2009-3#52)(2009-4#32)(2009-5#66)(2009-6#55)(2009-7#61)(2009-8#89)(2009-9#55)(2010-1#34)(2010-10#47)(2010-11#57)(2010-12#81)(2010-2#54)(2010-3#73)(2010-4#67)(2010-5#74)(2010-6#40)(2010-7#39)(2010-8#127)(2010-9#24)(2011-1#186)(2011-10#6)(2011-2#582)(2011-3#32)(2011-7#1)(2011-9#1)(2012-1#63)(2012-12#146)(2012-2#300)(2012-3#207)(2012-4#7)(2012-5#5)(2012-6#2)(2012-7#11)(2012-8#2)(2012-9#1)(2013-1#444)(2013-2#2)(2013-7#63)(2013-8#187)
In(0##3##1##(2007-12#3)
In(2)O(3) and##2##2##(2008-10#1)(2008-7#1)
In(2)O(3)##3##1##(2008-10#2)(2008-7#1)
In(3+)##3##1##(2008-10#3)
In(III) in##4##2##(2008-10#4)
In(III)##17##1##(1997-7#1)(2008-10#15)(2009-12#1)
In)##2##1##(1997-7#1)(2008-10#1)
In-Ceram Spinell##2##2##(2009-8#2)
In-Ceram##3##1##(2009-8#3)
In-depth interviews were conducted with##2##5##(2008-12#1)(2011-1#1)
In-depth interviews were##5##3##(2008-12#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-12#1)
In-depth interviews##7##2##(1993-12#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#1)
In-depth##10##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
In-fiber##2##1##(2008-3#2)
In-flight##2##1##(1994-3#1)(1996-12#1)
In-home##3##1##(1992-3#1)(1993-1#1)(2010-4#1)
In-hospital##5##1##(2007-8#1)(2008-11#1)(2008-3#2)(2010-11#1)
In-house##3##1##(1992-2#1)(1997-3#1)(2008-5#1)
In-line##3##1##(2008-2#2)(2008-3#1)
In-plane##3##1##(2008-3#3)
In-situ##4##1##(2008-10#2)(2008-11#1)(2010-6#1)
InAs emitter##2##2##(2007-11#1)(2008-3#1)
InAs quantum dots##4##3##(2007-11#3)(2009-11#1)
InAs quantum##5##2##(2007-11#4)(2009-11#1)
InAs##10##1##(2007-11#7)(2008-3#2)(2009-11#1)
InBr(-)(4)##4##1##(2008-10#4)
InGaAs avalanche##2##2##(2007-11#1)(2008-3#1)
InGaAs laser diodes##3##3##(2008-3#3)
InGaAs laser##4##2##(2008-3#4)
InGaAs##14##1##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#7)(2009-11#2)
InGaAs/GaAs##2##1##(2007-12#1)(2009-11#1)
InGaAs/InP avalanche##4##2##(2007-11#1)(2008-3#3)
InGaAs/InP##5##1##(2007-11#1)(2008-3#4)
InGaAsP##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
InP##7##1##(2007-11#1)(2008-3#6)
InP-based##2##1##(2008-3#2)
InSatDb##2##1##(2008-10#2)
InSb##9##1##(2008-2#1)(2008-3#8)
Inability to##4##2##(1994-11#1)(1997-3#1)(2008-6#1)(2012-1#1)
Inaccurate##2##1##(1994-3#1)(2009-7#1)
Inactivated##2##1##(1990-2#1)(1995-5#1)
Inactivation of glutathione peroxidase##2##4##(1993-8#2)
Inactivation of the##2##3##(1993-11#1)(1994-3#1)
Inactivation of##14##2##(1991-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-6#1)(2008-10#2)(2012-2#2)(2013-8#1)
Inactivation##18##1##(1991-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#4)(1994-11#2)(1994-3#1)(1995-6#1)(2008-10#2)(2010-4#1)(2012-2#2)(2013-8#1)
Inactive##4##1##(1992-12#1)(1996-2#1)(2008-8#1)(2009-6#1)
Inadequacy##2##1##(1990-6#1)(2012-1#1)
Inadequate##4##1##(1992-3#1)(1993-12#1)(2010-2#1)(2010-6#1)
Inappropriate##8##1##(1991-3#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
Inasmuch as the##3##3##(2008-2#1)(2008-3#2)
Inasmuch as this##2##3##(1995-12#1)(2008-3#1)
Inasmuch as##10##2##(1995-12#1)(2008-2#2)(2008-3#5)(2009-5#1)(2013-7#1)
Inbred Line##2##2##(2008-10#2)
Inbred mouse strains##2##3##(1996-12#1)(2008-2#1)
Inbred##7##1##(1996-12#2)(2008-10#4)(2008-2#1)
Inbreds##3##1##(2008-10#3)
Inbreeding##2##1##(2008-9#1)(2012-3#1)
Inc##161##1##(1990-2#2)(1991-1#3)(1992-1#2)(1993-2#1)(1994-1#1)(1994-6#1)(1995-12#5)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(2006-12#1)(2007-10#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#63)(2008-8#1)(2009-11#2)(2009-4#8)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#26)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
Inc)##2##1##(1995-3#2)
Incarceration##2##1##(2008-12#1)(2012-12#1)
Incentives##3##1##(1996-12#1)(1996-3#1)(1997-1#1)
Incest##2##1##(2008-1#1)(2008-9#1)
Incidence and severity increased##2##4##(2008-10#2)
Incidence and severity of Verticillium wilt##2##6##(2008-10#2)
Incidence and severity of##4##4##(2008-10#4)
Incidence and severity##6##3##(2008-10#6)
Incidence and##16##2##(1993-11#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)
Incidence of ARMD is##2##4##(2011-2#2)
Incidence of adverse##2##3##(1996-8#1)(2008-11#1)
Incidence of congenital##2##3##(1990-9#1)(2008-7#1)
Incidence of leaf##2##3##(2008-10#2)
Incidence of treated end-stage renal disease##2##6##(2008-4#2)
Incidence of##46##2##(1990-9#1)(1991-1#1)(1992-5#1)(1993-9#2)(1995-9#2)(1996-8#2)(1997-3#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#7)(2012-2#1)(2013-1#1)(2013-8#1)
Incidence rate##2##2##(2008-8#1)(2011-2#1)
Incidence was##3##2##(1993-2#1)(1994-9#1)(2007-7#1)
Incidence##76##1##(1990-9#1)(1991-1#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-9#1)(1995-8#1)(1995-9#2)(1996-8#2)(1997-3#1)(2007-7#2)(2008-10#28)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-3#1)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Incidences of##3##2##(2008-9#3)
Incident##6##1##(1991-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
Incidental##3##1##(1991-3#1)(2008-7#1)(2013-1#1)
Incidents##2##1##(2009-11#1)(2013-8#1)
Incilaria fruhstorferi##2##2##(2008-6#2)
Incision##4##1##(2009-8#2)(2013-1#2)
Incisional hernia##3##2##(2007-10#1)(2010-8#1)(2011-2#1)
Incisional##7##1##(2007-10#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
Incisor##2##1##(2010-3#1)(2013-1#1)
Incited by##2##2##(2008-10#2)
Included are protocols for Southern blot analysis to monitor vector amplification##2##11##(2008-2#1)(2008-4#1)
Included are protocols for##3##4##(2008-2#1)(2008-4#2)
Included are##7##2##(1993-2#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)
Included in the##4##3##(1992-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
Included in this group are##2##5##(2007-12#1)(2008-10#1)
Included in this review are##2##5##(2008-11#1)(2012-2#1)
Included in this##7##3##(1992-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
Included in##12##2##(1992-1#1)(1992-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
Included studies were##2##3##(2013-1#2)
Included were##2##2##(1994-12#1)(2011-1#1)
Included##27##1##(1992-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
Including the##2##2##(2008-3#2)
Including##15##1##(1995-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-4#2)(2011-3#1)(2012-12#1)
Inclusion bodies##4##2##(2008-10#1)(2008-4#2)(2009-3#1)
Inclusion criteria were##3##3##(2008-6#1)(2008-9#1)(2010-11#1)
Inclusion criteria##5##2##(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2012-12#1)
Inclusion of an##2##3##(2008-9#1)(2010-5#1)
Inclusion of the##4##3##(1991-11#1)(1995-11#1)(2008-10#1)(2008-11#1)
Inclusion of##22##2##(1991-11#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
Inclusion##37##1##(1991-11#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Inclusions##4##1##(1997-6#1)(2008-10#2)(2008-3#1)
Incoherent##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Incoherent-to-Coherent##2##1##(2008-2#1)(2008-3#1)
Incoherent-to-coherent conversion##2##2##(2008-2#1)(2008-3#1)
Income##10##1##(1991-1#1)(1992-1#1)(1992-2#2)(1993-3#1)(1995-12#2)(1996-1#1)(2009-5#1)(2013-1#1)
Incompatibility##3##1##(2007-12#1)(2008-10#2)
Incompatible##3##1##(2008-10#3)
Incomplete##4##1##(2011-1#1)(2011-2#1)(2012-3#2)
Inconel##3##1##(2008-10#1)(2008-7#2)
Incontinentia pigmenti##2##2##(2012-3#2)
Incorporated##2##1##(2008-1#1)(2008-3#1)
Incorporating a##3##2##(1994-12#1)(2008-10#1)(2008-8#1)
Incorporating##17##1##(1994-12#1)(1994-6#1)(1995-12#1)(1997-7#2)(2007-4#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
Incorporation of a##2##3##(2007-11#1)(2008-8#1)
Incorporation of the##5##3##(1992-5#1)(2008-1#1)(2008-10#2)(2008-5#1)
Incorporation of##40##2##(1990-11#1)(1992-10#1)(1992-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
Incorporation##43##1##(1990-11#1)(1992-10#1)(1992-5#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
Incorrect##3##1##(2007-11#1)(2008-2#1)(2010-9#1)
Increase in##13##2##(1990-2#1)(1991-3#1)(1992-6#1)(1996-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-7#1)
Increase of plasma##2##3##(1990-12#1)(2012-2#1)
Increase of##9##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
Increase##26##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1996-1#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#2)(2009-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
Increased HSP60 mRNA expression##2##4##(2008-4#2)
Increased PKC##2##2##(1993-3#2)
Increased SRIF mRNA expression in layer IV##2##7##(1995-2#2)
Increased SRIF mRNA expression##3##4##(1995-2#3)
Increased age##2##2##(2008-1#1)(2011-2#1)
Increased attention##2##2##(2008-6#1)(2010-3#1)
Increased awareness of##2##3##(1991-3#1)(1995-1#1)
Increased awareness##4##2##(1991-3#1)(1995-1#1)(2011-2#1)(2013-1#1)
Increased body mass##2##3##(2011-1#1)(2012-12#1)
Increased concentrations of##2##3##(1995-3#1)(1997-6#1)
Increased expression of##6##3##(1990-8#1)(1991-9#1)(1997-3#1)(2008-1#1)(2009-2#1)(2011-2#1)
Increased fragmentation of##2##3##(1991-12#1)(1993-8#1)
Increased glucose##2##2##(1990-8#1)(1991-5#1)
Increased incidence of##3##3##(1992-6#1)(1996-11#1)(2008-7#1)
Increased incidences of##4##3##(1995-11#1)(2008-9#3)
Increased intracellular##2##2##(1990-8#1)(2008-1#1)
Increased levels of lipid peroxides in aged##2##7##(1990-5#2)
Increased levels of##5##3##(1990-5#2)(1992-2#1)(1993-12#1)(2008-5#1)
Increased mortality##2##2##(1996-6#1)(1997-6#1)
Increased nuchal translucency and pregnancy outcome##2##6##(2013-1#2)
Increased numbers of##4##3##(1992-3#1)(1996-12#1)(2008-10#1)(2011-1#1)
Increased oxidative stress##2##3##(2008-3#1)(2008-7#1)
Increased plasma##3##2##(1994-6#1)(1997-5#1)(2011-1#1)
Increased production of##2##3##(1997-3#1)(2008-11#1)
Increased serum##3##2##(2008-6#1)(2009-5#1)(2009-8#1)
Increased susceptibility to##2##3##(1991-12#1)(2008-7#1)
Increased##179##1##(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-6#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#3)(1997-7#1)(2007-8#1)(2008-1#5)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
Increases Resistance to##2##3##(2008-10#2)
Increases in the##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
Increases in##27##2##(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-7#1)(1997-1#2)(1997-3#3)(1997-6#1)(2006-12#1)(2008-10#6)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#3)
Increases##33##1##(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-7#1)(1997-1#2)(1997-3#3)(1997-6#1)(2006-12#1)(2008-10#9)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
Increasing age##3##2##(2008-8#1)(2012-12#1)(2012-3#1)
Increasing amounts of##2##3##(2008-10#1)(2008-8#1)
Increasing complexity of##2##3##(1994-8#1)(2008-10#1)
Increasing concentrations of##2##3##(1994-5#1)(1994-6#1)
Increasing concentrations##3##2##(1994-5#1)(1994-6#1)(1995-12#1)
Increasing constraints##2##2##(2008-8#2)
Increasing evidence indicates that##3##4##(1995-11#1)(2008-1#1)(2011-2#1)
Increasing evidence suggests that##4##4##(1991-9#1)(2008-11#1)(2008-12#1)(2012-2#1)
Increasing evidence##12##2##(1991-9#1)(1995-11#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#2)(2012-2#1)
Increasing levels of##2##3##(2008-10#1)(2011-2#1)
Increasing numbers of##2##3##(2008-7#1)(2013-1#1)
Increasing the number of##3##4##(1993-1#1)(1994-7#1)(2008-11#1)
Increasing the supply of##2##4##(1991-3#1)(1994-1#1)
Increasing the##28##2##(1990-8#1)(1991-3#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-7#1)(1997-2#1)(2007-10#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#2)(2011-1#1)(2013-1#1)
Increasing##95##1##(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
Increasingly sophisticated##2##2##(1992-3#1)(2008-8#1)
Increasingly##14##1##(1990-9#1)(1992-3#1)(1993-1#1)(1993-12#3)(1995-1#1)(1995-2#1)(2007-5#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
Incremental##6##1##(2007-12#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
Incubation at##3##2##(2008-10#1)(2011-2#2)
Incubation of [14C]TNT with##2##4##(1995-6#2)
Incubation of rat##3##3##(1990-7#1)(1993-11#1)(1994-12#1)
Incubation of the isolated##2##4##(1993-11#2)
Incubation of the##3##3##(1993-11#3)
Incubation of##35##2##(1990-11#2)(1990-12#2)(1990-7#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#2)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-8#2)(2009-8#1)
Incubation with##2##2##(1990-2#1)(1997-1#1)
Incubation##41##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#2)(1997-1#2)(1997-4#1)(2008-10#4)(2008-11#2)(2008-8#2)(2009-8#1)(2011-2#2)
Indeed##83##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
Indentation##2##1##(2009-7#1)(2010-10#1)
Independence##3##1##(1995-8#1)(2008-5#1)(2013-8#1)
Independent Medical Examination##2##3##(2008-3#2)
Independent Medicare Advisory Committee##2##4##(2012-3#2)
Independent Practice##2##2##(1993-12#1)(1997-3#1)
Independent and##2##2##(1993-5#1)(2008-10#1)
Independent component analysis (ICA)##2##4##(2008-7#1)(2009-6#1)
Independent of##2##2##(2008-10#1)(2008-9#1)
Independent predictors##2##2##(2007-10#2)
Independent risk factors for##2##4##(2011-2#1)(2013-1#1)
Independent variables##2##2##(2008-5#1)(2013-1#1)
Independent##40##1##(1991-1#1)(1992-3#1)(1993-12#1)(1993-5#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#1)(2012-3#3)(2013-1#3)
Independently of the##2##3##(2008-7#1)(2009-2#1)
Independently##5##1##(2008-7#2)(2009-2#1)(2009-8#1)(2013-1#1)
Indeterminate##2##1##(1992-6#1)(2010-5#1)
Index (CPI)##2##2##(1993-3#1)(2008-10#1)
Index (PPI)##2##2##(1991-1#1)(2011-2#1)
Index (RDI)##2##2##(2008-5#1)(2012-12#1)
Index and##7##2##(1990-5#1)(1991-12#1)(2008-10#1)(2008-12#1)(2012-3#1)(2012-7#1)(2013-1#1)
Index for volume##10##3##(2008-10#10)
Index for##16##2##(1993-1#2)(1995-2#1)(2008-10#10)(2008-11#1)(2012-3#1)(2013-8#1)
Index is##2##2##(2007-11#1)(2008-10#1)
Index of Well-being and##2##4##(1991-6#2)
Index of Well-being##3##3##(1991-6#3)
Index of##9##2##(1991-2#1)(1991-6#3)(1993-3#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-7#1)
Index was##4##2##(2007-10#1)(2007-11#1)(2008-5#1)(2012-12#1)
Index##137##1##(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#3)(1993-1#5)(1993-2#1)(1993-3#2)(1995-2#1)(1996-2#1)(1996-9#1)(2007-10#3)(2007-11#4)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#14)(2008-11#4)(2008-12#15)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#5)(2012-7#2)(2013-1#6)(2013-7#3)(2013-8#2)
Indexes##4##1##(1992-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
India and Thailand##2##3##(1996-9#2)
India and##17##2##(1996-4#1)(1996-9#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2009-4#3)(2011-1#1)(2011-2#1)(2012-1#1)
India are##2##2##(2009-12#1)(2010-12#1)
India at##2##2##(2011-2#2)
India for##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
India has##4##2##(1994-9#2)(2008-3#1)(2011-1#1)
India in##4##2##(1994-9#1)(2008-10#1)(2011-1#2)
India is##5##2##(1994-9#1)(1995-10#1)(2007-12#1)(2009-12#1)(2009-4#1)
India may##2##2##(1994-9#1)(1995-12#1)
India was##2##2##(2008-11#1)(2013-1#1)
India with the alleged involvement of Professor P##2##8##(2008-10#2)
India with the alleged involvement of##3##6##(2008-10#3)
India with##4##2##(2008-10#3)(2008-7#1)
India##239##1##(1992-11#1)(1994-3#5)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#13)(1995-10#2)(1995-12#4)(1995-6#1)(1996-1#1)(1996-11#1)(1996-4#3)(1996-8#2)(1996-9#8)(1997-5#1)(1997-8#1)(2007-12#4)(2007-2#2)(2007-7#15)(2007-8#1)(2008-1#5)(2008-10#31)(2008-11#7)(2008-12#4)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#6)(2009-10#4)(2009-12#5)(2009-2#1)(2009-4#9)(2009-5#2)(2009-9#3)(2010-10#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#9)(2011-2#11)(2012-1#4)(2012-12#3)(2012-2#14)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#10)
India's##4##1##(1994-3#1)(1994-7#1)(1995-12#1)(1997-5#1)
India)##4##1##(2008-10#2)(2013-7#1)(2013-8#1)
Indian Council of Medical Research##2##5##(1996-4#1)(2012-2#1)
Indian Council of##3##3##(1996-4#1)(2010-10#1)(2012-2#1)
Indian Grocery##2##2##(2008-10#2)
Indian Rural##2##2##(1994-3#1)(2011-1#1)
Indian and##3##2##(2007-5#1)(2011-2#1)(2013-1#1)
Indian clade##2##2##(2008-10#2)
Indian classical music##2##3##(2008-5#2)
Indian classical##3##2##(2008-5#3)
Indian context##3##2##(2007-7#1)(2013-1#2)
Indian head massage##2##3##(2013-8#2)
Indian isolates##3##2##(2008-10#2)(2013-1#1)
Indian males##2##2##(2010-12#1)(2011-2#1)
Indian market##3##2##(2007-7#2)(2008-5#1)
Indian palm squirrel##2##3##(1994-5#1)(2008-5#1)
Indian patients of##2##3##(1997-8#1)(2007-7#1)
Indian patients##10##2##(1997-8#6)(2007-12#1)(2007-7#1)(2008-3#1)(2009-11#1)
Indian perspective##4##2##(2008-8#1)(2009-11#2)(2012-2#1)
Indian population##11##2##(1997-8#2)(2008-11#1)(2010-5#1)(2012-2#5)(2012-3#1)(2013-1#1)
Indian scenario##2##2##(2012-2#1)(2013-8#1)
Indian subcontinent##5##2##(1996-8#1)(2007-12#1)(2008-10#2)(2011-2#1)
Indian women with##2##3##(2008-3#2)
Indian women##4##2##(1996-8#1)(2008-3#2)(2010-10#1)
Indian##150##1##(1991-12#3)(1991-3#4)(1992-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#9)(2007-12#2)(2007-5#2)(2007-7#8)(2007-8#1)(2008-10#13)(2008-11#5)(2008-12#4)(2008-3#4)(2008-5#7)(2008-8#2)(2008-9#1)(2009-11#4)(2009-5#1)(2009-6#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#5)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-2#15)(2012-3#1)(2013-1#10)(2013-8#10)
Indiana and##4##2##(2008-10#4)
Indiana tester isolate##2##3##(2008-10#2)
Indiana were##2##2##(2008-10#2)
Indiana##14##1##(1991-3#1)(2008-10#12)(2008-6#1)
Indians from the##2##3##(1991-12#2)
Indians from##3##2##(1991-12#2)(1997-9#1)
Indians with##3##2##(1991-12#1)(2007-7#1)(2008-3#1)
Indians##39##1##(1991-12#10)(1997-8#1)(1997-9#1)(2007-12#1)(2007-7#3)(2008-3#7)(2008-8#2)(2009-4#2)(2010-4#3)(2010-5#1)(2010-7#1)(2011-2#4)(2013-8#3)
Indica##2##1##(2008-4#2)
Indicates##2##1##(2008-10#2)
Indication for##3##2##(1996-6#1)(2010-3#1)(2012-3#1)
Indication##6##1##(1992-6#1)(1994-5#1)(1996-6#1)(1996-8#1)(2010-3#1)(2012-3#1)
Indications and##7##2##(1990-2#1)(1994-5#1)(1996-3#1)(2007-11#2)(2008-12#1)(2011-2#1)
Indications for surgery were##3##4##(1990-6#1)(2007-8#1)(2008-7#1)
Indications for surgery##4##3##(1990-6#1)(2007-11#1)(2007-8#1)(2008-7#1)
Indications for the##3##3##(1991-3#1)(1992-2#1)(2013-1#1)
Indications for##15##2##(1990-6#1)(1991-3#1)(1992-2#1)(2007-11#2)(2007-8#3)(2008-10#1)(2008-7#2)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
Indications included##2##2##(2007-8#2)
Indications##28##1##(1990-2#1)(1990-6#1)(1991-3#1)(1992-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-3#1)(2007-11#4)(2007-8#5)(2008-10#1)(2008-12#1)(2008-7#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Indicator Project##3##2##(1992-2#2)(2012-12#1)
Indicator##7##1##(1992-2#2)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
Indicators are##2##2##(1996-9#1)(1997-3#1)
Indicators for##3##2##(2008-11#2)(2008-5#1)
Indicators of##7##2##(1993-6#1)(1995-12#1)(2008-12#2)(2011-2#2)(2013-1#1)
Indicators##15##1##(1993-6#1)(1995-12#1)(1996-9#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-5#1)(2011-2#3)(2013-1#2)
Indices of##6##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
Indices that##2##2##(2008-11#1)(2008-4#1)
Indices##13##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
Indigenous Fijians##2##2##(2008-1#2)
Indigenous and##2##2##(2008-1#1)(2008-9#1)
Indigenous health##2##2##(2008-6#1)(2011-1#1)
Indigenous nurses##2##2##(2011-1#2)
Indigenous peoples##2##2##(2011-1#2)
Indigenous populations##2##2##(2011-1#2)
Indigenous##29##1##(2008-1#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#2)(2011-1#13)(2012-3#2)(2013-1#4)
Indigo carmine##5##2##(1990-6#2)(1993-8#3)
Indigo##7##1##(1990-6#2)(1991-8#1)(1993-8#4)
Indirect determination of##2##3##(2008-10#2)
Indirect effects##2##2##(2008-7#1)(2008-9#1)
Indirect estimation of gene flow##2##5##(2008-10#2)
Indirect evidence suggests##2##3##(1990-12#1)(1994-3#1)
Indirect evidence##4##2##(1990-12#1)(1993-6#1)(1994-3#1)(1997-3#1)
Indirect immunofluorescent##2##2##(2008-5#1)(2008-8#1)
Indirect##32##1##(1990-12#1)(1993-6#1)(1994-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#2)(2011-2#1)
Indirubin-3'-monoxime treatment##2##2##(2008-10#2)
Indium##3##1##(2008-10#2)(2008-2#1)
Individual and##3##2##(2008-10#2)(2008-11#1)
Individual compounds were##2##3##(1997-3#1)(2008-10#1)
Individual differences in##6##3##(2007-12#1)(2008-6#2)(2009-8#1)(2010-2#1)(2012-3#1)
Individual differences##7##2##(1993-6#1)(2007-12#1)(2008-6#2)(2009-8#1)(2010-2#1)(2012-3#1)
Individual members of##2##3##(1995-3#1)(1997-7#1)
Individual plants##2##2##(2008-10#2)
Individual risk##3##2##(2008-8#1)(2010-4#1)(2013-1#1)
Individual sclerotia##2##2##(2008-10#2)
Individual##62##1##(1990-9#1)(1992-3#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-12#2)(1997-3#3)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
Individualized##2##1##(1991-12#1)(2013-8#1)
Individualizing##3##1##(1992-12#1)(2010-11#1)(2010-6#1)
Individually##7##1##(1992-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)
Individuals carrying##2##2##(2011-1#2)
Individuals differ##2##2##(2008-11#1)(2012-3#1)
Individuals of##2##2##(2008-10#1)(2013-7#1)
Individuals were then##2##3##(2008-10#1)(2008-12#1)
Individuals were##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-4#1)
Individuals who received##2##3##(2008-11#1)(2008-12#1)
Individuals who##8##2##(1994-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)
Individuals with Disabilities Education##2##4##(2008-12#1)(2012-2#1)
Individuals with the##2##3##(1997-3#1)(2011-2#1)
Individuals with##23##2##(1997-3#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-10#1)(2009-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
Individuals##63##1##(1991-12#1)(1992-2#1)(1994-3#1)(1996-2#1)(1996-3#2)(1997-3#2)(2006-10#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
Individuals'##2##1##(2010-4#1)(2011-2#1)
Indo-1##3##1##(1990-5#1)(1990-7#1)(2008-4#1)
Indo-Pacific region##2##2##(2008-5#1)(2013-7#1)
Indo-Pacific##3##1##(2008-5#2)(2013-7#1)
Indo-US##2##1##(1996-4#1)(2010-10#1)
IndoFijians##4##1##(2008-1#4)
Indochinese tigers##5##2##(2009-4#5)
Indocyanine green video angiography##2##4##(2012-2#2)
Indocyanine##3##1##(2008-3#1)(2012-2#2)
Indoles##2##1##(2010-3#1)(2013-7#1)
Indomethacin inhibits##2##2##(1990-11#2)
Indomethacin##10##1##(1990-11#4)(1996-2#1)(2008-10#2)(2012-2#1)(2013-7#1)(2013-8#1)
Indonesia and the##2##3##(2007-5#1)(2008-5#1)
Indonesia##12##1##(1990-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)
Indonesian##5##1##(2008-10#1)(2008-11#3)(2011-2#1)
Indonesians##2##1##(2008-6#2)
Indoor##4##1##(2008-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
Induce##4##1##(2008-10#3)(2008-11#1)
Induced Resistance in##3##3##(2008-10#3)
Induced Resistance##6##2##(2008-10#6)
Induced Systemic Resistance##2##3##(2008-10#2)
Induced by##15##2##(1996-9#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-8#1)(2013-1#1)
Induced in##2##2##(2008-10#2)
Induced resistance was##2##3##(2008-10#2)
Induced resistance##6##2##(2008-10#5)(2008-8#1)
Induced##54##1##(1991-3#1)(1991-5#1)(1992-11#1)(1996-12#2)(1996-9#2)(2008-10#29)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
Induces Apoptosis in##2##3##(2008-6#1)(2010-6#1)
Induces##10##1##(2008-10#4)(2008-6#1)(2010-1#1)(2010-6#1)(2011-2#2)(2013-1#1)
Inducible##7##1##(1993-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2009-2#1)(2011-1#1)
Inducing##3##1##(2008-11#1)(2008-4#1)(2012-12#1)
Induction and Ongoing Weight Loss diets##2##6##(2008-3#2)
Induction and##4##2##(2007-10#1)(2008-3#2)(2008-4#1)
Induction in##2##2##(2008-10#1)(2008-11#1)
Induction of Defense##2##3##(2008-10#2)
Induction of GTPCH mRNA##2##4##(1993-8#2)
Induction of Soil##2##3##(2008-10#2)
Induction of Systemic Resistance##2##4##(2008-10#2)
Induction of a##5##3##(1992-6#1)(1995-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
Induction of c-fos##2##3##(1994-8#1)(1996-12#1)
Induction of preference and##2##4##(2008-8#2)
Induction of the##6##3##(1992-3#1)(2008-11#3)(2008-5#1)(2011-2#1)
Induction of##61##2##(1990-12#1)(1990-5#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-4#1)(1997-7#2)(2007-8#1)(2008-10#13)(2008-11#6)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2011-2#4)(2012-1#1)
Induction##77##1##(1990-12#1)(1990-5#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-4#1)(1997-7#2)(2007-10#1)(2007-8#1)(2008-10#18)(2008-11#8)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#2)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#1)
Inductively Coupled Plasma##2##3##(2008-10#2)
Inductively Coupled##4##2##(2008-10#3)(2013-8#1)
Inductively coupled plasma optical emission##3##5##(2008-10#2)(2011-2#1)
Inductively coupled##5##2##(2008-10#3)(2010-5#1)(2011-2#1)
Inductively##9##1##(2008-10#6)(2010-5#1)(2011-2#1)(2013-8#1)
Industrial##18##1##(1991-12#1)(1991-4#1)(1995-3#2)(1996-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-7#1)(2012-12#1)(2012-2#2)
Industrialization##2##1##(2008-7#1)(2011-1#1)
Industry##14##1##(1994-12#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-7#1)
Ineffective##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
Inelastic##3##1##(1992-11#1)(1996-2#1)(2012-2#1)
Inequalities in##2##2##(1996-1#1)(2009-10#1)
Inequality in##2##2##(1994-12#1)(2012-12#1)
Inequality##3##1##(1993-11#1)(1994-12#1)(2012-12#1)
Inequities##2##1##(2009-7#1)(2011-1#1)
Inertial##3##1##(1996-12#1)(2008-3#2)
Inertsil##2##1##(2008-10#1)(2012-12#1)
Inexpensive##4##1##(1991-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
Infant and Young Child Nutrition (IYCN) Working Group##2##8##(2010-5#2)
Infant and Young Child##3##4##(2010-5#3)
Infant mortality##4##2##(1990-6#1)(1992-3#1)(1993-2#1)(2013-1#1)
Infant with##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
Infant##26##1##(1990-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2010-5#4)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
Infantile Alexander disease##2##3##(2012-12#2)
Infantile hemangiomas##2##2##(2013-8#2)
Infantile##8##1##(2007-2#1)(2008-12#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-8#2)
Infants and Children (WIC)##2##4##(1996-12#2)
Infants and Children##3##3##(1996-12#3)
Infants and##5##2##(1996-12#3)(2008-11#1)(2013-8#1)
Infants in##2##2##(1996-11#1)(2011-1#1)
Infants of##2##2##(1996-9#1)(2007-2#1)
Infants with##3##2##(1996-2#1)(2010-12#1)(2010-9#1)
Infants##23##1##(1993-12#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-9#1)(2006-5#3)(2007-2#1)(2008-11#1)(2009-6#2)(2010-12#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-8#2)
Infarct volume##2##2##(2007-10#2)
Infarct##4##1##(2007-10#3)(2008-10#1)
Infected Patients##2##2##(2008-11#1)(2013-8#1)
Infected and##2##2##(2008-10#1)(2012-2#1)
Infected by the##2##3##(2008-10#2)
Infected by##3##2##(2008-10#3)
Infected cells##2##2##(1997-1#1)(2008-7#1)
Infected with##4##2##(2008-10#3)(2012-2#1)
Infected##31##1##(1997-1#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-3#1)(2012-2#5)(2013-1#1)(2013-8#1)
Infecting Tomato##2##2##(2008-10#2)
Infecting##11##1##(2008-10#9)(2008-11#1)(2008-9#1)
Infection Control##3##2##(2007-12#1)(2010-6#2)
Infection and Colonization of##3##4##(2008-10#3)
Infection and##15##2##(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
Infection by Monilinia vaccinii-corymbosi##2##4##(2008-10#2)
Infection by Pythium##3##3##(2008-10#3)
Infection by the##2##3##(2008-10#1)(2008-9#1)
Infection by##16##2##(2008-10#13)(2008-9#1)(2012-12#1)(2012-2#1)
Infection control in##2##3##(2006-5#1)(2009-5#1)
Infection control##4##2##(2006-5#1)(2008-11#1)(2009-5#1)(2013-1#1)
Infection efficiency##3##2##(2008-10#3)
Infection fighters##2##2##(2007-1#2)
Infection hyphae##2##2##(2008-10#2)
Infection in##5##2##(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
Infection is a##2##3##(2007-12#1)(2008-8#1)
Infection is##5##2##(1991-3#1)(2007-12#1)(2008-8#1)(2009-5#1)(2010-12#1)
Infection levels##2##2##(2008-10#1)(2009-5#1)
Infection occurred##2##2##(2008-10#1)(2013-8#1)
Infection of Rice##2##3##(2008-10#2)
Infection of Spodoptera frugiperda##2##4##(1993-6#1)(1994-11#1)
Infection of Strawberry##2##3##(2008-10#2)
Infection of the##2##3##(2008-10#1)(2008-2#1)
Infection of##50##2##(1991-8#1)(1993-6#1)(1994-11#1)(1997-3#1)(1997-4#2)(2006-10#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-2#2)
Infection rates of##2##3##(1997-6#1)(2008-10#1)
Infection rates##3##2##(1997-6#1)(2008-10#1)(2010-8#1)
Infection was##5##2##(1996-12#1)(2008-1#2)(2008-10#2)
Infection with##11##2##(1995-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Infection##185##1##(1991-3#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-2#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-5#1)(2007-1#2)(2007-12#5)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#94)(2008-11#3)(2008-12#2)(2008-2#8)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
Infections in##7##2##(2007-6#1)(2008-10#4)(2008-2#1)(2012-2#1)
Infections of the##2##3##(1997-4#1)(2010-12#1)
Infections of##3##2##(1997-4#1)(2008-10#1)(2010-12#1)
Infections with##2##2##(2008-10#1)(2010-6#1)
Infections##24##1##(1997-4#1)(2007-6#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#5)(2012-2#2)(2013-1#1)
Infectious Disease Hospital##2##3##(2008-7#1)(2013-8#1)
Infectious Disease##9##2##(1995-12#1)(2007-12#3)(2007-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
Infectious Diseases##10##2##(1994-9#1)(1996-11#1)(2007-12#1)(2007-2#1)(2008-5#3)(2009-2#1)(2011-2#1)(2013-8#1)
Infectious RNA##2##2##(2008-10#2)
Infectious bronchitis virus##2##3##(2007-6#1)(2008-5#1)
Infectious disease##2##2##(2012-1#1)(2012-3#1)
Infectious diseases in the emergency setting Part 1##2##8##(2006-5#2)
Infectious diseases##4##2##(2006-5#2)(2007-12#1)(2008-4#1)
Infectious myositis is##2##3##(2011-2#2)
Infectious##43##1##(1991-9#1)(1992-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-5#2)(2007-12#6)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#2)
Infective endocarditis##2##2##(2011-2#2)
Infective##4##1##(1991-3#1)(2008-10#1)(2011-2#2)
Infectivity##4##1##(2008-10#4)
Inference of##2##2##(2008-6#1)(2008-9#1)
Inference##7##1##(1996-9#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)
Inferences##3##1##(1996-6#1)(2012-3#1)(2013-1#1)
Inferior##3##1##(2008-12#1)(2008-7#1)(2013-1#1)
Inferred from##3##2##(2008-10#2)(2008-5#1)
Inferring##3##1##(2008-12#1)(2008-2#1)(2008-4#1)
Infertile##2##1##(1994-9#1)(2008-8#1)
Infertility is##2##2##(1990-3#1)(2011-1#1)
Infertility##5##1##(1990-3#1)(1992-1#1)(2008-4#1)(2011-1#1)(2013-7#1)
Infestation Foci of Potato Cyst Nematodes##2##6##(2008-10#2)
Infestation of##3##2##(2008-10#2)(2011-2#1)
Infestation##11##1##(2008-10#8)(2008-12#1)(2011-2#2)
Infested##2##1##(2008-10#2)
Infiernillo reservoir##3##2##(2008-5#3)
Infiltration of##2##2##(2008-10#2)
Infirmary during##2##2##(2007-2#1)(2008-10#1)
Infirmary##6##1##(2007-2#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-12#1)
Inflammaging##2##1##(2010-1#2)
Inflammation and##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)
Inflammation is##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
Inflammation##18##1##(1991-3#1)(1994-11#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-6#1)(2010-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
Inflammatory Bowel Disease##2##3##(2011-1#1)(2012-12#1)
Inflammatory Bowel Diseases##2##3##(2010-12#1)(2010-6#1)
Inflammatory Bowel##4##2##(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)
Inflammatory and##2##2##(1997-8#1)(2011-2#1)
Inflammatory arthritis##2##2##(2006-10#2)
Inflammatory bowel##2##2##(2009-12#1)(2010-12#1)
Inflammatory fibroid##2##2##(2013-8#2)
Inflammatory markers##2##2##(2008-3#2)
Inflammatory pseudotumor of the liver##3##5##(1990-10#2)(2010-12#1)
Inflammatory pseudotumor##4##2##(1990-10#2)(1991-9#1)(2010-12#1)
Inflammatory pseudotumour of the lung##2##5##(2008-7#1)(2013-1#1)
Inflammatory##45##1##(1990-10#2)(1991-3#1)(1991-8#1)(1991-9#1)(1997-8#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#5)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
Infliximab is a##2##3##(2010-12#2)
Infliximab is##3##2##(2010-12#3)
Infliximab##9##1##(2006-10#1)(2010-12#6)(2011-2#1)(2012-3#1)
Influence of Environmental Conditions on##2##5##(2008-10#2)
Influence of Temperature and##3##4##(2008-10#3)
Influence of a##6##3##(1996-5#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-12#1)(2012-3#1)
Influence of applied##2##3##(2008-5#1)(2009-12#1)
Influence of different##4##3##(1992-6#1)(2008-10#2)(2013-1#1)
Influence of optical##2##3##(2008-3#2)
Influence of pH##2##3##(2008-10#2)
Influence of surface##3##3##(2008-3#2)(2013-1#1)
Influence of the##24##3##(1990-7#1)(1992-9#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
Influence of treatment##2##3##(1994-6#1)(1995-10#1)
Influence of##180##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#4)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-5#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#36)(2008-11#9)(2008-12#7)(2008-2#10)(2008-3#19)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#9)(2013-8#2)
Influence on the##2##3##(2008-11#1)(2008-5#1)
Influence on##4##2##(1992-9#1)(2008-11#1)(2008-5#2)
Influence##190##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#5)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-5#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#38)(2008-11#10)(2008-12#7)(2008-2#10)(2008-3#19)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#11)(2013-8#2)
Influenced##2##1##(1995-12#1)(2008-10#1)
Influences in##2##2##(2008-11#1)(2010-9#1)
Influences of the##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
Influences of##6##2##(1990-12#1)(1991-2#1)(2008-10#3)(2008-9#1)
Influences on##2##2##(2008-10#1)(2010-10#1)
Influences##11##1##(1990-12#1)(1991-2#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-10#1)(2010-9#1)
Influencing physician referrals##2##3##(1995-1#1)(1995-3#1)
Influencing physician##3##2##(1995-1#2)(1995-3#1)
Influencing##10##1##(1993-12#1)(1995-1#2)(1995-3#1)(1996-3#1)(2008-10#3)(2009-11#1)(2013-1#1)
Influential##2##1##(2008-12#1)(2008-7#1)
Influenza A (H1N1)##2##3##(2011-1#1)(2011-2#1)
Influenza A and##2##3##(1991-8#1)(1992-5#1)
Influenza A##5##2##(1991-8#1)(1992-5#1)(2011-1#2)(2011-2#1)
Influenza and Other Respiratory Viruses 5(2)##9##6##(2011-2#9)
Influenza and other respiratory viruses in three Central American countries##2##10##(2011-2#2)
Influenza and##11##2##(2011-2#11)
Influenza in##2##2##(2011-2#1)(2013-1#1)
Influenza is##2##2##(2009-12#1)(2011-2#1)
Influenza mortality##2##2##(2011-2#2)
Influenza vaccination and the##2##4##(1990-9#1)(2008-7#1)
Influenza vaccination##4##2##(1990-9#1)(2007-12#1)(2008-7#1)(2009-12#1)
Influenza vaccine effectiveness##2##3##(2010-4#2)
Influenza virus##2##2##(2011-2#2)
Influenza##48##1##(1990-9#1)(1991-8#1)(1992-5#1)(1994-9#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-9#3)(2009-12#2)(2010-4#3)(2011-1#3)(2011-2#24)(2011-9#2)(2012-2#1)(2013-1#2)
Info##2##1##(2010-5#1)(2011-2#1)
Informal caregivers##2##2##(2009-5#2)
Informal##5##1##(1995-3#1)(2008-10#1)(2009-5#2)(2013-1#1)
Informatic surgery##2##2##(2011-2#2)
Informatics##2##1##(2008-7#1)(2010-5#1)
Information Age##2##2##(2008-1#2)
Information Center##2##2##(1991-8#1)(1994-12#1)
Information Content##3##2##(2008-12#2)(2011-2#1)
Information Criterion##4##2##(2008-6#1)(2008-9#2)(2011-1#1)
Information Network for Public Health Officials (INPHO)##3##7##(1995-12#2)(1996-1#1)
Information Network for Public Health Officials##5##6##(1995-12#2)(1996-1#3)
Information Network##8##2##(1995-1#2)(1995-12#2)(1996-1#3)(2012-12#1)
Information Service##4##2##(1991-3#1)(1992-1#2)(2013-1#1)
Information Services##3##2##(1991-12#1)(1995-1#1)(2013-1#1)
Information Set (HEDIS)##2##3##(1996-3#1)(1997-2#1)
Information Set##5##2##(1995-2#1)(1996-3#1)(1997-2#2)(1997-3#1)
Information System##11##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#1)(2007-5#1)(2009-7#1)(2011-2#2)(2012-12#2)
Information System)##2##2##(2007-10#1)(2008-10#1)
Information Systems##6##2##(2008-10#2)(2008-8#1)(2010-2#1)(2010-5#1)(2012-12#1)
Information Technology##3##2##(1996-3#1)(2008-7#1)(2013-1#1)
Information about the##5##3##(1994-3#1)(1995-2#1)(2007-12#2)(2012-12#1)
Information about##12##2##(1992-11#2)(1994-3#1)(1995-2#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2010-10#1)(2012-12#1)
Information and##5##2##(1994-2#1)(1997-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
Information for##5##2##(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#2)
Information from##5##2##(1994-11#1)(1994-5#1)(2008-10#1)(2008-3#1)(2009-7#1)
Information in##2##2##(1997-3#1)(2008-10#1)
Information is also##2##3##(2007-2#1)(2008-4#1)
Information is##8##2##(1992-12#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
Information management##4##2##(1994-12#2)(1994-2#1)(1995-2#1)
Information obtained##2##2##(2007-4#1)(2008-7#1)
Information of the##3##3##(1993-8#1)(1995-5#1)(2013-1#1)
Information of##5##2##(1993-8#1)(1995-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
Information on sample size##2##4##(2009-9#1)(2010-2#1)
Information on the##14##3##(1990-6#1)(1992-3#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)
Information on##32##2##(1990-6#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
Information pamphlets##2##2##(1990-2#2)
Information processing##2##2##(1993-6#1)(2008-3#1)
Information provided by##2##3##(1994-3#1)(1997-2#1)
Information provided includes##2##3##(2012-2#2)
Information provided##4##2##(1994-3#1)(1997-2#1)(2012-2#2)
Information systems for##3##3##(1992-12#1)(1994-1#1)(1997-1#1)
Information systems in##2##3##(1994-3#1)(1996-3#1)
Information systems management##2##3##(1992-12#2)
Information systems##11##2##(1992-12#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)
Information technology is##2##3##(1994-12#1)(1995-12#1)
Information technology##5##2##(1994-12#1)(1995-12#2)(2007-10#1)(2008-10#1)
Information was obtained from##2##4##(1997-4#1)(2008-11#1)
Information was##7##2##(1993-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
Information##214##1##(1990-2#2)(1990-6#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#1)(1995-1#4)(1995-12#6)(1995-2#7)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-12#3)(1996-3#5)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
Informative##4##1##(2009-5#2)(2009-9#2)
Informed consent and##3##3##(1990-2#1)(1993-3#1)(1997-3#1)
Informed consent##9##2##(1990-2#1)(1993-3#1)(1995-2#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-2#1)
Informed price setting##2##3##(1993-2#2)
Informed##16##1##(1990-2#1)(1993-2#2)(1993-3#1)(1995-2#1)(1997-3#2)(2006-10#1)(2008-12#2)(2008-4#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
Informing##2##1##(1991-1#1)(1992-1#1)
Infraorder##2##1##(2008-5#2)
Infrared Atmospheric Sounding Interferometer##4##4##(2008-2#2)(2008-3#2)
Infrared absorption spectroscopy##2##3##(2008-3#1)(2009-8#1)
Infrared and##4##2##(2008-10#2)(2008-3#1)(2010-12#1)
Infrared ellipsometry##2##2##(2008-10#1)(2008-3#1)
Infrared femtosecond laser##2##3##(2007-12#1)(2008-3#1)
Infrared optical##2##2##(1991-1#1)(2008-3#1)
Infrared spectra of##2##3##(1990-2#1)(2008-10#1)
Infrared spectra##4##2##(1990-2#1)(1997-2#1)(2008-10#2)
Infrared spectroscopy and##2##3##(2008-10#2)
Infrared spectroscopy##7##2##(2008-10#6)(2008-5#1)
Infrared study of##2##3##(1994-3#1)(2008-10#1)
Infrared##60##1##(1990-2#1)(1991-1#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#5)(2008-10#17)(2008-2#4)(2008-3#18)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
Infrastructure##3##1##(2011-2#2)(2013-8#1)
Infratentorial##2##1##(2007-9#1)(2012-12#1)
Infrequent##3##1##(1995-12#1)(2008-12#1)(2008-8#1)
Infusion of##6##2##(1992-6#1)(1993-6#1)(1995-12#1)(2008-7#1)(2009-9#1)(2013-8#1)
Infusion##8##1##(1990-5#1)(1992-6#1)(1993-6#1)(1995-12#1)(2008-11#1)(2008-7#1)(2009-9#1)(2013-8#1)
Infusions of##2##2##(1994-2#1)(2013-1#1)
Ingard##2##1##(2011-2#2)
Ingested##2##1##(1993-8#1)(2008-12#1)
Ingestion of##7##2##(1991-2#1)(1992-11#1)(1993-8#1)(1994-11#1)(2008-5#1)(2009-8#1)(2013-1#1)
Ingestion##9##1##(1991-2#1)(1992-11#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#2)
Ingie##3##1##(2012-1#3)
Inguinal hernia##2##2##(2011-2#2)
Inguinal vasal obstruction following##2##4##(2010-4#2)
Inguinal##5##1##(2010-4#2)(2011-2#2)(2012-3#1)
Inh##5##1##(2008-10#5)
Inhalation of##2##2##(1992-3#2)
Inhalation##5##1##(1992-3#4)(2012-3#1)
Inhaled corticosteroids##2##2##(2008-8#1)(2011-2#1)
Inhaled nitric oxide##3##3##(1997-1#1)(2008-12#2)
Inhaled##12##1##(1992-3#1)(1997-1#5)(2007-11#1)(2008-12#2)(2008-8#2)(2011-2#1)
Inherent in these##2##3##(1992-1#1)(1995-3#1)
Inherent in##3##2##(1992-1#1)(1995-3#1)(1996-7#1)
Inherent##8##1##(1992-1#1)(1995-3#1)(1996-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)
Inheritance and##3##2##(2008-10#2)(2008-4#1)
Inheritance is##2##2##(1997-3#1)(2008-12#1)
Inheritance of Race-Specific Resistance to##2##5##(2008-10#2)
Inheritance of Resistance to##4##4##(2008-10#4)
Inheritance of resistance to##4##4##(2008-10#4)
Inheritance of resistance##5##3##(2008-10#5)
Inheritance of##17##2##(2008-10#15)(2008-12#1)(2008-4#1)
Inheritance was##2##2##(2008-10#1)(2008-5#1)
Inheritance##33##1##(1997-3#1)(2007-7#1)(2008-10#19)(2008-12#2)(2008-4#6)(2008-5#1)(2008-9#2)(2009-5#1)
Inherited##9##1##(1994-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-5#1)(2013-8#1)
Inhibit##2##1##(2008-11#1)(2011-1#1)
Inhibited##4##1##(1990-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
Inhibition and##3##2##(1990-11#1)(1995-6#1)(2008-3#1)
Inhibition by##8##2##(1991-3#1)(1991-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-3#1)(2011-2#1)
Inhibition of DNA##5##3##(1992-3#1)(1992-6#1)(1993-8#1)(1995-9#1)(2012-2#1)
Inhibition of adenosine##3##3##(1993-11#1)(1994-8#1)(1997-7#1)
Inhibition of apoptosis##3##3##(1992-9#1)(2008-10#1)(2009-12#1)
Inhibition of appressorium formation by##2##5##(2008-10#2)
Inhibition of arachidonate release from##2##5##(2008-11#2)
Inhibition of carcinogenic exposures wherever possible should be the goal of cancer prevention programs to reduce exposures from all environmental carcinogens##2##21##(2013-1#2)
Inhibition of cell##3##3##(1995-2#1)(1995-6#1)(2009-8#1)
Inhibition of heat shock protein##2##5##(1994-8#1)(2012-1#1)
Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid##2##14##(1991-8#2)
Inhibition of protein kinase C##2##5##(1990-2#1)(1993-12#1)
Inhibition of protein synthesis##2##4##(1992-11#1)(2009-8#1)
Inhibition of protein##6##3##(1990-2#1)(1992-11#1)(1993-12#1)(2009-8#1)(2010-5#1)(2012-3#1)
Inhibition of the##14##3##(1990-5#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
Inhibition of these##2##3##(1994-11#1)(2008-5#1)
Inhibition of##123##2##(1990-11#2)(1990-2#3)(1990-5#3)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#6)(1995-9#3)(1996-11#1)(1996-5#1)(1997-7#1)(2006-6#1)(2008-10#12)(2008-11#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#5)
Inhibition was observed##4##3##(1990-11#1)(1991-2#1)(1991-9#1)(1994-11#1)
Inhibition was##5##2##(1990-11#1)(1991-2#1)(1991-9#1)(1994-11#1)(2008-11#1)
Inhibition##149##1##(1990-11#5)(1990-2#3)(1990-5#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#6)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#4)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#5)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#7)(1995-9#3)(1996-11#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-6#1)(2008-10#12)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#4)(2013-1#6)
Inhibitor##16##1##(1994-12#1)(2008-10#5)(2008-6#1)(2008-8#1)(2009-9#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#3)
Inhibitors of##19##2##(1990-10#1)(1990-9#1)(1992-3#1)(1992-8#1)(1995-3#1)(1996-5#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-7#1)(2012-2#1)
Inhibitors##28##1##(1990-10#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1995-3#1)(1996-5#4)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-9#1)(2010-2#1)(2010-7#1)(2012-2#2)
Inhibitory Effects of##3##3##(2008-10#2)(2008-5#1)
Inhibitory activity##2##2##(1993-8#1)(2010-5#1)
Inhibitory effect of##11##3##(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-8#1)(1997-6#1)(2008-11#2)(2008-7#1)(2010-11#1)
Inhibitory effects of##13##3##(1990-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#4)(2013-1#1)
Inhibitory effects##14##2##(1990-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#4)(2013-1#1)
Inhibitory##43##1##(1990-7#2)(1991-9#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-8#3)(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#6)(2008-11#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#2)(2010-11#1)(2010-5#2)(2013-1#1)
Inhibits##15##1##(1994-12#1)(2008-10#4)(2008-11#1)(2009-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
Inhomogeneous##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
Initial Experience##2##2##(2008-12#1)(2011-2#1)
Initial analysis##3##2##(1995-11#1)(2008-3#1)(2008-5#1)
Initial approach to the child who presents with##3##8##(2006-5#3)
Initial approach to the child who presents##5##7##(2006-5#5)
Initial approach to the##6##4##(2006-5#6)
Initial attempts to##2##3##(2008-5#1)(2008-6#1)
Initial evaluation##2##2##(2008-5#1)(2011-2#1)
Initial experience##2##2##(2009-5#1)(2009-9#1)
Initial experiments##3##2##(1992-11#1)(1997-6#1)(2007-12#1)
Initial findings##3##2##(1993-2#1)(1994-6#1)(2013-8#1)
Initial genome scan of the NIMH genetics initiative bipolar pedigrees##2##10##(1997-5#2)
Initial genome##3##2##(1997-5#3)
Initial management##2##2##(2006-10#1)(2011-2#1)
Initial rapid##2##2##(1992-6#1)(2008-8#1)
Initial results of##4##3##(1991-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
Initial results##9##2##(1990-10#1)(1991-5#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)
Initial studies of##2##3##(2007-11#1)(2008-10#1)
Initial studies##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
Initial velocity##3##2##(1991-12#1)(1991-9#1)(1995-11#1)
Initial##106##1##(1990-10#1)(1990-2#1)(1991-12#1)(1991-5#2)(1991-9#3)(1992-11#1)(1992-6#1)(1993-2#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-5#4)(1997-6#1)(1997-9#1)(2006-10#1)(2006-5#6)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Initially the##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
Initially##36##1##(1990-12#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#2)
Initials##3##1##(2008-7#3)
Initiating##3##1##(2009-10#1)(2012-2#1)(2013-1#1)
Initiation and##2##2##(1992-5#1)(2008-10#1)
Initiation of##7##2##(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(2009-10#1)
Initiation##14##1##(1992-5#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-4#1)(2008-10#2)(2009-10#1)(2012-1#1)(2013-1#1)
Initiative and##2##2##(1993-2#1)(2008-7#1)
Initiative for##5##2##(2009-6#1)(2010-5#2)(2011-1#1)(2012-12#1)
Initiative in##2##2##(2008-11#1)(2008-7#1)
Initiative##41##1##(1993-2#1)(1995-3#3)(1996-12#2)(1996-2#1)(1997-2#1)(1997-5#5)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#7)(2008-8#1)(2009-6#1)(2010-12#2)(2010-5#5)(2011-1#1)(2012-12#1)(2013-8#1)
Initiative)##2##1##(2008-4#1)(2008-7#1)
Initiatives##3##1##(2008-10#1)(2008-7#1)(2012-3#1)
Initio##3##1##(1996-2#1)(1997-7#1)(2012-2#1)
Injecting##2##1##(2008-10#1)(2008-8#1)
Injection and##2##2##(2008-4#1)(2008-5#1)
Injection in rat of##2##4##(1992-8#2)
Injection of the##2##3##(2012-1#1)(2013-1#1)
Injection of##16##2##(1990-7#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#2)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Injection site##2##2##(2007-7#1)(2008-8#1)
Injection##37##1##(1990-7#1)(1992-8#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#2)(2007-4#1)(2007-7#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Injections of##7##2##(1993-12#2)(1996-5#2)(1997-2#1)(1997-3#1)(2008-7#1)
Injections##9##1##(1991-2#1)(1993-12#2)(1996-5#2)(1997-2#1)(1997-3#1)(2008-7#1)(2012-1#1)
Injured##3##1##(1996-5#1)(2008-10#2)
Injuries of the##4##3##(2007-11#1)(2007-8#1)(2010-1#1)(2013-8#1)
Injuries to the##2##3##(1991-3#1)(2007-12#1)
Injuries to##3##2##(1991-3#1)(2007-12#1)(2013-8#1)
Injuries##14##1##(1991-3#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-1#2)(2013-8#3)
Injury and##2##2##(2006-10#1)(2008-8#1)
Injury of##2##2##(2007-11#1)(2013-8#1)
Injury to the##2##3##(1990-2#1)(2008-8#1)
Injury##30##1##(1990-2#1)(1990-8#1)(1992-6#1)(1994-11#1)(1995-2#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#2)(2013-1#2)(2013-8#3)
Inlet##3##1##(2007-5#1)(2010-8#2)
Innate immunity##2##2##(2008-9#1)(2012-3#1)
Innate##6##1##(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-1#1)
Inner Mongolia HEV71 strains##4##4##(2013-8#4)
Inner Mongolia in 2010 and##2##5##(2013-8#2)
Inner Mongolia in 2010##3##4##(2013-8#3)
Inner Mongolia##14##2##(2008-9#1)(2013-1#1)(2013-8#12)
Inner##19##1##(1991-2#1)(1991-8#1)(1995-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#12)
Innervation##4##1##(1996-5#2)(1997-1#1)(2008-5#1)
Innovation in##4##2##(1991-1#1)(1991-2#1)(2011-2#1)(2012-1#1)
Innovation##10##1##(1991-1#1)(1991-2#1)(1994-1#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
Innovations DVR-A##2##2##(2008-9#2)
Innovations in##4##2##(1991-1#1)(1994-3#1)(2008-1#1)(2012-12#1)
Innovations##7##1##(1991-1#1)(1994-3#1)(2008-1#1)(2008-6#1)(2008-9#2)(2012-12#1)
Innovatis##2##1##(2008-11#2)
Innovative approaches to##2##3##(1995-3#1)(2008-11#1)
Innovative approaches##3##2##(1995-3#1)(2008-11#1)(2008-12#1)
Innovative revenue generation##2##3##(1991-12#2)
Innovative##21##1##(1991-1#1)(1991-12#2)(1992-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#3)
Innsbruck##2##1##(2009-2#1)(2009-7#1)
Ino##3##1##(1994-8#3)
Inocula##2##1##(2008-10#2)
Inoculated plants##2##2##(2008-10#2)
Inoculated with##4##2##(2008-10#4)
Inoculated##15##1##(1997-6#1)(2008-10#14)
Inoculating##2##1##(2008-10#1)(2008-8#1)
Inoculation of bean##2##3##(2008-10#2)
Inoculation of the##3##3##(2008-10#3)
Inoculation of these##2##3##(2008-10#2)
Inoculation of##12##2##(1997-6#1)(2008-10#11)
Inoculation with a##2##3##(2008-10#2)
Inoculation with##7##2##(2008-10#7)
Inoculation##27##1##(1997-6#1)(2007-7#1)(2008-10#24)(2008-8#1)
Inoculations of##3##2##(2008-10#3)
Inoculations##7##1##(2008-10#7)
Inoculum Density and##2##3##(2008-10#2)
Inoculum Density##4##2##(2008-10#4)
Inoculum##16##1##(2008-10#14)(2008-11#1)(2008-9#1)
Inorganic and organic##2##3##(1996-12#1)(2008-10#1)
Inorganic and##3##2##(1996-12#1)(2008-10#2)
Inorganic arsenic##2##2##(2008-10#2)
Inorganic mercury##3##2##(1993-12#1)(2008-10#2)
Inorganic##12##1##(1993-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-10#7)(2008-7#1)
Inosine monophosphate##2##2##(2008-10#2)
Inosine##4##1##(2008-10#4)
Inositol 1##3##2##(1991-2#1)(1993-8#1)(1997-4#1)
Inositol hexakisphosphate##2##2##(1990-7#2)
Inositol##5##1##(1990-7#2)(1991-2#1)(1993-8#1)(1997-4#1)
Inoue-Melnick virus##2##2##(1992-8#2)
Inpatient treatment##2##2##(1991-2#2)
Inpatient##8##1##(1991-2#2)(1993-12#1)(2008-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
Input##5##1##(1997-7#1)(2008-2#1)(2008-3#2)(2008-9#1)
Inputs##2##1##(2008-3#1)(2010-5#1)
Inquiry##4##1##(1993-6#1)(2008-11#1)(2010-4#1)(2012-3#1)
Ins 1##7##2##(1997-1#7)
Ins##8##1##(1997-1#8)
Ins(1##19##1##(1990-12#3)(1990-7#8)(1994-8#4)(1997-1#4)
Ins1##2##1##(1993-6#2)
Ins2##2##1##(1996-10#2)
InsP(3) binding##3##2##(2008-8#3)
InsP(3) receptor could##2##3##(2008-8#2)
InsP(3) receptor##6##2##(2008-8#6)
InsP(3)##9##1##(2008-8#9)
InsP3 and InsP4##3##3##(1991-12#3)
InsP3 and##5##2##(1990-7#1)(1991-12#3)(1994-6#1)
InsP3##7##1##(1990-7#1)(1991-12#4)(1994-11#1)(1994-6#1)
InsP4##4##1##(1991-12#4)
Insect cell##3##2##(2008-11#2)(2012-2#1)
Insect##18##1##(1994-8#1)(1995-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#2)(2012-2#3)
Insecta##2##1##(1995-6#1)(2010-1#1)
Insecticide resistance##2##2##(2011-2#2)
Insecticide##4##1##(1996-3#1)(2008-10#1)(2011-2#2)
Insects##7##1##(1990-11#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-1#2)(2013-7#1)
Insensitivity##6##1##(2008-10#6)
Inserted##2##1##(1993-8#1)(2012-3#1)
Inserting##2##1##(2007-11#2)
Insertion of an##2##3##(1995-12#1)(2008-10#1)
Insertion of##11##2##(1990-11#1)(1991-10#1)(1992-11#1)(1995-12#1)(1995-6#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)
Insertion##15##1##(1990-11#1)(1991-10#1)(1992-11#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)
Insertional Mutagenesis##2##2##(2008-10#2)
Insertional##4##1##(1995-6#1)(2008-10#3)
Insertions##2##1##(1995-11#1)(2008-10#1)
Inside the##3##2##(1997-5#1)(2008-10#1)(2009-12#1)
Inside##8##1##(1992-2#1)(1995-1#1)(1997-5#1)(2008-10#3)(2009-11#1)(2009-12#1)
Insight and Responsibility##2##3##(2008-12#2)
Insight##8##1##(1990-9#1)(1993-11#1)(2008-1#2)(2008-10#1)(2008-12#2)(2009-2#1)
Insights from the##3##3##(1996-2#1)(2007-8#1)(2008-11#1)
Insights from##5##2##(1996-2#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-3#1)
Insights gained from##2##3##(1994-8#1)(2010-4#1)
Insights into the##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
Insights into##7##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2012-2#1)
Insights##18##1##(1994-8#1)(1996-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#2)
Insoluble##3##1##(2008-10#3)
Insomnia##4##1##(2008-5#1)(2012-2#1)(2013-1#2)
Inspection##5##1##(1991-9#1)(1992-5#1)(1995-2#1)(2010-4#1)(2012-2#1)
Inspector General v##2##3##(1992-3#1)(1993-1#1)
Inspector General##6##2##(1991-12#1)(1992-3#1)(1993-1#3)(1993-12#1)
Inspector##9##1##(1991-12#1)(1992-3#1)(1993-1#3)(1993-12#2)(1994-2#1)(2009-5#1)
Inspired by##2##2##(2008-7#1)(2010-4#1)
Inst##5##1##(1995-5#1)(2007-12#4)
Instability in##3##2##(2007-12#1)(2008-10#2)
Instability of##2##2##(2008-10#1)(2010-9#1)
Instability##6##1##(2007-12#1)(2008-10#3)(2010-9#1)(2012-3#1)
Instant##2##1##(2011-2#1)(2012-2#1)
Instead it must##2##3##(1996-4#1)(2008-3#1)
Instead it##3##2##(1996-4#1)(2008-3#1)(2010-11#1)
Instead of a##3##3##(2007-11#1)(2008-3#2)
Instead of being##3##3##(1994-12#1)(2008-8#1)(2012-2#1)
Instead of the##4##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
Instead of using a##3##4##(2007-12#1)(2008-2#1)(2010-8#1)
Instead of using##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)
Instead of##28##2##(1994-1#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
Instead we##2##2##(2008-2#2)
Instead##83##1##(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#3)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
Institut##11##1##(1990-10#1)(1992-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2010-1#3)
Institute Conference##2##2##(1991-1#1)(2008-5#1)
Institute and##2##2##(1990-11#1)(2010-1#1)
Institute as##2##2##(2008-9#1)(2009-6#1)
Institute for Health and Clinical Excellence (NICE)##3##7##(2008-7#1)(2012-3#1)(2013-8#1)
Institute for Health##5##3##(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
Institute for Medical Research##3##4##(1990-3#1)(2008-12#1)(2010-11#1)
Institute for##31##2##(1990-3#1)(1990-6#1)(1995-2#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
Institute in Warsaw##2##3##(2007-8#2)
Institute in##5##2##(2007-1#1)(2007-8#2)(2008-10#1)(2011-2#1)
Institute is##2##2##(1994-1#1)(2011-2#1)
Institute of Child Health##3##4##(1991-3#1)(1992-8#1)(1996-2#1)
Institute of Forensic##4##3##(1995-3#1)(1995-6#1)(1997-8#2)
Institute of Geography and##2##4##(1991-9#1)(2008-9#1)
Institute of Health##5##3##(1996-4#1)(1997-5#1)(2008-12#1)(2008-7#1)(2012-3#1)
Institute of Human##2##3##(1996-4#2)
Institute of Medical Sciences##3##4##(2009-7#1)(2012-2#1)(2013-8#1)
Institute of Medical##6##3##(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
Institute of Medicine (IOM)##3##4##(2007-12#1)(2008-1#1)(2010-3#1)
Institute of Medicine##9##3##(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-8#1)(2010-3#1)(2010-4#1)(2012-2#1)
Institute of Medicine's##2##3##(1996-1#1)(2013-1#1)
Institute of Oncology##2##3##(1991-12#1)(1994-7#1)
Institute of Public Health##5##4##(1996-6#1)(2008-10#2)(2010-6#1)(2011-2#1)
Institute of Standards and##12##4##(1996-12#1)(2008-10#3)(2008-2#2)(2008-3#6)
Institute of Standards##13##3##(1996-12#1)(2008-10#3)(2008-2#2)(2008-3#6)(2013-8#1)
Institute of Technology in##2##4##(1994-8#1)(2008-3#1)
Institute of Technology##3##3##(1993-12#1)(1994-8#1)(2008-3#1)
Institute of Tuberculosis and##3##4##(2009-5#1)(2011-2#2)
Institute of the##2##3##(1992-12#1)(2009-9#1)
Institute of##127##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#4)(1991-9#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#30)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Institute##263##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#5)(1991-5#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-1#4)(1994-2#1)(1994-3#3)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-4#5)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#2)(1997-8#3)(2007-1#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#15)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#13)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#41)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#14)(2013-8#7)
Institute's##3##1##(2008-9#1)(2010-7#1)(2011-2#1)
Institutes of Health##30##3##(1991-3#1)(1996-5#1)(1996-9#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-3#3)(2013-8#10)
Institutes of##33##2##(1991-3#1)(1994-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-3#3)(2013-8#10)
Institutes##38##1##(1991-3#1)(1994-12#2)(1994-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#3)(2013-8#10)
Institution##9##1##(1990-12#1)(2008-11#3)(2008-3#1)(2008-9#2)(2013-1#2)
Institutional Review##4##2##(1997-8#1)(2009-4#2)(2009-6#1)
Institutional##10##1##(1990-2#1)(1991-1#1)(1994-2#1)(1995-2#1)(1997-8#1)(2008-11#1)(2009-4#2)(2009-6#1)(2013-1#1)
Institutions##7##1##(2008-11#4)(2008-7#1)(2012-12#1)(2012-3#1)
Instituto Materno Infantil##2##3##(2013-1#2)
Instituto Nacional de##2##3##(2008-10#1)(2012-12#1)
Instituto Oswaldo Cruz##3##3##(1993-6#2)(2010-1#1)
Instituto Oswaldo##4##2##(1993-6#3)(2010-1#1)
Instituto##10##1##(1993-6#3)(2008-10#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
Instructions for##3##2##(2008-11#2)(2008-9#1)
Instructions to authors##4##3##(2008-11#3)(2010-12#1)
Instructions##9##1##(2008-11#5)(2008-4#1)(2008-9#1)(2010-12#1)(2011-3#1)
Instructors##3##1##(1995-1#1)(2008-12#1)(2011-2#1)
Instrum##2##1##(2007-12#1)(2008-2#1)
Instrument##13##1##(1990-10#1)(1993-2#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
Instrumental Activities of Daily Living (IADL)##2##6##(2008-7#2)
Instrumental methods##2##2##(2008-10#2)
Instrumental##10##1##(1995-1#1)(2008-10#5)(2008-3#2)(2008-7#2)
Instrumentation to##2##2##(2008-10#1)(2011-1#1)
Instrumentation##5##1##(2008-10#1)(2008-3#2)(2011-1#1)(2012-3#1)
Instrumented##3##1##(2012-3#3)
Instruments for##2##2##(2008-3#1)(2013-8#1)
Instruments##12##1##(2008-10#4)(2008-12#1)(2008-3#6)(2013-8#1)
Insufficient##5##1##(1996-2#1)(2008-10#1)(2008-12#1)(2008-9#2)
Insulin Resistance##4##2##(2008-1#1)(2008-3#1)(2011-1#1)(2012-2#1)
Insulin Secretion##2##2##(2009-3#1)(2011-1#1)
Insulin and##4##2##(1997-7#1)(2008-3#1)(2008-8#1)(2008-9#1)
Insulin has##2##2##(2008-3#1)(2010-11#1)
Insulin is##2##2##(2008-11#1)(2008-3#1)
Insulin receptor##4##2##(1992-12#1)(2008-4#1)(2008-6#1)(2010-11#1)
Insulin resistance and##3##3##(2008-11#1)(2008-3#2)
Insulin resistance in##2##3##(1994-12#1)(2008-4#1)
Insulin resistance is##2##3##(2008-3#1)(2012-5#1)
Insulin resistance was##2##3##(2008-3#2)
Insulin resistance##21##2##(1994-12#2)(1996-11#1)(1996-2#1)(2008-11#1)(2008-3#12)(2008-4#2)(2012-2#1)(2012-5#1)
Insulin secretion##4##2##(1991-6#1)(1995-8#1)(2008-11#1)(2008-4#1)
Insulin##80##1##(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-8#1)(1996-11#1)(1996-2#2)(1997-6#1)(1997-7#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#17)(2008-4#4)(2008-6#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-8#1)(2011-1#7)(2011-2#2)(2012-2#2)(2012-4#1)(2012-5#1)
Insulin-Like##2##1##(2012-3#1)(2013-1#1)
Insulin-like Growth##3##2##(2008-4#1)(2011-1#2)
Insulin-like growth factor##4##3##(1991-5#1)(1992-9#1)(2008-11#1)(2011-1#1)
Insulin-like growth##6##2##(1991-5#1)(1992-9#1)(1993-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
Insulin-like##9##1##(1991-5#1)(1992-9#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#3)
Insurance Act##2##2##(1991-8#1)(1995-2#1)
Insurance Company##3##2##(1997-5#2)(2008-10#1)
Insurance Plan##2##2##(1995-12#1)(1996-1#1)
Insurance##30##1##(1991-8#3)(1992-12#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-6#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
Insurers##4##1##(1992-3#1)(1993-3#1)(1996-11#1)(1997-3#1)
Int J##2##2##(2008-10#1)(2008-12#1)
Int##9##1##(1992-6#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-11#1)(2011-1#1)
Intact animals##2##2##(1992-3#1)(2008-5#1)
Intact enamel##2##2##(2013-1#2)
Intact##17##1##(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-8#2)(1996-5#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#2)
Intake and##2##2##(2011-1#1)(2012-2#1)
Intake of extra##2##3##(2008-10#2)
Intake##5##1##(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)
Integral and peripheral##2##3##(1995-5#2)
Integral and##3##2##(1995-5#2)(2007-11#1)
Integral##14##1##(1995-5#2)(1996-12#1)(2007-11#2)(2008-2#2)(2008-3#2)(2009-2#1)(2010-3#1)(2012-3#2)(2013-1#1)
Integrated delivery systems##4##3##(1995-12#1)(1996-1#1)(2008-1#1)(2008-11#1)
Integrated health care##2##3##(1995-3#1)(1997-1#1)
Integrated health##3##2##(1995-3#1)(1997-1#1)(1997-3#1)
Integrated optical##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
Integrated##55##1##(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#3)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
Integrating a##2##2##(1993-1#1)(2010-2#1)
Integrating information systems##3##3##(1994-12#1)(1994-3#1)(1997-2#1)
Integrating outcomes##2##2##(1992-3#1)(1996-1#1)
Integrating the##3##2##(1993-12#1)(2008-11#1)(2008-3#1)
Integrating total quality management##3##4##(1994-1#1)(1994-2#1)(1995-12#1)
Integrating##41##1##(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)
Integration in the##2##3##(1994-7#1)(2007-11#1)
Integration in##3##2##(1994-7#1)(2007-11#1)(2008-7#1)
Integration of clinical##2##3##(1994-2#1)(1994-3#1)
Integration of the##5##3##(1995-2#1)(1997-7#1)(2008-2#1)(2008-3#2)
Integration of these##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
Integration of##38##2##(1994-2#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#4)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
Integration##57##1##(1994-2#1)(1994-3#1)(1994-7#1)(1995-2#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)
Integrative approaches to couple therapy##2##5##(2012-2#2)
Integrative review of##2##3##(2008-4#1)(2009-6#1)
Integrative##7##1##(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-2#3)
Integrin##2##1##(1991-5#1)(2008-8#1)
Integrity and##2##2##(2009-4#1)(2010-7#1)
Integrity of##2##2##(2007-12#1)(2008-11#1)
Integrity##9##1##(2007-12#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-6#1)(2010-7#1)(2013-1#2)
Intel##2##1##(2008-3#1)(2011-1#1)
Intellectual Property##2##2##(2011-1#2)
Intellectual##4##1##(2010-10#1)(2010-12#1)(2011-1#2)
Intelligence##8##1##(1994-6#2)(1995-11#1)(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
Intelligent Systems for Molecular Biology##2##5##(2008-7#2)
Intended Adopters##3##2##(2010-8#3)
Intended Adopters'##3##2##(2010-8#3)
Intended##8##1##(1993-12#1)(2010-3#1)(2010-8#6)
Intense##11##1##(1990-2#1)(1990-7#1)(1995-12#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)
Intensified insulin##2##2##(1995-5#1)(1997-4#1)
Intensified##3##1##(1995-5#1)(1997-4#1)(2008-6#1)
Intensity and##2##2##(2007-11#1)(2013-1#1)
Intensity of##3##2##(2007-7#1)(2008-10#1)(2012-1#1)
Intensity on##2##2##(2008-6#1)(2012-12#1)
Intensity##26##1##(1991-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Intensity-dependent##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Intensity-modulated##3##1##(2008-2#2)(2008-3#1)
Intensive Care Unit of##2##4##(1991-6#1)(2010-9#1)
Intensive Care Unit##12##3##(1991-6#1)(1992-2#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-9#2)(2012-12#1)(2012-3#3)(2013-1#1)
Intensive Care Units in##2##4##(2010-4#1)(2012-2#1)
Intensive Care Units##4##3##(2007-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
Intensive Care##21##2##(1990-6#1)(1991-6#1)(1992-2#1)(2007-11#2)(2008-11#2)(2008-5#1)(2009-5#1)(2010-4#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
Intensive Medicines Monitoring Programme (IMMP)##3##5##(2008-11#2)(2008-8#1)
Intensive Medicines Monitoring Programme##4##4##(2008-11#2)(2008-8#2)
Intensive care##6##2##(1991-2#1)(1995-11#2)(1996-1#1)(1997-2#1)(2007-11#1)
Intensive insulin treatment after acute myocardial infarction in diabetes mellitus##3##10##(1997-8#3)
Intensive insulin treatment##4##3##(1990-11#1)(1997-8#3)
Intensive insulin##5##2##(1990-11#1)(1997-8#4)
Intensive psychotherapy##2##2##(1993-1#1)(2010-1#1)
Intensive##50##1##(1990-11#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#4)(2007-11#3)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#2)(2009-5#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)
Intentionally staged##2##2##(2008-7#2)
Intentions##2##1##(1997-5#1)(2009-12#1)
Inter##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
Inter- and##2##2##(1990-9#1)(2008-10#1)
Inter-professional##4##1##(2008-11#4)
Inter-rater##2##1##(1995-3#1)(2010-10#1)
Inter-retrotransposon##2##1##(2008-10#2)
InterMetro mobile workstations##2##3##(2011-2#2)
InterMetro##3##1##(2011-2#3)
InterPro##3##1##(2008-4#1)(2008-7#1)(2009-8#1)
Interacting##3##1##(2009-9#1)(2012-12#1)(2012-2#1)
Interaction Between Tomato##2##3##(2008-10#2)
Interaction Between the##2##3##(2008-10#2)
Interaction Between##9##2##(2008-10#9)
Interaction and##2##2##(2007-10#1)(2008-10#1)
Interaction between the##2##3##(1996-5#1)(2008-11#1)
Interaction between##16##2##(1994-6#1)(1994-9#3)(1995-12#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
Interaction of Fusarium##2##3##(2008-10#2)
Interaction of the##2##3##(1992-12#1)(2008-10#1)
Interaction of##43##2##(1990-2#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#1)(1997-5#1)(1997-6#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#2)(2011-1#1)(2013-8#1)
Interaction trap/two-hybrid system to identify##2##5##(2008-2#1)(2008-9#1)
Interaction with##4##2##(1992-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
Interaction##81##1##(1990-2#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Interactions Among##2##2##(2008-10#2)
Interactions Between Strains of##2##4##(2008-10#2)
Interactions Between Trichoderma##2##3##(2008-10#2)
Interactions Between the##2##3##(2008-10#2)
Interactions Between##11##2##(2008-10#11)
Interactions between the##6##3##(1992-6#1)(1995-2#1)(2008-10#2)(2009-8#1)(2012-12#1)
Interactions between##26##2##(1991-9#2)(1992-3#1)(1992-6#2)(1993-1#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-7#2)(2006-10#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
Interactions in##2##2##(2008-10#1)(2012-2#1)
Interactions of##19##2##(1990-12#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-8#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-4#1)(2009-12#1)(2010-2#1)
Interactions with##5##2##(2008-10#1)(2008-4#1)(2010-3#1)(2011-1#1)(2013-1#1)
Interactions##82##1##(1990-12#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-6#2)(1993-1#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-2#1)(2010-3#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
Interactive##9##1##(2007-8#1)(2008-11#3)(2008-2#2)(2008-6#1)(2009-10#1)(2011-2#1)
Interampatteness##2##1##(2010-10#2)
Intercalibration of SUMER and CDS on SOHO##2##7##(2008-3#2)
Intercalibration##3##1##(2008-3#3)
Interceed (TC7) plus heparin##2##4##(1992-1#2)
Interceed (TC7) plus##4##3##(1992-1#4)
Interceed (TC7)##7##2##(1992-1#7)
Interceed##8##1##(1991-1#1)(1992-1#7)
Intercellular##3##1##(2008-10#2)(2008-5#1)
Interdisciplinary education and##2##3##(1996-1#1)(2008-12#1)
Interdisciplinary##5##1##(1996-1#1)(2008-12#1)(2008-9#2)(2009-9#1)
Interest in the##2##3##(2008-5#1)(2011-2#1)
Interest in##13##2##(1991-6#1)(1997-5#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)
Interest##17##1##(1991-6#1)(1997-5#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
Interesting##8##1##(2008-10#2)(2008-3#3)(2011-2#2)(2012-12#1)
Interestingly the##3##2##(1991-5#1)(1996-12#1)(2010-2#1)
Interestingly##162##1##(1990-12#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#3)(1996-12#2)(1996-5#1)(1997-2#2)(1997-4#3)(1997-7#3)(2006-6#2)(2007-7#1)(2008-1#3)(2008-10#21)(2008-11#16)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#10)(2008-9#1)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#9)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#7)(2013-8#1)
Interface##9##1##(1991-9#1)(1996-9#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-8#2)(2012-12#1)(2013-8#1)
Interfacial roughness##2##2##(2008-2#2)
Interfacial##3##1##(2008-2#2)(2012-2#1)
Interference between the##2##3##(2008-2#1)(2008-3#1)
Interference between##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
Interference effects in##2##3##(2007-12#1)(2008-3#1)
Interference from##7##2##(2008-10#7)
Interference of##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-12#1)
Interference studies were##2##3##(2008-10#2)
Interference studies##5##2##(2008-10#5)
Interference with##4##2##(1994-11#1)(1997-7#1)(2008-1#1)(2008-3#1)
Interference##47##1##(1994-11#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#20)(2008-2#4)(2008-3#11)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)
Interference-free##2##1##(2008-10#2)
Interferences from metal ions could be##2##6##(2008-10#2)
Interferences from various##2##3##(2008-10#2)
Interferences from##7##2##(2008-10#7)
Interferences in the##2##3##(2008-10#1)(2013-1#1)
Interferences in##3##2##(2008-10#2)(2013-1#1)
Interferences##16##1##(2008-10#15)(2013-1#1)
Interfering##3##1##(2008-10#2)(2008-7#1)
Interferograms##2##1##(2008-2#1)(2008-3#1)
Interferometer##20##1##(2007-11#1)(2008-2#5)(2008-3#14)
Interferometric gravitational-wave##2##2##(2007-11#1)(2008-3#1)
Interferometric measurement of the##2##4##(2008-2#1)(2008-3#1)
Interferometric measurement of##3##3##(2008-2#1)(2008-3#2)
Interferometric##20##1##(2007-11#3)(2007-12#2)(2008-2#8)(2008-3#7)
Interferometry##7##1##(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#1)
Interferon regulatory factor-2##2##3##(1995-12#2)
Interferon β-1a##2##2##(2013-8#2)
Interferon##9##1##(1991-12#1)(1995-10#1)(1995-12#2)(1996-2#1)(2007-11#1)(2013-8#3)
Interferon-alpha##2##1##(1992-10#1)(2012-12#1)
Interferon-induced##2##1##(1990-9#1)(2008-6#1)
Interferon-tau##2##1##(2007-11#2)
Interferons##2##1##(1991-3#1)(1997-1#1)
Intergenerational##2##1##(1991-12#1)(2013-8#1)
Intergroup##4##1##(2010-3#4)
Interhemispheric##3##1##(1994-3#2)(2013-1#1)
Interim##6##1##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
Interlaboratory study of the##2##4##(2008-10#2)
Interlaboratory##6##1##(1997-4#1)(2008-10#5)
Interleukin 1 (IL-1) has been shown to##2##7##(1990-11#1)(1990-12#1)
Interleukin 1##6##2##(1990-11#1)(1990-12#2)(1990-5#2)(1996-2#1)
Interleukin 10 (IL-10)##2##3##(1993-8#1)(1994-8#1)
Interleukin##16##1##(1990-11#1)(1990-12#3)(1990-5#2)(1993-8#1)(1994-8#1)(1996-2#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2013-7#1)
Interleukin-1 beta (IL-1 beta)##2##4##(1995-12#1)(1996-12#1)
Interleukin-1 beta##6##2##(1990-10#1)(1990-2#1)(1994-11#1)(1995-12#2)(1996-12#1)
Interleukin-1 receptor##3##2##(1995-12#1)(2008-10#2)
Interleukin-1##13##1##(1990-10#1)(1990-12#2)(1990-2#1)(1993-8#1)(1994-11#2)(1995-12#3)(1996-12#1)(2008-10#2)
Interleukin-2 (IL-2)##2##2##(1994-11#1)(1994-5#1)
Interleukin-2 concentration##2##2##(2008-11#2)
Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer##2##11##(2008-6#2)
Interleukin-2##7##1##(1994-11#1)(1994-5#1)(2008-11#3)(2008-6#2)
Interleukin-4 (IL-4)##2##2##(1994-3#1)(2008-7#1)
Interleukin-4##3##1##(1994-3#1)(2008-7#1)(2013-8#1)
Interleukin-5##2##1##(1995-6#1)(2012-3#1)
Interleukin-6 (IL-6)##2##2##(1995-12#1)(1997-7#1)
Interleukin-6 and Tumor Necrosis Factor-alpha##2##5##(2008-10#1)(2008-11#1)
Interleukin-6##5##1##(1995-12#2)(1997-7#1)(2008-10#1)(2008-11#1)
Interleukins##2##1##(1990-9#2)
Interlibrary loan##2##2##(1992-2#1)(1995-2#1)
Intermedia##2##1##(2007-11#2)
Intermediate##16##1##(1990-11#1)(1995-11#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-7#1)
Intermediates##2##1##(2009-2#1)(2010-2#1)
Intermittent##10##1##(1990-9#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
Intermountain Health Care##2##3##(1996-1#1)(1996-2#1)
Internal Medicine##13##2##(1992-5#1)(1994-3#1)(1995-11#1)(1996-11#2)(1997-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#3)
Internal Revenue Code##3##3##(1991-2#2)(1996-3#1)
Internal Revenue##4##2##(1991-2#2)(1992-12#1)(1996-3#1)
Internal Transcribed Spacer##5##3##(2008-10#4)(2012-2#1)
Internal Transcribed Spacer-rDNA##2##3##(2008-10#2)
Internal Transcribed##8##2##(2008-10#7)(2012-2#1)
Internal and External##2##3##(2010-8#1)(2012-3#1)
Internal and external##2##3##(2007-9#1)(2008-12#1)
Internal and##4##2##(2007-9#1)(2008-12#1)(2010-8#1)(2012-3#1)
Internal audit##2##2##(2007-9#2)
Internal consistency##3##2##(2009-11#1)(2009-12#1)(2010-11#1)
Internal transcribed spacer##2##3##(2008-10#2)
Internal##67##1##(1990-3#1)(1991-2#2)(1992-12#1)(1992-5#1)(1994-3#2)(1995-11#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-6#1)(1997-7#1)(2007-8#2)(2007-9#3)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
Internalization of##2##2##(1990-11#1)(2009-8#1)
Internally##2##1##(2008-10#2)
International AIDS##4##2##(1990-11#2)(1991-5#1)(2013-1#1)
International Classification of Diseases##4##4##(1991-9#1)(2008-12#1)(2008-3#1)(2012-12#1)
International Classification of Functioning##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
International Classification of Primary Care##2##5##(1991-9#1)(1994-6#1)
International Classification of##10##3##(1991-12#1)(1991-9#2)(1994-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#2)
International Classification##13##2##(1991-12#1)(1991-9#2)(1994-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#2)(2013-1#2)(2013-8#1)
International Code of Nomenclature of Bacteria##2##6##(2008-10#2)
International Code of##4##3##(2008-10#3)(2010-5#1)
International Collaborating Clinics/American College of Rheumatology##2##6##(2006-10#1)(2011-2#1)
International Commission on##2##3##(1995-12#1)(2010-12#1)
International Committee##2##2##(1991-6#1)(2012-3#1)
International Conference in##2##3##(1995-12#1)(2008-12#1)
International Conference on Harmonization##2##4##(2008-10#1)(2010-11#1)
International Conference on Population and Development##3##6##(1994-9#2)(2008-11#1)
International Conference on##17##3##(1992-1#1)(1994-9#2)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
International Conference##24##2##(1992-1#1)(1994-9#2)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
International Congress of##4##3##(1997-7#1)(2008-10#1)(2008-5#1)(2010-3#1)
International Congress on##7##3##(1996-2#1)(2008-7#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
International Congress##13##2##(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#2)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
International Development##2##2##(1997-2#1)(2009-4#1)
International Federation of##3##3##(1995-3#1)(2007-4#1)(2008-10#1)
International Federation##4##2##(1994-3#1)(1995-3#1)(2007-4#1)(2008-10#1)
International Health Regulations##2##3##(2009-10#1)(2010-5#1)
International Journal of##2##3##(2008-11#1)(2009-4#1)
International Medical##2##2##(2009-12#1)(2012-3#1)
International Meeting on##2##3##(2008-5#1)(2013-8#1)
International Meeting##3##2##(2008-5#2)(2013-8#1)
International Neuroblastoma##2##2##(2011-2#2)
International Normalized Ratio##2##3##(1997-2#1)(2011-2#1)
International Prognostic Index##2##3##(2007-5#1)(2010-11#1)
International Prognostic##4##2##(2007-5#1)(2009-2#1)(2010-11#2)
International Pty Ltd##2##3##(2011-1#1)(2013-1#1)
International Quality of Life Assessment (IQOLA)##2##6##(1994-3#1)(2013-1#1)
International Registry##3##2##(2008-7#2)(2011-3#1)
International Society for##9##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#3)(2011-9#1)
International Society##15##2##(1994-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2009-11#1)(2011-2#4)(2011-9#1)(2012-2#1)
International Standard##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
International Stroke Society##2##3##(2008-8#2)
International Stroke Trial##2##3##(1997-5#2)
International Stroke##6##2##(1997-5#2)(2008-8#4)
International Summer School##2##3##(2008-7#2)
International Symposium of the##2##4##(2008-7#1)(2010-10#1)
International Symposium on High Performance##2##5##(1994-9#1)(1997-2#1)
International Symposium on the##2##4##(2008-11#1)(2008-4#1)
International Symposium on##11##3##(1994-9#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)
International Symposium##15##2##(1994-9#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)
International Workshop on##2##3##(2008-4#1)(2011-2#1)
International Workshop##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
International advisory board##3##3##(1997-6#1)(2008-5#2)
International and local students##2##4##(2008-11#2)
International and##4##2##(1993-3#1)(2008-11#2)(2013-1#1)
International disease surveillance##2##3##(1996-6#1)(2009-6#1)
International disease##3##2##(1996-6#1)(2009-6#2)
International studies##2##2##(1994-6#1)(2011-2#1)
International##265##1##(1990-11#2)(1990-4#1)(1990-9#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#5)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-6#2)(1997-2#4)(1997-3#1)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#26)(2008-11#22)(2008-12#5)(2008-3#4)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#10)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-10#1)(2011-2#17)(2011-3#1)(2011-9#1)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#7)
Internationale de l'Eclairage)##2##3##(2008-2#1)(2008-3#1)
Internationale##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
Internationally recognized##2##2##(2007-11#1)(2013-1#1)
Internet access and##2##3##(1996-5#1)(1997-1#1)
Internet access##3##2##(1996-2#1)(1996-5#1)(1997-1#1)
Internet and information technology##3##4##(2008-11#3)
Internet and other##2##3##(2008-5#1)(2011-1#1)
Internet and##11##2##(1994-3#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)
Internet as a##2##3##(1997-4#1)(2009-5#1)
Internet as##4##2##(1997-4#1)(2009-5#2)(2013-1#1)
Internet has##6##2##(2007-2#1)(2008-12#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)
Internet is##5##2##(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)
Internet resources##4##2##(1997-3#1)(2008-4#2)(2008-7#1)
Internet sites##2##2##(2007-2#1)(2013-7#1)
Internet use##11##2##(2007-12#1)(2009-5#3)(2009-7#5)(2013-1#2)
Internet##126##1##(1994-12#2)(1994-3#3)(1995-1#1)(1995-12#1)(1996-12#3)(1996-2#9)(1996-3#2)(1996-5#4)(1996-8#1)(1997-1#3)(1997-3#3)(1997-4#1)(2007-11#1)(2007-12#6)(2007-2#4)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#12)(2008-12#3)(2008-2#2)(2008-4#8)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#11)(2009-7#5)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
Internet-based##3##1##(2007-12#1)(2009-5#1)(2012-2#1)
Interobserver variation##2##2##(1991-12#1)(2009-11#1)
Interobserver##5##1##(1991-12#1)(2009-11#1)(2011-5#1)(2012-12#2)
Interoperability##2##1##(2008-7#2)
Interorganizational##2##1##(1991-12#2)
Interparental conflict##2##2##(2010-1#2)
Interpersonal##5##1##(1996-1#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-8#1)
Interphase in##2##2##(1993-12#1)(2008-3#1)
Interplay##2##1##(1993-5#1)(2010-7#1)
Interpolation##2##1##(1990-12#1)(2008-10#1)
Interpower##2##1##(2011-2#2)
Interpretation and##2##2##(2008-12#1)(2013-8#1)
Interpretation of the##2##3##(1992-2#1)(1992-4#1)
Interpretation of##10##2##(1992-2#1)(1992-4#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-6#1)
Interpretation##14##1##(1992-2#1)(1992-4#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-12#2)(2008-5#1)(2010-6#1)(2011-2#2)(2013-8#1)
Interpretative Phenomenological Analysis##3##3##(2007-12#1)(2013-1#2)
Interpreting##3##1##(1995-12#1)(2008-7#1)(2013-8#1)
Interprofessional Capability Framework##2##3##(2008-11#2)
Interprofessional education##4##2##(2008-11#3)(2008-12#1)
Interprofessional learning##2##2##(2013-7#2)
Interprofessional##12##1##(2008-11#8)(2008-12#2)(2013-7#2)
Interrater reliability##3##2##(1996-7#1)(2007-8#1)(2008-12#1)
Interrupted##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
Interruptions##2##1##(2010-5#1)(2011-1#1)
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)##2##8##(2007-1#1)(2008-5#1)
Intersex##3##1##(2008-10#2)(2013-1#1)
Interspecific crosses##2##2##(2008-10#2)
Interspecific##12##1##(2008-10#8)(2008-5#1)(2008-8#2)(2008-9#1)
Interstitial##7##1##(1991-8#1)(1995-9#1)(1997-3#2)(2008-5#1)(2009-11#1)(2009-12#1)
Interval and##2##2##(2008-10#1)(2011-1#1)
Interval##7##1##(1995-12#1)(2007-7#1)(2008-10#3)(2008-6#1)(2011-1#1)
Intervention Trial##3##2##(1991-5#1)(1991-8#1)(1992-9#1)
Intervention for##3##2##(2009-11#1)(2013-7#1)(2013-8#1)
Intervention on##2##2##(2012-2#1)(2012-3#1)
Intervention studies##2##2##(1992-4#1)(2008-7#1)
Intervention##37##1##(1991-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#2)(2010-10#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
Interventional cardiology##2##2##(2008-7#2)
Interventional neuroradiology##2##2##(1991-3#1)(1997-6#1)
Interventional radiology in##2##3##(2008-1#1)(2009-9#1)
Interventional radiology is##2##3##(2008-1#1)(2011-2#1)
Interventional radiology##4##2##(2008-1#2)(2009-9#1)(2011-2#1)
Interventional##12##1##(1991-3#1)(1993-2#1)(1996-9#1)(1997-6#1)(2008-1#3)(2008-7#2)(2009-10#1)(2009-9#1)(2011-2#1)
Interventions in##4##2##(1990-9#1)(1992-11#1)(2008-2#1)(2013-1#1)
Interventions to##3##2##(2008-11#1)(2010-1#1)(2010-4#1)
Interventions with##2##2##(2010-8#1)(2011-2#1)
Interventions##23##1##(1990-9#1)(1991-6#1)(1992-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#3)
Intervertebral##2##1##(1996-9#1)(2012-3#1)
Interview and the##2##3##(2011-1#2)
Interview and##3##2##(2009-7#1)(2011-1#2)
Interview by Barbara##2##3##(1994-2#1)(1995-5#1)
Interview by Bjørn Arild Ostby]##2##5##(1993-3#2)
Interview by Dr##12##3##(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)
Interview by Elisabeth B##2##4##(1996-3#1)(1996-8#1)
Interview by Elisabeth##3##3##(1996-3#1)(1996-8#1)(1997-2#1)
Interview by Jill L##2##4##(1993-12#1)(1996-1#1)
Interview by Maria R##2##4##(1995-3#1)(1996-2#1)
Interview by Marie E##7##4##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Interview by Marit Fonn]##2##4##(1993-3#2)
Interview by Mark##2##3##(1994-3#1)(2013-1#1)
Interview by Mary Grayson##2##4##(1992-3#1)(1993-3#1)
Interview by Mette Fjordbo]##2##4##(1993-3#2)
Interview by Patrick##3##3##(1995-12#1)(1997-3#1)(2008-6#1)
Interview by Steven Harulow##2##4##(2008-6#2)
Interview by Terry G##2##4##(1996-2#1)(1997-1#1)
Interview by Tom Heinemann]##2##4##(1993-3#2)
Interview by Tonny van de Pasch]##2##6##(1997-3#1)(1997-5#1)
Interview by Tonny van##3##4##(1997-3#2)(1997-5#1)
Interview by##85##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-4#1)(1992-3#1)(1993-12#2)(1993-3#13)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-5#2)(1997-6#1)(1997-8#5)(2008-11#1)(2008-5#1)(2008-6#5)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
Interview for##4##2##(2008-11#1)(2012-12#2)(2013-1#1)
Interview with##4##2##(2007-2#1)(2010-5#1)(2010-8#1)(2013-1#1)
Interview##112##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-4#1)(1992-3#1)(1993-12#2)(1993-3#13)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#6)(1997-5#2)(1997-6#1)(1997-8#5)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#5)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#5)(2013-8#3)
Interviewed##2##1##(1996-3#1)(2013-1#1)
Interviews were analyzed using##2##4##(2010-10#1)(2013-1#1)
Interviews were analyzed##3##3##(2010-10#1)(2010-8#1)(2013-1#1)
Interviews were conducted with##2##4##(2009-5#1)(2009-9#1)
Interviews were conducted##3##3##(2009-5#1)(2009-9#1)(2013-1#1)
Interviews were##9##2##(2009-5#2)(2009-9#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
Interviews with##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
Interviews##14##1##(1990-10#1)(1995-2#1)(2008-11#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#3)
Intestinal Epithelial Cells##2##3##(2008-11#1)(2009-12#1)
Intestinal ischemia/reperfusion##2##2##(2010-5#2)
Intestinal obstruction##2##2##(2012-3#1)(2013-1#1)
Intestinal##28##1##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1992-2#1)(1992-9#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#4)(2009-12#1)(2010-5#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
Intestinal-type adenocarcinoma of the##2##4##(1990-6#1)(1993-6#1)
Inthe##2##1##(2008-11#2)
Inthis article##2##2##(2008-11#2)
Inthis##3##1##(2008-11#3)
Intima-Media Thickness##2##2##(2008-11#1)(2011-1#1)
Intimal hyperplasia##3##2##(1992-9#1)(2006-6#1)(2008-1#1)
Intimal##4##1##(1992-9#1)(1995-12#1)(2006-6#1)(2008-1#1)
Intimate##3##1##(1994-5#1)(2008-12#1)(2010-11#1)
Into Practice##2##2##(1996-2#1)(2009-12#1)
Into the##5##2##(1992-2#1)(1996-2#1)(2008-10#2)(2008-4#1)
Into##11##1##(1992-2#1)(1996-2#2)(2008-10#4)(2008-2#1)(2008-4#1)(2009-12#1)(2011-2#1)
Intra operative##3##2##(2012-2#3)
Intra##6##1##(1995-3#1)(2007-9#1)(2008-5#1)(2012-2#3)
Intra- and extracellular##2##3##(1994-8#1)(1996-2#1)
Intra- and inter-assay coefficients of variation##2##6##(1990-11#1)(2010-5#1)
Intra- and##5##2##(1990-11#1)(1994-8#1)(1996-2#1)(2008-10#1)(2010-5#1)
Intra-arterial thrombolysis##3##2##(2007-10#2)(2007-9#1)
Intra-arterial##7##1##(1994-2#1)(1997-3#1)(2007-10#2)(2007-9#1)(2008-3#1)(2008-8#1)
Intra-articular##3##1##(2009-8#1)(2013-1#2)
Intra-day and inter-day##2##3##(2008-10#2)
Intra-operative##2##1##(2010-8#1)(2012-12#1)
Intracavity##13##1##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#6)
Intracellular Ca2+##2##2##(1994-6#1)(1996-2#1)
Intracellular calcium##2##2##(1994-2#1)(2008-10#1)
Intracellular distribution##2##2##(1991-11#1)(2008-11#1)
Intracellular free##2##2##(1992-6#1)(2008-9#1)
Intracellular recordings were made from##2##5##(2008-8#1)(2008-9#1)
Intracellular recordings##3##2##(1992-3#1)(2008-8#1)(2008-9#1)
Intracellular sodium##2##2##(1994-3#2)
Intracellular trafficking of##2##3##(2012-3#2)
Intracellular##52##1##(1990-5#2)(1990-8#2)(1991-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#5)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#5)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-3#2)
Intracerebral Hemorrhage##2##2##(2012-3#2)
Intracerebral hemorrhage##4##2##(2007-10#1)(2007-9#1)(2008-7#1)(2008-8#1)
Intracerebral##9##1##(2007-10#1)(2007-9#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-1#1)(2012-3#2)
Intracerebroventricular##2##1##(1990-7#1)(1995-11#1)
Intraclass correlation coefficient##2##3##(2008-12#1)(2013-1#1)
Intraclass correlation coefficients##2##3##(1993-12#1)(2010-12#1)
Intraclass correlation##6##2##(1993-12#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-1#1)
Intraclass##8##1##(1993-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)(2011-1#1)(2013-1#1)
Intracoronary##3##1##(2008-4#1)(2011-1#1)(2012-2#1)
Intracranial Aneurysms##2##2##(1995-11#1)(1997-3#1)
Intracranial pressure##2##2##(2008-7#1)(2008-9#1)
Intracranial##24##1##(1991-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(1996-6#2)(1997-3#1)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
Intractable##3##1##(1994-3#1)(1997-8#1)(2011-2#1)
Intracystic##2##1##(1992-2#1)(2011-2#1)
Intraductal breast carcinoma##2##3##(1990-12#1)(1991-8#1)
Intraductal papillary mucinous##2##3##(2012-2#1)(2012-3#1)
Intraductal##5##1##(1990-12#1)(1991-8#1)(1994-7#1)(2012-2#1)(2012-3#1)
Intradural##2##1##(2010-9#1)(2012-3#1)
Intrafix device##2##2##(2008-11#2)
Intragastric##2##1##(2008-5#2)
Intrahippocampal##3##1##(1993-12#1)(1995-12#1)(2009-12#1)
Intralesional##5##1##(2007-11#1)(2007-7#4)
Intralipid##4##1##(2008-3#4)
Intramedullary arthrodesis##2##2##(2008-8#2)
Intramedullary##10##1##(2007-11#1)(2007-8#1)(2008-7#3)(2008-8#2)(2010-5#1)(2012-3#2)
Intramolecular autophosphorylation of##2##3##(1995-2#2)
Intramolecular##11##1##(1992-6#1)(1995-2#2)(1996-2#1)(1996-5#3)(2008-10#1)(2008-8#1)(2009-5#1)(2010-6#1)
Intramuscular haemangioma of##2##3##(2010-5#2)
Intramuscular pretreatment with##2##3##(2008-4#2)
Intramuscular##8##1##(1990-12#1)(1991-8#1)(1997-8#1)(2007-11#1)(2008-4#2)(2010-5#2)
Intraocular light scatter##2##3##(2008-3#2)
Intraocular##5##1##(2008-3#2)(2011-1#2)(2013-1#1)
Intraoperative HD##2##2##(2007-8#2)
Intraoperative assessment##2##2##(2006-10#1)(2007-8#1)
Intraoperative monitoring##2##2##(2009-4#1)(2010-8#1)
Intraoperative mortality was##2##3##(2007-8#2)
Intraoperative##31##1##(1991-3#1)(1996-9#1)(2006-10#1)(2007-8#7)(2008-10#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Intraoperatively##5##1##(2007-11#1)(2008-12#2)(2010-12#1)(2011-2#1)
Intraoral##2##1##(2007-12#1)(2007-8#1)
Intraosseous##3##1##(1990-5#1)(2007-12#1)(2010-3#1)
Intrapartum##2##1##(2009-4#1)(2011-2#1)
Intraperitoneal##4##1##(1995-12#2)(2008-1#1)(2008-10#1)
Intraplatelet##2##1##(2008-7#1)(2011-1#1)
Intrapleural##2##1##(1991-6#1)(1994-6#1)
Intrapopulation##2##1##(2008-8#1)(2008-9#1)
Intraspecific variation in##3##3##(2012-2#2)(2013-7#1)
Intraspecific variation##5##2##(2008-10#1)(2008-9#1)(2012-2#2)(2013-7#1)
Intraspecific##11##1##(2008-10#6)(2008-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
Intrasporangium calvum##2##2##(2011-2#2)
Intrasporangium##4##1##(2011-2#4)
Intrastriatal##2##1##(1995-12#1)(2008-7#1)
Intrathecal administration of##2##3##(1995-12#1)(1996-12#1)
Intrathecal injection of##2##3##(2008-12#1)(2010-12#1)
Intrathecal##8##1##(1990-9#1)(1991-1#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-12#1)(2008-7#1)(2010-12#1)
Intrathoracic migration of Steinman##2##4##(2007-8#2)
Intrathoracic##5##1##(2007-8#2)(2012-2#1)(2013-1#2)
Intratumoral##2##1##(1993-9#1)(2012-3#1)
Intratumoural##2##1##(2008-7#2)
Intrauterine##6##1##(1990-9#1)(1996-5#2)(2008-9#1)(2013-1#2)
Intravascular Cooling in the Treatment of Stroke (ICTuS)##2##8##(2007-10#2)
Intravascular ultrasound##2##2##(1996-8#1)(2008-11#1)
Intravascular##8##1##(1996-6#1)(1996-8#1)(2007-10#2)(2007-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
Intravenous administration of##8##3##(1990-5#1)(1995-12#2)(1995-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-10#1)
Intravenous drug use##2##3##(2012-1#2)
Intravenous drug##4##2##(1991-1#1)(2012-1#2)(2012-2#1)
Intravenous immunoglobulin in the Guillain-Barré syndrome##2##6##(1996-11#2)
Intravenous immunoglobulin##3##2##(1994-9#1)(1996-11#2)
Intravenous injection of##2##3##(1991-5#1)(1994-11#1)
Intravenous iron##2##2##(2007-7#1)(2011-2#1)
Intravenous self-administration##2##2##(2008-4#2)
Intravenous tissue plasminogen activator##2##4##(2007-10#1)(2013-8#1)
Intravenous##40##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-11#2)(1996-12#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#3)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-8#1)
Intraventricular##3##1##(2007-10#1)(2008-7#2)
Intravesical##4##1##(1993-11#1)(2008-10#2)(2008-7#1)
Intravitreal bevacizumab##2##2##(2010-10#1)(2011-2#1)
Intravitreal##4##1##(2010-10#1)(2010-9#1)(2011-2#2)
Intriguingly##7##1##(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
Intrinsic and##2##2##(2008-11#1)(2010-10#1)
Intrinsic##12##1##(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)
Introduced##4##1##(1996-5#1)(2008-10#2)(2012-2#1)
Introducing a##4##2##(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)
Introducing the##7##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-2#1)(2013-8#1)
Introducing##27##1##(1991-5#1)(1992-12#2)(1993-3#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
Introduction and##3##2##(1995-2#1)(2012-12#1)(2013-8#1)
Introduction of a##8##3##(1990-12#1)(1994-3#1)(1995-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#1)(2013-1#1)
Introduction of pchBA into##2##4##(2008-10#2)
Introduction of the##4##3##(1992-8#1)(2007-11#1)(2008-11#1)(2012-1#1)
Introduction of##31##2##(1990-12#1)(1992-8#2)(1993-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#1)(1997-4#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-6#1)(2012-1#1)(2013-1#1)
Introduction to peptide synthesis##3##4##(2008-2#1)(2008-4#2)
Introduction to the special issue##2##5##(2008-4#1)(2013-1#1)
Introduction to the##9##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
Introduction to##25##2##(1990-12#1)(1992-1#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#7)(2008-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Introduction##158##1##(1990-12#2)(1991-12#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-11#2)(1995-2#2)(1997-4#1)(1997-6#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#12)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-6#1)(2012-1#1)(2012-12#26)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#17)(2013-8#6)
Introgression##2##1##(2008-10#1)(2008-2#1)
Introgressions##2##1##(2008-10#2)
Intron##4##1##(1991-1#1)(1996-5#1)(2008-10#1)(2008-7#1)
Introns were identified in approximately##2##5##(1997-6#1)(1997-8#1)
Inuit##6##1##(2007-12#1)(2008-4#1)(2012-3#2)(2013-1#2)
Inula helenium L##3##3##(2008-10#1)(2008-5#2)
Inula##8##1##(2008-10#6)(2008-5#2)
Invading##2##1##(2008-10#2)
Invariant##3##1##(1990-12#1)(2008-2#1)(2008-3#1)
Invasion and##4##2##(2008-10#2)(2008-11#1)(2009-5#1)
Invasion of##5##2##(2008-10#2)(2008-4#1)(2010-8#1)(2012-3#1)
Invasion##12##1##(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
Invasive fungal infections##3##3##(2008-7#2)(2011-2#1)
Invasive fungal##4##2##(2008-7#2)(2011-2#2)
Invasive pulmonary aspergillosis##2##3##(2011-2#2)
Invasive##26##1##(1991-2#1)(1991-8#1)(1992-8#1)(1995-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-6#1)(2010-7#2)(2011-2#7)(2013-1#1)
Inventory of##2##2##(2009-5#2)
Inventory##53##1##(1991-2#1)(1992-2#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-1#1)(2007-12#3)(2007-7#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#3)(2009-5#2)(2009-9#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#2)
Inventory) and##2##2##(2008-2#1)(2011-1#1)
Inventory)##3##1##(1992-1#1)(2008-2#1)(2011-1#1)
Inverse relationship between##2##3##(1994-6#1)(1997-3#1)
Inverse scattering problem##2##3##(2008-2#2)
Inverse##12##1##(1992-11#1)(1994-6#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-1#2)(2011-2#1)
Inversion##3##1##(2008-3#2)(2009-11#1)
Invertebrates such as##2##3##(2007-5#1)(2008-12#1)
Inverted##3##1##(1993-5#1)(2010-8#1)(2011-2#1)
Invest##2##1##(2008-10#1)(2008-5#1)
Investigated##3##1##(1990-2#1)(2008-12#1)(2008-7#1)
Investigating the##5##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
Investigating##17##1##(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#2)
Investigation and##3##2##(1992-3#1)(2008-10#1)(2013-8#1)
Investigation into the##4##3##(2008-10#1)(2008-7#1)(2009-1#1)(2012-2#1)
Investigation into##5##2##(2008-10#1)(2008-7#1)(2009-1#1)(2010-10#1)(2012-2#1)
Investigation of a##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
Investigation of the effects of##2##5##(1990-2#1)(2008-3#1)
Investigation of the##29##3##(1990-2#1)(1992-12#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-6#1)(2008-10#9)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
Investigation of##73##2##(1990-2#1)(1992-12#1)(1992-2#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
Investigation on the##5##3##(2008-10#2)(2008-5#1)(2008-9#1)(2013-7#1)
Investigation on##9##2##(2008-10#5)(2008-5#1)(2008-9#2)(2013-7#1)
Investigation was##4##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)
Investigation##104##1##(1990-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-6#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
Investigations into the##6##3##(1991-12#1)(2007-11#1)(2008-10#2)(2010-8#1)(2012-2#1)
Investigations into##9##2##(1991-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)(2012-2#1)
Investigations of the##2##3##(2008-10#2)
Investigations of##10##2##(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)
Investigations on the##3##3##(1994-5#1)(2007-11#1)(2008-10#1)
Investigations on##5##2##(1994-5#1)(2007-11#1)(2008-10#1)(2012-12#1)(2013-7#1)
Investigations revealed a##2##3##(2008-6#1)(2013-1#1)
Investigations revealed##4##2##(2008-11#1)(2008-6#1)(2010-9#1)(2013-1#1)
Investigations were##2##2##(2008-10#1)(2008-7#1)
Investigations##46##1##(1991-12#1)(1991-8#1)(1992-1#1)(1993-3#1)(1994-5#1)(1995-2#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#3)(2008-10#12)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
Investigators have##3##2##(1991-3#1)(1992-9#1)(2010-11#1)
Investigators##15##1##(1991-3#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-8#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#3)
Investing in##2##2##(2008-11#1)(2008-5#1)
Investment in##4##2##(1997-4#1)(2008-11#2)(2008-8#1)
Investment##5##1##(1997-4#1)(2008-11#2)(2008-8#1)(2011-2#1)
Investments##3##1##(1996-3#1)(2007-2#1)(2008-5#1)
Invited commentary##3##2##(2013-1#3)
Invited##4##1##(2008-8#1)(2013-1#3)
Involved in the Suppression of##2##5##(2008-10#2)
Involved in##5##2##(2008-10#4)(2008-6#1)
Involvement in##3##2##(1994-1#1)(2008-10#2)
Involvement of protein kinase C##2##5##(1997-1#1)(2008-11#1)
Involvement of spinal##2##3##(1991-1#1)(2008-4#1)
Involvement of the##6##3##(1990-5#1)(1994-12#1)(1995-11#1)(1996-9#1)(1997-5#1)(2010-5#1)
Involvement of##40##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
Involvement##47##1##(1990-2#2)(1990-5#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#1)
Involving patients##2##2##(2008-12#1)(2013-8#1)
Involving##8##1##(1995-9#1)(1997-1#1)(1997-7#1)(2008-12#2)(2011-1#1)(2012-1#1)(2013-8#1)
Inward##3##1##(1995-11#1)(2008-10#1)(2008-8#1)
In vitro##2##1##(2013-1#2)
Ioannina##4##1##(2008-10#4)
Iodide##4##1##(2008-10#3)(2008-3#1)
Iodine overload##2##2##(2011-1#2)
Iodine##6##1##(2011-1#3)(2012-2#1)(2012-3#2)
Iodized salt##2##2##(2007-11#2)
Iohexol##2##1##(1992-2#1)(2008-7#1)
Ion channels are##4##3##(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
Ion channels##7##2##(1995-11#1)(2008-8#2)(2009-5#2)(2012-2#1)(2012-3#1)
Ion chromatographic determination of some##2##5##(2008-10#2)
Ion chromatographic##3##2##(2008-10#3)
Ion chromatography##2##2##(2008-10#1)(2008-6#1)
Ion exchange##2##2##(2008-10#2)
Ion mobility spectrometry##2##3##(2008-10#1)(2010-9#1)
Ion mobility##4##2##(2008-10#3)(2010-9#1)
Ion##41##1##(1990-7#1)(1995-11#1)(1996-2#3)(1996-9#1)(1997-7#3)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-12#1)(2009-5#2)(2009-8#1)(2010-2#2)(2010-5#1)(2010-9#1)(2012-2#2)(2012-3#1)
Ion-assisted##2##1##(2008-3#2)
Ion-beam##2##1##(2008-3#2)
Ion-exchange##4##1##(1997-2#1)(2008-10#3)
Ion-exclusion/adsorption chromatography of dimethylsulfoxide##2##4##(2008-10#2)
Ion-pair extraction##3##2##(2008-10#3)
Ion-pair formation##2##2##(2008-10#2)
Ion-pair##6##1##(2008-10#6)
Ion-selective electrode for##2##3##(2008-10#2)
Ion-selective electrodes (ISEs)##2##3##(2008-10#2)
Ion-selective electrodes##5##2##(2008-10#5)
Ion-selective##7##1##(2008-10#7)
Ionic liquids##3##2##(2008-10#1)(2010-7#1)(2012-1#1)
Ionic##10##1##(2008-10#5)(2009-12#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#1)
Ionization of##2##2##(1990-2#1)(2008-10#1)
Ionizing radiation-induced##2##2##(1995-12#1)(2008-11#1)
Ionizing##3##1##(1995-12#1)(2008-11#1)(2010-3#1)
Ions##4##1##(1996-12#1)(1996-9#1)(2008-10#1)(2012-12#1)
Iowa Gambling Task##2##3##(2008-10#1)(2013-8#1)
Iowa State University Press##2##4##(1997-6#1)(2008-5#1)
Iowa and##2##2##(2008-10#2)
Iowa from##3##2##(1994-2#1)(2008-10#2)
Iowa##38##1##(1991-9#1)(1994-2#4)(1995-2#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#20)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
Ip##2##1##(1995-5#2)
Ip-induced fluorescence##2##2##(1995-5#2)
Ip1##4##1##(1995-5#4)
Ip2##3##1##(1995-5#3)
Ipomoea hederacea##2##2##(2008-8#2)
Ipomoea nil##3##2##(2008-10#3)
Ipomoea##10##1##(2008-10#3)(2008-8#2)(2008-9#4)(2011-2#1)
Ipomopsis aggregata##3##2##(2008-8#1)(2008-9#2)
Ipomopsis##4##1##(2008-8#2)(2008-9#2)
Ipomovirus##2##1##(2008-10#2)
Ips##3##1##(2008-10#1)(2011-2#2)
Ipsilateral##4##1##(1994-8#2)(1996-2#1)(2008-2#1)
Ir and##3##2##(2008-10#3)
Ir##17##1##(2007-12#2)(2008-10#15)
Ir(IV)##3##1##(2008-10#3)
Iralukast##2##1##(2008-5#2)
Iramba##2##1##(2010-8#2)
Iran and the United States##2##5##(2012-2#2)
Iran and##6##2##(2008-12#3)(2012-2#2)(2013-1#1)
Iran during##3##2##(2008-12#2)(2012-2#1)
Iran in 2007##2##3##(2010-8#1)(2011-2#1)
Iran##105##1##(1996-8#1)(2007-2#1)(2007-7#3)(2007-9#3)(2008-10#8)(2008-12#41)(2008-3#2)(2008-7#3)(2010-8#5)(2011-2#5)(2012-12#4)(2012-2#16)(2012-3#1)(2013-1#10)(2013-7#2)
Iran)##9##1##(2008-10#1)(2008-12#5)(2011-2#3)
Iranian Sistani cattle##2##3##(2008-12#2)
Iranian Sistani##3##2##(2008-12#3)
Iranian isolate##4##2##(2008-10#1)(2008-12#3)
Iranian maize##2##2##(2008-12#2)
Iranian manufacturers##2##2##(2008-12#2)
Iranian patients with##4##3##(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
Iranian patients##7##2##(2008-12#3)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
Iranian women##3##2##(2008-12#1)(2013-1#2)
Iranian##51##1##(2008-10#1)(2008-12#25)(2008-7#2)(2008-8#2)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#5)
Iraq and Afghanistan##2##3##(2013-1#2)
Iraq and##6##2##(1992-6#2)(2007-7#1)(2008-12#1)(2013-1#2)
Iraq##9##1##(1992-6#2)(2007-7#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#2)
Iraqi##7##1##(1992-6#2)(2007-10#1)(2008-4#1)(2011-2#1)(2013-1#2)
Ireland and##2##2##(1997-4#1)(2008-7#1)
Ireland##27##1##(1993-2#2)(1997-4#1)(1997-8#2)(2008-10#3)(2008-11#6)(2008-12#1)(2008-7#1)(2008-9#2)(2009-5#2)(2010-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
Irgarol 1051 and##4##3##(2008-10#4)
Irgarol 1051##5##2##(2008-10#4)(2008-11#1)
Iridium##4##1##(1993-9#1)(2008-10#3)
Irinotecan##4##1##(2008-7#1)(2008-8#1)(2010-8#2)
Iris yellow spot virus##3##4##(2008-10#3)
Iris##6##1##(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
Irish perspective##2##2##(2008-11#2)
Irish population##2##2##(1991-12#2)
Irish##16##1##(1991-11#1)(1991-12#3)(1997-8#1)(2008-10#2)(2008-11#4)(2008-12#2)(2009-7#1)(2012-2#1)(2013-8#1)
Iron and copper##2##3##(2008-10#2)
Iron and##6##2##(1995-3#1)(2008-10#4)(2008-6#1)
Iron deficiency##2##2##(2008-1#1)(2012-2#1)
Iron is an##2##3##(1993-11#1)(2008-10#1)
Iron is##4##2##(1993-11#1)(2008-10#2)(2013-8#1)
Iron programs##2##2##(2007-11#2)
Iron was##3##2##(1996-5#1)(2008-10#2)
Iron##43##1##(1993-11#1)(1993-2#1)(1994-5#1)(1995-3#2)(1996-5#2)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
Iron(II)##2##1##(2008-10#1)(2008-5#1)
Iron(III) and##2##2##(1997-7#1)(2008-10#1)
Iron(III) in##2##2##(1997-7#1)(2008-10#1)
Iron(III) was##2##2##(2008-10#2)
Iron(III)##12##1##(1997-7#4)(2008-10#8)
Irradiance##3##1##(2008-2#1)(2008-3#2)
Irradiated males##2##2##(2012-12#2)
Irradiated##7##1##(1993-9#1)(1995-8#1)(1996-9#1)(2008-11#1)(2008-2#1)(2012-12#2)
Irradiation of the##3##3##(1990-10#1)(1993-11#1)(1995-6#1)
Irradiation of##7##2##(1990-10#1)(1992-5#1)(1993-11#1)(1995-6#1)(1996-5#1)(2007-11#1)(2012-2#1)
Irradiation##16##1##(1990-10#1)(1992-5#1)(1993-11#1)(1995-6#3)(1996-5#1)(2007-11#1)(2008-11#2)(2008-2#3)(2008-5#1)(2012-2#2)
Irrational##2##1##(2010-5#2)
Irrespective of the##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
Irrespective of##10##2##(1993-2#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-8#1)
Irreversible formation of##2##3##(1992-4#2)
Irreversible##3##1##(1992-4#2)(2008-8#1)
Irrigation Water##3##2##(2008-10#3)
Irrigation of##3##2##(1994-5#1)(2008-10#1)(2012-3#1)
Irrigation##12##1##(1994-5#1)(2008-10#9)(2008-12#1)(2012-3#1)
Irritable Bowel Syndrome##3##3##(2013-1#2)(2013-7#1)
Irritable bowel##2##2##(2008-9#1)(2013-1#1)
Irritable##5##1##(2008-9#1)(2013-1#3)(2013-7#1)
Irritation at the site of application occurred in all dosed##2##10##(2008-9#2)
Irritation at the site of application occurred in##5##8##(2008-9#5)
Irritation at the site of application##6##6##(2008-9#6)
Irritation was##2##2##(2008-5#2)
Irritation##11##1##(2008-5#5)(2008-9#6)
Irving##2##1##(1992-8#1)(1997-2#1)
Irwin##2##1##(2008-12#1)(2008-6#1)
Is Affected by##2##3##(2008-10#2)
Is Associated with a##2##4##(2008-10#2)
Is Associated with##6##3##(2008-10#5)(2012-12#1)
Is Associated##7##2##(2008-10#5)(2012-12#1)(2013-7#1)
Is Caused by##2##3##(2008-10#2)
Is Characterized by##2##3##(2008-10#1)(2013-1#1)
Is It##3##2##(2011-2#2)(2012-3#1)
Is Mediated by##2##3##(2008-10#1)(2011-2#1)
Is Not##4##2##(2007-12#1)(2008-10#3)
Is There##3##2##(1996-9#1)(2012-2#1)(2013-1#1)
Is a Distinct##3##3##(2008-10#3)
Is a Mass Prevention and Control Program for Pandemic (H1N1) 2009 Good Value for Money? Evidence from the Chinese Experience##2##20##(2013-1#2)
Is a Novel##2##3##(2008-10#2)
Is a##21##2##(1995-12#2)(2008-10#10)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
Is an##2##2##(2008-3#1)(2012-3#1)
Is bigger really better?##2##4##(1994-3#2)
Is breast cancer##2##3##(1991-12#1)(1994-3#1)
Is it a##2##3##(1993-11#1)(2012-2#1)
Is it just a little poke?##2##6##(2008-11#2)
Is it necessary for##2##4##(1991-1#1)(1992-2#1)
Is it possible to##5##4##(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
Is it##30##2##(1991-1#1)(1991-3#1)(1992-2#1)(1993-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
Is laser surgery superior to cryosurgery for the treatment of high grade CIN?##2##13##(1992-1#2)
Is montelukast effective and well tolerated in the management of asthma in young children?##2##14##(2008-11#2)
Is the##22##2##(1991-11#1)(1991-2#1)(1992-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(2007-8#2)(2008-10#3)(2008-5#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)
Is there a case for##2##5##(2008-7#1)(2008-9#1)
Is there a doctor in the house? (There could be another one##2##12##(2009-3#2)
Is there a place for##2##5##(1995-1#1)(2008-11#1)
Is there a relationship between##2##5##(1992-2#1)(2012-2#1)
Is there a role for##6##5##(1994-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)
Is there a##29##3##(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-8#2)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
Is there an##4##3##(2007-11#1)(2008-10#2)(2009-10#1)
Is there any##3##3##(1994-1#1)(2007-2#1)(2008-7#1)
Is there##41##2##(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-8#2)(1995-1#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
Is this##4##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
Is your##3##2##(1995-12#1)(1996-3#1)(2007-9#1)
Is##262##1##(1990-3#1)(1990-5#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#3)(1995-5#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-9#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#56)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-5#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#15)(2012-1#2)(2012-12#7)(2012-2#12)(2012-3#8)(2013-1#12)(2013-7#5)(2013-8#1)
Isa1##2##1##(2008-7#2)
Isabella volatiles##3##2##(2008-10#3)
Isabella##5##1##(2008-10#5)
Isatis##2##1##(2012-3#1)(2013-8#1)
Isc##5##1##(2008-1#3)(2008-5#2)
Iscador##5##1##(1997-6#1)(2008-10#4)
Ischaemic stroke##2##2##(2012-2#1)(2013-1#1)
Ischaemic##7##1##(1990-6#1)(1997-5#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)
Ischemia was##2##2##(1994-11#1)(1996-12#1)
Ischemia##8##1##(1992-9#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-6#1)(2009-12#1)(2012-3#1)(2013-1#1)
Ischemic Damage##2##2##(2008-11#1)(2012-3#1)
Ischemic Heart Disease##3##3##(2008-1#1)(2013-1#2)
Ischemic brain##2##2##(1993-6#1)(2008-2#1)
Ischemic preconditioning##2##2##(1996-9#1)(2007-8#1)
Ischemic stroke in##2##3##(2007-10#2)
Ischemic stroke##5##2##(2007-10#3)(2012-1#1)(2012-3#1)
Ischemic##25##1##(1992-5#1)(1993-6#2)(1996-9#1)(2007-10#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-6#1)(2012-1#1)(2012-3#2)(2013-1#4)
Isfahan##12##1##(2008-10#1)(2008-12#5)(2010-8#3)(2012-12#3)
Ishikawa##3##1##(1992-4#1)(1994-9#2)
Ishikawa's criteria##3##2##(1997-8#3)
Ising model##2##2##(1992-11#1)(1993-5#1)
Ising##4##1##(1991-9#1)(1992-11#1)(1993-5#1)(2008-3#1)
Isla##3##1##(2008-5#2)(2011-2#1)
Islam##3##1##(2008-12#2)(2012-2#1)
Islamabad##5##1##(2009-7#1)(2012-2#1)(2013-7#3)
Islamic Republic of##2##3##(2008-12#2)
Islamic##4##1##(2008-12#3)(2008-3#1)
Island and##2##2##(2011-1#1)(2012-3#1)
Island of New Zealand##2##4##(2008-12#1)(2011-1#1)
Island of##7##2##(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#3)(2013-8#1)
Island were##2##2##(2008-5#1)(2012-3#1)
Island##77##1##(1990-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-2#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-6#2)(2008-1#6)(2008-10#12)(2008-12#2)(2008-3#3)(2008-5#10)(2008-8#4)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#4)(2012-3#5)(2013-8#3)
Islander##5##1##(1997-2#2)(2008-8#1)(2012-2#2)
Islanders##5##1##(1996-3#1)(2008-1#1)(2012-12#1)(2012-2#2)
Islands of##4##2##(1992-2#2)(2008-1#1)(2008-9#1)
Islands##71##1##(1992-2#2)(1992-6#1)(1994-9#3)(1996-4#1)(2007-5#2)(2008-1#21)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#7)(2011-4#1)(2012-12#6)(2012-3#1)(2013-8#19)
Islet amyloid polypeptide##2##3##(1992-6#1)(1994-8#1)
Islet cell antibodies (ICA)##2##4##(1994-12#2)
Islet cell##5##2##(1994-12#2)(2008-1#1)(2010-10#1)(2013-1#1)
Islet transplantation##2##2##(2010-10#1)(2010-12#1)
Islet##12##1##(1992-6#1)(1994-12#2)(1994-8#2)(2008-1#2)(2008-11#1)(2010-10#2)(2010-12#1)(2013-1#1)
Islets##2##1##(2009-3#1)(2010-11#1)
Isoarecolone##2##1##(1995-5#2)
Isochrones##2##1##(2008-7#2)
Isocratic##2##1##(1996-5#1)(2008-10#1)
Isocyanates##2##1##(1996-5#2)
Isodon##2##1##(2007-1#1)(2013-8#1)
Isoelectric focusing (IEF)##2##3##(1990-12#1)(2008-11#1)
Isoelectric focusing##3##2##(1990-12#1)(1991-12#1)(2008-11#1)
Isoenzymes of##2##2##(1991-5#1)(1992-11#1)
Isoflavonoids##2##1##(2011-1#2)
Isoflurane##3##1##(2010-7#1)(2012-3#2)
Isolate CS-1##2##2##(2008-10#2)
Isolate CS-20##2##2##(2008-10#2)
Isolate of##6##2##(2008-10#6)
Isolate##28##1##(2008-10#27)(2008-11#1)
Isolate-Specific##2##1##(2008-10#2)
Isolated cerebral##2##2##(2008-12#2)
Isolated dissection of##2##3##(2013-1#2)
Isolated fibroblast-like cells were cultured in the presence of osteogenic factors and differentiation determined by Alizarin Red S staining##2##19##(2008-11#2)
Isolated from##17##2##(2008-10#14)(2008-12#1)(2010-5#1)(2013-8#1)
Isolated rat##2##2##(1993-11#1)(1996-9#1)
Isolated##66##1##(1990-5#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-8#1)(1996-12#2)(1996-9#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#15)(2008-11#3)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
Isolates Causing##2##2##(2008-10#2)
Isolates Collected from Potato##2##4##(2008-10#2)
Isolates Collected from##3##3##(2008-10#3)
Isolates and##2##2##(2008-10#2)
Isolates derived from parent##2##4##(2008-10#2)
Isolates derived from##3##3##(2008-10#3)
Isolates from Wheat##3##3##(2008-10#3)
Isolates from a##2##3##(2008-10#2)
Isolates from all##2##3##(2008-10#2)
Isolates from the##6##3##(2008-10#6)
Isolates from these##2##3##(2008-10#2)
Isolates from##40##2##(1992-8#1)(2008-10#38)(2011-2#1)
Isolates in the##2##3##(2008-10#1)(2012-2#1)
Isolates in##8##2##(2008-10#7)(2012-2#1)
Isolates obtained from##2##3##(2008-10#2)
Isolates obtained##3##2##(2008-10#3)
Isolates of Bean pod mottle virus##2##6##(2008-10#2)
Isolates of Botrytis cinerea##3##4##(2008-10#3)
Isolates of C##7##3##(2008-10#7)
Isolates of Colletotrichum lindemuthianum##2##4##(2008-10#2)
Isolates of Colletotrichum spp##3##4##(2008-10#3)
Isolates of Colletotrichum##6##3##(2008-10#6)
Isolates of F##3##3##(2008-10#3)
Isolates of Fusarium##2##3##(2008-10#2)
Isolates of Magnaporthe##2##3##(2008-10#2)
Isolates of P##6##3##(2008-10#6)
Isolates of Phytophthora infestans##2##4##(2008-10#2)
Isolates of Phytophthora##3##3##(2008-10#3)
Isolates of Puccinia##4##3##(2008-10#4)
Isolates of Rhizoctonia solani##3##4##(2008-10#3)
Isolates of Rhizoctonia##4##3##(2008-10#4)
Isolates of S##2##3##(2008-10#2)
Isolates of Venturia inaequalis##2##4##(2008-10#2)
Isolates of Verticillium dahliae Pathogenic##2##5##(2008-10#2)
Isolates of Verticillium##3##3##(2008-10#3)
Isolates of a##2##3##(2008-10#2)
Isolates of the##7##3##(2008-10#7)
Isolates of##87##2##(2008-10#85)(2009-6#1)(2011-2#1)
Isolates resistant to##2##3##(2008-10#1)(2008-5#1)
Isolates resistant##3##2##(2008-10#2)(2008-5#1)
Isolates that were##3##3##(2008-10#3)
Isolates that##6##2##(2008-10#6)
Isolates were characterized##2##3##(2008-10#2)
Isolates were found to##2##4##(2008-10#2)
Isolates were identified##2##3##(2008-10#1)(2012-3#1)
Isolates were sampled in##3##4##(2008-10#3)
Isolates were scored for##2##4##(2008-10#2)
Isolates were##20##2##(2008-10#19)(2012-3#1)
Isolates with##5##2##(2008-10#5)
Isolates##213##1##(1992-8#1)(2007-12#1)(2008-10#201)(2008-5#2)(2009-6#1)(2011-2#2)(2012-2#3)(2012-3#2)
Isolating##3##1##(2008-10#1)(2008-11#1)(2012-1#1)
Isolation and Characterization of a##2##5##(2008-10#2)
Isolation and Characterization of##8##4##(2008-10#5)(2008-11#1)(2010-2#1)(2013-8#1)
Isolation and analysis of a##2##5##(1991-6#1)(1996-10#1)
Isolation and analysis of##5##4##(1990-7#1)(1991-6#1)(1996-10#1)(2008-10#1)(2008-9#1)
Isolation and characterization of a human##2##6##(1993-11#1)(2008-8#1)
Isolation and characterization of a##12##5##(1990-12#1)(1990-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-6#1)(1996-6#1)(1997-2#2)(1997-4#1)(2008-8#2)
Isolation and characterization of cDNAs encoding##2##6##(1991-6#1)(1992-12#1)
Isolation and characterization of##30##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-2#2)(1997-4#2)(2008-10#1)(2008-8#3)(2011-1#1)(2013-1#1)
Isolation and expression##2##3##(1993-9#1)(2010-5#1)
Isolation and functional analysis of##2##5##(2008-4#1)(2008-9#1)
Isolation and functional##4##3##(1994-11#1)(2008-4#2)(2008-9#1)
Isolation and genetic##2##3##(1996-12#1)(2012-2#1)
Isolation and identification of a##2##5##(1991-12#1)(2012-2#1)
Isolation and identification of##6##4##(1990-12#1)(1990-8#1)(1991-12#1)(2007-7#1)(2008-5#1)(2012-2#1)
Isolation and purification of##2##4##(2008-11#1)(2008-2#1)
Isolation and sequence analysis of##2##5##(1990-5#1)(1990-8#1)
Isolation and structural characterization of##2##5##(1993-8#1)(2008-10#1)
Isolation and structure##2##3##(1992-3#1)(2007-11#1)
Isolation and##85##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#4)(1990-8#3)(1991-12#1)(1991-6#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-6#1)(1995-11#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#2)(2007-11#2)(2007-7#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-4#5)(2008-5#1)(2008-8#6)(2008-9#3)(2009-10#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Isolation of a##11##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(1997-7#2)(2008-5#1)(2008-8#1)(2012-2#1)
Isolation of human##7##3##(1995-12#1)(2008-4#4)(2008-9#2)
Isolation of mesenchymal stem cells from##2##6##(2008-9#2)
Isolation of mononuclear cells from##2##5##(2008-4#1)(2008-9#1)
Isolation of progenitor cells from cord blood using adhesion matrices##2##10##(2008-11#2)
Isolation of the##6##3##(1993-12#1)(1993-2#1)(2008-4#1)(2008-5#2)(2010-2#1)
Isolation of##83##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-5#2)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-7#2)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#14)(2008-5#7)(2008-8#2)(2008-9#9)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)
Isolation##185##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-7#5)(1990-8#3)(1991-12#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#2)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-2#1)(2007-7#3)(2008-1#4)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#2)(2008-4#19)(2008-5#8)(2008-6#1)(2008-8#9)(2008-9#12)(2009-10#1)(2009-2#1)(2010-2#5)(2010-5#2)(2011-1#2)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
Isolator##2##1##(1990-9#1)(2008-3#1)
Isolators##2##1##(2012-2#2)
Isomers of##2##2##(1996-2#1)(2010-2#1)
Isometric##4##1##(1995-12#1)(2007-10#1)(2008-10#1)(2012-2#1)
Isoniazid##3##1##(1995-2#1)(2008-7#2)
Isophya stysi##2##2##(2013-8#2)
Isophya##18##1##(2013-8#18)
Isopoda##2##1##(2007-12#1)(2008-7#1)
Isoprenoid##2##1##(1990-12#1)(2012-2#1)
Isoprocarb##2##1##(2008-10#2)
Isoproterenol increased##2##2##(2008-11#1)(2011-2#1)
Isoproterenol##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
Isospora and S##2##3##(2007-7#2)
Isospora##5##1##(1996-12#2)(2007-7#2)(2011-1#1)
Isothiocyanates##3##1##(1996-5#1)(2008-10#2)
Isotonic##3##1##(2008-10#1)(2010-2#1)(2011-1#1)
Isotope##6##1##(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#1)
Isotopic##5##1##(1991-5#1)(1997-5#1)(2008-1#1)(2008-10#1)(2010-3#1)
Isotopically##2##1##(1992-11#1)(2009-7#1)
Isotretinoin##2##1##(1996-8#2)
Isovalerylcarnitine##2##1##(1990-2#2)
Isovolemic hemodilution with##2##3##(1997-6#2)
Isozyme Q2##3##2##(1993-6#3)
Isozyme##7##1##(1993-6#3)(2008-10#4)
Isozymes##2##1##(2008-10#1)(2011-2#1)
Israel and the United States##2##5##(2008-10#1)(2008-5#1)
Israel and##11##2##(2008-1#1)(2008-10#5)(2008-5#1)(2009-2#3)(2011-2#1)
Israel are##2##2##(2008-10#1)(2008-11#1)
Israel during##2##2##(2008-10#2)
Israel were##2##2##(2008-10#2)
Israel##79##1##(1993-12#1)(1996-2#2)(1997-1#1)(1997-8#2)(2007-10#1)(2008-1#3)(2008-10#49)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#4)(2011-2#7)(2013-8#1)
Israeli Arabs##3##2##(2008-1#3)
Israeli and##2##2##(2008-10#2)
Israeli isolates##2##2##(2008-10#2)
Israeli population##2##2##(2008-1#1)(2008-10#1)
Israeli##33##1##(1997-8#4)(2007-2#1)(2008-1#9)(2008-10#13)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#2)(2013-1#1)
Issue##7##1##(2008-11#3)(2008-12#1)(2008-3#1)(2011-2#1)(2012-1#1)
Issues and challenges for##3##4##(2012-12#3)
Issues and challenges##4##3##(1992-12#1)(2012-12#3)
Issues and##7##2##(1992-12#1)(1995-5#1)(2008-12#1)(2012-12#3)(2012-3#1)
Issues are raised##2##3##(1992-3#1)(1995-2#1)
Issues in the##2##3##(1996-3#1)(2007-12#1)
Issues in##13##2##(1991-1#1)(1992-2#1)(1992-3#1)(1994-1#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-9#1)(2007-12#1)(2008-11#1)(2008-6#1)
Issues of##2##2##(1992-12#1)(2008-7#1)
Issues related to the##2##4##(1994-12#1)(2008-2#1)
Issues related to##4##3##(1994-12#1)(1996-6#1)(2008-2#1)(2009-6#1)
Issues relating to##2##3##(1990-11#1)(2008-4#1)
Issues such as##5##3##(1995-3#1)(2008-10#2)(2008-2#1)(2011-2#1)
Issues that##2##2##(2008-11#1)(2012-2#1)
Issues##52##1##(1990-11#1)(1991-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1994-1#2)(1994-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(2007-10#1)(2007-12#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
Istituto Nazionale##6##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2008-4#1)(2011-2#1)
Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise 'G##2##8##(2010-4#2)
Istituto##12##1##(1990-12#1)(1991-12#2)(1991-4#1)(1991-6#1)(2008-10#1)(2008-4#2)(2010-3#1)(2010-4#2)(2011-2#1)
It accounts for##5##3##(2008-1#2)(2008-7#1)(2012-12#1)(2012-2#1)
It activates##2##2##(1997-7#1)(2008-9#1)
It addresses the issue of##2##5##(2008-7#1)(2008-9#1)
It addresses the##3##3##(2008-12#1)(2008-7#1)(2008-9#1)
It addresses##7##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)
It affects the##2##3##(1997-1#1)(2008-12#1)
It affects##8##2##(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2012-3#1)
It aimed to##2##3##(2008-1#1)(2008-11#1)
It aims to##2##3##(2008-7#2)
It allows for the##2##4##(2007-11#1)(2008-3#1)
It allows for##4##3##(2007-11#1)(2008-3#1)(2013-1#2)
It allows the##2##3##(2008-10#1)(2008-4#1)
It allows to##2##3##(2007-11#1)(2008-10#1)
It allows##15##2##(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2010-12#1)(2013-1#2)
It also allows##5##3##(1994-2#1)(1996-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
It also considers##5##3##(1996-2#1)(2008-11#2)(2008-8#1)(2010-12#1)
It also contains##4##3##(1991-3#1)(1993-12#1)(1994-8#1)(2007-11#1)
It also demonstrates that##3##4##(2008-3#1)(2010-2#1)(2013-1#1)
It also demonstrates##4##3##(1995-12#1)(2008-3#1)(2010-2#1)(2013-1#1)
It also describes the##4##4##(1990-6#1)(2008-11#1)(2008-7#1)(2010-3#1)
It also describes##5##3##(1990-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
It also discusses##6##3##(1991-12#1)(1996-9#1)(2008-1#2)(2008-4#2)
It also gave##2##3##(2008-10#1)(2010-2#1)
It also has##3##3##(2008-5#1)(2008-6#1)(2009-3#1)
It also identifies##2##3##(2008-9#1)(2011-2#1)
It also illustrates##2##3##(2007-2#1)(2008-6#1)
It also includes a##2##4##(1996-3#1)(2008-2#1)
It also may##2##3##(1992-8#1)(2008-9#1)
It also offers##2##3##(2007-12#1)(2008-4#1)
It also presents##5##3##(1991-3#1)(1996-1#1)(2008-12#1)(2008-2#1)(2010-11#1)
It also produces##2##3##(2008-10#1)(2008-7#1)
It also provides a##6##4##(1993-12#1)(1993-3#1)(1996-2#1)(2007-11#2)(2008-8#1)
It also provides an##2##4##(2008-4#1)(2008-9#1)
It also provides##13##3##(1993-12#1)(1993-3#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2013-8#1)
It also reviews the##2##4##(1991-2#1)(2008-2#1)
It also reviews##3##3##(1991-2#1)(2008-2#1)(2013-1#1)
It also showed that the##2##5##(2008-8#1)(2011-2#1)
It also showed that##3##4##(1990-12#1)(2008-8#1)(2011-2#1)
It also showed##6##3##(1990-12#1)(1992-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
It also shows a##2##4##(1997-4#1)(2008-3#1)
It also shows that##2##4##(2010-7#1)(2011-2#1)
It also shows##5##3##(1997-4#1)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#1)
It also suggests that the##2##5##(2008-10#1)(2009-11#1)
It also suggests that##3##4##(2008-10#1)(2009-11#1)(2011-2#1)
It also suggests##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#1)
It also takes into##2##4##(2008-2#1)(2008-4#1)
It also tells##3##3##(1994-6#2)(2008-7#1)
It also will##2##3##(2008-10#1)(2008-9#1)
It also##148##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#4)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-4#1)(2007-11#5)(2007-12#3)(2007-2#1)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#9)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-7#1)(2011-2#8)(2012-2#3)(2013-1#8)(2013-8#1)
It analyzes##2##2##(2009-10#1)(2010-8#1)
It appeared that the##4##4##(2008-10#2)(2008-5#1)(2012-3#1)
It appeared to be##2##4##(1993-12#1)(2008-11#1)
It appeared##11##2##(1991-3#1)(1993-12#2)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
It appears that the##8##4##(1991-6#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
It appears that this##2##4##(2010-8#1)(2012-2#1)
It appears that##30##3##(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
It appears to be a##2##5##(2008-10#1)(2010-7#1)
It appears##38##2##(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
It applies##2##2##(2008-3#1)(2010-8#1)
It argues that##3##3##(1995-1#1)(2008-1#1)(2008-7#1)
It assesses##2##2##(2008-11#1)(2012-2#1)
It avoids the##2##3##(2010-12#1)(2012-3#1)
It avoids##3##2##(1993-3#1)(2010-12#1)(2012-3#1)
It bases##2##2##(1994-2#1)(2008-10#1)
It became##5##2##(1991-1#1)(1991-12#1)(1996-9#1)(2008-11#1)(2008-5#1)
It becomes##4##2##(1997-8#1)(2007-7#1)(2008-11#1)(2008-7#1)
It begins by##3##3##(2008-11#2)(2009-9#1)
It begins##4##2##(2008-11#2)(2008-12#1)(2009-9#1)
It binds##2##2##(2008-6#1)(2012-2#1)
It brings##2##2##(2008-9#2)
It can also be used as##2##6##(2008-10#1)(2008-7#1)
It can also be used to##3##6##(2008-3#2)(2008-4#1)
It can also be used##6##5##(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)
It can also be##11##4##(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2010-7#1)
It can also##16##3##(2008-10#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#2)(2010-7#1)
It can be clearly##2##4##(1991-2#1)(2008-3#1)
It can be concluded that##6##5##(1994-8#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-3#1)
It can be concluded##7##4##(1994-8#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-3#1)(2013-1#1)
It can be easily##3##4##(1994-11#1)(2012-3#1)(2013-7#1)
It can be said that##2##5##(1990-2#1)(2011-2#1)
It can be used as##2##5##(1992-5#1)(2013-8#1)
It can be used for##2##5##(2007-8#1)(2008-4#1)
It can be used to##4##5##(2008-11#1)(2008-4#1)(2009-7#1)(2010-7#1)
It can be used##14##4##(1992-5#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-7#1)(2010-7#1)(2013-8#1)
It can be##62##3##(1990-2#1)(1991-2#1)(1992-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
It can occur in##2##4##(2008-12#1)(2011-2#1)
It can occur##3##3##(2007-5#1)(2008-12#1)(2011-2#1)
It can provide##2##3##(2008-10#1)(2008-4#1)
It can##105##2##(1990-2#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
It causes a##2##3##(2007-12#1)(2008-10#1)
It causes##6##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
It combines a##2##3##(2007-12#1)(2008-3#1)
It combines the##3##3##(2008-3#3)
It combines##7##2##(2007-12#1)(2008-10#1)(2008-3#4)(2011-2#1)
It compares the##2##3##(1995-1#1)(2009-5#1)
It compares##4##2##(1995-1#1)(2008-10#1)(2008-9#1)(2009-5#1)
It comprised##2##2##(1991-9#1)(2008-10#1)
It concerns##2##2##(1990-12#1)(2008-10#1)
It concludes by##2##3##(1996-12#1)(1997-3#1)
It concludes that##3##3##(1996-12#1)(2011-1#1)(2013-8#1)
It concludes with a discussion of##2##6##(2008-9#1)(2012-2#1)
It concludes with##6##3##(1996-3#1)(1996-9#1)(1997-2#1)(2008-9#1)(2009-3#1)(2012-2#1)
It concludes##11##2##(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
It considers##2##2##(2008-8#1)(2009-4#1)
It consisted of##3##3##(1997-6#1)(2008-5#1)(2012-3#1)
It consists in the##2##4##(1992-8#1)(2008-10#1)
It consists in##3##3##(1992-8#1)(1994-5#1)(2008-10#1)
It consists of a##11##4##(1994-2#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)
It consists of four##2##4##(1993-2#1)(2008-3#1)
It consists of##25##3##(1990-12#1)(1990-2#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
It consists##28##2##(1990-12#1)(1990-2#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
It contains an##2##3##(1994-12#1)(1997-7#1)
It contains##12##2##(1991-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-8#1)
It contributes to##2##3##(2008-1#1)(2008-7#1)
It contributes##3##2##(2008-1#1)(2008-11#1)(2008-7#1)
It could be inferred that##2##5##(2008-8#1)(2010-6#1)
It could be shown that##2##5##(1997-1#1)(2008-5#1)
It could be shown##4##4##(1997-1#2)(2008-10#1)(2008-5#1)
It could be used for##2##5##(2008-10#1)(2011-2#1)
It could be used##4##4##(2008-10#3)(2011-2#1)
It could be##13##3##(1990-2#1)(1997-1#2)(2008-10#5)(2008-5#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#1)
It could detect##2##3##(2008-10#2)
It could##20##2##(1990-2#1)(1991-6#1)(1995-6#1)(1997-1#2)(2008-10#8)(2008-5#1)(2008-8#2)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
It covers##5##2##(1994-3#1)(2008-11#1)(2008-2#1)(2008-9#2)
It crystallizes in the##2##4##(1997-7#1)(2013-1#1)
It defines##2##2##(2008-2#1)(2008-4#1)
It demonstrated##2##2##(2008-9#1)(2013-1#1)
It demonstrates how##2##3##(1995-1#1)(2007-8#1)
It demonstrates that##2##3##(2008-9#1)(2010-4#1)
It demonstrates##5##2##(1995-1#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-4#1)
It describes the##9##3##(1990-2#1)(1994-12#1)(2008-1#1)(2008-9#2)(2009-10#2)(2012-12#1)(2012-3#1)
It describes##15##2##(1990-2#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-4#3)(2008-9#2)(2009-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
It did not##3##3##(1995-6#1)(2008-10#2)
It did##4##2##(1992-6#1)(1995-6#1)(2008-10#2)
It differs from H##2##4##(2013-7#2)
It differs from##6##3##(2008-5#3)(2010-6#1)(2013-7#2)
It discusses selecting the solid support and common coupling reagents##2##10##(2008-4#2)
It discusses the##6##3##(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2008-6#1)(2011-2#1)
It discusses##13##2##(1992-2#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-12#1)(2011-2#1)
It does not interfere with the coupling reaction and leads to very good coupling yields under DNA-coupling conditions##2##18##(2008-4#2)
It does not necessarily##2##4##(1997-6#1)(2008-4#1)
It does not##13##3##(1991-3#1)(1992-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#2)(2008-3#1)(2008-4#3)(2008-5#1)
It does##15##2##(1991-3#1)(1992-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)
It employs##2##2##(2007-5#1)(2010-8#1)
It enables##5##2##(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)
It encodes a protein of##2##5##(1997-7#1)(2008-10#1)
It encodes a protein##3##4##(1997-7#1)(2007-7#1)(2008-10#1)
It encodes a##5##3##(1993-9#1)(1994-9#1)(1997-7#1)(2007-7#1)(2008-10#1)
It exhibits##5##2##(1993-3#1)(2008-10#3)(2008-11#1)
It exists in##2##3##(1990-6#1)(2012-3#1)
It exists##3##2##(1990-6#1)(2008-4#1)(2012-3#1)
It exploits##2##2##(1990-11#1)(2007-12#1)
It explores the##2##3##(2008-11#1)(2013-8#1)
It explores##3##2##(2008-11#1)(2013-8#2)
It facilitates##2##2##(2008-10#1)(2010-10#1)
It focuses##2##2##(1997-3#1)(2009-5#1)
It follows that##3##3##(1994-5#1)(1997-1#1)(2009-11#1)
It follows##5##2##(1992-2#1)(1994-5#1)(1997-1#1)(2008-10#1)(2009-11#1)
It further##11##2##(1994-12#1)(1996-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
It gave##2##2##(2007-8#1)(2008-10#1)
It generally##2##2##(2008-10#1)(2008-7#1)
It generates##3##2##(1995-2#1)(2008-2#1)(2008-5#1)
It gives##4##2##(1994-12#1)(1994-3#1)(2008-10#1)(2012-2#1)
It had a##5##3##(2007-8#1)(2008-10#3)(2013-1#1)
It had been applied to the determination of##2##8##(2008-10#2)
It had been applied to the##3##6##(2008-10#3)
It had been##6##3##(1997-4#1)(2008-10#3)(2008-5#1)(2012-3#1)
It had no effect on##2##5##(1993-5#1)(2008-4#1)
It had##16##2##(1992-12#1)(1993-5#1)(1997-4#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
It has a fast response time of &lt##3##8##(2008-10#3)
It has a fast response time of about 10 s and##2##11##(2008-10#2)
It has a fast response time of##6##7##(2008-10#6)
It has a rapid##2##4##(2008-10#2)
It has a response time of &lt##3##7##(2008-10#3)
It has a response time of##4##6##(2008-10#4)
It has a significant impact on##2##6##(2009-8#1)(2011-2#1)
It has a##25##3##(1996-2#1)(1997-2#1)(2008-10#13)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)
It has already##2##3##(2008-3#1)(2013-8#1)
It has also become##2##4##(2008-1#1)(2011-1#1)
It has also been found##2##5##(2008-10#1)(2008-12#1)
It has also been shown that##5##6##(1994-2#1)(1994-8#1)(2008-3#1)(2008-7#2)
It has also been##12##4##(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)
It has also##16##3##(1994-2#1)(1994-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)
It has an##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
It has become a##2##4##(2009-9#1)(2012-2#1)
It has become an important##2##5##(1997-4#1)(2008-9#1)
It has become apparent that##2##5##(2008-4#1)(2008-9#1)
It has become##8##3##(1997-4#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-9#1)(2012-2#1)(2013-8#1)
It has been a##2##4##(2012-12#1)(2012-2#1)
It has been also found that##2##6##(2008-10#2)
It has been also##3##4##(2008-10#2)(2008-5#1)
It has been applied to##2##5##(2008-10#2)
It has been assumed that##2##5##(2008-11#1)(2008-2#1)
It has been concluded that##2##5##(1990-9#1)(2008-10#1)
It has been confirmed that##4##5##(1995-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
It has been demonstrated that the##2##6##(2008-11#1)(2008-12#1)
It has been demonstrated that##15##5##(1992-8#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2013-1#1)
It has been demonstrated##17##4##(1992-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2013-1#1)
It has been described##2##4##(2008-12#1)(2008-5#1)
It has been developed##3##4##(1994-2#1)(2008-10#1)(2013-1#1)
It has been established that##5##5##(1990-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
It has been established##6##4##(1990-5#1)(1995-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
It has been estimated that##4##5##(1994-2#1)(2007-2#1)(2008-11#1)(2009-5#1)
It has been found that the##5##6##(2007-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
It has been found that##10##5##(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#2)(2010-4#1)(2013-8#1)
It has been found##12##4##(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#2)(2010-4#1)(2013-8#1)
It has been hypothesized that##4##5##(2008-2#1)(2009-8#1)(2010-5#1)(2011-3#1)
It has been known for##2##5##(2008-2#1)(2012-1#1)
It has been known##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2012-1#1)
It has been linked to##2##5##(2008-7#1)(2011-2#1)
It has been observed that the##2##6##(2008-10#2)
It has been observed that##3##5##(2008-10#3)
It has been postulated that##5##5##(1990-5#1)(1991-2#1)(1994-5#1)(1996-3#1)(2008-10#1)
It has been postulated##6##4##(1990-5#1)(1991-2#1)(1994-5#1)(1996-3#1)(2008-10#1)(2009-5#1)
It has been previously demonstrated that##2##6##(1995-6#1)(2011-2#1)
It has been previously shown that##2##6##(2008-12#1)(2009-7#1)
It has been previously##5##4##(1994-2#1)(1995-6#1)(2008-12#1)(2009-7#1)(2011-2#1)
It has been proposed that the positive##2##7##(1994-2#1)(1997-7#1)
It has been proposed that the##5##6##(1990-5#1)(1994-2#1)(1997-7#1)(2007-11#1)(2011-1#1)
It has been proposed that##12##5##(1990-12#1)(1990-5#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-4#2)(2008-8#1)(2009-8#1)(2011-1#1)
It has been proposed##13##4##(1990-12#1)(1990-5#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-11#3)(2008-4#2)(2008-8#1)(2009-8#1)(2011-1#1)
It has been proved that##4##5##(2008-10#2)(2008-9#1)(2011-2#1)
It has been proven##2##4##(2008-11#2)
It has been recently demonstrated that##2##6##(1994-8#1)(2011-1#1)
It has been recently##3##4##(1994-8#1)(2009-5#1)(2011-1#1)
It has been recommended that##2##5##(2008-1#1)(2008-12#1)
It has been reported in##2##5##(2007-10#1)(2011-1#1)
It has been reported that##13##5##(1991-2#1)(1992-12#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)(2009-12#1)(2011-2#2)
It has been reported##15##4##(1991-2#1)(1992-12#1)(1995-11#1)(1996-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#2)
It has been said that##2##5##(2007-12#1)(2008-4#1)
It has been shown that the##6##6##(1993-11#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-4#1)
It has been shown that these##2##6##(2008-11#1)(2011-2#1)
It has been shown that##25##5##(1991-9#1)(1992-11#1)(1993-11#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
It has been shown to##5##5##(1993-3#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
It has been shown##35##4##(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
It has been speculated that##2##5##(2008-10#1)(2008-5#1)
It has been speculated##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
It has been stated that##2##5##(2008-11#1)(2010-10#1)
It has been successfully applied to##3##6##(2008-10#3)
It has been successfully used as an indicator electrode in##2##10##(2008-10#2)
It has been successfully##5##4##(2008-10#5)
It has been suggested that a##2##6##(1991-2#1)(2010-6#1)
It has been suggested that the##5##6##(1991-2#1)(1991-9#1)(1997-3#1)(2008-4#1)(2008-8#1)
It has been suggested that##30##5##(1990-5#1)(1991-2#2)(1991-9#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
It has been suggested##31##4##(1990-5#1)(1991-2#2)(1991-9#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
It has been used for the##2##6##(2008-10#2)
It has been used for##4##5##(2008-10#4)
It has been used##6##4##(2007-12#1)(2008-10#5)
It has been well##2##4##(2008-2#1)(2010-2#1)
It has been widely used##2##5##(2008-10#1)(2012-3#1)
It has been##238##3##(1990-12#1)(1990-5#4)(1990-9#1)(1991-2#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#5)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#45)(2008-11#20)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#13)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
It has long been known that##2##6##(2008-8#1)(2012-2#1)
It has long been##6##4##(1992-2#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#2)
It has not been##3##4##(2008-8#1)(2009-2#1)(2011-1#1)
It has not##4##3##(1990-11#1)(2008-8#1)(2009-2#1)(2011-1#1)
It has previously been##3##4##(1994-2#1)(2008-8#1)(2012-8#1)
It has recently been##4##4##(1990-3#1)(2007-8#1)(2010-11#1)(2013-1#1)
It has recently##5##3##(1990-3#1)(2007-8#1)(2008-8#1)(2010-11#1)(2013-1#1)
It has the advantage of##2##5##(2010-3#1)(2011-2#1)
It has the potential to##3##5##(1994-9#1)(2008-1#1)(2008-2#1)
It has the##11##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-7#1)
It has##369##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#7)(1994-5#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#68)(2008-11#24)(2008-12#7)(2008-2#7)(2008-3#12)(2008-4#6)(2008-5#20)(2008-6#2)(2008-7#12)(2008-8#13)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#2)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#8)(2011-2#19)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#6)(2012-8#1)(2013-1#9)(2013-7#2)(2013-8#6)
It helps##3##2##(1996-1#1)(2007-8#1)(2008-1#1)
It highlights some##2##3##(2008-10#1)(2008-11#1)
It highlights the importance of##2##5##(2008-11#1)(2009-10#1)
It highlights##6##2##(2008-10#1)(2008-11#3)(2008-12#1)(2009-10#1)
It improves the##2##3##(2010-8#1)(2013-8#1)
It includes a##3##3##(1994-2#1)(2008-4#1)(2013-1#1)
It includes methods for##2##4##(2008-4#1)(2008-9#1)
It includes methods##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
It includes the##2##3##(2011-2#1)(2013-7#1)
It includes##12##2##(1994-2#1)(1994-3#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
It incorporates##2##2##(2008-3#1)(2010-5#1)
It increased##2##2##(1990-10#1)(2008-10#1)
It increases the##2##3##(1996-3#1)(2008-5#1)
It indicates that the##2##4##(2008-10#1)(2013-1#1)
It indicates that##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
It infers that##2##3##(2008-4#1)(2008-8#1)
It involves a##2##3##(1992-3#1)(2008-7#1)
It involves the##4##3##(1990-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
It involves##14##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#2)
It is a complex##2##4##(2008-5#1)(2011-2#1)
It is a first##2##4##(2008-1#1)(2008-5#1)
It is a rare disease##2##5##(1996-3#1)(2007-10#1)
It is a relatively##2##4##(2008-1#1)(2012-3#1)
It is a reversible##2##4##(2008-3#1)(2011-2#1)
It is a simple##4##4##(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
It is a##89##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
It is also a##2##4##(1994-8#1)(2010-1#1)
It is also an##3##4##(2008-9#1)(2012-1#1)(2012-2#1)
It is also demonstrated that##2##5##(1990-7#1)(2008-3#1)
It is also found in##2##5##(1997-2#1)(2008-5#1)
It is also found that the##3##6##(2008-5#1)(2008-7#1)(2010-7#1)
It is also found that##4##5##(2007-12#1)(2008-5#1)(2008-7#1)(2010-7#1)
It is also found##6##4##(1997-2#1)(2007-12#1)(2008-5#2)(2008-7#1)(2010-7#1)
It is also important to##3##5##(1993-6#1)(2008-7#2)
It is also important##4##4##(1993-6#1)(2008-7#3)
It is also known that##2##5##(2008-7#1)(2010-11#1)
It is also known##3##4##(2008-7#1)(2010-11#1)(2010-3#1)
It is also necessary to##2##5##(2009-6#1)(2011-2#1)
It is also of##3##4##(1993-11#1)(1994-2#1)(2008-9#1)
It is also possible to##2##5##(1997-4#1)(2008-6#1)
It is also possible##3##4##(1997-4#1)(2007-10#1)(2008-6#1)
It is also shown that the##6##6##(1990-8#1)(1992-5#1)(2008-2#2)(2008-3#2)
It is also shown that##16##5##(1990-2#1)(1990-8#1)(1992-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-7#1)
It is also suggested that##3##5##(1990-12#1)(1993-12#1)(2009-9#1)
It is also used##3##4##(1994-3#1)(2008-9#1)(2013-1#1)
It is also useful##2##4##(1994-11#1)(2007-2#1)
It is also well##2##4##(1996-3#1)(2008-3#1)
It is also##71##3##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
It is an effective##2##4##(1995-3#1)(2008-11#1)
It is an extremely##2##4##(1991-9#1)(2008-12#1)
It is an outgrowth of##2##5##(1992-1#1)(2008-3#1)
It is an##23##3##(1991-12#1)(1991-9#1)(1992-1#1)(1995-3#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#2)(2010-10#1)(2010-6#1)(2011-2#3)(2012-3#1)
It is anticipated that##5##4##(1991-2#1)(1997-7#1)(2007-5#1)(2008-4#1)(2009-5#1)
It is anticipated##6##3##(1991-2#1)(1997-7#1)(2007-5#1)(2008-12#1)(2008-4#1)(2009-5#1)
It is apparent that both##2##5##(2007-9#1)(2012-2#1)
It is apparent that the##2##5##(2006-6#1)(2008-10#1)
It is apparent that##6##4##(1995-12#1)(2006-6#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
It is apparent##7##3##(1991-1#1)(1995-12#1)(2006-6#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
It is argued that nursing outcomes and interventions that include findings of CS are difficult to interpret due to lack of an operational definition##2##24##(2013-1#2)
It is argued that the##7##5##(1990-7#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-9#1)(2009-11#1)
It is argued that this is##2##6##(1991-3#1)(2008-10#1)
It is argued that##20##4##(1990-7#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-9#1)(2013-1#2)
It is argued##21##3##(1990-7#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-9#1)(2010-6#1)(2013-1#2)
It is as##2##3##(2008-1#1)(2009-11#1)
It is associated with a##2##5##(1995-2#1)(2010-3#1)
It is associated with an##2##5##(2006-10#1)(2009-8#1)
It is associated with##6##4##(1995-2#1)(1997-1#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-3#1)
It is assumed that##10##4##(1992-4#1)(1994-3#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
It is based on a##7##5##(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#4)
It is based on an##2##5##(2007-12#1)(2008-2#1)
It is based on the adsorption of##2##7##(2008-10#2)
It is based on the catalytic effect of##2##8##(2008-10#2)
It is based on the direct##2##6##(2008-10#2)
It is based on the reaction between##2##7##(2008-10#2)
It is based on the reaction##3##6##(2008-10#3)
It is based on the##32##5##(1995-12#1)(1995-3#1)(2008-10#24)(2008-3#4)(2008-5#1)(2008-9#1)
It is based on##59##4##(1991-5#1)(1991-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#32)(2008-2#3)(2008-3#10)(2008-5#1)(2008-9#1)
It is based##60##3##(1991-5#1)(1991-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#32)(2008-2#3)(2008-3#10)(2008-5#1)(2008-9#1)
It is becoming increasingly##2##4##(2007-11#1)(2010-6#1)
It is becoming##5##3##(2007-11#1)(2008-3#1)(2009-4#2)(2010-6#1)
It is believed that the##2##5##(2012-1#1)(2012-12#1)
It is believed that these##2##5##(2008-7#1)(2012-2#1)
It is believed that this new##2##6##(2008-10#1)(2008-3#1)
It is believed that this##3##5##(2008-10#1)(2008-3#2)
It is believed that##14##4##(1991-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
It is believed##16##3##(1991-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
It is built##2##3##(2008-11#1)(2008-3#1)
It is capable of##2##4##(2008-2#2)
It is capable##3##3##(2008-2#2)(2008-7#1)
It is caused by##2##4##(2007-8#1)(2013-1#1)
It is characterized by an##2##5##(2008-11#1)(2008-12#1)
It is characterized by the##2##5##(2008-4#1)(2010-6#1)
It is characterized by##13##4##(1995-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-5#1)(2010-6#1)(2012-3#1)(2013-1#1)
It is clear from the##4##5##(2007-12#1)(2008-11#2)(2009-1#1)
It is clear from##5##4##(2007-12#1)(2008-11#2)(2008-12#1)(2009-1#1)
It is clear that the##5##5##(1990-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
It is clear that##14##4##(1990-3#1)(1995-11#1)(1996-3#1)(2006-5#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
It is clear##21##3##(1990-3#1)(1995-11#1)(1996-3#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2011-2#1)
It is commonly assumed that##2##5##(2008-10#1)(2008-4#1)
It is commonly believed that the##2##6##(1990-8#1)(2008-4#1)
It is commonly##5##3##(1990-8#1)(2008-10#1)(2008-4#2)(2012-2#1)
It is completely stable to all reaction conditions applied during assembly and the first deprotection step##2##16##(2008-4#2)
It is composed of##6##4##(1994-5#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
It is conceivable that##3##4##(1995-6#1)(2008-7#1)(2009-10#1)
It is concerned with##2##4##(2007-8#1)(2008-9#1)
It is concluded from##3##4##(2008-12#1)(2008-6#1)(2011-2#1)
It is concluded that both##2##5##(1993-2#1)(1995-11#1)
It is concluded that in##2##5##(1994-2#1)(2007-7#1)
It is concluded that it is##2##6##(2008-11#1)(2008-8#1)
It is concluded that it##3##5##(2008-11#1)(2008-8#1)(2010-10#1)
It is concluded that nitric oxide##2##6##(1995-12#1)(2013-7#1)
It is concluded that the##24##5##(1991-2#2)(1991-6#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#2)
It is concluded that this##3##5##(1991-12#1)(2008-3#1)(2009-7#1)
It is concluded that##130##4##(1990-12#2)(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#4)(1996-3#2)(1996-5#3)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#4)(1997-9#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
It is concluded##137##3##(1990-12#2)(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#3)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#4)(1996-3#2)(1996-5#3)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#4)(1997-9#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
It is considered that the##2##5##(2008-10#1)(2008-6#1)
It is considered that##4##4##(2008-10#2)(2008-6#1)(2009-7#1)
It is considered##9##3##(2008-10#2)(2008-6#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
It is contended that the##3##5##(2008-11#2)(2008-3#1)
It is contended that##4##4##(2008-11#2)(2008-3#1)(2009-6#1)
It is critical to have##2##5##(2008-11#1)(2011-2#1)
It is critical to##4##4##(2008-11#1)(2008-7#1)(2011-2#2)
It is critical##7##3##(1996-3#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)
It is crucial that##3##4##(1995-5#1)(2010-9#1)(2013-1#1)
It is crucial to##2##4##(1997-2#1)(2008-5#1)
It is crucial##5##3##(1995-5#1)(1997-2#1)(2008-5#1)(2010-9#1)(2013-1#1)
It is currently unknown##2##4##(2009-11#1)(2012-2#1)
It is currently##4##3##(2008-5#1)(2009-11#1)(2010-4#1)(2012-2#1)
It is demonstrated for the first time that##3##8##(2008-10#2)(2008-2#1)
It is demonstrated for the first time##4##7##(2007-11#1)(2008-10#2)(2008-2#1)
It is demonstrated that the##8##5##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)
It is demonstrated that##32##4##(1993-8#1)(1996-4#1)(2007-11#4)(2007-12#2)(2008-10#4)(2008-2#6)(2008-3#9)(2008-5#2)(2008-8#2)(2013-1#1)
It is demonstrated##42##3##(1993-8#1)(1996-4#1)(2007-11#5)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#11)(2008-5#2)(2008-8#2)(2013-1#1)
It is desirable to##2##4##(2008-2#1)(2012-2#1)
It is determined##2##3##(2008-10#1)(2008-3#1)
It is diagnosed##2##3##(1994-5#1)(2008-3#1)
It is difficult to##9##4##(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
It is difficult##10##3##(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
It is discussed##2##3##(1994-8#1)(2012-3#1)
It is doubtful that##2##4##(1994-8#1)(2008-10#1)
It is easy to##2##4##(2008-10#1)(2008-11#1)
It is effective##2##3##(1990-5#1)(2008-9#1)
It is emphasized that##6##4##(1991-11#1)(1992-11#1)(1996-12#1)(2008-1#1)(2008-7#1)(2010-11#1)
It is emphasized##7##3##(1991-11#1)(1991-3#1)(1992-11#1)(1996-12#1)(2008-1#1)(2008-7#1)(2010-11#1)
It is envisaged that##2##4##(2008-9#1)(2012-2#1)
It is essential that##3##4##(2007-11#1)(2008-11#1)(2008-4#1)
It is essential to##9##4##(1992-11#1)(1992-3#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-12#1)
It is essential##13##3##(1992-11#1)(1992-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-12#1)
It is established##4##3##(2008-2#1)(2011-2#2)(2013-1#1)
It is estimated that about##2##5##(1990-2#1)(2009-8#1)
It is estimated that the##2##5##(1991-6#1)(1995-6#1)
It is estimated that##11##4##(1990-2#1)(1991-6#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)
It is estimated##12##3##(1990-2#1)(1991-6#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)
It is even##2##3##(2007-9#1)(2008-10#1)
It is evident that##10##4##(1992-1#1)(1993-12#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-3#1)
It is evident##11##3##(1992-1#1)(1993-12#1)(2007-12#1)(2008-3#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-3#1)
It is expected from these findings that##2##7##(2008-11#2)
It is expected that the##2##5##(2008-3#1)(2008-7#1)
It is expected that this##2##5##(2008-10#1)(2012-2#1)
It is expected that##16##4##(1991-1#1)(1994-5#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-7#2)(2012-2#1)(2012-3#1)
It is expected##18##3##(1991-1#1)(1994-5#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-7#2)(2012-2#1)(2012-3#1)
It is experimentally##2##3##(2007-11#1)(2007-12#1)
It is first##2##3##(2008-6#1)(2008-8#1)
It is for##2##3##(1991-5#1)(2008-10#1)
It is found that a##2##5##(2007-12#1)(2008-3#1)
It is found that the fluorescence intensity of##2##8##(2008-10#2)
It is found that the fluorescence##3##6##(2008-10#3)
It is found that the##39##5##(1990-2#1)(1990-8#3)(1992-6#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-2#6)(2008-3#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#2)(2013-8#1)
It is found that##63##4##(1990-2#1)(1990-3#1)(1990-8#3)(1992-6#1)(1994-9#1)(1996-5#1)(2007-11#4)(2007-12#4)(2008-10#11)(2008-2#8)(2008-3#17)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-3#1)(2013-1#2)(2013-8#1)
It is found##71##3##(1990-2#1)(1990-3#1)(1990-8#3)(1992-6#1)(1994-9#1)(1996-5#1)(2007-11#4)(2007-12#4)(2008-10#11)(2008-2#10)(2008-3#19)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
It is free##2##3##(1991-8#1)(2008-10#1)
It is frequently##2##3##(2009-10#1)(2011-2#1)
It is fully##2##3##(2007-12#1)(2008-2#1)
It is further argued that the absence of a consistent operational definition is incompatible with EBPs which require standardization of terminology##2##21##(2013-1#2)
It is further argued that the##3##6##(2008-9#1)(2013-1#2)
It is further proposed that the##2##6##(1993-8#1)(2013-8#1)
It is further##9##3##(1993-8#1)(2008-2#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#3)(2013-8#1)
It is generally accepted that##4##5##(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
It is generally agreed that##4##5##(1992-3#1)(2007-12#1)(2008-10#1)(2009-8#1)
It is generally##16##3##(1992-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-10#1)(2012-3#2)(2013-8#1)
It is hard to##2##4##(1996-4#1)(2008-12#1)
It is highly##6##3##(1990-11#1)(2008-10#2)(2011-2#2)(2013-1#1)
It is hoped that by##2##5##(2008-11#1)(2013-1#1)
It is hoped that our##2##5##(2008-11#1)(2010-8#1)
It is hoped that the preliminary findings from the concept analysis presented in this article will facilitate the work of such a consensus forum##2##24##(2013-1#2)
It is hoped that the##8##5##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2013-1#2)
It is hoped that this##6##5##(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2012-2#1)
It is hoped that##20##4##(1991-1#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
It is hoped##23##3##(1991-1#1)(1994-1#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#2)(2012-2#1)(2013-1#3)
It is however##2##3##(1992-9#1)(2008-11#1)
It is hypothesized that the##5##5##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
It is hypothesized that this##4##5##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
It is hypothesized that##12##4##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
It is imperative for##2##4##(2008-4#1)(2013-8#1)
It is imperative that##3##4##(1992-1#1)(1993-12#1)(2007-4#1)
It is imperative##5##3##(1992-1#1)(1993-12#1)(2007-4#1)(2008-4#1)(2013-8#1)
It is important for the##2##5##(2008-11#1)(2012-1#1)
It is important for##6##4##(1992-3#1)(1995-9#1)(2008-11#1)(2009-9#1)(2012-1#1)(2012-3#1)
It is important that the##3##5##(1995-6#1)(2008-12#1)(2008-7#1)
It is important that we##2##5##(1991-1#1)(2008-5#1)
It is important that##14##4##(1991-1#1)(1992-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
It is important to be##3##5##(1993-12#1)(1995-2#1)(2008-2#1)
It is important to determine##3##5##(2008-1#1)(2008-5#1)(2008-8#1)
It is important to distinguish##3##5##(2011-1#1)(2011-2#2)
It is important to examine##2##5##(1992-11#1)(2012-2#1)
It is important to know##3##5##(1992-4#1)(1993-12#1)(2008-2#1)
It is important to realize that##3##6##(1991-2#1)(1994-9#1)(2008-10#1)
It is important to remember##2##5##(1991-11#1)(1995-3#1)
It is important to understand the##2##6##(2008-10#1)(2008-5#1)
It is important to understand##5##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
It is important to##50##4##(1990-7#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
It is important##73##3##(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
It is in accordance with the cryo-electron density##2##8##(2008-5#2)
It is in phase II##2##5##(2008-5#2)
It is in phase##3##4##(2008-5#3)
It is in this##2##4##(2008-2#1)(2009-11#1)
It is in##10##3##(2008-11#1)(2008-2#1)(2008-5#5)(2008-9#1)(2009-11#1)(2012-12#1)
It is increasingly##4##3##(2007-12#1)(2009-9#1)(2010-1#1)(2012-3#1)
It is indicated that the##3##5##(2008-2#1)(2012-3#1)(2013-8#1)
It is indicated that##4##4##(2008-2#1)(2012-3#2)(2013-8#1)
It is indicated##5##3##(2008-2#1)(2008-3#1)(2012-3#2)(2013-8#1)
It is inferred##2##3##(1991-6#1)(2008-2#1)
It is intended##2##3##(2008-4#2)
It is interesting that##3##4##(1992-12#1)(2008-11#1)(2008-9#1)
It is interesting##4##3##(1992-12#1)(2008-11#2)(2008-9#1)
It is involved in##2##4##(2008-5#1)(2012-2#1)
It is known that an##2##5##(2008-12#1)(2008-2#1)
It is known that some##2##5##(1993-3#1)(1997-2#1)
It is known that##12##4##(1991-3#1)(1991-9#1)(1993-3#1)(1997-2#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-12#1)
It is known to##2##4##(1997-6#1)(2010-11#1)
It is known##17##3##(1991-3#1)(1991-9#1)(1993-3#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#1)
It is largely##3##3##(2007-7#1)(2008-5#1)(2013-8#1)
It is likely that some##2##5##(2007-11#1)(2008-7#1)
It is likely that the##6##5##(1990-12#1)(1996-4#1)(2008-1#1)(2009-12#1)(2009-4#1)(2013-1#1)
It is likely that this##2##5##(1992-5#1)(1996-1#1)
It is likely that##19##4##(1990-12#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-4#1)(2013-1#1)
It is likely##22##3##(1990-12#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2013-1#1)
It is more common in##2##5##(2008-1#1)(2010-8#1)
It is more##6##3##(1994-12#1)(2007-7#1)(2008-1#1)(2010-8#1)(2011-2#2)
It is most##5##3##(1992-1#1)(1996-11#1)(2008-10#1)(2008-5#1)(2010-8#1)
It is necessary to##14##4##(1992-9#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
It is necessary##15##3##(1992-9#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
It is neither##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
It is not always easy##2##5##(2008-11#1)(2010-9#1)
It is not clear whether these##2##6##(2008-11#2)
It is not clear whether##5##5##(1990-6#1)(2008-10#2)(2008-11#2)
It is not clear yet##2##5##(2008-10#1)(2008-11#1)
It is not clear##11##4##(1990-6#1)(1991-12#1)(1993-12#1)(2008-10#3)(2008-11#3)(2008-7#1)(2010-8#1)
It is not easy##2##4##(1994-1#1)(2009-10#1)
It is not known whether##3##5##(1990-5#1)(2008-11#1)(2008-7#1)
It is not known##7##4##(1990-5#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-7#2)
It is not uncommon##2##4##(2007-12#1)(2013-8#1)
It is not##47##3##(1990-5#1)(1990-6#1)(1991-12#2)(1991-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-11#7)(2008-4#1)(2008-5#4)(2008-7#3)(2009-10#1)(2009-5#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
It is noteworthy that there##2##5##(1992-12#1)(2008-8#1)
It is noteworthy that##6##4##(1992-12#1)(1995-8#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-2#1)
It is now accepted that##2##5##(1997-7#1)(2008-5#1)
It is now becoming##2##4##(2008-7#1)(2009-3#1)
It is now clear that##3##5##(2008-4#1)(2008-7#1)(2011-2#1)
It is now generally##2##4##(2007-11#1)(2012-1#1)
It is now known that##2##5##(2009-4#1)(2011-2#1)
It is now possible to##4##5##(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
It is now recognised##2##4##(2008-11#1)(2010-12#1)
It is now the##2##4##(1992-5#1)(2013-1#1)
It is now well established that##2##6##(1994-11#1)(1997-1#1)
It is now well##3##4##(1994-11#1)(1995-6#1)(1997-1#1)
It is now##31##3##(1992-5#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
It is observed that the##3##5##(2008-10#2)(2008-3#1)
It is observed that##5##4##(2008-10#3)(2008-3#1)(2011-2#1)
It is of particular##3##4##(1992-5#1)(1997-1#1)(2008-7#1)
It is of phylogenetic interest because of##2##7##(2011-2#2)
It is of phylogenetic interest because##3##6##(2011-2#3)
It is of utmost importance##2##5##(1991-6#1)(2011-1#1)
It is of##17##3##(1990-12#1)(1991-6#1)(1992-5#1)(1995-11#1)(1995-8#1)(1997-1#1)(2007-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#2)(2011-2#4)
It is often the##2##4##(1995-1#1)(2008-4#1)
It is often##12##3##(1993-3#1)(1995-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-11#1)(2013-1#1)
It is one of the##4##5##(1993-11#1)(2008-1#1)(2008-10#1)(2010-5#1)
It is one of##5##4##(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#1)(2010-5#1)
It is only##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
It is our##6##3##(1992-2#1)(1994-1#1)(1994-6#1)(1997-3#1)(2009-11#1)(2011-2#1)
It is particularly useful##2##4##(2008-11#1)(2008-8#1)
It is particularly##7##3##(1990-5#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)
It is performed in##2##4##(2007-11#1)(2013-1#1)
It is performed##3##3##(2007-11#1)(2012-2#1)(2013-1#1)
It is poorly##2##3##(2010-3#1)(2011-2#1)
It is possible that a##6##5##(1994-3#1)(1995-8#1)(2007-7#1)(2008-5#2)(2009-1#1)
It is possible that the##8##5##(1994-5#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2013-1#1)
It is possible that there is a##2##7##(2007-10#1)(2008-8#1)
It is possible that##30##4##(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
It is possible to extract##2##5##(2008-10#1)(2008-11#1)
It is possible to##13##4##(1991-11#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)
It is possible##44##3##(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
It is postulated that the##3##5##(1992-2#1)(2007-10#1)(2008-3#1)
It is postulated that##8##4##(1992-12#1)(1992-2#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)
It is postulated##9##3##(1992-12#1)(1992-2#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#1)
It is preferable to##2##4##(2008-11#1)(2013-1#1)
It is preferable##3##3##(2008-11#2)(2013-1#1)
It is present##2##3##(1993-9#1)(2008-10#1)
It is presently##2##3##(1993-6#1)(2010-12#1)
It is presumed that the##2##5##(1995-8#1)(2012-2#1)
It is presumed that##4##4##(1993-8#1)(1995-8#1)(2011-2#1)(2012-2#1)
It is probable that##3##4##(1991-1#1)(1995-8#1)(2008-12#1)
It is probably caused by##2##5##(2007-11#1)(2008-7#1)
It is probably##5##3##(1994-2#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
It is proposed that the##11##5##(1993-3#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-10#1)(2013-8#1)
It is proposed that these##3##5##(1996-12#1)(2008-11#1)(2011-1#1)
It is proposed that##31##4##(1990-12#1)(1991-2#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
It is proposed##33##3##(1990-12#1)(1991-2#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
It is proved that##2##4##(2011-1#1)(2011-2#1)
It is quite##4##3##(2008-5#2)(2008-8#1)(2008-9#1)
It is rarely##2##3##(2008-11#1)(2010-10#1)
It is reasonable to##4##4##(1991-6#1)(2007-11#1)(2008-4#1)(2008-6#1)
It is recommended that the##3##5##(2008-1#1)(2008-5#1)(2012-12#1)
It is recommended that this##2##5##(2007-11#1)(2008-11#1)
It is recommended that##10##4##(1991-3#1)(1996-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
It is recommended to##3##4##(1992-11#1)(2008-2#1)(2011-2#1)
It is recommended##16##3##(1991-3#1)(1992-11#1)(1996-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
It is relatively##2##3##(1992-4#1)(1992-8#1)
It is reported that##7##4##(1990-11#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2011-2#2)
It is reported##8##3##(1990-11#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2011-2#2)(2013-1#1)
It is revealed that##2##4##(2008-3#1)(2010-2#1)
It is said that##2##4##(2007-10#1)(2009-3#1)
It is seen that##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
It is seen##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
It is shown both theoretically and experimentally that##3##8##(2008-3#3)
It is shown here that##3##5##(1992-3#1)(2008-10#1)(2008-3#1)
It is shown how a##2##5##(2007-12#1)(2008-2#1)
It is shown how##5##4##(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)
It is shown that a##13##5##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#7)(2008-5#1)
It is shown that all##2##5##(2007-11#1)(2008-2#1)
It is shown that an##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
It is shown that both##3##5##(2008-10#1)(2008-3#2)
It is shown that for##6##5##(2007-12#1)(2008-2#3)(2008-3#2)
It is shown that in the##3##6##(2007-11#1)(2008-10#2)
It is shown that in##6##5##(2007-11#2)(2008-10#2)(2008-2#2)
It is shown that one can##2##6##(2007-11#1)(2008-3#1)
It is shown that substantial##2##5##(2008-1#1)(2008-2#1)
It is shown that the absorption##2##6##(2008-3#2)
It is shown that the frequency##2##6##(2007-11#1)(2008-3#1)
It is shown that the initial##2##6##(2008-2#1)(2009-11#1)
It is shown that the instrument is##2##7##(2008-10#1)(2010-12#1)
It is shown that the intensity##3##6##(2007-12#2)(2008-3#1)
It is shown that the maximum##2##6##(2008-2#2)
It is shown that the technique##2##6##(2007-11#1)(2010-8#1)
It is shown that the use of##2##7##(2008-10#1)(2008-3#1)
It is shown that the##80##5##(1992-6#1)(1995-6#1)(1997-2#2)(2007-11#8)(2007-12#8)(2008-10#12)(2008-2#16)(2008-3#24)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
It is shown that there is a##2##7##(2007-12#1)(2008-2#1)
It is shown that these##3##5##(2008-10#2)(2008-3#1)
It is shown that this##6##5##(1990-8#1)(2008-2#1)(2008-3#4)
It is shown that when the##2##6##(2008-3#2)
It is shown that when##3##5##(1991-3#1)(2008-3#2)
It is shown that##219##4##(1990-11#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-2#2)(2007-11#19)(2007-12#21)(2008-1#1)(2008-10#31)(2008-11#1)(2008-2#43)(2008-3#73)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
It is shown##244##3##(1990-11#1)(1990-8#1)(1991-3#1)(1992-3#2)(1992-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-2#2)(2007-11#19)(2007-12#27)(2008-1#1)(2008-10#35)(2008-11#2)(2008-2#46)(2008-3#82)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
It is simple##2##3##(1997-2#1)(2012-3#1)
It is speculated that##8##4##(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
It is still##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
It is stressed that##4##4##(1990-9#1)(1991-5#1)(1994-9#1)(2009-10#1)
It is stressed##5##3##(1990-5#1)(1990-9#1)(1991-5#1)(1994-9#1)(2009-10#1)
It is suggested that a##5##5##(1993-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
It is suggested that an##3##5##(1994-3#1)(2008-7#1)(2008-8#1)
It is suggested that complete research must be performed in order to find out the source of aflatoxin M1 contamination##2##20##(2013-1#2)
It is suggested that in##2##5##(2008-11#1)(2013-1#1)
It is suggested that patients##2##5##(1997-8#1)(2008-6#1)
It is suggested that the##29##5##(1990-12#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
It is suggested that there##2##5##(2008-10#1)(2008-8#1)
It is suggested that these##2##5##(1991-12#1)(1992-3#1)
It is suggested that this##6##5##(1990-2#1)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-12#1)
It is suggested that##101##4##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#6)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#3)
It is suggested##106##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#7)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
It is suitable for##5##4##(1994-3#1)(2008-3#1)(2008-4#1)(2011-1#2)
It is suitable##6##3##(1994-3#1)(2008-3#1)(2008-4#1)(2011-1#2)(2013-8#1)
It is supposed that the##2##5##(1990-11#1)(2008-10#1)
It is the aim of this##3##6##(1994-5#1)(2008-7#1)(2012-12#1)
It is the first##5##4##(1994-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
It is the most##3##4##(2007-8#1)(2008-2#1)(2010-3#1)
It is the only##3##4##(2007-12#1)(2008-4#1)(2010-6#1)
It is the responsibility of##2##5##(1995-9#1)(2008-11#1)
It is the result of##2##5##(2007-11#1)(2008-5#1)
It is the##37##3##(1990-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
It is then##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)
It is therefore concluded that the##2##6##(1991-5#1)(2008-8#1)
It is therefore concluded that##4##5##(1991-5#1)(2008-1#1)(2008-8#1)(2013-1#1)
It is therefore desirable to##2##5##(2008-10#1)(2008-11#1)
It is therefore important that the##2##6##(1996-1#1)(2010-8#1)
It is therefore important that##3##5##(1996-1#1)(2010-12#1)(2010-8#1)
It is therefore important to determine##2##6##(1994-6#1)(2008-10#1)
It is therefore important to##9##5##(1994-6#1)(1994-9#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
It is therefore important##12##4##(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
It is therefore likely that##2##5##(1992-6#1)(2010-3#1)
It is therefore likely##3##4##(1992-6#1)(2008-10#1)(2010-3#1)
It is therefore necessary##2##4##(1990-2#1)(2012-3#1)
It is therefore not surprising that##2##6##(2007-12#1)(2009-3#1)
It is therefore of##3##4##(2009-1#1)(2009-10#1)(2012-1#1)
It is therefore possible##2##4##(1993-9#1)(2013-8#1)
It is therefore suggested that##2##5##(2008-7#1)(2008-8#1)
It is therefore##43##3##(1990-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
It is thought that##5##4##(1990-3#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)
It is thought##6##3##(1990-3#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-6#1)
It is thus##8##3##(1991-4#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)
It is unclear what the##2##5##(2009-8#1)(2012-12#1)
It is unclear whether##4##4##(1991-2#1)(2008-11#1)(2008-6#1)(2012-3#1)
It is unclear##8##3##(1991-2#1)(1991-9#1)(2008-11#2)(2008-6#1)(2009-8#1)(2012-12#1)(2012-3#1)
It is unknown whether##2##4##(1995-5#1)(2007-10#1)
It is unknown##4##3##(1990-9#1)(1995-5#1)(2007-10#1)(2010-5#1)
It is unlikely that any##2##5##(1996-12#1)(2008-5#1)
It is unlikely that##4##4##(1995-12#1)(1996-12#1)(2007-12#1)(2008-5#1)
It is unusual##3##3##(2008-7#1)(2008-8#1)(2012-1#1)
It is up to the##2##5##(1994-3#1)(2008-5#1)
It is used to##4##4##(2007-11#1)(2008-9#1)(2009-11#1)(2010-7#1)
It is used##7##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-11#1)(2010-7#1)
It is useful##2##3##(2011-2#1)(2013-8#1)
It is usually##13##3##(1995-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
It is valuable##2##3##(2008-11#1)(2008-9#1)
It is verified##2##3##(2007-11#1)(2008-3#1)
It is very difficult to##2##5##(2008-7#1)(2013-8#1)
It is very important to##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
It is very##11##3##(1994-2#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
It is well established that##4##5##(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
It is well established##5##4##(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#2)
It is well known that an##2##6##(2008-2#1)(2009-12#1)
It is well known that nerve##2##6##(1992-6#1)(2008-10#1)
It is well known that the##4##6##(1993-3#1)(1997-2#1)(2008-3#2)
It is well known that##24##5##(1992-6#1)(1993-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
It is well##32##3##(1990-9#1)(1992-6#1)(1993-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#2)(2009-12#1)(2009-2#1)(2010-12#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
It is well-known that##2##4##(2008-12#1)(2010-11#1)
It is well-known##3##3##(2008-1#1)(2008-12#1)(2010-11#1)
It is widely accepted that the##2##6##(2008-4#1)(2009-7#1)
It is widely accepted that##5##5##(1994-9#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-7#1)
It is widely##14##3##(1993-11#1)(1994-9#1)(1995-12#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-5#1)(2009-7#1)(2011-2#1)
It is within##2##3##(2008-1#1)(2010-12#1)
It is worth##4##3##(1993-11#1)(1997-3#1)(2008-5#1)(2012-12#1)
It is##2065##2##(1990-11#4)(1990-12#10)(1990-2#7)(1990-3#4)(1990-5#5)(1990-6#2)(1990-7#5)(1990-8#8)(1990-9#3)(1991-1#5)(1991-11#3)(1991-12#6)(1991-2#10)(1991-3#8)(1991-4#1)(1991-5#8)(1991-6#11)(1991-8#2)(1991-9#5)(1992-1#6)(1992-11#5)(1992-12#15)(1992-2#4)(1992-3#13)(1992-4#3)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#8)(1993-12#9)(1993-2#6)(1993-3#7)(1993-6#4)(1993-8#4)(1993-9#5)(1994-1#5)(1994-11#6)(1994-12#4)(1994-2#9)(1994-3#14)(1994-5#9)(1994-6#7)(1994-7#2)(1994-8#11)(1994-9#10)(1995-1#3)(1995-11#6)(1995-12#12)(1995-2#13)(1995-3#6)(1995-4#1)(1995-5#9)(1995-6#9)(1995-8#6)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#14)(1996-2#6)(1996-3#10)(1996-4#4)(1996-5#11)(1996-6#3)(1996-7#2)(1996-9#5)(1997-1#5)(1997-2#17)(1997-3#7)(1997-4#8)(1997-5#4)(1997-6#5)(1997-7#7)(1997-8#10)(1997-9#1)(2006-10#2)(2006-5#1)(2006-6#4)(2007-10#12)(2007-11#52)(2007-12#62)(2007-2#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#16)(2007-8#9)(2007-9#2)(2008-1#35)(2008-10#199)(2008-11#99)(2008-12#30)(2008-2#114)(2008-3#197)(2008-4#35)(2008-5#77)(2008-6#24)(2008-7#71)(2008-8#50)(2008-9#38)(2009-1#4)(2009-10#10)(2009-11#10)(2009-12#6)(2009-2#5)(2009-3#4)(2009-4#5)(2009-5#12)(2009-6#6)(2009-7#9)(2009-8#10)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#9)(2010-12#10)(2010-2#2)(2010-3#10)(2010-4#4)(2010-5#7)(2010-6#7)(2010-7#4)(2010-8#17)(2010-9#3)(2011-1#19)(2011-10#1)(2011-2#72)(2011-3#1)(2012-1#8)(2012-12#15)(2012-2#35)(2012-3#33)(2013-1#58)(2013-7#4)(2013-8#26)
It leads##3##2##(2007-11#1)(2008-11#1)(2008-5#1)
It led##2##2##(2011-1#1)(2012-12#1)
It looks at the##2##4##(1992-12#1)(2008-7#1)
It looks##3##2##(1992-12#1)(2008-7#1)(2008-8#1)
It lyses##2##2##(1994-2#1)(1994-3#1)
It makes use of##2##4##(2008-2#2)
It makes use##3##3##(2008-10#1)(2008-2#2)
It makes##6##2##(1996-1#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-8#1)
It may also be##2##4##(2008-12#1)(2008-5#1)
It may also##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
It may be caused by##2##5##(2008-5#1)(2008-7#1)
It may be especially##2##4##(2008-3#1)(2008-7#1)
It may be related to the##2##6##(1992-6#1)(2006-10#1)
It may be used##2##4##(2008-1#1)(2008-7#1)
It may be##22##3##(1991-6#1)(1992-4#1)(1992-6#1)(1995-2#1)(1997-1#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2011-2#1)(2012-1#1)(2012-3#2)
It may have a##2##4##(2012-3#1)(2013-8#1)
It may have##3##3##(1993-3#1)(2012-3#1)(2013-8#1)
It may occur##3##3##(2007-8#2)(2013-1#1)
It may present##3##3##(2008-8#1)(2008-9#1)(2011-1#1)
It may well##2##3##(1990-5#1)(2007-2#1)
It may##49##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
It means##2##2##(2007-11#1)(2013-1#1)
It might be a##2##4##(2008-8#1)(2010-4#1)
It might be##6##3##(1996-3#1)(1997-5#1)(2008-12#2)(2008-8#1)(2010-4#1)
It might##10##2##(1996-3#1)(1997-5#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
It must be##4##3##(1994-9#1)(1995-4#1)(2007-12#1)(2008-10#1)
It not only##4##3##(1995-6#1)(2008-11#1)(2012-3#1)(2013-8#1)
It now##2##2##(2008-10#1)(2012-2#1)
It occurs##6##2##(1997-1#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
It offers##4##2##(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
It often presents##2##3##(2008-10#1)(2008-12#1)
It often##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
It opens with##2##3##(2008-4#2)
It opens##3##2##(2008-4#2)(2008-8#1)
It outlines the##2##3##(1996-2#1)(2012-12#1)
It outlines##3##2##(1996-2#1)(2008-9#1)(2012-12#1)
It permits##4##2##(2008-3#3)(2008-7#1)
It places##2##2##(2008-6#1)(2009-5#1)
It plays a##2##3##(2006-8#1)(2008-4#1)
It presents a##3##3##(1990-7#1)(1992-1#1)(2013-1#1)
It presents an##2##3##(1993-2#1)(1994-12#1)
It presents##14##2##(1990-7#1)(1992-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#2)(1997-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2013-1#2)
It produces a##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
It produces##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
It proves that##2##3##(2008-6#1)(2011-1#1)
It proves##3##2##(2007-11#1)(2008-6#1)(2011-1#1)
It provides a##8##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)
It provides an##4##3##(1993-1#1)(1993-12#1)(2008-11#1)(2008-7#1)
It provides information##2##3##(2008-2#1)(2008-5#1)
It provides##24##2##(1993-1#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
It rarely##2##2##(2008-7#1)(2008-9#1)
It recommends##2##2##(2007-10#1)(2010-4#1)
It relies on##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
It relies##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
It remains to be determined whether this##2##7##(2006-10#1)(2010-8#1)
It remains to be determined whether##4##6##(2006-10#1)(2008-11#1)(2010-12#1)(2010-8#1)
It remains to be seen##2##5##(1994-3#1)(2007-7#1)
It remains to be##8##4##(1992-3#1)(1994-3#1)(2006-10#1)(2007-7#1)(2008-11#2)(2010-12#1)(2010-8#1)
It remains unclear##4##3##(2008-8#1)(2010-5#1)(2012-1#1)(2013-1#1)
It remains unknown##3##3##(2010-3#1)(2010-4#1)(2012-3#1)
It remains##20##2##(1992-3#1)(1994-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
It represents the first##2##4##(1991-3#1)(2008-10#1)
It represents the##5##3##(1991-3#1)(1991-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
It represents##9##2##(1990-9#1)(1991-3#1)(1991-9#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
It required##2##2##(2008-10#1)(2008-11#1)
It requires##7##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
It results from##3##3##(1991-6#1)(2008-10#1)(2008-2#1)
It results in a##2##4##(2007-8#1)(2008-7#1)
It results in##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)
It results##8##2##(1991-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)
It revealed that##2##3##(2008-9#1)(2010-8#1)
It reveals##2##2##(2011-1#1)(2011-2#1)
It reviews the##2##3##(2008-11#1)(2008-4#1)
It reviews##5##2##(2007-2#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-8#1)
It seems likely that##3##4##(1992-6#1)(1995-5#1)(2008-10#1)
It seems possible that##2##4##(1990-2#1)(1997-5#1)
It seems that in##4##4##(2007-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
It seems that the##8##4##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)
It seems that these##2##4##(1995-12#1)(2007-12#1)
It seems that##26##3##(1991-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
It seems therefore that##2##4##(1991-12#1)(1995-11#1)
It seems to be##3##4##(1994-2#1)(2007-11#1)(2011-2#1)
It seems to##5##3##(1994-2#1)(1997-4#1)(2007-11#1)(2008-11#1)(2011-2#1)
It seems##44##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#1)
It shares##2##2##(1993-11#1)(2008-4#1)
It should be considered in the differential diagnosis of refractory chronic joint effusion and synovial swelling around the knee joint##2##20##(2009-3#2)
It should be considered in the##3##6##(2009-3#2)(2011-2#1)
It should be considered in##4##5##(2007-2#1)(2009-3#2)(2011-2#1)
It should be considered##6##4##(2007-2#1)(2008-12#1)(2009-3#2)(2011-1#1)(2011-2#1)
It should be emphasized that##2##5##(1993-12#1)(2008-4#1)
It should be noted that the##3##6##(2008-10#2)(2010-6#1)
It should be noted that##4##5##(2008-10#2)(2010-6#1)(2011-2#1)
It should be noted##5##4##(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#1)
It should be##28##3##(1990-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-6#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
It should##31##2##(1990-3#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-6#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
It showed a##3##3##(1994-11#1)(2008-10#2)
It showed##12##2##(1994-11#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#2)(2009-6#1)
It shows a##2##3##(2008-10#1)(2008-8#1)
It shows good##2##3##(2008-10#2)
It shows that##7##3##(1993-11#1)(1994-3#1)(1995-1#1)(1997-8#2)(2008-10#1)(2008-11#1)
It shows##20##2##(1990-12#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-1#1)(1997-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2009-3#1)(2010-4#1)(2013-1#1)
It significantly##2##2##(2011-2#1)(2013-8#1)
It started##2##2##(2008-5#1)(2011-3#1)
It starts with##2##3##(1994-1#1)(1995-1#1)
It starts##4##2##(1994-1#1)(1995-1#1)(1996-3#1)(2009-10#1)
It suggests that the##2##4##(1990-2#1)(2008-10#1)
It suggests that##8##3##(1990-2#1)(1991-5#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-8#2)(2008-9#1)
It suggests##10##2##(1990-2#1)(1991-5#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)
It summarizes##2##2##(2008-6#1)(2008-9#1)
It supports##2##2##(2008-11#1)(2008-8#1)
It takes into account##2##4##(2008-11#1)(2010-10#1)
It takes##6##2##(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#1)(2010-10#1)(2010-12#1)
It then describes##2##3##(1995-3#1)(2013-1#1)
It then discusses the##2##4##(2008-5#1)(2008-9#1)
It then discusses##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
It then##9##2##(1995-3#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-1#1)
It therefore appears that##2##4##(1990-5#1)(1992-6#1)
It therefore##7##2##(1990-5#1)(1990-7#1)(1992-6#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-8#1)
It thus##2##2##(1990-7#1)(1996-3#1)
It turned out to be##2##5##(1990-3#1)(1990-5#1)
It turned out##3##3##(1990-3#1)(1990-5#1)(2012-2#1)
It turns out that##2##4##(2008-10#1)(2008-11#1)
It typically##2##2##(2007-7#1)(2011-2#1)
It uses a##3##3##(2008-3#2)(2008-5#1)
It uses the##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
It uses##12##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-9#1)
It usually occurs##2##3##(1990-5#1)(2009-10#1)
It usually##3##2##(1990-5#1)(2009-10#1)(2012-3#1)
It utilizes##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
It was a simple##2##4##(2008-10#2)
It was a##11##3##(1992-12#1)(1993-3#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
It was also an##2##4##(1995-3#1)(2008-8#1)
It was also associated with##2##5##(2007-9#1)(2012-2#1)
It was also demonstrated that the##4##6##(2008-10#2)(2008-3#1)(2008-8#1)
It was also demonstrated that##8##5##(1993-8#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-5#1)
It was also found that the##9##6##(1990-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
It was also found that##14##5##(1990-2#1)(1995-2#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#2)
It was also found##15##4##(1990-2#1)(1995-2#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#2)(2012-3#1)
It was also inhibited by##2##5##(1990-2#1)(1993-3#1)
It was also observed that the##2##6##(1995-11#1)(2008-3#1)
It was also observed that##9##5##(1992-6#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2013-8#1)
It was also shown that##3##5##(2008-10#1)(2008-6#1)(2009-3#1)
It was also##67##3##(1990-2#2)(1992-10#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-3#2)(2009-5#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
It was an##2##3##(1990-2#1)(2010-7#1)
It was applied successfully to the determination of##2##8##(2008-10#2)
It was applied to the determination of##2##7##(2008-10#2)
It was applied to the##3##5##(2008-10#3)
It was applied to##4##4##(2008-10#3)(2008-2#1)
It was applied##8##3##(2008-10#7)(2008-2#1)
It was assumed that##2##4##(2008-10#1)(2008-11#1)
It was assumed##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
It was based on the##4##5##(2008-10#4)
It was based on##6##4##(2008-10#6)
It was calculated that##2##4##(1995-8#1)(2008-10#1)
It was carried out at##2##5##(2008-10#1)(2012-3#1)
It was carried out##4##4##(2008-10#2)(2012-3#2)
It was concluded that a##2##5##(2009-10#1)(2013-1#1)
It was concluded that fibronectin increased adhesion rates and isolation potential of cord blood mesenchymal progenitor cells##2##17##(2008-11#2)
It was concluded that the##16##5##(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2012-2#1)
It was concluded that##55##4##(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
It was concluded##57##3##(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
It was confirmed that##3##4##(1991-9#1)(2008-10#2)
It was decided that##2##4##(2007-12#1)(2008-10#1)
It was deduced from the##2##5##(2008-10#1)(2008-5#1)
It was demonstrated that the##12##5##(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
It was demonstrated that##18##4##(1993-8#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
It was demonstrated##22##3##(1991-8#1)(1991-9#1)(1993-8#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-1#1)(2013-8#1)
It was designed##2##3##(1996-2#1)(2008-3#1)
It was determined that the##2##5##(1991-4#1)(1991-9#1)
It was determined that##4##4##(1991-4#1)(1991-9#1)(1995-2#1)(2008-10#1)
It was developed##3##3##(2008-3#1)(2012-2#2)
It was difficult to##3##4##(1990-10#1)(2008-12#1)(2013-1#1)
It was discovered that##2##4##(2008-3#1)(2012-3#1)
It was discovered##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
It was distributed##2##3##(2008-10#2)
It was established that the##2##5##(1995-9#1)(2008-10#1)
It was established that##5##4##(1995-9#1)(2008-10#4)
It was evaluated##2##3##(2008-10#1)(2013-1#1)
It was evident that##2##4##(2007-5#1)(2008-10#1)
It was evident##3##3##(2007-5#1)(2008-10#2)
It was firstly##2##3##(2008-9#1)(2011-2#1)
It was found that a##3##5##(1997-6#1)(2008-12#1)(2011-1#1)
It was found that at##3##5##(1991-5#1)(1994-3#1)(2007-12#1)
It was found that both##2##5##(2008-10#1)(2008-11#1)
It was found that for##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
It was found that in the presence of##2##8##(1993-8#1)(2008-10#1)
It was found that in the##4##6##(1993-8#1)(1994-8#1)(2008-10#2)
It was found that in##6##5##(1993-1#1)(1993-8#1)(1994-8#1)(2008-10#2)(2011-1#1)
It was found that most of the##2##7##(2008-6#1)(2011-2#1)
It was found that only##3##5##(1994-5#1)(1994-8#1)(2008-10#1)
It was found that the binding of##2##7##(2008-10#1)(2008-8#1)
It was found that the model##2##6##(2008-3#1)(2011-2#1)
It was found that the presence of##2##7##(1995-8#1)(2008-10#1)
It was found that the relative##2##6##(2008-10#1)(2013-8#1)
It was found that the sensitivity##2##6##(2008-10#1)(2008-3#1)
It was found that the##100##5##(1990-8#1)(1991-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#5)(2008-10#39)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-6#2)(2009-7#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
It was found that there were##2##6##(1993-2#1)(2013-1#1)
It was found that there##5##5##(1993-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
It was found that this##4##5##(2008-10#2)(2008-3#1)(2013-1#1)
It was found that with##2##5##(2007-11#1)(2008-10#1)
It was found that##234##4##(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-3#3)(1994-5#2)(1994-8#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-7#3)(2007-8#1)(2008-10#77)(2008-11#8)(2008-12#7)(2008-2#6)(2008-3#15)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#10)(2008-9#2)(2009-11#2)(2009-12#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#3)
It was found to##2##4##(1997-6#1)(2008-10#1)
It was found##247##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-3#3)(1994-5#2)(1994-8#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-7#3)(2007-8#1)(2008-10#83)(2008-11#8)(2008-12#7)(2008-2#6)(2008-3#15)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#2)(2009-11#2)(2009-12#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-2#2)(2010-4#2)(2010-7#2)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#3)
It was further##4##3##(2008-1#1)(2008-8#1)(2008-9#2)
It was hypothesized that the##2##5##(2008-10#1)(2013-1#1)
It was hypothesized that##8##4##(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
It was identified that##2##4##(2007-11#1)(2008-9#1)
It was identified##4##3##(1994-11#1)(2007-11#1)(2008-9#1)(2012-3#1)
It was indicated that the##2##5##(2008-10#1)(2008-8#1)
It was indicated that##3##4##(2008-10#1)(2008-8#2)
It was inferred that##2##4##(2008-10#1)(2008-8#1)
It was initially thought##2##4##(2008-10#1)(2009-8#1)
It was intended to##2##4##(2008-5#2)
It was interesting that##2##4##(2008-11#1)(2008-12#1)
It was lower##2##3##(1991-11#1)(1997-8#1)
It was necessary to##2##4##(1992-9#1)(1997-8#1)
It was not possible to##4##5##(2007-8#1)(2008-10#2)(2008-5#1)
It was not##13##3##(1996-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-5#1)(2009-6#1)(2013-1#1)
It was noted that##2##4##(2007-7#1)(2008-10#1)
It was noticed that##3##4##(2008-12#1)(2008-8#1)(2012-3#1)
It was observed in##3##4##(1990-11#1)(1990-2#1)(2008-6#1)
It was observed that the##7##5##(2008-10#6)(2012-2#1)
It was observed that##24##4##(1990-5#1)(1991-5#1)(1991-9#1)(1994-12#1)(1996-2#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
It was observed##30##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1994-12#1)(1996-2#1)(1997-4#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)
It was often##2##3##(2008-10#1)(2008-11#1)
It was only##2##3##(1997-5#1)(2008-12#1)
It was our##2##3##(2007-10#1)(2012-2#1)
It was performed##2##3##(2011-2#1)(2012-3#1)
It was possible to##8##4##(1997-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
It was possible##9##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
It was predicted##2##3##(1990-5#1)(1996-8#1)
It was previously##2##3##(1995-11#1)(2008-12#1)
It was proposed##2##3##(1994-11#1)(2011-1#1)
It was proved that the##2##5##(2008-9#1)(2013-8#1)
It was proved that##5##4##(2008-10#1)(2008-8#1)(2008-9#2)(2013-8#1)
It was recently reported that##2##5##(2008-2#1)(2008-8#1)
It was recently##5##3##(2008-2#1)(2008-8#1)(2009-6#1)(2011-2#2)
It was recommended that##2##4##(1997-1#1)(2010-8#1)
It was reported that##2##4##(2008-11#2)
It was revealed that##7##4##(1992-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2009-4#1)
It was satisfactory to apply this method to##2##8##(2008-10#2)
It was seen##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
It was showed that the##2##5##(2008-10#1)(2013-8#1)
It was shown that in##2##5##(1990-5#1)(2008-11#1)
It was shown that the##15##5##(1992-6#1)(1995-12#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-6#1)(2008-8#2)(2013-1#1)
It was shown that this##2##5##(2008-10#1)(2011-2#1)
It was shown that##54##4##(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-12#2)(1997-3#1)(2007-6#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#5)(2011-2#1)(2012-3#1)(2013-1#2)
It was shown##60##3##(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#2)(1997-2#1)(1997-3#1)(2007-6#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#5)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
It was speculated that##2##4##(1992-3#1)(2012-12#1)
It was stripped from##2##4##(2008-10#2)
It was strongly##2##3##(1990-5#1)(1995-8#1)
It was successfully applied to the##2##6##(2008-10#2)
It was successfully applied##3##4##(2008-10#3)
It was successfully##6##3##(2008-10#4)(2010-5#1)(2013-8#1)
It was suggested that some##2##5##(2008-10#1)(2010-4#1)
It was suggested that##13##4##(1991-1#1)(1992-5#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
It was suggested##14##3##(1991-1#1)(1992-5#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
It was suitable for##2##4##(2008-10#2)
It was tested##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
It was the##7##3##(1990-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2012-12#1)
It was then##3##3##(2008-10#2)(2008-12#1)
It was therefore concluded that##2##5##(1996-2#1)(2008-10#1)
It was therefore##3##3##(1996-2#1)(2008-10#2)
It was thus possible to##2##5##(1990-2#1)(1990-8#1)
It was thus##4##3##(1990-2#1)(1990-8#1)(2008-10#1)(2009-8#1)
It was treated##2##3##(2008-12#1)(2010-12#1)
It was used as an indicator electrode in potentiometric titration of##3##11##(2008-10#3)
It was used to determine##2##5##(2008-10#2)
It was used to##3##4##(1994-6#1)(2008-10#2)
It was used##7##3##(1994-6#1)(2008-10#5)(2013-8#1)
It was validated##2##3##(2008-10#2)
It was verified that##3##4##(2008-10#3)
It was verified##4##3##(1991-9#1)(2008-10#3)
It was##815##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-8#3)(1991-9#5)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#7)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#4)(1994-12#2)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-12#6)(1996-2#6)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2006-10#1)(2006-6#1)(2007-10#5)(2007-11#13)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#244)(2008-11#30)(2008-12#24)(2008-2#13)(2008-3#31)(2008-4#3)(2008-5#25)(2008-6#8)(2008-7#15)(2008-8#42)(2008-9#19)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#5)(2009-8#5)(2010-1#2)(2010-12#2)(2010-2#4)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#4)(2011-1#10)(2011-2#17)(2012-1#5)(2012-12#5)(2012-2#15)(2012-3#14)(2013-1#25)(2013-7#1)(2013-8#11)
It will also describe##2##4##(1994-3#1)(2013-1#1)
It will also##8##3##(1994-3#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
It will be shown##2##4##(2008-10#1)(2008-3#1)
It will be##7##3##(1994-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-7#1)
It will help##2##3##(2008-8#1)(2011-2#1)
It will##26##2##(1990-2#1)(1994-12#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#3)
It works##2##2##(2008-10#2)
It would be##6##3##(1995-1#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
It would##12##2##(1990-2#1)(1995-1#2)(1995-6#1)(1996-12#1)(1997-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
It##4525##1##(1990-10#2)(1990-11#9)(1990-12#22)(1990-2#22)(1990-3#11)(1990-5#19)(1990-6#8)(1990-7#11)(1990-8#10)(1990-9#8)(1991-1#9)(1991-11#6)(1991-12#13)(1991-2#16)(1991-3#17)(1991-4#2)(1991-5#13)(1991-6#15)(1991-7#1)(1991-8#6)(1991-9#17)(1992-1#8)(1992-10#1)(1992-11#6)(1992-12#25)(1992-2#9)(1992-3#22)(1992-4#4)(1992-5#9)(1992-6#14)(1992-7#1)(1992-8#10)(1992-9#7)(1993-1#4)(1993-11#16)(1993-12#22)(1993-2#15)(1993-3#21)(1993-5#1)(1993-6#7)(1993-8#10)(1993-9#8)(1994-1#8)(1994-11#15)(1994-12#16)(1994-2#27)(1994-3#31)(1994-5#15)(1994-6#11)(1994-7#2)(1994-8#20)(1994-9#17)(1995-1#12)(1995-11#11)(1995-12#27)(1995-2#22)(1995-3#10)(1995-4#2)(1995-5#12)(1995-6#20)(1995-8#13)(1995-9#3)(1996-1#9)(1996-11#3)(1996-12#27)(1996-2#21)(1996-3#24)(1996-4#4)(1996-5#15)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#11)(1997-1#16)(1997-2#34)(1997-3#22)(1997-4#16)(1997-5#7)(1997-6#16)(1997-7#17)(1997-8#18)(1997-9#1)(2006-10#9)(2006-5#1)(2006-6#5)(2006-8#1)(2007-1#1)(2007-10#20)(2007-11#90)(2007-12#91)(2007-2#11)(2007-4#2)(2007-5#7)(2007-6#3)(2007-7#36)(2007-8#33)(2007-9#3)(2008-1#67)(2008-10#652)(2008-11#209)(2008-12#84)(2008-2#172)(2008-3#295)(2008-4#91)(2008-5#164)(2008-6#57)(2008-7#155)(2008-8#144)(2008-9#117)(2009-1#5)(2009-10#26)(2009-11#17)(2009-12#10)(2009-2#7)(2009-3#13)(2009-4#9)(2009-5#21)(2009-6#12)(2009-7#19)(2009-8#20)(2009-9#8)(2010-1#5)(2010-10#12)(2010-11#14)(2010-12#24)(2010-2#11)(2010-3#17)(2010-4#15)(2010-5#18)(2010-6#16)(2010-7#16)(2010-8#35)(2010-9#3)(2011-1#49)(2011-10#1)(2011-2#154)(2011-3#7)(2012-1#22)(2012-12#32)(2012-2#80)(2012-3#72)(2012-8#1)(2013-1#137)(2013-7#13)(2013-8#63)
It's a##7##2##(1991-12#1)(1991-3#1)(1994-2#1)(2007-11#1)(2008-9#1)(2010-5#1)(2013-8#1)
It's all##2##2##(2008-6#1)(2010-6#1)
It's not##2##2##(1997-2#1)(2009-10#1)
It's time for a##2##4##(2007-12#1)(2008-12#1)
It's time##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
It's##27##1##(1991-12#1)(1991-3#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-12#3)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
ItaI##2##1##(1993-12#2)
Itai-Itai disease##6##2##(1997-4#6)
Itai-Itai##7##1##(1997-4#7)
Italian National Health##2##3##(1994-6#1)(2010-11#1)
Italian National##3##2##(1990-6#1)(1994-6#1)(2010-11#1)
Italian centenarians##4##2##(2008-7#4)
Italian general denaturant##2##3##(2008-10#2)
Italian hospital##3##2##(1994-2#1)(2013-1#2)
Italian isolate##2##2##(2008-8#2)
Italian migrants##2##2##(1994-2#2)
Italian population##5##2##(1992-8#1)(1994-6#1)(2008-5#1)(2008-7#1)(2010-11#1)
Italian questionnaire##2##2##(2008-11#2)
Italian region##2##2##(1994-12#1)(2008-12#1)
Italian regions##2##2##(1991-12#1)(1992-2#1)
Italian ryegrass##5##2##(2008-10#2)(2012-2#3)
Italian seed lots##2##3##(2008-10#2)
Italian study##2##2##(2008-1#1)(2008-5#1)
Italian version of the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
Italian women##2##2##(1992-2#1)(1994-6#1)
Italian x perennial ryegrass##2##4##(2008-10#2)
Italian x##3##2##(2008-10#3)
Italian##110##1##(1990-3#2)(1990-6#3)(1990-8#4)(1991-12#2)(1991-2#2)(1991-6#2)(1991-8#1)(1992-10#1)(1992-2#3)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#3)(1994-2#5)(1994-6#4)(2008-1#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2010-1#1)(2010-11#3)(2010-3#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-5#2)(2013-1#6)(2013-8#1)
Italy and abroad##2##3##(1992-9#1)(2008-7#1)
Italy and the##2##3##(2008-10#1)(2011-2#1)
Italy and##11##2##(1992-9#1)(1994-2#1)(1994-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
Italy are##2##2##(1990-3#1)(1993-2#1)
Italy in##4##2##(1992-8#1)(1993-3#1)(2008-10#1)(2008-5#1)
Italy was##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
Italy were##3##2##(1994-6#1)(2008-10#2)
Italy##142##1##(1990-12#2)(1990-2#2)(1990-3#2)(1990-8#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-4#2)(1992-2#1)(1992-8#2)(1992-9#4)(1993-2#4)(1993-3#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#3)(1995-9#2)(1996-3#1)(1997-5#2)(1997-8#1)(2007-7#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#10)(2008-8#8)(2009-10#2)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#10)(2011-3#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#10)
Italy)##15##1##(1990-2#1)(1992-8#1)(1994-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-7#1)(2010-4#1)(2012-7#1)
Itch gene##2##2##(2012-2#2)
Itch promoter##2##2##(2012-2#2)
Itch##7##1##(2008-5#1)(2012-2#6)
Item##4##1##(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
Items##8##1##(1996-1#2)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
Iterative algorithm for##2##3##(2007-11#1)(2008-3#1)
Iterative optimization routine##2##3##(2009-2#2)
Iterative##10##1##(2007-11#1)(2008-2#1)(2008-3#4)(2009-2#2)(2010-9#1)(2012-1#1)
Ito cell mitogenesis occurs##2##4##(1994-6#2)
Ito cell##3##2##(1994-6#3)
Ito##4##1##(1994-6#4)
Itraconazole##4##1##(2008-3#2)(2009-11#1)(2011-2#1)
Its N-terminal##2##2##(1995-8#1)(2008-9#1)
Its ability to##5##3##(1995-12#1)(1995-2#1)(2008-2#1)(2012-2#2)
Its activity may##2##3##(1994-6#1)(2009-12#1)
Its activity was##2##3##(1992-12#1)(2008-11#1)
Its activity##5##2##(1992-12#1)(1994-6#1)(2008-11#2)(2009-12#1)
Its affinity##2##2##(1993-3#1)(1995-11#1)
Its application to the##2##4##(1993-5#1)(1995-1#1)
Its application to##6##3##(1993-5#1)(1994-9#1)(1995-1#1)(2008-10#2)(2008-3#1)
Its application##9##2##(1993-5#1)(1994-9#1)(1995-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
Its biological##2##2##(1997-1#1)(2011-1#1)
Its clinical##3##2##(2010-8#1)(2011-1#1)(2013-8#1)
Its cost##2##2##(1996-1#1)(2008-10#1)
Its critical##2##2##(2008-10#1)(2009-4#1)
Its deduced amino acid sequence##2##5##(1995-11#1)(1997-7#1)
Its detection limit##3##3##(2008-10#3)
Its development##2##2##(1996-12#1)(2008-2#1)
Its diagnostic##2##2##(2008-7#1)(2013-1#1)
Its effects##3##2##(1994-8#1)(2008-11#1)(2012-12#1)
Its efficacy##2##2##(2007-11#1)(2008-11#1)
Its expression##4##2##(1994-10#1)(1995-8#1)(2008-8#1)(2010-2#1)
Its main##3##2##(1992-1#1)(1995-5#1)(2008-5#1)
Its management##2##2##(2011-2#2)
Its molecular##2##2##(1995-11#1)(2008-8#1)
Its nucleotide sequence##2##3##(1990-11#1)(2008-10#1)
Its objectives##2##2##(1995-3#1)(2009-10#1)
Its occurrence in##3##3##(1991-8#1)(1995-12#1)(2009-1#1)
Its occurrence##4##2##(1991-8#1)(1995-12#1)(2007-11#1)(2009-1#1)
Its pathology##2##2##(1991-3#1)(1997-3#1)
Its performance was##2##3##(2008-10#1)(2010-8#1)
Its performance##3##2##(2008-10#2)(2010-8#1)
Its physiological##2##2##(1995-6#1)(2008-11#1)
Its potential##2##2##(2007-12#1)(2008-11#1)
Its precise##2##2##(2008-7#1)(2010-12#1)
Its presence in##2##3##(1991-8#1)(2008-5#1)
Its presence is##2##3##(2008-1#1)(2008-10#1)
Its presence##5##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-5#1)
Its primary##3##2##(1990-2#1)(2008-10#1)(2012-3#1)
Its purpose is to##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
Its rapid##2##2##(2007-7#1)(2008-4#1)
Its role##3##2##(1996-6#1)(2007-7#1)(2009-9#1)
Its safety##2##2##(2008-3#1)(2008-7#1)
Its sensitivity and##2##3##(2008-3#1)(2013-1#1)
Its sensitivity##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
Its structure##3##2##(1992-3#1)(1997-7#1)(2008-5#1)
Its unique##2##2##(2009-12#1)(2011-2#1)
Its use allows##2##3##(2008-10#1)(2011-7#1)
Its use in##2##3##(2006-10#1)(2008-2#1)
Its use is##3##3##(1996-5#1)(2008-4#1)(2012-12#1)
Its use##8##2##(1992-2#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-7#1)(2012-12#1)
Its widespread use##2##3##(2008-9#1)(2012-3#1)
Its widespread##3##2##(1996-5#1)(2008-9#1)(2012-3#1)
Its##297##1##(1990-11#2)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#4)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#4)(2006-10#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#3)(2008-1#3)(2008-10#66)(2008-11#10)(2008-2#10)(2008-3#8)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#3)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#9)(2012-2#4)(2012-3#6)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#3)
Iturins##2##1##(1994-2#2)
Ivermectin##2##1##(1991-12#1)(2010-8#1)
Ivorian##2##1##(2013-1#2)
Ivory Coast##5##2##(2008-10#4)(2013-1#1)
Iwao'##2##1##(2008-10#2)
IxN/2bx##2##1##(2008-4#2)
Ixabepilone##2##1##(2009-9#2)
Ixodes ricinus##4##2##(2007-12#2)(2008-12#1)(2013-8#1)
Ixodes##12##1##(1997-4#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
Ixodidae)##2##1##(1996-12#1)(2007-12#1)
I} data##2##2##(2008-10#2)
IκBα degradation##3##2##(2012-2#1)(2012-3#2)
J &amp##3##2##(2007-10#3)
J (O)/J(F)##2##2##(2008-8#2)
J =##2##2##(2007-12#1)(2008-10#1)
J Biol Chem##3##3##(1994-8#1)(2008-4#1)(2009-9#1)
J Med##4##2##(1997-3#1)(2008-4#1)(2012-3#2)
J Obstet Gynecol Reprod##2##4##(1994-5#2)
J Phys Anthropol##9##3##(2011-2#9)
J and##4##2##(1992-10#1)(1994-8#2)(2008-9#1)
J at##2##2##(2007-11#1)(2008-3#1)
J cm(-2) for##2##3##(2008-3#2)
J cm(-2)##6##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
J is##4##2##(1997-7#3)(2009-5#1)
J mol(-1) K(-1) and##2##4##(2008-10#2)
J mol(-1) K(-1)##5##3##(1996-2#3)(2008-10#2)
J mol(-1)##7##2##(1996-2#3)(2008-10#2)(2008-3#2)
J mol(-1))##2##2##(2011-1#2)
J of##2##2##(2007-12#2)
J point and##2##3##(2008-7#1)(2012-3#1)
J point##3##2##(2008-7#2)(2012-3#1)
J pulses with a pulse width of##2##7##(2007-12#2)
J##389##1##(1990-11#7)(1990-12#3)(1990-2#1)(1990-5#5)(1990-7#7)(1990-8#7)(1991-12#11)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#8)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#5)(1992-3#9)(1992-4#2)(1992-5#1)(1992-6#10)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#17)(1994-6#2)(1994-8#5)(1995-11#4)(1995-12#3)(1995-2#20)(1995-3#2)(1995-5#5)(1995-6#12)(1996-1#1)(1996-11#1)(1996-2#3)(1996-5#6)(1997-2#7)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#2)(2007-10#4)(2007-11#3)(2007-12#7)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#9)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#5)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#4)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#27)(2011-3#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
J'##4##1##(2008-8#4)
J'=0##2##1##(2013-7#2)
J) and##2##2##(1994-8#1)(2008-2#1)
J)##4##1##(1994-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
J-aggregates##4##1##(1993-11#1)(2008-7#2)(2010-4#1)
J-shaped dose-response##2##2##(2008-7#2)
J-shaped##6##1##(2008-7#6)
J/cm(2) with##2##2##(2008-3#1)(2012-2#1)
J/cm(2)##16##1##(2007-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#3)(2012-2#3)
J/cm2 and##2##2##(1992-9#1)(2008-3#1)
J/cm2 of energy (mean ± SD 6##2##7##(2013-1#2)
J/cm2 of energy (mean ±##3##5##(2013-1#3)
J/cm2##10##1##(1992-9#3)(2007-8#1)(2008-3#2)(2012-2#1)(2013-1#3)
J/cm2)##3##1##(2013-1#3)
J13##2##1##(2011-2#2)
J2 were added##2##3##(2008-10#2)
J2 were##3##2##(2008-10#3)
J2##19##1##(1991-9#2)(2008-10#15)(2010-2#2)
J4##2##1##(2008-10#2)
J774 cells was##2##3##(1990-7#2)
J774 cells##8##2##(1990-7#5)(1994-8#3)
J774 macrophage##2##2##(1995-3#2)
J774 macrophages##2##2##(1995-11#1)(1996-2#1)
J774##19##1##(1990-7#5)(1990-8#1)(1994-11#1)(1994-8#4)(1995-11#1)(1995-3#2)(1996-12#3)(1996-2#1)(2008-11#1)
JA##3##1##(2009-8#3)
JAACT Issue##2##2##(2008-11#2)
JAK##3##1##(1996-2#2)(2008-1#1)
JAK2 ( V617F ) allele##2##5##(2009-8#2)
JAK2 ( V617F ) in##3##5##(2009-8#3)
JAK2 ( V617F )##8##4##(2009-8#8)
JAK2##9##1##(2008-10#1)(2009-8#8)
JAKs##4##1##(1996-2#4)
JAOS##2##1##(2013-1#2)
JAR cells##2##2##(1994-6#1)(2008-10#1)
JAR##3##1##(1994-6#2)(2008-10#1)
JASCO##2##1##(2008-10#2)
JAmyb##2##1##(2008-10#2)
JB25 and JB26##3##3##(2011-3#3)
JB25##5##1##(2011-3#5)
JB26##5##1##(2011-3#5)
JC##3##1##(1991-8#1)(2008-12#2)
JC-1##6##1##(1993-11#2)(2008-9#4)
JC1 was##2##2##(1997-6#2)
JC1##6##1##(1997-6#6)
JCAHO standards##2##2##(1993-2#1)(1995-1#1)
JCAHO survey##2##2##(1995-1#1)(1997-2#1)
JCAHO surveyors##2##2##(1993-2#1)(1995-1#1)
JCAHO##22##1##(1991-1#1)(1993-12#1)(1993-2#6)(1994-12#2)(1995-1#6)(1995-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-2#1)
JCAHO's##5##1##(1993-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-6#1)
JCV##2##1##(2008-12#2)
JCVI##3##1##(2011-2#3)
JDBM alloy##2##2##(2012-2#2)
JDBM##3##1##(2012-2#3)
JDR##3##1##(2013-1#3)
JDRC 8##2##2##(2008-10#2)
JE and##2##2##(1993-6#1)(1994-9#1)
JE##13##1##(1993-6#2)(1994-9#8)(2008-12#1)(2011-2#2)
JF##6##1##(2008-5#6)
JFrTC architectures##2##2##(2008-2#2)
JFrTC can##2##2##(2008-2#2)
JFrTC##4##1##(2008-2#4)
JH is##2##2##(2012-2#2)
JH segments##2##2##(1991-6#1)(1997-9#1)
JH synthesis##6##2##(1995-11#1)(2008-7#5)
JH##24##1##(1991-6#2)(1992-6#1)(1995-11#5)(1997-9#1)(2008-7#6)(2012-2#9)
JH-binding##2##1##(2012-2#2)
JH-bound JHBP##2##2##(2012-2#2)
JHBP##4##1##(2012-2#4)
JIMT1 cells##2##2##(2013-1#2)
JIMT1##3##1##(2013-1#3)
JJ45B##3##1##(2009-6#3)
JK-0346##2##1##(2008-10#2)
JK-21##2##1##(1993-6#2)
JLN syndrome##3##2##(2012-2#3)
JM##3##1##(2008-8#1)(2010-1#1)(2011-2#1)
JMMT website##2##2##(2008-12#2)
JNDs##3##1##(1990-11#3)
JNK and##2##2##(1996-2#1)(2008-4#1)
JNK pathway is##2##3##(2008-1#2)
JNK pathway##8##2##(2008-1#8)
JNK##25##1##(1996-2#1)(2008-1#8)(2008-4#4)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-7#1)
JNK1 and##3##2##(2012-12#3)
JNK1##8##1##(2008-4#2)(2012-12#6)
JPEG (Joint Photographic Experts Group)##2##5##(2008-3#2)
JPEG##6##1##(2008-12#1)(2008-2#1)(2008-3#4)
JQ1##3##1##(2012-12#3)
JR##4##1##(1997-6#1)(2008-10#2)(2011-2#1)
JST##2##1##(1994-3#1)(2009-5#1)
JSTP has##2##2##(2012-1#2)
JSTP##4##1##(2012-1#4)
JTC bias##2##2##(2012-1#2)
JTC is##2##2##(2008-2#1)(2008-3#1)
JTC##13##1##(2008-2#4)(2008-3#6)(2012-1#3)
JTPS##3##1##(2008-3#3)
JUPITER trial##2##2##(2010-12#2)
JUPITER##3##1##(2010-12#3)
JW##2##1##(2008-11#2)
JY-6##2##1##(2008-11#2)
JYG-MMTV##5##1##(1994-12#5)
Jaagiella##2##1##(2008-7#2)
Jaccard index##4##2##(2008-10#4)
Jaccard##5##1##(2008-10#5)
Jaccard's similarity##3##2##(2008-10#2)(2013-7#1)
Jaccard's##4##1##(2008-10#2)(2010-5#1)(2013-7#1)
Jack bean meal##2##3##(2008-10#2)
Jack of all trades##2##4##(2007-4#1)(2009-8#1)
Jack were##2##2##(2008-10#1)(2008-11#1)
Jack##13##1##(1997-4#1)(2007-4#1)(2008-10#6)(2008-11#4)(2009-8#1)
Jackson##10##1##(1993-12#1)(1994-1#2)(2008-7#4)(2011-2#2)(2013-8#1)
Jackson's##2##1##(1994-2#1)(2008-7#1)
Jacobian##3##1##(2008-3#2)(2008-9#1)
Jacobs##3##1##(1990-3#1)(1995-12#1)(2010-8#1)
Jacobson##2##1##(2008-10#1)(2011-2#1)
Jadad##2##1##(2008-10#2)
Jaffé reaction##2##2##(2008-10#2)
Jaffé##4##1##(2008-10#4)
Jahn-Teller##6##1##(1992-8#1)(1996-2#5)
Jain##2##1##(1994-3#1)(2008-11#1)
Jakubowski##2##1##(2007-8#2)
Jalisco##5##1##(2008-12#1)(2008-5#1)(2011-2#1)(2013-7#2)
Jamaica##34##1##(1997-2#1)(2007-5#4)(2008-10#1)(2009-7#12)(2011-2#16)
Jamaican children##5##2##(2009-7#3)(2011-2#2)
Jamaican##11##1##(2009-7#6)(2010-1#1)(2011-2#4)
James Knight##3##2##(2008-8#3)
James##18##1##(1990-8#1)(1991-3#1)(1993-6#2)(1994-12#2)(1996-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#5)(2009-10#1)
James's##2##1##(1993-2#1)(2010-4#1)
Jan##6##1##(1994-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-7#1)(2011-1#1)
Jane Doe##2##2##(1993-3#1)(1997-5#1)
Jane##4##1##(1993-3#1)(1996-5#1)(1997-5#1)(2009-12#1)
Janet##4##1##(1995-2#2)(2007-11#1)(2008-7#1)
Jann_2411##3##1##(2010-10#3)
Janolus##3##1##(2008-5#3)
January 1##18##2##(1992-1#1)(1994-1#1)(1996-1#1)(1996-3#2)(2007-12#2)(2007-8#1)(2008-11#1)(2009-6#1)(2011-2#6)(2013-1#2)
January 1975##2##2##(2008-6#1)(2012-12#1)
January 1983 and##2##3##(1990-12#1)(1990-3#1)
January 1984##2##2##(1991-2#1)(1993-5#1)
January 1985 to December##2##4##(1992-5#1)(1994-1#1)
January 1985 to##3##3##(1992-5#1)(1994-1#1)(2012-2#1)
January 1985##5##2##(1992-10#1)(1992-5#1)(1994-1#1)(1995-5#1)(2012-2#1)
January 1986##2##2##(1990-2#1)(1990-6#1)
January 1987##3##2##(1991-12#1)(1991-8#1)(2008-7#1)
January 1988##2##2##(1990-12#1)(2008-5#1)
January 1989 to##2##3##(1994-11#1)(2007-8#1)
January 1989##3##2##(1992-4#1)(1994-11#1)(2007-8#1)
January 1990 and December##2##4##(2007-8#1)(2010-3#1)
January 1990 and##3##3##(1994-12#1)(2007-8#1)(2010-3#1)
January 1990##4##2##(1992-2#1)(1994-12#1)(2007-8#1)(2010-3#1)
January 1991 and##3##3##(1992-5#1)(2008-7#1)(2013-8#1)
January 1991##8##2##(1991-12#1)(1992-5#2)(1992-9#2)(1997-8#1)(2008-7#1)(2013-8#1)
January 1992##4##2##(1992-1#1)(1992-12#1)(1995-1#1)(1996-9#1)
January 1993##8##2##(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-5#1)(2008-9#1)
January 1994##3##2##(1994-3#1)(1994-9#1)(2008-1#1)
January 1995 to##2##3##(2008-4#1)(2008-5#1)
January 1995##6##2##(1996-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
January 1996##3##2##(1996-1#1)(2007-7#1)(2011-2#1)
January 1997##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
January 1998##7##2##(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#3)
January 1999 and##3##3##(2007-7#1)(2007-8#2)
January 1999 to##2##3##(2007-10#1)(2007-11#1)
January 1999##5##2##(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)
January 1st##2##2##(2008-1#1)(2011-2#1)
January 2000 and##4##3##(2007-10#1)(2007-8#1)(2008-8#1)(2012-12#1)
January 2000 to##2##3##(2008-1#1)(2008-12#1)
January 2000##8##2##(1996-1#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2012-12#1)
January 2001##6##2##(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#1)
January 2002##9##2##(2007-10#2)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
January 2003 to##3##3##(2008-10#1)(2008-7#1)(2010-6#1)
January 2003##7##2##(2007-7#1)(2008-10#1)(2008-7#2)(2010-6#1)(2013-1#1)(2013-8#1)
January 2004##7##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
January 2005##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
January 2006##4##2##(2011-2#3)(2013-1#1)
January 2007##4##2##(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
January 2008##8##2##(2009-5#1)(2009-9#1)(2011-2#4)(2012-12#2)
January 2009##5##2##(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
January 2010##10##2##(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
January 2011##2##2##(2012-2#1)(2013-8#1)
January 31##3##2##(1993-2#1)(1997-1#1)(2011-2#1)
January 5th##2##2##(2008-10#1)(2008-2#1)
January and December##3##3##(2008-11#1)(2008-6#1)(2012-12#1)
January and##7##2##(1994-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
January through##3##2##(1992-6#1)(1996-2#1)(2012-3#1)
January to March##3##3##(1993-12#1)(1996-6#1)(2009-6#1)
January to##11##2##(1993-12#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2009-8#1)(2010-5#1)(2013-7#3)
January##230##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#2)(2007-10#6)(2007-11#2)(2007-12#3)(2007-7#5)(2007-8#11)(2008-1#6)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#27)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#5)
Janus##6##1##(1996-2#2)(1996-3#1)(2008-4#1)(2010-11#1)(2010-3#1)
Japan and##23##2##(1992-3#1)(1993-2#1)(1997-8#1)(2007-7#1)(2008-10#8)(2008-11#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
Japan for 3 years##2##4##(1997-7#1)(2008-10#1)
Japan for##6##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
Japan from##3##2##(1994-7#1)(2008-10#2)
Japan have##3##2##(2006-10#1)(2007-10#1)(2008-10#1)
Japan in##4##2##(1993-12#1)(2008-5#1)(2010-4#1)(2010-6#1)
Japan is##4##2##(1995-12#1)(1996-4#1)(2006-10#1)(2008-10#1)
Japan were examined for##2##4##(1997-3#1)(2009-3#1)
Japan were##8##2##(1997-3#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-3#1)
Japan##279##1##(1991-11#2)(1991-2#2)(1991-8#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-4#2)(1996-6#1)(1997-3#3)(1997-4#4)(1997-7#3)(1997-8#5)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#7)(2008-10#66)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#18)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#2)(2009-2#4)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#9)(2010-2#1)(2010-3#1)(2010-4#6)(2010-6#2)(2010-8#21)(2010-9#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#8)(2013-1#9)(2013-8#5)
Japan's##5##1##(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#1)(2012-2#1)
Japan)##3##1##(2007-12#1)(2008-10#2)
Japanese Black and Holstein##2##4##(2013-1#2)
Japanese Black and##3##3##(2013-1#3)
Japanese Black cattle##4##3##(2010-2#2)(2012-2#2)
Japanese Black##13##2##(2010-2#2)(2012-2#2)(2013-1#9)
Japanese Erwinia##3##2##(2008-10#3)
Japanese Society of##7##3##(1994-12#3)(2010-1#1)(2012-1#3)
Japanese Strains of##2##3##(2008-10#2)
Japanese acupuncture##2##2##(2008-10#2)
Japanese adult##2##2##(2008-3#2)
Japanese advanced lung cancer##2##4##(2010-2#2)
Japanese and##3##2##(2008-10#3)
Japanese blood##2##2##(1993-12#2)
Japanese cedar pollen##5##3##(2012-12#5)
Japanese cedar pollinosis##9##3##(2008-11#2)(2012-12#7)
Japanese cedar##14##2##(2008-11#2)(2012-12#12)
Japanese differential cultivars##2##3##(2008-10#2)
Japanese eel Anguilla japonica##2##4##(2010-8#2)
Japanese encephalitis virus (JEV)##2##4##(1995-12#1)(2011-2#1)
Japanese encephalitis virus##3##3##(1995-12#2)(2011-2#1)
Japanese encephalitis##6##2##(1995-12#2)(2008-12#1)(2011-2#3)
Japanese female##2##2##(2008-5#2)
Japanese flounder Paralichthys olivaceus##3##4##(2008-6#1)(2010-8#2)
Japanese flounder##8##2##(2008-6#2)(2009-7#4)(2010-8#2)
Japanese immigrants##2##2##(2008-2#2)
Japanese isolate##2##2##(2008-10#2)
Japanese medaka (Oryzias latipes)##2##4##(2008-8#2)
Japanese men with type 2 DM##2##6##(2008-3#2)
Japanese men##5##2##(2007-9#1)(2008-3#2)(2012-3#1)(2013-1#1)
Japanese native horses##4##3##(2013-1#4)
Japanese native##6##2##(2012-1#2)(2013-1#4)
Japanese nurses##4##2##(2008-11#4)
Japanese patients with##6##3##(2008-4#1)(2009-8#1)(2012-12#1)(2012-2#3)
Japanese patients##15##2##(1995-8#1)(1997-8#4)(2007-12#1)(2008-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#4)
Japanese pear scab##2##3##(2008-10#2)
Japanese pear##8##2##(2008-10#8)
Japanese people##2##2##(2010-4#1)(2012-12#1)
Japanese plum fruit##2##3##(2011-2#2)
Japanese plum##8##2##(2008-10#5)(2011-2#3)
Japanese population##8##2##(1993-3#2)(1997-8#2)(2007-10#2)(2008-7#1)(2010-2#1)
Japanese quail (Coturnix coturnix japonica)##2##5##(1997-3#2)
Japanese quail (Coturnix##3##3##(1997-3#2)(2008-12#1)
Japanese quail##4##2##(1997-3#2)(2008-12#2)
Japanese quails with##2##3##(2008-12#2)
Japanese quails##4##2##(1997-3#1)(2008-12#3)
Japanese rice cultivars##2##3##(2008-10#2)
Japanese rice##3##2##(2008-10#3)
Japanese strains of##2##3##(2008-10#2)
Japanese style acupuncture and moxibustion##2##5##(2008-10#2)
Japanese style acupuncture##3##3##(2008-10#3)
Japanese traditional##3##2##(2008-10#2)(2008-6#1)
Japanese victims##4##2##(1997-4#4)
Japanese volunteers##2##2##(2008-5#1)(2012-12#1)
Japanese woman with##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
Japanese woman##7##2##(1994-7#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Japanese women##5##2##(1994-12#1)(1996-3#1)(1997-4#1)(2008-5#2)
Japanese##280##1##(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#3)(1993-3#2)(1993-8#1)(1994-12#6)(1994-7#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#9)(2007-1#2)(2007-10#2)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#59)(2008-11#12)(2008-12#6)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#12)(2008-6#6)(2008-7#6)(2008-8#2)(2009-5#1)(2009-7#7)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#7)(2010-3#1)(2010-4#2)(2010-8#11)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#6)(2012-12#18)(2012-2#10)(2012-3#2)(2012-8#1)(2013-1#24)
Japonica##2##1##(2008-4#2)
Jaragua National Park##3##3##(2008-5#3)
Jarvik 2000##2##2##(2010-8#2)
Jatropha##2##1##(2009-3#1)(2010-9#1)
Jaundice##5##1##(1990-8#1)(1990-9#1)(2007-7#1)(2008-11#1)(2008-9#1)
Java##7##1##(2008-10#4)(2008-5#1)(2011-2#1)(2011-3#1)
Jay##2##1##(1994-2#1)(1995-1#1)
Jean##6##1##(1994-1#1)(1995-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)
Jeddah##11##1##(2007-12#1)(2007-7#4)(2008-1#5)(2013-1#1)
Jefferson##3##1##(1994-3#1)(2008-10#1)(2013-1#1)
Jeffrey pine##4##2##(2008-10#4)
Jeffrey##5##1##(2008-10#4)(2008-4#1)
Jeffries Wyman##2##2##(1990-8#2)
Jehovah's Witness##6##2##(2008-11#5)(2009-4#1)
Jehovah's Witnesses patients##2##3##(2013-8#2)
Jehovah's Witnesses##6##2##(1996-9#2)(2013-8#4)
Jehovah's##13##1##(1996-9#3)(2008-11#5)(2009-4#1)(2013-8#4)
Jeju##2##1##(2011-1#2)
Jejunal##3##1##(1991-12#1)(1994-6#1)(1995-10#1)
Jen-Chung point##3##2##(1995-12#3)
Jerphagnon and Kurtz'sformula##2##3##(2008-2#2)
Jerphagnon##3##1##(2008-2#3)
Jersey##36##1##(1991-1#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-5#2)(1997-3#2)(2007-10#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-8#5)(2010-9#1)
Jerusalem artichoke powder##3##3##(2013-1#3)
Jerusalem artichoke##5##2##(1991-5#1)(2013-1#4)
Jerusalem##11##1##(1991-5#1)(1995-3#1)(2008-1#2)(2011-2#2)(2013-1#4)(2013-8#1)
Jervell and Lange-Nielsen##2##3##(2012-2#2)
Jessamy##2##1##(1994-12#2)
Jessore##2##1##(2008-10#2)
Jet Neuf##2##2##(2008-10#2)
Jet Propulsion Laboratory##2##3##(2008-2#2)
Jet Propulsion##3##2##(2008-2#2)(2008-3#1)
Jet##7##1##(1997-6#1)(2008-10#3)(2008-2#2)(2008-3#1)
Jewish and##2##2##(2012-12#2)
Jewish medical##3##2##(2013-8#3)
Jewish students##3##2##(2013-8#3)
Jewish##18##1##(1992-1#1)(1992-2#1)(1994-1#1)(1996-2#1)(2008-1#1)(2008-7#1)(2009-11#1)(2012-12#3)(2013-8#8)
Jews from##2##2##(2008-12#1)(2013-8#1)
Jews##9##1##(1997-8#1)(2007-7#1)(2008-1#2)(2008-12#2)(2009-11#1)(2013-8#2)
Jialing River##2##2##(2008-10#1)(2011-2#1)
Jiangsu##4##1##(2008-8#2)(2011-1#1)(2012-3#1)
Jiangxi##2##1##(2008-10#1)(2012-3#1)
Jill L##3##2##(1993-12#1)(1996-1#2)
Jim##3##1##(1993-12#1)(2008-7#1)(2012-2#1)
Jinan##3##1##(2008-8#1)(2008-9#1)(2012-12#1)
Jinmi##4##1##(2008-10#4)
Jinuo population##2##2##(2011-1#2)
Jinuo##5##1##(2011-1#5)
Jixian county##3##2##(2011-1#3)
Jixian##4##1##(2011-1#4)
Jk(a-b-)##4##1##(1995-6#4)
Jka and Jkb MAbs##2##4##(1994-3#2)
Jka and##3##2##(1994-3#3)
Jlm1##3##1##(2008-10#3)
Joanne Stubbe##2##2##(2008-5#2)
Joanne##3##1##(2008-5#2)(2012-3#1)
Joao##2##1##(1991-6#1)(2012-3#1)
Job aids##2##2##(1991-2#2)
Job content and salary survey##2##5##(1995-1#1)(1995-3#1)
Job content and##3##3##(1995-1#1)(1995-2#1)(1995-3#1)
Job satisfaction of##2##3##(1995-3#1)(2013-1#1)
Job satisfaction##3##2##(1994-1#1)(1995-3#1)(2013-1#1)
Job turnover##2##2##(1994-3#2)
Job##21##1##(1991-2#3)(1993-3#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(2008-10#3)(2008-12#1)(2009-10#1)(2013-1#2)
Job's##3##1##(2008-10#3)
Joe##2##1##(1996-11#1)(1996-5#1)
Johannes##3##1##(2013-1#2)(2013-8#1)
Johannesburg##3##1##(2008-12#1)(2010-1#1)(2010-3#1)
John B##2##2##(2010-7#2)
John D##4##2##(1995-1#2)(1996-5#1)(2008-4#1)
John Paul##2##2##(1990-6#2)
John S##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
John Wiley &amp##141##3##(2008-11#36)(2008-7#62)(2008-9#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#7)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
John Wiley##142##2##(2008-11#37)(2008-7#62)(2008-9#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#7)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
John##185##1##(1990-6#2)(1990-8#1)(1992-12#1)(1992-5#1)(1995-1#2)(1995-12#1)(1995-6#2)(1996-5#3)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#41)(2008-12#2)(2008-4#2)(2008-7#67)(2008-9#2)(2009-11#1)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#14)(2012-1#1)(2012-2#7)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)(2013-8#1)
John's##3##1##(2008-11#1)(2008-8#1)(2013-8#1)
Johns Hopkins Hospital##3##3##(1993-3#1)(1994-3#1)(2008-3#1)
Johns Hopkins University##4##3##(1996-9#1)(1997-1#1)(1997-5#1)(2011-2#1)
Johns Hopkins##20##2##(1992-3#1)(1993-1#1)(1993-3#3)(1994-12#1)(1994-3#1)(1995-2#2)(1996-9#1)(1997-1#1)(1997-5#1)(2008-1#2)(2008-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
Johnson Controls##2##2##(1990-2#2)
Johnson et al##4##3##(1990-11#1)(1990-8#1)(2008-12#1)(2009-3#1)
Johnson##21##1##(1990-11#2)(1990-2#2)(1990-8#1)(1992-1#1)(1992-6#1)(1993-2#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-12#1)(2008-3#3)(2009-3#1)(2010-8#2)(2011-2#1)(2013-1#2)
Johnston##4##1##(2008-10#2)(2008-11#2)
Johnston's organ##4##2##(2008-9#4)
Johnstown##2##1##(2010-1#2)
Join the##3##2##(1992-12#1)(2008-6#1)(2011-2#1)
Joining##5##1##(1997-7#1)(2008-4#2)(2008-7#1)(2013-7#1)
Joint Commission on##4##3##(1993-2#1)(1995-2#2)(1995-3#1)
Joint Commission##12##2##(1993-2#3)(1995-2#2)(1995-3#1)(2006-5#1)(2011-1#1)(2012-2#4)
Joint Commission's##5##2##(1993-2#1)(1995-1#1)(1995-2#1)(2006-5#1)(2012-2#1)
Joint Committee##2##2##(2011-2#1)(2011-4#1)
Joint Council of Governmental Public Health Agencies##4##7##(1996-3#4)
Joint Genome Institute##2##3##(2009-9#1)(2011-2#1)
Joint World Congress on##2##4##(2008-8#2)
Joint transform##2##2##(2008-3#2)
Joint##66##1##(1993-2#4)(1993-3#1)(1995-1#1)(1995-2#5)(1995-3#1)(1996-3#4)(2006-5#2)(2007-11#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#2)(2011-1#3)(2011-2#3)(2011-4#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#3)
Jonathan##4##1##(1990-11#1)(2008-10#2)(2012-3#1)
Jones calculus##3##2##(2008-3#3)
Jones matrices##2##2##(2008-2#2)
Jones matrix eigenanalysis##2##3##(2007-12#1)(2008-3#1)
Jones matrix##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Jones##23##1##(1992-12#1)(1992-2#2)(1992-3#3)(1993-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2012-12#2)(2013-1#1)
Jones'##2##1##(1995-3#1)(2008-7#1)
Jones-matrix##3##1##(2008-2#1)(2008-3#2)
Jordan University Hospital##2##3##(2007-10#1)(2008-1#1)
Jordan##21##1##(1992-3#2)(1994-3#1)(2007-10#3)(2007-7#4)(2008-1#3)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#2)(2012-2#1)(2013-7#1)
Jordanian surgical##2##2##(2010-7#2)
Jordanian##4##1##(2010-12#1)(2010-7#2)(2012-1#1)
Joseph##10##1##(1990-11#1)(1991-2#1)(1991-9#1)(1994-12#1)(1997-5#1)(1997-6#1)(2008-10#2)(2012-2#1)(2013-1#1)
Joseph's Health Centre##2##3##(1993-12#1)(1994-1#1)
Joseph's Hospital and Medical Center##2##5##(1991-3#1)(2011-2#1)
Joseph's Hospital##4##2##(1991-3#2)(1995-6#1)(2011-2#1)
Joseph's##7##1##(1991-3#2)(1993-12#1)(1994-1#1)(1995-6#1)(2009-9#1)(2011-2#1)
Josephson junctions##4##2##(2008-7#4)
Josephson##5##1##(1990-4#1)(2008-7#4)
Joslin##2##1##(2011-2#2)
Joubert##2##1##(2011-1#1)(2011-2#1)
Journal Net##2##2##(2011-2#2)
Journal and the##2##3##(2011-4#1)(2013-1#1)
Journal impact factors##2##3##(1995-8#2)
Journal is##2##2##(2008-10#1)(2011-4#1)
Journal of Advanced Nursing##5##4##(2008-11#4)(2008-12#1)
Journal of Dental##2##3##(2008-11#1)(2013-1#1)
Journal of Experimental Botany##2##4##(2009-8#2)
Journal of Nursing##5##3##(2008-11#1)(2012-3#4)
Journal of Personality 17##2##4##(2012-3#2)
Journal of Psychiatry##4##3##(2011-3#1)(2011-4#3)
Journal of the##4##3##(1990-6#1)(2008-3#2)(2008-4#1)
Journal of##61##2##(1990-6#1)(1993-1#1)(1993-11#1)(1997-2#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#6)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#3)(2010-12#6)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2011-4#3)(2012-3#6)(2013-1#5)
Journal##90##1##(1990-6#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-2#1)(2007-7#2)(2008-10#5)(2008-11#6)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#6)(2010-12#6)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#1)(2011-4#5)(2012-3#7)(2013-1#7)
Journals##4##1##(1991-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
Journey##3##1##(1994-2#1)(2008-7#1)(2013-1#1)
Joy of rapid responses##5##4##(2007-8#5)
Joyce##3##1##(1997-5#1)(2007-9#2)
Joydebpur##2##1##(2008-10#2)
João##5##1##(2008-9#2)(2009-10#3)
Jr##21##1##(1990-10#1)(1990-12#1)(1990-3#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1994-1#2)(1994-5#1)(1995-12#1)(1995-6#2)(2008-4#2)(2009-4#1)(2011-2#2)
Jsa (K6)##2##2##(1994-12#2)
Jsa##4##1##(1994-12#4)
Jubilee##3##1##(1992-12#1)(2008-10#1)(2011-1#1)
Judd-Ofelt##3##1##(2008-2#2)(2008-3#1)
Jude the##2##2##(2012-2#2)
Jude##3##1##(2008-8#1)(2012-2#2)
Judge John##3##2##(1995-12#1)(1996-5#1)(1997-5#1)
Judge says##2##2##(1995-12#1)(1997-5#1)
Judge##16##1##(1994-7#1)(1995-12#6)(1995-6#1)(1996-5#3)(1997-5#4)(2009-8#1)
Judging##2##1##(2012-1#1)(2013-8#1)
Judgment##2##1##(2008-6#1)(2009-9#1)
Judgmental##4##1##(2008-11#1)(2009-8#1)(2010-4#2)
Judith##2##1##(1995-6#1)(2008-10#1)
Juglans regia##2##2##(2008-10#1)(2013-1#1)
Juice##3##1##(2008-10#3)
Jules##2##1##(2007-4#1)(2010-1#1)
July 1##2##2##(1991-1#1)(2013-7#1)
July 12-14##2##2##(2008-7#1)(2011-2#1)
July 15##2##2##(1990-2#1)(2009-2#1)
July 1988##2##2##(1991-2#1)(1991-5#1)
July 1990##2##2##(1991-11#1)(1993-12#1)
July 1992##2##2##(1994-12#1)(1994-7#1)
July 1994##3##2##(1995-6#1)(1996-1#1)(2008-10#1)
July 1995 and##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
July 1995##4##2##(1996-5#1)(2007-10#1)(2008-10#1)(2011-2#1)
July 1996##7##2##(2007-7#1)(2008-10#2)(2008-2#2)(2008-5#2)
July 1997 to June 1999##2##5##(2007-2#2)
July 1997##8##2##(2007-2#2)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#1)
July 1998##11##2##(2008-10#1)(2008-5#10)
July 1999 to##2##3##(2008-1#1)(2008-6#1)
July 1999##6##2##(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#2)
July 2000##3##2##(2007-2#1)(2008-3#2)
July 2001##2##2##(2007-8#1)(2008-10#1)
July 2002##7##2##(2007-7#1)(2008-1#1)(2008-10#4)(2008-7#1)
July 2004##2##2##(2008-4#1)(2008-8#1)
July 2005##2##2##(2008-1#1)(2010-9#1)
July 2006##4##2##(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)
July 2007##2##2##(2011-1#1)(2011-3#1)
July 2008##4##2##(2010-8#1)(2011-2#2)(2013-8#1)
July 2009##3##2##(2011-3#1)(2012-3#2)
July 2010##2##2##(2010-3#1)(2012-3#1)
July 2011##2##2##(2012-12#1)(2013-1#1)
July 2012##3##2##(2013-1#3)
July 22##2##2##(1990-2#1)(1995-6#1)
July 26##4##2##(1991-12#1)(1994-1#1)(1995-6#1)(1996-1#1)
July and August##3##3##(2008-10#2)(2011-1#1)
July and October##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
July and September##3##3##(2008-5#1)(2009-12#2)
July and##16##2##(2008-10#6)(2008-12#1)(2008-5#3)(2009-12#4)(2011-1#1)(2011-2#1)
July in##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
July of##2##2##(1993-1#1)(2010-10#1)
July to##5##2##(1995-12#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-5#1)
July was##3##2##(2008-10#1)(2012-2#2)
July##160##1##(1990-2#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#5)(1996-1#2)(1996-12#2)(1996-5#2)(1997-2#1)(2007-10#2)(2007-11#1)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#24)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#20)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#5)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2012-6#2)(2013-1#6)(2013-7#2)(2013-8#1)
Jump##2##1##(1995-2#1)(2012-2#1)
Jumps##2##1##(1993-11#1)(2008-3#1)
Jun##9##1##(1995-11#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(2011-1#1)
Jun-B##2##1##(1991-2#2)
Junction##2##1##(2008-7#1)(2012-3#1)
Junctional##3##1##(2008-5#1)(2008-7#1)(2010-5#1)
June 1##3##2##(1996-5#1)(2006-10#1)(2013-1#1)
June 11##2##2##(1992-3#1)(1997-6#1)
June 1986##3##2##(1990-2#1)(1990-6#1)(1995-2#1)
June 1989##4##2##(1990-2#1)(1993-12#1)(1993-5#1)(1994-1#1)
June 1990##4##2##(1991-1#1)(1991-2#1)(1994-3#1)(2013-7#1)
June 1991##2##2##(1992-9#1)(2008-2#1)
June 1993##4##2##(1994-9#2)(1995-1#1)(2007-10#1)
June 1994##4##2##(1996-2#2)(2007-10#1)(2007-7#1)
June 1996##4##2##(1997-2#1)(2008-2#1)(2008-5#2)
June 1997##3##2##(1997-8#1)(2008-3#2)
June 1998##13##2##(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#9)
June 1999##9##2##(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
June 2000##3##2##(2007-10#1)(2007-7#1)(2008-5#1)
June 2001##3##2##(2007-7#1)(2008-6#1)(2011-2#1)
June 2002##3##2##(2007-10#1)(2007-2#1)(2007-8#1)
June 2003##2##2##(2007-11#1)(2008-10#1)
June 2004##3##2##(2008-10#2)(2008-12#1)
June 2007##2##2##(2011-2#2)
June 2008##5##2##(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
June 2009##9##2##(2010-4#2)(2011-2#5)(2012-2#1)(2013-7#1)
June 2010##3##2##(2012-3#1)(2013-7#1)(2013-8#1)
June 23##2##2##(1995-6#1)(2012-1#1)
June 30##4##2##(1991-1#1)(2007-12#2)(2013-8#1)
June and##6##2##(1994-9#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#2)
June for##2##2##(1995-6#1)(2008-10#1)
June from##2##2##(2008-10#2)
June to##8##2##(2007-11#1)(2008-10#3)(2008-12#1)(2012-2#2)(2013-7#1)
June##187##1##(1990-2#4)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#7)(1996-10#1)(1996-12#3)(1996-2#3)(1996-5#3)(1997-2#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#3)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-2#2)(2010-4#3)(2010-6#2)(2011-1#1)(2011-2#20)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#2)
June)##3##1##(2008-10#1)(2011-2#1)(2013-8#1)
June-July##3##1##(2008-5#1)(2011-2#1)(2013-7#1)
Jupiter's##2##1##(1995-6#2)
Juran##2##1##(1992-2#1)(1993-2#1)
Jurkat cell##2##2##(2008-8#1)(2012-12#1)
Jurkat cells##6##2##(1991-9#1)(1992-11#1)(1992-6#1)(1994-11#1)(1994-6#1)(2008-7#1)
Jurkat tumor cells##2##3##(2012-1#2)
Jurkat##17##1##(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-6#3)(2008-7#2)(2008-8#2)(2012-1#2)(2012-12#1)
Just a##2##2##(2009-3#1)(2011-1#1)
Just above Transition Zone##2##4##(2008-7#2)
Just above##3##2##(2008-7#3)
Just after##2##2##(2007-11#1)(2008-10#1)
Just as in##2##3##(1997-6#1)(2008-10#1)
Just as##7##2##(1990-9#1)(1994-1#1)(1994-12#1)(1997-6#1)(2008-10#1)(2010-6#1)(2011-2#1)
Just before##2##2##(2007-12#1)(2008-7#1)
Just like##2##2##(2009-6#1)(2011-2#1)
Just##31##1##(1990-9#1)(1992-2#1)(1994-1#1)(1994-12#2)(1994-8#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#2)(2008-12#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)
Justice Department##4##2##(1995-12#1)(1995-6#2)(1996-5#1)
Justice and##2##2##(1995-1#1)(2008-8#1)
Justice##14##1##(1991-1#1)(1992-8#1)(1995-1#1)(1995-12#2)(1995-6#3)(1996-12#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-8#1)(2008-9#1)
Justices##2##1##(1990-10#1)(1995-6#1)
Justification##2##1##(2008-11#1)(2008-7#1)
Justifying##2##1##(1991-1#1)(1994-2#1)
Juvenile growth##2##2##(2008-11#2)
Juvenile ossifying fibroma##2##3##(2013-1#2)
Juvenile polyposis syndrome##3##3##(2011-2#3)
Juvenile systemic lupus erythematosus##2##4##(2012-2#2)
Juvenile##20##1##(2007-12#1)(2007-7#2)(2008-11#3)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)
Juveniles of##2##2##(2008-10#2)
Juveniles##3##1##(2008-10#2)(2008-12#1)
K &lt##2##2##(2008-3#1)(2008-7#1)
K (+)##2##2##(2010-11#1)(2011-2#1)
K 8644 (1 microM) enhanced the##2##6##(1993-3#1)(1997-2#1)
K 8644##3##2##(1993-3#1)(1996-2#1)(1997-2#1)
K = 0##5##3##(2008-5#2)(2008-9#2)(2013-1#1)
K = 4##2##3##(1992-9#1)(2008-2#1)
K =##9##2##(1992-9#1)(1996-2#1)(2008-2#2)(2008-5#2)(2008-9#2)(2013-1#1)
K and that##2##3##(2008-3#2)
K and the##2##3##(2008-2#1)(2008-3#1)
K and was##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
K and##36##2##(1990-11#1)(1992-6#1)(1993-3#1)(1995-12#1)(1996-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#10)(2008-7#1)(2009-5#1)(2009-7#1)
K are##4##2##(1996-2#1)(2008-10#1)(2008-3#2)
K at##6##2##(2008-2#1)(2008-3#5)
K channel##3##2##(1992-11#2)(2012-2#1)
K concentrations##2##2##(2008-12#1)(2012-3#1)
K domain##4##2##(1997-2#3)(1997-8#1)
K for the##4##3##(1996-2#2)(2008-10#2)
K for##11##2##(1996-2#2)(1996-6#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-3#2)
K from##2##2##(1996-4#1)(2008-10#1)
K has been##2##3##(1992-9#1)(2008-3#1)
K in a##3##3##(1996-4#1)(2008-2#1)(2008-3#1)
K in the##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
K in##14##2##(1996-4#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#5)(2010-7#1)(2013-7#1)
K is##5##2##(1990-8#1)(1997-7#1)(2008-3#2)(2008-7#1)
K peaks were##2##3##(2008-9#2)
K protein##11##2##(1992-8#1)(1995-12#7)(2008-8#3)
K provide a##3##3##(1996-4#1)(2010-2#2)
K strain##3##2##(2008-10#3)
K subunit##2##2##(1994-8#2)
K temperature##2##2##(2008-10#1)(2008-2#1)
K that##2##2##(2008-12#1)(2008-2#1)
K to##5##2##(1993-6#1)(2007-12#1)(2010-2#2)(2012-2#1)
K values##2##2##(2008-10#1)(2013-7#1)
K was##5##2##(1994-8#1)(2007-12#1)(2008-10#3)
K were determined by##3##4##(1996-2#1)(2008-10#1)(2008-3#1)
K were determined##4##3##(1996-2#1)(2008-10#2)(2008-3#1)
K were##5##2##(1996-2#1)(2008-10#2)(2008-3#1)(2013-7#1)
K with a##2##3##(1992-10#1)(2008-10#1)
K##483##1##(1990-11#1)(1990-2#2)(1990-5#3)(1990-7#3)(1990-8#5)(1991-10#1)(1991-5#2)(1991-7#2)(1992-10#5)(1992-11#2)(1992-12#6)(1992-5#1)(1992-6#8)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#3)(1994-7#1)(1994-8#10)(1994-9#4)(1995-12#13)(1995-2#2)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#20)(1996-4#5)(1996-5#2)(1996-6#2)(1997-2#9)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#15)(1997-8#1)(2007-11#2)(2007-12#11)(2007-7#2)(2007-8#1)(2008-10#125)(2008-11#2)(2008-12#7)(2008-2#24)(2008-3#55)(2008-4#5)(2008-5#7)(2008-7#12)(2008-8#9)(2008-9#9)(2009-11#6)(2009-5#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#4)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#3)
K' greater than##2##3##(1990-8#2)
K'##5##1##(1990-8#5)
K'-1##2##1##(1990-8#2)
K(+) ATP channel##3##3##(2011-1#3)
K(+) and##8##2##(2008-10#8)
K(+) binding##2##2##(2008-10#1)(2012-2#1)
K(+) channel##11##2##(2008-4#1)(2008-6#2)(2008-8#4)(2008-9#1)(2011-1#1)(2013-8#2)
K(+) channels in##2##3##(2008-4#1)(2008-8#1)
K(+) channels##13##2##(2008-4#2)(2008-8#9)(2010-8#1)(2013-7#1)
K(+) concentration##2##2##(2013-8#2)
K(+) current (I(K##2##3##(2008-8#2)
K(+) current##12##2##(2008-8#8)(2009-12#4)
K(+) currents##3##2##(2008-7#1)(2008-8#1)(2009-12#1)
K(+) ions##2##2##(2008-10#2)
K(+) outward##2##2##(2008-8#1)(2009-2#1)
K(+)##110##1##(2007-8#1)(2008-10#45)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#29)(2008-9#3)(2009-12#6)(2009-2#2)(2010-4#1)(2010-8#1)(2011-1#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
K(+)&gt##3##1##(2008-10#3)
K(+))##2##1##(2008-10#1)(2008-4#1)
K(+)-ATPase activity##3##2##(1995-12#2)(2011-2#1)
K(+)-ATPase##12##1##(1992-12#1)(1995-12#3)(1995-6#6)(2011-2#2)
K(+)-channel activators##2##2##(1990-7#2)
K(+)-channel##5##1##(1990-11#1)(1990-7#2)(1993-3#2)
K(+)-evoked##9##1##(1992-6#2)(1992-7#2)(1993-3#1)(1996-12#2)(1997-2#2)
K(+)-induced##3##1##(1992-11#1)(1995-11#2)
K(-1) and##4##2##(2008-10#2)(2008-3#2)
K(-1)##10##1##(1996-2#3)(2008-10#2)(2008-2#1)(2008-3#4)
K(0##3##1##(2008-10#1)(2009-5#2)
K(1)##7##1##(2008-10#7)
K(2)##2##1##(2008-10#2)
K(2)CO(3)##3##1##(2008-10#3)
K(2)Cr(2)O(7) was##2##2##(2008-10#2)
K(2)Cr(2)O(7)##4##1##(2008-10#4)
K(2)S(2)O(8)##5##1##(2008-10#4)(2008-9#1)
K(3)##2##1##(2008-10#1)(2008-11#1)
K(3)Fe(CN)(6)##3##1##(2008-10#3)
K(ATP) channels##4##2##(1997-7#3)(2008-8#1)
K(ATP)##5##1##(1997-7#3)(2008-8#2)
K(AgL)##3##1##(2008-10#3)
K(AgLPic) and##2##2##(2008-10#2)
K(AgLPic)##3##1##(2008-10#3)
K(D)##5##1##(2008-10#5)
K(M(L16C5)A)##2##1##(2008-10#2)
K(M)##2##1##(2008-11#1)(2008-9#1)
K(MLA) value##2##2##(2008-10#2)
K(MLA) values##2##2##(2008-10#2)
K(MLA)##8##1##(2008-10#8)
K(S)##3##1##(2008-10#3)
K(TNOBS)##3##1##(2008-10#3)
K(TNOBS))##2##1##(2008-10#2)
K(TpClPB)##2##1##(2008-10#2)
K(a)##4##1##(2008-10#4)
K(alpha) x-ray##3##2##(2010-1#3)
K(alpha)##5##1##(2007-11#1)(2008-3#1)(2010-1#3)
K(cat) value and##2##3##(2008-9#2)
K(d)##2##1##(2008-10#2)
K(d)&gt##2##1##(2008-3#2)
K(d)(z)##2##1##(2008-2#2)
K(dist)##2##1##(2008-10#2)
K(e)##2##1##(2008-10#2)
K(ex##7##1##(2008-10#7)
K(ex) and the##2##3##(2008-10#2)
K(ex) for##3##2##(2008-10#3)
K(ex) values were##2##3##(2008-10#2)
K(ex) was##3##2##(2008-10#3)
K(ex) were##2##2##(2008-10#2)
K(ex)##17##1##(2008-10#17)
K(f)##4##1##(2008-10#4)
K(i##4##1##(2008-10#4)
K(i) of##3##2##(2008-10#1)(2008-11#2)
K(i)##8##1##(1992-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-2#1)
K(ijk)##4##1##(2008-10#4)
K(m) and##3##2##(2008-10#3)
K(m) for the alcohol##2##4##(2008-7#2)
K(m) for the##4##3##(2008-7#4)
K(m) for##8##2##(2008-7#7)(2009-2#1)
K(m) is##2##2##(2008-10#2)
K(m) of##3##2##(2008-7#2)(2008-8#1)
K(m) value##2##2##(2008-10#1)(2008-7#1)
K(m) values were##3##3##(1996-7#2)(1997-2#1)
K(m) values##7##2##(1996-7#2)(1997-2#2)(2008-11#1)(2009-2#1)(2010-11#1)
K(m) were##2##2##(2008-10#1)(2008-7#1)
K(m)##37##1##(1990-11#1)(1996-7#2)(1997-2#2)(2008-10#12)(2008-11#2)(2008-7#13)(2008-8#1)(2009-2#2)(2010-11#1)(2011-3#1)
K(obs) and##2##2##(1997-2#2)
K(p)##2##1##(2008-10#2)
K(v)2##9##1##(2008-8#9)
K) and a##2##3##(2008-10#1)(2008-3#1)
K) and##5##2##(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
K) are##2##2##(1997-7#2)
K) is presented##2##3##(2008-10#1)(2008-9#1)
K)##32##1##(1992-10#1)(1994-8#1)(1995-3#2)(1996-2#2)(1997-7#3)(2007-11#2)(2008-10#12)(2008-2#1)(2008-3#7)(2008-9#1)
K+ and NH4+##2##3##(2008-11#2)
K+ and##8##2##(1990-11#1)(1990-7#1)(1991-11#2)(1992-11#1)(2008-11#3)
K+ channel activation##2##3##(1994-11#1)(1996-2#1)
K+ channel in##2##3##(1992-6#1)(1994-12#1)
K+ channel##17##2##(1991-9#1)(1992-6#2)(1992-9#2)(1994-11#2)(1994-12#3)(1996-2#4)(2008-8#3)
K+ channels in##4##3##(1994-11#3)(1994-12#1)
K+ channels##19##2##(1990-8#2)(1991-8#2)(1994-11#3)(1994-12#2)(1996-2#4)(1997-1#1)(1997-7#1)(2007-10#1)(2008-8#3)
K+ concentration##2##2##(1993-11#1)(2008-8#1)
K+ concentrations##2##2##(1994-11#1)(2008-4#1)
K+ conductance in##2##3##(1990-7#1)(1994-3#1)
K+ conductance##3##2##(1990-7#2)(1994-3#1)
K+ current##5##2##(1991-9#4)(1996-5#1)
K+ currents in##2##3##(1995-12#1)(2008-9#1)
K+ currents##9##2##(1992-11#1)(1994-11#1)(1995-11#1)(1995-12#2)(1996-2#2)(1996-5#1)(2008-9#1)
K+ efflux in##2##3##(1994-3#2)
K+ efflux##4##2##(1992-6#2)(1994-3#2)
K+ in##2##2##(1994-12#1)(1995-12#1)
K+ increases##2##2##(1991-11#1)(1997-2#1)
K+ ions##2##2##(2008-3#2)
K+ medium##2##2##(1993-11#2)
K+ on##2##2##(1997-1#1)(2008-11#1)
K+ or hyposmolarity##2##3##(1990-7#2)
K+ or##4##2##(1990-7#2)(1995-12#1)(2008-8#1)
K+ to##3##2##(1996-2#1)(1997-1#1)(2008-8#1)
K+##152##1##(1990-11#6)(1990-12#1)(1990-7#9)(1990-8#2)(1991-11#5)(1991-5#1)(1991-7#3)(1991-8#6)(1991-9#5)(1992-11#2)(1992-6#8)(1992-9#2)(1993-11#6)(1993-12#1)(1993-3#2)(1994-11#7)(1994-12#7)(1994-2#4)(1994-3#4)(1995-11#1)(1995-12#6)(1995-5#2)(1996-2#13)(1996-5#4)(1997-1#10)(1997-2#3)(1997-7#2)(2007-10#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#14)(2008-9#1)
K+-channel##2##1##(1996-2#1)(2007-10#1)
K+-stimulated##2##1##(1992-3#2)
K+/H+##2##1##(1990-12#1)(1993-11#1)
K-##3##1##(1994-12#3)
K-1##2##1##(1991-12#1)(1997-2#1)
K-12##22##1##(1990-11#1)(1990-5#1)(1991-11#2)(1993-9#1)(1996-12#6)(1996-6#3)(2008-10#4)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)
K-7259##3##1##(1995-8#3)
K-9 teams##2##2##(1992-2#2)
K-ATPase alpha subunits##2##3##(1994-8#2)
K-ATPase alpha##3##2##(1994-8#3)
K-ATPase and##2##2##(1992-12#1)(1994-8#1)
K-ATPase##12##1##(1990-11#1)(1992-12#2)(1994-8#9)
K-B##2##1##(2008-3#2)
K-Cl##2##1##(2008-8#2)
K-citrate##2##1##(2007-7#2)
K-dependent gamma-carboxylation of##2##3##(1992-12#2)
K-dependent##7##1##(1990-5#2)(1992-12#3)(1992-9#1)(2009-11#1)
K-means clustering##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)
K-means##5##1##(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#2)
K-ras 116Y##3##2##(1993-11#3)
K-ras mutations##2##2##(2009-12#1)(2013-1#1)
K-ras##9##1##(1991-9#1)(1993-11#5)(2009-12#1)(2009-8#1)(2013-1#1)
K-region oxide##4##2##(1991-12#4)
K/K35##4##1##(1993-11#4)
K04##2##1##(2011-2#2)
K1##14##1##(1991-8#4)(1992-11#1)(1992-12#1)(1995-2#1)(2008-11#3)(2008-6#1)(2009-12#3)
K100M##2##1##(2011-1#1)(2012-2#1)
K12##12##1##(1990-5#1)(2008-12#2)(2008-6#1)(2008-7#5)(2008-9#1)(2013-1#2)
K1a values##2##2##(2008-6#2)
K1a##3##1##(2008-6#3)
K22DAP##3##1##(2008-10#3)
K233A##2##1##(1995-5#2)
K252a and##2##2##(1990-8#1)(2008-10#1)
K252a##12##1##(1990-12#5)(1990-8#3)(1994-11#2)(2008-10#1)(2008-11#1)
K2O##2##1##(2008-12#2)
K2P##2##1##(2013-8#2)
K3##8##1##(1991-12#6)(2008-10#2)
K31##2##1##(1990-11#2)
K329E##2##1##(1991-8#2)
K443E and##2##2##(1995-8#2)
K443E##7##1##(1995-8#7)
K4M##4##1##(1990-8#1)(2010-5#1)(2012-2#2)
K562 cells in##2##3##(2008-11#2)
K562 cells##25##2##(1990-11#1)(1994-11#1)(2008-11#6)(2008-7#1)(2008-8#5)(2008-9#9)(2012-12#2)
K562##38##1##(1990-11#2)(1992-5#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#2)(1995-3#1)(1997-7#1)(2008-11#7)(2008-7#1)(2008-8#7)(2008-9#11)(2012-12#2)
K562/ADM##2##1##(1995-11#2)
K57N was##2##2##(2011-1#2)
K57N##5##1##(2011-1#5)
K65R##6##1##(2013-1#6)
K7 and##2##2##(2008-6#1)(2010-3#1)
K7##3##1##(2008-6#1)(2010-3#1)(2013-8#1)
K70E##2##1##(2013-1#2)
K77H##2##1##(1995-6#2)
K78H)##2##1##(1995-6#2)
K8##2##1##(2008-2#1)(2013-8#1)
K84##7##1##(2008-10#7)
K=0##2##1##(2013-7#2)
K=8##2##1##(2008-10#2)
KA and##2##2##(1995-5#1)(2008-10#1)
KA##4##1##(1995-5#3)(2008-10#1)
KA-672##3##1##(2008-5#3)
KAA8##3##1##(1994-12#3)
KASH##4##1##(2008-9#4)
KAT1##4##1##(1994-12#4)
KATP channel activity##3##3##(1995-5#3)
KATP channel##8##2##(1995-5#4)(1996-9#2)(2008-1#1)(2008-8#1)
KATP channels##2##2##(1995-5#2)
KATP##18##1##(1995-2#1)(1995-5#6)(1996-9#2)(2008-1#1)(2008-5#7)(2008-8#1)
KB and##2##2##(1991-10#1)(2008-7#1)
KB exercise##3##2##(1991-10#1)(1991-12#2)
KB##21##1##(1991-10#10)(1991-12#6)(1992-3#1)(2008-12#2)(2008-5#1)(2008-7#1)
KBAB4##2##1##(2011-2#2)
KBD##3##1##(2011-2#3)
KBP##2##1##(2008-7#2)
KBr##15##1##(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#1)
KBrO(3)##3##1##(2008-10#3)
KC##5##1##(1994-9#3)(2008-10#2)
KC/gro protein##5##2##(1993-11#5)
KC70 was##4##2##(2010-5#4)
KC70##9##1##(2010-5#9)
KCI-induced##6##1##(1996-5#4)(1997-6#1)(2007-10#1)
KCN##5##1##(1990-7#2)(2008-10#3)
KCNJ##2##1##(2013-7#2)
KCNJ2##2##1##(2008-8#1)(2013-7#1)
KChIP2##2##1##(2008-8#2)
KChIP2b##8##1##(2008-8#8)
KCl (0##2##2##(2008-10#2)
KCl and MgCl2##2##3##(1993-9#1)(2008-1#1)
KCl and NaCl##2##3##(1992-6#1)(1993-3#1)
KCl and##10##2##(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-12#1)(2008-1#1)(2008-10#4)
KCl as##2##2##(2008-10#2)
KCl at##2##2##(2008-10#2)
KCl concentration##2##2##(1990-11#1)(1990-5#1)
KCl in##3##2##(1995-12#1)(2008-10#2)
KCl or##2##2##(1992-6#1)(2008-10#1)
KCl##64##1##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#2)(1992-11#1)(1992-6#4)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#2)(1995-11#1)(1995-12#5)(1996-2#2)(1996-5#2)(2007-10#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)
KCl-induced contraction##2##2##(1995-12#2)
KCl-induced depolarization##2##2##(1992-9#1)(1994-9#1)
KCl-induced##6##1##(1992-9#1)(1994-9#1)(1995-12#3)(1996-5#1)
KD cases##2##2##(2012-2#2)
KD had##2##2##(2012-1#2)
KD##22##1##(1990-7#2)(1992-2#1)(2008-12#1)(2011-2#7)(2012-1#4)(2012-2#7)
KD*P##2##1##(2008-2#1)(2008-3#1)
KD4326##3##1##(2008-10#3)
KDN-gp##4##1##(1994-5#4)
KDO(2)-Lipid A##2##2##(2012-12#2)
KDP##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
KDR in##3##2##(1992-9#1)(1994-11#1)(2008-9#1)
KDR receptor##2##2##(1992-9#1)(1994-11#1)
KDR##13##1##(1992-9#4)(1994-11#5)(2008-9#4)
KDa as##2##2##(1991-12#1)(2008-11#1)
KDa##7##1##(1991-12#2)(1993-11#2)(1994-11#1)(1994-9#1)(2008-11#1)
KE and##2##2##(2008-12#2)
KE##3##1##(2008-12#3)
KE2 and##2##2##(1994-12#2)
KEGG##2##1##(2008-7#1)(2010-4#1)
KEM1##2##1##(1995-9#2)
KEX2##3##1##(1991-9#1)(1997-1#2)
KEY WORDS##9##2##(2009-10#1)(2009-8#1)(2013-1#7)
KEY##10##1##(1997-3#1)(2009-10#1)(2009-8#1)(2013-1#7)
KEYWORDS##7##1##(2012-3#6)(2013-1#1)
KF cells##3##2##(1993-9#3)
KF##12##1##(1993-9#5)(1996-5#3)(2008-10#4)
KF19514 inhibited##3##2##(1997-7#3)
KF19514##9##1##(1997-7#9)
KFR##2##1##(2011-1#2)
KG-1 and##3##2##(1990-2#1)(1996-10#2)
KG-1##12##1##(1990-2#1)(1993-12#3)(1995-8#2)(1996-10#3)(1996-2#3)
KGd(WO(4))(2) crystal##2##2##(2007-11#2)
KGd(WO(4))(2) laser is demonstrated##2##4##(2007-11#1)(2008-3#1)
KGd(WO(4))(2) laser with##2##3##(2007-11#1)(2007-12#1)
KGd(WO(4))(2) laser##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
KGd(WO(4))(2)##10##1##(2007-11#4)(2007-12#4)(2008-3#2)
KH(2)PO(4) crystals##4##2##(2007-12#4)
KH(2)PO(4)##5##1##(2007-12#4)(2008-10#1)
KHPh##3##1##(2008-10#3)
KI and##4##2##(2008-10#3)(2008-8#1)
KI oxidation##2##2##(2008-10#2)
KI##19##1##(2008-10#17)(2008-3#1)(2008-8#1)
KIF5A##3##1##(2012-2#3)
KII##2##1##(1996-12#2)
KIN3##4##1##(1990-5#4)
KIO(4)##4##1##(2008-10#4)
KIR##2##1##(2008-8#2)
KISS1 (GPR54)##3##2##(2009-6#3)
KIT##4##1##(2008-6#1)(2008-8#1)(2010-4#1)(2012-3#1)
KK and MH cells was##2##5##(1993-9#2)
KK and MH cells were##2##5##(1993-9#2)
KK and MH cells##5##4##(1993-9#5)
KK and MH##6##3##(1993-9#6)
KK cells##2##2##(1993-9#2)
KK##12##1##(1993-9#8)(2008-10#4)
KK/Ta mice##3##2##(2008-1#3)
KK/Ta mouse##2##2##(2008-1#2)
KK/Ta##5##1##(2008-1#5)
KKU 40##2##2##(2008-12#2)
KLC1##6##1##(2010-11#6)
KLF6##3##1##(2011-2#3)
KLH in##3##2##(2008-10#3)
KLH##18##1##(2008-10#16)(2008-4#1)(2008-9#1)
KLHL18##2##1##(2012-12#2)
KLK10##2##1##(2009-4#2)
KM value##2##2##(1991-12#1)(1994-5#1)
KM##6##1##(1990-3#1)(1991-12#1)(1994-5#3)(1995-8#1)
KM110##3##1##(2012-2#3)
KM50##3##1##(2008-11#3)
KM697##3##1##(1994-2#3)
KM750 was##2##2##(1994-2#2)
KM750##4##1##(1994-2#4)
KM796##2##1##(1994-2#2)
KMB17 cells##6##2##(2013-8#6)
KMS-11 clone##2##2##(2008-3#2)
KMS-11##4##1##(2008-3#4)
KMSKS##2##1##(1993-8#2)
KMapp and kcat/KMapp were##2##4##(1997-2#2)
KMnO(4) and##2##2##(2008-10#2)
KMnO(4) in##6##2##(2008-10#6)
KMnO(4)##18##1##(2008-10#18)
KN-04##3##1##(1996-2#3)
KN-62 and KN-04##2##3##(1996-2#2)
KN-62 inhibited##2##2##(1995-8#1)(1996-2#1)
KN-62##7##1##(1995-8#1)(1996-2#5)(2008-8#1)
KNO(3)##9##1##(2008-10#9)
KNO(3))##3##1##(2008-10#3)
KNSBN crystal##2##2##(2007-12#2)
KNSBN##6##1##(2007-12#2)(2008-3#4)
KNSBN)##3##1##(2007-12#1)(2008-3#2)
KNbO(3) crystal##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
KNbO(3)##10##1##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#3)
KOH and##2##2##(2007-7#1)(2012-3#1)
KOH preparation##3##2##(2007-7#2)(2009-2#1)
KOH solution##5##2##(2008-10#5)
KOH##24##1##(2007-7#6)(2008-10#12)(2008-5#1)(2008-6#3)(2009-2#1)(2012-3#1)
KOH/IPA##3##1##(2008-10#3)
KP San Francisco Medical Center##2##5##(2010-8#2)
KP and##2##2##(2009-6#2)
KP##12##1##(2009-6#3)(2009-9#5)(2010-8#4)
KP's##2##1##(2010-8#2)
KP1##5##1##(1991-2#2)(1991-9#3)
KPI##5##1##(1992-12#1)(1996-12#4)
KPI-containing##2##1##(1996-12#2)
KPLS##2##1##(2008-10#2)
KPN03535 (gi|152972051)##2##2##(2010-10#2)
KPS##2##1##(2008-7#1)(2011-2#1)
KS and ND##2##3##(2008-10#2)
KS and##4##2##(1992-2#2)(2008-10#2)
KS cells##2##2##(2008-6#2)
KS is a##2##3##(1991-8#1)(2008-6#1)
KS is##3##2##(1991-8#1)(2008-6#1)(2013-1#1)
KS levels in patients with##2##5##(1993-2#2)
KS levels##4##2##(1993-2#4)
KS skin lesions##2##3##(1992-2#2)
KS skin##3##2##(1992-2#3)
KS was##2##2##(1990-9#1)(2012-3#1)
KS##30##1##(1990-9#2)(1991-12#3)(1991-8#1)(1992-2#7)(1993-2#5)(1996-8#1)(2008-10#2)(2008-6#4)(2010-8#1)(2012-3#2)(2013-1#2)
KSA##13##1##(2008-1#6)(2008-4#1)(2008-7#4)(2013-1#2)
KSCN in##2##2##(1990-7#2)
KSCN##5##1##(1990-7#2)(2008-10#3)
KSD can##2##2##(2010-4#2)
KSD exercise##2##2##(2010-4#2)
KSD##5##1##(2010-4#5)
KSF to##2##2##(2013-1#2)
KSF##7##1##(2013-1#7)
KT 5720##2##2##(2009-12#2)
KT and##2##2##(2008-11#1)(2013-1#1)
KT##19##1##(2008-11#2)(2008-9#3)(2009-12#2)(2011-2#3)(2013-1#9)
KT5720##2##1##(2008-10#2)
KTP OPO we achieved##2##4##(2007-11#1)(2008-3#1)
KTP OPO##4##2##(2007-11#1)(2008-3#3)
KTP and##2##2##(2008-3#2)
KTP crystal##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
KTP crystals##3##2##(2008-3#3)
KTP optical parametric oscillator##2##4##(2008-2#1)(2008-3#1)
KTP parametric oscillator##2##3##(2008-2#1)(2008-3#1)
KTP##41##1##(2007-11#10)(2007-12#6)(2008-10#1)(2008-2#9)(2008-3#15)
KTP-based##3##1##(2007-11#2)(2008-3#1)
KTZ##2##1##(2008-5#2)
KTiOAsO(4)##4##1##(2007-12#3)(2008-3#1)
KTiOPO(4) (KTP)##2##2##(2008-3#2)
KTiOPO(4) and##3##2##(2007-12#3)
KTiOPO(4) crystal##8##2##(2007-12#7)(2008-2#1)
KTiOPO(4) was used##2##3##(2007-11#1)(2008-2#1)
KTiOPO(4) was##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
KTiOPO(4)##32##1##(2007-11#4)(2007-12#20)(2008-2#3)(2008-3#5)
KTiOPO4 crystals##3##2##(2008-3#3)
KTiOPO4##6##1##(2008-2#1)(2008-3#5)
KTpClPB##4##1##(2008-10#4)
KU-P-M670##2##1##(2008-10#2)
KU1##2##1##(2008-10#2)
KU812 cell line##2##3##(1990-5#2)
KU812 cells into##2##3##(2008-11#2)
KU812 cells##29##2##(1990-5#2)(2008-11#27)
KU812##34##1##(1990-5#5)(2008-11#29)
KU812F cells##4##2##(2008-11#4)
KU812F##5##1##(2008-11#5)
KV##3##1##(1992-6#1)(2010-12#2)
KV2##4##1##(2010-12#4)
KW co-digestions##3##2##(2013-1#3)
KY(WO(4))(2) laser##4##2##(2007-11#2)(2007-12#2)
KY(WO(4))(2) regenerative amplifiers##2##3##(2007-11#2)
KY(WO(4))(2)##6##1##(2007-11#4)(2007-12#2)
KYN-54 at##2##2##(1992-9#2)
K[nido-7-CH3(CH2)15-7##3##1##(1995-2#3)
Ka values##4##2##(1995-2#4)
Ka##9##1##(1994-5#1)(1995-2#8)
Kabuki##2##1##(2011-1#2)
Kadomtsev-Petviashvili##2##1##(1994-2#1)(1996-9#1)
Kaduna##5##1##(1997-4#2)(2009-4#1)(2011-2#1)(2013-1#1)
Kaede##2##1##(2011-1#2)
Kahlbaum##3##1##(2008-7#3)
Kaiser Permanente##7##2##(1995-2#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-8#2)(2011-2#1)
Kaiser Permanente's##3##2##(1993-12#1)(2010-8#2)
Kaiser##13##1##(1993-12#1)(1995-2#1)(1997-2#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#4)(2011-2#2)
Kaiser's##3##1##(1993-5#1)(1997-2#1)(1997-6#1)
Kala-azar##6##1##(1990-7#2)(2008-12#1)(2008-7#3)
Kallmann's syndrome##3##2##(2008-10#3)
Kallmann's##4##1##(1992-7#1)(2008-10#3)
Kalman filter##10##2##(2008-10#2)(2008-2#2)(2008-3#4)(2009-9#1)(2010-5#1)
Kalman##11##1##(2008-10#3)(2008-2#2)(2008-3#4)(2009-9#1)(2010-5#1)
Kalpha##2##1##(2008-2#1)(2008-3#1)
Kampala##5##1##(2009-4#3)(2010-8#2)
Kampo medicine##2##2##(2008-10#2)
Kampo##5##1##(2008-10#5)
Kangaroo Care##2##2##(1994-3#2)
Kangaroo##4##1##(1994-3#4)
Kano##2##1##(1994-12#1)(2013-1#1)
Kanpur##2##1##(2009-12#2)
Kansas##14##1##(1993-12#1)(1995-3#3)(1996-1#1)(2008-1#2)(2008-10#6)(2010-12#1)
Kant##6##1##(1990-2#1)(2012-12#2)(2012-2#3)
Kanti##2##1##(2008-3#1)(2008-7#1)
Kaolin##3##1##(2008-10#1)(2008-7#1)(2008-9#1)
Kaolinite as##2##2##(2008-10#2)
Kaolinite##3##1##(2008-10#3)
Kapalabhati--yogic cleansing exercise##2##3##(1991-10#1)(1991-12#1)
Kaplan and##2##2##(2008-11#1)(2008-6#1)
Kaplan##4##1##(1994-7#1)(2007-11#1)(2008-11#1)(2008-6#1)
Kaplan-Meier analysis##2##2##(2011-2#1)(2013-8#1)
Kaplan-Meier estimates##2##2##(1990-9#1)(1995-2#1)
Kaplan-Meier estimator##2##2##(2008-7#1)(2012-3#1)
Kaplan-Meier survival curves were##2##4##(2007-7#1)(2013-1#1)
Kaplan-Meier survival curves##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
Kaplan-Meier survival##4##2##(2007-7#1)(2013-1#2)(2013-8#1)
Kaplan-Meier##15##1##(1990-9#1)(1991-8#1)(1994-1#1)(1995-2#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Kaposi sarcoma##2##2##(1990-3#1)(2007-9#1)
Kaposi##4##1##(1990-3#1)(1992-12#1)(2007-9#1)(2008-1#1)
Kaposi's sarcoma (KS)##6##3##(1990-9#1)(1991-12#1)(1991-8#1)(1996-8#1)(2008-6#1)(2012-3#1)
Kaposi's sarcoma and##3##3##(1992-12#1)(1996-3#1)(2011-3#1)
Kaposi's sarcoma is##2##3##(1990-8#1)(2007-7#1)
Kaposi's sarcoma on a##2##4##(1992-12#2)
Kaposi's sarcoma##29##2##(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#2)(1991-8#2)(1992-12#3)(1992-2#4)(1992-3#2)(1996-3#1)(1996-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#1)(2011-3#1)(2012-3#1)
Kaposi's sarcomas##2##2##(1992-3#1)(2008-4#1)
Kaposi's##33##1##(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#2)(1991-8#2)(1992-12#3)(1992-2#4)(1992-3#3)(1996-3#1)(1996-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-6#2)(2011-3#1)(2012-3#2)
Kappa coefficient##2##2##(2010-5#1)(2013-1#1)
Kappa statistics##2##2##(2007-8#1)(2009-8#1)
Kappa##11##1##(1992-8#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2013-1#1)
Karachi##6##1##(2007-7#1)(2012-2#2)(2013-7#2)(2013-8#1)
Karaj##3##1##(2008-12#2)(2012-2#1)
Karasek##2##1##(2008-10#1)(2008-11#1)
Karen##4##1##(1992-2#1)(1995-1#1)(2012-2#1)(2013-7#1)
Karim and##2##2##(2008-12#2)
Karim##4##1##(2008-12#4)
Karl Albrecht##3##2##(1995-1#3)
Karl Fischer (KF)##3##3##(2008-10#3)
Karl Fischer titration##5##3##(2008-10#5)
Karl Fischer##11##2##(2008-10#11)
Karl##18##1##(1990-10#1)(1991-3#1)(1994-1#1)(1995-1#3)(2008-10#11)(2008-7#1)
Karlovac##2##1##(2011-2#2)
Karnal bunt##7##2##(2008-10#7)
Karnal##8##1##(2008-10#8)
Karnataka##5##1##(2008-10#3)(2010-5#1)(2013-1#1)
Karnofski scale##5##2##(2008-1#5)
Karnofsky performance status##2##3##(1991-2#1)(2008-7#1)
Karnofsky scale##2##2##(2007-11#2)
Karnofsky##9##1##(1991-2#1)(1991-6#2)(2007-11#4)(2008-7#1)(2011-2#1)
Karst##2##1##(2008-5#2)
Karyotype##4##1##(1997-3#1)(2007-11#1)(2008-12#1)(2009-2#1)
Karyotypes##3##1##(2008-12#1)(2008-6#2)
Karyotypic##3##1##(2008-8#1)(2009-2#1)(2012-3#1)
Kasabach-Merritt syndrome##4##2##(2008-7#3)(2009-1#1)
Kasai##2##1##(2013-1#2)
Kasegaon##3##1##(2013-8#3)
Kashmir##10##1##(2008-5#2)(2008-7#1)(2011-2#5)(2012-2#1)(2013-8#1)
Kasper reduced sapstain of##2##4##(2008-10#2)
Kasper##7##1##(2008-10#6)(2012-3#1)
Katayama syndrome##2##2##(1996-8#2)
Kathleen M##2##2##(1995-6#1)(2012-3#1)
Kathleen##3##1##(1995-6#1)(2008-10#1)(2012-3#1)
Kathmandu Medical College##2##3##(2008-7#2)
Kathmandu Medical##3##2##(2008-7#3)
Kathmandu valley##4##2##(2008-11#1)(2008-7#2)(2012-3#1)
Kathmandu##14##1##(2008-11#2)(2008-7#8)(2012-3#4)
Katrina is##2##2##(2011-2#2)
Katrina##10##1##(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#4)(2012-2#1)(2012-3#2)
Katy and##2##2##(2008-10#2)
Katy##3##1##(2008-10#3)
Kava##2##1##(2008-1#2)
Kawasaki disease (KD)##2##3##(2011-2#1)(2012-2#1)
Kawasaki disease##9##2##(1993-12#1)(2008-11#3)(2011-2#1)(2012-2#2)(2013-1#2)
Kawasaki##11##1##(1993-12#1)(1996-3#1)(2008-11#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
Kaweah##2##1##(1996-3#2)
Kayser-Fleischer's ring##4##2##(2008-9#4)
Kazakhstan##3##1##(2008-10#2)(2013-1#1)
Kb was present in##2##4##(1992-12#2)
Kb was##3##2##(1992-12#3)
Kb##14##1##(1990-2#2)(1992-12#3)(1992-3#2)(1993-11#1)(1994-11#1)(1994-6#1)(1995-2#3)(2008-11#1)
Kc cells##5##2##(1995-6#5)
Kd =##5##2##(1990-5#2)(1990-7#2)(1996-5#1)
Kd approximately##2##2##(1994-8#1)(1995-6#1)
Kd for##6##2##(1991-5#2)(1994-5#1)(1995-6#2)(1997-2#1)
Kd of 2##2##3##(1993-11#1)(1994-6#1)
Kd of##14##2##(1990-10#1)(1990-2#1)(1990-5#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)
Kd that##2##2##(1991-2#1)(1992-8#1)
Kd value of##2##3##(1992-12#1)(1994-5#1)
Kd value##3##2##(1992-12#1)(1994-5#1)(1996-2#1)
Kd values of 0##2##4##(1994-3#1)(1995-8#1)
Kd values##8##2##(1991-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-8#2)(1996-5#1)(2008-8#1)
Kd##51##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#5)(1990-7#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-12#3)(1993-8#5)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-6#4)(1995-8#4)(1996-2#1)(1996-5#2)(1997-2#2)(2008-8#1)(2012-2#1)
Kd)##3##1##(1993-6#2)(1996-7#1)
Kd2##3##1##(1991-8#2)(1995-11#1)
Kebangsaan Malaysia##7##2##(2008-10#2)(2008-12#1)(2008-8#1)(2011-1#3)
Keele##3##1##(2008-11#2)(2008-7#1)
Keep##3##1##(1994-2#1)(1994-8#1)(1997-5#1)
Keeping in mind that##2##4##(2008-3#1)(2012-3#1)
Keeping it##2##2##(2008-11#1)(2008-8#1)
Keeping##11##1##(1991-5#1)(1994-2#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
Kefir extract##7##2##(2008-11#7)
Kefir##10##1##(2008-11#10)
Kefram-Kefir##6##1##(2008-11#6)
Keggin##5##1##(1996-2#1)(2008-7#1)(2010-5#1)(2010-6#2)
Keil]##3##1##(1996-8#1)(1996-9#1)(1997-8#1)
Keith##2##1##(2008-11#1)(2010-5#1)
Kelantan##2##1##(2008-8#2)
Kell blood group##2##3##(2012-2#1)(2013-1#1)
Kell##4##1##(1994-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
Kelley##2##1##(1991-8#1)(1997-7#1)
Kelly##3##1##(1993-12#1)(2008-10#1)(2008-11#1)
Keloids##2##1##(2010-8#2)
Kelulau##2##1##(2008-1#2)
Kelvin image point##2##3##(2010-12#2)
Kelvin##3##1##(2008-11#1)(2010-12#2)
Ken##2##1##(2007-11#1)(2010-11#1)
Kendall's##2##1##(1995-2#1)(2008-9#1)
Kenkey is##2##2##(1997-4#2)
Kenneth##4##1##(2008-10#1)(2008-7#1)(2011-2#2)
Kent County##5##2##(2008-10#5)
Kent##6##1##(2008-10#5)(2008-7#1)
Kentucky nursing homes##2##3##(1995-2#2)
Kentucky##19##1##(1991-1#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#2)(2007-10#1)(2008-10#8)(2008-4#2)(2008-8#1)
Kentucky's##2##1##(1993-12#1)(1994-3#1)
Kenwood##2##1##(2008-10#2)
Kenya and##2##2##(2008-10#1)(2011-2#1)
Kenya##17##1##(1990-6#1)(2008-10#5)(2009-3#4)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
Kenyan##3##1##(1997-4#1)(2008-10#1)(2011-2#1)
Kenyon cell##2##2##(2007-12#2)
Kenyon cells##3##2##(2007-12#1)(2009-8#2)
Kenyon##5##1##(2007-12#3)(2009-8#2)
Keoflo##3##1##(1995-3#3)
Keokuk County##2##2##(2008-12#2)
Kerala State##2##2##(1994-3#1)(2011-1#1)
Kerala##3##1##(1994-3#1)(2008-11#1)(2011-1#1)
Keratin##2##1##(1996-2#1)(2008-5#1)
Keratinocyte##4##1##(1994-11#1)(2008-11#1)(2008-5#1)(2009-12#1)
Keratinocytes##3##1##(2009-2#1)(2011-2#1)(2012-8#1)
Keratoconus is a##3##3##(2009-7#1)(2011-1#2)
Kerman##2##1##(2008-10#1)(2011-1#1)
Kern##3##1##(2008-10#1)(2009-5#1)(2011-2#1)
Kernel##8##1##(2008-10#6)(2008-7#1)(2011-2#1)
Kernels##4##1##(2008-10#4)
Kerr coefficient##2##2##(2008-2#1)(2008-3#1)
Kerr effect and##2##3##(2007-12#1)(2008-3#1)
Kerr effect in##2##3##(2007-12#1)(2008-2#1)
Kerr effect##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
Kerr lens mode-locked##2##3##(2007-12#2)
Kerr media##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Kerr medium##6##2##(2007-11#1)(2007-12#5)
Kerr nonlinearities##2##2##(2007-11#2)
Kerr nonlinearity##6##2##(2007-11#2)(2007-12#4)
Kerr propagation##2##2##(2007-11#2)
Kerr signal##3##2##(2007-12#2)(2008-3#1)
Kerr##40##1##(2007-11#10)(2007-12#21)(2008-2#3)(2008-3#6)
Kerr-lens mode locking##2##3##(2007-11#1)(2007-12#1)
Kerr-lens mode-locked Cr##4##3##(2007-11#1)(2007-12#3)
Kerr-lens mode-locked Ti##7##3##(2007-11#4)(2007-12#3)
Kerr-lens mode-locked Yb##2##3##(2007-12#2)
Kerr-lens mode-locked laser##2##3##(2007-11#1)(2007-12#1)
Kerr-lens mode-locked lasers##2##3##(2007-11#1)(2007-12#1)
Kerr-lens mode-locked##24##2##(2007-11#9)(2007-12#14)(2008-3#1)
Kerr-lens##26##1##(2007-11#10)(2007-12#15)(2008-3#1)
Kerr-nonlinear coefficient##2##2##(2007-11#2)
Kerr-nonlinear##3##1##(2007-11#3)
Ketamine##3##1##(2007-4#2)(2011-2#1)
Ketanserin##2##1##(1995-3#2)
Ketoconazole##5##1##(1990-9#1)(2007-7#1)(2008-5#1)(2011-2#2)
Ketone##2##1##(2008-5#1)(2010-7#1)
Ketteler##2##1##(2013-1#2)
Kettner##3##1##(1993-11#2)(1993-8#1)
Key Words##9##2##(2008-10#9)
Key areas##3##2##(2008-11#1)(2009-10#1)(2010-6#1)
Key elements##2##2##(1994-2#1)(1996-2#1)
Key factors in##2##3##(1995-3#1)(1997-2#1)
Key factors##3##2##(1995-3#1)(1997-2#1)(2007-12#1)
Key features of##3##3##(2008-8#1)(2009-3#1)(2013-8#1)
Key features##4##2##(1996-1#1)(2008-8#1)(2009-3#1)(2013-8#1)
Key findings##2##2##(1993-3#1)(2008-7#1)
Key issues##2##2##(2008-1#1)(2008-12#1)
Key questions##3##2##(1997-2#1)(2010-12#1)(2011-2#1)
Key to the##2##3##(2008-10#1)(2008-9#1)
Key to##4##2##(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)
Key words##11##2##(1991-6#1)(2008-11#1)(2009-8#8)(2013-1#1)
Key##77##1##(1991-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#3)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#8)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Keys to##6##2##(1991-12#2)(1994-3#1)(1997-3#1)(2007-5#1)(2013-8#1)
Keys##19##1##(1991-12#2)(1994-3#1)(1997-3#1)(2006-5#1)(2007-5#13)(2013-8#1)
Keystone##4##1##(2008-7#1)(2011-1#3)
Keyword##2##1##(2009-2#1)(2010-12#1)
Keywords##19##1##(2008-9#4)(2010-1#15)
Kg/m2)##3##1##(2008-10#3)
Kh5##3##1##(2008-10#3)
Khambhat (Gujarat)##2##2##(2009-12#2)
Khambhat##3##1##(2009-12#3)
Khan##5##1##(2007-7#1)(2008-12#3)(2013-8#1)
Khartoum city##2##2##(2013-1#2)
Khartoum##6##1##(2007-10#1)(2013-1#5)
Khon Kaen##6##2##(2008-12#2)(2011-2#4)
Khuzestan##4##1##(2008-12#4)
Khyd##2##1##(1991-8#2)
Ki = 0##4##3##(1991-12#1)(1991-5#2)(1993-8#1)
Ki =##12##2##(1990-7#2)(1991-12#3)(1991-5#3)(1992-3#2)(1993-8#1)(1994-8#1)
Ki for##2##2##(1990-7#1)(1995-2#1)
Ki of 1##2##3##(1994-12#1)(1995-3#1)
Ki of##7##2##(1991-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-3#2)
Ki value of##5##3##(1994-11#1)(1995-3#4)
Ki value##7##2##(1992-8#1)(1994-11#1)(1995-3#4)(1995-6#1)
Ki values are##2##3##(1992-8#1)(1994-6#1)
Ki values for##5##3##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-8#1)
Ki values in##2##3##(1990-2#1)(1995-12#1)
Ki values of##5##3##(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#1)
Ki values##20##2##(1990-12#1)(1990-2#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-3#1)(2008-10#1)
Ki##57##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#3)(1991-12#5)(1991-5#4)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#7)(1995-6#1)(2008-10#4)(2012-2#1)
Ki-67 and##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
Ki-67 antigen in##2##3##(2013-8#2)
Ki-67 in##2##2##(2010-8#1)(2012-1#1)
Ki-67 labeling index##2##3##(2008-11#1)(2009-1#1)
Ki-67##21##1##(1993-11#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2009-1#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#2)(2013-8#5)
Ki-67) were##2##2##(1997-8#1)(2012-1#1)
Ki-energy can##2##2##(2008-10#2)
Ki-energy is##2##2##(2008-10#2)
Ki-energy may have a##2##4##(2008-10#2)
Ki-energy may##3##2##(2008-10#3)
Ki-energy##11##1##(2008-10#11)
Ki14##3##1##(2012-3#3)
KiS##2##1##(1995-3#2)
Kidd antigens##2##2##(1994-3#1)(1995-6#1)
Kidd##5##1##(1994-3#1)(1995-6#4)
Kidney Disease##6##2##(2008-1#2)(2010-6#1)(2012-12#1)(2013-1#2)
Kidney Transplant##2##2##(2008-1#1)(2013-1#1)
Kidney biopsy##2##2##(2007-7#1)(2008-1#1)
Kidney transplant##2##2##(2011-2#1)(2012-2#1)
Kidney transplantation in##2##3##(2008-10#1)(2011-2#1)
Kidney transplantation##3##2##(2008-10#1)(2011-2#2)
Kidney##37##1##(1997-4#1)(1997-5#1)(2007-7#2)(2008-1#9)(2008-10#2)(2008-11#4)(2008-7#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
Kidneys##2##1##(2008-1#1)(2012-3#1)
Kids##6##1##(1991-3#1)(1996-12#2)(2008-12#3)
Kieffer##2##1##(2010-1#1)(2011-2#1)
Kienbock's disease##3##2##(2012-3#3)
Kier-Hall##2##1##(2007-11#2)
Kierzek##2##1##(1991-8#2)
Kikuchi's disease##3##2##(2011-2#3)
Kikuchi's##5##1##(1991-3#1)(2011-2#4)
Kill##3##1##(2008-10#2)(2012-2#1)
Killer##2##1##(2008-4#2)
Kilohertz##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
Kilosa##2##1##(2010-8#2)
Kim##11##1##(1991-12#2)(1992-3#1)(1995-6#1)(1997-8#2)(2008-10#1)(2009-3#1)(2010-7#2)(2012-2#1)
Kin##2##1##(2008-8#1)(2009-10#1)
Kinase Balpha##2##2##(2008-11#2)
Kinase in##2##2##(2008-10#1)(2011-2#1)
Kinase##12##1##(2008-10#3)(2008-11#3)(2008-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
Kinases##3##1##(2008-4#1)(2009-5#1)(2009-8#1)
Kinematic##3##1##(2008-10#1)(2009-12#1)(2011-2#1)
Kinetic analyses of##2##3##(1994-5#1)(1994-8#1)
Kinetic analysis of##6##3##(1991-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-6#1)(1997-2#1)
Kinetic analysis##13##2##(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-2#2)(2012-2#1)
Kinetic and equilibrium##2##3##(2008-10#2)
Kinetic and##4##2##(1991-12#1)(1995-2#1)(2008-10#2)
Kinetic constants##2##2##(1990-8#1)(1995-8#1)
Kinetic determination of##5##3##(2008-10#5)
Kinetic determinations##2##2##(1997-2#1)(2008-10#1)
Kinetic isotope effects on##2##4##(1995-2#2)
Kinetic isotope effects##3##3##(1995-2#2)(1995-6#1)
Kinetic measurements##2##2##(1991-6#1)(1994-5#1)
Kinetic modeling of##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
Kinetic parameters (the Michaelis constant K(m) and the maximum##2##9##(2008-10#2)
Kinetic parameters were##2##3##(1991-5#1)(2013-8#1)
Kinetic parameters##8##2##(1991-5#1)(1996-7#1)(2008-10#4)(2010-11#1)(2013-8#1)
Kinetic resistance##2##2##(2008-11#2)
Kinetic spectrophotometric determination of##2##4##(2008-10#2)
Kinetic spectrophotometric##3##2##(2008-10#3)
Kinetic studies of##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
Kinetic studies showed##2##3##(1990-11#1)(2008-11#1)
Kinetic studies using##2##3##(1995-6#1)(2008-10#1)
Kinetic studies##12##2##(1990-11#1)(1990-7#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
Kinetic study on##2##3##(1994-5#1)(2008-10#1)
Kinetic study##3##2##(1994-5#1)(2008-10#2)
Kinetic##86##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-5#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Kinetic-spectrophotometric determination of trace amounts of##2##6##(2008-10#2)
Kinetic-spectrophotometric determination of##3##3##(2008-10#3)
Kinetic-spectrophotometric##4##1##(2008-10#4)
Kinetics and##7##2##(1992-12#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
Kinetics of the##2##3##(1990-12#1)(2007-11#1)
Kinetics of##8##2##(1990-12#1)(1994-5#2)(2007-11#1)(2008-10#4)
Kinetics##17##1##(1990-12#1)(1992-12#1)(1994-5#2)(1996-11#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-12#1)(2011-2#1)
King Hussein Medical Center##2##4##(2007-7#1)(2008-1#1)
King##19##1##(1995-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-7#3)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#2)(2009-3#1)(2010-11#1)
King's medium B##3##3##(2008-10#3)
King's##5##1##(1990-9#1)(2008-10#3)(2013-8#1)
Kingdom Central Council for Nursing##5##5##(2008-11#5)
Kingdom Central Council##6##3##(2008-11#6)
Kingdom and Ireland##2##3##(2008-9#2)
Kingdom and##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#2)
Kingdom in##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
Kingdom of Saudi Arabia##7##4##(2008-1#3)(2008-4#2)(2010-11#1)(2013-1#1)
Kingdom of##10##2##(1994-3#1)(2008-1#3)(2008-10#1)(2008-4#2)(2009-10#1)(2010-11#1)(2013-1#1)
Kingdom##94##1##(1991-2#1)(1991-3#2)(1991-8#2)(1992-1#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-7#2)(1995-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-12#3)(2007-2#4)(2008-1#7)(2008-10#13)(2008-11#15)(2008-12#6)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
Kingdom)##3##1##(2007-12#2)(2008-10#1)
Kingston##4##1##(2007-5#1)(2009-7#1)(2011-2#2)
Kinkazan Island##2##2##(2008-5#2)
Kinkazan##7##1##(2008-5#7)
Kinmen##2##1##(1994-12#2)
Kinship##4##1##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
Kinston##3##1##(2008-10#3)
Kinyarwanda coronal harmony##2##3##(2009-12#2)
Kinyarwanda##4##1##(2009-12#4)
Kir2##11##1##(2008-8#6)(2009-12#1)(2013-7#4)
Kir3 activity##2##2##(2008-8#2)
Kir3 channels##2##2##(1996-2#2)
Kir3 current inhibition##3##3##(2008-8#3)
Kir3##11##1##(1996-2#2)(2008-8#9)
Kir3/PIP2 interactions##2##2##(2008-8#2)
Kir4##9##1##(2008-6#1)(2008-8#8)
Kirby Bauer##2##2##(2011-2#1)(2012-3#1)
Kirby-Bauer##3##1##(2007-7#1)(2008-7#1)(2013-8#1)
Kirchhoff diffraction##3##2##(2007-11#1)(2008-3#2)
Kirchhoff##12##1##(2007-11#2)(2008-2#3)(2008-3#7)
Kirchhoff's law##2##2##(2008-2#2)
Kirchhoff's##4##1##(2008-2#4)
Kiribati##6##1##(2011-2#2)(2012-12#4)
Kirkpatrick-Baez##4##1##(2008-3#4)
Kirschner wire fixation##3##3##(2011-2#3)
Kirschner wire##6##2##(2007-8#3)(2011-2#3)
Kirschner wires##6##2##(2007-8#4)(2009-3#1)(2013-1#1)
Kirschner##13##1##(2007-8#7)(2009-3#1)(2011-2#4)(2013-1#1)
Kishino-Hasegawa##2##1##(2008-10#2)
Kissei##4##1##(2008-5#4)
Kit##4##1##(2008-1#1)(2008-12#1)(2008-7#1)(2013-1#1)
Kitosatospora##2##1##(2008-10#2)
Kits##2##1##(2007-12#1)(2012-12#1)
Kiurushi lacquer film##2##3##(2008-10#2)
Kiurushi##3##1##(2008-10#3)
Kiyosawa and Shiyomi##4##3##(2008-10#4)
Kjeldahl digestion##3##2##(2008-10#3)
Kjeldahl method##5##2##(2008-10#4)(2008-5#1)
Kjeldahl nitrogen##4##2##(2008-10#4)
Kjeldahl##19##1##(2008-10#18)(2008-5#1)
Klang##3##1##(2011-1#3)
Klaroid##2##1##(2008-9#2)
Klarsicht##6##1##(2008-9#6)
Klatskin##2##1##(2008-4#2)
Klebsiella oxytoca##4##2##(1993-9#1)(2008-8#1)(2010-4#1)(2010-6#1)
Klebsiella pneumoniae and Staphylococcus##2##4##(1997-4#2)
Klebsiella pneumoniae and##4##3##(1997-4#2)(2008-9#1)(2013-8#1)
Klebsiella pneumoniae##20##2##(1997-4#2)(1997-7#2)(2007-7#4)(2008-5#1)(2008-9#2)(2010-10#2)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Klebsiella sp##2##2##(2010-4#1)(2011-1#1)
Klebsiella##39##1##(1991-3#1)(1993-12#1)(1993-9#1)(1995-11#2)(1997-4#2)(1997-7#2)(2007-11#1)(2007-7#8)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#2)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
Kleihauer##5##1##(2009-3#5)
Klein##4##1##(2011-1#3)(2011-2#1)
Klenow fragment##2##2##(2008-4#2)
Klett's method##2##2##(2008-2#1)(2008-3#1)
Klinefelter syndrome##2##2##(2006-10#1)(2013-1#1)
Klinefelter##3##1##(2006-10#1)(2008-11#1)(2013-1#1)
Klippel-Feil deformity##2##2##(2008-7#2)
Kluyveromyces lactis##7##2##(1991-5#1)(1993-2#1)(1995-8#2)(1997-4#2)(2008-10#1)
Kluyveromyces marxianus##2##2##(1995-6#1)(2008-6#1)
Kluyveromyces##10##1##(1991-5#1)(1993-2#1)(1995-6#2)(1995-8#2)(1997-4#2)(2008-10#1)(2008-6#1)
Km =##2##2##(1991-5#1)(1992-3#1)
Km and Ki values##2##4##(1990-12#1)(1991-12#1)
Km and Vmax##4##3##(1994-5#1)(1994-6#1)(1997-6#2)
Km and##7##2##(1990-12#1)(1991-12#1)(1994-5#2)(1994-6#1)(1997-6#2)
Km by##2##2##(1994-8#1)(1995-2#1)
Km for##16##2##(1990-11#5)(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#3)(1992-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#1)
Km genotyping##2##2##(1997-8#2)
Km of 3##2##3##(1992-3#1)(1992-6#1)
Km of the##2##3##(1991-5#1)(1992-6#1)
Km of##14##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-3#2)(1992-6#2)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-7#1)
Km value for##3##3##(1991-12#1)(1992-11#1)(1992-3#1)
Km value##10##2##(1990-8#1)(1991-12#2)(1992-11#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-2#2)(2008-8#1)
Km values for aspartate and##2##5##(1995-6#2)
Km values for##14##3##(1990-10#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-3#2)(1994-11#1)(1995-2#2)(1995-6#4)(2008-8#1)
Km values in##2##3##(1990-2#1)(1990-5#1)
Km values of##3##3##(1995-5#1)(1995-8#2)
Km values##22##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-3#3)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#2)(2008-8#1)
Km was##3##2##(1990-7#1)(1990-8#1)(1994-8#1)
Km##107##1##(1990-10#1)(1990-11#8)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#4)(1991-5#3)(1991-9#2)(1992-11#2)(1992-3#12)(1992-6#6)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#1)(1995-11#1)(1995-2#10)(1995-5#4)(1995-6#5)(1995-8#3)(1997-2#1)(1997-6#2)(1997-8#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)
Km*1##10##1##(1997-8#10)
Km*3##5##1##(1997-8#5)
Km/Ki ratio 0##2##3##(1994-6#2)
Km1##2##1##(1992-3#2)
Km2##2##1##(1992-3#2)
KmFru6P##3##1##(1995-2#3)
Kmy2##4##1##(1997-8#4)
Knee Arthroplasty##6##2##(2013-1#6)
Knee Implant##2##2##(2013-1#2)
Knee Osteoarthritis##2##2##(2013-1#2)
Knee Society##2##2##(2013-1#2)
Knee power generated by##2##4##(2013-1#2)
Knee##30##1##(1995-3#2)(2007-8#1)(2008-12#2)(2009-4#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#20)
Knees were##2##2##(2008-8#1)(2012-2#1)
Knight##6##1##(1993-8#1)(2008-8#4)(2011-2#1)
Knight's death##2##2##(2008-8#2)
Knock!##2##1##(1996-3#2)
Knock##2##1##(2007-5#2)
Knock-down of##2##2##(2011-1#1)(2012-12#1)
Knockdown of##2##2##(2011-2#1)(2012-2#1)
Knocking##2##1##(2008-2#2)
Knockout##2##1##(1995-2#1)(2013-7#1)
Knoevenagel condensation##3##2##(2007-11#2)(2009-7#1)
Knoevenagel##6##1##(2007-11#3)(2009-7#2)(2010-5#1)
Knot##3##1##(1996-1#1)(2008-10#1)(2013-7#1)
Know your##2##2##(1997-2#1)(2012-3#1)
Know##6##1##(1993-12#1)(1997-2#1)(2008-6#1)(2011-1#1)(2012-3#2)
Knowing that##2##2##(1990-11#1)(2008-10#1)
Knowing the##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
Knowing when to##2##3##(1995-3#1)(2008-1#1)
Knowing##12##1##(1990-11#1)(1995-3#1)(1996-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
Knowledge about the##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
Knowledge about##9##2##(1991-1#1)(1992-9#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-7#2)(2012-3#1)
Knowledge and Skills Framework##2##4##(2013-1#2)
Knowledge and attitude##2##3##(2011-1#1)(2013-7#1)
Knowledge and attitudes of##4##4##(1996-6#1)(2008-11#1)(2010-11#1)(2011-2#1)
Knowledge and practice of##2##4##(2011-2#1)(2013-1#1)
Knowledge and##18##2##(1991-6#1)(1993-12#1)(1993-2#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#2)
Knowledge in##2##2##(2008-11#1)(2012-1#1)
Knowledge of specific##2##3##(2007-8#1)(2011-2#1)
Knowledge of the mechanism##2##4##(2008-11#1)(2008-7#1)
Knowledge of the##25##3##(1990-12#1)(1993-12#1)(1993-5#1)(1995-5#1)(1996-3#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-6#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
Knowledge of these##2##3##(2007-8#1)(2012-2#1)
Knowledge of##51##2##(1990-12#1)(1993-12#1)(1993-2#2)(1993-5#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-2#2)(2007-8#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#7)(2008-6#3)(2008-7#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#4)(2013-1#2)
Knowledge on##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
Knowledge regarding##3##2##(1997-8#1)(2008-8#1)(2012-12#1)
Knowledge##114##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-6#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-5#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-6#3)(1997-8#2)(2006-10#1)(2007-2#2)(2007-8#2)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#7)(2008-4#1)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#4)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#12)(2013-7#2)
Knowledge-based##3##1##(1995-2#1)(1997-8#1)(2010-10#1)
Known##4##1##(1992-3#1)(1996-12#1)(2008-10#1)(2012-2#1)
Knox-Thompson##2##1##(2008-3#2)
Ko RBCs##2##2##(1994-6#2)
Ko##5##1##(1993-8#2)(1994-6#3)
Kobs for a 13-mer##2##4##(1995-2#2)
Kobs for##3##2##(1995-2#3)
Kobs##4##1##(1995-2#4)
Koch##7##1##(1995-6#1)(2007-12#4)(2011-2#2)
Koch's postulates have not been##2##5##(2008-10#2)
Koch's postulates were completed by##2##5##(2008-10#2)
Koch's postulates were##3##3##(2008-10#2)(2009-6#1)
Koch's postulates##9##2##(2008-10#8)(2009-6#1)
Kocide##2##1##(2008-10#2)
Kodak##3##1##(1995-1#2)(2008-3#1)
Koebner phenomenon##3##2##(2007-7#3)
Koenigs-Knorr synthesis of##2##3##(2007-11#2)
Kogan##2##1##(2007-12#1)(2012-3#1)
Koh##3##1##(2011-2#3)
Kohonen##6##1##(2008-10#5)(2008-3#1)
Kojour##2##1##(2008-12#2)
Kolkata##4##1##(2007-7#2)(2011-2#1)(2012-2#1)
Kolmogorov phase screen##3##3##(2008-3#3)
Kolmogorov phase##4##2##(2008-3#4)
Kolmogorov statistics##2##2##(2008-3#2)
Kolmogorov##7##1##(2008-3#6)(2008-8#1)
Kolmogorov-Arnold-Moser transition##2##2##(2007-11#2)
Kommerrell's##2##1##(2010-7#2)
Kondo##2##1##(1993-8#1)(2012-2#1)
Konstancin##3##1##(2007-11#1)(2007-8#1)(2013-1#1)
Konuklu##2##1##(2008-12#2)
Korea and other##2##3##(2008-10#2)
Korea and the##2##3##(2008-10#1)(2008-8#1)
Korea and##11##2##(2008-10#7)(2008-5#1)(2008-8#2)(2013-8#1)
Korea have##2##2##(2008-10#1)(2010-12#1)
Korea##53##1##(1997-3#1)(1997-6#1)(1997-8#2)(2008-10#18)(2008-5#1)(2008-7#1)(2008-8#4)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-6#4)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#4)
Korea]##4##1##(1990-10#1)(1990-12#1)(1991-2#2)
Korean Adolescents##2##2##(2010-6#1)(2013-1#1)
Korean American##4##2##(2008-8#2)(2009-11#2)
Korean and##3##2##(1997-2#1)(2010-3#1)(2012-12#1)
Korean ginseng (Panax ginseng C##2##5##(1997-2#2)
Korean ginseng##5##2##(1997-2#4)(2012-3#1)
Korean immigrant discipline##2##3##(2010-11#2)
Korean isolate of##4##3##(1997-2#2)(1997-6#1)(2008-10#1)
Korean isolate##6##2##(1997-2#3)(1997-6#1)(2008-10#2)
Korean medical##2##2##(2008-10#2)
Korean patients with##5##3##(1997-4#2)(1997-8#2)(2013-8#1)
Korean patients##6##2##(1997-4#2)(1997-8#2)(2013-3#1)(2013-8#1)
Korean strain##2##2##(2008-10#2)
Korean women##5##2##(2011-2#5)
Korean##65##1##(1992-12#1)(1994-11#2)(1995-6#2)(1997-2#9)(1997-4#2)(1997-6#2)(1997-8#3)(2006-6#1)(2007-2#1)(2008-10#13)(2008-8#3)(2009-11#2)(2009-12#1)(2009-3#1)(2010-11#2)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#1)(2013-3#1)(2013-8#3)
Koreans and##2##2##(1997-4#1)(2012-12#1)
Koreans##6##1##(1997-4#1)(1997-8#3)(2008-12#1)(2012-12#1)
Korsakoff syndrome##2##2##(2008-7#2)
Korsakoff's syndrome##2##2##(2008-7#2)
Korsmeyer##2##1##(2012-2#2)
Kosman's##2##1##(2008-10#2)
Kosovo##2##1##(2008-11#1)(2008-12#1)
Kostrena##5##1##(2011-2#5)
Koszla##2##1##(2007-8#2)
Kotar and Islands##3##3##(2011-2#3)
Kotar and##4##2##(2011-2#4)
Kotar##8##1##(2011-2#8)
Kotz phasal currents on##2##4##(2007-11#2)
Kotz phasal currents##3##3##(2007-11#3)
Kotz##4##1##(2007-11#4)
Kovats##2##1##(2008-10#2)
Kovner##2##1##(1995-2#1)(2012-3#1)
Kováts indices##2##2##(1996-5#1)(2008-10#1)
Koyanagi##3##1##(2008-10#1)(2009-5#2)
Kościuszko##2##1##(2008-12#2)
Kp NifA##2##2##(2008-9#2)
Kpc##4##1##(1991-5#4)
Kpeptide##2##1##(1995-2#2)
KpnI##5##1##(1993-2#1)(1993-3#1)(1993-8#1)(2008-10#1)(2009-3#1)
Kr##3##1##(2007-11#2)(2007-12#1)
Kr-h1##2##1##(2012-2#2)
KrF excimer laser with##2##4##(2007-11#2)
KrF excimer laser##7##3##(2007-11#3)(2008-2#2)(2008-3#2)
KrF excimer lasers##3##3##(2007-11#2)(2008-2#1)
KrF excimer##10##2##(2007-11#5)(2008-2#3)(2008-3#2)
KrF laser##4##2##(1992-8#1)(2007-11#2)(2008-2#1)
KrF##14##1##(1992-8#1)(2007-11#7)(2008-2#4)(2008-3#2)
Kraepelin##2##1##(2008-7#1)(2011-2#1)
Kraft pulp was##2##3##(2008-6#2)
Kragujevac during##2##2##(2011-1#2)
Krakow##2##1##(2008-9#1)(2011-2#1)
Kramers##2##1##(1996-12#2)
Kramers-Kronig##6##1##(2007-11#1)(2008-2#1)(2008-3#4)
Kraut##2##1##(1995-2#2)
Krawczak##2##1##(2008-12#2)
Krebs solution##2##2##(1992-9#1)(2011-2#1)
Krebs##7##1##(1992-9#1)(1993-11#2)(1993-8#1)(1994-3#1)(2009-11#1)(2011-2#1)
Kred values for the##2##4##(1993-11#2)
Kred values for##3##3##(1993-11#3)
Kred##5##1##(1993-11#5)
Kreuger##3##1##(1996-1#3)
Kribbella flavida##2##2##(2011-2#2)
Kribbella##5##1##(2011-2#5)
Krk##3##1##(2011-1#3)
Kromoscopy##2##1##(2008-3#2)
Krox 24##2##2##(1993-6#1)(1996-12#1)
Krox-20 and Krox-24##2##3##(1991-9#2)
Krox-20 and##3##2##(1991-9#3)
Krox-20##6##1##(1991-9#4)(1993-3#1)(1993-6#1)
Krox-24##3##1##(1991-9#3)
Krukenberg tumour##4##2##(2012-2#4)
Kruskal-Wallis test##4##2##(1991-2#1)(2010-3#1)(2013-1#2)
Kruskal-Wallis##8##1##(1991-2#1)(1994-2#1)(2008-9#1)(2010-3#1)(2013-1#4)
Krylov subspace methods##2##3##(2008-7#2)
Krylov##3##1##(2008-7#3)
Krüppel##3##1##(2007-12#1)(2012-2#2)
Krüppel-like factor 6##2##3##(2011-2#2)
Kt/V is##2##2##(2007-12#2)
Kt/V##16##1##(2007-12#9)(2008-1#1)(2010-5#1)(2011-2#5)
Ktr/Trk/HKT-type transporters##2##2##(2008-8#2)
Ku DNA binding##2##3##(2013-1#2)
Ku##6##1##(1996-2#3)(1997-7#1)(2013-1#2)
Ku70##2##1##(2012-12#1)(2013-1#1)
Kuala Lumpur##8##2##(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#3)(2011-1#2)
Kubelka-Munk theory##2##2##(2008-3#2)
Kubelka-Munk##6##1##(2008-10#3)(2008-3#3)
Kukhtarev equations##2##2##(2007-12#1)(2008-2#1)
Kulm##6##1##(2008-10#6)
Kumar##2##1##(2008-3#2)
Kuna##3##1##(2010-4#3)
Kunitz-type serine protease inhibitor domain##2##5##(1991-11#1)(1994-11#1)
Kunitz-type##5##1##(1991-11#2)(1994-11#1)(1996-12#2)
Kunz [Appl##2##2##(2008-3#2)
Kupffer cell##3##2##(1992-11#1)(1995-3#1)(1997-6#1)
Kupffer cells in##2##3##(1991-2#1)(1992-11#1)
Kupffer cells to produce nitric oxide##2##6##(1994-6#2)
Kupffer cells treated with##4##4##(1997-4#4)
Kupffer cells was##2##3##(1991-2#1)(1992-3#1)
Kupffer cells##27##2##(1991-2#6)(1992-11#3)(1992-3#2)(1992-6#1)(1994-6#4)(1995-3#1)(1997-4#8)(2006-10#1)(2008-4#1)
Kupffer##34##1##(1991-2#6)(1992-11#4)(1992-3#2)(1992-6#1)(1993-6#2)(1994-6#6)(1995-3#2)(1997-4#8)(1997-6#1)(2006-10#1)(2008-4#1)
Kuraray)##2##1##(2009-8#2)
Kuromeurushi lacquer film##2##3##(2008-10#2)
Kuromeurushi##3##1##(2008-10#3)
Kuwait##8##1##(1991-8#1)(1992-6#2)(1997-4#2)(2008-1#1)(2008-10#1)(2008-7#1)
Kv1##4##1##(1997-2#3)(2009-12#1)
Kv11##8##1##(2008-8#8)
Kv4##9##1##(2008-8#8)(2009-12#1)
Kv7##4##1##(2008-8#4)
KwaZulu-Natal##7##1##(2010-3#1)(2011-1#1)(2012-12#4)(2013-8#1)
Kwazulu/Natal##2##1##(1997-4#2)
Kyoto##7##1##(1996-5#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
Kyphoplasty and vertebroplasty##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
Kyphoplasty##5##1##(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#1)
Kyphosis##2##1##(2007-11#1)(2008-7#1)
Kyrgyzstan##5##1##(2008-10#3)(2013-1#2)
Kyuri green mottle mosaic virus##2##5##(2008-10#2)
Kyushu##2##1##(1992-2#1)(2008-5#1)
Kölliker-Fuse nucleus##2##2##(1996-5#2)
Küntscher##2##1##(2007-11#2)
L =##2##2##(1997-7#2)
L RNA##2##2##(2008-10#2)
L alpha -I and I-HII##2##5##(1994-3#2)
L alpha -I##4##3##(1994-3#4)
L alpha##6##2##(1990-12#1)(1993-11#1)(1994-3#4)
L and##12##2##(1990-2#1)(1995-2#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
L bioreactor##2##2##(2008-11#2)
L cell##2##2##(1993-6#1)(1997-4#1)
L cells##10##2##(1990-11#1)(1990-2#2)(1990-7#2)(1991-5#2)(1993-11#1)(1993-6#1)(1997-3#1)
L chains##4##2##(1993-6#1)(1995-2#3)
L extract on##3##3##(2008-5#2)(2013-1#1)
L extract##4##2##(2008-5#3)(2013-1#1)
L genes##3##2##(2008-10#3)
L h(-1) m(-2))##2##3##(2008-7#2)
L in##2##2##(2008-10#2)
L is the##2##3##(1995-6#1)(2007-11#1)
L is##5##2##(1992-12#1)(1995-6#1)(1995-8#1)(2007-11#1)(2013-1#1)
L mol(-)(1) cm(-)(1))##3##3##(1997-7#3)
L of the##2##3##(1995-5#1)(2007-12#1)
L of##5##2##(1995-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
L per##2##2##(2007-12#2)
L protein##3##2##(2008-10#3)
L strain isolates##4##3##(2008-10#4)
L strain##5##2##(2008-10#5)
L was##4##2##(1990-12#1)(1996-3#1)(1997-7#1)(2008-5#1)
L were##5##2##(1990-12#1)(1995-6#1)(2008-10#3)
L when##2##2##(2008-10#1)(2011-2#1)
L##713##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#6)(1990-6#8)(1990-7#3)(1990-8#5)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1992-12#3)(1992-5#1)(1992-6#4)(1992-8#3)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#4)(1994-11#4)(1994-3#4)(1994-5#4)(1994-8#1)(1995-2#9)(1995-5#5)(1995-6#16)(1995-8#4)(1996-1#2)(1996-10#3)(1996-12#12)(1996-2#1)(1996-3#11)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#6)(2006-10#3)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#14)(2007-2#1)(2007-8#1)(2008-10#148)(2008-11#23)(2008-12#40)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#45)(2008-6#16)(2008-7#14)(2008-8#16)(2008-9#30)(2009-11#1)(2009-12#4)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#5)(2010-10#2)(2010-3#5)(2010-4#5)(2010-8#11)(2011-1#15)(2011-10#2)(2011-2#42)(2011-3#2)(2012-12#2)(2012-2#16)(2012-3#13)(2012-4#1)(2013-1#15)(2013-7#1)(2013-8#22)
L'association de la leucémie aiguë##2##5##(2013-1#2)
L'association##3##1##(2011-2#1)(2013-1#2)
L'objectif de ce travail##2##4##(2013-1#2)
L'vov platform##2##2##(2008-10#2)
L( *)##5##2##(2010-4#5)
L( *)a( *)b( *) color values##2##6##(2010-4#2)
L(##8##1##(2010-4#8)
L(+) lactic acid##2##3##(2008-5#2)
L(+)##3##1##(2007-11#1)(2008-5#2)
L(-1) H(2)O(2) and##3##3##(2008-10#3)
L(-1) NH(4)(+)##3##2##(2008-10#3)
L(-1) NaCl##2##2##(2008-9#2)
L(-1) and 0##2##3##(2008-10#2)
L(-1) and 1##2##3##(2008-10#2)
L(-1) and##11##2##(2008-10#9)(2010-5#1)(2011-3#1)
L(-1) for##6##2##(2008-10#5)(2013-8#1)
L(-1) in##2##2##(2011-3#1)(2013-1#1)
L(-1) of##7##2##(2008-10#6)(2008-7#1)
L(-1) was##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
L(-1)##118##1##(2007-12#1)(2008-10#62)(2008-11#5)(2008-12#19)(2008-7#5)(2008-9#7)(2010-5#3)(2011-2#2)(2011-3#7)(2012-12#2)(2013-1#1)(2013-8#4)
L(-1)) and##3##2##(2008-10#2)(2008-9#1)
L(-1)) of##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
L(-1))##28##1##(2008-10#9)(2008-11#2)(2008-12#8)(2008-7#2)(2008-9#1)(2010-5#1)(2011-3#5)
L(1) and##2##2##(2008-10#1)(2008-8#1)
L(1)##6##1##(2008-10#2)(2008-3#2)(2008-8#1)(2009-9#1)
L(2) = cis-dppen##3##3##(2009-9#3)
L(2) =##5##2##(2009-9#5)
L(2)##11##1##(2008-10#4)(2008-5#2)(2009-9#5)
L(OP)##2##1##(2010-8#2)
L(S)##6##1##(2010-8#6)
L(T)##3##1##(2008-10#1)(2010-8#2)
L(T))##2##1##(2010-8#2)
L(u)##2##1##(2008-2#2)
L)##16##1##(1990-2#1)(1990-5#1)(1991-2#1)(1995-12#1)(1996-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#2)(2009-8#1)(2012-12#1)
L- and##2##2##(2008-10#1)(2009-12#1)
L- or D-amino##2##3##(1992-11#1)(2008-10#1)
L- or##3##2##(1992-11#1)(1993-9#1)(2008-10#1)
L-##8##1##(1992-11#1)(1993-11#1)(1993-9#1)(1996-5#2)(2008-10#2)(2009-12#1)
L-(+)-lactic acid##3##2##(2008-6#3)
L-1##3##1##(2008-11#2)(2008-3#1)
L-15 medium##3##2##(2008-11#3)
L-163##11##1##(1995-12#11)
L-364##5##1##(1995-11#3)(1995-12#1)(1996-2#1)
L-365##4##1##(1992-3#1)(1995-12#2)(1996-2#1)
L-574-1##7##1##(2008-10#7)
L-6##4##1##(1995-8#3)(2008-11#1)
L-659##3##1##(2008-8#3)
L-668##2##1##(2008-8#2)
L-680##3##1##(1993-8#3)
L-689##5##1##(1991-12#5)
L-694##2##1##(1991-12#2)
L-701##5##1##(1997-7#5)
L-929##2##1##(1991-12#1)(1992-9#1)
L-A dsRNA##4##2##(1997-3#4)
L-A##5##1##(1997-3#5)
L-Arg-L-Phe##6##1##(1991-2#6)
L-Arginine##2##1##(1991-6#1)(1995-12#1)
L-Arm##3##1##(2007-11#3)
L-Cys##2##1##(1994-5#2)
L-D isomer##2##2##(1993-8#2)
L-D##4##1##(1993-8#4)
L-DOPA at##2##2##(1995-3#2)
L-DOPA intake##2##2##(2008-7#2)
L-DOPA##8##1##(1995-3#5)(2008-7#3)
L-FABP and ACBP##3##3##(1994-8#3)
L-FABP##11##1##(1994-8#8)(2013-1#3)
L-Glu##5##1##(1997-2#5)
L-Glutamine##2##1##(2007-12#1)(2008-9#1)
L-L and##2##2##(1993-8#1)(1994-3#1)
L-L##5##1##(1993-8#4)(1994-3#1)
L-Leucine##2##1##(2008-11#1)(2012-9#1)
L-N6-(1-iminoethyl)-lysine potently##2##2##(1995-12#2)
L-N6-(1-iminoethyl)-lysine##6##1##(1995-12#6)
L-NAC##2##1##(1994-5#2)
L-NAME + L-arginine##2##3##(1997-7#2)
L-NAME completely##2##2##(1995-12#1)(1997-7#1)
L-NAME or##2##2##(1995-12#1)(2008-11#1)
L-NAME was##3##2##(1995-12#1)(1996-5#1)(1997-7#1)
L-NAME##20##1##(1992-3#1)(1995-12#3)(1995-5#3)(1996-5#3)(1997-7#8)(2008-11#2)
L-NAME-blood pressure increase##2##3##(1997-7#2)
L-NG-nitroarginine methyl ester##2##3##(1995-11#2)
L-NMMA##3##1##(1991-9#1)(1992-3#1)(2011-2#1)
L-NNA##2##1##(1997-2#2)
L-OES##2##1##(2008-10#2)
L-PHP expression##2##2##(2013-7#2)
L-PHP may##3##2##(2013-7#3)
L-PHP##16##1##(2013-7#16)
L-R##2##1##(2010-9#2)
L-T4##4##1##(1994-6#1)(2008-7#1)(2011-1#2)
L-TGF-beta 1##7##2##(1990-2#7)
L-ZGP##3##1##(1995-6#3)
L-acetylcarnitine##5##1##(1990-3#2)(2008-7#3)
L-alanine##3##1##(1992-6#2)(1995-12#1)
L-alpha-H-amino acids##2##2##(1992-11#2)
L-amino acid##3##2##(1991-5#1)(1997-3#1)(2008-10#1)
L-amino acids by##2##3##(1995-3#2)
L-amino acids##6##2##(1992-11#1)(1995-11#1)(1995-3#4)
L-amino##9##1##(1991-5#1)(1992-11#1)(1995-11#1)(1995-3#4)(1997-3#1)(2008-10#1)
L-arginine (200 mg/kg##2##3##(1997-2#1)(1997-7#1)
L-arginine and##7##2##(1990-12#1)(1991-9#2)(1994-11#1)(2008-11#1)(2009-9#1)(2010-12#1)
L-arginine by##2##2##(2008-5#1)(2010-12#1)
L-arginine oxidation##3##2##(1993-3#3)
L-arginine##62##1##(1990-12#7)(1991-12#1)(1991-6#1)(1991-9#7)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#3)(1993-8#4)(1994-11#1)(1995-11#3)(1995-12#4)(1997-2#5)(1997-7#11)(2007-10#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#2)
L-arginine-nitric oxide##3##2##(1993-3#1)(1993-8#1)(1995-12#1)
L-ascorbic acid##7##2##(1993-12#2)(2008-10#1)(2008-11#1)(2013-1#3)
L-ascorbic##8##1##(1993-12#2)(2008-10#1)(2008-11#1)(2013-1#4)
L-asparaginase##8##1##(2010-11#2)(2011-2#5)(2012-3#1)
L-buthionine-S##2##1##(1993-9#2)
L-carnitine (200##2##2##(2011-2#2)
L-carnitine caused a##2##3##(2009-8#2)
L-carnitine in##2##2##(2008-10#1)(2012-2#1)
L-carnitine supplementation##3##2##(2011-2#3)
L-carnitine##19##1##(1991-12#3)(1993-6#1)(2008-10#2)(2009-8#5)(2011-2#6)(2012-2#1)(2013-1#1)
L-chain degradation##2##2##(1995-2#2)
L-chain##4##1##(1992-3#1)(1995-2#3)
L-citrulline and##2##2##(1991-12#1)(1992-3#1)
L-citrulline##8##1##(1990-12#2)(1991-12#1)(1992-3#1)(1995-11#1)(2007-10#3)
L-cysteine##7##1##(1991-9#1)(1994-5#1)(1994-6#2)(1995-3#1)(2009-11#1)(2009-6#1)
L-cystine##2##1##(2008-11#1)(2010-11#1)
L-deprenyl treatment on##2##3##(1994-6#2)
L-deprenyl##11##1##(1994-6#10)(2008-7#1)
L-dopa concentration##3##2##(2008-10#1)(2008-7#2)
L-dopa in pharmaceutical formulations##2##4##(2008-10#2)
L-dopa##16##1##(1990-8#1)(1995-3#1)(2007-7#1)(2008-10#9)(2008-7#4)
L-dopa/carbidopa##5##1##(2008-7#5)
L-dropropizine##2##1##(1990-6#2)
L-dsRNA##4##1##(2008-10#4)
L-erythrulose from##2##2##(2008-7#2)
L-erythrulose##3##1##(2008-7#3)
L-glutamate and##2##2##(1996-5#1)(2008-7#1)
L-glutamate##13##1##(1992-11#1)(1993-9#2)(1995-12#1)(1995-2#1)(1996-5#3)(1997-2#2)(2008-7#3)
L-glutamine##4##1##(1990-12#1)(1995-8#1)(2008-11#1)(2008-8#1)
L-histidine and##2##2##(1995-8#1)(2008-11#1)
L-histidine##17##1##(1995-8#10)(1997-1#1)(2008-11#6)
L-isoproterenol##2##1##(2008-9#2)
L-kynurenine##2##1##(1992-3#1)(1993-12#1)
L-lactate dehydrogenase##5##2##(1993-11#2)(1994-11#1)(2008-6#1)(2010-12#1)
L-lactate##10##1##(1991-5#1)(1993-11#2)(1994-11#1)(1994-3#1)(2008-6#4)(2010-12#1)
L-lactic acid in##2##3##(2008-6#2)
L-lactic acid##9##2##(2008-6#8)(2008-7#1)
L-lactide)##2##1##(2008-5#2)
L-leucine and KIC##7##3##(2008-11#7)
L-leucine and##8##2##(2008-11#8)
L-leucine##11##1##(1990-2#1)(1992-3#1)(2008-11#8)(2008-4#1)
L-lysine acetate has been##2##4##(2013-1#2)
L-lysine acetate##4##2##(2013-1#4)
L-lysine##7##1##(2008-11#1)(2008-7#2)(2013-1#4)
L-malic acid bioconversion##2##3##(2008-6#2)
L-malic acid##5##2##(2008-6#5)
L-malic##6##1##(2008-6#6)
L-menthol##10##1##(2012-2#10)
L-methionine for##2##2##(1992-6#1)(2008-10#1)
L-methionine##11##1##(1991-9#3)(1992-6#1)(1992-9#1)(1995-3#1)(1996-2#2)(2008-10#2)(2010-11#1)
L-pABA hydrolyzing activity in##2##4##(1990-8#2)
L-pABA hydrolyzing activity##3##3##(1990-8#3)
L-pABA##4##1##(1990-8#4)
L-phenylephrine in the##2##3##(1997-7#2)
L-phenylephrine##3##1##(1997-7#3)
L-proline transporter##2##2##(1995-6#2)
L-proline##6##1##(1991-12#1)(1995-2#1)(1995-6#2)(2008-10#2)
L-proline)##2##1##(1995-2#2)
L-pyroglutamyl-L-prolyl-L-valine-p-nitroanilide##2##1##(1990-2#2)
L-rhamnose##2##1##(1992-12#2)
L-selectin is##2##2##(1992-12#2)
L-selectin##8##1##(1992-12#4)(1996-2#1)(2008-10#3)
L-thyroxine##2##1##(1990-12#1)(2011-1#1)
L-tryptophan##5##1##(1990-10#1)(1990-8#1)(1996-7#2)(2008-10#1)
L-type Ca2+ channel##3##3##(1994-6#1)(1995-12#1)(1997-2#1)
L-type Ca2+ channels##5##3##(1990-8#1)(1993-11#1)(1997-2#1)(2009-8#1)(2010-11#1)
L-type Ca2+##10##2##(1990-8#1)(1993-11#1)(1994-6#1)(1995-12#3)(1997-2#2)(2009-8#1)(2010-11#1)
L-type calcium channel##4##3##(1994-11#1)(1995-3#2)(2008-8#1)
L-type calcium channels##6##3##(1994-6#1)(1995-3#1)(1996-5#1)(1997-1#1)(2008-8#2)
L-type calcium##10##2##(1994-11#1)(1994-6#1)(1995-3#3)(1996-5#1)(1997-1#1)(2008-8#3)
L-type channels##2##2##(1994-11#1)(1994-9#1)
L-type pyruvate kinase##4##3##(1990-8#4)
L-type voltage sensitive Ca2+##2##4##(1997-2#2)
L-type##35##1##(1990-8#5)(1993-11#1)(1994-11#2)(1994-6#2)(1994-9#2)(1995-12#3)(1995-3#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#5)(2008-8#4)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-5#1)
L-tyrosine##4##1##(2008-10#3)(2008-9#1)
L/min##3##1##(1996-3#1)(2008-8#1)(2010-7#1)
L0##3##1##(2008-3#3)
L1 and##2##2##(1993-11#1)(2011-2#1)
L1 elements##3##2##(2008-11#3)
L1 expression is##2##3##(1995-2#1)(2008-7#1)
L1 in CNS myelination##2##4##(2008-7#2)
L1 in##6##2##(1995-2#1)(1996-12#2)(2008-10#1)(2008-7#2)
L1 is##2##2##(1996-12#1)(2008-7#1)
L1##43##1##(1991-11#3)(1993-11#3)(1993-12#2)(1995-2#4)(1995-6#1)(1996-12#6)(1997-2#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-7#7)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
L1-Fc fusion##2##2##(2008-7#2)
L100I (TTA--&gt##2##2##(2011-3#2)
L11##6##1##(1995-6#1)(2008-10#5)
L14##2##1##(1990-12#1)(2009-9#1)
L16C5##7##1##(2008-10#7)
L17##2##1##(1995-6#2)
L17A homologue##2##2##(1991-6#2)
L17A##7##1##(1991-6#7)
L1CAM##3##1##(1993-6#3)
L2 and L4##2##3##(1991-2#2)
L2 and##3##2##(1991-11#1)(1991-2#2)
L2 production##2##2##(2011-2#2)
L2##14##1##(1990-5#1)(1991-11#2)(1991-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
L2-3 and L3-4##3##3##(2013-1#3)
L2-3##5##1##(2012-3#1)(2013-1#4)
L20B##2##1##(2012-2#2)
L24 mutant the##2##3##(2008-8#2)
L24 mutant##7##2##(2008-8#2)(2008-9#5)
L27##2##1##(1993-11#2)
L29##2##1##(1994-12#1)(2008-10#1)
L2d-dauer##2##1##(1993-12#2)
L3 and L4##2##3##(2008-10#1)(2008-8#1)
L3 and##5##2##(1991-2#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
L3 ventral##2##2##(1993-12#2)
L3##25##1##(1991-11#3)(1991-2#5)(1992-8#5)(1993-12#2)(1994-6#1)(1996-6#1)(2008-10#4)(2008-3#1)(2008-8#2)(2012-12#1)
L3-4 and lumbar curvature##2##4##(2013-1#2)
L3-4##6##1##(2012-3#2)(2013-1#4)
L3-L4 levels##2##2##(2007-11#2)
L3-L4##6##1##(2007-11#4)(2011-2#2)
L32##4##1##(1991-5#2)(1991-8#2)
L32phe##2##1##(1991-8#2)
L32tyr##3##1##(1991-8#3)
L34arg##2##1##(1991-8#2)
L364718##6##1##(1994-6#6)
L365260 and L364718##3##3##(1994-6#3)
L365260##4##1##(1994-6#4)
L4##11##1##(1991-2#2)(1996-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#4)
L4-5##6##1##(2008-3#1)(2012-2#2)(2012-3#3)
L4-L5 and L5-S1##2##3##(1996-6#1)(2007-11#1)
L4-L5 and##3##2##(1996-6#1)(2007-11#2)
L4-L5 level##3##2##(1996-6#2)(2007-11#1)
L4-L5##9##1##(1996-6#3)(2007-11#3)(2007-7#1)(2009-3#1)(2011-2#1)
L5 nerve##2##2##(2012-2#2)
L5 ventral root as compared with the##2##7##(1993-12#2)
L5 ventral root##3##3##(1993-12#3)
L5##13##1##(1993-12#4)(1995-5#1)(2007-11#3)(2008-10#1)(2009-3#1)(2012-2#3)
L5-S1 level##2##2##(2007-11#1)(2012-2#1)
L5-S1##14##1##(1996-6#3)(2007-11#7)(2009-3#1)(2011-2#1)(2012-2#2)
L5178Y lymphoma line##3##3##(1992-9#3)
L5178Y lymphoma##4##2##(1992-9#4)
L5178Y##5##1##(1991-9#1)(1992-9#4)
L6 and##3##2##(1992-12#1)(1993-3#2)
L6 cells##3##2##(1992-6#1)(1993-3#1)(2008-11#1)
L6 myotubes##15##2##(1994-11#2)(2008-11#13)
L6##26##1##(1990-12#1)(1992-12#1)(1992-6#1)(1993-3#4)(1994-11#3)(2008-11#15)(2010-10#1)
L929 cells and mice splenocytes##2##5##(2008-5#2)
L929 cells and##4##3##(1990-11#1)(2008-10#1)(2008-5#2)
L929 cells##7##2##(1990-11#1)(1990-12#1)(1994-8#2)(2008-10#1)(2008-5#2)
L929 fibroblast cells##2##3##(2008-5#2)
L929##15##1##(1990-11#1)(1990-12#2)(1994-3#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-5#5)(2008-8#1)(2009-2#1)
LA and CRY##2##3##(2009-8#2)
LA and##7##2##(1994-11#1)(2008-5#1)(2009-8#2)(2011-2#3)
LA in##4##2##(1992-5#1)(2007-7#1)(2008-5#2)
LA is a##2##3##(2007-7#1)(2008-10#1)
LA is##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
LA may be##2##3##(1992-5#1)(2007-7#1)
LA sampling##2##2##(2008-10#2)
LA##50##1##(1992-5#3)(1994-11#1)(1994-3#1)(1995-12#1)(2007-7#3)(2007-8#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#11)(2008-7#2)(2009-5#1)(2009-8#2)(2011-2#5)(2013-1#4)
LA-AI##2##1##(2008-8#2)
LA-ICP-MS##14##1##(2008-10#13)(2010-11#1)
LA-ICPMS##2##1##(2008-10#2)
LA4+##5##1##(2008-10#5)
LAA##2##1##(2007-8#2)
LAB and bifidobacteria##2##3##(2009-5#2)
LAB and##5##2##(2009-5#3)(2013-1#2)
LAB diet##5##2##(2011-1#5)
LAB##18##1##(2008-6#2)(2009-5#4)(2011-1#6)(2012-2#3)(2013-1#3)
LABC##3##1##(2007-5#3)
LAC##2##1##(1994-9#1)(2008-2#1)
LAD therapy##2##2##(2013-1#2)
LAD##17##1##(2007-8#3)(2008-4#1)(2011-2#2)(2013-1#7)(2013-7#4)
LADA and##2##2##(2008-3#2)
LADA patients##6##2##(2008-3#6)
LADA##10##1##(2008-3#10)
LADH##3##1##(1995-5#3)
LAFB##2##1##(2008-7#2)
LAI##4##1##(2008-12#4)
LAIV and TIV##4##3##(2011-2#4)
LAIV was##3##2##(2011-2#3)
LAIV##8##1##(2011-2#8)
LAK activity##2##2##(2008-4#2)
LAK cell##2##2##(1991-8#1)(2008-11#1)
LAK cells and##2##3##(1990-12#1)(1992-2#1)
LAK cells##10##2##(1990-12#3)(1992-2#1)(1993-6#1)(1994-6#1)(2008-11#1)(2008-4#3)
LAK precursor##2##2##(2008-4#2)
LAK##21##1##(1990-12#3)(1991-8#1)(1992-2#5)(1993-6#1)(1994-12#1)(1994-6#1)(2008-11#2)(2008-4#7)
LAKs##2##1##(1990-12#2)
LAMP method##3##2##(2009-6#3)
LAMP##4##1##(2009-6#4)
LAMP-1##4##1##(1990-12#3)(1994-6#1)
LAN##4##1##(2007-12#3)(2008-3#1)
LANs##4##1##(1994-12#1)(2008-7#3)
LAP crystal##2##2##(2008-2#2)
LAP##8##1##(1991-4#3)(1992-5#1)(1993-3#2)(2008-2#2)
LARC##2##1##(2013-1#2)
LAS surfactants##3##2##(2008-10#3)
LAS##14##1##(2008-10#14)
LAS)##2##1##(2008-10#2)
LASA##2##1##(1993-1#2)
LASIK monovision##5##2##(2011-2#5)
LASSO##5##1##(2008-6#1)(2012-3#4)
LAT##5##1##(1990-6#4)(1992-6#1)
LATEBLIGHT##9##1##(2008-10#9)
LAV##2##1##(2008-10#2)
LAVH and##2##2##(1994-2#1)(2010-3#1)
LAVH procedure##2##2##(1995-1#1)(2010-3#1)
LAVH##18##1##(1994-2#4)(1995-1#2)(1995-3#2)(1996-2#2)(2010-3#8)
LAY ABSTRACT##8##2##(2012-2#8)
LAs were##2##2##(2007-10#2)
LAs##4##1##(2007-10#4)
LB and SP##2##3##(2008-10#2)
LB and XN4##2##3##(2008-10#2)
LB and##4##2##(2008-10#4)
LB film##2##2##(2008-10#2)
LB films and##2##3##(2007-12#1)(2008-10#1)
LB films are##2##3##(2008-10#2)
LB films were##3##3##(2008-10#3)
LB films##15##2##(2007-12#1)(2008-10#11)(2008-11#3)
LB x SP##2##3##(2008-10#2)
LB x XN4 and XN4 x SP##2##7##(2008-10#2)
LB x XN4##3##3##(2008-10#3)
LB x##6##2##(2008-10#6)
LB##42##1##(1997-6#1)(2007-12#1)(2008-10#24)(2008-11#9)(2008-3#1)(2008-9#1)(2012-2#2)(2013-1#3)
LB31##4##1##(2008-10#4)
LBA4404##2##1##(2006-12#1)(2008-9#1)
LBL films##2##2##(2008-10#2)
LBL##4##1##(2008-10#3)(2009-11#1)
LBMA##2##1##(2008-9#2)
LBO crystal##3##2##(2007-12#2)(2008-3#1)
LBO##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
LBP and##2##2##(2010-9#1)(2012-12#1)
LBP group##2##2##(2010-9#2)
LBP without##2##2##(2012-2#2)
LBP##17##1##(2010-12#3)(2010-3#1)(2010-9#5)(2012-12#4)(2012-2#3)(2013-1#1)
LBR##3##1##(2011-2#3)
LBVV and MiLV##2##3##(2008-10#2)
LBVV##6##1##(2008-10#6)
LBW##3##1##(2008-12#2)(2008-7#1)
LC Vs##2##2##(2008-10#2)
LC and##6##2##(2008-10#5)(2008-3#1)
LC in##2##2##(1995-12#1)(2008-10#1)
LC method for simultaneous##2##4##(2008-10#2)
LC method for##3##3##(2008-10#3)
LC method##5##2##(2008-10#5)
LC methods##2##2##(2008-10#2)
LC separation and determination##2##4##(2008-10#2)
LC separation and##4##3##(2008-10#4)
LC separation##6##2##(2008-10#6)
LC##59##1##(1995-12#2)(1995-6#2)(2007-12#3)(2008-10#39)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#3)(2011-2#1)(2013-1#1)
LC(50)##2##1##(2008-10#2)
LC(99##4##1##(2011-2#4)
LC-ESI-MS##3##1##(2008-10#3)
LC-HG-ICP-MS##2##1##(2008-10#2)
LC-ICP-MS##6##1##(2008-10#6)
LC-ICP-ORS-MS and##2##2##(2008-10#2)
LC-MS analysis of##2##3##(2008-10#2)
LC-MS and##4##2##(2008-10#2)(2010-11#1)(2010-2#1)
LC-MS data##2##2##(2012-12#2)
LC-MS with##2##2##(2008-10#1)(2010-4#1)
LC-MS##24##1##(1997-2#1)(2008-10#11)(2010-11#3)(2010-2#2)(2010-4#3)(2011-2#1)(2012-12#3)
LC-MS/MS method##4##2##(2008-10#1)(2011-3#2)(2013-1#1)
LC-MS/MS##16##1##(2008-10#1)(2008-4#1)(2010-11#7)(2010-12#1)(2011-3#4)(2012-1#1)(2013-1#1)
LC-UV##2##1##(2008-10#2)
LC-UV-MS##2##1##(2008-10#2)
LC/ES/MS##2##1##(2008-10#2)
LC/MS##4##1##(1994-11#1)(2008-10#2)(2009-8#1)
LC2##2##1##(1993-9#2)
LC50##8##1##(2008-11#1)(2008-12#3)(2008-7#1)(2011-2#3)
LC50(7d)##2##1##(2008-11#2)
LCA consisting mainly of##2##4##(1997-6#2)
LCA consisting##4##2##(1997-6#4)
LCA##9##1##(1997-4#1)(1997-6#4)(2008-11#1)(2010-10#1)(2010-12#1)(2011-2#1)
LCAT##17##1##(1993-6#9)(1993-8#7)(2008-7#1)
LCD monitor##3##2##(2010-9#3)
LCD panel##2##2##(2007-11#2)
LCD##10##1##(2007-11#2)(2008-2#3)(2008-3#2)(2010-9#3)
LCF6##2##1##(1990-12#2)
LCH##3##1##(2010-10#1)(2011-1#1)(2012-3#1)
LCIS##3##1##(1992-8#3)
LCLs##2##1##(2008-2#2)
LCM##11##1##(2008-11#2)(2010-12#6)(2010-6#3)
LCN2-null mice##3##2##(2013-8#3)
LCU rating##5##2##(2011-2#5)
LCU##8##1##(2011-2#8)
LCV injection of PGE2 at##2##5##(1997-2#2)
LCW##5##1##(2008-10#3)(2008-2#2)
LCWS##3##1##(2008-3#3)
LChD##9##1##(2008-10#9)
LChV-1##3##1##(2008-10#3)
LChV-2 is##2##2##(2008-10#2)
LChV-2##5##1##(2008-10#5)
LChV-3 CP##2##2##(2008-10#2)
LChV-3 is##2##2##(2008-10#2)
LChV-3##7##1##(2008-10#7)
LCs##2##1##(1996-12#1)(2008-10#1)
LD 24##3##2##(2008-7#3)
LD and##3##2##(2007-10#1)(2007-11#1)(2008-5#1)
LD between##2##2##(2008-12#1)(2008-9#1)
LD muscle and marbling images##2##5##(2010-4#2)
LD muscle##4##2##(2010-4#3)(2011-2#1)
LD therapy##2##2##(2008-7#2)
LD use##2##2##(2008-7#2)
LD##41##1##(1994-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#14)(2008-8#1)(2008-9#1)(2010-4#3)(2011-2#1)(2012-5#2)
LD(50)##4##1##(2008-10#1)(2008-11#2)(2008-9#1)
LD12##2##1##(1995-12#2)
LD50 value##4##2##(1992-11#1)(1992-12#1)(2008-12#1)(2008-4#1)
LD50##8##1##(1990-5#1)(1992-11#1)(1992-12#2)(2008-11#1)(2008-12#2)(2008-4#1)
LDA##7##1##(2008-10#2)(2008-3#2)(2008-6#2)(2008-7#1)
LDF##2##1##(2011-2#2)
LDH activity in the medium##2##5##(2008-11#2)
LDH activity##6##2##(1993-12#1)(2008-11#2)(2011-2#1)(2013-1#2)
LDH and##3##2##(1992-11#1)(1994-11#1)(2011-2#1)
LDH enzyme##3##2##(2011-2#3)
LDH from rabbit muscle##3##4##(2008-11#3)
LDH is##2##2##(1994-11#1)(2008-11#1)
LDH isoenzymes##2##2##(1993-12#2)
LDH leakage##4##2##(1994-11#1)(1994-5#2)(1995-11#1)
LDH release##4##2##(1994-6#1)(1995-12#1)(1996-9#1)(2008-11#1)
LDH was##4##2##(2008-11#3)(2011-2#1)
LDH##63##1##(1992-11#5)(1993-11#1)(1993-12#3)(1994-11#6)(1994-2#1)(1994-5#3)(1994-6#1)(1995-11#2)(1995-12#1)(1996-9#1)(1997-7#1)(2007-2#1)(2008-10#4)(2008-11#16)(2010-4#3)(2011-2#6)(2011-3#3)(2013-1#5)
LDH-C##2##1##(1994-11#2)
LDI-TOF MS##2##2##(2008-10#2)
LDKT##3##1##(2011-2#3)
LDL alpha-tocopherol##4##2##(1991-12#4)
LDL and HDL cholesterol##3##4##(1991-2#1)(1991-6#1)(2012-3#1)
LDL and VLDL##3##3##(1994-3#1)(1994-6#1)(1995-8#1)
LDL and positively charged##2##4##(1994-9#2)
LDL and that##2##3##(1991-12#1)(2008-10#1)
LDL and##16##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-5#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-8#1)(1997-8#1)(2008-10#2)(2009-8#1)(2012-3#1)(2013-1#1)
LDL cholesterol and##4##3##(1990-3#1)(1991-2#1)(2008-7#1)(2010-12#1)
LDL cholesterol in##2##3##(2007-7#1)(2008-3#1)
LDL cholesterol levels##6##3##(2008-3#2)(2010-12#1)(2012-2#3)
LDL cholesterol lowering##2##3##(2008-1#1)(2010-12#1)
LDL cholesterol##30##2##(1990-3#1)(1991-2#2)(1991-6#1)(1992-11#1)(1993-12#2)(1995-12#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-3#6)(2008-5#1)(2008-7#1)(2010-12#4)(2011-2#1)(2012-2#4)(2012-6#1)(2013-8#1)
LDL concentration##4##2##(1995-8#1)(2008-9#3)
LDL from##4##2##(1991-2#2)(1995-6#1)(2008-8#1)
LDL in##4##2##(1991-2#1)(1991-5#1)(1992-5#1)(1996-2#1)
LDL is##4##2##(1992-5#1)(1994-3#1)(1995-6#1)(2011-1#1)
LDL levels##2##2##(2010-3#1)(2011-1#1)
LDL metabolism was##2##3##(1993-6#2)
LDL metabolism##6##2##(1993-6#6)
LDL on##2##2##(1990-12#1)(1994-9#1)
LDL oxidation by##2##3##(1995-12#1)(1996-11#1)
LDL oxidation##10##2##(1991-12#3)(1992-9#1)(1994-11#1)(1994-9#1)(1995-12#3)(1996-11#1)
LDL particle size##5##3##(1995-8#1)(2008-3#1)(2011-1#3)
LDL particle##9##2##(1995-8#1)(1996-8#1)(2008-3#2)(2008-5#1)(2011-1#4)
LDL particles##5##2##(1994-3#1)(1995-5#1)(2008-10#1)(2009-8#1)(2012-2#1)
LDL receptor in##2##3##(1990-7#2)
LDL receptor##19##2##(1990-11#1)(1990-2#1)(1990-7#8)(1991-2#2)(1993-8#1)(1995-6#1)(2008-6#4)(2008-8#1)
LDL receptors##4##2##(1990-11#2)(1995-8#1)(2012-2#1)
LDL to##8##2##(1991-12#1)(1991-5#1)(1995-12#3)(1995-5#1)(1996-3#1)(1997-8#1)
LDL uptake##2##2##(2012-2#1)(2013-1#1)
LDL was##3##2##(1991-5#1)(1995-8#1)(1996-2#1)
LDL which##2##2##(1994-9#1)(1995-5#1)
LDL with##5##2##(1994-8#1)(1995-5#1)(2008-3#1)(2009-8#1)(2013-1#1)
LDL##234##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#8)(1990-8#6)(1991-12#11)(1991-2#13)(1991-5#3)(1991-6#3)(1991-8#1)(1992-11#1)(1992-5#6)(1992-9#1)(1993-12#3)(1993-2#2)(1993-6#11)(1993-8#3)(1994-11#4)(1994-3#7)(1994-6#1)(1994-8#1)(1994-9#10)(1995-12#10)(1995-2#2)(1995-5#7)(1995-6#7)(1995-8#5)(1996-11#1)(1996-2#5)(1996-3#2)(1996-8#1)(1997-8#2)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-3#16)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-8#12)(2010-12#4)(2010-3#1)(2011-1#7)(2011-2#1)(2012-2#9)(2012-3#1)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#1)
LDL)##3##1##(1991-2#1)(1992-5#1)(2008-2#1)
LDL-C and##3##2##(2012-6#2)(2013-1#1)
LDL-C##21##1##(1990-2#1)(2008-1#3)(2008-12#2)(2011-1#1)(2011-2#4)(2012-6#5)(2013-1#5)
LDL-cholesterol##16##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-11#1)(1993-12#2)(1993-2#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-5#3)(2013-1#1)
LDL-hypercholesterolemia##2##1##(2008-5#2)
LDL-like##2##1##(1993-8#1)(1995-6#1)
LDL-stimulated##2##1##(1994-9#1)(1995-12#1)
LDLR##7##1##(1995-2#3)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
LDLRs##2##1##(2009-8#2)
LDLT for a patient##2##4##(2013-8#2)
LDLT##4##1##(2013-8#4)
LDM##2##1##(2008-10#2)
LDMC flaps in a spiral fashion##2##6##(2011-2#2)
LDR##10##1##(2008-10#1)(2008-7#5)(2009-2#1)(2013-1#3)
LDS##3##1##(2008-10#1)(2008-3#2)
LDT the##2##2##(2011-2#2)
LDT##6##1##(2011-2#6)
LDs and LAs##2##3##(2007-10#2)
LDs##5##1##(2007-10#2)(2007-11#1)(2008-10#2)
LE##7##1##(1995-8#2)(2008-10#5)
LEADS TO##2##2##(2008-1#1)(2013-1#1)
LEANDRE II##4##2##(2008-3#4)
LEAP is##2##2##(1996-3#2)
LEAP##7##1##(1996-3#7)
LEB##2##1##(2008-10#2)
LEC rats##3##2##(1995-3#3)
LEC##4##1##(1995-3#3)(2008-7#1)
LED as light source##2##4##(2008-10#1)(2008-3#1)
LED as the##2##3##(2007-11#1)(2008-10#1)
LED as##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
LED colorimeter##2##2##(2008-10#2)
LED excitation##2##2##(2008-10#1)(2008-7#1)
LED is##2##2##(2008-10#2)
LED light##3##2##(2008-11#3)
LED##36##1##(2007-11#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#7)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
LED's##7##1##(2007-11#1)(2007-12#3)(2008-3#3)
LED-based photometer##2##2##(2008-10#2)
LED-based##6##1##(2008-10#5)(2011-2#1)
LEDGF/p75##3##1##(2013-1#3)
LEDGF/p75-IN inhibitors##3##2##(2013-1#3)
LEDGF/p75-IN##5##1##(2013-1#5)
LEDs as##2##2##(2007-11#1)(2008-10#1)
LEDs were##2##2##(2008-10#2)
LEDs##12##1##(1995-3#1)(2007-11#1)(2008-10#8)(2008-7#1)(2013-1#1)
LEE##2##1##(2011-1#2)
LEF-1##6##1##(1995-8#6)
LEH##11##1##(1994-11#5)(1994-12#6)
LEH-induced##2##1##(1994-11#2)
LEI##2##1##(2008-1#1)(2008-10#1)
LEOPARD syndrome is##2##3##(2013-8#2)
LEOPARD syndrome##4##2##(2013-8#4)
LES pressure##2##2##(2013-8#2)
LES##7##1##(2011-2#1)(2013-8#6)
LES&amp##2##1##(2009-2#2)
LESS##8##1##(2007-8#4)(2009-2#4)
LET radiation##11##2##(2008-7#11)
LET##15##1##(2008-7#15)
LEU4##2##1##(1996-3#2)
LEW/N##3##1##(1994-2#3)
LF##4##1##(2008-4#1)(2009-2#2)(2011-3#1)
LF-0023##2##1##(2008-10#2)
LFD tests and##2##3##(2008-10#2)
LFD tests##3##2##(2008-10#3)
LFD##8##1##(2008-10#8)
LFF##2##1##(2007-12#2)
LFLX##3##1##(2008-10#3)
LFP##2##1##(1990-5#1)(2008-11#1)
LFS##5##1##(1990-12#4)(2011-2#1)
LG inequalities##5##2##(2012-2#5)
LG##18##1##(2007-12#2)(2008-10#4)(2008-5#1)(2008-7#5)(2012-2#6)
LG2##3##1##(2008-10#3)
LG7##4##1##(2008-10#4)
LGA##3##1##(2011-1#3)
LGB youth##3##2##(2010-8#3)
LGB##7##1##(2008-12#1)(2010-8#6)
LGBT-positive##2##1##(2008-12#2)
LGBTQ children##2##2##(2009-7#2)
LGBTQ parents##3##2##(2009-7#3)
LGBTQ##6##1##(2009-7#6)
LGG##3##1##(2009-12#3)
LGL were found to##2##4##(1990-12#2)
LGL##11##1##(1990-12#9)(1992-5#2)
LGN##6##1##(1996-2#2)(2008-1#2)(2008-8#2)
LGR##2##1##(2008-10#1)(2012-2#1)
LGS##3##1##(2008-3#3)
LH and##5##2##(1991-6#1)(1995-2#1)(2008-1#1)(2008-3#1)(2008-7#1)
LH beta chimera##2##3##(1995-2#2)
LH beta mRNA levels by##2##5##(1997-2#2)
LH beta mRNA levels##4##4##(1997-2#4)
LH beta mRNA##13##3##(1997-2#13)
LH beta subunit##2##3##(1995-2#1)(1997-2#1)
LH beta##18##2##(1995-2#4)(1997-2#14)
LH in##3##2##(1990-6#1)(1996-2#1)(2010-3#1)
LH lesions##3##2##(2009-10#3)
LH levels and##2##3##(1995-2#1)(1995-3#1)
LH levels were##2##3##(1995-3#2)
LH levels##6##2##(1995-2#1)(1995-3#4)(2011-2#1)
LH over AH##2##3##(2010-3#2)
LH receptor and inhibin##2##4##(2008-8#2)
LH receptor and##3##3##(1996-5#1)(2008-8#2)
LH receptor mRNA##3##3##(2008-5#3)
LH receptor##13##2##(1996-5#3)(2008-5#4)(2008-8#6)
LH release##3##2##(1996-2#3)
LH stimulation##4##2##(2009-10#4)
LH##88##1##(1990-12#1)(1990-6#1)(1991-11#1)(1991-6#2)(1993-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#5)(1996-2#7)(1996-5#4)(1996-7#4)(1997-2#15)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#6)(2009-10#11)(2010-3#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
LH-20##5##1##(1990-11#1)(1991-12#1)(1993-2#1)(2011-2#1)(2011-3#1)
LH-RH analogues##2##2##(1990-2#1)(1991-2#1)
LH-RH##7##1##(1990-2#1)(1991-2#1)(1993-1#5)
LH-hCG receptor##2##2##(1993-6#2)
LH/CG##2##1##(1990-12#2)
LH/hCG receptor##4##2##(1995-8#4)
LH/hCG##5##1##(1995-8#5)
LH1##2##1##(2010-2#2)
LHA##3##1##(1995-5#3)
LHC-II complexes##3##2##(2008-4#3)
LHC-II##4##1##(2008-4#4)
LHCs##4##1##(2008-8#4)
LHD##2##1##(1996-2#2)
LHDs##2##1##(1996-2#2)
LHR expression##2##2##(2008-8#2)
LHR gene##3##2##(1996-5#3)
LHR mRNA##6##2##(2008-8#6)
LHR promoter activity##2##3##(1996-5#2)
LHR promoter##7##2##(1996-5#7)
LHR##24##1##(1996-5#13)(2008-8#11)
LHRH agonists##3##2##(1990-11#1)(2008-4#2)
LHRH analogues##3##2##(2008-4#3)
LHRH neurons##2##2##(1995-12#2)
LHRH##17##1##(1990-11#1)(1992-12#3)(1994-9#1)(1995-12#2)(2008-4#10)
LHSs##2##1##(1992-12#2)
LHW##2##1##(2013-1#2)
LI##5##1##(1990-2#2)(2008-4#3)
LI-4##3##1##(2008-10#3)
LIBS measurements##2##2##(2008-2#2)
LIBS system was calibrated##2##4##(2008-10#1)(2008-2#1)
LIBS system##3##2##(2008-10#1)(2008-2#2)
LIBS##11##1##(2008-10#2)(2008-2#8)(2013-8#1)
LIC##3##1##(1997-4#3)
LIDO in##2##2##(1996-12#2)
LIDO##5##1##(1996-12#5)
LIDT was##2##2##(2007-11#1)(2008-3#1)
LIDT##12##1##(2007-11#5)(2007-12#1)(2008-3#6)
LIDT's of##2##2##(2008-3#2)
LIDT's##3##1##(2008-3#3)
LIF and##3##2##(2008-2#1)(2008-3#1)(2009-3#1)
LIF calibration functions##2##3##(2008-2#2)
LIF calibration##3##2##(2008-2#3)
LIF concentrations##2##2##(2008-11#2)
LIF detection##3##2##(2008-10#2)(2008-2#1)
LIF had no##2##3##(1995-2#2)
LIF knockout mice show reduced stress-induced ACTH secretion##2##8##(2008-4#2)
LIF measurements##2##2##(2008-3#2)
LIF method##2##2##(2008-2#2)
LIF spectra of macroscopic##2##4##(2008-3#2)
LIF spectra of##6##3##(2008-3#6)
LIF##58##1##(1995-11#1)(1995-2#6)(1996-2#2)(1997-7#4)(2008-10#3)(2008-11#9)(2008-2#8)(2008-3#13)(2008-4#6)(2008-8#1)(2009-3#5)
LIGHT##2##1##(2012-2#2)
LIGO##4##1##(2007-11#1)(2008-3#3)
LII for##3##2##(2008-2#3)
LII intensity profiles##2##3##(2008-2#2)
LII signals##2##2##(2008-2#2)
LII##14##1##(2008-2#9)(2008-3#5)
LILACS##7##1##(2011-2#1)(2012-3#4)(2013-8#2)
LIM domain##2##2##(2007-12#1)(2012-3#1)
LIM protein RBTN2##2##3##(1994-8#2)
LIM protein##4##2##(1994-8#2)(2008-9#1)(2010-6#1)
LIM##10##1##(1990-7#1)(1994-11#1)(1994-8#3)(2007-12#1)(2008-9#2)(2010-6#1)(2012-3#1)
LIMA##2##1##(2007-8#2)
LIMA-LAD anastomoses##4##2##(2007-8#4)
LIMM##3##1##(1990-12#3)
LIN-12##7##1##(1994-12#1)(2007-12#6)
LINC##2##1##(2009-8#2)
LINC1-GFP##2##1##(2009-8#2)
LINE-1##4##1##(1995-2#2)(2008-11#2)
LIP and MNP##2##3##(2008-6#2)
LIP protein##2##2##(1990-12#1)(2008-6#1)
LIP##9##1##(1990-12#5)(2008-6#4)
LIPID MAPS##2##2##(2012-12#2)
LIPUS##5##1##(2013-1#5)
LIR##5##1##(2008-9#5)
LIS##2##1##(1996-12#1)(2008-10#1)
LITA and RITA##2##3##(2007-8#2)
LITA signals##3##2##(2007-12#1)(2008-3#2)
LITA##12##1##(2007-12#1)(2007-8#6)(2008-3#5)
LITERATURE##2##1##(2009-10#1)(2011-1#1)
LIX##2##1##(2008-10#2)
LIYV##2##1##(2008-10#2)
LJ proportion method##2##3##(2007-7#2)
LJ##4##1##(2007-7#2)(2013-1#2)
LJUNGSKILE##2##1##(2008-10#2)
LKSD-1##2##1##(2008-10#2)
LL patients##3##2##(2007-7#3)
LL##9##1##(2007-7#7)(2012-1#1)(2012-2#1)
LL-H were##2##2##(1994-12#2)
LL-H##3##1##(1994-12#3)
LL-carriers##2##1##(2012-1#2)
LLC-PK(1) cells##3##2##(2008-7#2)(2012-12#1)
LLC-PK1 cells##5##2##(1991-12#3)(1991-5#1)(1992-11#1)
LLC-PK1##7##1##(1991-12#4)(1991-5#1)(1992-11#1)(2012-12#1)
LLC-PK1A cells##6##2##(1992-5#6)
LLC-PK1A##7##1##(1992-5#7)
LLD##6##1##(2008-11#6)
LLE##3##1##(2008-10#3)
LLETZ cone##3##2##(1994-2#3)
LLETZ##8##1##(1994-2#8)
LLNA##7##1##(2008-10#4)(2008-5#3)
LLPS##3##1##(2008-10#3)
LLS in##2##2##(2008-10#2)
LLS##8##1##(2008-10#5)(2008-3#3)
LM##16##1##(1991-8#1)(1992-5#4)(2008-11#1)(2008-3#3)(2008-6#3)(2008-9#1)(2010-4#2)(2011-1#1)
LM-PCR##2##1##(2008-8#1)(2011-2#1)
LM-acupoints##2##1##(2008-9#2)
LM/SL##3##1##(2012-12#3)
LMA CTrach##3##2##(2010-7#3)
LMA##11##1##(2008-8#2)(2010-7#7)(2012-9#2)
LMCT band##2##2##(1997-7#2)
LMD##4##1##(2008-7#1)(2013-8#3)
LMF of the##2##3##(2008-11#2)
LMF##5##1##(2008-11#5)
LMH##8##1##(1993-12#8)
LMICs##4##1##(2012-12#4)
LMIF##2##1##(1991-12#2)
LMM##4##1##(2011-2#4)
LMNA##2##1##(2009-12#1)(2011-2#1)
LMP-I##3##1##(1993-9#3)
LMP2 as##3##2##(2012-2#3)
LMP2##9##1##(1997-9#1)(2012-2#7)(2012-3#1)
LMS and##2##2##(2008-6#2)
LMS##17##1##(2008-6#13)(2012-2#4)
LMV isolates##4##2##(2008-10#4)
LMV##5##1##(2008-10#5)
LMV-0-GFP##2##1##(2008-10#2)
LMV-Common##2##1##(2008-10#2)
LMV-Most##5##1##(2008-10#5)
LMV-RoW##2##1##(2008-10#2)
LMW HA##2##2##(2010-8#2)
LMW species##2##2##(2008-10#2)
LMW##6##1##(1990-12#1)(2008-10#3)(2010-8#2)
LMWH have##2##2##(2008-10#2)
LMWH##16##1##(2007-10#1)(2007-7#2)(2008-1#5)(2008-10#5)(2008-3#1)(2008-8#1)(2013-1#1)
LMX1B##2##1##(2008-7#2)
LN in##3##2##(2008-1#3)
LN##11##1##(1993-9#1)(1995-1#1)(2007-11#1)(2008-1#6)(2008-10#1)(2011-2#1)
LNA oligomers##2##2##(2008-4#2)
LNA##5##1##(1994-11#1)(2008-4#4)
LNAC##3##1##(1996-12#3)
LNCaP cells##5##2##(2008-6#1)(2010-1#1)(2011-2#3)
LNCaP##7##1##(2008-6#2)(2010-1#1)(2011-2#4)
LNF-I##3##1##(1991-12#3)
LNG vapor clouds##2##3##(2013-1#2)
LNG##6##1##(2008-10#3)(2013-1#3)
LNK##4##1##(2012-2#4)
LNN##4##1##(2008-2#2)(2008-3#2)
LNT model##4##2##(2008-7#2)(2013-1#2)
LNT##8##1##(1991-12#1)(2008-7#5)(2013-1#2)
LOCAH##4##1##(1990-11#4)
LOD and LOQ##2##3##(2008-10#2)
LOD is 0##2##3##(2008-10#2)
LOD is##3##2##(2008-10#3)
LOD of the##3##3##(2008-10#3)
LOD of##10##2##(2008-10#10)
LOD results are lower for##2##5##(2008-10#2)
LOD results##3##2##(2008-10#3)
LOD score##2##2##(1997-5#1)(2008-10#1)
LOD to 0##3##3##(2013-8#3)
LOD to##4##2##(2008-10#1)(2013-8#3)
LOD was found to be 0##2##6##(2008-10#2)
LOD was found to be##3##5##(2008-10#3)
LOD was##5##2##(2008-10#5)
LOD##48##1##(1997-5#2)(2008-10#39)(2008-6#1)(2012-1#1)(2012-3#1)(2013-8#4)
LODs for##2##2##(2008-10#1)(2010-5#1)
LODs of##3##2##(2008-10#3)
LODs were##2##2##(2008-10#2)
LODs##12##1##(2008-10#10)(2010-5#1)(2012-1#1)
LOE(50)##4##1##(2013-1#4)
LOGSTORY##2##1##(1994-6#2)
LOH##6##1##(1994-12#1)(2008-4#1)(2008-8#1)(2011-1#2)(2013-8#1)
LOMM##4##1##(2008-3#4)
LOOH##4##1##(2008-10#1)(2008-11#3)
LOOH-induced cytotoxicity##2##2##(2008-11#2)
LOPAT##2##1##(2008-10#2)
LOQ of##2##2##(2008-10#2)
LOQ##9##1##(1992-8#1)(2008-10#7)(2011-3#1)
LOQs##3##1##(2008-10#1)(2012-1#2)
LOS for##4##2##(1993-12#3)(1995-3#1)
LOS reduction##2##2##(1995-12#1)(1995-2#1)
LOS##21##1##(1991-12#1)(1993-12#6)(1994-3#5)(1995-12#3)(1995-2#2)(1995-3#2)(1997-2#2)
LOS-I##5##1##(1993-11#5)
LOSs from##2##2##(1993-11#2)
LOSs##3##1##(1993-11#3)
LOV##5##1##(2008-10#2)(2011-1#3)
LOWTRAN##2##1##(2008-2#2)
LOX##7##1##(1997-4#1)(2008-3#1)(2008-6#2)(2008-7#1)(2011-10#2)
LP and##2##2##(2008-10#1)(2008-5#1)
LP in##2##2##(2008-12#1)(2011-2#1)
LP##33##1##(1994-5#2)(1995-8#3)(2007-7#5)(2008-10#12)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)
LP(01) core mode and the exact (1m) cladding modes occurs##2##10##(2008-3#2)
LP(01)##6##1##(2007-11#2)(2007-12#1)(2008-3#3)
LP(01)-LP(02) mode converters##2##3##(2007-12#2)
LP(11)##5##1##(2007-11#1)(2007-12#4)
LP-MFM is##2##2##(2008-2#2)
LP-MFM##4##1##(2008-2#4)
LPA receptor##2##2##(2010-3#2)
LPA##15##1##(1997-6#1)(2010-3#7)(2011-2#7)
LPC and##2##2##(1995-3#2)
LPC##20##1##(1995-3#7)(2008-8#9)(2009-9#3)(2013-1#1)
LPD##2##1##(2013-1#2)
LPFG##2##1##(2008-3#2)
LPG sensor##3##2##(2008-10#3)
LPG##7##1##(2008-10#6)(2009-10#1)
LPIA is##2##2##(2008-3#2)
LPIA##6##1##(2008-3#6)
LPL activity##3##2##(1992-3#1)(2008-11#1)(2008-7#1)
LPL and##2##2##(1992-3#1)(2008-11#1)
LPL cDNA##3##2##(1994-11#1)(1995-6#1)(2008-11#1)
LPL gene##4##2##(1993-3#2)(1994-11#1)(2008-11#1)
LPL in##3##2##(1992-12#1)(1992-3#1)(2008-11#1)
LPL was##2##2##(1992-12#1)(2008-11#1)
LPL##38##1##(1991-12#5)(1992-12#3)(1992-3#8)(1993-3#4)(1993-8#2)(1994-11#4)(1995-6#4)(2008-11#7)(2008-7#1)
LPL)##2##1##(1991-12#2)
LPO##4##1##(2008-10#1)(2013-1#3)
LPP##5##1##(1994-8#4)(2008-5#1)
LPS + IFN gamma##5##4##(1993-3#5)
LPS C##2##2##(1993-11#2)
LPS S##2##2##(1993-11#2)
LPS alone##2##2##(1995-12#1)(2008-11#1)
LPS and PMA##2##3##(2008-8#2)
LPS and##5##2##(2008-11#1)(2008-8#4)
LPS but##2##2##(1994-10#1)(2009-12#1)
LPS concentration##2##2##(1992-3#1)(2008-10#1)
LPS in##2##2##(1993-8#1)(2008-10#1)
LPS increased##2##2##(1997-2#1)(2011-2#1)
LPS injection##5##2##(1993-6#1)(1997-2#1)(2008-10#1)(2012-1#2)
LPS treatment##3##2##(1993-6#1)(1995-12#1)(2008-12#1)
LPS##76##1##(1992-3#2)(1992-8#2)(1993-11#5)(1993-3#5)(1993-6#5)(1993-8#1)(1994-10#1)(1994-8#3)(1995-12#8)(1995-5#1)(1996-12#1)(1997-1#2)(1997-2#2)(1997-8#1)(2008-10#11)(2008-11#9)(2008-12#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-1#5)
LPS-activated##3##1##(1994-8#1)(2008-10#2)
LPS-induced IL-12 p40 and p35 mRNA##2##6##(2008-8#2)
LPS-induced IL-12##3##2##(2008-8#3)
LPS-induced NF-κB/Rel##2##2##(2011-2#2)
LPS-induced cytokine production##4##3##(2008-10#4)
LPS-induced expression of##2##3##(1994-8#1)(2011-2#1)
LPS-induced##18##1##(1992-8#1)(1994-8#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-8#6)(2011-2#3)
LPS-mediated##2##1##(2008-8#1)(2008-9#1)
LPS-primed alveolar macrophages##5##3##(1992-8#5)
LPS-serum complex##3##2##(1992-3#3)
LPS-stimulated lymphocyte proliferation##2##3##(2008-11#2)
LPS-stimulated murine macrophages##2##3##(1990-12#2)
LPS-stimulated##6##1##(1990-12#2)(1993-12#1)(1994-8#1)(2008-11#2)
LPS-triggered activation of##2##3##(2009-8#2)
LPS-triggered##3##1##(1994-8#1)(2009-8#2)
LPS/IFN##3##1##(1993-8#3)
LPS/IFN-induced##2##1##(1993-8#2)
LPSN##3##1##(1994-3#3)
LPSP##2##1##(1990-7#2)
LPa##3##1##(2008-1#3)
LQT-3 mutations##2##2##(2008-8#2)
LQT-3##5##1##(2008-8#5)
LR asymmetry##2##2##(2008-10#2)
LR parsing algorithm##3##3##(2011-3#3)
LR parsing##4##2##(2011-3#4)
LR##18##1##(2008-10#8)(2008-6#4)(2008-7#1)(2010-3#1)(2011-3#4)
LRAP components##2##2##(1993-11#2)
LRAP##5##1##(1993-11#5)
LRH filter##3##2##(2008-3#3)
LRM##3##1##(2012-1#3)
LRMC's &quot##3##2##(1994-2#3)
LRP##3##1##(2008-11#2)(2008-4#1)
LRPs##3##1##(2008-4#3)
LRR##2##1##(2009-6#1)(2009-8#1)
LRR-containing proteins##2##2##(2009-6#2)
LRS##2##1##(2011-2#2)
LRYGB versus##3##2##(2013-1#3)
LRYGB##5##1##(2013-1#5)
LS and##2##2##(2008-4#1)(2012-3#1)
LS is##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
LS method##3##2##(2008-10#3)
LS##27##1##(1992-8#1)(1997-7#4)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#6)(2012-3#4)
LS)##2##1##(1997-7#1)(2008-1#1)
LS-11##4##1##(2008-10#4)
LS-28##4##1##(2008-10#4)
LS-CMV##5##1##(2008-10#5)
LS11##3##1##(2008-10#3)
LS174T##2##1##(1990-8#1)(1997-2#1)
LSC##4##1##(2008-9#3)(2013-1#1)
LSCs are##3##2##(2011-2#2)(2013-1#1)
LSCs##8##1##(2011-2#7)(2013-1#1)
LSD and##2##2##(1997-7#1)(2008-10#1)
LSD##14##1##(1997-7#4)(2008-10#5)(2008-12#1)(2012-1#3)(2013-1#1)
LSF##2##1##(2008-2#2)
LSG at##2##2##(2013-1#2)
LSG##7##1##(2013-1#7)
LSI##4##1##(2008-10#1)(2010-11#3)
LSL##3##1##(2008-7#3)
LSM##2##1##(2008-1#1)(2008-2#1)
LSP compared with##3##3##(2006-8#3)
LSP had##2##2##(2006-8#2)
LSP##9##1##(2006-8#9)
LSU rDNA##2##2##(1995-8#1)(2008-10#1)
LSU##8##1##(1993-11#1)(1995-8#2)(2008-10#1)(2010-3#4)
LT##14##1##(1990-9#1)(1994-2#6)(1994-8#1)(2011-3#5)(2012-3#1)
LT-GaAs-based##2##1##(2008-2#2)
LT50 and##2##2##(2011-2#2)
LTA and WTA##3##3##(1995-6#3)
LTA##6##1##(1995-6#6)
LTB4 production##2##2##(1991-8#2)
LTB4##5##1##(1991-8#3)(1994-8#2)
LTBI##2##1##(2010-5#2)
LTC homes##2##2##(2010-10#2)
LTC insurance is##2##3##(1992-12#2)
LTC insurance##5##2##(1992-12#4)(1994-2#1)
LTC##19##1##(1992-12#6)(1993-12#1)(1994-2#3)(1996-2#1)(1997-3#2)(2008-1#1)(2009-4#3)(2010-10#2)
LTC4##2##1##(1993-9#2)
LTD and##3##2##(1995-2#2)(2012-2#1)
LTD##13##1##(1993-12#5)(1995-2#3)(2009-8#2)(2012-2#3)
LTD4 and LTE4##2##3##(1993-9#1)(2008-5#1)
LTD4##3##1##(1993-9#1)(1994-9#1)(2008-5#1)
LTE4##5##1##(1993-9#4)(2008-5#1)
LTF for ANG II##2##4##(1991-5#2)
LTF##4##1##(1991-5#4)
LTFU##2##1##(2012-12#2)
LTH##3##1##(1993-5#1)(2008-10#2)
LTI (+)##2##2##(2013-1#2)
LTK7##2##1##(1995-2#2)
LTOC##3##1##(1996-9#3)
LTOT##3##1##(2008-1#3)
LTP and LTD in##2##4##(1993-12#2)
LTP and LTD##4##3##(1993-12#3)(1995-2#1)
LTP and##5##2##(1993-12#3)(1995-2#1)(2009-8#1)
LTP at##2##2##(1995-2#1)(2009-8#1)
LTP in##7##2##(1996-2#3)(2008-7#3)(2008-9#1)
LTP induction##4##2##(1990-5#1)(1997-2#1)(2008-7#2)
LTP is##5##2##(1996-2#1)(2008-7#4)
LTP of##3##2##(1993-12#2)(2008-9#1)
LTP was##10##2##(1993-12#2)(1995-12#3)(1996-5#2)(2008-7#3)
LTP##72##1##(1990-5#3)(1992-12#1)(1993-12#10)(1995-12#6)(1995-2#4)(1996-2#5)(1996-5#3)(1997-2#6)(2008-7#19)(2008-9#4)(2009-8#4)(2012-2#5)(2012-3#2)
LTP-reinforcement##2##1##(2008-7#2)
LTR activation##2##2##(1994-11#1)(2012-12#1)
LTR of##3##2##(1994-11#1)(1994-12#1)(2008-9#1)
LTR promoter##2##2##(1995-6#2)
LTR##23##1##(1990-8#1)(1991-2#1)(1992-6#2)(1993-8#1)(1994-11#5)(1994-12#2)(1994-9#1)(1995-6#3)(1995-8#2)(1997-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
LTRS system##2##2##(2007-11#2)
LTRs##2##1##(2008-7#2)
LTS##3##1##(2008-10#1)(2010-9#2)
LTT##7##1##(2007-2#6)(2008-10#1)
LTs##3##1##(1994-8#3)
LTx##2##1##(2011-3#2)
LU##2##1##(2008-10#1)(2008-7#1)
LUCA##2##1##(2009-6#2)
LURT##2##1##(2008-1#2)
LUciferase gene eXpression##2##3##(2008-10#1)(2013-1#1)
LV and MTX##4##3##(2008-10#4)
LV and##7##2##(2008-10#7)
LV apical rotation##2##3##(2013-7#2)
LV function##2##2##(2010-5#1)(2011-2#1)
LV hypertrophy is##2##3##(2011-2#2)
LV hypertrophy##3##2##(2011-2#3)
LV twist and untwist##2##4##(2011-2#2)
LV untwisting rate##2##3##(2011-2#2)
LV vent valves##2##3##(1991-3#2)
LV vent##4##2##(1991-3#4)
LV##40##1##(1991-3#4)(2007-8#1)(2008-10#9)(2010-5#1)(2011-2#15)(2012-12#1)(2012-2#5)(2013-7#4)
LV)##2##1##(2008-10#1)(2008-11#1)
LVADs have##2##2##(2010-6#1)(2010-8#1)
LVADs##7##1##(2010-6#2)(2010-8#5)
LVEF##4##1##(2007-8#1)(2008-10#1)(2013-7#2)
LVFX and MFLX##2##3##(2011-2#2)
LVH##9##1##(2009-1#5)(2010-8#4)
LVHR##2##1##(2010-8#2)
LVP and SSP##2##3##(1993-1#2)
LVP##6##1##(1993-1#3)(2007-8#3)
LVSS-CE##3##1##(1996-5#3)
LVs##5##1##(2008-11#3)(2008-4#2)
LW blood group system##2##4##(1992-12#2)
LW##5##1##(1992-12#4)(2010-2#1)
LW(a-)##2##1##(1994-12#2)
LXA4 and LXB4##3##3##(1991-5#3)
LXA4##4##1##(1991-5#4)
LY 294002##9##2##(2008-4#9)
LY##11##1##(2008-10#2)(2008-4#9)
LY294002##3##1##(1995-8#3)
LYS7##4##1##(1995-8#4)
L]##2##1##(2008-10#1)(2011-3#1)
La Brillante and Little Gem##2##5##(2008-10#2)
La Guajira is an##2##4##(2008-5#2)
La Guajira##4##2##(2008-5#4)
La Palma##4##2##(2008-10#3)(2008-2#1)
La Pared##2##2##(2013-7#2)
La Pietà##2##2##(1995-3#2)
La Plata##6##2##(2008-5#4)(2013-7#2)
La and##2##2##(2008-10#2)
La pauvreté##2##2##(2008-11#2)
La survenue##2##2##(2011-2#1)(2013-1#1)
La##89##1##(1992-11#3)(1992-8#1)(1993-8#2)(1994-2#1)(1994-9#1)(1995-3#2)(1996-2#1)(1996-9#1)(2007-10#1)(2007-5#2)(2007-8#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#17)(2009-7#3)(2010-6#1)(2011-2#12)(2013-1#11)(2013-7#4)
La(3+) can##2##2##(2008-10#1)(2008-9#1)
La(3+) in##2##2##(2008-10#1)(2008-9#1)
La(3+) ions##2##2##(2008-10#2)
La(3+)##21##1##(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#7)
La(III) and Nd(III)##3##3##(2008-10#3)
La(III) and##5##2##(2008-10#5)
La(III)##24##1##(2008-10#24)
La/B(4)C multilayers##2##2##(2007-11#1)(2008-3#1)
La/B(4)C##3##1##(2007-11#2)(2008-3#1)
La2-xSrxCuO4##2##1##(1992-8#1)(1996-9#1)
La3+ (0##2##2##(1990-7#1)(1996-2#1)
La3+##9##1##(1990-7#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#5)
LaAlO(3)##2##1##(2008-3#2)
LaCOB##3##1##(2007-11#3)
LaF(3)##2##1##(2007-11#1)(2008-3#1)
LaF(3)-membrane and stainless steel##2##4##(2008-10#2)
LaF(3)-membrane and##3##2##(2008-10#3)
LaGrue##3##1##(2008-10#3)
Lab##5##1##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)
Lab-at-Valve##2##1##(2008-10#2)
LabVIEW software and##2##3##(2008-10#1)(2011-1#1)
LabVIEW software##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
LabVIEW##6##1##(2008-10#3)(2008-3#2)(2011-1#1)
LabVIEW-based software for the##2##4##(2008-10#2)
LabVIEW-based##3##1##(2008-10#3)
Label-free##2##1##(2008-10#1)(2012-2#1)
Labeled##5##1##(1993-12#1)(1993-6#1)(1993-8#1)(2008-10#1)(2012-12#1)
Labeling of##3##2##(1990-11#1)(2008-9#1)(2013-1#1)
Labeling with##2##2##(1991-5#1)(2008-10#1)
Labeling##13##1##(1990-11#1)(1990-6#1)(1991-12#1)(1991-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
Labelled##4##1##(1990-5#1)(1993-2#1)(1996-5#1)(2008-5#1)
Labels##2##1##(1992-3#1)(2012-2#1)
Lablab##2##1##(2008-12#2)
Labor market##2##2##(1991-3#1)(1992-12#1)
Labor##10##1##(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-2#1)(1997-2#1)(2007-2#2)(2011-2#1)(2013-1#1)
Laboratories of the##2##3##(2007-8#1)(2011-2#1)
Laboratories##21##1##(1997-2#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#1)
Laboratories'##2##1##(1997-2#1)(2008-3#1)
Laboratory Automation##3##2##(2008-10#3)
Laboratory Centre for Disease Control##2##5##(1995-12#1)(2007-12#1)
Laboratory Improvement##2##2##(1994-2#2)
Laboratory Maintenance of##2##3##(2008-9#2)
Laboratory Standards##4##2##(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
Laboratory and clinical##2##3##(2008-2#1)(2009-7#1)
Laboratory and the##3##3##(2008-3#1)(2008-4#1)(2011-1#1)
Laboratory and##9##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)
Laboratory at the##3##3##(1990-2#1)(2008-4#1)(2010-4#1)
Laboratory automation##2##2##(2008-10#2)
Laboratory bioassays##2##2##(2008-12#1)(2011-2#1)
Laboratory data##2##2##(2008-1#1)(2011-2#1)
Laboratory diagnosis##2##2##(1993-3#1)(2012-3#1)
Laboratory evaluation##2##2##(2011-1#1)(2013-8#1)
Laboratory examination##2##2##(2008-8#1)(2011-1#1)
Laboratory experiments##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
Laboratory findings##5##2##(1991-11#1)(2007-12#1)(2010-1#1)(2011-2#1)(2013-1#1)
Laboratory for##7##2##(1994-12#1)(1997-6#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)
Laboratory investigations##2##2##(1991-11#1)(2011-1#1)
Laboratory maintenance of Mycobacterium##2##4##(2008-9#2)
Laboratory maintenance of##7##3##(2008-9#7)
Laboratory measurements##4##2##(2008-3#3)(2013-8#1)
Laboratory models of##2##3##(2008-10#1)(2010-5#1)
Laboratory models##3##2##(2008-10#2)(2010-5#1)
Laboratory of the##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
Laboratory of##11##2##(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
Laboratory parameters##2##2##(2008-7#1)(2013-1#1)
Laboratory studies##6##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
Laboratory study##2##2##(2011-2#1)(2013-1#1)
Laboratory tests##4##2##(2008-12#1)(2008-7#1)(2010-1#1)(2011-2#1)
Laboratory to##3##2##(1995-9#1)(2008-3#2)
Laboratory##162##1##(1990-11#1)(1990-2#1)(1991-11#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#3)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-4#1)(1997-3#2)(1997-6#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#5)(2008-2#6)(2008-3#19)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#9)(2009-11#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#11)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#7)
Laboratory's##3##1##(2008-3#2)(2010-8#1)
Laboratory)##2##1##(1990-11#1)(2009-11#1)
Labour and##2##2##(2007-12#1)(2008-10#1)
Labour##8##1##(1991-12#2)(1992-5#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
Labrador retriever was presented##2##4##(2013-8#2)
Labrador retriever##4##2##(2013-8#4)
Labs##2##1##(2008-2#1)(2008-5#1)
Lac repressor##5##2##(1995-3#5)
Lac##6##1##(1993-11#1)(1995-3#5)
LacZ reporter gene##3##3##(1990-5#1)(2008-11#1)(2008-8#1)
LacZ##7##1##(1990-5#1)(1997-4#1)(2007-12#2)(2008-11#1)(2008-8#1)(2010-11#1)
Laccaria##6##1##(2011-1#6)
Laccase##3##1##(2008-10#2)(2011-1#1)
Lacey##2##1##(2007-12#2)
Lack of a##2##3##(1991-1#1)(2008-10#1)
Lack of access to##2##4##(2008-7#1)(2009-5#1)
Lack of awareness of##2##4##(1995-8#1)(2012-12#1)
Lack of awareness##3##3##(1995-8#1)(1997-1#1)(2012-12#1)
Lack of correlation##2##3##(1994-8#1)(2011-2#1)
Lack of effect of##2##4##(1991-3#1)(2010-10#1)
Lack of significant##2##3##(1997-4#1)(2013-8#1)
Lack of##43##2##(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-12#2)(1993-8#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
Lacking##6##1##(1997-1#1)(2008-10#3)(2010-12#1)(2012-3#1)
Lactate and##3##2##(1995-8#1)(2008-11#2)
Lactate dehydrogenase##4##2##(1993-12#1)(2008-11#2)(2008-9#1)
Lactate##12##1##(1990-5#1)(1991-5#1)(1993-12#1)(1995-8#1)(2008-11#4)(2008-9#1)(2012-12#2)(2013-8#1)
Lactic Acid##2##2##(2008-10#1)(2010-3#1)
Lactic acid bacteria##3##3##(1997-4#2)(2010-10#1)
Lactic acid fermentation##2##3##(2008-6#1)(2008-7#1)
Lactic acid yields##2##3##(2008-6#2)
Lactic acid##11##2##(1997-4#2)(2008-6#6)(2008-7#2)(2010-10#1)
Lactic##14##1##(1997-4#2)(2008-10#1)(2008-6#6)(2008-7#2)(2009-5#1)(2010-10#1)(2010-3#1)
Lactobacilli were isolated from##2##4##(2008-12#2)
Lactobacilli##7##1##(2008-12#6)(2012-2#1)
Lactobacillus acidophilus strain isolated from##2##5##(2012-2#2)
Lactobacillus acidophilus##4##2##(2008-5#2)(2012-2#2)
Lactobacillus brevis##2##2##(2008-6#1)(2012-2#1)
Lactobacillus casei subsp##2##3##(2008-5#1)(2008-7#1)
Lactobacillus casei##5##2##(1993-11#1)(1995-6#1)(2008-5#1)(2008-7#2)
Lactobacillus coryniformis##2##2##(2012-2#2)
Lactobacillus delbrueckii subsp##4##3##(1994-12#2)(1995-8#2)
Lactobacillus delbrueckii##6##2##(1994-12#2)(1995-8#2)(2008-11#2)
Lactobacillus paracasei K71##2##3##(2011-1#2)
Lactobacillus plantarum##3##2##(2008-6#2)(2012-2#1)
Lactobacillus reuteri##2##2##(2012-2#1)(2013-1#1)
Lactobacillus rhamnosus GG##2##3##(2009-12#2)
Lactobacillus sp##3##2##(2008-6#2)(2010-4#1)
Lactobacillus species##2##2##(2012-1#1)(2012-2#1)
Lactobacillus strains##3##2##(2008-12#2)(2012-2#1)
Lactobacillus##52##1##(1993-11#1)(1993-12#1)(1994-12#2)(1994-6#2)(1995-6#1)(1995-8#2)(1997-4#3)(2008-11#5)(2008-12#4)(2008-5#3)(2008-6#5)(2008-7#2)(2009-12#2)(2010-4#1)(2011-1#2)(2012-1#2)(2012-2#12)(2013-1#2)
Lactococcus lactis spp##2##3##(2008-6#2)
Lactococcus lactis subsp##4##3##(2008-6#1)(2008-7#2)(2012-2#1)
Lactococcus lactis##11##2##(1991-9#2)(1992-3#1)(1995-8#1)(2008-6#4)(2008-7#2)(2012-2#1)
Lactococcus##18##1##(1991-9#2)(1992-3#1)(1993-12#4)(1995-8#1)(1997-4#2)(2008-6#4)(2008-7#3)(2012-2#1)
Lactoferrin##2##1##(2008-10#1)(2013-8#1)
Lactuca sativa##2##2##(2008-10#1)(2008-5#1)
Lactuca##3##1##(2008-10#1)(2008-5#2)
Lactulose##2##1##(1990-2#2)
Lacunar##2##1##(2007-10#2)
Lag##2##1##(2011-2#2)
Lagoa Baiazinha)##2##2##(2013-7#2)
Lagoa do Peixe floodplain##2##4##(2013-7#2)
Lagoa do Peixe##4##3##(2013-7#4)
Lagoa do##5##2##(2013-7#5)
Lagoa##7##1##(2013-7#7)
Lagoon##17##1##(2007-5#8)(2008-5#1)(2011-2#1)(2012-2#3)(2013-7#4)
Lagos University Teaching Hospital##4##4##(2010-9#3)(2013-1#1)
Lagos##7##1##(2010-9#5)(2012-12#1)(2013-1#1)
Lagrange multipliers##2##2##(2008-2#2)
Lagrange##3##1##(2008-2#2)(2011-1#1)
Lagrangian##6##1##(2008-10#1)(2008-2#1)(2008-7#3)(2013-1#1)
Laguerre-Gauss beam##3##2##(2007-11#3)
Laguerre-Gauss wave##3##2##(2007-11#3)
Laguerre-Gauss##6##1##(2007-11#6)
Laguerre-Gaussian modes##3##2##(2007-12#3)
Lagunas de##2##2##(2008-5#1)(2013-7#1)
Lagunas##3##1##(2008-5#2)(2013-7#1)
Laing's##2##1##(2008-7#2)
Lake Baikal##3##2##(2008-3#2)(2010-8#1)
Lake Tahoe##7##2##(2008-10#6)(2008-2#1)
Lake Tanganyika##5##2##(1996-6#3)(2008-5#1)(2010-8#1)
Lake Van##4##2##(2013-8#4)
Lake and##2##2##(2008-10#1)(2008-3#1)
Lake area##2##2##(2011-1#1)(2012-3#1)
Lake##53##1##(1996-1#1)(1996-6#3)(2008-10#15)(2008-2#1)(2008-3#5)(2008-5#5)(2008-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#7)
Lakes##6##1##(1996-6#1)(2008-10#1)(2008-11#4)
Lam##11##1##(2008-10#8)(2010-2#1)(2011-2#1)(2012-2#1)
Lamarckian ideas##2##2##(2010-1#2)
Lamb dip##2##2##(2008-3#2)
Lamb##4##1##(2007-11#1)(2008-3#2)(2012-12#1)
Lamb-dip##2##1##(2007-11#1)(2008-3#1)
Lambda##5##1##(1994-2#2)(1996-6#1)(2008-10#1)(2008-3#1)
Lambert model##2##2##(2008-10#2)
Lambert##3##1##(2008-10#3)
Lambert's general##2##2##(2008-10#2)
Lambert's##3##1##(1996-5#1)(2008-10#2)
Lambertian assumption##2##2##(2008-2#1)(2008-3#1)
Lambertian behavior##2##2##(2008-3#2)
Lambertian surface##2##2##(2008-2#1)(2008-3#1)
Lambertian##16##1##(2008-2#5)(2008-3#11)
Lambs##3##1##(1994-7#1)(2010-4#2)
Lamellae##2##1##(2008-7#2)
Lamellar Gel##4##2##(2008-5#4)
Lamellar##5##1##(1997-7#1)(2008-5#4)
Lamiaceae##2##1##(2008-12#1)(2013-7#1)
Laminaria##4##1##(2008-10#2)(2013-1#2)
Laminin##2##1##(1997-1#1)(1997-4#1)
Lamins##2##1##(2008-8#1)(2011-2#1)
Lamivudine##2##1##(2006-10#1)(2009-8#1)
Lamp##2##1##(1996-5#1)(2008-2#1)
Lampetra fluviatilis##2##2##(1997-3#2)
Lampito mauritii##2##2##(2008-7#2)
Lamport##2##1##(1991-12#2)
Lancet##2##1##(1996-5#1)(2008-11#1)
Land application of sewage sludge in China##2##7##(1997-4#2)
Land##7##1##(1992-5#1)(1996-3#1)(1997-4#2)(2008-2#1)(2008-3#1)(2010-11#1)
Lande##2##1##(2008-8#2)
Landers earthquake##3##2##(1996-4#2)(2008-3#1)
Landers##5##1##(1996-4#4)(2008-3#1)
Landmark##2##1##(2008-1#1)(2013-1#1)
Landmark-based##2##1##(1996-7#2)
Landolt reading##2##2##(2013-8#2)
Landolt##6##1##(2013-8#6)
Landrace##2##1##(2008-8#1)(2008-9#1)
Landsat##5##1##(2007-5#3)(2008-2#1)(2008-8#1)
Landscape##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
Landspítalinn##2##1##(2006-8#2)
Langbein et al##3##3##(2008-5#3)
Langdon##2##1##(2008-10#1)(2008-4#1)
Langerhans Cell Histiocytosis (LCH) is a##2##6##(2010-10#1)(2012-3#1)
Langerhans Cell Histiocytosis##3##3##(2010-10#2)(2012-3#1)
Langerhans cell histiocytosis (LCH)##2##4##(2007-10#1)(2011-1#1)
Langerhans cell histiocytosis##6##3##(2007-10#2)(2007-7#1)(2011-1#2)(2011-2#1)
Langerhans cells##7##2##(1996-12#1)(2008-5#4)(2008-9#1)(2012-3#1)
Langerhans##26##1##(1994-8#1)(1995-8#2)(1996-12#1)(1997-4#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#2)
Langerhans'##2##1##(2006-10#1)(2008-5#1)
Langevin##2##1##(1993-5#1)(2007-12#1)
Langill##2##1##(1992-3#2)
Langley##7##1##(2008-2#3)(2008-3#4)
Langley-plot technique##2##2##(2008-2#2)
Langmuir adsorption isotherm##2##3##(2008-10#2)
Langmuir adsorption##3##2##(2008-10#3)
Langmuir and Freundlich equations##2##4##(2008-10#1)(2010-4#1)
Langmuir and Freundlich##4##3##(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)
Langmuir equation was##2##3##(1996-5#1)(2008-10#1)
Langmuir equation##3##2##(1996-5#1)(2008-10#2)
Langmuir film##2##2##(1994-5#1)(2008-10#1)
Langmuir isotherm##9##2##(2008-10#8)(2010-5#1)
Langmuir isotherms##2##2##(2008-10#2)
Langmuir##36##1##(1994-5#1)(1996-5#1)(2008-10#27)(2008-12#1)(2008-6#2)(2010-4#1)(2010-5#2)(2013-1#1)
Langmuir-Blodgett (LB) and##2##3##(2008-11#2)
Langmuir-Blodgett (LB) film##2##3##(2008-10#1)(2008-8#1)
Langmuir-Blodgett (LB) films##4##3##(2007-12#1)(2008-10#3)
Langmuir-Blodgett (LB)##11##2##(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2010-10#1)
Langmuir-Blodgett technique##2##2##(2007-11#1)(2008-10#1)
Langmuir-Blodgett##20##1##(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
Langrangian##2##1##(2008-11#2)
Language Development##2##2##(2008-2#1)(2010-4#1)
Language Processing##3##2##(2010-12#1)(2010-5#1)(2012-3#1)
Language and##2##2##(2008-9#1)(2011-2#1)
Language##30##1##(1995-2#1)(2007-6#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#5)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)
Lanthanide##2##1##(2008-10#1)(2012-12#1)
Lanthanides are##2##2##(2008-10#2)
Lanthanides##3##1##(2008-10#3)
Lanthanum##5##1##(1992-11#1)(1993-3#1)(2008-10#3)
Lanzarote##3##1##(2008-10#3)
LapSVM can be##2##3##(2010-7#2)
LapSVM##4##1##(2010-7#4)
Laparoscopic adrenalectomy##3##2##(2007-10#1)(2007-9#1)(2008-8#1)
Laparoscopic assisted vaginal hysterectomy##2##4##(1995-3#2)
Laparoscopic management of##4##3##(1991-2#1)(1992-3#1)(2010-8#1)(2013-1#1)
Laparoscopic myolysis##2##2##(1994-2#2)
Laparoscopic myomectomy##3##2##(1993-12#1)(1994-2#1)(1994-9#1)
Laparoscopic orchidopexy##2##2##(2011-2#2)
Laparoscopic repair of##2##3##(2010-8#1)(2012-2#1)
Laparoscopic resection of##3##3##(2011-2#1)(2013-1#2)
Laparoscopic supracervical##2##2##(1994-2#2)
Laparoscopic surgery for##2##3##(2008-5#1)(2011-2#1)
Laparoscopic surgery has##2##3##(2012-12#1)(2013-1#1)
Laparoscopic surgery##7##2##(1992-12#1)(1994-1#1)(1997-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
Laparoscopic##58##1##(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-2#6)(1994-3#2)(1994-9#1)(1995-10#1)(1995-3#2)(1996-3#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)
Laparoscopically assisted vaginal hysterectomy##2##4##(1993-12#2)
Laparoscopically##3##1##(1993-12#2)(2008-5#1)
Laparoscopy for##2##2##(2011-2#2)
Laparoscopy##10##1##(1995-3#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#4)
Laparoscopy-assisted vaginal hysterectomy##2##3##(1991-3#1)(1993-2#1)
Laparoscopy-assisted##3##1##(1991-3#2)(1993-2#1)
Laparotomy##2##1##(1993-6#1)(1997-3#1)
Laplace approximation##2##2##(2012-1#2)
Laplace##6##1##(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#2)
Laplacian support vector machine##2##4##(2010-7#2)
Laplacian##4##1##(2008-2#1)(2008-6#1)(2010-7#2)
Large Cell##2##2##(1996-9#1)(2013-1#1)
Large amounts of##3##3##(2008-10#2)(2009-8#1)
Large and##4##2##(1997-3#1)(2007-11#1)(2008-4#1)(2012-2#1)
Large animal##2##2##(1994-3#1)(2008-4#1)
Large differences in##3##3##(2008-10#2)(2008-5#1)
Large earthquakes##2##2##(1990-11#1)(1996-4#1)
Large numbers of##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
Large proportions##2##2##(1994-12#1)(2010-4#1)
Large scale##5##2##(1991-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
Large##89##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-10#2)(2007-11#4)(2007-12#6)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
Large-angle##2##1##(2008-3#2)
Large-scale##13##1##(1991-9#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)
Large-volume sample stacking##2##3##(1996-5#2)
Large-volume##4##1##(1996-5#2)(2008-3#1)(2011-1#1)
Largely##3##1##(1997-6#1)(2008-7#1)(2010-8#1)
Larger amounts of##2##3##(1992-12#1)(2008-10#1)
Larger clinical##2##2##(2008-7#1)(2011-2#1)
Larger##13##1##(1992-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
Laromustine##3##1##(2010-11#3)
Larry##2##1##(1997-5#1)(2012-2#1)
Larvae of##3##2##(2010-8#1)(2013-1#1)(2013-8#1)
Larvae were##2##2##(2008-5#1)(2010-8#1)
Larvae##12##1##(2008-5#3)(2008-9#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Larval development##2##2##(2007-12#1)(2008-5#1)
Larval growth##2##2##(2007-5#1)(2010-8#1)
Larval##8##1##(1995-2#1)(2007-12#2)(2007-5#1)(2008-5#1)(2009-10#1)(2010-8#1)(2013-8#1)
Laryngomalacia##2##1##(2013-8#2)
Laryngoscopy##2##1##(2008-11#1)(2013-1#1)
Las Vegas##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
Las##10##1##(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#6)(2012-12#1)
Lasegu's test##2##2##(2007-11#2)
Lasegu's##3##1##(2007-11#3)
Laser Beams##2##2##(1996-9#1)(2008-2#1)
Laser Capture Microdissection##2##3##(2010-6#2)
Laser Diffraction Particle Sizing##2##4##(2008-11#2)
Laser Diode##2##2##(2008-2#2)
Laser Doppler##4##2##(1996-5#1)(2007-11#1)(2008-3#1)(2011-2#1)
Laser End##2##2##(2008-2#2)
Laser Interferometer##7##2##(2007-11#1)(2008-3#6)
Laser Pulses##3##2##(2008-2#1)(2008-3#2)
Laser Raman spectroscopy##2##3##(2008-8#2)
Laser Speckle Imaging##2##3##(2010-11#2)
Laser System##2##2##(2008-2#1)(2008-3#1)
Laser ablation in##2##3##(2008-10#2)
Laser ablation inductively coupled plasma mass spectrometry##2##7##(2008-10#1)(2010-11#1)
Laser ablation is##2##3##(2008-10#1)(2008-3#1)
Laser ablation of##2##3##(1993-1#1)(2008-1#1)
Laser ablation##13##2##(1993-1#1)(2008-1#2)(2008-10#8)(2008-3#1)(2010-11#1)
Laser action##3##2##(2007-12#2)(2008-2#1)
Laser applications to chemical and environmental analysis##2##7##(2008-2#1)(2008-3#1)
Laser at 1##2##3##(2008-2#2)
Laser at##5##2##(2008-2#4)(2008-3#1)
Laser beam shaping##2##3##(2008-3#1)(2008-9#1)
Laser beam##5##2##(2007-12#1)(2008-3#3)(2008-9#1)
Laser biostimulation##2##2##(2007-8#2)
Laser capture microdissection##3##3##(2008-4#2)(2010-12#1)
Laser emission##2##2##(2007-12#1)(2008-3#1)
Laser for##3##2##(2008-2#2)(2008-3#1)
Laser from##2##2##(2008-2#1)(2008-3#1)
Laser in##2##2##(2011-2#1)(2012-3#1)
Laser induced breakdown##2##3##(2008-10#2)
Laser light##2##2##(1994-3#1)(2008-3#1)
Laser photolysis of cytosine##2##4##(1992-8#2)
Laser radar##2##2##(2008-2#1)(2008-3#1)
Laser safety##2##2##(1993-3#2)
Laser speckle##2##2##(2008-2#1)(2008-3#1)
Laser therapy##2##2##(2007-8#1)(2010-8#1)
Laser treatment of##2##3##(1991-2#1)(1991-9#1)
Laser with a##3##3##(2008-2#1)(2008-3#2)
Laser with##10##2##(2008-2#4)(2008-3#5)(2012-2#1)
Laser##199##1##(1991-1#1)(1991-2#1)(1991-3#2)(1991-9#3)(1992-10#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-3#2)(1994-3#1)(1996-12#2)(1996-5#2)(1996-9#1)(2007-11#7)(2007-12#7)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#52)(2008-3#66)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#1)(2009-4#1)(2010-11#3)(2010-12#1)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
Laser-Doppler##2##1##(2007-12#1)(2008-3#1)
Laser-Induced Fluorescence##2##2##(2008-3#2)
Laser-Induced##4##1##(2008-3#4)
Laser-assisted indocyanine green##2##3##(2013-1#2)
Laser-assisted##3##1##(2008-10#1)(2013-1#2)
Laser-diode##2##1##(2008-3#2)
Laser-excited##2##1##(2008-10#1)(2008-2#1)
Laser-induced breakdown spectrometry##3##3##(2008-10#1)(2008-2#2)
Laser-induced breakdown##4##2##(2008-10#1)(2008-2#3)
Laser-induced fluorescence (LIF)##4##3##(2008-10#1)(2008-3#3)
Laser-induced fluorescence measurements of##2##4##(2008-2#1)(2008-3#1)
Laser-induced fluorescence of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
Laser-induced fluorescence##13##2##(2008-10#3)(2008-2#3)(2008-3#7)
Laser-induced incandescence##4##2##(2008-2#1)(2008-3#3)
Laser-induced##31##1##(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#8)(2008-3#12)(2008-8#1)
Laser-produced lithium##2##2##(2008-2#2)
Laser-to-fiber##2##1##(2008-2#1)(2008-3#1)
Lasers and##2##2##(2007-12#1)(2008-2#1)
Lasers##15##1##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#6)(2008-9#2)
Lasing##4##1##(2007-11#1)(2007-12#1)(2008-2#2)
Lask et al##2##3##(2008-11#2)
Lassa##2##1##(1995-6#1)(1995-9#1)
Last word on point##2##4##(2011-2#2)
Last year##3##2##(1994-1#1)(1996-5#1)(2013-8#1)
Last##17##1##(1992-1#1)(1992-12#1)(1994-1#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Lastly##32##1##(1990-6#1)(1991-6#2)(1993-6#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-9#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
Late Blight##3##2##(2008-10#3)
Late blight##4##2##(2008-10#4)
Late complications##2##2##(2010-11#1)(2012-2#1)
Late presentation##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
Late##43##1##(1990-8#2)(1991-12#1)(1991-4#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-6#1)(2010-11#1)(2010-2#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
Late-onset##2##1##(1991-8#1)(2008-1#1)
Late-season##2##1##(2008-10#2)
Lately##2##1##(1993-12#1)(2009-8#1)
Latency##3##1##(1993-12#1)(2008-10#1)(2008-7#1)
Latent Infection of Prune##2##4##(2008-10#2)
Latent Infection##3##2##(2008-10#3)
Latent autoimmune diabetes in##2##4##(2008-3#1)(2009-5#1)
Latent inhibition##2##2##(2008-4#2)
Latent periods##2##2##(2008-10#2)
Latent variable##2##2##(2008-12#1)(2009-7#1)
Latent##22##1##(1990-2#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-7#1)
Later he##2##2##(2011-2#1)(2013-1#1)
Later##27##1##(1990-7#1)(1990-8#1)(1992-6#1)(1993-6#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#3)(2009-7#1)(2009-9#1)(2010-1#1)(2011-2#5)(2013-1#2)
Lateral ankle##2##2##(2007-11#1)(2013-1#1)
Lateral column lengthening using allograft##2##5##(2009-10#2)
Lateral column lengthening##3##3##(2009-10#3)
Lateral ventricular##2##2##(1991-12#1)(1995-5#1)
Lateral##37##1##(1991-12#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#3)(2009-11#1)(2011-2#2)(2012-1#1)(2013-1#4)
Lateralization of##2##2##(1994-3#1)(2013-1#1)
Lateralization##3##1##(1992-11#1)(1994-3#1)(2013-1#1)
Lates calcarifer##2##2##(2008-7#1)(2009-5#1)
Latest##3##1##(2008-10#1)(2008-8#1)(2009-2#1)
Latex beads##6##2##(2008-6#6)
Latex##9##1##(2008-10#1)(2008-5#1)(2008-6#7)
Lathyrus##6##1##(1993-8#1)(2008-5#5)
Latin America and the Caribbean##2##5##(1991-3#1)(2008-11#1)
Latin America and the##3##4##(1991-3#1)(2008-11#1)(2008-5#1)
Latin America and##4##3##(1991-3#1)(1997-7#1)(2008-11#1)(2008-5#1)
Latin America##29##2##(1990-6#1)(1991-3#1)(1991-9#2)(1992-5#1)(1993-1#1)(1993-3#1)(1993-6#2)(1997-7#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#2)
Latin America]##3##2##(1990-6#1)(1992-5#1)(2012-2#1)
Latin American Consensus##2##3##(2009-6#1)(2013-1#1)
Latin American countries##4##3##(1992-5#2)(2011-2#1)(2013-1#1)
Latin American immigrant##2##3##(2008-12#2)
Latin American##23##2##(1992-5#3)(1993-6#2)(1995-12#1)(2008-10#3)(2008-12#4)(2008-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#3)(2013-1#3)
Latin##63##1##(1990-6#2)(1991-3#1)(1991-9#2)(1992-5#5)(1993-1#2)(1993-3#1)(1993-6#4)(1995-12#1)(1997-7#1)(2006-9#1)(2008-10#7)(2008-11#2)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#8)(2012-2#2)(2013-1#5)(2013-8#1)
Latin-America##3##1##(1990-6#1)(2011-2#2)
Latino adolescents##3##2##(2010-2#2)(2013-1#1)
Latino children##5##2##(2009-9#3)(2012-2#2)
Latino gay and bisexual men##2##5##(2008-12#2)
Latino inmates##3##2##(1997-5#3)
Latino migrant farmworker##2##3##(2008-12#1)(2010-9#1)
Latino prisoners##3##2##(1997-5#3)
Latino youth##4##2##(2012-2#2)(2013-1#2)
Latino##36##1##(1996-3#1)(1997-5#6)(2008-12#5)(2009-5#3)(2009-7#3)(2009-9#3)(2010-2#3)(2010-9#2)(2012-2#4)(2013-1#6)
Latino&quot##2##1##(2011-2#2)
Latinos##5##1##(2011-2#1)(2013-1#4)
Latissimus dorsi##2##2##(1991-5#1)(2008-9#1)
Latium##3##1##(1992-9#3)
Lattice##2##1##(2008-10#1)(2008-7#1)
Latvia##2##1##(2011-2#2)
Lau fringes##3##2##(2007-11#3)
Laughter##2##1##(2008-10#2)
Laupala##4##1##(2008-8#4)
Laureth 4##2##2##(2008-5#2)
Lausanne##3##1##(2007-8#1)(2008-10#1)(2008-3#1)
Lava##3##1##(2009-8#3)
Lavidor##2##1##(2009-2#2)
Lavoie et al##2##3##(2009-9#2)
Law and##2##2##(2009-9#1)(2010-4#1)
Law was##3##2##(2008-10#2)(2010-4#1)
Law##38##1##(1991-1#1)(1991-12#2)(1991-3#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-5#1)(1994-1#1)(1994-3#3)(1995-12#1)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-4#3)(2012-2#1)(2012-3#1)(2013-8#1)
Lawler##2##1##(1993-1#1)(2009-12#1)
Lawrence Weed##2##2##(2010-8#2)
Lawrence##9##1##(1994-1#1)(2008-11#1)(2008-3#5)(2010-8#2)
Laws##3##1##(1992-3#1)(1994-12#1)(2008-4#1)
Lawton##2##1##(1997-5#1)(2008-7#1)
Layer thickness##2##2##(2008-10#1)(2008-3#1)
Layer##12##1##(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
Layered Learning##4##2##(1995-2#4)
Layered##10##1##(1994-9#1)(1995-2#5)(1997-7#2)(2010-4#1)(2010-8#1)
Layers##4##1##(2008-10#3)(2009-9#1)
Lazarillo##3##1##(2007-12#3)
Lazarus##3##1##(1990-10#1)(1994-12#2)
LbL##2##1##(2013-1#2)
Lbs##6##1##(2008-7#6)
Lck##2##1##(1995-6#1)(2013-8#1)
LdT##2##1##(2013-1#2)
Le Fort III osteotomy##2##4##(2007-12#2)
Le Fort##3##2##(2007-12#2)(2011-2#1)
Le diagnostic de##3##3##(2013-1#3)
Le diagnostic est##3##3##(2011-2#2)(2013-1#1)
Le diagnostic##7##2##(2011-2#3)(2013-1#4)
Le traitement##2##2##(2011-2#1)(2013-1#1)
Le##27##1##(1997-3#2)(1997-5#1)(2007-12#2)(2008-11#1)(2008-5#2)(2009-10#1)(2010-6#1)(2011-2#9)(2013-1#8)
Le(x)##2##1##(1991-12#1)(1992-12#1)
LeCAS expression##3##2##(2008-10#3)
LeCAS##5##1##(2008-10#5)
Lea##3##1##(1991-12#1)(1993-12#2)
Leaching of##2##2##(2008-10#1)(2010-3#1)
Leaching tests##2##2##(2008-10#2)
Leaching##6##1##(2008-10#3)(2010-3#1)(2011-1#1)(2011-2#1)
Lead acetate##2##2##(1997-4#1)(2008-7#1)
Lead in##2##2##(1992-3#1)(2008-5#1)
Lead ion##2##2##(2008-10#2)
Lead is##3##2##(2008-10#3)
Lead poisoning of children in Africa##2##6##(1997-4#2)
Lead poisoning##3##2##(1990-3#1)(1997-4#2)
Lead was##2##2##(2008-10#2)
Lead##34##1##(1990-2#1)(1990-3#1)(1992-3#1)(1994-1#1)(1994-11#1)(1997-4#4)(2008-10#18)(2008-5#1)(2008-7#2)(2009-2#1)(2010-1#1)(2011-1#1)(2013-8#1)
Lead(II)##2##1##(2008-10#2)
Leader##3##1##(2008-6#1)(2013-8#2)
Leaders who##2##2##(1994-2#1)(2012-3#1)
Leaders##10##1##(1994-2#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
Leadership Conference##2##2##(1996-3#1)(2008-6#1)
Leadership Forum##2##2##(1995-2#1)(2008-6#1)
Leadership in##2##2##(1993-12#1)(2009-8#1)
Leadership spotlight##4##2##(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)
Leadership##26##1##(1993-12#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-6#3)(2009-5#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Leading causes of death were due to##2##7##(2013-8#2)
Leading the##2##2##(1996-1#1)(1996-2#1)
Leading##9##1##(1993-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(2008-1#1)(2010-2#1)(2011-1#1)(2013-8#2)
Leads to##5##2##(2008-10#4)(2012-2#1)
Leaf Area Index (LAI)##3##4##(2008-12#3)
Leaf Blight##3##2##(2008-10#3)
Leaf Curl##5##2##(2008-10#5)
Leaf Rust##8##2##(2008-10#8)
Leaf Scald##3##2##(2008-10#3)
Leaf Scorch Disease##2##3##(2008-10#2)
Leaf Spot Disease##2##3##(2008-10#2)
Leaf Spot and##2##3##(2008-10#2)
Leaf Spot of##3##3##(2008-10#3)
Leaf Spot on##2##3##(2008-10#2)
Leaf Spot##13##2##(2008-10#12)(2012-3#1)
Leaf Tissue##2##2##(2008-10#2)
Leaf and##3##2##(2008-10#2)(2008-5#1)
Leaf position##2##2##(2008-10#2)
Leaf rust populations##2##3##(2008-10#2)
Leaf rust resistance gene##2##4##(2008-10#2)
Leaf rust resistance##3##3##(2008-10#3)
Leaf rust##8##2##(2008-10#8)
Leaf samples##2##2##(2008-10#2)
Leaf##95##1##(2007-5#1)(2008-10#78)(2008-12#4)(2008-5#6)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-7#1)
Leaf-associated##2##1##(2008-10#2)
Leafhopper##3##1##(2008-10#3)
League Against##2##2##(2009-7#1)(2012-3#1)
League##8##1##(1995-6#1)(2009-10#1)(2009-7#1)(2010-1#2)(2012-3#1)(2013-1#2)
Leakage from##2##2##(1990-9#1)(1991-3#1)
Leakage##3##1##(1990-9#1)(1991-3#1)(2008-1#1)
Lean##4##1##(1996-12#1)(2012-2#1)(2013-8#2)
Learn to##2##2##(1997-4#1)(2008-5#1)
Learn##4##1##(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
Learned##2##1##(2009-6#1)(2012-3#1)
Learning (PBL)##2##2##(2008-11#1)(2010-3#1)
Learning Objectives##3##2##(2008-7#3)
Learning Styles Inventory##2##3##(2012-2#2)
Learning and Development##2##3##(2008-11#1)(2011-1#1)
Learning and##4##2##(1992-1#1)(2008-11#1)(2008-12#1)(2011-1#1)
Learning contracts##2##2##(2008-11#2)
Learning for##2##2##(2008-12#2)
Learning from##4##2##(1992-5#1)(2008-4#1)(2011-2#1)(2013-1#1)
Learning how to##2##3##(2008-11#1)(2008-8#1)
Learning in##2##2##(2008-12#1)(2010-4#1)
Learning on the Web##2##4##(2007-12#1)(2008-1#1)
Learning styles of##2##3##(2008-7#1)(2012-3#1)
Learning through##3##2##(1994-12#1)(2008-1#1)(2008-11#1)
Learning to##6##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)
Learning##72##1##(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#4)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-11#17)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-11#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
Least Squares##6##2##(2008-10#6)
Least squares##2##2##(2008-10#2)
Least##15##1##(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
Least-squares refinement of the model based on##2##7##(1997-7#2)
Least-squares refinement##3##2##(1997-7#3)
Leave##3##1##(1994-2#1)(1994-3#1)(2012-3#1)
Leaves and##3##2##(2008-10#2)(2008-8#1)
Leaves by##5##2##(2008-10#5)
Leaves of##11##2##(2008-10#4)(2008-5#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#2)
Leaves were##2##2##(2008-10#1)(2008-12#1)
Leaves##37##1##(1995-2#1)(2008-10#26)(2008-12#1)(2008-5#1)(2008-8#2)(2010-3#1)(2010-5#2)(2011-1#1)(2013-1#2)
Leaving##3##1##(1997-3#1)(2008-11#1)(2011-1#1)
Lebanese##2##1##(2008-7#1)(2012-3#1)
Lebanon and##2##2##(2008-1#1)(2009-2#1)
Lebanon##6##1##(1993-2#3)(2008-1#1)(2009-2#1)(2010-4#1)
Leber hereditary optic neuropathy and##3##5##(1991-12#1)(1992-9#2)
Leber hereditary optic neuropathy##6##4##(1991-12#3)(1992-9#3)
Lebsock##2##1##(2012-3#2)
Lecithin##3##1##(1993-6#1)(2008-5#2)
Lectin##7##1##(1994-11#1)(2008-10#2)(2008-6#1)(2011-2#3)
Lecture##10##1##(1991-1#1)(1992-3#1)(1992-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2010-1#1)(2013-8#1)
Lecturers##2##1##(1994-9#1)(2008-11#1)
Lee algorithm##2##2##(2008-2#2)
Lee##13##1##(1991-8#1)(1993-3#1)(1994-12#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-8#1)
Lee's index##2##2##(2013-1#2)
Leeds##2##1##(2008-12#1)(2008-9#1)
Leek strains##3##2##(2008-10#3)
Leek##5##1##(2008-10#5)
Left Ventricular##2##2##(2008-3#1)(2010-4#1)
Left atrial##2##2##(2007-8#2)
Left main##2##2##(2008-3#2)
Left ventricular ejection fraction increased##2##5##(2008-7#1)(2011-2#1)
Left ventricular ejection fraction##3##4##(2008-7#1)(2011-2#1)(2013-7#1)
Left ventricular volume during diastasis is not the physiological in vivo equilibrium volume and is not related to diastolic suction##2##20##(2011-2#2)
Left ventricular volume during diastasis is/is not the physiological in vivo equilibrium volume and is/is not related to diastolic suction##3##20##(2011-2#3)
Left ventricular volume during diastasis##5##5##(2011-2#5)
Left ventricular##14##2##(1990-3#1)(1994-12#1)(2008-7#1)(2009-1#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-2#1)(2013-7#1)
Left##31##1##(1990-3#1)(1992-12#1)(1994-12#1)(2007-8#3)(2008-12#1)(2008-3#3)(2008-7#2)(2009-1#1)(2010-4#2)(2010-5#1)(2011-2#8)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)
Left-sided##2##1##(2007-12#1)(2011-2#1)
Leg ulcer care##2##3##(1996-7#2)
Leg##7##1##(1991-11#1)(1995-2#1)(1996-7#2)(2007-12#1)(2008-5#1)(2009-1#1)
Legacies##2##1##(1996-3#1)(1997-3#1)
Legacy##3##1##(1991-8#1)(1997-5#1)(2008-10#1)
Legal issues##3##2##(1995-2#1)(1996-1#1)(2011-2#1)
Legal##16##1##(1991-12#1)(1992-2#2)(1992-3#1)(1995-2#1)(1995-6#2)(1996-1#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-6#1)(2011-2#2)
Leghorn##3##1##(2008-10#2)(2008-12#1)
Legionella pneumophila##5##2##(1990-9#1)(1992-5#1)(2007-12#1)(2008-12#2)
Legionella##7##1##(1990-9#1)(1992-5#1)(1994-9#1)(2007-12#1)(2008-12#3)
Legionnaires' disease##2##2##(1990-3#1)(2007-12#1)
Legislation##4##1##(1993-8#1)(1994-1#1)(1997-1#1)(2008-4#1)
Legislative##7##1##(1992-1#1)(1992-12#1)(1994-2#1)(1997-3#1)(2008-4#1)(2012-2#2)
Legius##2##1##(2012-3#2)
Legume##2##1##(2008-10#1)(2008-11#1)
Legumes##3##1##(2008-10#3)
Leguminosae##2##1##(2008-10#2)
Leguminous##2##1##(2008-10#1)(2008-6#1)
Leiden##3##1##(1994-5#1)(2012-12#1)(2013-8#1)
Leigh##3##1##(1993-8#1)(1994-8#2)
Leiomyoma of the##2##3##(2012-2#2)
Leiomyomatosis peritonealis disseminata##2##3##(2013-1#2)
Leiomyosarcoma of the##2##3##(2008-6#2)
Leiomyosarcoma of##4##2##(2008-6#3)(2008-7#1)
Leiomyosarcoma##5##1##(2008-6#4)(2008-7#1)
Leiomyosarcomas##2##1##(2008-6#2)
Leipzig##7##1##(2008-11#1)(2008-5#1)(2008-7#4)(2013-8#1)
Leisegang##2##1##(1994-2#1)(2012-3#1)
Leishmania (Viannia) DNA##3##3##(2013-1#3)
Leishmania (Viannia)##4##2##(2013-1#4)
Leishmania bodies##3##2##(1991-11#1)(2012-12#2)
Leishmania chagasi##4##2##(2007-12#2)(2008-7#1)(2010-12#1)
Leishmania donovani##2##2##(1990-7#1)(1997-7#1)
Leishmania has##2##2##(2012-2#2)
Leishmania infantum##2##2##(2008-12#1)(2008-9#1)
Leishmania is##2##2##(2012-2#1)(2013-1#1)
Leishmania spp##8##2##(2012-2#8)
Leishmania##49##1##(1990-7#1)(1991-11#1)(1991-6#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-12#1)(2008-7#5)(2008-8#2)(2008-9#2)(2010-12#1)(2012-12#2)(2012-2#16)(2013-1#9)
Leishmaniasis##7##1##(1991-11#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
Leishmanicidal activity of##2##3##(2007-11#1)(2010-2#1)
Leishmanicidal##3##1##(2007-11#1)(2010-2#1)(2012-2#1)
Leitoscoloplos##2##1##(2008-5#2)
Lemhi##5##1##(2008-10#5)
Lemierre syndrome##2##2##(1990-3#2)
Lemildipine##2##1##(2008-5#2)
Lemna minor##5##2##(2008-10#2)(2008-7#1)(2011-1#2)
Lemon##8##1##(2008-10#2)(2008-12#6)
Lena##3##1##(2010-8#3)
Length and##3##2##(2008-10#1)(2008-2#1)(2009-5#1)
Length of stay##5##3##(1995-3#1)(1997-2#1)(2012-2#1)(2013-1#2)
Length of##9##2##(1995-3#1)(1997-2#1)(2008-10#3)(2012-2#2)(2013-1#2)
Length##37##1##(1995-3#1)(1996-12#1)(1996-9#2)(1997-2#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
Lengthening##2##1##(2008-10#1)(2009-3#1)
Leningrad##2##1##(1991-11#1)(2012-3#1)
Lennard-Jones##2##1##(2009-2#1)(2010-2#1)
Lenoir##5##1##(2012-2#5)
Lens##7##1##(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
Lentigo maligna##2##2##(2011-2#2)
Lentinus squarrosulus (Mont) Singer##2##4##(2008-12#2)
Lentiviral vectors##2##2##(2008-3#1)(2008-4#1)
Lentiviral##4##1##(2008-2#1)(2008-3#1)(2008-4#1)(2012-3#1)
Lenz##3##1##(1992-6#2)(1995-11#1)
Leonard##5##1##(2007-11#1)(2008-10#2)(2009-10#1)(2013-1#1)
Leonard's##2##1##(2008-10#2)
Leonie##2##1##(2008-10#2)
Leonurine##3##1##(2012-2#3)
Lepage's test##2##2##(2012-1#2)
Lepidoptera##4##1##(2008-5#1)(2010-2#1)(2011-2#2)
Lepidoptera)##3##1##(2008-7#1)(2008-8#1)(2010-4#1)
Lepidopteran##2##1##(2008-10#1)(2010-11#1)
Leporinus reinhardti##2##2##(2008-7#2)
Leporinus##3##1##(2008-7#2)(2013-7#1)
Lepromatous Leprosy##2##2##(2011-2#2)
Lepromatous##3##1##(2011-2#2)(2012-12#1)
Leprosy is a chronic##2##4##(2007-7#1)(2009-5#1)
Leprosy##9##1##(2007-7#3)(2009-5#2)(2010-2#1)(2011-2#3)
Leptin##10##1##(2007-8#1)(2008-4#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
Leptosphaeria maculans in##2##3##(2008-10#2)
Leptosphaeria maculans##22##2##(2008-10#20)(2011-10#2)
Leptosphaeria##24##1##(2008-10#22)(2011-10#2)
Leptospira antibodies##3##2##(2007-7#3)
Leptospira biflexa##3##2##(2007-7#1)(2008-9#2)
Leptospira interrogans serovar##3##3##(1991-8#3)
Leptospira##18##1##(1991-8#3)(2007-7#5)(2008-9#10)
Leptospiral##2##1##(2008-9#2)
Ler##3##1##(2011-1#1)(2012-3#2)
Leri-Weill dyschondrosteosis##2##2##(2008-7#1)(2013-1#1)
Lernaea cyprinacea##2##2##(2008-12#2)
Les données##2##2##(2013-1#2)
Les suites opératoires ont été##2##5##(2013-1#2)
Les##22##1##(2008-11#1)(2008-5#9)(2009-10#1)(2011-2#1)(2013-1#10)
Lesion of##3##2##(2008-12#1)(2008-2#1)(2012-3#1)
Lesion size##2##2##(2008-10#1)(2012-2#1)
Lesion##15##1##(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-2#1)(2012-3#1)
Lesions and##2##2##(1994-12#1)(2010-6#1)
Lesions in##6##2##(2008-10#1)(2012-3#2)(2013-1#2)(2013-8#1)
Lesions of the central nucleus of the amygdala##2##8##(1993-12#2)
Lesions of the pedunculopontine tegmental nucleus##2##6##(1994-2#1)(1994-3#1)
Lesions of the pedunculopontine##3##4##(1994-2#1)(1994-3#2)
Lesions of the##9##3##(1993-12#2)(1993-6#1)(1994-2#2)(1994-3#2)(1994-7#1)(1996-12#1)
Lesions of##11##2##(1993-12#2)(1993-6#2)(1994-2#2)(1994-3#2)(1994-7#1)(1996-12#1)(2008-10#1)
Lesions on##3##2##(1990-6#1)(2008-10#2)
Lesions were##3##2##(1992-10#1)(1993-12#1)(2008-10#1)
Lesions##35##1##(1990-6#1)(1992-10#1)(1993-12#3)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1996-12#1)(2008-10#10)(2008-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
Less common##2##2##(2008-12#1)(2013-8#1)
Less frequent##2##2##(2009-1#1)(2012-2#1)
Less frequently##2##2##(2009-8#1)(2012-12#1)
Less severe##2##2##(2008-10#1)(2008-2#1)
Less than 10% of##2##4##(2008-7#1)(2013-1#1)
Less than 50%##2##3##(1992-6#1)(1995-11#1)
Less than half of the##2##5##(2011-2#1)(2013-1#1)
Less than half##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
Less than##13##2##(1992-6#1)(1993-2#1)(1993-8#1)(1995-11#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#2)
Less##28##1##(1991-2#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-8#1)(1995-11#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Lesser##2##1##(2012-2#1)(2013-1#1)
Lesson##6##1##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(2012-2#1)
Lessons for##3##2##(1993-12#1)(1995-5#1)(2013-1#1)
Lessons from successful micronutrient programs##3##5##(2007-11#3)
Lessons from the##7##3##(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
Lessons from##16##2##(1995-12#1)(2007-10#1)(2007-11#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)
Lessons learned from the##3##4##(2006-10#1)(2008-12#1)(2011-2#1)
Lessons learned from##8##3##(2006-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#2)
Lessons learned##11##2##(1992-1#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#2)
Lessons##38##1##(1991-11#2)(1992-1#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#2)
Let us##2##2##(1995-8#1)(2009-10#1)
Let##5##1##(1994-1#1)(1995-8#1)(2007-9#1)(2009-10#1)(2010-8#1)
Let's##3##1##(1991-2#1)(1994-12#1)(2009-5#1)
Let-7##3##1##(2010-7#3)
Lethal intakes are expected to##2##5##(2008-7#2)
Lethal##7##1##(1996-6#1)(2008-10#3)(2008-12#1)(2008-7#2)
Lett##48##1##(1990-11#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-6#2)(1997-8#1)(2007-11#9)(2007-12#11)(2008-10#2)(2008-2#1)(2008-3#7)(2010-2#1)(2011-1#1)
Letter [Opt##2##2##(2007-12#2)
Letter from the Southwest##2##4##(2008-8#2)
Letter from the editor##3##4##(2012-2#1)(2013-1#2)
Letter from the##10##3##(2008-12#1)(2008-8#4)(2012-2#2)(2013-1#3)
Letter from##13##2##(2008-12#1)(2008-3#1)(2008-8#4)(2012-2#2)(2013-1#5)
Letter to the Editor##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
Letter to the editor##17##4##(1995-8#1)(1996-9#1)(1997-3#1)(2008-11#3)(2008-12#8)(2008-9#2)(2011-2#1)
Letter to the##21##3##(1995-8#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#8)(2008-9#2)(2009-10#1)(2011-2#2)
Letter##44##1##(1995-8#1)(1996-9#2)(1997-3#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-11#3)(2008-12#9)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#2)(2009-10#1)(2011-2#2)(2012-2#4)(2013-1#5)
Letters##5##1##(1990-12#1)(1996-1#1)(2008-10#1)(2008-6#1)(2013-1#1)
Letting and making death happen##2##5##(1991-2#2)
Lettuce Drop Incidence##2##3##(2008-10#2)
Lettuce Drop##3##2##(2008-10#3)
Lettuce big-vein virus (LBVV)##2##4##(2008-10#2)
Lettuce big-vein virus##4##3##(2008-10#4)
Lettuce drop incidence was##2##4##(2008-10#2)
Lettuce drop incidence##4##3##(2008-10#4)
Lettuce mosaic virus (LMV)##3##4##(2008-10#3)
Lettuce mosaic virus##4##3##(2008-10#4)
Lettuce necrotic stunt virus##2##4##(2008-10#2)
Lettuce##32##1##(2008-10#32)
Leu 55 Gln mutation in exon 1##3##7##(2008-2#3)
Leu 55 Gln mutation in##4##5##(2008-2#4)
Leu 55 Gln##5##3##(2008-2#5)
Leu##22##1##(1990-7#1)(1991-7#1)(1991-9#2)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-8#1)(1997-3#1)(2008-2#5)(2008-8#1)
Leu--&gt##2##1##(1994-5#1)(2008-1#1)
Leu-enkephalin##2##1##(1994-2#2)
Leu21##2##1##(1994-5#2)
Leu3Pro##2##1##(2008-9#2)
Leu8##2##1##(1994-8#1)(2008-9#1)
Leuconostoc mesenteroides subsp##2##3##(2012-2#2)
Leuconostoc mesenteroides##4##2##(1995-8#1)(2012-2#2)(2013-1#1)
Leuconostoc##7##1##(1995-8#1)(1997-4#3)(2012-2#2)(2013-1#1)
Leucostoma##3##1##(2008-10#3)
Leukaemia inhibitory factor (LIF)##2##4##(1997-7#1)(2008-11#1)
Leukaemia inhibitory factor##3##3##(1997-7#2)(2008-11#1)
Leukaemia##4##1##(1997-7#2)(2008-11#1)(2008-12#1)
Leukemia Cells##3##2##(2010-6#1)(2012-12#1)(2013-1#1)
Leukemia and##3##2##(1990-3#1)(1991-8#1)(2011-2#1)
Leukemia inhibitory factor##2##3##(1995-2#2)
Leukemia##19##1##(1990-3#1)(1991-8#1)(1995-2#2)(2007-2#2)(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#2)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)
Leukocyte Count##2##2##(2008-12#2)
Leukocyte adhesion deficiency type##2##4##(2011-2#2)
Leukocyte adhesion deficiency##4##3##(2011-2#4)
Leukocyte##12##1##(1991-12#1)(1991-4#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#4)
Leukocytosis##3##1##(1991-12#1)(2008-7#1)(2009-6#1)
Leur##2##1##(2008-5#1)(2011-2#1)
Leuven##3##1##(2009-7#1)(2010-12#2)
Levamisole was##2##2##(2008-1#2)
Levamisole##5##1##(2007-11#2)(2008-1#3)
Level 1##2##2##(2008-7#1)(2012-12#1)
Level I##2##2##(2007-9#2)
Level II##3##2##(2007-9#2)(2008-10#1)
Level in##2##2##(2008-10#1)(2013-1#1)
Level of##6##2##(1991-6#1)(2007-2#1)(2008-2#1)(2008-7#2)(2013-8#1)
Level##31##1##(1991-6#1)(1995-2#1)(1996-9#2)(2007-2#1)(2007-9#4)(2008-10#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-9#4)(2009-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
Level-2##2##1##(2011-3#2)
Levels and##2##2##(2008-8#1)(2011-1#1)
Levels of##40##2##(1990-2#1)(1992-12#1)(1992-9#2)(1994-12#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-12#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
Levels were##2##2##(1994-3#1)(2008-5#1)
Levels##58##1##(1990-2#1)(1991-12#1)(1992-12#1)(1992-9#2)(1994-12#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-12#2)(2007-6#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#1)
Levene##2##1##(2012-1#2)
Leveraging##4##1##(1995-3#1)(1996-3#1)(1997-1#1)(2010-5#1)
Levin and##2##2##(1992-6#1)(2007-4#1)
Levin##4##1##(1992-6#1)(1994-3#2)(2007-4#1)
Levine##4##1##(1992-1#1)(1995-6#1)(2010-4#2)
Levocetirizine##2##1##(2008-3#2)
Levodopa (LD) is the most##2##5##(2008-7#1)(2010-12#1)
Levodopa##3##1##(2008-10#1)(2008-7#1)(2010-12#1)
Levodropropizine##2##1##(1990-6#1)(1991-2#1)
Levofloxacin##2##1##(2008-7#2)
Lewinsohn and colleagues##2##3##(2011-2#2)
Lewis acid catalyst##2##3##(1993-11#1)(2008-7#1)
Lewis acid##4##2##(1993-11#1)(1996-5#1)(2008-7#1)(2009-2#1)
Lewis acids##3##2##(1996-5#2)(2009-2#1)
Lewis and##3##2##(1996-1#1)(2008-7#1)(2013-8#1)
Lewis rats##3##2##(1995-12#1)(2008-5#1)(2008-9#1)
Lewis##29##1##(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-5#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-7#1)(2013-8#1)
LewisX##4##1##(1993-8#4)
Lewisburg Community Hospital v##2##4##(1993-1#1)(1993-3#1)
Lewisite I and##2##3##(2008-11#2)
Lewisite I##3##2##(2008-11#3)
Lewisite II and##2##3##(2008-11#2)
Lewisite II##3##2##(2008-11#3)
Lewisite##8##1##(2008-10#1)(2008-11#7)
Lewy bodies and Lewy neurites##2##5##(2008-7#2)
Lewy bodies and##6##3##(2008-7#6)
Lewy bodies in##3##3##(2008-7#3)
Lewy bodies##13##2##(2008-7#13)
Lewy body dementia##2##3##(1995-12#2)
Lewy body type-degeneration in##3##4##(2008-11#3)
Lewy body##7##2##(1995-12#2)(2008-11#3)(2008-7#2)
Lewy##24##1##(1995-12#2)(2008-11#3)(2008-7#19)
Lexical##3##1##(1991-2#1)(2008-4#1)(2009-11#1)
Lexington Avenue##2##2##(2008-8#2)
Lexington##3##1##(2008-10#1)(2008-8#2)
Leydig cell function##3##3##(1990-6#1)(1992-12#2)
Leydig cell hyperplasia##2##3##(1996-5#1)(2012-12#1)
Leydig cell volume##5##3##(1992-12#5)
Leydig cell##16##2##(1990-5#1)(1990-6#1)(1992-12#9)(1992-3#1)(1996-5#1)(2008-4#1)(2009-10#1)(2012-12#1)
Leydig cells in the##2##4##(2009-10#1)(2012-2#1)
Leydig cells in##3##3##(1996-5#1)(2009-10#1)(2012-2#1)
Leydig cells##11##2##(1990-6#1)(1992-12#1)(1992-3#1)(1996-5#4)(2009-10#2)(2012-2#2)
Leydig##29##1##(1990-5#1)(1990-6#2)(1992-12#10)(1992-3#2)(1996-5#7)(2008-4#1)(2009-10#3)(2012-12#1)(2012-2#2)
Lgr5##5##1##(2011-2#1)(2012-2#4)
Li and Tiwari##2##3##(2012-3#2)
Li and##5##2##(2008-10#3)(2012-3#2)
Li##23##1##(1997-7#2)(2007-11#2)(2008-10#9)(2008-2#3)(2008-5#1)(2008-8#1)(2012-3#2)(2012-7#1)(2013-1#2)
Li(+) and Cu(2+)##2##3##(2008-10#2)
Li(+) and##3##2##(2008-10#3)
Li(+) in##2##2##(2008-10#1)(2008-2#1)
Li(+)##19##1##(2008-10#16)(2008-2#1)(2012-7#2)
Li(2)SO(4)##2##1##(2008-10#1)(2008-9#1)
Li+ and##2##2##(1992-8#1)(1996-12#1)
Li+##17##1##(1990-11#3)(1990-7#3)(1991-8#1)(1992-6#5)(1992-8#1)(1996-12#4)
Li-Cor##2##1##(2008-3#2)
Li-Fraumeni syndrome (LFS)##2##3##(1990-12#1)(2011-2#1)
Li-Fraumeni syndrome##7##2##(1990-12#1)(1994-12#1)(2010-3#2)(2011-2#3)
Li/Na##4##1##(2008-10#4)
LiB(3)O(5)##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
LiB3O5##2##1##(2007-12#1)(2008-3#1)
LiCAF laser pumped by##2##4##(2007-12#2)
LiCAF laser##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
LiCAF##7##1##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
LiCF(3)SO(3) and gamma-LiAlO(2)##3##3##(2008-10#3)
LiCF(3)SO(3)##4##1##(2008-10#4)
LiCaAlF(6)##2##1##(2007-11#2)
LiChrosorb RP-18##2##2##(2008-10#2)
LiChrospher(R)##2##1##(2008-10#2)
LiCl##12##1##(1992-6#6)(1993-12#1)(1993-3#1)(1993-6#1)(1995-12#2)(2008-10#1)
LiF was##2##2##(2008-10#2)
LiF##18##1##(2007-12#3)(2008-10#2)(2008-2#6)(2008-3#7)
LiLuF##2##1##(2008-3#2)
LiLuF(4)##3##1##(2007-11#2)(2008-2#1)
LiMn2O4##3##1##(2013-8#3)
LiNbO (3) waveguide##2##3##(2007-11#2)
LiNbO (3)##3##2##(2007-11#3)
LiNbO(3) Fabry-Perot etalon for frequency stabilization and tuning of a single-mode quasi-continuous-wave##2##12##(2007-11#2)
LiNbO(3) Fabry-Perot etalon##3##3##(2007-11#3)
LiNbO(3) and LiTaO(3)##3##3##(2007-11#1)(2008-3#2)
LiNbO(3) and##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
LiNbO(3) crystal##12##2##(2007-11#4)(2007-12#5)(2008-3#3)
LiNbO(3) crystals##8##2##(2007-11#3)(2007-12#2)(2008-3#3)
LiNbO(3) is##2##2##(2007-12#1)(2008-3#1)
LiNbO(3) optical parametric oscillator (OPO)##2##5##(2008-2#2)
LiNbO(3) optical parametric##4##3##(2007-12#2)(2008-2#2)
LiNbO(3) plate##2##2##(2007-12#1)(2008-3#1)
LiNbO(3) waveguide##4##2##(2008-2#3)(2008-3#1)
LiNbO(3) waveguides##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
LiNbO(3)##99##1##(2007-11#19)(2007-12#38)(2008-2#16)(2008-3#26)
LiNbO3 crystal##2##2##(2007-12#1)(2008-3#1)
LiNbO3##8##1##(2007-12#3)(2008-3#5)
LiNdP(4)O(12) laser##4##2##(2007-12#4)
LiNdP(4)O(12)##6##1##(2007-11#1)(2007-12#5)
LiP##3##1##(1991-11#2)(2012-2#1)
LiP2##2##1##(1991-11#2)
LiSAF laser has been##2##4##(2007-12#2)
LiSAF laser##11##2##(2007-12#9)(2008-2#2)
LiSAF unstable laser resonator##2##4##(2008-2#2)
LiSAF##15##1##(2007-12#9)(2008-2#6)
LiSrAlF(6)##2##1##(2008-2#2)
LiTaO(3)##20##1##(2007-11#5)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#7)
LiTaO3##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
LiYF(4)##2##1##(2007-12#1)(2008-3#1)
Liability##5##1##(1991-1#1)(1991-12#1)(1996-12#1)(2007-3#1)(2008-4#1)
Liangyoupeijiu had##2##2##(2008-9#2)
Liangyoupeijiu##6##1##(2008-9#6)
Liaoning##3##1##(2008-10#1)(2008-9#2)
Liberal##2##1##(1990-12#1)(2009-7#1)
Liberase##3##1##(2010-11#3)
Liberia##2##1##(1995-12#1)(2007-7#1)
Liberty Mutual##5##2##(1997-5#5)
Libido##2##1##(2008-1#2)
Librarians at the##2##3##(1991-3#1)(1997-3#1)
Librarians at##3##2##(1991-3#1)(1992-12#1)(1997-3#1)
Librarians##7##1##(1991-12#1)(1991-3#2)(1992-12#1)(1996-12#1)(1997-1#1)(1997-3#1)
Libraries##7##1##(1991-12#1)(1992-2#1)(1996-1#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-4#1)
Library and##6##2##(1992-12#1)(1996-1#3)(2011-2#2)
Library at##3##2##(1995-1#1)(1995-3#1)(1997-3#1)
Library staff##2##2##(1995-3#1)(1996-12#1)
Library##48##1##(1991-2#2)(1991-3#2)(1992-1#3)(1992-12#2)(1992-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#2)(1996-1#5)(1996-12#2)(1996-2#2)(1996-3#1)(1997-3#2)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
Libya##3##1##(1994-12#2)(2008-10#1)
Libyan##2##1##(1994-12#1)(2012-2#1)
License##2##1##(1997-2#1)(2013-8#1)
Licensing##3##1##(1997-1#1)(2012-3#2)
Licensure##2##1##(1992-1#1)(2008-10#1)
Lich##2##1##(2008-1#2)
Lich-Gregoire##2##1##(2008-1#2)
Lichen planus is a common##2##5##(1991-2#1)(2007-7#1)
Lichen planus##4##2##(1991-2#1)(1996-2#1)(2007-7#2)
Licorice##3##1##(2008-10#3)
Lidar equations for##2##3##(2008-3#2)
Lidar in##3##2##(2008-3#3)
Lidar##25##1##(2008-10#1)(2008-2#5)(2008-3#19)
Lidocaine##2##1##(1996-9#1)(2008-9#1)
Life Change Unit as##2##4##(2011-2#2)
Life Change##3##2##(2011-2#3)
Life Cycle##4##2##(1997-3#1)(2008-11#2)(2012-2#1)
Life Insurance##2##2##(1996-5#1)(1997-5#1)
Life Sciences##2##2##(2008-4#1)(2008-5#1)
Life after##3##2##(2008-10#1)(2008-8#2)
Life and death decisions##2##4##(2007-3#1)(2008-11#1)
Life and##3##2##(2007-3#1)(2008-11#1)(2013-1#1)
Life cycle##4##2##(2008-12#1)(2009-2#1)(2010-2#1)(2011-1#1)
Life events and##2##3##(1993-7#1)(2008-10#1)
Life events##3##2##(1993-7#1)(2008-10#1)(2011-2#1)
Life expectancy in##2##3##(1996-11#1)(2008-7#1)
Life expectancy was##2##3##(1996-3#1)(2008-7#1)
Life expectancy##8##2##(1996-11#1)(1996-3#3)(1997-6#1)(2008-7#2)(2011-2#1)
Life in##7##2##(1994-12#1)(1995-4#1)(2009-12#1)(2012-3#1)(2013-1#3)
Life or##2##2##(1991-12#1)(2012-3#1)
Life table##2##2##(1991-12#2)
Life##94##1##(1991-12#3)(1991-2#1)(1992-1#1)(1992-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#2)(1994-3#3)(1995-4#1)(1995-6#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-7#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#2)(2007-3#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#1)
Life'##3##1##(2008-7#3)
Life-style##2##1##(1992-8#1)(2008-1#1)
Life-threatening bradycardia with narrow QRS complex##2##6##(2007-5#2)
Life-threatening##5##1##(1992-6#1)(2007-5#2)(2011-2#1)(2012-12#1)
Lifelong##2##1##(1994-1#1)(2008-12#1)
Lifesaving##2##1##(1990-5#1)(2010-8#1)
Lifespan##3##1##(2010-3#1)(2010-7#1)(2012-2#1)
Lifestyle##6##1##(1991-12#1)(2008-12#1)(2008-3#2)(2010-12#1)(2011-2#1)
Lifetime is up to 25 days of use##2##8##(2008-10#2)
Lifetime of##2##2##(1990-4#1)(2008-2#1)
Lifetime##9##1##(1990-4#1)(1991-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2013-1#1)
LigaSure##2##1##(2007-8#1)(2010-8#1)
Ligament##5##1##(2008-11#1)(2008-12#1)(2013-1#3)
Ligand 1##2##2##(2008-10#1)(2012-3#1)
Ligand binding to##2##3##(1994-5#1)(2012-2#1)
Ligand binding##4##2##(1992-3#1)(1993-1#1)(1994-5#1)(2012-2#1)
Ligand blot analysis##2##3##(1995-6#1)(2008-11#1)
Ligand##25##1##(1992-3#1)(1993-1#1)(1994-5#1)(1995-6#1)(1996-2#5)(1997-7#4)(2008-10#2)(2008-11#3)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Ligands can be introduced at the 5' terminus of an oligonucleotide by adding a linker to the ligand and modifying the 5' terminus of the oligonucleotide##2##26##(2008-4#2)
Ligands##10##1##(1996-2#3)(2008-10#3)(2008-4#3)(2013-1#1)
Ligasure##10##1##(2007-8#1)(2009-2#4)(2011-2#5)
Ligation of##2##2##(1993-12#1)(1997-7#1)
Ligation##4##1##(1993-12#1)(1997-7#1)(2010-12#1)(2012-3#1)
Light Scattering from##2##3##(2008-3#2)
Light Scattering##5##2##(2008-2#1)(2008-3#3)(2012-1#1)
Light absorption by##2##3##(2008-3#2)
Light and electron microscopic##2##4##(1995-6#1)(2011-2#1)
Light and electron microscopy showed##2##5##(1992-9#1)(2012-1#1)
Light and electron microscopy##3##4##(1992-9#1)(2008-10#1)(2012-1#1)
Light and electron##5##3##(1992-9#1)(1995-6#1)(2008-10#1)(2011-2#1)(2012-1#1)
Light and transmission electron microscopy##3##5##(2008-10#1)(2008-7#2)
Light and transmission electron##4##4##(2008-10#2)(2008-7#2)
Light and##16##2##(1992-9#1)(1994-2#1)(1995-6#1)(2008-10#6)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#2)
Light beams with##2##3##(2007-11#1)(2007-12#1)
Light emission##3##2##(2008-10#2)(2008-3#1)
Light intensity##2##2##(2008-2#1)(2008-3#1)
Light microscopic##2##2##(1990-11#1)(2008-9#1)
Light microscopy##2##2##(2008-10#1)(2011-2#1)
Light on##2##2##(1996-9#1)(2008-10#1)
Light scatter##3##2##(2008-9#3)
Light scattering and absorption##2##4##(2007-12#1)(2008-3#1)
Light scattering and##3##3##(2007-12#1)(2008-3#2)
Light scattering by##2##3##(2007-11#1)(2008-3#1)
Light scattering from##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
Light scattering##13##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)(2008-9#1)
Light##101##1##(1990-11#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-9#2)(2007-11#5)(2007-12#5)(2008-10#19)(2008-12#1)(2008-2#11)(2008-3#21)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#2)(2013-8#2)
Light-induced##6##1##(1990-12#1)(1992-6#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-5#1)
Light-scattering##4##1##(2008-10#1)(2008-3#3)
Light-transmittance predictions under multiple-light-scattering conditions##2##5##(2008-3#2)
Lighting##2##1##(1994-9#1)(2008-3#1)
Lignin peroxidase##2##2##(1991-11#1)(2008-5#1)
Lignin##3##1##(1991-11#1)(2008-10#1)(2008-5#1)
Lignocellulosic##3##1##(2008-6#2)(2011-1#1)
Like an##2##2##(1994-1#1)(2008-10#1)
Like controls##2##2##(1993-12#1)(2008-11#1)
Like human##2##2##(1992-11#1)(1994-5#1)
Like in##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
Like many other##2##3##(2008-8#1)(2012-12#1)
Like many##3##2##(1995-12#1)(2008-8#1)(2012-12#1)
Like other##8##2##(1995-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-2#2)
Like the other##2##3##(2008-1#1)(2009-10#1)
Like the##11##2##(1993-12#1)(1993-2#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)
Like##56##1##(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
Likelihood and##2##2##(2008-8#1)(2011-2#1)
Likelihood ratio tests##2##3##(1994-11#1)(2008-9#1)
Likelihood##10##1##(1994-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
Likely##3##1##(1991-10#1)(1997-2#1)(2008-10#1)
Likert Scale##2##2##(2013-1#2)
Likert scale##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
Likert scales and##2##3##(2010-1#1)(2012-1#1)
Likert##8##1##(1991-2#1)(1993-3#1)(2008-12#1)(2008-9#1)(2010-1#1)(2012-1#1)(2013-1#2)
Likewise##41##1##(1990-9#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
Liliaceae##3##1##(2008-10#1)(2009-12#2)
Lilium and##2##2##(1995-6#2)
Lilium##5##1##(1995-6#2)(2008-8#2)(2009-12#1)
Lillehammer##3##1##(1996-3#3)
Lilly disposable pen##2##3##(2009-11#2)
Lilly##3##1##(1990-2#1)(2009-11#2)
Lim##2##1##(1991-5#1)(2008-10#1)
Lim15##2##1##(1995-6#2)
Lima##8##1##(1991-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-12#2)
Limax##2##1##(1990-5#2)
Limb salvage surgery##2##3##(1990-12#1)(2010-3#1)
Limb salvage##4##2##(1990-12#1)(2010-3#2)(2011-2#1)
Limb##18##1##(1990-12#1)(1992-11#1)(1994-11#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2009-10#1)(2010-3#3)(2011-2#2)(2013-1#2)
Limb-sparing##2##1##(2008-6#1)(2011-2#1)
Limbal stem##2##2##(2008-11#1)(2011-1#1)
Limbal##3##1##(2008-11#1)(2010-10#1)(2011-1#1)
Limit of detection (LOD)##2##4##(2008-10#2)
Limit of detection##5##3##(2008-10#4)(2011-2#1)
Limit of detections##2##3##(2008-10#2)
Limit of##8##2##(2008-10#7)(2011-2#1)
Limit##10##1##(2008-10#7)(2008-11#1)(2011-2#1)(2013-1#1)
Limitation of##3##2##(1996-9#1)(2010-2#1)(2012-2#1)
Limitation##6##1##(1993-1#1)(1996-9#1)(2008-10#1)(2010-2#1)(2012-2#2)
Limitations and##4##2##(2008-3#1)(2009-11#1)(2011-2#1)(2012-1#1)
Limitations include##2##2##(1996-5#1)(2008-3#1)
Limitations of##5##2##(1993-1#1)(1993-12#1)(2008-1#1)(2008-11#1)(2009-10#1)
Limitations##17##1##(1991-12#1)(1993-1#1)(1993-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#4)(2009-10#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
Limited availability of##2##3##(2007-2#1)(2008-8#1)
Limited data##3##2##(2011-2#2)(2012-3#1)
Limited information is available on the##2##6##(2008-10#1)(2012-3#1)
Limited information is available##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
Limited information##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-3#1)
Limited numbers of PL and NP mice were sacrificed at the end of each reproductive round##3##16##(1997-4#3)
Limited##41##1##(1992-6#1)(1993-8#1)(1996-3#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)
Limiting the##2##2##(1991-2#1)(2007-11#1)
Limiting##4##1##(1991-2#1)(1992-1#1)(2007-11#2)
Limits of detection (LOD)##2##4##(2008-10#2)
Limits of detection at the pg ml(-1) level were estimated for##2##11##(2008-10#2)
Limits of detection at the##3##5##(2008-10#3)
Limits of detection at##4##4##(2008-10#3)(2008-3#1)
Limits of detection for##5##4##(2008-10#5)
Limits of detection of 0##3##5##(2008-10#3)
Limits of detection were##2##4##(2008-10#1)(2009-6#1)
Limits of detection##20##3##(1996-5#1)(2008-10#16)(2008-3#1)(2009-6#1)(2012-2#1)
Limits of quantitation##2##3##(2008-10#2)
Limits of##28##2##(1996-5#1)(2008-10#20)(2008-2#1)(2008-3#3)(2008-8#1)(2009-6#1)(2012-2#1)
Limits to##2##2##(1995-3#1)(2008-8#1)
Limits##33##1##(1992-3#1)(1995-3#1)(1996-5#1)(2008-1#1)(2008-10#20)(2008-2#1)(2008-3#3)(2008-8#2)(2009-6#1)(2012-2#1)(2013-8#1)
Limonium spp##2##2##(2008-10#2)
Limonium##3##1##(2008-10#3)
Lin##2##1##(1991-2#1)(2013-8#1)
Lin-28##3##1##(2010-7#3)
Lincoln index##2##2##(2011-2#2)
Lincoln##8##1##(1991-9#1)(2008-11#1)(2008-12#2)(2008-7#2)(2011-2#2)
Line of##2##2##(2008-11#1)(2012-2#1)
Line shapes in##2##3##(2008-3#2)
Line shapes##3##2##(2008-2#1)(2008-3#2)
Line##30##1##(1991-6#1)(1993-12#3)(1993-2#1)(1994-12#1)(1996-9#1)(1997-7#2)(1997-9#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#4)(2010-8#1)(2011-2#2)(2012-2#1)
Lineage##6##1##(1992-3#1)(2008-10#4)(2012-3#1)
Lineages of##4##2##(2008-10#4)
Lineages##8##1##(2008-10#8)
Linear Discriminant Analysis##3##3##(2008-10#3)
Linear Models##3##2##(2008-12#1)(2009-5#1)(2011-2#1)
Linear and quadratic##2##3##(2007-11#1)(2008-10#1)
Linear and##6##2##(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2013-1#1)
Linear calibration curve was obtained##2##5##(2008-10#2)
Linear calibration curve##3##3##(2008-10#3)
Linear calibration curves were##2##4##(2008-10#2)
Linear calibration curves##3##3##(2008-10#3)
Linear calibration graphs were obtained for##3##6##(2008-10#3)
Linear calibration graphs were obtained##5##5##(2008-10#5)
Linear calibration graphs were##6##4##(2008-10#6)
Linear calibration graphs##8##3##(2008-10#8)
Linear calibration in the range of 0##2##7##(2008-10#2)
Linear calibration plots were obtained for##2##6##(2008-10#2)
Linear calibration plots##4##3##(2008-10#4)
Linear calibration##23##2##(1995-3#1)(2008-10#22)
Linear calibrations were obtained##2##4##(2008-10#2)
Linear calibrations##3##2##(2008-10#3)
Linear discriminant analysis##2##3##(2008-10#1)(2009-4#1)
Linear discriminant##3##2##(2008-10#2)(2009-4#1)
Linear programming##3##2##(2008-11#3)
Linear ranges were##4##3##(2008-10#4)
Linear regression analysis##3##3##(2008-10#2)(2009-11#1)
Linear regression##9##2##(2007-8#1)(2008-10#2)(2009-11#1)(2009-3#1)(2011-2#2)(2012-3#2)
Linear regressions of##2##3##(2008-10#2)
Linear relationship##2##2##(2008-10#2)
Linear relationships between the responses and concentrations of##2##8##(2008-10#2)
Linear relationships between##3##3##(2008-10#3)
Linear response##3##2##(2008-10#3)
Linear responses of##2##3##(2008-10#2)
Linear responses were##2##3##(2008-10#2)
Linear responses##6##2##(2008-10#6)
Linear sweep##2##2##(2008-10#2)
Linear##103##1##(1993-5#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-9#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#63)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#1)
Linearity for##2##2##(2008-10#1)(2010-3#1)
Linearity of the analytical curve is##2##6##(2008-10#2)
Linearity of the##3##3##(2008-10#2)(2011-1#1)
Linearity of##5##2##(2008-10#4)(2011-1#1)
Linearity was found##2##3##(2008-10#2)
Linearity was observed##2##3##(2008-10#2)
Linearity was obtained##2##3##(1993-2#1)(2008-10#1)
Linearity was##10##2##(1993-2#1)(2008-10#8)(2008-5#1)
Linearity##22##1##(1993-2#1)(1995-2#1)(2008-10#17)(2008-5#1)(2010-3#1)(2011-1#1)
Linearly polarized##2##2##(2007-12#1)(2008-2#1)
Linearly##3##1##(2007-12#2)(2008-2#1)
Lines from##2##2##(2008-11#1)(2008-3#1)
Lines of the##2##3##(2008-10#1)(2008-3#1)
Lines of##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
Lines##18##1##(1997-5#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-11#1)(2010-8#1)
Lineweaver-Burk plot##4##2##(1990-11#1)(1990-2#1)(2008-10#2)
Lineweaver-Burk plots##2##2##(2008-5#1)(2010-11#1)
Lineweaver-Burk##6##1##(1990-11#1)(1990-2#1)(2008-10#2)(2008-5#1)(2010-11#1)
Linewidths##2##1##(1996-12#1)(2008-3#1)
Linezolid##2##1##(2006-10#1)(2008-8#1)
Linfinity =##2##2##(2008-5#2)
Linfinity##3##1##(2008-5#2)(2013-7#1)
Link##2##1##(2008-12#1)(2008-4#1)
Linkage analyses##2##2##(2008-10#1)(2011-2#1)
Linkage analysis of##2##3##(1997-3#1)(2008-10#1)
Linkage analysis##7##2##(1997-3#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-7#2)
Linkage between##2##2##(2008-10#2)
Linkage disequilibrium##2##2##(2008-10#1)(2008-11#1)
Linkage of##3##2##(1996-12#1)(2008-10#1)(2008-12#1)
Linkage##24##1##(1994-9#1)(1996-12#1)(1997-3#1)(1997-5#3)(2007-10#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-1#1)(2011-2#1)
Linked to##7##2##(2008-10#6)(2008-9#1)
Linked##15##1##(1997-7#1)(2008-10#8)(2008-12#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#2)
Linking the##4##2##(1994-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
Linking theory##2##2##(1991-2#1)(2008-12#1)
Linking##22##1##(1991-1#1)(1991-2#1)(1994-2#1)(1994-3#1)(1997-3#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-6#1)(2013-8#1)
Links to##3##2##(2007-2#1)(2008-11#1)(2010-3#1)
Links##6##1##(2007-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
Linn##6##1##(2010-2#2)(2010-9#1)(2011-1#2)(2013-1#1)
Linnaeus##5##1##(2007-12#3)(2008-5#1)(2013-1#1)
Linoleic acid##6##2##(1990-12#1)(1992-5#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-3#1)
Linoleic##8##1##(1990-12#1)(1992-5#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-3#1)
Linz##2##1##(1990-8#1)(2008-11#1)
Lip##4##1##(2008-6#1)(2013-1#3)
Lip(SH)2 or DTT##3##3##(1992-3#3)
Lip(SH)2##4##1##(1992-3#4)
Lipase##3##1##(2008-6#1)(2008-7#1)(2008-8#1)
Lipases secreted by##2##3##(2010-10#2)
Lipases##3##1##(2010-10#2)(2012-2#1)
Lipid Res##2##2##(1991-12#1)(1993-12#1)
Lipid abnormalities##2##2##(2008-12#1)(2008-2#1)
Lipid levels##2##2##(1991-6#1)(2010-8#1)
Lipid lowering##2##2##(2008-4#1)(2008-8#1)
Lipid peroxidation##4##2##(1990-12#1)(1990-3#1)(2008-10#1)(2011-2#1)
Lipid##39##1##(1990-12#1)(1990-3#1)(1990-5#4)(1990-8#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1995-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
Lipid-lowering##3##1##(2007-11#1)(2009-8#1)(2012-3#1)
Lipid-soluble##2##1##(2008-10#2)
Lipidessence##2##1##(2008-5#2)
Lipids##8##1##(1997-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
Lipoamidase##2##1##(1990-8#2)
Lipoamide dehydrogenase##2##2##(1992-3#1)(1996-12#1)
Lipocalin-2##3##1##(2012-3#1)(2013-8#2)
Lipodystrophy##2##1##(2007-7#1)(2008-3#1)
Lipoma##3##1##(2009-3#1)(2010-6#1)(2012-2#1)
Lipomas##3##1##(1993-9#3)
Lipomatosis of the##2##3##(2009-3#1)(2011-2#1)
Lipomatosis of##3##2##(2009-3#1)(2011-2#2)
Lipomatosis##4##1##(1997-5#1)(2009-3#1)(2011-2#2)
Lipophilic##4##1##(1991-5#1)(1995-3#1)(2008-10#1)(2008-8#1)
Lipopolysaccharide##6##1##(1992-3#2)(1992-8#1)(1997-1#2)(2008-10#1)
Lipoprotein (a)##2##2##(2008-1#1)(2013-7#1)
Lipoprotein creams##3##2##(2008-5#3)
Lipoprotein lipase (LPL)##2##3##(1992-12#1)(1992-3#1)
Lipoprotein##15##1##(1992-12#4)(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2013-1#1)(2013-7#1)
Lipoprotein(a) (Lp(a))##2##2##(1993-2#1)(1995-6#1)
Lipoprotein(a) [Lp(a)]##2##2##(1996-8#1)(2008-6#1)
Lipoprotein(a) and##2##2##(1992-9#2)
Lipoprotein(a)##10##1##(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1995-6#1)(1996-8#1)(2008-6#2)
Lipoproteins##4##1##(1992-11#1)(1993-12#1)(2008-5#2)
Liposomal influenza vaccine##4##3##(2007-11#4)
Liposomal##8##1##(1995-5#1)(1997-1#1)(2007-11#4)(2008-11#1)(2008-5#1)
Liposome##3##1##(2008-10#3)
Liposome-mediated NGF##2##2##(1996-2#2)
Liposomes##11##1##(1991-5#1)(1994-11#1)(1995-5#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-5#1)
Lipowheat##4##1##(2008-5#4)
Liq##3##1##(1990-8#1)(2011-3#2)
Liquid Chromatography##6##2##(2008-10#2)(2008-12#1)(2009-8#3)
Liquid chromatographic determination of##4##4##(2008-10#4)
Liquid chromatographic##8##2##(2008-10#7)(2012-2#1)
Liquid chromatography##2##2##(2008-1#1)(2008-10#1)
Liquid crystalline##2##2##(2008-10#2)
Liquid hot water##2##3##(2013-1#2)
Liquid##40##1##(1995-3#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#21)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
Liquid-Liquid##2##1##(2008-10#2)
Liquid-crystal##4##1##(2008-3#4)
Liquid-liquid distribution of ion associates of##2##6##(2008-10#2)
Liquid-liquid extraction of##4##3##(2008-10#4)
Liquid-liquid extraction##6##2##(2008-10#6)
Liquid-liquid##8##1##(2008-10#8)
Liquid-liquid-liquid phase microextraction##2##3##(2008-10#2)
Liquids##2##1##(2008-2#1)(2012-1#1)
Liriomyza trifolii##2##2##(2011-2#2)
Lisbon##4##1##(2008-10#2)(2008-5#1)(2008-7#1)
Lisinopril and albumin excretion in diabetes##4##6##(1997-8#4)
Lispro insulin##3##2##(2008-4#3)
Lissorhoptrus oryzophilus##2##2##(2013-8#2)
List of##2##2##(2010-7#1)(2013-8#1)
List##6##1##(1991-11#1)(1995-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2013-8#1)
Listeners##3##1##(2008-9#1)(2011-1#1)(2013-8#1)
Listening to##2##2##(2008-11#1)(2008-9#1)
Listeria and##2##2##(2008-7#1)(2012-12#1)
Listeria monocytogenes and Salmonella Enteritidis##2##5##(2010-4#2)
Listeria monocytogenes in##2##3##(1996-12#1)(2012-3#1)
Listeria monocytogenes infection##2##3##(1996-12#1)(2012-12#1)
Listeria monocytogenes is##2##3##(2008-7#1)(2011-2#1)
Listeria monocytogenes meningitis and##2##4##(2008-8#2)
Listeria monocytogenes##35##2##(1994-12#2)(1994-8#1)(1996-12#5)(2006-10#2)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
Listeria##47##1##(1994-12#2)(1994-8#2)(1996-12#6)(1997-4#1)(2006-10#2)(2008-10#4)(2008-11#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#5)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#1)
Literacy##5##1##(1996-1#1)(2008-11#2)(2008-12#1)(2011-2#1)
Literary data##2##2##(2011-2#1)(2013-1#1)
Literary##3##1##(2009-10#1)(2011-2#1)(2013-1#1)
Literature Review##6##2##(2006-10#1)(2011-2#3)(2012-3#2)
Literature and medicine##2##3##(1997-5#1)(2009-11#1)
Literature and##4##2##(1997-5#1)(2009-11#1)(2009-5#1)(2010-12#1)
Literature data##3##2##(1994-5#1)(2008-10#1)(2013-1#1)
Literature in##2##2##(2009-8#2)
Literature review##2##2##(2007-11#1)(2008-7#1)
Literature reviews##4##2##(1993-12#1)(1994-3#1)(1994-6#1)(1994-9#1)
Literature survey##2##2##(2008-10#2)
Literature##51##1##(1991-12#2)(1991-2#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-3#1)(1997-5#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#4)(2013-1#6)
Lithium Niobate##2##2##(2008-2#1)(2008-3#1)
Lithium##20##1##(1992-2#2)(1992-6#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-9#1)(2009-7#1)(2009-8#2)
Lithographic##2##1##(2007-12#1)(2008-2#1)
Lithography##3##1##(2007-5#1)(2008-2#1)(2012-2#1)
Lithuania##2##1##(2013-8#2)
Lithuanian health system##3##3##(2013-8#3)
Lithuanian##4##1##(2007-10#1)(2013-8#3)
Litopenaeus vannamei##2##2##(2008-5#2)
Litopenaeus##3##1##(2008-5#3)
Little attention has been given to##2##6##(1992-1#1)(2010-8#1)
Little attention has been##4##4##(1992-1#1)(2010-8#2)(2011-1#1)
Little cherry virus##4##3##(2008-10#4)
Little cherry virus-2 (LChV-2)##2##4##(2008-10#2)
Little cherry virus-2##3##3##(2008-10#3)
Little cherry##10##2##(2008-10#10)
Little data##2##2##(1992-10#1)(2008-3#1)
Little difference was observed in##2##5##(1990-12#1)(2008-3#1)
Little difference was##3##3##(1990-12#1)(1997-3#1)(2008-3#1)
Little empirical evidence exists to##2##5##(2008-11#1)(2008-8#1)
Little has been written about the##2##6##(1992-1#1)(1994-8#1)
Little information is available on##2##5##(1993-1#1)(2008-10#1)
Little information is available##4##4##(1993-1#1)(2007-10#1)(2008-10#2)
Little information##5##2##(1993-1#1)(2007-10#1)(2007-12#1)(2008-10#2)
Little is known about the ecology##2##6##(2008-5#1)(2009-4#1)
Little is known about the##18##5##(1990-2#1)(1993-12#1)(1994-11#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
Little is known about##24##4##(1990-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
Little is known of how##2##5##(1992-10#1)(2008-11#1)
Little is known of##3##4##(1992-10#1)(1996-6#1)(2008-11#1)
Little is known##31##3##(1990-2#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Little or no##3##3##(1994-11#1)(2008-10#2)
Little research has##3##3##(1994-3#1)(2010-12#1)(2012-12#1)
Little research##4##2##(1994-3#1)(2008-9#1)(2010-12#1)(2012-12#1)
Little variation##2##2##(1996-12#1)(2011-2#1)
Little##89##1##(1990-12#1)(1990-2#1)(1991-3#1)(1992-1#2)(1992-10#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-12#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Littorina littorea##2##2##(2008-10#2)
Littorina##3##1##(2008-10#3)
Littrow configuration##2##2##(2007-11#1)(2008-3#1)
Littrow mounting##2##2##(2008-3#2)
Littrow##6##1##(2007-11#2)(2008-2#1)(2008-3#3)
Liu##7##1##(1995-5#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-1#3)
Live cell imaging##2##3##(2012-2#1)(2013-8#1)
Live cells are treated with formaldehyde to generate##2##8##(2008-2#2)
Live cells##3##2##(2008-2#2)(2008-4#1)
Live imaging##2##2##(2008-7#1)(2009-5#1)
Live kidney##2##2##(2008-5#2)
Live##18##1##(1991-5#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
Liver Cell##2##2##(2009-8#2)
Liver Metastases##2##2##(1994-12#1)(1995-4#1)
Liver biopsy##2##2##(2008-1#2)
Liver cytosols##2##2##(1990-11#2)
Liver function##2##2##(1991-1#1)(2013-8#1)
Liver resection##2##2##(2011-2#1)(2012-3#1)
Liver slices##2##2##(1995-11#2)
Liver transplantation##7##2##(1992-6#1)(2006-10#1)(2010-6#1)(2013-8#4)
Liver##52##1##(1990-11#2)(1990-2#2)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-6#2)(2006-10#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-6#1)(2009-8#2)(2010-12#2)(2010-6#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#7)
Liverpool##3##1##(1997-8#1)(2008-11#1)(2009-10#1)
Livers##3##1##(1996-12#1)(2008-11#1)(2010-12#1)
Lives##3##1##(2008-11#1)(2013-1#2)
Livestock##5##1##(2012-12#4)(2012-2#1)
Living Conditions##2##2##(2008-7#1)(2013-1#1)
Living Sky Health District##3##4##(1996-1#3)
Living donor kidney transplantation allows##2##5##(2011-2#2)
Living donor kidney transplantation is##2##5##(2011-2#2)
Living donor kidney transplantation##5##4##(2007-10#1)(2011-2#4)
Living donor##6##2##(2007-10#1)(2011-2#4)(2013-8#1)
Living in##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
Living unrelated##2##2##(2008-1#2)
Living with HIV/AIDS##2##3##(2011-1#1)(2013-1#1)
Living with##6##2##(1995-1#1)(1995-8#1)(1996-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
Living##47##1##(1991-2#1)(1992-1#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#3)(1996-7#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#7)(2009-5#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#4)(2013-1#3)(2013-8#1)
Living-donor lobar lung transplantation##2##4##(2007-8#2)
Lixiscope examination##3##2##(1997-3#3)
Lixiscope##6##1##(1997-3#6)
Lizards from##2##2##(2008-8#2)
Lizards##4##1##(2008-10#1)(2008-8#2)(2010-3#1)
Ljubljana##2##1##(1994-5#1)(2008-11#1)
Lloyd##4##1##(2009-7#1)(2013-1#3)
Lloyd's mirror##2##2##(2007-12#2)
Lloyd's##3##1##(2007-12#2)(2008-10#1)
Lm##3##1##(1994-12#3)
Lmo2##5##1##(2008-9#5)
Ln##4##1##(1997-7#3)(2008-10#1)
LoVo##2##1##(1994-8#2)
Load increases##2##2##(2010-1#2)
Load##5##1##(2007-12#1)(2008-1#1)(2010-1#2)(2010-12#1)
Loading##7##1##(1992-6#1)(2008-10#2)(2008-4#1)(2010-11#1)(2010-7#1)(2013-1#1)
Lobar##2##1##(1997-8#1)(2012-2#1)
Lobbying##2##1##(1996-3#1)(2007-10#1)
Local Anesthesia##2##2##(2008-1#1)(2008-5#1)
Local Health##2##2##(1991-2#1)(2011-2#1)
Local and Systemic##2##3##(2008-10#2)
Local and##6##2##(1992-3#1)(1995-3#1)(2008-10#2)(2008-3#1)(2009-3#1)
Local and/or##2##2##(2008-10#1)(2012-3#1)
Local authorities##2##2##(1992-11#1)(1996-9#1)
Local capture##2##2##(2008-4#2)
Local control for##3##3##(2010-3#3)
Local control rates##3##3##(2007-11#1)(2008-6#1)(2010-3#1)
Local control##10##2##(1990-6#1)(1991-8#1)(2007-11#1)(2008-6#2)(2010-3#4)(2012-2#1)
Local factors##2##2##(2008-9#1)(2013-1#1)
Local foods##2##2##(1994-9#1)(2008-1#1)
Local hospital systems##3##3##(1992-12#3)
Local intra-arterial##2##2##(1994-11#1)(1997-6#1)
Local management##2##2##(2009-12#2)
Local recurrence##3##2##(1993-3#1)(1994-12#1)(2007-10#1)
Local recurrences##2##2##(2011-1#1)(2013-1#1)
Local##133##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-8#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#5)(2007-12#2)(2008-1#2)(2008-10#10)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#6)(2010-5#4)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
Localisation##2##1##(1993-12#1)(1993-5#1)
Localization and##5##2##(1992-11#2)(2008-3#1)(2009-12#1)(2012-3#1)
Localization of a##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
Localization of the##3##3##(1995-6#1)(2008-10#1)(2008-9#1)
Localization of##24##2##(1990-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
Localization performance##2##2##(2008-9#2)
Localization##31##1##(1990-8#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2012-3#1)
Localizations of bone metastases are as follow##2##7##(2007-11#2)
Localized and##2##2##(2009-11#1)(2009-9#1)
Localized heating##2##2##(2007-12#1)(2008-3#1)
Localized##14##1##(1992-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-3#2)(2009-11#1)(2009-9#1)(2011-1#1)(2012-3#1)
Locally##5##1##(1991-8#1)(2008-10#1)(2008-3#2)(2008-7#1)
Located##2##1##(2008-10#1)(2010-8#1)
Locating##4##1##(1995-1#1)(1996-1#1)(2008-11#1)(2008-3#1)
Location and##4##2##(1991-7#1)(1993-12#1)(1993-5#1)(2011-1#1)
Location in##2##2##(2008-10#1)(2012-2#1)
Location of##2##2##(2008-10#2)
Location##11##1##(1991-7#1)(1993-12#1)(1993-5#1)(2008-10#4)(2010-9#1)(2011-1#1)(2012-2#2)
Locations##4##1##(2008-10#3)(2008-7#1)
Loci conferring##2##2##(2008-10#2)
Loci for##7##2##(2008-10#6)(2013-8#1)
Loci in##4##2##(2008-10#3)(2012-3#1)
Loci##28##1##(2008-10#24)(2008-7#1)(2012-3#2)(2013-8#1)
Locked nucleic acids (LNAs) are RNA derivatives that have an O-methylene linkage between the 2 and 4 positions of the ribose##2##21##(2008-4#2)
Locked nucleic acids##3##3##(2008-4#3)
Locked##5##1##(2007-11#1)(2008-2#1)(2008-4#3)
Locking in##2##2##(2007-12#1)(2008-3#1)
Locking##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Locomotion##3##1##(2011-2#1)(2012-2#1)(2013-1#1)
Locomotor##8##1##(1993-12#1)(1993-6#1)(2007-11#2)(2007-8#1)(2008-5#3)
Locus in##2##2##(2008-10#2)
Locus of##2##2##(1993-11#1)(2008-10#1)
Locus##12##1##(1993-11#1)(2008-10#8)(2008-12#1)(2012-3#1)(2013-8#1)
Locusta migratoria##2##2##(1991-5#1)(1992-12#1)
Lodi##2##1##(2008-10#2)
Lodz##5##1##(2007-11#1)(2008-12#3)(2008-9#1)
Log TG/HDL-C ratio##4##3##(2008-3#4)
Log##11##1##(1997-7#1)(2007-10#1)(2008-10#2)(2008-3#6)(2008-6#1)
Log-Rank test)##2##2##(1996-9#2)
Log-rank##2##1##(2007-7#1)(2011-2#1)
LogMAR##2##1##(2013-1#2)
Logan Rep protein##3##3##(2008-10#3)
Logan##5##1##(2008-10#5)
Logging##2##1##(2008-5#1)(2008-7#1)
Logic##5##1##(2009-11#3)(2011-2#1)(2012-3#1)
Logistic regression analyses were performed to##2##6##(2007-10#1)(2008-3#1)
Logistic regression analyses were##4##4##(2007-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
Logistic regression analyses##5##3##(2007-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
Logistic regression analysis showed that##2##5##(2008-10#1)(2011-2#1)
Logistic regression analysis showed##3##4##(2008-10#2)(2011-2#1)
Logistic regression analysis was used to##2##6##(2011-1#1)(2013-1#1)
Logistic regression analysis was##3##4##(2011-1#2)(2013-1#1)
Logistic regression analysis##9##3##(1995-1#1)(2008-10#2)(2008-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-1#1)
Logistic regression models were used to##2##6##(2012-2#1)(2013-1#1)
Logistic regression models##7##3##(2008-10#3)(2012-2#1)(2012-3#2)(2013-1#1)
Logistic regression was used to##5##5##(2008-10#2)(2010-2#1)(2010-6#1)(2013-8#1)
Logistic regression was##7##3##(2007-12#1)(2008-10#2)(2009-5#1)(2010-2#1)(2010-6#1)(2013-8#1)
Logistic regression##31##2##(1994-11#1)(1995-1#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
Logistic##38##1##(1991-12#1)(1994-11#1)(1995-1#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-8#3)(2009-5#1)(2010-2#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
Logit##2##1##(1995-2#1)(2012-2#1)
Lola##3##1##(2012-12#3)
Lolium##4##1##(1996-5#1)(2008-10#3)
Loma Linda University##2##3##(1993-2#2)
Loma Linda##6##2##(1993-2#6)
Loma Prieta earthquake##3##3##(1990-11#2)(1992-12#1)
Loma Prieta##4##2##(1990-11#2)(1992-12#1)(1996-4#1)
Loma##10##1##(1990-11#2)(1992-12#1)(1993-2#6)(1996-4#1)
Lombardy##4##1##(1992-10#1)(1994-8#1)(2011-2#2)
London in##2##2##(1992-3#1)(2011-1#1)
London##69##1##(1990-9#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-8#7)(1997-1#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#14)(2008-12#7)(2008-4#1)(2008-5#10)(2008-7#2)(2008-9#1)(2009-10#1)(2010-1#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
London's##3##1##(1993-2#1)(1995-3#1)(2011-2#1)
London) were##2##2##(2008-10#1)(2008-11#1)
London)##5##1##(2008-10#1)(2008-11#4)
London]##3##1##(2008-11#2)(2008-12#1)
Loneliness##2##1##(2011-2#2)
Long Island##3##2##(1996-2#1)(2008-3#1)(2011-2#1)
Long Range##2##2##(1993-2#1)(1996-9#1)
Long Term Care##3##3##(1993-12#2)(1993-8#1)
Long Term##4##2##(1993-12#2)(1993-8#1)(2013-1#1)
Long bone osteomyelitis##2##3##(2010-6#2)
Long bone##3##2##(2010-6#2)(2011-2#1)
Long term care##5##3##(1992-12#1)(1992-2#1)(1993-1#1)(1996-3#1)(2008-7#1)
Long term results##2##3##(1991-6#1)(2007-11#1)
Long term##15##2##(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1996-3#1)(2007-11#1)(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
Long##65##1##(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#4)(2008-7#7)(2008-8#3)(2009-10#1)(2009-9#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Long(TM)R(3)IGF-I##2##1##(2008-11#2)
Long-Evans male rats##2##3##(1991-12#1)(2008-3#1)
Long-Evans rats##4##2##(1992-11#3)(1996-5#1)
Long-Evans##6##1##(1991-12#1)(1992-11#3)(1996-5#1)(2008-3#1)
Long-Term Care##5##2##(1991-1#1)(1993-3#1)(1995-3#1)(2011-2#1)(2013-7#1)
Long-Term##13##1##(1990-11#1)(1991-1#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#2)
Long-acting##2##1##(2008-11#1)(2009-9#1)
Long-distance##6##1##(1997-7#1)(2008-10#3)(2011-2#1)(2012-2#1)
Long-lived##2##1##(1992-12#1)(1995-2#1)
Long-period##2##1##(2007-11#1)(2007-12#1)
Long-pulse##2##1##(2008-2#2)
Long-range##3##1##(2007-8#1)(2008-2#1)(2010-4#1)
Long-term care and the##2##4##(1994-3#1)(1996-2#1)
Long-term care##7##2##(1992-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-1#2)
Long-term data##2##2##(2008-8#2)
Long-term effects of##4##3##(1996-2#1)(1996-7#1)(1997-1#1)(2010-10#1)
Long-term effects##5##2##(1996-2#1)(1996-7#1)(1997-1#1)(2010-10#1)(2012-3#1)
Long-term experience##2##2##(2008-10#1)(2008-3#1)
Long-term exposure##2##2##(2008-7#1)(2009-8#1)
Long-term follow-up is needed to##2##5##(2007-8#1)(2011-2#1)
Long-term follow-up is##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
Long-term follow-up##7##2##(1991-8#1)(1996-6#1)(2007-8#2)(2008-7#1)(2011-1#1)(2011-2#1)
Long-term food restriction##2##3##(1990-3#2)
Long-term home health care##2##4##(1995-1#1)(1996-12#1)
Long-term monitoring of##2##3##(2008-11#1)(2009-4#1)
Long-term mortality after##2##3##(1992-12#1)(1992-5#1)
Long-term mortality in patients after a British trial of anticoagulants in acute myocardial infarction##2##14##(1993-12#2)
Long-term mortality##5##2##(1992-12#1)(1992-5#1)(1993-12#2)(1993-2#1)
Long-term outcome of##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)
Long-term outcome##7##2##(1995-9#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-10#1)
Long-term potentiation (LTP)##2##3##(1993-12#1)(1997-2#1)
Long-term potentiation##5##2##(1990-8#1)(1993-12#1)(1993-5#1)(1997-2#1)(2008-7#1)
Long-term results of##5##3##(1993-11#1)(1993-9#1)(1995-9#1)(2007-8#1)(2008-11#1)
Long-term results with the##2##4##(1990-2#1)(2009-3#1)
Long-term results##9##2##(1990-2#1)(1993-11#1)(1993-9#1)(1995-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-3#1)
Long-term stability##2##2##(2008-10#1)(2008-5#1)
Long-term survival##2##2##(1996-2#1)(2008-7#1)
Long-term survivors##2##2##(2010-11#1)(2011-2#1)
Long-term treatment with##2##3##(1996-12#1)(2007-11#1)
Long-term##140##1##(1990-2#1)(1990-3#2)(1990-8#1)(1991-2#1)(1991-8#2)(1992-12#3)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#5)(1997-2#1)(1997-7#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)
Long-wavelength##3##1##(1992-11#1)(2007-11#1)(2008-3#1)
Longbow##2##1##(2008-10#2)
Longer##9##1##(1994-11#1)(1995-2#1)(1996-3#1)(2008-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
Longer-distance##2##1##(2008-10#2)
Longest##3##1##(2008-1#3)
Longevity and##2##2##(1994-3#1)(2008-10#1)
Longevity##6##1##(1992-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
Longhorn Array Database (LAD)##2##4##(2008-4#2)
Longissimus##5##1##(2010-4#5)
Longitudinal Data##2##2##(2008-8#1)(2009-8#1)
Longitudinal Study of##6##3##(2009-10#1)(2009-7#1)(2010-7#2)(2012-12#1)(2013-8#1)
Longitudinal Study##10##2##(2007-2#1)(2009-10#1)(2009-3#2)(2009-7#1)(2010-7#2)(2012-12#2)(2013-8#1)
Longitudinal associations between##2##3##(2010-2#1)(2012-2#1)
Longitudinal data were collected##2##4##(2010-1#1)(2013-1#1)
Longitudinal data##4##2##(2009-11#1)(2009-7#1)(2010-1#1)(2013-1#1)
Longitudinal patterns of##2##3##(1991-12#1)(2010-9#1)
Longitudinal studies##5##2##(1992-11#1)(1993-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
Longitudinal##40##1##(1991-12#1)(1991-5#1)(1992-11#1)(1993-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Longo##2##1##(2009-2#1)(2013-1#1)
Lonicera##2##1##(1994-11#1)(2008-9#1)
Lonidamine##3##1##(1990-6#2)(1991-2#1)
Look at##2##2##(1997-2#1)(2008-12#1)
Look##5##1##(1994-3#1)(1997-2#1)(2008-12#1)(2013-1#2)
Looking at the##2##3##(2008-11#1)(2010-5#1)
Looking at##5##2##(1993-5#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
Looking for##2##2##(1997-2#1)(1997-6#1)
Looking forward##5##2##(2010-12#1)(2012-12#1)(2012-2#3)
Looking##20##1##(1991-12#1)(1992-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
Loop##4##1##(1990-6#1)(1997-1#1)(2008-3#1)(2012-2#1)
Loop7 region##5##2##(2008-9#5)
Loop7##6##1##(2008-9#6)
Loose##2##1##(2013-1#2)
Loosening and##2##2##(2013-1#2)
Loosening##3##1##(1996-1#1)(2013-1#2)
Loperamide##2##1##(1990-3#1)(2013-1#1)
Lopez-Neyra##3##1##(2011-2#3)
Lor##2##1##(2008-12#2)
Lord##3##1##(2008-11#2)(2012-2#1)
Lorentz##3##1##(2008-2#2)(2008-3#1)
Lorentzian model##2##2##(2008-10#1)(2008-3#1)
Lorentzian##5##1##(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
Lorenz-Mie##12##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#8)
Lorestan province##2##2##(2008-12#2)
Lorestan##3##1##(2008-12#2)(2012-2#1)
Lori##7##1##(1994-8#1)(1995-3#1)(2008-12#5)
Los Alamos##2##2##(2008-2#1)(2013-1#1)
Los Angeles##13##2##(1991-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Los Mochis##2##2##(2008-10#2)
Los Petenes&quot##2##2##(2013-7#2)
Los##27##1##(1991-12#1)(1991-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#6)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#1)
Losartan and Valsartan##3##3##(2008-10#3)
Losartan##4##1##(2008-10#3)(2008-11#1)
Loss and##5##2##(1994-12#1)(2008-10#1)(2010-7#1)(2013-1#1)(2013-7#1)
Loss of the##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
Loss of##33##2##(1990-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)
Loss##53##1##(1990-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-6#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)
Losses were##2##2##(2008-10#1)(2008-2#1)
Losses##5##1##(2008-10#3)(2008-2#2)
Lost##4##1##(2008-9#1)(2009-5#1)(2013-1#2)
Lot##2##1##(1992-3#1)(2008-10#1)
Lotka-Volterra competition equations##2##3##(2008-10#1)(2008-8#1)
Lotka-Volterra equations##2##2##(2008-10#1)(2008-8#1)
Lotka-Volterra##11##1##(2008-10#2)(2008-8#7)(2013-8#2)
Lotus japonicus##2##2##(2009-8#1)(2011-2#1)
Louie##3##1##(1996-5#3)
Louie's##2##1##(1996-5#2)
Louis Guérette and Jean-Pierre Rodriguez##2##5##(2008-2#2)
Louis##12##1##(1992-8#1)(1994-1#1)(1995-12#2)(1996-5#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)
Louisiana##17##1##(1995-12#1)(1996-1#2)(1997-5#1)(2008-10#11)(2012-3#1)(2013-8#1)
Louisville##2##1##(2006-12#1)(2007-10#1)
Love waves##3##2##(2008-10#3)
Love##5##1##(1996-1#1)(1997-3#1)(2008-10#3)
Lovelace Health##3##2##(1996-1#1)(1996-12#2)
Lovelace##4##1##(1996-1#2)(1996-12#2)
Low Birth Weight##2##3##(2012-1#1)(2012-3#1)
Low CHO Diet##2##3##(2008-3#2)
Low CHO##3##2##(2008-3#3)
Low Cal##2##2##(2008-3#2)
Low Density Lipoprotein##2##3##(1992-12#1)(2008-10#1)
Low Dose##3##2##(1994-7#1)(2008-7#1)(2012-3#1)
Low Energy##2##2##(1996-12#1)(2008-10#1)
Low and##2##2##(1993-2#1)(1996-12#1)
Low anterior resection##2##3##(1990-9#1)(2007-8#1)
Low back pain##5##3##(1990-6#1)(1991-8#1)(1993-7#1)(2007-8#1)(2008-12#1)
Low concentrations of##8##3##(1990-12#1)(1990-7#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
Low concentrations##9##2##(1990-12#1)(1990-2#1)(1990-7#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
Low density lipoprotein receptor##2##4##(1991-2#1)(2008-8#1)
Low density lipoprotein##3##3##(1991-2#1)(1994-3#1)(2008-8#1)
Low detection limits##2##3##(2008-10#1)(2013-1#1)
Low detection##3##2##(2008-10#2)(2013-1#1)
Low dose##5##2##(2007-8#1)(2010-6#1)(2012-12#1)(2013-1#2)
Low doses of radiation##2##4##(2008-7#2)
Low doses of##6##3##(1991-1#1)(1995-8#1)(1995-9#1)(2008-7#2)(2008-8#1)
Low doses##9##2##(1991-1#1)(1992-11#1)(1995-8#1)(1995-9#1)(2008-7#3)(2008-8#1)(2013-1#1)
Low energy##2##2##(1992-8#1)(1992-9#1)
Low grade##2##2##(1994-12#1)(2011-3#1)
Low intensity##2##2##(1996-5#1)(2011-2#1)
Low level##3##2##(1990-3#1)(2008-12#1)(2010-5#1)
Low levels of##11##3##(1990-11#1)(1994-7#1)(1994-8#1)(1996-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
Low molecular weight heparin##4##4##(2007-10#2)(2008-10#1)(2008-3#1)
Low molecular weight##8##3##(1991-5#1)(1992-6#1)(1993-3#1)(2007-10#2)(2008-10#2)(2008-3#1)
Low perceived##2##2##(2009-11#1)(2011-2#1)
Low platelet##2##2##(2007-10#1)(2008-3#1)
Low population##2##2##(2008-10#1)(2012-7#1)
Low power##3##2##(2008-10#1)(2009-7#1)(2013-7#1)
Low risk##2##2##(2008-7#1)(2013-1#1)
Low serum##2##2##(2008-11#1)(2011-1#1)
Low sulphur##2##2##(2008-10#2)
Low temperature##2##2##(2008-10#1)(2009-8#1)
Low##158##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#3)(1993-7#1)(1994-12#2)(1994-3#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#4)(2007-11#2)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#25)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#1)
Low-Field##3##1##(2011-1#1)(2011-2#2)
Low-affinity##2##1##(1993-9#1)(1997-7#1)
Low-carbohydrate##2##1##(2007-2#1)(2008-3#1)
Low-coherence##2##1##(2007-11#1)(2008-3#1)
Low-cost##4##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
Low-density lipoprotein (7 micrograms/ml) induced##2##5##(1990-2#2)
Low-density lipoprotein receptor##2##3##(1990-2#2)
Low-density lipoprotein##8##2##(1990-2#7)(2010-12#1)
Low-density##9##1##(1990-2#8)(2010-12#1)
Low-dose aspirin##2##2##(1991-8#1)(1997-6#1)
Low-dose caffeine##2##2##(1991-1#2)
Low-dose##13##1##(1991-1#2)(1991-11#1)(1991-8#1)(1994-6#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-6#1)
Low-energy##2##1##(2008-7#1)(2012-2#1)
Low-frequency wavelength modulation spectroscopy##2##4##(2008-3#2)
Low-frequency##6##1##(2007-11#1)(2008-3#4)(2011-2#1)
Low-grade##2##1##(2008-7#1)(2013-8#1)
Low-income##3##1##(1995-9#1)(2009-5#1)(2012-3#1)
Low-level##3##1##(2008-10#3)
Low-loss##5##1##(2007-11#2)(2007-12#1)(2008-3#2)
Low-molecular-weight##2##1##(1990-11#1)(1997-8#1)
Low-noise##2##1##(2007-11#1)(2009-5#1)
Low-temperature##3##1##(2007-11#1)(2007-12#2)
Low-threshold##3##1##(1993-9#1)(2007-11#1)(2007-12#1)
Lowbush##2##1##(2008-10#2)
Lower Extremity##3##2##(1996-3#1)(2008-6#1)(2009-8#1)
Lower concentrations of##3##3##(2008-10#3)
Lower concentrations##6##2##(1990-3#1)(1991-5#1)(2008-10#4)
Lower extremity##3##2##(1995-8#1)(2008-7#1)(2009-12#1)
Lower gastrointestinal bleeding##2##3##(2011-2#1)(2013-1#1)
Lower levels of##2##3##(2008-3#1)(2012-2#1)
Lower limb##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
Lower##45##1##(1990-3#1)(1991-5#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
Lowered##2##1##(1994-2#1)(2013-7#1)
Lowering of##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
Lowering the##2##2##(1995-2#1)(2008-10#1)
Lowering##9##1##(1994-2#1)(1995-2#1)(2007-10#2)(2008-10#2)(2008-12#1)(2009-8#1)(2010-1#1)
Lowest detectable##2##2##(2008-10#2)
Lowest##5##1##(2008-10#3)(2008-12#1)(2011-2#1)
Lowland##2##1##(2008-10#1)(2012-2#1)
Lowry##11##1##(2007-2#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)
LoxP##2##1##(2008-9#2)
Lp##4##1##(2008-7#4)
Lp(a) concentration##5##2##(1991-12#1)(1995-2#1)(1996-8#3)
Lp(a) formation##2##2##(1995-6#2)
Lp(a) has##2##2##(2008-6#2)
Lp(a) in##2##2##(1991-12#1)(1996-8#1)
Lp(a) levels##6##2##(1991-12#3)(2008-6#3)
Lp(a) mass##2##2##(1995-2#2)
Lp(a) was##2##2##(1993-2#1)(1995-2#1)
Lp(a)##48##1##(1991-12#6)(1993-12#3)(1993-2#10)(1995-2#7)(1995-6#2)(1996-8#10)(2008-6#6)(2012-12#1)(2013-7#3)
Lr##2##1##(2008-10#2)
Lr10##4##1##(2008-10#4)
Lr13 and##3##2##(2008-10#3)
Lr13##4##1##(2008-10#4)
Lr16##2##1##(2008-10#2)
Lr23##7##1##(2008-10#7)
Lr26 virulent and##2##3##(2008-10#2)
Lr26 virulent##3##2##(2008-10#3)
Lr26##11##1##(2008-10#11)
Lr2a##3##1##(2008-10#3)
Lr3##2##1##(2008-10#2)
Lr34##12##1##(2008-10#12)
Lr34/Yr18##7##1##(2008-10#7)
Lr46 and##2##2##(2008-10#2)
Lr46##7##1##(2008-10#7)
Lrd1##3##1##(2008-10#3)
Ltd##90##1##(2008-10#1)(2008-11#38)(2008-2#1)(2008-5#5)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-2#6)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#10)
Ltd)##8##1##(1995-3#7)(2010-7#1)
Ltnα and##2##2##(2011-1#2)
Ltnα##3##1##(2011-1#3)
Ltnβ##3##1##(2011-1#3)
Lu##4##1##(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)
Lu(2)O(3)##4##1##(2010-4#4)
Lu(3+)##4##1##(2008-10#3)(2010-4#1)
Lu) in##2##2##(2008-10#1)(2010-4#1)
Lu)##4##1##(1997-7#1)(2008-10#2)(2010-4#1)
LuAG##2##1##(2008-3#2)
LuMA cells##5##2##(2008-11#5)
Lublin##7##1##(2007-11#3)(2007-8#4)
Lubricin and##2##2##(2010-10#2)
Lubricin##3##1##(2010-10#3)
Lucas##2##1##(2010-8#1)(2012-2#1)
Lucifer yellow##3##2##(1994-2#1)(1995-5#2)
Luciferase##2##1##(2008-10#1)(2010-5#1)
Luciferase-reporter##2##1##(2009-8#2)
Lucilia##2##1##(1997-7#1)(2008-2#1)
Luke##4##1##(1992-12#3)(2008-12#1)
Luke's Medical Center##2##3##(1994-1#1)(1994-3#1)
Luke's##6##1##(1991-3#1)(1992-12#1)(1993-5#1)(1994-1#1)(1994-3#1)(1997-2#1)
Lukosz's technique##2##2##(2008-3#2)
Lumbar disc##3##2##(2007-8#2)(2012-12#1)
Lumbar##13##1##(1991-11#1)(1993-6#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
Lumbosacral plexopathy##2##2##(2008-12#2)
Lumbosacral##3##1##(2008-12#3)
Lumigen##2##1##(2008-10#2)
Luminal A##2##2##(2010-12#2)
Luminal B##3##2##(2010-12#3)
Luminal subtype##2##2##(2010-12#2)
Luminal##8##1##(2010-12#8)
Luminescence##8##1##(1996-9#1)(2008-11#1)(2008-2#3)(2010-1#1)(2012-12#1)(2012-2#1)
Luminescent##2##1##(2008-10#1)(2008-2#1)
Luna##2##1##(2008-10#2)
Lunar##5##1##(2008-8#3)(2010-3#1)(2010-8#1)
Lund##2##1##(2007-12#1)(2008-3#1)
Lunella coronatus and##2##3##(1997-4#2)
Lung Cancer##29##2##(1996-8#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#20)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
Lung Disease##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
Lung Institute##2##2##(2008-5#2)
Lung Transplantation Group Groningen]##2##4##(1996-6#2)
Lung Transplantation##3##2##(1996-6#2)(2011-3#1)
Lung cancer is the##2##4##(2011-3#1)(2012-1#1)
Lung cancer##9##2##(1990-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)
Lung damage and##2##3##(1995-11#1)(1995-3#1)
Lung function tests##2##3##(2006-10#1)(2008-7#1)
Lung function##4##2##(1997-1#1)(2006-10#1)(2008-7#1)(2011-2#1)
Lung metastases##2##2##(2008-6#1)(2010-3#1)
Lung transplantation is##3##3##(2007-8#1)(2011-3#2)
Lung transplantation##6##2##(2007-8#1)(2008-1#1)(2011-3#4)
Lung##96##1##(1990-12#1)(1992-12#2)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#2)(1996-6#2)(1996-8#1)(1997-1#1)(2006-10#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#24)(2011-1#1)(2011-2#5)(2011-3#7)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Lupinus albus##2##2##(2008-10#1)(2008-12#1)
Lupinus##5##1##(1990-5#3)(2008-10#1)(2008-12#1)
Lupus nephritis was the commonest##2##5##(2007-7#1)(2008-1#1)
Lupus nephritis##5##2##(2007-7#1)(2008-1#4)
Lupus##11##1##(1994-1#1)(2006-10#1)(2007-7#2)(2008-1#5)(2011-2#1)(2012-12#1)
Luria-Bertani##2##1##(2009-6#1)(2013-7#1)
Lushene##3##1##(1995-12#2)(2010-6#1)
Luteinizing##2##1##(2008-4#1)(2008-7#1)
Luteoviridae##3##1##(2008-10#3)
Luteovirus##2##1##(2008-10#2)
Lutjanus##2##1##(2008-5#1)(2010-8#1)
Lutzomyia cruzi##3##2##(2007-12#3)
Lutzomyia##10##1##(2007-12#9)(2008-8#1)
LuxA##2##1##(2008-11#2)
LuxS from Streptococcus suis serotype 2##2##6##(2009-6#2)
LuxS##5##1##(2009-6#5)
Luyksgestel##2##1##(1992-12#2)
Ly-49##4##1##(1995-2#4)
Ly-49+ NK cells##3##3##(1995-2#3)
Ly-49+ subset##2##2##(1995-2#2)
Ly-49+##6##1##(1995-2#6)
Lyapunov exponent##2##2##(2008-9#1)(2010-8#1)
Lyapunov##3##1##(2008-9#2)(2010-8#1)
Lyase##3##1##(2008-10#2)(2008-4#1)
Lycopersicon esculentum##5##2##(1993-12#1)(2008-10#4)
Lycopersicon hirsutum##5##2##(2008-10#5)
Lycopersicon##12##1##(1993-12#1)(2008-10#11)
Lygus##5##1##(2007-12#2)(2011-2#3)
Lykken##2##1##(2009-9#2)
Lykken's theory of primary psychopathy##2##5##(2009-9#2)
Lykken's theory##3##2##(2009-9#3)
Lykken's##4##1##(2009-9#4)
Lyman##4##1##(2008-2#1)(2008-3#3)
Lyman- alpha##2##2##(2007-12#2)
Lyman-alpha image##2##2##(1991-8#2)
Lyman-alpha line##2##2##(2008-2#2)
Lyman-alpha##5##1##(1991-8#2)(2007-12#1)(2008-2#2)
Lymantria dispar##2##2##(2010-11#2)
Lymantriidae##2##1##(2007-12#2)
Lyme Disease##2##2##(2008-10#1)(2008-11#1)
Lyme borreliosis is##2##3##(2008-10#1)(2012-2#1)
Lyme borreliosis##9##2##(1991-11#2)(1994-6#2)(2008-10#4)(2012-2#1)
Lyme disease by##2##3##(1997-3#1)(2010-6#1)
Lyme disease risk##2##3##(2008-11#2)
Lyme disease##33##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1997-3#10)(1997-4#3)(1997-7#2)(2007-12#2)(2008-10#1)(2008-11#3)(2008-8#2)(2008-9#2)(2010-6#2)(2011-1#1)(2013-8#1)
Lyme##49##1##(1990-2#1)(1991-11#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1994-6#2)(1996-8#1)(1997-3#10)(1997-4#3)(1997-7#3)(2007-12#2)(2008-10#6)(2008-11#4)(2008-8#2)(2008-9#2)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Lymnaea##2##1##(2008-12#1)(2012-2#1)
Lymph Node##5##2##(2008-10#2)(2008-11#1)(2012-12#2)
Lymph node##4##2##(1990-2#1)(2007-8#1)(2008-11#1)(2010-11#1)
Lymph nodes were##2##3##(1994-12#1)(2008-10#1)
Lymph nodes##4##2##(1994-12#1)(2008-10#1)(2011-2#2)
Lymph##14##1##(1990-2#1)(1994-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2010-11#1)(2011-2#2)(2012-12#2)
Lymphangioma##2##1##(2013-1#2)
Lymphangitic##2##1##(1991-2#2)
Lymphatic##2##1##(2008-1#2)
Lymphedema of the hand##2##4##(2009-3#2)
Lymphedema##3##1##(2009-3#2)(2011-1#1)
Lymphocyte##5##1##(1995-12#1)(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
Lymphocytes from##3##2##(1997-6#2)(2008-7#1)
Lymphocytes were##2##2##(1995-12#1)(2013-1#1)
Lymphocytes##11##1##(1990-7#1)(1991-6#1)(1995-12#1)(1997-6#2)(2008-7#2)(2008-8#2)(2013-1#2)
Lymphoid##4##1##(1995-8#1)(1997-1#1)(2008-11#1)(2013-1#1)
Lymphoma and Myeloma##2##3##(2010-11#2)
Lymphoma##13##1##(1992-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
Lymphomas##2##1##(1992-2#1)(2009-8#1)
Lyn##5##1##(1995-11#1)(1995-6#3)(2009-6#1)
Lyncei##2##1##(2010-1#2)
Lynch syndrome##4##2##(2011-2#1)(2012-3#3)
Lynch##7##1##(2008-10#1)(2011-2#2)(2012-3#4)
Lyon##6##1##(2008-10#2)(2009-3#1)(2009-4#2)(2011-2#1)
Lyons score##2##2##(1994-3#2)
Lyons##5##1##(1994-3#2)(1995-6#1)(2009-7#2)
Lyprinol(R)##4##1##(2008-10#4)
Lys and##2##2##(1997-3#1)(2011-2#1)
Lys at##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
Lys in##3##2##(1990-5#1)(1992-3#1)(1993-12#1)
Lys residues##3##2##(1990-2#1)(1995-6#1)(2008-4#1)
Lys##25##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#2)(1992-3#2)(1992-8#3)(1992-9#1)(1993-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#3)
Lys) were##2##2##(1990-2#1)(1990-8#1)
Lys)##3##1##(1990-2#1)(1990-8#1)(2006-12#1)
Lys- Pro-##2##2##(1991-5#2)
Lys-##3##1##(1991-5#3)
Lys-122 and Arg-125##2##3##(1994-6#2)
Lys-122##3##1##(1994-6#3)
Lys-21 and##2##2##(1992-6#2)
Lys-82 beta##2##2##(1993-8#2)
Lys-C##4##1##(1990-7#1)(1992-8#2)(1995-2#1)
Lys214##3##1##(1992-3#3)
Lys358##2##1##(1993-11#2)
Lys37p##2##1##(1995-3#2)
LysK##6##1##(2009-6#6)
Lysholm and##3##2##(2011-2#1)(2013-1#2)
Lysholm scale##2##2##(2013-1#2)
Lysholm##9##1##(2011-2#2)(2013-1#7)
Lysine##3##1##(1994-8#1)(2008-11#2)
Lysiphlebus testaceipes (Cresson) and Aphidius colemani Viereck##2##7##(2008-6#2)
Lysiphlebus testaceipes##4##2##(2008-6#2)(2013-8#2)
Lysis of##2##2##(1996-1#1)(2013-1#1)
Lysobacter enzymogenes Strain C3##2##4##(2008-10#2)
Lysobacter enzymogenes##4##2##(2008-10#4)
Lysophosphatidic acid (LPA)##2##3##(2010-3#2)
Lysophosphatidylcholine##2##1##(1995-3#1)(2008-8#1)
Lysosomal##5##1##(1991-12#1)(1992-12#1)(1993-12#1)(1995-6#1)(2010-8#1)
Lysosomes##3##1##(1992-12#2)(2008-7#1)
Lysozyme##2##1##(2008-10#1)(2008-7#1)
Lyticase##2##1##(2008-4#1)(2013-1#1)
M (0##5##2##(2008-10#5)
M (H##3##2##(2008-10#3)
M (IgM)##2##2##(1996-12#1)(2008-7#1)
M (r=0##2##2##(2008-10#2)
M 5-sulfaminouracil##2##2##(2008-10#2)
M = Mn##2##3##(2008-10#1)(2009-11#1)
M =##16##2##(1994-11#2)(1994-5#2)(1996-2#2)(1996-4#2)(1997-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#2)
M CFZ##2##2##(2008-10#2)
M Ca(2+)##2##2##(2008-10#2)
M CaCl2##2##2##(1990-7#1)(1992-11#1)
M Co(NH(3))(6)Cl(3)##2##2##(2008-10#2)
M Fe(III)##2##2##(2008-10#2)
M GdnHCl##3##2##(1992-6#3)
M GnRH##2##2##(1993-11#2)
M H(2)SO(4) and##2##3##(2008-10#2)
M H(2)SO(4) solution##2##3##(2008-10#1)(2009-10#1)
M H(2)SO(4)##10##2##(2008-10#9)(2009-10#1)
M H2O2##3##2##(1992-12#3)
M H2SO4##3##2##(1991-7#3)
M HCl and##2##3##(2008-10#2)
M HCl as##2##3##(2008-10#2)
M HCl for##3##3##(2008-10#3)
M HCl or##4##3##(1997-2#1)(2008-10#3)
M HCl##23##2##(1997-2#1)(2008-10#22)
M HCl) as##2##3##(2008-10#2)
M HCl)##8##2##(1993-12#1)(2008-10#7)
M HNO(3) and##4##3##(2008-10#4)
M HNO(3) for##3##3##(2008-10#3)
M HNO(3)##18##2##(2008-10#18)
M KCl and##3##3##(1993-8#1)(2008-10#2)
M KCl##9##2##(1990-8#1)(1992-11#1)(1993-8#2)(2008-10#5)
M KNO(3)##3##2##(2008-10#3)
M Na(2)CO(3) and##2##3##(2008-10#2)
M Na+ concentration##2##3##(1995-2#2)
M NaCl and##3##3##(1990-11#1)(1995-6#1)(2008-10#1)
M NaCl at##2##3##(1994-5#1)(2008-10#1)
M NaCl##38##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#2)(1994-5#1)(1995-6#2)(1996-5#2)(1997-2#2)(2008-10#10)(2008-11#1)(2011-2#1)
M NaCl)##5##2##(1992-8#1)(1994-8#2)(1995-2#1)(2008-6#1)
M NaOH solution##5##3##(2008-10#4)(2008-11#1)
M NaOH##11##2##(1995-6#1)(2008-10#8)(2008-11#1)(2008-6#1)
M Pb(II)##4##2##(2008-10#4)
M RA##7##2##(1993-9#7)
M RNA of WSMV##3##4##(2008-10#3)
M RNA##6##2##(2008-10#6)
M Tris-HCl##2##2##(1990-2#1)(1990-8#1)
M acetic acid##4##3##(1992-11#1)(1994-8#1)(2008-10#2)
M acid##4##2##(2008-10#4)
M after##4##2##(1992-8#1)(1996-3#1)(2008-10#2)
M amazonicum##2##2##(2013-7#2)
M ammonium acetate##2##3##(2008-10#2)
M ammonium##3##2##(2008-10#3)
M and 0##8##3##(1993-12#1)(2008-10#7)
M and S RNAs##2##4##(2008-10#2)
M and S##3##3##(2008-10#2)(2013-8#1)
M and a##3##3##(1991-8#1)(2008-10#2)
M and for##3##3##(2008-10#3)
M and the##4##3##(2008-10#4)
M and##49##2##(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-4#1)(2007-8#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
M aqueous##3##2##(2007-11#1)(2008-10#2)
M at 25 degrees C##4##5##(2008-10#4)
M at##8##2##(1991-11#1)(2008-10#7)
M avium##2##2##(2007-12#1)(2008-11#1)
M by##2##2##(2008-10#2)
M can be##2##3##(2008-10#2)
M concentration range##3##3##(2008-10#3)
M concentration##5##2##(1993-3#1)(2008-10#3)(2010-12#1)
M could##2##2##(2008-10#1)(2008-8#1)
M ethanol##3##2##(1990-12#1)(1992-6#2)
M for I##2##3##(2008-10#2)
M for II and 2x10(-7)##2##5##(2008-10#2)
M for III##2##3##(2008-10#2)
M for SPME and##2##4##(2008-10#2)
M for##33##2##(1990-5#1)(1993-11#1)(1993-9#1)(2008-10#30)
M genotypes were##2##3##(2008-10#2)
M genotypes##4##2##(2008-10#4)
M guanidine##3##2##(1992-3#1)(1993-6#1)(2008-10#1)
M holograms##3##2##(2007-12#3)
M hydrochloric acid and##3##4##(2008-10#3)
M hydrochloric acid##11##3##(2008-10#11)
M hydrochloric##12##2##(2008-10#12)
M hyopneumoniae##2##2##(1992-5#2)
M in 0##2##3##(2008-10#2)
M in the presence of##2##5##(2008-10#2)
M in the##5##3##(1990-5#1)(2008-10#4)
M in##16##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-6#1)(2008-10#11)
M ionic strength##3##3##(2008-10#3)
M is##5##2##(1994-11#1)(1995-6#1)(2007-11#1)(2009-12#1)(2013-1#1)
M layer##2##2##(2007-12#2)
M level##4##2##(1994-9#1)(2008-10#3)
M matrix##3##2##(2008-3#3)
M methanol##2##2##(1992-6#2)
M model##2##2##(2008-10#2)
M mucosal concentration##2##3##(2010-12#2)
M nitric acid##4##3##(2008-10#4)
M of Cs(+)##2##3##(2008-10#2)
M of somatostatin##3##3##(1997-4#3)
M of##20##2##(1997-4#4)(2007-12#1)(2008-10#14)(2008-11#1)
M on##2##2##(1994-11#1)(1995-6#1)
M or greater than##2##4##(1997-4#2)
M or greater##5##3##(1990-10#1)(1994-5#2)(1997-4#2)
M or##9##2##(1990-10#1)(1990-5#1)(1994-5#3)(1997-4#3)(2008-10#1)
M pH##3##2##(2008-10#3)
M patients##3##2##(2012-3#3)
M phosphate buffer##5##3##(1992-10#1)(2008-10#4)
M phosphate##8##2##(1992-10#1)(1997-7#1)(2008-10#6)
M phosphoric acid medium##2##4##(2008-10#2)
M potassium dihydrogen phosphate##2##4##(2008-10#1)(2010-3#1)
M potassium##5##2##(2008-10#4)(2010-3#1)
M protein in the serum##2##5##(2008-7#2)
M protein in##4##3##(2008-7#4)
M protein##6##2##(1997-4#1)(2007-8#1)(2008-7#4)
M proteins##3##2##(1997-4#1)(2008-5#2)
M quinine##3##2##(1992-11#2)(1993-12#1)
M range##2##2##(2008-10#2)
M series##2##2##(2010-9#2)
M sodium acetate buffer at pH##2##6##(2008-10#2)
M sodium borate##3##3##(1990-3#3)
M sodium chloride##3##3##(1992-10#1)(1993-12#1)(2008-10#1)
M sodium hydroxide solution##2##4##(2008-10#2)
M sodium##17##2##(1990-3#3)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1996-5#1)(2008-10#9)
M strains##2##2##(2013-1#2)
M sucrose##6##2##(1990-11#1)(1992-11#1)(1993-12#2)(2008-10#1)(2008-11#1)
M sulfadiazine##2##2##(2008-10#2)
M sulfamethazine##2##2##(2008-10#2)
M sulfamethoxazole##2##2##(2008-10#2)
M sulfasalazine##2##2##(2008-10#2)
M sulfathiazole##2##2##(2008-10#2)
M sulphuric acid##2##3##(2008-10#2)
M to##10##2##(1995-3#1)(1997-2#2)(1997-4#5)(2008-10#2)
M total iron(III)##2##3##(2008-10#2)
M urea##10##2##(1991-9#1)(1992-3#1)(1995-11#1)(1995-2#2)(1995-5#1)(2008-10#3)(2009-3#1)
M using##2##2##(2008-10#2)
M was achieved##2##3##(2008-10#2)
M was##6##2##(1994-3#1)(1997-4#1)(2008-10#4)
M were achieved##2##3##(2008-10#2)
M with a Nernstian slope of 59##2##7##(2008-10#2)
M with a detection limit of 1##3##7##(2008-10#3)
M with a detection limit of 2##3##7##(2008-10#3)
M with a detection limit of##10##6##(2008-10#10)
M with a response time##2##5##(2008-10#2)
M with a##18##3##(2008-10#18)
M with and##2##3##(1991-5#2)
M with correlation##2##3##(2008-10#2)
M with electrode II##2##4##(2008-10#2)
M with the##2##3##(1997-7#1)(2008-10#1)
M with##34##2##(1991-5#2)(1997-7#1)(2007-12#1)(2008-10#28)(2008-5#1)(2010-4#1)
M without BSA##2##3##(1991-5#2)
M##1725##1##(1990-10#4)(1990-11#6)(1990-12#10)(1990-2#2)(1990-3#3)(1990-5#13)(1990-6#1)(1990-7#5)(1990-8#8)(1991-10#2)(1991-11#4)(1991-12#4)(1991-3#2)(1991-5#10)(1991-7#3)(1991-8#9)(1991-9#5)(1992-1#2)(1992-10#6)(1992-11#12)(1992-12#9)(1992-2#1)(1992-3#9)(1992-5#4)(1992-6#21)(1992-8#6)(1992-9#1)(1993-11#13)(1993-12#14)(1993-2#4)(1993-3#11)(1993-6#4)(1993-8#9)(1993-9#9)(1994-1#5)(1994-11#10)(1994-12#4)(1994-2#4)(1994-3#7)(1994-5#16)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#5)(1995-11#6)(1995-12#10)(1995-2#25)(1995-3#2)(1995-5#7)(1995-6#23)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#8)(1996-3#5)(1996-4#4)(1996-5#6)(1996-9#1)(1997-2#12)(1997-3#12)(1997-4#21)(1997-6#2)(1997-7#5)(1997-8#2)(2007-11#6)(2007-12#15)(2007-2#1)(2007-7#6)(2007-8#7)(2008-1#5)(2008-10#881)(2008-11#26)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#43)(2008-6#35)(2008-7#19)(2008-8#4)(2008-9#23)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#3)(2010-10#6)(2010-12#4)(2010-2#6)(2010-3#4)(2010-4#13)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#13)(2010-9#3)(2011-1#2)(2011-10#6)(2011-2#36)(2011-3#1)(2011-6#1)(2012-12#3)(2012-2#16)(2012-3#22)(2013-1#19)(2013-7#5)(2013-8#2)
M#ENTITYSTARTX000E9##2##1##(2011-2#2)
M(-)(1) s(-)(1))##2##2##(1996-5#2)
M(-1) and##2##2##(2008-8#2)
M(-1) cm(-1)##2##2##(2008-10#2)
M(-1) for the##4##3##(2008-10#4)
M(-1) for##10##2##(2008-10#9)(2009-8#1)
M(-1) s(-1)##3##2##(1997-7#1)(2008-10#2)
M(-1)##29##1##(1997-7#1)(2007-11#1)(2008-10#21)(2008-11#1)(2008-8#4)(2009-8#1)
M(-1)s(-1))##3##1##(2007-11#3)
M(1) and##3##2##(2007-11#1)(2008-11#1)(2010-5#1)
M(1)##7##1##(2007-11#1)(2008-11#1)(2010-5#1)(2011-2#4)
M(2) = 1##3##3##(2007-11#1)(2008-12#1)(2008-2#1)
M(2) =##6##2##(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#1)
M(2) approximately 1##2##3##(2007-11#1)(2007-12#1)
M(2) approximately##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
M(2) of##3##2##(2007-12#1)(2008-3#2)
M(2) value##2##2##(2007-12#1)(2008-3#1)
M(2)##35##1##(2007-11#5)(2007-12#6)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#9)
M(2))##2##1##(2008-10#1)(2008-3#1)
M(2)L##2##1##(2008-10#2)
M(2+)##3##1##(2008-10#3)
M(3))##2##1##(2008-10#2)
M(II) = Mn##2##3##(1996-2#2)
M(II) =##3##2##(1996-2#3)
M(VOPO(4))(2)##3##1##(1997-7#3)
M(n) (GPC) =##2##3##(2008-12#2)
M(n)##5##1##(2008-12#5)
M(r) 66##4##2##(1994-5#4)
M(r) =##3##2##(1992-9#1)(1994-2#1)(1995-11#1)
M(r) of approximately##2##3##(1994-12#1)(2012-3#1)
M(r) of the##2##3##(1992-8#1)(1994-9#1)
M(r) of##19##2##(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-10#2)(2012-3#1)
M(r)##42##1##(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#5)(1994-2#2)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-2#4)(2008-10#2)(2010-4#1)(2012-3#1)
M(sum)##5##1##(2013-1#5)
M) alone##2##2##(1994-11#1)(2008-4#1)
M) and##9##2##(1990-7#1)(1991-5#1)(1993-6#1)(1995-12#2)(2008-10#4)
M) appeared to##2##3##(1995-12#2)
M) at##3##2##(1990-5#1)(1990-8#1)(1997-2#1)
M) concentrations of##2##3##(1996-2#2)
M) concentrations##3##2##(1992-5#1)(1996-2#2)
M) did not##3##3##(1997-4#2)(1997-7#1)
M) for##2##2##(2008-10#1)(2008-11#1)
M) in##2##2##(1995-12#1)(2008-10#1)
M) inhibited##3##2##(1995-12#1)(1995-6#1)(2008-11#1)
M) is##2##2##(1995-12#1)(2008-10#1)
M) of##3##2##(1990-7#1)(1995-12#1)(2008-10#1)
M) was used##2##3##(2008-10#2)
M) was##6##2##(2008-10#3)(2008-4#3)
M) were##2##2##(1993-6#1)(2008-10#1)
M) with a Nernstian slope of##2##6##(2008-10#2)
M) with a limit of detection of##2##7##(2008-10#2)
M) with a slope of##3##5##(2008-10#3)
M) with a##8##3##(2008-10#8)
M) with##9##2##(1995-12#1)(2008-10#8)
M)##137##1##(1990-12#2)(1990-5#3)(1990-7#5)(1990-8#2)(1991-5#5)(1991-9#1)(1992-5#3)(1992-6#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#5)(1994-6#1)(1995-12#29)(1995-5#2)(1995-6#1)(1996-2#5)(1996-5#2)(1997-2#2)(1997-4#8)(1997-7#3)(2007-8#1)(2008-10#38)(2008-11#3)(2008-4#6)(2008-6#1)(2009-12#1)(2010-4#1)
M+TTH##3##1##(2012-3#3)
M-1 and##4##2##(1992-10#1)(1994-5#2)(1995-2#1)
M-1 min-1 for binding to##2##5##(1993-1#2)
M-1 min-1##3##2##(1993-1#3)
M-1 s-1 at##2##3##(1993-8#1)(1994-5#1)
M-1 s-1##5##2##(1993-8#1)(1994-5#3)(1997-2#1)
M-1##24##1##(1990-11#1)(1991-12#1)(1992-10#2)(1993-1#3)(1993-8#3)(1994-5#5)(1995-2#8)(1997-2#1)
M-1)##5##1##(1991-8#1)(1992-4#3)(1994-8#1)
M-201##2##1##(2008-10#2)
M-CSF gene##2##2##(1991-5#1)(1994-6#1)
M-CSF production##2##2##(1990-5#1)(2008-11#1)
M-CSF##15##1##(1990-5#2)(1991-5#6)(1994-6#5)(2008-11#1)(2008-8#1)
M-FISH was##2##2##(2010-1#2)
M-FISH##7##1##(2008-1#4)(2010-1#3)
M-O7e cells##2##2##(2008-4#2)
M-O7e##3##1##(2008-4#3)
M-estimators##3##1##(2008-10#2)(2009-9#1)
M-profile fiber laser##3##3##(2007-12#1)(2008-2#2)
M-profile fiber##4##2##(2007-12#2)(2008-2#2)
M-type##2##1##(2008-2#2)
M/###9##1##(2007-11#3)(2007-12#2)(2008-3#4)
M/2##2##1##(1991-5#1)(2007-11#1)
M/E ratio##3##2##(2008-10#3)
M/F ratio##3##2##(2008-1#3)
M/Fe mole ratio of##2##4##(2008-10#2)
M/Fe mole ratio##3##3##(2008-10#3)
M/Ms were##2##2##(1991-2#2)
M/Ms##5##1##(1991-2#5)
M0)##2##1##(2008-4#2)
M1 and M2##7##3##(1990-2#2)(1992-10#2)(1992-8#1)(1996-5#1)(1997-7#1)
M1 and##12##2##(1990-2#2)(1992-10#2)(1992-8#1)(1996-5#1)(1997-3#2)(1997-7#1)(2008-10#1)(2008-12#1)(2008-9#1)
M1 stimulation##2##2##(2011-2#2)
M1##55##1##(1990-2#5)(1992-10#3)(1992-2#1)(1992-8#1)(1993-9#1)(1994-9#5)(1996-5#1)(1997-2#1)(1997-3#6)(1997-7#1)(2008-10#7)(2008-12#5)(2008-9#1)(2011-2#4)(2012-2#1)(2013-1#9)(2013-8#3)
M1/M2##4##1##(1992-8#1)(2007-10#1)(2013-1#2)
M10##2##1##(1993-8#2)
M11 delta##3##2##(1993-8#3)
M11##5##1##(1993-8#4)(2008-10#1)
M13 and##2##2##(1997-4#1)(2008-10#1)
M13##9##1##(1990-5#1)(1994-12#3)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)
M13mp19##2##1##(1990-7#1)(1995-12#1)
M16##2##1##(2008-10#2)
M170A##3##1##(2012-2#3)
M2 and M5##3##3##(1997-3#3)
M2 and##8##2##(1992-10#1)(1995-12#3)(1997-3#4)
M2 mRNA##2##2##(1990-2#1)(1992-10#1)
M2 macrophages##2##2##(2012-2#2)
M2 muscarinic##2##2##(1992-3#1)(2010-4#1)
M2 receptor##2##2##(1992-8#1)(1995-12#1)
M2 receptor-mediated##2##2##(1995-12#2)
M2 receptors##6##2##(1990-5#1)(1995-12#4)(1997-7#1)
M2##46##1##(1990-2#5)(1990-5#2)(1992-10#3)(1992-3#1)(1992-8#3)(1994-9#5)(1995-12#11)(1996-5#1)(1997-3#5)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2010-4#1)(2012-2#2)
M2(D)##4##1##(2008-8#4)
M2)##3##1##(1990-5#1)(1997-3#1)(2008-10#1)
M2+##3##1##(1991-8#3)
M2-muscarinic receptors##2##2##(1997-2#1)(2011-2#1)
M2-muscarinic##3##1##(1997-2#2)(2011-2#1)
M24 protein##2##2##(1996-12#2)
M3 and##2##2##(1991-2#1)(2007-10#1)
M3 or M4##2##3##(1997-7#2)
M3 receptors##6##2##(1995-12#3)(1997-7#3)
M3##18##1##(1990-8#5)(1991-2#1)(1995-12#4)(1996-4#1)(1997-7#5)(2007-10#1)(2011-2#1)
M344 could##4##2##(2010-6#4)
M344 is a potent##2##4##(2010-6#2)
M344 is##3##2##(2010-6#3)
M344##10##1##(2010-6#10)
M3Ad##5##1##(1990-8#5)
M4 and M5##2##3##(1991-2#1)(2008-11#1)
M4 from##2##2##(2008-8#1)(2008-9#1)
M4 in##2##2##(2008-8#2)
M4##18##1##(1991-2#1)(1997-7#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-8#5)(2008-9#3)
M4-TNF##2##1##(1997-2#2)
M4/m4 receptors##2##2##(1997-7#2)
M41##5##1##(1997-6#2)(2007-6#1)(2008-5#2)
M41)##2##1##(2007-6#1)(2008-5#1)
M44##2##1##(1995-6#2)
M5 and##2##2##(1991-2#1)(1997-3#1)
M5##10##1##(1991-2#2)(1997-3#4)(2008-10#1)(2008-11#1)(2008-5#2)
M6##7##1##(1991-2#1)(1997-7#2)(2008-10#2)(2008-5#2)
M7##3##1##(1995-12#2)(2008-10#1)
M79 is##2##2##(2008-8#2)
M79##9##1##(2008-8#9)
M8##7##1##(1992-8#3)(2008-10#3)(2008-9#1)
M9 delta##2##2##(1993-8#2)
M9##3##1##(1993-8#3)
M</ForeName>##3##1##(1994-5#1)(2013-8#2)
MA and the##2##3##(1990-8#1)(2008-3#1)
MA and##6##2##(1990-8#1)(1994-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
MA is the##2##3##(2011-1#2)
MA is##4##2##(2011-1#3)(2012-3#1)
MA were##2##2##(1997-4#1)(2013-1#1)
MA##49##1##(1990-8#4)(1991-12#1)(1992-4#1)(1994-2#9)(1995-11#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-1#1)(2011-1#3)(2012-3#3)(2013-1#2)(2013-8#3)
MA(2)##3##1##(2008-10#3)
MA) is##2##2##(2008-11#1)(2013-1#1)
MA)##5##1##(2008-10#1)(2008-11#1)(2013-1#3)
MAA##2##1##(2008-10#1)(2008-5#1)
MAC genome##5##2##(2012-3#5)
MAC##14##1##(2007-12#2)(2008-10#1)(2008-4#2)(2008-5#2)(2011-2#1)(2012-3#6)
MAC-1##2##1##(1994-6#2)
MACE##2##1##(2008-3#2)
MAD##3##1##(2008-9#3)
MAD-3##2##1##(1991-7#2)
MADRS##5##1##(2008-6#2)(2012-3#3)
MADS box gene##5##3##(1997-2#2)(1997-8#1)(2008-8#2)
MADS box genes that encode regulatory proteins##2##7##(1997-2#1)(1997-8#1)
MADS box genes that##3##4##(1997-2#1)(1997-8#2)
MADS box genes##4##3##(1997-2#1)(1997-8#2)(2008-8#1)
MADS box##13##2##(1997-2#3)(1997-8#3)(2008-8#6)(2009-8#1)
MADS domain##2##2##(1997-2#1)(1997-8#1)
MADS##16##1##(1997-2#5)(1997-8#4)(2008-8#6)(2009-8#1)
MADS-box##6##1##(2008-8#2)(2009-8#4)
MAE of##3##2##(2008-10#3)
MAE##9##1##(2008-10#8)(2008-11#1)
MAF##7##1##(2010-11#2)(2011-1#5)
MAG = 3but##2##3##(1993-8#2)
MAGE##6##1##(2009-11#2)(2012-4#1)(2012-5#3)
MAGE-A antigens##2##2##(2011-2#2)
MAGE-A4##3##1##(2011-2#3)
MAGGY##2##1##(2008-10#2)
MAGNITUDE##2##1##(2009-6#1)(2010-4#1)
MAIN OUTCOME MEASURES##2##3##(2012-12#2)
MAIN##6##1##(1992-11#1)(1992-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
MAIS scores post-implantation##2##3##(2011-1#2)
MAIS scores##3##2##(2011-1#2)(2012-2#1)
MAL500##2##1##(2008-9#2)
MALDI TOF MS##3##3##(2012-3#3)
MALDI mass spectrometry##2##3##(2010-7#1)(2012-1#1)
MALDI##6##1##(2008-10#1)(2010-7#1)(2012-1#1)(2012-3#3)
MALDI-MS##2##1##(2008-7#1)(2010-11#1)
MALDI-TOF MS##2##2##(2008-10#1)(2010-12#1)
MALDI-TOF mass spectrometry##5##3##(1995-11#1)(2008-10#2)(2009-2#1)(2010-8#1)
MALDI-TOF##10##1##(1995-11#1)(1997-3#1)(2008-10#4)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#1)
MALDI-TOF-MS##3##1##(2008-10#1)(2009-9#1)(2010-12#1)
MALT lymphoma and##2##3##(1997-1#2)
MALT lymphoma was##2##3##(2009-8#1)(2013-1#1)
MALT lymphoma##9##2##(1997-1#4)(2008-12#1)(2009-8#3)(2013-1#1)
MALT lymphomas are##2##3##(1997-1#1)(2009-8#1)
MALT lymphomas##3##2##(1997-1#2)(2009-8#1)
MALT##16##1##(1997-1#7)(2008-12#1)(2008-5#2)(2009-8#5)(2013-1#1)
MAN##2##1##(2008-10#1)(2009-5#1)
MANAGEMENT##6##1##(2007-11#2)(2008-9#1)(2012-12#3)
MANAGERS##2##1##(2012-12#2)
MANOVA##2##1##(1992-6#1)(2008-9#1)
MAO B##4##2##(2009-12#4)
MAO activity compared##2##3##(2008-3#1)(2009-8#1)
MAO activity##6##2##(1994-2#1)(1995-11#2)(2008-3#2)(2009-8#1)
MAO and##2##2##(1995-11#2)
MAO inhibitory activity##3##3##(1994-3#3)
MAO##17##1##(1991-12#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-11#4)(2008-3#2)(2009-12#4)(2009-8#1)
MAO-A##3##1##(1994-8#2)(2012-2#1)
MAO-B##12##1##(1992-11#4)(1994-6#3)(1994-8#3)(2008-7#2)
MAOB activity##3##2##(1994-2#3)
MAOB is##2##2##(1994-2#2)
MAOB##7##1##(1994-2#7)
MAP and##3##2##(2008-9#1)(2013-7#1)(2013-8#1)
MAP kinase activation by a##2##5##(1995-8#2)
MAP kinase activation by##3##4##(1995-8#3)
MAP kinase activation##7##3##(1995-8#7)
MAP kinase and cPLA2##2##4##(1994-11#2)
MAP kinase and##3##3##(1994-11#2)(2008-7#1)
MAP kinase by##2##3##(1995-8#1)(1997-6#1)
MAP kinase cascade##2##3##(1995-2#1)(2009-8#1)
MAP kinase kinase##2##3##(1995-2#2)
MAP kinase signaling##2##3##(2008-7#1)(2009-10#1)
MAP kinase##34##2##(1992-8#3)(1993-8#3)(1994-11#2)(1995-2#5)(1995-8#10)(1996-2#2)(1997-6#2)(2007-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)
MAP kinases##5##2##(1993-8#1)(1997-6#1)(2008-11#1)(2008-4#2)
MAP psychosis##3##2##(1996-7#3)
MAP systems##4##2##(2008-4#4)
MAP was##3##2##(1991-5#1)(2008-7#1)(2008-9#1)
MAP##78##1##(1991-5#2)(1992-8#3)(1993-8#4)(1994-11#2)(1994-2#1)(1995-2#5)(1995-8#10)(1996-2#2)(1996-7#5)(1997-6#3)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#11)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#4)(2011-2#2)(2013-7#1)(2013-8#4)
MAP-2 immunoreactivity##2##2##(2008-7#2)
MAP-2 immunostaining##4##2##(2008-7#4)
MAP-2##7##1##(2008-7#7)
MAP-kinase kinase##2##2##(1997-4#2)
MAP-kinase##4##1##(1997-4#4)
MAPH##2##1##(2008-4#2)
MAPK activation##10##2##(1995-6#7)(1996-2#1)(2008-10#1)(2008-11#1)
MAPK activities##2##2##(1995-6#1)(2008-9#1)
MAPK activity##4##2##(1995-6#1)(2008-9#3)
MAPK and##2##2##(2008-11#1)(2008-4#1)
MAPK in##2##2##(2009-10#1)(2009-7#1)
MAPK pathway##4##2##(2008-11#3)(2009-8#1)
MAPK signaling pathway##2##3##(2010-12#2)
MAPK signaling##3##2##(2008-11#1)(2010-12#2)
MAPK##51##1##(1995-2#3)(1995-6#9)(1996-2#1)(2008-10#1)(2008-11#9)(2008-4#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#8)(2010-1#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
MAPK/ERK##2##1##(1995-2#1)(2009-4#1)
MAPKK##5##1##(1995-2#5)
MAPKK1##2##1##(1995-2#2)
MAPKs and##2##2##(1995-2#1)(2013-7#1)
MAPKs have##2##2##(1995-6#1)(2008-9#1)
MAPKs##15##1##(1995-2#1)(1995-6#4)(1996-2#1)(2008-10#1)(2008-9#3)(2009-6#2)(2009-8#1)(2013-7#2)
MAPPING OF##2##2##(2008-11#2)
MAPs and##2##2##(2008-9#1)(2009-8#1)
MAPs at different stimulation##2##4##(2008-9#2)
MAPs##12##1##(2008-4#1)(2008-9#8)(2009-8#3)
MAR##2##1##(2008-10#1)(2008-8#1)
MAR4 and MAR5##2##3##(1992-2#2)
MARS were##2##2##(2008-10#2)
MARS##3##1##(2008-10#3)
MARYBLYT 4##2##2##(2008-10#2)
MARYBLYT and Cougarblight##2##3##(2008-10#2)
MARYBLYT##7##1##(2008-10#7)
MAS data##3##2##(2008-3#3)
MAS##17##1##(1996-2#5)(2008-1#5)(2008-10#2)(2008-3#5)
MASAMB##2##1##(2008-7#2)
MASERATI##4##1##(2008-3#4)
MAST Quadrant##2##2##(2011-2#2)
MAT activity##2##2##(1992-6#2)
MAT is##2##2##(1992-6#1)(1992-9#1)
MAT##15##1##(1992-6#5)(1992-9#1)(2007-7#2)(2008-10#3)(2008-8#1)(2013-1#3)
MAT-1 cells##2##2##(2008-10#2)
MAT-1 mating type##2##3##(2008-10#2)
MAT-1 pheromone##3##2##(2008-10#3)
MAT-1##7##1##(2008-10#7)
MATERIAL AND METHODS##5##3##(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
MATERIAL AND##7##2##(2009-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
MATERIAL##26##1##(2009-8#1)(2010-1#2)(2010-4#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#3)
MATERIALS AND METHODS##22##3##(1995-4#1)(2007-10#1)(2008-6#1)(2010-3#1)(2011-2#9)(2012-2#6)(2012-3#2)(2013-1#1)
MAV##4##1##(2008-10#4)
MAVS##6##1##(2013-1#6)
MAVS-mediated antiviral##2##2##(2013-1#2)
MAVS-mediated##3##1##(2013-1#3)
MAX##9##1##(1995-6#9)
MAb against##2##2##(2007-10#1)(2008-11#1)
MAb concentration##3##2##(2008-11#2)(2008-7#1)
MAb development and##2##3##(2008-10#2)
MAb medium##3##2##(2008-11#3)
MAb production##2##2##(1994-5#2)
MAb productivity as compared to##2##5##(2008-11#2)
MAb secretion##2##2##(2008-11#2)
MAb therapeutics##2##2##(2008-10#2)
MAb##41##1##(1990-2#2)(1993-9#2)(1994-3#1)(1994-5#2)(2007-10#1)(2008-10#13)(2008-11#18)(2008-4#1)(2008-7#1)
MAb98##2##1##(1991-2#2)
MAbs against##2##2##(2008-10#1)(2008-11#1)
MAbs and##2##2##(1994-3#1)(2008-10#1)
MAbs were##3##2##(1992-2#1)(2008-11#2)
MAbs##22##1##(1990-12#1)(1992-2#3)(1994-3#4)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#1)
MB and NMB on bare SOWG##2##6##(2008-10#2)
MB and NMB on##3##4##(2008-10#3)
MB and NMB##4##3##(2008-10#4)
MB and the##3##3##(1993-8#1)(2008-10#2)
MB and##10##2##(1993-8#1)(2008-10#9)
MB at##2##2##(2008-10#1)(2011-2#1)
MB in the##2##3##(2008-10#2)
MB in##3##2##(2008-10#2)(2012-2#1)
MB isoform##2##2##(2008-10#2)
MB isoforms##2##2##(1992-3#2)
MB was##2##2##(2008-10#2)
MB##39##1##(1992-3#2)(1993-8#1)(2008-10#32)(2011-2#2)(2012-2#1)(2013-1#1)
MB-ODNs and their##2##3##(2008-4#2)
MB-ODNs##7##1##(2008-4#7)
MB0##2##1##(1992-3#2)
MB1 dominant##2##2##(1992-3#2)
MB1##6##1##(1992-3#6)
MB2 and MB1##3##3##(1992-3#3)
MB2##7##1##(1992-3#7)
MB3 was##3##2##(1992-3#3)
MB3##6##1##(1992-3#6)
MBAS##3##1##(2007-12#3)
MBC =1##2##2##(2008-12#2)
MBC##4##1##(2008-12#3)(2012-3#1)
MBCK I##3##2##(1993-6#3)
MBDCG##5##1##(2008-2#5)
MBI##8##1##(2008-10#5)(2008-11#2)(2008-9#1)
MBIgG##3##1##(1991-5#3)
MBL pathway##2##2##(2008-4#2)
MBL##8##1##(2008-4#3)(2012-3#5)
MBOA##2##1##(2008-10#2)
MBP##18##1##(1992-11#3)(1992-9#4)(1993-3#3)(1993-6#3)(1995-12#3)(1996-5#1)(2012-3#1)
MBP-ECD or##2##2##(1995-12#2)
MBP-RT##3##1##(1997-6#3)
MBR##3##1##(2013-1#3)
MBRS##2##1##(2008-10#2)
MBS##2##1##(2008-3#2)
MBSR and MBCT##2##3##(2013-1#2)
MBSRQ subscales##2##2##(2007-12#2)
MBT##6##1##(2008-10#3)(2008-11#2)(2013-1#1)
MBTH##4##1##(2008-10#4)
MBq##2##1##(2007-11#1)(2008-7#1)
MBq/kg-body-mass)##2##1##(2008-7#2)
MBr1##3##1##(1990-12#3)
MBr8##4##1##(1990-12#4)
MC ICP MS##3##3##(2008-10#3)
MC and##4##2##(2007-11#1)(2008-11#1)(2013-7#2)
MC code##2##2##(2011-1#2)
MC in##5##2##(2011-2#2)(2012-12#2)(2013-7#1)
MC is##3##2##(1994-8#1)(2007-11#1)(2008-10#1)
MC sustains##2##2##(2007-11#2)
MC##58##1##(1990-7#1)(1992-11#1)(1992-3#1)(1993-11#2)(1994-8#5)(1995-2#3)(1995-3#1)(1996-5#1)(2007-11#8)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#4)(2011-2#7)(2012-12#8)(2013-7#4)
MC-simulated##2##1##(2008-3#2)
MC1R##7##1##(2008-9#6)(2010-4#1)
MC3T3-E1##7##1##(1991-12#2)(1997-1#3)(2008-8#2)
MC540##8##1##(1994-12#4)(2008-10#3)(2008-9#1)
MC65 cells##2##2##(2013-1#2)
MCA and##5##2##(1996-5#1)(1997-6#1)(2008-10#2)(2008-7#1)
MCA bifurcation##3##2##(2008-12#3)
MCA stenosis##2##2##(2007-10#2)
MCA territory##2##2##(1997-2#1)(2008-12#1)
MCA was##4##2##(1990-8#1)(2007-10#2)(2008-12#1)
MCA##35##1##(1990-8#6)(1992-2#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(2007-10#8)(2008-10#3)(2008-12#8)(2008-7#1)(2013-1#1)
MCAD deficiency##4##2##(1990-8#2)(1991-8#2)
MCAD##7##1##(1990-8#5)(1991-8#2)
MCAO and##2##2##(2008-10#1)(2011-2#1)
MCAO induced##2##2##(1997-2#2)
MCAO rats##2##2##(2008-10#2)
MCAO##20##1##(1997-2#5)(2007-10#7)(2008-10#3)(2008-8#1)(2011-2#4)
MCAT##2##1##(1995-2#1)(2008-12#1)
MCB##3##1##(2009-7#3)
MCBS (Medicare Current Beneficiary Survey)##3##5##(1994-1#1)(1996-2#1)(1997-1#1)
MCBS##4##1##(1994-1#1)(1995-2#1)(1996-2#1)(1997-1#1)
MCC cells##2##2##(2013-1#1)(2013-8#1)
MCC is a##2##3##(1993-3#1)(2011-2#1)
MCC##14##1##(1993-3#1)(2011-2#3)(2013-1#7)(2013-8#3)
MCCB##4##1##(2012-12#4)
MCCs##4##1##(2013-1#4)
MCD is##3##2##(2008-1#3)
MCD##7##1##(2008-1#7)
MCDK##2##1##(2008-10#2)
MCE is##2##2##(2011-2#2)
MCE##8##1##(2010-8#2)(2011-2#6)
MCF laser##2##2##(2007-11#2)
MCF##4##1##(2007-11#2)(2008-10#1)(2008-11#1)
MCF-10A cells##2##2##(1994-11#2)
MCF-7 and##2##2##(1992-9#1)(1993-1#1)
MCF-7 breast cancer cells##5##4##(1993-1#1)(1997-7#1)(2007-11#1)(2012-2#1)(2012-3#1)
MCF-7 cell##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
MCF-7 cells by##2##3##(1992-4#1)(1993-9#1)
MCF-7 cells were##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
MCF-7 cells##25##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-6#1)(1993-9#3)(1994-11#1)(1995-8#1)(2007-11#3)(2008-11#9)(2008-9#1)(2011-2#1)
MCF-7 human breast cancer cells##3##5##(2008-11#3)
MCF-7 human breast cancer##5##4##(2008-11#4)(2012-3#1)
MCF-7##46##1##(1991-2#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#3)(1993-6#1)(1993-9#3)(1994-11#2)(1994-12#1)(1995-8#1)(1997-7#1)(2007-11#4)(2008-11#15)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
MCF/HER2-18 cells##3##2##(1993-1#3)
MCF/HER2-18 tumors##3##2##(1993-1#3)
MCF/HER2-18##7##1##(1993-1#7)
MCF7 and ECC1 cells##2##4##(2011-2#2)
MCF7##6##1##(1992-2#1)(1995-6#1)(2008-11#1)(2011-2#3)
MCG##6##1##(2008-10#6)
MCGs and##2##2##(2008-10#2)
MCGs of S##2##3##(2008-10#2)
MCGs were##3##2##(2008-10#3)
MCGs##14##1##(2008-10#14)
MCH##2##1##(1993-5#1)(1995-12#1)
MCI cases##3##2##(2009-10#3)
MCI in PD##4##3##(2008-6#4)
MCI patients##2##2##(2010-7#1)(2013-1#1)
MCI##25##1##(1997-2#2)(2008-5#4)(2008-6#5)(2009-10#5)(2010-7#2)(2013-1#1)(2013-8#6)
MCKD##5##1##(2007-7#5)
MCKD2 and FJHN##2##3##(2007-7#2)
MCKD2##5##1##(2007-7#5)
MCL##13##1##(2008-8#1)(2008-9#2)(2009-1#4)(2009-8#6)
MCLs##2##1##(2008-9#1)(2013-1#1)
MCM##3##1##(2008-10#1)(2008-3#1)(2008-5#1)
MCM-41 mesoporous material modified carbon paste electrode##2##7##(2008-10#2)
MCM-41##7##1##(2008-10#4)(2010-4#3)
MCML##2##1##(2011-1#2)
MCN1 and##2##2##(1995-11#2)
MCN1##6##1##(1995-11#6)
MCO##7##1##(1994-12#1)(2012-2#6)
MCOs are##2##2##(1996-2#1)(1996-3#1)
MCOs to##2##2##(1996-3#1)(2008-6#1)
MCOs will##2##2##(1994-1#2)
MCOs##11##1##(1994-1#3)(1996-2#3)(1996-3#3)(2008-6#2)
MCP##12##1##(1992-11#1)(1995-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#6)
MCP-1 concentrations##3##2##(2011-2#3)
MCP-1##11##1##(1994-11#3)(2008-10#2)(2008-11#2)(2011-2#3)(2013-1#1)
MCP-1/CCL2##3##1##(2012-1#3)
MCP-2##2##1##(1994-11#2)
MCPG (500 mu M)##2##4##(1995-12#2)
MCPG##4##1##(1995-12#3)(2008-4#1)
MCPs##2##1##(1994-11#2)
MCQ examinations##2##2##(2008-11#2)
MCQ##3##1##(2008-11#3)
MCQs##3##1##(2008-12#2)(2010-11#1)
MCR##3##1##(1990-11#1)(2008-11#2)
MCS scores##2##2##(2007-8#2)
MCS##17##1##(1994-12#4)(2007-8#2)(2008-11#2)(2008-5#1)(2010-3#3)(2011-2#2)(2012-3#1)(2013-1#2)
MCS+ procedures##3##2##(2011-2#3)
MCS+##6##1##(2011-2#6)
MCT administration##3##2##(1994-5#3)
MCT##5##1##(1994-5#5)
MCT-treated rats##3##2##(1994-5#3)
MCT-treated##5##1##(1994-5#5)
MCV##2##1##(1990-3#1)(2008-5#1)
MCV4##6##1##(2010-10#6)
MCl(3)[N(SiMe(2)CH(2)NMe(2))(2)]##2##1##(1997-7#2)
MCs##10##1##(1992-6#1)(2008-10#1)(2008-11#1)(2010-5#3)(2012-12#2)(2013-1#2)
MD Anderson Cancer##2##3##(2011-2#2)
MD cutaneous##3##2##(1997-6#1)(2008-5#2)
MD phytoplasmas##2##2##(2008-10#2)
MD##48##1##(1990-3#1)(1991-8#2)(1993-1#1)(1995-2#1)(1996-1#1)(1996-5#3)(1997-6#2)(2008-10#8)(2008-4#3)(2008-5#7)(2008-6#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#5)
MD) were##2##2##(2006-12#1)(2008-7#1)
MD)##4##1##(1994-6#1)(2006-12#1)(2008-7#2)
MD-2##3##1##(2010-5#3)
MD/PT = 0##2##3##(2008-7#2)
MD/RN = 0##2##3##(2008-7#2)
MD/RTT = 0##2##3##(2008-7#2)
MDA and NO were##3##4##(2011-3#3)
MDA and##4##2##(2009-5#1)(2011-3#3)
MDA content and electrolyte leakage##2##5##(2008-12#2)
MDA level##2##2##(2008-10#1)(2011-3#1)
MDA levels in##2##3##(2008-10#1)(2013-1#1)
MDA levels were detected##2##4##(2009-5#2)
MDA levels were##4##3##(2009-5#2)(2013-1#1)(2013-8#1)
MDA levels##11##2##(2008-10#1)(2009-5#5)(2013-1#2)(2013-8#3)
MDA quantity##2##2##(2011-1#2)
MDA##35##1##(1991-1#1)(1996-2#4)(2007-12#4)(2008-10#2)(2008-12#3)(2008-5#1)(2009-5#7)(2011-1#2)(2011-3#4)(2012-2#1)(2013-1#3)(2013-8#3)
MDA-MB-231 cells were##2##3##(1992-9#1)(1993-9#1)
MDA-MB-231 cells##8##2##(1992-9#1)(1993-9#2)(2008-11#2)(2011-2#1)(2013-1#2)
MDA-MB-231##11##1##(1992-4#1)(1992-9#1)(1993-9#3)(2008-11#3)(2011-2#1)(2013-1#2)
MDA-MB-435 (GRPR(-)/integrin alpha(v)beta(3)(+))##2##3##(2010-6#2)
MDC and T cells##2##4##(2010-3#2)
MDC derivatives##2##2##(1990-8#2)
MDC##8##1##(1990-8#3)(2010-3#4)(2013-7#1)
MDC1##3##1##(2011-2#3)
MDCK and##4##2##(1994-6#1)(1995-11#2)(2012-12#1)
MDCK cell line##2##3##(1990-11#1)(2008-11#1)
MDCK cells##9##2##(1990-5#1)(1994-6#1)(2008-11#5)(2008-9#1)(2012-12#1)
MDCK##17##1##(1990-11#1)(1990-5#1)(1994-6#2)(1995-11#3)(2008-11#7)(2008-9#1)(2012-12#2)
MDCK4 cells##5##2##(1992-5#5)
MDCK4##7##1##(1992-5#7)
MDCT of the abdomen##2##4##(2008-7#2)
MDCT of the##5##3##(2008-7#5)
MDCT provides##2##2##(2008-7#1)(2011-2#1)
MDCT##32##1##(2008-7#20)(2011-2#9)(2012-2#3)
MDD and##3##2##(2008-10#1)(2009-9#1)(2013-8#1)
MDD##16##1##(1997-5#1)(2008-10#2)(2008-4#1)(2009-9#4)(2011-1#2)(2011-2#2)(2012-3#2)(2013-8#2)
MDE##4##1##(1991-1#1)(2008-10#2)(2008-4#1)
MDG 5##3##2##(2010-12#1)(2011-1#2)
MDG##4##1##(2010-12#1)(2011-1#3)
MDGs##2##1##(2011-1#1)(2012-12#1)
MDHs##2##1##(1992-12#2)
MDI and##3##2##(1992-3#2)(1996-1#1)
MDI can be used##2##4##(1992-3#1)(1996-1#1)
MDI products##2##2##(1996-1#1)(1997-2#1)
MDI with##4##2##(1996-1#2)(1996-2#1)(2008-3#1)
MDI##33##1##(1992-3#13)(1996-1#11)(1996-2#3)(1997-1#2)(1997-2#1)(2008-3#1)(2009-11#1)(2012-4#1)
MDIs will##3##2##(1992-3#1)(1996-1#2)
MDIs##17##1##(1992-3#4)(1996-1#12)(1996-2#1)
MDL was##3##2##(1996-2#3)
MDL##7##1##(1995-12#1)(1996-2#6)
MDM##4##1##(2008-3#4)
MDM's##2##1##(2008-3#2)
MDM2 blockade##2##2##(2013-1#2)
MDM2 gene amplification##2##3##(1994-12#2)
MDM2 gene##4##2##(1994-12#4)
MDM2 inhibition##2##2##(2013-1#2)
MDM2 protein is##2##3##(1994-12#2)
MDM2 protein##3##2##(1994-12#3)
MDM2##23##1##(1994-12#9)(2011-2#3)(2013-1#11)
MDMA##2##1##(1991-1#2)
MDMV##2##1##(2008-10#2)
MDP values were##2##3##(2007-10#2)
MDP##4##1##(2007-10#3)(2008-10#1)
MDPs##2##1##(2009-8#2)
MDQ-C##2##1##(2011-1#2)
MDR TB##4##2##(2011-2#4)
MDR cells##7##2##(1990-2#6)(1993-3#1)
MDR##25##1##(1990-2#6)(1993-3#1)(1995-11#1)(1997-5#1)(2008-11#9)(2010-2#1)(2010-4#1)(2011-2#4)(2013-1#1)
MDR-Enterococcus##4##1##(2011-2#4)
MDR-TB patients##3##2##(2013-1#3)
MDR-TB##12##1##(2007-7#1)(2010-5#4)(2013-1#5)(2013-7#1)(2013-8#1)
MDR1 DNA copies##2##3##(1995-11#2)
MDR1 DNA##4##2##(1995-11#4)
MDR1 cDNA##2##2##(1994-5#2)
MDR1 copies and##2##3##(1995-11#2)
MDR1 gene##5##2##(1991-12#1)(2008-11#3)(2011-2#1)
MDR1 genes in##2##3##(1995-11#2)
MDR1 in##2##2##(1995-11#1)(2007-10#1)
MDR1 overexpression##2##2##(2007-10#2)
MDR1##33##1##(1991-12#2)(1994-5#3)(1995-11#11)(2007-10#8)(2008-11#6)(2011-2#2)(2012-12#1)
MDR2##2##1##(2008-11#2)
MDRD2##2##1##(2011-2#2)
MDS and##3##2##(2008-11#1)(2010-1#2)
MDS is##2##2##(1997-3#1)(2010-8#1)
MDS samples with##2##3##(2008-11#2)
MDS##22##1##(1994-10#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-4#1)(2009-8#6)(2010-1#2)(2010-8#4)(2011-2#1)(2012-12#1)
MDSS2 and MDSS2N##2##3##(2008-11#2)
MDSS2##7##1##(2008-11#7)
MDSS2N##9##1##(2008-11#9)
MDT##7##1##(2007-7#4)(2009-5#3)
MDV##6##1##(2007-6#5)(2008-5#1)
MDX and DMD##2##3##(1992-12#2)
MDX myotubes##2##2##(1992-12#2)
MDX##8##1##(1992-12#8)
MDYKAFDNL was##2##2##(1997-3#2)
MDYKAFDNL##4##1##(1997-3#4)
MDYKDDDDK##4##1##(1997-3#4)
MDa##2##1##(2009-8#1)(2011-2#1)
ME had##2##2##(2011-2#2)
ME yields##2##2##(2013-1#2)
ME##16##1##(1993-9#1)(1995-2#2)(2008-10#2)(2008-12#1)(2011-2#6)(2013-1#2)(2013-8#2)
ME-180##3##1##(1992-2#3)
ME1##3##1##(2008-10#3)
MEA##3##1##(2008-10#1)(2009-12#1)(2010-3#1)
MEASUREMENTS##2##1##(2011-1#1)(2013-1#1)
MECC##5##1##(1994-9#3)(2008-10#2)
MECL##2##1##(2012-3#2)
MED-EL cochlear implant users##2##4##(2008-9#2)
MED-EL cochlear implant##3##3##(2008-9#3)
MED-EL##10##1##(2008-9#10)
MEDDF##5##1##(2008-8#5)
MEDICAL##3##1##(2009-9#1)(2011-2#2)
MEDLINE and EMBASE##3##3##(1994-3#2)(2012-1#1)
MEDLINE and MeSH##2##3##(1993-3#2)
MEDLINE and##10##2##(1991-1#1)(1992-12#1)(1993-3#2)(1994-3#2)(2008-6#1)(2012-1#1)(2013-1#2)
MEDLINE database##4##2##(1991-1#1)(1992-2#2)(2013-1#1)
MEDLINE end-user##2##2##(1992-1#2)
MEDLINE on CD-ROM##3##3##(1991-1#2)(1995-3#1)
MEDLINE on##5##2##(1991-1#3)(1991-3#1)(1995-3#1)
MEDLINE search##7##2##(2006-10#1)(2007-10#1)(2008-3#1)(2008-8#2)(2011-7#1)(2013-1#1)
MEDLINE searching##2##2##(1992-1#1)(1995-1#1)
MEDLINE to##2##2##(1993-2#1)(1995-1#1)
MEDLINE##59##1##(1991-1#8)(1991-12#1)(1991-3#4)(1992-1#4)(1992-12#4)(1992-2#3)(1993-2#1)(1993-3#3)(1994-3#5)(1995-1#3)(1995-3#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-7#3)(2011-2#2)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#6)(2013-8#1)
MEF##4##1##(2008-8#2)(2009-12#1)(2009-9#1)
MEF25##2##1##(2007-2#2)
MEFV##2##1##(2007-7#1)(2008-7#1)
MEFs##7##1##(2008-2#4)(2010-3#2)(2011-2#1)
MEG##3##1##(1996-2#1)(1996-5#1)(2008-10#1)
MEGA 8 and MEGA 9##2##5##(1990-12#2)
MEGA##4##1##(1990-12#4)
MEH##2##1##(2013-1#2)
MEI##4##1##(1992-2#3)(1994-1#1)
MEK (MAPK/ERK kinase)##2##3##(1996-2#1)(2010-10#1)
MEK##7##1##(1995-2#2)(1996-2#1)(2008-10#2)(2008-4#1)(2010-10#1)
MEK--&gt##3##1##(2008-8#3)
MEK-ERK##3##1##(2011-2#3)
MEK1/2##2##1##(2008-8#2)
MEKA protein##2##2##(1990-7#1)(1993-3#1)
MEKA##5##1##(1990-7#4)(1993-3#1)
MEKC and##2##2##(1990-8#1)(2008-10#1)
MEKC to##2##2##(1994-9#1)(2008-10#1)
MEKC##11##1##(1990-8#2)(1994-9#2)(2008-10#5)(2010-7#2)
MEL cells##2##2##(1993-6#1)(2008-9#1)
MEL is##2##2##(2008-11#1)(2010-8#1)
MEL##17##1##(1993-6#2)(2008-11#6)(2008-9#2)(2010-8#7)
MEL-A##4##1##(2008-11#4)
MEL-TF19##3##1##(2008-9#3)
MELAS was##2##2##(1990-12#1)(1990-3#1)
MELAS##7##1##(1990-12#3)(1990-3#3)(2007-10#1)
MEM##4##1##(2008-11#1)(2008-3#1)(2008-7#2)
MEME##7##1##(2008-9#7)
MEMS structures##2##2##(2008-2#2)
MEMS##7##1##(2008-2#3)(2009-9#2)(2012-1#2)
MEN 2 syndromes##2##3##(2008-1#2)
MEN 2##4##2##(2008-1#4)
MEN syndromes##2##2##(2011-2#2)
MEN##9##1##(1997-4#1)(2008-1#6)(2011-2#2)
MEP##11##1##(2008-11#2)(2008-7#3)(2010-7#2)(2011-2#1)(2012-2#3)
MEP2##2##1##(1995-9#2)
MEPP frequencies and##2##3##(2008-4#2)
MEPP##3##1##(2008-4#3)
MEPs##3##1##(2010-7#2)(2011-2#1)
MES##5##1##(2007-8#4)(2008-10#1)
MESS-2##5##1##(2008-10#5)
MET##2##1##(2012-1#2)
MET3 promoter##2##2##(1995-6#2)
MET3##3##1##(1995-6#3)
MET3-GLC7##2##1##(1995-6#2)
MET4##2##1##(1996-3#2)
METHOD AND RESULTS##2##3##(2012-2#2)
METHOD##27##1##(1993-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#7)(2013-1#7)
METHODS #ENTITYSTARTX00026##3##2##(2010-7#1)(2012-3#1)(2013-1#1)
METHODS AND RESULTS##7##3##(1997-7#1)(2008-11#2)(2008-12#2)(2012-2#1)(2013-1#1)
METHODS AND##10##2##(1997-7#1)(2008-11#3)(2008-12#2)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
METHODS##243##1##(1995-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#3)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#5)(2010-12#4)(2010-3#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#37)(2011-2#32)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#39)(2012-3#34)(2013-1#38)
MEX alleles in##2##3##(2008-10#2)
MEX##3##1##(1997-2#1)(2008-10#2)
MEX1##2##1##(2008-10#2)
MEZ##3##1##(1992-2#3)
MEs##5##1##(1992-12#2)(2008-3#3)
MEtAMCD##3##1##(2013-1#3)
MF alpha 1 gene##2##4##(1995-6#2)
MF alpha 1##3##3##(1993-9#1)(1995-6#2)
MF animals##2##2##(1992-5#2)
MF##11##1##(1992-5#3)(1993-9#1)(1994-6#2)(1995-6#2)(2008-10#1)(2010-9#1)(2013-1#1)
MFA##4##1##(1997-6#1)(2008-10#2)(2009-3#1)
MFA2##2##1##(1995-9#2)
MFAP-4 expression was##2##3##(2012-2#2)
MFAP-4##5##1##(2012-2#5)
MFB##4##1##(1991-2#1)(1993-12#1)(2008-10#2)
MFC##2##1##(2010-9#1)(2012-3#1)
MFE##3##1##(2008-10#3)
MFG-IRAP##2##1##(2008-5#2)
MFH##5##1##(1990-12#1)(1990-8#1)(2008-6#3)
MFN##4##1##(2008-11#4)
MFO##3##1##(2007-10#1)(2008-11#1)(2008-8#1)
MFS##14##1##(1994-1#6)(1994-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-6#3)(2011-1#1)
MG 63 cells##2##3##(2012-2#2)
MG and##2##2##(2008-10#2)
MG was found to##2##4##(2008-10#1)(2008-11#1)
MG were##2##2##(1997-6#1)(2008-10#1)
MG##39##1##(1996-2#1)(1997-6#3)(1997-7#1)(2007-12#1)(2007-8#3)(2008-10#14)(2008-11#5)(2008-6#8)(2012-12#1)(2012-2#2)
MG12 cells##2##2##(2008-11#2)
MG12##4##1##(2008-11#4)
MG2 and##2##2##(2008-10#2)
MG2##4##1##(2008-10#4)
MG96-36##4##1##(2008-10#4)
MGA 2##2##2##(1997-6#2)
MGBG##3##1##(2008-10#3)
MGC803 cell##3##2##(2008-9#3)
MGC803##5##1##(2008-9#5)
MGCT##3##1##(2011-2#3)
MGED ontology##4##2##(2008-7#4)
MGED##5##1##(2008-7#5)
MGMA comments on proposed##2##4##(2008-4#1)(2012-3#1)
MGMA##5##1##(2008-4#2)(2012-3#3)
MGMT gene##3##2##(1992-3#3)
MGMT##11##1##(1992-3#10)(2008-7#1)
MGN##2##1##(2008-1#1)(2008-3#1)
MGR583##2##1##(2008-10#2)
MGR586 lineages##3##2##(2008-10#3)
MGR586##11##1##(2008-10#11)
MH cell lines##2##3##(1993-9#1)(2012-1#1)
MH cells##6##2##(1993-9#5)(2012-1#1)
MH in##2##2##(2008-9#1)(2012-1#1)
MH##24##1##(1993-9#6)(2008-9#9)(2010-4#2)(2011-1#1)(2012-1#5)(2012-12#1)
MH2##2##1##(1995-2#1)(2011-2#1)
MHA##5##1##(1992-3#1)(1995-12#1)(1996-3#2)(2008-10#1)
MHA-P complexes##2##2##(2008-10#2)
MHC Class II+ cell##2##4##(1996-12#2)
MHC Class II+##3##3##(1996-12#3)
MHC and##3##2##(2008-4#2)(2008-7#1)
MHC class I and beta 2-microglobulin gene expression##2##8##(1995-12#2)
MHC class I and class II##2##6##(1995-5#1)(2008-9#1)
MHC class I and##4##4##(1995-12#2)(1995-5#1)(2008-9#1)
MHC class I antigens##2##4##(1994-5#1)(2008-8#1)
MHC class I is##2##4##(2008-1#2)
MHC class I molecules##6##4##(2008-11#1)(2008-4#1)(2008-8#4)
MHC class I proteins##2##4##(2008-1#2)
MHC class I##30##3##(1994-5#1)(1995-12#2)(1995-5#3)(1997-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#7)(2008-9#2)
MHC class II antigen##3##4##(1993-6#3)
MHC class II antigens##2##4##(1991-8#1)(1997-8#1)
MHC class II molecules##4##4##(1991-2#1)(1994-11#1)(1995-12#1)(2008-8#1)
MHC class II##13##3##(1991-2#1)(1991-8#1)(1993-6#3)(1994-11#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
MHC class##49##2##(1991-2#1)(1991-8#1)(1993-6#3)(1994-11#1)(1994-5#1)(1995-12#4)(1995-5#4)(1996-10#1)(1997-8#1)(1997-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#7)(2008-7#1)(2008-8#8)(2008-9#3)(2012-12#1)(2013-8#2)
MHC gene##3##2##(1992-11#1)(1994-5#1)(2008-9#1)
MHC genes##2##2##(1992-11#1)(1994-5#1)
MHC molecules on##2##3##(1993-6#1)(1995-5#1)
MHC molecules##10##2##(1990-5#1)(1991-2#1)(1993-3#1)(1993-6#1)(1995-5#4)(2008-9#2)
MHC##100##1##(1990-5#2)(1991-2#2)(1991-8#1)(1992-11#2)(1993-3#6)(1993-6#4)(1994-11#1)(1994-5#4)(1995-11#1)(1995-12#5)(1995-5#8)(1996-10#1)(1996-12#3)(1997-6#2)(1997-8#1)(1997-9#3)(2008-1#7)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#16)(2008-5#1)(2008-7#2)(2008-8#10)(2008-9#7)(2009-2#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
MHC-I##2##1##(2008-4#2)
MHC-nonrestricted manner##2##2##(2008-11#2)
MHC-peptide##3##1##(2008-4#3)
MHIT##2##1##(2012-2#2)
MHL##2##1##(2008-10#2)
MHMS##2##1##(2012-12#2)
MHO phenotype##5##2##(2013-1#5)
MHO##6##1##(2013-1#6)
MHPG##2##1##(1993-1#1)(1996-7#1)
MHSIP##3##1##(1992-12#3)
MHTT##3##1##(2013-1#3)
MHV-A59 and##2##2##(1997-3#2)
MHV-A59##5##1##(1997-3#5)
MHV-A59-infected cells and##2##3##(1997-3#2)
MHV-A59-infected##3##1##(1997-3#3)
MHV-RI spike gene##3##3##(1997-3#3)
MHV-RI##4##1##(1997-3#4)
MHZPA##3##1##(1992-8#3)
MHz and a##2##3##(2007-12#1)(2009-5#1)
MHz and an average##2##4##(2007-12#1)(2008-3#1)
MHz and##12##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2009-5#1)
MHz by use of##2##4##(2007-12#1)(2008-3#1)
MHz by##3##2##(2007-12#1)(2008-3#2)
MHz have been obtained##2##4##(2008-2#1)(2008-3#1)
MHz of##2##2##(1993-11#1)(2008-3#1)
MHz to##3##2##(1993-3#1)(2007-12#2)
MHz with a##2##3##(2007-12#1)(2009-5#1)
MHz with##5##2##(2007-12#3)(2008-3#1)(2009-5#1)
MHz##95##1##(1991-12#1)(1993-11#1)(1993-3#1)(1994-5#1)(1997-7#3)(2007-11#15)(2007-12#20)(2008-10#4)(2008-2#8)(2008-3#23)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#3)(2010-10#1)(2010-8#2)(2011-2#1)(2012-3#1)
MHz)##12##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)(2008-7#1)(2009-5#1)(2009-9#1)
MHz/Torr##2##1##(2008-2#2)
MHz/Torr)##2##1##(2008-2#2)
MI is##4##2##(2007-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
MI patients##5##2##(2008-3#1)(2013-1#4)
MI##47##1##(1990-2#1)(1991-1#1)(1993-12#1)(1993-8#1)(2007-11#3)(2007-8#3)(2008-10#4)(2008-3#5)(2008-5#5)(2009-5#2)(2010-10#2)(2011-2#1)(2012-2#4)(2013-1#6)(2013-8#8)
MIB-1##3##1##(1995-4#1)(2008-6#2)
MIB1 index##2##2##(1997-7#2)
MIB1##5##1##(1997-7#5)
MIBG##6##1##(2008-11#1)(2012-2#5)
MIBI##3##1##(2008-10#1)(2009-7#2)
MIBK##4##1##(2008-10#4)
MIC and##3##2##(2007-7#1)(2008-12#1)(2011-2#1)
MIC genome##2##2##(2012-3#2)
MIC of##3##2##(1991-8#1)(2008-8#1)(2012-3#1)
MIC value of##2##3##(2008-5#1)(2012-3#1)
MIC values of##3##3##(2008-11#2)(2008-5#1)
MIC values##5##2##(2008-11#2)(2008-5#3)
MIC was##2##2##(1991-8#1)(2008-5#1)
MIC##28##1##(1991-8#3)(1992-8#1)(2007-1#1)(2007-7#4)(2008-11#2)(2008-12#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2012-3#4)
MICA/B and ULBP2 expressions and##2##5##(2013-1#2)
MICA/B and ULBP2 expressions##3##4##(2013-1#3)
MICA/B and ULBP2##4##3##(2013-1#4)
MICE Groups of 10##2##4##(2008-9#2)
MICE Groups of 15##2##4##(2008-9#2)
MICE Groups of##5##3##(2008-9#5)
MICE##28##1##(2008-8#3)(2008-9#25)
MICs for##2##2##(2008-7#2)
MICs of##9##2##(2008-12#1)(2008-5#6)(2010-6#1)(2011-2#1)
MICs##17##1##(2008-10#1)(2008-12#1)(2008-5#9)(2008-7#3)(2010-6#1)(2011-2#1)(2012-3#1)
MID2##5##1##(1994-12#5)
MIDCAB##5##1##(2007-8#5)
MIF was##2##2##(2008-10#1)(2009-6#1)
MIF##17##1##(1993-2#1)(2008-10#5)(2009-6#9)(2012-2#2)
MIG##4##1##(1992-2#3)(2008-10#1)
MIH##9##1##(2008-6#1)(2008-7#1)(2013-1#7)
MII##2##1##(1990-2#1)(2013-1#1)
MIMS##9##1##(2008-10#9)
MIN##14##1##(2008-10#9)(2008-2#4)(2011-2#1)
MIN6 cells##4##2##(1996-5#3)(2010-11#1)
MIN6##6##1##(1996-5#4)(2010-11#2)
MINT contains##2##2##(2008-4#2)
MINT##5##1##(2008-4#5)
MIP layer##2##2##(2008-10#2)
MIP to##2##2##(2009-9#2)
MIP was##3##2##(2008-10#2)(2009-9#1)
MIP##18##1##(1993-2#2)(2008-10#10)(2009-9#5)(2013-1#1)
MIP-3alpha##2##1##(2008-5#2)
MIPAS scan##2##2##(2008-3#2)
MIPAS##4##1##(2008-3#4)
MIPO##2##1##(2011-2#1)(2012-12#1)
MIPS##4##1##(2008-7#1)(2012-3#3)
MIR##3##1##(2007-12#1)(2008-10#1)(2008-11#1)
MIR604 in the field##3##4##(2011-2#3)
MIR604 in the##4##3##(2011-2#4)
MIR604 in##5##2##(2011-2#5)
MIR604 transgenic##2##2##(2011-2#2)
MIR604##9##1##(2011-2#9)
MIRA prosthesis##2##2##(2007-8#2)
MIRA##3##1##(2007-8#3)
MIRRs##2##1##(2012-2#2)
MIRU##2##1##(2011-2#2)
MIRU-VNTR##3##1##(2008-12#3)
MIS##6##1##(1993-12#2)(1996-2#1)(2008-8#1)(2011-2#2)
MITO##4##1##(1991-12#4)
MIVAT##2##1##(2012-12#2)
MIXED##3##1##(2008-10#1)(2009-8#2)
MK##4##1##(2012-3#4)
MK-447##6##1##(1991-8#6)
MK-801 (0##2##2##(1990-5#1)(1991-2#1)
MK-801 (1##2##2##(1990-5#1)(1991-2#1)
MK-801##15##1##(1990-5#5)(1991-2#4)(1992-3#1)(1994-11#1)(1995-12#1)(1997-7#3)
MK801##7##1##(1990-5#4)(1994-8#2)(1997-2#1)
MKB 249##2##2##(2008-10#2)
MKB##7##1##(2008-10#7)
MKL-4##4##1##(1994-12#4)
MKR gene##4##2##(2008-8#4)
MKR##5##1##(2008-8#5)
MKs##3##1##(2008-4#3)
ML and##2##2##(2008-10#1)(2008-8#1)
ML diet##2##2##(2012-2#2)
ML was##2##2##(2008-8#2)
ML##20##1##(1992-3#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2012-2#2)
ML(2)##5##1##(2008-10#5)
ML-60218##2##1##(2012-12#2)
ML1##2##1##(1993-3#2)
MLA##7##1##(1996-9#6)(2008-3#1)
MLA(2)##2##1##(2008-10#2)
MLA))##2##1##(2008-10#2)
MLC kinase##3##2##(1992-9#3)
MLC##9##1##(1992-9#7)(2010-11#2)
MLC20 phosphorylation##2##2##(1994-11#2)
MLC20##7##1##(1994-11#7)
MLC601##10##1##(2013-1#10)
MLCT##2##1##(1996-2#2)
MLD alleles##3##2##(1997-3#3)
MLD patients##3##2##(1997-3#3)
MLD##9##1##(1997-3#7)(2008-10#2)
MLH1##2##1##(2011-2#1)(2013-1#1)
MLHs##2##1##(2008-10#2)
MLL proto-oncogene##2##2##(2011-3#2)
MLL##7##1##(1995-11#1)(2011-3#6)
MLM##5##1##(2008-3#2)(2009-8#3)
MLN##2##1##(2008-11#2)
MLN-derived##2##1##(2008-11#2)
MLP and##2##2##(2008-10#2)
MLP values for CI 13227##2##5##(2008-10#2)
MLP##9##1##(2008-10#9)
MLP(-/-) mice##2##2##(2010-6#2)
MLP(-/-)##4##1##(2010-6#4)
MLP-I##4##1##(2010-5#4)
MLPA##4##1##(2008-4#2)(2012-12#1)(2012-3#1)
MLR and ANN##2##3##(2008-10#2)
MLR##5##1##(2008-10#5)
MLRT##2##1##(2007-12#2)
MLS 128##2##2##(1992-8#2)
MLS##3##1##(1992-8#2)(2012-2#1)
MLT and##2##2##(2013-7#2)
MLT levels##2##2##(2013-7#2)
MLT##15##1##(1992-12#2)(2013-7#13)
MLV##2##1##(1993-9#1)(2008-11#1)
MM and##5##2##(2008-1#1)(2008-7#1)(2010-12#2)(2010-4#1)
MM bone disease##2##3##(2010-4#2)
MM cells##2##2##(2010-12#2)
MM patients##2##2##(2010-4#2)
MM##26##1##(1990-12#1)(1991-8#3)(1997-7#1)(2008-1#2)(2008-10#4)(2008-7#1)(2010-12#6)(2010-4#6)(2011-2#1)(2012-2#1)
MM3##5##1##(1991-2#2)(1995-11#1)(1996-5#2)
MMA and As(V)##2##3##(2008-10#2)
MMA and DMA##2##3##(2008-10#2)
MMA and##6##2##(2008-10#6)
MMA##19##1##(1995-11#1)(2007-9#2)(2008-10#11)(2008-12#3)(2008-7#1)(2010-8#1)
MMA)##3##1##(2008-10#1)(2008-3#2)
MMA-SS is##2##2##(2008-10#2)
MMA-SS##6##1##(2008-10#6)
MMAA##2##1##(2008-10#2)
MMAD##4##1##(1992-2#2)(1996-12#1)(1996-2#1)
MMBs##2##1##(2010-5#2)
MMC##5##1##(1992-12#1)(2006-6#1)(2008-11#3)
MMD and AMD##2##3##(2013-1#2)
MMD and##3##2##(2013-1#3)
MMD##8##1##(2008-10#5)(2013-1#3)
MME consisting of a##2##4##(2008-3#2)
MME##3##1##(2008-3#3)
MMG##2##1##(2009-3#2)
MMI##2##1##(2007-12#2)
MML##3##1##(2008-8#3)
MMN##15##1##(1995-5#4)(2008-7#4)(2008-8#7)
MMP activity##2##2##(2008-4#1)(2009-3#1)
MMP production##2##2##(1992-9#1)(2008-5#1)
MMP##12##1##(1992-9#1)(1997-4#2)(2008-2#2)(2008-4#2)(2008-5#3)(2009-3#1)(2013-8#1)
MMP-1 and MMP-9 expressions##3##4##(2012-3#3)
MMP-1 and MMP-9 mRNA and protein expressions##2##7##(2012-3#2)
MMP-1 and MMP-9 mRNA expressions were##2##6##(2012-3#2)
MMP-1 and MMP-9 mRNA##4##4##(2012-3#4)
MMP-1 and MMP-9##8##3##(2012-3#8)
MMP-1 and TIMP-1##3##3##(2008-5#3)
MMP-1 and##12##2##(2008-5#3)(2012-3#8)(2013-1#1)
MMP-1##17##1##(1993-3#1)(2008-4#1)(2008-5#5)(2012-3#9)(2013-1#1)
MMP-2 activity##4##2##(2011-2#3)(2013-8#1)
MMP-2 and MMP-9##3##3##(1997-3#3)
MMP-2 and##7##2##(1997-3#4)(2008-9#1)(2009-3#1)(2013-7#1)
MMP-2 was##3##2##(2008-9#2)(2013-8#1)
MMP-2##23##1##(1992-9#4)(1993-3#1)(1997-3#4)(2008-11#1)(2008-9#4)(2009-3#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
MMP-3 and##2##2##(1993-3#1)(2010-8#1)
MMP-3##3##1##(1993-3#1)(2010-8#1)(2011-2#1)
MMP-9 and##2##2##(1992-9#1)(1997-3#1)
MMP-9##19##1##(1992-9#2)(1993-3#1)(1997-3#3)(2010-8#1)(2012-1#1)(2012-3#11)
MMP2##2##1##(2011-1#1)(2013-1#1)
MMPB##2##1##(2012-12#2)
MMPI##2##1##(1994-2#1)(2007-2#1)
MMPs and##2##2##(2008-9#1)(2013-1#1)
MMPs in##2##2##(2008-11#2)
MMPs##11##1##(2008-11#5)(2008-4#2)(2008-9#1)(2013-1#3)
MMRPE (+) and##3##3##(2013-1#3)
MMRPE (+) cases##2##3##(2013-1#2)
MMRPE (+)##8##2##(2013-1#8)
MMRPE and##2##2##(2013-1#2)
MMRPE##13##1##(2013-1#13)
MMS preparation##3##2##(2011-1#3)
MMS##4##1##(2011-1#4)
MMSE &gt##2##2##(2010-12#2)
MMSE score##2##2##(2008-7#2)
MMSE##14##1##(2006-10#1)(2008-7#8)(2008-9#1)(2010-12#3)(2013-1#1)
MMTV env##2##2##(1994-7#2)
MMTV integration##2##2##(1994-7#1)(2013-7#1)
MMTV species##2##2##(1994-12#2)
MMTV##16##1##(1994-11#4)(1994-12#3)(1994-7#8)(2013-7#1)
MMV and##2##2##(2007-2#1)(2008-10#1)
MMV##7##1##(2007-2#3)(2008-10#4)
MMX##2##1##(2008-3#2)
MN##6##1##(1991-9#1)(1993-12#1)(2008-10#2)(2010-1#1)(2013-1#1)
MN)##2##1##(2008-10#2)
MNC##5##1##(1991-2#2)(2008-5#1)(2008-9#1)(2010-6#1)
MNCs adhered to all types of matrices with the greatest adhesion rates on fibronectin##2##14##(2008-11#2)
MNCs in##3##2##(2008-9#3)
MNCs##6##1##(2008-11#3)(2008-9#3)
MNDO##2##1##(1992-10#1)(1996-5#1)
MNDO/d##4##1##(2008-11#4)
MNG##4##1##(2012-3#4)
MNN##3##1##(2007-5#3)
MNNG-treated cells##2##2##(1997-4#2)
MNP##3##1##(2008-6#3)
MNQ##6##1##(2009-9#6)
MNS is specialized##2##3##(2008-11#2)
MNS is##3##2##(2008-11#3)
MNS##9##1##(2008-11#9)
MNU##4##1##(1993-11#1)(1994-5#2)(1995-2#1)
MNX##3##1##(2008-10#3)
MO calculations##2##2##(1996-5#2)
MO is##2##2##(1996-2#1)(2013-8#1)
MO##22##1##(1994-3#1)(1995-12#1)(1996-2#4)(1996-5#2)(2008-10#2)(2008-3#4)(2008-4#1)(2013-8#7)
MO-induced hindpaw shaking behaviour and increases in extravasated Evans' blue dye concentration##2##12##(2008-4#2)
MO-induced nociceptive behaviour and inflammation in the masseter##2##8##(2008-4#2)
MO-induced nociceptive behaviour and inflammation in the##3##7##(2008-4#3)
MO-induced##5##1##(2008-4#5)
MOD score##2##2##(1997-5#2)
MODEL FOR##3##2##(2009-5#1)(2010-11#1)(2010-5#1)
MODEL##6##1##(2008-11#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
MODELLER##2##1##(2008-4#2)
MODELS##4##1##(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
MODELTEST##2##1##(2008-4#2)
MODIS##2##1##(2008-3#2)
MODQ##3##1##(2012-2#3)
MODTRAN##2##1##(2008-2#1)(2008-3#1)
MODY##3##1##(2008-1#1)(2009-3#1)(2009-8#1)
MOEE##9##1##(2008-10#9)
MOEE- and DXM-treated rats##2##4##(2008-10#2)
MOF##8##1##(1992-5#1)(2008-10#2)(2008-4#1)(2009-7#1)(2010-12#3)
MOG##4##1##(1996-12#4)
MOI of 0##5##3##(2008-11#4)(2008-9#1)
MOI of##8##2##(2008-11#6)(2008-9#2)
MOI##16##1##(2008-11#13)(2008-9#2)(2013-8#1)
MOLT-4 cells##4##2##(1995-2#2)(2008-11#2)
MOLT-4##8##1##(1992-6#1)(1992-8#1)(1993-6#1)(1995-2#2)(2008-11#3)
MOM22 and CPT1##2##3##(1995-9#2)
MON88017##3##1##(2011-2#3)
MOPITT##4##1##(2008-3#4)
MOPS buffer##2##2##(2008-10#1)(2008-9#1)
MORE##3##1##(2011-2#1)(2013-1#2)
MORs##3##1##(2009-7#3)
MOS##3##1##(2007-11#1)(2008-10#1)(2009-5#1)
MOS7/Nup88##3##1##(2011-2#3)
MOSFET drain current##2##3##(2009-5#2)
MOSFET##4##1##(2009-5#4)
MOTION##2##1##(2010-5#1)(2010-6#1)
MOUs in##2##2##(2010-3#2)
MOUs##5##1##(2010-3#5)
MOmega##3##1##(2008-10#3)
MOmega)##3##1##(2007-12#1)(2008-10#2)
MOs (7##2##2##(1990-2#2)
MOs##8##1##(1990-2#7)(1996-2#1)
MOv18##3##1##(1990-2#3)
MP (P &lt##2##3##(2010-2#2)
MP activity##4##2##(1991-8#4)
MP and##5##2##(1997-3#1)(2008-12#2)(2008-9#1)(2013-1#1)
MP flexion##3##2##(2008-9#3)
MP joint of the little finger##2##6##(2008-9#2)
MP was##3##2##(1991-8#1)(1997-3#1)(2008-10#1)
MP were detected##2##3##(2008-10#2)
MP##49##1##(1991-8#7)(1997-3#9)(2008-10#9)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#11)(2010-2#2)(2011-1#1)(2013-1#5)(2013-8#1)
MP-73##4##1##(1993-6#4)
MP-PCR data##2##2##(2008-10#2)
MP-PCR##3##1##(2008-10#3)
MP-RNA complexes##3##2##(1997-3#3)
MP-TMV RNA complexes that##2##4##(1997-3#2)
MP12##2##1##(1996-6#2)
MP50##2##1##(1994-3#2)
MPA for##2##2##(1994-9#1)(1995-4#1)
MPA in##2##2##(1993-8#1)(1994-9#1)
MPA##19##1##(1993-1#5)(1993-8#1)(1994-9#3)(1995-11#1)(1995-4#4)(2008-10#2)(2012-12#3)
MPC is##2##2##(2008-11#2)
MPC of##2##2##(1996-2#2)
MPC provides a##2##3##(2007-12#1)(2008-10#1)
MPC##10##1##(1994-5#1)(1996-2#2)(2007-12#1)(2008-10#2)(2008-11#3)(2011-2#1)
MPD##14##1##(2008-10#5)(2012-2#9)
MPF##2##1##(2008-5#2)
MPFC##5##1##(2008-11#5)
MPGN##4##1##(2008-1#3)(2013-1#1)
MPH##2##1##(1997-3#1)(2008-1#1)
MPI scanners##2##2##(2013-1#2)
MPI yield##3##2##(1995-6#3)
MPI##16##1##(1995-2#3)(1995-6#5)(2008-2#1)(2013-1#7)
MPL/CWS##2##1##(1991-5#2)
MPM##4##1##(1997-4#2)(2008-10#2)
MPMMA##2##1##(2008-3#2)
MPN data##2##2##(2008-10#2)
MPN##7##1##(2008-10#2)(2009-8#5)
MPNST cell lines##2##3##(2008-7#2)
MPNSTs##2##1##(2008-7#2)
MPO activity##2##2##(2012-2#1)(2013-1#1)
MPO##8##1##(1992-10#5)(2008-12#1)(2012-2#1)(2013-1#1)
MPOA opiate receptor density##2##4##(1992-5#2)
MPOA##6##1##(1992-5#4)(1994-2#2)
MPP##4##1##(1993-8#2)(2007-11#1)(2008-2#1)
MPP(+)##3##1##(2008-7#3)
MPP(+)-induced apoptosis##2##2##(1991-12#1)(2008-7#1)
MPP+ and rotenone##2##3##(1995-11#2)
MPP+ and##4##2##(1990-5#1)(1995-11#3)
MPP+##10##1##(1990-5#2)(1995-11#4)(1995-5#4)
MPQ##8##1##(2012-2#8)
MPR images##3##2##(2011-2#3)
MPR##5##1##(2011-2#4)(2013-1#1)
MPT##3##1##(2008-1#2)(2008-11#1)
MPTP and##2##2##(1990-7#1)(2008-7#1)
MPTP##19##1##(1990-7#7)(1992-11#3)(2008-7#9)
MPTP-induced##5##1##(1990-7#1)(2008-7#2)(2013-7#2)
MPa and I=0##2##3##(2008-10#2)
MPa and the##2##3##(2008-10#1)(2009-8#1)
MPa and##11##2##(2008-10#6)(2008-2#1)(2009-4#2)(2009-7#1)(2009-8#1)
MPa for the##2##3##(2009-4#1)(2009-7#1)
MPa for##4##2##(2008-11#2)(2009-4#1)(2009-7#1)
MPa in##2##2##(2010-4#2)
MPa on##2##2##(2008-10#1)(2013-8#1)
MPa to##3##2##(2008-10#1)(2009-7#2)
MPa was##5##2##(2008-10#2)(2008-5#1)(2009-7#2)
MPa##63##1##(1990-7#2)(2007-11#1)(2007-12#2)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#6)(2009-7#9)(2009-8#1)(2010-4#6)(2013-8#1)
MPa)##7##1##(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#1)
MPs##7##1##(1990-3#1)(2007-11#2)(2008-10#1)(2008-7#3)
MQ-based##2##1##(2008-10#2)
MR Imaging in##2##3##(2008-6#1)(2009-11#1)
MR Imaging##4##2##(1995-4#1)(2008-6#2)(2009-11#1)
MR and CT##3##3##(2008-7#2)(2012-2#1)
MR and##7##2##(1992-3#1)(2007-7#1)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#1)
MR angiogram##2##2##(2007-10#2)
MR angiography with##2##3##(1995-11#1)(2011-2#1)
MR angiography##10##2##(1995-11#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-7#3)(2011-2#1)(2013-1#2)
MR arthrography##2##2##(2007-11#2)
MR characteristics##2##2##(2012-2#2)
MR contrast agent##2##3##(2008-7#2)
MR contrast agents##3##3##(2008-7#1)(2009-6#1)(2009-8#1)
MR contrast##5##2##(2008-7#3)(2009-6#1)(2009-8#1)
MR examination##2##2##(2007-10#2)
MR features of##2##3##(1997-8#2)
MR findings of##3##3##(1995-4#1)(1997-8#1)(2012-2#1)
MR findings##8##2##(1995-4#1)(1996-6#1)(1997-8#2)(2011-2#2)(2012-2#2)
MR image##4##2##(1995-5#1)(2007-11#1)(2009-7#2)
MR images of##3##3##(1997-8#2)(2008-5#1)
MR images##14##2##(1995-4#1)(1997-8#7)(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
MR imaging (MRI)##2##3##(2008-7#1)(2012-2#1)
MR imaging findings##2##3##(1997-8#2)
MR imaging in##4##3##(2009-11#2)(2012-12#1)(2012-2#1)
MR imaging is##3##3##(2008-6#1)(2008-9#1)(2011-2#1)
MR imaging of the CNS##2##5##(2008-7#2)
MR imaging of the##3##4##(1997-8#1)(2008-7#2)
MR imaging of##8##3##(1997-8#4)(2008-7#3)(2010-9#1)
MR imaging techniques such as##2##5##(2008-7#2)
MR imaging techniques##4##3##(1997-8#1)(2008-6#1)(2008-7#2)
MR imaging were##2##3##(1995-11#1)(1997-8#1)
MR imaging##44##2##(1991-11#1)(1995-11#1)(1997-6#1)(1997-8#17)(2007-11#1)(2008-1#2)(2008-6#2)(2008-7#7)(2008-9#1)(2009-11#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#5)
MR in##4##2##(1990-11#1)(1996-6#2)(2008-1#1)
MR is##2##2##(1990-11#2)
MR mammography##6##2##(1997-8#6)
MR scan##2##2##(2012-3#1)(2013-8#1)
MR showed##2##2##(1996-6#1)(2012-12#1)
MR signal change##2##3##(1994-8#1)(2011-1#1)
MR signal##4##2##(1994-8#3)(2011-1#1)
MR spectroscopy##2##2##(2010-12#1)(2012-2#1)
MR was##2##2##(2007-11#2)
MR##194##1##(1990-10#2)(1990-11#5)(1991-11#1)(1992-3#4)(1993-12#2)(1994-2#1)(1994-8#3)(1995-11#3)(1995-3#5)(1995-4#4)(1995-5#1)(1996-6#9)(1997-6#1)(1997-8#39)(2007-10#6)(2007-11#11)(2007-7#3)(2008-1#3)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#18)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#20)(2012-3#2)(2013-1#4)(2013-8#1)
MR)##2##1##(1992-3#1)(2009-11#1)
MR-compatible bioartificial liver##2##3##(2012-2#2)
MR-compatible##4##1##(2012-2#4)
MR64##2##1##(2008-8#2)
MRA and##3##2##(1997-8#1)(2008-10#2)
MRA of the##2##3##(2008-7#2)
MRA of##5##2##(2008-7#5)
MRA techniques##3##2##(2008-7#3)
MRA was##3##2##(2007-10#1)(2008-7#2)
MRA##32##1##(1997-8#3)(2007-10#1)(2008-10#5)(2008-7#22)(2012-2#1)
MRAP##2##1##(2011-1#2)
MRC twin panel##2##3##(1994-2#2)
MRC##6##1##(1990-11#1)(1990-2#1)(1991-11#1)(1994-2#2)(2008-10#1)
MRCMLM##2##1##(2012-2#2)
MRD detection##2##2##(2011-2#2)
MRD monitoring##2##2##(2011-2#2)
MRD##8##1##(2011-2#8)
MRD/PD##2##1##(2009-11#2)
MRF-1 is##2##2##(2008-6#2)
MRF-1##4##1##(2008-6#4)
MRI (fMRI)##3##2##(1995-12#1)(2009-6#1)(2009-9#1)
MRI allows##2##2##(2007-10#1)(2007-11#1)
MRI analysis##2##2##(2008-7#1)(2010-12#1)
MRI and CT##5##3##(1996-6#1)(2007-12#1)(2008-7#1)(2012-2#2)
MRI and its##2##3##(2008-1#1)(2010-9#1)
MRI and##22##2##(1996-5#2)(1996-6#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-1#1)(2008-7#3)(2010-9#2)(2012-12#1)(2012-2#3)(2012-3#1)
MRI can##6##2##(1992-3#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-9#1)
MRI confirmed##2##2##(2008-11#1)(2009-3#1)
MRI contrast agent##2##3##(1997-7#1)(2012-12#1)
MRI contrast##3##2##(1997-7#1)(2010-12#1)(2012-12#1)
MRI data##3##2##(2009-11#1)(2010-9#1)(2012-12#1)
MRI diagnosis of##2##3##(2008-1#1)(2009-9#1)
MRI evaluation of##2##3##(2008-1#1)(2008-8#1)
MRI evaluations##3##2##(2007-11#3)
MRI examination##2##2##(1996-9#1)(2007-4#1)
MRI features##4##2##(2009-9#1)(2012-12#2)(2012-2#1)
MRI finding##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
MRI findings##9##2##(1996-11#1)(2007-10#1)(2007-4#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)
MRI for##3##2##(2010-11#1)(2010-9#1)(2012-12#1)
MRI has been shown to##2##5##(2008-8#1)(2010-5#1)
MRI has the##2##3##(2012-2#1)(2013-1#1)
MRI has##6##2##(2008-1#1)(2008-8#1)(2010-5#1)(2012-2#2)(2013-1#1)
MRI have##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
MRI image##2##2##(2007-11#1)(2011-2#1)
MRI images##4##2##(2007-10#1)(2012-12#3)
MRI imaging##2##2##(2007-8#1)(2013-1#1)
MRI in the##5##3##(1996-11#1)(2008-1#2)(2010-12#1)(2011-2#1)
MRI in##20##2##(1994-2#1)(1996-11#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
MRI increases##2##2##(1995-1#1)(2012-3#1)
MRI is a##3##3##(1997-8#1)(2008-12#1)(2010-12#1)
MRI is of##2##3##(1996-11#1)(2008-1#1)
MRI is the##3##3##(1996-9#1)(2009-3#1)(2010-12#1)
MRI is##15##2##(1994-2#1)(1996-11#1)(1996-9#1)(1997-8#1)(2007-4#1)(2008-1#3)(2008-12#1)(2008-7#1)(2009-3#2)(2010-12#3)
MRI may be##3##3##(2009-11#1)(2012-12#1)(2012-2#1)
MRI may##4##2##(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#1)
MRI methods for the##2##4##(2012-2#2)
MRI of the intervertebral disc in##2##6##(2007-11#2)
MRI of the##8##3##(2007-11#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
MRI of##13##2##(1991-11#1)(1992-3#1)(1997-8#1)(2007-11#2)(2008-1#2)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#1)
MRI or CT scan##2##4##(2008-10#1)(2009-7#1)
MRI or CT##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
MRI or##6##2##(2007-10#1)(2007-11#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-7#1)
MRI parameters##2##2##(2008-6#1)(2012-2#1)
MRI performed##2##2##(2008-3#1)(2012-2#1)
MRI researchers##3##2##(2013-1#3)
MRI revealed##4##2##(1996-11#1)(2009-6#1)(2010-7#1)(2012-3#1)
MRI safety of##2##3##(2008-9#2)
MRI scan##5##2##(1992-3#2)(2007-8#1)(2008-9#1)(2010-6#1)
MRI scanning##2##2##(2008-7#1)(2010-3#1)
MRI scans##11##2##(1990-5#1)(1992-3#2)(1996-11#1)(1996-5#1)(2006-10#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-9#1)
MRI seems to be an##2##5##(1992-3#1)(2012-2#1)
MRI sequences##3##2##(2008-7#2)(2010-12#1)
MRI showed a##2##3##(1991-11#1)(1994-2#1)
MRI showed##7##2##(1991-11#1)(1994-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
MRI signal##2##2##(2008-10#1)(2012-12#1)
MRI staging##2##2##(2007-4#2)
MRI studies have##2##3##(2008-11#1)(2013-1#1)
MRI studies##4##2##(1996-7#1)(2007-8#1)(2008-11#1)(2013-1#1)
MRI study##2##2##(2008-3#2)
MRI technique##3##2##(1992-6#1)(1997-8#1)(2012-12#1)
MRI techniques##3##2##(2010-12#1)(2010-6#1)(2010-9#1)
MRI to##4##2##(1997-8#1)(2007-8#1)(2010-9#1)(2012-2#1)
MRI was used##2##3##(1994-2#1)(1996-7#1)
MRI was##10##2##(1991-11#1)(1994-2#1)(1996-7#1)(2007-10#1)(2007-11#2)(2008-3#3)(2011-2#1)
MRI were##2##2##(2007-8#1)(2012-12#1)
MRI with##5##2##(2007-10#1)(2007-11#1)(2008-1#2)(2008-7#1)
MRI##389##1##(1990-5#1)(1991-11#4)(1991-12#2)(1992-3#16)(1992-6#2)(1994-2#5)(1995-1#4)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#5)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-7#1)(1997-8#9)(2006-10#3)(2007-10#11)(2007-11#23)(2007-12#1)(2007-4#9)(2007-7#1)(2007-8#8)(2008-1#19)(2008-10#7)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#10)(2008-5#2)(2008-6#2)(2008-7#26)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#6)(2009-12#1)(2009-3#6)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#6)(2010-11#3)(2010-12#17)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#2)(2010-9#14)(2011-1#4)(2011-2#11)(2012-12#31)(2012-2#37)(2012-3#7)(2013-1#17)(2013-8#4)
MRI)##3##1##(1996-5#1)(2007-11#1)(2010-11#1)
MRI-guided method##2##2##(2010-7#2)
MRIP##3##1##(1995-12#3)
MRIs##3##1##(1991-9#1)(2007-11#2)
MRL##6##1##(1993-3#2)(1997-8#2)(2008-10#2)
MRL(+/+) and##2##2##(2008-10#2)
MRL(+/+) mice exposed to##2##4##(2008-10#2)
MRL(+/+) mice were##2##3##(2008-10#2)
MRL(+/+) mice##22##2##(2008-10#22)
MRL(+/+)##25##1##(2008-10#25)
MRL-lpr mice##4##2##(1993-3#4)
MRL-lpr##5##1##(1993-3#5)
MRL/gld mice##2##2##(1997-8#2)
MRL/gld##3##1##(1997-8#3)
MRL/lpr and##2##2##(1997-8#2)
MRL/lpr##3##1##(1992-9#1)(1997-8#2)
MRM##3##1##(1995-4#3)
MRP NBDs##2##2##(2008-11#2)
MRP or##2##2##(2008-11#2)
MRP##14##1##(2008-11#13)(2012-3#1)
MRP/GS-X pump##3##2##(2008-11#3)
MRP1##3##1##(2008-11#2)(2012-3#1)
MRP14 and MRP8##3##3##(1992-6#3)
MRPs##5##1##(2013-8#5)
MRS 2179 (10(-3) M) was##2##5##(2008-4#2)
MRS 2179##6##2##(2008-4#6)
MRS##14##1##(1996-5#1)(2008-2#1)(2008-4#6)(2008-6#2)(2010-2#1)(2012-2#3)
MRSA nasal##2##2##(2011-2#2)
MRSA osteomyelitis##3##2##(2012-2#3)
MRSA strains##4##2##(2010-4#2)(2011-2#2)
MRSA##22##1##(1996-11#3)(2007-7#1)(2008-10#2)(2010-4#2)(2010-8#6)(2011-2#5)(2012-2#3)
MRV##4##1##(2011-2#1)(2012-3#3)
MRs##2##1##(1996-6#1)(2012-2#1)
MS analysis##3##2##(2008-10#1)(2010-12#1)(2012-3#1)
MS and its##2##3##(2008-3#2)
MS and the##2##3##(2008-3#1)(2009-6#1)
MS and##18##2##(2007-11#1)(2008-10#5)(2008-3#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
MS as##2##2##(2008-10#1)(2010-12#1)
MS basal media##2##3##(2008-12#1)(2013-1#1)
MS could##2##2##(2008-3#2)
MS data##2##2##(2008-10#2)
MS detection##3##2##(2008-10#3)
MS e_nose##2##2##(2008-10#2)
MS for##2##2##(2010-12#2)
MS had##2##2##(2008-3#1)(2011-1#1)
MS have##5##2##(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
MS in the##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
MS in##7##2##(2008-10#1)(2008-3#3)(2008-5#1)(2011-1#1)(2011-2#1)
MS is a##2##3##(1995-12#1)(2012-3#1)
MS is##7##2##(1995-12#1)(2008-3#4)(2012-3#2)
MS medium containing##5##3##(2008-10#2)(2013-1#3)
MS medium supplemented with##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
MS medium with##2##3##(2008-12#1)(2009-6#1)
MS medium##13##2##(2008-10#4)(2008-12#4)(2008-8#1)(2009-6#1)(2013-1#3)
MS model##2##2##(2008-7#2)
MS neurons##2##2##(1996-12#2)
MS of##2##2##(2010-7#2)
MS patients and##4##3##(1995-12#1)(2012-3#3)
MS patients##17##2##(1995-12#4)(2008-11#1)(2008-3#1)(2010-12#3)(2010-2#1)(2012-3#7)
MS score including##2##3##(2011-1#2)
MS score##6##2##(2011-1#6)
MS using##2##2##(2008-10#1)(2008-3#1)
MS was defined##2##3##(2008-3#2)
MS was found##2##3##(2008-10#1)(2008-3#1)
MS was significantly##2##3##(2008-3#1)(2011-1#1)
MS was##8##2##(2008-10#2)(2008-3#5)(2011-1#1)
MS were significantly higher##3##4##(2008-3#1)(2011-1#2)
MS were##8##2##(2008-10#1)(2008-3#1)(2010-11#1)(2011-1#4)(2013-1#1)
MS##237##1##(1991-3#1)(1993-11#1)(1994-3#2)(1994-6#1)(1995-12#9)(1996-12#4)(2006-12#1)(2007-11#6)(2008-10#37)(2008-11#2)(2008-12#6)(2008-3#33)(2008-4#1)(2008-5#3)(2008-7#14)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#3)(2010-11#6)(2010-12#17)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#21)(2011-2#6)(2011-3#2)(2011-7#2)(2012-12#3)(2012-2#4)(2012-3#26)(2013-1#12)(2013-8#2)
MS(2) was employed for quantitative##2##5##(2008-10#2)
MS(n)##3##1##(2008-10#1)(2011-2#2)
MS) and##2##2##(2008-10#1)(2012-3#1)
MS) is##2##2##(2008-10#2)
MS)##8##1##(1994-3#1)(2008-10#4)(2008-11#1)(2011-1#1)(2012-3#1)
MS-50##2##1##(2008-10#2)
MS-ATP##6##1##(2008-3#6)
MS-WHO##7##1##(2008-3#7)
MS/MS spectra##4##2##(2008-4#4)
MS/MS spectrum of##2##3##(2008-8#2)
MS/MS spectrum##3##2##(2008-4#1)(2008-8#2)
MS/MS##15##1##(2008-10#4)(2008-4#5)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#2)
MS/MS) method##2##2##(2011-1#2)
MS/MS)##3##1##(2011-1#3)
MSA and SA##3##3##(2008-10#3)
MSA and##4##2##(2008-10#3)(2012-3#1)
MSA cases##2##2##(2008-7#2)
MSA##14##1##(1993-12#2)(2008-10#3)(2008-11#2)(2008-7#5)(2012-3#2)
MSA-P was similar##2##3##(2008-7#2)
MSA-P##7##1##(2008-7#7)
MSAFP##6##1##(1996-12#1)(2011-2#5)
MSC are##2##2##(2011-1#2)
MSC##19##1##(2008-5#6)(2008-9#1)(2009-10#1)(2011-1#7)(2012-12#2)(2012-7#1)(2013-8#1)
MSCC##2##1##(1996-9#2)
MSCT has##2##2##(2008-7#2)
MSCT##4##1##(2008-7#4)
MSCs as a potential##2##4##(2008-5#1)(2012-12#1)
MSCs for##5##2##(2008-11#1)(2009-10#2)(2012-12#2)
MSCs in##2##2##(2012-12#1)(2012-7#1)
MSCs were##5##2##(2008-5#3)(2012-12#1)(2012-7#1)
MSCs##45##1##(2008-11#2)(2008-5#8)(2008-9#1)(2009-10#3)(2009-12#1)(2010-8#1)(2012-12#22)(2012-7#7)
MSD##4##1##(1992-9#1)(2008-3#2)(2008-4#1)
MSDchem##4##1##(2008-4#4)
MSE##4##1##(2008-10#1)(2008-3#3)
MSF##4##1##(2013-8#4)
MSFA method was##2##3##(2008-10#2)
MSFA##4##1##(2008-10#4)
MSH receptor##2##2##(1993-5#1)(1996-5#1)
MSH##7##1##(1993-5#2)(1994-2#1)(1995-12#2)(1996-5#1)(2008-8#1)
MSH/KM9/2009 strain isolated##2##3##(2013-8#2)
MSH/KM9/2009 strain##4##2##(2013-8#4)
MSH/KM9/2009##6##1##(2013-8#6)
MSH2 and##2##2##(2011-2#1)(2013-1#1)
MSH2##3##1##(2011-2#2)(2013-1#1)
MSH27##3##1##(2008-8#3)
MSH27Ep##3##1##(2008-8#3)
MSH6##2##1##(2011-2#1)(2013-1#1)
MSI##3##1##(2008-10#3)
MSI-78##7##1##(2008-5#7)
MSKCC##3##1##(2011-2#3)
MSKK##2##1##(2008-2#2)
MSM##13##1##(2008-3#1)(2009-5#8)(2011-1#3)(2011-2#1)
MSNs##4##1##(2008-7#1)(2013-8#3)
MSOPD##3##1##(2008-10#3)
MSP##6##1##(2008-10#2)(2008-8#4)
MSP-1##2##1##(1994-12#2)
MSP8##2##1##(1997-7#2)
MSPD##3##1##(2008-10#3)
MSS4##2##1##(1994-9#2)
MSTN##2##1##(2012-12#2)
MSTS##2##1##(2008-6#2)
MSU##3##1##(1992-12#1)(2007-10#1)(2008-12#1)
MSUD##3##1##(2012-3#3)
MSV isolates##2##2##(2008-10#2)
MSV resistance##4##2##(2008-10#4)
MSV was detected in the##2##5##(2008-10#2)
MSV##11##1##(2008-10#11)
MSV-Tas and MSV-VW##3##3##(2008-10#3)
MSWV##3##1##(2008-10#3)
MSc##3##1##(2008-11#3)
MStV##5##1##(2008-10#5)
MT and bZIP##2##3##(2008-10#2)
MT and##6##2##(1993-12#1)(1994-11#1)(2008-10#4)
MT as##2##2##(1996-7#1)(2008-11#1)
MT contents##2##2##(2008-10#1)(2008-11#1)
MT dynamics##2##2##(1992-6#1)(2009-10#1)
MT forms##2##2##(2008-10#2)
MT fraction##2##2##(2008-10#2)
MT in human##2##3##(2008-10#1)(2008-11#1)
MT in the##4##3##(1993-12#1)(1995-3#1)(2008-10#2)
MT in##13##2##(1993-12#1)(1995-3#1)(2008-10#7)(2008-11#4)
MT is##2##2##(1993-12#1)(2009-11#1)
MT isoform##2##2##(2008-10#2)
MT isoforms can be##2##4##(2008-10#2)
MT isoforms##13##2##(2008-10#12)(2011-2#1)
MT levels were##2##3##(1996-7#2)
MT levels##4##2##(1996-7#3)(2008-10#1)
MT may##2##2##(1993-12#1)(2008-10#1)
MT samples##2##2##(2008-10#2)
MT solubility##2##2##(2008-11#2)
MT subisoforms##3##2##(2008-10#3)
MT synthesis##3##2##(1993-12#1)(1995-3#2)
MT was##6##2##(1996-12#1)(2008-10#1)(2008-11#3)(2009-11#1)
MT were##2##2##(2008-10#2)
MT##135##1##(1992-6#3)(1993-12#8)(1994-11#4)(1995-3#3)(1996-12#6)(1996-4#1)(1996-7#4)(1997-4#1)(2008-10#70)(2008-11#21)(2008-5#2)(2008-7#1)(2009-10#2)(2009-11#3)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#2)
MT-1 isoform##3##2##(2008-10#3)
MT-1##6##1##(2008-10#6)
MT-2 cells##2##2##(2011-3#2)
MT-2 isoform was separated##2##4##(2008-10#2)
MT-2 isoform was##3##3##(2008-10#3)
MT-2##10##1##(1994-6#1)(2008-10#7)(2011-3#2)
MT-2a##2##1##(2008-10#2)
MT-2d and##2##2##(2008-10#2)
MT-2d##3##1##(2008-10#3)
MT-4##2##1##(2011-3#2)
MT-I##3##1##(2008-10#3)
MT-Leu1##2##1##(2008-4#2)
MT-Leu2##2##1##(2008-4#2)
MT-level##2##1##(2008-10#2)
MT-type##2##1##(2008-3#2)
MT/V5##2##1##(2012-3#2)
MT1 receptor##5##2##(2013-7#5)
MT1##8##1##(2008-10#1)(2013-7#7)
MT2-MMP##2##1##(1997-2#2)
MT20##3##1##(2008-10#3)
MT539MG##2##1##(1995-2#2)
MT8148##2##1##(1992-9#2)
MTA##6##1##(2012-12#2)(2013-1#4)
MTAC##2##1##(2011-2#2)
MTAD##3##1##(2013-1#3)
MTB##3##1##(2008-10#2)(2011-2#1)
MTBE concentrations##3##2##(2008-12#3)
MTBE treatments##2##2##(2008-12#2)
MTBE##10##1##(2008-12#8)(2009-8#2)
MTBI##5##1##(1997-2#5)
MTC##10##1##(2008-7#10)
MTD##5##1##(2008-10#1)(2008-6#3)(2012-3#1)
MTEC1 cells were##2##3##(2008-8#2)
MTEC1 cells##4##2##(2008-8#4)
MTEC1##5##1##(2008-8#5)
MTF for##2##2##(2011-1#1)(2013-8#1)
MTF of the##2##3##(2008-2#2)
MTF of##3##2##(2008-2#2)(2008-3#1)
MTF was measured##2##3##(2008-2#1)(2011-1#1)
MTF was##4##2##(2008-2#2)(2011-1#2)
MTF##17##1##(2008-2#9)(2008-3#2)(2011-1#5)(2013-8#1)
MTHFR##7##1##(1997-8#1)(2008-8#4)(2012-2#2)
MTNs##2##1##(1997-2#2)
MTP##3##1##(2007-8#3)
MTP-PE##2##1##(1993-9#2)
MTR##4##1##(1996-1#4)
MTS##4##1##(1994-12#1)(2007-9#1)(2008-6#1)(2010-2#1)
MTSC4 were##2##2##(2008-8#2)
MTSC4##7##1##(2008-8#7)
MTT and##5##2##(1994-5#1)(2007-2#2)(2008-8#1)(2008-9#1)
MTT assay##11##2##(1992-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2011-2#1)(2011-3#2)(2012-3#2)(2013-1#1)(2013-7#1)
MTT method and##3##3##(1995-8#1)(2008-10#1)(2008-9#1)
MTT method##5##2##(1995-8#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-3#1)
MTT reduction by flavonoids in the absence of cells##2##9##(2008-11#2)
MTT reduction##8##2##(2008-11#6)(2009-9#2)
MTT test##2##2##(2008-8#2)
MTT volume##3##2##(2007-10#3)
MTT##46##1##(1992-2#1)(1994-5#1)(1995-8#1)(2007-10#4)(2007-2#6)(2008-10#1)(2008-11#10)(2008-5#1)(2008-8#4)(2008-9#4)(2009-9#2)(2011-1#1)(2011-2#1)(2011-3#4)(2012-3#3)(2013-1#1)(2013-7#1)
MTU##4##1##(1992-12#1)(2008-10#3)
MTX accumulation##3##2##(1992-8#3)
MTX in##2##2##(1990-8#1)(2008-10#1)
MTX uptake##5##2##(1992-8#5)
MTX##27##1##(1990-8#1)(1991-4#1)(1992-8#14)(1994-2#1)(1995-2#1)(2006-10#1)(2008-10#4)(2008-11#3)(2008-8#1)
MTZ resistant##2##2##(1997-7#2)
MTZ##6##1##(1997-7#6)
MTases##3##1##(1991-9#1)(1993-9#1)(1994-12#1)
MTs I+II##2##2##(2013-7#2)
MTs are also##2##3##(2011-2#1)(2013-7#1)
MTs are##5##2##(1996-12#1)(2008-10#1)(2011-2#2)(2013-7#1)
MTs##32##1##(1992-6#2)(1996-12#1)(2008-10#11)(2008-11#3)(2009-10#5)(2009-8#1)(2011-2#3)(2013-7#6)
MU##6##1##(1993-9#2)(1997-7#1)(2008-10#2)(2009-8#1)
MUAP amplitude decreased##2##3##(1993-9#2)
MUAP area##2##2##(1993-9#2)
MUAP##7##1##(1993-9#7)
MUAPs were##2##2##(1993-9#2)
MUAPs##4##1##(1993-9#4)
MUC-1 is##2##2##(1994-9#2)
MUC-1##6##1##(1994-9#6)
MUC1##3##1##(1993-2#3)
MUC5AC##6##1##(1997-7#6)
MUFA diets##2##2##(2008-10#2)
MUFA##5##1##(2008-10#3)(2010-2#1)(2013-1#1)
MUFA/SFA and USFA/SFA ratios##2##4##(2010-2#2)
MUIS-C##2##1##(2010-10#2)
MUMmer##3##1##(2008-4#3)
MUSS scores##2##2##(2011-1#1)(2012-2#1)
MUSS##3##1##(2011-1#2)(2012-2#1)
MUs##4##1##(1993-9#3)(2013-1#1)
MV X-ray##2##2##(1991-2#1)(2013-1#1)
MV and##3##2##(2012-1#1)(2013-1#1)(2013-8#1)
MV photon beams##2##3##(2008-3#1)(2012-1#1)
MV##18##1##(1991-2#1)(1997-6#2)(2008-3#3)(2009-11#2)(2009-4#1)(2009-8#1)(2012-1#2)(2013-1#4)(2013-8#2)
MVA##7##1##(1995-12#2)(2011-1#3)(2012-2#1)(2013-8#1)
MVB group##8##2##(2007-7#8)
MVB##12##1##(2007-7#12)
MVC##5##1##(1993-12#3)(2013-8#2)
MVD and BA##2##3##(2012-2#2)
MVD and##3##2##(2011-2#1)(2012-2#2)
MVD##9##1##(2010-12#3)(2011-2#4)(2012-2#2)
MVIP##4##1##(2007-10#4)
MVK##4##1##(1995-11#1)(1996-5#2)(2008-7#1)
MVMCA at##2##2##(2007-8#2)
MVMCA##3##1##(2007-8#3)
MVP1-4 was##2##2##(2008-10#2)
MVP1-4##7##1##(2008-10#7)
MVPAs##3##1##(2008-10#3)
MVT##6##1##(2011-2#6)
MW ablation##3##2##(2007-8#3)
MW of##5##2##(1991-2#1)(2007-12#1)(2008-10#2)(2008-9#1)
MW were##2##2##(2007-12#1)(2008-10#1)
MW##35##1##(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#2)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#8)(2008-5#2)(2008-9#1)(2010-2#1)(2013-8#6)
MW/cm(2) for##3##2##(2008-2#2)(2008-3#1)
MW/cm(2)##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
MWI##2##1##(2013-1#2)
MWNT-film coated GCE##2##3##(2008-10#2)
MWNT-film##3##1##(2008-10#3)
MWNTs were##2##2##(2008-10#2)
MWNTs##10##1##(2008-10#6)(2009-3#3)(2010-5#1)
MWNTs/chitosan##2##1##(2008-10#2)
MWP symptoms##2##2##(2008-10#2)
MWP##6##1##(2008-10#6)
MWU##3##1##(2008-11#3)
MWs of##2##2##(2008-10#1)(2008-6#1)
MX and MXS##2##3##(2008-10#2)
MX and##3##2##(2008-10#3)
MX##11##1##(2008-10#10)(2011-2#1)
MX-1##3##1##(1990-7#3)
MX169##4##1##(2008-10#4)
MXS##4##1##(2008-10#4)
MXT mammary cancer##3##3##(1993-1#3)
MXT mammary tumor##2##3##(1993-1#2)
MXT mammary##5##2##(1993-1#5)
MXT##7##1##(1993-1#7)
MY##4##1##(2008-10#4)
MY(2-)##2##1##(2008-10#2)
MY(2-))##3##1##(2008-10#3)
MYC##4##1##(1994-12#1)(2009-2#2)(2011-2#1)
MYCN amplification##4##2##(2011-2#4)
MYCN is##2##2##(2011-2#2)
MYCN##14##1##(2011-2#14)
MZ and DZ##3##3##(1997-4#3)
MZ and##4##2##(1997-4#3)(2009-7#1)
MZ##8##1##(1997-4#5)(2008-10#1)(2009-7#2)
MZEF##4##1##(2008-9#4)
Ma##4##1##(1997-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
Ma)##2##1##(2011-2#2)
MaMPRV##8##1##(2008-10#8)
MaSp1##2##1##(2012-2#2)
MaYMFV and MaMPRV##4##3##(2008-10#4)
MaYMFV are##2##2##(2008-10#2)
MaYMFV##9##1##(2008-10#9)
Maackia amurensis##2##2##(1994-11#1)(2008-7#1)
Mab detected a lipopolysaccharide##2##4##(2008-5#2)
Mab detected##3##2##(2008-5#3)
Mab yield##2##2##(2008-11#2)
Mab##9##1##(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2012-3#2)
Mabs##5##1##(2008-5#5)
Mac-1##4##1##(1994-5#1)(1997-3#3)
Mac387##2##1##(1991-2#2)
Macaca##2##1##(1994-2#2)
Macaronesia##2##1##(1996-4#2)
Mach##2##1##(2007-12#1)(2008-3#1)
Mach-Zehnder amplitude modulator##2##3##(2008-3#2)
Mach-Zehnder configuration##2##2##(2007-12#1)(2008-3#1)
Mach-Zehnder interferometer##13##2##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#5)(2010-4#1)
Mach-Zehnder interferometers##2##2##(2007-12#1)(2008-3#1)
Mach-Zehnder##27##1##(2007-11#7)(2007-12#5)(2008-2#3)(2008-3#11)(2010-4#1)
Machiavellian##3##1##(2008-11#3)
Machine Learning##2##2##(2010-12#1)(2010-7#1)
Machine learning for##2##3##(2008-11#1)(2012-2#1)
Machine learning##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
Machine##8##1##(2008-11#1)(2010-12#1)(2010-7#1)(2010-8#3)(2012-2#1)(2012-3#1)
Machines##3##1##(1997-6#1)(2010-8#1)(2013-8#1)
Macintosh##3##1##(1995-9#1)(2008-9#2)
Macro CK-MM3##2##2##(1991-2#2)
Macro##5##1##(1991-2#2)(2008-10#1)(2008-11#1)(2009-5#1)
Macrobrachium amazonicum##2##2##(2013-7#2)
Macrobrachium##3##1##(2012-3#1)(2013-7#2)
Macrocyclic##4##1##(1997-7#1)(2008-10#2)(2008-5#1)
Macrofungi##2##1##(2008-12#2)
Macromolecular##4##1##(2008-11#1)(2008-4#2)(2009-5#1)
Macrophage Migration Inhibitory Factor##2##4##(2009-6#2)
Macrophage##4##1##(1991-5#1)(2009-6#2)(2010-12#1)
Macrophages##4##1##(1991-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
Macrophomina phaseolina##2##2##(2008-10#2)
Macroporous chitin##2##2##(2008-7#2)
Macroptilium lathyroides##2##2##(2008-10#2)
Macroptilium##4##1##(2008-10#4)
Macropus eugenii##2##2##(1996-5#2)
Macroscopic and microscopic##2##3##(2008-5#1)(2013-7#1)
Macroscopic and##3##2##(1992-10#1)(2008-5#1)(2013-7#1)
Macroscopic##5##1##(1992-10#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
Macroscopically##3##1##(1993-6#1)(1995-6#1)(2012-1#1)
Macrosiphum##2##1##(2008-10#2)
Macrosteles##2##1##(2008-10#2)
Macrulin##5##1##(2008-5#5)
Macular thickness##2##2##(2013-1#2)
Macular##7##1##(2011-2#4)(2013-1#3)
Madagascar##5##1##(2008-10#1)(2009-4#1)(2010-6#2)(2011-2#1)
Maddix##2##1##(1993-12#1)(1994-1#1)
Made##4##1##(2008-10#1)(2008-2#1)(2009-9#1)(2012-3#1)
Madeira wines according to main grape varieties##2##7##(2008-10#2)
Madeira##6##1##(1993-6#2)(1996-4#1)(2008-10#3)
Madelung deformity##2##2##(2013-1#2)
Madin-Darby canine kidney (MDCK) cells##2##5##(2008-11#1)(2011-2#1)
Madin-Darby canine kidney##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
Madin-Darby##5##1##(2008-11#3)(2008-8#1)(2011-2#1)
Madinah##5##1##(2008-1#5)
Madison##3##1##(1994-12#1)(1994-3#1)(2010-11#1)
Madopar Dispersible##2##2##(2008-7#2)
Madopar##4##1##(2008-10#1)(2008-7#3)
Madras and Hermiston##2##3##(2008-10#2)
Madras##5##1##(1992-11#1)(1996-9#1)(2008-10#2)(2011-2#1)
Madrid (Spain)##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
Madrid honeys##3##2##(2011-2#3)
Madrid##16##1##(2007-6#1)(2008-10#4)(2008-11#5)(2008-7#1)(2011-2#5)
Maewo##7##1##(2008-1#7)
MafA expression##2##2##(2012-2#2)
MafA##5##1##(2010-11#2)(2012-2#3)
MafB##2##1##(2010-11#2)
Mag##2##1##(2008-2#1)(2008-3#1)
Mag-H##2##1##(2007-11#2)
MagPluronics##2##1##(2013-1#2)
Magainin has##2##2##(2008-5#2)
Magainin is##2##2##(2008-5#2)
Magainin##7##1##(2008-5#7)
Magdalena##5##1##(2008-12#1)(2008-5#4)
Mage##2##1##(2008-9#2)
Maggiore##3##1##(1993-3#1)(2008-10#2)
Magic 1##3##2##(1997-3#3)
Magic##5##1##(1994-3#1)(1997-3#4)
Magnaporthe grisea and##3##3##(2008-10#3)
Magnaporthe grisea in##2##3##(2008-10#2)
Magnaporthe grisea on##2##3##(2008-10#2)
Magnaporthe grisea##38##2##(1997-4#1)(1997-6#1)(2008-10#33)(2009-10#1)(2010-7#2)
Magnaporthe oryzae in##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
Magnaporthe oryzae##12##2##(2008-10#8)(2009-6#1)(2012-2#2)(2013-8#1)
Magnaporthe##51##1##(1997-4#1)(1997-6#1)(2008-10#42)(2009-10#1)(2009-6#1)(2010-7#2)(2012-2#2)(2013-8#1)
Magnesium deficiency##3##2##(2008-6#3)
Magnesium is##3##2##(2008-6#1)(2010-12#1)(2011-2#1)
Magnesium##18##1##(1991-5#1)(1993-6#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-6#6)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
Magnetic Field##2##2##(1995-3#1)(2008-10#1)
Magnetic Particle Imaging (MPI)##2##4##(2013-1#2)
Magnetic Properties of##2##3##(1997-7#2)
Magnetic Resonance Images##2##3##(2010-8#1)(2013-1#1)
Magnetic Resonance Imaging (MRI)##3##4##(2006-10#1)(2008-7#1)(2013-1#1)
Magnetic Resonance Imaging##8##3##(1992-3#1)(2006-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Magnetic Resonance##18##2##(1991-2#1)(1992-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
Magnetic beads##3##2##(2007-12#1)(2008-10#2)
Magnetic nanoparticles##2##2##(2012-2#1)(2013-1#1)
Magnetic resonance angiography (MRA) is##2##5##(2008-7#2)
Magnetic resonance angiography (MRA)##3##4##(1997-8#1)(2008-7#2)
Magnetic resonance angiography##5##3##(1997-8#1)(2008-1#1)(2008-12#1)(2008-7#2)
Magnetic resonance image##2##3##(2008-12#1)(2013-8#1)
Magnetic resonance images##2##3##(2008-7#1)(2012-3#1)
Magnetic resonance imaging (MRI) is a##2##6##(2008-7#1)(2010-12#1)
Magnetic resonance imaging (MRI) is##5##5##(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
Magnetic resonance imaging (MRI) showed##2##5##(2008-7#1)(2013-8#1)
Magnetic resonance imaging (MRI)##17##4##(1994-2#1)(1996-9#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
Magnetic resonance imaging and##6##4##(1992-3#1)(2007-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
Magnetic resonance imaging demonstrated##2##4##(2006-10#1)(2008-7#1)
Magnetic resonance imaging in##4##4##(2007-11#1)(2008-1#1)(2008-7#1)(2010-12#1)
Magnetic resonance imaging is the##2##5##(2010-6#1)(2012-12#1)
Magnetic resonance imaging is##3##4##(2008-6#1)(2010-6#1)(2012-12#1)
Magnetic resonance imaging of the##5##5##(2009-3#2)(2010-12#1)(2010-9#1)(2011-2#1)
Magnetic resonance imaging of##10##4##(1997-8#1)(2009-3#2)(2010-12#4)(2010-9#1)(2011-2#1)(2012-2#1)
Magnetic resonance imaging revealed##6##4##(2007-10#2)(2008-12#2)(2009-3#1)(2013-8#1)
Magnetic resonance imaging showed##3##4##(2008-7#1)(2011-2#1)(2013-7#1)
Magnetic resonance imaging##68##3##(1990-11#1)(1992-3#1)(1994-2#1)(1996-3#1)(1996-9#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-4#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-3#5)(2010-12#8)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#4)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
Magnetic resonance spectroscopy##2##3##(2010-11#1)(2010-12#1)
Magnetic resonance tomography##2##3##(2007-11#1)(2007-5#1)
Magnetic resonance##88##2##(1990-11#1)(1992-3#1)(1994-2#1)(1996-3#1)(1996-9#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#5)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#5)(2008-6#2)(2008-7#13)(2008-8#1)(2008-9#4)(2009-3#5)(2010-1#1)(2010-11#1)(2010-12#10)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
Magnetic stimulation##3##2##(1992-3#1)(2008-7#2)
Magnetic##139##1##(1990-11#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-8#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-7#7)(1997-8#3)(2006-10#2)(2007-10#2)(2007-11#5)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-12#6)(2008-2#1)(2008-6#2)(2008-7#18)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#5)(2010-1#1)(2010-11#1)(2010-12#10)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
Magnetically induced##2##2##(2008-3#1)(2008-7#1)
Magnetically##3##1##(2008-3#1)(2008-7#1)(2009-11#1)
Magnetization##2##1##(1990-12#1)(2006-4#1)
Magneto-optical##2##1##(2008-3#1)(2009-11#1)
Magnetoencephalography (MEG) was##2##3##(1996-2#1)(2012-2#1)
Magnetoencephalography##3##1##(1996-2#1)(2008-9#1)(2012-2#1)
Magnification##2##1##(2008-2#1)(2009-5#1)
Magnitude##4##1##(2009-11#1)(2012-12#3)
Magnolia dealbata##2##2##(2008-5#2)
Magnolia officinalis##3##2##(2011-2#1)(2012-3#2)
Magnolia##6##1##(2008-5#3)(2011-2#1)(2012-3#2)
Magoh##5##1##(2012-2#5)
Magot et al##2##3##(2011-2#2)
Mahalanobis##2##1##(2008-1#1)(2011-2#1)
Mahale##2##1##(2009-10#2)
Maharashtra##4##1##(2009-10#1)(2013-8#3)
Mahasarakham University##2##2##(2008-12#2)
Mahasarakham##4##1##(2008-12#4)
Maheu et al##2##3##(2008-2#2)
Mahlavu cells##7##2##(1990-8#3)(1997-1#4)
Mahlavu##9##1##(1990-8#4)(1997-1#5)
Maillard reaction##3##2##(1991-5#1)(1994-6#1)(1996-2#1)
Main Outcome##2##2##(2011-2#2)
Main outcome measures included##3##4##(2008-3#1)(2011-2#2)
Main outcome measures were##3##4##(2008-5#1)(2011-2#2)
Main outcome measures##9##3##(2008-3#1)(2008-5#1)(2011-2#7)
Main outcome##12##2##(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#8)
Main plots##2##2##(2008-10#1)(2008-12#1)
Main##35##1##(1990-11#1)(1990-9#1)(1991-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#12)(2013-1#1)(2013-8#1)
Maine##13##1##(1991-1#1)(1992-2#1)(1992-3#1)(1994-2#2)(1996-3#1)(1997-2#3)(2008-10#2)(2008-8#2)
Maine's##3##1##(1991-1#1)(1992-12#1)(2008-5#1)
Mainly##8##1##(1990-6#2)(2007-8#1)(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)
Mainstream##2##1##(2011-1#1)(2011-2#1)
Maintaining Radiation Protection Records##2##4##(1994-12#1)(1995-1#1)
Maintaining Radiation Protection##3##3##(1994-12#1)(1995-1#1)(1995-2#1)
Maintaining a##2##2##(2008-10#1)(2013-1#1)
Maintaining##16##1##(1991-5#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-5#1)(2007-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#2)(2013-1#2)
Maintenance of##14##2##(1992-7#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
Maintenance therapies for reflux esophagitis##2##5##(1996-2#2)
Maintenance##26##1##(1990-11#1)(1992-7#1)(1993-3#1)(1995-2#1)(1996-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
Mainz##2##1##(1996-3#1)(1997-6#1)
Maisonneuve fracture##4##2##(2009-1#4)
Maize (Zea mays L##2##4##(2012-3#2)
Maize Inbred##2##2##(2008-10#2)
Maize Kernel##2##2##(2008-10#2)
Maize Kernels##3##2##(2008-10#3)
Maize Leaves##2##2##(2008-10#2)
Maize chlorotic mottle virus##2##4##(2008-10#2)
Maize fine streak virus##2##4##(2008-10#2)
Maize grain##2##2##(2012-2#2)
Maize streak virus##3##3##(2008-10#3)
Maize stripe virus##2##3##(2008-10#2)
Maize yield in##2##3##(2008-12#2)
Maize##45##1##(2008-10#35)(2008-12#3)(2008-6#1)(2008-8#1)(2012-2#2)(2012-3#3)
MaizeDB##3##1##(2008-7#3)
Majocchi's granuloma and onychomycosis##2##4##(2009-2#2)
Majocchi's granuloma##3##2##(2009-2#3)
Major Depressive Disorder (MDD)##2##4##(2008-10#1)(2012-3#1)
Major Depressive##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
Major Gene##3##2##(2008-10#3)
Major Genetic##2##2##(2008-10#2)
Major advances have been##2##4##(2010-3#1)(2011-2#1)
Major advances in the##3##4##(1996-9#1)(2006-10#1)(2008-7#1)
Major advances in##4##3##(1996-9#1)(2006-10#1)(2007-9#1)(2008-7#1)
Major advances##6##2##(1996-9#1)(2006-10#1)(2007-9#1)(2008-7#1)(2010-3#1)(2011-2#1)
Major areas##2##2##(2008-10#1)(2008-12#1)
Major changes##3##2##(1991-3#1)(2008-7#1)(2009-7#1)
Major complications##3##2##(1990-3#1)(2008-11#1)(2008-9#1)
Major components of##2##3##(1996-3#1)(2012-2#1)
Major differences##2##2##(2008-10#1)(2011-2#1)
Major effects on##2##3##(1992-9#1)(1996-1#1)
Major factors##2##2##(1996-1#1)(2008-10#1)
Major findings include##2##3##(1993-1#1)(1995-2#1)
Major findings##3##2##(1991-12#1)(1993-1#1)(1995-2#1)
Major histocompatibility complex (MHC)##2##4##(2008-7#1)(2008-9#1)
Major histocompatibility complex##3##3##(2008-7#1)(2008-9#1)(2009-2#1)
Major issues in##2##3##(1997-3#1)(2008-2#1)
Major issues##3##2##(1997-3#1)(2008-2#1)(2009-4#1)
Major##98##1##(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#3)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#2)
Majorcan Catalan listeners##2##3##(2013-8#2)
Majorcan Catalan##3##2##(2013-8#3)
Majority of cases##2##3##(2011-2#1)(2013-1#1)
Majority of patients##3##3##(2007-7#1)(2011-2#1)(2012-3#1)
Majority of the##5##3##(2007-7#3)(2009-10#1)(2011-1#1)
Majority of##13##2##(2007-7#4)(2009-10#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
Majority##20##1##(2007-7#5)(2007-8#1)(2009-10#1)(2010-5#2)(2010-9#2)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
Majuro##4##1##(2008-1#3)(2013-8#1)
Make##8##1##(1993-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2009-5#1)(2010-12#1)(2013-1#1)
Maker's fringe##2##2##(2007-12#2)
Making a Difference (Department of Health##2##6##(2008-11#2)
Making a Difference##7##3##(2008-11#7)
Making a difference##4##3##(1997-1#1)(2008-11#1)(2008-12#1)(2009-12#1)
Making a##12##2##(1992-5#1)(1997-1#1)(2008-11#8)(2008-12#1)(2009-12#1)
Making health##2##2##(1995-2#1)(2011-2#1)
Making real sense of MRSA##3##5##(1996-11#3)
Making sense of##2##3##(1991-12#1)(2012-12#1)
Making sense##5##2##(1991-12#1)(1996-3#3)(2012-12#1)
Making such##2##2##(2008-7#1)(2008-8#1)
Making the change##2##3##(1994-1#1)(1997-2#1)
Making the##9##2##(1994-1#1)(1995-5#1)(1997-2#1)(2007-9#1)(2010-8#1)(2012-3#2)(2013-8#2)
Making##54##1##(1991-12#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#3)(1996-3#3)(1997-1#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#3)
Makkah##2##1##(2010-11#1)(2013-7#1)
Mal 90##2##2##(2008-11#2)
Malachite Green (MG)##2##3##(2008-10#2)
Malachite Green##4##2##(1997-6#1)(2008-10#3)
Malachite green##2##2##(1997-6#1)(2008-10#1)
Malachite##6##1##(1997-6#2)(2008-10#4)
Malacostraca##4##1##(2007-12#3)(2011-2#1)
Malakoplakia of the ureter##2##4##(2009-5#2)
Malaria and Crimean-Congo##2##3##(2012-2#2)
Malaria and##3##2##(2007-2#1)(2012-2#2)
Malaria in##3##2##(2007-2#1)(2012-2#1)(2012-3#1)
Malaria is a##3##3##(2007-2#2)(2012-12#1)
Malaria is##4##2##(2007-2#2)(2012-12#1)(2012-3#1)
Malaria was##2##2##(1991-12#1)(2007-2#1)
Malaria##39##1##(1990-9#1)(1991-12#1)(1997-6#1)(2007-2#15)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#5)(2012-12#3)(2012-2#4)(2012-3#4)
Malarial##2##1##(2012-3#2)
Malassezia furfur##5##2##(2008-5#4)(2010-6#1)
Malassezia spp##9##2##(2008-5#9)
Malassezia sympodialis##2##2##(2008-5#2)
Malassezia##26##1##(2007-7#2)(2008-5#23)(2010-6#1)
Malathion##5##1##(2008-10#2)(2008-11#3)
Malawi and##3##2##(1996-6#1)(2008-10#2)
Malawi##21##1##(1996-12#5)(1996-6#1)(1997-6#1)(2008-10#5)(2009-4#1)(2009-6#2)(2010-12#4)(2012-2#2)
Malawian##2##1##(2008-10#1)(2009-6#1)
Malay##2##1##(2008-8#1)(2013-1#1)
Malayan##2##1##(1994-6#2)
Malays##3##1##(2008-8#2)(2011-1#1)
Malaysia and##4##2##(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)
Malaysia as##2##2##(2008-12#2)
Malaysia were##4##2##(2007-12#2)(2008-10#1)(2011-1#1)
Malaysia##61##1##(1993-8#2)(2007-12#4)(2008-10#12)(2008-12#11)(2008-8#5)(2010-2#3)(2011-1#20)(2011-2#1)(2012-2#2)(2013-1#1)
Malaysian women##2##2##(2011-1#1)(2012-2#1)
Malaysian##20##1##(2008-10#1)(2008-12#2)(2008-8#5)(2011-1#5)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)
Malcolm Baldrige National Quality Award##3##5##(1994-3#1)(1995-2#2)
Malcolm##4##1##(1994-2#1)(1994-3#1)(1995-2#2)
Maldives##2##1##(1994-3#1)(2007-5#1)
Male Breast##2##2##(1991-8#1)(1997-7#1)
Male Sprague-Dawley rats were##3##4##(1993-12#1)(1997-2#1)(2013-1#1)
Male Sprague-Dawley rats##4##3##(1993-12#1)(1994-6#1)(1997-2#1)(2013-1#1)
Male Wistar rats##4##3##(1996-5#1)(2007-10#1)(2009-5#1)(2012-2#1)
Male Wistar##5##2##(1996-5#1)(2007-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
Male and female F344/N rats and B6C3F(1) mice were administered technical grade##2##12##(2008-9#2)
Male and female F344/N rats and##3##6##(2008-9#3)
Male and female Tg##9##4##(2008-8#1)(2008-9#8)
Male and female##20##3##(1992-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#14)(2010-8#1)
Male and##21##2##(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#14)(2010-8#1)
Male patients##2##2##(2013-1#1)(2013-8#1)
Male##78##1##(1990-12#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-5#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#2)(2008-10#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#15)(2009-12#2)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
Male-specific##2##1##(2007-12#1)(2013-1#1)
Maleic##2##1##(2008-10#1)(2013-1#1)
Males and females##3##3##(1997-3#1)(2008-8#1)(2008-9#1)
Males had##3##2##(1993-6#1)(2008-9#1)(2011-2#1)
Males of##2##2##(2008-12#1)(2011-2#1)
Males were##3##2##(1995-2#1)(2008-12#1)(2008-5#1)
Males with##2##2##(2008-3#1)(2008-5#1)
Males##31##1##(1990-8#1)(1993-6#1)(1995-2#1)(1995-6#1)(1997-3#1)(2007-7#1)(2008-12#3)(2008-3#2)(2008-5#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
Malformation##5##1##(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#2)
Malformations##6##1##(1995-11#1)(1996-3#1)(1997-6#1)(2008-9#1)(2012-3#2)
Mali and##2##2##(2008-10#1)(2009-4#1)
Mali##9##1##(2008-10#2)(2008-8#4)(2008-9#1)(2009-4#1)(2010-1#1)
Malic acid##2##2##(2008-10#2)
Malignancies##3##1##(2006-10#1)(2008-7#1)(2013-1#1)
Malignancy##5##1##(1992-2#1)(1997-4#1)(2008-10#1)(2010-8#1)(2013-7#1)
Malignant fibrous histiocytoma (MFH)##2##4##(1990-8#1)(2008-6#1)
Malignant granular cell##2##3##(2011-2#2)
Malignant melanoma##4##2##(1990-12#2)(2007-8#1)(2011-2#1)
Malignant mesothelioma is a##2##4##(1993-9#1)(2010-12#1)
Malignant mesothelioma is##4##3##(1993-9#2)(2010-12#1)(2010-5#1)
Malignant mesothelioma##6##2##(1992-11#1)(1993-9#2)(2010-1#1)(2010-12#1)(2010-5#1)
Malignant myoepithelioma##2##2##(2013-1#2)
Malignant peripheral nerve sheath##2##4##(1991-2#1)(2008-7#1)
Malignant pleural mesothelioma##2##3##(2007-8#1)(2010-5#1)
Malignant pleural##3##2##(1991-6#1)(2007-8#1)(2010-5#1)
Malignant syndrome is a##2##4##(2009-11#2)
Malignant syndrome##3##2##(2009-11#3)
Malignant transformation of##2##3##(2008-7#1)(2009-1#1)
Malignant transformation##4##2##(2007-8#1)(2008-7#1)(2009-1#1)(2013-8#1)
Malignant##57##1##(1990-12#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-12#1)(1995-4#1)(1997-3#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-6#5)(2008-7#2)(2009-1#1)(2009-11#3)(2010-1#2)(2010-12#2)(2010-5#2)(2011-2#4)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
Mallet##4##1##(2008-10#2)(2013-1#2)
Mallophaga##2##1##(2011-2#2)
Malmö##2##1##(1992-8#1)(2011-2#1)
Malnutrition is##2##2##(2012-12#1)(2012-2#1)
Malnutrition##4##1##(2012-12#2)(2012-2#2)
Malondialdehyde##2##1##(1993-2#1)(2013-8#1)
Malpighian tubules of##2##3##(2007-12#2)
Malpighian tubules##10##2##(1991-5#1)(2007-12#4)(2008-10#1)(2008-7#4)
Malpighian##11##1##(1991-5#1)(2007-12#4)(2008-10#1)(2008-7#5)
Malpractice claims##2##2##(1995-12#1)(1997-2#1)
Malpractice insurance##2##2##(2007-3#1)(2008-6#1)
Malpractice##6##1##(1995-12#1)(1996-3#1)(1997-2#1)(2007-3#1)(2008-6#1)(2012-3#1)
Malus hupehensis##2##2##(2011-10#2)
Malus spp##2##2##(2008-10#2)
Malus##10##1##(2008-10#7)(2011-1#1)(2011-10#2)
Malva##3##1##(2008-10#3)
Malvaceae##4##1##(2008-10#4)
Malvazia##2##1##(2008-10#2)
Malvern##2##1##(1993-2#1)(1995-3#1)
Mammalian cell##3##2##(2008-11#3)
Mammalian cells##5##2##(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#2)
Mammalian target of rapamycin##2##4##(2009-7#1)(2011-2#1)
Mammalian##31##1##(1990-11#1)(1990-7#1)(1991-9#1)(1993-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-11#8)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-6#1)(2009-7#1)(2009-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
Mammals##2##1##(1995-12#1)(1996-3#1)
Mammary Tumor##4##2##(1994-12#1)(1994-7#1)(2008-11#1)(2013-7#1)
Mammary gland##2##2##(1990-11#1)(2008-8#1)
Mammary##11##1##(1990-11#1)(1994-11#1)(1994-12#2)(1994-7#1)(2008-11#1)(2008-8#1)(2009-1#1)(2013-7#1)(2013-8#2)
Mammographic screening in##2##3##(1991-11#1)(1995-9#1)
Mammography and##2##2##(1993-12#1)(1995-4#1)
Mammography##8##1##(1990-12#2)(1990-2#1)(1993-12#1)(1995-4#1)(2008-10#1)(2011-2#1)(2012-1#1)
Man and##2##2##(1995-6#1)(2008-9#1)
Man is##2##2##(2008-7#1)(2012-3#1)
Man##22##1##(1992-1#1)(1993-11#2)(1995-6#2)(1997-7#2)(2007-7#1)(2008-4#4)(2008-7#1)(2008-9#3)(2009-10#3)(2012-3#2)(2013-1#1)
Man(beta##2##1##(1990-7#1)(1991-12#1)
Man6GlcNAc2-ol##3##1##(1995-2#3)
Man6P##4##1##(1990-5#4)
Managed Care##5##2##(1991-3#3)(1995-3#1)(1996-12#1)
Managed care and chronic##2##4##(1997-1#2)
Managed care and cost##2##4##(1994-3#1)(1997-3#1)
Managed care and##6##3##(1994-3#1)(1995-1#1)(1995-12#1)(1997-1#2)(1997-3#1)
Managed care for##2##3##(1994-2#1)(1997-1#1)
Managed care has##2##3##(1997-2#1)(2008-11#1)
Managed care in the crystal ball##4##6##(1997-7#4)
Managed care organizations##2##3##(1994-12#1)(1997-1#1)
Managed care plans##3##3##(1997-1#1)(1997-2#1)(1997-3#1)
Managed care##53##2##(1991-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#7)(1994-1#5)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-7#4)(2008-11#2)(2008-12#2)(2008-6#1)
Managed mental##2##2##(1991-3#1)(1995-1#1)
Managed##66##1##(1991-12#2)(1991-3#4)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#7)(1994-1#5)(1994-12#2)(1994-2#2)(1994-3#3)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-7#4)(2008-11#2)(2008-12#2)(2008-6#2)
Management Agency##2##2##(2008-10#1)(2011-1#1)
Management Information System##2##3##(1992-3#1)(1993-12#1)
Management Model##3##2##(1996-12#1)(2008-11#2)
Management Program##5##2##(1991-2#1)(2008-3#4)
Management System##4##2##(1994-1#1)(2008-7#1)(2009-10#1)(2010-8#1)
Management Team##2##2##(2008-11#1)(2010-8#1)
Management and##8##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
Management at##4##2##(1991-2#1)(1996-1#1)(1997-2#1)(1997-3#1)
Management in##3##2##(1993-12#1)(1994-2#1)(2008-11#1)
Management of Acute##3##3##(2008-12#1)(2008-3#1)(2008-4#1)
Management of a##2##3##(2010-3#1)(2013-1#1)
Management of acute##2##3##(1996-3#1)(2008-3#1)
Management of an##2##3##(2008-9#1)(2013-8#1)
Management of childhood##2##3##(1991-11#1)(1991-3#1)
Management of complex##2##3##(2008-6#1)(2013-1#1)
Management of patients with##2##4##(1990-3#1)(2008-8#1)
Management of patients##3##3##(1990-3#1)(2008-8#1)(2013-1#1)
Management of the##9##3##(1990-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-1#1)(2009-12#1)(2010-12#1)(2012-3#1)
Management of type 2 diabetes##2##5##(1994-12#1)(2008-3#1)
Management of##124##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-7#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#9)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#8)(2008-12#4)(2008-2#1)(2008-3#10)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
Management training##2##2##(1993-1#2)
Management##250##1##(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#4)(1993-12#5)(1993-3#1)(1993-7#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#2)(1995-1#3)(1995-11#2)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#11)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#14)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#14)(2008-4#3)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#3)
Management's##3##1##(1991-12#2)(2008-11#1)
Manager##2##1##(2008-10#1)(2012-3#1)
Managerial##4##1##(1994-3#1)(1997-1#1)(2008-1#1)(2012-3#1)
Managers##10##1##(1991-12#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1997-3#1)(2008-8#3)(2010-10#1)
Managing a##3##2##(1995-12#1)(1996-6#1)(2008-8#1)
Managing diversity##2##2##(1991-9#1)(1994-12#1)
Managing ethical issues in sexual violence##2##6##(2010-3#2)
Managing the##9##2##(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#1)
Managing these##2##2##(1994-12#1)(2008-12#1)
Managing##64##1##(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-2#3)(1992-3#1)(1992-5#1)(1993-1#2)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
Manakov##2##1##(2007-12#2)
Manaus##3##1##(2008-10#1)(2011-2#2)
Manchester##10##1##(1992-11#1)(2008-11#2)(2008-7#5)(2008-9#1)(2013-1#1)
Mancozeb and##3##2##(2008-10#3)
Mancozeb##10##1##(2008-10#10)
Mandarin monosyllabic lexical##2##3##(2008-9#2)
Mandarin tone##2##2##(2008-9#2)
Mandarin##10##1##(2008-9#6)(2013-8#4)
Mandibular##10##1##(2007-12#2)(2008-7#1)(2012-12#2)(2012-2#1)(2012-3#4)
Manduca sexta##13##2##(1991-12#2)(1995-11#2)(1995-6#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#2)
Manduca##15##1##(1991-12#2)(1995-11#2)(1995-6#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#4)
Manfred##3##1##(1997-6#2)(2008-5#1)
Manganese##10##1##(1995-6#1)(2007-11#2)(2008-10#7)
Manganese(II)##4##1##(2008-10#3)(2008-5#1)
Mange##2##1##(1990-3#1)(1996-3#1)
Manger##5##1##(1993-3#2)(1993-6#3)
Mangifera indica##2##2##(2008-10#1)(2010-5#1)
Mangiferin##2##1##(2010-5#2)
Mango malformation disease##2##3##(2008-10#2)
Mango##5##1##(2008-10#5)
Manhattan##4##1##(1992-1#1)(1996-5#1)(2008-12#1)(2013-7#1)
Manifestations of##2##2##(1997-3#1)(2008-12#1)
Manipulating##3##1##(2008-12#1)(2008-6#1)(2012-2#1)
Manipulation of cells##2##3##(2008-11#2)
Manipulation of the##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
Manipulation of##14##2##(1994-5#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-10#1)(2013-8#1)
Manipulation##16##1##(1994-5#1)(1994-6#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-12#2)(2010-7#1)(2011-1#1)(2011-10#1)(2013-8#1)
Manipulative therapy##2##2##(2008-12#2)
Manipur##2##1##(2007-7#2)
Manitoba##14##1##(1993-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2007-12#3)(2008-10#3)(2010-8#3)
Manitoba's##2##1##(1996-3#2)
Manizales##3##1##(2012-12#3)
Mann hopes##2##2##(1990-11#2)
Mann##11##1##(1990-11#6)(1990-3#1)(1997-8#1)(2007-11#1)(2008-7#1)(2011-2#1)
Mann-Whitney U##3##2##(1994-2#1)(2007-8#1)(2008-6#1)
Mann-Whitney U-test##2##2##(2007-10#1)(2013-8#1)
Mann-Whitney U-test)##2##2##(1995-8#2)
Mann-Whitney and Kruskal-Wallis##2##3##(2008-9#1)(2013-1#1)
Mann-Whitney test##4##2##(2008-10#2)(2010-5#1)(2013-1#1)
Mann-Whitney##17##1##(1992-6#1)(1994-2#1)(1995-8#2)(1997-3#2)(2007-10#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-5#1)(2013-1#3)(2013-8#1)
Mannan-binding lectin##2##2##(2012-3#2)
Manner##2##1##(2008-10#1)(2008-11#1)
Mannich reaction##3##2##(2008-10#3)
Mannich##4##1##(2008-10#3)(2011-3#1)
Mannitol##3##1##(2008-1#1)(2008-10#1)(2008-8#1)
Manno-oligosaccharides##2##1##(1991-12#2)
Mannose##2##1##(1991-9#1)(1995-2#1)
Mannose-binding lectin##3##2##(2013-1#3)
Mannosylerythritol lipid##2##2##(2008-11#2)
Mansonella##2##1##(1990-8#2)
Mansonia titillans##2##2##(2008-5#2)
Mansonia##4##1##(2008-12#1)(2008-5#2)(2008-7#1)
Mantel test##2##2##(2010-6#1)(2011-2#1)
Mantel##6##1##(2008-10#3)(2010-6#1)(2011-2#2)
Mantle cell lymphoma##2##3##(2008-3#1)(2009-1#1)
Mantle cell##3##2##(2008-3#1)(2009-1#1)(2009-8#1)
Mantle##4##1##(2008-3#1)(2009-1#1)(2009-8#1)(2013-7#1)
Mantoux test##3##2##(1993-3#1)(2008-1#1)(2012-3#1)
Mantoux##6##1##(1990-6#3)(1993-3#1)(2008-1#1)(2012-3#1)
Manual for##3##2##(1995-2#2)(2010-6#1)
Manual of##14##2##(1996-2#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#6)(2013-1#1)
Manual##27##1##(1994-2#1)(1995-2#2)(1996-11#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#7)(2013-1#1)
Manuel Ferreira da Câmara##2##4##(2009-10#2)
Manuel##3##1##(2009-10#2)(2011-1#1)
Manufacturers##3##1##(1996-1#1)(2008-11#1)(2008-7#1)
Manufacturing##6##1##(1995-5#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Manure##2##1##(2008-10#1)(2008-6#1)
Many agents##2##2##(1995-11#1)(2008-5#1)
Many are##2##2##(1997-3#1)(2012-12#1)
Many aspects of##2##3##(2009-3#1)(2011-2#1)
Many attempts##2##2##(2008-10#1)(2008-11#1)
Many authors##2##2##(1997-8#1)(2008-5#1)
Many bacteria##3##2##(2008-10#1)(2008-9#2)
Many bacterial##2##2##(1994-9#1)(1995-6#1)
Many cases##2##2##(2008-1#1)(2013-8#1)
Many challenges##2##2##(1997-2#1)(2011-1#1)
Many chemical##3##2##(1991-5#1)(2008-10#1)(2008-7#1)
Many children##2##2##(1996-12#1)(2012-2#1)
Many clinical trials##2##3##(1991-8#1)(1997-4#1)
Many clinical##3##2##(1991-8#1)(1997-3#1)(1997-4#1)
Many coexisting metal ions##2##4##(2008-10#2)
Many current##2##2##(1993-12#1)(2008-8#1)
Many different##10##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#2)
Many differential diagnoses##2##3##(2011-2#2)
Many diseases##2##2##(2008-4#1)(2008-9#1)
Many empirical studies##2##3##(2008-8#1)(2008-9#1)
Many exciting##2##2##(2008-10#1)(2008-5#1)
Many experiments##2##2##(2008-10#1)(2013-8#1)
Many factors are##4##3##(2008-5#1)(2009-1#1)(2011-2#1)(2013-1#1)
Many factors##9##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Many family##2##2##(2008-11#1)(2010-4#1)
Many groups simply run out of storage space and are in need of an efficient and cost-effective way to manage this problem##2##22##(1994-3#2)
Many health##3##2##(1995-2#1)(1996-1#1)(2013-1#1)
Many hospitals and##2##3##(1996-3#1)(2008-11#1)
Many hospitals##4##2##(1991-1#1)(1996-3#1)(2008-11#2)
Many important##2##2##(1993-12#1)(2012-2#1)
Many individuals##2##2##(2007-12#1)(2013-1#1)
Many medical groups have a problem storaging and managing inactive medical records##2##12##(1994-3#2)
Many medical groups##3##3##(1993-1#1)(1994-3#2)
Many medical##4##2##(1993-1#1)(1994-3#2)(2010-8#1)
Many methods have been described for##2##6##(2008-5#1)(2013-1#1)
Many methods##4##2##(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
Many new##3##2##(2008-2#1)(2010-3#1)(2011-2#1)
Many of our##2##3##(1992-9#1)(2008-1#1)
Many of the applications##2##4##(2008-7#1)(2008-9#1)
Many of the studies##2##4##(2008-3#1)(2012-3#1)
Many of the##34##3##(1992-3#2)(1993-6#1)(1994-1#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
Many of these are##3##4##(2008-10#1)(2009-10#1)(2010-11#1)
Many of these contributions were presented at the Optical Society of America Topical Meeting on Laser Applications to Chemical and Environmental Analysis##2##22##(2008-2#1)(2008-3#1)
Many of these injuries can be avoided in an ergonomically designed office##2##12##(1994-3#2)
Many of these##31##3##(1990-8#1)(1992-8#1)(1994-2#1)(1994-3#2)(1996-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-8#2)
Many of those##2##3##(1997-8#1)(2013-8#1)
Many of##72##2##(1990-8#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#3)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
Many organizations are##6##3##(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-3#1)
Many other factors##2##3##(1994-11#1)(2009-10#1)
Many other##9##2##(1992-3#1)(1994-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2013-1#2)(2013-8#1)
Many patients who##2##3##(2008-11#1)(2009-11#1)
Many patients with##5##3##(1997-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2011-1#1)
Many patients##17##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-3#1)(1992-5#1)(1994-12#1)(1996-3#1)(1997-3#1)(2006-10#2)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)
Many people##6##2##(1992-3#1)(1995-1#1)(1996-5#1)(2008-1#1)(2008-7#1)(2008-9#1)
Many physicians hire financial directors and accountants to manage their bottom line##2##12##(1994-1#2)
Many physicians##3##2##(1990-2#1)(1994-1#2)
Many plant##2##2##(2008-10#1)(2008-7#1)
Many plants##2##2##(2008-9#1)(2009-8#1)
Many popular##2##2##(1997-8#1)(2007-12#1)
Many products##2##2##(2008-1#1)(2008-7#1)
Many research##2##2##(2006-6#1)(2008-11#1)
Many respondents##4##2##(2007-12#1)(2010-5#2)(2012-2#1)
Many risk factors##2##3##(2008-10#1)(2012-12#1)
Many studies demonstrate##2##3##(2010-11#1)(2010-7#1)
Many studies have##6##3##(2007-7#1)(2008-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
Many studies indicate##2##3##(1996-9#1)(2011-2#1)
Many studies on##2##3##(1993-12#1)(2012-3#1)
Many studies##16##2##(1990-5#1)(1993-12#1)(1996-9#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Many techniques##2##2##(1995-3#1)(2008-10#1)
Many therapeutic##2##2##(2010-12#1)(2011-2#1)
Many types of cancer##2##4##(1993-12#1)(2007-11#1)
Many types of##4##3##(1993-12#1)(2006-6#1)(2007-11#1)(2008-11#1)
Many variables##3##2##(1996-1#1)(2008-12#1)(2008-9#1)
Many##454##1##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#6)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#5)(2006-10#2)(2006-6#2)(2007-11#5)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#10)(2008-10#24)(2008-11#20)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#8)(2008-5#22)(2008-6#4)(2008-7#26)(2008-8#21)(2008-9#24)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#8)(2011-10#1)(2011-2#19)(2011-3#2)(2012-12#7)(2012-2#8)(2012-3#10)(2013-1#13)(2013-8#8)
Manzanillo cv##3##2##(2008-12#3)
Manzanillo##4##1##(2008-12#4)
Mao-to##7##1##(2010-7#7)
Maoa##2##1##(2009-8#2)
Maori and Pacific##2##3##(2008-8#2)
Maori and##3##2##(2008-1#1)(2008-8#2)
Maori health##3##2##(2008-1#3)
Maori men's perceptions and experiences of health seeking for prostate health problems##2##12##(2008-1#2)
Maori##24##1##(2008-1#21)(2008-8#3)
Map##18##1##(1995-3#5)(2008-10#3)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)
Mapmaker##3##1##(2008-10#2)(2008-4#1)
Mapping and##6##2##(2008-10#4)(2010-5#1)(2012-3#1)
Mapping of a Gene##3##4##(2008-10#3)
Mapping of a##6##3##(1996-2#1)(2008-10#4)(2008-8#1)
Mapping of the##5##3##(1992-3#1)(1995-6#1)(2008-10#3)
Mapping of##25##2##(1992-3#1)(1994-11#1)(1995-6#1)(1996-2#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)
Mapping the##12##2##(1991-1#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
Mapping##66##1##(1991-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
Maps of##4##2##(2008-10#3)(2008-7#1)
Maps##12##1##(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
Mapuche foods##2##2##(2012-2#2)
Mapuche persons##3##2##(2012-2#3)
Mapuche##8##1##(2012-2#8)
Maquet Servo-i ventilator##2##3##(2011-2#2)
Maquet##3##1##(2008-12#1)(2011-2#2)
Mar##3##1##(1996-11#1)(2008-5#1)(2010-11#1)
Maranhão##3##1##(2008-6#1)(2008-9#2)
Marbled Godwit and Willet##2##4##(2013-7#2)
Marbled##3##1##(2013-7#3)
Marburg##2##1##(1995-6#1)(2007-9#1)
Marcel##2##1##(2008-4#2)
March 11##2##2##(2012-2#2)
March 17##16##2##(2007-10#1)(2011-1#15)
March 1983##2##2##(1990-12#1)(1990-3#1)
March 1985##2##2##(1991-2#1)(1995-6#1)
March 1987 to##2##3##(1991-2#1)(2008-5#1)
March 1987##3##2##(1990-12#1)(1991-2#1)(2008-5#1)
March 1988##2##2##(1990-8#1)(1996-5#1)
March 1990##2##2##(1991-2#1)(1995-2#1)
March 1994##5##2##(1995-5#1)(1996-6#1)(2007-8#1)(2008-7#2)
March 1995##3##2##(1996-9#1)(2008-7#1)(2010-3#1)
March 1996##3##2##(1996-6#1)(1997-5#1)(2008-3#1)
March 1997##2##2##(2008-2#1)(2008-5#1)
March 1998##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)
March 1999##2##2##(2008-5#2)
March 2000##4##2##(2007-7#2)(2008-5#1)(2010-8#1)
March 2001 to March##2##4##(2008-5#1)(2008-9#1)
March 2001##5##2##(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#1)
March 2002##4##2##(2007-8#2)(2008-1#1)(2008-7#1)
March 2003##6##2##(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
March 2004##3##2##(2008-11#1)(2008-7#1)(2013-7#1)
March 2005##4##2##(2008-12#2)(2008-9#1)(2010-3#1)
March 2006##6##2##(2008-12#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
March 2007##4##2##(2008-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
March 2008##4##2##(2009-6#1)(2010-3#1)(2011-1#1)(2012-1#1)
March 2010##5##2##(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
March 2011##3##2##(2012-12#1)(2012-3#1)(2013-1#1)
March 31##5##2##(2008-11#1)(2010-6#1)(2012-1#2)(2013-1#1)
March 5-9##2##2##(2008-10#2)
March and April##3##3##(2008-10#2)(2012-2#1)
March and##5##2##(1996-6#1)(2008-10#2)(2008-5#1)(2012-2#1)
March to##3##2##(2008-10#1)(2012-6#2)
March##155##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#4)(1996-9#2)(1997-2#1)(1997-5#1)(2007-10#1)(2007-5#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#2)(2008-5#14)(2008-7#7)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#18)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#2)(2012-6#2)(2013-1#3)(2013-7#2)(2013-8#5)
March)##2##1##(2008-10#1)(2012-1#1)
March-June 1997 and##2##3##(2008-5#2)
Marchiafava##2##1##(2010-1#2)
Marcus##2##1##(1995-2#1)(1997-7#1)
Marcusenius pongolensis##2##2##(2009-8#2)
Marek's disease (MD) skin##2##4##(1997-6#1)(2008-5#1)
Marek's disease virus##4##3##(2007-6#2)(2008-5#2)
Marek's disease##12##2##(1997-6#2)(2007-6#4)(2008-5#6)
Marfan syndrome is##2##3##(2013-1#2)
Marfan syndrome##18##2##(2007-8#2)(2008-8#2)(2009-3#1)(2009-7#1)(2012-1#2)(2012-3#1)(2013-1#9)
Marfan##21##1##(2007-8#2)(2008-8#5)(2009-3#1)(2009-7#1)(2012-1#2)(2012-3#1)(2013-1#9)
Marfan's syndrome##3##2##(2007-8#2)(2011-1#1)
Marfan's##4##1##(2007-8#2)(2011-1#1)(2012-2#1)
Margaret Hospital##3##2##(1992-2#2)(1992-3#1)
Marginal##10##1##(1992-9#1)(1997-4#2)(1997-8#1)(2008-10#2)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
Margins of the##2##3##(1991-1#1)(2011-1#1)
Margins##3##1##(1991-1#1)(1995-4#1)(2011-1#1)
Maria##7##1##(1995-3#1)(1996-2#1)(2008-10#2)(2008-9#1)(2010-1#1)(2011-2#1)
Marian##3##1##(2007-8#2)(2013-1#1)
Marie E##8##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Marie##11##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
Marijuana##3##1##(1991-1#1)(2012-12#2)
Marine Park##2##2##(2007-5#2)
Marine##26##1##(2007-5#8)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#2)(2011-1#1)(2013-7#1)
Marinobacter adhaerens##2##2##(2011-2#2)
Marinobacter##3##1##(2008-10#1)(2011-2#2)
Marinos Gerulanos##2##2##(2009-7#2)
Marion##3##1##(2007-5#1)(2008-10#1)(2008-5#1)
Maris##2##1##(2007-11#1)(2008-10#1)
Marisa cornuarietis##4##2##(2008-11#4)
Marit##13##1##(1993-3#2)(2011-2#11)
Marital##4##1##(2007-10#2)(2007-2#1)(2011-2#1)
Maritime##3##1##(2008-11#2)(2008-2#1)
Marjolin's ulcer##2##2##(2008-9#2)
Mark 3 (HUI3)##2##3##(2007-10#1)(2008-7#1)
Mark##9##1##(1994-2#1)(1994-3#1)(2007-10#3)(2007-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
Marked##11##1##(1990-2#1)(1991-4#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
Marker##13##1##(1990-11#1)(1993-11#1)(1994-11#1)(1994-8#1)(2007-7#1)(2008-10#5)(2008-3#1)(2012-2#1)(2013-8#1)
Markers Linked to a##2##4##(2008-10#2)
Markers Linked to the##2##4##(2008-10#2)
Markers Linked to##6##3##(2008-10#6)
Markers and##3##2##(1994-7#1)(2008-10#2)
Markers for the##2##3##(2008-10#2)
Markers for##5##2##(1996-12#1)(2008-10#4)
Markers in##5##2##(2008-10#4)(2009-5#1)
Markers of##4##2##(1994-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
Markers to##2##2##(2007-11#1)(2008-6#1)
Markers##43##1##(1994-12#1)(1994-7#1)(1996-12#1)(2007-11#1)(2008-10#29)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-5#1)(2012-3#1)
Market##4##1##(1994-2#1)(1995-12#1)(2008-11#1)(2013-1#1)
Marketers##2##1##(1996-3#1)(2008-12#1)
Marketing a##2##2##(1992-3#1)(1996-2#1)
Marketing medical services to an aging America##2##7##(1994-3#2)
Marketing medical##3##2##(1991-3#1)(1994-3#2)
Marketing of##4##2##(1993-12#1)(1995-1#1)(2008-10#1)(2010-5#1)
Marketing specialty physician services##2##4##(1994-1#2)
Marketing##25##1##(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-3#3)(1995-1#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-5#1)
Markov chain Monte Carlo (MCMC) method##2##6##(2009-4#1)(2012-7#1)
Markov chain Monte Carlo (MCMC)##3##5##(2009-12#1)(2009-4#1)(2012-7#1)
Markov chain Monte Carlo methods##2##5##(2009-9#1)(2010-2#1)
Markov chain Monte Carlo##10##4##(1995-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-3#1)(2012-7#1)
Markov chain##12##2##(1995-12#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-3#1)(2012-7#1)
Markov chains##2##2##(2008-7#2)
Markov decision##2##2##(2009-3#1)(2009-4#1)
Markov model was##2##3##(2012-12#2)
Markov model##13##2##(1996-12#2)(1997-2#2)(1997-6#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-8#1)(2012-12#2)
Markov models (HMM)##2##3##(2008-7#1)(2009-7#1)
Markov models to##2##3##(2008-4#1)(2009-3#1)
Markov models##10##2##(2008-4#3)(2008-7#2)(2009-3#2)(2009-7#2)(2012-12#1)
Markov random##2##2##(2007-12#1)(2008-6#1)
Markov##50##1##(1995-12#1)(1995-9#1)(1996-12#2)(1997-2#2)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#4)(2008-6#4)(2008-7#6)(2008-8#2)(2009-12#1)(2009-3#4)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#1)(2012-12#3)(2012-3#1)(2012-7#1)(2013-8#1)
Markovian mixture##2##2##(2008-2#2)
Markovian##4##1##(2008-2#3)(2008-3#1)
Marlex##2##1##(2008-6#2)
Marmara##3##1##(1997-3#2)(2008-10#1)
Marquardt-Levenberg##3##1##(2008-2#3)
Marriage##4##1##(1990-6#1)(1994-6#1)(2008-11#1)(2009-11#1)
Married women##2##2##(1990-12#1)(2011-1#1)
Married##3##1##(1990-12#1)(1995-2#1)(2011-1#1)
Mars##6##1##(1995-3#1)(1995-6#1)(2008-10#2)(2008-4#1)(2012-3#1)
Marshall Islands (RMI)##3##3##(2008-1#1)(2013-8#2)
Marshall Islands##15##2##(1994-9#3)(2008-1#8)(2008-10#1)(2013-8#3)
Marshall McIntosh##3##2##(2008-10#3)
Marshall Space Flight Center##2##4##(2008-3#2)
Marshall##22##1##(1992-3#1)(1994-9#3)(2008-1#8)(2008-10#4)(2008-3#2)(2011-2#1)(2013-8#3)
Martin##7##1##(1992-2#1)(1995-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#2)
Martina Franca##2##2##(2010-4#2)
Martins##2##1##(2011-1#2)
Marx##3##1##(1994-1#2)(2008-10#1)
Mary##7##1##(1992-3#1)(1993-3#1)(1994-1#2)(1995-6#2)(2009-9#1)
Mary's Hospital in##2##3##(1995-12#1)(1996-2#1)
Mary's Hospital##3##2##(1993-12#1)(1995-12#1)(1996-2#1)
Mary's##4##1##(1992-1#1)(1993-12#1)(1995-12#1)(1996-2#1)
Maryhaven##4##1##(2008-6#4)
Maryland and##4##2##(1997-5#1)(2008-10#2)(2012-3#1)
Maryland##21##1##(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#2)
Mas-DP II##2##2##(1991-12#2)
Masaoka's stages##2##2##(2007-8#2)
Masfjorden##2##1##(1994-11#2)
Mashad##5##1##(2008-12#5)
Mashhad##5##1##(2007-7#2)(2011-2#3)
Mashona heifers##3##2##(1996-12#3)
Mashona##4##1##(1996-12#4)
Masked##2##1##(2007-11#1)(2012-12#1)
Masking##2##1##(2008-5#1)(2012-2#1)
Maslow##2##1##(1995-2#1)(2013-8#1)
Mason Tenders##3##2##(1995-12#3)
Mason##4##1##(1995-12#3)(2008-11#1)
Mason-Pfizer monkey virus##2##3##(2009-7#2)
Maspin is##2##2##(1995-6#2)
Mass Index##10##2##(2007-8#2)(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
Mass Spectrometry##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
Mass distribution##2##2##(1993-2#1)(2008-10#1)
Mass measurements##2##2##(1990-8#1)(1991-12#1)
Mass spectra##2##2##(2008-10#2)
Mass spectral analysis##2##3##(1990-7#1)(1995-2#1)
Mass spectral##3##2##(1990-7#1)(1995-2#1)(2008-10#1)
Mass spectrometric##3##2##(1992-8#1)(1995-5#1)(2008-10#1)
Mass spectrometry of##2##3##(2008-10#2)
Mass spectrometry was used to##2##5##(1997-3#1)(2008-10#1)
Mass spectrometry##8##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-9#1)(2012-12#1)
Mass transfer##2##2##(1990-12#1)(2008-7#1)
Mass##70##1##(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1992-8#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1997-3#1)(1997-6#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)
Mass-transport##2##1##(2008-3#2)
Massachusetts Bay##2##2##(1994-8#2)
Massachusetts General Hospital##14##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-10#1)(2008-4#1)(2010-5#1)
Massachusetts experience##2##2##(1997-2#2)
Massachusetts study##2##2##(2007-2#2)
Massachusetts##48##1##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-4#2)(2008-5#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
Massage therapy##2##2##(2008-10#1)(2008-12#1)
Massage##4##1##(2008-10#2)(2008-12#1)(2009-9#1)
Masserann technique##2##2##(2008-7#2)
Masserann##3##1##(2008-7#3)
Massive goiter with retrosternal extension##2##5##(2011-1#2)
Massive##6##1##(1992-9#1)(2007-8#2)(2011-1#2)(2012-1#1)
Massively##2##1##(2007-12#1)(2009-5#1)
Masson's trichrome##2##2##(2008-11#1)(2011-2#1)
Masson's##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
Masson-Fontana##2##1##(2008-5#2)
Mast cell##2##2##(1995-11#1)(2011-2#1)
Mast cells are##2##3##(1995-12#1)(2011-2#1)
Mast cells##5##2##(1995-12#1)(2008-4#1)(2008-7#2)(2011-2#1)
Mast##9##1##(1995-11#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#3)
Mastectomy##2##1##(1995-4#1)(2011-2#1)
Master of##3##2##(1992-1#1)(1994-12#1)(2010-3#1)
Master patient scheduling##2##3##(1996-2#2)
Master##14##1##(1992-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(2008-11#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)
Master's##4##1##(1992-2#1)(1996-1#1)(2008-11#2)
Masters##3##1##(2008-12#1)(2012-12#1)(2013-8#1)
Mastigocladus laminosus##3##2##(1993-11#3)
Mastoparan##6##1##(1991-5#2)(1997-1#4)
Mastrevirus)##2##1##(2008-10#2)
Mat1a(-/-)##2##1##(2013-1#2)
Mata##2##1##(2011-2#1)(2013-8#1)
Matched##3##1##(1995-1#1)(2009-11#1)(2012-12#1)
Matching##10##1##(1994-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
Material and Methods##35##3##(2007-11#2)(2007-8#1)(2010-12#1)(2012-3#1)(2013-1#21)(2013-8#9)
Material and method##6##3##(2007-11#1)(2007-8#4)(2008-7#1)
Material and methods##133##3##(2006-10#2)(2006-8#3)(2007-11#77)(2007-8#33)(2009-8#1)(2011-1#1)(2011-2#9)(2012-12#4)(2013-1#3)
Material and##178##2##(2006-10#2)(2006-8#3)(2007-11#81)(2007-8#38)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#9)(2012-12#4)(2012-3#1)(2013-1#25)(2013-8#9)
Material andMethods##2##2##(2013-8#2)
Material consists of##2##3##(2007-11#2)
Material##202##1##(1993-2#1)(1997-6#1)(2006-10#2)(2006-8#3)(2007-11#85)(2007-8#40)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#4)(2012-3#1)(2013-1#25)(2013-8#15)
Material/Methods##10##1##(2013-1#10)
Materials and Methods##22##3##(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#15)(2013-8#3)
Materials and methods##39##3##(2007-10#4)(2007-11#1)(2007-8#1)(2009-4#1)(2009-8#1)(2012-12#22)(2013-1#8)(2013-8#1)
Materials and##62##2##(2007-10#4)(2007-11#1)(2007-12#1)(2007-8#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-12#23)(2012-2#1)(2012-3#1)(2013-1#23)(2013-8#4)
Materials were##2##2##(2008-5#1)(2013-1#1)
Materials##93##1##(1994-9#1)(1996-9#1)(1997-3#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-7#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#23)(2012-2#1)(2012-3#2)(2013-1#25)(2013-8#6)
Maternal HIV-1##2##2##(2011-1#2)
Maternal Health##2##2##(1996-3#1)(2008-7#1)
Maternal and##6##2##(1995-12#1)(2007-10#1)(2008-1#1)(2009-1#1)(2010-3#2)
Maternal effects##2##2##(1997-7#1)(2008-5#1)
Maternal mortality##2##2##(1994-3#1)(2008-7#1)
Maternal personality##2##2##(2008-2#1)(2010-6#1)
Maternal position and other variables##2##5##(2013-1#2)
Maternal self-esteem##2##2##(1993-3#2)
Maternal serum##2##2##(1995-8#2)
Maternal##60##1##(1993-10#1)(1993-3#2)(1994-3#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-2#2)(1996-3#1)(1997-7#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-10#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
Maternal-Fetal##2##1##(2007-2#1)(2011-2#1)
Maternal-fetal##2##1##(1995-8#1)(2007-2#1)
Maternally##2##1##(2008-7#1)(2013-8#1)
Maternity Hospital##3##2##(2008-11#1)(2008-9#1)(2009-10#1)
Maternity##6##1##(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
Math##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
Mathematica##3##1##(2008-2#2)(2008-3#1)
Mathematical analysis##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
Mathematical model##2##2##(2008-10#1)(2008-2#1)
Mathematical modeling of##2##3##(2013-8#2)
Mathematical modeling##3##2##(2008-3#1)(2013-8#2)
Mathematical models are##2##3##(1995-2#1)(2008-9#1)
Mathematical models of##4##3##(2008-1#1)(2008-10#3)
Mathematical models##11##2##(1991-12#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
Mathematical##30##1##(1991-12#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#8)
Mating Type of##2##3##(2008-10#2)
Mating Type##4##2##(2008-10#4)
Mating and##2##2##(2008-10#2)
Mating type and##2##3##(2008-10#2)
Mating type##3##2##(2008-10#3)
Mating##18##1##(1995-6#1)(2008-10#12)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
Matlab##3##1##(2008-10#1)(2008-6#1)(2013-8#1)
Mato Grosso##6##2##(1991-12#2)(2008-5#2)(2010-8#1)(2013-7#1)
Matric##3##1##(2008-10#3)
Matrigel##20##1##(2008-11#9)(2008-4#1)(2008-6#3)(2008-8#1)(2012-4#2)(2012-5#4)
Matrigel-cultured cells##2##2##(2008-7#2)
Matrine##2##1##(2008-10#1)(2010-8#1)
Matrix effect##2##2##(2008-10#1)(2010-11#1)
Matrix effects were##2##3##(2008-10#2)
Matrix effects##3##2##(2008-10#3)
Matrix ions of##2##3##(2008-10#2)
Matrix metalloproteinases are a##2##4##(2008-1#1)(2009-5#1)
Matrix metalloproteinases##6##2##(2008-1#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
Matrix related##2##2##(2008-10#1)(2012-12#1)
Matrix##30##1##(1994-3#1)(1996-9#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Matteo##2##1##(1993-5#1)(1993-6#1)
Matter##9##1##(2008-10#2)(2008-11#1)(2008-12#3)(2009-10#1)(2010-6#1)(2010-7#1)
Matters##3##1##(1995-1#1)(2006-10#1)(2011-9#1)
Matthews##2##1##(1990-8#1)(1995-2#1)
Maturation and##3##2##(2008-10#3)
Maturation of##7##2##(1995-6#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-9#1)
Maturation##10##1##(1995-6#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-9#1)
Mature cultures##2##2##(2008-10#2)
Mature cystic##2##2##(2013-1#1)(2013-8#1)
Mature spermatozoa##2##2##(2008-7#2)
Mature##20##1##(1995-1#1)(1996-5#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2013-1#1)(2013-8#1)
Matured##2##1##(2007-8#1)(2008-5#1)
Maturity onset diabetes of the##2##5##(2008-1#2)
Maturity##3##1##(2008-1#2)(2008-10#1)
Mauna##2##1##(1990-8#1)(2008-2#1)
Mauthner##2##1##(1990-5#2)
Max##4##1##(1991-5#1)(1991-9#2)(2010-10#1)
Max-EPA##2##1##(1990-7#2)
Maxillary sinus cancer##2##3##(2008-3#2)
Maxillary sinus##3##2##(2008-2#1)(2008-3#2)
Maxillary##9##1##(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#1)
Maxillofacial##2##1##(2009-12#1)(2013-1#1)
Maximal activation##2##2##(1992-5#1)(1992-6#1)
Maximal induction was##2##3##(1990-5#1)(1995-8#1)
Maximal yields close to 100%##2##5##(2008-10#2)
Maximal##26##1##(1990-5#1)(1990-8#1)(1991-12#1)(1992-5#1)(1992-6#2)(1993-9#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
Maximizer##6##1##(2008-11#6)
Maximizing##4##1##(1994-1#1)(2007-10#1)(2008-10#1)(2008-7#1)
Maximum absorbance is at##2##4##(2008-10#2)
Maximum absorbance##3##2##(2008-10#3)
Maximum activity##2##2##(1992-6#1)(2008-10#1)
Maximum isolation##2##2##(2007-7#2)
Maximum likelihood##2##2##(2008-3#1)(2008-9#1)
Maximum parsimony analysis of##2##4##(2008-10#2)
Maximum parsimony##3##2##(2008-10#3)
Maximum pyrolysis##2##2##(2008-10#2)
Maximum sorption of##2##3##(2008-10#2)
Maximum total##2##2##(2009-7#1)(2012-1#1)
Maximum##65##1##(1991-6#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1996-5#1)(2007-7#2)(2008-10#27)(2008-11#3)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
Maxwell's equations##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Maxwell's##5##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
Maxwell-Bloch equations##2##2##(2007-11#1)(2007-12#1)
Maxwell-Garnett##4##1##(2008-2#1)(2008-3#3)
Maxyl and##2##2##(2011-10#2)
May 15-17##2##2##(1992-3#1)(2010-1#1)
May 1989##2##2##(1990-11#1)(1992-1#1)
May 1993##2##2##(1994-3#1)(1996-9#1)
May 1994##2##2##(2008-2#1)(2008-5#1)
May 1995##2##2##(1996-9#1)(2008-2#1)
May 1997##5##2##(1997-6#1)(2008-11#1)(2008-5#3)
May 1998##9##2##(2008-5#9)
May 1999##2##2##(2008-3#1)(2009-10#1)
May 2000##2##2##(2008-11#1)(2008-5#1)
May 2002##3##2##(2007-7#1)(2008-10#2)
May 2003 to##2##3##(2008-12#1)(2012-2#1)
May 2003##3##2##(2007-2#1)(2008-12#1)(2012-2#1)
May 2004 and##2##3##(2008-10#2)
May 2004##6##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)
May 2005##3##2##(2008-12#2)(2011-2#1)
May 2006##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)
May 2007 to##2##3##(2011-2#1)(2012-2#1)
May 2008##2##2##(2010-6#1)(2012-2#1)
May 2009##4##2##(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
May 2010##2##2##(2012-3#2)
May 2011##5##2##(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#2)
May 31##2##2##(1991-5#1)(2006-10#1)
May 5-8##2##2##(2011-1#1)(2011-2#1)
May and October##2##3##(1996-11#1)(2008-5#1)
May and##9##2##(1996-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
May of##3##2##(1995-3#1)(1996-3#1)(2013-1#1)
May to August##2##3##(2007-5#1)(2007-7#1)
May to July##2##3##(2008-10#1)(2008-7#1)
May to October##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
May to September##3##3##(1996-12#1)(1997-6#1)(2013-8#1)
May to##17##2##(1995-6#1)(1996-12#2)(1997-6#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#2)
May##167##1##(1990-10#1)(1990-11#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-1#2)(1992-3#1)(1992-6#1)(1994-3#1)(1995-3#2)(1995-6#2)(1996-11#2)(1996-12#4)(1996-3#1)(1996-5#6)(1996-9#2)(1997-2#1)(1997-6#2)(2006-10#1)(2007-2#1)(2007-5#2)(2007-7#4)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#9)(2008-2#2)(2008-3#1)(2008-5#21)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#7)(2013-8#3)
May)##4##1##(1996-11#1)(2008-10#3)
Maybe##5##1##(1994-2#1)(2007-9#1)(2008-5#1)(2009-5#1)(2009-8#1)
Mayer##2##1##(1996-5#1)(2009-9#1)
Mayer's##3##1##(1996-5#2)(2013-8#1)
Mayo Clinic##5##2##(1997-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)
Mayo##16##1##(1992-11#1)(1997-2#1)(2008-1#2)(2008-5#1)(2008-9#4)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2012-3#1)(2013-1#1)
Mazandaran##4##1##(2008-12#2)(2011-2#1)(2012-2#1)
Maze##2##1##(1992-8#1)(2007-8#1)
Mazurka##2##1##(2008-10#2)
Mb and##3##2##(2008-10#2)(2010-7#1)
Mb for chromosome##2##3##(1996-12#2)
Mb in##2##2##(1994-5#1)(2008-10#1)
Mb is##2##2##(1994-5#2)
Mb of##8##2##(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-6#1)
Mb##51##1##(1994-5#7)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-6#3)(1996-8#1)(1997-2#2)(1997-6#1)(2008-10#13)(2008-7#1)(2009-10#1)(2010-3#1)(2010-4#9)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
Mb)##2##1##(2009-5#1)(2013-1#1)
Mb-2C(12)N(+)PA(-) films##3##2##(2008-10#3)
Mb-PAM film electrodes##2##3##(2008-10#2)
Mb-PAM##5##1##(2008-10#5)
MbSA)##4##1##(2011-2#4)
Mbits/s per channel##3##3##(2008-2#2)(2008-3#1)
Mbits/s##4##1##(2008-2#3)(2008-3#1)
Mbp##7##1##(1997-2#1)(2010-7#1)(2011-2#4)(2012-12#1)
Mc##3##1##(1990-2#2)(1991-3#1)
McAb2C9##2##1##(2008-8#2)
McAb3D3 and McAb4D8##3##3##(2008-8#3)
McArdle's disease##2##2##(2008-7#2)
McBride##5##1##(1993-2#1)(2009-10#3)(2012-12#1)
McCoy##3##1##(2008-11#3)
McCoy-Plovdiv##4##1##(2008-11#4)
McDonald##2##1##(1993-1#1)(2008-10#1)
McGill Pain Questionnaire##4##3##(2009-12#1)(2010-6#1)(2012-2#2)
McGill University##2##2##(2008-10#1)(2009-4#1)
McGill and##2##2##(2008-2#2)
McGill##11##1##(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-12#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#2)
McKenzie##2##1##(2008-12#1)(2012-2#1)
McMaster University##2##2##(1992-2#1)(2008-5#1)
McMaster##3##1##(1992-2#2)(2008-5#1)
McMurry##2##1##(1996-5#2)
McNamara##2##1##(1991-3#1)(1994-1#1)
McNemar##2##1##(1992-6#1)(2013-1#1)
McNemar's test for##2##3##(1992-6#1)(2013-8#1)
MchAI##3##1##(1993-9#3)
MchAII was##2##2##(1993-9#2)
MchAII##3##1##(1993-9#3)
Mcl-1 expression##2##2##(2013-1#2)
Mcl-1##8##1##(2012-12#4)(2013-1#4)
Mcl-1/Bim##3##1##(2013-1#3)
Me##5##1##(1996-2#2)(1997-7#1)(2010-4#1)(2012-3#1)
MeA##3##1##(1997-3#2)(2008-10#1)
MeATP##2##1##(1995-11#2)
MeBPHT##2##1##(2008-10#2)
MeBr##6##1##(1995-3#6)
MeCN##3##1##(1996-2#1)(1997-7#2)
MeDZHQ##4##1##(1993-11#4)
MeHg##4##1##(2008-10#2)(2008-7#2)
MeHg(+)##6##1##(2008-10#6)
MeIQ##3##1##(1992-2#1)(2008-10#2)
MeJA and Carr##2##3##(2011-10#2)
MeJA and##3##2##(2011-10#3)
MeJA application##2##2##(2011-10#2)
MeJA##7##1##(2008-10#2)(2011-10#5)
MeOH extract from a##2##4##(2008-11#2)
MeOH extract##3##2##(2008-11#3)
MeOH##18##1##(1996-5#1)(2008-10#13)(2008-11#4)
MeOSuc-Ala-Ala-Pro-boroPhe##2##1##(1993-11#2)
MeSH terms##3##2##(2011-2#2)(2013-1#1)
MeSH##14##1##(1991-1#2)(1992-12#1)(1993-2#1)(1993-3#2)(1995-1#3)(2008-1#1)(2008-6#1)(2011-2#2)(2013-1#1)
MeV for##2##2##(2008-3#1)(2009-11#1)
MeV linear accelerator##2##3##(1990-12#1)(1992-12#1)
MeV##13##1##(1990-12#1)(1992-12#1)(1994-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2012-1#2)
Meager Shoal##3##2##(2008-5#2)(2011-2#1)
Mealybug##2##1##(2008-10#2)
Mean (SD)##2##2##(1991-8#1)(2008-3#1)
Mean +/-##2##2##(2008-12#1)(2012-2#1)
Mean Corpuscular Haemoglobin##2##3##(2008-12#2)
Mean Corpuscular##3##2##(2008-12#3)
Mean Fluorescence Intensity##2##3##(2007-2#2)
Mean GSH##2##2##(1990-2#1)(2008-10#1)
Mean Hb##2##2##(2008-7#2)
Mean Square##2##2##(2008-10#1)(2010-6#1)
Mean age at diagnosis was##2##5##(1992-2#1)(1992-5#1)
Mean age of patients was##2##5##(2007-11#2)
Mean age of##6##3##(1994-9#1)(2007-11#2)(2008-5#1)(2012-2#1)(2013-1#1)
Mean age was##13##3##(1990-11#1)(1993-11#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-3#1)
Mean age##24##2##(1990-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-9#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Mean angle##2##2##(2009-12#2)
Mean annual##2##2##(2007-5#1)(2010-8#1)
Mean arterial##2##2##(2009-8#1)(2011-2#1)
Mean birth weight##2##3##(2007-12#1)(2011-1#1)
Mean birth##3##2##(1990-8#1)(2007-12#1)(2011-1#1)
Mean body weights of 175##2##5##(2008-9#2)
Mean body weights of 350 and 700 mg/L males were less than those of the controls##2##16##(2008-9#2)
Mean body weights of 400##2##5##(2008-9#2)
Mean body weights of dosed groups of mice were similar to those of the vehicle controls##2##16##(2008-9#2)
Mean body weights of dosed groups##3##6##(2008-9#3)
Mean body weights of dosed males##2##6##(2008-9#2)
Mean body weights of dosed##6##5##(2008-9#6)
Mean body weights of males exposed to 350 or 700 mg/L were less than those of the controls##2##18##(2008-9#2)
Mean body weights of##23##4##(2008-8#2)(2008-9#21)
Mean body weights##25##3##(2008-8#2)(2008-9#23)
Mean body##26##2##(2008-3#1)(2008-8#2)(2008-9#23)
Mean color differences##2##3##(2009-8#2)
Mean daily##2##2##(1992-2#1)(2008-12#1)
Mean duration of##7##3##(1991-2#1)(1994-12#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
Mean duration##8##2##(1991-2#1)(1994-12#1)(1994-2#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
Mean follow-up was##3##3##(2007-7#1)(2007-8#1)(2009-3#1)
Mean follow-up##5##2##(2007-7#1)(2007-8#1)(2009-3#1)(2012-3#1)(2013-8#1)
Mean group##2##2##(1995-11#1)(2010-10#1)
Mean hospital stay was##2##4##(2013-1#2)
Mean hospital##3##2##(2007-8#1)(2013-1#2)
Mean length of##2##3##(2007-8#1)(2009-3#1)
Mean monthly##2##2##(2008-10#1)(2011-2#1)
Mean number of##3##3##(1992-12#1)(2008-10#2)
Mean observation time was##2##4##(1993-11#1)(2007-11#1)
Mean observation##3##2##(1993-11#1)(1997-4#1)(2007-11#1)
Mean percent##2##2##(2008-10#1)(2013-1#1)
Mean postoperative##2##2##(2007-8#1)(2012-2#1)
Mean recoveries were##2##3##(2008-10#2)
Mean recoveries##3##2##(2008-10#3)
Mean reproductive##2##2##(2010-8#2)
Mean serum levels of##2##4##(1990-2#1)(2011-2#1)
Mean serum##4##2##(1990-2#1)(1991-6#1)(2008-7#1)(2011-2#1)
Mean time of follow-up since surgical procedure was##2##8##(2007-11#2)
Mean time of##3##3##(2007-11#3)
Mean time##4##2##(1992-11#1)(2007-11#3)
Mean total##2##2##(2008-12#1)(2013-1#1)
Mean tumor diameter was##2##4##(2013-8#2)
Mean validation##3##2##(2008-10#3)
Mean values for##2##3##(1990-11#1)(2008-8#1)
Mean values of##2##3##(1991-12#1)(2008-10#1)
Mean values##5##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
Mean##240##1##(1990-11#4)(1990-2#4)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#2)(1993-2#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#27)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#24)(2009-12#3)(2009-2#1)(2009-3#3)(2009-8#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#10)
Mean-field##2##1##(2008-2#2)
Meaningful##3##1##(2011-1#2)(2012-3#1)
Means of##7##2##(1990-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-2#1)
Means were##2##2##(1993-2#1)(2007-11#1)
Means##12##1##(1990-8#1)(1993-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#2)(2011-2#1)(2012-2#1)
Meanwhile##34##1##(1991-5#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-3#3)(2013-1#1)(2013-8#3)
Measles##5##1##(1991-3#1)(1992-5#1)(1996-6#2)(1997-5#1)
Measurable##2##1##(1990-11#1)(2008-3#1)
Measure of##5##2##(2008-1#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
Measure##16##1##(1994-12#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Measured by Coherent##2##3##(1996-12#1)(2008-3#1)
Measured by##4##2##(1993-9#1)(1996-12#1)(2008-3#1)(2009-8#1)
Measured values##3##2##(2008-11#2)(2008-3#1)
Measured##19##1##(1993-9#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#8)(2009-11#1)(2009-5#1)(2009-8#1)
Measurement and Testing##2##3##(2008-10#2)
Measurement and##8##2##(2008-10#2)(2008-3#3)(2008-5#1)(2009-7#1)(2013-1#1)
Measurement by##3##2##(2008-2#2)(2008-3#1)
Measurement error##2##2##(2008-12#1)(2008-3#1)
Measurement is##2##2##(2008-11#1)(2008-3#1)
Measurement of a##2##3##(2007-11#1)(2008-3#1)
Measurement of birefringence##3##3##(2007-11#2)(2008-3#1)
Measurement of blood##2##3##(2008-10#1)(2011-1#1)
Measurement of cellular##2##3##(2008-10#1)(2008-4#1)
Measurement of in vitro##2##4##(2008-4#2)
Measurement of interleukin##2##3##(2008-4#2)
Measurement of intracellular##2##3##(2008-4#1)(2008-9#1)
Measurement of mouse and human interleukin##2##6##(2008-4#2)
Measurement of mouse and human##3##5##(2008-4#3)
Measurement of mouse##4##3##(2008-4#4)
Measurement of particle##2##3##(1992-3#1)(1993-2#1)
Measurement of polyclonal immunoglobulin synthesis using##2##6##(2008-4#2)
Measurement of polyclonal##3##3##(2008-4#3)
Measurement of proliferative responses of##2##5##(2008-4#2)
Measurement of pulse##2##3##(2007-12#2)
Measurement of the ability of##2##5##(1994-8#1)(2008-9#1)
Measurement of the lidar##2##4##(2008-2#2)
Measurement of the nonlinear##2##4##(2007-11#1)(2007-12#1)
Measurement of the##41##3##(1991-11#1)(1991-4#1)(1991-9#1)(1992-3#1)(1994-8#1)(1995-6#1)(1996-9#1)(2007-11#5)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#11)(2008-4#1)(2008-6#1)(2008-9#2)
Measurement of##168##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-11#12)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-2#15)(2008-3#36)(2008-4#27)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#5)(2009-11#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2012-12#1)(2012-2#1)
Measurement results##2##2##(2008-3#1)(2010-10#1)
Measurement##208##1##(1990-5#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-11#12)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#18)(2008-3#47)(2008-4#27)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#5)(2009-1#1)(2009-11#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
Measurements and Testing Programme##2##4##(2008-10#2)
Measurements and Testing##4##3##(2008-10#4)
Measurements and##7##2##(2008-10#4)(2008-11#1)(2008-2#2)
Measurements are made at##2##4##(2008-10#1)(2008-2#1)
Measurements are made##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
Measurements are performed on a##2##5##(2007-11#1)(2008-3#1)
Measurements are presented##3##3##(2008-3#3)
Measurements are##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)
Measurements by use of##2##4##(2008-2#1)(2008-3#1)
Measurements by##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
Measurements have been##2##3##(2008-10#1)(2008-2#1)
Measurements in a##2##3##(2007-12#1)(2008-2#1)
Measurements in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Measurements indicate that##2##3##(2007-12#1)(2008-3#1)
Measurements made##2##2##(2008-3#2)
Measurements obtained by##2##3##(2006-12#1)(2008-3#1)
Measurements of CO(2)##2##3##(2008-2#1)(2008-3#1)
Measurements of NH(3) and CO(2)##2##5##(2008-3#2)
Measurements of Pollution in the Troposphere (MOPITT)##2##7##(2008-3#2)
Measurements of benzene concentration##2##4##(2008-3#2)
Measurements of birefringence##2##3##(2007-11#1)(2008-2#1)
Measurements of the##27##3##(1991-5#1)(1994-11#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#10)(2008-5#1)(2013-7#1)
Measurements of##81##2##(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2007-11#5)(2007-12#7)(2008-10#5)(2008-11#3)(2008-2#15)(2008-3#28)(2008-5#2)(2011-2#1)(2013-1#2)(2013-7#1)
Measurements on a##3##3##(1992-7#1)(2008-2#1)(2008-3#1)
Measurements on##9##2##(1992-7#1)(2008-2#3)(2008-3#4)(2008-7#1)
Measurements show that##2##3##(2008-1#1)(2008-3#1)
Measurements taken##2##2##(2008-2#1)(2008-3#1)
Measurements were carried out in the##2##6##(2008-10#1)(2008-2#1)
Measurements were carried out##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
Measurements were made at##3##4##(2008-10#2)(2008-2#1)
Measurements were made in##2##4##(2008-10#2)
Measurements were made of##3##4##(1996-2#1)(2008-3#2)
Measurements were made##12##3##(1996-2#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-9#1)
Measurements were performed at##2##4##(2008-10#1)(2008-5#1)
Measurements were performed##4##3##(2008-10#3)(2008-5#1)
Measurements were taken##2##3##(2008-5#1)(2012-2#1)
Measurements were##24##2##(1996-2#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2012-2#1)
Measurements with##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Measurements##180##1##(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-11#6)(2007-12#15)(2008-1#1)(2008-10#23)(2008-11#5)(2008-2#30)(2008-3#58)(2008-5#6)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
Measures included##4##2##(2008-12#1)(2011-1#1)(2013-1#2)
Measures of##15##2##(1991-2#1)(1993-1#1)(1994-12#2)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-4#2)(2010-3#1)(2012-12#1)
Measures that##2##2##(1996-3#1)(2008-12#1)
Measures to##3##2##(1993-11#1)(1996-12#1)(2007-12#1)
Measures##42##1##(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-12#3)(1994-2#1)(1995-12#1)(1996-12#3)(1996-3#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#5)(2008-4#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
Measuring and##2##2##(1995-3#1)(2008-10#1)
Measuring geographic##2##2##(1992-2#1)(1995-3#1)
Measuring natural selection##2##3##(2008-8#1)(2010-4#1)
Measuring physician##2##2##(1993-1#1)(1993-12#1)
Measuring quality of##2##3##(1996-2#1)(2011-2#1)
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting##2##16##(2010-1#2)
Measuring the##12##2##(1993-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-1#2)(2013-1#1)(2013-8#1)
Measuring##65##1##(1992-1#1)(1992-12#2)(1992-2#3)(1993-1#1)(1993-12#4)(1993-3#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(2007-12#2)(2008-1#3)(2008-10#6)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#2)
Meat hygiene service##2##3##(1991-8#1)(1996-3#1)
Meat##8##1##(1991-8#1)(1996-3#1)(1997-6#1)(2008-2#1)(2010-4#4)
Mechai##2##1##(1994-3#2)
Mechanical and##2##2##(2008-12#1)(2008-9#1)
Mechanical circulatory support of the##2##5##(2011-2#2)
Mechanical circulatory support##4##3##(2008-11#1)(2009-10#1)(2011-2#2)
Mechanical compression##2##2##(2011-1#1)(2011-2#1)
Mechanical factors such as##2##4##(1997-1#1)(2010-12#1)
Mechanical loading##2##2##(1994-6#1)(2012-7#1)
Mechanical properties of non-functionalized##2##4##(2009-11#2)
Mechanical properties of##6##3##(2007-11#1)(2008-11#1)(2009-11#2)(2009-4#2)
Mechanical properties were##2##3##(2010-4#1)(2012-2#1)
Mechanical properties##9##2##(2007-11#1)(2008-11#1)(2009-11#2)(2009-4#2)(2010-4#1)(2012-2#2)
Mechanical stimulation##2##2##(2012-2#2)
Mechanical testing##3##2##(2009-11#1)(2009-7#1)(2012-2#1)
Mechanical ventilation##3##2##(2007-10#1)(2007-11#1)(2007-8#1)
Mechanical##47##1##(1992-6#1)(1994-6#1)(1997-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-4#2)(2009-7#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#6)(2012-7#1)
Mechanically##4##1##(1992-12#1)(1993-5#1)(2008-10#1)(2012-2#1)
Mechanics##3##1##(2007-11#1)(2010-2#1)(2010-3#1)
Mechanism and##2##2##(1990-5#1)(2013-1#1)
Mechanism for the##3##3##(1990-5#1)(1993-11#1)(2008-10#1)
Mechanism for##4##2##(1990-5#1)(1993-11#1)(1996-12#1)(2008-10#1)
Mechanism of Action##2##3##(2009-11#1)(2010-10#1)
Mechanism of action of##2##4##(1992-6#1)(2009-12#1)
Mechanism of action##4##3##(1992-6#1)(2008-10#1)(2009-12#1)(2011-2#1)
Mechanism of inhibition of##2##4##(1992-6#1)(1993-8#1)
Mechanism of the##2##3##(1992-3#1)(1995-1#1)
Mechanism of##33##2##(1990-5#1)(1992-3#1)(1992-6#2)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-6#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)
Mechanism studies##3##2##(2008-10#2)(2011-2#1)
Mechanism##46##1##(1990-5#3)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#2)(1993-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-12#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
Mechanism-based##2##1##(2007-11#1)(2008-3#1)
Mechanisms and##5##2##(1990-6#1)(2008-10#1)(2008-4#1)(2010-8#1)(2013-1#1)
Mechanisms for##4##2##(1991-7#1)(1994-8#1)(1996-2#1)(2008-3#1)
Mechanisms of drug##2##3##(1991-1#2)
Mechanisms of resistance##2##3##(2008-11#2)
Mechanisms of##35##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1994-5#3)(1995-11#1)(1996-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-8#3)(2009-8#1)(2010-1#1)(2010-11#1)(2012-1#1)(2012-2#1)
Mechanisms underlying##5##2##(1991-8#1)(1993-12#1)(2007-7#1)(2008-11#1)(2008-8#1)
Mechanisms##66##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-5#3)(1994-8#1)(1995-11#1)(1996-10#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2009-8#2)(2010-1#2)(2010-11#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#2)
Mechanistic studies on##2##3##(1995-3#1)(2010-2#1)
Mechanistic studies##5##2##(1990-7#1)(1995-3#1)(2009-12#1)(2010-2#1)(2013-1#1)
Mechanistic##15##1##(1990-7#1)(1990-8#1)(1995-3#1)(2007-10#1)(2008-10#2)(2009-12#1)(2009-9#1)(2010-2#1)(2012-2#3)(2013-1#3)
Mechanistically##5##1##(1995-2#1)(2013-1#4)
Mechanotherapy##2##1##(2008-12#2)
Meckel's diverticulum is##2##3##(2009-8#1)(2013-1#1)
Meckel's diverticulum##9##2##(1990-6#2)(1991-5#1)(2009-8#2)(2013-1#3)(2013-7#1)
Meckel's##14##1##(1990-6#2)(1991-5#2)(2009-8#2)(2011-2#3)(2013-1#4)(2013-7#1)
Med##19##1##(1991-3#1)(1995-3#3)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#3)
Med-El Combi##2##2##(2008-9#2)
Med-El##5##1##(2008-9#5)
MedDRA##3##1##(2008-11#3)
Medaka##3##1##(2008-5#2)(2008-6#1)
Medecins sans Frontieres (Doctors without Borders)##2##6##(1997-6#2)
Medecins sans Frontieres##3##3##(1997-6#3)
Medellin##5##1##(2011-2#1)(2012-12#2)(2013-1#2)
Medellín##8##1##(2008-5#1)(2009-7#3)(2011-2#1)(2012-12#3)
Medfly##2##1##(2009-9#1)(2012-3#1)
Medford##2##1##(2008-10#2)
Media relations##2##2##(1991-3#1)(2008-12#1)
Media with##3##2##(2008-10#1)(2008-2#2)
Media##19##1##(1991-3#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
Medial prefrontal##2##2##(2008-11#2)
Medial septal##2##2##(1992-10#1)(1996-12#1)
Medial##9##1##(1991-2#1)(1992-10#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-11#2)(2012-2#1)(2013-1#1)
Median age##2##2##(1990-9#1)(2008-6#1)
Median duration of remission##2##4##(1991-4#1)(1992-2#1)
Median duration of response was##3##5##(1990-8#1)(1991-6#1)(1992-2#1)
Median duration of##7##3##(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#2)(1995-2#1)
Median duration##8##2##(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-9#1)(1995-2#1)
Median follow-up was##2##3##(1991-2#1)(2010-1#1)
Median follow-up##3##2##(1991-2#1)(2008-6#1)(2010-1#1)
Median nerve##2##2##(2008-9#1)(2009-11#1)
Median overall survival##4##3##(1990-6#1)(1990-9#1)(2008-6#1)(2011-2#1)
Median ratings##2##2##(2010-12#2)
Median survival time was##3##4##(1991-2#1)(2007-11#1)(2008-10#1)
Median survival time##5##3##(1991-2#1)(2007-11#3)(2008-10#1)
Median survival was##3##3##(1990-2#1)(1991-2#1)(1991-6#1)
Median survival##10##2##(1990-2#1)(1991-2#2)(1991-6#1)(1997-5#1)(2007-11#3)(2008-10#1)(2008-7#1)
Median##55##1##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#3)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#5)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
Mediastinal##5##1##(1997-8#1)(2007-2#1)(2011-2#2)(2012-3#1)
Mediate##2##1##(2008-11#1)(2010-8#1)
Mediated by##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
Mediated##12##1##(1991-3#1)(1996-5#2)(2007-2#1)(2008-10#4)(2008-12#1)(2009-12#1)(2010-2#1)(2011-2#1)
Mediating##2##1##(2010-2#1)(2013-8#1)
Mediation by##2##2##(1995-5#1)(2008-8#1)
Mediation of##5##2##(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-8#1)
Mediation##9##1##(1991-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-8#2)(2010-2#1)
Mediator of##2##2##(2008-4#1)(2011-2#1)
Mediator##3##1##(2008-4#1)(2011-2#1)(2013-7#1)
Mediators of##2##2##(2008-11#1)(2010-12#1)
Mediators##5##1##(1995-12#1)(2008-11#1)(2009-7#1)(2010-12#1)(2013-1#1)
Medica##5##1##(1995-12#1)(2008-10#1)(2009-10#3)
Medicago sativa L##3##3##(2008-5#1)(2008-8#2)
Medicago sativa##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
Medicago species##5##2##(2008-5#5)
Medicago truncatula and##2##3##(2008-10#1)(2008-7#1)
Medicago truncatula##11##2##(2008-10#6)(2008-7#1)(2009-10#1)(2009-8#2)(2011-2#1)
Medicago##22##1##(2008-10#7)(2008-5#7)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#3)(2011-2#1)
Medicaid Competition Demonstrations##2##3##(1991-2#2)
Medicaid Voluntary Contribution and Provider-Specific Tax Amendments of 1991 (Public Law 102-234)##2##12##(1993-1#2)
Medicaid and Medicare##3##3##(1995-12#1)(1995-3#1)(2010-5#1)
Medicaid and##16##2##(1991-1#1)(1991-3#1)(1992-2#3)(1994-3#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#1)(2008-6#1)(2010-5#1)
Medicaid anti-kickback##2##2##(1992-12#1)(1993-1#1)
Medicaid are##2##2##(1996-2#1)(1997-2#1)
Medicaid as##2##2##(1992-2#1)(1996-1#1)
Medicaid beneficiaries to##2##3##(1996-3#1)(1997-2#1)
Medicaid beneficiaries##14##2##(1991-3#1)(1994-2#2)(1996-1#2)(1996-2#2)(1996-3#3)(1997-2#1)(1997-3#2)(1997-6#1)
Medicaid benefits##2##2##(1994-1#1)(1994-2#1)
Medicaid block grants##3##3##(1996-3#1)(1997-2#1)(1997-3#1)
Medicaid claims##2##2##(1996-1#1)(1997-1#1)
Medicaid cost-containment policies##2##3##(1992-2#1)(1993-3#1)
Medicaid cost-containment##3##2##(1992-2#1)(1993-3#2)
Medicaid costs and birth outcomes##2##5##(1993-3#2)
Medicaid costs##6##2##(1991-9#1)(1993-3#5)
Medicaid data##3##2##(1996-2#1)(1996-3#1)(1997-2#1)
Medicaid disproportionate share##2##3##(1996-1#2)
Medicaid drug##2##2##(1995-1#2)
Medicaid eligibility##8##2##(1992-2#5)(1994-2#2)(1995-12#1)
Medicaid enrollees##5##2##(1991-2#1)(1995-1#1)(1996-2#1)(1997-3#2)
Medicaid enrollment##3##2##(1992-2#2)(1996-1#1)
Medicaid expenditure growth##3##3##(1996-1#3)
Medicaid expenditure##4##2##(1995-3#1)(1996-1#3)
Medicaid expenditures after##2##3##(1995-2#2)
Medicaid expenditures and##2##3##(1992-12#1)(1996-1#1)
Medicaid expenditures for##3##3##(1992-3#2)(1995-12#1)
Medicaid expenditures##13##2##(1992-12#1)(1992-3#3)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#4)
Medicaid fee-for-service##2##2##(1996-12#1)(1996-2#1)
Medicaid fees##7##2##(1994-1#2)(1996-3#5)
Medicaid health maintenance organization##2##4##(1991-2#1)(1994-3#1)
Medicaid health##3##2##(1991-2#1)(1994-3#1)(1997-2#1)
Medicaid in##2##2##(1992-2#1)(1994-3#1)
Medicaid is##2##2##(1994-1#1)(1995-12#1)
Medicaid managed care and##2##4##(1997-2#2)
Medicaid managed care plans##2##4##(1997-2#1)(2008-11#1)
Medicaid managed care program##2##4##(1995-12#1)(1997-2#1)
Medicaid managed care programs##2##4##(1994-3#1)(1996-1#1)
Medicaid managed care##20##3##(1994-3#2)(1995-12#2)(1996-1#1)(1996-12#3)(1996-2#2)(1997-1#1)(1997-2#7)(2008-11#1)(2009-6#1)
Medicaid mental health##3##3##(1997-2#3)
Medicaid nursing home payment systems##2##5##(1992-3#2)
Medicaid nursing home reimbursement##3##4##(1994-2#3)
Medicaid nursing home##5##3##(1992-3#2)(1994-2#3)
Medicaid patients who##2##3##(1995-2#1)(1997-2#1)
Medicaid patients##4##2##(1995-2#2)(1996-2#1)(1997-2#1)
Medicaid payment policies for nursing home care##2##7##(1992-3#1)(1993-3#1)
Medicaid payment##3##2##(1992-3#2)(1993-3#1)
Medicaid payments##2##2##(1992-8#1)(1995-1#1)
Medicaid policies for##2##3##(1995-1#1)(1995-2#1)
Medicaid policies##3##2##(1995-1#1)(1995-2#2)
Medicaid policy##2##2##(1995-3#1)(1996-1#1)
Medicaid population##3##2##(1992-3#1)(1995-3#1)(1997-2#1)
Medicaid program##13##2##(1991-3#1)(1992-2#2)(1992-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#4)(1997-2#1)(2010-12#1)
Medicaid programs##19##2##(1991-2#1)(1992-1#1)(1994-12#1)(1995-1#3)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#3)
Medicaid recipients in##3##3##(1991-1#1)(1991-2#1)(1992-2#1)
Medicaid recipients with AIDS##2##4##(1995-2#2)
Medicaid recipients with##3##3##(1991-12#1)(1995-2#2)
Medicaid recipients##17##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#3)(1994-2#2)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1997-2#1)
Medicaid reimbursement##2##2##(1991-3#1)(1996-3#1)
Medicaid spending would increase##2##4##(1994-1#2)
Medicaid spending##5##2##(1994-1#3)(1995-1#1)(1995-6#1)
Medicaid waiver for the mentally retarded##2##6##(1991-1#2)
Medicaid waiver for##4##3##(1991-1#2)(1993-1#1)(1996-2#1)
Medicaid waiver program##2##3##(1993-1#1)(1997-2#1)
Medicaid waiver##8##2##(1991-1#2)(1992-2#1)(1993-1#2)(1996-2#1)(1997-2#2)
Medicaid was##2##2##(1992-2#1)(1995-12#1)
Medicaid##333##1##(1990-4#1)(1991-1#5)(1991-12#5)(1991-2#8)(1991-3#12)(1991-9#1)(1992-1#5)(1992-12#5)(1992-2#27)(1992-3#13)(1992-8#1)(1992-9#1)(1993-1#7)(1993-12#3)(1993-3#9)(1993-5#1)(1994-1#11)(1994-12#2)(1994-2#19)(1994-3#13)(1995-1#14)(1995-12#14)(1995-2#12)(1995-3#7)(1995-6#1)(1996-1#28)(1996-12#8)(1996-2#20)(1996-3#18)(1997-1#4)(1997-2#33)(1997-3#7)(1997-6#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-6#1)(2009-6#2)(2010-12#2)(2010-5#1)(2011-2#2)(2013-1#3)
Medical Academy of Lublin##2##4##(2007-11#2)
Medical Academy##6##2##(2007-11#3)(2008-7#1)(2008-9#1)(2011-2#1)
Medical Association##22##2##(1990-6#2)(1991-2#1)(1991-8#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-12#2)(1997-5#1)(1997-6#1)(1997-8#3)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#1)
Medical Birth Registry##3##3##(1991-11#1)(1995-6#1)(1996-11#1)
Medical Care##2##2##(1991-1#1)(2011-2#1)
Medical Center and##4##3##(1993-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
Medical Center at##2##3##(1993-3#1)(1996-1#1)
Medical Center in New##2##4##(1993-2#1)(1997-2#1)
Medical Center in##8##3##(1992-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)
Medical Center##79##2##(1990-11#3)(1991-1#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#6)(1997-2#3)(1997-3#3)(1997-8#1)(2007-10#1)(2007-3#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-3#2)(2010-8#3)(2011-2#3)(2012-3#1)(2013-1#1)
Medical Center's##3##2##(1992-1#1)(1996-2#1)(2010-8#1)
Medical Centre##7##2##(1992-1#1)(2007-11#1)(2008-12#2)(2010-8#2)(2011-1#1)
Medical College Teaching Hospital##2##4##(2008-7#1)(2012-3#1)
Medical College and##2##3##(1994-1#1)(2008-3#1)
Medical College of the State of South Carolina##2##8##(1991-8#2)
Medical College of##4##3##(1991-8#2)(1993-12#1)(1994-2#1)
Medical College##18##2##(1991-8#2)(1993-12#1)(1994-1#1)(1994-2#1)(1997-2#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#5)
Medical Corporation##2##2##(1992-12#1)(2010-11#1)
Medical Device##2##2##(1997-2#1)(2012-3#1)
Medical Directory of Australia##2##4##(2007-2#2)
Medical Education##10##2##(1991-8#3)(2007-11#1)(2007-4#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Medical Entomology##3##2##(2010-1#3)
Medical Expenditure Panel##2##3##(2010-3#1)(2013-1#1)
Medical Faculty##4##2##(1993-6#1)(2007-8#1)(2008-10#1)(2011-3#1)
Medical Forensic System##2##3##(2010-8#2)
Medical Genetics##2##2##(2008-4#1)(2008-5#1)
Medical Graduates##2##2##(2012-3#2)
Medical Group##3##2##(1991-1#2)(1996-1#1)
Medical Humanities course##2##3##(2011-2#2)
Medical Library##6##2##(1991-3#1)(1992-12#1)(1994-12#1)(1995-1#1)(1996-1#2)
Medical Licensing Examination##2##3##(2012-3#2)
Medical Officer##3##2##(1990-6#1)(1993-3#2)
Medical Outcomes##3##2##(1994-3#1)(2008-10#1)(2010-2#1)
Medical Products##3##2##(1993-2#1)(1994-6#1)(1995-3#1)
Medical Psychology##4##2##(2011-1#1)(2013-1#3)
Medical Record##3##2##(1992-4#1)(2010-8#2)
Medical Records##4##2##(1993-12#1)(1994-3#2)(2010-8#1)
Medical Research Council##8##3##(1993-9#1)(1995-6#1)(1996-8#1)(1997-5#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
Medical Research Institute##2##3##(1996-12#1)(2008-10#1)
Medical Research##16##2##(1990-3#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
Medical School and##2##3##(2010-1#1)(2013-1#1)
Medical School##18##2##(1990-9#1)(1991-6#1)(1993-3#1)(1995-11#1)(1997-8#1)(2007-12#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-1#1)(2010-5#2)(2011-2#1)(2013-1#1)
Medical Sciences##14##2##(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Medical Services##7##2##(1993-12#1)(1994-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-3#1)
Medical Students##2##2##(2009-12#1)(2013-8#1)
Medical Subject Headings (MeSH)##2##4##(1993-3#1)(1995-1#1)
Medical Subject Headings##3##3##(1993-3#1)(1995-1#1)(2012-3#1)
Medical University in##5##3##(2007-11#3)(2007-8#1)(2011-2#1)
Medical University of Plovdiv##2##4##(2013-1#1)(2013-8#1)
Medical University of Warsaw##2##4##(2007-8#1)(2013-1#1)
Medical University of##8##3##(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
Medical University on##2##3##(2009-5#2)
Medical University##22##2##(2007-11#5)(2007-8#3)(2008-7#1)(2008-9#4)(2009-5#2)(2011-2#2)(2013-1#3)(2013-8#2)
Medical abortion##3##2##(1992-2#2)(2011-2#1)
Medical and Psychiatric##2##3##(2009-4#1)(2013-8#1)
Medical and health##2##3##(1997-3#1)(2011-2#1)
Medical and surgical##3##3##(2007-12#1)(2008-8#1)(2011-2#1)
Medical and##12##2##(1991-9#1)(1993-6#1)(1997-3#1)(2007-12#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#2)(2011-3#1)(2013-8#2)
Medical care in the##2##4##(1994-3#1)(2012-3#1)
Medical care##5##2##(1992-5#1)(1993-2#1)(1994-3#1)(2012-12#1)(2012-3#1)
Medical complications##2##2##(1995-11#1)(2012-3#1)
Medical decision analysis##2##3##(2007-12#2)
Medical device##2##2##(1993-3#1)(2012-2#1)
Medical emergencies in children of orthodox Jehovah's Witness families##4##9##(2008-11#4)
Medical emergencies in dental##2##4##(2008-1#2)
Medical emergencies in##6##3##(2008-1#2)(2008-11#4)
Medical ethics##4##2##(1997-8#3)(2007-12#1)
Medical evaluation##2##2##(2006-10#1)(2008-4#1)
Medical genetics##2##2##(1994-9#1)(2013-1#1)
Medical group##3##2##(1991-1#1)(1991-3#1)(1997-3#1)
Medical groups that ignore the importance of service excellence will find themselves trailing those groups that provide superior service to their patients##2##22##(1994-1#2)
Medical groups that plan and manage for patients' service needs will achieve market differentiation##2##14##(1994-1#2)
Medical groups that##4##3##(1994-1#4)
Medical imaging##2##2##(1996-2#1)(2009-4#1)
Medical information##2##2##(1991-3#1)(2008-11#1)
Medical liability##3##2##(2008-4#3)
Medical malpractice##5##2##(1991-1#1)(1991-12#2)(1992-2#1)(1993-2#1)
Medical management of##2##3##(1994-2#1)(2008-8#1)
Medical management##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
Medical oncology##2##2##(1991-8#1)(1993-2#1)
Medical play and preparation##3##4##(1992-3#3)
Medical records of##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
Medical schools##2##2##(2009-10#1)(2011-2#1)
Medical services provided in the group practice setting must be structured to accommodate the unique needs of their increasing number of elderly patients##2##23##(1994-3#2)
Medical staff contracting##3##3##(1993-3#1)(1994-1#1)(1994-3#1)
Medical staff privileges and the antitrust laws##2##7##(1993-1#2)
Medical staff##10##2##(1991-2#1)(1992-2#2)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(2013-1#1)
Medical technology##2##2##(1994-12#1)(1994-3#1)
Medical treatment of##3##3##(1992-2#1)(1993-12#1)(1996-3#1)
Medical treatment##6##2##(1990-9#1)(1992-2#1)(1993-12#1)(1995-1#1)(1996-3#1)(2007-8#1)
Medical##544##1##(1990-11#3)(1990-3#1)(1990-4#2)(1990-6#3)(1990-9#2)(1991-1#7)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#8)(1991-6#4)(1991-8#9)(1991-9#1)(1992-1#8)(1992-12#10)(1992-2#9)(1992-3#5)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-12#9)(1993-2#10)(1993-3#9)(1993-5#1)(1993-6#3)(1993-9#1)(1994-1#7)(1994-12#9)(1994-2#10)(1994-3#12)(1994-6#1)(1994-9#1)(1995-1#6)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#2)(1996-1#10)(1996-11#3)(1996-12#9)(1996-2#11)(1996-3#5)(1996-4#2)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#7)(1997-5#4)(1997-6#1)(1997-8#9)(2006-10#1)(2007-10#1)(2007-11#13)(2007-12#7)(2007-2#3)(2007-3#4)(2007-4#2)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#10)(2008-11#11)(2008-12#9)(2008-2#1)(2008-3#7)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#15)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#6)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-8#15)(2010-9#1)(2011-1#7)(2011-2#34)(2011-3#2)(2012-12#3)(2012-2#7)(2012-3#24)(2013-1#23)(2013-7#1)(2013-8#10)
Medically##3##1##(2009-6#2)(2013-1#1)
Medicare Alzheimer's Project##2##3##(1992-1#1)(1995-3#1)
Medicare Cost##2##2##(1992-1#1)(2008-11#1)
Medicare Current Beneficiary Survey (MCBS)##11##5##(1994-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
Medicare Current Beneficiary Survey##12##4##(1994-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
Medicare D##2##2##(2008-11#2)
Medicare ESRD populations##2##3##(1995-12#2)
Medicare Economic Index##2##3##(1992-2#2)
Medicare Fee Schedule (MFS)##2##4##(1995-12#1)(1996-3#1)
Medicare HMO enrollees##2##3##(1994-3#2)
Medicare HMO enrollment##2##3##(1994-3#2)
Medicare HMO##6##2##(1993-12#1)(1993-3#1)(1994-3#4)
Medicare PPS##4##2##(1992-12#1)(1992-2#1)(1993-3#2)
Medicare Part A##4##3##(1991-1#2)(1993-3#1)(1994-12#1)
Medicare Part D##3##3##(2008-11#2)(2010-5#1)
Medicare Part##10##2##(1991-1#2)(1993-3#1)(1994-12#1)(1996-2#2)(2008-11#3)(2010-5#1)
Medicare Transaction System##2##3##(1994-12#2)
Medicare access##2##2##(1995-12#2)
Medicare aged##2##2##(1993-12#1)(1995-2#1)
Medicare and Medicaid beneficiaries##6##4##(1991-3#1)(1996-2#2)(1997-2#1)(1997-3#2)
Medicare and Medicaid risk##2##4##(1991-3#1)(1997-3#1)
Medicare and Medicaid##30##3##(1991-12#2)(1991-2#2)(1991-3#3)(1992-12#4)(1992-3#1)(1994-3#1)(1995-3#1)(1996-2#6)(1996-3#3)(1997-2#3)(1997-3#3)(2008-11#1)
Medicare and non-Medicare beneficiaries##2##4##(1995-12#1)(1997-3#1)
Medicare and the##3##3##(1993-3#1)(1995-3#1)(1997-3#1)
Medicare and##41##2##(1991-12#3)(1991-2#2)(1991-3#3)(1992-12#4)(1992-2#2)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-12#3)(1996-2#6)(1996-3#3)(1997-2#3)(1997-3#5)(2008-11#1)
Medicare antidumping provision##2##3##(1991-2#2)
Medicare beneficiaries are##3##3##(1991-3#1)(1995-12#1)(1996-2#1)
Medicare beneficiaries##42##2##(1991-1#1)(1991-2#3)(1991-3#4)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#5)(1994-1#3)(1994-12#1)(1994-3#1)(1995-12#6)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(2009-12#1)
Medicare beneficiaries'##2##2##(1994-1#1)(1997-2#1)
Medicare beneficiary##4##2##(1991-1#1)(1991-3#1)(1997-3#2)
Medicare bill##2##2##(1994-1#1)(2007-9#1)
Medicare capitation payments##3##3##(1993-3#1)(1997-1#2)
Medicare capitation##4##2##(1993-3#1)(1997-1#3)
Medicare claims##2##2##(1994-12#1)(1995-12#1)
Medicare costs##2##2##(1995-3#1)(1997-1#1)
Medicare coverage of##2##3##(1995-1#1)(2008-4#1)
Medicare coverage##7##2##(1992-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-3#1)(2008-4#1)
Medicare data to##2##3##(1995-2#1)(1997-3#1)
Medicare data##8##2##(1992-11#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#4)
Medicare dependent hospitals##2##3##(1992-12#2)
Medicare end stage renal disease##2##5##(1991-3#1)(1997-1#1)
Medicare enrollees##11##2##(1991-3#1)(1992-2#3)(1993-1#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)
Medicare expenditures##3##2##(1992-1#2)(1992-12#1)
Medicare fee schedule (MFS)##5##4##(1994-1#3)(1994-12#1)(1996-1#1)
Medicare fee schedule##11##3##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#5)(1994-12#1)(1996-1#1)(1996-3#1)
Medicare fee##13##2##(1991-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#5)(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)
Medicare fee-for-service (FFS)##2##3##(1993-12#1)(1995-3#1)
Medicare fees are##2##3##(1994-1#2)
Medicare fees##6##2##(1994-1#5)(1997-1#1)
Medicare for##3##2##(1992-3#1)(1995-1#1)(1997-6#1)
Medicare fraud##2##2##(1991-1#1)(1997-3#1)
Medicare has##2##2##(1992-1#1)(1996-12#1)
Medicare health maintenance organization (HMO)##2##5##(1994-3#1)(1995-3#1)
Medicare health maintenance organization##3##4##(1994-3#2)(1995-3#1)
Medicare home health care##2##4##(1995-2#1)(1995-3#1)
Medicare home health##11##3##(1992-3#1)(1994-2#4)(1995-2#1)(1995-3#5)
Medicare home##12##2##(1992-3#1)(1994-2#4)(1995-2#2)(1995-3#5)
Medicare hospice benefit##4##3##(1991-3#1)(1993-12#1)(1994-12#1)(1995-2#1)
Medicare hospice##5##2##(1991-3#1)(1993-12#1)(1994-12#2)(1995-2#1)
Medicare hospital outpatient services##2##4##(1991-2#1)(1992-12#1)
Medicare hospital##6##2##(1991-2#1)(1992-12#2)(1993-1#1)(1994-12#1)(1997-2#1)
Medicare in##2##2##(1991-12#1)(1991-3#1)
Medicare inpatient##5##2##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)
Medicare insurance##2##2##(2008-11#1)(2012-3#1)
Medicare insured group##2##3##(1992-2#2)
Medicare managed care##9##3##(1995-12#1)(1996-12#1)(1997-1#2)(1997-2#4)(1997-3#1)
Medicare or##2##2##(1992-1#1)(1994-2#1)
Medicare outpatient##2##2##(1992-2#1)(1995-1#1)
Medicare patients##13##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#2)(1994-12#3)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#1)
Medicare payment system for physician services##2##6##(1992-1#1)(1992-12#1)
Medicare payment##17##2##(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#3)(1992-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#2)(1996-1#1)(1997-2#1)(2008-4#1)(2008-6#1)
Medicare payments for##2##3##(1992-2#1)(1994-12#1)
Medicare payments to health maintenance organizations##2##6##(1991-1#2)
Medicare payments##5##2##(1991-1#2)(1992-2#1)(1994-12#1)(2012-2#1)
Medicare physician fees##3##3##(1994-1#3)
Medicare physician payment system##2##4##(1991-12#1)(1992-1#1)
Medicare physician payment##4##3##(1991-1#1)(1991-12#1)(1992-1#1)(1995-12#1)
Medicare physician##10##2##(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-1#3)(1994-3#1)(1995-12#1)(2012-3#1)
Medicare population and##2##3##(1991-3#1)(1995-12#1)
Medicare population##12##2##(1991-1#1)(1991-3#1)(1993-12#2)(1994-12#1)(1995-12#4)(1995-2#1)(1996-12#1)(1996-3#1)
Medicare program and##3##3##(1993-12#1)(1997-3#1)(2008-10#1)
Medicare program##15##2##(1991-1#3)(1991-2#1)(1991-3#2)(1992-12#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1997-3#2)(2008-10#1)
Medicare prospective payment system##7##4##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)
Medicare prospective payment##10##3##(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#3)(1993-12#1)(1993-3#1)(1996-2#1)
Medicare provider analysis and review (MEDPAR) file##2##7##(1993-12#1)(1995-2#1)
Medicare provider analysis and review (MEDPAR)##3##6##(1993-12#2)(1995-2#1)
Medicare provider analysis and review##4##5##(1991-12#1)(1993-12#2)(1995-2#1)
Medicare provider analysis##5##3##(1991-12#1)(1992-12#1)(1993-12#2)(1995-2#1)
Medicare reform##2##2##(1996-3#1)(2008-11#1)
Medicare regulations and the##2##4##(1991-12#1)(1995-2#1)
Medicare regulations and##3##3##(1991-12#1)(1995-2#1)(2008-11#1)
Medicare reimbursement##5##2##(1992-1#1)(1994-3#1)(1995-3#1)(2008-6#1)(2012-3#1)
Medicare risk contracts##4##3##(1995-12#2)(1996-3#1)(1997-2#1)
Medicare risk##7##2##(1994-12#2)(1995-12#2)(1996-3#2)(1997-2#1)
Medicare service use##2##3##(1993-1#1)(1995-3#1)
Medicare service##4##2##(1991-1#1)(1993-1#1)(1994-1#1)(1995-3#1)
Medicare short-stay hospital##2##3##(1991-1#1)(1992-2#1)
Medicare spending for##2##3##(1991-2#2)
Medicare spending##7##2##(1991-2#2)(1992-2#1)(1994-1#1)(1995-12#1)(2008-7#1)(2012-3#1)
Medicare supplementary insurance##2##3##(1995-12#1)(1996-3#1)
Medicare system##2##2##(1995-3#1)(1996-1#1)
Medicare##534##1##(1990-4#2)(1991-1#19)(1991-12#12)(1991-2#17)(1991-3#22)(1992-1#15)(1992-11#1)(1992-12#24)(1992-2#26)(1992-3#4)(1993-1#11)(1993-12#27)(1993-2#2)(1993-3#17)(1993-5#1)(1994-1#33)(1994-12#25)(1994-2#8)(1994-3#16)(1995-1#8)(1995-12#33)(1995-2#15)(1995-3#26)(1996-1#3)(1996-12#17)(1996-2#15)(1996-3#18)(1997-1#19)(1997-2#21)(1997-3#25)(1997-6#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-11#12)(2008-4#9)(2008-6#8)(2008-7#4)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#8)
Medicare's prospective payment system (PPS)##2##5##(1992-12#1)(1994-12#1)
Medicare's prospective payment system##3##4##(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's prospective payment##4##3##(1991-1#1)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's prospective##5##2##(1991-1#2)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's##18##1##(1991-1#2)(1992-12#2)(1992-2#2)(1993-3#1)(1994-12#5)(1994-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)
Medicare-covered services##2##2##(1995-1#1)(1995-12#1)
Medicare-covered##6##1##(1992-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-1#1)
Medicare/Medicaid##6##1##(1991-9#1)(1993-3#1)(1996-1#1)(1997-3#1)(2008-11#2)
Medicare?##5##1##(1993-1#1)(1994-3#1)(1997-3#2)(2008-6#1)
Medication assistance programs##2##3##(2011-2#2)
Medication##11##1##(1991-11#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
Medications##4##1##(2008-11#1)(2008-6#2)(2009-9#1)
Medicinal Chemistry Division##2##3##(2008-5#2)
Medicinal Chemistry##3##2##(2008-5#3)
Medicinal Plants##2##2##(2010-3#1)(2012-3#1)
Medicinal Products##2##2##(2008-5#1)(2008-7#1)
Medicinal surface modification of silicon nanowires##2##6##(2010-3#2)
Medicinal##11##1##(1997-8#1)(2008-10#1)(2008-5#4)(2008-7#1)(2010-3#3)(2012-3#1)
Medicine -##2##2##(2008-7#1)(2013-8#1)
Medicine Department##2##2##(1996-11#1)(2007-11#1)
Medicine Unit##2##2##(1996-2#1)(2011-2#1)
Medicine and Health##3##3##(2007-2#1)(2008-1#2)
Medicine and management##2##3##(1991-3#1)(1997-2#1)
Medicine and nursing##7##3##(1995-9#7)
Medicine and the##2##3##(1996-9#1)(2013-1#1)
Medicine and##27##2##(1991-3#1)(1995-2#1)(1995-8#2)(1995-9#7)(1996-8#1)(1996-9#1)(1997-2#2)(2007-2#2)(2008-1#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
Medicine as##3##2##(1990-2#1)(2008-1#1)(2009-5#1)
Medicine at the##2##3##(1992-12#1)(1996-11#1)
Medicine at##4##2##(1992-12#1)(1994-1#1)(1996-11#1)(2013-1#1)
Medicine has##3##2##(1996-1#1)(2010-5#1)(2013-8#1)
Medicine in the##3##3##(2007-11#1)(2012-1#1)(2013-8#1)
Medicine in##12##2##(1990-12#1)(1991-11#1)(1993-11#1)(1997-8#1)(2006-12#1)(2007-11#1)(2010-1#2)(2012-1#1)(2013-8#3)
Medicine of the University of##4##5##(1994-2#1)(1995-3#1)(2008-10#1)(2009-7#1)
Medicine of the##7##3##(1991-12#2)(1994-2#1)(1995-3#1)(2008-10#1)(2009-7#1)(2010-4#1)
Medicine of##13##2##(1991-12#2)(1992-1#1)(1994-2#1)(1995-11#1)(1995-3#1)(1997-3#1)(2008-10#1)(2009-7#1)(2010-4#1)(2012-3#2)(2013-1#1)
Medicine were##2##2##(2009-5#1)(2012-2#1)
Medicine##196##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#2)(1995-9#7)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#3)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-5#1)(2007-8#2)(2008-1#10)(2008-10#12)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#15)(2013-8#8)
Medicine&quot##3##1##(2012-2#1)(2013-1#2)
Medicine]##2##1##(1993-5#1)(2008-7#1)
Medicines##20##1##(1996-11#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
Medicus##2##1##(1993-12#2)
Medigap##3##1##(1992-2#1)(1993-3#1)(1997-3#1)
Meditation##6##1##(1992-2#1)(2008-10#3)(2008-3#1)(2010-8#1)
Mediterranean Sea##2##2##(2008-10#1)(2008-2#1)
Mediterranean area##2##2##(2008-7#1)(2008-8#1)
Mediterranean climate##2##2##(2008-10#2)
Mediterranean coastal##2##2##(1992-3#1)(2012-5#1)
Mediterranean countries##3##2##(1990-8#1)(1993-9#1)(2012-2#1)
Mediterranean fever##3##2##(1992-9#1)(1996-6#1)(1997-5#1)
Mediterranean fruit fly##3##3##(2008-11#1)(2008-3#1)(2009-9#1)
Mediterranean fruit##4##2##(2008-11#1)(2008-3#2)(2009-9#1)
Mediterranean regions##2##2##(2011-2#1)(2012-7#1)
Mediterranean spotted fever##2##3##(2013-8#2)
Mediterranean##61##1##(1990-8#3)(1991-12#1)(1992-3#2)(1992-9#1)(1993-9#1)(1996-4#1)(1996-6#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#3)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#9)(2012-2#1)(2012-5#1)(2012-7#3)(2013-1#5)(2013-8#2)
Mediterranean-African##2##1##(2008-10#2)
Medium (DMEM)##2##2##(2008-11#1)(2013-1#1)
Medium for##4##2##(2008-10#3)(2008-11#1)
Medium with##2##2##(2008-10#1)(2008-11#1)
Medium##20##1##(1991-8#1)(2007-11#1)(2008-10#9)(2008-11#6)(2008-3#1)(2008-7#1)(2013-1#1)
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is##2##6##(1990-8#1)(1991-8#1)
Medline and##2##2##(2008-11#1)(2011-2#1)
Medline search##2##2##(2008-1#1)(2008-7#1)
Medline##24##1##(1992-12#1)(1994-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2009-2#1)(2011-1#2)(2011-2#6)(2013-1#2)
Medroxyprogesterone Acetate##2##2##(1995-4#1)(1997-7#1)
Medtronic##6##1##(2006-12#1)(2010-7#2)(2011-2#1)(2012-1#2)
Medullary##2##1##(2007-7#1)(2008-7#1)
Medulloblastoma##2##1##(1997-3#1)(2008-7#1)
Meet the##2##2##(1991-1#1)(1992-12#1)
Meet##3##1##(1991-1#1)(1992-12#1)(1992-3#1)
Meeting Report##6##2##(2008-10#1)(2008-7#2)(2011-2#3)
Meeting Review##2##2##(2008-7#2)
Meeting highlights##2##2##(2008-7#2)
Meeting of the American##7##4##(2008-5#2)(2008-7#4)(2009-6#1)
Meeting of the Italian##2##4##(1991-6#1)(2011-2#1)
Meeting of the Society for##2##5##(2008-7#1)(2012-1#1)
Meeting of the Society##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
Meeting of the##27##3##(1991-6#1)(1996-1#1)(1996-9#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-1#1)
Meeting of##29##2##(1991-6#2)(1996-1#1)(1996-9#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-1#1)(2013-1#1)
Meeting on##6##2##(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
Meeting review##5##2##(2008-7#5)
Meeting the challenge##2##3##(1995-3#1)(1996-2#1)
Meeting the challenges of##2##4##(2008-11#1)(2008-12#1)
Meeting the needs of##4##4##(1991-1#1)(2007-5#1)(2008-11#1)(2008-4#1)
Meeting the##14##2##(1991-1#1)(1991-10#1)(1993-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2010-8#1)
Meeting##110##1##(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#25)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#19)(2008-8#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#10)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Meetings##3##1##(2008-5#1)(2010-12#1)(2012-1#1)
Mefenoxam Insensitivity##2##2##(2008-10#2)
Megabalanus rosa##6##2##(1990-5#4)(1993-6#2)
Megsin##2##1##(2008-7#2)
Meharry Medical College##3##3##(1997-2#1)(2012-3#2)
Meier method##2##2##(1994-7#1)(2008-6#1)
Meier##3##1##(1994-7#1)(2008-6#2)
Meigen##2##1##(2007-12#1)(2010-1#1)
Meinel##2##1##(2008-3#2)
Meiosis##3##1##(2008-7#3)
Meiothermus ruber##2##2##(2011-2#2)
Meiothermus silvanus##2##2##(2011-2#2)
Meiothermus##8##1##(2011-2#8)
Meiotic##8##1##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2012-3#1)
Mel##5##1##(1995-12#2)(1997-5#1)(2008-5#2)
Melampsora larici-populina##11##2##(2008-10#11)
Melampsora medusae f##3##3##(2008-10#3)
Melampsora medusae##5##2##(2008-10#5)
Melampsora xcolumbiana##2##2##(2008-10#2)
Melampsora##19##1##(2008-10#19)
Melanie##2##1##(1997-3#2)
Melanie's##2##1##(1997-3#2)
Melanocortins##3##1##(1993-5#3)
Melanocytes##2##1##(2008-5#2)
Melanoma##11##1##(2007-12#1)(2008-7#1)(2009-3#1)(2010-6#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Melanotropic peptides##2##2##(1993-5#2)
Melanotropins as##2##2##(1993-5#2)
Melastoma malabathricum##2##2##(2009-8#2)
Melatonin and##5##2##(1995-11#1)(1995-12#1)(2008-10#1)(2013-7#2)
Melatonin synthesis in the##2##4##(1994-5#1)(2008-5#1)
Melatonin treatment##2##2##(2011-2#2)
Melatonin##27##1##(1990-2#1)(1990-5#1)(1991-12#2)(1994-5#5)(1995-11#4)(1995-12#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-12#2)(2010-8#1)(2011-2#4)(2013-7#2)
Melbourne Categories##3##2##(2008-9#3)
Melbourne##15##1##(1991-6#1)(1995-6#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-8#3)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
Meldola Blue##2##2##(2008-10#2)
Meldola's blue##3##2##(2008-10#3)
Melhus graduate student symposium##2##4##(2008-10#2)
Meloidogyne artiellia##2##2##(2008-10#2)
Meloidogyne baetica n##2##3##(2008-10#2)
Meloidogyne chitwoodi and M##6##4##(2008-10#6)
Meloidogyne chitwoodi##9##2##(2008-10#9)
Meloidogyne incognita and##3##3##(2008-10#2)(2011-2#1)
Meloidogyne incognita##10##2##(1994-12#2)(2008-10#7)(2011-2#1)
Meloidogyne javanica##7##2##(2008-10#7)
Meloidogyne marylandi##2##2##(2008-10#2)
Meloidogyne spp##6##2##(2008-10#6)
Meloidogyne##47##1##(1994-12#2)(2008-10#44)(2011-2#1)
Melon yellow spot virus##3##4##(2008-10#3)
Melon##7##1##(2008-10#7)
Melphalan##2##1##(2011-3#1)(2012-12#1)
Melt inclusions in Nakhla##2##4##(2008-10#2)
Melt##3##1##(2008-10#2)(2009-11#1)
Member Countries##2##2##(2011-2#2)
Member Societies##2##2##(2011-2#1)(2012-12#1)
Member of the##5##3##(2008-10#3)(2008-9#2)
Member satisfaction##3##2##(1996-3#3)
Member##19##1##(1994-2#1)(1996-3#3)(2007-10#1)(2008-10#4)(2008-9#2)(2009-4#1)(2011-2#5)(2012-12#1)(2013-8#1)
Members of a##2##3##(1996-5#1)(2008-10#1)
Members of the genus##4##4##(2008-10#1)(2011-2#3)
Members of the##17##3##(1991-11#1)(1993-9#1)(1994-12#3)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#3)(2009-8#1)(2010-5#1)(2011-2#4)
Members of this##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
Members of##28##2##(1991-11#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#6)
Members##33##1##(1991-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#6)
Membership and##2##2##(1994-12#1)(2010-3#1)
Membership##3##1##(1994-12#1)(2010-3#1)(2012-3#1)
Membrane Protein##2##2##(2008-10#1)(2008-12#1)
Membrane currents in##2##3##(1993-12#1)(1993-3#1)
Membrane electrodes##2##2##(2008-10#2)
Membrane fatty acid composition is##2##5##(2009-5#2)
Membrane filtration studies of aquatic humic substances and their metal species##2##11##(2008-10#2)
Membrane fusion##3##2##(1991-5#2)(1992-6#1)
Membrane imaging by simultaneous second-harmonic generation and two-photon microscopy##2##9##(2007-12#2)
Membrane potential and##2##3##(1994-11#1)(1997-1#1)
Membrane potential##4##2##(1990-8#1)(1994-11#1)(1997-1#1)(2008-9#1)
Membrane preparations##2##2##(1990-5#1)(1993-11#1)
Membrane topology of##2##3##(1993-11#1)(2008-11#1)
Membrane##50##1##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-1#1)(2007-12#2)(2007-7#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
Membranes##6##1##(2008-10#4)(2009-12#1)(2012-1#1)
Membranous##5##1##(2008-1#3)(2009-5#1)(2010-6#1)
Memorial Award##2##2##(1991-1#1)(2010-5#1)
Memorial Hospital##8##2##(1991-2#1)(1993-12#1)(1994-1#2)(1995-1#2)(1995-3#1)(1997-2#1)
Memorial##18##1##(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)
Memories##4##1##(1991-1#1)(2008-2#2)(2008-7#1)
Memory Performance in##2##3##(2008-12#1)(2010-7#1)
Memory Self-Efficacy and##2##3##(2008-12#1)(2008-9#1)
Memory Self-Efficacy##3##2##(2008-12#2)(2008-9#1)
Memory and Concentration##2##3##(1991-9#2)
Memory and##4##2##(1991-9#2)(1997-4#1)(2008-12#1)
Memory in##3##2##(2007-12#1)(2007-8#1)(2010-6#1)
Memory##33##1##(1991-2#2)(1991-9#2)(1994-6#2)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2013-1#1)
Memphis Business Group on Health##3##5##(1994-12#3)
Memphis##7##1##(1994-12#4)(1995-12#1)(2013-8#2)
Memórias do Instituto Oswaldo##2##4##(1993-6#2)
Men and women##3##3##(1993-6#1)(2009-5#1)(2012-12#1)
Men and##4##2##(1993-6#1)(2009-5#1)(2012-12#1)(2013-1#1)
Men in##2##2##(1995-2#1)(2009-5#1)
Men of##2##2##(2008-4#2)
Men were##2##2##(2008-12#1)(2009-5#1)
Men who have sex with men##2##6##(2009-5#2)
Men who have##3##3##(2009-5#2)(2011-2#1)
Men with##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
Men##29##1##(1993-11#1)(1993-6#1)(1995-2#1)(1996-5#1)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#7)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Men's Appraisals of Their Military Experiences in World War II##2##10##(2013-1#2)
Men's Health##2##2##(1991-2#1)(2009-9#1)
Men's appraisals at both time points were generally##2##8##(2013-1#2)
Men's##6##1##(1991-2#1)(2009-9#1)(2013-1#4)
MenACWY-CRM##4##1##(2013-1#4)
Menadione-catalyzed H(2)O(2) production by viable##2##5##(2008-11#2)
Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to genomics researchers##3##19##(2008-4#2)(2008-9#1)
Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to##4##17##(2008-4#3)(2008-9#1)
Mendelian Inheritance in Man (OMIM)##6##5##(2008-4#4)(2008-9#2)
Mendelian Inheritance in Man##7##4##(2007-7#1)(2008-4#4)(2008-9#2)
Mendelian Inheritance in##8##3##(2007-7#1)(2008-4#4)(2008-9#2)(2009-5#1)
Mendelian diseases##3##2##(1994-9#1)(2008-4#1)(2011-2#1)
Mendelian ratios##2##2##(2008-10#2)
Mendelian segregation##5##2##(2008-10#4)(2012-3#1)
Mendelian##25##1##(1994-9#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#5)(2008-5#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)
Meniere's disease is##2##3##(2012-3#2)
Meniere's disease##4##2##(2012-3#4)
Meningeal##2##1##(2008-7#1)(2012-2#1)
Meningiomas##4##1##(2006-12#2)(2011-2#1)(2012-3#1)
Meningitis and##2##2##(1994-9#1)(2008-9#1)
Meningitis caused by##3##3##(2007-12#1)(2009-11#1)(2011-2#1)
Meningitis is##2##2##(2008-9#2)
Meningitis##13##1##(1994-9#1)(2007-12#1)(2008-9#5)(2009-11#2)(2009-12#1)(2011-2#3)
Meningococcal##2##1##(1990-6#1)(2011-1#1)
Meningococcemia##2##1##(2008-5#1)(2009-4#1)
Menkes disease##5##2##(1993-11#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
Menkes##7##1##(1993-11#3)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
Mennen##3##1##(2008-7#3)
Mental Health Problems in##2##4##(2012-12#1)(2013-1#1)
Mental Health Problems##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
Mental Health Services##2##3##(1994-1#1)(2012-12#1)
Mental Health##36##2##(1992-12#1)(1994-1#2)(1995-1#1)(1995-2#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#3)
Mental Hospital##2##2##(2009-7#1)(2012-3#1)
Mental State##6##2##(1994-6#1)(2006-10#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
Mental Status##2##2##(2008-7#1)(2010-12#1)
Mental health nursing##2##3##(2008-11#1)(2011-2#1)
Mental health service##2##3##(2008-12#1)(2008-7#1)
Mental health services##4##3##(1992-2#1)(1995-1#2)(2010-4#1)
Mental health##25##2##(1992-2#1)(1994-1#2)(1994-2#2)(1995-1#3)(1995-12#1)(1997-4#1)(1997-8#1)(2006-9#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)
Mental illness##2##2##(2009-7#1)(2011-1#1)
Mental nerve neuropathy##2##3##(2007-5#2)
Mental time travel may##2##4##(2013-8#2)
Mental time travel##3##3##(2013-8#3)
Mental##99##1##(1991-2#1)(1992-12#1)(1992-2#1)(1994-1#4)(1994-2#2)(1994-6#1)(1995-1#6)(1995-12#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-5#2)(2008-10#1)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#7)(2009-10#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#6)
Mentha arvensis L##2##3##(2013-1#2)
Mentha piperita L##4##3##(2008-10#1)(2013-1#3)
Mentha piperita##5##2##(2008-10#1)(2013-1#4)
Mentha##15##1##(2008-10#7)(2013-1#8)
Menthofuran##2##1##(1991-5#1)(2013-1#1)
Menthol##3##1##(1994-6#1)(2008-10#1)(2013-1#1)
Mentoring##5##1##(1993-12#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
Mentors##2##1##(2008-11#1)(2012-12#1)
Mentype Argus X-8##2##3##(2008-12#2)
Mepacrine##2##1##(2008-11#2)
Merck &amp##2##2##(2013-1#2)
Merck and##2##2##(2008-5#2)
Merck##12##1##(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#7)(2013-1#2)
Mercury BLASTP##3##2##(2009-6#3)
Mercury determination by##2##3##(2008-10#2)
Mercury determination##3##2##(2008-10#3)
Mercury##22##1##(1993-12#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#13)(2008-7#1)(2009-6#3)(2013-1#1)
Mercury(II)##2##1##(2008-10#2)
Merger##2##1##(1992-2#1)(1996-1#1)
Merging##4##1##(1992-12#1)(1995-1#1)(1996-9#1)(2008-11#1)
Merida##2##1##(1994-2#1)(2008-9#1)
Merimna atrata (Coleoptera##2##3##(2007-12#2)
Merimna atrata##5##2##(2007-12#5)
Merit##2##1##(1991-12#1)(1997-1#1)
Merkel cell carcinoma (MCC) is a rare##2##7##(2011-2#1)(2013-8#1)
Merkel cell carcinoma (MCC)##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
Merkel cell carcinoma##8##3##(2007-5#1)(2011-2#3)(2013-1#2)(2013-8#2)
Merkel cell##10##2##(1993-3#1)(2007-5#1)(2011-2#3)(2013-1#3)(2013-8#2)
Merkel##12##1##(1993-3#1)(2007-5#1)(2011-2#3)(2013-1#5)(2013-8#2)
Merle d'Aubigne classification##3##3##(2007-11#3)
Merle d'Aubigne's##2##2##(2007-11#1)(2007-8#1)
Merle##5##1##(2007-11#4)(2007-8#1)
Merocyanine 540##3##2##(1992-6#1)(2008-10#1)(2008-9#1)
Meropenem##2##1##(2008-7#1)(2011-2#1)
Merr##6##1##(1990-5#1)(2011-2#5)
Merrifield chloromethylated resin##4##3##(2008-10#4)
Merrifield##7##1##(2007-11#1)(2008-10#6)
Merritt to##2##2##(1996-5#2)
Merritt##6##1##(1996-5#5)(2008-10#1)
Mersey Region##2##2##(1991-8#1)(2008-6#1)
Mersey##3##1##(1991-8#1)(2008-6#2)
Mersilene suture##2##2##(2012-3#2)
Mersilene##4##1##(1993-9#1)(2012-3#3)
Mes##2##1##(1996-2#1)(2009-11#1)
Mesalamine##2##1##(2010-12#2)
Mesalazine##2##1##(2010-12#2)
Mesangioproliferative GN##2##2##(2008-1#2)
Mesenchymal Stem Cells##4##3##(2008-11#2)(2011-1#1)(2012-12#1)
Mesenchymal Stem##5##2##(2008-11#3)(2011-1#1)(2012-12#1)
Mesenchymal stem cells##6##3##(2008-11#2)(2008-5#3)(2013-1#1)
Mesenchymal stem##7##2##(2008-11#2)(2008-5#3)(2012-7#1)(2013-1#1)
Mesenchymal stromal##2##2##(2009-10#2)
Mesenchymal##16##1##(2008-11#5)(2008-5#3)(2008-6#1)(2009-10#2)(2011-1#1)(2012-12#2)(2012-7#1)(2013-1#1)
Mesenteric##4##1##(1992-3#1)(2008-11#3)
Mesh and A##2##3##(2008-12#2)
Mesh##5##1##(2008-12#3)(2009-7#1)(2011-2#1)
Mesoamerican##4##1##(2008-10#4)
Mesocyclops thermocyclopoides##2##2##(2008-5#2)
Mesoporous silica nanoparticles##2##3##(2008-7#1)(2010-4#1)
Mesoporous##4##1##(2008-10#2)(2008-7#1)(2010-4#1)
Mesoscopic##3##1##(1996-9#2)(2010-10#1)
Mesostructured tin oxide##2##3##(2008-10#2)
Mesothelioma##4##1##(1991-12#2)(2008-10#2)
Mesotheliomas##2##1##(1991-12#2)
Message##4##1##(2008-7#1)(2010-6#1)(2010-8#1)(2012-3#1)
Messages##3##1##(1996-11#1)(2009-6#1)(2010-11#1)
Messenger RNA##2##2##(1995-12#1)(1996-12#1)
Messenger##3##1##(1995-12#1)(1996-12#2)
Mestizo##2##1##(2008-12#1)(2008-3#1)
Mestizos##2##1##(2008-12#1)(2008-3#1)
Met L248--&gt##2##2##(1993-11#2)
Met was##2##2##(1995-6#1)(2008-11#1)
Met##20##1##(1990-8#1)(1991-12#1)(1991-9#1)(1992-9#2)(1993-11#3)(1993-12#1)(1994-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-12#1)(2011-2#3)
Met)##2##1##(1994-8#1)(2010-11#1)
Met- NH2 (ranatachykinin##4##3##(1991-5#4)
Met- NH2##6##2##(1991-5#6)
Met-Met##2##1##(2008-10#2)
Met-Phe##2##1##(2008-10#2)
Met-enkephalin##3##1##(1992-3#1)(1994-2#2)
Met-tRNA(fMet)##5##1##(1991-12#5)
Met590##2##1##(1995-5#2)
MetNet##4##1##(2008-7#4)
MetNetDB##2##1##(2008-7#2)
MetS and obesity were not##2##5##(2013-8#2)
MetS##17##1##(2010-10#6)(2011-1#3)(2012-2#1)(2013-8#7)
Meta-Analysis##3##1##(1997-7#1)(2007-12#1)(2008-6#1)
Meta-analysis and##2##2##(1996-6#1)(2008-2#1)
Meta-analysis in##3##2##(1996-6#1)(2007-7#1)(2008-10#1)
Meta-analysis is a##2##3##(2008-10#1)(2008-9#1)
Meta-analysis is an##2##3##(1996-6#1)(2008-11#1)
Meta-analysis is##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
Meta-analysis of##6##2##(1994-7#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
Meta-analysis##20##1##(1994-7#1)(1996-6#5)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
Meta-ethnography##2##1##(2008-7#2)
Metabolic Syndrome (MS)##2##3##(2011-1#1)(2013-1#1)
Metabolic Syndrome in##4##3##(2008-3#4)
Metabolic Syndrome##10##2##(2008-11#1)(2008-3#5)(2008-8#1)(2011-1#1)(2013-1#2)
Metabolic activation of##2##3##(1991-2#1)(1995-6#1)
Metabolic activation##3##2##(1991-2#1)(1992-8#1)(1995-6#1)
Metabolic and##2##2##(2008-7#2)
Metabolic effects of##4##3##(1991-5#1)(1995-8#1)(2008-5#1)(2009-12#1)
Metabolic effects##5##2##(1991-5#1)(1995-8#1)(2008-5#1)(2008-7#1)(2009-12#1)
Metabolic engineering of##3##3##(2008-6#1)(2008-7#1)(2011-1#1)
Metabolic labeling and##2##3##(1994-11#1)(2008-1#1)
Metabolic labeling##3##2##(1994-11#1)(2008-1#2)
Metabolic profiling##2##2##(2008-10#1)(2010-5#1)
Metabolic studies##2##2##(1991-1#1)(1992-8#1)
Metabolic syndrome and##2##3##(2008-3#1)(2010-10#1)
Metabolic syndrome in##3##3##(2008-3#1)(2012-12#1)(2012-3#1)
Metabolic syndrome is a##2##4##(2008-11#1)(2008-3#1)
Metabolic syndrome##14##2##(2008-11#4)(2008-3#4)(2009-10#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Metabolic##69##1##(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#2)(1993-1#1)(1994-11#2)(1994-8#1)(1995-6#1)(1995-8#1)(2008-1#3)(2008-10#3)(2008-11#11)(2008-12#1)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
Metabolically##2##1##(1994-5#1)(2013-1#1)
Metabolism and##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
Metabolism in##4##2##(2008-11#3)(2008-5#1)
Metabolism of##8##2##(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#3)(2011-2#1)
Metabolism##20##1##(1991-5#1)(1993-8#1)(1996-1#1)(2008-10#3)(2008-11#6)(2008-4#3)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
Metabolites##6##1##(1993-12#1)(2008-10#2)(2008-11#1)(2010-11#2)
Metabotropic glutamate##3##2##(1995-12#1)(2008-7#2)
Metabotropic##4##1##(1995-12#2)(2008-7#2)
Metagagrella tenuipes (Arachnida##2##3##(2008-5#2)
Metagenomics##3##1##(2011-1#1)(2011-2#2)
Metal concentration was determined by flame atomic absorption spectrometry (FAAS)##2##10##(2008-10#2)
Metal concentration##3##2##(2008-10#2)(2008-5#1)
Metal ion##4##2##(2008-10#4)
Metal ions were##4##3##(2008-10#4)
Metal ions##8##2##(1997-7#1)(2008-10#7)
Metal speciation##3##2##(2008-10#3)
Metal##33##1##(1991-12#1)(1996-2#1)(1997-7#2)(2008-10#21)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)
Metal-binding##2##1##(1992-12#1)(2010-11#1)
Metalaxyl##5##1##(2008-10#5)
Metalfix Chelamine##2##2##(2008-10#2)
Metalfix-Chelamine##3##1##(2008-10#3)
Metallic##4##1##(1990-12#1)(1995-3#1)(2008-9#1)(2011-1#1)
Metalloproteases##2##1##(2008-4#2)
Metalloproteomics##2##1##(2010-11#2)
Metallothionein (MT)##4##2##(1994-11#1)(2008-10#2)(2013-1#1)
Metallothionein##11##1##(1990-5#1)(1993-12#1)(1994-11#1)(2008-10#6)(2013-1#1)(2013-7#1)
Metallothioneins (MT)##2##2##(2008-10#1)(2013-7#1)
Metallothioneins (MTs) are##2##3##(2011-2#1)(2013-7#1)
Metallothioneins (MTs)##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
Metallothioneins##7##1##(2008-10#4)(2011-2#1)(2013-7#2)
Metals were##2##2##(2008-10#2)
Metals##9##1##(1996-5#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-11#1)
Metanephric adenoma##2##2##(2008-10#2)
Metaphase##2##1##(2008-4#2)
Metapopulation##3##1##(2008-8#2)(2008-9#1)
Metarhizium anisopliae##9##2##(2008-6#4)(2010-10#5)
Metarhizium##10##1##(2008-6#4)(2010-10#5)(2011-2#1)
Metarrhizium sp##2##2##(2008-9#2)
Metastases and spinal cord compression##2##5##(1992-12#2)
Metastases to##2##2##(1993-12#1)(2009-10#1)
Metastases##12##1##(1992-12#2)(1993-12#1)(1994-12#1)(1995-4#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)
Metastasis from##2##2##(2011-2#1)(2012-1#1)
Metastasis of##4##2##(1994-12#1)(2007-4#1)(2007-5#1)(2013-1#1)
Metastasis to the##2##3##(1997-3#1)(2007-10#1)
Metastasis to##3##2##(1997-3#1)(2007-10#1)(2010-11#1)
Metastasis##12##1##(1994-12#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-5#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#3)
Metastatic Ewing's Sarcoma##2##3##(2008-6#1)(2012-3#1)
Metastatic bone##2##2##(2007-11#1)(2009-10#1)
Metastatic##26##1##(1990-12#1)(1990-8#1)(1992-11#1)(1994-7#1)(1996-9#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#3)(2009-10#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
Metatarsus adductus##2##2##(2012-2#1)(2012-3#1)
Meteorological##5##1##(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
Meter##3##1##(2008-5#3)
Metered dose inhalers##2##3##(1992-3#1)(2008-3#1)
Metered##3##1##(1992-3#2)(2008-3#1)
Metered-dose propellant-driven aerosols##2##3##(1996-1#2)
Metered-dose##3##1##(1996-1#2)(1996-2#1)
Metformin hydrochloride##2##2##(2012-2#1)(2013-1#1)
Metformin##13##1##(1994-8#2)(1995-8#2)(1996-2#1)(2008-1#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
Meth-A cells##3##2##(1994-11#2)(1994-5#1)
Meth-A##4##1##(1992-9#1)(1994-11#2)(1994-5#1)
Methadone##4##1##(1991-1#1)(2008-6#1)(2008-7#2)
Methamphetamine##4##1##(1990-8#1)(1994-2#1)(2008-10#1)(2013-1#1)
Methane##3##1##(2008-3#1)(2008-6#2)
Methanococcus##2##1##(1990-2#1)(2008-7#1)
Methanol##14##1##(1990-8#1)(1992-6#1)(1995-2#1)(1995-3#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
Methanolic extracts of##2##3##(1997-2#1)(2008-10#1)
Methanomicrobiales##2##1##(2011-2#2)
Methanoplanus petrolearius##2##2##(2011-2#2)
Methanoplanus##5##1##(2011-2#5)
Methanothermus fervidus##2##2##(2011-2#2)
Methanothermus##3##1##(2011-2#3)
Methemoglobinemia##3##1##(2007-8#3)
Methicillin-Resistant Staphylococcus aureus##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
Methicillin-resistant Staphylococcus aureus##2##3##(2008-10#1)(2013-8#1)
Methicillin-resistant##4##1##(2008-10#2)(2008-7#1)(2013-8#1)
Methiocarb##2##1##(2008-10#2)
Methionine##4##1##(1991-9#1)(1993-9#1)(2008-10#2)
Method 314##3##2##(2008-10#3)
Method The##2##2##(2013-1#2)
Method This was a##2##4##(2011-2#1)(2012-12#1)
Method This was##3##3##(2011-2#2)(2012-12#1)
Method This##4##2##(2011-2#2)(2012-12#1)(2013-8#1)
Method and##3##2##(1994-2#1)(2013-8#2)
Method detection limits##3##3##(2008-10#3)
Method development##4##2##(1997-2#1)(2008-10#3)
Method for measuring the##2##4##(2007-12#2)
Method for measuring##3##3##(2007-12#2)(2008-3#1)
Method for the Simultaneous Estimation of##2##6##(2010-5#1)(2012-2#1)
Method for the##9##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)
Method for##39##2##(1995-6#1)(1996-5#2)(1997-1#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-5#2)(2010-8#1)(2012-2#1)(2013-1#3)
Method of##9##2##(1996-9#1)(2007-11#2)(2008-2#1)(2008-3#2)(2010-5#1)(2012-1#1)(2012-3#1)
Method performance was evaluated by##2##5##(2008-10#2)
Method to##9##2##(2008-10#3)(2008-11#2)(2008-3#2)(2009-12#1)(2010-12#1)
Method##151##1##(1991-11#1)(1991-2#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-7#1)(2008-10#28)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#13)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#3)(2009-8#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#4)(2010-8#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#12)(2013-8#9)
Method)##2##1##(1995-12#1)(2008-10#1)
Methodist##6##1##(1991-1#1)(1995-2#2)(1996-3#1)(1997-3#1)(2010-3#1)
Methodologic##5##1##(1991-12#2)(1992-9#1)(1996-12#1)(2007-10#1)
Methodological and##2##2##(1995-2#1)(2008-4#1)
Methodological##13##1##(1990-6#1)(1994-6#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
Methodologies for##2##2##(2008-10#2)
Methodologies##4##1##(2008-10#2)(2008-11#1)(2013-8#1)
Methodology A##2##2##(2012-12#2)
Methodology This was a##2##4##(2012-12#2)
Methodology for the##4##3##(2008-10#1)(2008-3#1)(2010-2#1)(2013-8#1)
Methodology for##6##2##(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-8#2)
Methodology of##2##2##(2008-10#1)(2011-2#1)
Methodology##30##1##(1996-1#1)(2008-10#7)(2008-3#2)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#7)(2012-2#1)(2013-1#5)(2013-8#3)
Methods &amp##4##2##(2012-3#4)
Methods -##5##2##(2008-11#5)
Methods A cross-sectional##3##3##(2011-2#2)(2012-12#1)
Methods A descriptive##2##3##(2011-2#1)(2013-1#1)
Methods A##12##2##(2008-10#1)(2011-2#5)(2012-12#4)(2013-1#2)
Methods The study##2##3##(2011-2#2)
Methods The##7##2##(2011-2#3)(2012-12#2)(2013-8#2)
Methods This was a cross-sectional study##2##6##(2012-12#1)(2013-1#1)
Methods This was a descriptive study##2##6##(2012-12#1)(2013-1#1)
Methods This was a descriptive##4##5##(2011-2#1)(2012-12#2)(2013-1#1)
Methods This was a retrospective##2##5##(2012-12#1)(2013-1#1)
Methods This was a##10##4##(2011-2#2)(2012-12#5)(2013-1#3)
Methods We searched##2##3##(2011-2#2)
Methods and Results##3##3##(2011-2#2)(2012-3#1)
Methods and materials##2##3##(2008-6#1)(2012-8#1)
Methods and results##2##3##(2008-6#2)
Methods and##9##2##(2008-10#1)(2008-6#3)(2011-2#2)(2012-3#1)(2012-8#1)(2013-8#1)
Methods are##7##2##(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#2)
Methods available for##2##3##(2008-11#1)(2009-10#1)
Methods for controlling##2##3##(1991-12#1)(2008-7#1)
Methods for detecting##2##3##(2012-3#2)
Methods for the direct determination of##3##6##(2008-10#3)
Methods for the##8##3##(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)
Methods for##49##2##(1991-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
Methods have been developed##2##4##(2008-10#2)
Methods have been##3##3##(2008-10#2)(2010-6#1)
Methods in##5##2##(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
Methods of prophylaxis and therapy for emporiatrics##2##7##(2013-1#2)
Methods of##14##2##(1990-5#1)(1993-3#1)(1995-5#1)(1997-1#1)(2007-11#3)(2008-10#2)(2008-2#2)(2009-3#1)(2013-1#2)
Methods to analyze##2##3##(2008-1#1)(2008-9#1)
Methods to reduce##2##3##(2008-3#1)(2010-11#1)
Methods to##16##2##(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#2)
Methods used##2##2##(2008-3#1)(2009-9#1)
Methods##547##1##(1990-5#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-9#1)(1996-9#2)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#10)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#40)(2008-11#11)(2008-12#2)(2008-2#7)(2008-3#19)(2008-4#13)(2008-5#7)(2008-6#26)(2008-7#14)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#19)(2011-2#48)(2012-1#7)(2012-12#34)(2012-2#11)(2012-3#29)(2012-8#1)(2013-1#124)(2013-7#2)(2013-8#48)
Methods- The##2##2##(2008-11#2)
Methods-##5##1##(2008-11#5)
Methods  A##3##2##(2011-2#1)(2012-1#1)(2012-3#1)
Methods ##13##1##(2011-2#6)(2012-1#5)(2012-3#2)
Method ##2##1##(2012-3#2)
Methomyl##3##1##(2008-10#2)(2008-7#1)
Methotrexate toxicity##2##2##(2012-2#2)
Methotrexate##13##1##(1990-6#1)(1992-8#1)(1993-12#1)(1995-8#3)(2006-10#1)(2007-10#2)(2007-11#1)(2010-12#1)(2012-2#2)
Methyl Ester##2##2##(2008-10#1)(2008-8#1)
Methyl##13##1##(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-8#1)(2009-7#1)(2011-2#2)
Methylation of the##2##3##(1996-7#1)(2011-1#1)
Methylation of##5##2##(1996-7#1)(2008-4#1)(2010-11#1)(2010-8#1)(2011-1#1)
Methylation##7##1##(1991-2#1)(1996-7#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)
Methylene##2##1##(2008-10#1)(2012-2#1)
Methylglyoxal##3##1##(2008-11#2)(2012-1#1)
Methylphenidate##2##1##(1995-11#1)(2010-4#1)
Metolcarb##2##1##(2008-10#2)
Metopolophium##2##1##(2008-10#2)
Metoprolol##2##1##(1994-9#1)(2012-2#1)
Metrioidea##2##1##(2008-5#2)
Metro Toronto##3##2##(1994-1#2)(1997-3#1)
Metro##4##1##(1994-1#2)(1997-3#1)(2011-2#1)
Metrohm 756##2##2##(2008-10#2)
Metrohm##3##1##(2008-10#3)
Metronidazole##2##1##(1991-8#1)(2008-10#1)
Metropolitan Region##6##2##(2008-9#1)(2012-2#3)(2013-1#2)
Metropolitan Toronto##8##2##(1991-2#2)(1993-1#1)(1994-1#3)(1996-3#2)
Metropolitan##24##1##(1991-12#1)(1991-2#2)(1993-1#1)(1994-1#3)(1996-3#2)(1997-5#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-5#3)(2008-9#1)(2011-2#2)(2012-2#3)(2013-1#2)
Mets motifs##2##2##(2010-11#2)
Mex+##5##1##(1992-3#5)
Mex- cells##2##2##(1992-3#2)
Mex-##4##1##(1992-3#4)
Mexican American women##3##3##(2007-12#3)
Mexican American##7##2##(2007-12#3)(2009-7#2)(2010-2#1)(2012-2#1)
Mexican Americans##3##2##(2007-12#1)(2010-12#1)(2012-3#1)
Mexican National Potato Program##2##4##(2008-10#2)
Mexican Zanthoxylum species##2##3##(2007-11#2)
Mexican and##3##2##(2008-10#1)(2012-12#1)(2013-7#1)
Mexican immigrants##4##2##(2010-12#3)(2013-8#1)
Mexican isolates##2##2##(2008-10#2)
Mexican lime##2##2##(2008-10#2)
Mexican origin##2##2##(2008-10#1)(2013-8#1)
Mexican waters##2##2##(2009-2#2)
Mexican##69##1##(1993-6#1)(1996-2#1)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-10#15)(2008-11#1)(2008-12#2)(2008-5#4)(2008-8#2)(2009-2#3)(2009-4#2)(2009-7#3)(2010-12#5)(2010-2#2)(2011-2#5)(2012-12#7)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#3)
Mexican-American##3##1##(2006-10#1)(2007-10#1)(2012-2#1)
Mexican-Americans##2##1##(2006-10#1)(2013-8#1)
Mexicans##3##1##(2008-12#1)(2012-3#1)(2013-8#1)
Mexico City##9##2##(1996-12#1)(2006-8#1)(2008-11#1)(2008-12#5)(2009-7#1)
Mexico and the##4##3##(1994-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
Mexico and##17##2##(1994-11#1)(1996-12#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-5#4)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
Mexico to##2##2##(2013-7#2)
Mexico was##2##2##(2008-10#2)
Mexico##159##1##(1990-8#1)(1991-3#1)(1992-5#1)(1994-11#1)(1996-12#2)(1996-2#1)(1997-3#3)(1997-8#4)(1997-9#1)(2006-8#2)(2007-2#1)(2008-10#45)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#4)(2008-5#28)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#2)(2009-7#2)(2009-8#2)(2009-9#1)(2011-1#4)(2011-2#13)(2012-12#3)(2012-3#3)(2013-1#2)(2013-7#8)(2013-8#3)
Mexico]##17##1##(2008-11#2)(2008-5#10)(2012-3#1)(2013-7#4)
Meyer##3##1##(1990-3#1)(2010-4#1)(2011-2#1)
Meyer)##2##1##(1997-2#2)
Mezerein##2##1##(1992-2#1)(1995-11#1)
Mg and##5##2##(2007-12#1)(2008-10#3)(2008-5#1)
Mg are##2##2##(2008-10#2)
Mg in##4##2##(2008-10#4)
Mg levels##3##2##(2008-10#3)
Mg was##2##2##(2008-10#2)
Mg x 609 A and Mg x 624 A##2##9##(2008-3#2)
Mg x 609 A##4##4##(2008-3#4)
Mg x##8##2##(2008-3#8)
Mg##94##1##(1991-5#3)(1995-6#2)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#72)(2008-3#8)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#3)
Mg(+)&gt##2##1##(2008-10#2)
Mg(2)SiO(4)##2##1##(2007-12#2)
Mg(2+) (0##2##2##(2008-10#1)(2008-8#1)
Mg(2+) and Ca(2+)##2##3##(1997-7#1)(2008-10#1)
Mg(2+) and##7##2##(1997-7#1)(2008-10#3)(2008-4#1)(2008-9#2)
Mg(2+) and/or##3##2##(2008-10#2)(2008-4#1)
Mg(2+) for##2##2##(2008-11#1)(2008-9#1)
Mg(2+) in the##3##3##(2008-8#1)(2013-1#2)
Mg(2+) in##6##2##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#2)
Mg(2+) inhibition##2##2##(2008-8#2)
Mg(2+) ions##3##2##(2008-10#3)
Mg(2+) is##4##2##(2008-10#4)
Mg(2+) were##3##2##(2008-10#2)(2010-4#1)
Mg(2+)##76##1##(1997-7#1)(2008-10#52)(2008-11#3)(2008-4#2)(2008-8#7)(2008-9#6)(2009-6#1)(2009-7#1)(2010-4#1)(2013-1#2)
Mg(2+)&gt##2##1##(2008-10#2)
Mg(2+))##3##1##(2008-10#2)(2008-6#1)
Mg(2+)-dependent protein phosphatase alpha##2##4##(1993-8#2)
Mg(2+)-dependent##4##1##(1992-6#1)(1993-3#1)(1993-8#2)
Mg(CH3COO)2##3##1##(1995-3#3)
Mg(II) and Ca(II)##2##3##(2008-10#2)
Mg(II) and##3##2##(2008-10#3)
Mg(II) with##2##2##(2008-10#2)
Mg(II)##17##1##(1992-9#1)(2008-10#16)
Mg(NO(3))(2)##3##1##(2008-10#3)
Mg)##3##1##(2008-10#3)
Mg++##2##1##(1993-11#1)(1993-8#1)
Mg-CPC##2##1##(2008-10#2)
Mg-W cell-electrodeposition method##2##3##(2008-10#2)
Mg-W cell-electrodeposition##4##2##(2008-10#4)
Mg-dependent protein phosphatase##3##3##(1993-6#3)
Mg-x##2##1##(2012-2#2)
Mg2+ and##6##2##(1991-2#1)(1991-9#1)(1992-11#2)(1995-11#1)(1995-2#1)
Mg2+ are##2##2##(1990-7#1)(1992-3#1)
Mg2+ concentration##4##2##(1990-7#1)(1991-9#1)(1992-3#1)(1994-6#1)
Mg2+ concentrations##2##2##(1992-3#1)(1995-5#1)
Mg2+ in the##2##3##(1993-6#1)(1995-6#1)
Mg2+ in##3##2##(1993-6#1)(1994-6#1)(1995-6#1)
Mg2+ ion##3##2##(1993-11#1)(1995-6#2)
Mg2+ or ADP##4##3##(1992-3#4)
Mg2+ or##6##2##(1990-5#2)(1992-3#4)
Mg2+ was##3##2##(1990-5#1)(1991-11#1)(1993-11#1)
Mg2+##92##1##(1990-2#1)(1990-5#4)(1990-7#9)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#15)(1993-11#9)(1993-6#4)(1993-8#1)(1994-5#4)(1994-6#4)(1994-8#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#15)(1997-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
MgADP and Mg2+##2##3##(1993-11#2)
MgADP and MgATP bound to##2##5##(1993-11#2)
MgADP and##6##2##(1992-3#2)(1993-11#4)
MgADP stimulation of##2##3##(2008-8#2)
MgADP stimulation##3##2##(2008-8#3)
MgADP##15##1##(1992-3#6)(1993-11#4)(1994-5#2)(2008-8#3)
MgATP##5##1##(1992-11#1)(1992-5#1)(1993-11#3)
MgAl(2)O(4) crystal was##2##3##(2008-3#2)
MgAl(2)O(4) crystal##3##2##(2008-3#3)
MgAl(2)O(4) plate as##2##3##(2008-3#2)
MgAl(2)O(4)##6##1##(2008-3#6)
MgAl2O4 powder##2##2##(2013-8#2)
MgAl2O4##5##1##(2008-3#1)(2013-8#4)
MgAl2O4/Ce##4##1##(2013-8#4)
MgB(2)##2##1##(2010-7#2)
MgCO3##2##1##(1997-4#2)
MgCarb##5##1##(1994-5#5)
MgCl(2)##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
MgCl2 in##2##2##(1990-7#1)(1995-12#1)
MgCl2##19##1##(1990-7#3)(1991-5#1)(1992-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-11#1)(1995-12#6)(2008-1#1)(2008-6#1)
MgF(2) and##2##2##(2008-10#1)(2008-3#1)
MgF(2)##5##1##(2008-10#2)(2008-2#1)(2008-3#2)
MgGDP##3##1##(1992-3#3)
MgO and##3##2##(2007-12#2)(2008-3#1)
MgO##17##1##(2007-11#2)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#3)(2013-8#1)
MgO-Al(2)O(3)-ZrO(2)##2##1##(2008-2#2)
MgO-doped##3##1##(2007-11#2)(2007-12#1)
MgUDP##3##1##(1992-3#3)
MhNPR1 expression##3##2##(2011-10#3)
MhNPR1##9##1##(2011-10#9)
Mhc genes##3##2##(2008-8#3)
Mhc##7##1##(2008-8#7)
Mi and##3##2##(1995-11#1)(2008-10#2)
Mi##8##1##(1995-11#2)(2008-10#6)
MiLV##7##1##(2008-10#7)
MiR-218##2##1##(2011-2#2)
Miami##3##1##(2008-10#1)(2008-12#1)(2008-6#1)
Mianserin (5 mg/kg intraperitoneal) significantly enhanced the suppressant effect of a low dose of raclopride (0##2##16##(2008-6#2)
Miao##3##1##(1995-6#2)(2008-9#1)
Mice are##2##2##(1994-5#1)(2008-8#1)
Mice as##2##2##(1995-9#1)(2012-3#1)
Mice carrying##3##2##(1993-12#1)(1993-3#1)(1997-8#1)
Mice injected with##2##3##(2008-4#1)(2008-7#1)
Mice pretreated with##2##3##(1995-3#1)(2010-5#1)
Mice that##3##2##(1995-2#2)(2008-7#1)
Mice were divided into##2##4##(2008-10#1)(2008-11#1)
Mice were##14##2##(1990-12#1)(1995-12#1)(1997-4#1)(2007-2#1)(2008-10#6)(2008-11#1)(2010-7#1)(2013-1#1)(2013-8#1)
Mice with##6##2##(1994-3#1)(1997-2#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-7#1)
Mice##69##1##(1990-12#1)(1990-5#1)(1990-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-4#2)(2008-7#4)(2008-8#2)(2009-12#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
Micellar electrokinetic capillary chromatography##4##4##(1994-9#1)(2008-10#3)
Micellar electrokinetic##5##2##(1994-9#1)(2008-10#3)(2010-7#1)
Micellar liquid chromatography##2##3##(2008-10#1)(2010-11#1)
Micellar##17##1##(1994-9#1)(1995-3#1)(2008-10#11)(2009-8#1)(2010-11#2)(2010-7#1)
Micellar-enhanced##2##1##(2008-10#2)
Micelle##2##1##(2008-10#2)
Micelles##3##1##(1996-5#2)(2008-10#1)
Michael Ashburner##2##2##(2008-7#2)
Michael Sars##2##2##(1993-3#2)
Michael South##2##2##(2008-5#2)
Michael addition##4##2##(2007-11#1)(2008-10#3)
Michael##22##1##(1990-3#2)(1993-11#1)(1993-3#2)(1994-2#1)(1995-12#1)(1996-5#2)(2007-11#1)(2008-10#3)(2008-5#2)(2008-7#4)(2009-12#1)(2010-8#1)(2013-1#1)
Michaelian##2##1##(1990-8#2)
Michaelis complex##2##2##(1993-8#1)(1995-2#1)
Michaelis constant and##2##3##(2008-10#2)
Michaelis constant of##2##3##(1990-5#1)(1995-3#1)
Michaelis constant##10##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-3#1)(1994-5#1)(1995-3#1)(2008-10#4)
Michaelis constants##4##2##(1991-5#2)(1993-9#1)(1994-8#1)
Michaelis##17##1##(1990-5#1)(1991-5#3)(1991-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-6#1)
Michaelis-Menten constant was##2##3##(2008-10#2)
Michaelis-Menten constant##6##2##(2008-10#5)(2009-10#1)
Michaelis-Menten constants##2##2##(2008-10#1)(2008-4#1)
Michaelis-Menten kinetics##5##2##(1994-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-2#1)
Michaelis-Menten##17##1##(1994-3#1)(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#8)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-2#1)
Michel Foucault has##2##3##(1993-11#2)
Michel##5##1##(1993-11#2)(2012-3#2)(2013-1#1)
Michelson interferometer and##2##3##(2007-11#2)
Michelson interferometer for##3##3##(2007-12#1)(2008-3#2)
Michelson interferometer to##2##3##(2007-11#1)(2008-2#1)
Michelson interferometer with a##5##4##(2007-11#3)(2008-2#1)(2008-3#1)
Michelson interferometer with##8##3##(2007-11#3)(2008-2#4)(2008-3#1)
Michelson interferometer##29##2##(2007-11#11)(2007-12#3)(2008-2#5)(2008-3#10)
Michelson interferometers##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
Michelson interferometry##2##2##(2008-2#2)
Michelson##45##1##(2007-11#12)(2007-12#5)(2008-2#12)(2008-3#16)
Michigan Department of##2##3##(1996-2#1)(1996-3#1)
Michigan and##4##2##(1991-1#1)(1995-3#1)(2008-10#2)
Michigan hospital medians##2##3##(1994-12#1)(1995-3#1)
Michigan orchards##3##2##(2008-10#3)
Michigan##75##1##(1991-1#2)(1991-3#1)(1992-12#1)(1992-2#4)(1992-3#3)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#4)(1995-3#4)(1996-1#2)(1996-2#3)(1996-3#5)(1997-1#1)(1997-7#1)(2007-10#1)(2008-10#29)(2008-11#1)(2008-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
Michigan's rural##2##2##(1996-2#2)
Michigan's##3##1##(1996-2#2)(1997-7#1)
Micro RNAs are##2##3##(2011-2#2)
Micro##4##1##(2008-10#1)(2010-11#1)(2011-2#2)
Micro-Angiographic Fluoroscope (MAF)##2##3##(2011-1#2)
Micro-Cirrus##2##1##(1995-3#2)
MicroHex((R))##3##1##(2008-11#3)
MicroRNA and Cancer##2##3##(2008-7#1)(2009-5#1)
MicroRNA expression##2##2##(2010-4#1)(2012-3#1)
MicroRNA##8##1##(2008-7#1)(2009-5#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
MicroRNAs (miRNAs) are##2##3##(2008-7#1)(2013-1#1)
MicroRNAs (miRNAs)##5##2##(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#2)
MicroRNAs##10##1##(2008-11#2)(2008-7#1)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
MicroSol-IEF##2##1##(2008-4#2)
Microalbuminuria is##2##2##(2013-1#2)
Microalbuminuria##4##1##(2009-7#1)(2012-3#1)(2013-1#2)
Microanalysis of##2##2##(2008-1#1)(2008-10#1)
Microarray Data##2##2##(2008-6#1)(2008-7#1)
Microarray Gene Expression##2##3##(2008-7#1)(2010-3#1)
Microarray analysis of##4##3##(2008-10#1)(2008-7#3)
Microarray analysis##5##2##(2008-10#1)(2008-7#3)(2010-6#1)
Microarray data##2##2##(2008-4#1)(2008-7#1)
Microarray experiments##2##2##(2008-7#1)(2011-3#1)
Microarray studies##2##2##(2012-2#2)
Microarray technology##5##2##(2008-10#1)(2008-7#3)(2010-12#1)
Microarray##28##1##(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#13)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)
Microarrays for##3##2##(2008-7#3)
Microarrays##8##1##(2008-4#2)(2008-7#5)(2012-3#1)
Microbacterium##2##1##(2008-10#2)
Microbes##3##1##(2008-10#1)(2008-7#1)(2013-7#1)
Microbial Biotechnology##2##2##(2011-1#2)
Microbial biomass##2##2##(2008-10#1)(2013-7#1)
Microbial growth##2##2##(2008-7#1)(2008-8#1)
Microbial metabolomics##2##2##(2012-3#2)
Microbial##37##1##(1991-12#1)(1997-4#1)(2007-3#1)(2007-7#1)(2008-10#12)(2008-11#4)(2008-6#3)(2008-7#2)(2008-8#1)(2011-1#4)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
Microbicide##2##1##(2007-7#2)
Microbiol##3##1##(1992-7#1)(1995-2#1)(1995-6#1)
Microbiological quality##2##2##(2008-1#1)(2008-5#1)
Microbiological##9##1##(2007-12#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-9#2)(2012-2#1)
Microbiology Laboratory of the##2##4##(2008-10#1)(2010-8#1)
Microbiology and##2##2##(2007-12#1)(2008-5#1)
Microbiology at##2##2##(2007-7#1)(2013-8#1)
Microbiology##13##1##(1997-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#2)
Microbiology</DescriptorName> </MeshHeading>##2##2##(1997-4#2)
Microbodies##3##1##(2008-10#3)
Microcavity##2##1##(2007-12#1)(2008-7#1)
Microcerotermes diversus##2##2##(2011-2#2)
Microchip capillary electrophoresis with electrochemical detector for##2##7##(2008-10#2)
Microchip capillary electrophoresis with##3##4##(2008-10#3)
Microchip capillary electrophoresis##5##3##(2008-10#5)
Microchip capillary##6##2##(2008-10#6)
Microchip electrophoresis##2##2##(2008-10#2)
Microchip##10##1##(2008-10#10)
Microcirculation##2##1##(2009-11#1)(2010-1#1)
Micrococcus luteus##8##2##(1992-3#1)(1994-2#1)(1997-6#2)(2008-10#1)(2008-12#2)(2012-3#1)
Micrococcus##10##1##(1992-3#1)(1994-2#1)(1997-6#3)(2008-10#1)(2008-12#2)(2010-4#1)(2012-3#1)
Microcolumn##2##1##(1994-9#1)(2008-10#1)
Microcracks##2##1##(2009-7#2)
Microcycle##2##1##(2008-10#2)
Microcystins##2##1##(2008-10#1)(2012-12#1)
Microdialysis probes were##2##3##(1997-7#1)(2008-10#1)
Microdialysis##5##1##(1995-5#2)(1997-7#1)(2008-10#1)(2008-8#1)
Microdissection##3##1##(2008-9#1)(2010-6#2)
Microdochium nivale##3##2##(2008-10#3)
Microdosimetric##2##1##(1994-3#1)(1996-6#1)
Microejections of lidocaine##2##3##(1990-9#2)
Microelectrode##2##1##(1992-3#1)(2010-2#1)
Microencapsulation##2##1##(1994-12#1)(2008-11#1)
Microenvironment##2##1##(2009-10#1)(2013-1#1)
Microextraction##2##1##(2008-10#1)(2009-8#1)
Microfabricated##3##1##(2008-10#2)(2008-7#1)
Microfine##2##1##(2008-5#2)
Microflora##2##1##(2008-10#2)
Microfluidic##9##1##(2008-10#3)(2008-12#1)(2009-12#1)(2009-2#3)(2010-8#1)
Microfluidics##2##1##(2009-12#1)(2012-2#1)
Microglial##3##1##(1997-3#2)(2008-6#1)
Microgramma##2##1##(2013-7#2)
Microhardness##2##1##(2008-12#2)
Microinjection of##6##2##(1993-6#1)(1993-8#2)(1997-2#2)(2008-9#1)
Microinjection##7##1##(1992-12#1)(1993-6#1)(1993-8#2)(1997-2#2)(2008-9#1)
Microinjections of##3##2##(1990-7#1)(1993-6#1)(1994-2#1)
Microinjections##4##1##(1990-7#1)(1993-6#1)(1994-2#1)(1996-2#1)
Microlens arrays##2##2##(2008-2#2)
Microlens##6##1##(2008-2#3)(2008-3#3)
Microlenses and##2##2##(2008-2#2)
Micromachined##4##1##(2008-2#1)(2008-3#2)(2009-11#1)
Micromechanics-based wavelength-sensitive photonic##2##3##(2008-3#2)
Micromirrors##2##1##(2007-12#1)(2008-3#1)
Micromolar##2##1##(1990-2#1)(1994-2#1)
Micromonospora##2##1##(2012-2#2)
Micronesia and the##2##3##(2008-1#1)(2008-10#1)
Micronesia##14##1##(2008-1#5)(2008-10#4)(2013-8#5)
Microorganisms and##2##2##(1990-6#1)(2008-5#1)
Microorganisms##6##1##(1990-6#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
Microphysical particle parameters from extinction and backscatter lidar data by inversion with regularization##3##13##(2008-3#3)
Microplitis##2##1##(2010-2#2)
Microplots##2##1##(2008-10#2)
Micropogonias furnieri##3##2##(2009-7#1)(2010-8#2)
Microsatellite Markers##3##2##(2008-10#1)(2008-5#2)
Microsatellite markers##3##2##(1994-6#1)(2008-10#2)
Microsatellite##12##1##(1994-6#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-7#1)(2013-8#1)
Microsatellites##4##1##(2008-10#2)(2009-5#1)(2012-3#1)
Microscale##4##1##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
Microsclerotia of Verticillium dahliae##2##4##(2008-10#2)
Microsclerotia##3##1##(2008-10#3)
Microscope##10##1##(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#1)
Microscopic examination of the##2##4##(1992-11#1)(1993-3#1)
Microscopic examination of##5##3##(1992-11#1)(1993-3#1)(2007-7#1)(2008-5#1)(2012-2#1)
Microscopic examination revealed a##2##4##(2011-1#1)(2011-2#1)
Microscopic examination##8##2##(1992-11#1)(1993-3#1)(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
Microscopic examinations##2##2##(2008-6#1)(2011-2#1)
Microscopic observation##3##2##(2008-10#2)(2008-11#1)
Microscopic observations##2##2##(2008-10#2)
Microscopic##27##1##(1991-3#1)(1992-11#1)(1993-3#1)(1995-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-6#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
Microscopical##4##1##(2008-10#2)(2008-5#2)
Microscopically##9##1##(1991-8#1)(1993-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
Microscopy and##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
Microscopy of##3##2##(1996-12#1)(2009-9#1)(2010-10#1)
Microscopy##21##1##(1990-11#1)(1990-7#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#2)
Microsoft Excel 4##2##3##(1994-2#1)(1994-3#1)
Microsoft Excel##6##2##(1994-2#1)(1994-3#2)(2008-10#2)(2013-1#1)
Microsoft##13##1##(1994-2#1)(1994-3#2)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#1)(2010-8#1)(2013-1#1)
Microsomacanthus microsoma##2##2##(2011-2#2)
Microsomacanthus##12##1##(2011-2#12)
Microsomal lipid peroxidation##2##3##(1990-12#1)(1995-6#1)
Microsomal##6##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-9#1)(1994-6#1)(1995-6#1)
Microsomes from##2##2##(1993-11#1)(1993-8#1)
Microsphaeropsis amaranthi##2##2##(2008-10#2)
Microsphaeropsis ochracea on the##2##4##(2008-10#2)
Microsphaeropsis sp##20##2##(2008-10#20)
Microsphaeropsis##24##1##(2008-10#24)
Microsphere##2##1##(2008-3#1)(2008-9#1)
Microspheres##2##1##(2008-7#1)(2008-8#1)
Microspores##2##1##(2008-5#2)
Microsporum canis##3##2##(2008-5#3)
Microsporum##5##1##(2008-5#4)(2012-3#1)
Microstereolithography##3##1##(2008-2#1)(2008-3#1)(2012-2#1)
Microstructure and##2##2##(2009-7#2)
Microstructure##5##1##(2009-7#4)(2010-12#1)
Microstructures##3##1##(2008-3#1)(2009-7#1)(2013-8#1)
Microsupport with two-dimensional geometry (2D-MS)##2##5##(2008-11#2)
Microsupport with##3##2##(2008-11#3)
Microsurgery##2##1##(2008-7#1)(2011-2#1)
Microsurgical##7##1##(1994-12#1)(1995-11#1)(2008-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
Microtrombidiidae)##2##1##(2007-12#2)
Microtubules are##2##2##(2009-10#2)
Microtubules##8##1##(1992-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-8#1)(2011-2#1)
Microtus pennsylvanicus##3##2##(1994-3#2)(1994-8#1)
Microvascular##6##1##(1996-2#1)(2008-4#2)(2009-8#1)(2012-2#1)(2013-8#1)
Microvesicles##3##1##(1997-3#3)
Microwave##10##1##(2007-8#2)(2008-10#3)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2013-8#1)
Microwave-accelerated##2##1##(2007-11#1)(2008-10#1)
Microwave-assisted extraction (MAE)##2##3##(2008-10#2)
Microwave-assisted extraction##4##2##(2008-10#4)
Microwave-assisted##6##1##(2008-10#5)(2012-2#1)
Micturating cystourethrograms are not necessary for all cases of antenatally diagnosed##2##11##(2008-10#2)
Micturating##3##1##(2008-10#2)(2008-4#1)
Mid- to##2##2##(2008-10#1)(2012-1#1)
Mid-Atlantic##2##1##(1996-1#1)(2008-10#1)
Mid-Infrared##2##1##(2008-2#1)(2008-3#1)
Mid-infrared##6##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
Mid-term memory and swim speed were measured##2##7##(2008-12#2)
Midas##3##1##(2013-1#3)
Midazolam##2##1##(1997-2#1)(2008-8#1)
Midbrain##4##1##(1993-12#1)(2007-10#1)(2008-7#1)(2012-12#1)
Middle American beans##3##3##(2008-10#3)
Middle American##5##2##(2008-10#5)
Middle American)##2##2##(2008-10#2)
Middle Cerebral Artery##2##3##(2008-12#1)(2012-3#1)
Middle East and North##3##4##(1997-8#3)
Middle East and##6##3##(1997-8#3)(2008-10#1)(2009-2#1)(2011-2#1)
Middle East##23##2##(1991-11#1)(1995-3#3)(1997-8#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-2#3)(2011-2#3)
Middle Eastern##4##2##(2007-7#1)(2008-10#2)(2011-2#1)
Middle cerebral artery##3##3##(2007-10#1)(2011-2#2)
Middle ear##3##2##(1993-9#1)(2008-4#1)(2012-12#1)
Middle##60##1##(1991-11#1)(1993-9#1)(1995-3#3)(1997-8#3)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-7#1)(2009-10#1)(2009-2#4)(2009-7#1)(2009-9#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
Middle-aged rats##2##2##(1994-6#2)
Middle-aged##4##1##(1994-6#2)(2010-9#1)(2013-1#1)
Midfoot##2##1##(2010-3#2)
Midgut##2##1##(2008-10#2)
Midland##4##1##(1991-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
Midlife##2##1##(2009-5#1)(2012-1#1)
Midline##3##1##(1995-5#1)(1997-6#1)(2012-12#1)
Midterm##2##1##(2007-8#1)(2013-1#1)
Midwest##10##1##(1993-5#1)(2007-10#2)(2007-9#2)(2008-10#3)(2009-7#1)(2009-8#1)
Midwestern city##2##2##(2012-3#1)(2013-1#1)
Midwestern health##2##2##(1997-1#1)(2008-11#1)
Midwestern##8##1##(1997-1#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-11#1)(2012-3#1)(2013-1#1)
Midwifery and Health Visiting Contribution to Health and Health Care##2##10##(2008-11#2)
Midwifery and Health Visiting Contribution to Health##3##7##(2008-11#3)
Midwifery and Health Visiting##11##4##(2008-11#11)
Midwifery and Health##12##3##(2008-11#12)
Midwifery##18##1##(2008-11#17)(2008-12#1)
Midwives at##2##2##(1993-3#1)(1997-4#1)
Midwives##4##1##(1993-3#1)(1997-4#1)(2013-1#2)
Mie calculations for##2##3##(2008-3#2)
Mie calculations##4##2##(2008-2#1)(2008-3#3)
Mie particles##3##2##(2007-11#1)(2008-2#2)
Mie scattering theory##3##3##(2008-2#1)(2008-3#2)
Mie scattering##11##2##(2007-12#1)(2008-2#4)(2008-3#5)(2009-12#1)
Mie theory and##2##3##(2008-2#1)(2008-3#1)
Mie theory calculations##2##3##(2008-3#2)
Mie theory for##2##3##(2008-3#2)
Mie theory##33##2##(2007-11#2)(2008-2#13)(2008-3#17)(2009-6#1)
Mie##64##1##(2007-11#4)(2007-12#1)(2008-2#24)(2008-3#33)(2009-12#1)(2009-6#1)
Mie-equivalent average##2##2##(2008-2#2)
Mie-scattering calculations##2##2##(2008-3#2)
Might##2##1##(1992-12#1)(2010-3#1)
Migraine##4##1##(1990-3#1)(2008-9#2)(2010-2#1)
Migrant##3##1##(2008-8#2)(2012-3#1)
Migrants##3##1##(2008-10#1)(2010-8#1)(2013-1#1)
Migration and##4##2##(1993-6#1)(2008-10#1)(2009-9#1)(2012-3#1)
Migration of##9##2##(1990-12#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
Migration##27##1##(1990-12#1)(1993-6#1)(1994-3#1)(1994-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#2)(2009-9#2)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Mike##3##1##(1995-12#1)(1996-5#1)(2011-2#1)
Milan##19##1##(1990-12#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-6#1)(2008-10#3)(2008-7#4)(2010-6#1)(2011-2#1)(2013-8#2)
Milano##2##1##(1990-12#1)(2008-6#1)
Mild Cognitive Impairment##2##3##(2008-11#1)(2010-7#1)
Mild and##3##2##(1996-5#1)(2009-10#1)(2013-8#1)
Mild anemia##2##2##(2008-7#2)
Mild cognitive impairment##3##3##(2008-6#1)(2009-10#1)(2013-8#1)
Mild##26##1##(1990-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#3)
Mildew of##2##2##(2008-10#2)
Mildew##9##1##(2008-10#8)(2012-3#1)
Milestones##2##1##(2007-10#1)(2012-2#1)
Military Hospital##2##2##(2007-11#1)(2007-8#1)
Military##9##1##(1992-5#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)(2013-1#2)
Milk consumption##2##2##(2009-2#2)
Milk samples##2##2##(2008-10#1)(2012-3#1)
Milk##11##1##(1991-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-2#2)(2010-12#1)(2012-2#1)(2012-3#1)
Mill##4##1##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
Millard##2##1##(2013-1#2)
Millard's##3##1##(2013-1#3)
Millennium Development Goals##5##3##(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)
Millennium Development##6##2##(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
Millennium##9##1##(2007-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2013-1#1)
Miller and##2##2##(2008-5#1)(2009-5#1)
Miller##11##1##(1992-7#1)(1995-12#1)(1996-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-5#1)
Miller-Dieker syndrome##2##2##(1997-3#2)
Millimolar##2##1##(1994-5#1)(2008-7#1)
Millions of people##2##3##(2008-11#1)(2011-2#1)
Millions of##4##2##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
Millipore##4##1##(1992-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
Millipore5##2##1##(2008-10#2)
Mills##4##1##(1990-8#1)(2008-10#3)
Mills'##2##1##(2008-10#2)
Milsana treatment##2##2##(2008-10#2)
Milsana##12##1##(2008-10#12)
Mimicking##4##1##(2006-10#1)(2008-6#1)(2010-8#1)(2012-3#1)
Mimics##2##1##(2008-6#1)(2012-2#1)
Mimotopes##2##1##(2008-7#2)
Minas Gerais##11##2##(2008-5#4)(2008-6#3)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
Mind and##2##2##(1995-1#1)(2008-11#1)
Mind the##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
Mind##9##1##(1992-12#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
Mindfulness##4##1##(2008-3#1)(2012-2#2)(2013-1#1)
Mindfulness-Based##3##1##(2013-1#3)
Mindfulness-Oriented Recovery Enhancement##2##3##(2013-1#2)
Mineral content##2##2##(2008-10#1)(2008-5#1)
Mineral##8##1##(1991-12#1)(1997-4#1)(2008-10#3)(2008-5#1)(2010-5#1)(2012-2#1)
Mineralization##2##1##(2008-10#1)(2008-11#1)
Mineralized biological##2##2##(2009-7#1)(2012-2#1)
Mineralized##4##1##(2009-7#1)(2009-8#2)(2012-2#1)
Minerals##2##1##(1997-4#1)(2008-5#1)
Minghui 63##2##2##(2008-10#1)(2008-4#1)
Mini##11##1##(1994-6#1)(2008-11#4)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
Mini-Mental State Exam##2##3##(2008-12#1)(2008-6#1)
Mini-Mental State Examination (MMSE)##3##4##(2008-6#1)(2008-7#2)
Mini-Mental State Examination##8##3##(2008-6#2)(2008-7#5)(2013-1#1)
Mini-Mental State##11##2##(2008-12#1)(2008-6#3)(2008-7#6)(2013-1#1)
Mini-Mental##12##1##(2008-12#1)(2008-6#3)(2008-7#6)(2010-12#1)(2013-1#1)
MiniMeds##2##1##(2012-3#2)
Miniature##5##1##(2008-10#4)(2010-7#1)
Miniaturized##2##1##(2008-10#1)(2008-11#1)
Minicontainer-test##2##1##(2008-11#2)
Miniinvasive##2##1##(2012-12#1)(2013-8#1)
Minimal Change Disease##2##3##(2008-1#2)
Minimal changes##2##2##(2010-4#1)(2012-2#1)
Minimal decreases in hematocrit##2##4##(2008-9#2)
Minimal invasive##2##2##(2007-8#1)(2010-8#1)
Minimal research has##2##3##(2007-10#1)(2011-1#1)
Minimal##28##1##(1992-6#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-6#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
Minimally Invasive##2##2##(2011-2#1)(2013-1#1)
Minimally invasive approaches to##2##4##(2011-2#2)
Minimally invasive surgery for##2##4##(2008-7#1)(2008-9#1)
Minimally invasive surgery##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
Minimally invasive technique##2##3##(2011-2#1)(2013-1#1)
Minimally invasive treatments##2##3##(2007-8#1)(2012-12#1)
Minimally invasive video-assisted##2##3##(2012-12#2)
Minimally invasive##20##2##(2007-8#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#5)(2012-12#4)(2012-3#2)(2013-1#3)
Minimally##22##1##(2007-8#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#6)(2012-12#4)(2012-3#2)(2013-1#4)
Minimizing risk##2##2##(1992-12#1)(1994-3#1)
Minimizing the##2##2##(2008-3#2)
Minimizing##8##1##(1992-12#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)
Minimum Data Set##5##3##(1995-2#1)(1996-2#1)(2008-11#2)(2008-7#1)
Minimum inhibitory concentration (MIC) values##2##5##(2008-5#1)(2008-7#1)
Minimum inhibitory##3##2##(2008-5#1)(2008-7#1)(2010-2#1)
Minimum##23##1##(1991-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
Mining is##2##2##(2012-2#1)(2013-1#1)
Mining##4##1##(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
Minister of Health##3##3##(1995-1#1)(2008-1#1)(2009-5#1)
Minister of##4##2##(1995-1#1)(1996-4#1)(2008-1#1)(2009-5#1)
Minister##6##1##(1992-5#1)(1995-1#1)(1996-4#1)(1997-6#1)(2008-1#1)(2009-5#1)
Ministering to##2##2##(1991-2#1)(1993-1#1)
Ministry of Health (MOH)##2##4##(2008-1#1)(2011-2#1)
Ministry of Health and Welfare##2##5##(1997-8#1)(2008-5#1)
Ministry of Health and##11##4##(1991-2#1)(1993-1#1)(1993-6#2)(1994-2#1)(1997-8#1)(2007-5#1)(2008-5#1)(2011-2#1)(2013-1#2)
Ministry of Health in##2##4##(1994-1#1)(2008-7#1)
Ministry of Health of##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
Ministry of Health regulations##2##4##(2008-10#2)
Ministry of Health to##2##4##(2008-1#2)
Ministry of Health##44##3##(1991-2#3)(1993-1#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#1)(1996-4#1)(1997-8#1)(2007-5#1)(2008-1#7)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
Ministry of Health's##3##3##(1995-2#1)(2010-10#1)(2012-12#1)
Ministry of Public Health##3##4##(1990-3#1)(2008-10#1)(2008-8#1)
Ministry of Public##4##3##(1990-3#1)(1991-3#1)(2008-10#1)(2008-8#1)
Ministry of the Environment##2##4##(2010-4#1)(2013-1#1)
Ministry of the##3##3##(2010-4#1)(2012-12#1)(2013-1#1)
Ministry of##62##2##(1990-3#1)(1991-2#3)(1991-3#1)(1993-1#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-8#1)(2007-5#1)(2008-1#7)(2008-10#7)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-5#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-2#5)(2012-12#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Ministry##69##1##(1990-3#1)(1991-2#4)(1991-3#1)(1993-1#1)(1993-6#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-1#7)(2008-10#7)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-5#1)(2010-10#1)(2010-4#3)(2010-8#1)(2011-2#6)(2012-12#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Minnaert's Cigar##3##2##(2008-3#3)
Minneola tangelo##3##2##(2008-10#3)
Minneola##7##1##(2008-10#7)
Minnesota in##2##2##(2008-10#2)
Minnesota locations##2##2##(2008-10#2)
Minnesota##60##1##(1990-2#2)(1991-2#2)(1993-3#4)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-10#1)(2008-10#23)(2008-12#2)(2009-7#2)(2010-1#1)(2011-2#1)(2012-12#4)(2012-2#1)
Minnesota's##2##1##(1996-12#1)(2012-12#1)
Minocycline##3##1##(2006-10#1)(2008-7#2)
Minor##17##1##(1993-12#2)(1993-3#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-2#1)(2008-10#4)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#2)(2013-8#1)
Minority##4##1##(1991-8#1)(2008-12#1)(2008-2#1)(2010-8#1)
Mint virus 1##2##3##(2008-10#2)
Minute competition##2##2##(2008-10#2)
Minute##6##1##(1995-6#1)(1996-3#1)(2008-10#3)(2008-11#1)
Miocene##4##1##(2008-10#1)(2008-6#1)(2011-2#2)
Mir##2##1##(2008-3#2)
Mirafiori lettuce virus (MiLV)##2##4##(2008-10#2)
Mirafiori lettuce virus##4##3##(2008-10#4)
Miranda##3##1##(2008-10#1)(2008-7#1)(2013-7#1)
Mirau interferometer##3##2##(2007-11#2)(2008-2#1)
Miridae)##2##1##(2007-12#1)(2011-2#1)
Mirror##6##1##(2008-2#2)(2008-3#3)(2008-6#1)
Misalignment##3##1##(2008-3#3)
Misbehaviour##2##1##(2012-12#2)
Miscellaneous##4##1##(2007-12#1)(2008-9#1)(2009-6#1)(2011-2#1)
Misconceptions##2##1##(2008-5#1)(2010-8#1)
Misericordia Hospital##2##2##(1991-2#1)(1992-1#1)
Misericordia##3##1##(1991-2#1)(1992-1#1)(1994-1#1)
Misericórdia##2##1##(2009-10#2)
Mishel Uncertainty in Illness##2##4##(2010-10#2)
Mishel##3##1##(2010-10#3)
Misleading##2##1##(2008-7#1)(2009-6#1)
Mismatch negativity##3##2##(1995-5#1)(2008-8#1)(2008-9#1)
Mismatch##6##1##(1995-5#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-8#1)
Mismatched filtering##2##2##(2008-2#2)
Mismatched##3##1##(2008-2#2)(2010-9#1)
Misoprostol##3##1##(2008-11#2)(2012-12#1)
Miss##2##1##(1992-11#1)(1994-2#1)
Missed opportunities for##2##3##(1996-12#2)
Missed##4##1##(1996-12#2)(2007-7#1)(2013-1#1)
Missing Data##3##2##(2009-12#2)(2009-8#1)
Missing##11##1##(1993-2#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#1)
Mission education##2##2##(1991-3#1)(1992-3#1)
Mission##8##1##(1991-1#1)(1991-3#1)(1992-3#1)(2008-2#1)(2008-3#1)(2012-12#2)(2012-3#1)
Missions##2##1##(2012-3#1)(2013-8#1)
Mississippi physicians##2##2##(2010-9#2)
Mississippi public school students##2##4##(2012-12#2)
Mississippi##25##1##(2008-10#8)(2008-8#5)(2009-3#3)(2010-9#6)(2012-12#2)(2013-7#1)
Missouri Department of Health##2##4##(1991-12#1)(1995-12#1)
Missouri law##2##2##(1994-2#1)(1995-6#1)
Missouri##34##1##(1991-12#2)(1991-2#1)(1992-3#1)(1994-1#1)(1994-2#1)(1995-12#3)(1995-6#2)(1996-2#2)(1997-1#1)(1997-5#1)(2007-3#1)(2008-10#12)(2008-3#1)(2008-8#1)(2011-2#2)(2013-8#2)
Missouri's##2##1##(1992-11#1)(1997-5#1)
Mistletoe##3##1##(1993-3#2)(2008-10#1)
Misty##2##1##(2008-10#1)(2011-2#1)
Misuse of##2##2##(1993-3#2)
Misuse##3##1##(1993-3#2)(2009-12#1)
Mithun##2##1##(2011-1#2)
Mitigation##2##1##(2009-5#1)(2013-1#1)
Mitochondria isolated from##2##3##(1990-11#1)(1994-8#1)
Mitochondria##9##1##(1990-11#1)(1994-5#1)(1994-8#2)(2008-10#1)(2008-7#1)(2009-8#1)(2010-3#1)(2013-1#1)
Mitochondrial Cytochrome b Gene##2##4##(2008-10#1)(2008-5#1)
Mitochondrial DNA control region variation in##2##6##(2008-12#2)
Mitochondrial DNA control region##3##4##(2008-12#3)
Mitochondrial DNA##11##2##(1995-12#1)(1996-9#1)(2008-10#1)(2008-12#4)(2008-6#2)(2009-5#1)(2010-2#1)
Mitochondrial Genome##2##2##(2008-10#1)(2008-5#1)
Mitochondrial dysfunction##3##2##(1994-5#1)(2011-2#1)(2013-1#1)
Mitochondrial##31##1##(1990-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#4)(2008-12#4)(2008-5#2)(2008-6#2)(2008-7#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Mitogen-activated protein##3##2##(1995-8#1)(2009-8#1)(2012-2#1)
Mitogenic##3##1##(1990-11#1)(1994-11#1)(1995-2#1)
Mitomycin C (MC)##2##3##(1993-11#1)(1995-2#1)
Mitomycin C##6##2##(1992-12#1)(1993-11#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-11#1)
Mitomycin##7##1##(1992-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(2008-11#1)
Mitosis is a##2##3##(2008-10#1)(2009-8#1)
Mitotane##2##1##(1992-10#1)(1997-5#1)
Mitotic##8##1##(1995-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
Mitovirus##5##1##(2008-10#5)
Mitoxantrone as a##2##3##(1991-6#1)(2012-3#1)
Mitoxantrone##3##1##(1991-6#2)(2012-3#1)
Mitral valve replacement##2##3##(2007-8#2)
Mitral valve##4##2##(1993-1#1)(2007-8#2)(2013-1#1)
Mitral##9##1##(1993-1#1)(1993-3#1)(2007-8#4)(2008-11#1)(2013-1#2)
Mixed Infections and##2##3##(2008-10#1)(2013-1#1)
Mixed infections of##2##3##(2008-10#2)
Mixed infections were##5##3##(2008-10#4)(2012-3#1)
Mixed infections##8##2##(2008-10#7)(2012-3#1)
Mixed reagents of##2##3##(2008-10#2)
Mixed##34##1##(1990-2#1)(1994-12#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Mixing and##2##2##(1997-7#1)(2008-3#1)
Mixing in##2##2##(2008-2#2)
Mixing ratios##2##2##(2008-3#2)
Mixing##11##1##(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#3)(2008-3#3)(2011-2#1)(2012-2#1)
Mixture Models##2##2##(2009-9#1)(2010-9#1)
Mixture of##2##2##(2007-11#1)(2008-10#1)
Mixture##9##1##(2007-11#1)(2008-10#3)(2008-3#1)(2009-7#1)(2009-9#1)(2010-9#1)(2012-3#1)
Mixtures of##11##2##(2008-10#9)(2008-2#1)(2008-5#1)
Mixtures##17##1##(2008-10#15)(2008-2#1)(2008-5#1)
Ml 36##2##2##(2011-2#2)
Ml##3##1##(2011-2#3)
MlRE##6##1##(2008-10#6)
Mll##6##1##(1995-11#6)
Mlo##5##1##(2008-10#5)
MluI##4##1##(1993-8#1)(2008-10#1)(2008-5#2)
Mm##2##1##(1997-7#2)
MmLim15##3##1##(1995-6#3)
Mmd1 and Mxc3 in that##2##5##(2008-10#2)
Mmd1##9##1##(2008-10#9)
Mn SOD activity##2##3##(1996-9#2)
Mn SOD##3##2##(1996-9#3)
Mn and Ni##5##3##(2008-10#5)
Mn and Pb##4##3##(2008-10#4)
Mn and Zn##5##3##(2008-10#3)(2010-5#1)(2011-2#1)
Mn and##21##2##(2008-10#18)(2010-5#1)(2010-6#1)(2011-2#1)
Mn availability##2##2##(2008-10#2)
Mn by##2##2##(2008-10#2)
Mn concentration##2##2##(2008-10#1)(2008-12#1)
Mn crystals##2##2##(2007-11#1)(2007-12#1)
Mn in the##2##3##(2008-10#2)
Mn in##7##2##(2008-10#6)(2010-8#1)
Mn increased##2##2##(2008-10#2)
Mn ions in##2##3##(2008-10#1)(2008-8#1)
Mn ions##4##2##(2008-10#1)(2008-8#3)
Mn oxidation##2##2##(2008-10#2)
Mn was##4##2##(2008-10#4)
Mn##164##1##(1996-2#3)(1996-9#3)(1997-4#1)(2007-11#3)(2007-12#2)(2008-10#129)(2008-12#3)(2008-3#2)(2008-7#1)(2008-8#3)(2009-11#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-2#2)(2013-1#1)(2013-8#3)
Mn(+2) concentration##2##2##(2008-7#2)
Mn(2+) and##2##2##(2008-10#1)(2008-11#1)
Mn(2+) ions##2##2##(2008-10#1)(2008-7#1)
Mn(2+)##22##1##(2008-10#15)(2008-11#1)(2008-7#2)(2011-1#2)(2012-12#2)
Mn(2+)-dependent peroxidase##2##2##(2011-1#2)
Mn(I)##3##1##(1996-2#3)
Mn(II##2##1##(2008-10#2)
Mn(II) and Cr(III)##3##3##(2008-10#3)
Mn(II) and##7##2##(2008-10#7)
Mn(II) in##2##2##(2008-10#2)
Mn(II) were##2##2##(2008-10#2)
Mn(II)##50##1##(1996-2#1)(2008-10#49)
Mn(IV)##3##1##(2008-10#3)
Mn- and##2##2##(2008-10#2)
Mn-P(r)##2##1##(2008-10#2)
Mn-TCPP##2##1##(2008-10#2)
Mn-cluster##2##1##(2008-8#2)
Mn-doped ZnO##2##2##(2008-10#2)
Mn-reducing bacteria##2##2##(2008-10#2)
Mn2+ and Ca2+ ions##2##4##(1995-6#2)
Mn2+ and Ca2+##4##3##(1991-11#1)(1995-6#3)
Mn2+ and##5##2##(1991-11#1)(1994-6#1)(1995-6#3)
Mn2+ entry##2##2##(1990-5#1)(1992-5#1)
Mn2+ ion##2##2##(1993-8#1)(1995-6#1)
Mn2+ or##3##2##(1990-2#1)(1996-5#1)(1997-3#1)
Mn2+ was removed from##2##4##(1992-5#2)
Mn2+##30##1##(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1992-11#1)(1992-5#8)(1993-6#1)(1993-8#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-6#5)(1996-5#1)(1997-3#1)(1997-7#1)
Mn2O2##3##1##(2008-8#3)
MnCl(2)##2##1##(2008-10#1)(2008-7#1)
MnCl2##4##1##(1992-6#4)
MnHCF##2##1##(2008-10#2)
MnO(2) nucleation##2##2##(2008-10#2)
MnO(2)##9##1##(2008-10#8)(2011-2#1)
MnO(2)-impregnated fibers##4##2##(2008-10#4)
MnO(4)(-)##4##1##(2008-10#4)
MnP gene##2##2##(2011-1#2)
MnP##7##1##(2008-7#4)(2011-1#3)
MnSOD activity and mRNA##2##4##(1995-6#2)
MnSOD gene##2##2##(1995-6#2)
MnSOD mRNA by irradiation##3##4##(1995-6#3)
MnSOD mRNA##6##2##(1995-6#6)
MnSOD transcripts##2##2##(1995-6#2)
MnSOD##20##1##(1994-6#2)(1995-6#13)(2008-5#4)(2012-2#1)
Mo and Bi##4##3##(2008-10#4)
Mo and##9##2##(1995-2#1)(2008-10#8)
Mo in##4##2##(2008-10#4)
Mo on##2##2##(2009-11#2)
Mo was##4##2##(2008-10#3)(2009-11#1)
Mo with##2##2##(2008-10#2)
Mo##65##1##(1994-2#1)(1995-2#7)(1996-2#2)(2007-3#1)(2008-10#43)(2008-3#3)(2008-5#1)(2009-11#5)(2010-1#1)(2013-8#1)
Mo(6+)##2##1##(2008-10#2)
Mo(V) &quot##2##2##(1993-11#2)
Mo(V)##4##1##(1993-11#3)(2008-10#1)
Mo(VI) and W(VI)##3##3##(2008-10#3)
Mo(VI) and##5##2##(2008-10#5)
Mo(VI) is##2##2##(2008-10#2)
Mo(VI)##22##1##(2008-10#21)(2010-11#1)
Mo+Pd+TA or Mo+Pt+TA##2##3##(2008-10#2)
Mo-Au surface alloying##2##3##(2009-11#2)
Mo-O bond##2##2##(1996-2#2)
Mo-Sr##2##1##(2007-11#2)
Mo/B(4)C##3##1##(2007-11#2)(2008-3#1)
Mo/Be##3##1##(2008-3#3)
Mo/Si and Mo/Be multilayer thin films##2##6##(2008-3#2)
Mo/Si##10##1##(2008-2#3)(2008-3#7)
Mo17 and##2##2##(2008-10#2)
Mo17##10##1##(2008-10#10)
MoAb binding##2##2##(1993-1#2)
MoAb production##3##2##(2008-11#3)
MoAb##9##1##(1990-7#1)(1993-1#2)(2008-11#3)(2008-7#2)(2008-8#1)
MoAbs against cell-binding domains##2##4##(1993-8#2)
MoAbs##10##1##(1991-2#1)(1993-1#2)(1993-8#3)(1995-12#2)(2008-5#1)(2008-7#1)
MoM and 0##2##3##(1995-8#2)
MoM##10##1##(1995-8#4)(1996-12#5)(2009-7#1)
MoO(2)##3##1##(1996-2#1)(2008-10#2)
MoRu-Be multilayer coatings##2##3##(2008-3#2)
MoRu-Be multilayer##3##2##(2007-11#1)(2008-3#2)
MoRu-Be multilayer-coated##2##2##(2007-11#1)(2008-3#1)
MoRu-Be##5##1##(2007-11#2)(2008-3#3)
MoS(2)##3##1##(2010-4#3)
MoSi/Si multilayer##2##2##(2008-3#2)
Mobile phase was##2##3##(2008-10#2)
Mobile##10##1##(1992-5#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#1)
Mobility##4##1##(1992-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
Mobilization of##5##2##(1991-8#1)(1992-12#1)(1995-3#1)(2008-7#1)(2010-8#1)
Mobilization##8##1##(1991-8#1)(1992-12#1)(1995-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
Mochima National Park##2##3##(2008-5#2)
Mochima##4##1##(2008-5#4)
Mock##5##1##(1992-12#1)(1992-3#1)(1994-5#1)(2008-8#2)
Modafinil##3##1##(2006-10#1)(2009-7#2)
Modal##7##1##(2007-11#2)(2008-2#3)(2008-3#2)
Modalities##2##1##(2010-7#1)(2013-1#1)
Mode locking##2##2##(2007-11#1)(2007-12#1)
Mode of##6##2##(1990-12#1)(1991-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
Mode##18##1##(1990-12#1)(1991-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)
Mode-Locked##2##1##(2008-3#2)
Mode-hop-free##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Mode-locked##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
Model 2##2##2##(2008-10#1)(2008-8#1)
Model 8000##2##2##(2011-2#2)
Model P21W##2##2##(2008-3#2)
Model and##3##2##(2008-11#2)(2008-12#1)
Model calculations are##2##3##(2008-3#2)
Model calculations##4##2##(2008-10#1)(2008-3#3)
Model fit##2##2##(2008-10#1)(2008-8#1)
Model for##20##2##(1992-2#1)(2008-10#5)(2008-11#2)(2008-3#2)(2009-11#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Model is##3##2##(1996-12#1)(2010-8#1)(2012-12#1)
Model of the##2##3##(2008-10#1)(2008-3#1)
Model of##19##2##(1990-4#1)(1993-9#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Model parameters##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
Model predictions were##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
Model predictions##7##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#1)
Model results##2##2##(2008-3#2)
Model simulations##4##2##(1996-4#1)(2008-2#1)(2008-7#1)(2013-8#1)
Model systems##2##2##(1996-12#1)(2007-12#1)
Model to##2##2##(1992-3#1)(2013-1#1)
Model was designed##2##3##(2010-8#2)
Model was##3##2##(2008-10#1)(2010-8#2)
Model with##2##2##(2011-2#1)(2012-3#1)
Model##160##1##(1990-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-9#1)(1996-12#5)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#25)(2008-11#14)(2008-12#2)(2008-2#3)(2008-3#19)(2008-4#5)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#2)
Model-based##5##1##(2008-2#1)(2008-3#2)(2009-11#1)(2013-1#1)
Modeled##3##1##(2008-3#2)(2011-1#1)
Modeling and optimization of##2##4##(2008-3#1)(2008-7#1)
Modeling and##8##2##(2008-10#1)(2008-3#4)(2008-7#1)(2010-10#1)(2010-7#1)
Modeling in##2##2##(2008-10#1)(2012-2#1)
Modeling of scattering and depolarizing electro-optic devices##2##7##(2008-2#2)
Modeling of the##12##3##(1994-5#1)(2008-10#3)(2008-2#1)(2008-3#5)(2010-11#1)(2012-2#1)
Modeling of##27##2##(1994-5#1)(2008-10#6)(2008-2#8)(2008-3#7)(2009-12#2)(2010-11#1)(2012-2#1)(2013-8#1)
Modeling the##14##2##(1992-3#1)(1993-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-5#1)(2011-3#1)
Modeling##86##1##(1992-3#2)(1993-12#2)(1994-5#1)(1995-1#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#18)(2008-4#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#5)(2013-1#1)(2013-8#4)
Modelling of the##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
Modelling of##8##2##(1990-9#1)(1991-12#1)(1994-6#1)(2008-10#3)(2008-11#2)
Modelling the##6##2##(1994-5#1)(2008-10#2)(2010-8#1)(2011-3#1)(2013-8#1)
Modelling##25##1##(1990-9#2)(1991-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
Models and##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
Models based on##3##3##(1996-4#1)(2008-7#1)(2008-9#1)
Models based##4##2##(1996-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
Models for the##2##3##(1996-2#1)(2008-10#1)
Models for##9##2##(1996-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-9#1)(2012-12#1)(2013-1#1)
Models in##2##2##(2008-6#1)(2013-1#1)
Models of case management in long term home health care##4##10##(1996-1#4)
Models of the effects of##2##5##(2008-10#1)(2008-9#1)
Models of the##8##3##(2008-10#3)(2008-7#1)(2008-9#2)(2009-6#1)(2013-8#1)
Models of##31##2##(1992-7#1)(1996-1#4)(1996-4#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
Models on##2##2##(2009-3#1)(2011-2#1)
Models using##2##2##(2008-10#2)
Models were##2##2##(2008-10#2)
Models without##2##2##(2008-9#1)(2010-10#1)
Models##86##1##(1992-7#1)(1995-3#1)(1996-1#4)(1996-2#1)(1996-4#3)(1997-3#1)(2007-5#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Moderate Resolution Imaging Spectroradiometer (MODIS)##3##5##(2008-3#2)(2008-8#1)
Moderate levels of##2##3##(2008-10#2)
Moderate##24##1##(1990-10#1)(1991-5#1)(1994-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-2#1)(2012-1#1)(2012-3#1)
Moderately##4##1##(2008-10#1)(2008-2#1)(2009-10#1)(2013-8#1)
Moderators of the##2##3##(2012-12#1)(2012-2#1)
Modern medicine##2##2##(1993-11#1)(2008-10#1)
Modern research##2##2##(1994-2#1)(2008-7#1)
Modern techniques##2##2##(2006-10#1)(2008-10#1)
Modern##41##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Modernising##2##1##(2008-11#1)(2009-4#1)
Modes of##3##2##(2008-3#1)(2008-8#1)(2012-1#1)
Modes##4##1##(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#1)
Modest##4##1##(1995-11#1)(1996-3#1)(1997-5#1)(2008-5#1)
Modification and##4##2##(2008-1#1)(2008-10#1)(2008-2#2)
Modification of Diet in Renal Disease##2##6##(1994-3#1)(2011-2#1)
Modification of the##6##3##(1991-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)
Modification of##32##2##(1990-2#2)(1991-12#1)(1992-5#1)(1992-7#1)(1994-3#1)(1995-2#2)(1995-3#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)
Modification to the##2##3##(1990-7#1)(2011-7#1)
Modification##41##1##(1990-2#2)(1990-7#1)(1991-12#1)(1992-5#1)(1992-7#1)(1994-3#1)(1995-2#2)(1995-3#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)
Modifications of the##4##3##(1990-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
Modifications of##10##2##(1990-2#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)
Modifications to the##2##3##(1997-5#1)(2008-11#1)
Modifications##20##1##(1990-12#1)(1990-2#1)(1993-2#1)(1994-5#1)(1997-5#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2011-2#1)
Modified Fite Faraco##2##3##(2007-7#2)
Modified Rapid AFB method##2##4##(2007-7#2)
Modified Rapid AFB##3##3##(2007-7#3)
Modified Wendan Decoction can##2##4##(2008-10#2)
Modified coupled-wave##2##2##(2008-3#2)
Modified radical mastectomy##2##3##(1990-12#1)(2008-10#1)
Modified##49##1##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1997-1#1)(2007-10#2)(2007-12#1)(2007-7#5)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#6)(2008-6#2)(2008-9#2)(2009-7#1)(2009-8#2)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)
Modifier##2##1##(2008-10#1)(2008-8#1)
Modifying the##2##2##(1991-1#1)(1996-12#1)
Modifying##5##1##(1991-1#1)(1992-9#1)(1993-12#1)(1996-12#1)(2008-7#1)
Modular##5##1##(1991-5#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)
Modulated##2##1##(2008-10#1)(2013-8#1)
Modulating##4##1##(2006-10#1)(2007-12#1)(2012-2#1)(2013-7#1)
Modulation Spectroscopy with##2##3##(2008-2#2)
Modulation by external##2##3##(1990-12#1)(2008-2#1)
Modulation by##3##2##(1990-12#1)(2008-11#1)(2008-2#1)
Modulation of cell##2##3##(2008-11#1)(2010-4#1)
Modulation of cellular##2##3##(1992-12#2)
Modulation of synaptic##2##3##(2009-8#1)(2013-8#1)
Modulation of the##4##3##(1993-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
Modulation of##49##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Modulation transfer function measurement##2##4##(2008-2#1)(2008-3#1)
Modulation transfer function of##2##4##(2008-2#1)(2008-3#1)
Modulation transfer function##5##3##(2008-2#2)(2008-3#3)
Modulation##65##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#4)(2008-2#8)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Modulational instability##4##2##(2007-11#1)(2007-12#3)
Modulations##2##1##(1994-6#1)(1994-8#1)
Modulator##4##1##(1993-8#1)(2008-2#3)
Modulators of##3##2##(1992-8#1)(2008-7#1)(2012-3#1)
Modulatory effects of##2##3##(2007-7#1)(2009-3#1)
Modulatory##4##1##(1996-2#1)(1997-2#1)(2007-7#1)(2009-3#1)
Module##4##1##(2008-11#1)(2008-12#1)(2008-3#1)(2009-9#1)
Modules##4##1##(2008-3#2)(2009-9#1)(2012-12#1)
Modulus##4##1##(2008-5#1)(2008-9#2)(2010-4#1)
Mogenson##3##1##(1993-6#3)
Mohs micrographic surgery for##3##4##(2007-12#1)(2010-8#2)
Mohs micrographic surgery is##2##4##(2010-8#2)
Mohs micrographic surgery##12##3##(2007-12#1)(2010-8#11)
Moina macrocopa##2##2##(2011-2#2)
Moiré##2##1##(2008-3#2)
Moist Forest##2##2##(2008-5#2)
Moisture induced solid phase degradation of l-ascorbic acid part##2##9##(2008-10#2)
Moisture induced solid phase degradation of l-ascorbic acid##3##8##(2008-10#3)
Moisture induced##4##2##(2008-10#4)
Moisture retention##2##2##(2008-5#2)
Moisture##16##1##(2008-10#10)(2008-12#1)(2008-5#3)(2008-6#2)
Moisturizing##3##1##(2008-5#3)
Mol##27##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-5#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-1#1)
Molar volumes and solubility parameters of##2##6##(2008-10#2)
Molar##5##1##(2008-10#2)(2010-10#1)(2012-12#1)(2013-1#1)
Mold##10##1##(2008-10#10)
Molec##2##1##(1990-10#1)(1992-9#1)
Molecular Beacons##2##2##(2008-10#2)
Molecular Biology##6##2##(1997-7#2)(2008-10#1)(2008-11#1)(2008-7#2)
Molecular Characterization of Fusarium oxysporum##2##5##(2008-10#2)
Molecular Characterization of a##2##4##(2008-10#1)(2008-6#1)
Molecular Characterization of##10##3##(2008-10#8)(2008-6#1)(2012-2#1)
Molecular Characterization##12##2##(2008-10#10)(2008-6#1)(2012-2#1)
Molecular Detection of Phytophthora ramorum##2##5##(2008-10#2)
Molecular Detection of##4##3##(2008-10#4)
Molecular Diagnosis##2##2##(2008-10#1)(2012-2#1)
Molecular Diversity##3##2##(2008-10#3)
Molecular Dynamics Simulations##2##3##(2008-10#1)(2009-5#1)
Molecular Dynamics##6##2##(2008-10#2)(2008-11#1)(2009-5#1)(2009-7#1)(2012-2#1)
Molecular Ecology##5##2##(2013-1#5)
Molecular Evidence##3##2##(2008-10#3)
Molecular Identification and##2##3##(2008-10#1)(2012-2#1)
Molecular Identification##4##2##(2008-10#3)(2012-2#1)
Molecular Imaging of##2##3##(2012-2#2)
Molecular Imaging##3##2##(2012-2#2)(2013-1#1)
Molecular Mapping of the##2##4##(2008-10#2)
Molecular Mapping of##5##3##(2008-10#5)
Molecular Markers Linked to##2##4##(2008-10#2)
Molecular Markers##6##2##(2008-10#5)(2008-6#1)
Molecular Mechanics##2##2##(2007-11#1)(2010-2#1)
Molecular Orbital##2##2##(1996-2#1)(2008-11#1)
Molecular Phylogenetic Analyses of##2##4##(2008-10#2)
Molecular Properties of##2##3##(2008-10#1)(2008-4#1)
Molecular Recognition Theory##4##3##(2008-1#4)
Molecular Recognition##6##2##(1996-5#1)(2008-1#4)(2013-1#1)
Molecular Structure of##2##3##(1996-2#2)
Molecular Structure##4##2##(1996-2#4)
Molecular Variability Within##2##3##(2008-10#2)
Molecular Variability##3##2##(2008-10#3)
Molecular analyses of the##2##4##(2008-10#2)
Molecular analyses of##4##3##(2008-10#4)
Molecular analyses##7##2##(2008-10#7)
Molecular analysis of a##2##4##(1995-12#1)(2008-5#1)
Molecular analysis of an##2##4##(1990-12#1)(2008-10#1)
Molecular analysis of the##4##4##(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
Molecular analysis of##14##3##(1990-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2013-1#1)
Molecular analysis##19##2##(1990-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-8#1)(2011-2#1)(2013-1#1)
Molecular and Biological Characterization of##3##5##(2008-10#3)
Molecular and Biological##4##3##(2008-10#4)
Molecular and##17##2##(1992-3#1)(1992-6#1)(1993-3#1)(1995-3#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)
Molecular approaches to##2##3##(2007-12#1)(2008-6#1)
Molecular approaches##3##2##(2007-12#1)(2008-6#1)(2011-1#1)
Molecular aspects of##2##3##(2008-10#1)(2009-4#1)
Molecular basis for##2##3##(1990-8#1)(1994-5#1)
Molecular basis of##3##3##(1996-9#1)(2007-7#1)(2009-1#1)
Molecular basis##5##2##(1990-8#1)(1994-5#1)(1996-9#1)(2007-7#1)(2009-1#1)
Molecular beacons are single-stranded nucleic acid##2##6##(2008-10#1)(2008-9#1)
Molecular beacons##3##2##(2008-10#2)(2008-9#1)
Molecular biology and immunology for clinicians##2##6##(2006-10#2)
Molecular biology and##3##3##(1997-7#1)(2006-10#2)
Molecular biology##4##2##(1997-7#1)(2006-10#2)(2007-7#1)
Molecular cancer vaccines##2##3##(2008-5#2)
Molecular chaperones##3##2##(1994-11#1)(1995-2#1)(2010-4#1)
Molecular characteristics of##2##3##(1993-3#1)(2008-10#1)
Molecular characterization and##2##3##(1992-9#1)(2009-2#1)
Molecular characterization of a##3##4##(1997-4#1)(1997-8#1)(2008-10#1)
Molecular characterization of the##5##4##(1992-12#1)(1997-7#1)(2008-10#3)
Molecular characterization of##14##3##(1990-7#1)(1992-12#1)(1992-3#1)(1993-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-8#1)
Molecular characterization##16##2##(1990-7#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-8#1)(2009-2#1)
Molecular cloning and characterization of the##2##6##(1993-3#1)(1997-8#1)
Molecular cloning and characterization of##6##5##(1990-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-8#1)
Molecular cloning and expression of##2##5##(1990-11#1)(1990-5#1)
Molecular cloning and expression##3##4##(1990-11#1)(1990-5#1)(2008-8#1)
Molecular cloning and sequencing of##2##5##(1993-3#1)(1997-1#1)
Molecular cloning and##18##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-8#2)
Molecular cloning of a novel##3##5##(1994-12#1)(1994-6#1)(1997-7#1)
Molecular cloning of a##5##4##(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1997-7#1)
Molecular cloning of human##3##4##(1991-12#1)(1993-3#1)(1994-11#1)
Molecular cloning of rat##3##4##(1991-12#1)(1993-6#1)(1994-11#1)
Molecular cloning of the##3##4##(1992-11#1)(1992-8#1)(1994-11#1)
Molecular cloning of##19##3##(1990-8#1)(1991-12#2)(1992-11#1)(1992-6#1)(1992-8#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-6#1)(1997-7#1)(2008-2#1)
Molecular cloning##42##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-12#3)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#2)(1994-11#4)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-2#1)(2008-8#5)
Molecular determinants##2##2##(1993-5#1)(1994-6#1)
Molecular diagnostics##2##2##(2008-10#1)(2013-7#1)
Molecular dynamics and##2##3##(1991-9#1)(1995-3#1)
Molecular dynamics of the anti-fluorescein 4-4-20 antigen-binding fragment##2##8##(1995-5#2)
Molecular dynamics simulations of##2##4##(1993-11#1)(1995-3#1)
Molecular dynamics simulations were##2##4##(1993-11#1)(2008-10#1)
Molecular dynamics simulations##5##3##(1993-11#3)(1995-3#1)(2008-10#1)
Molecular dynamics##11##2##(1991-9#1)(1993-11#4)(1995-3#2)(1995-5#3)(2008-10#1)
Molecular epidemiology of##4##3##(2008-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
Molecular epidemiology##5##2##(2008-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Molecular evidence##5##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-8#2)
Molecular evolution of##3##3##(1997-6#1)(2010-5#1)(2012-2#1)
Molecular evolution##6##2##(1997-6#3)(2008-1#1)(2010-5#1)(2012-2#1)
Molecular genetic##5##2##(1995-2#1)(1997-5#1)(2009-3#1)(2011-1#1)(2013-1#1)
Molecular genetics of##2##3##(1995-9#1)(2008-7#1)
Molecular heterogeneity of##2##3##(1993-9#1)(2010-7#1)
Molecular identification##2##2##(2008-10#1)(2011-2#1)
Molecular imaging with targeted contrast agents##2##6##(2010-9#2)
Molecular imaging##4##2##(2008-2#1)(2010-9#2)(2011-1#1)
Molecular machines##2##2##(2008-7#2)
Molecular mapping of the##2##4##(2008-10#2)
Molecular mapping of##5##3##(2008-10#4)(2008-8#1)
Molecular mapping##6##2##(2008-10#5)(2008-8#1)
Molecular marker##4##2##(2008-10#3)(2008-5#1)
Molecular markers##6##2##(1995-9#1)(2008-10#3)(2008-5#1)(2013-8#1)
Molecular mechanics##3##2##(1994-3#1)(1995-5#1)(2008-10#1)
Molecular mechanism of##4##3##(2008-4#1)(2008-8#2)(2008-9#1)
Molecular mechanisms of##5##3##(1992-6#1)(2008-1#1)(2008-4#1)(2009-5#1)(2010-7#1)
Molecular mechanisms underlying##3##3##(1997-8#1)(2009-10#1)(2010-5#1)
Molecular mechanisms##9##2##(1992-6#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#1)
Molecular methods##2##2##(2008-4#1)(2011-2#1)
Molecular mimicry##3##2##(1995-3#1)(2008-7#1)(2010-5#1)
Molecular modeling of nucleic acid structure##3##6##(2008-4#3)
Molecular modeling of##4##3##(2008-4#3)(2011-2#1)
Molecular modeling studies##2##3##(1992-3#1)(1994-5#1)
Molecular modeling##9##2##(1992-3#1)(1994-5#2)(2008-10#1)(2008-4#3)(2008-8#1)(2011-2#1)
Molecular modelling##2##2##(1994-11#1)(2008-4#1)
Molecular orientation of##3##3##(2008-10#3)
Molecular orientation##5##2##(2007-11#1)(2008-10#4)
Molecular phylogenetic analyses##2##3##(2008-10#2)
Molecular phylogenetic##5##2##(2008-10#3)(2008-6#1)(2008-8#1)
Molecular physiology of##2##3##(2008-8#2)
Molecular polymorphism##2##2##(2008-10#2)
Molecular recognition and##2##3##(2008-10#2)
Molecular recognition##3##2##(2008-10#3)
Molecular self-assembly##2##2##(2008-7#1)(2013-8#1)
Molecular studies##3##2##(2009-8#1)(2011-2#2)
Molecular variability of##2##3##(2008-10#2)
Molecular variability##3##2##(2008-10#3)
Molecular weights of the##2##4##(1992-3#1)(2011-2#1)
Molecular##421##1##(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#6)(1994-12#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#3)(1996-10#1)(1996-12#1)(1996-2#6)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#3)(2006-10#2)(2007-11#3)(2007-12#5)(2007-7#2)(2008-1#7)(2008-10#131)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#12)(2008-5#8)(2008-6#6)(2008-7#11)(2008-8#16)(2008-9#4)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#3)(2010-9#2)(2011-1#5)(2011-2#14)(2012-12#1)(2012-2#13)(2013-1#13)(2013-7#1)(2013-8#3)
Molecularly imprinted polymers##2##3##(2008-10#2)
Molecularly imprinted##3##2##(2008-10#3)
Molecule##4##1##(1996-12#2)(1997-7#1)(2008-10#1)
Molecules in##4##2##(1992-9#1)(1996-12#1)(2008-12#1)(2008-8#1)
Molecules##12##1##(1992-9#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-8#1)
Molndal technique##7##2##(2011-2#7)
Moloney murine leukemia virus##3##4##(1990-12#1)(1991-5#1)(2008-11#1)
Moloney murine##4##2##(1990-12#1)(1991-5#1)(2008-11#2)
Moloney##6##1##(1990-12#1)(1991-5#1)(2008-11#4)
Molt-4##3##1##(1997-4#3)
Molt-Inhibiting##2##1##(2008-5#1)(2008-6#1)
Molten##2##1##(1996-9#1)(2007-11#1)
Molybdate##2##1##(2008-10#2)
Molybdenum##8##1##(1997-7#2)(2008-10#5)(2008-11#1)
Momentum##2##1##(1996-9#1)(2010-10#1)
Monash##2##1##(2008-7#1)(2010-8#1)
Monastic##2##1##(2008-11#2)
Monastir##3##1##(2007-8#3)
Monday to Friday##2##3##(2013-1#2)
Mondini dysplasia##2##2##(2008-9#2)
Monduli##2##1##(2010-8#2)
Mongol of##2##2##(2008-9#2)
Mongol##3##1##(1995-6#1)(2008-9#2)
Mongolia##18##1##(2008-12#1)(2008-9#1)(2009-4#3)(2013-1#1)(2013-8#12)
Mongolian##3##1##(1992-12#2)(1995-12#1)
Mongolians##2##1##(2008-12#2)
Monheit##2##1##(1992-3#2)
Moniezia expansa##2##2##(1993-6#2)
Monilinia fructicola and##3##3##(2008-10#3)
Monilinia fructicola##20##2##(2008-10#20)
Monilinia oxycocci##2##2##(2008-10#2)
Monilinia vaccinii-corymbosi on##2##3##(2008-10#2)
Monilinia vaccinii-corymbosi##10##2##(2008-10#10)
Monilinia vacciniicorymbosi##2##2##(2008-10#2)
Monilinia##36##1##(2008-10#36)
Monitor for##2##2##(2008-2#1)(2008-3#1)
Monitor##12##1##(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#2)(2010-7#1)(2013-1#1)
Monitoring Program##3##2##(1997-4#1)(2008-11#1)(2008-2#1)
Monitoring System##3##2##(1992-12#1)(2013-1#1)(2013-8#1)
Monitoring and##4##2##(1997-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
Monitoring for##2##2##(2008-10#1)(2008-7#1)
Monitoring in##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
Monitoring of pigmented##2##3##(2008-10#2)
Monitoring of##25##2##(1992-12#1)(1992-2#1)(1994-11#1)(1994-6#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-1#1)(2013-1#1)(2013-8#1)
Monitoring the##7##2##(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-7#1)(2013-7#1)
Monitoring##103##1##(1990-3#1)(1991-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1994-1#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#6)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#4)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#2)
Moniz de Souza##3##3##(2009-10#3)
Monkey##3##1##(1992-11#1)(1994-8#1)(2012-2#1)
Mono Lake##2##2##(2008-3#2)
Mono Mac 6##2##3##(1997-1#2)
Mono Q HR 5/5##2##4##(2008-10#2)
Mono Q##6##2##(1991-12#2)(1994-6#1)(2008-10#3)
Mono S##5##2##(1990-7#1)(1990-8#1)(1991-12#2)(1992-8#1)
Mono##17##1##(1990-7#1)(1990-8#1)(1991-12#4)(1992-8#1)(1992-9#1)(1994-6#1)(1997-1#2)(2008-10#4)(2008-3#2)
Mono- and##3##2##(1995-11#1)(2008-10#1)(2012-12#1)
Monoamine oxidase##2##2##(1990-12#1)(2011-2#1)
Monoamine##3##1##(1990-12#1)(2008-7#1)(2011-2#1)
Monoclonal Antibodies##5##2##(2008-10#4)(2012-2#1)
Monoclonal Antibody##4##2##(1997-7#1)(2008-11#1)(2008-7#1)(2012-3#1)
Monoclonal antibodies (MoAbs)##2##3##(1993-8#1)(2008-5#1)
Monoclonal antibodies against##5##3##(1995-12#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
Monoclonal antibodies specific for##2##4##(1994-2#1)(2008-10#1)
Monoclonal antibodies##17##2##(1990-5#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)
Monoclonal antibody##10##2##(1990-5#1)(1992-3#1)(1994-5#2)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)
Monoclonal##38##1##(1990-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)
Monocular##2##1##(1992-10#1)(1994-8#1)
Monocytes and##2##2##(2007-8#1)(2008-8#1)
Monocytes##5##1##(1993-9#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-8#1)
Monod##5##1##(1990-8#1)(1997-2#2)(2008-6#1)(2008-7#1)
Monod-Wyman-Changeux##3##1##(1990-8#1)(2012-1#2)
Monod-type##2##1##(2008-11#1)(2008-7#1)
Monodispersed FePt##2##2##(2008-10#2)
Monogenic##2##1##(2008-10#1)(2009-12#1)
Monolayer##2##1##(2008-10#2)
Monolayers##2##1##(1995-12#1)(2009-5#1)
Monolithic##6##1##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
Monolithically integrated##2##2##(2007-11#1)(2008-2#1)
Monomer##3##1##(2008-10#1)(2009-10#1)(2010-5#1)
Monomers##3##1##(2008-10#1)(2008-2#1)(2013-1#1)
Monomorium pharaonis##3##2##(2007-12#2)(2008-6#1)
Monomorium##4##1##(2007-12#2)(2008-6#2)
Mononuclear cells (MNCs) were isolated by Ficoll-Paque gradient and plated onto 48-well culture plates precoated with##2##16##(2008-11#2)
Mononuclear cells are##2##3##(2008-4#1)(2008-9#1)
Mononuclear cells were##2##3##(2009-11#1)(2011-2#1)
Mononuclear cells##7##2##(1991-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)
Mononuclear##11##1##(1990-12#1)(1991-2#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
Monoshunt##3##1##(2007-8#3)
Monosiga brevicollis##5##2##(2010-2#5)
Monostotic fibrous dysplasia##2##3##(2013-1#2)
Monoterpenes##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
Monotherapy with##2##2##(1991-6#1)(2011-1#1)
Monotherapy##4##1##(1991-6#1)(2007-7#1)(2011-1#1)(2012-12#1)
Monotone##2##1##(2008-11#2)
Monovalent cations##2##2##(1992-6#1)(2008-6#1)
Monsanto##2##1##(1991-5#1)(1994-3#1)
Montaigne##3##1##(2012-3#3)
Montana radon health##2##3##(2008-7#2)
Montana##4##1##(2008-10#1)(2008-7#2)(2008-8#1)
Montanide ISA50##3##2##(1996-12#3)
Montanide##4##1##(1995-5#1)(1996-12#3)
Montastraea coral##2##2##(2007-5#2)
Monte Carlo (MC)##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
Monte Carlo algorithm##2##3##(2008-3#2)
Monte Carlo analysis##2##3##(2008-2#1)(2008-3#1)
Monte Carlo and##2##3##(2008-10#1)(2008-3#1)
Monte Carlo approach##3##3##(2008-3#2)(2012-3#1)
Monte Carlo code##4##3##(2008-2#1)(2008-3#3)
Monte Carlo method is##2##4##(2008-3#2)
Monte Carlo method##16##3##(1992-6#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-6#1)(2012-3#1)
Monte Carlo methods for##2##4##(1992-11#1)(2008-2#1)
Monte Carlo methods##7##3##(1992-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-9#1)(2010-2#1)
Monte Carlo model##2##3##(2008-2#1)(2008-3#1)
Monte Carlo numerical##2##3##(1995-12#1)(2008-3#1)
Monte Carlo or##2##3##(2009-9#1)(2012-3#1)
Monte Carlo photon simulation##2##4##(2008-3#2)
Monte Carlo procedure##2##3##(2008-2#2)
Monte Carlo radiative transfer##2##4##(2008-2#1)(2008-3#1)
Monte Carlo results##2##3##(1992-9#1)(2007-12#1)
Monte Carlo simulation for##3##4##(2008-10#1)(2008-3#2)
Monte Carlo simulation methods##2##4##(2008-10#1)(2008-8#1)
Monte Carlo simulation of light scattering##2##6##(2008-3#2)
Monte Carlo simulation of the##3##5##(2008-3#2)(2009-11#1)
Monte Carlo simulation of##6##4##(2008-2#1)(2008-3#4)(2009-11#1)
Monte Carlo simulation results##2##4##(2008-2#1)(2011-1#1)
Monte Carlo simulation##30##3##(1990-12#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#14)(2008-4#1)(2008-8#1)(2009-11#2)(2011-1#1)(2011-2#2)(2013-8#1)
Monte Carlo simulations and##5##4##(2008-2#3)(2008-3#2)
Monte Carlo simulations of light scattering##2##6##(2008-2#2)
Monte Carlo simulations of the##3##5##(1990-8#1)(2007-11#1)(2008-3#1)
Monte Carlo simulations of##6##4##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
Monte Carlo simulations to##4##4##(2008-2#2)(2008-3#1)(2011-2#1)
Monte Carlo simulations were##4##4##(1997-2#1)(2008-3#2)(2012-3#1)
Monte Carlo simulations##38##3##(1990-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#13)(2008-3#14)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Monte Carlo statistical##2##3##(2008-3#2)
Monte Carlo stochastic##2##3##(1994-3#1)(2008-10#1)
Monte Carlo study##2##3##(2008-2#1)(2013-1#1)
Monte Carlo techniques##2##3##(2008-10#1)(2008-3#1)
Monte Carlo##157##2##(1990-12#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#9)(2008-12#2)(2008-2#38)(2008-3#62)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-2#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#4)(2012-7#1)(2013-1#2)(2013-8#1)
Monte carlo##3##2##(2008-2#2)(2008-3#1)
Monte##161##1##(1990-12#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#9)(2008-12#2)(2008-2#40)(2008-3#64)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-2#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#4)(2012-7#1)(2013-1#2)(2013-8#1)
Monte-Carlo analysis##2##2##(2008-10#2)
Monte-Carlo simulation##2##2##(2008-10#2)
Monte-Carlo##5##1##(2008-10#5)
Monterey##3##1##(2008-10#2)(2008-11#1)
Monterrey##3##1##(2011-1#3)
Month##6##1##(1995-1#4)(2008-12#2)
Monthly fluctuations of worm burdens and##2##6##(1996-12#2)
Monthly##10##1##(1991-12#1)(1991-3#1)(1996-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-7#2)
Months##3##1##(2008-12#1)(2008-6#1)(2013-1#1)
Montipora##3##1##(2008-6#3)
Montreal Protocol is##2##3##(1992-3#1)(1996-1#1)
Montreal Protocol##6##2##(1992-3#2)(1996-1#3)(1996-2#1)
Montreal##20##1##(1991-12#1)(1992-3#3)(1995-3#1)(1996-1#4)(1996-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#3)(2011-2#1)(2012-12#1)(2013-1#1)
Montréal##4##1##(1992-2#1)(2008-2#3)
Mood disorders##4##2##(2008-6#2)(2008-7#1)(2012-12#1)
Mood was##2##2##(2008-12#1)(2009-3#1)
Mood##11##1##(2008-12#1)(2008-6#4)(2008-7#1)(2009-3#1)(2011-1#2)(2012-12#1)(2012-3#1)
Moog Curlin 6000 CMS infusion##2##5##(2011-2#2)
Moog##4##1##(2011-2#4)
Moore and##2##2##(2010-3#1)(2013-8#1)
Moore##5##1##(1991-12#1)(2008-10#1)(2009-10#1)(2010-3#1)(2013-8#1)
Moral##7##1##(1991-2#1)(1993-2#1)(1997-2#1)(2008-11#3)(2013-8#1)
Moran##4##1##(2008-5#2)(2008-8#2)
Moraxella bovis##2##2##(2011-2#1)(2013-8#1)
Moraxella sp##5##2##(1997-6#5)
Moraxella##8##1##(1994-11#1)(1997-6#5)(2011-2#1)(2013-8#1)
Morbidity and mortality##2##3##(2006-10#1)(2007-7#1)
Morbidity and##6##2##(1992-12#1)(1995-3#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-7#1)
Morbidity##22##1##(1990-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#4)(2009-10#1)(2011-2#1)(2011-9#1)(2012-12#1)(2013-7#1)
Morbus Gaucher##2##2##(2008-10#2)
More Individuals Hypothesis##4##3##(2008-9#4)
More aggressive##2##2##(2008-10#1)(2011-2#1)
More and more##2##3##(1994-1#1)(2008-11#1)
More attention##3##2##(2008-6#1)(2009-7#1)(2011-3#1)
More cases##2##2##(2008-7#1)(2012-2#1)
More clinical trials##2##3##(1993-3#1)(2010-12#1)
More complex##3##2##(1996-4#1)(2008-8#1)(2009-11#1)
More data##2##2##(1997-6#1)(2013-1#1)
More detailed##4##2##(1991-12#1)(1996-7#1)(2008-10#1)(2008-2#1)
More effective##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
More generally##5##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
More highly aligned alliances##2##4##(2013-1#2)
More highly##3##2##(2008-4#1)(2013-1#2)
More important##3##2##(1996-12#1)(2008-3#1)(2009-10#1)
More importantly##9##2##(1990-12#1)(1992-9#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2011-7#1)
More interestingly##2##2##(2008-11#1)(2008-8#1)
More knowledge##2##2##(1993-6#1)(2008-7#1)
More often##3##2##(1992-5#1)(2008-1#1)(2008-10#1)
More on##4##2##(1994-6#1)(1995-11#2)(2009-12#1)
More rarely##2##2##(2007-8#1)(2008-1#1)
More recent data##3##3##(1996-3#1)(2008-3#1)(2008-8#1)
More recent studies##3##3##(1993-11#1)(2010-11#1)(2010-8#1)
More recent##11##2##(1992-11#1)(1993-11#1)(1995-11#1)(1996-3#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)
More recently it has##2##4##(1990-9#1)(1997-8#1)
More recently it##3##3##(1990-9#1)(1997-8#1)(2011-2#1)
More recently##34##2##(1990-8#1)(1990-9#1)(1991-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#3)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
More research is needed to##2##5##(2007-12#1)(2009-12#1)
More research is needed##3##4##(1990-9#1)(2007-12#1)(2009-12#1)
More research is##5##3##(1990-9#1)(2007-12#2)(2009-12#1)(2013-8#1)
More research##9##2##(1990-9#1)(2007-12#2)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
More serious##2##2##(1996-11#1)(2013-8#1)
More severe##2##2##(1996-3#1)(2008-10#1)
More significantly##2##2##(1997-3#1)(2013-1#1)
More specifically##20##2##(1997-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
More studies are needed to##4##5##(1991-3#1)(2008-8#1)(2009-8#1)(2012-3#1)
More studies are##5##3##(1991-3#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
More studies##7##2##(1991-3#1)(2008-8#1)(2009-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
More than 1##2##3##(2011-1#1)(2013-1#1)
More than 100##2##3##(2007-5#2)
More than 130##2##3##(2008-1#1)(2008-11#1)
More than 2##2##3##(2008-6#1)(2009-4#1)
More than 3##2##3##(1990-12#1)(2008-9#1)
More than 30##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
More than 300##2##3##(2008-10#1)(2010-12#1)
More than 40##3##3##(1993-3#1)(2008-11#1)(2010-11#1)
More than 50% of##4##4##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
More than 60##3##3##(1991-6#1)(2012-12#1)(2013-8#1)
More than 60% of the##2##5##(1995-6#1)(2008-3#1)
More than 70% of##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
More than 75% of the##2##5##(1995-8#1)(1997-3#1)
More than 80% of all##2##5##(1992-6#1)(2008-6#1)
More than 80% of##4##4##(1992-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
More than 90% of##2##4##(1995-3#1)(2008-7#1)
More than 90%##4##3##(1995-3#1)(2008-10#1)(2008-7#2)
More than a##2##3##(2008-11#1)(2008-5#1)
More than ever##2##3##(1994-3#1)(2008-9#1)
More than half of the patients##2##6##(1990-9#1)(1992-6#1)
More than half of the##7##5##(1990-9#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-1#1)
More than half of##10##4##(1990-9#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-2#1)
More than half##14##3##(1990-9#1)(1992-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
More than one##5##3##(1994-7#1)(1996-8#1)(2008-10#2)(2013-1#1)
More than two-thirds of##2##4##(2008-11#1)(2008-4#1)
More than##89##2##(1990-12#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#3)(1993-3#1)(1994-3#2)(1994-7#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2008-1#2)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
More work is##2##3##(2008-10#1)(2010-4#1)
More work##5##2##(1994-3#1)(2008-10#2)(2008-4#1)(2010-4#1)
More##332##1##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#3)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-3#4)(1997-4#1)(1997-6#3)(1997-8#3)(2006-10#1)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#42)(2008-11#15)(2008-2#3)(2008-3#6)(2008-4#12)(2008-5#7)(2008-6#6)(2008-7#10)(2008-8#9)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#3)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#13)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#14)(2013-8#10)
Moreira##3##1##(2009-10#3)
Morelos##3##1##(2008-5#3)
Morene##2##1##(2008-10#2)
Moreover in##2##2##(1990-9#1)(2008-7#1)
Moreover the##8##2##(1990-3#1)(1994-2#1)(1994-6#1)(2008-10#2)(2008-3#1)(2009-6#1)(2011-3#1)
Moreover there##2##2##(1997-3#1)(2011-2#1)
Moreover##730##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#3)(1992-8#2)(1992-9#8)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#10)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#11)(1995-2#4)(1995-4#1)(1995-6#6)(1995-8#4)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-7#4)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#9)(2007-12#10)(2007-6#1)(2007-7#6)(2008-1#7)(2008-10#124)(2008-11#52)(2008-12#8)(2008-2#12)(2008-3#21)(2008-4#12)(2008-5#16)(2008-6#7)(2008-7#30)(2008-8#12)(2008-9#13)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#5)(2010-10#4)(2010-11#7)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#5)(2010-7#2)(2010-8#3)(2011-1#10)(2011-10#2)(2011-2#34)(2011-3#3)(2012-1#3)(2012-12#6)(2012-2#15)(2012-3#12)(2012-5#1)(2012-6#1)(2012-9#1)(2013-1#30)(2013-7#3)(2013-8#12)
Morganella##2##1##(1994-2#1)(2007-11#1)
Morimoto##2##1##(1993-8#2)
Morin-APSG was##2##2##(2008-10#2)
Morinda citrifolia L##2##3##(2008-10#2)
Moringa oleifera Lam##4##3##(2008-10#4)
Moringa oleifera##8##2##(2008-10#8)
Morisita##2##1##(2008-6#1)(2013-7#1)
Morisita's I(delta)##2##2##(2008-8#2)
Mormyrus rume proboscirostris##2##3##(2010-8#2)
Morning##3##1##(1996-1#1)(2011-2#1)(2013-1#1)
Moroccan argan##2##2##(2011-2#2)
Moroccan##8##1##(1995-12#1)(1996-11#1)(2007-7#1)(2008-10#2)(2010-3#1)(2011-2#2)
Morocco##8##1##(2007-7#1)(2008-10#3)(2008-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
Morocco]##2##1##(1994-12#1)(2013-1#1)
Morphine and##2##2##(1992-3#1)(2008-10#1)
Morphine##14##1##(1991-1#1)(1991-5#1)(1991-6#1)(1992-3#2)(1993-12#2)(1994-8#2)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)
Morphofunctional aspects of##2##3##(1993-5#1)(2008-7#1)
Morphofunctional##3##1##(1993-5#2)(2008-7#1)
Morphogenesis##2##1##(1992-12#1)(2008-10#1)
Morphol##7##1##(2011-2#7)
Morphologic##6##1##(1992-12#1)(1992-2#1)(2007-11#1)(2008-10#1)(2010-1#1)(2010-12#1)
Morphological and##8##2##(1994-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-2#1)
Morphological aspects of##2##3##(1994-9#1)(2007-12#1)
Morphological aspects##3##2##(1994-9#1)(2007-12#1)(2008-5#1)
Morphological changes##2##2##(2008-11#1)(2008-5#1)
Morphological characteristics##2##2##(2008-10#2)
Morphological characterization##2##2##(2008-10#2)
Morphological information##2##2##(2008-10#1)(2008-9#1)
Morphological transformation of Syrian hamster embryo cells by##2##8##(1990-7#1)(1992-2#1)
Morphological##46##1##(1990-7#1)(1991-5#1)(1992-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
Morphologically##5##1##(1990-5#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
Morphology and##13##2##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-5#3)(2010-6#1)(2011-2#1)(2013-7#1)
Morphology of a##2##3##(2007-12#2)
Morphology of the##4##3##(1992-6#1)(1994-9#1)(2007-12#1)(2009-3#1)
Morphology of##6##2##(1992-6#1)(1994-9#1)(2007-12#3)(2009-3#1)
Morphology##25##1##(1992-6#1)(1994-9#1)(1996-6#1)(2007-11#1)(2007-12#5)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#3)(2009-3#1)(2010-6#1)(2011-2#1)(2013-7#1)
Morphometric analysis of the##2##4##(2007-11#1)(2007-12#1)
Morphometric analysis of##3##3##(2007-11#2)(2007-12#1)
Morphometric analysis##4##2##(2007-11#2)(2007-12#1)(2008-8#1)
Morphometric##9##1##(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-7#1)
Morquio##2##1##(1990-2#2)
Morris water maze task##2##4##(1994-3#1)(2008-10#1)
Morris water maze test##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
Morris water maze##22##3##(1992-8#1)(1993-12#8)(1993-3#2)(1994-3#2)(1994-6#2)(1997-2#1)(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-3#1)
Morris water task##5##3##(1992-11#5)
Morris water##28##2##(1992-11#5)(1992-8#1)(1993-12#9)(1993-3#2)(1994-3#2)(1994-6#2)(1997-2#1)(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-3#1)
Morris##36##1##(1992-11#5)(1992-8#1)(1993-12#9)(1993-3#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1996-5#2)(1997-2#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#2)
Morrocoy National Park##3##3##(2011-2#3)
Morrocoy##5##1##(2008-5#2)(2011-2#3)
Mortality and##3##2##(1996-12#1)(2008-7#1)(2009-9#1)
Mortality associated with##2##3##(2013-8#2)
Mortality attributable to pandemic influenza A (H1N1) 2009 in San Luis Potosí##2##12##(2011-2#2)
Mortality for##2##2##(2007-8#1)(2008-7#1)
Mortality from##4##2##(1992-6#1)(1994-8#1)(1996-2#1)(2011-2#1)
Mortality in a##2##3##(2009-10#1)(2012-3#1)
Mortality in patients##2##3##(1992-12#1)(1993-2#1)
Mortality in##12##2##(1990-3#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(1997-6#1)(2009-10#2)(2010-6#1)(2011-2#1)(2012-3#1)
Mortality is##2##2##(2007-10#1)(2012-2#1)
Mortality of western corn rootworm##2##5##(2011-2#2)
Mortality of##6##2##(1990-6#1)(2008-10#2)(2008-12#1)(2011-2#2)
Mortality rates were##2##3##(1995-3#1)(2013-8#1)
Mortality related to##2##3##(1993-6#1)(2011-2#1)
Mortality was##4##2##(1997-6#1)(2007-8#1)(2011-2#1)(2013-8#1)
Mortality##65##1##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-6#2)(2007-10#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#5)
Morton##2##1##(1995-6#2)
Morton's neuroma##4##2##(2007-11#3)(2012-2#1)
Morton's##8##1##(1995-6#3)(2007-11#4)(2012-2#1)
Morus alba##7##2##(2008-5#3)(2011-3#4)
Morvant##4##1##(1995-6#4)
Mos kinase##2##2##(1994-8#2)
Mos##11##1##(1994-8#9)(1995-2#2)
Mosaic##5##1##(2008-10#3)(2008-12#1)(2011-1#1)
Moser##2##1##(1994-5#2)
Mosher##2##1##(1994-5#1)(2009-10#1)
Mosquito##2##1##(2007-5#1)(2013-1#1)
Mossbauer##3##1##(1997-7#2)(2012-12#1)
Most (&gt##2##2##(1997-3#1)(2008-10#1)
Most (94%)##2##2##(2008-9#1)(2011-1#1)
Most GPs##2##2##(2007-2#2)
Most Informative Positive (MIP)##2##4##(2009-9#2)
Most authors##3##2##(2008-1#1)(2008-3#1)(2010-11#1)
Most available##3##2##(1995-6#1)(2008-11#1)(2013-1#1)
Most cases of##6##3##(1991-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-8#1)
Most cases##11##2##(1991-12#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-8#1)(2013-8#1)
Most cells in##2##3##(2013-1#2)
Most cells##3##2##(2007-12#1)(2013-1#2)
Most clinical##2##2##(1992-9#1)(2008-8#1)
Most common##7##2##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-2#2)
Most commonly##5##2##(1996-12#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
Most current##4##2##(1995-5#1)(2007-12#1)(2008-11#1)(2011-3#1)
Most data##3##2##(2008-12#1)(2009-7#1)(2010-3#1)
Most favorable##2##2##(2008-10#2)
Most frequent##2##2##(2011-1#2)
Most frequently##4##2##(1990-8#1)(1995-5#1)(2007-11#1)(2010-8#1)
Most group##2##2##(1992-3#1)(1995-2#1)
Most had##2##2##(1992-8#1)(2012-12#1)
Most health care organizations##2##4##(1995-12#1)(1995-3#1)
Most health##3##2##(1994-3#1)(1995-12#1)(1995-3#1)
Most hospitals##2##2##(1994-12#1)(1997-2#1)
Most important##6##2##(1990-6#1)(1990-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
Most importantly##21##2##(1993-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#2)
Most individuals##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
Most methods##3##2##(1994-11#1)(1997-4#1)(2008-3#1)
Most models##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
Most modern##2##2##(2008-9#1)(2011-2#1)
Most mutants##2##2##(1997-4#1)(2008-10#1)
Most newer##2##2##(2008-9#1)(2012-2#1)
Most notably##7##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-3#1)
Most of our##2##3##(2007-12#1)(2009-8#1)
Most of the analysis##2##4##(2008-3#1)(2008-9#1)
Most of the cases##2##4##(2010-6#1)(2011-1#1)
Most of the children##2##4##(2006-10#1)(2012-2#1)
Most of the clinical##2##4##(2007-11#1)(2008-5#1)
Most of the common##2##4##(2008-10#2)
Most of the genes##2##4##(2008-10#1)(2008-9#1)
Most of the isolates##2##4##(2008-10#1)(2008-5#1)
Most of the mothers##2##4##(1990-10#1)(1993-6#1)
Most of the observed##2##4##(1996-12#1)(2008-11#1)
Most of the patients were##4##5##(1996-6#1)(2007-7#1)(2007-8#1)(2011-1#1)
Most of the patients##14##4##(1990-6#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)
Most of the recent##2##4##(2008-10#1)(2008-2#1)
Most of the remaining##2##4##(1995-11#1)(2008-10#1)
Most of the reported##2##4##(2008-1#1)(2011-2#1)
Most of the research##2##4##(2011-2#1)(2013-1#1)
Most of the study##2##4##(2008-1#1)(2008-12#1)
Most of the tests##2##4##(2008-10#1)(2012-2#1)
Most of the topics##2##4##(2008-11#1)(2008-4#1)
Most of the tumours were##2##5##(2006-8#2)
Most of the users##2##4##(1997-6#2)
Most of the##154##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-7#5)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
Most of them are##3##4##(2008-10#1)(2009-5#1)(2012-12#1)
Most of them remain asymptomatic##2##5##(2009-8#1)(2011-2#1)
Most of them were##3##4##(1997-6#1)(2010-3#1)(2012-3#1)
Most of them##15##3##(1991-8#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
Most of these compounds##2##4##(1992-8#1)(1995-3#1)
Most of these studies##3##4##(1993-11#1)(1993-3#1)(2008-7#1)
Most of these were##2##4##(2007-2#1)(2008-5#1)
Most of these##33##3##(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2010-1#1)(2011-2#2)
Most of this##2##3##(1997-2#1)(2009-6#1)
Most of us##2##3##(1994-2#1)(2010-8#1)
Most of##212##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#4)(1997-8#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-7#3)(2007-8#6)(2008-1#5)(2008-10#29)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#8)(2008-7#9)(2008-8#1)(2008-9#7)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#1)
Most often##4##2##(1995-3#1)(2008-10#1)(2009-5#1)(2011-2#1)
Most participants were##2##3##(2008-12#1)(2012-12#1)
Most participants##5##2##(2008-12#1)(2009-6#2)(2010-9#1)(2012-12#1)
Most patients have##2##3##(2008-7#1)(2013-1#1)
Most patients were##2##3##(2008-8#1)(2012-3#1)
Most patients with##3##3##(1991-1#1)(1996-7#1)(2008-7#1)
Most patients##17##2##(1991-1#1)(1991-3#1)(1991-8#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2010-8#1)(2012-3#2)(2013-1#1)
Most people##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
Most physicians##5##2##(1990-2#2)(1994-12#1)(1995-6#1)(2011-2#1)
Most previous##2##2##(2011-1#1)(2013-1#1)
Most primary##2##2##(2008-10#1)(2008-6#1)
Most probably##2##2##(1992-6#1)(2008-10#1)
Most protocols##2##2##(2008-10#1)(2008-2#1)
Most published##2##2##(2008-7#1)(2008-8#1)
Most recently##3##2##(1990-3#1)(2010-3#1)(2012-2#1)
Most reports##2##2##(1997-3#1)(2008-10#1)
Most research has##3##3##(2012-1#1)(2012-2#2)
Most research##4##2##(2008-1#1)(2012-1#1)(2012-2#2)
Most respondents believed that##2##4##(2012-12#2)
Most respondents##8##2##(1993-3#1)(1995-2#1)(1996-1#1)(2008-8#1)(2012-12#3)(2013-1#1)
Most species were##2##3##(2008-5#1)(2013-7#1)
Most species##3##2##(2008-5#1)(2010-6#1)(2013-7#1)
Most studies have##3##3##(1993-2#1)(2008-9#1)(2012-3#1)
Most studies of##2##3##(2008-11#1)(2008-8#1)
Most studies on##2##3##(2008-11#1)(2008-7#1)
Most studies##13##2##(1991-2#1)(1993-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Most users##2##2##(1997-6#1)(2011-2#1)
Most victims were##2##3##(2007-2#1)(2011-2#1)
Most were##2##2##(1992-6#1)(2013-1#1)
Most women##2##2##(2011-1#1)(2011-2#1)
Most##626##1##(1990-10#1)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#5)(1993-6#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-4#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#2)(2006-10#3)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#6)(2007-5#2)(2007-7#6)(2007-8#8)(2008-1#9)(2008-10#81)(2008-11#21)(2008-12#12)(2008-2#7)(2008-3#18)(2008-4#7)(2008-5#16)(2008-6#2)(2008-7#20)(2008-8#15)(2008-9#24)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#7)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#30)(2011-3#1)(2012-1#4)(2012-12#14)(2012-2#18)(2012-3#12)(2013-1#21)(2013-7#1)(2013-8#4)
Mot V##2##2##(1990-9#2)
Mot##3##1##(1990-9#2)(1995-2#1)
MotA and AsiA proteins##2##4##(1995-2#2)
Mother Nature##2##2##(1995-3#1)(2012-2#1)
Mother and Child##3##3##(2008-9#1)(2010-6#2)
Mother and##4##2##(2008-9#1)(2009-12#1)(2010-6#2)
Mother##12##1##(1994-9#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
Mother-Infant##2##1##(1990-12#1)(2009-11#1)
Motherhood##7##1##(1994-3#2)(2010-12#4)(2010-2#1)
Mothers in##2##2##(1995-1#1)(2013-1#1)
Mothers with##2##2##(2009-12#1)(2010-10#1)
Mothers##18##1##(1993-12#1)(1993-6#1)(1995-1#1)(1997-3#2)(2008-12#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
Mothers'##3##1##(1993-12#1)(2009-10#1)(2012-3#1)
Motif##3##1##(1997-8#1)(2008-10#1)(2008-4#1)
Motility##2##1##(2011-2#1)(2013-1#1)
Motion##8##1##(2007-8#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
Motivated by##3##2##(2007-12#1)(2008-12#1)(2008-8#1)
Motivating##3##1##(2009-7#1)(2013-1#2)
Motivation for dietary changes##2##4##(1990-6#2)
Motivation##11##1##(1990-6#2)(1995-2#1)(1996-7#2)(2007-8#1)(2009-5#2)(2009-9#1)(2010-4#1)(2011-2#1)
Motivational##2##1##(2007-12#1)(2008-6#1)
Motor Control and##2##3##(1997-8#2)
Motor oil##2##2##(2008-10#2)
Motor oils##4##2##(2008-10#4)
Motor##27##1##(1995-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-10#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2011-2#3)(2011-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
Motorcycle##2##1##(2012-12#1)(2013-8#1)
Motorola Optobus##2##2##(2008-3#2)
Motorola##3##1##(1995-12#1)(2008-3#2)
Mount Barker##4##2##(2008-10#4)
Mount Clemens General Hospital##2##4##(1994-2#1)(1996-3#1)
Mount Desert Island Biological Laboratory##2##5##(2008-8#2)
Mount Sinai Medical Center##2##4##(1995-8#1)(1997-2#1)
Mount Sinai##4##2##(1991-12#1)(1995-8#1)(1996-3#1)(1997-2#1)
Mount##15##1##(1991-12#1)(1994-2#1)(1995-8#1)(1996-3#2)(1997-2#1)(2008-10#4)(2008-2#1)(2008-8#2)(2008-9#1)(2010-6#1)
Mountain##8##1##(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#4)
Mountains of##3##2##(2007-12#1)(2008-10#2)
Mountains##8##1##(2007-12#1)(2008-10#4)(2008-11#1)(2009-10#1)(2013-1#1)
Mountcastle##2##1##(2009-5#2)
Mounting evidence suggests##2##3##(2008-7#1)(2013-8#1)
Mounting##3##1##(2008-11#1)(2008-7#1)(2013-8#1)
Moura##3##1##(1994-5#3)
Mourant et al##2##3##(2008-3#2)
Moure##3##1##(2008-6#3)
Mouse Mammary Tumor Virus##3##4##(1994-12#1)(1994-7#1)(2008-11#1)
Mouse Model of##2##3##(2010-11#1)(2012-12#1)
Mouse and##2##2##(1990-5#1)(1997-9#1)
Mouse models##2##2##(2008-2#1)(2011-2#1)
Mouse##41##1##(1990-5#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-9#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
Moutan Cortex##6##2##(2008-10#6)
Mouth##2##1##(2006-10#1)(2013-1#1)
Mov##2##1##(2010-3#2)
Movement of the##2##3##(2008-10#2)
Movement of##8##2##(2008-10#7)(2008-12#1)
Movement##28##1##(1996-12#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)
Moving forward##3##2##(1995-1#1)(2008-8#1)(2010-10#1)
Moving the##2##2##(2007-11#1)(2009-8#1)
Moving##11##1##(1994-12#1)(1995-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#1)
Mozambican##2##1##(1997-6#2)
Mozambique##14##1##(1991-11#2)(1997-6#8)(2007-2#3)(2012-12#1)
Mozuku of Cladosiphon novae-caledoniae kylin##2##5##(2008-11#2)
Mp420##2##1##(2008-10#2)
Mr = 80##6##3##(1990-10#5)(1990-11#1)
Mr =##9##2##(1990-10#5)(1990-11#1)(1990-12#1)(1990-7#2)
Mr approximately 3##2##3##(2008-11#2)
Mr approximately##3##2##(2008-11#3)
Mr of 30##2##3##(1991-7#1)(2008-10#1)
Mr of##13##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#1)(1991-7#1)(1991-9#1)(1994-11#1)(1996-2#2)(2008-10#1)(2010-11#1)
Mr##86##1##(1990-10#6)(1990-11#5)(1990-12#4)(1990-5#7)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#4)(1992-1#3)(1992-2#2)(1993-12#1)(1993-2#4)(1993-3#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#5)(1995-1#3)(1995-2#2)(1996-2#2)(1997-7#3)(1997-9#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-11#1)
Mr-IAG##5##1##(2012-3#5)
MrNomogram##3##1##(2008-10#3)
MrVIA##5##1##(2008-8#5)
Mre11 complex##4##2##(2011-2#4)
Mre11 complexes##2##2##(2011-2#2)
Mre11##9##1##(2011-2#9)
Mrs##4##1##(1991-2#1)(1992-4#1)(1993-5#1)(2010-11#1)
Ms##13##1##(1991-1#1)(1991-12#1)(1992-12#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)
MseI##6##1##(2008-10#5)(2010-4#1)
Msp##2##1##(1990-2#1)(2009-10#1)
MspI and##2##2##(1990-5#1)(2008-4#1)
Mss4##3##1##(1995-8#3)
Msx##2##1##(2008-6#1)(2012-12#1)
Msx-1##6##1##(1995-5#6)
Msx1 and Msx2##2##3##(2012-12#2)
Msx1 and##3##2##(1994-11#1)(2012-12#2)
Msx1 expression##2##2##(2012-12#2)
Msx1##11##1##(1994-11#2)(2012-12#9)
Msx1(lacZ) is expressed##2##3##(2012-12#2)
Msx1(lacZ)##4##1##(2012-12#4)
Msx2##4##1##(2012-12#3)(2013-1#1)
Msx2(lacZ)##2##1##(2012-12#2)
Mt assembly##3##2##(2008-6#3)
Mt##19##1##(1995-12#1)(1997-5#2)(2007-2#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#2)(2009-8#1)
MtSERF1##3##1##(2009-8#3)
Mtn induced##2##2##(1991-4#2)
Mtn##3##1##(1991-4#3)
Mtrm##2##1##(2012-3#2)
Mtx##4##1##(2008-10#2)(2011-2#2)
Mu element##2##2##(2012-3#2)
Mu elements##4##2##(2012-3#4)
Mu##12##1##(1990-11#1)(1990-2#1)(1994-12#2)(1997-4#1)(2012-3#7)
Mu13 is##2##2##(2012-3#2)
Mu13##5##1##(2012-3#5)
Muc5AC##2##1##(1997-7#2)
Much attention has been##2##4##(2008-1#1)(2008-10#1)
Much effort has been##2##4##(1997-6#1)(2011-2#1)
Much effort has##3##3##(1994-3#1)(1997-6#1)(2011-2#1)
Much effort##4##2##(1991-6#1)(1994-3#1)(1997-6#1)(2011-2#1)
Much has been written about##2##5##(2008-11#1)(2010-10#1)
Much has been written##4##4##(2008-1#1)(2008-11#1)(2010-10#1)(2010-2#1)
Much has been##5##3##(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-2#1)
Much less##2##2##(1990-5#1)(1992-6#1)
Much more##3##2##(1991-1#1)(1993-3#1)(2008-10#1)
Much of the recent##2##4##(1991-12#1)(2006-10#1)
Much of the##13##3##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2013-8#1)
Much of this##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2009-12#1)
Much of##21##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2013-8#1)
Much progress##3##2##(2008-7#1)(2010-7#1)(2011-1#1)
Much remains##2##2##(2010-6#1)(2011-2#1)
Much research is##2##3##(1997-5#1)(2012-2#1)
Much research##5##2##(1995-6#1)(1997-5#1)(2008-10#1)(2010-5#1)(2012-2#1)
Much work##3##2##(1997-1#1)(2007-8#1)(2008-10#1)
Much##63##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
Mucin##3##1##(1993-2#1)(2008-12#1)(2012-1#1)
Mucinous##2##1##(2009-5#1)(2010-12#1)
Muco-cutaneous lesions##2##2##(2007-7#1)(2012-2#1)
Mucor circinelloides##3##2##(2008-5#1)(2008-8#2)
Mucor sp##2##2##(2008-12#1)(2008-6#1)
Mucor##12##1##(1997-3#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#3)(2010-4#1)(2012-3#2)
Mucormycosis is a rare##2##4##(2010-10#1)(2013-1#1)
Mucormycosis##3##1##(2007-7#1)(2010-10#1)(2013-1#1)
Mucosal##9##1##(1994-6#1)(2007-9#1)(2008-10#1)(2008-5#3)(2010-12#1)(2011-2#1)(2013-8#1)
Mucositis##4##1##(2008-7#4)
Mud##2##1##(1997-7#1)(2013-1#1)
Mueller matrices for##2##3##(2008-2#1)(2008-3#1)
Mueller matrices of##2##3##(2008-3#2)
Mueller matrices##11##2##(2007-11#1)(2008-2#1)(2008-3#9)
Mueller matrix are##3##3##(2008-2#2)(2008-3#1)
Mueller matrix elements##3##3##(2008-2#1)(2008-3#2)
Mueller matrix for##2##3##(2007-11#1)(2008-3#1)
Mueller matrix is##2##3##(2008-3#2)
Mueller matrix of a##2##4##(2007-11#1)(2008-3#1)
Mueller matrix of##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
Mueller matrix spectroscopy##2##3##(2007-12#1)(2008-3#1)
Mueller matrix##36##2##(2007-11#5)(2007-12#3)(2008-2#7)(2008-3#21)
Mueller##51##1##(2007-11#6)(2007-12#3)(2008-2#9)(2008-3#33)
Mueller-Hinton agar##2##2##(2008-12#1)(2008-9#1)
Mueller-Jones matrix##2##2##(2008-2#2)
Mueller-matrix##2##1##(2007-11#1)(2008-3#1)
Muggli##2##1##(1995-12#2)
Muir-Torre syndrome##4##2##(1991-6#2)(2010-8#2)
Muir-Torre##5##1##(1991-6#2)(2010-8#3)
Mulberry Leaves##2##2##(2008-10#2)
Mulberry##3##1##(2008-10#3)
Mullen##3##1##(1995-12#2)(2008-6#1)
Muller##2##1##(2008-11#1)(2013-7#1)
Muller's morphs##2##2##(2012-12#2)
Muller's##3##1##(2012-12#3)
Mullerian duct##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
Mullerian##6##1##(2007-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#2)
Mulligan##2##1##(2007-3#1)(2008-12#1)
Multi##4##1##(2007-2#1)(2010-8#1)(2011-2#2)
Multi-Disciplinary##2##1##(2008-6#2)
Multi-detector##2##1##(2008-1#1)(2008-7#1)
Multi-dose##2##1##(1992-3#1)(2008-10#1)
Multi-element##2##1##(2008-10#2)
Multi-pumping flow systems##2##3##(2008-10#2)
Multi-scale##4##1##(2009-12#1)(2010-7#1)(2010-8#1)(2012-2#1)
Multi-slice##2##1##(2007-8#1)(2010-10#1)
Multi-walled carbon##2##2##(2008-10#2)
MultiHance##11##1##(2008-7#11)
MultiPipMaker##3##1##(2008-4#3)
MultiSimplex##2##1##(2008-10#2)
Multiangle Imaging Spectroradiometer##3##3##(2008-2#2)(2008-3#1)
Multiangle##5##1##(2008-2#2)(2008-3#2)(2008-4#1)
Multicenter Study Group##2##3##(1990-11#2)
Multicenter Study##3##2##(1990-11#2)(2008-5#1)
Multicenter##11##1##(1990-11#2)(1992-11#1)(1995-8#1)(2008-5#3)(2010-9#1)(2011-2#1)(2012-3#2)
Multicentre##3##1##(2008-10#1)(2008-5#1)(2009-1#1)
Multicentric##2##1##(2008-7#1)(2012-1#1)
Multichannel##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
Multicolor##3##1##(2007-11#1)(2008-9#1)(2009-11#1)
Multicommutation-NIR##2##1##(2008-10#2)
Multicomponent analysis of##3##3##(2008-10#3)
Multicomponent analysis##4##2##(2008-10#4)
Multicomponent##11##1##(1996-5#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#1)
Multicultural##2##1##(1997-2#1)(2010-8#1)
Multidetector CT is##2##3##(2010-6#2)
Multidetector computed tomography (MDCT)##3##4##(2008-12#1)(2008-7#1)(2012-2#1)
Multidetector computed tomography##4##3##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
Multidetector##7##1##(2008-12#1)(2008-7#2)(2010-6#2)(2011-2#1)(2012-2#1)
Multidimensional Measure##2##2##(2010-2#1)(2012-2#1)
Multidimensional##20##1##(1994-2#1)(1995-5#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#1)(2008-9#1)(2010-2#2)(2012-2#2)(2013-1#1)
Multidisciplinary approach##2##2##(2010-8#1)(2011-2#1)
Multidisciplinary teams##2##2##(1997-1#1)(2011-1#1)
Multidisciplinary##10##1##(1997-1#1)(2007-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Multidrug resistance##2##2##(2008-10#1)(2013-8#1)
Multidrug resistant##3##2##(1996-6#1)(2007-7#1)(2010-4#1)
Multidrug##7##1##(1996-6#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
Multidrug- and extensively drug-resistant TB##2##5##(2010-5#2)
Multidrug-resistant##4##1##(1992-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
Multielemental##4##1##(2008-1#1)(2008-10#3)
Multienzyme##2##1##(2008-10#2)
Multifocal##4##1##(2006-10#1)(2008-3#1)(2009-4#1)(2013-1#1)
Multifrequency##2##1##(2007-11#1)(2008-3#1)
Multifunctional##5##1##(1997-4#1)(2007-11#2)(2009-11#1)(2010-5#1)
Multigene##2##1##(2008-10#2)
Multilayer coatings for##2##3##(2008-3#2)
Multilayer coatings with##2##3##(2008-2#2)
Multilayer coatings##6##2##(2008-2#3)(2008-3#3)
Multilayer films##2##2##(2008-10#2)
Multilayer##16##1##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#4)(2009-9#1)
Multilayer-coated##2##1##(2008-2#1)(2008-3#1)
Multilayered Films##2##2##(2008-12#1)(2009-11#1)
Multilevel analyses##2##2##(2009-7#1)(2010-1#1)
Multilevel analysis of##2##3##(2010-1#1)(2012-3#1)
Multilevel modeling##3##2##(2008-12#1)(2009-7#1)(2010-9#1)
Multilevel##15##1##(2007-11#2)(2008-11#1)(2008-12#1)(2009-12#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
Multilocus##8##1##(1997-5#1)(2007-12#1)(2008-10#4)(2008-5#1)(2012-3#1)
Multimodal##5##1##(2007-12#1)(2008-12#1)(2011-2#3)
Multimodality##3##1##(2008-9#1)(2012-2#1)(2013-1#1)
Multimode##4##1##(1990-12#1)(2007-12#1)(2008-2#2)
Multimorbidity##2##1##(2012-3#2)
Multinational##5##1##(2008-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#1)
Multinomial##4##1##(2009-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
Multiorgan##4##1##(1992-5#1)(2007-12#1)(2012-1#1)(2013-8#1)
Multiparameter analysis of##2##3##(2008-9#2)
Multiparameter##6##1##(1990-7#1)(2008-4#2)(2008-9#2)(2010-1#1)
Multiphoton##4##1##(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
Multiple Myeloma##2##2##(2010-9#1)(2011-2#1)
Multiple Sclerosis##4##2##(2008-8#1)(2013-1#2)(2013-8#1)
Multiple cutaneous metastases##2##3##(2009-4#1)(2013-8#1)
Multiple cutaneous##3##2##(2009-4#1)(2012-3#1)(2013-8#1)
Multiple endocrine neoplasia type 2##2##5##(2008-1#2)
Multiple factors##2##2##(2012-12#1)(2013-1#1)
Multiple foci and a long filament##2##6##(2007-11#2)
Multiple foci##3##2##(2007-11#3)
Multiple forms of##3##3##(1990-5#1)(1991-5#1)(1995-11#1)
Multiple genes##2##2##(2011-2#1)(2012-2#1)
Multiple light scattering##2##3##(2008-3#2)
Multiple linear regression analysis showed##2##5##(1993-2#1)(2011-1#1)
Multiple linear regression analysis##4##4##(1993-2#2)(2008-10#1)(2011-1#1)
Multiple linear regression was##2##4##(2008-10#1)(2013-1#1)
Multiple linear regression##8##3##(1993-2#2)(2007-11#1)(2008-10#2)(2009-5#1)(2011-1#1)(2013-1#1)
Multiple logistic regression##2##3##(2008-11#1)(2011-2#1)
Multiple mechanisms##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
Multiple members of the##2##4##(1992-3#1)(1995-2#1)
Multiple methods##2##2##(1990-7#1)(2010-6#1)
Multiple myeloma##2##2##(1991-5#1)(2010-4#1)
Multiple primary##4##2##(1993-8#1)(2007-8#1)(2011-2#2)
Multiple regression analyses showed##2##4##(2008-10#1)(2011-1#1)
Multiple regression analyses##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
Multiple regression analysis revealed##3##4##(1996-7#1)(2008-7#1)(2012-12#1)
Multiple regression analysis showed##2##4##(2008-12#1)(2008-7#1)
Multiple regression analysis was##2##4##(1993-8#1)(2008-12#1)
Multiple regression analysis##8##3##(1993-8#1)(1996-7#1)(2008-12#2)(2008-7#2)(2011-1#1)(2012-12#1)
Multiple regression##14##2##(1993-8#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2011-1#2)(2012-12#1)(2012-2#1)
Multiple response##2##2##(2008-10#2)
Multiple scattering of##2##3##(2008-2#1)(2008-3#1)
Multiple scattering##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
Multiple sclerosis (MS) is a##2##5##(2008-7#1)(2012-3#1)
Multiple sclerosis (MS) is##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
Multiple sclerosis and##2##3##(2007-12#1)(2011-2#1)
Multiple sclerosis is##2##3##(2010-12#1)(2012-2#1)
Multiple sclerosis##9##2##(2007-12#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
Multiple sequence alignment##2##3##(2008-4#1)(2008-9#1)
Multiple sequence alignments##2##3##(2008-7#2)
Multiple sequence##4##2##(2008-4#1)(2008-7#2)(2008-9#1)
Multiple systemic##2##2##(2012-3#1)(2013-1#1)
Multiple##205##1##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#4)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#5)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#3)(2011-1#6)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#4)
Multiple-beam##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
Multiple-channel wavelength conversion##2##3##(2007-12#2)
Multiple-scattering##3##1##(2008-2#1)(2008-3#2)
Multiplex PCR##3##2##(2008-12#2)(2011-2#1)
Multiplex Polymerase Chain Reaction##2##4##(2008-10#2)
Multiplex Real-Time Polymerase Chain Reaction##2##5##(2008-10#2)
Multiplex Real-Time##3##2##(2008-10#3)
Multiplex fluorescence in situ hybridization##2##5##(2010-1#2)
Multiplex##17##1##(2008-10#7)(2008-12#3)(2008-3#1)(2009-6#1)(2010-1#2)(2010-11#1)(2011-2#1)(2013-8#1)
Multiplexed microsphere-based##2##2##(2008-9#2)
Multiplexed##7##1##(2007-11#1)(2008-3#1)(2008-9#4)(2010-11#1)
Multiplexing of##2##2##(2008-2#1)(2008-3#1)
Multiplexing##5##1##(2007-12#1)(2008-2#2)(2008-3#1)(2009-10#1)
Multiply##2##1##(2008-2#1)(2009-12#1)
Multipoint##4##1##(1997-5#2)(2007-12#1)(2008-10#1)
Multipole##2##1##(2007-11#1)(2007-12#1)
Multiprobe##2##1##(2008-4#1)(2009-5#1)
Multiracial##2##1##(2013-8#2)
Multiresidue determination of##2##3##(2008-10#2)
Multiresolution##4##1##(2008-3#1)(2008-6#3)
Multiscale##3##1##(2008-2#1)(2008-7#1)(2011-1#1)
Multisimplex program##2##2##(2008-10#2)
Multispectral##3##1##(2007-12#1)(2008-2#1)(2011-1#1)
Multistage##3##1##(2008-3#2)(2012-3#1)
Multivalent##2##1##(2008-10#1)(2008-5#1)
Multivalvular endocarditis##2##2##(2011-2#2)
Multivariable##3##1##(2008-10#1)(2009-7#1)(2010-11#1)
Multivariate analyses##2##2##(2008-10#1)(2011-2#1)
Multivariate analysis demonstrated##2##3##(2008-7#1)(2011-1#1)
Multivariate analysis of the##2##4##(2008-10#1)(2008-9#1)
Multivariate analysis of##4##3##(2008-10#3)(2008-9#1)
Multivariate analysis showed that##2##4##(2008-7#1)(2010-4#1)
Multivariate analysis showed##3##3##(2008-7#1)(2010-4#1)(2013-1#1)
Multivariate analysis##17##2##(1993-12#1)(1995-12#1)(2008-10#6)(2008-7#2)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
Multivariate calibration##5##2##(2008-10#4)(2008-3#1)
Multivariate data analysis##2##3##(2008-10#1)(2008-11#1)
Multivariate logistic regression analysis##3##4##(2008-3#2)(2012-3#1)
Multivariate logistic regression##6##3##(1993-12#1)(2008-3#2)(2010-3#1)(2012-1#1)(2012-3#1)
Multivariate optimisation of##2##3##(2008-10#2)
Multivariate regression analysis##2##3##(1991-1#1)(2007-10#1)
Multivariate regression##5##2##(1991-1#1)(2007-10#1)(2008-10#2)(2008-3#1)
Multivariate statistical##2##2##(2008-10#2)
Multivariate##61##1##(1991-1#1)(1991-2#1)(1993-12#2)(1995-12#1)(1995-4#1)(2007-10#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
Multiwatt##2##1##(2007-12#1)(2008-3#1)
Multiwavelength output##2##2##(2007-11#1)(2008-2#1)
Multiwavelength spectrophotometric determination of##2##4##(2008-10#2)
Multiwavelength##11##1##(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)
Mumbai##5##1##(2008-7#2)(2012-1#1)(2013-8#2)
Mundt##2##1##(2008-10#2)
Munich##6##1##(1994-3#2)(2008-10#1)(2008-5#3)
Munich/Germany##2##1##(2008-11#2)
Municipal Institute##2##2##(1997-5#1)(2010-11#1)
Municipal##13##1##(1990-2#1)(1993-3#1)(1994-1#1)(1997-5#1)(2008-5#5)(2008-9#2)(2009-10#1)(2010-11#1)
Municipalities##2##1##(2013-8#2)
Municipality##3##1##(1991-6#2)(2008-5#1)
Mupirocin##2##1##(1991-8#1)(2007-12#1)
Murashige and Skoog (MS)##2##4##(2008-10#1)(2008-8#1)
Murchison##3##1##(1995-11#3)
Murine models of##2##3##(2008-9#1)(2010-7#1)
Murine##23##1##(1990-12#1)(1990-2#1)(1992-11#2)(1994-2#1)(1994-5#1)(1995-8#1)(1997-6#1)(2007-2#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
Murphy##2##1##(1995-12#1)(2008-6#1)
Murray cod Maccullochella peelii peelii##2##5##(2010-8#2)
Murray##4##1##(2008-12#1)(2010-8#3)
Mus##2##1##(1993-9#1)(2008-9#1)
Musca domestica##4##2##(2007-11#2)(2013-1#2)
Muscarinic##3##1##(1993-12#1)(1993-9#1)(1995-12#1)
Muscidae) in##2##2##(2011-2#1)(2013-1#1)
Muscidae)##3##1##(2011-2#2)(2013-1#1)
Muscle Nerve##4##2##(2013-1#4)
Muscle hypertrophy##2##2##(2008-2#1)(2008-5#1)
Muscle of##2##2##(1995-12#1)(2008-10#1)
Muscle samples were##2##3##(2010-4#1)(2011-2#1)
Muscle##33##1##(1990-7#1)(1991-5#1)(1992-5#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#5)(2013-8#1)
Muscles##2##1##(1995-11#1)(2012-1#1)
Muscovy and Pekin ducklings##2##4##(2008-5#2)
Muscular Dystrophy##4##2##(2007-8#2)(2008-7#2)
Muscular##6##1##(2007-11#1)(2007-8#2)(2008-7#2)(2009-3#1)
Musculoskeletal Tumour Society##2##3##(2008-6#2)
Musculoskeletal##12##1##(1990-6#1)(1997-5#1)(1997-6#1)(2006-10#1)(2008-3#1)(2008-6#4)(2008-8#1)(2012-1#1)(2012-2#1)
Museum of##2##2##(2010-1#1)(2011-2#1)
Museum##6##1##(2008-5#1)(2010-1#3)(2010-6#1)(2011-2#1)
Mushroom##4##1##(2008-10#2)(2012-3#1)(2013-8#1)
Music and##2##2##(1995-1#1)(2008-11#1)
Music##6##1##(1991-12#1)(1995-1#1)(2008-11#2)(2008-5#1)(2008-9#1)
Muslim Faith Healers perceptions of mental##2##6##(2008-12#2)
Muslim##8##1##(1994-9#1)(2008-12#3)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
Muslims##2##1##(1996-8#1)(2011-2#1)
Must##3##1##(1997-3#1)(2008-10#1)(2012-3#1)
Mustela##3##1##(2008-6#3)
Mustelus dorsalis##2##2##(2008-5#2)
Mutagenesis of the##2##3##(1997-8#1)(2008-11#1)
Mutagenesis of##5##2##(1992-8#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
Mutagenesis##10##1##(1990-3#1)(1991-5#1)(1992-2#1)(1992-8#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-11#1)
Mutagenic##4##1##(1992-5#1)(1992-6#1)(1993-11#1)(1994-5#1)
Mutant and##2##2##(2008-10#1)(2013-8#1)
Mutant p53##2##2##(2009-4#1)(2009-5#1)
Mutant##23##1##(1990-11#1)(1990-2#1)(1993-12#1)(1993-3#1)(1994-5#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(2008-10#7)(2009-4#1)(2009-5#2)(2013-8#2)
Mutants M1##2##2##(2008-10#2)
Mutants defective in##2##3##(2008-10#1)(2011-2#1)
Mutants of##10##2##(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#6)(2009-6#1)
Mutants with the##2##3##(1994-11#2)
Mutants##32##1##(1994-11#2)(1994-5#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#17)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)
Mutat##3##1##(1995-6#3)
Mutation and##2##2##(2012-2#1)(2013-8#1)
Mutation in the##4##3##(2008-10#4)
Mutation in##7##2##(2008-10#5)(2010-9#1)(2012-2#1)
Mutation of the##6##3##(1991-11#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-9#1)(2009-6#1)
Mutation of##14##2##(1991-11#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
Mutation##37##1##(1991-11#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-7#2)(2008-10#5)(2008-12#1)(2008-4#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
Mutational analysis of the##3##4##(1993-2#2)(2008-9#1)
Mutational analysis of##4##3##(1993-2#2)(2008-8#1)(2008-9#1)
Mutational analysis##5##2##(1993-2#2)(2008-10#1)(2008-8#1)(2008-9#1)
Mutational##8##1##(1991-11#1)(1993-2#2)(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
Mutations affecting the##3##3##(1992-3#1)(1995-2#1)(2012-12#1)
Mutations affecting##5##2##(1992-3#1)(1994-5#1)(1995-2#1)(2012-12#1)(2013-8#1)
Mutations and##3##2##(2008-2#1)(2008-4#1)(2012-3#1)
Mutations in the##13##3##(1992-3#1)(1994-11#1)(1997-7#1)(2008-1#2)(2008-10#2)(2008-4#2)(2011-1#1)(2012-2#1)(2012-3#2)
Mutations in##25##2##(1991-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#3)(2008-7#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Mutations of the##3##3##(1991-11#1)(2008-4#1)(2012-2#1)
Mutations of##5##2##(1991-11#1)(1995-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
Mutations that##5##2##(1992-9#1)(2008-1#2)(2008-10#2)
Mutations were##3##2##(1992-2#1)(2008-6#1)(2013-1#1)
Mutations##56##1##(1990-5#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-8#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-1#4)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
Mutator##4##1##(2012-3#4)
Mutual##10##1##(1996-6#1)(1997-5#5)(1997-7#1)(2008-3#1)(2008-8#1)(2013-1#1)
Mw##3##1##(2012-2#3)
Mwanza##2##1##(2010-8#2)
MxA protein##3##2##(2008-7#3)
MxA##6##1##(2008-7#6)
Mxc2##2##1##(2008-10#2)
Mxc3##3##1##(2008-10#3)
My doctor##3##2##(2008-10#1)(2010-12#1)(2013-7#1)
My microscopy##2##2##(2008-8#2)
My personal##2##2##(2008-7#1)(2013-1#1)
My##33##1##(1992-2#1)(1992-3#1)(1993-9#1)(1997-8#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#3)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
My-DTome##3##1##(2012-2#3)
MyD##2##1##(1992-12#2)
MySQL##2##1##(2008-4#1)(2008-7#1)
Myanmar##4##1##(2011-1#3)(2013-8#1)
Myasthenia gravis##4##2##(1997-5#1)(2009-11#1)(2012-12#1)(2012-3#1)
Myc##14##1##(1991-5#1)(1995-11#6)(2008-10#1)(2008-11#3)(2011-2#2)(2013-1#1)
MycER##3##1##(2008-11#3)
Mycelia of##2##2##(2008-10#2)
Mycelia##4##1##(2008-10#4)
Mycelial growth##3##2##(2008-10#3)
Mycelial##11##1##(2008-10#11)
Mycelium of##5##2##(2008-10#5)
Mycelium##9##1##(2008-10#9)
MycoSep 225 column##2##3##(2008-10#2)
Mycobacteria##4##1##(2010-11#1)(2012-2#2)(2013-7#1)
Mycobacterial##3##1##(2007-7#1)(2011-2#2)
Mycobacterium abscessus##2##2##(2007-12#1)(2012-12#1)
Mycobacterium avium complex (MAC)##2##4##(2007-12#1)(2008-5#1)
Mycobacterium avium complex##4##3##(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
Mycobacterium avium##6##2##(1992-12#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-8#1)
Mycobacterium bovis##9##2##(1996-11#2)(1997-4#1)(1997-8#1)(2008-7#1)(2011-2#2)(2012-3#2)
Mycobacterium chelonei##2##2##(1993-9#2)
Mycobacterium fortuitum##6##2##(2007-12#2)(2007-7#1)(2008-8#1)(2011-2#2)
Mycobacterium gordonae##2##2##(1993-11#2)
Mycobacterium intracellulare##2##2##(2008-1#2)
Mycobacterium kansasii##2##2##(2007-12#1)(2008-8#1)
Mycobacterium leprae##2##2##(2008-8#1)(2011-2#1)
Mycobacterium marinum infection##2##3##(2008-9#2)
Mycobacterium marinum##3##2##(2008-9#3)
Mycobacterium paratuberculosis##2##2##(1991-8#1)(1993-2#1)
Mycobacterium tuberculosis H37Rv##2##3##(2008-7#1)(2012-3#1)
Mycobacterium tuberculosis and Mycobacterium bovis##3##5##(1997-4#1)(2012-3#2)
Mycobacterium tuberculosis and##4##3##(1997-4#1)(2008-7#1)(2012-3#2)
Mycobacterium tuberculosis in a##2##4##(2009-7#1)(2013-1#1)
Mycobacterium tuberculosis infection##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
Mycobacterium tuberculosis##66##2##(1990-9#1)(1993-2#1)(1993-3#1)(1995-2#2)(1996-11#3)(1997-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#9)(2009-6#2)(2009-7#5)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#1)
Mycobacterium vanbaalenii##2##2##(2011-1#1)(2012-2#1)
Mycobacterium##125##1##(1990-9#1)(1991-11#2)(1991-8#1)(1992-12#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-9#2)(1995-2#2)(1995-3#1)(1996-11#5)(1997-4#4)(1997-8#1)(2007-12#9)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#8)(2008-8#7)(2008-9#12)(2009-6#2)(2009-7#5)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#12)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#6)(2013-8#1)
Mycological##2##1##(1997-3#1)(2010-4#1)
Mycoparasite##6##1##(2008-10#6)
Mycoparasitism##2##1##(2008-10#2)
Mycophenolate##3##1##(2008-1#2)(2011-2#1)
Mycoplasma capricolum##2##2##(1994-12#2)
Mycoplasma gallisepticum##5##2##(1993-12#1)(1997-3#1)(1997-6#2)(2010-9#1)
Mycoplasma genitalium is##2##3##(2011-2#2)
Mycoplasma genitalium##3##2##(2011-2#3)
Mycoplasma genomes##4##2##(2012-2#4)
Mycoplasma hominis##5##2##(1997-3#2)(2007-12#1)(2011-2#1)(2012-3#1)
Mycoplasma hyopneumoniae##2##2##(1992-5#2)
Mycoplasma pneumoniae and##2##3##(1992-5#2)
Mycoplasma pneumoniae##10##2##(1992-5#2)(1997-3#1)(2007-11#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
Mycoplasma wenyonii##3##2##(2012-3#3)
Mycoplasma##47##1##(1992-5#4)(1993-12#1)(1994-12#2)(1997-3#6)(1997-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)(2010-9#1)(2011-2#8)(2012-2#6)(2012-3#7)(2013-1#1)(2013-8#1)
Mycoplasmas##2##1##(1990-6#1)(2008-11#1)
Mycoreovirus##2##1##(2008-10#2)
Mycorrhizal##2##1##(2008-10#2)
Mycoses##2##1##(1995-8#1)(2011-2#1)
Mycosis##3##1##(1995-1#2)(2010-6#1)
Mycosphaerella citri##7##2##(2008-10#7)
Mycosphaerella fijiensis##3##2##(2008-10#3)
Mycosphaerella graminicola (anamorph Septoria tritici)##3##5##(2008-10#3)
Mycosphaerella graminicola on##3##3##(2008-10#3)
Mycosphaerella graminicola populations##2##3##(2008-10#2)
Mycosphaerella graminicola##38##2##(2008-10#36)(2011-10#2)
Mycosphaerella is##2##2##(2008-10#2)
Mycosphaerella musicola##2##2##(2008-10#2)
Mycosphaerella populorum##2##2##(2008-10#2)
Mycosphaerella spp##6##2##(2008-10#6)
Mycosphaerella##79##1##(2008-10#77)(2011-10#2)
Mycosphaerellaceae##3##1##(2010-3#3)
Mycotic##5##1##(1995-9#1)(1997-8#1)(2011-1#1)(2012-1#2)
Mycotoxin Accumulation##2##2##(2008-10#2)
Mycotoxin##4##1##(1993-3#1)(2008-10#3)
Myelin##4##1##(1993-6#1)(1996-5#1)(2008-7#1)(2009-6#1)
Myelodysplastic syndrome (MDS)##2##3##(2010-8#1)(2012-12#1)
Myelodysplastic syndrome##3##2##(2010-8#2)(2012-12#1)
Myeloid Leukemia##4##2##(2008-10#1)(2012-12#2)(2013-1#1)
Myeloid##6##1##(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
Myeloma##5##1##(2010-11#2)(2010-9#1)(2011-2#1)(2013-1#1)
Myelopathy##2##1##(2008-12#1)(2013-1#1)
Myelosuppression was##2##2##(2007-11#1)(2008-6#1)
Myf-5 or MyoD##2##3##(1993-12#2)
Myf-5##5##1##(1993-12#5)
Myf5 and MyoD##3##3##(2009-3#3)
Myf5 and myogenin##2##3##(1996-2#2)
Myf5 and##5##2##(1996-2#2)(2009-3#3)
Myf5##10##1##(1996-2#6)(2009-3#4)
Myiasis##4##1##(2007-7#1)(2008-12#1)(2008-2#1)(2013-1#1)
Myo-D1 and##2##2##(1993-2#2)
Myo-D1 gene##2##2##(1993-2#2)
Myo-D1##14##1##(1993-2#10)(1994-12#4)
Myo31DF##2##1##(2008-10#2)
MyoD##11##1##(1993-12#6)(1996-2#1)(2008-7#1)(2009-3#3)
MyoD1 expression##2##2##(1992-8#2)
MyoD1##5##1##(1992-8#5)
Myocardial Contrast Echocardiography##2##3##(2010-8#1)(2011-2#1)
Myocardial Infarction##5##2##(2008-11#1)(2008-12#2)(2008-3#1)(2012-3#1)
Myocardial infarction##2##2##(1991-3#1)(1997-8#1)
Myocardial protection##2##2##(1996-9#1)(2007-9#1)
Myocardial##36##1##(1991-3#1)(1991-9#2)(1992-3#1)(1992-5#1)(1996-9#6)(1997-6#2)(1997-8#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-8#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
Myocarditis##5##1##(2008-11#2)(2010-5#2)(2010-7#1)
Myocytes##2##1##(1995-5#1)(1996-9#1)
Myoepithelioma of##2##2##(2008-4#1)(2013-8#1)
Myoepithelioma##3##1##(2008-4#2)(2013-8#1)
Myofibroma##3##1##(2010-6#2)(2011-1#1)
Myogenic##2##1##(1995-6#1)(2008-5#1)
Myoglobin##2##1##(1997-7#1)(2008-10#1)
Myomectomy##2##1##(1994-9#1)(2010-11#1)
Myopia##2##1##(2010-1#1)(2011-1#1)
Myosin V##2##2##(2012-2#2)
Myosin heavy chain##2##3##(2008-5#1)(2013-8#1)
Myosin##10##1##(1992-4#1)(1994-5#1)(1996-9#1)(2008-10#3)(2008-5#1)(2012-2#2)(2013-8#1)
Myosins##2##1##(2008-10#1)(2008-11#1)
Myotis##2##1##(2008-5#1)(2013-1#1)
Myr##3##1##(1993-12#1)(1997-5#2)
Myristica fragrans##2##2##(2008-5#2)
Myrosma##2##1##(2008-5#2)
Mystery##2##1##(2007-2#1)(2008-10#1)
Myth##2##1##(2007-12#1)(2007-5#1)
Mythimna separata##2##2##(2008-11#2)
Myths and##4##2##(1995-1#1)(2007-4#1)(2010-11#2)
Myths##8##1##(1991-3#1)(1993-12#1)(1995-1#1)(2007-4#1)(2009-9#1)(2010-11#2)(2010-6#1)
Mytilus##4##1##(1995-12#1)(1995-8#1)(2008-11#1)(2010-5#1)
Myxobacter Sp##3##2##(2009-3#3)
Myxoid##2##1##(2008-6#1)(2013-1#1)
Myxoviruses##2##1##(2012-2#2)
Myzus persicae##5##2##(2008-10#4)(2009-8#1)
Mz2-12##2##1##(1994-6#2)
Málaga##3##1##(1997-6#1)(2008-10#2)
Mário Viana&quot##2##2##(2008-5#2)
Mäntele##3##1##(1992-6#3)
Mäori and##2##2##(2008-1#2)
Mäori children##3##2##(2008-1#3)
Mäori##13##1##(2008-1#11)(2012-12#2)
Médica de##4##2##(2013-1#4)
Mérida##5##1##(2007-10#2)(2008-10#2)(2008-9#1)
México and##2##2##(2011-1#1)(2012-12#1)
México##5##1##(2008-3#1)(2008-5#2)(2011-1#1)(2012-12#1)
México]##2##1##(2008-5#1)(2012-12#1)
Mössbauer##4##1##(1992-8#1)(1996-2#1)(2006-4#2)
Müller cell##5##2##(1996-5#1)(2008-4#1)(2008-7#3)
Müller cells##8##2##(1991-10#1)(2008-5#3)(2008-7#4)
Müller##16##1##(1991-10#1)(1996-5#1)(2008-4#2)(2008-5#3)(2008-7#7)(2011-2#1)(2013-8#1)
Müllerian duct##3##2##(2008-10#3)
Müllerian##7##1##(2008-10#4)(2011-2#2)(2013-1#1)
Münchhausen's syndrome##3##2##(1995-5#3)
Māori and non-Māori##2##3##(2012-12#2)
Māori##6##1##(2012-12#6)
N &lt##3##2##(1997-6#1)(2008-2#2)
N (approximately##2##2##(2007-8#2)
N (comparing##2##2##(2012-9#2)
N = 149) = 4##2##5##(2010-3#2)
N = 149) =##5##4##(2010-3#5)
N = 36 plants)##2##4##(2008-5#2)
N =##32##2##(1990-7#1)(1994-1#4)(1994-11#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#5)(2009-1#1)(2009-4#1)(2009-5#1)(2009-9#6)(2010-3#5)(2013-1#1)
N Vpu##2##2##(2013-1#2)
N activity##2##2##(1990-2#1)(2008-11#1)
N and NSC concentrations##2##4##(2012-5#2)
N and NSC##4##3##(2012-5#4)
N and P##3##3##(2008-12#1)(2008-5#2)
N and the##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
N and##31##2##(1990-11#1)(1995-5#2)(1997-8#1)(2008-10#9)(2008-12#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-2#1)(2011-1#2)(2012-2#1)(2012-5#5)
N application rate##2##3##(2008-12#2)
N application##3##2##(2008-12#3)
N are##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
N at 180 mg/liter##2##4##(2008-10#2)
N at##3##2##(2008-10#3)
N can##2##2##(2008-10#2)
N concentration of 360##2##4##(2008-10#2)
N concentration of##3##3##(2008-10#3)
N concentration##5##2##(2008-10#3)(2008-2#1)(2012-9#1)
N content##2##2##(2012-8#2)
N epsilon 2 of##2##4##(1991-3#2)
N epsilon##4##2##(1991-3#2)(1994-5#1)(1995-3#1)
N for##2##2##(2008-10#2)
N gene##7##2##(2008-10#7)
N in the##4##3##(2008-2#1)(2011-1#1)(2012-8#1)(2013-1#1)
N in##8##2##(1995-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-8#2)(2013-1#1)
N is the number of##3##5##(2007-11#1)(2008-8#1)(2009-12#1)
N is the##4##3##(2007-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
N is##8##2##(2007-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#1)(2011-1#1)
N metabolism##3##2##(2008-12#1)(2012-1#1)(2012-9#1)
N neurons on##3##3##(1997-3#3)
N of##2##2##(2008-10#1)(2008-2#1)
N omega-nitro-L-arginine methyl ester##2##4##(1996-5#2)
N omega-nitro-L-arginine##3##2##(1995-2#1)(1996-5#2)
N or##2##2##(1992-11#1)(2008-10#1)
N protein##6##2##(2008-10#6)
N proteins##2##2##(2008-10#2)
N sampling units##3##3##(2008-10#3)
N sampling##4##2##(2008-10#3)(2008-3#1)
N sources##2##2##(2008-10#2)
N stage##3##2##(1991-8#3)
N supply##2##2##(2008-5#1)(2013-8#1)
N terminal##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
N terminus##10##2##(1990-5#1)(1992-4#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-6#2)(2008-10#2)(2008-6#1)
N to##2##2##(2008-10#2)
N uptake##2##2##(2008-12#1)(2012-1#1)
N was##2##2##(2007-11#1)(2008-5#1)
N##651##1##(1990-11#2)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#6)(1993-2#1)(1993-5#1)(1993-8#2)(1994-1#4)(1994-11#2)(1994-12#1)(1994-5#5)(1994-8#4)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#10)(1995-5#9)(1995-6#3)(1995-8#3)(1996-1#2)(1996-12#1)(1996-2#8)(1996-3#1)(1996-5#4)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-11#10)(2007-12#10)(2007-2#2)(2007-3#1)(2007-8#5)(2008-10#237)(2008-11#5)(2008-12#28)(2008-2#17)(2008-3#19)(2008-4#2)(2008-5#38)(2008-6#6)(2008-7#4)(2008-8#9)(2008-9#9)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-9#7)(2010-2#4)(2010-3#7)(2010-5#1)(2010-7#4)(2010-8#4)(2011-1#10)(2011-2#4)(2012-1#8)(2012-12#1)(2012-2#8)(2012-3#8)(2012-5#5)(2012-8#9)(2012-9#7)(2013-1#11)(2013-8#4)
N&quot##4##1##(1993-8#2)(2008-12#2)
N' = 4##2##3##(2008-2#2)
N'##30##1##(1993-12#2)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#15)(2008-12#1)(2008-2#3)(2008-5#3)(2009-11#1)(2009-2#1)(2013-1#1)
N''##3##1##(2008-10#3)
N''-pentaacetic##2##1##(2008-10#2)
N'-(o-phenylene)-bis-benzenesulfonamide##2##1##(2008-10#2)
N'-bis(2-hydroxy-3-sulfopropyl)tolidine##2##1##(2008-10#2)
N'-bis(2-hydroxy-5-bromo-benzyl)1##2##1##(2008-10#2)
N'-bis(2-hydroxyl-3-sulfopropyl)-tolidine##2##1##(2008-10#2)
N'-bis(2-hydroxyphenylmethyl)-N##2##1##(2008-10#2)
N'-bis(2-pyridylmethyl)-1##2##1##(2008-10#2)
N'-bis(salicylidene)-2##2##1##(2008-10#2)
N'-di-3-propionate##2##1##(2008-10#2)
N'-dialkylbenzylethylenediamine (alkyl=butyl##2##2##(2008-10#2)
N'-dialkylbenzylethylenediamine##3##1##(2008-10#3)
N'-dibenzyl-1##2##1##(2008-10#2)
N'-dibenzyl-18-crown-6##2##1##(2008-10#2)
N'-dinaphthyl-N##2##1##(2008-10#2)
N'-diphenyl-3##2##1##(2008-10#2)
N'-diphenylbenzamidine##2##1##(2008-10#2)
N'-disalicylidene-1##2##1##(2008-10#2)
N'-oxy-DM-bis (2-TFMA)##2##2##(1995-3#2)
N'-oxy-DM-bis##3##1##(1995-3#3)
N'-oxydimethylenebis(2-trifluoromethylaniline)##2##1##(1995-3#2)
N'-tetraacetate##2##1##(2008-10#2)
N'-tetraacetic acid##4##2##(1996-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
N'-tetraoctyl diglycolamide##2##2##(2008-10#2)
N(1) of the coenzyme##2##4##(1992-6#2)
N(1)##3##1##(1992-6#2)(2008-10#1)
N(1)-oxide##4##1##(2008-10#4)
N(1/2)##2##1##(2008-3#2)
N(2) adsorption-desorption isotherms and##2##4##(2008-10#1)(2009-11#1)
N(2) adsorption-desorption##4##2##(2008-10#3)(2009-11#1)
N(2) and Ar##2##3##(2008-3#2)
N(2) and##7##2##(2007-12#1)(2008-10#2)(2008-3#3)(2010-12#1)
N(2) cleavage##2##2##(2010-12#2)
N(2) in##2##2##(2007-12#1)(2008-3#1)
N(2) were##2##2##(2008-2#1)(2008-3#1)
N(2)##44##1##(1997-6#1)(2007-12#6)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#15)(2008-9#1)(2009-11#1)(2010-12#4)(2011-1#1)(2012-8#1)
N(2))##2##1##(2008-10#1)(2013-1#1)
N(2)/CH(4) gas flow##2##3##(2008-10#2)
N(2)/CH(4)##4##1##(2008-10#4)
N(2)H(5)(+)##2##1##(2008-10#2)
N(2)O and CH(4)##2##3##(2007-12#1)(2008-3#1)
N(2)O treatment##2##2##(2009-12#2)
N(2)O##15##1##(2007-12#2)(2008-2#1)(2008-3#5)(2009-12#5)(2012-2#2)
N(2)O-treated##2##1##(2009-12#2)
N(3)##3##1##(2008-8#1)(2011-1#2)
N(6)##4##1##(2008-8#1)(2012-2#3)
N(7)- and N(9)-acyclonucleosides##2##3##(1994-8#2)
N(G)-hydroxy-L-arginine##3##1##(2008-10#1)(2010-12#2)
N(G)-nitro-L-arginine methyl ester (L-NAME)##2##4##(1995-12#1)(2008-11#1)
N(G)-nitro-L-arginine methyl ester##3##3##(1995-12#2)(2008-11#1)
N(G)-nitro-L-arginine methylester##2##2##(1997-7#2)
N(G)-nitro-L-arginine##7##1##(1995-12#2)(1997-2#2)(1997-7#2)(2008-11#1)
N(e)##5##1##(2008-3#1)(2009-3#1)(2013-1#3)
N(m)##2##1##(2008-10#2)
N(max)##2##1##(2008-3#1)(2011-2#1)
N(p)##4##1##(1997-6#3)(2008-3#1)
N) and##2##2##(2008-10#1)(2008-5#1)
N)##15##1##(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#1)(2013-8#1)
N+TT##2##1##(2011-1#2)
N- and C-terminal##8##3##(1990-7#1)(1991-5#1)(1992-6#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-4#1)(2013-1#1)
N- and C-termini##2##3##(1997-4#1)(2011-2#1)
N- and O-linked##2##3##(1992-6#1)(2008-1#1)
N- and##17##2##(1990-7#1)(1991-5#1)(1992-6#3)(1994-5#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
N- or C-terminal##3##3##(1996-12#1)(1996-6#1)(2011-2#1)
N- or##4##2##(1991-5#1)(1996-12#1)(1996-6#1)(2011-2#1)
N-##24##1##(1990-7#1)(1991-12#2)(1991-5#2)(1992-6#3)(1993-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-1#1)
N-(1'##2##1##(1995-3#1)(2012-12#1)
N-(2##2##1##(1990-8#1)(2008-10#1)
N-(2-mercapto-2-methylpropanoyl)-L-cysteine (bucillamine)##2##2##(1994-5#1)(1995-3#1)
N-(3##2##1##(2008-10#1)(2008-5#1)
N-(4-nitrophenyl)-L-prolinol##3##1##(2007-12#3)
N-(5-dimethylamine-1-naphthalenesulfonylo)-1##2##1##(2008-10#2)
N-(phosphonomethyl)glycine##2##1##(2008-10#2)
N-1##6##1##(2008-10#6)
N-1-naphthyl ethylene diamine dihydrochloride##2##4##(2008-10#2)
N-3##2##1##(2008-3#1)(2013-1#1)
N-Ac-4-S-CAP in pigmented melanoma##2##4##(1992-3#2)
N-Ac-4-S-CAP in##3##2##(1992-3#3)
N-Acetylated##2##1##(1990-8#1)(1994-3#1)
N-Acetylcysteine##3##1##(1991-9#3)
N-CAM enriched##2##2##(1995-12#2)
N-CDAD was##2##2##(2007-12#2)
N-CDAD##9##1##(2007-12#9)
N-Cn-glucosylamines##3##1##(1990-5#3)
N-Gas Model##3##2##(1996-12#3)
N-Gas##4##1##(1996-12#4)
N-H##3##1##(1995-11#1)(2007-11#1)(2008-5#1)
N-MYR##3##1##(2009-8#3)
N-Me-Phe4##2##1##(1995-12#1)(1996-2#1)
N-Methyl-D-aspartate (NMDA##2##2##(1995-12#2)
N-N rotation##2##2##(1996-5#2)
N-N##5##1##(1996-5#2)(2008-10#3)
N-Nitrosamines##2##1##(2008-12#1)(2008-5#1)
N-Nitroso##2##1##(1992-8#2)
N-Nitroso-2##2##1##(1996-5#2)
N-Nitroso-N-methylurea##2##1##(2013-1#2)
N-O##2##1##(1992-10#1)(2009-11#1)
N-Terminal amino acid##2##3##(1992-3#1)(1993-11#1)
N-Terminal sequence analysis of##2##4##(1992-8#1)(1994-6#1)
N-Terminal##5##1##(1992-3#1)(1992-8#1)(1993-11#1)(1994-6#1)(2008-10#1)
N-Vpus##3##1##(2013-1#3)
N-acetyl benzothiazole##2##2##(2010-2#2)
N-acetyl galactosamine##2##2##(1994-11#2)
N-acetyl##14##1##(1990-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-11#3)(1994-2#1)(1994-8#1)(2008-8#1)(2010-11#1)(2010-2#2)
N-acetyl-4-S-cysteaminylphenol##2##1##(1992-3#2)
N-acetyl-D-glucosamine##5##1##(1990-11#1)(1992-6#1)(1994-5#1)(1997-3#1)(2008-10#1)
N-acetyl-L-cysteine (NAC)##2##2##(2008-11#2)
N-acetyl-L-cysteine##8##1##(1991-9#1)(1994-5#1)(1994-6#1)(1996-12#2)(2008-11#3)
N-acetyl-beta-D-glucosaminidase (NAG)##2##2##(1994-5#1)(1996-12#1)
N-acetyl-beta-D-glucosaminidase activity##2##2##(1990-12#2)
N-acetyl-beta-D-glucosaminidase##8##1##(1990-12#5)(1994-5#1)(1996-12#1)(2013-8#1)
N-acetyl-beta-D-hexosaminidase B##4##2##(1990-5#4)
N-acetyl-beta-D-hexosaminidase##5##1##(1990-5#4)(1997-6#1)
N-acetyl-cysteine##4##1##(1993-12#1)(2008-5#3)
N-acetyl-d-glucosamine##4##1##(2008-10#3)(2012-2#1)
N-acetyl-d-neuraminic acid##2##2##(2012-2#2)
N-acetyl-galactosamine##2##1##(1991-9#1)(2008-5#1)
N-acetyl-glucosamine##2##1##(1991-9#1)(2008-5#1)
N-acetyl-p-benzoquinoneimine##2##1##(2008-10#2)
N-acetylaspartate (NAA)##2##2##(2007-10#1)(2008-7#1)
N-acetylaspartate production##3##2##(1996-5#3)
N-acetylaspartate##7##1##(1996-5#4)(2007-10#2)(2008-7#1)
N-acetylated##6##1##(1992-6#1)(1993-5#1)(1994-3#2)(2008-4#2)
N-acetylcysteine (NAC)##3##2##(1991-9#2)(2008-10#1)
N-acetylcysteine and##4##2##(1991-9#2)(2008-10#1)(2008-11#1)
N-acetylcysteine in##5##2##(1991-9#5)
N-acetylcysteine increases##2##2##(1991-9#2)
N-acetylcysteine may##2##2##(1991-9#2)
N-acetylcysteine or##2##2##(1991-9#2)
N-acetylcysteine##44##1##(1991-11#4)(1991-9#25)(1992-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#6)(2008-11#1)(2009-4#1)(2012-12#1)(2012-3#1)
N-acetylgalactosamine##5##1##(1992-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
N-acetylglucosamine and##2##2##(1990-2#1)(1992-9#1)
N-acetylglucosamine##18##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-9#3)(1996-12#1)(1997-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)
N-acetylimidazole##3##1##(2008-4#3)
N-acetyllactosamine##2##1##(1993-11#2)
N-acetylneuraminic acid##4##2##(1993-11#2)(1995-12#2)
N-acetylserotonin##2##1##(1991-12#2)
N-acetyltransferase (NAT) activity##2##3##(1994-2#1)(1995-3#1)
N-acetyltransferase (NAT)##3##2##(1994-2#1)(1995-11#1)(1995-3#1)
N-acetyltransferase (NAT2)##2##2##(1993-3#1)(1995-9#1)
N-acetyltransferase##9##1##(1993-3#2)(1994-2#1)(1995-11#2)(1995-3#1)(1995-9#1)(2008-5#2)
N-acy-l-homoserine##2##1##(2013-1#2)
N-acyl homoserine lactones##2##3##(2008-10#1)(2008-9#1)
N-acyl##3##1##(1993-11#1)(2008-10#1)(2008-9#1)
N-alkyl 1- and 2-benzazepinones##2##4##(1994-11#2)
N-alkyl##4##1##(1994-11#2)(1995-3#1)(2008-10#1)
N-alkylated##2##1##(2007-11#2)
N-alkylation##2##1##(2007-11#1)(2008-10#1)
N-ammin-nickel(II)##2##1##(2008-10#2)
N-and##2##1##(1992-6#1)(1993-3#1)
N-aryl-2-[[[5-[(dimethylamino)methyl]-2-##3##1##(1992-8#3)
N-benzoyl-N-phenylhydroxylamine##2##1##(2008-10#2)
N-bromoacetyl 5-methoxytryptamine##2##2##(1993-6#2)
N-bromosuccinimide (NBS) or##2##3##(2008-10#2)
N-bromosuccinimide (NBS)##4##2##(1992-6#1)(2008-10#3)
N-bromosuccinimide##10##1##(1992-6#1)(2008-10#9)
N-bromosuccinimide-luminol##2##1##(2008-10#2)
N-cadherin##4##1##(2008-8#4)
N-chlorohydantoins##2##1##(2010-2#2)
N-chlorosuccinimide##3##1##(2008-10#3)
N-containing##3##1##(2008-10#3)
N-dealkylated##2##1##(2011-3#2)
N-dibutyl##2##1##(2008-10#2)
N-dibutyl-N'-benzoylthiourea##3##1##(2008-10#3)
N-diethyl-1##2##1##(2008-10#2)
N-diethyl-m-toluamide##2##1##(1991-9#1)(2008-5#1)
N-diethyl-p-phenylenediamine##2##1##(2008-10#2)
N-diisopropylphosphoramidite##2##1##(2008-4#2)
N-dimethyl-p-phenylenediamine in the presence of##2##5##(2008-10#2)
N-dimethyl-p-phenylenediamine##3##1##(2008-10#3)
N-dimethylaniline (DMA) to form##2##4##(2008-10#2)
N-dimethylaniline##5##1##(2008-10#5)
N-dimethylaniline)-chloramine-T reaction##2##2##(2008-10#2)
N-dimethylenephosphonic acid##2##2##(2008-10#2)
N-dimethylformamide (DMF)##2##2##(2008-10#2)
N-dimethylformamide##11##1##(2007-11#1)(2008-10#9)(2009-9#1)
N-ethyl-N-nitrosourea (ENU)##2##2##(1992-9#1)(2008-4#1)
N-ethylmaleimide (NEM)##2##2##(1990-2#1)(1995-8#1)
N-ethylmaleimide##9##1##(1990-11#2)(1990-2#2)(1990-7#1)(1995-8#2)(2008-5#1)(2009-8#1)
N-ethylmalemide##2##1##(1993-11#1)(2008-11#1)
N-fatty acyl##3##2##(1990-12#2)(1995-6#1)
N-fatty##4##1##(1990-12#2)(1995-6#2)
N-formyl-Met-Leu-Phe##2##1##(1993-6#1)(1996-2#1)
N-formylamino acids##5##2##(2008-10#5)
N-gene transgenic##2##2##(2008-10#2)
N-gene##3##1##(1992-12#1)(2008-10#2)
N-glycan processing##2##2##(1995-2#2)
N-glycan structures##2##2##(2008-11#2)
N-glycan##6##1##(1995-2#2)(2008-11#4)
N-glycanase##4##1##(1990-11#1)(1991-12#1)(1995-11#1)(1995-6#1)
N-glycans##2##1##(1992-12#1)(1995-2#1)
N-glycolyl-##2##1##(1993-11#2)
N-glycosidase F##2##2##(1991-12#1)(2008-4#1)
N-glycosidase mechanism##2##2##(2008-8#2)
N-glycosidase##8##1##(1990-11#1)(1991-12#1)(1992-3#2)(1994-11#1)(2008-4#1)(2008-8#2)
N-glycosylated##3##1##(1994-11#1)(1994-8#1)(2008-11#1)
N-glycosylation of ZP glycoproteins##2##4##(2013-1#2)
N-glycosylation of zona##2##3##(2013-1#2)
N-glycosylation of##5##2##(1992-6#1)(2013-1#4)
N-glycosylation sites##4##2##(1991-12#1)(1991-6#1)(1993-8#1)(2011-2#1)
N-glycosylation##19##1##(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#2)(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#8)
N-heterocyclic carbene##2##2##(2010-3#1)(2010-7#1)
N-heterocyclic##5##1##(2010-3#1)(2010-5#1)(2010-7#1)(2012-12#2)
N-hydroxy##4##1##(1992-6#4)
N-hydroxy-2-aminofluorene##2##1##(1993-11#2)
N-hydroxyethylethylenediamine##2##1##(2008-10#2)
N-lauroylsarcosinate##2##1##(2012-2#2)
N-linkage to##2##2##(1994-8#1)(2008-4#1)
N-linked carbohydrate chain##2##3##(1990-11#1)(1990-5#1)
N-linked carbohydrate##3##2##(1990-11#1)(1990-5#1)(2008-4#1)
N-linked glycan##2##2##(1994-5#2)
N-linked glycosylation and##2##3##(1996-12#1)(2008-11#1)
N-linked glycosylation of##3##3##(1992-12#2)(2008-4#1)
N-linked glycosylation site of##2##4##(1994-11#2)
N-linked glycosylation sites##4##3##(1992-12#1)(1992-9#1)(1993-2#1)(2008-9#1)
N-linked glycosylation##18##2##(1992-12#4)(1992-9#1)(1993-2#1)(1994-11#2)(1994-8#1)(1995-2#2)(1996-12#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)
N-linked oligosaccharide biosynthesis##2##3##(2008-7#2)
N-linked oligosaccharide chains##4##3##(1992-12#1)(2008-11#1)(2008-4#2)
N-linked oligosaccharide##9##2##(1992-12#2)(1994-5#1)(2008-11#1)(2008-4#2)(2008-7#3)
N-linked oligosaccharides##3##2##(1992-10#1)(1992-12#1)(1993-11#1)
N-linked##45##1##(1990-11#1)(1990-5#2)(1991-9#1)(1992-10#1)(1992-12#7)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-5#4)(1994-8#1)(1995-2#2)(1996-12#1)(2008-11#6)(2008-4#5)(2008-7#7)(2008-9#1)
N-methyl##6##1##(1993-12#1)(1995-11#1)(1995-12#3)(2010-5#1)
N-methyl-D-aspartate (NMDA) glutamate receptor antagonist##2##5##(1994-8#1)(2012-12#1)
N-methyl-D-aspartate (NMDA) glutamate receptor##3##4##(1994-8#1)(1997-6#1)(2012-12#1)
N-methyl-D-aspartate (NMDA) receptor##5##3##(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)
N-methyl-D-aspartate (NMDA) receptors##3##3##(2009-8#1)(2011-1#1)(2012-2#1)
N-methyl-D-aspartate (NMDA)##22##2##(1992-8#1)(1994-8#3)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#3)(1997-6#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
N-methyl-D-aspartate and##2##2##(1990-7#1)(1995-12#1)
N-methyl-D-aspartate receptor##7##2##(1990-7#2)(1994-8#1)(1996-2#1)(1997-2#1)(2009-8#1)(2012-2#1)
N-methyl-D-aspartate##38##1##(1990-7#3)(1990-8#1)(1991-12#1)(1992-8#1)(1994-8#6)(1995-12#5)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-2#4)(1997-6#1)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-2#3)
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)##3##2##(1995-9#1)(1997-4#2)
N-methyl-N'-nitro-N-nitrosoguanidine##6##1##(1992-3#1)(1995-9#1)(1997-3#1)(1997-4#2)(2008-10#1)
N-methyl-d-aspartate##2##1##(2008-7#1)(2012-2#1)
N-methyl-d-glucamine##3##1##(2008-10#3)
N-methyl-scopolamine##2##1##(1992-11#2)
N-methylated phospholipids##2##2##(1990-7#2)
N-methylated##4##1##(1990-7#2)(1991-8#1)(2008-9#1)
N-methyltransferase##4##1##(1991-5#1)(1996-5#1)(2013-1#1)(2013-8#1)
N-myc and c-myc##3##3##(1991-4#3)
N-myc##11##1##(1991-4#4)(1991-9#1)(1992-6#1)(1992-8#1)(1994-10#4)
N-myristoyl##3##1##(1990-12#2)(2009-8#1)
N-myristoylation sites##2##2##(2008-12#2)
N-myristoylation##5##1##(2008-12#2)(2009-8#3)
N-n-Octylaniline in xylene is used for##2##6##(2008-10#2)
N-n-octylaniline in##2##2##(2008-10#2)
N-n-octylaniline##8##1##(2008-10#8)
N-nitro-L-arginine methyl ester and naloxone##2##5##(1995-12#2)
N-nitro-L-arginine methyl ester##3##3##(1995-12#3)
N-nitrosamine##3##1##(1990-6#1)(2008-12#2)
N-nitrosamines##3##1##(1996-5#1)(2008-12#1)(2008-5#1)
N-nitroso##2##1##(2008-5#1)(2010-8#1)
N-nitrosoamines##3##1##(2008-10#3)
N-octanoylaminopropyl##2##1##(1990-8#2)
N-oxide at the formazyl carbon##2##5##(2008-10#2)
N-oxide metabolite in human plasma##2##5##(2008-10#2)
N-oxide##20##1##(1994-3#1)(1995-3#5)(1996-2#1)(2008-10#12)(2008-6#1)
N-oxides##3##1##(1995-3#1)(2008-10#1)(2013-8#1)
N-phenyl-2-cyano-1-azadiene 4##2##2##(1996-5#2)
N-ras gene##3##2##(1995-2#2)(2008-9#1)
N-ras##9##1##(1990-9#1)(1992-9#2)(1995-2#5)(2008-9#1)
N-salicylideneamine derivatives##2##2##(2007-11#2)
N-substituted##5##1##(1991-5#1)(1992-11#1)(1995-3#1)(1997-2#1)(2007-11#1)
N-terminal 153##2##2##(2008-8#2)
N-terminal aa sequence of##2##4##(1990-5#1)(1994-12#1)
N-terminal aa##3##2##(1990-11#1)(1990-5#1)(1994-12#1)
N-terminal amino acid sequence of the##3##6##(1991-12#1)(2008-6#1)(2009-2#1)
N-terminal amino acid sequence of##4##5##(1990-11#1)(1991-12#1)(2008-6#1)(2009-2#1)
N-terminal amino acid sequence##9##4##(1990-11#1)(1991-12#1)(1991-2#1)(1993-11#1)(1994-12#1)(1995-8#1)(1996-10#1)(2008-6#1)(2009-2#1)
N-terminal amino acid sequences of##3##5##(1993-9#1)(1997-4#1)(1997-6#1)
N-terminal amino acid sequences##4##4##(1992-8#1)(1993-9#1)(1997-4#1)(1997-6#1)
N-terminal amino acid##17##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-8#2)(1996-10#1)(1997-4#1)(1997-6#1)(2008-6#1)(2009-2#1)
N-terminal amino acids##2##3##(1994-6#1)(2008-8#1)
N-terminal amino##19##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-8#2)(1996-10#1)(1997-4#1)(1997-6#1)(2008-6#1)(2008-8#1)(2009-2#1)
N-terminal amphiphilic sequence##2##3##(1991-10#2)
N-terminal amphiphilic##4##2##(1991-10#4)
N-terminal and C-terminal domains of##2##5##(1992-9#1)(1995-2#1)
N-terminal and C-terminal##3##3##(1992-9#1)(1995-2#1)(2008-6#1)
N-terminal and##7##2##(1992-11#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-6#1)
N-terminal arm##5##2##(1995-5#2)(2008-9#3)
N-terminal domain of NifA##2##4##(2008-9#2)
N-terminal domain of pepsin##2##4##(1990-2#2)
N-terminal domain of the##5##4##(1992-4#1)(1992-8#1)(2006-6#2)(2012-2#1)
N-terminal domain of##19##3##(1990-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1994-8#1)(1997-7#1)(2006-6#3)(2008-9#3)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
N-terminal domain##29##2##(1990-2#2)(1990-5#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-6#1)(1997-7#1)(2006-6#3)(2008-4#1)(2008-8#1)(2008-9#3)(2009-7#4)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#2)
N-terminal end##4##2##(1991-9#1)(1993-8#1)(1995-11#1)(1995-8#1)
N-terminal extension of##2##3##(1991-6#1)(1992-3#1)
N-terminal extension##4##2##(1991-6#2)(1992-3#1)(1994-9#1)
N-terminal extracellular or C-terminal intracellular domains##2##6##(1992-9#2)
N-terminal extracellular##5##2##(1991-12#2)(1992-9#3)
N-terminal fragment##2##2##(2008-5#1)(2008-7#1)
N-terminal half##7##2##(1994-2#1)(1995-8#1)(1997-2#1)(2008-10#3)(2011-1#1)
N-terminal kinase##5##2##(2008-4#2)(2010-12#1)(2011-2#1)(2013-7#1)
N-terminal kinases##3##2##(1995-2#1)(2012-12#1)(2012-2#1)
N-terminal of##4##2##(1990-2#1)(2006-6#1)(2008-11#1)(2008-8#1)
N-terminal or##2##2##(1992-9#1)(2008-9#1)
N-terminal peptide fragments##2##3##(2008-8#2)
N-terminal peptide##3##2##(1996-12#1)(2008-8#2)
N-terminal peptides##2##2##(1990-7#2)
N-terminal portion of the##3##4##(1991-9#1)(1994-12#1)(1994-6#1)
N-terminal pro-B-type natriuretic peptide##4##4##(2008-7#1)(2011-2#2)(2012-2#1)
N-terminal region of##8##3##(1991-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1996-3#1)(2008-10#1)(2009-7#2)
N-terminal region##17##2##(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#2)(2008-10#2)(2008-11#1)(2009-7#2)
N-terminal regions##2##2##(1991-10#1)(2008-10#1)
N-terminal residue##2##2##(1997-6#1)(2008-8#1)
N-terminal residues##2##2##(1994-11#1)(1994-5#1)
N-terminal segment##2##2##(1991-5#1)(2008-8#1)
N-terminal sequence analysis##3##3##(1990-12#1)(1990-8#1)(1991-9#1)
N-terminal sequence of the##4##4##(1991-10#1)(1991-11#1)(1992-11#1)(1994-11#1)
N-terminal sequence of##7##3##(1990-12#1)(1991-10#1)(1991-11#1)(1992-11#1)(1994-11#1)(1994-12#1)(2008-10#1)
N-terminal sequence##21##2##(1990-12#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1997-6#3)(2008-10#1)
N-terminal sequences that##2##3##(1993-2#1)(1996-3#1)
N-terminal sequences##4##2##(1990-2#1)(1993-2#1)(1996-3#1)(1997-7#1)
N-terminal sequencing of##2##3##(1990-2#1)(1995-5#1)
N-terminal sequencing##7##2##(1990-11#1)(1990-2#1)(1993-12#1)(1994-8#1)(1995-5#1)(1997-8#1)(2008-10#1)
N-terminal signal sequence##2##3##(1993-12#1)(1994-12#1)
N-terminal to the##3##3##(1992-10#1)(1994-9#1)(1995-12#1)
N-terminal to##4##2##(1992-10#2)(1994-9#1)(1995-12#1)
N-terminal truncated##5##2##(1995-2#5)
N-terminal##271##1##(1990-11#3)(1990-12#2)(1990-2#6)(1990-5#2)(1990-7#8)(1990-8#2)(1991-10#8)(1991-11#2)(1991-12#3)(1991-2#1)(1991-5#4)(1991-6#2)(1991-9#4)(1992-10#2)(1992-11#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#7)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#8)(1994-2#1)(1994-5#5)(1994-6#7)(1994-8#6)(1994-9#3)(1995-11#2)(1995-12#3)(1995-2#10)(1995-3#2)(1995-5#5)(1995-6#6)(1995-8#4)(1996-10#1)(1996-12#2)(1996-3#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#7)(1997-7#4)(1997-8#1)(2006-6#4)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#1)(2010-10#2)(2010-12#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#5)(2013-7#1)
N-terminally elongated fragments of galanin(1-16)##2##5##(1994-8#2)
N-terminally elongated##4##2##(1994-8#4)
N-terminally##9##1##(1990-7#1)(1994-5#1)(1994-8#5)(2008-4#1)(2008-8#1)
N-termini of##3##2##(1990-2#1)(1991-12#1)(1991-6#1)
N-termini##4##1##(1990-2#1)(1991-12#1)(1991-6#1)(2009-5#1)
N-terminus consisting of##2##3##(1990-12#2)
N-terminus of the flagellins from##2##5##(1990-2#2)
N-terminus of the##6##3##(1990-2#3)(1992-6#1)(1997-3#1)(2008-10#1)
N-terminus of##15##2##(1990-2#4)(1990-7#1)(1990-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
N-terminus that##2##2##(1990-5#1)(2010-11#1)
N-terminus##44##1##(1990-11#1)(1990-12#3)(1990-2#4)(1990-5#2)(1990-7#4)(1990-8#2)(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-8#1)(1997-3#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-7#1)(2008-8#3)(2008-9#4)(2010-11#2)(2012-2#1)
N-type Ca2+ channels##2##3##(1993-11#1)(1996-5#1)
N-type Ca2+##3##2##(1993-11#1)(1996-5#2)
N-type calcium channels in##3##4##(1993-9#2)(2008-8#1)
N-type calcium channels##4##3##(1993-9#2)(2008-8#2)
N-type channel##3##2##(2008-8#3)
N-type##14##1##(1993-11#2)(1993-9#3)(1996-5#2)(2008-10#1)(2008-8#6)
N-unprotected##3##1##(2008-4#3)
N/P##3##1##(2008-5#2)(2012-2#1)
N/mm##7##1##(2007-12#1)(2009-4#6)
N/s##2##1##(2009-4#1)(2012-3#1)
N0 and N1##2##3##(1990-6#1)(1991-8#1)
N0##5##1##(1990-6#1)(1991-8#2)(1993-1#1)(2007-8#1)
N1 and##3##2##(1990-6#1)(1993-1#1)(2008-8#1)
N1 to##2##2##(1997-1#1)(2007-8#1)
N1##17##1##(1990-6#3)(1991-3#1)(1991-8#2)(1993-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-4#1)(2008-8#3)
N1-acetyltransferase##7##1##(1991-9#3)(1992-10#2)(1995-2#2)
N1-guanyl-1##2##1##(1997-1#2)
N100m to##2##2##(1996-5#2)
N100m##4##1##(1996-5#4)
N170##2##1##(2007-8#2)
N17Ras##2##1##(1994-8#2)
N1E-115 cells##2##2##(1994-11#2)
N1E-115##4##1##(1992-6#2)(1994-11#2)
N1E115##2##1##(1993-3#2)
N1S1##3##1##(1994-6#3)
N1c##3##1##(2013-1#3)
N1d##3##1##(2013-1#3)
N2 and##4##2##(1990-6#1)(1991-8#1)(1993-11#1)(2008-10#1)
N2 disease##2##2##(2007-8#2)
N2 strains##4##2##(2008-10#4)
N2##30##1##(1990-6#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-3#2)(2013-8#3)
N23 cells##2##2##(1990-11#2)
N23##3##1##(1990-11#3)
N2O with##2##2##(1992-8#2)
N2O##12##1##(1992-3#1)(1992-8#5)(1993-1#4)(2008-3#2)
N3 patients##2##2##(1991-8#1)(1995-8#1)
N3##8##1##(1990-6#2)(1991-8#1)(1993-11#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
N3UDP##4##1##(1993-11#4)
N4-ethenocytosine##2##1##(1993-11#2)
N417/AMSA cells##4##2##(1994-8#4)
N417/AMSA##5##1##(1994-8#5)
N5##4##1##(1995-2#2)(1997-1#1)(2008-10#1)
N52I##6##1##(1995-5#6)
N6-ethenoadenine##2##1##(1993-11#2)
N7 and##2##2##(1993-11#1)(2008-4#1)
N7 nitrogen##2##2##(1992-6#2)
N7##8##1##(1992-6#2)(1993-11#2)(2008-10#1)(2008-11#1)(2008-4#2)
N7Guo##2##1##(1994-8#2)
N7Ino##3##1##(1994-8#3)
N8##2##1##(1995-2#2)
N927##2##1##(2008-8#2)
N=10)##2##1##(2009-7#2)
N=3)##3##1##(2008-10#2)(2009-7#1)
NA and Ad concentrations##2##4##(1997-7#2)
NA and Ad##3##3##(1997-7#3)
NA and DA in the##2##5##(2008-7#2)
NA and DA in##3##4##(2008-7#3)
NA and DA##5##3##(2008-7#5)
NA and##16##2##(1994-3#2)(1997-7#3)(2008-10#3)(2008-3#1)(2008-7#6)(2011-1#1)
NA contents##2##2##(1997-7#2)
NA in##6##2##(2008-10#1)(2008-7#1)(2008-8#2)(2010-11#2)
NA increased##2##2##(2008-7#1)(2008-8#1)
NA is##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
NA of##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
NA release##4##2##(1997-7#4)
NA##81##1##(1994-3#3)(1994-6#1)(1994-8#2)(1995-3#1)(1997-7#16)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#7)(2008-7#14)(2008-8#7)(2010-11#5)(2011-1#1)(2013-8#1)
NA)##2##1##(1995-3#1)(2008-10#1)
NA-VCG4##2##1##(2008-10#2)
NA1##3##1##(2008-10#3)
NA2##3##1##(2008-10#3)
NA3##2##1##(2008-10#2)
NAA and##6##2##(2008-10#4)(2008-12#2)
NAA was##3##2##(1996-5#1)(2007-10#1)(2008-10#1)
NAA were##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
NAA##26##1##(1996-5#3)(2007-10#5)(2008-10#7)(2008-12#5)(2008-7#2)(2008-8#1)(2013-1#3)
NAADP synthesis##2##2##(2010-11#2)
NAADP##4##1##(2010-11#4)
NABE##4##1##(1991-9#4)
NAC##16##1##(1991-9#4)(1996-5#2)(2008-11#3)(2008-6#2)(2008-7#1)(2009-9#2)(2011-2#2)
NACE##3##1##(2008-10#3)
NACP##7##1##(1997-2#7)
NAD and GTP##2##3##(1990-7#1)(1995-11#1)
NAD and##4##2##(1990-7#2)(1995-11#1)(2008-10#1)
NAD##17##1##(1990-7#3)(1992-6#1)(1993-8#1)(1995-11#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)
NAD(+) and NADH##4##3##(2008-10#4)
NAD(+)##13##1##(2008-1#1)(2008-10#10)(2008-11#1)(2010-5#1)
NAD(+)-dependent 5##3##2##(1990-7#3)
NAD(+)-dependent##6##1##(1990-7#3)(1994-12#1)(2008-10#1)(2012-2#1)
NAD(P)H fluorescence##2##2##(1996-2#2)
NAD(P)H##13##1##(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#3)(2008-10#4)(2008-11#3)
NAD(P)H-dependent##2##1##(1990-7#1)(1994-12#1)
NAD(P)H-flavin##2##1##(1994-11#2)
NAD+ and NADH##3##3##(1990-11#1)(2008-10#1)(2009-9#1)
NAD+ and##5##2##(1990-11#1)(1990-7#2)(2008-10#1)(2009-9#1)
NAD+ concentration##2##2##(1990-10#1)(1990-11#1)
NAD+##27##1##(1990-10#8)(1990-11#5)(1990-7#2)(1992-11#1)(1992-3#3)(1994-11#2)(1995-5#2)(2008-10#1)(2008-4#1)(2009-9#1)(2012-2#1)
NAD+/NADH ratio##3##2##(1990-11#3)
NAD+/NADH##4##1##(1990-11#4)
NAD-binding##2##1##(1991-6#1)(1993-12#1)
NAD-dependent formate dehydrogenase##2##3##(1995-8#2)
NAD-dependent##4##1##(1990-7#1)(1992-11#1)(1995-8#2)
NAD-independent H##2##2##(2008-5#2)
NAD-independent bacteria##2##2##(2008-5#2)
NAD-independent##4##1##(2008-5#4)
NADA##2##1##(2008-10#2)
NADH and ascorbic acid##3##4##(2008-10#3)
NADH and##10##2##(1990-10#1)(1990-8#1)(1992-6#1)(1994-6#1)(2008-10#6)
NADH as the##2##3##(1992-3#1)(1995-6#1)
NADH as##4##2##(1992-3#1)(1995-6#1)(2008-11#1)(2008-8#1)
NADH cytochrome c reductase activity##3##5##(1990-11#3)
NADH cytochrome c reductase##4##4##(1990-11#4)
NADH dehydrogenase and##2##3##(1990-5#1)(2008-10#1)
NADH dehydrogenase##10##2##(1990-11#1)(1990-5#1)(1992-6#1)(1994-11#1)(1995-3#3)(2007-12#1)(2008-10#1)(2009-9#1)
NADH did##2##2##(1994-8#1)(1996-6#1)
NADH in the##2##3##(2008-10#1)(2008-6#1)
NADH in##8##2##(1993-11#1)(2008-10#6)(2008-6#1)
NADH levels##4##2##(1994-8#2)(2008-9#1)(2009-9#1)
NADH oxidase##2##2##(1990-11#1)(2009-9#1)
NADH oxidation in phosphate buffer##2##5##(2008-10#2)
NADH oxidation in##3##3##(1990-5#1)(2008-10#2)
NADH oxidation##8##2##(1990-5#1)(1992-11#1)(2008-10#5)(2008-6#1)
NADH peroxidase##3##2##(1995-5#3)
NADH reductase component of the steroid 9alpha-hydroxylase fromMycobacterium fortuitum##2##9##(2008-11#2)
NADH reductase component of the steroid 9alpha-hydroxylase##3##7##(2008-11#3)
NADH reductase##4##2##(2008-11#4)
NADH was##3##2##(2008-10#2)(2008-11#1)
NADH with##2##2##(1994-8#1)(2008-10#1)
NADH##126##1##(1990-10#1)(1990-11#9)(1990-5#2)(1990-7#4)(1990-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#5)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#5)(1995-3#5)(1995-5#5)(1995-6#1)(1995-8#3)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#43)(2008-11#7)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#7)(2010-5#3)(2013-1#3)
NADH-dependent activity##2##2##(2008-6#2)
NADH-dependent##4##1##(2008-6#2)(2009-9#2)
NADH-mediated##2##1##(1992-6#1)(2010-5#1)
NADP##7##1##(1990-11#1)(1990-7#4)(1995-11#1)(1995-5#1)
NADP(+)##5##1##(2008-10#1)(2008-7#1)(2008-9#1)(2012-5#2)
NADP(+)-dependent glyceraldehyde-3-phosphate dehydrogenases##2##3##(1991-12#2)
NADP+ and##2##2##(1990-11#1)(1991-12#1)
NADP+##4##1##(1990-11#1)(1991-12#1)(1993-6#1)(2008-11#1)
NADP-dependent glutamate dehydrogenase##2##3##(1997-1#2)
NADP-dependent##4##1##(1990-7#1)(1997-1#2)(2008-10#1)
NADPH and##2##2##(1990-12#1)(1991-5#1)
NADPH as##2##2##(1991-12#1)(1991-5#1)
NADPH binding site##2##3##(1993-8#1)(1995-8#1)
NADPH binding##4##2##(1992-3#1)(1993-8#1)(1994-8#1)(1995-8#1)
NADPH cytochrome P450 reductase##2##4##(1995-6#2)
NADPH cytochrome P450##3##3##(1995-6#3)
NADPH diaphorase activity##4##3##(1992-3#3)(1995-11#1)
NADPH diaphorase##5##2##(1992-3#3)(1992-8#1)(1995-11#1)
NADPH for the##2##3##(1993-3#1)(2010-12#1)
NADPH for##3##2##(1992-3#1)(1993-3#1)(2010-12#1)
NADPH oxidase activity##2##3##(1990-2#1)(1993-6#1)
NADPH oxidase and##4##3##(1993-6#1)(1994-6#1)(2008-4#1)(2012-2#1)
NADPH oxidase in a cell-free system##3##6##(1990-5#2)(1993-8#1)
NADPH oxidase in##4##3##(1990-2#1)(1990-5#2)(1993-8#1)
NADPH oxidase inhibitor##2##3##(1990-2#1)(1994-6#1)
NADPH oxidase##37##2##(1990-2#3)(1990-5#2)(1991-12#3)(1991-5#3)(1993-6#3)(1993-8#4)(1994-6#3)(1995-6#1)(1997-7#1)(2008-1#3)(2008-10#1)(2008-4#1)(2009-12#3)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
NADPH oxidases##2##2##(2009-8#1)(2013-8#1)
NADPH produced##2##2##(2008-10#1)(2008-7#1)
NADPH to##2##2##(1993-3#1)(1994-8#1)
NADPH was##2##2##(2008-10#1)(2008-8#1)
NADPH##103##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#2)(1990-8#1)(1991-12#5)(1991-2#1)(1991-5#7)(1992-11#1)(1992-12#2)(1992-3#8)(1992-8#1)(1993-3#3)(1993-6#3)(1993-8#9)(1994-6#3)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#6)(1995-8#4)(1997-7#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
NADPH-binding protein of the neutrophil superoxide-generating oxidase##2##7##(1994-8#2)
NADPH-binding##3##1##(1994-8#3)
NADPH-cyt##3##1##(1991-5#3)
NADPH-cytochrome P450 oxidoreductase##2##3##(1994-8#2)
NADPH-cytochrome P450 reductase##3##3##(1991-5#1)(1996-3#2)
NADPH-cytochrome P450##5##2##(1991-5#1)(1994-8#2)(1996-3#2)
NADPH-cytochrome##9##1##(1991-5#1)(1993-6#2)(1994-8#2)(1996-3#3)(2008-8#1)
NADPH-d histochemical activity##2##3##(1995-12#2)
NADPH-d##7##1##(1995-12#3)(1997-2#4)
NADPH-dependent##12##1##(1991-12#1)(1991-5#6)(1995-6#1)(1997-2#1)(2008-6#1)(2009-10#1)(2011-2#1)
NADPH-diaphorase##5##1##(1992-12#3)(1995-12#2)
NADPH-diaphorase-positive neurons##2##2##(1992-12#1)(1997-2#1)
NADPH-diaphorase-positive##5##1##(1992-12#4)(1997-2#1)
NAFLD and##2##2##(2010-6#1)(2013-1#1)
NAFLD##4##1##(2010-6#2)(2013-1#2)
NAG##3##1##(1994-5#3)
NAGO##7##1##(1995-5#7)
NAHAM##2##1##(1991-1#1)(1993-12#1)
NAHAM's##3##1##(1993-1#1)(1995-1#1)(1997-3#1)
NAHC##2##1##(2011-2#2)
NAL was##2##2##(2008-10#2)
NAL##8##1##(2008-10#8)
NAM9##5##1##(1995-8#3)(1995-9#2)
NAM9-1##4##1##(1995-8#4)
NANC contractions##2##2##(1997-4#2)
NANC##7##1##(1996-5#1)(1997-4#6)
NAP##4##1##(2009-11#4)
NAPPH##3##1##(1991-1#1)(1992-2#2)
NAR##4##1##(1992-11#3)(2008-5#1)
NAS and##2##2##(2008-9#1)(2009-10#1)
NAS mastectomies##4##2##(2011-2#4)
NAS##21##1##(1990-11#1)(1993-12#2)(1993-6#3)(2008-10#2)(2008-9#3)(2009-10#3)(2009-9#1)(2010-11#2)(2011-2#4)
NASA Johnson Space Center##2##4##(2008-3#2)
NASA airborne mission##2##3##(2008-2#2)
NASA##13##1##(2007-12#2)(2008-2#5)(2008-3#5)(2012-3#1)
NASA's##3##1##(2008-3#3)
NASH##3##1##(2009-2#1)(2013-1#2)
NASICON based Na(+) ion selective##2##5##(2008-10#2)
NASICON##4##1##(2008-10#4)
NAT activity##3##2##(1995-11#1)(1995-3#2)
NAT and NAB in mainstream cigarette smoke##2##7##(2011-1#2)
NAT and NAB were##2##4##(2011-1#2)
NAT and NAB##5##3##(2011-1#5)
NAT techniques##3##2##(2011-2#3)
NAT##17##1##(1994-2#2)(1995-11#1)(1995-3#2)(2011-1#5)(2011-2#7)
NAT2##2##1##(1993-3#2)
NATs##2##1##(2011-2#2)
NAcc rats##3##2##(1993-6#3)
NAcc##5##1##(1993-6#5)
NB cholinergic##2##2##(1991-9#2)
NB filters##2##2##(2008-3#2)
NB protein##2##2##(2008-10#2)
NB##11##1##(1991-9#4)(2008-10#2)(2008-3#2)(2013-8#3)
NB-RCNMV-MP(+)##3##1##(2008-10#3)
NB-TMV-MP(+)##2##1##(2008-10#2)
NB1-RGB cells cultured on##2##4##(2008-11#2)
NB1-RGB cells on the##3##4##(2008-11#3)
NB1-RGB cells on##4##3##(2008-11#4)
NB1-RGB cells##9##2##(2008-11#9)
NB1-RGB##10##1##(2008-11#10)
NBB19##3##1##(2008-9#3)
NBC1##3##1##(2009-12#3)
NBCCEDP##2##1##(1997-1#2)
NBCCS##6##1##(1997-3#5)(2007-4#1)
NBD fluorescence##3##2##(1994-2#2)(1994-5#1)
NBD peptides##5##2##(2012-3#5)
NBD##11##1##(1994-2#2)(1994-5#1)(2009-12#1)(2012-3#7)
NBD-Cl)##3##1##(1992-6#3)
NBD-labeled##3##1##(1993-11#3)
NBD1##2##1##(2008-11#2)
NBD2##2##1##(2008-11#2)
NBDs##4##1##(2008-11#4)
NBF)##2##1##(1990-8#2)
NBF1##8##1##(2008-8#8)
NBI##2##1##(2011-2#2)
NBI-ME findings##2##2##(2012-2#2)
NBI-ME##4##1##(2012-2#4)
NBL as##2##2##(2011-2#2)
NBL##17##1##(2008-3#1)(2011-2#16)
NBM lesions##3##2##(1991-12#1)(1993-3#2)
NBM##12##1##(1991-12#1)(1993-3#7)(1995-12#1)(2008-8#3)
NBMPR##3##1##(1994-8#2)(1995-8#1)
NBMPR-insensitive equilibrative##2##2##(1994-8#1)(1995-8#1)
NBMPR-insensitive##4##1##(1994-8#1)(1995-8#3)
NBMPR-sensitive nucleoside##3##2##(1994-8#3)
NBMPR-sensitive transporter##3##2##(1995-8#3)
NBMPR-sensitive##7##1##(1994-8#3)(1995-8#4)
NBQX##7##1##(1994-2#7)
NBS or##2##2##(2008-10#2)
NBS with##3##2##(2008-10#3)
NBS##16##1##(1992-6#1)(2008-10#15)
NBS-AFLP markers##2##2##(2008-10#2)
NBS-LRR resistance gene##2##3##(2008-8#2)
NBS1 polymorphisms##2##2##(2011-1#2)
NBS1##7##1##(2011-1#7)
NBT##2##1##(1993-3#1)(2008-10#1)
NBT-II cell##2##2##(2013-8#2)
NBW##2##1##(2008-12#2)
NC and##4##2##(1991-4#1)(2008-10#1)(2010-2#2)
NC recipient soil populations##2##4##(2008-10#2)
NC strip##3##2##(2008-10#3)
NC##38##1##(1991-4#1)(1995-12#1)(1996-7#3)(2007-10#1)(2008-10#21)(2008-11#2)(2008-5#1)(2010-2#6)(2010-5#1)(2012-12#1)
NC)##3##1##(1997-1#1)(2008-9#1)(2011-2#1)
NC-1800##5##1##(1997-7#5)
NC300##2##1##(2008-10#2)
NC65##2##1##(1997-7#2)
NC96BGTA5##6##1##(2008-10#6)
NCA##6##1##(1992-11#1)(1993-8#1)(1994-2#1)(2011-2#3)
NCA-160##3##1##(1993-8#3)
NCAH is##2##2##(2008-1#2)
NCAH##6##1##(2008-1#6)
NCAM##4##1##(1995-5#4)
NCBI##8##1##(2008-12#1)(2008-4#4)(2008-7#1)(2012-3#1)(2013-1#1)
NCD##22##1##(2012-12#2)(2013-8#20)
NCDC dose-dependently inhibited##2##3##(1991-12#2)
NCDC##6##1##(1991-12#6)
NCDs or diabetes##2##3##(2013-8#2)
NCDs will##2##2##(2012-12#2)
NCDs##25##1##(2012-12#7)(2013-8#18)
NCER##3##1##(2008-10#3)
NCHS##5##1##(1996-3#1)(1997-3#2)(2008-12#1)(2012-2#1)
NCI##16##1##(1991-9#1)(1992-1#1)(1992-12#2)(1997-1#1)(2008-10#1)(2008-7#5)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
NCI's##2##1##(1997-1#1)(2013-1#1)
NCI-H460 cells##3##2##(2012-2#3)
NCKX proteins##3##2##(2008-8#3)
NCKX##4##1##(2008-8#4)
NCL proteins##2##2##(2009-5#2)
NCL##5##1##(2009-5#5)
NCLB##2##1##(2008-10#2)
NCPM##2##1##(2007-11#1)(2007-12#1)
NCR was##2##2##(2008-9#2)
NCR##7##1##(2008-7#1)(2008-9#6)
NCS DC##2##2##(2008-10#2)
NCS##3##1##(2008-10#2)(2013-1#1)
NCS(-)##2##1##(2008-10#2)
NCSTI##2##1##(2013-1#2)
NCX-4016##6##1##(2008-5#6)
NCySAAE##3##1##(1996-12#3)
ND patients##2##2##(2013-8#2)
ND##16##1##(1995-2#4)(1997-6#1)(2008-10#7)(2008-12#2)(2013-8#2)
ND)##3##1##(2008-10#3)
ND-6##2##1##(1992-9#2)
ND12##2##1##(2008-10#2)
ND15##2##1##(2008-10#2)
ND4 genes##2##2##(2008-8#2)
ND4##7##1##(2007-12#2)(2008-2#2)(2008-5#1)(2008-8#2)
ND4L and##2##2##(2008-8#2)
ND7##2##1##(1995-6#1)(2008-10#1)
NDA##5##1##(2008-5#5)
NDC myeloblast##2##2##(2008-11#2)
NDC##4##1##(2008-11#4)
NDELA content##3##2##(2008-5#3)
NDELA in##2##2##(2008-5#2)
NDELA##11##1##(2008-5#11)
NDF##2##1##(2008-12#1)(2013-7#1)
NDI##6##1##(2012-12#1)(2012-3#5)
NDPK is##3##2##(1996-2#1)(1997-7#2)
NDPK##11##1##(1996-2#7)(1997-7#4)
NDV in##3##2##(1997-6#1)(2008-5#2)
NDV strains##2##2##(2007-6#1)(2008-5#1)
NDV##13##1##(1997-6#2)(2007-6#2)(2008-5#5)(2008-9#4)
NE (10 mumol)##2##3##(2008-4#2)
NE and##5##2##(1994-6#2)(1996-12#1)(2011-2#2)
NE could##2##2##(1991-11#1)(2008-4#1)
NE in##4##2##(1991-11#1)(2008-3#3)
NE levels##3##2##(1996-7#3)
NE muld##2##2##(2008-4#2)
NE was##2##2##(2008-3#2)
NE##45##1##(1991-11#5)(1994-6#6)(1996-12#5)(1996-7#3)(2008-10#4)(2008-2#2)(2008-3#9)(2008-4#5)(2008-7#2)(2011-2#3)(2013-8#1)
NE)##2##1##(1994-6#1)(2009-4#1)
NECA##8##1##(1993-6#1)(1994-6#4)(1995-12#3)
NED##5##1##(2008-10#2)(2013-1#3)
NEE##5##1##(2008-10#5)
NEECHAM scores##2##2##(2010-10#2)
NEECHAM##4##1##(2010-10#4)
NEHAP##2##1##(2008-1#2)
NEM at##2##2##(1995-8#2)
NEM inhibition##2##2##(1995-8#2)
NEM##10##1##(1990-2#1)(1994-12#1)(1995-8#8)
NEO##2##1##(2008-11#2)
NEO-PI-R##3##1##(2008-11#3)
NEOTRANS(3)##3##1##(2008-7#3)
NEP##2##1##(1991-2#1)(2008-11#1)
NEP1 disruption##2##2##(2008-10#2)
NEP1##6##1##(2008-10#6)
NEP1-overexpressing transformant 15##2##3##(2008-10#2)
NEP1-overexpressing##3##1##(2008-10#3)
NER activity##2##2##(2008-11#2)
NER##4##1##(2008-11#4)
NET/NEP##2##1##(2008-12#2)
NETs##7##1##(2010-4#1)(2011-2#6)
NEW##3##1##(2008-12#1)(2011-2#1)(2013-8#1)
NEXIS##5##1##(1991-2#5)
NF kappa B##3##3##(1991-9#1)(1994-6#1)(1994-8#1)
NF##8##1##(1991-3#3)(1991-9#1)(1994-6#1)(1994-8#1)(1996-3#1)(2007-11#1)
NF-1 and##2##2##(1991-3#2)
NF-1##3##1##(1991-3#3)
NF-2##4##1##(1991-3#4)
NF-AT and NF-kappaB transcription factors##2##5##(2008-11#2)
NF-AT##3##1##(1994-11#1)(2008-11#2)
NF-B##14##1##(2010-10#14)
NF-E2 p45##4##2##(1994-8#4)
NF-E2##8##1##(1994-8#7)(2008-9#1)
NF-H##4##1##(1995-12#2)(1995-3#1)(2008-8#1)
NF-L is##2##2##(2008-8#2)
NF-L##10##1##(1996-5#2)(1997-2#1)(2008-8#7)
NF-M and##4##2##(1997-2#1)(2008-8#3)
NF-M##5##1##(1997-2#1)(2008-8#4)
NF-VII##2##1##(1991-3#2)
NF-Y##2##1##(1997-8#2)
NF-kB activation##3##2##(2010-3#3)
NF-kB##5##1##(2010-3#5)
NF-kappa B activation##6##3##(1992-12#3)(1993-3#2)(2008-10#1)
NF-kappa B and##3##3##(1992-12#1)(1995-12#1)(2008-9#1)
NF-kappa B##32##2##(1991-7#2)(1992-12#4)(1992-8#4)(1993-3#2)(1993-9#1)(1994-11#2)(1995-12#6)(1995-2#2)(1995-6#5)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
NF-kappa B/I kappa B##2##4##(1995-2#2)
NF-kappa##37##1##(1991-7#3)(1992-12#4)(1992-8#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1995-12#6)(1995-2#5)(1995-6#5)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
NF-kappaB and##2##2##(2008-9#1)(2010-3#1)
NF-kappaB is##3##2##(2010-3#2)(2010-8#1)
NF-kappaB signal##2##2##(2008-8#2)
NF-kappaB transcription##3##2##(2008-11#2)(2010-6#1)
NF-kappaB##29##1##(2008-10#1)(2008-11#6)(2008-8#5)(2008-9#5)(2010-3#9)(2010-6#1)(2010-8#1)(2012-1#1)
NF-κB activation##2##2##(2012-2#1)(2012-3#1)
NF-κB activity##3##2##(2012-3#3)
NF-κB p65##2##2##(2012-2#2)
NF-κB signaling##2##2##(2011-2#1)(2013-1#1)
NF-κB transcriptional activity##2##3##(2012-3#2)
NF-κB##16##1##(2011-2#3)(2012-2#3)(2012-3#7)(2013-1#3)
NF-κB/Rel##6##1##(2011-2#6)
NF1 gene##3##2##(1991-5#1)(1997-3#1)(2013-1#1)
NF1 protein##2##2##(1991-5#1)(1992-8#1)
NF1##15##1##(1991-5#2)(1992-8#2)(1994-12#1)(1994-6#1)(1997-3#2)(2008-7#3)(2012-3#3)(2013-1#1)
NF1-GRD##5##1##(1992-8#5)
NF2##6##1##(1997-3#1)(2008-10#3)(2010-11#2)
NFC supplement##2##2##(2012-2#2)
NFC##4##1##(2007-12#2)(2012-2#2)
NFP hospital##3##2##(2008-11#3)
NFP##5##1##(2008-10#1)(2008-11#4)
NFTs in the##2##3##(1991-1#2)
NFκB and##3##2##(2011-2#3)
NFκB##11##1##(2010-11#3)(2011-2#8)
NG##5##1##(1992-8#2)(2008-10#1)(2013-8#2)
NG-methyl-L-arginine##2##1##(1995-11#2)
NG-monomethyl L-arginine (L-NMMA)##2##3##(1991-9#1)(2009-4#1)
NG-monomethyl-L-arginine##8##1##(1992-3#1)(1993-8#1)(1994-6#1)(1995-12#5)
NG-nitro-L-arginine (100 microM) or##2##4##(1993-8#2)
NG-nitro-L-arginine methyl ester (L-NAME)##2##4##(1992-3#1)(1995-12#1)
NG-nitro-L-arginine methyl ester##3##3##(1992-3#1)(1995-12#1)(1997-2#1)
NG-nitro-L-arginine##6##1##(1992-3#1)(1993-8#2)(1995-11#1)(1995-12#1)(1997-2#1)
NG108-15 cells##4##2##(1997-2#4)
NG108-15##5##1##(1997-2#5)
NG2##3##1##(1996-5#1)(2008-7#1)(2013-1#1)
NG2(+) cells##7##2##(2008-7#7)
NGAL concentration##2##2##(2010-5#2)
NGAL##11##1##(2010-5#11)
NGE##2##1##(2008-3#2)
NGF and BDNF##3##3##(1994-8#1)(1996-12#1)(2008-11#1)
NGF and##9##2##(1991-12#1)(1994-8#2)(1996-12#2)(1997-2#1)(2008-11#2)(2008-7#1)
NGF cDNA##3##2##(1996-12#3)
NGF can induce##2##3##(1993-12#2)
NGF can##3##2##(1993-12#2)(2010-8#1)
NGF gene transfection increases##2##4##(1996-12#1)(1996-2#1)
NGF gene transfection##6##3##(1996-12#4)(1996-2#2)
NGF gene##8##2##(1990-8#2)(1996-12#4)(1996-2#2)
NGF in##6##2##(1995-12#1)(1996-2#1)(1997-2#1)(2010-8#3)
NGF is##2##2##(1996-2#1)(2010-8#1)
NGF level in the##3##4##(1996-2#3)
NGF mRNA expression##2##3##(1997-6#2)
NGF mRNA##3##2##(1997-6#3)
NGF receptor##2##2##(1993-9#1)(1996-12#1)
NGF treatment##3##2##(1992-12#2)(1992-9#1)
NGF was##4##2##(1990-8#3)(1993-12#1)
NGF##88##1##(1990-8#9)(1991-12#6)(1992-12#3)(1992-9#2)(1993-12#5)(1993-9#1)(1994-8#4)(1995-12#2)(1995-5#1)(1996-12#11)(1996-2#12)(1996-5#1)(1997-2#8)(1997-6#5)(2008-11#9)(2008-4#2)(2008-5#1)(2008-7#1)(2010-8#5)
NGF)##2##1##(1995-12#1)(2008-5#1)
NGF-dependent neurite outgrowth##4##3##(2008-4#4)
NGF-producing target##2##2##(1996-2#2)
NGF-response element##3##2##(1992-12#3)
NGF-secreting implants##2##2##(2008-5#2)
NGF-treated##2##1##(1993-12#1)(1997-6#1)
NGFI-A mRNA##3##2##(1996-12#3)
NGFI-B mRNA##8##2##(1996-12#8)
NGFI-B##20##1##(1991-5#6)(1995-12#2)(1996-12#12)
NGO##2##1##(1996-5#1)(2012-12#1)
NGO1945##4##1##(2010-10#4)
NGOs##5##1##(2007-2#4)(2013-1#1)
NGP##2##1##(1992-12#1)(2008-5#1)
NGS##3##1##(2008-12#1)(2012-2#2)
NH##13##1##(1991-12#2)(1991-5#1)(2008-10#4)(2008-2#4)(2010-10#1)(2011-1#1)
NH(2) column##2##2##(2008-10#2)
NH(2)##3##1##(2008-10#3)
NH(2)-terminal##2##1##(2008-11#2)
NH(3) and##8##2##(2008-10#1)(2008-3#6)(2012-2#1)
NH(3) concentration##2##2##(2008-3#1)(2009-8#1)
NH(3) gas is##2##3##(2008-10#2)
NH(3) gas##4##2##(2008-10#4)
NH(3) in##3##2##(2008-10#2)(2008-2#1)
NH(3) plasma treatment##2##3##(2008-5#2)
NH(3) plasma##4##2##(2008-5#4)
NH(3) with##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
NH(3)##37##1##(1997-7#1)(2008-10#18)(2008-2#3)(2008-3#8)(2008-5#4)(2009-8#1)(2010-7#1)(2012-2#1)
NH(3)(+)##2##1##(2008-10#2)
NH(3)-NH(4)Cl buffer##2##2##(2008-10#2)
NH(3)-NH(4)Cl##3##1##(2008-10#3)
NH(4)##4##1##(2008-10#4)
NH(4)(+) and##4##2##(2008-10#4)
NH(4)(+)##22##1##(2008-10#22)
NH(4)(+)-selective##2##1##(2008-10#2)
NH(4)Cl##3##1##(2008-10#3)
NH(4)F##4##1##(2008-10#4)
NH(4)H(2)PO(4)##4##1##(2008-10#4)
NH(4)NO(3) as##2##2##(2008-10#2)
NH(4)NO(3)##12##1##(2008-10#12)
NH(4)OH##3##1##(2008-10#3)
NH(4)SCN##4##1##(2008-10#4)
NH(4)VO(3)##5##1##(2008-10#5)
NH)##2##1##(1991-11#1)(1991-3#1)
NH+4##2##1##(1995-8#2)
NH2 terminus##7##2##(1992-12#1)(1992-9#1)(1993-3#1)(1995-6#4)
NH2##25##1##(1991-5#6)(1992-12#1)(1992-6#1)(1992-9#10)(1993-3#1)(1994-9#1)(1995-6#4)(2008-10#1)
NH2-terminal amino acid sequence of##3##5##(1991-12#1)(1991-2#2)
NH2-terminal amino acid sequence##7##4##(1990-8#1)(1991-12#3)(1991-2#2)(1995-6#1)
NH2-terminal fragment of##3##3##(1990-12#2)(1997-1#1)
NH2-terminal modification of the phosphatase 2A catalytic subunit##2##8##(1992-9#2)
NH2-terminal sequence of##2##3##(1995-6#1)(1997-2#1)
NH2-terminal sequence##3##2##(1990-12#1)(1995-6#1)(1997-2#1)
NH2-terminal##31##1##(1990-11#1)(1990-12#5)(1990-8#1)(1991-12#4)(1991-2#3)(1992-12#1)(1992-3#1)(1992-9#4)(1995-12#1)(1995-6#4)(1997-1#3)(1997-2#1)(2008-8#1)(2010-12#1)
NH2-terminus of##5##2##(1991-10#1)(1992-12#2)(1997-1#1)(2008-8#1)
NH2-terminus##10##1##(1991-10#1)(1991-5#1)(1992-12#2)(1992-4#1)(1992-8#2)(1997-1#1)(2008-8#2)
NH3##4##1##(2007-12#2)(2008-10#2)
NH4+##13##1##(1990-11#1)(1994-6#1)(2008-11#5)(2008-8#6)
NH4Cl##11##1##(1990-7#1)(1991-12#1)(1992-11#2)(1992-6#2)(1994-6#3)(2008-11#2)
NHA##3##1##(1993-2#3)
NHC##6##1##(2013-8#6)
NHE##5##1##(1993-5#3)(1997-7#1)(2008-10#1)
NHE3##3##1##(2009-12#3)
NHEJ##2##1##(1997-7#2)
NHEKs##4##1##(2008-4#4)
NHI women##2##2##(2008-12#2)
NHI women's##2##2##(2008-12#2)
NHI##8##1##(2008-12#5)(2010-8#2)(2011-1#1)
NHK##3##1##(1994-3#3)
NHL of the oral cavity##2##5##(2012-3#2)
NHL##17##1##(1990-12#1)(1994-10#1)(1996-8#1)(2007-10#2)(2012-3#5)(2013-1#5)(2013-7#2)
NHML##2##1##(1991-6#2)
NHP##5##1##(2009-3#4)(2010-9#1)
NHS Direct##3##2##(2008-11#3)
NHS Executive##4##2##(1997-7#1)(2008-11#3)
NHS Trust##3##2##(2008-11#3)
NHS Trusts##2##2##(2008-11#2)
NHS reforms##2##2##(1991-8#1)(1996-8#1)
NHS staff##2##2##(2013-8#2)
NHS treatment##2##2##(1991-11#1)(1996-11#1)
NHS trust##4##2##(1995-9#1)(1997-7#1)(2013-8#2)
NHS##84##1##(1991-11#1)(1991-3#3)(1991-6#1)(1991-8#2)(1992-12#1)(1994-8#2)(1995-9#1)(1996-11#4)(1996-3#1)(1996-8#3)(1997-5#5)(1997-7#2)(1997-8#3)(2008-10#1)(2008-11#23)(2008-12#2)(2008-5#1)(2008-7#5)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#17)
NHS-stimulated##2##1##(1994-8#2)
NHT##2##1##(2011-1#2)
NI to##2##2##(2013-8#2)
NI##7##1##(1993-2#2)(2011-2#1)(2013-8#4)
NIC card##2##2##(2008-3#2)
NIC##4##1##(2008-3#3)(2013-1#1)
NICE##10##1##(2008-7#3)(2010-2#3)(2010-8#1)(2013-8#3)
NICE's##2##1##(2008-7#2)
NICU infants##2##2##(1991-12#1)(1991-2#1)
NICU stresses##2##2##(1991-1#2)
NICU##24##1##(1991-1#4)(1991-12#7)(1991-2#1)(1994-2#4)(1995-1#2)(2008-10#1)(2008-3#1)(2009-6#1)(2010-10#1)(2011-2#2)
NICU's##2##1##(1991-12#2)
NIDDK##2##1##(2008-4#2)
NIDDM in##2##2##(2008-5#1)(2010-2#1)
NIDDM##9##1##(1991-12#1)(1991-7#3)(2008-5#4)(2010-2#1)
NIES CRM No##2##3##(2008-10#2)
NIES CRM##3##2##(2008-10#3)
NIES##7##1##(2008-10#7)
NIF##4##1##(2008-10#3)(2008-3#1)
NIH 3T3 cells##9##3##(1991-12#2)(1993-11#2)(1994-8#1)(1995-2#4)
NIH 3T3##14##2##(1991-12#2)(1992-7#1)(1993-11#3)(1994-8#2)(1995-2#4)(2009-12#1)(2012-12#1)
NIH guidelines##2##2##(2008-11#2)
NIH recommendations##2##2##(2008-11#2)
NIH##30##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-7#1)(1993-11#3)(1993-12#1)(1993-8#1)(1994-8#2)(1995-2#4)(1996-3#1)(1997-3#1)(2008-11#4)(2008-2#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-3#2)
NIH(ret) cells##2##2##(1993-8#2)
NIH(ret)##3##1##(1993-8#3)
NIH-3T3 cells##2##2##(1995-6#1)(2008-11#1)
NIH-3T3##4##1##(1992-8#2)(1995-6#1)(2008-11#1)
NIH/3T3 cells##3##2##(1991-5#3)
NIH/3T3##6##1##(1991-5#5)(2008-11#1)
NIH3T3 cells##7##2##(1991-11#1)(1993-11#1)(1993-2#1)(1997-1#3)(2008-11#1)
NIH3T3##11##1##(1991-11#1)(1991-9#2)(1993-11#1)(1993-2#1)(1997-1#3)(2008-11#1)(2008-8#1)(2010-11#1)
NIHL##2##1##(2013-8#2)
NIIRS##3##1##(2008-2#2)(2008-3#1)
NIL sets##3##2##(2008-10#3)
NIL##7##1##(1992-12#1)(2008-10#6)
NILs and##2##2##(2008-10#2)
NILs of##2##2##(2008-10#2)
NILs##15##1##(2008-10#15)
NIM1/NPR1 gene##2##2##(2008-10#2)
NIMAs and##2##2##(1990-11#2)
NIMAs##3##1##(1990-11#3)
NIMH Genetics Initiative on Bipolar Disorder##2##6##(1997-5#2)
NIMH Genetics Initiative##4##3##(1997-5#4)
NIMH##10##1##(1997-5#10)
NINDS rt-PA trial##2##3##(2007-10#2)
NIOSH##3##1##(1991-5#1)(2008-10#1)(2008-8#1)
NIPRD-AM1##6##1##(2011-2#6)
NIR dye##2##2##(2012-2#2)
NIR reflectance##2##2##(2008-10#1)(2008-3#1)
NIR spectra of RPP and BPP##2##6##(2007-12#2)
NIR spectra of##5##3##(2007-12#2)(2008-10#2)(2013-8#1)
NIR spectra##9##2##(2007-12#2)(2008-10#5)(2011-1#1)(2013-8#1)
NIR spectrometry and##2##3##(2008-10#2)
NIR spectroscopy##7##2##(2008-10#6)(2008-3#1)
NIR wavelengths##2##2##(2008-3#2)
NIR##44##1##(2007-12#3)(2008-1#1)(2008-10#27)(2008-3#5)(2011-1#2)(2012-12#1)(2012-2#4)(2013-8#1)
NIR-conPK11195 and free##2##3##(2012-2#2)
NIRS technology##2##2##(2008-10#1)(2008-3#1)
NIRS##11##1##(2008-10#10)(2008-3#1)
NIS##4##1##(1995-3#1)(1997-1#1)(2008-3#2)
NIST 1515##2##2##(2008-10#2)
NIST 1648##3##2##(2008-10#3)
NIST SRM 2670##2##3##(2008-10#2)
NIST SRM##10##2##(1995-6#1)(2008-10#9)
NIST and##2##2##(2008-2#1)(2008-3#1)
NIST reference material##2##3##(2008-10#2)
NIST reference##3##2##(2008-10#3)
NIST##45##1##(1995-6#1)(2008-1#1)(2008-10#35)(2008-2#1)(2008-3#7)
NIT##3##1##(2008-10#3)
NIV contents##2##2##(2008-10#2)
NIV##3##1##(2008-10#3)
NIV)##2##1##(2008-10#2)
NIV-producing##2##1##(2008-10#2)
NIb##3##1##(2008-10#3)
NJ##10##1##(1991-1#1)(1994-1#1)(1995-2#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-7#1)(2013-1#1)
NJ)##2##1##(2008-11#1)(2013-1#1)
NJE##4##1##(2013-8#4)
NK T cells##3##3##(2008-4#2)(2010-5#1)
NK T##6##2##(2008-4#5)(2010-5#1)
NK cell activity##3##3##(2008-10#3)
NK cell function##2##3##(1991-8#1)(2006-10#1)
NK cell lysis##2##3##(2013-1#2)
NK cell##17##2##(1990-12#1)(1991-8#1)(2006-10#2)(2008-10#3)(2008-4#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
NK cells and##3##3##(2008-4#3)
NK cells in##4##3##(2006-10#2)(2008-10#1)(2011-2#1)
NK cells is##2##3##(2008-8#1)(2008-9#1)
NK cells or##2##3##(2008-4#2)
NK cells##36##2##(1991-6#1)(1991-8#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#3)(2006-10#2)(2008-10#4)(2008-4#8)(2008-8#8)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
NK cytotoxicity##2##2##(2008-8#2)
NK##74##1##(1990-12#1)(1991-1#1)(1991-6#2)(1991-8#2)(1992-2#1)(1993-6#2)(1993-9#1)(1994-9#1)(1995-2#3)(2006-10#5)(2008-10#7)(2008-4#17)(2008-7#2)(2008-8#11)(2008-9#4)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#8)
NK-1 receptor antagonists##3##3##(2008-7#3)
NK-1##5##1##(2008-7#3)(2008-8#2)
NK-2 receptor##4##2##(1993-3#4)
NK-2##6##1##(1993-3#4)(2008-8#2)
NK-cell activation##2##2##(2008-9#2)
NK-resistant##2##1##(2008-4#2)
NK1 and NK2 receptors##3##4##(1995-12#3)
NK1 and NK2##7##3##(1995-12#5)(1997-4#2)
NK1 receptor##3##2##(1995-12#1)(1997-4#1)(2008-5#1)
NK1##13##1##(1995-12#6)(1997-4#3)(2008-5#2)(2008-9#2)
NK2 receptor antagonist##2##3##(1995-12#1)(1997-4#1)
NK2 receptor##5##2##(1995-12#2)(1997-4#3)
NK2##8##1##(1995-12#5)(1997-4#3)
NK433##7##1##(1996-2#7)
NKA##10##1##(1990-11#2)(1990-12#3)(1993-3#1)(1994-8#1)(2008-4#1)(2008-8#2)
NKCC2 and NCC##3##3##(2012-12#3)
NKG2D##6##1##(2011-2#1)(2013-1#5)
NL##3##1##(2008-10#1)(2008-7#2)
NL-3 D##6##2##(2008-10#6)
NL-3 K Strain##2##3##(2008-10#2)
NL-3 K##12##2##(2008-10#12)
NL-3##21##1##(2008-10#19)(2010-7#2)
NLE##3##1##(1993-5#3)
NLM##8##1##(1991-2#1)(1995-1#2)(1996-3#2)(1997-3#1)(2010-5#2)
NLM's##7##1##(1991-2#1)(1992-1#1)(1993-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(2008-7#1)
NLS##2##1##(1994-11#1)(2008-3#1)
NLT##2##1##(2010-3#2)
NM##8##1##(1995-5#6)(2010-12#2)
NMBA##2##1##(2013-1#2)
NMDA and AMPA##2##3##(1995-5#1)(2008-7#1)
NMDA and non-NMDA receptors##3##4##(1995-12#3)
NMDA and non-NMDA##4##3##(1995-12#3)(1995-5#1)
NMDA and##8##2##(1995-12#3)(1995-5#2)(1996-5#1)(1997-2#1)(2008-7#1)
NMDA antagonist and a##2##4##(2008-5#2)
NMDA antagonist##6##2##(1993-5#1)(1996-2#1)(1997-2#1)(2008-5#2)(2008-7#1)
NMDA application##2##2##(1996-6#1)(2008-8#1)
NMDA receptor activation##2##3##(1995-5#1)(1996-12#1)
NMDA receptor antagonist##11##3##(1990-5#2)(1991-1#1)(1992-3#1)(1992-8#1)(1993-5#1)(1997-2#2)(1997-7#1)(2008-8#1)(2009-12#1)
NMDA receptor function##2##3##(1995-5#1)(2011-1#1)
NMDA receptor is##2##3##(1994-8#2)
NMDA receptor mRNA##2##3##(1993-12#2)
NMDA receptor subunit##3##3##(1996-12#2)(1996-5#1)
NMDA receptor##52##2##(1990-5#3)(1991-1#2)(1992-3#1)(1992-8#1)(1993-12#7)(1993-5#1)(1994-6#2)(1994-8#6)(1995-5#2)(1996-12#4)(1996-2#4)(1996-5#1)(1997-2#4)(1997-7#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#2)(2012-12#2)
NMDA receptor-mediated currents##2##3##(1995-5#2)
NMDA receptor-mediated##5##2##(1992-3#1)(1995-12#1)(1995-5#2)(2008-7#1)
NMDA receptors and##3##3##(1997-2#1)(2009-12#1)(2009-8#1)
NMDA receptors are##4##3##(1993-5#1)(1996-12#1)(1997-2#1)(1997-7#1)
NMDA receptors in the##3##4##(1990-5#1)(1997-2#1)(2008-7#1)
NMDA receptors in##5##3##(1990-5#1)(1991-1#1)(1997-2#1)(1997-7#1)(2008-7#1)
NMDA receptors may##2##3##(1994-8#1)(1996-12#1)
NMDA receptors produces##2##3##(1991-2#1)(1996-2#1)
NMDA receptors##29##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1993-5#1)(1994-8#1)(1995-11#3)(1996-12#2)(1996-2#1)(1997-2#6)(1997-6#1)(1997-7#2)(2008-7#2)(2009-12#1)(2009-8#2)(2011-1#2)(2012-12#1)
NMDA##144##1##(1990-5#4)(1990-7#1)(1991-1#3)(1991-2#1)(1992-3#2)(1992-8#5)(1993-12#7)(1993-5#5)(1994-2#1)(1994-6#2)(1994-8#8)(1995-11#3)(1995-12#7)(1995-5#8)(1996-12#6)(1996-2#7)(1996-5#9)(1996-6#4)(1997-2#18)(1997-6#1)(1997-7#8)(2008-11#1)(2008-5#4)(2008-7#8)(2008-8#7)(2009-12#3)(2009-8#3)(2010-4#1)(2011-1#4)(2012-12#3)
NMDA-R1##4##1##(1993-12#4)
NMDA-glycine site agonists##2##3##(1996-5#2)
NMDA-glycine site##3##2##(1996-5#3)
NMDA-independent##2##1##(1990-5#1)(2009-8#1)
NMDA-induced cell swelling##2##3##(1996-5#2)
NMDA-induced##7##1##(1995-12#1)(1996-5#3)(1997-2#1)(2008-5#1)(2008-8#1)
NMDA-mediated##2##1##(1994-8#1)(2008-7#1)
NMDA-receptor##3##1##(1995-12#1)(1997-7#2)
NMDA/glycine receptor antagonist##2##3##(1997-7#2)
NMDAR##2##1##(2012-2#2)
NMDAR1##7##1##(1994-8#1)(1995-5#1)(1997-2#5)
NMDAR2B mRNA expression##3##3##(1996-2#3)
NMDAR2B mRNA##5##2##(1996-2#5)
NMDAR2B##6##1##(1996-2#5)(1997-7#1)
NMDARs##2##1##(2009-7#2)
NMDS analysis of##2##3##(1995-5#2)
NMDS to##2##2##(1995-5#2)
NMDS##12##1##(1995-5#12)
NME##4##1##(1993-5#1)(1993-8#1)(1994-12#1)(2013-7#1)
NMF is##3##2##(2008-10#3)
NMF##8##1##(2008-10#8)
NMJ##5##1##(1990-5#2)(2009-11#2)(2009-8#1)
NMJs##7##1##(1992-8#4)(2009-11#3)
NMO##2##1##(2013-8#2)
NMPABAO##2##1##(2008-5#2)
NMR ((1)H##2##2##(2008-10#2)
NMR allows the##3##3##(2008-3#1)(2009-9#2)
NMR analysis of the##2##4##(1993-11#1)(2008-8#1)
NMR analysis##3##2##(1993-11#1)(1994-11#1)(2008-8#1)
NMR and FTIR##2##3##(2013-1#1)(2013-8#1)
NMR and MRI researchers##2##4##(2013-1#2)
NMR and MS##3##3##(2009-10#1)(2010-6#1)(2011-3#1)
NMR and X-ray##2##3##(1991-11#1)(1997-7#1)
NMR and mass##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
NMR and molecular##3##3##(1994-11#1)(1994-3#1)(1995-3#1)
NMR and restrained##2##3##(1993-11#1)(1994-5#1)
NMR and##37##2##(1991-11#1)(1991-5#1)(1991-8#1)(1993-11#2)(1994-11#1)(1994-3#1)(1994-5#2)(1995-3#2)(1996-2#2)(1997-1#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#2)(2010-6#2)(2011-3#1)(2013-1#4)(2013-8#1)
NMR assignment of the N-terminal##2##5##(2009-7#2)
NMR assignment of the##5##4##(2009-7#5)
NMR assignment of##8##3##(2008-11#1)(2009-7#7)
NMR assignment##9##2##(2008-11#1)(2009-7#8)
NMR assignments for##3##3##(1992-8#1)(2009-7#2)
NMR assignments of the##8##4##(1990-9#1)(2009-7#7)
NMR assignments of##14##3##(1990-9#1)(2009-7#13)
NMR assignments##18##2##(1990-9#1)(1992-8#1)(2008-11#1)(2009-7#15)
NMR chemical shift assignments for the##2##6##(2009-7#2)
NMR chemical shift assignments##4##4##(2009-7#4)
NMR chemical shift##8##3##(1993-11#1)(1996-5#1)(2008-10#1)(2009-7#4)(2010-7#1)
NMR chemical shifts##4##3##(1993-11#1)(1995-5#1)(2008-10#1)(2012-2#1)
NMR chemical##12##2##(1993-11#2)(1995-5#1)(1996-5#1)(2008-10#2)(2009-7#4)(2010-7#1)(2012-2#1)
NMR data and##2##3##(1990-5#1)(1996-5#1)
NMR data##13##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-1#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-9#1)(2010-6#1)(2013-8#1)
NMR experiments have##2##3##(1993-11#1)(2013-1#1)
NMR experiments##14##2##(1992-8#1)(1993-11#2)(1994-5#2)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-7#2)(2011-2#1)(2013-1#2)
NMR for##2##2##(1991-11#1)(2008-10#1)
NMR imaging##4##2##(1992-12#2)(1992-3#1)(2008-7#1)
NMR in##5##2##(1994-5#1)(1996-2#1)(2012-1#1)(2012-8#2)
NMR investigation of##3##3##(1994-5#1)(1995-11#1)(2008-9#1)
NMR measurements##2##2##(1993-3#1)(2008-10#1)
NMR methodology##2##2##(2008-1#2)
NMR methods##3##2##(1994-5#3)
NMR of##5##2##(1992-3#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)
NMR properties##2##2##(1994-5#1)(2008-10#1)
NMR relaxation##5##2##(1991-5#1)(1991-8#1)(1995-11#1)(1995-5#1)(1997-7#1)
NMR resonance assignment of the##2##5##(2009-7#2)
NMR resonance assignment##4##3##(1991-11#1)(2009-7#3)
NMR resonance##5##2##(1991-11#1)(2009-7#4)
NMR results##4##2##(1992-3#1)(1993-11#1)(2008-10#1)(2008-7#1)
NMR signals##5##2##(1994-12#1)(1994-3#2)(1994-5#2)
NMR spectra and##2##3##(1994-5#1)(1996-5#1)
NMR spectra of the##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
NMR spectra of##10##3##(1992-12#1)(1993-8#1)(1997-7#2)(2008-10#2)(2008-5#2)(2008-9#2)
NMR spectra to##2##3##(1994-8#1)(2008-10#1)
NMR spectra were##3##3##(1995-2#1)(1996-5#1)(2008-10#1)
NMR spectra##33##2##(1991-11#1)(1992-10#1)(1992-12#3)(1993-8#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-7#3)(2008-10#6)(2008-5#2)(2008-7#3)(2008-9#2)
NMR spectral analysis##2##3##(2008-10#1)(2010-5#1)
NMR spectral data##2##3##(2011-1#1)(2012-2#1)
NMR spectral##9##2##(1994-5#1)(2008-10#3)(2009-7#2)(2010-5#1)(2011-1#1)(2012-2#1)
NMR spectroscopic##7##2##(1992-12#1)(1994-8#1)(1997-4#1)(2008-10#2)(2011-1#1)(2013-1#1)
NMR spectroscopy and##5##3##(1992-4#1)(1993-11#1)(1993-3#1)(1996-5#1)(2008-10#1)
NMR spectroscopy has##2##3##(1994-8#1)(2008-7#1)
NMR spectroscopy in##2##3##(1996-5#1)(2006-12#1)
NMR spectroscopy is##2##3##(1995-2#1)(2008-4#1)
NMR spectroscopy of##5##3##(1991-3#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-2#1)
NMR spectroscopy##58##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-4#2)(1993-11#4)(1993-3#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-11#3)(1995-2#2)(1996-2#1)(1996-5#3)(2006-12#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-7#3)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#2)(2013-1#2)
NMR spectrum of##3##3##(1992-3#1)(1993-8#1)(2008-10#1)
NMR spectrum##5##2##(1992-3#1)(1993-8#2)(2008-10#2)
NMR structural studies of##2##4##(1993-11#1)(2008-5#1)
NMR structure determination##2##3##(2009-7#2)
NMR structure##3##2##(2008-9#1)(2009-7#2)
NMR studies have##2##3##(1996-2#1)(1996-5#1)
NMR studies of the##2##4##(1991-5#1)(1992-12#1)
NMR studies of##7##3##(1991-5#1)(1991-9#1)(1992-12#2)(1992-4#1)(1994-5#1)(2012-2#1)
NMR studies on##2##3##(1990-8#1)(2008-10#1)
NMR studies##18##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-11#1)(1994-5#2)(1996-2#1)(1996-5#1)(2008-10#2)(2008-4#1)(2009-7#1)(2012-2#1)
NMR study of##4##3##(1990-5#1)(1992-12#2)(2008-9#1)
NMR study##10##2##(1990-5#1)(1991-11#1)(1992-12#2)(1993-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-9#1)
NMR techniques and##3##3##(1994-3#1)(2008-9#1)(2013-1#1)
NMR techniques##8##2##(1990-9#1)(1991-11#1)(1994-3#1)(2007-1#1)(2008-8#1)(2008-9#2)(2013-1#1)
NMR titration##2##2##(2008-10#2)
NMR to##8##2##(1991-11#1)(1992-10#1)(1992-3#1)(1995-8#1)(1997-7#1)(2008-10#1)(2009-8#1)(2012-3#1)
NMR was used to study##2##5##(1990-11#1)(1993-8#1)
NMR was used to##4##4##(1990-11#1)(1991-12#1)(1993-8#1)(2008-3#1)
NMR##431##1##(1990-11#2)(1990-12#3)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-11#9)(1991-12#1)(1991-3#1)(1991-5#5)(1991-8#5)(1991-9#1)(1992-10#3)(1992-12#13)(1992-3#10)(1992-4#3)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#19)(1993-3#4)(1993-8#6)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#22)(1994-8#8)(1995-11#7)(1995-12#1)(1995-2#6)(1995-3#6)(1995-5#2)(1995-8#1)(1996-2#13)(1996-5#9)(1997-1#1)(1997-2#4)(1997-4#1)(1997-7#10)(2006-12#1)(2007-1#1)(2007-11#3)(2007-9#1)(2008-1#6)(2008-10#58)(2008-11#8)(2008-12#2)(2008-3#5)(2008-4#6)(2008-5#7)(2008-7#11)(2008-8#3)(2008-9#7)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#43)(2009-8#1)(2009-9#6)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#3)(2010-7#3)(2011-1#5)(2011-2#5)(2011-3#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2012-7#3)(2012-8#4)(2013-1#14)(2013-8#2)
NMR)##7##1##(1990-7#1)(1991-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
NMR-based##2##1##(2008-10#1)(2013-1#1)
NMR-derived constraints##2##2##(1991-8#1)(1994-5#1)
NMR-derived##5##1##(1991-8#1)(1993-11#1)(1994-5#3)
NMRI##3##1##(1992-8#1)(1996-5#2)
NMS##7##1##(1996-5#2)(2012-2#4)(2012-3#1)
NMU##3##1##(2011-1#1)(2013-1#2)
NMWCO##2##1##(2008-10#2)
NMe(3)##2##1##(1996-2#2)
NN##8##1##(1996-2#3)(2008-10#5)
NN525##2##1##(2008-10#2)
NNDSS##2##1##(1997-3#2)
NNK by##4##2##(1990-6#3)(1993-11#1)
NNK in##2##2##(1990-6#1)(1992-9#1)
NNK##17##1##(1990-6#4)(1992-9#3)(1993-11#5)(2011-1#5)
NNN##5##1##(2011-1#5)
NNRTI##2##1##(2011-3#2)
NNRTIs and##2##2##(2008-5#1)(2011-3#1)
NNRTIs##3##1##(2008-5#1)(2011-3#2)
NNS##4##1##(2009-6#4)
NO also##2##2##(1995-5#1)(2008-8#1)
NO and##14##2##(1990-8#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#2)(2013-1#1)(2013-8#2)
NO are##2##2##(2008-10#1)(2010-7#1)
NO as##2##2##(1994-11#1)(1994-6#1)
NO at##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
NO biology##2##2##(2011-2#2)
NO by##3##2##(1992-3#1)(2008-3#1)(2010-6#1)
NO concentration##3##2##(1997-2#2)(2008-2#1)
NO concentrations##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
NO does##2##2##(1991-12#1)(2008-4#1)
NO donor##4##2##(1995-5#1)(2008-11#1)(2008-7#2)
NO donors##7##2##(1995-5#5)(2008-7#1)(2009-5#1)
NO fluorescence##2##2##(2008-2#1)(2008-3#1)
NO formation##3##2##(1992-5#1)(1996-5#1)(2011-2#1)
NO generated##2##2##(2008-10#2)
NO in biological##2##3##(2008-10#2)
NO in human##2##3##(1997-2#1)(2008-3#1)
NO in##17##2##(1992-5#2)(1993-8#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)
NO is involved in##2##4##(2008-8#1)(2011-2#1)
NO is##19##2##(1991-9#1)(1995-2#1)(1996-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-10#2)(2011-2#2)(2012-2#1)
NO itself##2##2##(1994-11#1)(1996-5#1)
NO level##3##2##(2008-8#1)(2008-9#1)(2010-4#1)
NO levels in##2##3##(2007-10#1)(2013-1#1)
NO levels##3##2##(2007-10#1)(2008-7#1)(2013-1#1)
NO may##3##2##(1991-12#1)(1992-12#1)(2011-2#1)
NO measurement##2##2##(2008-10#1)(2010-6#1)
NO of##2##2##(1995-5#1)(2008-3#1)
NO produced##2##2##(1993-6#1)(1995-11#1)
NO production and##2##3##(2008-7#1)(2008-8#1)
NO production from##2##3##(1991-9#1)(2008-10#1)
NO production in##2##3##(1992-5#1)(2011-1#1)
NO production##22##2##(1991-9#1)(1992-5#1)(1994-11#1)(1994-6#2)(1995-11#1)(2006-10#3)(2008-10#2)(2008-4#1)(2008-7#4)(2008-8#2)(2011-1#2)(2012-2#1)(2013-1#1)
NO reduced was##2##3##(1992-3#2)
NO release and##2##3##(1991-3#1)(2008-3#1)
NO release from##3##3##(1997-2#2)(2008-10#1)
NO release##6##2##(1991-3#1)(1995-5#1)(1997-2#2)(2008-10#1)(2008-3#1)
NO species##3##2##(2008-10#3)
NO synthase (NOS##2##3##(1991-12#1)(1992-3#1)
NO synthase enzyme##3##3##(1992-12#3)
NO synthase in##2##3##(1995-11#2)
NO synthase inhibitor##3##3##(1995-11#1)(1995-12#1)(1995-5#1)
NO synthase##28##2##(1991-12#2)(1991-3#2)(1992-12#4)(1992-3#2)(1995-11#8)(1995-12#1)(1995-5#1)(1996-2#2)(1997-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
NO synthesis##5##2##(1993-8#2)(1997-7#1)(2008-10#1)(2010-4#1)
NO to##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
NO was##4##2##(2008-10#2)(2008-3#1)(2010-4#1)
NO with##2##2##(2008-10#2)
NO##285##1##(1990-8#2)(1991-12#4)(1991-3#3)(1991-9#2)(1992-12#6)(1992-3#7)(1992-5#4)(1992-8#1)(1993-6#2)(1993-8#3)(1994-11#3)(1994-2#1)(1994-6#6)(1995-11#11)(1995-12#2)(1995-2#4)(1995-5#19)(1995-8#1)(1996-2#4)(1996-5#2)(1997-2#8)(1997-7#10)(2006-10#3)(2007-10#3)(2007-11#1)(2008-10#47)(2008-11#2)(2008-2#15)(2008-3#19)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#20)(2008-8#13)(2008-9#2)(2009-10#2)(2009-5#1)(2010-12#1)(2010-4#4)(2010-6#6)(2010-7#4)(2011-1#5)(2011-2#13)(2011-3#3)(2012-2#3)(2013-1#3)(2013-8#4)
NO() in##3##2##(2008-10#3)
NO()##9##1##(2008-10#9)
NO(2) and##2##2##(2008-10#1)(2008-3#1)
NO(2) gas##2##2##(2008-10#2)
NO(2) in the air samples##2##5##(2008-10#2)
NO(2) in the air##3##4##(2008-10#3)
NO(2) in the##4##3##(2008-10#4)
NO(2) in##8##2##(2008-10#7)(2012-2#1)
NO(2)##31##1##(2008-10#16)(2008-11#3)(2008-2#5)(2008-3#6)(2012-2#1)
NO(2)(-) in##2##2##(2008-10#2)
NO(2)(-)##12##1##(2008-10#12)
NO(2)(-)-Nml(-1) and##2##2##(2008-10#2)
NO(2)-N##6##1##(2008-10#6)
NO(3) and##2##2##(2008-10#2)
NO(3)##6##1##(2008-10#4)(2009-6#1)(2011-1#1)
NO(3)(-) and SO(4)(2-)##2##3##(2008-10#2)
NO(3)(-) and##3##2##(2008-10#3)
NO(3)(-)##13##1##(2008-10#13)
NO(3)(-)-Nml(-1)##2##1##(2008-10#2)
NO(A)##2##1##(2008-8#2)
NO(x)##6##1##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)
NO)##5##1##(2007-10#3)(2008-10#1)(2011-1#1)
NO-donor##2##1##(1997-3#1)(2008-10#1)
NO-induced##2##1##(1993-3#1)(2008-7#1)
NO-synthase##5##1##(1995-12#4)(2013-1#1)
NO2 and O3##4##3##(1992-9#3)(2011-2#1)
NO2 and##6##2##(1992-9#3)(1996-12#2)(2011-2#1)
NO2 or O3##2##3##(1992-9#2)
NO2##15##1##(1992-9#7)(1995-5#1)(1996-12#3)(2008-11#1)(2008-3#2)(2011-2#1)
NO2- and NO3-##2##3##(1993-3#2)
NO2-##4##1##(1993-3#2)(1995-5#1)(1996-5#1)
NO2-modification##2##1##(1990-5#2)
NO2-modified##2##1##(1990-5#2)
NO3-##4##1##(1993-3#2)(1995-5#2)
NOC##6##1##(2011-1#4)(2013-1#2)
NOCs##2##1##(1992-8#1)(2011-1#1)
NOD mice##6##2##(1992-7#1)(1995-12#2)(2008-10#2)(2010-11#1)
NOD##11##1##(1992-7#1)(1995-12#3)(2007-5#1)(2008-10#3)(2010-11#3)
NOE studies of##2##3##(1991-8#1)(2008-11#1)
NOE##12##1##(1991-11#1)(1991-8#1)(1992-8#1)(1993-11#3)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)
NOE-derived##3##1##(1991-11#1)(1995-5#2)
NOESY data##2##2##(1991-12#1)(1994-5#1)
NOESY##6##1##(1991-11#1)(1991-12#1)(1994-3#1)(1994-5#1)(2007-1#1)(2008-9#1)
NOEs and##3##2##(1991-8#1)(1992-3#2)
NOEs##6##1##(1991-11#1)(1991-8#2)(1992-3#2)(1995-5#1)
NOK##12##1##(1990-2#1)(1990-9#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-2#4)(1997-4#3)
NOL7##8##1##(2013-1#8)
NOLM##4##1##(2007-11#2)(2007-12#2)
NOM##13##1##(1992-5#2)(2008-10#1)(2008-11#9)(2008-3#1)
NOOPEs##2##1##(2011-1#2)
NOR and ENO in##3##4##(2008-10#3)
NOR and##5##2##(2008-10#5)
NOR site##2##2##(2008-5#2)
NOR##16##1##(2008-10#9)(2008-12#1)(2008-5#2)(2010-3#2)(2013-8#2)
NOR-1 gene expression##2##3##(1995-12#2)
NOR-1##10##1##(1994-12#3)(1995-12#7)
NOR-bearing pair##2##2##(2008-12#1)(2010-3#1)
NORs##14##1##(1993-12#11)(2008-12#1)(2008-5#1)(2010-3#1)
NOS activity##8##2##(1992-3#2)(1993-8#1)(1994-11#1)(1994-6#2)(2008-8#1)(2011-1#1)
NOS and##4##2##(1992-3#1)(1992-8#1)(1993-8#1)(2008-10#1)
NOS gene##2##2##(1993-3#2)
NOS in##2##2##(1995-12#2)
NOS inhibitor##2##2##(1995-12#1)(2009-4#1)
NOS is##2##2##(1993-3#1)(2008-7#1)
NOS levels##2##2##(1995-12#2)
NOS type##2##2##(1992-3#1)(2011-1#1)
NOS##59##1##(1991-12#4)(1992-3#7)(1992-8#1)(1993-3#3)(1993-8#3)(1994-11#2)(1994-6#3)(1995-12#8)(1997-5#1)(1997-6#1)(2006-8#1)(2008-10#7)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#4)(2009-4#1)(2009-9#1)(2010-12#2)(2011-1#2)
NOS-2##3##1##(2008-12#3)
NOS-3##3##1##(2011-1#3)
NOS/NO##3##1##(2008-10#1)(2009-10#2)
NOT##4##1##(2009-11#1)(2009-12#1)(2010-5#1)(2012-3#1)
NOTES and LESS##3##3##(2009-2#3)
NOTES##5##1##(2009-2#3)(2009-8#2)
NOW Legal Defense and Education Fund##2##6##(1995-6#2)
NOx##5##1##(1994-3#1)(2007-10#4)
NP and##4##2##(1997-4#1)(2008-10#3)
NP females were either ovariectomized or sham-operated (SO)##3##8##(1997-4#3)
NP females were##4##3##(1997-4#4)
NP groups##3##2##(1997-4#3)
NP luminescence##2##2##(2012-12#2)
NP mice##5##2##(1997-4#5)
NP or##2##2##(2008-10#2)
NP reacted##2##2##(2008-10#2)
NP was##2##2##(2008-10#1)(2013-8#1)
NP were##2##2##(2008-10#1)(2008-8#1)
NP with##2##2##(2007-11#1)(2008-10#1)
NP##51##1##(1997-4#13)(2007-11#4)(2008-10#10)(2008-8#2)(2008-9#1)(2009-12#5)(2010-1#2)(2010-10#1)(2010-5#1)(2010-6#2)(2012-12#5)(2013-8#5)
NP24##2##1##(1997-4#1)(2008-10#1)
NPBnE##2##1##(2008-10#2)
NPC and##2##2##(1990-8#1)(1992-6#1)
NPC patients##2##2##(1990-8#2)
NPC##24##1##(1990-8#4)(1992-6#2)(2008-8#1)(2008-9#1)(2011-2#14)(2013-1#2)
NPD and##3##2##(2008-12#2)(2008-9#1)
NPD##8##1##(2008-12#5)(2008-9#3)
NPDC-1##4##1##(1995-2#4)
NPDR##2##1##(2010-8#2)
NPEVs##2##1##(2011-1#2)
NPH##5##1##(2007-7#5)
NPH-MCKD complex##3##2##(2007-7#3)
NPI##4##1##(2008-4#2)(2008-6#1)(2010-11#1)
NPIK was##2##2##(1997-8#2)
NPIK##9##1##(1997-8#9)
NPK application##2##2##(2008-12#2)
NPK##3##1##(2008-12#3)
NPM-ALK each##2##2##(2011-2#2)
NPM-ALK##3##1##(2011-2#3)
NPOE membranes##2##2##(2008-10#2)
NPOE##5##1##(2008-10#5)
NPP##4##1##(1994-9#1)(2008-4#2)(2011-2#1)
NPP1 in##2##2##(2008-4#2)
NPP1##3##1##(2008-4#3)
NPPV##5##1##(2008-1#5)
NPPs##3##1##(2009-12#3)
NPR1##5##1##(2008-10#3)(2011-10#1)(2011-2#1)
NPS Pharmaceuticals##2##2##(2008-10#2)
NPS##10##1##(2008-10#3)(2008-7#2)(2008-9#2)(2012-2#2)(2013-1#1)
NPSC##3##1##(2007-11#3)
NPSLE##3##1##(2012-3#3)
NPTs##5##1##(2010-11#5)
NPV##7##1##(1997-3#1)(1997-4#1)(2008-11#1)(2011-2#3)(2012-12#1)
NPWE##2##1##(2012-1#2)
NPXY##2##1##(1990-11#1)(1995-2#1)
NPY and NADPH-d##2##3##(1997-2#2)
NPY and##5##2##(1997-2#2)(1997-4#1)(2009-8#1)(2013-8#1)
NPY gene##4##2##(1992-12#3)(1996-12#1)
NPY in##2##2##(1995-3#2)
NPY or C-PON immunoreactivity##2##4##(1990-5#2)
NPY or C-PON##3##3##(1990-5#3)
NPY or##4##2##(1990-5#3)(1996-12#1)
NPY##22##1##(1990-5#3)(1992-12#3)(1995-3#2)(1996-12#2)(1997-2#2)(1997-4#7)(2008-4#1)(2009-8#1)(2013-8#1)
NPY(13-36)##3##1##(1997-4#3)
NPY-IR##3##1##(1997-2#1)(1997-4#2)
NPs are##3##2##(2009-12#1)(2010-12#1)(2012-12#1)
NPs in##2##2##(2010-5#1)(2012-6#1)
NPs were##2##2##(2012-6#2)
NPs##17##1##(2007-10#1)(2009-12#2)(2010-12#1)(2010-5#4)(2012-12#2)(2012-6#6)(2013-8#1)
NQO1 activity##2##2##(1994-8#2)
NQO1##5##1##(1994-8#5)
NQS and##2##2##(2008-10#2)
NQS##4##1##(2008-10#4)
NR apoenzyme##2##2##(1993-6#2)
NR##13##1##(1993-6#2)(2008-10#7)(2008-11#3)(2010-9#1)
NR-1##3##1##(2008-9#3)
NR-2##2##1##(2008-9#2)
NR-3 and NR-4##2##3##(2008-9#2)
NR2A and NR2B##2##3##(1997-2#2)
NR2A##4##1##(1997-2#4)
NR2B gene- and caspase-3 protein-expression##2##5##(2012-2#2)
NR2B in##2##2##(1997-2#1)(2012-2#1)
NR2B is##2##2##(1996-5#1)(2012-2#1)
NR2B##13##1##(1996-5#2)(1997-2#7)(2012-2#4)
NR2C##7##1##(1996-12#7)
NRAS and BRAF##2##3##(2009-4#2)
NRAS##4##1##(2009-4#4)
NRBC alone##2##2##(1996-12#2)
NRC vision for##2##3##(2011-1#2)
NRC vision##3##2##(2011-1#3)
NRC##9##1##(1991-5#1)(2008-10#1)(2008-12#1)(2010-2#2)(2011-1#4)
NRCC##3##1##(2008-10#3)
NREMS##3##1##(1991-9#3)
NRK cells##4##2##(1991-12#1)(1991-8#2)(1992-9#1)
NRK in##2##2##(1991-12#2)
NRK##8##1##(1991-12#5)(1991-8#2)(1992-9#1)
NRMs##4##1##(2008-12#4)
NRRL##6##1##(2008-10#2)(2008-6#3)(2012-2#1)
NRT is##2##2##(2008-6#1)(2012-3#1)
NRT or##2##2##(2008-9#1)(2011-2#1)
NRT##19##1##(2008-6#2)(2008-9#6)(2011-2#1)(2012-3#10)
NRT-based MAP##2##2##(2008-9#2)
NRT-based MAPs##3##2##(2008-9#3)
NRT-based##5##1##(2008-9#5)
NRs##3##1##(2010-9#3)
NS and##3##2##(2008-10#2)(2008-6#1)
NS##12##1##(1996-5#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-1#2)(2011-1#1)(2012-2#1)
NS)##5##1##(1994-12#2)(2011-2#1)(2013-1#2)
NS-1176##2##1##(2008-10#2)
NS-398##2##1##(1997-1#2)
NS-49 is##2##2##(1995-11#2)
NS-49##7##1##(1995-11#7)
NS/0##4##1##(2008-11#4)
NS0 cell lines##2##3##(2008-11#2)
NS0 cell##4##2##(2008-11#3)(2008-7#1)
NS0 cells in##2##3##(2008-11#2)
NS0 cells##3##2##(2008-11#3)
NS0 mouse##2##2##(1994-5#1)(2008-11#1)
NS0##13##1##(1994-5#1)(2008-11#10)(2008-7#2)
NS2 protein##2##2##(2012-2#2)
NS2##3##1##(2012-2#3)
NS2(Pro) homodimerization##2##2##(2012-2#2)
NS2(Pro)##6##1##(2012-2#6)
NS3##2##1##(2008-10#2)
NSAID and##2##2##(1990-6#1)(2009-5#1)
NSAID therapy##2##2##(2006-10#1)(2008-11#1)
NSAID use##3##2##(2006-10#1)(2008-11#1)(2008-8#1)
NSAID was##2##2##(2006-10#1)(2008-11#1)
NSAID##19##1##(1990-6#1)(1991-8#1)(1991-9#1)(2006-10#5)(2008-11#4)(2008-12#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
NSAIDS##2##1##(2008-11#1)(2009-5#1)
NSAIDs and##3##2##(1993-11#1)(2006-10#1)(2007-11#1)
NSAIDs as##2##2##(2008-12#1)(2011-2#1)
NSAIDs in##2##2##(2008-11#1)(2008-3#1)
NSAIDs on the##2##3##(1991-2#1)(2008-10#1)
NSAIDs on##3##2##(1991-2#1)(1997-1#1)(2008-10#1)
NSAIDs to##2##2##(2008-11#1)(2008-8#1)
NSAIDs##42##1##(1990-11#1)(1991-2#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(2006-10#5)(2007-11#2)(2007-4#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#3)(2011-2#6)(2013-1#2)
NSC##7##1##(2008-4#1)(2011-2#2)(2012-5#4)
NSCLC and##3##2##(1992-12#1)(2012-1#1)(2013-8#1)
NSCLC cells##3##2##(2013-1#3)
NSCLC is##2##2##(2010-8#1)(2012-1#1)
NSCLC patients treated with##2##4##(2010-8#2)
NSCLC patients##5##2##(2010-8#3)(2012-1#2)
NSCLC were##2##2##(2007-8#1)(2012-3#1)
NSCLC##40##1##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#3)(2007-6#1)(2007-8#2)(2008-10#3)(2008-4#1)(2010-8#7)(2012-1#5)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#3)
NSCLCs##3##1##(2008-4#3)
NSCs cultured in suspension##2##4##(2008-11#2)
NSCs cultured in##4##3##(2008-11#4)
NSCs##13##1##(2008-11#8)(2008-4#2)(2009-10#3)
NSDA's##2##1##(1996-1#2)
NSE concentrations in##2##3##(1992-11#2)
NSE concentrations##3##2##(1992-11#3)
NSE##16##1##(1990-6#5)(1990-8#1)(1991-8#1)(1992-11#3)(2008-11#1)(2011-2#5)
NSF and NPGI##2##3##(2008-7#2)
NSF##4##1##(2008-7#3)(2010-12#1)
NSI##5##1##(2013-1#5)
NSP 5a3a##8##2##(2011-2#8)
NSP 5a3a's##3##2##(2011-2#3)
NSP proteins##2##2##(2012-12#2)
NSP##16##1##(2011-2#11)(2012-12#5)
NSP-CAS signaling##2##2##(2012-12#2)
NSP-CAS##3##1##(2012-12#3)
NSP-tree##2##1##(2009-9#2)
NSP49##2##1##(1995-9#2)
NSS processing##2##2##(2008-9#2)
NSS##4##1##(2008-10#1)(2008-9#3)
NSSF##5##1##(2008-6#5)
NST##4##1##(1993-12#3)(2008-5#1)
NSTE ACS##2##2##(2008-3#2)
NSTEMI##3##1##(2008-3#1)(2011-2#2)
NSW##6##1##(1990-2#3)(2011-2#1)(2013-1#2)
NSm and G1/G2 proteins##2##4##(2008-10#2)
NSm##4##1##(2008-10#4)
NSs protein##5##2##(2008-10#5)
NSs proteins##3##2##(2008-10#3)
NSs##14##1##(2008-10#14)
NT and NN##2##3##(1996-2#2)
NT and##4##2##(1996-2#2)(2008-10#1)(2008-7#1)
NT in##2##2##(2008-11#1)(2008-5#1)
NT##25##1##(1990-5#4)(1994-8#1)(1996-2#3)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-8#1)
NT- and##2##2##(1994-3#1)(2008-7#1)
NT-3 modification##2##2##(2009-10#2)
NT-3##13##1##(1994-8#2)(2008-5#3)(2008-8#3)(2009-10#5)
NT-3cDNA/CHO##2##1##(2008-8#2)
NT-4##3##1##(2008-5#3)
NT-4/5##2##1##(1994-8#2)
NT-proBNP levels##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
NT-proBNP##12##1##(2008-3#3)(2008-7#3)(2011-2#6)
NT-stimulated##3##1##(1994-3#3)
NT/NMN precursor processing##2##3##(1994-8#2)
NT/NMN##3##1##(1994-8#3)
NT2/D1##2##1##(1994-9#1)(2008-7#1)
NTA##3##1##(2008-10#2)(2008-9#1)
NTAB##2##1##(1996-12#2)
NTDB data points##17##3##(2008-4#15)(2008-5#1)(2008-6#1)
NTE##2##1##(1996-12#1)(2008-10#1)
NTG##7##1##(1991-9#7)
NTI##2##1##(2008-7#2)
NTM disease##2##2##(2011-2#2)
NTM##3##1##(2011-2#3)
NTO##4##1##(2008-11#4)
NTP and##2##2##(2008-11#1)(2008-7#1)
NTP report on the toxicology studies of##3##7##(2008-8#1)(2008-9#2)
NTP##13##1##(1990-7#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#5)(2010-7#1)(2010-8#2)
NTPDase##6##1##(2008-4#6)
NTPDase3##12##1##(2008-4#12)
NTPDases 1##4##2##(2008-4#4)
NTPDases##17##1##(2008-4#17)
NTPs##3##1##(2008-7#1)(2010-7#2)
NTR##2##1##(2009-10#1)(2013-8#1)
NTRs##2##1##(2009-10#1)(2011-2#1)
NTS##7##1##(1992-3#2)(1995-12#1)(1997-2#4)
NTs and NWs##2##3##(2008-7#2)
NTs##3##1##(1990-5#1)(2008-7#2)
NU concepts##2##2##(2010-10#2)
NU##5##1##(2010-10#5)
NU7441 and##2##2##(2013-1#2)
NU7441##6##1##(2013-1#6)
NUE##3##1##(2012-1#3)
NV##4##1##(2007-8#1)(2008-1#2)(2008-5#1)
NVIDIA##2##1##(2011-1#1)(2012-2#1)
NVivo##2##1##(2011-1#2)
NW of##3##2##(2008-10#2)(2008-11#1)
NW##8##1##(2008-10#2)(2008-11#1)(2008-7#5)
NW-nitro L-arginine benzyl ester##2##4##(1991-9#2)
NWFP##5##1##(2008-12#3)(2009-7#1)(2010-11#1)
NWTs##2##1##(2008-7#2)
NWs##3##1##(2008-10#1)(2008-7#2)
NXIIts##5##1##(2008-8#5)
NY cells##2##2##(1993-12#2)
NY##8##1##(1993-12#2)(1995-2#1)(2008-10#2)(2008-5#1)(2013-1#2)
NY-RPV##3##1##(2008-10#3)
NYAPs were##2##2##(2008-10#2)
NYAPs##5##1##(2008-10#5)
NYC##7##1##(1991-1#2)(1996-1#1)(1996-3#4)
NYHA functional class##2##3##(2007-8#2)
NYHA status##2##2##(2007-8#2)
NYHA##11##1##(1994-11#2)(2007-8#5)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)
NYR##4##1##(2010-7#4)
NYT##4##1##(2008-10#4)
NZ IMMP##2##2##(2008-11#1)(2008-8#1)
NZ##6##1##(2008-10#2)(2008-11#2)(2008-8#2)
NZB##2##1##(1994-8#2)
Na and Cl##3##3##(2008-9#2)(2012-12#1)
Na and K##3##3##(2008-10#3)
Na and Si##3##3##(2008-10#3)
Na and glucose##2##3##(1991-9#2)
Na and##17##2##(1991-9#2)(2008-10#10)(2008-2#1)(2008-5#1)(2008-9#2)(2012-12#1)
Na channel##2##2##(2008-1#1)(2012-12#1)
Na concentration##2##2##(2008-5#2)
Na ions##2##2##(2008-10#1)(2008-5#1)
Na##88##1##(1990-11#1)(1991-9#3)(1992-12#2)(1992-8#1)(1993-12#1)(1994-8#9)(1997-4#2)(1997-6#1)(1997-7#3)(2008-1#1)(2008-10#36)(2008-11#3)(2008-2#3)(2008-5#7)(2008-8#2)(2008-9#4)(2010-3#1)(2011-2#1)(2012-12#2)(2012-5#2)(2013-8#3)
Na(+) and Ca(2+)##2##3##(2008-10#1)(2009-12#1)
Na(+) and K(+) and##2##4##(2008-10#2)
Na(+) and K(+)##10##3##(2008-10#8)(2008-7#1)(2012-12#1)
Na(+) and##19##2##(2008-10#13)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2012-12#1)
Na(+) channel##4##2##(2008-8#4)
Na(+) channels##7##2##(2008-8#7)
Na(+) concentration##3##2##(2008-10#2)(2008-5#1)
Na(+) currents were##2##3##(2008-8#2)
Na(+) excretion##2##2##(2011-2#2)
Na(+) extraction selectivity##2##3##(2008-10#2)
Na(+) in##2##2##(2012-7#2)
Na(+) ion##3##2##(2008-10#3)
Na(+) ions##6##2##(2008-10#3)(2008-8#3)
Na(+)##103##1##(2008-10#63)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#19)(2008-9#1)(2009-12#2)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-7#2)(2013-1#1)
Na(+)&gt##4##1##(2008-10#4)
Na(+)- and##2##2##(1992-6#1)(2008-10#1)
Na(+)-##3##1##(1992-6#1)(1995-6#1)(2008-10#1)
Na(+)-ATPase activity was##2##3##(1990-5#2)
Na(+)-H+ antiport##4##2##(1992-5#4)
Na(+)-H+ antiporter##2##2##(1992-5#2)
Na(+)-H+ exchange##3##2##(1992-5#3)
Na(+)-H+##10##1##(1992-5#10)
Na(+)-K(+) ATPase##2##2##(1994-8#2)
Na(+)-K(+)-2Cl-##3##1##(2008-8#3)
Na(+)-K(+)-ATPase##2##1##(2008-8#2)
Na(+)-K(+)ATPase activity##2##2##(1994-8#2)
Na(+)-K+##3##1##(1994-8#1)(2008-8#2)
Na(+)-dependent glucose transporter (SGLT1)##2##4##(1991-12#2)
Na(+)-dependent##6##1##(1990-12#1)(1990-2#1)(1991-12#2)(1991-5#1)(1995-8#1)
Na(+)-independent phosphorylation##2##2##(1990-11#2)
Na(+)-independent##3##1##(1990-11#3)
Na(+)/Ca(2+)##2##1##(2008-11#2)
Na(+)/K(+)-ATPase activity##2##2##(2008-7#2)
Na(+)/K(+)-ATPase and##2##2##(2007-12#2)
Na(+)/K(+)-ATPase##7##1##(2007-12#2)(2008-7#3)(2009-12#2)
Na(2) SO(4)##3##2##(2012-7#3)
Na(2)CO(3) and##3##2##(2008-10#3)
Na(2)CO(3) fusion##3##2##(2008-10#3)
Na(2)CO(3)##9##1##(2008-10#9)
Na(2)O and##2##2##(2008-10#1)(2008-5#1)
Na(2)O##7##1##(2007-12#3)(2008-10#3)(2008-5#1)
Na(2)SO(3)##2##1##(2008-10#2)
Na(2)SO(4) and Na(3)PO(4)##3##3##(2008-10#3)
Na(2)SO(4) and##5##2##(2008-10#5)
Na(2)SO(4)##12##1##(2008-10#12)
Na(3)PO(4)##4##1##(2008-10#4)
Na(4)HTmDOTP##2##1##(1997-7#2)
Na(V) 1##4##2##(2013-1#4)
Na(V) channels##3##2##(2008-8#3)
Na(V)##7##1##(2008-8#3)(2013-1#4)
Na(V)1##4##1##(2008-8#4)
Na(v)1##4##1##(2008-8#4)
Na)##2##1##(2008-10#1)(2008-3#1)
Na)NO(3)##2##1##(2008-10#2)
Na+ and Ca2+##2##3##(1995-5#2)
Na+ and K+##3##3##(1990-7#1)(1992-6#2)
Na+ and Li+##2##3##(1990-11#1)(1992-6#1)
Na+ and##15##2##(1990-11#2)(1990-7#2)(1991-8#2)(1992-6#3)(1995-12#1)(1995-5#2)(1997-2#1)(2008-12#2)
Na+ binding site##2##3##(1995-5#1)(1997-2#1)
Na+ binding##4##2##(1995-5#1)(1997-2#3)
Na+ channel clusters##2##3##(2008-7#2)
Na+ channel##5##2##(1995-11#1)(2008-7#4)
Na+ channels##4##2##(1992-7#1)(1995-11#1)(2008-11#1)(2008-8#1)
Na+ concentration##5##2##(1992-5#1)(1993-12#1)(1994-6#1)(1995-2#2)
Na+ electrochemical potential##3##3##(1997-8#3)
Na+ influx##2##2##(1993-12#1)(1995-5#1)
Na+ or##4##2##(1992-11#1)(1993-11#1)(1995-5#2)
Na+ permeability of##2##3##(1992-6#1)(1993-12#1)
Na+ pump##2##2##(1990-11#1)(1997-8#1)
Na+ transport##7##2##(1992-6#2)(1995-5#2)(2008-8#3)
Na+##105##1##(1990-11#15)(1990-2#2)(1990-7#3)(1991-5#1)(1991-8#6)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#10)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-8#1)(1994-6#2)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#2)(1995-5#8)(1996-12#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-8#4)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#4)(2008-8#5)
Na+/Ca2+-K+ exchangers (NCKX)##2##3##(2008-8#2)
Na+/H+ antiport activity##2##3##(1990-2#2)
Na+/H+ antiport##4##2##(1990-2#3)(1992-10#1)
Na+/H+ exchange activity##2##3##(1992-10#2)
Na+/H+ exchange##6##2##(1992-10#3)(1994-3#1)(1995-8#2)
Na+/H+ exchanger##4##2##(1993-3#4)
Na+/H+##14##1##(1990-2#3)(1992-10#4)(1993-3#4)(1994-3#1)(1995-8#2)
Na+/K(+)-ATPase activation by trypsin##2##4##(1990-5#2)
Na+/K(+)-ATPase activity of##2##3##(1990-12#1)(1994-6#1)
Na+/K(+)-ATPase activity##5##2##(1990-12#2)(1994-6#3)
Na+/K(+)-ATPase stimulation##2##2##(1990-5#2)
Na+/K(+)-ATPase##23##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#7)(1994-12#1)(1994-6#6)(1995-6#2)
Na+/K+ ATPase##3##2##(1990-12#2)(2007-10#1)
Na+/K+ and proline##2##3##(2008-12#2)
Na+/K+ and##3##2##(2008-12#3)
Na+/K+##9##1##(1990-12#2)(1993-1#2)(1997-1#1)(2007-10#1)(2008-12#3)
Na+/glucose cotransporter##2##2##(1991-12#2)
Na-AsA##2##1##(1992-3#2)
Na-Ca exchange##3##2##(2008-8#1)(2013-1#2)
Na-Ca+K exchange##3##2##(1995-5#3)
Na-Ca+K exchanger##3##2##(1995-5#3)
Na-Ca+K##6##1##(1995-5#6)
Na-K ATPase molecules may##2##4##(1995-8#2)
Na-K ATPase##4##2##(1995-8#4)
Na-K-2Cl cotransporter##4##2##(2007-7#1)(2008-8#3)
Na-K-2Cl##5##1##(2007-7#1)(2008-8#4)
Na-ZSM-5##2##1##(2008-10#2)
Na-butyrate##5##1##(2008-11#5)
Na-montmorillonite##2##1##(2008-10#2)
Na/K##3##1##(2008-4#2)(2008-8#1)
Na2CO3##2##1##(1993-11#1)(2013-1#1)
Na2SO4##6##1##(1994-5#1)(2008-6#5)
NaAlO(2)##3##1##(2008-10#3)
NaB##6##1##(1992-3#6)
NaBH(4) and##3##2##(2008-10#3)
NaBH(4) in##4##2##(2008-10#4)
NaBH(4) were##3##2##(2008-10#3)
NaBH(4)##21##1##(1996-5#1)(2008-10#20)
NaBH4##7##1##(1991-5#1)(1995-3#1)(2007-11#3)(2008-10#2)
NaBr##8##1##(1995-5#1)(2008-10#7)
NaCl 0##2##2##(2008-10#2)
NaCl and water##2##3##(2008-5#1)(2008-8#1)
NaCl and##15##2##(1990-11#1)(1992-6#1)(1995-6#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-10#3)(2013-1#1)
NaCl as##2##2##(2008-10#2)
NaCl at concentrations##2##3##(1993-9#1)(2008-10#1)
NaCl at##7##2##(1993-3#1)(1993-9#1)(1994-5#1)(2008-10#4)
NaCl concentration##11##2##(1990-7#1)(1997-2#3)(2008-11#1)(2008-5#6)
NaCl concentrations##6##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-7#2)
NaCl for##2##2##(1992-6#1)(2011-2#1)
NaCl from the##2##3##(1994-6#1)(2008-5#1)
NaCl from##3##2##(1992-3#1)(1994-6#1)(2008-5#1)
NaCl in the##2##3##(1992-3#1)(2008-10#1)
NaCl in##5##2##(1992-3#1)(1993-12#1)(2008-10#3)
NaCl intake##8##2##(1993-12#6)(1997-4#2)
NaCl is##5##2##(1993-12#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
NaCl levels##2##2##(1997-4#1)(2008-12#1)
NaCl or##4##2##(1992-6#1)(2008-10#2)(2008-11#1)
NaCl release##2##2##(1997-2#2)
NaCl saturated##2##2##(2008-10#1)(2012-2#1)
NaCl solution##6##2##(1993-12#1)(2008-10#3)(2013-1#2)
NaCl solutions##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
NaCl treatment##2##2##(1997-8#1)(2008-11#1)
NaCl was##4##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
NaCl were used##2##3##(1991-11#1)(2008-10#1)
NaCl were##9##2##(1990-12#1)(1991-11#1)(1993-12#1)(1997-2#1)(2008-10#5)
NaCl with##2##2##(1991-8#1)(1994-8#1)
NaCl within##2##2##(1993-3#1)(2008-10#1)
NaCl##209##1##(1990-11#1)(1990-12#2)(1990-5#3)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-3#5)(1992-6#6)(1992-8#1)(1993-12#13)(1993-3#3)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-5#2)(1997-2#13)(1997-4#5)(1997-8#1)(2007-3#4)(2008-10#72)(2008-11#10)(2008-12#3)(2008-4#1)(2008-5#12)(2008-6#3)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#2)(2009-8#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#3)(2013-1#4)
NaCl)##12##1##(1992-8#1)(1994-8#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-3#1)(2013-8#1)
NaCl-best##2##1##(2009-10#2)
NaClO(4) aqueous solution##2##3##(2008-10#2)
NaClO(4) at##2##2##(2008-10#2)
NaClO(4)##13##1##(2008-10#13)
NaF for 3 min daily##2##5##(2013-1#2)
NaF for 3 min every 2 weeks##2##7##(2013-1#2)
NaF for 3 min##4##4##(2013-1#4)
NaF increased##2##2##(1993-3#2)
NaF solution##3##2##(2008-10#1)(2013-1#2)
NaF treatment##3##2##(2008-10#3)
NaF##27##1##(1990-7#2)(1990-8#4)(1992-11#1)(1993-3#4)(2008-10#8)(2013-1#8)
NaH##4##1##(1996-2#1)(1996-5#2)(2007-11#1)
NaH(2)PO(4)##5##1##(2008-10#5)
NaHCO(3)##2##1##(2008-10#2)
NaHCO(3))##2##1##(2008-10#2)
NaI##3##1##(1992-12#1)(2008-10#1)(2013-1#1)
NaNO(2)##3##1##(2008-10#3)
NaNO(3) solution##3##2##(2008-10#3)
NaNO(3)##15##1##(2008-10#14)(2008-5#1)
NaOCl and##5##2##(2008-10#2)(2012-3#1)(2013-1#2)
NaOCl was##2##2##(2008-12#1)(2013-1#1)
NaOCl##17##1##(2008-10#3)(2008-12#2)(2012-3#1)(2013-1#11)
NaOH and##4##2##(2008-10#3)(2011-2#1)
NaOH as a##2##3##(2008-10#2)
NaOH from##2##2##(2008-10#2)
NaOH in##3##2##(1994-9#1)(2007-11#1)(2008-10#1)
NaOH solution##13##2##(2008-10#11)(2008-11#1)(2008-5#1)
NaOH treatment##3##2##(1997-4#2)(2011-2#1)
NaOH##53##1##(1992-3#1)(1994-9#1)(1995-6#1)(1997-4#2)(2007-11#1)(2008-10#39)(2008-11#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
NaOH)##2##1##(1992-3#1)(2008-10#1)
NaP##5##1##(2011-2#5)
NaTPB##7##1##(2008-10#7)
NaV1##6##1##(2010-12#1)(2012-3#5)
NaY(WO(4))(2)##2##1##(2008-3#2)
Nab##3##1##(2008-10#3)
Nabedryk##4##1##(1992-6#4)
Nac1##4##1##(2010-11#4)
Nacional San Esteban##2##3##(2011-2#2)
Nacional de##5##2##(2008-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
Nacional##18##1##(2008-10#1)(2008-5#4)(2008-6#3)(2011-2#6)(2012-12#2)(2012-3#1)(2013-7#1)
Nacionales'##2##1##(2009-7#2)
Nafion and##3##2##(2008-10#3)
Nafion film##2##2##(2008-10#2)
Nafion films##5##2##(2008-10#5)
Nafion membrane##4##2##(2008-10#4)
Nafion was##2##2##(2008-10#2)
Nafion##35##1##(2008-10#35)
Nafion((R))##2##1##(2008-10#2)
Nafion(R)##4##1##(2008-10#4)
Nafion(R)-coated carbon paste electrodes##2##4##(2008-10#2)
Nafion(R)-coated carbon paste##3##3##(2008-10#3)
Nafion(R)-coated carbon##4##2##(2008-10#4)
Nafion-modified glassy carbon electrode##2##4##(2008-10#2)
Nafion/MV modified carbon fiber##2##4##(2008-10#2)
Nafion/MV modified##5##2##(2008-10#5)
Nafion/MV##6##1##(2008-10#6)
Nafion/mercury film##2##2##(2008-10#2)
Nagabuna and Gengoroubuna##3##3##(2008-5#3)
Nagabuna##7##1##(2008-5#7)
Nagasaki##4##1##(1996-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
Nagase analbuminemic rats##2##3##(1992-11#2)
NahG plants##2##2##(2008-10#2)
NahG##5##1##(2008-10#3)(2012-2#2)
Nai##2##1##(1994-3#2)
Nailing##3##1##(1995-6#1)(2009-3#1)(2013-8#1)
Nairobi##2##1##(2007-12#1)(2009-5#1)
Naive##2##1##(2008-11#1)(2008-5#1)
Naja naja atra##4##3##(1997-7#4)
Najran##3##1##(2007-2#1)(2008-1#2)
Nakamurella multipartita##2##2##(2011-2#2)
Nakamurella##3##1##(2011-2#3)
Nakayama##2##1##(1992-12#1)(1995-12#1)
Nakdong##6##1##(2008-10#6)
Naked-eye##2##1##(2008-10#2)
Nakhichevanees patients##2##2##(2008-12#2)
Nakhla##4##1##(2008-10#4)
NalR##2##1##(1994-12#1)(1995-8#1)
Naloxonazine##2##1##(1996-2#2)
Naloxone##2##1##(1991-5#1)(1992-12#1)
Named##2##1##(1996-11#1)(2008-9#1)
Namely##9##1##(1993-3#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Namibia##14##1##(1997-6#4)(2008-12#1)(2010-4#4)(2011-1#4)(2011-2#1)
Namibian##3##1##(1997-6#1)(2010-4#2)
Nanban lacquer film##2##3##(2008-10#2)
Nanchititla##2##1##(2013-7#2)
Nancy##2##1##(2008-5#2)
NanoBuds##2##1##(2008-7#2)
NanoCoPc##2##1##(2008-10#2)
Nanobiotechnology##2##1##(2008-7#2)
Nanocrystals##3##1##(2008-10#1)(2009-11#1)(2009-7#1)
Nanofilter##2##1##(2008-10#2)
Nanoindentation##2##1##(2008-3#1)(2010-4#1)
Nanomaterials##7##1##(2008-7#3)(2009-11#1)(2010-7#2)(2013-1#1)
Nanomechanical##2##1##(2008-7#1)(2010-10#1)
Nanomedicine##2##1##(2008-7#2)
Nanometer titanium dioxide immobilized on silica gel##2##7##(2008-10#2)
Nanometer##5##1##(2007-11#1)(2008-10#2)(2008-3#1)(2009-11#1)
Nanoparticles and##2##2##(2008-7#1)(2009-9#1)
Nanoparticles##15##1##(2008-10#5)(2008-11#2)(2008-7#3)(2009-11#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-6#1)
Nanoparticulate##2##1##(2008-5#1)(2009-12#1)
Nanorods##3##1##(2008-11#1)(2008-7#1)(2010-1#1)
Nanoscale##9##1##(2007-12#1)(2008-10#2)(2008-7#2)(2009-11#1)(2009-2#1)(2010-4#1)(2010-7#1)
Nanoscience &amp##2##2##(2013-1#2)
Nanoscience##3##1##(2008-10#1)(2013-1#2)
Nanosecond##7##1##(1991-12#1)(1991-5#1)(1994-11#1)(1995-2#1)(2007-12#2)(2008-3#1)
Nanosensors##2##1##(2008-10#1)(2008-7#1)
Nanostructured##4##1##(2008-7#1)(2009-12#1)(2010-4#2)
Nanostructures##4##1##(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)
Nanosystems##2##1##(2008-5#1)(2010-12#1)
Nanotechnology is a##2##3##(2008-11#2)
Nanotechnology is##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
Nanotechnology##8##1##(2008-10#1)(2008-11#4)(2008-12#1)(2010-12#2)
Nanotube##2##1##(2008-10#1)(2008-7#1)
Nantong City##4##2##(2012-3#4)
Nap3Phe6[6/8]##2##1##(1995-2#2)
Naphtylazoxine 6S##3##2##(2008-10#3)
Naples##7##1##(1991-6#1)(1993-5#2)(1994-5#1)(2008-10#2)(2008-2#1)
Naproxen##2##1##(2008-10#2)
Narcissus##3##1##(1990-7#1)(2008-2#2)
Narrative##8##1##(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
Narrow##4##1##(2008-2#1)(2010-10#1)(2011-1#1)(2012-2#1)
Narrow-band##6##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-6#1)
Narrow-sense heritabilities##2##2##(2008-10#2)
Narrowing##2##1##(1992-12#1)(2008-7#1)
Nasal septal##2##2##(2008-2#1)(2011-1#1)
Nasal##9##1##(1990-6#1)(1997-3#1)(2007-12#1)(2008-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Nascent##3##1##(2012-3#3)
Nash and Snyder medium##2##4##(1997-6#2)
Nash##4##1##(1997-6#2)(2008-10#1)(2008-8#1)
Nashville##2##1##(2008-10#1)(2012-3#1)
Nasonia vitripennis (Walker)##2##3##(2008-6#2)
Nasopharyngeal##2##1##(2010-7#1)(2013-8#1)
Nat##3##1##(2008-10#1)(2008-7#1)(2011-1#1)
Natal##4##1##(2008-10#1)(2010-3#3)
Nathan##3##1##(1991-1#1)(1991-8#1)(2009-4#1)
Nation##9##1##(1991-2#1)(1992-3#2)(1993-3#1)(1996-1#1)(1997-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
Nation's##9##1##(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-6#1)
National AIDS Control##2##3##(1996-4#1)(1997-6#1)
National AIDS Policy##2##3##(1995-6#2)
National AIDS##5##2##(1995-6#2)(1996-4#1)(1997-6#1)(2008-7#1)
National Academy of##2##3##(2007-6#1)(2011-3#1)
National Advisory Committee on Immunization (NACI)##4##6##(1994-9#1)(1995-11#2)(1995-6#1)
National Advisory Committee on Immunization##5##5##(1994-11#1)(1994-9#1)(1995-11#2)(1995-6#1)
National Association of People with AIDS (NAPWA)##3##7##(1995-6#1)(1996-5#2)
National Association of Private Psychiatric Hospitals##4##6##(1991-1#2)(1992-2#1)(1992-3#1)
National Association of##8##3##(1991-1#2)(1992-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-5#2)
National Asthma##2##2##(1990-9#1)(2009-6#1)
National Biological Dosimetry Response Plan##2##5##(2008-7#2)
National Blood##2##2##(1996-11#1)(2008-12#1)
National Board of Health##2##4##(1990-12#1)(1996-9#1)
National Board of##3##3##(1990-12#1)(1996-9#1)(2012-3#1)
National Board##7##2##(1990-12#1)(1996-7#1)(1996-9#1)(2008-11#3)(2012-3#1)
National Breast and Cervical Cancer Early Detection Program##2##8##(1997-1#2)
National Cancer Institute (NCI)##3##4##(1997-1#1)(1997-3#1)(2013-1#1)
National Cancer Institute##21##3##(1991-3#1)(1991-5#1)(1993-6#1)(1995-11#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
National Cancer Research Institute##2##4##(2009-4#2)
National Cancer##29##2##(1991-3#1)(1991-5#1)(1993-6#1)(1995-11#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
National Center for Health Statistics (NCHS)##2##6##(1997-3#1)(2008-12#1)
National Center for Health Statistics##3##5##(1997-3#1)(2008-12#1)(2012-2#1)
National Center for##9##3##(1993-2#1)(1997-3#3)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
National Center##10##2##(1993-2#1)(1997-3#3)(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
National Children's Study##2##3##(2013-1#2)
National Cholesterol Education Program Expert Panel on Detection##2##8##(2008-3#2)
National Cholesterol Education Program Expert Panel##3##6##(2008-1#1)(2008-3#2)
National Cholesterol Education Program##5##4##(1991-8#1)(2008-1#1)(2008-3#3)
National Cholesterol##6##2##(1991-4#1)(1991-8#1)(2008-1#1)(2008-3#3)
National Committee for Quality Assurance##2##5##(1995-2#1)(1996-3#1)
National Committee for##4##3##(1995-2#1)(1996-3#1)(2008-5#1)(2010-8#1)
National Community##2##2##(1992-1#1)(2008-6#1)
National Congress of the Italian Society of##2##7##(1991-6#1)(2011-2#1)
National Council on Radiation Protection and Measurements##4##7##(1994-12#1)(1995-1#1)(1995-2#2)
National Council##6##2##(1990-6#1)(1994-12#1)(1995-1#1)(1995-2#2)(2010-3#1)
National Environmental Health Action Plan##3##5##(2008-1#3)
National Football League##2##3##(2013-1#2)
National Forest##3##2##(2013-7#3)
National Guideline Clearinghouse Databases##3##4##(2012-12#3)
National Health Insurance##3##3##(2007-5#1)(2010-8#1)(2013-8#1)
National Health Interview Survey##5##4##(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2010-11#1)
National Health Interview##6##3##(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#2)(2010-11#1)
National Health Service (NHS)##6##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
National Health Service##18##3##(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-4#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
National Health Survey##2##3##(1994-6#1)(2011-2#1)
National Health and Nutrition Examination Survey##3##6##(2008-1#1)(2008-12#1)(2010-12#1)
National Health and##4##3##(1991-1#1)(2008-1#1)(2008-12#1)(2010-12#1)
National Health##43##2##(1991-1#1)(1991-2#1)(1991-6#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
National Heart##8##2##(1992-12#1)(2008-3#2)(2008-5#1)(2009-12#2)(2011-2#1)(2013-1#1)
National Imagery Interpretability Rating Scale##2##5##(2008-2#1)(2008-3#1)
National Institute for Health and Clinical Excellence (NICE)##2##8##(2008-7#1)(2012-3#1)
National Institute for Occupational Safety and Health (NIOSH)##2##8##(2008-10#1)(2008-12#1)
National Institute for Occupational Safety and Health##3##7##(2008-10#1)(2008-12#1)(2012-12#1)
National Institute for##10##3##(1990-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
National Institute of Allergy and Infectious Diseases##3##7##(2008-5#2)(2011-2#1)
National Institute of Child Health and Human Development##2##8##(1992-8#1)(1996-2#1)
National Institute of Neurological##2##4##(2008-7#2)
National Institute of Public Health##2##5##(1996-6#1)(2011-2#1)
National Institute of Standards and Technology (NIST)##5##7##(2008-10#2)(2008-2#1)(2008-3#2)
National Institute of Standards and Technology##11##6##(1996-12#1)(2008-10#2)(2008-2#2)(2008-3#6)
National Institute of Standards##12##4##(1996-12#1)(2008-10#2)(2008-2#2)(2008-3#6)(2013-8#1)
National Institute of##37##3##(1991-3#3)(1992-12#1)(1992-8#1)(1994-7#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#3)(2008-9#2)(2011-2#2)(2013-8#1)
National Institute on Drug Abuse##2##5##(1996-4#2)
National Institute on##5##3##(1992-3#1)(1996-4#2)(2009-5#1)(2010-5#1)
National Institute##52##2##(1990-3#1)(1991-3#3)(1992-12#1)(1992-3#1)(1992-8#1)(1994-7#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#4)(2008-7#4)(2008-9#2)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
National Institutes of Health Stroke Scale##2##6##(2007-10#1)(2007-9#1)
National Institutes of Health study##2##5##(2008-7#1)(2012-3#1)
National Institutes of Health##29##4##(1991-3#1)(1996-5#1)(1996-9#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#3)(2013-8#10)
National Institutes of##31##3##(1991-3#1)(1994-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#3)(2013-8#10)
National Instruments##3##2##(2008-10#2)(2008-3#1)
National Insurance Scheme##3##3##(1991-8#2)(1997-6#1)
National Insurance##6##2##(1991-8#3)(1995-2#1)(1997-6#2)
National Knowledge Infrastructure##2##3##(2011-2#2)
National Laboratory##9##2##(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2013-1#1)
National Library of Medicine (NLM)##5##5##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-1#1)
National Library of Medicine##13##4##(1991-2#2)(1992-1#2)(1992-2#1)(1994-12#1)(1995-1#2)(1996-3#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-3#1)
National Library of##15##3##(1991-2#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1995-11#1)(1996-3#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-3#1)
National Long-Term Care Surveys##2##4##(1991-1#1)(1995-3#1)
National Long-Term Care##3##3##(1991-1#1)(1993-3#1)(1995-3#1)
National Longitudinal Survey of Youth to##2##6##(2009-8#1)(2011-2#1)
National Longitudinal##7##2##(2009-7#1)(2009-8#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
National Marine##3##2##(2007-5#2)(2008-8#1)
National Meeting of##2##3##(1991-6#1)(2008-5#1)
National Notifiable Diseases Surveillance System##2##5##(1997-3#2)
National Park in##2##3##(2008-10#2)
National Park is##2##3##(2008-5#1)(2011-2#1)
National Park##29##2##(1997-7#1)(2008-10#2)(2008-5#17)(2010-4#1)(2011-2#5)(2013-7#3)
National Patient Safety##2##3##(2008-6#1)(2011-1#1)
National Practitioner Data Bank##8##4##(1991-3#1)(1992-1#2)(1992-3#2)(1994-1#1)(1994-2#2)
National Practitioner Data##9##3##(1991-3#1)(1992-1#3)(1992-3#2)(1994-1#1)(1994-2#2)
National Public Health Laboratory##3##4##(2011-2#1)(2012-3#2)
National Public Health##4##3##(1997-3#1)(2011-2#1)(2012-3#2)
National Quality Award in 1992##2##5##(1994-2#1)(1994-3#1)
National Quality Award##4##3##(1994-2#1)(1994-3#1)(1995-2#2)
National Research Council##6##3##(1990-6#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
National Research Institute of Tuberculosis and Lung##2##7##(2011-2#2)
National Research##10##2##(1990-6#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
National Science Foundation's##3##3##(1997-6#1)(2010-10#1)(2010-12#1)
National Science##5##2##(1997-6#1)(2008-10#1)(2010-10#1)(2010-12#1)(2013-8#1)
National Security Committee##2##3##(1995-6#1)(1996-5#1)
National Service##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
National Space Development Agency of Japan##2##6##(2008-3#2)
National Surgical##2##2##(1995-11#1)(2013-1#1)
National Trachoma##2##2##(2010-8#2)
National University Hospital##4##3##(2006-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
National University##6##2##(2006-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
National Work Group Hereditary Mamma Carcinoma]##2##6##(1996-6#2)
National and##3##2##(1995-1#1)(1997-2#1)(2008-11#1)
National data##2##2##(1992-12#1)(2007-11#1)
National health expenditures##8##3##(1991-2#1)(1992-12#2)(1992-3#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-3#1)
National health##13##2##(1991-2#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-8#1)(2009-7#1)
National medical##2##2##(2011-1#1)(2012-12#1)
National nursing agencies##2##3##(2013-1#2)
National programs##2##2##(2007-11#1)(2012-1#1)
National##527##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#4)(1991-12#2)(1991-2#6)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#4)(1991-9#1)(1992-1#7)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#6)(1992-5#2)(1992-6#1)(1992-8#1)(1993-2#4)(1993-3#3)(1993-6#1)(1994-1#1)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#5)(1995-11#6)(1995-12#1)(1995-2#7)(1995-3#5)(1995-6#8)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#9)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#38)(2008-11#15)(2008-12#6)(2008-2#5)(2008-3#36)(2008-4#3)(2008-5#33)(2008-6#4)(2008-7#15)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#26)(2011-3#1)(2011-9#1)(2012-1#7)(2012-12#12)(2012-2#1)(2012-3#10)(2013-1#22)(2013-7#7)(2013-8#20)
Nationally##6##1##(1995-1#1)(1995-12#1)(2008-11#2)(2010-1#1)(2013-1#1)
Nations Children's Fund##4##3##(1992-3#1)(2010-12#3)
Nations##20##1##(1990-3#1)(1992-3#1)(1992-6#1)(1994-7#1)(1996-1#1)(2007-12#1)(2008-11#6)(2008-9#1)(2010-12#3)(2011-2#3)(2012-12#1)
Nationwide##4##1##(1994-12#1)(1996-6#1)(2012-3#2)
Native American##3##2##(1995-12#1)(2008-4#1)(2010-10#1)
Native Americans##2##2##(2011-2#2)
Native Hawaiian well-being##5##3##(2008-1#5)
Native Hawaiian women##2##3##(2008-1#2)
Native Hawaiian##10##2##(2008-1#9)(2009-12#1)
Native PAGE Zymography##2##3##(2012-2#2)
Native and##5##2##(1996-5#1)(2008-1#1)(2008-10#2)(2013-7#1)
Native arterio-venous##2##2##(2007-7#2)
Native people##3##2##(2011-2#1)(2013-1#2)
Native##45##1##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-5#1)(2007-7#2)(2008-1#11)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
Natl Acad Sci##2##3##(1991-12#1)(2008-4#1)
Natl Acad##3##2##(1991-12#1)(2006-4#1)(2008-4#1)
Natl##31##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-2#2)(1995-5#2)(1995-6#2)(1997-2#1)(2006-4#1)(2008-4#1)
Natrix piscator##2##2##(2010-3#2)
Natronobacterium pharaonis##4##2##(1993-11#2)(1994-5#2)
Natrum##2##1##(2008-10#2)
Natural History and##2##3##(2010-1#1)(2013-8#1)
Natural History##5##2##(2010-1#1)(2011-1#2)(2011-2#1)(2013-8#1)
Natural Hybrids of Phytophthora nicotianae and##2##6##(2008-10#2)
Natural Language Processing##2##3##(2010-12#1)(2010-5#1)
Natural Park##2##2##(2008-5#1)(2013-7#1)
Natural Populations of##3##3##(2008-10#2)(2008-5#1)
Natural Products##2##2##(2010-6#1)(2010-7#1)
Natural and##3##2##(2008-10#2)(2012-3#1)
Natural disasters##2##2##(1991-2#1)(2013-1#1)
Natural history of##3##3##(1996-11#1)(2008-10#1)(2008-7#1)
Natural infection of##2##3##(2012-12#2)
Natural killer (NK) cells##2##4##(2006-10#1)(2008-4#1)
Natural killer cell##3##3##(1991-8#1)(2008-7#2)
Natural killer cells are##2##4##(2006-10#1)(2008-4#1)
Natural killer##9##2##(1991-8#1)(2006-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2010-5#1)
Natural occurrence of##3##3##(1997-6#1)(2010-8#1)(2012-1#1)
Natural or##2##2##(1990-5#1)(2008-10#1)
Natural selection and##3##3##(1996-6#1)(2008-9#1)(2012-3#1)
Natural selection##5##2##(1996-6#1)(2008-8#1)(2008-9#2)(2012-3#1)
Natural##97##1##(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#1)(1993-9#2)(1996-11#1)(1996-5#1)(1996-6#1)(1997-6#2)(1997-8#1)(2006-10#2)(2007-7#2)(2008-10#23)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
Naturally Occurring##4##2##(2008-10#3)(2010-2#1)
Naturally occurring##5##2##(2008-10#2)(2010-11#1)(2012-2#1)(2012-3#1)
Naturally##16##1##(1992-8#1)(1996-12#1)(2008-10#8)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#2)
Nature and Science##2##3##(2011-1#2)
Nature and##4##2##(2008-10#1)(2010-11#1)(2011-1#2)
Nature of##4##2##(1996-2#1)(2008-10#2)(2012-2#1)
Nature##34##1##(1990-11#1)(1992-10#1)(1992-4#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-7#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#4)(2012-2#2)(2013-1#1)
Nature's##2##1##(1997-7#1)(2008-5#1)
Nausea and vomiting were##2##4##(1991-6#1)(2011-2#1)
Nausea was##2##2##(1990-12#1)(2008-3#1)
Nausea##5##1##(1990-12#1)(1991-6#1)(1991-9#1)(2008-3#1)(2011-2#1)
Nautilus##4##1##(1997-4#2)(2009-8#2)
Naval##3##1##(1996-12#1)(2011-2#1)(2013-1#1)
Navarra##2##1##(1995-2#1)(2013-1#1)
Navarre##16##1##(2011-2#1)(2013-1#15)
Navier-Stokes equation##2##2##(2008-3#1)(2008-7#1)
Navier-Stokes##4##1##(2008-3#2)(2008-7#1)(2009-6#1)
Navigating the##2##2##(2012-2#1)(2013-1#1)
Navigation##6##1##(2006-12#1)(2009-4#2)(2011-2#1)(2013-1#2)
Navigation-CT##2##1##(2008-12#2)
Navon##3##1##(2008-11#3)
Navy##3##1##(1995-5#1)(1996-12#1)(2011-2#1)
Naz##2##1##(2008-12#2)
Nazi##2##1##(2008-12#2)
Naïve##2##1##(2010-8#1)(2013-8#1)
Nb and Mo##2##3##(2008-10#2)
Nb and Ta in##2##4##(2008-10#2)
Nb and Ta##3##3##(2008-10#3)
Nb and##5##2##(2008-10#5)
Nb##10##1##(2008-10#7)(2008-12#1)(2008-2#2)
Nb(V) and Ta(V) were##2##4##(2008-10#2)
Nb(V) and Ta(V)##3##3##(2008-10#3)
Nb-28 Ta-3##2##2##(2009-7#2)
NbF##3##1##(1990-7#3)
NbS2##3##1##(1992-5#3)
Nc##3##1##(1992-8#1)(2008-10#2)
Nck cDNA##2##2##(1997-4#2)
Nck protein##2##2##(1997-4#2)
Nck##11##1##(1997-4#11)
Ncm##5##1##(2013-1#5)
Ncm)##3##1##(2013-1#3)
Nco I##2##2##(1997-7#2)
Nco##3##1##(1997-7#2)(2008-11#1)
Nd and Sm##2##3##(2008-10#2)
Nd and##3##2##(2008-10#2)(2008-2#1)
Nd concentrations##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Nd ions##2##2##(2007-12#2)
Nd##333##1##(1991-3#2)(1992-1#2)(1993-1#2)(1993-6#2)(1994-2#1)(1995-2#3)(2007-11#46)(2007-12#70)(2008-1#1)(2008-10#16)(2008-2#94)(2008-3#89)(2008-5#1)(2011-2#3)(2012-2#1)
Nd(3)+##2##1##(2007-12#1)(2008-3#1)
Nd(3+) -doped##2##2##(2007-11#2)
Nd(3+) concentration##2##2##(2007-11#2)
Nd(3+) ions##2##2##(2007-11#2)
Nd(3+) laser##2##2##(2007-11#2)
Nd(3+)##20##1##(2007-11#10)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)
Nd(III) dipyr NO species##2##4##(2008-10#2)
Nd(III)##15##1##(2008-10#15)
Nd-1##2##1##(2008-10#2)
Nd-YAG laser therapy##2##3##(2010-8#2)
Nd-YAG laser##4##2##(2007-12#1)(2008-10#1)(2010-8#2)
Nd-doped##4##1##(2007-11#2)(2007-12#1)(2008-2#1)
Nd3+##2##1##(2008-3#2)
NdGaO(3)##2##1##(2012-2#2)
Ne##9##1##(1996-5#1)(2007-12#3)(2008-8#5)
Neanderthals##2##1##(2008-1#1)(2011-2#1)
Near 2##3##2##(2008-2#1)(2008-3#2)
Near infrared spectroscopy##2##3##(2008-10#1)(2008-6#1)
Near infrared##5##2##(2008-10#3)(2008-6#1)(2013-8#1)
Near the##2##2##(1993-3#1)(2007-11#1)
Near##24##1##(1993-3#1)(1994-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#5)(2008-6#1)(2009-11#1)(2010-5#2)(2012-2#1)(2012-9#1)(2013-8#1)
Near-IR##2##1##(2008-3#1)(2009-3#1)
Near-Infrared##3##1##(2008-2#1)(2008-3#2)
Near-Isogenic##2##1##(2008-10#2)
Near-field intensity##2##2##(2007-12#1)(2008-3#1)
Near-field optical##3##2##(2007-12#2)(2008-2#1)
Near-field probing of##2##3##(2007-11#1)(2007-12#1)
Near-field##13##1##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#3)
Near-infrared (NIR)##4##2##(2008-10#3)(2008-3#1)
Near-infrared spectroscopy##2##2##(2008-10#1)(2008-3#1)
Near-infrared##12##1##(1991-5#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#2)
Near-isogenic lines (NILs)##2##3##(2008-10#2)
Near-isogenic##3##1##(2008-10#3)
Near-total resection of the nasal septum was##2##7##(2012-12#2)
Nearly 1##2##2##(2008-3#1)(2010-9#1)
Nearly 50%##3##2##(1994-6#1)(2009-5#1)(2009-8#1)
Nearly all patients##2##3##(2008-6#1)(2008-8#1)
Nearly all##11##2##(1990-9#1)(1995-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-12#1)
Nearly half of the##2##4##(1995-12#1)(2011-2#1)
Nearly half##3##2##(1995-12#1)(2010-8#1)(2011-2#1)
Nearly transform-limited##2##2##(2007-11#1)(2008-2#1)
Nearly##37##1##(1990-9#1)(1992-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
Nebraska##6##1##(1997-6#1)(2008-10#1)(2008-8#3)(2010-9#1)
Nebraska)##2##1##(2008-12#1)(2008-8#1)
Nebulin is##2##2##(2008-6#2)
Nebulin##3##1##(2008-6#3)
Nebulized##4##1##(1992-3#1)(1994-12#1)(2008-11#1)(2008-7#1)
Nebulizer##2##1##(1992-3#1)(1994-12#1)
Necdin and##2##2##(2008-9#2)
Necdin##4##1##(2008-9#4)
Necessary for##2##2##(2008-10#1)(2013-1#1)
Necessary##5##1##(1991-3#1)(1996-3#1)(2008-10#1)(2009-12#1)(2013-1#1)
Necessity of##2##2##(2007-11#1)(2011-2#1)
Neck Disability Index##4##3##(2008-12#2)(2012-12#2)
Neck discomfort##2##2##(1996-9#2)
Neck##23##1##(1990-9#1)(1995-2#1)(1995-8#1)(1996-9#2)(1997-3#1)(1997-6#3)(2007-11#1)(2008-1#1)(2008-12#2)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
Necker##3##1##(2007-5#3)
Necrosis Factor##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
Necrosis and##3##2##(1991-8#1)(2008-11#1)(2008-7#1)
Necrosis of##3##2##(2006-10#1)(2008-10#2)
Necrosis##16##1##(1991-8#1)(2006-10#1)(2008-10#7)(2008-11#2)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
Necrosis-Inducing##2##1##(2008-10#2)
Necrotic Leaf##2##2##(2008-10#2)
Necrotic symptoms##2##2##(2008-10#2)
Necrotic##12##1##(2008-1#1)(2008-10#9)(2008-5#1)(2009-5#1)
Necrotizing fasciitis##2##2##(2007-8#2)
Necrotizing lung infection caused by the protozoan##2##7##(2007-12#2)
Necrotizing sialometaplasia##2##2##(1991-11#1)(2009-1#1)
Necrotizing##9##1##(1991-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2009-1#1)(2013-1#2)
Necrotrophic##3##1##(2008-10#3)
Nectria haematococca##2##2##(2008-10#2)
Nedd-8##4##1##(1993-8#4)
Need for##7##2##(1991-6#1)(1992-2#1)(2007-12#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)
Need of the hour##2##4##(2012-1#1)(2012-3#1)
Need of##3##2##(2010-4#1)(2012-1#1)(2012-3#1)
Need##12##1##(1991-6#1)(1992-2#1)(1993-12#1)(2007-12#1)(2008-1#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-3#1)
Needed##3##1##(1996-1#1)(1996-12#1)(2013-1#1)
Needle and dread##2##3##(2008-11#2)
Needle##9##1##(1991-1#1)(1994-7#1)(1995-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-8#1)
Needs for##2##2##(2007-2#1)(2013-8#1)
Needs##8##1##(1994-3#1)(2007-2#1)(2008-12#1)(2012-12#1)(2013-1#2)(2013-8#2)
Neem##2##1##(2011-2#2)
Neer's##2##1##(2007-8#2)
Nef##8##1##(1997-3#5)(2011-2#3)
Negative Syndrome Scale (PANSS)##2##4##(1995-8#1)(2008-6#1)
Negative Syndrome Scale##4##3##(1995-8#1)(1996-5#1)(2008-6#1)(2011-1#1)
Negative contributions##2##2##(1991-9#1)(1992-6#1)
Negative effects##2##2##(2008-10#1)(2013-7#1)
Negative regulation of##2##3##(1992-8#1)(1994-9#1)
Negative results were obtained##2##4##(2008-8#1)(2008-9#1)
Negative results were##3##3##(2008-8#2)(2008-9#1)
Negative##47##1##(1990-2#1)(1991-9#1)(1992-6#2)(1992-7#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#2)(2007-7#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
Negeri Sembilan##2##2##(2008-8#1)(2011-1#1)
Neglect of##2##2##(2008-3#1)(2012-2#1)
Neglect patients##2##2##(2009-10#2)
Neglect##5##1##(1996-5#1)(2008-3#1)(2009-10#2)(2012-2#1)
Neglected##4##1##(2008-1#1)(2009-4#2)(2013-8#1)
Negligible##3##1##(1992-12#1)(2008-3#1)(2008-8#1)
Negotiating##2##1##(1994-12#1)(2011-2#1)
Negro##11##1##(2008-10#5)(2008-5#5)(2009-7#1)
Nei's average gene diversity across seven RFLP loci was 0##2##10##(2008-10#2)
Nei's genetic##2##2##(2008-10#2)
Nei's##13##1##(2008-10#13)
Neighbor Joining##2##2##(2008-4#2)
Neighbor##3##1##(2008-10#1)(2008-4#2)
Neighborhood##5##1##(2007-10#1)(2008-1#1)(2008-11#1)(2009-9#1)(2012-12#1)
Neighborhood-level##2##1##(2007-10#1)(2008-1#1)
Neighborhoods and##2##2##(2012-12#1)(2013-1#1)
Neighborhoods##6##1##(2008-1#2)(2008-5#1)(2012-12#1)(2013-1#2)
Neishabour##2##1##(2008-12#2)
Neisseria gonorrhoeae##10##2##(1993-12#1)(1993-9#2)(1995-6#1)(1996-6#1)(2007-7#1)(2007-8#3)(2010-10#1)
Neisseria meningitidis isolates##2##3##(2007-12#2)
Neisseria meningitidis##22##2##(1993-12#2)(2006-5#1)(2007-12#5)(2008-12#4)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2013-1#4)
Neisseria##39##1##(1993-12#4)(1993-9#2)(1995-3#1)(1995-6#1)(1996-6#1)(2006-5#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-12#4)(2009-5#1)(2009-7#2)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#5)
Neither indomethacin##2##2##(2008-11#2)
Neither of these two##3##4##(2007-7#1)(2008-10#2)
Neither of these##5##3##(1992-9#1)(1994-2#1)(2007-7#1)(2008-10#2)
Neither of##6##2##(1992-12#1)(1992-9#1)(1994-2#1)(2007-7#1)(2008-10#2)
Neither plasminogen##2##2##(1992-12#1)(1993-2#1)
Neither the survival rate nor the disease-free survival rate differed significantly between the groups##2##14##(1997-7#2)
Neither the##21##2##(1990-5#1)(1991-6#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-7#2)(2008-10#4)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#2)
Neither was##2##2##(2008-9#1)(2012-12#1)
Neither wortmannin nor##2##3##(1995-8#1)(2008-4#1)
Neither##121##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(2007-7#2)(2007-8#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-4#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
Nelore##2##1##(2012-1#2)
Nelson##3##1##(1995-1#2)(2008-10#1)
Nemastoma lugubre##2##2##(2007-12#2)
Nematicidal activity of essential oils##2##5##(2008-10#2)
Nematoda##2##1##(2008-7#1)(2011-2#1)
Nematode Meloidogyne##2##2##(2008-10#2)
Nematode reproduction##2##2##(2008-10#2)
Nematode##25##1##(1996-12#1)(2008-10#24)
Nematode-trapping fungi##2##2##(2008-10#2)
Nematodes##11##1##(1997-3#1)(2008-10#10)
Nematodirus##2##1##(1996-12#2)
Nematophagous Fungus##2##2##(2008-10#2)
Neo-Sensitabs##4##1##(2008-5#4)
NeoTherapeutics##4##1##(2008-5#4)
Neoadjuvant chemotherapy##3##2##(1992-12#1)(1993-11#1)(2013-8#1)
Neoadjuvant##7##1##(1992-12#1)(1993-11#1)(2007-8#1)(2012-3#2)(2013-8#2)
Neogonodactylus oerstedii##2##2##(2007-12#2)
Neoheterobothrium hirame##2##2##(2010-8#2)
Neointima##2##1##(1992-9#1)(2007-8#1)
Neolamprologus pulcher##2##2##(2010-8#2)
Neomycin##2##1##(1994-11#2)
Neonatal diabetes mellitus##2##3##(2011-1#2)
Neonatal follow-up programs##2##3##(2008-11#2)
Neonatal sciatic##2##2##(1993-12#2)
Neonatal##36##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#2)(1995-5#1)(1997-5#1)(2008-11#6)(2009-12#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#2)(2011-1#6)(2011-2#2)(2012-2#1)(2013-8#1)
Neonate##2##1##(2008-11#1)(2012-1#1)
Neoplasia##2##1##(2008-1#1)(2011-2#1)
Neoplasms##4##1##(2007-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
Neoplastic##7##1##(1990-6#1)(1991-12#1)(1994-5#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
Neopterin was##2##2##(2008-10#2)
Neopterin##4##1##(2008-10#2)(2009-12#2)
Neosartorya##3##1##(2008-10#1)(2009-2#2)
Neospora##2##1##(1996-6#1)(2012-2#1)
Neotetrazolium chloride##2##2##(2008-10#2)
Neotibilis (Neotibilis)##3##2##(2008-6#3)
Neotibilis##6##1##(2008-6#6)
Neotropical Anopheles (Nyssorhynchus)##2##3##(2007-12#2)
Neotropical##5##1##(2007-12#2)(2008-5#3)
Neovascular##2##1##(2011-1#2)
Neovascularization##2##1##(2010-9#1)(2011-1#1)
Nep1 (5 mug/ml)##2##3##(2008-10#2)
Nep1 in liquid culture##2##4##(2008-10#2)
Nep1 in##3##2##(2008-10#3)
Nep1 was##4##2##(2008-10#4)
Nep1##19##1##(2008-10#19)
Nepal Medical College##3##3##(2012-3#3)
Nepal during##2##2##(2008-10#1)(2012-3#1)
Nepal has##2##2##(2010-4#1)(2012-3#1)
Nepal in this##2##3##(2008-7#2)
Nepal is a##2##3##(2008-7#1)(2010-8#1)
Nepal is##4##2##(2008-3#1)(2008-7#2)(2010-8#1)
Nepal##111##1##(1994-3#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-7#40)(2008-8#1)(2010-11#4)(2010-4#8)(2010-5#1)(2010-8#10)(2011-2#2)(2012-3#21)(2013-8#1)
Nepal's##2##1##(2008-7#1)(2012-3#1)
Nepalese isolates##2##2##(2008-10#2)
Nepalese male and female##2##4##(2012-3#2)
Nepalese people##3##2##(2012-3#3)
Nepalese##19##1##(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-8#1)(2012-3#9)
Nephila##2##1##(2008-7#1)(2012-2#1)
Nephrin is##2##2##(2007-7#1)(2008-1#1)
Nephritis##3##1##(2008-1#2)(2010-12#1)
Nephrocalcin##2##1##(1991-12#2)
Nephrogenic adenoma##2##2##(2008-10#2)
Nephrogenic diabetes insipidus##2##3##(1994-8#2)
Nephrogenic##4##1##(1994-8#2)(2008-10#2)
Nephrolithiasis##2##1##(2008-10#1)(2011-2#1)
Nephrology##3##1##(2008-1#2)(2011-2#1)
Nephropathy##9##1##(2007-7#2)(2008-1#3)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#1)
Nephrotic Syndrome##2##2##(2008-1#2)
Nephrotic syndrome was the##2##4##(2008-1#2)
Nephrotic##4##1##(2008-1#4)
Nephrotoxicity was##2##2##(1994-5#1)(2012-12#1)
Nephrotoxicity##3##1##(1994-5#1)(2008-8#1)(2012-12#1)
Nereidae)##2##1##(1996-2#2)
Nernstian behavior##2##2##(2008-10#2)
Nernstian potentiometric response##2##3##(2008-10#2)
Nernstian response for##12##3##(2008-10#12)
Nernstian response##23##2##(2008-10#23)
Nernstian slope of 29 mV per decade##2##7##(2008-10#2)
Nernstian slope of 29##5##4##(2008-10#5)
Nernstian slope of##22##3##(2008-10#22)
Nernstian slope##23##2##(2008-10#23)
Nernstian##60##1##(2008-10#60)
Nerve Root##2##2##(2012-3#2)
Nerve conduction##2##2##(2008-12#1)(2012-2#1)
Nerve growth factor##3##3##(1993-12#1)(1994-8#1)(1997-2#1)
Nerve growth##4##2##(1993-12#1)(1994-8#2)(1997-2#1)
Nerve transfers are used when spinal roots are avulsed##2##9##(2008-9#2)
Nerve transfers##4##2##(2008-8#1)(2008-9#3)
Nerve##33##1##(1993-12#1)(1993-5#1)(1994-8#3)(1997-2#1)(2006-12#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#3)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
Nervoheel N##6##2##(2008-10#6)
Nervoheel##7##1##(2008-10#7)
Nervosa (n =##2##3##(2008-11#2)
Nervosa##5##1##(2008-11#2)(2012-2#2)(2013-1#1)
Nervous System##8##2##(2007-11#1)(2008-2#3)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Nervous##9##1##(2007-11#1)(2008-2#3)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
Nest predation##2##2##(1995-3#1)(2008-9#1)
Nest##4##1##(1995-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
Nested polymerase chain reaction (PCR)##2##5##(2008-10#2)
Nested##9##1##(1990-8#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#5)
Nestin##4##1##(2011-2#3)(2012-7#1)
Net analyte##2##2##(2008-10#2)
Net##14##1##(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#3)
Netherlands and##4##2##(1990-9#1)(1996-1#1)(2008-10#2)
Netherlands was##2##2##(1997-8#1)(2009-9#1)
Netherlands##89##1##(1990-3#4)(1990-9#2)(1991-11#2)(1991-4#1)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-5#1)(1994-12#4)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#4)(1997-3#1)(1997-5#2)(1997-8#2)(2007-12#1)(2007-4#1)(2008-10#20)(2008-11#2)(2008-12#5)(2008-2#1)(2008-7#4)(2009-12#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#3)
Netherlands)##4##1##(1991-8#2)(2008-10#2)
Network Model##2##2##(2009-3#1)(2009-9#1)
Network and##2##2##(2007-2#1)(2010-8#1)
Network for Public Health##6##4##(1995-12#2)(1996-1#3)(2008-11#1)
Network for##10##2##(1995-12#2)(1995-6#1)(1996-1#3)(2008-11#2)(2008-3#1)(2008-7#1)
Network in##4##2##(2010-5#1)(2010-8#1)(2013-8#2)
Network of##5##2##(1991-3#1)(1997-2#1)(2006-10#1)(2008-12#1)(2009-10#1)
Network##84##1##(1991-3#3)(1992-3#1)(1993-1#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#3)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-5#2)(2010-8#6)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-7#3)(2013-8#6)
Network)##2##1##(1995-11#1)(1995-2#1)
Networking##3##1##(1992-12#1)(1997-6#1)(2012-3#1)
Networks for##2##2##(1994-3#1)(2010-8#1)
Networks in##2##2##(2008-11#1)(2012-12#1)
Networks is##2##2##(2008-10#1)(2008-9#1)
Networks of##3##2##(2008-1#1)(2008-11#1)(2013-8#1)
Networks##28##1##(1994-3#1)(1995-9#1)(1996-11#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
Neu5Ac with##2##2##(1992-11#1)(2012-2#1)
Neu5Ac##7##1##(1992-11#3)(2012-2#4)
Neu5Gc alpha 2--&gt##9##3##(1994-11#9)
Neufeld##2##1##(1995-12#2)
Neumann boundary conditions##2##3##(2008-3#2)
Neumann##4##1##(2008-3#4)
Neuprex as an##2##3##(2008-5#2)
Neuprex as##3##2##(2008-5#3)
Neuprex in##2##2##(2008-5#2)
Neuprex is##3##2##(2008-5#3)
Neuprex##13##1##(2008-5#13)
Neural Network##6##2##(2008-10#2)(2009-3#1)(2010-8#3)
Neural Networks##5##2##(2008-10#3)(2008-11#1)(2010-8#1)
Neural correlates of##2##3##(2010-2#1)(2012-1#1)
Neural fibrolipoma##2##2##(2009-5#2)
Neural network##3##2##(2008-10#2)(2008-3#1)
Neural response telemetry##2##3##(2008-9#2)
Neural stem cells (NSCs)##2##4##(2008-11#1)(2008-4#1)
Neural stem cells##3##3##(2008-11#2)(2008-4#1)
Neural systems##2##2##(2007-8#1)(2008-11#1)
Neural##40##1##(1990-3#1)(1991-1#1)(1992-11#1)(1995-11#1)(2007-8#1)(2008-10#7)(2008-11#8)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-2#1)(2010-8#4)(2011-2#1)(2012-1#1)(2013-8#1)
Neuraminidase##2##1##(1990-12#1)(2008-7#1)
NeuroD##6##1##(2010-11#6)
Neurobehavioral##5##1##(1996-12#3)(2013-1#2)
Neurobiologic perspectives##2##2##(2008-2#1)(2008-3#1)
Neurobiological##4##1##(2008-11#1)(2008-2#1)(2012-12#1)(2013-7#1)
Neurobiology##2##1##(1997-7#1)(2008-4#1)
Neuroblastoma (NBL)##2##2##(2011-2#2)
Neuroblastoma##7##1##(2008-12#1)(2011-2#6)
Neurochemical and##2##2##(1992-6#1)(2011-2#1)
Neurochemical##4##1##(1992-6#2)(2008-10#1)(2011-2#1)
Neurochemistry##3##1##(1992-9#1)(2008-11#1)(2008-7#1)
Neurocognitive functioning##2##2##(2008-2#1)(2011-2#1)
Neurocognitive##6##1##(2008-2#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
Neurocysticercosis##3##1##(2008-7#2)(2012-3#1)
Neurodegeneration##2##1##(2008-11#1)(2013-1#1)
Neuroendocrine neoplasms are##2##3##(2012-3#2)
Neuroendocrine tumors (NETs)##2##3##(2011-2#2)
Neuroendocrine tumors##4##2##(2008-3#1)(2011-2#2)(2013-1#1)
Neuroendocrine##13##1##(1991-1#1)(1991-6#1)(1994-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#3)(2012-3#2)(2013-1#1)
Neuroethics##2##1##(2012-2#2)
Neurofibromatosis type 1 (NF1)##2##4##(1994-12#1)(2008-7#1)
Neurofibromatosis type 1##3##3##(1994-12#1)(2008-7#1)(2013-1#1)
Neurofibromatosis type##4##2##(1994-12#1)(1997-3#1)(2008-7#1)(2013-1#1)
Neurofibromatosis##5##1##(1991-3#1)(1994-12#1)(1997-3#1)(2008-7#1)(2013-1#1)
Neurofilaments##2##1##(1997-2#1)(2008-8#1)
Neurofunctional##2##1##(1991-1#1)(2012-3#1)
Neurogen##3##1##(2008-10#1)(2008-5#2)
Neurogenesis##3##1##(2007-12#1)(2008-7#2)
Neurogenic##4##1##(1990-3#1)(1992-9#1)(2009-3#1)(2012-1#1)
Neuroimaging and##2##2##(2008-8#1)(2010-5#1)
Neuroimaging has##2##2##(2007-8#1)(2010-12#1)
Neuroimaging of migraine##2##3##(2008-9#2)
Neuroimaging of##4##2##(2008-6#1)(2008-8#1)(2008-9#2)
Neuroimaging techniques##2##2##(2011-2#1)(2013-1#1)
Neuroimaging##16##1##(2007-10#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-12#3)(2010-5#1)(2011-2#1)(2013-1#1)
Neuroinflammation##5##1##(2008-7#2)(2008-8#1)(2013-1#2)
Neurokinin A##2##2##(1990-12#2)
Neurokinin##3##1##(1990-12#2)(2008-5#1)
Neuroleptic malignant syndrome##3##3##(2012-2#2)(2012-3#1)
Neuroleptic##5##1##(1996-7#1)(2012-2#2)(2012-3#2)
Neurologic##6##1##(2007-10#1)(2008-2#1)(2010-12#1)(2010-5#1)(2012-3#2)
Neurological and##2##2##(1994-12#1)(2008-7#1)
Neurological disorders##2##2##(1996-2#1)(2008-4#1)
Neurological examination##2##2##(2007-11#1)(2008-7#1)
Neurological symptoms##2##2##(1993-3#1)(1997-6#1)
Neurological##25##1##(1993-3#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-11#2)(2008-4#1)(2008-7#5)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
Neurology and##2##2##(2008-6#1)(2013-8#1)
Neurology##11##1##(1997-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-5#1)(2013-8#1)
Neuroma##2##1##(2007-11#1)(2012-3#1)
Neuromuscular disorders##2##2##(2012-3#2)
Neuromuscular##6##1##(1993-5#1)(1996-5#2)(2007-11#1)(2012-3#2)
Neuromyelitis optica##4##2##(2013-8#4)
Neuron to##2##2##(2008-5#1)(2008-7#1)
Neuron##5##1##(1990-6#1)(1994-3#1)(1995-6#1)(2008-5#1)(2008-7#1)
Neuron-specific##2##1##(1993-8#1)(2007-12#1)
Neuronal activity##2##2##(1991-5#1)(1994-2#1)
Neuronal cell death##3##3##(1992-3#1)(1994-2#1)(2008-7#1)
Neuronal cell##4##2##(1991-12#1)(1992-3#1)(1994-2#1)(2008-7#1)
Neuronal responses##2##2##(1993-6#2)
Neuronal##22##1##(1991-12#1)(1991-5#1)(1992-3#1)(1993-6#2)(1994-2#2)(1995-12#1)(1995-6#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
Neuronavigation##2##1##(2012-3#2)
Neurons in the##4##3##(1991-12#1)(1995-11#1)(1997-3#1)(2008-11#1)
Neurons in##5##2##(1991-12#1)(1995-11#1)(1997-3#1)(2008-11#1)(2008-12#1)
Neurons were##3##2##(1991-12#1)(1991-6#1)(1997-3#1)
Neurons##17##1##(1991-12#3)(1991-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-7#1)(2008-11#2)(2008-12#1)(2009-12#1)(2009-8#1)
Neuropathic pain is##2##3##(2008-4#1)(2008-9#1)
Neuropathic pain##6##2##(2008-4#1)(2008-7#1)(2008-9#3)(2010-7#1)
Neuropathic##8##1##(2008-4#1)(2008-7#1)(2008-9#5)(2010-7#1)
Neuropathy##2##1##(2012-2#1)(2013-1#1)
Neuropeptide Y##4##2##(1990-5#1)(1995-12#3)
Neuropeptides##2##1##(2007-2#2)
Neuroprostheses##2##1##(2012-12#2)
Neuroprotection by##2##2##(2008-4#1)(2011-2#1)
Neuroprotection##5##1##(2008-2#1)(2008-4#1)(2008-8#2)(2011-2#1)
Neuroprotective##2##1##(2008-11#1)(2009-12#1)
Neuropsychiatric aspects of electrical injury##2##5##(1994-5#2)
Neuropsychiatric systemic lupus erythematosus##2##4##(2012-3#2)
Neuropsychiatric##8##1##(1994-5#2)(2008-2#1)(2010-12#1)(2011-2#2)(2012-3#2)
Neuropsychologic##2##1##(2011-1#1)(2011-2#1)
Neuropsychological testing##3##2##(2007-8#1)(2008-6#1)(2009-6#1)
Neuropsychological##4##1##(2007-8#1)(2008-6#1)(2009-6#1)(2011-1#1)
Neurosarcoidosis##4##1##(2008-7#2)(2012-3#2)
Neurosci##4##1##(1996-5#1)(1997-2#1)(2008-4#1)(2009-5#1)
Neuroscience##6##1##(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-1#1)(2013-8#1)
Neurosciences##5##1##(1996-3#1)(2007-10#1)(2008-5#2)(2008-7#1)
Neuroscientific##2##1##(2008-1#1)(2011-2#1)
Neurospora crassa and##4##3##(2008-10#1)(2009-6#1)(2010-7#1)(2012-3#1)
Neurospora crassa##23##2##(1992-3#2)(1992-8#2)(1993-12#1)(1995-2#3)(1996-6#1)(1997-4#3)(2008-10#3)(2008-6#2)(2009-6#1)(2010-7#2)(2012-3#3)
Neurospora##25##1##(1992-3#2)(1992-8#2)(1993-12#1)(1995-2#3)(1996-6#1)(1997-4#3)(2008-10#3)(2008-6#2)(2009-6#1)(2010-7#2)(2012-3#4)(2013-1#1)
Neurostatin##2##1##(2008-7#2)
Neurosurgeons##4##1##(2006-7#2)(2011-2#2)
Neurosurgery in##3##2##(2011-2#2)(2013-8#1)
Neurosurgery##10##1##(1995-11#1)(2007-3#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-8#2)
Neurosurgical##9##1##(2008-1#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#3)
Neuroticism##3##1##(2008-11#1)(2008-6#1)(2011-1#1)
Neurotoxicity of##2##2##(1990-5#1)(2008-7#1)
Neurotoxicity##5##1##(1990-5#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
Neurotransmitter##2##1##(1993-3#1)(2008-8#1)
Neurotransmitters##3##1##(1991-1#1)(1991-12#1)(2008-5#1)
Neurotrophic Factor##4##2##(2012-2#1)(2013-1#1)(2013-8#2)
Neurotrophic factors##2##2##(1996-2#1)(1996-5#1)
Neurotrophic##6##1##(1996-2#1)(1996-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
Neurotrophin##3##1##(1995-8#1)(1996-12#1)(2010-8#1)
Neurotrophins##2##1##(1996-12#1)(1996-5#1)
Neurovascular##2##1##(1997-6#1)(2012-3#1)
NeutrAvidin was##2##2##(2008-10#2)
NeutrAvidin##5##1##(2008-10#5)
NeutrAvidin-tagged liposomes##4##2##(2008-10#4)
NeutrAvidin-tagged##6##1##(2008-10#6)
Neutral Red##3##2##(2008-10#3)
Neutral##8##1##(1997-8#1)(2008-10#3)(2008-11#1)(2011-2#3)
Neutralization##2##1##(1996-12#1)(2008-12#1)
Neutralizing antibodies##2##2##(1996-2#1)(2012-12#1)
Neutralizing##3##1##(1996-2#1)(2008-10#1)(2012-12#1)
Neutron Scattering##2##2##(1996-2#1)(2012-2#1)
Neutron##7##1##(1991-5#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-9#1)(2012-2#1)
Neutrons##2##1##(1991-5#1)(2008-10#1)
Neutropenia and##2##2##(2008-5#1)(2008-6#1)
Neutropenia##10##1##(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#4)
Neutrophil##5##1##(1993-8#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-5#1)
Neutrophils##3##1##(1991-8#1)(1997-1#1)(2007-10#1)
Nevada##8##1##(1996-9#1)(1997-1#1)(2007-7#1)(2008-10#3)(2008-2#1)(2012-3#1)
Never##5##1##(1990-6#1)(1991-6#1)(2007-2#1)(2008-11#2)
Nevertheless the##5##2##(1994-6#1)(1996-6#1)(2008-3#1)(2011-7#1)(2013-1#1)
Nevertheless##179##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-11#2)(1992-5#2)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#4)(1997-1#1)(1997-7#2)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#2)(2009-6#4)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#10)(2011-7#1)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
Nevirapine##2##1##(2008-10#1)(2011-1#1)
Nevoid basal cell carcinoma syndrome##2##5##(1997-3#2)
Nevoid##3##1##(1997-3#2)(2011-2#1)
Nevomelanocytic##2##1##(2007-7#2)
Nevus##2##1##(2010-6#1)(2012-3#1)
New 1##2##2##(2007-11#2)
New Anastomosis##2##2##(2008-10#2)
New Approach for##3##3##(2008-10#2)(2011-2#1)
New Brunswick##6##2##(1991-2#1)(1993-1#1)(1994-1#1)(1995-1#1)(1996-1#2)
New Caledonia##4##2##(2008-1#3)(2010-8#1)
New Castle County##3##3##(1994-12#1)(2013-1#2)
New Castle##4##2##(1994-12#1)(2013-1#2)(2013-7#1)
New Class of##2##3##(1996-5#1)(2012-3#1)
New Delhi##12##2##(1994-8#1)(1995-12#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2010-5#1)
New Directions in##3##3##(1990-8#1)(2010-11#1)(2011-1#1)
New Drugs for##3##3##(2008-10#2)(2008-5#1)
New Drugs##4##2##(2008-10#3)(2008-5#1)
New England##4##2##(1993-12#1)(2009-7#1)(2011-2#2)
New Guinea##4##2##(1991-12#1)(2008-1#2)(2012-12#1)
New Hampshire##4##2##(1993-1#1)(2008-10#1)(2012-12#2)
New Haven##2##2##(1997-1#1)(2011-2#1)
New Jersey##33##2##(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-5#2)(1997-3#2)(2007-10#1)(2008-10#10)(2008-11#1)(2008-8#5)(2010-9#1)
New Jersey's##2##2##(1993-1#2)
New Jersey)##2##2##(1996-2#1)(2008-8#1)
New Medicare##2##2##(1992-3#1)(2008-6#1)
New Method for##2##3##(1996-5#1)(2013-1#1)
New Mexico and##2##3##(1994-11#1)(2008-10#1)
New Mexico##17##2##(1990-8#1)(1991-3#1)(1994-11#1)(1997-3#3)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)
New Orleans##12##2##(1990-6#1)(1993-2#1)(1995-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#6)
New Public Health##2##3##(1995-1#2)
New Public##3##2##(1995-1#3)
New South Wales (NSW)##2##4##(1990-2#1)(2011-2#1)
New South Wales##10##3##(1990-2#2)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#2)
New Species##3##2##(2008-10#2)(2013-8#1)
New Treatment##2##2##(2008-11#1)(2012-3#1)
New World begomoviruses##2##3##(2008-10#2)
New World locations were##2##4##(2008-10#2)
New World strains##3##3##(2008-10#3)
New World##26##2##(2007-12#1)(2008-10#11)(2008-11#3)(2008-5#4)(2008-8#1)(2011-2#3)(2012-2#3)
New York Academy of Sciences##3##5##(1990-3#2)(1994-12#1)
New York City (NYC)##5##4##(1996-1#1)(1996-3#3)(2012-2#1)
New York City Board of Education##3##6##(1991-12#3)
New York City##36##3##(1991-1#2)(1991-12#3)(1992-3#1)(1994-2#1)(1994-9#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#6)(1996-5#1)(1997-1#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#5)(2011-2#2)(2012-2#2)(2013-8#1)
New York Heart Association functional class##2##6##(2010-10#1)(2011-2#1)
New York Heart Association##3##4##(2008-3#1)(2010-10#1)(2011-2#1)
New York State Department of Health##4##6##(1994-12#1)(1996-3#2)(1997-1#1)
New York State Security Guard Act of##2##7##(1994-2#1)(1996-2#1)
New York State##29##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1997-1#1)(2008-10#3)
New York University's##2##3##(2008-5#2)
New York and##6##3##(1992-1#1)(1992-12#2)(1995-5#1)(2008-10#1)(2008-7#1)
New York in##4##3##(2008-10#2)(2011-1#2)
New York state##4##3##(1992-1#2)(1992-8#2)
New York strains##2##3##(2011-1#2)
New York##169##2##(1990-11#4)(1990-3#5)(1990-8#2)(1991-1#3)(1991-12#7)(1991-2#1)(1991-3#2)(1992-1#6)(1992-12#4)(1992-3#5)(1992-8#3)(1993-1#1)(1993-2#3)(1993-3#2)(1993-5#1)(1994-12#6)(1994-2#2)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#10)(1996-12#5)(1996-2#4)(1996-3#11)(1996-5#2)(1997-1#4)(1997-2#1)(2007-4#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#6)(2009-3#1)(2009-5#5)(2010-10#1)(2011-1#4)(2011-2#7)(2012-2#2)(2013-1#2)(2013-8#3)
New York&quot##4##2##(2011-2#4)
New York's##3##2##(1992-8#1)(1994-1#1)(2008-10#1)
New York)##6##2##(1991-2#1)(1995-12#1)(2008-11#1)(2008-12#2)(2009-3#1)
New Zealand (NZ)##2##3##(2008-10#1)(2008-11#1)
New Zealand Intensive Medicines Monitoring Programme (IMMP)##2##7##(2008-11#1)(2008-8#1)
New Zealand Intensive Medicines Monitoring Programme##3##6##(2008-11#1)(2008-8#2)
New Zealand Intensive##4##3##(2008-11#1)(2008-8#2)(2011-2#1)
New Zealand White rabbits##3##4##(1994-3#2)(2008-5#1)
New Zealand and Australia##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
New Zealand and##7##3##(2008-1#2)(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)
New Zealand born##4##3##(1990-2#4)
New Zealand giant wetas (Orthoptera##2##5##(2007-12#2)
New Zealand has##3##3##(1992-1#1)(2008-12#1)(2012-3#1)
New Zealand health##3##3##(1991-2#1)(1992-1#1)(1994-3#1)
New Zealand is##2##3##(2008-8#1)(2012-3#1)
New Zealand male soft##2##4##(2007-12#2)
New Zealand mixed mice##2##4##(2008-10#2)
New Zealand population##2##3##(2008-8#1)(2011-1#1)
New Zealand rabbits were##3##4##(1992-3#2)(2012-3#1)
New Zealand rabbits##6##3##(1992-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
New Zealand were##3##3##(1996-12#1)(2008-8#1)(2012-12#1)
New Zealand white rabbits were##2##5##(2008-8#1)(2008-9#1)
New Zealand white rabbits##5##4##(1993-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
New Zealand##135##2##(1990-2#9)(1991-2#2)(1992-1#5)(1992-11#2)(1992-3#2)(1993-1#1)(1994-3#3)(1996-12#2)(1996-7#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2008-1#16)(2008-10#12)(2008-11#5)(2008-12#9)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#13)(2008-9#1)(2009-3#1)(2010-6#2)(2011-1#8)(2011-2#5)(2012-12#7)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#1)
New Zealand's##5##2##(1991-2#2)(1996-6#1)(2009-12#1)(2012-3#1)
New Zealanders##3##2##(1990-2#1)(2008-1#1)(2012-12#1)
New advances in##3##3##(2010-8#1)(2012-2#1)(2013-1#1)
New and##4##2##(2008-3#1)(2008-5#1)(2009-3#1)(2010-5#1)
New applications of##2##3##(1994-3#1)(2008-10#1)
New approach to##3##3##(2008-10#1)(2012-2#1)(2013-7#1)
New approach##4##2##(2008-10#2)(2012-2#1)(2013-7#1)
New approaches in##2##3##(2008-5#1)(2009-4#1)
New approaches to the##2##4##(1997-7#1)(2009-1#1)
New approaches to##3##3##(1997-7#1)(2008-6#1)(2009-1#1)
New approaches##5##2##(1997-7#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-4#1)
New aspects##2##2##(1994-9#1)(2008-8#1)
New challenges in##2##3##(2008-7#1)(2008-8#1)
New concepts##2##2##(1993-2#1)(1997-8#1)
New data on##3##3##(1992-2#1)(2008-11#1)(2008-5#1)
New data##5##2##(1992-2#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-5#1)
New developments in the##6##4##(1992-11#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-8#1)
New developments in##8##3##(1992-11#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2009-8#1)
New developments##10##2##(1992-11#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-8#1)
New diagnostic##2##2##(1997-3#1)(2008-7#1)
New directions for##2##3##(1994-12#1)(1995-12#1)
New drugs drug news##2##4##(2009-9#2)
New drugs##3##2##(1995-5#1)(2009-9#2)
New emerging##2##2##(2011-2#1)(2012-2#1)
New end##2##2##(1991-12#1)(2012-3#1)
New evidence##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
New factors##2##2##(2007-8#1)(2011-1#1)
New feasibilities##2##2##(2008-3#2)
New findings##2##2##(1993-2#1)(2008-8#1)
New frontiers in##2##3##(1997-8#1)(2013-8#1)
New global recommendations##2##3##(2008-7#2)
New insights into the##2##4##(2008-11#1)(2008-8#1)
New insights into##6##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-3#1)
New insights##8##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#3)(2012-3#1)(2013-1#1)
New knowledge on the##2##4##(1993-2#1)(2008-8#1)
New knowledge##4##2##(1993-2#1)(2008-4#1)(2008-8#1)(2009-5#1)
New management##2##2##(1992-1#1)(1996-2#1)
New material##2##2##(2008-9#1)(2010-5#1)
New materials##2##2##(2008-3#1)(2008-7#1)
New mechanisms of##2##3##(1991-2#1)(2007-4#1)
New mechanisms##3##2##(1991-2#1)(1997-1#1)(2007-4#1)
New method for##2##3##(2008-10#1)(2012-12#1)
New method##3##2##(2008-10#2)(2012-12#1)
New methodology##2##2##(2008-10#1)(2012-3#1)
New methods of##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
New methods##8##2##(2007-11#1)(2008-10#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
New model for##2##3##(2008-11#1)(2009-2#1)
New models##2##2##(1991-12#1)(1996-2#1)
New molecular##2##2##(2011-1#1)(2012-1#1)
New options##2##2##(1993-2#1)(2009-12#1)
New perspectives on##2##3##(2008-4#1)(2010-10#1)
New perspectives##3##2##(2008-2#1)(2008-4#1)(2010-10#1)
New polymeric##2##2##(2007-12#1)(2010-4#1)
New recommendations##2##2##(1996-6#1)(2007-12#1)
New records##2##2##(2008-12#1)(2008-5#1)
New research avenues in##2##4##(1996-12#2)
New research##5##2##(1996-12#2)(2008-3#1)(2008-7#2)
New roles for##2##3##(1993-9#1)(2009-6#1)
New screening##2##2##(2010-11#1)(2011-2#1)
New sets of##2##3##(2008-10#1)(2008-2#1)
New software##2##2##(2008-10#2)
New synthetic##2##2##(2007-11#1)(2008-10#1)
New techniques##2##2##(1992-11#1)(2008-10#1)
New technologies##3##2##(2008-11#1)(2008-7#1)(2010-9#1)
New technology##5##2##(1992-2#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-12#1)
New therapeutic##2##2##(1991-3#1)(2012-1#1)
New tools##2##2##(2008-1#1)(2008-3#1)
New treatment##3##2##(1990-6#1)(1991-8#1)(1993-11#1)
New trends in##3##3##(1991-1#1)(1992-2#1)(2008-6#1)
New vistas in##2##3##(2008-2#1)(2012-2#1)
New##934##1##(1990-10#1)(1990-11#6)(1990-2#14)(1990-3#5)(1990-5#1)(1990-6#3)(1990-8#4)(1991-1#7)(1991-11#1)(1991-12#12)(1991-2#10)(1991-3#8)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#15)(1992-11#6)(1992-12#4)(1992-2#5)(1992-3#9)(1992-6#1)(1992-8#9)(1992-9#1)(1993-1#8)(1993-11#1)(1993-12#1)(1993-2#10)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#10)(1994-2#2)(1994-3#7)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#4)(1995-12#8)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#4)(1996-1#14)(1996-11#2)(1996-12#9)(1996-2#9)(1996-3#13)(1996-5#14)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#11)(1997-2#2)(1997-3#10)(1997-6#2)(1997-7#5)(1997-8#4)(2006-10#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#12)(2007-2#3)(2007-4#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#26)(2008-10#153)(2008-11#38)(2008-12#22)(2008-2#13)(2008-3#22)(2008-4#6)(2008-5#25)(2008-6#7)(2008-7#20)(2008-8#42)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#3)(2010-8#3)(2010-9#3)(2011-1#19)(2011-2#37)(2011-9#1)(2012-1#5)(2012-12#17)(2012-2#24)(2012-3#19)(2013-1#15)(2013-7#3)(2013-8#6)
New-onset##4##1##(2008-1#2)(2011-2#1)(2013-1#1)
Newark##3##1##(1991-1#1)(2008-10#1)(2013-1#1)
Newbonnet##2##1##(2008-10#2)
Newborn screening##3##2##(2008-11#2)(2010-8#1)
Newborn with##2##2##(2008-11#1)(2013-1#1)
Newborn##10##1##(2007-2#1)(2008-10#2)(2008-11#3)(2010-8#3)(2013-1#1)
Newcastle disease (ND)##2##3##(1997-3#1)(1997-6#1)
Newcastle disease virus (NDV)##3##4##(1997-6#1)(2007-6#1)(2008-9#1)
Newcastle disease virus##8##3##(1997-6#2)(2007-6#2)(2008-11#1)(2008-5#1)(2008-9#2)
Newcastle disease viruses (NDV)##3##4##(1997-3#1)(2007-6#1)(2008-5#1)
Newcastle disease viruses##5##3##(1997-3#2)(2007-6#2)(2008-5#1)
Newcastle disease##20##2##(1997-3#3)(1997-6#3)(2007-6#4)(2008-11#1)(2008-5#5)(2008-9#2)(2013-1#1)(2013-7#1)
Newcastle##21##1##(1993-2#1)(1997-3#3)(1997-6#3)(2007-6#4)(2008-11#1)(2008-5#5)(2008-9#2)(2013-1#1)(2013-7#1)
Newer##15##1##(1993-9#1)(1995-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
Newfoundland and##3##2##(2008-10#2)(2010-8#1)
Newfoundland##8##1##(2007-12#1)(2008-10#5)(2009-7#1)(2010-8#1)
Newington##2##1##(1992-3#2)
Newly Described##2##2##(2008-10#2)
Newly Diagnosed##2##2##(2008-3#1)(2008-6#1)
Newly emerged##2##2##(1990-3#1)(2008-6#1)
Newly hatched##3##2##(2007-12#1)(2008-6#1)(2010-8#1)
Newly synthesized##3##2##(1994-9#1)(2008-10#1)(2008-7#1)
Newly##26##1##(1990-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-6#3)(2008-7#1)(2009-8#1)(2010-8#1)
News Plus##2##2##(1991-2#2)
News and##3##2##(1993-3#1)(2009-11#1)(2011-2#1)
News from the##3##3##(1991-1#1)(2008-10#1)(2009-4#1)
News##20##1##(1991-1#1)(1991-2#2)(1992-4#1)(1993-3#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
Newton##2##1##(1991-8#1)(2011-2#1)
Newton-Raphson algorithm##2##2##(1992-12#1)(2008-3#1)
Newton-Raphson##5##1##(1992-12#1)(2008-2#1)(2008-3#3)
Newtonian and Cassegrainian telescopes##2##4##(2008-2#2)
Newtonian behavior##2##2##(2008-5#2)
Newtonian##11##1##(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2013-8#4)
Next Generation##2##2##(2008-11#1)(2008-7#1)
Next the##2##2##(2008-2#1)(2012-1#1)
Next to##3##2##(1996-2#1)(2011-1#2)
Next we##3##2##(1994-1#1)(2008-2#1)(2010-11#1)
Next##51##1##(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1996-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-8#1)
Next-generation sequencing##3##2##(2012-3#1)(2013-1#2)
Next-generation##5##1##(2007-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
Ney##3##1##(1996-5#3)
NeyTumorin##6##1##(1997-4#6)
Neyman type A distribution##2##4##(2008-10#2)
Nezu##2##1##(2008-11#2)
Nf##2##1##(2008-10#2)
Nf-1##4##1##(1991-12#4)
Nfrl##2##1##(1997-7#2)
Ngn3 expression##2##2##(2010-11#2)
Ngn3##5##1##(2010-11#5)
NgoII restriction-modification##2##2##(1993-9#2)
NgoII##4##1##(1993-9#4)
Nh##2##1##(2008-8#2)
NheI##3##1##(1990-7#3)
Ni and C films were##2##5##(2008-2#2)
Ni and Cd by flame atomic absorption spectrophotometry##2##8##(2008-10#2)
Ni and Cd by##3##4##(2008-10#3)
Ni and Cd##5##3##(2008-10#5)
Ni and Cr in##3##4##(2008-10#3)
Ni and Cr##5##3##(2008-10#5)
Ni and Cu in##3##4##(2008-10#3)
Ni and Cu##9##3##(2008-10#9)
Ni and Pb##4##3##(2008-10#3)(2011-2#1)
Ni and Zn##6##3##(1997-4#1)(2008-10#5)
Ni and##40##2##(1997-4#1)(2008-10#36)(2008-2#2)(2011-2#1)
Ni in steel##2##3##(2008-10#2)
Ni in##14##2##(2007-11#1)(2008-10#13)
Ni##194##1##(1997-4#4)(2006-4#1)(2007-11#1)(2008-10#172)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-8#2)
Ni(2+) (6##2##2##(2008-10#2)
Ni(2+) and##5##2##(2008-10#4)(2013-1#1)
Ni(2+) binding##2##2##(2013-1#2)
Ni(2+) ions##2##2##(2008-10#2)
Ni(2+) uptake of the recombinant strains##2##6##(2013-1#2)
Ni(2+) uptake##3##2##(2013-1#3)
Ni(2+) was##2##2##(2008-10#2)
Ni(2+)##47##1##(1997-7#1)(2008-10#33)(2010-11#2)(2013-1#11)
Ni(2+)-uptake##2##1##(2013-1#2)
Ni(3)S(2)##2##1##(2008-10#2)
Ni(4)##4##1##(2009-5#4)
Ni(80)Nb(20)- MgO##2##2##(2007-12#2)
Ni(II) and 0##2##3##(2008-10#2)
Ni(II) and 3##2##3##(2008-10#2)
Ni(II) and Co(II)##8##3##(2008-10#8)
Ni(II) and Cu(II) were##2##4##(2008-10#2)
Ni(II) and Cu(II)##4##3##(2008-10#4)
Ni(II) and Fe(II) were##2##4##(2008-10#2)
Ni(II) and Fe(II)##3##3##(2008-10#3)
Ni(II) and Zn(II)##2##3##(2008-10#2)
Ni(II) and##26##2##(2008-10#26)
Ni(II) are##2##2##(2008-10#2)
Ni(II) ions##3##2##(2008-10#3)
Ni(II) is##2##2##(2008-10#2)
Ni(II) protoporphyrin IX##3##3##(1993-8#3)
Ni(II) was used to##2##4##(2008-10#2)
Ni(II) was##4##2##(2008-10#4)
Ni(II) were##2##2##(2008-10#2)
Ni(II)##101##1##(1993-8#3)(2008-10#96)(2008-5#2)
Ni(II))=0##2##1##(2008-10#2)
Ni(II))=1##2##1##(2008-10#2)
Ni(II)-Fe(II) hybrid##2##2##(1993-8#2)
Ni(III)##3##1##(1993-3#1)(2008-10#2)
Ni)##3##1##(1994-5#1)(2008-10#1)(2008-5#1)
Ni+Pd+NH(4)H(2)PO(4)##3##1##(2008-10#3)
Ni-NTA##3##1##(1995-8#1)(1997-4#1)(2011-1#1)
Ni-NiO-Ni diodes##2##2##(2007-12#1)(2008-2#1)
Ni-Ti alloy##3##2##(2008-10#3)
Ni-Ti##5##1##(2008-10#5)
Ni-dimethylglyoximato complex##2##2##(2008-10#2)
Ni2+##6##1##(1994-2#3)(1997-7#1)(2008-11#1)(2008-12#1)
Ni27(n)##3##1##(2008-10#3)
Ni3S2 + MgCarb##2##3##(1994-5#2)
Ni3S2 +##5##2##(1994-5#5)
Ni3S2 alone##4##2##(1994-5#4)
Ni3S2##16##1##(1994-5#13)(1995-3#3)
NiCoTs##4##1##(2013-1#4)
NiHCF films##2##2##(2008-10#2)
NiHCF##4##1##(2008-10#4)
NiHCF-modified##2##1##(2008-10#2)
NiO layer##2##2##(2008-10#2)
NiO##5##1##(2008-10#4)(2012-2#1)
NiS##11##1##(2008-10#11)
NiSO(4) and##2##2##(2008-10#2)
NiSO(4)##3##1##(2008-10#2)(2008-11#1)
NiSO4##3##1##(1995-3#3)
NiTMpyP and##2##2##(2008-10#2)
NiTMpyP##6##1##(2008-10#6)
NiV##5##1##(2008-12#5)
Niagara District Health Council##2##4##(1991-2#1)(1991-3#1)
Niagara##4##1##(1991-2#1)(1991-3#2)(2008-10#1)
Niagara's##2##1##(1991-3#2)
NicOx SA##2##2##(2008-5#2)
NicOx is##2##2##(2008-5#2)
NicOx##8##1##(2008-5#8)
Nicaragua are##2##2##(2008-5#1)(2012-12#1)
Nicaragua##6##1##(2007-12#1)(2008-5#1)(2011-2#2)(2012-12#2)
Nicaraguan##3##1##(2009-9#2)(2013-1#1)
Nice##2##1##(2008-3#1)(2008-5#1)
Nicholas##2##1##(1995-6#1)(2008-10#1)
Nick##4##1##(2008-11#1)(2008-9#1)(2010-11#1)(2013-8#1)
Nickel and##3##2##(1995-3#1)(2008-10#2)
Nickel is quantitatively##2##3##(2008-10#2)
Nickel was##2##2##(2008-10#2)
Nickel##14##1##(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#9)(2008-6#2)
Nickel(II)##3##1##(1997-7#1)(2008-10#2)
Nickel-titanium##3##1##(2008-10#2)(2008-7#1)
Nicorandil##3##1##(2010-8#3)
Nicotiana benthamiana and##2##3##(2008-10#2)
Nicotiana benthamiana leaves##2##3##(2008-10#2)
Nicotiana benthamiana plants were##2##4##(1995-2#1)(2008-10#1)
Nicotiana benthamiana plants##6##3##(1995-2#1)(2008-10#4)(2011-2#1)
Nicotiana benthamiana##29##2##(1995-2#1)(2008-10#26)(2008-9#1)(2011-2#1)
Nicotiana clevelandii##3##2##(2008-10#3)
Nicotiana hybrid##2##2##(2008-7#2)
Nicotiana occidentalis plants##2##3##(2008-10#2)
Nicotiana occidentalis##4##2##(2008-10#4)
Nicotiana tabacum and##2##3##(1997-2#1)(2008-10#1)
Nicotiana tabacum##7##2##(1997-2#1)(2008-10#4)(2008-7#1)(2012-2#1)
Nicotiana##62##1##(1995-2#1)(1997-2#1)(2008-10#49)(2008-11#1)(2008-7#4)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
Nicotinamide##5##1##(1992-12#1)(2008-10#1)(2008-5#3)
Nicotine could##2##2##(2013-1#2)
Nicotine dependence##2##2##(1991-1#1)(2011-2#1)
Nicotine was##2##2##(2008-10#2)
Nicotine##20##1##(1990-7#1)(1991-1#2)(1993-1#1)(1995-12#1)(1995-5#1)(1996-2#2)(2008-10#3)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#4)
Nicotinic acetylcholine##2##2##(2007-8#1)(2008-8#1)
Nicotinic##3##1##(2007-8#1)(2008-8#1)(2011-1#1)
Nicoya##7##1##(2008-5#5)(2013-7#2)
Niemann-Pick disease type C##2##4##(1992-6#2)
Niemann-Pick disease##4##2##(1990-8#2)(1992-6#2)
Niemann-Pick##5##1##(1990-8#2)(1992-6#2)(2013-1#1)
NifA and NifL##3##3##(2008-4#1)(2008-9#2)
NifA central domain##7##3##(2008-9#7)
NifA is##2##2##(1993-12#1)(2008-9#1)
NifA protein is##3##3##(2008-9#3)
NifA protein##5##2##(2008-9#5)
NifA##31##1##(1993-12#2)(2008-4#5)(2008-9#24)
NifL and##2##2##(2008-4#1)(2008-9#1)
NifL in the##2##3##(2008-9#2)
NifL##11##1##(2008-4#5)(2008-9#6)
Nifedipine##2##1##(1995-12#1)(2008-11#1)
Nigella sativa seeds##2##3##(1992-3#2)
Nigella sativa##5##2##(1992-3#2)(2008-12#2)(2009-7#1)
Niger##3##1##(2007-7#1)(2008-10#1)(2008-8#1)
Nigeria and##7##2##(1990-3#1)(2008-10#2)(2008-12#1)(2010-8#1)(2011-1#2)
Nigeria in##2##2##(1990-3#1)(2013-7#1)
Nigeria##92##1##(1990-3#4)(1992-5#1)(1995-9#1)(1997-4#2)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#6)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#4)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#3)(2010-4#4)(2010-8#6)(2010-9#2)(2011-1#12)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#14)(2013-7#1)
Nigeria's##4##1##(2009-10#3)(2011-1#1)
Nigerian##18##1##(1990-3#1)(1992-4#1)(2008-10#1)(2009-10#2)(2009-4#1)(2010-9#1)(2011-1#3)(2012-12#4)(2013-1#3)(2013-8#1)
Nigerians##2##1##(2009-4#1)(2012-12#1)
Nightingale##5##1##(2009-5#1)(2011-2#4)
Nigrostriatal##2##1##(2008-7#1)(2012-2#1)
Niklasson##2##1##(2008-2#2)
Nikon##2##1##(2008-8#1)(2010-1#1)
Nile Delta and South##2##4##(2013-1#2)
Nile River##4##2##(2008-10#4)
Nile blue##4##2##(2008-10#4)
Nile red##2##2##(2008-5#1)(2011-2#1)
Nile tilapia##3##2##(2010-8#2)(2013-7#1)
Nile virus##17##2##(2007-12#5)(2007-2#3)(2008-10#3)(2009-10#2)(2009-5#3)(2010-8#1)
Nile##37##1##(2007-12#5)(2007-2#3)(2008-10#14)(2008-5#1)(2009-10#2)(2009-5#3)(2010-3#1)(2010-8#3)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Nimes##3##1##(2008-10#3)
Nimesulide##2##1##(1990-10#2)
Nine cases##2##2##(2008-1#1)(2008-7#1)
Nine hundred##2##2##(2007-6#1)(2011-2#1)
Nine months later##3##3##(1990-11#1)(1997-2#1)(2008-7#1)
Nine of 16 studies##2##4##(2009-6#2)
Nine of the 18##2##4##(1996-3#1)(1996-5#1)
Nine of the##5##3##(1996-3#1)(1996-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
Nine of these##2##3##(2008-12#1)(2010-12#1)
Nine of##14##2##(1991-6#1)(1992-10#2)(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-12#1)
Nine patients had##2##3##(1990-3#1)(1990-9#1)
Nine patients were##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
Nine patients with##2##3##(2007-7#1)(2008-7#1)
Nine patients##11##2##(1990-3#1)(1990-9#1)(1993-2#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
Nine years##2##2##(1990-6#1)(2013-1#1)
Nine##84##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-10#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#2)
Nineteen children with##2##3##(2011-1#1)(2012-2#1)
Nineteen of##2##2##(2011-2#1)(2013-1#1)
Nineteen patients had##2##3##(1991-12#1)(1992-8#1)
Nineteen patients##4##2##(1991-12#1)(1992-8#1)(2008-10#1)(2008-9#1)
Nineteen percent##2##2##(2009-2#1)(2013-1#1)
Nineteen studies##2##2##(2007-12#1)(2013-1#1)
Nineteen##33##1##(1991-12#1)(1992-5#1)(1992-8#1)(1994-2#1)(1995-12#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)
Nineteenth##3##1##(1997-3#1)(2008-10#1)(2013-1#1)
Ninety patients##3##2##(2007-10#1)(2010-7#1)(2012-3#1)
Ninety percent of##3##3##(1994-2#1)(1996-9#1)(1997-6#1)
Ninety##19##1##(1994-2#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-7#1)
Ninety-eight percent of the##2##4##(2008-10#1)(2012-3#1)
Ninety-eight##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
Ninety-five percent of the##2##4##(1992-5#1)(2008-4#1)
Ninety-five percent of##3##3##(1992-5#1)(2008-4#1)(2012-2#1)
Ninety-five##6##1##(1991-8#1)(1992-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
Ninety-four##5##1##(1991-6#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-7#1)
Ninety-nine##4##1##(1995-1#1)(1997-3#1)(2008-10#1)(2012-2#1)
Ninety-one##4##1##(1990-3#1)(1994-2#1)(2008-10#1)(2008-7#1)
Ninety-seven percent of##2##3##(1997-3#1)(2008-8#1)
Ninety-seven##3##1##(1997-3#1)(2008-3#1)(2008-8#1)
Ninety-six percent of##2##3##(1997-6#1)(2011-2#1)
Ninety-six##8##1##(1997-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)
Ninety-three percent##2##2##(1990-2#1)(2008-11#1)
Ninety-three##4##1##(1990-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
Ning##2##1##(2008-10#1)(2011-3#1)
Ningxia##4##1##(2011-1#4)
Ninhydrin##2##1##(2008-10#2)
Nipah virus outbreak in Malaysia##2##5##(2008-12#2)
Nipah virus outbreak##3##3##(2008-12#2)(2008-8#1)
Nipah virus##4##2##(2008-12#3)(2008-8#1)
Nippon##2##1##(1990-8#1)(2008-10#1)
Nipponbare and##2##2##(1995-6#1)(2008-10#1)
Nipponbare##4##1##(1995-6#1)(2008-10#3)
Nipponbare)##2##1##(1996-12#1)(2009-10#1)
Nisin production##2##2##(2008-6#2)
Nissl bodies##2##2##(2008-7#2)
Nissl##4##1##(1992-12#1)(2008-7#2)(2009-12#1)
Nit mutants produced##2##3##(2008-10#2)
Nit mutants##3##2##(2008-10#3)
Nit##4##1##(2008-10#4)
NitM##3##1##(2008-10#3)
Nitralin##3##1##(2008-10#3)
Nitrate and##3##2##(2008-10#1)(2008-11#2)
Nitrate was##2##2##(2008-10#1)(2010-4#1)
Nitrate##12##1##(1991-9#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2010-4#1)
Nitrate-Nonutilizing##2##1##(2008-10#2)
Nitric Oxide##5##2##(2008-8#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-7#1)
Nitric oxide (NO) has##2##4##(2010-6#1)(2011-2#1)
Nitric oxide (NO) is##4##4##(2008-10#2)(2008-7#1)(2010-7#1)
Nitric oxide (NO) plays##2##4##(1995-11#1)(2006-10#1)
Nitric oxide (NO)##12##3##(1991-3#1)(1995-11#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Nitric oxide is involved in##2##5##(1995-12#1)(1996-9#1)
Nitric oxide is##3##3##(1993-8#1)(1995-12#1)(1996-9#1)
Nitric oxide synthase##2##3##(1992-3#1)(2009-9#1)
Nitric oxide##26##2##(1991-3#1)(1992-3#1)(1993-3#3)(1993-8#1)(1994-2#1)(1995-11#2)(1995-12#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Nitric##32##1##(1991-3#1)(1992-3#1)(1993-3#3)(1993-8#1)(1994-2#1)(1995-11#2)(1995-12#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
Nitrile##2##1##(1997-4#1)(2008-10#1)
Nitriles##2##1##(2009-6#1)(2009-8#1)
Nitrite and citrulline were measured##2##5##(2006-10#1)(2008-7#1)
Nitrite production by##2##3##(1993-11#2)
Nitrite was##2##2##(2008-10#2)
Nitrite##11##1##(1993-11#2)(1994-11#1)(1996-2#1)(2006-10#1)(2008-10#5)(2008-7#1)
Nitrofurantoin##2##1##(2008-10#1)(2009-5#1)
Nitrogen and##3##2##(1997-7#1)(2013-1#2)
Nitrogen##21##1##(1996-2#2)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-9#1)(2013-1#3)
Nitrogen-Containing##2##1##(1996-2#1)(1997-7#1)
Nitroglycerin##2##1##(1991-9#2)
Nitrosyl##2##1##(1996-2#1)(2008-10#1)
Nitrous oxide##5##2##(1990-3#1)(1991-6#1)(2008-8#1)(2009-12#1)(2013-8#1)
Nitrous##7##1##(1990-3#1)(1991-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#1)
Nkx6##2##1##(2007-12#1)(2010-11#1)
NleA##4##1##(2011-2#4)
Nnewi##2##1##(2013-1#2)
No 1##2##2##(2008-10#1)(2008-5#1)
No 2##2##2##(2008-10#1)(2008-5#1)
No DNA##2##2##(2008-10#1)(2008-11#1)
No PCR##2##2##(1996-12#1)(2008-10#1)
No abstract##2##2##(2007-7#1)(2011-2#1)
No accumulation of##2##3##(2008-10#1)(2010-12#1)
No activity##2##2##(1995-2#1)(2006-6#1)
No adverse effects were observed##2##5##(1996-3#1)(2007-11#1)
No adverse effects were##3##4##(1991-2#1)(1996-3#1)(2007-11#1)
No adverse effects##6##3##(1991-2#1)(1996-3#1)(2007-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
No adverse##11##2##(1990-9#1)(1991-2#1)(1996-3#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-11#1)(2013-1#1)
No alteration of##2##3##(1995-3#1)(2008-10#1)
No apparent##2##2##(1990-7#1)(1996-12#1)
No association between##4##3##(1997-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
No association was found between##4##5##(1993-10#1)(1997-5#1)(2008-6#1)(2011-1#1)
No association was found##6##4##(1993-10#1)(1993-9#1)(1997-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
No association##11##2##(1991-12#1)(1993-10#1)(1993-9#1)(1997-5#2)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
No case##3##2##(1990-8#1)(1991-12#1)(2013-8#1)
No cases of##4##3##(1994-2#1)(1995-8#1)(2007-8#1)(2013-1#1)
No cases##6##2##(1992-11#1)(1994-2#1)(1995-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
No causal relationship with vaccines##2##5##(2008-10#1)(2008-11#1)
No causal##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
No change in the##2##4##(1991-11#1)(1997-2#1)
No change in##3##3##(1991-11#1)(1997-2#1)(2008-7#1)
No change was##2##3##(1995-5#1)(2007-11#1)
No change##5##2##(1991-11#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-7#1)
No changes in##2##3##(1992-8#1)(1994-6#1)
No changes were##4##3##(1993-12#1)(1996-12#1)(2008-7#1)(2008-8#1)
No changes##6##2##(1992-8#1)(1993-12#1)(1994-6#1)(1996-12#1)(2008-7#1)(2008-8#1)
No clear##5##2##(1990-8#1)(1994-8#1)(1995-1#1)(2007-12#1)(2008-10#1)
No clinical##2##2##(1992-5#1)(2007-11#1)
No complete##2##2##(1990-10#1)(1990-2#1)
No complication occurred##2##3##(2013-1#2)
No complications occurred##2##3##(1994-9#1)(1995-11#1)
No complications were encountered##2##4##(1991-2#1)(2007-8#1)
No complications were observed##4##4##(1992-9#1)(1994-9#1)(2008-7#1)(2013-1#1)
No complications were##8##3##(1990-8#1)(1991-2#1)(1992-9#1)(1994-9#1)(2007-8#1)(2008-7#1)(2013-1#1)(2013-7#1)
No complications##12##2##(1990-8#2)(1991-2#1)(1992-9#1)(1994-9#2)(1995-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
No connection was##2##3##(1991-2#1)(2011-2#1)
No consistent##3##2##(1994-1#1)(1996-5#1)(2008-10#1)
No controlled##2##2##(1997-5#1)(2006-10#1)
No correlation between the##2##4##(1991-9#1)(1995-8#1)
No correlation between##6##3##(1991-9#1)(1995-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
No correlation could be##2##4##(1993-5#1)(2008-10#1)
No correlation was found between the##7##6##(1994-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#1)
No correlation was found between##16##5##(1990-12#1)(1992-9#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-8#1)
No correlation was found##17##4##(1990-12#1)(1990-2#1)(1992-9#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-8#1)
No correlation was##19##3##(1990-12#1)(1990-2#1)(1992-9#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-8#1)
No correlation with##2##3##(2008-6#1)(2008-7#1)
No correlation##30##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-9#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
No correlations were found between the##2##6##(1991-6#1)(2013-8#1)
No correlations were found between##3##5##(1990-8#1)(1991-6#1)(2013-8#1)
No correlations##4##2##(1990-8#1)(1991-6#1)(2008-10#1)(2013-8#1)
No current##2##2##(2008-10#1)(2010-5#1)
No data##2##2##(1992-6#1)(2013-8#1)
No deaths##2##2##(1997-8#1)(2008-8#1)
No decrease##2##2##(1991-2#1)(2011-2#1)
No detectable amount of the##2##5##(1996-5#2)
No detectable##4##2##(1991-5#1)(1994-11#1)(1996-5#2)
No device##2##2##(2012-12#2)
No difference between##2##3##(2007-12#1)(2008-7#1)
No difference in the##2##4##(1990-11#1)(2013-1#1)
No difference in##11##3##(1990-11#1)(1992-5#1)(1993-9#1)(1997-4#1)(1997-8#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
No difference was found between##2##5##(1994-5#1)(2011-2#1)
No difference was found##3##4##(1994-5#1)(2008-9#1)(2011-2#1)
No difference was observed between##3##5##(1992-12#1)(2008-10#1)(2008-5#1)
No difference was observed in the##2##6##(1992-3#1)(2011-2#1)
No difference was observed##5##4##(1992-12#1)(1992-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
No difference was##11##3##(1991-2#1)(1992-12#1)(1992-3#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)
No difference##27##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-5#1)(1995-8#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#1)
No differences existed##2##3##(2009-7#1)(2012-3#1)
No differences in the##2##4##(1990-6#1)(2011-2#1)
No differences in##18##3##(1990-3#1)(1990-6#1)(1991-5#1)(1994-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-8#1)
No differences were found in the##2##6##(1995-11#1)(2008-6#1)
No differences were found in##3##5##(1995-11#1)(2008-10#1)(2008-6#1)
No differences were found##5##4##(1995-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)
No differences were observed in##4##5##(2008-10#1)(2010-3#1)(2010-6#1)(2012-12#1)
No differences were seen in##3##5##(1991-12#1)(2008-5#1)(2012-12#1)
No differences were##13##3##(1991-12#1)(1995-11#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-6#1)(2012-12#2)
No differences##34##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-5#1)(1994-6#1)(1995-11#1)(1997-7#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
No disease was##2##3##(2008-10#2)
No disease##4##2##(2007-5#1)(2008-10#3)
No effect of##7##3##(1993-1#1)(1993-3#1)(1997-4#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)
No effect was observed##2##4##(2008-10#1)(2008-6#1)
No effect was##4##3##(1991-6#1)(2008-10#1)(2008-6#1)(2013-1#1)
No effect##11##2##(1991-6#1)(1993-1#1)(1993-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
No effects were##2##3##(1995-12#1)(2009-11#1)
No effects##4##2##(1995-12#1)(2008-9#1)(2009-11#1)(2011-2#1)
No evidence for the##2##4##(1997-5#1)(2008-10#1)
No evidence for##6##3##(1995-8#1)(1997-5#2)(2008-10#2)(2008-9#1)
No evidence of##6##3##(1994-11#1)(1995-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
No evidence was found to##2##5##(1993-12#1)(2008-10#1)
No evidence was found##6##4##(1990-12#1)(1993-12#1)(1994-8#1)(2008-10#2)(2013-1#1)
No evidence was##7##3##(1990-12#1)(1993-12#1)(1994-8#1)(2008-10#3)(2013-1#1)
No evidence##21##2##(1990-11#1)(1990-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-5#2)(2008-10#7)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#2)
No firm##2##2##(1994-2#1)(2007-11#1)
No fungal##2##2##(2008-10#2)
No further##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
No gender##2##2##(1996-2#1)(2008-4#1)
No germination occurred at##2##4##(2008-10#2)
No germination##3##2##(2008-10#3)
No gross##2##2##(1992-8#1)(2011-1#1)
No group differences were observed in##2##6##(2008-6#2)
No group##4##2##(2008-10#1)(2008-6#2)(2013-1#1)
No identifiable##2##2##(1995-2#1)(2007-10#1)
No improvement##2##2##(1995-6#1)(2008-2#1)
No increase in the frequency of micronucleated erythrocytes was observed in peripheral blood samples from##2##15##(2008-9#2)
No increase in the##3##4##(1996-12#1)(2008-9#2)
No increase in##10##3##(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)
No increase was##2##3##(1991-11#1)(1993-12#1)
No increase##12##2##(1991-11#1)(1993-12#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)
No influence of the##2##4##(2008-10#1)(2008-5#1)
No influence of##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
No inhibition of##2##3##(1990-8#1)(2008-8#1)
No interaction between##2##3##(2008-10#2)
No interaction##3##2##(2008-10#2)(2008-11#1)
No interference from##4##3##(1993-9#1)(2008-10#3)
No interference was found##3##4##(2008-10#3)
No interference was observed from common pharmaceutical adjuvants##3##8##(2008-10#3)
No interference was observed from##5##5##(2008-10#5)
No interference was observed##7##4##(2008-10#7)
No interference was##10##3##(2008-10#10)
No interference##14##2##(1993-9#1)(2008-10#13)
No interferences were observed from excipients and the validity of the##2##11##(2008-10#2)
No interferences were observed from##3##5##(2008-10#3)
No interferences##5##2##(2008-10#5)
No intraoperative complications##2##3##(2008-10#1)(2012-12#1)
No isolates of##2##3##(2008-10#2)
No isolates##3##2##(2008-10#3)
No labeling##2##2##(1990-9#1)(2008-10#1)
No large##2##2##(2009-8#1)(2010-8#1)
No macroscopic##2##2##(2008-10#1)(2008-7#1)
No major complications##2##3##(1990-3#1)(2007-7#1)
No major##6##2##(1990-3#1)(1990-6#1)(1994-2#1)(1996-9#1)(2007-2#1)(2007-7#1)
No marked##2##2##(2008-10#2)
No matter##2##2##(1997-1#1)(2008-1#1)
No mortality##3##2##(2007-8#1)(2008-5#1)(2008-6#1)
No mutagenicity was detected in##2##5##(2008-8#2)
No need of##2##3##(2007-8#1)(2008-10#1)
No neoplasms or nonneoplastic lesions were attributed to##2##8##(2008-8#1)(2008-9#1)
No neoplasms or nonneoplastic lesions##3##5##(2008-8#1)(2008-9#2)
No neoplasms were attributed to##2##5##(2008-9#2)
No neoplasms##5##2##(2008-8#1)(2008-9#4)
No new##3##2##(1993-2#1)(1997-6#1)(2012-1#1)
No nucleotide##2##2##(2008-10#1)(2008-8#1)
No objective##2##2##(1992-12#2)
No obvious##5##2##(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(2008-8#1)
No other significant##2##3##(1994-5#1)(2009-10#1)
No other##10##2##(1991-4#1)(1991-6#1)(1991-8#1)(1994-5#1)(2007-10#1)(2007-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
No particular##2##2##(1992-1#1)(1997-5#1)
No patient developed##2##3##(2008-9#1)(2011-2#1)
No patient died##3##3##(1990-8#1)(2008-6#1)(2011-3#1)
No patient had##2##3##(2007-10#1)(2008-7#1)
No patient with##2##3##(1990-10#1)(2008-10#1)
No patient##14##2##(1990-10#1)(1990-8#1)(1993-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-6#2)(2008-7#2)(2008-9#2)(2011-2#1)(2011-3#1)
No patients required##2##3##(2007-8#1)(2008-7#1)
No patients##11##2##(1990-12#1)(1990-2#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-3#1)(2013-1#1)
No positive##3##2##(1994-7#1)(2008-10#1)(2008-8#1)
No postoperative complications were observed##2##5##(2007-11#1)(2008-10#1)
No postoperative##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
No previous##5##2##(1996-9#1)(2008-10#2)(2008-8#1)(2012-12#1)
No recurrence was observed##3##4##(2007-7#1)(2007-8#1)(2010-11#1)
No recurrence##4##2##(2007-7#1)(2007-8#1)(2008-7#1)(2010-11#1)
No reduction in##3##3##(2007-12#1)(2007-8#1)(2009-9#1)
No relapse##2##2##(1991-3#1)(2007-7#1)
No relation was found between##2##5##(1991-6#1)(2013-1#1)
No relation was found##3##4##(1991-6#1)(2008-10#1)(2013-1#1)
No relation was##4##3##(1991-6#1)(1994-9#1)(2008-10#1)(2013-1#1)
No relationship was found between##3##5##(1991-2#1)(2008-10#2)
No relationship was##4##3##(1991-2#2)(2008-10#2)
No relationship##5##2##(1991-2#2)(2008-10#2)(2011-2#1)
No research##2##2##(2013-1#2)
No sample##2##2##(2008-10#2)
No serious adverse events were reported##2##6##(1996-1#1)(2008-10#1)
No serious adverse##3##3##(1996-1#1)(2008-10#1)(2011-2#1)
No serious##8##2##(1990-11#1)(1990-8#1)(1993-11#1)(1996-1#1)(2008-10#2)(2011-2#2)
No side effects were observed##2##5##(1990-11#1)(1991-3#1)
No side effects were##3##4##(1990-11#1)(1991-3#1)(1996-11#1)
No side##4##2##(1990-11#1)(1991-3#1)(1996-11#1)(2008-10#1)
No sign of##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
No significant associations##2##3##(2013-1#1)(2013-8#1)
No significant change in##2##4##(2011-2#1)(2013-1#1)
No significant change was##2##4##(1991-1#1)(2010-5#1)
No significant change##4##3##(1991-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
No significant changes in##7##4##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
No significant changes were seen in##4##6##(1991-12#1)(2008-5#2)(2011-2#1)
No significant changes were##7##4##(1991-12#1)(1994-3#1)(1995-3#1)(2008-5#2)(2011-2#2)
No significant changes##14##3##(1991-12#1)(1994-3#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#3)(2011-2#3)(2012-1#1)
No significant correlation was##2##4##(1990-5#1)(1991-6#1)
No significant difference at##2##4##(2008-10#2)
No significant difference in the##6##5##(1991-12#1)(1991-2#1)(1997-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
No significant difference in##12##4##(1991-12#1)(1991-2#1)(1992-12#1)(1997-4#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-8#1)
No significant difference was found between##3##6##(1990-3#1)(2008-10#1)(2011-2#1)
No significant difference was found##5##5##(1990-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
No significant difference was observed##2##5##(1993-1#1)(1996-9#1)
No significant difference was##9##4##(1990-3#1)(1993-1#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
No significant difference##27##3##(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
No significant differences (at 95% probability level) were found between the proposed##2##12##(2008-10#2)
No significant differences in the##5##5##(1990-7#1)(1991-12#1)(1997-6#1)(2008-9#1)(2012-2#1)
No significant differences in##14##4##(1990-7#1)(1991-12#1)(1997-6#1)(2008-10#4)(2008-12#2)(2008-9#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-5#1)
No significant differences were found between the##2##7##(1992-3#1)(1993-2#1)
No significant differences were found between##6##6##(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(2008-10#1)
No significant differences were found in##3##6##(2008-10#1)(2008-7#1)(2011-2#1)
No significant differences were found##10##5##(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#1)
No significant differences were observed in##2##6##(1992-3#1)(2008-5#1)
No significant differences were observed##5##5##(1992-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
No significant differences were seen in the cellular##2##8##(2008-5#2)
No significant differences were seen in the##3##7##(1997-6#1)(2008-5#2)
No significant differences were seen in##4##6##(1997-6#1)(2008-5#2)(2013-1#1)
No significant differences were##21##4##(1990-5#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-5#3)(2008-7#1)(2011-2#2)(2013-1#1)
No significant differences##42##3##(1990-5#1)(1990-7#1)(1991-12#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-4#1)(1997-6#2)(2008-10#13)(2008-12#2)(2008-5#4)(2008-7#2)(2008-9#1)(2011-10#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#2)
No significant effect was##2##4##(1993-6#1)(2008-5#1)
No significant increase##2##3##(2008-8#1)(2013-1#1)
No significant reduction in##2##4##(1990-5#1)(2008-5#1)
No significant relationship was##2##4##(2008-5#1)(2012-12#1)
No significant relationships were##2##4##(1991-2#1)(2008-8#1)
No significant statistical difference was found##2##6##(1994-3#1)(2010-8#1)
No significant variations##2##3##(2008-10#1)(2009-5#1)
No significant##137##2##(1990-11#1)(1990-3#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-6#1)(1992-12#2)(1992-3#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#3)(1995-12#3)(1995-3#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-4#2)(1997-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#29)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#8)(2013-8#2)
No single##7##2##(1991-8#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-1#1)
No specific##4##2##(1991-12#1)(1994-2#1)(2008-11#1)(2012-12#1)
No statistical difference##2##3##(2008-10#1)(2008-8#1)
No statistical differences were##2##4##(2008-12#1)(2010-3#1)
No statistical differences##3##3##(2008-12#1)(2010-3#1)(2012-12#1)
No statistical##6##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2012-12#1)
No statistically significant difference was found##2##6##(2011-1#1)(2011-2#1)
No statistically significant difference was##3##5##(2011-1#1)(2011-2#1)(2013-1#1)
No statistically significant difference##5##4##(1992-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
No statistically significant differences in the##2##6##(1991-4#1)(2012-3#1)
No statistically significant differences in##3##5##(1991-4#1)(1996-12#1)(2012-3#1)
No statistically significant differences were observed in##2##7##(2008-10#1)(2012-3#1)
No statistically significant differences were observed##4##6##(2008-10#2)(2008-5#1)(2012-3#1)
No statistically significant differences were##6##5##(1992-12#1)(1996-7#1)(2008-10#2)(2008-5#1)(2012-3#1)
No statistically significant differences##10##4##(1991-4#1)(1992-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-5#1)(2012-3#2)
No statistically significant##18##3##(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
No structural##2##2##(1992-9#1)(2007-8#1)
No study has##3##3##(1992-2#1)(2008-3#1)(2012-2#1)
No substantial##4##2##(1990-2#1)(1990-5#1)(1993-9#1)(1996-1#1)
No such##7##2##(1996-3#1)(2008-10#3)(2008-11#2)(2009-11#1)
No systematic##2##2##(2008-10#1)(2009-1#1)
No treatment-related neoplasms were seen in male or female Tg##2##10##(2008-9#2)
No treatment-related##3##2##(1992-2#1)(2008-9#2)
No use##3##2##(1996-6#1)(2008-10#1)(2008-3#1)
No viral##2##2##(1991-2#1)(1992-2#1)
No virus##3##2##(2008-10#3)
No##1031##1##(1990-10#2)(1990-11#7)(1990-12#6)(1990-2#5)(1990-3#3)(1990-5#6)(1990-6#4)(1990-7#2)(1990-8#12)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#14)(1991-2#12)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#4)(1992-11#3)(1992-12#7)(1992-2#5)(1992-3#7)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#7)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#8)(1994-3#5)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#5)(1995-5#8)(1995-6#2)(1995-8#10)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#10)(1996-2#2)(1996-3#8)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#5)(1997-4#8)(1997-5#10)(1997-6#6)(1997-7#1)(1997-8#7)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#9)(2007-11#10)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#9)(2007-8#11)(2008-1#6)(2008-10#230)(2008-11#21)(2008-12#12)(2008-2#6)(2008-3#7)(2008-4#6)(2008-5#39)(2008-6#19)(2008-7#40)(2008-8#28)(2008-9#32)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#11)(2011-10#1)(2011-2#47)(2011-3#2)(2012-1#3)(2012-12#15)(2012-2#9)(2012-3#8)(2012-5#2)(2013-1#35)(2013-7#1)(2013-8#10)
NoV##2##1##(2009-3#2)
No_T##2##1##(2009-8#2)
Nobel Prize in Chemistry##2##4##(2010-12#1)(2010-7#1)
Nobel Prize in##4##3##(2008-7#2)(2010-12#1)(2010-7#1)
Nobel Prize##6##2##(2008-7#2)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
Nobel##8##1##(2008-7#2)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
Noble##2##1##(1996-9#1)(2008-1#1)
Nobre et al##2##3##(2011-2#2)
Nocardia asteroides canaliculitis##2##3##(2007-7#2)
Nocardia asteroides was##2##3##(2006-10#1)(2008-7#1)
Nocardia asteroides##7##2##(1992-5#1)(2006-10#1)(2007-7#4)(2008-7#1)
Nocardia mediterranei##2##2##(1994-8#2)
Nocardia##11##1##(1992-5#1)(1994-8#2)(2006-10#1)(2007-2#1)(2007-7#5)(2008-7#1)
Nocardioides sp##2##2##(2009-2#1)(2011-2#1)
Nocardiopsis dassonvillei##2##2##(2011-2#2)
Nocardiopsis##4##1##(2011-2#4)
Nocardiosis##3##1##(2006-10#1)(2007-7#1)(2009-9#1)
Nociceptive##2##1##(1997-2#1)(2008-7#1)
Noctuidae)##11##1##(1990-8#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-2#1)(2011-2#2)(2013-8#1)
Nocturnal##4##1##(1996-7#1)(2008-6#1)(2009-7#1)(2013-8#1)
Nod factor##2##2##(1994-8#2)
Nod factors##4##2##(1994-8#4)
Nod##10##1##(1994-8#7)(2011-2#3)
NodA is##2##2##(1994-8#2)
NodA##5##1##(1994-8#5)
NodB##3##1##(1994-8#3)
NodD binds to target DNA in isologous octamer##2##8##(2008-8#2)
NodD##3##1##(2008-8#3)
Nodal##3##1##(2009-3#2)(2010-4#1)
Nodules##2##1##(2008-11#1)(2008-5#1)
Nogales##5##1##(2006-10#3)(2011-2#2)
Noggin##2##1##(2012-12#2)
Noise and##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
Noise in##2##2##(2008-2#1)(2008-3#1)
Noise reduction##2##2##(2007-12#1)(2010-3#1)
Noise##26##1##(1992-2#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-8#2)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
Noise-induced hearing loss##2##3##(2009-5#1)(2013-8#1)
Nomarski##2##1##(2008-3#1)(2008-5#1)
Nomenclature##4##1##(2008-10#3)(2008-4#1)
Nominal##2##1##(2007-12#1)(2009-4#1)
Non##14##1##(1991-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Non-Ag##2##1##(2008-10#2)
Non-CP##2##1##(2008-10#2)
Non-Communicable##2##1##(1993-2#1)(2013-8#1)
Non-Ewald methods##2##2##(2013-1#2)
Non-Hispanic White##3##2##(2010-7#3)
Non-Hispanic##5##1##(2010-10#1)(2010-7#3)(2012-12#1)
Non-Hodgkin lymphoma##3##2##(2009-10#1)(2010-3#1)(2013-1#1)
Non-Hodgkin##4##1##(2009-10#1)(2009-11#1)(2010-3#1)(2013-1#1)
Non-Hodgkin's Lymphoma##2##2##(2008-7#1)(2013-1#1)
Non-Hodgkin's##3##1##(2008-7#1)(2012-3#1)(2013-1#1)
Non-IDU##2##1##(2012-1#2)
Non-Invasive##2##1##(2009-11#1)(2013-8#1)
Non-Small Cell Lung Cancer##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
Non-albicans Candida##2##2##(2011-2#2)
Non-chromatographic speciation##2##2##(2008-10#2)
Non-coding RNA##2##2##(2008-4#1)(2012-2#1)
Non-communicable diseases (NCD) have been identified as a health emergency in the US-affiliated Pacific Islands (USAPI)##8##16##(2013-8#8)
Non-communicable diseases (NCD) have been identified as a health emergency in the##9##12##(2013-8#9)
Non-communicable diseases (NCD) have been##11##5##(2013-8#11)
Non-communicable diseases##13##2##(2008-1#1)(2012-12#1)(2013-8#11)
Non-destructive##6##1##(2008-10#4)(2011-1#2)
Non-fucosylated therapeutic antibodies##2##3##(2008-11#2)
Non-interacting##2##1##(2008-11#2)
Non-invasive##7##1##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)
Non-linear dose response##2##3##(2008-7#2)
Non-linear##7##1##(2008-10#2)(2008-11#1)(2008-7#3)(2013-1#1)
Non-parametric methods##2##2##(1995-12#2)
Non-parametric##6##1##(1995-12#3)(1997-4#1)(2008-10#2)
Non-perforating pericardial##2##2##(2007-8#2)
Non-pharmacological treatment##2##2##(1994-11#1)(1994-6#1)
Non-profit##2##1##(1992-12#1)(1993-1#1)
Non-significant##3##1##(1993-9#1)(2008-10#1)(2013-1#1)
Non-small Cell Lung Cancer##12##4##(2010-8#11)(2012-1#1)
Non-small cell lung cancer (NSCLC)##2##5##(2008-4#1)(2012-1#1)
Non-small cell##3##2##(1997-5#1)(2008-4#1)(2012-1#1)
Non-small##16##1##(1997-5#1)(2008-4#1)(2010-8#12)(2012-1#2)
Non-small-cell lung cancer##2##3##(2010-5#1)(2012-1#1)
Non-specific##2##1##(1990-2#1)(1990-5#1)
Non-steroidal anti-inflammatory drugs and##2##4##(1990-3#1)(1995-5#1)
Non-steroidal anti-inflammatory drugs##6##3##(1990-3#1)(1991-8#1)(1995-5#2)(1996-3#1)(2008-5#1)
Non-steroidal anti-inflammatory##7##2##(1990-3#1)(1990-8#1)(1991-8#1)(1995-5#2)(1996-3#1)(2008-5#1)
Non-surgical##2##1##(2010-3#2)
Non-traditional##2##1##(1991-12#1)(1992-12#1)
Non-traumatic##4##1##(1994-12#1)(2009-4#1)(2012-2#1)(2013-8#1)
Non-typhoidal salmonella##2##2##(2007-7#2)
Non-users##2##1##(2008-11#1)(2008-9#1)
Nonalcoholic fatty liver disease##2##4##(2010-6#1)(2013-1#1)
Nonbacterial thrombotic endocarditis##2##3##(1996-11#2)
Nonbacterial##3##1##(1996-11#2)(2011-2#1)
Nonchemical management##2##2##(2008-10#2)
Nonchemical methods##2##2##(2008-10#2)
Nonchemical##4##1##(2008-10#4)
Noncoding RNAs##2##2##(2012-3#2)
Noncoding##3##1##(2012-3#3)
Noncollinear##3##1##(2007-12#2)(2008-2#1)
Noncovalent##2##1##(1992-4#1)(2007-11#1)
Nondegenerate four-wave mixing##3##3##(2007-12#3)
Nondegenerate##4##1##(2007-12#4)
Nondestructive method for##2##3##(2007-12#1)(2008-2#1)
Nondestructive##8##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
None declared##34##2##(2011-1#34)
None had any##2##3##(2012-2#2)
None had##4##2##(2008-10#1)(2008-6#1)(2012-2#2)
None of 102 patients experienced intraoperative complications or infections##2##9##(2007-11#2)
None of the animals##2##4##(1993-9#1)(2008-10#1)
None of the other##3##4##(2008-10#2)(2008-2#1)
None of the patients developed##2##5##(2007-7#1)(2008-1#1)
None of the patients##8##4##(1993-2#1)(2007-7#1)(2008-1#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-5#1)(2013-1#1)
None of the studies##3##4##(1995-2#1)(2008-11#1)(2011-2#1)
None of the treatments##2##4##(2008-10#2)
None of the##76##3##(1990-11#1)(1990-3#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-2#3)(2012-5#1)(2013-1#4)
None of them##3##3##(1991-9#1)(1997-6#1)(2008-10#1)
None of these##15##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-5#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
None of##103##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-2#4)(2012-5#1)(2013-1#5)
None showed##2##2##(1991-2#1)(1994-8#1)
None##156##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#7)(2008-1#2)(2008-10#27)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#37)(2011-2#8)(2011-3#1)(2012-2#7)(2012-5#1)(2013-1#5)
Nonelderly patients##2##2##(2013-8#2)
Nonemergent##2##1##(2008-3#2)
Nonendometrioid##2##1##(2011-2#2)
Nonetheless##36##1##(1991-12#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-6#1)(2007-11#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
Nonhost##3##1##(2008-10#3)
Nonhuman##3##1##(2007-12#1)(2008-9#1)(2009-5#1)
Nonidet##3##1##(1991-12#1)(1994-8#2)
Noninvasive carcinomas showed##2##3##(1997-8#2)
Noninvasive optical##2##2##(2007-12#1)(2011-1#1)
Noninvasive##21##1##(1991-12#1)(1993-6#1)(1994-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2009-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)
Nonisotopic molecular##2##2##(2008-10#2)
Nonisotopic##5##1##(2008-1#1)(2008-10#2)(2008-4#2)
Nonlinear Crystal at Different Temperatures##2##5##(2008-2#2)
Nonlinear Optical##2##2##(2008-2#1)(2009-7#1)
Nonlinear absorption of##2##3##(1994-2#1)(2008-3#1)
Nonlinear absorption##4##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
Nonlinear effects##2##2##(2007-11#2)
Nonlinear filtering##2##2##(2008-2#1)(2008-3#1)
Nonlinear optical##5##2##(1990-8#1)(2007-11#3)(2008-3#1)
Nonlinear propagation##4##2##(2007-11#1)(2007-12#3)
Nonlinear##61##1##(1990-8#1)(1991-9#1)(1994-2#1)(1995-3#1)(1997-2#3)(2007-11#16)(2007-12#10)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#13)(2009-5#1)(2009-7#1)(2009-8#2)(2012-1#1)
Nonlinearities##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Nonlinearity##3##1##(2007-12#1)(2008-2#2)
Nonmedical##2##1##(2011-1#2)
Nonneoplastic lesions noted at the site of application included##2##9##(2008-9#2)
Nonneoplastic lesions noted at the site of application##3##8##(2008-9#3)
Nonneoplastic##4##1##(2008-9#4)
Nono##2##1##(2008-10#2)
Nonoperative management##2##2##(1991-6#1)(2011-2#1)
Nonparametric analysis of##2##3##(1997-5#1)(2008-10#1)
Nonparametric methods##2##2##(1997-5#1)(2010-12#1)
Nonparametric tests##2##2##(2008-10#2)
Nonparametric##10##1##(1997-5#2)(2008-10#3)(2010-1#2)(2010-12#1)(2010-9#1)(2011-2#1)
Nonparaphilic##2##1##(2008-1#1)(2013-8#1)
Nonpathogenic Binucleate Rhizoctonia##2##3##(2008-10#2)
Nonpathogenic Fusarium oxysporum Fo47##2##4##(2008-10#2)
Nonpathogenic Fusarium oxysporum##3##3##(2008-10#3)
Nonpathogenic Fusarium##5##2##(2008-10#5)
Nonpathogenic##14##1##(2008-10#14)
Nonprofit organizations##2##2##(1992-3#1)(1995-3#1)
Nonprofit##6##1##(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1995-3#2)
Nonprofits##3##1##(1992-3#1)(1994-2#2)
Nonsignificant##3##1##(2007-10#1)(2008-11#1)(2013-1#1)
Nonspecific##4##1##(1992-6#1)(2008-10#2)(2010-9#1)
Nonsteroidal anti-inflammatory drugs (NSAIDs)##2##4##(2008-11#1)(2012-2#1)
Nonsteroidal anti-inflammatory drugs##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
Nonsteroidal##6##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
Nonsurgical##4##1##(2010-3#1)(2010-6#1)(2012-12#1)(2013-1#1)
Nontransmissible##2##1##(2008-10#2)
Nontrivial##3##1##(1996-9#1)(2008-2#1)(2008-3#1)
Nontuberculous mycobacteria##2##2##(2007-12#1)(2011-2#1)
Nonunion##4##1##(2009-3#2)(2011-2#1)(2013-1#1)
Nonvolatile##3##1##(2007-12#2)(2008-3#1)
Nor##4##1##(1991-12#1)(1995-2#1)(1996-9#1)(2007-6#1)
Norcantharidin##2##1##(2011-3#2)
Norchip##2##1##(2008-10#2)
NordiFlex PenMate##2##2##(2012-3#2)
NordiFlex##3##1##(2012-3#3)
Nordic Journal of Psychiatry##3##4##(2011-4#3)
Nordic Psychiatric Association was##2##4##(2011-4#2)
Nordic Psychiatric Association##3##3##(2011-4#3)
Nordic Psychiatric Congress in##2##4##(2011-4#2)
Nordic Psychiatric Congress##4##3##(2011-4#4)
Nordic Psychiatric##8##2##(2011-4#8)
Nordic countries##14##2##(1990-11#2)(1990-6#1)(1991-11#1)(1992-11#1)(1993-2#2)(1995-8#1)(1997-6#1)(2008-10#3)(2011-4#2)
Nordic##38##1##(1990-11#3)(1990-6#1)(1991-11#1)(1991-2#2)(1992-11#1)(1993-2#2)(1995-8#1)(1997-6#1)(2008-10#7)(2008-2#1)(2008-7#1)(2011-4#17)
Nordisk##3##1##(2007-8#1)(2008-6#1)(2012-3#1)
Norepinephrine##3##1##(2008-2#1)(2013-1#2)
Norfloxacin is a##2##3##(2012-2#2)
Norfloxacin is##3##2##(2012-2#3)
Norfolk##2##1##(1993-3#1)(2009-11#1)
Norm is##2##2##(2008-10#2)
Norm##5##1##(2008-10#5)
Normal and##6##2##(1992-3#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)
Normal human skin##2##3##(2008-11#1)(2008-5#1)
Normal human##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
Normal plasma##2##2##(1991-4#1)(1996-2#1)
Normal##52##1##(1990-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
Normal-incidence##3##1##(2007-11#2)(2008-3#1)
Normal-phase##2##1##(1997-2#1)(2008-10#1)
Normalization of##4##2##(2008-10#1)(2008-2#1)(2010-8#1)(2012-12#1)
Normalization##5##1##(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-12#1)
Normalized##6##1##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
Normally##11##1##(1994-9#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
Norman##2##1##(1997-6#1)(2008-10#1)
Normative data##2##2##(2008-9#1)(2011-1#1)
Normativity##2##1##(2012-2#2)
Norms##2##1##(2008-1#1)(2010-5#1)
Norplant##3##1##(1996-11#3)
Norse##5##1##(1993-3#2)(2008-3#3)
North Africa##3##2##(1993-3#1)(1997-8#2)
North Am J Med Sci 2011##2##6##(2012-3#2)
North America and Costa Rica##2##5##(2008-5#2)
North America and Europe##5##4##(1991-9#1)(2006-10#1)(2008-7#1)(2009-2#2)
North America and Western Europe##2##5##(1997-1#1)(2009-4#1)
North America and is##2##4##(2008-10#2)
North America and##23##3##(1991-9#1)(1992-1#1)(1997-1#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#2)(2011-10#1)(2012-2#1)(2013-8#1)
North America have##2##3##(2008-11#1)(2008-8#1)
North America in##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
North America or Europe##2##4##(2008-7#1)(2012-3#1)
North America or##3##3##(1992-9#1)(2008-7#1)(2012-3#1)
North America was##2##3##(2008-10#1)(2013-1#1)
North America with##3##3##(1996-1#1)(2008-11#1)(2008-5#1)
North America##138##2##(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-9#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#62)(2008-11#8)(2008-2#1)(2008-5#6)(2008-7#5)(2008-8#12)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-3#1)(2011-10#1)(2011-2#6)(2011-9#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
North American C##2##3##(2008-10#2)
North American PVY(NTN)##2##3##(2008-10#2)
North American birds##3##3##(2008-9#3)
North American insulation workers##2##4##(1991-12#2)
North American isolates##3##3##(2008-10#3)
North American populations##5##3##(2008-10#4)(2010-8#1)
North American##54##2##(1991-12#2)(1993-12#2)(1996-2#1)(1996-5#2)(2007-2#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#2)(2010-10#4)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
North Atlantic##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
North Carolina (NC)##2##3##(2008-10#2)
North Carolina State University##2##4##(1997-6#1)(2008-7#1)
North Carolina and##2##3##(2008-10#1)(2011-2#1)
North Carolina sample##4##3##(2008-10#4)
North Carolina were##2##3##(2007-10#1)(2008-10#1)
North Carolina##37##2##(1993-3#3)(1994-3#1)(1995-1#1)(1995-12#1)(1997-6#1)(2007-10#1)(2008-10#19)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-1#3)
North Central Cancer Treatment Group##2##5##(2008-11#1)(2008-7#1)
North Central Cancer##3##3##(1992-8#1)(2008-11#1)(2008-7#1)
North Central##6##2##(1991-1#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
North Dakota##9##2##(2008-10#8)(2010-5#1)
North Dakota's##2##2##(2010-5#2)
North East##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
North India##2##2##(2007-7#1)(2009-10#1)
North Indian##2##2##(1997-8#1)(2008-11#1)
North Pacific##2##2##(2008-10#1)(2010-8#1)
North Sea are##2##3##(2008-10#1)(2009-10#1)
North Sea##6##2##(1996-6#1)(2008-10#2)(2009-10#3)
North and South America##3##4##(2008-10#1)(2008-5#2)
North and South##8##3##(1992-2#1)(1996-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-9#1)(2012-3#1)
North and##12##2##(1992-2#1)(1996-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-9#3)(2011-2#1)(2012-3#1)(2013-7#1)
North of##7##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2012-2#1)
North to##2##2##(1992-2#1)(2011-2#1)
North##329##1##(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-2#5)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#5)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#5)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#116)(2008-11#15)(2008-12#7)(2008-2#2)(2008-3#4)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#18)(2008-9#5)(2009-10#4)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-9#4)(2010-1#1)(2010-10#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#14)(2011-9#1)(2012-12#1)(2012-2#7)(2012-3#9)(2013-1#7)(2013-7#3)(2013-8#1)
North-Central##2##1##(2008-10#2)
North-East##2##1##(1991-4#1)(2008-7#1)
North-Western##2##1##(2008-10#1)(2008-12#1)
Northeast Thailand##5##2##(2008-10#1)(2008-12#4)
Northeast##16##1##(1995-6#2)(2007-10#4)(2008-10#1)(2008-12#5)(2008-9#1)(2009-7#1)(2011-2#1)(2013-7#1)
Northeastern Brazil##4##2##(1993-6#1)(2008-10#1)(2008-6#1)(2013-7#1)
Northeastern##10##1##(1993-6#1)(2008-10#2)(2008-5#1)(2008-6#2)(2013-7#4)
Northern California Kaiser Permanente##2##4##(2008-11#1)(2008-3#1)
Northern California##4##2##(1995-3#1)(2008-11#1)(2008-3#1)(2009-2#1)
Northern Ireland##4##2##(1997-8#1)(2008-11#1)(2013-8#2)
Northern Ireland's##2##2##(1993-7#1)(2009-4#1)
Northern Israel##2##2##(2007-10#1)(2009-2#1)
Northern Italy##2##2##(1990-2#1)(1993-9#1)
Northern Ontario##5##2##(1994-3#3)(2009-12#2)
Northern Plains##2##2##(2010-9#1)(2013-1#1)
Northern analyses##3##2##(1990-11#1)(1993-9#1)(2008-7#1)
Northern analysis and##3##3##(1992-8#1)(1995-11#1)(1996-5#1)
Northern analysis of##5##3##(1990-5#1)(1992-8#1)(1993-6#1)(1997-7#1)(2008-9#1)
Northern analysis revealed##3##3##(1994-12#1)(1994-6#2)
Northern analysis using##3##3##(1992-6#1)(1994-11#1)(1996-12#1)
Northern analysis##22##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-6#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-5#1)(2008-9#2)
Northern and Southern##3##3##(1990-2#1)(2009-10#1)(2013-7#1)
Northern and Western blot##2##4##(2006-12#1)(2008-8#1)
Northern and Western##3##3##(1993-8#1)(2006-12#1)(2008-8#1)
Northern and##7##2##(1990-2#1)(1993-8#1)(2006-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2013-7#1)
Northern blot analyses indicated that the##2##6##(1992-3#1)(1997-8#1)
Northern blot analyses indicated that##3##5##(1992-3#1)(1993-12#1)(1997-8#1)
Northern blot analyses of##2##4##(1993-3#1)(2008-10#1)
Northern blot analyses##9##3##(1990-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#1)
Northern blot analysis and##2##4##(2008-6#1)(2008-8#1)
Northern blot analysis demonstrated##2##4##(1994-12#1)(1994-9#1)
Northern blot analysis indicated##3##4##(1990-2#1)(1993-3#1)(2008-9#1)
Northern blot analysis of the##4##5##(1993-9#1)(1995-8#1)(1997-8#1)(2008-10#1)
Northern blot analysis of##11##4##(1990-12#1)(1991-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#1)
Northern blot analysis revealed that the##3##6##(1992-9#1)(1997-7#1)(2008-6#1)
Northern blot analysis revealed that##7##5##(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1997-7#1)(1997-8#1)(2008-6#1)
Northern blot analysis revealed##11##4##(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)
Northern blot analysis showed that a##2##6##(1991-2#1)(1995-6#1)
Northern blot analysis showed that the##3##6##(1994-12#1)(1996-12#1)(2008-8#1)
Northern blot analysis showed that##9##5##(1991-11#1)(1991-2#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-4#1)(2008-11#1)(2008-8#1)
Northern blot analysis showed##12##4##(1990-12#1)(1991-11#1)(1991-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-4#1)(2008-11#1)(2008-8#1)
Northern blot analysis using a##2##5##(1992-8#1)(1993-8#1)
Northern blot analysis using##7##4##(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-10#1)(2008-9#1)
Northern blot analysis with##2##4##(1995-6#1)(2008-8#1)
Northern blot analysis##77##3##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-9#2)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#4)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#6)(2008-9#2)
Northern blot and##6##3##(1990-2#1)(1993-12#1)(1993-3#1)(1997-7#1)(2008-9#1)(2010-5#1)
Northern blot experiments##2##3##(1994-12#1)(1995-6#1)
Northern blot hybridization##4##3##(1990-11#1)(1992-3#1)(1994-9#1)(2008-10#1)
Northern blot hybridizations##2##3##(1997-3#1)(2008-10#1)
Northern blot results##2##3##(2008-7#1)(2008-8#1)
Northern blot##118##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-9#2)(1992-3#4)(1992-4#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#6)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#6)(1995-8#2)(1996-10#1)(1996-12#4)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#5)(1997-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#9)(2008-9#6)(2010-5#1)
Northern blots of##2##3##(1990-12#1)(1994-9#1)
Northern blots to##2##3##(1991-6#1)(1993-8#1)
Northern blots##9##2##(1990-12#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-9#1)(2008-10#2)(2008-7#2)
Northern blotting analysis##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
Northern blotting and##3##3##(1992-10#1)(1995-12#1)(2008-6#1)
Northern blotting of##2##3##(1992-9#1)(1994-11#1)
Northern blotting##18##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-9#1)(1994-11#1)(1994-9#2)(1995-12#1)(1996-10#1)(1996-6#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
Northern hybridization analysis demonstrated that##2##5##(1995-8#1)(1996-2#1)
Northern hybridization revealed that##2##4##(2008-8#2)
Northern hybridization##13##2##(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#4)
Northern##265##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#2)(1991-9#3)(1992-10#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#6)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-11#8)(1994-12#8)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#7)(1995-8#3)(1996-10#2)(1996-12#6)(1996-2#2)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#7)(1997-8#6)(1997-9#1)(2006-12#1)(2007-10#1)(2008-1#6)(2008-10#18)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#17)(2008-9#9)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#2)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#8)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#7)
Northern-blot analysis##2##2##(1991-9#1)(1992-9#1)
Northern-blot##4##1##(1990-11#1)(1991-9#2)(1992-9#1)
Northern-blotting analysis##2##2##(1995-12#2)
Northridge##2##1##(1996-4#2)
Northumbria##3##1##(2008-11#3)
Northwest Territories##2##2##(1997-4#1)(2008-11#1)
Northwest of the##3##3##(2008-10#2)(2008-12#1)
Northwest of##5##2##(2008-10#2)(2008-12#3)
Northwest##27##1##(1995-6#1)(1997-4#1)(2008-10#16)(2008-11#1)(2008-12#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
Northwestern University##3##2##(1996-12#1)(1997-2#1)(2008-5#1)
Northwestern##15##1##(1993-3#1)(1994-1#4)(1996-12#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
Norton##2##1##(2008-11#1)(2008-7#1)
Norway and Sweden##2##3##(1990-11#1)(2011-4#1)
Norway and the##2##3##(1991-9#1)(1995-5#1)
Norway and##11##2##(1990-11#1)(1990-6#1)(1991-9#1)(1992-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-10#2)(2011-4#1)
Norway during the##3##3##(1990-9#1)(1991-9#1)(1997-6#1)
Norway has the##2##3##(1990-6#1)(1992-4#1)
Norway has##4##2##(1990-6#1)(1992-4#1)(1992-9#1)(1993-6#1)
Norway spruce seedlings##3##3##(2008-10#3)
Norway spruce##6##2##(2008-10#6)
Norway the##5##2##(1992-4#1)(1995-6#1)(1997-2#1)(1997-6#1)(2008-7#1)
Norway##169##1##(1990-11#6)(1990-2#4)(1990-6#11)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#4)(1991-4#1)(1991-6#8)(1991-9#6)(1992-11#3)(1992-4#5)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#5)(1993-6#6)(1994-11#1)(1994-2#4)(1994-6#6)(1994-9#1)(1995-11#1)(1995-2#4)(1995-5#6)(1995-6#6)(1995-8#2)(1996-11#16)(1996-3#2)(1996-6#4)(1996-9#1)(1997-2#5)(1997-4#2)(1997-6#5)(1997-8#3)(2008-10#16)(2008-12#1)(2008-3#1)(2008-7#6)(2009-10#1)(2011-2#1)(2011-4#1)(2012-3#1)
Norway's##4##1##(1990-6#1)(1991-6#1)(1993-3#1)(1993-6#1)
Norway]##12##1##(1990-6#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-4#2)(1993-3#1)(1996-11#3)(1997-6#1)
Norwegian Canine Cancer##2##3##(1995-2#1)(2011-2#1)
Norwegian Gastrointestinal Cancer##2##3##(1997-8#2)
Norwegian National Insurance##2##3##(1991-8#1)(1997-6#1)
Norwegian adolescents##2##2##(1990-9#2)
Norwegian community##2##2##(1996-11#1)(1997-2#1)
Norwegian counties##4##2##(1991-6#3)(2008-7#1)
Norwegian delivery units##2##3##(1995-6#2)
Norwegian delivery##3##2##(1995-6#3)
Norwegian general practitioners and to##2##5##(1993-2#2)
Norwegian general practitioners##4##3##(1993-2#3)(1995-5#1)
Norwegian general##6##2##(1993-2#3)(1995-5#1)(1996-6#1)(1996-9#1)
Norwegian health##4##2##(1990-9#1)(1996-9#1)(1997-6#1)(1997-8#1)
Norwegian hospital##2##2##(1992-6#1)(1995-11#1)
Norwegian hospitals##2##2##(1993-2#1)(1997-8#1)
Norwegian legislation##4##2##(1991-9#1)(1992-9#1)(1993-6#1)(1995-5#1)
Norwegian medical schools##2##3##(1991-2#2)
Norwegian physicians##3##2##(1992-5#1)(1996-3#1)(1997-6#1)
Norwegian population##7##2##(1990-6#3)(1992-11#1)(1994-11#1)(1996-3#1)(1996-9#1)
Norwegian reference##2##2##(1996-3#2)
Norwegian school children##2##3##(1991-9#2)
Norwegian society##2##2##(1996-11#1)(1996-8#1)
Norwegian soldiers##2##2##(1993-2#2)
Norwegian##145##1##(1990-11#1)(1990-2#1)(1990-6#7)(1990-9#5)(1991-11#3)(1991-2#3)(1991-6#9)(1991-8#1)(1991-9#5)(1992-11#4)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#1)(1993-2#6)(1993-3#2)(1993-6#3)(1994-11#1)(1994-2#4)(1994-6#3)(1994-9#2)(1995-11#3)(1995-2#1)(1995-5#3)(1995-6#7)(1995-8#1)(1996-11#3)(1996-3#6)(1996-6#4)(1996-8#3)(1996-9#5)(1997-2#3)(1997-6#12)(1997-8#7)(2007-10#1)(2008-10#1)(2008-7#1)(2009-10#2)(2010-10#1)(2010-6#3)(2011-2#7)(2012-3#3)
Norwegians ranged##2##2##(1996-3#2)
Norwegians##12##1##(1990-2#1)(1990-6#1)(1991-2#1)(1991-6#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-6#4)
Norwich-Eaton##2##1##(2008-5#2)
Nos##3##1##(2008-10#1)(2013-1#2)
Nose and##2##2##(1991-11#1)(1997-2#1)
Nosocomial infections##2##2##(2012-12#2)
Nosocomial transmission of##2##3##(2007-12#1)(2007-7#1)
Nosocomial##10##1##(1991-3#1)(2007-12#3)(2007-7#3)(2008-5#1)(2012-12#2)
Not I linking clones##2##4##(1995-8#1)(1997-8#1)
Not I linking##3##3##(1995-8#2)(1997-8#1)
Not I##4##2##(1995-8#2)(1997-2#1)(1997-8#1)
Not all##8##2##(1991-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2012-12#1)(2012-2#1)
Not being##2##2##(2009-9#1)(2011-1#1)
Not every##2##2##(1995-12#1)(2007-2#1)
Not mention of their more or less scientific aspects##2##9##(2013-1#2)
Not only are##2##3##(2008-7#1)(2008-9#1)
Not only do##2##3##(1997-2#1)(2012-12#1)
Not only does##2##3##(2008-5#1)(2012-2#1)
Not only is##3##3##(1991-8#1)(2008-10#1)(2010-5#1)
Not only the##2##3##(1992-3#1)(2012-3#1)
Not only##26##2##(1991-8#1)(1992-3#1)(1994-12#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Not so##3##2##(1996-2#1)(2008-10#1)(2012-3#1)
Not surprisingly##5##2##(1996-12#1)(2008-7#1)(2010-12#1)(2012-3#2)
Not the##4##2##(1990-6#1)(2008-10#2)(2009-12#1)
Not##87##1##(1990-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-2#3)(1997-8#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#14)(2008-11#4)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#1)
NotI##4##1##(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#1)
Notable differences##2##2##(1993-3#1)(1995-12#1)
Notable##5##1##(1993-3#1)(1994-12#1)(1995-12#1)(2008-10#1)(2012-3#1)
Notably##22##1##(1994-2#1)(1994-3#2)(1995-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Notch 1##2##2##(2010-3#2)
Notch 2##2##2##(2010-3#2)
Notch pathway expression##2##3##(2010-3#2)
Notch pathway is##2##3##(2010-3#2)
Notch pathway##4##2##(2010-3#4)
Notch signaling in the C##2##5##(2007-12#2)
Notch signaling in##4##3##(2007-12#3)(2010-3#1)
Notch signaling##9##2##(2007-12#5)(2009-5#1)(2010-3#3)
Notch##27##1##(1993-12#1)(2007-12#7)(2008-2#1)(2008-7#1)(2009-5#1)(2010-3#16)
Notching##2##1##(2012-12#1)(2013-1#1)
Note is made of##2##4##(2008-10#1)(2011-2#1)
Note##11##1##(1996-1#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#2)
Notes on##2##2##(1995-9#1)(2008-7#1)
Notes##6##1##(1993-1#1)(1995-9#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
Nothobranchius furzeri##2##2##(2012-3#2)
Notice##2##1##(1997-6#1)(2008-3#1)
Notification System for Infectious Diseases##2##5##(1994-9#1)(1996-11#1)
Notification##4##1##(1994-9#1)(1996-11#1)(1997-2#1)(2013-8#1)
Noting that##2##2##(1992-12#1)(2008-1#1)
Noting##3##1##(1992-12#1)(1994-12#1)(2008-1#1)
Notre##3##1##(2009-10#1)(2011-2#2)
Nottingham##6##1##(1991-6#1)(1994-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)
Notwithstanding the##4##2##(1995-6#1)(2008-10#2)(2013-1#1)
Notwithstanding##7##1##(1995-6#1)(1996-6#1)(2008-10#3)(2008-9#1)(2013-1#1)
Nous avons##2##2##(2011-2#1)(2013-1#1)
Nous en##2##2##(2011-2#2)
Nous rapportons le cas d'un##3##5##(2011-2#1)(2013-1#2)
Nous rapportons##7##2##(2011-2#1)(2013-1#6)
Nous##13##1##(2011-2#5)(2013-1#8)
Noushahr##2##1##(2008-12#2)
Nova Iguaçu##2##2##(2008-6#2)
Nova Scotia##9##2##(1993-12#1)(1996-1#2)(2007-12#5)(2008-11#1)
Nova##14##1##(1993-12#1)(1996-1#2)(2007-12#5)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#2)
Novak curette##2##2##(1991-12#1)(1992-12#1)
Novartis##5##1##(2008-10#1)(2008-5#3)(2013-1#1)
Novel approach##2##2##(2008-1#1)(2008-6#1)
Novel approaches##5##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-11#1)
Novel insights##2##2##(2007-5#1)(2011-2#1)
Novel vaccines##2##2##(1997-7#2)
Novel##135##1##(1990-12#1)(1990-4#1)(1991-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-3#3)(1996-2#1)(1996-5#9)(1996-9#1)(1997-4#2)(1997-7#6)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#3)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#1)
November 1983##2##2##(1991-9#1)(1993-12#1)
November 1989##2##2##(1991-3#1)(2007-7#1)
November 1991 to##3##3##(2008-2#3)
November 1991##5##2##(1993-11#1)(2007-10#1)(2008-2#3)
November 1993##4##2##(1995-11#1)(1996-2#1)(2008-2#2)
November 1995 to##2##3##(2007-7#1)(2008-11#1)
November 1997##3##2##(2008-3#1)(2008-5#2)
November 1998##7##2##(2008-1#1)(2008-10#1)(2008-3#4)(2008-6#1)
November 1999##2##2##(2007-8#1)(2008-10#1)
November 2000##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
November 2002##5##2##(2007-10#1)(2007-8#1)(2008-8#1)(2009-3#1)(2012-3#1)
November 2003##4##2##(2007-11#1)(2008-10#2)(2009-4#1)
November 2005##3##2##(2008-12#1)(2010-5#1)(2013-8#1)
November 2007##6##2##(2009-3#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-7#1)
November 2008##2##2##(2011-2#2)
November 2009##4##2##(2011-2#2)(2012-1#1)(2013-7#1)
November 2011##3##2##(2013-1#3)
November 23-26##2##2##(1996-2#1)(2008-10#1)
November 30##2##2##(1995-3#1)(2010-12#1)
November 5##2##2##(1991-12#1)(2007-12#1)
November and December##3##3##(1991-8#1)(1995-3#1)(2013-8#1)
November of##4##2##(1996-2#1)(2008-5#2)(2012-3#1)
November to##2##2##(2008-5#1)(2010-8#1)
November##101##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-1#1)(1996-12#3)(1996-2#3)(1997-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#11)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
Novi Vinodolski and##2##3##(2011-2#2)
Novice##2##1##(1994-2#1)(2010-6#1)
Novo Nordisk##2##2##(2008-6#1)(2012-3#1)
Novo##6##1##(2008-11#1)(2008-6#3)(2012-3#1)(2013-7#1)
NovoSeven(R)##3##1##(2007-8#3)
Now I##2##2##(1992-3#1)(2013-7#1)
Now a##2##2##(2008-5#1)(2008-9#1)
Now it##2##2##(1995-8#1)(2008-11#1)
Now that##5##2##(1992-3#1)(2008-4#1)(2008-8#1)(2011-2#2)
Now the##6##2##(1990-4#1)(1992-1#1)(1993-2#1)(2008-7#1)(2010-9#1)(2011-2#1)
Now##44##1##(1990-4#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#2)(1993-12#2)(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#2)(1995-8#1)(1996-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
Nowadays##24##1##(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Nox1 in##2##2##(2010-1#2)
Nox1-mediated##2##1##(2010-1#2)
Noxa expression##2##2##(2010-3#1)(2012-12#1)
Noxa##8##1##(2010-3#5)(2012-12#3)
Np L3##2##2##(2008-10#2)
Np##3##1##(2008-10#3)
Np(IV)##2##1##(2008-10#2)
Np(V)##2##1##(2008-10#2)
Nrf-2##2##1##(2008-7#1)(2012-2#1)
NtWIF##7##1##(2009-8#7)
Ntcp##3##1##(2008-11#3)
NuH Hair##3##2##(2012-3#3)
NuMA that##2##2##(2010-5#2)
NuMA##9##1##(2010-5#9)
NuRD activity##2##2##(2012-12#2)
Nubac disc arthroplasty via the posterior approach##3##7##(2011-2#3)
Nuc was##2##2##(1992-8#2)
Nuc##6##1##(1992-8#6)
Nucl##2##1##(1991-9#1)(1997-6#1)
Nuclear Division##2##2##(2012-3#2)
Nuclear Magnetic Resonance##5##3##(1992-3#1)(2009-11#1)(2011-1#2)(2011-2#1)
Nuclear Medicine##5##2##(1994-1#1)(2007-11#1)(2008-10#1)(2012-2#2)
Nuclear Overhauser##2##2##(1993-3#1)(2008-11#1)
Nuclear Power##2##2##(2009-12#1)(2012-2#1)
Nuclear genes##2##2##(2008-7#1)(2010-4#1)
Nuclear imaging##3##2##(2008-8#3)
Nuclear localization of##3##3##(1994-6#1)(1997-1#1)(2007-8#1)
Nuclear magnetic resonance (NMR)##2##4##(1991-5#1)(2008-10#1)
Nuclear magnetic resonance studies##2##4##(1991-5#1)(2008-10#1)
Nuclear magnetic resonance##6##3##(1991-5#2)(2008-10#3)(2008-7#1)
Nuclear matrix##2##2##(2008-8#2)
Nuclear medicine##4##2##(2008-2#1)(2010-6#1)(2010-9#1)(2013-8#1)
Nuclear pore##2##2##(2011-2#2)
Nuclear run-off##2##2##(1992-8#1)(2008-4#1)
Nuclear transfer into##2##3##(2008-8#2)
Nuclear##77##1##(1991-2#1)(1991-5#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-6#2)(1996-9#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
Nuclease##3##1##(1991-5#2)(2008-4#1)
Nucleation##2##1##(2008-6#1)(2012-2#1)
Nuclei##4##1##(1996-9#1)(2008-11#1)(2009-10#1)(2013-1#1)
Nucleic Acids Res##2##3##(1991-9#1)(1993-12#1)
Nucleic Acids##3##2##(1991-9#1)(1993-12#1)(2008-10#1)
Nucleic acid##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
Nucleic acids##3##2##(2010-10#1)(2012-2#1)(2013-8#1)
Nucleic##10##1##(1991-9#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
NucleoCounter##2##1##(2008-11#2)
Nucleolar##2##1##(1997-8#1)(2011-2#1)
Nucleophilic addition of##2##3##(1990-8#1)(2009-10#1)
Nucleophilic##5##1##(1990-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2009-10#1)
Nucleorhabdovirus##2##1##(2008-10#2)
Nucleoside 2-deoxyribosyltransferase##2##2##(1995-6#2)
Nucleoside diphosphate##2##2##(1996-2#1)(1997-7#1)
Nucleoside##9##1##(1994-8#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-4#2)
Nucleotide (nt)##2##2##(1990-11#1)(1993-12#1)
Nucleotide Binding##2##2##(2008-10#1)(2008-8#1)
Nucleotide Sequence and##2##3##(2008-10#2)
Nucleotide Sequence##3##2##(1994-12#1)(2008-10#2)
Nucleotide sequence analysis of the##3##5##(1990-11#1)(1995-8#1)(1997-3#1)
Nucleotide sequence analysis of##5##4##(1990-11#1)(1990-5#1)(1992-3#1)(1995-8#1)(1997-3#1)
Nucleotide sequence analysis revealed an##2##5##(1994-12#1)(2008-10#1)
Nucleotide sequence analysis##10##3##(1990-11#1)(1990-5#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-6#1)
Nucleotide sequence and##3##3##(1990-11#1)(1990-5#1)(2008-10#1)
Nucleotide sequence identity##2##3##(1993-11#1)(2008-10#1)
Nucleotide sequence of a##2##4##(1996-10#1)(1997-2#1)
Nucleotide sequence of the##6##4##(1990-11#2)(1990-12#1)(1992-10#1)(1993-8#1)(1996-10#1)
Nucleotide sequence of##8##3##(1990-11#2)(1990-12#1)(1992-10#1)(1993-8#1)(1996-10#2)(1997-2#1)
Nucleotide sequence##28##2##(1990-11#4)(1990-12#1)(1990-5#3)(1992-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#2)(1995-8#2)(1996-10#2)(1997-2#2)(1997-3#1)(2008-10#5)(2008-6#1)
Nucleotide sequences of##5##3##(1991-6#2)(2008-10#3)
Nucleotide sequences##6##2##(1991-6#2)(1997-6#1)(2008-10#3)
Nucleotide##49##1##(1990-11#5)(1990-12#1)(1990-5#3)(1991-6#2)(1992-10#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#3)(1995-8#2)(1996-10#2)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#15)(2008-11#1)(2008-6#2)(2008-8#1)(2012-3#1)
Nucleotides##5##1##(2008-11#1)(2008-4#2)(2008-5#2)
Nucleus 22##2##2##(2008-9#2)
Nucleus 24 cochlear implant##8##4##(2008-9#8)
Nucleus 24##9##2##(2008-9#9)
Nucleus 5 device##3##3##(2012-2#3)
Nucleus 5##5##2##(2012-2#5)
Nucleus Freedom##3##2##(2008-9#1)(2012-2#2)
Nucleus cochlear implant##2##3##(2008-9#2)
Nucleus##35##1##(1995-8#1)(2008-9#25)(2012-2#9)
Nude##2##1##(1991-8#1)(1994-12#1)
Nueva Granada's##2##2##(2011-2#2)
Nuevo Leon##3##2##(2011-1#3)
Nuffield##2##1##(1996-11#1)(2013-8#1)
Nugent test##3##2##(2013-1#3)
Null##2##1##(2008-3#1)(2009-10#1)
Nulling interferometry##2##2##(2007-11#1)(2008-3#1)
Nulliparous##2##1##(2013-1#2)
Number of##22##2##(1993-8#1)(1994-2#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-8#1)
Number##34##1##(1992-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Numbers of##9##2##(2008-10#4)(2008-12#2)(2009-9#1)(2010-12#1)(2011-3#1)
Numbers##13##1##(2007-9#1)(2008-10#4)(2008-12#3)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
Numerical analysis of##2##3##(2008-10#1)(2008-3#1)
Numerical analysis##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Numerical and##2##2##(2007-12#1)(2008-3#1)
Numerical calculations##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
Numerical data are given for experimental conditions adapted to those of the airborne limb sounder MIPAS-FT##2##16##(2008-3#2)
Numerical estimations##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Numerical examples are##3##3##(2007-12#1)(2008-3#2)
Numerical examples##5##2##(2007-12#1)(2008-3#3)(2011-2#1)
Numerical experiments show that##2##4##(2008-2#1)(2008-3#1)
Numerical experiments##4##2##(2008-2#2)(2008-3#1)(2009-12#1)
Numerical modelling##2##2##(2008-7#2)
Numerical results are compared with##2##5##(2007-11#1)(2008-2#1)
Numerical results are presented for##2##5##(2008-3#2)
Numerical results are##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
Numerical results demonstrate that##3##4##(2007-12#1)(2008-2#1)(2010-2#1)
Numerical results demonstrate##4##3##(2007-12#1)(2008-2#1)(2010-12#1)(2010-2#1)
Numerical results show that##2##4##(2008-3#1)(2013-8#1)
Numerical results##16##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#7)(2010-12#1)(2010-2#1)(2013-8#1)
Numerical simulation of##3##3##(2008-2#1)(2008-3#2)
Numerical simulation##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
Numerical simulations are performed##2##4##(2008-3#2)
Numerical simulations are##4##3##(2007-12#1)(2008-3#2)(2013-8#1)
Numerical simulations based on##2##4##(1992-6#1)(2008-3#1)
Numerical simulations show that##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
Numerical simulations with##2##3##(2007-11#1)(2007-12#1)
Numerical simulations##22##2##(1992-6#1)(2007-11#3)(2007-12#4)(2008-12#1)(2008-2#2)(2008-3#9)(2013-8#2)
Numerical solutions##2##2##(2008-10#1)(2008-2#1)
Numerical tests##2##2##(2008-2#1)(2008-3#1)
Numerical##95##1##(1991-9#1)(1992-6#1)(2007-11#8)(2007-12#15)(2008-10#4)(2008-12#1)(2008-2#16)(2008-3#39)(2008-7#2)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#3)
Numerically##2##1##(2008-11#1)(2008-3#1)
Numerous electron##2##2##(2007-12#1)(2008-7#1)
Numerous lines of evidence indicate that##2##6##(2009-2#1)(2009-7#1)
Numerous studies have##7##3##(1990-9#1)(1992-9#1)(1994-9#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-5#1)
Numerous studies##9##2##(1990-9#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-5#1)
Numerous techniques##2##2##(2008-12#1)(2008-9#1)
Numerous##66##1##(1990-9#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1997-3#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
Nun##9##1##(1995-3#7)(2008-10#2)
Nups are##2##2##(2011-2#2)
Nups##5##1##(2011-2#5)
Nuremberg##2##1##(1993-2#1)(2012-2#1)
Nurse Care##2##2##(2011-1#2)
Nurse Education##10##2##(2008-11#5)(2008-12#5)
Nurse Practitioner##3##2##(2008-12#1)(2011-1#2)
Nurse education in##2##3##(2008-11#2)
Nurse education##3##2##(2008-11#2)(2008-12#1)
Nurse educators have an important role##2##6##(2008-11#2)
Nurse educators##6##2##(2008-11#3)(2008-12#2)(2013-8#1)
Nurse practitioners##2##2##(1997-3#1)(2007-5#1)
Nurse prescribers##2##2##(2008-12#1)(2012-12#1)
Nurse training##2##2##(2008-11#1)(2008-12#1)
Nurse##55##1##(1992-2#2)(1993-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-1#3)(2008-11#18)(2008-12#12)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
Nursery##3##1##(2008-10#3)
Nurses and##3##2##(1992-4#1)(2008-1#1)(2008-11#1)
Nurses are##2##2##(1995-2#1)(2009-11#1)
Nurses can##2##2##(1997-7#1)(2010-11#1)
Nurses in##3##2##(2007-10#1)(2012-3#1)(2013-7#1)
Nurses must##2##2##(2008-12#1)(2013-8#1)
Nurses need to be##2##4##(2010-11#1)(2012-3#1)
Nurses need to##3##3##(2010-11#2)(2012-3#1)
Nurses reported less agreement with the statement about the care plans offering them the ability to determine the status of their patient's nursing care needs##2##25##(2013-1#2)
Nurses reported##5##2##(2008-11#1)(2013-1#4)
Nurses should##2##2##(1995-1#1)(1995-9#1)
Nurses will##2##2##(2008-11#1)(2013-8#1)
Nurses##60##1##(1990-10#1)(1992-1#1)(1992-3#1)(1992-4#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-8#1)(1997-7#1)(2007-10#3)(2007-11#1)(2008-1#2)(2008-11#10)(2008-12#2)(2008-6#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-11#6)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
Nurses' perceptions of##3##3##(1996-7#1)(1997-4#1)(2010-7#1)
Nurses' perceptions##4##2##(1996-7#1)(1997-4#1)(2010-7#1)(2012-12#1)
Nurses'##15##1##(1995-9#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-10#3)(2007-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)(2012-12#1)
Nursing Home##6##2##(1992-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-12#1)(2012-12#1)
Nursing Practice##5##2##(2008-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
Nursing Research and##4##3##(2008-11#2)(2013-1#2)
Nursing Research##6##2##(2008-11#4)(2013-1#2)
Nursing Standard##5##2##(2008-11#2)(2008-12#2)(2013-8#1)
Nursing Student Research Assistant Program##2##5##(2010-10#2)
Nursing and Health##2##3##(2008-11#1)(2008-12#1)
Nursing and Midwifery##6##3##(2008-11#5)(2008-12#1)
Nursing and##14##2##(1996-2#1)(1997-3#1)(2008-11#7)(2008-12#2)(2013-1#3)
Nursing care in##2##3##(2012-3#2)
Nursing care##5##2##(2008-1#1)(2008-6#1)(2010-3#1)(2012-3#2)
Nursing child Assessment##2##3##(1990-12#2)
Nursing course##2##2##(2008-11#1)(2012-3#1)
Nursing curriculum##2##2##(2008-11#1)(2008-12#1)
Nursing education##4##2##(2008-12#1)(2012-3#3)
Nursing home##4##2##(1993-2#1)(1993-3#1)(1997-1#1)(2012-12#1)
Nursing homes in##3##3##(1995-3#1)(1996-3#1)(2010-10#1)
Nursing in##2##2##(1992-2#1)(2008-11#1)
Nursing management##2##2##(1993-2#1)(1995-12#1)
Nursing students##3##2##(1996-7#1)(2008-11#1)(2010-3#1)
Nursing students'##3##2##(2008-12#2)(2010-3#1)
Nursing teachers' perception##2##3##(2012-3#2)
Nursing##185##1##(1990-12#2)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#2)(1993-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#4)(2007-10#2)(2007-11#1)(2008-1#5)(2008-10#1)(2008-11#59)(2008-12#24)(2008-3#1)(2008-6#1)(2009-12#1)(2010-10#6)(2010-3#9)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#25)(2013-1#11)(2013-8#3)
Nurturing the##2##2##(2011-2#1)(2012-3#1)
Nus factors##2##2##(1995-3#2)
Nutrient digestibility##2##2##(2009-4#2)
Nutrient utilization and##2##3##(2008-7#1)(2010-2#1)
Nutrient##15##1##(1990-8#1)(1993-9#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#2)(2009-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
Nutrients##3##1##(1994-8#1)(2008-10#2)
Nutrigenomics##4##1##(2008-10#3)(2008-7#1)
Nutrition Committee##2##2##(2008-3#1)(2012-2#1)
Nutrition Month campaign##2##3##(1995-1#2)
Nutrition Month##4##2##(1995-1#4)
Nutrition in##5##2##(1990-9#1)(1991-2#1)(2007-2#1)(2012-12#1)(2013-1#1)
Nutrition knowledge##2##2##(1991-2#2)
Nutrition##37##1##(1990-9#1)(1991-2#4)(1992-2#1)(1995-1#4)(1996-12#1)(1997-3#1)(2007-1#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2010-12#1)(2010-5#3)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
Nutritional and##2##2##(1993-12#1)(2008-3#1)
Nutritional factors##2##2##(1990-8#1)(2012-2#1)
Nutritional status##2##2##(2011-1#1)(2013-1#1)
Nutritional##22##1##(1990-8#1)(1991-2#2)(1993-12#1)(1995-2#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-7#1)
Ny##3##1##(2008-10#3)
Nymphs##3##1##(2008-6#2)(2011-2#1)
Nyquist frequency##2##2##(2008-2#1)(2013-8#1)
Nyquist plot##3##2##(2008-10#3)
Nyquist rate##3##2##(2008-3#1)(2012-2#2)
Nyquist##13##1##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#4)(2012-2#2)(2013-8#1)
N°##2##1##(2013-1#2)
O and##12##2##(1992-6#1)(1994-3#2)(1996-3#1)(2008-10#1)(2008-3#2)(2010-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
O antigen of lipopolysaccharide##2##4##(1996-12#2)
O antigen of##4##3##(1996-12#3)(2008-9#1)
O antigen##6##2##(1996-12#3)(2008-9#3)
O atoms##3##2##(2008-10#1)(2010-4#2)
O biosynthesis##2##2##(1992-12#2)
O in##2##2##(2008-10#2)
O or##2##2##(1996-2#1)(2010-4#1)
O stretching##5##2##(1990-2#3)(1994-3#1)(1996-2#1)
O transfer##3##2##(2008-6#3)
O##200##1##(1990-2#5)(1990-7#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-12#6)(1992-4#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1994-12#2)(1994-3#4)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#14)(1996-2#6)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-7#3)(2007-10#1)(2007-11#2)(2007-2#3)(2008-10#57)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#5)(2010-11#2)(2010-4#4)(2010-8#6)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#6)
O&quot##2##1##(1990-9#1)(1993-11#1)
O'##2##1##(2008-10#2)
O'Brien##3##1##(1996-3#1)(1997-3#1)(2008-11#1)
O'Brien's##2##1##(1996-3#1)(1997-3#1)
O'Reilly Bioinformatics Technology Conference##2##4##(2008-7#2)
O'Reilly##5##1##(2008-7#5)
O(2) A-band absorption correction##2##4##(2008-2#2)
O(2) A-band absorption##5##3##(2008-2#5)
O(2) and##10##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2010-4#1)(2011-2#1)
O(2) binding##2##2##(1997-7#2)
O(2) concentration##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
O(2) from##2##2##(2007-12#1)(2008-10#1)
O(2) kg(-1)##3##2##(2008-10#1)(2010-8#2)
O(2) kg(-1))##2##2##(2008-10#2)
O(2) levels##4##2##(2011-2#4)
O(2) production##2##2##(2008-10#2)
O(2)##70##1##(1996-2#1)(1997-7#2)(2007-12#8)(2008-10#17)(2008-11#1)(2008-2#8)(2008-3#11)(2008-7#1)(2008-8#1)(2010-4#2)(2010-7#2)(2010-8#2)(2011-2#12)(2012-2#1)(2013-1#1)
O(2)(-) and##2##2##(2008-10#1)(2008-8#1)
O(2)(-)##4##1##(2008-10#3)(2008-8#1)
O(2)(a(1)D) and O(2)(X(3)?)##2##3##(2008-2#2)
O(3) and##3##2##(2008-2#1)(2008-3#2)
O(3) line##2##2##(2008-2#1)(2008-3#1)
O(3)##32##1##(2008-10#1)(2008-11#3)(2008-2#7)(2008-3#12)(2008-5#9)
O(N) complexity##2##2##(2010-12#2)
O(T)O is diagonal##2##3##(2008-3#2)
O(rd)##5##1##(2008-12#5)
O) and##2##2##(1996-2#2)
O) recombinant##2##2##(2008-10#2)
O)##11##1##(1994-5#1)(1996-2#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#5)
O-2##3##1##(1990-9#2)(1995-3#1)
O-3##2##1##(1990-9#1)(1995-11#1)
O-301##3##1##(2008-10#3)
O-ATR##3##1##(2008-2#3)
O-D-apio-beta-D-furanosyl-(1--&gt##2##1##(2008-11#2)
O-DMA is##2##2##(2012-2#2)
O-DMA producers##2##2##(2012-2#2)
O-DMA##11##1##(2012-2#11)
O-Dma##2##1##(1993-12#2)
O-GlcNAc modification##2##2##(2008-11#2)
O-GlcNAc modified proteins##2##3##(2008-11#1)(2008-4#1)
O-GlcNAc##11##1##(2008-11#5)(2008-2#2)(2008-4#4)
O-H##3##1##(1995-5#1)(2008-3#1)(2009-10#1)
O-acetate groups in##2##3##(1994-9#2)
O-acetate##3##1##(1994-9#3)
O-acetyl##2##1##(1995-11#1)(1996-5#1)
O-acetylated##8##1##(1990-2#4)(1992-6#3)(1994-9#1)
O-acetylation of##2##2##(1992-6#2)
O-atom energy##3##2##(2010-4#3)
O-buffer is##3##2##(2008-6#3)
O-buffer##7##1##(2008-6#7)
O-buffers##7##1##(2008-6#7)
O-containing##2##1##(2010-4#1)(2013-8#1)
O-dealkylase activities##2##2##(2008-11#2)
O-dealkylation##3##1##(1994-8#3)
O-deethylase (EROD) activity was##2##4##(1992-8#1)(1993-12#1)
O-deethylase##4##1##(1992-3#1)(1992-8#1)(1993-12#1)(2008-11#1)
O-diethyl##2##1##(2007-11#1)(2008-10#1)
O-diethyl-dithiophosphate##2##1##(2008-10#2)
O-glycans##2##1##(2009-8#2)
O-glycosides##5##1##(2008-12#1)(2009-8#4)
O-glycosidically linked##3##2##(1994-9#2)(1995-5#1)
O-glycosidically##4##1##(1994-5#1)(1994-9#2)(1995-5#1)
O-glycosylated oligosaccharide on the alpha chain##2##6##(1992-12#2)
O-glycosylated oligosaccharide##5##2##(1992-12#5)
O-glycosylated##8##1##(1992-12#6)(1994-11#1)(1994-5#1)
O-glycosylation##2##1##(1994-12#1)(2011-1#1)
O-linked GlcNAc##2##2##(1994-5#1)(2008-4#1)
O-linked glycans##2##2##(2008-1#1)(2012-3#1)
O-linked##13##1##(1990-5#1)(1992-6#1)(1994-5#2)(1994-9#3)(2008-1#1)(2008-2#2)(2008-4#2)(2012-3#1)
O-methyl-apigenin-C-deoxyhexoside-O-hexoside##2##1##(2008-10#2)
O-phosphoseryl-tRNA([Ser]Sec)##3##1##(2012-2#3)
O-polysaccharide##2##1##(1992-12#2)
O-selective##2##1##(2008-4#2)
O-sulfation##2##1##(2008-4#2)
O/O(2)##4##1##(2010-4#4)
O/W emulsion and##3##3##(2008-5#3)
O/W emulsion##5##2##(2008-5#5)
O/W##12##1##(2008-5#12)
O1##8##1##(1992-5#1)(1995-3#2)(2007-7#1)(2008-12#3)(2011-2#1)
O111##3##1##(2012-2#3)
O145##3##1##(2012-2#3)
O157 Phazyme##2##2##(2012-2#2)
O157##20##1##(1995-2#2)(1996-3#1)(1997-3#1)(2008-10#6)(2008-9#2)(2010-4#2)(2012-2#6)
O2 and##3##2##(1997-1#1)(1997-2#1)(2008-10#1)
O2 binding##6##2##(1991-10#3)(1997-2#2)(2007-11#1)
O2 in N2##3##3##(2008-10#3)
O2 is##2##2##(1997-2#1)(2008-10#1)
O2 or##2##2##(1993-6#1)(1995-3#1)
O2 pulse##2##2##(2013-8#2)
O2##57##1##(1991-10#3)(1991-3#2)(1991-5#1)(1991-9#1)(1992-8#2)(1993-6#1)(1994-11#2)(1994-2#1)(1995-3#1)(1995-6#4)(1996-12#1)(1997-1#2)(1997-2#5)(2007-11#4)(2008-10#10)(2008-11#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#5)
O2*-##2##1##(2008-4#1)(2013-8#1)
O2- formation in HL-60 cells##2##5##(1994-8#2)
O2- formation##3##2##(1994-8#3)
O2- generated##2##2##(1992-5#2)
O2- production in##2##3##(1992-3#1)(1996-2#1)
O2- production##11##2##(1992-3#1)(1996-2#8)(1996-9#2)
O2-##30##1##(1991-2#2)(1992-3#1)(1992-5#4)(1994-6#2)(1994-8#3)(1995-8#1)(1996-2#10)(1996-5#2)(1996-9#4)(2007-11#1)
O2-Hb##2##1##(1997-2#2)
O2-binding##2##1##(1997-2#2)
O2-production##2##1##(1995-6#2)
O26##4##1##(1993-9#2)(2012-2#2)
O3##11##1##(1990-8#1)(1992-9#6)(1995-3#1)(2008-3#2)(2011-2#1)
O4##3##1##(1995-2#2)(2008-3#1)
O45##4##1##(1995-11#4)
O45-related antigen##2##2##(1995-11#2)
O45-related##4##1##(1995-11#4)
O6 is about##2##3##(1993-8#2)
O6-alkylguanine-DNA alkyltransferase##5##2##(1992-8#2)(1993-11#1)(1995-5#1)(2008-5#1)
O6-benzylguanine##5##1##(1995-5#5)
O6-methylguanine##4##1##(1992-8#1)(1993-11#1)(1995-5#2)
O6-methylguanine-DNA methyltransferase##2##2##(1992-3#2)
O66##3##1##(1995-11#3)
OA and##7##2##(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1997-4#1)(2013-1#2)
OA progression##2##2##(2009-12#1)(2013-1#1)
OA was##3##2##(1994-11#1)(2010-8#1)(2013-1#1)
OA##50##1##(1992-12#3)(1992-3#6)(1993-2#1)(1993-6#5)(1994-11#4)(1994-3#1)(1997-4#1)(2007-11#3)(2008-7#1)(2008-9#2)(2009-12#1)(2010-11#3)(2010-8#3)(2013-1#16)
OA-induced##2##1##(1993-6#1)(1994-11#1)
OAA and##3##2##(2008-10#3)
OAA##4##1##(2008-10#4)
OAA-treated mice##2##2##(2008-10#2)
OAH##10##1##(2008-7#10)
OAP system in CHO cells##2##5##(2008-11#2)
OAP system##4##2##(2008-11#4)
OAS##2##1##(2008-6#2)
OASIS##3##1##(2006-4#2)(2010-8#1)
OAT##3##1##(2009-12#3)
OATs##2##1##(1990-5#2)
OAV##4##1##(1997-3#4)
OB interneurons##3##2##(2012-2#3)
OB subjects##3##2##(2008-2#3)
OB##20##1##(1990-7#1)(1996-5#1)(2008-2#11)(2012-2#6)(2013-1#1)
OB-fold##3##1##(2010-10#3)
OBIC##2##1##(2007-12#2)
OBJECTIVE AND IMPORTANCE##3##3##(2012-2#3)
OBJECTIVE AND##4##2##(2007-11#1)(2012-2#3)
OBJECTIVE##108##1##(2006-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-1#27)(2011-2#11)(2012-12#4)(2012-2#17)(2012-3#23)(2013-1#5)
OBJECTIVES##30##1##(2009-4#1)(2010-6#1)(2011-1#5)(2011-2#3)(2011-7#1)(2012-12#4)(2012-2#13)(2013-1#2)
OBO ester##2##2##(2007-11#2)
OBP##2##1##(2008-8#2)
OBRA##2##1##(1992-2#1)(1994-1#1)
OC and##2##2##(2008-10#1)(2008-3#1)
OC symptoms##3##2##(2008-3#2)(2008-6#1)
OC##19##1##(1994-5#4)(1996-11#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-6#4)
OC/BC##2##1##(2008-10#2)
OCA##3##1##(1997-4#3)
OCCL##2##1##(2013-8#2)
OCD and MDD##3##3##(2009-9#3)
OCD and##4##2##(2009-9#3)(2013-1#1)
OCD in##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
OCD loose body##3##3##(2013-1#3)
OCD loose##4##2##(2013-1#4)
OCD##23##1##(2008-1#2)(2008-11#2)(2008-3#2)(2008-6#4)(2009-9#4)(2013-1#7)(2013-8#2)
OCE##4##1##(2011-2#4)
OCH(3)##3##1##(2008-10#3)
OCI is##3##2##(2008-2#3)
OCI##4##1##(2008-2#4)
OCIP##2##1##(1993-3#2)
OCL##2##1##(2008-11#2)
OCMO##2##1##(1995-12#2)
OCPs in natural##2##3##(2008-10#2)
OCPs##4##1##(2008-10#4)
OCT and##4##2##(2008-3#1)(2011-1#1)(2011-2#2)
OCT as##3##2##(2011-1#2)(2011-7#1)
OCT for##2##2##(2008-2#1)(2011-1#1)
OCT has the potential to##2##5##(2011-7#2)
OCT images of##2##3##(2007-12#1)(2008-3#1)
OCT images were##3##3##(2007-11#1)(2011-7#2)
OCT images##8##2##(2007-11#1)(2007-12#2)(2008-3#2)(2011-7#3)
OCT imaging##6##2##(2007-11#1)(2011-7#5)
OCT in the diagnosis and##3##5##(2011-7#3)
OCT in the##5##3##(2008-7#1)(2010-9#1)(2011-7#3)
OCT in##7##2##(2008-7#1)(2010-9#1)(2011-7#5)
OCT is##2##2##(2008-2#1)(2008-3#1)
OCT measurements##2##2##(2008-5#1)(2011-7#1)
OCT scope##2##2##(2007-12#2)
OCT signals##2##2##(2007-11#1)(2008-3#1)
OCT systems##6##2##(2007-11#1)(2007-12#2)(2010-12#1)(2011-7#2)
OCT##94##1##(2007-11#5)(2007-12#9)(2008-2#2)(2008-3#9)(2008-5#1)(2008-7#2)(2010-12#3)(2010-9#1)(2011-1#9)(2011-2#12)(2011-7#32)(2012-2#2)(2013-1#7)
OCT-negative cases##2##2##(2011-2#2)
OCTS data##2##2##(2008-3#2)
OCTS##3##1##(2008-3#3)
OCl(-) and##2##2##(2008-10#2)
OCl(-)##3##1##(2008-10#3)
OCs administration##2##2##(1994-5#2)
OCs##6##1##(1994-5#4)(1996-11#2)
OD and SB##3##3##(1992-2#3)
OD values##2##2##(1990-3#2)
OD##16##1##(1990-11#1)(1990-3#2)(1991-12#1)(1992-2#5)(1995-1#1)(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#1)(2012-2#2)
ODA##10##1##(1995-12#4)(2008-10#5)(2010-5#1)
ODA-H(2)O(2)-HRP##2##1##(2008-10#2)
ODC activity##5##2##(1995-8#2)(2008-10#3)
ODC##11##1##(1992-9#2)(1993-8#1)(1995-8#3)(2008-10#5)
ODD behavior##2##2##(2012-2#2)
ODD##3##1##(2012-2#3)
ODI##4##1##(2008-12#3)(2012-12#1)
ODN (ISIS##2##2##(2008-10#2)
ODN##20##1##(2008-10#15)(2011-2#5)
ODNs and##2##2##(1994-12#1)(2008-10#1)
ODNs containing##2##2##(2008-10#2)
ODNs were##2##2##(1994-12#2)
ODNs##15##1##(1994-12#8)(1996-12#1)(2008-10#4)(2008-4#2)
ODS column##5##2##(1993-2#1)(2008-10#4)
ODS##21##1##(1990-8#1)(1993-2#1)(2008-10#18)(2012-12#1)
ODS-SOWG##2##1##(2008-10#2)
ODT##4##1##(2007-12#3)(2009-6#1)
OE##2##1##(2007-12#1)(2008-3#1)
OEC##6##1##(2008-7#4)(2008-8#2)
OECD countries##4##2##(1993-2#1)(1994-1#1)(1996-3#2)
OECD##9##1##(1993-2#1)(1994-1#1)(1996-3#3)(2008-5#1)(2011-1#3)
OECs and Schwann cells##2##4##(2008-7#2)
OECs##8##1##(2008-7#8)
OEG##11##1##(2008-7#5)(2013-1#6)
OEM##3##1##(1996-2#2)(2013-1#1)
OES##4##1##(2008-10#4)
OF 401(K)##2##2##(2011-2#2)
OF A##4##2##(2008-12#1)(2009-11#1)(2009-5#1)(2012-12#1)
OF THE##11##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
OF surface##2##2##(2008-10#2)
OF##82##1##(1997-3#1)(1997-5#1)(2007-2#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-9#6)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-12#6)(2012-2#3)(2012-3#7)(2013-1#2)(2013-8#4)
OFDI swine##2##2##(2011-1#2)
OFDI##5##1##(2011-1#5)
OFDS##2##1##(1997-3#2)
OFF##5##1##(2007-12#1)(2008-7#4)
OFLO and ENRO##2##3##(2008-10#2)
OFLO##3##1##(2008-10#3)
OFLX##4##1##(2008-10#4)
OFSTED##3##1##(2008-7#3)
OG concentrations in##2##3##(1995-12#2)
OG concentrations##3##2##(1995-12#3)
OG##4##1##(1995-12#4)
OG-solubilized##2##1##(1994-5#2)
OGTT and CIGMA##2##3##(1994-12#2)
OGTT##8##1##(1994-12#2)(2011-2#4)(2012-3#1)(2012-7#1)
OH 131##2##2##(2008-10#2)
OH 182##7##2##(2008-10#7)
OH and##4##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
OH at##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
OH band##2##2##(2007-12#2)
OH concentration##4##2##(2008-3#4)
OH concentrations were##2##3##(2008-2#2)
OH concentrations##3##2##(1992-9#1)(2008-2#2)
OH group of##3##3##(1993-11#1)(2007-12#1)(2008-8#1)
OH group##7##2##(1993-11#1)(2007-12#3)(2008-10#2)(2008-8#1)
OH groups are##2##3##(2007-12#1)(2008-10#1)
OH groups##6##2##(2007-12#2)(2008-10#4)
OH impurity in optical fibers##2##5##(2007-11#2)
OH impurity##4##2##(2007-11#4)
OH in##2##2##(2008-2#2)
OH is also##2##3##(2008-10#1)(2008-3#1)
OH number densities in a series of near-adiabatic flames at equivalence ratios##2##12##(2008-3#2)
OH number density##3##3##(2008-3#3)
OH number##5##2##(2008-3#5)
OH of##2##2##(2007-12#1)(2008-10#1)
OH radical concentration in##3##4##(2008-2#2)(2008-3#1)
OH radical##5##2##(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
OH radicals##10##2##(1997-2#1)(1997-8#3)(2007-11#1)(2008-10#2)(2008-11#3)
OH stretching##4##2##(2007-12#2)(2008-2#2)
OH vitamin D##2##3##(1991-11#1)(2008-1#1)
OH with##2##2##(1995-6#1)(2008-9#1)
OH##136##1##(1990-5#3)(1991-11#1)(1991-9#1)(1992-9#5)(1993-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#6)(2007-11#6)(2007-12#12)(2008-1#2)(2008-10#30)(2008-11#4)(2008-2#15)(2008-3#29)(2008-4#1)(2008-8#1)(2008-9#5)(2009-4#1)(2010-9#1)(2013-1#1)
OH(-) in##2##2##(2008-10#2)
OH(-)##8##1##(2008-10#7)(2008-3#1)
OH)##6##1##(1990-5#1)(1991-9#1)(1994-11#1)(1995-12#1)(2006-12#1)(2008-8#1)
OH-NA##3##1##(2008-10#3)
OH-O-Dma)##2##1##(1993-12#2)
OH-Tam##3##1##(1990-12#3)
OH-radical generation##3##2##(1993-8#3)
OH-radical##4##1##(1993-8#3)(2008-11#1)
OH-radicals##2##1##(1993-8#1)(2008-11#1)
OHA##5##1##(1992-6#4)(2012-4#1)
OHIP-14##2##1##(2011-2#2)
OHN students were##2##3##(2010-3#2)
OHN students##3##2##(2010-3#3)
OHS##9##1##(1995-12#1)(2011-1#2)(2012-12#6)
OI's##3##1##(2008-3#3)
OIE has##2##2##(2011-2#2)
OIE##15##1##(2011-2#15)
OIG##3##1##(1993-1#1)(1994-2#1)(2008-11#1)
OIS##3##1##(2009-2#3)
OIs##3##1##(2008-2#1)(2008-3#2)
OK##6##1##(1991-3#1)(1992-8#1)(1994-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
OK&quot##3##1##(1994-1#3)
OKT-3##2##1##(1993-9#2)
OKT3##2##1##(2008-7#2)
OL##8##1##(1995-5#4)(2007-12#3)(2008-7#1)
OL1##4##1##(1992-4#4)
OLIO+ is##2##2##(1991-12#2)
OLIO+##4##1##(1991-12#4)
OLL1073R-1/SM inhibited secretion of proinflammatory cytokines##2##6##(2008-11#2)
OLL1073R-1/SM##3##1##(2008-11#3)
OLP and##2##2##(2013-1#2)
OLP##9##1##(1997-4#2)(2013-1#7)
OLR of 20g-glucose/L/day##2##3##(2013-1#2)
OLR##4##1##(2013-1#4)
OLS regression##2##2##(2010-2#1)(2012-3#1)
OLS##3##1##(2008-10#1)(2010-2#1)(2012-3#1)
OLV##3##1##(2011-2#3)
OM and##2##2##(2010-2#1)(2013-8#1)
OM##18##1##(2008-10#1)(2008-12#1)(2008-5#2)(2009-11#2)(2010-2#3)(2011-2#1)(2012-4#1)(2013-1#2)(2013-8#5)
OMC and##2##2##(2008-5#2)
OMC reacted##2##2##(1995-12#2)
OMC##8##1##(1995-12#4)(2008-5#4)
OMEGA##3##1##(2008-2#3)
OMIM##7##1##(2008-4#4)(2008-9#2)(2009-5#1)
OMP and##2##2##(1990-12#1)(2008-12#1)
OMP extracted##2##2##(2008-12#2)
OMP##10##1##(1990-12#2)(1994-8#1)(1995-12#1)(2008-12#4)(2008-5#1)(2013-1#1)
OMR##2##1##(2011-2#2)
OMS##3##1##(2011-2#3)
ON FOUR##2##2##(2007-12#1)(2007-2#1)
ON THE##2##2##(2009-11#1)(2009-4#1)
ON and OFF states##4##4##(2008-7#4)
ON and##6##2##(2008-10#1)(2008-7#4)(2011-7#1)
ON##23##1##(2007-12#2)(2007-2#2)(2008-10#3)(2008-7#4)(2008-9#4)(2009-11#3)(2009-12#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-7#1)
ON-OFF##2##1##(2008-7#1)(2008-9#1)
ONCAB##3##1##(2007-8#3)
ONCHIT##7##1##(2010-8#7)
ONOO(-)##4##1##(2008-10#2)(2008-7#2)
ONS##4##1##(1995-2#4)
OO and##3##2##(2008-2#2)(2013-1#1)
OO subjects##2##2##(2008-2#2)
OO##12##1##(2008-2#11)(2013-1#1)
OOC##2##1##(2013-1#2)
OP and##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
OP in##3##2##(2008-10#1)(2011-2#2)
OP insecticides##2##2##(2011-1#2)
OP pesticides and##2##3##(2010-5#2)
OP pesticides residue in fruits and vegetables that may not induce early clinical features##2##14##(2013-1#2)
OP pesticides##10##2##(2010-5#4)(2013-1#6)
OP variation in##3##3##(2011-1#3)
OP was##2##2##(2008-10#1)(2011-2#1)
OP##53##1##(1996-2#4)(2008-10#7)(2008-12#3)(2010-12#1)(2010-5#4)(2011-1#6)(2011-2#8)(2013-1#20)
OP-1##4##1##(1994-6#4)
OPA##4##1##(2007-11#1)(2008-10#1)(2008-2#2)
OPB03(1##2##1##(2008-10#2)
OPBP1##2##1##(2008-8#2)
OPC##11##1##(2008-5#5)(2008-7#1)(2010-10#4)(2012-4#1)
OPC2(441R)##2##1##(2008-10#2)
OPCAB and##2##2##(2007-8#2)
OPCAB in##2##2##(2007-8#1)(2010-5#1)
OPCAB patients##2##2##(2007-8#2)
OPCAB##20##1##(2007-8#15)(2007-9#1)(2008-10#2)(2010-5#1)(2010-8#1)
OPCAB)##2##1##(2007-8#1)(2008-10#1)
OPCARE##2##1##(2007-8#2)
OPCs were##2##2##(2012-4#2)
OPCs##10##1##(2008-7#7)(2012-4#3)
OPD##13##1##(1995-11#1)(2007-7#1)(2008-10#2)(2008-3#7)(2012-2#1)(2013-1#1)
OPDs##2##1##(2013-8#2)
OPG and vWF levels##2##4##(2013-8#2)
OPG and##3##2##(2013-8#3)
OPG was##2##2##(2008-12#1)(2011-1#1)
OPG##13##1##(2008-12#3)(2011-1#2)(2013-8#8)
OPG10(340)##2##1##(2008-10#2)
OPM03/04_480##2##1##(2008-10#2)
OPN expression##3##2##(2010-11#3)
OPN in##3##2##(2010-11#3)
OPN is an##2##3##(2009-7#2)
OPN is##3##2##(2009-7#2)(2010-11#1)
OPN promoter##3##2##(2010-11#3)
OPN transcription##2##2##(2010-11#2)
OPN##18##1##(2009-7#3)(2010-11#15)
OPO and##2##2##(2007-12#1)(2008-3#1)
OPO cavity##4##2##(2008-2#2)(2008-3#2)
OPO generated signal##2##3##(2007-12#2)
OPO generated##3##2##(2007-12#3)
OPO generates 1##2##3##(2007-11#1)(2008-3#1)
OPO generates##3##2##(2007-11#1)(2008-3#2)
OPO in##2##2##(2007-12#1)(2008-3#1)
OPO is based on##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
OPO is##9##2##(2007-11#5)(2007-12#2)(2008-3#2)
OPO operation with pump pulse energies##2##6##(2007-12#2)
OPO shows##2##2##(2007-12#1)(2008-3#1)
OPO system##2##2##(2008-10#1)(2008-3#1)
OPO to##2##2##(2008-2#1)(2008-3#1)
OPO with a##2##3##(2007-12#1)(2008-3#1)
OPO##64##1##(2007-11#11)(2007-12#24)(2008-10#1)(2008-2#8)(2008-3#20)
OPPs##3##1##(2008-10#3)
OPS##4##1##(2007-10#4)
OPS-1 versus##2##2##(2007-10#2)
OPS-1##4##1##(2007-10#4)
OPS-2##3##1##(2007-10#3)
OPV or EP-IPV##2##3##(1995-5#2)
OPV##12##1##(1994-9#2)(1995-5#10)
OPY20(830C)##3##1##(2008-10#3)
OPZ##2##1##(1992-8#2)
OPZ04(560) was linked in coupling phase##2##6##(2008-10#2)
OPs##5##1##(2008-10#5)
OPtiMAL test##3##2##(2007-7#3)
OPtiMAL##4##1##(2007-7#4)
OR (95% CI)##3##3##(2012-2#1)(2013-1#2)
OR 0##4##2##(2008-10#3)(2011-1#1)
OR 1##6##2##(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
OR = 1##2##3##(1990-8#2)
OR = 3##2##3##(2013-1#2)
OR = 4##2##3##(1990-8#1)(2008-9#1)
OR =##12##2##(1990-8#5)(1991-12#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#2)
OR and##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
OR gate##2##2##(2008-11#1)(2012-2#1)
OR of##4##2##(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
OR value##7##2##(2011-1#7)
OR##69##1##(1990-8#5)(1991-12#1)(1992-11#1)(1994-3#1)(1997-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-1#10)(2011-2#9)(2012-2#4)(2012-3#6)(2013-1#7)
ORA##6##1##(2008-2#3)(2008-3#3)
ORAC values##3##2##(2008-10#3)
ORAC##5##1##(2008-10#3)(2008-7#2)
ORE##4##1##(2008-10#4)
ORF C##2##2##(2008-10#2)
ORF I##4##2##(2008-10#4)
ORF S2##2##2##(2008-9#2)
ORF encodes a protein of##2##5##(1997-7#1)(2008-10#1)
ORF encodes a##4##3##(1996-6#1)(1997-7#1)(2008-10#1)(2008-8#1)
ORF is##5##2##(1993-12#1)(1994-12#1)(1995-9#1)(1996-8#1)(1997-3#1)
ORF length##2##2##(1996-3#1)(2008-7#1)
ORF located on the viral##2##5##(2008-10#2)
ORF located##3##2##(1995-8#1)(2008-10#2)
ORF of##7##2##(1995-8#1)(1996-6#3)(1997-4#1)(2008-10#1)(2008-7#1)
ORF organization##2##2##(2008-7#2)
ORF risk-level##2##2##(2008-12#2)
ORF was found##2##3##(1990-11#1)(2008-10#1)
ORF was##7##2##(1990-11#1)(1995-6#1)(1995-8#1)(1997-3#2)(2008-10#1)(2008-8#1)
ORF which##2##2##(1992-3#1)(1993-2#1)
ORF with##2##2##(1993-12#1)(2008-12#1)
ORF##96##1##(1990-11#4)(1991-7#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#1)(1994-12#7)(1995-6#4)(1995-8#3)(1995-9#5)(1996-3#1)(1996-6#7)(1996-8#2)(1997-3#10)(1997-4#3)(1997-7#2)(2008-10#21)(2008-12#4)(2008-7#6)(2008-8#5)(2008-9#4)(2010-5#1)
ORF-2##3##1##(1994-12#3)
ORF-36##5##1##(1990-11#5)
ORF-4##2##1##(1994-12#2)
ORF1##2##1##(2008-10#1)(2008-9#1)
ORF186 (finO)##2##2##(1991-7#2)
ORF186##4##1##(1991-7#4)
ORF2##3##1##(2008-10#1)(2008-9#2)
ORF248 and##2##2##(1991-7#2)
ORF248##3##1##(1991-7#3)
ORF286##2##1##(1991-7#2)
ORF3 protein##3##2##(1997-4#3)
ORF3##7##1##(1997-4#4)(2008-10#3)
ORF4##4##1##(2008-10#4)
ORF7##5##1##(2008-10#5)
ORFans are##2##2##(2008-7#2)
ORFans##6##1##(2008-7#6)
ORFs and##2##2##(1995-12#1)(1997-3#1)
ORFs are##6##2##(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#2)(2008-7#1)
ORFs as##2##2##(1995-12#1)(1995-8#1)
ORFs encoding##2##2##(2008-8#2)
ORFs had##2##2##(1996-3#1)(2008-10#1)
ORFs have##2##2##(1994-12#1)(1996-3#1)
ORFs in##2##2##(1996-10#1)(2008-10#1)
ORFs is##2##2##(1996-6#1)(2008-7#1)
ORFs of##6##2##(1996-3#3)(1997-3#2)(1997-6#1)
ORFs on##2##2##(1995-12#1)(1997-3#1)
ORFs present similarities##2##3##(1995-9#1)(1997-3#1)
ORFs show##2##2##(1995-9#1)(1996-3#1)
ORFs were##7##2##(1994-12#2)(1995-12#2)(1996-12#1)(2008-10#2)
ORFs##96##1##(1990-5#1)(1991-9#3)(1993-2#1)(1994-12#6)(1995-12#10)(1995-6#1)(1995-8#4)(1995-9#6)(1996-10#1)(1996-12#1)(1996-3#16)(1996-6#5)(1996-8#2)(1997-3#17)(1997-4#1)(1997-6#3)(2008-10#7)(2008-7#8)(2008-8#2)(2011-1#1)
ORFs)##2##1##(1995-12#1)(2008-7#1)
ORIF##3##1##(2008-8#3)
ORIGINALITY/VALUE##2##1##(2012-3#2)
ORL1 peptide-stimulated [35S]GTP gamma S binding was##2##7##(1996-2#2)
ORL1 peptide-stimulated [35S]GTP gamma S binding##3##6##(1996-2#3)
ORL1 peptide-stimulated##4##2##(1996-2#4)
ORL1##6##1##(1996-2#6)
ORNs in##2##2##(2007-12#2)
ORNs##6##1##(2007-12#6)
ORO##4##1##(2008-11#4)
ORS##5##1##(1991-9#4)(2008-10#1)
ORTHOSPHERE(®)##3##1##(2010-11#3)
ORrab2 is a##2##3##(1997-4#2)
ORrab2##4##1##(1997-4#4)
ORs##6##1##(2008-12#1)(2008-8#2)(2011-2#2)(2012-12#1)
OS and HS##2##3##(2008-5#2)
OS and##5##2##(1992-10#1)(2008-5#2)(2011-2#2)
OS in##2##2##(1992-10#1)(1993-1#1)
OS of the##2##3##(2011-2#2)
OS rate##4##2##(1993-1#3)(2008-10#1)
OS##31##1##(1991-8#1)(1992-10#2)(1993-1#4)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-10#2)(2010-3#8)(2011-2#6)
OS1p##2##1##(2008-10#2)
OSA and##2##2##(2010-5#1)(2013-7#1)
OSA patients##3##2##(2012-2#3)
OSA##10##1##(2008-3#1)(2009-9#1)(2010-5#2)(2012-2#4)(2013-7#2)
OSC is##2##2##(2008-10#1)(2008-6#1)
OSC##19##1##(1992-8#3)(2008-10#3)(2008-5#4)(2008-6#9)
OSCC##10##1##(2010-12#4)(2012-3#1)(2013-1#5)
OSCE in##2##2##(1994-2#2)
OSCE is##3##2##(1994-2#2)(2008-11#1)
OSCE##9##1##(1994-2#5)(2008-11#4)
OSHA##5##1##(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(2007-3#1)
OSHA's bloodborne pathogens standard##2##4##(1993-2#1)(1994-3#1)
OSHA's##3##1##(1992-12#1)(1993-2#1)(1994-3#1)
OSI##3##1##(2007-12#3)
OSM##7##1##(1991-11#6)(1996-2#1)
OSM)##3##1##(1991-11#3)
OSR##3##1##(2008-10#3)
OT alone##2##2##(2010-12#2)
OT##6##1##(1990-5#1)(2008-10#2)(2010-12#3)
OT32##2##1##(2008-10#2)
OTA in wheat##2##3##(2008-10#2)
OTA in##4##2##(2008-10#4)
OTA plasma levels##2##3##(2011-2#2)
OTA plasma##3##2##(2011-2#3)
OTA##18##1##(1991-1#1)(2008-10#9)(2011-2#8)
OTC and SCP##3##3##(2008-10#3)
OTC and##4##2##(2008-10#4)
OTC deficiency##3##2##(2009-8#3)
OTC drugs##3##2##(2008-7#3)
OTC##15##1##(2008-10#7)(2008-5#1)(2008-7#3)(2009-8#4)
OTDR signal##2##2##(2008-3#2)
OTF9##2##1##(1997-2#2)
OTG##2##1##(2008-7#2)
OTU##2##1##(2012-2#2)
OTUs##2##1##(2012-2#2)
OUR##10##1##(2008-11#3)(2008-7#7)
OUTCOMES #ENTITYSTARTX00026##3##2##(2010-7#1)(2012-3#1)(2013-1#1)
OUTCOMES##4##1##(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#1)
OV##2##1##(2008-10#2)
OVA 323-339##2##2##(1991-2#2)
OVA and##3##2##(2008-11#3)
OVA peptide##2##2##(2008-11#2)
OVA##16##1##(1991-2#2)(1993-12#2)(2008-10#1)(2008-11#11)
OVA-specific IL-10 production##2##3##(2008-11#2)
OVA-specific IgA##2##2##(2008-10#1)(2008-11#1)
OVA-specific cytokine production##2##3##(2008-11#2)
OVA-specific##11##1##(2008-10#1)(2008-11#10)
OVA/IL12 protein##4##2##(2008-11#4)
OVA/IL12##5##1##(2008-11#5)
OVCAR-3 cells##2##2##(1992-9#1)(1993-8#1)
OVCAR-3##3##1##(1992-9#2)(1993-8#1)
OVX##3##1##(2010-10#3)
OWC##4##1##(2008-10#4)
OWG##10##1##(2008-10#10)
OX-42##2##1##(2008-11#1)(2009-12#1)
OY-M and OY-NIM##2##3##(2008-10#2)
OY-M##6##1##(2008-10#6)
OY-NIM##4##1##(2008-10#4)
OY-W##5##1##(2008-10#5)
OYDV and LYSV##2##3##(2008-10#2)
OYDV and##3##2##(2008-10#3)
OYDV##4##1##(2008-10#4)
Oak Ridge National Laboratory##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
Oak##8##1##(2008-10#4)(2008-4#1)(2009-6#1)(2013-1#1)(2013-8#1)
Oakland##2##1##(1993-12#1)(1996-3#1)
Oaks##3##1##(2008-12#2)(2012-7#1)
Oasis HLB SPE##2##3##(2008-10#1)(2011-1#1)
Oasis HLB##5##2##(2008-10#4)(2011-1#1)
Oasis##7##1##(2008-10#6)(2011-1#1)
Oat in##2##2##(2008-10#2)
Oat##6##1##(1992-7#1)(2008-10#4)(2012-2#1)
Oats##4##1##(2008-10#4)
Ob/Gyn departments##2##2##(1997-1#2)
Ob/Gyn physicians##2##2##(2013-1#2)
Ob/Gyn##6##1##(1997-1#3)(2013-1#3)
Ob1771 cells##2##2##(1990-12#2)
Ob1771##4##1##(1990-12#4)
Obama##3##1##(2010-9#1)(2012-2#2)
Obese##14##1##(1994-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#4)
Obesity Prevention##2##2##(2011-1#1)(2013-1#1)
Obesity among##2##2##(2012-3#2)
Obesity and other##2##3##(2010-5#1)(2011-2#1)
Obesity and##11##2##(1993-1#1)(1993-9#1)(2008-3#2)(2008-5#2)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
Obesity can##2##2##(2008-12#1)(2013-8#1)
Obesity in Children##2##3##(2008-1#1)(2008-12#1)
Obesity in##4##2##(2008-1#1)(2008-12#2)(2010-3#1)
Obesity is a##2##3##(2009-2#1)(2012-5#1)
Obesity is associated with##3##4##(2011-2#1)(2012-2#2)
Obesity is##11##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
Obesity##55##1##(1993-1#1)(1993-9#1)(1996-12#1)(2008-1#3)(2008-10#2)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#1)
Obituary##4##1##(2008-5#2)(2010-11#1)(2011-2#1)
Object##8##1##(1995-9#1)(2008-3#3)(2009-12#1)(2011-1#1)(2013-8#2)
Objective Analysing##2##2##(2011-2#1)(2012-12#1)
Objective Assessing the##3##3##(2012-12#2)(2013-1#1)
Objective Assessing##5##2##(2012-12#3)(2013-1#2)
Objective Describing the##2##3##(2012-12#1)(2013-1#1)
Objective Describing##3##2##(2012-12#1)(2013-1#2)
Objective Determining##3##2##(2011-2#2)(2012-12#1)
Objective Establishing##3##2##(2011-2#1)(2012-12#2)
Objective Identifying##3##2##(2012-12#3)
Objective Structured Clinical Examination##3##4##(1996-2#1)(2008-11#2)
Objective Structured Clinical##4##3##(1996-2#1)(2008-11#2)(2012-3#1)
Objective The present study##2##4##(2011-2#1)(2012-12#1)
Objective The present##3##3##(2011-2#2)(2012-12#1)
Objective The##6##2##(2011-2#3)(2012-12#2)(2013-8#1)
Objective This study##3##3##(2012-12#1)(2013-8#2)
Objective To assess the##2##4##(2008-8#1)(2013-8#1)
Objective To evaluate the##2##4##(2008-8#1)(2013-8#1)
Objective To##9##2##(2008-8#2)(2011-2#1)(2013-8#6)
Objective Using##2##2##(2011-2#1)(2012-12#1)
Objective and##2##2##(1992-6#1)(1993-12#1)
Objective responses##4##2##(1991-2#1)(1991-6#1)(1994-8#1)(2008-6#1)
Objective##223##1##(1991-2#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1996-2#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-7#1)(2009-8#1)(2010-1#2)(2010-6#1)(2010-8#7)(2011-1#18)(2011-2#28)(2012-1#1)(2012-12#54)(2012-2#2)(2012-3#8)(2013-1#32)(2013-7#1)(2013-8#25)
Objectives Assessing##2##2##(2011-2#1)(2013-1#1)
Objectives Determining the##2##3##(2012-12#2)
Objectives Establishing##2##2##(2012-12#1)(2013-1#1)
Objectives To##2##2##(2011-2#1)(2013-1#1)
Objectives##53##1##(1994-3#1)(1996-9#1)(2007-11#1)(2007-2#4)(2008-11#1)(2008-7#3)(2011-2#7)(2012-12#11)(2012-2#1)(2012-3#2)(2013-1#14)(2013-8#7)
Objectives  The##2##2##(2012-1#1)(2013-1#1)
Objectives  To##4##2##(2011-2#3)(2012-1#1)
Objectives  We##3##2##(2011-2#1)(2012-1#2)
Objectives ##10##1##(2011-2#5)(2012-1#4)(2013-1#1)
Objectivity##2##1##(2012-2#1)(2013-8#1)
Objects that##3##2##(2008-2#1)(2008-3#2)
Objects##7##1##(2008-2#2)(2008-3#4)(2009-11#1)
Obligate##3##1##(1996-6#1)(2008-10#2)
Oblique##3##1##(1997-8#1)(2008-2#1)(2013-8#1)
Obliquity leadership##2##2##(2012-3#2)
Obscure##2##1##(2012-2#2)
Observation and##2##2##(2007-11#1)(2013-1#1)
Observation of a##5##3##(1990-3#1)(1996-12#1)(2007-11#1)(2007-12#2)
Observation of the##5##3##(1996-9#2)(2008-3#2)(2008-5#1)
Observation of##40##2##(1990-3#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-6#2)(1996-12#3)(1996-8#1)(1996-9#2)(2007-11#9)(2007-12#9)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-8#1)
Observation was the preferred strategy##2##5##(2012-3#2)
Observation##54##1##(1990-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-6#2)(1996-12#3)(1996-8#1)(1996-9#2)(2007-11#10)(2007-12#9)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
Observational studies##2##2##(1996-3#1)(2013-7#1)
Observational##9##1##(1993-12#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
Observations and##2##2##(2008-3#1)(2008-8#1)
Observations from##3##2##(1990-9#1)(2011-2#1)(2012-2#1)
Observations of the##2##3##(2008-2#1)(2008-5#1)
Observations of##12##2##(1991-6#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-5#1)(2009-2#1)(2010-8#1)(2012-1#1)(2013-7#1)
Observations on the##3##3##(1991-12#1)(1994-7#1)(2008-9#1)
Observations were carried out##2##4##(2007-11#1)(2013-1#1)
Observations were made##5##3##(2008-10#4)(2008-5#1)
Observations were##8##2##(2007-11#2)(2008-10#4)(2008-5#1)(2013-1#1)
Observations##41##1##(1990-9#1)(1991-12#2)(1991-6#1)(1994-7#1)(1995-6#1)(1996-6#1)(2007-11#4)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Observatory (LIGO)##4##2##(2007-11#1)(2008-3#3)
Observatory (SOHO)##3##2##(2008-2#1)(2008-3#2)
Observatory##17##1##(2007-11#1)(2008-2#1)(2008-3#13)(2011-2#1)(2013-7#1)
Observed and##2##2##(2008-10#1)(2012-12#1)
Observed changes in the##2##4##(2008-10#1)(2008-4#1)
Observed##22##1##(1995-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
Observer variation in##2##3##(1990-2#1)(1993-1#1)
Observer##5##1##(1990-2#1)(1993-1#1)(2007-8#1)(2009-8#1)(2011-2#1)
Observers##2##1##(2008-11#1)(2008-2#1)
Observing System##4##2##(2008-3#3)(2013-8#1)
Observing patients (4##2##3##(1991-2#2)
Observing##12##1##(1991-2#3)(2008-2#4)(2008-3#3)(2013-8#2)
Obsessive Compulsive##3##2##(2008-3#3)
Obsessive##4##1##(2008-3#3)(2012-2#1)
Obstacles to adherence##2##3##(2008-7#2)
Obstacles to##6##2##(1993-2#1)(1996-1#1)(2008-11#1)(2008-7#2)(2013-8#1)
Obstet Gynecol##3##2##(1994-5#2)(1996-11#1)
Obstetric##7##1##(2006-10#1)(2010-3#1)(2011-1#2)(2013-1#2)(2013-8#1)
Obstetrical Art##2##2##(1991-6#2)
Obstetrical##4##1##(1991-6#2)(1997-3#1)(2013-1#1)
Obstetrician and##2##2##(2008-3#1)(2010-9#1)
Obstetrician##3##1##(2008-3#2)(2010-9#1)
Obstetrics and Gynaecology##4##3##(1996-1#1)(2008-12#2)(2008-3#1)
Obstetrics and Gynecology##7##3##(1990-10#2)(1991-3#2)(1994-5#1)(1995-3#1)(1996-9#1)
Obstetrics and##12##2##(1990-10#2)(1991-3#2)(1994-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(2008-12#2)(2008-3#1)
Obstetrics##22##1##(1990-10#2)(1991-3#2)(1991-6#1)(1994-5#2)(1995-3#2)(1996-1#1)(1996-3#1)(1996-9#1)(2007-4#1)(2008-12#3)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
Obstruction of##2##2##(1990-9#1)(2011-1#1)
Obstructive Sleep##2##2##(2010-8#1)(2013-7#1)
Obstructive sleep apnea##4##3##(1992-5#1)(2009-9#1)(2010-5#2)
Obstructive sleep##5##2##(1992-5#1)(1997-8#1)(2009-9#1)(2010-5#2)
Obstructive##11##1##(1992-5#1)(1997-8#2)(2008-10#1)(2009-1#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-7#1)
Obtained by##2##2##(2008-10#1)(2008-3#1)
Obtained results were compared with the##2##6##(2008-10#2)
Obtained results were compared with##3##5##(2008-10#3)
Obtained results were##4##3##(2008-10#4)
Obtained results##10##2##(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2011-1#1)(2013-1#1)
Obtained##15##1##(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Obtaining a##3##2##(2007-7#1)(2008-12#1)(2008-3#1)
Obtaining the##2##2##(2007-11#1)(2011-2#1)
Obtaining##12##1##(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-11#1)(2011-2#2)(2012-1#1)
Obvious##2##1##(1995-8#1)(2008-3#1)
Obviously##5##1##(1992-11#1)(2008-11#2)(2008-7#1)(2010-12#1)
Occasionally##14##1##(1990-5#1)(1991-4#1)(1991-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
Occidental##3##1##(2008-5#2)(2010-8#1)
Occipital encephalocele (max diameter##2##4##(2012-3#2)
Occipital##4##1##(1991-5#1)(2012-3#2)(2013-1#1)
Occipitocervical Fusion in##2##3##(2012-3#2)
Occluded##2##1##(1995-8#1)(2008-12#1)
Occlusal##2##1##(2013-1#1)(2013-7#1)
Occlusion of the##3##3##(2008-12#1)(2010-3#1)(2012-3#1)
Occlusion##4##1##(2008-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
Occult##3##1##(1993-3#1)(2006-10#1)(2013-1#1)
Occultation Radiometer##2##2##(2008-3#2)
Occultation##5##1##(2008-3#5)
Occupational Medicine##2##2##(1990-12#1)(1991-12#1)
Occupational Outlook Handbook##2##3##(1993-3#2)
Occupational Safety and Health Administration (OSHA)##3##6##(1991-12#1)(1993-3#1)(1995-12#1)
Occupational Safety and Health Administration##4##5##(1991-12#1)(1993-3#1)(1994-3#1)(1995-12#1)
Occupational Safety and Health##8##4##(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2012-12#1)
Occupational Therapy##2##2##(2008-11#1)(2012-1#1)
Occupational and##2##2##(1991-10#1)(2009-12#1)
Occupational health services##2##3##(1991-3#2)
Occupational health##6##2##(1991-3#2)(2009-12#2)(2010-3#1)(2012-1#1)
Occupational therapists##2##2##(2012-2#1)(2013-8#1)
Occupational##41##1##(1990-12#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#2)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#3)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Occurrence and##4##2##(1993-11#1)(2007-7#1)(2008-10#2)
Occurrence of a##2##3##(1993-11#1)(1994-6#1)
Occurrence of the##2##3##(2008-10#1)(2008-8#1)
Occurrence of##22##2##(1993-11#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
Occurrence##30##1##(1993-11#2)(1994-2#1)(1994-6#1)(1997-3#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
Occurring in##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
Occurring##8##1##(2007-2#1)(2008-10#4)(2010-2#1)(2013-1#2)
Ocean inherent optical property##2##4##(2008-2#1)(2008-3#1)
Ocean were##2##2##(1992-7#1)(2008-11#1)
Ocean##27##1##(1992-7#1)(1996-4#2)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#8)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Oceania##3##1##(2008-1#1)(2009-4#1)(2010-3#1)
Oceanic##4##1##(2008-2#2)(2008-3#2)
Oceanographic##2##1##(2008-2#2)
Oceanside##2##1##(2008-3#2)
Ochnaflavone##2##1##(1994-11#2)
Ochratoxin##2##1##(2011-2#2)
Ocimum sanctum##4##2##(2008-5#1)(2010-3#2)(2012-2#1)
Ocimum##9##1##(2008-5#3)(2010-3#2)(2010-5#3)(2012-2#1)
Oct-1 and Oct-3##2##3##(1994-9#2)
Oct-1 and##3##2##(1994-12#1)(1994-9#2)
Oct-1##6##1##(1992-8#1)(1994-12#2)(1994-9#3)
Oct-2##9##1##(1992-6#3)(1992-8#1)(1994-12#5)
Oct-3 in##2##2##(1994-9#2)
Oct-3##4##1##(1994-9#4)
Oct-4##6##1##(2008-11#6)
Octadecyl##2##1##(2008-10#2)
October 1##5##2##(1992-2#1)(1997-5#1)(2007-10#2)(2012-12#1)
October 1985##2##2##(1991-3#1)(2008-1#1)
October 1987##2##2##(1990-12#1)(1995-3#1)
October 1988 to##2##3##(1994-3#1)(1997-7#1)
October 1988##3##2##(1991-12#1)(1994-3#1)(1997-7#1)
October 1992##4##2##(1993-6#1)(1995-5#1)(2008-2#2)
October 1993##4##2##(1994-9#1)(1996-1#1)(2008-11#2)
October 1995##3##2##(1996-5#1)(1997-2#1)(2008-10#1)
October 1996##2##2##(2008-11#1)(2012-3#1)
October 1997 and##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
October 1997##7##2##(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)
October 1998##4##2##(2007-7#1)(2008-10#2)(2013-1#1)
October 1999##5##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
October 2000##3##2##(2008-10#1)(2008-5#1)(2011-3#1)
October 2001##7##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
October 2003##3##2##(2007-8#1)(2008-10#1)(2008-12#1)
October 2004 to##2##3##(2008-12#1)(2008-7#1)
October 2004##5##2##(2008-12#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-2#1)
October 2005##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
October 2006 and##2##3##(2008-8#1)(2013-1#1)
October 2006##3##2##(2008-8#1)(2013-1#1)(2013-7#1)
October 2008##4##2##(2010-1#1)(2010-5#3)
October 2009##3##2##(2011-2#1)(2012-3#1)(2013-7#1)
October 2010##2##2##(2012-12#2)
October 26-29##2##2##(2008-8#2)
October 31##2##2##(1995-12#1)(1996-1#1)
October 6##2##2##(1996-12#1)(2009-5#1)
October and##3##2##(1994-9#1)(2011-2#1)(2013-1#1)
October at##2##2##(2008-10#1)(2008-3#1)
October of##2##2##(1991-12#1)(1996-2#1)
October to##6##2##(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2013-7#1)
October##142##1##(1990-12#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#3)(1993-6#1)(1994-1#1)(1994-3#1)(1994-9#3)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#4)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#3)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#5)(2013-8#2)
October)##2##1##(2008-12#1)(2011-2#1)
October/November##2##1##(1991-6#1)(2008-10#1)
Octopus vulgaris##3##2##(2008-10#2)(2008-7#1)
Octopus##5##1##(2008-10#2)(2008-5#1)(2008-7#2)
Octreotide##3##1##(1991-8#1)(1992-5#1)(2008-8#1)
Ocular##11##1##(1992-2#1)(1995-12#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-1#2)(2012-12#1)
Odds Ratio##2##2##(2008-6#1)(2012-12#1)
Odds ratio##2##2##(2010-9#1)(2013-8#1)
Odds##7##1##(1995-3#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
Odegård's##2##1##(1993-6#2)
Odontogenic keratocysts##2##2##(2007-12#2)
Odontogenic##4##1##(2007-12#4)
Odontoma##2##1##(1990-3#1)(2008-9#1)
Odontotremataceae##3##1##(2010-10#3)
Odour perception##2##2##(2008-7#2)
Oenothera berteriana and Arabidopsis thaliana##2##5##(1991-6#2)
Oesophageal cancer with##2##3##(2011-2#2)
Oesophageal##6##1##(1995-10#1)(1997-6#1)(2010-9#1)(2011-1#1)(2011-2#2)
Oestrogen##3##1##(1990-11#1)(1992-8#1)(2011-2#1)
Oestrogens##2##1##(1990-11#1)(2008-4#1)
Oestrus ovis##2##2##(2010-10#2)
Oestrus##3##1##(1994-7#1)(2010-10#2)
Of 11##2##2##(1997-3#1)(2008-10#1)
Of 14##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
Of 15##2##2##(2008-10#1)(2008-11#1)
Of 16##2##2##(1990-2#1)(1991-2#1)
Of 3##2##2##(2008-7#1)(2011-1#1)
Of 33##2##2##(1993-8#1)(2008-7#1)
Of 75##2##2##(1990-2#1)(1991-8#1)
Of a total of##2##4##(1995-2#1)(2012-2#1)
Of about##2##2##(1995-12#1)(2010-10#1)
Of all the changes##2##4##(2008-4#1)(2010-2#1)
Of all the compounds##2##4##(1994-11#1)(2008-11#1)
Of all the##10##3##(1994-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2013-7#1)(2013-8#1)
Of all##15##2##(1991-6#1)(1994-11#1)(1995-12#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
Of concern##2##2##(1997-4#1)(2011-2#1)
Of course##6##2##(1994-1#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
Of dead sperm##3##3##(2008-12#3)
Of dead##4##2##(2008-12#4)
Of further##2##2##(2006-6#1)(2009-8#1)
Of greater##2##2##(1996-7#1)(2008-6#1)
Of importance##2##2##(2008-7#1)(2013-1#1)
Of interest##7##2##(1992-8#1)(1994-8#1)(1996-12#1)(2006-8#1)(2010-12#1)(2010-3#1)(2013-8#1)
Of particular interest is the##4##5##(1994-9#1)(1995-2#1)(2008-5#1)(2010-4#1)
Of particular interest is##5##4##(1993-11#1)(1994-9#1)(1995-2#1)(2008-5#1)(2010-4#1)
Of particular interest##8##3##(1993-11#1)(1994-9#1)(1995-2#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-4#1)
Of particular##11##2##(1991-12#1)(1993-11#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-4#1)
Of patients##3##2##(1991-1#1)(1996-3#1)(2007-11#1)
Of primary##2##2##(2008-11#1)(2008-9#1)
Of six##2##2##(2008-10#1)(2011-1#1)
Of special interest##2##3##(1995-2#1)(2008-4#1)
Of special##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
Of the 11##3##3##(2008-10#3)
Of the 13##3##3##(1994-5#1)(1994-7#1)(2008-3#1)
Of the 14##2##3##(1993-8#1)(2008-10#1)
Of the 19##2##3##(1992-6#1)(2013-8#1)
Of the 20##2##3##(2008-3#1)(2013-1#1)
Of the 22##2##3##(1991-2#1)(1993-8#1)
Of the 23 patients who##2##5##(1991-2#1)(2008-6#1)
Of the 26##2##3##(1995-2#1)(2012-3#1)
Of the 38##2##3##(2010-8#1)(2011-2#1)
Of the 45##2##3##(1996-11#1)(2007-7#1)
Of the 6##3##3##(1995-12#1)(2008-6#1)(2013-8#1)
Of the 85##2##3##(2007-7#1)(2011-2#1)
Of the 9##2##3##(1992-8#1)(1993-9#1)
Of the Agricultural Production-Crops establishments that required respirator use##2##9##(2008-12#2)
Of the compounds##2##3##(1990-12#1)(1990-5#1)
Of the different##2##3##(2008-6#1)(2011-1#1)
Of the five##7##3##(1990-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
Of the four##4##3##(2008-10#3)(2013-1#1)
Of the instruments adopted##2##4##(2013-1#2)
Of the isolates in VCG##2##5##(2008-10#2)
Of the isolates##3##3##(1991-3#1)(2008-10#2)
Of the other##2##3##(1990-11#1)(2012-3#1)
Of the patients treated##2##4##(1991-4#1)(2008-7#1)
Of the patients with##3##4##(2008-1#1)(2010-12#1)(2013-8#1)
Of the patients##10##3##(1991-4#1)(1991-8#1)(1992-5#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-12#1)(2013-8#1)
Of the remaining##4##3##(1994-12#1)(1996-3#1)(2008-10#1)(2012-3#1)
Of the seven patients##2##4##(2008-1#1)(2008-6#1)
Of the seven##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
Of the six##2##3##(1995-2#1)(2009-5#1)
Of the surviving##2##3##(2008-9#2)
Of the tested##2##3##(2008-11#1)(2013-8#1)
Of the three patients##2##4##(2008-3#1)(2013-1#1)
Of the three##10##3##(1990-5#1)(1992-12#1)(1993-8#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
Of the total##10##3##(1991-3#1)(2007-7#2)(2008-10#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
Of the two##8##3##(1992-3#1)(1996-5#1)(2008-10#4)(2008-7#1)(2011-2#1)
Of the variety of##2##4##(2008-9#1)(2010-9#1)
Of the various##3##3##(2008-10#3)
Of the##251##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-7#2)(2006-10#1)(2007-10#7)(2007-11#1)(2007-12#1)(2007-7#9)(2007-8#3)(2008-1#9)(2008-10#46)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#7)(2008-7#10)(2008-8#1)(2008-9#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#10)(2013-8#9)
Of them##8##2##(1994-12#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
Of these patients##7##3##(1991-3#1)(1991-6#1)(2008-1#1)(2008-7#4)
Of these##86##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
Of those patients##2##3##(2008-1#1)(2008-3#1)
Of those who##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
Of those##20##2##(1995-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
Of##531##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#7)(1995-2#6)(1995-3#1)(1995-5#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#1)(1996-7#3)(1996-9#2)(1997-1#4)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#11)(2007-11#3)(2007-12#2)(2007-7#14)(2007-8#5)(2008-1#16)(2008-10#78)(2008-11#12)(2008-12#15)(2008-2#9)(2008-3#15)(2008-4#8)(2008-5#9)(2008-6#11)(2008-7#30)(2008-8#8)(2008-9#15)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#28)(2012-1#1)(2012-12#10)(2012-2#8)(2012-3#7)(2013-1#20)(2013-7#4)(2013-8#16)
Off##2##1##(1992-3#1)(2008-10#1)
Off-axis holograms recorded with a##2##5##(2008-3#2)
Off-axis##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
Off-label use of##3##3##(2009-12#1)(2010-5#1)(2012-12#1)
Off-line##3##1##(2008-10#2)(2009-6#1)
Off-pump coronary surgery in selected patients##2##6##(2007-8#1)(2013-8#1)
Off-pump coronary##3##2##(2007-8#1)(2013-1#1)(2013-8#1)
Off-pump##5##1##(2007-8#3)(2013-1#1)(2013-8#1)
Offered by##2##2##(1995-6#1)(2013-1#1)
Offering##2##1##(1996-11#1)(1997-2#1)
Office for##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
Office of Inspector General##3##4##(1991-12#1)(1993-1#1)(1993-12#1)
Office of the##2##3##(2008-1#1)(2012-12#1)
Office of##13##2##(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-12#1)
Office staff##2##2##(1991-12#2)
Office##41##1##(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#2)(1992-12#1)(1993-1#1)(1993-12#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1997-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-7#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Office-based##2##1##(2008-7#1)(2012-1#1)
Officer for##2##2##(1994-3#1)(2008-12#1)
Officer##8##1##(1990-6#1)(1992-12#1)(1993-3#2)(1994-1#1)(1994-3#1)(2008-1#1)(2008-12#1)
Official figures##2##2##(1993-8#1)(1997-6#1)
Official##8##1##(1993-8#1)(1997-6#2)(2008-10#4)(2008-9#1)
Officials##7##1##(1993-2#1)(1995-12#3)(1996-1#3)
Offord##3##1##(1996-5#2)(2008-11#1)
Offset##2##1##(2008-3#1)(2012-2#1)
Offspring##5##1##(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
Often the##4##2##(1990-6#1)(1991-2#1)(2007-11#1)(2008-7#1)
Often these##3##2##(2008-10#1)(2008-6#1)(2010-3#1)
Often##28##1##(1990-6#1)(1991-2#1)(1994-3#1)(1995-1#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
Ogawa##3##1##(1990-11#1)(2012-3#2)
Ogle and##2##2##(2008-10#2)
Ogle##4##1##(2008-10#4)
Oh##2##1##(2008-11#1)(2008-6#1)
Oh516##4##1##(2008-10#4)
Ohio 88119##2##2##(2008-10#2)
Ohio and##3##2##(2008-10#3)
Ohio are##2##2##(1997-1#1)(2008-10#1)
Ohio##46##1##(1991-9#1)(1992-3#1)(1993-8#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(2007-3#3)(2008-10#28)(2008-12#2)(2008-4#1)(2010-9#1)
Oidium neolycopersici##3##2##(2008-10#3)
Oil Mill##2##2##(2008-10#1)(2008-12#1)
Oil red-O##2##2##(2008-11#2)
Oil##17##1##(1995-3#1)(2007-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#4)
Oil-in-water (o/w)##2##2##(2008-5#2)
Oils##3##1##(2008-10#1)(2009-8#1)(2012-2#1)
Oilseed Rape##2##2##(2008-10#2)
Oilseed##3##1##(2008-10#3)
Okadaic acid##3##2##(1992-12#1)(1992-8#1)(1993-8#1)
Okadaic##4##1##(1992-12#1)(1992-8#1)(1993-8#1)(1997-4#1)
Okajima##2##1##(1990-7#1)(1993-8#1)
Okayama Prefecture##2##2##(1993-1#2)
Okazaki fragment##4##2##(1992-3#4)
Okazaki##5##1##(1992-3#5)
Okinawa##20##1##(2008-10#13)(2008-2#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)
Okinawans##4##1##(2008-2#2)(2008-7#2)
Oklahoma biotypes##2##2##(2008-10#2)
Oklahoma##9##1##(1994-3#1)(1995-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2013-8#2)
Olathe##3##1##(2008-10#3)
Old Order Anabaptist##3##3##(2008-12#3)
Old Order##8##2##(2008-12#8)
Old World monkeys##2##3##(1995-11#2)
Old World##8##2##(1995-11#2)(2008-10#1)(2008-5#4)(2012-2#1)
Old age##2##2##(2007-7#1)(2008-7#1)
Old and New World##2##4##(2007-12#1)(2008-8#1)
Old and New##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
Old and##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
Old##35##1##(1992-1#1)(1995-11#2)(1995-4#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#8)(2008-2#1)(2008-5#4)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
Older Adults##7##2##(2008-8#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
Older LGBT##2##2##(2013-8#2)
Older adults##2##2##(1994-6#1)(2010-11#1)
Older age##2##2##(2008-12#2)
Older patients##4##2##(1991-12#1)(2008-3#1)(2010-3#1)(2012-12#1)
Older women##5##2##(1994-2#2)(2011-2#2)(2012-2#1)
Older##42##1##(1991-12#1)(1994-2#2)(1994-6#1)(1995-2#1)(1997-1#1)(1997-3#2)(2007-5#1)(2008-1#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#2)(2013-1#2)(2013-8#3)
Oleander##2##1##(2008-10#1)(2008-12#1)
Olefin##2##1##(2008-11#1)(2009-6#1)
Oleic acid##3##2##(1990-7#1)(2008-10#1)(2009-3#1)
Oleic##5##1##(1990-7#1)(2008-10#1)(2008-12#2)(2009-3#1)
Olfactory tract transection##2##3##(2013-1#2)
Olfactory##11##1##(2006-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#2)(2013-1#2)
Oligo(ethylene glycol) (OEG) and poly(ethylene glycol) (PEG) exhibit several desirable properties including biocompatibility and resistance to fouling by protein adsorption##2##20##(2013-1#2)
Oligo(ethylene glycol)##4##2##(2013-1#4)
Oligo(ethylene##5##1##(2008-10#1)(2013-1#4)
Oligoculm##3##1##(2008-10#3)
Oligomers##2##1##(1991-7#1)(1994-11#1)
Oligonucleotide primers##3##2##(2008-10#3)
Oligonucleotide##7##1##(1996-12#1)(2008-10#5)(2008-9#1)
Oligonucleotides containing##2##2##(1995-2#1)(2008-4#1)
Oligonucleotides were##2##2##(1991-5#1)(2008-10#1)
Oligonucleotides##9##1##(1991-5#1)(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-4#2)
Oligosaccharides##3##1##(1992-10#1)(1992-6#1)(1994-9#1)
Olive tail moment##2##3##(2008-10#2)
Olive##8##1##(2008-10#7)(2008-12#1)
Olmed##2##1##(1991-9#2)
Olmesartan##2##1##(2008-11#1)(2009-1#1)
Olpidium brassicae##4##2##(2008-10#3)(2010-10#1)
Olpidium isolates from##2##3##(2010-10#2)
Olpidium isolates##3##2##(2010-10#3)
Olpidium##7##1##(2008-10#3)(2010-10#4)
Olsenella uli##2##2##(2011-2#2)
Olsenella##4##1##(2011-2#4)
Olympic##3##1##(1996-3#1)(1996-6#1)(2007-2#1)
Olympics##2##1##(1996-2#1)(2008-11#1)
Olympus PK CMV system##2##4##(1992-6#2)
Olympus##7##1##(1990-11#1)(1992-6#5)(2010-8#1)
Omalizumab##4##1##(2010-5#3)(2012-3#1)
Oman##2##1##(2007-2#1)(2008-10#1)
Omega cm##2##2##(2008-3#2)
Omega impedance change##2##3##(2008-10#2)
Omega##12##1##(1995-3#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-8#1)
Omega(E)##2##1##(2008-3#2)
Omega-3##3##1##(1992-9#1)(2008-3#1)(2010-1#1)
Omental cakes##2##2##(2012-2#2)
Omeprazole##5##1##(1991-8#1)(1993-11#1)(1995-9#1)(2012-2#2)
Omission of##4##2##(1992-4#1)(1997-4#1)(1997-5#1)(2008-10#1)
Omnibus Budget Reconciliation Act (OBRA) of##4##6##(1991-12#1)(1994-1#1)(1994-3#1)(1997-3#1)
Omnibus Budget Reconciliation Act of 1993##2##6##(1994-3#1)(1996-3#1)
Omnibus Budget Reconciliation Act of##5##5##(1991-12#1)(1991-3#1)(1994-1#1)(1994-3#1)(1996-3#1)
Omnibus Budget Reconciliation Act##9##4##(1991-12#2)(1991-3#1)(1994-1#2)(1994-3#2)(1996-3#1)(1997-3#1)
Omnibus Budget Reconciliation##10##3##(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)
Omnibus##13##1##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)(2013-1#1)
Omnidirectional##2##1##(2008-3#2)
OmpC##6##1##(1990-11#1)(1992-12#4)(1995-8#1)
OmpF and OmpC##3##3##(1992-12#3)
OmpF##5##1##(1990-11#1)(1992-12#4)
OmpR##10##1##(1995-8#10)
OmpR-like##2##1##(1995-8#1)(2009-6#1)
OmpT##4##1##(1991-5#1)(2008-8#3)
OmpU and OmpT##2##3##(2008-8#2)
OmpU##3##1##(2008-8#3)
Omphalocele##3##1##(1997-3#1)(2010-8#2)
On &quot##2##2##(2006-12#2)
On August##4##2##(1994-3#1)(1996-12#1)(1996-3#1)(2008-9#1)
On Day##2##2##(1993-12#1)(1995-11#1)
On December##5##2##(1991-3#1)(1993-1#1)(1993-3#1)(1996-12#1)(2011-2#1)
On July 26##2##3##(1994-1#1)(1996-1#1)
On July##3##2##(1994-1#1)(1996-1#1)(1996-12#1)
On June##5##2##(1995-3#1)(1995-6#3)(1996-12#1)
On MRI##2##2##(2007-8#1)(2012-12#1)
On November##2##2##(1991-12#1)(1996-12#1)
On October##3##2##(1991-1#1)(1996-12#1)(2012-3#1)
On T1-weighted images##2##3##(1995-4#1)(1997-8#1)
On a##15##2##(1992-11#1)(1994-11#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2013-1#2)
On abdominal##2##2##(1993-6#1)(2008-10#1)
On account of##2##3##(1990-5#1)(2008-5#1)
On acidic soil##2##3##(2012-6#2)
On admission he##2##3##(1990-6#1)(2013-8#1)
On admission##9##2##(1990-6#1)(1994-12#1)(1994-7#1)(2008-12#1)(2008-6#2)(2009-5#1)(2013-8#2)
On all##2##2##(2008-10#1)(2013-8#1)
On an average##2##3##(2008-1#1)(2008-10#1)
On an##5##2##(1995-11#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)
On appeal##2##2##(1990-2#1)(1996-5#1)
On arrival##2##2##(1997-7#1)(2008-1#1)
On average##30##2##(1990-6#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-5#1)(2006-8#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
On basis of the##2##4##(2008-10#2)
On basis of##4##3##(1990-12#1)(2008-10#2)(2008-8#1)
On being##3##2##(1990-9#1)(2008-8#1)(2013-1#1)
On both##4##2##(2008-10#3)(2009-9#1)
On call##8##2##(2008-1#1)(2008-10#4)(2008-2#1)(2010-9#1)(2012-2#1)
On chromosome##4##2##(1995-5#1)(1997-2#1)(1997-5#2)
On comparing the##2##3##(1995-12#1)(2008-10#1)
On comparing##3##2##(1995-12#1)(2007-10#1)(2008-10#1)
On comparison with the##2##4##(2008-10#1)(2008-7#1)
On comparison##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
On completion of##3##3##(2007-2#1)(2012-12#1)(2012-3#1)
On day 3##2##3##(2007-10#1)(2011-2#1)
On day 4##2##3##(1992-6#1)(2011-2#1)
On day 6##2##3##(1994-6#1)(2010-2#1)
On day 7##4##3##(1994-5#1)(2007-12#1)(2007-2#1)(2013-8#1)
On day 8##2##3##(1993-12#1)(2008-8#1)
On day##23##2##(1991-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-2#2)(2013-1#1)(2013-8#2)
On days##4##2##(1993-12#1)(1995-3#1)(2008-10#1)(2008-5#1)
On each trial##2##3##(1992-11#1)(2010-5#1)
On each##4##2##(1992-11#1)(2008-4#1)(2010-5#1)(2011-2#1)
On examination##5##2##(1990-9#1)(2007-11#1)(2007-12#1)(2010-10#1)(2012-3#1)
On follow up##2##3##(2010-12#1)(2013-7#1)
On follow-up##4##2##(1991-2#1)(1993-2#1)(2008-4#1)(2009-3#1)
On investigation##3##2##(2007-7#1)(2009-11#1)(2009-7#1)
On leaves##2##2##(2008-10#2)
On microscopic##2##2##(2008-12#1)(2008-4#1)
On multiple regression analysis##2##4##(2007-8#1)(2012-2#1)
On multivariate analysis##2##3##(2012-3#2)
On multivariate logistic##2##3##(2012-3#1)(2013-1#1)
On multivariate##4##2##(2012-3#3)(2013-1#1)
On one hand##7##3##(1996-5#1)(2008-10#3)(2008-11#1)(2009-5#1)(2009-8#1)
On one##9##2##(1994-7#1)(1996-5#2)(2008-10#3)(2008-11#1)(2009-5#1)(2009-8#1)
On petals##2##2##(2008-10#2)
On physical exam##2##3##(2009-4#1)(2012-12#1)
On physical examination##7##3##(1994-7#1)(2006-10#1)(2008-6#1)(2008-9#1)(2011-1#2)(2013-8#1)
On physical##9##2##(1994-7#1)(2006-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#2)(2012-12#1)(2013-8#1)
On postmortem examination##2##3##(1997-3#1)(2013-8#1)
On review of the##2##4##(2008-7#1)(2012-3#1)
On review of##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
On skin##2##2##(1997-3#1)(2008-5#1)
On the average##3##3##(1993-2#1)(1997-8#1)(2007-8#1)
On the basis of a##6##5##(1990-9#1)(1994-11#1)(1996-9#1)(2007-12#1)(2008-3#1)(2013-1#1)
On the basis of an analysis of##2##7##(2008-10#1)(2008-3#1)
On the basis of an##3##5##(2008-10#1)(2008-3#1)(2010-6#1)
On the basis of clinical##2##5##(1993-12#1)(2008-10#1)
On the basis of experimental results##2##6##(1995-11#2)
On the basis of molecular##2##5##(2008-10#1)(2013-1#1)
On the basis of our experience##2##6##(1991-2#1)(2007-7#1)
On the basis of our findings##2##6##(1996-11#1)(2012-2#1)
On the basis of our##9##5##(1991-2#1)(1992-12#1)(1995-12#1)(1996-11#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#1)
On the basis of the amino acid##2##7##(1993-6#1)(2010-5#1)
On the basis of the analysis of##2##7##(2008-7#1)(2013-1#1)
On the basis of the data obtained##2##7##(1991-2#1)(1993-6#1)
On the basis of the data##3##6##(1991-2#1)(1993-6#1)(2008-10#1)
On the basis of the results obtained##2##7##(1990-6#1)(1991-3#1)
On the basis of the results of##3##7##(1991-9#1)(1995-12#1)(2008-10#1)
On the basis of the results##7##6##(1990-5#1)(1990-6#1)(1991-3#1)(1991-9#1)(1995-12#1)(1997-6#1)(2008-10#1)
On the basis of the##54##5##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#4)
On the basis of theoretical##2##5##(2008-2#1)(2008-3#1)
On the basis of these findings##3##6##(2012-1#3)
On the basis of these observations##2##6##(1996-2#1)(2008-7#1)
On the basis of these results##12##6##(1993-1#1)(1993-11#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)
On the basis of these values##2##6##(2008-10#1)(2008-3#1)
On the basis of these##27##5##(1991-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-1#3)
On the basis of this##12##5##(1991-2#1)(1995-6#1)(2008-2#1)(2008-3#7)(2008-5#1)(2012-3#1)
On the basis of##158##4##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-11#4)(1995-12#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#21)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#7)
On the contrary##57##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-2#2)(1995-12#1)(1995-5#2)(1996-2#1)(1997-2#1)(2007-10#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2011-2#4)(2013-1#2)(2013-8#2)
On the importance of##2##4##(2008-7#1)(2008-8#1)
On the mechanism of##2##4##(1992-3#1)(1994-11#1)
On the occasion of##3##4##(2007-8#1)(2008-4#1)(2011-1#1)
On the one hand##6##4##(1996-3#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
On the origin of##2##4##(2008-11#1)(2008-7#1)
On the origin##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
On the other hand the##4##5##(1992-12#1)(2008-11#1)(2011-2#1)(2011-7#1)
On the other hand##284##4##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#5)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1997-2#4)(1997-4#2)(1997-7#2)(1997-8#4)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#48)(2008-11#23)(2008-12#6)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#11)(2008-6#10)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#4)(2011-1#4)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#2)(2013-1#5)(2013-7#2)(2013-8#1)
On the other##287##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#5)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#1)(1997-2#4)(1997-4#2)(1997-7#2)(1997-8#4)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#48)(2008-11#23)(2008-12#6)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#11)(2008-6#10)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#4)(2011-1#4)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#2)(2013-1#5)(2013-7#2)(2013-8#1)
On the otherhand##2##3##(2008-11#2)
On the role of##2##4##(2007-12#1)(2008-10#1)
On the second##2##3##(2010-12#1)(2013-1#1)
On the surface of##2##4##(2008-8#2)
On the use of##5##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)
On the whole##11##3##(1991-8#1)(1997-3#1)(1997-6#1)(2008-10#4)(2009-4#1)(2010-5#2)(2012-12#1)
On the##633##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#4)(1991-1#1)(1991-12#5)(1991-2#6)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#4)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-6#5)(1993-8#8)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#8)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#7)(1995-12#7)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#7)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#7)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#6)(2007-10#1)(2007-11#7)(2007-12#7)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#96)(2008-11#38)(2008-12#10)(2008-2#10)(2008-3#34)(2008-4#7)(2008-5#21)(2008-6#12)(2008-7#19)(2008-8#14)(2008-9#14)(2009-10#4)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#6)(2011-1#7)(2011-2#12)(2011-7#1)(2012-1#5)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#20)(2013-7#2)(2013-8#5)
On these##5##2##(1995-12#1)(1997-3#1)(2008-10#2)(2011-2#1)
On this basis a##2##4##(2008-10#1)(2011-2#1)
On this basis##8##3##(1990-11#1)(1992-3#1)(1995-6#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-2#1)
On this##13##2##(1990-11#1)(1992-3#1)(1994-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
On three##2##2##(2008-11#1)(2013-1#1)
On univariate##2##2##(1995-4#1)(2011-2#1)
On use of##2##3##(1992-9#1)(2007-11#1)
On##1039##1##(1990-11#6)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#6)(1990-6#5)(1990-7#4)(1990-8#3)(1990-9#7)(1991-1#5)(1991-12#7)(1991-2#8)(1991-3#6)(1991-4#2)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#8)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#8)(1992-8#5)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#13)(1993-2#3)(1993-3#3)(1993-6#7)(1993-8#8)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#6)(1994-3#10)(1994-5#6)(1994-6#3)(1994-7#6)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#9)(1995-12#12)(1995-2#3)(1995-3#4)(1995-4#4)(1995-5#7)(1995-6#9)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#7)(1996-3#4)(1996-5#11)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#10)(1997-3#5)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#8)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#4)(2007-11#10)(2007-12#12)(2007-2#3)(2007-7#4)(2007-8#10)(2007-9#1)(2008-1#11)(2008-10#164)(2008-11#49)(2008-12#18)(2008-2#13)(2008-3#36)(2008-4#12)(2008-5#28)(2008-6#20)(2008-7#31)(2008-8#23)(2008-9#21)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#4)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#6)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#29)(2011-7#1)(2012-1#6)(2012-12#10)(2012-2#10)(2012-3#11)(2012-6#3)(2013-1#34)(2013-7#3)(2013-8#19)
On-axis##2##1##(2008-3#2)
On-line coupling of##2##3##(2008-10#2)
On-line determination of trace##2##4##(2008-10#2)
On-line determination of##4##3##(2008-10#4)
On-line dilution##2##2##(2008-10#2)
On-line microdialysis##2##2##(2008-10#2)
On-line monitoring of##2##3##(2008-10#1)(2008-11#1)
On-line monitoring##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
On-line preconcentration and determination of##4##5##(2008-10#4)
On-line preconcentration and##6##3##(2008-10#6)
On-line preconcentration of##4##3##(2008-10#4)
On-line preconcentration system for##2##4##(2008-10#2)
On-line preconcentration##14##2##(2008-10#14)
On-line##64##1##(2008-1#2)(2008-10#47)(2008-11#5)(2008-3#4)(2008-7#4)(2009-6#1)(2010-4#1)
On-site##3##1##(2008-10#3)
On-the-job##2##1##(1991-3#1)(1993-2#1)
Once a##4##2##(1995-1#1)(2009-6#1)(2011-2#1)(2013-8#1)
Once activated##2##2##(1994-5#1)(1996-5#1)
Once again we##2##3##(1995-12#1)(2010-4#1)
Once again##5##2##(1991-12#1)(1995-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
Once assembled##2##2##(2008-2#1)(2008-9#1)
Once inside the##2##3##(2008-10#1)(2008-11#1)
Once the coupling procedure has been performed##2##7##(2008-4#2)
Once the##21##2##(1993-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#2)
Once these##3##2##(1996-11#1)(2007-4#1)(2008-3#1)
Once this##3##2##(1993-3#1)(1996-1#1)(2008-10#1)
Once##78##1##(1990-12#1)(1991-1#1)(1991-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
Onchocerca volvulus and##2##3##(1991-9#1)(2010-1#1)
Oncidium orchid##3##2##(2008-10#3)
Oncogene##2##1##(2008-11#1)(2008-9#1)
Oncogenic osteomalacia##2##2##(2008-6#2)
Oncogenic##6##1##(1992-9#1)(1994-2#1)(2008-6#3)(2008-8#1)
Oncoimmunin-M##2##1##(1994-6#2)
Oncologic##3##1##(2007-8#1)(2008-6#1)(2008-9#1)
Oncological##3##1##(2008-6#1)(2008-7#1)(2008-9#1)
Oncologico##2##1##(1991-12#1)(1991-4#1)
Oncologists##2##1##(2012-3#2)
Oncology Center##3##2##(2007-10#2)(2008-5#1)
Oncology Clinic##2##2##(2008-9#2)
Oncology Group study##2##3##(1991-6#1)(1993-9#1)
Oncology Group##16##2##(1991-2#1)(1991-6#1)(1993-9#2)(1994-8#1)(2007-7#1)(2008-4#1)(2008-6#3)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)
Oncology and Hematology##2##3##(2011-2#2)
Oncology and Hematology]##4##3##(2008-9#4)
Oncology and##14##2##(2008-10#5)(2008-9#6)(2010-11#1)(2011-2#2)
Oncology at the##3##3##(1993-3#1)(2008-9#2)
Oncology at##4##2##(1993-3#1)(2008-9#3)
Oncology of the##3##3##(1991-12#1)(1991-3#1)(2008-9#1)
Oncology of##4##2##(1991-12#1)(1991-3#1)(1992-5#1)(2008-9#1)
Oncology##78##1##(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#3)(1992-12#1)(1992-5#1)(1993-3#2)(1993-9#2)(1994-3#2)(1994-7#1)(1994-8#1)(1995-5#1)(1997-4#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#8)(2008-9#16)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#1)
Oncolytic##3##1##(2013-1#2)(2013-8#1)
Oncomelania hupensis##3##2##(2008-8#2)(2012-3#1)
Oncomelania snails##2##2##(2012-3#2)
Oncomelania##6##1##(2008-8#2)(2012-3#4)
Oncorhynchus mykiss (Walbaum)##3##3##(2009-5#2)(2009-6#1)
Oncorhynchus mykiss##7##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#2)(2009-6#1)(2010-8#1)
Oncorhynchus##13##1##(1990-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-8#5)
One ORF##2##2##(1995-9#2)
One advantage of##2##3##(2010-8#1)(2012-1#1)
One alternative##3##2##(1991-1#1)(1994-11#1)(2008-10#1)
One analysis##2##2##(1990-8#1)(2008-10#1)
One and##2##2##(1994-1#1)(2008-1#1)
One approach to##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
One approach##7##2##(1991-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)
One area##3##2##(2010-4#1)(2010-6#1)(2013-1#1)
One assay##3##2##(2008-10#3)
One can also##3##3##(2008-2#2)(2008-3#1)
One can use the##3##4##(1997-8#1)(2008-3#2)
One can use##4##3##(1995-9#1)(1997-8#1)(2008-3#2)
One can##23##2##(1995-9#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#7)(2008-4#1)(2010-6#1)
One candidate##2##2##(2008-4#1)(2008-5#1)
One case of##4##3##(1992-5#1)(1996-12#1)(2008-1#1)(2011-2#1)
One case##12##2##(1991-6#1)(1992-5#1)(1993-8#1)(1996-12#1)(2007-2#1)(2008-1#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
One class of##3##3##(1990-5#1)(2008-4#1)(2009-5#1)
One class##4##2##(1990-5#1)(1994-12#1)(2008-4#1)(2009-5#1)
One clinical##2##2##(2008-3#1)(2012-3#1)
One clone##3##2##(1993-3#1)(2008-7#1)(2008-9#1)
One cluster##2##2##(1990-8#1)(2008-10#1)
One common##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
One component of##2##3##(1997-9#1)(2008-3#1)
One component##3##2##(1994-5#1)(1997-9#1)(2008-3#1)
One compound##2##2##(1992-8#1)(2009-10#1)
One concludes that the##2##4##(2008-9#1)(2012-3#1)
One day##2##2##(1992-11#1)(2010-2#1)
One died##2##2##(2007-11#1)(2008-12#1)
One drawback##2##2##(2008-10#1)(2010-3#1)
One enzyme##2##2##(2008-4#1)(2010-3#1)
One example is the##2##4##(2008-7#1)(2010-3#1)
One example is##5##3##(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#2)
One example of##2##3##(1997-3#1)(2011-2#1)
One example##8##2##(1991-8#1)(1997-3#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#3)
One exception is##3##3##(1991-5#1)(1994-8#1)(2012-12#1)
One exception##4##2##(1991-5#1)(1994-8#1)(2008-10#1)(2012-12#1)
One explanation for##2##3##(1992-2#1)(2008-8#1)
One explanation##3##2##(1992-2#1)(2006-10#1)(2008-8#1)
One factor that##2##3##(2007-11#1)(2008-7#1)
One factor##3##2##(2007-11#1)(2008-5#1)(2008-7#1)
One female##2##2##(2008-9#2)
One fifth of##2##3##(1990-9#1)(2008-7#1)
One finger##2##2##(1990-5#1)(2008-9#1)
One form##2##2##(1995-12#1)(2010-5#1)
One gene##2##2##(1993-12#1)(2008-10#1)
One group of##4##3##(1991-12#1)(2008-5#2)(2012-2#1)
One group##9##2##(1991-12#1)(1995-1#1)(2008-10#3)(2008-5#3)(2012-2#1)
One half of##2##3##(2007-12#1)(2008-1#1)
One has##2##2##(2008-10#1)(2008-5#1)
One hospital's##2##2##(1993-12#1)(1997-1#1)
One hundred and fifteen##2##4##(2011-1#1)(2013-7#1)
One hundred and fifty##3##4##(1993-1#1)(2008-4#1)(2008-9#1)
One hundred and forty-three##2##4##(1991-8#1)(2010-2#1)
One hundred and four##3##4##(2008-10#1)(2008-6#1)(2010-3#1)
One hundred and fourteen##3##4##(1995-3#1)(2008-5#1)(2011-2#1)
One hundred and nine##2##4##(1993-2#1)(1995-6#1)
One hundred and one##4##4##(2007-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
One hundred and seventy##3##4##(2007-7#1)(2008-12#1)(2008-9#1)
One hundred and sixty-two##2##4##(1996-10#1)(2011-2#1)
One hundred and thirteen##2##4##(2008-5#1)(2013-8#1)
One hundred and thirty##3##4##(2008-5#1)(2008-6#1)(2011-2#1)
One hundred and three##2##4##(2007-8#1)(2010-4#1)
One hundred and twenty (120) patients candidate for valvular heart surgery were selected for this study##2##16##(2013-1#2)
One hundred and twenty##5##4##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#2)
One hundred and twenty-nine##2##4##(1995-12#1)(2011-1#1)
One hundred and##57##3##(1990-2#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-1#2)(1993-2#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-10#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-4#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
One hundred ninty##2##3##(2008-12#1)(2013-8#1)
One hundred patients##2##3##(2007-7#1)(2008-12#1)
One hundred percent of the##2##5##(1990-2#1)(1991-4#1)
One hundred seventy##2##3##(2008-12#1)(2013-8#1)
One hundred twenty-six##2##3##(2008-10#1)(2008-5#1)
One hundred##99##2##(1990-2#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-4#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
One hypothesis is that##2##4##(1995-12#1)(2008-10#1)
One important##7##2##(1994-5#1)(1996-3#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-1#1)(2011-2#1)
One is a##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)
One is that the##2##4##(2007-11#1)(2008-3#1)
One is that##4##3##(1992-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
One is the##5##3##(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
One is##24##2##(1990-7#1)(1992-3#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#6)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
One isolate was##2##3##(2008-10#2)
One isolate##4##2##(2008-10#4)
One issue is##2##3##(1992-1#1)(1997-1#1)
One issue##3##2##(1992-1#1)(1995-1#1)(1997-1#1)
One key to its success is its strategic planning process##2##10##(1994-2#1)(1994-3#1)
One key to##3##3##(1994-2#1)(1994-3#1)(2007-11#1)
One long-standing##2##2##(2008-9#1)(2011-2#1)
One major##9##2##(1990-2#1)(1994-3#1)(2008-10#3)(2008-8#1)(2010-1#1)(2012-2#2)
One mechanism##2##2##(2007-10#1)(2008-9#1)
One method is##2##3##(2008-2#1)(2008-3#1)
One method of doing so would be to support a consensus convergence to review and select the optimal measures of CS for nursing research##2##24##(2013-1#2)
One method of##5##3##(2008-10#1)(2008-2#1)(2013-1#2)(2013-8#1)
One method##13##2##(1995-9#1)(1996-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2013-1#3)(2013-8#1)
One might##2##2##(2008-10#1)(2009-7#1)
One min##2##2##(1996-5#1)(2009-1#1)
One mole of##3##3##(1993-11#1)(1994-5#1)(2008-10#1)
One must##2##2##(1991-12#1)(2007-11#1)
One novel##2##2##(2008-8#2)
One of eight##2##3##(1990-12#1)(2012-2#1)
One of its##5##3##(1993-11#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
One of our##2##3##(2008-7#1)(2010-8#1)
One of the biggest problems facing##2##6##(1991-2#2)
One of the common##2##4##(2007-8#1)(2009-1#1)
One of the earliest##2##4##(1997-8#1)(2008-4#1)
One of the effects of##2##5##(2008-5#1)(2013-7#1)
One of the findings##2##4##(1991-6#1)(2008-12#1)
One of the four##2##4##(2008-10#2)
One of the goals of Current Protocols is to provide information from the very basic level to the very advanced##2##20##(2008-9#2)
One of the goals of##4##5##(1994-3#1)(2008-10#1)(2008-9#2)
One of the important##3##4##(1995-5#1)(2008-3#1)(2008-8#1)
One of the isolated##2##4##(1993-6#1)(2010-12#1)
One of the key##4##4##(1995-1#1)(2009-8#1)(2010-12#1)(2011-1#1)
One of the main objectives##2##5##(2008-11#1)(2011-2#1)
One of the main##6##4##(2007-11#1)(2008-11#2)(2009-10#1)(2009-11#1)(2011-2#1)
One of the major##9##4##(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
One of the methods##2##4##(2007-11#1)(2008-6#1)
One of the more##3##4##(2008-3#1)(2008-4#1)(2012-3#1)
One of the most common##6##5##(2008-11#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-1#2)
One of the most frequent##2##5##(2010-12#1)(2013-1#1)
One of the most frequently##2##5##(2008-7#1)(2013-1#1)
One of the most important##11##5##(1992-2#1)(1992-9#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#1)(2012-3#1)
One of the most significant##2##5##(1993-12#1)(2008-1#1)
One of the most widely##2##5##(2008-5#2)
One of the most##44##4##(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-5#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)
One of the new##2##4##(1996-6#1)(2009-11#1)
One of the possible##2##4##(1990-9#1)(2010-5#1)
One of the problems##3##4##(1994-2#1)(2008-6#1)(2011-2#1)
One of the reasons##2##4##(1996-9#1)(2010-12#1)
One of the streams##2##4##(2008-10#2)
One of the two##2##4##(1990-12#1)(2008-7#1)
One of the##177##3##(1990-12#2)(1990-9#2)(1991-2#2)(1991-6#1)(1991-7#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-5#4)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#5)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
One of them is##2##4##(1992-9#1)(2008-10#1)
One of them##8##3##(1992-12#1)(1992-9#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
One of these factors##2##4##(1990-12#1)(2009-10#1)
One of these genes##4##4##(1993-12#1)(2008-9#1)(2010-5#1)(2013-1#1)
One of these is##3##4##(1992-11#1)(1997-1#1)(2008-10#1)
One of these patients##2##4##(1990-9#1)(1991-3#1)
One of these##32##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-11#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
One of three##2##3##(1990-6#1)(1993-12#1)
One of two##2##3##(1993-9#1)(1997-8#1)
One of##239##2##(1990-11#1)(1990-12#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#26)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#5)(2010-5#3)(2010-8#4)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#3)
One or more##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
One or##6##2##(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)
One out of##3##3##(1995-12#1)(2008-1#1)(2008-5#1)
One part of##2##3##(1996-12#1)(2011-1#1)
One part##3##2##(1996-12#1)(1997-7#1)(2011-1#1)
One particularly##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
One patient developed##4##3##(1990-8#1)(1997-2#1)(2007-7#1)(2011-2#1)
One patient died of##2##4##(2008-6#1)(2008-7#1)
One patient died##4##3##(1991-4#1)(1993-5#1)(2008-6#1)(2008-7#1)
One patient had##8##3##(1990-2#1)(1991-3#1)(1992-6#1)(1994-9#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)
One patient presented with a##2##5##(1991-8#1)(2008-7#1)
One patient presented with##3##4##(1991-8#1)(2008-7#1)(2011-1#1)
One patient received##2##3##(2008-7#1)(2009-11#1)
One patient suffered##2##3##(1994-11#1)(2007-2#1)
One patient was treated##2##4##(1990-8#1)(1992-2#1)
One patient was##5##3##(1990-8#1)(1991-8#1)(1992-2#1)(1997-6#1)(2008-6#1)
One patient with a##3##4##(1996-2#1)(2008-1#1)(2011-1#1)
One patient with##6##3##(1994-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-7#1)(2011-1#1)
One patient##52##2##(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-6#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-3#1)(2011-1#3)(2011-2#1)
One plasmid##2##2##(1991-5#1)(1994-12#1)
One plate of##2##3##(2008-10#1)(2008-3#1)
One population##2##2##(2008-11#1)(2013-1#1)
One possibility is that##2##4##(2008-6#1)(2008-9#1)
One possibility is to##2##4##(2008-3#1)(2011-2#1)
One possibility is##4##3##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
One possibility##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
One possible explanation##2##3##(2007-7#1)(2009-7#1)
One possible##7##2##(1994-8#1)(2007-7#1)(2009-10#1)(2009-7#2)(2013-1#2)
One potential##3##2##(1997-2#1)(2008-8#1)(2012-3#1)
One problem with##2##3##(1991-9#1)(2008-3#1)
One problem##3##2##(1991-9#1)(2008-3#2)
One procedure##3##2##(1993-9#1)(1994-2#1)(2008-12#1)
One prominent##2##2##(2008-2#1)(2008-6#1)
One promising##2##2##(2009-5#1)(2012-3#1)
One question of##2##3##(1994-2#1)(1997-2#1)
One question##3##2##(1994-2#1)(1997-2#1)(2008-6#1)
One reason##4##2##(1992-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
One recent##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
One run was##2##3##(1992-11#1)(1995-3#1)
One series of##2##3##(2007-8#2)
One set##2##2##(2008-3#1)(2013-1#1)
One side##2##2##(2008-10#1)(2013-1#1)
One single##2##2##(2007-7#1)(2013-8#1)
One specific##3##2##(1991-12#1)(1994-11#1)(2008-7#1)
One step##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
One strain##3##2##(2007-6#1)(2008-10#1)(2011-2#1)
One strategy##3##2##(2012-1#1)(2012-2#1)(2013-1#1)
One study##2##2##(2008-7#1)(2012-12#1)
One such class##2##3##(1995-8#1)(2011-2#1)
One such group##2##3##(1992-6#1)(2008-7#1)
One such technique##2##3##(2008-4#1)(2008-9#1)
One such##23##2##(1992-6#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
One suffered##2##2##(1993-2#1)(1996-8#1)
One third of##4##3##(1996-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
One thousand##4##2##(1994-2#1)(2007-11#1)(2011-1#1)(2011-2#1)
One to##5##2##(1995-2#1)(2008-10#1)(2009-12#1)(2009-7#1)(2012-12#1)
One transgenic##2##2##(2008-11#1)(2008-9#1)
One type of##5##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
One type##8##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)
One untreated##2##2##(1994-3#1)(2008-5#1)
One uses##2##2##(2008-3#2)
One was##8##2##(1993-11#1)(1993-6#1)(1996-4#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-9#1)
One way to prevent##2##4##(2008-5#1)(2010-7#1)
One way to##8##3##(1992-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
One way##10##2##(1992-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
One week after##4##3##(1991-2#1)(1995-3#1)(2007-8#1)(2008-8#1)
One year after surgery##2##4##(2007-8#1)(2009-1#1)
One year after the##2##4##(2007-10#1)(2010-10#1)
One year after##5##3##(2007-10#1)(2007-8#1)(2008-10#1)(2009-1#1)(2010-10#1)
One year later##2##3##(1994-12#1)(2010-3#1)
One year##11##2##(1994-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-3#1)(2013-8#1)
One##984##1##(1990-11#2)(1990-12#4)(1990-2#6)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#7)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#3)(1992-11#6)(1992-12#5)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#8)(1993-2#6)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#10)(1994-2#10)(1994-3#5)(1994-5#7)(1994-8#3)(1994-9#2)(1995-1#6)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#4)(1995-5#5)(1995-6#5)(1995-8#1)(1995-9#4)(1996-1#4)(1996-10#1)(1996-12#3)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#7)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#4)(1997-9#1)(2006-10#2)(2006-12#1)(2007-10#5)(2007-11#17)(2007-12#13)(2007-2#5)(2007-6#1)(2007-7#9)(2007-8#8)(2008-1#17)(2008-10#108)(2008-11#22)(2008-12#20)(2008-2#31)(2008-3#45)(2008-4#22)(2008-5#34)(2008-6#12)(2008-7#33)(2008-8#26)(2008-9#34)(2009-1#3)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#7)(2009-8#4)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#10)(2010-9#3)(2011-1#18)(2011-2#32)(2011-3#2)(2012-1#3)(2012-12#12)(2012-2#19)(2012-3#21)(2013-1#27)(2013-7#2)(2013-8#14)
One- and two-dimensional##2##3##(2007-12#1)(2008-2#1)
One-Dimensional##2##1##(2008-10#1)(2008-2#1)
One-Step##3##1##(2008-10#2)(2008-3#1)
One-day-old##2##1##(1990-8#1)(2008-5#1)
One-dimensional##4##1##(1996-2#1)(2007-12#1)(2008-2#1)(2008-6#1)
One-fourth of patients##2##3##(1990-9#1)(1991-6#1)
One-fourth of##3##2##(1990-9#1)(1991-6#1)(1997-4#1)
One-half of the##3##3##(1994-3#1)(1997-4#1)(2008-5#1)
One-half of##4##2##(1994-3#1)(1997-4#1)(2008-5#1)(2012-3#1)
One-hundred and##2##2##(2008-12#1)(2008-5#1)
One-hundred##3##1##(2008-12#1)(2008-5#1)(2008-7#1)
One-stage##2##1##(2007-7#1)(2009-3#1)
One-step two-wavelength holography##2##3##(2008-2#2)
One-step##6##1##(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#2)
One-stop shopping##2##2##(1996-12#1)(1997-3#1)
One-third of##2##2##(1994-3#1)(2008-8#1)
One-third##5##1##(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
One-way ANOVA##2##2##(1993-2#1)(2008-9#1)
One-way##4##1##(1993-2#1)(2008-3#1)(2008-9#1)(2009-1#1)
One-year##4##1##(2007-10#1)(2008-1#1)(2010-8#1)(2013-1#1)
OneView strategy##2##2##(1997-3#2)
OneView##3##1##(1997-3#3)
Ongoing efforts to##2##3##(2008-11#1)(2010-11#1)
Ongoing research##2##2##(2008-1#1)(2013-8#1)
Ongoing studies##2##2##(2008-5#1)(2008-7#1)
Ongoing##25##1##(1993-2#1)(1995-5#1)(1995-8#1)(2008-1#1)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Onion##8##1##(2008-10#8)
Online Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to genomics researchers##2##20##(2008-4#1)(2008-9#1)
Online Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to##3##18##(2008-4#2)(2008-9#1)
Online Mendelian Inheritance in Man (OMIM)##5##6##(2008-4#3)(2008-9#2)
Online Mendelian Inheritance in Man##6##5##(2007-7#1)(2008-4#3)(2008-9#2)
Online databases##2##2##(2010-10#1)(2012-3#1)
Online##29##1##(1991-1#1)(1991-12#2)(1993-2#1)(1994-1#1)(1997-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-9#3)(2009-12#1)(2010-10#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
Only 0##4##2##(1991-3#1)(1993-8#1)(2008-10#1)(2011-2#1)
Only 1##2##2##(1991-5#1)(2013-8#1)
Only 10##2##2##(2006-12#1)(2007-7#1)
Only 10%##3##2##(1990-12#1)(1991-12#1)(2008-3#1)
Only 14##2##2##(2012-12#2)
Only 15##2##2##(1996-7#1)(2008-7#1)
Only 16##3##2##(1991-6#1)(2008-1#1)(2008-9#1)
Only 17##2##2##(1996-3#1)(2012-3#1)
Only 18 cases##2##3##(2008-7#1)(2010-6#1)
Only 18##3##2##(2008-7#1)(2010-6#1)(2011-1#1)
Only 2##5##2##(1990-12#1)(2008-9#2)(2009-3#1)(2012-2#1)
Only 25%##2##2##(2012-2#1)(2012-3#1)
Only 3 of the##2##4##(1991-2#1)(2008-10#1)
Only 3##9##2##(1991-2#1)(1991-8#2)(2008-10#3)(2008-12#1)(2008-5#1)(2009-12#1)
Only 3% of the##2##4##(1991-11#1)(1991-3#1)
Only 35%##2##2##(2008-10#1)(2008-8#1)
Only 4##4##2##(2008-10#1)(2008-7#1)(2012-12#2)
Only 5##2##2##(1993-9#1)(2008-11#1)
Only 6##2##2##(1991-9#1)(2013-1#1)
Only 67% of##2##3##(1996-9#1)(2007-10#1)
Only 7##2##2##(1991-11#1)(1997-5#1)
Only 8##2##2##(1990-2#1)(2008-7#1)
Only S422##2##2##(1995-11#2)
Only a few cases have been reported##2##7##(2008-7#1)(2011-1#1)
Only a few cases of##2##5##(2008-1#1)(2010-6#1)
Only a few cases##4##4##(2008-1#1)(2008-7#1)(2010-6#1)(2011-1#1)
Only a few##10##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#3)(2011-1#1)
Only a limited number of##2##5##(2008-1#1)(2008-5#1)
Only a limited##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
Only a single##2##3##(1997-7#1)(2008-8#1)
Only a##23##2##(1990-11#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#1)
Only about##6##2##(1991-4#1)(1992-8#1)(1993-6#1)(1997-2#1)(2008-1#1)(2011-2#1)
Only approximately##2##2##(1994-11#1)(1995-11#1)
Only by##4##2##(1991-12#1)(1996-2#1)(2008-11#1)(2008-8#1)
Only few cases have been reported##2##6##(2013-1#2)
Only few studies##2##3##(1997-6#1)(2008-1#1)
Only few##6##2##(1997-6#1)(2008-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
Only for##2##2##(2008-10#1)(2008-8#1)
Only four##2##2##(1994-12#1)(2008-5#1)
Only half of the##2##4##(1996-5#1)(2008-11#1)
Only half of##3##3##(1996-5#1)(2007-12#1)(2008-11#1)
Only if the##3##3##(1991-6#1)(2008-8#2)
Only if##5##2##(1991-6#1)(1997-4#1)(2008-8#2)(2013-8#1)
Only in one case##2##4##(2007-11#1)(2008-10#1)
Only in the##6##3##(1991-4#1)(1991-5#1)(1995-1#1)(2007-8#1)(2008-12#1)(2010-5#1)
Only in##15##2##(1991-4#1)(1991-5#1)(1992-9#1)(1995-1#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
Only minor##5##2##(1994-5#1)(2008-10#2)(2008-6#1)(2013-1#1)
Only nine##2##2##(2008-10#1)(2008-7#1)
Only one of the##3##4##(1992-2#1)(1992-6#1)(2008-10#1)
Only one of##5##3##(1992-2#1)(1992-6#1)(1994-5#1)(2008-10#2)
Only one patient##5##3##(1991-8#1)(1996-9#1)(2007-8#1)(2008-7#2)
Only one##38##2##(1990-5#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#3)
Only patients with##2##3##(1991-12#1)(2008-6#1)
Only patients##3##2##(1991-12#1)(2008-6#1)(2008-7#1)
Only recently have##2##3##(2008-10#1)(2010-7#1)
Only recently##3##2##(2008-10#1)(2008-12#1)(2010-7#1)
Only six##2##2##(2008-10#2)
Only small##2##2##(2008-10#1)(2008-11#1)
Only the first##2##3##(2008-3#1)(2012-12#1)
Only the##42##2##(1990-5#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
Only then##2##2##(1990-6#1)(1993-11#1)
Only three patients##2##3##(1997-4#1)(2008-1#1)
Only three##9##2##(1992-11#1)(1994-11#1)(1997-4#1)(2007-5#2)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)
Only two of##2##3##(1994-12#1)(2008-7#1)
Only two previous##2##3##(2008-10#1)(2011-2#1)
Only two##19##2##(1990-6#1)(1993-2#1)(1994-12#2)(1997-9#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#2)
Only when##2##2##(1996-9#1)(2008-12#1)
Only##386##1##(1990-11#2)(1990-12#3)(1990-2#4)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#3)(1994-6#3)(1995-1#3)(1995-11#4)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#3)(1996-11#2)(1996-12#1)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#6)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#4)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#9)(2008-10#57)(2008-11#12)(2008-12#9)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#15)(2008-6#6)(2008-7#17)(2008-8#8)(2008-9#7)(2009-12#1)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#15)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#14)(2013-8#8)
Onset of##3##2##(2008-6#1)(2009-8#1)(2013-1#1)
Onset##5##1##(2008-1#1)(2008-6#1)(2009-2#1)(2009-8#1)(2013-1#1)
Ontario Cancer##2##2##(1992-3#1)(2008-6#1)
Ontario Ministry of##6##3##(1991-2#2)(1994-1#1)(1995-2#1)(1995-3#1)(2011-2#1)
Ontario N1G 2W1##3##3##(2013-8#3)
Ontario Veterinary College##3##3##(2013-8#3)
Ontario and##5##2##(1993-3#1)(2007-12#2)(2008-10#2)
Ontario communities##2##2##(1995-3#1)(1996-12#1)
Ontario community hospital##2##3##(1994-3#1)(1995-12#1)
Ontario health##2##2##(2007-12#2)
Ontario hospitals##5##2##(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-3#1)
Ontario soils##3##2##(2008-10#3)
Ontario to##4##2##(1995-3#1)(1996-1#1)(1997-1#1)(2008-10#1)
Ontario was##3##2##(1994-1#1)(1994-3#1)(2007-12#1)
Ontario##129##1##(1991-12#1)(1991-2#7)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#5)(1993-2#1)(1993-3#2)(1994-1#8)(1994-12#1)(1994-2#2)(1994-3#7)(1994-8#2)(1995-12#1)(1995-2#4)(1995-3#4)(1996-1#3)(1996-12#3)(1997-1#5)(1997-3#3)(2007-1#1)(2007-12#16)(2007-5#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#3)(2009-12#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#2)(2013-8#9)
Ontario's global budgeting system##2##4##(1993-1#2)
Ontario's##10##1##(1991-12#1)(1991-2#1)(1993-1#2)(1995-1#1)(1997-2#1)(1997-3#2)(2008-11#1)(2009-3#1)
Ontario)##3##1##(2008-11#2)(2008-12#1)
Ontogenic resistance##3##2##(2008-10#3)
Ontogenic##5##1##(2008-10#4)(2008-11#1)
Ontogeny of the##3##3##(1994-8#1)(2007-12#1)(2008-10#1)
Ontogeny of##5##2##(1994-8#1)(2007-12#2)(2008-10#1)(2008-11#1)
Ontologies##4##1##(2008-7#3)(2008-9#1)
Ontology Consortium##8##2##(2008-7#8)
Ontology##28##1##(2008-4#2)(2008-7#17)(2008-9#3)(2010-1#1)(2010-4#1)(2011-2#2)(2013-1#2)
OnuMV3a##2##1##(2008-10#2)
Oocysts were more prevalent in##2##5##(1996-12#2)
Oocysts##3##1##(1996-12#2)(2012-3#1)
Oocyte##3##1##(1990-6#1)(2012-3#1)(2013-1#1)
Oolong teas##3##2##(2008-10#3)
Oolong##7##1##(2008-10#7)
Oomycete##4##1##(2008-10#4)
Oomycetes##4##1##(2008-10#4)
Oospore Formation##2##2##(2008-10#2)
Oospore##4##1##(2008-10#4)
Oospores were##2##2##(2008-10#2)
Oospores##4##1##(2008-10#4)
Op18##5##1##(1991-9#5)
OpZ20410##3##1##(2008-5#3)
Opaque-2##2##1##(2009-10#2)
Opata 85##3##2##(2008-10#3)
Open reading frames##2##3##(1994-12#1)(2008-10#1)
Open source##2##2##(2010-8#1)(2011-1#1)
Open tibia fractures##2##3##(2010-12#2)
Open##28##1##(1990-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
Open-ended questions##2##2##(2008-12#1)(2011-2#1)
Open-ended##5##1##(1995-12#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
Open-path##2##1##(2007-12#1)(2008-10#1)
Opening of##3##2##(1996-5#2)(2008-7#1)
Opening the &quot##2##3##(1991-1#1)(2013-7#1)
Opening the##4##2##(1991-1#1)(2007-11#1)(2008-11#1)(2013-7#1)
Opening##11##1##(1991-1#1)(1991-5#1)(1996-5#2)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
Openness##3##1##(2010-12#2)(2011-2#1)
Operable Breast Cancer##2##3##(1994-12#1)(1994-7#1)
Operable##3##1##(1994-12#1)(1994-7#1)(2008-3#1)
Operated##2##1##(2008-3#1)(2012-3#1)
Operating Arm System##2##3##(2008-7#2)
Operating Room##2##2##(1995-3#1)(2012-3#1)
Operating with##2##2##(2008-10#1)(2008-3#1)
Operating##19##1##(1995-3#2)(1997-2#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-6#1)(2012-12#1)(2012-3#2)
Operation Iraqi##2##2##(2008-4#1)(2013-1#1)
Operation is##2##2##(2007-12#2)
Operation of a##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
Operation of the##2##3##(2008-10#1)(2008-3#1)
Operation of##10##2##(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2011-1#1)
Operation##22##1##(1991-3#1)(1994-9#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
Operational Satellite##2##2##(2008-2#2)
Operational Vertical Sounder##2##3##(2008-2#2)
Operational##24##1##(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#1)(2010-5#1)(2010-8#1)(2012-3#1)
Operations##8##1##(1993-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
Operative findings##3##2##(2008-7#1)(2008-9#1)(2010-5#1)
Operative laparoscopy##5##2##(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-3#1)
Operative management of testicular torsion##2##5##(2008-10#2)
Operative management of##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
Operative mortality was##3##3##(1990-2#1)(1991-6#1)(2007-8#1)
Operative mortality##6##2##(1990-2#1)(1991-6#1)(2007-8#2)(2008-7#2)
Operative strategies for minimizing hearing loss##2##6##(2011-2#2)
Operative treatment##2##2##(2008-7#1)(2012-2#1)
Operative##37##1##(1990-2#1)(1991-6#1)(1991-9#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-9#3)(1995-2#1)(1996-3#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#2)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#2)
Operators##3##1##(2010-3#1)(2010-8#1)(2011-2#1)
Ophioninae##2##1##(2008-5#2)
Ophionotus victoriae##2##2##(2013-8#2)
Ophiosphaerella agrostis##3##2##(2008-10#3)
Ophiostoma clavigerum##2##2##(2008-10#2)
Ophiostoma novo-ulmi Mitovirus##2##3##(2008-10#2)
Ophiostoma novo-ulmi mitovirus##2##3##(2008-10#2)
Ophiostoma novo-ulmi##5##2##(2008-10#5)
Ophiostoma piceae##4##2##(2008-10#4)
Ophiostoma sp##3##2##(2008-10#3)
Ophiostoma##14##1##(2008-10#14)
Ophiuroidea larvae##2##2##(2011-2#2)
Ophiuroidea##3##1##(2011-2#3)
Ophthalmic##3##1##(1991-5#1)(2007-11#1)(2008-7#1)
Ophthalmology##3##1##(2008-11#1)(2010-10#1)(2011-2#1)
Opiate receptor density##2##3##(1992-5#2)
Opiliones##3##1##(2007-12#3)
Opiliones)##2##1##(2008-5#2)
Opinion##6##1##(1995-2#1)(1997-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-9#1)
Opinions on##2##2##(2009-6#1)(2010-12#1)
Opinions##5##1##(2008-11#1)(2009-4#1)(2009-6#1)(2010-12#1)(2013-8#1)
Opioid dependent##2##2##(2009-9#2)
Opioid receptor densities were measured##2##5##(2008-11#2)
Opioid receptor##4##2##(1993-12#1)(1995-3#1)(2008-11#2)
Opioid##17##1##(1991-1#3)(1993-12#1)(1995-3#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#2)(2010-4#2)(2012-1#1)
Opioids##5##1##(1991-1#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
Opium##2##1##(2008-10#2)
Oppenheimer's##2##1##(2008-12#2)
Opportunistic Infections##2##2##(2008-2#1)(2008-5#1)
Opportunistic##5##1##(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
Opportunities and##2##2##(1992-11#1)(2012-2#1)
Opportunities for##9##2##(1991-12#1)(1992-2#1)(1992-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-4#1)(2009-2#1)
Opportunities in##3##2##(1994-12#1)(2008-6#1)(2008-7#1)
Opportunities##18##1##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#1)(2012-2#1)(2013-1#1)
Opportunity##8##1##(1995-12#2)(1995-6#2)(1997-2#1)(2007-4#1)(2012-1#1)(2013-8#1)
Opposite##4##1##(1996-2#1)(2008-5#1)(2011-2#2)
Opt##85##1##(2007-12#4)(2008-2#25)(2008-3#56)
Optetrak##3##1##(2008-8#3)
OptiMAbtrade mark##5##2##(2008-11#5)
OptiPrep##2##1##(2008-1#2)
Optic##8##1##(1990-2#1)(1992-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)
Optical Coherence Tomography (OCT)##2##4##(2011-1#2)
Optical Coherence Tomography##5##3##(2011-1#4)(2013-8#1)
Optical Fiber##2##2##(2008-2#2)
Optical Parametric Oscillator Based on##2##5##(2008-3#2)
Optical Parametric Oscillator##5##3##(2008-2#1)(2008-3#4)
Optical Parametric##6##2##(2008-2#2)(2008-3#4)
Optical Properties of##3##3##(2008-2#2)(2008-3#1)
Optical Properties##4##2##(2008-2#2)(2008-3#2)
Optical Range##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Optical Spectroscopy##2##2##(2009-9#1)(2010-8#1)
Optical alignment of##2##3##(2007-12#1)(2008-3#1)
Optical alignment##3##2##(2007-12#2)(2008-3#1)
Optical and##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
Optical biosensor for##2##3##(2008-10#2)
Optical characteristics of##2##3##(2007-11#1)(2008-3#1)
Optical characterization of##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
Optical characterization##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
Optical coherence tomography (OCT) has##4##5##(2011-2#1)(2011-7#3)
Optical coherence tomography (OCT) is##2##5##(2011-7#1)(2012-2#1)
Optical coherence tomography (OCT)##6##4##(2011-2#1)(2011-7#4)(2012-2#1)
Optical coherence tomography in the diagnosis and management of##2##9##(2011-7#2)
Optical coherence tomography##12##3##(2009-5#1)(2010-12#1)(2011-2#2)(2011-7#6)(2012-2#1)(2013-8#1)
Optical coherence##15##2##(2007-11#2)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#2)(2011-7#6)(2012-2#1)(2013-8#1)
Optical configuration##2##2##(2008-2#1)(2008-3#1)
Optical correlation##2##2##(2008-2#1)(2008-3#1)
Optical design##2##2##(2008-3#2)
Optical encryption system##2##3##(2008-2#1)(2008-3#1)
Optical encryption##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Optical fiber##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
Optical fibers##2##2##(2008-10#1)(2008-2#1)
Optical frequency-domain##2##2##(2008-3#2)
Optical image##2##2##(2007-12#1)(2008-2#1)
Optical imaging and##2##3##(2008-3#1)(2012-2#1)
Optical imaging##4##2##(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
Optical implementation of fuzzy-logic controllers##2##5##(2008-2#1)(2008-3#1)
Optical implementation of the##2##4##(2008-2#2)
Optical implementation of##8##3##(2007-12#1)(2008-2#4)(2008-3#3)
Optical levitation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
Optical limiting##3##2##(2008-2#1)(2008-3#2)
Optical low-coherence##2##2##(2007-12#2)
Optical measurements on##2##3##(2008-10#2)
Optical measurements##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
Optical microscopy##2##2##(2009-5#1)(2009-7#1)
Optical model for##2##3##(2008-2#1)(2008-3#1)
Optical parametric amplification of a##2##5##(2007-12#2)
Optical parametric amplification##3##3##(2007-11#1)(2007-12#2)
Optical parametric oscillator##3##3##(2007-11#2)(2008-2#1)
Optical parametric##11##2##(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#1)
Optical properties of a##2##4##(2008-3#2)
Optical properties of##8##3##(2008-10#1)(2008-2#3)(2008-3#4)
Optical properties were derived from spectrophotometric measurements##2##7##(2008-2#2)
Optical properties##12##2##(2008-10#1)(2008-2#6)(2008-3#5)
Optical property measurements of##2##4##(2008-3#2)
Optical property##3##2##(2008-3#3)
Optical pulse##2##2##(2007-12#1)(2008-2#1)
Optical remote sensing of ocean color is a well-established technique##2##10##(2008-2#1)(2008-3#1)
Optical remote sensing of##5##4##(2008-2#2)(2008-3#3)
Optical resolution##2##2##(1994-9#2)
Optical scattering##2##2##(2008-2#1)(2008-3#1)
Optical sensor##2##2##(2008-10#1)(2008-2#1)
Optical switching##3##2##(1995-6#1)(2007-12#1)(2008-3#1)
Optical time-domain reflectometry##2##3##(2008-3#2)
Optical vortices##3##2##(2007-12#2)(2008-2#1)
Optical waveguide##2##2##(2007-11#1)(2008-10#1)
Optical##308##1##(1990-3#1)(1990-8#1)(1991-2#1)(1994-3#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-7#1)(2007-11#20)(2007-12#36)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#76)(2008-3#107)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#7)(2011-2#3)(2011-7#6)(2012-2#5)(2013-8#2)
Optically Active##3##2##(1996-5#2)(1997-7#1)
Optically active##2##2##(1996-5#1)(2008-7#1)
Optically anisotropic##2##2##(2008-2#1)(2008-3#1)
Optically##16##1##(1996-2#1)(1996-5#3)(1997-7#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)
Opticlean##2##1##(2008-3#2)
Optics in Computing##2##3##(2008-2#2)
Optics in##3##2##(2008-2#2)(2008-3#1)
Optics##19##1##(2008-10#1)(2008-2#6)(2008-3#11)(2011-1#1)
Optimal allocation of amplifiers in a dispersion-managed line##2##8##(2007-12#2)
Optimal conditions are determined for##2##5##(2007-12#1)(2008-10#1)
Optimal conditions for the##4##4##(1992-9#1)(1994-12#1)(2008-10#2)
Optimal conditions for##7##3##(1990-2#1)(1992-9#1)(1993-9#1)(1994-12#1)(2008-10#2)(2008-3#1)
Optimal conditions were found to be##2##6##(2008-10#2)
Optimal conditions##14##2##(1990-2#1)(1992-9#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-10#8)(2008-3#1)
Optimal control##2##2##(2008-1#1)(2008-3#1)
Optimal experimental conditions##2##3##(2008-10#1)(2008-3#1)
Optimal experimental##3##2##(2008-10#2)(2008-3#1)
Optimal foraging##2##2##(2008-9#2)
Optimal growth##2##2##(2008-6#1)(2010-11#1)
Optimal initial##2##2##(2008-10#1)(2008-7#1)
Optimal oral anticoagulation for patients with##2##6##(1995-11#2)
Optimal results##2##2##(1991-2#1)(2008-10#1)
Optimal temperature for##2##3##(1990-11#1)(2008-9#1)
Optimal treatment##2##2##(1990-6#1)(2008-6#1)
Optimal##80##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#2)(1992-9#1)(1993-9#1)(1994-12#1)(1995-11#3)(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#19)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-9#1)(2010-11#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)
Optimality##2##1##(2009-9#1)(2010-1#1)
Optimisation and##2##2##(2008-10#2)
Optimisation of the##3##3##(2008-10#2)(2008-11#1)
Optimisation of##14##2##(1991-12#1)(2008-10#11)(2008-11#2)
Optimisation##16##1##(1991-12#1)(2008-10#13)(2008-11#2)
Optimising##5##1##(2008-10#2)(2008-11#1)(2012-1#1)(2013-8#1)
Optimization and##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)
Optimization by##2##2##(2008-10#2)
Optimization of a##5##3##(1995-6#1)(2008-10#3)(2008-2#1)
Optimization of an##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
Optimization of experimental conditions##2##4##(2008-10#2)
Optimization of experimental##3##3##(2008-10#3)
Optimization of the##13##3##(1991-6#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-6#1)
Optimization of transfection##2##3##(2008-1#1)(2008-2#1)
Optimization of##54##2##(1991-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#3)(2008-6#3)(2008-7#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-2#1)
Optimization##66##1##(1991-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#6)(2008-6#3)(2008-7#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)
Optimized##20##1##(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-2#2)
Optimizing the##6##2##(2008-7#1)(2009-3#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
Optimizing##20##1##(1994-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
Optimum activity##2##2##(2008-10#1)(2008-6#1)
Optimum conditions for determining##4##4##(2008-10#4)
Optimum conditions for the formation of##2##6##(2008-10#2)
Optimum conditions for the##7##4##(2008-10#7)
Optimum conditions for##14##3##(2008-10#13)(2008-11#1)
Optimum conditions were found##3##4##(2008-10#3)
Optimum conditions were##4##3##(2008-10#4)
Optimum conditions##20##2##(2008-10#19)(2008-11#1)
Optimum experimental conditions##2##3##(2008-10#2)
Optimum pH##4##2##(2008-10#4)
Optimum performance was observed with##2##5##(2008-10#2)
Optimum performance##4##2##(2008-10#4)
Optimum reaction conditions##2##3##(1991-5#1)(2008-10#1)
Optimum separation##2##2##(2008-10#2)
Optimum##63##1##(1991-5#1)(1994-3#1)(1996-12#1)(2008-10#44)(2008-11#2)(2008-2#3)(2008-3#6)(2008-6#2)(2008-9#1)(2010-2#1)(2010-5#1)
Option##3##1##(1995-1#3)
Options for##3##2##(1994-3#1)(1996-1#1)(2008-11#1)
Options##5##1##(1994-3#1)(1994-6#1)(1996-1#1)(2008-11#1)(2010-4#1)
Optoacoustic##2##1##(2008-3#2)
Optoelectronic##9##1##(2008-2#5)(2008-3#4)
Optokinetic##3##1##(2008-4#2)(2010-3#1)
Optosensing properties of fac-Re(CO)(3)(dpknph)Cl (dpknph=di-2-pyridyl ketone p-nitrophenyl hydrazone)##2##8##(2008-10#2)
Opus 51##2##2##(2013-1#2)
Or##3##1##(1994-2#1)(2008-8#1)(2008-9#1)
Or0##2##1##(2013-8#2)
Oracle##3##1##(2008-7#2)(2010-8#1)
Orai1 and##3##2##(2008-8#3)
Oral Administration of##2##3##(2008-10#1)(2008-11#1)
Oral Health##2##2##(2011-2#2)
Oral administration of##7##3##(1991-8#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
Oral administration##8##2##(1991-8#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
Oral and maxillofacial##2##3##(2007-12#1)(2011-2#1)
Oral and##5##2##(1991-11#1)(2007-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Oral cancer##3##2##(2008-1#1)(2009-6#1)(2010-11#1)
Oral cavity rare##2##3##(2011-7#2)
Oral cavity##3##2##(2008-5#1)(2011-7#2)
Oral contraceptive##2##2##(2008-8#1)(2012-12#1)
Oral contraceptives and venous thromboembolism##5##5##(1997-2#1)(1997-5#4)
Oral contraceptives##6##2##(1994-9#1)(1997-2#1)(1997-5#4)
Oral fluoroquinolones##2##2##(2007-12#1)(2010-6#1)
Oral health##2##2##(2008-5#1)(2012-2#1)
Oral lesions##5##2##(2007-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
Oral lichen planus##2##3##(2008-4#1)(2009-6#1)
Oral malignant##2##2##(2012-3#2)
Oral manifestations##2##2##(2010-3#1)(2012-2#1)
Oral rehydration##2##2##(1991-3#1)(2008-1#1)
Oral squamous cell carcinoma (OSCC)##2##5##(2010-12#1)(2013-1#1)
Oral##113##1##(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-8#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#4)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-7#4)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#6)(2009-6#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-7#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#2)
Orally##3##1##(2008-11#1)(2008-7#2)
Oranga Kaumatua##2##2##(2008-1#2)
Orange II##3##2##(2008-10#1)(2011-1#2)
Orange##14##1##(1991-9#1)(1992-2#1)(2008-10#9)(2008-4#1)(2011-1#2)
Orbital##15##1##(1996-2#1)(2007-11#1)(2008-11#1)(2008-7#2)(2010-10#2)(2010-11#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#1)
Orcas Island##2##2##(2008-5#2)
Orchards##8##1##(2008-10#8)
Orchid bees##3##2##(2008-5#3)
Orchid##4##1##(2008-10#1)(2008-5#3)
Order and Industriousness##2##3##(2012-1#2)
Order##18##1##(2007-11#1)(2008-11#1)(2008-12#8)(2008-3#1)(2008-9#1)(2010-1#1)(2010-8#1)(2012-1#3)(2013-1#1)
Ordered bundles##2##2##(2007-12#2)
Ordered##3##1##(2007-12#2)(2008-9#1)
Ordering and##2##2##(1991-9#1)(1996-9#1)
Ordering##3##1##(1991-9#1)(1996-9#1)(2009-6#1)
Orders##3##1##(1992-6#1)(2010-8#1)(2011-2#1)
Ordinary runs analysis##3##3##(2008-10#3)
Ordinary runs##4##2##(2008-10#4)
Ordinary##8##1##(1994-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2013-1#1)
Ore##2##1##(2007-12#1)(2007-9#1)
Oregon Health##2##2##(1995-1#1)(1996-1#1)
Oregon Medicaid##4##2##(1992-2#3)(1992-9#1)
Oregon and Washington##2##3##(2008-10#1)(2008-9#1)
Oregon and##3##2##(2008-10#2)(2008-9#1)
Oregon is##3##2##(1995-1#2)(1996-1#1)
Oregon was##4##2##(2008-10#2)(2013-1#2)
Oregon##58##1##(1992-1#1)(1992-2#8)(1992-9#1)(1993-1#1)(1993-12#2)(1995-1#4)(1995-3#1)(1996-1#5)(1997-2#1)(2008-10#24)(2008-12#3)(2008-9#2)(2010-12#2)(2012-3#1)(2013-1#2)
Oregon's##3##1##(1992-12#1)(1995-1#1)(2008-10#1)
Oreochromis niloticus (Perciformes##2##3##(2013-7#2)
Oreochromis niloticus##5##2##(2010-8#2)(2013-7#3)
Oreochromis##8##1##(1993-5#1)(2008-5#2)(2010-8#2)(2013-7#3)
Org 10172##5##2##(1997-2#5)
Org 2766##4##2##(1993-5#4)
Org##9##1##(1993-5#4)(1997-2#5)
Org-31806##2##1##(2008-5#2)
Organ donation##2##2##(2007-7#1)(2008-12#1)
Organ##16##1##(1993-2#1)(1993-8#1)(1995-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-12#1)
Organelle##2##1##(2008-4#2)
Organic Matter##2##2##(2008-10#2)
Organic Pollutants##2##2##(2008-11#1)(2009-8#1)
Organic acids in##2##3##(1992-3#1)(1994-9#1)
Organic acids##4##2##(1992-3#2)(1994-9#1)(2008-4#1)
Organic arsenic##2##2##(2008-10#2)
Organic electronics##2##2##(2008-7#2)
Organic materials##2##2##(2008-7#2)
Organic substances##2##2##(2008-11#1)(2013-1#1)
Organic##41##1##(1990-8#1)(1992-3#2)(1994-5#1)(1994-9#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#13)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
Organic-inorganic##3##1##(2008-10#1)(2008-5#1)(2010-4#1)
Organisation for##10##2##(2008-1#1)(2008-11#1)(2010-11#1)(2011-2#6)(2013-1#1)
Organisation##19##1##(1996-4#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)
Organisational##2##1##(2008-11#1)(2013-1#1)
Organisms##3##1##(2007-12#1)(2008-10#1)(2008-9#1)
Organization and##11##2##(1990-5#1)(1991-1#1)(1994-12#1)(1996-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-5#1)(2011-2#2)
Organization as##2##2##(1996-9#1)(2008-2#1)
Organization for Research and Treatment of Cancer##4##7##(1994-3#1)(2008-7#3)
Organization for Research and Treatment of##5##6##(1994-3#1)(2008-7#3)(2011-2#1)
Organization for Standardization##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
Organization for##14##2##(1993-2#1)(1993-3#2)(1994-1#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#3)(2011-2#2)
Organization is##2##2##(1993-11#1)(2011-2#1)
Organization of the##2##3##(1991-6#1)(2013-8#1)
Organization of##9##2##(1991-6#1)(1993-11#1)(1995-6#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
Organization##116##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#4)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-2#2)(2007-5#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#7)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#11)(2011-7#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
Organizational commitment##2##2##(1996-1#1)(1997-3#1)
Organizational culture##3##2##(1991-1#1)(1993-2#2)
Organizational justice is##2##3##(2011-2#2)
Organizational justice##4##2##(2011-2#4)
Organizational##22##1##(1990-11#2)(1991-1#1)(1992-1#1)(1993-2#5)(1995-1#1)(1996-1#1)(1996-2#2)(1997-3#1)(2008-7#2)(2011-2#4)(2012-1#1)(2013-1#1)
Organizations##15##1##(1991-2#1)(1991-3#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-9#2)(2009-4#1)
Organizing##5##1##(1991-1#1)(1994-9#1)(1996-2#1)(2008-4#1)(2012-12#1)
Organon##2##1##(2008-5#2)
Organophosphates##2##1##(1994-5#1)(2009-3#1)
Organophosphorous (OP) pesticides are used frequently in agriculture##2##8##(2013-1#2)
Organophosphorus##2##1##(1992-2#1)(1994-7#1)
Organotins are used commercially as##2##5##(2008-10#2)
Organs##5##1##(1993-1#1)(2008-10#1)(2008-11#1)(2011-2#2)
Oriental lacquer##2##2##(2008-10#2)
Oriental##4##1##(2008-10#2)(2008-8#1)(2012-3#1)
Orientation of##2##2##(2008-6#1)(2010-2#1)
Orientation##12##1##(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-2#1)(2013-8#1)
Oriented##3##1##(1993-1#1)(1995-3#1)(2009-11#1)
Origanum##2##1##(2008-10#1)(2008-11#1)
Origin and distribution of##2##4##(1992-12#1)(2008-10#1)
Origin and##5##2##(1992-12#1)(2008-10#2)(2009-6#1)(2010-3#1)
Origin of the##4##3##(1997-7#1)(2008-10#2)(2008-3#1)
Origin of##17##2##(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
Origin##26##1##(1992-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
Original images##2##2##(2007-11#1)(2007-12#1)
Original##10##1##(1994-11#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-1#1)(2012-3#1)
Originally##5##1##(2008-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
Origins of##3##2##(1990-11#1)(1991-3#1)(2008-10#1)
Origins##5##1##(1990-11#1)(1991-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
Orinoco##4##1##(2008-10#2)(2013-7#2)
Orissa##5##1##(2007-7#2)(2012-1#3)
Orlando##10##1##(1992-11#1)(1992-3#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)
Orlistat##2##1##(2008-5#2)
Ornithine decarboxylase##2##2##(1992-9#2)
Ornithine##3##1##(1992-9#2)(2009-8#1)
Ornithodoros lahorensis Neuman##2##3##(2008-12#2)
Ornithodoros##3##1##(2008-12#2)(2012-3#1)
Orobanche crenata##2##2##(2008-10#2)
Orobanche pycnostachya##2##2##(2011-2#2)
Orobanche ramosa##2##2##(2008-10#2)
Orobanche##12##1##(2008-10#10)(2011-2#2)
Orofacial##4##1##(2009-10#1)(2009-5#1)(2009-6#1)(2013-1#1)
Oromia##3##1##(2008-8#1)(2011-2#2)
Oropharyngeal##3##1##(1997-5#1)(2008-5#1)(2011-2#1)
Orphan##5##1##(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)
Orphanin##2##1##(1996-5#2)
Orpington Prognostic Scale within##2##4##(2007-10#2)
Orpotrin analogs##2##2##(2011-2#2)
Orpotrin##5##1##(2011-2#5)
Orthezia praelonga Douglas##2##3##(2008-6#2)
Orthezia##3##1##(2007-12#1)(2008-6#2)
Ortheziidae##2##1##(2007-12#2)
OrthoPilot computer navigation system##2##4##(2007-8#2)
OrthoPilot##3##1##(2007-8#3)
Orthodontic treatment##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
Orthodontic##8##1##(1995-3#1)(2007-12#3)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
Orthodontics##2##1##(2010-3#2)
Orthognathic surgery##2##2##(2007-12#2)
Orthogonal##5##1##(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
Orthopaedic Clinic of##2##3##(2007-11#2)
Orthopaedic Clinic##3##2##(2007-11#3)
Orthopaedic Registry (GLORY)##7##3##(2011-2#7)
Orthopaedic##27##1##(1994-1#1)(2007-11#5)(2007-8#2)(2008-12#1)(2008-6#1)(2008-8#2)(2009-10#3)(2011-2#8)(2012-2#3)(2013-1#1)
Orthopaedics##10##1##(1991-9#1)(2007-11#3)(2007-8#3)(2009-4#1)(2013-1#2)
Orthopedic Clinic##3##2##(2007-11#1)(2007-8#2)
Orthopedic and Traumatology##3##3##(2007-11#2)(2007-8#1)
Orthopedic and##4##2##(2007-11#2)(2007-8#2)
Orthopedic oncology##3##2##(2010-3#3)
Orthopedic##15##1##(1997-6#1)(2007-11#4)(2007-8#5)(2010-3#3)(2012-3#2)
Orthopedics and Traumatology of the Locomotor System at the Medical University##2##11##(2007-11#1)(2007-8#1)
Orthopedics and Traumatology of the##3##5##(2007-11#2)(2007-8#1)
Orthopedics and Traumatology##5##3##(2007-11#3)(2007-8#2)
Orthopedics##10##1##(2007-11#4)(2007-8#3)(2008-8#1)(2011-2#1)(2012-3#1)
Orthophosphate##2##1##(2008-10#2)
Orthoptera Tettigonioidea##2##2##(2008-7#2)
Orthoptera##5##1##(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#1)
Orthoses##2##1##(2007-8#2)
Orthosiphon##5##1##(2008-10#5)
Ortigas river##3##2##(2008-10#3)
Ory s 23##2##3##(2009-10#2)
Ory s##7##2##(2009-10#7)
Oryza grandiglumis##2##2##(2008-5#2)
Oryza isolate##2##2##(2008-10#2)
Oryza meyeriana##2##2##(2008-8#2)
Oryza sativa L##5##3##(1996-10#1)(2008-9#4)
Oryza sativa##12##2##(1996-10#1)(2008-10#3)(2008-9#7)(2009-10#1)
Oryza##21##1##(1996-10#1)(2008-10#6)(2008-5#2)(2008-8#3)(2008-9#7)(2009-10#2)
Oryzias latipes##8##2##(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#2)(2009-7#2)
Oryzias##9##1##(2008-1#1)(2008-11#1)(2008-5#3)(2008-6#2)(2009-7#2)
Os##4##1##(2008-10#4)
OsH(2)(eta(2)-CH(2)=CHEt)(CO)(P(i)Pr(3))(2)##2##1##(1996-2#2)
OsMADS5##5##1##(1997-2#5)
OsMADS50##2##1##(2009-8#2)
OsMADS7 and 8##4##3##(1997-8#4)
OsMADS7 and##5##2##(1997-8#5)
OsMADS7##6##1##(1997-8#5)(2008-8#1)
OsPBP1 is a##2##3##(2009-10#2)
OsPBP1##7##1##(2009-10#7)
OsRLCKs##5##1##(2009-10#5)
Osa Peninsula##2##2##(2008-5#2)
Osaka City##4##2##(2013-8#4)
Osaka##6##1##(1990-5#1)(2007-12#1)(2013-8#4)
Oscillations in##2##2##(1990-8#1)(2008-8#1)
Oscillations were##2##2##(1991-5#1)(1996-6#1)
Oscillations##6##1##(1990-8#1)(1991-5#1)(1996-6#1)(2008-2#1)(2008-8#1)(2009-8#1)
Oscillator##9##1##(1996-9#1)(2008-2#2)(2008-3#5)(2009-10#1)
Oscillatory Electric Potential on the Olfactory Epithelium##2##7##(2008-5#1)(2008-6#1)
Oscillatory##8##1##(2007-12#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)
Oscillomat device##2##2##(1991-3#2)
Oscillomat##3##1##(1991-3#3)
Osedax spp##2##2##(2009-8#2)
Osgood-Schlatter disease##2##2##(2008-9#2)
Oshar##5##1##(2008-12#5)
Oslo with##2##2##(1994-6#1)(1995-8#1)
Oslo##26##1##(1990-11#1)(1990-2#1)(1990-9#1)(1992-5#2)(1992-6#4)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-8#2)(2008-2#1)(2011-2#1)
Oslo]##4##1##(1995-11#2)(1997-4#1)(1997-6#1)
Osmoadaptation##2##1##(1993-3#1)(2008-7#1)
Osmotic##6##1##(1992-6#1)(2008-11#1)(2008-8#1)(2009-12#2)(2013-7#1)
OspA of##2##2##(2012-2#2)
OspA##3##1##(2012-2#3)
Ossifying##2##1##(1994-2#1)(2008-10#1)
Osteoarthritis (OA) is a##3##4##(2008-9#1)(2010-11#1)(2013-1#1)
Osteoarthritis is##2##2##(2007-11#1)(2013-1#1)
Osteoarthritis of the##3##3##(1997-6#1)(2010-12#2)
Osteoarthritis of##4##2##(1997-6#1)(2010-12#2)(2013-1#1)
Osteoarthritis##17##1##(1997-6#1)(2007-11#1)(2008-10#4)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2013-1#5)
Osteoblastoma of##2##2##(2010-5#2)
Osteoblastoma##3##1##(2010-5#3)
Osteoblasts##3##1##(2008-11#1)(2008-8#1)(2010-10#1)
Osteochondritis dissecans (OCD)##2##3##(2013-1#2)
Osteochondritis##3##1##(2013-1#3)
Osteoclast##2##1##(1991-11#1)(1991-5#1)
Osteodystrophy in chronic##2##3##(2008-1#1)(2008-4#1)
Osteogenesis##2##1##(2007-12#1)(2008-11#1)
Osteogenic sarcoma of the##3##4##(1992-2#1)(1993-8#1)(2008-6#1)
Osteogenic##5##1##(1992-2#1)(1993-8#1)(2008-11#1)(2008-6#1)(2012-4#1)
Osteoid osteoma of the great toe##2##6##(2010-5#2)
Osteoid##3##1##(2010-5#2)(2012-1#1)
Osteoma cutis is##2##3##(2010-6#2)
Osteoma cutis##3##2##(2010-6#3)
Osteomyelitis of the craniofacial skeleton##2##5##(2010-6#2)
Osteomyelitis of the##4##3##(2010-11#1)(2010-6#3)
Osteomyelitis##10##1##(1995-9#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-6#6)
Osteonecrosis of the##2##3##(2009-3#1)(2012-12#1)
Osteonecrosis##3##1##(2009-3#2)(2012-12#1)
Osteonevus of Nanta##2##3##(2012-12#2)
Osteopathic##3##1##(1991-12#1)(2007-11#1)(2013-1#1)
Osteopathy##2##1##(2010-12#2)
Osteoplasty##2##1##(2012-12#1)(2013-1#1)
Osteoporosis and##3##2##(2008-8#1)(2010-10#2)
Osteoporosis in men##2##3##(1993-11#1)(1997-6#1)
Osteoporosis in##3##2##(1993-11#1)(1995-11#1)(1997-6#1)
Osteoporosis is a##2##3##(1993-11#1)(2008-7#1)
Osteoporosis is##3##2##(1993-11#1)(2008-7#1)(2008-8#1)
Osteoporosis##18##1##(1993-11#5)(1995-11#2)(1997-6#2)(2007-7#1)(2008-7#1)(2008-8#3)(2010-10#2)(2010-3#1)(2012-2#1)
Osteoporotic##3##1##(2008-12#1)(2010-10#1)(2010-3#1)
Osteosarcoma Study Group##2##3##(2010-3#2)
Osteosarcoma has also been associated with##2##6##(2010-3#2)
Osteosarcoma has##3##2##(2010-3#3)
Osteosarcoma is a##2##3##(2008-8#1)(2010-3#1)
Osteosarcoma is##4##2##(2008-8#1)(2010-3#2)(2013-1#1)
Osteosarcoma of the##2##3##(1992-6#1)(2008-6#1)
Osteosarcoma##32##1##(1992-6#1)(2008-6#4)(2008-8#1)(2010-3#25)(2013-1#1)
Osteotomy##4##1##(2006-12#2)(2012-3#1)(2013-1#1)
Ostertagia##3##1##(1996-12#3)
Osteryoung##2##1##(2008-10#2)
Ostrinia nubilalis##2##2##(2008-7#1)(2011-2#1)
Ostwald ripening##2##2##(2008-7#1)(2009-11#1)
Oswaldo Cruz 33 (1938) 349] and Lutzomyia##2##7##(2007-12#2)
Oswaldo Cruz##8##2##(1993-6#2)(2007-12#4)(2010-1#2)
Oswaldo##9##1##(1993-6#3)(2007-12#4)(2010-1#2)
Oswestry Disability Index (ODI)##2##4##(2008-12#1)(2012-12#1)
Oswestry Disability Index##5##3##(2008-12#1)(2009-3#1)(2012-12#1)(2012-3#2)
Oswestry Disability##6##2##(2008-12#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
Oswestry##9##1##(2007-11#2)(2008-11#1)(2008-12#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
Otago##2##1##(2008-12#1)(2013-1#1)
Other advantages of the##4##4##(2007-11#1)(2007-8#1)(2008-10#2)
Other advantages##5##2##(2007-11#1)(2007-8#1)(2008-10#3)
Other agents##3##2##(1991-1#1)(1995-11#1)(2008-9#1)
Other areas##2##2##(2008-1#1)(2008-2#1)
Other aspects of the##2##4##(1995-5#1)(2007-12#1)
Other aspects of##4##3##(1995-5#1)(2007-12#2)(2011-1#1)
Other aspects##5##2##(1995-5#1)(2007-12#2)(2008-11#1)(2011-1#1)
Other causes of##4##3##(1997-8#1)(2007-2#1)(2007-7#1)(2013-1#1)
Other causes##5##2##(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
Other changes in##2##3##(1992-9#1)(2008-10#1)
Other complications##2##2##(2008-7#1)(2011-1#1)
Other countries##2##2##(1992-5#1)(2011-2#1)
Other data##3##2##(2008-12#1)(2013-8#2)
Other demographic##2##2##(1994-12#1)(2008-12#1)
Other diseases##2##2##(1994-5#1)(2007-7#1)
Other factors initiate consecutive genetic mutations that would eventually alter the normal pathway of cellular proliferations and differentiation##2##18##(2013-1#2)
Other factors than##2##3##(1996-12#1)(2012-1#1)
Other factors##10##2##(1996-12#1)(1996-3#3)(2008-10#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
Other features of##2##3##(1992-4#1)(1996-10#1)
Other findings show significant gaps in the system of administrative##9##10##(2013-8#9)
Other findings show##10##3##(2013-8#10)
Other findings##13##2##(2007-2#1)(2009-2#1)(2010-6#1)(2013-8#10)
Other group of##2##3##(2008-10#1)(2008-5#1)
Other important##3##2##(1991-8#1)(1996-12#1)(2008-8#1)
Other less##2##2##(1997-5#1)(2009-10#1)
Other metals##3##2##(2008-10#2)(2010-11#1)
Other methods##2##2##(1997-3#1)(2008-7#1)
Other model predictions##2##3##(2008-8#2)
Other observations##2##2##(2011-2#1)(2012-2#1)
Other parameters##4##2##(1992-10#1)(2008-1#1)(2008-10#1)(2012-2#1)
Other possibilities for##2##3##(2008-2#1)(2008-3#1)
Other potential##4##2##(2007-10#1)(2008-10#1)(2009-12#1)(2011-2#1)
Other problems##2##2##(1995-5#1)(2008-10#1)
Other products##2##2##(1991-9#1)(1993-8#1)
Other profitable features such as##4##5##(2008-10#4)
Other protocols##3##2##(2007-11#1)(2008-2#1)(2008-9#1)
Other semiempirical molecular orbital methods have mean unsigned errors (MUEs) of 3 to 8 kcal/mol##2##15##(2012-12#2)
Other species are##2##3##(2007-5#1)(2008-5#1)
Other species##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
Other strategies##2##2##(1994-2#1)(2008-7#1)
Other studies##6##2##(1994-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-1#1)
Other than the##2##3##(1992-3#1)(1994-12#1)
Other than##6##2##(1992-3#1)(1994-12#1)(1994-3#1)(2008-2#1)(2009-8#1)(2011-2#1)
Other variables##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
Other##333##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-9#3)(1993-11#2)(1993-2#1)(1993-6#2)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-8#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#60)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#15)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#24)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#13)
Others believe that##2##3##(1995-2#1)(2011-2#1)
Others##14##1##(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
Otherwise##17##1##(1990-9#1)(1992-6#1)(1995-5#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-12#1)
Otitis media##2##2##(1995-5#1)(2013-8#1)
Otoacoustic Emissions##2##2##(2008-2#2)
Otolaryngology##3##1##(2008-8#1)(2011-2#1)(2013-1#1)
Ots1BML##2##1##(2008-11#2)
Otsuka##2##1##(2008-5#2)
Ottawa##10##1##(1992-3#1)(1995-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2012-2#1)(2013-1#2)
Ottoman##4##1##(2008-11#1)(2009-7#2)(2011-2#1)
Otwock##2##1##(2007-11#2)
Ouabain##2##1##(1990-11#1)(1995-11#1)
Ouagadougou##4##1##(2008-12#2)(2009-10#2)
Oulu##2##1##(2010-10#2)
Our ability to##2##3##(1993-3#1)(2010-4#1)
Our ailing public hospitals##3##4##(1996-2#3)
Our aim is to present##2##5##(2008-3#2)
Our aim is to##7##4##(2008-11#1)(2008-3#4)(2008-9#1)(2009-4#1)
Our aim was to assess the##2##6##(2008-9#1)(2012-8#1)
Our aim was to determine the##2##6##(2011-2#1)(2013-8#1)
Our aim was to evaluate##3##5##(2007-10#1)(2007-8#1)(2011-2#1)
Our aim was to##16##4##(2007-10#2)(2007-8#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-3#1)(2012-8#1)(2013-8#2)
Our aim was##17##3##(1995-11#1)(2007-10#2)(2007-8#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-3#1)(2012-8#1)(2013-8#2)
Our aim##24##2##(1995-11#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-3#1)(2012-8#1)(2013-8#2)
Our algorithm##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
Our analyses indicate that##2##4##(2008-7#1)(2013-7#1)
Our analyses##6##2##(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
Our analysis also##3##3##(2008-3#1)(2008-7#1)(2009-4#1)
Our analysis indicates that##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
Our analysis of##6##3##(1993-2#1)(1997-5#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
Our analysis reveals##4##3##(2007-12#2)(2008-8#1)(2012-2#1)
Our analysis showed that##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
Our analysis shows that##3##4##(2008-11#1)(2008-3#1)(2008-9#1)
Our analysis suggests that##2##4##(1997-7#1)(2008-8#1)
Our analysis##34##2##(1993-2#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#4)
Our approach can##2##3##(2008-8#1)(2013-8#1)
Our approach extends the##2##4##(1994-11#1)(2010-2#1)
Our approach is to##2##4##(1997-4#1)(2008-6#1)
Our approach is##4##3##(1997-4#1)(2008-6#2)(2012-3#1)
Our approach to##2##3##(2008-2#1)(2012-12#1)
Our approach##21##2##(1992-9#1)(1994-11#1)(1994-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#4)(2008-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Our calculations##2##2##(2008-3#2)
Our case is##4##3##(2007-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
Our case report##2##3##(1990-10#1)(2008-12#1)
Our case suggests##2##3##(2010-6#1)(2011-2#1)
Our case##9##2##(1990-10#1)(2007-8#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Our cases##2##2##(2007-10#1)(2011-2#1)
Our clinical##3##2##(1997-8#1)(2010-6#1)(2011-2#1)
Our computations have##2##3##(1996-12#2)
Our conclusion is that##2##4##(1990-12#1)(2007-8#1)
Our conclusion##3##2##(1990-12#1)(2007-8#1)(2008-7#1)
Our conclusions are##2##3##(2008-7#1)(2009-8#1)
Our conclusions##3##2##(2008-7#1)(2009-3#1)(2009-8#1)
Our current##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
Our data also indicate that##2##5##(1994-5#1)(2008-8#1)
Our data also suggest that##3##5##(1992-9#1)(2008-8#1)(2008-9#1)
Our data also suggest##4##4##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
Our data also##6##3##(1992-9#1)(1994-5#1)(2008-10#1)(2008-8#2)(2008-9#1)
Our data are##4##3##(1990-5#1)(1995-12#1)(1995-3#1)(2008-2#1)
Our data confirm that##2##4##(1990-6#1)(1994-11#1)
Our data confirm##3##3##(1990-6#1)(1994-11#1)(2007-8#1)
Our data demonstrate that the##2##5##(2008-10#2)
Our data demonstrate that##6##4##(2008-10#2)(2008-11#2)(2012-3#1)(2013-1#1)
Our data demonstrate##7##3##(2008-10#2)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
Our data do not##2##4##(2008-10#1)(2011-2#1)
Our data have##2##3##(1991-9#1)(2012-3#1)
Our data indicate that the##4##5##(1995-6#1)(1995-8#1)(2008-11#1)(2008-7#1)
Our data indicate that##16##4##(1990-12#1)(1991-8#1)(1993-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
Our data indicate##19##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-2#1)(1993-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
Our data provide evidence##2##4##(2008-4#1)(2013-1#1)
Our data provide the first##2##5##(2008-10#1)(2010-11#1)
Our data provide##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
Our data reveal that##3##4##(1990-11#1)(1994-5#1)(2013-1#1)
Our data reveal##4##3##(1990-11#1)(1994-5#1)(2012-12#1)(2013-1#1)
Our data show that the##2##5##(2008-11#1)(2008-5#1)
Our data show that##8##4##(1991-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
Our data show##9##3##(1991-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-6#1)
Our data showed that##3##4##(1997-2#1)(2011-2#1)(2012-2#1)
Our data strongly suggest that the##2##6##(1996-5#1)(2008-5#1)
Our data strongly##3##3##(1994-12#1)(1996-5#1)(2008-5#1)
Our data suggest that the##15##5##(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-6#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
Our data suggest that##43##4##(1990-11#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1996-11#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-2#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
Our data suggest##45##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-2#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
Our data suggested that##2##4##(1991-9#1)(2008-10#1)
Our data suggested##3##3##(1991-9#1)(2008-10#1)(2012-12#1)
Our data support the##4##4##(1990-2#1)(1995-2#1)(2008-10#1)(2008-11#1)
Our data support##5##3##(1990-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
Our data therefore##3##3##(1992-5#1)(1995-12#1)(2008-11#1)
Our data were collected##2##4##(2008-5#1)(2012-12#1)
Our data##145##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#12)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#2)(2009-4#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-6#1)(2011-10#1)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#4)(2013-8#1)
Our device has a##2##4##(2007-11#1)(2007-12#1)
Our device##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Our efforts to##2##3##(2008-10#1)(2008-11#1)
Our evaluation##3##2##(1994-3#1)(2008-8#1)(2010-5#1)
Our experience demonstrates that##2##4##(1991-6#1)(2007-8#1)
Our experience in##4##3##(1996-1#1)(1997-2#1)(2007-12#1)(2011-2#1)
Our experience of##2##3##(1994-11#1)(2011-2#1)
Our experience with##4##3##(1992-5#2)(1993-9#1)(2008-9#1)
Our experience##20##2##(1991-6#1)(1992-5#2)(1993-9#1)(1994-11#1)(1996-1#1)(1997-2#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-7#3)(2008-9#1)(2009-3#1)(2011-2#3)
Our experience]##10##2##(1990-3#2)(1990-6#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-9#1)(2011-2#1)
Our experiences##2##2##(2007-11#1)(2008-7#1)
Our experiment##4##2##(1996-5#1)(2007-11#2)(2007-12#1)
Our experimental results show##2##4##(2008-3#2)
Our experimental results##4##3##(2008-10#1)(2008-3#2)(2011-1#1)
Our experimental##8##2##(2007-12#3)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
Our experiments in##2##3##(2007-12#1)(2008-3#1)
Our experiments indicate that##2##4##(2008-9#1)(2009-6#1)
Our experiments show that##3##4##(2008-3#1)(2008-9#1)(2009-9#1)
Our experiments were##2##3##(2007-11#1)(2012-2#1)
Our experiments##15##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-9#3)(2009-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
Our finding that##2##3##(2009-8#1)(2011-2#1)
Our finding was##2##3##(2008-11#1)(2012-2#1)
Our finding##9##2##(1992-8#1)(1996-12#1)(2008-11#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-2#2)
Our findings also suggest##2##4##(2008-4#1)(2010-8#1)
Our findings also##5##3##(2008-11#2)(2008-4#1)(2010-8#1)(2013-1#1)
Our findings are##4##3##(1994-2#1)(2007-7#1)(2008-3#1)(2012-2#1)
Our findings confirm that##2##4##(2008-7#1)(2012-2#1)
Our findings demonstrate##2##3##(1991-12#1)(1997-4#1)
Our findings have##2##3##(2008-8#2)
Our findings highlight the##2##4##(2008-10#1)(2012-12#1)
Our findings indicate that##11##4##(1992-2#1)(1992-8#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
Our findings indicate##12##3##(1992-2#1)(1992-8#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
Our findings may##2##3##(1993-1#1)(2010-11#1)
Our findings provide##3##3##(1991-6#1)(2012-12#1)(2012-2#1)
Our findings revealed##2##3##(2008-10#1)(2012-12#1)
Our findings show that##6##4##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Our findings show##7##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Our findings strongly suggest##2##4##(1995-12#1)(2012-3#1)
Our findings strongly##3##3##(1995-12#1)(1997-7#1)(2012-3#1)
Our findings suggest that the##6##5##(1992-8#1)(2007-4#1)(2008-10#1)(2012-2#2)(2013-1#1)
Our findings suggest that##22##4##(1990-2#1)(1991-8#1)(1992-2#1)(1992-8#1)(1995-2#1)(2007-4#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Our findings suggest##26##3##(1990-2#1)(1991-8#1)(1992-2#1)(1992-8#1)(1995-11#1)(1995-2#1)(2007-4#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Our findings support the##3##4##(1990-12#1)(2010-1#1)(2010-3#1)
Our findings will help##2##4##(2008-11#1)(2012-2#1)
Our findings##107##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#2)(1993-1#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-4#2)(2007-7#1)(2008-10#9)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-4#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#4)(2013-8#3)
Our first experience with##2##4##(2008-10#1)(2010-3#1)
Our first##7##2##(1992-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-3#1)
Our focus is##2##3##(2010-5#1)(2012-2#1)
Our focus##4##2##(1995-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
Our genetic##2##2##(2008-10#1)(2012-3#1)
Our goal is to##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
Our goal was to develop a##2##6##(2008-10#2)
Our goal was to##4##4##(2007-12#2)(2008-10#2)
Our goal##7##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
Our goals##3##2##(2008-8#1)(2009-8#1)(2013-8#1)
Our group##3##2##(1996-9#1)(2008-9#1)(2010-6#1)
Our hypothesis was that##2##4##(2009-8#1)(2011-1#1)
Our hypothesis was##3##3##(2008-10#1)(2009-8#1)(2011-1#1)
Our hypothesis##6##2##(2008-10#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
Our in vitro##4##3##(1995-8#1)(2008-10#1)(2009-5#1)(2012-2#1)
Our in vivo##2##3##(2008-6#1)(2008-8#1)
Our in##6##2##(1995-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-2#1)
Our initial##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
Our investigation##2##2##(1994-10#1)(1997-6#1)
Our investigations##2##2##(2008-10#1)(2008-2#1)
Our knowledge of##2##3##(2008-11#1)(2010-4#1)
Our knowledge##3##2##(2008-11#1)(2010-3#1)(2010-4#1)
Our laboratory has##5##3##(1992-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
Our laboratory##7##2##(1992-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)
Our language both reflects and influences our attitudes and behavior##2##10##(2013-1#2)
Our main findings##2##3##(2008-3#1)(2011-2#1)
Our main result##2##3##(2008-9#2)
Our main##8##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)
Our mathematical##2##2##(2012-2#1)(2013-8#1)
Our measurements##3##2##(2007-12#2)(2008-7#1)
Our method does##2##3##(2008-1#1)(2013-1#1)
Our method is##10##3##(1995-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
Our method##27##2##(1995-11#1)(1995-2#1)(1996-5#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-7#1)(2012-3#3)(2013-1#3)
Our methodology##3##2##(2008-6#1)(2008-8#1)(2009-4#1)
Our model makes##2##3##(2008-8#2)
Our model predicts##2##3##(2008-8#2)
Our model provides##2##3##(2007-12#1)(2008-8#1)
Our model shows that##2##4##(2008-8#2)
Our model##22##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#13)(2008-9#2)(2013-7#1)
Our modeling approach##2##3##(2008-11#1)(2013-1#1)
Our modeling##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
Our objective is to##3##4##(2008-6#1)(2009-8#1)(2012-3#1)
Our objective was to assess the##4##6##(1994-3#1)(1995-1#1)(1996-1#1)(2012-12#1)
Our objective was to assess##5##5##(1994-3#1)(1995-1#1)(1996-1#1)(2007-8#1)(2012-12#1)
Our objective was to determine if##2##6##(1995-3#1)(2008-10#1)
Our objective was to determine##5##5##(1995-3#1)(2008-10#3)(2008-8#1)
Our objective was to evaluate the##2##6##(1996-2#1)(2012-2#1)
Our objective was to evaluate##3##5##(1996-2#1)(2011-2#1)(2012-2#1)
Our objective was to examine the##2##6##(2007-10#1)(2013-1#1)
Our objective was to examine##4##5##(2007-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
Our objective was to study##2##5##(2007-10#1)(2011-2#1)
Our objective was to##28##4##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-10#3)(2007-8#1)(2008-10#6)(2008-3#1)(2008-8#2)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
Our objective##34##2##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-10#3)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Our objectives were to##4##4##(2008-10#4)
Our objectives were##5##3##(1997-5#1)(2008-10#4)
Our objectives##7##2##(1997-5#1)(2008-10#5)(2008-9#1)
Our observation##2##2##(2008-5#1)(2012-3#1)
Our observations indicate that##2##4##(1996-5#1)(2009-6#1)
Our observations showed that##2##4##(2008-7#1)(2013-7#1)
Our observations suggest that##4##4##(1992-3#1)(1994-2#1)(2008-7#1)(2011-2#1)
Our observations##12##2##(1992-3#1)(1994-2#1)(1996-5#1)(1997-6#1)(2008-7#2)(2009-6#1)(2010-4#1)(2011-2#3)(2013-7#1)
Our optimal##2##2##(2008-6#1)(2012-12#1)
Our overall mean value for##2##5##(2008-3#2)
Our overall##4##2##(1997-1#1)(2008-3#2)(2013-1#1)
Our own##4##2##(1997-4#1)(2008-3#2)(2008-7#1)
Our paper##3##2##(1990-8#1)(2007-8#1)(2009-8#1)
Our patient was a##2##4##(2008-1#1)(2012-2#1)
Our patient was##3##3##(2006-10#1)(2008-1#1)(2012-2#1)
Our patient##9##2##(1990-3#1)(2006-10#3)(2008-1#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
Our pilot##2##2##(2008-11#1)(2011-2#1)
Our population##2##2##(2008-5#1)(2011-2#1)
Our postoperative##2##2##(1991-8#1)(2012-2#1)
Our predictions##2##2##(2007-11#1)(2012-2#1)
Our preliminary data indicate that##2##5##(1992-12#1)(2008-4#1)
Our preliminary results show that##2##5##(2007-8#1)(2008-10#1)
Our preliminary results show##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
Our preliminary results suggest that##2##5##(1995-4#1)(2011-2#1)
Our preliminary results##7##3##(1995-4#1)(2007-8#2)(2008-10#2)(2008-5#1)(2011-2#1)
Our preliminary##13##2##(1992-12#1)(1995-4#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#2)(2011-2#2)(2012-12#1)(2013-1#1)
Our present knowledge##2##3##(1993-11#1)(2008-4#1)
Our present##4##2##(1992-11#1)(1993-11#1)(2008-4#2)
Our previous studies have##2##4##(1992-8#1)(2013-1#1)
Our previous studies showed that##3##5##(2008-11#1)(2008-9#2)
Our previous studies##10##3##(1992-8#1)(1994-12#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-1#1)(2013-1#1)
Our previous study##2##3##(1994-5#1)(2008-6#1)
Our previous work has##2##4##(1993-6#1)(2011-2#1)
Our previous work##4##3##(1993-11#1)(1993-6#1)(2008-10#1)(2011-2#1)
Our previous##21##2##(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
Our primary##2##2##(2008-12#1)(2008-3#1)
Our proposal##2##2##(2012-2#1)(2012-3#1)
Our protocol##2##2##(2008-8#1)(2012-2#1)
Our purpose in this##2##4##(1994-1#1)(2010-9#1)
Our purpose in##3##3##(1994-1#1)(2008-3#1)(2010-9#1)
Our purpose is to##2##4##(2008-5#1)(2012-3#1)
Our purpose is##3##3##(2008-5#1)(2010-3#1)(2012-3#1)
Our purpose of launching##3##4##(2010-12#3)
Our purpose was to##6##4##(1990-7#1)(1993-9#1)(1995-12#1)(2013-1#3)
Our purpose##16##2##(1990-7#1)(1993-9#1)(1994-1#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#3)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#3)
Our recent research##2##3##(2008-11#1)(2009-8#1)
Our recent studies##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
Our recent##10##2##(1992-3#1)(1993-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#3)(2011-1#1)(2011-2#1)
Our recommendations##2##2##(2011-2#1)(2013-1#1)
Our report suggests that##2##4##(2007-7#1)(2012-2#1)
Our report##3##2##(2007-7#1)(2008-7#1)(2012-2#1)
Our research involved##4##3##(2007-11#2)(2007-8#2)
Our research was##2##3##(2007-11#1)(2010-8#1)
Our research##15##2##(1997-1#1)(2007-11#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-8#2)(2012-2#2)
Our result##6##2##(1990-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#2)
Our results allowed##2##3##(2008-8#1)(2013-7#1)
Our results also indicate that##2##5##(1995-8#1)(2008-4#1)
Our results also indicate##3##4##(1995-8#1)(2008-4#1)(2013-1#1)
Our results also indicated that##2##5##(2008-8#1)(2008-9#1)
Our results also provide##2##4##(1992-3#1)(2008-8#1)
Our results also show that##2##5##(2008-10#1)(2008-9#1)
Our results also suggest that a##2##6##(2008-10#1)(2009-10#1)
Our results also suggest that##5##5##(2008-10#2)(2008-8#1)(2009-10#1)(2012-3#1)
Our results also##15##3##(1992-3#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-4#1)(2008-8#3)(2008-9#2)(2009-10#1)(2012-3#1)(2013-1#1)
Our results and the##2##4##(1990-10#1)(2008-8#1)
Our results and##3##3##(1990-10#1)(2008-6#1)(2008-8#1)
Our results are compared with##2##5##(2008-3#1)(2008-5#1)
Our results are consistent with the hypothesis that##2##8##(1995-2#1)(2007-12#1)
Our results are consistent with the##6##6##(1990-8#1)(1991-12#1)(1992-6#1)(1995-2#1)(2007-12#1)(2008-8#1)
Our results are consistent with##9##5##(1990-8#1)(1991-12#1)(1992-6#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-8#1)(2009-11#1)(2010-8#1)
Our results are similar to those##2##6##(1995-5#1)(2011-2#1)
Our results are##22##3##(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#2)(1995-2#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-3#1)
Our results clearly demonstrate##2##4##(2008-5#1)(2009-7#1)
Our results clearly show that##2##5##(1994-5#1)(2008-5#1)
Our results clearly##6##3##(1994-5#1)(1997-1#1)(2008-10#1)(2008-5#2)(2009-7#1)
Our results confirm that##5##4##(1990-2#1)(1990-8#1)(1997-6#1)(2008-10#1)(2009-6#1)
Our results confirm the##3##4##(1990-8#1)(1996-8#1)(2008-6#1)
Our results confirm##10##3##(1990-2#1)(1990-8#2)(1996-8#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-6#1)(2011-2#1)
Our results confirmed that##2##4##(2008-10#1)(2012-2#1)
Our results confirmed##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
Our results corroborate##2##3##(2007-12#1)(2008-10#1)
Our results demonstrate a##2##4##(2008-9#1)(2010-10#1)
Our results demonstrate that both##2##5##(1995-2#1)(2008-12#1)
Our results demonstrate that the##8##5##(1997-6#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-3#1)(2013-1#2)
Our results demonstrate that this##2##5##(1997-7#1)(2011-2#1)
Our results demonstrate that##29##4##(1990-12#1)(1991-11#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
Our results demonstrate the##2##4##(2008-3#1)(2008-5#1)
Our results demonstrate##35##3##(1990-11#1)(1990-12#1)(1991-11#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
Our results demonstrated the##2##4##(2008-10#1)(2009-6#1)
Our results demonstrated##4##3##(2008-10#1)(2009-6#1)(2012-2#2)
Our results extend##2##3##(1994-12#1)(2008-9#1)
Our results for##2##3##(2007-12#1)(2008-10#1)
Our results from##5##3##(1990-3#1)(2008-10#1)(2008-7#1)(2010-6#1)(2013-7#1)
Our results further##2##3##(1992-12#1)(2008-10#1)
Our results give##2##3##(1997-3#1)(2008-11#1)
Our results have##3##3##(2008-9#1)(2013-1#1)(2013-7#1)
Our results highlight the##2##4##(2008-8#1)(2012-3#1)
Our results imply that##2##4##(2008-3#1)(2009-8#1)
Our results indicate a##2##4##(1991-4#1)(2008-10#1)
Our results indicate an undertreatment of osteoporosis##2##7##(2010-3#2)
Our results indicate that a##4##5##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
Our results indicate that both##2##5##(2008-8#1)(2012-3#1)
Our results indicate that increased##2##5##(2012-6#1)(2013-8#1)
Our results indicate that the##16##5##(1990-12#1)(1991-9#1)(1992-9#1)(1994-11#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)
Our results indicate that##74##4##(1990-12#3)(1991-12#1)(1991-9#1)(1992-12#1)(1992-9#2)(1994-11#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#1)
Our results indicate the##3##4##(1992-6#1)(2008-7#1)(2012-12#1)
Our results indicate##82##3##(1990-12#3)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#2)(1994-11#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#14)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#1)
Our results indicated that the##3##5##(2008-10#3)
Our results indicated that##9##4##(2008-10#5)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
Our results indicated##10##3##(2007-11#1)(2008-10#5)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
Our results may##2##3##(2007-10#1)(2008-10#1)
Our results on##2##3##(1996-9#1)(2008-11#1)
Our results point to##2##4##(2008-10#1)(2012-3#1)
Our results point##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
Our results provide evidence for##2##5##(1996-2#1)(1997-2#1)
Our results provide evidence that##2##5##(2008-10#1)(2013-1#1)
Our results provide evidence##4##4##(1996-2#1)(1997-2#1)(2008-10#1)(2013-1#1)
Our results provide##10##3##(1991-10#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
Our results provided##2##3##(2008-12#1)(2008-8#1)
Our results reveal that##2##4##(2007-11#1)(2012-3#1)
Our results reveal##3##3##(2007-11#1)(2008-7#1)(2012-3#1)
Our results revealed that##2##4##(2008-12#2)
Our results revealed##3##3##(1997-3#1)(2008-12#2)
Our results show a##2##4##(1990-5#1)(2008-3#1)
Our results show that both##2##5##(1997-3#1)(2008-3#1)
Our results show that changes##2##5##(2008-11#1)(2008-3#1)
Our results show that the##13##5##(1995-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-2#1)
Our results show that##58##4##(1990-3#1)(1991-12#1)(1992-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#8)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#2)(2009-9#1)(2010-6#1)(2011-2#4)(2012-3#2)(2012-6#1)(2013-1#1)
Our results show the##2##4##(2010-10#1)(2012-2#1)
Our results show##68##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#10)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#1)
Our results showed that both##2##5##(2008-10#1)(2008-9#1)
Our results showed that the##7##5##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
Our results showed that##20##4##(1992-12#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#3)
Our results showed##23##3##(1992-12#1)(1993-8#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#3)
Our results strongly suggest that the##2##6##(1993-6#1)(1997-4#1)
Our results strongly suggest that##3##5##(1993-6#1)(1997-4#1)(2013-1#1)
Our results suggest a##5##4##(1990-11#1)(1993-3#1)(1994-9#1)(2007-12#1)(2010-6#1)
Our results suggest that a##5##5##(2008-10#1)(2010-4#1)(2012-1#1)(2013-1#2)
Our results suggest that an##2##5##(1990-2#1)(2013-8#1)
Our results suggest that living##2##5##(1995-11#1)(2007-7#1)
Our results suggest that several##2##5##(2008-10#1)(2010-6#1)
Our results suggest that the##17##5##(1990-12#1)(1994-12#1)(1995-11#1)(1995-12#2)(1997-2#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2011-2#2)(2012-2#1)
Our results suggest that when##2##5##(2008-8#1)(2012-2#1)
Our results suggest that##87##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1996-5#2)(1997-2#1)(1997-3#2)(1997-8#2)(2007-7#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
Our results suggest the possibility of##2##6##(1994-8#1)(2009-11#1)
Our results suggest the##5##4##(1992-10#1)(1994-8#1)(1995-8#1)(2008-10#1)(2009-11#1)
Our results suggest##102##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#2)(1995-8#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-8#2)(2007-12#1)(2007-7#1)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
Our results suggested that the##3##5##(2008-11#2)(2008-6#1)
Our results suggested that##4##4##(1997-4#1)(2008-11#2)(2008-6#1)
Our results suggested##5##3##(1990-5#1)(1997-4#1)(2008-11#2)(2008-6#1)
Our results support the hypothesis that##2##6##(2008-4#1)(2012-12#1)
Our results support the hypothesis##3##5##(2008-10#1)(2008-4#1)(2012-12#1)
Our results support the##6##4##(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
Our results support##7##3##(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-1#1)(2012-12#1)
Our results##485##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#2)(1991-6#1)(1991-9#2)(1992-10#2)(1992-12#4)(1992-3#4)(1992-6#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#4)(1995-11#3)(1995-12#3)(1995-2#6)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#9)(2007-7#1)(2008-1#2)(2008-10#72)(2008-11#16)(2008-12#7)(2008-2#7)(2008-3#22)(2008-4#2)(2008-5#10)(2008-6#6)(2008-7#16)(2008-8#25)(2008-9#15)(2009-10#3)(2009-11#4)(2009-2#2)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#4)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#19)(2012-1#2)(2012-12#5)(2012-2#16)(2012-3#14)(2012-6#2)(2013-1#19)(2013-7#8)(2013-8#5)
Our review of##2##3##(2008-1#1)(2011-2#1)
Our review##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
Our sample##2##2##(2009-7#1)(2010-8#1)
Our search##2##2##(2008-12#1)(2009-5#1)
Our simulation##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
Our simulations##6##2##(2008-11#2)(2008-3#1)(2008-8#2)(2010-7#1)
Our strategy##2##2##(2007-8#1)(2012-12#1)
Our studies demonstrate that##4##4##(1993-8#1)(1994-8#1)(2008-11#1)(2011-2#1)
Our studies have##2##3##(1996-9#1)(2008-5#1)
Our studies indicate that the##2##5##(1997-8#1)(2008-10#1)
Our studies indicate that##3##4##(1997-8#1)(2008-10#1)(2008-5#1)
Our studies revealed that##2##4##(1993-12#1)(2012-3#1)
Our studies show that the##2##5##(2007-11#1)(2008-10#1)
Our studies show that##4##4##(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
Our studies showed that##3##4##(1992-8#1)(2008-5#1)(2008-7#1)
Our studies suggest that##4##4##(1991-12#1)(1996-12#1)(2008-10#1)(2008-7#1)
Our studies##32##2##(1991-12#2)(1991-9#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-7#4)(2008-9#1)(2011-2#2)(2012-3#1)
Our study also##5##3##(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)
Our study assessed##2##3##(2009-6#1)(2011-2#1)
Our study demonstrated that##3##4##(2009-3#1)(2011-2#1)(2013-8#1)
Our study demonstrated##4##3##(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
Our study demonstrates that##4##4##(1993-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Our study demonstrates##5##3##(1993-2#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
Our study differs from##2##4##(2008-10#1)(2008-11#1)
Our study enrolled##2##3##(2011-2#2)
Our study further##3##3##(2008-1#1)(2008-7#1)(2009-8#1)
Our study has##2##3##(1993-11#1)(1997-6#1)
Our study highlights##2##3##(2007-7#1)(2013-1#1)
Our study indicates that we can achieve a reduction in the incidence of acute intra-dialytic symptoms with the use of vitamin E-modified membrane as compared to cuprophane and polysulfone##2##29##(2007-7#1)(2008-1#1)
Our study indicates that##9##4##(1994-12#1)(1996-12#1)(2007-7#2)(2008-1#2)(2008-11#1)(2011-1#1)(2013-8#1)
Our study indicates##10##3##(1994-12#1)(1995-11#1)(1996-12#1)(2007-7#2)(2008-1#2)(2008-11#1)(2011-1#1)(2013-8#1)
Our study investigated##2##3##(2008-9#1)(2011-2#1)
Our study is##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
Our study provides##2##3##(2009-2#1)(2013-1#1)
Our study revealed that##2##4##(2008-3#1)(2012-3#1)
Our study revealed##3##3##(2008-3#1)(2010-12#1)(2012-3#1)
Our study reveals that the##3##5##(2008-3#1)(2012-12#1)(2012-2#1)
Our study reveals##5##3##(2007-12#1)(2008-3#1)(2012-12#1)(2012-2#2)
Our study showed that the##3##5##(2008-10#2)(2008-5#1)
Our study showed that##4##4##(2008-10#2)(2008-12#1)(2008-5#1)
Our study showed##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2012-6#1)
Our study shows that the##2##5##(2007-10#1)(2008-1#1)
Our study shows that##7##4##(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#2)(2012-2#1)
Our study shows##10##3##(2007-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#2)
Our study suggests that more##2##5##(2008-1#2)
Our study suggests that the##3##5##(2008-3#1)(2008-8#1)(2011-2#1)
Our study suggests that##21##4##(1990-2#1)(1993-9#1)(1995-8#1)(1996-2#1)(2007-7#3)(2008-1#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
Our study suggests##22##3##(1990-2#1)(1993-9#1)(1995-8#1)(1996-2#1)(2007-7#3)(2008-1#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
Our study##113##2##(1990-2#1)(1990-3#1)(1991-2#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#10)(2007-8#2)(2008-1#9)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2012-6#1)(2013-1#7)(2013-8#4)
Our technique##9##2##(2007-12#1)(2008-3#4)(2010-8#1)(2011-1#1)(2011-2#2)
Our theme is##2##3##(1996-2#1)(2008-11#1)
Our theoretical and##2##3##(2007-11#1)(2008-8#1)
Our theoretical##4##2##(1993-12#1)(2007-11#1)(2008-3#1)(2008-8#1)
Our two##4##2##(1990-2#1)(1991-5#1)(2007-8#1)(2008-9#1)
Our understanding of the##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
Our understanding of##5##3##(1997-5#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
Our understanding##6##2##(1992-9#1)(1997-5#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
Our work is##2##3##(2008-8#1)(2010-12#1)
Our work##15##2##(2007-7#1)(2008-2#1)(2008-8#1)(2009-8#2)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Our##1606##1##(1990-10#2)(1990-11#6)(1990-12#8)(1990-2#9)(1990-3#6)(1990-5#4)(1990-6#6)(1990-7#3)(1990-8#5)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#10)(1992-5#4)(1992-6#8)(1992-8#6)(1992-9#6)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#6)(1993-6#4)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#4)(1994-8#7)(1994-9#5)(1995-1#1)(1995-11#10)(1995-12#9)(1995-2#11)(1995-3#7)(1995-4#2)(1995-5#6)(1995-6#4)(1995-8#6)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#9)(1996-3#1)(1996-5#11)(1996-8#1)(1996-9#4)(1997-1#5)(1997-2#7)(1997-3#6)(1997-4#6)(1997-5#5)(1997-6#8)(1997-7#7)(1997-8#4)(2006-10#4)(2007-10#8)(2007-11#20)(2007-12#40)(2007-2#1)(2007-4#2)(2007-7#18)(2007-8#19)(2008-1#15)(2008-10#158)(2008-11#67)(2008-12#14)(2008-2#20)(2008-3#83)(2008-4#12)(2008-5#39)(2008-6#29)(2008-7#61)(2008-8#82)(2008-9#47)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#7)(2009-6#8)(2009-7#7)(2009-8#28)(2009-9#6)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#7)(2010-2#8)(2010-3#10)(2010-4#9)(2010-5#6)(2010-6#9)(2010-7#7)(2010-8#11)(2010-9#2)(2011-1#12)(2011-10#2)(2011-2#93)(2011-3#1)(2012-1#6)(2012-12#23)(2012-2#67)(2012-3#37)(2012-6#3)(2012-7#1)(2012-8#1)(2013-1#59)(2013-7#13)(2013-8#22)
Out of 30##2##3##(2007-7#1)(2008-5#1)
Out of 65##2##3##(1990-3#1)(2011-2#1)
Out of a total of##3##5##(1991-12#1)(1992-9#1)(2013-8#1)
Out of a##4##3##(1990-9#1)(1991-12#1)(1992-9#1)(2013-8#1)
Out of the total##3##4##(2008-10#1)(2013-8#2)
Out of the##26##3##(1990-12#2)(1990-6#2)(1991-3#1)(1991-6#1)(1993-12#1)(1996-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#4)
Out of these##4##3##(1990-8#1)(2007-7#1)(2011-1#2)
Out of##64##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-9#1)(1993-12#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#7)
Out##67##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#7)
Out-patient##2##1##(1991-6#1)(2011-2#1)
Outbreak of##6##2##(1995-3#1)(1995-9#1)(1996-8#1)(2007-12#1)(2008-4#1)(2012-3#1)
Outbreak##8##1##(1995-3#1)(1995-9#1)(1996-8#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Outbreaks of##4##2##(1990-3#1)(2007-12#1)(2008-10#1)(2009-5#1)
Outbreaks##7##1##(1990-3#1)(1992-6#1)(2007-12#2)(2007-2#1)(2008-10#1)(2009-5#1)
Outcome Measures##2##2##(2011-2#1)(2012-12#1)
Outcome Scale##3##2##(1997-3#1)(2012-3#1)(2013-8#1)
Outcome after##2##2##(1994-3#1)(2012-3#1)
Outcome and##3##2##(1997-2#1)(2008-6#1)(2008-7#1)
Outcome assessments and air ambulance services##2##6##(1996-6#2)
Outcome findings##2##2##(1996-3#2)
Outcome in##2##2##(2012-1#1)(2013-8#1)
Outcome is##2##2##(1996-11#1)(2012-2#1)
Outcome measurements included##2##3##(2007-12#1)(2010-9#1)
Outcome measures were implant##2##4##(2013-1#2)
Outcome measures were##5##3##(2008-6#2)(2013-1#3)
Outcome measures##15##2##(1992-2#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#5)
Outcome of##19##2##(1991-3#1)(1993-12#1)(1995-11#1)(1995-3#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
Outcome results of##2##3##(1991-12#1)(2012-1#1)
Outcome variables##3##2##(1994-3#1)(2008-12#1)(2013-1#1)
Outcome was##5##2##(1994-9#1)(2008-7#2)(2011-1#1)(2012-3#1)
Outcome##80##1##(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-3#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#2)
Outcomes &amp##4##2##(2012-3#4)
Outcomes and##3##2##(1997-2#1)(2008-11#1)(2012-1#1)
Outcomes assessment##2##2##(1996-3#2)
Outcomes in##4##2##(2007-8#1)(2008-7#1)(2009-4#1)(2013-7#1)
Outcomes management##2##2##(1991-12#1)(1997-1#1)
Outcomes of##10##2##(1991-1#1)(1991-2#1)(1993-3#1)(2008-10#1)(2010-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
Outcomes research##3##2##(1993-12#1)(1995-2#1)(1997-1#1)
Outcomes were assessed##2##3##(2008-12#1)(2013-1#1)
Outcomes were compared##2##3##(2010-10#1)(2012-2#1)
Outcomes were##5##2##(2007-10#1)(2008-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
Outcomes##65##1##(1991-1#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#2)(1996-3#2)(1997-1#2)(1997-2#2)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#1)(2009-4#1)(2010-10#2)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#2)
Outer Membrane##2##2##(2008-12#1)(2012-2#1)
Outer##3##1##(2008-1#1)(2008-12#1)(2012-2#1)
Outgrowth##2##1##(1997-3#1)(2008-11#1)
Outlier payments##2##2##(1991-3#1)(1997-1#1)
Outline of##2##2##(2008-11#1)(2013-1#1)
Outlook##5##1##(1991-1#1)(1992-3#1)(1993-3#2)(1997-6#1)
Outpatient Clinic##2##2##(2007-11#1)(2008-11#1)
Outpatient comparison of buprenorphine and methadone maintenance##2##7##(1991-1#2)
Outpatient management of fever in selected infants##3##7##(1994-3#3)
Outpatient management of##4##3##(1994-3#3)(2012-3#1)
Outpatient pulmonary rehabilitation##2##3##(2011-2#2)
Outpatient##21##1##(1991-1#2)(1991-6#2)(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#3)(1997-8#1)(2007-11#1)(2008-11#2)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
Outpatients##3##1##(1994-12#1)(2008-6#1)(2012-12#1)
Output Power##2##2##(2008-2#2)
Output from##2##2##(2008-3#1)(2008-8#1)
Output powers##3##2##(2007-12#2)(2008-2#1)
Output##15##1##(1991-12#1)(2007-12#5)(2008-2#6)(2008-3#2)(2008-8#1)
Outreach and##2##2##(2013-1#2)
Outreach##6##1##(1995-3#1)(2010-8#1)(2012-12#1)(2013-1#3)
Outside##4##1##(1994-8#1)(1996-12#1)(2008-10#1)(2009-12#1)
OvHV-2 in##2##2##(2011-1#2)
OvHV-2##3##1##(2011-1#3)
Ovarian Cancer##2##2##(2010-11#1)(2010-7#1)
Ovarian cancer is##2##3##(2012-3#1)(2013-8#1)
Ovarian cancer##5##2##(1995-9#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-8#1)
Ovarian##18##1##(1993-5#1)(1994-2#1)(1994-7#1)(1995-9#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-7#2)(2011-1#1)(2012-3#1)(2013-8#2)
Ovariectomy##2##1##(1993-5#1)(1995-12#1)
Ovariole##2##1##(2008-12#2)
Ovary##19##1##(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)
Over 1##2##2##(1996-3#1)(2011-2#1)
Over 100##2##2##(2008-6#1)(2012-12#1)
Over 3 years##2##3##(2008-10#2)
Over 3##3##2##(1993-2#1)(2008-10#2)
Over 40##4##2##(1990-6#1)(2008-5#1)(2008-7#1)(2013-8#1)
Over 80% of##2##3##(2008-10#1)(2011-2#1)
Over 80%##4##2##(1994-12#2)(2008-10#1)(2011-2#1)
Over a five year period##2##5##(2007-7#2)
Over a period of##9##4##(1991-6#1)(1995-3#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#1)
Over a range of##2##4##(2007-11#1)(2012-2#1)
Over a##26##2##(1990-12#1)(1991-6#1)(1992-1#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-7#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-2#2)(2012-3#1)
Over all##4##2##(2008-10#4)
Over half of##4##3##(2007-11#1)(2008-10#1)(2009-4#1)(2013-8#1)
Over half##5##2##(2007-11#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-8#1)
Over the counter (OTC)##2##4##(2008-7#2)
Over the course of the##3##5##(1993-3#1)(2008-10#2)
Over the course of##5##4##(1993-3#1)(2008-10#2)(2008-8#1)(2012-2#1)
Over the entire##2##3##(2007-12#1)(2008-8#1)
Over the last 20 years##2##5##(2008-10#1)(2008-4#1)
Over the last 25 years##3##5##(2007-10#1)(2008-3#1)(2012-3#1)
Over the last decade there has been##2##7##(2008-12#1)(2009-7#1)
Over the last decade##8##4##(1994-12#1)(2008-1#1)(2008-12#2)(2009-7#1)(2009-9#1)(2010-10#1)(2013-1#1)
Over the last few decades##2##5##(2008-5#1)(2012-2#1)
Over the last few years##3##5##(2008-1#1)(2010-8#1)(2013-1#1)
Over the last few##5##4##(2008-1#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
Over the last two decades##2##5##(2007-8#1)(2008-7#1)
Over the last##27##3##(1990-6#1)(1994-12#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
Over the next##2##3##(2008-11#1)(2013-8#1)
Over the past 10 years##2##5##(1997-1#1)(2008-11#1)
Over the past 20 years##3##5##(2007-8#1)(2008-7#1)(2009-9#1)
Over the past 20##4##4##(2007-8#1)(2008-7#1)(2008-8#1)(2009-9#1)
Over the past 30 years##2##5##(2008-11#1)(2010-11#1)
Over the past century##2##4##(1997-7#1)(2009-5#1)
Over the past decade there has been##2##7##(2007-12#1)(2008-11#1)
Over the past decade##17##4##(1992-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
Over the past few decades##2##5##(1994-5#1)(2008-11#1)
Over the past few years##6##5##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)
Over the past few##8##4##(1994-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
Over the past several years##5##5##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
Over the past several##6##4##(1992-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
Over the past three decades##3##5##(1996-2#1)(2009-9#1)(2010-8#1)
Over the past two decades##2##5##(2008-11#2)
Over the past two##3##4##(1991-2#1)(2008-11#2)
Over the past##60##3##(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-7#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#12)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#4)(2009-4#1)(2009-5#2)(2009-9#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)
Over the range##4##3##(2008-10#4)
Over the years##6##3##(1997-6#1)(2008-4#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
Over the##119##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#12)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#6)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
Over time##5##2##(1991-3#1)(1994-3#1)(2008-7#1)(2009-2#1)(2012-12#1)
Over##214##1##(1990-12#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#6)(2007-8#3)(2008-1#5)(2008-10#27)(2008-11#14)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#3)
Over-expression and purification of##2##4##(1990-5#1)(2008-4#1)
Over-expression of##4##2##(1996-12#1)(2008-11#2)(2010-10#1)
Over-expression##7##1##(1990-5#1)(1996-12#1)(2008-11#2)(2008-4#1)(2010-10#1)(2010-11#1)
Over-head traction##3##2##(2007-8#3)
Overall accuracy##2##2##(1992-11#1)(2008-5#1)
Overall and##2##2##(1991-12#1)(2008-6#1)
Overall mean##2##2##(2007-8#1)(2013-8#1)
Overall mortality was##4##3##(1996-3#1)(2007-8#1)(2008-7#1)(2011-2#1)
Overall prevalence of##2##3##(2007-12#1)(2008-11#1)
Overall recoveries##2##2##(2008-10#2)
Overall results##3##2##(1990-6#1)(1992-6#1)(2013-8#1)
Overall satisfaction##2##2##(1996-3#1)(2012-3#1)
Overall survival##2##2##(1997-3#1)(2008-7#1)
Overall the##2##2##(1995-11#1)(2013-1#1)
Overall##259##1##(1990-11#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#6)(1997-3#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#4)(2007-8#7)(2008-1#3)(2008-10#21)(2008-11#12)(2008-12#8)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#18)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#22)(2013-7#1)(2013-8#9)
Overcoming barriers##2##2##(1997-3#2)
Overcoming the##2##2##(1994-1#1)(2008-10#1)
Overcoming##12##1##(1992-1#1)(1992-12#1)(1994-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-10#1)(2013-1#1)
Overdose##3##1##(1992-2#1)(2008-11#1)(2010-1#1)
Overestimation of##3##2##(2007-12#2)(2009-7#1)
Overexpressed in##2##2##(2008-10#1)(2012-12#1)
Overexpressing##2##1##(2008-10#1)(2011-1#1)
Overexpression of a##2##3##(1993-3#1)(2008-10#1)
Overexpression of the##7##3##(1990-5#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
Overexpression of##34##2##(1990-5#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-6#2)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#4)(2011-10#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#1)
Overexpression##38##1##(1990-5#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#3)(1995-6#2)(1996-12#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#4)(2011-10#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#1)
Overhauser effect##4##2##(1993-11#2)(1993-3#1)(1994-5#1)
Overhauser##12##1##(1990-5#1)(1992-3#1)(1992-4#1)(1993-11#4)(1993-3#1)(1993-8#1)(1994-5#2)(2008-11#1)
Overlap##3##1##(1993-12#1)(2007-12#1)(2013-8#1)
Overlapping##9##1##(1990-5#1)(1992-10#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-3#1)
Overload##2##1##(2008-10#1)(2008-7#1)
Overnight##3##1##(2010-7#1)(2011-2#2)
Overproduction of the##3##3##(1991-10#1)(1995-8#1)(1997-7#1)
Overproduction of##5##2##(1991-10#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#1)
Overproduction##6##1##(1991-10#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#1)
Overseas training for doctors from developing countries##2##7##(1992-2#2)
Overseas##3##1##(1992-2#2)(2007-2#1)
Overshadowing##2##1##(2008-5#2)
Overtraining is##2##2##(1993-2#1)(2008-5#1)
Overview and##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
Overview of flow cytometry##2##4##(2008-4#1)(2008-9#1)
Overview of nucleic acid##2##4##(2008-4#1)(2008-9#1)
Overview of the##8##3##(2008-10#1)(2008-2#3)(2008-4#3)(2011-2#1)
Overview of##43##2##(1990-8#1)(1991-3#1)(1996-12#2)(1996-2#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#6)(2008-4#14)(2008-6#1)(2008-9#5)(2011-2#2)(2013-1#1)
Overview on##2##2##(2008-10#1)(2008-4#1)
Overview##50##1##(1990-8#1)(1991-3#1)(1996-12#2)(1996-2#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#1)(2008-4#15)(2008-6#1)(2008-7#1)(2008-9#5)(2011-2#2)(2012-2#1)(2013-1#2)
Overweight and obesity##2##3##(2011-2#1)(2012-2#1)
Overweight and##4##2##(2006-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
Overweight##9##1##(1990-9#1)(2006-10#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Overwintering of##3##2##(2008-10#3)
Overwintering##4##1##(2008-10#4)
Ovine##3##1##(1993-2#1)(2010-12#2)
Owensby##2##1##(1994-5#2)
Owing to its high sensitivity##2##5##(2008-10#1)(2008-3#1)
Owing to its high##4##4##(2008-10#2)(2008-3#1)(2009-12#1)
Owing to its##10##3##(1990-12#1)(1991-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#1)
Owing to the high##2##4##(1992-5#1)(2008-10#1)
Owing to the##23##3##(1992-5#1)(1995-2#1)(1995-8#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#3)(2012-2#2)(2013-1#2)
Owing to their##3##3##(1997-8#1)(2009-8#1)(2013-7#1)
Owing to##48##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-5#2)(1995-12#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#3)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-7#1)
Own experience##2##2##(2007-11#1)(2012-12#1)
Own##4##1##(2007-11#1)(2007-2#1)(2008-12#1)(2012-12#1)
Owners##2##1##(1992-11#1)(2012-12#1)
Ownership and##2##2##(1996-11#1)(1996-3#1)
Ownership##3##1##(1996-11#1)(1996-3#1)(2013-1#1)
Ox IgG1 Fab was##2##4##(1993-6#2)
Ox IgG1 Fab##3##3##(1993-6#3)
Ox IgG1##4##2##(1993-6#4)
Ox IgG3 Fab fragments##2##4##(1993-6#2)
Ox IgG3##4##2##(1993-6#4)
Ox##9##1##(1993-6#8)(2008-10#1)
Ox-LDL##4##1##(1990-8#4)
OxLDL##5##1##(1995-2#5)
Oxalate bioavailability##2##2##(2012-2#2)
Oxalate##10##1##(1991-11#1)(2008-10#5)(2012-2#4)
Oxaloacetate##2##1##(1993-6#2)
Oxamyl##2##1##(2008-10#2)
Oxford Handicap Scale score##2##4##(2007-10#2)
Oxford University Press##2##3##(1997-6#1)(2008-12#1)
Oxford University##3##2##(1993-12#1)(1997-6#1)(2008-12#1)
Oxford##16##1##(1992-5#1)(1993-12#1)(1994-2#2)(1996-1#1)(1997-6#2)(2007-10#3)(2007-11#1)(2007-2#1)(2008-12#2)(2008-2#1)(2011-2#1)
Oxfordshire Community Stroke##3##3##(2007-10#3)
Oxidants and##3##2##(1991-9#2)(2008-5#1)
Oxidants##4##1##(1991-9#3)(2008-5#1)
Oxidase in##2##2##(2008-10#2)
Oxidase##5##1##(2008-10#4)(2013-1#1)
Oxidation State##2##2##(1997-7#2)
Oxidation of low-density lipoprotein (LDL)##2##5##(1995-12#1)(1996-3#1)
Oxidation of the##2##3##(1996-5#2)
Oxidation of##14##2##(1992-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#2)(2008-10#3)(2008-4#1)(2009-8#1)(2010-6#1)(2013-1#1)
Oxidation##27##1##(1992-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#2)(1997-7#3)(2007-11#1)(2008-10#10)(2008-4#1)(2009-8#1)(2010-6#1)(2010-7#1)(2013-1#2)
Oxidative Modifications##2##2##(2009-8#2)
Oxidative Stress##5##2##(2008-10#1)(2008-7#1)(2013-1#2)(2013-8#1)
Oxidative damage##3##2##(1996-9#1)(2008-4#1)(2008-7#1)
Oxidative metabolism of##2##3##(1991-9#1)(1993-6#1)
Oxidative metabolism##3##2##(1991-9#1)(1993-6#1)(2008-9#1)
Oxidative status and##2##3##(2010-12#1)(2013-7#1)
Oxidative stress and##5##3##(2008-1#1)(2008-5#2)(2008-7#1)(2010-5#1)
Oxidative stress is##3##3##(2008-7#1)(2010-2#1)(2012-2#1)
Oxidative stress markers##2##3##(2009-6#1)(2010-5#1)
Oxidative stress##22##2##(1991-9#2)(2008-1#3)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-2#1)(2010-5#4)(2011-1#1)(2012-2#3)
Oxidative##57##1##(1991-12#2)(1991-5#2)(1991-9#4)(1993-11#1)(1993-6#1)(1994-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#2)(2009-6#1)(2009-8#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
Oxide##8##1##(1996-5#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-7#1)
Oxidized EGH##2##2##(1990-8#2)
Oxidized##4##1##(1990-8#3)(1996-2#1)
Oxonol V##2##2##(1990-12#2)
OxyContin##6##1##(2008-3#6)
Oxygen (DO)##2##2##(2008-12#1)(2010-4#1)
Oxygen binding to##2##3##(1990-8#1)(1997-2#1)
Oxygen binding##3##2##(1990-8#1)(1997-2#2)
Oxygen consumption##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
Oxygen free##2##2##(1991-9#1)(1996-9#1)
Oxygen is##2##2##(2008-10#1)(2008-8#1)
Oxygen therapy##2##2##(2008-8#1)(2013-1#1)
Oxygen uptake##4##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
Oxygen##38##1##(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-8#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-7#1)(2006-10#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Oxymizer pendant##3##2##(1992-11#3)
Oxymizer##4##1##(1992-11#4)
Oxytetracycline##2##1##(2008-12#1)(2013-8#1)
Oyster##2##1##(2008-10#1)(2010-8#1)
Ozer##4##1##(1995-12#4)
Ozone Monitoring##6##2##(2008-2#2)(2008-3#4)
Ozone and##2##2##(1994-3#1)(2008-3#1)
Ozone therapy - i##2##4##(2007-11#1)(2007-8#1)
Ozone therapy##3##2##(2007-11#1)(2007-8#1)(2012-2#1)
Ozone##25##1##(1991-6#1)(1992-3#2)(1994-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#10)(2012-2#2)
Ozonolysis of 3a-d##2##3##(1996-5#2)
Ozonolysis of the endo adducts##2##5##(1996-5#2)
Ozonolysis of the endo##3##4##(1996-5#3)
Ozonolysis of##6##2##(1996-5#5)(2007-11#1)
Ozonolysis##7##1##(1996-5#5)(2007-11#1)(2008-10#1)
P &gt##6##2##(1994-2#2)(1997-6#1)(2008-10#1)(2008-6#1)(2011-1#1)
P &lt##225##2##(1992-11#2)(1992-12#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#8)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#2)(1995-12#10)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#8)(1997-5#1)(1997-6#1)(1997-7#5)(2007-10#6)(2007-8#2)(2008-10#32)(2008-3#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-9#2)(2009-3#1)(2009-4#2)(2009-8#2)(2010-1#2)(2010-2#1)(2010-3#5)(2010-4#14)(2010-6#1)(2010-7#1)(2011-1#12)(2011-2#7)(2011-3#14)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#14)(2013-8#2)
P (P-gp)##2##2##(2008-11#2)
P = 0##130##3##(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(1997-5#3)(2007-10#3)(2007-8#1)(2008-10#34)(2008-3#8)(2008-4#3)(2008-7#8)(2008-9#1)(2009-11#2)(2010-1#5)(2010-8#2)(2011-1#14)(2011-2#4)(2012-12#2)(2012-3#9)(2013-1#11)(2013-8#8)
P = 1##4##3##(2008-10#1)(2012-3#3)
P = 2##2##3##(2010-2#1)(2012-3#1)
P =##183##2##(1990-2#2)(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(1997-5#3)(2007-10#16)(2007-8#1)(2008-10#36)(2008-12#1)(2008-3#8)(2008-4#3)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-8#8)(2010-1#5)(2010-12#1)(2010-2#2)(2010-4#8)(2010-8#2)(2011-1#14)(2011-2#4)(2012-12#2)(2012-3#15)(2013-1#18)(2013-8#8)
P PO(4)(3-)l(-1)##3##2##(2008-10#3)
P and F##2##3##(2008-10#1)(2010-3#1)
P and K##3##3##(2008-12#3)
P and N neurons on capsules##2##6##(1997-3#2)
P and N##3##3##(1997-3#2)(2010-2#1)
P and##24##2##(1990-2#1)(1992-3#2)(1993-12#1)(1993-8#1)(1995-8#1)(1997-3#2)(2007-11#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-2#2)(2010-3#1)(2010-7#2)
P component##2##2##(2008-10#1)(2010-12#1)
P compounds##2##2##(2008-10#2)
P concentration##2##2##(1994-9#1)(2008-9#1)
P concentrations##4##2##(1995-8#1)(2008-12#2)(2011-10#1)
P cuadrijuga##5##2##(2013-7#5)
P digestibility##3##2##(2010-2#3)
P dominance##2##2##(1995-11#2)
P excretion##3##2##(2010-2#3)
P falciparum##2##2##(1991-5#2)
P ferox##4##2##(2013-7#4)
P for##2##2##(2008-3#1)(2009-7#1)
P from##3##2##(1993-11#1)(2010-2#1)(2011-1#1)
P have##2##2##(2008-7#1)(2009-10#1)
P in the##3##3##(1993-11#1)(2008-10#1)(2009-11#1)
P in##7##2##(1993-11#2)(1994-8#1)(1995-12#1)(2008-10#1)(2008-5#1)(2009-11#1)
P is the##2##3##(2007-12#1)(2008-10#1)
P is##6##2##(1991-9#1)(1995-6#1)(2007-12#1)(2008-10#1)(2009-10#1)(2013-1#1)
P less than 0##14##4##(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#6)(1991-5#2)(1992-5#1)
P nitens##4##2##(2013-7#4)
P of##2##2##(2008-10#1)(2008-5#1)
P or##3##2##(1991-12#1)(1994-8#1)(1995-6#1)
P ratio##3##2##(2008-5#1)(2008-9#2)
P resorption##2##2##(2008-12#2)
P rich##2##2##(2008-5#1)(2008-9#1)
P strains in##2##3##(2008-10#2)
P stress##2##2##(2011-10#2)
P supply##3##2##(2008-5#2)(2008-8#1)
P value &lt##3##3##(1995-12#1)(2008-7#1)(2013-1#1)
P value##7##2##(1995-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
P was##6##2##(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
P wave##2##2##(2011-1#1)(2012-12#1)
P were##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
P##2010##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#11)(1990-5#3)(1990-7#3)(1990-8#2)(1991-12#8)(1991-2#8)(1991-3#2)(1991-5#5)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#8)(1992-4#1)(1992-5#5)(1992-6#5)(1992-8#2)(1992-9#4)(1993-11#17)(1993-12#4)(1993-2#2)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#10)(1994-2#5)(1994-3#6)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#13)(1994-9#3)(1995-11#6)(1995-12#17)(1995-2#14)(1995-3#5)(1995-5#7)(1995-6#13)(1995-8#12)(1996-10#1)(1996-12#5)(1996-2#2)(1996-5#4)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#8)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#1)(2007-10#22)(2007-11#2)(2007-12#4)(2007-2#7)(2007-3#2)(2007-5#2)(2007-7#11)(2007-8#9)(2008-10#1024)(2008-11#5)(2008-12#45)(2008-2#2)(2008-3#19)(2008-4#13)(2008-5#63)(2008-6#14)(2008-7#34)(2008-8#13)(2008-9#12)(2009-10#4)(2009-11#3)(2009-2#6)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#7)(2009-7#1)(2009-8#11)(2009-9#3)(2010-1#8)(2010-10#1)(2010-12#4)(2010-2#20)(2010-3#21)(2010-4#33)(2010-5#3)(2010-6#2)(2010-7#9)(2010-8#7)(2011-1#45)(2011-10#5)(2011-2#48)(2011-3#14)(2011-6#1)(2012-1#6)(2012-12#19)(2012-2#15)(2012-3#36)(2012-7#1)(2013-1#50)(2013-7#16)(2013-8#18)
P&amp##7##1##(1992-6#1)(1996-2#4)(1997-7#2)
P&gt##3##1##(2008-10#2)(2008-9#1)
P&lt##60##1##(1993-9#1)(1995-12#1)(2007-8#8)(2008-10#13)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#21)(2008-8#4)(2008-9#2)(2009-4#1)(2009-5#1)(2013-1#2)
P(+)-ion implantation##2##2##(2007-12#2)
P(+III)##8##1##(2008-10#8)
P(0)##2##1##(2008-10#2)
P(1##2##1##(2008-10#2)
P(1)##5##1##(2007-11#2)(2008-10#3)
P(12)##2##1##(2007-12#2)
P(2)##3##1##(2008-10#3)
P(2)O(5) in##2##2##(2008-10#1)(2008-5#1)
P(2)O(5)##4##1##(2008-10#3)(2008-5#1)
P(2)O(7)(4-) and##2##2##(2008-10#2)
P(54)##2##1##(2008-3#2)
P(870)##2##1##(2008-8#2)
P(?)##3##1##(2008-2#3)
P(HEMA##2##1##(2008-3#2)
P(III)##3##1##(2008-4#2)(2009-9#1)
P(N)##4##1##(2012-7#4)
P(ST)##2##1##(2012-3#1)(2013-1#1)
P(V)##8##1##(2008-10#6)(2008-11#2)
P(app) (A --&gt##2##3##(2011-3#2)
P(app)##3##1##(2011-3#3)
P(crit) and##2##2##(2013-1#2)
P(crit)##5##1##(2013-1#5)
P(z)##2##1##(2008-10#2)
P)##14##1##(1991-9#1)(1992-3#1)(1992-9#1)(1996-1#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-8#1)(2012-2#1)
P- and##2##2##(1997-3#1)(2009-8#1)
P- or Q-type##2##3##(1996-5#2)
P-##7##1##(1993-11#1)(1994-8#1)(1996-5#2)(1997-3#1)(2008-5#1)(2009-8#1)
P-2##2##1##(2008-10#2)
P-20##3##1##(2010-10#3)
P-2245 and PV-61##3##3##(2008-10#3)
P-2245##6##1##(2008-10#6)
P-4##2##1##(1991-12#1)(1993-11#1)
P-450 and##3##2##(1990-11#1)(1990-5#1)(2009-8#1)
P-450 dependent##2##2##(1990-7#2)
P-450 reductase##5##2##(1991-5#1)(1993-6#2)(1995-8#1)(2008-11#1)
P-450##45##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#9)(1991-5#3)(1991-9#1)(1992-11#6)(1992-3#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-8#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)
P-450(11 beta)##7##2##(1990-5#7)
P-450(11)beta##2##1##(1990-11#2)
P-450(14)DM##4##1##(1992-3#4)
P-450C21##10##1##(1993-11#10)
P-450LDM##2##1##(2008-5#2)
P-450aldo##4##1##(1990-11#4)
P-450arom##9##1##(1995-8#9)
P-60##4##1##(1990-5#1)(1992-3#1)(1992-9#1)(1997-6#1)
P-CARS##2##1##(2007-12#2)
P-HA##2##1##(2008-10#2)
P-R interval##6##2##(1994-5#3)(1994-6#3)
P-SG64 was##2##2##(1994-11#2)
P-SG64##5##1##(1994-11#5)
P-SG67##2##1##(1994-11#2)
P-T-Q index##3##2##(1994-6#3)
P-cadherin##2##1##(1991-5#1)(2012-12#1)
P-dependent##2##1##(1995-11#2)
P-diastereomers##2##1##(2008-4#2)
P-dominant##2##1##(1995-11#2)
P-element##3##1##(2007-12#1)(2008-9#1)(2013-1#1)
P-glycoprotein (P-gp)##2##2##(2008-7#1)(2012-3#1)
P-glycoprotein expression##3##2##(1995-11#2)(2008-11#1)
P-glycoprotein is a##2##3##(2008-11#2)
P-glycoprotein is##3##2##(2008-11#3)
P-glycoprotein on the##3##3##(2008-10#1)(2011-3#2)
P-glycoprotein##50##1##(1992-12#2)(1993-8#1)(1994-5#1)(1995-11#8)(1997-4#1)(2007-2#2)(2008-10#2)(2008-11#25)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#2)
P-glycoproteins##4##1##(1994-12#1)(2008-11#3)
P-gp and CYP3A##2##3##(2011-3#2)
P-gp and##4##2##(2007-2#1)(2008-8#1)(2011-3#2)
P-gp substrates##2##2##(2008-11#1)(2008-7#1)
P-gp##22##1##(2007-2#4)(2008-11#6)(2008-7#2)(2008-8#1)(2011-2#1)(2011-3#5)(2012-3#3)
P-gp+ phenotype##2##2##(2007-2#2)
P-gp+##4##1##(2007-2#4)
P-like##2##1##(1993-11#1)(1997-2#1)
P-selectin and##2##2##(1997-7#1)(2006-6#1)
P-selectin##14##1##(1993-8#1)(1997-7#3)(2006-6#4)(2008-1#1)(2008-4#1)(2008-9#2)(2011-2#2)
P-side Schiff base intermediate##2##4##(1992-3#2)
P-side##3##1##(1992-3#3)
P-type##6##1##(1990-12#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(2013-8#1)
P/A/M##2##1##(2008-7#2)
P/D##6##1##(2008-2#6)
P1 (P1)##2##2##(1997-8#1)(2008-10#1)
P1 and P2 protamines##2##4##(1994-6#2)
P1 and P2##5##3##(1992-9#1)(1994-6#3)(2008-9#1)
P1 and##8##2##(1992-9#1)(1994-6#3)(1996-8#1)(2008-10#2)(2008-9#1)
P1 clones and##2##3##(1996-2#2)
P1 clones##8##2##(1996-2#2)(1997-6#2)(1997-8#4)
P1 conidia##5##2##(2008-10#5)
P1 downstream sequence##2##3##(2008-9#2)
P1 expression##2##2##(2008-9#2)
P1 from##2##2##(1992-6#2)
P1 is the##2##3##(1992-9#1)(1996-12#1)
P1 protein##2##2##(2008-10#2)
P1 receptor##3##2##(1994-11#1)(1994-6#1)(2008-2#1)
P1 region##3##2##(2008-10#1)(2008-8#2)
P1 residue##2##2##(1994-6#2)
P1##92##1##(1991-5#1)(1992-6#7)(1992-9#4)(1993-12#4)(1994-11#2)(1994-5#2)(1994-6#7)(1995-6#2)(1996-12#3)(1996-2#3)(1996-8#1)(1997-6#3)(1997-8#6)(2007-12#5)(2008-10#20)(2008-2#3)(2008-4#2)(2008-8#5)(2008-9#7)(2011-2#2)(2012-3#2)(2013-8#1)
P1'##2##1##(1992-8#1)(1994-6#1)
P1- and P3-450 RNA levels##2##5##(1990-3#2)
P1-##3##1##(1990-3#3)
P1-derived artificial chromosome##2##3##(1997-8#1)(2008-8#1)
P1-mediated fluorescence postlabeling##2##3##(1991-5#2)
P1-mediated##3##1##(1991-5#2)(1995-8#1)
P1/P7##3##1##(2008-10#3)
P10##2##1##(1996-5#1)(2012-12#1)
P11##5##1##(2008-2#2)(2008-3#3)
P12##2##1##(2008-3#2)
P130##2##1##(1993-11#2)
P130A##2##1##(2008-10#2)
P130A)##2##1##(2008-10#2)
P14##2##1##(1996-5#1)(1997-2#1)
P19 cells to##2##3##(1990-11#1)(1994-11#1)
P19 cells##7##2##(1990-11#2)(1992-12#2)(1994-11#3)
P19 embryonal carcinoma cells##3##4##(1992-12#2)(1995-2#1)
P19 teratocarcinoma cells##3##3##(1994-11#3)
P19##16##1##(1990-11#2)(1991-2#1)(1992-12#5)(1994-11#6)(1995-2#1)(2011-2#1)
P2 Tin protein##5##3##(1997-3#5)
P2 and P3##4##3##(1995-8#2)(2008-8#1)(2013-8#1)
P2 and P4##2##3##(1990-11#2)
P2 and adenosine receptor##2##4##(2008-4#2)
P2 and##8##2##(1990-11#2)(1995-8#2)(2008-4#2)(2008-8#1)(2013-8#1)
P2 is##3##2##(1992-9#1)(1995-12#2)
P2 nucleotide##3##2##(2008-4#3)
P2 operon##4##2##(1995-8#4)
P2 protein##3##2##(1995-12#3)
P2 purinergic agonists##2##3##(1995-11#2)
P2 purinergic##3##2##(1995-11#2)(2008-4#1)
P2 purinoceptor stimulation##2##3##(1990-7#2)
P2 purinoceptor##4##2##(1990-7#2)(1995-11#2)
P2 receptor agonist##2##3##(2008-2#1)(2008-4#1)
P2 receptor##9##2##(1993-8#1)(1995-8#1)(2008-2#1)(2008-4#5)(2013-8#1)
P2 receptor-mediated##3##2##(2008-4#2)(2013-8#1)
P2 receptors and##3##3##(2008-4#3)
P2 receptors in atherosclerosis and postangioplasty restenosis##2##7##(2008-4#2)
P2 receptors in##5##3##(2008-4#5)
P2 receptors mediate many other functions##2##6##(2008-4#2)
P2 receptors##24##2##(1995-8#1)(2008-4#23)
P2##103##1##(1990-11#4)(1990-2#1)(1990-7#3)(1990-8#1)(1992-9#3)(1993-8#1)(1994-6#6)(1995-11#4)(1995-12#6)(1995-8#11)(1996-12#1)(1997-2#1)(1997-3#7)(2008-11#5)(2008-2#2)(2008-4#37)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
P2(1)##2##1##(2008-8#1)(2013-1#1)
P2(1)/c (No##3##2##(1996-2#2)(1997-7#1)
P2(1)/c##13##1##(1996-2#10)(1997-7#2)(2007-11#1)
P2(1)/n (No##2##2##(1996-2#1)(1997-7#1)
P2(1)/n##10##1##(1996-2#5)(1996-5#1)(1997-7#4)
P2(1)2(1)2(1)##3##1##(1996-2#2)(2008-9#1)
P2000##3##1##(2008-3#3)
P21##6##1##(1996-5#3)(2008-10#2)(2012-12#1)
P21W##3##1##(2008-3#3)
P22##7##1##(2008-3#2)(2008-4#1)(2009-5#4)
P25##3##1##(2008-10#1)(2012-2#1)(2013-1#1)
P256 induced##2##2##(1990-5#2)
P256##6##1##(1990-5#6)
P29 and 'Abe'##2##3##(2008-10#2)
P29 and T##2##3##(2008-10#2)
P29 and##4##2##(2008-10#4)
P29 was##2##2##(2008-10#2)
P29##15##1##(2008-10#13)(2008-5#2)
P2O##3##1##(2008-6#3)
P2O5##2##1##(2008-12#2)
P2X and##3##2##(2008-4#3)
P2X purinergic pathways##2##3##(2008-4#2)
P2X purinoceptors##2##2##(1995-12#1)(2008-7#1)
P2X receptor##3##2##(2008-4#3)
P2X receptor-mediated purinergic sensory pathways to##2##6##(2008-4#2)
P2X receptor-mediated##3##2##(2008-4#3)
P2X receptors are##4##3##(2008-4#4)
P2X receptors##13##2##(2008-4#13)
P2X##29##1##(1995-12#1)(2008-4#26)(2008-7#1)(2009-12#1)
P2X(2)##2##1##(2008-4#2)
P2X(3) and##3##2##(2008-4#3)
P2X(3)##7##1##(2008-4#3)(2009-12#4)
P2X(3)-expressing##2##1##(2009-12#2)
P2X(4) receptors##4##2##(2008-4#4)
P2X(4)##7##1##(2008-4#7)
P2X(5) and P2X(7) receptors##4##4##(2008-4#4)
P2X(5) and P2X(7)##5##3##(2008-4#5)
P2X(5) receptors##2##2##(2008-4#2)
P2X(5)##8##1##(2008-4#8)
P2X(7) nucleotide##2##2##(2008-4#2)
P2X(7) receptor##2##2##(2008-4#2)
P2X(7)##14##1##(2008-4#14)
P2X(7)R##4##1##(2008-4#4)
P2X/Y receptors##2##2##(2008-4#2)
P2X7##2##1##(2008-4#1)(2008-5#1)
P2Y (12)##2##2##(2008-4#2)
P2Y nucleotide receptors##2##3##(2008-4#2)
P2Y purinoceptor##2##2##(1995-11#1)(1995-12#1)
P2Y receptor subtypes##2##3##(2008-4#2)
P2Y receptor##9##2##(2008-4#9)
P2Y receptors and##2##3##(2008-4#2)
P2Y receptors are##2##3##(2008-4#2)
P2Y receptors##25##2##(2008-4#24)(2009-3#1)
P2Y##52##1##(1995-11#2)(1995-12#2)(2008-4#46)(2009-3#1)(2013-1#1)
P2Y(1) and P2Y(12) receptor##3##4##(2008-4#3)
P2Y(1) and P2Y(12)##4##3##(2008-4#4)
P2Y(1) and P2Y(2)##2##3##(2008-4#2)
P2Y(1) and the##2##3##(2008-4#2)
P2Y(1) and##8##2##(2008-4#8)
P2Y(1) receptor and the##2##4##(2008-4#1)(2008-7#1)
P2Y(1) receptor is involved in##2##5##(2008-4#2)
P2Y(1) receptor is##3##3##(2008-4#3)
P2Y(1) receptor was##2##3##(2008-4#2)
P2Y(1) receptor##20##2##(2008-4#19)(2008-7#1)
P2Y(1) receptors##5##2##(2008-4#5)
P2Y(1)##43##1##(2008-4#42)(2008-7#1)
P2Y(1)-/- mice exhibited a##2##4##(2008-4#2)
P2Y(1)-/- mice##4##2##(2008-4#4)
P2Y(12) and##2##2##(2008-4#2)
P2Y(12) receptor##8##2##(2008-4#8)
P2Y(12)##18##1##(2008-4#18)
P2Y(13)-like receptors##2##2##(2008-4#2)
P2Y(15)##3##1##(2008-4#3)
P2Y(2) and##3##2##(2008-4#3)
P2Y(2) receptor##4##2##(2008-4#4)
P2Y(2) receptors##6##2##(2008-4#6)
P2Y(2)##15##1##(2008-4#15)
P2Y(4)##4##1##(2008-4#4)
P2Y(6)##4##1##(2008-4#4)
P2Y1##3##1##(1995-11#1)(2008-5#1)(2013-1#1)
P2Y2 receptors in NHEKs##2##4##(2008-4#2)
P2Y2 receptors##3##2##(2008-4#3)
P2Y2##6##1##(2008-4#6)
P3 and##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
P3##28##1##(1994-5#3)(1995-5#1)(1995-8#3)(2008-10#8)(2008-6#1)(2008-8#5)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
P3'##2##1##(1992-8#1)(1994-6#1)
P3)##3##1##(1996-12#1)(2008-10#1)(2012-3#1)
P3-450 RNA levels##3##3##(1990-3#3)
P3-450##4##1##(1990-3#4)
P3-6H##2##1##(2008-10#2)
P3-X63-Ag8-653##4##1##(2008-11#4)
P3/P4##2##1##(1994-3#2)
P300##6##1##(1991-1#1)(2008-11#3)(2008-7#2)
P327 and##3##2##(2008-10#3)
P327##4##1##(2008-10#4)
P35X##3##1##(1994-12#3)
P36##3##1##(1994-11#3)
P37##8##1##(1997-7#1)(2006-6#7)
P388 leukemia cells##6##3##(1990-6#1)(1991-12#3)(1991-4#2)
P388 leukemia##7##2##(1990-6#1)(1991-12#3)(1991-4#2)(1992-5#1)
P388/ADR##2##1##(1991-12#2)
P388/Adr cells##3##2##(1991-4#3)
P388/Adr##4##1##(1991-4#4)
P388/S cells##2##2##(1991-4#2)
P388/S##4##1##(1991-12#1)(1991-4#3)
P4 and##3##2##(1996-5#1)(2008-5#2)
P4 cos##2##2##(1990-11#2)
P4 medicine will##2##3##(2013-8#2)
P4 medicine##3##2##(2013-8#3)
P4##16##1##(1990-11#3)(1996-5#3)(2008-10#1)(2008-5#5)(2008-6#1)(2013-8#3)
P4)##2##1##(2008-10#1)(2011-2#1)
P40##5##1##(1997-7#2)(2006-6#3)
P426L##2##1##(1997-3#2)
P450 3A4##5##2##(2008-10#2)(2008-3#1)(2012-3#2)
P450 4A4##5##2##(1993-8#5)
P450 active site##2##3##(1994-5#2)
P450 enzyme system##3##3##(2009-9#3)
P450 enzyme##6##2##(2008-10#1)(2009-9#4)(2012-12#1)
P450 enzymes##4##2##(1994-5#1)(2009-9#3)
P450 families##2##2##(2009-9#2)
P450 forms##5##2##(1994-8#5)
P450 gene##2##2##(1990-11#1)(1991-9#1)
P450 in##2##2##(1992-8#1)(1994-6#1)
P450 monooxygenases##4##2##(1991-2#1)(1991-5#1)(2009-9#2)
P450 oxidoreductase##5##2##(1994-8#2)(2008-4#1)(2009-9#2)
P450 reductase in##3##3##(1991-5#2)(1994-8#1)
P450 reductase##14##2##(1991-5#2)(1994-8#7)(1994-9#1)(1995-6#2)(1996-3#2)
P450 residues##2##2##(1994-6#2)
P450 was##2##2##(1995-11#1)(2008-7#1)
P450##138##1##(1990-11#1)(1990-5#4)(1991-2#4)(1991-5#5)(1991-9#3)(1992-11#1)(1992-8#6)(1993-11#2)(1993-6#6)(1993-8#5)(1994-11#1)(1994-5#4)(1994-6#10)(1994-8#19)(1994-9#2)(1995-11#2)(1995-3#4)(1995-5#1)(1995-6#5)(1996-12#2)(1996-3#3)(2007-11#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-4#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-7#1)(2009-9#17)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
P450(11beta)-related##2##1##(2008-4#2)
P450(14DM)##3##1##(1994-6#3)
P4501A1 (CYP1A1)##2##2##(1994-6#1)(2008-11#1)
P4501A1##4##1##(1994-6#2)(1994-8#1)(2008-11#1)
P4502B4 (LM2)##2##2##(1992-8#2)
P450BM-3##3##1##(1994-9#3)
P450IIIA##2##1##(1991-5#2)
P450SCC##4##1##(1997-2#4)
P450c17##4##1##(2008-4#4)
P450cam##16##1##(1992-11#3)(1992-8#1)(1993-8#4)(1994-6#8)
P450s##19##1##(1991-2#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-5#4)(1997-7#1)(2008-7#1)(2008-9#6)(2009-8#1)(2009-9#1)
P450scc##2##1##(1996-5#1)(2008-10#1)
P450sccK201E##3##1##(2008-10#3)
P46##2##1##(2008-10#2)
P4P##5##1##(2008-4#4)(2008-6#1)
P5 readthrough protein##2##3##(2008-10#2)
P5##5##1##(1994-5#1)(2008-10#3)(2008-3#1)
P50 in transgenic plants was##2##5##(2008-10#2)
P50 plants inoculated with##2##4##(2008-10#2)
P50##10##1##(1994-12#1)(2008-10#7)(2011-1#2)
P53##7##1##(1992-3#1)(1993-8#1)(2008-9#2)(2011-2#1)(2012-1#2)
P556##3##1##(2008-2#3)
P59##2##1##(1993-8#2)
P7 and##2##2##(1996-5#2)
P7##4##1##(1996-5#3)(2008-8#1)
P77PMC##3##1##(2008-8#3)
P8##2##1##(2008-8#2)
P85 alpha##2##2##(1995-6#2)
P85##3##1##(1995-6#2)(2013-1#1)
P89##5##1##(2008-10#5)
P95-2##3##1##(1997-7#1)(2006-6#2)
P97 and##2##2##(1997-7#1)(2006-6#1)
P= 0##3##2##(1997-7#3)
P=##8##1##(1997-7#3)(2008-8#2)(2010-6#2)(2011-2#1)
P=0##33##1##(1993-9#1)(1997-7#1)(2007-2#2)(2007-8#11)(2008-10#6)(2008-12#2)(2008-7#1)(2009-4#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
P=95%)##2##1##(2008-10#2)
PA and NA are##2##4##(2008-11#2)
PA and NA##3##3##(2008-11#3)
PA and##8##2##(2007-12#1)(2008-10#1)(2008-11#3)(2008-8#2)(2012-2#1)
PA in##2##2##(2008-10#1)(2013-1#1)
PA is##2##2##(2008-10#1)(2012-2#1)
PA system##3##2##(2008-10#3)
PA was##3##2##(2007-12#1)(2008-12#1)(2009-3#1)
PA were##2##2##(1992-12#1)(2008-10#1)
PA##65##1##(1992-12#1)(1992-2#1)(1995-8#2)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#4)(2009-11#1)(2009-3#3)(2009-6#3)(2010-1#1)(2011-1#1)(2011-2#4)(2012-2#8)(2013-1#3)
PA)##2##1##(1995-1#1)(2013-1#1)
PA-BJ##9##1##(1995-5#9)
PA-d(31) molecules##2##2##(2008-10#2)
PA-d(31)##5##1##(2008-10#5)
PA1994##2##1##(2010-10#2)
PA5185##3##1##(2009-11#3)
PAA complexes##2##2##(2008-10#2)
PAA grafted cellulose membrane##3##4##(2008-10#3)
PAA##11##1##(1991-1#1)(2008-10#9)(2009-12#1)
PAAs will##2##2##(1991-1#2)
PAAs##6##1##(1991-1#5)(2008-10#1)
PABA (Cas RN##4##3##(2008-5#4)
PABA (Cas##5##2##(2008-5#5)
PABA and##2##2##(1992-11#1)(2008-5#1)
PABA##10##1##(1992-11#2)(2008-5#8)
PABzt##2##1##(2008-10#2)
PAC in##2##2##(2008-10#1)(2008-11#1)
PAC spectra##2##2##(1995-5#2)
PAC##11##1##(1990-12#1)(1995-5#2)(1997-8#1)(2008-10#4)(2008-11#2)(2010-12#1)
PAC579##2##1##(2008-8#2)
PACAP precursor##2##2##(1990-12#2)
PACAP##18##1##(1990-12#8)(1995-11#9)(2013-8#1)
PACAP27##3##1##(1990-7#3)
PACAP38##3##1##(1990-7#3)
PACE##6##1##(1992-1#2)(2008-7#4)
PACNS##4##1##(2012-3#4)
PACS and teleradiology##2##3##(1997-8#1)(2012-2#1)
PACS and##4##2##(1996-2#2)(1997-8#1)(2012-2#1)
PACS requires##2##2##(1997-8#1)(2008-7#1)
PACS##31##1##(1996-2#15)(1997-8#3)(2007-4#1)(2008-7#9)(2012-2#3)
PACT III##2##2##(2013-1#2)
PACT##5##1##(2008-5#1)(2013-1#4)
PACs##3##1##(1990-4#1)(2008-10#2)
PAD and AAC##2##3##(2008-10#2)
PAD and##4##2##(2008-10#3)(2008-8#1)
PAD is##2##2##(2008-8#2)
PAD response to##2##3##(2008-10#2)
PAD was##3##2##(2008-8#3)
PAD waveform##3##2##(2008-10#3)
PAD##25##1##(1995-2#1)(2008-10#14)(2008-8#10)
PADGEM)##2##1##(1991-12#2)
PADPRP##5##1##(1991-12#5)
PAEC by##2##2##(2008-8#2)
PAEC##5##1##(2008-8#5)
PAEE##3##1##(2013-1#3)
PAEP##2##1##(1993-2#2)
PAF acetylhydrolase activity##2##3##(1997-7#2)
PAF acetylhydrolase##3##2##(1997-7#3)
PAF binding##5##2##(2008-3#5)
PAF receptor gene expression##2##4##(1991-12#2)
PAF receptor##5##2##(1991-12#4)(2008-11#1)
PAF responsiveness##2##2##(1991-12#2)
PAF##31##1##(1991-12#6)(1991-5#2)(1992-3#1)(1994-9#2)(1997-7#3)(2008-11#2)(2008-3#8)(2009-3#3)(2012-3#2)(2013-1#2)
PAGE##13##1##(1990-11#2)(1992-6#1)(1992-8#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-2#2)
PAGE)##2##1##(1992-6#1)(2008-11#1)
PAGE-SDS##2##1##(2012-2#2)
PAH abundance and distribution##2##4##(2008-10#2)
PAH and other mutagenic PAC##2##5##(2008-11#2)
PAH are##2##2##(2008-10#1)(2010-10#1)
PAH in##3##2##(2008-10#2)(2010-10#1)
PAH screening##2##2##(2008-10#2)
PAH##46##1##(1995-11#3)(2008-10#18)(2008-11#4)(2009-10#3)(2010-10#13)(2010-5#1)(2011-1#3)(2013-1#1)
PAH-CHD##5##1##(2010-10#5)
PAHs and the##3##3##(2008-10#3)
PAHs by##2##2##(2008-10#2)
PAHs in the aerosols##2##4##(2008-10#2)
PAHs in##13##2##(2008-10#11)(2008-11#1)(2010-5#1)
PAHs on##2##2##(2008-10#2)
PAHs recoveries##2##2##(2008-10#2)
PAHs tested##2##2##(2008-10#2)
PAHs was##4##2##(2008-10#4)
PAHs were##7##2##(2008-10#5)(2010-5#2)
PAHs with##4##2##(2008-10#4)
PAHs##85##1##(1995-9#1)(1997-4#1)(2008-10#68)(2008-11#6)(2008-7#1)(2010-5#7)(2011-1#1)
PAI synthase##2##2##(1995-2#2)
PAI##14##1##(1990-8#1)(1995-2#10)(2008-10#2)(2008-3#1)
PAI-1 and##3##2##(1995-8#2)(2011-2#1)
PAI-1 antisense ODN##3##3##(2011-2#3)
PAI-1 antisense##4##2##(2011-2#4)
PAI-1 cDNA##3##2##(2008-4#3)
PAI-1 is##2##2##(1993-12#1)(2008-3#1)
PAI-1 protein##3##2##(1994-9#2)(2008-4#1)
PAI-1##35##1##(1993-12#2)(1994-9#8)(1995-8#7)(2008-3#1)(2008-4#7)(2011-2#7)(2012-2#1)(2013-1#2)
PAIN##2##1##(2008-3#2)
PAK##3##1##(1995-2#1)(2008-10#1)(2012-12#1)
PAL activity##2##2##(2008-10#2)
PAL##6##1##(1995-5#1)(2008-10#5)
PALA-liganded##2##1##(1990-8#2)
PALS##2##1##(2008-3#2)
PAM and##2##2##(1993-5#1)(2008-9#1)
PAM is##3##2##(2008-7#3)
PAM##27##1##(1993-5#3)(1993-8#4)(1994-11#3)(1996-3#1)(2008-10#1)(2008-7#10)(2008-9#3)(2012-12#2)
PAMAM dendrimers##2##2##(2010-8#2)
PAMAM##5##1##(2010-12#1)(2010-8#4)
PAN##10##1##(2006-10#1)(2008-10#9)
PAN-treated rats##2##2##(2009-6#2)
PAN-treated##4##1##(2009-6#4)
PANDAS##2##1##(2011-2#2)
PANI film was##2##3##(2008-10#2)
PANI film##4##2##(2008-10#4)
PANI##9##1##(2008-10#9)
PANSS##3##1##(2008-12#2)(2008-6#1)
PANZEA is##3##2##(2008-7#3)
PANZEA##4##1##(2008-7#4)
PAO##5##1##(1993-6#5)
PAO1##2##1##(2009-11#2)
PAOM is##2##2##(2011-7#2)
PAOM##3##1##(2011-7#3)
PAP can##2##2##(2008-10#2)
PAP in##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
PAP was##2##2##(1990-9#1)(2008-12#1)
PAP##29##1##(1990-11#1)(1990-9#2)(1995-11#1)(2008-10#9)(2008-11#7)(2008-12#5)(2008-2#1)(2009-1#2)(2010-7#1)
PAPER##2##1##(2008-10#1)(2010-12#1)
PAPS##7##1##(1991-12#4)(2008-10#2)(2008-8#1)
PAPS) and##2##2##(2008-10#2)
PAR and##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
PAR solution##3##2##(2008-10#3)
PAR##30##1##(2008-10#17)(2008-3#6)(2008-7#4)(2009-8#2)(2012-12#1)
PAR-1 and PAFR##2##3##(2009-3#2)
PAR-1##3##1##(2009-3#3)
PAR-insensitive##2##1##(2008-10#2)
PAR-sensitive cultivars##2##2##(2008-10#2)
PAR-sensitive##3##1##(2008-10#3)
PAR1 and PAR2##3##3##(2009-8#3)
PAR1 region##3##2##(2008-7#3)
PAR1##11##1##(2008-7#7)(2009-8#4)
PAR2##7##1##(2008-7#2)(2009-8#5)
PARAFAC analysis of##2##3##(2009-8#2)
PARAFAC analysis##3##2##(2008-10#1)(2009-8#2)
PARAFAC model##3##2##(2008-10#3)
PARAFAC##11##1##(2008-10#9)(2009-8#2)
PARP cleavage##3##2##(2008-12#1)(2009-9#1)(2013-1#1)
PARP protein##2##2##(1993-12#1)(2012-12#1)
PARP##16##1##(1992-11#1)(1993-12#5)(2008-12#2)(2009-9#1)(2010-6#4)(2012-12#2)(2013-1#1)
PARPs##2##1##(1993-12#1)(2008-1#1)
PARTICIPANTS##10##1##(2009-10#1)(2011-1#1)(2011-2#2)(2012-12#5)(2013-1#1)
PAS and##3##2##(1996-1#1)(2008-7#1)(2009-7#1)
PAS in##2##2##(1992-11#1)(1996-1#1)
PAS spectra##2##2##(2007-12#2)
PAS stain##2##2##(1992-2#1)(2012-3#1)
PAS##17##1##(1992-11#1)(1992-2#1)(1994-2#1)(1996-1#5)(2007-12#4)(2007-7#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-3#1)
PAS-Port proximal##2##2##(2007-8#2)
PASE##2##1##(2008-4#1)(2013-1#1)
PASMCs##5##1##(2011-3#5)
PATIENTS AND METHODS##3##3##(2008-3#1)(2011-2#2)
PATIENTS##9##1##(1997-3#2)(2007-12#1)(2008-3#2)(2011-2#3)(2013-8#1)
PAULA##3##1##(2009-3#3)
PAUP*##6##1##(2008-4#4)(2008-9#2)
PAUP*)##2##1##(2008-4#1)(2008-9#1)
PAV and MAV##2##3##(2008-10#2)
PAV infection##2##2##(2008-10#2)
PAV##17##1##(2008-10#17)
PAVMs##4##1##(2008-1#4)
PAZoA##3##1##(2008-10#3)
PAl 5##4##2##(2011-2#4)
PB and##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
PB film##3##2##(2008-10#3)
PB films##3##2##(2008-10#3)
PB##26##1##(1990-7#1)(1997-2#1)(2008-10#22)(2011-2#2)
PB-PCNE##2##1##(1990-7#2)
PB-induced##4##1##(1990-12#1)(1994-8#3)
PB/HC-OES method##3##2##(2010-11#3)
PBB 169##2##2##(2008-10#2)
PBB at##2##2##(2008-10#2)
PBB##11##1##(2008-10#11)
PBC##5##1##(1992-6#4)(2006-10#1)
PBD##4##1##(1992-12#4)
PBDEs in##2##2##(2008-10#2)
PBDEs were detected in##2##4##(2008-10#2)
PBDEs were##3##2##(2008-10#3)
PBDEs##13##1##(2008-10#13)
PBDO-700##2##1##(2008-10#2)
PBE0##2##1##(2010-7#2)
PBFD##2##1##(2008-5#2)
PBFR##2##1##(2008-10#2)
PBGS##3##1##(1992-3#3)
PBI derivatives##2##2##(2008-11#2)
PBI##5##1##(2008-11#5)
PBL and TL##2##3##(1995-12#2)
PBL and##3##2##(1995-12#2)(1997-4#1)
PBL approach##2##2##(2008-11#1)(2008-12#1)
PBL as a teaching and learning strategy##2##7##(2008-11#2)
PBL in##6##2##(1997-4#1)(2008-12#5)
PBL method##2##2##(2013-8#2)
PBL was##2##2##(2008-11#1)(2008-12#1)
PBL##47##1##(1991-9#1)(1992-2#1)(1995-12#2)(1997-4#2)(2008-10#4)(2008-11#12)(2008-12#12)(2010-3#1)(2011-1#2)(2012-2#4)(2013-1#2)(2013-8#4)
PBLs##7##1##(2008-11#6)(2012-2#1)
PBMC from##2##2##(2008-7#1)(2012-2#1)
PBMC##29##1##(1992-12#3)(2008-11#5)(2008-4#7)(2008-7#4)(2010-12#3)(2011-2#6)(2012-2#1)
PBMCs##7##1##(1997-2#2)(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#1)
PBN neurons##2##2##(2009-10#2)
PBN##13##1##(1993-3#1)(1993-6#2)(1995-12#1)(2008-7#2)(2009-10#7)
PBQ and##2##2##(2008-10#2)
PBQ##3##1##(2008-10#3)
PBS and##2##2##(2007-2#1)(2012-3#1)
PBS in##2##2##(2008-10#1)(2008-8#1)
PBS solution##2##2##(2008-10#1)(2013-1#1)
PBS to remove residual media##2##5##(2008-8#2)
PBS was##3##2##(2008-8#3)
PBS##32##1##(1994-8#2)(1995-2#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-8#11)(2008-9#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
PBS's##2##1##(2008-3#2)
PBS)##2##1##(1990-12#1)(2013-1#1)
PBT cells for apoptosis##2##4##(1995-2#2)
PBT cells##8##2##(1995-2#8)
PBTC##2##1##(2010-5#2)
PC and##11##2##(1990-11#2)(1995-2#1)(1995-8#2)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
PC bound##2##2##(2008-10#2)
PC by##2##2##(1990-11#1)(2008-10#1)
PC composition##2##2##(1995-8#2)
PC exposure##5##2##(2012-3#5)
PC hydrolysis##3##2##(1991-5#3)
PC is##4##2##(1995-9#1)(2008-10#2)(2008-7#1)
PC may##2##2##(1995-8#1)(2011-2#1)
PC metabolism##2##2##(1995-8#2)
PC or BCP mutations##5##4##(2013-1#5)
PC software##2##2##(1994-2#1)(1994-3#1)
PC values were##2##3##(2012-1#2)
PC values##3##2##(2012-1#3)
PC variables##2##2##(1996-5#1)(2008-10#1)
PC was##3##2##(1992-9#1)(1995-8#1)(2008-4#1)
PC with##2##2##(1990-6#1)(2009-5#1)
PC##118##1##(1990-11#4)(1990-6#4)(1991-5#6)(1992-10#2)(1992-9#3)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#2)(1995-2#3)(1995-8#14)(1995-9#1)(1996-5#2)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#16)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#5)(2010-9#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#10)
PC's##2##1##(2008-3#1)(2010-8#1)
PC)##4##1##(2008-1#1)(2008-10#1)(2008-6#1)(2012-1#1)
PC-12 cells##4##2##(1990-2#2)(1992-6#1)(2008-5#1)
PC-3 prostate cancer##2##3##(2008-8#1)(2010-6#1)
PC-3##3##1##(1990-12#1)(2008-8#1)(2010-6#1)
PC-ACP##2##1##(2010-4#2)
PC-FILE##2##1##(1991-3#2)
PC-PLC##2##1##(1997-2#2)
PC-based##4##1##(1994-2#1)(2008-10#2)(2008-3#1)
PC-compatible##2##1##(2008-10#1)(2008-3#1)
PC/FA##2##1##(1994-12#2)
PC/JW/FI##2##1##(1993-9#2)
PC12 and##2##2##(1993-8#1)(2008-11#1)
PC12 cell differentiation##3##3##(2008-11#3)
PC12 cell line##4##3##(1997-2#1)(1997-6#3)
PC12 cell##10##2##(1997-2#1)(1997-6#3)(2008-11#4)(2013-8#2)
PC12 cells and##2##3##(1993-8#1)(1997-2#1)
PC12 cells by##3##3##(1990-5#1)(2008-11#2)
PC12 cells from##2##3##(2012-12#1)(2013-8#1)
PC12 cells via##3##3##(2008-10#2)(2008-4#1)
PC12 cells were##4##3##(1993-8#1)(2008-11#3)
PC12 cells with##3##3##(1990-5#1)(2008-11#2)
PC12 cells##61##2##(1990-5#4)(1990-8#1)(1992-12#4)(1992-6#1)(1992-9#3)(1993-12#1)(1993-8#4)(1995-12#1)(1996-12#3)(1997-2#3)(2008-10#6)(2008-11#23)(2008-4#4)(2009-9#1)(2012-12#1)(2013-8#1)
PC12 pheochromocytoma cells##5##3##(1994-6#1)(1995-2#1)(1997-2#1)(2008-11#2)
PC12 rat phaeochromocytoma##2##3##(2013-7#2)
PC12##92##1##(1990-5#5)(1990-8#1)(1992-12#4)(1992-6#1)(1992-9#3)(1993-12#1)(1993-8#5)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#3)(1997-2#5)(1997-6#3)(2008-10#7)(2008-11#39)(2008-4#4)(2009-9#1)(2012-12#1)(2013-7#2)(2013-8#3)
PC12D##3##1##(2008-11#3)
PC16##2##1##(1995-8#2)
PC2##2##1##(2008-10#2)
PCA algorithm##2##2##(2008-10#2)
PCA and##3##2##(2008-10#2)(2008-6#1)
PCA is##5##2##(2008-10#2)(2010-7#2)(2010-8#1)
PCA of##2##2##(2008-10#2)
PCA score plot##2##3##(2011-1#2)
PCA to##2##2##(1997-6#1)(2008-10#1)
PCA was##3##2##(1995-11#1)(2008-10#2)
PCA##49##1##(1992-6#1)(1995-11#1)(1996-5#3)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#28)(2008-6#1)(2008-7#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2012-3#1)(2013-8#2)
PCAs##2##1##(1997-6#2)
PCB 126##4##2##(2008-10#3)(2008-7#1)
PCB 153##2##2##(2008-10#2)
PCB compounds##2##2##(2008-10#1)(2008-7#1)
PCB congeners##5##2##(1996-12#1)(2008-10#3)(2008-11#1)
PCB##29##1##(1996-12#1)(2008-10#19)(2008-11#1)(2008-7#6)(2012-2#1)(2013-1#1)
PCB-induced##4##1##(1995-3#1)(2008-10#2)(2008-7#1)
PCBs and PCDD/Fs##2##3##(2008-10#2)
PCBs and##6##2##(1994-3#1)(2008-10#4)(2008-11#1)
PCBs as##2##2##(2008-10#1)(2008-7#1)
PCBs in##8##2##(2008-10#6)(2008-11#1)(2008-8#1)
PCBs##31##1##(1994-3#1)(1996-12#1)(1997-4#1)(2008-10#22)(2008-11#4)(2008-7#1)(2008-8#1)
PCBs)##2##1##(2008-10#1)(2008-8#1)
PCC 7002##3##2##(1992-3#3)
PCC 7120##6##2##(1992-12#1)(2008-8#5)
PCC 7601##2##2##(1992-12#2)
PCC##15##1##(1992-12#3)(1992-3#3)(1996-12#2)(1996-6#2)(2008-8#5)
PCC4 cells##4##2##(1993-9#4)
PCC4##5##1##(1993-9#5)
PCC7002##3##1##(1995-6#1)(1997-4#2)
PCCC data##2##2##(2010-6#2)
PCCC##4##1##(2010-6#4)
PCCM##2##1##(1994-3#2)
PCCOs##2##1##(1997-3#2)
PCD in WEHI 231 cells##2##5##(1994-10#2)
PCD in##5##2##(1994-10#3)(2009-10#2)
PCD##13##1##(1994-10#4)(2009-10#8)(2009-8#1)
PCDD/F + 4##2##3##(2008-10#2)
PCDD/F and##2##2##(1995-11#1)(2008-10#1)
PCDD/F mixture##2##2##(2008-10#2)
PCDD/F##11##1##(1995-11#1)(2008-10#10)
PCDD/F) and##2##2##(2008-10#1)(2008-7#1)
PCDD/Fs and##3##2##(2008-10#3)
PCDD/Fs##7##1##(2008-10#7)
PCDDs/PCDFs and##3##2##(2008-10#3)
PCDFs##3##1##(2008-10#3)
PCE and##2##2##(1993-8#1)(2008-10#1)
PCE##11##1##(1993-8#2)(2008-10#1)(2009-2#4)(2012-12#4)
PCET##2##1##(2008-10#2)
PCF##4##1##(2007-11#4)
PCFV is##3##2##(2008-10#3)
PCFV##7##1##(2008-10#7)
PCFs##2##1##(2007-11#2)
PCI can##3##2##(2008-3#3)
PCI##20##1##(2008-3#12)(2009-11#1)(2011-2#3)(2013-1#3)(2013-8#1)
PCIOL##2##1##(2011-2#2)
PCL reconstruction##3##2##(2013-1#3)
PCL##11##1##(2010-4#6)(2013-1#5)
PCLCL##3##1##(2012-3#3)
PCMH##3##1##(2012-3#3)
PCNA gene##3##2##(1995-6#3)
PCNA##16##1##(1994-12#4)(1994-7#1)(1995-4#2)(1995-6#5)(2009-8#1)(2011-2#2)(2012-1#1)
PCNL##4##1##(2007-10#1)(2008-12#2)(2012-12#1)
PCNSL##2##1##(2008-7#2)
PCO##2##1##(1990-8#1)(1994-5#1)
PCO2##2##1##(1994-7#1)(1996-3#1)
PCOS is##3##2##(2008-4#2)(2013-1#1)
PCOS patients who became pregnant and were##2##7##(2013-1#2)
PCOS patients##3##2##(2013-1#2)(2013-8#1)
PCOS to be##2##3##(2008-4#2)
PCOS##34##1##(2008-1#1)(2008-3#9)(2008-4#14)(2010-11#1)(2013-1#8)(2013-8#1)
PCOs##2##1##(2008-5#2)
PCP in soils##2##3##(2008-10#2)
PCP in##5##2##(2008-10#4)(2009-3#1)
PCP using##2##2##(2008-10#1)(2009-3#1)
PCP was##2##2##(2008-10#2)
PCP##20##1##(1991-1#3)(2008-10#11)(2009-3#5)(2012-12#1)
PCPA treatment##5##2##(1992-11#5)
PCPA##7##1##(1992-11#7)
PCPs##3##1##(1995-3#1)(2007-12#1)(2013-7#1)
PCR Amplification##3##2##(2008-10#2)(2008-12#1)
PCR also##3##2##(2008-10#3)
PCR amplicons##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
PCR amplification and##3##3##(1994-8#1)(2009-5#1)(2010-10#1)
PCR amplification of cDNA##2##4##(1990-11#1)(2008-1#1)
PCR amplification of the##6##4##(1992-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
PCR amplification of##10##3##(1990-11#1)(1992-9#1)(1994-12#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)
PCR amplification using##3##3##(1994-12#1)(2008-2#1)(2008-8#1)
PCR amplification with##4##3##(1996-8#1)(2008-10#3)
PCR amplification##34##2##(1990-11#2)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#3)(1994-8#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
PCR amplifications##5##2##(1990-7#1)(1993-6#1)(1997-6#1)(2008-10#1)(2008-8#1)
PCR amplified##6##2##(1993-12#1)(1993-6#1)(1997-4#1)(2008-10#2)(2008-4#1)
PCR analysis and##3##3##(1994-12#1)(2008-9#1)(2009-8#1)
PCR analysis of##7##3##(1990-7#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
PCR analysis reveals##2##3##(2008-7#1)(2013-1#1)
PCR analysis##16##2##(1990-7#1)(1993-2#1)(1994-12#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
PCR and PLS##2##3##(2008-10#2)
PCR and PLS2##2##3##(2008-10#2)
PCR and Southern blot analysis##2##5##(2008-10#1)(2008-9#1)
PCR and Southern blot##3##4##(2006-12#1)(2008-10#1)(2008-9#1)
PCR and Southern##4##3##(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
PCR and an##2##3##(2008-4#1)(2008-8#1)
PCR and immunofluorescence##2##3##(2008-5#1)(2011-2#1)
PCR and in##2##3##(1994-8#2)
PCR and sequencing##3##3##(1995-8#1)(2009-3#1)(2013-1#1)
PCR and the##4##3##(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
PCR and##51##2##(1992-12#1)(1992-8#2)(1994-3#1)(1994-8#4)(1995-8#3)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#11)(2008-12#2)(2008-4#3)(2008-5#3)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
PCR are##2##2##(2008-10#1)(2008-4#1)
PCR as a##2##3##(2008-11#1)(2013-8#1)
PCR assay for the##2##4##(1995-6#1)(2008-12#1)
PCR assay provides##2##3##(2008-10#2)
PCR assay to detect##2##4##(1996-6#1)(2008-10#1)
PCR assay using the##2##4##(2008-10#2)
PCR assay was##3##3##(2008-10#1)(2010-4#1)(2013-8#1)
PCR assay##30##2##(1995-6#1)(1996-6#1)(2008-10#17)(2008-12#1)(2008-5#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
PCR assays were also##2##4##(2008-10#2)
PCR assays were developed##3##4##(2008-10#3)
PCR assays were##7##3##(2008-10#6)(2012-2#1)
PCR assays##28##2##(2008-10#22)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#2)
PCR based##3##2##(1994-11#1)(2013-1#2)
PCR can be##2##3##(1997-4#1)(2008-2#1)
PCR can##4##2##(1990-7#1)(1997-4#1)(2008-2#1)(2010-6#1)
PCR cloning and sequence of##2##5##(1990-7#1)(1993-2#1)
PCR cloning and##3##3##(1990-7#1)(1992-3#1)(1993-2#1)
PCR cloning of##2##3##(1992-11#1)(2011-1#1)
PCR cloning##6##2##(1990-7#1)(1992-11#1)(1992-3#1)(1993-2#1)(2008-8#1)(2011-1#1)
PCR detected##2##2##(2013-1#1)(2013-8#1)
PCR detection of##2##3##(2008-10#2)
PCR detection##4##2##(2008-10#3)(2008-8#1)
PCR efficiencies##2##2##(2008-10#2)
PCR for amplification of##2##4##(2008-4#1)(2008-9#1)
PCR for the##2##3##(1996-12#1)(2013-1#1)
PCR for##13##2##(1990-9#1)(1996-12#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
PCR fragment##2##2##(1990-8#1)(1993-8#1)
PCR fragments##5##2##(1991-9#1)(2008-10#3)(2008-2#1)
PCR from the##3##3##(1995-8#1)(1996-8#1)(2011-1#1)
PCR from##6##2##(1995-8#1)(1996-8#1)(2008-9#2)(2011-1#1)(2011-2#1)
PCR has##3##2##(2008-10#2)(2008-5#1)
PCR in the##4##3##(1994-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
PCR in##16##2##(1993-6#1)(1994-1#2)(1995-11#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2011-2#3)
PCR inhibition##2##2##(2008-10#1)(2008-12#1)
PCR inhibitors in forensic samples##2##5##(2008-12#2)
PCR inhibitors in##3##3##(1996-12#1)(2008-12#2)
PCR inhibitors##5##2##(1996-12#1)(2008-11#1)(2008-12#3)
PCR is a##2##3##(1993-6#1)(2011-2#1)
PCR is##6##2##(1993-6#1)(1996-8#1)(1997-7#1)(2008-10#2)(2011-2#1)
PCR method and##2##3##(1995-6#1)(2008-9#1)
PCR method##10##2##(1994-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-8#2)
PCR methods for##2##3##(1997-4#1)(2008-9#1)
PCR methods##4##2##(1997-4#1)(2008-10#1)(2008-9#1)(2012-3#1)
PCR on##2##2##(1994-9#1)(2011-1#1)
PCR or##8##2##(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
PCR positive samples##2##3##(2008-10#1)(2008-12#1)
PCR positive##5##2##(2008-10#2)(2008-12#2)(2010-1#1)
PCR primer##3##2##(1990-12#1)(2008-10#2)
PCR primers to##2##3##(2008-10#2)
PCR primers were##2##3##(2008-10#2)
PCR primers##12##2##(2008-10#10)(2008-5#1)(2008-9#1)
PCR procedures##2##2##(2008-10#1)(2011-2#1)
PCR product was##4##3##(1992-3#1)(1994-12#1)(2008-10#1)(2008-7#1)
PCR product##17##2##(1992-3#1)(1993-12#1)(1994-12#2)(1997-7#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#2)
PCR products are##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
PCR products can be##2##4##(2008-2#2)
PCR products can##3##3##(2008-2#2)(2008-4#1)
PCR products for##5##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#2)
PCR products from##5##3##(1993-3#1)(1994-11#1)(1997-3#1)(2008-10#1)(2012-12#1)
PCR products of the##3##4##(1992-8#2)(2008-10#1)
PCR products of##7##3##(1992-8#2)(2008-10#3)(2009-5#1)(2010-4#1)
PCR products to##2##3##(2008-2#1)(2008-9#1)
PCR products were##8##3##(1997-3#2)(2008-10#6)
PCR products with##2##3##(1993-6#1)(2008-10#1)
PCR products##52##2##(1992-8#4)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-6#2)(1997-3#3)(1997-4#1)(2008-10#18)(2008-2#8)(2008-4#6)(2008-9#2)(2009-5#2)(2010-4#1)(2012-12#1)
PCR protocol##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
PCR reaction mixture##2##3##(1997-4#2)
PCR reaction##6##2##(1994-11#1)(1997-4#2)(2008-10#2)(2008-8#1)
PCR reactions##2##2##(2008-10#1)(2008-11#1)
PCR restriction fragment length polymorphism##2##5##(2008-10#2)
PCR restriction##3##2##(1997-3#1)(2008-10#2)
PCR result##2##2##(2008-10#1)(2011-2#1)
PCR results##4##2##(2008-10#1)(2009-6#1)(2012-12#2)
PCR revealed##3##2##(2008-11#1)(2013-1#2)
PCR strategy##2##2##(1993-12#1)(2010-5#1)
PCR technique##6##2##(1991-5#1)(1995-12#1)(2008-10#2)(2008-8#2)
PCR techniques##3##2##(1990-12#1)(1993-8#1)(2008-10#1)
PCR technology##3##2##(1994-12#1)(2008-11#1)(2008-9#1)
PCR template##2##2##(1997-2#1)(2008-8#1)
PCR testing##3##2##(2008-12#1)(2009-5#1)(2013-8#1)
PCR tests##3##2##(2007-2#1)(2008-10#1)(2008-12#1)
PCR to##11##2##(1990-3#1)(1994-11#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-3#1)
PCR using a##2##3##(1995-8#1)(1997-7#1)
PCR using##13##2##(1992-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
PCR was developed##2##3##(1993-6#1)(2011-1#1)
PCR was performed##2##3##(2008-10#1)(2009-12#1)
PCR was used to##2##4##(2008-10#1)(2013-8#1)
PCR was##14##2##(1993-6#1)(1994-1#1)(1995-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-8#1)
PCR were##3##2##(2008-10#2)(2008-8#1)
PCR with specific##2##3##(2008-10#1)(2008-5#1)
PCR with the##2##3##(2008-10#2)
PCR with##15##2##(1992-3#1)(1996-6#1)(1997-2#3)(2008-10#6)(2008-12#2)(2008-5#1)(2012-2#1)
PCR##692##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#8)(1992-9#4)(1993-12#8)(1993-2#2)(1993-3#3)(1993-6#6)(1993-8#2)(1993-9#1)(1994-1#6)(1994-11#7)(1994-12#14)(1994-3#1)(1994-5#1)(1994-8#7)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#5)(1996-12#7)(1996-6#4)(1996-8#6)(1997-2#5)(1997-3#8)(1997-4#12)(1997-6#2)(1997-7#3)(1997-8#2)(2006-12#1)(2007-2#2)(2007-7#1)(2008-1#3)(2008-10#213)(2008-11#9)(2008-12#30)(2008-2#33)(2008-4#26)(2008-5#14)(2008-6#1)(2008-7#10)(2008-8#27)(2008-9#28)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#5)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-4#5)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#11)(2011-2#21)(2012-1#2)(2012-12#10)(2012-2#13)(2012-3#10)(2013-1#18)(2013-8#12)
PCR)##3##1##(2008-1#1)(2008-10#1)(2012-2#1)
PCR-DGGE patterns##2##2##(2008-10#2)
PCR-ELISA##3##1##(2008-12#3)
PCR-RFLP and##4##2##(2008-10#2)(2013-1#2)
PCR-RFLP in##2##2##(2011-2#1)(2013-1#1)
PCR-RFLP methods##2##2##(2008-12#2)
PCR-RFLP on the##2##3##(2008-12#2)
PCR-RFLP##24##1##(1997-8#1)(2008-10#8)(2008-12#6)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
PCR-amplified fragments##2##2##(1997-4#2)
PCR-amplified##14##1##(1991-7#1)(1993-12#1)(1993-6#1)(1997-4#3)(2008-10#6)(2008-2#1)(2008-9#1)
PCR-based analyses##2##2##(1997-8#1)(2012-2#1)
PCR-based assay##6##2##(2008-10#5)(2008-4#1)
PCR-based genotyping##2##2##(2008-10#1)(2008-12#1)
PCR-based methods to detect##2##4##(1994-11#1)(2011-2#1)
PCR-based methods##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
PCR-based##34##1##(1994-11#2)(1994-12#1)(1995-11#2)(1995-6#1)(1997-2#2)(1997-8#2)(2008-10#12)(2008-12#1)(2008-4#3)(2008-5#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
PCR-derived##3##1##(1995-8#2)(1996-12#1)
PCR-mediated HBV DNA detection methods##2##5##(1997-4#2)
PCR-mediated##8##1##(1995-8#1)(1997-4#3)(2008-2#3)(2008-9#1)
PCR-positive##4##1##(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)
PCR-restriction fragment length polymorphism (RFLP)##2##5##(2008-10#1)(2010-4#1)
PCR-ribotype 027##2##2##(2011-2#2)
PCRs targeting##2##2##(2011-2#1)(2013-1#1)
PCRs##6##1##(2008-10#1)(2008-7#1)(2011-2#3)(2013-1#1)
PCS##8##1##(1995-5#1)(2011-2#1)(2012-3#1)(2013-1#5)
PCSG##2##1##(2009-5#2)
PCSGs##3##1##(2009-5#3)
PCSK9 and##2##2##(2013-1#2)
PCSK9 deficiency##2##2##(2013-1#2)
PCSK9##5##1##(2013-1#5)
PCT##10##1##(1992-9#2)(2007-11#1)(2008-10#1)(2008-11#2)(2010-2#1)(2010-8#1)(2012-12#2)
PCTs##2##1##(2008-11#2)
PCV in##2##2##(2008-10#1)(2008-12#1)
PCV##5##1##(2008-10#1)(2008-12#3)(2008-5#1)
PCV-2 DNA in##2##3##(2012-3#2)
PCV-2 DNA##5##2##(2012-3#5)
PCV-2 quantification##3##2##(2012-3#3)
PCV-2##10##1##(2012-3#10)
PCV-2b + BVDV-1-like virus##2##4##(2012-3#2)
PCV-2b##5##1##(2012-3#5)
PCV2##2##1##(2013-1#2)
PCV2b##3##1##(2013-1#3)
PCVAD##7##1##(2012-3#4)(2013-1#3)
PCa cells##6##2##(2013-1#6)
PCa##18##1##(2013-1#18)
PCr##3##1##(1991-5#1)(1994-2#1)(2007-10#1)
PCs##18##1##(1994-2#5)(2007-11#4)(2008-10#4)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#2)
PCu##3##1##(1990-5#3)
PD 146923##2##2##(1997-2#2)
PD and##21##2##(1990-5#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#4)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
PD are##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
PD catheter##4##2##(2011-2#4)
PD dementia##3##2##(2008-7#3)
PD has increased##2##3##(2008-7#1)(2013-8#1)
PD height loss##3##3##(2011-2#3)
PD in##7##2##(1990-6#1)(2008-10#3)(2008-12#1)(2009-10#1)(2011-2#1)
PD is a##2##3##(2008-7#2)
PD is##11##2##(2008-10#1)(2008-6#1)(2008-7#4)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
PD management##2##2##(2007-12#1)(2008-10#1)
PD model##2##2##(2008-10#1)(2008-12#1)
PD nurse##3##2##(2007-12#3)
PD nurses##2##2##(2007-12#2)
PD or##2##2##(2007-10#1)(2009-4#1)
PD patients and##6##3##(2008-11#1)(2008-7#5)
PD patients are##2##3##(2007-12#1)(2008-7#1)
PD patients as well as##2##5##(2008-7#2)
PD patients have##3##3##(2008-7#3)
PD patients showed##4##3##(2008-7#3)(2013-1#1)
PD patients treated at##2##4##(2011-2#2)
PD patients were##2##3##(2008-7#1)(2009-10#1)
PD patients who##2##3##(2008-7#1)(2009-10#1)
PD patients with##6##3##(2008-7#4)(2012-12#1)(2013-1#1)
PD patients##68##2##(2007-12#6)(2008-11#1)(2008-7#45)(2009-10#3)(2011-2#10)(2012-12#1)(2013-1#2)
PD phytoplasma##3##2##(2008-10#3)
PD solution##4##2##(2011-2#4)
PD than##2##2##(2008-7#2)
PD therapy##6##2##(2011-2#6)
PD treatment##2##2##(2009-10#1)(2011-2#1)
PD was##3##2##(2008-7#2)(2013-1#1)
PD##297##1##(1990-2#1)(1990-5#1)(1990-6#3)(1991-4#1)(1995-12#2)(1995-5#1)(1997-2#2)(2007-10#1)(2007-12#16)(2008-10#21)(2008-11#3)(2008-12#14)(2008-5#1)(2008-6#5)(2008-7#116)(2008-8#3)(2009-10#7)(2009-4#8)(2010-12#2)(2010-8#2)(2011-2#54)(2012-12#8)(2012-3#2)(2013-1#14)(2013-7#4)(2013-8#5)
PD+HD therapy##9##2##(2011-2#9)
PD-1 blockade##3##2##(2010-5#3)
PD-1##5##1##(2010-5#4)(2012-3#1)
PD-L1 protein##2##2##(2012-3#2)
PD-L1##10##1##(2010-8#1)(2012-3#9)
PD-infected##2##1##(2008-10#2)
PD98059 and##2##2##(1996-2#1)(2011-2#1)
PD98059##6##1##(1996-2#1)(2008-10#1)(2011-2#3)(2013-1#1)
PDA and##2##2##(2008-10#2)
PDA can##2##2##(2010-2#1)(2012-2#1)
PDA is##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
PDA system##2##2##(2008-3#2)
PDA##32##1##(1994-3#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#4)(2008-3#4)(2010-2#1)(2010-4#1)(2012-12#3)(2012-2#5)
PDAC##2##1##(2013-1#2)
PDAs##2##1##(2007-3#1)(2012-2#1)
PDB ligand dictionary##2##3##(2008-4#2)
PDB##11##1##(2008-10#1)(2008-4#4)(2008-7#3)(2011-3#3)
PDC##7##1##(2007-7#4)(2008-10#3)
PDC-E2##2##1##(2010-12#2)
PDDG/PM3##4##1##(2008-11#4)
PDE IV inhibitors##4##3##(2008-5#4)
PDE##7##1##(2008-5#4)(2008-6#1)(2008-7#1)(2013-1#1)
PDEI5##2##1##(2008-8#2)
PDF##8##1##(2008-6#3)(2008-9#1)(2011-1#4)
PDF1##4##1##(2009-8#4)
PDFs##2##1##(2008-10#2)
PDG##4##1##(2011-1#2)(2013-1#2)
PDGF and bFGF##2##3##(1997-6#2)
PDGF and##3##2##(1997-6#2)(2012-2#1)
PDGF beta receptor##3##3##(1994-6#2)(1997-6#1)
PDGF stimulation##2##2##(1994-6#1)(1997-7#1)
PDGF##24##1##(1991-12#2)(1992-9#1)(1993-8#2)(1994-6#5)(1995-11#5)(1997-6#3)(1997-7#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
PDGF-AA##2##1##(1991-12#1)(1995-2#1)
PDGF-B##2##1##(2008-9#2)
PDGF-BB##8##1##(1991-12#2)(1995-8#1)(1997-7#3)(2008-10#2)
PDGF-betaR##5##1##(1997-7#5)
PDGF-betaR-mediated##3##1##(1997-7#3)
PDGF-betaRWT##3##1##(1997-7#3)
PDGF-dependent##2##1##(1993-8#1)(1995-2#1)
PDGF-induced transcription##2##2##(1995-2#2)
PDGF-induced##5##1##(1994-6#2)(1995-11#1)(1995-2#2)
PDGFB-driven##3##1##(2013-1#3)
PDGFR##4##1##(2009-7#1)(2011-2#2)(2013-1#1)
PDGFRA##5##1##(2011-2#1)(2013-1#3)(2013-8#1)
PDH kinase activity##3##3##(1996-5#3)
PDH kinase##4##2##(1996-5#4)
PDH##8##1##(1994-11#2)(1996-5#4)(1997-7#1)(2013-1#1)
PDI = 1##2##3##(2008-12#2)
PDI clusters##2##2##(2013-1#2)
PDI##16##1##(1990-7#2)(2008-12#2)(2008-3#2)(2008-7#3)(2013-1#7)
PDL cell lines##2##3##(2008-11#2)
PDL cells##3##2##(2013-1#3)
PDL##17##1##(1995-8#1)(2008-11#8)(2008-3#5)(2013-1#3)
PDLC##5##1##(2008-2#3)(2008-3#2)
PDLLA films##3##2##(2008-5#3)
PDLLA##4##1##(2008-5#4)
PDM##3##1##(2007-12#3)
PDMCs##4##1##(2008-9#4)
PDMDAAC-SiO(2)##3##1##(2008-10#3)
PDMS and##2##2##(2008-10#1)(2009-2#1)
PDMS channel plate##2##3##(2007-8#2)
PDMS channels##2##2##(2008-10#1)(2009-2#1)
PDMS fiber##3##2##(2008-10#3)
PDMS microchannel##3##2##(2008-10#3)
PDMS microchannels##3##2##(2007-5#1)(2008-10#1)(2009-2#1)
PDMS microfluidic##2##2##(2008-10#2)
PDMS##26##1##(2007-5#1)(2007-8#2)(2008-10#13)(2008-5#3)(2009-11#1)(2009-2#4)(2010-8#2)
PDMS/DVB##5##1##(2008-10#5)
PDO##4##1##(2008-10#1)(2008-5#3)
PDPH##2##1##(1993-10#2)
PDR##10##1##(2008-10#2)(2008-11#1)(2013-1#7)
PDS gene##3##2##(1995-2#1)(2011-1#2)
PDS##14##1##(1995-2#4)(2008-2#1)(2008-9#1)(2011-1#6)(2011-2#1)(2012-12#1)
PDSI demonstrated##2##2##(2008-7#2)
PDSI##4##1##(2008-7#4)
PDT could##2##2##(2008-3#1)(2012-3#1)
PDT for##2##2##(1994-1#1)(2009-4#1)
PDT in##7##2##(2007-8#2)(2009-4#3)(2012-3#2)
PDT using##3##2##(1992-8#1)(2008-5#2)
PDT were##2##2##(1992-9#1)(2009-4#1)
PDT with##2##2##(1992-8#1)(2008-8#1)
PDT##43##1##(1990-11#1)(1992-6#1)(1992-8#2)(1992-9#2)(1994-1#3)(2007-8#3)(2008-3#1)(2008-5#5)(2008-8#1)(2009-4#15)(2010-8#1)(2011-1#1)(2012-3#6)(2013-8#1)
PDT/HBO##2##1##(2007-8#2)
PDTC was##3##2##(1993-3#2)(2008-3#1)
PDTC##10##1##(1993-3#4)(2008-3#2)(2012-3#4)
PDTRC##2##1##(2008-1#2)
PDV was##2##2##(2008-10#2)
PDV##7##1##(1993-12#2)(2008-10#5)
PDW##2##1##(2007-12#1)(2008-3#1)
PDZ domain##2##2##(2009-5#1)(2011-2#1)
PDZ domain-containing proteins##2##3##(2008-7#2)
PDZ domains at excitatory synapses##2##5##(2008-7#2)
PDZ##9##1##(2008-7#6)(2009-5#1)(2011-2#2)
PDZ-binding domain##3##2##(2011-2#3)
PE absorption##3##2##(2008-3#3)
PE and##3##2##(1991-8#1)(2012-2#2)
PE and/or DVT##4##3##(2012-2#4)
PE and/or##5##2##(2012-2#5)
PE is##3##2##(1991-1#1)(2010-6#2)
PE##54##1##(1991-1#5)(1991-8#1)(1992-10#2)(1994-12#1)(1994-3#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#1)(2010-5#1)(2010-6#4)(2011-2#9)(2012-2#9)
PE04##3##1##(1993-9#3)
PEA3##4##1##(1994-11#1)(1997-7#1)(1997-8#2)
PEB##4##1##(2007-12#1)(2008-3#3)
PEBBLE##2##1##(2008-10#2)
PEBBLEs##2##1##(2008-10#2)
PEC##3##1##(2008-8#3)
PED##5##1##(1992-5#1)(2011-2#4)
PEDF levels##4##2##(2012-5#4)
PEDF##9##1##(2012-5#9)
PEDOT##9##1##(2008-10#1)(2009-11#7)(2013-1#1)
PEEK##3##1##(2008-10#1)(2010-4#2)
PEF and##2##2##(2007-2#1)(2011-2#1)
PEF##8##1##(1996-3#3)(2007-2#3)(2008-1#1)(2011-2#1)
PEFR and##3##2##(2008-7#2)(2012-2#1)
PEFR##5##1##(1996-1#2)(2008-7#2)(2012-2#1)
PEG 6000##5##2##(2008-10#1)(2008-12#3)(2012-1#1)
PEG and##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
PEG hydrogel##7##2##(2012-3#7)
PEG molar##2##2##(2011-2#2)
PEG molecular weight##2##3##(2008-6#1)(2012-1#1)
PEG##50##1##(1990-12#1)(1994-9#1)(2007-12#2)(2008-10#14)(2008-12#6)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#4)(2012-1#6)(2012-3#7)
PEG-600 when##2##2##(2008-10#2)
PEG-600##3##1##(2008-10#3)
PEG-rich phase##3##2##(2008-10#1)(2011-2#2)
PEG4600##2##1##(2008-10#2)
PEHR##3##1##(2010-4#3)
PEHRs##2##1##(2010-4#2)
PEI 25 kDa##2##3##(2008-11#2)
PEI but not##2##3##(2008-10#2)
PEI concentration##2##2##(2008-10#2)
PEI in##2##2##(1992-11#1)(1996-5#1)
PEI soils##2##2##(2008-10#2)
PEI were##2##2##(1992-9#2)
PEI##21##1##(1992-11#1)(1992-9#2)(1996-5#1)(2008-10#10)(2008-11#6)(2010-4#1)
PEM##5##1##(1990-12#2)(2008-8#2)(2009-11#1)
PENTAX VNL-1330##2##2##(2008-5#2)
PENTAX##3##1##(2008-5#3)
PENs##2##1##(2011-2#2)
PEO##10##1##(1991-1#1)(2008-10#6)(2008-5#3)
PEO-PPO-PEO block copolymer##2##3##(2013-1#2)
PEP inhibition##3##2##(1995-5#3)
PEP##13##1##(1995-5#4)(1997-3#1)(2007-2#2)(2009-12#6)
PEP-inhibited T-state##2##2##(1995-2#2)
PEPCK and##2##2##(1995-3#1)(2010-11#1)
PEPCK gene expression by insulin##5##5##(1995-6#3)(1996-2#2)
PEPCK gene expression##7##3##(1995-6#5)(1996-2#2)
PEPCK gene transcription##4##3##(1996-2#4)
PEPCK gene##13##2##(1995-6#6)(1996-2#7)
PEPCK##19##1##(1995-3#3)(1995-6#8)(1996-2#7)(2010-11#1)
PEPF##2##1##(1994-12#2)
PER##4##1##(2008-12#2)(2008-3#2)
PER1##2##1##(2008-10#2)
PERIWMSA##2##1##(2009-10#2)
PERT/CPM##2##1##(1995-12#2)
PET D/P Cr##2##3##(2011-2#2)
PET and CT##2##3##(2012-12#2)
PET and##6##2##(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
PET findings##2##2##(2007-10#1)(2008-7#1)
PET imaging##7##2##(2010-6#2)(2011-2#3)(2012-12#1)(2013-1#1)
PET scans##2##2##(1996-5#1)(1996-7#1)
PET studies##3##2##(1991-1#1)(1993-9#1)(2008-7#1)
PET study##3##2##(1996-5#2)(2008-9#1)
PET tracers##2##2##(2008-1#2)
PET##65##1##(1991-1#1)(1992-11#2)(1993-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#4)(1996-7#1)(2007-10#1)(2008-1#6)(2008-10#4)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#2)(2013-1#4)
PET-CT##2##1##(2010-6#1)(2013-1#1)
PET/CT fusion##2##2##(2009-2#2)
PET/CT in the##3##3##(2012-1#1)(2012-12#2)
PET/CT in##5##2##(2009-9#1)(2012-1#1)(2012-12#3)
PET/CT scan##2##2##(2012-12#2)
PET/CT##24##1##(2008-2#1)(2009-2#6)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#11)(2012-2#1)(2012-3#1)(2013-1#1)
PET/MRI##3##1##(2012-2#3)
PETE1##2##1##(2009-10#2)
PETE2 in the##2##3##(2009-10#2)
PETE2##4##1##(2009-10#4)
PETN##6##1##(2008-10#3)(2008-3#2)(2009-5#1)
PEUs##5##1##(2008-11#5)
PEX##2##1##(2011-2#2)
PF contact loading##2##3##(2011-2#2)
PF contact##3##2##(2011-2#3)
PF loading##4##2##(2011-2#4)
PF##12##1##(1990-12#1)(2008-10#2)(2011-2#9)
PF-68##4##1##(2011-2#4)
PF-LIF signal waveforms##2##3##(2008-2#2)
PF-LIF signal##3##2##(2008-2#3)
PF-LIF##6##1##(2008-2#5)(2008-3#1)
PF06475##2##1##(2010-10#2)
PF08866##2##1##(2010-10#2)
PF09836##2##1##(2010-10#2)
PF127##2##1##(2011-1#2)
PFA##2##1##(1996-2#1)(2007-8#1)
PFBBr derivatization##2##2##(2008-10#2)
PFBBr##7##1##(2008-10#7)
PFBV##3##1##(2008-10#3)
PFC and##4##2##(1994-1#1)(2013-8#3)
PFC regions##2##2##(2013-8#2)
PFC##36##1##(1993-12#2)(1994-1#3)(1995-12#1)(1996-1#3)(1996-5#3)(1997-2#7)(2008-11#4)(2008-4#2)(2008-7#2)(2013-8#9)
PFC-HC##2##1##(2013-8#2)
PFCA##5##1##(1994-2#1)(1995-12#2)(1997-3#1)(2013-1#1)
PFD##2##1##(1993-12#1)(2010-10#1)
PFDA treatment##2##2##(1994-8#2)
PFDA##6##1##(1994-8#6)
PFE locus##2##2##(2008-9#2)
PFE##7##1##(2008-9#7)
PFF using##2##2##(1990-12#2)
PFF##4##1##(1990-12#4)
PFG NMR##3##2##(2008-3#3)
PFG##5##1##(2008-3#5)
PFG-3##3##1##(2008-11#3)
PFG-3-1##2##1##(2008-11#2)
PFG-4##2##1##(2008-11#2)
PFGE analysis of##2##3##(1993-6#1)(2008-10#1)
PFGE analysis##6##2##(1993-12#1)(1993-6#1)(2008-10#3)(2008-11#1)
PFGE##17##1##(1992-6#2)(1993-12#2)(1993-6#1)(2008-10#6)(2008-11#5)(2008-4#1)
PFH##5##1##(1992-12#5)
PFI##2##1##(2008-10#1)(2013-8#1)
PFK##6##1##(1995-2#4)(1995-5#2)
PFK-1##2##1##(1994-3#2)
PFK-2##2##1##(1994-3#2)
PFK-M gene transcripts was##2##4##(1990-12#2)
PFK-M##3##1##(1990-12#3)
PFK1##2##1##(1996-3#2)
PFLP##4##1##(2008-10#4)
PFM exercise##3##2##(2010-12#3)
PFM strength and endurance##2##4##(2010-12#2)
PFM##5##1##(2010-12#5)
PFO was##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
PFO##12##1##(1996-6#2)(2007-10#6)(2008-7#2)(2011-2#2)
PFR##2##1##(2008-7#2)
PFS##14##1##(1991-8#1)(1996-3#2)(2008-10#7)(2008-11#3)(2010-2#1)
PFT values##2##2##(2007-2#2)
PFT##7##1##(1995-2#2)(2007-2#3)(2012-2#1)(2013-1#1)
PFTase##3##1##(1993-9#3)
PG activity and the##2##4##(2008-10#2)
PG activity and##3##3##(2008-10#3)
PG activity##4##2##(2008-10#4)
PG and##2##2##(2008-11#2)
PG cell##4##2##(2007-12#1)(2008-8#3)
PG cells##2##2##(2008-8#2)
PG electrodes was greatly##2##4##(2008-10#2)
PG in PD##2##3##(2013-8#2)
PG in##4##2##(2011-10#1)(2013-1#1)(2013-8#2)
PG increased##2##2##(2008-11#2)
PG isozymes##6##2##(2008-10#6)
PG students##3##2##(2013-1#3)
PG was##3##2##(1990-2#1)(1994-9#1)(2008-11#1)
PG##69##1##(1990-2#10)(1994-9#6)(2007-12#2)(2008-10#19)(2008-11#11)(2008-8#10)(2011-10#1)(2011-2#1)(2013-1#4)(2013-8#5)
PG%##4##1##(2011-2#4)
PGA##4##1##(2008-12#1)(2009-7#1)(2009-8#1)(2011-2#1)
PGC column##3##2##(1996-5#2)(2008-10#1)
PGC-1alpha##5##1##(2008-1#5)
PGC-1α induction##2##2##(2012-12#2)
PGC-1α##7##1##(2012-12#7)
PGCs (male PGCs to##2##4##(2008-11#2)
PGCs to female##2##3##(2008-11#2)
PGCs to male##2##3##(2008-11#2)
PGCs to##4##2##(2008-11#4)
PGCs##14##1##(2008-11#14)
PGD in##2##2##(2008-1#2)
PGD##6##1##(2008-1#2)(2008-4#1)(2012-3#3)
PGD-S in the##2##3##(1996-2#2)
PGD-S isolated from##2##3##(1996-2#2)
PGD-S##9##1##(1996-2#9)
PGE##10##1##(1994-6#4)(2008-11#5)(2008-8#1)
PGE(1)##2##1##(2008-7#2)
PGE(2) and TXB(2)##3##3##(2008-10#3)
PGE(2) and##4##2##(2008-10#3)(2008-11#1)
PGE(2)##13##1##(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#2)(2012-2#2)
PGE(3)##2##1##(2008-7#2)
PGE-processing plants##3##2##(2008-11#3)
PGE-processing##4##1##(2008-11#4)
PGE1 and##4##2##(1993-12#1)(1994-2#1)(1994-6#2)
PGE1##10##1##(1993-12#2)(1993-8#1)(1994-2#3)(1994-6#4)
PGE2 synthesis##4##2##(1990-2#4)
PGE2##25##1##(1990-11#2)(1990-2#6)(1993-12#3)(1994-9#1)(1995-11#1)(1995-3#2)(1997-1#2)(1997-2#6)(2008-5#1)(2013-8#1)
PGE2-induced##2##1##(1993-12#2)
PGEs##4##1##(2008-10#4)
PGF(2alpha)##3##1##(2008-8#3)
PGF2 alpha was##2##3##(1990-8#2)
PGF2 alpha##5##2##(1990-12#1)(1990-8#4)
PGF2alpha##6##1##(1997-7#6)
PGGT-I##3##1##(1995-2#3)
PGH synthase##6##2##(1991-8#1)(1992-8#5)
PGH synthase-1##2##2##(1992-3#2)
PGH##9##1##(1991-8#1)(1992-3#2)(1992-8#6)
PGI##5##1##(1990-11#2)(2008-10#1)(2010-10#2)
PGI2 release##5##2##(1995-11#5)
PGI2##7##1##(1990-5#1)(1994-5#1)(1995-11#5)
PGIP##2##1##(2008-10#2)
PGIPs##4##1##(2011-10#4)
PGK##2##1##(1991-9#1)(2008-8#1)
PGK-1##4##1##(1992-8#3)(2008-5#1)
PGL##3##1##(2013-1#3)
PGMs and gold##2##3##(2008-10#2)
PGMs##3##1##(2008-10#3)
PGP 9##4##2##(1996-6#1)(2008-5#1)(2013-8#2)
PGP##7##1##(1996-6#1)(1997-4#2)(2008-5#2)(2013-8#2)
PGP-AML 94##2##2##(2011-2#2)
PGP-AML 98##2##2##(2011-2#2)
PGP-AML##5##1##(2011-2#5)
PGPR strains##5##2##(2008-10#5)
PGPR##8##1##(2008-10#8)
PGSF##3##1##(1992-9#3)
PGs##10##1##(1990-2#2)(1994-6#1)(1994-8#1)(2008-11#1)(2008-7#4)(2011-10#1)
PGx in##2##2##(2010-8#2)
PGx##7##1##(2008-10#2)(2010-8#5)
PH after surgery##3##3##(2010-10#1)(2010-6#2)
PH and##3##2##(2009-4#1)(2010-6#2)
PH unit##2##2##(2008-3#2)
PH##28##1##(1992-9#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-4#2)(2009-7#2)(2010-10#4)(2010-6#6)(2011-1#3)(2013-8#1)
PH(3)##3##1##(2008-10#3)
PHA and##3##2##(1995-8#2)(2011-2#1)
PHA##13##1##(1994-5#1)(1995-8#2)(1997-5#1)(2007-2#1)(2011-2#1)(2013-1#7)
PHA-L##2##1##(1995-12#1)(2008-4#1)
PHB accumulation##2##2##(2008-7#2)
PHB concentration of##2##3##(2008-7#2)
PHB concentration##3##2##(2008-7#3)
PHB##14##1##(2008-10#4)(2008-6#3)(2008-7#7)
PHC##11##1##(1994-3#1)(2007-8#1)(2008-1#5)(2011-2#4)
PHCs##3##1##(1994-3#2)(2011-1#1)
PHE##3##1##(2008-5#3)
PHENOTYPES##2##1##(2009-9#1)(2011-1#1)
PHF##2##1##(1992-6#2)
PHFs##2##1##(1992-6#2)
PHGPx##2##1##(2009-10#2)
PHIV youth were##2##3##(2009-7#2)
PHM##2##1##(2008-10#2)
PHMB##4##1##(2008-10#4)
PHN skin##2##2##(1996-6#2)
PHN##4##1##(1996-6#3)(2008-9#1)
PHO exposure##2##2##(2013-1#2)
PHO is##2##2##(2013-1#2)
PHO##9##1##(2008-10#1)(2013-1#8)
PHP##4##1##(2010-6#2)(2011-1#2)
PHR1##4##1##(1996-3#4)
PHS##6##1##(1993-8#1)(1997-2#1)(2012-3#4)
PHV and PepGMV##2##3##(2008-10#2)
PHV and##3##2##(2008-10#2)(2008-5#1)
PHV##8##1##(2008-10#4)(2008-5#4)
PHWE##2##1##(2008-10#2)
PI 255956##2##2##(2008-10#2)
PI 271322##2##2##(2008-10#2)
PI 3-kinase activity##3##3##(1994-11#3)
PI 3-kinase and##2##3##(1994-11#1)(1995-8#1)
PI 3-kinase is##3##3##(1994-11#1)(1996-2#1)(2008-11#1)
PI 3-kinase##15##2##(1994-11#8)(1995-8#1)(1996-2#2)(1997-6#1)(2008-11#3)
PI 345629##2##2##(2008-10#2)
PI 378159##3##2##(2008-10#3)
PI 478214##2##2##(2008-10#2)
PI 535278##2##2##(2008-10#2)
PI 548708##3##2##(2008-10#3)
PI 548734##3##2##(2008-10#3)
PI 548747##3##2##(2008-10#3)
PI 88788##7##2##(2008-10#7)
PI 94749##2##2##(2012-3#2)
PI and##2##2##(1996-2#1)(1996-6#1)
PI catabolism##2##2##(1994-9#2)
PI indices of##3##3##(2009-3#3)
PI polynomial of##3##3##(2009-3#3)
PI theory##2##2##(2008-2#2)
PI to##2##2##(2006-5#1)(2008-4#1)
PI treatments##2##2##(2011-2#2)
PI turnover##3##2##(1993-11#1)(1993-9#2)
PI values than##2##3##(2011-2#2)
PI was##2##2##(1992-10#1)(2011-2#1)
PI##123##1##(1990-5#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-9#2)(1994-11#10)(1994-9#4)(1995-12#1)(1995-8#1)(1996-1#2)(1996-2#7)(1996-6#1)(1997-3#1)(1997-6#1)(2006-5#1)(2008-10#44)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#2)(2008-8#5)(2008-9#4)(2009-3#6)(2009-6#1)(2009-8#1)(2011-2#10)(2012-3#2)(2013-1#1)
PI#555543##2##1##(2008-10#2)
PI#555573##2##1##(2008-10#2)
PI-3 kinase or casein kinase II##3##6##(2008-4#3)
PI-3 kinase##5##2##(2008-4#5)
PI-PLC##4##1##(1993-8#1)(1995-8#3)
PI-increases upon##2##2##(2009-6#2)
PI-stained##2##1##(2008-10#1)(2008-9#1)
PI134417##2##1##(2008-10#2)
PI3 kinase##4##2##(2010-11#4)
PI3##6##1##(2008-11#1)(2010-11#5)
PI3-kinase##6##1##(1996-2#1)(2008-6#1)(2008-8#4)
PI3-kinases##2##1##(1996-2#2)
PI3K activity##3##2##(2011-1#3)
PI3K##18##1##(1996-2#6)(2010-9#4)(2011-1#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
PI3K-AKT##2##1##(2013-1#1)(2013-7#1)
PI4##4##1##(2013-1#4)
PI478742##2##1##(2008-10#2)
PIA predictions##2##2##(1994-3#1)(1997-3#1)
PIA##5##1##(1994-3#3)(1997-3#2)
PIBs production##2##2##(2008-11#2)
PIBs##9##1##(2008-11#9)
PIC and HET values of 0##3##6##(2008-12#3)
PIC##7##1##(2008-12#3)(2009-11#1)(2010-3#1)(2011-2#2)
PICA##3##1##(2008-7#3)
PICC##4##1##(2009-4#4)
PICH##7##1##(2007-10#7)
PICP##3##1##(1997-1#3)
PICs##3##1##(2008-1#2)(2008-8#1)
PID##3##1##(2007-7#2)(2008-10#1)
PIES method##2##2##(2008-3#2)
PIES##3##1##(2008-3#3)
PIF##2##1##(2008-10#1)(2009-8#1)
PIGN##2##1##(2011-2#2)
PIH##12##1##(1994-3#6)(2012-12#1)(2012-2#5)
PIHCP##4##1##(2008-1#4)
PII fractions##2##2##(1996-2#2)
PILP##5##1##(2009-11#5)
PIN targeting##2##2##(2009-10#2)
PIN##9##1##(2008-3#1)(2009-10#8)
PIP total##2##2##(2008-9#2)
PIP##8##1##(2008-9#7)(2012-2#1)
PIP(2) sensitivity##2##2##(2008-8#2)
PIP(2)##6##1##(2008-8#6)
PIP(3)##4##1##(2008-11#4)
PIP2 depletion and##2##3##(2008-8#2)
PIP2 depletion##3##2##(2008-8#3)
PIP2 hydrolysis##2##2##(2008-8#2)
PIP2 levels##2##2##(2008-8#2)
PIP2##18##1##(1992-12#1)(1993-6#3)(1993-8#3)(2008-8#11)
PIP2-mediated##3##1##(1993-6#3)
PIP3 was##2##2##(1993-8#2)
PIP3##7##1##(1993-8#7)
PIPKIα##2##1##(2013-1#2)
PIPKs##2##1##(2013-1#2)
PIPLC##2##1##(1992-3#2)
PIR##5##1##(1997-2#1)(2008-3#2)(2008-5#2)
PIS##2##1##(2008-10#2)
PISHG##6##1##(2008-3#6)
PIT##2##1##(2010-8#2)
PITP##2##1##(2008-4#2)
PIV insertion##3##2##(2012-2#3)
PIV stereocamera##2##2##(2008-2#2)
PIV system##2##2##(2008-2#1)(2008-3#1)
PIV##11##1##(2008-2#5)(2008-3#2)(2012-2#4)
PIs##2##1##(2008-12#1)(2009-6#1)
PK and Verysise##2##3##(2011-2#2)
PK and implantation of##2##4##(2011-2#2)
PK and##4##2##(2011-2#4)
PK repeat##3##2##(2010-11#3)
PK##24##1##(1992-6#2)(1993-9#2)(2008-7#1)(2009-5#1)(2010-11#3)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#6)
PK-C##4##1##(1991-2#1)(1992-3#2)(1993-6#1)
PK11195 and N-methyl protoporphyrin IX##2##5##(1995-12#2)
PK11195 and##3##2##(1995-12#2)(2012-2#1)
PK11195##7##1##(1995-12#3)(2012-2#4)
PK2##3##1##(2008-10#2)(2008-7#1)
PKA activity levels##3##3##(2008-10#3)
PKA activity##6##2##(2008-10#5)(2010-11#1)
PKA in##3##2##(1995-2#1)(2009-12#1)(2009-2#1)
PKA or PKC##2##3##(1992-3#2)
PKA phosphorylation##2##2##(2008-8#2)
PKA with##2##2##(1994-8#2)
PKA##42##1##(1990-12#1)(1992-3#2)(1993-3#2)(1994-8#8)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#6)(2009-12#2)(2009-2#2)(2010-11#1)(2011-2#2)(2012-2#1)
PKA-mediated phosphorylation of##2##3##(2010-1#1)(2011-2#1)
PKA-mediated##4##1##(1995-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
PKC activation##10##2##(1991-9#1)(1992-12#2)(1992-9#4)(1997-7#1)(2008-4#1)(2008-8#1)
PKC activator##3##2##(1995-11#2)(2008-4#1)
PKC activities in the##2##4##(1993-9#2)
PKC activities##4##2##(1993-9#2)(1994-11#1)(1997-4#1)
PKC activity in##3##3##(1992-11#1)(1997-2#1)(1997-6#1)
PKC activity was##3##3##(1994-11#1)(1997-6#1)(2008-11#1)
PKC activity##21##2##(1992-11#6)(1992-8#1)(1992-9#1)(1993-8#2)(1993-9#1)(1994-11#3)(1997-2#1)(1997-6#3)(1997-7#1)(2008-10#1)(2008-11#1)
PKC alpha at##2##3##(1995-11#2)
PKC alpha##16##2##(1992-11#1)(1993-3#3)(1994-2#1)(1994-5#1)(1995-11#9)(1997-4#1)
PKC and##7##2##(1991-5#1)(1992-6#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-8#1)(2009-7#1)
PKC beta and##2##3##(1993-3#1)(1997-4#1)
PKC beta##4##2##(1992-11#1)(1993-3#2)(1997-4#1)
PKC by##5##2##(1992-9#1)(1993-6#1)(1996-12#1)(1997-1#1)(2008-8#1)
PKC delta##5##2##(1992-9#2)(1994-2#3)
PKC down-regulation by##2##3##(1992-9#2)
PKC down-regulation##4##2##(1992-8#1)(1992-9#2)(1995-3#1)
PKC epsilon##8##2##(1994-2#1)(1995-2#7)
PKC gamma##3##2##(1993-12#2)(2013-8#1)
PKC gamma-mutant mice##2##3##(1993-12#2)
PKC had no effect on##2##5##(1995-5#2)
PKC in the mechanism##2##4##(1996-5#1)(1997-1#1)
PKC in the##4##3##(1994-6#2)(1996-5#1)(1997-1#1)
PKC in##14##2##(1992-12#1)(1992-9#2)(1994-6#2)(1995-11#1)(1996-12#1)(1996-5#2)(1997-1#2)(2008-4#2)(2008-8#1)
PKC inhibitor staurosporine##2##3##(1992-9#1)(1993-3#1)
PKC inhibitor##6##2##(1992-11#1)(1992-9#1)(1993-3#1)(1995-11#1)(1997-1#1)(2008-4#1)
PKC inhibitors##6##2##(1991-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(1997-1#1)
PKC is not involved##2##4##(1992-9#1)(2008-11#1)
PKC is##7##2##(1992-6#1)(1992-9#2)(1995-5#1)(2008-11#1)(2008-4#2)
PKC isoenzymes##4##2##(1993-3#2)(1994-11#1)(1994-2#1)
PKC isoforms in pancreatic beta-cells##2##5##(1996-5#2)
PKC isoforms##7##2##(1992-11#1)(1994-6#1)(1996-5#2)(1996-9#2)(1997-4#1)
PKC isozyme##2##2##(1993-12#1)(1995-3#1)
PKC isozymes##4##2##(1992-6#1)(1994-11#1)(1995-2#1)(1996-6#1)
PKC may be##2##3##(1992-11#1)(1993-9#1)
PKC may##4##2##(1992-11#1)(1992-6#1)(1993-8#1)(1993-9#1)
PKC pathway##3##2##(1996-12#1)(1997-1#1)(2008-4#1)
PKC phosphorylation##3##2##(1992-3#1)(1992-9#1)(1997-9#1)
PKC plays a##2##3##(1993-3#1)(1997-7#1)
PKC signaling pathway##2##3##(1993-3#1)(2008-8#1)
PKC to##4##2##(1992-9#2)(1993-12#1)(1993-8#1)
PKC was the##2##3##(1992-9#1)(2008-8#1)
PKC was##7##2##(1991-12#1)(1992-11#1)(1992-9#1)(1997-6#1)(2008-11#1)(2008-8#2)
PKC were##2##2##(1997-4#1)(2008-9#1)
PKC##242##1##(1990-5#2)(1991-12#2)(1991-2#3)(1991-5#3)(1991-9#2)(1992-11#12)(1992-12#7)(1992-3#2)(1992-6#8)(1992-8#5)(1992-9#24)(1993-11#2)(1993-12#6)(1993-3#12)(1993-6#4)(1993-8#4)(1993-9#6)(1994-11#11)(1994-2#9)(1994-5#1)(1994-6#6)(1994-8#2)(1995-11#15)(1995-2#8)(1995-3#2)(1995-5#9)(1995-6#1)(1995-8#5)(1996-12#3)(1996-5#5)(1996-6#1)(1996-9#4)(1997-1#6)(1997-2#2)(1997-4#5)(1997-6#4)(1997-7#5)(1997-9#1)(2008-10#1)(2008-11#6)(2008-4#9)(2008-8#12)(2008-9#1)(2009-7#1)(2010-11#1)(2013-8#2)
PKC-##3##1##(1993-8#1)(1997-2#2)
PKC-alpha and PKC-sigma were detected in##2##6##(1995-11#2)
PKC-alpha and##4##2##(1995-11#2)(1995-3#1)(2008-8#1)
PKC-alpha##14##1##(1994-6#3)(1995-11#4)(1995-3#3)(1996-5#3)(2008-8#1)
PKC-beta##6##1##(1990-7#2)(1991-12#3)(1992-12#1)
PKC-beta-LI##2##1##(1991-12#2)
PKC-dependent##2##1##(1991-9#1)(2013-1#1)
PKC-epsilon was detected in the apical region of acinar cells and##2##11##(1995-11#2)
PKC-epsilon##9##1##(1990-7#3)(1995-11#5)(2008-8#1)
PKC-mediated##3##1##(1995-11#1)(1995-5#1)(2008-8#1)
PKC-sigma##4##1##(1995-11#4)
PKC-zeta was detected over the luminal##2##6##(1995-11#2)
PKC-zeta was detected##3##3##(1995-11#3)
PKC-zeta was##4##2##(1994-6#1)(1995-11#3)
PKC-zeta##7##1##(1994-6#3)(1995-11#4)
PKC-α phosphorylation##3##2##(2012-3#3)
PKC-α siRNA##2##2##(2012-3#2)
PKC-α##7##1##(2012-3#7)
PKC1##4##1##(1996-6#2)(1997-3#2)
PKCalpha translocation##2##2##(2008-9#2)
PKCalpha was##3##2##(2008-9#3)
PKCalpha##7##1##(2008-9#7)
PKCs##3##1##(1994-8#2)(2008-9#1)
PKCγ and##2##2##(2013-8#2)
PKCγ##4##1##(2013-8#4)
PKD contains##2##2##(1994-8#2)
PKD##5##1##(1994-8#5)
PKI##4##1##(1995-2#4)
PKL##2##1##(2009-8#2)
PKMzeta##2##1##(2009-6#1)(2013-8#1)
PKMζ activity##2##2##(2012-3#2)
PKMζ is necessary##2##3##(2012-3#2)
PKMζ is##3##2##(2012-3#3)
PKMζ##7##1##(2012-3#7)
PKR1##3##1##(2008-7#3)
PKS##5##1##(1994-12#4)(2008-8#1)
PKs##4##1##(1993-2#3)(2008-7#1)
PL and##5##2##(1994-3#1)(1997-4#3)(2008-12#1)
PL as a##2##3##(2008-10#2)
PL chains##2##2##(1990-12#2)
PL females having successfully borne at least three litters were ovariectomized (OV) to mimic human menopause##3##16##(1997-4#3)
PL females##4##2##(1997-4#4)
PL groups##3##2##(1994-6#1)(1997-4#2)
PL head group##2##3##(1994-3#2)
PL studies##3##2##(1994-6#1)(2008-10#2)
PL##44##1##(1990-12#2)(1991-12#1)(1993-11#1)(1993-8#1)(1994-3#6)(1994-6#3)(1997-4#13)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#7)(2009-11#1)(2013-1#1)
PL(+) mice taken##2##3##(1997-4#2)
PL(+)##3##1##(1997-4#3)
PL(-) females taken at the end of round (R)-1##2##9##(1997-4#2)
PL(-)##3##1##(1997-4#3)
PL-3##2##1##(2008-10#2)
PL-free diet group##4##3##(2008-7#4)
PL-supplemented diet groups##3##3##(2008-7#3)
PLA films##2##2##(2008-6#2)
PLA##7##1##(1991-11#1)(2008-5#2)(2008-6#4)
PLA2 activation##2##2##(1994-6#2)
PLA2 activity##2##2##(1990-8#1)(1991-5#1)
PLA2##17##1##(1990-11#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-5#1)(1993-11#2)(1993-9#2)(1994-6#4)(2013-7#3)
PLA2-H##2##1##(1990-7#2)
PLA2-L##7##1##(1990-7#7)
PLA₂##2##1##(2013-1#2)
PLC and##3##2##(1991-12#1)(2007-11#1)(2011-2#1)
PLC on##2##2##(2007-11#2)
PLC##22##1##(1991-12#2)(1991-2#1)(1992-12#1)(1993-8#1)(1997-4#3)(2007-11#6)(2008-4#3)(2009-3#3)(2010-11#1)(2011-2#1)
PLC-dependent##2##1##(2008-4#1)(2008-8#1)
PLC-gamma 1 and PLC-gamma 2##3##5##(1993-3#3)
PLC-gamma 1##6##2##(1992-7#3)(1993-3#3)
PLC-gamma##13##1##(1992-7#3)(1993-3#8)(1997-7#2)
PLC/PRF/5##2##1##(1990-8#2)
PLCgamma2##5##1##(2008-11#5)
PLCs##2##1##(1997-4#2)
PLD activation##4##2##(1991-2#2)(1993-3#2)
PLD activity in##2##3##(1995-8#2)
PLD activity##7##2##(1991-2#4)(1995-8#3)
PLD##20##1##(1991-2#9)(1992-12#1)(1993-3#2)(1995-8#7)(2011-2#1)
PLDD##4##1##(2007-8#4)
PLDMV##3##1##(2008-10#3)
PLE##4##1##(1990-2#2)(2008-10#2)
PLFF##2##1##(2012-2#2)
PLG##5##1##(1995-2#5)
PLGA particles##6##2##(2009-7#6)
PLGA surfaces##2##2##(2009-11#2)
PLGA##16##1##(2009-11#5)(2009-7#9)(2013-1#2)
PLIF##3##1##(2008-2#2)(2008-3#1)
PLL##7##1##(1991-5#1)(2008-10#5)(2008-11#1)
PLLA##3##1##(2009-7#3)
PLMDs##3##1##(2012-3#3)
PLP and DM-20##2##3##(1993-6#2)
PLP and##3##2##(1992-6#1)(1993-6#2)
PLP form##2##2##(1992-6#2)
PLP##11##1##(1992-6#3)(1993-6#2)(1997-7#1)(2008-7#1)(2009-6#4)
PLP-AMP##2##1##(1991-12#2)
PLRV in extracts of infected potato##2##6##(2008-10#2)
PLRV##12##1##(2008-10#12)
PLS and ANN##2##3##(2008-10#2)
PLS and##5##2##(2008-10#5)
PLS calibration model##2##3##(2007-12#1)(2008-10#1)
PLS calibration##5##2##(2007-11#1)(2007-12#1)(2008-10#3)
PLS components##2##2##(2008-5#2)
PLS discriminant analysis and##2##4##(2008-5#2)
PLS model##3##2##(2007-11#1)(2008-10#2)
PLS models are##2##3##(2008-10#2)
PLS models##4##2##(2007-11#1)(2008-10#3)
PLS regression##4##2##(2008-10#4)
PLS##56##1##(1994-12#1)(2007-11#3)(2007-12#1)(2008-10#43)(2008-5#5)(2013-8#3)
PLS)##2##1##(2008-10#2)
PLS-1 and##3##2##(2008-10#3)
PLS-1 method##2##2##(2008-10#2)
PLS-1 models were##2##3##(2008-10#2)
PLS-1 models##3##2##(2008-10#3)
PLS-1 regression##2##2##(2008-10#2)
PLS-1##16##1##(2008-10#16)
PLS-2 and PCR##2##3##(2008-10#2)
PLS-2##4##1##(2008-10#4)
PLS-DA##4##1##(2008-10#4)
PLS2 calibration##2##2##(2008-10#2)
PLS2##3##1##(2008-10#3)
PLSVC is##4##2##(2010-11#1)(2011-2#1)(2012-2#2)
PLSVC##10##1##(2010-11#4)(2011-2#2)(2012-2#4)
PLTP##4##1##(1997-4#4)
PLWHIV##3##1##(2009-10#3)
PLZF##2##1##(2011-2#2)
PM 10##2##2##(2008-11#2)
PM 1648 and PM(2##4##4##(2008-10#4)
PM 1648 and##5##3##(2008-10#5)
PM 1648##10##2##(2008-10#10)
PM and##5##2##(1994-12#1)(2008-10#1)(2008-7#2)(2013-7#1)
PM in the##2##3##(2008-7#2)
PM in##3##2##(2008-1#1)(2008-7#2)
PM of WGA-fed larvae##2##4##(2008-7#2)
PM of##3##2##(2008-7#3)
PM##62##1##(1993-11#2)(1994-12#2)(2007-11#1)(2008-1#3)(2008-10#21)(2008-11#4)(2008-6#1)(2008-7#20)(2009-10#1)(2009-7#2)(2011-2#1)(2013-7#4)
PM(10) concentrations##2##2##(2009-7#2)
PM(10)##6##1##(2008-10#2)(2009-7#4)
PM(2##13##1##(2008-10#5)(2008-5#8)
PM-DRGs##3##1##(1993-12#3)
PM10 concentrations##2##2##(2011-2#2)
PM10##9##1##(2008-10#1)(2009-7#1)(2011-2#7)
PM13- and PM100-BSA##2##3##(1993-11#2)
PM3##9##1##(1996-5#2)(2007-11#1)(2008-10#3)(2008-11#3)
PMA (1##2##2##(1997-1#1)(2008-4#1)
PMA and that##2##3##(1995-2#1)(2008-11#1)
PMA and##8##2##(1990-2#1)(1993-6#2)(1995-2#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-4#1)
PMA is##2##2##(1991-2#1)(1993-6#1)
PMA or forskolin##3##3##(1997-2#3)
PMA or##5##2##(1991-1#1)(1994-3#1)(1997-2#3)
PMA was##3##2##(1993-6#1)(1994-6#1)(1995-11#1)
PMA were##2##2##(1995-6#1)(1997-1#1)
PMA##53##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1993-6#10)(1994-3#1)(1994-6#4)(1994-8#5)(1995-11#1)(1995-2#2)(1995-6#3)(1995-8#2)(1996-2#2)(1997-1#5)(1997-2#4)(2006-6#3)(2008-11#2)(2008-4#2)(2008-8#2)
PMA-differentiated##3##1##(2008-10#3)
PMA-induced MAPK##2##2##(1995-6#2)
PMA-induced differentiation##3##2##(1994-8#1)(2008-10#2)
PMA-induced##10##1##(1993-6#1)(1994-8#2)(1995-6#2)(2008-10#2)(2008-11#3)
PMA-stimulated##3##1##(1991-2#1)(1991-9#1)(1994-6#1)
PMBCL##6##1##(2009-8#6)
PMBCLs##2##1##(2009-8#2)
PMBCs##3##1##(1991-11#3)
PMC##5##1##(1992-3#2)(2008-5#1)(2013-1#2)
PMCs##4##1##(2013-1#4)
PMD vector##2##2##(2007-11#1)(2007-12#1)
PMD##20##1##(2007-11#15)(2007-12#2)(2008-3#3)
PME production##2##2##(1991-9#2)
PME##9##1##(1991-9#7)(2008-2#1)(2008-8#1)
PMET##4##1##(2009-9#4)
PMHS##2##1##(2013-8#2)
PMI##3##1##(2007-8#1)(2009-10#2)
PMID##4##1##(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
PML##8##1##(1991-9#4)(2008-3#2)(2010-2#1)(2013-1#1)
PML-RAR protein##2##2##(1991-9#2)
PML-RAR##3##1##(1991-9#3)
PML-RARA##2##1##(2011-2#2)
PML-RARa transcripts##2##2##(2007-4#2)
PML-RARa##3##1##(2007-4#3)
PMM and##2##2##(2007-12#2)
PMM##6##1##(2007-12#6)
PMMA in##2##2##(2007-12#1)(2008-2#1)
PMMA microchip##2##2##(2008-10#2)
PMMA with##3##2##(2008-3#3)
PMMA##25##1##(1991-1#1)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#7)(2008-5#1)(2009-11#1)(2010-4#4)(2013-1#1)
PMME measurements##2##2##(2008-3#2)
PMME##3##1##(2008-3#3)
PMMV-k##7##1##(1997-6#7)
PMMV-s##2##1##(1997-6#2)
PMMoV##2##1##(2008-10#2)
PMN activation##2##2##(1995-6#1)(1996-2#1)
PMN adhesion to##2##3##(1996-2#2)
PMN functional##2##2##(1991-2#1)(1995-6#1)
PMN functions##2##2##(1991-9#1)(2008-10#1)
PMN##21##1##(1991-2#3)(1991-8#1)(1991-9#2)(1993-11#1)(1993-3#1)(1993-6#3)(1995-6#2)(1996-2#3)(2008-10#4)(2008-12#1)
PMNLs IP3 formation##2##3##(1993-1#2)
PMNLs and##5##2##(1993-1#1)(2010-1#4)
PMNLs##8##1##(1993-1#4)(2010-1#4)
PMNs and##5##2##(1996-2#1)(2008-4#1)(2009-10#3)
PMNs from ARDS patients was significantly##2##6##(1991-9#2)
PMNs of patients##2##3##(2008-4#2)
PMNs of##3##2##(2008-4#3)
PMNs##23##1##(1991-9#4)(1992-5#2)(1993-6#4)(1995-6#2)(1996-2#3)(2008-4#5)(2009-10#3)
PMP##5##1##(1992-6#3)(2009-5#2)
PMP22 locus##2##2##(1997-3#2)
PMP22##3##1##(1997-3#3)
PMS and selected dehydrogenase enzymes##2##5##(2008-10#2)
PMS##6##1##(2008-10#5)(2008-11#1)
PMSF and##2##2##(1996-2#2)
PMSF##6##1##(1991-2#1)(1996-2#4)(2008-8#1)
PMSG##4##1##(2008-5#3)(2008-8#1)
PMT activity##3##2##(2013-8#3)
PMT##16##1##(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#7)
PMTCT efforts##2##2##(2012-2#2)
PMTCT##3##1##(2012-2#3)
PMV satRNAs##2##2##(2008-10#2)
PMWaV from##2##2##(2008-10#2)
PMWaV##4##1##(2008-10#4)
PMWaV-1-free and PMWaV-1-infected plants##2##4##(2008-10#2)
PMWaV-1-free##3##1##(2008-10#3)
PMWaV-1-infected plants that##2##3##(2008-10#2)
PMWaV-1-infected plants##3##2##(2008-10#3)
PMWaV-2##5##1##(2008-10#5)
PMe(3)##2##1##(1996-2#2)
PN mode##3##2##(2008-10#3)
PN solutions in the range##2##5##(2008-10#2)
PN##17##1##(2008-10#8)(2008-7#6)(2011-1#1)(2013-1#2)
PN-2/APP in##3##2##(1991-2#1)(1992-12#2)
PN-2/APP is##4##2##(1991-2#2)(1992-12#2)
PN-2/APP##13##1##(1991-2#7)(1992-12#6)
PN2-3##2##1##(2009-7#2)
PNA is##2##2##(2008-1#1)(2008-2#1)
PNA was##2##2##(2008-2#2)
PNA##7##1##(2008-1#2)(2008-2#5)
PNA)##2##1##(2008-4#1)(2008-9#1)
PNAs##4##1##(2008-4#4)
PNB##3##1##(1994-12#3)
PNBCE##4##1##(1994-12#4)
PND 5-10##2##2##(1996-5#2)
PND##9##1##(1993-11#4)(1996-5#4)(2009-11#1)
PNDB's##2##1##(2008-3#2)
PNDC myeloblast counts##2##3##(2008-11#2)
PNDC##6##1##(2008-11#6)
PNE##4##1##(2007-7#4)
PNET##4##1##(2007-7#2)(2008-7#2)
PNF##3##1##(2007-11#1)(2009-1#2)
PNF-LI##4##1##(1991-12#4)
PNFA patients##2##2##(2008-4#1)(2009-9#1)
PNH##4##1##(1996-8#1)(2008-4#1)(2008-9#2)
PNIPAAm##2##1##(2008-10#2)
PNIPAM particles##3##2##(2008-10#3)
PNIPAM##6##1##(2008-10#6)
PNMT##2##1##(1997-3#1)(2013-1#1)
PNN##6##1##(2010-8#6)
PNP##3##1##(1994-8#2)(2010-4#1)
PNP)##3##1##(1994-8#3)
PNPase##2##1##(1997-2#2)
PNPs##2##1##(2010-4#2)
PNR-519##2##1##(2008-12#2)
PNRSV isolates##3##2##(2008-10#3)
PNRSV##13##1##(2008-10#13)
PNS##13##1##(1993-6#2)(1995-12#1)(2008-6#1)(2008-7#7)(2011-1#1)(2011-2#1)
PNW##4##1##(2008-10#4)
PNZIP gene##2##2##(2008-9#2)
PNZIP promoter##3##2##(2008-9#3)
PNZIP##5##1##(2008-9#5)
PNs##4##1##(2011-2#3)(2012-12#1)
PO are##2##2##(1993-8#1)(2008-7#1)
PO in the##2##3##(1993-8#1)(2011-10#1)
PO in##4##2##(1993-8#1)(2008-10#1)(2011-10#2)
PO##13##1##(1993-8#3)(1997-2#2)(2008-10#3)(2008-7#1)(2011-1#1)(2011-10#3)
PO(2)##2##1##(2008-10#1)(2008-6#1)
PO(4)(3-) limitation and Cd stress##2##5##(2013-1#2)
PO(4)(3-) limitation and Cd##3##4##(2013-1#3)
PO(4)(3-) limitation##6##2##(2013-1#6)
PO(4)(3-)##12##1##(2008-10#4)(2013-1#8)
PO)##2##1##(2010-5#1)(2011-2#1)
PO2 levels##2##2##(2013-8#2)
PO2##4##1##(2013-8#4)
POA and##2##2##(1991-12#1)(1991-5#1)
POA##9##1##(1991-12#3)(1991-5#3)(2008-8#3)
POB##3##1##(2008-12#2)(2013-8#1)
POC##3##1##(2008-10#2)(2013-1#1)
POD##2##1##(2008-10#1)(2013-8#1)
POD-like activity##4##2##(2008-10#4)
POD-like##5##1##(2008-10#5)
POD1##2##1##(2012-2#2)
PODS##3##1##(2008-10#3)
POF's had a##2##3##(2008-3#2)
POF's##5##1##(2008-3#5)
POI duration##2##2##(2010-4#2)
POI##5##1##(2008-10#2)(2010-4#3)
POINTS##2##1##(1992-11#1)(1992-9#1)
POL and PLL1 are##2##4##(2009-8#2)
POL##3##1##(2008-10#1)(2009-8#2)
POL1##2##1##(1996-3#2)
POLDER##3##1##(2008-3#3)
POLIB silencing##2##2##(2010-2#2)
POLIB##7##1##(2010-2#7)
POM and TiO2##2##3##(2008-10#2)
POM##8##1##(1995-2#1)(2008-10#4)(2010-6#3)
POM-mediated##3##1##(2008-10#3)
POMC gene expression##3##3##(1993-5#3)
POMC mRNA levels##2##3##(1993-5#2)
POMC mRNA##3##2##(1993-5#2)(1996-12#1)
POMC##17##1##(1993-5#13)(1994-9#1)(1996-12#1)(2008-4#2)
POMC-derived##2##1##(1993-5#1)(1995-12#1)
POMS##3##1##(2008-12#1)(2008-3#2)
PON1 activity##3##2##(2012-12#3)
PONPE 7##2##2##(2008-10#2)
POPC##6##1##(1990-7#1)(1992-6#3)(1997-2#2)
POPS##5##1##(1990-7#4)(2008-11#1)
POPULATION##3##1##(2007-12#1)(2010-8#1)(2012-3#1)
POPs such as##2##3##(2008-7#2)
POPs##9##1##(2008-10#1)(2008-7#8)
POR and##2##2##(1995-5#2)
POR##6##1##(1993-1#2)(1995-5#3)(2008-10#1)
POSSIBLE EU®##3##2##(2011-1#3)
POU domain and##2##3##(1992-6#2)
POU domain##9##2##(1990-11#1)(1992-6#6)(1992-9#1)(1993-8#1)
POU##14##1##(1990-11#1)(1992-6#7)(1992-9#2)(1993-8#1)(1995-6#1)(1996-12#2)
POU-domain gene##2##2##(1992-9#2)
POU-specific subdomain and##2##3##(1992-6#2)
POX + ALO##2##3##(1997-4#2)
POX##8##1##(1997-4#6)(2008-10#2)
POX1##2##1##(1996-3#2)
POX18##4##1##(1990-5#3)(1991-9#1)
PP DCs##4##2##(2008-11#4)
PP RTA##3##2##(2007-12#3)
PP and SPL cells##2##4##(2008-11#2)
PP and##6##2##(2008-10#2)(2008-11#3)(2010-11#1)
PP cells##4##2##(2008-11#4)
PP increased##2##2##(2008-11#1)(2010-4#1)
PP##37##1##(1991-5#1)(1996-5#1)(2007-12#3)(2008-10#3)(2008-11#13)(2008-5#2)(2008-6#1)(2009-8#1)(2010-11#2)(2010-4#3)(2011-1#2)(2012-4#1)(2013-1#4)
PP(i) generation##3##2##(2008-4#3)
PP(i) levels##3##2##(2008-4#3)
PP(i)##10##1##(2008-4#10)
PP)##3##1##(1996-5#1)(2008-1#1)(2012-4#1)
PP-2A##2##1##(1995-5#2)
PP-positive##2##1##(2008-5#2)
PP1 in##2##2##(1995-6#1)(2012-12#1)
PP1##8##1##(1995-6#2)(2012-12#6)
PPA 316##3##2##(2008-7#3)
PPA and##2##2##(1996-2#1)(2008-4#1)
PPA##10##1##(1990-7#2)(1990-9#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#4)
PPA316##2##1##(2008-7#2)
PPAR activators##2##2##(1994-12#1)(1995-6#1)
PPAR gamma 2 is##2##4##(1994-12#2)
PPAR gamma 2##5##3##(1994-12#5)
PPAR gamma##7##2##(1994-12#6)(2008-11#1)
PPAR##15##1##(1994-12#7)(1995-6#2)(2008-1#4)(2008-11#1)(2008-5#1)
PPAR-gamma##2##1##(2008-7#2)
PPAR-α activation##2##2##(2013-7#2)
PPAR-α##4##1##(2013-7#4)
PPARalpha and PPARgamma##3##3##(2008-1#3)
PPARalpha and##4##2##(2008-1#3)(2008-5#1)
PPARalpha##9##1##(2008-1#7)(2008-3#1)(2008-5#1)
PPARdelta is##2##2##(2008-1#2)
PPARdelta##10##1##(2008-1#8)(2008-3#1)(2008-5#1)
PPARg2##2##1##(2006-8#2)
PPARgamma and##2##2##(2008-11#1)(2008-5#1)
PPARgamma has##2##2##(2008-3#2)
PPARgamma##24##1##(2008-1#9)(2008-11#1)(2008-3#8)(2008-5#6)
PPARs##4##1##(2008-1#1)(2008-5#2)(2013-7#1)
PPC##5##1##(1991-6#2)(2008-7#1)(2009-10#1)(2011-3#1)
PPCs##4##1##(2011-2#4)
PPD and BOP##2##3##(2013-1#2)
PPD and##3##2##(2007-2#1)(2013-1#2)
PPD test##2##2##(1997-2#1)(2008-5#1)
PPD##18##1##(1996-12#2)(1997-2#1)(2007-2#3)(2008-5#2)(2010-5#1)(2012-3#3)(2013-1#6)
PPE and##2##2##(2008-5#2)
PPE is##2##2##(2012-1#2)
PPE##11##1##(1991-3#2)(1996-12#2)(2008-5#4)(2012-1#3)
PPF's##4##1##(2008-3#4)
PPG##6##1##(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)
PPG-1025&gt##2##1##(2008-10#2)
PPG2000##2##1##(2008-7#2)
PPH due to uterine atony##2##5##(2011-2#2)
PPH is##2##2##(1997-5#2)
PPH was##2##2##(1997-5#2)
PPH##11##1##(1992-12#1)(1997-5#7)(2011-2#3)
PPI and##2##2##(2008-11#1)(2008-7#1)
PPI breakdown##2##2##(2008-8#2)
PPI hydrolysis and##2##3##(1996-5#1)(2008-8#1)
PPI hydrolysis##9##2##(1996-5#8)(2008-8#1)
PPI##33##1##(1991-1#1)(1996-5#8)(1997-4#1)(2008-11#7)(2008-7#3)(2008-8#5)(2011-2#1)(2012-2#3)(2013-1#4)
PPID##2##1##(2008-2#2)
PPII and triple helix##3##4##(2013-1#3)
PPII##6##1##(2013-1#6)
PPIP##2##1##(1996-2#2)
PPIs##2##1##(2006-10#1)(2012-2#1)
PPK##2##1##(1994-11#2)
PPL##2##1##(1996-3#1)(2013-1#1)
PPLN OPO##2##2##(2007-12#1)(2008-3#1)
PPLN crystal##3##2##(2007-12#3)
PPLN##11##1##(2007-12#9)(2008-3#2)
PPM##3##1##(2008-3#2)(2011-2#1)
PPN##2##1##(2008-7#2)
PPO and##3##2##(1993-12#1)(2008-10#2)
PPO##14##1##(1992-2#2)(1993-12#2)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#6)
PPOs##6##1##(1992-2#2)(1993-12#1)(1994-2#2)(1997-1#1)
PPP free##2##2##(1997-7#2)
PPP##7##1##(1997-7#5)(2008-7#2)
PPPT##2##1##(2008-12#2)
PPR antigen##2##2##(2011-2#2)
PPR##9##1##(1995-12#3)(2011-2#6)
PPS has been##3##3##(1992-2#3)
PPS has##5##2##(1992-2#5)
PPS payment##3##2##(1992-12#2)(1992-2#1)
PPS payments##2##2##(1992-12#2)
PPS##42##1##(1992-1#1)(1992-12#8)(1992-2#16)(1993-3#8)(1994-3#1)(1995-3#2)(2006-5#2)(2008-2#3)(2008-7#1)
PPS-excluded hospitals##2##2##(1992-1#2)
PPT##5##1##(1992-9#1)(2009-5#2)(2010-12#1)(2013-1#1)
PPTases##2##1##(2013-1#2)
PPTg##5##1##(1994-2#4)(1995-12#1)
PPV HC-Pro##5##2##(2008-10#5)
PPV in##2##2##(2008-10#2)
PPV infections##2##2##(2008-10#2)
PPV isolates##2##2##(2008-10#2)
PPV spread##2##2##(2008-10#2)
PPV##22##1##(2007-10#1)(2008-10#20)(2012-12#1)
PPV-D##8##1##(2008-10#8)
PPV-M infection##2##2##(2008-10#2)
PPV-M##11##1##(2008-10#11)
PPV-M-specific monoclonal##2##2##(2008-10#2)
PPV-infected##4##1##(2008-10#4)
PPV2##2##1##(2013-1#2)
PPX##3##1##(1994-11#3)
PPY##3##1##(1997-6#2)(2008-10#1)
PPa##5##1##(2008-8#5)
PPase##2##1##(2008-11#2)
PPh(2)Me##2##1##(1996-2#2)
PPh(3)##3##1##(1996-2#3)
PPy coated##2##2##(2008-10#2)
PPy film##4##2##(2008-10#4)
PPy##6##1##(2008-10#6)
PPy-calcion film##3##2##(2008-10#3)
PPy-calcion##4##1##(2008-10#4)
PPy/FeCN##2##1##(2008-10#2)
PPy/alpha-NS(-)/PMMA##2##1##(2008-10#2)
PQ##12##1##(1995-8#8)(2008-10#4)
PQC##9##1##(2008-10#9)
PQRS reporting of##2##3##(2012-2#2)
PQS##2##1##(2009-6#2)
PR and##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
PR coated on##2##3##(2008-10#2)
PR for##2##2##(1994-9#2)
PR gene##3##2##(2008-10#3)
PR genes##3##2##(2008-10#3)
PR in the##2##3##(1994-9#1)(1996-5#1)
PR in##7##2##(1990-12#2)(1994-9#2)(1995-4#1)(1996-5#1)(2013-8#1)
PR patients##2##2##(2010-1#2)
PR proteins##5##2##(2008-10#5)
PR to P##3##3##(2008-10#3)
PR were##3##2##(1991-9#2)(1997-7#1)
PR with##2##2##(1991-9#1)(1994-9#1)
PR##65##1##(1990-12#2)(1991-3#1)(1991-9#3)(1992-2#1)(1993-9#1)(1994-9#8)(1995-2#1)(1995-4#1)(1996-5#2)(1997-7#3)(2008-10#26)(2008-12#1)(2008-3#1)(2010-1#4)(2011-2#1)(2011-3#2)(2013-1#3)(2013-8#4)
PR(1)##2##1##(2008-10#2)
PR(2)##2##1##(2008-10#2)
PR)##3##1##(1992-2#2)(1996-5#1)
PR-1##3##1##(2008-10#3)
PR-10##2##1##(2008-10#2)
PR-1B##3##1##(2008-10#3)
PR-1a##4##1##(2008-10#4)
PR-5##6##1##(1997-4#3)(2008-10#3)
PRACTICE IMPLICATIONS##5##2##(2011-2#1)(2013-1#4)
PRACTICE##8##1##(2011-2#1)(2012-12#1)(2013-1#6)
PRAs##2##1##(2008-7#2)
PRBS##2##1##(2008-2#2)
PRC##4##1##(2007-12#1)(2008-12#1)(2010-12#2)
PRCA##7##1##(2007-10#2)(2008-10#5)
PRE##11##1##(2012-2#6)(2012-3#5)
PRES##3##1##(2013-1#3)
PRESENTATION##5##1##(2012-2#4)(2013-1#1)
PRETRAHGUAD##2##1##(2008-10#2)
PREVALENCE##2##1##(2010-8#1)(2013-8#1)
PRI##2##1##(2008-10#1)(2010-9#1)
PRIDE##4##1##(1991-1#1)(1992-3#1)(1994-1#1)(2009-5#1)
PRINCIPAL##3##1##(2009-9#2)(2011-2#1)
PRINS and##2##2##(2008-9#2)
PRINS##4##1##(2008-9#4)
PRK##8##1##(2008-3#2)(2009-10#6)
PRL expression##4##2##(1994-3#2)(2008-10#2)
PRL level after##2##3##(2008-7#2)
PRL level was##2##3##(2008-7#2)
PRL level##5##2##(2008-7#5)
PRL levels##2##2##(1994-3#1)(2011-2#1)
PRL mRNA##2##2##(1994-3#2)
PRL profile curve##2##3##(2008-7#2)
PRL profile was##2##3##(2008-7#2)
PRL profile##6##2##(2008-7#6)
PRL secretion and##2##3##(1990-7#2)
PRL secretion in##2##3##(1993-11#1)(2008-7#1)
PRL secretion##8##2##(1990-7#4)(1993-11#1)(1994-3#2)(2008-7#1)
PRL##54##1##(1990-7#4)(1991-12#2)(1991-6#2)(1993-11#1)(1994-3#10)(2008-10#6)(2008-6#3)(2008-7#19)(2011-2#6)(2013-1#1)
PRL-R mRNA##4##2##(2011-2#4)
PRL-R##10##1##(2011-2#10)
PRML##2##1##(2008-3#2)
PRN##5##1##(1997-6#4)(2010-6#1)
PRO and##2##2##(2008-10#2)
PRO##8##1##(1991-1#1)(1991-3#1)(1993-2#1)(1995-12#2)(2008-10#3)
PROBLEM##2##1##(2009-11#1)(2009-12#1)
PROCEDURES##4##1##(2009-9#1)(2010-7#1)(2012-3#1)(2013-1#1)
PROGRAMS##2##1##(2008-10#1)(2009-9#1)
PROLIFERA##2##1##(2008-10#2)
PROM##7##1##(2012-12#1)(2012-3#6)
PROMETHEE and GAIA##2##3##(2008-10#2)
PROMETHEE##3##1##(2008-10#3)
PROSITE##2##1##(1996-10#1)(2008-7#1)
PROT mRNA##2##2##(1995-6#2)
PROT protein##5##2##(1995-6#5)
PROT##9##1##(1995-6#9)
PROWL##3##1##(2008-4#3)
PRP group##4##2##(2007-9#4)
PRP##13##1##(1995-5#1)(2007-9#6)(2008-7#4)(2011-2#1)(2013-1#1)
PRPSE##5##1##(2008-2#2)(2008-3#3)
PRRC pathogens##2##2##(2008-10#2)
PRRC##3##1##(2008-10#3)
PRRS lines##2##2##(2008-3#2)
PRRS##5##1##(2008-3#5)
PRSV YK##2##2##(2008-10#2)
PRSV type##2##2##(2008-10#2)
PRSV##9##1##(2008-10#9)
PRWE##4##1##(2008-9#4)
PRX##3##1##(2008-5#3)
PRms##8##1##(2008-10#8)
PRs in donors vs recipients in a shared##2##8##(1994-9#2)
PRs in##4##2##(1994-9#4)
PRs##10##1##(1991-2#1)(1994-9#9)
PS (p=0##2##2##(2008-10#2)
PS I##2##2##(1995-12#1)(2010-7#1)
PS and PS##2##3##(2008-10#2)
PS and##4##2##(1995-8#1)(2007-11#1)(2008-10#2)
PS bonds##2##2##(2008-10#2)
PS matrix##2##2##(2008-10#2)
PS primers##2##2##(2008-10#2)
PS was##2##2##(1990-2#1)(2008-10#1)
PS##51##1##(1990-2#2)(1991-9#1)(1992-10#2)(1993-11#6)(1995-12#3)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#5)(2008-3#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2010-7#1)(2013-1#1)
PS-(DEA)(2) for Hg(2+)##2##3##(2008-10#2)
PS-1 and##2##2##(1995-12#1)(2008-10#1)
PS-1##3##1##(1995-12#2)(2008-10#1)
PS-264 and stearic acid was##2##5##(2008-10#2)
PS-264##5##1##(2008-10#5)
PS-DEA for Cu(2+)##3##3##(2008-10#3)
PS-OCT##2##1##(2007-11#2)
PS-SCL are tested for their##2##5##(2008-4#2)
PS-SCL##4##1##(2008-4#4)
PS-anh was##2##2##(2009-11#2)
PS-oligos##4##1##(2008-4#4)
PS/PDI##4##1##(2008-3#4)
PS1 and PS2##5##3##(1995-8#4)(2008-10#1)
PS1##7##1##(1995-8#6)(2008-10#1)
PS2##6##1##(1995-8#5)(2008-10#1)
PSA and##2##2##(2008-4#1)(2010-8#1)
PSA forms##2##2##(2010-12#2)
PSA levels##2##2##(2009-5#1)(2010-12#1)
PSA promoter##5##2##(2008-4#1)(2008-9#4)
PSA secretion##2##2##(2010-1#2)
PSA was##2##2##(1990-9#1)(2011-2#1)
PSA##54##1##(1990-9#6)(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#7)(2008-9#4)(2009-4#1)(2009-5#3)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#10)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)
PSA)##2##1##(2008-7#1)(2009-4#1)
PSA-NCAM##4##1##(2009-8#4)
PSB##2##1##(1996-9#1)(2008-7#1)
PSC geometries##2##2##(2010-10#2)
PSC##7##1##(2010-10#7)
PSCT was##2##2##(2007-5#2)
PSCT##4##1##(2007-5#4)
PSD is used to detect the position of the##2##9##(2008-3#2)
PSD is##3##2##(1996-12#1)(2008-3#2)
PSD structure##2##2##(1996-12#2)
PSD##23##1##(1996-12#9)(1997-2#2)(2008-11#1)(2008-3#9)(2010-8#2)
PSD's##3##1##(2008-3#3)
PSD-95 clustering##2##2##(2012-3#2)
PSD-95##8##1##(2012-3#8)
PSDs##3##1##(1996-12#3)
PSF and##2##2##(2008-3#2)
PSF##10##1##(2008-2#2)(2008-3#8)
PSG and##2##2##(2008-3#2)
PSG##4##1##(1990-5#1)(2008-3#2)(2012-3#1)
PSH-1##2##1##(2008-10#2)
PSH-10##2##1##(2008-10#2)
PSH-13##2##1##(2008-10#2)
PSH-14##2##1##(2008-10#2)
PSH-20##3##1##(2008-10#3)
PSH-4##2##1##(2008-10#2)
PSH-48##2##1##(2008-10#2)
PSHB##4##1##(2007-12#4)
PSI##5##1##(2008-10#1)(2008-7#3)(2008-8#1)
PSICAM##2##1##(2008-3#2)
PSII particles##5##2##(2008-4#5)
PSII proteins##2##2##(2008-8#2)
PSII##15##1##(2008-10#1)(2008-4#7)(2008-8#4)(2008-9#2)(2012-7#1)
PSIS##2##1##(2009-9#2)
PSJTC##5##1##(2008-2#3)(2008-3#2)
PSO at T11##2##3##(2012-12#2)
PSO for##2##2##(2012-12#2)
PSO##7##1##(2007-9#2)(2012-12#5)
PSP 24##3##2##(2007-12#3)
PSP and MSA##2##3##(2008-7#2)
PSP and##4##2##(2008-10#1)(2008-7#2)(2012-12#1)
PSP##25##1##(1992-8#2)(1994-12#2)(1996-7#1)(2007-12#3)(2008-10#2)(2008-3#9)(2008-7#3)(2012-12#3)
PSPMH##2##1##(2008-10#2)
PSS increases##2##2##(2009-11#2)
PSS solution##3##2##(2009-11#3)
PSS##17##1##(2007-10#3)(2008-3#2)(2009-11#10)(2010-1#2)
PST (1-49)##3##2##(1990-12#3)
PST (33-49) and PST (35-49)##2##5##(1990-12#2)
PST (33-49)##4##2##(1990-12#4)
PST (35-49)##5##2##(1990-12#5)
PST (37-49) and PST (39-49) were##2##6##(1990-12#2)
PST in##2##2##(1994-11#1)(2008-10#1)
PST is##2##2##(1990-12#1)(2008-9#1)
PST##30##1##(1990-12#20)(1994-11#2)(2008-10#6)(2008-9#2)
PST-21 of P##2##3##(2008-10#2)
PSTI##5##1##(1990-12#5)
PSU##2##1##(1992-12#1)(2007-5#1)
PSV CP##3##2##(2008-10#3)
PSV strains##4##2##(2008-10#4)
PSV subgroup I##2##3##(2008-10#2)
PSV subgroup II##2##3##(2008-10#2)
PSV subgroup##4##2##(2008-10#4)
PSV##21##1##(2007-10#3)(2008-1#1)(2008-10#16)(2013-8#1)
PSV-BV-15 RNA2##4##2##(2008-10#4)
PSV-BV-15##5##1##(2008-10#5)
PSV-W (subgroup II)##2##3##(2008-10#2)
PSV-W##4##1##(2008-10#4)
PT 20210 G-A##2##3##(2012-12#2)
PT and DT cells##4##4##(1995-11#4)
PT and##6##2##(1995-11#4)(1995-5#1)(2013-1#1)
PT fluorescence##2##2##(1994-8#2)
PT on##3##2##(2012-2#3)
PT taste##2##2##(1993-12#2)
PT##23##1##(1993-1#1)(1993-12#3)(1994-8#3)(1995-11#6)(1995-5#2)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
PT-61##2##1##(1994-11#2)
PT-responsive sites##3##2##(1993-12#3)
PT-responsive##4##1##(1993-12#4)
PT/RN = 0##2##3##(2008-7#2)
PT/RTT = 0##2##3##(2008-7#2)
PTA##7##1##(1990-2#1)(1995-2#1)(2008-1#1)(2008-7#3)(2013-1#1)
PTB cases of the##2##4##(2013-8#2)
PTB cases##3##2##(2013-8#3)
PTB##10##1##(2008-1#6)(2008-2#1)(2013-8#3)
PTB1##2##1##(2008-9#2)
PTC##6##1##(1990-9#1)(1997-3#1)(2008-12#2)(2008-4#1)(2008-5#1)
PTCA in##5##2##(1992-9#2)(2007-8#3)
PTCA##22##1##(1992-4#2)(1992-9#4)(1994-11#1)(2006-8#3)(2007-8#9)(2008-5#2)(2009-12#1)
PTCCSL##3##1##(2008-5#3)
PTDM##12##1##(2008-1#12)
PTE and##2##2##(2008-1#1)(2010-6#1)
PTE##7##1##(2008-1#1)(2008-10#2)(2010-6#4)
PTEN and##2##2##(2010-12#1)(2011-2#1)
PTEN##4##1##(2010-12#1)(2011-2#2)(2013-8#1)
PTFE coiled reactor positioned##2##4##(2008-10#2)
PTFE graft##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
PTFE grafts##5##2##(1991-6#1)(2007-7#3)(2008-1#1)
PTFE group##2##2##(2007-7#2)
PTFE in##2##2##(1990-9#1)(2008-10#1)
PTFE packed column##2##3##(2008-10#2)
PTFE reaction coil##2##3##(2008-10#2)
PTFE tube##2##2##(2008-10#2)
PTFE tubing##3##2##(2008-10#3)
PTFE##48##1##(1990-9#3)(1991-6#1)(2007-7#10)(2007-8#1)(2008-1#1)(2008-10#29)(2008-3#1)(2011-2#2)
PTGS and##2##2##(2008-10#2)
PTGS##9##1##(2008-10#8)(2008-9#1)
PTH (1-34)##4##2##(2008-8#4)
PTH (1-34)-induced##2##2##(2008-8#2)
PTH and 1##4##3##(1993-6#1)(1994-11#2)(1997-7#1)
PTH and##10##2##(1993-3#1)(1993-6#1)(1994-11#2)(1995-6#1)(1997-7#1)(2008-12#1)(2011-1#3)
PTH from##2##2##(2008-1#1)(2011-1#1)
PTH in##2##2##(1991-3#1)(1991-5#1)
PTH levels##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
PTH values##3##2##(2008-1#1)(2008-10#2)
PTH##62##1##(1990-11#2)(1990-2#1)(1991-12#3)(1991-3#4)(1991-5#1)(1991-6#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#5)(1994-6#2)(1995-6#1)(1997-7#5)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#10)(2011-1#8)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
PTH(1-84) was##2##2##(1994-6#2)
PTH(1-84)##7##1##(1994-6#7)
PTH-amino acids##3##2##(2008-10#3)
PTH2 receptor##3##2##(1995-6#3)
PTHrP expression vectors##2##3##(1993-3#2)
PTHrP was##2##2##(1994-7#2)
PTHrP##18##1##(1993-3#9)(1994-7#7)(1995-6#1)(2013-7#1)
PTK activity##2##2##(1997-6#2)
PTK inhibitors##2##2##(1995-11#2)
PTK##7##1##(1994-6#2)(1994-8#1)(1995-11#2)(1997-6#2)
PTKs##7##1##(1993-3#3)(1995-11#4)
PTLD##3##1##(2008-5#3)
PTM##4##1##(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)
PTMs##2##1##(2008-7#1)(2009-5#1)
PTO##7##1##(1993-1#2)(2008-5#5)
PTOB##2##1##(2008-10#2)
PTOC##2##1##(1996-9#2)
PTOX##2##1##(2010-10#2)
PTP synthase##6##2##(1997-8#6)
PTP##8##1##(1994-6#2)(1997-8#6)
PTPN7##3##1##(2009-7#3)
PTPase activity##5##2##(1993-3#4)(2008-8#1)
PTPase##10##1##(1993-3#4)(1997-7#1)(2008-8#5)
PTPepsilon##4##1##(2009-6#4)
PTQA##2##1##(2008-10#2)
PTR##2##1##(1997-6#2)
PTS##7##1##(1997-7#1)(2007-11#1)(2008-7#4)(2011-2#1)
PTSD and depression##4##3##(2008-8#3)(2013-1#1)
PTSD and##8##2##(2008-10#3)(2008-8#3)(2009-11#1)(2013-1#1)
PTSD patients##2##2##(1996-7#2)
PTSD symptoms##6##2##(1996-7#1)(2009-11#3)(2010-10#2)
PTSD was##3##2##(1991-2#1)(2012-1#1)(2013-8#1)
PTSD##40##1##(1991-2#1)(1996-5#1)(1996-7#5)(2008-10#3)(2008-6#6)(2008-8#4)(2009-11#7)(2010-10#3)(2010-7#1)(2011-2#1)(2012-1#3)(2012-12#2)(2013-1#1)(2013-8#2)
PTSD-SA patients##2##2##(1996-5#2)
PTSD-SA##4##1##(1996-5#4)
PTTH (approximately##2##2##(1995-11#2)
PTTH##6##1##(1995-11#6)
PTTH-stimulated##4##1##(1995-11#4)
PTU##2##1##(1992-12#1)(1994-6#1)
PTV##7##1##(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#2)
PTV-LV-GC/MS/MS##3##1##(2008-10#3)
PTX##2##1##(2008-4#1)(2008-9#1)
PTX-insensitive##2##1##(2008-4#2)
PTX-sensitive##2##1##(1994-11#1)(2008-4#1)
PTs##2##1##(1993-1#1)(2008-7#1)
PU fibers##3##2##(2009-9#3)
PU foam##3##2##(2008-10#3)
PU##10##1##(2008-10#4)(2008-2#2)(2009-9#3)(2012-3#1)
PUB##4##1##(2008-3#4)
PUF##12##1##(2008-10#7)(2008-11#5)
PUFA and##3##2##(1994-2#1)(2010-6#2)
PUFA to##2##2##(1995-8#1)(2013-1#1)
PUFA##18##1##(1994-2#2)(1995-12#1)(1995-8#1)(2008-10#1)(2008-5#2)(2010-6#2)(2012-2#2)(2013-1#7)
PUFA/SFA ratio##2##2##(2010-4#2)
PUFAs on##4##2##(2010-6#1)(2013-1#3)
PUFAs##24##1##(2008-10#7)(2008-5#1)(2010-6#3)(2012-2#2)(2013-1#11)
PUO##3##1##(2007-7#1)(2008-10#2)
PUR##2##1##(2008-10#1)(2008-9#1)
PURPOSE OF THE##2##3##(2011-2#1)(2012-3#1)
PURPOSE OF##3##2##(2009-5#1)(2011-2#1)(2012-3#1)
PURPOSE##57##1##(1995-4#1)(2008-11#1)(2008-5#3)(2009-11#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-12#2)(2012-3#3)(2013-1#31)
PURPOSES##2##1##(2010-3#1)(2011-2#1)
PURSUIT##2##1##(2012-12#1)(2012-2#1)
PUT application##2##2##(2011-2#2)
PUT##6##1##(2011-2#6)
PUV in##3##2##(2008-1#2)(2008-10#1)
PUV##6##1##(2008-1#3)(2008-10#3)
PUVA treatment of Psoriasis##2##4##(2007-7#2)
PUVA treatment##5##2##(2007-7#5)
PUVA##6##1##(1995-5#1)(2007-7#5)
PV genome##2##2##(2008-11#2)
PV in##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
PV plus##3##2##(2008-10#3)
PV##25##1##(1996-5#4)(2008-10#9)(2008-11#4)(2010-5#1)(2010-7#1)(2011-2#6)
PV-61##4##1##(2008-10#4)
PVA added extraction resin##2##4##(2008-10#2)
PVA and Gly##2##3##(2008-5#2)
PVA and##6##2##(2008-10#3)(2008-5#3)
PVA hybrids with##2##3##(2008-5#2)
PVA in the##2##3##(2008-10#1)(2008-5#1)
PVA in##3##2##(2008-10#2)(2008-5#1)
PVA was##2##2##(2008-10#1)(2008-12#1)
PVA##42##1##(1993-11#1)(1997-6#1)(2008-10#22)(2008-12#1)(2008-5#14)(2009-12#1)(2012-3#2)
PVA-Gly##2##1##(2008-5#2)
PVA-SbQ##2##1##(1992-11#1)(2008-10#1)
PVA-derived hybrids were##2##3##(2008-5#2)
PVA-derived hybrids##3##2##(2008-5#3)
PVA-derived##5##1##(2008-5#5)
PVBA##3##1##(2008-12#3)
PVC (33%)##2##2##(2008-10#2)
PVC and##6##2##(1996-8#1)(2008-10#5)
PVC as##2##2##(2008-10#2)
PVC based membranes of##2##4##(2008-10#2)
PVC based##6##2##(2008-10#6)
PVC in the ratio##2##4##(2008-10#2)
PVC in##4##2##(2008-10#4)
PVC matrix membrane##2##3##(2008-10#2)
PVC matrix##11##2##(2008-10#11)
PVC membrane based on bis-pyridine tetramide macrocycle##2##7##(2008-10#2)
PVC membrane based on##3##4##(2008-10#3)
PVC membrane based##4##3##(2008-10#4)
PVC membrane electrode based on 5##2##6##(2008-10#2)
PVC membrane electrode based on##6##5##(2008-10#6)
PVC membrane electrode for##5##4##(2008-10#5)
PVC membrane electrode##15##3##(2008-10#15)
PVC membrane electrodes based on##3##5##(2008-10#3)
PVC membrane electrodes##6##3##(2008-10#6)
PVC membrane ion selective electrode for the determination of##2##9##(2008-10#2)
PVC membrane##37##2##(2008-10#37)
PVC membranes and##2##3##(2008-10#2)
PVC membranes##10##2##(2008-10#10)
PVC was##2##2##(2008-10#2)
PVC##110##1##(1996-8#1)(2007-7#1)(2008-10#108)
PVC) (w/w)##2##2##(2008-10#2)
PVC)##4##1##(2008-10#4)
PVC-COOH##2##1##(2008-10#2)
PVC-based membrane##5##2##(2008-10#5)
PVC-based##12##1##(2008-10#12)
PVDF##3##1##(2008-11#1)(2008-4#1)(2008-6#1)
PVM##5##1##(2012-2#1)(2013-8#4)
PVMV in##2##2##(2008-10#2)
PVMV##4##1##(2008-10#4)
PVN##6##1##(1993-12#2)(1994-8#3)(1995-12#1)
PVNS##4##1##(2010-3#1)(2013-1#3)
PVOD##3##1##(2010-10#3)
PVP##10##1##(1990-12#1)(2008-10#3)(2008-5#4)(2010-4#2)
PVP-AgNCs##2##1##(2013-1#2)
PVP/Pd/IrO(2) modified##2##2##(2008-10#2)
PVR##2##1##(2010-6#2)
PVSK##2##1##(2008-10#2)
PVSMC cultured in HG##2##4##(1992-8#2)
PVSMC##3##1##(1992-8#3)
PVV isolates##3##2##(2008-10#3)
PVV##7##1##(2008-10#7)
PVX RNA was detected##2##4##(2008-10#2)
PVX recombinant##2##2##(2008-10#2)
PVX##28##1##(2008-10#28)
PVY 0 AT##2##3##(2008-10#2)
PVY 1-2##4##2##(2008-10#4)
PVY and PVA##2##3##(2008-10#2)
PVY isolates##2##2##(2008-10#2)
PVY##21##1##(2008-10#21)
PVY(N##5##1##(2008-10#5)
PVY(NTN) isolates##2##2##(2008-10#2)
PVY(NTN)##4##1##(2008-10#4)
PVY(O)##3##1##(2008-10#3)
PVase activity)##2##2##(1996-12#2)
PW##7##1##(2008-2#7)
PW12O403-##2##1##(2008-10#2)
PWB##3##1##(2008-10#1)(2010-8#2)
PWC170##3##1##(2012-2#3)
PWCs##4##1##(2012-2#4)
PWG mode##2##2##(2008-3#2)
PWG##7##1##(2008-2#2)(2008-3#5)
PWG's##4##1##(2008-2#1)(2008-3#3)
PWI##4##1##(2007-10#1)(2007-9#3)
PWS##3##1##(2007-12#3)
PWV and distensibility##3##3##(2013-3#3)
PWV of##2##2##(2007-10#2)
PWV was##5##2##(2007-10#3)(2013-3#2)
PWV##14##1##(2007-10#8)(2013-3#6)
PWs segmented##2##2##(2008-2#2)
PWs##5##1##(2008-2#5)
PX##4##1##(2008-10#3)(2009-10#1)
PXP-18##5##1##(1990-5#5)
PY##4##1##(1992-10#1)(2012-2#3)
PY)##4##1##(1992-10#1)(2012-2#3)
PYE##2##1##(2008-10#2)
PYK2##4##1##(1995-8#4)
PYY##3##1##(2010-11#1)(2012-3#2)
PZDE##3##1##(2008-10#3)
PZFX 500 mg x 2/day##2##5##(2011-2#2)
PZFX##5##1##(2011-2#5)
Pa##20##1##(1992-8#1)(1993-5#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-7#3)(2010-8#2)(2011-2#1)(2011-3#1)
Pa)##4##1##(2008-10#2)(2008-2#1)(2008-7#1)
PaCO2##2##1##(1991-2#2)
PaEXG2##5##1##(2008-10#5)
PaO2##8##1##(1990-3#2)(1991-2#2)(1997-3#1)(2007-11#1)(2007-8#1)(2011-2#1)
PaO2/FiO2##2##1##(2007-8#2)
Pac##3##1##(1991-12#2)(1996-11#1)
Pacemaker##2##1##(1994-11#1)(2009-10#1)
PacifiCare##2##1##(1997-1#1)(1997-3#1)
Pacific Coast of##4##3##(2008-5#1)(2009-2#1)(2013-7#2)
Pacific Health##3##2##(2008-1#1)(2012-12#2)
Pacific Island Countries and Territories (PICTs)##2##6##(2012-12#2)
Pacific Island Countries##4##3##(2008-1#1)(2012-12#3)
Pacific Island countries##2##3##(2008-1#1)(2012-12#1)
Pacific Island##8##2##(2008-1#4)(2012-12#4)
Pacific Islander##4##2##(1997-2#2)(2012-2#2)
Pacific Islanders##3##2##(2012-12#1)(2012-2#2)
Pacific Islands (USAPI)##12##3##(2013-8#12)
Pacific Islands##17##2##(2008-1#3)(2013-8#14)
Pacific Northwest (PNW)##2##3##(2008-10#2)
Pacific Northwest##16##2##(2008-10#15)(2008-5#1)
Pacific Ocean##10##2##(1992-7#1)(1996-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-8#1)
Pacific Symposium on Biocomputing##2##4##(2011-2#2)
Pacific Telesis##2##2##(1996-3#2)
Pacific and##3##2##(2008-1#2)(2012-12#1)
Pacific coast of##5##3##(2008-10#1)(2008-5#2)(2009-2#1)(2012-12#1)
Pacific coast##7##2##(2008-10#1)(2008-5#3)(2009-2#1)(2012-12#2)
Pacific countries##3##2##(2008-1#3)
Pacific cultural values##3##3##(2008-1#3)
Pacific island health##2##3##(2008-1#2)
Pacific island##4##2##(1994-11#1)(2008-1#3)
Pacific of Panama##2##3##(2008-5#2)
Pacific of##3##2##(2008-5#3)
Pacific people##4##2##(2008-1#3)(2008-8#1)
Pacific region##5##2##(2008-1#4)(2010-10#1)
Pacific salmon##5##2##(1990-12#1)(1995-11#3)(2008-8#1)
Pacific##201##1##(1990-12#1)(1990-8#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-3#1)(1996-3#2)(1996-4#1)(1997-2#2)(2007-5#1)(2008-1#61)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#18)(2008-6#1)(2008-8#6)(2008-9#2)(2009-2#3)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#10)(2010-9#1)(2011-2#3)(2012-12#26)(2012-2#5)(2013-7#6)(2013-8#16)
Pacificans in New Zealand##2##4##(2008-1#2)
Pacificans##6##1##(2008-1#6)
Pacificans'##3##1##(2008-1#3)
Pacifier##2##1##(2007-10#1)(2009-6#1)
Pacinian corpuscle hyperplasia following dog bite##2##6##(2008-12#2)
Pacinian corpuscle hyperplasia##4##3##(2008-12#4)
Package for##2##2##(2007-5#1)(2011-1#1)
Package##5##1##(2007-5#1)(2008-4#3)(2011-1#1)
Packaging##3##1##(1992-8#1)(2010-7#1)(2013-1#1)
Packed##2##1##(2008-10#2)
Packet##2##1##(1996-12#1)(2008-5#1)
Packets##2##1##(1996-12#1)(2008-3#1)
Packing##4##1##(2008-10#1)(2009-11#1)(2010-2#1)(2012-12#1)
Paclitaxel is an##3##3##(2008-3#1)(2008-6#1)(2008-7#1)
Paclitaxel is##4##2##(2008-3#1)(2008-6#2)(2008-7#1)
Paclitaxel##11##1##(2007-4#1)(2008-3#2)(2008-6#5)(2008-7#1)(2010-11#2)
Paddy##2##1##(2008-10#1)(2008-12#1)
Padlock probes##2##2##(2008-4#2)
Padlock##3##1##(2008-4#2)(2008-7#1)
Padova##2##1##(2008-10#1)(2013-1#1)
Padua was##2##2##(2013-8#2)
Padua##6##1##(1990-2#1)(2013-8#5)
Padé approximant##2##2##(2007-11#2)
Paecilomyces##2##1##(2010-3#2)
Paediatr Child Health 2007##4##4##(2008-11#4)
Paediatric Expert Group on the Immunization Programme##2##7##(2009-5#2)
Paediatric HIV infection##2##3##(1996-11#2)
Paediatric and Perinatal Epidemiology##2##4##(2011-2#1)(2012-2#1)
Paediatric and##5##2##(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
Paediatric asthma exacerbations##2##3##(2008-11#2)
Paediatric cochlear##3##2##(2008-9#3)
Paediatric emergency##2##2##(2008-11#2)
Paediatric##34##1##(1994-11#1)(1996-11#2)(1997-8#1)(2008-10#2)(2008-11#14)(2008-3#1)(2008-9#4)(2009-5#2)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Paediatricians and family##2##3##(2008-11#2)
Paediatricians and##3##2##(2008-11#2)(2009-5#1)
Paediatricians who##2##2##(2008-11#1)(2012-12#1)
Paediatricians##5##1##(2008-11#3)(2009-5#1)(2012-12#1)
Paediatrics##6##1##(1997-8#1)(2008-11#3)(2009-5#1)(2012-12#1)
Paedodontics##2##1##(2013-1#2)
Paenibacillus sp##3##2##(2008-10#3)
Paenibacillus spp##4##2##(2008-10#4)
Paenibacillus##8##1##(2008-10#8)
Paeonia suffruticosa##2##2##(2008-10#1)(2008-5#1)
Page serovar A##2##3##(1997-3#1)(2008-5#1)
Page serovar C##4##3##(2008-5#4)
Page serovar##7##2##(1997-3#1)(2008-5#6)
Page##9##1##(1997-3#1)(2007-2#1)(2008-5#6)(2010-5#1)
Paget's disease is##3##3##(2007-11#2)(2008-6#1)
Paget's disease of bone##2##4##(1990-6#1)(1997-6#1)
Paget's disease of the##3##4##(2008-8#1)(2011-2#1)(2012-1#1)
Paget's disease of vulva and perineum##2##6##(1993-1#2)
Paget's disease of##7##3##(1990-6#1)(1993-1#2)(1997-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
Paget's disease##22##2##(1990-6#2)(1991-11#3)(1991-5#1)(1993-1#2)(1994-12#1)(1997-6#1)(2007-11#4)(2008-5#1)(2008-6#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
Paget's##27##1##(1990-6#2)(1991-11#3)(1991-5#1)(1993-1#2)(1994-12#1)(1997-6#1)(2007-11#5)(2008-10#1)(2008-5#2)(2008-6#3)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)
Paid##4##1##(1991-3#1)(1992-3#1)(2008-10#1)(2011-2#1)
Pain Syndrome##4##2##(1996-3#1)(2008-12#1)(2008-9#1)(2010-9#1)
Pain and##14##2##(1991-1#1)(1992-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
Pain assessment##2##2##(2008-5#1)(2010-7#1)
Pain in##5##2##(1991-2#1)(1993-2#1)(2008-10#1)(2008-11#1)(2010-12#1)
Pain intensity##2##2##(2007-8#1)(2010-12#1)
Pain is##8##2##(1991-11#1)(2007-11#2)(2008-5#1)(2008-7#1)(2010-12#2)(2011-2#1)
Pain of##2##2##(2007-11#1)(2008-7#1)
Pain scores##3##2##(1995-3#2)(2011-2#1)
Pain##88##1##(1991-1#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-2#1)(1995-3#3)(1996-3#1)(1996-5#1)(1997-3#1)(2006-12#2)(2007-11#5)(2007-5#1)(2007-8#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#3)
Painful peripheral##2##2##(2008-4#1)(2008-7#1)
Painful##4##1##(2008-12#1)(2008-4#1)(2008-7#2)
Painting##4##1##(2007-7#2)(2011-2#1)(2012-12#1)
Pair##4##1##(1990-4#1)(1996-2#1)(2008-8#1)(2009-5#1)
Paired comparisons##2##2##(2007-8#1)(2008-4#1)
Paired t-tests##2##2##(2009-4#1)(2011-2#1)
Paired##7##1##(2007-8#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#2)
Pairing##3##1##(1996-9#1)(2008-10#1)(2011-2#1)
Pairs of##6##2##(1993-3#1)(1997-3#1)(2008-10#2)(2008-3#2)
Pairs##10##1##(1993-3#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#2)(2009-11#1)(2012-3#1)
Pairwise comparisons##2##2##(2008-10#1)(2008-12#1)
Pairwise##8##1##(1990-7#1)(2008-10#5)(2008-12#1)(2009-5#1)
Pak##2##1##(1990-8#1)(2008-10#1)
Pakistan and the##2##3##(2008-12#1)(2012-2#1)
Pakistan and##3##2##(2008-12#1)(2012-2#2)
Pakistan to evaluate##2##3##(2007-7#1)(2008-12#1)
Pakistan with##2##2##(2008-9#1)(2012-2#1)
Pakistan##39##1##(1994-3#1)(1994-9#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-12#4)(2008-9#1)(2009-4#1)(2009-7#5)(2010-11#3)(2010-4#1)(2012-2#11)(2013-7#2)(2013-8#1)
Pakistani##8##1##(1997-6#3)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
Pakistanis##2##1##(1997-6#2)
Palaemonetes pugio##4##2##(2010-4#4)
Palau Area Health Education Center##2##5##(2008-1#2)
Palau Community##2##2##(2008-1#2)
Palau and Thailand##2##3##(2008-10#2)
Palau and##7##2##(2008-1#4)(2008-10#2)(2013-8#1)
Palau is##2##2##(2008-1#2)
Palau to##2##2##(2008-1#1)(2013-8#1)
Palau was##3##2##(2008-1#3)
Palau##54##1##(2008-1#49)(2008-10#3)(2013-8#2)
Palau's##4##1##(2008-1#4)
Palauan adolescents##2##2##(2008-1#2)
Palauan elderly##2##2##(2008-1#2)
Palauan society##5##2##(2008-1#5)
Palauan##11##1##(2008-1#11)
Palauans##2##1##(2008-1#2)
Paleozoic dissorophoid amphibians##2##3##(2010-6#2)
Paleozoic stromatoporoids##2##2##(1990-11#2)
Paleozoic##5##1##(1990-11#3)(2010-6#2)
Palivizumab##2##1##(2008-11#1)(2010-10#1)
Palladium and magnesium##2##3##(2008-10#2)
Palladium and##3##2##(2008-10#3)
Palladium##11##1##(1996-12#1)(2008-10#9)(2008-11#1)
Palladium(II)##3##1##(2008-10#3)
Pallen##2##1##(2007-12#2)
Palliation of##2##2##(1990-12#1)(1991-6#1)
Palliative Care##2##2##(2008-11#1)(2008-7#1)
Palliative care##7##2##(1991-1#1)(2007-10#1)(2008-7#1)(2010-8#1)(2012-3#3)
Palliative surgery##2##2##(1990-9#1)(2007-11#1)
Palliative##21##1##(1990-9#1)(1991-1#1)(1993-6#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2010-8#1)(2011-2#2)(2012-3#5)
Palm Beach County##4##3##(1994-2#1)(2008-10#3)
Palm Beach##5##2##(1994-2#1)(1996-5#1)(2008-10#3)
Palm##15##1##(1994-2#1)(1996-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
Palmar##2##1##(1997-3#1)(2008-10#1)
Palmar-plantar##2##1##(2008-7#1)(2009-5#1)
Palmitic acid##2##2##(1991-12#1)(1995-5#1)
Palmitoyl-CoA##2##1##(1990-5#1)(1993-3#1)
Palpomyia##3##1##(2008-5#3)
Pamidronate##2##1##(2006-10#1)(2010-9#1)
Pampas region##3##2##(2013-7#3)
Pan##8##1##(1992-5#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-7#1)(2013-1#1)
Panama##11##1##(2007-5#1)(2008-10#4)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)
Panamic##2##1##(2008-5#1)(2013-7#1)
Panavia on##2##2##(2009-8#2)
Panavia##7##1##(2009-8#7)
Panax ginseng##3##2##(1995-8#2)(2008-10#1)
Panax##4##1##(1995-8#2)(2008-10#1)(2013-8#1)
Panaxynol in##2##2##(2008-10#2)
Panaxynol##3##1##(2008-10#3)
Pancharatnam-Berry phase optical elements##4##4##(2007-11#4)
Pancharatnam-Berry phase##5##2##(2007-11#4)(2007-12#1)
Pancharatnam-Berry##6##1##(2007-11#5)(2007-12#1)
Pancreas##2##1##(2008-9#1)(2013-1#1)
Pancreastatin (PST)##2##2##(1990-12#1)(1994-11#1)
Pancreastatin##3##1##(1990-12#2)(1994-11#1)
Pancreatic Cancer##3##2##(2012-3#1)(2013-8#2)
Pancreatic beta##2##2##(2008-10#1)(2008-4#1)
Pancreatic cancer##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
Pancreatic heterotopia##2##2##(2013-7#1)(2013-8#1)
Pancreatic islet transplantation##2##3##(2010-11#1)(2010-12#1)
Pancreatic##29##1##(1990-6#1)(1990-8#1)(1991-8#1)(1993-6#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
Pancreatitis complicating##2##2##(2007-2#1)(2011-2#1)
Pancreatitis##10##1##(1991-8#1)(2007-2#1)(2008-3#1)(2008-9#1)(2009-12#2)(2011-2#2)(2013-8#2)
Pandemic##4##1##(2011-2#2)(2013-1#2)
Pandemics##2##1##(2008-10#1)(2011-2#1)
Pandemrix##3##1##(2011-2#3)
Pandora's##2##1##(1991-1#1)(2013-1#1)
Panel discussion##2##2##(1991-12#1)(1996-12#1)
Panel on##5##2##(2008-3#2)(2010-12#2)(2011-2#1)
Panel##24##1##(1991-12#1)(1991-5#1)(1994-9#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#5)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)
Panelists##2##1##(1995-3#1)(2008-5#1)
Paneth cells of##2##3##(1992-9#1)(1993-9#1)
Paneth cells##3##2##(1992-9#1)(1993-9#2)
Paneth##6##1##(1992-9#1)(1993-11#1)(1993-9#4)
Paneuphorbia diet##2##2##(2013-1#2)
Panhandle##5##1##(2008-10#5)
Panicle##3##1##(2008-10#3)
Panicum mosaic virus##2##3##(2008-10#2)
Panicum##5##1##(1996-10#1)(2008-10#2)(2013-1#2)
Panonychus citri##2##2##(2011-2#2)
Panoramic radiographs##2##2##(2008-12#2)
Panoramic##3##1##(2008-12#2)(2010-3#1)
Pantoea agglomerans strain##4##3##(2008-10#4)
Pantoea agglomerans strains Eh252 and C9-1##3##6##(2008-10#3)
Pantoea agglomerans strains##4##3##(2008-10#4)
Pantoea agglomerans##18##2##(2008-10#18)
Pantoea ananatis##3##2##(2008-10#3)
Pantoea##25##1##(2008-10#25)
Pantopoda##4##1##(2007-12#4)
Panum's limiting case##4##3##(2008-9#4)
Panum's limiting##5##2##(2008-9#5)
Pap smear compliance##3##3##(2011-2#3)
Pap smear screening##4##3##(2011-2#4)
Pap smear##18##2##(1990-8#3)(1991-6#4)(1992-3#3)(2011-2#8)
Pap smears and##2##3##(1990-12#1)(1992-3#1)
Pap smears##5##2##(1990-12#2)(1992-3#3)
Pap test##4##2##(1991-6#2)(1994-1#1)(2008-11#1)
Pap##30##1##(1990-12#3)(1990-8#3)(1991-6#6)(1992-3#6)(1994-1#1)(1997-2#1)(2008-11#1)(2009-6#1)(2011-2#8)
Pap1/Pap2##3##1##(2008-10#3)
Pap1/Pap3##2##1##(2008-10#2)
Papal##2##1##(1990-6#2)
Papanicolaou##3##1##(1992-1#2)(2008-11#1)
Papaver somniferum##4##2##(2008-10#4)
Papaver##6##1##(2008-10#5)(2009-10#1)
Papaverine##2##1##(2008-10#2)
Papaya leaf##3##2##(2008-10#3)
Papaya ringspot virus (PRSV)##3##4##(2008-10#3)
Papaya ringspot virus##5##3##(2008-10#5)
Papaya##9##1##(2008-10#9)
Paper##9##1##(1990-11#1)(1994-1#1)(1996-3#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-8#2)
Papers##8##1##(1997-3#1)(1997-8#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
Papilio##5##1##(2008-2#1)(2008-3#4)
Papillae##3##1##(2008-10#2)(2008-5#1)
Papillary##4##1##(2006-12#2)(2010-8#1)(2011-2#1)
Papua New Guinea##3##3##(2008-1#2)(2012-12#1)
Par-1 and PP2A##2##3##(2008-9#2)
Par-1##5##1##(2008-9#5)
Para##2##1##(2008-1#1)(2012-3#1)
Paracanthurus##2##1##(2008-5#2)
Paracentrotus lividus##2##2##(1997-4#1)(1997-6#1)
Paracoccidioides brasiliensis##3##2##(2008-5#3)
Paracoccus denitrificans##3##2##(1992-3#2)(1994-8#1)
Paracoccus pantotrophus##2##2##(2008-7#2)
Paracoccus##5##1##(1992-3#2)(1994-8#1)(2008-7#2)
Paradigm refers to##2##3##(1994-11#2)
Paradigm##12##1##(1992-2#1)(1994-11#6)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
Paradox##2##1##(2008-3#1)(2008-5#1)
Paradoxical embolism##3##2##(2008-7#2)(2009-10#1)
Paradoxical##8##1##(1991-11#1)(1993-9#1)(2008-11#1)(2008-7#2)(2009-10#2)(2013-1#1)
Paradoxically##7##1##(1991-12#1)(1991-7#1)(1994-11#1)(1997-1#2)(2007-8#1)(2011-2#1)
Parafac2##3##1##(2013-1#3)
Paraffin##3##1##(1992-6#1)(1997-8#1)(2011-2#1)
Parafilm##2##1##(2008-10#2)
Paragonimus westermani##2##2##(1997-6#2)
Paraguay##2##1##(1992-5#1)(2008-5#1)
Parainfluenza##3##1##(1990-5#1)(2008-11#2)
Paralichthys olivaceus##4##2##(2008-6#2)(2010-8#2)
Parallel Factor Analysis (PARAFAC)##2##4##(2008-10#2)
Parallel detection of the speckle field formed by the transmitted laser light was implemented with the source-synchronous-illumination lock-in technique to improve the signal-to-noise ratio##2##24##(2007-12#1)(2008-3#1)
Parallel detection##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Parallel to these changes##2##4##(1994-8#1)(1997-4#1)
Parallel##30##1##(1992-4#1)(1993-9#1)(1994-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#5)(2008-2#3)(2008-3#4)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)
Paralysis##2##1##(2007-10#1)(2009-3#1)
Paramagnetic##7##1##(1992-11#1)(1993-8#1)(1994-5#2)(1996-2#1)(1997-7#1)(2008-1#1)
Paramecia##2##1##(1992-6#2)
Paramecium and##3##2##(1992-6#1)(2008-12#1)(2008-4#1)
Paramecium tetraurelia##2##2##(1990-7#2)
Paramecium##20##1##(1990-7#3)(1992-6#1)(2008-12#11)(2008-4#4)(2008-5#1)
Parameter##11##1##(1996-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-9#1)(2009-10#1)
Parameters affecting##2##2##(2008-10#2)
Parameters for##2##2##(1991-12#1)(2008-10#1)
Parameters influencing extraction such as sonication time##2##7##(2008-10#2)
Parameters influencing##3##2##(2008-10#3)
Parameters of##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
Parameters such as the pH effect on the##2##8##(2008-10#2)
Parameters such as the##4##4##(2008-1#1)(2008-10#2)(2008-2#1)
Parameters such as##10##3##(1996-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-7#1)(2012-2#1)
Parameters that affect the##3##4##(1994-9#1)(2008-10#1)(2008-2#1)
Parameters that may affect the##2##5##(2008-10#2)
Parameters that##5##2##(1994-9#1)(2008-10#3)(2008-2#1)
Parameters were##2##2##(2008-10#1)(2013-8#1)
Parameters##40##1##(1991-12#1)(1994-7#1)(1994-9#1)(1996-12#1)(2008-1#1)(2008-10#21)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Parametric amplifiers driven by two pump waves##2##7##(2007-11#2)
Parametric and##2##2##(1997-5#1)(2008-10#1)
Parametric##13##1##(1997-5#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#5)(2013-8#1)
Paramphistomum eggs##3##2##(1996-12#3)
Paramyxoviridae##2##1##(2008-12#1)(2008-8#1)
Paraneoplastic##3##1##(1997-8#1)(2009-3#1)(2011-2#1)
Paraná##2##1##(2008-5#1)(2009-11#1)
Paraplegia##2##1##(1996-3#1)(2008-7#1)
Paraquat##3##1##(1995-8#1)(2008-10#2)
Parasexual##2##1##(2008-10#2)
Parasite##5##1##(2007-2#1)(2008-9#2)(2012-2#1)(2013-1#1)
Parasite-driven##2##1##(2008-8#2)
Parasites##7##1##(2008-9#3)(2010-8#2)(2012-2#1)(2013-1#1)
Parasitic and##2##2##(2008-10#1)(2008-8#1)
Parasitic##8##1##(2007-12#1)(2008-10#3)(2008-8#1)(2011-2#2)(2012-2#1)
Parasitism of##2##2##(2008-10#2)
Parasitism##3##1##(2008-10#2)(2008-6#1)
Parasitized##2##1##(2008-10#1)(2010-4#1)
Parasitological##2##1##(2013-1#2)
Parasitology at##2##2##(2010-1#1)(2011-2#1)
Parasitology##4##1##(2007-10#1)(2010-1#1)(2011-2#2)
Parasola species##2##2##(2010-3#2)
Parasola##6##1##(2010-3#6)
Parastomal##2##1##(2011-2#2)
Parathyroid Hormone##2##2##(2008-8#1)(2011-1#1)
Parathyroid hormone (PTH)##4##3##(1993-12#1)(1995-6#1)(2008-8#1)(2011-1#1)
Parathyroid hormone##5##2##(1993-12#1)(1994-11#1)(1995-6#1)(2008-8#1)(2011-1#1)
Parathyroid##11##1##(1993-12#1)(1993-3#1)(1994-11#1)(1994-7#1)(1995-6#1)(2008-12#1)(2008-8#2)(2011-1#3)
Paratuberculosis was##2##2##(1993-2#2)
Paratuberculosis##3##1##(1993-2#3)
Paratyphi A##6##2##(2012-3#6)
Paraíba State##2##2##(2008-9#2)
Paraíba##3##1##(1993-6#1)(2008-9#2)
Pardosa lugubris##2##2##(2007-12#2)
Parent##11##1##(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(2008-11#2)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#2)
Parent-Adolescent Communication##2##2##(1990-12#2)
Parent-Adolescent##4##1##(1990-12#3)(2013-7#1)
Parental care##2##2##(2008-4#1)(2008-8#1)
Parental environmental effects##2##3##(2008-9#2)
Parental perceptions of##2##3##(1996-2#1)(2007-2#1)
Parental presence##2##2##(2013-8#2)
Parental rights and children's best interests##2##6##(1990-6#2)
Parental##37##1##(1990-6#2)(1991-1#1)(1992-2#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-4#1)(2010-9#2)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
Parenteral nutrition##2##2##(2012-12#1)(2013-1#1)
Parenteral##5##1##(1990-7#1)(1994-6#1)(2008-4#1)(2012-12#1)(2013-1#1)
Parenthood##5##1##(1993-3#1)(1994-2#1)(1997-6#1)(2009-10#1)(2009-11#1)
Parenting##10##1##(1995-2#3)(2008-11#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2012-2#1)
Parents and##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
Parents may##2##2##(1995-12#1)(2007-10#1)
Parents of children with chronic health##2##6##(1993-1#2)
Parents of children with##6##4##(1993-1#2)(1993-3#1)(1995-2#1)(2008-11#1)(2009-5#1)
Parents of##11##2##(1991-9#1)(1993-1#2)(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)
Parents were##2##2##(2010-2#1)(2012-3#1)
Parents##32##1##(1990-6#1)(1991-9#1)(1993-1#2)(1993-3#1)(1995-12#2)(1995-2#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
Parents'##6##1##(1993-1#1)(2008-11#1)(2009-5#1)(2010-11#1)(2010-3#1)(2012-12#1)
Parhelic##2##1##(2008-2#2)
Paridae##3##1##(2008-9#3)
Parietal##3##1##(1990-5#2)(1994-3#1)
Parineb##5##1##(1996-12#5)
Paris and##3##2##(2008-11#1)(2008-2#1)(2013-8#1)
Paris area##3##2##(2007-12#1)(2008-2#2)
Paris sex-ratio##2##2##(2012-3#2)
Paris##26##1##(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2009-7#1)(2010-1#5)(2011-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
Pariser##2##1##(2008-6#2)
Parish##2##1##(1996-3#1)(1997-3#1)
Park in##5##2##(2007-5#1)(2008-10#2)(2011-1#1)(2013-7#1)
Park##50##1##(1991-12#1)(1994-3#1)(1995-2#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-5#2)(2008-10#4)(2008-5#20)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#7)(2013-7#5)
Parker##4##1##(1994-3#1)(1997-5#1)(2007-7#1)(2008-5#1)
Parkfield##2##1##(1996-4#2)
Parkinson Disease##2##2##(2008-11#1)(2013-8#1)
Parkinson Disease's##2##2##(2012-12#2)
Parkinson disease (PD)##2##3##(2013-1#1)(2013-8#1)
Parkinson disease##12##2##(1995-2#1)(2010-4#2)(2011-2#1)(2013-1#2)(2013-8#6)
Parkinson##25##1##(1995-2#1)(2008-11#1)(2008-7#5)(2010-4#2)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#10)
Parkinson's Disease Rating Scale##3##4##(2008-7#3)
Parkinson's Disease##9##2##(2008-11#2)(2008-7#5)(2009-10#1)(2010-5#1)
Parkinson's and##3##2##(2008-4#1)(2008-9#1)(2010-5#1)
Parkinson's caregivers##2##2##(2008-7#2)
Parkinson's disease (PD) and##5##4##(2008-5#1)(2008-6#1)(2008-7#3)
Parkinson's disease (PD) are##3##4##(2008-7#1)(2010-12#1)(2012-12#1)
Parkinson's disease (PD) is a neurological##2##6##(2009-10#1)(2010-8#1)
Parkinson's disease (PD) is a##6##5##(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)
Parkinson's disease (PD) is an##2##5##(2008-7#2)
Parkinson's disease (PD) is associated with##2##6##(2008-7#2)
Parkinson's disease (PD) is##10##4##(2008-12#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-8#1)
Parkinson's disease (PD) patients##7##4##(1995-12#1)(2008-7#5)(2013-1#1)
Parkinson's disease (PD)##51##3##(1995-12#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#32)(2008-8#1)(2009-10#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Parkinson's disease and mitochondrial encephalomyopathies##2##5##(1991-5#2)
Parkinson's disease and mitochondrial##3##4##(1991-5#3)
Parkinson's disease and##11##3##(1991-5#3)(1995-3#1)(1997-2#1)(2008-7#3)(2009-5#1)(2010-11#1)(2010-8#1)
Parkinson's disease during##3##3##(2009-8#2)(2011-2#1)
Parkinson's disease is##6##3##(1995-3#1)(2008-7#4)(2010-12#1)
Parkinson's disease patients##6##3##(1995-12#1)(2008-7#4)(2010-5#1)
Parkinson's disease symptom inventory (PDSI)##2##5##(2008-7#2)
Parkinson's disease without##2##3##(1992-3#1)(2009-11#1)
Parkinson's disease##208##2##(1991-5#3)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#5)(1995-3#2)(1995-5#2)(1995-8#1)(1996-3#3)(1997-2#2)(2007-10#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#4)(2008-7#121)(2008-8#2)(2009-10#3)(2009-11#4)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#6)(2010-5#4)(2010-8#3)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
Parkinson's##230##1##(1991-5#3)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#5)(1995-3#2)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#3)(1997-2#2)(2007-10#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#132)(2008-8#2)(2008-9#1)(2009-10#4)(2009-11#4)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#6)(2010-5#7)(2010-8#3)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#2)
Parkinsonian patients##8##2##(1996-5#1)(2008-7#7)
Parkinsonian##14##1##(1996-5#1)(2008-10#3)(2008-7#10)
Parkinsonism (IP)##2##2##(2008-7#2)
Parkinsonism is##3##2##(2008-7#3)
Parkinsonism##14##1##(2007-10#1)(2008-7#13)
Parks Medical Flo-Lab 2100-SX##2##4##(2011-2#2)
Parks Medical##3##2##(2011-2#3)
Parks##4##1##(2009-10#1)(2011-2#3)
Parliament##4##1##(2007-5#1)(2008-11#1)(2009-7#2)
Parma##4##1##(2008-10#1)(2008-2#1)(2011-2#2)
Parotid##4##1##(1990-11#1)(1993-9#1)(2011-2#1)(2013-8#1)
Paroxetine was used as internal standard##2##6##(2008-10#2)
Paroxetine##3##1##(2008-10#2)(2012-2#1)
Paroxysmal nocturnal hemoglobinuria##2##3##(2008-4#1)(2008-9#1)
Paroxysmal nocturnal##3##2##(1996-8#1)(2008-4#1)(2008-9#1)
Paroxysmal##5##1##(1996-8#1)(2008-1#1)(2008-4#2)(2008-9#1)
Parque Nacional Morrocoy##2##3##(2008-5#2)
Parque Nacional##8##2##(2008-5#4)(2011-2#4)
Parque##9##1##(2008-5#4)(2008-6#1)(2011-2#4)
Parroid arc##3##2##(2008-2#3)
Parry arc or a##2##4##(2008-2#2)
Parry arc##7##2##(2008-2#2)(2008-3#5)
Parry##8##1##(2008-2#2)(2008-3#6)
Pars##3##1##(2008-12#1)(2013-1#2)
Parsimony##3##1##(2008-10#3)
Parson##2##1##(2008-12#2)
Parsonage-Turner syndrome##2##2##(2008-8#1)(2008-9#1)
Parsonage-Turner##3##1##(2008-8#1)(2008-9#2)
Part 1 of this article##2##5##(1995-1#1)(1995-3#1)
Part 1 of this##3##4##(1995-1#1)(1995-3#1)(1997-2#1)
Part 1 of##4##3##(1995-1#1)(1995-3#1)(1997-2#1)(2013-1#1)
Part 1##35##2##(1990-3#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-1#1)(1995-1#2)(1995-2#2)(1995-3#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-5#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Part 11##4##2##(2008-10#4)
Part 2##26##2##(1991-6#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#2)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-7#1)
Part 2]##2##2##(2008-6#1)(2012-12#1)
Part 3##3##2##(1992-11#1)(2008-10#1)(2008-2#1)
Part 6##3##2##(1993-2#1)(2009-9#1)(2013-8#1)
Part 8##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
Part A##11##2##(1991-1#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#3)(2009-5#1)
Part B##15##2##(1991-2#2)(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#3)(1996-2#2)(2008-10#1)(2008-11#3)(2009-5#1)
Part D##4##2##(2008-11#2)(2010-4#1)(2010-5#1)
Part I of this##5##4##(1991-2#1)(1994-1#2)(2008-10#1)(2008-2#1)
Part I of##6##3##(1991-2#1)(1993-1#1)(1994-1#2)(2008-10#1)(2008-2#1)
Part I##53##2##(1991-2#2)(1991-5#1)(1992-12#2)(1992-3#2)(1993-1#1)(1993-2#3)(1994-1#7)(1994-12#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-2#1)(2007-11#1)(2007-5#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-2#3)(2009-8#1)(2010-5#2)(2010-9#1)(2012-2#1)(2012-3#1)
Part II of this article##2##5##(1996-1#1)(2012-3#1)
Part II of this##5##4##(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2012-3#1)
Part II of##7##3##(1991-3#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-5#1)(2012-3#1)
Part II will##2##3##(1995-1#1)(1996-1#1)
Part II##61##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-3#3)(1992-12#1)(1992-3#2)(1993-1#1)(1993-2#3)(1994-1#4)(1994-2#4)(1995-1#1)(1995-2#5)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-3#1)(2007-5#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
Part III##15##2##(1991-12#2)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#3)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2010-3#1)(2012-3#1)
Part IV##7##2##(2007-5#2)(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
Part four##3##2##(1995-6#1)(2010-9#1)(2013-1#1)
Part of its##2##3##(1995-2#1)(2013-8#1)
Part of the##4##3##(1991-9#1)(1996-5#1)(2008-10#1)(2011-2#1)
Part of##7##2##(1991-9#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
Part##274##1##(1990-2#1)(1990-3#1)(1991-1#3)(1991-12#3)(1991-2#5)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#8)(1993-3#2)(1993-6#2)(1994-1#14)(1994-12#3)(1994-2#6)(1994-3#4)(1994-9#1)(1995-1#6)(1995-11#4)(1995-12#1)(1995-2#9)(1995-3#12)(1995-6#3)(1996-1#4)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(2006-5#2)(2007-11#3)(2007-3#1)(2007-5#6)(2008-1#1)(2008-10#33)(2008-11#19)(2008-12#3)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-2#5)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-9#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#4)
Partial Least Squares Regression##2##4##(2008-10#2)
Partial Least Squares##4##3##(2008-10#4)
Partial Least##6##2##(2008-10#5)(2008-5#1)
Partial Resistance to##8##3##(2008-10#8)
Partial Resistance##10##2##(2008-10#10)
Partial amino acid sequencing##2##4##(1990-2#1)(1997-1#1)
Partial amino acid##3##3##(1990-2#1)(1997-1#1)(2008-10#1)
Partial characterization of a##2##4##(1990-2#1)(2008-10#1)
Partial cystectomy##2##2##(1992-3#1)(2008-10#1)
Partial hospitalization is##2##3##(1991-1#1)(1992-1#1)
Partial least square (PLS)##2##4##(2008-10#2)
Partial least squares regression##2##4##(2008-10#2)
Partial least squares##5##3##(2008-10#5)
Partial least##7##2##(2008-10#7)
Partial least-squares##3##2##(2007-12#1)(2008-10#2)
Partial purification of the##2##4##(1992-9#1)(2008-10#1)
Partial purification of##4##3##(1992-9#1)(1994-11#1)(1995-6#1)(2008-10#1)
Partial purification##6##2##(1992-9#1)(1993-8#1)(1994-11#1)(1995-6#1)(1997-6#1)(2008-10#1)
Partial resistance to##6##3##(2008-10#6)
Partial resistance##8##2##(2008-10#8)
Partial response##2##2##(1990-2#1)(1990-6#1)
Partial sequencing of the##2##4##(1995-11#1)(2008-10#1)
Partial sequencing of##3##3##(1995-11#1)(1997-6#1)(2008-10#1)
Partial##96##1##(1990-11#1)(1990-2#3)(1990-5#1)(1990-6#1)(1991-1#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-6#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-6#3)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#51)(2008-11#3)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
Partial-hospitalization##2##1##(1992-1#2)
Partially Resistant Wheat Cultivars##2##4##(2008-10#2)
Partially purified##2##2##(1990-8#1)(1993-8#1)
Partially##11##1##(1990-8#1)(1993-8#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-5#1)
Participant##4##1##(2008-10#1)(2012-12#1)(2013-1#2)
Participants completed measures of##3##4##(2007-12#2)(2009-5#1)
Participants completed##6##2##(1995-1#1)(2007-12#2)(2008-10#1)(2009-5#1)(2013-1#1)
Participants high in##2##3##(2007-12#1)(2009-8#1)
Participants in##4##2##(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
Participants include##2##2##(2011-2#2)
Participants included##5##2##(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
Participants made##2##2##(2008-11#1)(2012-3#1)
Participants received##2##2##(2008-9#1)(2013-1#1)
Participants viewed##4##2##(2007-4#1)(2008-11#1)(2009-8#1)(2010-10#1)
Participants were asked to##2##4##(2008-11#1)(2012-12#1)
Participants were asked##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
Participants were divided into three groups##2##6##(2011-2#1)(2013-8#1)
Participants were divided into##4##4##(1992-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
Participants were randomized to##2##4##(2013-1#2)
Participants were recruited##3##3##(2007-2#1)(2010-8#1)(2013-8#1)
Participants were##43##2##(1992-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#5)(2010-1#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
Participants who##2##2##(2007-12#1)(2008-6#1)
Participants with high levels of##2##5##(2010-12#1)(2012-3#1)
Participants with##6##2##(2007-12#1)(2008-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)
Participants##118##1##(1992-1#1)(1993-12#1)(1995-1#1)(1997-7#1)(2007-10#2)(2007-12#10)(2007-2#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#9)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#13)(2013-8#4)
Participants' responses##2##2##(2013-1#1)(2013-8#1)
Participants'##5##1##(2007-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Participating in##2##2##(2007-6#1)(2009-5#1)
Participating##6##1##(2007-10#1)(2007-2#1)(2007-6#1)(2009-5#1)(2010-3#1)(2013-1#1)
Participation Questionnaire##3##2##(1994-3#1)(2009-4#2)
Participation in##6##2##(1993-2#1)(1995-12#1)(1996-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
Participation of physicians in capital punishment##6##6##(1994-3#6)
Participation of##9##2##(1990-8#1)(1993-6#1)(1994-3#6)(1997-1#1)
Participation##22##1##(1990-8#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-3#7)(1995-12#1)(1996-9#1)(1997-1#1)(2009-12#1)(2009-4#3)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Participative Conference - for##2##4##(2008-11#2)
Participatory##4##1##(1997-3#1)(2008-1#1)(2012-2#2)
Particle Sizer##2##2##(1995-3#1)(2008-3#1)
Particle size##4##2##(1994-12#1)(2008-10#2)(2008-3#1)
Particle sizing in##2##3##(2007-12#1)(2008-3#1)
Particle##24##1##(1994-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#6)(2008-9#1)(2010-11#1)(2013-1#3)
Particles in##2##2##(1992-6#1)(2011-1#1)
Particles##12##1##(1992-6#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2011-1#1)(2012-1#1)
Particular attention has been paid to##2##6##(1990-2#1)(2008-4#1)
Particular attention is given to the##4##6##(2008-10#1)(2008-3#2)(2008-9#1)
Particular attention is given to##6##5##(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)
Particular attention is##8##3##(1990-9#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)
Particular attention should be##2##4##(2008-9#1)(2011-2#1)
Particular attention was paid to##4##5##(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)
Particular attention was##5##3##(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-7#1)
Particular attention##18##2##(1990-2#1)(1990-9#1)(1992-12#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2013-7#1)
Particular emphasis is placed on##5##5##(1993-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
Particular emphasis is##6##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
Particular##37##1##(1990-2#1)(1990-5#1)(1990-9#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
Particularly in##2##2##(1990-2#1)(2008-7#1)
Particularly interesting##2##2##(1995-5#1)(2012-2#1)
Particularly##27##1##(1990-2#1)(1990-9#1)(1991-12#1)(1992-8#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-10#1)(2012-2#2)(2013-1#1)
Particulate matter##2##2##(2008-10#2)
Particulate##6##1##(1997-1#1)(2007-12#1)(2008-10#4)
Parties to the##2##3##(1992-12#1)(1996-1#1)
Parties##4##1##(1992-12#1)(1996-1#3)
Partition##3##1##(1995-3#1)(2008-10#1)(2009-9#1)
Partitioning##7##1##(1993-11#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
Partly##2##1##(2011-3#1)(2012-2#1)
Partner##6##1##(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
Partnered Research Center for Quality Care##3##6##(2012-2#3)
Partnered##6##1##(2012-2#6)
Partners in Health##3##3##(1997-2#3)
Partners in##5##2##(1995-1#1)(1997-2#3)(2012-2#1)
Partners##10##1##(1990-4#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-2#3)(2009-6#1)(2012-2#1)(2013-1#1)
Partnership for##2##2##(2008-7#1)(2012-12#1)
Partnership##10##1##(1993-5#1)(1994-12#2)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-12#2)(2013-8#1)
Partnerships for##2##2##(2008-1#1)(2008-12#1)
Partnerships##8##1##(1993-2#1)(1996-2#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-10#1)(2012-3#2)
Parts of the##2##3##(1993-8#1)(2012-3#1)
Parts of##3##2##(1993-8#1)(2008-10#1)(2012-3#1)
Parts##6##1##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
Party##2##1##(1996-8#1)(2010-12#1)
Parus caeruleus##3##2##(1994-3#1)(2008-8#1)(2008-9#1)
Parus major##2##2##(2008-8#1)(2008-9#1)
Parus##7##1##(1994-3#2)(2008-8#2)(2008-9#3)
Pascal##4##1##(2008-10#3)(2013-1#1)
Pasch]##3##1##(1997-3#2)(1997-5#1)
Paspalum simplex##2##2##(2008-5#2)
Pasqua and AC Taber##2##4##(2008-10#2)
Pasqua##4##1##(2008-10#4)
Pass-35##2##1##(2008-10#2)
Passage of the##2##3##(1996-1#1)(2011-2#1)
Passage of##4##2##(1996-1#1)(2007-10#1)(2008-3#1)(2011-2#1)
Passage##5##1##(1996-1#1)(2007-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
Passages were CD45(-)##2##3##(2008-11#2)
Passenger##2##1##(1996-12#1)(2013-1#1)
Passeriformes##2##1##(2011-2#2)
Passing##3##1##(1994-12#1)(2008-2#1)(2010-8#1)
Passive Q switching of a##3##5##(2008-3#3)
Passive Q switching##5##3##(2007-12#1)(2008-3#4)
Passive Q##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
Passive avoidance response##2##3##(1991-12#1)(2008-8#1)
Passive##33##1##(1991-12#2)(1991-3#1)(1993-1#1)(1993-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#13)(2008-4#1)(2008-8#2)(2012-2#1)
Passively Q-Switched Nd##2##3##(2008-3#2)
Passively Q-Switched##4##2##(2008-3#4)
Passively Q-switched##2##2##(2007-12#1)(2008-3#1)
Passively##8##1##(2007-12#1)(2008-3#7)
Past research has##4##3##(1992-12#1)(1993-12#1)(2010-2#1)(2010-7#1)
Past research##6##2##(1992-12#1)(1993-12#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-7#1)
Past studies##2##2##(2007-12#1)(2013-8#1)
Past##28##1##(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
Paste##2##1##(2008-10#1)(2008-6#1)
Pasteur##8##1##(2008-11#2)(2010-1#5)(2011-2#1)
Pasteurella multocida##2##2##(2011-2#1)(2012-2#1)
Pasteurella##9##1##(1994-2#1)(2008-5#5)(2010-4#1)(2011-2#1)(2012-2#1)
Pasteurization of##2##2##(2008-10#2)
Pastoral##3##1##(1991-2#2)(2010-9#1)
Pasture##2##1##(1996-12#1)(2008-5#1)
Patch occupancy##2##2##(2008-8#2)
Patch testing##2##2##(2007-7#2)
Patch##12##1##(2007-7#2)(2008-10#1)(2008-11#4)(2008-8#3)(2012-2#1)(2013-1#1)
Patch-clamp##3##1##(1993-6#1)(2008-4#1)(2012-2#1)
Patches##2##1##(2008-5#1)(2013-1#1)
Patchy##2##1##(2008-8#2)
Patella##3##1##(2009-4#1)(2013-1#2)
Patellar##3##1##(2009-3#1)(2013-1#2)
Patellofemoral Pain Syndrome (PFPS)##2##4##(1996-3#1)(2010-9#1)
Patency of arteriovenous fistula in##2##5##(2007-7#2)
Patency of##3##2##(1997-8#1)(2007-7#2)
Patent foramen ovale and decompression illness in divers##2##8##(1996-11#2)
Patent foramen ovale and##4##4##(1996-11#2)(2007-10#1)(2007-9#1)
Patent foramen ovale##6##3##(1996-11#2)(2007-10#1)(2007-9#1)(2008-11#1)(2011-2#1)
Patent##12##1##(1996-11#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-11#1)(2010-12#2)(2011-2#1)
Patents on##2##2##(2010-7#2)
Patents##5##1##(2008-2#3)(2010-7#2)
Paternal inheritance of##2##3##(2008-8#2)
Paternal##5##1##(2008-8#2)(2010-11#1)(2011-1#1)(2012-3#1)
Paternity##2##1##(2008-12#1)(2008-9#1)
Path Length##2##2##(2008-2#1)(2012-12#1)
Path##11##1##(1995-12#2)(1995-3#2)(1996-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
Pathfinder##3##1##(1996-7#1)(2008-3#1)(2008-4#1)
PathoGenesis##2##1##(2008-5#2)
Pathobiology##2##1##(1997-1#1)(2013-8#1)
Pathogen Rhynchosporium secalis##2##3##(2008-10#2)
Pathogen ingress##2##2##(2008-10#2)
Pathogen of##3##2##(2008-10#3)
Pathogen populations##2##2##(2008-10#2)
Pathogen##45##1##(2008-10#43)(2008-7#1)(2011-2#1)
Pathogenesis of Alfalfa mosaic virus in Soybean (Glycine max) and Expression of Chimeric Rabies Peptide in Virus-Infected Soybean##2##18##(2008-10#2)
Pathogenesis of##9##2##(1992-8#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-4#1)(2011-2#1)
Pathogenesis##14##1##(1990-6#1)(1992-12#1)(1992-8#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)
Pathogenesis-Related##3##1##(2008-10#3)
Pathogenic Variation in##2##3##(2008-10#2)
Pathogenic Variation##3##2##(2008-10#3)
Pathogenic and Genetic##3##3##(2008-10#3)
Pathogenic and Nonpathogenic Lifestyles in Colletotrichum acutatum##2##7##(2008-10#2)
Pathogenic and Nonpathogenic##3##3##(2008-10#3)
Pathogenic and##7##2##(2008-10#7)
Pathogenic fungi##2##2##(2008-10#1)(2008-5#1)
Pathogenic to##4##2##(2008-10#4)
Pathogenic variation in##2##3##(2008-10#2)
Pathogenic variation##3##2##(2008-10#3)
Pathogenic##40##1##(1994-12#1)(2008-10#36)(2008-5#1)(2009-8#1)(2013-1#1)
Pathogenicity and##5##2##(2008-10#5)
Pathogenicity of##21##2##(2008-10#19)(2008-5#1)(2008-6#1)
Pathogenicity on##2##2##(2008-10#2)
Pathogenicity tests on##2##3##(2008-10#2)
Pathogenicity tests##5##2##(2008-10#5)
Pathogenicity to##2##2##(2008-10#2)
Pathogenicity was##2##2##(2008-10#2)
Pathogenicity##48##1##(2008-10#44)(2008-5#3)(2008-6#1)
Pathogens were##2##2##(1990-9#1)(2008-10#1)
Pathogens##14##1##(1990-9#1)(1993-2#1)(2008-10#10)(2008-7#1)(2010-3#1)
Pathologic analysis##2##2##(2011-2#1)(2013-1#1)
Pathologic conditions involving##2##3##(1996-6#1)(2013-8#1)
Pathologic examination of the##2##4##(2008-11#1)(2010-3#1)
Pathologic examination##3##2##(2008-11#1)(2010-3#1)(2011-2#1)
Pathologic##15##1##(1995-4#2)(1996-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
Pathological and##2##2##(1993-5#1)(2010-4#1)
Pathological examination revealed##2##3##(2008-7#1)(2012-2#1)
Pathological examination##4##2##(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
Pathological fractures##2##2##(2007-11#2)
Pathological studies##2##2##(1997-8#1)(2012-2#1)
Pathological##20##1##(1990-2#1)(1991-5#1)(1993-12#1)(1993-5#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#1)
Pathologically##3##1##(1994-12#1)(2008-1#1)(2008-5#1)
Pathologists##6##1##(1994-12#2)(1994-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
Pathology confirmed##2##2##(2008-6#1)(2013-1#1)
Pathology of the##2##3##(2006-10#1)(2011-2#1)
Pathology of##4##2##(2006-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Pathology revealed a##2##3##(2007-8#1)(2012-3#1)
Pathology##32##1##(1991-5#1)(1991-9#1)(1992-8#1)(1994-12#4)(1994-9#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2011-2#5)(2012-1#2)(2012-3#1)(2013-1#4)(2013-8#2)
Pathophysiological processes##2##2##(1993-2#1)(2008-10#1)
Pathophysiology and##2##2##(2010-12#1)(2011-2#1)
Pathophysiology of itching##4##3##(1996-11#4)
Pathophysiology of the##2##3##(2008-3#1)(2013-1#1)
Pathophysiology of##11##2##(1992-2#1)(1996-11#4)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
Pathophysiology##14##1##(1992-2#1)(1996-11#4)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
Pathotype##6##1##(2008-10#6)
Pathotypes of the##2##3##(2008-10#2)
Pathotypes of##4##2##(2008-10#4)
Pathotypes##6##1##(2008-10#6)
Pathovars##3##1##(2008-10#3)
Pathway for##2##2##(2008-10#1)(2008-3#1)
Pathway in##4##2##(2008-6#1)(2010-8#2)(2012-12#1)
Pathway of##3##2##(2008-10#2)(2013-1#1)
Pathway##25##1##(1991-6#1)(2008-10#5)(2008-3#4)(2008-6#1)(2008-7#1)(2010-12#3)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
Pathways for##3##2##(1997-7#1)(2008-11#1)(2012-1#1)
Pathways in##3##2##(2008-3#2)(2012-12#1)
Pathways were##2##2##(2008-3#1)(2010-4#1)
Pathways##12##1##(1995-12#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-3#4)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
Patient 1##5##2##(2008-1#2)(2011-2#3)
Patient 2##3##2##(2008-1#1)(2011-2#2)
Patient Access and Care##2##4##(1994-3#2)
Patient Focused Care program will##2##5##(1993-12#1)(1994-2#1)
Patient Focused Care program##4##4##(1993-12#1)(1994-1#1)(1994-2#2)
Patient Focused Care programs##2##4##(1993-1#1)(1994-2#1)
Patient Focused Care##14##3##(1993-1#1)(1993-12#5)(1994-1#3)(1994-2#5)
Patient Focused care team design##2##5##(1994-2#2)
Patient Focused care team##4##4##(1994-2#4)
Patient Focused care##5##3##(1994-2#5)
Patient Focused education##3##3##(1993-3#1)(1994-1#2)
Patient Focused program##2##3##(1994-2#1)(1994-3#1)
Patient Focused restructuring##6##3##(1993-12#3)(1994-1#1)(1994-2#1)(1994-3#1)
Patient Focused##36##2##(1993-1#1)(1993-12#8)(1993-3#2)(1994-1#9)(1994-2#14)(1994-3#2)
Patient Gateway##4##2##(2007-12#4)
Patient Health##2##2##(1994-1#1)(2013-1#1)
Patient Safety##4##2##(2008-6#1)(2011-1#2)(2011-2#1)
Patient Self-Determination Act##4##3##(1992-12#1)(1993-3#2)(1994-1#1)
Patient Simulator##2##2##(2008-11#1)(2013-1#1)
Patient acceptability##2##2##(1992-12#2)
Patient and physician##2##3##(2008-10#1)(2008-3#1)
Patient and proxy##2##3##(2008-7#2)
Patient and##9##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-8#1)(2013-1#1)
Patient assessment##2##2##(2009-6#1)(2012-12#1)
Patient care##3##2##(1992-12#1)(1995-3#1)(2007-10#1)
Patient cohorts##2##2##(2008-11#1)(2011-2#1)
Patient education is a##2##4##(1990-6#1)(1993-6#1)
Patient education is##3##3##(1990-6#1)(1993-6#1)(1997-2#1)
Patient education##4##2##(1990-6#1)(1993-6#1)(1997-2#1)(2010-5#1)
Patient expectations of##2##3##(1996-3#1)(2012-2#1)
Patient focused care##2##3##(1993-2#1)(1994-2#1)
Patient focused##3##2##(1992-12#1)(1993-2#1)(1994-2#1)
Patient had##2##2##(2010-12#1)(2011-2#1)
Patient information##2##2##(2009-12#2)
Patient records##3##2##(1990-6#1)(1994-1#1)(2008-8#1)
Patient reports##2##2##(1996-3#1)(2008-4#1)
Patient safety##2##2##(2007-12#1)(2010-3#1)
Patient satisfaction and##2##3##(1996-1#1)(2009-6#1)
Patient satisfaction##8##2##(1994-1#1)(1994-12#1)(1996-1#2)(1996-3#2)(2006-10#1)(2009-6#1)
Patient selection and##2##3##(2008-7#1)(2011-2#1)
Patient selection##4##2##(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#1)
Patient underwent##3##2##(2010-11#1)(2011-2#1)(2013-7#1)
Patient was##4##2##(2010-12#1)(2012-2#1)(2013-1#2)
Patient with##8##2##(1994-12#1)(2008-12#2)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Patient##243##1##(1990-11#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#5)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#10)(1993-2#1)(1993-3#5)(1993-6#1)(1994-1#14)(1994-12#4)(1994-2#15)(1994-3#8)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1996-1#4)(1996-2#1)(1996-3#7)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-7#3)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#16)(2008-7#9)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#16)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#3)
Patient's##3##1##(1991-12#1)(2007-8#1)(2008-7#1)
Patient-based##2##1##(1994-3#1)(1996-3#1)
Patient-centered care##3##2##(1992-8#1)(1994-12#1)(2012-12#1)
Patient-centered##5##1##(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(2012-12#1)
Patient-focused care##2##2##(1993-12#1)(1994-1#1)
Patients Receiving##2##2##(2008-3#1)(2012-3#1)
Patients Treated with##3##3##(1994-12#1)(1995-4#1)(2008-10#1)
Patients Treated##4##2##(1994-12#1)(1995-4#1)(2006-10#1)(2008-10#1)
Patients With##3##2##(2006-10#2)(2008-6#1)
Patients after##2##2##(1994-12#1)(2012-3#1)
Patients age##3##2##(1991-12#1)(2007-10#1)(2008-4#1)
Patients aged##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
Patients and Methods##33##3##(2008-10#6)(2008-6#4)(2008-7#10)(2011-2#3)(2013-1#9)(2013-8#1)
Patients and methods##12##3##(2007-10#3)(2007-7#1)(2008-6#6)(2011-1#1)(2011-2#1)
Patients and physicians##2##3##(1996-1#1)(2011-1#1)
Patients and##52##2##(1996-1#1)(1996-11#1)(1997-5#1)(1997-7#1)(2007-10#3)(2007-12#1)(2007-7#1)(2008-10#6)(2008-6#10)(2008-7#10)(2011-1#2)(2011-2#4)(2013-1#9)(2013-8#2)
Patients are usually##2##3##(2008-1#1)(2008-12#1)
Patients are##8##2##(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-11#1)(2013-8#1)
Patients at##3##2##(1990-6#1)(1992-5#1)(2012-2#1)
Patients classified as##2##3##(2010-3#1)(2011-2#1)
Patients found to##2##3##(2008-1#1)(2008-8#1)
Patients from group##2##3##(2007-11#1)(2008-3#1)
Patients from##6##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)
Patients had a##2##3##(2008-12#1)(2012-3#1)
Patients had##7##2##(1991-4#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
Patients have##2##2##(1996-8#1)(2011-2#1)
Patients in RLE group##2##4##(2011-2#2)
Patients in group L##2##4##(1996-3#2)
Patients in the Northeast##2##4##(2007-10#2)
Patients in the##8##3##(2007-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-8#1)(2012-12#1)
Patients in whom##2##3##(2013-1#1)(2013-8#1)
Patients in##22##2##(1996-3#3)(2007-10#2)(2007-8#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#1)
Patients included##2##2##(1996-9#1)(2009-10#1)
Patients may have##2##3##(2009-3#1)(2010-3#1)
Patients may##5##2##(1995-2#1)(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#1)
Patients must be##2##3##(2008-3#1)(2013-8#1)
Patients must##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
Patients need##2##2##(2007-11#1)(2012-12#1)
Patients not##2##2##(2010-8#1)(2012-2#1)
Patients of both sexes##2##4##(1990-11#1)(2008-7#1)
Patients of##3##2##(1990-11#1)(2008-7#1)(2012-3#1)
Patients often##2##2##(2011-1#1)(2011-2#1)
Patients on chronic##2##3##(2006-10#1)(2013-1#1)
Patients on##6##2##(1997-5#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)
Patients randomized to##2##3##(2008-7#1)(2012-2#1)
Patients received##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
Patients receiving chemotherapy##2##3##(2008-7#2)
Patients receiving##5##2##(2008-3#1)(2008-7#3)(2013-1#1)
Patients recovering from##2##3##(2007-11#1)(2013-1#1)
Patients should be##4##3##(1996-3#1)(1997-8#1)(2011-2#1)(2013-8#1)
Patients should##5##2##(1996-3#1)(1997-8#1)(2008-3#1)(2011-2#1)(2013-8#1)
Patients suffering from##3##3##(1991-9#1)(1996-5#1)(2007-8#1)
Patients that##2##2##(2007-10#1)(2011-2#1)
Patients treated##2##2##(1993-12#1)(2011-2#1)
Patients typically##2##2##(2007-5#1)(2007-7#1)
Patients undergoing##7##2##(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
Patients underwent a##2##3##(2007-9#1)(2012-12#1)
Patients underwent##4##2##(2007-11#1)(2007-9#1)(2012-12#1)(2013-1#1)
Patients were asked##2##3##(2007-10#1)(2008-11#1)
Patients were assessed with the##2##5##(2012-2#1)(2013-8#1)
Patients were assessed##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
Patients were divided into##6##4##(1990-12#1)(1993-2#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
Patients were divided##7##3##(1990-12#1)(1993-2#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#2)
Patients were evaluated##3##3##(2007-11#1)(2008-11#1)(2009-10#1)
Patients were examined##2##3##(2011-2#2)
Patients were followed for 4##2##5##(1991-4#1)(2013-1#1)
Patients were followed for##3##4##(1991-4#1)(2013-1#2)
Patients were followed##4##3##(1991-4#1)(2007-8#1)(2013-1#2)
Patients were grouped##3##3##(2008-5#1)(2011-2#2)
Patients were initially##2##3##(2008-12#1)(2008-9#1)
Patients were not##2##3##(1990-5#1)(2011-2#1)
Patients were randomized to##2##4##(1992-8#1)(2008-3#1)
Patients were randomized##3##3##(1992-8#1)(2008-3#1)(2011-2#1)
Patients were randomly assigned to##3##5##(1992-8#1)(2008-5#1)(2011-2#1)
Patients were randomly##4##3##(1992-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
Patients were selected##2##3##(1996-12#1)(2008-3#1)
Patients were then##2##3##(1994-2#1)(1997-7#1)
Patients were treated with##2##4##(2008-10#1)(2011-1#1)
Patients were treated##4##3##(1994-12#1)(2008-10#2)(2011-1#1)
Patients were##58##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-4#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#13)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
Patients who are undergoing##2##4##(2012-2#1)(2013-1#1)
Patients who are##7##3##(1991-3#1)(1992-6#1)(1996-9#1)(1997-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Patients who did not##3##4##(2008-3#1)(2008-6#1)(2008-7#1)
Patients who experienced##3##3##(2008-7#2)(2013-1#1)
Patients who had##4##3##(2008-1#1)(2008-7#1)(2010-8#1)(2012-3#1)
Patients who have##5##3##(1992-3#1)(2009-10#1)(2010-9#2)(2011-2#1)
Patients who received home##2##4##(1997-4#1)(2011-2#1)
Patients who underwent##5##3##(1993-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
Patients who were##2##3##(1992-1#1)(2011-2#1)
Patients who##42##2##(1990-3#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#5)(2009-10#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Patients will be randomly##2##4##(2007-8#1)(2008-7#1)
Patients will##3##2##(1994-1#1)(2007-8#1)(2008-7#1)
Patients with Acute##2##3##(2008-8#1)(2012-3#1)
Patients with a history of##4##5##(1990-3#1)(1992-6#1)(1996-3#1)(2008-11#1)
Patients with a##9##3##(1990-3#1)(1992-6#1)(1993-1#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
Patients with advanced##2##3##(2007-11#1)(2008-9#1)
Patients with breast cancer##3##4##(2008-7#2)(2013-1#1)
Patients with cancer##4##3##(2008-1#1)(2008-7#1)(2010-9#1)(2013-1#1)
Patients with chronic liver disease##2##5##(2008-1#1)(2009-8#1)
Patients with chronic##5##3##(1995-12#1)(2008-1#1)(2009-3#1)(2009-8#1)(2012-12#1)
Patients with cystic fibrosis##2##4##(1991-2#1)(2013-1#1)
Patients with diabetes mellitus are##2##5##(2008-1#1)(2008-3#1)
Patients with diabetes##3##3##(2008-1#1)(2008-3#1)(2008-7#1)
Patients with estrogen##2##3##(1997-7#2)
Patients with focal##2##3##(1996-5#1)(2013-1#1)
Patients with homozygous##2##3##(2009-10#1)(2009-4#1)
Patients with hypoxemia had significantly##2##5##(2012-2#2)
Patients with less than##2##4##(2008-10#2)
Patients with more than##2##4##(2008-10#1)(2012-12#1)
Patients with persistent##2##3##(2008-1#1)(2012-12#1)
Patients with renal##2##3##(2006-10#1)(2012-3#1)
Patients with severe##4##3##(2008-7#1)(2011-2#2)(2012-3#1)
Patients with stage IIIC and IV##2##6##(2011-2#2)
Patients with stage##4##3##(2006-10#1)(2007-8#1)(2011-2#2)
Patients with suspected##3##3##(1990-9#1)(2009-8#1)(2011-2#1)
Patients with the##3##3##(1996-6#1)(2008-1#1)(2010-2#1)
Patients with these##2##3##(2007-11#1)(2008-10#1)
Patients with this condition##2##4##(2007-11#1)(2008-11#1)
Patients with this##3##3##(2007-11#1)(2008-11#1)(2008-6#1)
Patients with type##2##3##(1996-11#1)(2008-1#1)
Patients with##225##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-11#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2006-10#4)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#7)(2008-10#7)(2008-11#10)(2008-12#2)(2008-3#7)(2008-5#1)(2008-6#6)(2008-7#15)(2008-8#6)(2008-9#1)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#11)(2012-4#1)(2013-1#18)(2013-8#7)
Patients without##4##2##(1996-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
Patients##618##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#2)(1996-1#4)(1996-11#3)(1996-12#1)(1996-3#6)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#5)(1997-8#5)(2006-10#8)(2007-1#1)(2007-10#13)(2007-11#9)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#10)(2007-8#10)(2007-9#1)(2008-1#19)(2008-10#19)(2008-11#18)(2008-12#8)(2008-3#20)(2008-4#2)(2008-5#6)(2008-6#31)(2008-7#49)(2008-8#13)(2008-9#5)(2009-10#7)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#4)(2010-8#10)(2010-9#3)(2011-1#9)(2011-2#66)(2011-7#1)(2012-1#6)(2012-12#10)(2012-2#12)(2012-3#25)(2012-4#1)(2012-5#1)(2013-1#47)(2013-7#1)(2013-8#23)
Patients' age##2##2##(2007-11#1)(2007-8#1)
Patients' preferences##2##2##(1990-3#1)(2010-3#1)
Patients' views of##2##3##(1992-2#1)(2008-12#1)
Patients'##23##1##(1990-3#1)(1992-2#1)(1994-11#1)(1996-1#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#3)(2013-1#2)
Patients/methods##2##1##(2008-6#2)
Patna (India)##2##2##(1990-6#2)
Patoc##2##1##(2007-7#2)
Patrick##6##1##(1995-12#1)(1996-2#1)(1997-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
Patsy Fleming##2##2##(1995-6#2)
Pattern and##2##2##(1991-8#1)(2012-2#1)
Pattern of Ascospores##2##3##(2008-10#2)
Pattern of##9##2##(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2012-12#1)
Pattern recognition procedures##2##3##(2008-10#2)
Pattern recognition techniques##2##3##(2008-10#2)
Pattern recognition##6##2##(2008-10#4)(2008-2#1)(2010-7#1)
Pattern##28##1##(1991-8#1)(2007-12#1)(2007-7#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-6#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
Patterned after##2##2##(1996-2#1)(2008-11#1)
Patterning##2##1##(1994-12#1)(2009-2#1)
Patterns and##2##2##(1991-3#1)(1992-8#1)
Patterns as##3##2##(2008-3#1)(2010-5#1)(2012-3#1)
Patterns of failure##2##3##(1994-8#1)(1995-9#1)
Patterns of##42##2##(1990-7#1)(1991-1#1)(1991-6#1)(1992-1#1)(1994-8#1)(1995-2#2)(1995-9#1)(1996-10#1)(1996-3#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-12#2)(2008-8#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#3)(2013-7#1)(2013-8#1)
Patterns##52##1##(1990-7#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#1)(1994-8#1)(1995-2#2)(1995-9#1)(1996-10#1)(1996-3#1)(2007-12#1)(2007-5#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
Patterson and Wang's [Strain 27##2##5##(2008-3#2)
Patterson and##3##2##(2008-3#2)(2008-9#1)
Paul B##2##2##(1994-2#1)(2010-5#1)
Paul##22##1##(1990-6#3)(1990-8#1)(1994-1#2)(1994-2#1)(1995-12#2)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-7#2)(2009-7#2)(2010-12#1)(2010-5#1)(2010-6#1)(2012-2#2)
Pauli spin blockade##3##3##(2012-2#3)
Pauli##4##1##(2012-2#4)
Paulo##39##1##(1990-12#3)(1993-8#5)(1996-12#1)(2008-10#14)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
Paulo) and##2##2##(2008-12#1)(2012-3#1)
Paulo)##3##1##(2008-12#1)(2011-2#1)(2012-3#1)
Paving the way for##2##4##(2010-4#1)(2011-1#1)
Paving the##3##2##(1995-3#1)(2010-4#1)(2011-1#1)
Pavlik harness is##2##3##(2007-8#2)
Pavlik harness##10##2##(2007-8#10)
Pavlik splint##2##2##(2007-11#1)(2007-8#1)
Pavlik##14##1##(2007-11#1)(2007-8#12)(2011-2#1)
Pavlovian conditioned##3##2##(2008-4#1)(2009-11#2)
Pavlovian##5##1##(2008-4#2)(2009-11#2)(2011-1#1)
Pawliszyn##2##1##(2008-10#2)
Pax7##4##1##(2009-3#4)
Pay for performance##3##3##(1996-3#1)(2008-4#1)(2008-6#1)
Payer's##2##1##(2008-10#1)(2010-9#1)
Paying attention to##2##3##(2012-3#1)(2013-1#1)
Paying for##2##2##(1993-2#1)(2008-4#1)
Paying##5##1##(1993-2#1)(1995-1#1)(2008-4#1)(2012-3#1)(2013-1#1)
Payment##8##1##(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-1#1)(2008-7#1)(2012-2#1)(2013-7#1)
Pb (II)##2##2##(2008-10#1)(2013-8#1)
Pb accumulation##2##2##(1992-3#2)
Pb and Cu##4##3##(2008-10#4)
Pb and Ni is##2##4##(2008-10#2)
Pb and Ni##6##3##(2008-10#6)
Pb and Pd##2##3##(2008-10#2)
Pb and Tl in##2##4##(2008-10#2)
Pb and Tl##4##3##(2008-10#4)
Pb and U##2##3##(2008-10#2)
Pb and V##2##3##(2008-10#2)
Pb and Zn in##6##4##(2008-10#6)
Pb and Zn were##2##4##(2008-10#1)(2013-8#1)
Pb and Zn##14##3##(2008-10#12)(2010-5#1)(2013-8#1)
Pb and Zn)##3##3##(2008-10#3)
Pb and##53##2##(1997-4#2)(2008-10#48)(2010-5#1)(2011-1#1)(2013-8#1)
Pb at##2##2##(1995-3#1)(2011-2#1)
Pb by using the proposed modifier mixture##2##7##(2008-10#2)
Pb by using##3##3##(2008-10#3)
Pb by##8##2##(2008-10#8)
Pb concentration in the##3##4##(1992-3#2)(2008-1#1)
Pb concentration in##4##3##(1992-3#3)(2008-1#1)
Pb concentration##6##2##(1992-3#4)(2008-1#1)(2008-10#1)
Pb concentrations##4##2##(2008-10#1)(2008-5#1)(2011-1#2)
Pb content in##2##3##(2008-10#2)
Pb content##3##2##(1992-3#1)(2008-10#2)
Pb from##3##2##(2008-10#3)
Pb in the##2##3##(1997-4#1)(2008-10#1)
Pb in##22##2##(1997-4#1)(2008-1#1)(2008-10#17)(2011-2#1)(2013-8#2)
Pb is##2##2##(1992-3#1)(2008-10#1)
Pb isotope##2##2##(2013-8#2)
Pb isotopic composition of##2##4##(2013-8#2)
Pb isotopic composition##3##3##(2013-8#3)
Pb isotopic##6##2##(2013-8#6)
Pb on##2##2##(2008-10#1)(2008-7#1)
Pb ratio##2##2##(2013-8#2)
Pb was 3##2##3##(2008-10#2)
Pb was##4##2##(2008-10#4)
Pb were 4##2##3##(2008-10#2)
Pb were##5##2##(2008-10#5)
Pb##272##1##(1992-3#10)(1995-3#5)(1997-4#3)(2008-1#2)(2008-10#214)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#4)(2010-5#1)(2011-1#6)(2011-2#4)(2013-8#15)
Pb(2)Sn(2)O(6)##4##1##(2009-11#4)
Pb(2+) and Al(3+)##2##3##(2008-10#2)
Pb(2+) and Cd(2+) were##2##4##(2008-10#2)
Pb(2+) and Cd(2+)##6##3##(2008-10#6)
Pb(2+) and Zn(2+)##5##3##(2008-10#5)
Pb(2+) and##15##2##(2008-10#15)
Pb(2+) in the concentration range##2##5##(2008-10#2)
Pb(2+) in##5##2##(2008-10#5)
Pb(2+) ions##5##2##(2008-10#5)
Pb(2+) over##6##2##(2008-10#6)
Pb(2+) using##2##2##(2008-10#2)
Pb(2+) with##2##2##(2008-10#2)
Pb(2+)##65##1##(2008-10#65)
Pb(2+)-selective##2##1##(2008-10#2)
Pb(CMC)(2)-THBF##3##1##(2008-10#3)
Pb(II) and Cu(II) extraction##2##4##(2008-10#2)
Pb(II) and Cu(II)##3##3##(2008-10#3)
Pb(II) and Mn(II)##2##3##(2008-10#2)
Pb(II) and Ni(II)##2##3##(2008-10#2)
Pb(II) and Zn(II)##5##3##(2008-10#5)
Pb(II) and the apparent molar absorptivity is##2##7##(2008-10#2)
Pb(II) and##20##2##(2008-10#20)
Pb(II) at pH##2##3##(2008-10#2)
Pb(II) at##5##2##(2008-10#5)
Pb(II) could##2##2##(2008-10#2)
Pb(II) from##4##2##(2008-10#4)
Pb(II) in##5##2##(2008-10#5)
Pb(II) ion-selective electrode##2##3##(2008-10#2)
Pb(II) ions were##2##3##(2008-10#2)
Pb(II) ions##5##2##(2008-10#4)(2013-1#1)
Pb(II) was##3##2##(2008-10#3)
Pb(II) with##3##2##(2008-10#3)
Pb(II)##119##1##(2008-10#117)(2013-1#2)
Pb(II))##2##1##(2008-10#2)
Pb(II)-ISE##2##1##(2008-10#2)
Pb)##8##1##(2008-10#7)(2009-11#1)
Pb-induced##2##1##(1995-3#2)
Pb-ion selective electrode##4##3##(2008-10#4)
Pb-stimulated##2##1##(1995-3#2)
Pb2+ on##3##2##(1995-11#2)(2013-8#1)
Pb2+ phosphor##2##2##(2013-8#2)
Pb2+##19##1##(1995-11#10)(1997-7#1)(2013-8#8)
PbB level##2##2##(1997-4#2)
PbB levels##4##2##(1997-4#4)
PbB was##2##2##(1997-4#2)
PbB##11##1##(1997-4#11)
PbO##5##1##(2013-8#5)
PbO(2) film##2##2##(2008-10#2)
PbO(2)##10##1##(2008-10#10)
PbO2##5##1##(2008-10#5)
PbS##3##1##(2008-10#2)(2008-3#1)
PbWO(4)##3##1##(2008-3#3)
Pc =##2##2##(1997-8#2)
Pc genes##5##2##(2008-10#5)
Pc##7##1##(1997-8#2)(2008-10#5)
Pc-1##2##1##(1992-6#1)(2010-2#1)
Pc-2##2##1##(1992-6#1)(2010-2#1)
PcDNA##2##1##(1995-11#2)
PcMV and CMLV##3##3##(2008-10#3)
PcMV##10##1##(2008-10#10)
PcpD was##3##2##(2009-3#3)
PcpD##7##1##(2009-3#7)
Pcq1##3##1##(2008-10#3)
Pcq2##3##1##(2008-10#3)
Pcsk9(-/-) mice##3##2##(2013-1#3)
Pcsk9(-/-)##4##1##(2013-1#4)
Pd + NH(4)NO(3)##4##3##(2008-10#4)
Pd +##5##2##(2008-10#5)
Pd and Pt##4##3##(2008-10#3)(2008-11#1)
Pd and Pt)##2##3##(2008-10#2)
Pd and##10##2##(2008-10#8)(2008-11#2)
Pd as a permanent modifier##3##5##(2008-10#3)
Pd as##6##2##(2008-10#6)
Pd coated##2##2##(2008-10#2)
Pd in##2##2##(2008-10#2)
Pd is##2##2##(2008-10#2)
Pd was used##2##3##(2008-10#2)
Pd was##5##2##(2008-10#5)
Pd##74##1##(2007-12#2)(2008-10#62)(2008-11#8)(2009-12#2)
Pd(0)##2##1##(1995-3#1)(2008-10#1)
Pd(2 +)##3##2##(2008-10#3)
Pd(II) and Pt(IV) by##2##4##(2008-10#2)
Pd(II) and Pt(IV)##4##3##(2008-10#4)
Pd(II) in##2##2##(2008-10#2)
Pd(II) ions##2##2##(2008-10#2)
Pd(II) was##2##2##(2008-10#2)
Pd(II) were##2##2##(2008-10#2)
Pd(II)##34##1##(2008-10#33)(2009-12#1)
Pd(II))=0##2##1##(2008-10#2)
Pd(II))=1##2##1##(2008-10#2)
Pd(II)TMPyP was##2##2##(2008-10#2)
Pd(II)TMPyP##5##1##(2008-10#5)
Pd(MQ)(2)##3##1##(2008-10#3)
Pd(NO(3))(2) were##2##2##(2008-10#2)
Pd(NO(3))(2)##3##1##(2008-10#3)
Pd(OAc)(2)##3##1##(2008-10#2)(2009-10#1)
Pd(acac)(2)##2##1##(2008-10#2)
Pd)##3##1##(2008-10#2)(2013-1#1)
Pd-catalyzed##2##1##(2009-5#1)(2010-8#1)
PdO##2##1##(2008-10#2)
Pdx is the##2##3##(1994-5#2)
Pdx##11##1##(1994-5#11)
Pdx-1 gene##2##2##(2010-11#2)
Pdx-1 protein##3##2##(2010-11#3)
Pdx-1##7##1##(2010-11#7)
Pdx1##3##1##(2010-11#3)
Pea##10##1##(2008-10#10)
Peace Corps##2##2##(1991-5#2)
Peace##3##1##(1990-2#1)(1991-5#2)
Peach mosaic virus##2##3##(2008-10#2)
Peach##17##1##(1992-12#1)(2008-10#15)(2008-11#1)
Peak area ratios among##2##4##(2008-10#2)
Peak flow##2##2##(1997-2#1)(2012-2#1)
Peak height##2##2##(2008-10#2)
Peak##25##1##(1990-12#2)(1994-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#3)(2010-3#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
Peaks##3##1##(1997-2#1)(2008-10#2)
Peanut (Arachis hypogaea)##2##3##(2008-10#2)
Peanut Stunt##2##2##(2008-10#2)
Peanut bud necrosis virus##2##4##(2008-10#2)
Peanut stunt virus##2##3##(2008-10#2)
Peanut##14##1##(1996-8#1)(2008-10#13)
Pear and Apple##3##3##(2008-10#3)
Pear and##4##2##(2008-10#4)
Pear plants inoculated with##2##4##(2008-10#2)
Pear##18##1##(2008-10#18)
Pearl##3##1##(1997-4#1)(2008-10#1)(2010-8#1)
Pears##2##1##(2008-10#2)
Pearson correlation coefficients##4##3##(2008-12#2)(2008-3#1)(2011-2#1)
Pearson correlation##9##2##(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#1)(2011-2#3)(2012-2#1)
Pearson correlations and##2##3##(2009-12#1)(2013-1#1)
Pearson correlations##3##2##(2009-12#1)(2011-1#1)(2013-1#1)
Pearson r = 0##2##4##(2011-3#2)
Pearson##19##1##(1992-2#1)(1992-3#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#1)(2013-1#2)
Pearson's r##2##2##(2008-7#1)(2008-9#1)
Pearson's##4##1##(2008-7#1)(2008-9#1)(2009-11#1)(2012-2#1)
Peat##4##1##(2008-10#4)
Pectin##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
Pectobacterium spp##4##2##(2008-10#4)
Pectobacterium##6##1##(2008-10#6)
Pectoral##2##1##(2008-5#1)(2009-7#1)
Peculiarities of##2##2##(2008-10#1)(2011-1#1)
Peculiarities##3##1##(1990-6#1)(2008-10#1)(2011-1#1)
Ped gene##4##2##(2008-5#4)
Ped##6##1##(2008-5#6)
Pedagogical##2##1##(2011-2#2)
Pedal##2##1##(2010-2#1)(2011-2#1)
Pedestrian##2##1##(2010-12#1)(2013-8#1)
Pediatric Brain Tumor Consortium##2##4##(2010-5#2)
Pediatric Cardiac Care Consortium##2##4##(2010-6#2)
Pediatric Cardiac##3##2##(2008-11#1)(2010-6#2)
Pediatric Clinic##3##2##(2008-9#2)(2011-1#1)
Pediatric Emergency Department##2##3##(2013-8#2)
Pediatric Emergency##3##2##(2011-2#1)(2013-8#2)
Pediatric Endocrinology##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
Pediatric Oncology##5##2##(1993-9#1)(2008-9#3)(2011-2#1)
Pediatric and adult##2##3##(2010-3#1)(2010-4#1)
Pediatric and##3##2##(2010-3#2)(2010-4#1)
Pediatric nurse##2##2##(2009-6#1)(2010-4#1)
Pediatric##73##1##(1990-2#1)(1992-2#2)(1993-9#1)(1995-11#1)(1995-5#1)(1996-9#1)(2006-10#2)(2007-12#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#6)(2009-3#1)(2009-6#3)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2011-1#3)(2011-2#13)(2012-12#2)(2013-1#3)(2013-8#5)
Pediatricians##2##1##(2007-12#2)
Pediatrics##12##1##(1991-6#1)(1996-6#1)(2008-11#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
Pedigree##4##1##(1993-12#1)(2008-12#1)(2008-4#1)(2008-5#1)
Pediococcus pentosaceus##2##2##(1995-2#1)(2012-2#1)
Pediococcus##5##1##(1995-2#1)(1997-4#2)(2012-2#2)
Pedon 1##4##2##(2008-12#4)
Pedon 2##3##2##(2008-12#3)
Pedon 3##3##2##(2008-12#3)
Pedon 4##3##2##(2008-12#3)
Pedon 5##5##2##(2008-12#5)
Pedon##19##1##(2008-12#19)
Pedro##4##1##(2007-10#1)(2008-3#1)(2009-7#2)
Peel##3##1##(1991-2#1)(2007-12#1)(2012-3#1)
Peer review##2##2##(1995-1#1)(1996-2#1)
Peer support##2##2##(1993-3#1)(2009-5#1)
Peer##15##1##(1991-1#1)(1993-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(1996-9#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#3)
Peers##3##1##(2012-12#1)(2013-1#2)
Peg-Interferon and ribavirin##2##3##(2013-1#2)
Peg-Interferon and##3##2##(2013-1#3)
Peg-Interferon##5##1##(2013-1#5)
Pej-SGP-III##2##1##(2008-5#2)
Pelotas##2##1##(1993-6#2)
Peltier cooling##2##2##(2008-10#1)(2008-3#1)
Peltier##5##1##(2008-10#1)(2008-3#1)(2008-9#3)
Pelvic actinomycosis##2##2##(2009-5#2)
Pelvic##11##1##(1990-6#1)(1994-1#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2009-5#2)(2011-2#1)(2012-12#2)
Pelvis##2##1##(2008-6#1)(2011-2#1)
Pemberton osteotomy##3##2##(2009-3#3)
Pen X##2##2##(2009-11#2)
PenMate##3##1##(2012-3#3)
Pena##2##1##(1995-6#2)
Penaeus japonicus##4##2##(2008-5#2)(2008-6#2)
Penalized##2##1##(2008-6#1)(2010-5#1)
Penalties##2##1##(2008-11#1)(2008-6#1)
Penang##3##1##(2008-8#1)(2011-1#2)
Penedés##2##1##(2008-10#2)
Penetrating##5##1##(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Penetration and##2##2##(2008-10#1)(2008-3#1)
Penetration by##2##2##(2008-10#2)
Penetration occurred##2##2##(2008-10#2)
Penetration of the##3##3##(2008-10#3)
Penetration of##8##2##(2008-10#6)(2008-3#1)(2008-5#1)
Penetration##17##1##(2008-10#12)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)
Peng##2##1##(2008-11#1)(2009-10#1)
Penh##3##1##(2008-10#2)(2010-11#1)
Penicillin##5##1##(1993-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
Penicillins##2##1##(2011-1#1)(2011-2#1)
Penicillium and##2##2##(2008-6#1)(2010-7#1)
Penicillium canescens##2##2##(2008-6#2)
Penicillium digitatum were##2##3##(2008-10#2)
Penicillium digitatum##9##2##(2008-10#9)
Penicillium expansum##12##2##(2008-10#12)
Penicillium janthinellum##2##2##(2008-6#2)
Penicillium marneffei##3##2##(2008-5#1)(2011-2#2)
Penicillium oxalicum##4##2##(2008-10#4)
Penicillium sp##2##2##(2008-12#1)(2008-6#1)
Penicillium spp##3##2##(2008-10#2)(2013-1#1)
Penicillium##51##1##(1992-5#1)(1993-12#1)(1994-11#1)(2008-10#34)(2008-12#1)(2008-5#1)(2008-6#6)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
Penile fracture##2##2##(2008-7#2)
Penile prosthesis insertion##2##3##(2013-8#2)
Penile##9##1##(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2011-2#1)(2013-8#3)
Peninsula Malaysia##3##2##(2011-1#3)
Peninsula##20##1##(2008-1#1)(2008-10#2)(2008-5#5)(2008-7#1)(2009-2#1)(2010-3#2)(2010-8#1)(2011-1#4)(2013-7#2)(2013-8#1)
Peninsular##2##1##(2008-12#1)(2009-8#1)
Penis##2##1##(2007-5#1)(2012-12#1)
Pennisetum flowering##2##2##(2008-10#2)
Pennisetum glaucum subsp##2##3##(2008-10#2)
Pennisetum glaucum##3##2##(2008-10#3)
Pennisetum##8##1##(1990-5#1)(2008-10#7)
Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE)##2##8##(1992-1#1)(1995-1#1)
Pennsylvania and##3##2##(1996-12#1)(1997-5#1)(2008-10#1)
Pennsylvania isolates##3##2##(2008-10#3)
Pennsylvania to##2##2##(1990-11#1)(1994-3#1)
Pennsylvania##39##1##(1990-11#1)(1992-1#3)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-11#1)(2012-12#1)
Pension##2##1##(1993-3#1)(2008-12#1)
Pentaerythritol triacrylate was##2##3##(2008-9#2)
Pentaerythritol triacrylate##3##2##(2008-9#3)
Pentagon##3##1##(1992-3#1)(1996-5#2)
Pentalogy of Cantrell##2##3##(2013-8#2)
Pentastiridius##2##1##(2008-10#2)
Pentatomidae) feeding##2##2##(2011-2#2)
Pentatomidae)##7##1##(2008-7#2)(2011-2#4)(2013-8#1)
People Living##2##2##(2009-5#1)(2013-1#1)
People are##3##2##(1997-6#1)(2009-9#1)(2011-2#1)
People in##3##2##(2008-8#1)(2010-11#1)(2013-1#1)
People living##2##2##(2007-2#1)(2008-10#1)
People with AIDS##4##3##(1995-6#2)(1996-5#2)
People with##14##2##(1995-6#2)(1996-5#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
People##54##1##(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#2)(1995-1#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-5#2)(1997-6#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
People's Republic of China in##4##5##(2007-7#1)(2008-7#1)(2012-3#2)
People's Republic of China##7##4##(1997-3#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-12#1)(2012-3#2)
People's##13##1##(1990-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2012-3#2)(2013-8#1)
Peoples##2##1##(2012-3#1)(2013-1#1)
Pep13##2##1##(2008-10#2)
PepGMV did not##2##3##(2008-10#2)
PepGMV##8##1##(2008-10#8)
PepGMV-D##2##1##(2008-10#2)
PepGMV-Ser##3##1##(2008-10#3)
PepMV##3##1##(2008-10#3)
PepMoV##5##1##(2008-10#5)
PepT-1##2##1##(2012-2#2)
Pepper (Capsicum annuum)##2##3##(2008-10#2)
Pepper golden mosaic virus (PepGMV)##2##5##(2008-10#2)
Pepper golden mosaic virus##4##4##(2008-10#4)
Pepper huasteco virus##2##3##(2008-10#2)
Pepper mild mottle virus (PMMoV)##2##5##(2008-10#2)
Pepper mild mottle virus##4##4##(2008-10#4)
Pepper mottle virus##3##3##(2008-10#3)
Pepper plants##2##2##(2008-10#2)
Pepper veinal mottle virus##2##4##(2008-10#2)
Pepper##30##1##(2008-10#29)(2008-12#1)
Peptic ulcer was##2##3##(2008-5#1)(2011-2#1)
Peptic ulcer##3##2##(1996-11#1)(2008-5#1)(2011-2#1)
Peptic##5##1##(1995-3#1)(1996-11#1)(1997-1#1)(2008-5#1)(2011-2#1)
Peptidase##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
Peptide analogs of##2##3##(1992-9#1)(1995-3#1)
Peptide antigenicity##2##2##(1997-6#2)
Peptide hormones##2##2##(2008-1#1)(2008-4#1)
Peptide in##3##2##(2008-10#3)
Peptide mapping of the##2##4##(1990-7#1)(1992-9#1)
Peptide mapping of##3##3##(1990-7#1)(1991-2#1)(1992-9#1)
Peptide mapping##8##2##(1990-7#2)(1991-12#1)(1991-2#2)(1992-9#1)(2008-10#1)(2012-3#1)
Peptide##51##1##(1990-7#2)(1991-12#1)(1991-2#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1995-3#1)(1996-5#2)(1997-6#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#2)(2009-9#1)(2010-2#1)(2011-2#5)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#1)
Peptides and##2##2##(1995-3#1)(2011-3#1)
Peptides corresponding to##2##3##(1991-3#1)(1993-3#1)
Peptides from##2##2##(1994-3#1)(2008-9#1)
Peptides##17##1##(1991-3#2)(1993-3#1)(1993-5#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)
Peptidoglycan##2##1##(1990-2#1)(1990-7#1)
Peptostreptococcus spp##3##2##(2007-7#3)
Peptostreptococcus##4##1##(1990-12#1)(2007-7#3)
Per##5##1##(1992-3#1)(2007-7#1)(2008-10#1)(2009-7#1)(2012-2#1)
Per2##2##1##(2009-8#2)
Pera##2##1##(2008-10#2)
Perak##2##1##(2011-1#2)
Perceived parental warmth##2##3##(2009-11#1)(2010-1#1)
Perceived##21##1##(1996-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-4#2)(2009-7#3)(2010-1#3)(2010-7#1)(2010-9#1)(2011-10#1)(2011-2#3)(2013-8#1)
Percent germination of##2##3##(2008-10#2)
Percent germination##3##2##(2008-10#3)
Percent wilt (Y)##2##3##(2008-10#2)
Percent##13##1##(1990-8#2)(1993-12#1)(2008-10#8)(2008-5#1)(2012-3#1)
Percentage Rise in##2##3##(2012-2#2)
Percentage of##5##2##(2008-10#3)(2008-12#1)(2009-6#1)
Percentage##14##1##(1993-3#1)(2008-10#4)(2008-12#1)(2009-6#1)(2010-2#1)(2012-2#5)(2013-7#1)
Percentages of##3##2##(1993-8#1)(2008-11#1)(2011-2#1)
Perception and##2##2##(2009-10#1)(2011-1#1)
Perception of##11##2##(1991-2#1)(1996-2#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
Perception##17##1##(1991-2#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
Perceptions and##3##2##(2010-10#1)(2010-11#1)(2010-4#1)
Perceptions of##14##2##(1990-6#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-3#2)(2013-1#1)
Perceptions##20##1##(1990-6#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2012-3#2)(2013-1#1)
Perceptual##3##1##(2007-12#1)(2010-8#1)(2013-8#1)
Perchlorate##5##1##(2008-10#5)
Percoll gradient centrifugation##2##3##(1995-12#1)(2008-4#1)
Percoll gradients##2##2##(1994-8#1)(2008-4#1)
Percoll##7##1##(1991-11#1)(1994-8#1)(1995-12#1)(2008-11#1)(2008-4#2)(2008-8#1)
Percutaneous Transluminal Angioplasty##2##3##(1990-2#1)(2008-11#1)
Percutaneous aortic valve##2##3##(2009-5#1)(2011-2#1)
Percutaneous endoscopic##2##2##(1992-5#1)(2010-9#1)
Percutaneous fixation of##2##3##(2012-2#2)
Percutaneous renal biopsy##2##3##(2008-1#2)
Percutaneous transhepatic##2##2##(2008-5#2)
Percutaneous transluminal angioplasty##3##3##(2008-1#2)(2008-11#1)
Percutaneous transluminal coronary angioplasty (PTCA)##3##5##(1992-4#1)(1992-9#1)(1994-11#1)
Percutaneous transluminal coronary angioplasty##5##4##(1992-4#1)(1992-9#1)(1994-11#1)(2008-11#2)
Percutaneous transluminal coronary##6##3##(1991-3#1)(1992-4#1)(1992-9#1)(1994-11#1)(2008-11#2)
Percutaneous transluminal##10##2##(1991-3#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-9#1)(2008-1#2)(2008-11#3)
Percutaneous treatment of a##2##4##(1997-8#2)
Percutaneous treatment of##3##3##(1997-8#3)
Percutaneous vertebroplasty is##2##3##(2007-11#2)
Percutaneous vertebroplasty with##2##3##(2007-11#1)(2007-8#1)
Percutaneous vertebroplasty##5##2##(2007-11#4)(2007-8#1)
Percutaneous##58##1##(1990-2#1)(1990-8#1)(1991-3#3)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-9#1)(1996-6#1)(1997-8#3)(2007-11#4)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)
Perennial Ryegrass##2##2##(2008-10#2)
Perennial##5##1##(2008-10#3)(2008-3#1)(2013-8#1)
Perf-MRI##2##1##(1997-8#2)
Perf-WM-MRI##2##1##(1997-8#2)
Perforation##3##1##(1995-10#2)(2008-2#1)
Perforations##2##1##(1991-3#1)(2011-2#1)
Performance Citation Award##2##3##(1991-3#1)(1992-3#1)
Performance Citation##3##2##(1991-3#1)(1992-3#1)(1996-2#1)
Performance Liquid Chromatography##2##3##(2008-10#2)
Performance Liquid##3##2##(1997-2#1)(2008-10#2)
Performance RP-18e##2##2##(2008-10#2)
Performance analysis of##2##3##(2008-3#2)
Performance and##7##2##(1995-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)
Performance assessment##2##2##(1995-12#1)(2008-7#1)
Performance characteristics of a##2##4##(2008-10#1)(2008-7#1)
Performance evaluation of##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
Performance feedback##2##2##(2007-10#1)(2013-1#1)
Performance in##6##2##(1992-12#1)(2008-12#1)(2008-3#1)(2010-7#1)(2012-3#1)(2013-8#1)
Performance indicators are##2##3##(2007-4#1)(2013-1#1)
Performance indicators##4##2##(1992-12#1)(1994-2#1)(2007-4#1)(2013-1#1)
Performance of the velocity estimates is characterized by the##2##9##(2008-2#2)
Performance of the##15##3##(1993-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-2#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
Performance of##31##2##(1993-12#1)(1993-3#1)(1994-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
Performance on a##2##3##(1997-3#1)(2011-1#1)
Performance on##3##2##(1996-5#1)(1997-3#1)(2011-1#1)
Performance status##2##2##(1992-2#1)(2008-7#1)
Performance was##3##2##(1995-3#2)(2013-1#1)
Performance##116##1##(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#9)(2008-5#5)(2008-7#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#2)
Performances##2##1##(2008-10#1)(2008-3#1)
Performed##3##1##(2007-11#1)(2007-8#1)(2008-1#1)
Performing arts medicine - instrumentalist musicians##3##6##(2010-3#3)
Performing multiple analyses of the spiked samples assessed the repeatability of the procedure##2##13##(2008-10#2)
Performing the##2##2##(2007-12#1)(2010-9#1)
Performing##15##1##(1991-3#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2010-11#1)(2010-3#3)(2010-9#1)
Perfusion imaging##2##2##(2008-7#2)
Perfusion with##3##2##(1994-5#1)(1996-9#1)(2008-6#1)
Perfusion##12##1##(1993-3#1)(1994-5#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-6#2)(2008-7#2)(2009-11#2)(2012-3#1)
Pergolide##2##1##(1991-9#1)(2008-7#1)
Perhaps more importantly##2##3##(1995-2#1)(1995-5#1)
Perhaps the##6##2##(1994-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
Perhaps##16##1##(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-9#1)
Peri-implant##2##1##(2008-11#2)
Peri-operative blood##2##2##(2008-8#1)(2013-1#1)
Peri-operative##5##1##(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#2)
Peri-procedural platelet##2##2##(2009-5#2)
Periacetabular##2##1##(2007-8#2)
Perianal##2##1##(1997-8#1)(2010-12#1)
Periapical##2##1##(2007-12#1)(2011-2#1)
Pericardiectomy##2##1##(2007-8#2)
Perilipin##2##1##(2010-4#2)
Perinatal Study##3##2##(2008-12#2)(2011-2#1)
Perinatal##17##1##(1991-8#1)(1992-4#1)(1994-3#2)(2007-2#2)(2008-10#1)(2008-11#1)(2008-12#2)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)
Perineal##4##1##(2009-5#1)(2010-11#1)(2011-2#2)
Period in##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
Period##12##1##(2007-1#1)(2008-10#5)(2008-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
Periodic limb movements##2##3##(2008-11#1)(2012-3#1)
Periodic##19##1##(2007-11#3)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#2)(2013-7#1)
Periodically Poled##3##2##(2008-2#1)(2008-3#2)
Periodically poled##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Periodically##9##1##(1995-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
Periodontal diseases##2##2##(1990-12#1)(2012-3#1)
Periodontal##7##1##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#2)
Periodontitis##2##1##(2011-1#1)(2013-1#1)
Periodontology##2##1##(2012-3#1)(2013-1#1)
Periods##4##1##(2008-10#3)(2011-1#1)
Perioperative hemodynamic##2##2##(2007-8#1)(2012-12#1)
Perioperative management of##2##3##(2008-8#1)(2012-2#1)
Perioperative management##4##2##(2007-8#2)(2008-8#1)(2012-2#1)
Perioperative##21##1##(1991-8#1)(1995-5#1)(1996-3#1)(2006-10#1)(2007-8#4)(2007-9#1)(2008-3#2)(2008-8#3)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Periosteal Ewing's##2##2##(2008-6#2)
Periosteal##5##1##(2008-5#1)(2008-6#4)
Periosteum-derived##2##1##(2008-11#2)
Peripartum cardiomyopathy##4##2##(2008-4#1)(2008-7#1)(2013-8#2)
Peripartum##5##1##(2008-4#1)(2008-7#1)(2012-1#1)(2013-8#2)
Peripheral Blood##2##2##(2013-1#1)(2013-8#1)
Peripheral arterial disease##2##3##(2008-8#2)
Peripheral benzodiazepine##3##2##(1995-12#2)(2008-6#1)
Peripheral blood micronucleus tests##2##4##(2008-8#1)(2008-9#1)
Peripheral blood samples were##3##4##(2009-11#1)(2011-2#1)(2013-1#1)
Peripheral blood samples##4##3##(2009-11#1)(2010-1#1)(2011-2#1)(2013-1#1)
Peripheral blood##13##2##(1991-2#1)(1991-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#1)(2013-1#2)
Peripheral motor##2##2##(2008-7#2)
Peripheral neuropathy##3##2##(2008-2#1)(2008-7#2)
Peripheral or##2##2##(2008-10#1)(2011-1#1)
Peripheral##45##1##(1990-7#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-12#1)(1995-12#2)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Periplaneta americana##3##2##(1990-5#2)(1992-12#1)
Periprocedural##2##1##(2008-3#2)
Periprosthetic##3##1##(2008-7#1)(2008-8#1)(2010-3#1)
Peritoneal Dialysis##4##2##(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#1)
Peritoneal dialysis (PD)##2##3##(2011-2#2)
Peritoneal dialysis##6##2##(2007-12#1)(2011-2#5)
Peritoneal##23##1##(1990-2#1)(1994-9#1)(2007-12#5)(2007-7#3)(2008-1#2)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#7)(2012-2#1)
Peritonitis##6##1##(2007-7#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
Peritrophic membrane##2##2##(2008-7#2)
Perkin Elmer##3##2##(2008-10#1)(2010-5#2)
Perl's Prussian##3##2##(2013-8#3)
Perlidae##2##1##(2007-12#2)
Perlodidae##2##1##(2007-12#2)
Perloza##4##1##(2008-7#4)
Permanent gases inside##2##3##(1993-3#2)
Permanent##11##1##(1993-3#2)(1994-8#1)(1995-3#1)(1995-4#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
Permanente##9##1##(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-8#3)(2011-2#1)
Permeability##2##1##(1992-3#1)(2011-3#1)
Permethrin was##2##2##(2007-5#2)
Permethrin##3##1##(2007-5#2)(2011-2#1)
Permutation##2##1##(2008-10#1)(2008-7#1)
Perna canaliculus##2##2##(2008-10#1)(2009-6#1)
Perna##3##1##(2008-10#2)(2009-6#1)
Pernambuco State##2##2##(2008-9#2)
Pernambuco##4##1##(1991-9#1)(2008-10#1)(2008-9#2)
Peromyscus##2##1##(2010-6#2)
Peronospora tabacina##15##2##(2008-10#15)
Peronospora##18##1##(2008-10#18)
Peroperative##2##1##(1990-11#1)(2008-5#1)
Perovskia abrotanoides##2##2##(2010-5#2)
Peroxidase##8##1##(1994-5#1)(2008-10#6)(2008-8#1)
Peroxidase-like##2##1##(2008-10#2)
Peroxisome Proliferator##2##2##(2008-7#1)(2012-2#1)
Peroxisome proliferator-activated receptor##2##3##(1994-12#1)(2008-1#1)
Peroxisome proliferator-activated receptors (PPARs) are members of the##2##8##(2008-1#1)(2008-3#1)
Peroxisome proliferator-activated receptors (PPARs) are##3##5##(2008-1#1)(2008-3#1)(2013-7#1)
Peroxisome proliferator-activated##5##2##(1994-12#1)(2008-1#2)(2008-3#1)(2013-7#1)
Peroxisome##8##1##(1993-9#1)(1994-12#1)(2008-1#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-7#1)
Peroxynitrite##4##1##(2008-10#3)(2011-1#1)
Perrault##4##1##(1997-5#4)
Perrella et al##2##3##(1990-8#1)(1997-2#1)
Perry##3##1##(2009-4#1)(2012-12#2)
Persea americana##2##2##(2011-2#2)
Persian Gulf##7##2##(1992-12#1)(2008-10#1)(2008-12#4)(2012-2#1)
Persian##11##1##(1992-12#1)(2008-10#1)(2008-12#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Persistence of##7##2##(1995-9#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-6#1)(2012-2#1)
Persistence##11##1##(1995-9#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2012-2#1)(2013-1#1)
Persistent Mullerian duct syndrome##2##4##(2007-2#1)(2008-10#1)
Persistent holograms are recorded##2##4##(2007-12#2)
Persistent infection##2##2##(1994-8#1)(2012-2#1)
Persistent##33##1##(1990-5#1)(1992-5#2)(1993-1#1)(1994-8#1)(1995-9#1)(1996-9#1)(2006-10#1)(2007-12#3)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
Persistently##3##1##(2007-12#1)(2008-11#1)(2011-2#1)
Personal and##4##2##(2008-1#1)(2008-7#1)(2012-1#2)
Personal experience##4##2##(1990-3#2)(1992-5#1)(2008-4#1)
Personal interviews##2##2##(1993-9#1)(2011-2#1)
Personal protection##3##2##(1994-2#1)(2007-2#1)(2011-2#1)
Personal##29##1##(1990-3#2)(1990-9#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#1)
Personality Disorder##2##2##(1994-2#1)(2008-1#1)
Personality characteristics of##2##3##(2009-5#1)(2010-1#1)
Personality characteristics##3##2##(2009-5#1)(2009-8#1)(2010-1#1)
Personality traits were##2##3##(2010-12#1)(2011-1#1)
Personality traits##5##2##(2010-10#1)(2010-12#1)(2011-1#3)
Personality##23##1##(1994-2#3)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-11#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#3)(2012-3#2)
Personalized##5##1##(2008-10#1)(2009-7#1)(2012-1#1)(2013-1#2)
Personnel##8##1##(1991-1#1)(1991-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-8#1)
Persons with##6##2##(1992-5#1)(1994-1#1)(1995-8#1)(1996-1#1)(2009-4#1)(2009-6#1)
Persons##12##1##(1992-3#1)(1992-5#1)(1994-1#1)(1995-8#1)(1996-1#1)(1996-11#1)(2007-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2013-1#2)
Perspective on##2##2##(2008-6#1)(2011-1#1)
Perspective##18##1##(1991-12#1)(2008-6#1)(2009-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
Perspectives and challenges##2##3##(2008-10#1)(2010-10#1)
Perspectives in##4##2##(1997-1#1)(2008-11#1)(2010-5#1)(2011-2#1)
Perspectives on psychological burnout##2##4##(1992-1#1)(1997-1#1)
Perspectives on the##2##3##(1991-12#1)(1992-7#1)
Perspectives on##15##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-11#2)(2009-4#1)(2010-1#1)
Perspectives##30##1##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-1#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
Perth and Sydney##2##3##(2008-10#2)
Perth##5##1##(2007-10#1)(2008-10#3)(2008-5#1)
Perthes disease##7##2##(1992-11#1)(2007-11#6)
Perthes##9##1##(1992-11#1)(2007-11#7)(2011-2#1)
Pertinent##3##1##(2007-12#1)(2008-7#1)(2008-9#1)
Perturbation of##2##2##(1993-8#1)(2009-12#1)
Perturbation##5##1##(1993-8#1)(2007-12#1)(2008-3#1)(2009-12#1)(2009-9#1)
Perturbations##3##1##(1993-8#1)(2008-10#2)
Pertussis toxin##7##2##(1990-12#1)(1991-12#3)(1991-9#2)(1996-2#1)
Pertussis toxin-biotin##3##2##(1991-9#3)
Pertussis##16##1##(1990-11#1)(1990-12#1)(1991-12#3)(1991-9#5)(1992-2#1)(1992-9#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-12#1)
Peru and##3##2##(2008-5#1)(2008-8#2)
Peru for##3##2##(2007-6#1)(2008-10#1)(2008-7#1)
Peru##29##1##(1991-8#2)(1992-5#3)(2007-6#2)(2008-10#10)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2013-1#4)
Peruvian Andes##2##2##(2008-10#2)
Peruvian##18##1##(2008-10#8)(2008-3#2)(2008-8#2)(2011-2#2)(2013-8#4)
Peshawar##3##1##(2008-12#1)(2009-7#1)(2010-11#1)
Pest Management Regulatory##2##3##(2008-11#2)
Pesticide residues##2##2##(2008-10#1)(2011-2#1)
Pesticide##8##1##(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2011-2#1)
Pet##7##1##(1995-9#1)(2010-4#1)(2011-1#4)(2013-1#1)
Petaurista##2##1##(2008-5#2)
Peter R##2##2##(1993-12#2)
Peter Torkildsen (R-MA)##2##3##(1996-5#2)
Peter##15##1##(1990-11#1)(1993-12#2)(1994-1#1)(1995-12#2)(1996-5#2)(2007-2#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-5#1)
Petersburg##5##1##(2008-12#3)(2008-3#1)(2013-8#1)
Peterson##2##1##(1994-5#2)
Petri dish##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
Petri dishes##3##2##(2008-11#3)
Petri net##2##2##(2008-2#2)
Petri##10##1##(2008-10#1)(2008-11#4)(2008-2#3)(2008-7#1)(2009-8#1)
Petroselinum crispum (Parsley)##2##3##(2008-12#2)
Petroselinum crispum##5##2##(2008-12#5)
Petrous##4##1##(2008-7#1)(2011-2#3)
Petunia hybrida##5##2##(2008-10#2)(2008-9#3)
Petunia inflata##2##2##(1992-8#2)
Petunia##8##1##(1992-8#2)(2008-10#3)(2008-9#3)
Peutz-Jeghers syndrome##3##2##(2009-12#3)
Peyer's Patch##4##2##(2008-11#3)(2013-1#1)
Peyer's patch (PP)##2##3##(2008-11#2)
Peyer's patch cells##6##3##(1994-2#1)(2008-10#2)(2008-11#3)
Peyer's patch##9##2##(1994-2#1)(2008-10#2)(2008-11#6)
Peyer's patches##4##2##(1997-1#1)(2008-11#1)(2012-1#2)
Peyer's##19##1##(1994-2#1)(1997-1#1)(2008-10#2)(2008-11#10)(2009-9#1)(2012-1#2)(2013-1#2)
Pf##4##1##(1994-12#2)(2010-12#2)
Pf-5##7##1##(2008-10#7)
Pf1 coat protein##3##3##(1991-5#3)
Pf1##4##1##(1991-5#4)
PfHT as a##2##3##(2010-2#2)
PfHT##3##1##(2010-2#3)
PfODCase##4##1##(2013-7#4)
PfTrx-2##6##1##(2012-2#6)
Pfam family##5##2##(2010-10#5)
Pfam##16##1##(2008-4#7)(2009-10#1)(2009-8#1)(2010-10#7)
Pfizer Canada##2##2##(2008-6#2)
Pfizer##4##1##(2008-11#1)(2008-5#1)(2008-6#2)
Pfm1##3##1##(2008-10#3)
Pfs25##4##1##(1991-5#4)
Pg genes##4##2##(2008-10#4)
Pg10 line##2##2##(2008-10#2)
Pg10 was##2##2##(2008-10#2)
Pg10##7##1##(2008-10#7)
PgR and##3##2##(2008-12#3)
PgR##11##1##(1991-12#3)(1995-4#1)(2008-12#7)
Pgh3-2##2##1##(1993-9#2)
Pgi##2##1##(2012-3#2)
Pgp##3##1##(2008-11#3)
Pgt-QCCJ##3##1##(2008-10#3)
Ph##21##1##(1993-12#2)(1994-12#3)(1994-3#1)(1995-2#2)(1995-3#1)(1996-2#6)(2008-10#1)(2008-12#4)(2008-2#1)
Ph)##2##1##(1996-2#2)
Ph+ ALL cells##2##3##(2011-1#2)
Ph+ ALL patients##2##3##(2012-12#2)
Ph+ ALL##5##2##(2011-1#3)(2012-12#2)
Ph+ acute lymphoblastic leukemia##2##4##(2012-12#2)
Ph+##7##1##(2011-1#3)(2012-12#4)
PhCN##2##1##(1996-2#1)(2009-9#1)
PhD##6##1##(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#2)
PhHg and Hg (II)##2##4##(2008-10#2)
PhIP##8##1##(1992-6#2)(1997-2#3)(1997-4#3)
Phaeocryptopus gaeumannii##5##2##(2008-10#5)
Phaeoisariopsis griseola##3##2##(2008-10#3)
Phaeoisariopsis##4##1##(2008-10#4)
Phaeophyta##3##1##(2008-5#3)
Phaeosphaeria nodorum##7##2##(2008-10#7)
Phaeosphaeria##8##1##(2008-10#8)
Phage HK022 Nun protein##2##4##(1995-3#2)
Phage display is##2##3##(2008-4#1)(2008-7#1)
Phage display##5##2##(1993-8#1)(2008-4#3)(2008-7#1)
Phage##17##1##(1991-9#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-3#2)(2008-10#3)(2008-4#3)(2008-7#1)(2009-5#1)(2012-2#2)
Phages##2##1##(2009-5#1)(2012-2#1)
Phagocytosis##2##1##(1994-6#1)(2008-6#1)
Phakopsora pachyrhizi and P##2##4##(2008-10#2)
Phakopsora pachyrhizi##4##2##(2008-10#4)
Phakopsora##5##1##(2008-10#5)
Phallusia mamillata##2##2##(2008-5#2)
Phanerochaete chrysosporium is##2##3##(1991-11#1)(2009-9#1)
Phanerochaete chrysosporium was##2##3##(2008-11#1)(2008-6#1)
Phanerochaete chrysosporium##13##2##(1990-12#1)(1991-11#2)(1993-3#1)(1994-11#2)(2008-11#1)(2008-6#3)(2008-7#2)(2009-9#1)
Phantom##4##1##(2007-11#1)(2007-12#1)(2009-11#2)
Pharaoh##3##1##(2011-2#3)
Pharm##2##1##(2008-10#1)(2008-5#1)
Pharma##4##1##(2008-10#1)(2008-3#3)
Pharmaceutical Co Ltd##2##3##(2008-5#2)
Pharmaceutical approval update##3##3##(2009-6#2)(2009-9#1)
Pharmaceutical residues##2##2##(2008-10#2)
Pharmaceutical##31##1##(1992-1#1)(1995-1#3)(1996-3#1)(1997-1#2)(2008-10#8)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
Pharmaceuticals Inc##3##2##(2008-3#1)(2008-5#1)(2010-2#1)
Pharmaceuticals##13##1##(2008-10#6)(2008-3#1)(2008-5#4)(2010-11#1)(2010-2#1)
Pharmacia##2##1##(2008-5#2)
Pharmacists##4##1##(1994-12#1)(2011-1#3)
Pharmacoepidemiology##4##1##(2008-11#4)
Pharmacogenetic##2##1##(2008-9#1)(2009-12#1)
Pharmacogenetics and pharmacogenomics##2##3##(2008-10#2)
Pharmacogenomic testing##2##2##(2013-8#2)
Pharmacogenomics##4##1##(2007-3#1)(2008-10#1)(2008-8#1)(2013-8#1)
Pharmacokinetic interaction between##2##3##(2007-12#1)(2011-2#1)
Pharmacokinetic parameters of##2##3##(1997-7#1)(2011-2#1)
Pharmacokinetic parameters##5##2##(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#2)
Pharmacokinetic studies##3##2##(1997-1#1)(2008-3#1)(2008-7#1)
Pharmacokinetic##21##1##(1990-9#1)(1991-2#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#4)(2013-8#1)
Pharmacokinetics and##2##2##(1997-7#1)(2009-11#1)
Pharmacokinetics of##6##2##(2007-11#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-3#1)(2013-7#1)
Pharmacokinetics##9##1##(1997-7#1)(2007-11#1)(2008-7#1)(2009-11#2)(2011-1#1)(2011-3#1)(2012-12#1)(2013-7#1)
Pharmacol##4##1##(1990-10#1)(1991-8#1)(2008-4#1)(2012-3#1)
Pharmacologic ascorbate can##2##3##(2012-2#2)
Pharmacologic##9##1##(1991-1#1)(1996-9#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-10#1)(2012-2#2)
Pharmacological agents##2##2##(2008-5#1)(2008-7#1)
Pharmacological and##2##2##(2011-2#1)(2012-3#1)
Pharmacological effects of##2##3##(1992-6#1)(2013-1#1)
Pharmacological management##2##2##(2008-8#1)(2011-2#1)
Pharmacological strategies##2##2##(1992-9#1)(2010-3#1)
Pharmacological studies##2##2##(1995-11#1)(2009-7#1)
Pharmacological therapy##2##2##(2008-8#1)(2011-2#1)
Pharmacological treatment##2##2##(2007-8#1)(2008-7#1)
Pharmacological##28##1##(1991-3#1)(1991-7#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
Pharmacologists##2##1##(1994-11#1)(2008-5#1)
Pharmacology and Drug Therapy##2##4##(2013-1#2)
Pharmacology and##4##2##(2008-4#2)(2013-1#2)
Pharmacology of the pyrroloimidazole##3##4##(1991-8#3)
Pharmacology##13##1##(1991-8#3)(2008-4#2)(2008-5#2)(2009-9#1)(2011-2#1)(2013-1#2)(2013-7#2)
Pharmacopoeia procedure at##2##3##(2008-10#2)
Pharmacopoeia procedure##3##2##(2008-10#3)
Pharmacopoeia##11##1##(2008-10#11)
Pharmacopoeias##2##1##(2008-10#1)(2008-5#1)
Pharmacotherapy and psychotherapy##2##3##(2008-4#1)(2013-1#1)
Pharmacotherapy for##2##2##(2008-4#1)(2009-12#1)
Pharmacotherapy of##2##2##(2008-4#1)(2011-2#1)
Pharmacotherapy##10##1##(1995-2#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Pharmacovigilance##3##1##(2008-11#1)(2008-3#2)
Pharmacy and##4##2##(2008-6#1)(2011-1#1)(2012-3#2)
Pharmacy##15##1##(1991-3#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-3#3)(2011-1#2)(2012-3#2)(2013-1#1)
Phascolopsis gouldii##2##2##(1992-8#2)
Phase 1##3##2##(2008-8#2)(2011-1#1)
Phase 2##4##2##(2008-8#1)(2011-1#1)(2011-2#2)
Phase I and II##2##4##(1996-12#1)(2012-3#1)
Phase I studies##3##3##(1995-8#1)(2008-5#1)(2008-8#1)
Phase I study of##2##4##(1992-10#1)(1996-10#1)
Phase I##16##2##(1992-10#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#1)(2008-5#1)(2008-8#1)(2012-3#5)
Phase II Study of##2##4##(2008-6#2)
Phase II Study##3##3##(2008-10#1)(2008-6#2)
Phase II study of##2##4##(1995-9#1)(2008-7#1)
Phase II study##3##3##(1990-10#1)(1995-9#1)(2008-7#1)
Phase II trials##3##3##(1990-10#1)(2008-5#2)
Phase II##15##2##(1990-10#2)(1990-2#1)(1994-9#1)(1995-9#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2013-8#1)
Phase III clinical##2##3##(2008-4#1)(2010-11#1)
Phase III##10##2##(1995-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Phase Maps##2##2##(2008-2#1)(2008-3#1)
Phase Separations##2##2##(1997-2#1)(2008-10#1)
Phase Shift##2##2##(2008-2#1)(2008-3#1)
Phase and##2##2##(2007-12#2)
Phase correction in##2##3##(2007-12#1)(2008-2#1)
Phase correlations##2##2##(2008-2#2)
Phase imaging##3##2##(2006-4#2)(2007-12#1)
Phase matching##2##2##(2007-12#1)(2008-3#1)
Phase retrieval##2##2##(2008-3#1)(2008-8#1)
Phase transitions##2##2##(2008-10#1)(2009-11#1)
Phase unwrapping through##2##3##(2008-2#1)(2008-3#1)
Phase unwrapping with the branch-cut method##3##6##(2008-3#3)
Phase unwrapping##6##2##(2008-2#1)(2008-3#5)
Phase##131##1##(1990-10#2)(1990-2#1)(1991-3#1)(1992-10#1)(1994-1#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-7#1)(2006-4#2)(2007-11#5)(2007-12#10)(2008-10#5)(2008-2#18)(2008-3#20)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#5)(2009-11#2)(2009-4#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#2)
Phase-Doppler interferometry##2##2##(2008-3#2)
Phase-conjugate energy##2##2##(2007-12#2)
Phase-conjugate resonant holographic interferometry##2##4##(2008-2#2)
Phase-conjugate##5##1##(2007-12#2)(2008-2#3)
Phase-dependent##2##1##(2007-12#2)
Phase-locked##5##1##(2007-11#2)(2007-12#3)
Phase-modulated##2##1##(2008-3#2)
Phase-shift##2##1##(2007-12#1)(2008-3#1)
Phase-shifting interferometry##2##2##(2008-3#2)
Phase-shifting point-diffraction interferometry at##2##4##(2008-3#2)
Phase-shifting shearing interferometer&quot##2##3##(2007-11#2)
Phase-shifting shearing##3##2##(2007-11#3)
Phase-shifting##14##1##(2007-11#7)(2008-3#7)
Phaseolus coccineus##2##2##(2008-10#1)(2008-3#1)
Phaseolus spp##2##2##(2008-10#2)
Phaseolus vulgaris L##2##3##(2008-12#1)(2013-8#1)
Phaseolus vulgaris leucoagglutinin (PHA-L)##2##4##(1995-12#1)(2008-4#1)
Phaseolus vulgaris##13##2##(1995-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2010-3#1)(2013-8#2)
Phaseolus##19##1##(1995-12#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2010-3#1)(2013-8#2)
Phases##7##1##(1994-8#1)(2008-10#2)(2009-12#1)(2009-8#1)(2012-3#2)
Phazyme assay##3##2##(2012-2#3)
Phazyme assays correctly##2##3##(2012-2#2)
Phazyme assays##3##2##(2012-2#3)
Phazyme##6##1##(2012-2#6)
Phe M197--&gt##3##2##(1993-11#3)
Phe and Arg##2##3##(1992-4#2)
Phe and##3##2##(1992-4#2)(1992-8#1)
Phe or##2##2##(1992-4#1)(1995-2#1)
Phe psi Ala##3##3##(1992-8#3)
Phe psi Gly##5##3##(1992-8#5)
Phe psi Leu##2##3##(1992-8#2)
Phe psi NorVal##3##3##(1992-8#3)
Phe psi Phe##3##3##(1992-8#3)
Phe psi##16##2##(1992-8#16)
Phe##35##1##(1990-11#1)(1992-3#2)(1992-4#4)(1992-8#19)(1993-11#3)(1993-2#1)(1995-2#2)(2008-4#1)(2008-9#2)
Phe- Tyr- Ala- Pro- Met- NH2##2##6##(1991-5#2)
Phe- Tyr- Gly- Leu- Met- NH2 (ranatachykinin##2##7##(1991-5#2)
Phe- Tyr-##4##2##(1991-5#4)
Phe-##6##1##(1991-5#6)
Phe-Met##3##1##(2008-10#3)
Phe3##3##1##(1991-9#1)(1993-3#1)(1995-3#1)
Phellinus extract##3##2##(2008-8#3)
Phellinus fastuosus as##2##3##(2008-8#2)
Phellinus##11##1##(1991-5#1)(2008-10#3)(2008-8#7)
Phenetic##2##1##(2008-10#2)
Phenolic compounds##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
Phenolic##7##1##(1994-11#1)(1995-9#1)(2008-10#3)(2008-5#1)(2011-2#1)
Phenology##3##1##(2008-10#3)
Phenols in##2##2##(2008-10#2)
Phenols##3##1##(1990-8#1)(2008-10#2)
Phenomena##5##1##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)
Phenomenological##5##1##(2007-12#1)(2008-12#1)(2008-6#1)(2013-1#2)
Phenomenology##3##1##(2007-10#1)(2008-1#1)(2010-8#1)
Phenotype analysis##2##2##(2008-5#1)(2008-8#1)
Phenotype and##2##2##(2008-4#1)(2011-2#1)
Phenotype in##2##2##(2012-3#1)(2013-1#1)
Phenotype##10##1##(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Phenotypes of##2##2##(2008-10#2)
Phenotypes##5##1##(2008-10#3)(2008-6#1)(2010-5#1)
Phenotypic Variation##2##2##(2008-10#1)(2012-3#1)
Phenotypic analysis of##2##3##(2008-10#1)(2008-9#1)
Phenotypic analysis##3##2##(2008-10#1)(2008-9#2)
Phenotypic and##4##2##(2008-10#4)
Phenotypic diversity##2##2##(2008-10#1)(2012-3#1)
Phenotypic plasticity##3##2##(2010-3#1)(2013-7#2)
Phenotypic selection##2##2##(2008-8#1)(2013-1#1)
Phenotypic##25##1##(2008-10#13)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
Phenotypically##3##1##(2008-10#1)(2008-12#1)(2008-8#1)
Phenoxyl##2##1##(2007-11#1)(2008-10#1)
Phentanil and##2##2##(2012-3#2)
Phentanil##3##1##(2012-3#3)
Phenyl##2##1##(1997-2#1)(1997-7#1)
Phenylalkylamine##2##1##(1991-1#2)
Phenylarsine oxide##2##2##(1994-8#1)(1995-5#1)
Phenylephrine did not##2##3##(1991-3#1)(1994-3#1)
Phenylephrine##5##1##(1990-12#1)(1991-12#1)(1991-3#1)(1994-3#1)(1995-12#1)
Phenytoin##4##1##(1994-2#1)(1995-12#1)(2008-11#2)
Pheochromocytoma##2##1##(2009-1#2)
Pheophorbide a##2##2##(2008-8#2)
Phi##3##1##(2008-10#3)
PhiC31##2##1##(2008-11#2)
PhiEa1h lysozyme##3##2##(2008-10#3)
PhiEa1h##4##1##(2008-10#4)
Phialophora gregata##4##2##(2008-10#4)
Phialophora##6##1##(2008-10#6)
Philadelphia chromosome##4##2##(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
Philadelphia##22##1##(1991-1#1)(1991-12#1)(1992-2#2)(1996-5#1)(1997-6#1)(2007-11#4)(2007-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)
Philanthropy and the##3##3##(1991-1#1)(1993-3#1)(1997-3#1)
Philanthropy##5##1##(1991-1#1)(1993-3#2)(1995-1#1)(1997-3#1)
Philip##5##1##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
Philippine races of##2##3##(2008-10#2)
Philippine strain##3##2##(2008-10#3)
Philippine##10##1##(1990-6#1)(1994-6#1)(2008-10#8)
Philippines##11##1##(1990-6#1)(2007-5#2)(2008-10#2)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)
Philips##2##1##(2008-3#1)(2008-7#1)
Philips-Elekta##2##1##(2008-3#2)
Phillip##2##1##(2008-10#1)(2008-8#1)
Phillips##3##1##(1993-11#1)(1995-12#1)(1995-3#1)
Philometra##2##1##(2010-8#1)(2012-2#1)
Philonthus marginatus##2##2##(2007-12#2)
Philonthus varians##2##2##(2007-12#2)
Philonthus##5##1##(2007-12#5)
Philosopher's##2##1##(2008-4#1)(2012-3#1)
Philosophy##3##1##(2010-3#2)(2011-2#1)
Phl p 1##3##3##(2012-2#3)
Phl production##2##2##(2008-10#2)
Phl##6##1##(2008-10#3)(2012-2#3)
Phlebotominae sand flies are##2##4##(2008-12#2)
Phlebotominae sand flies##4##3##(2008-12#4)
Phlebotominae##6##1##(2008-12#5)(2013-1#1)
Phlebotomus##4##1##(2008-12#1)(2010-1#1)(2013-1#2)
Phlebovirus is##3##2##(2013-8#3)
Phlebovirus##5##1##(2013-8#5)
Phloem##2##1##(2008-10#2)
Phlomobacter##3##1##(2008-10#3)
PhoA activity##2##2##(1994-12#1)(1995-8#1)
PhoA proteins##2##2##(1994-12#2)
PhoA##5##1##(1994-12#4)(1995-8#1)
PhoE##3##1##(1990-11#1)(1994-12#2)
Phobia##2##1##(2013-1#2)
Phoenix##4##1##(1991-3#1)(2012-12#3)
Pholidoptera##2##1##(2008-12#2)
Phoma macdonaldii##2##2##(2008-10#2)
Phoma medicaginis##2##2##(2008-10#2)
Phoma species are##2##3##(2008-10#2)
Phoma##14##1##(2008-10#14)
Phomopsis leaf blight##4##3##(2008-10#4)
Phomopsis longicolla##5##2##(2008-10#5)
Phomopsis sp##2##2##(2008-10#2)
Phomopsis viticola##4##2##(2008-10#4)
Phomopsis##29##1##(2008-10#29)
Phonological words##2##2##(2008-2#2)
Phonological##3##1##(2008-2#2)(2012-3#1)
Phoracantha semipunctata##2##2##(2007-12#2)
Phorbol esters##3##2##(1990-12#1)(1993-8#1)(1995-6#1)
Phorbol##6##1##(1990-12#1)(1990-2#1)(1992-8#1)(1993-8#1)(1995-6#1)(1997-1#1)
Phoridae)##2##1##(2007-12#1)(2008-6#1)
Phosphatase##2##1##(2008-11#1)(2008-12#1)
Phosphate and##2##2##(2007-3#1)(2008-10#1)
Phosphate##13##1##(1997-7#2)(2007-3#1)(2008-10#4)(2008-11#2)(2008-6#1)(2009-10#1)(2011-1#1)(2013-1#1)
Phosphatidylcholine and##2##2##(1994-12#1)(2012-12#1)
Phosphatidylcholine##3##1##(1994-12#1)(2011-2#1)(2012-12#1)
Phosphatidylethanolamine##2##1##(1990-5#1)(1991-11#1)
Phosphatidylinositol 3-kinase (PI 3-kinase)##2##4##(1993-8#1)(1994-11#1)
Phosphatidylinositol 3-kinase##4##2##(1993-8#1)(1994-11#1)(1995-6#1)(2011-1#1)
Phosphatidylinositol 4-kinase##3##2##(1991-8#3)
Phosphatidylinositol##12##1##(1991-8#3)(1992-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-4#2)(2011-1#1)
Phosphatidylserine##3##1##(1995-2#1)(2008-8#1)(2012-2#1)
Phosphine##6##1##(1996-2#2)(1997-7#1)(2008-11#3)
Phosphite##3##1##(1996-5#1)(2008-10#2)
Phosphoenolpyruvate carboxykinase (PEPCK)##2##3##(1995-6#1)(1996-2#1)
Phosphoenolpyruvate carboxykinase##3##2##(1995-6#1)(1996-2#1)(2010-4#1)
Phosphoinositide 3-kinases##2##2##(1996-2#1)(2010-9#1)
Phospholipase A2 (PLA2)##2##3##(1990-7#1)(2013-7#1)
Phospholipase A2##5##2##(1990-2#1)(1990-7#1)(1993-11#1)(1996-9#1)(2013-7#1)
Phospholipase##7##1##(1990-2#1)(1990-7#1)(1993-11#1)(1996-9#1)(2008-8#1)(2011-2#1)(2013-7#1)
Phospholipid##9##1##(1990-11#1)(1990-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(2008-4#1)(2009-8#1)(2011-2#2)
Phospholipids in##2##2##(2008-10#1)(2009-8#1)
Phospholipids##4##1##(1991-5#1)(2008-10#1)(2009-8#2)
Phosphonic##3##1##(1996-5#1)(2008-10#2)
Phosphorus##11##1##(1996-2#2)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)(2013-1#1)
Phosphorus-31 NMR spectra of##2##4##(1997-7#2)
Phosphorylated##3##1##(1993-8#1)(2009-8#1)(2013-1#1)
Phosphorylation and##3##2##(1990-11#1)(1994-11#1)(1995-6#1)
Phosphorylation of the human##2##4##(1990-11#1)(1993-3#1)
Phosphorylation of the##8##3##(1990-10#1)(1990-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-2#1)(2009-5#1)
Phosphorylation of tyrosine residues##2##4##(2008-1#1)(2012-3#1)
Phosphorylation of##24##2##(1990-10#1)(1990-11#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-3#1)
Phosphorylation##35##1##(1990-10#1)(1990-11#2)(1990-8#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#4)(2012-3#2)
Photo-induced##3##1##(1992-8#1)(2008-11#1)(2008-8#1)
Photoacoustic ophthalmoscopy##2##2##(2011-7#2)
Photoacoustic spectroscopy##2##2##(2007-11#1)(2007-12#1)
Photoacoustic##14##1##(1994-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2009-12#1)(2011-7#2)
Photoaffinity labeling##2##2##(1990-12#1)(1992-12#1)
Photoaffinity##3##1##(1990-11#1)(1990-12#1)(1992-12#1)
Photobacterium damselae subsp##2##3##(2009-5#2)
Photobacterium##3##1##(2008-11#1)(2009-5#2)
Photobleaching##5##1##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)
Photocatalytic##3##1##(1994-3#1)(2008-10#1)(2009-8#1)
Photochemical##10##1##(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)
Photochromic##3##1##(2007-11#1)(2008-3#1)(2009-9#1)
Photodarkening##2##1##(2008-3#2)
Photodiagnosis and##2##2##(2012-3#2)
Photodynamic Therapy##3##2##(2008-5#2)(2009-12#1)
Photodynamic therapy (PDT) involves the##2##5##(2008-8#1)(2012-3#1)
Photodynamic therapy (PDT) is##2##4##(1992-8#1)(2013-8#1)
Photodynamic therapy (PDT)##9##3##(1992-8#1)(1994-1#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-8#2)
Photodynamic therapy for##2##3##(2007-8#1)(2012-3#1)
Photodynamic therapy##19##2##(1992-1#1)(1992-8#1)(1993-11#1)(1994-1#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-3#6)(2013-8#3)
Photodynamic##26##1##(1992-1#1)(1992-8#1)(1993-11#1)(1994-1#1)(2007-8#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#6)(2013-8#5)
Photofrin II was##3##3##(1993-8#2)(1994-1#1)
Photofrin II##6##2##(1993-8#5)(1994-1#1)
Photofrin##9##1##(1992-9#1)(1993-8#5)(1994-1#1)(2008-5#1)(2009-4#1)
Photographic and##2##2##(1994-2#1)(2008-5#1)
Photographic##8##1##(1994-2#1)(2008-2#2)(2008-3#3)(2008-5#1)(2013-1#1)
Photographs of##2##2##(2008-2#2)
Photographs were taken##2##3##(2008-5#1)(2012-3#1)
Photographs were##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
Photographs##5##1##(2008-10#1)(2008-2#2)(2008-5#1)(2012-3#1)
Photoinduced##8##1##(1995-5#1)(1996-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#2)
Photoinduction of##2##2##(1992-8#1)(2008-2#1)
Photolabeling of the alpha-neuraminidase/beta-galactosidase complex##2##5##(1990-11#2)
Photoluminescence##3##1##(1992-11#1)(2007-11#1)(2009-11#1)
Photolysis of caged##2##3##(1995-3#1)(2008-4#1)
Photolysis of##7##2##(1994-6#1)(1995-3#1)(1996-2#1)(1996-5#2)(2008-4#2)
Photolysis##8##1##(1994-6#1)(1995-3#2)(1996-2#1)(1996-5#2)(2008-4#2)
Photometric methods for determining the optical constants and the thicknesses of thin absorbing films##2##14##(2008-3#2)
Photometric##5##1##(2008-10#3)(2008-3#2)
Photon correlation spectroscopy##2##3##(2008-2#2)
Photon correlation##3##2##(2008-2#2)(2008-3#1)
Photon##18##1##(1994-2#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2009-12#1)(2011-1#1)
Photon-number##2##1##(2007-12#2)
Photonic crystal##4##2##(2007-11#3)(2007-12#1)
Photonic##13##1##(1996-9#1)(2007-11#6)(2007-12#1)(2008-3#3)(2008-7#1)(2009-12#1)
Photonics##2##1##(2008-2#1)(2008-3#1)
Photophysical##2##1##(2009-12#1)(2010-2#1)
Photoreceptor##2##1##(2007-12#1)(2008-7#1)
Photorefractive##15##1##(2007-11#3)(2007-12#2)(2008-2#7)(2008-3#3)
Photorhabdus luminescens##2##2##(2008-10#1)(2008-11#1)
Photosensitive##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
Photosensitivity##3##1##(2011-2#3)
Photosensitizer##2##1##(2008-11#1)(2013-8#1)
Photosynthesis##2##1##(1992-2#1)(2009-4#1)
Photosynthetic##4##1##(2008-10#1)(2008-8#1)(2011-1#1)(2012-6#1)
Phototherapy##4##1##(1992-4#1)(1997-6#2)(1997-8#1)
Photothermal lensing##2##2##(2008-2#2)
Photothermal phase-shift##2##2##(2008-2#2)
Photothermal##9##1##(2008-2#5)(2008-3#4)
Phototrophic biofilms##2##2##(2009-4#2)
Phragmatopoma californica##3##2##(1992-6#2)(2010-2#1)
Phragmatopoma##4##1##(1992-6#3)(2010-2#1)
Phragmites##2##1##(2008-12#1)(2008-5#1)
Phrap##3##1##(2008-4#3)
Phreatoicidea##4##1##(2007-12#4)
Phred##2##1##(2008-4#2)
Phrenic##2##1##(1997-6#1)(2009-4#1)
Phrynosomatinae##2##1##(2008-8#1)(2010-3#1)
Phycobilisomes##2##1##(1993-11#1)(2008-8#1)
Phyllocnistis citrella Stainton##2##3##(2008-6#2)
Phyllodes Tumor##2##2##(1994-12#1)(1995-4#1)
Phyllomedusa bicolor##2##2##(1993-3#1)(1994-5#1)
Phyllomedusa##4##1##(1993-3#2)(1994-5#2)
Phylloplane##2##1##(2008-10#2)
Phyllosphere##3##1##(2008-10#3)
Phyllosticta##4##1##(2008-10#4)
Phyllotaxis##2##1##(2009-8#2)
Phylogenetic Analyses of##3##3##(2008-10#3)
Phylogenetic Analysis of##2##3##(2008-10#2)
Phylogenetic Analysis##3##2##(2008-10#3)
Phylogenetic Relationships##3##2##(2008-10#2)(2008-5#1)
Phylogenetic analyses of##3##3##(2008-10#3)
Phylogenetic analyses revealed that the##2##5##(2008-10#1)(2010-3#1)
Phylogenetic analyses using##2##3##(2008-10#2)
Phylogenetic analyses were used for quality assurance purposes and for the determination of the haplogroup affiliation of the samples##2##19##(2008-12#2)
Phylogenetic analyses were##3##3##(2008-10#1)(2008-12#2)
Phylogenetic analyses##16##2##(2008-10#12)(2008-12#2)(2010-3#1)(2011-1#1)
Phylogenetic analysis based on##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
Phylogenetic analysis of the ITS##2##5##(2008-10#1)(2010-3#1)
Phylogenetic analysis of the##10##4##(1993-12#1)(2008-10#5)(2008-12#1)(2010-3#1)(2010-8#1)(2013-8#1)
Phylogenetic analysis of##19##3##(1993-12#1)(2008-10#14)(2008-12#1)(2010-3#1)(2010-8#1)(2013-8#1)
Phylogenetic analysis revealed that##2##4##(2008-10#1)(2013-8#1)
Phylogenetic analysis revealed##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
Phylogenetic analysis showed that##2##4##(2008-10#1)(2010-5#1)
Phylogenetic analysis showed##3##3##(2008-10#1)(2010-5#1)(2010-8#1)
Phylogenetic analysis using##2##3##(2008-10#1)(2012-1#1)
Phylogenetic analysis##38##2##(1993-12#1)(2008-10#23)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#3)
Phylogenetic and##3##2##(1994-5#1)(2008-10#1)(2013-1#1)
Phylogenetic diversity in##2##3##(2008-10#1)(2013-1#1)
Phylogenetic relationships among six species of Epistylis##2##7##(2008-9#2)
Phylogenetic relationships within the##3##4##(2008-10#1)(2008-6#1)(2010-4#1)
Phylogenetic relationships##9##2##(2008-10#1)(2008-6#3)(2008-9#2)(2010-3#2)(2010-4#1)
Phylogenetic studies##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
Phylogenetic tree##4##2##(2008-8#2)(2011-1#1)(2013-8#1)
Phylogenetic trees##8##2##(1995-3#1)(2007-6#1)(2008-10#3)(2008-5#2)(2010-8#1)
Phylogenetic##101##1##(1993-12#2)(1994-5#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-6#1)(2008-10#53)(2008-12#4)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#6)
Phylogenetically Different##2##2##(2008-10#2)
Phylogenetically##5##1##(1997-4#1)(2008-10#3)(2008-7#1)
Phylogenic##2##1##(1997-9#1)(2008-10#1)
Phylogenies##2##1##(2008-10#2)
Phylogeny and##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
Phylogeny of##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-6#1)
Phylogeny##8##1##(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#1)
Phylogeography and##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
Phylogeography of the##2##3##(2008-10#1)(2010-8#1)
Phylogeography##5##1##(2008-10#2)(2010-8#2)(2013-1#1)
Phys##21##1##(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#3)(2008-7#1)(2009-2#1)(2010-2#1)(2011-2#9)
Physalospora vaccinii##2##2##(2008-10#2)
Physical Activity Questionnaire##2##3##(2011-2#1)(2012-3#1)
Physical Activity Scale for the Elderly##2##6##(2008-4#1)(2013-1#1)
Physical Activity and##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
Physical Activity##16##2##(2007-2#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)
Physical Chemistry##3##2##(2009-9#1)(2012-1#2)
Physical Functioning##2##2##(2013-1#2)
Physical Mapping##2##2##(2008-10#1)(2012-3#1)
Physical Properties##2##2##(1997-3#1)(2008-10#1)
Physical Therapy##2##2##(1994-3#1)(2008-12#1)
Physical activity and obesity in##2##5##(2011-2#2)
Physical activity and##6##3##(1991-2#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
Physical activity was##2##3##(2009-9#1)(2013-1#1)
Physical activity##16##2##(1991-2#1)(1993-2#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#3)
Physical aging##2##2##(1995-3#2)
Physical and chemical##2##3##(2008-10#1)(2010-4#1)
Physical and##8##2##(1991-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-8#1)(2013-8#1)
Physical examination and##2##3##(1991-3#1)(2011-2#1)
Physical examination revealed##2##3##(1992-11#1)(2012-12#1)
Physical examination##9##2##(1991-3#1)(1992-11#1)(1994-5#1)(2007-2#1)(2008-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
Physical health##2##2##(2010-2#1)(2013-1#1)
Physical mapping of rice chromosomes##2##5##(1996-12#1)(1997-2#1)
Physical mapping of rice##3##4##(1996-10#1)(1996-12#1)(1997-2#1)
Physical mapping of##5##3##(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)
Physical mapping##7##2##(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#1)
Physical maps of##3##3##(1997-2#2)(2008-5#1)
Physical properties of##2##3##(1991-1#1)(1996-3#1)
Physical therapists##2##2##(1992-3#2)
Physical therapy management##2##3##(2008-12#2)
Physical therapy##6##2##(1996-1#1)(1996-3#1)(1996-6#1)(2008-12#2)(2012-2#1)
Physical training##2##2##(1996-11#1)(1996-9#1)
Physical##127##1##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-3#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-10#10)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#1)
Physically##3##1##(2008-2#1)(2008-4#1)(2009-12#1)
Physician Payment Review Commission (PPRC)##2##5##(1994-1#1)(1996-1#1)
Physician cost##2##2##(1993-1#1)(2007-8#1)
Physician extenders##2##2##(1995-3#1)(1996-12#1)
Physician impact analysis##2##3##(1997-3#2)
Physician leadership##2##2##(1992-1#1)(1994-1#1)
Physician payment reform##4##3##(1991-12#1)(1991-2#1)(1992-12#1)(1994-1#1)
Physician payment##7##2##(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1994-1#2)
Physician##54##1##(1991-1#1)(1991-12#3)(1991-2#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-1#6)(1994-12#2)(1994-2#4)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#3)(1996-12#2)(1996-3#2)(1997-1#3)(1997-3#4)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-2#2)(2010-8#2)(2012-1#1)(2012-2#1)
Physician's##2##1##(1994-3#1)(2013-1#1)
Physician-patient##3##1##(1992-12#1)(2008-3#1)(2009-5#1)
Physicians and community##2##3##(2008-11#1)(2011-1#1)
Physicians and other health care##2##5##(1993-1#1)(2010-9#1)
Physicians and##10##2##(1990-4#1)(1993-1#1)(1994-1#1)(1994-12#1)(2008-11#2)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
Physicians are##2##2##(1994-2#1)(2008-4#1)
Physicians have##2##2##(1996-3#1)(2008-11#1)
Physicians in a##2##3##(1996-1#1)(2008-4#1)
Physicians in##4##2##(1992-3#1)(1996-1#1)(2008-4#2)
Physicians must##4##2##(1994-2#1)(2007-12#1)(2012-12#1)(2013-8#1)
Physicians need##2##2##(2008-3#1)(2012-3#1)
Physicians of##4##2##(1990-9#1)(1993-12#1)(1996-8#2)
Physicians should be aware of the##3##6##(2008-7#1)(2009-8#1)(2011-2#1)
Physicians should be##4##3##(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
Physicians should##7##2##(2007-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
Physicians take into account many factors when making referral decisions##2##10##(1994-1#2)
Physicians who##2##2##(2007-7#1)(2010-9#1)
Physicians##71##1##(1990-4#2)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#4)(1994-1#4)(1994-12#3)(1994-2#2)(1996-1#2)(1996-12#1)(1996-3#2)(1996-8#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
Physicians' autonomy##2##2##(1993-9#2)
Physicians'##9##1##(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#2)(1995-2#1)(2010-12#1)(2010-4#1)(2010-8#1)
Physico-chemical properties##2##2##(1994-12#1)(2013-1#1)
Physico-chemical##3##1##(1992-12#1)(1994-12#1)(2013-1#1)
Physicochemical##2##1##(2008-10#1)(2008-5#1)
Physics##3##1##(1990-11#1)(2008-10#1)(2008-3#1)
PhysioDirect##3##1##(2011-2#3)
Physiol##5##1##(1994-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-4#1)
Physiologic and pathologic##2##3##(2008-4#1)(2010-6#1)
Physiologic##6##1##(1996-5#1)(2008-4#1)(2010-6#1)(2013-7#2)(2013-8#1)
Physiological and biochemical responses of##2##5##(2008-12#1)(2012-6#1)
Physiological and biochemical##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2012-6#1)
Physiological and##8##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-6#1)
Physiological##25##1##(1992-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
Physiology and##2##2##(2010-10#1)(2013-1#1)
Physiology of pulmonary##2##3##(2006-10#1)(2007-9#1)
Physiology of##4##2##(2006-10#1)(2007-9#1)(2009-5#1)(2011-2#1)
Physiology##10##1##(2006-10#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Physiopathological##2##1##(1990-5#1)(1991-6#1)
Physiotherapists##3##1##(1993-3#1)(1994-3#1)(2008-3#1)
Physiotherapy##16##1##(1991-3#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-3#2)(1995-12#1)(1995-2#1)(1996-2#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
Physique##2##1##(2007-12#1)(2012-3#1)
Phytase##3##1##(2008-4#1)(2010-2#1)(2012-12#1)
Phytochemical##6##1##(2007-1#1)(2008-12#3)(2010-9#1)(2013-1#1)
Phytochemistry##2##1##(1990-5#1)(2013-7#1)
Phytoestrogens are##2##2##(2008-10#2)
Phytoestrogens##4##1##(1996-8#1)(2008-10#2)(2008-11#1)
Phytohealth&quot##2##1##(2008-10#2)
Phytolacca heterotepala##2##2##(2008-10#2)
Phytolacca##3##1##(1990-11#1)(2008-10#2)
Phytomonas françai##2##2##(2008-10#2)
Phytomonas##3##1##(2008-10#3)
Phytomyxea##2##1##(2012-2#2)
Phytopathogenic##3##1##(2008-10#3)
Phytopathological##4##1##(2008-10#4)
Phytophthora and##3##2##(2008-10#3)
Phytophthora cactorum##2##2##(2008-10#2)
Phytophthora capsici##17##2##(2008-10#17)
Phytophthora cinnamomi is the##2##4##(2008-10#2)
Phytophthora cinnamomi was##2##3##(2008-10#2)
Phytophthora cinnamomi##16##2##(2008-10#16)
Phytophthora infestans in##15##3##(2008-10#15)
Phytophthora infestans is##3##3##(2008-10#3)
Phytophthora infestans isolates##2##3##(2008-10#2)
Phytophthora infestans was##2##3##(2008-10#2)
Phytophthora infestans were##3##3##(2008-10#3)
Phytophthora infestans##82##2##(2008-10#80)(2008-8#1)(2009-6#1)
Phytophthora megasperma)##2##2##(2008-10#2)
Phytophthora multivora sp##2##3##(2010-3#2)
Phytophthora multivora##3##2##(2010-3#3)
Phytophthora nicotianae and P##4##4##(2008-10#4)
Phytophthora nicotianae and##5##3##(2008-10#5)
Phytophthora nicotianae##11##2##(2008-10#11)
Phytophthora parasitica var##4##3##(2008-10#4)
Phytophthora parasitica##16##2##(2008-10#16)
Phytophthora ramorum##21##2##(2008-10#20)(2009-2#1)
Phytophthora root rot##3##3##(2008-10#3)
Phytophthora root##4##2##(2008-10#4)
Phytophthora sojae in##3##3##(2008-10#3)
Phytophthora sojae##10##2##(1997-6#2)(2008-10#8)
Phytophthora sp##2##2##(2008-10#2)
Phytophthora sp-h isolates##6##3##(2008-10#6)
Phytophthora species##7##2##(2008-10#6)(2010-3#1)
Phytophthora spp##27##2##(2008-10#27)
Phytophthora taxon##2##2##(2008-10#2)
Phytophthora##272##1##(1997-6#2)(2008-10#260)(2008-11#2)(2008-8#1)(2009-2#2)(2009-6#1)(2010-3#4)
Phytoplankton##3##1##(2008-8#1)(2009-8#1)(2013-8#1)
Phytoplasma and##2##2##(2008-10#2)
Phytoplasma##14##1##(2008-10#14)
Phytoplasmas were detected##2##3##(2008-10#2)
Phytoplasmas##5##1##(2008-10#5)
Phytosanitary##2##1##(2008-10#1)(2011-2#1)
Pi and##3##2##(1990-8#1)(1991-12#1)(1993-12#1)
Pi##20##1##(1990-11#2)(1990-2#3)(1990-5#2)(1990-8#3)(1991-12#1)(1991-5#1)(1992-3#2)(1993-12#2)(1995-6#1)(1997-7#1)(2010-8#2)
Pi-ta allele##3##2##(2008-10#3)
Pi-ta and##2##2##(2008-10#2)
Pi-ta gene##2##2##(2008-10#2)
Pi-ta locus##2##2##(2008-10#2)
Pi-ta##20##1##(2008-10#20)
Pi19(t) was##2##2##(2008-10#2)
Pi19(t)##3##1##(2008-10#3)
Pi34 and##2##2##(2008-10#2)
Pi34##8##1##(2008-10#8)
Pi7(t)##8##1##(2008-10#8)
PiPWR##2##1##(2012-12#2)
Piaget##2##1##(2009-10#2)
Picea abies##2##2##(2008-7#2)
Picea##4##1##(2008-10#1)(2008-7#3)
Pichia anomala Strain K##2##4##(2008-10#2)
Pichia anomala strain K##2##4##(2008-10#2)
Pichia anomala##5##2##(2008-10#5)
Pichia guilermondii##5##2##(2008-10#5)
Pichia pastoris##22##2##(1994-11#2)(1994-3#2)(1997-4#5)(1997-7#2)(2008-11#1)(2008-7#2)(2009-9#1)(2010-5#2)(2011-2#2)(2013-1#3)
Pichia##40##1##(1994-11#2)(1994-3#2)(1995-8#1)(1997-4#7)(1997-7#2)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#2)(2013-1#4)
Pick##7##1##(2008-8#6)(2008-9#1)
Picking the right change strategy##3##5##(1993-1#1)(1993-12#1)(1993-2#1)
Picking the##4##2##(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)
Picking##5##1##(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)(2011-2#1)
Picosecond pulses##2##2##(2008-2#1)(2008-3#1)
Picosecond##10##1##(2007-1#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
Picotamide induces##2##2##(1990-5#2)
Picotamide##6##1##(1990-12#1)(1990-5#4)(1991-6#1)
Picrotoxin##2##1##(1990-5#1)(1995-12#1)
Picture##4##1##(1996-2#1)(2008-7#2)(2008-9#1)
Piedmont##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
Pierce##3##1##(1995-6#3)
Pierce's disease (PD) of##2##4##(2008-10#2)
Pierce's disease (PD)##4##3##(2008-10#4)
Pierce's disease##8##2##(2008-10#8)
Pierce's##11##1##(2008-10#11)
Pieris rapae##3##2##(2008-5#1)(2008-6#1)(2008-8#1)
Pierre##4##1##(1990-5#1)(2008-3#2)(2012-2#1)
Piezoelectric##5##1##(2008-10#4)(2008-9#1)
Pig##4##1##(1992-3#1)(1992-8#2)(1995-9#1)
Pigeonpea##3##1##(2008-10#1)(2010-10#2)
Pigeons##2##1##(2008-5#2)
Pigment dispersion was##2##3##(2008-8#2)
Pigment epithelium-derived factor##2##3##(2008-7#1)(2012-5#1)
Pigment##6##1##(2008-10#2)(2008-7#1)(2008-8#2)(2012-5#1)
Pigmentation##2##1##(2008-5#1)(2008-6#1)
Pigmented Bowen's disease##2##3##(2010-6#2)
Pigmented Bowen's##3##2##(2010-6#3)
Pigmented villonodular synovitis (PVNS) is a##2##6##(2010-3#1)(2013-1#1)
Pigmented villonodular synovitis##3##3##(2010-3#2)(2013-1#1)
Pigmented##8##1##(1993-9#1)(2010-3#2)(2010-6#3)(2013-1#2)
Pigments##2##1##(2008-2#1)(2008-5#1)
Pigs were slaughtered##2##3##(2010-2#1)(2012-2#1)
Pigs were##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
Pigs##6##1##(2008-10#1)(2010-2#2)(2010-4#1)(2012-2#2)
Pilates and taiji quan##4##4##(2009-3#4)
Pilates##6##1##(2009-3#6)
PileUp##2##1##(2008-4#2)
Pilgrim##3##1##(1997-2#1)(2008-10#1)(2008-2#1)
Pilocarpine##4##1##(1991-7#1)(1995-6#1)(2006-10#2)
Pilot Study of##2##3##(2012-3#1)(2013-1#1)
Pilot Study##9##2##(2008-12#3)(2010-4#1)(2012-3#2)(2013-1#2)(2013-8#1)
Pilot study of##4##3##(1996-12#1)(2008-11#2)(2012-1#1)
Pilot study##6##2##(1996-12#1)(2008-11#2)(2009-5#1)(2012-1#1)(2013-1#1)
Pilot##26##1##(1995-12#1)(1996-12#1)(1997-3#1)(2008-11#5)(2008-12#4)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#3)(2012-1#2)(2012-3#2)(2013-1#3)(2013-8#1)
Pima S-7 x##2##3##(2008-10#2)
Pima S-7##6##2##(2008-10#6)
Pima##8##1##(2008-10#6)(2010-7#2)
Pimelodidae)##2##1##(2008-12#1)(2008-7#1)
Pimelodus heraldoi and##2##3##(2008-12#2)
Pimelodus sp##3##2##(2008-12#3)
Pimelodus##6##1##(2008-12#6)
Pinaceae##2##1##(2008-5#1)(2008-7#1)
Pinard had##2##2##(1995-6#2)
Pinard##6##1##(1995-6#6)
Pinatubo eruption##2##2##(2008-2#2)
Pinatubo##7##1##(2008-2#6)(2008-3#1)
Pinch##2##1##(1990-3#1)(2008-9#1)
Pinctada##2##1##(1997-4#2)
Pine Rest##2##2##(1992-12#2)
Pine##14##1##(1992-12#2)(1992-2#1)(2008-10#10)(2008-11#1)
Pineal cross-transplantation##2##2##(1994-5#2)
Pineal##5##1##(1994-5#3)(2008-5#1)(2012-2#1)
Pineapple##3##1##(2008-10#3)
Pinning##2##1##(1991-9#1)(1996-11#1)
Pinocchio##2##1##(2007-12#2)
Pins and##2##2##(2008-7#1)(2012-3#1)
Pinto##3##1##(1992-10#1)(2008-10#2)
Pinus and Picea##2##3##(2008-10#1)(2008-7#1)
Pinus nigra L##3##3##(2013-8#3)
Pinus pinaster##3##2##(2008-10#1)(2011-10#2)
Pinus radiata##4##2##(2008-10#4)
Pinus sylvestris##2##2##(2011-10#2)
Pinus taeda##5##2##(2008-7#4)(2010-3#1)
Pinus##26##1##(2008-10#13)(2008-7#5)(2010-3#1)(2011-10#4)(2013-8#3)
Pioneer##3##1##(1991-8#1)(2008-10#2)
PipMaker##5##1##(2008-4#5)
Pipeline##6##1##(2008-12#3)(2008-4#3)
Piper sarmentosum##3##2##(2013-1#3)
Pipizini and##4##2##(2008-8#4)
Pipizini##6##1##(2008-8#6)
Piptadeniastrum africanum##2##2##(2008-12#2)
Piq6(t)##3##1##(2008-10#3)
Pirellula staleyi##2##2##(2011-2#2)
Pirellula##3##1##(2011-2#3)
Piriformospora indica##2##2##(2008-10#2)
Piriformospora##4##1##(2008-10#4)
Pisa##3##1##(2008-10#1)(2008-12#1)(2013-8#1)
Pistachio##4##1##(2008-10#4)
Pistacia##2##1##(2008-10#1)(2010-2#1)
Pisum sativum##2##2##(2008-10#1)(2011-2#1)
Pisum##4##1##(2008-10#2)(2008-11#1)(2011-2#1)
Pit-1##5##1##(1993-8#5)
Pit-1/GHF-1##2##1##(1993-8#2)
Pitch angle or roll angle##2##5##(2008-3#2)
Pitch canker##3##2##(2008-10#3)
Pitch##5##1##(2008-10#3)(2008-3#2)
Pitfalls in the##3##3##(1991-3#1)(1995-9#1)(2011-1#1)
Pitfalls in##6##2##(1991-3#1)(1995-9#1)(2008-1#1)(2009-8#1)(2010-5#1)(2011-1#1)
Pitfalls##9##1##(1991-3#1)(1995-3#1)(1995-9#1)(2007-8#1)(2008-1#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)
Pittsburgh Conference##8##2##(2008-10#8)
Pittsburgh##19##1##(1992-12#1)(1993-2#4)(2008-1#1)(2008-10#8)(2008-5#2)(2009-5#1)(2011-2#1)(2013-8#1)
Pituitary##13##1##(1990-4#1)(1992-2#1)(1995-11#1)(2008-4#2)(2008-9#1)(2009-7#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Pityrosporum ovale extract##2##3##(1992-9#2)
Pityrosporum ovale##3##2##(1992-9#3)
Pityrosporum##5##1##(1992-9#4)(2007-7#1)
Pitzer equations##3##2##(2008-10#3)
Pitzer##4##1##(2008-10#4)
Piwi proteins##3##2##(2009-3#3)
Piwi##6##1##(2009-3#6)
Piwi-interacting RNAs (piRNAs)##2##3##(2009-3#2)
Piwi-piRNA##2##1##(2009-3#2)
Pixelated##2##1##(2008-3#2)
Pizl &amp##2##2##(2008-7#2)
Pk##2##1##(1994-12#2)
Pka1##4##1##(1994-12#4)
Pl(-1)##6##1##(2008-10#6)
Place of##2##2##(1993-9#1)(1995-11#1)
Place##5##1##(1993-9#1)(1995-11#1)(2008-1#1)(2008-4#1)(2009-8#1)
Placebo Factors in##2##3##(2009-10#1)(2009-9#1)
Placebo response##2##2##(2012-2#2)
Placebo##8##1##(2007-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-2#3)
Placebo-controlled##2##1##(2008-5#1)(2010-5#1)
Placement of##4##2##(1995-5#1)(2008-1#1)(2008-10#1)(2009-2#1)
Placement##6##1##(1991-1#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)
Placenta##2##1##(1990-12#1)(2013-1#1)
Placental##3##1##(1994-12#1)(2007-2#1)(2008-9#1)
Placing##4##1##(1996-5#1)(2008-10#2)(2008-4#1)
Plackett-Burman design##4##2##(2008-10#4)
Plackett-Burman experimental design##3##3##(2008-10#3)
Plackett-Burman##9##1##(2008-10#9)
Plagioscion##3##1##(2008-7#2)(2013-7#1)
Plague##2##1##(1994-9#1)(2008-7#1)
Plain radiographs and##2##3##(2009-3#1)(2010-7#1)
Plain radiography of his left##2##5##(2009-1#2)
Plain radiography##3##2##(2009-1#2)(2012-2#1)
Plain##13##1##(1992-5#1)(2007-11#1)(2008-12#4)(2009-1#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
Plains##19##1##(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
Plan (a##3##2##(1996-3#3)
Plan for##2##2##(1991-2#1)(2008-7#1)
Plan of##4##2##(1993-3#2)(1995-12#1)(1997-1#1)
Plan was##2##2##(1996-3#1)(2010-8#1)
Plan##47##1##(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-2#2)(1995-1#2)(1995-12#2)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#6)(1997-1#1)(1997-2#1)(2008-1#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#4)(2008-9#1)(2010-8#4)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Plan's##2##1##(1993-3#1)(1996-1#1)
Plan)##2##1##(1996-9#1)(2013-1#1)
Planar##7##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
Planarians##2##1##(2008-5#2)
Planck density##3##2##(2007-12#3)
Planck function##3##2##(2008-2#1)(2008-3#2)
Planck##6##1##(2007-12#3)(2008-2#1)(2008-3#2)
Planctomyces limnophilus##2##2##(2011-2#2)
Plane##2##1##(2008-2#1)(2012-3#1)
Planes##3##1##(1996-9#1)(2008-3#1)(2009-9#1)
Planet##2##1##(1990-11#1)(2008-3#1)
Planetary##4##1##(2008-2#3)(2008-3#1)
Planned Behavior##3##2##(2008-4#1)(2011-1#1)(2013-1#1)
Planned Parenthood of Southeastern Pennsylvania v##2##6##(1993-3#1)(1994-2#1)
Planned Parenthood of##3##3##(1993-3#1)(1994-2#1)(1997-6#1)
Planned##7##1##(1993-3#2)(1994-2#1)(1997-6#1)(2008-4#1)(2011-1#1)(2013-1#1)
Planning Committee##2##2##(1993-2#1)(1996-3#1)
Planning and##9##2##(1991-1#1)(1991-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#1)
Planning for##8##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1996-1#1)(2013-1#1)
Planning of##2##2##(1996-3#1)(2009-11#1)
Planning##37##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Plans##7##1##(1993-1#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-3#1)
Plant Disease##3##2##(2008-10#3)
Plant Extracts##2##2##(2008-10#1)(2008-5#1)
Plant Genome##2##2##(2008-7#1)(2010-10#1)
Plant Journal we##2##3##(2009-8#2)
Plant Journal##4##2##(1996-10#1)(2009-8#3)
Plant Material##2##2##(2008-10#2)
Plant Ontology Consortium is##2##4##(2008-7#2)
Plant Ontology Consortium##6##3##(2008-7#6)
Plant Ontology##7##2##(2008-7#7)
Plant Pathogen##2##2##(2008-10#2)
Plant Pathogenic##2##2##(2008-10#2)
Plant Resistance##2##2##(2008-10#2)
Plant age##2##2##(2008-10#2)
Plant extracts##2##2##(2008-5#2)
Plant growth##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
Plant height##2##2##(2008-10#1)(2011-2#1)
Plant pathogen culture collections##2##4##(2008-10#2)
Plant polyphenols##3##2##(2009-8#2)(2012-12#1)
Plant polyploidy##2##2##(2008-9#2)
Plant responses to##2##3##(2008-4#1)(2009-8#1)
Plant##112##1##(1990-11#1)(1990-8#1)(1992-3#1)(1996-10#1)(2006-12#1)(2007-12#1)(2008-10#48)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#9)(2008-8#2)(2008-9#5)(2009-2#1)(2009-8#10)(2010-10#1)(2010-7#1)(2011-10#1)(2011-2#10)(2011-3#1)(2012-1#10)(2012-12#1)(2013-1#1)
Plant-Parasitic Nematodes##2##2##(2008-10#2)
Plant-Parasitic##4##1##(2008-10#4)
Planta##8##1##(2008-10#5)(2009-8#3)
Plantago##4##1##(2008-10#3)(2013-1#1)
Plantar##4##1##(2008-7#1)(2010-11#1)(2012-2#2)
Plantation##3##1##(2008-10#2)(2012-2#1)
Plantations##3##1##(2008-10#3)
Planting##4##1##(2008-10#4)
Plants Expressing##2##2##(2008-10#2)
Plants and##4##2##(2008-10#2)(2009-3#1)(2009-6#1)
Plants by the##2##3##(2008-10#2)
Plants by##4##2##(2008-10#4)
Plants can##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
Plants exposed to##2##3##(2008-10#2)
Plants from##2##2##(2008-10#2)
Plants grown##3##2##(2008-10#3)
Plants have##2##2##(2011-2#1)(2012-1#1)
Plants in##2##2##(2008-10#1)(2011-2#1)
Plants of the##2##3##(2008-10#2)
Plants that##2##2##(2008-10#2)
Plants were inoculated at the two-leaf stage and disease reaction was assessed##2##12##(2008-10#2)
Plants were inoculated##3##3##(2008-10#3)
Plants were sampled##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
Plants were##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
Plants within##2##2##(2008-10#2)
Plants##92##1##(1997-8#1)(2008-10#66)(2008-5#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#2)(2009-8#2)(2010-3#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-1#3)(2012-3#1)(2013-8#1)
Plaque Assay##6##2##(2008-10#6)
Plaque##11##1##(2008-1#1)(2008-10#6)(2010-12#1)(2011-1#1)(2012-2#2)
Plaques were##2##2##(1991-1#1)(2007-10#1)
Plaques##3##1##(1991-1#1)(2007-10#1)(2010-12#1)
Plasma and##4##2##(2008-10#1)(2009-11#1)(2011-2#1)(2012-3#1)
Plasma antioxidant##2##2##(2008-10#1)(2008-7#1)
Plasma cells are##2##3##(2008-7#1)(2008-9#1)
Plasma cells##3##2##(2008-7#1)(2008-9#1)(2010-12#1)
Plasma concentration##2##2##(1990-5#1)(2008-11#1)
Plasma concentrations of##6##3##(1992-3#1)(1994-6#1)(1996-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
Plasma cortisol##2##2##(2008-6#1)(2010-4#1)
Plasma from##2##2##(1991-9#1)(2012-3#1)
Plasma homocysteine concentrations in##2##4##(2008-7#1)(2012-3#1)
Plasma homocysteine concentrations##3##3##(2008-7#2)(2012-3#1)
Plasma homocysteine##5##2##(2008-3#1)(2008-7#3)(2012-3#1)
Plasma levels of##9##3##(1991-1#1)(1996-7#3)(1997-2#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
Plasma lipase##2##2##(1994-7#2)
Plasma lipid##2##2##(1992-2#1)(2008-4#1)
Plasma lipids and apolipoproteins##2##4##(1990-12#1)(1993-12#1)
Plasma membrane vesicles##2##3##(1993-8#1)(2008-11#1)
Plasma membrane##5##2##(1993-8#1)(1995-12#1)(1996-7#1)(2008-11#1)(2009-9#1)
Plasma nitric oxide##2##3##(2007-10#2)
Plasma samples were##2##3##(2008-10#2)
Plasma triglycerides##2##2##(2008-3#1)(2011-1#1)
Plasma##117##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-6#1)(1994-7#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#6)(1996-8#1)(1997-2#2)(1997-3#1)(2007-10#4)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#13)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#4)
Plasmadiafiltration##2##1##(2011-1#2)
Plasmapheresis##2##1##(2008-1#1)(2013-1#1)
Plasmid DNAs##2##2##(2008-12#2)
Plasmid##17##1##(1990-11#1)(1990-5#2)(1995-2#1)(1995-8#1)(1997-4#2)(2008-10#6)(2008-12#2)(2008-5#1)(2011-1#1)
Plasmids containing the##2##3##(1994-12#1)(1994-9#1)
Plasmids##7##1##(1990-5#1)(1991-7#1)(1994-12#1)(1994-9#1)(2008-10#2)(2008-11#1)
Plasminogen activator inhibitor-1##2##3##(1995-8#1)(2011-2#1)
Plasminogen activator##4##2##(1990-11#1)(1995-8#1)(2011-2#2)
Plasminogen and##2##2##(1992-3#1)(1994-11#1)
Plasminogen##7##1##(1990-11#1)(1992-3#1)(1994-11#1)(1995-8#2)(2011-2#2)
Plasmodiophora brassicae##4##2##(2008-10#4)
Plasmodium berghei##5##2##(1992-6#1)(1993-8#1)(2009-4#1)(2010-2#1)(2012-2#1)
Plasmodium falciparum (Pf)##2##3##(1994-12#1)(2010-12#1)
Plasmodium falciparum CTL##2##3##(2008-8#2)
Plasmodium falciparum Malaria##2##3##(2008-8#2)
Plasmodium falciparum and##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
Plasmodium falciparum in##4##3##(1991-2#1)(1991-8#1)(1992-6#1)(1997-4#1)
Plasmodium falciparum malaria##4##3##(1991-2#1)(2008-8#1)(2012-2#2)
Plasmodium falciparum##50##2##(1990-12#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1992-6#1)(1993-2#2)(1994-12#2)(1995-12#1)(1997-4#2)(2007-2#1)(2008-10#2)(2008-4#1)(2008-8#8)(2008-9#1)(2009-10#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-7#2)(2013-8#1)
Plasmodium knowlesi infections##2##3##(2011-1#2)
Plasmodium knowlesi##6##2##(1990-2#2)(2011-1#2)(2012-12#2)
Plasmodium plasmepsins and &quot##2##4##(2008-4#2)
Plasmodium species##2##2##(2010-2#1)(2012-12#1)
Plasmodium spp##2##2##(2010-2#1)(2012-3#1)
Plasmodium vivax malaria##2##3##(2012-12#2)
Plasmodium vivax##6##2##(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#3)
Plasmodium##79##1##(1990-12#2)(1990-2#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1992-6#2)(1993-2#2)(1993-8#1)(1994-12#4)(1995-12#1)(1997-4#2)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#3)(2010-2#4)(2011-1#2)(2011-2#2)(2012-12#10)(2012-2#8)(2012-3#4)(2013-7#2)(2013-8#1)
Plasmon##5##1##(1990-4#1)(1994-12#1)(2007-11#1)(2008-11#2)
Plasmopara viticola##15##2##(2008-10#15)
Plasmopara##17##1##(2008-10#17)
Plastic##9##1##(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)
Plasticity and##2##2##(1993-5#1)(2012-2#1)
Plasticity##6##1##(1993-5#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#2)
Plasticized##2##1##(2008-10#2)
Plastids in##2##2##(1997-6#1)(2011-2#1)
Plata##11##1##(2008-5#4)(2010-8#5)(2013-7#2)
Plate##5##1##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
Plateau (QTP)##2##2##(2009-5#1)(2012-3#1)
Plateau##7##1##(2008-9#3)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Platelet MAO activity##2##3##(1994-2#1)(1995-11#1)
Platelet activation##3##2##(1997-7#2)(2006-6#1)
Platelet aggregates##2##2##(1991-8#2)
Platelet aggregation##4##2##(1990-12#1)(1991-12#1)(1992-12#1)(2011-1#1)
Platelet count##2##2##(1991-6#1)(2007-10#1)
Platelet factor 4##2##3##(1992-8#2)
Platelet function##2##2##(1992-12#1)(2007-10#1)
Platelet hyperreactivity##2##2##(1990-5#1)(1992-12#1)
Platelet lysate##2##2##(2008-11#2)
Platelet##38##1##(1990-12#1)(1990-5#2)(1991-12#1)(1991-6#1)(1991-8#2)(1992-12#5)(1992-8#2)(1994-2#1)(1995-11#1)(1996-7#1)(1997-6#1)(1997-7#3)(2006-6#3)(2007-10#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-3#1)(2011-1#1)
Platelet-activating factor##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
Platelet-derived growth factor (PDGF)##2##4##(1993-8#1)(1994-9#1)
Platelet-derived growth factor##3##3##(1993-8#1)(1994-9#1)(2012-3#1)
Platelets are##2##2##(2006-6#1)(2008-9#1)
Platelets##8##1##(1993-8#1)(2006-6#3)(2008-11#1)(2008-9#2)(2013-8#1)
Platemys platycephala##2##2##(2010-3#2)
Plates##3##1##(2008-11#1)(2008-3#1)(2013-1#1)
Platform for##4##2##(2009-9#1)(2010-2#1)(2012-1#1)(2013-8#1)
Platform##8##1##(2008-10#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
Platforms##2##1##(2008-10#1)(2009-3#1)
Platination##2##1##(1991-9#1)(1996-2#1)
Platinum Nanoparticles##2##2##(2008-10#1)(2008-11#1)
Platinum and##2##2##(2008-10#2)
Platinum##12##1##(2008-10#7)(2008-11#1)(2008-3#1)(2009-10#1)(2010-11#1)(2010-8#1)
Platinum(II) was##2##2##(2008-10#2)
Platinum(II)##3##1##(2008-10#2)(2010-2#1)
Plato##2##1##(1990-2#1)(2013-7#1)
Platycopia compacta##2##2##(2008-5#2)
Platycopia is##2##2##(2008-5#2)
Platycopia##6##1##(2008-5#6)
Platynereis dumerilii (Polychaeta##2##3##(1996-2#2)
Platynereis dumerilii##3##2##(1990-5#1)(1996-2#2)
Platynereis##4##1##(1990-5#2)(1996-2#2)
Plausible##2##1##(1992-9#1)(2008-10#1)
Plavix##2##1##(2013-7#2)
Play##8##1##(1991-3#2)(1997-2#1)(2008-10#1)(2009-11#2)(2013-1#2)
Players##3##1##(2010-1#1)(2011-2#1)(2012-3#1)
Playing##3##1##(1995-9#1)(1996-6#1)(2008-8#1)
Playuela##3##1##(2008-5#3)
Please cite this paper as##9##5##(2011-2#9)
Please see Elsevier Policy on Article Withdrawal (http##3##8##(2008-10#3)
Please see http##35##3##(2011-1#15)(2011-2#10)(2012-1#10)
Please see##38##2##(2008-10#3)(2011-1#15)(2011-2#10)(2012-1#10)
Please##48##1##(2008-10#3)(2008-4#1)(2011-1#15)(2011-2#19)(2012-1#10)
Plecoptera##6##1##(2007-12#6)
Plectropomus leopardus##2##2##(2010-8#2)
Pleistocene##9##1##(1996-6#1)(2008-8#1)(2008-9#2)(2010-8#3)(2011-2#2)
Pleomorphic adenoma##3##2##(2008-8#2)(2009-6#1)
Pleomorphic xanthoastrocytoma##2##2##(2008-12#2)
Pleomorphic##6##1##(1991-12#1)(2008-12#2)(2008-8#2)(2009-6#1)
Pleospora papaveracea and##2##3##(2008-10#2)
Pleospora papaveracea##6##2##(2008-10#6)
Pleural effusion in##2##3##(2008-7#2)
Pleural effusion##3##2##(2008-7#3)
Pleural##14##1##(1991-12#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-7#3)(2011-2#1)(2013-7#2)
Pleurotus ostreatus##5##2##(2008-10#1)(2008-5#2)(2011-1#2)
Pleurotus##9##1##(2008-10#4)(2008-5#2)(2011-1#3)
Plexiglas##6##1##(2008-10#4)(2008-2#1)(2008-5#1)
PlgB##2##1##(1995-6#2)
PlgF##2##1##(1995-6#2)
Pliocene##2##1##(1994-3#1)(2010-8#1)
Plocamium cartilagineum##2##2##(2008-11#2)
Plots of the##2##3##(1992-3#1)(2008-10#1)
Plots of##5##2##(1992-3#2)(2008-10#2)(2008-3#1)
Plots were 6##2##3##(2008-10#2)
Plots were##5##2##(2008-10#5)
Plots##11##1##(1992-3#2)(2008-10#7)(2008-2#1)(2008-3#1)
Plts##2##1##(2009-11#2)
Plum pox virus (PPV)##5##4##(2008-10#5)
Plum pox virus##10##3##(2008-10#10)
Plum pox##12##2##(2008-10#12)
Plum##14##1##(2008-10#13)(2011-2#1)
Plunket##3##1##(1990-2#3)
Pluralism##2##1##(1995-2#1)(2009-8#1)
Pluronic F-68##2##2##(2008-11#1)(2011-2#1)
Pluronic##6##1##(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#2)
Plus##25##1##(1991-1#5)(1991-12#3)(1991-2#2)(1992-11#1)(1992-2#1)(1993-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-8#1)(2011-1#2)
Plutella xylostella (Lepidoptera##2##3##(2011-2#2)
Plutella xylostella##5##2##(2010-4#1)(2011-2#4)
Plutellidae)##3##1##(2011-2#3)
Plysate##2##1##(2008-11#2)
Pm##4##1##(2011-1#4)
Pm-AMP1##5##1##(2008-10#5)
Pm3##3##1##(2008-10#3)
Pm3a##2##1##(2008-10#2)
Pm4b##3##1##(2008-10#3)
PmCh4A protein##2##2##(2008-10#2)
PmCh4A##5##1##(2008-10#5)
PmTLP in##2##2##(2008-10#2)
PmTLP was##2##2##(2008-10#2)
PmTLP##9##1##(2008-10#9)
PmV##2##1##(2008-10#2)
PmXII##2##1##(2008-10#2)
Pmax##2##1##(2008-8#2)
Pn / gs##2##3##(2008-5#2)
Pn##6##1##(1994-5#1)(1997-7#1)(2008-5#4)
Pn117 for 3 days##2##4##(2008-10#2)
Pn117##6##1##(2008-10#6)
Pn198 and##2##2##(2008-10#2)
Pna##3##1##(2008-10#3)
Pna2(1)##2##1##(1997-7#2)
Pneumatosis intestinalis##4##2##(2007-5#1)(2010-12#1)(2012-2#2)
Pneumocephalus##3##1##(2008-7#2)(2009-6#1)
Pneumococcal bacteraemia and##2##3##(1991-3#1)(1995-3#1)
Pneumococcal##4##1##(1991-3#1)(1995-3#1)(2006-10#1)(2011-2#1)
Pneumocystis carinii pneumonia##4##3##(1990-9#1)(1993-2#1)(2006-10#1)(2007-12#1)
Pneumocystis carinii##5##2##(1990-11#1)(1990-9#1)(1993-2#1)(2006-10#1)(2007-12#1)
Pneumocystis jiroveci##2##2##(2010-12#2)
Pneumocystis##10##1##(1990-11#1)(1990-9#1)(1991-12#1)(1992-2#1)(1993-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-12#2)
Pneumonia##5##1##(1996-9#1)(2007-12#2)(2010-7#1)(2012-12#1)
Pneumothorax##3##1##(1995-5#1)(2008-1#1)(2012-2#1)
Po##2##1##(2008-10#1)(2008-11#1)
Po-210##7##1##(2008-7#7)
PoBH##3##1##(1997-6#3)
Poaceae##4##1##(2008-10#2)(2008-5#1)(2013-7#1)
Pochapsky##2##1##(1994-5#2)
Pochonia chlamydosporia##2##2##(2008-10#2)
Pockels cell that##2##3##(2008-2#1)(2008-3#1)
Pockels cell##8##2##(2008-2#1)(2008-3#7)
Pockels readout optical modulator##4##4##(2008-2#4)
Pockels##13##1##(2008-2#5)(2008-3#8)
Podlasie##3##1##(2008-10#2)(2008-12#1)
Podocoryna carnea##2##2##(2009-8#1)(2010-2#1)
Podophyllotoxin##2##1##(1991-9#1)(2008-11#1)
Podophyllum hexandrum##2##2##(2008-11#2)
Podoplanin is##2##2##(2013-1#2)
Podoplanin##5##1##(2013-1#5)
Podospora anserina##2##2##(1993-2#1)(2009-8#1)
Poecilia formosa##2##2##(2009-2#2)
Poecilia##4##1##(2008-5#1)(2009-2#2)(2009-6#1)
Poecilimon##2##1##(2013-8#2)
Poem##4##1##(2008-8#4)
Poetry##3##1##(1996-3#1)(2008-8#2)
Pohnpei##3##1##(2008-1#2)(2013-8#1)
Poincaré sphere representation##2##3##(2007-12#2)
Poincaré sphere##6##2##(2007-12#2)(2008-3#4)
Poincaré vortices##2##2##(2007-12#2)
Poincaré##8##1##(2007-12#4)(2008-3#4)
Point Mutation in##2##3##(2008-10#2)
Point Process##2##2##(2009-9#1)(2010-5#1)
Point and##2##2##(2008-10#1)(2012-1#1)
Point mutations in##2##3##(1997-2#1)(2012-2#1)
Point mutations##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
Point of view##3##3##(1994-2#2)(2008-7#1)
Point of##6##2##(1994-2#2)(1996-2#2)(2007-12#1)(2008-7#1)
Point prevalence##2##2##(2013-8#2)
Point##27##1##(1994-2#2)(1995-5#1)(1996-2#3)(1997-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
Point-of-Care##2##1##(2007-12#1)(2011-2#1)
Point-spread functions##2##2##(2008-3#2)
Pointe-St-Charles##3##1##(2008-2#3)
Pointing##3##1##(2007-12#2)(2008-3#1)
Points of##4##2##(1993-3#1)(2008-3#1)(2008-4#1)(2012-2#1)
Points to##2##2##(2009-3#1)(2010-6#1)
Points##12##1##(1993-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#2)(2010-6#1)(2012-2#1)(2013-1#4)
Poiret##2##1##(2012-5#2)
Poiseuille##2##1##(1996-12#1)(2013-1#1)
Poison##2##1##(1991-8#1)(2010-8#1)
Poisoning by these agents##2##4##(2013-1#2)
Poisoning of##2##2##(1991-8#1)(2009-12#1)
Poisoning##7##1##(1991-8#1)(2008-12#1)(2009-12#1)(2012-12#1)(2013-1#3)
Poisson distribution##5##2##(1995-6#1)(2008-10#3)(2008-9#1)
Poisson noise##3##2##(2008-3#3)
Poisson probability##2##2##(2008-10#1)(2008-3#1)
Poisson process##2##2##(1996-2#1)(2012-3#1)
Poisson ratio of##2##3##(2007-11#1)(2008-3#1)
Poisson ratio##4##2##(2007-11#2)(2008-3#2)
Poisson regression models##2##3##(1994-2#1)(2008-11#1)
Poisson regression was used to##2##5##(2011-1#1)(2012-1#1)
Poisson regression##9##2##(1994-2#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)(2012-1#1)(2013-1#1)
Poisson spike trains##2##3##(2008-11#1)(2013-8#1)
Poisson sum##2##2##(2007-11#1)(2008-3#1)
Poisson##40##1##(1994-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#12)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Poisson's ratio and##2##3##(2008-3#2)
Poisson's ratio##5##2##(1992-7#3)(2008-3#2)
Poisson's##7##1##(1992-7#4)(2008-3#2)(2009-7#1)
Poisson-Boltzmann equation##3##2##(1997-2#1)(2009-5#1)(2013-1#1)
Poisson-Boltzmann##6##1##(1997-2#2)(2008-4#1)(2009-5#1)(2013-1#2)
Pokhara##3##1##(2008-7#3)
Pokkali were##2##2##(2008-12#2)
Pokkali##5##1##(2008-12#5)
Pol III core##5##3##(1992-3#5)
Pol III##7##2##(1992-3#6)(1997-2#1)
Pol##9##1##(1992-3#6)(1997-2#3)
Poland and##5##2##(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#2)
Poland##54##1##(1991-1#1)(1994-12#2)(1995-3#1)(1997-3#1)(2007-11#3)(2007-8#14)(2008-10#2)(2008-11#2)(2008-12#5)(2008-5#1)(2008-8#1)(2008-9#5)(2009-5#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#7)
Poland]##12##1##(2008-9#10)(2009-5#1)(2012-3#1)
Polar auxin transport##2##3##(2009-8#2)
Polar cap##2##2##(2008-3#2)
Polar nephelometer##2##2##(2007-11#1)(2008-3#1)
Polar##15##1##(1990-2#1)(1996-5#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#4)(2009-8#2)(2012-3#1)
Polarimetric measurements of##2##3##(2008-3#2)
Polarimetric##4##1##(2008-3#4)
Polariton local states in periodic Bragg multiple-quantum-well structures##2##8##(2007-11#1)(2007-12#1)
Polarization Sagnac interferometer with##2##4##(2007-12#2)
Polarization characteristics of##2##3##(2008-2#1)(2008-3#1)
Polarization effects in##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
Polarization microscopy##3##2##(2008-1#1)(2008-3#1)(2008-8#1)
Polarization mode dispersion##4##3##(2007-11#3)(2007-12#1)
Polarization mode##5##2##(2007-11#4)(2007-12#1)
Polarization of the##2##3##(2008-3#1)(2012-1#1)
Polarization of##3##2##(2007-11#1)(2008-3#1)(2012-1#1)
Polarization properties of##4##3##(2007-11#1)(2008-2#3)
Polarization properties##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
Polarization response##2##2##(2008-2#1)(2011-1#1)
Polarization rotation##2##2##(2007-11#2)
Polarization##61##1##(1990-12#1)(2007-11#15)(2007-12#12)(2008-1#1)(2008-10#1)(2008-2#16)(2008-3#11)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
Polarization-maintaining##2##1##(2007-11#1)(2007-12#1)
Polarized light propagation through tissue phantoms containing densely packed scatterers##2##10##(2007-12#2)
Polarized light##4##2##(2007-12#2)(2008-3#1)(2011-1#1)
Polarized optical##2##2##(2007-12#1)(2008-10#1)
Polarized##13##1##(1993-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#3)(2011-1#1)
Polarizing##2##1##(2008-2#1)(2008-3#1)
Polarographic chemometric##2##2##(2008-10#2)
Polarographic determination of##5##3##(2008-10#5)
Polarographic##13##1##(1995-8#1)(2008-10#12)
Polarography##2##1##(2008-10#2)
Pole##4##1##(2008-10#3)(2013-8#1)
Polerovirus##3##1##(2008-10#3)
Polfix##4##1##(2007-8#4)
Police and##2##2##(1992-2#1)(2008-10#1)
Police##9##1##(1991-6#1)(1992-12#1)(1992-2#2)(2008-10#3)(2009-10#1)(2011-1#1)
Policies and##2##2##(1994-2#1)(2011-2#1)
Policies##8##1##(1992-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(1997-8#1)(2011-2#2)(2012-2#1)
Policing##2##1##(1993-2#1)(2012-2#1)
Policlinico##3##1##(1993-5#1)(1993-6#1)(2013-1#1)
Policy and##7##2##(1992-8#1)(1993-12#1)(1995-2#1)(1996-3#1)(2009-7#1)(2011-1#1)(2012-12#1)
Policy implications for##2##3##(1995-2#1)(1997-3#1)
Policy makers and##2##3##(2008-10#1)(2013-1#1)
Policy##45##1##(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-1#2)(1996-3#1)(1997-2#2)(1997-3#2)(2008-10#6)(2008-11#5)(2008-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
Policymakers##3##1##(1995-3#1)(2008-11#1)(2010-4#1)
Polinius##2##1##(2008-10#2)
Polio##2##1##(1994-9#1)(2008-11#1)
Polioencephalomalacia##2##1##(2011-1#2)
Poliomyelitis##2##1##(2008-11#1)(2009-3#1)
Polish Orthopaedic##2##2##(2007-8#2)
Polish Orthopaedics##2##2##(2007-8#2)
Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG)##3##6##(2011-2#3)
Polish Pediatric Leukemia/Lymphoma Study Group##5##5##(2011-2#5)
Polish Pediatric##6##2##(2011-2#6)
Polish intelligentsia##4##2##(2008-12#4)
Polish literature##2##2##(2007-8#1)(2013-7#1)
Polish society##2##2##(2008-12#1)(2011-2#1)
Polish version of##2##3##(2012-12#1)(2013-1#1)
Polish##59##1##(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#14)(2008-10#1)(2008-11#2)(2008-12#8)(2008-7#2)(2008-9#3)(2009-5#1)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
Polishing##4##1##(2008-10#1)(2008-2#2)(2010-4#1)
Political and##3##2##(2007-5#1)(2008-8#1)(2011-2#1)
Political##11##1##(1991-5#1)(1995-3#2)(2007-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#3)
Politics and##2##2##(1994-3#1)(1996-1#1)
Politics##5##1##(1994-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2010-11#1)
Polity##2##1##(2013-7#2)
Politzer##3##1##(2008-4#3)
Pollen##11##1##(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#3)(2011-2#2)(2012-2#1)(2013-1#1)
Pollination of##2##2##(2008-10#2)
Pollination##3##1##(2008-10#3)
Pollinator behavior##2##2##(2008-8#1)(2008-9#1)
Pollutants##4##1##(2008-10#1)(2008-11#2)(2009-8#1)
Pollution##4##1##(2008-11#1)(2008-3#3)
Polo##3##1##(2012-3#3)
Polr3##3##1##(2012-12#3)
Poly##2##1##(2008-8#2)
Poly(ADP-ribose)polymerase##2##1##(1991-12#1)(1992-11#1)
Poly(L-lysine)##2##1##(1992-6#1)(2008-10#1)
Poly(beta-hydroxybutyrate) accumulation was##2##3##(2008-7#2)
Poly(dimethylsiloxane)##2##1##(2008-10#1)(2009-2#1)
Poly(ethylene##4##1##(2008-10#3)(2008-8#1)
Poly(vinyl chloride) (PVC) based membranes##2##5##(2008-10#2)
Poly(vinyl chloride) (PVC)##3##3##(2008-10#3)
Poly(vinyl chloride) membrane##3##3##(2008-10#3)
Poly(vinyl chloride)##8##2##(2008-10#8)
Poly(vinyl chloride)-based##2##2##(2008-10#2)
Poly(vinyl##11##1##(2008-10#11)
Poly-lys##3##1##(1990-6#3)
PolyGlu4Tyr phosphorylating capacity##2##3##(1995-11#2)
PolyGlu4Tyr##4##1##(1995-11#4)
Polyacrylamide gel electrophoresis##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
Polyacrylamide gel##4##2##(1990-11#1)(1991-12#1)(2008-10#1)(2011-2#1)
Polyadenylation##2##1##(2008-11#1)(2010-4#1)
Polyamine##2##1##(1997-7#1)(2008-8#1)
Polyamines and polyamine##2##3##(1997-3#1)(2008-10#1)
Polyamines and##3##2##(1992-6#1)(1997-3#1)(2008-10#1)
Polyamines##10##1##(1992-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-8#3)(2009-10#1)
Polyandrocarpa misakiensis##2##2##(2008-5#2)
Polyandrocarpa##3##1##(2008-5#3)
Polyarteritis nodosa##4##2##(1997-8#2)(2006-10#2)
Polycelis nigra##2##2##(2008-5#2)
Polychaeta##2##1##(2007-12#1)(2008-5#1)
Polychaeta)##3##1##(2008-5#3)
Polychlorinated##2##1##(2008-10#1)(2008-8#1)
Polychromatic##3##1##(2008-2#1)(2008-3#1)(2008-9#1)
Polyclonal and monoclonal##2##3##(1995-12#1)(2008-5#1)
Polyclonal antibodies against##2##3##(1990-11#1)(2008-10#1)
Polyclonal antibodies##4##2##(1990-11#2)(2008-10#1)(2008-7#1)
Polyclonal antiserum##2##2##(2008-10#1)(2008-8#1)
Polyclonal intravenous immunoglobulin##2##3##(2007-12#2)
Polyclonal##13##1##(1990-11#2)(1990-8#1)(1992-12#2)(1995-12#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
Polycomb group (Pc-G) genes##2##4##(1995-11#1)(1997-7#1)
Polycomb group proteins##2##3##(2012-3#2)
Polycomb group##5##2##(1995-11#1)(1997-7#1)(2012-3#3)
Polycomb##6##1##(1995-11#1)(1997-7#1)(2009-3#1)(2012-3#3)
Polycrystalline##2##1##(2008-10#1)(2008-3#1)
Polycyclic aromatic hydrocarbons (PAH)##2##4##(2008-10#2)
Polycyclic aromatic hydrocarbons (PAHs)##2##4##(1994-3#1)(2008-10#1)
Polycyclic aromatic hydrocarbons##4##3##(1994-3#1)(2008-10#3)
Polycyclic##6##1##(1994-3#1)(2008-10#4)(2013-7#1)
Polycystic Ovary Syndrome##2##3##(2008-3#1)(2008-4#1)
Polycystic ovary syndrome (PCOS) is##2##5##(2008-4#1)(2013-1#1)
Polycystic##8##1##(2008-3#2)(2008-4#2)(2010-11#1)(2010-6#1)(2013-1#2)
Polyethylene Glycol##2##2##(2008-12#1)(2012-3#1)
Polyethylene glycol##2##2##(2010-3#1)(2011-2#1)
Polyethylene##6##1##(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
Polygala alpestris##2##2##(2008-11#2)
Polygenic##2##1##(2008-10#1)(2013-1#1)
Polygonal##2##1##(2007-11#1)(2008-3#1)
Polygonum viviparum##2##2##(2009-5#2)
Polygonum##4##1##(2009-5#2)(2012-3#2)
Polylepis cuadrijuga##2##2##(2013-7#2)
Polylysine##3##1##(1992-3#1)(1994-11#1)(2008-6#1)
Polymer##19##1##(2008-10#4)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2013-8#2)
Polymerase Chain Reaction (PCR)##6##4##(2008-12#5)(2013-8#1)
Polymerase Chain Reaction Assay for##2##5##(2008-10#2)
Polymerase Chain Reaction Assay##7##4##(2008-10#7)
Polymerase Chain Reaction Assays##2##4##(2008-10#2)
Polymerase Chain Reaction Detection of##3##5##(2008-10#3)
Polymerase Chain Reaction Identification of##2##5##(2008-10#2)
Polymerase Chain Reaction Using##2##4##(2008-10#2)
Polymerase Chain Reaction and##4##4##(2008-10#4)
Polymerase Chain Reaction##41##3##(1990-12#1)(2007-10#1)(2008-10#33)(2008-12#5)(2013-8#1)
Polymerase Chain Reaction-Based##3##3##(2008-10#3)
Polymerase Chain##46##2##(1990-12#1)(2007-10#1)(2008-10#37)(2008-12#5)(2012-2#1)(2013-8#1)
Polymerase chain reaction (PCR) amplification of##2##6##(1993-2#1)(2008-10#1)
Polymerase chain reaction (PCR)##9##4##(1990-12#1)(1993-2#1)(1994-9#1)(2008-10#6)
Polymerase chain reaction (PCR)-based assays##2##5##(2008-10#2)
Polymerase chain reaction amplification of##2##5##(1993-3#1)(2008-10#1)
Polymerase chain reaction analysis##2##4##(2007-12#1)(2008-10#1)
Polymerase chain reaction and##3##4##(2007-2#1)(2008-10#1)(2011-1#1)
Polymerase chain reaction assays##2##4##(2008-10#2)
Polymerase chain reaction was##2##4##(1990-12#1)(1991-5#1)
Polymerase chain reaction##27##3##(1990-12#2)(1991-5#1)(1993-2#1)(1993-3#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#16)(2011-1#2)(2013-1#1)
Polymerase chain##29##2##(1990-12#2)(1991-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#17)(2011-1#2)(2013-1#1)
Polymerase##80##1##(1990-12#3)(1991-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#55)(2008-11#1)(2008-12#5)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Polymeric##8##1##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#2)
Polymerization of##2##2##(2008-10#1)(2008-12#1)
Polymerization##3##1##(2008-10#1)(2008-12#1)(2009-10#1)
Polymers##10##1##(1996-12#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
Polymorphic##12##1##(1991-2#1)(1993-2#1)(1993-3#1)(2008-10#6)(2008-12#2)(2008-8#1)
Polymorphism (SSCP)##2##2##(2008-12#2)
Polymorphism and##4##2##(2008-10#2)(2010-1#1)(2012-3#1)
Polymorphism in the##3##3##(2008-10#2)(2008-12#1)
Polymorphism in##6##2##(2008-10#4)(2008-12#1)(2008-8#1)
Polymorphism of##5##2##(1994-12#1)(1997-9#1)(2009-3#1)(2011-1#1)(2013-8#1)
Polymorphism##28##1##(1994-12#1)(1997-2#1)(1997-9#1)(2008-10#14)(2008-12#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
Polymorphisms in the##6##3##(2008-1#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-12#1)
Polymorphisms in##12##2##(2008-1#1)(2008-10#3)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
Polymorphisms of the##2##3##(1997-7#1)(2008-12#1)
Polymorphisms of##5##2##(1997-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)
Polymorphisms##24##1##(1997-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
Polymorphonuclear leukocyte##2##2##(1991-8#1)(1997-1#1)
Polymorphonuclear##4##1##(1991-11#1)(1991-8#1)(1994-8#1)(1997-1#1)
Polymyxa betae##2##2##(2008-10#2)
Polymyxa graminis##3##2##(2008-10#3)
Polymyxa##5##1##(2008-10#5)
Polymyxins##2##1##(2008-10#2)
Polynesian family##2##2##(1992-6#2)
Polynesian##8##1##(1992-6#3)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
Polynomial##3##1##(2008-2#1)(2008-3#1)(2010-3#1)
Polyoxometalate##2##1##(1996-2#1)(2010-6#1)
Polyoxyethylene alkyl##2##2##(2008-10#2)
Polyoxyethylene##3##1##(2008-10#3)
Polyp##2##1##(2008-11#1)(2009-12#1)
Polypeptide##2##1##(1990-5#1)(2010-8#1)
Polypeptides of##2##2##(1997-4#2)
Polypeptides##3##1##(1996-2#1)(1997-4#2)
Polyphasic##2##1##(2008-10#1)(2010-3#1)
Polyphenols##3##1##(2008-7#1)(2009-12#1)(2009-3#1)
Polyphosphate metabolism in Escherichia coli##2##5##(1994-11#2)
Polyps in##2##2##(2009-12#2)
Polyps##5##1##(2008-9#1)(2009-12#3)(2010-2#1)
Polypurine/polypyrimidine sequences##2##2##(1997-4#2)
Polyquaternium 44##3##2##(2008-5#3)
Polyquaternium##5##1##(2008-5#5)
Polysaccharide##3##1##(2008-10#1)(2009-10#1)(2011-1#1)
Polyscias##5##1##(2008-10#5)
Polyspermy##2##1##(2008-8#1)(2008-9#1)
Polytechnic##3##1##(2008-12#1)(2008-2#1)(2008-3#1)
Polytetrafluoroethylene##4##1##(2007-10#2)(2008-1#1)(2008-10#1)
Polyunsaturated Fatty##2##2##(2008-3#1)(2013-1#1)
Polyunsaturated fatty acids##3##3##(2008-10#1)(2010-11#1)(2010-6#1)
Polyunsaturated##5##1##(2008-10#1)(2008-3#1)(2010-11#1)(2010-6#1)(2013-1#1)
Polyurethane##2##1##(2008-10#2)
Polyvalent##3##1##(1994-9#1)(2008-10#1)(2009-10#1)
Polyvinyl alcohol##2##2##(2008-5#1)(2012-3#1)
Polyvinyl chloride (PVC)##2##3##(2008-10#2)
Polyvinyl##7##1##(2008-10#3)(2008-4#1)(2008-5#2)(2012-3#1)
Pom-Atasta system##2##2##(2008-5#2)
Pom-Atasta##4##1##(2008-5#4)
Pomaceous##2##1##(2008-10#2)
Pomegranate##3##1##(2013-8#3)
Pomerania##3##1##(2008-12#2)(2013-1#1)
Pomeranian##3##1##(2012-12#1)(2013-8#2)
Pomorze Zachodnie (NW Poland)##2##4##(2008-12#2)
Pompe disease##6##2##(2012-12#4)(2013-1#2)
Ponceau 4R##9##2##(2008-10#9)
Ponceau S staining##2##3##(2008-4#2)
Ponceau S##3##2##(2008-10#1)(2008-4#2)
Ponceau##14##1##(2008-10#12)(2008-4#2)
Poncirus##2##1##(2008-10#1)(2008-5#1)
Pond##2##1##(1991-8#1)(2008-10#1)
Pony Club horses##5##3##(2012-12#5)
Pony##6##1##(2012-12#6)
Pool##2##1##(2008-10#1)(2011-2#1)
Pooled##6##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
Pooling##2##1##(2008-11#1)(2008-7#1)
Poor adherence##2##2##(2008-1#1)(2008-3#1)
Poor survival##2##2##(1993-9#1)(2009-10#1)
Poor##31##1##(1990-12#1)(1990-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1997-6#1)(2007-11#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Poor-quality##2##1##(2008-8#1)(2013-7#1)
Pope and Fry##2##3##(2008-3#2)
Pope and##3##2##(2007-9#1)(2008-3#2)
Pope##5##1##(1990-6#1)(1995-3#1)(2007-9#1)(2008-3#2)
Poplar##6##1##(2008-10#6)
Popular##2##1##(1994-1#1)(2008-10#1)
Popularity##2##1##(2009-7#1)(2013-1#1)
Population Analysis of##2##3##(2008-10#2)
Population Dynamics of Fusarium##2##4##(2008-10#2)
Population Dynamics of##4##3##(2008-10#4)
Population Genetic Analysis##2##3##(2008-10#2)
Population Genetic Structure of##2##4##(2008-10#2)
Population Genetic Structure##3##3##(2008-10#3)
Population Genetic##5##2##(2008-10#5)
Population Genetics of##2##3##(2008-10#2)
Population Health##4##2##(1996-3#1)(2011-1#1)(2011-9#1)(2012-12#1)
Population Screening##3##2##(1996-8#2)(2012-3#1)
Population Sizes##2##2##(2008-10#2)
Population Structure of Botryosphaeria dothidea from##2##6##(2008-10#2)
Population Structure of Phytophthora infestans##2##5##(2008-10#2)
Population Structure of##7##3##(2008-10#7)
Population and Development##4##3##(1994-3#1)(1994-9#2)(2008-11#1)
Population based##2##2##(1996-3#1)(1997-5#1)
Population densities of H##2##4##(2008-10#2)
Population densities##4##2##(2008-10#4)
Population differentiation##2##2##(2008-10#2)
Population diversity##2##2##(2008-10#1)(2012-2#1)
Population dynamics of##4##3##(2008-10#2)(2008-5#2)
Population dynamics##8##2##(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2013-8#2)
Population genetic##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)
Population genetics##3##2##(2008-12#1)(2010-8#1)(2012-3#1)
Population in##2##2##(2008-10#2)
Population of Phytophthora##2##3##(2008-10#2)
Population of##5##2##(2008-10#4)(2008-5#1)
Population size of##2##3##(2008-10#2)
Population sizes of##4##3##(2008-10#4)
Population structure##4##2##(2008-10#3)(2010-2#1)
Population survey##2##2##(2013-8#2)
Population surveys show that##2##4##(2013-8#2)
Population##119##1##(1991-3#1)(1991-6#1)(1993-3#1)(1994-3#1)(1994-9#2)(1995-11#1)(1996-3#2)(1996-8#2)(1997-5#1)(2008-1#1)(2008-10#52)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#6)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#11)
Population-Based##2##1##(1995-12#1)(2012-12#1)
Population-based surveillance of##2##3##(2007-12#2)
Population-based##12##1##(1997-3#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
Populations from the Caucasus##2##4##(2008-10#2)
Populations from##10##2##(2008-10#10)
Populations in##9##2##(2008-10#8)(2013-8#1)
Populations of Alternaria spp##3##4##(2008-10#3)
Populations of Colletotrichum gloeosporioides from##2##5##(2008-10#2)
Populations of Gibberella zeae##2##4##(2008-10#2)
Populations of Mycosphaerella graminicola##4##4##(2008-10#4)
Populations of Mycosphaerella##5##3##(2008-10#5)
Populations of Phaeosphaeria nodorum##2##4##(2008-10#2)
Populations of Phytophthora infestans in##3##5##(2008-10#3)
Populations of Phytophthora infestans##5##4##(2008-10#5)
Populations of Phytophthora##7##3##(2008-10#7)
Populations of Puccinia##4##3##(2008-10#4)
Populations of Rhizoctonia solani##2##4##(2008-10#2)
Populations of Xanthomonas##2##3##(2008-10#2)
Populations of the##12##3##(2008-10#10)(2008-9#1)(2010-3#1)
Populations of##78##2##(2008-10#70)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#2)
Populations on##4##2##(2008-10#4)
Populations##124##1##(2008-10#106)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#2)(2010-3#2)(2011-1#2)(2012-3#2)(2013-8#1)
Populus deltoides 'S9-2'##2##3##(2008-10#2)
Populus deltoides x P##3##4##(2008-10#3)
Populus deltoides##10##2##(2008-10#8)(2011-2#2)
Populus trichocarpa x P##2##4##(2008-10#2)
Populus##25##1##(2008-10#15)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#4)(2012-3#2)(2013-1#1)
PorA##4##1##(1993-12#3)(2008-11#1)
Porcellio laevis##2##2##(2008-7#2)
Porcine circovirus-2 (PCV-2)##2##3##(2012-3#2)
Porcine circovirus-2##6##2##(2012-3#6)
Porcine##21##1##(1990-12#1)(1990-7#1)(1991-2#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-8#1)(1995-6#1)(1995-8#1)(2008-11#2)(2008-5#1)(2012-3#7)(2013-1#1)
Pordenone##2##1##(2008-10#2)
Pore-forming peptides##2##2##(1994-5#2)
Pore-forming##4##1##(1994-2#2)(1994-5#2)
Porous##5##1##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
Porphobilinogen##2##1##(1991-2#1)(1992-3#1)
Porphyria cutanea##2##2##(2012-12#2)
Porphyrin##6##1##(1996-2#1)(1996-5#1)(1997-7#3)(2009-5#1)
Porphyrins##4##1##(1996-2#1)(1996-5#1)(2008-10#1)(2009-12#1)
Porphyromonas gingivalis and##3##3##(2008-12#2)(2013-1#1)
Porphyromonas gingivalis##8##2##(2007-7#1)(2008-12#3)(2008-9#2)(2013-1#2)
Porphyromonas##10##1##(2007-7#1)(2008-12#3)(2008-5#1)(2008-9#3)(2013-1#2)
Port of##2##2##(2007-8#1)(2013-7#1)
Port##7##1##(2007-5#2)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-7#1)
Porta-Sonic and Respirgard II##2##4##(1993-2#2)
Porta-Sonic##5##1##(1993-2#5)
Portable##6##1##(2008-10#2)(2008-7#2)(2010-8#1)(2013-8#1)
Portal hypertension##2##2##(1995-10#1)(2006-10#1)
Portal##5##1##(1995-10#2)(2006-10#1)(2008-10#1)(2008-2#1)
Portfolio Selection##2##2##(2012-12#1)(2013-1#1)
Portfolio##4##1##(1997-3#1)(2012-12#2)(2013-1#1)
Portions of the##3##3##(1996-12#1)(2007-6#1)(2010-5#1)
Portions of##5##2##(1994-5#1)(1996-12#1)(2007-6#1)(2008-10#1)(2010-5#1)
Portland cement##5##2##(2008-10#3)(2013-1#2)
Portland##8##1##(1992-1#1)(1995-3#1)(1997-2#1)(2008-10#3)(2013-1#2)
Porto Alegre##3##2##(2012-1#1)(2013-8#2)
Porto##7##1##(2008-6#2)(2009-7#1)(2012-1#1)(2012-3#1)(2013-8#2)
Portugal and##3##2##(1997-7#1)(2008-1#1)(2008-12#1)
Portugal##22##1##(1997-5#3)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-1#3)
Portuguese##13##1##(2008-11#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-7#4)(2012-1#2)(2013-8#1)
Portunus##2##1##(2008-10#2)
Posaconazole##2##1##(2011-2#2)
Position and##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Position##10##1##(1995-3#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-9#1)(2010-3#1)(2011-1#1)
Positional plagiocephaly is a##2##4##(2007-12#2)
Positional plagiocephaly##3##2##(2007-12#3)
Positional##10##1##(1995-3#1)(2007-12#4)(2008-12#1)(2008-7#1)(2009-5#2)(2012-3#1)
Positioning of##2##2##(2008-2#2)
Positioning##10##1##(1993-12#2)(1996-3#1)(2007-5#1)(2008-2#3)(2008-3#1)(2013-1#2)
Positions of Soret##2##3##(2008-10#2)
Positions of##4##2##(2008-10#4)
Positive Region##2##2##(2009-9#2)
Positive Rheumatoid factor (RF)##2##4##(2013-1#2)
Positive and Negative Affect Schedule (PANAS)##2##6##(2013-8#2)
Positive and Negative##5##3##(1996-5#1)(2008-6#1)(2011-1#1)(2013-8#2)
Positive and negative##5##3##(1995-11#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
Positive and##10##2##(1995-11#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-8#3)
Positive correlations##2##2##(1991-12#1)(2011-1#1)
Positive ion##2##2##(2008-10#2)
Positive results##4##2##(1991-6#1)(1997-6#1)(2008-5#1)(2009-9#1)
Positive##65##1##(1990-2#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-9#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-9#7)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#5)(2011-2#7)(2012-7#1)(2013-1#4)(2013-8#3)
Positively##2##1##(1993-8#1)(2013-1#1)
Positron emission tomography (PET)##2##4##(1996-5#1)(2012-12#1)
Positron emission tomography with##2##4##(1993-9#1)(2008-7#1)
Positron emission tomography##6##3##(1993-11#1)(1993-9#1)(1996-5#1)(2008-7#2)(2012-12#1)
Positron##8##1##(1993-11#1)(1993-9#1)(1996-5#1)(1996-9#1)(2008-7#2)(2012-12#2)
Possibilities for##2##2##(2008-10#1)(2008-3#1)
Possibilities of##6##2##(1992-5#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-3#1)
Possibilities##8##1##(1992-5#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-3#2)(2011-3#1)
Possibility of##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
Possible applications##2##2##(2008-2#1)(2012-3#1)
Possible causes##2##2##(1996-11#1)(2008-7#1)
Possible etiologies##3##2##(1993-8#1)(2007-10#1)(2011-2#1)
Possible explanations for the##2##4##(2008-10#1)(2008-4#1)
Possible explanations for##4##3##(1992-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
Possible explanations##6##2##(1990-11#1)(1992-12#1)(1995-11#1)(2008-10#1)(2008-4#1)(2011-1#1)
Possible implications for##3##3##(1993-8#1)(2008-5#1)(2009-5#1)
Possible implications##4##2##(1993-8#1)(2008-11#1)(2008-5#1)(2009-5#1)
Possible interactions between##2##3##(2008-10#2)
Possible interferences##2##2##(2008-10#2)
Possible involvement of phospholipase##2##4##(2008-11#2)
Possible involvement of##6##3##(1991-10#1)(1992-6#1)(1994-9#1)(1997-2#1)(2008-11#2)
Possible mechanisms and##2##3##(1992-9#1)(2008-7#1)
Possible mechanisms for##4##3##(1991-9#1)(1995-6#1)(2008-3#1)(2011-1#1)
Possible mechanisms of##3##3##(1990-12#1)(2007-11#1)(2012-1#1)
Possible mechanisms##10##2##(1990-12#1)(1991-9#1)(1992-9#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)
Possible origins##3##2##(1997-2#2)(1997-6#1)
Possible reasons for the##2##4##(1994-6#1)(1995-11#1)
Possible reasons for this##2##4##(1994-8#1)(2008-9#1)
Possible reasons for##4##3##(1994-6#1)(1994-8#1)(1995-11#1)(2008-9#1)
Possible reasons##5##2##(1994-6#1)(1994-8#1)(1995-11#1)(2008-8#1)(2008-9#1)
Possible role of##2##3##(1993-5#1)(2011-1#1)
Possible solutions##2##2##(2009-5#1)(2011-1#1)
Possible use of##2##3##(2008-10#1)(2008-5#1)
Possible##101##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-2#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#4)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
Possibly##8##1##(1991-12#1)(1994-12#1)(2008-11#1)(2008-5#2)(2008-8#1)(2012-12#2)
Post mortem##3##2##(1993-2#1)(1995-9#1)(2008-7#1)
Post##24##1##(1993-2#1)(1995-9#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
Post-Transplant##2##1##(2008-1#1)(2011-2#1)
Post-Traumatic Stress Disorder (PTSD)##2##4##(2008-10#1)(2012-12#1)
Post-acute##2##1##(1995-3#1)(2012-2#1)
Post-column##3##1##(2008-10#2)(2008-7#1)
Post-dialysis##2##1##(2008-4#2)
Post-embryonic##2##1##(2007-12#2)
Post-graduate##2##1##(1994-12#1)(2009-10#1)
Post-hospital##2##1##(1995-3#1)(2008-1#1)
Post-mortem examination##3##2##(2011-2#2)(2012-12#1)
Post-mortem##5##1##(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
Post-normalization##2##1##(2008-7#2)
Post-operative##3##1##(1997-7#1)(2010-3#1)(2011-2#1)
Post-operatively##2##1##(2008-1#1)(2008-12#1)
Post-translational##5##1##(1992-6#1)(2008-9#1)(2009-5#2)(2011-1#1)
Post-transplant lymphoproliferative##2##2##(2008-5#2)
Post-transplant##4##1##(2007-7#1)(2008-4#1)(2008-5#2)
Post-traumatic stress disorder##2##3##(2008-6#1)(2012-1#1)
Post-traumatic stress##3##2##(1993-8#1)(2008-6#1)(2012-1#1)
Post-traumatic##8##1##(1993-8#1)(1997-3#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-1#1)(2013-1#1)
Post-treatment##3##1##(2008-1#2)(2008-10#1)
Postconcussion syndrome##2##2##(2008-7#1)(2013-1#1)
Posterior epidural disc##2##3##(2011-2#2)
Posterior reversible encephalopathy syndrome##3##4##(2012-12#2)(2013-1#1)
Posterior##26##1##(1991-2#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#3)(2013-8#1)
Posterolateral corner injuries of the##2##5##(2012-2#2)
Posteromedial##2##1##(2013-1#2)
Postgraduate training##2##2##(1994-12#1)(2007-2#1)
Postgraduate##9##1##(1990-9#1)(1991-2#1)(1993-12#1)(1994-1#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-2#1)(2009-10#1)
Postharvest Citrus##2##2##(2008-10#2)
Postharvest Decay of##3##3##(2008-10#3)
Postharvest##11##1##(2008-10#11)
Postinfection##3##1##(2008-10#3)
Postinfectious##2##1##(2010-12#1)(2011-2#1)
Postmenopausal##3##1##(2008-3#1)(2009-12#1)(2013-1#1)
Postmortem##5##1##(1995-3#1)(2008-7#3)(2012-3#1)
Postnatal##8##1##(1996-9#1)(2007-8#3)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
Postnatally##3##1##(2008-10#1)(2008-5#1)(2012-12#1)
Postoperative Adjuvant##2##2##(1994-7#2)
Postoperative analgesia was##2##3##(2007-11#1)(2007-8#1)
Postoperative complications##2##2##(1992-11#1)(1994-6#1)
Postoperative course was##3##3##(1993-9#1)(2008-7#1)(2009-5#1)
Postoperative intensive care in cardiac surgery##2##6##(2006-10#2)
Postoperative pain##4##2##(1994-3#1)(2007-9#1)(2010-6#2)
Postoperative treatment and##2##3##(2007-11#1)(2008-7#1)
Postoperative wound##2##2##(2007-7#1)(2013-1#1)
Postoperative##65##1##(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-9#2)(1994-3#2)(1994-6#1)(1994-7#2)(1994-9#2)(1995-3#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#6)(2008-9#2)(2009-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
Postoperatively##15##1##(1992-6#1)(1993-1#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-7#1)
Postpartum depression##2##2##(2013-1#2)
Postpartum##8##1##(1996-12#1)(2006-10#1)(2007-2#1)(2011-2#1)(2013-1#4)
Postprocedural##2##1##(2011-2#1)(2012-12#1)
Posttranscriptional##2##1##(2008-10#1)(2010-5#1)
Posttransplant##2##1##(2007-7#1)(2013-1#1)
Posttraumatic Stress Disorder##2##3##(2008-8#1)(2013-1#1)
Posttraumatic stress disorder##3##3##(1996-7#1)(2012-1#1)(2013-8#1)
Posttraumatic stress##4##2##(1996-7#1)(2010-10#1)(2012-1#1)(2013-8#1)
Posttraumatic##8##1##(1996-7#1)(2008-8#2)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Postural##3##1##(1995-5#2)(1997-5#1)
Posture##2##1##(2012-1#1)(2013-7#1)
Postwar appraisals strongly predicted later-life appraisals and mediated the effects of objective service variables##2##14##(2013-1#2)
Pot2##4##1##(2008-10#4)
Potamon niloticus##2##2##(2008-7#2)
Potamon##3##1##(2008-7#3)
Potassium channel##4##2##(1990-7#1)(1990-8#1)(2008-8#2)
Potassium phosphate buffer##2##3##(2008-10#2)
Potassium##17##1##(1990-7#1)(1990-8#1)(1991-11#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-8#2)(2013-1#1)
Potato (Solanum##2##2##(2008-10#2)
Potato and##2##2##(2008-10#2)
Potato in North Carolina##2##4##(2008-10#2)
Potato in##5##2##(2008-10#5)
Potato leafroll##2##2##(2008-10#2)
Potato virus A##3##3##(2008-10#3)
Potato virus X (PVX)##5##4##(2008-10#5)
Potato virus X##7##3##(2008-10#7)
Potato virus Y##5##3##(2008-10#5)
Potato virus##17##2##(2008-10#17)
Potato##56##1##(2008-10#55)(2011-2#1)
Potato-faba intercrops##2##2##(2008-10#2)
Potatoes##3##1##(2008-10#3)
Potebniamyces pyri##2##2##(2008-10#2)
Potency##2##1##(1994-6#1)(1995-8#1)
Potent##13##1##(1991-12#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#2)(2013-1#4)
Potential Therapeutic##2##2##(2009-10#1)(2011-1#1)
Potential advantages of##2##3##(2008-10#1)(2010-10#1)
Potential advantages##3##2##(1992-8#1)(2008-10#1)(2010-10#1)
Potential alterations in##2##3##(1995-5#1)(2008-10#1)
Potential and##2##2##(1996-9#1)(2010-10#1)
Potential application##2##2##(1995-3#1)(2008-10#1)
Potential applications of this##2##4##(2007-12#1)(2008-2#1)
Potential applications of##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2013-1#1)
Potential applications##8##2##(2007-12#3)(2008-10#2)(2008-2#2)(2013-1#1)
Potential explanations for##2##3##(1991-2#1)(2008-8#1)
Potential for tumor##2##3##(1993-11#1)(1994-5#1)
Potential for##7##2##(1993-11#1)(1994-5#1)(2008-10#3)(2008-7#1)(2011-2#1)
Potential interference from##2##3##(2008-10#2)
Potential of##10##2##(1994-12#1)(2008-10#6)(2008-5#2)(2012-2#1)
Potential on##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
Potential role of##5##3##(1992-12#1)(1992-9#1)(1997-8#1)(2009-7#1)(2012-2#1)
Potential role##6##2##(1992-12#1)(1992-9#1)(1997-8#1)(2007-12#1)(2009-7#1)(2012-2#1)
Potential roles for##2##3##(1993-9#1)(1994-9#1)
Potential roles##3##2##(1993-9#1)(1994-9#1)(2012-2#1)
Potential sources of##2##3##(1997-4#1)(2007-5#1)
Potential use of##3##3##(1994-11#1)(2008-2#1)(2011-2#1)
Potential##139##1##(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#37)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#6)(2013-1#6)(2013-8#4)
Potentially##12##1##(1990-10#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
Potentials##5##1##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
Potentiation of##7##2##(1990-9#1)(1991-1#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-4#1)(2008-4#1)
Potentiation##9##1##(1990-9#1)(1991-1#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-4#1)
Potentiometric and##2##2##(2008-10#2)
Potentiometric biosensors based on##2##4##(2008-10#2)
Potentiometric determination of##5##3##(2008-10#5)
Potentiometric evaluation of the##2##4##(2008-10#2)
Potentiometric flow injection determination of##2##5##(2008-10#2)
Potentiometric flow##3##2##(2008-10#3)
Potentiometric pH sensors based on##2##5##(2008-10#2)
Potentiometric properties of##2##3##(2008-10#2)
Potentiometric study of the##3##4##(2008-10#3)
Potentiometric study of##6##3##(2008-10#6)
Potentiometric titration of##2##3##(2008-10#2)
Potentiometric titration##3##2##(2008-10#3)
Potentiometric titrations were carried out##2##5##(2008-10#2)
Potentiometric titrations##5##2##(2008-10#5)
Potentiometric##44##1##(2008-10#44)
Pott's puffy tumour##3##3##(2012-8#3)
Pott's##5##1##(2007-8#1)(2009-4#1)(2012-8#3)
Potter [Appl##2##2##(2008-2#1)(2008-3#1)
Potter##5##1##(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#1)
Potting Mixes##2##2##(2008-10#2)
Potting##4##1##(2008-10#4)
Potyviridae##11##1##(2008-10#11)
Potyvirus##14##1##(2008-10#14)
Poultry##5##1##(1993-2#1)(1996-3#1)(1997-6#1)(2008-5#2)
Poults##3##1##(1997-3#1)(1997-6#1)(2008-5#1)
Poverty##8##1##(1994-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-8#1)
Powder Diffraction##2##2##(1997-7#1)(2008-7#1)
Powder##5##1##(1992-3#1)(1997-7#2)(2008-5#1)(2008-7#1)
Powdery Mildew##4##2##(2008-10#4)
Powdery##8##1##(2008-10#8)
Power Knee##2##2##(2013-1#2)
Power and##6##2##(1992-6#1)(2008-3#3)(2008-9#1)(2011-1#1)
Power of##3##2##(1996-9#1)(2009-11#1)(2013-1#1)
Power spectral##2##2##(2008-3#1)(2011-2#1)
Power##37##1##(1992-1#1)(1992-6#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#10)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
Power-law##2##1##(1990-12#1)(2008-8#1)
PowerPlex Y system##2##3##(2008-12#2)
PowerPoint presentation##2##2##(2008-10#2)
Powerful##5##1##(2007-11#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
Powers ratio##3##2##(2012-12#3)
Poyang Lake##3##2##(2013-8#3)
Poznan##4##1##(2007-11#2)(2007-8#1)(2008-9#1)
Poznań##4##1##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
Pp##3##1##(1997-7#3)
Pp3##3##1##(2007-12#3)
Pp523##4##1##(2012-3#4)
Pp99##5##1##(2008-10#5)
PpIX##3##1##(1992-8#2)(2012-3#1)
PptT##8##1##(2013-1#8)
Pr with##2##2##(2008-10#2)
Pr##17##1##(1997-7#1)(2007-12#3)(2008-10#11)(2008-3#2)
Pr(3+)##9##1##(2007-12#3)(2008-10#4)(2008-3#2)
Pr-doped##2##1##(2007-12#2)
Pr55gag##2##1##(1991-9#2)
PrEP##8##1##(2012-2#6)(2013-1#2)
Practical and##2##2##(2008-12#1)(2011-2#1)
Practical applications of##2##3##(2008-5#1)(2012-3#1)
Practical applications##4##2##(2007-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
Practical considerations##5##2##(1992-2#1)(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
Practical examples##3##2##(2008-4#1)(2008-5#1)(2010-12#1)
Practical experience with##2##3##(1996-12#1)(2012-2#1)
Practical hints##2##2##(2008-2#1)(2013-1#1)
Practical implications for health care##2##5##(1994-12#1)(2010-2#1)
Practical implications##3##2##(1994-12#1)(2008-12#1)(2010-2#1)
Practical limitations##2##2##(2008-3#2)
Practical strategies##2##2##(1994-1#1)(2008-1#1)
Practical##55##1##(1991-3#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Practically##2##1##(2008-10#1)(2008-2#1)
Practice Guidelines##4##2##(2007-4#3)(2008-12#1)
Practice Nurses##5##2##(2008-11#5)
Practice Research Network##2##3##(2013-8#2)
Practice Research##3##2##(2008-11#1)(2013-8#2)
Practice Study##2##2##(1992-1#1)(2013-1#1)
Practice and##5##2##(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)
Practice guidelines##4##2##(1991-12#1)(1996-12#1)(2008-3#1)(2009-7#1)
Practice in##3##2##(1990-3#1)(1991-12#1)(2009-8#1)
Practice nurses##2##2##(2008-11#1)(2012-3#1)
Practice of##4##2##(1990-6#1)(2008-11#1)(2009-4#1)(2010-11#1)
Practice patterns##2##2##(1995-3#1)(2011-2#1)
Practice##94##1##(1990-3#1)(1990-6#1)(1991-12#2)(1992-1#2)(1993-12#2)(1994-3#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#2)(2007-11#3)(2007-4#3)(2007-5#3)(2008-1#1)(2008-10#2)(2008-11#27)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
Practices for##2##2##(2008-12#1)(2013-1#1)
Practices in##2##2##(2009-3#1)(2012-3#1)
Practices of##5##2##(2012-12#4)(2012-3#1)
Practices on##2##2##(2008-10#2)
Practices##19##1##(1994-2#1)(2007-2#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-11#1)(2009-3#2)(2012-12#5)(2012-3#2)(2013-1#2)
Practising##2##1##(2008-11#1)(2010-12#1)
Practitioner##15##1##(1991-1#1)(1991-3#1)(1992-1#3)(1992-3#2)(1994-1#1)(1994-2#2)(1995-1#1)(2008-12#1)(2011-1#3)
Practitioners in the##2##3##(1994-1#1)(2008-1#1)
Practitioners in##4##2##(1993-2#1)(1994-1#1)(2008-1#2)
Practitioners must also##2##3##(2007-11#1)(2012-12#1)
Practitioners must##3##2##(2007-11#2)(2012-12#1)
Practitioners of##2##2##(1994-3#1)(2006-10#1)
Practitioners##19##1##(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(2006-10#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
Practitioners'##2##1##(1994-2#1)(2007-11#1)
Pradesh##5##1##(1997-8#1)(2007-7#2)(2009-4#1)(2009-5#1)
Pragmatic##2##1##(2008-7#1)(2012-3#1)
Prague##3##1##(1995-5#2)(1996-5#1)
Prajer##3##1##(2008-12#3)
Praseodymium##2##1##(2008-10#2)
Pratylenchus penetrans##5##2##(2008-10#5)
Pratylenchus spp##2##2##(2008-10#2)
Pratylenchus thornei##2##2##(2008-10#2)
Pratylenchus##11##1##(2008-10#11)
Pravastatin##7##1##(1991-12#3)(1991-6#1)(1995-12#1)(2011-1#2)
Prawn##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
Pray For Elves##2##3##(2008-9#2)
Prayer##2##1##(2008-1#1)(2008-12#1)
Prc-MIH##6##1##(2008-6#6)
Pre##3##1##(2013-1#3)
Pre- and postoperative##3##3##(2007-11#1)(2008-9#2)
Pre- and##12##2##(1993-5#1)(2007-11#1)(2008-11#3)(2008-9#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-5#1)(2013-1#1)
Pre- or##2##2##(2008-10#1)(2012-12#1)
Pre-##14##1##(1993-5#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-9#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-1#1)
Pre-clinical##2##1##(2009-7#1)(2011-2#1)
Pre-concentration##2##1##(2008-10#2)
Pre-contact##2##1##(2009-9#2)
Pre-dialysis##2##1##(2008-1#2)
Pre-eclampsia##2##1##(1996-6#1)(2011-2#1)
Pre-emergence##2##1##(2008-10#1)(2011-1#1)
Pre-employment testing##2##2##(1997-1#2)
Pre-emptive##2##1##(1993-12#1)(2007-12#1)
Pre-end##2##1##(2008-1#2)
Pre-existing##2##1##(2008-10#1)(2011-2#1)
Pre-incubation of##2##2##(1995-11#2)
Pre-inoculation of##2##2##(2008-10#2)
Pre-mRNA splicing##2##2##(1995-6#1)(2012-2#1)
Pre-operative counselling##2##2##(2008-7#1)(2012-2#1)
Pre-operative##8##1##(2007-10#1)(2008-7#2)(2012-12#2)(2012-2#2)(2012-3#1)
Pre-registration##2##1##(2008-11#2)
Pre-steady-state##2##1##(1992-6#1)(1995-6#1)
Pre-test##2##1##(2007-11#1)(2008-12#1)
Pre-treatment with##5##2##(1993-9#2)(1995-12#1)(1997-7#1)(2009-6#1)
Pre-treatment##11##1##(1991-1#1)(1993-9#2)(1995-12#1)(1997-7#1)(2008-10#1)(2009-6#2)(2010-12#1)(2010-3#1)(2011-1#1)
PreOp group##2##2##(2011-2#2)
PreOp##3##1##(2011-2#3)
PreS1 region##2##2##(1994-8#1)(2013-1#1)
PreZad was##2##2##(1991-10#2)
Precautionary##2##1##(2008-11#1)(2012-2#1)
Precautions are also detailed for routine handling of viable pathogenic microorganisms##2##11##(2008-4#1)(2008-9#1)
Precautions##5##1##(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
Preceptorship in##2##2##(2008-11#2)
Precipitates##2##1##(2008-10#1)(2013-1#1)
Precipitation##2##1##(2008-10#1)(2008-8#1)
Precise and accurate determinations were obtained##2##6##(2008-10#2)
Precise and##4##2##(2008-10#3)(2008-3#1)
Precise results##2##2##(2008-10#2)
Precise##24##1##(1990-6#1)(1992-3#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-3#6)(2008-7#1)(2012-2#1)(2012-3#1)
Precision (R##2##2##(2008-10#2)
Precision IPM##2##2##(2008-10#2)
Precision and##2##2##(2008-10#2)
Precision of the##4##3##(2008-10#3)(2010-5#1)
Precision of##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2010-5#1)(2012-3#1)
Precision was also##2##3##(2008-10#2)
Precision was evaluated##2##3##(2008-10#2)
Precision was##5##2##(2008-10#4)(2008-2#1)
Precision##35##1##(1990-8#1)(1994-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-2#4)(2008-3#3)(2010-10#1)(2010-5#1)(2012-3#1)
Preclinical and clinical##2##3##(2008-7#1)(2008-8#1)
Preclinical and##3##2##(2008-7#1)(2008-8#2)
Preclinical evaluation of the##3##4##(1991-1#1)(1994-3#1)(2007-5#1)
Preclinical evaluation of##4##3##(1991-1#1)(1994-3#1)(2007-5#1)(2008-5#1)
Preclinical models##2##2##(2007-7#1)(2008-4#1)
Preclinical studies with##2##3##(2008-5#2)
Preclinical studies##8##2##(2008-3#1)(2008-5#2)(2008-8#2)(2013-1#1)(2013-8#2)
Preclinical##26##1##(1991-1#1)(1994-3#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
Preconcentration and determination of##4##4##(2008-10#4)
Preconcentration and separation of##3##4##(2008-10#3)
Preconcentration and separation##4##3##(2008-10#4)
Preconcentration and speciation of chromium in##2##6##(2008-10#2)
Preconcentration and speciation of chromium##3##5##(2008-10#3)
Preconcentration and speciation of##4##4##(2008-10#4)
Preconcentration and##14##2##(2008-10#14)
Preconcentration factors##2##2##(2008-10#2)
Preconcentration of lead##2##3##(2008-10#2)
Preconcentration of trace##7##3##(2008-10#7)
Preconcentration of traces of##2##4##(2008-10#2)
Preconcentration of##17##2##(2008-10#17)
Preconcentration with membrane cell and adsorptive polarographic determination of##2##9##(2008-10#2)
Preconcentration with##3##2##(2008-10#3)
Preconcentration##43##1##(2008-10#43)
Preconcentrative separation of##2##3##(2008-10#2)
Preconditioned##2##1##(1995-3#1)(1996-9#1)
Preconditioning##3##1##(1996-9#3)
Precursor##7##1##(1992-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Precursors of##2##2##(2008-7#1)(2010-12#1)
Precursors##3##1##(2008-11#1)(2008-7#1)(2010-12#1)
Predator-mediated##2##1##(2008-9#2)
Predators##2##1##(2008-4#1)(2008-8#1)
Predialysis##2##1##(2008-1#1)(2008-4#1)
Predict##5##1##(2009-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
Predictability##3##1##(1991-11#1)(2011-2#1)(2012-2#1)
Predictable##2##1##(2008-7#2)
Predicted secondary##2##2##(2008-4#1)(2009-9#1)
Predicted##14##1##(1992-3#1)(1996-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
Predicting the risk of##2##4##(2012-2#1)(2013-1#1)
Predicting the##10##2##(1990-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
Predicting##27##1##(1990-9#1)(1996-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
Prediction accuracy##2##2##(2008-10#1)(2008-3#1)
Prediction and##2##2##(2008-10#1)(2008-2#1)
Prediction of molecular function of proteins has become an important task in the genomics era##2##15##(2008-2#1)(2008-4#1)
Prediction of the coding sequences of unidentified human genes##4##9##(1995-8#1)(1996-10#1)(1996-2#2)
Prediction of the##7##3##(1992-9#1)(1995-8#1)(1996-10#1)(1996-2#2)(2008-10#2)
Prediction of##36##2##(1990-9#1)(1992-2#1)(1992-9#2)(1993-11#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Prediction tests##2##2##(2008-2#1)(2008-3#1)
Prediction##50##1##(1990-9#1)(1992-2#1)(1992-9#2)(1993-11#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#1)(2010-1#1)(2010-10#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Predictions of##4##2##(1996-4#1)(2008-3#2)(2008-7#1)
Predictions##11##1##(1993-12#1)(1995-2#1)(1996-4#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)
Predictive Value##2##2##(2008-8#1)(2009-9#1)
Predictive factors for##2##3##(2008-10#1)(2011-2#1)
Predictive factors##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
Predictive model for##2##3##(2012-12#1)(2013-1#1)
Predictive models of##2##3##(1990-9#1)(2008-11#1)
Predictive models##4##2##(1990-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
Predictive value of##4##3##(2008-10#1)(2008-5#1)(2009-3#1)(2012-2#1)
Predictive##22##1##(1990-9#1)(1994-5#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
Predictome##2##1##(2008-4#2)
Predictor##2##1##(1995-4#1)(2008-12#1)
Predictors of non-uptake of human immunodeficiency virus testing by tuberculosis public primary patients in three districts##2##16##(2013-1#2)
Predictors of outcome##2##3##(2008-9#1)(2010-4#1)
Predictors of##32##2##(1991-1#1)(2007-10#5)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
Predictors##36##1##(1991-1#1)(2007-10#6)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
Predicts##7##1##(2008-10#1)(2009-8#2)(2012-12#1)(2012-3#1)(2013-1#2)
Predisposing factors##2##2##(2008-2#1)(2012-3#1)
Predisposition to##2##2##(1991-12#1)(1997-3#1)
Predisposition##3##1##(1991-12#1)(1997-3#1)(2008-10#1)
Predominance of##2##2##(2007-12#1)(2013-8#1)
Predominance zone diagrams##3##3##(2008-10#3)
Predominance##5##1##(2007-12#1)(2008-10#3)(2013-8#1)
Predominant##4##1##(1992-2#1)(1994-5#1)(1994-8#1)(2008-10#1)
Predominantly##3##1##(1994-3#1)(2010-8#1)(2012-12#1)
Preeclampsia is##2##2##(2008-11#1)(2009-8#1)
Preeclampsia##3##1##(2008-11#1)(2009-8#2)
Preface##32##1##(2007-12#1)(2008-10#9)(2008-11#10)(2008-7#2)(2008-8#2)(2008-9#3)(2009-9#1)(2011-2#3)(2012-2#1)
Prefecture##7##1##(1993-1#2)(1994-2#1)(1995-4#1)(2008-8#1)(2010-8#1)(2011-2#1)
Preference for##2##2##(1994-2#1)(2012-3#1)
Preference##7##1##(1994-2#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
Preferences for##6##2##(1993-12#1)(2007-2#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
Preferences in##3##2##(2007-12#2)(2010-12#1)
Preferences##12##1##(1992-3#1)(1993-12#1)(2007-12#3)(2007-2#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
Preferential##6##1##(1990-12#1)(1990-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)
Preferred provider organizations##2##3##(1997-1#2)
Preferred##5##1##(1992-2#1)(1992-3#1)(1997-1#2)(2009-3#1)
Prefrontal##5##1##(1995-12#2)(2011-2#1)(2012-1#1)(2013-8#1)
Pregabalin is##3##2##(2008-9#3)
Pregabalin##6##1##(2008-9#4)(2013-8#2)
Pregnancies##3##1##(1990-3#1)(2010-12#1)(2011-2#1)
Pregnancy Risk Assessment##2##3##(2013-1#1)(2013-8#1)
Pregnancy in##5##2##(1995-9#1)(2007-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
Pregnancy outcome in##2##3##(1991-12#1)(1994-3#1)
Pregnancy outcome##4##2##(1991-12#1)(1992-2#1)(1994-3#1)(2013-1#1)
Pregnancy rates##2##2##(1991-3#1)(1994-9#1)
Pregnancy##35##1##(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-12#1)(2007-2#2)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#2)
Pregnant Women##3##2##(2008-12#1)(2009-9#1)(2013-1#1)
Pregnant rats were given##2##4##(1996-5#1)(2008-10#1)
Pregnant rats were##3##3##(1995-11#1)(1996-5#1)(2008-10#1)
Pregnant women##4##2##(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#1)
Pregnant##16##1##(1995-11#1)(1995-6#1)(1996-11#1)(1996-5#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
Pregnenolone##2##1##(1990-11#1)(1996-2#1)
Preimplantation genetic diagnosis##2##3##(1996-8#1)(2012-3#1)
Preimplantation genetic screening##2##3##(2009-7#1)(2012-3#1)
Preimplantation genetic##5##2##(1996-8#1)(2009-7#1)(2012-3#3)
Preincubation of cells##2##3##(1994-11#1)(1994-6#1)
Preincubation of the##4##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-6#1)
Preincubation of##15##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-6#1)
Preincubation with the##2##3##(2008-11#1)(2008-7#1)
Preincubation with##6##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-6#1)(2008-11#1)(2008-7#1)
Preincubation##21##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-3#2)(1992-6#1)(1992-8#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-6#2)(2008-11#1)(2008-7#1)
Preinoculation of##3##2##(2008-10#3)
Preinoculation##5##1##(2008-10#5)
Preliminary Findings##2##2##(1997-3#1)(2007-4#1)
Preliminary Raman##2##2##(2007-11#1)(2008-10#1)
Preliminary Results of##2##3##(1994-12#1)(2008-1#1)
Preliminary analysis##2##2##(1994-2#1)(2011-2#1)
Preliminary characterization of##2##3##(1993-8#1)(2008-10#1)
Preliminary characterization##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
Preliminary data from##2##3##(2008-10#1)(2012-3#1)
Preliminary data##4##2##(1991-1#1)(1995-2#1)(2008-10#1)(2012-3#1)
Preliminary evaluation of##2##3##(2008-12#1)(2011-1#1)
Preliminary evidence##5##2##(1991-1#1)(1994-9#1)(2008-2#1)(2008-4#1)(2009-5#1)
Preliminary experimental results##5##3##(2008-2#2)(2008-3#3)
Preliminary experimental##6##2##(2008-2#3)(2008-3#3)
Preliminary experiments were carried out##2##5##(2007-12#1)(2008-3#1)
Preliminary experiments were performed##2##4##(2008-10#1)(2008-2#1)
Preliminary experiments were##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Preliminary experiments##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
Preliminary findings##2##2##(1993-12#1)(1993-3#1)
Preliminary investigation##2##2##(2008-8#1)(2010-3#1)
Preliminary report##3##2##(1990-10#1)(1991-1#1)(2013-1#1)
Preliminary results indicate##2##3##(1990-6#1)(1992-12#1)
Preliminary results of a##3##4##(1990-3#1)(1991-3#1)(2008-10#1)
Preliminary results of the##2##4##(1991-12#1)(2007-11#1)
Preliminary results of##9##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-5#1)(2007-11#2)(2007-8#1)(2008-10#1)
Preliminary results showed##2##3##(2008-10#1)(2008-9#1)
Preliminary results suggest that this##2##5##(2008-2#1)(2008-3#1)
Preliminary results suggest that##4##4##(2008-2#2)(2008-3#1)(2010-12#1)
Preliminary results with a##2##4##(2007-11#1)(2008-3#1)
Preliminary results##29##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-5#1)(1994-12#1)(1996-9#1)(2007-11#3)(2007-8#2)(2008-10#4)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)
Preliminary studies have shown that##2##5##(2008-5#1)(2008-7#1)
Preliminary studies of the##2##4##(1997-7#1)(2008-10#1)
Preliminary studies of##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
Preliminary studies##10##2##(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#4)(2008-7#1)
Preliminary study on##2##3##(1991-8#1)(2009-10#1)
Preliminary study##3##2##(1991-8#1)(2009-10#1)(2011-2#1)
Preliminary trials of##2##3##(1991-3#1)(2008-10#1)
Preliminary##127##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#4)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#3)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#6)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
Prelude##2##1##(2008-10#2)
Premating isolation is determined by##2##5##(2008-8#1)(2008-9#1)
Premature infants##2##2##(1994-6#1)(2008-11#1)
Premature##8##1##(1994-6#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-12#1)
Premier##2##1##(1993-5#1)(1994-2#1)
Premium##2##1##(2008-7#1)(2010-9#1)
Prenatal WIC participation was associated with##2##6##(1993-3#2)
Prenatal diagnosis of##4##3##(1992-6#1)(1997-3#1)(2008-4#1)(2013-1#1)
Prenatal diagnosis##7##2##(1990-8#1)(1992-6#1)(1997-3#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
Prenatal screening for Down's syndrome##6##5##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#1)
Prenatal screening for##7##3##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#2)
Prenatal treatment of congenital adrenal hyperplasia##3##6##(2008-4#3)
Prenatal treatment##4##2##(2008-4#4)
Prenatal##42##1##(1990-5#1)(1990-8#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1995-12#1)(1996-12#4)(1996-5#2)(1997-3#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#5)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#2)
Preneoplastic##2##1##(2008-4#1)(2013-1#1)
Prentice-Hall##2##1##(2008-11#2)
Preoperative and##2##2##(2008-9#1)(2013-1#1)
Preoperative assessment of##2##3##(1991-11#1)(2008-7#1)
Preoperative diagnosis##2##2##(1991-6#1)(2010-12#1)
Preoperative embolisation##2##2##(1996-9#1)(2008-7#1)
Preoperative evaluation##3##2##(1992-5#1)(2009-5#1)(2011-2#1)
Preoperative serum##2##2##(2007-8#1)(2011-2#1)
Preoperative##40##1##(1991-11#1)(1991-6#1)(1992-5#1)(1994-7#1)(1994-8#2)(1996-6#1)(1996-9#1)(2006-10#2)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Preoperatively##2##1##(1990-12#1)(2011-2#1)
Preparation and application of##3##4##(2008-10#2)(2008-4#1)
Preparation and characterization of##5##4##(1995-11#1)(2008-10#3)(2008-8#1)
Preparation and evaluation of##8##4##(1990-8#1)(2008-10#4)(2010-3#2)(2010-5#1)
Preparation and properties of##2##4##(2008-10#1)(2009-7#1)
Preparation and##30##2##(1990-8#1)(1995-11#1)(1996-2#1)(2008-10#16)(2008-4#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-3#2)(2010-5#1)
Preparation for##4##2##(1991-2#1)(2009-4#1)(2012-3#1)(2013-1#1)
Preparation of a##4##3##(1992-6#1)(2008-10#2)(2012-2#1)
Preparation of nuclear##2##3##(2008-11#1)(2008-2#1)
Preparation of the##3##3##(1996-2#1)(2008-4#2)
Preparation of##55##2##(1990-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-7#1)(2007-11#4)(2008-1#1)(2008-10#11)(2008-11#7)(2008-2#6)(2008-3#1)(2008-4#8)(2010-2#2)(2010-6#1)(2012-2#2)
Preparation##97##1##(1990-12#1)(1990-8#1)(1991-2#1)(1992-2#2)(1992-6#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-2#2)(1996-5#3)(1997-1#1)(1997-7#1)(2007-11#4)(2008-1#1)(2008-10#30)(2008-11#8)(2008-2#7)(2008-3#1)(2008-4#11)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#2)(2012-2#2)(2012-3#1)(2013-1#1)
Preparations of##3##2##(1990-12#1)(2008-10#2)
Preparations##6##1##(1990-12#1)(2008-10#3)(2008-5#1)(2009-11#1)
Preparative##5##1##(1992-11#1)(1994-12#2)(1996-5#1)(1997-2#1)
Prepare##2##1##(1993-12#1)(2013-1#1)
Prepared##4##1##(1993-3#1)(1997-7#1)(2010-6#1)(2011-2#1)
Preparedness##3##1##(1991-12#2)(2010-8#1)
Preparing a##3##2##(1992-3#1)(1995-3#1)(2008-11#1)
Preparing for health care reform##2##5##(1994-12#1)(1994-2#1)
Preparing for health care##3##4##(1994-12#1)(1994-2#1)(1995-2#1)
Preparing for health##4##3##(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#1)
Preparing for##8##2##(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)
Preparing##25##1##(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-1#1)(2007-9#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
Prepenetration##2##1##(2008-10#2)
Preprofessional pipeline programs##2##3##(2012-3#2)
Prepubertal##2##1##(2008-10#1)(2011-1#1)
Presbyterian##2##1##(1992-8#1)(2008-3#1)
Preschool##2##1##(2008-11#2)
Prescribed##3##1##(1997-2#1)(2010-3#2)
Prescribing by general practitioner fundholders##2##5##(1996-3#2)
Prescribing preventive##2##2##(2008-11#2)
Prescribing##12##1##(1996-2#1)(1996-3#2)(1997-8#1)(2007-7#1)(2008-11#3)(2008-3#2)(2008-7#1)(2009-6#1)
Prescription drug misuse##2##3##(2013-8#2)
Prescription drug##7##2##(1995-1#1)(2008-11#2)(2009-6#1)(2010-5#1)(2013-8#2)
Prescription of##2##2##(2010-12#2)
Prescription##17##1##(1992-12#1)(1995-1#1)(2007-9#1)(2008-11#2)(2008-8#1)(2009-6#1)(2010-12#2)(2010-5#2)(2012-1#1)(2013-1#2)(2013-8#3)
Presence of a##2##3##(1994-6#1)(2007-12#1)
Presence of the##2##3##(2008-10#1)(2008-5#1)
Presence of##32##2##(1990-12#1)(1994-6#1)(1994-7#1)(1996-5#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#3)(2009-7#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-2#1)
Presence##35##1##(1990-12#1)(1991-9#1)(1994-6#1)(1994-7#1)(1996-5#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#3)(2009-7#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#1)
Present and##2##2##(2007-11#1)(2008-11#1)
Present communication##2##2##(1993-11#1)(2008-7#1)
Present data indicate##2##3##(2008-12#1)(2008-3#1)
Present data##5##2##(1991-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)
Present results also##2##3##(2008-10#1)(2008-12#1)
Present results showed##3##3##(2008-12#3)
Present results##8##2##(2007-12#1)(2008-10#1)(2008-12#5)(2013-1#1)
Present study was conducted to##2##5##(2007-7#1)(2008-12#1)
Present study was##4##3##(2007-7#1)(2008-12#2)(2012-3#1)
Present study##9##2##(2007-7#2)(2008-12#5)(2012-3#1)(2013-8#1)
Present##43##1##(1991-12#1)(1992-9#1)(1993-11#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#13)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Presentation of a case##3##4##(1990-6#1)(1993-5#1)(2009-8#1)
Presentation of a clinical case##2##5##(1990-5#1)(1993-5#1)
Presentation of a clinical case]##2##5##(1993-5#1)(1993-6#1)
Presentation of a clinical##4##4##(1990-5#1)(1993-5#2)(1993-6#1)
Presentation of a##9##3##(1990-5#1)(1990-6#1)(1991-6#1)(1993-5#3)(1993-6#1)(2008-6#1)(2009-8#1)
Presentation of##14##2##(1990-5#2)(1990-6#1)(1991-6#1)(1993-5#3)(1993-6#1)(1994-11#1)(1995-3#1)(2008-1#1)(2008-6#1)(2009-8#1)(2011-2#1)
Presentation##36##1##(1990-5#2)(1990-6#1)(1991-6#1)(1993-5#3)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-11#11)(2008-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Presentations##10##1##(2008-1#1)(2008-11#8)(2009-5#1)
Presented at the##3##3##(1992-3#1)(2008-11#1)(2008-6#1)
Presented here is an##2##4##(1995-2#1)(2009-11#1)
Presented here##3##2##(1995-2#1)(2008-4#1)(2009-11#1)
Presented in this article are##2##5##(1991-2#1)(1992-1#1)
Presented in this##4##3##(1991-2#1)(1992-1#1)(2007-12#1)(2008-9#1)
Presented is a##3##3##(1991-1#1)(2008-1#1)(2008-7#1)
Presented is##4##2##(1991-1#1)(2008-1#1)(2008-7#1)(2008-8#1)
Presented study##2##2##(2007-8#1)(2009-6#1)
Presented##21##1##(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1995-2#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#1)
Presenting as Acute##2##3##(2007-7#1)(2008-11#1)
Presenting as a##2##3##(2009-3#1)(2013-8#1)
Presenting as##5##2##(2007-7#1)(2008-11#1)(2009-3#1)(2012-12#1)(2013-8#1)
Presenting the##2##2##(1992-11#1)(2011-1#1)
Presenting##13##1##(1991-3#1)(1992-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Presently##8##1##(1990-2#1)(1996-3#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#2)(2012-3#1)
Preservation of##6##2##(1990-11#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)
Preservation##7##1##(1990-11#1)(1996-9#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)
Preservative tolerance##2##2##(2008-5#2)
Preservative##3##1##(2008-5#3)
Preserving##2##1##(2009-7#1)(2012-3#1)
Presidency##2##1##(2008-4#1)(2012-12#1)
President Bush##2##2##(1991-12#1)(1994-1#1)
President Clinton has##2##3##(1995-2#1)(1995-6#1)
President Clinton##12##2##(1994-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#2)
President Clinton's Advisory Council on HIV/AIDS##2##6##(1995-12#1)(1995-6#1)
President Clinton's##5##2##(1995-12#1)(1995-2#1)(1995-6#1)(2008-7#2)
President and Chief Executive Officer##2##5##(1994-1#1)(2008-1#1)
President of the##4##3##(1992-3#1)(1994-1#1)(2008-7#1)(2009-7#1)
President of##7##2##(1992-3#1)(1994-1#1)(1995-1#1)(2008-7#2)(2009-7#1)(2010-6#1)
President##42##1##(1991-12#2)(1991-2#1)(1991-3#3)(1992-3#1)(1993-1#1)(1994-1#4)(1994-3#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-6#4)(1996-1#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#2)(2008-1#1)(2008-7#4)(2009-7#1)(2010-6#1)(2012-12#1)
President's##6##1##(1993-3#1)(1993-5#1)(1995-12#1)(2008-12#1)(2010-1#1)(2010-6#1)
Presidential Address##2##2##(1994-12#1)(2008-11#1)
Presidential address##3##2##(2007-7#1)(2008-6#2)
Presidential##7##1##(1994-12#1)(1995-6#1)(2007-7#1)(2008-11#1)(2008-6#2)(2008-8#1)
Press##24##1##(1990-11#3)(1990-3#1)(1990-8#3)(1997-6#2)(2007-11#1)(2007-2#1)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)
Pressure and##2##2##(1995-3#1)(1995-6#1)
Pressure##19##1##(1994-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Pressure-induced##3##1##(1993-5#1)(2008-2#1)(2010-12#1)
Pressures##2##1##(1996-2#1)(2008-7#1)
Prestige disc) versus##2##3##(2012-12#2)
Prestige##4##1##(2008-10#1)(2012-12#3)
Prestige's##3##1##(2008-10#3)
Presumably##10##1##(1990-11#1)(1990-2#1)(1991-5#1)(1994-11#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#1)
Presynaptic##4##1##(1995-11#1)(1995-12#1)(1996-12#1)(1997-3#1)
Preterm infants##3##2##(2007-11#1)(2010-5#1)(2011-2#1)
Preterm##6##1##(1994-3#1)(2007-11#1)(2007-2#2)(2010-5#1)(2011-2#1)
Preto##4##1##(2008-6#1)(2008-9#2)(2012-3#1)
Pretoria##2##1##(2007-7#1)(2008-12#1)
Pretransfnsion##2##1##(1994-9#2)
Pretreatment of BBMV with##2##4##(1992-6#2)
Pretreatment of mice with##2##4##(2010-10#1)(2011-2#1)
Pretreatment of##19##2##(1990-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#7)(2010-10#1)(2011-2#1)
Pretreatment with MK-801##2##3##(1990-5#1)(1991-2#1)
Pretreatment with the##3##3##(1992-8#1)(1994-2#1)(1995-3#1)
Pretreatment with##29##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-2#1)(1996-5#2)(1997-2#1)(1997-7#2)(2008-10#2)(2012-3#1)(2013-1#1)
Pretreatment##53##1##(1990-11#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-6#1)(1992-3#4)(1992-6#2)(1992-8#3)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-3#4)(1996-2#1)(1996-5#2)(1997-2#1)(1997-7#2)(2008-10#9)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
Prevalence and associated##2##3##(1991-3#1)(2013-1#1)
Prevalence and causes of##2##4##(2008-1#1)(2010-8#1)
Prevalence and correlates of##3##4##(1995-11#1)(2011-2#1)(2013-1#1)
Prevalence and predictors of##3##4##(2006-10#1)(2007-10#1)(2012-2#1)
Prevalence and risk factors for##2##5##(2011-2#1)(2012-3#1)
Prevalence and risk factors##3##4##(2011-2#2)(2012-3#1)
Prevalence and##27##2##(1991-3#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#2)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)
Prevalence of HIV##2##3##(2007-7#2)
Prevalence of UI##2##3##(2011-1#2)
Prevalence of amblyopia##2##3##(2008-7#1)(2013-1#1)
Prevalence of asthma##2##3##(1991-6#1)(2008-12#1)
Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes##2##15##(2012-2#2)
Prevalence of hepatitis C##2##4##(2007-7#1)(2008-1#1)
Prevalence of hypertension##2##3##(2008-11#1)(2011-1#1)
Prevalence of intestinal parasites##3##4##(1996-12#1)(2009-10#1)(2012-3#1)
Prevalence of overweight and obesity##2##5##(2008-3#1)(2011-2#1)
Prevalence of the metabolic syndrome in##2##6##(2008-3#1)(2011-2#1)
Prevalence of the metabolic syndrome##3##5##(2008-3#2)(2011-2#1)
Prevalence of the##4##3##(2008-3#3)(2011-2#1)
Prevalence of##91##2##(1990-2#1)(1990-9#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1995-9#1)(1996-11#1)(1996-12#2)(2007-12#1)(2007-7#8)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#10)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#8)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
Prevalence rates were##2##3##(2012-3#2)
Prevalence rates##3##2##(1994-6#1)(2012-3#2)
Prevalence ratios##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
Prevalence##140##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-12#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#9)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#12)(2008-3#6)(2008-5#1)(2008-7#7)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#11)(2011-2#12)(2012-12#4)(2012-2#8)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#3)
Prevalences##2##1##(1991-3#1)(1996-12#1)
Prevalent##5##1##(1997-4#1)(1997-6#1)(2008-10#1)(2009-11#1)(2013-8#1)
Prevent##4##1##(1996-2#1)(2008-1#1)(2009-12#1)(2013-1#1)
Preventing needlestick injuries##2##3##(1991-3#1)(1991-6#1)
Preventing##16##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(2007-12#3)(2008-11#2)(2009-4#1)(2009-5#1)(2010-1#1)(2011-2#2)(2013-8#1)
Prevention Program##2##2##(2009-6#1)(2013-1#1)
Prevention Project##2##2##(2009-7#1)(2011-2#1)
Prevention Trial##3##2##(1991-8#1)(1994-6#1)(1995-9#1)
Prevention and Control##4##3##(2010-4#1)(2013-1#2)(2013-8#1)
Prevention and treatment of##2##4##(2008-7#1)(2009-5#1)
Prevention and##14##2##(1994-1#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
Prevention in##3##2##(1995-5#1)(2007-2#1)(2008-8#1)
Prevention is##3##2##(2008-11#1)(2010-1#1)(2010-5#1)
Prevention of acute##2##3##(2008-4#1)(2008-7#1)
Prevention of cardiovascular disease##2##4##(2010-6#1)(2013-1#1)
Prevention of congenital##2##3##(1990-9#1)(2008-11#1)
Prevention of mother-to-child##2##3##(2009-4#1)(2009-7#1)
Prevention of##47##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-6#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-9#2)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Prevention programs##2##2##(1995-3#1)(2009-7#1)
Prevention strategies##2##2##(2011-2#1)(2013-8#1)
Prevention with##2##2##(2008-11#1)(2010-6#1)
Prevention##126##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-5#3)(1995-6#4)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#2)(2006-10#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#4)
Prevention)##3##1##(1996-6#1)(2008-4#1)(2008-9#1)
Preventive Services Task Force##2##4##(1994-2#1)(2013-1#1)
Preventive Services##3##2##(1994-2#1)(1996-2#1)(2013-1#1)
Preventive measures in OP exposure are of great importance in human health in developing countries##2##15##(2013-1#2)
Preventive measures##5##2##(1994-5#1)(2007-7#2)(2013-1#2)
Preventive##25##1##(1993-11#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#6)
Previous animal##2##2##(2008-10#1)(2008-4#1)
Previous attempts to##2##3##(2007-10#1)(2008-9#1)
Previous data indicate that##2##4##(1990-11#1)(1995-11#1)
Previous data##3##2##(1990-11#1)(1995-11#1)(2008-10#1)
Previous experiments##2##2##(1997-3#2)
Previous exposure to##2##3##(1990-6#1)(2007-2#1)
Previous investigations##2##2##(2008-10#1)(2008-7#1)
Previous methods to##3##3##(2008-6#1)(2008-9#1)(2010-3#1)
Previous modeling of##2##3##(2008-3#2)
Previous reports have##5##3##(2007-10#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-3#1)
Previous reports##11##2##(2007-10#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
Previous research has##6##3##(1995-12#1)(2008-11#2)(2009-7#1)(2012-2#1)(2012-3#1)
Previous research on##2##3##(2008-3#1)(2011-2#1)
Previous research suggests that the##2##5##(2011-1#1)(2011-2#1)
Previous research suggests that##3##4##(2008-8#1)(2011-1#1)(2011-2#1)
Previous research##17##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-7#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
Previous researchers##2##2##(1994-3#1)(2011-2#1)
Previous results##4##2##(1994-8#1)(1996-5#1)(2008-10#1)(2012-3#1)
Previous reviews have##2##3##(2008-10#1)(2008-9#1)
Previous studies from##2##3##(1991-3#1)(2008-10#1)
Previous studies have demonstrated that##5##5##(1990-12#1)(1992-8#1)(1993-12#1)(2008-9#1)(2011-3#1)
Previous studies have demonstrated the##2##5##(1992-1#1)(2012-2#1)
Previous studies have demonstrated##7##4##(1990-12#1)(1992-1#1)(1992-8#1)(1993-12#1)(2008-9#1)(2011-3#1)(2012-2#1)
Previous studies have indicated that there may##2##7##(1994-12#1)(2008-8#1)
Previous studies have indicated that##5##5##(1994-12#1)(1995-11#1)(1995-6#1)(2008-8#1)(2011-2#1)
Previous studies have shown that the##3##6##(1990-11#1)(1994-5#2)
Previous studies have shown that##14##5##(1990-11#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-8#1)
Previous studies have shown##15##4##(1990-11#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#1)
Previous studies have##38##3##(1990-11#1)(1990-12#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
Previous studies indicate that##2##4##(1991-12#1)(1995-11#1)
Previous studies indicated that##2##4##(1993-12#1)(2008-10#1)
Previous studies on the##2##4##(1990-8#1)(2009-7#1)
Previous studies on##4##3##(1990-7#1)(1990-8#1)(2009-7#1)(2011-2#1)
Previous studies showed that##4##4##(1995-5#1)(2008-10#1)(2008-7#1)(2010-5#1)
Previous studies using##3##3##(1994-2#1)(2008-1#1)(2008-10#1)
Previous studies with##2##3##(2008-6#1)(2008-9#1)
Previous studies##66##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-4#1)(2009-7#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
Previous study##2##2##(2008-10#1)(2010-7#1)
Previous work has shown that##2##5##(1992-11#1)(1994-8#1)
Previous work has shown##3##4##(1992-11#1)(1994-8#1)(2008-11#1)
Previous work has##5##3##(1992-11#1)(1994-8#1)(1995-12#1)(2008-11#1)(2008-9#1)
Previous work suggested that the##2##5##(1991-9#1)(2008-10#1)
Previous work suggested that##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
Previous work##13##2##(1991-9#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2012-12#1)
Previous works##2##2##(2010-10#1)(2012-7#1)
Previous##188##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#4)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#3)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#1)
Previously [Opt##2##2##(2007-11#2)
Previously published##2##2##(2008-10#1)(2010-10#1)
Previously we have shown that##2##5##(1992-8#1)(1994-6#1)
Previously we showed that##2##4##(2008-11#1)(2012-3#1)
Previously we##8##2##(1990-12#1)(1992-8#1)(1994-6#1)(1997-6#1)(2008-11#2)(2008-8#1)(2012-3#1)
Previously##72##1##(1990-11#1)(1990-12#3)(1990-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#8)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Prevotella##4##1##(2007-7#1)(2008-5#1)(2013-1#2)
Prey selection and functional##2##4##(2010-8#2)
Prey##5##1##(2009-10#1)(2010-8#4)
PriB##2##1##(1991-7#2)
Priapism is##2##2##(2008-10#2)
Price##8##1##(1992-3#1)(1993-1#2)(1993-3#2)(1994-1#1)(1997-3#1)(2010-8#1)
Pride##2##1##(2010-8#1)(2012-3#1)
Prilliman##4##1##(1997-5#4)
Primarily##2##1##(1990-2#1)(2008-7#1)
Primary Care Policy Fellowship##2##4##(1996-1#2)
Primary Care##11##2##(1991-9#1)(1994-6#1)(1995-12#1)(1996-1#3)(1996-2#1)(2007-2#1)(2008-1#1)(2008-7#1)(2011-1#1)
Primary Care]##2##2##(1991-9#1)(1997-5#1)
Primary Cutaneous##2##2##(2008-5#1)(2012-3#1)
Primary Health Care##3##3##(1990-6#1)(2009-10#1)(2011-1#1)
Primary Health##4##2##(1990-6#1)(2009-10#1)(2011-1#1)(2013-8#1)
Primary Prevention##2##2##(1991-8#1)(2010-8#1)
Primary Sjögren's syndrome##2##3##(2007-10#2)
Primary and Secondary##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
Primary and secondary##4##3##(1991-6#1)(1992-11#1)(2007-7#1)(2008-7#1)
Primary and##10##2##(1991-6#1)(1992-11#1)(1993-3#1)(1994-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
Primary bilateral##2##2##(2011-2#1)(2013-1#1)
Primary bone##2##2##(2007-5#1)(2008-2#1)
Primary breast lymphoma##3##3##(2012-2#2)(2013-8#1)
Primary carcinoid##2##2##(2011-2#1)(2012-2#1)
Primary carcinosarcoma##2##2##(2010-8#2)
Primary care diabetes##2##3##(2008-7#2)
Primary care physicians and##2##4##(2008-11#1)(2008-6#1)
Primary care physicians##4##3##(1995-3#1)(2008-11#1)(2008-6#1)(2009-9#1)
Primary care staff##2##3##(1997-1#1)(2010-11#1)
Primary care##14##2##(1995-3#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-6#1)(2008-7#2)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
Primary central nervous system lymphoma##2##5##(2008-7#1)(2009-8#1)
Primary cultures expressed endothelial/macrophage RNA markers whether cultured on fibronectin or polystyrene and these markers decreased upon passage##2##18##(2008-11#2)
Primary cultures were analyzed by histochemistry and third passage cells by FACS##2##12##(2008-11#2)
Primary cultures were##3##3##(2008-11#3)
Primary cultures##7##2##(1993-6#1)(2008-1#1)(2008-11#5)
Primary cutaneous##4##2##(2007-7#2)(2012-3#1)(2013-8#1)
Primary data##2##2##(1995-12#1)(2010-8#1)
Primary disease gradients of##2##4##(2008-10#2)
Primary disease gradients##3##3##(2008-10#3)
Primary gastric T cell lymphoma##2##5##(2009-8#2)
Primary gastric##4##2##(1992-8#1)(1997-1#1)(2009-8#2)
Primary health care##2##3##(1994-3#1)(1995-9#1)
Primary human##3##2##(2008-11#2)(2011-2#1)
Primary infection##2##2##(2007-7#1)(2010-4#1)
Primary intrarenal neuroblastoma##2##3##(2008-10#2)
Primary lymphoma of the central nervous system##2##7##(1991-2#2)
Primary lymphoma of the##3##4##(1991-2#2)(2013-1#1)
Primary mediastinal##2##2##(2009-8#2)
Primary mucinous carcinoma of the skin##2##6##(2010-3#2)
Primary mucinous##3##2##(2009-5#1)(2010-3#2)
Primary multiple##2##2##(2007-8#1)(2008-7#1)
Primary non-refluxing megaureters##2##3##(2008-10#2)
Primary outcome##2##2##(2007-8#1)(2013-1#1)
Primary ovarian##2##2##(2013-8#2)
Primary prevention##2##2##(2008-11#1)(2013-1#1)
Primary rabbit##2##2##(2007-11#1)(2008-8#1)
Primary resection and##2##3##(2010-8#2)
Primary spinal epidural##2##3##(1992-12#2)
Primary structure of##3##3##(1991-6#1)(1994-12#1)(2010-4#1)
Primary structure##4##2##(1990-11#1)(1991-6#1)(1994-12#1)(2010-4#1)
Primary synovial##2##2##(2010-5#1)(2013-1#1)
Primary treatment##4##2##(1997-3#1)(2007-8#1)(2008-6#1)(2013-8#1)
Primary trisomics##2##2##(2009-12#2)
Primary varicella##3##2##(2010-8#3)
Primary##265##1##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-1#3)(1996-2#3)(1996-3#1)(1996-5#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#2)(2006-10#1)(2007-10#4)(2007-11#2)(2007-2#5)(2007-5#2)(2007-7#6)(2007-8#6)(2008-1#5)(2008-10#24)(2008-11#21)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#7)(2008-7#10)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#10)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#10)
Primates##4##1##(2007-12#1)(2009-8#1)(2011-2#2)
Primatone RL##5##2##(2008-7#5)
Primatone##6##1##(2008-7#6)
Prime Minister##2##2##(1992-5#1)(1997-6#1)
Prime Time participants##2##3##(2013-1#2)
Prime Time##5##2##(2013-1#5)
Prime##7##1##(1992-5#1)(1997-6#1)(2013-1#5)
Primed##2##1##(1995-5#1)(2008-10#1)
Primer design##2##2##(2008-10#2)
Primer extension analysis##5##3##(1992-10#1)(1993-3#1)(1997-7#1)(1997-8#1)(2008-9#1)
Primer extension experiments##2##3##(1993-12#1)(1993-8#1)
Primer extension##10##2##(1991-11#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1997-7#1)(1997-8#1)(2008-9#1)
Primer pairs##2##2##(2008-10#2)
Primer##16##1##(1991-11#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1997-7#1)(1997-8#1)(2008-10#5)(2008-7#1)(2008-9#1)
Primers for##3##2##(2008-10#3)
Primers were designed from the##2##5##(1993-6#1)(2008-8#1)
Primers were designed from##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
Primers were designed that##2##4##(2008-10#2)
Primers were designed##6##3##(1993-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
Primers##16##1##(1993-6#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-8#1)
Priming with##2##2##(1995-12#1)(1996-12#1)
Priming##5##1##(1992-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2010-8#1)
Primitive neuroectodermal##2##2##(2007-7#1)(2008-7#1)
Primitive##3##1##(2007-7#1)(2008-7#1)(2010-11#1)
Primorsko-Goranska County##8##2##(2011-2#8)
Primorsko-Goranska##10##1##(2011-2#10)
Primula##4##1##(2008-10#4)
Prince Edward Island##9##3##(2008-10#1)(2010-8#1)(2012-3#5)(2013-8#2)
Prince of Wales Hospital##2##4##(1996-1#1)(2012-6#1)
Prince##15##1##(1996-1#1)(2008-10#2)(2008-7#3)(2010-8#1)(2012-3#5)(2012-6#1)(2013-8#2)
Princely church of Curtea de Arges##3##6##(2008-10#3)
Princess Margaret Hospital##2##3##(1992-2#2)
Princess##5##1##(1992-2#2)(1996-11#1)(2010-8#1)(2011-2#1)
Princeton##4##1##(1993-3#1)(2008-11#2)(2008-7#1)
Principal Component Analysis##6##3##(2008-10#2)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)
Principal Components Analysis##2##3##(2010-7#1)(2012-2#1)
Principal Components plots##2##3##(2008-10#2)
Principal Components##6##2##(2008-10#3)(2009-9#1)(2010-7#1)(2012-2#1)
Principal component analysis (PCA) was applied in order to##2##9##(1996-5#1)(2008-10#1)
Principal component analysis (PCA) was applied##3##6##(1996-5#1)(2008-10#2)
Principal component analysis (PCA) was##4##5##(1996-5#1)(2008-10#3)
Principal component analysis (PCA)##7##4##(1996-5#1)(2008-10#4)(2010-5#2)
Principal component analysis and cluster analysis##2##6##(2008-10#2)
Principal component analysis and cluster##3##5##(2008-10#2)(2008-12#1)
Principal component analysis and##4##4##(2008-10#2)(2008-12#1)(2008-2#1)
Principal component analysis##16##3##(1996-5#1)(2008-10#10)(2008-12#1)(2008-2#1)(2010-5#2)(2011-2#1)
Principal component and##2##3##(2008-10#2)
Principal component##21##2##(1996-5#1)(2008-10#15)(2008-12#1)(2008-2#1)(2010-5#2)(2011-2#1)
Principal components analysis##3##3##(1992-1#1)(1996-7#1)(2010-7#1)
Principal components##4##2##(1992-1#1)(1996-7#1)(2007-1#1)(2010-7#1)
Principal##43##1##(1992-1#1)(1996-5#1)(1996-7#1)(2007-1#1)(2008-10#20)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
Principle for##2##2##(1996-9#2)
Principle##6##1##(1991-2#1)(1996-9#2)(2007-5#1)(2008-10#1)(2010-8#1)
Principles and Practice##2##3##(2008-11#1)(2008-4#1)
Principles and##8##2##(1995-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
Principles for the##3##3##(1992-3#1)(1994-2#1)(2007-11#1)
Principles for##7##2##(1990-7#1)(1991-12#1)(1992-3#1)(1994-2#1)(2007-11#2)(2008-6#1)
Principles in##2##2##(2008-1#1)(2008-3#1)
Principles of##17##2##(1990-3#1)(1990-8#1)(1992-3#2)(1994-1#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-8#3)(2008-9#3)(2011-2#1)(2013-1#1)
Principles##41##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#3)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-2#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#6)(2008-9#5)(2010-3#1)(2011-2#1)(2013-1#1)
Printed##3##1##(1997-3#1)(2010-10#2)
Prion protein immunohistochemistry##2##3##(2008-5#2)
Prion##3##1##(2007-11#1)(2008-5#2)
Prior quantum chemical studies suffered from short simulation timescales failing to capture free energy contributions due to relaxation of the surrounding aqueous environment##2##23##(2013-1#2)
Prior research##3##2##(2008-12#1)(2008-8#1)(2013-8#1)
Prior to the##10##3##(1990-6#1)(1995-5#1)(1995-9#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
Prior to##35##2##(1990-6#1)(1991-11#1)(1992-5#1)(1994-12#1)(1995-5#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#4)(2012-7#1)
Prior##61##1##(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-12#1)(1995-5#2)(1995-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-5#1)(2011-2#5)(2012-7#1)(2013-1#2)(2013-8#3)
Priorities##3##1##(1996-3#1)(2008-7#1)(2011-2#1)
Prioritizing##4##1##(1994-1#1)(2007-9#1)(2012-1#1)(2012-2#1)
Priority administrative and clinical issues were identified##2##7##(2013-8#2)
Priority issues and##2##3##(2013-8#2)
Priority##7##1##(1995-8#1)(2008-10#1)(2011-2#1)(2013-8#4)
Prism##5##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
Prison of Love&quot##2##3##(2012-2#2)
Prison of##3##2##(2012-2#3)
Prison##7##1##(1991-11#1)(1992-2#1)(1993-2#1)(1997-5#1)(2012-2#3)
Pritchard##2##1##(1991-12#2)
Privacy and##2##2##(1991-3#1)(1995-12#1)
Private accreditation##2##2##(1995-3#2)
Private and##2##2##(1996-12#1)(2008-11#1)
Private payers##2##2##(2008-11#1)(2013-7#1)
Private practice##5##2##(1996-11#5)
Private##25##1##(1991-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-12#1)(1993-2#1)(1995-3#2)(1996-11#5)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-9#1)(2013-7#1)
Prize for##2##2##(1995-12#1)(2010-8#1)
Prize##15##1##(1991-12#1)(1992-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-7#4)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
Pro 66##3##2##(1992-6#3)
Pro and##2##2##(1997-7#1)(2007-7#1)
Pro at position##2##3##(1994-3#1)(1995-3#1)
Pro##28##1##(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#2)(1997-7#3)(2007-7#1)(2008-11#1)(2008-12#1)(2009-3#2)(2011-2#2)
Pro-##7##1##(1991-5#7)
Pro-Argin##2##1##(2011-2#2)
Pro-Pro-[3H]benzylamide##3##1##(1992-3#3)
Pro34]NPY##3##1##(1997-4#3)
Pro34]neuropeptide Y##2##2##(1995-12#2)
Pro9##2##1##(1992-12#2)
Pro9-NHEt] sGnRH##3##2##(1994-8#3)
ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE)##2##9##(2008-3#2)
ProDisc##2##1##(2009-3#2)
ProFlu ST test was##2##4##(2011-2#2)
ProNova stent##2##2##(2008-11#2)
ProNova##5##1##(2008-11#5)
Probabilistic##7##1##(1990-11#1)(1996-4#1)(2008-7#1)(2009-11#3)(2010-8#1)
Probabilities##5##1##(1990-11#1)(2008-10#3)(2012-3#1)
Probability of##2##2##(2009-11#1)(2013-8#1)
Probability##4##1##(2008-2#1)(2008-3#1)(2009-11#1)(2013-8#1)
Probable##4##1##(2008-10#3)(2008-5#1)
Probably in##2##2##(1993-11#1)(2007-11#1)
Probably the##3##2##(1996-11#1)(2006-10#1)(2008-7#1)
Probably##15##1##(1992-11#1)(1993-11#1)(1995-8#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
Probe##10##1##(2008-10#2)(2008-3#2)(2008-4#2)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)
Probed##2##1##(1996-9#1)(2007-1#1)
Probes for##2##2##(2006-6#1)(2008-10#1)
Probes##7##1##(1990-11#1)(1992-6#1)(2006-6#1)(2008-10#3)(2013-1#1)
Probing RNA##2##2##(2008-4#2)
Probing of##2##2##(2008-7#1)(2008-8#1)
Probing the##4##2##(1990-7#1)(2007-11#1)(2009-9#1)(2013-1#1)
Probing with##2##2##(2008-10#2)
Probing##21##1##(1990-7#1)(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#1)
Probiotics and##7##2##(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
Probiotics are##2##2##(2008-10#1)(2013-8#1)
Probiotics##12##1##(2008-10#2)(2008-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
Probit##4##1##(1992-2#1)(2008-10#1)(2009-4#1)(2011-1#1)
Problem Behaviors##2##2##(2008-9#1)(2009-7#1)
Problem lists in letters##4##4##(1993-2#4)
Problem of##5##2##(1992-8#1)(2007-11#1)(2008-2#2)(2012-2#1)
Problem##30##1##(1992-8#1)(1993-1#1)(1993-2#4)(1995-3#1)(1996-12#1)(2007-11#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#5)(2013-1#2)
Problem-based Learning##2##2##(2008-12#2)
Problem-based learning##2##2##(2008-12#1)(2011-1#1)
Problem-based##4##1##(2008-12#3)(2011-1#1)
Problem-solving##2##1##(2012-1#1)(2012-3#1)
Problems are##3##2##(1997-2#1)(2008-11#1)(2011-1#1)
Problems encountered in##2##3##(1991-12#1)(2008-3#1)
Problems in the treatment of##2##5##(2007-11#2)
Problems in the##3##3##(1997-3#1)(2007-11#2)
Problems in##8##2##(1991-3#1)(1997-3#1)(2007-11#3)(2008-11#1)(2012-12#1)(2013-1#1)
Problems of##8##2##(1991-1#3)(1995-9#1)(1996-9#1)(2008-10#2)(2013-8#1)
Problems with the##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
Problems with##6##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
Problems##49##1##(1991-1#4)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-2#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-3#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-3#3)(2008-4#1)(2008-9#1)(2009-6#2)(2010-12#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Proc##26##1##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#2)(1997-2#1)(2006-4#1)
Procalcitonin (PCT)##2##2##(2008-5#2)
Procalcitonin for##3##2##(2008-5#3)
Procalcitonin in##3##2##(2008-5#3)
Procalcitonin##10##1##(2008-5#9)(2011-2#1)
Procalcitonin-a new##2##2##(2008-5#2)
Procalcitonin-a##3##1##(2008-5#3)
Procambarus clarkii##3##2##(2008-5#1)(2008-6#2)
Procedural##2##1##(2008-10#1)(2008-2#1)
Procedure for##2##2##(2008-10#2)
Procedure##11##1##(1991-3#1)(1995-12#1)(2008-10#3)(2010-7#1)(2010-8#1)(2011-2#4)
Procedures are described##2##3##(2008-1#1)(2008-10#1)
Procedures are##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
Procedures describing##2##2##(2008-9#2)
Procedures for the##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
Procedures for##10##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#2)
Procedures to##2##2##(1996-12#1)(2008-2#1)
Procedures##33##1##(1992-3#1)(1993-3#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-4#4)(2008-7#4)(2008-9#4)(2009-11#1)(2010-12#1)(2012-3#5)(2013-1#1)
Proceedings and abstracts of the##3##5##(2008-9#1)(2009-9#1)(2013-1#1)
Proceedings of a conference##9##4##(1992-12#1)(1992-3#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-8#1)(2008-8#1)
Proceedings of a##14##3##(1991-12#1)(1992-12#1)(1992-3#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-8#1)(2008-6#1)(2008-8#1)(2012-1#2)
Proceedings of an international##2##4##(1993-1#1)(1995-9#1)
Proceedings of the 1st##2##4##(2008-4#1)(2008-6#1)
Proceedings of the 2010##2##4##(2011-2#2)
Proceedings of the 5th##2##4##(2008-5#1)(2011-2#1)
Proceedings of the Seventh##2##4##(2011-2#1)(2013-8#1)
Proceedings of the Third International##2##5##(2008-7#1)(2011-2#1)
Proceedings of the##30##3##(1991-1#2)(1992-3#1)(1994-1#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Proceedings of##46##2##(1991-1#2)(1991-12#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-1#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#8)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Proceedings##53##1##(1990-11#1)(1991-1#2)(1991-12#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#8)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Process Strategy Teams##3##3##(1996-1#3)
Process cheese##3##2##(2008-10#3)
Process for##2##2##(1996-5#1)(1997-7#1)
Process##112##1##(1991-12#2)(1991-6#1)(1991-9#2)(1993-12#1)(1994-7#1)(1996-1#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-7#1)(2008-10#10)(2008-11#9)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#8)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#11)(2012-2#15)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#11)
Processes and##5##2##(1992-12#1)(2008-10#1)(2008-6#1)(2010-10#1)(2012-2#1)
Processes of##3##2##(2008-12#1)(2012-2#1)(2012-3#1)
Processes##18##1##(1992-12#1)(1996-12#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-3#1)(2012-2#2)(2012-3#1)
Processing and analysis of image data require very different methods than those used in flow cytometry##2##16##(2008-9#2)
Processing and##4##2##(2008-3#1)(2008-9#3)
Processing of##10##2##(1994-11#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-11#2)(2009-6#1)(2010-5#1)(2011-1#1)
Processing##43##1##(1994-11#1)(1995-6#1)(1995-8#1)(1997-3#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
Procrustes rotation##3##2##(2008-10#2)(2008-11#1)
Procrustes##4##1##(2008-10#3)(2008-11#1)
Procter##2##1##(2008-5#2)
Prodromal##2##1##(2008-3#1)(2011-8#1)
Produced by##7##2##(1991-12#1)(2008-10#5)(2008-3#1)
Producer##2##1##(1992-3#1)(2008-11#1)
Produces##4##1##(2008-10#3)(2010-8#1)
Producing##6##1##(1997-1#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
Product Line Management##3##3##(1993-12#3)
Product##7##1##(1993-12#4)(1994-3#1)(2008-10#1)(2010-2#1)
Production and characterization of a##2##5##(1993-2#1)(2008-8#1)
Production and characterization of##5##4##(1992-2#1)(1993-2#1)(2007-12#1)(2008-6#1)(2008-8#1)
Production and purification of##4##4##(1997-4#1)(2008-11#1)(2008-6#2)
Production and##20##2##(1992-2#1)(1992-8#1)(1993-2#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#3)(2008-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
Production by Fusarium##2##3##(2008-10#2)
Production by Pseudomonas##2##3##(2008-10#2)
Production by##8##2##(2008-10#7)(2013-1#1)
Production for##2##2##(1996-9#1)(2008-11#1)
Production in##6##2##(1996-9#1)(2008-10#4)(2011-2#1)
Production of a##8##3##(1992-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
Production of antibodies that recognize specific tyrosine-phosphorylated peptides##2##8##(2008-1#1)(2008-4#1)
Production of interferon-beta by##2##4##(2008-11#2)
Production of interferon-beta##3##3##(2008-11#3)
Production of lipases by##2##4##(2008-8#2)
Production of monoclonal antibodies##3##4##(1994-9#1)(2008-11#1)(2008-9#1)
Production of recombinant human##2##4##(2008-12#1)(2008-7#1)
Production of recombinant##5##3##(1993-6#1)(2008-11#1)(2008-12#1)(2008-7#2)
Production of secondary conidia##2##4##(2008-10#2)
Production of secondary##3##3##(2008-10#3)
Production of the##5##3##(2008-10#5)
Production of##104##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#3)(1996-7#1)(1997-2#2)(1997-4#2)(2007-1#1)(2008-1#1)(2008-10#30)(2008-11#13)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#11)(2008-7#2)(2008-8#4)(2008-9#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
Production##163##1##(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#3)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#3)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#53)(2008-11#19)(2008-12#2)(2008-4#4)(2008-5#1)(2008-6#14)(2008-7#2)(2008-8#5)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#8)(2013-1#6)(2013-8#1)
Productive##2##1##(1996-12#1)(2008-9#1)
Productivity and##3##2##(2007-5#2)(2011-2#1)
Productivity enhancement##3##2##(1991-3#2)(2008-11#1)
Productivity in##2##2##(2011-2#1)(2013-1#1)
Productivity ranged from##2##3##(2007-5#1)(2008-5#1)
Productivity##22##1##(1991-3#2)(1992-2#1)(1996-1#1)(2007-5#5)(2008-10#1)(2008-11#5)(2008-5#2)(2008-8#1)(2011-2#3)(2013-1#1)
Products &amp##5##2##(1992-2#1)(1992-7#1)(1994-9#1)(1995-3#1)(1995-6#1)
Products for##2##2##(2007-10#1)(2011-1#1)
Products in##2##2##(2012-2#1)(2012-3#1)
Products of the##2##3##(1990-12#1)(2008-7#1)
Products of##6##2##(1990-12#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
Products were##2##2##(1992-12#1)(2008-5#1)
Products with##2##2##(1996-11#1)(2011-2#1)
Products##33##1##(1990-12#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-11#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-8#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
Prof##20##1##(1990-10#1)(1990-6#1)(1991-6#1)(2007-11#1)(2007-8#2)(2008-10#12)(2008-8#1)(2010-10#1)
Profession##2##1##(2008-11#1)(2012-3#1)
Professional Library##3##2##(1995-2#1)(1996-2#2)
Professional confidence##2##2##(2008-11#1)(2008-12#1)
Professional identity##2##2##(1993-3#2)
Professional##32##1##(1990-10#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#2)(1997-3#1)(2007-3#2)(2008-11#4)(2008-12#3)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#3)
Professionalism##4##1##(1991-3#1)(1992-1#1)(2012-1#1)(2013-1#1)
Professionals##2##1##(2010-1#2)
Professor Abeles##4##2##(2008-5#4)
Professor Chiranjeevi was given the opportunity to respond to these allegations##3##11##(2008-10#3)
Professor Chiranjeevi##7##2##(2008-10#7)
Professor of##7##2##(1993-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)
Professor##45##1##(1990-8#1)(1992-5#1)(1993-12#2)(1996-4#1)(1997-2#1)(2007-12#3)(2008-10#13)(2008-12#1)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
Profile measurement taken with liquid-crystal gratings##2##6##(2008-3#2)
Profile of Patients with##2##4##(2009-10#1)(2012-3#1)
Profile of a##2##3##(1996-3#1)(2007-12#1)
Profile of the##2##3##(2013-7#1)(2013-8#1)
Profile of##19##2##(1993-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-7#3)(2008-3#1)(2008-7#2)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
Profile##42##1##(1991-6#1)(1993-2#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-2#1)(2007-12#2)(2007-7#3)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-6#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
Profiles and##2##2##(2008-3#1)(2012-2#1)
Profiles of log##2##3##(1991-9#2)
Profiles of##5##2##(1991-9#2)(2008-10#1)(2008-3#1)(2011-1#1)
Profiles##13##1##(1991-9#2)(2008-10#3)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
Profiling of##2##2##(2008-1#1)(2013-1#1)
Profiling##11##1##(1996-1#1)(1997-2#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-12#1)(2013-1#2)
Profilometry##2##1##(2008-3#2)
Profits##2##1##(1991-3#1)(1994-3#1)
Prog##23##1##(1992-6#1)(2011-2#22)
Progenitor Cells##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
Progenitor##5##1##(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2013-1#1)
Progeny from##2##2##(2008-10#2)
Progeny of##3##2##(2008-10#2)(2008-5#1)
Progeny virus derived from##2##4##(2008-10#2)
Progeny##15##1##(1994-12#1)(2008-10#12)(2008-5#2)
Progeria##3##1##(2007-8#2)(2011-2#1)
Progesterone and##2##2##(1993-11#1)(1995-11#1)
Progesterone##7##1##(1990-11#2)(1991-9#1)(1993-11#1)(1995-11#1)(2008-12#1)(2008-4#1)
Prognosis is##3##2##(2007-8#1)(2008-7#1)(2012-12#1)
Prognosis of##3##2##(1997-5#1)(2008-7#1)(2012-12#1)
Prognosis##10##1##(1997-5#1)(1997-8#1)(2007-8#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-12#2)(2012-3#1)
Prognostic Index##3##2##(2007-5#1)(2010-11#1)(2011-2#1)
Prognostic Scoring System##3##3##(2009-2#1)(2010-11#2)
Prognostic Significance##2##2##(1994-7#1)(2008-10#1)
Prognostic Value##2##2##(2011-2#1)(2013-1#1)
Prognostic factors and##2##3##(2012-3#1)(2013-8#1)
Prognostic factors for local control##2##5##(2010-3#2)
Prognostic factors for survival##2##4##(2010-3#2)
Prognostic factors for##4##3##(2010-3#4)
Prognostic factors in##3##3##(1990-6#1)(1992-2#1)(2010-3#1)
Prognostic factors##11##2##(1990-6#1)(1992-2#1)(2008-10#1)(2009-4#1)(2010-3#5)(2012-3#1)(2013-8#1)
Prognostic impact of##2##3##(1990-8#1)(2011-2#1)
Prognostic indicators##2##2##(1993-11#1)(2008-11#1)
Prognostic or risk models##2##4##(2008-7#2)
Prognostic significance of##5##3##(1993-1#1)(1993-9#1)(2008-12#1)(2008-7#2)
Prognostic significance##6##2##(1993-1#1)(1993-9#1)(2008-10#1)(2008-12#1)(2008-7#2)
Prognostic value of##8##3##(1991-4#1)(1993-11#1)(1995-9#1)(1997-7#1)(1997-8#1)(2009-4#1)(2010-4#1)(2012-12#1)
Prognostic##53##1##(1990-6#1)(1990-8#1)(1991-4#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-7#1)(1995-4#2)(1995-9#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#4)(2009-2#1)(2009-4#2)(2010-11#5)(2010-3#5)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
Program Evaluation##2##2##(1995-12#1)(2008-7#1)
Program at##2##2##(1994-3#1)(1997-2#1)
Program between##2##2##(1990-10#1)(1993-3#1)
Program development##2##2##(1994-2#1)(2009-11#1)
Program for Women##2##3##(1996-12#2)
Program for##15##2##(1991-1#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-12#2)(2008-12#2)(2008-6#1)(2010-1#1)(2012-3#1)(2013-1#4)
Program has##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
Program in##8##2##(1991-1#1)(1991-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-9#3)
Program is to##2##3##(2008-7#1)(2012-2#1)
Program is##4##2##(1994-3#1)(1997-1#1)(2008-7#1)(2012-2#1)
Program management##2##2##(1994-12#1)(1995-2#1)
Program of the##3##3##(1994-12#1)(1996-12#1)(2012-3#1)
Program of##6##2##(1991-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-5#1)(2012-3#1)
Program on##3##2##(1991-12#1)(1991-8#1)(2011-2#1)
Program to##3##2##(1991-2#1)(2007-12#1)(2012-3#1)
Program was##5##2##(1990-10#1)(1997-4#1)(2008-3#2)(2013-1#1)
Program##180##1##(1990-10#2)(1990-2#1)(1991-1#3)(1991-12#6)(1991-2#8)(1991-8#2)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#4)(1994-2#4)(1994-3#7)(1995-1#1)(1995-12#5)(1995-2#4)(1996-1#3)(1996-12#6)(1996-2#4)(1996-3#1)(1997-1#7)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(2007-12#6)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#5)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#11)(2013-8#5)
Program]##2##1##(1990-10#1)(2008-1#1)
Programmable##3##1##(2008-3#1)(2008-7#1)(2009-10#1)
Programmatic##2##1##(2010-5#1)(2012-2#1)
Programme are##2##2##(2008-10#1)(2009-5#1)
Programme in##5##2##(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-4#1)
Programme on Functional Genomics##2##4##(2008-7#2)
Programme on##5##2##(2008-7#5)
Programme##37##1##(1996-1#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-5#4)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-7#1)
Programmed Cell Death##2##3##(2008-10#1)(2012-2#1)
Programmed cell death##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
Programmed##8##1##(2008-10#2)(2008-8#1)(2009-10#1)(2012-1#1)(2012-2#1)(2012-3#2)
Programmes##3##1##(2009-7#1)(2011-2#2)
Programming of##2##2##(1996-5#1)(2008-10#1)
Programming##4##1##(1996-5#1)(2007-12#1)(2008-10#1)(2009-11#1)
Programs for##2##2##(1997-7#1)(2012-12#1)
Programs##15##1##(1991-1#2)(1992-1#2)(1992-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-7#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
Progress and##3##2##(1995-5#1)(2009-12#1)(2011-3#1)
Progress has been made##2##4##(2006-10#1)(2008-10#1)
Progress in Purinergic Receptor Pharmacology and Function&quot##2##7##(2008-4#2)
Progress in anaesthesiology and intensive care medicine&quot##2##7##(2009-5#2)
Progress in the##5##3##(2007-11#1)(2007-8#1)(2008-6#1)(2010-10#1)(2011-1#1)
Progress in understanding##2##3##(2008-10#1)(2008-6#1)
Progress in##21##2##(1996-4#1)(1997-1#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#2)(2010-10#2)(2011-1#1)(2012-3#1)
Progress of##3##2##(1996-6#1)(2008-10#2)
Progress##42##1##(1995-5#2)(1995-6#1)(1996-4#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#2)(2010-10#4)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
Progressing##2##1##(2009-12#1)(2013-8#1)
Progression by##2##2##(2008-10#1)(2013-1#1)
Progression in##2##2##(1996-6#1)(2010-9#1)
Progression of##7##2##(2008-10#2)(2010-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
Progression##17##1##(1996-6#2)(2008-10#3)(2010-1#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
Progressive loss of##2##3##(1990-7#1)(1994-5#1)
Progressive sensorineural##2##2##(2008-7#1)(2011-1#1)
Progressive##27##1##(1990-3#1)(1990-7#2)(1992-12#1)(1992-5#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
Prohibition of##2##2##(1990-2#1)(1990-6#1)
Proinflammatory cytokines##2##2##(1997-7#1)(2011-2#1)
Proinflammatory##3##1##(1997-7#1)(2008-10#1)(2011-2#1)
Project 2000##5##2##(2008-11#4)(2008-12#1)
Project and the##2##3##(1991-8#1)(2011-1#1)
Project and##3##2##(1991-8#1)(1995-2#1)(2011-1#1)
Project for##2##2##(1995-3#1)(2013-8#1)
Project has##2##2##(2007-7#2)
Project in##3##2##(1992-1#1)(1992-2#2)
Project##81##1##(1991-1#1)(1991-8#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-12#2)(1993-3#3)(1993-8#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#3)
Project)##2##1##(2007-10#1)(2008-7#1)
Project--a##2##1##(1994-9#1)(1996-2#1)
Project]##2##1##(2007-3#1)(2012-3#1)
Projected##4##1##(1993-1#1)(2008-2#1)(2008-3#1)(2010-8#1)
Projection of##2##2##(1992-10#1)(2008-10#1)
Projection##4##1##(1992-10#1)(2008-10#1)(2008-2#1)(2012-2#1)
Projections of##2##2##(1992-3#1)(2008-9#1)
Projections##5##1##(1992-3#1)(1992-9#1)(1993-12#1)(2008-9#1)(2011-2#1)
Projects##7##1##(1993-1#1)(2008-10#2)(2008-2#1)(2008-3#3)
Prokaryotic##3##1##(2008-4#1)(2011-1#1)(2012-3#1)
Prolactin (PRL)##2##2##(1994-3#1)(2011-2#1)
Prolactin##5##1##(1994-3#1)(1994-6#1)(1997-7#1)(2008-4#1)(2011-2#1)
Proliferating##3##1##(1992-2#1)(1994-8#1)(2011-1#1)
Proliferation and##4##2##(2007-12#1)(2008-6#1)(2010-6#1)(2010-8#1)
Proliferation of##8##2##(1993-3#1)(1993-6#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Proliferation##22##1##(1993-3#1)(1993-6#1)(1993-9#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#3)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#1)
Proliferative activity##3##2##(2008-6#3)
Proliferative index##2##2##(2008-6#2)
Proliferative##11##1##(1991-9#1)(1994-12#1)(1997-3#1)(2008-1#1)(2008-4#1)(2008-6#5)(2011-1#1)
Proline##2##1##(1991-12#1)(2012-8#1)
Prolongation of##2##2##(2008-10#1)(2008-11#1)
Prolonged development##2##2##(2008-9#2)
Prolonged exposure##2##2##(1995-5#1)(2008-8#1)
Prolonged survival##3##2##(2008-7#2)(2009-2#1)
Prolonged treatment##2##2##(1991-12#1)(2011-2#1)
Prolonged##39##1##(1990-12#1)(1990-3#2)(1990-7#1)(1991-12#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#1)(2010-1#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
Prominent##3##1##(1994-5#1)(2008-12#1)(2012-1#1)
Promise##2##1##(2009-8#1)(2011-2#1)
Promising Practices##2##2##(2009-3#2)
Promising##10##1##(1990-9#1)(1994-5#1)(2008-10#2)(2008-11#1)(2009-3#2)(2011-1#1)(2011-2#1)(2013-1#1)
Promote##2##1##(2008-12#1)(2009-11#1)
Promoter regions##2##2##(1993-9#1)(1995-6#1)
Promoter##10##1##(1991-9#1)(1993-9#2)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
Promotes##3##1##(2006-11#1)(2008-10#1)(2013-7#1)
Promoting effect of##2##3##(2008-11#1)(2008-8#1)
Promoting evidence-based##2##2##(2008-11#1)(2011-2#1)
Promoting the##2##2##(2008-12#1)(2010-9#1)
Promoting##27##1##(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-1#1)(1996-1#1)(2008-11#6)(2008-12#2)(2008-8#2)(2009-6#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#1)
Promotion and##3##2##(1991-1#1)(1994-3#1)(2008-1#1)
Promotion of##5##2##(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
Promotion##12##1##(1990-7#1)(1991-1#1)(1994-3#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2011-1#1)(2013-1#1)(2013-8#1)
Prompt diagnosis and##2##3##(2008-7#1)(2011-2#1)
Prompt##9##1##(1994-11#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
Prompted by the##3##3##(1993-9#1)(2006-10#1)(2008-8#1)
Pronase E##2##2##(1994-11#2)
Pronephrium simplex##2##2##(2008-10#2)
Pronounced##4##1##(1992-6#1)(1995-8#1)(2007-12#1)(2008-2#1)
Proof##2##1##(2008-7#1)(2011-9#1)
Propagation of##9##2##(1997-7#1)(2007-12#3)(2008-3#3)(2008-7#1)(2008-8#1)
Propagation##16##1##(1996-8#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
Propagule densities of##2##3##(2008-10#2)
Propagule##3##1##(2008-10#2)(2008-8#1)
Propanil##2##1##(2008-10#2)
Propensity score##2##2##(2011-1#2)
Propensity##3##1##(2011-1#2)(2012-2#1)
Proper alignment and adjustment of the light microscope##3##8##(2008-4#2)(2008-9#1)
Proper knowledge of##2##3##(1997-4#1)(2008-7#1)
Proper##35##1##(1991-12#1)(1993-2#1)(1995-12#2)(1995-3#1)(1995-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Properly##3##1##(1991-12#1)(2011-2#1)(2013-8#1)
Properties and##3##2##(1995-3#1)(2008-11#1)(2013-1#1)
Properties of a##7##3##(1991-5#1)(1993-11#1)(2008-10#4)(2009-9#1)
Properties of the##7##3##(1996-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
Properties of##36##2##(1991-5#1)(1992-1#1)(1993-11#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-7#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-8#1)
Properties##46##1##(1991-5#1)(1992-1#1)(1993-11#1)(1995-3#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#3)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
Prophylactic##14##1##(1991-3#2)(1992-8#1)(1993-10#1)(1997-4#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-7#2)(2013-1#2)
Prophylaxis##5##1##(2007-12#2)(2009-10#1)(2010-7#1)(2012-2#1)
Propiconazole##2##1##(1991-6#1)(2008-10#1)
Propofol and postoperative infections##3##4##(1995-11#3)
Propofol and##6##2##(1993-1#1)(1995-11#3)(2010-7#2)
Propofol##8##1##(1993-1#1)(1995-11#3)(2010-7#2)(2012-3#2)
Propolis##4##1##(2008-10#4)
Proponents of##3##2##(1995-2#1)(2008-11#1)(2008-6#1)
Proponents##4##1##(1995-2#1)(1996-5#1)(2008-11#1)(2008-6#1)
Proportion of##5##2##(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-2#1)
Proportion##6##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-2#1)
Proportional##3##1##(2008-8#1)(2011-2#1)(2012-3#1)
Proportions of##2##2##(1992-6#1)(2011-2#1)
Proportions##4##1##(1992-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
Proposal for a##2##3##(2008-7#1)(2013-8#1)
Proposal for##5##2##(1990-5#1)(1995-11#1)(2008-2#1)(2008-7#1)(2013-8#1)
Proposal of an##2##3##(1992-6#1)(2008-10#1)
Proposal of##3##2##(1992-6#1)(1996-6#1)(2008-10#1)
Proposal##9##1##(1990-5#1)(1992-6#1)(1995-11#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
Proposals for##3##2##(1992-6#1)(2007-5#1)(2009-5#1)
Proposals to##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
Proposals##8##1##(1991-2#1)(1991-3#1)(1992-6#1)(1996-3#1)(2007-5#1)(2008-10#1)(2009-5#1)(2011-2#1)
Proposed here is a##3##4##(2010-8#3)
Proposed here is##4##3##(2010-8#4)
Proposed mechanisms##2##2##(2008-5#1)(2010-3#1)
Proposed method##2##2##(2008-10#1)(2010-5#1)
Proposed model##2##2##(2010-8#2)
Proposed##19##1##(1994-2#1)(1996-3#2)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#7)
Propranolol##4##1##(1992-5#1)(1994-5#1)(2008-12#1)(2013-8#1)
Proprietary##2##1##(1996-2#1)(2008-5#1)
Proprioception##2##1##(2007-11#2)
Proptosis##2##1##(2008-7#1)(2008-8#1)
Prorhinotermes simplex##4##2##(2007-12#4)
Prorocentrum##2##1##(2008-5#2)
Pros##2##1##(2012-2#2)
Prosopis strombulifera##2##2##(2012-7#2)
Prosopis##3##1##(2012-7#2)(2013-1#1)
Prospect##3##1##(1994-1#1)(2010-8#2)
Prospective Cohort Study##2##3##(2010-5#1)(2013-1#1)
Prospective Cohort##3##2##(2010-5#1)(2013-1#2)
Prospective Randomized##2##2##(2008-6#1)(2012-3#1)
Prospective Study##2##2##(2008-1#2)
Prospective cohort study of##2##4##(2013-1#2)
Prospective cohort##3##2##(2013-1#2)(2013-8#1)
Prospective evaluation of##4##3##(2008-7#1)(2011-2#1)(2012-1#2)
Prospective evaluation##5##2##(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#2)
Prospective memory##2##2##(2013-7#2)
Prospective multicentre##2##2##(1992-2#1)(2008-4#1)
Prospective randomized##2##2##(2006-10#1)(2013-1#1)
Prospective studies##4##2##(1997-6#1)(2007-10#1)(2008-1#1)(2012-12#1)
Prospective study of##2##3##(1997-3#1)(2008-11#1)
Prospective study##4##2##(1995-9#1)(1997-3#1)(2008-11#1)(2011-2#1)
Prospective##44##1##(1992-1#1)(1992-2#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
Prospectively collected##2##2##(2008-3#1)(2013-1#1)
Prospects for##9##2##(1991-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
Prospects##10##1##(1991-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
Prospero is distributed unequally##2##4##(2008-7#2)
Prospero is present##2##3##(2008-7#2)
Prospero is##6##2##(2008-7#6)
Prospero##10##1##(2008-7#10)
Prostacyclin analogs##2##2##(2008-10#1)(2008-11#1)
Prostacyclin##4##1##(1992-6#1)(1994-5#1)(2008-10#1)(2008-11#1)
Prostaglandin E##2##2##(1994-6#1)(2012-2#1)
Prostaglandin E(2)##2##2##(2008-4#1)(2008-7#1)
Prostaglandin E2##5##2##(1990-12#1)(1993-11#1)(1993-12#1)(1995-12#2)
Prostaglandin F2 alpha##2##3##(1990-8#2)
Prostaglandin##16##1##(1990-11#1)(1990-12#1)(1990-8#2)(1993-11#1)(1993-12#1)(1994-6#2)(1995-12#2)(1996-2#1)(1997-7#1)(2008-4#2)(2008-7#1)(2012-2#1)
Prostaglandins##2##1##(1996-2#1)(2008-11#1)
Prostate Cancer##5##2##(2008-6#1)(2009-5#1)(2012-12#2)(2013-1#1)
Prostate Tumor##2##2##(2011-2#1)(2012-12#1)
Prostate cancer is a##4##4##(2010-12#1)(2011-2#3)
Prostate cancer is the most##2##5##(1995-11#1)(2008-5#1)
Prostate cancer is the##3##4##(1995-11#1)(2008-5#1)(2009-5#1)
Prostate cancer is##8##3##(1995-11#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#3)(2013-1#1)
Prostate cancer screening in African American##2##6##(2008-4#1)(2009-5#1)
Prostate cancer screening##3##3##(2007-10#1)(2008-4#1)(2009-5#1)
Prostate cancer##19##2##(1992-2#1)(1994-3#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-4#2)(2008-5#1)(2009-5#3)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#2)
Prostate##34##1##(1992-2#1)(1994-3#1)(1995-11#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-5#5)(2010-11#1)(2010-12#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#4)
Prostate-specific antigen (PSA) was##2##4##(1990-9#1)(2008-4#1)
Prostate-specific antigen##3##2##(1990-9#1)(2008-4#1)(2010-12#1)
Prostate-specific##5##1##(1990-9#1)(1997-5#1)(2008-4#2)(2010-12#1)
Prostatic acid phosphatase##2##3##(1990-9#1)(2008-12#1)
Prostatic##4##1##(1990-9#1)(2008-10#1)(2008-12#2)
Prostatitis##2##1##(2008-10#1)(2011-1#1)
Prostheses##3##1##(2009-1#2)(2013-1#1)
Prosthesis##2##1##(2008-1#1)(2013-1#1)
Prosthetic##5##1##(2007-12#2)(2008-4#1)(2011-2#1)(2013-1#1)
Prosthetics##2##1##(2007-11#1)(2010-3#1)
ProtEx stationary phases##2##3##(1997-2#2)
ProtEx##3##1##(1997-2#3)
Protease Inhibition##2##2##(2008-5#2)
Protease Inhibitors##2##2##(1992-12#1)(1996-5#1)
Protease inhibition##2##2##(1992-12#2)
Protease##16##1##(1991-2#1)(1992-12#3)(1992-8#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-12#1)
Proteases and##2##2##(1992-12#1)(2009-10#1)
Proteases in##2##2##(2012-3#2)
Proteases##4##1##(1992-12#1)(2009-10#1)(2012-3#2)
Proteasome##2##1##(2008-5#1)(2008-8#1)
Protect##8##1##(2008-10#3)(2008-12#1)(2010-6#1)(2012-2#1)(2012-3#2)
Protected##5##1##(1996-2#1)(2007-5#1)(2008-5#1)(2009-9#1)(2013-1#1)
Protecting our gifts and securing our future##2##7##(2008-11#2)
Protecting our##3##2##(1997-7#1)(2008-11#2)
Protecting the##4##2##(1990-7#1)(1994-5#1)(2008-5#1)(2009-4#1)
Protecting##15##1##(1990-7#1)(1994-5#1)(1995-12#2)(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
Protection Act##4##2##(1991-12#1)(1996-8#2)(1997-5#1)
Protection Against##5##2##(2008-10#4)(2009-8#1)
Protection Agency (EPA)##8##3##(1992-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)
Protection Agency##14##2##(1992-1#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#3)(2010-5#1)(2013-1#1)
Protection Program##2##2##(1990-2#1)(1995-2#1)
Protection against##6##2##(1995-8#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-5#1)
Protection and##5##2##(1994-12#1)(1995-1#1)(1995-2#2)(2011-1#1)
Protection by##2##2##(1993-8#1)(1994-8#1)
Protection from##2##2##(1996-10#1)(2008-5#1)
Protection in##2##2##(2008-10#2)
Protection is##3##2##(1992-11#1)(1995-2#1)(2008-7#1)
Protection of##9##2##(1990-5#1)(1992-12#1)(1993-9#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)
Protection was##3##2##(1994-5#1)(2008-10#1)(2011-2#1)
Protection##76##1##(1990-2#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#6)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-5#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-5#5)(2008-7#5)(2008-9#5)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Protective Effect of##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
Protective effect of##5##3##(1995-12#1)(2008-11#1)(2010-11#1)(2010-2#1)(2012-2#1)
Protective effect##6##2##(1992-5#1)(1995-12#1)(2008-11#1)(2010-11#1)(2010-2#1)(2012-2#1)
Protective effects of##5##3##(1994-11#1)(1995-6#1)(2008-5#1)(2010-5#1)(2011-1#1)
Protective immunity##2##2##(1995-12#1)(1995-2#1)
Protective##30##1##(1991-1#1)(1992-5#1)(1992-9#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#2)(1997-6#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)
Protects##2##1##(2008-10#1)(2009-12#1)
Protein A##2##2##(1990-12#1)(2008-10#1)
Protein C##2##2##(2007-12#1)(2008-12#1)
Protein Crystallization##2##2##(2007-5#1)(2008-10#1)
Protein Data Bank (PDB)##2##4##(2008-4#1)(2011-3#1)
Protein Data Bank##5##3##(2008-4#3)(2011-3#2)
Protein Folding##2##2##(1996-12#2)
Protein G##2##2##(1990-12#1)(2008-11#1)
Protein Gene##6##2##(2008-10#5)(2013-1#1)
Protein Kinase##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
Protein and##9##2##(1994-7#1)(2008-10#4)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
Protein carbonyl##2##2##(2008-3#2)
Protein concentration##2##2##(1997-2#1)(2008-7#1)
Protein databases have become a crucial part of modern biology##2##10##(2008-2#1)(2008-4#1)
Protein databases on the internet##2##5##(2008-2#1)(2008-4#1)
Protein databases##4##2##(2008-2#2)(2008-4#2)
Protein disulfide##2##2##(1995-3#1)(2011-2#1)
Protein farnesyltransferase##3##2##(1993-11#1)(1993-9#1)(2008-5#1)
Protein folding##3##2##(1994-12#1)(2009-9#1)(2010-4#1)
Protein from##3##2##(2008-10#2)(2010-12#1)
Protein glycosylation##2##2##(2010-11#1)(2010-12#1)
Protein identification##2##2##(1993-8#1)(2008-4#1)
Protein in##3##2##(1994-7#1)(2008-10#2)
Protein interactions##2##2##(2008-4#1)(2008-7#1)
Protein kinase C (PKC) is##2##5##(1992-9#1)(1995-2#1)
Protein kinase C (PKC)##3##4##(1992-9#1)(1994-11#1)(1995-2#1)
Protein kinase C activity##2##4##(1990-2#1)(1993-8#1)
Protein kinase C and exocytosis in Mammalian spermatozoa##2##8##(2008-4#2)
Protein kinase C and##3##4##(2008-4#3)
Protein kinase C in##2##4##(1996-5#2)
Protein kinase C##18##3##(1990-2#1)(1990-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-2#2)(1996-5#2)(1997-1#1)(2008-4#3)(2013-1#1)
Protein kinase##22##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-2#2)(1996-5#2)(1997-1#1)(2008-4#3)(2008-8#1)(2012-3#1)(2013-1#1)
Protein of Apple chlorotic leaf spot virus##2##7##(2008-10#2)
Protein of##4##2##(2008-10#4)
Protein phosphatase inhibitors are useful when deciphering physiological events regulated by reversible protein phosphorylation but the hormonal stimuli or signaling pathways involved are not known##2##25##(2008-2#1)(2008-4#1)
Protein phosphatase inhibitors##3##3##(1994-11#1)(2008-2#1)(2008-4#1)
Protein phosphorylation##2##2##(1995-12#1)(2009-5#1)
Protein profiles##2##2##(1997-8#1)(2008-10#1)
Protein profiling##2##2##(2008-4#2)
Protein synthesis in##2##3##(1994-5#1)(2008-11#1)
Protein synthesis was##2##3##(1992-11#1)(1994-11#1)
Protein synthesis##7##2##(1991-2#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-5#1)(1997-7#1)(2008-11#1)
Protein tyrosine##2##2##(1995-8#1)(2009-6#1)
Protein##238##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-5#1)(1994-7#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#41)(2008-11#15)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#21)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#5)(2011-3#4)(2012-1#2)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#10)
Protein)##2##1##(2008-11#1)(2012-1#1)
Protein-A##2##1##(1993-8#1)(2008-10#1)
Protein-DNA##3##1##(2008-2#2)(2008-7#1)
Protein-bound##2##1##(1991-12#2)
Protein-protein##2##1##(2008-2#1)(2008-9#1)
Protein-tyrosine kinase p72syk is activated by##2##6##(1992-6#1)(1993-11#1)
Proteins Associated with##2##3##(2008-10#1)(2010-11#1)
Proteins and##2##2##(2008-5#1)(2010-8#1)
Proteins are##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
Proteins from##3##2##(1996-5#1)(2009-5#1)(2010-12#1)
Proteins in##4##2##(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
Proteins of##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
Proteins that##4##2##(1993-9#1)(2008-1#1)(2008-11#1)(2010-11#1)
Proteins were##5##2##(1996-1#2)(2008-7#1)(2010-12#1)(2012-3#1)
Proteins##62##1##(1990-7#1)(1991-12#2)(1991-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-5#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
Proteolipid protein##2##2##(1993-6#2)
Proteolysis of##4##2##(1990-7#1)(1992-11#1)(1995-6#2)
Proteolytic activation of##2##3##(1990-7#1)(1992-12#1)
Proteolytic and keratinolytic activities##2##4##(2008-6#2)
Proteolytic cleavage of##2##3##(1992-11#1)(1996-12#1)
Proteolytic processing of##2##3##(1990-12#1)(1992-6#1)
Proteolytic##13##1##(1990-12#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-12#3)(1992-6#1)(1995-11#1)(1996-12#1)(2008-6#2)(2013-8#1)
Proteome analysis##2##2##(2008-7#1)(2010-12#1)
Proteome##6##1##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)
Proteomic Analysis of##2##3##(2010-11#1)(2012-12#1)
Proteomic analyses##2##2##(2008-8#1)(2008-9#1)
Proteomic analysis in##2##3##(2008-12#1)(2010-12#1)
Proteomic analysis of##3##3##(2008-7#1)(2008-9#1)(2009-10#1)
Proteomic analysis##8##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)
Proteomic profiling of##3##3##(2008-11#1)(2010-12#2)
Proteomic profiling##4##2##(2008-11#1)(2010-12#3)
Proteomic##23##1##(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#7)(2010-9#1)(2012-12#1)
Proteomics Standards Initiative##5##3##(2008-7#5)
Proteomics and##2##2##(2008-4#1)(2012-2#1)
Proteomics##16##1##(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#7)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
Proteus mirabilis##3##2##(2008-10#1)(2009-6#1)(2010-6#1)
Proteus##9##1##(1994-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2009-6#1)(2010-4#2)(2010-6#1)
Prothrombin##2##1##(1991-11#1)(2012-12#1)
ProtoNet-3D##2##1##(2008-7#2)
Protocol 1 describes##2##3##(2008-4#2)
Protocol 1 provides##2##3##(2008-4#2)
Protocol 1##8##2##(2008-4#6)(2008-9#2)
Protocol 2 describes a##2##4##(2008-4#1)(2008-9#1)
Protocol 2 describes##4##3##(2008-4#3)(2008-9#1)
Protocol 2##7##2##(2008-4#6)(2008-9#1)
Protocol describes the use of##2##5##(2008-4#2)
Protocol describes the##5##3##(2008-4#5)
Protocol describes##15##2##(2008-4#12)(2008-9#3)
Protocol details##2##2##(2008-4#2)
Protocol for##6##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
Protocol in##4##2##(1996-1#1)(2008-4#2)(2012-3#1)
Protocol is an##2##3##(1996-1#1)(2008-4#1)
Protocol is##4##2##(1992-3#1)(1996-1#1)(2008-4#2)
Protocol##75##1##(1990-2#1)(1992-3#2)(1995-11#1)(1996-1#4)(1996-2#2)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#45)(2008-6#1)(2008-7#1)(2008-9#8)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
Protocols Edited by##2##3##(2008-4#2)
Protocols are given for both##2##5##(2008-4#2)
Protocols are given for##3##4##(2008-4#2)(2008-9#1)
Protocols are included##2##3##(2008-1#1)(2008-9#1)
Protocols are provided for##3##4##(2008-4#2)(2008-9#1)
Protocols are provided in this unit for##2##7##(2008-4#2)
Protocols are provided##7##3##(2008-4#6)(2008-9#1)
Protocols are##16##2##(2008-1#1)(2008-4#10)(2008-9#5)
Protocols describe preparation of##2##4##(2008-4#1)(2008-9#1)
Protocols describe##7##2##(2008-4#6)(2008-9#1)
Protocols for the##2##3##(2008-4#1)(2013-8#1)
Protocols for##8##2##(2008-2#1)(2008-4#4)(2008-9#2)(2013-8#1)
Protocols in this unit describe the##2##6##(2008-9#2)
Protocols in this unit##3##4##(2008-9#3)
Protocols in##4##2##(2008-4#1)(2008-9#3)
Protocols##48##1##(1993-5#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#25)(2008-6#1)(2008-9#15)(2013-8#1)
Proton NMR investigation of##2##4##(1994-5#1)(2008-9#1)
Proton NMR##4##2##(1990-8#1)(1993-8#1)(1994-5#1)(2008-9#1)
Proton magnetic resonance spectroscopy##2##4##(1992-3#1)(2008-6#1)
Proton pump inhibitors##2##3##(2006-10#1)(2010-12#1)
Proton##18##1##(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2012-12#4)
Protonation and##2##2##(2008-10#2)
Protonation constant##2##2##(2008-10#2)
Protonation constants of##4##3##(2008-10#4)
Protonation of##3##2##(2008-10#3)
Protonation##13##1##(2008-10#13)
Protoplast fusion##2##2##(2008-11#2)
Protoplast##3##1##(2008-11#2)(2008-9#1)
Protoplasts from##2##2##(2008-9#2)
Protoplasts##8##1##(2008-10#1)(2008-2#1)(2008-9#6)
Prototypes##2##1##(2008-5#2)
Protozoa##2##1##(2008-12#1)(2012-2#1)
Protracted##2##1##(1995-12#1)(2011-2#1)
Provence##2##1##(2008-10#1)(2008-3#1)
Proventil 1##2##2##(1992-2#2)
Proventil##5##1##(1992-2#5)
Provide##3##1##(2008-3#1)(2011-2#1)(2012-2#1)
Provided by##2##2##(2008-10#1)(2012-3#1)
Provided that the##2##3##(2007-11#1)(2007-12#1)
Provided that##7##2##(1990-11#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
Provided##14##1##(1990-11#1)(1992-3#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-3#1)
Providence Health System##6##3##(1994-2#1)(1996-12#2)(1996-2#1)(1997-2#2)
Providence##8##1##(1992-1#1)(1994-2#1)(1996-12#3)(1996-2#1)(1997-2#2)
Provider Reimbursement Review Board##2##4##(1996-1#2)
Provider and##2##2##(1994-12#1)(2011-1#1)
Provider##13##1##(1992-11#1)(1992-2#1)(1993-12#2)(1993-5#1)(1994-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2007-3#1)(2011-1#1)
Providers##13##1##(1991-3#1)(1992-2#1)(1992-8#1)(1994-1#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
Providers'##2##1##(2011-1#2)
Provides##2##1##(2008-10#2)
Providing##13##1##(1991-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-12#1)(2007-2#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Province and##5##2##(2008-5#1)(2011-1#2)(2012-12#1)(2013-8#1)
Province in China##2##3##(2008-10#1)(2013-8#1)
Province in##4##2##(2008-10#2)(2013-8#2)
Province of##9##2##(1991-2#1)(1991-6#1)(1992-12#1)(1995-12#1)(2007-7#1)(2010-3#1)(2011-1#2)(2012-2#1)
Province were##2##2##(2008-9#1)(2012-12#1)
Province##53##1##(1991-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-12#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#9)
Province]##2##1##(2012-3#1)(2013-1#1)
Provincial health directors##2##3##(2012-12#2)
Provincial health##5##2##(2012-12#5)
Provincial##9##1##(1992-3#1)(1994-2#1)(2008-9#1)(2012-12#6)
Proviral##3##1##(1994-7#1)(2008-9#2)
Provision is##2##2##(2008-10#1)(2008-7#1)
Provision of##9##2##(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
Provision##13##1##(1995-12#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Provisional Measure##2##2##(2008-9#2)
Provisional##3##1##(2008-10#1)(2008-9#2)
Provox##2##1##(2011-2#2)
Proximal femur fractures##2##3##(2007-11#2)
Proximal##11##1##(2007-11#3)(2007-8#1)(2008-12#2)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#2)
Proximate constraints on##2##3##(1991-5#2)
Proximate##3##1##(1991-5#2)(2013-7#1)
Proximity Effect##2##2##(1996-9#2)
Proxy##2##1##(1994-1#1)(2008-7#1)
Prtp##2##1##(1993-9#2)
Prune Fruit##2##2##(2008-10#2)
Prune dwarf virus##3##3##(2008-10#3)
Prune##7##1##(2008-10#7)
Prunella##2##1##(2008-8#1)(2012-3#1)
Prunus necrotic ringspot virus (PNRSV)##4##5##(2008-10#4)
Prunus necrotic ringspot virus##6##4##(2008-10#6)
Prunus persica##2##2##(2008-10#2)
Prunus species in##2##3##(2011-2#2)
Prunus species##13##2##(2008-10#1)(2008-9#1)(2011-2#11)
Prunus spp##14##2##(2008-10#14)
Prunus##46##1##(2008-10#28)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#15)
Pruritus##3##1##(2010-8#2)(2012-3#1)
Prussian Blue (PB)##3##3##(2008-10#3)
Prussian Blue and##2##3##(2008-10#2)
Prussian Blue##11##2##(2008-10#11)
Prussian blue (PB)##3##3##(2008-10#3)
Prussian blue modified##2##3##(2008-10#2)
Prussian blue##12##2##(2008-10#9)(2010-5#1)(2013-8#2)
Prussian carp Carassius gibelio (Bloch##2##5##(2008-12#2)
Prussian##29##1##(2008-10#23)(2008-12#2)(2010-5#1)(2013-8#3)
Przhevalskiana##4##1##(2008-12#4)
Ps##2##1##(2012-2#2)
Ps95##6##1##(2008-10#6)
PsA##3##1##(2006-10#3)
PsCV##2##1##(2008-5#2)
PsENOD12a and PsENOD5##2##3##(2011-2#2)
PsENOD12a##3##1##(2011-2#3)
PsENOD5##4##1##(2011-2#4)
Pseudacteon wasmanni##2##2##(2007-12#2)
Pseudaletia separata (Lepidoptera##2##3##(1992-6#1)(2007-12#1)
Pseudaletia separata##3##2##(1992-6#1)(2007-12#2)
Pseudo##4##1##(1990-9#1)(2007-7#2)(2008-7#1)
Pseudoaneurysm of the##3##3##(2008-12#1)(2009-7#1)(2010-7#1)
Pseudoaneurysm of##5##2##(2008-12#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-12#1)
Pseudoaneurysm##9##1##(2007-10#1)(2008-12#1)(2008-7#1)(2009-7#2)(2010-7#1)(2012-12#2)(2012-2#1)
Pseudoaneurysms##2##1##(2007-8#1)(2008-7#1)
Pseudocerastes persicus##2##2##(2013-1#2)
Pseudoephedrine##2##1##(2008-10#1)(2008-7#1)
Pseudohypoparathyroidism (PHP)##2##2##(2010-6#1)(2011-1#1)
Pseudohypoparathyroidism##3##1##(2010-6#1)(2011-1#2)
Pseudomonads##2##1##(2008-10#1)(2008-7#1)
Pseudomonas acidophila##2##2##(2008-6#2)
Pseudomonas aeruginosa and##2##3##(2010-3#1)(2012-2#1)
Pseudomonas aeruginosa exotoxin A##2##4##(2008-10#2)
Pseudomonas aeruginosa is##2##3##(2012-3#1)(2013-1#1)
Pseudomonas aeruginosa##53##2##(1990-11#1)(1990-6#1)(1992-11#1)(1994-2#2)(1995-2#2)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#2)(2009-6#4)(2010-10#2)(2010-3#2)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#5)(2013-8#1)
Pseudomonas aeruginosa-induced##3##2##(2012-2#3)
Pseudomonas amyloderamosa JD210##2##3##(1990-11#2)
Pseudomonas and##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
Pseudomonas biocontrol##2##2##(2008-10#2)
Pseudomonas cepacia##3##2##(2008-4#1)(2008-7#2)
Pseudomonas chloritidismutans##2##2##(2009-2#2)
Pseudomonas chlororaphis##2##2##(2008-10#2)
Pseudomonas exotoxin A##2##3##(1993-3#1)(1997-4#1)
Pseudomonas fluorescens A506##3##3##(2008-10#3)
Pseudomonas fluorescens B5##9##3##(2008-10#9)
Pseudomonas fluorescens Pf-5##2##3##(2008-10#2)
Pseudomonas fluorescens SS101##3##3##(2008-10#3)
Pseudomonas fluorescens Strain A506##2##4##(2008-10#2)
Pseudomonas fluorescens Strain##3##3##(2008-10#3)
Pseudomonas fluorescens and##2##3##(2008-10#2)
Pseudomonas fluorescens bv##2##3##(2008-10#2)
Pseudomonas fluorescens strain A506##5##4##(2008-10#5)
Pseudomonas fluorescens strain##8##3##(2008-10#8)
Pseudomonas fluorescens strains##2##3##(2008-10#2)
Pseudomonas fluorescens##54##2##(2008-10#52)(2008-8#1)(2011-1#1)
Pseudomonas infections##2##2##(2008-12#1)(2013-1#1)
Pseudomonas phage ATCC 14209-B1##2##4##(2008-10#2)
Pseudomonas phage##3##2##(1990-5#1)(2008-10#2)
Pseudomonas putida 06909-rif/nal on##2##4##(2008-10#2)
Pseudomonas putida 06909-rif/nal was applied##2##5##(2008-10#2)
Pseudomonas putida 06909-rif/nal was##4##4##(2008-10#4)
Pseudomonas putida 06909-rif/nal##15##3##(2008-10#15)
Pseudomonas putida 54G biofilm##2##4##(2008-7#2)
Pseudomonas putida GNA5##3##3##(2011-2#3)
Pseudomonas putida P35X##2##3##(1994-12#2)
Pseudomonas putida WCS358##3##3##(2008-10#3)
Pseudomonas putida biofilms##2##3##(2008-7#2)
Pseudomonas putida mt-2##2##3##(1990-11#1)(1994-12#1)
Pseudomonas putida was##2##3##(2008-10#1)(2008-7#1)
Pseudomonas putida##55##2##(1990-11#1)(1991-5#1)(1991-7#2)(1993-11#2)(1994-12#3)(1994-5#1)(1994-6#1)(1995-8#1)(1997-2#2)(2008-10#28)(2008-6#1)(2008-7#5)(2011-1#1)(2011-2#4)(2012-2#2)
Pseudomonas savastanoi pv##4##3##(2008-10#4)
Pseudomonas sp##6##2##(1994-12#1)(2008-10#4)(2008-7#1)
Pseudomonas species##4##2##(1990-7#1)(2008-10#2)(2010-4#1)
Pseudomonas spp##41##2##(2007-7#1)(2008-10#38)(2011-1#1)(2013-8#1)
Pseudomonas strains##2##2##(1991-3#1)(2008-10#1)
Pseudomonas syringae and##3##3##(2008-10#3)
Pseudomonas syringae pv##33##3##(2008-10#32)(2009-6#1)
Pseudomonas syringae pvs##3##3##(2008-10#3)
Pseudomonas syringae subsp##2##3##(2008-10#2)
Pseudomonas syringae##58##2##(2008-10#55)(2009-6#1)(2009-8#2)
Pseudomonas##327##1##(1990-11#4)(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#2)(1991-5#1)(1991-7#3)(1992-11#1)(1993-11#2)(1993-3#1)(1994-12#6)(1994-2#2)(1994-5#2)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-12#2)(2007-7#4)(2008-10#204)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#12)(2008-8#3)(2009-11#2)(2009-2#2)(2009-6#6)(2009-8#2)(2010-10#2)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#15)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
Pseudonocardia##4##1##(2012-2#4)
Pseudoperonospora cubensis resistance##2##3##(2008-10#2)
Pseudoperonospora cubensis##6##2##(2008-10#6)
Pseudorandom encoding##2##2##(2008-3#2)
Pseudorecombination##2##1##(2008-10#2)
Pseudosclerotia##2##1##(2008-10#2)
Pseudothecia and##3##2##(2008-10#3)
Pseudothecia##10##1##(2008-10#10)
Pseudothecial Development##2##2##(2008-10#2)
Pseudotsuga##2##1##(2008-10#2)
Pseudotumoural soft tissue lesions of the##2##6##(2012-2#2)
Pseudozyma flocculosa##2##2##(2008-10#2)
Pseudozyma##4##1##(2008-10#4)
Psi(55)##5##1##(2008-8#5)
Psi(w)##5##1##(2008-10#5)
Psidium##3##1##(2013-1#2)(2013-7#1)
Psoas##2##1##(2008-10#1)(2009-4#1)
Psoriasiform##2##1##(2012-1#1)(2012-2#1)
Psoriasis##12##1##(1991-8#1)(1997-8#1)(2007-7#4)(2008-5#1)(2008-6#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
Psorophora cingulata##2##2##(2008-5#2)
PspA##2##1##(1995-5#2)
Pssym10##2##1##(2011-2#2)
Pssym7##2##1##(2011-2#2)
Pst I DNA fragment##2##4##(1996-6#1)(2008-8#1)
Pst##3##1##(1996-6#1)(2008-8#1)(2009-6#1)
PstI and##2##2##(1995-12#1)(2008-10#1)
PstI genomic##2##2##(1997-7#1)(2008-5#1)
PstI##8##1##(1990-12#2)(1991-9#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)
PstI(-)##3##1##(2011-1#3)
PsycINFO and##2##2##(2009-7#1)(2009-9#1)
PsycINFO##4##1##(2009-7#1)(2009-9#1)(2013-1#2)
PsycLIT and##2##2##(1991-1#1)(2008-6#1)
PsycLIT##3##1##(1991-1#2)(2008-6#1)
Psychiatric Association was##3##3##(2011-4#3)
Psychiatric Association##6##2##(2009-6#1)(2011-2#1)(2011-4#4)
Psychiatric Hospitals##6##2##(1991-1#2)(1992-2#1)(1992-3#1)(1997-8#2)
Psychiatric Nursing##4##2##(2008-11#3)(2008-12#1)
Psychiatric Rating##4##2##(1996-7#1)(2008-1#1)(2010-9#1)(2011-1#1)
Psychiatric Symptoms##2##2##(2012-1#2)
Psychiatric and##2##2##(2008-4#1)(2009-6#1)
Psychiatric manifestations##3##2##(2012-2#3)
Psychiatric symptoms##2##2##(1991-1#1)(2008-6#1)
Psychiatric##62##1##(1991-1#3)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#1)(1995-1#1)(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#6)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-4#10)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#4)
Psychiatrists##3##1##(1990-6#1)(1993-1#1)(2008-9#1)
Psychiatry and##4##2##(1996-1#1)(2008-7#1)(2011-3#1)(2012-12#1)
Psychiatry##25##1##(1990-4#1)(1991-12#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2011-2#1)(2011-3#1)(2011-4#4)(2012-12#1)(2012-2#1)(2013-8#1)
Psychoactive##2##1##(2008-9#1)(2012-3#1)
Psychoanalytic##2##1##(2008-4#1)(2011-4#1)
Psychobiological##2##1##(1993-12#2)
Psychodidae)##4##1##(2007-12#3)(2013-1#1)
Psychodynamic##2##1##(2008-11#1)(2009-10#1)
Psychological Association##4##2##(1994-12#3)(1995-2#1)
Psychological Distress##2##2##(2010-8#1)(2013-1#1)
Psychological and##3##2##(2007-8#1)(2008-11#1)(2008-8#1)
Psychological problems and##2##3##(2009-7#1)(2011-2#1)
Psychological##31##1##(1990-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Psychologists##2##1##(2009-7#1)(2010-6#1)
Psychology and##3##2##(2010-12#1)(2010-2#1)(2013-1#1)
Psychology##16##1##(1991-12#1)(2008-12#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
Psychometric##6##1##(1996-3#1)(1996-7#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
Psychomotricity##2##1##(2007-6#2)
Psychoneuroimmunology##3##1##(2008-2#2)(2008-7#1)
Psychopathology##2##1##(2008-6#2)
Psychopathy##2##1##(1991-1#1)(2009-9#1)
Psychopharmacology##3##1##(1991-12#1)(2008-2#1)(2008-4#1)
Psychophysical##2##1##(2008-3#1)(2008-9#1)
Psychosis##3##1##(1995-9#1)(2008-4#1)(2011-1#1)
Psychosocial and##2##2##(1995-9#1)(2011-2#1)
Psychosocial aspects##2##2##(2007-12#1)(2008-6#1)
Psychosocial factors and##2##3##(2008-1#1)(2009-4#1)
Psychosocial factors##3##2##(2008-1#1)(2008-8#1)(2009-4#1)
Psychosocial##17##1##(1993-1#1)(1994-1#1)(1994-3#1)(1995-9#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
Psychosomatic##4##1##(1995-6#1)(1996-11#1)(1996-9#1)(2008-1#1)
Psychotherapy##4##1##(2008-4#2)(2012-12#1)(2012-2#1)
Psychotic##2##1##(1992-3#1)(2011-2#1)
Psychotria##2##1##(2008-7#1)(2008-8#1)
Pt and Ir modifiers##2##4##(2008-10#2)
Pt and Pd##3##3##(2008-10#2)(2008-11#1)
Pt and Pt-Ru catalysts##2##4##(2008-10#2)
Pt and##8##2##(2008-10#7)(2008-11#1)
Pt cathode##2##2##(2008-10#1)(2010-5#1)
Pt electrode##5##2##(2008-10#5)
Pt electrodes##3##2##(2008-10#3)
Pt fluxes are##2##3##(2008-11#2)
Pt in##2##2##(2008-10#1)(2008-11#1)
Pt nanoparticles##4##2##(2008-10#3)(2012-3#1)
Pt nps is a##2##4##(2008-11#2)
Pt nps##8##2##(2008-11#8)
Pt was##2##2##(2008-10#2)
Pt##72##1##(2008-10#48)(2008-11#21)(2010-12#1)(2010-5#1)(2012-3#1)
Pt(2+)##2##1##(2010-11#2)
Pt(3)(&amp##2##1##(1996-2#2)
Pt(II) and Rh(III)##3##3##(2008-10#3)
Pt(II)##5##1##(2008-10#5)
Pt(II)-N(pyridine) coordinative##2##2##(2007-11#2)
Pt(IV)##7##1##(2008-10#7)
Pt-Bs##2##1##(2008-10#2)
Pt-Ir microelectrode##2##2##(2008-10#2)
Pt-Ir##3##1##(2008-10#3)
Pt-Ne##2##1##(2008-3#2)
Pt-Pt distances of 2##2##4##(1996-2#2)
Pt-Pt distances##3##2##(1996-2#3)
Pt-Rh thermocouple##2##2##(2008-10#2)
Pt-Rh##3##1##(2008-10#3)
Pt-based drugs##3##2##(2010-11#3)
Pt-based##4##1##(2010-11#3)(2012-2#1)
Pt-containing drugs##4##2##(2010-11#4)
Pt/C##2##1##(2008-10#1)(2008-3#1)
Pt/Rh##2##1##(2008-11#1)(2009-2#1)
Pt/SAM/PB/PPy-ChOx/Nf##2##1##(2008-10#2)
PtGA and PhGA##2##3##(2012-1#2)
PtOEP##4##1##(2008-10#4)
PtRu##2##1##(2008-10#2)
PtdIns 3-kinase##5##2##(1992-12#5)
PtdIns##7##1##(1992-12#5)(1993-6#2)
PtdIns(4##3##1##(2009-6#3)
PtdInsP2 in##2##2##(1997-1#2)
PtdInsP2##5##1##(1993-6#2)(1997-1#3)
PtdSer##3##1##(1992-9#3)
Pten##6##1##(2011-2#6)
Pteris##5##1##(1994-11#2)(2008-5#3)
Pterocarya fraxinifolia##3##2##(2011-1#3)
Pteropus##4##1##(2007-5#2)(2009-4#1)(2013-1#1)
Ptiliidae##4##1##(2007-12#4)
Ptilonorhynchus violaceus##2##2##(2008-8#2)
Pto##4##1##(2009-8#4)
Ptpre(-/-) mice##2##2##(2009-6#2)
Ptr ToxA and Ptr ToxB##3##5##(2008-10#3)
Ptr ToxA is##2##3##(2008-10#2)
Ptr ToxA##17##2##(2008-10#17)
Ptr ToxB##8##2##(2008-10#8)
Ptr ToxC##4##2##(2008-10#4)
Ptr##34##1##(2008-10#34)
Pu isotope##2##2##(2008-10#2)
Pu isotopes in settling particles##2##5##(2008-10#2)
Pu isotopes##3##2##(2008-10#3)
Pu was##2##2##(2008-10#2)
Pu##19##1##(1995-5#2)(2008-10#17)
PubMed and##5##2##(2009-11#1)(2009-5#1)(2010-6#1)(2012-12#1)(2013-8#1)
PubMed search##2##2##(2007-12#1)(2011-1#1)
PubMed were##2##2##(2009-9#1)(2012-3#1)
PubMed##32##1##(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
PubMed/MEDLINE##2##1##(2009-10#1)(2012-3#1)
Public Health Association##2##3##(1991-2#1)(2008-12#1)
Public Health Improvement Plan##2##4##(1995-12#1)(1996-2#1)
Public Health Laboratory##6##3##(2008-10#2)(2011-2#2)(2012-3#2)
Public Health Practice##3##3##(1997-2#1)(2011-1#1)(2012-12#1)
Public Health Service##6##3##(1991-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(2009-8#1)(2012-2#1)
Public Health Surveillance System##3##4##(1997-3#1)(2012-12#2)
Public Health Syphilis Study at Tuskegee##2##6##(2013-1#2)
Public Health and##5##3##(1996-1#1)(1997-2#1)(2008-1#2)(2011-2#1)
Public Health of##3##3##(2008-12#1)(2012-2#1)(2012-3#1)
Public Health##99##2##(1990-3#1)(1991-1#1)(1991-2#5)(1992-3#1)(1995-1#2)(1995-11#1)(1995-12#5)(1996-1#8)(1996-12#1)(1996-2#4)(1996-3#4)(1996-6#1)(1997-2#3)(1997-3#2)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#17)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
Public Law 101-239##2##3##(1991-3#2)
Public Law##5##2##(1991-3#2)(1994-1#1)(1997-4#1)(2012-2#1)
Public Service Division##2##3##(2012-12#2)
Public and##2##2##(1993-12#1)(1994-3#1)
Public financing##2##2##(1994-2#1)(2013-8#1)
Public goods##3##2##(2008-10#2)(2012-3#1)
Public health and##3##3##(1991-2#1)(1996-8#1)(2011-2#1)
Public health assessment in##2##4##(1996-1#2)
Public health in##2##3##(1995-2#1)(1996-12#1)
Public health policy##4##3##(1995-12#1)(1996-2#1)(2011-1#1)(2012-12#1)
Public health practice##2##3##(1996-1#1)(1996-12#1)
Public health surveillance##2##3##(1997-3#2)
Public health##39##2##(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(1994-3#2)(1995-12#4)(1995-2#1)(1996-1#4)(1996-12#3)(1996-2#4)(1996-3#2)(1996-8#1)(1997-1#1)(1997-3#3)(1997-4#1)(2008-1#1)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)
Public involvement##2##2##(2008-7#1)(2010-11#1)
Public opinion about AIDS##2##4##(1992-2#1)(1993-1#1)
Public relations##2##2##(2008-12#2)
Public##186##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#6)(1991-3#4)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#3)(1995-1#4)(1995-11#1)(1995-12#10)(1995-2#2)(1995-3#1)(1996-1#12)(1996-12#4)(1996-2#9)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#2)(2007-2#1)(2008-1#7)(2008-10#10)(2008-11#4)(2008-12#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#18)(2011-2#11)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#3)
Publication##4##1##(1991-2#1)(1993-12#1)(2008-11#1)(2008-3#1)
Publications from##2##2##(1994-2#1)(2013-1#1)
Publications##4##1##(1994-2#1)(2010-3#1)(2013-1#1)(2013-8#1)
Publicly##2##1##(1992-2#1)(2009-10#1)
Published by##2##2##(2012-2#1)(2013-1#1)
Published reports##2##2##(2008-3#1)(2009-8#1)
Published##12##1##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Publisher##12##1##(2008-10#1)(2008-11#8)(2008-7#1)(2011-2#1)(2012-3#1)
Publisher's Note##2##2##(2006-12#1)(2008-7#1)
Publisher's##3##1##(2006-12#1)(2007-2#1)(2008-7#1)
Publishing Company##2##2##(1997-6#1)(2008-5#1)
Publishing##5##1##(1997-6#1)(2008-5#1)(2008-7#1)(2013-1#2)
Pubmed##4##1##(2009-5#1)(2012-12#2)(2013-1#1)
Puccinia allii##3##2##(2008-10#3)
Puccinia coronata##6##2##(2008-10#6)
Puccinia graminis f##6##3##(2008-10#6)
Puccinia graminis subsp##3##3##(2008-10#3)
Puccinia graminis##11##2##(2008-10#11)
Puccinia hordei##5##2##(2008-10#5)
Puccinia jaceae var##2##3##(2008-10#2)
Puccinia punctiformis##2##2##(2008-10#2)
Puccinia recondita##3##2##(2008-10#3)
Puccinia spp##3##2##(2008-10#3)
Puccinia striiformis f##6##3##(2008-10#6)
Puccinia striiformis##11##2##(2008-10#11)
Puccinia triticina##23##2##(2008-10#23)
Puccinia##74##1##(2008-10#74)
Puck Bay##2##2##(2008-11#2)
Pue##3##1##(2011-3#3)
Puerto Carreño municipality##2##3##(2012-12#2)
Puerto Carreño##4##2##(2012-12#4)
Puerto Rico##21##2##(2006-10#4)(2007-5#4)(2008-10#7)(2008-11#1)(2011-1#2)(2011-2#3)
Puerto Rico)##2##2##(1994-2#1)(2007-5#1)
Puerto##29##1##(1994-2#1)(2006-10#4)(2007-5#5)(2008-10#7)(2008-11#1)(2011-1#2)(2011-2#3)(2012-12#4)(2013-1#1)(2013-8#1)
PufX##2##1##(2010-2#2)
Puff City##3##2##(2013-1#3)
Puget##2##1##(1990-11#1)(2008-10#1)
Puisque##2##1##(2008-11#1)(2008-5#1)
Pulchrosoma pulchrosoma##2##2##(2007-6#2)
Pulling the##2##2##(1995-2#1)(1996-2#1)
Pulling##3##1##(1995-2#2)(1996-2#1)
Pullman##2##1##(2008-10#2)
Pulmonary Function##2##2##(2011-1#1)(2012-2#1)
Pulmonary Tuberculosis##2##2##(2011-2#1)(2013-1#1)
Pulmonary alveolar proteinosis##2##3##(2010-7#2)
Pulmonary alveolar##3##2##(2010-7#2)(2012-12#1)
Pulmonary and##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
Pulmonary arterial hypertension (PAH)##2##4##(2010-10#1)(2010-5#1)
Pulmonary arterial hypertension##4##3##(2007-8#1)(2010-10#2)(2010-5#1)
Pulmonary arteriography##2##2##(2008-1#1)(2010-6#1)
Pulmonary artery##4##2##(1997-8#2)(2010-10#1)(2012-12#1)
Pulmonary clearance##2##2##(1991-8#2)
Pulmonary complications##2##2##(2007-8#1)(2012-12#1)
Pulmonary disease##2##2##(2007-12#2)
Pulmonary embolism##2##2##(1993-9#1)(2008-7#1)
Pulmonary function tests (PFTs)##2##4##(2006-10#1)(2007-2#1)
Pulmonary function tests##7##3##(1997-3#1)(2006-10#1)(2007-2#1)(2012-2#2)(2013-1#2)
Pulmonary function##8##2##(1997-3#1)(2006-10#1)(2007-2#1)(2012-2#2)(2013-1#3)
Pulmonary hypertension (PH)##2##3##(2008-1#1)(2009-4#1)
Pulmonary hypertension##5##2##(2008-1#1)(2009-4#1)(2011-2#2)(2012-2#1)
Pulmonary involvement##3##2##(2006-10#1)(2007-12#1)(2011-2#1)
Pulmonary metastases from##2##3##(2010-3#1)(2012-1#1)
Pulmonary metastases##3##2##(2010-3#2)(2012-1#1)
Pulmonary rehabilitation##2##2##(2007-6#1)(2013-8#1)
Pulmonary tuberculosis##4##2##(2007-7#1)(2008-7#1)(2009-5#1)(2012-3#1)
Pulmonary##93##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-8#2)(1993-9#1)(1995-3#1)(1997-3#1)(1997-8#2)(2006-10#3)(2007-11#1)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#6)(2008-12#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#2)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#7)(2013-8#1)
Pulp##3##1##(2008-6#2)(2010-3#1)
Pulse Energy##2##2##(2008-3#2)
Pulse broadening##3##2##(2007-11#1)(2008-3#2)
Pulse compression##2##2##(2007-11#2)
Pulse duration and##2##3##(2007-11#1)(2013-7#1)
Pulse durations##2##2##(2007-12#2)
Pulse immunization##5##2##(1994-9#5)
Pulse rate##2##2##(2010-10#1)(2013-7#1)
Pulse therapy##2##2##(2007-7#2)
Pulse##45##1##(1993-1#1)(1994-9#5)(1996-12#1)(2007-11#10)(2007-12#5)(2007-7#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#6)(2010-10#1)(2012-2#1)(2012-3#1)(2013-7#4)
Pulse-chase##3##1##(1991-9#1)(1997-3#1)(2008-7#1)
Pulsed digital holography for##2##4##(2008-3#2)
Pulsed digital##3##2##(2008-3#3)
Pulsed fast/thermal neutron analysis##2##4##(2008-10#2)
Pulsed field gel electrophoresis was used##2##6##(2012-3#2)
Pulsed field gel electrophoresis##4##4##(1992-6#1)(2008-10#1)(2012-3#2)
Pulsed laser##2##2##(2008-10#1)(2008-2#1)
Pulsed##25##1##(1992-6#1)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#9)(2012-2#1)(2012-3#2)
Pulsed-field gel electrophoresis##4##3##(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
Pulsed-field##5##1##(1996-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
Pulses as short as##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
Pulses in##2##2##(2008-3#1)(2008-5#1)
Pulses with##2##2##(2007-11#1)(2008-2#1)
Pulses##12##1##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#4)(2008-5#1)
Pump##4##1##(2007-12#2)(2007-9#1)(2008-10#1)
Pumped by a##3##3##(2007-12#1)(2008-2#2)
Pumped by an##2##3##(2007-11#1)(2008-2#1)
Pumped by##6##2##(2007-11#1)(2007-12#2)(2008-2#3)
Pumping##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Puncture##2##1##(1997-8#1)(2012-3#1)
Pungtungia herzi##2##2##(2010-8#2)
Punica granatum##2##2##(2008-10#1)(2010-3#1)
Punitive##2##1##(1995-12#1)(1996-2#1)
Punjab##9##1##(1997-8#1)(2008-10#4)(2008-12#1)(2009-7#1)(2010-11#1)(2011-2#1)
Punta##2##1##(2010-8#2)
Puntarenas##3##1##(2008-5#1)(2013-7#2)
Puntius##14##1##(2008-12#14)
PurE##3##1##(2006-4#3)
PurR protein##2##2##(2008-8#2)
PurR##8##1##(2008-8#8)
Purchase##2##1##(1992-12#1)(1996-3#1)
Purchasers##2##1##(1994-1#1)(1996-1#1)
Purchasing##4##1##(1990-4#1)(1995-12#1)(1996-2#1)(1996-8#1)
Purdue Pharma##3##2##(2008-3#3)
Purdue##4##1##(2008-12#1)(2008-3#3)
Pure 1##2##2##(1996-5#2)
Pure laparoscopic hepatectomy##2##3##(2013-8#2)
Pure uterine lipoma##3##3##(2013-7#3)
Pure##23##1##(1995-3#1)(1996-2#2)(1996-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#2)
Purification and biochemical characterization of##2##5##(1991-9#1)(1993-8#1)
Purification and characterization of a human##2##6##(1991-12#1)(1991-5#1)
Purification and characterization of a##8##5##(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-9#1)(1994-8#1)(1995-6#1)(2009-2#1)
Purification and characterization of an##2##5##(1997-2#1)(1997-4#1)
Purification and characterization of##24##4##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-2#2)(1997-4#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-2#1)
Purification and characterization##25##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-2#2)(1997-4#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-2#1)
Purification and identification of##2##4##(1990-11#1)(1990-7#1)
Purification and properties of##5##4##(1990-11#1)(1992-7#1)(1995-2#1)(1995-3#1)(2008-8#1)
Purification and##47##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1991-12#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-4#2)(1997-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-2#1)(2010-4#1)
Purification by##2##2##(1992-12#1)(1992-6#1)
Purification of a##3##3##(2008-10#1)(2008-12#1)(2010-12#1)
Purification of human placenta diamine oxidase##2##6##(1992-8#2)
Purification of human##4##3##(1992-8#3)(2008-4#1)
Purification of the##6##3##(1990-11#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
Purification of##32##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-8#3)(1995-6#2)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#7)(2010-12#1)(2013-1#1)
Purification##90##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-12#3)(1991-5#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-6#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#11)(2008-8#3)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
Purified VLP preparations##2##3##(2008-10#2)
Purified fibrinogen##2##2##(2008-10#2)
Purified##43##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#1)(1997-4#1)(2008-10#16)(2008-5#1)(2008-8#1)(2013-8#1)
Purine##4##1##(1994-8#1)(1995-12#1)(1996-5#1)(2008-4#1)
Purinergic agents##2##2##(1995-8#2)
Purinergic##10##1##(1993-8#1)(1995-8#3)(2008-4#5)(2013-8#1)
Purity##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
Purkinje cell##9##2##(1992-12#2)(1992-9#1)(1996-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
Purkinje cells##12##2##(1991-2#1)(1991-7#1)(1992-12#2)(1992-9#1)(1994-2#1)(1996-2#2)(1996-5#1)(1997-8#2)(2012-2#1)
Purkinje fibers##2##2##(1992-3#1)(2008-10#1)
Purkinje neurons##3##2##(1995-8#3)
Purkinje##28##1##(1991-2#1)(1991-7#1)(1992-12#4)(1992-3#1)(1992-9#2)(1994-2#1)(1995-8#3)(1996-2#3)(1996-5#1)(1997-8#2)(2008-10#1)(2010-4#1)(2012-2#5)(2013-1#1)(2013-8#1)
Purkinje/molecular##2##1##(1995-12#2)
Purple##4##1##(1997-8#1)(2008-10#2)(2009-11#1)
Purpose - The##2##3##(2008-11#2)
Purpose -##4##2##(2008-11#4)
Purpose of##2##2##(1991-12#1)(2013-8#1)
Purpose##111##1##(1991-12#1)(1996-9#1)(2007-10#7)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#6)(2008-3#1)(2008-6#53)(2008-7#2)(2011-2#1)(2012-1#7)(2012-3#5)(2013-1#18)(2013-8#2)
Purpose- To##2##2##(2008-11#2)
Purpose-To##2##1##(2008-11#2)
Purpose/results/discussion##2##1##(2008-6#2)
Pus culture##2##2##(2007-7#1)(2008-1#1)
Put##5##1##(1990-8#1)(1995-1#1)(1996-2#2)(2010-3#1)
Putative F(1)##2##2##(2008-10#2)
Putative##16##1##(1991-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(2007-12#1)(2008-10#6)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Putatively nonpathogenic##2##2##(2008-10#2)
Putatively##3##1##(2008-10#2)(2012-3#1)
Putrescine##2##1##(1995-2#1)(2013-8#1)
Putting##8##1##(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-10#1)(2009-12#1)(2012-1#1)(2013-1#1)
Puumala virus##3##2##(1991-11#3)
Puzzle##2##1##(2008-12#1)(2008-7#1)
Pv bZIP1##2##2##(2013-8#2)
Pv##4##1##(2013-8#4)
PvSR2 gene was##2##3##(2008-9#2)
PvSR2 gene##3##2##(2008-9#3)
PvSR2##9##1##(2008-9#9)
PvZIP12##5##1##(2013-8#5)
PvZIP13##3##1##(2013-8#3)
PvZIP16##2##1##(2013-8#2)
PvuII pp genotype##2##3##(2011-2#2)
PvuII##5##1##(1993-2#1)(2011-2#4)
Pwt1 and Pwt2##2##3##(2008-10#2)
Pwt1##3##1##(2008-10#3)
Pwt2##3##1##(2008-10#3)
Pwt3##3##1##(2008-10#3)
Pwt4##4##1##(2008-10#4)
PxB and PxE##3##3##(2008-10#3)
PxB##4##1##(2008-10#4)
PxE##4##1##(2008-10#4)
Py##2##1##(1995-5#1)(2008-5#1)
Py-GC/MS##2##1##(2008-10#2)
Pycnogonida##2##1##(2007-12#2)
Pycnogonum litorale##2##2##(2007-12#2)
Pyeloureteritis cystica##2##2##(2011-2#2)
Pygmy T-cell line##3##3##(1993-6#3)
Pygmy##8##1##(1993-6#6)(1995-8#1)(2011-2#1)
Pyoderma gangrenosum##5##2##(2007-7#1)(2010-12#4)
Pyomyositis##2##1##(2006-10#2)
Pyostomatitis vegetans##2##2##(2011-2#2)
Pyr and D-Pyr in##2##4##(1994-12#2)
Pyr and D-Pyr##3##3##(1994-12#3)
Pyr##4##1##(1994-12#4)
Pyracantha spp##3##2##(2008-10#3)
Pyracantha##5##1##(2008-10#5)
Pyralidae)##3##1##(2007-12#1)(2008-6#2)
Pyramidal##2##1##(2008-4#1)(2012-2#1)
Pyramiding##2##1##(2008-10#1)(2009-10#1)
Pyrazinamide##2##1##(2008-7#1)(2008-8#1)
Pyrazolo[3##2##1##(2013-7#2)
Pyrenopeziza brassicae##3##2##(2008-10#3)
Pyrenophora semeniperda##2##2##(2008-10#2)
Pyrenophora teres##5##2##(2008-10#5)
Pyrenophora tritici-repentis Race##3##3##(2008-10#3)
Pyrenophora tritici-repentis and##2##3##(2008-10#2)
Pyrenophora tritici-repentis race##2##3##(2008-10#2)
Pyrenophora tritici-repentis##24##2##(2008-10#24)
Pyrenophora##33##1##(2008-10#33)
Pyrex##3##1##(2008-10#1)(2008-2#1)(2009-7#1)
Pyricularia grisea is##2##3##(2008-10#2)
Pyricularia grisea##13##2##(2008-10#12)(2008-9#1)
Pyricularia oryzae and##2##3##(2008-10#2)
Pyricularia oryzae##3##2##(2008-10#3)
Pyricularia##17##1##(2008-10#16)(2008-9#1)
Pyridinium##2##1##(1994-12#1)(2008-10#1)
Pyridoxine##2##1##(2011-1#1)(2013-1#1)
Pyrococcus furiosus##4##2##(1993-9#1)(1994-12#2)(1995-5#1)
Pyrococcus##7##1##(1993-12#1)(1993-9#2)(1994-12#2)(1995-5#1)(2008-9#1)
Pyrolysis temperatures##2##2##(2008-10#2)
Pyrolysis##3##1##(2008-10#3)
Pyrrolidine dithiocarbamate##2##2##(1993-3#2)
Pyrus##2##1##(2008-10#2)
Pyruvate##3##1##(1990-5#1)(1995-2#1)(1995-5#1)
Pythium Damping-Off##2##2##(2008-10#2)
Pythium and##2##2##(2008-10#2)
Pythium aphanidermatum in Cucumber Grown on Rockwool##2##7##(2008-10#2)
Pythium aphanidermatum##11##2##(2008-10#11)
Pythium arrhenomanes##3##2##(2008-10#3)
Pythium damping-off##3##2##(2008-10#3)
Pythium group F##5##3##(2008-10#5)
Pythium group##7##2##(2008-10#7)
Pythium infection##2##2##(2008-10#2)
Pythium irregulare##2##2##(2008-10#2)
Pythium oligandrum and##2##3##(2008-10#2)
Pythium oligandrum##10##2##(2008-10#10)
Pythium populations##2##2##(2008-10#2)
Pythium root rot of##2##4##(2008-10#2)
Pythium root rot##3##3##(2008-10#3)
Pythium root##5##2##(2008-10#5)
Pythium sp##3##2##(2008-10#3)
Pythium spp##37##2##(2008-10#37)
Pythium ultimum and##3##3##(2008-10#3)
Pythium ultimum on##2##3##(2008-10#2)
Pythium ultimum var##4##3##(2008-10#4)
Pythium ultimum##20##2##(2008-10#20)
Pythium were##2##2##(2008-10#2)
Pythium##129##1##(2008-10#129)
P &lt##3##1##(2012-6#1)(2012-7#2)
P &lt##14##1##(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#7)
P = 0##13##1##(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)
P≤0##4##1##(2013-1#4)
Q -switched Nd##6##3##(2007-11#5)(2007-12#1)
Q -switched##25##2##(2007-11#13)(2007-12#11)(2008-2#1)
Q ICP MS##3##3##(2008-10#3)
Q Sepharose##3##2##(1991-12#1)(1991-5#1)(1997-1#1)
Q Switches##2##2##(2008-3#2)
Q and##7##2##(1991-12#1)(1992-11#1)(2007-11#2)(2008-10#2)(2008-9#1)
Q biotype of##2##3##(2011-2#2)
Q biotype##4##2##(2011-2#4)
Q factors##2##2##(2007-12#2)
Q fever in##2##3##(2007-12#2)
Q fever##8##2##(1994-12#1)(1995-12#1)(2007-12#5)(2008-4#1)
Q switch##6##2##(2007-11#1)(2008-3#5)
Q switched by##2##3##(2008-3#2)
Q switched##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
Q switching and##2##3##(2007-12#1)(2008-3#1)
Q switching is##3##3##(2008-3#3)
Q switching of a tunable alexandrite##2##6##(2008-3#2)
Q switching of a##8##4##(2007-11#1)(2008-3#7)
Q switching of##10##3##(2007-11#1)(2008-3#9)
Q switching##19##2##(2007-11#2)(2007-12#3)(2008-3#14)
Q value##3##2##(2007-12#1)(2008-3#2)
Q were obtained for##2##4##(2008-10#2)
Q were##3##2##(2008-10#3)
Q##197##1##(1990-5#1)(1991-12#3)(1991-3#1)(1991-5#1)(1992-11#4)(1992-2#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-11#27)(2007-12#30)(2007-8#1)(2008-10#20)(2008-12#2)(2008-2#6)(2008-3#34)(2008-4#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-10#2)(2011-2#5)(2012-5#18)(2012-6#12)(2012-7#6)(2012-9#7)(2013-8#1)
Q&gt##2##1##(2007-11#2)
Q&quot##2##1##(1995-1#1)(2008-10#1)
Q(+)##2##1##(2008-10#2)
Q(MAX)##3##1##(2011-2#3)
Q(ST) s of##2##3##(2012-3#2)
Q(ST)##4##1##(2012-3#4)
Q(o)I fungicides##2##2##(2008-10#2)
Q(o)I##3##1##(2008-10#3)
Q)##4##1##(1992-9#1)(1994-5#1)(2008-10#2)
Q-10##2##1##(2013-1#2)
Q-PCR and##2##2##(2008-10#2)
Q-PCR##6##1##(2008-10#6)
Q-RT-PCR##3##1##(2008-10#2)(2008-9#1)
Q-Sepharose##4##1##(1995-11#1)(1997-4#1)(2008-10#2)
Q-Switched Diode-Pumped##2##2##(2008-2#1)(2008-3#1)
Q-Switched Nd##3##2##(2008-2#1)(2008-3#2)
Q-Switched##8##1##(2008-2#3)(2008-3#5)
Q-T##3##1##(1994-6#2)(1996-2#1)
Q-branch##2##1##(2008-3#2)
Q-mode factor analysis##2##3##(2008-10#2)
Q-switch##3##1##(2008-2#1)(2008-3#2)
Q-switched 1##3##2##(2008-3#3)
Q-switched Nd##15##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#4)(2008-5#1)
Q-switched diode-pumped Nd##3##3##(2008-3#3)
Q-switched diode-pumped##4##2##(2008-3#4)
Q-switched fiber##2##2##(2007-12#2)
Q-switched laser pulse##2##3##(2008-3#2)
Q-switched laser##11##2##(2007-12#2)(2008-2#3)(2008-3#6)
Q-switched mode locking##3##3##(2007-11#3)
Q-switched mode##7##2##(2007-11#3)(2008-3#4)
Q-switched operation of the##2##4##(2008-2#2)
Q-switched operation of##3##3##(2008-2#2)(2008-3#1)
Q-switched operation##6##2##(2008-2#4)(2008-3#2)
Q-switched pulse##4##2##(2008-3#4)
Q-switched pulses##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Q-switched##94##1##(2007-11#10)(2007-12#17)(2008-1#1)(2008-2#21)(2008-3#44)(2008-5#1)
Q-switching##11##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
Q-type Ca2+ channels##2##3##(1996-5#2)
Q-type##3##1##(1996-5#3)
Q/R site editing##2##3##(1993-12#2)
Q/R site##5##2##(1993-12#3)(1995-5#2)
Q1##7##1##(1995-6#1)(2008-11#1)(2012-3#5)
Q10##7##1##(1991-5#2)(1992-11#1)(1992-3#1)(1993-3#1)(1996-9#1)(2009-8#1)
Q14##2##1##(2008-10#2)
Q2##6##1##(1993-6#3)(2011-3#1)(2012-3#2)
Q2-87##4##1##(2008-10#4)
Q3D QDs##2##2##(2009-11#2)
Q3D##3##1##(2009-11#3)
Q8##2##1##(1991-5#1)(1994-11#1)
Q8r1-96##11##1##(2008-10#11)
QA and QB##2##3##(1992-6#2)
QA and##4##2##(1992-6#3)(1993-2#1)
QA program##3##2##(1991-1#1)(1993-2#2)
QA##15##1##(1991-1#1)(1992-12#2)(1992-6#3)(1993-2#4)(1994-2#1)(1994-3#1)(1995-3#1)(2007-7#2)
QA-810V##2##1##(2008-10#2)
QA-stimulated PPI hydrolysis in cells prepared from the##2##8##(1996-5#2)
QA-stimulated PPI hydrolysis in cells prepared from##3##7##(1996-5#3)
QADEAA##2##1##(2008-10#2)
QAE##5##1##(2008-10#5)
QAI##2##1##(2013-1#2)
QAS exchange center##2##3##(2008-10#2)
QAS##5##1##(2008-10#5)
QC lasers##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
QC##10##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2009-12#3)(2011-2#1)
QCCJ##3##1##(2008-10#3)
QCD##2##1##(1992-8#2)
QCM immunosensor##2##2##(2008-10#2)
QCM is##2##2##(2008-10#2)
QCM with##3##2##(2008-10#3)
QCM##23##1##(2008-10#23)
QCMs##2##1##(2008-10#2)
QCR9##3##1##(1995-6#2)(1997-3#1)
QCT##4##1##(1994-8#4)
QD##7##1##(2008-7#3)(2013-1#4)
QDA##6##1##(2008-10#6)
QDs prepared in water phase##2##5##(2008-10#2)
QDs##16##1##(2008-10#5)(2009-11#8)(2013-8#3)
QEEF##3##1##(1993-9#3)
QEEG##3##1##(1996-7#3)
QFISH staining##2##2##(2008-9#2)
QFT conversion##4##2##(2013-1#4)
QFT-G##2##1##(2008-10#2)
QFTs##3##1##(1994-2#3)
QHCl##2##1##(2009-10#2)
QI activities##7##2##(2013-1#7)
QI##14##1##(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(2013-1#9)
QI-based##2##1##(1994-3#1)(1996-2#1)
QIs and##2##2##(1996-2#1)(2012-3#1)
QIs were##2##2##(1996-2#1)(2012-3#1)
QIs##9##1##(1996-2#3)(2012-3#5)(2013-1#1)
QK##2##1##(1995-6#2)
QLrP##5##1##(2008-10#5)
QM and##2##2##(2008-10#1)(2009-8#1)
QM/MM simulations##3##2##(2008-10#1)(2013-1#2)
QM/MM##9##1##(2008-10#3)(2013-1#6)
QMC##3##1##(2008-7#3)
QMHC interview##7##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)
QMHC interviewed##4##2##(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)
QMHC##12##1##(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#1)
QOL among##2##2##(2010-5#1)(2012-2#1)
QOL in##2##2##(1994-12#1)(1995-4#1)
QOL score##4##2##(1994-12#3)(2012-2#1)
QOL scores##3##2##(1995-4#2)(2011-2#1)
QOL##38##1##(1994-12#7)(1995-4#6)(2008-4#1)(2008-6#3)(2008-7#7)(2010-4#1)(2010-5#5)(2011-1#1)(2011-2#4)(2012-2#3)
QPCR##5##1##(2008-10#3)(2012-2#1)(2013-1#1)
QPM GaAs##2##2##(2007-11#2)
QPM grating##2##2##(2007-12#2)
QPM##12##1##(2007-11#3)(2007-12#4)(2012-2#5)
QPS##2##1##(2007-12#2)
QRS complex##5##2##(2007-5#2)(2010-8#2)(2012-3#1)
QRS complexes##3##2##(1992-5#1)(2008-10#1)(2012-3#1)
QRS duration##4##2##(1992-6#1)(2008-10#2)(2010-1#1)
QRS##21##1##(1991-3#1)(1992-5#1)(1992-6#1)(2007-5#2)(2008-10#7)(2008-11#1)(2009-10#1)(2010-1#1)(2010-8#2)(2012-12#1)(2012-3#2)(2013-8#1)
QS regulatory##2##2##(2010-10#2)
QS##6##1##(2008-10#1)(2009-6#2)(2010-10#2)(2013-1#1)
QS-21##2##1##(1997-4#2)
QS-L1##5##1##(1997-4#5)
QSAR descriptors##2##2##(2007-11#2)
QSAR model##2##2##(2007-11#1)(2008-10#1)
QSAR modeling##2##2##(2008-10#2)
QSAR models##3##2##(2008-10#1)(2009-3#1)(2012-3#1)
QSAR studies##2##2##(2009-3#1)(2011-3#1)
QSAR##24##1##(2007-11#9)(2008-10#7)(2009-3#2)(2010-12#1)(2011-3#2)(2012-2#1)(2012-3#2)
QSAR-3D/CoMFA##2##1##(2007-11#2)
QSARs##3##1##(2007-11#3)
QSPR models##2##2##(2007-11#2)
QSPR##6##1##(2007-11#5)(2008-10#1)
QSPR/QSAR studies of##2##3##(2007-11#2)
QSPR/QSAR studies##3##2##(2007-11#3)
QSR##3##1##(2008-1#1)(2011-1#1)(2013-1#1)
QSRR##3##1##(2008-10#3)
QSS##2##1##(2008-4#1)(2008-8#1)
QST713##2##1##(2008-10#2)
QT interval##7##2##(2006-10#1)(2008-8#3)(2009-12#1)(2010-6#1)(2012-2#1)
QT syndrome##7##2##(2008-7#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#3)
QT##27##1##(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-8#7)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
QT-interval prolongation and##2##3##(2013-8#2)
QT-interval##3##1##(2012-1#1)(2013-8#2)
QTL analyses##3##2##(2008-8#3)
QTL analysis##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
QTL and##4##2##(2008-10#3)(2008-8#1)
QTL associated with##3##3##(2008-10#3)
QTL controlling the##2##3##(2012-3#2)
QTL controlling##6##2##(2008-10#2)(2012-3#4)
QTL detection##2##2##(2008-10#2)
QTL effects on##2##3##(2008-8#2)
QTL effects##3##2##(2008-10#1)(2008-8#2)
QTL explained##2##2##(2008-10#1)(2012-3#1)
QTL for leaf##2##3##(2008-10#2)
QTL for##27##2##(2008-10#17)(2008-12#1)(2008-8#6)(2012-3#2)(2013-8#1)
QTL genes##2##2##(2009-10#1)(2009-5#1)
QTL have##2##2##(2008-8#1)(2009-5#1)
QTL intervals##2##2##(2008-10#1)(2012-3#1)
QTL mapping##5##2##(2008-10#1)(2008-8#2)(2012-3#2)
QTL markers##2##2##(2011-3#2)
QTL on LG1##2##3##(2008-10#2)
QTL on LG7##2##3##(2008-10#2)
QTL on chromosome 3##2##4##(2008-10#1)(2012-3#1)
QTL on chromosome##5##3##(2008-10#4)(2012-3#1)
QTL on chromosomes##2##3##(2008-10#2)
QTL on linkage groups##2##4##(2008-10#2)
QTL on linkage##3##3##(2008-10#3)
QTL on##24##2##(2008-10#23)(2012-3#1)
QTL regions##2##2##(2009-5#2)
QTL to##2##2##(2008-10#2)
QTL was identified on##2##4##(2008-10#2)
QTL was##4##2##(2008-10#4)
QTL were identified with##2##4##(2008-10#2)
QTL were identified##5##3##(2008-10#5)
QTL were##14##2##(2008-10#14)
QTL with##2##2##(2008-8#2)
QTL##176##1##(2008-10#107)(2008-12#2)(2008-7#1)(2008-8#22)(2009-10#3)(2009-5#9)(2011-1#1)(2011-3#2)(2012-3#28)(2013-8#1)
QTL-environment interactions##2##2##(2008-10#2)
QTLMapper##2##1##(2008-10#2)
QTLnet##2##1##(2011-1#2)
QTLs and##2##2##(2008-8#1)(2011-1#1)
QTLs are##2##2##(2009-10#1)(2011-1#1)
QTLs for##14##2##(2008-10#2)(2008-8#6)(2008-9#4)(2009-10#1)(2013-8#1)
QTLs in##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
QTLs of##2##2##(2009-10#1)(2012-3#1)
QTLs on##3##2##(2008-10#3)
QTLs were detected##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
QTLs were identified##2##3##(2008-10#1)(2008-9#1)
QTLs were##7##2##(2008-10#2)(2008-4#2)(2008-9#3)
QTLs##58##1##(2008-10#21)(2008-4#3)(2008-8#10)(2008-9#12)(2009-10#6)(2011-1#4)(2012-3#1)(2013-8#1)
QTP##3##1##(2009-5#1)(2012-3#2)
QTc interval##3##2##(2011-1#2)(2012-12#1)
QTc##16##1##(2008-8#10)(2010-1#1)(2011-1#4)(2012-12#1)
QTsc##3##1##(2008-10#3)
QUAC##5##1##(2013-8#5)
QUAD##5##1##(1994-11#5)
QUAD-bound##2##1##(1994-11#2)
QUAL##2##1##(2008-3#2)
QUEST##2##1##(2010-12#2)
QUIN##2##1##(1993-12#2)
QWB and##2##2##(1996-7#2)
QWB##5##1##(1996-7#5)
QWP##4##1##(2008-2#1)(2008-3#3)
Qa-2##3##1##(2008-5#2)(2008-9#1)
Qa-2(a)##3##1##(2008-5#3)
Qanadli##2##1##(2011-2#2)
Qassim University##2##2##(2013-8#2)
Qassim##3##1##(2013-8#3)
Qatar##3##1##(2007-10#1)(2010-11#1)(2013-8#1)
QbD framework##3##2##(2012-2#3)
QbD##9##1##(2012-2#9)
Qc to##3##2##(1993-8#3)
Qc##5##1##(1993-8#5)
Qd##2##1##(2010-12#2)
Qd-RGD and Cy3-AS1411##2##3##(2010-12#2)
Qd-RGD##3##1##(2010-12#3)
Qdot##2##1##(2008-10#2)
Qfhs##3##1##(2008-10#3)
Qi Gong exercises and##2##4##(2010-6#2)
Qi Gong exercises##4##3##(2010-6#4)
Qi and##2##2##(2012-3#1)(2013-8#1)
Qi in##2##2##(2012-3#2)
Qi##14##1##(2008-4#1)(2008-9#1)(2010-6#4)(2012-3#5)(2013-1#1)(2013-8#2)
Qiagen HPV Sign Genotyping Test##2##5##(2013-7#2)
Qigong and##2##2##(2013-1#2)
Qigong exercise##2##2##(2013-1#2)
Qigong##8##1##(2008-10#3)(2013-1#5)
Qing' e Pills##3##3##(2011-1#3)
Qinghai-Tibet##4##1##(2008-9#3)(2009-5#1)
Qmax##3##1##(1991-8#3)
QoI application##2##2##(2008-10#2)
QoL and##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
QoL in the##2##3##(2008-10#1)(2012-12#1)
QoL in##6##2##(2008-10#2)(2012-1#2)(2012-12#1)(2013-1#1)
QoL##29##1##(2008-10#7)(2008-3#3)(2008-6#1)(2011-2#3)(2012-1#6)(2012-12#3)(2013-1#6)
Qorf4 and##2##2##(1997-8#2)
Qu Du Zeng##2##3##(2011-3#2)
Quad##6##1##(2008-3#1)(2013-1#5)
Quadratic##3##1##(2007-12#1)(2012-2#1)(2013-8#1)
Quadrature detection##2##2##(2007-11#1)(2008-2#1)
Quadrature##3##1##(2007-11#2)(2008-2#1)
Quadriceps muscle##2##2##(2006-10#1)(2011-2#1)
Quadriceps##5##1##(2006-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
Quadricuspid aortic valve is a rare##2##6##(2008-11#1)(2012-3#1)
Quadricuspid aortic valve##4##3##(2008-11#2)(2009-2#1)(2012-3#1)
Quadrilateral space syndrome##2##3##(2008-8#2)
Quadriplegic##2##1##(1993-3#1)(2008-7#1)
Quadrupole##2##1##(2007-12#1)(2008-10#1)
Quaker##3##1##(2012-2#3)
Quakers##2##1##(2012-2#2)
Qualification##2##1##(2007-11#1)(2008-10#1)
Qualitative Analysis##2##2##(2012-3#1)(2013-8#1)
Qualitative analyses##2##2##(2008-1#1)(2009-5#1)
Qualitative analysis of##2##3##(1990-8#1)(2008-10#1)
Qualitative analysis##4##2##(1990-8#1)(2008-10#1)(2008-9#1)(2010-10#1)
Qualitative and quantitative analysis of organophosphorus pesticide residues##2##8##(2008-10#2)
Qualitative and quantitative analysis of##3##5##(2008-10#2)(2011-1#1)
Qualitative and quantitative##6##3##(2008-10#2)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
Qualitative research##2##2##(2008-12#1)(2012-12#1)
Qualitative##37##1##(1990-8#1)(1991-11#1)(1992-9#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-10#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Qualitatively##5##1##(1997-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-11#1)
Quality Algorithms##3##2##(1996-12#1)(1996-3#1)(1997-1#1)
Quality Assessment##4##2##(1997-2#1)(2008-12#1)(2008-9#1)(2011-2#1)
Quality Assurance Department##2##3##(2008-10#2)
Quality Assurance Reform Initiative (QARI)##2##5##(1996-2#1)(1997-2#1)
Quality Assurance##9##2##(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
Quality Award##5##2##(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#2)
Quality Cup##2##2##(1996-12#2)
Quality Improvement Initiative##2##3##(1993-2#1)(2011-1#1)
Quality Improvement Program##5##3##(1992-3#1)(1996-2#3)(2013-1#1)
Quality Improvement##16##2##(1991-1#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1995-12#1)(1996-2#3)(1997-2#1)(2011-1#1)(2013-1#1)
Quality Index##3##2##(2011-2#1)(2012-1#1)(2013-1#1)
Quality Management##8##2##(1992-2#1)(1994-2#1)(1996-2#2)(1996-3#1)(1997-3#2)(2010-9#1)
Quality Monitoring##2##2##(1997-4#1)(2008-10#1)
Quality Share##2##2##(1996-3#2)
Quality and##8##2##(1993-3#1)(1995-12#1)(2007-2#1)(2007-3#1)(2008-3#1)(2009-4#1)(2012-2#2)
Quality assessment##3##2##(1993-2#1)(1996-12#1)(2008-8#1)
Quality assurance (QA)##2##3##(1994-2#1)(2007-7#1)
Quality assurance and quality##2##4##(1991-1#1)(2008-4#1)
Quality assurance in##4##3##(1990-6#1)(1991-12#1)(1995-3#1)(2007-7#1)
Quality assurance is##2##3##(1992-11#1)(1992-9#1)
Quality assurance##14##2##(1990-6#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-2#3)(1995-3#1)(2007-7#2)(2008-3#1)(2008-4#1)
Quality control and##2##3##(1997-8#1)(2008-10#1)
Quality control for##2##3##(1992-10#1)(2008-10#1)
Quality control in##2##3##(2008-9#2)
Quality control of##2##3##(1995-8#1)(2008-10#1)
Quality control##11##2##(1992-10#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-9#2)
Quality criteria for##2##3##(2008-11#2)
Quality improvement in##2##3##(1995-12#1)(1997-1#1)
Quality improvement teams##3##3##(1993-12#3)
Quality improvement##11##2##(1993-12#3)(1993-2#2)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-3#2)
Quality in##2##2##(2007-10#1)(2008-11#1)
Quality indicators##2##2##(1997-1#1)(2008-7#1)
Quality management##3##2##(1991-1#1)(1993-3#1)(1997-1#1)
Quality of Care##2##3##(1997-1#1)(2012-3#1)
Quality of Life Inventory##2##4##(2007-12#1)(2012-2#1)
Quality of Life Questionnaire##3##4##(2010-4#1)(2011-2#2)
Quality of Life in##6##4##(1994-12#1)(1995-4#1)(2012-3#1)(2013-1#3)
Quality of Life##20##3##(1994-12#1)(1994-3#3)(1995-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
Quality of care in##2##4##(1996-2#1)(2007-5#1)
Quality of care##6##3##(1990-6#1)(1995-3#1)(1996-2#2)(1997-3#1)(2007-5#1)
Quality of life after penile reconstruction##2##6##(2011-2#2)
Quality of life after##3##4##(2008-7#1)(2011-2#2)
Quality of life and psychological##2##5##(2008-9#1)(2009-11#1)
Quality of life and##3##4##(2008-5#1)(2008-9#1)(2009-11#1)
Quality of life for##2##4##(2007-10#1)(2008-10#1)
Quality of life in elderly##2##5##(1996-7#1)(2007-12#1)
Quality of life in##7##4##(1993-3#1)(1996-7#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
Quality of life##24##3##(1990-12#1)(1991-8#1)(1993-3#1)(1996-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-3#1)(2010-5#2)(2011-2#4)(2011-3#1)(2013-1#1)
Quality of##63##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#3)(1995-3#1)(1995-4#1)(1996-2#2)(1996-7#4)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#7)
Quality##239##1##(1990-12#1)(1990-6#2)(1991-1#4)(1991-12#2)(1991-3#2)(1991-8#1)(1992-10#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#5)(1994-1#3)(1994-12#6)(1994-2#6)(1994-3#5)(1995-1#1)(1995-12#4)(1995-2#4)(1995-3#5)(1995-4#1)(1995-8#1)(1996-1#2)(1996-12#5)(1996-2#9)(1996-3#7)(1996-7#4)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#14)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#16)
QuantiFERON-TB Gold##2##2##(2008-10#1)(2013-1#1)
Quantification by##2##2##(2008-10#1)(2011-1#1)
Quantification of Phytophthora##2##3##(2008-10#2)
Quantification of the##7##3##(1990-2#1)(2008-10#4)(2008-11#1)(2008-5#1)
Quantification of##38##2##(1990-2#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#25)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#3)
Quantification was performed##2##3##(2008-10#1)(2011-3#1)
Quantification##47##1##(1990-2#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#3)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
Quantify##5##1##(2008-10#5)
Quantifying the##7##2##(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
Quantifying##16##1##(1993-1#1)(1997-6#1)(2008-10#5)(2008-3#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#1)
Quantitation by##2##2##(1995-11#1)(2008-10#1)
Quantitation of the##2##3##(1990-11#1)(1997-3#1)
Quantitation of##16##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-9#2)(1992-12#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)
Quantitation was carried out by the peak area method##2##9##(2008-10#2)
Quantitation was##3##2##(2008-10#3)
Quantitation##21##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-9#2)(1992-12#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)
Quantitative Analysis of##2##3##(2008-10#1)(2010-5#1)
Quantitative EEG##2##2##(1991-1#1)(1991-12#1)
Quantitative PCR##4##2##(1993-6#1)(2008-10#1)(2009-12#1)(2012-12#1)
Quantitative RT-PCR##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
Quantitative Real-Time##2##2##(2008-10#2)
Quantitative Resistance to##2##3##(2008-10#2)
Quantitative Trait Loci (QTL)##2##4##(2008-10#1)(2008-7#1)
Quantitative Trait Loci Analysis##2##4##(2008-10#2)
Quantitative Trait Loci in##2##4##(2008-10#2)
Quantitative Trait Loci##11##3##(2008-10#9)(2008-7#1)(2012-3#1)
Quantitative Trait##12##2##(2008-10#10)(2008-7#1)(2012-3#1)
Quantitative analyses exhibited##2##3##(2008-10#2)
Quantitative analyses of the##3##4##(1996-1#1)(1997-2#2)
Quantitative analyses##6##2##(1996-1#1)(1997-2#2)(2008-10#3)
Quantitative analysis of OP and their degradation products in plasma and urine by mass spectrometric methods is a more specific method##2##21##(2013-1#2)
Quantitative analysis of the##2##4##(1994-6#1)(2008-10#1)
Quantitative analysis of##24##3##(1990-2#1)(1992-11#1)(1994-6#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
Quantitative analysis##28##2##(1990-2#1)(1992-11#1)(1994-6#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#12)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
Quantitative and qualitative##6##3##(1994-2#1)(2008-10#3)(2010-7#1)(2012-12#1)
Quantitative and##7##2##(1994-2#1)(2008-10#4)(2010-7#1)(2012-12#1)
Quantitative approaches##2##2##(2008-11#1)(2009-5#1)
Quantitative autoradiography##2##2##(1991-9#1)(1994-2#1)
Quantitative data##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
Quantitative determination of##10##3##(1990-12#1)(2008-1#1)(2008-10#8)
Quantitative determination##11##2##(1990-12#1)(2008-1#1)(2008-10#9)
Quantitative determinations have been made by##3##6##(2008-10#3)
Quantitative estimates##2##2##(1992-12#1)(2008-10#1)
Quantitative evaluation of##3##3##(1994-1#1)(1997-3#1)(2013-1#1)
Quantitative extraction##2##2##(2008-10#2)
Quantitative extractions##2##2##(2008-10#2)
Quantitative fluorescence in situ hybridization##2##5##(2008-1#1)(2008-9#1)
Quantitative fluorescence##3##2##(1994-5#1)(2008-1#1)(2008-9#1)
Quantitative hydroxyl concentration time-series measurements##2##5##(2008-3#2)
Quantitative image analysis##2##3##(1995-12#1)(2008-2#1)
Quantitative in situ hybridization##3##4##(1996-12#1)(2008-4#2)
Quantitative in situ##4##3##(1996-12#1)(2008-3#1)(2008-4#2)
Quantitative in##5##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#2)
Quantitative protein##2##2##(2008-4#2)
Quantitative real-time PCR##2##3##(2011-2#1)(2013-1#1)
Quantitative real-time polymerase chain reaction##5##5##(2008-10#2)(2012-1#1)(2012-2#1)(2012-3#1)
Quantitative real-time##7##2##(2008-10#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Quantitative recoveries (&gt##2##3##(2008-10#2)
Quantitative recoveries for##2##3##(2008-10#2)
Quantitative recoveries of##2##3##(1990-2#1)(2008-10#1)
Quantitative recoveries##8##2##(1990-2#1)(2008-10#7)
Quantitative recovery of##5##3##(2008-10#5)
Quantitative reverse##2##2##(1997-1#1)(2012-3#1)
Quantitative separation of##2##3##(2008-10#2)
Quantitative structure-retention relationship (QSRR)##2##4##(2008-10#2)
Quantitative studies##2##2##(2007-12#1)(2008-7#1)
Quantitative study##2##2##(2008-3#1)(2013-8#1)
Quantitative trait Loci mapping##2##4##(2008-10#2)
Quantitative trait Loci##3##3##(2008-10#3)
Quantitative trait loci (QTLs)##2##4##(2008-10#1)(2009-10#1)
Quantitative trait##5##2##(2008-10#4)(2009-10#1)
Quantitative two-dimensional##2##2##(2008-3#1)(2008-5#1)
Quantitative##232##1##(1990-12#1)(1990-2#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#6)(2007-12#2)(2008-1#2)(2008-10#98)(2008-11#5)(2008-2#5)(2008-3#13)(2008-4#5)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-5#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#2)
Quantitatively##2##1##(1997-8#1)(2009-11#1)
Quantities##2##1##(2008-11#1)(2008-2#1)
Quantity##2##1##(2008-10#2)
Quantized##2##1##(2007-11#1)(2008-7#1)
Quantum and classical dynamics simulations of ATP hydrolysis in solution##2##10##(2013-1#2)
Quantum chemical##3##2##(1992-8#1)(2007-11#2)
Quantum dots##2##2##(2008-10#1)(2010-12#1)
Quantum theoretical calculations on an##2##5##(2010-2#2)
Quantum##29##1##(1990-11#1)(1991-9#1)(1992-8#1)(1993-5#1)(1996-9#5)(2007-11#3)(2008-10#2)(2008-3#4)(2008-5#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2012-2#1)(2013-1#2)
Quantum-mechanical##2##1##(2007-11#1)(2012-2#1)
Quantum-sized ZnO##2##2##(2009-8#2)
Quarterly##2##1##(1997-1#1)(2008-1#1)
Quartz crystal microbalance##2##3##(2008-10#1)(2008-6#1)
Quartz crystal##3##2##(2008-10#2)(2008-6#1)
Quartz##4##1##(2008-10#2)(2008-6#1)(2010-5#1)
Quasi phase matching was##2##4##(2007-11#1)(2007-12#1)
Quasi phase matching##3##3##(2007-11#1)(2007-12#2)
Quasi##4##1##(2007-11#1)(2007-12#3)
Quasi-One-Dimensional##2##1##(1996-12#1)(2008-2#1)
Quasi-phase-matched##3##1##(2007-11#2)(2007-12#1)
Quasi-static##3##1##(2007-12#1)(2008-3#1)(2012-2#1)
Quaternary##2##1##(1990-8#1)(1996-5#1)
Quebec experience##3##2##(2008-11#1)(2012-2#2)
Quebec##46##1##(1991-12#1)(1992-1#3)(1993-1#1)(1993-12#2)(1995-3#2)(1996-1#2)(1996-2#1)(1997-2#1)(1997-5#2)(1997-7#1)(2007-12#9)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-2#2)
Quebec's healthcare##2##2##(2011-2#1)(2012-12#1)
Quebec's##4##1##(1997-2#1)(2008-11#1)(2011-2#1)(2012-12#1)
Queen Elizabeth##4##2##(1990-2#1)(1994-3#3)
Queen##12##1##(1990-2#1)(1994-3#3)(2008-10#1)(2008-5#1)(2009-2#4)(2009-7#2)
Queen's##2##1##(1996-2#1)(2012-2#1)
Queens##3##1##(1996-2#1)(2008-5#1)(2008-8#1)
Queensland##12##1##(2008-12#1)(2008-3#1)(2008-9#2)(2010-10#1)(2010-8#3)(2011-1#1)(2012-12#1)(2013-8#2)
Quenching of##2##2##(1995-2#1)(2008-2#1)
Quenching##5##1##(1995-2#1)(1995-5#1)(2008-2#3)
Quercetin and luteolin##2##3##(2008-4#2)
Quercetin and##3##2##(2008-10#1)(2008-4#2)
Quercetin##6##1##(2008-10#3)(2008-4#2)(2009-12#1)
Quercus ilex##3##2##(2008-10#1)(2011-10#2)
Quercus pubescens##2##2##(2012-6#2)
Quercus robur##5##2##(2008-10#1)(2009-6#1)(2012-6#1)(2012-9#1)(2013-8#1)
Quercus species (Q##2##3##(2012-5#1)(2012-6#1)
Quercus species##6##2##(2012-5#3)(2012-6#2)(2012-9#1)
Quercus spp##3##2##(2008-10#1)(2012-5#2)
Quercus suber##2##2##(2009-12#2)
Quercus##27##1##(2008-10#4)(2008-12#2)(2008-8#1)(2009-12#2)(2009-6#1)(2010-2#1)(2011-10#2)(2012-5#6)(2012-6#5)(2012-9#2)(2013-8#1)
Question##3##1##(1996-2#1)(2010-12#1)(2012-3#1)
Questioning##2##1##(1992-1#1)(2010-12#1)
Questionnaire and the Child##2##4##(2006-10#1)(2009-11#1)
Questionnaire and the##3##3##(2006-10#1)(2009-11#1)(2013-1#1)
Questionnaire and##6##2##(2006-10#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#2)
Questionnaire for Children##2##3##(2009-4#1)(2010-9#1)
Questionnaire for##5##2##(1994-12#1)(1995-4#1)(2009-4#1)(2010-9#1)(2011-2#1)
Questionnaire in##2##2##(2012-3#2)
Questionnaire was used to##2##4##(1995-2#1)(2010-4#1)
Questionnaire was##4##2##(1995-2#1)(1996-3#1)(2007-11#1)(2010-4#1)
Questionnaire were##2##2##(2010-4#1)(2010-9#1)
Questionnaire##69##1##(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#2)(2010-11#1)(2010-4#2)(2010-6#1)(2010-9#3)(2011-1#4)(2011-2#5)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#7)
Questionnaire-Revised##2##1##(2008-11#1)(2009-12#1)
Questionnaires were distributed to##2##4##(2007-11#1)(2013-1#1)
Questionnaires were distributed##3##3##(2007-11#1)(2011-1#1)(2013-1#1)
Questionnaires were used to##2##4##(2007-7#1)(2008-11#1)
Questionnaires were##8##2##(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
Questionnaires##14##1##(1992-4#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Questions about##2##2##(1992-12#1)(2008-9#1)
Questions and answers on immunization##2##5##(2008-11#2)
Questions and answers##3##3##(2008-11#2)(2011-2#1)
Questions were raised as to the volume of publications##3##9##(2008-10#3)
Questions were##4##2##(2008-10#3)(2008-12#1)
Questions##19##1##(1992-12#1)(1992-5#1)(1995-2#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
Quick BASIC 4##2##3##(2008-10#2)
Quick##7##1##(1994-3#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-8#1)(2012-1#1)
QuickDOC##2##1##(1992-2#2)
QuickVue test##2##2##(2011-2#2)
QuickVue##7##1##(2008-1#1)(2011-1#1)(2011-2#5)
Quiescent cells##2##2##(1993-6#1)(2008-11#1)
Quil A##2##2##(1995-5#1)(2009-6#1)
Quill mite (Dermoglyphus passerinus) infestation of canaries (Serinus canaria)##2##9##(1997-3#2)
Quill##3##1##(1997-3#3)
Quillaja saponaria##3##2##(1997-4#3)
Quinobene##3##1##(1992-9#3)
Quinoline oxidoreductase##2##2##(1993-11#2)
Quinoline##6##1##(1993-11#4)(2008-7#2)
Quinolones are##2##2##(2012-3#2)
Quinolones##3##1##(2012-3#3)
Quinone##3##1##(1990-11#2)(1990-7#1)
Quinta##3##1##(2008-10#3)
Quintana Roo##5##2##(2008-5#5)
Quis custodiet ipsos custodes##2##4##(1995-11#1)(2012-2#1)
Quis custodiet ipsos##3##3##(1995-11#2)(2012-2#1)
Quite##3##1##(1992-9#1)(1993-12#1)(2008-3#1)
Quiz corner##3##2##(2007-4#3)
Quiz##5##1##(2007-4#3)(2007-7#2)
Quorum sensing##3##2##(1995-2#2)(2010-10#1)
Québec##13##1##(1994-1#1)(1996-3#1)(2008-10#2)(2008-2#7)(2010-4#1)(2013-1#1)
R (2)##2##2##(2008-10#1)(2013-8#1)
R +##2##2##(1992-6#1)(2008-4#1)
R 50 595##6##3##(1990-5#6)
R = 0##15##3##(1992-3#1)(1995-6#1)(1996-2#10)(1997-7#2)(2013-8#1)
R = Me##3##3##(1996-2#2)(1997-7#1)
R =##27##2##(1992-3#1)(1995-6#1)(1996-2#14)(1997-7#7)(2007-12#1)(2008-12#1)(2009-9#1)(2013-8#1)
R alleles##3##2##(2008-10#3)
R and##9##2##(1990-7#1)(2008-10#2)(2008-8#3)(2010-5#2)(2013-7#1)
R factor of##3##3##(1991-3#1)(1992-8#1)(2008-8#1)
R factor was 0##2##4##(2008-8#1)(2008-9#1)
R factor##5##2##(1991-3#1)(1992-8#1)(2008-8#2)(2008-9#1)
R gene##5##2##(2008-10#4)(2008-8#1)
R gene-mediated##2##2##(2008-10#1)(2009-6#1)
R genes in##4##3##(2008-10#3)(2011-2#1)
R genes were##2##3##(2008-10#1)(2011-2#1)
R genes##17##2##(2008-10#12)(2008-8#1)(2011-2#4)
R in##2##2##(2008-10#1)(2010-5#1)
R islets##4##2##(1995-8#4)
R levels##2##2##(2008-10#2)
R lines of##2##3##(2007-11#1)(2008-2#1)
R or##2##2##(1995-8#1)(2010-5#1)
R package##2##2##(2009-7#1)(2011-3#1)
R state##5##2##(1990-8#5)
R strains from##2##3##(2008-10#2)
R strains##5##2##(1995-8#1)(2008-10#4)
R to the##3##3##(1990-8#2)(2008-8#1)
R to##4##2##(1990-8#2)(2008-10#1)(2008-8#1)
R value##3##2##(1993-8#1)(1996-5#1)(2013-8#1)
R wave and R/S ratio in lead aVR##2##8##(2010-1#2)
R wave##6##2##(1996-6#4)(2010-1#2)
R were##2##2##(2008-10#1)(2010-4#1)
R##772##1##(1990-10#2)(1990-11#2)(1990-2#1)(1990-5#11)(1990-6#2)(1990-7#4)(1990-8#12)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#12)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#6)(1992-7#3)(1992-8#1)(1993-11#6)(1993-12#2)(1993-6#8)(1993-8#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#11)(1995-3#3)(1995-5#4)(1995-6#10)(1995-8#8)(1996-2#15)(1996-5#3)(1996-6#4)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#440)(2008-11#2)(2008-12#13)(2008-2#8)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#13)(2008-8#20)(2008-9#5)(2009-2#4)(2009-6#6)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-4#1)(2010-5#8)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#12)(2011-3#2)(2012-2#7)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#3)(2013-7#5)(2013-8#4)
R#ENTITYSTARTX000E9##3##1##(2011-2#3)
R&amp##9##1##(1995-6#1)(2008-5#2)(2008-7#1)(2008-8#4)(2009-5#1)
R&lt##2##1##(2008-10#2)
R'-disubstituted##2##1##(2007-11#2)
R(0) values##2##2##(1997-7#2)
R(0)##8##1##(1997-7#3)(2008-10#5)
R(0-)##2##1##(2008-3#2)
R(1) and R(2)##2##3##(2008-10#1)(2009-6#1)
R(1)##8##1##(1997-7#1)(2008-10#5)(2008-9#1)(2009-6#1)
R(2) = 0##4##3##(2008-10#3)(2008-3#1)
R(2) =##5##2##(2008-10#3)(2008-3#1)(2009-9#1)
R(2) and##2##2##(2008-10#2)
R(2) for##2##2##(2008-10#1)(2011-1#1)
R(2) value##2##2##(2008-10#2)
R(2) values of 0##2##4##(2008-10#2)
R(2) values of ca##2##4##(2009-3#2)
R(2) values of##4##3##(2008-10#2)(2009-3#2)
R(2) values##5##2##(2008-10#3)(2009-3#2)
R(2)##28##1##(2008-10#18)(2008-3#2)(2009-11#2)(2009-3#2)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)
R(2)=0##10##1##(2008-10#5)(2009-7#4)(2010-4#1)
R(3)N##2##1##(2008-10#2)
R(E)##3##1##(2008-11#3)
R(F)##2##1##(1997-7#1)(2008-12#1)
R(P))##2##1##(1996-2#2)
R(P))- and (R##5##3##(1996-2#5)
R(P))-5##4##1##(1996-2#4)
R(P))-8##2##1##(1996-2#2)
R(T)R(V) and##2##2##(2008-10#2)
R(T)R(V)##6##1##(2008-10#6)
R(T)S(V)##3##1##(2008-10#3)
R(TRES)##2##1##(2008-8#2)
R(TRES)R(TRES)##2##1##(2008-8#2)
R(US)##3##1##(2008-10#3)
R(b) from##2##2##(2008-3#2)
R(e-s)##4##1##(1996-6#4)
R(f)##4##1##(2008-10#2)(2008-11#1)(2010-5#1)
R(infinity) and K(infinity)##3##3##(2008-2#3)
R(m)##3##1##(2008-10#2)(2008-3#1)
R(rs)##7##1##(2008-2#3)(2008-3#4)
R(w) = 0##6##3##(1996-2#4)(1997-7#2)
R(w)##7##1##(1996-2#4)(1997-7#2)(2008-2#1)
R(z) and##2##2##(2008-2#2)
R) and##2##2##(2008-8#2)
R)##7##1##(1995-8#1)(2008-10#1)(2008-8#4)(2011-2#1)
R-##3##1##(1994-8#2)(2008-10#1)
R-(+)- and S-(-)-ofloxacin##2##3##(2008-10#2)
R-(+)- and##3##2##(2008-10#3)
R-(+)-OFLX##2##1##(2008-10#2)
R-(-)- and##2##2##(2008-10#2)
R-16##3##1##(1997-4#3)
R-3##3##1##(1994-6#2)(1997-4#1)
R-6##3##1##(1997-4#3)
R-E##2##1##(2011-2#2)
R-M system##2##2##(1991-9#1)(1993-9#1)
R-N6-phenyl-isopropyladenosine##3##1##(1995-8#3)
R-PIA##8##1##(1997-1#5)(1997-2#3)
R-R intervals and##3##3##(1991-10#1)(2009-9#1)(2010-5#1)
R-R intervals##4##2##(1991-10#2)(2009-9#1)(2010-5#1)
R-R##6##1##(1991-10#3)(1994-3#1)(2009-9#1)(2010-5#1)
R-allele frequencies measured##2##3##(2008-10#2)
R-allele##3##1##(2008-10#3)
R-banding##2##1##(2009-2#1)(2010-1#1)
R-captopril##3##1##(2008-10#3)
R-enantiomer##3##1##(1993-3#1)(1994-8#1)(2008-10#1)
R-factor of 19##3##3##(1993-8#1)(1997-4#1)(1997-6#1)
R-factor of##5##2##(1992-4#1)(1993-8#1)(1997-4#1)(1997-6#1)(2008-8#1)
R-factor##7##1##(1992-4#2)(1993-8#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-8#1)
R-gene##3##1##(2008-10#3)
R-ibuprofen##2##1##(1994-8#2)
R-phycoerythrin##2##1##(2008-8#2)
R-state##5##1##(1990-8#2)(1995-2#1)(1995-6#2)
R-sulphoximine##2##1##(1993-9#2)
R-type II and##2##3##(2012-3#2)
R-type##4##1##(2012-3#4)
R-types##3##1##(2012-3#3)
R0 is##3##2##(2008-8#1)(2013-8#2)
R0##8##1##(2008-8#2)(2011-2#3)(2012-12#1)(2013-8#2)
R1 = 0##4##3##(1996-2#4)
R1 =##5##2##(1990-12#1)(1996-2#4)
R1 and R2##6##3##(1993-11#3)(2008-7#1)(2010-3#2)
R1 and##7##2##(1993-11#4)(2008-7#1)(2010-3#2)
R1##28##1##(1990-12#2)(1991-7#1)(1993-11#9)(1996-2#4)(2007-7#1)(2008-10#3)(2008-7#1)(2010-3#3)(2011-2#2)(2013-1#2)
R1-5##3##1##(1995-11#3)
R1-5bsr##2##1##(1995-11#2)
R100 and##2##2##(1990-11#1)(1991-7#1)
R100##4##1##(1990-11#3)(1991-7#1)
R1408B##4##1##(2008-9#4)
R16##3##1##(2007-7#3)
R1881##7##1##(1990-11#4)(1991-5#2)(2010-1#1)
R2 &gt##3##2##(2008-12#3)
R2 protein##4##2##(1993-11#4)
R2##34##1##(1991-11#1)(1992-9#1)(1993-11#12)(1993-12#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#3)(2011-2#2)(2013-1#3)(2013-8#1)
R2-guided region selection##2##3##(1995-3#2)
R22L TCS##2##2##(2008-8#2)
R22L##3##1##(2008-8#3)
R32##2##1##(1994-9#1)(2008-8#1)
R32NS1(81)##2##1##(1991-5#2)
R338W was##2##2##(1995-8#2)
R338W##11##1##(1995-8#11)
R3616##2##1##(1995-2#2)
R3bv2##2##1##(2008-10#2)
R4009##3##1##(1995-2#3)
R514 and R1408B##3##3##(2008-9#3)
R514##4##1##(2008-9#4)
R6-5##5##1##(1991-7#5)
R6K##2##1##(1994-5#2)
R70A##2##1##(1995-6#2)
R8##2##1##(2007-7#1)(2008-10#1)
R=0##6##1##(2008-10#5)(2013-1#1)
R?0##2##1##(2007-11#2)
RA alone##2##2##(2008-5#1)(2010-12#1)
RA and##6##2##(1993-9#1)(2008-11#2)(2008-7#2)(2012-3#1)
RA can##3##2##(1990-6#1)(2008-8#1)(2012-1#1)
RA for##4##2##(1993-9#1)(1994-9#1)(2008-11#1)(2012-3#1)
RA may be##2##3##(2006-10#1)(2008-11#1)
RA may##3##2##(2006-10#1)(2008-11#2)
RA patients##6##2##(1993-2#1)(2008-5#1)(2011-2#2)(2012-2#2)
RA therapy##2##2##(1991-9#1)(2013-8#1)
RA treatment##2##2##(1992-5#1)(1996-5#1)
RA were##5##2##(1990-6#1)(1993-2#1)(2007-8#1)(2008-7#2)
RA with##3##2##(2007-8#1)(2008-11#2)
RA##110##1##(1990-6#4)(1991-9#2)(1992-5#2)(1993-2#2)(1993-3#1)(1993-9#10)(1994-11#3)(1994-6#1)(1994-9#1)(1996-5#6)(2006-10#2)(2007-8#5)(2008-10#1)(2008-11#16)(2008-5#12)(2008-7#8)(2008-8#4)(2010-12#5)(2011-2#5)(2012-1#4)(2012-2#8)(2012-3#5)(2013-8#3)
RA-XT##3##1##(1993-12#3)
RA-treated##2##1##(1990-6#1)(1993-9#1)
RA5##3##1##(2008-6#3)
RA538 gene##2##2##(2008-8#2)
RA538##6##1##(2008-8#6)
RABA##3##1##(1990-12#3)
RAC protein##2##2##(1994-11#2)
RAC##3##1##(1994-11#2)(2012-3#1)
RAC-PK alpha and beta##3##4##(1994-11#3)
RAC-PK##5##1##(1994-11#5)
RACE##9##1##(1994-11#3)(1994-12#2)(2008-8#2)(2010-5#1)(2011-1#1)
RAD##2##1##(2008-11#2)
RAD3##4##1##(1993-12#3)(1995-9#1)
RAD51##3##1##(1995-6#1)(1997-4#2)
RAD52##5##1##(1995-6#5)
RAD9##2##1##(1996-3#2)
RAF##3##1##(1996-6#1)(1997-1#1)(2008-8#1)
RAFT polymerization of##2##3##(2008-12#2)
RAFT polymerization##3##2##(2008-12#3)
RAFT##4##1##(2008-12#3)(2009-10#1)
RAG##2##1##(1997-7#2)
RAG1##2##1##(1997-9#2)
RAM 7s##5##2##(1993-8#5)
RAM and AFLP##3##3##(2008-10#3)
RAM##12##1##(1993-8#5)(2008-10#5)(2012-2#2)
RAM1 and RAM2##3##3##(1993-9#3)
RAM1##4##1##(1993-9#4)
RAND##5##1##(2008-10#2)(2008-6#1)(2010-12#1)(2012-12#1)
RANK##2##1##(2007-8#1)(2008-7#1)
RANKL and vWF in HUVEC##2##5##(2013-8#2)
RANKL and vWF##4##3##(2013-8#4)
RANKL was##2##2##(2008-11#1)(2011-1#1)
RANKL##14##1##(2008-11#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2013-8#5)
RANTES/CCL5##3##1##(2012-1#3)
RAP140a##3##1##(2008-8#3)
RAPA and##2##2##(2011-2#2)
RAPA##3##1##(2011-2#3)
RAPB##5##1##(2008-9#5)
RAPD Analysis##2##2##(2008-10#1)(2008-5#1)
RAPD analyses##4##2##(2008-10#3)(2008-5#1)
RAPD analysis could##2##3##(2008-10#2)
RAPD analysis##10##2##(1995-6#1)(2008-10#7)(2008-5#2)
RAPD and AFLP analyses##2##4##(2008-10#2)
RAPD and AFLP##3##3##(2008-10#3)
RAPD and RFLP markers##3##4##(2008-5#2)(2008-8#1)
RAPD and##9##2##(2008-10#4)(2008-5#4)(2008-8#1)
RAPD banding patterns##2##3##(2008-10#2)
RAPD data##4##2##(2008-10#3)(2008-5#1)
RAPD fragments##2##2##(2008-10#1)(2008-5#1)
RAPD group##2##2##(2008-10#2)
RAPD marker##13##2##(2008-10#11)(2008-5#1)(2008-9#1)
RAPD markers for##2##3##(2008-5#2)
RAPD markers in##2##3##(2008-5#2)
RAPD markers linked to the##2##5##(1995-6#1)(2008-10#1)
RAPD markers linked to##3##4##(1995-6#1)(2008-10#2)
RAPD markers that were##2##4##(2008-10#2)
RAPD markers that##3##3##(2008-10#3)
RAPD markers were obtained##2##4##(2008-10#2)
RAPD markers were##5##3##(1995-6#1)(2008-10#2)(2008-5#2)
RAPD markers##29##2##(1995-6#2)(2008-10#14)(2008-5#12)(2008-9#1)
RAPD or AFLP analyses##2##4##(2008-10#2)
RAPD or##3##2##(2008-10#3)
RAPD patterns and##2##3##(2008-10#2)
RAPD patterns##3##2##(2008-10#2)(2008-8#1)
RAPD primers used##2##3##(2008-10#2)
RAPD primers##7##2##(2008-10#5)(2013-7#2)
RAPD profiles##2##2##(2008-10#2)
RAPD variation##2##2##(2008-10#2)
RAPD##124##1##(1995-6#3)(2008-10#90)(2008-5#25)(2008-8#2)(2008-9#2)(2013-7#2)
RAPD-PCR were##2##2##(2008-10#1)(2011-2#1)
RAPD-PCR##6##1##(2008-10#2)(2008-12#2)(2011-2#2)
RAPDs were mapped##2##3##(2008-5#2)
RAPDs were##6##2##(2008-5#6)
RAPDs##12##1##(2008-10#1)(2008-5#11)
RAPET##2##1##(2008-10#2)
RAPs##4##1##(2008-10#4)
RAR alpha##2##2##(1991-9#2)
RAR##4##1##(1991-9#2)(2008-4#2)
RAR-alpha##2##1##(2007-11#2)
RAR-beta##3##1##(1992-8#1)(2007-11#1)(2008-7#1)
RARB##3##1##(2008-7#3)
RAS blockers##2##2##(2013-1#2)
RAS##8##1##(1993-8#2)(2008-6#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#2)
RAS-ACS##2##1##(2008-4#2)
RAS2##2##1##(1996-3#2)
RASE apparatus##3##2##(2008-10#3)
RASE##5##1##(2008-10#5)
RAST##3##1##(1990-3#3)
RATS##6##1##(2008-9#6)
RAUSPC##3##1##(2008-10#3)
RAV-2##2##1##(2007-6#2)
RAW 264##7##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#2)
RAW264##2##1##(1991-2#1)(1993-3#1)
RAtreatment##2##1##(2008-11#2)
RB in##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
RB protein in the##2##4##(1993-8#2)
RB protein##10##2##(1993-8#7)(1996-2#2)(1997-7#1)
RB strains have##2##3##(2008-10#2)
RB##38##1##(1992-8#2)(1993-5#1)(1993-8#9)(1994-12#3)(1996-2#2)(1997-7#5)(2008-10#10)(2010-11#1)(2013-1#5)
RB1##3##1##(1994-12#1)(2007-5#1)(2010-3#1)
RB3 and##2##2##(1994-2#2)
RB51##5##1##(2010-4#5)
RBAP-1##2##1##(1992-8#2)
RBBB##2##1##(2008-7#1)(2010-5#1)
RBC and##2##2##(2008-10#1)(2008-7#1)
RBC in##3##2##(2008-12#1)(2013-1#2)
RBC##28##1##(1995-2#1)(1996-7#1)(2008-10#6)(2008-12#3)(2008-2#2)(2008-3#3)(2008-7#3)(2009-11#1)(2010-8#1)(2013-1#7)
RBC's##4##1##(2008-2#1)(2008-3#3)
RBCM##6##1##(1994-12#6)
RBCs and##3##2##(1994-12#1)(1994-9#1)(1995-2#1)
RBCs but##2##2##(1994-6#1)(1994-9#1)
RBCs of##2##2##(1994-12#2)
RBCs was##2##2##(1994-12#1)(1994-6#1)
RBCs were##5##2##(1994-3#1)(1994-9#3)(2013-1#1)
RBCs##50##1##(1994-12#14)(1994-3#3)(1994-6#12)(1994-9#11)(1995-2#2)(2008-8#2)(2008-9#1)(2009-11#4)(2013-1#1)
RBD patients with UN##2##4##(2009-2#2)
RBD patients with##3##3##(2009-2#3)
RBD##4##1##(1997-2#1)(2009-2#3)
RBE##2##1##(1994-3#1)(2008-3#1)
RBF##2##1##(2008-10#2)
RBF-ANN##2##1##(2008-10#2)
RBK1##2##1##(1991-9#2)
RBL 2H3 cells##2##3##(2009-12#1)(2011-2#1)
RBL 2H3##3##2##(2009-12#1)(2011-2#2)
RBL##4##1##(1990-8#1)(2009-12#1)(2011-2#2)
RBL-2H3 cells##3##2##(1991-5#2)(2008-8#1)
RBLP##2##1##(2013-7#2)
RBM's##2##1##(2007-2#2)
RBM3 transcripts##2##2##(1997-7#2)
RBM3##7##1##(1997-7#7)
RBRVS and##2##2##(1994-12#2)
RBRVS reimbursement##2##2##(1993-1#1)(1993-12#1)
RBRVS##8##1##(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#4)
RBS##4##1##(1997-4#3)(2012-2#1)
RBTN1 and##2##2##(1994-8#2)
RBTN2 and TAL1 are##2##4##(1994-8#2)
RBTN2 and the##2##3##(1994-8#2)
RBTN2 and##4##2##(1994-8#4)
RBTN2##5##1##(1994-8#5)
RBV dose reduction##2##3##(2013-1#2)
RBV##8##1##(2013-1#8)
RC practices##2##2##(2008-12#2)
RC##12##1##(2008-10#3)(2008-12#5)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
RC-160 inhibited##2##2##(1995-2#2)
RC-160 on cell##2##3##(1995-2#2)
RC-160##11##1##(1995-2#11)
RC-2##5##1##(2008-10#5)
RC-3 cells##2##2##(1991-12#2)
RC-LH1##2##1##(2010-2#2)
RC-LH1-PufX##2##1##(2010-2#2)
RC-PDDA-DMSA##2##1##(2008-8#2)
RC3/neurogranin phosphorylation##2##2##(1997-2#2)
RC3/neurogranin##5##1##(1997-2#5)
RCA and##2##2##(2011-2#1)(2013-2#1)
RCA cells##3##2##(1992-3#3)
RCA##11##1##(1992-3#4)(2008-10#1)(2008-11#3)(2011-2#1)(2013-2#1)(2013-8#1)
RCC is##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
RCC pulmonary metastases##4##3##(2013-1#4)
RCC##30##1##(1990-2#1)(2007-4#1)(2008-1#5)(2008-8#3)(2011-2#7)(2012-3#3)(2013-1#10)
RCC1 and##2##2##(1995-2#1)(2012-12#1)
RCC1##4##1##(1995-2#2)(2012-12#2)
RCCs##2##1##(2012-3#2)
RCF medication chart##2##3##(2012-12#2)
RCF medication##3##2##(2012-12#3)
RCF##4##1##(2012-12#4)
RCK7 was##3##2##(2008-11#3)
RCK7##7##1##(2008-11#7)
RCM##2##1##(2007-12#2)
RCMV and BBSV##2##3##(1995-12#2)
RCN##2##1##(1996-2#1)(2008-11#1)
RCNMV##2##1##(2008-10#2)
RCNSNS(*) (R =##2##3##(1996-2#2)
RCNSNS(*)##5##1##(1996-2#5)
RCNSSN(*)##2##1##(1996-2#2)
RCT in##2##2##(2010-11#1)(2011-2#1)
RCT##14##1##(2008-10#2)(2008-11#1)(2009-4#1)(2010-11#2)(2010-9#2)(2011-2#3)(2012-12#2)(2012-3#1)
RCTs are##2##2##(2009-8#2)
RCTs##15##1##(1993-12#1)(1996-8#1)(2007-7#2)(2008-10#5)(2009-11#1)(2009-8#2)(2010-3#1)(2012-12#2)
RCs##2##1##(2008-8#1)(2008-9#1)
RD and RP1##2##3##(1997-6#2)
RD and##4##2##(1997-6#3)(2008-7#1)
RD##12##1##(1991-4#3)(1997-6#4)(2008-7#3)(2012-2#2)
RD-2586##2##1##(2008-12#2)
RDA##4##1##(2008-5#2)(2008-9#2)
RDC8##5##1##(1990-12#5)
RDCs from##2##2##(2012-8#2)
RDCs##3##1##(2012-8#3)
RDKs##2##1##(2008-10#2)
RDPR##4##1##(1993-11#4)
RDRGs##3##1##(1993-12#3)
RDS##6##1##(1995-5#1)(1997-1#1)(2007-11#1)(2009-9#2)(2013-1#1)
RDV##6##1##(2008-10#6)
RDV-I##3##1##(2008-10#3)
RDX and HMX##2##3##(2008-10#2)
RDX and##4##2##(2008-10#4)
RDX concentration range of##2##4##(2008-10#2)
RDX in##2##2##(2008-10#1)(2008-7#1)
RDX using##2##2##(2008-10#2)
RDX was##3##2##(2008-10#3)
RDX##31##1##(2008-10#23)(2008-3#2)(2008-7#5)(2009-3#1)
RDX)##3##1##(2008-10#2)(2008-11#1)
RE and##3##2##(2008-10#2)(2013-1#1)
RE##20##1##(2008-10#9)(2008-8#10)(2013-1#1)
RE(III)##2##1##(2008-10#2)
RE714##3##1##(2008-10#3)
RE8##3##1##(2008-10#3)
REALIS##5##1##(2008-7#5)
REASON##3##1##(2008-10#3)
REB##4##1##(2008-9#4)
RECENT##2##1##(2007-2#1)(2009-4#1)
RECK in##2##2##(2011-2#2)
RECK is##2##2##(2011-2#2)
RECK##6##1##(2011-2#6)
RECONSTRUCTION##2##1##(2009-5#1)(2012-12#1)
REE and##2##2##(2008-10#2)
REE concentrations of the##2##4##(2008-10#2)
REE concentrations##3##2##(2008-10#3)
REE##26##1##(2008-10#21)(2012-2#4)(2013-8#1)
REE-chl##2##1##(2008-9#2)
REEs in the##2##3##(2008-10#2)
REEs in##6##2##(2008-10#6)
REEs were##3##2##(2008-10#3)
REEs##23##1##(2008-10#22)(2008-9#1)
REGIA##4##1##(2008-7#4)
REGISTRATION##3##1##(2008-11#1)(2011-2#2)
REL data##4##2##(2013-1#4)
RELATED##2##1##(2009-8#1)(2009-9#1)
RELATIVE##2##1##(2010-8#1)(2012-3#1)
REM and##2##2##(2008-10#1)(2012-3#1)
REM sleep##14##2##(1990-7#6)(1991-5#2)(1994-8#1)(2008-11#2)(2008-7#1)(2013-8#2)
REM##17##1##(1990-7#6)(1991-5#2)(1994-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-3#1)(2013-8#2)
REMI##3##1##(2008-10#3)
REMS for##3##2##(1991-9#1)(2013-1#2)
REMS##6##1##(1991-9#1)(2013-1#5)
REP values##3##2##(2008-10#3)
RER##7##1##(1992-6#1)(2008-3#1)(2008-4#3)(2008-5#1)(2013-8#1)
RES and ELI MOs##4##4##(1990-2#4)
RES and##5##2##(1990-2#5)
RES uptake##2##2##(1993-8#2)
RES##13##1##(1990-2#6)(1992-3#4)(1993-8#3)
RESEARCH ON##2##2##(2007-2#2)
RESEARCH QUESTIONS##2##2##(2011-2#2)
RESEARCH##9##1##(2007-12#1)(2007-2#2)(2008-11#2)(2009-4#1)(2011-2#2)(2012-3#1)
RESPONSE##2##1##(2011-1#1)(2013-8#1)
RESULT##2##1##(2008-7#1)(2013-1#1)
RESULTS AND CONCLUSION##2##3##(2010-11#1)(2012-2#1)
RESULTS AND##4##2##(1993-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
RESULTS##270##1##(1993-2#1)(1993-3#1)(1995-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-4#2)(2008-10#1)(2008-11#8)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#5)(2010-12#4)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#39)(2011-2#32)(2011-7#1)(2012-1#1)(2012-12#11)(2012-2#46)(2012-3#36)(2013-1#38)
RET is##2##2##(2008-2#2)
RET##4##1##(2008-2#4)
RETRACTED##4##1##(2008-10#4)
REV##4##1##(2008-5#1)(2013-8#3)
REV-S and##2##2##(2008-5#2)
REVIEW##11##1##(1991-3#1)(1995-12#1)(2008-5#1)(2009-4#1)(2009-5#1)(2012-3#6)
REp##6##1##(2008-5#6)
RF IgM##2##2##(2011-2#2)
RF Impedance is being used##2##5##(2008-11#2)
RF Impedance is##3##3##(2008-11#3)
RF and##4##2##(1992-3#1)(1994-8#1)(2011-2#1)(2012-2#1)
RF energy##2##2##(2011-2#2)
RF isotypes##2##2##(2011-2#2)
RF lesions##2##2##(2010-6#2)
RF of##2##2##(1992-3#1)(2008-10#1)
RF power##6##2##(1992-3#3)(2008-10#2)(2009-10#1)
RF##46##1##(1992-3#10)(1994-8#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-8#2)(2009-10#7)(2009-4#1)(2010-12#2)(2010-6#3)(2011-2#10)(2012-2#1)
RF2##3##1##(1995-11#2)(2008-11#1)
RFA##13##1##(2008-9#7)(2011-2#1)(2012-2#5)
RFA-binding proteins##2##2##(2008-9#2)
RFED##3##1##(2012-2#3)
RFID sensor and##2##3##(2008-7#2)
RFID sensors##2##2##(2008-7#2)
RFID##7##1##(2008-12#3)(2008-7#4)
RFLP analyses##4##2##(1992-9#1)(2008-10#3)
RFLP analysis of##7##3##(2008-10#3)(2008-5#1)(2008-8#3)
RFLP analysis with##2##3##(2008-10#2)
RFLP analysis##18##2##(2008-10#9)(2008-5#4)(2008-8#5)
RFLP and AFLP##2##3##(2008-10#1)(2008-5#1)
RFLP and RAPD##3##3##(2008-5#3)
RFLP and##12##2##(2008-10#6)(2008-5#6)
RFLP data##2##2##(2008-10#2)
RFLP group##2##2##(2008-10#2)
RFLP groups##3##2##(2008-10#3)
RFLP haplotype##2##2##(2008-10#2)
RFLP haplotypes were##4##3##(2008-10#4)
RFLP haplotypes##7##2##(2008-10#7)
RFLP linkage##2##2##(1996-8#1)(2008-8#1)
RFLP loci##8##2##(2008-10#8)
RFLP mapping##3##2##(2008-8#3)
RFLP marker##8##2##(2008-10#3)(2008-5#2)(2008-8#2)(2008-9#1)
RFLP markers and##2##3##(2008-5#1)(2008-8#1)
RFLP markers are##2##3##(2008-5#2)
RFLP markers in a high density linkage map of sugar beet##2##11##(2008-5#2)
RFLP markers##19##2##(1996-12#1)(2008-10#4)(2008-5#10)(2008-8#3)(2008-9#1)
RFLP pattern##2##2##(2008-10#2)
RFLP##108##1##(1992-9#1)(1993-2#1)(1996-12#1)(1996-8#1)(1997-9#1)(2008-10#62)(2008-12#2)(2008-5#22)(2008-8#14)(2008-9#2)(2012-2#1)
RFLPs and##2##2##(2008-10#1)(2008-5#1)
RFLPs##8##1##(2008-10#6)(2008-5#2)
RFN##5##1##(1993-12#2)(1996-5#2)(1997-2#1)
RFP##2##1##(1997-3#1)(2009-5#1)
RFS##4##1##(2008-6#1)(2011-2#2)(2012-3#1)
RFZ20##2##1##(2008-5#2)
RG 26##3##2##(2008-10#3)
RG I and RG II##2##5##(2008-10#2)
RG I##4##2##(2008-10#4)
RG II##5##2##(2008-10#5)
RG III##4##2##(2008-10#4)
RG IV##3##2##(2008-10#3)
RG##19##1##(2008-10#19)
RG/C2##2##1##(1993-9#2)
RG57 fingerprint##2##2##(2008-10#2)
RG57##12##1##(2008-10#12)
RGA##2##1##(2008-10#2)
RGAF##2##1##(2008-10#2)
RGAP marker##2##2##(2008-10#2)
RGAP markers and##2##3##(2008-10#2)
RGAP markers for the##2##4##(2008-10#2)
RGAP markers##4##2##(2008-10#4)
RGAP##7##1##(2008-10#7)
RGAs were##7##2##(2008-10#7)
RGAs##13##1##(2008-10#13)
RGC axons##2##2##(2008-7#2)
RGC##5##1##(2008-7#3)(2009-12#2)
RGCs##3##1##(2009-12#3)
RGD peptide##2##2##(1994-11#1)(2008-7#1)
RGD##17##1##(1990-5#2)(1992-12#1)(1994-11#4)(1995-6#5)(2008-4#1)(2008-7#2)(2010-6#2)
RGD-BBN heterodimer##2##2##(2010-6#2)
RGD-BBN tracers for##2##3##(2010-6#2)
RGD-BBN tracers##3##2##(2010-6#3)
RGD-BBN##7##1##(2010-6#7)
RGD-containing##3##1##(1990-5#1)(1994-11#1)(2009-7#1)
RGDS##4##1##(1990-5#2)(1994-6#1)(2008-11#1)
RGH treatment##2##2##(2013-7#2)
RGH##3##1##(2013-7#3)
RGK5##3##1##(1991-9#3)
RGMV##2##1##(2008-10#2)
RGP##10##1##(1995-2#10)
RGR##6##1##(2008-5#1)(2008-8#5)
RGS proteins##3##2##(2008-4#2)(2009-7#1)
RGS##4##1##(2008-4#3)(2009-7#1)
RH &lt##2##2##(2008-10#2)
RH ( approximately##2##3##(2008-10#2)
RH (more than##2##3##(1996-12#2)
RH and##3##2##(2007-11#2)(2008-10#1)
RH but##4##2##(2008-10#4)
RH for 3##2##3##(2010-3#2)
RH in##3##2##(2008-10#3)
RH of##2##2##(1996-12#1)(2008-10#1)
RH on##3##2##(2008-10#3)
RH or##2##2##(2008-10#2)
RH was##2##2##(2008-10#2)
RH were##2##2##(1994-12#1)(2008-10#1)
RH##85##1##(1992-8#1)(1994-12#3)(1996-12#3)(2007-11#2)(2008-10#64)(2008-2#1)(2008-6#2)(2008-8#2)(2010-3#2)(2011-2#4)(2012-2#1)
RH)##5##1##(2008-10#3)(2010-10#1)(2010-4#1)
RH5344##2##1##(1991-9#2)
RHA on one side and conventional##2##6##(2012-2#2)
RHA##6##1##(2012-2#6)
RHA/Verh##3##1##(1994-2#3)
RHD gene##5##2##(2012-2#5)
RHD##17##1##(2012-12#1)(2012-2#11)(2012-3#5)
RHR##5##1##(2008-11#5)
RI &lt##2##2##(2013-1#2)
RI and##4##2##(1994-5#1)(1995-2#2)(2013-8#1)
RI by##2##2##(1995-2#1)(2013-1#1)
RI changes of aqueous##2##4##(2008-10#2)
RI group##5##2##(2013-1#5)
RI lines were##2##3##(2008-10#2)
RI lines##3##2##(2008-10#3)
RI strains##2##2##(1994-8#2)
RI ≥ 0##2##3##(2013-1#2)
RI##42##1##(1991-7#1)(1994-5#1)(1994-8#4)(1995-2#4)(1996-6#1)(1997-3#2)(2007-11#5)(2008-1#1)(2008-10#8)(2010-11#1)(2013-1#12)(2013-8#2)
RIA in##2##2##(1991-12#1)(2008-7#1)
RIA was##2##2##(1990-11#2)
RIA##13##1##(1990-11#2)(1990-2#1)(1991-12#2)(1991-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(2008-7#3)(2008-9#1)
RIANA##2##1##(2008-10#2)
RIBDB##3##1##(2008-7#3)
RID of RPGRIP1α(1)##2##3##(2012-12#2)
RIDT##2##1##(2011-1#2)
RIF effect##2##2##(2009-10#2)
RIF##3##1##(2009-10#3)
RIG##3##1##(2008-10#3)
RIHD##3##1##(2013-1#3)
RII beta-type PKA##2##3##(1994-8#2)
RII beta-type##3##2##(1994-8#3)
RII##8##1##(1994-8#3)(1995-11#1)(1995-2#4)
RII-binding##3##1##(1995-11#3)
RIII mice##3##2##(1990-3#3)
RIL population##6##2##(2008-10#6)
RIL29##2##1##(2008-10#2)
RILs were##5##2##(2008-10#5)
RILs##19##1##(2008-10#19)
RIM1##3##1##(2008-8#3)
RIN m5F cells##2##3##(1993-3#2)
RIN m5F##3##2##(1993-3#3)
RING##4##1##(1997-3#2)(1997-7#1)(2009-7#1)
RINm5F##4##1##(1996-5#1)(2010-11#3)
RIP isolated from##2##3##(2008-10#2)
RIP##13##1##(1990-12#1)(2008-10#9)(2008-2#2)(2012-1#1)
RIP1 (ROP##2##2##(2009-10#2)
RIP1 was##2##2##(2009-10#2)
RIP1##10##1##(2009-10#8)(2012-2#2)
RIPs against##2##2##(2008-10#1)(2008-8#1)
RIPs##10##1##(1990-11#1)(1990-12#2)(2008-10#3)(2008-8#4)
RIR##2##1##(2012-1#2)
RIS can##3##2##(1991-1#1)(1994-2#2)
RIS##10##1##(1991-1#1)(1993-2#1)(1994-2#4)(1996-1#1)(1996-3#2)(2008-7#1)
RISK MANAGEMENT FOR CHIROPRACTORS AND OSTEOPATHS##2##6##(2007-11#2)
RISK##4##1##(2007-11#2)(2010-8#1)(2013-8#1)
RIW credit##3##2##(1991-12#3)
RIW##6##1##(1991-12#5)(1995-1#1)
RIWs##3##1##(1991-12#2)(1995-1#1)
RJA and##3##2##(2013-1#3)
RJA##10##1##(2013-1#10)
RK judgments##2##2##(2009-8#2)
RK motif##4##2##(1995-6#4)
RK##9##1##(1995-6#6)(2009-8#3)
RKY2##2##1##(2008-6#2)
RKY5 was##2##2##(2008-6#2)
RKY5##4##1##(2008-6#4)
RL and##3##2##(2008-10#3)
RL could##2##2##(2008-7#1)(2011-2#1)
RL##16##1##(2008-10#8)(2008-5#1)(2008-7#5)(2011-2#2)
RLA/Verh rats##3##2##(1994-2#3)
RLC-16 cells##2##2##(2008-11#2)
RLC-16##4##1##(2008-11#4)
RLE##3##1##(2011-2#3)
RLS and PD##2##3##(2012-12#2)
RLS and##6##2##(2008-10#1)(2012-12#4)(2012-3#1)
RLS intensity##6##2##(2008-10#6)
RLS is##2##2##(2008-10#1)(2012-12#1)
RLS of##5##2##(2008-10#5)
RLS signals##8##2##(2008-10#8)
RLS symptoms##2##2##(2012-12#2)
RLS##45##1##(1997-4#1)(2008-10#31)(2012-12#12)(2012-3#1)
RLs##8##1##(2011-2#8)
RM + XRT patients##2##4##(1991-4#2)
RM + XRT##3##3##(1991-4#3)
RM##18##1##(1991-4#3)(1991-7#2)(1994-12#6)(1996-2#1)(2008-10#3)(2008-5#2)(2013-1#1)
RM151 and RM259##2##3##(2008-10#2)
RM4/TNF##5##1##(1997-2#5)
RMB##2##1##(2008-9#2)
RME##2##1##(2011-2#1)(2013-1#1)
RMEC##3##1##(1995-11#3)
RMF##4##1##(1995-11#4)
RMS##8##1##(1992-4#1)(2008-10#2)(2010-2#1)(2010-9#2)(2011-1#1)(2013-8#1)
RMS(CV) error of 0##2##4##(2007-11#2)
RMSE of##2##2##(2008-10#1)(2013-8#1)
RMSE##4##1##(2008-10#1)(2008-2#1)(2013-8#2)
RMSEA = 0##2##3##(2010-2#2)
RMSEP##3##1##(2008-10#3)
RMUC 176 clone##2##3##(1991-12#2)
RMUC 176##3##2##(1991-12#3)
RN 21245-02-3)##2##2##(2008-5#2)
RN as gatekeeper##3##3##(2008-12#3)
RN as##5##2##(2008-1#1)(2008-12#3)(2010-11#1)
RN##21##1##(1992-12#1)(1997-2#1)(2008-1#1)(2008-12#6)(2008-5#9)(2010-11#1)(2010-2#1)(2010-4#1)
RN's##4##1##(2010-11#4)
RNA (##3##2##(1991-12#2)(2008-11#1)
RNA (dsRNA)##12##2##(2008-10#9)(2008-2#1)(2008-9#1)(2013-1#1)
RNA (ncRNA)##2##2##(2007-11#1)(2008-4#1)
RNA 1 and 2 in##2##5##(1997-6#2)
RNA 1 and 2##4##4##(1997-6#3)(2008-10#1)
RNA 1 and##6##3##(1997-6#3)(2008-10#3)
RNA 2 of##3##3##(2008-10#3)
RNA 2##8##2##(2008-10#8)
RNA 3 was##3##3##(2008-10#3)
RNA 3 were##2##3##(2008-10#1)(2008-8#1)
RNA 3##9##2##(1997-6#1)(2008-10#6)(2008-8#2)
RNA N-glycosidase##2##2##(1990-11#1)(1992-3#1)
RNA Polymerase##2##2##(2008-10#1)(2012-3#1)
RNA Silencing Suppression##2##3##(2008-10#2)
RNA Silencing##3##2##(2008-10#3)
RNA accumulated##2##2##(2008-10#2)
RNA accumulation##4##2##(1994-12#1)(2008-10#3)
RNA amplification##3##2##(2008-1#2)(2008-4#1)
RNA analysis##3##2##(1990-5#1)(2008-4#2)
RNA and DNA##17##3##(1992-3#7)(1994-11#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#3)(2011-2#1)
RNA and protein level##2##4##(2008-4#1)(2011-2#1)
RNA and protein levels##2##4##(1997-7#1)(2011-2#1)
RNA and protein##10##3##(1991-9#1)(1992-8#1)(1994-8#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-9#1)(2011-2#2)
RNA and proteins##5##3##(1991-8#2)(1992-8#1)(2008-10#1)(2008-7#1)
RNA and the##3##3##(2008-10#3)
RNA and##63##2##(1990-7#3)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#8)(1992-8#3)(1993-8#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#3)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#2)(2008-9#3)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
RNA aptamers##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
RNA arbitrarily##2##2##(2008-11#2)
RNA are##3##2##(2008-9#1)(2009-3#1)(2012-3#1)
RNA as##4##2##(1995-12#1)(1997-6#1)(2008-10#1)(2008-8#1)
RNA at##2##2##(2008-10#2)
RNA binding protein##2##3##(2009-7#2)
RNA binding##6##2##(1997-2#2)(2008-2#1)(2008-8#1)(2009-7#2)
RNA blot analysis revealed that##2##5##(1993-3#1)(1997-6#1)
RNA blot analysis showed##2##4##(1990-5#1)(1994-11#1)
RNA blot analysis##7##3##(1990-5#1)(1990-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1997-6#1)
RNA blot##11##2##(1990-5#1)(1990-7#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-6#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-9#1)
RNA blots##2##2##(1991-12#1)(1991-6#1)
RNA by PCR##2##3##(1997-3#1)(2008-2#1)
RNA by the polymerase##2##4##(2008-2#1)(2011-1#1)
RNA by the##4##3##(1994-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
RNA by##13##2##(1994-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-4#3)(2009-5#1)(2011-1#1)(2011-2#1)
RNA can be##2##3##(1994-8#1)(2008-9#1)
RNA component##3##2##(2008-11#1)(2008-9#2)
RNA concentration in##3##3##(2011-1#2)(2012-2#1)
RNA concentration##4##2##(2011-1#3)(2012-2#1)
RNA containing##7##2##(1991-9#1)(1993-8#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-9#1)
RNA content##5##2##(1991-12#1)(1992-3#1)(2008-11#1)(2008-9#2)
RNA corresponding to##2##3##(1994-12#1)(2008-10#1)
RNA could be##2##3##(2008-10#1)(2011-2#1)
RNA decreased##2##2##(1990-3#2)
RNA degradation##4##2##(1997-2#1)(2008-2#1)(2008-9#1)(2010-4#1)
RNA during##2##2##(1991-2#1)(2008-10#1)
RNA editing of##2##3##(1993-12#1)(1997-2#1)
RNA editing##11##2##(1990-11#1)(1990-7#1)(1992-11#1)(1993-12#2)(1997-2#2)(2010-9#2)(2012-2#2)
RNA encoding##2##2##(1995-12#1)(1996-12#1)
RNA expressed##3##2##(1991-9#1)(1995-12#1)(1995-2#1)
RNA expression##4##2##(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
RNA extracted from the##4##4##(1992-3#1)(1994-8#1)(2008-10#2)
RNA extracted from##9##3##(1990-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(2008-10#4)(2008-4#1)
RNA extraction and##2##3##(2008-10#1)(2010-6#1)
RNA extraction##5##2##(2008-10#2)(2008-9#1)(2010-6#1)(2013-8#1)
RNA folding##4##2##(2008-4#4)
RNA for##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
RNA from a##2##3##(1990-11#1)(2008-7#1)
RNA from the##2##3##(1991-9#2)
RNA from total RNA##2##4##(2008-2#1)(2008-9#1)
RNA from total##3##3##(1997-3#1)(2008-2#1)(2008-9#1)
RNA from##31##2##(1990-11#1)(1991-11#1)(1991-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1997-3#3)(2007-6#1)(2008-10#5)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2013-1#1)
RNA gel blot##3##3##(2008-9#1)(2012-3#2)
RNA gel##4##2##(1992-11#1)(2008-9#1)(2012-3#2)
RNA gene##10##2##(1996-3#1)(2008-10#3)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
RNA genes and is part of the Genomic Encyclopedia of Bacteria and Archaea project##3##14##(2011-2#3)
RNA genes and##4##3##(2008-10#1)(2011-2#3)
RNA genes in##4##3##(1992-3#1)(2008-1#1)(2008-5#1)(2008-9#1)
RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##20##14##(2011-2#20)
RNA genes is a part of the Genomic Encyclopedia of##21##10##(2011-2#21)
RNA genes is a part of the##22##7##(2011-2#22)
RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##16##13##(2011-2#16)
RNA genes is##38##3##(2011-2#38)
RNA genes##52##2##(1992-3#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-9#1)(2011-2#41)
RNA genome of##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
RNA genome##8##2##(2008-10#4)(2008-9#2)(2009-11#1)(2013-1#1)
RNA genomes##5##2##(2008-9#4)(2013-1#1)
RNA granules##2##2##(2012-2#2)
RNA hairpin##3##2##(1993-11#1)(1994-8#2)
RNA has been##4##3##(1992-8#1)(2008-10#2)(2008-8#1)
RNA has##5##2##(1992-8#1)(2008-10#2)(2008-2#1)(2008-8#1)
RNA have##2##2##(2008-8#1)(2012-3#1)
RNA helicase##4##2##(1995-6#2)(1997-7#1)(2008-10#1)
RNA immunoprecipitation##2##2##(2008-2#2)
RNA in the##2##3##(1993-2#1)(2012-12#1)
RNA in vitro##3##3##(1991-9#1)(1992-8#1)(1997-6#1)
RNA in##22##2##(1991-9#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-8#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-9#4)(2009-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
RNA interference (RNAi)##5##3##(2008-2#2)(2009-3#1)(2010-2#1)(2010-5#1)
RNA interference in##4##3##(2008-2#2)(2009-9#1)(2010-5#1)
RNA interference to##2##3##(2008-6#1)(2011-1#1)
RNA interference##22##2##(2008-2#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
RNA internal##2##2##(1991-8#1)(2008-10#1)
RNA into##4##2##(2008-4#2)(2008-9#1)(2013-8#1)
RNA is discussed##2##3##(2008-10#1)(2008-4#1)
RNA is presented##2##3##(1990-5#1)(2011-2#1)
RNA is##32##2##(1990-5#2)(1991-2#1)(1991-9#2)(1995-6#1)(1997-2#1)(1997-7#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-4#6)(2008-7#1)(2008-9#3)(2011-2#1)
RNA isolated directly from tissue homogenate##2##6##(2008-5#2)
RNA isolated from##5##3##(1990-11#1)(1991-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
RNA isolated##7##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)
RNA level##3##2##(1990-5#1)(1993-6#1)(1994-11#1)
RNA levels for##2##3##(1991-12#1)(1996-12#1)
RNA levels##10##2##(1990-3#3)(1991-12#1)(1996-12#2)(2008-10#3)(2008-4#1)
RNA may##2##2##(1993-11#1)(2008-9#1)
RNA metabolism##2##2##(2011-2#2)
RNA molecule##4##2##(2008-4#1)(2008-7#2)(2010-12#1)
RNA molecules are##2##3##(2008-7#2)
RNA molecules in##2##3##(2008-10#1)(2008-7#1)
RNA molecules of##3##3##(2008-10#3)
RNA molecules that##2##3##(1993-9#1)(2009-5#1)
RNA molecules##16##2##(1992-6#1)(1993-9#1)(2008-10#5)(2008-2#1)(2008-7#5)(2009-11#1)(2009-5#1)(2011-2#1)
RNA motifs in##2##3##(2008-1#1)(2008-7#1)
RNA motifs##4##2##(2008-1#1)(2008-7#3)
RNA of a##2##3##(1990-5#1)(2008-10#1)
RNA of the virus##2##4##(2008-10#2)
RNA of the##5##3##(1994-11#1)(2008-10#3)(2008-9#1)
RNA of##30##2##(1990-5#1)(1994-11#1)(1996-6#1)(1997-3#2)(2008-10#18)(2008-11#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2012-2#1)
RNA oligonucleotides##2##2##(2008-4#1)(2012-2#1)
RNA on the##2##3##(1994-3#1)(2008-9#1)
RNA only##2##2##(2008-7#1)(2011-2#1)
RNA or DNA molecules##2##4##(1997-6#1)(2008-9#1)
RNA or DNA##10##3##(1992-3#1)(1997-4#1)(1997-6#2)(2008-4#4)(2008-9#2)
RNA or##12##2##(1990-7#1)(1992-3#1)(1997-4#1)(1997-6#2)(2008-11#1)(2008-4#4)(2008-9#2)
RNA polymerase (RdRp)##2##3##(2008-10#1)(2011-1#1)
RNA polymerase II and##3##4##(1994-3#1)(2009-5#1)(2012-2#1)
RNA polymerase II expression##2##4##(2008-5#1)(2008-9#1)
RNA polymerase II holoenzyme##2##4##(1994-3#2)
RNA polymerase II occupancy at the##2##6##(2010-11#2)
RNA polymerase II##28##3##(1993-12#1)(1994-3#8)(1994-8#3)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-11#2)(2011-2#2)(2012-2#2)(2012-3#1)
RNA polymerase III##4##3##(1994-12#2)(1997-7#1)(2012-12#1)
RNA polymerase activity##2##3##(1991-5#1)(2012-3#1)
RNA polymerase alpha subunit##2##4##(1995-6#2)
RNA polymerase and##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
RNA polymerase containing##4##3##(1990-12#1)(1993-12#1)(1995-6#1)(2008-9#1)
RNA polymerase core##2##3##(1995-6#1)(2008-10#1)
RNA polymerase from##3##3##(1990-7#2)(1995-6#1)
RNA polymerase gene##3##3##(1991-9#1)(2008-10#2)
RNA polymerase has##2##3##(1993-9#1)(2008-1#1)
RNA polymerase in##4##3##(1990-12#1)(1995-2#1)(1997-4#1)(2011-1#1)
RNA polymerase is##2##3##(1990-7#1)(1991-9#1)
RNA polymerase transcription##2##3##(1997-3#1)(2008-8#1)
RNA polymerase##103##2##(1990-11#1)(1990-12#3)(1990-7#3)(1991-12#2)(1991-5#3)(1991-9#4)(1993-11#1)(1993-12#2)(1993-9#2)(1994-12#3)(1994-3#8)(1994-5#1)(1994-8#5)(1995-2#5)(1995-3#1)(1995-6#6)(1995-8#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-7#3)(2008-1#1)(2008-10#14)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
RNA polymerases##11##2##(1995-6#1)(1997-4#1)(2008-10#3)(2010-6#1)(2010-7#3)(2012-3#1)(2013-8#1)
RNA pool##3##2##(2008-11#1)(2008-4#2)
RNA populations##2##2##(2008-10#1)(2008-2#1)
RNA precursor##2##2##(1995-8#1)(2008-9#1)
RNA preparations##3##2##(2008-10#1)(2008-4#2)
RNA present##2##2##(1992-11#1)(2010-5#1)
RNA probe##4##2##(1994-11#1)(1995-11#1)(1997-6#1)(2008-10#1)
RNA probes##8##2##(1990-12#1)(1994-2#1)(2008-4#5)(2008-9#1)
RNA processing and##2##3##(1992-6#1)(1995-2#1)
RNA processing##6##2##(1990-7#1)(1992-6#3)(1993-12#1)(1995-2#1)
RNA product##4##2##(1994-8#1)(2008-4#3)
RNA purified from##2##3##(2008-10#1)(2008-9#1)
RNA recombination##2##2##(1997-3#2)
RNA remained##2##2##(2008-10#1)(2008-7#1)
RNA replication and##3##3##(1994-8#1)(2011-1#1)(2012-2#1)
RNA replication is##2##3##(2008-10#1)(2008-11#1)
RNA replication##7##2##(1994-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
RNA samples##5##2##(1991-9#1)(1996-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
RNA secondary structure analysis##2##4##(2008-4#2)
RNA secondary structure that##2##4##(1991-9#2)
RNA secondary structure##7##3##(1991-9#3)(1994-8#1)(2008-4#2)(2011-3#1)
RNA secondary structures##7##3##(1997-6#1)(2009-11#2)(2011-3#3)(2013-1#1)
RNA secondary##15##2##(1991-9#3)(1994-8#1)(1997-6#1)(2008-4#3)(2009-11#2)(2011-3#4)(2013-1#1)
RNA segments##3##2##(1997-4#1)(2008-10#2)
RNA sequence##4##2##(2008-11#1)(2008-2#1)(2011-3#1)(2013-8#1)
RNA sequences with##2##3##(2008-4#2)
RNA sequences##6##2##(2008-2#2)(2008-4#3)(2008-7#1)
RNA showed##2##2##(1992-12#1)(2008-7#1)
RNA silencing and##2##3##(2008-10#1)(2012-2#1)
RNA silencing suppressor##2##3##(2008-10#1)(2012-2#1)
RNA silencing triggering##2##3##(2011-1#2)
RNA silencing##17##2##(2008-10#6)(2008-2#1)(2008-9#1)(2009-3#1)(2011-1#4)(2011-2#1)(2012-2#3)
RNA species was##2##3##(1993-12#1)(1996-12#1)
RNA species##10##2##(1991-2#1)(1993-12#1)(1996-12#1)(2008-10#4)(2008-2#1)(2009-3#1)(2012-12#1)
RNA splicing and##2##3##(2008-7#1)(2009-2#1)
RNA splicing##10##2##(1990-12#1)(1992-6#1)(1993-6#1)(1995-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
RNA stability##2##2##(2008-7#1)(2012-3#1)
RNA strand##2##2##(2008-4#1)(2009-2#1)
RNA structural dynamics and function##2##5##(2008-4#2)
RNA structural##3##2##(2008-4#2)(2011-3#1)
RNA structure and metal-binding##2##4##(2008-4#2)
RNA structure##9##2##(1991-5#1)(1994-11#1)(1994-8#2)(2008-10#1)(2008-4#2)(2008-7#2)
RNA structures##2##2##(1991-5#1)(2008-7#1)
RNA synthesis in##2##3##(2008-10#1)(2008-9#1)
RNA synthesis##13##2##(1990-12#1)(1995-2#4)(1996-2#1)(2008-10#2)(2008-4#1)(2008-9#3)(2012-3#1)
RNA target##2##2##(2008-10#2)
RNA template##3##2##(1997-3#2)(2008-9#1)
RNA tertiary structure##3##3##(2008-4#3)
RNA that##3##2##(1994-8#1)(1997-3#1)(2007-12#1)
RNA to##5##2##(1990-5#1)(1991-9#1)(1993-11#1)(1994-3#1)(2008-7#1)
RNA transcript levels##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
RNA transcript##12##2##(1992-8#4)(1994-11#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#1)
RNA transcripts##9##2##(1992-8#1)(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#2)
RNA using##2##2##(2008-10#1)(2010-5#1)
RNA viral vector##2##3##(1995-2#2)
RNA virus##5##2##(1994-11#1)(2008-9#2)(2012-3#1)(2013-8#1)
RNA viruses belonging to the##2##5##(2008-9#1)(2013-8#1)
RNA viruses##10##2##(2008-10#4)(2008-4#1)(2008-9#2)(2011-3#2)(2013-8#1)
RNA was detected in##2##4##(1997-3#1)(2008-10#1)
RNA was detected##4##3##(1997-3#1)(2008-10#3)
RNA was determined to be##3##5##(2008-10#2)(2008-11#1)
RNA was extracted and##3##4##(1995-11#1)(1997-6#1)(2008-10#1)
RNA was extracted from##5##4##(1991-2#1)(1992-9#1)(2008-10#1)(2008-9#1)(2010-6#1)
RNA was extracted##8##3##(1991-2#1)(1992-9#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-9#1)(2010-6#1)
RNA was isolated from##2##4##(1993-2#1)(1995-11#1)
RNA was isolated##3##3##(1993-2#1)(1993-8#1)(1995-11#1)
RNA was prepared##2##3##(1996-2#1)(2011-2#1)
RNA was used##3##3##(1992-12#1)(1992-6#1)(2011-2#1)
RNA was##44##2##(1991-12#2)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#2)(1995-11#2)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#5)(1997-6#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-2#1)
RNA were##8##2##(1990-11#1)(1994-6#1)(1997-3#3)(2008-10#3)
RNA which##3##2##(1990-11#1)(2008-10#1)(2010-9#1)
RNA with a##2##3##(2008-10#2)
RNA with the##2##3##(1991-5#1)(1997-3#1)
RNA with##10##2##(1991-5#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#2)(2010-9#1)
RNA##1298##1##(1990-11#9)(1990-12#9)(1990-3#6)(1990-5#10)(1990-7#12)(1991-11#1)(1991-12#14)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#8)(1991-6#1)(1991-8#4)(1991-9#21)(1992-11#10)(1992-12#2)(1992-3#23)(1992-6#12)(1992-8#13)(1992-9#1)(1993-1#3)(1993-11#6)(1993-12#9)(1993-2#5)(1993-3#5)(1993-6#6)(1993-8#9)(1993-9#6)(1994-11#13)(1994-12#10)(1994-2#1)(1994-3#12)(1994-5#2)(1994-6#4)(1994-8#24)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#21)(1995-3#2)(1995-5#1)(1995-6#16)(1995-8#6)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#14)(1997-3#33)(1997-4#7)(1997-6#20)(1997-7#11)(1997-8#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#2)(2008-1#15)(2008-10#269)(2008-11#22)(2008-12#2)(2008-2#39)(2008-4#96)(2008-5#11)(2008-6#2)(2008-7#42)(2008-8#27)(2008-9#85)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#10)(2009-5#4)(2009-6#4)(2009-7#3)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-4#3)(2010-5#9)(2010-6#3)(2010-7#3)(2010-9#6)(2011-1#15)(2011-2#71)(2011-3#13)(2012-1#1)(2012-12#5)(2012-2#21)(2012-3#22)(2013-1#22)(2013-7#1)(2013-8#11)
RNA)##6##1##(1990-7#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-9#1)
RNA-1##3##1##(2008-10#3)
RNA-2 from##2##2##(2008-10#2)
RNA-2##6##1##(2008-10#6)
RNA-RNA solution hybridisation-RNase protection##2##4##(1996-12#2)
RNA-RNA##4##1##(1996-12#2)(2008-10#1)(2008-7#1)
RNA-based sensor##2##2##(2008-10#2)
RNA-based##4##1##(2008-10#4)
RNA-binding protein##7##2##(1993-12#1)(1994-12#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-8#1)
RNA-binding proteins##4##2##(1992-8#2)(2007-12#1)(2012-12#1)
RNA-binding sites##2##2##(1993-11#2)
RNA-binding##13##1##(1992-8#2)(1993-11#2)(1993-12#1)(1994-12#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-8#1)(2012-12#1)
RNA-dependent DNA methylation##2##3##(2011-2#2)
RNA-dependent RNA polymerase##14##3##(2008-10#10)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
RNA-dependent RNA##17##2##(2008-10#13)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
RNA-dependent##19##1##(2008-10#13)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
RNA-editing##2##1##(1992-11#1)(1997-2#1)
RNA-encoded nonstructural##2##2##(2008-10#2)
RNA-mediated##3##1##(2008-10#2)(2010-9#1)
RNA-protein complexes##6##2##(2008-2#6)
RNA-protein interactions##3##2##(1995-2#1)(2008-2#1)(2008-7#1)
RNA-protein##12##1##(1992-11#1)(1995-2#1)(2008-2#9)(2008-7#1)
RNA-terminator hairpin and U-rich 3' tail##2##6##(1997-2#2)
RNA/DNA hybrids that##2##3##(2009-2#2)
RNA1 and 2##2##3##(2008-10#2)
RNA1 and RNA2##2##3##(2008-10#1)(2008-8#1)
RNA1 and##4##2##(2008-10#3)(2008-8#1)
RNA1 from strain##2##3##(2008-10#2)
RNA1##17##1##(1992-8#1)(1995-2#1)(2008-10#14)(2008-8#1)
RNA2 and RNA3##2##3##(2008-10#2)
RNA2 and##5##2##(1992-8#2)(2008-10#3)
RNA2 is##2##2##(1992-8#1)(2008-8#1)
RNA2##19##1##(1992-8#7)(2008-10#10)(2008-8#2)
RNA3 from##2##2##(2008-10#2)
RNA3 levels##2##2##(2008-10#2)
RNA3##12##1##(2008-10#12)
RNAVLab##4##1##(2009-11#4)
RNAi and##4##2##(2008-2#2)(2008-4#1)(2010-4#1)
RNAi in##3##2##(2008-2#3)
RNAi mutant strains##2##3##(2009-2#2)
RNAi was##2##2##(2008-9#1)(2011-1#1)
RNAi##32##1##(2008-2#9)(2008-4#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)
RNApasta##4##1##(2011-3#4)
RNApol##2##1##(1997-4#2)
RNApolII##5##1##(1997-4#5)
RNAs (ncRNAs)##2##2##(2008-1#1)(2008-9#1)
RNAs (satRNAs)##2##2##(2008-10#2)
RNAs 1 and 2 and the##2##6##(2008-10#1)(2008-8#1)
RNAs 1 and 2##3##4##(2008-10#2)(2008-8#1)
RNAs and##10##2##(1990-12#1)(1993-9#1)(1994-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)(2011-3#1)
RNAs are##11##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2009-3#1)(2011-2#2)(2012-2#1)
RNAs at multiple sites##2##4##(2008-10#2)
RNAs during##4##2##(1991-2#1)(2008-10#2)(2008-2#1)
RNAs encoding##3##2##(1996-12#1)(2012-12#2)
RNAs extracted from##2##3##(2008-10#2)
RNAs from##8##2##(1992-6#1)(1992-9#1)(1995-6#1)(2008-10#3)(2008-9#2)
RNAs have##2##2##(1993-8#1)(2009-3#1)
RNAs in Cryphonectria parasitica##2##4##(2008-10#2)
RNAs in the##3##3##(2008-10#2)(2011-2#1)
RNAs in vitro##2##3##(1997-3#1)(2008-10#1)
RNAs in##18##2##(1994-8#1)(1997-3#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-9#1)(2011-2#1)
RNAs of a##2##3##(2008-8#1)(2008-9#1)
RNAs of##8##2##(2008-10#6)(2008-8#1)(2008-9#1)
RNAs that are##5##3##(2008-11#1)(2008-2#1)(2009-3#2)(2010-7#1)
RNAs that##10##2##(2008-11#2)(2008-2#1)(2009-3#3)(2010-4#1)(2010-7#2)(2013-1#1)
RNAs was##3##2##(1993-8#1)(1997-3#1)(2008-4#1)
RNAs were##10##2##(1990-12#1)(1993-8#1)(2008-10#5)(2008-8#2)(2009-10#1)
RNAs with##3##2##(1994-8#1)(2008-4#2)
RNAs##182##1##(1990-11#1)(1990-12#2)(1991-2#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-8#4)(1995-6#2)(1996-12#1)(1997-3#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#6)(2008-10#63)(2008-11#7)(2008-2#11)(2008-4#6)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#13)(2009-10#1)(2009-3#10)(2010-11#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
RNAse##2##1##(1991-6#1)(1996-5#1)
RNN is##3##2##(2010-8#3)
RNPs##2##1##(1993-8#1)(2008-10#1)
RNS signaling##2##2##(2011-2#2)
RNS##4##1##(2008-5#1)(2009-8#1)(2011-2#2)
RNase A##14##2##(1992-11#5)(2008-9#2)(2011-1#6)(2011-2#1)
RNase H##4##2##(2008-4#1)(2008-8#1)(2009-2#1)(2010-2#1)
RNase H1##3##2##(2009-2#3)
RNase H2##2##2##(2009-2#2)
RNase HS was##2##3##(1990-7#2)
RNase HS##4##2##(1990-7#4)
RNase P##4##2##(1993-11#1)(1995-6#3)
RNase in##3##2##(1990-5#1)(1990-7#1)(1992-11#1)
RNase protection assay##4##3##(1993-6#1)(1997-7#1)(2008-4#2)
RNase protection assays##4##3##(1992-11#1)(1996-12#1)(2008-10#1)(2008-4#1)
RNase protection##13##2##(1991-11#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-4#4)
RNase##74##1##(1990-11#1)(1990-5#6)(1990-7#12)(1991-11#1)(1991-9#1)(1992-11#8)(1992-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-4#6)(2008-8#1)(2008-9#2)(2009-2#10)(2010-2#1)(2011-1#6)(2011-2#1)(2012-3#3)
RNases H are##2##3##(2009-2#2)
RNases H##4##2##(2009-2#4)
RNases##5##1##(2009-2#5)
RNdex Top 100##2##3##(1996-3#2)
RNs##9##1##(2008-11#1)(2008-12#3)(2008-7#1)(2010-10#2)(2010-4#1)(2013-8#1)
RO 11-2933##6##2##(1990-2#6)
RO##13##1##(1990-2#6)(2008-11#6)(2008-12#1)
ROC curve##9##2##(1997-3#1)(2007-8#2)(2008-10#1)(2010-8#1)(2010-9#1)(2012-1#3)
ROC curve)##2##2##(2007-8#1)(2010-8#1)
ROC curves##2##2##(1997-3#2)
ROC##15##1##(1997-3#3)(2007-8#3)(2008-10#1)(2008-12#1)(2010-8#2)(2010-9#1)(2012-1#3)(2012-12#1)
ROCK##3##1##(2013-1#3)
ROD##2##1##(2008-4#2)
ROE##8##1##(2008-5#8)
ROH##3##1##(2008-10#3)
ROI quantification is##2##3##(2010-2#2)
ROI quantification##5##2##(2010-2#5)
ROI tracking##3##2##(2010-8#3)
ROI##16##1##(2008-11#1)(2009-3#2)(2010-2#8)(2010-8#4)(2011-2#1)
ROI-induced##2##1##(2008-7#2)
ROIs##2##1##(2008-7#2)
ROM##11##1##(2007-11#1)(2007-12#1)(2008-12#4)(2008-3#1)(2009-1#3)(2013-1#1)
ROP1##5##1##(2009-10#5)
ROR gamma##6##2##(1994-12#6)
ROR##7##1##(1994-12#7)
ROR-C##3##1##(1996-12#3)
ROR/RZR##2##1##(1994-12#2)
ROS 17/2##2##2##(1991-3#1)(1993-3#1)
ROS and RNS##2##3##(2009-8#1)(2011-2#1)
ROS and##6##2##(1994-11#1)(2008-11#1)(2009-8#2)(2010-5#1)(2011-2#1)
ROS by##4##2##(1994-5#2)(2008-11#1)(2008-5#1)
ROS can##2##2##(2008-10#1)(2009-8#1)
ROS cells##3##2##(1993-3#3)
ROS formation in##2##3##(2009-6#1)(2010-1#1)
ROS formation##5##2##(1994-6#2)(2009-6#1)(2010-1#2)
ROS generation##2##2##(2008-11#1)(2009-5#1)
ROS in the##2##3##(2008-11#1)(2013-8#1)
ROS in##4##2##(2008-11#2)(2011-2#1)(2013-8#1)
ROS levels in diabetes##2##4##(2011-2#2)
ROS levels##4##2##(2008-11#2)(2011-2#2)
ROS may be##2##3##(2010-12#1)(2011-1#1)
ROS overproduction##2##2##(2008-1#1)(2011-2#1)
ROS production and##3##3##(2009-12#1)(2009-8#1)(2013-1#1)
ROS production in##2##3##(2008-1#1)(2012-2#1)
ROS production was##5##3##(1994-5#1)(2008-4#2)(2010-12#2)
ROS production##13##2##(1994-5#1)(2008-1#1)(2008-4#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#3)(2012-2#1)(2013-1#2)
ROS signaling##2##2##(2009-8#1)(2011-2#1)
ROS was##2##2##(1994-5#1)(2008-5#1)
ROS##100##1##(1991-3#1)(1992-12#1)(1993-3#4)(1994-11#2)(1994-5#4)(1994-6#3)(1995-5#2)(1997-1#2)(2008-1#3)(2008-10#7)(2008-11#14)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#6)(2010-1#2)(2010-12#5)(2010-5#1)(2011-1#1)(2011-2#11)(2012-2#2)(2012-3#2)(2012-6#3)(2013-1#3)(2013-8#2)
ROS-induced##2##1##(1994-11#1)(2008-7#1)
RP HPLC##3##2##(2008-10#1)(2010-3#1)(2012-2#1)
RP and##2##2##(2008-10#1)(2010-10#1)
RP genome##2##2##(2008-10#2)
RP##28##1##(2008-10#7)(2008-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#1)
RP-18 column using##2##3##(2008-10#2)
RP-18 column##4##2##(1996-5#1)(2008-10#3)
RP-18##12##1##(1996-5#1)(2008-10#10)(2008-5#1)
RP-18e##5##1##(2008-10#4)(2013-1#1)
RP-73401##2##1##(2008-5#2)
RP-C(18)##2##1##(2008-10#2)
RP-HPLC analysis##2##2##(2008-10#1)(2008-5#1)
RP-HPLC and##5##2##(1996-5#2)(2008-10#1)(2011-1#1)(2012-2#1)
RP-HPLC determination of##2##3##(2008-10#2)
RP-HPLC method was##2##3##(1990-8#2)
RP-HPLC method##7##2##(1990-8#2)(1995-6#1)(2008-10#3)(2008-5#1)
RP-HPLC##35##1##(1990-2#1)(1990-8#4)(1995-6#1)(1996-5#9)(2008-10#13)(2008-5#2)(2010-3#1)(2011-1#2)(2012-2#2)
RP-HPLC/UV##2##1##(2008-10#2)
RP-LC##5##1##(2008-10#5)
RP1##4##1##(1997-6#4)
RPA##4##1##(2008-10#3)(2013-1#1)
RPE cells##4##2##(1996-5#1)(2008-4#3)
RPE that corresponded to 50% of oxygen uptake reserve##2##9##(2013-8#2)
RPE that corresponded to##4##4##(2013-8#4)
RPE##14##1##(1996-5#1)(2008-4#6)(2013-1#1)(2013-8#6)
RPGR and RPGRIP1##2##3##(2012-12#2)
RPGR disease-mutations##2##2##(2012-12#2)
RPGR isoforms##2##2##(2012-12#2)
RPGR##7##1##(2012-12#7)
RPGR(1-19)##4##1##(2012-12#4)
RPGR(ORF15)##5##1##(2012-12#5)
RPGRIP1##6##1##(2012-12#6)
RPGRIP1α(1)##7##1##(2012-12#7)
RPH was##2##2##(2008-10#2)
RPH##3##1##(2008-10#3)
RPL17##2##1##(1995-6#2)
RPL17A##3##1##(1995-6#3)
RPL17B##6##1##(1995-6#6)
RPL29##4##1##(1994-12#4)
RPL32##2##1##(1991-5#2)
RPLC##2##1##(2008-10#2)
RPMI 1640##4##2##(2008-11#4)
RPMI##13##1##(1990-12#4)(1992-6#1)(2008-10#1)(2008-11#6)(2008-9#1)
RPOS##2##1##(2008-2#2)
RPP and BPP##3##3##(2007-12#3)
RPP and##4##2##(2007-12#4)
RPP or##2##2##(2007-12#2)
RPP##16##1##(2007-12#16)
RPR-II and##2##2##(1992-11#2)
RPS##2##1##(2008-6#2)
RPT##8##1##(2008-3#8)
RPV##4##1##(2008-10#4)
RPs##8##1##(2008-7#8)
RR 1##4##2##(1993-9#2)(2011-2#2)
RR =##4##2##(2012-3#4)
RR interval##2##2##(2008-7#2)
RR of##3##2##(1992-11#2)(2011-1#1)
RR spectrum##3##2##(1995-5#3)
RR values##3##2##(2008-10#3)
RR##36##1##(1992-11#3)(1992-6#1)(1993-9#2)(1995-5#4)(1997-3#1)(2008-10#6)(2008-5#1)(2008-7#3)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#3)
RR(Tres)##2##1##(2008-8#2)
RRE##12##1##(1993-8#9)(1994-8#2)(2011-3#1)
RRF##4##1##(2007-12#4)
RRFF flap based on##2##4##(2008-9#2)
RRFF flap##4##2##(2008-9#4)
RRFF##5##1##(2008-9#5)
RRRGL##2##1##(1994-9#2)
RRS technology##3##2##(2008-10#3)
RRS##11##1##(2008-10#11)
RRT were##2##2##(2012-3#2)
RRT##4##1##(2011-2#1)(2012-3#3)
RRs##3##1##(1993-9#2)(2013-1#1)
RS and##4##2##(2008-10#2)(2008-12#2)
RS domain or##2##3##(2009-2#2)
RS domain##4##2##(1995-6#1)(2009-2#3)
RS extract##10##2##(2008-11#10)
RS were##2##2##(2008-8#2)
RS##37##1##(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#6)(2008-11#11)(2008-12#4)(2008-6#2)(2008-8#5)(2009-2#4)(2010-8#1)(2013-8#1)
RS+ a##2##2##(1997-8#2)
RS+##6##1##(1997-8#6)
RS-SR##2##1##(1993-6#2)
RS13##2##1##(2008-8#2)
RS4##2##1##(2010-8#2)
RS4(XL)##3##1##(2010-8#3)
RSA##6##1##(2008-10#1)(2010-10#5)
RSB##4##1##(2013-1#4)
RSC##5##1##(2008-10#2)(2012-12#3)
RSCs##4##1##(2008-10#2)(2012-12#2)
RSD and##3##2##(2008-10#3)
RSD for five##2##3##(2008-10#2)
RSD for##6##2##(2008-10#6)
RSD is##3##2##(2008-10#3)
RSD of 2##3##3##(2008-10#3)
RSD of the##6##3##(2008-10#6)
RSD of##12##2##(2008-10#12)
RSD smaller than##2##3##(2008-10#2)
RSD values##3##2##(2008-10#3)
RSD was##8##2##(2008-10#7)(2013-8#1)
RSD were##2##2##(2008-10#1)(2012-3#1)
RSD##61##1##(2007-12#1)(2008-10#56)(2012-1#1)(2012-3#1)(2013-8#2)
RSD% of##3##2##(2008-10#3)
RSD%##5##1##(2008-10#5)
RSD) for##2##2##(2008-10#2)
RSD)##5##1##(2008-10#5)
RSDs of##2##2##(2008-10#1)(2013-8#1)
RSDs##8##1##(2008-10#6)(2011-1#1)(2013-8#1)
RSEP##2##1##(2008-10#2)
RSP##6##1##(2008-10#1)(2008-3#2)(2010-9#3)
RSS##5##1##(2008-12#4)(2008-7#1)
RSV LTR##2##2##(1995-6#2)
RSV##11##1##(1992-5#1)(1994-11#1)(1995-6#3)(2010-10#1)(2011-2#5)
RSs##2##1##(2008-12#2)
RT activity in##3##3##(2008-11#3)
RT alone and tumor location##2##5##(2010-3#2)
RT alone##5##2##(2010-3#5)
RT and##4##2##(1995-5#1)(2008-9#1)(2011-2#2)
RT in##3##2##(1990-11#1)(1997-6#1)(2007-10#1)
RT inhibitors##2##2##(1992-8#2)
RT is the##2##3##(2008-3#1)(2011-2#1)
RT of##2##2##(2007-10#1)(2008-11#1)
RT plus surgery vs##4##4##(2010-3#4)
RT was##4##2##(2007-10#1)(2008-6#1)(2010-3#2)
RT were##2##2##(2007-10#1)(2010-3#1)
RT##75##1##(1990-11#4)(1990-12#1)(1992-8#2)(1992-9#1)(1995-5#1)(1997-3#3)(1997-6#4)(2007-10#5)(2008-10#2)(2008-11#6)(2008-3#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-11#1)(2010-1#2)(2010-3#20)(2010-8#2)(2011-2#5)(2013-1#7)
RT)##2##1##(1994-6#1)(2011-2#1)
RT-PCR amplified##4##2##(1993-11#1)(1993-9#1)(2008-10#2)
RT-PCR analysis of##3##3##(1994-12#1)(2008-5#1)(2011-2#1)
RT-PCR analysis showed that##3##4##(2008-11#1)(2008-8#2)
RT-PCR analysis##13##2##(1994-11#1)(1994-12#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-5#1)(2011-2#1)
RT-PCR and electron dispersive spectroscopy (EDS)##2##6##(2008-11#2)
RT-PCR and immunohistochemistry##2##3##(2010-11#1)(2012-1#1)
RT-PCR and sequencing##2##3##(2008-9#2)
RT-PCR and the##2##3##(2008-10#1)(2011-3#1)
RT-PCR and##25##2##(1993-9#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-2#1)(2013-8#2)
RT-PCR assay##9##2##(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)(2013-8#5)
RT-PCR data##2##2##(2008-11#1)(2008-8#1)
RT-PCR demonstrated##2##2##(1994-11#1)(2008-11#1)
RT-PCR for##4##2##(2007-10#1)(2008-10#1)(2008-9#1)(2012-2#1)
RT-PCR from##2##2##(2008-8#1)(2011-1#1)
RT-PCR in##4##2##(2008-10#2)(2008-12#1)(2011-3#1)
RT-PCR of##2##2##(2008-10#1)(2008-11#1)
RT-PCR products##3##2##(2008-10#3)
RT-PCR reaction##2##2##(2008-10#2)
RT-PCR revealed that##2##3##(2008-11#1)(2008-9#1)
RT-PCR revealed##4##2##(2007-10#1)(2007-4#1)(2008-11#1)(2008-9#1)
RT-PCR showed that##2##3##(1995-12#1)(2008-11#1)
RT-PCR system##3##2##(2008-10#2)(2013-8#1)
RT-PCR technique##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
RT-PCR using##4##2##(1993-3#1)(2008-10#2)(2008-9#1)
RT-PCR was##4##2##(2007-4#1)(2008-10#1)(2008-5#1)(2011-1#1)
RT-PCR were##2##2##(2008-5#1)(2008-8#1)
RT-PCR with##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
RT-PCR##172##1##(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-9#1)(1995-12#2)(1996-12#2)(1997-2#1)(1997-3#3)(1997-9#1)(2007-10#3)(2007-11#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#36)(2008-11#16)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#16)(2008-9#18)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#5)(2011-3#3)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#12)
RT-PCR)##2##1##(2013-8#2)
RT-PCR-Based##2##1##(2008-10#2)
RT-PCR/nested PCR##2##2##(2008-10#2)
RT/PCR clones were sequenced from##2##5##(1993-6#2)
RT/PCR##3##1##(1992-12#1)(1993-6#2)
RTA##7##1##(1992-3#1)(2007-12#3)(2008-1#1)(2008-3#1)(2012-12#1)
RTB##6##1##(2013-1#6)
RTC##2##1##(1994-2#1)(2008-2#1)
RTC-CRM##2##1##(2008-10#2)
RTI##5##1##(1991-12#1)(2008-12#1)(2010-5#3)
RTI-COC-31 and##2##2##(1991-12#2)
RTI-COC-31##3##1##(1991-12#3)
RTI-COC-32##3##1##(1991-12#3)
RTI-based assessment practices##2##3##(2008-12#2)
RTI-based assessment##3##2##(2008-12#3)
RTK##3##1##(1993-8#1)(2010-4#2)
RTKs##4##1##(1995-8#1)(2009-8#1)(2009-9#2)
RTLS##2##1##(2011-2#2)
RTOG##2##1##(1992-10#1)(1995-9#1)
RTP emission##6##2##(2008-10#6)
RTP quenching##3##2##(2008-10#3)
RTP signals##4##2##(2008-10#4)
RTP##30##1##(1993-9#2)(2008-10#28)
RTP-91E and##2##2##(2008-11#2)
RTPs##2##1##(2008-10#2)
RTS and AIS##2##3##(2008-10#2)
RTS and##3##2##(2008-10#3)
RTS##10##1##(2008-10#6)(2008-7#1)(2011-2#3)
RTSV##5##1##(2008-10#5)
RTT##3##1##(2008-7#1)(2012-2#2)
RTU formulations##2##2##(2011-2#2)
RTX##9##1##(1994-2#1)(2008-8#6)(2013-8#2)
RTs##2##1##(2010-1#2)
RU 39##7##2##(1992-5#7)
RU 486##3##2##(1992-1#1)(1994-9#1)(2008-4#1)
RU##14##1##(1992-1#1)(1992-5#7)(1994-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
RU1##3##1##(2008-10#3)
RU486 treatment##2##2##(2008-9#2)
RU486##10##1##(1994-9#1)(1996-5#4)(2008-9#5)
RU9101001##2##1##(2008-10#2)
RUC##3##1##(2009-7#3)
RUG-II##2##1##(1994-12#2)
RUGs##4##1##(1993-12#4)
RV is the dominant##2##4##(2008-10#2)
RV##8##1##(2008-10#7)(2011-2#1)
RVC and##2##2##(2008-10#2)
RVC##6##1##(2008-10#6)
RVD##2##1##(2008-10#2)
RVF##2##1##(1994-9#2)
RVR##2##1##(2008-3#1)(2013-1#1)
RVS##2##1##(1992-3#1)(2008-10#1)
RVU##2##1##(1992-3#1)(2013-1#1)
RVUs##7##1##(2013-1#7)
RVUs/WTE##2##1##(2012-2#2)
RW##6##1##(2008-11#6)
RWA##3##1##(2008-9#3)
RWC##2##1##(2008-12#2)
RWJF##3##1##(2013-1#3)
RWPC##2##1##(2008-10#2)
RXR alpha##3##2##(1993-3#3)
RXR##9##1##(1993-3#6)(1995-8#1)(2008-1#1)(2008-4#1)
RYR##3##1##(1994-9#2)(1997-3#1)
RYSV##3##1##(2008-8#3)
RZK-6##2##1##(2011-2#2)
Ra and##2##2##(2008-12#1)(2008-5#1)
Rab GDI was phosphorylated##2##4##(1994-9#2)
Rab GDI##3##2##(1994-9#3)
Rab proteins##3##2##(1995-6#1)(1995-8#1)(1997-1#1)
Rab##19##1##(1994-12#2)(1994-9#4)(1995-6#2)(1995-8#2)(1997-1#4)(2008-8#1)(2011-2#4)
Rab/Ypt##3##1##(2008-11#3)
Rab11##5##1##(1996-6#1)(1997-1#3)(2009-8#1)
Rab27B##3##1##(2011-2#3)
Rab3A small GTP-binding protein##2##4##(1994-11#1)(1994-9#1)
Rab3A##7##1##(1994-11#1)(1994-9#6)
RabMabs##3##1##(2012-12#3)
Rabbit antibodies##3##2##(1991-12#1)(1991-9#1)(1995-6#1)
Rabbit##14##1##(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(2007-4#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-1#1)
Rabbits##4##1##(1994-8#1)(1995-12#1)(1996-3#1)(2008-9#1)
Rabi##3##1##(2007-11#2)(2008-3#1)
Rabies and quarantine##2##3##(1996-11#1)(1996-8#1)
Rabies requirements##2##2##(1992-2#2)
Rabies virus##3##2##(1995-2#1)(2012-3#2)
Rabies##14##1##(1992-2#2)(1995-2#1)(1996-11#1)(1996-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2012-12#1)(2012-3#2)(2013-1#1)
Rabphilin-3A is##2##2##(1994-11#1)(1994-9#1)
Rabphilin-3A##8##1##(1994-11#2)(1994-9#6)
Rabphilin-3A-interacting protein##2##2##(1994-11#2)
Rac proteins##2##2##(1997-7#2)
Rac##10##1##(1996-12#1)(1996-2#2)(1997-7#3)(2008-1#1)(2011-1#3)
Rac1 activity##3##2##(1996-2#2)(2012-7#1)
Rac1##14##1##(1996-2#3)(1997-7#3)(2008-10#1)(2011-2#5)(2012-7#2)
Rac2##7##1##(1997-7#7)
Race 1##6##2##(2008-10#6)
Race 3 of##3##3##(2008-10#3)
Race 3##8##2##(2008-10#8)
Race Ct0##2##2##(2008-10#2)
Race and##2##2##(2010-10#1)(2012-12#1)
Race of##3##2##(2008-10#3)
Race##35##1##(2008-10#32)(2009-7#1)(2010-10#1)(2012-12#1)
Race-Specific Resistance##3##2##(2008-10#3)
Race-Specific##4##1##(2008-10#4)
Races 0##3##2##(2008-10#3)
Races 1 and 2##2##4##(2008-10#2)
Races in##2##2##(2008-10#2)
Races of Pyrenophora tritici-repentis##2##4##(2008-10#2)
Races of##4##2##(2008-10#4)
Races##18##1##(2008-1#1)(2008-10#17)
Racial and ethnic differences in indication for primary cesarean delivery at term##2##12##(2013-1#2)
Racial and ethnic disparities in##2##5##(2011-2#1)(2012-3#1)
Racial and ethnic##5##3##(2011-2#2)(2012-3#1)(2013-1#2)
Racial and##6##2##(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
Racial differences in##2##3##(1995-12#1)(2010-11#1)
Racial##11##1##(1995-12#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#2)
Racial/ethnic disparities##2##2##(2009-5#2)
Rackham's Cay##2##2##(2007-5#2)
Rad1-Rad10##3##1##(1994-9#3)
Rad50##3##1##(2011-2#3)
Rad51##2##1##(1995-6#1)(1997-4#1)
Radar##2##1##(2008-3#2)
Radial artery (RA)##2##3##(2007-8#1)(2011-2#1)
Radial artery##4##2##(2007-8#1)(2011-2#3)
Radial growth##2##2##(2008-10#2)
Radial##18##1##(1992-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#6)(2012-1#1)(2013-8#1)
Radially##2##1##(2007-11#1)(2012-2#1)
Radiance X Illumination##2##3##(2011-2#2)
Radiance##9##1##(2008-2#3)(2008-3#2)(2011-2#4)
Radiation Center##3##2##(2008-2#2)(2008-3#1)
Radiation Oncology and Radiobiology##2##4##(2008-10#2)
Radiation Oncology and##5##3##(2008-10#5)
Radiation Oncology##11##2##(1994-3#2)(2008-10#7)(2008-6#1)(2011-2#1)
Radiation Protection##10##2##(1994-12#2)(1995-1#2)(1995-2#5)(1996-6#1)
Radiation Therapy Oncology##3##3##(1993-9#1)(2008-7#2)
Radiation Therapy##5##2##(1993-9#1)(1994-12#1)(2008-6#1)(2008-7#2)
Radiation and##4##2##(1995-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
Radiation effects##2##2##(1994-3#1)(1996-6#1)
Radiation in##3##2##(2008-2#1)(2011-2#2)
Radiation induced##2##2##(1992-8#1)(2008-7#1)
Radiation is##2##2##(2008-5#1)(2013-8#1)
Radiation oncology##2##2##(1995-10#1)(2007-4#1)
Radiation pressure##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Radiation therapy##11##2##(1991-2#3)(1991-8#1)(1993-9#1)(1994-3#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
Radiation##88##1##(1991-2#3)(1991-8#1)(1992-8#1)(1993-9#2)(1994-12#4)(1994-3#4)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#7)(1996-6#3)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#10)(2008-11#1)(2008-2#9)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#2)(2009-11#1)(2009-6#1)(2011-2#4)(2013-1#3)(2013-7#1)(2013-8#3)
Radiation-induced bystander##2##2##(2008-7#2)
Radiation-induced##8##1##(1990-12#1)(2008-12#1)(2008-2#1)(2008-7#3)(2013-1#1)(2013-8#1)
Radiative Transfer##3##2##(2008-3#3)
Radiative transfer over small distances from a heated metal##3##9##(2007-11#2)(2007-12#1)
Radiative transfer over small distances from a heated##4##8##(2007-11#3)(2007-12#1)
Radiative transfer##9##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)
Radiative##14##1##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#6)
Radical prostatectomy##3##2##(2009-5#1)(2010-10#1)(2013-1#1)
Radical##29##1##(1993-11#1)(1996-2#2)(1996-5#7)(1997-7#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
Radicals##5##1##(1996-5#3)(2009-5#1)(2010-7#1)
Radiculopathy Index##2##2##(2007-11#2)
Radiculopathy##8##1##(1991-2#1)(2007-11#4)(2007-8#1)(2008-12#1)(2012-3#1)
Radiello((R))##4##1##(2008-10#4)
Radio##2##1##(2008-3#1)(2009-3#1)
Radio-frequency##2##1##(2008-11#1)(2011-2#1)
Radioactive##6##1##(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)
Radiobiological##3##1##(1993-9#1)(2008-10#1)(2008-7#1)
Radiobiology##3##1##(2008-10#2)(2012-3#1)
Radiochemical##2##1##(2008-10#1)(2012-12#1)
Radiofrequency ablation of atrial flutter combined with##2##7##(2007-8#2)
Radiofrequency ablation of##4##3##(2007-8#2)(2012-2#2)
Radiofrequency ablation##5##2##(2007-8#2)(2012-2#3)
Radiofrequency##10##1##(2007-12#1)(2007-8#3)(2010-11#1)(2010-3#1)(2010-8#1)(2012-2#3)
Radiographic evaluation##3##2##(2008-9#1)(2009-10#1)(2012-12#1)
Radiographic examination##2##2##(2007-11#1)(2013-1#1)
Radiographic presentation##2##2##(2007-11#1)(2013-1#1)
Radiographic##17##1##(1990-6#1)(2007-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
Radiographs of the##2##3##(1991-12#1)(2008-9#1)
Radiographs##4##1##(1991-12#1)(2008-2#1)(2008-9#1)(2010-3#1)
Radiography##3##1##(2011-2#2)(2011-6#1)
Radioimmunoassay of##2##2##(1990-11#1)(1990-7#1)
Radioimmunoassay##4##1##(1990-11#1)(1990-7#1)(1994-9#1)(2007-11#1)
Radiolabeled##2##1##(1997-8#1)(2010-6#1)
Radioligand binding studies##2##3##(1995-11#1)(1997-2#1)
Radioligand binding##4##2##(1995-11#1)(1997-2#1)(2008-4#2)
Radiologic##4##1##(1996-3#2)(2010-4#1)(2011-2#1)
Radiological and##2##2##(2007-11#2)
Radiological assessment of##2##3##(2007-11#1)(2012-2#1)
Radiological examination##2##2##(2007-8#1)(2008-7#1)
Radiological examinations##2##2##(1993-5#1)(2008-10#1)
Radiological investigations revealed##2##3##(2008-10#1)(2011-2#1)
Radiological investigations##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
Radiological##26##1##(1991-12#1)(1993-3#1)(1993-5#1)(1995-12#1)(2007-11#6)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-5#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)
Radiologist workload##4##2##(2012-2#4)
Radiologist##7##1##(2012-2#7)
Radiologists are##2##2##(2007-7#1)(2008-1#1)
Radiologists##4##1##(2007-7#1)(2008-1#2)(2012-2#1)
Radiology Information Service##2##3##(1992-1#2)
Radiology Management##7##2##(1991-2#1)(1994-12#1)(1995-1#1)(1995-2#3)(1996-1#1)
Radiology administrators and##2##3##(1994-1#1)(1996-2#1)
Radiology administrators##4##2##(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)
Radiology and##2##2##(1994-1#1)(1995-3#1)
Radiology departments##2##2##(1995-3#1)(1996-1#1)
Radiology nurses##3##2##(1995-3#3)
Radiology##51##1##(1990-10#1)(1991-2#2)(1992-1#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#5)(1995-3#5)(1995-9#1)(1996-1#3)(1996-2#3)(1996-3#2)(2007-4#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#2)(2012-2#8)
Radiolytic reduction of##2##3##(1995-3#2)
Radiometer##7##1##(1995-6#1)(2008-3#4)(2008-8#2)
Radiometric sensitivity##2##2##(2008-3#2)
Radiometric##6##1##(2008-10#1)(2008-2#3)(2008-3#2)
Radionics Image Fusiontrade mark and Stereoplantrade mark##2##7##(2008-7#2)
Radionics##3##1##(2008-7#3)
Radionuclide assessment of patients with urinary tract infection and##2##9##(2008-4#2)
Radionuclide##6##1##(1991-2#1)(1992-3#1)(1994-5#1)(2008-4#2)(2010-3#1)
Radiosensitization of##2##2##(1995-9#1)(2011-2#1)
Radiosensitization##3##1##(1995-9#1)(2008-9#1)(2011-2#1)
Radiostereometric##2##1##(2008-8#1)(2012-3#1)
Radiosurgery##7##1##(1996-3#1)(1997-4#1)(2008-7#2)(2011-2#1)(2012-3#2)
Radiotherapy for rectal cancer##3##4##(1997-7#3)
Radiotherapy for##4##2##(1997-7#3)(2008-6#1)
Radiotherapy in##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
Radiotherapy is##6##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-11#1)(2010-3#1)
Radiotherapy of the##2##3##(1990-10#2)
Radiotherapy of##4##2##(1990-10#2)(1993-9#1)(2007-11#1)
Radiotherapy planning##2##2##(2008-2#2)
Radiotherapy was administered##2##3##(1990-8#1)(2008-7#1)
Radiotherapy was##3##2##(1990-8#1)(1992-12#1)(2008-7#1)
Radiotherapy##38##1##(1990-10#2)(1990-8#1)(1992-12#2)(1993-9#2)(1997-7#3)(2007-10#2)(2007-11#6)(2008-10#6)(2008-2#3)(2008-6#3)(2008-7#2)(2009-11#1)(2010-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
Radium-226##2##1##(1990-10#2)
Radix##7##1##(2008-10#3)(2011-2#1)(2013-1#1)(2013-8#2)
Radon##4##1##(1990-5#1)(1991-3#1)(2007-12#1)(2008-7#1)
Radon-Wigner display##2##2##(2008-2#2)
Radopholus similis##2##2##(2008-10#2)
Raf kinase##2##2##(2009-8#2)
Raf##5##1##(1994-6#1)(1996-2#1)(2008-10#1)(2009-8#2)
Raf-1##3##1##(1995-2#1)(2008-8#2)
Raf1 and JNK1 kinases for anti-tumor treatment##2##7##(2012-12#2)
Raf1 and JNK1##3##3##(2012-12#3)
Raf1##6##1##(2012-12#6)
Raf55-132##3##1##(1995-5#3)
Rafalowski##3##1##(1997-5#3)
Ragona##3##1##(1990-11#3)
Ragusa##7##1##(1991-2#5)(1992-12#2)
Rai##2##1##(1991-4#1)(2013-8#1)
Railroad##3##1##(2008-2#1)(2008-8#1)(2009-7#1)
Rain splash##2##2##(2008-10#2)
Rain##7##1##(2008-10#6)(2008-6#1)
Rainbow refractometry##2##2##(2008-2#2)
Rainbow##10##1##(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-2#2)
Raindrop##2##1##(1995-3#2)
Rainfall was##2##2##(2008-10#2)
Rainfall##4##1##(2008-10#4)
Raised##5##1##(1990-5#1)(1990-6#1)(1991-12#1)(2010-5#1)(2012-3#1)
Raising the bar##2##3##(2012-12#1)(2012-3#1)
Raising the##6##2##(1990-7#1)(1994-3#1)(2008-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
Raising##7##1##(1990-7#1)(1994-3#1)(2008-10#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
Raji cells##2##2##(1993-3#1)(1993-8#1)
Raji##3##1##(1993-3#1)(1993-8#1)(1995-2#1)
Rajkot district##2##2##(2013-8#2)
Rajkot##4##1##(2013-8#4)
Ralph##4##1##(1990-3#1)(1993-12#1)(1995-6#2)
Ralstonia mannitolilytica##2##2##(2007-7#2)
Ralstonia solanacearum biovar 2##2##4##(2008-10#2)
Ralstonia solanacearum in##4##3##(2008-10#4)
Ralstonia solanacearum is a##2##4##(2008-10#2)
Ralstonia solanacearum is##3##3##(2008-10#3)
Ralstonia solanacearum race##2##3##(2008-10#2)
Ralstonia solanacearum##35##2##(2008-10#35)
Ralstonia##38##1##(2007-7#2)(2008-10#36)
Ramadan fasting##2##2##(2011-1#2)
Ramadan##18##1##(1992-2#1)(2008-4#4)(2009-7#1)(2010-11#1)(2011-1#4)(2012-3#7)
Ramalina stenospora##2##2##(2008-10#2)
Ramalina##4##1##(2008-10#2)(2008-11#2)
Raman DIAL##4##2##(2008-3#4)
Raman Spectroscopy##5##2##(2007-1#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
Raman absolute intensity##2##3##(2013-8#2)
Raman amplification and##2##3##(2007-11#2)
Raman amplification##6##2##(2007-11#6)
Raman amplifier##2##2##(2007-11#1)(2007-12#1)
Raman amplifiers##5##2##(2007-11#4)(2007-12#1)
Raman and infrared spectra##2##4##(1996-2#1)(2010-5#1)
Raman and##6##2##(1995-2#1)(1996-2#1)(2008-10#1)(2008-3#2)(2010-5#1)
Raman backscatter##3##2##(2008-3#3)
Raman band intensities##2##3##(2008-10#2)
Raman band##4##2##(1990-8#1)(1991-5#1)(2008-10#2)
Raman cell##2##2##(2008-2#2)
Raman compression##3##2##(2007-11#3)
Raman conversion##2##2##(2007-12#2)
Raman detection##2##2##(2007-11#1)(2008-3#1)
Raman difference spectroscopy##2##3##(2011-1#2)
Raman differential absorption lidar (DIAL)##2##5##(2008-3#2)
Raman differential absorption lidar##6##4##(2007-12#1)(2008-3#5)
Raman effects in##2##3##(2007-11#1)(2007-12#1)
Raman emissions##2##2##(2008-10#1)(2008-2#1)
Raman excitation##2##2##(2008-3#1)(2009-12#1)
Raman gain coefficient##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
Raman gain coefficients of##2##4##(2008-3#2)
Raman gain coefficients##3##3##(2007-12#1)(2008-3#2)
Raman gain measurement##2##3##(2007-12#2)
Raman gain spectrum##2##3##(2007-11#2)
Raman gain##23##2##(2007-11#11)(2007-12#7)(2008-3#5)
Raman gains##2##2##(2007-11#1)(2007-12#1)
Raman gas##2##2##(2007-11#1)(2007-12#1)
Raman generation##4##2##(2007-11#4)
Raman images##3##2##(2007-11#2)(2007-12#1)
Raman imaging##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
Raman intensities##3##2##(1992-8#1)(2008-10#1)(2013-1#1)
Raman intensity##2##2##(1991-5#1)(2008-2#1)
Raman laser based on##2##4##(2007-12#1)(2008-3#1)
Raman laser in H(2)##3##4##(2007-11#3)
Raman laser in##4##3##(2007-11#3)(2007-12#1)
Raman laser##13##2##(2007-11#8)(2007-12#4)(2008-3#1)
Raman lidar system##2##3##(2008-2#2)
Raman lidar##12##2##(2008-2#4)(2008-3#8)
Raman lidars##4##2##(2007-12#1)(2008-3#3)
Raman light##2##2##(2007-11#2)
Raman line at##2##3##(2007-12#1)(2008-3#1)
Raman line##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Raman lines of##2##3##(2008-3#2)
Raman measurements of##5##3##(2008-2#1)(2008-3#1)(2011-1#3)
Raman measurements##9##2##(2008-2#3)(2008-3#1)(2011-1#5)
Raman microspectroscopic##3##2##(2008-9#3)
Raman microspectroscopy##4##2##(2008-3#1)(2010-10#3)
Raman or high spectral resolution##2##5##(2008-2#2)
Raman peak intensity##2##3##(2010-10#1)(2013-8#1)
Raman probe design##4##3##(2011-1#4)
Raman probe##9##2##(1992-4#1)(2007-12#1)(2008-2#1)(2011-1#6)
Raman scattering (SERS)##7##3##(2007-12#2)(2008-10#3)(2010-5#1)(2013-1#1)
Raman scattering and##5##3##(2007-12#2)(2008-2#1)(2010-7#1)(2013-8#1)
Raman scattering are##2##3##(2007-12#1)(2008-3#1)
Raman scattering by##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Raman scattering can be##2##4##(2007-12#1)(2009-4#1)
Raman scattering coefficient of water##2##5##(2008-3#2)
Raman scattering coefficient##4##3##(2008-2#2)(2008-3#2)
Raman scattering cross section of##3##5##(2007-12#1)(2008-3#2)
Raman scattering cross section##4##4##(2007-12#2)(2008-3#2)
Raman scattering for##3##3##(2008-10#1)(2008-3#2)
Raman scattering from##2##3##(2007-12#1)(2008-3#1)
Raman scattering in##10##3##(2007-11#2)(2007-12#5)(2008-2#2)(2013-8#1)
Raman scattering is then##2##4##(2008-3#2)
Raman scattering is##3##3##(2008-3#3)
Raman scattering of##8##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-8#2)
Raman scattering to the##4##4##(2008-3#4)
Raman scattering to##5##3##(2008-3#5)
Raman scattering with##2##3##(2008-10#1)(2008-2#1)
Raman scattering##104##2##(2007-11#13)(2007-12#24)(2008-10#13)(2008-2#11)(2008-3#29)(2009-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#6)
Raman self-focusing##2##2##(2007-11#2)
Raman shift##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Raman shifters##2##2##(2008-2#2)
Raman shifting of##2##3##(2008-2#1)(2008-3#1)
Raman signal##6##2##(2007-12#1)(2008-10#2)(2008-3#2)(2009-4#1)
Raman signals##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
Raman spectra are##3##3##(2008-10#1)(2008-2#2)
Raman spectra can##2##3##(2008-10#2)
Raman spectra of##17##3##(1992-8#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
Raman spectra that##2##3##(2008-10#1)(2008-3#1)
Raman spectra were collected##3##4##(2007-11#1)(2008-3#1)(2013-8#1)
Raman spectra were##6##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
Raman spectra##45##2##(1990-8#1)(1992-8#1)(1996-2#1)(2007-1#1)(2007-11#2)(2007-12#7)(2008-10#17)(2008-2#5)(2008-3#4)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#3)
Raman spectrometer##4##2##(2008-10#1)(2008-2#1)(2011-1#1)(2013-8#1)
Raman spectrometers##3##2##(2008-10#2)(2013-8#1)
Raman spectroscopic study of##2##4##(2008-8#2)
Raman spectroscopic##5##2##(2008-10#2)(2008-8#3)
Raman spectroscopy (SERS)##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-1#1)
Raman spectroscopy are##2##3##(2008-2#1)(2008-4#1)
Raman spectroscopy as##2##3##(2008-10#1)(2009-12#1)
Raman spectroscopy at##2##3##(2008-10#1)(2008-3#1)
Raman spectroscopy for##3##3##(2007-11#2)(2008-10#1)
Raman spectroscopy has##2##3##(2008-10#1)(2013-8#1)
Raman spectroscopy in##3##3##(2008-10#2)(2008-3#1)
Raman spectroscopy is##2##3##(2008-3#1)(2009-4#1)
Raman spectroscopy of##5##3##(2007-11#2)(2008-10#1)(2008-4#1)(2010-2#1)
Raman spectroscopy system for##2##4##(2007-12#1)(2008-2#1)
Raman spectroscopy system##3##3##(2007-12#2)(2008-2#1)
Raman spectroscopy to the study of plant cell##2##8##(2013-8#2)
Raman spectroscopy to##5##3##(1991-5#1)(2008-10#1)(2008-3#1)(2013-8#2)
Raman spectroscopy was used to##2##5##(1996-2#1)(2008-8#1)
Raman spectroscopy was##3##3##(1996-2#1)(2008-8#1)(2013-8#1)
Raman spectroscopy with##2##3##(2008-2#1)(2013-8#1)
Raman spectroscopy##89##2##(1991-5#2)(1992-8#2)(1995-5#1)(1996-2#1)(2007-11#8)(2007-12#6)(2008-10#23)(2008-2#12)(2008-3#9)(2008-4#2)(2008-8#2)(2009-12#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-1#3)(2013-8#12)
Raman spectroscopy]##2##2##(2013-8#2)
Raman spectrum##9##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2013-8#1)
Raman story##2##2##(2011-2#2)
Raman studies##3##2##(1990-8#1)(2008-10#2)
Raman system##2##2##(2008-2#2)
Raman technique##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
Raman techniques are##2##3##(1990-8#1)(2008-4#1)
Raman tweezer##2##2##(2009-12#2)
Raman tweezers##3##2##(2009-12#3)
Raman##548##1##(1990-8#4)(1991-5#4)(1992-4#1)(1992-8#6)(1993-11#1)(1995-2#1)(1995-5#2)(1996-2#7)(2007-1#2)(2007-11#87)(2007-12#68)(2008-10#86)(2008-2#61)(2008-3#107)(2008-4#8)(2008-5#1)(2008-8#7)(2008-9#3)(2009-12#7)(2009-4#4)(2010-10#5)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#19)(2011-2#3)(2012-1#3)(2012-2#1)(2013-1#5)(2013-8#37)
Raman-Nath##4##1##(2007-12#1)(2008-2#3)
Raman-active##2##1##(2007-11#1)(2007-12#1)
Raman-excited spin coherences##2##3##(2007-11#2)
Raman-induced##2##1##(2007-11#2)
Raman-scattered##2##1##(2008-2#2)
Raman-scattering##7##1##(2008-2#3)(2008-3#4)
Raman-shifted and frequency-doubled##2##3##(2007-12#2)
Raman-shifted##5##1##(2007-12#3)(2008-3#2)
Ramos cells##2##2##(2009-11#2)
Ramsay##2##1##(2008-7#1)(2008-8#1)
Ramsey fringes##2##2##(2007-12#2)
Ramsey##6##1##(1991-3#2)(2007-12#2)(2012-12#2)
Ran GTPase##3##2##(2011-2#1)(2012-12#2)
Ran and##2##2##(1995-2#1)(2011-2#1)
Ran##8##1##(1995-2#4)(2011-2#2)(2012-12#2)
RanGAP1 is##2##2##(1995-2#2)
RanGAP1##4##1##(1995-2#4)
Rana catesbeiana##4##2##(1990-5#1)(1992-3#1)(1993-5#1)(1997-7#1)
Rana rugosa##2##2##(1994-11#2)
Rana temporaria##5##2##(2008-7#2)(2011-2#2)(2013-1#1)
Rana##18##1##(1990-5#1)(1992-3#1)(1993-5#2)(1994-11#3)(1997-3#1)(1997-7#1)(2008-7#2)(2011-2#4)(2012-12#1)(2013-1#2)
Rand##2##1##(2008-7#1)(2010-5#1)
Random Amplified Polymorphic DNA##4##4##(2008-10#4)
Random amplified microsatellites##2##3##(2008-10#2)
Random amplified polymorphic DNA (RAPD) and##2##6##(2008-10#1)(2008-5#1)
Random amplified polymorphic DNA (RAPD)##6##5##(2008-10#5)(2008-5#1)
Random amplified polymorphic DNA analyses of##2##6##(2008-10#2)
Random amplified polymorphic DNA markers##2##5##(2008-10#2)
Random amplified polymorphic DNA##12##4##(2008-10#11)(2008-5#1)
Random amplified##14##2##(2008-10#13)(2008-5#1)
Random mating##2##2##(2008-10#2)
Random##30##1##(1991-5#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#21)(2008-12#2)(2008-5#1)(2009-11#1)(2012-2#1)
RandomWalk##2##1##(2010-2#2)
Randomisation##2##1##(1996-3#1)(2008-8#1)
Randomised controlled##2##2##(1991-6#1)(2007-7#1)
Randomised trials##2##2##(1996-8#1)(2007-6#1)
Randomised##14##1##(1991-6#1)(1991-8#1)(1992-5#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-8#1)
Randomized Clinical Trial##2##3##(2008-7#1)(2013-7#1)
Randomized Complete##2##2##(2008-12#2)
Randomized Trial##4##2##(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
Randomized clinical trial##2##3##(2010-10#1)(2012-2#1)
Randomized clinical##3##2##(2008-10#1)(2010-10#1)(2012-2#1)
Randomized controlled trial##2##3##(2008-3#1)(2013-1#1)
Randomized controlled trials##4##3##(2008-10#1)(2009-7#1)(2009-9#1)(2013-1#1)
Randomized controlled##7##2##(2008-10#1)(2008-3#1)(2009-11#1)(2009-7#1)(2009-9#1)(2013-1#2)
Randomized trials##4##2##(1993-12#1)(1996-6#2)(2009-9#1)
Randomized##36##1##(1990-6#1)(1993-12#2)(1993-6#1)(1994-8#1)(1996-6#2)(2006-10#1)(2008-10#2)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
Randomly##2##1##(2008-10#2)
Range information##2##2##(2008-3#2)
Range of motion##2##3##(2008-12#1)(2010-12#1)
Range of##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)
Range quail##2##2##(2008-12#2)
Range##32##1##(1993-2#1)(1996-9#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#7)(2010-12#1)(2010-4#1)
Ranges and##2##2##(2008-10#1)(2009-12#1)
Ranges##6##1##(1995-6#2)(2008-10#2)(2009-12#2)
Rangpur lime##3##2##(2008-10#3)
Ranibizumab##4##1##(2010-9#1)(2013-1#3)
Ranitidine##2##1##(1992-11#1)(1992-2#1)
Rank##3##1##(2008-10#2)(2008-6#1)
Rankin Scale##5##2##(2007-10#1)(2012-3#3)(2013-1#1)
Rankin##7##1##(1995-12#1)(2007-10#1)(2008-8#1)(2012-3#3)(2013-1#1)
Ranking the##2##2##(2008-3#1)(2008-9#1)
Ranking##7##1##(1991-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2013-1#1)
Ranunculaceae##2##1##(2011-3#2)
Ranunculus asiaticus##2##2##(2008-10#2)
Ranunculus##3##1##(2008-10#3)
Rao##2##1##(1994-5#1)(2007-4#1)
Raoult's law##2##2##(1990-8#1)(2008-7#1)
Rap##2##1##(1995-2#1)(2008-8#1)
Rap1##3##1##(2008-11#2)(2010-11#1)
Rapamycin and##2##2##(2009-7#2)
Rapamycin##3##1##(2009-7#2)(2010-11#1)
Rape##3##1##(2008-10#2)(2013-1#1)
Raphanus##2##1##(2008-5#1)(2008-8#1)
Raphaël Blanchard##2##2##(2010-1#2)
Rapid Assessment##2##2##(2008-1#1)(2009-9#1)
Rapid Detection of##3##3##(2008-10#2)(2012-2#1)
Rapid Diagnostic##2##2##(2008-10#2)
Rapid and Sensitive Detection of##2##5##(2008-10#2)
Rapid and accurate##2##3##(2008-5#1)(2008-9#1)
Rapid and sensitive##3##3##(2008-10#3)
Rapid and simple##2##3##(2007-2#1)(2010-6#1)
Rapid and##22##2##(1992-1#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-9#3)(2010-6#1)(2011-2#1)(2013-8#1)
Rapid aqueous sample extraction of##2##5##(2008-10#2)
Rapid aqueous sample extraction##3##4##(2008-10#3)
Rapid automated##2##2##(1993-9#1)(2008-10#1)
Rapid brain##2##2##(1996-2#1)(2012-12#1)
Rapid change##2##2##(1992-3#1)(1994-2#1)
Rapid desensitization##2##2##(2008-8#1)(2011-1#1)
Rapid detection of##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
Rapid determination of##9##3##(1993-9#1)(2007-11#1)(2008-10#7)
Rapid determination##10##2##(1990-8#1)(1993-9#1)(2007-11#1)(2008-10#7)
Rapid diagnosis of##4##3##(1990-8#1)(1991-11#1)(2010-5#1)(2011-2#1)
Rapid diagnosis##5##2##(1990-8#1)(1991-11#1)(2010-1#1)(2010-5#1)(2011-2#1)
Rapid progression##2##2##(2010-1#2)
Rapid responses are useful##2##4##(2007-8#2)
Rapid screening##2##2##(2008-10#1)(2008-4#1)
Rapid separation##2##2##(2008-10#1)(2008-11#1)
Rapid turnover of##2##3##(1990-7#2)
Rapid##137##1##(1990-3#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-5#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#44)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-4#1)(2009-9#2)(2010-1#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
RapidArc and##2##2##(2013-1#2)
RapidArc##10##1##(2013-1#10)
Rapidly evolving##2##2##(1997-2#1)(2010-12#1)
Rapidly##7##1##(1997-2#1)(2007-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)
Rapp SS/Jr rats##2##3##(1993-12#2)
Rare association of##2##3##(2010-11#1)(2012-2#1)
Rare association##3##2##(2009-1#1)(2010-11#1)(2012-2#1)
Rare cases##2##2##(2009-3#1)(2013-1#1)
Rare earth##3##2##(2008-10#2)(2008-7#1)
Rare##28##1##(1994-9#1)(1996-12#1)(1997-8#1)(2007-7#2)(2008-10#4)(2008-6#2)(2008-7#2)(2009-1#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
Rarely##7##1##(1997-8#1)(2007-7#1)(2007-8#1)(2008-8#2)(2009-9#1)(2011-1#1)
Ras activation##4##2##(1994-8#3)(1997-6#1)
Ras can be activated by insulin in the PC12 cell line##2##11##(1997-6#2)
Ras can##3##2##(1996-2#1)(1997-6#2)
Ras function##2##2##(2013-7#2)
Ras in##3##2##(1994-8#2)(1997-6#1)
Ras is##3##2##(1994-8#3)
Ras proteins##8##2##(1994-12#2)(1994-8#1)(1996-2#1)(1997-4#1)(2008-5#1)(2013-7#2)
Ras to##3##2##(1995-2#1)(1996-2#2)
Ras transforming##2##2##(1994-8#1)(1995-2#1)
Ras##73##1##(1993-11#1)(1994-12#3)(1994-8#18)(1995-11#1)(1995-2#13)(1995-5#2)(1995-8#2)(1996-2#9)(1997-4#2)(1997-6#5)(1997-7#3)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-7#5)(2013-8#3)
Ras-GAP##2##1##(1997-6#2)
Ras-binding site is##2##3##(1995-5#1)(2013-8#1)
Ras-binding##4##1##(1995-5#3)(2013-8#1)
Ras-dependent MAP kinase activation##2##4##(1995-8#2)
Ras-dependent##4##1##(1995-8#2)(1997-7#1)(2013-7#1)
Ras-related##2##1##(1995-2#2)
Ras-specific##3##1##(1994-12#1)(2013-8#2)
RasGRP1 and Ras##2##3##(2013-8#2)
RasGRP1 and##3##2##(2013-8#3)
RasGRP1 is##2##2##(2013-8#2)
RasGRP1##8##1##(2013-8#8)
Rasch analysis##3##2##(2011-1#1)(2011-2#2)
Rasch model##8##2##(2008-11#1)(2009-11#1)(2012-2#6)
Rasch modeling##3##2##(2012-2#3)
Rasch scaling##2##2##(2012-2#2)
Rasch##23##1##(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#17)
Rash##2##1##(1990-3#1)(2007-2#1)
Rashes##2##1##(2013-1#2)
Rassin##2##1##(2012-3#2)
Rat L6 myotubes##2##3##(2008-11#2)
Rat Model##2##2##(2011-2#1)(2012-3#1)
Rat and mouse##2##3##(1992-6#1)(1997-7#1)
Rat ascites hepatoma##2##3##(1993-8#1)(2008-11#1)
Rat liver##4##2##(1990-11#1)(1991-2#1)(1993-12#1)(1994-8#1)
Rat##51##1##(1990-11#3)(1990-12#2)(1990-2#1)(1991-2#3)(1991-5#2)(1992-12#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2011-2#2)(2012-1#2)(2012-3#3)(2013-1#2)
Rat-2 fibroblasts##2##2##(1995-2#1)(1997-6#1)
Rat1A/Myc-ER cells##2##2##(1996-12#2)
RatLab##5##1##(2013-8#5)
Rate constants for##4##3##(1996-5#1)(1996-7#1)(1997-7#1)(2008-2#1)
Rate of##13##2##(1996-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
Rate##37##1##(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-12#6)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#2)
Rate)##2##1##(2008-5#2)
Rate-of-processing ability##2##2##(2008-9#2)
Rater##2##1##(2012-3#2)
Rates in##3##2##(1996-9#2)(2012-2#1)
Rates of##19##2##(1992-2#1)(1992-5#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)
Rates were##2##2##(1994-12#1)(2013-8#1)
Rates##25##1##(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1996-9#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Rathayibacter toxicus##2##2##(2008-10#2)
Rather than a##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
Rather than being##2##3##(2008-1#1)(2011-2#1)
Rather than focusing##2##3##(2008-11#1)(2010-10#1)
Rather than##23##2##(1994-12#1)(1995-2#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
Rather##48##1##(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Rathke##2##1##(2012-3#2)
Rathke's cleft cysts##2##3##(2008-7#2)
Rathke's cleft##3##2##(2008-7#3)
Rathke's##4##1##(2008-7#3)(2011-2#1)
Rating Scale (UPDRS) and##2##4##(2008-7#2)
Rating Scale (UPDRS)##3##3##(2008-7#3)
Rating Scale and the##2##4##(2006-10#1)(2008-7#1)
Rating Scale for##2##3##(2008-6#2)
Rating Scale scores##2##3##(2011-2#1)(2012-2#1)
Rating Scale were##2##3##(1991-2#1)(2008-7#1)
Rating Scale##29##2##(1991-2#1)(1994-6#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#8)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
Rating##40##1##(1991-2#1)(1994-6#1)(1996-7#1)(1997-3#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#4)(2008-7#8)(2008-9#2)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-8#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
Ratings in##2##2##(2008-11#1)(2008-7#1)
Ratio and##3##2##(1996-9#1)(2008-10#1)(2013-1#1)
Ratio of##4##2##(1996-8#1)(2008-12#2)(2012-12#1)
Ratio##21##1##(1992-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Ratio)##2##1##(2008-5#1)(2008-6#1)
Rational design of##2##3##(2007-11#1)(2012-2#1)
Rational##6##1##(2007-11#1)(2008-10#2)(2008-11#1)(2012-2#2)
Rationale for##6##2##(1991-12#1)(1991-3#1)(1991-8#1)(2008-1#1)(2011-7#1)(2012-3#1)
Rationale##11##1##(1991-12#1)(1991-3#1)(1991-8#1)(1994-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
Rationing health care##9##3##(1996-8#9)
Rationing##11##1##(1992-3#1)(1992-5#1)(1996-8#9)
Ratios##3##1##(1991-6#1)(2008-10#1)(2012-12#1)
Rats in##4##2##(1993-5#1)(1994-8#1)(2012-1#1)(2012-3#1)
Rats of##2##2##(1994-6#1)(2012-2#1)
Rats that##2##2##(1993-12#1)(2008-7#1)
Rats treated##2##2##(2008-10#1)(2010-6#1)
Rats were divided into##2##4##(2008-10#1)(2008-12#1)
Rats were fed##2##3##(2008-11#1)(2011-2#1)
Rats were given##2##3##(1991-6#1)(2008-4#1)
Rats were randomly##2##3##(2012-3#1)(2013-1#1)
Rats were trained to##2##4##(1992-11#1)(1993-12#1)
Rats were trained##4##3##(1991-2#1)(1992-11#1)(1993-12#1)(1994-3#1)
Rats were treated with##3##4##(1996-2#1)(2010-6#1)(2013-8#1)
Rats were treated##4##3##(1995-12#1)(1996-2#1)(2010-6#1)(2013-8#1)
Rats were##31##2##(1990-7#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#4)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#4)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Rats with a##2##3##(1992-8#1)(2009-12#1)
Rats with##11##2##(1992-11#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#2)(1996-2#2)(1996-5#1)(2009-12#1)(2012-2#1)
Rats##82##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-6#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-8#1)(1993-12#8)(1993-3#1)(1993-5#2)(1993-6#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#4)(1996-12#1)(1996-2#3)(1996-5#1)(2007-10#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
Rattus norvegicus##3##2##(1994-12#2)(2008-12#1)
Raw and##2##2##(2008-10#1)(2010-4#1)
Raw##6##1##(2008-10#2)(2008-5#1)(2009-12#1)(2010-4#1)(2013-1#1)
Rawalpindi##2##1##(2013-7#2)
Ray##7##1##(2007-12#1)(2008-2#2)(2008-3#4)
Ray-tracing##3##1##(2008-2#2)(2008-3#1)
Rayleigh and aerosol##2##3##(2008-2#2)
Rayleigh and##3##2##(2008-2#2)(2008-3#1)
Rayleigh backscatter##5##2##(2008-2#2)(2008-3#3)
Rayleigh light scattering (RLS)##2##4##(2008-10#2)
Rayleigh light scattering##5##3##(2008-10#5)
Rayleigh light##6##2##(2008-10#6)
Rayleigh ranges##2##2##(2007-11#1)(2008-2#1)
Rayleigh scattering and##4##3##(2008-2#2)(2008-3#2)
Rayleigh scattering are##2##3##(2007-11#1)(2008-2#1)
Rayleigh scattering cross sections##2##4##(2007-12#2)
Rayleigh scattering method##2##3##(2008-10#2)
Rayleigh scattering of silica core optical##2##6##(2008-2#2)
Rayleigh scattering##33##2##(1992-8#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-2#8)(2008-3#13)
Rayleigh##73##1##(1992-8#1)(2007-11#6)(2007-12#4)(2008-10#12)(2008-2#21)(2008-3#29)
Rayleigh-Mie Doppler wind lidar for atmospheric measurements##2##7##(2008-3#2)
Rayleigh-Mie Doppler##3##2##(2008-3#3)
Rayleigh-Mie lidar##2##2##(2008-3#2)
Rayleigh-Mie##6##1##(2007-11#1)(2008-3#5)
Rayleigh-scattering##2##1##(2008-2#2)
Rayleigh-to-aerosol##2##1##(2008-2#2)
Raynaud's phenomenon##5##2##(1991-3#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-11#1)
Raynaud's##6##1##(1991-3#1)(1995-11#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-11#1)
Rb from##2##2##(2008-10#2)
Rb##38##1##(1992-6#1)(1993-11#2)(1993-8#1)(1995-2#7)(1997-7#3)(2007-11#2)(2007-12#2)(2008-10#12)(2008-2#3)(2008-8#4)(2013-8#1)
Rb(+) and##2##2##(2008-10#2)
Rb(+)##5##1##(2008-10#5)
Rb(+)&gt##2##1##(2008-10#2)
Rb)##2##1##(1997-7#1)(2008-7#1)
Rb+##2##1##(1990-11#1)(1992-6#1)
Rb1##3##1##(2008-11#2)(2010-12#1)
RbTiOAsO(4)##7##1##(2007-12#3)(2008-3#4)
RbsR(His) binding##2##2##(2011-1#2)
RbsR(His)##3##1##(2011-1#3)
Rc##3##1##(2008-8#3)
Rcm 2##4##2##(2008-10#4)
Rcm 5##4##2##(2008-10#4)
Rcm##8##1##(2008-10#8)
Rd15##2##1##(2008-10#2)
RdRp##9##1##(2008-10#5)(2011-1#4)
Rdc##2##1##(2008-10#2)
Rdc2##2##1##(2008-10#2)
Re##35##1##(1996-2#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#8)(2008-6#1)(2011-1#1)(2012-12#1)
Re(2)O(7) are##2##2##(1996-2#2)
Re(2)O(7)##6##1##(1996-2#6)
Re(I)##5##1##(1996-2#4)(2009-9#1)
Re-engineering##5##1##(1995-2#3)(1996-1#1)(1996-12#1)
Re-evaluation of##2##2##(1994-3#1)(2010-11#1)
Re-examination of##3##2##(1991-6#1)(1992-11#1)(2008-5#1)
Re-examining##2##1##(2007-12#1)(2008-1#1)
Reaching##5##1##(1995-1#1)(1996-2#1)(2007-12#1)(2010-7#1)(2013-1#1)
Reaction conditions were##2##3##(2008-10#1)(2008-6#1)
Reaction for##2##2##(2008-10#1)(2010-4#1)
Reaction in##4##2##(1995-6#1)(1996-5#1)(2008-10#2)
Reaction kinetics were##2##3##(2008-10#2)
Reaction mechanism##2##2##(1995-3#1)(2008-10#1)
Reaction of 2-methyl-endo-tricyclo[3##2##3##(1996-5#2)
Reaction of alcohol group##2##4##(2008-10#2)
Reaction of the##2##3##(2007-11#1)(2008-10#1)
Reaction of##24##2##(1990-12#1)(1995-3#1)(1996-2#3)(1996-5#3)(1997-7#3)(2007-11#2)(2008-10#6)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2012-12#1)
Reaction time##2##2##(2008-6#1)(2013-1#1)
Reaction with##3##2##(1996-5#3)
Reaction##108##1##(1990-12#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#3)(1996-5#10)(1997-7#4)(2007-10#1)(2007-11#2)(2008-10#54)(2008-11#2)(2008-12#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Reactions between##2##2##(2008-1#1)(2008-10#1)
Reactions in##3##2##(1992-8#1)(2008-10#2)
Reactions of##9##2##(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2012-2#1)
Reactions to##3##2##(1992-2#1)(1996-12#1)(2013-8#1)
Reactions with##2##2##(2008-11#1)(2009-11#1)
Reactions##32##1##(1992-2#1)(1992-8#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2009-10#1)(2009-11#1)(2009-8#1)(2012-2#1)(2013-8#1)
Reactivation of##4##2##(1991-2#1)(2007-11#1)(2009-4#1)(2012-3#1)
Reactive Oxygen Species##2##3##(2011-2#1)(2012-2#1)
Reactive Red 41##3##3##(2008-10#3)
Reactive Red 96##3##3##(2008-10#3)
Reactive Red##8##2##(1991-5#1)(2008-10#7)
Reactive astrocytes##2##2##(1995-12#1)(2013-7#1)
Reactive oxygen species (ROS)##3##4##(2008-11#1)(2009-8#1)(2011-1#1)
Reactive oxygen species are##2##4##(1991-9#2)
Reactive oxygen species in##2##4##(1991-9#1)(2008-7#1)
Reactive oxygen species##11##3##(1991-9#3)(1992-9#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-8#1)
Reactive##32##1##(1990-6#1)(1991-5#2)(1991-9#3)(1992-9#1)(1995-11#1)(1995-12#1)(1996-9#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-12#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
Reactivity of the##3##3##(1996-2#2)(2012-3#1)
Reactivity of##11##2##(1994-6#1)(1996-2#2)(1996-5#1)(1997-6#1)(2008-10#2)(2008-4#1)(2009-12#1)(2012-12#1)(2012-3#1)
Reactivity ratios##2##2##(2012-12#2)
Reactivity##14##1##(1994-12#1)(1994-6#1)(1996-2#2)(1996-5#1)(1997-6#1)(2008-10#2)(2008-4#1)(2009-12#1)(2012-12#3)(2012-3#1)
Reactome##4##1##(2008-4#4)
Reactor##5##1##(2008-10#2)(2008-11#2)(2008-6#1)
Read##2##1##(2008-2#1)(2011-6#1)
Readability##3##1##(2011-1#2)(2012-3#1)
Readers##3##1##(2007-8#1)(2008-1#1)(2008-4#1)
Readiness##2##1##(1996-1#1)(2008-12#1)
Reading First##3##2##(2008-12#3)
Reading##11##1##(1990-3#1)(1997-7#1)(2008-12#5)(2008-3#1)(2009-11#1)(2010-8#1)(2012-3#1)
Readout##7##1##(2008-2#2)(2008-3#5)
Readthrough##2##1##(2008-10#2)
Ready##4##1##(1994-12#1)(1996-1#1)(2009-8#1)(2011-1#1)
Reagan##9##1##(1991-1#6)(1993-2#2)(2008-6#1)
Reagan's colon cancer episode##3##4##(1991-3#3)
Reagent consumption##2##2##(2008-10#2)
Reagent##9##1##(1993-3#1)(1997-7#1)(2008-10#5)(2009-12#1)(2010-6#1)
Reagentless biosensor##2##2##(2008-10#2)
Reagentless##3##1##(2008-10#3)
Reagents##8##1##(1995-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)
Real Seal##3##2##(2013-1#3)
Real de Salinas##4##3##(2008-5#4)
Real samples##2##2##(2008-10#2)
Real water samples##2##3##(2008-10#2)
Real##24##1##(1991-2#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#3)
Real-Time PCR##4##2##(2008-12#3)(2008-7#1)
Real-Time Polymerase Chain Reaction Assay##5##5##(2008-10#5)
Real-Time Polymerase Chain Reaction##14##4##(2008-10#14)
Real-Time Quantitative##2##2##(2008-10#2)
Real-Time##24##1##(2008-10#18)(2008-12#4)(2008-7#1)(2010-8#1)
Real-time PCR is##2##3##(2008-10#1)(2011-2#1)
Real-time PCR##9##2##(2008-10#4)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
Real-time RT-PCR##2##2##(2008-10#1)(2008-11#1)
Real-time control by multiwavelength##2##4##(2008-2#2)
Real-time data##2##2##(2008-10#1)(2009-6#1)
Real-time detection of##2##3##(2007-12#1)(2009-12#1)
Real-time detection##3##2##(2007-12#2)(2009-12#1)
Real-time finite element##2##3##(2008-6#2)
Real-time holographic##2##2##(2008-2#1)(2008-3#1)
Real-time immunoassay of##2##3##(2008-10#2)
Real-time locating systems##2##3##(2010-9#1)(2011-2#1)
Real-time measurement##2##2##(2008-10#1)(2008-2#1)
Real-time monitoring of##2##3##(2007-12#1)(2010-11#1)
Real-time three-dimensional##2##2##(2007-8#1)(2008-3#1)
Real-time##63##1##(2007-11#8)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#6)(2008-3#10)(2008-6#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-9#1)(2012-2#2)(2013-1#1)
RealBest DNA Anaplasma phagocytophilum/Ehrlichia muris##2##5##(2013-1#2)
Realistic##4##1##(1994-2#1)(2008-2#1)(2011-1#1)(2011-2#1)
Reality##4##1##(1992-1#1)(1994-2#1)(2009-1#1)(2010-9#1)
Realization of##4##2##(1994-7#1)(2008-2#2)(2008-3#1)
Realization##5##1##(1994-7#1)(2008-2#2)(2008-3#2)
Realized heritability##2##2##(2008-10#2)
Realized##4##1##(2008-10#2)(2008-9#1)(2010-8#1)
Realizing the##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
Realizing##4##1##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
Really##4##1##(1991-11#1)(1994-5#1)(2009-6#1)(2012-3#1)
Reanalysis and##2##2##(1995-11#1)(2013-1#1)
Reanalysis##3##1##(1995-11#1)(2008-10#1)(2013-1#1)
Reaping##2##1##(1991-8#1)(2012-2#1)
Rear##2##1##(2013-8#2)
Rearing##3##1##(2008-10#1)(2008-11#1)(2010-10#1)
Rearrangement of the##2##3##(2008-6#1)(2009-2#1)
Rearrangement of##4##2##(1996-5#2)(2008-6#1)(2009-2#1)
Rearrangement##8##1##(1996-2#1)(1996-5#4)(2008-6#2)(2009-2#1)
Reason##4##1##(1995-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
Reasonable##4##1##(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
Reasoned Action##4##2##(1993-3#1)(2008-4#1)(2011-1#1)(2012-12#1)
Reasoning##5##1##(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
Reasons for the##2##3##(2008-11#1)(2011-1#1)
Reasons for this##3##3##(2008-9#1)(2010-12#1)(2012-1#1)
Reasons for##13##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Reasons to##2##2##(1996-2#1)(1997-3#1)
Reasons##18##1##(1996-2#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Reassessment of the##3##3##(2008-10#2)(2009-1#1)
Reassessment of##4##2##(2008-10#2)(2008-11#1)(2009-1#1)
Reassessment##5##1##(2008-10#2)(2008-11#1)(2009-1#1)(2012-3#1)
Reassortant##2##1##(2008-10#2)
Reassortment##4##1##(2008-10#3)(2012-12#1)
Rebleeding rate was 20##2##4##(2013-1#2)
Rebleeding##5##1##(2008-7#1)(2011-2#1)(2013-1#3)
Rebound##2##1##(2008-4#1)(2013-1#1)
RecA##11##1##(1993-9#3)(1995-2#1)(1995-8#1)(1997-4#3)(2008-4#1)(2009-7#2)
RecA-independent recombination##2##2##(1995-2#2)
RecA-like##3##1##(1990-5#1)(1995-6#1)(1995-8#1)
RecB8-LacZ##2##1##(2008-11#2)
RecQ##2##1##(2010-2#2)
RecQ5##3##1##(2011-1#3)
Receiver operating characteristic##3##3##(2012-2#1)(2012-3#1)(2013-7#1)
Receiver##4##1##(2008-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
Receiving##6##1##(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2012-3#1)
Recent Advances in##3##3##(1996-12#1)(2008-4#1)(2009-10#1)
Recent advancements in##2##3##(2008-5#1)(2008-8#1)
Recent advances focus on blood alkalinisation and magnesium sulphate as promising adjunctive therapies##2##13##(2013-1#2)
Recent advances have##2##3##(2008-10#1)(2009-6#1)
Recent advances in genetic##2##4##(2008-7#1)(2008-8#1)
Recent advances in molecular biology have##2##6##(2007-7#1)(2009-1#1)
Recent advances in paediatric cardiac##2##5##(2007-9#2)
Recent advances in the##13##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Recent advances in##53##3##(1990-9#1)(1994-5#1)(1995-5#1)(1996-12#1)(1997-8#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-9#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-1#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
Recent advances##62##2##(1990-9#1)(1994-5#1)(1995-5#1)(1996-12#1)(1997-8#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-9#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-1#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
Recent and##2##2##(1990-11#1)(1993-12#1)
Recent animal studies##2##3##(2008-8#1)(2009-10#1)
Recent applications of##2##3##(2008-10#2)
Recent applications##3##2##(2008-10#3)
Recent changes in##4##3##(1991-1#1)(1995-12#1)(2008-11#2)
Recent changes##5##2##(1991-1#1)(1995-12#1)(1996-2#1)(2008-11#2)
Recent clinical##4##2##(2007-9#1)(2008-10#1)(2008-6#1)(2010-8#1)
Recent computational##2##2##(2008-7#2)
Recent data has##2##3##(2008-11#1)(2008-7#1)
Recent data have##2##3##(1993-9#1)(2011-2#1)
Recent data show##2##3##(2008-7#1)(2011-2#1)
Recent data suggest that##4##4##(1991-7#1)(1997-1#1)(2010-11#1)(2011-2#1)
Recent data suggest##5##3##(1991-7#1)(1997-1#1)(2008-3#1)(2010-11#1)(2011-2#1)
Recent data##15##2##(1991-7#1)(1993-9#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#3)(2013-1#1)
Recent developments in the field of microbiology and research on the origin of life have suggested a##2##17##(2008-10#2)
Recent developments in the field of##3##6##(2008-10#2)(2010-9#1)
Recent developments in the treatment##2##5##(2007-12#1)(2009-7#1)
Recent developments in the##7##4##(1991-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-9#1)
Recent developments in##12##3##(1991-8#1)(1993-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-7#1)(2010-9#1)(2012-2#1)
Recent developments##17##2##(1991-8#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)
Recent discoveries##2##2##(1997-1#1)(2008-4#1)
Recent electron##2##2##(1991-9#1)(2010-2#1)
Recent electrophysiological##2##2##(2008-11#1)(2008-5#1)
Recent evidence has##4##3##(2008-11#1)(2009-8#2)(2010-11#1)
Recent evidence suggests that##5##4##(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-5#1)
Recent evidence suggests##6##3##(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-5#1)(2010-7#1)
Recent evidence##17##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#4)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)
Recent experience has##2##3##(2008-11#1)(2011-2#1)
Recent experimental evidence##4##3##(1993-9#1)(2008-5#1)(2008-9#1)(2011-2#1)
Recent experimental##5##2##(1993-9#1)(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
Recent experiments##4##2##(1997-2#1)(2008-4#1)(2009-6#1)(2010-7#1)
Recent findings from##2##3##(1991-12#1)(2008-10#1)
Recent findings have##2##3##(2008-7#1)(2011-2#1)
Recent findings indicate that##4##4##(2008-1#2)(2008-5#1)(2012-2#1)
Recent findings suggest##2##3##(1992-12#1)(2008-7#1)
Recent findings##13##2##(1991-12#1)(1992-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2011-2#2)(2012-2#1)
Recent genetic##2##2##(2008-5#1)(2009-6#1)
Recent improvements in##2##3##(2008-3#1)(2008-7#1)
Recent insights##2##2##(2011-2#1)(2013-1#1)
Recent interest##2##2##(2008-10#1)(2008-8#1)
Recent investigations have##3##3##(1995-11#1)(2006-10#1)(2013-1#1)
Recent investigations##7##2##(1995-11#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
Recent landmark trials in cardiology##3##5##(2008-11#3)
Recent landmark##4##2##(2008-11#3)(2010-5#1)
Recent methods##2##2##(2008-10#1)(2009-10#1)
Recent models##2##2##(2008-11#1)(2008-9#1)
Recent neuroimaging##2##2##(2008-11#1)(2010-5#1)
Recent preclinical##2##2##(2008-6#1)(2008-7#1)
Recent progress has##2##3##(1997-3#1)(2008-10#1)
Recent progress in the##3##4##(2008-3#1)(2008-7#1)(2012-12#1)
Recent progress in##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
Recent progress##7##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
Recent publications in##2##3##(1997-3#1)(2008-7#1)
Recent publications##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
Recent publicity surrounding##2##3##(1991-2#1)(2008-8#1)
Recent reports have shown##2##4##(2008-10#1)(2008-7#1)
Recent reports have##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
Recent reports of##3##3##(1992-12#1)(1997-5#1)(2008-10#1)
Recent reports suggest that##2##4##(1993-6#1)(2008-4#1)
Recent reports##12##2##(1992-12#1)(1993-6#1)(1996-2#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
Recent research has focused on##2##5##(1997-6#1)(2008-5#1)
Recent research has identified##2##4##(2008-6#1)(2009-5#1)
Recent research has shown##2##4##(2008-10#1)(2008-6#1)
Recent research has##10##3##(1997-6#1)(2008-10#2)(2008-5#2)(2008-6#2)(2009-5#1)(2010-8#1)(2011-9#1)
Recent research in##2##3##(2008-12#1)(2009-2#1)
Recent research on##2##3##(2008-10#1)(2013-1#1)
Recent research suggests##2##3##(2008-5#1)(2013-1#1)
Recent research trends##2##3##(2010-7#1)(2013-1#1)
Recent research##26##2##(1997-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-9#1)(2013-1#3)(2013-8#1)
Recent results##3##2##(1991-6#1)(1997-1#1)(2012-12#1)
Recent studies conclude that the ankle/arm blood pressure index (AAI) is a useful clinical tool for refining cardiovascular risk classification in the elderly##2##23##(1993-12#2)
Recent studies have begun to##2##5##(2007-8#1)(2011-2#1)
Recent studies have confirmed##2##4##(1995-2#1)(2008-12#1)
Recent studies have demonstrated that##4##5##(1993-12#1)(1994-8#1)(1996-2#1)(2010-11#1)
Recent studies have demonstrated##6##4##(1993-12#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-4#1)(2010-11#1)
Recent studies have found##2##4##(1996-7#1)(2008-12#1)
Recent studies have identified##2##4##(2007-12#1)(2008-8#1)
Recent studies have indicated that##2##5##(2008-9#1)(2011-2#1)
Recent studies have indicated##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
Recent studies have reported##2##4##(2008-11#1)(2013-1#1)
Recent studies have revealed that##2##5##(1997-8#1)(2008-11#1)
Recent studies have shown that the##2##6##(1993-11#1)(1996-12#1)
Recent studies have shown that##12##5##(1993-11#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
Recent studies have shown##14##4##(1993-11#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
Recent studies have##46##3##(1993-11#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#3)
Recent studies in our##2##4##(2008-7#1)(2009-6#1)
Recent studies in the field##2##5##(2009-10#1)(2013-8#1)
Recent studies in##5##3##(2008-1#1)(2008-7#1)(2009-10#1)(2009-6#1)(2013-8#1)
Recent studies indicate that##5##4##(1990-12#1)(1997-7#1)(2008-1#1)(2008-3#1)(2008-5#1)
Recent studies of##5##3##(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-2#1)
Recent studies on the##2##4##(2007-11#1)(2007-12#1)
Recent studies on##5##3##(1990-6#1)(2007-11#1)(2007-12#2)(2012-1#1)
Recent studies reveal that##2##4##(2008-11#1)(2012-2#1)
Recent studies show that##3##4##(2009-6#1)(2011-2#1)(2012-1#1)
Recent studies show##4##3##(2008-11#1)(2009-6#1)(2011-2#1)(2012-1#1)
Recent studies suggest that the##2##5##(2012-2#1)(2012-3#1)
Recent studies suggest that##5##4##(1991-4#1)(1992-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
Recent studies suggest##6##3##(1991-4#1)(1992-12#1)(2007-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Recent studies using##3##3##(1992-8#1)(2009-10#1)(2009-5#1)
Recent studies##95##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#4)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#4)(2009-12#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
Recent theoretical##2##2##(2008-12#1)(2008-8#1)
Recent trends##3##2##(2008-7#1)(2009-4#1)(2011-1#1)
Recent work has revealed##2##4##(2011-2#1)(2012-2#1)
Recent work has##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
Recent work##9##2##(1997-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
Recent years have seen the emergence of##2##7##(2008-9#1)(2009-5#1)
Recent years have seen##3##4##(2008-11#1)(2008-9#1)(2009-5#1)
Recent years have witnessed##2##4##(2007-8#1)(2009-12#1)
Recent years have##5##3##(2007-8#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-5#1)
Recent##449##1##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-6#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#5)(2006-9#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#10)(2008-10#36)(2008-11#31)(2008-12#7)(2008-2#3)(2008-3#11)(2008-4#14)(2008-5#16)(2008-6#10)(2008-7#24)(2008-8#17)(2008-9#11)(2009-1#2)(2009-10#7)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#6)(2009-6#7)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#6)(2010-9#3)(2011-1#5)(2011-2#30)(2011-7#1)(2011-9#1)(2012-1#4)(2012-12#8)(2012-2#14)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#3)
Recently a family of##2##4##(1993-3#1)(1995-2#1)
Recently a##10##2##(1993-3#1)(1995-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2009-2#1)(2010-12#1)
Recently developed##4##2##(1991-1#1)(1994-3#1)(2008-4#1)(2008-5#1)
Recently it has been reported that##2##6##(1997-6#1)(2013-8#1)
Recently it has been##3##4##(1992-5#1)(1997-6#1)(2013-8#1)
Recently it has##4##3##(1992-5#1)(1997-6#1)(2008-5#1)(2013-8#1)
Recently it##6##2##(1992-5#1)(1997-6#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
Recently recognized##2##2##(2008-11#1)(2011-2#1)
Recently several##2##2##(1995-8#1)(2008-3#1)
Recently the##9##2##(1993-8#1)(1994-12#1)(2006-8#1)(2008-2#2)(2008-5#1)(2011-2#3)
Recently there has been a##2##5##(1992-9#1)(2013-8#1)
Recently there has been##3##4##(1992-9#1)(2009-1#1)(2013-8#1)
Recently there##4##2##(1992-2#1)(1992-9#1)(2009-1#1)(2013-8#1)
Recently we have shown that##2##5##(1994-8#1)(2011-2#1)
Recently we have##3##3##(1994-8#1)(2011-1#1)(2011-2#1)
Recently we reported##3##3##(2009-8#1)(2009-9#1)(2011-2#1)
Recently we##10##2##(1993-8#1)(1994-8#1)(1997-6#1)(2007-11#1)(2008-3#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)
Recently##256##1##(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#15)(2008-11#10)(2008-12#4)(2008-2#7)(2008-3#10)(2008-4#6)(2008-5#9)(2008-7#17)(2008-8#2)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#10)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#18)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#4)(2012-8#1)(2013-1#7)(2013-8#6)
Receptor activator##2##2##(2008-11#1)(2013-1#1)
Receptor binding##2##2##(1993-5#1)(1994-6#1)
Receptor for##2##2##(2008-10#1)(2012-3#1)
Receptor##41##1##(1993-5#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
Receptor-Mediated##2##1##(2013-1#2)
Receptor-binding##2##1##(1990-4#1)(1993-9#1)
Receptor-mediated activation of##2##3##(1991-5#1)(2010-9#1)
Receptor-mediated##6##1##(1991-12#1)(1991-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(2010-9#1)
Receptors and##2##2##(2008-4#1)(2009-12#1)
Receptors for##2##2##(1990-11#1)(1993-5#1)
Receptors in##2##2##(1995-12#1)(2008-4#1)
Receptors##11##1##(1990-11#1)(1993-5#1)(1995-12#1)(1996-5#1)(2008-4#4)(2009-12#1)(2011-2#1)(2012-12#1)
Recessive##5##1##(2008-10#4)(2011-1#1)
Recherche##4##1##(2008-3#2)(2008-7#2)
Recidives##2##1##(2007-11#2)
Recife##4##1##(2008-9#4)
Recipes##2##1##(2007-11#1)(2008-2#1)
Reciprocal changes in##2##3##(1994-12#2)
Reciprocal##5##1##(1990-11#1)(1994-12#2)(2008-11#1)(2012-12#1)
Reciprocally##2##1##(1990-11#1)(2008-5#1)
Reciprocity##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
Reck##2##1##(2011-2#2)
Recklinghausen##2##1##(1991-3#1)(1992-9#1)
Recklinghausen's disease##6##2##(1991-2#1)(1992-9#1)(1994-6#1)(2007-8#2)(2008-10#1)
Recklinghausen's neurofibromatosis##3##2##(2008-10#3)
Recklinghausen's##9##1##(1991-2#1)(1992-9#1)(1994-6#1)(2007-8#2)(2008-10#4)
Recognition and##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
Recognition of an##2##3##(1993-11#1)(2007-2#1)
Recognition of the##3##3##(2009-4#1)(2012-2#1)(2012-3#1)
Recognition of this##3##3##(1995-5#1)(1996-9#1)(2008-7#1)
Recognition of##25##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1995-2#2)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2012-2#1)(2012-3#1)
Recognition that a##2##3##(1996-9#1)(2008-11#1)
Recognition##46##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-5#2)(1996-8#1)(1996-9#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Recognized##4##1##(1994-12#2)(2008-10#1)(2008-11#1)
Recognizing and supporting the##2##4##(1993-12#1)(1997-3#1)
Recognizing and##4##2##(1993-12#1)(1994-2#1)(1995-12#1)(1997-3#1)
Recognizing emotion from facial expressions##2##5##(2007-8#2)
Recognizing that##2##2##(2008-8#1)(2012-3#1)
Recognizing the##4##2##(2008-12#1)(2010-10#1)(2010-6#1)(2011-2#1)
Recognizing##16##1##(1993-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2007-8#2)(2008-12#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)
Recombinant CHO cell##2##3##(2008-11#2)
Recombinant DNA##2##2##(2008-10#1)(2008-4#1)
Recombinant PAI-1##2##2##(2008-4#2)
Recombinant adeno-associated virus (rAAV)##2##4##(2008-5#1)(2008-9#1)
Recombinant adeno-associated virus##3##3##(2008-5#2)(2008-9#1)
Recombinant adenovirus##2##2##(1994-5#1)(1997-4#1)
Recombinant adenoviruses##2##2##(1995-2#1)(2008-11#1)
Recombinant antibodies##2##2##(2008-10#1)(2013-8#1)
Recombinant baculoviruses##2##2##(1993-6#1)(1993-8#1)
Recombinant cell##2##2##(2008-10#1)(2008-7#1)
Recombinant factor VIIa##2##3##(2007-8#1)(2008-9#1)
Recombinant human erythropoietin##2##3##(1995-1#1)(2007-5#1)
Recombinant human topoisomerase II##2##4##(1995-6#2)
Recombinant human##9##2##(1990-10#1)(1990-7#1)(1992-12#1)(1994-8#1)(1995-1#1)(1995-6#2)(2007-5#1)(2008-8#1)
Recombinant protein##3##2##(1994-8#1)(2008-11#2)
Recombinant virus##2##2##(2008-10#1)(2008-8#1)
Recombinant viruses were##2##3##(1991-6#1)(1997-4#1)
Recombinant##85##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-8#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Recombinants##3##1##(2008-10#3)
Recombination and##3##2##(2008-10#3)
Recombination between##2##2##(1995-12#1)(2008-8#1)
Recombination in##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
Recombination of##2##2##(1996-9#1)(2008-4#1)
Recombination##18##1##(1995-12#1)(1995-6#1)(1996-9#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-8#2)
Recommendation##2##1##(1996-11#1)(2012-12#1)
Recommendations are made for##5##4##(1991-1#1)(1992-12#1)(1992-3#1)(2007-10#1)(2013-8#1)
Recommendations are made##7##3##(1991-1#1)(1992-12#1)(1992-3#1)(1995-9#1)(1997-1#1)(2007-10#1)(2013-8#1)
Recommendations are provided##2##3##(2008-12#1)(2009-8#1)
Recommendations are##13##2##(1991-1#1)(1992-12#1)(1992-3#1)(1995-9#1)(1997-1#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-8#1)(2010-9#1)(2013-8#1)
Recommendations for the##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
Recommendations for##16##2##(1992-3#1)(1993-3#1)(1995-9#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Recommendations included##2##2##(2008-11#2)
Recommendations of the##3##3##(1993-12#1)(2008-3#1)(2010-5#1)
Recommendations of##4##2##(1993-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
Recommendations on the##2##3##(2007-2#1)(2009-8#1)
Recommendations on##4##2##(2007-2#1)(2008-12#1)(2009-11#1)(2009-8#1)
Recommendations to##2##2##(2009-10#1)(2011-2#1)
Recommendations were made##2##3##(2008-12#1)(2013-1#1)
Recommendations were##4##2##(2008-12#1)(2009-5#1)(2010-5#1)(2013-1#1)
Recommendations##57##1##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-9#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-3#2)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Recommended optimization conditions are included##2##5##(2008-2#1)(2008-9#1)
Recommended treatment##2##2##(1993-3#1)(2010-11#1)
Recommended##12##1##(1993-3#1)(1995-2#1)(1997-4#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)
Reconciliation Act of##6##3##(1991-1#1)(1991-12#1)(1991-3#1)(1994-1#1)(1994-3#1)(1996-3#1)
Reconciliation Act##10##2##(1991-1#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-3#2)(1996-3#1)(1997-3#1)
Reconciliation##12##1##(1991-1#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)(2008-8#1)
Reconciling##4##1##(1995-1#1)(1996-1#1)(1996-2#1)(2008-9#1)
Reconfigurable##3##1##(2007-11#1)(2008-3#1)(2009-3#1)
Reconstitution of a##3##3##(1990-2#1)(1993-6#1)(1995-3#1)
Reconstitution of the##3##3##(1990-11#1)(1992-3#1)(1994-8#1)
Reconstitution of##14##2##(1990-11#1)(1990-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-2#1)
Reconstitution##16##1##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-2#1)
Reconstruct##2##1##(2011-2#1)(2013-8#1)
Reconstructed##5##1##(2008-3#2)(2011-2#1)(2011-7#1)(2013-1#1)
Reconstructing an##2##2##(2008-8#1)(2010-1#1)
Reconstructing the##5##2##(2008-11#1)(2010-5#1)(2012-2#1)(2013-1#2)
Reconstructing##10##1##(2007-12#2)(2008-11#1)(2008-8#2)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#2)
Reconstruction for##2##2##(2008-9#1)(2010-2#1)
Reconstruction in##2##2##(2012-3#2)
Reconstruction of a##2##3##(2008-9#1)(2011-2#1)
Reconstruction of osteomyelitis defects##2##4##(2010-6#2)
Reconstruction of the##8##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
Reconstruction of##26##2##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
Reconstruction was##2##2##(2007-5#1)(2008-9#1)
Reconstruction##43##1##(2007-12#5)(2007-5#1)(2008-1#1)(2008-2#3)(2008-3#4)(2008-6#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-2#1)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
Reconstructions##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
Reconstructive##2##1##(1993-11#1)(2008-9#1)
Record##13##1##(1992-4#1)(1993-1#1)(2008-11#2)(2008-7#2)(2010-8#4)(2011-1#1)(2011-2#1)(2013-1#1)
Recordati##2##1##(1996-1#1)(2008-5#1)
Recorded##4##1##(2007-11#1)(2008-2#1)(2008-3#1)(2010-3#1)
Recording and##2##2##(2007-11#1)(2008-4#1)
Recording of##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
Recording the##3##2##(1990-10#1)(1991-11#1)(1997-8#1)
Recording##19##1##(1990-10#1)(1991-11#1)(1991-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-8#1)
Recordings of the##2##3##(1995-12#1)(2012-12#1)
Recordings were made from##2##4##(1995-2#1)(1997-2#1)
Recordings##5##1##(1995-12#1)(1995-2#1)(1997-2#1)(2008-4#1)(2012-12#1)
Records of##6##2##(1991-11#1)(1991-3#1)(1995-10#1)(2008-5#1)(2010-8#1)(2011-1#1)
Records were##3##2##(1996-1#1)(2007-10#1)(2012-12#1)
Records##29##1##(1991-11#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-2#3)(1996-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#5)(2011-1#1)(2012-12#2)
Recovered from##2##2##(2008-10#2)
Recovered##3##1##(2008-10#3)
Recoveries are 99##2##3##(2008-10#2)
Recoveries are##3##2##(1995-12#1)(2008-10#2)
Recoveries between##2##2##(2008-10#2)
Recoveries for##4##2##(2008-10#4)
Recoveries from spiked##3##3##(2008-10#3)
Recoveries from##8##2##(1993-2#1)(2008-10#7)
Recoveries in the##2##3##(2008-10#2)
Recoveries obtained##2##2##(2008-10#2)
Recoveries of spike additions##2##4##(2008-10#2)
Recoveries of spiked##3##3##(2008-10#3)
Recoveries of##22##2##(2008-10#22)
Recoveries ranged from 99 to 101% and the relative standard deviation is around##2##13##(2008-10#2)
Recoveries ranged from##3##3##(2008-10#3)
Recoveries were 99##2##3##(2008-10#2)
Recoveries were between 92 and##2##5##(2008-10#2)
Recoveries were between##4##3##(2008-10#4)
Recoveries were##14##2##(2008-10#14)
Recoveries within##3##2##(2008-10#3)
Recoveries##69##1##(1993-2#1)(1995-12#1)(2008-10#67)
Recoverin##3##1##(1995-6#3)
Recovering##4##1##(1993-1#1)(1997-1#1)(2009-11#1)(2012-1#1)
Recovery 1 and 2##3##4##(1994-2#3)
Recovery 1 and##4##3##(1994-2#4)
Recovery 1##5##2##(1994-2#5)
Recovery after##2##2##(2013-1#1)(2013-8#1)
Recovery experiments have also been performed##2##6##(2008-10#2)
Recovery experiments##3##2##(2008-10#3)
Recovery from Work##2##3##(2011-2#2)
Recovery from##8##2##(1993-5#1)(1995-11#1)(1996-2#1)(2008-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
Recovery in samples spiked with two different##2##7##(2008-10#2)
Recovery in##5##2##(2008-10#3)(2008-2#1)(2011-1#1)
Recovery of the##7##3##(1995-2#1)(1996-5#1)(2008-10#3)(2008-11#2)
Recovery of##25##2##(1990-6#1)(1990-8#1)(1991-12#2)(1991-9#1)(1992-9#1)(1995-2#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-10#12)(2008-11#2)(2013-8#1)
Recovery studies on natural##2##4##(2008-10#2)
Recovery studies on##3##3##(2008-10#3)
Recovery studies were performed at##2##5##(2008-10#2)
Recovery studies were performed##3##4##(2008-10#3)
Recovery studies##11##2##(2008-10#11)
Recovery values from urine samples##2##5##(2008-10#2)
Recovery values from##3##3##(2008-10#3)
Recovery values##6##2##(2008-10#6)
Recovery##80##1##(1990-6#1)(1990-8#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-5#1)(1994-2#6)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-10#42)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#6)(2013-8#2)
Recreational##5##1##(1993-2#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
Recruiting patients##2##2##(2012-3#2)
Recruiting physicians for rural states##2##5##(1994-1#2)
Recruiting##7##1##(1991-12#1)(1994-1#2)(2008-5#1)(2011-2#1)(2012-3#2)
Recruitment and retention##2##3##(1994-3#1)(2008-11#1)
Recruitment and##4##2##(1993-3#1)(1994-3#1)(1997-2#1)(2008-11#1)
Recruitment of a##2##3##(1993-3#1)(2013-1#1)
Recruitment of physicians to rural states is complicated by several barriers precipitated by non-metropolitan locations##2##15##(1994-1#2)
Recruitment of##7##2##(1993-3#1)(1994-1#2)(2010-8#1)(2011-2#1)(2013-1#2)
Recruitment to##2##2##(1996-8#1)(2012-3#1)
Recruitment##20##1##(1993-3#2)(1993-8#1)(1994-1#2)(1994-3#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
Rectal complications in patients with carcinoma of the cervix##2##9##(1994-3#2)
Rectal endometriosis##2##2##(2009-8#2)
Rectal mucosal prolapse was characterized by the protrusion of the mucosa alone in the##2##14##(2013-1#2)
Rectal##10##1##(1990-9#1)(1993-11#1)(1994-3#2)(2008-12#1)(2009-8#2)(2012-12#1)(2013-1#2)
Recurrence of##4##2##(1991-11#1)(1991-8#1)(1992-4#1)(2008-1#1)
Recurrence rates##2##2##(2007-11#1)(2010-8#1)
Recurrence##14##1##(1991-11#1)(1991-8#1)(1992-4#1)(1995-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)
Recurrent Breast Cancer##2##3##(1994-12#1)(1994-7#1)
Recurrent meningitis in children##2##4##(2013-7#2)
Recurrent or##2##2##(1991-2#1)(2008-6#1)
Recurrent priapism##2##2##(2008-10#2)
Recurrent solitary##2##2##(1990-8#2)
Recurrent##42##1##(1990-8#2)(1991-2#1)(1992-2#1)(1994-12#1)(1994-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#3)(2009-1#1)(2009-3#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-7#3)
Recurring##2##1##(2007-10#1)(2008-10#1)
Recursive partitioning analysis##3##3##(1991-12#3)
Recursive partitioning##4##2##(1991-12#3)(2013-1#1)
Recursive##5##1##(1991-12#3)(2008-2#1)(2013-1#1)
Recycling of##2##2##(1993-11#1)(2008-6#1)
Recycling##4##1##(1993-11#1)(1996-1#1)(1996-12#1)(2008-6#1)
Red Book##2##2##(2007-12#1)(2011-1#1)
Red Cross in##2##3##(1991-11#1)(1992-12#1)
Red Cross##8##2##(1991-11#1)(1992-12#2)(1995-6#1)(1997-5#1)(2008-10#1)(2012-1#2)
Red Fortified##2##2##(2008-10#2)
Red LaSoda##3##2##(2008-10#3)
Red Queen hypothesis##4##3##(2009-2#4)
Red S-zirconium(IV)##2##2##(2008-10#2)
Red Winter Wheat##2##3##(2008-10#2)
Red and##3##2##(2008-10#3)
Red blood cell##5##3##(1991-6#1)(1996-7#2)(2008-10#1)(2012-2#1)
Red cell##3##2##(1992-12#1)(1993-12#1)(1994-3#1)
Red cells from the proposita##2##5##(1992-12#2)
Red flags##2##2##(2008-12#2)
Red onion##2##2##(2008-10#2)
Red##104##1##(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#5)(1993-12#2)(1994-3#1)(1995-6#1)(1996-6#1)(1996-7#2)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#50)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#5)(2009-12#2)(2009-2#4)(2010-2#1)(2011-1#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Redefining the##4##2##(1991-12#1)(1993-12#1)(1996-3#1)(2008-8#1)
Redefining##6##1##(1991-12#1)(1993-12#1)(1996-3#1)(1997-6#1)(2008-8#1)(2010-12#1)
Redeploy##2##1##(1996-3#1)(1997-2#1)
Redesign of##2##2##(1995-12#1)(2007-12#1)
Redesigning##2##1##(1993-3#1)(1996-3#1)
Redirected Free Exploration with Distractors##2##5##(2012-2#2)
Redisplacement##2##1##(2011-2#2)
Redo##2##1##(2008-6#1)(2012-2#1)
Redox##9##1##(1996-9#1)(1997-7#1)(2008-10#4)(2008-7#1)(2009-2#1)(2011-2#1)
Reduce the##2##2##(1997-2#1)(2010-1#1)
Reduce##8##1##(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-3#1)
Reduced energy intake##2##3##(2008-11#2)
Reduced glutathione##2##2##(1990-12#1)(2008-4#1)
Reduced growth##2##2##(2008-10#1)(2008-8#1)
Reduced inorganic##2##2##(2008-10#2)
Reduced plasma##2##2##(1992-2#1)(1994-5#1)
Reduced sensitivity was found for##2##5##(2007-6#2)
Reduced##73##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#4)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Reduces##8##1##(2008-10#3)(2009-12#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
Reducing the risk of burns##2##5##(2010-9#1)(2011-2#1)
Reducing the risk of##3##4##(2008-8#1)(2010-9#1)(2011-2#1)
Reducing the##14##2##(1993-1#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Reducing##35##1##(1992-12#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-9#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-3#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
Reductase##2##1##(1996-2#1)(2008-12#1)
Reduction in the##2##3##(1994-2#1)(2012-2#1)
Reduction in##15##2##(1994-2#2)(1994-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
Reduction of mercury(II) by tropical river humic substances (Rio##2##9##(2008-10#2)
Reduction of skylight reflection effects in the above-water measurement of diffuse marine reflectance##2##13##(2008-3#2)
Reduction of the##9##3##(1993-8#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-3#2)
Reduction of##49##2##(1990-7#1)(1991-1#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
Reduction##72##1##(1990-7#1)(1991-1#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#4)(2013-8#1)
Reductions in##4##2##(2007-12#1)(2008-10#3)
Reductions##5##1##(1996-12#1)(2007-12#1)(2008-10#3)
Reductive Amination##2##2##(1996-5#2)
Reductive##7##1##(1993-11#1)(1995-3#1)(1996-5#3)(2008-10#1)(2008-11#1)
Redundant##4##1##(1994-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
Reduviidae)##2##1##(2007-12#1)(2013-7#1)
Reed##2##1##(1990-2#1)(2008-7#1)
Reef##7##1##(2007-5#6)(2008-5#1)
Reengineering and##2##2##(1994-1#1)(1995-12#1)
Reengineering##10##1##(1994-1#1)(1994-12#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)
Reexamination##2##1##(2008-10#1)(2009-1#1)
Ref##4##1##(2007-11#1)(2007-12#2)(2008-8#1)
Reference (BCR)##3##2##(2008-10#3)
Reference Laboratories and Collaborating Centres##2##5##(2011-2#2)
Reference Laboratories##4##2##(2008-10#1)(2011-2#3)
Reference Laboratory for##4##3##(1997-6#1)(2008-10#1)(2011-2#2)
Reference Laboratory##6##2##(1997-6#1)(2007-10#1)(2008-10#1)(2011-2#2)(2013-8#1)
Reference Materials##6##2##(2007-12#1)(2008-10#4)(2008-2#1)
Reference is made to the##3##5##(1996-9#1)(2007-6#1)(2011-1#1)
Reference is made to##4##4##(1996-9#1)(2007-6#1)(2008-4#1)(2011-1#1)
Reference laboratories##2##2##(2008-12#1)(2011-2#1)
Reference to the##2##3##(1993-2#1)(2008-6#1)
Reference to##4##2##(1993-2#1)(1996-9#1)(2008-1#1)(2008-6#1)
Reference values for the##2##4##(1994-5#1)(2008-10#1)
Reference values for##3##3##(1990-2#1)(1994-5#1)(2008-10#1)
Reference values##6##2##(1990-2#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-7#1)
Reference##62##1##(1990-2#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-9#2)(1997-1#1)(1997-6#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#17)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Reference)##2##1##(2008-10#1)(2008-11#1)
Reference-beam##2##1##(2008-2#1)(2008-3#1)
References##3##1##(2008-4#1)(2008-9#1)(2013-1#1)
Referral##9##1##(1990-9#1)(1993-12#1)(2007-2#1)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
Referrals from##3##2##(1992-3#1)(2010-10#1)(2012-2#1)
Referrals##7##1##(1991-1#1)(1991-11#1)(1992-3#1)(1996-3#1)(2008-9#1)(2010-10#1)(2012-2#1)
Referred to##2##2##(2008-10#1)(2011-2#1)
Referred##3##1##(2008-10#1)(2010-9#1)(2011-2#1)
Refined##3##1##(1993-12#1)(1993-3#1)(2008-8#1)
Refinement##3##1##(1994-12#1)(1997-7#1)(2008-11#1)
Reflectance measurements and optical constants##2##5##(2008-3#2)
Reflectance measurements##3##2##(2008-3#3)
Reflectance##9##1##(2008-10#2)(2008-2#2)(2008-3#5)
Reflected##4##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
Reflecting on##2##2##(2008-11#2)
Reflecting##4##1##(2008-11#3)(2008-12#1)
Reflection and transmission##2##3##(2007-11#1)(2007-12#1)
Reflection hologram for reconstructing deep images##2##6##(2007-12#1)(2008-1#1)
Reflection optical encoders##2##3##(2008-3#2)
Reflection##14##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#1)
Reflection-type polarization holograms##2##3##(2007-12#2)
Reflection-type##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
Reflections of a##2##3##(2008-8#1)(2012-12#1)
Reflections of##3##2##(1993-1#1)(2008-8#1)(2012-12#1)
Reflections on the##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
Reflections on##8##2##(1990-11#1)(1994-12#1)(1996-9#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-7#1)
Reflections##15##1##(1990-11#1)(1993-1#1)(1994-12#1)(1996-9#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Reflective practice##3##2##(1997-4#1)(2008-11#2)
Reflective##8##1##(1997-4#1)(2008-11#2)(2008-2#2)(2008-3#2)(2012-12#1)
Reflectivity##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Reflex##2##1##(1995-8#1)(2009-4#1)
Reform Act of##2##3##(1992-1#1)(1992-2#1)
Reform and##2##2##(1993-12#1)(1995-12#1)
Reform in##2##2##(2007-5#1)(2011-2#1)
Reform of##2##2##(1992-1#1)(1997-2#1)
Reform##16##1##(1991-9#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-1#2)(1996-2#1)(1997-2#3)(2007-5#1)(2011-2#1)(2012-2#1)
Refraction##2##1##(2008-2#1)(2008-3#1)
Refractive Index##2##2##(2008-2#1)(2010-2#1)
Refractive Indices of##2##3##(2008-2#1)(2008-3#1)
Refractive index of##2##3##(2008-2#2)
Refractive index##3##2##(2008-10#1)(2008-2#2)
Refractive indices and extinction coefficients of##2##6##(2008-2#2)
Refractive indices of##2##3##(2008-2#1)(2008-3#1)
Refractive indices##4##2##(2008-2#3)(2008-3#1)
Refractive lens exchange##2##3##(2011-2#2)
Refractive##18##1##(2008-10#1)(2008-2#8)(2008-3#6)(2010-2#1)(2011-2#2)
Refractive-Index##3##1##(2008-2#1)(2008-3#2)
Refractive-index and##2##2##(2008-3#2)
Refractive-index##7##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
Refractory##7##1##(1993-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-8#1)
Refuge##6##1##(1993-12#2)(2008-5#4)
Refugees##2##1##(2008-7#1)(2013-1#1)
Refugio##2##1##(2008-5#1)(2011-2#1)
Refusal rates were##2##3##(2008-11#2)
Refusal##3##1##(1991-6#1)(2008-11#2)
RegA##5##1##(2011-1#5)
Regarding &quot##2##2##(2008-7#1)(2008-9#1)
Regarding the##26##2##(1993-12#1)(1994-7#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Regarding to##2##2##(2008-12#2)
Regarding##55##1##(1992-3#1)(1993-12#1)(1993-9#1)(1994-7#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#3)(2010-6#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
Regardless of temperature##2##3##(2008-10#2)
Regardless of the type of##2##5##(2007-12#1)(2009-7#1)
Regardless of the##17##3##(1990-5#1)(1990-9#1)(1994-7#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-11#1)(2012-2#3)
Regardless of treatment##2##3##(2008-10#1)(2008-6#1)
Regardless of##35##2##(1990-5#1)(1990-9#1)(1994-7#1)(1995-1#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-9#2)(2009-7#2)(2009-9#1)(2010-11#1)(2012-2#3)
Regenerated host axons##2##3##(2011-2#2)
Regenerated##3##1##(2008-10#1)(2011-2#2)
Regeneration of bacteriorhodopsin##2##3##(1990-11#2)
Regeneration of the##2##3##(2008-10#1)(2008-5#1)
Regeneration of##9##2##(1990-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)
Regeneration##14##1##(1990-11#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2012-2#1)
Regenerative##2##1##(2008-3#1)(2012-12#1)
Regensburg##2##1##(2008-9#2)
Regents##2##1##(1991-12#1)(2008-4#1)
Regime##3##1##(2011-2#2)(2013-7#1)
Regimen##6##1##(1990-12#2)(1994-7#1)(1997-7#1)(2010-8#1)(2012-3#1)
Regina##2##1##(1990-8#1)(1995-6#1)
Region in##2##2##(2008-10#1)(2011-2#1)
Region of Interest##2##3##(2009-3#1)(2010-8#1)
Region of Turkey##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2009-8#1)
Region of the##2##3##(2007-2#1)(2008-10#1)
Region of##15##2##(1997-3#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Region##62##1##(1990-3#1)(1991-8#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-10#4)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
Regional Assistance Mission##2##3##(2012-12#2)
Regional Health##2##2##(1994-3#1)(2013-8#1)
Regional Hospital##3##2##(1990-2#2)(1992-12#1)
Regional Medical Center##5##3##(1991-3#1)(1996-2#1)(1997-3#1)(2007-3#1)(2007-9#1)
Regional Medical##6##2##(1991-3#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-3#1)(2007-9#1)
Regional Office for##2##3##(1991-12#1)(2008-8#1)
Regional anaesthesia in##2##3##(2006-10#1)(2012-2#1)
Regional anaesthesia##4##2##(1992-11#1)(2006-10#1)(2011-1#1)(2012-2#1)
Regional cerebral blood flow in##2##5##(1995-5#1)(1996-5#1)
Regional cerebral blood flow##4##4##(1995-5#1)(1996-2#1)(1996-5#2)
Regional differences in the##4##4##(1994-2#1)(1996-12#1)(1997-2#1)(2006-10#1)
Regional differences in##5##3##(1994-2#2)(1996-12#1)(1997-2#1)(2006-10#1)
Regional health##2##2##(1994-12#1)(2013-1#1)
Regional odontodysplasia##2##2##(2008-12#2)
Regional variation in##3##3##(1995-8#1)(2007-10#1)(2008-8#1)
Regional variation##4##2##(1995-8#2)(2007-10#1)(2008-8#1)
Regional##77##1##(1990-2#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-8#2)(2006-10#3)(2007-10#1)(2007-3#1)(2007-9#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-3#2)(2013-7#1)(2013-8#2)
Regional's##2##1##(2007-9#2)
Regionally##2##1##(1996-2#1)(2011-2#1)
Regions in##2##2##(2008-10#2)
Regions of##4##2##(1990-4#1)(1991-9#1)(2007-11#1)(2011-2#1)
Regions with##2##2##(2008-2#1)(2013-1#1)
Regions##16##1##(1990-4#1)(1991-9#1)(1992-12#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
Regioselective##5##1##(1996-5#2)(2008-11#1)(2008-4#1)(2008-8#1)
Register from##2##2##(2010-3#1)(2011-2#1)
Register of##2##2##(1994-12#1)(2007-8#1)
Register##8##1##(1991-11#1)(1994-12#1)(2007-8#1)(2008-10#2)(2010-3#2)(2011-2#1)
Registered Nurses##2##2##(2008-1#1)(2013-7#1)
Registered nurses##2##2##(2008-11#1)(2010-8#1)
Registered readers (see &quot##6##4##(2012-3#6)
Registered##14##1##(1995-3#1)(2007-11#1)(2008-1#1)(2008-11#2)(2010-8#1)(2011-1#1)(2012-3#6)(2013-7#1)
Registrar##3##1##(2008-10#1)(2008-3#1)(2009-4#1)
Registrar's##2##1##(1991-2#1)(2012-12#1)
Registration of##3##2##(2008-10#2)(2008-3#1)
Registration##12##1##(1992-1#1)(1992-11#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2013-8#2)
Registries##2##1##(2008-3#1)(2009-12#1)
Registry and##2##2##(2008-3#2)
Registry data##2##2##(2010-10#1)(2011-2#1)
Registry for##2##2##(1990-2#1)(2011-2#1)
Registry of the##2##3##(1993-9#1)(2011-2#1)
Registry of##8##2##(1993-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)
Registry to##2##2##(1996-3#1)(2008-3#1)
Registry##59##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-12#1)(1993-9#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-3#2)(2006-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
Registry)##2##1##(2008-11#1)(2008-3#1)
Regression analyses showed that##2##4##(2009-4#1)(2009-8#1)
Regression analyses were##2##3##(2008-10#1)(2009-7#1)
Regression analyses##11##2##(1992-3#1)(1993-12#1)(2008-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
Regression analysis of Beer's##2##4##(2008-10#2)
Regression analysis of the##2##4##(2008-10#2)
Regression analysis of##4##3##(2008-10#4)
Regression analysis revealed that##2##4##(1994-2#1)(2010-12#1)
Regression analysis##10##2##(1994-2#1)(1995-2#1)(2008-10#4)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)
Regression and artificial neural network##2##5##(2008-10#2)
Regression equations revealed linear relationships (correlation coefficients##2##7##(2008-10#2)
Regression equations##3##2##(1996-12#1)(2008-10#2)
Regression models##4##2##(1997-4#1)(2008-10#2)(2008-7#1)
Regression of##4##2##(1990-12#1)(1990-2#1)(1991-4#1)(2008-10#1)
Regression slopes##2##2##(2008-10#2)
Regression##49##1##(1990-12#1)(1990-2#1)(1990-4#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#20)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
Regular##18##1##(1992-11#1)(1992-9#1)(1993-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Regularization##3##1##(2008-2#1)(2008-3#2)
Regularized##2##1##(2008-2#1)(2012-3#1)
Regulate##5##1##(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
Regulated##6##1##(1994-11#1)(2008-11#3)(2009-10#1)(2011-1#1)
Regulates##5##1##(2011-1#1)(2013-1#4)
Regulating##5##1##(1997-2#1)(2008-11#1)(2008-8#1)(2009-3#1)(2013-1#1)
Regulation and##3##2##(1991-1#1)(2008-9#1)(2011-1#1)
Regulation of cytoplasmic##2##3##(1990-2#1)(1992-6#1)
Regulation of expression of##2##4##(1995-8#2)
Regulation of gene expression##2##4##(1995-6#1)(2012-2#1)
Regulation of human##2##3##(1993-6#1)(1995-2#1)
Regulation of neuronal##3##3##(1992-12#1)(1993-5#1)(2008-4#1)
Regulation of rat##2##3##(1994-11#1)(1995-12#1)
Regulation of the expression of##2##5##(1990-7#1)(1992-12#1)
Regulation of the##8##3##(1990-7#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(2008-4#1)(2012-12#1)
Regulation of##81##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#3)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Regulation##91##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#3)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-3#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Regulations##6##1##(1994-1#1)(1995-3#1)(2008-11#1)(2009-10#2)(2010-5#1)
Regulator##2##1##(2012-3#1)(2013-8#1)
Regulatory Agency##2##2##(1991-3#1)(2008-11#1)
Regulatory Networks##2##2##(2010-7#1)(2011-2#1)
Regulatory##19##1##(1991-3#2)(1992-5#1)(1992-9#1)(1994-1#1)(1994-9#1)(1996-12#1)(1997-4#1)(2008-11#3)(2008-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
Rehabilitation Act##3##2##(1995-12#3)
Rehabilitation Center in Konstancin##2##4##(2007-11#1)(2007-8#1)
Rehabilitation Center##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
Rehabilitation after##3##2##(1991-11#1)(2007-8#2)
Rehabilitation and##2##2##(2007-11#1)(2013-1#1)
Rehabilitation has##2##2##(2008-9#1)(2013-1#1)
Rehabilitation in##3##2##(1991-12#1)(2006-5#1)(2012-3#1)
Rehabilitation of##4##2##(1994-5#1)(2008-12#1)(2013-1#2)
Rehabilitation##37##1##(1991-11#1)(1991-12#1)(1992-3#2)(1994-5#1)(1995-12#3)(1995-5#1)(2006-5#1)(2007-11#4)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#3)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
Rehovot##2##1##(2008-10#1)(2013-8#1)
Reid##2##1##(1991-9#1)(2010-11#1)
Reiki##2##1##(2008-1#2)
Reimbursement##6##1##(1996-1#3)(2008-11#1)(2009-8#1)(2012-2#1)
Reimplantation##2##1##(2008-10#1)(2012-2#1)
Reinforcement of##2##2##(2009-7#1)(2011-1#1)
Reinforcement##5##1##(1996-5#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)
Reiter's syndrome##4##2##(1990-6#2)(2008-8#1)(2012-2#1)
Reiter's##5##1##(1990-6#2)(2008-8#1)(2012-2#2)
Reitt##2##1##(2008-12#2)
Rejection##3##1##(2008-2#1)(2008-8#1)(2009-7#1)
Relapse##4##1##(1991-1#1)(1994-6#1)(2008-1#1)(2008-7#1)
Relapse-free##2##1##(1992-10#1)(2008-6#1)
Relapses occurred in##2##3##(2011-2#2)
Relapses##3##1##(2008-1#1)(2011-2#2)
Relapsing##2##1##(1990-6#1)(2013-7#1)
Related Groups##2##2##(1993-12#1)(1994-3#1)
Related Pathovars##2##2##(2008-10#2)
Related Species##3##2##(2008-10#2)(2013-8#1)
Related to##8##2##(1996-5#1)(2008-10#5)(2011-2#1)(2013-1#1)
Related##40##1##(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(2007-1#1)(2007-10#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Relatedness##4##1##(2007-6#1)(2008-10#1)(2008-8#1)(2009-10#1)
Relating to##2##2##(1995-2#1)(2012-3#1)
Relating##3##1##(1995-2#1)(2008-10#1)(2012-3#1)
Relation between##8##2##(1994-2#1)(1995-9#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-12#1)
Relation of##3##2##(1992-2#1)(1996-11#1)(2009-10#1)
Relation to##12##2##(1995-4#1)(2008-10#8)(2008-11#1)(2008-12#1)(2013-7#1)
Relation##23##1##(1992-2#1)(1994-2#1)(1995-4#1)(1995-9#1)(1996-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-7#1)
Relational databases are##2##3##(2008-4#2)
Relational databases##3##2##(2008-4#3)
Relational##13##1##(1996-2#1)(2008-4#3)(2009-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#1)
Relations between##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
Relations for the##2##3##(1996-12#1)(2008-3#1)
Relations##13##1##(1993-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
Relationship Between##9##2##(2008-10#6)(2010-6#1)(2013-8#2)
Relationship between the##6##3##(2008-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
Relationship between visual##2##3##(2008-10#1)(2008-8#1)
Relationship between##57##2##(1991-11#1)(1993-6#1)(1994-7#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-1#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
Relationship in##2##2##(2008-10#1)(2008-5#1)
Relationship of##12##2##(1992-3#1)(1992-9#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-9#1)(2011-2#2)(2012-1#1)
Relationship to##9##2##(1991-8#1)(2008-10#5)(2008-6#1)(2009-11#1)(2013-1#1)
Relationship with a##2##3##(2008-10#1)(2012-3#1)
Relationship with##6##2##(2008-10#3)(2010-8#1)(2011-2#1)(2012-3#1)
Relationship##102##1##(1991-11#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-7#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
Relationships Between##7##2##(2008-10#7)
Relationships among the##2##3##(2008-10#1)(2009-9#1)
Relationships among##8##2##(1994-2#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)
Relationships between the##4##3##(1993-12#1)(2008-10#2)(2008-9#1)
Relationships between##18##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-5#1)(2013-8#2)
Relationships of##5##2##(2008-10#5)
Relationships with##4##2##(1993-3#1)(2009-4#1)(2010-10#1)(2011-2#1)
Relationships##52##1##(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#2)(2007-11#2)(2008-10#23)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-2#1)(2010-4#1)(2011-2#3)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
Relative Humidity##5##2##(2008-10#5)
Relative abundance##2##2##(1994-8#1)(2008-5#1)
Relative growth rates##2##3##(2011-1#2)
Relative humidity##2##2##(2007-11#1)(2008-10#1)
Relative intensity fluctuations##2##3##(2007-11#2)
Relative standard deviation (R##3##4##(2008-10#3)
Relative standard deviation was##2##4##(2008-10#2)
Relative standard deviation##8##3##(2008-10#8)
Relative standard deviations of the##2##5##(2008-10#2)
Relative standard deviations of##4##4##(2008-10#4)
Relative standard deviations were##2##4##(2008-10#2)
Relative standard deviations##10##3##(2008-10#10)
Relative standard##18##2##(2008-10#18)
Relative strength of##2##3##(1991-2#2)
Relative to the##6##3##(1996-12#1)(1996-5#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
Relative to##17##2##(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Relative value units (RVUs) were##2##5##(2012-2#1)(2013-1#1)
Relative value units##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
Relative##99##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-4#1)(2007-11#4)(2008-10#39)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)
Relatively few##5##2##(1992-12#1)(2007-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
Relatively high##4##2##(2008-10#3)(2008-3#1)
Relatively little is known about the##3##6##(2008-1#1)(2008-10#1)(2012-2#1)
Relatively little is known##4##4##(2008-1#1)(2008-10#2)(2012-2#1)
Relatively##22##1##(1992-12#1)(1992-6#1)(1993-12#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
Relatives##4##1##(1993-6#1)(2008-10#1)(2009-10#1)(2009-8#1)
Relaxation##6##1##(1990-12#1)(1996-12#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-3#1)
Relaxin levels in##2##3##(1995-8#2)
Relay##2##1##(2008-2#2)
Release and##4##2##(2008-10#3)(2008-4#1)
Release of##19##2##(1991-2#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-11#1)
Release##33##1##(1991-2#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#3)(2008-5#4)(2008-8#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
Released##2##1##(2008-12#1)(2009-8#1)
Releasing Hormone##3##2##(2008-4#1)(2009-6#1)(2013-7#1)
Relevance of##3##2##(1992-12#1)(1995-12#1)(2008-7#1)
Relevance to clinical practice##10##4##(2010-10#9)(2013-1#1)
Relevance to##12##2##(2008-11#1)(2010-10#9)(2013-1#2)
Relevance##18##1##(1992-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#10)(2013-1#3)
Relevant information##2##2##(2008-10#1)(2011-2#1)
Relevant literature is reviewed##2##4##(2008-10#1)(2013-1#1)
Relevant literature##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
Relevant##18##1##(1996-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2011-2#4)(2012-3#1)(2013-1#3)
Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies##3##11##(2013-8#3)
Reliability and accuracy of##4##4##(2008-10#1)(2013-8#3)
Reliability and validity of the##2##5##(2011-1#2)
Reliability and validity##4##3##(1996-7#1)(2008-11#1)(2011-1#2)
Reliability and##10##2##(1996-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#2)(2011-2#1)(2013-8#3)
Reliability of a##2##3##(1993-12#1)(2012-1#1)
Reliability of the##2##3##(2008-11#1)(2011-1#1)
Reliability of##15##2##(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-5#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
Reliability##30##1##(1993-12#2)(1996-12#1)(1996-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#3)(2011-2#1)(2011-5#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
Reliable and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
Reliable detection##2##2##(2008-10#1)(2011-2#1)
Reliable##15##1##(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
Reliance##2##1##(2008-5#1)(2011-1#1)
Relief of dysphagia is##2##4##(1992-9#1)(1993-6#1)
Relief of##4##2##(1992-9#1)(1993-6#1)(2008-2#1)(2008-6#1)
Religion and##2##2##(2009-7#1)(2010-8#1)
Religion##6##1##(2008-12#1)(2009-11#2)(2009-7#2)(2010-8#1)
Religious##8##1##(1993-12#1)(2008-12#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)
Religiousness##2##1##(2009-11#1)(2009-7#1)
RelyX Unicem##2##2##(2009-8#2)
Remaining##6##1##(1994-11#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-3#1)(2008-5#1)
Remarkable##3##1##(2008-12#1)(2011-1#1)(2013-1#1)
Remarkably##19##1##(1990-11#1)(1990-12#1)(1991-2#1)(1992-2#1)(1993-11#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-7#1)
Remarks on##2##2##(1990-2#1)(2008-5#1)
Remating##2##1##(2008-5#2)
Rembrandt's##3##1##(2012-2#2)(2013-8#1)
Remembering##2##1##(1994-5#1)(2007-8#1)
Reminding##2##1##(1996-12#1)(2012-3#1)
Remission##2##1##(2008-1#1)(2012-2#1)
Remodeling of##2##2##(1994-8#1)(2012-12#1)
Remodeling##4##1##(1994-8#1)(2012-12#3)
Remote Sensing of##3##3##(2008-2#1)(2008-3#2)
Remote Sensing##8##2##(2008-12#1)(2008-2#2)(2008-3#4)(2008-8#1)
Remote detection of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
Remote sensing of ocean color##2##5##(2008-2#2)
Remote sensing##5##2##(2008-10#1)(2008-2#2)(2008-8#2)
Remote##21##1##(1996-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-8#3)(2011-2#1)(2013-1#2)
Removal and recovery of chromium##2##5##(2008-10#2)
Removal and##3##2##(2008-10#2)(2008-5#1)
Removal of the##13##3##(1990-12#1)(1991-10#1)(1992-11#2)(1993-8#1)(1995-11#1)(1995-6#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
Removal of##40##2##(1990-12#1)(1990-7#2)(1991-10#1)(1992-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#5)(2013-8#1)
Removal##46##1##(1990-12#1)(1990-7#2)(1991-10#1)(1992-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-5#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#5)(2013-8#2)
Removing the##2##2##(2008-3#1)(2010-10#1)
Removing##6##1##(2008-10#2)(2008-2#1)(2008-3#1)(2010-10#1)(2012-3#1)
Ren-Shen-Yang-Rong-Tang##2##1##(2008-10#2)
Renaissance##6##1##(2008-10#2)(2008-11#2)(2008-4#1)(2011-2#1)
Renal Artery##2##2##(2008-1#2)
Renal Cell Carcinoma##2##3##(2013-1#2)
Renal Disease##9##2##(1994-3#1)(2006-10#1)(2007-7#2)(2008-1#2)(2009-3#1)(2011-2#1)(2013-1#1)
Renal Failure and##3##3##(2008-1#2)(2008-4#1)
Renal Failure in##3##3##(2008-1#2)(2008-4#1)
Renal Failure##16##2##(2007-7#3)(2008-1#8)(2008-12#1)(2008-4#3)(2011-1#1)
Renal and##2##2##(1994-5#1)(1994-8#1)
Renal artery aneurysm##2##3##(2008-1#2)
Renal artery stenosis##2##3##(2008-12#2)
Renal artery##4##2##(2008-1#2)(2008-12#2)
Renal autotransplantation##2##2##(2008-8#1)(2013-1#1)
Renal biopsy showed##2##3##(2007-7#1)(2008-4#1)
Renal biopsy##5##2##(1996-6#1)(2007-7#2)(2008-4#1)(2011-2#1)
Renal cell carcinoma (RCC)##2##4##(2008-1#1)(2011-2#1)
Renal cell carcinoma##4##3##(1992-3#1)(2008-1#2)(2011-2#1)
Renal cell##5##2##(1992-3#1)(2008-1#2)(2011-2#2)
Renal complications of##2##3##(2007-6#1)(2012-2#1)
Renal disease##2##2##(2007-7#1)(2008-1#1)
Renal dysfunction##3##2##(2006-10#1)(2010-6#1)(2012-3#1)
Renal failure is##2##3##(2008-1#2)
Renal failure##4##2##(2006-10#1)(2008-1#3)
Renal function impairment##2##3##(1990-12#1)(2008-1#1)
Renal function##3##2##(1990-12#1)(1997-4#1)(2008-1#1)
Renal infarction##2##2##(2008-1#2)
Renal replacement therapy in##3##4##(2008-3#1)(2008-4#2)
Renal transplant##2##2##(2008-3#1)(2011-2#1)
Renal transplantation##4##2##(1991-11#1)(2007-7#1)(2007-8#1)(2008-4#1)
Renal ultrasound##2##2##(2007-7#1)(2008-1#1)
Renal##123##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1992-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-4#2)(1997-6#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#17)(2007-8#1)(2008-1#36)(2008-10#2)(2008-12#3)(2008-3#2)(2008-4#9)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
Renaturation of the##2##3##(1992-12#1)(2008-10#1)
Renaturation of##3##2##(1990-11#1)(1992-12#1)(2008-10#1)
Rendu-Osler-Weber disease##3##2##(1992-2#3)
Rendu-Osler-Weber syndrome##2##2##(2008-7#2)
Rendu-Osler-Weber##5##1##(1992-2#3)(2008-7#2)
Renewable##2##1##(2008-10#1)(2008-6#1)
Renfrew Victoria Hospital##2##3##(1996-2#2)
Renfrew Victoria##3##2##(1996-2#3)
Renfrew##4##1##(1996-2#4)
Renilla koellikeri##2##2##(2008-7#2)
Renilla##3##1##(2008-4#1)(2008-7#2)
Renin##3##1##(1990-5#1)(2007-8#1)(2009-6#1)
Reno##4##1##(1995-6#3)(1996-12#1)
Reno-vascular disease##2##2##(2008-12#2)
Renovascular hypertension##3##2##(1994-9#1)(2007-7#2)
Renovascular##4##1##(1994-9#1)(1997-2#1)(2007-7#2)
Reoperative##2##1##(2013-8#2)
Reorganization of the##2##3##(2008-10#1)(2009-8#1)
Reovirus##2##1##(2007-6#1)(2008-10#1)
Rep and##2##2##(2008-10#1)(2008-9#1)
Rep gene in##2##3##(2008-10#2)
Rep gene##7##2##(2008-10#7)
Rep protein##4##2##(2008-10#4)
Rep proteins##2##2##(2008-10#2)
Rep##25##1##(1993-11#1)(1995-12#2)(1995-6#1)(1996-5#2)(2008-10#17)(2008-9#1)(2012-2#1)
Rep-PCR##2##1##(2008-10#2)
RepK##8##1##(1997-6#8)
Repaglinide##2##1##(2010-4#2)
Repair of the##3##3##(2011-2#1)(2013-1#2)
Repair of##10##2##(1994-1#1)(2007-8#1)(2008-9#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)
Repair##19##1##(1994-1#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-1#3)(2012-3#4)(2013-1#3)
Repeat CT scan##2##3##(1990-6#1)(2011-2#1)
Repeat CT##3##2##(1990-6#1)(2007-10#1)(2011-2#1)
Repeat##25##1##(1990-6#1)(1992-6#1)(1994-12#1)(1995-11#2)(1995-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Repeatability and##5##2##(2008-10#4)(2013-8#1)
Repeatability of measurements##2##3##(1994-1#1)(2008-8#1)
Repeatability of the##2##3##(2008-10#1)(2013-1#1)
Repeatability of##6##2##(1994-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#2)
Repeatability was evaluated from 10 consecutive determinations being the results better than##2##12##(2008-10#2)
Repeatability was##5##2##(2008-10#5)
Repeatability##18##1##(1994-1#1)(2008-10#12)(2008-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
Repeatable##2##1##(2008-10#1)(2013-8#1)
Repeated application of##3##3##(2008-11#1)(2009-8#1)(2012-2#1)
Repeated applications of##2##3##(1997-3#1)(2008-2#1)
Repeated exposure to##2##3##(1993-12#2)
Repeated exposure##3##2##(1991-9#1)(1993-12#2)
Repeated injections of##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
Repeated measurements##2##2##(1997-8#1)(2008-5#1)
Repeated measures##5##2##(1992-9#1)(1996-7#1)(1997-7#1)(2008-12#1)(2010-1#1)
Repeated##50##1##(1990-3#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-12#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
Reperfusion##5##1##(2007-10#3)(2012-3#2)
Repetition rates##2##2##(2007-11#1)(2008-3#1)
Repetition##4##1##(2007-11#1)(2008-3#1)(2010-7#1)(2012-2#1)
Repetitive Applications of the Biocontrol##2##5##(2008-10#2)
Repetitive DNA Sequences##2##3##(2008-10#2)
Repetitive determination of##2##3##(2008-10#2)
Repetitive strain injuries##2##3##(1994-3#2)
Repetitive strain##3##2##(1990-2#1)(1994-3#2)
Repetitive transcranial magnetic stimulation (rTMS) is##2##6##(2012-2#1)(2013-1#1)
Repetitive transcranial magnetic stimulation (rTMS)##3##5##(2012-2#1)(2013-1#2)
Repetitive transcranial magnetic stimulation##6##4##(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#2)
Repetitive##35##1##(1990-2#1)(1994-3#2)(1994-6#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Replacement for##2##2##(2012-1#1)(2013-1#1)
Replacement of the putative##2##4##(1991-12#1)(1994-6#1)
Replacement of the##6##3##(1991-12#1)(1993-1#1)(1994-5#1)(1994-6#1)(1995-2#1)(2012-2#1)
Replacement of##20##2##(1990-9#1)(1991-12#2)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
Replacement##33##1##(1990-9#1)(1991-12#2)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#3)
Replacing the##3##2##(1990-5#1)(1992-8#1)(2010-12#1)
Replacing##6##1##(1990-5#1)(1992-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-3#1)
Replica##5##1##(1992-12#3)(2008-11#1)(2008-12#1)
Replicate##2##1##(2008-10#2)
Replicating##3##1##(2008-11#2)(2008-9#1)
Replication and##2##2##(2007-12#1)(2008-7#1)
Replication in##2##2##(1995-2#1)(2008-10#1)
Replication is##2##2##(2008-9#2)
Replication of##7##2##(1997-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#1)
Replication##18##1##(1994-5#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#3)(2010-2#1)(2012-3#1)(2013-1#1)
Replicative##2##1##(2008-10#1)(2008-5#1)
Reply to##10##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-2#1)(2013-8#2)
Reply##15##1##(1996-9#2)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#2)(2013-1#1)(2013-8#2)
Report and##9##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#3)(2013-1#1)
Report from Nurse Education Tomorrow##2##5##(2008-11#2)
Report from the##4##3##(1995-2#1)(2008-4#1)(2008-6#1)(2011-2#1)
Report from##7##2##(1995-12#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-6#1)(2011-2#1)
Report of Two##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
Report of a Case##2##4##(1994-7#1)(1996-6#1)
Report of a case##5##4##(1993-2#1)(1996-8#1)(2008-5#1)(2009-8#1)(2013-1#1)
Report of a##9##3##(1993-2#1)(1994-2#1)(1994-7#1)(1996-6#1)(1996-8#1)(2008-5#1)(2009-8#1)(2013-1#2)
Report of an##2##3##(2008-4#1)(2011-2#1)
Report of one case]##8##4##(2013-1#4)(2013-8#4)
Report of the 2006##2##4##(2008-6#2)
Report of the 2008-2009##2##4##(2010-3#2)
Report of the##10##3##(1990-4#1)(1993-12#1)(1993-2#1)(2008-11#1)(2008-4#1)(2008-6#3)(2010-3#2)
Report of two cases##4##4##(1992-10#1)(1992-12#1)(1992-8#1)(2009-8#1)
Report of two cases]##2##4##(2013-1#2)
Report of two##6##3##(1992-10#1)(1992-12#1)(1992-8#1)(2009-8#1)(2013-1#2)
Report of##51##2##(1990-4#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-2#1)(1994-7#1)(1996-3#1)(1996-6#1)(1996-8#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-3#2)(2010-9#1)(2011-2#3)(2013-1#10)(2013-8#5)
Report on the##6##3##(1994-3#1)(2008-11#3)(2008-12#1)(2008-7#1)
Report on##9##2##(1991-1#1)(1994-3#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)
Report to Congress##4##3##(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)
Report to##5##2##(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-11#1)
Report##137##1##(1990-4#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(2006-10#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#12)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#6)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-9#2)(2011-2#14)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#19)(2013-8#6)
Reported are the results of##2##5##(1991-2#1)(2008-3#1)
Reported are##3##2##(1991-10#1)(1991-2#1)(2008-3#1)
Reported herein##2##2##(1991-2#1)(2009-12#1)
Reported is##2##2##(2008-2#1)(2008-8#1)
Reported##19##1##(1991-10#1)(1991-2#2)(1994-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
Reporter gene##2##2##(2011-2#1)(2012-2#1)
Reporter##3##1##(2008-4#1)(2011-2#1)(2012-2#1)
Reporters of gene expression##2##4##(2008-9#2)
Reporting System##2##2##(1991-12#1)(2013-1#1)
Reporting of##7##2##(1991-3#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-12#2)(2008-4#1)
Reporting##19##1##(1991-12#2)(1991-3#1)(1992-2#2)(1993-12#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
Reports from##2##2##(1991-3#1)(2012-12#1)
Reports in the##2##3##(1995-12#1)(2008-5#1)
Reports of##8##2##(1991-2#1)(2007-2#1)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
Reports to##2##2##(1991-1#1)(1992-1#1)
Reports##25##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-5#1)(1995-12#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Repository of##2##2##(2010-7#2)
Repository##4##1##(2008-10#1)(2010-7#2)(2012-3#1)
Representation of##2##2##(1992-11#1)(2011-1#1)
Representation##4##1##(1992-11#1)(1996-9#1)(2010-8#1)(2011-1#1)
Representational difference analysis (RDA) couples subtractive hybridization to PCR-mediated kinetic enrichment for the detect##2##14##(2008-2#2)
Representational difference analysis (RDA) couples subtractive hybridization to PCR-mediated kinetic enrichment for the##3##13##(2008-2#3)
Representational difference analysis##4##3##(2008-2#4)
Representations of##2##2##(1996-7#1)(2012-2#1)
Representations##3##1##(1996-7#1)(2012-2#2)
Representative strains##2##2##(2008-10#1)(2011-2#1)
Representative##15##1##(1995-6#1)(1996-5#3)(1997-3#1)(2008-10#3)(2008-2#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
Representatives of##4##2##(1996-1#1)(2007-12#1)(2008-6#1)(2011-2#1)
Representatives##9##1##(1995-6#1)(1996-1#1)(1996-5#3)(1997-5#1)(2007-12#1)(2008-6#1)(2011-2#1)
Represses##2##1##(2008-10#1)(2013-1#1)
Repression of##3##2##(1990-5#1)(1992-12#1)(1995-8#1)
Repression##4##1##(1990-5#1)(1992-12#1)(1995-8#1)(2008-10#1)
Reprinted from##2##2##(1993-3#1)(2010-12#1)
Reprod##3##1##(1991-12#1)(1994-5#2)
Reproducibilities##2##1##(2008-10#2)
Reproducibility and stability##2##3##(2008-10#2)
Reproducibility of##2##2##(2009-8#1)(2013-8#1)
Reproducibility ranged from##2##3##(2008-10#2)
Reproducibility##13##1##(2008-10#10)(2008-7#1)(2009-8#1)(2013-8#1)
Reproducible##6##1##(1992-11#1)(1995-12#1)(2008-10#2)(2008-7#1)(2010-3#1)
Reproduction and##3##2##(1995-8#1)(2008-5#1)(2008-7#1)
Reproduction by##2##2##(2008-10#2)
Reproduction in##2##2##(2008-10#1)(2008-5#1)
Reproduction of##3##2##(2008-10#3)
Reproduction##16##1##(1990-11#1)(1995-8#1)(2008-10#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2013-1#1)
Reproductive Health##2##2##(1994-2#1)(2011-1#1)
Reproductive and##3##2##(2008-10#1)(2013-1#1)(2013-7#1)
Reproductive outcome after ovarian surgery##2##5##(1992-3#2)
Reproductive outcome after##3##3##(1992-3#2)(1993-1#1)
Reproductive##31##1##(1992-2#1)(1992-3#2)(1993-1#1)(1993-9#1)(1994-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)
Republic and##4##2##(1994-12#2)(2008-10#1)(2008-5#1)
Republic of Croatia##5##3##(2008-10#1)(2011-2#2)(2013-1#2)
Republic of Marshall Islands##2##4##(2008-1#2)
Republic of Palau and##4##4##(2008-1#3)(2013-8#1)
Republic of Palau##12##3##(2008-1#10)(2013-8#2)
Republic of South Africa##3##4##(1997-7#1)(2010-11#1)(2010-3#1)
Republic of the Marshall Islands (RMI)##2##6##(2013-8#2)
Republic of the Marshall Islands##6##5##(2008-1#3)(2013-8#3)
Republic of the##8##3##(2007-7#1)(2008-1#4)(2013-8#3)
Republic of##57##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#3)(1995-1#1)(1995-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-1#16)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#5)
Republic##96##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#5)(1994-12#3)(1995-1#2)(1995-3#1)(1996-5#1)(1996-7#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-1#16)(2008-10#16)(2008-11#4)(2008-12#2)(2008-5#5)(2008-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#6)
Republic)##2##1##(1996-7#1)(2008-10#1)
Republic]##4##1##(1990-11#1)(1996-7#1)(2007-10#1)(2008-5#1)
Republican##2##1##(1995-8#1)(1996-12#1)
Republicans##5##1##(1995-6#2)(1997-2#1)(1997-5#1)(2008-7#1)
Requests##2##1##(1992-8#1)(1994-3#1)
Required for##6##2##(2008-10#3)(2012-3#2)(2013-1#1)
Required##7##1##(2008-10#3)(2011-1#1)(2012-3#2)(2013-1#1)
Requirement for##3##2##(1992-9#1)(2011-2#1)(2012-3#1)
Requirement of##4##2##(2008-8#1)(2010-7#1)(2011-2#2)
Requirement##7##1##(1992-9#1)(2008-8#1)(2010-7#1)(2011-2#3)(2012-3#1)
Requirements for##5##2##(1996-4#1)(2007-11#1)(2008-10#2)(2008-3#1)
Requirements##9##1##(1996-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)
Requiring##4##1##(1990-2#1)(2007-7#2)(2008-3#1)
Res 38##2##2##(1994-8#1)(2008-4#1)
Res##39##1##(1990-5#2)(1990-7#1)(1991-12#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-8#3)(1995-12#1)(1995-6#4)(1995-8#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#5)(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
Rescue##2##1##(1995-5#1)(2013-8#1)
Research Center in##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
Research Center##14##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-2#3)(2012-3#1)
Research Centre for##2##3##(2008-10#1)(2013-1#1)
Research Centre##4##2##(2008-10#1)(2008-2#1)(2009-4#1)(2013-1#1)
Research Conference##4##2##(2008-10#2)(2008-11#1)(2010-12#1)
Research Council##15##2##(1990-6#1)(1993-9#1)(1995-6#1)(1996-8#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Research Database##2##2##(2008-11#2)
Research Foundation##4##2##(1992-12#1)(2009-3#1)(2012-2#1)(2013-8#1)
Research Group##4##2##(1993-9#1)(2008-11#1)(2010-11#1)(2012-3#1)
Research Institute of##4##3##(2008-3#1)(2011-2#3)
Research Institute##13##2##(1992-2#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#2)(2009-6#1)(2011-2#3)
Research Network##5##2##(2009-12#1)(2013-8#4)
Research Participation##2##2##(2009-4#2)
Research Program##4##2##(1992-12#1)(2008-7#1)(2010-10#1)(2013-8#1)
Research Projects Agency##3##3##(2008-2#1)(2008-3#2)
Research Projects##4##2##(2008-2#1)(2008-3#3)
Research Service##3##2##(2008-10#2)(2008-7#1)
Research Station##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
Research Team##2##2##(2012-12#1)(2013-1#1)
Research Triangle Park##4##3##(1994-3#1)(1997-1#1)(2008-10#1)(2011-2#1)
Research Unit of the Royal College of Physicians of London##2##10##(1990-9#1)(1996-8#1)
Research Unit##5##2##(1990-9#1)(1994-3#1)(1996-8#1)(2008-11#1)(2008-6#1)
Research and Education##3##3##(1997-2#1)(2008-2#1)(2013-8#1)
Research and Practice##4##3##(2008-11#2)(2008-7#2)
Research and##34##2##(1994-12#1)(1994-3#3)(1997-2#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#7)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#1)
Research by##2##2##(2008-5#2)
Research examining##3##2##(2007-12#1)(2009-9#1)(2012-12#1)
Research for##3##2##(1996-4#1)(2011-2#2)
Research has shown that##4##4##(1995-1#1)(2008-6#1)(2008-7#1)(2012-2#1)
Research has##8##2##(1995-1#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#2)
Research highlights##2##2##(2010-5#2)
Research in##9##2##(1992-12#1)(1996-7#1)(2006-10#1)(2008-1#2)(2010-10#1)(2010-8#1)(2012-2#2)
Research indicates that##2##3##(2009-5#1)(2010-1#1)
Research into##6##2##(1997-8#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
Research investigating##2##2##(2008-1#1)(2008-10#1)
Research is##6##2##(1994-2#1)(2007-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2011-1#1)
Research on biological##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
Research on the mechanisms##2##4##(2008-10#1)(2010-1#1)
Research on the##7##3##(1990-2#1)(2008-10#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-3#1)
Research on##28##2##(1990-2#1)(1992-12#1)(1993-1#1)(1995-12#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
Research priorities for##2##3##(2007-11#1)(2008-10#1)
Research priorities##3##2##(2007-11#2)(2008-10#1)
Research reports##2##2##(1990-3#1)(2008-7#1)
Research shows that##2##3##(2010-12#2)
Research suggests that spirituality is important to a large percentage of the older adult population##2##15##(2013-1#2)
Research suggests that##6##3##(1994-3#1)(2009-11#1)(2010-9#1)(2013-1#3)
Research suggests##7##2##(1994-3#1)(2008-9#1)(2009-11#1)(2010-9#1)(2013-1#3)
Research supervision is##2##3##(2012-3#2)
Research supervision##5##2##(2012-3#5)
Research to increase knowledge about what constitutes measurement and change##2##10##(2013-1#2)
Research to##8##2##(2008-10#1)(2008-7#1)(2009-4#1)(2010-4#2)(2011-1#1)(2013-1#2)
Research was conducted##2##3##(2008-10#1)(2013-1#1)
Research was undertaken##2##3##(1991-6#1)(2008-1#1)
Research was##6##2##(1990-2#1)(1991-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
Research##375##1##(1990-11#2)(1990-2#2)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#2)(1994-12#3)(1994-2#3)(1994-3#7)(1995-1#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#23)(2008-11#16)(2008-12#13)(2008-2#10)(2008-3#14)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#23)(2008-8#2)(2008-9#4)(2009-11#3)(2009-12#2)(2009-3#3)(2009-4#11)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#10)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#19)(2012-1#2)(2012-12#6)(2012-2#20)(2012-3#12)(2013-1#23)(2013-7#2)(2013-8#7)
Research)##2##1##(2008-10#1)(2008-11#1)
Researcher##3##1##(1994-9#1)(2009-4#1)(2010-2#1)
Researchers and clinicians acknowledge that pain conditions do not occur in isolation##2##12##(2013-1#2)
Researchers and##3##2##(2008-11#1)(2013-1#2)
Researchers are##6##2##(1992-3#1)(1994-3#1)(2008-6#1)(2008-7#2)(2009-12#1)
Researchers have##5##2##(2006-8#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
Researchers who##2##2##(1993-2#1)(2008-12#1)
Researchers##29##1##(1991-12#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Resection of a giant##2##4##(2013-1#2)
Resection of a##3##3##(2008-7#1)(2013-1#2)
Resection of the##2##3##(2011-1#1)(2012-12#1)
Resection of##15##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
Resection was##2##2##(1990-12#1)(1991-8#1)
Resection##21##1##(1990-12#1)(1991-8#1)(1994-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
Reserpine##2##1##(1995-2#1)(2008-12#1)
Reservation##2##1##(1991-12#2)
Reserve of##2##2##(2008-6#1)(2013-8#1)
Reserve##12##1##(2008-5#3)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#3)(2013-8#1)
Reservoir##3##1##(2008-10#1)(2010-8#2)
Reservoirs##2##1##(1992-9#1)(2008-10#1)
Reshaping##2##1##(1994-3#1)(2008-7#1)
Residence##4##1##(2008-10#1)(2009-3#1)(2010-5#1)(2011-1#1)
Residency Training##2##2##(1992-1#1)(2012-3#1)
Residency##4##1##(1992-1#2)(1993-12#1)(2012-3#1)
Resident participation in the Better Beginnings##2##6##(1995-3#2)
Resident participation##3##2##(1995-3#3)
Resident##10##1##(1993-2#1)(1993-3#1)(1994-2#1)(1995-3#3)(2007-5#1)(2008-6#1)(2010-12#1)(2011-2#1)
Residential##3##1##(2008-6#1)(2008-7#1)(2012-12#1)
Residents in##2##2##(1994-3#1)(2011-2#1)
Residents of##2##2##(2011-1#1)(2012-12#1)
Residents##10##1##(1994-3#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
Residual##19##1##(1992-3#1)(1992-9#1)(1993-2#1)(1995-9#1)(1996-8#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
Residue##5##1##(1994-9#1)(2008-10#3)(2008-11#1)
Residues in##2##2##(1995-5#1)(2009-8#1)
Residues of##5##2##(2008-10#2)(2008-11#3)
Residues##8##1##(1995-5#1)(2008-10#3)(2008-11#3)(2009-8#1)
Resilience Scale##5##2##(2011-1#5)
Resilience##6##1##(2011-1#6)
Resilon##2##1##(2013-1#2)
Resin##5##1##(2008-10#2)(2008-12#1)(2012-2#1)(2013-1#1)
Resistance Against##2##2##(2008-10#2)
Resistance Gene to##3##3##(2008-10#3)
Resistance Gene##10##2##(2008-10#10)
Resistance Genes##3##2##(2008-10#3)
Resistance Induced by##2##3##(2008-10#2)
Resistance Locus##3##2##(2008-10#2)(2012-3#1)
Resistance Mechanisms##2##2##(2008-10#2)
Resistance Responses to##2##3##(2008-10#2)
Resistance Training##2##2##(2010-1#2)
Resistance and##7##2##(2008-10#6)(2008-3#1)
Resistance by##3##2##(2008-10#3)
Resistance in Barley##2##3##(2008-10#2)
Resistance in Sugar##2##3##(2008-10#1)(2012-3#1)
Resistance in Tomato##2##3##(2008-10#2)
Resistance in Transgenic##2##3##(2008-10#2)
Resistance in an##2##3##(2008-10#2)
Resistance in##36##2##(1996-9#1)(2008-10#31)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
Resistance of##15##2##(1997-5#1)(2007-7#1)(2008-10#10)(2008-8#1)(2009-7#1)(2013-8#1)
Resistance rate##2##2##(2008-12#1)(2010-4#1)
Resistance to Aflatoxin##2##3##(2008-10#2)
Resistance to Aspergillus flavus##2##4##(2008-10#2)
Resistance to Bean##2##3##(2008-10#2)
Resistance to Botrytis cinerea##2##4##(2008-10#2)
Resistance to Cronartium ribicola in##2##5##(2008-10#2)
Resistance to Cronartium ribicola##3##4##(2008-10#3)
Resistance to Different##2##3##(2008-10#2)
Resistance to Leaf##2##3##(2008-10#2)
Resistance to Melampsora larici-populina Leaf Rust in Hybrid Poplars##2##9##(2008-10#2)
Resistance to Melampsora##3##3##(2008-10#3)
Resistance to Mycosphaerella graminicola##2##4##(2008-10#2)
Resistance to Puccinia hordei##2##4##(2008-10#2)
Resistance to Puccinia##4##3##(2008-10#4)
Resistance to Sclerotinia##2##3##(2008-10#2)
Resistance to Sclerotium rolfsii in##2##5##(2008-10#2)
Resistance to Septoria##2##3##(2008-10#2)
Resistance to Striga hermonthica in##2##5##(2008-10#2)
Resistance to Xanthomonas campestris pv##2##5##(2008-10#2)
Resistance to fluconazole and##2##4##(1996-11#1)(2008-5#1)
Resistance to race##2##3##(2008-10#2)
Resistance to races 1 and##2##5##(2008-10#2)
Resistance to the##5##3##(2008-10#5)
Resistance to##120##2##(1991-10#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-6#1)(2007-6#1)(2007-8#1)(2008-10#103)(2008-12#1)(2008-5#3)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#2)
Resistance was determined##2##3##(2008-10#1)(2013-8#1)
Resistance was not##2##3##(2008-10#2)
Resistance was##14##2##(2008-10#13)(2013-8#1)
Resistance##266##1##(1991-10#1)(1992-7#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#217)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#4)
Resistance)##2##1##(2008-11#2)
Resistance-Breaking##2##1##(2008-10#2)
Resistant and Susceptible##4##3##(2008-10#4)
Resistant and##6##2##(2008-10#6)
Resistant to##4##2##(2008-10#4)
Resistant##26##1##(1992-9#1)(1995-2#1)(2008-10#19)(2008-4#1)(2010-8#1)(2012-3#2)(2013-1#1)
Resistin##3##1##(2008-1#1)(2012-2#1)(2013-8#1)
Resisting##2##1##(1991-6#1)(1992-3#1)
Resistive##2##1##(1996-5#1)(2008-3#1)
Resolution Imaging##4##2##(2008-3#3)(2008-8#1)
Resolution enhancement in a##2##4##(2007-12#1)(2008-2#1)
Resolution of a##2##3##(1996-2#1)(2008-3#1)
Resolution of the##3##3##(2007-12#2)(2008-3#1)
Resolution of##16##2##(1996-2#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-12#1)
Resolution was##2##2##(1996-12#1)(2008-10#1)
Resolution##40##1##(1991-12#1)(1991-3#1)(1993-1#1)(1995-2#1)(1996-12#1)(1996-2#2)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#10)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Resolving the##3##2##(1992-3#1)(2008-10#2)
Resolving##10##1##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1996-12#1)(2008-10#3)(2008-9#1)(2013-1#1)
Resonance Energy Transfer##3##3##(2008-4#2)(2009-9#1)
Resonance Raman##2##2##(1996-2#1)(2007-1#1)
Resonance Rayleigh scattering##2##3##(2008-10#2)
Resonance and##2##2##(2007-11#1)(2008-9#1)
Resonance light scattering##2##3##(2008-10#2)
Resonance##36##1##(1991-2#1)(1992-3#1)(1994-12#1)(1996-2#1)(1996-9#1)(2006-10#1)(2007-1#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
Resonances##4##1##(1991-8#1)(1993-8#1)(1996-9#1)(2008-3#1)
Resonant optical##2##2##(2007-11#1)(2007-12#1)
Resonant##21##1##(1990-12#1)(1993-5#1)(1996-9#3)(2007-11#4)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#4)(2012-2#1)
Resonator##5##1##(2008-2#2)(2008-3#3)
Resonators##3##1##(1996-9#1)(2007-11#1)(2008-2#1)
Resource Center##3##2##(1991-12#2)(2008-1#1)
Resource Intensity##3##2##(1991-12#1)(1994-3#1)(1995-1#1)
Resource Utilization Groups##5##3##(1993-12#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-7#1)
Resource Utilization##6##2##(1993-12#1)(1993-2#1)(1994-12#2)(1997-1#1)(2008-7#1)
Resource utilization groups##2##3##(1991-2#1)(1993-12#1)
Resource##41##1##(1991-12#4)(1991-2#2)(1991-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#4)(1995-12#2)(1995-2#1)(1996-12#2)(1996-3#1)(1997-1#1)(2008-1#2)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#2)(2010-2#2)(2012-3#1)
Resources for##4##2##(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)
Resources of Nuclear##2##3##(2012-2#2)
Resources##17##1##(1994-1#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2010-3#1)(2010-7#1)(2012-2#2)
Respect to##2##2##(2008-10#1)(2010-12#1)
Respect##5##1##(1991-3#2)(2008-10#1)(2008-12#1)(2010-12#1)
Respectively##2##1##(2008-10#1)(2012-12#1)
Respiration of##2##2##(2008-5#1)(2008-7#1)
Respiration rate##2##2##(2008-7#1)(2013-1#1)
Respiration##6##1##(1993-3#1)(2008-1#1)(2008-5#1)(2008-7#2)(2013-1#1)
Respirator##3##1##(2008-12#3)
Respiratory disease in##2##3##(1992-2#1)(2008-12#1)
Respiratory rate##2##2##(1993-1#2)
Respiratory resistance##2##2##(2008-1#2)
Respiratory syncytial virus##2##3##(2008-10#1)(2010-10#1)
Respiratory##43##1##(1990-6#1)(1990-7#1)(1992-2#2)(1993-1#2)(1993-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#13)
Respirgard II##8##2##(1993-2#5)(1996-12#3)
Respite##3##1##(1991-3#1)(1992-2#1)(1993-2#1)
Respondents were##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
Respondents who##2##2##(2009-5#1)(2013-8#1)
Respondents with##2##2##(2008-12#1)(2009-10#1)
Respondents##15##1##(1993-2#2)(1996-1#1)(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
Responding to the##2##3##(1994-1#1)(2010-8#1)
Responding to##7##2##(1994-1#1)(1996-2#1)(2008-4#2)(2008-6#1)(2010-8#1)(2013-1#1)
Responding##9##1##(1990-11#1)(1994-1#1)(1996-2#1)(2008-4#2)(2008-6#1)(2010-8#1)(2013-1#2)
Responds to##2##2##(2008-10#1)(2011-1#1)
Response Factor##5##2##(1994-6#4)(2008-6#1)
Response Surface Methodology##2##3##(2008-10#2)
Response in##10##2##(2008-10#4)(2008-11#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Response of a Fabry-Perot##2##4##(2008-2#2)
Response of a##3##3##(2008-10#1)(2008-2#2)
Response of the chick ciliary ganglion-iris##2##6##(1990-5#2)
Response of the##3##3##(1990-5#2)(2008-7#1)
Response of##24##2##(1990-5#3)(1991-8#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2012-12#2)
Response rates and##2##3##(2008-6#1)(2010-8#1)
Response rates##4##2##(1994-3#1)(2008-6#1)(2010-11#1)(2010-8#1)
Response surface methodology##2##3##(2008-10#1)(2008-6#1)
Response surface##4##2##(2008-10#3)(2008-6#1)
Response times of ambulances to calls from##2##7##(2010-3#2)
Response times were##2##3##(2008-10#1)(2010-3#1)
Response times##6##2##(2008-10#2)(2009-12#1)(2010-3#3)
Response to &quot##2##3##(2009-9#1)(2012-3#1)
Response to a##2##3##(2007-12#1)(2012-3#1)
Response to treatment was##2##4##(2008-6#1)(2013-1#1)
Response to##42##2##(1992-6#1)(1993-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#3)(2013-8#1)
Response##154##1##(1990-5#3)(1991-8#3)(1992-6#1)(1993-9#1)(1994-3#1)(1994-6#5)(1995-3#1)(1995-6#1)(1996-5#3)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#41)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#21)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#6)(2012-7#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
Responses from##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
Responses in##3##2##(1993-6#1)(2008-10#1)(2010-8#1)
Responses of the##3##3##(2008-2#1)(2008-4#1)(2013-1#1)
Responses of##11##2##(1993-12#1)(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-5#1)(2013-1#1)
Responses to##14##2##(1990-8#1)(1992-6#1)(1996-8#1)(1996-9#1)(2008-10#6)(2008-8#2)(2013-1#2)
Responses were##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
Responses##47##1##(1990-8#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1996-8#1)(1996-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#17)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-8#1)(2011-2#4)(2012-3#1)(2012-5#1)(2013-1#3)
Responsibility for##3##2##(1990-3#1)(1996-8#1)(1997-5#1)
Responsibility##12##1##(1990-3#1)(1993-12#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(2008-12#2)(2010-12#1)(2012-1#3)
Responsible for##3##2##(2008-10#2)(2012-3#1)
Responsible##5##1##(2008-10#2)(2008-4#1)(2012-1#1)(2012-3#1)
Responsive##7##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-6#1)(2010-8#1)
Responsivity and##2##2##(2008-3#1)(2009-10#1)
Responsivity##3##1##(2008-3#2)(2009-10#1)
Rest##3##1##(1992-12#2)(1992-5#1)
Restenosis after##2##2##(1996-8#1)(2008-7#1)
Restenosis##6##1##(1992-4#2)(1992-9#1)(1996-8#1)(2007-8#1)(2008-7#1)
Restin##5##1##(2008-9#5)
Resting##8##1##(1990-2#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#1)
Restoration of elbow flexion is the primary goal in treating patients with severe brachial plexus injuries##2##16##(2008-9#2)
Restoration of elbow flexion##3##4##(2008-9#3)
Restoration of##21##2##(1990-6#1)(1991-5#1)(1991-6#1)(1995-9#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#6)(2012-3#1)(2013-1#1)
Restoration##26##1##(1990-6#1)(1991-5#1)(1991-6#1)(1995-9#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#6)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
Restorative##4##1##(2009-10#1)(2010-3#1)(2011-2#2)
Restores##2##1##(2008-10#2)
Restoring##4##1##(1996-6#1)(2008-4#1)(2009-12#1)(2012-2#1)
Restraint##3##1##(1991-12#1)(2011-2#2)
Restricted##5##1##(1990-3#1)(2008-10#3)(2010-8#1)
Restricting##2##1##(1997-2#1)(2007-11#1)
Restriction Enzyme-Mediated Integration##2##3##(2008-10#2)
Restriction Fragment Length Polymorphism##3##4##(2008-10#3)
Restriction Fragment Length Polymorphisms##2##4##(2008-10#2)
Restriction Fragment Length##5##3##(2008-10#5)
Restriction enzyme##3##2##(1997-3#1)(2008-10#2)
Restriction fragment length polymorphism (RFLP) analysis of##3##7##(1995-12#1)(2008-10#2)
Restriction fragment length polymorphism (RFLP)##6##5##(1995-12#1)(2008-10#5)
Restriction fragment length polymorphism analysis##2##5##(2008-10#2)
Restriction fragment length polymorphism and##2##5##(2008-10#2)
Restriction fragment length polymorphism##11##4##(1995-12#1)(2008-10#10)
Restriction fragment length polymorphisms (RFLPs) and##2##6##(2008-10#2)
Restriction fragment length polymorphisms (RFLPs) were used to##2##8##(2008-10#2)
Restriction fragment length polymorphisms (RFLPs)##4##5##(2008-10#4)
Restriction fragment length polymorphisms##5##4##(2008-10#5)
Restriction fragment length##17##3##(1995-12#1)(2008-10#15)(2008-12#1)
Restriction fragment##18##2##(1995-12#1)(2008-10#16)(2008-12#1)
Restriction mapping of the##2##4##(1990-8#1)(2008-10#1)
Restriction mapping##4##2##(1990-8#1)(1997-6#1)(2008-10#2)
Restriction##41##1##(1990-8#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#31)(2008-12#1)(2008-2#1)
Restrictions on##3##2##(1996-11#1)(1996-8#1)(2010-5#1)
Restrictions##4##1##(1991-6#1)(1996-11#1)(1996-8#1)(2010-5#1)
Restructured##2##1##(1995-2#1)(2008-11#1)
Restructuring critical care services##3##4##(1996-12#1)(1996-3#1)(1997-2#1)
Restructuring in a unionized environment##2##5##(1996-3#2)
Restructuring##13##1##(1992-2#1)(1993-12#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-3#3)(1997-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
Result of the study showed that##2##6##(2011-1#1)(2012-3#1)
Result of##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
Result##15##1##(1993-3#1)(1997-2#2)(2006-6#1)(2008-11#1)(2008-4#1)(2011-1#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
Resulting##12##1##(1993-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#2)
Results -##5##2##(2008-11#5)
Results A total of##2##4##(2011-2#1)(2013-8#1)
Results A##3##2##(2011-2#2)(2013-8#1)
Results From a##2##3##(2013-1#1)(2013-8#1)
Results In the##2##3##(2009-8#1)(2011-2#1)
Results In##3##2##(2009-8#1)(2011-2#1)(2013-1#1)
Results Most##2##2##(2011-2#2)
Results No##3##2##(2011-2#2)(2013-1#1)
Results The results##3##3##(2011-2#1)(2012-12#2)
Results The##18##2##(2011-2#4)(2012-12#9)(2013-1#1)(2013-8#4)
Results Writing##2##2##(2011-2#1)(2013-1#1)
Results after##2##2##(2011-1#1)(2013-1#1)
Results agreed with##2##3##(2008-10#2)
Results also suggested that##2##4##(1995-2#1)(2008-11#1)
Results also##8##2##(1995-2#1)(1996-1#1)(2008-11#2)(2008-12#2)(2008-9#1)(2009-7#1)
Results and Conclusions##10##3##(2007-11#7)(2007-8#3)
Results and Discussion##9##3##(2007-11#2)(2007-8#1)(2008-6#6)
Results and conclusions##4##3##(2007-11#1)(2007-8#1)(2013-1#1)(2013-8#1)
Results and##31##2##(1990-9#1)(1997-3#1)(2007-11#10)(2007-8#5)(2008-10#1)(2008-11#1)(2008-6#8)(2013-1#2)(2013-8#2)
Results are also presented which##2##5##(2008-10#1)(2008-6#1)
Results are compared with those##2##5##(2008-10#1)(2008-3#1)
Results are compared with##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
Results are discussed in light of current##2##7##(2008-2#1)(2008-9#1)
Results are discussed in light of the sample characteristics##2##9##(2013-1#2)
Results are discussed in light of##4##6##(2008-2#1)(2008-9#1)(2013-1#2)
Results are discussed in terms of the##4##7##(1992-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
Results are discussed in terms of##5##6##(1992-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
Results are discussed in the context of##2##7##(2007-11#1)(2011-1#1)
Results are discussed in##12##4##(1992-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
Results are discussed##13##3##(1992-12#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
Results are explained in terms of##2##6##(1992-12#1)(2008-12#1)
Results are in##2##3##(2008-10#1)(2009-11#1)
Results are precise (R##3##4##(2008-10#3)
Results are precise##4##3##(2008-10#4)
Results are presented for##5##4##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)
Results are presented from a##2##5##(2008-10#1)(2008-12#1)
Results are presented from##3##4##(2008-10#1)(2008-12#2)
Results are presented that demonstrate the accuracy##2##7##(2007-12#1)(2008-2#1)
Results are presented##12##3##(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2009-11#1)
Results are reported##4##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
Results are summarized##2##3##(2011-1#1)(2011-2#1)
Results are##57##2##(1992-12#2)(1994-12#1)(1994-5#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#11)(2008-11#2)(2008-12#5)(2008-2#7)(2008-3#7)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
Results based on##2##3##(2008-10#2)
Results can be##2##3##(2008-10#1)(2008-3#1)
Results confirm the##2##3##(2008-10#1)(2008-8#1)
Results confirmed##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
Results demonstrate that the##2##4##(2008-10#1)(2010-8#1)
Results demonstrate that##5##3##(1996-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-8#1)
Results demonstrate the##2##3##(1991-12#1)(2008-10#1)
Results demonstrate##9##2##(1991-12#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-8#1)
Results demonstrated that##7##3##(1991-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2011-2#1)
Results demonstrated##12##2##(1991-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#2)
Results for the##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
Results for##14##2##(1996-11#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
Results from a##8##3##(1993-2#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#2)(2010-12#1)(2011-2#1)
Results from an##2##3##(2008-12#1)(2012-3#1)
Results from earlier experiments in our laboratories revealed that both selective and##2##12##(2008-10#2)
Results from experiments##2##3##(2008-3#1)(2008-6#1)
Results from in situ hybridization##2##5##(1996-12#1)(2008-4#1)
Results from the medical outcomes study##2##6##(1992-4#2)
Results from the##14##3##(1992-4#2)(1993-12#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
Results from this study suggest that##2##6##(2008-10#2)
Results from this study##6##4##(1991-1#1)(2008-10#3)(2010-1#1)(2011-1#1)
Results from this##7##3##(1991-1#1)(2008-10#3)(2008-7#1)(2010-1#1)(2011-1#1)
Results from##81##2##(1990-5#1)(1991-1#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#3)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Results further##2##2##(2010-12#1)(2013-8#1)
Results have been##2##3##(1990-5#1)(2008-5#1)
Results have implications for##2##4##(2009-10#1)(2009-8#1)
Results have shown that the##2##5##(2008-10#1)(2008-8#1)
Results have shown that##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
Results have##9##2##(1990-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-5#1)
Results highlight##2##2##(1996-2#1)(2012-3#1)
Results imply that##2##3##(2007-6#1)(2008-4#1)
Results in##6##2##(1992-6#1)(1995-11#1)(2008-10#2)(2008-9#1)(2013-1#1)
Results indicate a##3##3##(2008-12#1)(2009-7#1)(2012-2#1)
Results indicate an##2##3##(1996-12#1)(2009-11#1)
Results indicate that both##2##4##(2008-10#1)(2012-2#1)
Results indicate that the##19##4##(1996-2#1)(1997-5#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#2)(2012-2#1)(2013-8#1)
Results indicate that this##2##4##(1992-8#1)(2008-10#1)
Results indicate that##58##3##(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#3)(1994-2#1)(1995-1#1)(1996-2#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#1)(2009-7#4)(2010-7#1)(2012-2#3)(2012-5#1)(2013-1#2)(2013-8#1)
Results indicate the##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
Results indicate##73##2##(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#3)(1994-2#1)(1995-1#1)(1996-12#1)(1996-2#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#6)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-5#1)(2013-1#2)(2013-8#1)
Results indicated that both the##2##5##(2007-6#1)(2008-11#1)
Results indicated that both##3##4##(2007-6#1)(2008-11#1)(2013-1#1)
Results indicated that participants##2##4##(2007-12#1)(2012-12#1)
Results indicated that the##15##4##(2007-6#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#2)(2009-7#1)(2010-5#1)(2011-2#1)
Results indicated that there##2##4##(1994-3#1)(2008-11#1)
Results indicated that##57##3##(1991-2#1)(1992-3#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#1)(2007-12#2)(2007-6#3)(2007-7#1)(2008-10#10)(2008-11#3)(2008-12#6)(2008-5#4)(2008-9#4)(2009-11#1)(2009-5#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Results indicated##66##2##(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#1)(2007-12#2)(2007-6#3)(2007-7#1)(2008-10#12)(2008-11#4)(2008-12#6)(2008-2#2)(2008-5#4)(2008-9#4)(2009-11#1)(2009-5#1)(2009-7#5)(2009-8#1)(2009-9#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Results may be useful to##2##5##(2008-12#1)(2008-9#1)
Results may##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2010-7#1)
Results obtained by both##3##4##(2008-10#3)
Results obtained by this method##3##5##(1990-2#1)(2008-10#2)
Results obtained by this##4##4##(1990-2#1)(2008-10#3)
Results obtained by##13##3##(1990-2#1)(2008-10#11)(2008-4#1)
Results obtained for##5##3##(2008-10#5)
Results obtained from Plackett-Burman designs suggest that##2##7##(2008-10#2)
Results obtained from##9##3##(1993-11#1)(2007-12#1)(2008-10#5)(2008-2#2)
Results obtained in##4##3##(1993-6#1)(2008-10#1)(2008-3#1)(2009-8#1)
Results obtained indicate that the##3##5##(2008-10#2)(2012-2#1)
Results obtained using##4##3##(2006-6#1)(2008-10#3)
Results obtained with a##2##4##(2007-12#2)
Results obtained with##6##3##(1990-10#1)(1992-6#1)(2007-12#4)
Results obtained##55##2##(1990-10#1)(1990-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1995-6#1)(2006-6#1)(2007-12#5)(2008-10#32)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#2)
Results of a detailed experimental##2##5##(2008-2#2)
Results of a multidisciplinary international expert panel-EPACT II##2##8##(2010-12#2)
Results of a multidisciplinary international expert##3##6##(2010-12#3)
Results of a multidisciplinary##4##4##(2010-12#4)
Results of a randomized##2##4##(1995-12#1)(1995-9#1)
Results of a study##3##4##(1993-12#1)(1993-3#1)(2008-5#1)
Results of a##35##3##(1990-9#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#5)(2010-5#1)(2013-8#1)
Results of an##4##3##(1990-9#1)(1994-3#1)(2008-3#1)(2008-6#1)
Results of conservative##3##3##(1990-2#1)(1992-5#1)(2007-11#1)
Results of in vivo##2##4##(1996-12#1)(2008-6#1)
Results of in##3##3##(1995-2#1)(1996-12#1)(2008-6#1)
Results of our study##2##4##(2008-11#1)(2011-2#1)
Results of our##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2011-2#1)
Results of simulations##2##3##(2007-12#1)(2008-3#1)
Results of the Canadian##2##4##(2007-12#1)(2009-5#1)
Results of the present study##3##5##(1994-3#1)(2008-10#1)(2010-5#1)
Results of the present##6##4##(1991-12#1)(1994-3#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
Results of the study##4##4##(1992-2#1)(1997-7#1)(2008-1#1)(2011-2#1)
Results of the treatment##2##4##(1994-2#1)(2007-11#1)
Results of the##50##3##(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-6#1)(1997-7#2)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
Results of these##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
Results of this analysis##2##4##(1994-3#1)(2008-11#1)
Results of this study indicate that##2##6##(1990-6#1)(2011-2#1)
Results of this study suggest that##6##6##(2008-10#2)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)
Results of this study##16##4##(1990-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
Results of this survey##2##4##(2009-11#1)(2011-2#1)
Results of this##23##3##(1990-6#1)(1991-9#1)(1994-3#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#4)(2013-1#1)
Results of treatment##2##3##(1991-8#1)(1996-8#1)
Results of##198##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#8)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#4)(2010-7#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#5)
Results on the##2##3##(2008-11#1)(2009-9#1)
Results on##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-9#1)(2010-10#1)
Results presented##3##2##(1992-3#1)(1996-5#1)(2008-11#1)
Results produced##2##2##(2008-10#1)(2008-2#1)
Results provide##3##2##(1993-12#1)(2009-8#1)(2013-8#1)
Results provided##2##2##(1993-1#1)(1995-2#1)
Results reinforce the idea that how men perceive their military experiences may be more important in predicting outcomes than the experiences themselves##2##22##(2013-1#2)
Results reveal##2##2##(2008-3#1)(2008-6#1)
Results revealed a##3##3##(2007-10#1)(2008-6#1)(2010-6#1)
Results revealed significant##2##3##(2007-6#1)(2008-12#1)
Results revealed that##7##3##(2007-2#1)(2008-1#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-3#2)
Results revealed##16##2##(1996-12#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-6#2)(2010-7#1)(2010-9#1)(2012-3#2)
Results show a##2##3##(2008-10#1)(2010-12#1)
Results show how##2##3##(2008-11#1)(2008-3#1)
Results show no##2##3##(2008-10#1)(2011-2#1)
Results show that a##2##4##(2008-7#1)(2009-6#1)
Results show that the##20##4##(1990-5#1)(1995-12#1)(1995-9#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2010-8#1)(2013-8#3)
Results show that##56##3##(1990-5#1)(1993-12#2)(1995-12#1)(1995-9#1)(1996-12#2)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#3)
Results show the##5##3##(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
Results show there##2##3##(2011-2#1)(2012-3#1)
Results show##74##2##(1990-5#1)(1993-12#2)(1993-2#1)(1995-12#1)(1995-9#1)(1996-12#2)(2007-12#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#9)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
Results showed a##4##3##(2008-12#1)(2009-12#1)(2009-4#1)(2013-1#1)
Results showed an##2##3##(2008-10#1)(2008-7#1)
Results showed that a##2##4##(2010-10#1)(2012-2#1)
Results showed that all##3##4##(2009-5#1)(2011-2#1)(2013-1#1)
Results showed that the##14##4##(2007-10#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-8#1)
Results showed that there was##2##5##(2008-12#1)(2008-8#1)
Results showed that there were##2##5##(1994-12#1)(2008-9#1)
Results showed that there##5##4##(1994-12#1)(2008-12#1)(2008-8#2)(2008-9#1)
Results showed that##82##3##(1991-8#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-10#3)(2008-10#18)(2008-11#4)(2008-12#6)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#7)(2013-8#1)
Results showed the##4##3##(1994-1#1)(2008-5#1)(2008-9#1)(2013-8#1)
Results showed##104##2##(1991-8#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-10#3)(2008-10#20)(2008-11#4)(2008-12#8)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#5)(2009-12#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#2)
Results suggest that a##2##4##(1992-12#1)(2013-1#1)
Results suggest that the##10##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
Results suggest that##39##3##(1992-12#2)(1994-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#4)
Results suggest##44##2##(1991-12#1)(1992-12#2)(1993-1#1)(1994-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#4)
Results suggested that##4##3##(1991-12#1)(2009-11#1)(2010-12#1)(2010-7#1)
Results support a##2##3##(1994-3#1)(2009-11#1)
Results support the##2##3##(1996-2#1)(2008-10#1)
Results support##7##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-6#1)(2009-11#1)(2010-7#1)(2012-3#1)
Results using##2##2##(2008-10#1)(2008-11#1)
Results were analyzed##3##3##(1995-11#1)(2008-7#1)(2013-1#1)
Results were compared to##2##4##(2008-10#2)
Results were compared with a##2##5##(2008-10#1)(2010-12#1)
Results were compared with those##2##5##(2008-10#2)
Results were compared with##10##4##(1990-6#1)(1997-8#1)(2008-10#5)(2008-3#1)(2010-12#1)(2010-8#1)
Results were compared##13##3##(1990-6#1)(1997-8#1)(2008-10#8)(2008-3#1)(2010-12#1)(2010-8#1)
Results were in agreement with those obtained##2##7##(2008-10#2)
Results were in agreement with##3##5##(2008-10#3)
Results were in##4##3##(2008-10#4)
Results were similar in##2##4##(2008-10#1)(2012-12#1)
Results were validated in a##2##5##(2007-10#1)(2008-10#1)
Results were##38##2##(1990-3#1)(1990-6#1)(1995-11#2)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#16)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Results with##8##2##(1990-11#1)(1990-8#1)(1995-5#1)(2008-10#4)(2008-3#1)
Results##1674##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#6)(1993-6#3)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#8)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#2)(2006-10#2)(2006-6#2)(2006-8#3)(2007-10#15)(2007-11#91)(2007-12#23)(2007-2#13)(2007-5#1)(2007-6#6)(2007-7#9)(2007-8#42)(2007-9#2)(2008-1#7)(2008-10#219)(2008-11#47)(2008-12#36)(2008-2#39)(2008-3#61)(2008-4#13)(2008-5#34)(2008-6#64)(2008-7#28)(2008-8#22)(2008-9#23)(2009-10#7)(2009-11#12)(2009-12#5)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#1)(2009-7#21)(2009-8#10)(2009-9#7)(2010-1#6)(2010-10#13)(2010-12#14)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#7)(2010-6#3)(2010-7#7)(2010-8#12)(2010-9#2)(2011-1#37)(2011-2#87)(2011-3#2)(2012-1#11)(2012-12#88)(2012-2#28)(2012-3#42)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#183)(2013-7#3)(2013-8#72)
Results- The##2##2##(2008-11#2)
Results-##4##1##(2008-11#4)
Results-The##3##1##(2008-11#3)
Results  A##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
Results  The##2##2##(2011-2#1)(2012-3#1)
Results ##17##1##(2011-2#7)(2012-1#5)(2012-3#4)(2013-1#1)
Resuscitation##7##1##(1990-3#1)(1993-7#1)(1994-11#1)(2008-11#2)(2008-3#1)(2012-2#1)
Resveratrol##8##1##(2008-10#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-4#3)
Retained##3##1##(1991-3#1)(2008-12#2)
Retention of##5##2##(1995-2#1)(2008-10#3)(2010-3#1)
Retention##12##1##(1993-12#1)(1994-8#2)(1995-2#1)(2008-10#6)(2009-9#1)(2010-3#1)
Rethinking##7##1##(1991-12#1)(1995-12#3)(1996-1#1)(1997-1#1)(2012-12#1)
Reticulated##3##1##(2006-6#1)(2008-10#1)(2008-9#1)
Reticulitermes##2##1##(2011-2#2)
Reticulocyte counts were##2##3##(2008-9#2)
Reticulocyte##3##1##(1994-5#1)(2008-9#2)
Retina##2##1##(2010-1#1)(2013-1#1)
Retinal vascular imaging##2##3##(2009-10#2)
Retinal vascular##3##2##(2009-10#2)(2009-7#1)
Retinal vasculitis##2##2##(2011-1#2)
Retinal##19##1##(1993-3#1)(1996-5#2)(2008-5#1)(2009-10#2)(2009-12#2)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#4)(2011-2#1)(2011-9#1)(2013-1#1)(2013-8#1)
Retinoblastoma##3##1##(1995-2#1)(2008-6#1)(2010-11#1)
Retinoic acid##5##2##(1992-8#2)(1993-12#1)(1994-11#2)
Retinoic##6##1##(1992-8#3)(1993-12#1)(1994-11#2)
Retinoids are known to##2##4##(2008-4#1)(2009-6#1)
Retinoids##6##1##(1991-11#1)(1994-6#1)(1995-9#1)(2008-4#2)(2009-6#1)
Retinol-binding protein and asialo-orosomucoid##2##4##(1995-6#2)
Retinol-binding protein##3##2##(1995-6#3)
Retinopathy of prematurity##2##3##(1993-2#1)(2011-1#1)
Retinopathy of##3##2##(1993-2#1)(2011-1#2)
Retinopathy##6##1##(1993-2#1)(1995-9#1)(2010-10#1)(2010-8#1)(2011-1#2)
Retirement##6##1##(1991-5#1)(1995-12#1)(2008-1#1)(2008-4#3)
Retraction##3##1##(2010-7#1)(2013-1#1)(2013-7#1)
Retrieval System##2##2##(1993-1#1)(1996-3#1)
Retrieval and##2##2##(1991-2#1)(2008-3#1)
Retrieval of the##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
Retrieval of##15##2##(2007-11#1)(2008-2#6)(2008-3#7)(2008-7#1)
Retrieval##24##1##(1991-2#1)(1993-1#1)(1996-3#1)(2007-11#2)(2008-1#1)(2008-2#7)(2008-3#10)(2008-7#1)
Retrograde##2##1##(1991-12#1)(2013-1#1)
Retroperitoneal##11##1##(1994-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-6#4)(2009-9#1)(2012-3#1)(2013-1#1)
Retroperitoneoscopically assisted##2##2##(2008-10#2)
Retrospective analysis of the##2##4##(1995-3#1)(2007-8#1)
Retrospective analysis of##5##3##(1992-6#1)(1994-12#1)(1995-3#2)(2007-8#1)
Retrospective analysis##6##2##(1992-6#1)(1994-12#1)(1995-3#2)(2007-8#1)(2012-3#1)
Retrospective evaluation of##3##3##(1993-6#1)(2007-11#2)
Retrospective review of##4##3##(2011-1#1)(2012-2#1)(2013-1#2)
Retrospective study of##6##3##(2007-8#2)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
Retrospective study##7##2##(2007-8#2)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
Retrospective##35##1##(1990-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#2)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#1)(2008-7#2)(2008-9#4)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
Retrospectively##4##1##(1990-8#1)(1992-11#1)(2008-1#1)(2011-2#1)
Retrosternal dislocation of the clavicle##2##5##(2007-8#2)
Retroviral vectors##2##2##(1994-5#1)(2008-11#1)
Retroviral##4##1##(1994-5#1)(1994-8#1)(2008-11#2)
Retrovirus##2##1##(1997-1#1)(2009-10#1)
Rett syndrome##6##2##(1997-5#4)(2012-2#2)
Rett##7##1##(1997-5#5)(2012-2#2)
Rett's syndrome##4##2##(1995-2#4)
Return migrants##2##2##(2013-8#2)
Return on investment##2##3##(2010-8#1)(2013-1#1)
Return to##4##2##(2008-7#1)(2010-1#1)(2012-12#1)(2012-3#1)
Return##10##1##(2008-10#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
Retzius##5##1##(1991-5#2)(1997-3#3)
Reunion Island##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
Reunion##4##1##(2008-10#2)(2008-3#1)(2011-1#1)
Reuse of##2##2##(2008-1#2)
Reuse##3##1##(2008-1#3)
Rev M11 delta 14##2##4##(1993-8#2)
Rev protein##2##2##(1994-8#1)(2011-3#1)
Rev proteins##2##2##(1993-2#1)(1993-8#1)
Rev regulation##2##2##(1994-8#2)
Rev responsive element##2##3##(1993-8#2)
Rev virus##4##2##(2007-6#4)
Rev##51##1##(1990-8#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-8#15)(1994-8#4)(1995-2#2)(1997-4#3)(2007-11#5)(2007-12#5)(2007-6#4)(2008-2#1)(2008-3#2)(2010-2#1)(2011-3#1)
Rev-dependent##4##1##(1994-8#2)(1995-2#1)(2011-3#1)
Rev-mediated RNA nuclear export##3##4##(2011-3#3)
Rev/Rex##2##1##(1993-8#2)
Rev81##3##1##(2008-10#3)
Revascularization of##2##2##(2007-8#1)(2008-12#1)
Revascularization##4##1##(2007-8#2)(2008-12#1)(2012-3#1)
Reveal a##2##2##(2008-10#1)(2012-3#1)
Reveal##3##1##(2008-10#1)(2012-3#2)
Revealed by##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
Revealed##6##1##(1994-9#1)(2008-10#3)(2008-5#1)(2012-3#1)
Reveals Its##2##2##(2008-10#1)(2008-6#1)
Reveals##6##1##(2008-10#5)(2008-6#1)
Revenue##5##1##(1991-2#2)(1992-12#1)(1996-3#2)
Reversal of the##2##3##(2008-10#1)(2013-1#1)
Reversal of##11##2##(1992-8#1)(1992-9#1)(1993-12#1)(1994-8#1)(2008-10#2)(2008-7#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Reversal##15##1##(1992-8#1)(1992-9#1)(1993-12#1)(1994-8#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Reverse Transcriptase##3##2##(2008-10#2)(2009-9#1)
Reverse Transcription-Polymerase Chain Reaction##4##4##(2008-10#4)
Reverse flow injection spectrophotometric determination of##2##6##(2008-10#2)
Reverse radial forearm##2##3##(2008-9#2)
Reverse saturable absorption and##2##4##(2008-3#2)
Reverse transcriptase polymerase chain reaction##3##5##(2007-4#1)(2007-6#1)(2012-2#1)
Reverse transcriptase##4##2##(2007-4#1)(2007-6#1)(2008-11#1)(2012-2#1)
Reverse transcriptase-polymerase chain reaction (RT-PCR)##3##5##(1997-2#1)(1997-6#1)(2008-5#1)
Reverse transcription polymerase chain reaction##2##5##(1993-8#1)(2008-10#1)
Reverse transcription##4##2##(1992-9#1)(1993-8#1)(1994-12#1)(2008-10#1)
Reverse transcription-polymerase chain reaction##3##4##(1994-11#1)(2008-10#2)
Reverse transcription-polymerase chain##5##3##(1994-11#1)(2008-10#3)(2008-9#1)
Reverse transcription-polymerase##6##2##(1994-11#1)(2008-10#3)(2008-11#1)(2008-9#1)
Reverse##41##1##(1992-9#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-8#1)(2012-2#1)
Reverse-transcriptase polymerase chain reaction##2##4##(2008-10#2)
Reverse-transcription##2##1##(2008-10#2)
Reversed phase liquid chromatography##3##4##(2008-10#3)
Reversed phase##5##2##(2008-10#5)
Reversed##8##1##(1992-2#1)(2008-10#7)
Reversed-phase HPLC##3##2##(1992-12#1)(2008-10#1)(2011-1#1)
Reversed-phase high-performance liquid chromatography##2##4##(2008-4#1)(2009-8#1)
Reversed-phase liquid chromatographic determination of##2##5##(2008-10#2)
Reversed-phase liquid chromatographic##3##3##(2008-10#3)
Reversed-phase##10##1##(1992-12#1)(2008-10#4)(2008-4#2)(2009-8#1)(2010-11#1)(2011-1#1)
Reversibility of##2##2##(1994-5#1)(1996-12#1)
Reversibility##3##1##(1994-11#1)(1994-5#1)(1996-12#1)
Reversible electroporation##2##2##(2009-11#2)
Reversible inhibition of##2##3##(1990-7#1)(1991-9#1)
Reversible protein phosphorylation is recognized as a major mechanism regulating the physiology of plant and animal cells##2##17##(2008-2#1)(2008-4#1)
Reversible##26##1##(1990-10#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-6#1)(2006-6#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#3)(2009-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
Reversing the##3##2##(1993-2#1)(2007-12#1)(2012-2#1)
Reversing##4##1##(1992-5#1)(1993-2#1)(2007-12#1)(2012-2#1)
Reversion##2##1##(2007-11#1)(2012-3#1)
Revertant##2##1##(1995-5#1)(2008-11#1)
Review Board##3##2##(1996-1#2)(2009-4#1)
Review article##4##2##(2009-8#4)
Review focuses on##2##3##(1996-2#1)(2011-2#1)
Review of Literature##2##3##(2008-1#1)(2012-3#1)
Review of Physical##3##3##(2012-1#2)(2012-2#1)
Review of a multicenter series of 350 cases##2##8##(1990-12#1)(1991-8#1)
Review of a##3##3##(1990-12#1)(1991-8#1)(1993-12#1)
Review of data from##2##4##(2012-12#1)(2012-2#1)
Review of general session##2##4##(2008-5#2)
Review of the Literature##10##4##(1997-3#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
Review of the literature and##3##5##(1990-10#1)(1993-3#1)(2008-10#1)
Review of the literature on##2##5##(1996-3#1)(2008-8#1)
Review of the literature##10##4##(1990-10#1)(1990-6#1)(1993-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-8#1)
Review of the literature]##2##4##(1993-5#1)(1996-9#1)
Review of the##32##3##(1990-10#1)(1990-6#1)(1991-12#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
Review of##104##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-9#3)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#18)(2011-2#11)(2012-1#10)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#3)
Review##175##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-9#3)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#18)(2011-2#17)(2011-4#1)(2012-1#10)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#9)(2013-8#4)
Reviewed##2##1##(2008-8#1)(2010-3#1)
Reviewing##2##1##(1996-2#1)(2008-11#1)
Reviews of the medical literature have always been an important resource for physicians##2##13##(2007-5#2)
Reviews##10##1##(1993-12#1)(2007-5#2)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
Revised Trauma Score##2##3##(2009-4#1)(2011-2#1)
Revised##16##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
Revision surgery##3##2##(2007-11#1)(2012-2#2)
Revision to##2##2##(2012-2#2)
Revision##14##1##(1995-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)
Revisions to the care plan terminology were completed as part of an evidence-based project by nurses at one facility##2##19##(2013-1#2)
Revisions to the##3##3##(1991-2#1)(2013-1#2)
Revisited##4##1##(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
Revisiting the Warburg effect in cancer cells with##2##8##(2010-12#2)
Revisiting the##6##2##(1991-3#1)(2008-3#2)(2010-12#2)(2012-2#1)
Revisiting##11##1##(1991-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(2008-3#2)(2008-5#1)(2010-12#2)(2012-2#2)
Revista Médica de Chile##3##4##(2013-1#3)
Revista##5##1##(2008-5#1)(2011-1#1)(2013-1#3)
Revolution##2##1##(1994-12#1)(2008-3#1)
Revolutionary##2##1##(1995-4#1)(1996-12#1)
Revolutionizing##2##1##(2008-7#1)(2011-1#1)
Reward Circuitry##2##2##(2012-12#2)
Reward##4##1##(1996-3#1)(2012-12#3)
Rewarding##2##1##(2009-5#1)(2010-5#1)
Rex##2##1##(1993-8#1)(1995-2#1)
Rex's recessus is a##2##4##(2008-10#2)
Rex-1##7##1##(1994-9#7)
Reye's syndrome##4##2##(1991-12#3)(1991-8#1)
Reye's##6##1##(1991-12#5)(1991-8#1)
Reykjavik##2##1##(2006-8#1)(2013-1#1)
Reynolds number##6##2##(1993-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
Reynolds numbers##3##2##(2007-8#1)(2008-2#1)(2009-11#1)
Reynolds##10##1##(1993-5#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
Rf values of 0##2##4##(1993-8#2)
Rf values##3##2##(1993-8#2)(1994-3#1)
Rf##6##1##(1993-8#2)(1994-3#1)(1996-2#1)(2008-10#1)(2012-2#1)
Rfam##2##1##(2008-4#2)
Rg1##6##1##(1995-8#3)(2008-11#1)(2010-12#1)(2012-3#1)
RgMADS1##3##1##(2008-8#3)
Rh and Ru##3##3##(2008-10#3)
Rh and##5##2##(2008-10#4)(2013-8#1)
Rh antibodies##4##2##(1992-12#2)(1994-12#1)(2011-1#1)
Rh antigens##2##2##(1992-12#2)
Rh blood group##2##3##(1994-12#1)(2012-2#1)
Rh deletion cells##2##3##(1992-9#2)
Rh deletion##3##2##(1992-9#2)(1994-12#1)
Rh immune globulin was##2##4##(1994-6#2)
Rh immune globulin##4##3##(1992-12#1)(1994-6#3)
Rh incompatibility##2##2##(2012-12#1)(2012-2#1)
Rh##47##1##(1992-12#6)(1992-9#2)(1994-12#10)(1994-6#3)(1996-3#3)(2008-10#13)(2008-11#1)(2008-2#3)(2011-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
Rh(III) and Os(IV)##2##3##(2008-10#2)
Rh(III) and##4##2##(2008-10#4)
Rh(III) complex##2##2##(2008-10#2)
Rh(III)##10##1##(2008-10#10)
Rh)##2##1##(2008-11#2)
Rh-C60##2##1##(2007-11#2)
Rh-like##2##1##(1992-9#2)
Rh-negative bone##2##2##(1992-12#2)
Rh-negative##4##1##(1992-12#3)(2008-10#1)
Rh-positive##3##1##(1992-12#2)(2008-10#1)
Rh640 (ClO(4))##2##2##(2008-2#2)
Rh640##3##1##(2008-2#3)
Rh6G (Cl)##2##2##(2008-2#2)
Rh6G##4##1##(2008-2#4)
RhB##3##1##(2008-10#3)
RhD##2##1##(2008-10#1)(2010-11#1)
RhG and##2##2##(2008-10#2)
RhS##3##1##(2008-10#3)
Rhabdomyolysis is##2##2##(2008-1#1)(2013-8#1)
Rhabdomyolysis##7##1##(1994-12#2)(2008-1#2)(2008-4#1)(2013-1#1)(2013-8#1)
Rhabdomyosarcoma##3##1##(2007-7#1)(2007-8#1)(2008-6#1)
Rhap residues##2##2##(1990-9#2)
Rheological characterization##2##2##(2008-5#1)(2011-2#1)
Rheological##8##1##(1994-8#1)(1997-6#1)(2008-5#3)(2011-2#2)(2011-3#1)
Rheology of##2##2##(2008-5#2)
Rheology##3##1##(2008-5#3)
Rheum palmatum##2##2##(2008-5#2)
Rheumaorthopaedic##2##1##(2007-8#2)
Rheumatic fever##2##2##(1996-12#1)(2011-2#1)
Rheumatism##2##1##(1990-6#1)(2012-3#1)
Rheumatoid Arthritis##4##2##(1993-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
Rheumatoid arthritis (RA) is a##2##5##(2008-5#1)(2012-2#1)
Rheumatoid arthritis (RA)##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
Rheumatoid arthritis is##3##3##(1990-6#1)(2012-3#2)
Rheumatoid arthritis##12##2##(1990-6#1)(1991-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#6)
Rheumatoid factor##3##2##(2011-2#1)(2013-1#2)
Rheumatoid##20##1##(1990-6#1)(1991-8#1)(1993-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#6)(2013-1#3)
Rheumatological findings in candidates for valvular heart surgery##2##8##(2013-1#2)
Rheumatological##4##1##(2007-11#1)(2007-8#1)(2013-1#2)
Rheumatologists##2##1##(1990-6#1)(2008-8#1)
Rheumatology##9##1##(1997-8#1)(2006-10#3)(2007-8#1)(2008-8#3)(2011-2#1)
Rhexocercosporidium spp##2##2##(2008-10#2)
Rhexocercosporidium##5##1##(2008-10#5)
Rhinitis##6##1##(2008-3#3)(2012-12#2)(2012-3#1)
Rhino biology##2##2##(1991-5#2)
Rhino##4##1##(1991-5#4)
Rhinolith##2##1##(2013-1#2)
Rhinology##2##1##(2011-1#1)(2012-1#1)
Rhinoplasty in##2##2##(2007-12#1)(2010-8#1)
Rhinoplasty##4##1##(2007-12#1)(2010-8#3)
Rhinotermitidae) infesting##2##2##(2011-2#2)
Rhinotermitidae)##7##1##(2007-12#2)(2009-5#1)(2011-2#4)
Rhipicephalus (Boophilus) microplus##3##3##(2010-10#3)
Rhipicephalus (Boophilus)##4##2##(2010-10#3)(2013-1#1)
Rhipicephalus##6##1##(2008-8#1)(2010-10#3)(2011-1#1)(2013-1#1)
Rhizobium etli G12##2##3##(2008-10#2)
Rhizobium leguminosarum bv trifolii is##2##5##(2011-2#2)
Rhizobium leguminosarum bv trifolii##3##4##(2011-2#3)
Rhizobium leguminosarum bv##4##3##(2011-2#4)
Rhizobium leguminosarum##5##2##(2008-8#1)(2011-2#4)
Rhizobium meliloti##3##2##(1994-8#2)(2008-11#1)
Rhizobium##12##1##(1994-8#3)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#4)
Rhizoctonia blight##3##2##(2008-10#3)
Rhizoctonia damping-off##4##2##(2008-10#4)
Rhizoctonia root rot of apple##2##5##(2008-10#2)
Rhizoctonia root rot##3##3##(2008-10#3)
Rhizoctonia solani Anastomosis Group##4##4##(2008-10#4)
Rhizoctonia solani Anastomosis##5##3##(2008-10#5)
Rhizoctonia solani anastomosis group 5##2##5##(2008-10#2)
Rhizoctonia solani anastomosis group##6##4##(2008-10#6)
Rhizoctonia solani and##3##3##(2008-10#3)
Rhizoctonia solani by##2##3##(2008-10#2)
Rhizoctonia solani in##3##3##(2008-10#3)
Rhizoctonia solani on##2##3##(2008-10#2)
Rhizoctonia solani or##2##3##(2008-10#2)
Rhizoctonia solani were##2##3##(2008-10#2)
Rhizoctonia solani##57##2##(2008-10#55)(2010-10#2)
Rhizoctonia spp##19##2##(2008-10#17)(2008-12#2)
Rhizoctonia##105##1##(2008-10#98)(2008-12#5)(2010-10#2)
Rhizophora mangle##2##2##(2011-2#2)
Rhizophora##3##1##(2008-5#1)(2011-2#2)
Rhizopus head rot##4##3##(2008-10#4)
Rhizopus oryzae NRRL 395##2##4##(2008-6#2)
Rhizopus oryzae##9##2##(2008-10#3)(2008-6#4)(2009-2#1)(2012-2#1)
Rhizopus sp##3##2##(2008-12#1)(2008-6#2)
Rhizopus##24##1##(2008-10#7)(2008-12#1)(2008-5#2)(2008-6#10)(2008-7#1)(2009-2#1)(2010-4#1)(2012-2#1)
Rhizosphere Colonization##2##2##(2008-10#2)
Rhizosphere priming##4##2##(2013-8#4)
Rhizosphere##15##1##(2008-10#11)(2013-8#4)
Rhnull##3##1##(1994-12#3)
Rho GTPase##2##2##(2011-2#1)(2012-7#1)
Rho GTPases##3##2##(2011-2#1)(2012-7#1)(2013-8#1)
Rho family##2##2##(1997-7#1)(2009-10#1)
Rho proteins##2##2##(1996-5#2)
Rho##13##1##(1996-5#2)(1997-7#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-7#2)(2013-1#1)(2013-8#1)
RhoA##2##1##(2012-12#1)(2012-7#1)
Rhodamine 6G and##4##3##(2008-10#3)(2008-3#1)
Rhodamine 6G dye##2##3##(2008-2#1)(2008-3#1)
Rhodamine 6G in##3##3##(2008-2#1)(2008-3#2)
Rhodamine 6G is##2##3##(2008-2#1)(2008-3#1)
Rhodamine 6G laser##2##3##(2008-2#1)(2008-3#1)
Rhodamine 6G##19##2##(2007-11#1)(2008-10#4)(2008-2#6)(2008-3#8)
Rhodamine B (RB)##4##3##(2008-10#4)
Rhodamine B encapsulation/release profile##2##4##(2009-11#2)
Rhodamine B##11##2##(2008-10#5)(2008-12#1)(2009-11#5)
Rhodamine##34##1##(2007-11#2)(2008-10#10)(2008-12#1)(2008-2#7)(2008-3#9)(2009-11#5)
Rhode Island Red##2##3##(2012-1#2)
Rhode Island##11##2##(1991-3#1)(1992-2#1)(1994-2#2)(1996-1#2)(1996-12#2)(2011-2#1)(2012-1#2)
Rhode##12##1##(1991-3#1)(1992-2#1)(1994-2#2)(1996-1#2)(1996-12#3)(2011-2#1)(2012-1#2)
Rhodes##2##1##(1993-12#1)(2008-5#1)
Rhodeus ocellatus ocellatus##2##3##(2008-5#2)
Rhodium##3##1##(2008-10#3)
Rhodnius##3##1##(2008-8#1)(2013-7#2)
Rhodobacter sphaeroides##14##2##(1992-6#1)(1993-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-8#3)(2008-9#2)(2010-2#3)
Rhodobacter##16##1##(1992-6#1)(1993-11#2)(1994-8#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-8#3)(2008-9#2)(2010-2#3)
Rhodococcus equi##3##2##(1991-3#1)(1991-8#2)
Rhodococcus sp##3##2##(1994-3#3)
Rhodococcus##10##1##(1991-3#1)(1991-8#2)(1994-3#3)(2008-10#1)(2008-6#2)(2008-8#1)
Rhodocyclus##2##1##(2008-8#2)
Rhododendron and##2##2##(2008-10#2)
Rhododendron##5##1##(2008-10#5)
Rhodophyta##3##1##(2008-5#3)
Rhodophyta)##3##1##(2008-11#2)(2008-5#1)
Rhodopseudomonas palustris##2##2##(1995-8#1)(2008-8#1)
Rhodopseudomonas viridis##3##2##(1993-8#3)
Rhodopseudomonas##6##1##(1993-11#1)(1993-8#3)(1995-8#1)(2008-8#1)
Rhodotorula glutinis##4##2##(2008-10#4)
Rhodotorula species##2##2##(2009-11#2)
Rhodotorula##9##1##(2008-10#4)(2008-5#1)(2009-11#4)
Rhodovulum sulfidophilum##2##2##(2008-6#2)
Rhone-Poulenc Rorer##2##2##(1996-5#1)(2008-5#1)
Rhopalosiphum maidis##3##2##(2008-10#3)
Rhopalosiphum padi##4##2##(2008-10#4)
Rhopalosiphum##7##1##(2008-10#7)
Rhus##3##1##(2008-10#2)(2008-5#1)
Rhy##3##1##(2011-3#3)
Rhynchosporium secalis isolates##2##3##(2008-10#2)
Rhynchosporium secalis##14##2##(2008-10#14)
Rhythm##5##1##(1991-12#1)(2008-5#1)(2008-6#2)(2010-9#1)
Rhythmic##4##1##(2010-9#2)(2012-12#1)(2012-2#1)
Rhythms##2##1##(2008-5#2)
Ri##2##1##(1991-7#1)(2008-10#1)
Rib cage##2##2##(2008-5#1)(2012-2#1)
Rib##3##1##(2008-5#1)(2012-1#1)(2012-2#1)
Riband##4##1##(2008-10#4)
Ribeira##2##1##(1990-12#2)
Ribes spp##2##2##(2008-10#2)
Ribes##4##1##(2008-10#2)(2012-2#1)(2012-4#1)
Riboflavin##5##1##(2008-10#4)(2008-9#1)
Ribonuclease H##2##2##(2009-2#1)(2010-2#1)
Ribonucleic acid (RNA)##2##3##(2008-10#1)(2010-9#1)
Ribonucleic acid##3##2##(2008-10#2)(2010-9#1)
Ribonucleotide reductase##3##2##(1990-2#1)(1993-11#2)
Ribosomal DNA##3##2##(2008-10#3)
Ribosomal protein##2##2##(1992-8#1)(1993-11#1)
Ribosomal##12##1##(1992-8#1)(1993-11#1)(1995-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2013-1#1)
Ribosome-Inactivating##2##1##(2008-10#2)
Ribosome-inactivating proteins (RIPs) are##2##4##(2008-10#2)
Ribosome-inactivating proteins (RIPs)##3##3##(1990-11#1)(2008-10#2)
Ribozymes##2##1##(1993-9#1)(2008-4#1)
Rican##6##1##(2008-10#1)(2008-5#3)(2011-2#1)(2013-8#1)
Rice Blast Fungus##2##3##(2008-10#2)
Rice Blast##5##2##(2008-10#5)
Rice GT Database##2##3##(2009-10#2)
Rice Sheath##2##2##(2008-10#2)
Rice blast##2##2##(2008-10#1)(2012-2#1)
Rice dwarf virus (RDV) is##2##5##(2008-10#1)(2008-8#1)
Rice dwarf virus##3##3##(2008-10#2)(2008-8#1)
Rice plants##2##2##(2008-10#2)
Rice##50##1##(1993-11#1)(2008-10#29)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#3)(2012-2#1)(2013-1#1)(2013-8#3)
Rich##3##1##(1997-8#1)(2008-10#1)(2010-3#1)
Richard III##2##2##(2009-3#2)
Richard J##2##2##(1996-5#1)(2008-4#1)
Richard Savage##2##2##(1996-8#2)
Richard##16##1##(1990-8#1)(1994-2#1)(1995-12#1)(1996-5#1)(1996-8#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-3#2)(2009-8#1)
Richards and##2##2##(2008-10#1)(2008-2#1)
Richards##9##1##(1993-11#1)(1997-3#1)(2008-10#6)(2008-2#1)
Richardson##4##1##(1995-8#1)(2008-12#1)(2013-8#2)
Richmond##3##1##(1990-8#1)(1991-1#1)(2010-7#1)
Rician distribution to##2##3##(2008-2#2)
Ricin##2##1##(1992-3#1)(1993-11#1)
Ricinus communis##4##2##(1993-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
Ricinus##5##1##(1993-11#1)(2008-11#1)(2009-10#1)(2013-1#1)(2013-8#1)
Rickettsia prowazekii##2##2##(1994-12#2)
Rickettsia slovaca##3##2##(1995-12#1)(2009-2#2)
Rickettsia##11##1##(1994-12#2)(1995-12#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-2#3)(2010-1#1)(2013-8#1)
Rickettsiae##4##1##(1991-8#4)
Rickettsial##2##1##(2007-2#1)(2013-8#1)
Rideout##2##1##(1995-12#2)
Ridge##10##1##(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
Riding##2##1##(1996-2#1)(1997-3#1)
Ridomil 2E##2##2##(2008-10#2)
Ridomil##4##1##(2008-10#4)
Riedel's thyroiditis##4##2##(2008-12#4)
Riemannian##2##1##(2009-10#2)
Rieske iron-sulfur##2##2##(1995-11#2)
Riesling and##2##2##(2008-10#2)
Riesling##4##1##(2008-10#4)
Rifalazil##2##1##(2008-5#2)
Rifamycin B production##2##3##(1994-8#2)
Rifle##2##1##(2013-8#2)
Rift Valley##2##2##(1994-9#2)
Right atrial myxoma##2##3##(2008-11#1)(2012-12#1)
Right atrial myxomas##2##3##(2012-12#2)
Right atrial##7##2##(2007-8#3)(2008-11#1)(2012-12#3)
Right ventricular##2##2##(1993-9#1)(2007-8#1)
Right##27##1##(1992-12#1)(1993-9#1)(1994-8#1)(2007-12#1)(2007-8#7)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Right-sided##2##1##(1993-9#1)(2010-5#1)
Righting##3##1##(1991-12#1)(2007-12#2)
Rights Act##3##2##(1994-1#1)(2008-11#2)
Rights and##3##2##(1993-9#1)(2008-9#1)(2012-3#1)
Rights##13##1##(1993-9#1)(1994-1#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-5#1)(1997-5#1)(2008-11#2)(2008-9#1)(2009-6#1)(2012-3#1)
Rigidity##2##1##(1990-12#1)(2008-10#1)
Rigorous coupled-wave analysis##2##3##(2007-12#1)(2008-3#1)
Rigorous##6##1##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-9#1)
Rijeka##6##1##(2011-1#1)(2011-2#5)
Rijswijk##2##1##(1996-8#2)
Riley##2##1##(2008-11#1)(2008-8#1)
Rinderpest##2##1##(1990-3#2)
Ring Laser##2##2##(2008-2#2)
Ring##14##1##(1991-8#1)(1994-5#1)(1996-5#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2013-8#1)
Ringer##4##1##(1995-11#1)(2008-10#1)(2008-12#2)
Ringer's lactate instillation##3##3##(1995-12#3)
Ringer's lactate##5##2##(1995-12#5)
Ringer's solution##5##2##(1990-7#1)(1992-1#1)(1997-1#1)(2008-10#1)(2008-5#1)
Ringer's##11##1##(1990-7#2)(1992-1#1)(1995-12#5)(1997-1#1)(2008-10#1)(2008-5#1)
Ringo##2##1##(1992-11#2)
Ringspot##2##1##(2008-10#2)
Rio Frio##3##2##(2008-5#3)
Rio Grande Valley##5##3##(2008-10#5)
Rio Grande do Sul##6##4##(1993-6#3)(2008-5#1)(2009-7#1)(2013-7#1)
Rio Grande##11##2##(1993-6#3)(2008-10#5)(2008-5#1)(2009-7#1)(2013-7#1)
Rio Negro##3##2##(2008-10#3)
Rio de Janeiro##18##3##(1991-6#5)(2008-10#1)(2008-6#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Rio de##19##2##(1991-6#6)(2008-10#1)(2008-6#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Rio##46##1##(1991-6#7)(1992-5#1)(1993-6#3)(2008-10#12)(2008-5#4)(2008-6#4)(2008-9#3)(2009-10#1)(2009-7#2)(2011-2#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#1)
Rioja##2##1##(2008-10#2)
Ripley's K-function##2##2##(2008-10#1)(2008-9#1)
Ripley's##3##1##(2008-10#2)(2008-9#1)
Rippey##7##1##(2008-3#7)
Rise##4##1##(2008-2#1)(2012-2#2)(2013-1#1)
Risedronate##3##1##(2008-5#3)
Rising##6##1##(1994-12#1)(1997-2#1)(1997-6#1)(2008-11#1)(2009-5#1)(2013-1#1)
Risk Analysis##3##2##(2008-10#2)(2008-9#1)
Risk Assessment##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
Risk Factor##8##2##(1991-8#1)(1992-9#1)(2008-12#2)(2009-5#1)(2011-1#1)(2011-2#2)
Risk Factors for##4##3##(2008-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
Risk Factors in##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
Risk Factors##8##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Risk Management Status of Waste Anesthetic Gases Using ECRI Institute Standards##2##11##(2013-1#2)
Risk Management##7##2##(1992-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2012-2#1)(2013-1#2)
Risk adjustment##3##2##(1994-3#1)(1995-2#1)(1997-1#1)
Risk analysis##2##2##(2012-2#2)
Risk and##3##2##(1990-8#1)(2007-12#1)(2010-5#1)
Risk assessment models for##2##4##(2008-10#2)
Risk assessment##6##2##(1993-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)
Risk factors associated with##3##4##(2010-10#1)(2011-2#1)(2013-1#1)
Risk factors for hypoxemia were##2##5##(2012-2#2)
Risk factors for spinal osteoporosis as compared with femoral osteoporosis in urban Iranian women##2##14##(2013-1#2)
Risk factors for the##2##4##(2008-1#1)(2010-9#1)
Risk factors for##24##3##(1990-6#1)(1991-12#1)(1992-10#1)(1992-12#1)(1996-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
Risk factors of##2##3##(2008-3#1)(2008-7#1)
Risk factors##37##2##(1990-6#1)(1991-12#1)(1992-10#1)(1992-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-2#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
Risk for##2##2##(2010-12#1)(2013-1#1)
Risk in Young##2##3##(2008-7#1)(2013-1#1)
Risk in##6##2##(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#2)(2013-8#1)
Risk management and medical##2##4##(1993-12#1)(1995-2#1)
Risk management and##6##3##(1991-3#1)(1992-2#2)(1993-12#1)(1995-2#1)(1996-2#1)
Risk management in##2##3##(1991-12#1)(1992-1#1)
Risk management##14##2##(1991-12#2)(1991-3#1)(1992-1#1)(1992-2#3)(1993-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)
Risk managers##2##2##(1993-1#1)(1995-1#1)
Risk of colorectal cancer following rectosigmoid adenomas##2##7##(1993-12#2)
Risk of colorectal cancer##3##4##(1993-12#2)(2012-2#1)
Risk of severe postpartum hemorrhage in low-risk childbearing women in new zealand##2##12##(2013-1#2)
Risk of##28##2##(1991-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1996-11#2)(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Risk prediction##3##2##(1991-12#1)(2008-7#2)
Risk stratification and##2##3##(2008-3#1)(2010-9#1)
Risk stratification##4##2##(2008-3#2)(2008-8#1)(2010-9#1)
Risk##181##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#5)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#4)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#20)(2013-7#1)(2013-8#9)
Risk&quot##4##1##(2008-1#4)
Risks and##2##2##(2008-7#2)
Risks of##3##2##(2007-3#1)(2011-2#1)(2012-2#1)
Risks##7##1##(2007-3#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
Risky##2##1##(2008-11#1)(2012-12#1)
Rissa##2##1##(1991-6#1)(2008-8#1)
Rita##2##1##(2010-8#1)(2012-3#1)
Rite-Aid##2##1##(1995-6#2)
Rituximab##2##1##(2007-10#1)(2011-2#1)
Ritz-Carlton##5##1##(1994-2#2)(1994-3#3)
River Analyser (RIANA)##2##3##(2008-10#2)
River Delta##4##2##(2008-10#3)(2008-11#1)
River Sediment##2##2##(2008-10#2)
River Valley##2##2##(2008-10#1)(2008-9#1)
River and##4##2##(2008-10#2)(2008-9#1)(2013-7#1)
River at##2##2##(1992-5#1)(2008-10#1)
River basin##3##2##(1993-6#1)(2008-12#2)
River in##2##2##(2008-10#1)(2011-2#1)
River water##2##2##(2008-10#2)
River##67##1##(1992-1#1)(1992-5#1)(1993-6#1)(1995-2#1)(1997-4#5)(2007-12#2)(2007-5#3)(2008-10#20)(2008-11#3)(2008-12#3)(2008-5#1)(2008-8#2)(2008-9#4)(2010-8#9)(2011-2#2)(2013-1#3)(2013-7#6)
River]##2##1##(2012-3#2)
Rivers in##2##2##(2008-10#1)(2010-8#1)
Riverside Methodist Hospitals in Columbus##2##5##(1995-2#1)(1996-3#1)
Riverside Methodist Hospitals##3##3##(1995-2#2)(1996-3#1)
Riverside##6##1##(1995-2#3)(1996-3#2)(2008-10#1)
Riverside's##2##1##(1995-2#1)(1996-3#1)
Rivulus marmoratus##2##2##(2008-5#2)
Rivulus##4##1##(2008-5#2)(2008-8#2)
Riyadh and##3##2##(2008-1#1)(2013-1#2)
Riyadh##15##1##(2007-2#1)(2007-7#1)(2008-1#9)(2013-1#4)
Rizaben##3##1##(2008-5#3)
Rlm1##3##1##(2008-10#3)
Rlm3##2##1##(2008-10#2)
Rlm4##2##1##(2008-10#2)
Rlm7##2##1##(2008-10#2)
Rlm9##2##1##(2008-10#2)
RnMYRV-3##3##1##(2008-10#3)
Rna1p##5##1##(1995-2#5)
Ro 20-1724##3##2##(1994-6#3)
Ro 40-8757##4##2##(1993-9#4)
Ro 5-4864##2##2##(1995-12#2)
Ro##12##1##(1991-12#2)(1993-9#4)(1994-2#1)(1994-6#3)(1995-12#2)
Ro-1539##2##1##(2008-11#2)
Ro15-4513##2##1##(1995-11#2)
RoDH##6##1##(1995-5#6)
Road Map##4##2##(2011-1#4)
Road##8##1##(2008-10#1)(2009-10#1)(2009-7#1)(2011-1#4)(2013-8#1)
Robert A##2##2##(1995-6#1)(2008-4#1)
Robert Dyer Lyons##2##3##(2009-7#2)
Robert Henie (1850-1919)##2##3##(1991-6#2)
Robert K##2##2##(1995-6#1)(1996-5#1)
Robert M##2##2##(1993-3#2)
Robert Oppenheimer##2##2##(2008-12#2)
Robert Wood Johnson Foundation's (RWJF's)##2##5##(2013-1#2)
Robert Wood Johnson Foundation's##3##4##(1996-12#1)(2013-1#2)
Robert Wood Johnson##5##3##(1993-2#1)(1996-12#1)(1996-2#1)(2013-1#2)
Robert##46##1##(1990-8#1)(1991-6#2)(1991-8#1)(1993-2#2)(1993-3#2)(1995-12#3)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-7#2)(2010-10#1)(2011-2#1)(2013-1#2)
Robertson's Mutator line##2##3##(2012-3#2)
Robertson's Mutator##3##2##(2012-3#3)
Robertsonian##4##1##(2008-12#1)(2010-3#3)
Robertus##2##1##(1992-3#2)
Robin##2##1##(2008-12#1)(2010-10#1)
Robinson##9##1##(1995-6#1)(1996-5#4)(2008-10#4)
Robles##2##1##(2010-1#2)
Robo1 expression##2##2##(2011-2#2)
Robo1 in##2##2##(2011-2#2)
Robo1##10##1##(2011-2#10)
Robot##4##1##(1992-11#1)(1996-1#1)(2007-8#1)(2009-12#1)
Robotic##8##1##(2007-8#1)(2008-10#2)(2008-11#2)(2010-7#1)(2011-2#1)(2013-8#1)
Robotics##4##1##(2008-10#2)(2009-10#1)(2013-1#1)
Robots##4##1##(2011-1#1)(2012-1#2)(2012-2#1)
Robust and##2##2##(2008-10#1)(2008-3#1)
Robust design##2##2##(1993-3#2)
Robust##20##1##(1993-3#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Robustness of##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
Robustness##6##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
Roc##2##1##(2009-8#2)
Rocatec##2##1##(2009-8#2)
Rocc##3##1##(2008-1#3)
Roche expects##2##2##(2008-5#2)
Roche##15##1##(1990-2#1)(1990-8#1)(2008-5#13)
Rochester##12##1##(1992-12#2)(1993-2#1)(1995-12#1)(1995-3#1)(1996-2#5)(2008-3#1)(2009-7#1)
Rock##3##1##(1996-4#1)(2008-9#2)
Rockefeller##5##1##(1995-1#3)(1997-3#1)(2013-8#1)
Rockville##3##1##(1993-1#1)(1996-1#1)(2008-5#1)
Rockwool##3##1##(2008-10#3)
Rocky Mountains##3##2##(2008-10#2)(2013-1#1)
Rocky##4##1##(2008-10#2)(2008-9#1)(2013-1#1)
Rod##3##1##(1994-12#1)(2008-2#1)(2012-3#1)
Rodel appliqués were##3##3##(2008-3#3)
Rodel appliqués##4##2##(2008-3#4)
Rodel##6##1##(2008-3#6)
Rodent sensory##2##2##(2008-4#2)
Rodent##4##1##(2008-11#1)(2008-4#2)(2012-3#1)
Rodents##3##1##(1992-5#1)(2012-12#1)(2013-1#1)
Rodolfo##2##1##(2010-1#1)(2012-2#1)
Rodriguez##6##1##(1993-9#3)(2008-2#3)
Rogaland Central Hospital##2##3##(1991-11#1)(1996-3#1)
Roger##3##1##(1995-12#1)(2008-10#1)(2008-9#1)
Rogers##2##1##(1993-12#1)(2008-11#1)
Rojas##2##1##(2008-5#2)
RolC-specific antibodies##2##2##(1991-7#2)
Roland##2##1##(2010-1#1)(2012-12#1)
Role Play##2##2##(2009-11#2)
Role for##2##2##(2008-10#1)(2011-2#1)
Role in Decision-Making##2##3##(2009-3#1)(2013-1#1)
Role in the##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
Role in##10##2##(1991-11#1)(2008-10#4)(2009-11#1)(2009-3#1)(2011-2#2)(2013-1#1)
Role of calcium##3##3##(2008-4#1)(2008-8#1)(2010-5#1)
Role of estrogen##2##3##(2007-10#1)(2013-1#1)
Role of fine needle aspiration cytology in##2##7##(2008-7#1)(2013-8#1)
Role of iron##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
Role of prophylactic##2##3##(2008-7#1)(2012-12#1)
Role of the visual input in recovery of function following unilateral vestibular lesion in the goldfish##2##16##(1991-2#2)
Role of the##29##3##(1990-5#1)(1990-8#1)(1991-2#2)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2011-2#1)(2013-1#2)
Role of##191##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#1)(1992-12#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-5#3)(1993-8#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#6)(2009-5#2)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#2)
Role##209##1##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1992-12#3)(1992-2#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-5#3)(1993-8#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#6)(2009-11#3)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#16)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
Roles for##3##2##(2008-4#1)(2009-9#1)(2012-12#1)
Roles of##12##2##(1994-8#1)(1997-7#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
Roles##18##1##(1994-8#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
Roll##2##1##(2007-2#1)(2012-12#1)
Rollback analysis##2##2##(2012-3#2)
Rolling##2##1##(2007-2#1)(2010-8#1)
Roma##3##1##(2008-10#1)(2008-9#1)(2011-3#1)
Romagna##4##1##(1991-12#1)(1994-12#1)(2012-7#2)
Roman age##5##2##(2008-10#5)
Roman hens##3##2##(2012-2#3)
Roman wall paintings##2##3##(2008-10#2)
Roman wall##3##2##(2008-10#3)
Roman##26##1##(1994-2#4)(2007-7#1)(2008-10#16)(2010-1#2)(2012-2#3)
Romania##13##1##(1991-6#1)(2008-1#1)(2008-10#6)(2010-10#1)(2010-4#3)(2013-8#1)
Romania]##2##1##(2010-4#1)(2013-7#1)
Romanian children##2##2##(1991-6#1)(2008-11#1)
Romanian##13##1##(1990-5#1)(1991-6#1)(1992-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2010-4#1)
Romantic##3##1##(2008-9#1)(2009-9#2)
Rome III criteria##2##3##(2013-1#2)
Rome##14##1##(1990-8#4)(1992-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-7#1)(2013-1#4)
Ronald##5##1##(1990-3#1)(1991-3#1)(1993-1#1)(1993-3#1)(2008-5#1)
Ronchi grating##2##2##(2008-2#1)(2008-3#1)
Ronchi test##9##2##(2008-2#2)(2008-3#7)
Ronchi tester##2##2##(2008-3#2)
Ronchi##17##1##(2007-12#1)(2008-2#4)(2008-3#12)
Rondonia##2##1##(1993-6#2)
Rondônia##3##1##(1991-12#2)(2008-6#1)
Rooks##2##1##(2008-9#1)(2012-2#1)
Room temperature phosphorescence##2##3##(2008-10#2)
Room temperature##4##2##(2008-10#2)(2008-12#1)(2009-11#1)
Room##11##1##(1994-8#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-1#1)
Room-Temperature##2##1##(2008-2#1)(2008-3#1)
Room-temperature operation of a##2##4##(2007-12#1)(2008-2#1)
Room-temperature phosphorescence##2##2##(2008-10#2)
Room-temperature##8##1##(1991-5#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-2#2)
Root Extract##2##2##(2011-1#1)(2012-2#1)
Root Infection##2##2##(2008-10#2)
Root Rot##6##2##(2008-10#6)
Root and Stem##2##3##(2008-10#2)
Root and shoot##2##3##(2008-10#1)(2008-12#1)
Root and##9##2##(2008-10#7)(2008-12#2)
Root colonization##2##2##(2008-10#2)
Root infection##2##2##(2008-10#2)
Root length density##2##3##(2008-10#2)
Root mucilage is##2##3##(2009-8#2)
Root mucilage##3##2##(2009-8#3)
Root of##2##2##(2008-10#2)
Root##53##1##(1994-12#1)(2007-12#1)(2008-10#36)(2008-12#2)(2008-5#1)(2008-9#1)(2009-8#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Root-Knot Nematode##5##2##(2008-10#5)
Root-Knot Nematodes##2##2##(2008-10#2)
Root-Knot##9##1##(2008-10#9)
Roots by##3##2##(2008-10#3)
Roots in##3##2##(2008-10#2)(2010-5#1)
Roots of##5##2##(2008-10#4)(2008-12#1)
Roots##17##1##(2008-10#13)(2008-12#1)(2010-3#1)(2010-5#1)(2012-1#1)
Rootstock##2##1##(2008-10#2)
Roper-Logan-Tierney##2##1##(2008-11#2)
Ropivacaine##2##1##(2012-3#2)
Ror##2##1##(2008-10#2)
Roraima##3##1##(1991-12#3)
Rosa DeLauro (D-CT)##2##3##(1995-6#1)(1996-5#1)
Rosa damascena##2##2##(2008-5#2)
Rosa##6##1##(1995-6#1)(1996-5#1)(2008-10#1)(2008-5#3)
Rosaceae##2##1##(2009-8#1)(2013-7#1)
Rosai-Dorfman disease##3##2##(2012-12#3)
Rosascos##4##1##(1996-5#4)
Rose Bengal##2##2##(2008-5#1)(2011-2#1)
Rose##6##1##(1994-12#1)(2008-10#2)(2008-5#2)(2011-2#1)
Rosellinia necatrix##6##2##(2008-10#6)
Rosenberg##2##1##(1991-12#1)(2013-1#1)
Rosenthal##2##1##(1996-9#1)(1997-6#1)
Ross operation##3##2##(2007-8#3)
Ross##10##1##(1990-10#2)(2007-8#4)(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#1)
Rosuvastatin##2##1##(2011-1#2)
Rot Caused by##3##3##(2008-10#3)
Rot Fungus##2##2##(2008-10#2)
Rot Pathogen##2##2##(2008-10#2)
Rot in##2##2##(2008-10#2)
Rot of##5##2##(2008-10#5)
Rot##24##1##(2008-10#24)
Rotary##5##1##(2007-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-2#1)
Rotating##7##1##(1996-7#1)(2008-10#3)(2008-3#1)(2008-5#2)
Rotation in##3##2##(1997-7#1)(2007-8#1)(2008-2#1)
Rotation##7##1##(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)
Rotation-invariant##3##1##(2008-2#1)(2008-3#1)(2008-6#1)
Rotational control##2##2##(2007-11#1)(2013-1#1)
Rotational##7##1##(1993-11#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
Rotavirus##6##1##(2008-12#1)(2008-5#1)(2011-2#3)(2013-8#1)
Rotaviruses##4##1##(2008-12#3)(2009-5#1)
Roth##2##1##(2012-2#1)(2013-8#1)
Rothmund-Thomson##2##1##(2010-3#1)(2011-2#1)
Rotorod Sampler##2##2##(2008-5#2)
Rotorod##4##1##(2008-5#4)
Rotterdam##4##1##(1991-3#1)(1992-5#3)
Rottlerin##2##1##(1994-2#2)
Rotylenchulus reniformis##4##2##(2008-10#4)
Rouen##2##1##(1990-3#1)(2008-10#1)
Rough surfaces##2##2##(2008-3#1)(2012-1#1)
Rough##7##1##(1995-2#1)(2008-10#3)(2008-3#2)(2012-1#1)
Roughly##3##1##(2008-10#1)(2008-7#1)(2010-9#1)
Roughness##4##1##(2008-3#3)(2013-1#1)
Round##5##1##(1990-8#1)(1993-1#1)(2009-5#1)(2010-7#1)(2012-12#1)
Roundtable##8##1##(1990-3#1)(2008-11#1)(2008-5#1)(2013-1#5)
Rous associated##2##2##(1993-6#1)(2007-6#1)
Rous sarcoma virus long terminal repeat##3##6##(1990-12#1)(1995-6#2)
Rous sarcoma virus##5##3##(1990-12#1)(1995-6#2)(1997-8#1)(2008-11#1)
Rous##8##1##(1990-12#1)(1993-6#1)(1995-6#2)(1997-8#1)(2007-6#1)(2008-11#1)(2012-12#1)
Rousettus##2##1##(2007-5#2)
Route to##6##2##(1996-5#5)(1997-7#1)
Route##7##1##(1996-5#5)(1997-7#1)(2010-6#1)
Routine screening for##2##3##(1991-8#1)(2009-5#1)
Routine screening##3##2##(1991-8#2)(2009-5#1)
Routine visual verification of gloves by trained personnel turns out to be a very reliable technique##2##16##(2012-2#2)
Routine##26##1##(1991-11#1)(1991-12#1)(1991-8#2)(1996-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
Routinely##4##1##(1997-4#1)(2007-8#1)(2008-10#1)(2010-11#1)
Routines##2##1##(2010-9#1)(2011-2#1)
Roux's##2##1##(1991-6#2)
Roux-en-Y gastric bypass##5##3##(2010-8#2)(2013-1#3)
Roux-en-Y##6##1##(2010-8#3)(2013-1#3)
Rowe##5##1##(1992-12#1)(1994-12#2)(1994-2#1)(2007-8#1)
Rowland mounting##2##2##(2008-3#2)
Rowland##5##1##(1994-12#1)(2008-3#4)
Roxb##2##1##(2008-10#1)(2008-5#1)
Roy##3##1##(2008-11#1)(2008-4#1)(2008-5#1)
Royal Australian College of Medical Administrators##2##6##(1992-1#2)
Royal College of##9##3##(1990-3#1)(1990-9#1)(1994-12#2)(1996-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
Royal College##10##2##(1990-3#1)(1990-9#1)(1994-12#2)(1996-8#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
Royal Infirmary##3##2##(2007-2#1)(2008-9#1)(2010-12#1)
Royal Prince Alfred Hospital##2##4##(2008-7#2)
Royal Society##2##2##(2008-5#2)
Royal##38##1##(1990-2#1)(1990-3#1)(1990-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#2)(1996-11#1)(1996-8#2)(1997-8#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)
Rp GyrA##2##2##(1994-12#2)
Rp gyrA##2##2##(1994-12#2)
Rp##9##1##(1990-12#1)(1994-12#6)(2008-10#1)(2009-2#1)
Rp-cAMPS (500 microM) inhibited##2##4##(1990-12#2)
Rp-cAMPS##9##1##(1990-12#3)(1993-6#4)(1996-5#1)(1997-6#1)
RpII LS##4##2##(1997-7#4)
Rpc1 and##4##2##(2008-10#4)
Rpc1##11##1##(2008-10#11)
Rph12##4##1##(2008-10#4)
Rph3##6##1##(2008-10#6)
Rph5 and##2##2##(2008-10#2)
Rph5##3##1##(2008-10#3)
Rph6##5##1##(2008-10#5)
Rph7##3##1##(2008-10#3)
Rph9 and Rph12##2##3##(2008-10#2)
Rph9 and##3##2##(2008-10#3)
Rph9##7##1##(2008-10#7)
RpoD##2##1##(1994-12#2)
RpoN##4##1##(1993-12#4)
Rps##2##1##(1993-11#1)(2008-8#1)
Rps2 and##2##2##(2008-10#2)
Rps2 in L76-1988##3##3##(2008-10#3)
Rps2##6##1##(2008-10#6)
Rpt1##2##1##(2008-10#2)
Rr##2##1##(2008-10#2)
Rs##7##1##(1992-3#1)(1996-6#1)(2010-5#4)(2011-1#1)
Rs=1##2##1##(2008-10#2)
RsGshT##3##1##(1995-2#3)
Rsa I##3##2##(2008-8#3)
RsaI##8##1##(1995-12#1)(2008-10#6)(2010-4#1)
RsbR##2##1##(2009-8#2)
Rsp genes on##2##3##(2008-10#2)
Rsp genes##6##2##(2008-10#6)
Rsp##8##1##(2008-10#8)
Rsp1##4##1##(2008-10#4)
Rsp2 and Rsp3##2##3##(2008-10#2)
Rsp2 at a##2##3##(2008-10#2)
Rsp2 in the Foster/CIho 4780##2##5##(2008-10#2)
Rsp2 in##4##2##(2008-10#4)
Rsp2##12##1##(2008-10#12)
Rsp3 in##2##2##(2008-10#2)
Rsp3##9##1##(2008-10#9)
Rsv1##2##1##(2008-10#2)
Rsv3##2##1##(2008-10#2)
Rsv4##3##1##(2008-10#3)
Rtx-500##2##1##(2008-10#2)
Ru (III)##4##2##(2008-10#4)
Ru##19##1##(2008-10#19)
Ru(II)##4##1##(2008-10#3)(2009-9#1)
Ru(III)##12##1##(1997-7#1)(2008-10#11)
Ru(bpy)(3)(2+) at the##2##3##(2008-10#2)
Ru(bpy)(3)(2+) modified electrode##2##3##(2008-10#2)
Ru(bpy)(3)(2+)##25##1##(2008-10#25)
Ru(bpy)(3)(3+)##6##1##(2008-10#6)
Ru-Rh##2##1##(2008-10#2)
Ru-bipy##3##1##(2008-12#3)
RuBisCO of Acinetobacter sp##2##4##(1997-6#2)
RuBisCO##3##1##(1997-6#3)
RuO(2)##2##1##(2010-4#2)
Rubella##8##1##(2007-2#3)(2007-7#4)(2008-11#1)
Rubia peregrina L##2##3##(2012-2#2)
Rubia##7##1##(2012-2#7)
Rubin##3##1##(1997-8#1)(2008-7#1)(2008-9#1)
Rubisco##6##1##(1993-11#3)(2008-8#2)(2012-6#1)
Ruby and##2##2##(1994-1#1)(2008-4#1)
Ruby##3##1##(1994-1#1)(2008-4#2)
Rudá##2##1##(2008-10#2)
Rufous-breasted Hermit##4##2##(2008-9#4)
Ruggie (1990##2##2##(1995-3#2)
Rule##7##1##(1996-12#1)(2008-11#3)(2009-4#2)(2011-2#1)
Rules of##3##2##(2008-10#2)(2008-8#1)
Rules##6##1##(2007-11#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-6#1)
Rumex##2##1##(2008-10#1)(2013-1#1)
Rumination has been##2##3##(2008-8#1)(2009-11#1)
Rumination##5##1##(2008-8#3)(2009-11#1)(2010-10#1)
Runaway Youths##2##2##(2008-6#1)(2008-9#1)
Runaway##5##1##(2008-6#1)(2008-9#3)(2013-1#1)
Running##5##1##(1992-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
Rupture of the##6##3##(1991-8#1)(1993-5#1)(1997-3#1)(2008-7#1)(2009-9#1)(2013-1#1)
Rupture of##8##2##(1991-8#1)(1993-5#1)(1997-3#1)(2008-7#2)(2009-9#1)(2010-7#1)(2013-1#1)
Rupture##13##1##(1991-8#1)(1993-5#1)(1997-3#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
Ruptured Cerebral Aneurysms##2##3##(1995-11#1)(1997-3#1)
Ruptured##13##1##(1995-10#1)(1995-11#1)(1997-3#2)(2008-7#1)(2008-8#5)(2011-2#1)(2013-1#1)(2013-8#1)
Rural Health Leaders Pipeline##2##4##(2008-12#2)
Rural Health##7##2##(1996-2#1)(1996-3#1)(2008-12#5)
Rural Medical##2##2##(1994-3#1)(2008-12#1)
Rural and##3##2##(1991-12#1)(1994-2#1)(2012-1#1)
Rural health care##2##3##(1991-1#1)(1993-2#1)
Rural health##4##2##(1991-1#1)(1993-12#1)(1993-2#1)(2008-12#1)
Rural women##2##2##(2013-1#2)
Rural##48##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-2#3)(1994-3#1)(1995-2#1)(1996-2#2)(1996-3#5)(2008-12#9)(2008-4#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#6)
Rush Prudential##2##2##(1996-3#2)
Rush##5##1##(1991-12#1)(1996-3#2)(2007-3#1)(2008-1#1)
Rusia##2##1##(2013-7#2)
Russell##4##1##(1995-6#1)(2007-3#1)(2008-10#1)(2013-1#1)
Russia and the##2##3##(1997-1#2)
Russia and##7##2##(1997-1#3)(2010-12#1)(2013-1#3)
Russia##37##1##(1992-5#1)(1993-3#1)(1994-12#2)(1996-3#1)(1997-1#11)(1997-6#4)(2008-11#1)(2008-12#4)(2008-3#1)(2010-12#5)(2011-2#1)(2012-3#1)(2013-1#4)
Russian health##2##2##(1997-1#2)
Russian wheat aphid##4##3##(2008-10#1)(2008-9#3)
Russian##26##1##(1992-2#1)(1995-3#1)(1997-1#3)(1997-6#3)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
Rust Fungi##3##2##(2008-10#3)
Rust Fungus Puccinia##2##3##(2008-10#2)
Rust Fungus##3##2##(2008-10#3)
Rust Resistance in##3##3##(2008-10#3)
Rust Resistance##4##2##(2008-10#4)
Rust in##3##2##(2008-10#3)
Rust on##2##2##(2008-10#2)
Rust ratings were##2##3##(2008-10#2)
Rust##29##1##(2008-10#29)
Rusted##2##1##(2008-10#2)
Ruthenium##6##1##(1996-2#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-7#1)
Rutherford backscattering spectrometry##2##3##(2007-12#1)(2008-2#1)
Rutherford##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Rutilus rutilus##3##2##(2010-8#3)
Rutilus##5##1##(2008-10#1)(2010-8#4)
RuvA and RuvB##3##3##(1995-3#3)
RuvA##4##1##(1995-3#4)
RuvAB##5##1##(1995-3#5)
RuvB protein##2##2##(1995-3#2)
RuvB##6##1##(1995-3#6)
Rwanda##4##1##(1993-3#1)(1994-9#2)(2011-1#1)
Rx for##2##2##(1993-12#1)(2009-1#1)
Rx##5##1##(1993-12#1)(1995-1#1)(2008-10#2)(2009-1#1)
Rx1##3##1##(2008-10#3)
Rx2##2##1##(2008-10#2)
Rx3##4##1##(2008-10#4)
RxNorm##5##1##(2010-8#5)
Ryan White CARE Act##3##4##(1995-12#1)(1996-5#1)(2008-8#1)
Ryan White##5##2##(1995-12#1)(1995-6#2)(1996-5#1)(2008-8#1)
Ryan##9##1##(1994-1#3)(1995-12#1)(1995-6#2)(1996-5#1)(2008-10#1)(2008-8#1)
Ryanodine##2##1##(1990-2#1)(1994-8#1)
Rye##3##1##(2008-10#3)
Rytov approximation and##2##3##(2008-2#1)(2008-3#1)
Rytov approximation##4##2##(2008-2#3)(2008-3#1)
Rytov##5##1##(2008-2#4)(2008-3#1)
Ryukyus exhibited##2##2##(2010-3#2)
Ryukyus##4##1##(2008-6#1)(2010-3#3)
Rz##3##1##(2008-11#2)(2008-5#1)
Rz1 cultivars##2##2##(2008-10#2)
Rz1##3##1##(2008-10#3)
Ría de Arousa estuary##3##4##(2008-10#1)(2010-5#2)
Ría##4##1##(2008-10#1)(2010-5#3)
Río de la Plata##5##4##(2010-8#5)
Río##6##1##(2009-7#1)(2010-8#5)
S (ARS)##5##2##(2008-10#4)(2013-7#1)
S (CAS)##3##2##(2008-10#2)(2013-1#1)
S (HbS)##2##2##(2009-4#1)(2012-12#1)
S 16474##6##2##(1995-12#6)
S = 1##2##3##(2012-12#2)
S = 1/2##2##3##(2007-11#1)(2008-7#1)
S = 2##3##3##(1994-3#1)(1995-6#1)(2012-12#1)
S =##14##2##(1991-5#1)(1994-3#2)(1995-6#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-5#2)(2008-7#1)(2012-12#3)
S RNA was determined to be##2##6##(2008-10#2)
S RNA##11##2##(2008-10#11)
S RNAs##3##2##(2008-10#3)
S and J'##3##3##(2008-8#3)
S and M##2##3##(1997-4#1)(2008-5#1)
S and g##2##3##(2008-2#2)
S and the##2##3##(1990-7#1)(2008-3#1)
S and##38##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-8#3)(1994-11#3)(1994-3#1)(1997-4#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#4)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
S aureus##9##2##(1996-8#1)(2006-5#1)(2007-12#5)(2008-11#1)(2012-2#1)
S beta-globin gene##2##3##(2012-12#2)
S by##3##2##(2008-10#2)(2008-3#1)
S cell cycle##2##3##(2008-11#1)(2011-2#1)
S cm(-1) in the##2##4##(2009-11#2)
S cm(-1)##3##2##(2009-11#2)(2010-12#1)
S column##4##2##(1995-3#3)(2013-1#1)
S enteritidis was##2##3##(1995-9#2)
S enteritidis##6##2##(1995-9#6)
S external fixator##3##3##(2007-8#3)
S from##4##2##(1990-2#1)(1991-9#1)(2008-10#1)(2013-1#1)
S function##3##2##(2008-3#3)
S gene##2##2##(1997-3#1)(2008-8#1)
S genes##2##2##(1997-3#2)
S genotype##2##2##(2008-10#2)
S had##2##2##(1992-11#1)(1995-11#1)
S in the presence of##2##5##(2008-10#2)
S in the##4##3##(2008-10#3)(2013-1#1)
S in##11##2##(1992-6#1)(1993-8#1)(2008-10#5)(2008-3#1)(2013-1#3)
S incidence##2##2##(2008-10#2)
S marcescens##3##2##(2009-5#3)
S or##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
S phase and##3##3##(1993-8#1)(2008-11#2)
S phase at##2##3##(1992-10#1)(1993-6#1)
S phase cells##2##3##(2008-11#2)
S phase##28##2##(1991-9#1)(1992-10#2)(1992-8#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1997-6#1)(2008-11#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)
S protein##2##2##(2008-10#1)(2008-8#1)
S radicals##2##2##(1995-5#2)
S rats##4##2##(1994-11#3)(2008-4#1)
S region##2##2##(1997-8#1)(2008-12#1)
S scabiei##3##2##(1990-3#3)
S staining##4##2##(2008-11#2)(2008-4#2)
S strain incidence at##2##4##(2008-10#2)
S strain incidence##8##3##(2008-10#8)
S strain isolates##8##3##(2008-10#8)
S strain##21##2##(2008-10#21)
S system##2##2##(1994-9#1)(2008-10#1)
S was##6##2##(1992-11#1)(1993-8#1)(1995-8#1)(1996-3#1)(2008-10#1)(2011-2#1)
S##1844##1##(1990-10#2)(1990-11#9)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#8)(1990-6#5)(1990-7#7)(1990-8#6)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#4)(1991-5#11)(1991-6#3)(1991-8#5)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#9)(1992-12#7)(1992-2#3)(1992-3#9)(1992-4#1)(1992-6#6)(1992-8#7)(1992-9#5)(1993-1#4)(1993-11#7)(1993-12#8)(1993-2#9)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#24)(1993-9#2)(1994-1#7)(1994-11#8)(1994-12#12)(1994-2#3)(1994-3#8)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#5)(1995-12#19)(1995-2#9)(1995-3#11)(1995-5#8)(1995-6#11)(1995-8#6)(1995-9#6)(1996-1#4)(1996-11#2)(1996-12#19)(1996-2#12)(1996-3#21)(1996-4#1)(1996-5#8)(1996-6#14)(1996-8#4)(1997-1#14)(1997-2#7)(1997-3#19)(1997-4#4)(1997-5#8)(1997-6#6)(1997-7#11)(1997-8#6)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#5)(2007-12#10)(2007-3#1)(2007-5#6)(2007-6#3)(2007-7#9)(2007-8#11)(2008-1#7)(2008-10#745)(2008-11#35)(2008-12#23)(2008-2#20)(2008-3#14)(2008-4#12)(2008-5#46)(2008-6#8)(2008-7#22)(2008-8#45)(2008-9#28)(2009-11#3)(2009-12#5)(2009-2#8)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#7)(2009-7#9)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#27)(2010-9#1)(2011-1#13)(2011-2#35)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#19)(2012-2#22)(2012-3#34)(2012-7#1)(2013-1#34)(2013-7#3)(2013-8#25)
S&quot##2##1##(2008-1#1)(2013-8#1)
S(0)/X(0)##3##1##(2008-7#3)
S(1)##7##1##(2007-1#3)(2009-9#4)
S(2)()##3##1##(1997-7#3)
S(2)O(3)(2-) in##2##2##(2008-10#2)
S(2)O(3)(2-)##4##1##(2008-10#4)
S(2-)##7##1##(2008-10#7)
S(D)##2##1##(2008-10#1)(2009-11#1)
S(IV) induced##2##2##(2008-10#2)
S(IV)##4##1##(2008-10#4)
S(P))-8##2##1##(1996-2#2)
S(P))-chloro[1-[1-(dimethylamino)ethyl]-2-naphthalenyl-C##2##1##(1996-2#2)
S(T)R(V)##4##1##(2008-10#4)
S(T)S(V) isolates clustered together##2##4##(2008-10#2)
S(T)S(V) parent isolates##3##3##(2008-10#3)
S(T)S(V)##9##1##(2008-10#9)
S(c) for##2##2##(2008-3#2)
S(c)##3##1##(2008-3#3)
S(f)##2##1##(2008-11#2)
S(rs)##3##1##(2008-2#3)
S) among##2##2##(2008-10#2)
S) and##3##2##(1990-5#1)(1990-8#1)(1993-8#1)
S) was##2##2##(2008-10#1)(2008-8#1)
S)##29##1##(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#1)(1992-6#1)(1993-8#3)(1994-3#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2013-7#1)
S)2 +##2##2##(2008-8#2)
S-##3##1##(1994-9#2)(2008-10#1)
S-1 binding##2##2##(1992-4#1)(1995-2#1)
S-1##14##1##(1991-5#7)(1992-4#1)(1994-8#3)(1995-2#3)
S-1(A2)##8##1##(1992-4#8)
S-100 protein and##2##3##(1990-8#1)(1993-8#1)
S-100 protein were##2##3##(1991-6#1)(2011-2#1)
S-100 protein##8##2##(1990-8#1)(1991-6#1)(1993-8#1)(1994-8#1)(2006-12#1)(2008-4#1)(2011-2#2)
S-100##22##1##(1990-8#1)(1991-2#1)(1991-6#3)(1993-8#1)(1994-8#1)(1997-4#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
S-14##6##1##(1993-3#2)(1994-11#4)
S-150##2##1##(2008-8#2)
S-180##2##1##(2008-4#2)
S-2##3##1##(2008-10#3)
S-2288##2##1##(1995-6#2)
S-28 and S-14##2##3##(1994-11#2)
S-28##3##1##(1993-3#1)(1994-11#2)
S-7 x##4##2##(2008-10#4)
S-7##8##1##(2008-10#8)
S-D##4##1##(2008-11#3)(2008-2#1)
S-FAP##3##1##(2008-2#3)
S-Graft##3##1##(2008-10#3)
S-HIDPA)(2)]##2##1##(2008-10#2)
S-Hir53-64##2##1##(1990-7#2)
S-PAC##2##1##(2008-10#1)(2008-11#1)
S-ROM prosthesis##2##2##(2009-3#2)
S-System##2##1##(2008-7#2)
S-adenosyl-L-methionine##3##1##(1992-3#1)(1995-2#1)(2008-8#1)
S-adenosylhomocysteinase##4##1##(1990-10#4)
S-adenosylhomocysteine##5##1##(1993-6#1)(1994-8#2)(2008-3#1)(2011-2#1)
S-adenosylmethionine decarboxylase (AdoMetDC)##2##3##(1992-11#1)(1992-8#1)
S-adenosylmethionine decarboxylase##7##2##(1991-12#2)(1992-11#2)(1992-8#2)(2008-8#1)
S-adenosylmethionine synthetase##2##2##(1992-8#2)
S-adenosylmethionine##19##1##(1991-12#4)(1992-11#2)(1992-8#4)(1993-6#1)(1994-8#1)(1995-11#1)(2008-3#1)(2008-8#1)(2009-8#2)(2010-10#1)(2013-1#1)
S-alkylated##2##1##(1991-12#1)(1992-8#1)
S-captopril assay##2##2##(2008-10#2)
S-captopril##3##1##(2008-10#3)
S-matrix##4##1##(2008-3#1)(2013-8#3)
S-methyltransferase##2##1##(1994-8#2)
S-naproxen##6##1##(1994-3#6)
S-nitroso##4##1##(1995-5#4)
S-nitrosothiols are##2##2##(1991-9#1)(2012-2#1)
S-nitrosothiols##5##1##(1991-9#3)(2008-7#1)(2012-2#1)
S-nitrosylation##2##1##(1997-7#1)(2008-7#1)
S-phase fraction (SPF)##2##3##(1993-1#1)(2008-6#1)
S-phase fraction##7##2##(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-4#1)(2008-6#2)
S-phase progression##2##2##(1997-1#1)(2012-3#1)
S-phase##19##1##(1993-1#1)(1993-11#3)(1993-9#1)(1994-10#1)(1994-12#2)(1995-4#1)(1997-1#2)(2008-11#2)(2008-4#1)(2008-6#2)(2009-6#1)(2012-2#1)(2012-3#1)
S-prenylation of Cys12##2##3##(1991-12#2)
S-proteins##3##1##(1992-8#3)
S-pyridinium derivative##2##2##(2008-10#2)
S-shaped##7##1##(1997-4#1)(2008-10#4)(2008-11#1)(2010-2#1)
S-strain incidence##3##2##(2008-10#3)
S-strain##5##1##(2008-10#5)
S-strand##2##1##(2008-7#2)
S-transferase P##2##2##(1992-6#2)
S-transferase activity##3##2##(1995-6#1)(2008-11#1)(2008-8#1)
S-transferase##28##1##(1991-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#2)(1994-12#2)(1995-2#1)(1995-6#4)(1995-8#1)(1996-12#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2010-5#1)(2013-1#1)
S-type lectin##2##2##(1990-12#2)
S-type##7##1##(1990-12#4)(1993-5#1)(1995-8#2)
S/G2##2##1##(2008-11#1)(2010-2#1)
S/HMO##3##1##(1992-1#1)(1993-12#2)
S/N##8##1##(2008-10#8)
S/N)##3##1##(2008-10#2)(2012-1#1)
S/N=3##2##1##(2008-10#2)
S/N=3) for##2##2##(2008-10#2)
S/N=3) was##2##2##(2008-10#2)
S/N=3)##6##1##(2008-10#6)
S1 and##3##2##(1997-2#1)(1997-3#1)(2008-10#1)
S1 in##2##2##(1994-5#1)(1997-3#1)
S1 mapping##3##2##(1990-7#1)(1991-9#1)(1993-2#1)
S1 nuclease protection##5##3##(1991-11#1)(1992-3#1)(1993-3#1)(2008-4#2)
S1 nuclease##9##2##(1991-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-4#2)(2008-8#1)(2008-9#1)
S1 protein##3##2##(1997-3#2)(2008-5#1)
S1 stoichiometry in the decorated##2##5##(1992-3#2)
S1 stoichiometry##3##2##(1992-3#3)
S1##62##1##(1990-11#1)(1990-7#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#8)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#7)(1995-3#2)(1995-6#3)(1997-2#3)(1997-3#8)(1997-9#1)(2007-11#1)(2008-10#3)(2008-12#4)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#1)(2010-12#1)(2012-12#1)
S1'##2##1##(1992-8#1)(1995-3#1)
S1)##2##1##(1997-2#1)(2011-2#1)
S100 beta transgenic mice##2##4##(1993-12#2)
S100 beta##5##2##(1993-12#5)
S100 proteins CAPL and CACY##2##5##(1994-5#2)
S100 proteins in##2##3##(2013-8#2)
S100 proteins##4##2##(1994-5#2)(2013-8#2)
S100##18##1##(1991-2#1)(1992-2#1)(1992-6#2)(1993-12#5)(1994-5#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#3)
S100A4##4##1##(2011-2#1)(2013-1#3)
S100A8 and S100A9##2##3##(2013-8#2)
S100A8##6##1##(2013-8#6)
S100A9##4##1##(2013-8#4)
S100B##3##1##(2007-10#3)
S12 mutant##3##2##(2008-8#3)
S143A##2##1##(1994-5#1)(1994-6#1)
S180##4##1##(2008-9#4)
S19##2##1##(1993-11#2)
S1AcNPV4##2##1##(1997-4#2)
S1NPV polh promoter is##2##4##(1997-4#2)
S1NPV polh promoter##3##3##(1997-4#3)
S1NPV##6##1##(1997-4#6)
S2 and S3 states##2##4##(1996-4#2)
S2 and##6##2##(1995-6#2)(1996-4#2)(2013-1#2)
S2 cells##4##2##(2008-11#4)
S2##19##1##(1995-6#3)(1996-4#2)(1997-2#1)(1997-9#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-9#3)(2013-1#3)
S2- and S3-proteins were##2##4##(1992-8#2)
S2- and S3-proteins##4##3##(1992-8#4)
S20 strain##2##2##(2008-6#2)
S214E##3##1##(1992-3#3)
S214K has##2##2##(1992-3#2)
S214K##3##1##(1992-3#3)
S218 and S222##2##3##(1995-2#2)
S218##6##1##(1995-2#6)
S222 was##2##2##(1995-2#2)
S222##6##1##(1995-2#6)
S25##2##1##(1995-2#1)(2008-11#1)
S298 and Y300##2##3##(1995-2#2)
S298##3##1##(1995-2#3)
S299##2##1##(1995-2#2)
S2MtEGFP cell cultures##2##3##(2008-11#2)
S2MtEGFP##5##1##(2008-11#5)
S2SS1 protein##2##2##(2008-8#2)
S2SS1##3##1##(2008-8#3)
S3 and##2##2##(1993-8#2)
S3##7##1##(1992-3#1)(1993-8#2)(1996-4#2)(2008-7#1)(2010-3#1)
S3a##6##1##(2008-11#6)
S4##6##1##(1995-8#3)(1997-9#1)(2008-10#1)(2008-8#1)
S422##5##1##(1995-11#5)
S465##2##1##(2008-8#2)
S6 kinase##3##2##(1996-2#2)(2011-2#1)
S6##16##1##(1993-2#1)(1995-6#4)(1996-2#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#3)
S649##2##1##(2008-8#2)
S65T##2##1##(2008-11#1)(2009-6#1)
S6c##7##1##(1991-11#4)(1992-12#2)(1994-11#1)
S8##5##1##(2008-10#3)(2008-5#1)(2012-2#1)
S9 activation##3##2##(1992-8#1)(2008-9#2)
S9 from##2##2##(1996-12#2)
S9 mix##4##2##(1992-5#1)(1992-8#1)(1997-4#2)
S9##19##1##(1992-2#1)(1992-5#1)(1992-8#2)(1996-12#2)(1996-2#1)(1997-4#2)(2008-8#4)(2008-9#6)
S96##4##1##(2008-10#4)
S</ForeName>##2##1##(1996-11#1)(2013-8#1)
SA accumulation in##2##3##(2008-10#1)(2009-6#1)
SA accumulation##3##2##(2008-10#1)(2009-6#2)
SA and##2##2##(2008-10#1)(2013-1#1)
SA concentration##4##2##(2008-10#2)(2008-12#2)
SA content##2##2##(2008-10#2)
SA ethnocultural background##2##3##(2011-2#2)
SA in##3##2##(2008-10#3)
SA is##2##2##(2008-10#2)
SA levels##3##2##(2008-10#3)
SA production##2##2##(2008-10#2)
SA signaling##4##2##(2009-6#4)
SA to learning##3##3##(2011-1#3)
SA to##5##2##(2008-10#2)(2011-1#3)
SA treatment##4##2##(2008-10#3)(2011-10#1)
SA under##2##2##(2008-10#2)
SA were##2##2##(2008-10#1)(2011-2#1)
SA##101##1##(1993-11#1)(1993-6#5)(1995-11#2)(2008-10#56)(2008-12#6)(2008-2#1)(2008-5#2)(2008-8#1)(2009-6#6)(2009-8#3)(2011-1#3)(2011-10#3)(2011-2#10)(2013-1#2)
SA-1171##2##1##(2008-10#2)
SA-independent##2##1##(2008-10#2)
SA-mediated##2##1##(2008-10#1)(2009-8#1)
SAA levels##2##2##(2009-10#2)
SAA##8##1##(2008-10#1)(2009-10#7)
SAA1 (+/- Arg-1) sequence##2##4##(1991-12#2)
SAA1 gene##2##2##(1991-12#2)
SAA1##6##1##(1991-12#6)
SAB1 gene##2##2##(1997-8#2)
SAB1##4##1##(1997-8#4)
SABA##2##1##(2008-6#1)(2011-2#1)
SABP in##2##2##(1997-6#2)
SABP##5##1##(1997-6#5)
SACD##2##1##(2008-5#2)
SACI##3##1##(2008-11#3)
SAD patients##3##2##(1995-11#3)
SAD##6##1##(1995-11#4)(2008-6#1)(2012-3#1)
SAD-3##4##1##(2012-3#4)
SADIE##5##1##(2008-10#5)
SAE##2##1##(2010-3#1)(2013-8#1)
SAF##3##1##(2008-10#1)(2008-6#2)
SAF-1##3##1##(2009-5#3)
SAFA##3##1##(2013-1#3)
SAG##4##1##(2008-10#4)
SAGE analysis##2##2##(2008-1#2)
SAGE##8##1##(2008-1#5)(2008-2#3)
SAGF medium##2##2##(2008-10#2)
SAH and##2##2##(1995-5#1)(2009-7#1)
SAH from##3##2##(2007-10#1)(2012-3#2)
SAH in##3##2##(1995-5#1)(2009-7#1)(2012-3#1)
SAH is##3##2##(1995-11#1)(2007-10#2)
SAH was##2##2##(2008-7#2)
SAH were##2##2##(2007-10#1)(2008-7#1)
SAH##36##1##(1995-11#1)(1995-5#5)(2007-10#6)(2008-7#11)(2009-7#3)(2012-2#2)(2012-3#7)(2013-8#1)
SAH-hydrolase##3##1##(1994-8#3)
SAILS##4##1##(2008-3#4)
SALT##2##1##(1991-11#1)(2009-8#1)
SAM (r =##2##3##(1995-11#2)
SAM and##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
SAM is##2##2##(2008-10#2)
SAM modified gold electrode##2##4##(2008-10#2)
SAM prepared##2##2##(2008-10#2)
SAM was##3##2##(2008-10#3)
SAM##37##1##(1994-5#2)(1995-11#3)(2008-10#23)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-8#1)
SAM-NS##4##1##(2008-10#4)
SAM-P/2##7##1##(1991-12#7)
SAM-R/1##4##1##(1991-12#4)
SAM-modified##2##1##(2008-10#2)
SAMDC##2##1##(2008-8#2)
SAMDCl and##2##2##(2008-8#2)
SAMP##3##1##(2010-7#3)
SAMP1TA/Ngs##2##1##(1995-8#2)
SAMP8 and SAMR1##3##3##(2008-7#3)
SAMP8##4##1##(2008-7#4)
SAMPL analysis##4##2##(2008-5#4)
SAMPL##6##1##(2008-5#6)
SAMPLE##5##1##(2008-10#3)(2008-5#1)(2011-2#1)
SAMPLs were##2##2##(2008-5#2)
SAMPLs##4##1##(2008-5#4)
SAMR1##4##1##(2008-7#4)
SAMs and##3##2##(2008-10#3)
SAMs##13##1##(2008-10#13)
SANS##2##1##(2008-10#1)(2009-12#1)
SAP##11##1##(2008-5#6)(2013-1#3)(2013-8#2)
SAPC##3##1##(1997-2#3)
SAPHO syndrome##3##2##(2006-10#3)
SAPHO##5##1##(2006-10#5)
SAR and##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
SAR are##2##2##(1991-1#1)(2008-10#1)
SAR data##2##2##(2008-2#1)(2013-1#1)
SAR in##2##2##(2008-10#2)
SAR is##2##2##(1992-3#1)(2011-10#1)
SAR of##4##2##(1992-3#1)(2008-3#2)(2011-3#1)
SAR that##2##2##(1991-1#1)(2008-10#1)
SAR##37##1##(1991-1#4)(1992-3#4)(1995-6#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#4)(2009-11#1)(2010-3#1)(2011-10#2)(2011-3#1)(2013-1#2)
SAR-inducing##4##1##(2008-10#4)
SARA##2##1##(2012-12#2)
SARM 19##2##2##(2008-10#2)
SARM##3##1##(2008-10#3)
SARS survivors##2##2##(2010-2#2)
SARS##20##1##(2007-11#1)(2007-12#2)(2007-5#4)(2007-7#3)(2007-9#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-2#3)
SARS-CoV##2##1##(2009-7#1)(2013-8#1)
SARs##3##1##(1991-1#1)(1992-3#2)
SAS PROC MIXED##2##3##(2008-10#1)(2009-8#1)
SAS program##2##2##(1992-1#1)(2012-1#1)
SAS##8##1##(1992-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#3)(2012-1#1)
SAS8##2##1##(2008-10#2)
SAT##6##1##(2007-11#1)(2010-2#1)(2011-2#1)(2013-1#3)
SAT-1 activity in##2##3##(1991-2#2)
SAT-1 activity##4##2##(1991-2#4)
SAT-1##5##1##(1991-2#5)
SAU##2##1##(2010-12#2)
SAW##6##1##(2007-12#2)(2008-3#4)
SAW's##2##1##(2007-12#1)(2008-3#1)
SAX##2##1##(2008-10#2)
SAXS data##2##2##(2008-10#1)(2009-6#1)
SAXS##8##1##(2008-10#3)(2008-11#2)(2008-5#1)(2009-11#1)(2009-6#1)
SB obstruction##4##2##(1997-8#4)
SB##17##1##(1992-2#5)(1993-3#1)(1995-12#1)(1997-8#4)(2008-11#3)(2008-12#1)(2008-5#1)(2010-11#1)
SB-204269##4##1##(2008-5#4)
SB203580##3##1##(2008-4#1)(2008-7#1)(2011-2#1)
SBA levels##6##2##(2013-1#6)
SBA##7##1##(1990-7#1)(2013-1#6)
SBB##3##1##(1994-9#3)
SBC cases were##2##3##(2009-2#2)
SBC##5##1##(2009-2#5)
SBCH##5##1##(2008-2#5)
SBI##6##1##(2006-5#4)(2008-3#2)
SBM##2##1##(2012-2#2)
SBML##2##1##(2010-10#2)
SBP and DBP increased during KB##2##6##(1991-10#2)
SBP and##4##2##(1991-10#4)
SBP##17##1##(1991-10#4)(2008-5#3)(2009-8#2)(2010-4#2)(2013-1#3)(2013-8#3)
SBPAX##4##1##(2010-10#4)
SBR##2##1##(2007-11#1)(2008-10#1)
SBS##13##1##(2007-11#1)(2007-12#1)(2008-2#8)(2009-11#1)(2009-8#2)
SBT##2##1##(2007-12#2)
SBTKR##4##1##(2008-8#4)
SBWMV transmission model##3##3##(2008-10#3)
SBWMV transmission##4##2##(2008-10#4)
SBWMV##11##1##(2008-10#9)(2008-8#2)
SC and##6##2##(1993-3#1)(2008-10#3)(2008-5#2)
SC barrier function##3##3##(2008-5#3)
SC have##2##2##(2008-5#2)
SC layer##4##2##(2008-5#4)
SC lipid##5##2##(2008-5#5)
SC may##2##2##(2008-5#1)(2011-2#1)
SC physical##2##2##(2008-5#2)
SC properties##2##2##(2008-5#2)
SC pulse##2##2##(2007-12#2)
SC samples##2##2##(2008-5#2)
SC was##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
SC##82##1##(1993-3#4)(2007-12#2)(2008-10#8)(2008-5#60)(2008-7#1)(2009-11#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
SC-236##5##1##(2008-10#5)
SC-245 and SC-791##2##3##(2008-10#2)
SC-245##6##1##(2008-10#6)
SC-791 and SC-245 were##2##4##(2008-10#2)
SC-791##9##1##(2008-10#9)
SC-CO(2) was##2##2##(2010-4#2)
SC-CO(2)##3##1##(2010-4#3)
SC1 was##2##2##(2012-2#2)
SC1##5##1##(2012-2#5)
SC2 and LP##2##3##(2012-2#2)
SC2##5##1##(2012-2#5)
SCA 4 l/min##3##3##(2011-2#3)
SCA and##2##2##(1991-8#1)(2009-4#1)
SCA##9##1##(1991-8#2)(2009-4#1)(2010-1#1)(2011-2#4)(2013-7#1)
SCAA##4##1##(2008-5#4)
SCAD##2##1##(1995-5#2)
SCAR and ARP2/3 complex-dependent actin polymerization##2##6##(2009-10#2)
SCAR complex subunits##3##3##(2009-10#3)
SCAR complex##4##2##(2009-10#4)
SCAR marker##2##2##(2008-10#1)(2008-5#1)
SCAR markers##3##2##(2008-10#1)(2008-5#2)
SCAR primers##2##2##(2008-10#2)
SCAR##18##1##(2008-10#8)(2008-5#3)(2009-10#7)
SCAVM##3##1##(1995-11#1)(1997-6#2)
SCAVMs##4##1##(1995-11#2)(1997-6#2)
SCC 13 and FL##2##4##(1992-2#2)
SCC 13##3##2##(1992-2#3)
SCC and##2##2##(2009-8#2)
SCC##13##1##(1991-8#1)(1992-2#3)(2008-4#1)(2009-1#1)(2009-8#4)(2012-3#2)(2013-1#1)
SCC-DFTB##4##1##(2008-10#2)(2012-12#2)
SCC-DFTB/MM##2##1##(2008-10#2)
SCC25 and HaCaT cells##2##4##(2010-2#2)
SCC25 and HaCaT##3##3##(2010-2#3)
SCCVII##2##1##(1997-4#2)
SCD in##4##2##(2009-9#1)(2012-3#3)
SCD##14##1##(2007-7#1)(2009-4#5)(2009-9#5)(2012-3#3)
SCE in##5##2##(1990-6#1)(1997-7#1)(2008-10#3)
SCE##16##1##(1990-6#1)(1996-5#1)(1997-7#1)(2008-10#11)(2008-11#2)
SCE) for##2##2##(2008-10#2)
SCE) in Britton-Robinson (BR) buffer##2##5##(2008-10#2)
SCE) in##5##2##(2008-10#5)
SCE) on##2##2##(2008-10#2)
SCE)##25##1##(2008-10#25)
SCEs frequency##2##2##(2008-4#2)
SCEs##6##1##(1990-6#2)(1996-2#1)(2008-11#1)(2008-4#2)
SCF technique##2##2##(2008-7#2)
SCF##7##1##(1992-3#3)(2008-7#4)
SCF+IL-3+HFT##2##1##(2008-8#2)
SCG##4##1##(1991-12#1)(1994-8#1)(1996-5#1)(2008-10#1)
SCGE assay##3##2##(1997-4#3)
SCGE##4##1##(1997-4#3)(2008-10#1)
SCH 23390##2##2##(1996-2#1)(2013-1#1)
SCH##6##1##(1996-2#1)(2008-10#1)(2012-3#3)(2013-1#1)
SCH23390 and##2##2##(1994-8#2)
SCH23390##4##1##(1992-3#1)(1994-8#3)
SCI in##2##2##(2008-8#2)
SCI##14##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#5)(2009-12#4)(2012-2#1)(2013-1#1)
SCID mice engrafted with human peripheral blood lymphocytes##2##8##(2010-12#2)
SCID mice##4##2##(1996-10#1)(2010-12#2)(2013-1#1)
SCID##7##1##(1991-1#2)(1994-2#1)(1996-10#1)(2010-12#2)(2013-1#1)
SCID-hu animals##2##2##(2008-11#2)
SCID-hu##4##1##(2008-11#4)
SCID/beige mice##4##2##(1991-8#4)
SCID/beige##5##1##(1991-8#5)
SCIENTIFIC BACKGROUND##2##2##(2011-2#2)
SCIT and SLIT with##2##4##(2011-2#2)
SCIT and##3##2##(2011-2#3)
SCIT##5##1##(2011-2#5)
SCKs##4##1##(2009-9#4)
SCL##2##1##(2008-4#2)
SCL-90-R OC##2##2##(2008-3#2)
SCL-90-R##4##1##(2008-11#1)(2008-3#3)
SCLC##4##1##(1996-9#2)(2009-11#2)
SCLP and CLP##3##3##(2012-3#3)
SCLP group##2##2##(2012-3#2)
SCLP injury##3##2##(2012-3#3)
SCLP##15##1##(2012-3#15)
SCLP/CLP genes##2##2##(2012-3#2)
SCM##3##1##(2008-10#1)(2009-9#1)(2011-2#1)
SCMV##11##1##(2008-10#10)(2008-9#1)
SCN is##2##2##(1994-2#1)(1994-5#1)
SCN##15##1##(1993-12#8)(1993-9#2)(1994-2#4)(1994-5#1)
SCN(-) ion##2##2##(2008-10#2)
SCN(-)##11##1##(2008-10#11)
SCN1A##4##1##(2012-12#4)
SCN4A##3##1##(1991-12#1)(1992-3#2)
SCN5A##3##1##(2008-12#1)(2008-8#1)(2009-5#1)
SCNIR##2##1##(2008-7#2)
SCNT##3##1##(2013-1#3)
SCORAD##3##1##(2012-1#3)
SCP##6##1##(2008-10#6)
SCR 20##2##2##(2008-10#2)
SCR##3##1##(2008-10#2)(2011-2#1)
SCR3##4##1##(2008-10#4)
SCRAM##5##1##(2008-11#5)
SCS##5##1##(1997-2#2)(2008-12#3)
SCSs##3##1##(2008-10#1)(2008-11#2)
SCTE activity was##2##3##(2008-5#2)
SCTE activity##3##2##(2008-5#3)
SCTE##4##1##(2008-5#4)
SCUBA##3##1##(1997-1#1)(2010-2#1)(2013-7#1)
SCUs##2##1##(2008-8#2)
SCr level of##3##3##(2008-1#3)
SCr level##4##2##(2008-1#4)
SCr##5##1##(2008-1#5)
SCs and astrocytes##2##3##(2008-7#2)
SCs and##3##2##(2008-7#3)
SCs##6##1##(2008-7#6)
SCysC##3##1##(2013-1#3)
SD 6##3##2##(2008-12#1)(2013-1#2)
SD 933##2##2##(2008-6#2)
SD = 1##2##3##(2009-7#1)(2010-1#1)
SD = 7##2##3##(1995-11#2)
SD =##12##2##(1993-1#2)(1995-1#1)(1995-11#4)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)
SD age##2##2##(2008-11#1)(2013-8#1)
SD and##2##2##(1990-2#1)(1993-12#1)
SD for##2##2##(2009-2#1)(2012-3#1)
SD in##5##2##(1996-12#1)(1996-7#4)
SD of##7##2##(2008-10#1)(2012-5#3)(2013-8#3)
SD patients##4##2##(2008-1#1)(2008-4#1)(2009-2#2)
SD rats and GEPR-3##2##4##(1996-12#2)
SD rats and##7##3##(1996-12#5)(1996-5#1)(2010-1#1)
SD rats were##3##3##(2008-10#2)(2010-1#1)
SD rats##18##2##(1993-12#1)(1996-12#8)(1996-5#1)(1997-6#1)(2008-10#5)(2010-1#2)
SD was##3##2##(1993-12#2)(2008-8#1)
SD##97##1##(1990-2#1)(1990-5#1)(1991-9#1)(1992-2#1)(1993-1#2)(1993-12#7)(1993-3#1)(1995-1#1)(1995-11#4)(1996-12#9)(1996-5#3)(1996-7#5)(1997-6#3)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#5)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-3#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2012-5#3)(2013-1#5)(2013-8#5)
SD) and##4##2##(1991-12#1)(1994-2#1)(2008-3#2)
SD)##19##1##(1990-5#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-2#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-2#1)(2009-6#2)(2010-2#1)(2011-2#1)(2012-2#2)
SD-NS##4##1##(2008-10#4)
SD-OCT##3##1##(2011-7#3)
SD-like depolarization##2##2##(1993-12#2)
SD-like##3##1##(1993-12#3)
SDA##3##1##(2008-12#3)
SDC##3##1##(1991-9#2)(2008-10#1)
SDCC and TCCA##2##3##(2008-10#2)
SDCL C/N##5##2##(2008-10#5)
SDCL##6##1##(2008-10#6)
SDF filters##3##2##(2008-3#3)
SDF##4##1##(2008-2#1)(2008-3#3)
SDF-1##2##1##(2008-7#1)(2010-8#1)
SDF-1α##2##1##(2012-2#1)(2012-3#1)
SDH mutations##2##2##(2012-2#2)
SDH##6##1##(1990-7#2)(2008-11#1)(2009-7#1)(2012-2#2)
SDHB##2##1##(2012-2#2)
SDHD mutations##2##2##(2012-2#2)
SDHD##10##1##(2010-5#8)(2012-2#2)
SDIF##2##1##(2008-6#2)
SDM##2##1##(1992-11#2)
SDME##7##1##(2008-10#7)
SDO##2##1##(1992-3#2)
SDOCT##2##1##(2011-1#2)
SDQ##2##1##(2008-10#2)
SDR##3##1##(1992-11#3)
SDS PAGE##2##2##(1992-8#1)(2008-11#1)
SDS and beta-mercaptoethanol##2##3##(1996-5#1)(2008-11#1)
SDS and##9##2##(1995-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2013-8#1)
SDS at##2##2##(1991-5#1)(2011-1#1)
SDS concentration##3##2##(2008-10#2)(2012-2#1)
SDS gel electrophoresis##3##3##(1990-5#1)(1990-7#1)(2008-2#1)
SDS gel##5##2##(1990-5#1)(1990-7#1)(2008-10#2)(2008-2#1)
SDS in##6##2##(1995-5#1)(2008-10#2)(2012-2#3)
SDS of the patients##2##4##(2011-1#2)
SDS polyacrylamide gel electrophoresis##3##4##(1993-6#1)(1996-9#1)(2008-8#1)
SDS showed##2##2##(2011-1#2)
SDS solution##2##2##(2008-10#2)
SDS was##5##2##(1990-11#1)(2008-10#2)(2012-2#2)
SDS with##2##2##(2008-10#2)
SDS##88##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-5#3)(1996-9#1)(1997-2#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-8#1)(2011-1#5)(2012-2#13)(2013-1#1)(2013-8#1)
SDS-PAGE analysis of the##3##4##(1990-2#1)(1994-11#1)(1994-8#1)
SDS-PAGE analysis revealed##2##3##(2008-11#1)(2009-9#1)
SDS-PAGE analysis##9##2##(1990-2#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-8#1)(2008-11#2)(2009-2#1)(2009-9#1)
SDS-PAGE and Western blot##3##4##(2008-11#1)(2008-9#1)(2011-1#1)
SDS-PAGE and Western blotting##2##4##(1995-8#1)(2010-12#1)
SDS-PAGE and Western##5##3##(1995-8#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
SDS-PAGE and immunoblotting##3##3##(1996-12#1)(2008-12#1)(2008-4#1)
SDS-PAGE and##20##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)
SDS-PAGE electrophoresis##3##2##(1990-11#2)(2008-10#1)
SDS-PAGE followed by##2##3##(1992-8#1)(2012-3#1)
SDS-PAGE in##3##2##(1995-11#2)(1997-4#1)
SDS-PAGE is##4##2##(1992-6#1)(2008-1#1)(2008-2#1)(2008-4#1)
SDS-PAGE of##2##2##(1996-2#1)(2008-4#1)
SDS-PAGE protein##2##2##(2008-1#1)(2008-12#1)
SDS-PAGE to##2##2##(2010-12#2)
SDS-PAGE under##3##2##(1990-12#1)(1997-2#1)(2008-8#1)
SDS-PAGE was##3##2##(1992-8#1)(1995-8#1)(1997-4#1)
SDS-PAGE##110##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#2)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#2)(1997-2#2)(1997-4#3)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-9#3)(2010-12#3)(2011-1#1)(2012-3#3)(2013-1#2)
SDS-PAGE)##2##1##(2008-10#1)(2008-2#1)
SDS-degrading bacteria##2##2##(2012-2#2)
SDS-degrading##3##1##(2012-2#3)
SDS-gel electrophoresis##4##2##(1990-7#1)(1992-8#1)(1994-11#1)(1994-6#1)
SDS-gel##5##1##(1990-7#1)(1991-12#1)(1992-8#1)(1994-11#1)(1994-6#1)
SDS-polyacrylamide gel electrophoresis##6##3##(1991-5#1)(1992-8#2)(1995-5#1)(1997-1#1)(2008-5#1)
SDS-polyacrylamide gel##9##2##(1991-5#1)(1992-8#2)(1993-11#1)(1995-5#1)(1997-1#1)(2008-4#2)(2008-5#1)
SDS-polyacrylamide gels##5##2##(1994-5#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-4#1)
SDS-polyacrylamide##15##1##(1991-5#1)(1992-8#2)(1993-11#1)(1994-5#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)
SDS-protein complexes and small DNA molecules##2##6##(2008-10#2)
SDS/PAGE##4##1##(1990-5#1)(1990-7#2)(1991-12#1)
SDZ ASM 981 is##2##4##(2007-11#2)
SDZ ASM 981##10##3##(2007-11#10)
SE 0##2##2##(2007-5#2)
SE is##3##2##(2008-10#2)(2008-3#1)
SE systems##3##2##(2008-10#3)
SE##29##1##(1994-6#1)(1997-6#1)(2007-5#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#2)(2009-8#2)(2012-1#2)
SE)##7##1##(1990-5#2)(1994-12#1)(1994-6#1)(2007-5#1)(2008-8#1)(2012-1#1)
SE-9000 haematology##2##2##(2008-10#2)
SE-9000##3##1##(2008-10#3)
SE34##3##1##(2008-10#3)
SE5-OH##5##1##(2010-1#5)
SEA and##2##2##(1993-6#1)(2010-12#1)
SEA##8##1##(1993-6#7)(2010-12#1)
SEA(121-149)##4##1##(1993-6#4)
SEAP##12##1##(2008-11#9)(2008-7#2)(2011-2#1)
SEAs##3##1##(2011-2#3)
SEC column##2##2##(1997-2#2)
SEC##15##1##(1991-2#1)(1996-5#2)(1997-2#6)(2008-10#6)
SEC62 and##2##2##(1991-2#2)
SEC62##3##1##(1991-2#3)
SEC63##2##1##(1991-2#1)(1993-11#1)
SECV##3##1##(2007-12#1)(2008-10#2)
SEE##6##1##(2007-11#2)(2007-5#2)(2008-10#1)(2009-11#1)
SEER##5##1##(1997-3#2)(2012-3#3)
SEIRAS##2##1##(2013-8#2)
SEL##4##1##(2012-2#4)
SELD enzyme##2##2##(1993-11#2)
SELDI TOF-MS analysis of the##2##5##(2011-2#2)
SELDI##4##1##(2008-10#1)(2008-4#1)(2011-2#2)
SELECTION##2##1##(2012-12#1)(2013-1#1)
SELEX##7##1##(2007-11#1)(2008-4#1)(2010-5#5)
SEM CFA##2##2##(2012-2#2)
SEM analysis##2##2##(2008-5#1)(2013-8#1)
SEM and AFM##3##3##(2008-10#1)(2008-8#2)
SEM and##5##2##(2008-10#2)(2008-8#2)(2012-2#1)
SEM are##2##2##(1990-11#1)(2008-5#1)
SEM image##2##2##(2008-10#1)(2013-8#1)
SEM images revealed##2##3##(2008-3#1)(2013-1#1)
SEM images##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
SEM micrographs##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
SEM##52##1##(1990-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-6#2)(1995-12#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#7)(2008-7#2)(2008-8#2)(2009-7#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
SEM)##2##1##(2008-12#1)(2008-7#1)
SEM/EDX##2##1##(2008-10#1)(2008-11#1)
SEM/EDXA micrographs##2##2##(2008-5#2)
SEMG##2##1##(2009-6#2)
SENIEUR protocol##2##2##(1994-5#1)(2008-7#1)
SENSE##2##1##(1993-12#1)(2008-7#1)
SEP to##2##2##(2008-10#2)
SEP##8##1##(2008-10#7)(2009-3#1)
SEPARATE TOPICS##2##2##(2007-2#2)
SEQUEST##5##1##(2008-4#4)(2008-8#1)
SER##3##1##(2011-2#3)
SEREX##2##1##(2008-4#2)
SERS activity##3##2##(2007-12#2)(2013-1#1)
SERS enhancement##4##2##(2007-12#2)(2012-2#1)(2013-1#1)
SERS in##2##2##(2010-5#1)(2013-1#1)
SERS of##4##2##(2008-10#1)(2013-8#3)
SERS signal##2##2##(2008-10#1)(2008-2#1)
SERS spectra of##3##3##(2008-10#1)(2013-8#2)
SERS spectrum##4##2##(2008-10#3)(2008-2#1)
SERS substrate##2##2##(2012-2#2)
SERS substrates##2##2##(2009-4#1)(2013-1#1)
SERS##46##1##(2007-12#8)(2008-10#8)(2008-2#5)(2008-7#1)(2009-4#2)(2010-5#4)(2012-1#1)(2012-2#4)(2013-1#6)(2013-8#7)
SERS-active polymers##2##2##(2008-12#2)
SERS-active substrates##4##2##(2007-12#1)(2008-10#3)
SERS-active##14##1##(2007-12#3)(2008-10#6)(2008-12#2)(2012-2#2)(2013-1#1)
SERVQUAL##4##1##(1993-12#3)(1995-3#1)
SES and gender##2##3##(2011-1#2)
SES categories##2##2##(2011-1#2)
SES information##2##2##(2010-3#2)
SES variables##2##2##(2010-3#2)
SES##25##1##(2008-11#1)(2010-10#1)(2010-11#2)(2010-3#4)(2011-1#10)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
SET domain##2##2##(1995-11#1)(1997-7#1)
SET##3##1##(1995-11#1)(1997-7#2)
SETTING##8##1##(2007-12#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
SF concentration was##2##3##(2009-3#2)
SF concentration##6##2##(2009-3#6)
SF females##2##2##(1995-8#2)
SF films##2##2##(2008-5#2)
SF quartile##3##2##(2009-3#3)
SF##26##1##(1994-8#4)(1995-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#11)(2012-1#4)
SF(6)##3##1##(2007-12#3)
SF)##2##1##(2008-10#2)
SF-12##5##1##(2008-9#1)(2011-2#2)(2012-3#2)
SF-36 and##2##2##(1994-3#1)(2010-5#1)
SF-36 questionnaire##2##2##(2011-2#2)
SF-36##12##1##(1994-3#3)(1996-3#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-12#3)
SF-CO(2) at##3##2##(2008-10#3)
SF-CO(2) was determined##2##3##(2008-10#2)
SF-CO(2)##13##1##(2008-10#13)
SF36##3##1##(2008-10#1)(2012-3#2)
SF6##3##1##(1997-1#1)(2008-3#2)
SF900II and##2##2##(2008-11#2)
SF900II##4##1##(2008-11#4)
SFA and cholesterol are##2##4##(2012-2#2)
SFA and cholesterol##3##3##(2012-2#3)
SFA and##4##2##(2008-10#1)(2012-2#3)
SFA##10##1##(2008-10#2)(2008-11#2)(2008-3#1)(2010-2#1)(2012-2#3)(2013-8#1)
SFC behavior##2##2##(2008-10#2)
SFC##7##1##(2008-10#5)(2008-6#2)
SFE and##3##2##(2008-10#3)
SFE conditions##3##2##(2008-10#3)
SFE was##2##2##(2008-10#2)
SFE with##2##2##(2008-10#2)
SFE##27##1##(2008-10#27)
SFG nonresonant signal##3##3##(2008-10#3)
SFG spectra##2##2##(2008-10#2)
SFG##7##1##(1995-12#1)(2008-10#6)
SFLLRN##5##1##(1992-4#4)(1997-7#1)
SFM for##2##2##(2008-7#2)
SFM##11##1##(1991-8#1)(2008-11#4)(2008-7#6)
SFME cells were##2##3##(2008-11#2)
SFME cells##10##2##(2008-11#10)
SFN##7##1##(2010-12#1)(2013-1#6)
SFO neurons##2##2##(1994-2#2)
SFO##8##1##(1992-5#3)(1994-2#4)(2013-1#1)
SFOAE##7##1##(2009-5#7)
SFRP2##2##1##(2012-12#2)
SFS##5##1##(2008-10#3)(2008-3#2)
SFS's##2##1##(2008-3#2)
SFT##6##1##(2007-8#2)(2012-2#3)(2013-1#1)
SFV and SIN replicons##2##4##(2008-4#2)
SFV and SIN##3##3##(2008-4#3)
SFV and##4##2##(2008-1#1)(2008-4#3)
SFV##10##1##(2008-1#2)(2008-11#4)(2008-4#4)
SG assembly through a##2##4##(2012-12#2)
SG assembly through##3##3##(2012-12#3)
SG assembly##6##2##(2012-12#6)
SG##20##1##(1993-12#2)(2008-10#2)(2012-12#6)(2012-2#9)(2013-8#1)
SG-64##2##1##(2009-10#2)
SGA infants##2##2##(2011-1#2)
SGA##10##1##(1994-3#1)(2011-1#3)(2013-1#4)(2013-8#2)
SGA1##2##1##(1995-6#2)
SGB##3##1##(2010-11#3)
SGC##11##1##(1995-2#3)(2008-3#3)(2010-8#5)
SGCs##2##1##(2008-6#2)
SGFL seedlings##2##2##(2008-10#2)
SGFL##3##1##(2008-10#3)
SGIII and SGIV##2##3##(2008-10#2)
SGIII and##3##2##(2008-10#3)
SGIII##4##1##(2008-10#4)
SGIV##4##1##(2008-10#4)
SGLT##2##1##(1991-12#1)(2008-7#1)
SGLT1##6##1##(1991-12#6)
SGOT##2##1##(1992-5#1)(2012-3#1)
SGP alone##2##2##(1994-11#2)
SGP and##2##2##(1994-11#1)(2013-1#1)
SGP involving the face##2##4##(2013-1#2)
SGP##9##1##(1994-11#5)(2013-1#4)
SGPT##2##1##(1992-5#1)(2012-3#1)
SGR##3##1##(2008-12#2)(2008-4#1)
SGT1##2##1##(2009-6#2)
SGs##2##1##(2012-12#2)
SH field##3##2##(2007-12#3)
SH groups##5##2##(1991-9#2)(1993-2#1)(2008-10#1)(2008-5#1)
SH##28##1##(1991-9#4)(1993-2#1)(1995-3#1)(1996-5#4)(2006-6#1)(2007-10#1)(2007-12#6)(2008-10#5)(2008-5#2)(2009-2#2)(2011-1#1)
SH-SY5Y cells and NG108-15 cells##2##5##(1997-2#2)
SH-SY5Y cells and##3##3##(1997-2#3)
SH-SY5Y cells##5##2##(1997-2#4)(2008-9#1)
SH-SY5Y neuroblastoma cells##2##3##(1996-12#1)(2010-6#1)
SH-SY5Y##10##1##(1996-12#1)(1997-2#5)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)
SH-groups##2##1##(1993-6#2)
SH2 and SH3##2##3##(1991-12#1)(2012-12#1)
SH2 and##3##2##(1991-12#1)(1997-4#1)(2012-12#1)
SH2 domain of##3##3##(1994-6#1)(1995-6#1)(1997-7#1)
SH2 domain##8##2##(1994-6#2)(1995-6#2)(1997-7#3)(2012-12#1)
SH2 domains of Src family kinases##2##6##(1995-6#2)
SH2 domains of Src##3##4##(1995-6#3)
SH2 domains of##4##3##(1995-6#4)
SH2 profiling##4##2##(2012-12#4)
SH2##24##1##(1991-12#1)(1994-6#3)(1995-6#7)(1996-2#1)(1997-4#1)(1997-7#3)(2009-6#1)(2012-12#7)
SH2-containing##2##1##(1995-6#1)(2012-12#1)
SH3 domains##3##2##(1997-4#1)(2008-6#1)(2012-12#1)
SH3##6##1##(1991-12#1)(1997-4#2)(2008-6#1)(2008-8#1)(2012-12#1)
SH3-domain##3##1##(2008-8#3)
SH3TC2##2##1##(2013-1#2)
SHB system##2##2##(2008-3#2)
SHB##3##1##(2008-3#3)
SHBG and##2##2##(1990-2#1)(2008-3#1)
SHBG levels##5##2##(1990-11#2)(1990-2#3)
SHBG##11##1##(1990-11#3)(1990-2#4)(2008-3#3)(2013-1#1)
SHE cells##2##2##(1990-7#2)
SHE##3##1##(1990-7#2)(1992-2#1)
SHG conversion##2##2##(2007-11#1)(2007-12#1)
SHG images##2##2##(2007-11#1)(2007-12#1)
SHG in 20G?20A?60S glass was##2##5##(2007-11#2)
SHG in##3##2##(2007-11#3)
SHG of a##2##3##(2007-12#2)
SHG##32##1##(2007-11#12)(2007-12#12)(2008-10#1)(2008-2#2)(2008-3#5)
SHI scheme##2##2##(2008-7#2)
SHI##6##1##(2008-7#6)
SHIP##2##1##(2013-1#2)
SHIP2##4##1##(2012-2#4)
SHIP2-SH2##6##1##(2012-2#6)
SHL##2##1##(2011-2#2)
SHLI ADRs##2##2##(2011-2#2)
SHLI##15##1##(2011-2#15)
SHM + VCD##2##3##(2010-10#2)
SHM##13##1##(2008-8#3)(2010-10#2)(2011-2#8)
SHOX haploinsufficiency##3##2##(2008-7#1)(2013-1#2)
SHOX##6##1##(2008-7#2)(2013-1#4)
SHR (p=0##3##2##(2006-8#3)
SHR rats has##2##3##(2011-1#2)
SHR rats##3##2##(1996-5#1)(2011-1#2)
SHR##28##1##(1990-7#2)(1994-2#3)(1994-8#1)(1996-5#4)(1997-6#5)(2006-8#8)(2011-1#5)
SHR-cp##3##1##(2008-2#3)
SHR/NDmcr-cp (SHR-cp)##2##2##(2008-2#2)
SHS##3##1##(1997-3#3)
SHSG##3##1##(2008-2#2)(2008-3#1)
SHZH98##5##1##(2008-8#5)
SI = 3##2##3##(2008-10#2)
SI =##3##2##(2008-10#3)
SI and Cg##3##3##(1995-12#3)
SI and##4##2##(1995-12#3)(2007-12#1)
SI is##2##2##(2008-7#2)
SI joint##6##2##(2012-2#6)
SI of subcutaneous fat##4##4##(2012-2#4)
SI system##4##2##(2008-10#4)
SI##46##1##(1993-10#2)(1995-12#4)(1996-2#1)(1997-6#1)(1997-8#2)(2007-12#2)(2008-10#14)(2008-11#1)(2008-7#6)(2008-9#1)(2011-2#1)(2012-2#11)
SI-GaAs-based##2##1##(2008-2#2)
SI-LC##2##1##(2008-10#2)
SI-SWV##2##1##(2008-10#2)
SIA method##2##2##(2008-10#2)
SIA system was##3##3##(2008-10#3)
SIA system##13##2##(2008-10#13)
SIA##32##1##(2008-10#32)
SIA/DSTD##2##1##(2008-10#2)
SIADH in##2##2##(2011-2#2)
SIADH##3##1##(2011-2#3)
SIB 124 and SIB 139##2##5##(1990-8#2)
SIB 139##3##2##(1990-8#3)
SIB is##2##2##(2008-3#1)(2009-10#1)
SIB##13##1##(1990-8#5)(2008-11#3)(2008-3#1)(2009-10#4)
SIBS##2##1##(2008-2#2)
SIC##2##1##(2008-10#2)
SICA##2##1##(2008-10#2)
SIDE##2##1##(1997-3#1)(2008-5#1)
SIDS among##3##2##(1992-11#1)(2008-1#2)
SIDS infants##2##2##(1991-11#1)(1992-11#1)
SIDS victims##2##2##(2013-1#2)
SIDS##34##1##(1991-11#4)(1992-11#11)(1992-4#5)(1993-12#1)(2008-1#6)(2011-1#2)(2013-1#5)
SIDS-cases from the##2##3##(1992-11#2)
SIDS-cases##3##1##(1992-11#3)
SIG and##2##2##(2008-7#2)
SIG##4##1##(2008-7#3)(2012-12#1)
SIGNIFICANCE##2##1##(2009-9#1)(2012-2#1)
SIGNIFICANT##2##1##(2008-7#1)(2009-4#1)
SII##2##1##(1994-8#2)
SIJ dysfunction as the cause for##2##6##(2010-1#2)
SIJ dysfunction##9##2##(2010-1#7)(2012-2#2)
SIJ##13##1##(2010-1#10)(2012-2#3)
SIL##8##1##(2008-3#3)(2012-12#5)
SILNH(2)##2##1##(2008-10#2)
SILS port##2##2##(2012-12#1)(2013-1#1)
SILS##6##1##(2012-12#1)(2013-1#5)
SIM results##2##2##(2007-12#2)
SIM##5##1##(2007-12#3)(2008-5#2)
SIMCA##2##1##(2008-10#2)
SIMD##2##1##(1990-11#1)(2008-3#1)
SIN and##2##2##(2012-2#1)(2013-1#1)
SIN##9##1##(2008-3#3)(2008-4#3)(2012-2#2)(2013-1#1)
SIN-1 and##2##2##(1995-11#1)(1997-4#1)
SIN-1 are##2##2##(1997-4#2)
SIN-1##9##1##(1995-11#3)(1997-4#6)
SIOD##3##1##(2011-2#3)
SIP influenced the##2##3##(1993-6#2)
SIP was##2##2##(1993-6#1)(2011-2#1)
SIP##17##1##(1993-6#6)(2008-3#7)(2011-2#4)
SIR was##3##2##(1993-9#3)
SIR##6##1##(1993-9#6)
SIRT1##13##1##(2009-12#1)(2012-2#11)(2012-3#1)
SIS model with##2##3##(2013-8#2)
SIS model##3##2##(2013-8#3)
SIT administration forms##2##3##(2011-2#2)
SIT with##4##2##(2011-2#4)
SIT##17##1##(2011-2#15)(2012-12#2)
SIV Vpr##2##2##(1997-3#2)
SIV and##3##2##(1991-9#1)(2010-10#1)(2013-1#1)
SIV protease##3##2##(1992-6#3)
SIV strains##3##2##(1997-3#2)(2010-10#1)
SIV##22##1##(1991-9#2)(1992-6#4)(1994-12#2)(1995-2#1)(1997-3#7)(2010-10#2)(2011-2#3)(2013-1#1)
SIV-PBj14##5##1##(1997-3#5)
SIV-PR##6##1##(1991-9#6)
SIVagm3mc##3##1##(1995-2#3)
SIVmutV##3##1##(1994-12#3)
SIVs and##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
SIVs were##2##2##(2013-1#2)
SIVs##11##1##(2011-2#3)(2013-1#6)(2013-8#2)
SIVsmmPBj1##4##1##(1995-2#4)
SIVsmmPBj14##3##1##(1995-2#1)(1997-3#2)
SIVwt##4##1##(1994-12#4)
SJL and AKR##2##3##(1997-7#2)
SJL##4##1##(1992-8#1)(1997-7#2)(2012-1#1)
SJL/J and A/J mice##2##4##(2012-1#2)
SJL/J and A/J##3##3##(2012-1#3)
SJL/J and##5##2##(1993-2#2)(2012-1#3)
SJL/J mice and##2##3##(1993-2#1)(1997-4#1)
SJL/J mice##9##2##(1993-2#3)(1997-4#3)(2008-4#1)(2012-1#2)
SJL/J##15##1##(1993-2#6)(1997-4#3)(2008-4#1)(2012-1#5)
SK complex could##2##3##(1993-8#2)
SK complex##3##2##(1993-8#3)
SK##10##1##(1993-8#9)(2012-2#1)
SK&amp##25##1##(1991-8#24)(1993-3#1)
SK-Br-3 and BT-474##2##3##(1993-1#2)
SK-LMS-1 cells##2##2##(2008-6#2)
SK-N-MC cells##5##2##(1992-6#1)(1992-9#1)(2008-4#1)(2008-7#2)
SK-N-MC##7##1##(1992-6#1)(1992-9#2)(2008-4#1)(2008-7#3)
SK-OV-3##2##1##(2008-11#1)(2008-8#1)
SKF 38393-induced grooming##2##3##(1996-2#2)
SKF##4##1##(1995-12#1)(1996-2#3)
SKF38393##2##1##(1992-3#2)
SKI2##3##1##(1997-3#2)(1997-6#1)
SKM##7##1##(2011-2#4)(2013-1#3)
SKOV-3##3##1##(1994-2#2)(2010-11#1)
SKW6 cells in##2##3##(2008-8#2)
SKW6 cells##5##2##(2008-8#5)
SKW6##8##1##(2008-8#8)
SL##12##1##(1990-8#3)(1991-4#3)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2013-1#2)
SL-15##2##1##(2008-3#2)
SL-selectin in##3##2##(1992-12#3)
SL-selectin##5##1##(1992-12#5)
SL1 sequence##2##2##(2007-12#2)
SL1##4##1##(2007-12#4)
SL2 trans-splicing##2##2##(2007-12#2)
SL2##4##1##(2007-12#4)
SLA##3##1##(2008-8#3)
SLAP lesions##2##2##(2007-11#1)(2008-8#1)
SLB resistance QTL##2##3##(2008-10#2)
SLB resistance##4##2##(2008-10#4)
SLB##7##1##(2008-10#7)
SLC24A5 gene##2##2##(2009-5#2)
SLC24A5##6##1##(2009-5#6)
SLC39##2##1##(2008-10#2)
SLCO1B1##5##1##(2011-2#5)
SLCV DNA was detected in##2##5##(2008-10#2)
SLCV##8##1##(2008-10#8)
SLCV-E at##2##2##(2008-10#2)
SLCV-E##8##1##(2008-10#8)
SLCV-R##3##1##(2008-10#3)
SLE and##2##2##(2011-2#2)
SLE in##4##2##(2006-10#4)
SLE is##2##2##(2006-10#1)(2013-1#1)
SLE patient##4##2##(2011-2#4)
SLE patients had##2##3##(2011-2#1)(2013-1#1)
SLE patients in the##2##4##(2008-1#2)
SLE patients treated in##2##4##(2006-10#2)
SLE patients##20##2##(2006-10#5)(2008-1#2)(2008-10#4)(2010-12#1)(2010-5#1)(2011-2#5)(2013-1#2)
SLE##61##1##(2006-10#12)(2007-7#1)(2008-1#6)(2008-10#6)(2008-4#1)(2010-12#2)(2010-5#4)(2011-2#17)(2012-12#1)(2012-2#1)(2013-1#10)
SLES##3##1##(2008-10#1)(2008-5#2)
SLI and NLI##2##3##(2009-8#2)
SLI and##3##2##(2009-8#2)(2012-3#1)
SLI##13##1##(2008-11#4)(2009-8#2)(2011-1#3)(2012-3#4)
SLIT with##3##2##(2011-2#3)
SLIT##8##1##(2008-8#1)(2011-2#7)
SLLH##2##1##(1995-2#2)
SLM laser##2##2##(2007-12#2)
SLM##20##1##(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#7)(2009-7#1)(2012-1#1)
SLM's##7##1##(2007-11#1)(2008-2#2)(2008-3#4)
SLM(046)##4##1##(2011-2#4)
SLMs##4##1##(2008-10#2)(2008-3#2)
SLN and##4##2##(1993-12#3)(2013-1#1)
SLN biopsy has##2##3##(2008-10#2)
SLN dispersions##2##2##(2008-5#2)
SLN formulations##2##2##(2008-5#2)
SLN mapping and##2##3##(2008-10#2)
SLN mapping##4##2##(2008-10#4)
SLN##30##1##(1993-12#6)(2008-10#8)(2008-5#14)(2013-1#2)
SLNs were##2##2##(2008-5#1)(2013-1#1)
SLNs##3##1##(2008-5#1)(2013-1#2)
SLO##3##1##(2011-1#3)
SLOS##3##1##(2010-7#3)
SLPs##2##1##(2009-11#2)
SLRS-4##3##1##(2008-10#3)
SLS##6##1##(2008-10#6)
SLSTT##3##1##(2012-2#3)
SLT##10##1##(2011-2#5)(2012-2#2)(2012-3#3)
SLTs with##2##2##(2012-3#2)
SLTs##5##1##(2012-3#5)
SLX##2##1##(2008-5#2)
SLex##4##1##(1991-12#4)
SM##17##1##(1994-8#1)(1996-2#1)(2008-5#3)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#7)
SM-BK(-/-) mice##2##2##(2009-2#2)
SM-NS##4##1##(2008-10#4)
SMA##6##1##(1994-2#2)(1994-8#2)(2008-9#1)(2009-9#1)
SMAC##2##1##(1993-12#1)(2008-6#1)
SMAD##7##1##(2008-9#3)(2011-2#4)
SMARCAL1##9##1##(2011-2#9)
SMART##5##1##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
SMBG in T2DM##4##3##(2009-11#4)
SMBG in##5##2##(2009-11#5)
SMBG intervention subjects##2##3##(2009-11#2)
SMBG intervention##3##2##(2009-11#3)
SMBG##18##1##(2008-8#8)(2009-11#10)
SMBG-driven interventions##2##2##(2009-11#2)
SMC were##2##2##(1994-11#2)
SMC##20##1##(1994-11#5)(1995-8#5)(2008-10#5)(2009-11#5)
SMD = -1##2##3##(2013-8#2)
SMD =##4##2##(2013-8#4)
SMD##13##1##(2008-10#7)(2009-7#1)(2009-9#1)(2013-8#4)
SMD-affected pigeonpea##2##2##(2008-10#2)
SMD-affected##3##1##(2008-10#3)
SMDE##2##1##(2008-10#2)
SMF dosage##2##2##(2008-10#2)
SMF treatment parameters##2##3##(2008-10#2)
SMF##11##1##(2007-11#1)(2008-10#10)
SMI##4##1##(1992-2#1)(2009-6#3)
SMKT R-3 cells##2##3##(1994-6#2)
SMMC-7721##2##1##(2008-8#1)(2013-7#1)
SMP##2##1##(1994-11#1)(2008-3#1)
SMPs##3##1##(2008-3#1)(2011-1#2)
SMR##5##1##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)
SMRs##2##1##(1995-2#1)(2008-7#1)
SMS##4##1##(1997-3#3)(2013-8#1)
SMS-KCNR##2##1##(1992-5#2)
SMT##8##1##(2007-11#4)(2008-10#1)(2013-1#3)
SMUC 41##2##2##(1993-8#2)
SMV HC-Pro##3##2##(2008-10#3)
SMV infection##4##2##(2008-10#4)
SMV isolates##3##2##(2008-10#3)
SMV strains##2##2##(2008-10#2)
SMV symptoms##2##2##(2008-10#2)
SMV##31##1##(2008-10#31)
SMV-G1##2##1##(2008-10#2)
SMV-infected##2##1##(2008-10#2)
SMVEA##6##1##(2008-10#6)
SN mapping##4##2##(2010-8#4)
SN##17##1##(1993-9#1)(1994-12#2)(1994-2#2)(1995-3#1)(2008-7#1)(2009-7#1)(2010-8#9)
SN-38 by##2##2##(2008-8#2)
SN-38##9##1##(1995-5#6)(2008-8#2)(2010-8#1)
SNAP-25 gene expression##2##3##(1995-6#2)
SNAP-25 gene##5##2##(1995-6#2)(1996-12#1)(1997-7#2)
SNAP-25##19##1##(1995-2#4)(1995-6#5)(1996-12#5)(1997-7#5)
SNARE##2##1##(2009-8#2)
SNAZOXS##3##1##(2008-10#3)
SNC##5##1##(1996-12#2)(2008-10#3)
SNF benefit##3##2##(1994-2#3)
SNF##5##1##(1994-12#2)(1994-2#3)
SNF2##2##1##(2011-2#2)
SNL##4##1##(2008-3#4)
SNOM##7##1##(2008-3#7)
SNP alleles##3##2##(2011-1#1)(2012-3#2)
SNP and##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
SNP array##2##2##(2008-7#1)(2009-7#1)
SNP arrays##2##2##(2009-7#2)
SNP database##2##2##(2008-7#2)
SNP databases##2##2##(2008-7#2)
SNP differentiation##2##2##(2013-1#2)
SNP discovery##3##2##(2008-4#1)(2010-10#1)(2012-3#1)
SNP for##2##2##(2008-11#2)
SNP genotyping and##3##3##(2008-12#1)(2012-3#2)
SNP genotyping using primer single-base extension (SBE)##2##7##(2008-9#2)
SNP genotyping##10##2##(2008-1#1)(2008-12#1)(2008-7#2)(2008-9#2)(2012-3#3)(2013-1#1)
SNP microarray analysis to##2##4##(2008-7#2)
SNP treated KU812 cells##4##4##(2008-11#4)
SNP##84##1##(1995-11#2)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#5)(2008-4#2)(2008-7#11)(2008-9#2)(2009-7#3)(2010-10#2)(2010-12#2)(2010-6#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#13)(2012-5#2)(2013-1#7)
SNP-PCR##3##1##(2011-2#3)
SNP/CGH##2##1##(2012-3#2)
SNPs (C13S522##2##2##(2012-3#2)
SNPs and##6##2##(2008-10#2)(2009-7#1)(2011-1#1)(2012-3#1)(2012-5#1)
SNPs associated with##2##3##(2009-4#1)(2010-12#1)
SNPs can##2##2##(2008-7#1)(2012-3#1)
SNPs for##2##2##(2008-12#1)(2012-3#1)
SNPs in a##2##3##(2008-9#1)(2012-3#1)
SNPs in strong linkage disequilibrium with each other##2##8##(2012-3#2)
SNPs in##9##2##(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-3#4)(2013-1#1)
SNPs to##2##2##(2012-3#1)(2013-1#1)
SNPs were##6##2##(2008-10#1)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
SNPs within##2##2##(2009-7#1)(2012-3#1)
SNPs##61##1##(2008-10#4)(2008-11#1)(2008-12#5)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#3)(2009-8#2)(2010-12#3)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#17)(2012-5#4)(2013-1#6)
SNR and dose##2##3##(2012-1#2)
SNR and##3##2##(2008-2#1)(2012-1#2)
SNR is##3##2##(2007-12#2)(2010-8#1)
SNR of##9##2##(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#1)(2010-8#1)(2013-8#2)
SNR values of##2##3##(2008-3#2)
SNR values##3##2##(2008-3#3)
SNR was##3##2##(2008-3#2)(2012-1#1)
SNR##34##1##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#14)(2008-9#2)(2009-5#1)(2010-8#3)(2011-1#1)(2012-1#5)(2013-8#2)
SNRPN and D15S63 loci##2##4##(2008-7#2)
SNS##10##1##(1996-12#1)(2011-1#9)
SNV##2##1##(2008-10#2)
SNX##3##1##(2008-7#3)
SNaPshot analysis##2##2##(2008-4#2)
SNase R##2##2##(2008-8#2)
SNc-VTA##2##1##(2008-7#2)
SNpr##4##1##(1993-12#4)
SNs##2##1##(2008-10#1)(2010-8#1)
SO and Px animals##2##4##(2008-5#2)
SO and##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
SO terms##2##2##(2008-7#2)
SO##12##1##(1990-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#6)
SO(2) and##2##2##(2008-10#1)(2008-3#1)
SO(2) gas##2##2##(2008-10#1)(2008-3#1)
SO(2) of the##2##3##(2008-3#2)
SO(2) prediction method##2##3##(2011-1#2)
SO(2) prediction##3##2##(2011-1#3)
SO(2) was##2##2##(2008-10#2)
SO(2)##32##1##(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#10)(2011-1#4)
SO(3)(2-)##2##1##(2008-10#2)
SO(4)##8##1##(2008-10#2)(2008-7#2)(2011-1#1)(2012-7#3)
SO(4)(2-) and##3##2##(2008-10#3)
SO(4)(2-)##16##1##(2008-10#16)
SO2##2##1##(1992-6#1)(1994-3#1)
SO3 and PT82##2##3##(2008-10#2)
SO3##7##1##(1994-11#4)(1994-3#1)(2008-10#2)
SO3(2-)##3##1##(1994-11#3)
SO3ANL##2##1##(2008-2#2)
SO4-4GalNAc beta 1##2##3##(1992-10#2)
SOA-derived atmospheric parameters##2##3##(2008-3#2)
SOA-derived##3##1##(2008-3#3)
SOAR##2##1##(2008-7#2)
SOC##7##1##(2008-7#2)(2008-8#4)(2012-12#1)
SOC(4)##3##1##(2011-2#3)
SOC/EXEC patients##2##2##(2008-4#1)(2009-9#1)
SOCS proteins##3##2##(2013-1#3)
SOD activity and##3##3##(1996-9#1)(2008-10#1)(2009-5#1)
SOD activity##8##2##(1992-11#1)(1996-9#2)(2008-10#1)(2008-7#1)(2009-5#1)(2013-1#2)
SOD and catalase##2##3##(1990-3#1)(1997-4#1)
SOD and##8##2##(1990-3#1)(1991-9#1)(1994-6#2)(1996-5#1)(1997-4#1)(2008-10#1)(2011-3#1)
SOD mimics##2##2##(2013-1#2)
SOD was##3##2##(1990-11#1)(2011-3#2)
SOD##43##1##(1990-11#2)(1990-3#2)(1991-9#1)(1992-11#2)(1994-6#2)(1996-5#1)(1996-9#3)(1997-4#5)(1997-8#3)(2008-10#5)(2008-5#1)(2008-7#2)(2009-5#3)(2011-3#4)(2013-1#7)
SOD1##3##1##(1994-6#2)(1996-5#1)
SOF##2##1##(2011-2#2)
SOG##3##1##(2008-2#3)
SOGON##4##1##(2011-1#4)
SOHO##7##1##(2008-2#3)(2008-3#4)
SOI##5##1##(2007-12#4)(2013-8#1)
SOLVERSTAT##3##1##(2008-10#3)
SOLiD##2##1##(2012-2#1)(2013-1#1)
SOM and##2##2##(1992-1#1)(2007-11#1)
SOM##8##1##(1992-1#2)(2007-11#1)(2008-4#1)(2012-3#2)(2013-8#2)
SON and PVN##2##3##(1993-12#2)
SON##3##1##(1993-12#2)(2008-11#1)
SONG correlation##2##2##(2008-3#2)
SOP##9##1##(2008-7#6)(2009-5#3)
SOPs##3##1##(2007-7#1)(2010-3#2)
SOS##5##1##(1995-2#1)(2008-10#1)(2011-2#1)(2013-8#2)
SOS1##4##1##(1994-8#4)
SOWG spectroelectrochemical cell##2##3##(2008-10#2)
SOWG##12##1##(2008-10#12)
SOX3##4##1##(2010-5#4)
SOX9##3##1##(2008-4#1)(2009-1#2)
SP (0##2##2##(1992-3#1)(2008-10#1)
SP DCs##2##2##(2008-11#2)
SP and CGRP##3##3##(1997-3#2)(2007-2#1)
SP and##5##2##(1997-3#2)(2007-2#1)(2008-10#2)
SP cells##3##2##(2008-4#1)(2008-9#1)(2010-6#1)
SP counselors##3##2##(2008-12#3)
SP were##2##2##(1991-6#1)(2008-10#1)
SP##48##1##(1991-12#1)(1991-6#1)(1992-3#2)(1993-3#1)(1997-3#4)(1997-4#1)(2007-2#1)(2008-10#18)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-6#2)(2013-1#3)
SP's##2##1##(2008-3#2)
SP(+) IENFs##2##2##(2013-8#2)
SP- and##2##2##(1994-8#1)(1997-3#1)
SP-##3##1##(1994-8#2)(1997-3#1)
SP-B analogues##2##2##(2007-11#2)
SP-B and SP-C##3##3##(2007-11#3)
SP-B##8##1##(2007-11#8)
SP-C analogues##4##2##(2007-11#4)
SP-C##8##1##(2007-11#7)(2008-9#1)
SP-LI##2##1##(1997-2#2)
SP-positive##2##1##(1997-3#2)
SP1 concentration##2##2##(1995-8#2)
SP1 finger##2##2##(1991-2#2)
SP1 increased significantly with##2##4##(1995-8#2)
SP1 zinc finger##2##3##(1991-2#2)
SP1##20##1##(1991-2#8)(1994-12#1)(1995-8#6)(2008-9#1)(2010-4#4)
SP2/0##2##1##(1995-2#1)(2008-11#1)
SP2/O##2##1##(1995-11#2)
SP3##2##1##(2012-2#2)
SP600125##2##1##(2011-2#2)
SPA##8##1##(1994-12#2)(2008-4#3)(2008-9#1)(2009-8#2)
SPAN##3##1##(1995-12#1)(2008-10#2)
SPARC##6##1##(2008-1#5)(2008-10#1)
SPB##3##1##(2012-12#3)
SPC mode##3##2##(2011-1#3)
SPC##9##1##(1995-2#4)(2008-10#1)(2011-1#4)
SPCEs##2##1##(2008-10#2)
SPD patients##3##2##(1995-11#3)
SPD##10##1##(1995-11#3)(2008-1#2)(2008-5#2)(2008-7#1)(2012-1#2)
SPDS##3##1##(2013-8#3)
SPDS1##3##1##(2013-8#3)
SPE and##2##2##(2008-10#2)
SPE are##2##2##(2008-10#1)(2013-1#1)
SPE cartridge##8##2##(1997-2#2)(2008-10#6)
SPE cartridges##2##2##(2008-10#2)
SPE clean-up##3##2##(2008-10#3)
SPE column##8##2##(2008-10#7)(2011-1#1)
SPE conditions##2##2##(2008-10#2)
SPE method##4##2##(1997-2#1)(2008-10#3)
SPE preconcentration##2##2##(2008-10#2)
SPE procedure##2##2##(2008-10#2)
SPE sorption##2##2##(2008-10#2)
SPE step##3##2##(2008-10#3)
SPE using##2##2##(2008-10#2)
SPE##78##1##(1992-2#1)(1997-2#7)(2007-11#1)(2008-10#65)(2011-1#1)(2011-2#1)(2013-1#2)
SPE(60)##3##1##(2008-10#3)
SPE-HPLC-UV##2##1##(2008-10#2)
SPE-LC-UV##2##1##(2008-10#2)
SPE-RTP##2##1##(2008-10#2)
SPE-based##2##1##(2008-10#2)
SPE/LC##3##1##(2008-10#3)
SPE/diffuse reflectance method##2##3##(2008-10#2)
SPEAK##4##1##(2008-9#4)
SPECIES##2##1##(2012-3#2)
SPECT and##3##2##(2009-8#2)(2012-2#1)
SPECT for##2##2##(2009-8#1)(2011-2#1)
SPECT in##5##2##(1994-1#2)(1996-5#1)(2009-8#1)(2011-2#1)
SPECT or##2##2##(2009-8#1)(2011-2#1)
SPECT study##3##2##(1996-12#1)(1996-5#2)
SPECT##30##1##(1994-1#2)(1996-12#1)(1996-5#5)(1996-7#1)(2008-11#1)(2009-8#12)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
SPECT-CT##2##1##(2012-2#2)
SPECT/CT imaging and photothermal therapy##2##5##(2012-12#2)
SPECT/CT imaging and##3##3##(2012-12#3)
SPECT/CT##4##1##(2011-2#1)(2012-12#3)
SPF value##2##2##(2008-5#2)
SPF values between##2##3##(2008-5#2)
SPF values##11##2##(2008-5#11)
SPF was##3##2##(1993-1#1)(1993-11#2)
SPF##30##1##(1992-5#2)(1993-1#2)(1993-11#4)(2008-5#22)
SPFMV and##2##2##(2008-10#2)
SPFMV isolates##2##2##(2008-10#2)
SPFMV##13##1##(2008-10#13)
SPFMV-infected##2##1##(2008-10#2)
SPFs##2##1##(2008-5#2)
SPH##2##1##(2013-1#2)
SPIDER is##2##2##(2007-12#2)
SPIDER##3##1##(2007-12#3)
SPIE##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
SPIO##3##1##(2009-6#1)(2012-12#1)(2013-1#1)
SPIOs in##2##2##(2013-1#2)
SPIOs were##2##2##(2013-1#2)
SPIOs##9##1##(2013-1#9)
SPL activation##2##2##(1996-2#2)
SPL cells##3##2##(2008-11#3)
SPL##12##1##(1996-2#2)(2008-11#4)(2011-1#6)
SPL-derived DCs##2##2##(2008-11#2)
SPM concentrate##2##2##(2012-2#2)
SPM diet##2##2##(2012-2#2)
SPM group##3##2##(2012-2#3)
SPM##17##1##(2008-10#4)(2008-2#4)(2012-2#9)
SPM2##2##1##(1996-6#2)
SPME and##4##2##(2008-10#4)
SPME conditions##2##2##(2008-10#2)
SPME fiber##8##2##(2008-10#7)(2009-8#1)
SPME fibre##6##2##(2008-10#6)
SPME fibres##2##2##(2008-10#1)(2012-12#1)
SPME method##4##2##(2008-10#4)
SPME was##2##2##(2008-10#2)
SPME##61##1##(2008-10#56)(2009-8#2)(2012-1#1)(2012-12#2)
SPME-HPLC interface##2##2##(2008-10#2)
SPME-HPLC##5##1##(2008-10#5)
SPMI##3##1##(2008-11#1)(2008-6#2)
SPN of the pancreas##2##4##(2013-1#2)
SPOM##3##1##(2008-8#3)
SPOMs##2##1##(2008-8#2)
SPR angle##3##2##(2008-10#1)(2008-3#2)
SPR biosensor has##2##3##(2008-10#2)
SPR biosensor is##2##3##(2008-10#2)
SPR biosensor##9##2##(2008-10#9)
SPR curve is##2##3##(2008-3#2)
SPR detector##3##2##(2008-10#3)
SPR probe##2##2##(2008-10#2)
SPR response##2##2##(2008-10#2)
SPR sensor chip##3##3##(2008-10#2)(2008-4#1)
SPR sensor was##2##3##(2008-10#2)
SPR sensor##11##2##(2008-10#10)(2008-4#1)
SPR sensors##2##2##(2008-10#2)
SPR##51##1##(1995-2#1)(2008-10#39)(2008-2#2)(2008-3#7)(2008-4#2)
SPR-EAE##2##1##(1995-12#2)
SPRED1##2##1##(2012-3#2)
SPS activity##2##2##(2011-2#2)
SPS##7##1##(2008-12#3)(2011-2#4)
SPSS software##3##2##(2007-7#1)(2008-12#1)(2013-8#1)
SPSS v##2##2##(2008-11#1)(2013-1#1)
SPSS##16##1##(1995-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-1#3)(2013-8#3)
SPT##2##1##(2008-10#1)(2012-3#1)
SPU##2##1##(2008-10#2)
SPVD##2##1##(2008-10#2)
SPs and##5##2##(2013-1#5)
SPs##11##1##(2010-4#1)(2013-1#10)
SQ##2##1##(1994-9#1)(2008-5#1)
SQG approach##4##2##(2012-1#4)
SQG indices##2##2##(2012-1#2)
SQG##8##1##(2012-1#8)
SQL##2##1##(2008-10#1)(2008-4#1)
SQUAD##3##1##(2008-10#3)
SQUAD(84)##2##1##(2008-10#2)
SR 48692 on##2##3##(1997-2#2)
SR 48692##4##2##(1997-2#4)
SR alpha##7##2##(1995-6#7)
SR beta##2##2##(1995-6#2)
SR in##3##2##(2008-6#1)(2008-8#1)(2013-8#1)
SR proteins##6##2##(2008-8#1)(2009-2#5)
SR##56##1##(1991-2#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-6#12)(1996-9#1)(1997-2#4)(1997-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#2)(2008-8#8)(2009-2#5)(2010-11#1)(2013-8#4)
SR2##3##1##(2008-10#1)(2008-2#2)
SR2-type##3##1##(2008-10#3)
SR95531##2##1##(1995-2#2)
SRA##4##1##(2012-2#4)
SRBC and##2##2##(2008-10#2)
SRBC##9##1##(2008-10#6)(2008-4#3)
SRBC-specific##2##1##(2008-10#2)
SRBCs##4##1##(1993-12#2)(2008-6#2)
SRC##3##1##(2010-11#1)(2012-12#1)(2012-2#1)
SRE##3##1##(1994-11#2)(2008-7#1)
SREs##5##1##(2008-7#5)
SRF##4##1##(1994-11#4)
SRGl##2##1##(2008-8#2)
SRH##8##1##(2011-2#4)(2013-1#4)
SRI##8##1##(2008-10#1)(2009-8#7)
SRIF mRNA expression in deeper cortical layers##2##7##(1995-2#2)
SRIF mRNA expression in##4##4##(1995-2#4)
SRIF mRNA expression##5##3##(1995-2#5)
SRIF mRNA##8##2##(1995-2#5)(1997-2#3)
SRIF pulse amplitude##2##3##(1997-2#2)
SRIF release##3##2##(1997-2#3)
SRIF##20##1##(1995-2#5)(1997-2#14)(2008-4#1)
SRL##5##1##(2008-8#5)
SRM 1649a##2##2##(2008-10#2)
SRM 2670##3##2##(2008-10#3)
SRM 2710 and SRM##2##4##(2008-10#2)
SRM 2710##3##2##(2008-10#3)
SRM 621##3##2##(2008-10#3)
SRM NIST##2##2##(2008-10#2)
SRM##50##1##(1995-6#1)(2008-10#48)(2009-9#1)
SRO##3##1##(2007-12#3)
SRP##6##1##(2012-3#6)
SRR intervention##2##2##(2013-1#2)
SRR##5##1##(2013-1#3)(2013-8#2)
SRS##10##1##(2008-2#1)(2008-3#5)(2008-7#2)(2012-12#2)
SRT1720##4##1##(2012-2#4)
SRY##2##1##(2008-12#1)(2008-4#1)
SRs##3##1##(2007-5#1)(2008-10#1)(2012-2#1)
SS activity was##2##3##(2011-2#2)
SS analogues##2##2##(2011-2#2)
SS coupons##3##2##(2013-8#3)
SS from##2##2##(2010-5#2)
SS to##2##2##(2008-12#1)(2010-5#1)
SS##47##1##(1993-12#1)(1993-8#2)(2007-11#7)(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#3)(2009-11#6)(2010-4#2)(2010-5#4)(2011-2#9)(2013-8#4)
SS-RTP emission##2##2##(2008-10#2)
SS-RTP##8##1##(2008-10#8)
SS-carriers##2##1##(2012-1#2)
SS-like immunoreactivity##3##2##(1996-5#3)
SS/Jr##3##1##(1993-12#3)
SS101 and##3##2##(2008-10#3)
SS101##7##1##(2008-10#7)
SS767 is##2##2##(2008-10#2)
SS767##5##1##(2008-10#5)
SSA and##2##2##(2008-8#1)(2013-1#1)
SSA##18##1##(1990-7#4)(1994-1#1)(1997-2#1)(2008-10#1)(2008-5#4)(2008-8#4)(2011-1#1)(2013-1#2)
SSA-performed chipmunks##3##2##(2008-5#3)
SSAT was##3##2##(1991-9#1)(1995-2#2)
SSAT##13##1##(1991-9#1)(1992-10#4)(1995-2#8)
SSB consumption##7##2##(2012-2#7)
SSB protein##2##2##(1997-2#2)
SSB##19##1##(1992-3#1)(1997-2#8)(2008-10#1)(2011-2#2)(2012-2#7)
SSC##2##1##(2008-9#1)(2012-2#1)
SSCF##2##1##(2008-6#2)
SSCP analysis of##2##3##(2008-10#2)
SSCP analysis##3##2##(2008-10#3)
SSCP##11##1##(1992-8#1)(2008-10#8)(2008-12#1)(2008-4#1)
SSCT of##2##2##(2008-9#2)
SSCT##9##1##(2008-9#9)
SSDS##6##1##(2008-3#6)
SSE (p = 0##2##4##(2013-8#2)
SSE##11##1##(2013-1#6)(2013-8#5)
SSE1 and SSE2##3##3##(1993-9#3)
SSE1##5##1##(1993-9#5)
SSE2##5##1##(1993-9#5)
SSEA-1 and##2##2##(2008-11#2)
SSEA-1##4##1##(2008-11#4)
SSEP##2##1##(1990-9#1)(2011-2#1)
SSF##5##1##(2008-6#4)(2013-1#1)
SSG##9##1##(1995-11#7)(2010-3#1)(2012-2#1)
SSH is a##2##3##(2008-7#1)(2012-12#1)
SSH##5##1##(2008-7#2)(2012-12#3)
SSI##5##1##(1995-12#1)(2008-8#1)(2010-12#3)
SSLB resistance##7##2##(2008-10#7)
SSLP markers##2##2##(2008-12#2)
SSM Health Care System##2##4##(1994-1#2)
SSM##4##1##(1994-1#2)(2008-5#2)
SSO##3##1##(1997-3#3)
SSO2##2##1##(1997-3#2)
SSP##8##1##(1991-3#1)(1993-1#2)(1994-12#2)(1997-7#1)(2010-2#2)
SSPE##2##1##(2007-7#1)(2012-12#1)
SSR genotypes##3##2##(2008-10#3)
SSR incidence was##2##3##(2008-10#2)
SSR incidence##5##2##(2008-10#5)
SSR loci##4##2##(2008-10#1)(2008-5#1)(2010-7#2)
SSR markers##6##2##(2008-10#5)(2008-5#1)
SSR prevalence##4##2##(2008-10#4)
SSR##36##1##(1996-8#2)(2008-10#24)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-7#3)
SSRD##2##1##(2008-7#2)
SSRI and##3##2##(2011-1#3)
SSRI treatment##4##2##(2008-6#1)(2011-1#3)
SSRI##16##1##(2008-1#1)(2008-3#1)(2008-6#3)(2011-1#8)(2012-3#2)(2013-1#1)
SSRIs##9##1##(1996-7#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)
SSRL##4##1##(2008-11#4)
SSRT##4##1##(2010-1#4)
SSRs and DRs##2##3##(2011-2#2)
SSRs are##3##2##(1996-8#2)(2010-10#1)
SSRs in the##3##3##(2008-5#1)(2008-7#1)(2010-7#1)
SSRs in##4##2##(1996-8#1)(2008-5#1)(2008-7#1)(2010-7#1)
SSRs##13##1##(1996-8#5)(2008-5#2)(2008-7#1)(2010-10#2)(2010-7#1)(2011-2#2)
SST##7##1##(1992-7#3)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)
SSTIs##7##1##(2009-4#7)
SSTR1 to##2##2##(1995-2#2)
SSTR1##5##1##(1995-2#4)(1997-2#1)
SSTR2 and SSTR5##3##3##(1995-2#3)
SSTR2 and##4##2##(1994-11#1)(1995-2#3)
SSTR2 subtype##2##2##(1993-3#2)
SSTR2##13##1##(1993-3#4)(1994-11#1)(1995-2#4)(1997-2#1)(2011-2#3)
SSTR2-expressing cells##2##2##(1995-2#2)
SSTR4##7##1##(1994-11#4)(1997-2#3)
SSTR5##5##1##(1995-2#4)(1997-2#1)
SSTR5-expressing cells##2##2##(1995-2#2)
SSU##3##1##(2010-3#1)(2013-1#2)
SSU71##4##1##(1995-6#4)
SSU81##2##1##(1995-6#2)
SSXII##4##1##(2011-1#4)
SSc##6##1##(2008-8#3)(2010-10#2)(2011-2#1)
ST depression and R wave amplitude##2##6##(1996-6#2)
ST elevation MI##2##3##(2008-3#2)
ST elevation myocardial infarction##5##4##(2008-3#2)(2009-12#1)(2010-5#1)(2013-8#1)
ST elevation##10##2##(2008-3#5)(2009-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
ST segment and##3##3##(1996-6#2)(2008-10#1)
ST segment depression##5##3##(2008-7#5)
ST segment elevation myocardial infarction##2##5##(2008-3#2)
ST segment elevation##7##3##(2008-12#1)(2008-3#4)(2011-2#1)(2012-3#1)
ST segment##16##2##(1996-6#2)(2008-10#2)(2008-12#1)(2008-3#4)(2008-7#5)(2011-2#1)(2012-3#1)
ST the##2##2##(2008-10#2)
ST##45##1##(1993-12#3)(1996-6#4)(2008-10#11)(2008-12#2)(2008-3#10)(2008-7#5)(2009-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
ST(e-s) + R(e-s) value##3##4##(1996-6#3)
ST-573##2##1##(2007-12#2)
ST-7##4##1##(2008-10#4)
ST-D##3##1##(2010-12#3)
ST-R##4##1##(2010-12#4)
ST-T##2##1##(2013-1#1)(2013-8#1)
ST-segment elevation in leads##2##4##(2008-12#2)
ST-segment elevation myocardial infarction##7##4##(2007-5#2)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#2)
ST-segment elevation##12##2##(2007-5#2)(2008-11#1)(2008-12#2)(2008-3#4)(2009-12#1)(2009-5#2)
ST-segment##13##1##(2007-5#2)(2008-11#1)(2008-12#2)(2008-3#4)(2009-12#1)(2009-5#2)(2012-12#1)
ST1-D10##2##1##(2008-10#2)
ST2##5##1##(2008-11#5)
ST3##8##1##(2008-4#8)
ST6##3##1##(2008-10#3)
ST638 and genistein##2##3##(1992-8#2)
ST638##6##1##(1992-8#3)(1993-3#1)(1994-6#2)
STA ion##3##2##(2008-10#3)
STA##7##1##(1995-6#2)(2008-10#4)(2008-11#1)
STA2##2##1##(1993-11#1)(1995-6#1)
STAGE##3##1##(2008-2#3)
STAR System focused microwave##2##4##(2008-10#2)
STAR##3##1##(2008-10#3)
STARD##5##1##(2007-12#1)(2008-12#3)(2013-7#1)
STAT (signal##2##2##(1996-2#1)(2009-3#1)
STAT##6##1##(1996-2#3)(2009-3#1)(2012-3#2)
STAT1##7##1##(2011-2#7)
STAT3 and survivin##2##3##(2011-2#2)
STAT3##7##1##(2008-3#1)(2008-7#1)(2011-2#3)(2012-3#2)
STAT5##2##1##(2008-8#2)
STATUS##3##1##(1997-5#1)(2008-7#1)(2009-5#1)
STATs 1 and 3 in cerebral##2##6##(2012-3#2)
STATs 1 and 3 in##3##5##(2012-3#3)
STATs 1 and 3##4##4##(2012-3#4)
STATs 1##5##2##(2012-3#5)
STATs##9##1##(1996-2#4)(2012-3#5)
STB##12##1##(1996-6#1)(2008-10#11)
STD cases##2##2##(2007-7#2)
STD clinic##3##2##(2007-7#3)
STD clinics##3##2##(2007-7#3)
STD##18##1##(1990-6#1)(1996-12#3)(2007-7#12)(2009-10#1)(2011-1#1)
STD/HIV##3##1##(1996-12#1)(2008-4#1)(2011-2#1)
STDP##3##1##(2009-8#3)
STDs##9##1##(1990-3#1)(1996-12#2)(1996-9#1)(2007-7#2)(2009-10#1)(2011-1#2)
STE7##3##1##(1997-4#3)
STEC serogroups##2##2##(2012-2#2)
STEC##6##1##(2012-2#5)(2012-3#1)
STELLS##3##1##(2012-3#3)
STEMI##11##1##(2008-3#9)(2011-2#1)(2012-3#1)
STG##2##1##(2008-5#1)(2009-10#1)
STH2##4##1##(2009-8#4)
STI and HIV##2##3##(2009-5#1)(2011-2#1)
STI and##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
STI##13##1##(2008-10#4)(2008-12#5)(2009-5#1)(2011-2#3)
STI/HIV##5##1##(2011-2#5)
STIKO##3##1##(1996-9#1)(2008-4#2)
STIMA-1##4##1##(2009-4#4)
STIs##5##1##(2007-7#1)(2008-12#2)(2011-2#2)
STL##2##1##(2008-10#2)
STLCV CR sequence##2##3##(2008-10#2)
STLCV is##2##2##(2008-10#2)
STLCV##11##1##(2008-10#11)
STLR and HEBB##2##3##(2008-11#2)
STM##10##1##(1993-12#1)(1994-11#2)(2008-7#2)(2008-8#1)(2010-7#3)(2010-9#1)
STMV 10##3##2##(2008-10#3)
STMV##8##1##(2008-10#8)
STN DBS did not##2##4##(2012-2#2)
STN DBS##7##2##(2012-2#7)
STN##9##1##(2009-8#1)(2012-2#8)
STP##4##1##(1994-11#3)(2008-10#1)
STP-like sequences##2##2##(1994-11#2)
STPP in##3##2##(2008-10#3)
STR loci in##3##3##(2008-12#3)
STR loci##15##2##(1995-11#1)(2008-12#14)
STR locus##2##2##(2008-12#2)
STR markers##5##2##(2008-12#5)
STR pairs##3##2##(2008-12#3)
STR profiling system for##2##4##(2008-12#2)
STR profiling##4##2##(1995-11#1)(2008-12#3)
STR typing##4##2##(2008-12#4)
STR##49##1##(1994-12#1)(1995-11#4)(2008-10#1)(2008-12#41)(2008-4#1)(2008-7#1)
STREAK and the##2##3##(2009-8#2)
STREAK##5##1##(2009-8#5)
STRs##7##1##(2008-12#5)(2008-6#1)(2011-1#1)
STS marker##2##2##(2008-10#2)
STS markers were##3##3##(2008-10#2)(2008-8#1)
STS markers##7##2##(1996-6#1)(2008-10#4)(2008-7#1)(2008-8#1)
STS##28##1##(1996-6#1)(2008-10#6)(2008-11#1)(2008-6#17)(2008-7#1)(2008-8#1)(2013-8#1)
STUDIES IN P53 HAPLOINSUFFICIENT MICE##2##5##(2008-9#2)
STUDIES IN TG##2##3##(2008-9#2)
STUDIES IN Tg##5##3##(2008-9#5)
STUDIES IN##11##2##(2008-9#11)
STUDIES##14##1##(2008-9#13)(2009-9#1)
STUDY DESIGN##5##2##(2009-6#1)(2011-2#3)(2012-12#1)
STUDY IN B6C3F 1 MICE Groups of##2##7##(2008-9#2)
STUDY IN B6C3F(1) MICE##4##4##(2008-9#4)
STUDY IN F344/N RATS Groups of##2##6##(2008-9#2)
STUDY IN FEMALE##2##3##(2008-9#2)
STUDY IN RATS##4##3##(2008-9#4)
STUDY IN Tg##5##3##(2008-8#1)(2008-9#4)
STUDY IN p53 HAPLOINSUFFICIENT MICE##3##5##(2008-8#1)(2008-9#2)
STUDY IN##23##2##(2008-8#3)(2008-9#20)
STUDY##36##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#20)(2009-4#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
STZ rat##2##2##(2008-4#1)(2011-1#1)
STZ rats##3##2##(1991-12#3)
STZ##10##1##(1991-12#4)(2008-4#2)(2011-1#1)(2012-3#2)(2013-1#1)
STZ-induced diabetic rat##2##3##(2011-1#2)
STZ-induced diabetic##3##2##(2011-1#2)(2012-3#1)
STZ-induced##7##1##(2008-10#1)(2011-1#2)(2012-3#1)(2013-1#3)
STZ-treated##2##1##(1996-12#1)(2011-1#1)
STox##4##1##(1993-6#4)
SU##2##1##(2008-10#2)
SU-8 resist##3##2##(2007-12#3)
SU-8##9##1##(2007-12#5)(2008-10#2)(2009-11#2)
SUBJECTS AND METHODS##3##3##(2009-1#1)(2010-11#2)
SUBSTANCE ABUSE##2##2##(1991-1#1)(2009-9#1)
SUD##2##1##(2009-11#1)(2009-9#1)
SUI##5##1##(2008-3#4)(2011-1#1)
SULTATS##2##1##(2011-2#2)
SUM2162##3##1##(2011-2#3)
SUMER detector A and##2##4##(2008-3#2)
SUMER detector##3##2##(2008-3#3)
SUMER in##3##2##(2008-3#3)
SUMER##19##1##(2008-2#7)(2008-3#12)
SUMMARY##36##1##(2009-1#1)(2010-3#3)(2010-7#17)(2010-9#7)(2011-1#1)(2011-2#7)
SUMO##5##1##(2008-4#2)(2009-7#3)
SUN protein that##2##3##(2008-9#2)
SUN##4##1##(2008-9#4)
SUPERQUAD program##3##2##(2008-10#3)
SUPERQUAD##4##1##(2008-10#4)
SUR##2##1##(2008-8#2)
SUR1##5##1##(2008-1#1)(2008-8#4)
SURF##2##1##(2013-8#2)
SURPASS##2##1##(2008-7#2)
SUS##3##1##(2012-3#1)(2013-1#2)
SUV##7##1##(1992-3#4)(2008-10#2)(2013-1#1)
SUVs##3##1##(2008-10#3)
SV 40 DNA##5##3##(1990-7#5)
SV 40##7##2##(1990-7#6)(1997-6#1)
SV##17##1##(1990-7#6)(1991-12#4)(1997-6#1)(2007-7#6)
SV-toxins I and II##3##4##(2008-10#3)
SV-toxins##5##1##(2008-10#5)
SV2 from##2##2##(1993-12#2)
SV2 is##2##2##(1993-12#2)
SV2##7##1##(1993-12#7)
SV2A##2##1##(1993-12#2)
SV40 DNA##3##2##(1993-8#1)(1994-6#1)(2008-11#1)
SV40 T antigen##2##3##(1993-8#1)(2008-4#1)
SV40 TAg##2##2##(1995-6#1)(2008-11#1)
SV40 early promoter##4##3##(1995-6#1)(2008-11#3)
SV40 promoter##3##2##(1990-12#1)(1993-12#1)(2008-11#1)
SV40##24##1##(1990-12#2)(1993-12#1)(1993-8#2)(1994-6#2)(1995-12#1)(1995-6#4)(1996-5#1)(2008-11#7)(2008-2#2)(2008-4#1)(2009-2#1)
SV40-transformed##4##1##(1994-11#2)(1997-4#1)(1997-7#1)
SVC syndrome##2##2##(2008-1#2)
SVC##8##1##(2007-8#4)(2008-1#3)(2011-2#1)
SVD##2##1##(2011-2#2)
SVG group##2##2##(2007-8#2)
SVG##6##1##(2007-8#6)
SVLS##2##1##(2008-3#2)
SVM##5##1##(2008-11#3)(2008-2#1)(2013-8#1)
SVM-based##2##1##(2008-11#2)
SVP##3##1##(1993-6#2)(2009-8#1)
SVP-group MADS-box proteins##3##3##(2009-8#3)
SVP-group MADS-box##4##2##(2009-8#4)
SVPC are##2##2##(2010-11#2)
SVPC##6##1##(2010-11#6)
SVR rates##4##2##(2012-1#2)(2013-1#2)
SVR##13##1##(2011-2#3)(2012-1#5)(2012-12#1)(2013-1#4)
SVV error##3##2##(2013-1#3)
SVV##4##1##(2013-1#4)
SVZ cells##2##2##(2008-7#2)
SVZ##7##1##(2008-7#7)
SW and A/J mice##2##4##(1991-8#2)
SW and##5##2##(1991-8#2)(2008-10#1)(2008-7#2)
SW mice##2##2##(1991-8#2)
SW##27##1##(1991-8#5)(1996-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#5)(2011-2#1)
SW-13##3##1##(1990-12#3)
SW1116##2##1##(1997-7#1)(2008-11#1)
SW480##2##1##(2008-11#2)
SW613-S##4##1##(1992-9#4)
SWASV##2##1##(2008-10#2)
SWB##5##1##(2013-1#5)
SWCNTs##3##1##(2013-1#3)
SWE/WRP-LC##2##1##(2008-10#2)
SWI is##3##2##(2012-2#3)
SWI##4##1##(2012-2#4)
SWI/SNF complex##4##2##(1996-2#4)
SWI/SNF##5##1##(1996-2#5)
SWISS mice##3##2##(2008-12#3)
SWISS-PROT database##2##2##(1990-7#1)(2008-7#1)
SWISS-PROT##3##1##(1990-7#1)(2008-7#2)
SWIs##3##1##(2007-8#3)
SWNT mats##2##2##(2008-10#2)
SWNT##5##1##(2008-10#2)(2008-7#2)(2009-11#1)
SWNTs by##2##2##(2008-10#1)(2009-11#1)
SWNTs with##2##2##(2008-7#1)(2009-11#1)
SWNTs##26##1##(2008-10#3)(2008-7#20)(2009-11#3)
SWOT##2##1##(2008-11#1)(2009-10#1)
SWS##3##1##(2007-12#2)(2008-11#1)
SWV##6##1##(2008-10#6)
SY##3##1##(2008-10#2)(2008-5#1)
SYBR Green I and##2##4##(2012-2#2)
SYBR Green I##6##3##(2008-10#1)(2008-9#1)(2012-2#3)(2012-3#1)
SYBR Green and##2##3##(2008-10#1)(2008-9#1)
SYBR Green##17##2##(2008-10#4)(2008-9#4)(2010-6#1)(2012-2#4)(2012-3#3)(2013-8#1)
SYBR Green-based##3##2##(2008-12#1)(2012-3#2)
SYBR green##2##2##(2008-10#1)(2012-3#1)
SYBR##22##1##(2008-10#5)(2008-12#1)(2008-9#4)(2010-6#1)(2012-2#4)(2012-3#6)(2013-8#1)
SYSTEM##4##1##(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
SYSTEMS##2##1##(2011-1#1)(2012-12#1)
SYSV and WoYSV##2##3##(2008-10#2)
SYSV and##4##2##(2008-10#4)
SYSV##8##1##(2008-10#8)
SYTO9##3##1##(2008-10#2)(2009-6#1)
SYTO9-stained##3##1##(2008-10#3)
SYTOX Green##4##2##(2008-10#1)(2008-9#3)
SZ##6##1##(1997-5#2)(2009-7#4)
SZA's##2##1##(2008-2#2)
Sa strain 1054##2##3##(1995-8#2)
Sa strain##3##2##(1995-8#2)(2008-8#1)
Sa##5##1##(1994-12#1)(1995-8#3)(2008-8#1)
SaO2##2##1##(1992-11#1)(2007-8#1)
Sabin 1##2##2##(2008-11#2)
Sabin##3##1##(2008-11#2)(2008-7#1)
Saboraud##2##1##(2008-5#1)(2013-1#1)
Sabouraud##2##1##(2008-5#2)
Sabouraud's##5##1##(2007-7#2)(2008-5#2)(2009-11#1)
Sac##6##1##(1990-5#3)(2008-11#1)(2008-2#2)
SacI##3##1##(1990-12#1)(2008-10#1)(2008-5#1)
SacII and ClaI)##2##3##(1994-12#2)
SacII site##2##2##(2008-8#2)
SacII##5##1##(1994-12#3)(2008-8#2)
Sacbrood##3##1##(2008-8#3)
Saccharomyces and##2##2##(2008-5#1)(2013-1#1)
Saccharomyces bayanus and Saccharomyces cerevisiae##2##5##(1996-6#2)
Saccharomyces boulardii##3##2##(1993-3#2)(2009-8#1)
Saccharomyces cerevisiae (Sc)##2##3##(1995-8#1)(1997-7#1)
Saccharomyces cerevisiae LYS7 gene##2##4##(1995-8#2)
Saccharomyces cerevisiae and Schizosaccharomyces pombe##2##5##(1995-2#1)(2008-4#1)
Saccharomyces cerevisiae and##6##3##(1991-12#1)(1995-2#1)(1996-3#2)(2008-4#1)(2008-7#1)
Saccharomyces cerevisiae by##5##3##(1991-8#1)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)
Saccharomyces cerevisiae cell##2##3##(1996-3#1)(1997-3#1)
Saccharomyces cerevisiae cells##3##3##(1993-8#1)(1995-9#1)(2008-4#1)
Saccharomyces cerevisiae chromosome VI##2##4##(1995-12#2)
Saccharomyces cerevisiae chromosome VII reveals##2##5##(1995-9#1)(1997-3#1)
Saccharomyces cerevisiae chromosome VII##9##4##(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#6)
Saccharomyces cerevisiae chromosome##16##3##(1994-9#2)(1995-12#2)(1995-9#1)(1996-3#3)(1996-6#1)(1997-3#7)
Saccharomyces cerevisiae contains four##2##4##(1995-6#1)(2009-5#1)
Saccharomyces cerevisiae contains##3##3##(1990-12#1)(1995-6#1)(2009-5#1)
Saccharomyces cerevisiae for##2##3##(1994-3#1)(2008-6#1)
Saccharomyces cerevisiae has been##4##4##(1991-9#1)(1996-3#1)(1996-6#1)(2008-6#1)
Saccharomyces cerevisiae has##8##3##(1991-9#1)(1992-10#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-4#1)(2008-6#1)(2012-3#1)
Saccharomyces cerevisiae immobilized on sepiolite and##2##6##(2008-10#2)
Saccharomyces cerevisiae immobilized##4##3##(2008-10#4)
Saccharomyces cerevisiae is##5##3##(1993-9#2)(1996-3#1)(1996-6#1)(2012-3#1)
Saccharomyces cerevisiae mutants defective in##2##5##(1996-3#2)
Saccharomyces cerevisiae mutants##4##3##(1995-2#1)(1996-3#2)(1997-3#1)
Saccharomyces cerevisiae of##2##3##(1996-3#1)(1997-7#1)
Saccharomyces cerevisiae protein##3##3##(1995-6#1)(1996-6#1)(2008-7#1)
Saccharomyces cerevisiae that##4##3##(1993-12#1)(1995-2#1)(1997-6#1)(1997-7#1)
Saccharomyces cerevisiae the##2##3##(1996-3#1)(1996-6#1)
Saccharomyces cerevisiae treated with an antifungal##2##6##(1992-11#2)
Saccharomyces cerevisiae was##9##3##(1994-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#1)(2008-6#1)
Saccharomyces cerevisiae##239##2##(1990-12#3)(1990-2#3)(1990-5#13)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#5)(1992-10#2)(1992-11#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#8)(1994-12#6)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#16)(1995-8#4)(1995-9#7)(1996-12#2)(1996-2#2)(1996-3#16)(1996-6#12)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#17)(1997-4#5)(1997-6#2)(1997-7#6)(1997-8#2)(2008-10#10)(2008-11#1)(2008-2#3)(2008-4#4)(2008-6#5)(2008-7#12)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#9)(2013-1#2)
Saccharomyces douglasii##2##2##(1993-2#2)
Saccharomyces sp##3##2##(2011-1#3)
Saccharomyces##262##1##(1990-12#3)(1990-2#3)(1990-5#13)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#5)(1992-10#2)(1992-11#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#3)(1993-9#8)(1994-12#7)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#18)(1995-8#4)(1995-9#7)(1996-12#2)(1996-2#2)(1996-3#16)(1996-6#14)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#17)(1997-4#5)(1997-6#2)(1997-7#7)(1997-8#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#12)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#5)(2012-2#1)(2012-3#13)(2013-1#3)
Saccharopolyspora##2##1##(1990-5#2)
Saccharum##3##1##(2008-10#3)
Sach##4##1##(2007-7#4)
Sach)##4##1##(2007-7#4)
Sacral##3##1##(2008-10#1)(2008-7#2)
Sacroiliac joint##3##2##(2010-1#3)
Safavi##2##1##(2008-10#2)
Safe Motherhood##6##2##(1994-3#2)(2010-12#4)
Safe Refuge##2##2##(1993-12#2)
Safe and effective##2##3##(2010-8#1)(2011-2#1)
Safe and##5##2##(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
Safe use of hazardous chemicals##2##5##(2008-2#1)(2008-9#1)
Safe use of##4##3##(2008-2#1)(2008-9#2)(2012-2#1)
Safe##32##1##(1991-2#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-3#4)(1997-3#1)(2007-2#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-9#3)(2010-12#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Safeguarding##2##1##(1991-12#1)(2007-5#1)
Safety Assessment of##2##3##(2008-11#1)(2013-1#1)
Safety Law##2##2##(2010-4#2)
Safety and tolerability of##3##4##(1996-1#1)(2008-3#1)(2012-2#1)
Safety and##21##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
Safety considerations##2##2##(1992-2#1)(1992-3#1)
Safety for##2##2##(2008-11#1)(2008-8#1)
Safety has been##2##3##(2008-8#1)(2012-3#1)
Safety in nuclear power plants##2##5##(2009-12#2)
Safety in the##2##3##(1992-2#1)(2007-2#1)
Safety in##6##2##(1991-12#1)(1992-2#1)(2007-2#1)(2009-12#2)(2012-12#1)
Safety issues##2##2##(1992-9#1)(2008-11#1)
Safety of##15##2##(1990-6#1)(1992-3#1)(1996-1#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
Safety##94##1##(1990-6#1)(1991-12#3)(1992-2#2)(1992-3#4)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#2)(2007-2#1)(2007-7#2)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#3)
Safety)##3##1##(1991-12#1)(1992-12#1)(1992-2#1)
Safoof Mohazzil##7##2##(2013-1#7)
Safranin O##2##2##(2008-11#2)
Safranine##5##1##(2008-10#4)(2008-11#1)
Sagas##2##1##(1993-3#2)
Sage##5##1##(2008-12#4)(2008-7#1)
Sagittae##2##1##(2013-7#2)
Sagnac interferometer with##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
Sagnac interferometer##17##2##(2007-11#4)(2007-12#9)(2008-2#2)(2008-3#2)
Sagnac loop##2##2##(2007-11#2)
Sagnac##25##1##(2007-11#7)(2007-12#10)(2008-2#5)(2008-3#3)
Saimiri##5##1##(2011-2#5)
Saint Camille Medical Centre##2##4##(2008-12#2)
Saint Gaudens##3##2##(2011-2#3)
Saint Paul##2##2##(1996-2#1)(2009-7#1)
Saint##13##1##(1996-2#1)(1996-4#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#3)
SalI##11##1##(1991-9#2)(1993-2#1)(1994-12#8)
Salamandrina##2##1##(2008-7#2)
Salambô##2##1##(2008-12#2)
Salamouni##3##1##(2008-10#3)
Salanx ariakensis##2##2##(2010-8#2)
Salaries##2##1##(1997-2#1)(2008-6#1)
Salary##2##1##(1991-1#1)(1991-3#1)
Sales##2##1##(1996-3#1)(2008-5#1)
Salicaceae##2##1##(2012-3#2)
Salicylate##2##1##(1993-12#1)(2008-10#1)
Salicylic Acid##4##2##(2008-10#4)
Salicylic acid (SA)##2##3##(2008-10#1)(2009-6#1)
Salicylic acid##3##2##(2007-7#1)(2008-10#1)(2009-6#1)
Salicylic##7##1##(2007-7#1)(2008-10#5)(2009-6#1)
Salient##2##1##(1993-5#1)(2008-7#1)
Salinas and Sniper were##2##4##(2008-10#2)
Salinas and##3##2##(2008-10#3)
Salinas##15##1##(2008-10#10)(2008-5#5)
Saline##4##1##(2008-11#1)(2010-10#1)(2012-5#1)(2012-7#1)
Salisbury Cove##2##2##(2008-8#2)
Salisbury##3##1##(2008-10#1)(2008-8#2)
Saliva##6##1##(1992-12#1)(2008-10#1)(2012-3#3)(2013-1#1)
Salivary gland tumours##2##3##(2012-2#2)
Salivary gland##3##2##(2007-5#1)(2012-2#2)
Salivary##7##1##(1990-6#1)(2007-5#1)(2008-10#1)(2011-1#1)(2012-2#2)(2013-8#1)
Salix viminalis##2##2##(2012-3#2)
Salix##5##1##(2012-3#5)
Salmo salar##2##2##(2009-6#1)(2013-1#1)
Salmo trutta##2##2##(2008-10#1)(2008-5#1)
Salmo##4##1##(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#1)
Salmon calcitonin##2##2##(1993-11#2)
Salmon##3##1##(1993-11#2)(2008-8#1)
Salmonella Enteritidis##4##2##(1997-3#1)(2010-4#2)(2011-2#1)
Salmonella Typhimurium##2##2##(2009-5#1)(2011-2#1)
Salmonella enterica serovar Typhimurium##3##4##(2008-10#1)(2008-11#2)
Salmonella enterica serovar##9##3##(1997-3#3)(2008-10#1)(2008-11#2)(2010-4#1)(2012-3#2)
Salmonella enterica subsp##2##3##(2007-6#2)
Salmonella enterica##12##2##(1997-3#3)(2007-6#2)(2007-7#1)(2008-10#1)(2008-11#2)(2010-4#1)(2012-3#2)
Salmonella enteritidis PT4##3##3##(1991-11#2)(1995-9#1)
Salmonella enteritidis in##2##3##(1990-6#1)(1994-7#1)
Salmonella enteritidis##13##2##(1990-12#1)(1990-6#1)(1991-11#2)(1993-2#1)(1994-7#1)(1995-9#3)(1997-3#1)(2007-8#2)(2008-10#1)
Salmonella enteritidis]##2##2##(1990-6#1)(1991-3#1)
Salmonella infection##3##2##(2011-2#1)(2013-8#2)
Salmonella infections##2##2##(1997-3#1)(2013-8#1)
Salmonella isolates were##2##3##(2008-10#1)(2011-2#1)
Salmonella species##3##2##(1995-5#1)(2007-12#2)
Salmonella spp non typhi##3##4##(1990-6#3)
Salmonella spp non##4##3##(1990-6#4)
Salmonella spp##5##2##(1990-6#4)(2008-10#1)
Salmonella typhi endotoxin##2##3##(1990-12#2)
Salmonella typhi##8##2##(1990-12#2)(2007-7#5)(2008-8#1)
Salmonella typhimurium TA100##2##3##(1992-2#1)(1996-2#1)
Salmonella typhimurium and##2##3##(1997-3#1)(2008-9#1)
Salmonella typhimurium##28##2##(1990-11#2)(1991-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-8#2)(1996-2#2)(1996-6#2)(1997-3#1)(2008-10#1)(2008-8#3)(2008-9#5)(2009-5#3)(2010-4#2)(2011-1#1)
Salmonella##122##1##(1990-11#2)(1990-12#4)(1990-3#2)(1990-5#1)(1990-6#6)(1991-11#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-9#3)(1996-2#4)(1996-6#2)(1997-3#8)(2007-12#4)(2007-6#2)(2007-7#8)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#6)(2009-5#5)(2009-8#4)(2010-4#6)(2010-8#1)(2011-1#2)(2011-2#10)(2012-3#3)(2013-1#1)(2013-8#7)
Salmonella-induced migration of##2##3##(2011-2#2)
Salt Lake##2##2##(1996-1#1)(2013-1#1)
Salt##5##1##(1996-1#1)(1997-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
Salts##2##1##(2007-11#1)(2009-10#1)
Saluda##2##1##(2008-10#2)
Salvador##13##1##(1991-9#2)(1992-5#1)(1994-2#1)(2008-10#2)(2008-9#1)(2009-10#3)(2010-10#1)(2011-2#2)
Salvage##6##1##(1994-8#1)(2008-6#3)(2009-1#1)(2012-3#1)
Salvelinus alpinus##3##2##(2010-8#3)
Salvelinus##4##1##(2010-8#4)
Salvia divinorum##2##2##(2008-12#1)(2009-12#1)
Salvia miltiorrhiza Bunge##2##3##(2008-10#2)
Salvia miltiorrhiza##5##2##(2008-10#5)
Salvia species##2##2##(2008-11#1)(2009-12#1)
Salvia splendens##3##2##(2008-5#1)(2009-12#2)
Salvia##20##1##(1990-7#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#2)(2009-12#4)(2012-3#1)(2013-7#1)
Sambucus ebulus##2##2##(2008-12#2)
Sambucus##3##1##(1994-11#1)(2008-12#2)
Same and Opposite##2##3##(2011-2#2)
Same##10##1##(1996-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Samoa and##3##2##(2012-12#2)(2013-8#1)
Samoa##9##1##(2008-1#5)(2012-12#2)(2013-8#2)
Samoan##3##1##(2008-1#3)
Samp1##2##1##(2011-2#2)
Sample and##4##2##(2008-10#4)
Sample collection##2##2##(2008-10#1)(2008-6#1)
Sample of##2##2##(2012-12#1)(2013-8#1)
Sample pre-treatment##2##2##(2008-10#2)
Sample preparation and##2##3##(2008-10#1)(2008-9#1)
Sample preparation for##2##3##(1994-7#1)(2012-2#1)
Sample preparation was##3##3##(2008-10#2)(2013-8#1)
Sample preparation##11##2##(1994-7#1)(2008-10#7)(2008-9#1)(2012-2#1)(2013-8#1)
Sample size and##2##3##(2007-7#1)(2008-10#1)
Sample size determination##2##3##(1994-2#1)(1995-9#1)
Sample size##13##2##(1994-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2012-3#2)(2013-1#1)
Sample sizes##2##2##(2010-6#1)(2012-3#1)
Sample solutions##4##2##(2008-10#4)
Sample throughput##2##2##(2008-10#2)
Sample throughputs##2##2##(2008-10#2)
Sample##73##1##(1992-12#1)(1994-2#1)(1994-7#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#2)(2007-12#1)(2007-7#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#2)
Sampled##3##1##(2007-11#1)(2008-10#1)(2008-5#1)
Sampler for the measurement of outdoor##2##6##(2008-5#2)
Sampler##11##1##(2008-4#1)(2008-5#9)(2010-5#1)
Samplers##4##1##(2008-10#1)(2008-5#3)
Samples are##3##2##(2008-10#3)
Samples from the##2##3##(2008-10#1)(2010-8#1)
Samples from##5##2##(1992-9#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
Samples of blood were taken from##2##6##(1997-5#1)(2008-5#1)
Samples of blood were##3##4##(1997-5#1)(2008-5#2)
Samples of different##2##3##(1994-9#1)(2008-3#1)
Samples of##28##2##(1991-12#1)(1991-6#1)(1994-8#1)(1994-9#1)(1997-5#1)(2007-10#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-7#1)(2012-1#1)(2012-2#2)(2013-8#2)
Samples were collected##5##3##(1992-3#1)(2008-10#3)(2011-2#1)
Samples were diluted##2##3##(2008-10#2)
Samples were dissolved##2##3##(2008-10#2)
Samples were dried##2##3##(2008-10#1)(2013-7#1)
Samples were extracted with##3##4##(2008-10#2)(2008-5#1)
Samples were extracted##4##3##(2008-10#3)(2008-5#1)
Samples were injected##2##3##(2008-10#2)
Samples were prepared##2##3##(2008-10#1)(2008-5#1)
Samples were subjected##2##3##(2007-7#1)(2008-10#1)
Samples were taken from##3##4##(1994-1#1)(2007-12#1)(2008-10#1)
Samples were taken in##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
Samples were taken##8##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-7#1)
Samples were##44##2##(1992-3#1)(1994-1#1)(2007-12#1)(2007-7#1)(2008-10#25)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
Samples##104##1##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#50)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
Sampling a##2##2##(2007-12#1)(2008-3#1)
Sampling and##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
Sampling by use of##2##4##(2008-2#1)(2008-3#1)
Sampling for##4##2##(2008-10#4)
Sampling in##2##2##(2008-10#2)
Sampling of the##2##3##(2008-10#1)(2008-3#1)
Sampling of##6##2##(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)
Sampling rate##2##2##(2008-10#1)(2012-3#1)
Sampling sites were##2##3##(1994-9#1)(2013-7#1)
Sampling strategies for the analysis of glass fragments by LA-ICP-MS Part##2##11##(2008-10#2)
Sampling was carried out##2##4##(2008-10#1)(2008-5#1)
Sampling was##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
Sampling##45##1##(1994-9#1)(2007-12#1)(2008-10#24)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Samuel##2##1##(2009-7#1)(2011-1#1)
Samy El-Shall##2##2##(2010-7#2)
San Andreas Fault##2##3##(1996-4#2)
San Andreas fault##3##3##(1990-11#1)(1996-4#2)
San Andreas##5##2##(1990-11#1)(1996-4#4)
San Antonio Breast Cancer Symposium##2##5##(2008-7#1)(2009-4#1)
San Antonio##8##2##(2008-1#1)(2008-7#2)(2009-11#1)(2009-4#1)(2012-12#3)
San Diego##20##2##(1990-8#1)(1993-12#2)(1994-9#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
San Francisco Medical##3##3##(2010-8#3)
San Francisco##18##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#4)(2011-2#1)
San Ignacio Lagoon##4##3##(2013-7#4)
San Joaquin Valley##5##3##(2008-10#4)(2011-2#1)
San Joaquin##9##2##(2008-10#8)(2011-2#1)
San Luis Potosí##4##3##(2011-2#4)
San Luis beach##2##3##(2013-7#2)
San Luis##8##2##(2011-2#5)(2013-7#3)
San Vicente de##2##3##(2012-12#2)
San##86##1##(1990-11#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-9#1)(1996-3#2)(1996-4#4)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2009-11#2)(2009-4#1)(2010-8#4)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#2)(2013-7#7)(2013-8#1)
Sand##4##1##(2008-12#1)(2008-3#1)(2013-1#2)
Sandell sensitivity##3##2##(2008-10#3)
Sandell's sensitivity of##3##3##(2008-10#3)
Sandell's sensitivity##14##2##(2008-10#14)
Sanger sequencing##2##2##(2010-10#1)(2012-2#1)
Sanger##5##1##(2006-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Sangli##2##1##(2013-8#2)
Sanguinarine##3##1##(2011-2#3)
Sanitation##2##1##(2008-1#1)(2009-10#1)
Sanjabi and Lori sheep##2##4##(2008-12#2)
Sanjabi and Lori##3##3##(2008-12#3)
Sanjabi##7##1##(2008-12#7)
Santa Casa##2##2##(2009-10#2)
Santa Catarina State##2##3##(2008-9#2)
Santa Clara##3##2##(1995-12#1)(2008-5#1)(2010-8#1)
Santa Cruz##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-10#1)
Santa Maria##3##2##(2008-10#2)(2011-2#1)
Santa##22##1##(1995-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-8#1)(2008-9#4)(2009-10#2)(2010-10#1)(2010-8#1)(2011-2#1)
Santander and Caquetá##2##3##(2012-12#2)
Santander##8##1##(2012-12#8)
Santiago de Cuba Techo strain##3##5##(2007-10#3)
Santiago de Cuba##8##3##(2007-10#7)(2008-7#1)
Santiago de##10##2##(2007-10#7)(2008-7#1)(2012-12#1)(2013-1#1)
Santiago##25##1##(1997-6#1)(2007-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#4)(2013-1#8)
Santos##2##1##(1994-5#1)(2013-8#1)
Sao Paulo##6##2##(1993-8#5)(2012-3#1)
Sao##7##1##(1993-8#5)(2012-3#2)
Saposhnikovia divaricata##2##2##(2008-10#2)
Sapphire##3##1##(2008-2#1)(2008-3#2)
Saprolegniales) as a mosquito larvae pathogen##2##6##(2008-5#2)
Saprophytic Activity##2##2##(2008-10#2)
Saprophytic##5##1##(2008-10#5)
Sapstain##3##1##(2008-10#3)
Sar-SP##2##1##(2008-8#2)
Sara##3##1##(2013-1#3)
Sarah Ben Ami Solodar##2##4##(2011-2#2)
Sarah##3##1##(2009-12#1)(2011-2#2)
Saranac##2##1##(2008-10#2)
Sarason##3##1##(1992-1#3)
Sarawak##5##1##(2008-12#4)(2011-1#1)
Sarcandra glabra and its medicinal preparations##2##6##(2008-10#2)
Sarcandra glabra and##3##3##(2008-10#3)
Sarcandra##4##1##(2008-10#4)
Sarcoidosis is an##2##3##(2010-6#1)(2012-12#1)
Sarcoidosis is##4##2##(2008-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
Sarcoidosis##7##1##(2008-4#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
Sarcoma Group##4##2##(2008-6#1)(2010-3#3)
Sarcoma of the##4##3##(1994-7#1)(2008-6#1)(2010-12#1)(2011-2#1)
Sarcoma of##5##2##(1994-7#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
Sarcoma##20##1##(1994-7#1)(2008-1#1)(2008-6#11)(2010-12#1)(2010-3#3)(2011-2#1)(2012-12#1)(2012-3#1)
Sarcomas of##2##2##(1994-6#1)(2008-6#1)
Sarcomas##7##1##(1994-6#2)(2008-6#5)
Sarcomatoid##2##1##(2009-5#2)
Sarcomatous##2##1##(1991-11#1)(2008-6#1)
Sarcoptes scabiei##4##2##(1990-3#1)(2008-12#3)
Sardinia (Italy)##2##2##(1993-8#1)(2013-8#1)
Sardinia##9##1##(1993-8#1)(2008-10#5)(2013-8#3)
Sardinian##3##1##(1990-8#1)(2008-10#1)(2012-2#1)
Sargassum sp##4##2##(2008-12#2)(2011-2#2)
Sargassum##13##1##(2008-10#4)(2008-11#2)(2008-12#2)(2011-2#5)
Sarin##2##1##(2008-10#1)(2008-2#1)
Sars##6##1##(1993-3#3)(2007-5#1)(2008-5#2)
Sasang types##2##2##(2012-12#2)
Sasang typology##4##2##(2012-12#4)
Sasang##6##1##(2012-12#6)
Saskatchewan River##2##2##(1992-5#1)(2007-12#1)
Saskatchewan and##2##2##(2007-12#1)(2010-8#1)
Saskatchewan was##2##2##(2008-12#1)(2008-7#1)
Saskatchewan##19##1##(1992-5#1)(1995-12#2)(1996-1#2)(2007-12#2)(2008-10#3)(2008-12#2)(2008-7#5)(2008-8#1)(2010-8#1)
Satellite Measurements##2##2##(2008-3#2)
Satellite RNA of##2##3##(2008-10#2)
Satellite RNA##3##2##(2008-10#3)
Satellite RNAs##2##2##(2008-10#2)
Satellite cells##2##2##(2008-7#1)(2009-3#1)
Satellite glial cells##2##3##(2008-6#2)
Satellite in##2##2##(2008-2#2)
Satellite##39##1##(1992-1#2)(1993-3#1)(1994-3#1)(2008-10#7)(2008-2#9)(2008-3#12)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
Satelliting##3##1##(1996-3#1)(2007-7#2)
Satisfaction of residents and families in long-term care##2##8##(1997-1#2)
Satisfaction of##3##2##(1993-3#1)(1997-1#2)
Satisfaction regarding##3##2##(2008-11#3)
Satisfaction with a modified form of in-hospital birth center care compared with standard maternity care##2##15##(2013-1#2)
Satisfaction with medical care##2##4##(1996-2#1)(1996-3#1)
Satisfaction with##9##2##(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2009-11#1)(2012-3#1)(2013-1#2)
Satisfaction##27##1##(1993-3#2)(1995-1#1)(1996-2#1)(1996-3#2)(1997-1#3)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#2)(2010-2#1)(2010-8#2)(2012-3#1)(2013-1#3)
Satisfactory recoveries were obtained in the analysis of##2##8##(2008-10#2)
Satisfactory results were obtained in the determination of##2##8##(2008-10#2)
Satisfactory results were obtained##5##4##(2008-10#5)
Satisfactory results##6##2##(2008-10#6)
Satisfactory##19##1##(2007-8#1)(2008-10#15)(2011-1#2)(2011-2#1)
Satisfying##3##1##(2008-10#1)(2008-12#1)(2008-4#1)
Satsumadori##3##1##(2012-1#3)
Saturable Absorber##6##2##(2008-2#1)(2008-3#5)
Saturable##9##1##(1992-3#2)(2008-2#1)(2008-3#6)
Saturated##3##1##(2008-3#1)(2008-5#1)(2009-5#1)
Saturation of the##2##3##(2008-3#1)(2008-5#1)
Saturation##9##1##(1990-7#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-1#1)(2013-1#1)
Saturday##3##1##(1993-2#1)(2008-7#1)(2013-8#1)
Satureja##2##1##(2008-11#1)(2008-5#1)
Sau3AI##2##1##(1991-6#1)(2008-10#1)
Saucy-Marbet##2##1##(2009-11#2)
Saudi Arabia to##3##3##(2008-1#3)
Saudi Arabia was##2##3##(2008-1#2)
Saudi Arabia were##5##3##(2007-7#1)(2008-1#3)(2008-10#1)
Saudi Arabia##67##2##(1994-2#1)(2007-12#1)(2007-2#4)(2007-7#5)(2008-1#38)(2008-10#2)(2008-12#2)(2008-4#7)(2010-11#2)(2013-1#2)(2013-7#1)(2013-8#2)
Saudi patients##3##2##(2008-1#1)(2008-4#1)(2009-7#1)
Saudi##82##1##(1994-2#1)(2007-12#1)(2007-2#7)(2007-7#6)(2008-1#42)(2008-10#2)(2008-12#2)(2008-4#9)(2008-8#1)(2009-7#1)(2010-11#3)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
Savanna##5##1##(2008-12#2)(2012-12#3)
Savannah##7##1##(2008-10#7)
Saving##3##1##(1995-1#1)(1996-12#1)(2010-11#1)
Savings##2##1##(1992-2#1)(2008-5#1)
Savitsky-Golay##2##1##(2008-10#2)
Savitzky-Golay##3##1##(2008-10#1)(2013-8#2)
Sawdust##3##1##(2008-12#3)
Saxony##4##1##(2008-11#4)
Say##3##1##(2008-10#1)(2009-1#1)(2010-4#1)
Saying##3##1##(1994-1#1)(2008-8#1)(2009-9#1)
Sb and Bi##2##3##(2008-10#2)
Sb and##5##2##(2008-10#5)
Sb in##5##2##(2008-10#5)
Sb was##4##2##(2008-10#4)
Sb##57##1##(2007-11#1)(2008-10#56)
Sb(3+) and##2##2##(2008-10#2)
Sb(3+)##3##1##(2008-10#3)
Sb(III) and Bi(III)##5##3##(2008-10#5)
Sb(III) and Sb(V)##12##3##(2008-10#12)
Sb(III) and##22##2##(2008-10#22)
Sb(III) for##2##2##(2008-10#2)
Sb(III) in##6##2##(2008-10#6)
Sb(III) with##2##2##(2008-10#2)
Sb(III)##43##1##(2008-10#43)
Sb(V) and TMSbCl(2)##2##3##(2008-10#2)
Sb(V) and##6##2##(2008-10#6)
Sb(V) in##3##2##(2008-10#3)
Sb(V)##34##1##(2008-10#34)
SbDV isolates##2##2##(2008-10#2)
SbDV##5##1##(2008-10#5)
SbF(6)(-)##2##1##(2008-10#2)
SbPRP was##2##2##(2008-8#2)
SbPRP##5##1##(2008-8#5)
Sc + Pd + NH(4)NO(3)##3##5##(2008-10#3)
Sc + Pd##4##3##(2008-10#4)
Sc +##6##2##(2008-10#6)
Sc J802##2##2##(1995-8#2)
Sc##19##1##(1995-2#1)(1995-8#5)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
Sc(3+) and Y(3+)##2##3##(2008-10#2)
ScA##4##1##(2008-11#4)
ScYLV##6##1##(2008-10#6)
Sca-1##4##1##(2010-11#2)(2010-8#2)
Sca-1(+)##2##1##(2010-11#2)
Scab Resistance##3##2##(2008-10#3)
Scab in##2##2##(2008-10#2)
Scab##16##1##(2008-10#16)
Scabies##3##1##(1991-12#1)(2007-7#1)(2010-6#1)
Scaffolds##2##1##(2009-10#1)(2013-1#1)
Scalability##2##1##(2008-3#1)(2008-7#1)
Scalable##2##1##(2007-11#1)(2010-10#1)
Scalar##3##1##(2007-12#1)(2008-2#2)
Scald Disease##2##2##(2008-10#2)
Scald Pathogen##3##2##(2008-10#3)
Scald##6##1##(2008-10#6)
Scale (GCS)##5##2##(1991-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
Scale (GDS)##4##2##(1994-6#1)(2006-10#2)(2008-7#1)
Scale and the##5##3##(2006-10#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)
Scale and##11##2##(1991-2#1)(1994-6#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
Scale for the##4##3##(1996-7#2)(2008-4#1)(2013-1#1)
Scale for##11##2##(1991-2#1)(1996-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
Scale in##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
Scale of##2##2##(1992-1#1)(2013-1#1)
Scale score was##2##3##(2007-10#1)(2012-3#1)
Scale score##4##2##(2007-10#2)(2012-12#1)(2012-3#1)
Scale scores##3##2##(2010-10#1)(2011-2#1)(2012-2#1)
Scale was##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
Scale were##4##2##(1991-2#1)(1996-7#1)(2008-7#2)
Scale##189##1##(1990-12#2)(1991-2#6)(1991-6#2)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#2)(1994-6#6)(1995-8#1)(1996-4#1)(1996-5#1)(1996-7#8)(1996-9#1)(1997-1#1)(1997-3#2)(2006-10#3)(2007-10#10)(2007-11#2)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#5)(2008-7#14)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#13)(2011-2#4)(2011-8#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#7)
Scale) and##2##2##(2007-12#1)(2013-1#1)
Scale)##6##1##(2007-12#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#2)
Scale-##2##1##(2006-10#1)(2010-2#1)
Scale-up of##2##2##(2008-10#1)(2008-11#1)
Scale]##2##1##(1990-2#1)(2011-2#1)
Scaled##3##1##(2008-2#1)(2008-3#1)(2013-8#1)
Scales##13##1##(1994-5#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-2#3)(2013-1#1)
Scaling of##4##2##(1990-4#1)(1996-12#1)(2008-3#1)(2008-9#1)
Scaling##11##1##(1990-4#1)(1991-9#1)(1992-8#1)(1996-12#2)(2007-11#1)(2007-12#1)(2008-3#2)(2008-9#1)(2010-5#1)
Scalp##4##1##(1995-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
Scan and##2##2##(2008-1#1)(2008-7#1)
Scan##3##1##(1992-6#1)(2008-1#1)(2008-7#1)
Scand##2##1##(1996-11#1)(2008-9#1)
Scandinavia##6##1##(1990-11#1)(1991-11#2)(1992-4#1)(1995-8#1)(2008-10#1)
Scandinavian Sarcoma Group##3##3##(2010-3#3)
Scandinavian countries##4##2##(1991-4#1)(1995-5#1)(2007-2#1)(2008-8#1)
Scandinavian##17##1##(1991-4#1)(1995-5#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#3)(2011-4#4)(2013-1#2)
Scanner##5##1##(2008-2#2)(2008-3#2)(2012-12#1)
Scanning Electron Microscopy##2##3##(2008-5#1)(2010-11#1)
Scanning Electron##3##2##(2008-11#1)(2008-5#1)(2010-11#1)
Scanning Tunneling Microscopy##2##3##(1990-11#1)(1996-9#1)
Scanning and transmission electron microscopy##3##5##(2007-12#1)(2007-7#1)(2013-8#1)
Scanning electron microscope investigations of##2##5##(2008-10#2)
Scanning electron microscope observations of##2##5##(1995-6#2)
Scanning electron microscope observations##3##4##(1995-6#2)(2008-10#1)
Scanning electron microscope##6##3##(1995-6#2)(2008-10#3)(2012-3#1)
Scanning electron microscopic##2##3##(2008-11#1)(2008-5#1)
Scanning electron microscopy (SEM)##2##4##(2008-10#1)(2013-1#1)
Scanning electron microscopy of the##2##5##(2008-3#1)(2008-5#1)
Scanning electron microscopy of##6##4##(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#1)
Scanning electron microscopy revealed that##2##5##(2008-10#1)(2008-8#1)
Scanning electron microscopy revealed##3##4##(2008-10#2)(2008-8#1)
Scanning electron microscopy showed##2##4##(2007-12#1)(2008-10#1)
Scanning electron microscopy##19##3##(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
Scanning electron##30##2##(1995-6#2)(2007-12#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
Scanning laser##4##2##(2008-3#1)(2008-9#2)(2011-1#1)
Scanning lidar##2##2##(2008-3#2)
Scanning tunneling microscope##2##3##(2008-8#2)
Scanning tunneling##3##2##(2008-8#2)(2010-7#1)
Scanning##62##1##(1990-11#1)(1995-6#2)(1996-9#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Scans##2##1##(2008-10#1)(2012-2#1)
Scapharca inaequivalvis##2##2##(1990-8#2)
Scapteromys##3##1##(2008-5#3)
Scar##3##1##(1997-8#1)(2007-12#1)(2008-9#1)
Scarabaeidae)##2##1##(2008-5#2)
Scarlet Macaw##3##2##(2008-5#3)
Scarlet Macaws##2##2##(2008-5#2)
Scarlet##7##1##(2008-10#2)(2008-5#5)
Scarring##3##1##(2008-9#2)(2011-2#1)
Scatchard analyses##4##2##(1990-11#1)(1990-5#2)(1991-5#1)
Scatchard analysis and##2##3##(1994-11#1)(2008-10#1)
Scatchard analysis of binding##3##4##(1990-12#1)(1990-2#1)(1993-8#1)
Scatchard analysis of##8##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-6#1)(1993-8#1)(1994-6#1)(1995-12#1)
Scatchard analysis##16##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#1)
Scatchard plot analysis##2##3##(1996-12#1)(2008-10#1)
Scatchard plot##6##2##(1996-12#1)(2008-10#5)
Scatchard plots##3##2##(1992-9#1)(2008-10#2)
Scatchard##30##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#8)
Scatter##3##1##(2008-10#1)(2008-5#2)
Scattered##2##1##(1991-6#1)(2007-12#1)
Scattering and absorption##2##3##(2007-11#1)(2008-2#1)
Scattering and##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
Scattering by##2##2##(1996-9#1)(2007-11#1)
Scattering from##4##2##(2008-2#2)(2008-3#2)
Scattering in##2##2##(1996-12#1)(2008-3#1)
Scattering measurements##2##2##(2008-3#1)(2012-2#1)
Scattering of a##2##3##(2007-12#1)(2008-2#1)
Scattering of s-polarized electromagnetic##2##4##(2008-3#2)
Scattering of##8##2##(1996-9#1)(2007-12#1)(2008-2#2)(2008-3#4)
Scattering##40##1##(1991-9#1)(1996-12#2)(1996-2#1)(1996-9#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#11)(2008-3#14)(2012-1#1)(2012-2#2)
Scavenging##2##1##(2008-11#1)(2010-5#1)
Scedosporium prolificans##2##2##(2008-5#2)
Scedosporium##3##1##(2008-5#3)
Sceloporus##11##1##(2008-8#1)(2010-3#10)
Scenario##2##1##(2008-10#1)(2010-11#1)
Schaffer Collateral-CA1##2##2##(2008-7#2)
Schaffer collateral##2##2##(1991-12#1)(1995-2#1)
Schaffer collaterals##2##2##(1995-12#1)(2008-11#1)
Schaffer##9##1##(1990-3#1)(1991-12#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-7#4)
Schedule##5##1##(1995-12#1)(1996-3#1)(2008-5#1)(2013-8#2)
Scheduling##3##1##(1991-2#1)(1994-2#1)(1996-1#1)
Schefflera##3##1##(2008-10#3)
Scheffé##2##1##(2008-10#1)(2008-5#1)
Scheimpflug##6##1##(2008-2#5)(2013-1#1)
Scheme 1##3##2##(2007-8#3)
Scheme 2##2##2##(2007-8#2)
Scheme for the##2##3##(2007-12#1)(2008-2#1)
Scheme for##3##2##(2007-12#1)(2008-2#1)(2009-5#1)
Scheme##18##1##(1991-8#2)(1997-6#1)(2007-12#1)(2007-8#5)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
Schemes for##2##2##(1994-6#1)(2007-11#1)
Scherzer##2##1##(2010-5#2)
Scheuerman disease##2##2##(2007-11#2)
Scheuermann's disease##5##2##(2007-11#5)
Scheuthauer-Marie-Sainton syndrome##2##2##(2013-1#2)
Schiff Base complexes##2##3##(2008-10#2)
Schiff Base##4##2##(2008-10#3)(2011-1#1)
Schiff base and##2##3##(1990-12#1)(2008-10#1)
Schiff base as##2##3##(2008-10#1)(2009-3#1)
Schiff base complexes##2##3##(2008-10#1)(2013-1#1)
Schiff base method##2##3##(2008-10#2)
Schiff base##26##2##(1990-12#1)(1991-5#1)(1992-3#2)(1994-5#2)(1995-5#3)(2007-11#1)(2008-10#14)(2009-3#1)(2013-1#1)
Schiff bases of##2##3##(2008-10#1)(2011-1#1)
Schiff bases##5##2##(1991-9#1)(2008-10#2)(2010-8#1)(2011-1#1)
Schiff##39##1##(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#2)(1994-5#2)(1995-5#3)(1996-5#1)(2007-11#1)(2008-10#21)(2009-3#1)(2009-7#1)(2010-8#1)(2011-1#2)(2013-1#1)
Schiff's##3##1##(2008-10#3)
Schiff(##3##1##(2008-10#3)
Schilling test##3##2##(1990-3#2)(2013-1#1)
Schistocerca gregaria##10##2##(2007-12#7)(2008-12#1)(2012-12#2)
Schistocerca##11##1##(2007-12#7)(2008-12#2)(2012-12#2)
Schistosoma haematobium##4##2##(1996-12#4)
Schistosoma japonicum antibody##3##3##(2008-10#3)
Schistosoma japonicum in##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
Schistosoma japonicum##11##2##(2008-10#3)(2008-8#3)(2011-2#1)(2012-3#4)
Schistosoma mansoni is##2##3##(1993-2#1)(2012-2#1)
Schistosoma mansoni##11##2##(1993-2#2)(1993-6#1)(1996-8#1)(1997-6#2)(2008-12#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Schistosoma##32##1##(1992-2#1)(1993-2#2)(1993-6#1)(1996-12#5)(1996-8#1)(1997-6#2)(2008-10#4)(2008-12#1)(2008-8#3)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
Schistosomes##2##1##(2013-1#1)(2013-8#1)
Schistosomiasis##5##1##(1996-12#2)(1996-8#1)(2011-1#1)(2013-8#1)
Schizaphis graminum##7##2##(1996-12#2)(2008-10#5)
Schizencephaly##2##1##(2012-12#2)
Schizophrenia and autism##2##3##(1997-8#1)(2008-9#1)
Schizophrenia and##4##2##(1997-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
Schizophrenia is##2##2##(1997-8#1)(2011-2#1)
Schizophrenia##12##1##(1997-7#1)(1997-8#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Schizosaccharomyces pombe gene##2##3##(1994-12#1)(1997-3#1)
Schizosaccharomyces pombe##30##2##(1994-12#3)(1995-2#3)(1995-8#3)(1995-9#1)(1996-7#2)(1997-2#1)(1997-3#3)(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#5)
Schleichera oleosa##2##2##(2012-2#2)
Schlieren effect in##2##3##(2008-10#2)
Schlieren effect is##2##3##(2008-10#2)
Schlieren effect##5##2##(2008-10#5)
Schlieren##6##1##(2008-10#6)
Schmallenberg##2##1##(1995-3#1)(2013-8#1)
Schmidt##6##1##(2008-3#4)(2008-7#1)(2011-2#1)
Schmitz##2##1##(2007-12#1)(2008-9#1)
Schneider##4##1##(1993-9#1)(1995-2#1)(2008-11#1)(2013-1#1)
Scholars Program##2##2##(2008-12#2)
Scholars##7##1##(1991-8#1)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#2)
Scholarship##3##1##(1992-3#1)(2008-11#1)(2009-4#1)
Scholtes##2##1##(1993-12#2)
School Children##3##2##(2008-7#1)(2009-7#1)(2013-1#1)
School in##2##2##(1994-9#1)(2008-7#1)
School of Medicine (SOM)##2##4##(1992-1#1)(2012-3#1)
School of Medicine and##2##4##(1996-9#1)(2008-1#1)
School of Medicine of the##2##5##(1991-12#1)(2008-10#1)
School of Medicine of##6##4##(1991-12#1)(1992-1#1)(1997-3#1)(2008-10#1)(2012-3#2)
School of Medicine##22##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#2)(1996-9#2)(1997-3#1)(2006-12#1)(2008-1#5)(2008-10#1)(2008-12#1)(2008-5#2)(2009-12#1)(2012-3#3)
School of Nursing and Midwifery##4##5##(2008-11#3)(2008-12#1)
School of Nursing##15##3##(2007-10#2)(2008-11#6)(2008-12#5)(2010-3#2)
School of Public Health and##2##5##(1996-1#1)(2008-1#1)
School of Public Health##5##4##(1991-2#2)(1996-1#1)(2008-1#1)(2008-12#1)
School of Veterinary Science##2##4##(1997-8#1)(2013-8#1)
School of Veterinary##4##3##(1997-8#2)(2013-8#2)
School of##64##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1996-1#2)(1996-9#2)(1997-3#1)(1997-8#3)(2006-12#1)(2007-10#2)(2008-1#7)(2008-10#4)(2008-11#6)(2008-12#8)(2008-5#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-3#3)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#3)
School##109##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-1#2)(1996-9#2)(1997-3#1)(1997-8#4)(2006-12#1)(2007-10#2)(2007-12#2)(2008-1#7)(2008-10#4)(2008-11#8)(2008-12#12)(2008-4#2)(2008-5#5)(2008-7#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-3#3)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#5)(2013-8#3)
School-based health centers##2##3##(1995-12#2)
School-based##6##1##(1995-12#3)(1997-2#1)(2008-10#1)(2013-1#1)
Schools of##2##2##(1997-2#1)(2012-3#1)
Schools##7##1##(1997-2#1)(2007-5#1)(2009-12#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
Schottky barrier##3##2##(2007-11#2)(2009-6#1)
Schottky diode##2##2##(2009-11#2)
Schottky##9##1##(2007-11#3)(2009-11#4)(2009-6#1)(2010-4#1)
Schroeder##2##1##(1990-8#1)(1997-2#1)
Schrödinger equation##7##2##(2007-11#3)(2007-12#4)
Schrödinger##9##1##(1994-2#1)(2007-11#3)(2007-12#5)
Schum##2##1##(2012-3#1)(2013-1#1)
Schumacher##2##1##(1994-5#1)(2011-2#1)
Schwabe##3##1##(2008-5#2)(2008-8#1)
Schwann cell incorporation of [3H]thymidine by##2##6##(1995-2#2)
Schwann cell incorporation of [3H]thymidine##3##5##(1995-2#3)
Schwann cell proliferation##2##3##(1995-2#2)
Schwann cell##11##2##(1995-2#6)(2008-7#4)(2009-11#1)
Schwann cell-like##2##2##(2008-7#2)
Schwann cells (SCs)##2##3##(2008-7#2)
Schwann cells and##6##3##(1990-8#1)(1995-2#1)(2008-7#3)(2009-3#1)
Schwann cells results in##2##4##(2008-7#2)
Schwann cells##26##2##(1990-11#1)(1990-8#1)(1993-5#1)(1995-2#5)(2008-7#14)(2009-11#2)(2009-3#1)(2011-2#1)
Schwann##39##1##(1990-11#1)(1990-8#1)(1993-5#1)(1995-2#11)(2008-7#20)(2009-11#3)(2009-3#1)(2011-2#1)
Schwannoma of##2##2##(2008-6#1)(2008-7#1)
Schwannoma##5##1##(2008-6#1)(2008-7#2)(2012-3#1)(2013-1#1)
Schwannomas are##2##2##(1997-8#1)(2008-8#1)
Schwannomas##4##1##(1997-8#1)(2008-8#1)(2009-3#1)(2012-3#1)
Schwartz##5##1##(1991-1#1)(1993-2#2)(2010-4#1)(2013-1#1)
Schwarzschild objective##2##2##(2008-2#1)(2008-3#1)
Schwarzschild##3##1##(2008-2#2)(2008-3#1)
Schätzel##2##1##(2008-3#2)
Sci##44##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#2)(1997-2#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#4)
SciELO##3##1##(2011-2#1)(2012-3#1)(2013-8#1)
Sciaenidae)##2##1##(2008-7#1)(2013-7#1)
Sciatic nerve##2##2##(2008-8#2)
Sciatic##3##1##(2008-8#3)
Science Citation Index##2##3##(2010-12#1)(2013-1#1)
Science Foundation##6##2##(2008-10#1)(2008-7#2)(2010-3#1)(2013-1#1)(2013-8#1)
Science and Technology##4##3##(1990-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
Science and the##2##3##(1997-3#1)(2010-3#1)
Science and##13##2##(1990-11#2)(1997-3#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#2)
Science in##2##2##(2008-10#1)(2008-9#1)
Science##104##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#2)(1996-8#4)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#3)(2010-4#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#2)(2013-1#6)(2013-8#4)
Sciences and##2##2##(2008-1#1)(2008-7#1)
Sciences in##2##2##(1996-12#1)(2013-1#1)
Sciences were studied##2##3##(2008-3#1)(2012-3#1)
Sciences##73##1##(1990-3#3)(1990-8#1)(1992-12#1)(1992-2#1)(1994-10#1)(1994-12#2)(1994-3#4)(1995-2#2)(1996-11#1)(1996-12#2)(1996-4#2)(1997-2#2)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#6)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
Sciencescope##3##1##(1991-8#1)(1994-9#1)(1995-6#1)
Scientific Meeting of the##6##4##(1991-6#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#1)
Scientific Meeting##8##2##(1991-6#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)
Scientific Sessions##2##2##(2009-6#1)(2011-1#1)
Scientific and##3##2##(1997-5#1)(2008-3#1)(2010-12#1)
Scientific##49##1##(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-2#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-5#3)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Scientifically##2##1##(2013-1#2)
Scientists##11##1##(1990-3#1)(1993-9#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2012-3#1)
Scimitar syndrome in##2##3##(2007-8#2)
Scimitar syndrome##5##2##(2007-8#5)
Scincidae)##2##1##(2008-8#1)(2010-3#1)
Scincus-Eumeces##2##1##(2010-3#2)
Scintillation proximity assay (SPA)##2##4##(2008-4#2)
Scintillation proximity assay##4##3##(2008-4#4)
Scintillation##9##1##(2007-12#1)(2008-3#3)(2008-4#4)(2011-1#1)
Sciuridae)##2##1##(2008-5#2)
Sciurus species##3##2##(2008-5#3)
Sciurus##11##1##(2008-5#11)
Scleral##2##1##(2011-2#1)(2013-1#1)
Scleranthus annuus##5##2##(2008-10#5)
Scleroderma is##2##2##(2008-10#1)(2008-5#1)
Scleroderma##4##1##(2008-10#2)(2008-5#2)
Scleroderris canker##2##2##(2008-10#2)
Sclerosis##5##1##(2008-5#1)(2008-8#1)(2013-1#2)(2013-8#1)
Sclerotia and##2##2##(2008-10#2)
Sclerotia of##3##2##(2008-10#3)
Sclerotia##10##1##(2008-10#10)
Sclerotial##4##1##(2008-10#4)
Sclerotinia disease##3##2##(2008-10#3)
Sclerotinia homoeocarpa##7##2##(2008-10#7)
Sclerotinia minor##6##2##(2008-10#6)
Sclerotinia sclerotiorum and##2##3##(2008-10#1)(2013-8#1)
Sclerotinia sclerotiorum in##4##3##(2008-10#4)
Sclerotinia sclerotiorum to##3##3##(2008-10#3)
Sclerotinia sclerotiorum##29##2##(2008-10#28)(2013-8#1)
Sclerotinia stem rot (SSR)##3##4##(2008-10#3)
Sclerotinia stem rot was##3##4##(2008-10#3)
Sclerotinia stem rot##10##3##(2008-10#10)
Sclerotinia trifoliorum and Sclerotium rolfsii##3##5##(2008-10#3)
Sclerotinia trifoliorum##9##2##(2008-10#9)
Sclerotinia##69##1##(2008-10#68)(2013-8#1)
Sclerotium rolfsii in##5##3##(2008-10#5)
Sclerotium rolfsii##22##2##(2008-10#18)(2008-6#2)(2008-8#2)
Sclerotium##23##1##(2008-10#19)(2008-6#2)(2008-8#2)
Scoliosis##3##1##(2008-11#3)
Scolytidae)##3##1##(2008-6#1)(2011-2#2)
Scope of Regional Lymph Node Surgery##2##6##(2012-12#2)
Scope of Work##3##3##(1993-2#3)
Scope of##6##2##(1993-2#3)(2011-1#1)(2012-12#2)
Scope##7##1##(1993-2#3)(2011-1#1)(2012-12#2)(2012-2#1)
Scopelocheirus##2##1##(2008-6#2)
Scophedal##4##1##(2007-5#4)
Scoping##2##1##(2011-2#1)(2012-12#1)
Scopolamine##2##1##(1992-11#1)(1994-8#1)
Scopulariopsis##3##1##(2008-5#1)(2008-6#1)(2010-4#1)
Scopus##2##1##(2011-2#1)(2013-1#1)
Score and the##2##3##(1991-6#1)(2011-1#1)
Score##23##1##(1991-6#2)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#4)(2013-1#2)(2013-8#3)
Scores from the##3##3##(2008-12#1)(2008-9#2)
Scores on the##3##3##(1995-12#1)(2012-1#1)(2013-1#1)
Scores on##4##2##(1995-12#1)(2008-9#1)(2012-1#1)(2013-1#1)
Scores were##3##2##(1996-3#1)(2010-3#1)(2013-1#1)
Scores##17##1##(1992-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-9#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
Scoring##10##1##(2007-11#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-12#1)
Scorpion probe##4##2##(2008-10#4)
Scorpiones##4##1##(2007-12#4)
Scotia Dietetic##2##2##(1996-1#2)
Scotia##10##1##(1993-12#1)(1996-1#3)(2007-12#5)(2008-11#1)
Scotland##17##1##(1990-9#1)(1991-3#1)(1991-6#1)(1995-6#1)(1997-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#3)(2009-9#1)(2011-2#1)
Scots pines##2##2##(2008-10#2)
Scott A##2##2##(2012-2#2)
Scott##4##1##(1994-3#1)(1995-6#1)(2012-2#2)
Scottish##9##1##(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)
Scp1##4##1##(1996-6#4)
ScrFI##3##1##(2008-10#3)
Screen##6##1##(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Screen-printed carbon electrodes##2##3##(2008-10#2)
Screen-printed##5##1##(2008-10#5)
Screening New Drugs for Immunotoxic Potential##2##6##(2008-10#2)
Screening Program for##2##3##(2010-1#1)(2012-3#1)
Screening Program##3##2##(1991-12#1)(2010-1#1)(2012-3#1)
Screening Test##2##2##(2011-2#1)(2013-1#1)
Screening and brief intervention in the##2##6##(2008-11#2)
Screening and brief intervention in##4##5##(2008-11#4)
Screening and##8##2##(1990-3#1)(2008-11#5)(2008-8#1)(2012-2#1)
Screening by##3##2##(1991-7#1)(2007-12#1)(2007-7#1)
Screening for##19##2##(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1995-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
Screening in general##2##3##(1991-6#1)(2008-11#1)
Screening in##3##2##(1991-6#1)(2008-11#1)(2013-1#1)
Screening of a##3##3##(1990-11#1)(1990-7#1)(2011-1#1)
Screening of the##4##3##(1991-6#1)(1996-12#1)(2008-5#1)(2009-8#1)
Screening of##29##2##(1990-11#1)(1990-7#1)(1991-6#1)(1993-8#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Screening##115##1##(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-11#4)(1994-6#2)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#11)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#2)
Screw##3##1##(2007-8#1)(2012-3#1)(2013-1#1)
Screws for##2##2##(2008-12#1)(2012-3#1)
Screws##3##1##(2008-12#1)(2012-3#1)(2013-1#1)
Scrotal##4##1##(1997-8#1)(2008-6#2)(2008-7#1)
Scrotoschisis##2##1##(2008-10#2)
Scuba diving##2##2##(1996-2#1)(2008-5#1)
Scytonema sp##2##2##(2008-6#2)
Sd##2##1##(1993-2#2)
Se (IV)##3##2##(2008-10#3)
Se and In in a sodium sulphate matrix##2##8##(2008-10#2)
Se and In in a##3##5##(2008-10#3)
Se and In in##4##4##(2008-10#4)
Se and Sb on titanium dioxide##2##6##(2008-10#2)
Se and Sb was##2##4##(2008-10#2)
Se and Sb were##2##4##(2008-10#2)
Se and Sb##6##3##(2008-10#6)
Se and Sn##2##3##(2008-10#2)
Se and##20##2##(2008-10#20)
Se by##2##2##(2008-10#2)
Se compounds##4##2##(2008-10#4)
Se concentration##7##2##(2008-10#5)(2012-2#2)
Se concentrations##2##2##(2008-10#1)(2012-2#1)
Se deficiency##4##2##(1993-6#1)(2012-2#3)
Se determination##3##2##(2008-10#3)
Se from##2##2##(2008-10#2)
Se in the##3##3##(2008-10#3)
Se in##14##2##(2008-10#12)(2011-2#2)
Se is##2##2##(1991-12#1)(2008-10#1)
Se levels##2##2##(2011-2#2)
Se losses##2##2##(2008-10#2)
Se recoveries##2##2##(2008-10#2)
Se speciation in##2##3##(2008-10#2)
Se speciation##4##2##(2008-10#4)
Se species##5##2##(2008-10#5)
Se status##2##2##(2012-2#2)
Se to##2##2##(2008-10#2)
Se toxicity##2##2##(2012-2#2)
Se was 0##2##3##(2008-10#2)
Se was##4##2##(2008-10#3)(2011-2#1)
Se were##5##2##(2008-10#5)
Se##150##1##(1991-12#2)(1993-6#1)(1994-8#1)(2006-4#1)(2008-10#121)(2011-2#6)(2012-2#17)(2013-8#1)
Se(IV) (n=11)##2##2##(2008-10#2)
Se(IV) and Se(VI) were##3##4##(2008-10#3)
Se(IV) and Se(VI)##6##3##(2008-10#6)
Se(IV) and##15##2##(2008-10#15)
Se(IV) are##2##2##(2008-10#2)
Se(IV) by##2##2##(2008-10#2)
Se(IV) in##5##2##(2008-10#5)
Se(IV)##68##1##(2008-10#68)
Se(VI) and total selenium##2##4##(2008-10#2)
Se(VI) and##4##2##(2008-10#4)
Se(VI) by##2##2##(2008-10#2)
Se(VI) is##3##2##(2008-10#3)
Se(VI) to Se(IV)##6##3##(2008-10#6)
Se(VI)##33##1##(2008-10#33)
Se)##5##1##(2008-10#4)(2010-11#1)
Se-B8##2##1##(2008-10#2)
Se-GSH-Px gene##2##2##(1991-12#2)
Se-GSH-Px##3##1##(1991-12#3)
Se-H6 and Se-C1##2##3##(2008-10#2)
Se-based chalcogenide glasses##2##3##(2007-12#2)
Se-deficient##3##1##(1991-12#2)(1993-6#1)
Se-enriched##3##1##(2008-10#2)(2010-11#1)
Se/g sample##4##2##(2008-10#4)
Se/g##7##1##(2008-10#5)(2012-2#2)
Se0##5##1##(2013-8#5)
SeH(2)##2##1##(2008-10#2)
SeMet and TMSe##2##3##(2008-10#2)
SeMet##5##1##(2008-10#5)
Sea Basin)##2##2##(2013-1#2)
Sea Cucumber##2##2##(2008-5#2)
Sea and##6##2##(2007-12#2)(2008-10#2)(2008-5#1)(2010-8#1)
Sea are##3##2##(2008-10#2)(2009-10#1)
Sea water##2##2##(2008-10#2)
Sea##55##1##(1996-3#1)(1996-6#1)(2007-12#2)(2008-10#10)(2008-11#3)(2008-2#6)(2008-3#3)(2008-5#9)(2008-6#1)(2009-10#3)(2009-8#1)(2010-8#8)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Sea-Viewing Wide Field-of-View Sensor##2##4##(2008-3#2)
Sea-Viewing Wide##3##2##(2008-3#3)
Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##5##5##(2008-2#1)(2008-3#4)
Sea-viewing Wide##7##2##(2008-2#1)(2008-3#6)
SeaWiFS bands##5##2##(2008-3#5)
SeaWiFS is the##2##3##(2008-3#2)
SeaWiFS is##4##2##(2008-2#1)(2008-3#3)
SeaWiFS measurements##3##2##(2008-2#1)(2008-3#2)
SeaWiFS##36##1##(2008-2#10)(2008-3#26)
Seafarers##2##1##(1991-11#1)(2011-2#1)
Sealant##4##1##(2012-3#4)
Search for##5##2##(1992-6#1)(1995-3#1)(1996-8#1)(2010-8#1)(2012-2#1)
Search##23##1##(1992-3#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-3#4)(1996-8#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-8#4)(2011-2#1)(2012-2#1)
Searching Online Mendelian Inheritance in Man (OMIM) for information for genetic loci involved in human disease##2##16##(2008-4#1)(2008-9#1)
Searching databases is often the first step in the study of a new protein##2##14##(2008-2#1)(2008-4#1)
Searching for the##4##3##(2007-11#1)(2007-12#1)(2008-8#2)
Searching for##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2011-3#1)
Searching the##2##2##(2008-4#2)
Searching##14##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
Searle##2##1##(2008-5#2)
Season in##2##2##(2008-10#1)(2008-6#1)
Season##5##1##(1997-7#1)(2008-10#3)(2008-6#1)
Seasonal and##2##2##(2008-10#1)(2013-8#1)
Seasonal patterns of##2##3##(2008-10#2)
Seasonal variability in##2##3##(2010-8#2)
Seasonal variation of##2##3##(2007-10#2)
Seasonal variation##3##2##(2007-10#2)(2010-8#1)
Seasonal##26##1##(1991-3#1)(1992-12#1)(1992-7#1)(2007-10#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
Seasonality##2##1##(2008-5#1)(2008-9#1)
Seat##3##1##(2013-8#3)
Seattle##8##1##(1992-1#1)(1996-12#1)(2007-9#1)(2008-5#5)
Seattle-King County##2##2##(1996-2#2)
Seawater samples##3##2##(2008-10#3)
Seawater##5##1##(2008-10#4)(2012-12#1)
Sebaceous metaplasia in##2##3##(2012-3#2)
Sebaceous##5##1##(2008-5#1)(2008-8#2)(2012-3#2)
Sebaldella termitidis##2##2##(2011-2#2)
Sebaldella##3##1##(2011-2#3)
Sebastes##3##1##(2008-7#1)(2010-8#2)
Sec##7##1##(1991-2#1)(2011-2#1)(2012-2#5)
Sec16##4##1##(2012-2#4)
Sec16A##3##1##(2012-2#3)
Sec16B##4##1##(2012-2#4)
Sec4 and Ypt1##3##3##(1992-8#3)
Sec4##9##1##(1992-8#8)(1995-8#1)
Sec61##3##1##(1991-2#2)(2012-1#1)
Sec62 and Sec63##2##3##(1991-2#2)
Sec7p##2##1##(1997-1#2)
SecA##5##1##(1997-8#1)(2008-10#3)(2012-1#1)
SecY in the##2##3##(1991-5#2)
SecY is an indispensable component of the##2##7##(1991-5#2)
SecY##8##1##(1991-5#7)(2012-1#1)
SecY-depleted##2##1##(1991-5#2)
Secale cereale##2##2##(1996-5#1)(2008-10#1)
Secale##3##1##(1996-5#1)(2008-10#1)(2008-12#1)
Second Avenue##3##2##(2008-8#3)
Second International##3##2##(2008-5#1)(2008-8#1)(2010-10#1)
Second World War##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2011-4#1)
Second and third trimester exposure is##2##6##(2013-1#2)
Second and third##3##3##(1993-1#1)(2013-1#2)
Second case##2##2##(2007-8#1)(2008-7#1)
Second derivative spectrophotometric##2##3##(2008-10#2)
Second derivative##3##2##(2008-10#3)
Second group##2##2##(2012-3#2)
Second method##2##2##(2008-8#1)(2010-5#1)
Second##155##1##(1990-11#1)(1990-4#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-12#7)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#9)(2008-8#17)(2008-9#3)(2009-10#2)(2009-12#2)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-4#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Second-Harmonic##2##1##(2008-2#1)(2011-1#1)
Second-harmonic generation (SHG)##2##3##(2007-11#1)(2007-12#1)
Second-harmonic generation from a##2##4##(2007-11#1)(2007-12#1)
Second-harmonic generation in a##2##4##(2007-12#2)
Second-harmonic generation in##5##3##(2007-12#5)
Second-harmonic generation was##3##3##(2007-11#1)(2007-12#2)
Second-harmonic generation##15##2##(2007-11#4)(2007-12#10)(2008-2#1)
Second-harmonic##17##1##(2007-11#4)(2007-12#11)(2008-2#2)
Second-line##2##1##(2008-1#1)(2010-12#1)
Second-order##4##1##(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)
Secondary analyses##3##2##(2009-10#1)(2009-11#1)(2012-12#1)
Secondary cleft surgery##2##3##(2007-12#2)
Secondary conidiation##2##2##(2008-10#2)
Secondary endpoints were##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
Secondary infection##2##2##(1996-6#1)(1997-3#1)
Secondary infections are##2##3##(2008-12#1)(2008-8#1)
Secondary metabolites##5##2##(2008-10#2)(2008-9#3)
Secondary outcomes##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
Secondary structure analysis##2##3##(2009-7#1)(2011-2#1)
Secondary structure##7##2##(1995-8#1)(2008-8#1)(2008-9#1)(2009-7#2)(2011-2#1)(2013-1#1)
Secondary syphilis##2##2##(1997-7#1)(2013-1#1)
Secondary to##2##2##(2013-8#2)
Secondary##80##1##(1990-8#1)(1991-11#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#3)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
Secondly we##2##2##(1991-9#1)(1992-12#1)
Secondly##24##1##(1991-9#1)(1992-12#2)(1995-11#1)(1995-12#1)(1996-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#3)
Secret Service##3##2##(1995-6#3)
Secret##4##1##(1995-6#4)
Secretary of Health and Human Services##2##6##(1991-12#1)(1994-1#1)
Secretary of##4##2##(1991-12#1)(1994-1#1)(1995-1#1)(1996-5#1)
Secretary##5##1##(1991-12#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-5#1)
Secretaría de##2##2##(2012-12#2)
Secreted##4##1##(2008-10#1)(2008-11#2)(2008-4#1)
Secretion and##2##2##(1994-9#1)(1995-6#1)
Secretion in##2##2##(2009-8#1)(2011-2#1)
Secretion of##16##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-5#1)(1996-12#1)(2008-10#3)(2008-11#4)(2008-8#1)(2009-8#1)(2012-1#2)
Secretion##26##1##(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-9#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)
Secretory##6##1##(1992-9#1)(2007-12#2)(2008-7#1)(2008-8#1)(2011-2#1)
Section 199##2##2##(1995-12#2)
Section 3##2##2##(1995-2#1)(2010-9#1)
Section of##3##2##(1992-3#1)(2007-11#1)(2008-2#1)
Section##16##1##(1991-2#1)(1992-3#2)(1993-9#1)(1995-12#2)(1995-2#3)(2007-11#2)(2008-10#1)(2008-2#1)(2010-6#1)(2010-9#1)(2011-1#1)
Sections of##3##2##(1993-12#1)(1995-12#1)(2008-3#1)
Sections were##2##2##(2011-2#1)(2013-7#1)
Sections##10##1##(1993-12#1)(1995-12#1)(1995-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
Sector##3##1##(1993-1#1)(1997-8#1)(2012-12#1)
Secure##3##1##(2007-11#1)(2008-3#2)
Securing the##2##2##(1993-12#1)(2008-4#1)
Securing##4##1##(1993-12#1)(2007-8#1)(2008-11#1)(2008-4#1)
Security Act##3##2##(1991-3#1)(1992-2#1)(1995-2#1)
Security and##4##2##(1994-2#1)(1995-2#2)(2008-3#1)
Security for##2##2##(1994-3#1)(1997-5#1)
Security##44##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#4)(1992-2#5)(1993-1#2)(1993-2#1)(1993-3#1)(1994-2#4)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
Sedation##2##1##(2007-11#1)(2011-2#1)
Sedentary behavior##2##2##(2008-4#1)(2013-1#1)
Sedentary##5##1##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#2)
Sediment BCR-CRM##2##2##(2008-10#2)
Sediment##7##1##(2008-10#5)(2008-11#1)(2011-2#1)
Sedimentation##3##1##(1990-7#1)(1990-8#1)(2008-10#1)
Sediments##2##1##(2007-5#1)(2010-5#1)
See also##2##2##(2008-8#1)(2011-1#1)
See##3##1##(2008-12#1)(2008-8#1)(2011-1#1)
Seed Extract##2##2##(2012-2#1)(2013-1#1)
Seed production##2##2##(2008-8#1)(2008-9#1)
Seed treatment with##4##3##(2008-10#4)
Seed##35##1##(2008-10#26)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#2)(2012-2#1)(2013-1#1)
Seedborne##4##1##(2008-10#4)
Seeding##3##1##(1996-9#1)(2008-10#1)(2012-2#1)
Seedling Damping-Off Caused by Pythium ultimum##2##6##(2008-10#2)
Seedling Resistance to##2##3##(2008-10#2)
Seedling##12##1##(2008-10#10)(2008-8#1)(2013-7#1)
Seedlings grown##2##2##(2008-10#2)
Seedlings in##2##2##(2008-10#2)
Seedlings of parents and F(1)##2##5##(2008-10#2)
Seedlings of##6##2##(2008-10#5)(2008-5#1)
Seedlings were##2##2##(2008-10#2)
Seedlings##21##1##(2008-10#20)(2008-5#1)
Seeds aqueous extract##2##3##(2008-12#2)
Seeds from the##2##3##(2008-10#1)(2008-12#1)
Seeds from##6##2##(2006-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)
Seeds of##5##2##(2007-1#1)(2008-10#2)(2008-8#1)(2010-5#1)
Seeds##19##1##(2006-11#1)(2007-1#1)(2008-10#8)(2008-12#4)(2008-8#2)(2010-5#1)(2010-8#1)(2012-3#1)
Seehra and Jordan##2##3##(1992-3#2)
Seeking##4##1##(1990-6#1)(2009-11#1)(2010-5#1)(2012-12#1)
Segment of##2##2##(1995-3#1)(2009-10#1)
Segment##4##1##(1995-3#1)(2009-10#1)(2010-9#1)(2012-3#1)
Segmental##9##1##(1992-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
Segmentation##6##1##(1995-8#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-9#1)
Segmenting##2##1##(2010-1#1)(2010-8#1)
Segments of the coronary arteries were received from##2##8##(2012-3#2)
Segments of##3##2##(2008-11#1)(2012-3#2)
Segments##4##1##(2008-11#1)(2008-7#1)(2012-3#2)
Segniliparus rotundus##2##2##(2011-2#2)
Segniliparus##3##1##(2011-2#3)
Segregation analyses indicated that##2##4##(2008-10#2)
Segregation analyses##3##2##(2007-6#1)(2008-10#2)
Segregation analysis of##2##3##(2008-10#1)(2008-5#1)
Segregation analysis##3##2##(2008-10#2)(2008-5#1)
Segregation of##9##2##(1993-2#1)(1995-2#1)(2008-10#6)(2008-5#1)
Segregation##19##1##(1993-2#1)(1995-2#1)(2007-6#1)(2008-10#13)(2008-5#2)(2012-2#1)
Seidel distortion##2##2##(2008-3#2)
Seidel##3##1##(2008-2#1)(2008-3#2)
Seine##3##1##(2008-10#3)
Seismic##2##1##(1996-6#1)(1997-5#1)
Seison nebaliae##2##2##(2008-7#2)
Seizure##5##1##(1993-3#1)(1997-3#1)(2007-2#1)(2010-8#1)(2012-2#1)
Seizures in##3##2##(1997-3#1)(2008-11#1)(2009-2#1)
Seizures##6##1##(1993-1#1)(1997-3#1)(1997-4#1)(2008-11#1)(2009-2#1)(2011-1#1)
Selaginella moellendorffii##3##2##(2009-8#3)
Selangor and##2##2##(2008-8#1)(2011-1#1)
Selangor##4##1##(2008-10#2)(2008-8#1)(2011-1#1)
Select Agent##2##2##(2008-9#2)
Select##5##1##(2008-10#1)(2008-11#2)(2008-9#2)
Selected applications##2##2##(2008-10#1)(2008-3#1)
Selected bibliography##5##2##(2008-9#5)
Selected clinical trials in supportive cancer therapy##6##7##(2008-7#6)
Selected for##2##2##(2008-10#2)
Selected isolates of##3##3##(2008-10#3)
Selected isolates##6##2##(2008-10#6)
Selected##56##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-6#1)(1996-1#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#6)(2008-9#5)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
Selecting the appropriate##2##3##(2012-1#1)(2013-8#1)
Selecting the right##2##3##(1996-3#1)(2008-9#1)
Selecting the##7##2##(1993-3#1)(1996-3#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
Selecting##21##1##(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Selection and##3##2##(1994-2#1)(2008-11#1)(2008-8#1)
Selection for increased##2##3##(2008-10#1)(2011-2#1)
Selection for##8##2##(1997-7#1)(2008-10#5)(2008-8#1)(2011-2#1)
Selection in##2##2##(2008-10#1)(2010-1#1)
Selection of a##2##3##(1993-3#1)(1997-3#1)
Selection of appropriate##2##3##(2008-11#1)(2008-2#1)
Selection of the appropriate##2##4##(2008-10#2)
Selection of the##9##3##(1990-8#1)(1992-10#1)(1994-12#2)(2008-10#3)(2008-3#1)(2012-1#1)
Selection of##30##2##(1990-12#1)(1990-8#1)(1992-10#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2009-2#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#1)
Selection on##2##2##(2008-10#2)
Selection with##2##2##(2008-10#1)(2013-1#1)
Selection##62##1##(1990-12#1)(1990-8#1)(1992-10#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#19)(2008-11#3)(2008-2#3)(2008-3#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
Selections of##2##2##(2008-10#1)(2008-4#1)
Selections##3##1##(2008-10#1)(2008-4#1)(2010-8#1)
Selective Media##2##2##(2008-10#2)
Selective and sensitive##2##3##(2008-10#2)
Selective and##5##2##(1992-8#1)(2008-10#4)
Selective angiography##3##2##(1995-11#1)(1996-9#1)(2007-8#1)
Selective cognitive##2##2##(1993-12#1)(2012-2#1)
Selective determination of##4##3##(2008-10#3)(2013-8#1)
Selective expression##2##2##(1994-5#2)
Selective extraction of##4##3##(2008-10#4)
Selective laser trabeculoplasty##2##3##(2011-2#2)
Selective preconcentration of##2##3##(2008-10#2)
Selective preconcentration##3##2##(2008-10#3)
Selective separation of##2##3##(2008-10#2)
Selective serotonin reuptake inhibitors (SSRIs)##2##5##(2008-6#1)(2013-1#1)
Selective serotonin reuptake inhibitors##3##4##(2008-6#1)(2008-9#1)(2013-1#1)
Selective serotonin##4##2##(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
Selective transport of##2##3##(2008-10#2)
Selective use of##2##3##(2008-11#1)(2008-3#1)
Selective##97##1##(1990-4#1)(1990-5#1)(1991-11#1)(1992-10#1)(1992-12#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#40)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
Selectively##4##1##(1994-5#1)(1995-2#1)(2008-3#1)(2008-5#1)
Selectivities##2##1##(2008-10#1)(2011-1#1)
Selectivity and##2##2##(2008-10#1)(2011-1#1)
Selectivity coefficient data for some common ions show negligible interference##2##10##(2008-10#2)
Selectivity coefficients for##3##3##(2008-10#3)
Selectivity coefficients##7##2##(2008-10#7)
Selectivity for##2##2##(2008-10#2)
Selectivity in##2##2##(1990-8#1)(1996-5#1)
Selectivity of the##2##3##(2008-10#1)(2008-3#1)
Selectivity of##4##2##(1995-12#1)(2008-10#2)(2008-3#1)
Selectivity##28##1##(1990-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#2)(2008-10#20)(2008-3#1)(2011-1#1)
Selenastrum capricornutum##2##2##(1994-11#2)
Selenastrum##3##1##(1994-11#2)(2008-10#1)
Selenium in##2##2##(2008-10#1)(2008-8#1)
Selenium is##2##2##(2009-10#1)(2012-2#1)
Selenium speciation##2##2##(2008-10#1)(2010-11#1)
Selenium species##2##2##(2008-10#2)
Selenium##16##1##(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#2)(2010-11#1)(2012-2#2)
Selenocystine##2##1##(2008-10#2)
Selenomethionine (SeMet)##2##2##(2008-10#2)
Selenomethionine##4##1##(2008-10#3)(2010-11#1)
Selenoprotein P##2##2##(2009-10#2)
Self and peer assessment##2##4##(2008-11#2)
Self##13##1##(1994-12#1)(1996-3#1)(2008-11#5)(2008-7#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-8#1)(2012-3#1)
Self-Assessment Scale-Geriatric and their##2##4##(1994-6#2)
Self-Assessment##4##1##(1994-6#2)(2012-2#2)
Self-Efficacy##4##1##(2008-12#2)(2008-9#1)(2012-3#1)
Self-Help Clearinghouse of Metropolitan Toronto##3##5##(1994-1#1)(1996-3#2)
Self-Help Clearinghouse##4##2##(1994-1#2)(1996-3#2)
Self-Modulated Laser##2##2##(1996-12#2)
Self-Regulation##3##1##(2012-12#1)(2012-3#2)
Self-Reported##2##1##(2008-12#1)(2013-8#1)
Self-Serving##2##1##(2008-6#1)(2009-9#1)
Self-assembled##3##1##(2008-10#2)(2009-11#1)
Self-assembly of##2##2##(2007-11#1)(2013-1#1)
Self-assembly##3##1##(2007-11#1)(2008-10#1)(2013-1#1)
Self-assessment##2##1##(1992-3#1)(2011-2#1)
Self-care##2##1##(2010-7#1)(2013-8#1)
Self-efficacy##3##1##(2008-12#1)(2009-3#1)(2010-2#1)
Self-expanding##2##1##(1990-8#1)(2008-11#1)
Self-induced phase matching in stimulated four-wave mixing in a nonbirefringent single-mode optical fiber##2##13##(2007-11#2)
Self-induced##6##1##(1991-9#1)(2007-11#5)
Self-management##2##1##(2012-12#1)(2013-1#1)
Self-monitoring of blood glucose##2##4##(1993-12#1)(2008-8#1)
Self-monitoring##4##1##(1993-12#1)(1996-7#1)(2008-11#1)(2008-8#1)
Self-optical parametric oscillation##2##3##(2007-11#2)
Self-perceived##2##1##(1993-2#1)(2012-12#1)
Self-reference##2##1##(2008-9#2)
Self-referenced##2##1##(2007-11#1)(2008-2#1)
Self-referencing of the carrier-envelope slip in a 6-fs visible parametric amplifier##2##11##(2007-11#2)
Self-renewing##2##1##(2010-11#1)(2012-12#1)
Self-report data were collected from##2##5##(2009-7#1)(2010-11#1)
Self-report of##2##2##(2010-3#1)(2011-1#1)
Self-report##6##1##(1994-2#1)(2008-12#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)
Self-reported##6##1##(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#2)
Self-serving judgments##2##2##(2008-6#2)
Self-similar##2##1##(2007-12#2)
Self-similarity##3##1##(2007-12#1)(2008-8#2)
Self-starting mode locking##2##3##(2007-11#1)(2007-12#1)
Self-starting##3##1##(2007-11#1)(2007-12#2)
Selfoc gradient-index lens##2##3##(2007-11#2)
Sellers argued that##2##3##(1996-5#2)
Sellers##3##1##(1996-5#3)
Sellmeier coefficients##3##2##(2008-2#3)
Sellmeier dispersion function##3##3##(2008-2#2)(2008-3#1)
Sellmeier equation for##2##3##(2007-12#1)(2008-2#1)
Sellmeier equation##3##2##(2007-12#1)(2008-2#2)
Sellmeier equations and##2##3##(2008-2#1)(2008-3#1)
Sellmeier equations##5##2##(2008-2#3)(2008-3#2)
Sellmeier##16##1##(2007-12#1)(2008-2#11)(2008-3#4)
Semantic##3##1##(2007-8#1)(2010-5#1)(2010-8#1)
Semaphorin##2##1##(1993-12#2)
Semen analysis was performed##2##4##(2008-12#1)(2011-2#1)
Semen quality##2##2##(1996-6#1)(2012-2#1)
Semen was collected##2##3##(2008-7#1)(2009-4#1)
Semen##11##1##(1996-6#1)(2008-12#3)(2008-7#3)(2009-4#2)(2011-2#1)(2012-2#1)
Semi-quantitative##5##1##(1990-11#1)(1992-8#1)(1993-12#1)(2007-10#1)(2011-2#1)
Semi-structured interviews were conducted with##2##5##(1995-1#1)(2007-12#1)
Semi-structured interviews were used to collect data##2##7##(2008-11#1)(2012-3#1)
Semi-structured interviews were##4##3##(1995-1#1)(2007-12#1)(2008-11#1)(2012-3#1)
Semi-structured interviews##6##2##(1995-1#1)(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#2)
Semi-structured##9##1##(1995-1#1)(2007-12#1)(2007-2#1)(2008-11#2)(2010-10#1)(2012-3#1)(2013-1#2)
Semiconductor##6##1##(2008-10#1)(2008-2#2)(2008-3#3)
Semiconductors##2##1##(1996-9#1)(2008-7#1)
Seminal plasmin##2##2##(1994-3#2)
Seminar##3##1##(1992-3#1)(1997-8#1)(2008-12#1)
Semiparametric##3##1##(2008-12#1)(2008-8#1)(2011-1#1)
Semiquantitative##2##1##(1991-2#1)(2008-10#1)
Semistructured##2##1##(2009-5#1)(2011-1#1)
Semliki Forest virus (SFV)##2##4##(2008-11#1)(2008-4#1)
Semliki Forest virus and##2##4##(1994-6#1)(2008-4#1)
Semliki Forest virus##6##3##(1994-6#2)(2008-11#2)(2008-4#2)
Semliki Forest##8##2##(1994-6#2)(2008-11#4)(2008-4#2)
Semmes-Weinstein##3##1##(2007-7#1)(2008-9#2)
Sen##2##1##(1995-6#2)
Senate and##2##2##(1995-1#1)(2010-12#1)
Senate##16##1##(1993-5#1)(1995-1#1)(1995-6#6)(1996-3#1)(1996-5#1)(1997-2#2)(2008-1#1)(2008-8#1)(2009-9#1)(2010-12#1)
Senator##2##1##(1995-1#1)(2012-3#1)
Senecio##5##1##(1990-7#2)(1991-8#1)(2008-10#2)
Senegal doves (Streptopelia senegalensis)##2##4##(2008-5#2)
Senegal doves##6##2##(2008-5#6)
Senegal sole Solea senegalensis##2##4##(2010-8#2)
Senegal##11##1##(1996-11#1)(2008-10#1)(2008-5#6)(2010-8#2)(2012-12#1)
Senescence##2##1##(2008-8#1)(2009-8#1)
Senile lentigo##2##2##(2011-2#2)
Senile##4##1##(2011-2#3)(2012-1#1)
Senior Citizens'##2##2##(2008-1#1)(2012-12#1)
Senior nurses##2##2##(1995-9#1)(2008-11#1)
Senior##14##1##(1994-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#2)(2013-1#1)
Seniors##4##1##(1994-3#1)(1997-2#1)(2008-11#1)(2008-9#1)
Sense and antisense##2##3##(1993-3#1)(1994-11#1)
Sense##5##1##(1993-3#1)(1994-1#1)(1994-11#1)(1997-7#1)(2010-3#1)
Sensing of##5##2##(2008-2#2)(2008-3#2)(2010-6#1)
Sensing##14##1##(2008-12#1)(2008-2#4)(2008-3#4)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-6#1)
Sensitive absorption spectroscopy##2##3##(2007-12#1)(2008-3#1)
Sensitive and##6##2##(1995-6#1)(2008-10#4)(2008-11#1)
Sensitive assay##2##2##(1990-8#1)(2008-10#1)
Sensitive detection##2##2##(2008-10#2)
Sensitive determination of##2##3##(2008-10#2)
Sensitive skin##4##2##(2008-5#4)
Sensitive##39##1##(1990-8#1)(1995-6#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2010-2#1)(2011-10#1)(2011-2#1)(2013-1#2)
Sensitivities of##2##2##(2008-10#2)
Sensitivities##4##1##(2008-10#2)(2009-9#1)(2010-2#1)
Sensitivity analyses##6##2##(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)
Sensitivity analysis##5##2##(2008-10#1)(2008-3#1)(2010-10#2)(2012-3#1)
Sensitivity and Specificity##2##3##(2007-12#1)(2013-1#1)
Sensitivity and detection limit##2##4##(2008-10#1)(2008-2#1)
Sensitivity and detection##3##3##(2008-10#2)(2008-2#1)
Sensitivity and specificity of rapid influenza testing of children in a community##2##12##(2011-2#2)
Sensitivity and specificity of##4##4##(1997-3#1)(2011-2#3)
Sensitivity and specificity##6##3##(1990-6#1)(1997-3#1)(2011-2#3)(2012-3#1)
Sensitivity and##14##2##(1990-6#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#3)(2012-3#1)(2013-1#1)
Sensitivity in##2##2##(2008-10#1)(2008-11#1)
Sensitivity of the##7##3##(1990-10#1)(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
Sensitivity of##29##2##(1990-10#1)(1990-7#1)(1992-11#1)(1992-2#1)(1994-2#1)(1997-8#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2009-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
Sensitivity studies##3##2##(2008-3#2)(2008-7#1)
Sensitivity to Ptr ToxA##3##4##(2008-10#3)
Sensitivity to Ptr##4##3##(2008-10#4)
Sensitivity to a##2##3##(2008-10#2)
Sensitivity to##17##2##(1992-1#1)(1995-8#1)(2007-11#1)(2008-10#10)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
Sensitivity was determined##2##3##(1994-11#1)(2008-10#1)
Sensitivity was##9##2##(1991-6#1)(1994-11#1)(2007-6#1)(2008-10#5)(2012-6#1)
Sensitivity##100##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-11#1)(1994-2#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-10#35)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#12)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#2)(2011-1#2)(2011-2#6)(2012-3#4)(2012-6#1)(2013-1#1)(2013-7#1)
Sensitization and##2##2##(1992-7#1)(2009-8#1)
Sensitization to aeroallergens in patients with respiratory allergies based on skin-prick test results##2##13##(2013-1#2)
Sensitization to##6##2##(1991-1#1)(2012-3#1)(2013-1#4)
Sensitization##12##1##(1990-2#1)(1991-1#1)(1991-3#1)(1992-7#1)(2008-10#2)(2009-8#1)(2012-3#1)(2013-1#4)
Sensitized##2##1##(1993-3#1)(2008-10#1)
Sensor (SeaWiFS) from##2##3##(2008-3#2)
Sensor (SeaWiFS)##9##2##(2008-2#1)(2008-3#8)
Sensor based on##2##3##(2007-11#1)(2008-10#1)
Sensor device prepared with this membrane has##2##7##(2008-10#2)
Sensor for##3##2##(2008-3#3)
Sensor performance##2##2##(2008-10#1)(2008-3#1)
Sensor##32##1##(2007-11#1)(2008-10#11)(2008-2#2)(2008-3#16)(2009-9#1)(2013-8#1)
Sensorimotor##2##1##(2007-12#1)(2013-8#1)
Sensors##10##1##(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-9#2)
Sensory and##2##2##(1990-5#1)(1993-1#1)
Sensory evaluation of##3##3##(1995-2#1)(2010-4#2)
Sensory quality##2##2##(2010-4#1)(2013-1#1)
Sensory##15##1##(1990-5#1)(1993-1#1)(1995-2#2)(1997-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#4)(2013-1#1)
Sentara##2##1##(1993-3#2)
Sentence##5##1##(2008-9#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-3#1)
Sentinel lymph node##4##3##(2008-10#2)(2010-11#1)(2011-2#1)
Sentinel##9##1##(1992-12#1)(2008-10#4)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
Sentinels##2##1##(2008-9#2)
Seoul##5##1##(1990-10#1)(1990-12#2)(1991-2#1)(2013-8#1)
Sep##3##1##(1991-12#2)(2008-10#1)
Sep-Pak C(18)##2##2##(2008-10#2)
Sep-Pak C18 cartridges##2##3##(1992-11#1)(1993-2#1)
Sep-Pak##4##1##(1992-11#1)(1993-2#1)(2008-10#2)
Separate measurement of##2##3##(2008-11#1)(2008-3#1)
Separate sections are devoted to##2##5##(2008-10#2)
Separate##19##1##(1992-10#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)
Separated##3##1##(2008-10#1)(2008-12#1)(2008-7#1)
Separately##5##1##(1993-9#1)(1995-8#1)(2007-12#1)(2011-2#1)(2012-3#1)
Separating the##3##2##(1994-12#1)(1995-5#1)(2008-3#1)
Separating##5##1##(1994-12#1)(1995-5#1)(2008-3#2)(2008-6#1)
Separation and detection##2##3##(2008-10#1)(2010-11#1)
Separation and determination of thorium##2##5##(2008-10#2)
Separation and determination of##11##4##(1990-8#1)(2008-10#10)
Separation and preconcentration of##3##4##(2008-10#3)
Separation and preconcentration##5##3##(2008-10#5)
Separation and simultaneous determination of##2##5##(2008-10#2)
Separation and##28##2##(1990-8#1)(1993-2#1)(1993-5#1)(1994-6#1)(2008-10#22)(2009-8#1)(2010-11#1)
Separation of the derivatized##2##4##(2008-10#2)
Separation of the two##2##4##(1991-9#1)(2008-10#1)
Separation of the##5##3##(1991-9#1)(2008-10#4)
Separation of##38##2##(1990-8#1)(1991-9#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-5#2)(1997-2#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#1)
Separation times are generally only a few minutes and the DNA is detected either by UV absorption or by fluorescent labeling##2##21##(2008-2#1)(2008-4#1)
Separation was performed##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
Separation was##6##2##(1991-7#1)(1995-6#1)(2008-10#2)(2011-2#1)(2012-3#1)
Separation##88##1##(1990-11#1)(1990-8#2)(1991-7#1)(1991-9#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-6#2)(1994-9#1)(1995-6#2)(1996-5#3)(1997-2#1)(2008-10#51)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
Separations in##2##2##(2008-10#2)
Separations of##2##2##(2008-10#2)
Separations were accomplished in less than##2##6##(2008-10#2)
Separations were performed##3##3##(2008-10#2)(2013-1#1)
Separations were##7##2##(1996-5#1)(2008-10#5)(2013-1#1)
Separations##12##1##(1996-5#1)(1997-2#1)(2008-10#9)(2013-1#1)
Separon##2##1##(1996-5#1)(2008-10#1)
Sephacryl S-200##3##2##(1990-11#1)(1997-2#1)(1997-4#1)
Sephacryl##6##1##(1990-11#1)(1990-12#1)(1997-2#2)(1997-4#1)(2008-8#1)
Sephadex G-100 column##3##3##(1991-2#1)(1993-6#1)(2008-11#1)
Sephadex G-100##6##2##(1990-11#1)(1991-2#1)(1993-6#1)(1997-2#1)(2008-11#1)(2010-11#1)
Sephadex G-75##3##2##(1990-7#1)(1992-12#1)(1995-6#1)
Sephadex LH-20 column##2##3##(1991-12#1)(1993-2#1)
Sephadex LH-20##4##2##(1990-11#1)(1991-12#1)(1993-2#1)(2011-3#1)
Sephadex QAE A-25 gel##2##4##(2008-10#2)
Sephadex QAE A-25##3##3##(2008-10#3)
Sephadex SP-C25##2##2##(2008-10#2)
Sephadex##34##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-6#1)(1995-6#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-8#1)(2010-11#1)(2011-3#1)
Sepharose 4B beads##2##3##(2011-2#1)(2012-3#1)
Sepharose 4B##4##2##(1993-12#1)(1996-2#1)(2011-2#1)(2012-3#1)
Sepharose 6B##3##2##(1993-11#1)(1996-2#1)(2008-8#1)
Sepharose CL-4B##2##2##(1992-6#1)(1997-2#1)
Sepharose CL-6B##3##2##(1990-12#1)(1997-2#2)
Sepharose and Perloza##3##3##(2008-7#3)
Sepharose and##5##2##(1990-12#1)(1997-1#1)(2008-7#3)
Sepharose column##3##2##(1990-12#1)(1992-12#1)(1995-12#1)
Sepharose##40##1##(1990-12#5)(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-2#2)(1997-1#3)(1997-2#3)(2008-1#1)(2008-10#2)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
Sepharose((R))-based##2##1##(2008-10#2)
Sepia pharaonis##2##2##(2013-7#2)
Sepia##7##1##(2008-7#5)(2013-7#2)
Sepsis and##2##2##(2008-4#1)(2011-2#1)
Sepsis is a leading cause of##2##6##(2010-7#1)(2011-2#1)
Sepsis##8##1##(2007-12#1)(2008-4#2)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#1)
Sept##2##1##(1990-3#1)(2013-1#1)
Septal Defect##2##2##(2008-11#1)(2012-1#1)
Septal##5##1##(1994-2#1)(2008-11#1)(2012-1#2)(2012-3#1)
Septate##2##1##(2008-10#1)(2011-1#1)
September 19-21##2##2##(1997-6#1)(2009-9#1)
September 1986##3##2##(1991-2#1)(1992-6#1)(1996-5#1)
September 1988 to##2##3##(1994-9#1)(1995-12#1)
September 1988##5##2##(1990-12#1)(1994-9#1)(1995-12#1)(2008-5#1)(2008-7#1)
September 1989##2##2##(1990-3#1)(1991-3#1)
September 1990##2##2##(1992-2#1)(1992-5#1)
September 1992##3##2##(1994-2#1)(1996-3#1)(1996-9#1)
September 1993##3##2##(1995-1#1)(1997-3#1)(2008-6#1)
September 1994##6##2##(1994-8#1)(1995-12#1)(1995-5#1)(2008-2#2)(2008-3#1)
September 1995##4##2##(2008-2#2)(2008-5#1)(2008-7#1)
September 1996##3##2##(1997-2#1)(1997-8#1)(2008-10#1)
September 1997##3##2##(2008-10#1)(2008-5#2)
September 1998##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
September 2001##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
September 2002 to##2##3##(2008-12#1)(2008-5#1)
September 2002##4##2##(2007-5#1)(2008-11#1)(2008-12#1)(2008-5#1)
September 2005##2##2##(2008-10#1)(2013-1#1)
September 2006##3##2##(2011-2#1)(2013-7#1)(2013-8#1)
September 2007 to##2##3##(2011-2#2)
September 2007##4##2##(2011-2#3)(2012-2#1)
September 2008##2##2##(2010-4#1)(2011-1#1)
September 2009##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
September 2010##2##2##(2012-2#2)
September 2011##2##2##(2012-12#1)(2013-8#1)
September 27##2##2##(1990-12#1)(2010-12#1)
September 9-11##2##2##(2011-2#1)(2013-8#1)
September and##4##2##(1996-12#1)(2008-10#3)
September to##3##2##(2008-10#2)(2008-5#1)
September##122##1##(1990-12#2)(1990-3#2)(1990-6#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#2)(2008-5#14)(2008-6#1)(2008-7#3)(2009-12#5)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#7)
Septic##4##1##(2008-7#1)(2012-12#2)(2012-2#1)
Septoria Tritici Blotch##3##3##(2008-10#3)
Septoria leaf blotch##2##3##(2008-10#2)
Septoria leaf spot##2##3##(2008-10#2)
Septoria leaf##4##2##(2008-10#4)
Septoria musiva##2##2##(2008-10#2)
Septoria musiva)##2##2##(2008-10#2)
Septoria passerinii##4##2##(2008-10#4)
Septoria speckled leaf blotch (SSLB)##3##5##(2008-10#3)
Septoria tritici Blotch##2##3##(2008-10#2)
Septoria tritici blotch (STB)##3##4##(2008-10#3)
Septoria tritici blotch##9##3##(2008-10#9)
Septoria tritici##19##2##(2008-10#19)
Septoria##46##1##(2008-10#46)
SeqLab##2##1##(2008-4#2)
Sequence Analysis##2##2##(2009-3#1)(2012-3#1)
Sequence Tag Analysis of Genomic Enrichment (STAGE)##2##7##(2008-2#2)
Sequence Tag##3##2##(2008-2#2)(2009-8#1)
Sequence alignment##2##2##(1995-5#1)(2008-10#1)
Sequence analyses of the##3##4##(1990-5#1)(2008-10#2)
Sequence analyses of##5##3##(1990-12#1)(1990-5#1)(2008-10#2)(2010-4#1)
Sequence analyses##7##2##(1990-12#1)(1990-5#1)(2008-10#4)(2010-4#1)
Sequence analysis and##4##3##(1993-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
Sequence analysis indicated##2##3##(1993-3#1)(2008-10#1)
Sequence analysis of a##6##4##(1990-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-8#1)
Sequence analysis of one of##2##5##(1992-8#1)(2008-8#1)
Sequence analysis of the complete internal transcribed spacer (ITS) region##2##10##(2008-10#2)
Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp##3##11##(1995-8#1)(1996-6#2)
Sequence analysis of the genome of##4##6##(1995-8#1)(1996-6#2)(2008-10#1)
Sequence analysis of the##26##4##(1990-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-4#1)(2008-10#10)(2008-12#1)(2011-2#1)
Sequence analysis of these##2##4##(1993-12#1)(2008-10#1)
Sequence analysis of##49##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#3)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#17)(2008-12#1)(2008-8#5)(2008-9#1)(2010-3#1)(2011-2#1)
Sequence analysis revealed that the##2##5##(1996-6#1)(2008-10#1)
Sequence analysis revealed that##6##4##(1996-6#1)(1997-7#1)(2008-10#3)(2008-9#1)
Sequence analysis revealed##8##3##(1996-6#1)(1997-7#1)(2008-10#4)(2008-9#1)(2013-1#1)
Sequence analysis showed that the##6##5##(2008-10#1)(2008-8#1)(2008-9#2)(2011-10#1)(2012-3#1)
Sequence analysis showed that##8##4##(2008-10#1)(2008-8#3)(2008-9#2)(2011-10#1)(2012-3#1)
Sequence analysis showed##11##3##(1997-8#1)(2008-10#1)(2008-8#3)(2008-9#2)(2011-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
Sequence analysis shows that##2##4##(1993-12#1)(2008-8#1)
Sequence analysis shows##3##3##(1991-6#1)(1993-12#1)(2008-8#1)
Sequence analysis##82##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#24)(2008-12#1)(2008-8#9)(2008-9#5)(2010-3#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Sequence and expression of a##2##5##(1991-2#1)(1993-6#1)
Sequence and phylogenetic analysis##2##4##(2008-10#2)
Sequence and phylogenetic##3##3##(2008-10#3)
Sequence and##13##2##(1991-2#1)(1991-6#1)(1991-7#1)(1993-6#1)(1997-2#1)(2008-10#8)
Sequence comparison of the##2##4##(1993-6#1)(2008-10#1)
Sequence comparison##8##2##(1993-6#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
Sequence comparisons and phylogenetic##2##4##(2008-10#1)(2008-8#1)
Sequence comparisons and##3##3##(2008-10#2)(2008-8#1)
Sequence comparisons of##2##3##(1995-2#1)(2008-10#1)
Sequence comparisons showed that##2##4##(2008-10#1)(2008-9#1)
Sequence comparisons##13##2##(1992-8#2)(1993-6#1)(1995-2#1)(1997-7#1)(1997-9#1)(2008-10#5)(2008-8#1)(2008-9#1)
Sequence data##2##2##(2008-10#1)(2008-8#1)
Sequence determination of the entire genome and assignment of potential protein-coding regions##2##12##(1996-6#2)
Sequence diversity##2##2##(2008-10#2)
Sequence evaluation was performed twice and validated by a third senior##2##11##(2008-12#2)
Sequence features of the##2##4##(1997-6#1)(1997-8#1)
Sequence features##4##2##(1995-8#1)(1996-8#1)(1997-6#1)(1997-8#1)
Sequence of the gene encoding the##2##6##(1991-9#1)(1994-12#1)
Sequence of the##8##3##(1991-9#2)(1993-12#1)(1993-2#2)(1994-12#3)
Sequence of##15##2##(1991-9#2)(1993-12#1)(1993-2#2)(1994-12#4)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)
Sequence requirements for##2##3##(1991-6#1)(1991-9#1)
Sequence specific 1H##2##3##(2009-7#2)
Sequence##204##1##(1990-11#1)(1990-12#2)(1990-5#1)(1991-2#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-3#1)(1992-8#3)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#8)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-3#1)(1996-5#2)(1996-6#6)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#2)(1997-9#1)(2007-10#1)(2007-12#2)(2008-10#62)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#13)(2008-9#9)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
Sequence-Characterized##2##1##(2008-10#2)
Sequence-specific 1H##2##2##(2009-7#2)
Sequence-specific##4##1##(1995-2#1)(2009-7#3)
Sequence-tagged##2##1##(1994-12#1)(2008-10#1)
Sequences from##3##2##(2008-10#2)(2013-1#1)
Sequences of the##5##3##(1990-7#1)(2008-10#4)
Sequences of##8##2##(1990-7#1)(1991-9#1)(2008-10#4)(2008-6#1)(2013-1#1)
Sequences##27##1##(1990-7#1)(1991-5#2)(1991-7#1)(1991-9#1)(1994-12#1)(1995-2#1)(1996-8#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#3)
Sequencing analysis##2##2##(2012-12#2)
Sequencing and Southern analysis showed that##2##6##(2008-8#2)
Sequencing and##4##2##(1991-9#1)(2008-10#1)(2008-8#2)
Sequencing data##3##2##(1990-2#1)(1992-3#1)(2008-8#1)
Sequencing of a##2##3##(1993-6#1)(2008-10#1)
Sequencing of the##9##3##(1994-12#1)(1994-9#1)(1997-3#1)(1997-4#1)(2008-10#3)(2009-6#1)(2012-3#1)
Sequencing of##16##2##(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-6#1)(2009-6#1)(2009-7#1)(2012-3#1)(2013-1#1)
Sequencing the##2##2##(1991-12#1)(2008-10#1)
Sequencing##36##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-4#1)(2008-6#1)(2008-8#4)(2009-6#1)(2009-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
Sequential addition of##2##3##(1990-2#1)(2010-3#1)
Sequential additions##2##2##(1992-6#2)
Sequential administration of##2##3##(1990-5#1)(1997-6#1)
Sequential determination of##3##3##(2008-10#3)
Sequential extraction of##2##3##(2008-10#2)
Sequential extraction procedure for speciation of inorganic##2##7##(2008-10#2)
Sequential extraction##6##2##(2008-10#6)
Sequential injection analysis system##2##4##(2008-10#2)
Sequential injection analysis##6##3##(2008-10#6)
Sequential injection spectrophotometric determination of##4##5##(2008-10#4)
Sequential injection spectrophotometric##5##3##(2008-10#5)
Sequential injection system with higher dimensional electrochemical sensor signals Part##2##10##(2008-10#2)
Sequential injection system##3##3##(2008-10#3)
Sequential injection with##2##3##(2008-10#2)
Sequential injection##22##2##(2008-10#22)
Sequential sampling##2##2##(2008-10#2)
Sequential##69##1##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#2)(1992-6#2)(1994-8#2)(1997-6#1)(2007-6#1)(2008-10#46)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
Sequestered##2##1##(2008-10#1)(2009-3#1)
Sequestration##3##1##(2008-11#1)(2013-1#2)
Sequoia District##3##2##(1996-3#3)
Ser 195##3##2##(1991-3#3)
Ser 342 and##2##3##(2012-2#2)
Ser at position##2##3##(1991-9#1)(1997-8#1)
Ser at##3##2##(1991-9#1)(1997-8#2)
Ser codon##2##2##(1992-3#1)(1994-12#1)
Ser or##2##2##(1992-4#1)(1994-8#1)
Ser##35##1##(1990-7#1)(1991-3#3)(1991-9#2)(1992-12#1)(1992-3#3)(1992-4#2)(1992-8#1)(1993-11#3)(1994-11#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-7#3)(1997-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#2)
Ser(727)##4##1##(2011-2#4)
Ser+1##2##1##(1991-9#2)
Ser- Phe-##2##2##(1991-5#2)
Ser-##4##1##(1991-5#4)
Ser-132##6##1##(1992-3#6)
Ser-143 is##2##2##(1994-6#2)
Ser-143##3##1##(1994-6#3)
Ser-159##2##1##(1995-2#2)
Ser/Thr##2##1##(1992-6#1)(1994-5#1)
Ser214##4##1##(1992-3#4)
Ser520##2##1##(2010-11#2)
Sera from##6##2##(1992-8#1)(1994-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-5#1)
Sera of##2##2##(1995-3#1)(2010-8#1)
Sera were##2##2##(1992-8#1)(2008-10#1)
Sera##12##1##(1992-8#2)(1993-9#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-5#1)
Serbia##9##1##(2007-5#1)(2008-10#1)(2008-11#2)(2011-2#5)
Serbian##4##1##(2008-11#1)(2008-7#2)(2011-2#1)
Sercial##2##1##(2008-10#2)
Serendipitous##2##1##(1991-8#1)(2013-1#1)
Sergent##4##1##(2010-1#4)
Serial blood samples were collected##2##5##(2008-3#1)(2010-8#1)
Serial histological sections##2##3##(2011-2#2)
Serial measurements##2##2##(1990-6#1)(1990-9#1)
Serial sections##2##2##(1997-2#1)(2008-5#1)
Serial##24##1##(1990-6#1)(1990-9#1)(1991-6#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-5#2)(2008-7#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
Sericin##2##1##(2008-11#2)
Series of##4##2##(1995-12#1)(1996-8#1)(2008-11#1)(2008-5#1)
Series##18##1##(1990-8#2)(1995-12#1)(1996-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-9#4)(2012-3#1)
Serine Protease Autotransporters of the Enterobacteriaceae##2##6##(2011-1#2)
Serine Protease##3##2##(2011-1#2)(2012-12#1)
Serine##13##1##(1990-7#1)(1997-1#2)(1997-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2011-1#2)(2012-12#1)
Serious##11##1##(1990-2#1)(1992-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)
Sero-prevalence of HIV##2##3##(2007-7#1)(2011-2#1)
Seroconversion##3##1##(1995-5#1)(2007-11#2)
Serodiagnosis of##3##2##(1991-11#1)(2007-7#1)(2008-8#1)
Seroepidemiological##2##1##(2011-2#1)(2012-2#1)
Seroepidemiology of crimean congo hemorrhagic Fever in slaughterhouse workers in north eastern iran##2##13##(2013-1#2)
Seroepidemiology of##3##2##(2007-12#1)(2013-1#2)
Serogroup##3##1##(2007-2#1)(2008-10#2)
Serogroups##2##1##(2008-10#1)(2008-12#1)
Serologic##10##1##(1990-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1996-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
Serological analysis##2##2##(2008-10#2)
Serological and biological##2##3##(2008-10#2)
Serological and##3##2##(2008-10#3)
Serological evidence of##2##3##(2007-12#1)(2009-8#1)
Serological evidence##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
Serological##24##1##(1990-3#1)(1991-11#2)(1992-2#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
Serology##4##1##(2008-10#1)(2011-2#3)
Seronorm Trace##2##2##(2008-10#2)
Seronormtrade mark Trace Elements in##3##5##(2008-10#3)
Seronormtrade mark Trace Elements##4##4##(2008-10#4)
Seropositive##2##1##(1993-11#1)(2009-3#1)
Seroprevalence of hepatitis B virus##2##5##(2007-7#1)(2008-7#1)
Seroprevalence of hepatitis B##4##4##(2007-7#1)(2008-7#1)(2009-7#1)(2010-11#1)
Seroprevalence of hepatitis##5##3##(2007-7#1)(2008-7#1)(2009-7#1)(2010-11#2)
Seroprevalence of##14##2##(2007-7#4)(2008-10#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#2)(2011-2#2)(2012-2#2)
Seroprevalence##15##1##(2007-7#4)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#2)(2011-2#2)(2012-2#2)
Serotonergic projection neurons##2##3##(2008-7#2)
Serotonergic##5##1##(1992-8#1)(1996-7#1)(2008-7#3)
Serotonin (5-HT)##2##2##(1996-12#1)(1996-5#1)
Serotonin##15##1##(1990-5#1)(1992-1#1)(1993-12#1)(1995-11#2)(1995-12#1)(1996-12#2)(1996-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-3#2)
Serotypes##2##1##(2008-10#2)
Serpins##3##1##(2008-4#3)
Serpulina##5##1##(1996-11#4)(2011-2#1)
Serratia marcescens##16##2##(1996-12#3)(2008-10#7)(2009-5#2)(2009-6#2)(2010-6#1)(2011-2#1)
Serratia plymuthica##2##2##(2008-10#2)
Serratia spp##2##2##(2008-10#2)
Serratia##22##1##(1996-12#3)(2007-11#1)(2008-10#12)(2009-5#2)(2009-6#2)(2010-6#1)(2011-2#1)
Sertoli and germ cells##2##4##(2009-10#2)
Sertoli and germ##3##3##(2009-10#3)
Sertoli and##6##2##(2009-10#4)(2011-2#1)(2012-2#1)
Sertoli cell tumours##2##3##(2011-2#2)
Sertoli cell##6##2##(1990-4#1)(2009-10#1)(2011-2#2)(2012-2#2)
Sertoli cells and##3##3##(2008-4#1)(2009-10#1)(2013-1#1)
Sertoli cells is##2##3##(2009-10#1)(2012-2#1)
Sertoli cells##21##2##(1995-6#1)(2008-4#3)(2009-10#10)(2010-11#1)(2010-5#1)(2012-2#4)(2013-1#1)
Sertoli##35##1##(1990-4#1)(1995-6#1)(2008-4#3)(2009-10#15)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#9)(2013-1#1)
Serum 25##2##2##(2008-1#1)(2011-1#1)
Serum 25(OH)D##4##2##(2011-1#1)(2011-2#3)
Serum Cu##2##2##(1995-3#2)
Serum IGF-I and IGFBP-3 levels##2##5##(2011-1#1)(2013-1#1)
Serum IgG##2##2##(1990-2#1)(2009-8#1)
Serum Levels of##2##3##(2008-8#1)(2012-3#1)
Serum Levels##3##2##(2008-8#2)(2012-3#1)
Serum PSA##2##2##(1990-9#2)
Serum Response Factor##4##3##(1994-6#4)
Serum Response##5##2##(1994-6#5)
Serum adiponectin levels##2##3##(2010-11#1)(2011-1#1)
Serum albumin and##2##3##(2008-10#1)(2012-2#1)
Serum albumin##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
Serum alkaline phosphatase##2##3##(1991-5#1)(1993-3#1)
Serum and urine nitrite##2##4##(2006-10#1)(2008-7#1)
Serum and urine##3##3##(2006-10#2)(2008-7#1)
Serum and##5##2##(2006-10#2)(2008-11#1)(2008-7#1)(2011-1#1)
Serum anti-Müllerian hormone##2##3##(2012-3#2)
Serum antibody levels to##2##4##(1991-8#2)
Serum antibody##3##2##(1991-8#2)(2012-3#1)
Serum bile##2##2##(2013-1#2)
Serum bone GLA-protein##3##3##(1990-2#3)
Serum concentration of##2##3##(2008-7#1)(2008-9#1)
Serum concentrations of##7##3##(1995-2#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
Serum corticosterone##2##2##(2008-10#2)
Serum creatine##2##2##(1997-3#1)(2008-12#1)
Serum creatinine##2##2##(1992-3#1)(2012-3#1)
Serum cystatin C##2##3##(2010-4#1)(2013-1#1)
Serum from##2##2##(1997-6#1)(2008-10#1)
Serum leptin##4##2##(2006-10#1)(2011-1#2)(2013-7#1)
Serum levels of tissue##2##4##(1990-8#1)(1994-3#1)
Serum levels of##8##3##(1990-11#1)(1990-2#1)(1990-8#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-6#1)(2008-10#1)
Serum levels##9##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-6#1)(2008-10#1)(2011-2#1)
Serum magnesium was##2##3##(2011-2#2)
Serum magnesium##4##2##(2008-6#1)(2011-2#3)
Serum markers of##2##3##(2013-8#2)
Serum p53##2##2##(2011-2#2)
Serum potassium##2##2##(2008-2#1)(2010-12#1)
Serum samples from##2##3##(1991-2#1)(1991-3#1)
Serum samples were##5##3##(1995-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2011-2#1)
Serum samples##10##2##(1991-2#1)(1991-3#1)(1995-2#1)(2007-10#1)(2008-10#4)(2008-12#1)(2011-2#1)
Serum stimulation of##2##3##(1992-3#1)(1997-1#1)
Serum testosterone##2##2##(1995-3#1)(2011-1#1)
Serum triglyceride and##2##3##(1992-6#1)(2011-1#1)
Serum vitamin##2##2##(1990-3#1)(1992-9#1)
Serum##193##1##(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#1)(1990-8#2)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#3)(1991-8#3)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#7)(1994-7#1)(1995-2#4)(1995-3#5)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#4)(1997-6#2)(2006-10#3)(2007-10#4)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#17)(2011-2#14)(2012-12#1)(2012-2#3)(2012-3#7)(2012-5#1)(2013-1#8)(2013-7#5)(2013-8#5)
Serum-free##8##1##(1991-8#1)(2008-11#7)
Serum/plasma Se##2##2##(2011-2#2)
Service Act##2##2##(1991-1#1)(1992-1#1)
Service and##2##2##(1991-3#1)(2008-12#1)
Service at##2##2##(1992-1#1)(2008-1#1)
Service d'Aéronomie du Centre National de la Recherche Scientifique##2##9##(2008-3#2)
Service in##3##2##(1992-5#1)(2012-2#1)(2013-1#1)
Service management##3##2##(1994-1#2)(1994-3#1)
Service of##3##2##(1991-3#1)(2012-3#1)(2013-1#1)
Service quality##2##2##(1995-3#1)(2013-8#1)
Service to##2##2##(1994-11#1)(2011-2#1)
Service##102##1##(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#3)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#7)(2008-11#8)(2008-12#5)(2008-3#4)(2008-7#4)(2008-8#1)(2009-8#1)(2010-3#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
Service)##2##1##(2008-2#1)(2011-1#1)
Services Act##3##2##(1995-2#1)(1996-1#2)
Services Research##11##2##(1994-12#1)(2009-3#1)(2010-11#1)(2010-3#1)(2012-2#7)
Services and##4##2##(1991-12#1)(1994-3#1)(1997-2#1)(2013-8#1)
Services for##5##2##(1991-1#1)(1997-3#1)(2012-12#1)(2013-8#2)
Services in##6##2##(1996-3#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-11#1)(2012-2#1)
Services project##2##2##(2008-7#1)(2011-2#1)
Services to##6##2##(1996-1#1)(1997-2#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
Services##112##1##(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#3)(1993-2#1)(1994-1#4)(1994-12#5)(1994-2#4)(1994-3#2)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#2)(1996-1#4)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-6#4)(2008-7#4)(2008-9#3)(2009-10#1)(2009-3#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-5#2)(2010-8#3)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#9)(2013-1#3)(2013-8#3)
Services'##2##1##(1996-3#1)(1997-3#1)
Serving the##2##2##(1993-2#1)(2008-11#1)
Serving##3##1##(1993-1#1)(1993-2#1)(2008-11#1)
Servo##2##1##(1992-2#1)(1994-12#1)
Session Presentations at the##8##4##(2008-11#8)
Session##10##1##(2008-10#1)(2008-11#9)
Sessions##3##1##(2009-6#1)(2011-1#1)(2011-2#1)
Set##23##1##(1991-3#1)(1993-2#4)(1995-2#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Set7/9 expression##2##2##(2010-11#2)
Set7/9##7##1##(2010-11#7)
Setaria digitata##4##2##(1991-5#2)(1994-11#2)
Setaria spp##2##2##(2008-10#2)
Setaria##8##1##(1991-5#2)(1994-11#2)(2008-10#4)
Setosphaeria turcica##4##2##(2008-10#4)
Sets of##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
Sets##5##1##(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
Setting the##2##2##(1994-12#1)(1996-2#1)
Setting up##4##2##(2007-12#1)(2008-10#1)(2009-12#1)(2010-4#1)
Setting##23##1##(1991-2#2)(1992-2#1)(1992-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)
Settings and Design##3##3##(2013-8#3)
Settings##5##1##(2011-2#2)(2013-8#3)
Seven (6##2##2##(2007-7#1)(2008-1#1)
Seven cases of##3##3##(1991-6#1)(1994-9#1)(2012-2#1)
Seven cases##5##2##(1991-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
Seven children##3##2##(1995-3#1)(2008-9#1)(2011-2#1)
Seven crystal##2##2##(2008-3#2)
Seven days after##4##3##(1990-5#1)(1995-12#1)(1996-5#1)(2007-12#1)
Seven days##5##2##(1990-5#1)(1995-12#1)(1996-5#2)(2007-12#1)
Seven different##6##2##(1993-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-3#1)
Seven human##2##2##(1990-12#1)(2013-1#1)
Seven hundred and##3##3##(1997-4#1)(2008-10#2)
Seven hundred##5##2##(1997-4#1)(2008-10#3)(2012-2#1)
Seven of eight##2##3##(2008-9#1)(2010-1#1)
Seven of the##6##3##(1992-6#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
Seven of these##2##3##(1991-6#1)(1993-8#1)
Seven of##14##2##(1991-5#1)(1991-6#1)(1992-6#1)(1993-8#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-12#1)
Seven out of##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
Seven patients had##2##3##(1997-8#1)(2008-8#1)
Seven patients underwent##2##3##(1991-9#1)(1993-2#1)
Seven patients were##2##3##(2008-4#1)(2008-7#1)
Seven patients with##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
Seven patients##14##2##(1991-8#1)(1991-9#1)(1993-2#1)(1995-10#1)(1997-8#2)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Seven percent of##3##3##(1992-1#1)(1994-3#1)(2013-1#1)
Seven studies compared##2##3##(2008-6#1)(2012-12#1)
Seven studies showed##2##3##(2009-2#1)(2013-1#1)
Seven studies##5##2##(2008-4#1)(2008-6#1)(2009-2#1)(2012-12#1)(2013-1#1)
Seven##149##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#29)(2008-11#6)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-2#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#2)
Seventeen of the##2##3##(1991-3#1)(2008-10#1)
Seventeen patients were##4##3##(1995-3#1)(2007-10#1)(2008-7#1)(2013-8#1)
Seventeen patients##12##2##(1990-2#1)(1995-3#1)(2007-10#3)(2008-6#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
Seventeen were##2##2##(2008-5#2)
Seventeen##40##1##(1990-2#1)(1990-3#1)(1991-3#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2007-10#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-9#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
Seventy family members##2##3##(2011-2#2)
Seventy five##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
Seventy percent of the##2##4##(1990-8#1)(2008-11#1)
Seventy percent of##4##3##(1990-8#1)(1993-1#1)(2008-11#1)(2011-1#1)
Seventy percent##7##2##(1990-8#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
Seventy two##2##2##(1995-12#1)(2013-1#1)
Seventy##24##1##(1990-8#1)(1993-1#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Seventy-eight##2##1##(1996-3#1)(2008-12#1)
Seventy-five per cent##2##3##(2008-10#1)(2011-2#1)
Seventy-five percent of##3##3##(1990-11#1)(2008-11#1)(2009-10#1)
Seventy-five percent##4##2##(1990-11#1)(2008-11#1)(2009-10#2)
Seventy-five##10##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
Seventy-four percent of the##2##4##(2008-10#1)(2008-3#1)
Seventy-four##3##1##(2008-10#1)(2008-3#1)(2008-4#1)
Seventy-one##2##1##(2006-10#1)(2013-1#1)
Seventy-seven percent##2##2##(1992-3#1)(2008-4#1)
Seventy-seven##6##1##(1992-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
Seventy-six percent##2##2##(1996-1#1)(2011-1#1)
Seventy-six##3##1##(1996-1#1)(2008-10#1)(2011-1#1)
Seventy-three patients##2##2##(2007-8#1)(2012-3#1)
Seventy-three##4##1##(1993-12#1)(2007-8#1)(2012-3#1)(2013-1#1)
Seventy-two consecutive##2##2##(1991-8#1)(1992-12#1)
Seventy-two patients##3##2##(2008-7#3)
Seventy-two##12##1##(1991-8#1)(1992-12#1)(1992-2#1)(2006-10#1)(2008-10#1)(2008-7#3)(2009-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
Several alternative##2##2##(2008-2#1)(2008-9#1)
Several analytical##2##2##(2008-10#1)(2008-3#1)
Several approaches to##3##3##(1995-1#1)(2008-3#1)(2008-7#1)
Several approaches##5##2##(1995-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
Several areas##4##2##(2007-8#2)(2008-12#1)(2008-2#1)
Several aspects of##4##3##(2008-10#1)(2008-12#1)(2009-11#2)
Several aspects##5##2##(2008-10#2)(2008-12#1)(2009-11#2)
Several authors have##4##3##(1990-11#1)(1992-6#1)(1995-9#1)(2008-8#1)
Several authors##5##2##(1990-11#1)(1992-5#1)(1992-6#1)(1995-9#1)(2008-8#1)
Several biological##3##2##(2008-8#1)(2009-11#1)(2011-2#1)
Several characteristics of##2##3##(1994-5#1)(2008-10#1)
Several characteristics##3##2##(1994-5#1)(2008-10#1)(2009-4#1)
Several chemical and flow variables##2##5##(2008-10#2)
Several classes of##2##3##(2010-4#1)(2011-2#1)
Several clinical trials have##2##4##(2008-10#1)(2012-12#1)
Several clinical##5##2##(1991-6#1)(1992-10#1)(2008-10#1)(2010-6#1)(2012-12#1)
Several complications##4##2##(1996-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
Several conclusions##2##2##(1992-11#1)(2008-10#1)
Several conserved##2##2##(1992-9#1)(1993-2#1)
Several criteria##2##2##(1990-8#1)(2010-2#1)
Several days##2##2##(2009-3#1)(2012-2#1)
Several different##9##2##(1993-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-8#1)
Several directions for future research##2##5##(1996-3#1)(2007-12#1)
Several examples are presented##3##4##(1996-4#1)(2008-10#1)(2008-2#1)
Several examples are##4##3##(1995-5#1)(1996-4#1)(2008-10#1)(2008-2#1)
Several examples of##2##3##(1993-12#1)(2008-2#1)
Several examples##8##2##(1992-9#1)(1993-12#1)(1995-5#1)(1996-4#1)(2008-10#1)(2008-2#2)(2013-8#1)
Several experimental and##2##3##(2008-5#1)(2012-1#1)
Several experimental##5##2##(1997-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-1#1)
Several experiments have been##2##4##(2008-5#1)(2008-6#1)
Several experiments were##2##3##(2008-3#1)(2008-5#1)
Several experiments##4##2##(2008-3#1)(2008-5#2)(2008-6#1)
Several explanations##2##2##(1993-9#1)(2008-10#1)
Several factors affecting the hydride generation##2##6##(2008-10#2)
Several factors affecting the##3##4##(2008-10#3)
Several factors have been##2##4##(1992-10#1)(2008-11#1)
Several factors##14##2##(1992-10#1)(1992-8#1)(1993-1#1)(1997-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#1)
Several forms of##2##3##(1993-8#1)(1997-8#1)
Several functional##2##2##(1990-8#1)(2012-2#1)
Several genes involved in##2##4##(2008-7#1)(2010-4#1)
Several genes##4##2##(1995-6#1)(2008-7#1)(2010-4#1)(2012-3#1)
Several groups##3##2##(1992-1#1)(2008-5#1)(2011-2#1)
Several have##2##2##(1997-3#1)(2012-12#1)
Several hundred##2##2##(2008-3#1)(2008-7#1)
Several hypotheses have been proposed##2##5##(2011-1#1)(2012-3#1)
Several hypotheses##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
Several important##4##2##(1994-2#1)(2008-10#1)(2008-9#1)(2010-3#1)
Several independent##2##2##(2008-10#1)(2010-2#1)
Several isolates from##2##3##(2008-10#2)
Several isolates were##2##3##(2008-10#1)(2008-5#1)
Several isolates##5##2##(2008-10#4)(2008-5#1)
Several key##3##2##(2007-11#1)(2007-12#1)(2009-11#1)
Several kinds of##2##3##(2007-7#1)(2008-3#1)
Several large##2##2##(2008-7#1)(2009-8#1)
Several lines of evidence suggest that##2##6##(2008-4#1)(2011-2#1)
Several lines of evidence##4##4##(2008-10#1)(2008-4#1)(2011-2#2)
Several mechanisms##3##2##(1996-11#1)(2008-10#1)(2008-3#1)
Several methods for##2##3##(2008-3#1)(2008-6#1)
Several methods have been##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
Several methods to##2##3##(2008-10#1)(2008-11#1)
Several methods##10##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-1#1)(2012-3#1)(2013-8#1)
Several models##4##2##(2007-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
Several modified##2##2##(2008-10#2)
Several molecular##2##2##(1992-11#1)(2012-2#1)
Several natural##2##2##(2007-11#1)(2009-11#1)
Several new##10##2##(1996-8#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
Several non-Ewald methods for calculating electrostatic interactions have recently been developed##2##11##(2013-1#2)
Several novel##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
Several of the##3##3##(1996-3#1)(2008-8#1)(2010-5#1)
Several of these##6##3##(1993-2#1)(1994-9#1)(1996-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
Several of##9##2##(1993-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-2#1)
Several other##10##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-1#1)(2009-9#1)(2012-2#2)
Several parameters of the extraction and desorption procedure were studied and optimized (such as types of fibers##2##17##(2008-10#2)
Several parameters##10##2##(2008-10#9)(2011-1#1)
Several plasmids were##2##3##(1990-5#1)(2008-9#1)
Several possible##2##2##(1992-12#1)(2008-2#1)
Several potential mechanisms##2##3##(1994-11#1)(2008-5#1)
Several potential##5##2##(1994-11#1)(1994-5#1)(1996-10#1)(2008-3#1)(2008-5#1)
Several previous##2##2##(2008-10#1)(2008-2#1)
Several procedures for##2##3##(2008-10#1)(2008-4#1)
Several processes##2##2##(2008-6#1)(2008-9#1)
Several recent studies have##3##4##(1993-11#1)(1996-2#1)(2011-2#1)
Several recent studies##5##3##(1993-11#1)(1996-2#1)(2006-10#1)(2010-1#1)(2011-2#1)
Several recent##12##2##(1993-11#1)(1996-2#1)(1997-5#1)(2006-10#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
Several reports have##3##3##(1994-3#1)(2008-11#1)(2008-5#1)
Several reports##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
Several research##2##2##(2008-3#1)(2008-8#1)
Several risk factors##2##3##(2007-7#1)(2010-6#1)
Several small##2##2##(2008-10#1)(2009-4#1)
Several species of##3##3##(2006-6#1)(2008-10#1)(2008-12#1)
Several strategies##2##2##(2008-10#2)
Several structural##2##2##(2009-12#1)(2010-12#1)
Several studies have been##2##4##(2008-11#1)(2013-1#1)
Several studies have demonstrated that the##2##6##(1990-3#1)(1994-8#1)
Several studies have indicated that##3##5##(1992-12#1)(2009-8#1)(2010-11#1)
Several studies have reported##4##4##(2007-10#1)(2008-11#3)
Several studies have shown that##6##5##(2008-2#1)(2008-7#2)(2011-2#1)(2012-3#2)
Several studies have##24##3##(1990-3#1)(1992-12#1)(1994-8#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#3)(2009-2#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
Several studies in##2##3##(2008-9#1)(2010-11#1)
Several studies##36##2##(1990-3#1)(1992-12#1)(1994-8#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-11#9)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Several substances##2##2##(1996-5#1)(2008-10#1)
Several synthetic##2##2##(1991-9#1)(2008-9#1)
Several techniques##2##2##(2008-10#1)(2013-1#1)
Several therapeutic##2##2##(2006-10#1)(2013-1#1)
Several transcripts##2##2##(2008-10#1)(2012-2#1)
Several types of##7##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#2)
Several variables##3##2##(1990-3#1)(2008-10#1)(2011-2#1)
Several years after##2##3##(2008-11#1)(2011-2#1)
Several years ago##2##3##(2008-2#1)(2010-8#1)
Several years##4##2##(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
Several##573##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#4)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#1)(1997-8#2)(1997-9#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-7#4)(2007-8#5)(2008-1#4)(2008-10#118)(2008-11#33)(2008-12#9)(2008-2#24)(2008-3#23)(2008-4#11)(2008-5#21)(2008-6#7)(2008-7#15)(2008-8#15)(2008-9#16)(2009-1#2)(2009-10#1)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#6)(2011-2#20)(2012-1#3)(2012-12#6)(2012-2#12)(2012-3#7)(2013-1#12)(2013-8#3)
Severance Hospice Home Care Program##2##5##(1990-10#2)
Severance Hospice Home Care##3##4##(1990-10#3)
Severance##4##1##(1990-10#3)(1990-2#1)
Severe VDD was##2##3##(2011-1#2)
Severe acute respiratory syndrome (SARS)##2##5##(2007-7#2)
Severe acute respiratory syndrome##5##4##(2007-12#2)(2007-7#3)
Severe and##2##2##(2008-6#1)(2010-8#1)
Severe anemia##2##2##(2012-3#1)(2013-1#1)
Severe bilateral microphthalmos in a Pomeranian pup - A##2##9##(2013-8#2)
Severe bilateral##3##2##(2012-2#1)(2013-8#2)
Severe hypotension##2##2##(1990-8#1)(2008-7#1)
Severe hypoxemia##2##2##(2012-2#1)(2013-1#1)
Severe injuries##2##2##(1990-9#2)
Severe skew foot deformity##2##4##(2012-3#2)
Severe thrombocytopenia##2##2##(2006-10#2)
Severe toxicity was observed at high concentrations and moderate toxicity at low concentrations in comparison with water control##2##18##(2008-12#2)
Severe toxicity was##3##3##(1992-8#1)(2008-12#2)
Severe##94##1##(1990-8#1)(1990-9#2)(1991-11#2)(1991-8#1)(1992-8#2)(1994-6#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-12#4)(2007-5#1)(2007-7#4)(2007-8#3)(2008-10#13)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#8)(2013-1#8)(2013-8#3)
Severely##2##1##(2010-8#1)(2013-1#1)
Severin##2##1##(2007-8#2)
Severin's classification##3##2##(2007-8#3)
Severity Index (CTSI)##2##3##(2009-8#2)
Severity Index##10##2##(1992-2#1)(1995-2#1)(2007-7#1)(2008-3#1)(2009-8#3)(2011-1#2)(2013-8#1)
Severity in##2##2##(2007-12#1)(2008-10#1)
Severity of disease##2##3##(2008-10#1)(2008-7#1)
Severity of symptoms##2##3##(2008-10#2)
Severity of##17##2##(1990-3#1)(2007-7#1)(2008-10#10)(2008-7#1)(2009-10#1)(2010-1#1)(2012-12#2)
Severity on##2##2##(2008-10#2)
Severity##38##1##(1990-3#1)(1992-2#1)(1995-2#1)(2007-12#1)(2007-7#2)(2008-10#16)(2008-3#1)(2008-7#3)(2009-10#1)(2009-8#3)(2010-1#1)(2011-1#2)(2012-12#2)(2013-8#3)
Sevoflurane had##3##2##(2012-3#3)
Sevoflurane##7##1##(2012-3#7)
Sewage##2##1##(1997-4#1)(2009-8#1)
Sewall Wright Award##3##3##(2008-8#1)(2008-9#2)
Sex allocation##3##2##(2008-9#3)
Sex and##5##2##(2008-11#1)(2008-5#1)(2009-12#2)(2013-7#1)
Sex chromosome##2##2##(2008-12#1)(2010-3#1)
Sex chromosomes and##2##3##(2008-8#1)(2010-5#1)
Sex chromosomes##3##2##(2008-8#1)(2010-3#1)(2010-5#1)
Sex determination##3##2##(1994-3#1)(1995-6#1)(2010-3#1)
Sex differences in the##6##4##(1994-2#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-12#1)(2010-6#1)
Sex differences in##10##3##(1994-2#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)
Sex differences were##2##3##(2007-12#1)(2008-9#1)
Sex differences##14##2##(1994-2#1)(1996-8#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#3)(2010-12#1)(2010-6#1)(2011-2#1)
Sex is##2##2##(1997-7#1)(2008-1#1)
Sex ratio was of##2##4##(2013-7#2)
Sex ratio##5##2##(2008-8#2)(2013-7#3)
Sex##59##1##(1990-2#1)(1991-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-7#2)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#6)(2009-12#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-7#4)(2013-8#2)
Sexting##4##1##(2013-1#4)
Sexual Reproduction##3##2##(2008-10#3)
Sexual Risk Behavior in##2##4##(2013-1#2)
Sexual Risk Behavior##3##3##(2012-1#1)(2013-1#2)
Sexual abuse is a problem of epidemic proportions in the United States##2##12##(2010-10#1)(2010-4#1)
Sexual abuse is a problem of epidemic proportions in##3##9##(2009-9#1)(2010-10#1)(2010-4#1)
Sexual abuse##4##2##(2009-9#1)(2010-10#2)(2010-4#1)
Sexual and##2##2##(2008-12#1)(2012-3#1)
Sexual behavior##2##2##(1992-12#1)(2009-7#1)
Sexual behaviour##3##2##(1993-2#2)(2011-2#1)
Sexual conflict and##2##3##(2008-8#1)(2008-9#1)
Sexual conflict##3##2##(2008-8#2)(2008-9#1)
Sexual dimorphism in the##2##4##(1995-6#2)
Sexual dimorphism in##4##3##(1995-6#2)(2008-9#1)(2010-6#1)
Sexual harassment##4##2##(1992-12#2)(1996-2#1)(1996-3#1)
Sexual health##2##2##(2008-7#1)(2012-12#1)
Sexual selection##3##2##(1995-2#3)
Sexual traits##2##2##(2012-3#2)
Sexual##72##1##(1990-6#2)(1990-8#1)(1991-3#1)(1992-12#3)(1993-2#2)(1994-2#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-5#1)(2009-7#1)(2009-9#4)(2010-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#3)
Sexually Transmitted##2##2##(2011-2#2)
Sexually active##2##2##(2008-7#1)(2013-1#1)
Sexually dimorphic##3##2##(1995-2#1)(2008-8#1)(2008-9#1)
Sexually immature##2##2##(2008-7#1)(2011-2#1)
Sexually transmitted diseases quarterly report##2##5##(1995-3#1)(1995-6#1)
Sexually transmitted##3##2##(1995-3#1)(1995-6#1)(2008-12#1)
Sexually##13##1##(1995-2#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#3)(2013-1#1)
Seymour##3##1##(1993-1#1)(2010-4#1)(2013-7#1)
Sf##4##1##(1993-8#1)(1997-4#1)(1997-8#2)
Sf-21##3##1##(2008-11#3)
Sf-9 and Trichoplusia##3##3##(2008-7#3)
Sf-9 cell cultures##3##3##(2008-11#1)(2008-7#2)
Sf-9 cell##4##2##(2008-11#2)(2008-7#2)
Sf-9 cells##7##2##(1997-4#1)(2008-11#1)(2008-7#5)
Sf-9 insect cell##3##3##(2008-11#2)(2008-7#1)
Sf-9##17##1##(1997-4#1)(2008-11#5)(2008-7#11)
Sf-900 II SFM##2##3##(2008-7#2)
Sf-900 II##4##2##(2008-7#4)
Sf9 cell##2##2##(1997-4#1)(2008-11#1)
Sf9 cells##11##2##(1992-3#1)(1997-4#2)(2008-1#1)(2008-11#5)(2008-8#2)
Sf9 insect cell line##3##4##(2008-11#3)
Sf9 insect cell##5##3##(2008-11#5)
Sf9 insect cells##5##3##(1992-10#1)(1993-8#1)(2008-11#1)(2008-4#2)
Sf9 insect##11##2##(1992-10#1)(1993-8#1)(2008-11#7)(2008-4#2)
Sf9##27##1##(1992-10#1)(1992-3#1)(1993-8#1)(1997-4#4)(2008-1#1)(2008-11#14)(2008-4#2)(2008-8#2)(2008-9#1)
Sf900 II medium##2##3##(2008-11#2)
Sf900 II##3##2##(2008-11#3)
Sg##6##1##(2012-7#6)
SgI(O) was##4##2##(2012-7#4)
SgI(O)##6##1##(2012-7#6)
SgIo##3##1##(2012-7#3)
Sh09B##2##1##(2008-10#2)
Sh12B##12##1##(2008-10#12)
Shack-Hartmann sensing##3##2##(2007-12#2)(2008-3#1)
Shack-Hartmann sensor##6##2##(2008-3#6)
Shack-Hartmann wave-front sensor##4##3##(2008-3#4)
Shack-Hartmann wave-front##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
Shack-Hartmann##16##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#12)
Shade##2##1##(2008-10#1)(2009-8#1)
Shadow##2##1##(2007-11#1)(2013-7#1)
Shahan##2##1##(2011-2#1)(2012-2#1)
Shaker##4##1##(1994-12#1)(2008-8#3)
Shall##2##1##(1994-3#1)(2010-9#1)
Shallot##2##1##(2008-10#1)(2008-9#1)
Sham##7##1##(1992-9#1)(1996-5#1)(1997-2#1)(2008-10#1)(2013-8#3)
Sham+EA##2##1##(2008-10#2)
Shame##2##1##(2008-1#1)(2013-1#1)
Shampoos##2##1##(2008-5#2)
Shams##5##1##(2008-10#5)
Shanghai##17##1##(1990-2#4)(1992-10#4)(1993-2#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-8#3)
Shannon Index##2##2##(2008-12#2)
Shannon##6##1##(2008-10#3)(2008-12#2)(2008-8#1)
Shannon's##3##1##(2008-10#2)(2008-2#1)
Shanyou63##4##1##(2008-9#4)
Shape of##2##2##(2008-3#1)(2012-3#1)
Shape##9##1##(2007-7#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-3#1)
Shapes of##2##2##(1996-2#1)(2008-7#1)
Shapes##3##1##(1996-2#1)(1996-9#1)(2008-7#1)
Shaping a preferred future##2##4##(1997-2#1)(1997-3#1)
Shaping##5##1##(1997-2#1)(1997-3#1)(2008-4#1)(2009-10#1)(2012-3#1)
Shared medical decision-making##2##3##(2008-4#2)
Shared##8##1##(1991-1#1)(1995-1#1)(1995-3#1)(2008-4#2)(2008-8#1)(2009-7#1)(2013-1#1)
Shares##2##1##(1993-5#1)(1997-1#1)
Sharing information##2##2##(1996-2#1)(1997-1#1)
Sharing the##2##2##(1995-3#1)(2008-12#1)
Sharing##10##1##(1992-9#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-9#1)(2012-12#1)
Sharp and##2##2##(2008-3#1)(2012-2#1)
Sharp##9##1##(1991-1#1)(1996-3#1)(1997-3#2)(2007-11#1)(2008-10#1)(2008-3#2)(2012-2#1)
Shc is##2##2##(1997-7#1)(2012-2#1)
Shc##18##1##(1995-8#3)(1997-7#10)(2008-6#1)(2012-2#4)
She also describes##2##3##(1993-2#1)(1994-12#1)
She also##5##2##(1991-12#1)(1993-2#1)(1994-12#1)(2009-2#1)(2010-9#1)
She developed##4##2##(2008-1#1)(2008-7#1)(2009-4#1)(2012-3#1)
She discusses##2##2##(1996-12#1)(2012-12#1)
She had a##6##3##(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#1)
She had been##2##3##(1996-11#1)(2010-11#1)
She had no##2##3##(2008-7#1)(2011-2#1)
She had received##2##3##(2007-7#1)(2008-5#1)
She had undergone a##3##4##(1994-7#1)(2008-10#1)(2013-8#1)
She had##25##2##(1994-7#1)(1995-12#1)(1996-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#5)(2013-8#4)
She has not##2##3##(2010-6#1)(2011-2#1)
She has##4##2##(2010-6#1)(2011-2#2)(2013-8#1)
She is##6##2##(2007-12#2)(2008-1#1)(2013-1#2)(2013-8#1)
She presented with##7##3##(2007-7#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-5#1)(2012-3#1)(2013-1#1)
She presented##8##2##(2007-7#1)(2008-11#1)(2009-1#1)(2009-10#2)(2009-5#1)(2012-3#1)(2013-1#1)
She recovered##3##2##(1995-12#1)(2007-7#1)(2013-1#1)
She reported##2##2##(2006-10#1)(2011-2#1)
She responded to##2##3##(2008-12#1)(2010-11#1)
She subsequently underwent##2##3##(1994-12#1)(2013-1#1)
She subsequently##4##2##(1994-12#1)(2006-10#1)(2011-2#1)(2013-1#1)
She then##3##2##(2007-5#1)(2008-10#1)(2012-12#1)
She underwent a##2##3##(2011-2#2)
She underwent##11##2##(1995-4#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#3)(2013-7#1)
She was admitted##3##3##(2007-10#1)(2009-1#1)(2011-2#1)
She was advised##2##3##(2008-8#1)(2012-2#1)
She was also##2##3##(2007-7#1)(2008-7#1)
She was diagnosed with##3##4##(2007-8#1)(2012-3#2)
She was found to have an##2##6##(2007-7#1)(2008-7#1)
She was found to have##5##5##(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-3#1)
She was maintained on##2##4##(2007-7#1)(2008-1#1)
She was managed##2##3##(2013-1#1)(2013-8#1)
She was treated by##2##4##(2009-5#1)(2011-1#1)
She was treated with##5##4##(1990-6#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
She was treated##7##3##(1990-6#1)(2007-10#1)(2007-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
She was##46##2##(1990-6#1)(1990-8#1)(1992-10#1)(1994-8#1)(1995-11#1)(2006-10#1)(2007-10#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-3#2)(2009-5#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#3)
She##151##1##(1990-6#1)(1990-8#1)(1991-12#1)(1992-10#1)(1993-2#1)(1994-12#3)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-4#1)(1996-11#1)(1996-12#1)(1997-5#1)(2006-10#3)(2007-10#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#9)(2007-8#3)(2008-1#8)(2008-10#3)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-1#2)(2009-10#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#3)(2010-9#1)(2011-1#3)(2011-2#16)(2012-12#3)(2012-2#2)(2012-3#8)(2013-1#15)(2013-7#1)(2013-8#10)
Shear bond strength##3##3##(2008-12#1)(2010-12#1)(2013-7#1)
Shear##9##1##(1993-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-4#2)(2012-2#1)(2013-7#1)
Shearing##2##1##(1995-5#1)(2008-2#1)
Sheath Blight##3##2##(2008-10#3)
Sheath##5##1##(2008-10#5)
Sheaths into##2##2##(2007-7#2)
Shedding##3##1##(2008-12#1)(2012-2#1)(2013-8#1)
Sheehan's syndrome##2##2##(2011-2#2)
Sheffield##3##1##(1996-7#1)(2008-12#2)
Sheldon##3##1##(1995-12#2)(2012-3#1)
Shelf##3##1##(2007-3#1)(2010-8#1)(2013-1#1)
Shell##3##1##(2008-12#1)(2009-9#1)(2010-2#1)
Shelter##2##1##(1995-3#1)(2010-5#1)
Shelton##4##1##(1990-8#2)(1994-3#2)
Shen##4##1##(2013-8#4)
Shephard##2##1##(1992-8#1)(2009-3#1)
Shepherd##2##1##(1996-5#1)(2009-5#1)
Shepody##2##1##(2008-10#2)
Sherer##3##1##(1993-12#1)(1996-1#2)
Sherman##2##1##(1991-1#1)(1995-3#1)
Sherry wines##4##2##(2008-10#4)
Sherry##6##1##(2008-10#6)
Sherwood number##2##2##(2008-7#2)
Shetland sheepdog and Collie were##2##5##(2011-2#2)
Shetland##3##1##(1996-6#1)(2011-2#2)
Shewanella alga##2##2##(2007-7#2)
Shewanella##3##1##(2007-7#2)(2008-10#1)
Shh signaling##2##2##(2013-1#2)
Shield##10##1##(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#3)(1996-1#1)(2008-4#1)(2011-1#1)(2012-3#1)
Shields##2##1##(2012-2#1)(2013-1#1)
Shiffman##2##1##(1996-1#2)
Shift Work##2##2##(2010-7#2)
Shift and exchange of information concerning patients(4##3##7##(1991-2#3)
Shift from##2##2##(1990-7#1)(2008-7#1)
Shift work is associated with##2##5##(2008-8#1)(2011-2#1)
Shift work is##3##3##(2008-8#1)(2010-7#1)(2011-2#1)
Shift work##5##2##(2008-8#1)(2010-7#1)(2011-2#3)
Shift##17##1##(1990-7#1)(1991-2#3)(1996-12#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#3)(2011-2#3)
Shifted##2##1##(1993-12#2)
Shifting the paradigm##3##3##(1993-1#1)(1997-2#1)(2013-1#1)
Shifting the##5##2##(1993-1#1)(1994-12#1)(1997-2#1)(2008-2#1)(2013-1#1)
Shifting##7##1##(1993-1#1)(1994-12#1)(1997-2#1)(2008-2#2)(2008-3#1)(2013-1#1)
Shifts in##4##2##(1992-2#1)(1995-5#1)(2008-10#1)(2010-4#1)
Shiga toxin B##5##3##(2009-2#5)
Shiga toxin producing Escherichia coli##2##5##(2012-2#2)
Shiga toxin##8##2##(2009-2#5)(2011-1#1)(2012-2#2)
Shiga##12##1##(2008-3#1)(2009-2#6)(2011-1#2)(2012-2#2)(2013-1#1)
Shiga-like toxin I##2##3##(1992-3#2)
Shiga-like##3##1##(1992-3#2)(2011-1#1)
Shigella flexneri##6##2##(1993-12#2)(2008-10#1)(2008-9#1)(2012-3#1)(2013-8#1)
Shigella sonnei##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
Shigella##15##1##(1993-12#2)(1994-9#1)(2008-10#4)(2008-9#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Shikonin production##3##2##(1994-11#3)
Shim-pack##3##1##(1990-8#1)(2008-10#2)
Shimada##2##1##(1990-8#1)(1994-10#1)
Shimadzu##4##1##(2008-10#3)(2008-12#1)
Shimane##3##1##(2008-5#1)(2010-8#1)(2010-9#1)
Shimla##2##1##(1995-10#1)(2013-1#1)
Shine-Dalgarno sequence##5##2##(1992-6#2)(1996-8#1)(1997-2#1)(1997-6#1)
Shine-Dalgarno##6##1##(1990-5#1)(1992-6#2)(1996-8#1)(1997-2#1)(1997-6#1)
Shionogi##2##1##(1990-11#1)(1995-3#1)
Shiraz##6##1##(2007-2#1)(2008-10#2)(2008-12#3)
Shock##4##1##(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)
Shock-wave lithotripsy##2##2##(2008-10#2)
Shock-wave##3##1##(1993-5#1)(2008-10#2)
Shoemaker Jr##2##2##(2011-2#2)
Shoemaker##3##1##(2011-2#3)
Shoemaker-Levy 9##3##2##(1995-6#3)
Shoot##5##1##(1997-2#1)(2008-10#3)(2008-5#1)
Shoots##5##1##(2008-10#5)
Shopping##2##1##(1993-2#1)(2007-9#1)
Short Form 36 (SF36)##2##4##(2008-1#1)(2008-10#1)
Short Form 36##5##3##(1996-3#1)(2008-1#2)(2008-10#1)(2012-12#1)
Short Form##8##2##(1996-3#1)(2007-11#1)(2008-1#2)(2008-10#2)(2012-12#2)
Short Stay##2##2##(2013-1#2)
Short term##2##2##(2008-7#1)(2010-3#1)
Short##42##1##(1990-3#1)(1991-6#1)(1992-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
Short- and long-term##3##3##(1990-12#1)(2008-7#1)(2013-8#1)
Short-Form 36##3##2##(2010-10#1)(2012-12#1)(2013-1#1)
Short-acting##2##1##(1997-1#1)(2009-9#1)
Short-duration LESS##3##2##(2007-8#3)
Short-duration##4##1##(2007-8#4)
Short-pulse##2##1##(2008-2#1)(2008-3#1)
Short-term effects##2##2##(2008-12#1)(2013-1#1)
Short-term stability studies on the formulations indicated##2##7##(2010-3#2)
Short-term##20##1##(1991-1#1)(1991-2#1)(1992-11#1)(1994-6#1)(1995-11#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#3)(2009-6#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
Shorter##5##1##(1992-11#1)(1993-9#1)(2008-5#1)(2008-7#1)(2009-5#1)
Shortly##2##1##(2008-7#1)(2011-2#1)
Shot-noise-limited##2##1##(2008-3#2)
Should I##3##2##(2006-9#1)(2008-11#1)(2010-9#1)
Should conization by hot loop or laser replace cervical biopsy?##2##10##(1992-3#2)
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?##2##14##(2009-12#2)
Should the##6##2##(1994-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-2#1)
Should there be an##2##4##(2011-2#1)(2013-1#1)
Should we##4##2##(1991-2#1)(1994-3#1)(2009-5#2)
Should##40##1##(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-6#1)(2009-12#2)(2009-5#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
Shoulder and##2##2##(2008-9#1)(2013-8#1)
Shoulder arthroscopy##4##2##(2007-11#4)
Shoulder pain##2##2##(1992-9#1)(2007-12#1)
Shoulder##17##1##(1992-9#1)(1996-9#1)(1997-1#1)(2007-11#6)(2007-12#1)(2008-12#1)(2008-9#3)(2009-1#1)(2010-7#1)(2013-8#1)
Shouldice##2##1##(1993-9#2)
Show##3##1##(1991-3#1)(2007-2#1)(2008-10#1)
Showing##3##1##(2008-10#1)(2008-9#1)(2010-10#1)
Shows##3##1##(2008-10#1)(2009-9#1)(2012-3#1)
Shpol'skii spectrometry##5##2##(2008-10#5)
Shpol'skii##8##1##(2008-10#8)
Shreveport##2##1##(1996-1#2)
Shriver##2##1##(1994-3#2)
Shuanghuanglian injection##3##2##(2011-2#3)
Shuanghuanglian##5##1##(2011-2#4)(2011-3#1)
Shuttle##3##1##(1996-12#2)(2008-2#1)
Si and Al##3##3##(2008-10#3)
Si and Ti)##2##3##(2008-10#2)
Si and##7##2##(2008-10#5)(2008-2#1)(2008-7#1)
Si bandgap energy##3##3##(2007-11#3)
Si in##3##2##(2008-10#2)(2008-7#1)
Si layer##4##2##(2007-11#3)(2008-3#1)
Si nanowires##2##2##(2008-7#2)
Si or##2##2##(2008-3#2)
Si substrate##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
Si surface##2##2##(2007-11#2)
Si##85##1##(1993-1#1)(1993-5#1)(1994-2#1)(2007-11#12)(2007-12#1)(2008-10#33)(2008-11#2)(2008-2#6)(2008-3#11)(2008-7#7)(2008-9#2)(2009-11#2)(2009-9#2)(2010-3#1)(2012-2#2)(2013-8#1)
Si(+) plants##2##2##(2008-10#2)
Si(+)##3##1##(2008-10#3)
Si(001)##2##1##(2007-12#1)(2008-2#1)
Si(100) surfaces##2##2##(2008-10#2)
Si(100)##3##1##(2008-10#2)(2008-7#1)
Si(111)##2##1##(1990-4#1)(1992-8#1)
Si(IV)##3##1##(2008-10#3)
Si+ plants##5##2##(2008-10#5)
Si+##6##1##(2008-10#6)
Si- and##2##2##(2008-10#1)(2008-9#1)
Si- plants##2##2##(2008-10#2)
Si-##5##1##(2008-10#4)(2008-9#1)
Si-O-Si##2##1##(2008-3#2)
Si-prism##2##1##(2008-3#2)
Si-sol##4##1##(2008-10#4)
Si-tot##3##1##(2008-10#3)
SiC and##2##2##(2007-11#1)(2008-2#1)
SiC##8##1##(2007-11#1)(2008-2#2)(2008-3#4)(2013-1#1)
SiGe alloy surfaces##2##3##(2008-10#2)
SiGe##4##1##(2007-11#1)(2008-10#3)
SiH bonds##2##2##(2008-10#2)
SiH##3##1##(2008-10#2)(2008-3#1)
SiMe(2)##2##1##(2009-9#2)
SiN##3##1##(2008-2#3)
SiN(x)##3##1##(2008-2#1)(2008-3#2)
SiN-based##2##1##(2008-2#2)
SiNPs were##2##2##(2011-1#2)
SiNPs##3##1##(2011-1#3)
SiO(2) and##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
SiO(2) composite films##2##3##(2007-12#2)
SiO(2) host##2##2##(2007-11#2)
SiO(2) modified##2##2##(2008-10#2)
SiO(2) nanoparticles##5##2##(2007-11#3)(2008-10#2)
SiO(2)##43##1##(1992-7#1)(2007-11#6)(2007-12#6)(2008-10#11)(2008-2#6)(2008-3#9)(2008-5#1)(2009-12#1)(2010-6#1)(2012-2#1)
SiO2##7##1##(1992-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)
SiOEP and PtOEP##2##3##(2008-10#2)
SiOEP##4##1##(2008-10#4)
SiR-HP##4##1##(1993-8#4)
Sialic acid##2##2##(1993-1#1)(1993-12#1)
Sialolithiasis##2##1##(2011-2#2)
Siberia##5##1##(2010-8#5)
Siberian and##2##2##(2010-8#2)
Siberian hamster##2##2##(1994-2#2)
Siberian tigers##2##2##(2009-4#2)
Siberian##15##1##(1994-2#3)(1996-6#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2010-8#5)
Sibling##3##1##(2008-10#3)
Sichuan##4##1##(2008-8#2)(2011-1#1)(2012-3#1)
Sicily##2##1##(1991-2#1)(1992-12#1)
Sick##5##1##(1992-3#1)(1994-12#1)(2007-11#1)(2008-11#1)(2013-8#1)
Sickle Cell##2##2##(2007-7#1)(2013-8#1)
Sickle cell disease##4##3##(2007-10#1)(2007-7#1)(2009-4#1)(2012-2#1)
Sickle cell##5##2##(2007-10#1)(2007-7#1)(2009-4#1)(2010-9#1)(2012-2#1)
Sickle##7##1##(2007-10#1)(2007-7#2)(2009-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
Sicyonia ingentis##2##2##(2007-12#2)
Sida##5##1##(2008-10#2)(2010-5#3)
Sidama##3##1##(2010-6#3)
Side Effects##2##2##(2008-6#1)(2008-7#1)
Side Impact##2##2##(2013-8#2)
Side effects of##4##3##(1997-6#1)(2007-7#1)(2008-1#1)(2011-2#1)
Side effects were##3##3##(1990-6#1)(1991-3#1)(2008-5#1)
Side effects##13##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-3#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
Side##20##1##(1990-2#2)(1990-6#1)(1990-8#1)(1991-3#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
Side-Stream##2##1##(1995-3#2)
Side-effects##2##1##(2008-7#1)(2012-2#1)
Sider and##2##2##(2008-10#2)
Sider##4##1##(2008-10#4)
Sideris buttoned##2##2##(1996-6#2)
Siemen's##2##1##(2007-7#1)(2008-3#1)
Siemens##3##1##(1992-2#1)(2008-3#1)(2008-8#1)
Sierra Nevada##3##2##(2008-10#3)
Sierra##7##1##(1990-6#1)(2007-7#1)(2008-10#4)(2013-7#1)
Sieving coefficients of##2##3##(2011-1#2)
Sig-1R##4##1##(2011-2#4)
SigA##2##1##(1994-12#2)
Sigatoka disease##2##2##(2008-10#2)
Sight##2##1##(2008-6#1)(2012-2#1)
Sigma Theta Tau##4##3##(1997-3#2)(2013-1#2)
Sigma##9##1##(1997-3#2)(2008-10#5)(2013-1#2)
Sigmodon##3##1##(2010-4#3)
Sigmoid transfer functions were used in the hidden and output layers to facilitate nonlinear calibration##2##15##(2008-10#2)
Sigmoid##6##1##(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#2)
Sigmoidal##2##1##(2008-10#2)
Sign Language (ASL)##2##3##(2011-2#2)
Sign##6##1##(2011-2#2)(2012-1#1)(2013-7#3)
Sign-out##2##1##(2010-12#1)(2011-1#1)
Signal Detection Theory##2##3##(1991-2#1)(2008-11#1)
Signal Detection##3##2##(1991-2#1)(2008-11#1)(2009-8#1)
Signal and##5##2##(1991-9#1)(2008-2#2)(2008-3#2)
Signal processing##2##2##(2008-3#2)
Signal transduction##7##2##(1991-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-4#1)(2008-9#1)(2013-1#1)
Signal##35##1##(1990-12#1)(1991-2#1)(1991-9#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
Signal-induced##2##1##(2008-3#2)
Signal-to-Noise Ratio##2##2##(1996-9#1)(2010-8#1)
Signal-to-noise ratios##2##2##(1993-5#1)(2008-3#1)
Signal-to-noise##4##1##(1993-5#1)(2007-12#1)(2008-3#2)
Signaling Pathway##2##2##(2010-8#1)(2011-2#1)
Signaling in##3##2##(2010-7#1)(2011-1#1)(2012-1#1)
Signaling of##2##2##(2008-12#1)(2011-2#1)
Signaling##26##1##(1993-5#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#3)
Signalling##5##1##(1991-2#1)(1996-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
Signals for##2##2##(1995-2#1)(1996-12#1)
Signals were measured as peak height by using an instrument software##2##11##(2008-10#2)
Signals were##4##2##(2008-10#3)(2012-3#1)
Signals##11##1##(1995-2#2)(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
Signatures##2##1##(2008-10#2)
Significance and##2##2##(1990-6#1)(2008-10#1)
Significance in##3##2##(1994-7#1)(2012-12#2)
Significance of##16##2##(1991-11#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#3)(2011-2#1)(2012-3#2)(2013-1#1)
Significance##23##1##(1990-6#1)(1991-11#1)(1994-7#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-8#4)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
Significant (P &lt##2##3##(2008-10#1)(2009-2#1)
Significant (P = 0##4##4##(2008-10#4)
Significant (P##6##2##(2008-10#5)(2009-2#1)
Significant Difference##2##2##(2012-2#1)(2013-1#1)
Significant advances##2##2##(2007-12#1)(2008-10#1)
Significant amounts of##2##3##(1997-4#1)(2010-2#1)
Significant and##2##2##(2007-11#1)(2010-12#1)
Significant association##2##2##(2008-10#1)(2008-12#1)
Significant cell##2##2##(1997-4#1)(2008-11#1)
Significant changes in##3##3##(1990-3#1)(2008-10#1)(2012-2#1)
Significant changes##4##2##(1990-3#1)(1991-2#1)(2008-10#1)(2012-2#1)
Significant complications##2##2##(2007-7#1)(2007-8#1)
Significant correlations were##3##3##(1994-5#1)(2008-12#1)(2011-1#1)
Significant correlations##8##2##(1994-5#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
Significant decreases in##3##3##(1994-3#1)(1996-7#1)(2012-12#1)
Significant difference was##2##3##(2008-12#2)
Significant differences (P &lt##2##4##(2008-10#2)
Significant differences among##2##3##(1993-1#1)(2008-10#1)
Significant differences are##2##3##(1992-4#1)(2008-1#1)
Significant differences between##4##3##(1992-6#1)(2008-1#1)(2011-1#1)(2013-7#1)
Significant differences in health##2##4##(1996-2#1)(2009-5#1)
Significant differences in the##5##4##(1992-8#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
Significant differences in##14##3##(1992-8#1)(1996-2#1)(2008-10#5)(2008-3#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
Significant differences were detected##2##4##(2009-5#1)(2013-8#1)
Significant differences were found in##2##5##(2008-6#1)(2008-7#1)
Significant differences were found##4##4##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
Significant differences were observed in##2##5##(1997-4#1)(2008-5#1)
Significant differences were observed##3##4##(1997-4#1)(2008-11#1)(2008-5#1)
Significant differences were##13##3##(1995-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
Significant differences##40##2##(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
Significant effects were##2##3##(2008-10#1)(2008-3#1)
Significant effects##4##2##(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
Significant factors##2##2##(1994-1#1)(2010-6#1)
Significant genetic##3##2##(1994-2#1)(2010-8#2)
Significant heterogeneity was##2##3##(1997-4#1)(2009-5#1)
Significant improvement in##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
Significant improvement was##4##3##(2007-8#1)(2008-1#1)(2008-7#2)
Significant improvement##8##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)
Significant improvements##3##2##(2008-2#1)(2008-5#1)(2013-1#1)
Significant increase##2##2##(2008-1#1)(2011-2#1)
Significant increases in the##2##4##(2008-8#1)(2008-9#1)
Significant increases in##4##3##(1993-12#1)(1994-3#1)(2008-8#1)(2008-9#1)
Significant increases##5##2##(1993-12#1)(1994-3#1)(1994-6#1)(2008-8#1)(2008-9#1)
Significant levels of##3##3##(1997-4#1)(1997-6#1)(2008-10#1)
Significant positive correlations were found##2##5##(2008-10#1)(2008-7#1)
Significant positive correlations were##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
Significant positive correlations##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
Significant positive##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
Significant predictors of##2##3##(2008-11#1)(2013-1#1)
Significant progress has been##2##4##(1997-6#1)(2010-8#1)
Significant progress##4##2##(1997-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
Significant reduction in##2##3##(1997-6#1)(2008-10#1)
Significant reductions in##4##3##(2007-3#1)(2008-5#1)(2008-7#1)(2009-9#1)
Significant relationships##2##2##(2008-4#1)(2011-2#1)
Significant research efforts have##2##4##(2009-11#1)(2012-12#1)
Significant statistical differences were##2##4##(2011-1#1)(2012-12#1)
Significant suppression of##2##3##(2008-10#1)(2008-7#1)
Significant variability##2##2##(2008-10#1)(2009-6#1)
Significant variation##2##2##(2008-10#1)(2012-3#1)
Significant variations in##2##3##(2008-8#1)(2009-5#1)
Significant##215##1##(1990-3#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#3)(2006-10#3)(2007-11#2)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#40)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#4)(2011-1#5)(2011-2#11)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#2)
Significantly fewer##2##2##(1997-3#1)(2008-10#1)
Significantly greater##2##2##(2008-10#1)(2009-7#1)
Significantly higher levels of##4##4##(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#1)
Significantly higher levels##5##3##(1992-2#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#1)
Significantly higher##7##2##(1992-2#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
Significantly increased incidences of skin lesions at the site of application included epidermal hyperplasia in##2##15##(2008-9#2)
Significantly increased##4##2##(2008-7#1)(2008-9#2)(2010-9#1)
Significantly lower##2##2##(1992-2#1)(1992-6#1)
Significantly more##4##2##(1995-10#1)(2008-10#2)(2011-2#1)
Significantly##39##1##(1991-5#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#2)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
Signs and##2##2##(2008-9#1)(2010-8#1)
Signs of infection##2##3##(2011-2#1)(2012-12#1)
Signs of##6##2##(1994-3#1)(1996-3#1)(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)
Signs##10##1##(1992-2#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
Sil-Ntga##2##1##(2008-10#2)
Silastic ligatures##2##2##(2007-8#2)
Silastic##8##1##(1995-1#1)(1996-3#2)(2007-8#2)(2008-5#1)(2008-8#1)(2011-2#1)
Silencing##8##1##(2008-10#4)(2012-3#2)(2013-1#2)
Silene##5##1##(2008-8#4)(2012-7#1)
Silesia##3##1##(2008-10#2)(2013-1#1)
Silesian##3##1##(2007-11#1)(2008-7#1)(2008-9#1)
Silica gel modified with##2##4##(2008-10#2)
Silica gel was##2##3##(2008-10#2)
Silica gel##8##2##(2008-10#8)
Silica##16##1##(1996-9#1)(2008-10#14)(2008-3#1)
SilicoSec##7##1##(2008-12#7)
Silicon nitride##2##2##(2008-3#2)
Silicon##23##1##(1992-7#1)(1996-9#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-2#1)(2010-5#1)(2012-12#2)(2012-2#1)
Silk##2##1##(2008-10#1)(2012-8#1)
Silkworm##2##1##(2008-5#1)(2008-9#1)
Silver halide sensitized gelatin (SHSG)##2##5##(2008-2#1)(2008-3#1)
Silver halide sensitized gelatin##3##4##(2008-2#2)(2008-3#1)
Silver halide##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
Silver nitrate##2##2##(1993-12#1)(2008-10#1)
Silver##20##1##(1990-11#1)(1992-2#1)(1993-12#1)(2007-12#2)(2008-10#7)(2008-2#2)(2008-3#2)(2008-7#1)(2009-7#1)(2011-1#1)(2012-3#1)
Silver(I) ion selective##2##3##(2008-10#2)
Silver(I) was##2##2##(2008-10#2)
Silver(I)##4##1##(2008-10#4)
Silver-based compound metal island##2##4##(2008-3#2)
Silvestre##2##1##(2008-5#1)(2011-2#1)
Silwet L-77##2##2##(2008-10#2)
Simazine and##2##2##(2008-10#2)
Simenchelys parasiticus##2##2##(2008-11#2)
Simian virus 40##2##3##(1995-6#1)(2011-2#1)
Simian##4##1##(1991-9#1)(1995-6#1)(2008-11#1)(2011-2#1)
Similar cases##2##2##(2006-10#1)(2008-7#1)
Similar changes in##3##3##(1990-12#1)(1992-6#1)(2008-10#1)
Similar changes##4##2##(1990-12#1)(1992-6#1)(2008-10#1)(2008-11#1)
Similar differences were##3##3##(1994-8#1)(1996-3#1)(2008-10#1)
Similar effects were observed##2##4##(1997-4#1)(2010-4#1)
Similar effects were##3##3##(1994-6#1)(1997-4#1)(2010-4#1)
Similar effects##4##2##(1994-6#1)(1997-4#1)(2008-8#1)(2010-4#1)
Similar enhancement in the##2##4##(2008-5#2)
Similar patterns were##2##3##(2013-1#2)
Similar patterns##5##2##(1996-12#1)(2008-10#1)(2010-3#1)(2013-1#2)
Similar results are##3##3##(1992-9#1)(1996-7#1)(2008-3#1)
Similar results have been##2##4##(1993-11#1)(1996-4#1)
Similar results were found for##4##5##(1997-1#1)(2008-10#1)(2008-9#1)(2010-9#1)
Similar results were observed##4##4##(1991-4#1)(1994-9#1)(2008-5#1)(2008-8#1)
Similar results were obtained after##2##5##(1990-2#1)(2007-8#1)
Similar results were obtained for##3##5##(1991-12#1)(1993-6#1)(2008-10#1)
Similar results were obtained in##4##5##(1990-2#1)(1994-8#1)(2008-10#1)(2008-7#1)
Similar results were obtained using##2##5##(2008-10#2)
Similar results were obtained when##2##5##(2008-10#2)
Similar results were obtained with the##4##6##(1992-5#1)(1995-8#1)(1997-3#1)(2008-10#1)
Similar results were obtained with##5##5##(1992-5#1)(1995-8#1)(1997-3#1)(2008-10#2)
Similar results were obtained##20##4##(1990-2#2)(1991-12#1)(1992-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-3#1)(2007-8#1)(2008-10#9)(2008-7#1)(2009-6#1)
Similar results were##32##3##(1990-2#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)
Similar results##39##2##(1990-2#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#12)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)
Similar studies##3##2##(1990-2#1)(1994-10#1)(2013-7#1)
Similar tests##3##2##(2008-10#1)(2008-3#2)
Similar to other##3##3##(1997-3#1)(2008-10#1)(2010-4#1)
Similar to previous##2##3##(1994-2#1)(1997-1#1)
Similar to the##3##3##(1992-3#1)(1997-4#1)(2008-6#1)
Similar to##19##2##(1992-3#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)
Similar treatment with##2##3##(1990-2#1)(1993-9#1)
Similar trends##3##2##(1994-5#1)(2007-5#1)(2008-7#1)
Similar##161##1##(1990-12#1)(1990-2#4)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-3#2)(1997-4#3)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#34)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-6#2)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Similarities and differences between##3##4##(1993-6#1)(1994-6#1)(2011-2#1)
Similarities and differences##4##3##(1993-6#1)(1994-6#1)(2008-2#1)(2011-2#1)
Similarities between##2##2##(2008-10#1)(2008-7#1)
Similarities in##2##2##(1992-6#1)(2008-8#1)
Similarities##10##1##(1992-6#1)(1993-6#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)
Similarity##7##1##(1991-6#1)(1995-6#2)(2008-10#4)
Similarly the##5##2##(1996-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)
Similarly to the##3##3##(1994-12#1)(1994-9#1)(2008-10#1)
Similarly to##5##2##(1992-9#1)(1994-12#1)(1994-9#1)(2008-10#2)
Similarly##165##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#1)(2011-3#1)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
Simmons##2##1##(2007-3#1)(2008-12#1)
Simon##6##1##(1990-3#1)(1995-11#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-1#1)
Simons##3##1##(2008-12#2)(2010-11#1)
Simple Method for##2##3##(1996-5#1)(2013-1#1)
Simple Method##3##2##(1996-5#1)(2008-3#1)(2013-1#1)
Simple Sequence Repeat##2##3##(2008-10#2)
Simple and rapid##2##3##(2008-10#2)
Simple and sensitive##3##3##(2008-10#3)
Simple and##12##2##(2008-10#8)(2008-11#1)(2008-3#1)(2009-12#1)(2011-1#1)
Simple expressions for##2##3##(2008-3#2)
Simple expressions##3##2##(2008-3#3)
Simple method for##7##3##(1990-8#1)(2007-12#1)(2007-8#1)(2008-3#4)
Simple method of##2##3##(2008-2#1)(2008-3#1)
Simple method##9##2##(1990-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#5)
Simple model for##2##3##(2008-2#1)(2008-3#1)
Simple model##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
Simple models##3##2##(2008-3#1)(2008-8#2)
Simple rules##2##2##(2009-10#1)(2009-3#1)
Simple sequence repeat##2##3##(2008-5#2)
Simple sequence##3##2##(2008-5#2)(2008-7#1)
Simple##101##1##(1990-12#1)(1990-8#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-7#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#5)(2007-12#7)(2007-4#1)(2007-8#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Simplex##3##1##(2008-10#1)(2008-7#1)(2013-8#1)
Simplicity and##2##2##(1996-2#1)(2008-3#1)
Simplified method for##2##3##(2007-12#1)(2008-2#1)
Simplified##7##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
Simplifying the##2##2##(1994-3#1)(2008-10#1)
Simply##3##1##(2008-10#1)(2008-3#2)
Simpson index##2##2##(2008-5#1)(2013-7#1)
Simpson##3##1##(2008-5#1)(2008-8#1)(2013-7#1)
Simpson's##2##1##(2008-10#1)(2011-2#1)
Simulated and##2##2##(2008-10#1)(2008-3#1)
Simulated yield losses##2##3##(2008-10#2)
Simulated##19##1##(1992-7#1)(1996-2#1)(2008-10#9)(2008-2#4)(2008-3#3)(2008-8#1)
Simulating the##3##2##(1994-2#1)(2008-1#1)(2008-10#1)
Simulating##4##1##(1994-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
Simulation and##3##2##(1994-9#1)(1995-2#1)(2008-3#1)
Simulation experiments##3##2##(2008-10#2)(2013-8#1)
Simulation of Potato Late Blight in the Andes##2##8##(2008-10#2)
Simulation of the##4##3##(1990-2#1)(2008-3#1)(2008-5#1)(2009-9#1)
Simulation of##19##2##(1990-11#1)(1990-2#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#2)
Simulation results are presented##3##4##(2008-3#3)
Simulation results are##4##3##(2008-2#1)(2008-3#3)
Simulation results confirm the##2##4##(2008-10#1)(2008-11#1)
Simulation results show that##4##4##(2007-12#1)(2008-2#2)(2010-8#1)
Simulation results show##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2010-8#1)
Simulation results##16##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#6)(2009-8#1)(2010-8#1)
Simulation studies are##2##3##(2010-11#1)(2010-5#1)
Simulation studies##6##2##(2008-10#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-5#1)(2013-1#1)
Simulation##68##1##(1990-11#1)(1990-2#1)(1992-1#3)(1994-9#1)(1995-2#1)(2007-12#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#11)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#3)
Simulation-Based##2##1##(2009-5#1)(2012-3#1)
Simulations and experiments##3##3##(2007-11#2)(2008-3#1)
Simulations and##4##2##(2007-11#3)(2008-3#1)
Simulations are performed##2##3##(2008-2#1)(2008-3#1)
Simulations are##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
Simulations indicate that the##2##4##(2008-11#1)(2012-1#1)
Simulations of the##2##3##(2008-3#2)
Simulations of##4##2##(1996-9#1)(2007-12#1)(2008-3#2)
Simulations show that the##5##4##(2008-2#1)(2008-3#4)
Simulations show that##8##3##(2007-11#1)(2008-2#2)(2008-3#4)(2013-8#1)
Simulations show##11##2##(1997-6#1)(2007-11#1)(2008-2#2)(2008-3#5)(2008-8#1)(2013-8#1)
Simulations##44##1##(1996-12#2)(1996-9#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#13)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#2)(2012-1#1)(2013-8#1)
Simulator##7##1##(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2013-1#1)
Simultaneous Detection of##3##3##(2008-10#2)(2008-2#1)
Simultaneous Estimation of##3##3##(2010-3#1)(2010-5#1)(2012-2#1)
Simultaneous analysis of##5##3##(1991-5#1)(2008-10#3)(2008-9#1)
Simultaneous analysis##6##2##(1991-5#1)(2008-10#4)(2008-9#1)
Simultaneous detection of##7##3##(2006-6#1)(2008-10#6)
Simultaneous determination of Fe(II) and Fe(III)##2##6##(2008-10#2)
Simultaneous determination of cadmium##2##4##(2008-10#2)
Simultaneous determination of copper and##2##5##(2008-10#2)
Simultaneous determination of copper##4##4##(2008-10#4)
Simultaneous determination of iron and##2##5##(2008-10#2)
Simultaneous determination of iron##3##4##(2008-10#3)
Simultaneous determination of lead##3##4##(1993-9#1)(2008-10#2)
Simultaneous determination of manganese and##2##5##(2008-10#2)
Simultaneous determination of nitrite and nitrate##2##6##(2008-10#2)
Simultaneous determination of pseudoephedrine##2##4##(2008-10#2)
Simultaneous determination of the##2##4##(2008-10#1)(2008-2#1)
Simultaneous determination of three##2##4##(2008-10#2)
Simultaneous determination of tin##2##4##(2008-10#2)
Simultaneous determination of trace##4##4##(2008-10#4)
Simultaneous determination of##76##3##(1993-9#1)(2008-10#71)(2008-2#2)(2008-5#1)(2012-2#1)
Simultaneous kinetic determination of##2##4##(2008-10#2)
Simultaneous kinetic spectrophotometric determination of##2##5##(2008-10#2)
Simultaneous kinetic##5##2##(1993-5#1)(2008-10#4)
Simultaneous kinetic-spectrophotometric determination of##2##4##(2008-10#2)
Simultaneous measurement of strain and temperature by use of a##2##10##(2008-3#2)
Simultaneous measurement of##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
Simultaneous multiple##2##2##(2008-10#1)(2010-11#1)
Simultaneous multiple-wavelength cw##2##3##(2008-3#2)
Simultaneous multiple-wavelength##3##2##(2008-3#3)
Simultaneous multiwavelength##2##2##(2007-11#1)(2008-3#1)
Simultaneous observations##2##2##(2008-11#1)(2008-2#1)
Simultaneous occurrence of##2##3##(1992-12#1)(2013-8#1)
Simultaneous or##2##2##(1995-2#1)(2007-5#1)
Simultaneous separation##2##2##(2008-10#2)
Simultaneous spectrofluorimetric determination of##2##4##(2008-10#2)
Simultaneous spectrophotometric determination of##9##4##(2008-10#9)
Simultaneous spectrophotometric##11##2##(2008-10#10)(2010-5#1)
Simultaneous voltammetric determination of##3##4##(2008-10#3)
Simultaneous voltammetric##4##2##(2008-10#4)
Simultaneous##227##1##(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#1)(2008-10#131)(2008-11#2)(2008-2#9)(2008-3#23)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
Simultaneously he##2##2##(1994-3#1)(2011-2#1)
Simultaneously##20##1##(1990-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
Simvastatin##7##1##(1991-6#3)(2009-6#2)(2012-2#2)
Sina##2##1##(2007-10#1)(2013-1#1)
Sinai Hospital##2##2##(1996-1#1)(1996-3#1)
Sinai Medical Center##3##3##(1995-12#1)(1995-8#1)(1997-2#1)
Sinai##7##1##(1991-12#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-5#1)
Sinaloa##5##1##(2008-10#4)(2008-8#1)
Sinapis##2##1##(2008-10#2)
Since 1977##2##2##(1992-1#1)(1994-9#1)
Since 1981##2##2##(1990-3#1)(1994-3#1)
Since 1983##3##2##(1990-3#1)(1992-2#1)(1993-12#1)
Since 1986##2##2##(1991-6#1)(1992-9#1)
Since 1989##2##2##(1996-2#1)(2008-3#1)
Since 1990##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
Since 1991##4##2##(1995-2#1)(1997-4#1)(1997-8#1)(2008-10#1)
Since 1992##4##2##(1996-3#2)(2008-1#1)(2008-5#1)
Since 1994##2##2##(2009-8#1)(2012-6#1)
Since 1995##3##2##(2007-12#1)(2007-8#1)(2008-7#1)
Since 1996##2##2##(2007-12#1)(2007-8#1)
Since 1998##2##2##(2007-8#1)(2008-4#1)
Since 1999##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
Since 2000##2##2##(2013-1#2)
Since 2002##4##2##(2007-12#1)(2007-8#1)(2012-12#1)(2013-8#1)
Since January##2##2##(1996-3#1)(2010-6#1)
Since M##3##2##(2008-5#1)(2008-7#1)(2009-8#1)
Since October 1999 the authors treated##2##6##(2007-11#1)(2007-8#1)
Since October##3##2##(1990-12#1)(2007-11#1)(2007-8#1)
Since a##9##2##(1990-5#1)(1991-11#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)
Since all##2##2##(1994-2#1)(2008-10#1)
Since both##6##2##(1991-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(2008-7#1)(2013-8#1)
Since each##2##2##(2008-4#1)(2009-2#1)
Since early##4##2##(1990-12#1)(1991-3#1)(1992-2#1)(2012-2#1)
Since in the##2##3##(1993-5#1)(1996-3#1)
Since in these##2##3##(1993-12#1)(2012-1#1)
Since in##10##2##(1990-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#1)(1996-3#1)(2008-3#1)(2008-9#1)(2012-1#1)
Since it is a##2##4##(2011-2#1)(2013-7#1)
Since it is##9##3##(1993-6#1)(1994-11#1)(1995-5#1)(2007-2#1)(2007-8#2)(2008-11#1)(2011-2#1)(2013-7#1)
Since it was##2##3##(2008-3#1)(2009-12#1)
Since it##15##2##(1993-6#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-4#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#2)(2013-7#1)
Since its adoption##2##3##(2008-3#2)
Since its first description##3##4##(2011-2#3)
Since its first##4##3##(2008-10#1)(2011-2#3)
Since its inception in##2##4##(1996-3#1)(2008-1#1)
Since its inception##4##3##(1996-3#1)(2008-1#1)(2008-12#1)(2008-9#1)
Since its##14##2##(1991-3#1)(1993-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#3)
Since little##2##2##(2008-2#1)(2008-5#1)
Since many##7##2##(1994-11#1)(1997-4#1)(2008-7#2)(2010-11#1)(2011-2#2)
Since most##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
Since neither##2##2##(1990-2#1)(2008-5#1)
Since no##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-9#1)
Since nuclear##2##2##(1993-3#1)(2008-9#1)
Since only a small##2##4##(2010-5#1)(2011-2#1)
Since only##3##2##(2009-3#1)(2010-5#1)(2011-2#1)
Since other##3##2##(1994-6#1)(1997-4#1)(2008-10#1)
Since our previous##2##3##(1993-1#1)(1995-2#1)
Since oxygen##2##2##(2008-10#1)(2008-2#1)
Since patient##2##2##(1992-12#1)(2011-2#1)
Since proteins##3##2##(1996-3#1)(2008-8#1)(2009-6#1)
Since several##2##2##(1990-6#1)(2011-2#1)
Since so##2##2##(1993-1#1)(2007-12#1)
Since some##2##2##(1991-8#1)(2008-5#1)
Since that time##3##3##(1990-8#1)(2008-1#1)(2013-1#1)
Since the 1960s##2##3##(1992-1#1)(2010-8#1)
Since the 1980s##2##3##(2007-12#1)(2011-1#1)
Since the 1990s##2##3##(2010-12#1)(2012-2#1)
Since the advent of##4##4##(2008-11#1)(2009-5#1)(2010-7#1)(2010-8#1)
Since the beginning of##2##4##(1997-6#1)(2008-11#1)
Since the discovery of##3##4##(1994-2#1)(2008-1#1)(2008-10#1)
Since the early##4##3##(1992-8#1)(2008-10#2)(2009-10#1)
Since the first##4##3##(1997-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
Since the introduction of the##2##5##(1997-5#1)(2008-5#1)
Since the introduction of##11##4##(1991-3#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-12#1)(2013-1#1)
Since the main##2##3##(1994-6#1)(2008-3#1)
Since the origins until today##2##5##(2008-10#2)
Since the peaks##2##3##(2008-10#2)
Since the##187##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#24)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
Since their introduction##2##3##(2010-12#1)(2013-1#1)
Since their##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
Since then##31##2##(1992-2#1)(1994-3#2)(1994-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#3)
Since there are##2##3##(1993-12#1)(1997-6#1)
Since there is##3##3##(1990-2#1)(1992-2#1)(2013-7#1)
Since there were no##3##4##(1991-5#1)(2007-8#1)(2011-2#1)
Since there were##4##3##(1991-5#1)(1996-12#1)(2007-8#1)(2011-2#1)
Since there##9##2##(1990-2#1)(1991-5#1)(1992-2#1)(1993-12#1)(1996-12#1)(1997-6#1)(2007-8#1)(2011-2#1)(2013-7#1)
Since these##12##2##(1992-2#1)(1993-11#1)(1993-5#1)(1994-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
Since this is##2##3##(1995-8#1)(2008-1#1)
Since this technique##2##3##(2008-3#1)(2012-12#1)
Since this##15##2##(1992-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
Since we##2##2##(1997-8#1)(2008-10#1)
Since##661##1##(1990-11#1)(1990-12#6)(1990-2#6)(1990-3#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#8)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#4)(1992-12#5)(1992-2#6)(1992-3#2)(1992-8#8)(1992-9#3)(1993-1#4)(1993-11#6)(1993-12#8)(1993-2#1)(1993-3#4)(1993-5#3)(1993-6#6)(1993-8#3)(1993-9#4)(1994-11#6)(1994-12#6)(1994-2#4)(1994-3#10)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#5)(1995-12#8)(1995-2#7)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#8)(1996-4#2)(1996-5#3)(1997-1#6)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#6)(1997-8#7)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#13)(2008-1#9)(2008-10#58)(2008-11#29)(2008-12#8)(2008-2#15)(2008-3#18)(2008-4#16)(2008-5#19)(2008-6#4)(2008-7#23)(2008-8#7)(2008-9#15)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#9)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#7)(2011-1#8)(2011-2#32)(2011-3#2)(2012-1#3)(2012-12#7)(2012-2#18)(2012-3#4)(2012-6#1)(2013-1#15)(2013-7#6)(2013-8#8)
Sindbis virus##8##2##(2008-4#2)(2008-9#6)
Sindbis##9##1##(2008-4#2)(2008-9#7)
Sindh##4##1##(2008-10#3)(2008-12#1)
Singapore Chinese##4##2##(2010-6#4)
Singapore and##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
Singapore##19##1##(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-6#4)(2010-8#1)(2012-12#1)(2012-2#3)(2013-7#1)
Singaporean##3##1##(1997-2#1)(2008-3#2)
Singer##3##1##(2008-12#2)(2012-2#1)
Singh##3##1##(1991-9#1)(1996-4#1)(2013-1#1)
Single Center Experience##2##3##(1995-11#1)(2008-1#1)
Single Photon Emission##2##3##(2008-2#1)(2009-12#1)
Single Photon##3##2##(2008-2#1)(2009-12#1)(2011-1#1)
Single amino acid##2##3##(1990-11#1)(1994-6#1)
Single and##4##2##(1997-7#1)(2007-12#1)(2008-3#1)(2012-1#1)
Single crystals of##2##3##(1992-11#1)(1996-2#1)
Single incision laparoscopic surgery##2##4##(2012-12#2)
Single molecule detection##2##3##(2012-2#2)
Single molecule##4##2##(2008-10#1)(2012-2#3)
Single nucleotide polymorphism##2##3##(2008-10#1)(2008-8#1)
Single nucleotide polymorphisms (SNPs)##4##4##(2008-10#2)(2012-2#1)(2012-3#1)
Single nucleotide polymorphisms##5##3##(2008-10#2)(2012-2#1)(2012-3#2)
Single nucleotide##8##2##(1993-12#1)(2008-10#3)(2008-8#1)(2012-2#1)(2012-3#2)
Single photon emission computed tomography##2##5##(1994-1#1)(1996-7#1)
Single photon emission##4##3##(1994-1#1)(1996-7#1)(2008-2#1)(2012-2#1)
Single##112##1##(1990-11#1)(1990-2#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#3)(2009-5#1)(2009-7#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
Single- and dual-fiber fluorescence probes##2##5##(2008-3#2)
Single- and multiple-pulse##2##3##(2008-3#2)
Single- and##5##2##(2008-2#1)(2008-3#4)
Single-Chain##2##1##(2008-10#2)
Single-Crystal##2##1##(1997-7#1)(2008-2#1)
Single-Molecule##2##1##(2009-12#1)(2010-2#1)
Single-Particle##2##1##(2008-11#1)(2008-3#1)
Single-Stranded##2##1##(1996-2#1)(2008-12#1)
Single-base resolution can be obtained on fragments up to several hundred base pairs##2##13##(2008-2#1)(2008-4#1)
Single-base##4##1##(2008-2#1)(2008-4#2)(2008-9#1)
Single-cell##4##1##(1997-4#1)(2008-10#1)(2008-4#1)(2010-10#1)
Single-chain##5##1##(1991-7#1)(1991-8#1)(1992-12#1)(2008-10#1)(2008-8#1)
Single-crystal sapphire-fiber optic sensors based on surface plasmon resonance##2##9##(2008-10#2)
Single-crystal##4##1##(1996-5#1)(2008-10#3)
Single-drug therapy for hypertension in men##3##6##(1993-9#3)
Single-frequency##5##1##(2007-11#1)(2007-12#3)(2008-2#1)
Single-longitudinal-mode##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Single-marker##2##1##(2008-10#2)
Single-mode optical##2##2##(2008-2#1)(2008-3#1)
Single-mode##11##1##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
Single-molecule##5##1##(2007-12#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-2#1)
Single-nucleotide sequence discrimination in situ using padlock probes##2##8##(2008-4#1)(2008-9#1)
Single-nucleotide##4##1##(2008-4#1)(2008-9#2)(2011-2#1)
Single-particle##2##1##(2008-2#1)(2008-3#1)
Single-pass##2##1##(1993-3#1)(2007-11#1)
Single-photon##4##1##(2007-11#1)(2008-3#2)(2009-10#1)
Single-shot measurement of##4##3##(2007-11#1)(2007-12#3)
Single-shot sonogram##2##2##(2007-11#2)
Single-shot##9##1##(2007-11#3)(2007-12#5)(2008-2#1)
Single-stage##2##1##(2008-10#1)(2008-8#1)
Single-step##3##1##(2008-10#2)(2008-3#1)
Single-strand conformation polymorphism (SSCP) analysis of##2##6##(1992-8#1)(2008-10#1)
Single-strand conformation polymorphism (SSCP)##3##4##(1992-8#1)(2008-10#1)(2008-4#1)
Single-strand conformation polymorphism analysis##4##4##(1991-12#1)(1992-8#1)(2008-10#1)(2008-4#1)
Single-strand conformation polymorphism##7##3##(1991-12#1)(1992-8#2)(2008-10#2)(2008-4#2)
Single-transverse-mode operation##2##2##(2007-11#1)(2008-3#1)
Single-walled carbon nanotubes (SWNTs)##2##4##(2008-10#1)(2008-7#1)
Single-walled carbon nanotubes##3##3##(2008-10#1)(2008-7#2)
Single-walled##4##1##(2007-12#1)(2008-10#1)(2008-7#2)
Singular##3##1##(2008-10#1)(2008-3#1)(2012-2#1)
Sinioris##7##1##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Sinomenine##3##1##(1994-8#3)
Sinonasal teratocarcinosarcoma##2##2##(2008-11#2)
Sinonasal undifferentiated carcinoma##2##3##(2008-3#2)
Sinonasal##9##1##(2008-11#2)(2008-3#2)(2008-7#1)(2009-1#1)(2011-2#1)(2012-1#2)
Sinorhizobium meliloti##2##2##(2008-9#2)
Sinularia##4##1##(2010-2#4)
Sinus##4##1##(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
Sinusitis is##2##2##(1993-2#2)
Sinusoidal wavelength-scanning##2##2##(2008-3#2)
Sinusoidal##4##1##(2007-11#1)(2008-3#3)
Siphonal length varied between##2##4##(2013-7#2)
Sir William Osler##2##3##(1990-4#1)(2008-10#1)
Sir##10##1##(1990-4#1)(1992-2#1)(1993-3#1)(2007-10#3)(2008-10#2)(2008-7#2)
Sir2##2##1##(2009-12#2)
Sirex noctilio##2##2##(2011-2#2)
Siricidae)##2##1##(2011-2#2)
Sirolimus##3##1##(2008-3#1)(2008-8#2)
Sirt1##2##1##(2012-2#2)
Sistani cattle##3##2##(2008-12#3)
Sistani##5##1##(2008-12#5)
Sister Chromatid##2##2##(2008-4#1)(2012-2#1)
Sister Mary##2##2##(1994-1#1)(2009-9#1)
Sister Ryan delivered##2##3##(1994-1#2)
Sister chromatid exchange##2##3##(1990-6#2)
Sister##8##1##(1990-6#2)(1994-1#3)(2008-4#1)(2009-9#1)(2012-2#1)
Sisters of Providence##2##3##(1992-1#1)(1994-2#1)
Sisters of##4##2##(1991-2#1)(1992-1#1)(1993-5#1)(1994-2#1)
Sisters##6##1##(1991-2#3)(1992-1#1)(1993-5#1)(1994-2#1)
Site directed mutagenesis##2##3##(1992-8#1)(1994-6#1)
Site directed##3##2##(1992-8#1)(1994-6#1)(2008-11#1)
Site of##2##2##(1996-2#1)(2009-10#1)
Site##13##1##(1992-8#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
Site-directed mutagenesis in##2##3##(1992-3#1)(1997-7#1)
Site-directed mutagenesis of##3##3##(1990-10#1)(1994-12#1)(2008-8#1)
Site-directed mutagenesis##7##2##(1990-10#1)(1992-3#1)(1994-12#1)(1995-2#2)(1997-7#1)(2008-8#1)
Site-directed##8##1##(1990-10#1)(1992-3#1)(1994-12#1)(1995-2#2)(1997-7#1)(2008-8#1)(2008-9#1)
Site-selective##2##1##(1994-2#1)(2008-3#1)
Site-specific##8##1##(1990-8#1)(1993-5#1)(1993-8#1)(1995-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-7#1)
Sites for##2##2##(1995-8#1)(2008-9#1)
Sites of disease##2##3##(1990-8#1)(1992-8#1)
Sites of##6##2##(1990-8#1)(1992-8#1)(1995-3#1)(2006-10#1)(2008-10#1)(2012-1#1)
Sites##15##1##(1990-8#1)(1992-8#1)(1994-7#1)(1995-3#1)(1995-8#1)(2006-10#1)(2007-2#2)(2008-10#3)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
Sitisi and##2##2##(2008-1#2)
Sitisi##6##1##(2008-1#6)
Sitobion avenae##2##2##(2008-10#2)
Sitting##2##1##(2008-12#1)(2013-7#1)
Situ##6##1##(2008-1#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
Situations##3##1##(2006-10#1)(2008-8#1)(2013-8#1)
Situs inversus with dextrocardia##2##4##(2008-7#2)
Situs inversus##4##2##(2008-7#2)(2009-8#2)
Six and##2##2##(2007-8#1)(2008-10#1)
Six cases##2##2##(1990-3#1)(2008-6#1)
Six categories##2##2##(1996-12#1)(2012-3#1)
Six common##2##2##(2008-10#1)(2012-2#1)
Six different variables were assessed##2##5##(2008-10#2)
Six different##9##2##(2008-10#6)(2008-11#1)(2008-12#1)(2011-2#1)
Six focus##2##2##(2010-8#1)(2011-1#1)
Six groups of##2##3##(1996-12#1)(2010-4#1)
Six groups##3##2##(1996-12#1)(2008-10#1)(2010-4#1)
Six hours after##2##3##(1993-8#1)(2009-1#1)
Six hours##3##2##(1993-8#1)(2009-1#1)(2013-1#1)
Six hundred and##3##3##(1996-8#2)(2007-12#1)
Six hundred##5##2##(1991-12#1)(1996-8#2)(2007-12#1)(2011-1#1)
Six independent##2##2##(2007-11#1)(2008-8#1)
Six months after surgery##2##4##(2007-8#1)(2012-1#1)
Six months after the##2##4##(2011-2#1)(2012-2#1)
Six months after##5##3##(2007-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
Six months later##4##3##(1992-5#1)(1997-4#1)(2007-8#1)(2009-1#1)
Six months##13##2##(1992-5#1)(1997-4#1)(2007-8#3)(2008-5#2)(2009-1#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
Six of the##5##3##(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#2)
Six of these patients##2##4##(2008-6#1)(2008-7#1)
Six of these##5##3##(1996-3#1)(1996-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
Six of##12##2##(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2010-11#1)
Six out of##2##3##(2008-10#1)(2013-1#1)
Six out##3##2##(1996-9#1)(2008-10#1)(2013-1#1)
Six patients died##2##3##(2012-3#1)(2013-1#1)
Six patients had##3##3##(1991-2#1)(1994-12#1)(2008-4#1)
Six patients underwent##2##3##(2008-11#1)(2008-7#1)
Six patients were##3##3##(1991-2#1)(1992-11#1)(2011-2#1)
Six patients with##3##3##(1991-6#1)(1994-2#1)(1997-3#1)
Six patients##16##2##(1991-12#1)(1991-2#2)(1991-6#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
Six studies##2##2##(2012-2#1)(2013-1#1)
Six subjects##2##2##(2008-11#1)(2008-12#1)
Six synthetic samples were determined##2##5##(2008-10#2)
Six weeks##2##2##(1991-9#1)(1992-2#1)
Six years##2##2##(2006-10#1)(2009-4#1)
Six##194##1##(1990-3#1)(1990-5#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#5)(2008-1#2)(2008-10#43)(2008-11#9)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-1#2)(2009-11#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
Six-Coordinate##2##1##(1996-2#2)
Six-week-old##3##1##(1994-6#1)(2008-10#2)
Sixteen cases##2##2##(1994-12#1)(2012-1#1)
Sixteen of##2##2##(1990-10#1)(2008-8#1)
Sixteen patients##4##2##(1990-3#1)(2008-6#1)(2008-9#1)(2012-3#1)
Sixteen subjects##2##2##(1994-12#1)(2007-6#1)
Sixteen##36##1##(1990-10#1)(1990-2#1)(1990-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-9#1)(1995-11#1)(1996-2#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
Sixth International##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
Sixth##8##1##(1995-12#1)(1996-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-3#1)
Sixty patients were##2##3##(2011-2#1)(2012-3#1)
Sixty patients##3##2##(1996-6#1)(2011-2#1)(2012-3#1)
Sixty percent of the##3##4##(1990-9#1)(2008-1#1)(2008-10#1)
Sixty percent of##5##3##(1990-9#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
Sixty percent##7##2##(1990-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
Sixty to##2##2##(1997-2#1)(2008-6#1)
Sixty##33##1##(1990-9#1)(1995-12#2)(1996-6#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#2)(2011-2#4)(2012-3#3)(2013-1#3)
Sixty-eight patients##2##2##(1990-3#1)(1993-5#1)
Sixty-eight percent of the##2##4##(1992-10#1)(2012-2#1)
Sixty-eight##7##1##(1990-3#1)(1992-10#1)(1993-5#1)(1994-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
Sixty-five patients##3##2##(1991-3#1)(2007-7#1)(2011-2#1)
Sixty-five percent##2##2##(1990-2#1)(2008-3#1)
Sixty-five##12##1##(1990-2#1)(1991-3#1)(1993-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#2)(2013-1#1)
Sixty-four patients##3##2##(1992-9#1)(2008-11#1)(2013-1#1)
Sixty-four##6##1##(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
Sixty-nine##5##1##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
Sixty-one patients##5##2##(1990-3#2)(1991-8#1)(1995-1#1)(2008-8#1)
Sixty-one percent of##2##3##(1996-2#1)(2011-2#1)
Sixty-one##11##1##(1990-2#1)(1990-3#2)(1991-8#1)(1995-1#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
Sixty-six##7##1##(1992-3#1)(1995-2#1)(1997-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)
Sixty-three##7##1##(1991-2#1)(1992-10#1)(1992-3#1)(1997-6#1)(2007-2#1)(2008-9#1)(2011-1#1)
Sixty-two##6##1##(1997-2#1)(2008-1#2)(2009-10#1)(2009-11#1)(2012-2#1)
Size and##3##2##(2007-11#1)(2008-10#1)(2009-5#1)
Size distribution did##2##3##(2008-9#2)
Size exclusion##2##2##(1992-6#1)(1994-12#1)
Size of drawings##2##3##(2007-12#2)
Size of##3##2##(1996-1#1)(2007-12#2)
Size##28##1##(1992-6#1)(1994-12#1)(1996-1#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2011-1#1)(2013-1#1)
Size-exclusion chromatography##3##2##(1997-2#1)(2008-4#1)(2010-11#1)
Size-exclusion##4##1##(1996-5#1)(1997-2#1)(2008-4#1)(2010-11#1)
Sizes##3##1##(2008-10#2)(2009-5#1)
SjAb in##3##2##(2008-10#3)
SjAb##6##1##(2008-10#6)
SjAg##3##1##(2008-10#3)
Sjogren's##3##1##(1990-2#2)(2008-12#1)
Sjolseth##2##1##(1994-1#2)
Sjögren's syndrome (SS)##2##3##(2007-11#1)(2011-2#1)
Sjögren's syndrome##15##2##(1990-2#3)(2006-10#2)(2007-10#2)(2007-11#2)(2008-7#3)(2009-8#1)(2011-2#1)(2012-3#1)
Sjögren's##17##1##(1990-2#3)(2006-10#4)(2007-10#2)(2007-11#2)(2008-7#3)(2009-8#1)(2011-2#1)(2012-3#1)
SkM mitochondrial structure and##2##4##(2012-3#2)
SkM mitochondrial##3##2##(2012-3#3)
SkM##5##1##(2012-3#5)
Skeletal muscle##4##2##(1991-12#1)(1993-9#1)(2008-1#1)(2008-5#1)
Skeletal##15##1##(1991-12#1)(1993-9#1)(1996-12#1)(1997-4#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-9#1)(2012-1#1)(2013-1#1)
Skeleton##2##1##(1994-2#2)
Skeletonized##2##1##(2007-8#2)
Skew##2##1##(1995-3#1)(2012-3#1)
Skilled##2##1##(2008-6#1)(2011-1#1)
Skills in##2##2##(1993-12#1)(2008-12#1)
Skills##10##1##(1993-12#1)(2008-11#2)(2008-12#2)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
Skin ageing##2##2##(2008-5#2)
Skin and##2##2##(2007-12#1)(2009-4#1)
Skin barrier##2##2##(2008-5#2)
Skin biopsy##3##2##(2007-7#1)(2010-8#1)(2012-3#1)
Skin cancer##3##2##(2007-12#1)(2010-8#1)(2011-2#1)
Skin care##2##2##(2008-11#1)(2010-8#1)
Skin color##2##2##(2008-5#2)
Skin colour##3##2##(2008-5#3)
Skin from##2##2##(1992-8#1)(2008-6#1)
Skin impedance##3##2##(2008-10#2)(2010-4#1)
Skin is##2##2##(2008-5#2)
Skin metastases##2##2##(1990-8#1)(2007-2#1)
Skin moisture##2##2##(2008-5#2)
Skin moisturisation and elasticity##2##4##(2008-5#2)
Skin penetration and##2##3##(2008-5#2)
Skin penetration##3##2##(2008-5#3)
Skin surface##3##2##(2008-5#3)
Skin##76##1##(1990-8#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-9#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#37)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-4#1)(2010-8#3)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
Skinks##2##1##(2010-3#2)
SkleroPro##3##1##(2008-10#3)
Skull Base Surgery##2##3##(2006-12#1)(2012-3#1)
Skull Base##9##2##(2006-12#4)(2011-2#2)(2012-3#3)
Skull##10##1##(2006-12#4)(2011-2#2)(2012-3#4)
Sky##6##1##(1996-1#3)(2007-12#1)(2008-2#2)
Sl cells##5##2##(2008-11#5)
Sl##7##1##(2008-11#7)
Sleep Loss and##2##3##(2010-7#1)(2013-1#1)
Sleep and##3##2##(1992-8#1)(1994-8#1)(2012-3#1)
Sleep apnoea##2##2##(1997-5#1)(2008-7#1)
Sleep deprivation##2##2##(1995-12#1)(2013-8#1)
Sleep disorders are##2##3##(2013-7#2)
Sleep loss is##2##3##(2011-2#1)(2013-1#1)
Sleep##29##1##(1992-8#1)(1994-8#1)(1995-12#2)(1996-11#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#1)
Sleep&quot##2##1##(2007-12#1)(2010-9#1)
Slice##2##1##(2011-2#1)(2013-8#1)
Slices##2##1##(1995-12#1)(2009-7#1)
Sliding##2##1##(2009-11#1)(2011-2#1)
Slight##5##1##(1993-3#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-5#1)
Slightly less##2##2##(2007-11#1)(2008-10#1)
Slightly more##2##2##(1995-2#1)(2007-12#1)
Slightly##7##1##(1993-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-8#1)
Slip complexity in##2##3##(1996-4#2)
Slip##3##1##(1996-4#2)(2007-7#1)
Sloan-Kettering Cancer Center##2##3##(2008-5#1)(2011-2#1)
Slope##6##1##(1995-8#1)(2008-10#2)(2008-3#3)
Slopes of##3##2##(1992-3#1)(2007-11#1)(2008-9#1)
Slot blot##2##2##(1990-2#1)(2008-10#1)
Slovakia##5##1##(1994-12#1)(1995-3#1)(1996-3#1)(2008-10#2)
Slovenia##4##1##(1994-5#1)(2008-11#2)(2011-2#1)
Slow and##2##2##(1993-12#1)(2012-2#1)
Slow channel congenital myasthenic syndrome##2##5##(2013-1#2)
Slow##12##1##(1992-6#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Slower##2##1##(2007-8#1)(2008-7#1)
Slowly##2##1##(1994-2#1)(2008-3#1)
Slp##5##1##(1995-2#5)
Slt-IA##5##1##(1992-3#5)
Sludge##3##1##(2008-10#1)(2008-12#1)(2008-5#1)
Slump Test##6##2##(2008-12#6)
Slump##7##1##(2008-12#7)
Slurry sampling ETAAS##3##3##(2008-10#3)
Slurry sampling##7##2##(2008-10#7)
Slurry##10##1##(2008-10#10)
Sm B##4##2##(1993-2#4)
Sm##18##1##(1993-12#2)(1993-2#4)(1997-9#1)(2008-10#10)(2011-1#1)
Sm(3+)##4##1##(2008-10#4)
Sm(III)##2##1##(2008-10#2)
Sm10##4##1##(2008-10#4)
Sm10T##4##1##(2008-10#4)
Sma I##3##2##(1992-6#2)(2008-8#1)
SmaI##3##1##(1993-8#1)(1996-12#1)(2008-10#1)
SmaI(-) BssHII(-) NaeI(-)##2##3##(2011-1#2)
Smac/DIABLO##4##1##(2008-11#4)
Smad##3##1##(2008-6#1)(2012-1#1)(2012-12#1)
Smad2 conditional##4##2##(2008-9#4)
Smad2 gene##2##2##(2008-9#2)
Smad2##9##1##(2008-9#9)
Smad5 double knockout ES cells##5##5##(2008-8#5)
Smad5##12##1##(2008-8#11)(2013-8#1)
Smad7 is##2##2##(2012-12#2)
Smad7##10##1##(2012-12#10)
Smads 2##2##2##(2008-6#2)
Smads##3##1##(2008-6#2)(2008-9#1)
Small Bowel##2##2##(2012-3#1)(2013-1#1)
Small Cell Lung Cancer##3##4##(2008-10#1)(2010-8#2)
Small Cell##4##2##(1996-9#1)(2008-10#1)(2010-8#2)
Small Grains##2##2##(2008-10#2)
Small RNA##4##2##(2008-10#1)(2008-9#1)(2009-3#1)(2012-12#1)
Small RNAs##2##2##(2008-2#1)(2009-10#1)
Small amounts of##4##3##(1990-2#1)(1992-9#1)(1995-3#1)(2008-10#1)
Small and##2##2##(1990-8#1)(1996-2#1)
Small bowel obstruction##2##3##(1997-8#1)(2009-8#1)
Small bowel##6##2##(1993-8#2)(1995-10#1)(1997-8#1)(2009-8#1)(2013-1#1)
Small cell carcinoma##3##3##(1992-12#1)(2007-7#1)(2009-1#1)
Small cell##5##2##(1992-12#1)(1995-8#1)(2007-7#1)(2009-1#1)(2011-2#1)
Small differences##3##2##(1992-12#1)(1994-5#1)(2008-2#1)
Small grant management##2##3##(2010-7#2)
Small molecule##2##2##(2009-10#1)(2010-2#1)
Small##98##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#3)(2009-3#2)(2009-7#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-7#2)(2010-8#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
Small-angle X-ray##2##2##(2008-10#1)(2008-8#1)
Small-angle measurement##2##2##(2008-3#2)
Small-angle##5##1##(2008-10#1)(2008-3#3)(2008-8#1)
Small-scale##2##1##(2008-10#1)(2009-6#1)
Smaller##10##1##(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-4#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
Smallpox##3##1##(1993-12#1)(1993-6#1)(2007-12#1)
Smart##8##1##(1994-9#1)(1995-11#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-8#2)(2011-1#1)
SmartWire##4##1##(1996-6#4)
Smead Jones##2##2##(1992-2#2)
Smith for##2##2##(2011-2#1)(2012-2#1)
Smith##12##1##(1990-8#3)(1995-12#1)(1997-1#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
Smith's##2##1##(2008-9#1)(2011-2#1)
Smith-Magenis syndrome##2##2##(1997-3#2)
Smith-Magenis##3##1##(1997-3#2)(2011-2#1)
SmithKline Beecham##6##2##(2008-5#6)
Smiths Medical CADD-Solis infusion pumps##2##5##(2011-2#2)
Smiths Medical Medfusion 3010a syringe##2##5##(2011-2#2)
Smiths Medical##6##2##(2011-2#6)
Smoke##3##1##(1996-12#2)(2013-7#1)
Smokers##7##1##(1992-9#1)(2009-5#1)(2010-4#2)(2013-7#1)(2013-8#2)
Smoking Cessation##3##2##(1991-5#1)(2010-4#1)(2011-2#1)
Smoking and##5##2##(2007-10#1)(2008-7#1)(2009-7#2)(2013-8#1)
Smoking cessation for##2##3##(1991-1#1)(2009-7#1)
Smoking cessation##9##2##(1991-1#2)(1997-3#1)(2008-11#2)(2008-3#1)(2009-1#1)(2009-7#1)(2011-2#1)
Smoking habits##2##2##(1990-2#1)(1991-6#1)
Smoking in##2##2##(1994-6#1)(2013-1#1)
Smoking is##2##2##(2011-2#1)(2013-1#1)
Smoking prevalence##2##2##(1994-6#2)
Smoking was##2##2##(1991-11#1)(2007-6#1)
Smoking##44##1##(1990-2#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1993-6#1)(1993-8#1)(1994-6#3)(1996-7#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-5#2)(2009-7#3)(2010-10#1)(2010-4#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#2)
Smooth muscle##5##2##(1992-9#1)(1993-6#1)(1994-6#1)(1995-2#1)(2011-2#1)
Smooth##10##1##(1992-9#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2011-2#1)
Smoothing##3##1##(2008-10#1)(2009-10#1)(2011-1#1)
Sms-enforcement##2##1##(1993-12#2)
Sn and Te##2##3##(2008-10#2)
Sn and##4##2##(2008-10#4)
Sn in##4##2##(2008-10#4)
Sn##24##1##(2008-10#22)(2008-12#1)(2009-9#1)
Sn(2+)##3##1##(2008-10#3)
Sn(II)##3##1##(2008-10#3)
Sn(IV)##5##1##(2008-10#5)
Sn2000 and##2##2##(2008-10#2)
Sn2000##4##1##(2008-10#4)
SnCl(2)##6##1##(2008-10#6)
SnO(2) with##2##2##(2008-10#2)
SnO(2)##9##1##(2007-12#2)(2008-10#7)
SnTox1##3##1##(2008-10#3)
Snail##6##1##(1997-6#1)(2011-1#5)
Snails in each##2##3##(2011-1#2)
Snails##8##1##(2011-1#8)
Snake##4##1##(2008-1#1)(2008-12#1)(2008-5#1)(2012-12#1)
Snakes##2##1##(1991-8#1)(2010-3#1)
Snn1##2##1##(2008-10#2)
Snodgrass procedure##2##2##(2009-5#2)
Snodgrass##4##1##(2008-10#2)(2009-5#2)
Snow##4##1##(2008-10#1)(2008-8#1)(2009-8#2)
Snu13p##2##1##(2009-7#2)
Snyder##5##1##(1991-7#1)(1995-6#1)(1997-6#2)(2012-2#1)
So far it##2##3##(2007-11#1)(2013-1#1)
So far no##2##3##(1997-2#1)(2009-5#1)
So far only##3##3##(1992-5#1)(2008-10#1)(2011-1#1)
So far##35##2##(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-8#1)(2013-1#4)
So it is considered that##2##5##(2008-9#2)
So it is suggested##2##4##(2008-8#1)(2013-8#1)
So it is##7##3##(2008-10#1)(2008-8#3)(2008-9#2)(2013-8#1)
So that##3##2##(1993-1#1)(2008-10#2)
So the##9##2##(2008-10#4)(2008-7#1)(2010-8#1)(2012-2#2)(2013-8#1)
So this##2##2##(2008-3#1)(2012-3#1)
So we##5##2##(2009-7#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
So you want to be a##3##6##(2008-1#1)(2012-2#1)(2013-8#1)
So you##4##2##(1997-3#1)(2008-1#1)(2012-2#1)(2013-8#1)
So##110##1##(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#4)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#6)(2013-8#5)
So-called##2##1##(2006-10#1)(2007-2#1)
Soap Chamber Test##2##3##(2008-5#2)
Soapnut oil##2##2##(2009-3#2)
Soay sheep##3##2##(1995-2#1)(1996-6#2)
Soc##15##1##(1992-8#1)(1995-2#3)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#5)
Soccer##3##1##(2010-1#1)(2012-3#2)
Social Action##4##2##(2008-11#4)
Social Activity##3##2##(2008-10#2)(2010-4#1)
Social Determinants of Health##4##4##(2010-12#1)(2011-1#3)
Social Determinants##5##2##(2010-12#1)(2011-1#4)
Social Health##3##2##(1996-5#1)(2007-10#1)(2008-7#1)
Social Networks##2##2##(2008-9#1)(2010-1#1)
Social Sciences##2##2##(2009-4#1)(2011-1#1)
Social Security Act##2##3##(1991-3#1)(1992-2#1)
Social Security and Medicare##2##4##(1994-2#1)(1995-2#1)
Social Security##11##2##(1991-3#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-2#1)(1995-2#1)(1997-5#1)(2011-2#2)(2012-12#1)
Social Services##3##2##(1994-1#1)(1995-3#1)(2013-8#1)
Social Support##5##2##(1992-1#1)(2010-1#2)(2010-3#1)(2011-2#1)
Social Welfare##2##2##(1995-5#1)(2011-2#1)
Social and##5##2##(1993-9#1)(1996-2#1)(2008-9#1)(2009-5#1)(2013-8#1)
Social health##2##2##(1992-1#1)(2008-7#1)
Social phobia is##2##3##(2008-4#2)
Social relationships##2##2##(2008-11#1)(2009-5#1)
Social support and##3##3##(2010-10#1)(2010-2#1)(2012-3#1)
Social support##10##2##(1992-3#1)(1996-3#1)(2007-4#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
Social##121##1##(1990-11#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#2)(1993-1#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#15)(2008-12#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#6)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
Socialization##5##1##(1992-6#1)(2008-5#1)(2011-2#1)(2012-12#2)
Socially##2##1##(2008-8#1)(2009-5#1)
Societies for##2##2##(1990-2#1)(2008-7#1)
Societies of##2##2##(2011-2#1)(2011-4#1)
Societies##7##1##(1990-2#1)(2008-2#1)(2008-7#1)(2011-2#2)(2011-4#1)(2012-12#1)
Society and the Canadian Thoracic Society##2##6##(2007-12#2)
Society and the##5##3##(1994-12#1)(2007-12#2)(2008-11#1)(2008-6#1)
Society and##12##2##(1994-12#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#5)(2013-1#1)
Society for Endocrinology##3##3##(1996-8#1)(2008-4#2)
Society for the Prevention of Cruelty to Animals##3##8##(2011-1#2)(2013-8#1)
Society for the Study of##2##5##(2008-5#1)(2013-1#1)
Society for the##5##3##(2008-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
Society for##36##2##(1992-3#1)(1994-12#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-11#1)(2010-10#1)(2011-1#4)(2011-2#8)(2011-9#1)(2012-1#1)(2013-1#4)(2013-8#2)
Society guidelines##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
Society of America##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
Society of Canada##3##3##(2008-10#2)(2008-5#1)
Society of Cardiology##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
Society of Clinical Chemistry##3##4##(1994-12#3)
Society of Clinical##12##3##(1994-12#4)(2008-5#2)(2008-7#3)(2009-4#1)(2010-11#1)(2013-1#1)
Society of Family##3##3##(1993-5#1)(1996-8#1)(1997-8#1)
Society of General Practitioners##2##4##(1994-6#2)
Society of Haematology##2##3##(1996-8#1)(2013-1#1)
Society of Hematology##4##3##(2008-7#1)(2009-4#1)(2010-11#2)
Society of India##2##3##(2008-11#1)(2008-12#1)
Society of Internal Medicine##3##4##(2008-7#1)(2008-8#1)(2013-1#1)
Society of Internal##4##3##(2008-7#2)(2008-8#1)(2013-1#1)
Society of Orthopaedics and Traumatology##2##5##(2007-11#1)(2007-8#1)
Society of Pneumology##2##3##(2007-6#1)(2008-1#1)
Society of Toxicologic Pathology##2##4##(2008-10#1)(2012-1#1)
Society of Toxicology (SOT)##2##4##(2008-10#2)
Society of Toxicology##5##3##(2008-10#3)(2011-2#1)(2012-1#1)
Society of##99##2##(1991-6#1)(1993-12#1)(1993-5#1)(1994-12#4)(1994-6#2)(1994-9#1)(1996-3#1)(1996-8#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#11)(2008-7#10)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#3)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#3)(2012-2#12)(2012-3#1)(2013-1#6)
Society##225##1##(1990-2#1)(1990-9#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-6#2)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#3)(1996-8#3)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#8)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#17)(2008-6#5)(2008-7#15)(2008-8#10)(2008-9#4)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#23)(2011-9#1)(2012-1#6)(2012-2#13)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#4)
Society]##3##1##(1991-3#1)(1993-6#1)(1994-12#1)
Socio-cultural##2##1##(2012-12#1)(2013-8#1)
Socio-demographic##3##1##(2008-11#1)(2012-12#1)(2012-3#1)
Socio-economic##4##1##(2008-3#1)(2010-11#2)(2011-2#1)
Sociocultural##3##1##(2007-12#2)(2010-9#1)
Socioeconomic factors##2##2##(2008-4#1)(2008-9#1)
Socioeconomic##13##1##(1995-9#1)(2008-4#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
Sodium and##2##2##(2008-10#1)(2008-12#1)
Sodium ascorbyl phosphate##2##3##(2008-5#2)
Sodium bromate##3##2##(2008-9#3)
Sodium butyrate##6##2##(1992-3#1)(1993-9#3)(2008-11#2)
Sodium channel##4##2##(1996-12#4)
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis##5##5##(1992-12#1)(2008-10#3)(2010-2#1)
Sodium dodecyl sulfate-polyacrylamide gel##6##4##(1991-2#1)(1992-12#1)(2008-10#3)(2010-2#1)
Sodium dodecyl##9##2##(1990-5#1)(1991-2#1)(1992-12#1)(1997-6#1)(2008-10#4)(2010-2#1)
Sodium fluoride##5##2##(1990-2#1)(1991-5#1)(1995-12#3)
Sodium methyldithiocarbamate##2##2##(2008-10#2)
Sodium sulfite##2##2##(2008-10#2)
Sodium##68##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-10#1)(1993-9#3)(1994-8#1)(1995-11#1)(1995-12#3)(1996-12#4)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-3#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
Soft Independent##2##2##(2008-10#2)
Soft Tissue Sarcoma##4##3##(2008-6#4)
Soft Tissue Sarcomas##3##3##(2008-6#3)
Soft Tissue##9##2##(2006-10#1)(2008-6#8)
Soft tissue sarcomas##2##3##(2008-6#1)(2009-3#1)
Soft tissue##8##2##(2007-12#2)(2008-6#2)(2008-9#1)(2009-3#1)(2011-2#2)
Soft##27##1##(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-6#10)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
Soft-X-Ray##2##1##(2008-2#1)(2008-3#1)
Soft-x-ray##2##1##(2007-12#1)(2008-3#1)
Software for##2##2##(2009-12#1)(2009-7#1)
Software was written in##2##4##(2008-10#2)
Software##13##1##(1995-9#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-6#1)(2011-2#1)
Soil Microbial Communities##2##3##(2008-10#2)
Soil Organic##2##2##(2008-10#2)
Soil Suppressiveness Against Heterodera schachtii##2##5##(2008-10#2)
Soil Suppressiveness Against##3##3##(2008-10#3)
Soil Texture and##2##3##(2008-10#2)
Soil and soybean stem samples##2##5##(2008-10#2)
Soil and##8##2##(2008-10#7)(2008-11#1)
Soil fumigation with methyl bromide##2##5##(2008-10#2)
Soil pH##2##2##(2008-10#2)
Soil samples collected##2##3##(2008-10#2)
Soil samples were collected##3##4##(2008-10#3)
Soil samples were placed in##2##5##(2008-10#1)(2008-6#1)
Soil samples were##9##3##(2008-10#8)(2008-6#1)
Soil samples##13##2##(2008-10#11)(2008-11#1)(2008-6#1)
Soil suppressiveness##2##2##(2008-10#2)
Soil type and##2##3##(2008-10#2)
Soil type##5##2##(2008-10#5)
Soil was collected from##2##4##(2008-10#2)
Soil was##3##2##(2008-10#3)
Soil##92##1##(1990-9#1)(1993-8#1)(1995-3#1)(2008-10#75)(2008-11#4)(2008-12#4)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
Soil-borne##4##1##(2008-8#4)
Soilborne wheat mosaic virus##3##4##(2008-10#3)
Soilborne##5##1##(2008-10#5)
Soils from##2##2##(2008-10#2)
Soils in##2##2##(2008-10#2)
Soils##10##1##(2008-10#10)
Soissons##3##1##(2008-10#3)
Sokoto##3##1##(1990-3#1)(2010-4#2)
Sol-Gel##4##1##(2008-10#4)
Sol-gel##3##1##(2008-10#3)
Solanaceae##8##1##(1993-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-7#1)
Solanum hosts##2##2##(2008-10#2)
Solanum spp##10##2##(2008-10#10)
Solanum tuberosum##4##2##(1992-12#2)(1993-12#1)(2008-7#1)
Solanum##28##1##(1992-12#2)(1993-12#1)(2008-10#22)(2008-11#1)(2008-7#1)(2008-9#1)
Solar and##3##2##(2008-2#1)(2008-3#2)
Solar##15##1##(2008-10#2)(2008-2#5)(2008-3#6)(2008-5#1)(2011-2#1)
Solc folded-type anisotropic##2##3##(2008-3#2)
Solc folded-type##3##2##(2008-3#3)
Solc-type anisotropic periodic##2##3##(2008-3#2)
Solc-type##3##1##(2008-3#3)
Solenopsis##3##1##(2007-12#3)
Solexa##2##1##(2010-10#2)
Solid Phase##2##2##(2011-2#2)
Solid State##4##2##(1996-2#1)(2011-1#2)(2012-1#1)
Solid contact electrodes##2##3##(2008-10#2)
Solid dispersions of##2##3##(2012-2#2)
Solid dispersions##3##2##(2012-2#3)
Solid phase extraction (SPE)##3##4##(2008-10#2)(2013-1#1)
Solid phase extraction and determination of##2##6##(2008-10#2)
Solid phase extraction and##4##4##(2008-10#4)
Solid phase extraction##11##3##(2008-10#10)(2013-1#1)
Solid phase extractive preconcentration of uranium(VI)##2##6##(2008-10#2)
Solid phase extractive preconcentration of##3##5##(2008-10#3)
Solid phase microextraction (SPME)##2##4##(2008-10#1)(2009-8#1)
Solid phase##18##2##(1996-12#1)(2008-10#15)(2009-8#1)(2013-1#1)
Solid pseudopapillary##2##2##(2013-1#2)
Solid variant of serous cystadenoma of the pancreas##2##8##(2012-2#2)
Solid##59##1##(1990-6#1)(1995-3#1)(1995-4#2)(1996-12#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#6)(2013-1#4)
Solid-Phase##4##1##(1995-8#1)(2008-10#1)(2009-8#1)(2009-9#1)
Solid-State##3##1##(1990-8#1)(2011-1#1)(2012-2#1)
Solid-contact##2##1##(2008-10#2)
Solid-liquid##2##1##(2008-10#1)(2008-5#1)
Solid-phase extraction (SPE)##2##3##(2008-10#2)
Solid-phase extraction and##2##3##(2008-10#2)
Solid-phase extraction was##2##3##(2008-10#2)
Solid-phase extraction with##2##3##(1991-7#1)(2008-10#1)
Solid-phase extraction##9##2##(1991-7#1)(2008-10#8)
Solid-phase microextraction##5##2##(2008-10#5)
Solid-phase synthesis of##2##3##(2008-4#2)
Solid-phase##24##1##(1991-7#1)(1995-8#1)(1997-4#1)(2008-10#18)(2008-4#3)
Solid-state nanopores##2##2##(2008-7#2)
Solid-state##7##1##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#3)
Solitaire##2##1##(2013-8#2)
Solitary fibrous tumor##2##3##(2007-5#2)
Solitary fibrous##4##2##(2007-5#2)(2007-8#1)(2011-1#1)
Solitary intracranial plasmacytoma##2##3##(2011-2#2)
Solitary metastasis##2##2##(1991-6#1)(2013-1#1)
Solitary##12##1##(1991-6#1)(1996-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
Soliton squeezing in##2##3##(2007-11#1)(2007-12#1)
Soliton##8##1##(1996-9#1)(2007-11#4)(2007-12#3)
Solitons and##2##2##(2007-12#2)
Solitons##4##1##(2007-11#1)(2007-12#3)
SoloSTAR##4##1##(2009-11#4)
Solomon Islands##6##2##(2008-1#1)(2012-12#5)
Solubility and##2##2##(2008-10#1)(2008-11#1)
Solubility##5##1##(2008-10#1)(2008-11#2)(2008-6#1)(2010-3#1)
Solubilization of the##2##3##(1990-2#1)(1994-12#1)
Solubilization of##5##2##(1990-2#1)(1994-12#2)(2008-4#2)
Solubilization##6##1##(1990-2#1)(1994-12#3)(2008-4#2)
Soluble HPRG##2##2##(1997-2#2)
Soluble##17##1##(1990-10#1)(1990-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-2#2)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
Solute##3##1##(1993-11#1)(2011-2#2)
Solution equilibria between##2##3##(2008-10#2)
Solution structure of##5##3##(1993-3#1)(1994-5#1)(1995-5#2)(2008-8#1)
Solution##28##1##(1991-5#1)(1993-3#1)(1994-5#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-7#2)(2008-10#7)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#2)
Solutions containing##3##2##(1990-7#1)(2008-10#1)(2010-3#1)
Solutions of##3##2##(2008-10#1)(2008-11#1)(2009-2#1)
Solutions to##3##2##(2008-10#2)(2008-3#1)
Solutions##19##1##(1990-7#1)(1992-3#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-3#1)(2010-3#1)
Solvated##2##1##(1996-2#2)
Solvent effect##2##2##(2008-10#2)
Solvent effects on##2##3##(2008-10#2)
Solvent extraction of##6##3##(2008-10#6)
Solvent extraction separation of##2##4##(2008-10#2)
Solvent extraction separation##3##3##(2008-10#3)
Solvent extraction was used to##2##5##(2008-10#2)
Solvent extraction##13##2##(2008-10#12)(2008-7#1)
Solvent kinetic isotope effects on V##2##6##(1992-3#2)
Solvent kinetic isotope effects##3##4##(1991-9#1)(1992-3#2)
Solvent kinetic isotope##4##3##(1991-9#1)(1992-3#3)
Solvent##29##1##(1991-8#1)(1991-9#1)(1992-3#3)(1996-2#1)(2008-10#18)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)
Solver##4##1##(2008-10#4)
Solving the##2##2##(1995-12#1)(2007-11#1)
Solving##4##1##(1995-12#1)(2007-11#1)(2008-2#1)(2012-2#1)
Solvolysis##2##1##(1996-5#1)(2011-1#1)
Somali##2##1##(2011-2#2)
Somalia from##2##2##(2007-7#1)(2011-2#1)
Somalia##6##1##(1995-3#1)(2007-7#1)(2011-2#4)
Somatic mutations##2##2##(1992-3#1)(2008-4#1)
Somatic##10##1##(1992-3#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-6#1)(2010-2#1)(2013-7#1)
Somatization##3##1##(1995-6#1)(2012-5#2)
Somatostatin and##2##2##(1997-2#1)(2011-2#1)
Somatostatin##5##1##(1997-2#2)(1997-4#1)(2008-4#1)(2011-2#1)
Sombre Hummingbird##4##2##(2008-9#4)
Some amino acids were##2##4##(2008-10#1)(2008-11#1)
Some applications##4##2##(1992-5#1)(2008-10#2)(2008-3#1)
Some aspects of the potential mechanism of action of##2##9##(2008-10#2)
Some aspects of the##3##4##(2008-10#3)
Some aspects of##9##3##(1990-3#1)(1991-4#1)(1992-9#1)(2007-11#1)(2008-10#3)(2008-5#1)(2011-2#1)
Some asymmetry was also detected for some spatial autocorrelation proximity patterns##2##11##(2008-10#2)
Some basic##2##2##(1997-8#1)(2009-11#1)
Some believe##2##2##(1995-2#1)(1997-2#1)
Some but not all##2##4##(2008-5#1)(2008-8#1)
Some cells had##2##3##(2008-11#1)(2012-1#1)
Some challenges##2##2##(1994-6#1)(2008-5#1)
Some characteristics of##6##3##(1992-11#1)(1995-3#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-6#1)
Some clinical##3##2##(1991-3#1)(2008-5#1)(2011-1#1)
Some compounds##2##2##(2008-11#1)(2011-2#1)
Some consequences of##2##3##(2007-12#1)(2008-10#1)
Some considerations##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
Some current##2##2##(2008-11#1)(2011-2#1)
Some differences in##2##3##(1992-6#1)(1995-5#1)
Some early##2##2##(2008-10#1)(2012-2#1)
Some evidence##2##2##(2008-9#1)(2009-7#1)
Some examples are##3##3##(2008-10#1)(2008-4#1)(2010-8#1)
Some examples of##2##3##(2008-10#2)
Some examples##5##2##(2008-10#3)(2008-4#1)(2010-8#1)
Some experimental results##3##3##(2008-3#3)
Some experimental##6##2##(2008-10#1)(2008-3#3)(2008-8#1)(2013-1#1)
Some experiments##2##2##(2008-2#1)(2008-7#1)
Some factors##2##2##(2008-11#1)(2008-7#1)
Some features of##2##3##(2006-4#1)(2008-1#1)
Some features##3##2##(2006-4#1)(2008-1#1)(2008-4#1)
Some general##3##2##(1994-3#1)(2008-10#1)(2008-2#1)
Some genes##3##2##(2010-1#1)(2010-4#2)
Some groups of##2##3##(1991-11#1)(2008-10#1)
Some groups##3##2##(1991-11#1)(2008-1#1)(2008-10#1)
Some have##2##2##(1996-2#1)(2008-4#1)
Some implications for##2##3##(1993-6#1)(2008-2#1)
Some implications##3##2##(1993-6#1)(1995-5#1)(2008-2#1)
Some important##2##2##(2008-10#1)(2008-11#1)
Some information##2##2##(1997-3#1)(2013-7#1)
Some isolates##2##2##(2008-10#2)
Some large##3##2##(1996-2#1)(1997-3#1)(2010-1#1)
Some lessons##2##2##(1993-2#1)(2008-11#1)
Some methods for##2##3##(2008-3#1)(2008-5#1)
Some methods##3##2##(2008-3#1)(2008-5#1)(2012-12#1)
Some new##5##2##(1995-5#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-3#1)
Some observations##3##2##(1990-3#1)(2008-11#1)(2008-8#1)
Some of its##3##3##(1991-1#1)(1992-1#1)(2012-1#1)
Some of the best##2##4##(1996-3#1)(2013-1#1)
Some of the lessons learned##2##5##(1995-12#1)(2007-11#1)
Some of the most important##2##5##(1990-12#1)(2008-5#1)
Some of the most##7##4##(1990-12#1)(1994-1#1)(1995-5#1)(2007-12#1)(2008-5#1)(2009-3#1)(2010-12#1)
Some of the novel##2##4##(2008-5#1)(2009-2#1)
Some of the problems##2##4##(1990-9#1)(1996-3#1)
Some of the results##2##4##(1993-8#1)(2008-3#1)
Some of the specific reagents covered are diaminobenzidine##2##8##(2008-4#1)(2008-9#1)
Some of the##79##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-3#5)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
Some of them are##4##4##(1994-8#1)(2007-11#1)(2008-10#2)
Some of them##9##3##(1994-5#1)(1994-8#1)(2007-11#2)(2008-10#3)(2010-10#1)(2013-1#1)
Some of these compounds##2##4##(2007-11#1)(2008-10#1)
Some of these functions##2##4##(1997-1#1)(2008-10#1)
Some of these marine##2##4##(2010-7#1)(2011-1#1)
Some of these measures##2##4##(2011-2#1)(2012-1#1)
Some of these##34##3##(1991-6#1)(1993-8#2)(1994-3#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#1)
Some of##128##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#3)(1994-1#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
Some other##3##2##(2007-2#1)(2008-10#1)(2008-3#1)
Some parameters##2##2##(1992-5#1)(2008-10#1)
Some patients have a well-known rheumatic condition##2##7##(2013-1#2)
Some patients may##5##3##(1992-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2010-6#1)
Some patients##16##2##(1992-12#1)(1992-5#1)(1992-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Some populations##2##2##(2008-10#2)
Some possible##2##2##(2007-11#1)(2008-10#1)
Some potential##2##2##(2008-2#1)(2008-7#1)
Some power cords manufactured by##2##5##(2011-1#1)(2011-2#1)
Some practical##3##2##(2008-3#1)(2009-5#1)(2013-1#1)
Some problems##2##2##(1993-12#1)(2008-11#1)
Some procedures##2##2##(2008-10#2)
Some properties of##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
Some recommendations are##2##3##(2008-12#1)(2008-3#1)
Some representative##2##2##(2008-2#1)(2010-7#1)
Some researchers##2##2##(1993-11#1)(2010-3#1)
Some risk factors may not cause cancer##2##7##(2013-1#2)
Some small##2##2##(1996-5#1)(2008-10#1)
Some species##2##2##(2008-9#1)(2010-10#1)
Some strains of##2##3##(2008-9#1)(2010-3#1)
Some strains##5##2##(2008-10#1)(2008-5#2)(2008-9#1)(2010-3#1)
Some studies found##3##3##(2008-1#1)(2008-3#1)(2009-4#1)
Some studies have indicated that##2##5##(1993-12#1)(2011-2#1)
Some studies have##7##3##(1993-12#1)(2008-11#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-1#1)
Some studies suggest##2##3##(1995-5#1)(2009-12#1)
Some studies##18##2##(1990-12#1)(1993-12#1)(1995-5#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
Some suggestions for improving##2##4##(1996-11#1)(2008-9#1)
Some thoughts##2##2##(1991-12#1)(1993-2#1)
Some transformants##3##2##(2008-10#2)(2008-8#1)
Some treatments##2##2##(2007-12#1)(2008-7#1)
Some ways##2##2##(2008-3#1)(2010-11#1)
Some were##2##2##(1995-2#1)(1996-3#1)
Some##603##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#5)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#9)(1993-2#3)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#8)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#8)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#6)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-7#3)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#11)(2007-12#9)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#2)(2008-1#10)(2008-10#98)(2008-11#30)(2008-12#7)(2008-2#18)(2008-3#28)(2008-4#10)(2008-5#28)(2008-6#4)(2008-7#18)(2008-8#18)(2008-9#16)(2009-10#7)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#4)(2010-4#7)(2010-6#3)(2010-7#2)(2010-8#6)(2011-1#10)(2011-2#16)(2012-1#5)(2012-12#5)(2012-2#9)(2012-3#5)(2013-1#17)(2013-7#6)(2013-8#5)
Someone##3##1##(1994-1#1)(1995-1#1)(2011-2#1)
Something##3##1##(1997-4#1)(2008-11#1)(2008-8#1)
Sometimes the##3##2##(1992-3#1)(1995-3#1)(2007-8#1)
Sometimes##12##1##(1992-11#1)(1992-3#1)(1994-3#1)(1995-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#2)
Somewhat##2##1##(2008-10#1)(2008-3#1)
Sommerfeld##2##1##(2008-2#2)
Sommers##2##1##(2008-10#1)(2009-11#1)
Son##2##1##(2008-8#1)(2013-1#1)
Sonchus asper plants##2##3##(2008-10#2)
Sonchus asper##5##2##(2008-10#5)
Sonic hedgehog expression##2##3##(1993-12#2)
Sonic hedgehog##10##2##(1993-12#6)(1994-12#4)
Sonication##2##1##(1991-3#1)(2013-1#1)
Sonnblick##2##1##(2008-3#2)
Sonnergaard##2##1##(2010-5#2)
SonoVue##4##1##(2008-7#4)
Sonographic examinations##2##2##(1997-8#2)
Sonographic##3##1##(1997-8#2)(2012-12#1)
Sonography is##2##2##(2010-6#1)(2010-8#1)
Sonography##5##1##(1990-10#1)(1997-8#1)(2008-8#1)(2010-6#1)(2010-8#1)
Sonora##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
Sonoran Desert##6##2##(2008-10#5)(2009-8#1)
Sons##141##1##(2008-11#36)(2008-7#62)(2008-9#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#7)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Sony##2##1##(2013-7#2)
Soon after##2##2##(2008-2#1)(2008-9#1)
Soon##3##1##(1990-3#1)(2008-2#1)(2008-9#1)
Soot##3##1##(2008-11#1)(2008-2#1)(2008-3#1)
Soothie pacifiers##2##2##(2009-6#2)
Soothie##4##1##(2009-6#4)
Sophisticated##2##1##(2008-9#1)(2010-7#1)
Sophora japonica##2##2##(2008-5#1)(2013-8#1)
Sorafenib (BAY 43-9006)##2##3##(2008-8#2)
Sorafenib##3##1##(2008-8#2)(2011-2#1)
Sorbent##4##1##(1990-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
Sorbinil##2##1##(1994-8#2)
Soret band##6##2##(1990-8#3)(1992-12#1)(1995-2#1)(2008-10#1)
Soret peak##3##2##(2008-6#1)(2009-2#2)
Soret##13##1##(1990-5#1)(1990-8#3)(1992-12#1)(1995-2#1)(2008-10#4)(2008-6#1)(2009-2#2)
Sorghum and##2##2##(1990-5#1)(2008-10#1)
Sorghum bicolor##3##2##(2008-10#3)
Sorghum ergot##2##2##(2008-10#2)
Sorghum##12##1##(1990-5#2)(2008-10#10)
Sorption behaviour of##3##3##(2008-10#3)
Sorption isotherms were##2##3##(2008-10#1)(2008-6#1)
Sorption isotherms##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
Sorption of##3##2##(2008-10#3)
Sorption properties of##2##3##(2008-10#2)
Sorption##13##1##(1996-5#1)(2008-10#11)(2008-6#1)
Sorting of##2##2##(1992-12#1)(2008-9#1)
Sorting##12##1##(1992-12#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2013-8#1)
Sos##3##1##(1995-8#3)
Sound localization in##2##3##(2008-9#2)
Sound localization##3##2##(2008-9#2)(2012-2#1)
Sound##15##1##(1990-11#1)(2007-12#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-6#1)(2012-2#2)
Sounder##6##1##(2007-5#1)(2008-2#2)(2008-3#3)
Source at##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
Source of##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-2#1)
Source##17##1##(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
Sources and##2##2##(2008-10#2)
Sources of error##2##3##(2008-10#2)
Sources of##11##2##(1994-3#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2011-2#1)
Sources##20##1##(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
South Africa and##4##3##(2008-10#1)(2011-1#2)(2011-2#1)
South Africa is##3##3##(2010-3#1)(2011-1#1)(2012-12#1)
South Africa##104##2##(1992-9#1)(1996-6#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#4)(2007-7#4)(2008-10#19)(2008-12#6)(2008-2#1)(2008-5#2)(2008-8#3)(2009-12#1)(2009-5#1)(2010-1#6)(2010-11#3)(2010-3#8)(2010-4#2)(2010-5#1)(2011-1#14)(2011-2#6)(2012-12#7)(2013-1#5)(2013-8#3)
South Africa)##2##2##(2007-11#1)(2008-9#1)
South African field isolates##2##4##(2011-1#2)
South African specimens##2##3##(2010-3#2)
South African##26##2##(2008-10#6)(2008-12#1)(2008-8#2)(2010-1#2)(2010-11#1)(2010-3#3)(2011-1#7)(2011-2#2)(2013-1#2)
South America and Africa##3##4##(2007-2#1)(2008-10#1)(2011-2#1)
South America and Japan##3##4##(2008-10#3)
South America and##11##3##(1991-11#1)(2007-2#1)(2008-10#7)(2011-2#1)(2012-3#1)
South America##45##2##(1991-11#1)(2006-10#1)(2007-2#2)(2008-1#1)(2008-10#22)(2008-5#4)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
South American countries##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
South American##16##2##(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#2)(2010-3#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
South Asia##4##2##(1994-3#1)(1995-3#1)(2008-10#2)
South Asian##4##2##(2009-12#1)(2011-2#2)(2013-1#1)
South Asians and##2##3##(2011-2#2)
South Asians in Canada##2##4##(2011-2#2)
South Asians##9##2##(2011-2#9)
South Australia##5##2##(2008-10#4)(2008-12#1)
South Carolina Medicaid##2##3##(1991-3#1)(2011-2#1)
South Carolina##23##2##(1991-2#1)(1991-3#1)(1991-8#3)(1993-3#2)(1994-12#1)(1996-1#1)(2007-3#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-12#3)(2013-1#4)
South Carolina's HIV/AIDS community long-term care Medicaid waiver##2##8##(1997-2#2)
South Carolina's HIV/AIDS community long-term care Medicaid##3##7##(1997-2#3)
South Central##2##2##(1992-3#1)(1996-1#1)
South China##4##2##(2010-8#3)(2013-8#1)
South Devon##2##2##(2010-4#2)
South Eastern Nigeria##2##3##(2008-5#1)(2012-3#1)
South Florida##4##2##(2007-5#1)(2009-5#1)(2009-9#1)(2012-1#1)
South India##5##2##(2007-7#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
South Indian##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
South Korea and##2##3##(2008-5#1)(2008-8#1)
South Korea##8##2##(1997-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
South Kyungsang Korean##2##3##(2013-8#2)
South Pacific##9##2##(2008-1#8)(2008-5#1)
South Texas was##2##3##(2008-10#2)
South Texas##7##2##(2008-10#7)
South and##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
South##362##1##(1990-11#1)(1990-2#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-8#3)(1991-9#2)(1992-2#6)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-12#2)(1994-3#1)(1995-3#1)(1996-1#3)(1996-6#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#4)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#5)(2008-1#9)(2008-10#74)(2008-11#5)(2008-12#12)(2008-2#2)(2008-3#2)(2008-5#15)(2008-6#2)(2008-7#1)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-9#3)(2010-1#9)(2010-11#4)(2010-12#1)(2010-3#12)(2010-4#4)(2010-5#2)(2010-8#4)(2011-1#22)(2011-2#34)(2012-1#1)(2012-12#12)(2012-2#1)(2012-3#9)(2013-1#27)(2013-7#3)(2013-8#11)
South-Asian Canadians##2##2##(2013-1#2)
South-Asian##3##1##(2013-1#3)
South-East Asia##2##2##(2007-2#1)(2009-5#1)
South-East##5##1##(2007-2#1)(2009-5#1)(2013-1#3)
South-Western Iran##2##2##(2008-12#2)
South-Western##4##1##(2007-2#1)(2008-12#2)(2010-4#1)
Southeast Asia##13##2##(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-5#3)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
Southeast Asian##2##2##(2008-10#2)
Southeast Michigan##3##2##(1996-3#1)(2011-2#2)
Southeast##29##1##(1995-1#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#3)(2009-5#4)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Southeastern Pennsylvania##3##2##(1993-3#1)(1994-2#1)(1995-6#1)
Southeastern##9##1##(1993-3#1)(1994-2#1)(1995-6#1)(1996-1#1)(2008-10#3)(2012-2#1)(2012-3#1)
Southern Africa##3##2##(2008-12#1)(2011-2#2)
Southern African##2##2##(2008-8#1)(2011-2#1)
Southern Alberta##2##2##(1993-12#2)
Southern California##13##2##(1992-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-4#3)(2008-10#1)(2008-2#2)(2010-8#1)(2011-2#1)(2013-1#1)
Southern Caribbean##2##2##(2008-5#2)
Southern China##3##2##(2008-11#2)(2008-8#1)
Southern Ethiopia##3##2##(2010-6#2)(2012-12#1)
Southern France##2##2##(2008-10#2)
Southern Hemisphere##2##2##(1990-8#1)(2008-10#1)
Southern Italy##2##2##(2008-3#1)(2008-7#1)
Southern Mexico##2##2##(2013-7#2)
Southern Ocean##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
Southern Spain##5##2##(2008-10#4)(2013-7#1)
Southern analyses indicated that##2##4##(1993-6#1)(2008-10#1)
Southern analyses##3##2##(1993-6#1)(2008-10#2)
Southern analysis indicated that##2##4##(1991-6#1)(2012-3#1)
Southern analysis indicated##3##3##(1991-6#1)(1997-2#1)(2012-3#1)
Southern analysis of human genomic DNA##2##6##(1991-6#1)(2008-9#1)
Southern analysis of##5##3##(1991-6#1)(1992-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
Southern analysis showed that##3##4##(1997-8#1)(2008-8#2)
Southern analysis##24##2##(1990-12#1)(1990-8#1)(1991-6#3)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-2#2)(1997-8#1)(2008-10#4)(2008-8#3)(2008-9#1)(2012-3#1)
Southern and Northern blot analyses##2##5##(1992-3#1)(1997-4#1)
Southern and Northern blot##3##4##(1992-3#1)(1995-6#1)(1997-4#1)
Southern and Northern##4##3##(1990-11#1)(1992-3#1)(1995-6#1)(1997-4#1)
Southern and##6##2##(1990-11#1)(1992-3#1)(1995-6#1)(1997-4#1)(2008-5#1)(2008-8#1)
Southern blot analyses of##2##4##(1995-8#1)(2008-10#1)
Southern blot analyses##6##3##(1993-12#1)(1995-8#1)(2006-12#1)(2008-10#2)(2008-6#1)
Southern blot analysis demonstrated that##2##5##(2008-5#1)(2008-8#1)
Southern blot analysis indicated that the##2##6##(1990-2#1)(1993-3#1)
Southern blot analysis of##5##4##(1990-12#1)(1991-2#1)(1992-11#1)(2008-10#2)
Southern blot analysis revealed that the##2##6##(1990-7#1)(1995-6#1)
Southern blot analysis revealed##3##4##(1990-7#1)(1995-6#1)(1997-7#1)
Southern blot analysis showed that##2##5##(1997-4#1)(1997-8#1)
Southern blot analysis showed##4##4##(1992-8#1)(1997-4#1)(1997-8#1)(2008-9#1)
Southern blot analysis suggested the##3##5##(1993-2#1)(1997-6#1)(2008-11#1)
Southern blot analysis suggested##4##4##(1993-2#1)(1997-2#1)(1997-6#1)(2008-11#1)
Southern blot analysis to##3##4##(1994-10#1)(2008-2#1)(2008-4#1)
Southern blot analysis##33##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)
Southern blot hybridization analysis##2##4##(2008-10#2)
Southern blot hybridization with##3##4##(1990-7#1)(1997-2#1)(2008-10#1)
Southern blot hybridization##13##3##(1990-7#1)(1992-3#1)(1997-2#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)
Southern blot##66##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-6#2)(1995-8#3)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-12#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#4)
Southern blots of##2##3##(2008-10#2)
Southern blots##9##2##(1990-11#1)(1990-5#1)(1991-8#1)(1993-2#1)(1995-8#1)(2008-10#3)(2008-5#1)
Southern blotting analysis##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
Southern blotting indicated that the##2##5##(1992-9#1)(2008-10#1)
Southern blotting##11##2##(1992-9#1)(1994-12#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#2)
Southern hybridization analysis##3##3##(2008-10#3)
Southern hybridization and DNA sequencing##2##5##(1997-7#1)(2008-8#1)
Southern hybridization and##5##3##(1996-10#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
Southern hybridization to##3##3##(1992-6#1)(2008-5#1)(2008-8#1)
Southern hybridization using##3##3##(1996-12#2)(1996-6#1)
Southern hybridization##33##2##(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-8#6)(2008-9#2)
Southern wilt##2##2##(2008-10#2)
Southern##234##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-2#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#5)(1995-8#5)(1996-10#2)(1996-12#2)(1996-4#3)(1996-6#2)(1997-2#5)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#4)(2006-12#1)(2008-1#2)(2008-10#48)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#18)(2008-9#9)(2009-10#1)(2009-2#1)(2009-6#1)(2010-6#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#13)(2013-8#2)
Southern-blot##2##1##(1991-9#2)
Southwest Iran##2##2##(2008-12#2)
Southwest##10##1##(1995-12#1)(1995-6#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#2)(2013-8#1)
Southwestern Medical Center##2##3##(1990-11#2)
Southwestern histochemistry##2##2##(1997-2#2)
Southwestern##8##1##(1990-11#2)(1993-12#1)(1993-8#1)(1997-2#2)(1997-7#1)(2008-12#1)
Soviet Psychiatry##2##2##(1990-4#1)(2013-8#1)
Soviet Union##6##2##(1990-3#1)(1995-3#1)(1997-1#1)(2008-12#2)(2011-2#1)
Soviet##13##1##(1990-3#4)(1990-4#1)(1995-3#1)(1997-1#1)(1997-6#2)(2008-12#2)(2011-2#1)(2013-8#1)
Sowing##4##1##(2008-10#2)(2008-12#1)(2010-1#1)
Sox genes##2##2##(2008-8#2)
Sox##3##1##(2008-8#3)
Sox9##3##1##(2010-5#3)
Sox9a was##2##2##(2010-5#2)
Sox9a##6##1##(2010-5#6)
Soxhlet and hot hexane extractions##2##5##(2008-10#2)
Soxhlet extraction and##2##3##(2008-10#2)
Soxhlet extraction##11##2##(2008-10#10)(2013-1#1)
Soxhlet extractions##2##2##(2008-10#2)
Soxhlet##28##1##(2008-10#26)(2008-11#1)(2013-1#1)
Soy milk##2##2##(2013-1#2)
Soy##6##1##(1995-12#1)(1996-2#1)(2008-12#1)(2013-1#3)
Soybean (Glycine##3##2##(2008-10#2)(2010-11#1)
Soybean Belt##2##2##(2008-10#2)
Soybean Brown Stem Rot##3##4##(2008-10#3)
Soybean Plants##2##2##(2008-10#2)
Soybean lines##2##2##(2008-10#2)
Soybean mosaic virus (SMV)##4##4##(2008-10#4)
Soybean mosaic virus##8##3##(2008-10#8)
Soybean mosaic##9##2##(2008-10#9)
Soybean##50##1##(1992-8#1)(2008-10#42)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-3#1)(2012-2#1)
Soybeans##2##1##(2008-10#2)
Sp##6##1##(1990-8#1)(1995-8#1)(2009-3#4)
Sp1 binding sites##2##3##(1991-7#1)(1997-3#1)
Sp1 binding##4##2##(1991-6#1)(1991-7#1)(1992-3#1)(1997-3#1)
Sp1 in##2##2##(1993-3#1)(2013-1#1)
Sp1##20##1##(1990-11#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1994-6#1)(1997-3#2)(1997-8#2)(2013-1#4)
Sp1-binding##3##1##(1991-6#1)(1993-2#1)(1993-6#1)
Sp1-responsiveness##3##1##(1997-3#3)
Sp2/ O-Ag14##2##2##(2008-11#2)
Sp2/##3##1##(2008-11#3)
Sp2/0-Ag14##3##1##(2008-11#3)
Sp2/0-Ag14cells##2##1##(2008-11#2)
SpA in the##2##3##(1994-6#2)
SpA in##3##2##(1994-6#3)
SpA##4##1##(1994-6#4)
SpM##2##1##(1995-8#2)
SpStrongylocins##2##1##(2011-2#2)
Spa##3##1##(1991-12#1)(2008-4#1)(2008-5#1)
Space Agency##4##2##(2008-2#1)(2008-3#3)
Space Shuttle##2##2##(1996-12#2)
Space Station##2##2##(2008-3#1)(2012-3#1)
Space##30##1##(1990-11#1)(1990-8#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-9#1)(2008-2#3)(2008-3#14)(2008-5#1)(2011-2#1)(2012-3#3)(2013-1#1)
Space-variant Pancharatnam-Berry phase optical elements##2##5##(2007-11#2)
Space-variant##3##1##(2007-11#2)(2008-2#1)
Spaceborne##4##1##(2008-2#1)(2008-3#3)
Spacer##8##1##(2008-10#7)(2012-2#1)
Spacing##2##1##(1996-2#1)(1997-4#1)
Spain and the##3##3##(2008-10#2)(2011-1#1)
Spain and##15##2##(2008-10#10)(2008-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
Spain as##2##2##(2008-10#1)(2013-1#1)
Spain in##7##2##(2008-10#4)(2008-5#1)(2012-2#1)(2013-1#1)
Spain since the##2##3##(2008-10#1)(2011-2#1)
Spain since##3##2##(2008-10#2)(2011-2#1)
Spain to##2##2##(2008-8#1)(2013-1#1)
Spain##135##1##(1990-3#1)(1990-8#2)(1991-11#1)(1991-4#1)(1993-8#1)(1994-12#2)(1996-1#1)(1996-12#3)(1996-7#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#64)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#4)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#4)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#12)(2013-7#1)(2013-8#2)
Spain) and##2##2##(1996-12#1)(2008-10#1)
Spain)##22##1##(1996-12#1)(2008-10#13)(2008-5#4)(2010-5#1)(2011-2#2)(2013-1#1)
Spain]##8##1##(1990-3#1)(1991-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(2009-7#1)(2011-2#1)
Span 80 and##2##3##(2008-10#2)
Span##3##1##(2008-10#2)(2008-12#1)
Span80##2##1##(2008-11#2)
Spanco##2##1##(2008-10#2)
Spanish Basque##2##2##(2009-5#2)
Spanish DO##2##2##(2008-10#2)
Spanish Society##2##2##(1993-5#1)(1994-12#1)
Spanish X##2##2##(2008-10#2)
Spanish isolates##5##2##(2008-10#5)
Spanish language##3##2##(1995-2#1)(2009-5#2)
Spanish market##3##2##(2008-10#3)
Spanish oak##2##2##(2008-10#2)
Spanish patients##2##2##(2008-5#2)
Spanish population##5##2##(1990-9#2)(1997-5#1)(2008-10#1)(2013-1#1)
Spanish populations##2##2##(2008-10#1)(2008-12#1)
Spanish speakers who stutter##2##4##(2008-2#2)
Spanish speakers##4##2##(1995-12#1)(2008-2#2)(2011-2#1)
Spanish strains##2##2##(2008-10#1)(2008-5#1)
Spanish##101##1##(1990-8#1)(1990-9#2)(1993-12#2)(1993-5#2)(1994-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-5#1)(1997-6#2)(2007-10#1)(2008-10#36)(2008-11#4)(2008-12#3)(2008-2#7)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#7)(2009-5#4)(2011-1#4)(2011-2#5)(2012-12#1)(2013-1#5)(2013-8#2)
Spanish)##2##1##(2007-10#1)(2012-12#1)
Spanish-speaking##5##1##(2010-8#1)(2011-2#2)(2013-8#2)
Sparfloxacin##2##1##(2007-7#1)(2008-7#1)
Sparrow##2##1##(2007-12#1)(2008-3#1)
Sparse##2##1##(2008-3#2)
Sparsity##3##1##(2008-3#2)(2010-7#1)
Sparus aurata##4##2##(2008-7#2)(2009-5#2)
Sparus##6##1##(2008-7#2)(2009-5#2)(2010-8#2)
Spathiphyllum##2##1##(2008-10#2)
Spatial Analysis##2##2##(2008-10#2)
Spatial Distribution of##2##3##(2008-10#2)
Spatial Light Modulator##3##3##(2008-2#3)
Spatial Patterns of##5##3##(2008-10#5)
Spatial analyses##3##2##(2008-10#3)
Spatial analysis of the##2##4##(2008-10#2)
Spatial analysis of##4##3##(2008-10#4)
Spatial analysis##5##2##(2008-10#5)
Spatial and temporal distribution of##2##5##(2008-10#2)
Spatial and temporal variations##2##4##(2008-5#1)(2008-6#1)
Spatial and temporal##14##3##(1992-9#1)(2007-12#1)(2008-10#9)(2008-5#1)(2008-6#1)(2011-2#1)
Spatial and##16##2##(1992-9#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-6#1)(2011-2#1)
Spatial autocorrelation analysis of proximity patterns suggested that aggregation often existed among quadrats of various sizes up to##2##18##(2008-10#2)
Spatial autocorrelation analysis##3##3##(2008-10#3)
Spatial autocorrelation##5##2##(2008-10#5)
Spatial beam cleanup of a##2##5##(2008-2#2)
Spatial beam##3##2##(2008-2#2)(2008-3#1)
Spatial coherence##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
Spatial development of##2##3##(2008-11#2)
Spatial distribution of##4##3##(1992-3#1)(2008-3#2)(2013-8#1)
Spatial distribution##6##2##(1992-3#1)(2007-5#1)(2008-10#1)(2008-3#2)(2013-8#1)
Spatial heterogeneity##2##2##(2008-8#2)
Spatial learning##2##2##(1993-3#1)(1996-2#1)
Spatial light modulation##2##3##(2007-12#2)
Spatial light##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Spatial mode control of a diode-pumped Nd##2##7##(2007-12#2)
Spatial pattern analysis of##3##4##(2008-10#3)
Spatial pattern of##2##3##(2008-10#1)(2008-3#1)
Spatial pattern##6##2##(2008-10#5)(2008-3#1)
Spatial patterns of##4##3##(2008-10#4)
Spatial patterns##7##2##(2007-12#1)(2008-10#5)(2012-2#1)
Spatial phase##2##2##(1996-2#1)(2008-3#1)
Spatial sampling##3##2##(2008-10#2)(2008-3#1)
Spatial soliton##2##2##(2007-11#1)(2008-3#1)
Spatial variation in##2##3##(2008-8#1)(2013-1#1)
Spatial##144##1##(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#2)(1996-5#1)(2007-11#9)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#59)(2008-11#3)(2008-2#9)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
Spatially resolved##6##2##(1994-11#1)(1995-3#1)(1997-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
Spatially##14##1##(1994-11#1)(1995-3#1)(1997-6#1)(2007-11#2)(2008-2#3)(2008-3#4)(2009-5#1)(2012-2#1)
Spatiotemporal Genetic Structure of Phytophthora capsici in Michigan##2##8##(2008-10#2)
Spatiotemporal analyses##2##2##(2008-10#2)
Spatiotemporal dynamics of##2##3##(2008-11#1)(2013-8#1)
Spatiotemporal##24##1##(1993-5#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#3)(2009-8#1)(2013-8#2)
Spawning##5##1##(2008-12#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-7#1)
SpeI##2##1##(2008-10#1)(2008-5#1)
Speak##3##1##(2009-7#2)(2012-2#1)
Speaker's Corner##3##2##(2008-8#3)
Speakers##6##1##(2008-2#2)(2008-7#2)(2010-5#1)(2011-2#1)
Spearman correlation##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
Spearman rank correlation##2##3##(2008-10#1)(2008-7#1)
Spearman rank##3##2##(2008-10#2)(2008-7#1)
Spearman##9##1##(2007-11#1)(2008-10#3)(2008-4#1)(2008-7#2)(2011-2#1)(2013-7#1)
Spearman's correlation##2##2##(2009-11#1)(2009-7#1)
Spearman's##5##1##(2007-11#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)
Special Health##3##2##(1994-3#1)(1995-12#1)(2013-1#1)
Special Issue##3##2##(2008-11#1)(2011-2#1)(2012-1#1)
Special attention has been##3##4##(1991-2#1)(1991-3#1)(1993-12#1)
Special attention is devoted to##2##5##(1995-5#1)(2008-10#1)
Special attention is given to the##3##6##(1991-6#1)(1992-3#1)(1997-4#1)
Special attention is given to##5##5##(1991-6#1)(1992-3#1)(1997-4#1)(1997-8#1)(2008-10#1)
Special attention is paid to the##4##6##(1991-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
Special attention is paid to##5##5##(1991-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
Special attention is##13##3##(1991-5#1)(1991-6#1)(1992-3#1)(1995-5#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)
Special attention must be paid to##2##6##(1993-6#1)(2010-11#1)
Special attention was paid to##2##5##(1992-6#1)(2008-10#1)
Special attention was##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
Special attention##22##2##(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-5#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)
Special considerations in the##2##4##(1991-2#1)(2010-6#1)
Special emphasis is given to##2##5##(1997-6#1)(2008-6#1)
Special emphasis is placed on##3##5##(1992-1#1)(2007-12#1)(2008-9#1)
Special emphasis is##8##3##(1992-1#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
Special emphasis##9##2##(1992-1#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
Special features of the##2##4##(1991-3#1)(2008-11#1)
Special issue dedicated to Professor##2##5##(1990-8#1)(2012-3#1)
Special issue dedicated to##4##4##(1990-8#1)(2008-7#1)(2009-4#1)(2012-3#1)
Special issue in##2##3##(1992-5#1)(2011-2#1)
Special issue##11##2##(1990-8#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)
Special programs##2##2##(1994-1#1)(1996-12#1)
Special##110##1##(1990-11#1)(1990-8#1)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#1)(1992-1#2)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#3)
Special'##2##1##(2008-10#1)(2011-1#1)
Specialist##5##1##(1994-9#1)(2007-10#1)(2007-11#1)(2008-4#1)(2012-2#1)
Specialists##3##1##(1996-1#1)(2008-9#1)(2011-2#1)
Specialization##3##1##(2008-10#2)(2008-7#1)
Specialized##6##1##(1992-1#1)(1995-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
Specially##4##1##(2007-11#1)(2008-10#2)(2008-3#1)
Specialty##3##1##(1996-3#1)(1997-1#1)(2011-2#1)
Speciation analysis of##2##3##(2008-10#2)
Speciation and##2##2##(2008-10#1)(2013-1#1)
Speciation of arsenic in##3##4##(2008-10#3)
Speciation of arsenic##5##3##(2008-10#5)
Speciation of inorganic selenium##2##4##(2008-10#2)
Speciation of inorganic##3##3##(2008-10#3)
Speciation of iron in##2##4##(2008-10#2)
Speciation of mercury in salmon egg cell cytoplasm##2##8##(2008-10#2)
Speciation of vanadium in##2##4##(2008-10#2)
Speciation of##24##2##(2008-10#23)(2008-11#1)
Speciation studies##2##2##(2008-10#2)
Speciation##34##1##(2008-10#31)(2008-11#1)(2008-8#1)(2013-1#1)
Species Belonging to##2##3##(2008-10#2)
Species Causing##2##2##(2008-10#2)
Species Complex##4##2##(2007-12#1)(2008-10#3)
Species and##9##2##(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-5#1)(2013-8#1)
Species diversity of##2##3##(2011-2#1)(2013-7#1)
Species diversity##4##2##(2008-5#2)(2011-2#1)(2013-7#1)
Species formed are ALH(r)##2##4##(2008-10#2)
Species formed##3##2##(2008-10#3)
Species from##2##2##(2008-10#1)(2013-8#1)
Species in##2##2##(2008-10#2)
Species of the Genus Tospovirus##2##5##(2008-10#2)
Species of the##4##3##(2008-10#3)(2008-6#1)
Species of##8##2##(2008-10#5)(2008-5#2)(2008-6#1)
Species richness and##2##3##(2008-8#2)
Species richness is##2##3##(2008-8#2)
Species richness##6##2##(2008-5#1)(2008-8#5)
Species variants of##2##3##(1991-5#1)(1997-2#1)
Species with##3##2##(2008-10#1)(2010-3#1)(2010-8#1)
Species##103##1##(1991-5#2)(1995-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#50)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-8#9)(2008-9#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#2)
Species-Specific Polymerase Chain Reaction##2##4##(2008-10#2)
Species-Specific##6##1##(2008-10#6)
Species-area curves##2##2##(2008-8#2)
Species-specific primer analysis was reliable##2##5##(2008-10#2)
Species-specific##7##1##(2008-10#7)
Specific IgE##2##2##(1995-11#2)
Specific Language Impairment##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
Specific Polymerase Chain Reaction##2##4##(2008-10#2)
Specific Polymerase Chain##3##3##(2008-10#3)
Specific activity of##3##3##(1994-12#1)(2008-7#1)(2012-2#1)
Specific and##3##2##(1991-12#1)(1995-12#1)(2008-10#1)
Specific binding of##6##3##(1991-2#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)
Specific binding##10##2##(1990-8#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-11#1)
Specific details for the expression##2##5##(2008-4#2)
Specific details##3##2##(2008-4#3)
Specific detection of##2##3##(2008-10#2)
Specific determination of##2##3##(2008-10#2)
Specific examples are##2##3##(2008-2#1)(2008-7#1)
Specific examples of##3##3##(1994-12#1)(2008-10#1)(2010-11#1)
Specific examples##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-11#1)
Specific growth##2##2##(1992-9#1)(2008-11#1)
Specific immunotherapy (SIT)##2##3##(2011-2#2)
Specific inhibition of##2##3##(1994-11#1)(1995-2#1)
Specific interaction of##2##3##(1993-3#1)(1993-8#1)
Specific interaction##3##2##(1993-3#1)(1993-8#1)(2008-10#1)
Specific issues##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
Specific monoclonal antibodies##2##3##(1992-9#1)(2008-10#1)
Specific primers and##2##3##(2008-10#1)(2010-4#1)
Specific productivity was##2##3##(2008-11#2)
Specific productivity##4##2##(2008-11#4)
Specific protocols for the##2##4##(2008-4#2)
Specific receptors for##2##3##(1993-3#1)(1995-12#1)
Specific sequences in RNA preparations can be detected by blotting and hybridization analysis using techniques very similar to those originally developed for DNA##2##23##(2008-4#2)
Specific##181##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-12#3)(2007-2#2)(2008-10#39)(2008-11#14)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#8)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#1)(2013-8#1)
Specifically##117##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-9#4)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
Specificity in##2##2##(2008-10#1)(2008-11#1)
Specificity of the##5##3##(1994-2#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#1)
Specificity of##20##2##(1991-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2010-12#1)
Specificity was##3##2##(1990-10#1)(2007-2#1)(2008-10#1)
Specificity##32##1##(1990-10#1)(1991-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(2007-12#1)(2007-2#1)(2008-10#17)(2008-11#3)(2008-3#1)(2010-12#1)(2011-3#1)(2013-1#1)
Specimens are##2##2##(2007-5#2)
Specimens of##2##2##(2008-5#1)(2013-7#1)
Specimens were subjected to##2##4##(2009-7#1)(2011-2#1)
Specimens were##4##2##(2008-12#1)(2009-3#1)(2009-7#1)(2011-2#1)
Specimens##12##1##(1993-8#1)(2007-5#2)(2008-12#1)(2008-5#1)(2009-3#1)(2009-7#2)(2011-2#2)(2013-1#1)(2013-7#1)
Speckle interferometry with temporal phase evaluation##2##6##(2008-2#2)
Speckle interferometry##3##2##(2008-2#2)(2008-3#1)
Speckle##14##1##(2008-2#7)(2008-3#4)(2008-8#1)(2010-11#2)
Spectacor##4##1##(1995-6#4)
Spectator##3##1##(1997-7#1)(2008-11#2)
Spectra Optia##6##2##(2011-2#6)
Spectra for##2##2##(1996-2#1)(2008-10#1)
Spectra of##10##2##(1990-11#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-3#2)
Spectra were acquired##2##3##(2007-11#1)(2008-10#1)
Spectra were##4##2##(2007-11#1)(2008-10#3)
Spectra with##2##2##(2008-3#1)(2012-2#1)
Spectra##33##1##(1990-11#1)(1996-2#2)(1997-7#2)(2007-11#3)(2008-10#8)(2008-2#3)(2008-3#5)(2008-7#1)(2011-2#6)(2012-2#1)(2013-8#1)
Spectral analysis##3##2##(1990-11#1)(1992-6#1)(2012-2#1)
Spectral and temporal features were##2##5##(2007-12#1)(2008-3#1)
Spectral changes##3##2##(1992-3#2)(1994-5#1)
Spectral characteristics##2##2##(2008-10#2)
Spectral characterization of##2##3##(2007-11#1)(2008-10#1)
Spectral data were##2##3##(2008-10#1)(2008-6#1)
Spectral domain##2##2##(2007-12#1)(2009-3#1)
Spectral hole##2##2##(2007-11#2)
Spectral phase##2##2##(2007-12#2)
Spectral transmission##2##2##(2008-3#2)
Spectral##52##1##(1990-11#1)(1992-3#2)(1992-6#1)(1994-5#1)(1994-6#1)(2007-11#8)(2007-12#6)(2007-5#1)(2008-10#6)(2008-2#7)(2008-3#13)(2008-6#2)(2008-9#1)(2009-3#1)(2012-2#1)
Spectrally##2##1##(2007-11#1)(2007-12#1)
Spectralon panels##2##2##(2008-2#1)(2008-3#1)
Spectralon##8##1##(2008-2#5)(2008-3#3)
Spectrin##2##1##(1990-5#1)(2011-2#1)
Spectrochemical##3##1##(2008-10#2)(2010-2#1)
Spectrofluorimetric determination of##12##3##(2008-10#12)
Spectrofluorimetric study of the##3##4##(2008-10#3)
Spectrofluorimetric##19##1##(2008-10#19)
Spectrofluorometric##2##1##(2008-10#2)
Spectrofluorometry##2##1##(2013-8#2)
Spectrograph##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
Spectrometer##20##1##(2008-10#1)(2008-2#3)(2008-3#16)
Spectrometric##2##1##(2008-10#2)
Spectrometry##17##1##(1990-5#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-8#1)
Spectromètre à Diodes Laser Accordables (SDLA)##2##6##(2008-3#2)
Spectromètre à Diodes Laser Accordables##3##5##(2008-3#3)
Spectrophotometer##2##1##(2008-3#1)(2010-6#1)
Spectrophotometric and##2##2##(2008-10#2)
Spectrophotometric determination of iron##2##4##(2008-10#2)
Spectrophotometric determination of lead in##4##5##(2008-10#4)
Spectrophotometric determination of molybdenum based on charge transfer##2##8##(2008-10#2)
Spectrophotometric determination of molybdenum##3##4##(2008-10#3)
Spectrophotometric determination of nitrite##2##4##(2008-10#2)
Spectrophotometric determination of protein concentration##2##5##(2008-1#1)(2008-4#1)
Spectrophotometric determination of trace##3##4##(2008-10#3)
Spectrophotometric determination of##55##3##(2008-1#1)(2008-10#53)(2008-4#1)
Spectrophotometric flow-injection determination of##3##4##(2008-10#3)
Spectrophotometric flow-injection##4##2##(2008-10#4)
Spectrophotometric method for determination##2##4##(2008-10#2)
Spectrophotometric methods##3##2##(2008-10#3)
Spectrophotometric studies##2##2##(2008-10#2)
Spectrophotometric study of the##3##4##(2008-10#3)
Spectrophotometric study of##5##3##(2008-10#5)
Spectrophotometric study##6##2##(2008-10#6)
Spectrophotometric##87##1##(1990-2#1)(2008-1#1)(2008-10#81)(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)
Spectrosc##4##1##(1992-6#1)(2008-10#2)(2008-2#1)
Spectroscopic analysis of##5##3##(2008-10#4)(2008-2#1)
Spectroscopic analysis##6##2##(2008-10#4)(2008-2#1)(2008-9#1)
Spectroscopic and##5##2##(1991-12#1)(1992-12#1)(1997-7#1)(2008-10#2)
Spectroscopic ellipsometry##2##2##(2008-2#2)
Spectroscopic properties of the##2##4##(2008-10#1)(2008-3#1)
Spectroscopic properties of these##2##4##(1996-5#1)(2009-5#1)
Spectroscopic properties of##4##3##(1996-5#1)(2008-10#1)(2008-3#1)(2009-5#1)
Spectroscopic studies of##2##3##(1995-6#1)(2008-3#1)
Spectroscopic studies##5##2##(1990-2#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-3#1)
Spectroscopic techniques##2##2##(2008-10#2)
Spectroscopic##45##1##(1990-2#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-5#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#14)(2008-2#4)(2008-3#9)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-8#3)
Spectroscopy and##4##2##(2008-2#2)(2009-9#2)
Spectroscopy of##6##2##(1996-12#1)(1996-9#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-1#1)
Spectroscopy##37##1##(1992-3#1)(1996-12#1)(1996-2#2)(1996-9#2)(2007-1#1)(2008-10#5)(2008-11#2)(2008-2#8)(2008-3#4)(2008-7#1)(2009-12#1)(2009-9#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-8#2)
Spectrum Disorders##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
Spectrum of##11##2##(1991-11#1)(1996-2#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-7#1)(2012-2#1)
Spectrum##18##1##(1991-11#1)(1996-2#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-7#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
Specular microscopy##2##2##(2011-2#2)
Speech and##2##2##(2007-8#1)(2012-3#1)
Speech perception in##2##3##(2008-9#2)
Speech perception##4##2##(2008-9#4)
Speech understanding##2##2##(2007-7#1)(2008-9#1)
Speech##19##1##(1991-11#1)(1996-3#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-9#11)(2011-1#1)(2012-3#2)
Speed of##2##2##(2008-12#1)(2009-12#1)
Speed##5##1##(2008-12#1)(2008-3#1)(2009-12#1)(2009-3#1)(2012-12#1)
Spencer##2##1##(2008-10#1)(2012-2#1)
Spending##2##1##(1991-2#1)(1992-12#1)
Spent##2##1##(2008-10#1)(2010-4#1)
Sperm competition##2##2##(2008-8#1)(2013-1#1)
Sperm motility##3##2##(2008-12#2)(2008-7#1)
Sperm##19##1##(1997-4#1)(2007-12#1)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Spermatogenesis and##2##2##(2009-10#1)(2012-2#1)
Spermatogenesis is a complex##2##4##(2009-10#2)
Spermatogenesis is a##4##3##(2009-10#3)(2012-2#1)
Spermatogenesis##8##1##(2008-5#1)(2009-10#5)(2012-2#2)
Spermine##4##1##(1990-7#1)(1991-5#1)(1994-11#1)(1996-2#1)
Spermiogenesis in##2##2##(2008-7#2)
Speron-Thiol resin##2##2##(2008-10#2)
Sphaeropsis sapinea##4##2##(2008-10#4)
Sphaeropsis##5##1##(2008-10#5)
Sphagnum##4##1##(2008-10#3)(2008-9#1)
Sphenodon punctatus##2##2##(2010-3#2)
Spherical aberration##3##2##(2008-2#3)
Spherical##12##1##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2010-11#1)(2012-6#1)
Sphingomonas##3##1##(1994-6#2)(2011-2#1)
Sphingosine##3##1##(1992-11#2)(1994-10#1)
Sphyraena ensis##2##2##(2012-2#2)
Spider##2##1##(2008-8#1)(2012-2#1)
Spiders##2##1##(2008-9#1)(2009-9#1)
Spike recovery##2##2##(2008-10#2)
Spike##5##1##(2008-1#1)(2008-10#4)
Spiked samples##2##2##(2008-10#2)
Spiked##4##1##(2008-10#4)
Spikelet##2##1##(2008-12#1)(2008-5#1)
Spikes##4##1##(2008-10#2)(2008-11#1)(2010-8#1)
Spilocaea##2##1##(2008-10#2)
Spin qubits##2##2##(2008-7#2)
Spin##9##1##(1992-11#1)(1996-12#1)(1996-9#3)(1997-7#1)(2008-10#1)(2008-7#2)
Spinach curly top virus##2##4##(2008-10#2)
Spinach##7##1##(2008-10#5)(2008-4#1)(2008-8#1)
Spinal Cord Arteriovenous Malformations##2##4##(1995-11#1)(1997-6#1)
Spinal Cord Injury##5##3##(1992-6#1)(2008-11#1)(2009-6#1)(2010-2#1)(2013-8#1)
Spinal Cord##9##2##(1992-6#1)(1995-11#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-2#1)(2013-8#1)
Spinal Fusion##2##2##(2012-3#2)
Spinal Surgery##2##2##(2011-2#1)(2012-3#1)
Spinal arteriovenous##2##2##(2008-7#1)(2013-1#1)
Spinal cord##7##2##(1993-9#1)(2007-11#2)(2008-12#1)(2008-7#1)(2009-3#1)(2012-1#1)
Spinal epidural abscess##2##3##(2011-2#2)
Spinal##46##1##(1991-1#1)(1992-6#1)(1993-9#1)(1995-11#2)(1996-12#1)(1997-6#2)(2007-11#5)(2007-8#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#1)
Spindle##2##1##(1990-12#1)(2011-2#1)
Spine Surgery##4##2##(2007-11#1)(2012-2#2)(2012-3#1)
Spine surgery##2##2##(2007-8#1)(2012-2#1)
Spine##14##1##(2007-11#5)(2007-8#1)(2008-12#2)(2012-12#1)(2012-2#3)(2012-3#2)
Spiral CT##2##2##(2012-2#1)(2012-3#1)
Spiral##10##1##(1991-11#3)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
Spirit##2##1##(1993-12#1)(1997-2#1)
Spiritual##11##1##(1991-12#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-11#1)(2013-1#2)(2013-8#1)
Spirituality and##3##2##(2008-4#1)(2009-10#1)(2010-10#1)
Spirituality as##2##2##(2008-12#2)
Spirituality##10##1##(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#4)(2009-10#1)(2010-10#1)
Spiro##2##1##(1996-5#1)(2011-1#1)
Spirochaeta smaragdinae##2##2##(2011-2#2)
Spirochaeta##4##1##(2011-2#2)(2013-8#2)
Spirochaetaceae##4##1##(2011-2#3)(2013-8#1)
Spirochaetales##3##1##(2008-9#1)(2013-8#2)
Spirochaetes or its different##2##4##(2013-8#2)
Spirochaetes##8##1##(2013-8#8)
Spirometric##3##1##(1996-3#1)(2011-2#1)(2012-12#1)
Spirometry##4##1##(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
Spiroplasma citri##8##2##(2008-10#8)
Spiroplasma##9##1##(2008-10#9)
Spirosoma linguale##2##2##(2011-2#2)
Spirulina platensis##4##2##(2008-10#1)(2008-8#3)
Splash Dispersal of##3##3##(2008-10#3)
Splash##5##1##(2008-10#5)
Spleen##6##1##(1992-9#1)(1994-5#1)(2008-11#3)(2008-7#1)
Splenectomized##2##1##(1994-9#2)
Splenectomy##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
Splenic epidermoid cyst##2##3##(2008-7#2)
Splenic metastasis of colon cancer is##2##6##(2007-8#2)
Splenic metastasis##4##2##(2007-8#2)(2011-2#2)
Splenic##14##1##(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2011-2#4)(2013-1#2)
Splenocytes##2##1##(2008-10#1)(2008-8#1)
Splicing of##3##2##(1993-11#1)(1995-8#1)(1997-7#1)
Splicing##4##1##(1993-11#1)(1995-8#1)(1997-3#1)(1997-7#1)
Split##7##1##(1992-5#1)(2007-4#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Spodoptera frugiperda (Sf-9)##2##3##(1997-4#1)(2008-11#1)
Spodoptera frugiperda (Sf9) cell culture##2##5##(2008-11#2)
Spodoptera frugiperda (Sf9)##6##3##(1992-3#1)(2008-11#4)(2008-7#1)
Spodoptera frugiperda Sf-9 and Trichoplusia ni BTI-Tn-5B1-4 (High##2##8##(2008-7#2)
Spodoptera frugiperda Sf-9##3##3##(2008-7#3)
Spodoptera frugiperda##22##2##(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-4#2)(2008-11#11)(2008-7#4)
Spodoptera littoralis (Lepidoptera##2##3##(2008-10#1)(2008-12#1)
Spodoptera littoralis##7##2##(2008-10#1)(2008-12#2)(2010-10#2)(2013-8#2)
Spodoptera litura##3##2##(1997-4#2)(2008-11#1)
Spodoptera##33##1##(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-4#4)(2008-10#1)(2008-11#12)(2008-12#2)(2008-7#5)(2010-10#2)(2013-8#2)
Spondyloarthritis is a##2##3##(2010-12#1)(2012-12#1)
Spondyloarthritis##3##1##(2010-12#1)(2011-2#1)(2012-12#1)
Spondylus americanus##2##2##(2008-5#2)
Sponges##2##1##(2008-5#1)(2011-2#1)
Spongospora subterranea f##2##3##(2008-10#2)
Spontaneous activity##3##2##(2008-11#2)(2013-8#1)
Spontaneous and##2##2##(1991-9#1)(1992-6#1)
Spontaneous bacterial peritonitis##2##3##(2009-8#2)
Spontaneous bilateral##2##2##(2009-9#1)(2010-11#1)
Spontaneous calcium oscillations in##2##4##(1993-5#1)(1994-11#1)
Spontaneous intraorbital hematoma##2##3##(2011-2#2)
Spontaneous pneumothorax in##2##3##(2006-10#1)(2012-3#1)
Spontaneous pneumothorax##3##2##(2006-10#2)(2012-3#1)
Spontaneous rupture of##2##3##(1992-2#1)(2007-2#1)
Spontaneous thrombosis##2##2##(1996-9#1)(2012-12#1)
Spontaneous##67##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-9#2)(1992-2#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-9#2)(2006-10#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
Sporangia from##2##2##(2008-10#2)
Sporangia##12##1##(2008-10#12)
Spore Germination##2##2##(2008-10#2)
Spore deposition##2##2##(2008-10#2)
Spore germination##2##2##(2008-10#1)(2011-2#1)
Spore shape and##2##3##(2008-10#1)(2010-3#1)
Spore##17##1##(2008-10#15)(2010-3#1)(2011-2#1)
Spores of##7##2##(2008-10#5)(2011-2#2)
Spores produced at##2##3##(2011-2#2)
Spores were##2##2##(2008-10#2)
Spores##20##1##(2008-10#11)(2010-1#1)(2010-10#1)(2011-2#7)
Sporisorium reilianum f##2##3##(2008-10#2)
Sporothrix schenckii##2##2##(2008-5#1)(2012-3#1)
Sport##4##1##(2008-10#1)(2008-12#1)(2009-7#1)(2010-6#1)
Sports##13##1##(1993-3#2)(1996-6#3)(1996-8#1)(2008-11#1)(2008-5#2)(2010-1#2)(2012-3#2)
Sporulation of Bremia lactucae##2##4##(2008-10#2)
Sporulation of##9##2##(2008-10#9)
Sporulation was##3##2##(2008-10#3)
Sporulation##20##1##(2007-5#1)(2008-10#17)(2011-2#1)(2012-2#1)
Spot Pathogen##2##2##(2008-10#2)
Spot Severity##2##2##(2008-10#2)
Spot of##13##2##(2008-10#13)
Spot##36##1##(1997-4#1)(2008-10#32)(2009-7#1)(2012-3#1)(2013-8#1)
Spotfire to##2##2##(2008-4#1)(2013-1#1)
Spotfire##10##1##(2008-4#9)(2013-1#1)
Spotted##5##1##(1995-12#1)(2008-10#4)
Spr3##7##1##(2009-10#7)
Sprague Dawley rats were##3##4##(2008-12#1)(2011-1#1)(2012-2#1)
Sprague Dawley rats##7##3##(1991-12#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
Sprague Dawley##10##2##(1991-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Sprague-Dawley (S-D)##2##2##(1995-3#1)(2008-11#1)
Sprague-Dawley (SD) rats##2##3##(1993-12#1)(1996-12#1)
Sprague-Dawley (SD)##3##2##(1993-12#1)(1996-12#1)(1996-5#1)
Sprague-Dawley male rats##2##3##(2007-11#1)(2009-12#1)
Sprague-Dawley rat animal model##2##4##(2008-2#2)
Sprague-Dawley rat##6##2##(1992-5#1)(1993-8#1)(2008-10#1)(2008-2#2)(2008-8#1)
Sprague-Dawley rats as##2##3##(1996-12#1)(1996-7#1)
Sprague-Dawley rats at##2##3##(1996-2#1)(2010-1#1)
Sprague-Dawley rats had##2##3##(1996-5#1)(2008-7#1)
Sprague-Dawley rats received##2##3##(2011-2#1)(2012-7#1)
Sprague-Dawley rats were used##2##4##(1993-3#1)(2008-2#1)
Sprague-Dawley rats were##10##3##(1993-12#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2013-1#2)
Sprague-Dawley rats##40##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-11#2)(1993-12#2)(1993-3#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-10#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#5)(2009-8#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-7#1)(2013-1#2)
Sprague-Dawley##57##1##(1990-5#1)(1991-12#1)(1991-9#1)(1992-11#2)(1992-5#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-7#5)(2008-8#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-7#1)(2013-1#2)
Spray inoculation##2##2##(2008-10#2)
Spray##4##1##(2008-10#2)(2013-1#2)
Spraying a##2##2##(2008-10#2)
Spraying##3##1##(2008-10#3)
Spread and##2##2##(2008-10#2)
Spread of Tomato spotted wilt virus##2##6##(2008-10#2)
Spread of endosepsis##2##3##(2008-10#2)
Spread of##21##2##(2008-10#19)(2009-5#1)(2013-1#1)
Spread##28##1##(2008-10#25)(2009-5#1)(2010-8#1)(2013-1#1)
Spring barley##2##2##(2008-12#2)
Spring##21##1##(1994-3#1)(1995-3#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#2)
Springer-Verlag##4##1##(1990-11#1)(1990-3#1)(1990-8#1)(2008-11#1)
Spunta##2##1##(2008-10#2)
Sputum##3##1##(2008-3#1)(2013-1#2)
Spătaru##2##1##(2008-10#2)
SqVYV##4##1##(2008-10#4)
Squamata##2##1##(2010-3#2)
Squamometry##6##1##(2008-5#6)
Squamous Cell Carcinomas##2##3##(2010-8#1)(2013-1#1)
Squamous Cell##3##2##(1996-9#1)(2010-8#1)(2013-1#1)
Squamous cell carcinoma##5##3##(2007-10#1)(2007-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
Squamous cell neoplasms at the site of application were associated with dermal application of##2##14##(2008-9#2)
Squamous cell##8##2##(2007-10#1)(2007-8#1)(2008-9#3)(2012-3#1)(2013-1#1)(2013-8#1)
Squamous##16##1##(1993-8#1)(1994-8#1)(1996-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-9#3)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Square wave voltammetry##3##3##(2008-10#3)
Square wave##6##2##(2008-10#6)
Square##11##1##(2008-10#7)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
Square-wave voltammetry##2##2##(2008-10#2)
Square-wave##6##1##(2008-10#6)
Squash leaf curl##3##3##(2008-10#3)
Squash##5##1##(2008-10#5)
Squeezing the##2##2##(1996-2#1)(2008-10#1)
Squeezing##3##1##(1990-4#1)(1996-2#1)(2008-10#1)
Squibb)##2##1##(1991-2#1)(2008-9#1)
Sr and Zn##2##3##(2008-10#1)(2012-2#1)
Sr and##3##2##(2008-10#2)(2012-2#1)
Sr in##2##2##(2008-10#2)
Sr##31##1##(1995-6#1)(2007-11#1)(2008-10#21)(2008-12#1)(2009-11#1)(2010-3#1)(2012-2#4)(2013-8#1)
Sr(2+)##6##1##(2008-10#6)
Sr(2+)&gt##3##1##(2008-10#3)
Sr(5)(PO(4))(3)F at##2##2##(2007-12#1)(2008-3#1)
Sr(5)(PO(4))(3)F##5##1##(2007-12#2)(2008-3#3)
Sr(II)##2##1##(2008-10#2)
Sr-89 therapy was##2##3##(2007-11#2)
Sr9b##2##1##(2008-10#2)
SrBi(2)Ta(2)O(9)##2##1##(2007-12#2)
SrSRI##5##1##(2009-8#5)
SrTiO(3) overlayer##2##2##(2008-3#2)
SrTiO(3) substrate samples##2##3##(2008-3#2)
SrTiO(3)##5##1##(2008-3#5)
Src activates Abl to##2##4##(2011-2#2)
Src and Abl##3##3##(2011-2#3)
Src and##8##2##(1995-6#2)(2011-2#3)(2012-12#2)(2013-1#1)
Src family kinases##4##3##(1995-11#1)(1995-6#3)
Src family##5##2##(1995-11#1)(1995-6#3)(2012-12#1)
Src inhibitors##3##2##(2012-3#3)
Src is a##2##3##(2012-12#1)(2012-3#1)
Src kinase##2##2##(2011-1#1)(2013-1#1)
Src regulates##2##2##(2012-12#1)(2012-3#1)
Src##54##1##(1994-8#1)(1995-11#4)(1995-6#13)(1996-2#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-1#8)(2011-2#7)(2012-12#8)(2012-3#6)(2013-1#3)
Src-phosphorylated EGF-R##2##2##(1995-6#2)
Sri Lanka and##2##3##(2007-5#1)(2012-12#1)
Sri Lanka##9##2##(1994-3#1)(2007-5#2)(2008-10#4)(2011-2#1)(2012-12#1)
Sri##18##1##(1994-3#1)(2007-5#2)(2008-10#13)(2011-2#1)(2012-12#1)
Srinagar##2##1##(2013-8#2)
Srinagarind Hospital##3##2##(2011-2#3)
Ss275##3##1##(2008-10#3)
SsEno##4##1##(2009-6#4)
Ssa20##2##1##(2008-11#2)
Ssh12##5##1##(2008-9#5)
Ssh7 binds##2##2##(2008-9#2)
Ssh7 proteins##3##2##(2008-9#3)
Ssh7##9##1##(2008-9#9)
Sso protein##2##2##(1997-3#2)
Sso##3##1##(1997-3#3)
SspI##2##1##(1997-3#2)
St Thomas'##2##2##(2007-8#2)
St chromosomes##2##2##(2008-9#2)
St##68##1##(1990-6#1)(1991-2#1)(1991-3#3)(1991-9#2)(1992-1#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-5#1)(1994-1#2)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#2)(2013-8#2)
St-A1c##3##1##(1990-8#3)
StAR##3##1##(1995-12#2)(2008-4#1)
Stabilisation of##2##2##(2008-10#2)
Stability and##4##2##(1992-5#1)(1995-3#1)(2009-9#2)
Stability constants##4##2##(2008-10#4)
Stability is##2##2##(2008-10#1)(2008-6#1)
Stability of a##3##3##(1996-12#1)(2007-12#1)(2008-10#1)
Stability of the##4##3##(2008-10#3)(2013-1#1)
Stability of##24##2##(1990-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-2#3)(2013-1#1)
Stability studies##3##2##(1995-6#2)(2008-10#1)
Stability##50##1##(1990-3#1)(1990-9#1)(1992-5#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#3)(2010-12#2)(2010-8#1)(2012-2#3)(2013-1#1)
Stabilization of the##3##3##(1993-8#1)(2008-10#1)(2012-2#1)
Stabilization of##11##2##(1993-8#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
Stabilization##18##1##(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-2#1)
Stabilized##5##1##(1996-2#2)(1997-7#1)(2008-3#1)(2009-6#1)
Stable Isotope##2##2##(2008-11#1)(2012-12#1)
Stable and##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
Stable expression of##5##3##(1994-9#1)(1995-6#1)(2008-11#3)
Stable expression##6##2##(1994-9#1)(1995-6#1)(2008-11#4)
Stable isotope##2##2##(1991-5#1)(2012-9#1)
Stable operation##2##2##(2007-12#1)(2008-3#1)
Stable transfectants##2##2##(2008-11#2)
Stable transfection of##2##3##(1990-5#1)(2008-11#1)
Stable##52##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#12)(2008-1#1)(2008-10#4)(2008-11#9)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-4#1)(2012-9#1)(2013-8#1)
Stably##2##1##(2008-11#1)(2008-2#1)
Stachybotrys chartarum##2##2##(2008-11#2)
Stacked##2##1##(1993-8#1)(2008-3#1)
Staff utilization##3##2##(1994-1#1)(1994-2#1)(1994-3#1)
Staff##20##1##(1994-1#2)(1994-2#2)(1994-3#2)(1996-3#2)(2007-11#2)(2008-11#1)(2008-12#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
Staffing in##2##2##(1996-3#1)(2012-3#1)
Staffordshire##3##1##(2008-12#1)(2013-8#2)
Stage 0##2##2##(1994-12#2)
Stage 1##2##2##(1991-12#1)(2008-1#1)
Stage 2##3##2##(1991-12#1)(2007-6#1)(2008-7#1)
Stage 3##2##2##(2007-8#1)(2008-7#1)
Stage I##5##2##(1994-12#1)(2007-8#1)(2008-6#1)(2013-8#2)
Stage II##5##2##(1994-12#2)(1997-7#1)(2013-8#2)
Stage III Non Small Cell Lung Cancer##2##7##(2008-10#1)(2010-8#1)
Stage III included tumors##2##4##(2007-8#2)
Stage III##8##2##(1994-2#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2010-8#1)
Stage IV##3##2##(2008-1#1)(2013-1#1)(2013-8#1)
Stage Renal##2##2##(2007-7#1)(2008-1#1)
Stage##45##1##(1991-12#2)(1994-12#5)(1994-2#1)(1997-3#1)(1997-7#3)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#5)(2008-10#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#2)(2011-2#1)(2013-1#3)(2013-8#5)
Stage-specific##2##1##(2008-6#1)(2009-3#1)
Staged##3##1##(2008-7#1)(2011-2#1)(2012-3#1)
Stages of##9##2##(1990-2#1)(2007-8#1)(2008-10#5)(2008-6#1)(2011-1#1)
Stages##13##1##(1990-2#1)(2007-8#2)(2008-10#5)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
Staging classification##2##2##(1990-2#1)(2008-1#1)
Staging of##2##2##(2007-8#1)(2008-6#1)
Staging##8##1##(1990-2#1)(1990-9#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-12#1)
Stagonospora blotch##3##2##(2008-10#3)
Stagonospora nodorum blotch (SNB)##2##4##(2008-10#2)
Stagonospora nodorum blotch##3##3##(2008-10#3)
Stagonospora nodorum in##2##3##(2008-10#2)
Stagonospora nodorum##15##2##(2008-10#15)
Stagonospora##18##1##(2008-10#18)
Stain##2##1##(2008-10#1)(2008-5#1)
Stain)##2##1##(2008-5#2)
Staining of proteins in SDS-polyacrylamide gels is described##2##8##(2008-2#1)(2008-4#1)
Staining of##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
Staining proteins in gels##2##4##(2008-2#1)(2008-4#1)
Staining was##2##2##(1991-5#1)(1992-8#1)
Staining with##2##2##(1997-6#1)(2008-7#1)
Staining##15##1##(1991-5#1)(1992-8#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
Stainton (Lepidoptera##2##2##(2008-6#2)
Stainton##3##1##(2008-6#3)
Staircase##2##1##(1990-11#1)(2008-7#1)
Stakeholders##6##1##(1992-1#1)(1996-1#1)(2007-2#1)(2008-11#1)(2008-6#1)(2012-12#1)
Stalk##2##1##(2008-10#2)
Stalkers##2##1##(2009-9#1)(2011-1#1)
Stamatoyannopoulos##2##1##(2008-5#2)
Stamford##2##1##(1996-5#1)(2008-3#1)
Stammering Research##5##2##(2008-4#5)
Stance##2##1##(1994-1#1)(2013-1#1)
Stand and deliver##2##3##(1990-3#1)(2011-2#1)
Stand##4##1##(1990-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
Standard HPLC equipment is used throughout##2##6##(2008-10#2)
Standard addition method was used##2##5##(2008-10#2)
Standard addition method was##3##4##(2008-10#3)
Standard addition method##5##3##(2008-10#5)
Standard and##2##2##(2008-5#1)(2012-1#1)
Standard curves##3##2##(1995-12#1)(2008-10#2)
Standard deviation##2##2##(2008-10#2)
Standard deviations##2##2##(2008-10#2)
Standard errors of##2##3##(2008-10#2)
Standard methods##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
Standard operating##2##2##(2010-3#1)(2011-2#1)
Standard treatment##2##2##(2007-8#1)(2012-1#1)
Standard##85##1##(1993-2#1)(1993-3#2)(1994-9#1)(1995-12#1)(1996-2#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Standardising crash call numbers##2##4##(1996-11#2)
Standardization of a##2##3##(1997-2#1)(2008-10#1)
Standardization of the##3##3##(2008-2#1)(2008-3#1)(2010-1#1)
Standardization of##13##2##(1991-11#1)(1991-3#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
Standardization##24##1##(1991-11#1)(1991-3#2)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
Standardized nursing diagnoses in an electronic health record##2##8##(2013-1#2)
Standardized##14##1##(1993-1#1)(1997-4#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
Standards and ontologies for functional genomics##2##6##(2008-7#2)
Standards and##16##2##(1996-12#1)(2008-10#3)(2008-2#2)(2008-3#6)(2008-7#4)
Standards are##2##2##(1994-12#1)(2007-4#1)
Standards for##5##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)
Standards of##2##2##(1994-3#2)
Standards##66##1##(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-4#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#12)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Stander##2##1##(2008-10#2)
Standing Committee on##2##3##(2008-12#1)(2010-3#1)
Standing Committee##4##2##(1990-2#1)(2008-12#1)(2008-7#1)(2010-3#1)
Stanford University##3##2##(1993-12#3)
Stanford##14##1##(1992-3#1)(1993-12#3)(1995-9#2)(2007-8#1)(2008-11#2)(2008-12#1)(2010-11#1)(2012-1#1)(2013-1#2)
Stanier##2##1##(2007-12#1)(2008-10#1)
Stanley Hall##2##2##(1994-12#2)
Stanley##5##1##(1994-12#2)(2008-11#1)(2009-10#1)(2010-8#1)
Stannyl##2##1##(1996-5#1)(2008-9#1)
Stanton##2##1##(2008-6#1)(2011-2#1)
Staphylinidae)##4##1##(2007-12#3)(2008-7#1)
Staphylococcal protein A##2##3##(1994-12#1)(1994-6#1)
Staphylococcal toxic shock syndrome##2##4##(2011-2#2)
Staphylococcal##8##1##(1991-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-12#1)(2008-8#1)(2011-2#2)
Staphylococci##3##1##(2008-5#1)(2010-4#1)(2012-3#1)
Staphylococcus aureus (MRSA)##12##3##(2007-12#1)(2007-7#2)(2008-10#1)(2008-3#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
Staphylococcus aureus Bacteremia##2##3##(2011-1#1)(2012-12#1)
Staphylococcus aureus V-8##2##3##(1990-2#1)(1990-5#1)
Staphylococcus aureus and Candida##2##4##(2008-11#1)(2010-6#1)
Staphylococcus aureus and Pseudomonas aeruginosa##2##5##(2009-6#1)(2012-2#1)
Staphylococcus aureus and Streptococcus##2##4##(1990-6#1)(1997-8#1)
Staphylococcus aureus and##10##3##(1990-6#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2012-2#1)
Staphylococcus aureus in a Canadian##3##5##(2007-12#1)(2008-10#2)
Staphylococcus aureus in a##4##4##(2007-12#1)(2008-10#2)(2008-11#1)
Staphylococcus aureus in the##2##4##(2007-12#1)(2012-1#1)
Staphylococcus aureus in##16##3##(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2011-2#1)(2012-1#2)(2012-3#1)
Staphylococcus aureus infection##2##3##(2007-12#1)(2011-2#1)
Staphylococcus aureus infections##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
Staphylococcus aureus is an##2##4##(2007-12#1)(2008-11#1)
Staphylococcus aureus is##5##3##(1995-8#1)(2006-6#1)(2007-12#1)(2008-11#1)(2010-6#1)
Staphylococcus aureus protein A##3##4##(1994-3#2)(1996-6#1)
Staphylococcus aureus skin##3##3##(2007-12#1)(2008-12#1)(2012-2#1)
Staphylococcus aureus was##3##3##(1996-12#2)(1997-4#1)
Staphylococcus aureus##135##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1991-3#1)(1991-9#3)(1992-6#1)(1993-2#1)(1994-3#2)(1995-5#1)(1995-8#3)(1996-12#6)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#13)(2007-7#7)(2008-10#8)(2008-11#7)(2008-12#9)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#5)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#1)(2013-8#4)
Staphylococcus chromogenes##2##2##(1997-5#1)(2008-5#1)
Staphylococcus epidermidis was the##2##4##(1991-11#1)(2008-1#1)
Staphylococcus epidermidis##9##2##(1991-11#1)(1991-3#1)(1993-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-4#2)(2012-2#1)
Staphylococcus hyicus##2##2##(2013-8#2)
Staphylococcus##159##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1991-11#1)(1991-3#4)(1991-9#3)(1992-6#1)(1993-2#1)(1993-9#1)(1994-3#2)(1995-5#1)(1995-8#3)(1996-12#6)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#13)(2007-7#8)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#9)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#5)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#6)
Star##4##1##(1996-5#1)(1996-9#1)(2010-6#1)(2013-1#1)
Star-PAP##9##1##(2013-1#9)
Starch##3##1##(2008-5#1)(2008-9#1)(2010-8#1)
Starches##2##1##(2008-12#1)(2012-1#1)
Stark effect##2##2##(2007-12#1)(2013-8#1)
Stark tuning rate of##2##4##(2008-10#2)
Stark tuning rate##4##3##(2008-10#4)
Stark tuning##5##2##(2007-12#1)(2008-10#4)
Stark##20##1##(1990-12#1)(1990-7#1)(1996-3#3)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2013-8#2)
Start##8##1##(1995-12#3)(1997-4#1)(2008-7#1)(2009-4#2)(2012-2#1)
Starting and##2##2##(1992-3#1)(2010-2#1)
Starting from a##5##3##(1990-11#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-9#1)
Starting from an##2##3##(2008-11#1)(2008-4#1)
Starting from the##2##3##(2008-2#1)(2010-2#1)
Starting from##13##2##(1990-11#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-2#1)
Starting in##3##2##(1994-2#2)(2011-2#1)
Starting with a##3##3##(1995-2#1)(2008-6#1)(2008-9#1)
Starting with the##2##3##(1992-3#1)(2008-8#1)
Starting with##7##2##(1992-3#1)(1995-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
Starting##31##1##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-2#2)(1995-2#1)(1996-1#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-2#2)(2011-2#2)(2013-1#1)
Stat##4##1##(1996-12#1)(1996-2#1)(1997-7#1)(2009-9#1)
Stat3##2##1##(2011-1#2)
Stata 9##2##2##(2011-2#1)(2012-12#1)
Stata##3##1##(2011-2#1)(2012-12#2)
State Court of Appeals##2##4##(1996-5#1)(1997-5#1)
State Department of Health has##2##5##(1997-1#1)(1997-2#1)
State Department of Health##5##4##(1994-12#1)(1996-3#2)(1997-1#1)(1997-2#1)
State Exam##3##2##(2008-12#1)(2008-6#1)(2011-2#1)
State Examination (MMSE)##4##3##(2008-6#1)(2008-7#2)(2013-1#1)
State Examination##11##2##(2008-6#2)(2008-7#6)(2012-2#1)(2013-1#2)
State Health##4##2##(1995-12#1)(1996-1#2)(1996-5#1)
State Medicaid agencies##3##3##(1994-3#1)(1996-2#2)
State Medicaid expenditures##2##3##(1994-1#1)(1996-1#1)
State Medicaid program##2##3##(1992-3#1)(2010-12#1)
State Medicaid programs##7##3##(1994-12#1)(1995-1#2)(1996-1#1)(1996-2#1)(1997-2#2)
State Medicaid##18##2##(1992-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#3)(1995-2#1)(1996-1#2)(1996-2#3)(1997-2#2)(2010-12#1)
State Supreme##2##2##(1992-1#1)(1996-5#1)
State University##11##2##(1996-1#4)(1997-6#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)
State and local##2##3##(1996-1#1)(1997-1#1)
State and##14##2##(1991-1#1)(1991-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-3#1)
State departments of public health##2##5##(1996-12#1)(1997-2#1)
State for##4##2##(1992-12#1)(1992-3#1)(1996-4#1)(1997-3#1)
State has##2##2##(1996-1#1)(2013-1#1)
State health care reform##3##4##(1996-1#3)
State health reform and##2##4##(1996-1#2)
State health reform##3##3##(1996-1#3)
State health##7##2##(1996-1#6)(1996-3#1)
State in##4##2##(1992-1#1)(2008-9#1)(2009-10#1)(2013-1#1)
State is##3##2##(1996-12#1)(2008-10#1)(2010-12#1)
State law##2##2##(1992-12#1)(1992-9#1)
State of Bahia##2##3##(1991-9#1)(2008-8#1)
State of Minas Gerais##3##4##(2008-5#1)(2008-6#1)(2010-10#1)
State of Rio Grande do Sul##2##6##(1993-6#1)(2013-7#1)
State of Rio de Janeiro##3##5##(2008-6#3)
State of Rio##5##3##(1993-6#1)(2008-6#3)(2013-7#1)
State of the art##4##4##(2008-11#3)(2011-2#1)
State of##38##2##(1990-11#1)(1991-1#1)(1991-8#2)(1991-9#1)(1993-6#1)(1994-9#1)(1996-12#1)(1996-9#2)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#4)(2008-8#2)(2009-11#1)(2009-4#1)(2010-10#2)(2011-2#3)(2013-7#3)(2013-8#4)
State perspectives##2##2##(1996-1#2)
State residents##2##2##(1992-1#1)(1995-12#1)
State to##3##2##(1996-2#1)(1997-2#1)(2013-1#1)
State was##2##2##(1992-2#1)(2008-10#1)
State were##2##2##(2008-10#1)(2011-1#1)
State##282##1##(1990-11#2)(1990-12#2)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#1)(1994-9#2)(1995-1#6)(1995-12#4)(1995-2#2)(1995-6#1)(1996-1#30)(1996-12#5)(1996-2#6)(1996-3#8)(1996-4#1)(1996-5#3)(1996-9#4)(1997-1#5)(1997-2#8)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#2)(2006-10#1)(2007-5#1)(2008-1#5)(2008-10#20)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#9)(2008-7#10)(2008-8#2)(2008-9#15)(2009-10#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#7)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#8)
State's##3##1##(1996-12#1)(1996-3#1)(2009-6#1)
State-Trait Anxiety Inventory##6##3##(1995-12#2)(2007-7#1)(2008-10#1)(2010-6#1)(2013-8#1)
State-level##2##1##(1996-1#1)(1996-3#1)
State-of-the-art##2##1##(2008-11#1)(2008-5#1)
Statement by the##2##3##(1990-9#1)(2012-2#1)
Statement of##3##2##(1990-6#1)(1993-11#1)(2008-4#1)
Statement on the##3##3##(2007-3#1)(2008-2#1)(2012-2#1)
Statement on##10##2##(1992-1#1)(1994-11#1)(1995-2#1)(1995-8#1)(2007-3#2)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
Statement##20##1##(1990-6#1)(1990-9#1)(1991-8#1)(1992-1#1)(1993-11#3)(1994-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(2007-3#2)(2008-2#1)(2008-4#2)(2008-6#2)(2012-2#2)
States Food and Drug##2##4##(2008-7#1)(2008-8#1)
States and a##2##3##(1993-12#1)(2007-2#1)
States and the##5##3##(1991-12#1)(1992-3#1)(1996-1#1)(1997-2#1)(2008-10#1)
States and##82##2##(1990-10#1)(1991-12#2)(1991-6#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-2#2)(1996-3#1)(1997-2#1)(2007-12#3)(2007-2#2)(2008-1#1)(2008-10#33)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#3)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
States are##10##2##(1991-2#1)(1992-1#1)(1993-1#1)(1996-1#2)(1996-3#1)(2008-10#1)(2009-6#1)(2010-6#1)(2011-2#1)
States as##4##2##(2008-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
States considering##2##2##(1991-2#1)(1992-3#1)
States for##6##2##(1991-1#1)(1992-12#1)(1996-9#1)(2008-10#2)(2008-11#1)
States has##7##2##(1995-2#1)(1996-11#1)(1997-2#1)(1997-5#1)(2008-10#1)(2009-3#1)(2010-3#1)
States have##12##2##(1993-3#2)(1994-3#4)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
States in the##2##3##(1995-8#1)(1996-9#1)
States in##15##2##(1993-2#1)(1994-1#1)(1994-2#2)(1995-8#1)(1996-9#1)(2008-10#8)(2011-2#1)
States of##17##2##(1992-3#1)(1994-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-3#1)(2012-12#1)(2013-8#9)
States on##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
States or##3##2##(1994-3#1)(2008-10#2)
States participated##2##2##(1995-3#1)(2008-12#1)
States pay##2##2##(1995-1#1)(1995-2#1)
States provide##2##2##(1995-1#1)(2008-4#1)
States that##3##2##(1993-12#1)(1997-1#1)(2011-2#1)
States to##8##2##(1996-1#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
States were##15##2##(1996-1#1)(2007-12#1)(2008-10#12)(2008-5#1)
States with a##2##3##(1991-12#1)(1993-2#1)
States with##6##2##(1991-12#2)(1993-2#1)(1994-1#1)(2008-8#1)(2010-10#1)
States would##3##2##(1994-1#1)(1997-2#1)(2011-1#1)
States##705##1##(1990-10#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#2)(1991-1#4)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#2)(1992-12#5)(1992-2#2)(1992-3#8)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#6)(1993-2#6)(1993-3#8)(1993-6#1)(1994-1#7)(1994-12#7)(1994-2#5)(1994-3#10)(1994-9#1)(1995-1#13)(1995-12#3)(1995-2#3)(1995-3#8)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#14)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#6)(1996-4#1)(1996-9#3)(1997-1#8)(1997-2#11)(1997-3#9)(1997-5#3)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#11)(2007-2#7)(2007-3#1)(2007-7#2)(2008-1#9)(2008-10#197)(2008-11#18)(2008-12#9)(2008-2#3)(2008-3#13)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#7)(2009-11#11)(2009-12#1)(2009-3#1)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#6)(2011-2#39)(2012-1#1)(2012-12#14)(2012-2#10)(2012-3#13)(2013-1#19)(2013-7#1)(2013-8#19)
States'##3##1##(1996-1#1)(1996-12#1)(2013-1#1)
States)##7##1##(1995-3#1)(2008-10#4)(2008-12#2)
Static and dynamic##4##3##(2008-3#2)(2008-5#1)(2012-2#1)
Static and##5##2##(2008-3#2)(2008-5#2)(2012-2#1)
Static headspace##2##2##(2008-10#2)
Static magnetic field##2##3##(2008-10#2)
Static##19##1##(1991-6#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#3)(2008-5#3)(2011-2#1)(2012-2#1)(2013-8#1)
Statin##4##1##(2008-3#1)(2013-1#2)(2013-8#1)
Station was##2##2##(1996-12#1)(2008-10#1)
Station##15##1##(1996-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Stationary and##2##2##(2007-12#1)(2008-3#1)
Stationary##5##1##(1996-7#1)(1996-9#1)(2007-12#2)(2008-3#1)
Statistic##2##1##(2008-7#1)(2009-11#1)
Statistical Analysis##2##2##(1996-9#1)(2013-8#1)
Statistical Resource Committee surveyed##2##4##(1991-2#1)(1994-1#1)
Statistical Resource Committee##7##3##(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-2#1)
Statistical analyses##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
Statistical analysis indicated a##2##4##(1990-6#1)(1995-3#1)
Statistical analysis indicated##3##3##(1990-6#1)(1995-3#1)(2008-9#1)
Statistical analysis of the##2##4##(2008-11#1)(2008-2#1)
Statistical analysis of##11##3##(1994-2#1)(1994-8#1)(1995-1#1)(2008-1#1)(2008-11#1)(2008-2#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
Statistical analysis showed that##2##4##(2008-1#1)(2008-12#1)
Statistical analysis showed##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
Statistical analysis was done using##2##5##(1997-8#1)(2007-7#1)
Statistical analysis was performed using Student's t-test##2##7##(2008-7#1)(2013-1#1)
Statistical analysis was performed using##3##5##(2008-7#1)(2008-9#1)(2013-1#1)
Statistical analysis was performed##5##4##(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)
Statistical analysis was##10##3##(1990-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
Statistical analysis##40##2##(1990-3#1)(1990-6#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
Statistical approaches##2##2##(2008-7#1)(2008-8#1)
Statistical comparison of the results with those of an official method shows excellent agreement and indicates no significant difference in precision##2##21##(2008-10#2)
Statistical comparisons##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
Statistical evaluation of##2##3##(2008-10#2)
Statistical method##2##2##(2008-10#1)(2013-8#1)
Statistical methods##2##2##(1992-2#1)(1995-2#1)
Statistical properties of the##2##4##(2008-2#2)
Statistical properties of##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#2)
Statistical significance##3##2##(2008-10#1)(2008-6#1)(2012-12#1)
Statistical significant##2##2##(2008-10#2)
Statistical tests of##2##3##(1997-5#1)(2011-2#1)
Statistical tests##5##2##(1992-3#1)(1997-5#1)(2008-10#2)(2011-2#1)
Statistical##129##1##(1990-12#1)(1990-3#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#4)(2009-8#1)(2009-9#1)(2010-11#2)(2010-8#1)(2011-1#3)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#5)
Statistically significant associations were found##2##5##(1993-9#1)(2010-2#1)
Statistically significant differences were found between##2##6##(2008-5#1)(2010-6#1)
Statistically significant differences were found##3##5##(1997-3#1)(2008-5#1)(2010-6#1)
Statistically significant differences were##5##4##(1994-1#1)(1997-3#1)(2008-2#1)(2008-5#1)(2010-6#1)
Statistically significant differences##7##3##(1994-1#1)(1996-2#1)(1997-3#1)(2008-2#1)(2008-5#1)(2010-5#1)(2010-6#1)
Statistically significant##20##2##(1992-8#1)(1993-9#1)(1994-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
Statistically##21##1##(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
Statisticaly significant##2##2##(2007-11#2)
Statistics Department##2##2##(2012-12#2)
Statistics from the##2##3##(1997-6#1)(2007-2#1)
Statistics from##3##2##(1997-6#1)(2007-2#1)(2008-11#1)
Statistics of the##2##3##(1996-9#1)(2008-3#1)
Statistics of##3##2##(1996-9#1)(2008-3#1)(2013-1#1)
Statistics on##2##2##(1991-11#1)(2008-11#1)
Statistics##33##1##(1991-11#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
Status Examination##2##2##(1991-1#1)(2010-12#1)
Status and##5##2##(2008-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
Status of##9##2##(1991-6#1)(2008-10#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
Status##31##1##(1991-1#1)(1991-6#1)(1991-9#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
Statute##2##1##(1993-1#1)(2008-9#1)
Staudinger##2##1##(2007-11#1)(2008-4#1)
Staufen protein##2##2##(1994-12#2)
Staurosporine##2##1##(1995-12#1)(2008-9#1)
Stay##4##1##(1997-1#1)(2008-8#1)(2013-1#2)
Staying in the##3##3##(2009-6#1)(2010-10#2)
Staying in##5##2##(1991-2#1)(2009-6#1)(2010-10#3)
Stb4 gene##2##2##(2008-10#2)
Stb4##9##1##(2008-10#9)
Stb6##5##1##(2008-10#5)
Stb8##3##1##(2008-10#3)
Std-##2##1##(2008-10#2)
Ste7##2##1##(1996-2#2)
Steady##2##1##(2007-12#1)(2008-10#1)
Steady-state##5##1##(1991-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-7#1)
Steel##2##1##(1996-3#1)(2008-10#1)
Steering Team##5##2##(1993-12#2)(1995-12#3)
Steering##8##1##(1993-12#2)(1995-12#5)(2008-3#1)
Steinert's dystrophy##3##2##(2013-1#3)
Steingelia##2##1##(2007-12#2)
Stellaria media##9##2##(2008-10#8)(2008-7#1)
Stellate##2##1##(2008-11#2)
Stem Bark##2##2##(2008-10#1)(2008-8#1)
Stem Cell##6##2##(2008-11#4)(2012-12#2)
Stem Cells in##2##3##(2008-11#1)(2012-3#1)
Stem Cells##12##2##(2008-11#4)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Stem Rot##4##2##(2008-10#4)
Stem Rust##2##2##(2008-10#2)
Stem and##2##2##(2008-10#1)(2008-11#1)
Stem cell factor##3##3##(1992-3#2)(2013-1#1)
Stem cell research is##2##4##(2008-11#1)(2009-3#1)
Stem cell research##4##3##(2008-10#1)(2008-11#2)(2009-3#1)
Stem cell transplantation for##2##4##(2010-5#1)(2012-12#1)
Stem cell##16##2##(1992-3#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-1#1)
Stem cell-based##2##2##(2009-9#1)(2012-12#1)
Stem cells##7##2##(2008-11#2)(2008-7#1)(2010-10#1)(2012-1#1)(2013-1#2)
Stem##64##1##(1992-3#2)(2007-12#1)(2008-10#15)(2008-11#14)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#4)
Stemphylium vesicarium##4##2##(2008-10#4)
Stemphylium##6##1##(2008-10#4)(2008-5#2)
Stems##3##1##(2008-10#3)
Stenosis##9##1##(1994-2#1)(2008-1#1)(2008-11#1)(2009-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
Stenotrophomonas maltophilia strain C3##3##4##(2008-10#3)
Stenotrophomonas maltophilia##7##2##(2008-10#7)
Stenotrophomonas##9##1##(2008-10#8)(2013-8#1)
Stent Thrombosis##2##2##(2008-11#2)
Stent##13##1##(2007-2#1)(2008-1#1)(2008-11#4)(2009-12#1)(2009-5#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Stents##2##1##(2008-11#2)
Step##7##1##(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)
Step-by-step protocols describe trypsinizing and subculturing monolayer cultures##2##8##(2008-4#1)(2008-9#1)
Stephen##13##1##(1992-9#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-5#1)(2007-2#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
Stepping##2##1##(2007-10#1)(2008-6#1)
Steps in##4##2##(1996-3#1)(2007-7#1)(2008-10#2)
Steps##9##1##(1990-9#1)(1996-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
Steptoe##8##1##(2008-10#7)(2008-5#1)
Stepwise logistic regression analysis##2##4##(2008-7#1)(2012-2#1)
Stepwise multiple##2##2##(1992-6#1)(2008-10#1)
Stepwise regression##2##2##(1996-5#1)(2007-6#1)
Stepwise##13##1##(1991-12#1)(1992-6#1)(1996-5#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)
Stereochemistry of##2##2##(1990-12#1)(1996-5#1)
Stereodivergent##2##1##(2009-8#2)
Stereological##2##1##(2008-12#1)(2011-1#1)
Stereoscopic##2##1##(1990-8#1)(2008-3#1)
Stereoselective Synthesis of##3##3##(1996-5#2)(2008-8#1)
Stereoselective##10##1##(1992-7#1)(1995-3#1)(1996-5#5)(1997-4#1)(1997-7#1)(2008-8#1)
Stereospecific##3##1##(1995-5#1)(1996-5#2)
Stereospecificity of##2##2##(1991-1#1)(1994-11#1)
Stereotactic radiosurgery as##2##3##(1995-9#1)(2010-9#1)
Stereotactic radiosurgery##4##2##(1995-9#1)(1997-4#1)(2010-9#1)(2011-2#1)
Stereotactic##6##1##(1995-9#1)(1996-3#1)(1997-4#1)(2008-7#1)(2010-9#1)(2011-2#1)
Stereotypes##2##1##(2011-2#1)(2012-3#1)
Steric Mass Action parameters of the##2##6##(2008-7#2)
Steric##4##1##(1992-10#1)(2008-7#2)(2012-2#1)
Sterically##2##1##(1996-5#1)(2007-12#1)
Sterile##5##1##(2008-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
Steris System 1##2##3##(2011-2#2)
Steris System##3##2##(2011-2#3)
Stern-Volmer plots##3##2##(2008-10#3)
Stern-Volmer quenching constant##2##3##(2008-10#2)
Stern-Volmer##9##1##(2008-10#9)
Steroid 9alpha-hydroxylase is##2##3##(2008-11#2)
Steroid hormones##2##2##(2008-4#1)(2008-8#1)
Steroid##16##1##(1992-5#1)(1992-8#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
Steroids having a##2##3##(1997-1#2)
Steroids##7##1##(1997-1#2)(2007-10#1)(2008-11#1)(2010-12#1)(2012-2#2)
Sterol 27-hydroxylase##2##2##(1994-8#2)
Sterol##4##1##(1994-8#2)(2008-10#2)
Sterols##3##1##(1990-11#1)(2008-12#2)
Stetter##3##1##(2010-6#2)(2011-2#1)
Steud##4##1##(2008-12#1)(2008-8#2)(2009-10#1)
Steve##2##1##(1995-6#1)(1996-2#1)
Steven##4##1##(2008-4#1)(2008-6#2)(2012-12#1)
Stevens##2##1##(2008-10#1)(2008-7#1)
Stewardship##3##1##(2012-2#1)(2013-1#2)
Stewart##3##1##(1992-8#1)(1994-1#1)(1994-5#1)
Stewart's disease of corn##2##4##(2008-10#2)
Stewart's wilt##3##2##(2008-10#3)
Stewart's##8##1##(2008-10#8)
Stiffness index##2##2##(2008-1#2)
Stiffness##8##1##(1994-6#1)(1995-12#1)(2008-1#2)(2008-10#1)(2008-6#2)(2009-6#1)
Stigma##2##1##(2010-10#1)(2012-1#1)
Stilbene##2##1##(2008-10#2)
Still disease##2##2##(2006-10#2)
Still needed are surgical glues and orthopedic cements##2##8##(2013-1#2)
Still##29##1##(1992-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-5#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
Still's disease##5##2##(1995-11#3)(2011-2#1)(2012-3#1)
Still's##7##1##(1990-9#1)(1995-11#3)(2011-2#2)(2012-3#1)
Stillbirth##2##1##(1992-2#1)(2008-11#1)
Stimulant##3##1##(1996-6#1)(2007-10#1)(2008-2#1)
Stimulated Brillouin Scattering##2##3##(1996-9#1)(2008-2#1)
Stimulated Raman scattering of##2##4##(2007-11#2)
Stimulated Raman##3##2##(2007-11#2)(2008-3#1)
Stimulated##14##1##(1995-12#1)(1996-9#1)(1997-7#1)(2007-11#5)(2008-10#1)(2008-2#2)(2008-3#2)(2012-12#1)
Stimulating##4##1##(1997-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
Stimulation by interleukin-1beta##2##3##(1997-1#2)
Stimulation by##5##2##(1990-12#2)(1992-3#1)(1997-1#2)
Stimulation of DNA synthesis##2##4##(1991-12#1)(1993-3#1)
Stimulation of glucose##2##3##(1992-11#1)(1994-8#1)
Stimulation of osteoclastic bone resorption##2##5##(1992-3#1)(1993-6#1)
Stimulation of the##8##3##(1990-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(2008-12#1)(2008-2#1)(2013-1#1)
Stimulation of##44##2##(1990-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
Stimulation was##2##2##(1996-5#1)(2008-11#1)
Stimulation with a##2##3##(1997-2#2)
Stimulation with##6##2##(1990-7#1)(1995-12#1)(1997-2#2)(2008-11#2)
Stimulation##68##1##(1990-10#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-8#1)(1996-5#1)(1997-1#3)(1997-2#4)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#3)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
Stimulatory effect of##2##3##(1993-5#1)(1995-8#1)
Stimuli that evoked##2##3##(1995-12#2)
Stimuli##3##1##(1990-11#1)(1995-12#2)
Stimuli-responsive##3##1##(1995-11#1)(2010-4#2)
Stimulus##4##1##(1990-5#1)(1993-12#1)(2008-5#1)(2009-5#1)
Stink bug##2##2##(2011-2#2)
StoThresh##3##1##(2008-7#3)
Stochastic modeling##2##2##(1991-2#1)(2008-3#1)
Stochastic##17##1##(1991-2#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-11#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
Stock##4##1##(1991-8#1)(2008-10#1)(2008-11#1)(2010-8#1)
Stockholm##11##1##(1990-10#1)(1993-1#1)(1993-6#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2011-4#1)(2012-2#1)
Stocks##2##1##(2008-10#1)(2008-9#1)
Stokes and anti-Stokes##3##3##(2007-1#1)(2007-11#2)
Stokes and##5##2##(2007-1#2)(2007-11#3)
Stokes component##2##2##(2008-2#2)
Stokes components are##2##3##(2007-11#1)(2007-12#1)
Stokes components##3##2##(2007-11#1)(2007-12#2)
Stokes emission##2##2##(2007-11#1)(2008-3#1)
Stokes generation##2##2##(2007-12#1)(2008-3#1)
Stokes laser##2##2##(2007-11#1)(2007-12#1)
Stokes parameter##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Stokes parameters of the##3##4##(2007-11#1)(2007-12#2)
Stokes parameters of##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
Stokes parameters##12##2##(2007-11#1)(2007-12#7)(2008-2#2)(2008-3#2)
Stokes polarimeter##3##2##(2008-2#1)(2008-3#2)
Stokes pulses##2##2##(2008-2#2)
Stokes radiation##2##2##(2007-11#1)(2008-2#1)
Stokes radius##2##2##(1990-11#1)(1993-8#1)
Stokes shift##5##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-2#1)
Stokes shifts of##2##3##(2008-10#1)(2008-2#1)
Stokes vector##2##2##(2008-3#2)
Stokes vectors in human skin##2##5##(2007-11#2)
Stokes vectors##7##2##(2007-11#5)(2008-2#1)(2008-3#1)
Stokes wave##2##2##(2007-12#2)
Stokes waves##2##2##(2007-12#2)
Stokes##85##1##(1990-11#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-4#1)(2007-1#4)(2007-11#19)(2007-12#23)(2008-10#3)(2008-11#1)(2008-2#18)(2008-3#12)
Stokes)##2##1##(2007-11#2)
Stokes-Einstein##2##1##(1995-3#1)(2008-2#1)
Stolon regression##2##2##(2009-8#2)
Stomach##3##1##(1996-12#1)(2008-9#1)(2009-12#1)
Stomatal and##2##2##(2011-10#1)(2012-7#1)
Stomatal conductance##2##2##(2008-10#1)(2008-5#1)
Stomatal movements##2##2##(1994-11#2)
Stomatal resistance in##2##3##(2008-10#2)
Stomatal resistance##3##2##(2008-10#3)
Stomatal##10##1##(1994-11#2)(2008-10#5)(2008-5#1)(2011-10#1)(2012-7#1)
Stone Fruit Trees##2##3##(2008-10#2)
Stone Fruit##3##2##(2008-10#3)
Stone##11##1##(1994-6#3)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-11#1)
Stones##2##1##(2007-10#1)(2011-2#1)
Stoneville 213##2##2##(2008-10#2)
Stool samples##2##2##(2007-7#1)(2008-12#1)
Stool##4##1##(1993-8#1)(2007-7#1)(2008-12#1)(2012-2#1)
Stop TB Strategy##2##3##(2010-5#1)(2013-8#1)
Stop##7##1##(2007-9#1)(2008-10#1)(2008-9#1)(2010-5#1)(2013-8#3)
Stoppa's technique##3##2##(1992-5#2)(1993-9#1)
Stopped-flow injection##2##2##(2008-10#2)
Stopped-flow spectrophotometric##2##2##(2008-10#2)
Stopped-flow##11##1##(1992-1#1)(1992-3#1)(1995-5#1)(2008-10#8)
Stopping##3##1##(1991-3#1)(1996-9#1)(2009-6#1)
Storage and##2##2##(2007-12#1)(2011-10#1)
Storage stability##2##2##(2008-10#2)
Storage##14##1##(1996-9#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2011-10#1)(2012-2#1)
Store##2##1##(1996-5#1)(2011-1#1)
Store-operated##2##1##(2008-8#2)
Stored##7##1##(2008-1#1)(2008-10#3)(2008-9#1)(2009-7#1)(2010-8#1)
Stories##3##1##(1992-9#1)(2008-12#1)(2011-2#1)
Storm##2##1##(1991-3#1)(2008-2#1)
Story##3##1##(2008-7#1)(2010-5#1)(2013-8#1)
Storytelling##3##1##(1992-12#2)(2008-11#1)
Stover##2##1##(2008-10#2)
Stovner##2##1##(1996-6#1)(1997-6#1)
Straight##4##1##(2007-12#1)(2009-7#1)(2011-1#1)(2012-2#1)
Straightforward##3##1##(2008-3#2)(2008-7#1)
Straightness##2##1##(2008-3#2)
Strain A506##5##2##(2008-10#5)
Strain C3##5##2##(2008-10#5)
Strain CHA0##4##2##(2008-10#4)
Strain LS11##2##2##(2008-10#2)
Strain and##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
Strain of##8##2##(2008-10#8)
Strain##92##1##(1991-1#1)(1991-8#1)(1993-9#1)(2007-10#1)(2007-12#1)(2008-10#68)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#2)(2009-1#1)(2011-2#7)(2012-2#2)(2013-1#2)
Strain-specific##3##1##(1996-12#1)(2008-10#1)(2008-12#1)
Strains Isolated from##2##3##(2008-10#2)
Strains from the##2##3##(1996-4#1)(2008-10#1)
Strains from##8##2##(1996-12#1)(1996-4#1)(2008-10#6)
Strains in the##2##3##(2008-10#1)(2011-1#1)
Strains in##5##2##(1994-12#1)(2008-10#2)(2008-5#1)(2011-1#1)
Strains isolated from##2##3##(2008-10#2)
Strains of Aphanomyces euteiches##2##4##(2008-10#2)
Strains of Botrytis cinerea##2##4##(2008-10#2)
Strains of Fusarium oxysporum f##2##5##(2008-10#2)
Strains of Pantoea##2##3##(2008-10#2)
Strains of Papaya ringspot virus##2##5##(2008-10#2)
Strains of Pseudomonas syringae pv##2##5##(2008-10#2)
Strains of Pseudomonas syringae##3##4##(2008-10#3)
Strains of Pseudomonas##4##3##(2008-10#4)
Strains of Ralstonia solanacearum##2##4##(2008-10#2)
Strains of Trichoderma##2##3##(2008-10#2)
Strains of Xanthomonas campestris pv##3##5##(2008-10#3)
Strains of Xanthomonas oryzae pv##2##5##(2008-10#2)
Strains of Xanthomonas##6##3##(2008-10#6)
Strains of the##4##3##(2008-10#3)(2011-2#1)
Strains of##45##2##(2008-10#42)(2008-2#1)(2011-2#2)
Strains that##2##2##(1993-9#1)(2008-10#1)
Strains to##2##2##(2008-10#2)
Strains were##6##2##(2008-10#5)(2013-8#1)
Strains with##2##2##(1995-5#1)(2008-10#1)
Strains##92##1##(1993-2#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-4#1)(2008-10#79)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
Strait##2##1##(1990-11#1)(2008-8#1)
Strand##6##1##(1991-9#1)(1996-5#1)(2008-12#1)(2009-11#2)(2012-3#1)
Strasbourg##3##1##(2008-1#2)(2008-5#1)
Strategic Plan##2##2##(1991-2#1)(1994-2#1)
Strategic alliances##3##2##(1992-1#2)(1997-3#1)
Strategic implications of##2##3##(1993-12#1)(1996-3#1)
Strategic planning for hotel operations##2##5##(1994-2#1)(1994-3#1)
Strategic planning for##3##3##(1991-2#1)(1994-2#1)(1994-3#1)
Strategic planning in##3##3##(1992-12#1)(1994-2#1)(2008-11#1)
Strategic planning##9##2##(1991-2#2)(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(2008-11#1)
Strategic##31##1##(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-3#2)(2006-5#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-12#1)
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE)##2##10##(2008-3#2)
Strategies and##7##2##(1991-8#1)(1994-3#1)(2008-10#1)(2008-3#2)(2009-12#1)(2011-3#1)
Strategies for developing##2##3##(1995-5#1)(2008-10#1)
Strategies for improving##2##3##(1993-12#1)(2009-8#1)
Strategies for reducing##2##3##(2008-10#1)(2008-8#1)
Strategies for the##6##3##(1991-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
Strategies for##38##2##(1990-12#1)(1991-3#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Strategies that##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
Strategies to increase the##2##4##(2008-5#1)(2009-9#1)
Strategies to##11##2##(1995-3#1)(1996-3#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)
Strategies##77##1##(1990-12#1)(1991-3#2)(1991-8#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2009-12#1)(2009-8#1)(2009-9#5)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Strategy for##5##2##(2008-3#1)(2009-8#1)(2010-5#3)
Strategy##22##1##(1991-2#1)(1992-1#1)(1994-3#1)(1996-1#3)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#4)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
Stratification##4##1##(1992-12#1)(1994-9#1)(2008-2#1)(2011-2#1)
Stratified##3##1##(2011-1#1)(2011-2#1)(2012-2#1)
Stratospheric Aerosol and Gas Experiment (SAGE)##2##6##(2008-2#2)
Stratospheric Aerosol and Gas Experiment II##3##6##(2008-2#2)(2008-3#1)
Stratospheric Aerosol and Gas Experiment##6##5##(2008-2#5)(2008-3#1)
Stratospheric##12##1##(2008-2#5)(2008-3#6)(2012-2#1)
Stratum corneum##3##2##(2008-5#3)
Stratum##5##1##(2008-5#4)(2008-9#1)
Stratus##2##1##(1993-8#1)(2013-8#1)
Strauss and Corbin's##2##3##(2008-12#1)(2010-3#1)
Strawberry Leaves##4##2##(2008-10#4)
Strawberry in##2##2##(2008-10#2)
Strawberry leaves##2##2##(2008-10#2)
Strawberry##17##1##(2008-10#17)
Streak##3##1##(2008-10#3)
Streamlining##2##1##(2008-5#1)(2012-3#1)
Street##7##1##(1996-3#1)(2008-8#3)(2009-10#1)(2012-2#2)
Strehl ratio and the##3##4##(2008-2#1)(2008-3#2)
Strehl ratio and##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
Strehl ratio as##2##3##(2008-2#1)(2008-3#1)
Strehl ratio##22##2##(2007-11#1)(2007-12#2)(2008-2#10)(2008-3#9)
Strehl ratios##4##2##(2008-3#4)
Strehl##28##1##(2007-11#1)(2007-12#2)(2008-2#10)(2008-3#15)
Strength and##2##2##(2007-12#1)(2013-1#1)
Strength##4##1##(2007-12#1)(2007-8#1)(2008-12#1)(2013-1#1)
Strengthening the Nursing##3##3##(2008-11#3)
Strengthening the##7##2##(1992-3#1)(1994-1#1)(2007-12#1)(2008-11#3)(2008-12#1)
Strengthening##13##1##(1992-3#2)(1994-1#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-11#3)(2008-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
Strengths and weaknesses##2##3##(1992-12#1)(1993-1#1)
Strengths and##4##2##(1992-12#1)(1993-1#1)(2008-10#2)
Strengths of##2##2##(1993-12#1)(2008-10#1)
Strengths##6##1##(1992-12#1)(1993-1#1)(1993-12#1)(2008-10#3)
Strenuous physical activity##2##3##(1991-12#2)
Strep##2##1##(1994-12#1)(2009-12#1)
Streptococcal##3##1##(1991-8#1)(2008-5#1)(2011-2#1)
Streptococci##2##1##(2011-1#2)
Streptococcus agalactiae##3##2##(1991-11#1)(1993-2#1)(2010-8#1)
Streptococcus bovis J2 40-2##2##4##(2010-2#2)
Streptococcus bovis infection##2##3##(1997-6#2)
Streptococcus bovis##4##2##(1997-6#2)(2010-2#2)
Streptococcus dysgalactiae##2##2##(1993-2#1)(1996-8#1)
Streptococcus equisimilis##3##2##(1991-9#2)(2012-2#1)
Streptococcus faecalis##2##2##(1990-6#1)(2008-11#1)
Streptococcus mutans and##2##3##(2007-7#1)(2012-2#1)
Streptococcus mutans##9##2##(1992-9#2)(1997-8#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
Streptococcus pneumoniae and##4##3##(1995-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
Streptococcus pneumoniae has##2##3##(1997-2#1)(2007-12#1)
Streptococcus pneumoniae is##2##3##(2008-7#1)(2012-12#1)
Streptococcus pneumoniae isolates from otorhinolaryngological##2##5##(2011-2#2)
Streptococcus pneumoniae to##2##3##(2008-7#1)(2013-8#1)
Streptococcus pneumoniae was##2##3##(1995-3#1)(1997-7#1)
Streptococcus pneumoniae##34##2##(1992-5#2)(1994-11#1)(1994-9#3)(1995-3#1)(1995-5#2)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#1)(2007-12#4)(2008-11#1)(2008-7#5)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
Streptococcus pyogenes infections##3##3##(1992-2#1)(2011-2#2)
Streptococcus pyogenes##17##2##(1992-2#2)(1994-11#1)(1995-8#2)(1996-12#2)(2007-8#1)(2008-8#1)(2008-9#2)(2011-2#6)
Streptococcus sanguinis##2##2##(2012-2#2)
Streptococcus sanguis and##2##3##(2006-6#1)(2008-5#1)
Streptococcus sanguis##3##2##(2006-6#1)(2008-5#2)
Streptococcus species##2##2##(2008-7#1)(2011-1#1)
Streptococcus suis serotype 2##3##4##(2009-6#3)
Streptococcus suis##6##2##(1991-8#2)(2009-6#4)
Streptococcus uberis##2##2##(1993-2#1)(1996-8#1)
Streptococcus##112##1##(1990-12#1)(1990-6#1)(1991-11#1)(1991-8#2)(1991-9#2)(1992-2#2)(1992-5#2)(1992-9#2)(1993-12#1)(1993-2#3)(1994-11#2)(1994-9#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-8#2)(1997-2#1)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#4)(2007-7#3)(2007-8#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-6#6)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-12#2)(2012-2#6)(2013-1#2)(2013-8#2)
Streptokinase##2##1##(1995-8#1)(2012-2#1)
Streptomyces coelicolor A3(2)##3##3##(1990-5#2)(2011-2#1)
Streptomyces coelicolor##13##2##(1990-5#2)(1994-12#2)(1995-8#2)(2008-8#5)(2011-2#1)(2012-2#1)
Streptomyces griseoflavus##3##2##(2008-12#3)
Streptomyces griseus##2##2##(2008-11#1)(2009-2#1)
Streptomyces ipomoeae##2##2##(2008-10#2)
Streptomyces lincolnensis##2##2##(2008-8#2)
Streptomyces lividans##5##2##(1994-12#1)(1994-3#2)(2011-1#2)
Streptomyces peucetius##2##2##(1994-12#2)
Streptomyces scabies##3##2##(2008-10#3)
Streptomyces sp##13##2##(1991-12#1)(2008-10#2)(2008-6#3)(2009-10#2)(2009-2#1)(2009-6#2)(2012-2#2)
Streptomyces spp##4##2##(2008-10#4)
Streptomyces strains##3##2##(2008-10#2)(2009-6#1)
Streptomyces##83##1##(1990-5#3)(1991-12#1)(1992-3#1)(1994-12#6)(1994-3#3)(1994-5#1)(1995-8#2)(2008-10#16)(2008-11#1)(2008-12#3)(2008-6#3)(2008-8#16)(2008-9#3)(2009-10#2)(2009-2#2)(2009-6#3)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#6)(2012-3#4)
Streptozotocin-Induced##3##1##(2008-8#1)(2012-3#1)(2013-1#1)
Streptozotocin-induced diabetes##2##2##(1993-8#1)(1994-11#1)
Streptozotocin-induced diabetic rats##2##3##(2008-10#2)
Streptozotocin-induced diabetic##3##2##(2008-10#2)(2011-2#1)
Streptozotocin-induced##5##1##(1993-8#1)(1994-11#1)(2008-10#2)(2011-2#1)
Stress Disorder##5##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
Stress Scale##2##2##(2008-3#1)(2010-10#1)
Stress and the##2##3##(1995-2#1)(2008-5#1)
Stress and##12##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#2)(2012-2#1)(2012-3#1)(2013-1#2)
Stress associated with##2##3##(2008-11#1)(2008-12#1)
Stress distribution##2##2##(2009-4#1)(2013-1#1)
Stress is##3##2##(1990-3#1)(2012-3#1)(2013-8#1)
Stress urinary incontinence (SUI)##2##4##(2008-3#1)(2011-1#1)
Stress was##4##2##(1994-6#1)(2008-12#1)(2008-2#1)(2008-6#1)
Stress##72##1##(1990-3#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
Stress-induced increases in##2##3##(2008-6#2)
Stress-induced##5##1##(1996-9#1)(2008-6#2)(2011-2#1)(2013-1#1)
StressDB##4##1##(2008-7#4)
Stresses##3##1##(2008-10#1)(2008-7#1)(2010-10#1)
Stressful##3##1##(2008-7#1)(2009-5#1)(2009-9#1)
Stressor##3##1##(1992-2#1)(1994-3#1)(2011-2#1)
Stressors##3##1##(2012-3#2)(2013-8#1)
Stretch##6##1##(1990-11#1)(1990-12#1)(2007-7#3)(2008-1#1)
Stretching##4##1##(1990-11#1)(1992-2#1)(2008-6#1)(2011-2#1)
Striatal dopamine##2##2##(1996-12#1)(1996-7#1)
Striatal##11##1##(1992-7#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-7#1)(2013-8#1)
Strict quality control##2##3##(1992-9#1)(2008-10#1)
Strict##10##1##(1992-9#1)(1994-1#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
Strictly##2##1##(1994-12#1)(1997-7#1)
Strictures##2##1##(2010-12#1)(2013-8#1)
Stridor##2##1##(2010-12#1)(2013-8#1)
Striga aspera and##2##3##(2008-10#2)
Striga gesnerioides##2##2##(2008-10#2)
Striga hermonthica##5##2##(2008-10#5)
Striga spp##4##2##(2008-10#4)
Striga##16##1##(2008-10#15)(2009-8#1)
Striking a balance##2##3##(2008-1#1)(2013-8#1)
Striking##6##1##(1991-5#1)(1997-2#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
Strikingly##8##1##(1992-7#1)(1994-3#1)(1997-3#1)(2008-2#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
Strip##2##1##(2007-10#1)(2009-2#1)
Stripe Rust##2##2##(2008-10#2)
Stripe rust##3##2##(2008-10#3)
Stripe##8##1##(2008-10#7)(2008-3#1)
Stripping##3##1##(2008-10#2)(2008-4#1)
Strobilurin##2##1##(2008-10#2)
Stroke Centers##2##2##(2007-9#1)(2013-8#1)
Stroke Council##2##2##(2008-8#1)(2012-12#1)
Stroke Scale##3##2##(2007-10#1)(2007-9#1)(2008-3#1)
Stroke Society##6##2##(2008-8#6)
Stroke Study##4##2##(2007-10#2)(2007-9#1)(2008-8#1)
Stroke and##3##2##(2008-8#2)(2012-2#1)
Stroke care in##2##3##(2008-8#2)
Stroke care##3##2##(2008-8#3)
Stroke epidemiology is relatively well characterized in China##2##8##(2008-8#2)
Stroke in the elderly treated for systolic hypertension (SHEP)##2##9##(1991-12#1)(1993-1#1)
Stroke in##6##2##(1991-12#1)(1993-1#1)(2007-10#1)(2008-8#3)
Stroke is the leading cause of##2##6##(2008-8#1)(2013-1#1)
Stroke is the##3##3##(2008-8#1)(2010-10#1)(2013-1#1)
Stroke is##6##2##(1995-5#1)(2008-8#3)(2010-10#1)(2013-1#1)
Stroke unit care##2##3##(2008-8#1)(2009-11#1)
Stroke##93##1##(1991-12#1)(1993-1#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-5#3)(2007-10#15)(2007-11#1)(2007-9#6)(2008-2#2)(2008-3#1)(2008-8#42)(2009-11#2)(2009-4#1)(2010-10#3)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Strokes##2##1##(2007-10#2)
Stromal##8##1##(1994-7#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#2)
Strong Coupling Expansion##2##3##(1996-9#2)
Strong beam coupling##2##3##(2007-12#2)
Strong correlations##3##2##(2009-8#1)(2010-4#1)(2013-1#1)
Strong dependence##2##2##(2008-2#1)(2008-3#1)
Strong evidence for##2##3##(1992-8#1)(2013-1#1)
Strong evidence##5##2##(1992-8#1)(1993-11#1)(2007-12#1)(2013-1#2)
Strong fluorescence##2##2##(1992-9#1)(2008-10#1)
Strong immunoreactivity of##2##3##(1992-8#2)
Strong immunoreactivity##3##2##(1990-7#1)(1992-8#2)
Strong resistance to##2##3##(2008-10#2)
Strong self-phase modulation##2##3##(2007-11#2)
Strong##67##1##(1990-7#1)(1991-1#1)(1992-12#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-8#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#2)(1997-7#1)(2007-11#8)(2007-12#8)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#1)
Stronger##3##1##(2008-6#1)(2008-7#1)(2013-1#1)
Strongly##2##1##(1996-9#1)(2008-11#1)
Strongylocentrotus##2##1##(2009-2#1)(2011-2#1)
Strongyloides stercoralis##2##2##(1997-3#1)(2012-2#1)
Strongyloides##4##1##(1997-3#1)(2008-8#1)(2012-12#1)(2012-2#1)
Stroop color-word##2##2##(2007-12#1)(2007-8#1)
Stroop effect##3##2##(2007-12#1)(2010-6#2)
Stroop task##4##2##(2007-12#1)(2013-1#3)
Stroop##13##1##(1995-11#1)(2007-12#3)(2007-8#1)(2010-6#4)(2013-1#4)
Struct##3##1##(1992-3#1)(1993-11#1)(2011-1#1)
Structural Genomics##2##2##(2008-11#1)(2008-4#1)
Structural MRI##2##2##(2008-11#1)(2008-9#1)
Structural analysis of Arabidopsis thaliana chromosome 5##2##7##(1997-6#1)(1997-8#1)
Structural analysis of the##2##4##(1992-12#1)(2009-7#1)
Structural analysis of##7##3##(1992-12#1)(1997-6#1)(1997-8#1)(2008-4#1)(2009-7#2)(2013-8#1)
Structural analysis##12##2##(1992-12#1)(1994-5#2)(1995-8#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-7#2)(2010-10#1)(2013-8#1)
Structural and functional analysis of##3##5##(1992-3#1)(1997-7#1)(2008-8#1)
Structural and functional##7##3##(1992-3#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-7#1)(2008-8#1)(2012-12#1)
Structural and##13##2##(1992-3#1)(1992-8#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#2)
Structural basis for##3##3##(1991-5#1)(1993-8#1)(1995-8#1)
Structural basis##4##2##(1991-5#1)(1993-8#1)(1995-8#1)(2008-10#1)
Structural changes in##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
Structural changes##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)
Structural characterization of##4##3##(1993-11#1)(1993-3#1)(1995-2#1)(1996-12#1)
Structural determinants##2##2##(1995-11#1)(2008-8#1)
Structural equation modeling##2##3##(2008-6#1)(2010-10#1)
Structural equation##3##2##(2008-6#1)(2010-10#2)
Structural features##2##2##(1995-11#1)(2008-4#1)
Structural information##2##2##(2008-10#2)
Structural insights into##2##3##(2012-2#2)
Structural model##2##2##(2009-3#1)(2010-2#1)
Structural modification of##2##3##(2008-12#1)(2012-1#1)
Structural organization of the##2##4##(1992-12#1)(2007-12#1)
Structural organization of##3##3##(1992-12#1)(2007-12#1)(2008-5#1)
Structural properties##2##2##(1992-5#1)(2008-7#1)
Structural solarization##2##2##(2008-10#2)
Structural studies of the##3##4##(1991-3#1)(1995-11#1)(2011-2#1)
Structural studies of##4##3##(1991-3#1)(1993-11#1)(1995-11#1)(2011-2#1)
Structural study of the##2##4##(1991-12#1)(1993-11#1)
Structural study of##4##3##(1991-12#1)(1991-3#1)(1993-11#1)(2008-10#1)
Structural study##5##2##(1991-12#1)(1991-3#1)(1993-11#1)(2008-10#1)(2008-4#1)
Structural##114##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#3)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#6)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#3)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#2)
Structurally##5##1##(2008-9#1)(2009-12#2)(2012-2#1)(2013-1#1)
Structure and Function##2##3##(2007-12#1)(2013-1#1)
Structure and expression of the##3##5##(1990-12#1)(1997-2#1)(1997-7#1)
Structure and expression of##4##4##(1990-12#1)(1993-2#1)(1997-2#1)(1997-7#1)
Structure and expression##5##3##(1990-12#1)(1993-2#1)(1997-2#1)(1997-7#2)
Structure and function of##3##4##(1990-7#1)(2008-5#1)(2008-8#1)
Structure and function##4##3##(1990-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
Structure and sequence of the human##2##6##(1996-8#1)(2008-7#1)
Structure and##41##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#3)(1997-9#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#3)
Structure determination##2##2##(2008-4#1)(2009-10#1)
Structure in##4##2##(2008-10#2)(2009-10#1)(2012-3#1)
Structure of Mycosphaerella##2##3##(2008-10#2)
Structure of Phytophthora infestans from##2##5##(2008-10#2)
Structure of Phytophthora infestans##3##4##(2008-10#3)
Structure of Phytophthora##5##3##(2008-10#5)
Structure of a Novel##2##4##(1996-2#1)(1997-7#1)
Structure of a##4##3##(1992-3#1)(1996-2#1)(1997-7#2)
Structure of an##2##3##(1993-8#1)(2010-10#1)
Structure of the human##2##4##(1992-10#1)(1994-11#1)
Structure of the##18##3##(1990-11#1)(1990-2#1)(1992-10#1)(1992-12#1)(1993-2#1)(1994-11#1)(1996-12#1)(1996-2#2)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#3)(2008-5#2)
Structure of##62##2##(1990-11#1)(1990-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#1)(1997-7#4)(1997-8#1)(2007-12#1)(2008-10#32)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#2)
Structure##134##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#10)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#7)(1997-8#1)(1997-9#1)(2006-4#1)(2007-12#2)(2008-10#42)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Structure-activity relationship of antioxidants for##2##5##(2008-11#2)
Structure-activity relationship##3##2##(1995-3#1)(2008-11#2)
Structure-activity relationships of##4##3##(1993-5#1)(1995-11#1)(2008-4#1)(2013-8#1)
Structure-activity relationships##5##2##(1993-5#1)(1995-11#1)(2007-11#1)(2008-4#1)(2013-8#1)
Structure-activity##11##1##(1992-3#1)(1992-6#1)(1993-5#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-8#1)
Structure-based##2##1##(1997-2#1)(2013-1#1)
Structure-function relationships in the##2##4##(1992-4#1)(2008-7#1)
Structure-function##4##1##(1991-2#1)(1991-9#1)(1992-4#1)(2008-7#1)
Structured Clinical Interview for##3##4##(2012-12#2)(2013-1#1)
Structured Clinical##7##2##(1996-2#1)(2008-11#2)(2012-12#2)(2012-3#1)(2013-1#1)
Structured Query Language (SQL)##2##4##(2008-4#2)
Structured##16##1##(1996-12#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-11#3)(2008-4#2)(2008-9#1)(2010-11#1)(2012-12#2)(2012-3#2)(2013-1#1)
Structures and##4##2##(2008-11#1)(2008-9#1)(2012-12#1)(2013-1#1)
Structures in##2##2##(2008-2#1)(2009-10#1)
Structures of##9##2##(1990-5#1)(1992-12#1)(1996-2#4)(1997-7#1)(2008-8#1)(2011-1#1)
Structures##21##1##(1990-5#1)(1992-12#1)(1996-1#1)(1996-2#4)(1997-7#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
Structuring group medical practices##4##4##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
Structuring##6##1##(1991-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)
Strzelecki Ranges##2##2##(2009-12#2)
Stuart H##3##2##(1994-12#2)(1994-3#1)
Stuart##4##1##(1994-12#2)(1994-3#1)(2008-10#1)
Student Nurse Stress Index##3##4##(2008-11#3)
Student nurses'##4##2##(2008-11#3)(2010-3#1)
Student perceptions of syndicate##2##4##(2012-1#2)
Student perceptions of##3##3##(2012-1#2)(2013-1#1)
Student t-test##2##2##(2011-1#1)(2011-2#1)
Student##26##1##(1997-2#1)(1997-8#1)(2008-11#7)(2008-12#2)(2009-8#1)(2010-10#2)(2010-3#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#2)
Student's t test##2##3##(2007-8#1)(2012-2#1)
Student's t##3##2##(2007-8#1)(2008-7#1)(2012-2#1)
Student's t-test##14##2##(1994-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
Student's##21##1##(1990-9#1)(1994-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Students also##4##2##(2008-11#3)(2009-7#1)
Students and##3##2##(2008-11#1)(2009-12#1)(2010-10#1)
Students are##2##2##(2008-11#2)
Students have##2##2##(1992-3#1)(1996-12#1)
Students identified##2##2##(2008-11#1)(2008-12#1)
Students in##2##2##(2008-12#1)(2013-8#1)
Students reported##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
Students who##2##2##(2011-1#1)(2012-1#1)
Students##44##1##(1992-3#1)(1992-6#1)(1994-1#1)(1996-12#1)(2008-1#1)(2008-11#12)(2008-12#7)(2008-5#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
Students'##8##1##(1992-6#2)(2008-11#1)(2010-3#3)(2012-2#2)
Studied by##5##2##(1996-2#1)(2008-10#2)(2009-8#1)(2013-1#1)
Studied##8##1##(1996-2#1)(1997-7#1)(2008-10#4)(2009-8#1)(2013-1#1)
Studier [Proc##2##2##(1990-11#1)(1990-5#1)
Studies 1 and 2##3##4##(2007-12#2)(2008-12#1)
Studies 1 and##4##3##(2007-12#3)(2008-12#1)
Studies and##5##2##(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#2)
Studies are also reviewed##2##4##(1993-12#1)(2010-10#1)
Studies are ongoing##2##3##(2008-7#1)(2009-4#1)
Studies are##5##2##(1993-12#1)(2007-10#1)(2008-7#1)(2009-4#1)(2010-10#1)
Studies at the##2##3##(1990-6#1)(1997-5#1)
Studies at##3##2##(1990-6#1)(1997-5#1)(2008-12#1)
Studies by##4##2##(1995-2#1)(2008-10#1)(2008-2#1)(2012-12#1)
Studies carried out##2##3##(2008-10#1)(2010-11#1)
Studies conducted in##2##3##(2007-12#1)(2010-11#1)
Studies conducted##3##2##(2007-12#1)(2008-5#1)(2010-11#1)
Studies evaluating##2##2##(2008-10#1)(2012-12#1)
Studies for##2##2##(2008-11#1)(2010-11#1)
Studies from our laboratory have##2##5##(1993-6#1)(2008-7#1)
Studies from##6##2##(1993-6#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
Studies have demonstrated that##2##4##(2010-12#1)(2010-3#1)
Studies have shown that##8##4##(2008-11#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Studies have shown##9##3##(2008-11#1)(2008-3#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Studies have suggested##2##3##(2008-10#1)(2012-3#1)
Studies have##22##2##(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
Studies in humans have##2##4##(2007-11#1)(2008-6#1)
Studies in humans##3##3##(2007-11#1)(2008-6#1)(2009-8#1)
Studies in mice##3##3##(1995-5#1)(2008-10#1)(2010-5#1)
Studies in the##3##3##(1990-3#1)(2008-10#1)(2008-4#1)
Studies in##23##2##(1990-3#1)(1991-3#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-9#1)
Studies indicate that##2##3##(2010-6#1)(2011-2#1)
Studies involving##2##2##(2008-1#1)(2008-10#1)
Studies of bosentan in##2##4##(2009-10#1)(2010-10#1)
Studies of human##2##3##(1995-12#1)(2008-2#1)
Studies of the##16##3##(1991-1#1)(1992-3#1)(1996-2#1)(1997-6#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-12#1)
Studies of##73##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-5#2)(1997-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#4)(2013-1#2)
Studies on derivatization##2##3##(2008-10#2)
Studies on the N-acetyl-beta-D-hexosaminidase B from germinating Lupinus luteus L##2##10##(1990-5#2)
Studies on the effect of##2##5##(1994-6#1)(2008-10#1)
Studies on the structure and##2##5##(1990-5#1)(1992-11#1)
Studies on the##40##3##(1990-11#1)(1990-5#3)(1991-12#1)(1991-5#1)(1992-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-5#1)(2006-6#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-12#1)(2013-1#1)
Studies on##80##2##(1990-11#1)(1990-5#3)(1991-12#1)(1991-5#1)(1992-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-5#3)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Studies show##2##2##(2007-12#1)(2008-8#1)
Studies suggest that##5##3##(1996-11#1)(2007-2#1)(2008-5#1)(2008-8#1)(2009-10#1)
Studies that##6##2##(2006-10#1)(2007-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
Studies to determine the##3##4##(1994-11#1)(2009-4#1)(2010-3#1)
Studies to evaluate##2##3##(2008-10#1)(2008-5#1)
Studies to##7##2##(1994-11#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-3#1)(2011-2#1)
Studies using isolated##2##3##(2012-2#2)
Studies using##9##2##(1990-11#1)(1992-11#1)(1993-11#1)(1994-9#1)(2007-8#1)(2008-10#1)(2012-2#2)(2013-1#1)
Studies were also##2##3##(1994-10#1)(1996-1#1)
Studies were carried out on the effect of retention and elution conditions for both##2##14##(2008-10#2)
Studies were conducted to##3##4##(2008-10#2)(2008-11#1)
Studies were conducted with female BALB/c mice to evaluate the potential for##2##12##(2008-9#2)
Studies were conducted##6##3##(2008-10#3)(2008-11#1)(2008-9#2)
Studies were performed on##2##4##(2009-8#1)(2011-2#1)
Studies were performed##4##3##(1994-3#1)(1996-2#1)(2009-8#1)(2011-2#1)
Studies were##19##2##(1994-10#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Studies which##2##2##(2012-12#1)(2013-8#1)
Studies with##8##2##(1992-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)
Studies##341##1##(1990-11#3)(1990-3#1)(1990-5#4)(1990-6#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-11#3)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-8#3)(2008-1#4)(2008-10#57)(2008-11#13)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#5)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2011-9#1)(2012-1#1)(2012-12#7)(2012-2#13)(2012-3#4)(2013-1#13)(2013-8#8)
Studies)##2##1##(1996-9#1)(2008-12#1)
Study 1##16##2##(1991-2#2)(1994-9#1)(2007-12#2)(2007-8#1)(2008-12#3)(2009-5#1)(2009-9#2)(2010-10#1)(2010-4#2)(2010-8#1)
Study 2 used##2##3##(1991-2#1)(2008-12#1)
Study 2##16##2##(1991-2#2)(1994-9#1)(2007-12#1)(2007-8#1)(2008-12#3)(2009-5#1)(2009-9#2)(2010-10#1)(2010-4#2)(2010-8#1)(2013-8#1)
Study 3##6##2##(1994-9#1)(2007-12#2)(2008-12#1)(2009-9#1)(2010-4#1)
Study Design##10##2##(2010-8#1)(2013-1#9)
Study Group##25##2##(1990-11#2)(1991-11#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1994-3#2)(1995-11#1)(1995-8#1)(1996-3#1)(1997-7#2)(1997-8#1)(2010-3#2)(2011-2#6)
Study Team##2##2##(1992-12#1)(1993-9#1)
Study and##3##2##(2008-10#3)
Study by##2##2##(1990-5#1)(1991-11#1)
Study design##21##2##(2012-12#19)(2013-1#2)
Study findings##2##2##(1994-3#1)(2010-4#1)
Study finds##2##2##(2007-1#2)
Study in##8##2##(2007-8#1)(2008-3#3)(2008-6#1)(2009-12#1)(2009-7#1)(2013-1#1)
Study is##2##2##(2007-11#1)(2008-12#1)
Study limitations##2##2##(2008-1#1)(2009-11#1)
Study of Prevalence##2##3##(2008-11#1)(2012-2#1)
Study of a##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2010-1#1)(2012-12#1)
Study of an##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
Study of antioxidant properties of##2##5##(2008-10#2)
Study of the mechanical##2##4##(2007-11#1)(2008-3#1)
Study of the##29##3##(1995-3#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#2)(2010-1#1)(2010-6#1)(2010-9#1)(2012-2#1)
Study of two##2##3##(2009-7#1)(2012-2#1)
Study of##125##2##(1991-11#1)(1992-2#1)(1993-11#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#3)(1996-5#1)(1997-5#1)(1997-7#2)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#4)(2009-7#3)(2010-1#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#3)
Study on the##13##3##(2008-10#7)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#2)
Study on##30##2##(1996-2#1)(2008-10#13)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
Study participants##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
Study rationale##2##2##(2012-12#2)
Study results indicate that##2##4##(2008-3#1)(2013-8#1)
Study results show that##2##4##(2008-12#1)(2013-8#1)
Study results show##3##3##(2008-12#1)(2013-8#2)
Study results##8##2##(1991-8#1)(1993-3#1)(1997-5#1)(2008-12#1)(2008-3#1)(2013-8#3)
Study revealed##2##2##(2007-7#1)(2011-2#1)
Study subjects##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
Study to##2##2##(2008-3#1)(2008-7#1)
Study was##3##2##(1991-2#1)(2007-11#1)(2011-2#1)
Study with##2##2##(2008-12#1)(2010-6#1)
Study##452##1##(1990-11#3)(1990-5#1)(1991-11#3)(1991-2#5)(1991-8#4)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-3#3)(1994-6#3)(1994-9#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#7)(1996-3#1)(1996-5#2)(1996-8#1)(1997-5#2)(1997-7#5)(1997-8#1)(2006-10#1)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#6)(2007-12#11)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#14)(2008-10#53)(2008-11#5)(2008-12#23)(2008-2#1)(2008-3#16)(2008-4#1)(2008-5#12)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#3)(2009-7#5)(2009-8#1)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#8)(2010-5#2)(2010-6#8)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#10)(2011-2#22)(2012-12#26)(2012-2#11)(2012-3#7)(2013-1#38)(2013-7#1)(2013-8#13)
Study)##2##1##(2012-12#1)(2012-2#1)
Studying the##7##2##(1994-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
Studying##17##1##(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-8#1)
Stunt##3##1##(2008-10#2)(2011-2#1)
Stuttering##2##1##(2008-2#1)(2012-12#1)
Stx##7##1##(2011-1#4)(2013-1#3)
Stx2##3##1##(2013-1#3)
StxB##4##1##(2008-8#3)(2011-1#1)
Styela##3##1##(2008-6#1)(2008-7#2)
Style##4##1##(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
Styles Inventory##3##2##(2012-2#3)
Stylosanthes populations##2##2##(2008-10#2)
Stylosanthes scabra##2##2##(2008-10#2)
Stylosanthes spp##3##2##(2008-10#3)
Stylosanthes##10##1##(2008-10#10)
Stöber##2##1##(2008-10#2)
SuMV##6##1##(2008-10#6)
Suaveolentes##2##1##(2013-1#2)
Sub-Doppler molecular-iodine transitions near the dissociation limit (523-498 nm)##2##9##(2007-11#2)
Sub-Doppler##4##1##(2007-11#3)(2008-2#1)
Sub-Saharan Africa##6##2##(1995-9#1)(1997-7#1)(2008-11#1)(2008-8#2)(2011-1#1)
SubSaharan##2##1##(2011-2#2)
Subacute##4##1##(1996-6#1)(2007-7#1)(2011-2#1)(2012-12#1)
Subarachnoid Hemorrhage##4##2##(1995-11#1)(2011-2#1)(2012-3#2)
Subarachnoid hemorrhage (SAH)##2##3##(1995-5#1)(2007-10#1)
Subarachnoid hemorrhage##3##2##(1995-5#1)(2007-10#1)(2012-2#1)
Subarachnoid##11##1##(1995-11#2)(1995-5#1)(2007-10#3)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
Subcellular distribution of rare earth elements##2##6##(2008-10#2)
Subcellular distribution of##3##3##(1990-5#1)(2008-10#2)
Subcellular fractionation of tissue culture cells##2##6##(2008-4#2)
Subcellular fractionation of##3##3##(1990-7#1)(2008-4#2)
Subcellular fractionation##4##2##(1990-7#1)(1995-6#1)(2008-4#2)
Subcellular localization of##5##3##(1990-5#1)(2008-9#2)(2009-8#1)(2011-2#1)
Subcellular##13##1##(1990-5#2)(1990-7#1)(1995-6#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#1)
Subcentimeter pulmonary nodules detected in patients with sarcoma##2##8##(2008-6#2)
Subcentimeter pulmonary nodules##3##3##(2008-6#3)
Subchronic##3##1##(1995-3#1)(1996-2#1)(2008-5#1)
Subclavian##5##1##(1993-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2010-5#1)
Subclinical cecal impaction##2##3##(2013-8#2)
Subclinical cerebral infarcts##2##3##(2008-8#2)
Subclinical##6##1##(2008-8#2)(2012-3#2)(2013-8#2)
Subcloning##2##1##(1990-11#1)(2008-6#1)
Subcommittee on##3##2##(1995-6#1)(1996-5#1)(2008-4#1)
Subcommittee##5##1##(1995-6#1)(1996-5#1)(2007-11#1)(2008-4#1)(2010-8#1)
Subcutaneous emphysema##2##2##(1993-1#2)
Subcutaneous fat##3##2##(2010-4#2)(2012-2#1)
Subcutaneous injection of##3##3##(1992-8#1)(1994-12#1)(1995-12#1)
Subcutaneous injection##4##2##(1992-8#1)(1994-12#1)(1995-12#1)(2008-5#1)
Subcutaneous phycomycosis##2##2##(2007-7#2)
Subcutaneous zygomycosis caused by Basidiobolus ranarum##2##6##(2007-7#2)
Subcutaneous zygomycosis##3##2##(2007-7#3)
Subcutaneous##24##1##(1991-5#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(2007-7#5)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-2#1)
Subdivision of the##2##3##(2008-10#1)(2011-2#1)
Subdural##3##1##(2007-2#1)(2012-2#1)(2012-3#1)
Subfamily##3##1##(2008-10#1)(2008-5#1)(2013-1#1)
Subglottic##2##1##(2010-4#1)(2011-2#1)
Subgroup I##2##2##(2008-10#2)
Subgroup##5##1##(2008-10#5)
Subgroups##4##1##(1991-11#1)(1995-12#1)(2008-10#1)(2011-2#1)
Subject##9##1##(1993-3#1)(1995-1#1)(1996-11#1)(2008-5#1)(2008-6#3)(2012-3#1)(2013-1#1)
Subjecting the##2##2##(2008-10#1)(2008-5#1)
Subjecting##4##1##(2007-6#1)(2008-10#1)(2008-5#1)(2010-4#1)
Subjective assessment of complications was##2##5##(1992-12#2)
Subjective invulnerability##3##2##(2010-7#3)
Subjective##20##1##(1991-8#1)(1992-12#2)(1996-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-6#2)(2010-7#3)(2011-2#1)(2012-3#2)(2013-1#2)
Subjects and Methods##6##3##(2008-6#2)(2013-1#3)(2013-8#1)
Subjects and methods##5##3##(2008-6#3)(2009-8#1)(2012-3#1)
Subjects and##12##2##(2008-6#5)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Subjects are##2##2##(1990-12#1)(2008-7#1)
Subjects at##2##2##(2008-3#1)(2009-12#1)
Subjects consisted of##2##3##(1994-7#1)(2007-6#1)
Subjects in either##2##3##(1994-3#1)(2007-6#1)
Subjects in the##6##3##(1991-12#1)(2008-4#3)(2008-5#2)
Subjects in##12##2##(1991-12#1)(1994-3#1)(2007-6#2)(2008-4#3)(2008-5#4)(2010-4#1)
Subjects then##2##2##(2008-5#1)(2008-9#1)
Subjects were instructed to##3##4##(1991-2#1)(2008-3#1)(2010-9#1)
Subjects were##23##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-1#1)(2010-7#1)(2010-9#1)(2012-2#2)(2013-1#3)
Subjects who##2##2##(2008-10#1)(2008-7#1)
Subjects with a##2##3##(2008-7#1)(2008-9#1)
Subjects with##13##2##(1993-9#1)(2008-1#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
Subjects##103##1##(1990-12#1)(1991-11#1)(1991-12#2)(1991-2#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-6#5)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#4)(2008-3#3)(2008-4#4)(2008-5#12)(2008-6#13)(2008-7#5)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
Sublethal##3##1##(1994-8#1)(2008-10#1)(2008-5#1)
Submandibular##2##1##(2011-1#2)
Submillimeter##2##1##(2008-3#2)
Submodel -- controls the##2##4##(1996-12#2)
Submodel -- determines##2##3##(1996-12#2)
Submodel --##5##2##(1996-12#5)
Subnanosecond##2##1##(2008-2#2)
Subpopulation##2##1##(2008-10#1)(2008-7#1)
Subpopulations of##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
Subpopulations##4##1##(1993-12#1)(2008-10#2)(2008-11#1)
Subretinal##2##1##(2010-9#1)(2012-3#1)
Subsaharan Africa##2##2##(1991-11#1)(2012-2#1)
Subsaharan##3##1##(1991-11#1)(2008-10#1)(2012-2#1)
Subscale##2##1##(2007-7#1)(2013-1#1)
Subsequent investigation##2##2##(2011-2#2)
Subsequent investigations##2##2##(2008-10#1)(2008-11#1)
Subsequent research##3##2##(2009-7#1)(2011-2#1)(2012-12#1)
Subsequent studies##2##2##(2008-11#1)(2012-1#1)
Subsequent to the##2##3##(2008-10#1)(2009-11#1)
Subsequent to##5##2##(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-11#1)
Subsequent work##2##2##(2008-11#1)(2011-1#1)
Subsequent##62##1##(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-3#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)
Subsequently the##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
Subsequently we##2##2##(1997-2#1)(2008-3#1)
Subsequently##86##1##(1990-12#1)(1990-6#1)(1990-9#1)(1992-10#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)
Subset##2##1##(1994-12#1)(1994-7#1)
Subsets##3##1##(2008-10#2)(2013-8#1)
Subsp##4##1##(2007-11#4)
Substance Abuse Treatment##3##3##(2010-10#1)(2010-11#1)(2012-12#1)
Substance Abuse##5##2##(2010-10#1)(2010-11#1)(2010-6#1)(2012-12#2)
Substance P##4##2##(1992-3#1)(1994-8#2)(2008-7#1)
Substance Use##7##2##(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
Substance abuse and##2##3##(1992-1#1)(2013-1#1)
Substance abuse##6##2##(1991-1#1)(1992-1#1)(2009-10#1)(2009-9#1)(2013-1#1)(2013-8#1)
Substance use##2##2##(1997-5#1)(2008-9#1)
Substance##29##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1994-8#2)(1997-5#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#4)(2013-1#3)(2013-7#1)(2013-8#1)
Substances##6##1##(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)
Substantial evidence indicates that##2##4##(2008-11#1)(2008-5#1)
Substantial evidence##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
Substantial##15##1##(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-4#1)(2013-7#1)
Substituted##8##1##(1996-10#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)
Substitutes##2##1##(2010-5#1)(2012-3#1)
Substitution and##2##2##(2006-10#1)(2008-9#1)
Substitution of asparagine for##2##4##(1991-9#1)(1997-3#1)
Substitution of##16##2##(1990-5#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1997-3#1)(2008-10#1)(2009-5#1)(2011-2#1)
Substitution##22##1##(1990-5#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-3#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
Substitutions at##2##2##(1994-5#1)(2013-1#1)
Substitutions in the##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
Substitutions in##4##2##(1997-4#1)(1997-9#1)(2008-10#1)(2012-3#1)
Substitutions##7##1##(1994-5#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
Substrate for##2##2##(1996-5#1)(2008-10#1)
Substrate specificity##2##2##(1992-3#1)(1995-2#1)
Substrate##16##1##(1992-3#1)(1992-8#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#4)(2011-2#1)
Substrate-dependent##2##1##(1990-12#1)(1990-7#1)
Substrates##3##1##(1995-6#1)(2009-5#1)(2009-6#1)
Subsurface##4##1##(2008-10#2)(2008-2#1)(2009-7#1)
Subtalar##2##1##(2008-12#1)(2012-3#1)
Subthalamic##2##1##(2008-9#1)(2012-2#1)
Subtraction of the##2##3##(2008-2#1)(2008-3#1)
Subtypes##4##1##(2006-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
Subtyping##2##1##(1994-2#1)(2007-10#1)
Subunit##3##1##(1990-5#1)(2008-8#1)(2012-3#1)
Subwavelength##2##1##(2007-12#1)(2008-3#1)
Success in##3##2##(1994-12#1)(1995-12#1)(2007-12#1)
Success is##2##2##(2008-10#1)(2008-11#1)
Success of##4##2##(1996-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
Success##20##1##(1992-2#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
Successful Treatment of##2##3##(2006-10#1)(2010-9#1)
Successful aging##2##2##(2008-8#1)(2013-1#1)
Successful application of##2##3##(2008-10#1)(2008-9#1)
Successful application##3##2##(2008-10#1)(2008-9#2)
Successful fund raising##2##3##(1991-1#1)(1997-1#1)
Successful health care##2##3##(1994-2#1)(1997-3#1)
Successful implementation of##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
Successful implementation##5##2##(1995-2#1)(1997-2#2)(2008-10#1)(2008-7#1)
Successful management of##4##3##(2007-10#1)(2008-10#2)(2008-7#1)
Successful management##5##2##(2006-10#1)(2007-10#1)(2008-10#2)(2008-7#1)
Successful medical treatment of##2##4##(2007-10#1)(2007-8#1)
Successful medical##3##2##(2007-10#1)(2007-8#1)(2013-8#1)
Successful outcome##3##2##(1995-3#1)(2012-12#1)(2013-1#1)
Successful outcomes##2##2##(1991-12#1)(2008-8#1)
Successful resection of##2##3##(2008-6#1)(2008-7#1)
Successful surgical##2##2##(2007-8#1)(2012-3#1)
Successful treatment of##7##3##(1991-4#1)(2008-1#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
Successful treatment with##2##3##(2009-8#1)(2010-8#1)
Successful treatment##12##2##(1991-4#1)(2008-1#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
Successful use of##2##3##(2008-1#1)(2008-3#1)
Successful##107##1##(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-1#2)(1993-12#2)(1994-1#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#3)
Successfully##6##1##(1990-12#1)(1993-2#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
Successive##6##1##(1995-3#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
Succinate##2##1##(1990-7#1)(2008-12#1)
Succinic acid##2##2##(2008-6#2)
Succinic semialdehyde##2##2##(1997-2#2)
Succinic##5##1##(1997-2#2)(2008-6#2)(2009-7#1)
Such &quot##3##2##(2008-8#1)(2009-8#1)(2010-10#1)
Such a change##2##3##(2008-11#1)(2010-7#1)
Such a high##2##3##(1991-6#1)(2007-11#1)
Such a model##3##3##(1996-12#1)(2013-1#1)(2013-8#1)
Such a phenomenon##3##3##(2007-12#1)(2008-10#2)
Such a process##2##3##(2008-3#1)(2012-12#1)
Such a relationship##2##3##(2008-5#1)(2008-9#1)
Such a response##2##3##(1994-3#1)(1997-3#1)
Such a system##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
Such a##80##2##(1990-2#1)(1990-5#2)(1991-12#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#3)(1996-12#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-11#5)(2007-12#3)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#11)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
Such ability of##2##3##(1995-11#1)(2008-10#1)
Such ability##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
Such activities##2##2##(1992-8#1)(1995-1#1)
Such an approach##5##3##(1990-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
Such an optical##2##3##(2007-11#1)(2008-3#1)
Such an##36##2##(1990-12#1)(1990-8#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
Such analyses##2##2##(1992-6#1)(1995-12#1)
Such approaches##2##2##(1996-7#1)(2008-4#1)
Such changes##4##2##(1991-12#1)(1993-9#1)(2008-10#1)(2011-2#1)
Such characteristics##2##2##(2008-11#2)
Such conditions##2##2##(2008-3#1)(2011-2#1)
Such cultures##2##2##(1994-11#1)(1995-6#1)
Such data suggest that##2##4##(1993-1#1)(2012-1#1)
Such data##7##2##(1992-10#1)(1993-1#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
Such designs##2##2##(1997-8#1)(2011-2#1)
Such devices could##2##3##(2008-2#1)(2008-7#1)
Such devices##4##2##(2008-2#2)(2008-3#1)(2008-7#1)
Such differences were##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
Such differences##4##2##(1993-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
Such disorders##2##2##(1991-3#1)(2013-1#1)
Such electrodes##2##2##(2008-10#2)
Such elements##2##2##(2007-11#1)(2008-3#1)
Such evidence##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
Such factors##2##2##(2009-5#1)(2010-11#1)
Such hybrid##2##2##(2008-7#1)(2010-4#1)
Such information can be##2##4##(2013-1#2)
Such information can##3##3##(2008-10#1)(2013-1#2)
Such information is##2##3##(2007-12#1)(2009-12#1)
Such information##8##2##(2006-12#1)(2007-12#1)(2008-10#3)(2009-12#1)(2013-1#2)
Such interactions##3##2##(2008-12#1)(2008-8#1)(2011-1#1)
Such investigations##2##2##(2008-10#1)(2011-2#1)
Such knowledge##4##2##(1993-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
Such lesions##3##2##(2006-10#1)(2008-12#1)(2012-12#1)
Such low##2##2##(2007-12#1)(2008-10#1)
Such measurements are##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
Such measures include##2##3##(2007-7#1)(2008-12#1)
Such measures##4##2##(1990-2#1)(2007-7#2)(2008-12#1)
Such methodology##2##2##(2008-10#1)(2012-2#1)
Such methods##5##2##(1994-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
Such models##2##2##(1994-11#1)(2008-5#1)
Such networks##2##2##(2008-11#1)(2008-3#1)
Such patients##2##2##(2010-5#1)(2012-2#1)
Such patterns##2##2##(2008-10#2)
Such procedures##2##2##(1993-6#1)(2008-2#1)
Such results suggested that##2##4##(1997-4#2)
Such results##6##2##(1993-3#1)(1997-4#2)(2007-11#1)(2008-3#1)(2008-5#1)
Such sequences have been##2##4##(1992-6#1)(1993-6#1)
Such sequences##3##2##(1992-6#1)(1993-6#1)(1995-11#1)
Such studies have##2##3##(2008-4#1)(2011-2#1)
Such studies##11##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#3)(2011-2#2)
Such systems##3##2##(2008-11#1)(2008-2#1)(2013-8#1)
Such##425##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#2)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#5)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#14)(2007-12#11)(2007-6#1)(2007-7#5)(2007-9#1)(2008-1#2)(2008-10#65)(2008-11#16)(2008-12#6)(2008-2#12)(2008-3#26)(2008-4#10)(2008-5#13)(2008-6#5)(2008-7#18)(2008-8#16)(2008-9#7)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#7)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#9)(2013-8#2)
Suck##2##1##(2009-6#2)
Sucre##7##1##(2007-5#1)(2008-12#2)(2008-5#1)(2011-2#3)
Sucrose##4##1##(1994-6#1)(2008-10#2)(2011-2#1)
Sud##3##1##(2008-11#1)(2008-3#1)(2010-6#1)
Sudan Black##2##2##(2009-7#2)
Sudan III##3##2##(1996-12#3)
Sudan III-pretreatment##2##2##(1996-12#2)
Sudan##28##1##(1992-2#1)(1996-12#6)(2007-10#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-4#2)(2008-8#1)(2009-2#1)(2009-7#2)(2011-2#2)(2013-1#3)
Sudanese women were##3##3##(2013-1#3)
Sudanese women##8##2##(2013-1#8)
Sudanese##9##1##(2013-1#9)
Sudden Cardiac Death##2##3##(2009-9#1)(2012-3#1)
Sudden Death Syndrome##2##3##(2008-10#2)
Sudden Infant Death Syndrome (SIDS) or##2##6##(2008-1#2)
Sudden Infant Death Syndrome (SIDS)##3##5##(2007-10#1)(2008-1#2)
Sudden Oak Death##2##3##(2008-10#2)
Sudden cardiac death in young athletes##2##6##(2012-3#2)
Sudden cardiac death##4##3##(1992-6#1)(2012-3#3)
Sudden death in##2##3##(1991-11#1)(2008-12#1)
Sudden death##6##2##(1991-11#1)(2008-10#2)(2008-12#1)(2009-10#1)(2011-1#1)
Sudden oak death##3##3##(2008-10#2)(2009-2#1)
Sudden##31##1##(1991-11#1)(1992-4#1)(1992-6#1)(1994-9#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)
Sue##2##1##(1993-9#1)(1997-5#1)
Suffering and suffering with the other - the perspective of perioperative nurse leaders##2##13##(2012-3#2)
Suffering as##2##2##(2012-3#2)
Suffering is##2##2##(2012-3#2)
Suffering##8##1##(1991-8#1)(2012-12#1)(2012-3#6)
Sufficient for##2##2##(2008-10#1)(2012-3#1)
Sufficient##8##1##(1994-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-12#1)(2012-3#1)
Sugar Beet##6##2##(2008-10#5)(2012-3#1)
Sugar and children's behavior##5##4##(1994-6#5)
Sugar and##6##2##(1994-6#5)(2008-10#1)
Sugar##22##1##(1992-12#1)(1994-6#5)(1996-5#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
Sugarcane##11##1##(2008-10#11)
Sugars##3##1##(2008-10#2)(2008-6#1)
Suggested##4##1##(1995-12#1)(2008-12#2)(2008-3#1)
Suggesting a cost##2##3##(2009-9#2)
Suggestions are##2##2##(1996-1#1)(2008-4#1)
Suggestions for future##2##3##(1997-2#1)(2010-9#1)
Suggestions for the##3##3##(1992-1#1)(1993-1#1)(2008-11#1)
Suggestions for##7##2##(1991-12#1)(1992-1#1)(1993-1#1)(1993-3#1)(1997-2#1)(2008-11#1)(2010-9#1)
Suggestions##15##1##(1991-12#1)(1992-1#1)(1993-1#2)(1993-3#1)(1994-2#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-9#1)(2012-2#1)(2013-7#1)
Suggests##7##1##(2008-10#7)
Suicidal behavior##2##2##(2012-12#1)(2013-1#1)
Suicidal ideation##2##2##(2008-11#1)(2013-1#1)
Suicidal risk factors##2##3##(2009-7#1)(2010-6#1)
Suicidal##11##1##(2008-11#1)(2009-7#2)(2010-6#1)(2010-8#1)(2012-12#3)(2013-1#3)
Suicide by##2##2##(2009-2#2)
Suicide##18##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2008-7#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-9#2)(2012-2#1)(2013-8#2)
Suitability##3##1##(2008-10#1)(2008-5#1)(2008-6#1)
Suitable##7##1##(1990-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-8#1)(2010-7#1)
Suite##3##1##(2011-1#1)(2012-12#2)
Sulfamic##2##1##(1993-1#1)(2008-10#1)
Sulfate transport##2##2##(2008-6#2)
Sulfate##8##1##(1992-12#1)(1997-6#2)(2008-6#2)(2012-2#2)(2013-8#1)
Sulfhydryl##2##1##(1991-9#1)(1993-6#1)
Sulfinimine-derived##2##1##(2008-11#2)
Sulfite##3##1##(1994-11#1)(2008-10#2)
Sulfolobus shibatae##2##2##(2008-9#2)
Sulfolobus##5##1##(1990-2#1)(2008-9#4)
Sulfonamides##3##1##(2008-10#2)(2010-6#1)
Sulfonylcalix[4]arenetetrasulfonate##2##1##(2008-10#2)
Sulfur##5##1##(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)
Sulfurimonas autotrophica##2##2##(2011-2#2)
Sulfurimonas##4##1##(2011-2#4)
Sulfurospirillum deleyianum##4##2##(1994-11#2)(2011-2#2)
Sulfurospirillum##6##1##(1994-11#2)(2011-2#4)
Sullivan was##2##2##(1997-5#2)
Sullivan##8##1##(1993-1#1)(1997-5#5)(2008-6#2)
Sullivan's method##3##2##(2011-2#3)
Sullivan's##9##1##(1997-5#5)(2011-2#4)
Sulphate##4##1##(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
Sulphoxine##2##1##(2008-10#2)
Sum Frequency##4##2##(2008-10#2)(2008-2#1)(2009-7#1)
Sum##5##1##(2008-10#2)(2008-2#1)(2009-7#1)(2012-3#1)
Sum-Frequency Mixing##2##2##(2008-2#2)
Sum-Frequency##3##1##(2008-2#2)(2008-3#1)
Sum-frequency##2##1##(2007-12#1)(2008-2#1)
Sumai 3##2##2##(2008-10#2)
Sumatriptan is##2##2##(1994-11#2)
Sumatriptan##3##1##(1994-11#3)
Summary of##7##2##(2007-12#2)(2007-2#1)(2007-8#1)(2008-8#1)(2012-12#1)(2013-8#1)
Summary##70##1##(1994-9#1)(1995-11#5)(1995-5#1)(1996-1#1)(1996-3#5)(1996-6#6)(1996-9#7)(1997-3#9)(1997-6#6)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#7)(2013-8#1)
Summer##8##1##(1993-3#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2013-1#1)
Summit##3##1##(2008-8#1)(2009-12#1)(2011-2#1)
Sumner##2##1##(2008-10#2)
Sun and##2##2##(2008-2#2)
Sun exposure##2##2##(2008-5#1)(2011-2#1)
Sun pillars##2##2##(2008-2#2)
Sun positions and##2##3##(2008-3#2)
Sun##40##1##(1991-6#1)(1991-9#1)(2007-10#3)(2007-12#1)(2008-10#1)(2008-2#13)(2008-3#11)(2008-5#3)(2010-8#3)(2011-2#3)
Sundays##2##1##(1994-9#1)(2008-10#1)
Sunflower mosaic virus##2##3##(2008-10#2)
Sunflower mosaic##3##2##(2008-10#3)
Sunflower##8##1##(2008-10#8)
Sunnybrook Health Science Centre##6##4##(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)
Sunnybrook Health Science##7##3##(1992-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)
Sunnybrook##13##1##(1992-1#1)(1992-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#3)(1997-3#1)(2007-9#1)(2008-7#2)
Sunnybrook's##2##1##(1992-12#1)(1996-2#1)
Sunnyvale##5##1##(1996-1#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)
Sunscreen##4##1##(1997-2#1)(2008-3#1)(2008-5#2)
Sunscreens are##3##2##(1991-6#1)(2011-2#2)
Sunscreens##4##1##(1991-6#1)(2008-5#1)(2011-2#2)
Sunset Yellow and##2##3##(2008-10#2)
Sunset Yellow##7##2##(2008-10#7)
Sunset##9##1##(2008-10#8)(2008-2#1)
Super Soothie##2##2##(2009-6#2)
Super##6##1##(2007-11#1)(2008-3#1)(2009-4#1)(2009-6#2)(2012-2#1)
Super-CHO cells##2##2##(2008-11#2)
Super-CHO##6##1##(2008-11#6)
Super-RENS##3##1##(2008-3#3)
Super-selective##2##1##(1991-6#1)(1997-3#1)
Superconducting##5##1##(1994-9#1)(1996-12#1)(1996-9#1)(2008-7#1)(2010-7#1)
Superconductivity##2##1##(1994-9#2)
Superconductors##2##1##(1990-8#1)(1996-12#1)
Supercritical carbon dioxide extraction##2##4##(2008-10#2)
Supercritical carbon dioxide##3##3##(2008-10#3)
Supercritical fluid extraction of resveratrol from grape skin of Vitis vinifera##2##11##(2008-10#2)
Supercritical fluid extraction of##5##4##(2008-10#5)
Supercritical fluid extraction##9##3##(2008-10#8)(2012-2#1)
Supercritical fluid technology##2##3##(2012-2#2)
Supercritical fluid##12##2##(2008-10#9)(2012-2#3)
Supercritical##16##1##(2008-10#13)(2012-2#3)
Superdex 200##2##2##(2008-10#2)
Superdex##6##1##(1995-11#1)(2008-10#5)
Superficial granulomatous pyoderma##4##3##(2013-1#4)
Superficial siderosis of the central nervous system##2##7##(2007-10#1)(2008-7#1)
Superficial venous vascular response##2##4##(2013-8#2)
Superficial##13##1##(1991-9#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Superfluid##2##1##(1996-12#1)(2008-7#1)
Superfusion with##2##2##(1995-12#2)
Superheated##2##1##(2008-10#2)
Superinduction##2##1##(1992-8#2)
Superinfection##2##1##(2008-8#2)
Superior Court of##2##3##(1993-3#1)(2008-9#1)
Superior Court##5##2##(1993-3#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-9#1)
Superior Vena Cava##2##3##(2008-12#1)(2011-2#1)
Superior service is the outcome of a dedicated planning methodology##2##10##(1994-1#2)
Superior vena##2##2##(1993-9#1)(2007-8#1)
Superior##21##1##(1993-3#1)(1993-9#1)(1994-1#2)(1995-12#1)(1995-6#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#3)
Superiority##2##1##(1994-6#1)(2009-11#1)
Superlattices##3##1##(1990-4#1)(1994-9#1)(1996-9#1)
Supernatant analysis##2##2##(2008-10#2)
Supernatant##3##1##(2008-10#2)(2008-7#1)
Supernatants of##3##2##(2013-1#3)
Supernatants##4##1##(1993-9#1)(2013-1#3)
Superoxide dismutase activity##2##3##(1990-3#1)(1991-5#1)
Superoxide dismutase##4##2##(1990-3#1)(1991-5#1)(1992-12#1)(2008-10#1)
Superoxide##8##1##(1990-12#1)(1990-3#1)(1991-5#2)(1992-12#1)(2008-10#2)(2013-8#1)
Superparamagnetic nanoparticles##2##2##(2010-5#2)
Superparamagnetic##3##1##(2010-5#2)(2013-1#1)
Superresolution optical##2##2##(2007-11#1)(2008-3#1)
Superresolution##6##1##(2007-11#1)(2007-12#1)(2008-3#4)
Supervised##2##1##(2008-2#1)(2010-9#1)
Supervision and##2##2##(2008-3#1)(2010-10#1)
Supervision##3##1##(2008-3#1)(2010-10#1)(2013-7#1)
Supervisory##2##1##(1992-12#1)(2007-7#1)
Suppl##3##1##(1996-11#1)(2007-12#1)(2008-3#1)
Supplement Use##2##2##(2008-10#1)(2013-8#1)
Supplement##5##1##(1994-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
Supplemental Security Income##5##3##(1991-1#1)(1992-1#1)(1992-2#1)(1995-12#2)
Supplemental##10##1##(1991-1#1)(1992-1#1)(1992-2#1)(1993-1#1)(1995-12#2)(1996-12#2)(2012-3#2)
Supplementary statement on##2##3##(1994-9#1)(1995-11#1)
Supplementary##4##1##(1994-9#1)(1995-11#1)(2008-7#2)
Supplementation of##8##2##(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#3)(2012-3#1)
Supplementation on##2##2##(2008-5#1)(2011-1#1)
Supplementation##11##1##(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-5#2)(2011-1#1)(2012-3#1)
Supplemented with##2##2##(2008-11#2)
Supplementing##3##1##(1990-3#1)(2009-8#1)(2010-2#1)
Suppliers##2##1##(2008-10#1)(2013-8#1)
Supply##2##1##(1991-1#1)(2008-7#1)
Support Group##3##2##(1991-11#1)(2013-1#2)
Support Program##2##2##(1996-12#1)(2012-12#1)
Support Protocol 1##2##3##(2008-4#2)
Support Protocol 2##2##3##(2008-4#2)
Support Protocol describes the##3##4##(2008-4#3)
Support Protocol describes##6##3##(2008-4#5)(2008-9#1)
Support Protocol##14##2##(2008-4#12)(2008-9#2)
Support Protocols describe##2##3##(2008-4#1)(2008-9#1)
Support Protocols##3##2##(2008-4#2)(2008-9#1)
Support System##3##2##(1995-12#1)(1995-2#1)(2010-8#1)
Support Vector Machine (SVM)##2##4##(2010-8#2)
Support Vector##3##2##(2010-8#3)
Support and##2##2##(2011-2#2)
Support for##7##2##(1993-12#1)(1997-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-12#1)
Support from##4##2##(1992-3#1)(2008-7#1)(2009-5#1)(2012-12#1)
Support in##2##2##(1993-3#1)(2013-1#1)
Support of##2##2##(2008-10#1)(2008-7#1)
Support protocols are provided for##2##5##(2008-4#1)(2008-9#1)
Support protocols are provided##3##4##(2008-4#2)(2008-9#1)
Support protocols are##4##3##(2008-4#3)(2008-9#1)
Support protocols cover##2##3##(2008-4#1)(2008-9#1)
Support protocols describe how to##2##5##(2008-4#1)(2008-9#1)
Support protocols describe methods for##2##5##(2008-4#2)
Support protocols describe replica plating as well as methods for storing strains as agar stabs or frozen glycerol stocks##2##19##(2008-2#1)(2008-9#1)
Support protocols describe the##3##4##(2008-4#3)
Support protocols describe##15##3##(2008-2#1)(2008-4#11)(2008-9#3)
Support protocols for preparing##2##4##(2008-4#2)
Support protocols for##4##3##(2008-4#3)(2008-9#1)
Support protocols##28##2##(2008-2#1)(2008-4#21)(2008-9#6)
Support##94##1##(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-5#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#36)(2008-7#3)(2008-8#1)(2008-9#9)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-3#1)(2010-7#1)(2010-8#4)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#6)
Supported by a##2##3##(2008-8#1)(2010-5#1)
Supported liquid membrane (SLM)##3##4##(2008-10#3)
Supported planar bilayers##2##3##(2008-4#2)
Supported##9##1##(1993-1#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)
Supporting the##3##2##(2008-11#1)(2010-4#1)(2011-2#1)
Supporting##14##1##(1995-1#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
Supportive and##3##2##(1993-2#1)(1995-1#1)(2008-7#1)
Supportive care in##3##3##(2007-5#1)(2008-7#2)
Supportive care##8##2##(2007-5#2)(2008-7#6)
Supportive##21##1##(1992-2#1)(1993-2#1)(1995-1#1)(2007-5#2)(2008-12#1)(2008-7#10)(2009-3#1)(2009-5#1)(2010-9#1)(2013-1#1)(2013-7#1)
Suppress##4##1##(2008-10#2)(2009-12#1)(2012-3#1)
Suppresses##6##1##(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Suppressing##2##1##(2008-10#1)(2013-8#1)
Suppression in##2##2##(1994-8#1)(2011-1#1)
Suppression of Fusarium Wilt##2##4##(2008-10#2)
Suppression of Fusarium##4##3##(2008-10#4)
Suppression of Phytophthora##2##3##(2008-10#2)
Suppression of Pythium##3##3##(2008-10#3)
Suppression of Rhizoctonia solani##2##4##(2008-10#2)
Suppression of Rhizoctonia##3##3##(2008-10#3)
Suppression of chaotic##2##3##(2007-12#2)
Suppression of the##3##3##(2007-12#1)(2008-10#2)
Suppression of##59##2##(1992-10#1)(1992-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-8#1)(2007-11#6)(2007-12#6)(2008-10#30)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
Suppression was##2##2##(1992-8#1)(1994-2#1)
Suppression##72##1##(1992-10#1)(1992-11#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-8#1)(2007-11#6)(2007-12#6)(2008-10#34)(2008-11#4)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
Suppressive effects of##2##3##(1997-2#1)(2008-10#1)
Suppressive##4##1##(1997-2#1)(2008-10#3)
Suppressiveness##7##1##(2008-10#7)
Supracondylar##3##1##(2008-7#1)(2009-3#1)(2013-1#1)
Supramolecular##2##1##(1996-2#1)(2008-7#1)
Supraspinal##2##1##(1996-5#1)(2008-11#1)
Supratentorial##2##1##(2012-12#1)(2013-8#1)
Supravesical##2##1##(2008-12#2)
Supreme Court decision##2##3##(1992-1#1)(1993-12#1)
Supreme Court##23##2##(1990-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#2)(1995-2#1)(1995-6#3)(1996-2#2)(1996-5#1)(1997-5#3)(1997-6#1)
Supreme Court's##4##2##(1991-12#1)(1992-2#1)(1996-5#1)(2009-9#1)
Supreme##30##1##(1990-11#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#2)(1995-2#1)(1995-6#3)(1996-2#2)(1996-5#2)(1997-5#3)(1997-6#1)(2008-12#1)(2008-4#1)(2009-9#1)(2013-1#1)
Sur##4##1##(2008-5#3)(2013-7#1)
Sure##2##1##(1994-3#1)(1995-3#1)
Sure-Grow 747##2##2##(2008-10#2)
SureSelect##2##1##(2012-2#1)(2013-1#1)
Surface Effects##2##2##(2008-2#1)(2008-3#1)
Surface Modification##3##2##(2008-10#1)(2009-10#1)(2011-1#1)
Surface Plasmon##3##2##(1994-12#1)(2008-11#2)
Surface characterization of##2##3##(2008-3#1)(2008-5#1)
Surface charge density of##2##4##(2008-10#1)(2009-8#1)
Surface electromyography##2##2##(2009-6#1)(2010-9#1)
Surface enhanced Raman scattering##3##4##(2009-4#2)(2010-5#1)
Surface enhanced Raman##4##3##(2008-10#1)(2009-4#2)(2010-5#1)
Surface morphology##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
Surface plasmons##2##2##(2008-3#1)(2012-2#1)
Surface properties of##2##3##(2008-10#1)(2008-12#1)
Surface roughness and##2##3##(2008-3#2)
Surface roughness##3##2##(2008-3#3)
Surface water##2##2##(2008-10#2)
Surface##89##1##(1990-11#2)(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-12#1)(1995-8#1)(1996-5#1)(1996-9#3)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#17)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#2)(2009-11#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
Surface-enhanced Raman spectroscopy##2##3##(2008-2#1)(2010-2#1)
Surface-enhanced Raman##4##2##(2007-12#1)(2008-2#1)(2010-2#1)(2013-8#1)
Surface-functionalized##2##1##(2008-10#1)(2008-7#1)
Surfaces##10##1##(1996-9#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-6#1)(2010-10#1)
Surfactant is##2##2##(1997-1#1)(2008-8#1)
Surfactant preparations##2##2##(2007-11#2)
Surfactant##11##1##(1991-11#1)(1994-5#1)(1996-5#1)(1997-1#2)(2007-11#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)
Surfactants##3##1##(2008-5#2)(2011-1#1)
Surg##6##1##(2007-8#2)(2008-12#1)(2008-9#3)
Surgeon General##2##2##(1993-3#1)(1996-5#1)
Surgeon General's##2##2##(2008-1#1)(2009-7#1)
Surgeon##11##1##(1993-3#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#2)(2009-7#1)
Surgeon-in-Chief##4##1##(2008-8#4)
Surgeons are##2##2##(2008-6#2)
Surgeons should##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
Surgeons##22##1##(1994-12#1)(1997-3#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-4#3)(2008-6#4)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
Surgeries##2##1##(1990-3#1)(2010-7#1)
Surgery Division##2##2##(1993-5#1)(2013-1#1)
Surgery Using##2##2##(2008-12#1)(2011-2#1)
Surgery and global health##2##4##(2008-6#2)
Surgery and##8##2##(1991-9#1)(1992-5#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-12#1)
Surgery at the University of##2##5##(1991-5#1)(2012-3#1)
Surgery at##4##2##(1991-5#1)(1992-3#1)(2012-3#2)
Surgery did not##2##3##(2012-12#1)(2013-8#1)
Surgery for##12##2##(1995-11#1)(1996-11#3)(2007-8#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
Surgery in the##2##3##(1992-6#1)(2008-10#1)
Surgery in##5##2##(1992-6#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-3#1)
Surgery is the only curative##2##5##(1992-8#1)(2008-6#1)
Surgery is the only##5##4##(1992-6#1)(1992-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
Surgery is##9##2##(1992-6#1)(1992-8#1)(2008-10#2)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
Surgery of cerebral##2##3##(2008-9#2)
Surgery of the human cerebrum##5##5##(2008-9#5)
Surgery of the human##6##4##(2008-9#6)
Surgery of the##9##3##(2007-12#1)(2007-8#2)(2008-9#6)
Surgery of##16##2##(1996-3#1)(2007-12#1)(2007-8#2)(2008-9#9)(2011-2#1)(2012-3#1)(2013-1#1)
Surgery remains the##2##3##(1990-2#1)(2007-7#1)
Surgery should be##2##3##(2009-3#1)(2010-6#1)
Surgery should##3##2##(2008-4#1)(2009-3#1)(2010-6#1)
Surgery was performed##2##3##(2008-12#1)(2008-7#1)
Surgery was##9##2##(1991-4#1)(2007-8#2)(2008-12#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-3#1)
Surgery##156##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1996-11#3)(1996-3#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#4)(2008-12#2)(2008-4#8)(2008-5#1)(2008-6#8)(2008-7#4)(2008-8#8)(2008-9#10)(2009-1#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-6#1)(2010-8#3)(2010-9#2)(2011-2#7)(2012-12#5)(2012-2#3)(2012-3#18)(2013-1#7)(2013-8#4)
Surgibonetrade mark##3##2##(2008-7#3)
Surgical Clinic##3##2##(2011-3#3)
Surgical Department of##4##3##(1990-2#1)(1990-9#1)(1993-3#1)(2008-10#1)
Surgical Department##6##2##(1990-2#1)(1990-9#1)(1992-4#1)(1992-6#1)(1993-3#1)(2008-10#1)
Surgical Treatment##2##2##(2012-1#1)(2012-3#1)
Surgical and##3##2##(1992-12#1)(2008-9#1)(2009-10#1)
Surgical aspects of##2##3##(2007-7#1)(2008-9#1)
Surgical complications##2##2##(2008-1#1)(2008-9#1)
Surgical correction of##4##3##(1994-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
Surgical correction##5##2##(1994-3#1)(2007-12#1)(2008-10#1)(2010-3#1)(2012-2#1)
Surgical excision of the##2##4##(2008-9#1)(2011-2#1)
Surgical excision of##4##3##(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
Surgical excision##7##2##(2007-12#1)(2007-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
Surgical experience with##2##3##(2007-8#1)(2008-3#1)
Surgical exploration##2##2##(2008-12#1)(2013-1#1)
Surgical exposure of##2##3##(2007-12#1)(2013-1#1)
Surgical exposure##3##2##(1990-5#1)(2007-12#1)(2013-1#1)
Surgical indications##3##2##(1990-3#1)(2007-11#1)(2008-7#1)
Surgical innovation##2##2##(2008-4#2)
Surgical intervention is##2##3##(1995-5#1)(2013-1#1)
Surgical intervention##6##2##(1990-9#1)(1993-5#1)(1995-5#1)(2007-8#2)(2013-1#1)
Surgical interventions##2##2##(1997-8#1)(2007-12#1)
Surgical lifestyles##9##2##(2008-4#5)(2008-6#4)
Surgical management of cutaneous##2##4##(2007-12#2)
Surgical management of the##2##4##(2007-12#1)(2010-7#1)
Surgical management of##12##3##(2007-12#5)(2008-1#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#1)(2012-2#1)(2012-3#1)
Surgical management##16##2##(2007-12#5)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Surgical margins##2##2##(1997-7#2)
Surgical options##2##2##(2008-9#1)(2011-2#1)
Surgical outcome##2##2##(1994-9#1)(2007-11#1)
Surgical procedures are##2##3##(2008-4#1)(2013-1#1)
Surgical removal of the##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
Surgical removal of##4##3##(2008-4#2)(2011-2#1)(2013-1#1)
Surgical resection of##2##3##(2012-1#1)(2013-1#1)
Surgical resection##4##2##(1990-11#1)(1991-6#1)(2012-1#1)(2013-1#1)
Surgical site##3##2##(2008-10#1)(2009-3#1)(2012-3#1)
Surgical strategies##2##2##(2010-3#1)(2012-3#1)
Surgical technique##2##2##(2007-8#1)(2011-2#1)
Surgical techniques##2##2##(2007-12#1)(2007-8#1)
Surgical therapy##2##2##(1993-1#1)(2008-1#1)
Surgical treatment for##3##3##(2008-6#1)(2010-3#1)(2011-1#1)
Surgical treatment is##6##3##(1990-12#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#2)
Surgical treatment of pericentral arteriovenous malformation##2##6##(2008-7#2)
Surgical treatment of##15##3##(1991-6#1)(1992-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#2)(2008-6#1)(2008-7#2)(2010-3#1)
Surgical treatment was##4##3##(1990-6#1)(1993-9#1)(2008-5#1)(2013-8#1)
Surgical treatment with##2##3##(1995-2#1)(2007-8#1)
Surgical treatment##38##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-6#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#5)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#3)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
Surgical waiting lists##2##3##(1992-12#1)(1993-2#1)
Surgical##218##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1996-8#1)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#16)(2007-7#2)(2007-8#15)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#7)(2008-3#1)(2008-4#15)(2008-5#1)(2008-6#11)(2008-7#6)(2008-9#10)(2009-10#2)(2009-3#1)(2010-3#6)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#3)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#1)
Surinam##4##1##(1990-9#2)(1994-12#1)(1996-11#1)
Suriname##3##1##(2010-3#3)
Surprisingly##51##1##(1990-2#1)(1991-2#3)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
Surrey Memorial Hospital##2##3##(1995-1#2)
Surrey##4##1##(1995-1#2)(2010-11#2)
Surrogate end points and their role in clinical##2##8##(2010-2#2)
Surrogate##5##1##(1995-12#1)(1995-5#1)(2009-10#1)(2010-2#2)
Suruí##5##1##(1991-12#5)
Surveillance Program##3##2##(2007-12#2)(2008-11#1)
Surveillance System##13##2##(1992-6#1)(1992-9#1)(1997-3#3)(2008-12#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#3)
Surveillance and##5##2##(1997-3#2)(1997-8#1)(2008-8#1)(2010-1#1)
Surveillance for##3##2##(1997-3#2)(2012-3#1)
Surveillance of the##2##3##(1995-5#1)(2007-8#1)
Surveillance of##8##2##(1994-5#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(2007-8#1)(2010-4#1)(2011-1#1)
Surveillance##48##1##(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#9)(1997-8#1)(2007-12#3)(2007-8#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2011-9#3)(2012-12#4)(2012-3#4)(2013-8#1)
Survey and##4##2##(1993-1#1)(1993-3#1)(2009-4#1)(2009-7#1)
Survey data##3##2##(1994-3#1)(1995-9#1)(2008-12#1)
Survey findings##3##2##(1994-2#1)(1996-1#1)(1996-2#1)
Survey for##2##2##(1992-2#1)(2009-7#1)
Survey of##20##2##(1990-3#1)(1992-2#2)(1996-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Survey on job content and salary##2##6##(1991-12#1)(1991-3#1)
Survey on##5##2##(1991-12#1)(1991-3#1)(2008-10#1)(2010-6#1)(2013-1#1)
Survey results##5##2##(1995-1#1)(1997-3#1)(2010-8#1)(2011-10#1)(2011-2#1)
Survey spectra of the##2##4##(2008-2#2)
Survey##112##1##(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#6)(2008-2#3)(2008-4#2)(2008-7#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)
Survey&quot##3##1##(2013-1#3)
Surveying congenital anomalies##2##3##(2008-11#2)
Surveying##3##1##(1996-2#1)(2008-11#2)
Surveys are##2##2##(1991-1#1)(2009-7#1)
Surveys for##2##2##(1993-3#1)(2008-10#1)
Surveys of##5##2##(1991-6#1)(1993-3#1)(2007-12#1)(2008-8#1)(2012-12#1)
Surveys##21##1##(1991-1#2)(1991-6#1)(1993-3#3)(1995-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-7#2)(2010-3#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
Survival after##2##2##(2006-10#1)(2007-8#1)
Survival analyses were##2##3##(2008-6#1)(2013-8#1)
Survival analysis##5##2##(1990-5#1)(1993-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
Survival and##8##2##(2008-10#3)(2008-9#2)(2010-3#1)(2012-3#1)(2013-1#1)
Survival at##2##2##(2007-8#2)
Survival data##2##2##(2008-6#1)(2012-2#1)
Survival in Parkinson's disease##2##4##(2008-7#2)
Survival in##4##2##(1993-2#1)(2008-1#1)(2008-7#2)
Survival of Fusarium##2##3##(2008-10#2)
Survival of Phytophthora infestans##2##4##(2008-10#2)
Survival of Phytophthora##3##3##(2008-10#3)
Survival of Ralstonia solanacearum##2##4##(2008-10#2)
Survival of all exposed groups was similar to that of the control groups##2##13##(2008-8#1)(2008-9#1)
Survival of all##3##3##(2008-8#1)(2008-9#2)
Survival of dosed##2##3##(2008-9#2)
Survival of exposed##2##3##(2008-9#2)
Survival of patients with##2##4##(1991-2#1)(1995-8#1)
Survival of patients##3##3##(1991-2#1)(1995-8#1)(2011-2#1)
Survival of the##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
Survival of##43##2##(1991-2#2)(1995-8#1)(1996-1#1)(2007-7#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#8)(2009-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Survival rates##2##2##(2008-9#2)
Survival was measured##2##3##(2008-10#1)(2008-7#1)
Survival was##11##2##(1992-12#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)
Survival##99##1##(1990-5#1)(1991-2#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(2006-10#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#13)(2009-10#1)(2010-3#5)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#3)
Survivin##2##1##(2011-2#2)
Surviving##3##1##(2008-11#1)(2008-6#1)(2010-5#1)
Susan##3##1##(2008-6#1)(2008-7#1)(2011-2#1)
Susanne Kammerer]##2##2##(1997-6#1)(1997-8#1)
Susanne##3##1##(1997-6#1)(1997-8#2)
Susceptibility and##2##2##(2008-10#1)(2011-2#1)
Susceptibility in##2##2##(2008-10#2)
Susceptibility of##9##2##(1995-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
Susceptibility to##14##2##(1995-8#1)(2007-12#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-5#1)(2013-8#2)
Susceptibility##31##1##(1995-11#1)(1995-8#1)(2007-12#2)(2008-10#15)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#4)(2013-8#2)
Susceptible Plants##2##2##(2008-10#2)
Susceptible and##3##2##(2008-10#3)
Susceptible to##2##2##(2008-10#2)
Susceptible##14##1##(2008-10#14)
Suspected##4##1##(1990-2#1)(2008-12#1)(2012-12#1)(2012-2#1)
Suspension of##2##2##(1992-3#1)(2008-11#1)
Suspension##5##1##(1992-3#1)(2008-11#3)(2008-8#1)
Suspicion of##2##2##(1997-8#1)(2008-9#1)
Suspicion##4##1##(1997-8#1)(2008-9#2)(2009-9#1)
Sustainable##4##1##(1997-7#2)(2008-10#2)
Sustained release##4##2##(1991-1#1)(2009-11#1)(2012-2#2)
Sustained##12##1##(1991-1#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-11#1)(2011-1#2)(2012-12#1)(2012-2#3)
Sutherland##3##1##(1994-2#2)(2013-1#1)
Sutter Health##2##2##(1995-3#2)
Sutter##3##1##(1995-3#3)
Suturing##2##1##(2007-12#1)(2008-6#1)
Suwon 92 and##2##3##(2008-10#2)
Suwon 92##5##2##(2008-10#5)
Suzanne##2##1##(2007-2#2)
Suzuki coupling##3##2##(2008-11#1)(2008-12#1)(2008-6#1)
Suzuki##10##1##(1996-5#2)(2008-11#2)(2008-12#2)(2008-6#1)(2009-12#2)(2013-8#1)
Sv is##2##2##(1996-6#2)
Sv##7##1##(1996-6#5)(1997-8#1)(2008-7#1)
Svalbard##2##1##(2008-3#1)(2011-4#1)
Sw 72469-6##4##2##(2008-10#4)
Sw##6##1##(2008-10#4)(2012-2#2)
Sw-5##2##1##(2008-10#2)
Swab samples were##2##3##(1997-5#1)(2013-8#1)
Swan##2##1##(2008-10#1)(2010-8#1)
Swan-Ganz catheter##3##2##(1995-2#2)(2010-8#1)
Swansea##2##1##(1996-7#1)(2008-11#1)
Swanson##6##1##(2008-2#1)(2008-9#4)(2010-2#1)
Swede midge##7##2##(2011-2#7)
Sweden and##4##2##(1991-4#1)(1992-8#1)(1992-9#1)(2013-7#1)
Sweden##51##1##(1990-11#2)(1990-2#1)(1991-2#2)(1991-4#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#3)(1994-6#1)(1995-1#4)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-10#4)(2010-12#3)(2010-3#2)(2010-4#2)(2011-2#4)(2011-4#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
Sweden's##2##1##(1993-6#1)(2008-7#1)
Sweden)##4##1##(2007-12#1)(2008-11#2)(2011-2#1)
Swedes##2##1##(2009-2#1)(2010-12#1)
Swedish Aspirin##2##2##(1991-11#2)
Swedish study##2##2##(2008-5#1)(2011-2#1)
Swedish subject##2##2##(1996-5#2)
Swedish##34##1##(1991-11#2)(1991-12#1)(1992-11#1)(1992-3#1)(1993-6#3)(1994-3#1)(1995-6#2)(1996-5#5)(1997-5#1)(2007-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2010-10#1)(2010-3#2)(2011-2#1)(2013-1#2)(2013-8#1)
Swedish-born subjects##2##2##(2008-7#2)
Sweeping##2##1##(2007-12#1)(2008-6#1)
Sweet potato feathery mottle virus##2##5##(2008-10#2)
Sweet##9##1##(2008-10#8)(2008-11#1)
Sweetpotato##4##1##(2008-10#4)
Swelling##4##1##(2008-5#2)(2010-5#1)(2011-2#1)
Swim##2##1##(2008-6#1)(2012-3#1)
Swimming##4##1##(1990-11#1)(1995-6#1)(2008-5#1)(2010-8#1)
Swine##7##1##(2008-10#3)(2011-2#1)(2013-8#3)
Swiss 3T3 cells##13##3##(1990-2#4)(1993-8#2)(1993-9#2)(1994-3#3)(1997-7#2)
Swiss 3T3##15##2##(1990-2#4)(1993-8#2)(1993-9#2)(1994-3#3)(1997-6#2)(1997-7#2)
Swiss Albino mice##2##3##(2008-5#1)(2012-3#1)
Swiss albino mice##5##3##(1992-2#2)(1992-5#1)(2010-1#1)(2013-1#1)
Swiss and##2##2##(1991-2#1)(2008-12#1)
Swiss chard##4##2##(2008-10#4)
Swiss mice##6##2##(1990-5#1)(1991-8#1)(1993-5#1)(2012-12#3)
Swiss needle cast##4##3##(2008-10#4)
Swiss population##3##2##(1991-11#2)(2008-10#1)
Swiss##62##1##(1990-2#4)(1990-5#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-5#1)(1993-5#1)(1993-8#2)(1993-9#4)(1994-3#3)(1996-11#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#2)(2007-2#1)(2008-10#10)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
Swiss-cheese##3##1##(2007-8#3)
Switched##2##1##(2008-3#2)
Switching is##2##2##(2007-11#1)(2008-2#1)
Switching of##2##2##(2008-2#1)(2008-3#1)
Switching##12##1##(1995-3#1)(1996-8#1)(2007-11#2)(2008-2#2)(2008-3#3)(2009-6#1)(2009-9#1)(2010-6#1)
Switzerland and##4##2##(1990-3#1)(1993-3#1)(2008-10#1)(2008-11#1)
Switzerland in##2##2##(1996-11#1)(2010-12#1)
Switzerland##50##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#5)(1991-2#1)(1991-4#1)(1991-6#1)(1993-3#1)(1993-8#1)(1996-11#2)(1996-6#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-5#2)(2013-7#1)
Switzerland)##3##1##(1991-4#1)(2007-8#1)(2008-2#1)
Swollen##2##1##(1997-3#1)(2008-5#1)
SyF spectra##2##2##(2008-10#2)
SyF##3##1##(2008-10#3)
SyFS##4##1##(2008-10#4)
Sydenham's chorea##3##2##(2008-7#3)
Sydney Brenner##2##2##(2008-7#2)
Sydney##18##1##(2007-11#1)(2007-2#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#2)(2010-8#1)(2011-1#1)
Syk##7##1##(1995-6#5)(2009-6#2)
Syllis##4##1##(2008-5#4)
Sylvian fissure##3##2##(1996-7#1)(2006-12#1)(2008-7#1)
Sylvian##4##1##(1996-7#1)(2006-12#1)(2008-12#1)(2008-7#1)
Symbiotic symbolization by hand and mouth##2##6##(2010-5#2)
Symmetric##5##1##(1997-4#1)(2008-3#2)(2008-8#1)(2010-3#1)
Symmetrical##6##1##(1996-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-12#1)
Symmetry##5##1##(1990-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2011-1#1)
Sympathetic##2##1##(1993-1#1)(2013-1#1)
Sympatry##2##1##(2008-10#2)
Symposia##2##1##(2008-5#1)(2010-4#1)
Symposium and##2##2##(2008-5#1)(2009-3#1)
Symposium of the##4##3##(2008-6#1)(2008-7#2)(2010-10#1)
Symposium of##5##2##(2007-11#1)(2008-6#1)(2008-7#2)(2010-10#1)
Symposium on Biotechnology for Fuels and Chemicals##2##7##(2008-10#1)(2008-6#1)
Symposium on Biotechnology for##3##4##(2008-10#2)(2008-6#1)
Symposium on##27##2##(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#2)
Symposium proceedings##5##2##(1995-12#1)(1996-9#1)(1997-6#1)(1997-8#2)
Symposium##54##1##(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
Symptom Checklist##4##2##(1992-1#1)(2008-4#1)(2012-1#1)(2012-5#1)
Symptom Development##2##2##(2008-10#2)
Symptom Expression##2##2##(2008-10#2)
Symptom Inventory##3##2##(2008-7#1)(2013-1#2)
Symptom Severity##2##2##(2008-10#1)(2008-7#1)
Symptom scores##2##2##(2008-1#1)(2008-3#1)
Symptom##22##1##(1991-1#1)(1992-1#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#4)(2009-11#1)(2011-2#2)(2012-1#1)(2012-5#1)(2013-1#3)
Symptomatic and##2##2##(1991-8#1)(1994-2#1)
Symptomatic treatment##2##2##(1996-6#1)(2008-7#1)
Symptomatic##24##1##(1990-3#1)(1990-6#1)(1991-8#1)(1992-9#1)(1994-2#1)(1996-6#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
Symptomless##5##1##(2008-10#5)
Symptoms and##5##2##(1997-5#1)(1997-8#1)(2008-10#1)(2008-6#1)(2011-8#1)
Symptoms are usually##2##3##(1993-9#1)(1997-3#1)
Symptoms are##3##2##(1993-9#1)(1997-3#1)(2008-7#1)
Symptoms in a##2##3##(2008-10#1)(2012-2#1)
Symptoms in##6##2##(2006-10#1)(2008-10#3)(2009-10#1)(2012-2#1)
Symptoms include##4##2##(2008-10#2)(2008-8#1)(2009-9#1)
Symptoms of##15##2##(1990-8#1)(1991-8#1)(1996-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#2)
Symptoms on##3##2##(2008-10#2)(2010-10#1)
Symptoms related to##3##3##(1996-12#1)(2008-7#2)
Symptoms##71##1##(1990-10#1)(1990-8#1)(1991-8#1)(1993-9#1)(1996-12#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#4)(2011-8#1)(2012-1#3)(2012-2#1)(2013-1#4)(2013-8#1)
Synantropic##2##1##(2008-6#2)
Synapses and##2##2##(2012-2#2)
Synapses are##2##2##(2008-1#1)(2009-8#1)
Synapses##5##1##(1994-8#1)(2008-1#1)(2009-8#1)(2012-2#2)
Synaptic plasticity##2##2##(2008-4#2)
Synaptic vesicles are##3##3##(2008-1#3)
Synaptic vesicles##4##2##(2008-1#4)
Synaptic##16##1##(1991-1#1)(1994-8#2)(1996-2#1)(1997-3#1)(2008-1#4)(2008-4#2)(2008-7#2)(2009-12#1)(2009-8#1)(2013-8#1)
Synchronization and##2##2##(1996-9#2)
Synchronization of##4##2##(2007-12#2)(2008-11#1)(2008-4#1)
Synchronization##7##1##(1996-9#2)(2007-12#2)(2008-11#1)(2008-4#1)(2012-2#1)
Synchronous fluorescence and##2##3##(2008-10#2)
Synchronous fluorescence##5##2##(2008-10#5)
Synchronous##15##1##(1993-9#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-3#2)(2011-1#1)(2011-2#1)
Synchronously pumped optical parametric##2##4##(2007-11#1)(2008-3#1)
Synchrony of##2##2##(1990-8#1)(2008-11#1)
Synchrotron radiation##2##2##(2008-10#1)(2010-5#1)
Synchrotron##4##1##(2008-10#1)(2008-11#1)(2009-7#1)(2010-5#1)
Syndecan-1##2##1##(2008-5#2)
Syndrome (IBS)##2##2##(2013-1#2)
Syndrome and##3##2##(2007-7#2)(2008-3#1)
Syndrome de glissement&quot##2##3##(2010-6#2)
Syndrome has##2##2##(2008-1#1)(2011-2#1)
Syndrome in##7##2##(2008-1#1)(2008-10#1)(2008-3#4)(2013-1#1)
Syndrome of##4##2##(1997-3#1)(2008-10#1)(2011-2#2)
Syndrome was##2##2##(2008-5#1)(2013-7#1)
Syndrome##99##1##(1991-11#1)(1993-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#3)(2007-10#1)(2007-7#2)(2008-1#9)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#1)
Syndrome)##2##1##(1992-9#1)(2008-10#1)
Syndromes##2##1##(2008-3#1)(2013-1#1)
Syndromic##2##1##(2007-10#1)(2011-9#1)
Synechococcus elongatus BDU 130911##2##4##(2013-1#2)
Synechococcus sp##7##2##(1992-3#3)(1994-12#1)(1995-6#1)(1996-6#2)
Synechococcus##11##1##(1992-3#3)(1994-12#1)(1995-6#1)(1996-6#2)(1997-4#2)(2013-1#2)
Synechocystis sp##16##2##(1995-12#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-6#2)
Synechocystis##18##1##(1995-12#4)(1995-6#1)(1995-8#2)(1996-12#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-6#2)
Synergetic##2##1##(2008-10#1)(2008-11#1)
Synergism in##2##2##(2008-10#2)
Synergism##7##1##(1992-10#1)(1992-2#1)(1997-1#1)(2008-10#3)(2008-7#1)
Synergistic and##2##2##(2008-10#1)(2011-2#1)
Synergistic effect##2##2##(2008-11#1)(2008-8#1)
Synergistic effects of##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-6#1)
Synergistic extraction of##3##3##(2008-10#3)
Synergistic interactions##2##2##(2008-10#1)(2012-2#1)
Synergistic##18##1##(2008-10#11)(2008-11#2)(2008-8#2)(2011-2#1)(2012-2#1)(2012-6#1)
Synergy##2##1##(1996-2#1)(2008-10#1)
Syngonium##3##1##(2008-10#3)
Synopses of editorial board##3##4##(2008-6#3)
Synopses##4##1##(2008-6#4)
Synopsis##3##1##(2008-10#1)(2008-5#2)
Synovial chondromatosis is##2##3##(1992-4#2)
Synovial chondromatosis##3##2##(1992-4#2)(2010-5#1)
Synovial lipomatosis is##2##3##(2009-3#2)
Synovial lipomatosis##3##2##(2009-3#3)
Synovial##10##1##(1992-4#2)(2006-10#1)(2009-3#4)(2010-5#2)(2013-1#1)
Syntheses of##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2010-2#1)
Syntheses##7##1##(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-2#1)
Synthesis and Biological##2##3##(2009-9#1)(2010-3#1)
Synthesis and Characterization of the##2##5##(1996-2#1)(1997-7#1)
Synthesis and Characterization of##6##4##(1996-2#2)(1997-7#2)(2008-10#1)(2009-11#1)
Synthesis and Structure of##3##4##(1996-5#1)(1997-7#2)
Synthesis and application of a functionalized resin##2##7##(2008-10#2)
Synthesis and application of##5##4##(2008-10#3)(2008-4#1)(2008-7#1)
Synthesis and applications##2##3##(2008-9#1)(2012-2#1)
Synthesis and biological activity##2##4##(1993-5#1)(2008-4#1)
Synthesis and biological evaluation of##3##5##(2008-11#1)(2008-8#1)(2012-2#1)
Synthesis and biological##7##3##(1992-12#1)(1993-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
Synthesis and catalytic properties of##2##5##(2008-10#1)(2009-10#1)
Synthesis and characterization of a##4##5##(1991-9#1)(2008-10#2)(2008-7#1)
Synthesis and characterization of##11##4##(1991-9#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-8#1)
Synthesis and evaluation of##2##4##(1991-1#1)(2011-1#1)
Synthesis and in vitro##2##4##(1995-3#1)(2012-2#1)
Synthesis and metal##2##3##(2008-10#1)(2009-7#1)
Synthesis and properties of##2##4##(2008-10#1)(2008-4#1)
Synthesis and##88##2##(1991-1#3)(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-5#1)(1995-3#3)(1996-2#5)(1996-5#3)(1997-7#7)(2007-11#9)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
Synthesis in##5##2##(1992-12#1)(1996-5#2)(2008-10#1)(2011-2#1)
Synthesis of 1##3##3##(1996-5#1)(2008-12#1)(2008-4#1)
Synthesis of Substituted##2##3##(2008-12#1)(2010-6#1)
Synthesis of [4##3##3##(1996-5#3)
Synthesis of a##8##3##(1992-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-7#1)(2012-3#1)
Synthesis of an##4##3##(1996-2#1)(1996-5#2)(2008-10#1)
Synthesis of novel##4##3##(1992-11#1)(2007-11#1)(2007-12#1)(2008-11#1)
Synthesis of some##3##3##(2007-11#2)(2012-2#1)
Synthesis of the##9##3##(1991-5#1)(1995-11#1)(1996-5#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-2#2)
Synthesis of##124##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1996-2#3)(1996-5#26)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#9)(2007-12#2)(2008-10#11)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#11)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#4)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Synthesis##245##1##(1990-11#1)(1991-1#3)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#8)(1996-2#13)(1996-5#31)(1997-3#1)(1997-6#1)(1997-7#8)(2007-11#20)(2007-12#3)(2008-10#34)(2008-11#7)(2008-12#3)(2008-3#4)(2008-4#17)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#5)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#1)
Synthesized##3##1##(2008-10#2)(2010-5#1)
Synthetic methods for##2##3##(1997-3#1)(2008-8#1)
Synthetic peptide##2##2##(1990-5#1)(2008-10#1)
Synthetic peptides corresponding to the##2##5##(1994-5#1)(1994-8#1)
Synthetic peptides corresponding to##3##4##(1994-5#1)(1994-8#1)(1995-2#1)
Synthetic peptides for production of antibodies that recognize intact proteins##3##10##(2008-2#1)(2008-4#2)
Synthetic peptides##6##2##(1994-5#1)(1994-8#1)(1995-2#1)(2008-2#1)(2008-4#2)
Synthetic studies##2##2##(2009-12#1)(2010-6#1)
Synthetic##47##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-3#1)
Synvisc(R)##5##1##(2007-11#5)
Syphilis Study at Tuskegee##6##4##(2013-1#6)
Syphilis in##2##2##(2007-7#1)(2011-2#1)
Syphilis##15##1##(1997-6#1)(1997-7#1)(2007-7#4)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#6)
Sypro Ruby##2##2##(2008-4#2)
SyrM to the##2##3##(2008-8#2)
SyrM##4##1##(2008-8#4)
Syria##5##1##(2008-1#1)(2008-10#2)(2008-12#1)(2012-12#1)
Syrian golden hamster##2##3##(1990-6#2)
Syrian hamster embryo##4##3##(1990-7#2)(1992-2#2)
Syrian hamster##9##2##(1990-7#6)(1992-2#2)(1996-8#1)
Syrian##17##1##(1990-6#2)(1990-7#6)(1992-2#2)(1992-5#2)(1996-8#2)(2008-11#1)(2009-2#1)(2011-1#1)
Syrphidae)##2##1##(2008-8#2)
Systellognatha##3##1##(2007-12#3)
System (CHESS) is##2##3##(1992-1#1)(1995-2#1)
System (CHESS)##3##2##(1992-1#2)(1995-2#1)
System and##7##2##(1992-1#1)(1993-12#1)(1994-6#1)(2007-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
System at##3##2##(2007-11#1)(2007-8#1)(2008-5#1)
System database##2##2##(1992-2#1)(2012-12#1)
System design##2##2##(2008-3#2)
System for the##3##3##(2008-11#1)(2008-2#1)(2012-3#1)
System for##22##2##(1994-1#1)(1994-6#1)(1994-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2009-2#1)(2010-8#5)(2012-3#1)(2013-1#1)
System has been##3##3##(1993-3#1)(2008-1#1)(2008-12#1)
System has##5##2##(1993-3#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-12#1)
System in##5##2##(1991-9#1)(2008-2#1)(2010-12#1)(2012-3#1)(2013-8#1)
System is a##4##3##(1994-1#1)(1994-6#2)(2012-3#1)
System is##11##2##(1992-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#2)(1996-12#1)(1997-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
System of Services for##2##4##(2013-8#2)
System of##7##2##(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
System on##2##2##(2010-8#1)(2012-12#1)
System operation is based on##2##5##(2007-11#1)(2008-10#1)
System to##5##2##(1993-1#1)(1997-3#1)(2008-3#1)(2008-4#1)(2012-2#1)
System under##2##2##(2008-10#2)
System with##2##2##(2008-2#1)(2008-3#1)
System##246##1##(1991-12#1)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#2)(1994-1#4)(1994-12#3)(1994-2#5)(1994-6#8)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#5)(1997-7#1)(2007-10#1)(2007-11#4)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#6)(2008-2#17)(2008-3#15)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#2)(2009-2#2)(2009-5#4)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#1)(2010-8#14)(2011-1#4)(2011-2#13)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#7)(2013-1#6)(2013-8#6)
System's##3##1##(1993-3#1)(1994-6#1)(1996-12#1)
System) in##2##2##(1993-2#1)(2008-5#1)
System)##10##1##(1991-2#1)(1993-2#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
Systematic Errors##2##2##(2008-3#2)
Systematic Review##6##2##(2008-7#1)(2009-7#1)(2010-8#1)(2013-1#3)
Systematic behavior##2##2##(2007-12#2)
Systematic discrepancies between##2##3##(2008-3#2)
Systematic errors are##2##3##(2008-3#2)
Systematic errors in##3##3##(2008-3#3)
Systematic errors##6##2##(2008-2#1)(2008-3#5)
Systematic review of##3##3##(1997-8#1)(2010-8#1)(2012-12#1)
Systematic review##5##2##(1997-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
Systematic reviews in emergency medicine##2##5##(2007-5#2)
Systematic searches##2##2##(2008-10#1)(2013-1#1)
Systematic studies of##2##3##(1992-11#1)(1996-6#1)
Systematic studies##3##2##(1992-11#1)(1996-6#1)(2008-10#1)
Systematic##57##1##(1990-12#1)(1991-1#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#10)(2008-7#1)(2009-7#1)(2009-9#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#2)
Systemic Lupus Erythematosus##2##3##(2006-10#1)(2012-12#1)
Systemic Lupus##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
Systemic Resistance##5##2##(2008-10#5)
Systemic acquired resistance##3##3##(2008-10#3)
Systemic administration of##2##3##(1994-2#1)(1995-12#1)
Systemic administration##3##2##(1994-2#1)(1995-12#1)(2008-7#1)
Systemic amyloidosis##2##2##(1996-11#1)(2011-2#1)
Systemic and Local##2##3##(2008-10#2)
Systemic and##3##2##(2008-10#3)
Systemic lupus erythematosus (SLE) in##2##5##(2008-1#1)(2008-4#1)
Systemic lupus erythematosus (SLE) is a##3##6##(2010-12#1)(2010-5#1)(2011-2#1)
Systemic lupus erythematosus (SLE)##5##4##(2008-1#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)
Systemic lupus erythematosus is##2##4##(2012-2#2)
Systemic lupus erythematosus##11##3##(1994-6#1)(2008-1#2)(2008-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)
Systemic nocardiosis##2##2##(2006-10#1)(2007-7#1)
Systemic sclerosis##4##2##(1995-11#2)(2007-7#2)
Systemic##69##1##(1992-3#1)(1992-8#1)(1993-2#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-11#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
Systems Biology##4##2##(2010-2#1)(2013-1#1)(2013-8#2)
Systems biology and##2##3##(2010-9#1)(2013-8#1)
Systems biology##4##2##(2010-9#1)(2012-2#1)(2013-8#2)
Systems for##5##2##(2008-10#1)(2008-3#2)(2008-7#2)
Systems in##4##2##(1991-8#1)(2008-11#1)(2010-12#1)(2011-1#1)
Systems of care##2##3##(1997-3#1)(2010-12#1)
Systems of##4##2##(1997-3#1)(2008-9#1)(2010-12#2)
Systems to##2##2##(2008-10#1)(2010-5#1)
Systems##71##1##(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#7)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
Systolic and diastolic##2##3##(1992-9#1)(2008-3#1)
Systolic##13##1##(1990-9#1)(1991-12#1)(1992-9#1)(1997-3#2)(2008-3#1)(2009-5#1)(2011-2#1)(2013-1#3)(2013-8#2)
Syzigium jambos##3##2##(2008-5#3)
Sz##4##1##(1994-12#4)
Szabo##2##1##(1995-2#2)
Szczecin##2##1##(2007-8#1)(2008-9#1)
São João de Deus##3##4##(2009-10#3)
São Paulo State##7##3##(1990-12#1)(2008-10#2)(2008-9#3)(2013-7#1)
São Paulo and##2##3##(2013-8#2)
São Paulo##32##2##(1990-12#3)(1996-12#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
São Pedro Hospice##2##3##(2009-7#2)
São##43##1##(1990-12#3)(1996-12#1)(2008-10#13)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#7)(2009-10#3)(2009-7#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
Sønderborg Hospital##2##2##(1991-9#2)
Sør-Varanger##2##1##(1990-6#2)
T &gt##4##2##(1994-12#1)(1995-5#1)(1997-6#1)(2008-8#1)
T &lt##4##2##(2008-10#1)(2008-3#3)
T 1-weighted images suggesting the##2##5##(1997-8#2)
T 1-weighted##3##2##(1997-8#3)
T 2-weighted##2##2##(1997-8#2)
T =##8##2##(1996-2#4)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
T Cell##2##2##(2008-11#1)(2008-8#1)
T Cells##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
T and B cells##3##4##(1997-8#1)(2007-5#1)(2008-4#1)
T and B##4##3##(1990-9#1)(1997-8#1)(2007-5#1)(2008-4#1)
T and DHT##2##3##(1990-11#2)
T and##24##2##(1990-11#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1995-1#1)(1995-6#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
T antigen bind to the same region##2##7##(1993-8#2)
T antigen##11##2##(1993-2#1)(1993-8#7)(1995-6#1)(1997-6#1)(2008-4#1)
T antigens##2##2##(1990-7#1)(1993-2#1)
T betagamma was##2##3##(1997-1#2)
T cell activation was##2##4##(2012-3#2)
T cell activation##11##3##(1994-11#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#5)
T cell anergy##2##3##(2008-4#2)
T cell clones##13##3##(1990-6#1)(1991-9#1)(1993-8#1)(2008-11#6)(2008-4#4)
T cell costimulatory molecules in##2##5##(2007-12#2)
T cell count##2##3##(2012-2#1)(2013-1#1)
T cell development##2##3##(2008-11#1)(2008-4#1)
T cell epitope##2##3##(1997-8#1)(2007-6#1)
T cell epitopes##2##3##(2008-4#1)(2008-5#1)
T cell function##5##3##(1992-11#1)(2008-4#2)(2011-1#1)(2011-2#1)
T cell immune##2##3##(2008-11#1)(2008-4#1)
T cell leukemia virus##3##4##(2008-11#1)(2011-2#1)(2012-12#1)
T cell leukemia##9##3##(1992-6#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)
T cell line##4##3##(1997-8#1)(2008-11#2)(2008-8#1)
T cell lines##12##3##(1992-6#1)(1995-12#2)(2008-11#6)(2008-4#3)
T cell lymphoma is##2##4##(2009-8#2)
T cell lymphoma##5##3##(2009-8#4)(2013-1#1)
T cell lymphomas##2##3##(2008-9#1)(2013-1#1)
T cell numbers in##2##4##(1995-12#2)
T cell population##2##3##(2008-11#1)(2012-12#1)
T cell populations##2##3##(2008-4#1)(2011-2#1)
T cell proliferation in##2##4##(2008-11#1)(2012-12#1)
T cell proliferation##5##3##(2008-11#2)(2012-12#1)(2012-3#2)
T cell proliferative responses##3##4##(2008-7#3)
T cell reactivity##2##3##(2013-1#2)
T cell receptor (TCR)##3##4##(2008-11#2)(2011-1#1)
T cell receptor excision circles##2##5##(2008-4#2)
T cell receptor transgenic mice##2##5##(2008-11#2)
T cell receptor transgenic##3##4##(2008-11#3)
T cell receptor##17##3##(1991-9#1)(1994-6#2)(1995-8#1)(2007-12#1)(2008-11#5)(2008-4#3)(2009-8#2)(2011-1#1)(2012-2#1)
T cell receptors (TCR) that##2##5##(2008-4#1)(2008-9#1)
T cell receptors##3##3##(2008-4#2)(2008-9#1)
T cell responses to##4##4##(1997-8#1)(2008-4#1)(2008-7#1)(2011-1#1)
T cell responses##10##3##(1995-5#3)(1997-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
T cell specificity##2##3##(2012-2#2)
T cell stimulation##2##3##(1994-9#1)(2008-7#1)
T cell subpopulations##6##3##(1991-1#1)(2008-11#1)(2008-4#4)
T cell subsets##6##3##(2008-4#4)(2008-7#1)(2012-2#1)
T cell tolerance##3##3##(2008-11#2)(2008-4#1)
T cell##198##2##(1990-12#3)(1990-6#2)(1991-1#1)(1991-9#4)(1992-11#1)(1992-2#3)(1992-6#3)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#6)(1995-5#5)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#3)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#35)(2008-4#41)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#6)(2009-8#9)(2010-2#2)(2010-5#2)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#11)(2012-3#8)(2013-1#7)
T cell-dependent##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
T cell-mediated immune responses##2##4##(2008-5#1)(2012-12#1)
T cell-mediated immune##3##3##(2008-5#1)(2012-12#1)(2012-3#1)
T cell-mediated immunity##2##3##(1995-12#1)(2008-5#1)
T cell-mediated##7##2##(1995-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-12#1)(2012-3#1)
T cell-rich population for##2##4##(2008-11#2)
T cell-rich population##4##3##(2008-11#4)
T cells and the##2##4##(2007-5#1)(2012-12#1)
T cells and##25##3##(1990-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-4#2)(2009-4#1)(2009-6#2)(2010-3#1)(2010-5#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
T cells are also##2##4##(2008-11#1)(2008-4#1)
T cells are##7##3##(2008-11#1)(2008-4#2)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
T cells as well as##2##5##(2007-11#1)(2008-8#1)
T cells as##3##3##(2007-11#1)(2008-8#1)(2012-2#1)
T cells by##4##3##(1995-2#1)(2008-11#2)(2011-2#1)
T cells can##2##3##(2006-10#1)(2008-4#1)
T cells derived##2##3##(2008-11#1)(2011-1#1)
T cells during##2##3##(2012-12#1)(2012-2#1)
T cells from ovalbumin (OVA)-specific T cell receptor##2##8##(2008-11#2)
T cells from##8##3##(2008-11#3)(2008-4#2)(2012-3#1)(2013-1#2)
T cells have##4##3##(2007-5#1)(2008-11#1)(2008-8#1)(2011-1#1)
T cells in the##4##4##(2008-11#1)(2013-8#3)
T cells in##19##3##(1991-9#1)(1993-8#2)(1996-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
T cells induced##2##3##(1994-12#1)(2008-11#1)
T cells is##4##3##(1995-5#1)(2008-4#2)(2011-2#1)
T cells may be##2##4##(1993-8#1)(2010-2#1)
T cells may##5##3##(1993-8#1)(1994-11#1)(1995-2#1)(2008-11#1)(2010-2#1)
T cells of##2##3##(1997-8#1)(2008-11#1)
T cells play##2##3##(2008-1#1)(2010-5#1)
T cells responding to##2##4##(2010-5#1)(2012-2#1)
T cells that are##4##4##(2008-4#2)(2010-11#1)(2012-12#1)
T cells that##7##3##(2008-4#3)(2010-11#2)(2012-12#1)(2012-2#1)
T cells to##11##3##(1992-6#1)(1995-2#1)(1997-6#1)(2007-5#1)(2008-11#4)(2008-4#1)(2008-5#1)(2013-1#1)
T cells using a##2##4##(2008-4#1)(2013-1#1)
T cells using##5##3##(2008-11#1)(2008-4#2)(2008-9#1)(2013-1#1)
T cells were not##2##4##(1993-8#1)(2008-8#1)
T cells were##11##3##(1993-8#2)(1996-12#1)(2007-5#1)(2008-11#4)(2008-8#2)(2012-3#1)
T cells which##2##3##(2008-11#1)(2008-9#1)
T cells will##2##3##(2007-5#1)(2011-1#1)
T cells with MHC class##2##5##(2008-9#2)
T cells with##7##3##(1991-2#1)(2008-9#3)(2010-1#1)(2011-1#1)(2012-2#1)
T cells##295##2##(1990-12#3)(1991-11#1)(1991-2#2)(1991-9#2)(1992-12#3)(1992-2#2)(1992-6#4)(1993-12#2)(1993-8#6)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#8)(1995-5#2)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2007-11#3)(2007-12#1)(2007-5#7)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#48)(2008-4#40)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#10)(2009-4#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-2#2)(2010-3#4)(2010-5#12)(2011-1#8)(2011-2#17)(2012-1#1)(2012-12#18)(2012-2#13)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#12)
T cells)##2##2##(2006-10#1)(2008-11#1)
T cells]##2##2##(2012-2#1)(2012-3#1)
T currents##2##2##(1992-8#2)
T growth model##2##3##(2013-8#2)
T growth##3##2##(2013-8#3)
T helper (Th) cells##2##4##(1994-8#1)(2008-11#1)
T helper 1##3##3##(1994-12#2)(2011-2#1)
T helper cell##2##3##(1994-5#1)(2008-11#1)
T helper cells##2##3##(1995-12#1)(2012-3#1)
T helper##14##2##(1990-9#1)(1991-6#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(2008-11#3)(2011-2#1)(2012-1#1)(2012-3#1)
T in the##2##3##(1990-11#1)(1995-8#1)
T is the##2##3##(2008-2#1)(2008-8#1)
T is##6##2##(1995-3#1)(2008-10#2)(2008-2#1)(2008-8#2)
T levels##4##2##(2013-8#4)
T lymphoblastoid##2##2##(1990-12#1)(2008-11#1)
T lymphocyte activity##2##3##(1995-3#1)(2008-3#1)
T lymphocyte subsets##2##3##(1990-2#1)(1991-6#1)
T lymphocyte##21##2##(1990-2#1)(1991-12#2)(1991-6#1)(1991-9#1)(1995-3#3)(1997-4#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#1)
T lymphocytes (CTL)##4##3##(1991-9#1)(2008-11#2)(2008-4#1)
T lymphocytes and##6##3##(1993-3#1)(1994-3#1)(1995-12#1)(1997-8#2)(2008-7#1)
T lymphocytes by##4##3##(1992-6#1)(1994-3#1)(2007-10#1)(2008-4#1)
T lymphocytes play##2##3##(1995-2#1)(1995-5#1)
T lymphocytes to##2##3##(1997-8#1)(2008-9#1)
T lymphocytes##48##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1997-8#3)(2007-10#1)(2008-11#4)(2008-4#10)(2008-7#1)(2008-9#3)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
T lymphocytes)##2##2##(1990-2#1)(1996-7#1)
T matrix in spheroidal coordinates##2##5##(2008-2#2)
T matrix in##3##3##(2008-2#3)
T matrix##8##2##(2008-2#6)(2008-3#2)
T model##2##2##(2013-8#2)
T mutation##2##2##(1997-7#1)(1997-8#1)
T or##3##2##(1990-8#1)(2008-8#1)(2010-1#1)
T stage##3##2##(1991-8#2)(2013-1#1)
T state##5##2##(1990-8#5)
T suppressor cells##2##3##(1991-6#2)
T to C at position 1578##2##6##(2008-12#2)
T to C at position##4##5##(2008-12#4)
T to##6##2##(1992-8#1)(2008-12#4)(2008-3#1)
T was##3##2##(1993-9#1)(2008-4#1)(2013-8#1)
T wave##5##2##(1993-1#2)(2008-10#1)(2010-8#1)(2013-8#1)
T waves##6##2##(1991-3#3)(1993-1#3)
T with##2##2##(2008-10#1)(2010-8#1)
T x##2##2##(2008-10#2)
T##1289##1##(1990-10#1)(1990-11#8)(1990-12#7)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#7)(1990-8#11)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#8)(1991-5#2)(1991-6#8)(1991-8#4)(1991-9#8)(1992-11#1)(1992-12#4)(1992-2#7)(1992-3#1)(1992-5#2)(1992-6#9)(1992-8#8)(1993-1#5)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#2)(1993-6#1)(1993-8#20)(1993-9#3)(1994-11#7)(1994-12#14)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#14)(1995-2#19)(1995-3#4)(1995-4#1)(1995-5#19)(1995-6#7)(1995-8#2)(1996-11#1)(1996-12#9)(1996-2#9)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#18)(2006-10#2)(2007-10#4)(2007-11#3)(2007-12#11)(2007-5#10)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#234)(2008-11#102)(2008-12#15)(2008-2#9)(2008-3#22)(2008-4#104)(2008-5#28)(2008-6#20)(2008-7#35)(2008-8#26)(2008-9#28)(2009-12#5)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#11)(2009-9#1)(2010-1#3)(2010-11#4)(2010-12#2)(2010-2#4)(2010-3#10)(2010-4#2)(2010-5#16)(2010-8#8)(2011-1#16)(2011-2#44)(2012-1#4)(2012-12#27)(2012-2#34)(2012-3#23)(2012-5#2)(2013-1#28)(2013-7#2)(2013-8#36)
T(0) and##2##2##(2007-8#1)(2008-8#1)
T(0)##4##1##(2007-8#2)(2008-8#2)
T(1) and T(2)##4##3##(2007-8#1)(2008-10#1)(2010-8#2)
T(1) value##2##2##(2008-10#2)
T(1)##23##1##(1997-7#2)(2007-8#2)(2008-10#8)(2008-7#1)(2008-8#3)(2010-8#6)(2012-2#1)
T(2) *##4##2##(2012-2#4)
T(2)##25##1##(2007-8#3)(2008-10#8)(2010-4#1)(2010-8#7)(2012-2#6)
T(3) and##2##2##(2007-8#1)(2008-7#1)
T(3) levels##2##2##(2009-12#2)
T(3) significantly increased ascites mortality##2##5##(1997-3#1)(1997-6#1)
T(3)##16##1##(1997-3#1)(1997-6#2)(2007-8#2)(2008-10#1)(2008-7#4)(2009-12#4)(2010-4#1)(2011-2#1)
T(382) in##2##2##(2008-10#2)
T(382)##6##1##(2008-10#6)
T(4) and##2##2##(2008-4#1)(2010-8#1)
T(4)##15##1##(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#2)(2009-12#3)(2009-6#1)(2010-4#1)(2010-8#2)(2011-2#1)
T(5)##2##1##(2008-10#1)(2011-2#1)
T(54)Psi(55)##2##1##(2008-8#2)
T(6)##2##1##(2008-10#1)(2011-2#1)
T(7)##3##1##(2008-10#2)(2011-2#1)
T(8)##3##1##(2008-10#2)(2011-2#1)
T(c)##6##1##(1996-2#3)(2008-3#1)(2012-2#2)
T(el)##3##1##(2012-2#3)
T(f) and plant population##2##4##(2008-12#2)
T(f) and plant##3##3##(2008-12#3)
T(f)##7##1##(2008-12#5)(2008-2#2)
T(g) of##2##2##(2009-7#1)(2010-4#1)
T(g)##16##1##(1995-3#5)(2007-12#2)(2008-2#2)(2008-9#3)(2009-7#2)(2010-4#2)
T(i)##2##1##(2008-10#2)
T(in)##10##1##(1995-2#4)(2008-4#6)
T(l)##2##1##(2012-2#2)
T(m) of##3##2##(2008-6#1)(2011-1#2)
T(m)##6##1##(2008-10#2)(2008-4#1)(2008-6#1)(2011-1#2)
T(max)##2##1##(2008-10#2)
T) and##3##2##(1993-8#1)(2008-8#2)
T)##17##1##(1990-8#1)(1993-8#2)(1995-5#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#5)(2010-8#1)(2012-2#1)(2012-3#1)
T- and B-cell##2##3##(1995-6#1)(2008-8#1)
T- and##7##2##(1990-8#1)(1995-6#1)(2008-10#3)(2008-8#1)(2008-9#1)
T--&gt##7##1##(1993-6#1)(1994-11#2)(1994-8#3)(1995-6#1)
T-112##2##1##(2008-12#2)
T-2 toxin and Kashin-Beck##2##4##(2011-2#2)
T-2 toxin##7##2##(1997-6#2)(2011-2#5)
T-20##4##1##(2008-5#3)(2011-3#1)
T-98##5##1##(1993-1#5)
T-CD4 T cells##10##3##(2012-12#10)
T-Cell##3##1##(2012-3#1)(2013-8#2)
T-Cells##3##1##(2008-10#2)(2013-8#1)
T-DNA##16##1##(1990-11#3)(2008-10#11)(2010-2#1)(2011-1#1)
T-DNAs##2##1##(2011-1#2)
T-LGL leukemia##4##2##(2009-8#4)
T-LGL##7##1##(2009-8#4)(2010-1#3)
T-PAHs##2##1##(2008-10#2)
T-SEARCH##3##1##(2008-11#3)
T-SR values##3##2##(1994-7#3)
T-SR##6##1##(1994-7#6)
T-antigen##6##1##(1996-5#2)(1997-7#1)(2008-11#3)
T-box gene##2##2##(2008-5#2)
T-box##3##1##(2008-5#2)(2008-8#1)
T-cell activation##4##2##(2008-10#1)(2008-4#1)(2012-2#1)(2012-9#1)
T-cell acute leukemia##2##3##(1994-8#2)
T-cell acute##5##2##(1994-8#4)(2008-10#1)
T-cell and##2##2##(1992-12#1)(2012-2#1)
T-cell antigen##2##2##(1993-9#1)(2012-2#1)
T-cell antigens##2##2##(2010-1#1)(2011-2#1)
T-cell clones##3##2##(1991-9#1)(1993-8#1)(1996-2#1)
T-cell cultures##2##2##(1990-5#1)(1992-8#1)
T-cell cytokine##2##2##(1994-12#1)(1994-8#1)
T-cell dependent antibody response (TDAR)##2##5##(2008-10#2)
T-cell dependent antibody response##3##4##(2008-10#3)
T-cell dependent##5##2##(1993-12#1)(2008-10#4)
T-cell differentiation##2##2##(2008-10#1)(2013-7#1)
T-cell epitope##6##2##(1995-2#4)(2008-10#1)(2011-2#1)
T-cell epitopes of gp120 of##2##5##(2008-12#2)
T-cell epitopes##9##2##(1991-12#1)(1994-8#1)(1995-2#2)(2007-6#1)(2008-10#1)(2008-12#3)
T-cell expansion##2##2##(2011-2#1)(2013-8#1)
T-cell leukaemia##2##2##(1991-11#1)(1991-8#1)
T-cell leukaemia/lymphoma##2##2##(2012-12#2)
T-cell leukemia virus type I##2##5##(1991-12#2)
T-cell leukemia virus##5##3##(1991-12#2)(2008-11#1)(2012-12#2)
T-cell leukemia##7##2##(1991-11#1)(1991-12#2)(2008-11#1)(2012-12#3)
T-cell line##6##2##(1993-6#5)(1995-2#1)
T-cell lines##3##2##(1993-6#1)(1995-2#1)(1997-3#1)
T-cell lymphoma##11##2##(1991-12#3)(1995-1#1)(1996-3#1)(2008-12#1)(2009-1#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
T-cell lymphomas##3##2##(2009-8#3)
T-cell lymphotropic virus type I##2##5##(1991-11#1)(2012-12#1)
T-cell mitogen##2##2##(1997-6#2)
T-cell priming##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
T-cell proliferation##4##2##(1990-5#1)(1995-2#1)(1995-5#1)(2008-11#1)
T-cell receptor (TCR)##3##3##(1994-3#1)(2008-11#1)(2009-8#1)
T-cell receptor##15##2##(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1997-2#1)(1997-7#1)(1997-9#3)(2008-10#1)(2008-11#1)(2009-8#1)
T-cell suppressed chickens##2##3##(1997-6#2)
T-cell suppressed##3##2##(1997-6#3)
T-cell suppression##2##2##(1997-6#2)
T-cell therapy##2##2##(2010-11#2)
T-cell##161##1##(1990-10#1)(1990-3#1)(1990-5#3)(1991-11#3)(1991-12#7)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#2)(1993-12#2)(1993-6#6)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#9)(1995-1#1)(1995-12#1)(1995-2#15)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#1)(1997-9#4)(2007-6#1)(2008-10#15)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#2)(2009-4#2)(2009-8#5)(2010-1#2)(2010-11#3)(2010-5#1)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#4)(2012-3#1)(2012-9#1)(2013-7#1)(2013-8#8)
T-cell-deficient chickens##3##2##(2008-5#3)
T-cell-deficient##4##1##(2008-5#4)
T-cell-dependent antibody response (TDAR)##2##4##(2008-10#2)
T-cell-dependent antibody response##4##3##(2008-10#4)
T-cell-dependent antibody##6##2##(2008-10#6)
T-cell-dependent##10##1##(1993-12#1)(1997-1#1)(2008-10#8)
T-cells and##6##2##(1991-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
T-cells in the##3##3##(2008-10#2)(2013-8#1)
T-cells in##7##2##(1991-12#1)(1996-12#1)(2008-10#3)(2011-2#1)(2013-8#1)
T-cells##39##1##(1991-12#3)(1991-6#1)(1993-6#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2008-10#14)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
T-cells)##2##1##(2008-10#2)
T-dependent antibody response##5##3##(2008-10#5)
T-dependent antigen##3##2##(1994-5#1)(2008-10#2)
T-dependent##8##1##(1994-5#1)(2008-10#7)
T-even phages##2##2##(1997-3#2)
T-even##4##1##(1997-3#4)
T-flask and##3##2##(2008-11#3)
T-flask based screening platform for evaluating and identifying plant hydrolysates for##2##11##(2008-11#2)
T-flask##12##1##(2008-11#12)
T-flasks##5##1##(2008-11#5)
T-helper cells##2##2##(1995-5#1)(2006-10#1)
T-helper##3##1##(1995-5#1)(2006-10#1)(2008-10#1)
T-lymphocyte IFN(gamma)##2##2##(2008-10#2)
T-lymphocyte activation##3##2##(2007-8#1)(2008-10#2)
T-lymphocyte cell##2##2##(1993-6#2)
T-lymphocyte effects##3##2##(1995-12#1)(2008-10#2)
T-lymphocyte##23##1##(1991-2#1)(1993-6#2)(1994-9#1)(1995-12#1)(1996-6#1)(2007-8#1)(2008-10#11)(2008-5#1)(2011-1#2)(2011-2#2)
T-lymphocyte-mediated##2##1##(2008-10#1)(2010-5#1)
T-lymphocytes (CD3 epsilon##2##3##(1996-12#2)
T-lymphocytes and##3##2##(1991-9#1)(1994-9#1)(2008-10#1)
T-lymphocytes can##2##2##(2008-10#1)(2008-11#1)
T-lymphocytes from##5##2##(2008-10#3)(2008-7#1)(2010-2#1)
T-lymphocytes in##5##2##(1996-12#1)(2008-10#3)(2008-11#1)
T-lymphocytes that##2##2##(1997-8#1)(2008-10#1)
T-lymphocytes##40##1##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-9#1)(1996-12#3)(1997-5#1)(1997-8#1)(2008-10#18)(2008-11#6)(2008-7#3)(2010-2#1)(2013-8#1)
T-lymphoid cell##2##2##(1991-6#2)
T-lymphoid##4##1##(1991-6#2)(1994-3#2)
T-lymphotropic##3##1##(1991-12#2)(2008-4#1)
T-matrix calculations are##2##3##(2008-2#1)(2008-3#1)
T-matrix calculations##4##2##(2008-2#1)(2008-3#3)
T-matrix computations of##2##3##(2008-2#2)
T-matrix results##2##2##(2008-2#2)
T-matrix##14##1##(2008-2#6)(2008-3#8)
T-maze alternation##2##2##(1991-2#1)(1994-8#1)
T-maze##9##1##(1991-2#1)(1992-6#1)(1993-3#3)(1994-8#2)(2012-2#1)(2013-1#1)
T-ray binary##2##2##(2007-11#2)
T-ray##3##1##(2007-11#3)
T-score##3##1##(2010-3#2)(2011-2#1)
T-strands##4##1##(2008-10#4)
T-structure##2##1##(2008-10#2)
T-toxin##3##1##(2008-10#3)
T-tube##5##1##(1991-3#3)(2008-3#2)
T-tubule##3##1##(1991-2#2)(2013-1#1)
T-type Ca(2+) channels##2##3##(2008-8#2)
T-type Ca(2+)##3##2##(2008-8#3)
T-type calcium channel blockers##3##4##(2008-8#3)
T-type calcium channels##2##3##(2008-8#2)
T-type calcium##5##2##(2008-8#5)
T-type##10##1##(2008-8#10)
T-wave inversion##2##2##(1993-1#1)(2013-8#1)
T-wave##3##1##(1993-1#1)(1994-1#1)(2013-8#1)
T-x phase##2##2##(2008-10#2)
T/A cloning##2##2##(1997-4#2)
T/C levels in##2##3##(2008-9#2)
T/C levels##5##2##(2008-9#5)
T/E(2)##3##1##(2008-3#3)
T0 and##2##2##(2007-8#1)(2013-1#1)
T0##3##1##(1990-5#1)(2007-8#1)(2013-1#1)
T1 and T2 relaxation##2##4##(1991-12#2)
T1 and T2##18##3##(1991-12#3)(1991-8#1)(1992-12#1)(2006-12#2)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-2#6)
T1 and##28##2##(1991-11#1)(1991-12#4)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(2006-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-2#6)(2010-9#1)(2011-2#1)
T1 in##2##2##(1991-8#1)(2013-1#1)
T1 patients##3##2##(1991-6#1)(1991-8#1)(2011-2#1)
T1 relaxation##2##2##(1995-11#1)(2008-7#1)
T1 relaxivity##2##2##(1990-2#1)(2008-7#1)
T1 strains##3##2##(2008-10#3)
T1 values##6##2##(1995-11#6)
T1 was##3##2##(1997-2#1)(2008-10#1)(2009-10#1)
T1##102##1##(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#7)(1991-4#3)(1991-6#2)(1991-8#4)(1992-12#1)(1992-4#2)(1994-8#1)(1995-11#8)(1997-2#7)(2006-12#2)(2007-8#2)(2008-1#1)(2008-10#15)(2008-12#4)(2008-5#1)(2008-7#3)(2009-10#3)(2009-7#3)(2010-2#12)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#9)
T1)##2##1##(1992-4#1)(2012-12#1)
T1- and T2-weighted images##2##4##(1997-8#1)(2012-12#1)
T1- and T2-weighted##4##3##(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
T1-weighted MRI##2##2##(1996-5#1)(2013-8#1)
T1-weighted images were##3##3##(2007-11#1)(2008-7#1)(2010-12#1)
T1-weighted images##10##2##(1991-11#1)(1995-4#1)(1997-8#2)(2007-11#3)(2008-7#2)(2010-12#1)
T1-weighted imaging##2##2##(2008-7#1)(2012-2#1)
T1-weighted##21##1##(1991-11#1)(1995-4#1)(1996-5#1)(1997-8#5)(2006-12#1)(2007-11#3)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
T1/2 of##2##2##(1993-11#1)(2011-3#1)
T1/2##4##1##(1993-11#1)(1996-1#2)(2011-3#1)
T11##4##1##(2008-8#1)(2012-12#3)
T12##5##1##(1991-11#1)(2008-12#1)(2009-3#1)(2013-1#2)
T1D is##3##2##(2010-5#1)(2011-2#2)
T1D##16##1##(2007-5#6)(2010-5#2)(2011-2#3)(2013-8#5)
T1N0##2##1##(2007-8#2)
T1R3##2##1##(2008-2#2)
T1T##2##1##(2013-1#2)
T2 and T3##3##3##(1990-6#1)(1991-8#1)(2010-2#1)
T2 and##5##2##(1990-2#1)(1990-6#1)(1991-8#1)(2009-10#1)(2010-2#1)
T2 gave the highest##2##4##(2008-12#2)
T2 hyperintensity in##2##3##(2009-11#2)
T2 in##2##2##(1991-8#1)(2013-1#1)
T2 or##2##2##(1997-2#1)(1997-3#1)
T2 than in C##8##4##(2010-2#8)
T2 than in##9##3##(2010-2#9)
T2 was##2##2##(2008-12#2)
T2##63##1##(1990-2#2)(1990-6#2)(1991-12#3)(1991-8#3)(1992-12#1)(1992-6#1)(1993-5#1)(1993-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(2006-12#2)(2007-8#2)(2008-10#2)(2008-12#7)(2008-5#1)(2008-7#3)(2009-10#3)(2009-11#2)(2009-3#1)(2009-7#4)(2010-2#10)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
T2*##3##1##(1996-2#1)(2008-7#1)(2010-9#1)
T2*-weighted perfusion##2##2##(2008-7#2)
T2-3##2##1##(1991-8#1)(2013-1#1)
T2-weighed##2##1##(2007-10#1)(2012-12#1)
T2-weighted MRI##4##2##(1996-5#1)(2007-10#3)
T2-weighted image##2##2##(2012-3#1)(2013-8#1)
T2-weighted images##5##2##(1991-11#2)(1997-8#1)(2008-7#1)(2012-12#1)
T2-weighted magnetic resonance images##2##4##(2006-12#1)(2011-2#1)
T2-weighted magnetic resonance##3##3##(2006-12#1)(2007-10#1)(2011-2#1)
T2-weighted##19##1##(1991-11#2)(1996-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#4)(2008-7#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
T21 was##2##2##(2008-8#2)
T21##8##1##(2008-8#5)(2008-9#3)
T22##9##1##(2008-10#9)
T24 cells##2##2##(1992-6#1)(1997-7#1)
T24##3##1##(1992-6#2)(1997-7#1)
T2D and##3##2##(2008-1#1)(2009-3#1)(2012-6#1)
T2D patients##5##2##(2011-2#4)(2012-6#1)
T2D##19##1##(2008-1#1)(2009-3#7)(2011-2#4)(2012-3#2)(2012-6#4)(2013-7#1)
T2DM in##2##2##(2008-3#1)(2011-1#1)
T2DM may##2##2##(2009-11#1)(2010-10#1)
T2DM patients##3##2##(2008-1#1)(2008-3#1)(2011-1#1)
T2DM##27##1##(2008-1#1)(2008-3#2)(2009-11#8)(2009-9#3)(2010-10#3)(2011-1#6)(2013-1#4)
T2HCA##4##1##(2013-1#4)
T2N0##2##1##(2007-8#2)
T2T##2##1##(2013-1#2)
T2W##2##1##(2008-6#1)(2009-11#1)
T3 and RA##2##3##(1994-11#2)
T3 and T30##2##3##(2008-10#2)
T3 and T4##2##3##(1990-2#1)(2008-7#1)
T3 and##8##2##(1990-2#1)(1990-6#1)(1990-8#1)(1994-11#2)(2008-10#2)(2008-7#1)
T3 binding##5##2##(1991-2#2)(1991-5#2)(1993-8#1)
T3 concentration##2##2##(1990-3#1)(2008-10#1)
T3 in the##3##3##(1996-5#1)(2008-10#1)(2010-2#1)
T3 in##7##2##(1994-11#1)(1996-5#1)(2008-10#3)(2010-2#1)(2013-1#1)
T3 is##2##2##(1994-11#1)(1996-5#1)
T3 levels were##2##3##(1996-5#1)(2008-7#1)
T3 receptor##2##2##(1995-8#2)
T3 strain##3##2##(2008-10#3)
T3 strains were inhibitory to##2##5##(2008-10#2)
T3 strains were##4##3##(2008-10#4)
T3 strains##5##2##(2008-10#5)
T3 was isolated from##2##4##(2008-10#2)
T3 was##5##2##(1994-11#1)(2008-10#3)(2008-12#1)
T3##98##1##(1990-2#1)(1990-3#4)(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#3)(1991-5#3)(1991-8#1)(1992-10#1)(1992-12#3)(1993-8#4)(1994-11#7)(1995-8#3)(1996-2#2)(1996-5#6)(1997-2#2)(2007-8#3)(2008-10#29)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#5)(2010-11#2)(2010-2#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#2)
T3-4##2##1##(1990-12#1)(2007-8#1)
T3-binding##2##1##(1991-5#1)(1995-8#1)
T30##10##1##(2008-10#8)(2013-7#2)
T32##3##1##(2008-9#3)
T36##10##1##(2008-10#10)
T3SS##2##1##(2013-1#2)
T4 DNA ligase##3##3##(1993-2#1)(1993-3#1)(1994-12#1)
T4 DNA##6##2##(1990-5#1)(1993-2#2)(1993-3#1)(1994-12#1)(1997-3#1)
T4 RNA ligase##3##3##(1990-7#1)(1993-11#1)(2008-8#1)
T4 RNA##4##2##(1990-7#1)(1993-11#1)(2008-2#1)(2008-8#1)
T4 and T3##6##3##(1990-3#2)(1991-12#1)(2008-7#1)(2011-1#2)
T4 and##7##2##(1990-3#2)(1991-12#2)(2008-7#1)(2011-1#2)
T4 gene##3##2##(1995-12#1)(1995-6#2)
T4 in##4##2##(1993-12#1)(1995-2#1)(2007-8#1)(2013-1#1)
T4 late transcription by##2##4##(1995-6#2)
T4 late##4##2##(1995-6#4)
T4 levels##4##2##(1993-12#3)(2008-7#1)
T4 lysozyme##5##2##(1997-2#2)(2008-10#3)
T4 patients##2##2##(1991-8#2)
T4 polymerase##3##2##(1991-9#3)
T4 showed a significant##2##4##(1991-12#1)(2008-6#1)
T4 treatment##2##2##(1990-6#1)(2008-6#1)
T4 were##2##2##(1991-12#1)(2008-6#1)
T4##103##1##(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#1)(1991-12#5)(1991-8#2)(1991-9#6)(1992-5#1)(1993-11#1)(1993-12#10)(1993-2#2)(1993-3#1)(1994-12#1)(1994-6#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#6)(1997-2#2)(1997-3#4)(1997-7#3)(2007-2#1)(2007-8#3)(2008-10#7)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#9)(2008-7#5)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
T4)##2##1##(2007-8#1)(2008-5#1)
T4/T8 ratios of lymphocytes##2##4##(1991-5#2)
T4/T8 ratios##3##2##(1991-5#3)
T4/T8##4##1##(1991-5#4)
T47D cells##3##2##(1992-9#1)(2008-11#2)
T47D##7##1##(1990-12#1)(1992-4#1)(1992-9#1)(2008-11#3)(2010-6#1)
T5-A2##3##1##(2008-10#3)
T6##2##1##(1990-11#1)(1995-6#1)
T7 RNA polymerase was##2##4##(1991-12#1)(1994-5#1)
T7 RNA polymerase##18##3##(1990-11#1)(1991-12#2)(1991-5#2)(1991-9#4)(1993-11#1)(1994-5#1)(1997-4#3)(2008-1#1)(2008-8#3)
T7 RNA polymerase-driven##2##3##(1991-12#1)(1993-6#1)
T7 RNA##22##2##(1990-11#1)(1991-12#3)(1991-5#2)(1991-9#4)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1997-4#3)(2008-1#1)(2008-10#1)(2008-8#3)
T7 infection##2##2##(1991-9#2)
T7 lysozyme##2##2##(1997-4#2)
T7 promoter and##2##3##(2008-11#1)(2008-8#1)
T7 promoter##10##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#2)(1994-5#1)(1997-4#1)(2008-11#1)(2008-8#2)
T7##53##1##(1990-11#1)(1990-5#1)(1991-12#5)(1991-5#4)(1991-9#9)(1992-12#5)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-6#1)(1995-8#1)(1997-4#8)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-8#6)(2009-3#1)
T7-SAGE##3##1##(2008-1#3)
T7-based RNA amplification##2##3##(2008-1#2)
T7-based##3##1##(2008-1#3)
T790M mutation##2##2##(2012-1#2)
T790M##8##1##(2012-1#8)
T8##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
T83##2##1##(2008-9#2)
T88-M cells##4##2##(1990-12#4)
T9##5##1##(1995-6#3)(2012-12#2)
T=1##2##1##(2008-8#2)
TA 28##2##2##(2008-10#2)
TA 870 and TA 874##2##5##(2008-10#2)
TA 870##3##2##(2008-10#3)
TA and##3##2##(1997-8#2)(2008-10#1)
TA can##2##2##(1991-9#1)(2008-10#1)
TA is a##2##3##(2013-1#2)
TA patients##3##2##(2007-10#3)
TA was##2##2##(1997-8#1)(2013-1#1)
TA with##2##2##(1997-8#1)(2007-8#1)
TA##43##1##(1991-9#2)(1997-3#1)(1997-8#14)(2007-10#3)(2007-8#1)(2008-10#13)(2008-3#2)(2013-1#7)
TA1##4##1##(1992-9#1)(1995-6#3)
TA100##8##1##(1992-2#1)(1992-5#1)(1996-2#2)(2008-8#1)(2008-9#3)
TA1535##6##1##(1992-9#2)(2008-8#1)(2008-9#3)
TA2##4##1##(1995-6#4)
TA352##2##1##(2008-8#2)
TA97##3##1##(2008-8#2)(2008-9#1)
TA98##5##1##(1996-2#1)(2008-8#1)(2008-9#3)
TAC##12##1##(1990-5#1)(1992-9#1)(2008-10#9)(2013-1#1)
TACTICS-TIMI 18##3##2##(2008-3#3)
TAD soils from Washington State##2##5##(2008-10#2)
TAD soils##9##2##(2008-10#9)
TAD##12##1##(1995-3#1)(2008-10#11)
TADs of p65##2##3##(1995-6#2)
TAE buffer##2##2##(2008-9#2)
TAE##3##1##(2008-7#1)(2008-9#2)
TAF##2##1##(1996-12#2)
TAG##5##1##(1994-12#1)(2008-12#1)(2008-8#1)(2010-8#1)(2013-1#1)
TAH##7##1##(1994-2#3)(1995-3#1)(1996-2#2)(2010-8#1)
TAI##2##1##(2008-3#2)
TAI-27 and##2##2##(2008-8#1)(2008-9#1)
TAI-27##8##1##(2008-8#3)(2008-9#5)
TAIM patients with IM fields treated with Co60##2##8##(2007-10#2)
TAIR##5##1##(2008-4#2)(2008-7#3)
TAK1##4##1##(2011-2#4)
TAL1 are##3##2##(1994-8#3)
TAL1##6##1##(1994-8#6)
TALF isolates##4##2##(2008-10#4)
TAM O-301##2##2##(2008-10#2)
TAM##12##1##(1993-1#1)(1994-7#2)(1997-7#2)(2008-10#6)(2008-12#1)
TAMC##3##1##(2008-1#3)
TAMRA is##2##2##(2009-8#2)
TAMRA##5##1##(2009-8#5)
TAO##2##1##(2006-10#2)
TAP is##2##2##(1991-8#2)
TAP##7##1##(1991-8#7)
TAPP##5##1##(2008-10#4)(2011-2#1)
TAR RNA##2##2##(2009-6#2)
TAR##11##1##(1992-12#1)(1994-8#4)(2007-8#3)(2008-9#1)(2009-6#2)
TARGET-DATE FUNDS##2##2##(2011-2#2)
TAS-ELISA##2##1##(2008-10#2)
TASER##3##1##(2010-1#2)(2012-3#1)
TASK-2 has been##3##3##(2013-8#3)
TASK-2 is##2##2##(2013-8#2)
TASK-2##9##1##(2013-8#9)
TAT peptide##4##2##(2009-6#4)
TAT specific activity##4##3##(1997-4#4)
TAT##19##1##(1991-3#2)(1997-4#4)(2008-1#1)(2008-11#1)(2009-6#5)(2010-3#1)(2011-2#5)
TATA box##15##2##(1992-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1997-2#3)(1997-6#1)(1997-8#1)(2008-9#1)(2010-5#1)
TATA boxes and other transcriptional regulatory elements in##2##8##(1993-12#1)(1993-6#1)
TATA boxes and##4##3##(1993-12#1)(1993-6#2)(1994-12#1)
TATA boxes of the##2##4##(1997-2#2)
TATA boxes##8##2##(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-6#1)(1997-2#2)
TATA element located##2##3##(1995-2#1)(1995-8#1)
TATA element##8##2##(1995-2#3)(1995-8#3)(1997-2#2)
TATA motif##2##2##(1995-6#1)(1997-7#1)
TATA or CCAAT##2##3##(1991-6#1)(1991-7#1)
TATA or##4##2##(1991-6#1)(1991-7#1)(1993-2#1)(1993-3#1)
TATA##40##1##(1991-6#1)(1991-7#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-12#3)(1995-2#3)(1995-6#2)(1995-8#5)(1996-10#1)(1997-2#7)(1997-6#1)(1997-7#1)(1997-8#1)(2008-9#1)(2010-5#1)
TATA-binding protein (TBP) interacts with##2##5##(1993-8#1)(1997-2#1)
TATA-binding protein (TBP)##5##3##(1993-2#2)(1993-8#1)(1993-9#1)(1997-2#1)
TATA-binding protein##9##2##(1993-2#2)(1993-8#2)(1993-9#2)(1997-2#2)(2008-2#1)
TATA-like##2##1##(1990-11#1)(1994-12#1)
TAU##4##1##(2009-11#4)
TAUM##4##1##(2011-1#4)
TAg##3##1##(1995-6#1)(2008-11#2)
TB (XDR-TB)##3##2##(2008-10#1)(2010-5#2)
TB DOT##2##2##(1996-3#2)
TB IRIS##6##2##(2010-5#6)
TB and HIV##4##3##(2008-10#1)(2010-4#3)
TB and HIV-1/AIDS##2##3##(2009-4#2)
TB and##18##2##(1996-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2009-4#3)(2010-4#5)(2010-5#3)(2013-1#1)(2013-7#1)
TB care##2##2##(2010-4#2)
TB case##2##2##(2010-5#1)(2013-1#1)
TB cases##3##2##(2011-2#1)(2013-1#2)
TB control##4##2##(1996-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
TB directly observed therapy##2##4##(1996-3#2)
TB immune reconstitution inflammatory syndrome##2##5##(2010-5#2)
TB in children##6##3##(2011-2#4)(2013-7#2)
TB in these##2##3##(2008-1#1)(2011-2#1)
TB in##14##2##(2007-2#2)(2008-1#1)(2008-10#1)(2010-4#1)(2010-5#2)(2011-2#5)(2013-7#2)
TB infection in##3##3##(2010-11#1)(2010-5#2)
TB infection##9##2##(2007-2#4)(2010-11#1)(2010-5#4)
TB is a##2##3##(2007-2#1)(2010-5#1)
TB is##6##2##(2007-2#1)(2010-5#3)(2011-1#1)(2011-2#1)
TB patients at high risk for##2##6##(2013-1#2)
TB patients##7##2##(1996-11#2)(2008-5#1)(2011-2#2)(2013-1#2)
TB skin##2##2##(2008-10#1)(2010-4#1)
TB testing##3##2##(1996-3#2)(1997-2#1)
TB transmission##2##2##(2013-1#1)(2013-8#1)
TB treatment##5##2##(2008-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
TB was##2##2##(2008-1#2)
TB were##2##2##(2008-1#1)(2013-1#1)
TB##170##1##(1992-9#1)(1993-5#1)(1994-12#1)(1996-11#3)(1996-3#9)(1997-2#1)(2006-10#3)(2007-2#10)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#5)(2010-11#2)(2010-4#12)(2010-5#35)(2010-8#1)(2011-1#3)(2011-2#23)(2012-3#2)(2013-1#14)(2013-7#7)(2013-8#6)
TB)##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
TB-A##2##1##(2007-11#2)
TB-suspected adolescents##2##2##(2013-1#2)
TBA##4##1##(2008-10#3)(2008-5#1)
TBAB##5##1##(1995-12#2)(2008-10#3)
TBABF(4)##2##1##(2008-10#2)
TBARS and##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
TBARS concentrations##4##2##(1993-2#4)
TBARS were##2##2##(2008-10#2)
TBARS##21##1##(1993-2#4)(1994-6#1)(1994-9#1)(1995-3#2)(2008-10#6)(2010-4#4)(2012-2#1)(2012-3#1)(2012-5#1)
TBAs in Ilorin##2##3##(2011-1#2)
TBAs##7##1##(1994-3#4)(2011-1#3)
TBBC##3##1##(2008-10#3)
TBE cases##2##2##(1996-11#1)(2007-2#1)
TBE foci are##2##3##(2007-2#2)
TBE infections##4##2##(1996-11#4)
TBE virus##3##2##(2007-2#2)(2008-8#1)
TBE##21##1##(1996-11#10)(2007-2#7)(2008-8#3)(2008-9#1)
TBG##5##1##(1990-2#5)
TBHQ##4##1##(2008-10#4)
TBHs##2##1##(2012-2#2)
TBI and##3##2##(2008-6#2)(2013-1#1)
TBI has##2##2##(2007-4#1)(2008-9#1)
TBI patients##13##2##(1996-1#2)(2007-11#5)(2008-10#1)(2008-9#4)(2010-9#1)
TBI##56##1##(1993-12#2)(1996-1#3)(2007-11#5)(2007-4#9)(2008-10#3)(2008-6#4)(2008-9#8)(2009-10#2)(2010-4#1)(2010-9#2)(2012-2#8)(2013-1#4)(2013-8#5)
TBII activity##2##2##(1991-5#2)
TBII##4##1##(1991-12#1)(1991-5#2)(1995-12#1)
TBL##4##1##(1992-2#4)
TBM##2##1##(2011-2#2)
TBO##2##1##(2008-10#2)
TBP and##4##2##(1993-8#1)(1997-2#1)(1997-6#1)(2008-10#1)
TBP in##3##2##(1997-2#1)(2008-1#1)(2008-10#1)
TBP may##2##2##(1993-8#1)(2008-1#1)
TBP##24##1##(1993-2#1)(1993-8#6)(1993-9#2)(1997-2#2)(1997-6#1)(2008-1#4)(2008-10#8)
TBPs##4##1##(1993-2#3)(1997-2#1)
TBSV##3##1##(2008-10#3)
TBT##6##1##(2008-10#1)(2008-11#5)
TBTCl##2##1##(1996-12#2)
TBTO were##2##2##(2008-10#2)
TBTO##8##1##(2008-10#8)
TBX1##2##1##(2012-12#2)
TBZ##7##1##(2008-10#2)(2011-10#5)
TC II##3##2##(1991-12#3)
TC and##4##2##(2007-7#1)(2008-12#1)(2009-5#2)
TC level##2##2##(1990-2#1)(2008-7#1)
TC levels##2##2##(1990-2#2)
TC measurements##2##2##(1992-10#2)
TC##36##1##(1990-2#3)(1991-12#4)(1992-10#2)(1992-3#3)(1992-6#1)(1993-6#1)(2007-11#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-7#2)(2009-5#4)(2011-1#1)(2011-2#4)(2013-1#1)
TCA and glycolytic intermediates##3##4##(1997-1#3)
TCA and##6##2##(1997-1#3)(2008-10#3)
TCA cycle##11##2##(1993-11#3)(1993-6#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-1#1)
TCA overdose##4##2##(2010-1#4)
TCA precipitation##2##2##(2008-4#1)(2008-9#1)
TCA therapy##2##2##(2010-12#2)
TCA was##2##2##(2008-10#1)(2010-12#1)
TCA##34##1##(1993-11#3)(1993-6#1)(1995-11#1)(1995-3#3)(1997-1#3)(2008-10#7)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#5)(2010-12#4)(2011-2#1)(2012-1#1)
TCA-pretreated##2##1##(1995-3#2)
TCAA##4##1##(2008-10#4)
TCAE##2##1##(1995-12#2)
TCAH did not##2##3##(2008-10#2)
TCAH##7##1##(2008-10#7)
TCAH-treated##2##1##(2008-10#2)
TCAM##9##1##(2009-6#9)
TCAs##3##1##(1996-7#1)(2008-10#1)(2010-1#1)
TCB##3##1##(1995-12#1)(2008-2#2)
TCC##4##1##(2008-10#1)(2008-4#2)(2012-3#1)
TCCCN models were##2##3##(2008-10#2)
TCCCN##4##1##(2008-10#4)
TCD monitoring##2##2##(2007-10#1)(2012-3#1)
TCD results##2##2##(2008-7#2)
TCD was##2##2##(1996-6#2)
TCD##18##1##(1996-6#4)(2007-10#3)(2008-7#2)(2008-8#1)(2012-1#7)(2012-3#1)
TCD-MCA##5##1##(2008-7#5)
TCD-defined vasospasm##7##2##(2007-10#7)
TCDD and##5##2##(1995-3#1)(2008-10#3)(2008-7#1)
TCDD at##2##2##(1992-12#1)(1995-3#1)
TCDD exposure##3##2##(2008-10#3)
TCDD treatment##3##2##(1992-12#1)(1995-11#1)(2008-10#1)
TCDD##45##1##(1992-12#4)(1992-8#1)(1993-6#2)(1994-5#4)(1995-11#3)(1995-3#10)(2008-10#16)(2008-11#3)(2008-7#2)
TCDD-induced CTL suppression is##2##4##(1995-3#2)
TCDD-induced##5##1##(1992-12#2)(1995-3#3)
TCDD-inducible##3##1##(1992-8#1)(1993-11#1)(2008-10#1)
TCDD-treated##2##1##(2008-10#2)
TCE and##2##2##(2008-10#2)
TCE exposure##3##2##(2008-10#3)
TCE in##4##2##(2008-10#2)(2010-4#2)
TCE or##2##2##(2008-10#2)
TCE##30##1##(2008-10#23)(2008-7#3)(2010-4#3)(2012-12#1)
TCE-exposed##3##1##(2008-10#3)
TCF##8##1##(1994-11#4)(2008-10#4)
TCI-R assessment##2##2##(2009-9#2)
TCI-R##7##1##(2009-9#7)
TCID(50) mL(-1)kg(-1))##2##2##(2009-6#2)
TCID(50) ml(-1)##2##2##(2008-11#2)
TCID(50)##6##1##(2008-11#2)(2009-6#4)
TCM and##2##2##(2009-6#1)(2011-2#1)
TCM##11##1##(2008-10#9)(2009-6#1)(2011-2#1)
TCM-9 was##2##2##(1992-8#2)
TCM-9##4##1##(1992-8#4)
TCMTB##7##1##(2008-10#7)
TCNB##3##1##(2007-11#3)
TCNQ##3##1##(2008-10#3)
TCP activity during##2##3##(1992-6#2)
TCP activity##4##2##(1992-6#4)
TCP and the##2##3##(1992-6#2)
TCP or ZnTCP##3##3##(2008-5#3)
TCP##20##1##(1992-6#12)(1994-2#1)(2008-10#2)(2008-5#4)(2009-8#1)
TCPC##4##1##(2007-12#1)(2007-8#3)
TCPP##12##1##(2008-10#12)
TCR gene##2##2##(2009-8#2)
TCR##20##1##(1994-3#3)(2008-11#9)(2008-4#3)(2009-8#3)(2011-1#2)
TCR-alphabeta(1)(+)##2##1##(2008-5#2)
TCRgammadelta(+)##3##1##(2008-11#3)
TCS and AMP##2##3##(2008-8#2)
TCS and##5##2##(2008-10#3)(2008-8#2)
TCS in##2##2##(2008-5#2)
TCS##22##1##(2008-10#11)(2008-5#5)(2008-8#6)
TD and##3##2##(1997-3#1)(2007-7#1)(2010-12#1)
TD in##2##2##(2010-12#2)
TD lesions##2##2##(1997-3#2)
TD x D##2##3##(2008-10#2)
TD##27##1##(1997-3#5)(2007-7#7)(2008-10#3)(2009-8#1)(2010-12#8)(2012-12#1)(2012-3#2)
TD)##2##1##(2008-10#1)(2011-1#1)
TDAR assays##2##2##(2008-10#2)
TDAR##11##1##(2008-10#11)
TDCPP and TPP##2##3##(2013-1#2)
TDCPP and##3##2##(2013-1#3)
TDCPP##7##1##(2013-1#7)
TDD-organo-clay##2##1##(2008-10#2)
TDF or##2##2##(2013-1#2)
TDF##3##1##(2013-1#3)
TDFs##2##1##(2009-6#2)
TDH3 promoter##2##2##(1995-8#2)
TDI##7##1##(2008-10#6)(2011-1#1)
TDM##5##1##(1991-11#2)(2008-3#1)(2008-7#2)
TDMTS##2##1##(2011-2#2)
TDT##5##1##(2008-4#3)(2008-9#2)
TDeltaS(0)##5##1##(2008-10#5)
TE =##2##2##(1997-8#2)
TE and TM polarizations##3##4##(2008-2#3)
TE and TM##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
TE has##2##2##(1993-12#2)
TE modes##2##2##(2007-12#1)(2008-3#1)
TE polarization the##2##3##(2007-11#1)(2008-3#1)
TE polarization##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
TE##45##1##(1993-12#4)(1997-8#2)(2007-11#4)(2007-12#3)(2008-10#3)(2008-11#4)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#4)(2010-3#4)
TE(0)##3##1##(2007-12#2)(2008-3#1)
TE(11##2##1##(2011-1#2)
TE-6 was##2##2##(1992-9#2)
TE-6##7##1##(1992-9#7)
TE1 and TE2##2##3##(1992-8#2)
TE1##3##1##(1992-8#2)(1997-2#1)
TE2-NS and TE3-OS cells##3##4##(1993-9#3)
TE85##3##1##(1994-6#3)
TEA CO2 laser##4##3##(2007-12#2)(2008-3#2)
TEA CO2##5##2##(2007-12#3)(2008-3#2)
TEA##12##1##(2007-12#3)(2008-10#5)(2008-3#3)(2008-8#1)
TEA+ (30mM)##2##2##(1993-3#2)
TEA+##3##1##(1993-3#2)(1994-11#1)
TEAC(2min)##2##1##(2008-10#2)
TECAB##3##1##(2007-8#3)
TEE##12##1##(2008-10#2)(2008-7#3)(2010-8#5)(2011-2#2)
TEEs##3##1##(2008-7#3)
TEF##2##1##(2008-1#1)(2008-10#1)
TEFRA##3##1##(1993-12#2)(1994-3#1)
TEG has##2##2##(2013-1#2)
TEG in patients with##2##4##(2013-1#2)
TEG##5##1##(1997-4#1)(2013-1#4)
TEGDMA presented##2##2##(2013-1#2)
TEGDMA##6##1##(2013-1#6)
TEHP##2##1##(2008-10#2)
TEM and##2##2##(2007-7#1)(2008-10#1)
TEM images##2##2##(2011-3#2)
TEM##25##1##(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-9#3)(2010-10#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)
TEM(00) mode##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
TEM(00) output##2##2##(2007-12#1)(2008-2#1)
TEM(00)##18##1##(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#6)
TEM)##2##1##(2008-11#1)(2008-4#1)
TEM00 mode##3##2##(2008-3#3)
TEM00##7##1##(2007-12#1)(2008-3#6)
TEMPO (2##2##2##(2007-11#1)(2008-8#1)
TEMPO##5##1##(2007-11#2)(2008-8#3)
TEMPO+##9##1##(2008-9#9)
TEMPPO##2##1##(2012-3#2)
TEN##3##1##(2007-7#3)
TENS##3##1##(1995-12#1)(2010-1#1)(2011-2#1)
TEP in freshwater##2##3##(2008-10#2)
TEP##6##1##(2008-10#4)(2011-2#1)(2012-3#1)
TEQ level##2##2##(2008-10#2)
TEQ values##4##2##(2008-10#4)
TEQ##13##1##(2008-10#13)
TEQ-value##2##1##(2008-10#2)
TEQ-values obtained by##2##3##(2008-10#2)
TEQ-values obtained##3##2##(2008-10#3)
TEQ-values##5##1##(2008-10#5)
TEQ/g fat##3##2##(2008-10#3)
TEQ/kg##2##1##(2008-10#2)
TER##8##1##(2008-10#6)(2008-11#1)(2012-1#1)
TERC##2##1##(2008-11#2)
TERS enhancements##2##2##(2012-1#2)
TERS##8##1##(2012-1#8)
TERT##4##1##(2008-11#4)
TES in##2##2##(2008-2#1)(2009-10#1)
TES##16##1##(1996-2#3)(2008-2#5)(2008-3#3)(2009-10#4)(2013-7#1)
TESS##2##1##(2008-3#1)(2008-6#1)
TEV##2##1##(2008-10#2)
TEVA extraction##2##2##(2008-10#2)
TEWL and skin##2##3##(2008-5#2)
TEWL and##5##2##(2008-5#5)
TEWL in##2##2##(2008-5#1)(2012-2#1)
TEWL is##2##2##(2008-5#2)
TEWL##20##1##(2008-5#19)(2012-2#1)
TEd##4##1##(1993-12#4)
TEs##4##1##(2009-3#1)(2010-3#3)
TF and PAI-1 expression##2##4##(1994-9#2)
TF and PAI-1 protein and mRNA##2##6##(1994-9#2)
TF and PAI-1##8##3##(1994-9#8)
TF and##9##2##(1994-9#8)(1995-6#1)
TF gene##2##2##(2008-7#2)
TF interaction##2##2##(1995-6#2)
TF##19##1##(1994-9#9)(1995-6#4)(2008-11#1)(2008-7#3)(2012-2#2)
TF-1##3##1##(1993-12#1)(1995-6#2)
TF103 strain##2##2##(2008-6#2)
TF103##4##1##(2008-6#4)
TFA and##2##2##(2008-10#1)(2012-2#1)
TFA in the##2##3##(2008-10#2)
TFA##9##1##(2007-11#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#1)
TFA-adducts##4##1##(1991-2#4)
TFAP groups##2##2##(2008-10#2)
TFAR19 gene##2##2##(2008-9#2)
TFAR19##5##1##(2008-9#5)
TFE##2##1##(2010-7#2)
TFF##3##1##(2008-7#3)
TFGS extract treatment##2##3##(2013-1#2)
TFGS##5##1##(2013-1#5)
TFHBM's##4##1##(2008-3#4)
TFI devices##2##2##(2008-2#2)
TFIIB and##3##2##(1995-2#2)(2008-9#1)
TFIIB##9##1##(1995-2#6)(1997-6#2)(2008-9#1)
TFIIF##3##1##(1995-6#2)(1997-3#1)
TFMT##2##1##(2008-2#2)
TFO##4##1##(1995-5#4)
TFOs##3##1##(2008-9#3)
TFP##2##1##(2008-2#1)(2008-8#1)
TFPI##3##1##(1992-10#3)
TFs (how to find them##2##5##(2008-9#2)
TFs in##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
TFs##17##1##(2008-11#2)(2008-7#4)(2008-9#4)(2011-2#5)(2012-2#2)
TG and HDL-C##2##3##(2008-3#2)
TG in##3##2##(2010-8#1)(2011-2#2)
TG levels##4##2##(2008-3#3)(2010-8#1)
TG neurons##6##2##(2009-12#6)
TG structures##3##2##(2012-2#3)
TG##44##1##(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#8)(2008-5#1)(2008-9#3)(2009-12#9)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#9)(2013-8#1)
TG-DTG##2##1##(2008-10#2)
TG/DTA-MS##2##1##(2008-10#2)
TG/GG##2##1##(2012-12#2)
TGA and##2##2##(2008-10#1)(2009-3#1)
TGA##9##1##(2007-11#1)(2008-10#4)(2009-3#1)(2009-6#2)(2013-1#1)
TGA1a##2##1##(2008-9#2)
TGB1##2##1##(2008-9#1)(2010-9#1)
TGB2##2##1##(2008-9#2)
TGB3##2##1##(2008-9#2)
TGCCA can be##2##3##(2009-12#2)
TGCCA##4##1##(2009-12#4)
TGF alpha##10##2##(1991-7#1)(1992-8#1)(1994-7#1)(1997-1#3)(1997-4#4)
TGF alpha-anti-Tac(Fv)-PE40##2##2##(1990-8#2)
TGF alpha-induced DNA synthesis##2##4##(1997-1#2)
TGF alpha-induced##4##2##(1997-1#4)
TGF beta 1##2##3##(1992-8#2)
TGF beta and activin A##2##5##(1990-12#2)
TGF beta inhibits##2##3##(1992-8#2)
TGF beta or retinoic acid or##2##6##(1991-12#2)
TGF beta##24##2##(1990-12#4)(1990-2#1)(1991-12#4)(1992-8#9)(1995-12#5)(2013-8#1)
TGF##44##1##(1990-12#4)(1990-2#1)(1990-8#3)(1991-12#4)(1991-7#1)(1992-8#10)(1994-7#1)(1995-12#5)(1997-1#9)(1997-4#4)(2008-11#1)(2013-8#1)
TGF-alpha and##3##2##(1992-9#1)(1993-9#2)
TGF-alpha production##2##2##(1992-9#2)
TGF-alpha##17##1##(1992-8#1)(1992-9#9)(1993-9#5)(1996-5#1)(2012-3#1)
TGF-beta 1 (2##2##3##(1990-8#2)
TGF-beta 1 did not##2##4##(1992-3#1)(1994-6#1)
TGF-beta 1 inhibition##2##3##(1990-8#2)
TGF-beta 1 was##2##3##(1992-3#2)
TGF-beta 1##25##2##(1990-5#6)(1990-8#6)(1991-12#1)(1992-3#7)(1994-11#2)(1994-6#1)(2008-9#2)
TGF-beta 3##2##2##(1992-9#1)(2008-11#1)
TGF-beta RI and##2##3##(1995-2#2)
TGF-beta RI##4##2##(1995-2#4)
TGF-beta RII kinase##2##3##(1995-2#2)
TGF-beta RII##4##2##(1995-2#4)
TGF-beta also##2##2##(1992-2#1)(2008-11#1)
TGF-beta at##2##2##(1990-12#2)
TGF-beta is##2##2##(2008-12#2)
TGF-beta signaling##3##2##(1995-2#1)(2008-11#2)
TGF-beta superfamily##2##2##(1994-12#2)
TGF-beta type II receptor##3##4##(1993-3#2)(1997-2#1)
TGF-beta type II receptors##2##4##(1993-3#1)(2011-2#1)
TGF-beta type II##5##3##(1993-3#3)(1997-2#1)(2011-2#1)
TGF-beta type##6##2##(1993-3#3)(1997-2#1)(2011-2#2)
TGF-beta##99##1##(1990-12#3)(1990-5#7)(1990-8#6)(1991-12#1)(1992-2#2)(1992-3#7)(1992-9#4)(1993-12#1)(1993-3#3)(1993-8#5)(1994-11#2)(1994-12#3)(1994-6#1)(1995-2#9)(1996-5#1)(1997-2#3)(1997-7#1)(2008-1#1)(2008-11#12)(2008-12#4)(2008-6#5)(2008-8#2)(2008-9#11)(2009-3#1)(2010-4#1)(2011-2#2)(2013-8#1)
TGF-beta-induced##2##1##(2008-9#2)
TGF-beta-treated SFME cells##3##3##(2008-11#3)
TGF-beta1 in##2##2##(2008-11#2)
TGF-beta1##5##1##(2008-11#2)(2011-2#2)(2012-2#1)
TGF-beta1-induced##2##1##(2008-5#1)(2011-2#1)
TGF-beta1/SMAD signaling pathway##7##3##(2011-2#7)
TGF-beta1/SMAD signaling##8##2##(2011-2#8)
TGF-beta1/SMAD##9##1##(2011-2#9)
TGF-β##3##1##(2011-2#2)(2012-12#1)
TGF-β1##2##1##(2011-2#2)
TGFB-2##2##1##(1995-11#2)
TGFbeta##3##1##(1994-10#1)(2008-11#1)(2012-2#1)
TGFbeta1##4##1##(1997-7#1)(2008-10#3)
TGMS##2##1##(2008-8#2)
TGase##2##1##(2008-5#2)
TGr clones##2##2##(1997-3#2)
TGr colonies##3##2##(1997-3#3)
TGr##6##1##(1997-3#6)
TGs##2##1##(2008-10#2)
TH activity##2##2##(2008-11#2)
TH and##5##2##(1990-6#1)(1996-12#3)(2013-1#1)
TH expression in the##2##4##(2008-10#1)(2011-2#1)
TH expression in##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
TH expression##4##2##(1997-6#2)(2008-10#1)(2011-2#1)
TH gene##3##2##(1992-12#2)(1997-5#1)
TH isoforms##2##2##(1993-8#2)
TH mRNA level was significantly##2##5##(1996-12#2)
TH mRNA##6##2##(1992-12#3)(1996-12#3)
TH##35##1##(1990-6#2)(1992-12#6)(1993-8#2)(1995-5#3)(1996-12#6)(1997-3#1)(1997-5#2)(1997-6#4)(2008-10#3)(2008-11#2)(2011-2#1)(2013-1#1)(2013-8#2)
TH-positive##2##1##(1996-5#1)(2008-7#1)
TH01##5##1##(2008-12#5)
TH1 cells##2##2##(1995-5#1)(2006-10#1)
TH1##5##1##(1993-12#3)(1995-5#1)(2006-10#1)
TH2##8##1##(1993-12#5)(1995-5#1)(2006-10#1)(2007-11#1)
TH3 alpha##3##2##(1993-12#3)
TH4 and TH5##3##3##(1993-12#3)
THA and TKA##2##3##(1994-3#1)(2011-2#1)
THA and##3##2##(1994-3#1)(2009-3#1)(2011-2#1)
THA on the other##2##4##(2012-2#2)
THA or TKA##3##3##(1994-3#3)
THA patients##4##2##(2007-8#1)(2009-3#1)(2011-2#2)
THA treatment##2##2##(1990-7#2)
THA##28##1##(1990-7#4)(1994-3#4)(2007-8#1)(2008-11#1)(2008-8#2)(2009-3#5)(2011-2#3)(2012-2#4)(2013-1#4)
THAN##2##1##(2008-11#1)(2011-2#1)
THAT##3##1##(2009-12#1)(2009-4#1)(2012-2#1)
THBA##4##1##(2008-10#4)
THC##11##1##(1991-1#1)(1991-10#5)(1996-5#3)(1997-8#1)(2008-10#1)
THD##4##1##(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
THE ABSTRACT IS AVAILABLE AT THE CLINICAL PANCREATIC DISORDER I##2##10##(2012-3#2)
THE AUTHOR##2##2##(2007-2#2)
THE OREGON HEALTH INSURANCE EXPERIMENT##2##5##(2013-1#2)
THE##57##1##(1997-2#1)(2007-2#2)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#4)(2008-9#2)(2009-11#4)(2009-4#4)(2009-6#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#10)(2013-1#4)(2013-8#1)
THEIR##4##1##(2011-2#2)(2012-2#1)(2012-3#1)
THF and##3##2##(2008-10#2)(2013-1#1)
THF##16##1##(1992-10#1)(1996-2#3)(1996-5#1)(1997-7#1)(2008-10#7)(2009-11#1)(2010-2#1)(2013-1#1)
THF)##3##1##(1996-5#1)(2008-10#2)
THG microscope##3##2##(2008-3#3)
THG##11##1##(2007-11#2)(2007-12#3)(2008-3#6)
THGA##2##1##(2008-10#2)
THIS ISSUE OF JERHRE##2##4##(2009-4#2)
THIS STUDY##2##2##(2008-10#1)(2009-4#1)
THIS##7##1##(2007-2#2)(2008-10#1)(2009-4#3)(2010-12#1)
THMs##2##1##(2008-10#2)
THP##3##1##(2009-7#3)
THP-1 cell membranes##3##3##(1993-6#3)
THP-1 cell##5##2##(1993-6#5)
THP-1 cells##8##2##(1993-6#1)(2008-10#2)(2008-11#2)(2010-6#3)
THP-1 macrophages##2##2##(2013-1#2)
THP-1 monocytes##2##2##(1991-2#1)(2012-2#1)
THP-1##26##1##(1991-2#1)(1993-6#8)(1995-6#2)(1995-8#1)(2008-10#3)(2008-11#2)(2010-6#5)(2012-2#1)(2013-1#3)
THP-A##2##1##(2009-7#2)
THP-B##3##1##(2009-7#3)
THR##4##1##(2007-11#3)(2009-3#1)
THW patients##2##2##(2013-1#2)
THW##3##1##(2013-1#3)
THz at##2##2##(2007-12#2)
THz color scanner##3##3##(2011-1#3)
THz imaging##2##2##(2007-12#2)
THz in the##2##3##(2007-12#1)(2010-5#1)
THz in##3##2##(2007-12#2)(2010-5#1)
THz is##2##2##(2007-11#1)(2007-12#1)
THz pulse##3##2##(2007-12#3)
THz pulses##4##2##(2007-11#3)(2007-12#1)
THz radiation##4##2##(2007-11#4)
THz wave##4##2##(2007-11#1)(2008-3#3)
THz##68##1##(2007-11#20)(2007-12#26)(2008-2#1)(2008-3#10)(2010-5#2)(2011-1#4)(2012-2#3)(2013-8#2)
THz)##2##1##(2007-11#2)
THz-TDS##2##1##(2013-8#2)
THz-wave##2##1##(2007-12#2)
TI arcuate neurones##3##3##(1992-8#3)
TI##15##1##(1991-12#2)(1992-8#3)(2007-7#1)(2008-10#8)(2011-1#1)
TIA and minor##2##3##(1991-11#1)(2008-8#1)
TIA or##2##2##(2008-8#2)
TIA patients##3##2##(2007-10#3)
TIA##8##1##(1991-11#1)(1994-6#1)(2007-10#3)(2008-8#3)
TIAs##4##1##(1991-11#1)(2007-10#2)(2011-2#1)
TIB was##2##2##(2013-1#2)
TIB##3##1##(2013-1#3)
TICKSIM##2##1##(2013-8#2)
TIE and TEK##2##3##(1993-8#2)
TIEG2##3##1##(2009-12#3)
TIEG2-MAO B##3##2##(2009-12#3)
TIF2##2##1##(1996-6#2)
TIGR##4##1##(2008-4#2)(2008-5#1)(2008-7#1)
TIMI 9 Registry##2##3##(2008-3#2)
TIMI##5##1##(2008-3#4)(2012-2#1)
TIMP mRNA##2##2##(1990-8#1)(1992-6#1)
TIMP##7##1##(1990-8#4)(1992-6#3)
TIMP-1 and##3##2##(1992-9#1)(2008-1#1)(2008-5#1)
TIMP-1##15##1##(1992-9#2)(1994-5#2)(2008-1#1)(2008-5#6)(2008-9#3)(2010-8#1)
TIMP-2 to the##2##3##(1992-2#2)
TIMP-2##11##1##(1992-2#5)(1992-9#2)(2010-1#4)
TIN##2##1##(2008-6#2)
TINC##3##1##(2013-1#3)
TIOA##2##1##(2008-10#2)
TIP##3##1##(2009-5#2)(2011-2#1)
TIPS##3##1##(2011-2#3)
TIQ##4##1##(1994-2#4)
TIR##7##1##(2008-3#2)(2008-8#2)(2009-6#1)(2012-3#2)
TIRF-based biosensor setup##2##3##(2008-10#2)
TIRF-based biosensor##3##2##(2008-10#3)
TIS##5##1##(1990-2#1)(2008-2#1)(2008-3#3)
TISTR 8208##2##2##(2008-6#2)
TIV##7##1##(2011-2#7)
TIVA##4##1##(2011-2#1)(2012-3#3)
TJ and##3##2##(2009-10#2)(2012-2#1)
TJ permeability in capsaicin-treated##2##4##(2008-11#2)
TJ permeability increase##2##3##(2008-11#2)
TJ permeability##6##2##(2008-11#6)
TJ##12##1##(2008-11#6)(2009-10#3)(2012-2#3)
TK1##2##1##(2011-2#2)
TK6 lymphoblastoid cells##2##3##(2008-5#2)
TKA and##2##2##(1994-3#1)(2009-3#1)
TKA patients##5##2##(2007-8#1)(2009-3#1)(2011-2#3)
TKA##29##1##(1994-3#4)(2007-8#4)(2008-8#4)(2009-3#4)(2011-2#3)(2013-1#10)
TKAs##7##1##(2009-3#2)(2013-1#5)
TKI therapy##4##2##(2009-10#1)(2010-4#2)(2012-1#1)
TKI##8##1##(2009-10#1)(2010-4#2)(2012-1#5)
TKIs##5##1##(2010-4#1)(2012-1#1)(2012-12#3)
TKR##9##1##(2007-8#1)(2008-8#4)(2009-4#1)(2012-2#1)(2013-1#2)
TL technique##2##2##(2008-3#2)
TL##17##1##(1995-12#3)(2008-3#11)(2008-8#1)(2010-11#1)(2013-7#1)
TLC analysis##2##2##(2008-10#2)
TLC and##7##2##(1990-2#1)(1996-2#1)(1996-5#2)(2008-11#1)(2008-5#2)
TLC plates##2##2##(2008-10#1)(2010-4#1)
TLC##36##1##(1990-2#1)(1990-5#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-12#1)(1996-2#7)(1996-5#4)(2008-10#9)(2008-11#2)(2008-5#4)(2008-8#1)(2010-4#1)(2011-2#1)
TLCV##3##1##(2008-10#3)
TLD's##2##1##(2007-10#2)
TLE##2##1##(2008-4#2)
TLH##6##1##(2010-3#6)
TLI (+)##3##2##(2013-1#3)
TLI##8##1##(2013-1#8)
TLR ligands##4##2##(2013-1#4)
TLR##5##1##(2008-10#1)(2013-1#4)
TLR2 population differentiation##2##3##(2012-3#2)
TLR2##4##1##(2012-3#4)
TLR4 in##2##2##(2010-8#1)(2013-8#1)
TLR4 receptor##3##2##(2008-10#1)(2013-8#2)
TLR4##17##1##(2008-10#4)(2008-3#4)(2010-8#3)(2013-8#6)
TLRs have been##2##3##(2009-3#1)(2013-1#1)
TLRs##4##1##(2009-3#2)(2013-1#2)
TLS##12##1##(2008-10#2)(2008-7#10)
TM and##2##2##(2008-3#1)(2012-2#1)
TM increases##3##2##(1991-8#3)
TM polarization##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
TM##35##1##(1991-8#5)(1994-3#2)(2007-11#3)(2007-12#2)(2007-2#2)(2008-10#1)(2008-2#5)(2008-3#7)(2008-7#1)(2009-7#6)(2012-2#1)
TM-polarized##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
TM300##3##1##(2008-5#3)
TMA and ovalbumin##3##3##(2008-10#3)
TMA and##4##2##(1995-11#1)(2008-10#3)
TMA concentration group##2##3##(2008-10#2)
TMA concentration##3##2##(2008-10#3)
TMA in##3##2##(2008-10#3)
TMA is##2##2##(2008-10#2)
TMA##22##1##(1995-11#1)(2008-10#21)
TMA-DPH##4##1##(1990-11#2)(1994-3#1)(2008-11#1)
TMA5##3##1##(2008-10#3)
TMAH solution##2##2##(2008-10#2)
TMAH##5##1##(2008-10#5)
TMAs##3##1##(2008-4#3)
TMB##2##1##(1990-12#1)(2008-10#1)
TMC1 mutations##2##2##(2011-1#2)
TMC1##4##1##(2011-1#4)
TMD##2##1##(2012-2#1)(2012-3#1)
TMFE##3##1##(2008-10#3)
TMG is##2##2##(2008-10#2)
TMG##6##1##(2008-10#6)
TMGMV-L##4##1##(2008-10#4)
TMGMV-S and -L##2##3##(2008-10#2)
TMGMV-S and##3##2##(2008-10#3)
TMGMV-S##8##1##(2008-10#8)
TMJ##7##1##(1990-10#2)(2011-2#3)(2012-3#2)
TMLR##7##1##(2007-8#7)
TMPAB-OSu##2##1##(2008-10#2)
TMPD and TCNB##2##3##(2007-11#2)
TMPD##3##1##(2007-11#3)
TMPRSS2##2##1##(2012-12#2)
TMPRSS2-ERG##3##1##(2012-12#3)
TMS##13##1##(2008-10#1)(2009-10#1)(2010-5#2)(2010-7#5)(2011-2#3)(2013-1#1)
TMSG-1 expression levels##2##3##(2008-9#2)
TMSG-1 protein was##2##3##(2008-9#2)
TMSG-1 protein##3##2##(2008-9#3)
TMSG-1 was a##2##3##(2008-9#2)
TMSG-1 was##5##2##(2008-9#5)
TMSG-1##20##1##(2008-9#20)
TMSH##2##1##(2013-1#2)
TMSe##3##1##(2008-10#3)
TMT and BT##2##3##(2008-10#2)
TMV MP##2##2##(2008-10#2)
TMV RNA##2##2##(1997-3#2)
TMV##16##1##(1997-3#2)(2008-10#12)(2008-8#1)(2008-9#1)
TMV-Cv(mp) and##2##2##(2008-9#2)
TMV-Cv(rease-mp)##2##1##(2008-9#2)
TMV-U1##2##1##(2008-8#2)
TMV-p##3##1##(1997-6#3)
TN##3##1##(2011-2#2)(2013-8#1)
TNDB-100 and##2##2##(2008-12#2)
TNDB-100##3##1##(2008-12#3)
TNDR selection##3##2##(2008-10#3)
TNDR##4##1##(2008-10#4)
TNF alpha and##3##3##(1993-6#1)(1994-3#1)(2008-6#1)
TNF alpha or GM-CSF##2##4##(1993-6#2)
TNF alpha##12##2##(1991-9#1)(1993-6#4)(1994-3#1)(1994-6#1)(1995-2#3)(2008-10#1)(2008-6#1)
TNF alpha-308 polymorphism##3##3##(1995-12#3)
TNF and##2##2##(1990-5#1)(1994-2#1)
TNF at a##2##3##(1994-2#2)
TNF binding##2##2##(1994-2#2)
TNF cytotoxicity##4##2##(1992-7#3)(1994-2#1)
TNF genes##2##2##(1991-6#2)
TNF in a##2##3##(1992-7#1)(1997-7#1)
TNF in##8##2##(1990-12#1)(1992-3#1)(1992-7#1)(1992-9#2)(1997-7#1)(2008-8#1)(2011-2#1)
TNF is##3##2##(1990-12#1)(1994-2#1)(2011-2#1)
TNF production##2##2##(1992-3#1)(1994-8#1)
TNF receptor##3##2##(1994-2#1)(2007-8#1)(2008-11#1)
TNF receptors##3##2##(1994-2#1)(2008-4#2)
TNF stimulation##2##2##(2010-10#2)
TNF treatment##2##2##(1997-7#2)
TNF was##2##2##(1992-9#1)(1997-2#1)
TNF with##2##2##(1994-2#2)
TNF##105##1##(1990-12#9)(1990-5#4)(1990-7#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-7#4)(1992-9#6)(1993-6#4)(1994-11#3)(1994-2#18)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#3)(1995-5#1)(1997-2#4)(1997-4#3)(1997-7#4)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-10#2)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#1)
TNF-alpha and IFN-gamma##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
TNF-alpha and TNF-beta##2##3##(1991-6#2)
TNF-alpha and verotoxin##2##3##(2008-11#2)
TNF-alpha and##14##2##(1991-6#2)(1993-6#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2009-12#1)(2010-5#1)(2011-2#1)
TNF-alpha expressing##2##2##(1995-12#1)(2013-1#1)
TNF-alpha in human##2##3##(1992-12#1)(2013-1#1)
TNF-alpha in##4##2##(1992-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
TNF-alpha levels were##2##3##(2009-9#1)(2011-2#1)
TNF-alpha levels##3##2##(2009-9#2)(2011-2#1)
TNF-alpha mRNA##4##2##(1992-12#1)(1992-8#2)(1995-12#1)
TNF-alpha or##2##2##(1993-6#1)(1996-12#1)
TNF-alpha production##3##2##(1992-12#1)(1995-12#1)(2009-9#1)
TNF-alpha serum##2##2##(2008-12#1)(2008-7#1)
TNF-alpha##81##1##(1991-6#3)(1992-12#5)(1992-2#1)(1992-3#4)(1992-8#5)(1993-3#1)(1993-6#3)(1994-6#1)(1995-12#7)(1996-12#4)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-9#6)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#11)
TNF-alpha-expressing breast cancer cells##2##4##(2013-1#2)
TNF-beta gene##4##2##(1991-6#1)(1997-7#3)
TNF-beta##9##1##(1991-6#3)(1995-5#1)(1997-7#5)
TNF-induced##7##1##(1992-7#4)(2011-2#3)
TNF-mediated##3##1##(1994-11#1)(1997-7#2)
TNF-related##3##1##(2008-4#1)(2008-5#1)(2012-2#1)
TNF-α and##3##2##(2010-11#1)(2013-1#2)
TNF-α antagonists##5##2##(2012-1#5)
TNF-α##13##1##(2010-11#1)(2012-1#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
TNF-α-activated##2##1##(2012-2#2)
TNF-α-induced##2##1##(2012-2#2)
TNF2##2##1##(1995-12#2)
TNFalpha and##6##2##(2008-5#2)(2008-6#3)(2013-8#1)
TNFalpha##16##1##(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#8)(2010-3#1)(2013-8#1)
TNFα##4##1##(2011-2#1)(2012-2#1)(2013-1#2)
TNH##2##1##(1996-2#2)
TNM classification system##2##3##(1993-11#1)(2011-2#1)
TNM classification##3##2##(1993-11#1)(2011-2#2)
TNM staging##3##2##(2011-2#2)(2012-3#1)
TNM##8##1##(1993-11#1)(2008-10#1)(2011-2#5)(2012-3#1)
TNM-FH##4##1##(2008-11#4)
TNNT3##4##1##(2008-7#4)
TNP solution##2##2##(2008-10#2)
TNP##4##1##(2008-10#4)
TNP-KLH conjugate##2##2##(2008-10#2)
TNP-keyhole limpet##2##2##(2008-10#2)
TNS##4##1##(2008-10#4)
TNT and##10##2##(1995-6#1)(2008-10#7)(2008-11#1)(2008-12#1)
TNT by##2##2##(1995-6#1)(2008-10#1)
TNT in##4##2##(2008-10#3)(2008-11#1)
TNT sensitivity##2##2##(2008-10#2)
TNT was##9##2##(1995-6#3)(2008-10#5)(2008-12#1)
TNT with##2##2##(1995-6#1)(2008-10#1)
TNT##69##1##(1995-6#10)(1997-5#2)(2008-10#35)(2008-11#7)(2008-12#8)(2008-2#2)(2008-3#4)(2009-3#1)
TNX##3##1##(2008-10#3)
TO LEARN##2##2##(2010-5#2)
TO##36##1##(1994-3#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-9#3)(2010-5#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
TO/beta-CD complex##2##2##(1994-3#2)
TOC##4##1##(2008-10#4)
TOF ICP MS and##2##4##(2008-10#2)
TOF##9##1##(1997-2#1)(2008-10#3)(2008-7#1)(2012-3#4)
TOP##2##1##(2008-11#1)(2010-6#1)
TOPA1##2##1##(2008-10#2)
TOPA1076##2##1##(2008-10#2)
TOPA814##2##1##(2008-10#2)
TOPICS##3##1##(1992-11#1)(2007-2#2)
TOPKAT##2##1##(2008-10#2)
TOPO##3##1##(2008-10#3)
TORCH##2##1##(2007-7#2)
TORT-2##2##1##(2008-10#2)
TOS-related##2##1##(2008-10#2)
TOTO-1##2##1##(2008-2#2)
TP expression in##2##3##(2008-12#2)
TP##10##1##(2008-10#1)(2008-12#5)(2008-3#1)(2009-8#2)(2012-2#1)
TP2##7##1##(1991-9#7)
TP53 gene##4##2##(2008-7#3)(2009-8#1)
TP53 mutation##3##2##(2011-2#3)
TP53##25##1##(1994-12#1)(2008-4#2)(2008-6#2)(2008-7#5)(2009-8#4)(2011-2#6)(2013-1#4)(2013-8#1)
TP53-dependent coupling of self-renewal and senescence pathways##2##7##(2013-1#2)
TP82##2##1##(1990-8#2)
TP82-induced##3##1##(1990-8#3)
TPA and##6##2##(1990-12#1)(1990-8#3)(1993-8#1)(1996-5#1)
TPA effects##2##2##(1992-8#1)(1992-9#1)
TPA for##3##2##(1993-9#3)
TPA in##6##2##(1990-8#2)(1991-8#1)(1992-9#1)(2007-12#2)
TPA induced##2##2##(1992-5#1)(1993-9#1)
TPA or##3##2##(1993-6#1)(1995-11#1)(1995-8#1)
TPA response element##2##3##(1991-2#2)
TPA responsive element##2##3##(1991-9#1)(1993-3#1)
TPA resulted in a##2##4##(1990-2#1)(1994-9#1)
TPA resulted in##3##3##(1990-2#1)(1994-9#1)(1996-5#1)
TPA to##2##2##(1993-6#1)(2008-8#1)
TPA treatment##3##2##(1994-6#1)(2008-9#1)(2013-1#1)
TPA was##5##2##(1990-2#1)(1990-8#2)(1992-9#1)(1997-1#1)
TPA##86##1##(1990-12#2)(1990-2#4)(1990-8#13)(1991-2#2)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#3)(1992-9#9)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#8)(1994-6#4)(1994-9#2)(1995-11#2)(1995-12#2)(1995-8#1)(1996-12#2)(1996-5#2)(1997-1#2)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-4#1)(2008-8#5)(2008-9#1)(2012-3#1)(2013-1#3)
TPA-induced PKC-α phosphorylation##2##3##(2012-3#2)
TPA-induced##11##1##(1990-2#2)(1992-3#1)(1992-9#1)(1993-8#2)(2008-9#1)(2012-3#4)
TPA-treated cells##2##2##(1994-9#1)(1996-5#1)
TPA-treated##3##1##(1992-8#1)(1994-9#1)(1996-5#1)
TPB##2##1##(2009-11#1)(2011-1#1)
TPC-1 cells##2##2##(1993-8#2)
TPC-1##3##1##(1993-8#3)
TPDE spectra##2##2##(2008-10#2)
TPDE##4##1##(2008-10#4)
TPDT##2##1##(1996-5#2)
TPE##4##1##(2011-1#1)(2011-2#3)
TPER##2##1##(2008-7#2)
TPF and SHG##2##3##(2007-11#2)
TPF signal##2##2##(2008-3#2)
TPF technique##2##2##(2008-3#2)
TPF##13##1##(2007-11#2)(2008-10#3)(2008-3#7)(2010-12#1)
TPFR##2##1##(2008-7#2)
TPGS is##2##2##(2008-12#2)
TPGS##5##1##(2008-12#5)
TPH##4##1##(2008-6#4)
TPI##3##1##(2008-10#1)(2011-2#2)
TPKI and TPKII##3##3##(1995-12#3)
TPKI##4##1##(1995-12#4)
TPL##4##1##(1997-8#1)(2010-1#3)
TPLO##3##1##(2012-3#3)
TPMT##5##1##(2013-1#5)
TPN##7##1##(1992-9#1)(1994-6#4)(2008-10#1)(2009-9#1)
TPO and##2##2##(2008-8#1)(2010-4#1)
TPO##14##1##(1995-12#2)(2008-8#10)(2010-4#2)
TPO-EPO fusion protein##3##3##(2008-8#3)
TPO2##5##1##(1995-12#5)
TPOX alleles##2##2##(2008-12#2)
TPOX##9##1##(2008-12#9)
TPP at##2##2##(2008-10#1)(2013-1#1)
TPP on##2##2##(2009-8#1)(2013-1#1)
TPP##15##1##(1996-2#1)(2007-5#2)(2008-10#3)(2009-8#3)(2013-1#6)
TPPS(4)##3##1##(2008-3#3)
TPQ cofactor##3##2##(1995-5#3)
TPR motifs##2##2##(1996-2#1)(1997-7#1)
TPR##4##1##(1996-2#2)(1997-7#2)
TPRD##2##1##(1996-2#2)
TPS##4##1##(1991-12#2)(2008-10#2)
TPW##3##1##(2008-10#2)(2008-2#1)
TQM and##5##2##(1992-2#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#1)
TQM applications##3##2##(2008-12#3)
TQM concepts##2##2##(1993-2#1)(1994-2#1)
TQM has##2##2##(1993-3#1)(1995-1#1)
TQM implementation##2##2##(1992-2#1)(1994-1#1)
TQM in health care##3##4##(1994-1#1)(1994-2#2)
TQM in##9##2##(1992-2#2)(1993-12#1)(1994-1#1)(1994-2#2)(1995-1#1)(1996-2#1)(1997-3#1)
TQM is##2##2##(1994-1#1)(1996-2#1)
TQM process##3##2##(1993-3#2)(1994-1#1)
TQM will##3##2##(1993-2#1)(1994-1#2)
TQM##60##1##(1992-2#6)(1993-12#3)(1993-2#4)(1993-3#5)(1994-1#9)(1994-12#1)(1994-2#12)(1995-1#7)(1995-3#4)(1996-2#4)(1996-3#1)(1997-3#1)(2008-12#3)
TR from the##2##3##(1990-8#1)(2008-7#1)
TR##16##1##(1990-11#1)(1990-8#2)(1994-11#1)(1995-8#1)(1996-2#2)(2008-3#1)(2008-5#1)(2008-7#7)
TR-CB7##2##1##(1995-5#2)
TRA is##2##2##(2011-2#2)
TRA##8##1##(2011-1#1)(2011-2#7)
TRA/TPB##2##1##(2008-4#2)
TRAF proteins##3##2##(2008-4#3)
TRAIL##6##1##(2009-2#1)(2009-3#1)(2009-9#3)(2012-2#1)
TRAIL-induced##3##1##(2009-9#2)(2012-2#1)
TRAMP mice##2##2##(2008-4#1)(2013-1#1)
TRAMP mouse##2##2##(2008-4#1)(2013-1#1)
TRAMP##7##1##(2008-4#4)(2013-1#3)
TRAMP-C2 cells##2##2##(2013-1#2)
TRANSIENT##2##1##(2008-11#2)
TRAP and LRAP##2##3##(1993-11#2)
TRAP##3##1##(1993-11#2)(2011-2#1)
TRAS##3##1##(2008-1#3)
TRAb##3##1##(2012-3#3)
TRBP##4##1##(1994-8#3)(2008-8#1)
TRE##2##1##(1991-2#1)(1991-9#1)
TRE-TSHalpha subunit##2##2##(1995-8#2)
TRE-pal2##2##1##(1995-8#2)
TREATMENT##2##1##(2009-9#1)(2011-1#1)
TREs##3##1##(1993-8#2)(1995-8#1)
TRF##3##1##(2008-10#3)
TRFT spectra##2##2##(2008-3#2)
TRH and GnRH##2##3##(1994-9#2)
TRH and##6##2##(1991-12#1)(1994-6#3)(1994-9#2)
TRH in##2##2##(1993-11#1)(2013-7#1)
TRH or##3##2##(1992-8#2)(2008-7#1)
TRH stimulation##3##2##(1992-11#1)(1993-8#1)(2008-4#1)
TRH testing##2##2##(2011-1#2)
TRH treatment##2##2##(1992-2#1)(2013-7#1)
TRH was##3##2##(1992-8#1)(1994-2#1)(2008-10#1)
TRH##51##1##(1991-12#2)(1991-6#2)(1992-11#1)(1992-2#6)(1992-6#2)(1992-8#6)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#3)(1994-6#7)(1994-9#3)(1995-5#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2013-7#7)
TRH)##2##1##(2013-7#2)
TRH-##2##1##(1991-6#1)(1995-5#1)
TRH-R##2##1##(1993-8#2)
TRH-T##3##1##(1990-3#3)
TRH-immunoreactivity##2##1##(1991-12#2)
TRH-induced##3##1##(1993-11#1)(1995-5#1)(1996-2#1)
TRH-stimulated##2##1##(1993-11#2)
TRH-treated##2##1##(1992-2#1)(2013-7#1)
TRI5##2##1##(2008-10#2)
TRITC##2##1##(2008-10#1)(2008-5#1)
TRK-100##3##1##(1994-6#3)
TRLFS system##2##2##(2008-10#2)
TRLFS##3##1##(2008-10#3)
TRM##9##1##(2008-1#9)
TRNOE##2##1##(1993-11#2)
TRP channels##2##2##(2008-7#1)(2013-1#1)
TRP##9##1##(1996-12#3)(1996-7#1)(2008-7#1)(2008-8#1)(2013-1#3)
TRP-1##2##1##(1995-2#1)(2008-8#1)
TRP-R##3##1##(1996-12#3)
TRP1 gene##2##2##(1997-8#2)
TRP1##6##1##(1994-12#1)(1996-6#1)(1997-3#2)(1997-8#2)
TRPA1##3##1##(2008-8#1)(2013-1#2)
TRPC1##3##1##(2008-8#3)
TRPM8##3##1##(2008-8#1)(2013-1#2)
TRPO##2##1##(2008-10#2)
TRPV##2##1##(2008-8#2)
TRPV1##15##1##(2008-7#4)(2008-8#4)(2009-12#5)(2011-2#2)
TRPV2##4##1##(2011-2#3)(2013-1#1)
TRPV3##4##1##(2011-2#1)(2013-1#3)
TRPV4##6##1##(2009-8#1)(2011-2#4)(2013-1#1)
TRR methods##2##2##(2008-3#2)
TRS 398##2##2##(2012-1#2)
TRS##4##1##(1994-5#2)(2012-1#2)
TRSV was##2##2##(2008-10#2)
TRSV##7##1##(2008-10#7)
TRU##2##1##(2008-10#2)
TRUS guided##2##2##(2011-2#2)
TRUS##8##1##(1997-8#3)(2011-2#5)
TRX f1##3##2##(2009-10#3)
TRX##4##1##(1997-7#1)(2009-10#3)
TRXs##3##1##(2009-10#3)
TRZ##5##1##(1996-12#5)
TRalpha##3##1##(2008-4#3)
TRbeta##6##1##(1995-8#1)(1997-1#2)(2008-4#3)
TRbeta1##5##1##(1995-8#5)
TS were##2##2##(2008-1#1)(2008-7#1)
TS##18##1##(1990-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-7#7)(2013-1#1)
TS-TEM##2##1##(2008-3#2)
TS-gel##2##1##(2008-10#2)
TS93-71B and TS93-71F##2##3##(2008-10#2)
TSA compared with##2##3##(1990-6#2)
TSA##7##1##(1990-6#2)(1995-12#2)(2007-11#1)(2008-9#2)
TSAH##3##1##(2008-7#3)
TSAT &lt##2##2##(2007-7#2)
TSAb activities##2##2##(1991-12#1)(1991-9#1)
TSAb activity but##2##3##(1991-5#2)
TSAb activity##3##2##(1991-12#1)(1991-5#2)
TSAb##7##1##(1991-12#2)(1991-5#3)(1991-9#2)
TSBAb activity##2##2##(1991-5#2)
TSBAb##3##1##(1991-5#3)
TSC##5##1##(1992-1#2)(1993-12#2)(2008-10#1)
TSC2##3##1##(1993-12#3)
TSD##8##1##(2008-2#2)(2009-9#2)(2010-3#4)
TSE##3##1##(2009-5#3)
TSH A and TSH C##2##5##(1993-8#2)
TSH A##4##2##(1993-8#4)
TSH B##2##2##(1993-8#2)
TSH C##4##2##(1993-8#4)
TSH Receptor##2##2##(2008-4#1)(2012-3#1)
TSH and##10##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
TSH as##2##2##(1996-5#1)(2008-4#1)
TSH binding##7##2##(1990-12#3)(1992-12#1)(1993-3#1)(1994-11#2)
TSH can##2##2##(2008-6#1)(2013-1#1)
TSH concentration##2##2##(2008-6#2)
TSH level##2##2##(2011-1#1)(2012-12#1)
TSH levels and##2##3##(1994-6#1)(2009-12#1)
TSH levels were##2##3##(1994-6#1)(2008-7#1)
TSH levels##12##2##(1994-6#2)(2008-4#4)(2008-7#1)(2009-12#1)(2012-12#1)(2012-3#3)
TSH or##2##2##(1992-12#1)(1995-5#1)
TSH receptor autoantibodies##2##3##(2012-3#2)
TSH receptor with##2##3##(1993-3#2)
TSH receptor##24##2##(1990-12#3)(1991-5#2)(1991-9#1)(1992-12#3)(1993-3#7)(1996-5#6)(2012-3#2)
TSH response to##2##3##(1995-5#1)(2008-4#1)
TSH secretion in##2##3##(1990-8#1)(1995-5#1)
TSH secretion##6##2##(1990-8#1)(1995-5#5)
TSH value##2##2##(1991-2#1)(2007-8#1)
TSH##117##1##(1990-12#8)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#10)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#12)(1993-8#11)(1994-11#4)(1994-6#2)(1995-5#8)(1995-8#1)(1996-5#8)(2007-8#1)(2008-4#10)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#1)(2009-12#1)(2011-1#3)(2012-12#3)(2012-3#6)(2013-1#4)
TSH-LHR-14##2##1##(1990-12#2)
TSH-binding inhibitor immunoglobulin (TBII) activities##3##5##(1991-12#1)(1991-5#1)(1991-9#1)
TSH-binding##4##1##(1991-12#1)(1991-5#1)(1991-9#1)(1994-11#1)
TSH-induced cell cycle-related genes##2##4##(1992-8#2)
TSH-induced##4##1##(1992-12#2)(1992-8#2)
TSHR##2##1##(1995-12#2)
TSHr promoter##2##2##(1994-11#2)
TSHr##9##1##(1994-11#6)(2008-4#3)
TSI##6##1##(2008-3#1)(2012-3#5)
TSK mutation##4##2##(1997-8#4)
TSK##9##1##(1990-8#1)(1996-5#1)(1997-8#5)(2008-10#2)
TSLIM##2##1##(2011-1#2)
TSM##4##1##(1992-9#1)(2008-10#1)(2008-2#2)
TSP and##5##2##(1991-2#1)(1993-9#2)(2007-3#1)(2008-10#1)
TSP may##2##2##(1993-6#1)(1993-9#1)
TSP was##2##2##(1993-6#1)(1993-9#1)
TSP##36##1##(1991-11#2)(1991-2#4)(1993-6#6)(1993-9#10)(2007-3#5)(2008-10#2)(2009-10#2)(2013-8#5)
TSP-1##3##1##(2008-1#3)
TSPO binding sites##4##3##(2012-2#4)
TSPO binding##5##2##(2012-2#5)
TSPO drug ligands##2##3##(2012-2#2)
TSPO drug##3##2##(2012-2#3)
TSPO expression levels and##2##4##(2012-2#2)
TSPO expression levels##5##3##(2012-2#5)
TSPO expression##9##2##(2012-2#9)
TSPO function##2##2##(2012-2#2)
TSPO has been##3##3##(2012-2#3)
TSPO is##6##2##(2012-2#6)
TSPO levels##2##2##(2012-2#2)
TSPO ligands with##2##3##(2012-2#2)
TSPO ligands##5##2##(2012-2#5)
TSPO##62##1##(2012-2#62)
TSPO-mediated##2##1##(2012-2#2)
TSPO-targeted##5##1##(2012-2#5)
TSS##9##1##(2008-10#4)(2012-3#1)(2013-8#4)
TSST-1 from##2##2##(1997-2#2)
TSST-1 molecule##3##2##(1993-3#3)
TSST-1##8##1##(1993-3#4)(1997-2#4)
TST##8##1##(2010-5#5)(2012-2#1)(2013-1#2)
TSV##3##1##(2008-5#3)
TSWV DI RNA generation##2##4##(2008-10#2)
TSWV GPs as viral attachment proteins and##2##7##(2008-10#2)
TSWV N##3##2##(2008-10#3)
TSWV and##6##2##(2008-10#6)
TSWV in##3##2##(2008-10#3)
TSWV infection in##2##3##(2008-10#2)
TSWV infection##3##2##(2008-10#3)
TSWV is##3##2##(2008-10#3)
TSWV isolates##3##2##(2008-10#3)
TSWV or##2##2##(2008-10#2)
TSWV replication##2##2##(2008-10#2)
TSWV spread to##2##3##(2008-10#2)
TSWV##68##1##(2008-10#68)
TSWV-10##2##1##(2008-10#2)
TSWV-D##3##1##(2008-10#3)
TSWV-GPs##2##1##(2008-10#2)
TSWV-infected##7##1##(2008-10#7)
TT (vs##2##2##(2012-2#2)
TT and WFT##2##3##(2008-10#2)
TT and##6##2##(2007-7#1)(2008-10#5)
TT cells##2##2##(1992-6#2)
TT##25##1##(1992-6#2)(1993-3#1)(1997-3#1)(2006-10#1)(2007-7#7)(2008-10#8)(2011-1#1)(2012-12#2)(2012-2#2)
TT4##4##1##(1995-3#2)(2008-7#2)
TTA##4##1##(2007-11#1)(2008-10#3)
TTBD control##3##2##(1997-7#3)
TTCTOHA##4##1##(2008-10#4)
TTD##3##1##(2008-3#3)
TTF##2##1##(1996-5#2)
TTF-TCNQ##3##1##(2008-10#3)
TTM at##2##2##(2013-1#2)
TTM stages##2##2##(2010-2#1)(2013-1#1)
TTM##18##1##(2007-12#4)(2010-12#4)(2010-2#2)(2012-2#2)(2013-1#6)
TTP was##2##2##(1991-3#1)(2009-4#1)
TTP##6##1##(1991-3#2)(1995-3#2)(2009-4#1)(2011-2#1)
TTR gene##2##2##(1992-8#2)
TTR mRNA##2##2##(1993-12#2)
TTR##5##1##(1992-8#2)(1993-12#3)
TTTAGGG or its variant##2##4##(2008-8#2)
TTX##6##1##(1992-6#1)(1995-12#1)(1996-2#1)(2008-8#2)(2009-3#1)
TTs##2##1##(2010-5#2)
TU treatment##3##2##(2013-8#3)
TU##5##1##(2013-8#5)
TUB2 gene##4##2##(1990-5#4)
TUB2##6##1##(1990-5#4)(2008-10#2)
TUG and##2##2##(2010-3#2)
TUG##8##1##(2010-3#8)
TUNEL assay##3##2##(2008-11#2)(2010-11#1)
TUNEL positive##2##2##(2007-10#1)(2008-8#1)
TUNEL reaction##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
TUNEL##15##1##(2007-10#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#2)(2010-11#1)(2013-1#1)
TUNEL-labeled##2##1##(2008-3#2)
TUR-BT##2##1##(2008-10#2)
TURBISCAN MA 2000##4##3##(2008-10#4)
TURBISCAN##5##1##(2008-10#5)
TV camera##2##2##(2008-3#2)
TV holography##5##2##(2008-2#3)(2008-3#2)
TV minimization##2##2##(2012-1#2)
TV shearography##3##2##(2008-3#3)
TV test##2##2##(1991-11#2)
TV##25##1##(1991-11#2)(1992-3#1)(1996-8#1)(1997-6#1)(2008-2#4)(2008-3#10)(2010-11#2)(2010-8#1)(2012-1#2)(2012-2#1)
TV-show##4##1##(1996-8#4)
TVP##2##1##(1993-9#1)(2011-2#1)
TW##3##1##(2007-11#2)(2007-12#1)
TW-CY2##2##1##(2008-10#2)
TW-NT1##3##1##(2008-10#3)
TW-TC1##3##1##(2008-10#3)
TW-TN3##4##1##(2008-10#4)
TW-TNML1##3##1##(2008-10#3)
TWIST##3##1##(1991-8#3)
TWO##4##1##(2007-2#1)(2008-10#1)(2009-11#1)(2012-3#1)
TX##11##1##(1990-11#3)(1992-8#3)(2007-8#1)(2008-10#3)(2008-7#1)
TX-100 and N##2##3##(2008-10#2)
TX-100##5##1##(2008-10#5)
TYLCSV population##2##2##(2008-10#2)
TYLCSV##3##1##(2008-10#3)
TYLCV DNA accumulation##2##3##(2008-10#2)
TYLCV DNA##3##2##(2008-10#3)
TYLCV and TYLCV-Mld##2##3##(2008-10#2)
TYLCV isolates##2##2##(2008-10#2)
TYLCV resistance##3##2##(2008-10#3)
TYLCV transmission##2##2##(2008-10#2)
TYLCV was detected in##2##4##(2008-10#2)
TYLCV was##5##2##(2008-10#5)
TYLCV##47##1##(2008-10#47)
TYLCV-CHI##3##1##(2008-8#3)
TYLCV-Is in tomato##2##3##(2008-10#2)
TYLCV-Is in##3##2##(2008-10#3)
TYLCV-Is##8##1##(2008-10#8)
TYLCV-Mld##4##1##(2008-10#4)
TYLCV-Sr##4##1##(2008-10#4)
TYLCV-[Alm]##2##1##(2008-10#2)
TYLCV-[DO]##2##1##(2008-10#2)
TYMC-XX and##2##2##(1997-3#2)
TYMC-XX##3##1##(1997-3#3)
TYMV##9##1##(1997-3#3)(2008-10#6)
TYS1##4##1##(1995-6#3)(1997-3#1)
TZ##4##1##(2012-3#4)
TZDs##3##1##(2008-3#1)(2010-10#2)
Ta##6##1##(2008-1#1)(2008-10#4)(2008-12#1)
Ta(2)O(5) and SiO(2)##2##3##(2008-3#2)
Ta(2)O(5) and##3##2##(2008-3#3)
Ta(2)O(5) is##2##2##(2008-3#2)
Ta(2)O(5)##7##1##(2008-3#7)
Tabasco##5##1##(2008-5#1)(2012-12#4)
Table##3##1##(1995-3#1)(2008-3#1)(2009-4#1)
Tables and Graphs are included##2##5##(1994-12#1)(1996-12#1)
Tables and##4##2##(1994-12#1)(1996-1#1)(1996-12#1)(2010-1#1)
Tables##5##1##(1994-12#1)(1996-1#1)(1996-12#1)(2008-3#1)(2010-1#1)
Tablet##4##1##(2008-10#1)(2010-5#2)(2012-2#1)
Tablets##5##1##(2008-5#1)(2010-3#2)(2010-5#2)
Tabulation##2##1##(2008-11#1)(2010-5#1)
Tackling##3##1##(1996-7#1)(1997-5#1)(2008-10#1)
Tacrine##3##1##(1991-12#2)(2011-3#1)
Tacrolimus##2##1##(2007-7#1)(2011-2#1)
Tadalafil##2##1##(2008-11#2)
Tadinia##4##1##(2008-10#4)
Taenia microsoma Creplin##2##3##(2011-2#2)
Taenia solium##2##2##(1991-8#1)(1995-12#1)
Taenia##8##1##(1991-8#1)(1995-12#1)(2008-7#1)(2011-2#4)(2012-3#1)
Taeniopteryx##3##1##(2007-12#1)(2013-1#2)
Tafel##3##1##(2008-10#2)(2010-4#1)
Tag##7##1##(1995-6#1)(1996-5#1)(2008-10#1)(2008-2#2)(2009-8#1)(2010-8#1)
Tagetes mendocina##3##2##(2008-11#3)
Tagging##3##1##(2007-12#1)(2008-10#2)
Tags##2##1##(2008-2#1)(2008-4#1)
Taguchi's methods as a basis##2##5##(2008-11#2)
Taguchi's methods##3##2##(2008-11#3)
Tai chi##2##2##(2008-10#2)
Tai##3##1##(2008-10#3)
Taif Governorate##2##2##(2008-10#2)
Tail DNA and##2##3##(2008-10#2)
Tail length##2##2##(2008-10#1)(2008-8#1)
Tail##11##1##(1990-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#2)(2012-2#1)
Tailored##3##1##(2009-6#1)(2009-7#1)(2012-12#1)
Tailoring##2##1##(2007-12#1)(2010-4#1)
Taimyr)##2##1##(2010-8#2)
Taiwan and##6##2##(2006-10#1)(2008-10#3)(2008-11#1)(2010-8#1)
Taiwan but##2##2##(2008-10#1)(2008-8#1)
Taiwan isolates##4##2##(2008-10#4)
Taiwan was##3##2##(2008-10#2)(2008-5#1)
Taiwan were##3##2##(2007-6#1)(2009-5#2)
Taiwan##68##1##(1997-3#1)(2006-10#1)(2007-6#3)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#4)(2008-8#9)(2009-5#4)(2010-11#1)(2010-3#1)(2010-8#6)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
Taiwan's NHI##2##2##(2010-8#2)
Taiwanese##4##1##(1991-11#1)(2007-6#1)(2008-7#1)(2009-2#1)
Tajikistan##3##1##(2008-10#3)
Takab##2##1##(2008-12#2)
Takahashi##2##1##(1992-12#1)(2007-2#1)
Takayasu arteritis (TA) is##2##4##(1997-8#2)
Takayasu arteritis (TA)##4##3##(1997-8#4)
Takayasu arteritis in##8##3##(1997-8#8)
Takayasu arteritis is a##2##4##(1997-8#2)
Takayasu arteritis were##2##3##(1997-8#2)
Takayasu arteritis##35##2##(1997-8#35)
Takayasu disease##2##2##(1997-8#2)
Takayasu##39##1##(1997-8#39)
Takayasu's arteritis##10##2##(1996-9#1)(1997-8#8)(2011-1#1)
Takayasu's##11##1##(1990-8#1)(1996-9#1)(1997-8#8)(2011-1#1)
Take##4##1##(1993-3#1)(1997-1#1)(1997-3#1)(2007-10#1)
Take-all##3##1##(2008-10#3)
Taken together these findings##2##4##(1993-3#1)(2008-7#1)
Taken together these results suggest that##2##6##(1994-12#1)(1994-7#1)
Taken together these results##3##4##(1993-6#1)(1994-12#1)(1994-7#1)
Taken together these##5##3##(1993-3#1)(1993-6#1)(1994-12#1)(1994-7#1)(2008-7#1)
Taken together with##5##3##(1990-8#1)(1991-12#1)(1996-6#1)(2008-6#1)(2012-1#1)
Taken together##109##2##(1990-11#1)(1990-8#2)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#5)(2012-1#3)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#4)(2013-8#2)
Taken##112##1##(1990-11#1)(1990-8#2)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#5)(2012-1#3)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#4)(2013-8#2)
Takeuchi##3##1##(2011-1#3)
Taking a##2##2##(1996-3#1)(2008-7#1)
Taking advantage of the##4##4##(1995-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
Taking advantage of##6##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
Taking advantage##7##2##(1993-6#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
Taking into account of##2##4##(1996-10#1)(2008-8#1)
Taking into account our##2##4##(1992-12#1)(2008-10#1)
Taking into account the importance of##2##6##(2008-10#1)(2008-11#1)
Taking into account the##9##4##(1990-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
Taking into account##17##3##(1990-6#1)(1992-12#1)(1996-10#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
Taking the lead##2##3##(1992-1#1)(1995-1#1)
Taking the serum##2##3##(2013-8#2)
Taking the##17##2##(1992-1#1)(1993-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-9#2)(2010-2#1)(2012-2#1)(2013-8#3)
Taking##60##1##(1990-6#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-3#2)(1996-10#1)(1996-3#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
Takotsubo cardiomyopathy is##2##3##(2011-2#1)(2013-1#1)
Takotsubo cardiomyopathy##11##2##(2009-6#2)(2010-5#3)(2010-7#1)(2011-2#2)(2013-1#3)
Talanta##4##1##(2008-10#4)
Talar##3##1##(2009-3#1)(2010-5#1)(2011-2#1)
Talaromyces flavus##4##2##(2008-10#4)
Talbot array illuminator for single-shot##2##5##(2008-3#2)
Talbot array illuminator##6##3##(2008-2#1)(2008-3#5)
Talbot array##7##2##(2008-2#1)(2008-3#6)
Talbot cavity##2##2##(2007-11#1)(2008-3#1)
Talbot effect and##2##3##(2007-11#1)(2008-3#1)
Talbot effect in##2##3##(2007-11#1)(2008-3#1)
Talbot effect##14##2##(2007-11#7)(2007-12#2)(2008-3#5)
Talbot imaging##2##2##(2007-12#1)(2012-12#1)
Talbot interferometry are##5##3##(2008-3#5)
Talbot interferometry is##3##3##(2008-3#3)
Talbot interferometry##13##2##(2008-3#13)
Talbot##42##1##(2007-11#9)(2007-12#3)(2008-2#1)(2008-3#28)(2012-12#1)
Tales of##2##2##(1993-2#1)(1994-9#1)
Talipexole##7##1##(2007-10#7)
Talk##3##1##(2012-12#1)(2012-2#1)(2013-1#1)
Talking about##4##2##(1994-1#1)(2009-9#1)(2013-1#2)
Talking##6##1##(1992-3#1)(1994-1#1)(2007-2#1)(2009-9#1)(2013-1#2)
Talks##3##1##(1995-6#1)(2007-5#1)(2008-7#1)
Tall Fescue##3##2##(2008-10#3)
Tallimustine##4##1##(1996-3#4)
Tamanu##2##1##(2008-5#2)
Tamarix spp##2##2##(2012-5#2)
Tamarix##3##1##(2012-5#3)
Tamoxifen##5##1##(1993-9#1)(1994-9#1)(1995-10#2)(2013-1#1)
Tampere##2##1##(2008-10#1)(2009-6#1)
Tan Spot of Wheat##3##4##(2008-10#3)
Tan##10##1##(1990-12#1)(2008-10#8)(2010-8#1)
Tanashi##2##1##(2008-10#2)
Tandem##13##1##(1991-12#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-5#2)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
Tang##3##1##(1990-11#1)(1997-3#1)(2008-11#1)
Tanganyika##6##1##(1996-6#4)(2008-5#1)(2010-8#1)
Tangential##2##1##(1995-12#1)(2008-7#1)
Tangerine##2##1##(2008-10#2)
Tangier disease##4##2##(1994-11#4)
Tanichthys albonubes was##2##3##(2010-5#2)
Tanichthys albonubes##7##2##(2010-5#7)
Tankships##2##1##(2008-11#2)
Tanne&quot##2##1##(2008-11#2)
Tanner stages of pubic hair and genital development##2##8##(2011-2#2)
Tanner stages##3##2##(2011-2#3)
Tanner##5##1##(2009-11#1)(2011-1#1)(2011-2#3)
Tantalum##3##1##(1997-7#1)(2008-10#2)
Tanzania has##2##2##(2008-10#1)(2010-8#1)
Tanzania##29##1##(1994-11#1)(1994-9#1)(1997-6#1)(2008-10#6)(2008-11#2)(2010-8#15)(2012-2#3)
Tapered##2##1##(2007-12#1)(2008-2#1)
Taperin##4##1##(2012-12#4)
Tapesia yallundae and T##3##4##(2008-10#3)
Tapesia yallundae##5##2##(2008-10#5)
Tapesia##6##1##(2008-10#6)
Taphozous perforatus and Taphozous nudiventris##2##5##(1994-11#2)
Taphozous##4##1##(1994-11#4)
Taphrina deformans##6##2##(2008-10#6)
Taphrina##7##1##(2008-10#7)
Tapia's##2##1##(2008-2#2)
Taping (FFT)##2##2##(2007-11#2)
Tapinoma##2##1##(2008-6#2)
Tapirus##2##1##(2008-5#2)
Taq 1B polymorphism##2##3##(2008-12#2)
Taq DNA polymerase from Thermus aquaticus has been shown to be very useful in the polymerase chain reaction method##2##19##(1997-6#1)(1997-8#1)
Taq DNA polymerase has a domain at##2##7##(1997-6#1)(1997-8#1)
Taq DNA polymerase is classified into the##2##7##(1997-6#1)(1997-8#1)
Taq DNA polymerase##17##3##(1994-12#1)(1997-4#1)(1997-6#8)(1997-8#4)(2008-5#3)
Taq or other thermostable DNA polymerases##2##6##(2008-2#1)(2008-9#1)
Taq or##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
Taq##24##1##(1991-6#1)(1994-12#1)(1997-4#1)(1997-6#8)(1997-8#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#2)
TaqI sites##3##2##(1994-12#3)
TaqI##13##1##(1993-2#1)(1994-12#7)(2008-10#4)(2008-5#1)
TaqMan assays##2##2##(2008-10#2)
TaqMan chemistry##5##2##(2008-10#5)
TaqMan primer/probe sets were##2##4##(2008-10#2)
TaqMan primer/probe##3##2##(2008-10#3)
TaqMan probe##4##2##(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
TaqMan probes and##2##3##(2008-10#2)
TaqMan probes##9##2##(2008-10#6)(2010-4#1)(2012-2#2)
TaqMan protocol##2##2##(2008-10#2)
TaqMan real-time##2##2##(2008-10#1)(2012-3#1)
TaqMan##39##1##(2008-10#29)(2008-12#1)(2010-4#2)(2011-1#1)(2012-2#3)(2012-3#3)
Taqman##3##1##(2013-1#1)(2013-8#2)
Tarasca embodies##2##2##(2009-10#2)
Tarasca##12##1##(2009-10#12)
Tarasov--the first dean of##2##4##(2011-1#2)
Target attainment of AUC/MIC was##2##5##(2011-2#2)
Target for##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
Target in##2##2##(2011-2#2)
Target##21##1##(1994-2#1)(1995-3#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
Targeted disruption of murine##2##4##(2008-8#1)(2008-9#1)
Targeted disruption of##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
Targeted toxins##2##2##(2008-5#2)
Targeted##20##1##(1994-12#1)(1995-2#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
Targeting and##2##2##(2008-7#1)(2013-1#1)
Targeting the brain##2##3##(1996-5#1)(1997-3#1)
Targeting the##5##2##(1996-5#1)(1997-3#1)(2010-7#1)(2012-2#2)
Targeting##22##1##(1996-12#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#2)(2010-7#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
Targets in##2##2##(2008-2#1)(2008-6#1)
Targets of##2##2##(1992-6#1)(2010-5#1)
Targets##6##1##(1992-6#1)(2008-2#2)(2008-6#1)(2010-5#1)(2012-1#1)
Tartrate##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
Tartrazine##7##1##(2008-10#7)
Tarzan##3##1##(2008-1#3)
Tas1r3##3##1##(2008-2#3)
Task Analysis##2##2##(2009-10#2)
Task Force for##5##3##(1990-12#2)(1992-8#1)(1993-12#2)
Task Force on##3##3##(1993-3#1)(1995-12#1)(2010-9#1)
Task Force report##2##3##(2007-4#1)(2009-11#1)
Task Force##21##2##(1990-12#2)(1990-6#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-12#1)(2007-4#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
Task in##2##2##(2007-12#1)(2008-7#1)
Task performance##2##2##(2009-10#1)(2013-8#1)
Task##39##1##(1990-12#2)(1990-6#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-12#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-10#7)(2009-11#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
Task)##2##1##(2009-9#1)(2010-8#1)
Taskforce for##2##2##(2011-8#1)(2011-9#1)
Tasl was##2##2##(2008-8#2)
Tasmania##3##1##(2008-10#1)(2008-9#1)(2010-8#1)
Tasmanian##4##1##(2008-10#2)(2008-9#2)
Taste##5##1##(2008-10#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
Tat protein##4##2##(1993-6#1)(2009-8#2)(2012-12#1)
Tat##16##1##(1993-2#2)(1993-6#1)(1994-11#1)(2009-8#9)(2012-12#3)
Tat-independent##3##1##(2012-12#3)
Tat/TAR transactivation##2##2##(2008-11#2)
Tat/TAR##3##1##(2008-11#3)
Tattooing with electrocauterization##2##3##(2007-7#2)
Tattooing##3##1##(2007-7#2)(2009-7#1)
TauD and##2##2##(2012-12#2)
TauD##3##1##(2012-12#3)
Taurine##3##1##(1993-2#1)(2008-10#1)(2008-5#1)
Tavas (Denizli)##2##2##(2008-12#2)
Tax Equity and Fiscal Responsibility Act##3##6##(1993-12#1)(1994-3#1)(1997-1#1)
Tax protein is##2##3##(2008-8#2)
Tax protein##4##2##(2008-8#4)
Tax##19##1##(1991-2#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-3#1)(1997-1#2)(2008-12#1)(2008-8#5)(2011-2#2)(2012-12#2)
Tax-exemption##2##1##(1991-2#1)(1993-1#1)
Tax-mediated transcription of##2##3##(1994-11#2)
Tax-mediated##5##1##(1994-11#4)(2012-12#1)
TaxAPU##3##1##(1994-5#3)
Taxane##2##1##(1994-11#1)(2010-12#1)
Taxol##7##1##(1994-11#2)(1994-5#2)(2008-11#1)(2008-5#1)(2008-7#1)
Taxonomic and##2##2##(2008-10#1)(2008-6#1)
Taxonomic##3##1##(2008-10#1)(2008-6#1)(2013-8#1)
Taxonomy of the##2##3##(2008-10#1)(2008-5#1)
Taxonomy of##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
Taxonomy##7##1##(2008-10#2)(2008-12#1)(2008-5#2)(2012-3#1)(2013-7#1)
Taxus pollen##2##2##(2012-7#2)
Taxus##11##1##(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-7#7)
Tayassu pecari##2##2##(2008-5#1)(2013-7#1)
Taylor Home##4##2##(1995-12#4)
Taylor expansion##2##2##(2008-10#1)(2011-1#1)
Taylor series expansion##2##3##(2008-3#1)(2011-1#1)
Taylor series##4##2##(1994-2#1)(2008-2#1)(2008-3#1)(2011-1#1)
Taylor##14##1##(1994-2#1)(1995-12#5)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#2)(2012-2#1)
Taylor's power-law##2##2##(2008-10#2)
Taylor's series expansion##2##3##(2008-2#2)
Taylor's##12##1##(1994-2#1)(1997-7#1)(2008-10#8)(2008-2#2)
Tayside##3##1##(1997-8#1)(2008-12#1)(2012-1#1)
Taï##2##1##(2009-10#2)
Tb##7##1##(2007-12#2)(2008-10#5)
Tb(3+)##5##1##(2008-10#5)
Tb(III)##9##1##(1991-5#5)(2008-10#4)
Tb-ATP-phen system##2##2##(2008-10#2)
Tb-TMA-beta-CD##3##1##(2008-10#3)
TbCSV##3##1##(2008-10#3)
TbCSV-[Y35]##8##1##(2008-10#8)
Tbit/s##2##1##(2008-3#2)
Tc 120 proteinase##2##3##(1992-9#2)
Tc##12##1##(1992-9#2)(1993-5#1)(1993-9#1)(1994-2#3)(1995-12#1)(2007-11#1)(2008-11#2)(2008-8#1)
Tc(2)O(7) and Re(2)O(7)##2##3##(1996-2#2)
Tc(2)O(7)##3##1##(1996-2#3)
Tc-99m mercaptoacetyltriglycine renal scan##2##4##(2012-12#2)
Tc-99m##5##1##(2009-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
TcPO2##5##1##(2013-1#5)
Tca DNA polymerase gene was##2##5##(1997-4#2)
Tca DNA polymerase##5##3##(1997-4#5)
Td approximately##2##2##(1992-8#2)
Td##3##1##(1992-8#2)(2008-10#1)
TdO##3##1##(1995-3#3)
TdP##3##1##(2010-8#3)
TdR kinase activity##3##3##(1992-8#3)
TdR kinase is##2##3##(1992-8#2)
TdR kinase which##2##3##(1992-8#2)
TdR kinase##7##2##(1992-8#7)
TdR##8##1##(1992-8#8)
TdT##11##1##(1997-9#11)
Te and Bi in milk##2##5##(2008-10#2)
Te and Bi##3##3##(2008-10#3)
Te and##4##2##(2008-10#4)
Te films##2##2##(2013-8#2)
Te##13##1##(2008-10#10)(2008-3#1)(2013-8#2)
Te(IV)##2##1##(2008-10#2)
Te)##2##1##(1994-8#1)(2008-10#1)
TeBr(6)(2-)##2##1##(2008-10#2)
Tea##5##1##(2008-10#2)(2009-11#1)(2009-9#1)(2011-1#1)
Teacher and##2##2##(2010-12#1)(2011-2#1)
Teacher##10##1##(1993-1#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#2)
Teachers of##2##2##(1997-5#1)(2008-11#1)
Teachers##8##1##(1997-5#1)(2006-10#1)(2007-5#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
Teachers'##3##1##(2008-12#1)(2011-2#2)
Teaching Hospital##20##2##(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#2)(2010-11#2)(2010-5#1)(2010-9#3)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Teaching about##2##2##(1996-1#1)(2008-11#1)
Teaching and Learning##2##3##(2008-11#2)
Teaching and##4##2##(1994-12#1)(2007-10#1)(2008-11#2)
Teaching health##2##2##(1994-3#2)
Teaching hospitals##4##2##(1993-9#1)(1995-1#3)
Teaching of##2##2##(2009-2#1)(2011-2#1)
Teaching##58##1##(1990-12#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#3)(1995-1#3)(1995-3#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-11#2)(2010-3#2)(2010-5#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
Teakettle##4##1##(2008-10#4)
Team is##2##2##(1995-12#1)(2008-10#1)
Team##31##1##(1992-12#2)(1993-12#3)(1993-9#1)(1994-1#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Teams and at##2##3##(2008-9#2)
Teams and##3##2##(2008-9#3)
Teams##12##1##(1994-2#1)(1995-12#1)(1996-1#5)(2008-9#4)(2011-2#1)
Teamwork##2##1##(2008-11#1)(2013-8#1)
Tech##3##1##(2006-12#1)(2008-11#1)(2008-3#1)
Technetium 99m##2##2##(1992-2#1)(2008-1#1)
Technical Standards##3##2##(2007-4#3)
Technical UK DNA working group##2##5##(2008-12#2)
Technical and##5##2##(2008-3#1)(2008-6#2)(2008-7#1)(2009-4#1)
Technical aspects of##3##3##(2011-2#2)(2013-1#1)
Technical aspects##4##2##(2008-6#1)(2011-2#2)(2013-1#1)
Technical note##2##2##(1997-6#1)(2011-2#1)
Technical note]##2##2##(1992-9#2)
Technical success##2##2##(2008-7#1)(2012-2#1)
Technical tip##2##2##(2008-9#1)(2012-2#1)
Technical##43##1##(1991-5#1)(1992-9#2)(1994-12#1)(1994-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-4#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)
Technicon##2##1##(2008-10#2)
Technique for##8##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)
Technique in##2##2##(2008-11#1)(2013-1#1)
Technique to##2##2##(2007-12#1)(2012-3#1)
Technique##33##1##(1995-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Techniques for mammalian cell tissue culture##2##6##(2008-4#1)(2008-9#1)
Techniques for##17##2##(1991-1#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#3)(2008-9#3)(2011-1#1)(2012-12#1)(2012-3#1)
Techniques of##3##2##(2007-8#1)(2008-9#1)(2012-3#1)
Techniques##37##1##(1991-1#1)(1994-12#1)(1995-11#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#6)(2008-4#3)(2008-8#2)(2008-9#5)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Technol##3##1##(2007-12#1)(2008-10#2)
Technological advances in##2##3##(2008-4#1)(2013-8#1)
Technological##12##1##(1992-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-11#2)(2008-4#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-8#1)
Technologies to##2##2##(2008-5#1)(2012-3#1)
Technologies##15##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Technologists##3##1##(1992-1#1)(1996-3#2)
Technology &amp##3##2##(2008-1#1)(2008-5#1)(2008-9#1)
Technology acquisition in Canadian hospitals##2##5##(1994-12#1)(1996-2#1)
Technology for##2##2##(2008-11#1)(2012-3#1)
Technology in##3##2##(1994-8#1)(2008-3#1)(2010-8#1)
Technology##61##1##(1990-11#1)(1990-3#1)(1993-12#1)(1993-3#1)(1994-12#4)(1994-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Teddy##2##1##(1990-2#1)(2008-10#1)
Teen pregnancies##2##2##(2008-7#2)
Teen##4##1##(1994-1#1)(2008-4#1)(2008-7#2)
Teenage##4##1##(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
Teenagers##2##1##(2008-11#1)(2013-1#1)
Teeth with##2##2##(1990-9#1)(2013-1#1)
Teeth##5##1##(1990-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Teflon AF##3##2##(2008-10#1)(2010-8#2)
Teflon AF-2400##3##2##(2008-10#3)
Teflon and##5##2##(2008-5#1)(2010-4#4)
Teflon filters##3##2##(2008-10#2)(2008-5#1)
Teflon membrane##2##2##(2008-10#2)
Teflon##30##1##(1990-3#1)(1995-6#1)(2008-10#15)(2008-5#2)(2010-4#6)(2010-8#4)(2012-2#1)
Tegner##2##1##(2011-2#2)
Tehran University of Medical Sciences##3##5##(2008-3#1)(2011-2#2)
Tehran##20##1##(2007-7#1)(2007-9#1)(2008-12#6)(2008-3#2)(2011-2#7)(2012-2#2)(2013-8#1)
Telbivudine##2##1##(2013-1#2)
TeleBAT##2##1##(2007-9#2)
Telecom##2##1##(1992-12#1)(2008-10#1)
Telecommunication##3##1##(1993-12#1)(2007-12#1)(2008-3#1)
Telecommunications##3##1##(1996-2#1)(1997-2#1)(2008-3#1)
Telemark##4##1##(1991-11#1)(1994-11#3)
Telemedicine and##3##2##(1996-2#2)(2008-4#1)
Telemedicine is##2##2##(1996-11#1)(2008-10#1)
Telemedicine##11##1##(1995-2#1)(1996-11#2)(1996-2#2)(1996-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)
Teleogryllus commodus##2##2##(2007-12#2)
Telepathology##5##1##(2008-1#5)
Telephone interviews##2##2##(2010-5#1)(2012-12#1)
Telephone surveys##2##2##(1997-2#1)(2011-1#1)
Telephone##13##1##(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Telescope##18##1##(1990-11#1)(1995-6#1)(2007-11#1)(2008-2#5)(2008-3#10)
Telescopes##2##1##(2008-3#2)
Television##6##1##(1994-3#1)(1997-6#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-11#1)
Teliospore##2##1##(2008-10#2)
Teliospores from##2##2##(2008-10#2)
Teliospores##3##1##(2008-10#3)
Tell the##2##2##(2008-6#1)(2009-3#1)
Tell##4##1##(2008-6#1)(2009-3#1)(2010-3#1)(2011-2#1)
Telmatochromis temporalis##2##2##(2008-5#2)
Telmisartan in##2##2##(2008-1#1)(2010-3#1)
Telomerase activity was##2##3##(2008-6#2)
Telomerase activity##4##2##(2008-1#1)(2008-6#3)
Telomerase is##2##2##(2008-11#2)
Telomerase##16##1##(2006-10#1)(2008-1#1)(2008-11#9)(2008-5#1)(2008-6#3)(2008-9#1)
Telomere length##2##2##(2008-1#1)(2012-3#1)
Telomere##7##1##(2008-1#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#2)
Telomeres are##2##2##(2008-11#1)(2008-9#1)
Telomeres shorten##2##2##(1990-5#1)(2006-10#1)
Telomeres##4##1##(1990-5#1)(2006-10#1)(2008-11#1)(2008-9#1)
Temecula1##2##1##(2008-10#2)
Temnothorax rugatulus##2##2##(2008-6#2)
Temperament and Character Inventory##2##4##(2009-9#1)(2011-1#1)
Temperament##8##1##(1991-1#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-8#3)
Temperate Climates##2##2##(2008-10#2)
Temperate##4##1##(2008-10#4)
Temperature and the##2##3##(1995-6#1)(2008-2#1)
Temperature and##19##2##(1995-6#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2013-1#1)
Temperature control##2##2##(2007-10#1)(2008-3#1)
Temperature dependence of##2##3##(1990-12#1)(2007-12#1)
Temperature dependence##4##2##(1990-12#1)(1992-3#1)(2007-12#1)(2008-3#1)
Temperature effects on##3##3##(2008-10#2)(2009-12#1)
Temperature effects##4##2##(2008-10#2)(2008-8#1)(2009-12#1)
Temperature on the##2##3##(2008-10#2)
Temperature on##5##2##(2008-10#5)
Temperature regimes##2##2##(2008-10#2)
Temperature sensitivity of##3##3##(1997-6#1)(2007-11#1)(2008-3#1)
Temperature treatments were##2##3##(2008-10#1)(2012-8#1)
Temperature tuning##2##2##(2007-11#1)(2008-2#1)
Temperature##84##1##(1990-12#1)(1991-11#1)(1992-3#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#37)(2008-11#1)(2008-2#5)(2008-3#11)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-6#1)(2012-8#2)(2013-1#1)
Temperature-Dependent##2##1##(1996-2#1)(2008-3#1)
Temperature-constrained cascade correlation networks (TCCCNs) were##2##6##(2008-10#2)
Temperature-dependent##5##1##(1992-6#1)(2007-12#1)(2008-3#2)(2013-8#1)
Temperature-induced##2##1##(2008-11#1)(2008-3#1)
Temperature-sensitive##3##1##(1991-8#1)(1992-3#1)(2008-10#1)
Temperatures in the range##2##4##(2007-12#1)(2008-3#1)
Temperatures in##3##2##(2007-12#1)(2008-3#2)
Temperatures of##2##2##(1991-1#1)(2008-10#1)
Temperatures##16##1##(1991-1#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#5)
Template##2##1##(2008-6#1)(2010-12#1)
Templeton##2##1##(2008-10#2)
Tempol##3##1##(1995-8#3)
Temporal Dynamics of##4##3##(2008-10#4)
Temporal analysis of##2##3##(2008-10#1)(2008-11#1)
Temporal and Spatial Dynamics of##2##5##(2008-10#2)
Temporal and Spatial##4##3##(2008-10#4)
Temporal and spatial##4##3##(1995-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
Temporal and##10##2##(1995-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
Temporal bone##2##2##(2008-9#1)(2012-2#1)
Temporal changes in##2##3##(2008-10#1)(2008-4#1)
Temporal properties of##2##3##(2008-1#1)(2008-2#1)
Temporal solitary waves##2##3##(2007-12#2)
Temporal variation##2##2##(2008-5#1)(2008-8#1)
Temporal##62##1##(1994-9#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-11#3)(2007-12#5)(2007-2#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Temporally##2##1##(1995-3#1)(2007-11#1)
Temporary##12##1##(1992-8#1)(1993-12#1)(1995-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
Ten cases##3##2##(2007-8#2)(2012-2#1)
Ten commandments##2##2##(1995-3#1)(2009-12#1)
Ten days later##4##3##(1993-3#1)(1994-2#1)(2008-9#1)(2012-3#1)
Ten days##6##2##(1993-3#1)(1994-2#1)(2007-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
Ten different##2##2##(2008-9#1)(2009-9#1)
Ten distinct##2##2##(2008-10#2)
Ten flaps were##2##3##(2008-9#2)
Ten male##2##2##(2008-12#1)(2008-5#1)
Ten microsatellite loci##2##3##(2008-11#1)(2013-8#1)
Ten months later##2##3##(2007-8#1)(2011-1#1)
Ten nM estradiol##2##3##(2008-11#2)
Ten nM##3##2##(2008-11#3)
Ten of the##7##3##(1990-2#1)(1991-2#1)(1994-12#1)(1997-8#1)(2008-11#1)(2010-3#1)(2010-8#1)
Ten of these##4##3##(1990-12#1)(1994-3#1)(1995-6#1)(2009-10#1)
Ten of##13##2##(1990-12#1)(1990-2#1)(1991-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-2#1)
Ten patients had##2##3##(1991-12#1)(2012-3#1)
Ten patients received##2##3##(2007-8#1)(2008-5#1)
Ten patients required##2##3##(2007-7#1)(2012-3#1)
Ten patients were treated##2##4##(1994-1#1)(2008-7#1)
Ten patients were##6##3##(1993-1#1)(1994-1#1)(1995-11#1)(2008-7#1)(2009-2#1)(2011-2#1)
Ten patients##19##2##(1990-8#1)(1991-12#1)(1993-1#1)(1993-2#1)(1994-1#2)(1995-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#5)(2009-2#1)(2011-2#1)(2012-3#2)
Ten percent of##2##3##(2010-8#1)(2013-1#1)
Ten protein spots were##2##4##(2008-10#1)(2010-12#1)
Ten specialty boards report accomplishments and plans##4##7##(2008-4#4)
Ten units##2##2##(1994-9#1)(2007-11#1)
Ten were##2##2##(2008-4#1)(2008-9#1)
Ten years after##2##3##(2009-12#1)(2013-1#1)
Ten years to VISION 2020##2##5##(2011-2#2)
Ten years##7##2##(1992-7#1)(1993-2#1)(2008-11#1)(2009-12#1)(2011-2#2)(2013-1#1)
Ten##145##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#3)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#20)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
Ten-year##2##1##(1994-12#1)(1995-8#1)
Tenax((R))##2##1##(2008-10#2)
Tenckhoff catheters##2##2##(2008-1#2)
Tenckhoff##3##1##(2008-1#3)
Tenderometer##4##1##(2013-1#4)
Tendon##2##1##(2009-3#1)(2013-1#1)
Tenebrio molitor##2##2##(2007-12#2)
Tenebrionidae)##3##1##(2008-12#1)(2011-2#2)
Tennessee was observed in broiler flocks##2##6##(1997-3#2)
Tennessee##16##1##(1993-2#1)(1996-1#2)(1997-3#7)(2008-10#3)(2008-8#1)(2012-3#1)(2013-1#1)
Tensile##2##1##(2009-7#2)
Tension##3##1##(1995-2#1)(1996-12#1)(2007-8#1)
Tensions##2##1##(2013-1#1)(2013-8#1)
Tensor##6##1##(1996-9#1)(2007-11#1)(2008-5#1)(2010-6#2)(2010-7#1)
Tentative##2##1##(1996-4#1)(2013-8#1)
Tenth##4##1##(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
Tephritidae) and##3##2##(2007-12#3)
Tephritidae) in##3##2##(2008-6#1)(2011-2#2)
Tephritidae)##16##1##(2007-12#3)(2008-11#1)(2008-6#1)(2009-9#1)(2011-2#9)(2013-8#1)
Teqing##3##1##(2008-10#1)(2008-8#2)
Terabit##2##1##(2007-12#1)(2008-3#1)
Terahertz radiation##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
Terahertz##11##1##(2007-11#1)(2008-2#1)(2008-3#1)(2010-5#5)(2012-12#1)(2012-2#1)(2013-8#1)
Teratogenic effects of##2##3##(1993-12#1)(1995-8#1)
Teratology Society##2##2##(2011-2#2)
Teratoma of the##2##3##(2008-10#1)(2008-7#1)
Teratomas are##2##2##(2008-10#2)
Teratomas##3##1##(2007-8#1)(2008-10#2)
Teratosphaeria##3##1##(2010-3#3)
Terbinafine##5##1##(2008-3#2)(2008-5#2)(2012-3#1)
Term##5##1##(1993-12#2)(1993-8#1)(2013-1#2)
Terminal##2##1##(1994-12#1)(2007-12#1)
Terminalia chebula##2##2##(2008-5#1)(2010-3#1)
Terminalia##3##1##(2008-12#1)(2008-5#1)(2010-3#1)
Terminals which##2##2##(1997-2#2)
Terminology##4##1##(2012-2#1)(2013-1#3)
Termites##3##1##(2008-6#1)(2011-2#1)(2013-8#1)
Termitidae)##3##1##(2011-2#2)(2013-8#1)
Terms of##2##2##(1992-5#1)(2011-2#1)
Terms##4##1##(1992-3#1)(1992-5#1)(2011-2#1)(2012-12#1)
Ternary Complex Factor##2##3##(1994-6#2)
Ternary mixtures of##2##3##(2008-10#2)
Ternary##8##1##(1994-6#2)(2008-10#2)(2008-2#1)(2008-6#1)(2010-6#1)(2012-2#1)
Terra##2##1##(2008-3#2)
Terres##2##1##(1995-6#2)
Terrestrial##4##1##(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
Territorial##4##1##(1994-2#1)(1995-12#1)(2008-5#1)(2013-1#1)
Territories##4##1##(1997-4#1)(2008-11#1)(2012-12#2)
Territory of##3##2##(2011-1#1)(2013-1#1)(2013-8#1)
Territory##6##1##(2008-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Territory-wide health##2##2##(2013-8#2)
Terry Gaasterland##2##2##(2008-7#2)
Terry##5##1##(1996-2#1)(1997-1#1)(1997-7#1)(2008-7#2)
Tertiary Care##3##2##(2009-10#1)(2011-1#1)(2012-2#1)
Tertiary##9##1##(1996-4#1)(1997-2#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
Terumo##2##1##(1992-2#1)(2010-5#1)
Tesla##12##1##(2008-10#1)(2008-12#1)(2008-9#3)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)
Tessier et al##2##3##(2008-10#2)
Tessier##7##1##(2008-10#7)
Test Guideline 487##2##3##(2011-1#2)
Test anxiety##2##2##(2012-1#2)
Test for##7##2##(1997-7#1)(2007-7#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#2)
Test in the##3##3##(1991-9#1)(2008-12#1)(2011-2#1)
Test in##5##2##(1991-9#1)(2008-12#2)(2011-2#1)(2012-12#1)
Test is##2##2##(2008-12#1)(2013-7#1)
Test of the##2##3##(2008-3#1)(2008-7#1)
Test of##10##2##(1992-6#1)(2007-11#3)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
Test results are##2##3##(2008-10#2)
Test results for##2##3##(2008-3#2)
Test results##7##2##(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-12#1)
Test##113##1##(1991-9#3)(1992-2#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-11#3)(1996-7#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#9)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#5)
Test)##4##1##(2007-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
Test-retest reliability##3##2##(2007-10#1)(2010-11#1)(2013-8#1)
Test-retest##5##1##(1996-7#1)(2007-10#1)(2010-11#1)(2011-1#1)(2013-8#1)
Testbed##3##1##(2008-2#2)(2008-3#1)
Tested##4##1##(2007-12#1)(2008-10#3)
Testes##2##1##(2007-12#2)
Testicular atrophy##2##2##(2011-2#2)
Testicular descent##2##2##(2008-10#2)
Testicular germ cell tumors##2##4##(2008-10#2)
Testicular##20##1##(1992-12#1)(1992-5#2)(1995-8#1)(1996-5#1)(2007-5#1)(2008-10#6)(2009-10#1)(2009-11#1)(2009-4#1)(2011-2#4)(2012-2#1)
Testimony##2##1##(1997-5#1)(2012-12#1)
Testing a##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
Testing and##2##2##(2011-1#1)(2012-12#1)
Testing different##2##2##(2008-11#1)(2013-8#1)
Testing for##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
Testing in##2##2##(2011-1#1)(2011-2#1)
Testing of the##2##3##(2008-3#1)(2011-2#1)
Testing of##9##2##(1990-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
Testing the##11##2##(1992-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2013-1#1)
Testing visual sensitivity##2##3##(2008-10#2)
Testing with##2##2##(2008-10#1)(2010-2#1)
Testing##67##1##(1990-4#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-10#1)(2007-9#1)(2008-10#15)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#1)(2008-5#3)(2008-8#5)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
Testosterone administration##2##2##(1996-5#1)(2008-7#1)
Testosterone and##2##2##(1991-12#1)(1995-2#1)
Testosterone##20##1##(1991-12#1)(1993-3#1)(1995-2#2)(1996-2#1)(1996-5#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
Tests for linkage##2##3##(1997-5#1)(2008-10#1)
Tests for##7##2##(1993-12#1)(1997-5#1)(2008-10#4)(2012-2#1)
Tests in##2##2##(2007-11#1)(2008-3#1)
Tests of the##4##3##(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)
Tests of##8##2##(1992-5#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-3#1)
Tests on a##2##3##(1996-12#1)(2008-10#1)
Tests on##4##2##(1996-12#1)(2008-10#3)
Tests show that##2##3##(2008-2#1)(2008-9#1)
Tests that##2##2##(2008-12#1)(2013-1#1)
Tests were performed##2##3##(2008-10#1)(2008-11#1)
Tests were##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
Tests with##6##2##(2006-12#1)(2007-6#1)(2008-10#4)
Tests##51##1##(1992-5#1)(1993-12#1)(1996-12#1)(1997-5#2)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
Testudines (TINC)##2##2##(2013-1#2)
Tetanic stimulation##2##2##(1991-12#1)(2008-7#1)
Tetanus##2##1##(2008-10#1)(2012-3#1)
Tetep##3##1##(2008-10#3)
Tetr plants##5##2##(2008-10#5)
Tetr seedlings##2##2##(2008-10#2)
Tetr tobacco##2##2##(2008-10#2)
Tetr##9##1##(2008-10#9)
Tetrabenzyl pyrophosphate##2##2##(2008-10#2)
Tetrachlorodibenzo-p-Dioxin (TCDD)##2##2##(2008-10#2)
Tetrad analysis##3##2##(1995-9#1)(2008-10#2)
Tetraethylammonium##2##1##(1991-9#1)(2008-8#1)
Tetragonia expansa##4##2##(2008-10#4)
Tetrahymena profilin##2##2##(1990-7#2)
Tetrahymena pyriformis##2##2##(2012-12#2)
Tetrahymena thermophila##5##2##(1994-12#1)(2008-3#2)(2012-3#2)
Tetrahymena##19##1##(1990-7#5)(1993-1#1)(1994-12#1)(2008-12#1)(2008-3#4)(2008-4#2)(2012-12#3)(2012-3#2)
Tetralogy of Fallot##2##3##(2012-3#2)
Tetrameres##2##1##(2011-1#2)
Tetranychidae)##2##1##(2011-2#2)
Tetranychus turkestani Ugarov and Nikolski##2##5##(2008-12#2)
Tetranychus##3##1##(2008-12#2)(2008-8#1)
Tetraodon nigroviridis##2##2##(2008-1#1)(2008-11#1)
Tetraploid##6##1##(2008-10#2)(2008-11#3)(2012-3#1)
Tetric Ceram##2##2##(2013-1#2)
Tettigoniidae)##2##1##(2008-12#1)(2013-8#1)
Tettigoniinae##2##1##(2008-12#2)
Tettigonioidea##3##1##(2008-7#3)
Tewameter##5##1##(2008-5#4)(2012-2#1)
Tex11##6##1##(2012-2#6)
Tex6##13##1##(2008-10#13)
Texas Medical##2##2##(1997-3#1)(2010-8#1)
Texas Red##2##2##(2008-9#2)
Texas in##2##2##(2008-10#2)
Texas were##2##2##(2008-10#2)
Texas##74##1##(1990-11#2)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-5#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#4)(1996-5#3)(1997-3#3)(2006-12#2)(2007-12#1)(2007-6#1)(2008-10#30)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Text##11##1##(1993-3#1)(1996-3#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#2)(2013-1#2)
Textbook of##2##2##(1995-12#1)(2008-4#1)
Texture##4##1##(1996-9#1)(2008-10#2)(2011-2#1)
Tf has##2##2##(2010-11#1)(2013-7#1)
Tf##15##1##(1990-8#3)(1995-2#1)(2010-11#7)(2013-7#4)
Tg to##2##2##(1991-6#1)(2008-10#1)
Tg##91##1##(1991-6#6)(2008-10#3)(2008-11#1)(2008-8#7)(2008-9#72)(2012-2#1)(2013-1#1)
Th 5 have##2##3##(1991-6#2)
Th and##3##2##(1995-12#1)(2008-10#2)
Th cell function##2##3##(1995-5#2)
Th cell##3##2##(1995-5#2)(2008-11#1)
Th cells##2##2##(2008-11#2)
Th##37##1##(1991-6#2)(1995-12#2)(1995-5#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#7)(2008-8#2)(2008-9#3)(2011-2#2)
Th(4+)##7##1##(2008-10#7)
Th(IV) and La(III) from##3##4##(2008-10#3)
Th(IV) and La(III)##5##3##(2008-10#5)
Th(IV) and U(VI)##2##3##(2008-10#2)
Th(IV) and##10##2##(2008-10#10)
Th(IV) from##6##2##(2008-10#6)
Th(IV) ions##2##2##(2008-10#2)
Th(IV) was##2##2##(2008-10#2)
Th(IV)##34##1##(2008-10#34)
Th(IV)-imprinted##3##1##(2008-10#3)
Th(PBI)(4) and UO(2)(PBI)(2)##2##3##(2008-10#2)
Th(PBI)(4)##3##1##(2008-10#3)
Th0##2##1##(2008-9#2)
Th1 and Th2##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
Th1 and##5##2##(1997-2#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
Th1 cytokine##2##2##(2008-11#2)
Th1 immune##2##2##(2008-4#1)(2012-2#1)
Th1##20##1##(1993-8#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
Th1/Th2##3##1##(1994-8#1)(2008-11#1)(2013-1#1)
Th17##5##1##(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
Th2 cells##2##2##(2010-5#2)
Th2 cytokines##5##2##(1996-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
Th2 immune##3##2##(2009-5#2)(2012-12#1)
Th2 polarization##2##2##(2008-11#1)(2012-2#1)
Th2 response##2##2##(1995-12#1)(2009-5#1)
Th2 responses##3##2##(2008-3#1)(2008-4#1)(2009-12#1)
Th2##29##1##(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-9#3)(2009-12#1)(2009-5#5)(2010-5#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
Th2-type cytokine producing cells##2##4##(2008-11#2)
Th2-type cytokine producing##3##3##(2008-11#3)
Th2-type cytokine##4##2##(2008-11#4)
Th2-type responses##2##2##(2008-11#1)(2011-2#1)
Th2-type##10##1##(2008-11#9)(2011-2#1)
Thai blood donors##2##3##(2011-2#2)
Thai##20##1##(1992-8#1)(1994-3#2)(2007-2#3)(2008-5#3)(2008-8#1)(2010-12#2)(2011-2#6)(2012-2#2)
Thailand and the##2##3##(2008-8#1)(2010-2#1)
Thailand and##4##2##(2008-8#1)(2010-2#2)(2011-2#1)
Thailand in the##2##3##(1990-3#1)(2008-12#1)
Thailand in##4##2##(1990-3#1)(2007-12#1)(2008-12#2)
Thailand##61##1##(1990-3#3)(1992-6#2)(1993-3#1)(1995-12#3)(1996-9#4)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-2#9)(2008-10#9)(2008-11#1)(2008-12#6)(2008-8#4)(2010-2#3)(2011-2#10)(2012-2#1)(2013-8#1)
Thailand's##3##1##(1990-3#2)(1995-12#1)
Thais##4##1##(1990-3#1)(2011-1#2)(2011-2#1)
Thal in##2##2##(2008-3#2)
Thal inhibition##2##2##(2008-3#2)
Thal treatment##3##2##(2008-3#3)
Thal##9##1##(2008-3#9)
Thalamic##2##1##(1995-8#1)(1997-2#1)
Thalassarachna basteri from the Baltic Sea and Halacarellus thomasi from McMurdo Sound (Antarctica)##2##13##(2007-12#2)
Thalassemia Major##2##2##(1994-12#2)
Thalassemia##3##1##(1994-12#2)(2008-10#1)
Thalassia testudinum##7##2##(2007-5#2)(2008-5#4)(2011-2#1)
Thalassia##11##1##(2007-5#4)(2008-5#6)(2011-2#1)
Thalidomide##4##1##(1992-2#1)(2008-3#1)(2008-5#2)
Thallium scintigraphy##3##2##(1991-11#1)(1991-2#1)(1996-3#1)
Thallium was##2##2##(1994-5#1)(2008-10#1)
Thallium##8##1##(1991-11#1)(1991-2#1)(1994-5#2)(1996-3#1)(1997-7#1)(2008-10#2)
Thallium(I)##2##1##(2008-10#2)
Thallium-201 uptake##2##2##(2007-8#2)
Thallium-201##3##1##(1992-5#1)(2007-8#2)
Thanatephorus##2##1##(2008-10#2)
Thank##2##1##(2006-12#1)(2007-5#1)
Thanks to a##2##3##(2008-3#1)(2008-6#1)
Thanks to its##3##3##(1996-12#1)(2008-5#2)
Thanks to the##3##3##(2007-8#1)(2008-2#1)(2009-12#1)
Thanks to##14##2##(1996-12#1)(2007-8#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#1)
Thapsigargin##2##1##(1992-11#1)(1996-2#1)
Thapsigargin-induced GVBD##2##2##(1992-11#2)
Thar Desert##2##2##(2013-7#2)
That Is##2##2##(2008-10#1)(2012-3#1)
That is why##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
That is##21##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#2)(1996-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)
That means##2##2##(1996-3#1)(2011-1#1)
That of the##2##3##(1996-5#1)(2012-1#1)
That same year##2##3##(1991-2#1)(2008-8#1)
That the##4##2##(1990-5#1)(1997-3#1)(2008-10#1)(2008-8#1)
That was##2##2##(2009-8#1)(2013-1#1)
That year##2##2##(1993-6#1)(2008-10#1)
That##94##1##(1990-5#2)(1991-1#1)(1991-2#2)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
That's##2##1##(1994-3#1)(1995-2#1)
Thatcher and the##2##3##(2008-10#2)
Thatcher and##4##2##(2008-10#4)
Thatcher lines##2##2##(2008-10#2)
Thatcher wheat##3##2##(2008-10#3)
Thatcher##17##1##(2008-10#15)(2008-5#2)
Thauera aromatica##2##2##(2011-1#2)
Thauera##3##1##(2011-1#2)(2013-8#1)
Thaumetopoea pityocampa##2##2##(2008-12#2)
Thaxtomin##2##1##(2008-10#2)
The &quot##39##2##(1991-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#2)(1995-5#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-9#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
The 'long and lonely road'##2##5##(2008-7#2)
The (1)H NMR##2##3##(1997-7#1)(2008-10#1)
The (1)H##4##2##(1997-7#2)(2008-10#1)(2013-1#1)
The (19)F##2##2##(2008-10#2)
The 0##3##2##(1991-10#1)(1993-8#1)(2013-1#1)
The 1##21##2##(1992-8#1)(1993-11#1)(1995-5#1)(1996-2#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#7)
The 1-##2##2##(2012-1#1)(2012-12#1)
The 10##2##2##(1991-4#1)(1995-8#1)
The 10-year##2##2##(1991-8#1)(2007-8#1)
The 11##2##2##(1994-7#1)(2008-8#1)
The 12##3##2##(2008-10#1)(2008-9#1)(2009-2#1)
The 120##2##2##(2008-2#1)(2008-4#1)
The 12th##2##2##(2006-9#1)(2008-1#1)
The 13##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
The 14-kDa##2##2##(1991-12#1)(2008-10#1)
The 15##4##2##(1990-5#1)(1991-12#1)(1991-2#1)(2008-12#1)
The 16##2##2##(1995-9#1)(2008-4#1)
The 165 kDa pro-EGF##2##4##(1990-12#2)
The 16S rRNA##4##3##(1992-6#1)(2009-6#1)(2012-2#1)(2013-7#1)
The 16S##5##2##(1992-6#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-7#1)
The 17-kDa protein##2##3##(2008-10#2)
The 1988##2##2##(1992-1#1)(1994-1#1)
The 1990##3##2##(1990-3#1)(1992-3#1)(1997-3#1)
The 1990s##2##2##(1991-3#1)(1996-3#1)
The 1991##2##2##(1992-11#1)(1992-12#1)
The 1994##3##2##(1994-9#1)(1995-2#1)(1997-4#1)
The 1H##2##2##(1993-11#1)(2009-7#1)
The 1st##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
The 2 groups##2##3##(1993-9#1)(2008-7#1)
The 2 patients##2##3##(1992-10#1)(2007-10#1)
The 2##30##2##(1992-10#1)(1992-3#1)(1993-9#2)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#2)(1997-9#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#9)
The 2-oxoglutarate/malate translocator of##2##4##(1995-2#2)
The 2-oxoglutarate/malate translocator##3##3##(1995-2#3)
The 2-year survival rate was##2##5##(2007-8#1)(2013-1#1)
The 2-year##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
The 20%##2##2##(2013-8#2)
The 2010##2##2##(2011-2#1)(2012-2#1)
The 20S proteasome is the catalytic core of the major extralysosomal proteolytic system of the cell##2##16##(2008-4#2)
The 20S proteasome##3##3##(2008-4#2)(2008-5#1)
The 21##3##2##(1993-6#1)(1994-1#1)(2011-2#1)
The 21st##2##2##(1994-1#1)(2008-1#1)
The 23##2##2##(2008-6#1)(2013-8#1)
The 24 Kd##2##3##(1993-8#2)
The 28-year-old male patient##2##4##(2009-8#1)(2012-12#1)
The 2D##3##2##(2008-6#1)(2011-1#1)(2012-1#1)
The 2nd##4##2##(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)
The 3##15##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#9)(2012-2#1)
The 3' end##2##3##(2008-10#1)(2008-11#1)
The 3' untranslated##2##3##(1990-5#1)(1994-11#1)
The 3'##10##2##(1990-5#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#2)
The 3'-terminal##2##2##(2008-10#1)(2008-8#1)
The 3-D deformation##2##3##(2008-3#2)
The 3-D structure##2##3##(2008-8#2)
The 3-D##13##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-8#2)(2010-5#1)(2011-2#2)(2012-2#1)
The 3-fold##2##2##(1992-10#1)(1996-2#1)
The 30##4##2##(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
The 30-day mortality rate##2##4##(2007-10#1)(2011-3#1)
The 30-day##3##2##(2007-10#1)(2008-7#1)(2011-3#1)
The 3D culture##2##3##(2008-11#2)
The 3D##3##2##(2008-11#2)(2012-3#1)
The 3sigma detection limit##2##4##(2008-10#2)
The 3sigma detection limits##2##4##(2008-10#2)
The 3sigma detection##4##3##(2008-10#4)
The 3sigma limit of detection##2##5##(2008-10#2)
The 3sigma##7##2##(2008-10#7)
The 4##8##2##(1991-12#1)(1992-3#1)(2011-2#6)
The 47##2##2##(2008-9#1)(2010-6#1)
The 4th Bologna Winter School##2##5##(2008-7#2)
The 4th##3##2##(2007-7#1)(2008-7#2)
The 5##9##2##(1993-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-2#1)(2011-2#4)
The 5' end##2##3##(1996-6#1)(2008-12#1)
The 5' flanking region##2##4##(1992-11#1)(1994-11#1)
The 5' flanking regions of##2##5##(1992-3#1)(1993-6#1)
The 5' flanking##4##3##(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#1)
The 5' terminus of the##2##5##(1992-11#1)(2008-11#1)
The 5' terminus##3##3##(1992-11#1)(2008-10#1)(2008-11#1)
The 5'##18##2##(1991-7#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-6#2)(1994-11#1)(1995-8#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)
The 5'- and##2##3##(2008-10#2)
The 5'-flanking region of the##2##5##(1997-6#1)(1997-8#1)
The 5'-flanking region of##3##4##(1994-6#1)(1997-6#1)(1997-8#1)
The 5'-flanking region##7##3##(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1997-6#1)(1997-8#1)
The 5'-flanking##8##2##(1991-7#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1997-6#1)(1997-8#1)
The 5-HT##2##2##(1992-7#1)(2008-6#1)
The 5-HT7 receptor##2##3##(2008-5#2)
The 5-year survival rate was##3##5##(1997-7#2)(2008-8#1)
The 5-year survival##4##3##(1997-7#2)(2008-3#1)(2008-8#1)
The 5-year##6##2##(1997-7#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
The 50##2##2##(1990-5#1)(1993-11#1)
The 50%##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
The 54##2##2##(2008-10#1)(2008-7#1)
The 5460S library##2##3##(2008-8#2)
The 6##8##2##(1992-1#1)(1996-5#1)(2008-11#2)(2008-4#1)(2011-2#3)
The 61##2##2##(1990-11#1)(1991-12#1)
The 7##3##2##(1990-9#1)(2011-2#1)(2012-3#1)
The 70 kD rat liver nucleoplasmic protein##2##7##(1993-8#2)
The 8##2##2##(2011-1#1)(2011-2#1)
The 9##2##2##(1995-11#1)(2013-1#1)
The 90% response time##2##4##(2008-10#2)
The 90%##3##2##(2008-10#3)
The 95% confidence interval##2##4##(1991-2#1)(1997-4#1)
The 95% confidence##3##3##(1991-2#1)(1997-4#1)(2008-10#1)
The 95%##6##2##(1991-2#1)(1997-4#1)(2008-10#3)(2012-2#1)
The 9th International##2##3##(2008-7#1)(2008-8#1)
The 9th##4##2##(1997-5#2)(2008-7#1)(2008-8#1)
The A and B##2##4##(2008-10#2)
The A and##3##3##(2008-10#2)(2008-11#1)
The A##13##2##(1990-5#2)(1993-1#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
The A1##2##2##(2008-10#1)(2008-12#1)
The A2 and A4##2##4##(2008-9#2)
The A2##5##2##(1992-8#1)(2008-10#1)(2008-12#1)(2008-9#2)
The AA##2##2##(2008-3#1)(2008-5#1)
The ABC and VED##2##4##(2011-1#2)
The ABC##5##2##(1993-12#2)(2011-1#2)(2012-3#1)
The ABTS(+)##2##2##(2008-10#2)
The AC##2##2##(2008-10#1)(2009-11#1)
The ACE##2##2##(1994-7#1)(2008-10#1)
The ACP##2##2##(1992-4#1)(1993-12#1)
The ACTH##2##2##(1994-2#1)(2008-1#1)
The ADHD##2##2##(2006-10#1)(2013-8#1)
The AF4Q initiative is##2##4##(2013-1#2)
The AFLP##2##2##(2008-10#2)
The AHRA Statistical Resource Committee presents the results of a recent survey of members about their job satisfaction##2##18##(1995-1#1)(1995-2#1)
The AHRA##3##2##(1995-1#1)(1995-12#1)(1995-2#1)
The AI##2##2##(2008-10#1)(2013-1#1)
The AIDS##5##2##(1992-9#1)(1995-1#2)(1996-5#1)(2008-4#1)
The AMPA effect##2##3##(2008-8#2)
The ANN##3##2##(2008-10#1)(2009-3#1)(2010-8#1)
The AP##2##2##(2010-4#2)
The AR##2##2##(1990-11#1)(2008-8#1)
The ARBs##2##2##(2008-8#2)
The ATP##2##2##(1990-5#1)(1993-6#1)
The ATR##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
The AUC for##3##3##(2008-7#2)(2013-1#1)
The AUC##4##2##(2008-11#1)(2008-7#2)(2013-1#1)
The AVF##2##2##(2007-7#2)
The African American##2##3##(2010-8#2)
The African##3##2##(2010-8#2)(2012-3#1)
The Ag/TiO2 films##3##3##(2007-12#3)
The Alberta##2##2##(1992-12#1)(2012-12#1)
The Allergic Rhinitis and its Impact on Asthma (ARIA)##2##9##(2008-3#1)(2012-12#1)
The Alliance##2##2##(1994-12#2)
The AlloMap test##2##3##(2008-10#2)
The Alternate Protocol describes a method##2##6##(2008-4#2)
The Alternate Protocol##3##3##(2008-4#3)
The Alzheimer's##2##2##(1991-3#1)(1992-12#1)
The American College of##3##4##(1996-12#1)(2008-3#1)(2013-1#1)
The American Dietetic Association##2##4##(1995-3#1)(2008-5#1)
The American Heart Association##2##4##(2008-11#1)(2009-11#1)
The American Society of##2##4##(2008-5#1)(2010-8#1)
The American health care system--managed care##2##6##(1992-12#2)
The American health care##5##4##(1992-12#2)(1993-9#1)(1994-2#1)(1994-3#1)
The American##26##2##(1991-1#1)(1991-12#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
The Americans with Disabilities Act##6##5##(1991-12#1)(1993-1#3)(1994-1#2)
The Americans##7##2##(1991-12#2)(1993-1#3)(1994-1#2)
The Analysis of##2##3##(2008-10#1)(2010-1#1)
The Andrew Pattullo Lecture##2##4##(1992-3#1)(1996-12#1)
The Andrew Pattullo##3##3##(1992-3#1)(1996-12#1)(1996-2#1)
The Annual##2##2##(2008-7#1)(2012-3#1)
The Arabidopsis Information Resource##2##4##(2008-4#1)(2008-7#1)
The Association between##2##3##(2011-2#1)(2013-1#1)
The Association for##2##3##(1994-3#1)(2011-2#1)
The Association##4##2##(1994-3#1)(2011-2#2)(2013-1#1)
The Australian##5##2##(1992-1#1)(2008-10#1)(2008-3#1)(2011-2#2)
The Authors conclude that##2##4##(1990-5#1)(1992-9#1)
The Authors describe a case of##3##6##(1991-5#1)(1991-6#1)(1992-9#1)
The Authors describe a rare case of##2##7##(1991-3#1)(1992-9#1)
The Authors describe a##5##4##(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#2)
The Authors describe##7##3##(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#2)(1993-6#1)
The Authors discuss##2##3##(1990-3#1)(1990-9#1)
The Authors emphasize the##2##4##(1992-9#1)(1993-6#1)
The Authors present a case of##2##6##(1991-3#1)(1991-6#1)
The Authors present##4##3##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)
The Authors report a case of##4##6##(1991-6#1)(1992-6#2)(1992-9#1)
The Authors report a##5##4##(1990-6#1)(1991-6#1)(1992-6#2)(1992-9#1)
The Authors report the##3##4##(1990-5#1)(1991-6#1)(1992-9#1)
The Authors report their experience of##2##6##(1990-9#1)(1992-6#1)
The Authors report their experience##3##5##(1990-5#1)(1990-9#1)(1992-6#1)
The Authors report their##4##4##(1990-5#1)(1990-9#2)(1992-6#1)
The Authors report##15##3##(1990-5#3)(1990-6#1)(1990-9#2)(1991-5#1)(1991-6#2)(1992-6#4)(1992-9#2)
The Authors##51##2##(1990-10#2)(1990-2#1)(1990-3#3)(1990-5#7)(1990-6#2)(1990-9#4)(1991-3#5)(1991-5#3)(1991-6#6)(1992-6#7)(1992-9#6)(1993-6#2)(2013-1#2)(2013-8#1)
The B##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
The BAC##3##2##(2008-4#2)(2008-7#1)
The BCF(2) families##2##3##(2008-10#2)
The BDD electrode provided##2##4##(2008-10#2)
The BDD electrode##3##3##(2008-10#3)
The BDD##4##2##(2008-10#3)(2012-12#1)
The BDS test##2##3##(2010-8#2)
The BP##2##2##(2008-10#1)(2008-7#1)
The BRDF##2##2##(2008-2#1)(2008-3#1)
The BREH##2##2##(2008-11#2)
The Bacillus subtilis##4##3##(1994-12#1)(1995-6#1)(2008-6#1)(2009-8#1)
The Bacillus##5##2##(1994-12#1)(1995-6#1)(2008-6#1)(2009-8#1)(2011-2#1)
The Bali bombings##2##3##(2008-10#2)
The Barcode of Life Data System##2##6##(2008-9#2)
The Basic Protocol describes the##2##5##(2008-4#2)
The Basic Protocol describes##5##4##(2008-4#4)(2008-9#1)
The Basic Protocol##12##3##(2008-4#10)(2008-9#2)
The Basic##15##2##(1992-1#1)(1995-2#1)(2008-11#1)(2008-4#10)(2008-9#2)
The Baxter Foundation Prize address##4##5##(1991-12#1)(1992-3#1)(1997-2#1)(1997-3#1)
The Bb 23S##2##3##(1995-8#2)
The Bland and Altman plot revealed##2##6##(2008-11#2)
The Board##2##2##(1993-3#1)(2008-8#1)
The Body Mass Index (BMI)##2##5##(2007-8#1)(2008-10#1)
The Body##5##2##(2007-12#3)(2007-8#1)(2008-10#1)
The Bombyx bombyxin##2##3##(2008-6#2)
The Bragg##2##2##(2008-3#2)
The Brazilian##2##2##(2010-10#1)(2012-3#1)
The British##7##2##(1991-6#1)(1992-2#1)(1995-9#1)(2007-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
The ByT-FAS##2##2##(2008-10#2)
The C##9##2##(1990-11#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-9#1)(2007-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
The C-terminal##7##2##(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(2008-9#1)(2010-10#1)
The C-terminus of the##2##4##(1993-8#1)(1994-12#1)
The C-terminus##3##2##(1991-7#1)(1993-8#1)(1994-12#1)
The C2##2##2##(1997-1#1)(2008-6#1)
The CA##5##2##(1994-12#1)(1995-11#1)(1995-3#2)(2008-11#1)
The CAD1##2##2##(2008-8#2)
The CALUX##2##2##(2008-10#2)
The CARC##2##2##(2012-2#2)
The CBCT##2##2##(2013-1#2)
The CC genotype##2##3##(2011-1#2)
The CC-516##2##2##(2008-5#2)
The CCP11##2##2##(2008-7#2)
The CCSV##2##2##(2008-10#2)
The CD spectrum##2##3##(1992-5#1)(1994-12#1)
The CD##6##2##(1990-2#1)(1992-5#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
The CD-ROM##3##2##(1993-2#1)(2008-11#2)
The CDKs##2##2##(1997-6#1)(2012-12#1)
The CDY##2##2##(2008-11#2)
The CE##3##2##(1996-5#1)(2008-10#2)
The CHO cell##2##3##(2008-11#1)(2008-8#1)
The CHO##3##2##(2008-11#2)(2008-8#1)
The CL emission##2##3##(2008-10#2)
The CL enhancement is##2##4##(2008-10#2)
The CL intensity was##2##4##(2008-10#2)
The CL signal produced by the reaction between luminol and##2##10##(2008-10#2)
The CL##17##2##(1991-2#1)(1995-3#1)(2008-10#15)
The CLIMEX model##2##3##(2008-10#2)
The CM##2##2##(2008-10#2)
The CMC##2##2##(2008-10#2)
The CME##3##2##(2008-10#3)
The CO##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
The CO(2) laser##2##3##(2012-3#2)
The CO(2)##3##2##(2008-10#1)(2012-3#2)
The COBRA##2##2##(1993-1#1)(1993-2#1)
The COCH coating was##2##4##(2008-10#2)
The COCH coating##3##3##(2008-10#3)
The COMFORT-B and##2##3##(2012-2#2)
The COPD##2##2##(1995-12#2)
The CP amino acid##2##4##(2008-10#2)
The CP gene##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
The CP##12##2##(1997-6#1)(2008-10#10)(2008-8#1)
The CSF##2##2##(1993-1#1)(1994-9#1)
The CT examination##2##3##(2007-11#2)
The CT scan##2##3##(2008-10#1)(2013-1#1)
The CT##7##2##(1997-8#2)(2007-11#2)(2008-10#1)(2012-2#1)(2013-1#1)
The Ca(2+)##2##2##(2007-11#1)(2008-8#1)
The Ca2+##3##2##(1993-3#1)(1995-2#1)(1997-1#1)
The California Court of##2##4##(1995-12#1)(1997-5#1)
The California Supreme Court##2##4##(1994-1#1)(1997-5#1)
The California##5##2##(1994-1#1)(1995-12#1)(1997-5#3)
The Canadian Dietetic Association##3##4##(1994-2#1)(1995-2#1)(1995-3#1)
The Canadian Health##2##3##(1994-12#1)(2008-12#1)
The Canadian Hospital Executive Simulation System (CHESS)##2##7##(1992-1#2)
The Canadian##15##2##(1992-1#2)(1992-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)
The Canon of Medicine&quot##2##4##(2013-1#2)
The Cardiovascular##2##2##(2008-7#1)(2009-12#1)
The Caribbean##4##2##(2007-12#1)(2007-5#1)(2009-7#2)
The Caucus will##2##3##(1996-5#2)
The Cavitron Ultrasonic Surgical Aspirator##2##5##(1995-12#2)
The Cd##2##2##(2008-10#1)(2008-9#1)
The Center for##5##3##(1997-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-11#1)
The Centers for Disease Control and Prevention (CDC)##3##8##(1996-12#1)(1996-5#1)(1997-3#1)
The Centers for Disease Control and Prevention##4##7##(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)
The Chi-square##2##2##(2009-7#1)(2013-8#1)
The Chikungunya##2##2##(2013-8#2)
The Chinese##3##2##(2008-10#2)(2010-12#1)
The Cleveland Clinic##2##3##(1994-3#1)(2011-2#1)
The Clinical##2##2##(1992-12#1)(2007-7#1)
The Clinton##2##2##(1994-12#2)
The CoMFA##2##2##(1995-3#1)(2010-12#1)
The Cochrane Collaboration##2##3##(1993-12#1)(2007-7#1)
The Cochrane Library##3##3##(2008-12#1)(2011-2#2)
The Cochrane##6##2##(1993-12#2)(2007-7#1)(2008-12#1)(2011-2#2)
The Commentary##2##2##(2008-9#2)
The Community Medical Alliance##2##4##(1997-1#2)
The Community Medical##3##3##(1992-1#1)(1997-1#2)
The Community##5##2##(1992-1#1)(1997-1#2)(1997-4#1)(2010-8#1)
The Complete##2##2##(2008-10#1)(2008-5#1)
The Comprehensive Health##2##3##(1994-1#1)(1995-2#1)
The Comprehensive##3##2##(1994-1#1)(1995-2#1)(2008-1#1)
The Coomassie##2##2##(2008-10#1)(2008-9#1)
The Course##2##2##(2008-10#1)(2008-11#1)
The Court of Appeals##2##4##(1995-12#1)(1996-5#1)
The Court of##3##3##(1995-12#1)(1996-5#1)(1997-5#1)
The Court##5##2##(1993-9#1)(1995-12#1)(1996-5#1)(1997-5#2)
The Cr(VI) is##2##3##(2008-10#2)
The Cr(VI)##5##2##(2008-10#5)
The Critical##2##2##(1995-3#1)(2012-3#1)
The Crk family of##2##4##(2012-12#2)
The Cronbach's alpha##2##3##(2008-10#1)(2011-1#1)
The Cu(2+)##2##2##(2008-10#2)
The D##2##2##(1997-4#1)(2008-10#1)
The D(M)##2##2##(2008-10#2)
The D-MRI##2##2##(2011-2#2)
The D3 receptor##2##3##(1995-2#2)
The DD##2##2##(2008-10#1)(2012-2#1)
The DIPD##3##2##(2008-10#3)
The DMFT##2##2##(2008-9#2)
The DNA binding##2##3##(1991-2#1)(1991-5#1)
The DNA biosensor is assembled by##2##6##(2008-10#2)
The DNA damage##2##3##(2009-6#1)(2011-2#1)
The DNA fragmentation##2##3##(2008-8#2)
The DNA fragments##4##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-8#1)
The DNA of A##2##4##(2013-1#2)
The DNA of##3##3##(2008-5#1)(2013-1#2)
The DNA sequence analysis##2##4##(1992-6#1)(2012-2#1)
The DNA sequence of##2##4##(1995-6#2)
The DNA sequence##6##3##(1992-6#1)(1995-6#2)(1997-2#1)(2008-10#1)(2012-2#1)
The DNA sequences##2##3##(1991-2#1)(2008-12#1)
The DNA##43##2##(1990-5#1)(1991-2#2)(1991-5#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
The DNA-binding domain of##2##4##(1992-3#1)(1996-3#1)
The DNA-binding##4##2##(1992-3#1)(1992-8#1)(1996-3#1)(2008-9#1)
The DNase##3##2##(1993-11#1)(1994-8#2)
The DOE##2##2##(2008-3#1)(2008-7#1)
The DOP##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The DP method##2##3##(2008-2#2)
The DPI##2##2##(2007-12#2)
The DSTD##2##2##(2008-10#2)
The Delphi##2##2##(2010-8#1)(2010-9#1)
The Department of Justice##2##4##(1991-1#1)(1995-6#1)
The Department of##6##3##(1990-10#1)(1991-1#1)(1995-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
The Development of##2##3##(1997-3#1)(2010-12#1)
The Diabetes##2##2##(1993-9#1)(2008-3#1)
The Diagnostic and Statistical Manual of Mental Disorders##2##8##(2009-10#1)(2011-2#1)
The Diskus##2##2##(1996-2#2)
The Division of##2##3##(1996-3#1)(2008-5#1)
The Donnan##2##2##(2011-2#2)
The Doppler bandwidth##2##3##(2007-11#2)
The Doppler shift##2##3##(2008-3#2)
The Doppler##8##2##(1991-12#1)(2007-11#2)(2007-12#2)(2008-3#3)
The Drosophila##9##2##(1993-2#1)(1993-6#1)(1993-9#1)(1995-2#1)(2008-2#1)(2008-7#1)(2008-9#3)
The Duke##2##2##(2012-3#2)
The Dynamics of##2##3##(2008-10#1)(2012-2#1)
The Dynastab S external fixator##2##5##(2007-8#2)
The E##4##2##(1990-11#1)(1992-8#1)(2007-6#1)(2008-10#1)
The E(pa)##2##2##(2008-10#2)
The E2##2##2##(1990-5#2)
The EC##2##2##(2008-10#2)
The EC50##2##2##(1990-8#1)(1996-2#1)
The ECM##3##2##(2008-3#3)
The ED50##2##2##(1990-7#1)(1991-5#1)
The EDM process with##2##4##(2012-2#2)
The EEG##4##2##(1990-9#2)(2008-7#2)
The EIT##2##2##(2007-12#1)(2011-2#1)
The ELISA was##2##3##(1992-5#1)(2008-10#1)
The ELISA##7##2##(1990-12#1)(1990-8#2)(1992-5#1)(2008-10#1)(2008-4#2)
The EM##2##2##(2008-2#2)
The EMG##2##2##(2009-3#1)(2010-8#1)
The EMPIRE##2##2##(2008-11#2)
The EN##2##2##(2008-11#2)
The ENETS##2##2##(2011-2#2)
The ENS and surrounding##2##4##(2008-8#2)
The ENS and##3##3##(2008-8#3)
The ENS##4##2##(2008-7#1)(2008-8#3)
The EO##2##2##(2013-1#2)
The EP##2##2##(2008-10#2)
The EPR##3##2##(1993-11#1)(1997-7#2)
The ERG##2##2##(2009-12#1)(2012-12#1)
The ES##3##2##(2008-11#2)(2008-8#1)
The ESF Programme on##2##4##(2008-7#2)
The ESF##3##2##(2008-7#2)(2010-3#1)
The ESR spectra of##2##4##(1990-2#1)(1994-3#1)
The ESR##7##2##(1990-2#1)(1994-3#3)(2008-10#2)(2012-2#1)
The EUCCLID study##2##3##(2008-7#2)
The Effect of Support Group Method on Quality of Life in Post-menopausal Women##2##13##(2013-1#2)
The Effect of Vitamin E-Modified Dialyzers on Acute Intra-dialytic Symptoms##2##10##(2007-7#1)(2008-1#1)
The Effect of##12##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-8#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
The Effectiveness of##2##3##(2008-5#1)(2012-2#1)
The Effects of##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2010-10#1)(2012-1#1)(2012-3#1)
The Elder##2##2##(1994-12#1)(1995-12#1)
The English##2##2##(2008-11#1)(2013-8#1)
The Epstein-Barr virus##2##3##(1993-8#1)(1997-3#1)
The Equal Employment Opportunity Commission (EEOC)##2##6##(1995-12#1)(1995-6#1)
The Er##3##2##(2008-2#1)(2008-7#2)
The Escherichia coli##4##3##(1993-12#1)(1995-8#1)(1997-4#1)(2008-7#1)
The Etest##2##2##(2008-7#2)
The European##13##2##(1992-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2012-2#1)
The FA##2##2##(2008-10#1)(2013-1#1)
The FASTA package provides a comprehensive set of similarity searching programs##2##11##(2008-4#2)
The FASTA programs work with a wide variety of database formats##2##11##(2008-4#2)
The FASTA##4##2##(2008-4#4)
The FBB##2##2##(2008-11#2)
The FDA##3##2##(1992-9#1)(2008-5#1)(2008-8#1)
The FI method was##2##4##(2008-10#2)
The FI method##4##3##(2008-10#4)
The FI##6##2##(2008-10#6)
The FIA system with##2##4##(2008-10#2)
The FIA system##3##3##(2008-10#3)
The FIA##5##2##(2008-10#5)
The FM##2##2##(2008-2#1)(2008-3#1)
The FT-IR##2##2##(1994-6#1)(2008-10#1)
The FTIR spectrum of##2##4##(2008-3#1)(2008-5#1)
The FTIR##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
The Fabry-Perot##2##2##(2007-11#1)(2008-2#1)
The Family##4##2##(1994-2#1)(2008-4#1)(2008-9#1)(2013-7#1)
The Father of##2##3##(2008-10#1)(2010-8#1)
The Federal##3##2##(1996-12#1)(1997-1#1)(2008-6#1)
The First##8##2##(1996-12#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
The Flu-6plx assay##2##3##(2011-2#2)
The Food and Drug Administration (FDA)##2##6##(1996-5#1)(2010-6#1)
The Fourier transform##4##3##(1993-11#1)(2008-3#2)(2013-1#1)
The Fourier##6##2##(1993-11#1)(2008-11#1)(2008-3#3)(2013-1#1)
The Fourier-transform##2##2##(2008-3#2)
The Fourth##2##2##(1993-2#1)(1994-11#1)
The Free##2##2##(2008-11#1)(2012-12#1)
The French Language##2##3##(1995-2#1)(2007-6#1)
The French##6##2##(1991-11#1)(1995-2#1)(2007-6#2)(2008-5#1)(2012-3#1)
The Fresnel##4##2##(2007-12#1)(2008-3#3)
The Freundlich constants 1/n and##2##5##(2008-10#2)
The Future of Public Health##2##5##(1996-1#2)
The Future of##3##3##(1996-1#2)(2011-1#1)
The G##2##2##(1993-11#1)(1997-4#1)
The GAM##2##2##(1997-7#2)
The GC x GC##2##4##(2008-10#2)
The GC##3##2##(2008-10#3)
The GC/MS##2##2##(2008-10#2)
The GDS##3##2##(1994-6#1)(2006-10#2)
The GH##2##2##(2013-1#1)(2013-7#1)
The GH/IGF-1 Axis##2##3##(2008-3#1)(2010-8#1)
The GH/IGF-1##3##2##(2008-3#1)(2010-8#2)
The GIQE##2##2##(2008-2#2)
The GUS##2##2##(1997-2#1)(2008-9#1)
The GVI was##2##3##(2013-7#2)
The GVI##3##2##(2013-7#3)
The Gateway cloning method allows a gene to be cloned and subsequently transferred into any vector by in vitro site-specific##2##20##(2008-4#2)
The Gene Ontology##2##3##(2008-7#1)(2008-9#1)
The Gene##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
The General##3##2##(1993-12#1)(1994-1#1)(2008-2#1)
The Genetic Structure of##2##4##(2008-10#2)
The Genetics Society of Canada##2##5##(2008-10#2)
The Genetics##4##2##(2008-10#2)(2008-4#2)
The Georgia Information Network for Public Health Officials##2##8##(1996-1#2)
The Georgia##3##2##(1996-1#3)
The German##2##2##(2007-5#1)(2008-10#1)
The Gibbs conference on biothermodynamics##2##5##(1997-2#2)
The Gibbs##4##2##(1997-2#2)(2008-4#1)(2011-1#1)
The Global Orthopaedic Registry (GLORY) offers##2##6##(2011-2#2)
The Global Orthopaedic Registry (GLORY)##3##5##(2011-2#3)
The Global##8##2##(2008-2#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-8#1)
The Gompertz##5##2##(2008-1#1)(2008-10#3)(2010-8#1)
The Group##5##2##(1997-5#1)(2008-10#2)(2009-5#1)(2013-1#1)
The Gulf of##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
The H##2##2##(1991-6#1)(2012-2#1)
The H(2)O(2)##2##2##(2008-10#2)
The H-Wave(R) device##2##3##(2010-1#2)
The H-point standard addition method (HPSAM)##3##6##(2008-10#3)
The H-point##4##2##(2008-10#4)
The HAPC sheet##2##3##(2008-11#2)
The HC##2##2##(2008-10#2)
The HCB##2##2##(2008-10#2)
The HD##2##2##(1997-7#1)(2011-10#1)
The HDL cholesterol##2##3##(2007-7#1)(2008-3#1)
The HEART score##2##3##(2012-2#2)
The HERG##2##2##(1996-2#1)(2008-8#1)
The HF-HR-IMS##2##2##(2008-10#2)
The HI activity of##2##4##(1992-9#2)
The HI##3##2##(1992-9#3)
The HIV prevalence##2##3##(1990-6#1)(2009-7#1)
The HIV##6##2##(1990-6#1)(1993-11#1)(2009-7#2)(2011-2#1)(2012-12#1)
The HIV-1##2##2##(2011-3#1)(2013-1#1)
The HMK and HSK genes##2##5##(1993-12#2)
The HMK##3##2##(1993-12#3)
The HMO##2##2##(1992-1#1)(1994-12#1)
The HPI is##2##3##(1992-12#2)
The HPI##3##2##(1992-12#2)(1996-2#1)
The HPLC method##3##3##(2008-10#2)(2011-1#1)
The HPLC separation was##2##4##(1996-5#1)(2011-1#1)
The HPLC##9##2##(1990-8#1)(1996-5#3)(2008-10#3)(2011-1#2)
The HPLC-EC method##2##3##(2008-10#2)
The HS##2##2##(2008-10#1)(2008-9#1)
The HXC-26 gene##2##3##(1996-10#2)
The Hague##4##2##(1990-3#1)(1992-5#3)
The Hartmann##2##2##(2008-3#2)
The HbO-HA ELISA##2##3##(1990-12#2)
The Health Care Financing Administration (HCFA) has##3##7##(1992-2#1)(1992-3#1)(1996-2#1)
The Health Care Financing Administration (HCFA)##5##6##(1992-2#1)(1992-3#1)(1996-1#1)(1996-2#1)(1997-2#1)
The Health Care Financing Administration##6##5##(1992-2#2)(1992-3#1)(1996-1#1)(1996-2#1)(1997-2#1)
The Health Care Financing Administration's##2##5##(1996-1#1)(1996-2#1)
The Health Care Financing##8##4##(1992-2#2)(1992-3#1)(1996-1#2)(1996-2#2)(1997-2#1)
The Health Care##10##3##(1992-1#1)(1992-2#2)(1992-3#1)(1996-1#2)(1996-2#2)(1997-2#1)(2011-1#1)
The Health##20##2##(1991-2#1)(1992-1#1)(1992-2#3)(1992-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-11#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
The Hillsborough tragedy##3##3##(1991-11#1)(1992-2#2)
The Hispanic##2##2##(1994-1#1)(2010-8#1)
The Honey-Wilson##2##2##(2008-3#2)
The Hospital for Sick Children##2##5##(1992-3#1)(2008-11#1)
The Hospital for the Ruptured and Crippled##2##7##(2008-8#2)
The Hospital for##4##3##(1992-3#1)(2008-11#1)(2008-8#2)
The House of Representatives approved a##2##6##(1996-5#2)
The House of Representatives approved##3##5##(1995-6#1)(1996-5#2)
The House##7##2##(1995-6#3)(1996-5#4)
The Human Figure Drawing##2##4##(2008-7#2)
The Human Genome Project##4##4##(1994-9#1)(1995-6#1)(2007-7#1)(2008-5#1)
The Human Rights##2##3##(1995-12#1)(2008-11#1)
The Human##9##2##(1994-9#1)(1995-12#1)(1995-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#3)
The I##2##2##(1995-8#1)(2010-4#1)
The I(3)(-)##2##2##(2008-10#2)
The IBG System is a##2##5##(1994-6#2)
The IBG System##4##3##(1994-6#4)
The IC(50)##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
The IC50 for##4##3##(1991-5#1)(1992-6#1)(1994-11#1)(1996-12#1)
The IC50 values of##2##4##(1995-11#1)(2008-11#1)
The IC50##7##2##(1991-5#1)(1991-8#1)(1992-6#1)(1994-11#1)(1995-11#1)(1996-12#1)(2008-11#1)
The IC50s for##2##3##(1991-5#1)(2009-6#1)
The ICC of left and right CSA for within day and between days reliability in##2##15##(2010-12#2)
The ICC of##3##3##(2010-12#2)(2011-2#1)
The IFN##2##2##(1995-12#1)(2008-11#1)
The IIIA sites##2##3##(1993-11#2)
The IIP-MF and##2##3##(1993-5#2)
The IL-1-dependent proliferation of RPMI 1788##2##6##(1990-12#2)
The IL-10##2##2##(1994-8#1)(2011-1#1)
The IL-18 levels##2##3##(2013-1#2)
The IMG##2##2##(2008-3#2)
The IMS##2##2##(2008-10#2)
The IMT of both##2##4##(2011-1#2)
The IN##2##2##(2007-1#1)(2008-10#1)
The IR##4##2##(1996-5#1)(2008-10#2)(2008-7#1)
The ISO##2##2##(1990-11#1)(2013-1#1)
The ITFDE##2##2##(1993-12#2)
The ITS sequences##2##3##(2008-10#2)
The ITS##4##2##(2008-10#4)
The IgE##2##2##(1995-11#1)(2008-10#1)
The IgG##4##2##(1994-6#1)(1996-2#1)(2007-10#1)(2008-11#1)
The Ilizarov technique##2##3##(2007-11#1)(2009-3#1)
The Ilizarov##3##2##(2007-11#1)(2008-8#1)(2009-3#1)
The Impact of##4##3##(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
The Importance of##3##3##(2010-3#1)(2010-9#1)(2012-2#1)
The InSb radiometers##2##3##(2008-3#2)
The Independent##2##2##(1995-2#1)(2012-3#1)
The Indian##3##2##(1994-3#1)(2008-10#1)(2012-2#1)
The Influence of##5##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2012-2#1)
The Institute for##2##3##(1997-2#1)(2013-8#1)
The Institute of##2##3##(1996-1#1)(1996-4#1)
The Institute##6##2##(1996-1#1)(1996-4#1)(1997-2#1)(1997-3#1)(2013-1#1)(2013-8#1)
The Interface##2##2##(2009-9#1)(2012-12#1)
The International Classification of##3##4##(1991-9#1)(2007-12#1)(2012-12#1)
The International Federation of##2##4##(1995-3#1)(2007-4#1)
The International##18##2##(1991-6#1)(1991-9#1)(1995-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-5#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
The Internet as##3##3##(1997-4#1)(2009-5#1)(2013-1#1)
The Internet has##2##3##(2010-10#1)(2010-4#1)
The Internet is##4##3##(1994-3#1)(1996-2#1)(1997-3#1)(2008-7#1)
The Internet##12##2##(1994-3#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-4#1)(2013-1#1)
The Interuniversity Consortium##2##3##(2008-11#2)
The Italian##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
The JAK2 ( V617F )##2##5##(2009-8#2)
The JCVI##2##2##(2011-2#2)
The Japanese##2##2##(2007-12#1)(2012-1#1)
The Jewish##2##2##(1992-1#1)(1994-1#1)
The Johns Hopkins Health System##2##5##(1993-3#2)
The Johns Hopkins Hospital##2##4##(1993-3#1)(2008-3#1)
The Johns Hopkins##5##3##(1993-3#3)(1997-1#1)(2008-3#1)
The Joint Commission's##2##3##(1995-1#1)(2006-5#1)
The Joint##6##2##(1995-1#1)(1996-3#1)(2006-5#1)(2008-11#1)(2011-4#1)(2012-2#1)
The Journal of Cancer Survivorship##2##5##(2008-7#2)
The Journal of##3##3##(2008-7#2)(2009-8#1)
The Journal##4##2##(2008-7#2)(2009-8#1)(2011-4#1)
The Journey##2##2##(1994-2#1)(2008-7#1)
The Judd-Ofelt analysis was##2##4##(2008-2#2)
The K(M(B18C6)A) value##2##3##(2008-10#2)
The K(MLA)##2##2##(2008-10#2)
The K(ex) value##2##3##(2008-10#2)
The K(ex)##3##2##(2008-10#3)
The K(m)##2##2##(2008-10#1)(2011-3#1)
The Kd##2##2##(1994-5#1)(1995-11#1)
The Kefir extract##2##3##(2008-11#2)
The Kerr##2##2##(2007-12#2)
The Ki values for##3##4##(1992-3#1)(1992-6#1)(1992-8#1)
The Ki values##5##3##(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-11#1)
The Km and Vmax for CO2 were##2##7##(1997-6#2)
The Km and Vmax##3##4##(1994-5#1)(1997-6#2)
The Km for##2##3##(1992-6#1)(1993-8#1)
The Km value for##2##4##(1991-12#1)(1992-11#1)
The Km##9##2##(1991-12#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1997-6#2)(1997-8#1)
The L##2##2##(2008-10#2)
The LB##2##2##(2008-10#2)
The LC##2##2##(2007-12#1)(2008-10#1)
The LC-MS/MS method##2##3##(2008-10#1)(2011-3#1)
The LD 24##2##3##(2008-7#2)
The LDL cholesterol##2##3##(2007-7#1)(2008-3#1)
The LDL##4##2##(1991-2#1)(1994-11#1)(2007-7#1)(2008-3#1)
The LED##3##2##(2008-10#3)
The LFD was##2##3##(2008-10#2)
The LIF##2##2##(2008-2#1)(2008-3#1)
The LOD for##3##3##(2008-10#3)
The LOD of##3##3##(2008-10#3)
The LOD was found to be##2##6##(2008-10#2)
The LOD##12##2##(2008-10#12)
The LODs##2##2##(2008-10#1)(2010-5#1)
The Lee##2##2##(2007-7#1)(2008-2#1)
The Lenoir thesis##2##3##(2012-2#2)
The Log##2##2##(2008-3#2)
The Ly-49##2##2##(1995-2#2)
The M RNA##2##3##(2008-10#2)
The M##6##2##(2007-8#1)(2008-10#4)(2012-2#1)
The M(r) of##2##3##(1994-9#1)(2008-10#1)
The MC##3##2##(2007-11#1)(2008-10#1)(2013-7#1)
The MDA##2##2##(2008-10#1)(2013-8#1)
The MDI##2##2##(1996-1#2)
The MEI##3##2##(1992-2#3)
The MGED ontology##2##3##(2008-7#2)
The MH##2##2##(2008-9#1)(2010-4#1)
The MHV-RI##2##2##(1997-3#2)
The MIC values of##2##4##(2008-11#2)
The MIC##5##2##(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)
The MICs ranges of##2##4##(2008-5#2)
The MID2 gene##2##3##(1994-12#2)
The MP##3##2##(2008-10#2)(2008-9#1)
The MR findings##2##3##(2012-2#2)
The MR signal##2##3##(1994-8#2)
The MR##8##2##(1994-8#2)(1997-8#2)(2007-10#1)(2012-12#1)(2012-2#2)
The MRI findings##2##3##(1996-11#1)(2012-12#1)
The MRI was more##2##4##(2008-3#2)
The MRI was##3##3##(2007-11#1)(2008-3#2)
The MRI##11##2##(1996-11#1)(1996-6#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-3#3)(2010-6#1)(2012-12#1)(2013-1#1)
The MS##4##2##(1994-6#1)(2008-10#2)(2008-3#1)
The MSFA##2##2##(2008-10#2)
The MT##2##2##(2008-11#2)
The MTF##3##2##(2008-2#1)(2011-1#2)
The MVB##2##2##(2007-7#2)
The MW-OCAPP##3##2##(2008-3#3)
The Malcolm Baldrige National Quality Award##2##6##(1995-2#2)
The Manitoba Centre for Health Policy and Evaluation (MCHPE)##2##9##(1995-2#1)(1996-3#1)
The Mayo##2##2##(1992-11#1)(2009-4#1)
The Mean##2##2##(2008-1#1)(2008-12#1)
The Medical College of##2##4##(1991-8#1)(1993-12#1)
The Medical##6##2##(1991-8#1)(1993-12#1)(1994-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
The Medicare Current Beneficiary Survey (MCBS)##2##6##(1996-2#1)(1997-3#1)
The Medicare and Medicaid##2##4##(1992-12#2)
The Medicare##14##2##(1991-2#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-11#1)
The Methodist Hospital##2##3##(1991-1#1)(2010-3#1)
The Mexican##2##2##(2008-10#1)(2008-8#1)
The Michaelis-Menten constant##2##3##(2008-10#1)(2009-10#1)
The Michaelis-Menten##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
The Michigan##4##2##(1996-2#1)(1996-3#1)(2008-10#1)(2013-1#1)
The Middle East##2##3##(1995-3#2)
The Ministry##2##2##(2008-7#1)(2010-4#1)
The Misericordia##2##2##(1992-1#1)(1994-1#1)
The Missouri##2##2##(1995-12#1)(1997-5#1)
The Model##2##2##(2010-6#1)(2011-2#1)
The Modified##2##2##(2007-7#1)(2008-3#1)
The Molecular##2##2##(2008-10#1)(2008-4#1)
The Monte Carlo method##2##4##(2008-3#2)
The Monte Carlo##3##3##(2008-3#2)(2011-1#1)
The Montreal Protocol##2##3##(1996-1#2)
The Mueller matrix##2##3##(2008-3#2)
The Mw##2##2##(2012-2#2)
The N##4##2##(2008-10#3)(2008-3#1)
The N-acetyl-beta-D-hexosaminidase B of germinating##2##5##(1990-5#2)
The N-aryl-2-[[[5-[(dimethylamino)methyl]-2-##2##2##(1992-8#2)
The N-methyl-D-aspartate (NMDA)##2##3##(1994-8#1)(1996-2#1)
The N-terminal amino acid sequence of##2##6##(1990-11#1)(1991-12#1)
The N-terminal amino acid##3##4##(1990-11#1)(1991-12#1)(1997-6#1)
The N-terminal domain##2##3##(1990-5#1)(2008-9#1)
The N-terminal region of##2##4##(1992-6#1)(1994-6#1)
The N-terminal sequence of##2##4##(1991-10#1)(2008-10#1)
The N-terminal##16##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-6#1)(1994-6#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
The N-terminus##3##2##(1990-12#2)(1992-9#1)
The N175m##2##2##(1996-5#2)
The NA##2##2##(1994-3#1)(2008-7#1)
The NADH reductase##2##3##(2008-11#2)
The NADH##4##2##(1990-11#2)(2008-11#2)
The NAM9-1 mutation##2##3##(1995-8#2)
The NAM9-1##3##2##(1995-8#3)
The NAS##2##2##(2008-10#2)
The NCI Thesaurus is##2##4##(2008-7#2)
The NDI##2##2##(2012-3#2)
The NH2-terminal amino acid sequence##3##5##(1990-8#1)(1991-2#1)(1995-6#1)
The NH2-terminal##4##2##(1990-8#1)(1991-2#1)(1995-6#1)(1997-2#1)
The NH2-terminus##2##2##(1991-5#1)(2008-8#1)
The NHS##3##2##(1996-8#1)(2013-1#1)(2013-8#1)
The NIR##2##2##(2007-12#1)(2008-10#1)
The NIST##2##2##(1995-6#1)(2008-3#1)
The NMDA-R1##2##2##(1993-12#2)
The NMR assignments of the##2##5##(2009-7#2)
The NMR assignments of##3##4##(2009-7#3)
The NMR##9##2##(1992-3#1)(1993-1#1)(1993-8#1)(1994-3#1)(1996-5#1)(2008-10#1)(2009-7#3)
The NO and CO volume fractions##2##6##(2013-8#2)
The NO##4##2##(2008-3#1)(2008-7#1)(2013-8#2)
The NO(2)##2##2##(2008-10#2)
The NSCs cultured in##2##4##(2008-11#2)
The NSCs population cultured in##2##5##(2008-11#2)
The NSCs##4##2##(2008-11#4)
The NSSF##2##2##(2008-6#2)
The NTP has explored the use of genetically altered mouse models as adjuncts to##2##14##(2008-8#1)(2008-9#1)
The NTPDase3##2##2##(2008-4#2)
The Na(+)##3##2##(2008-10#3)
The National Association of Private Psychiatric Hospitals (NAPPH)##2##8##(1991-1#1)(1992-2#1)
The National Association of Private Psychiatric Hospitals##3##7##(1991-1#2)(1992-2#1)
The National Association of##4##4##(1991-1#2)(1992-2#1)(1996-5#1)
The National Cancer Institute##4##4##(1995-11#1)(2008-9#2)(2013-1#1)
The National Heart##2##3##(1992-12#1)(2013-1#1)
The National Institute of##3##4##(1992-8#1)(1996-6#1)(2008-2#1)
The National Institute##5##3##(1992-8#1)(1996-6#1)(2008-2#1)(2013-1#2)
The National##33##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2010-8#1)(2011-3#1)(2012-1#1)(2013-1#6)
The Nd##3##2##(1995-2#1)(2007-11#1)(2007-12#1)
The Netherlands##16##2##(1990-3#2)(1990-9#2)(1991-8#1)(1994-12#1)(1996-11#2)(1996-12#1)(1996-6#2)(1997-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
The Netherlands]##11##2##(1990-9#2)(1991-11#1)(1991-6#1)(1992-2#1)(1992-5#2)(1995-12#2)(1996-11#1)(1996-6#1)
The New York City##2##4##(2008-10#1)(2011-2#1)
The New York Supreme Court for##2##6##(1995-2#1)(1996-2#1)
The New York Supreme Court##3##5##(1995-2#1)(1995-6#1)(1996-2#1)
The New York##6##3##(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#1)(2011-2#1)
The New Zealand##5##3##(1992-1#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-8#1)
The New##14##2##(1992-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2011-2#1)
The Ni##2##2##(2008-10#2)
The NifA protein##2##3##(2008-9#2)
The Nobel Prize in##2##4##(2008-7#1)(2010-12#1)
The Nordic##2##2##(2011-4#2)
The North##2##2##(2008-10#1)(2010-5#1)
The Northern##2##2##(1997-2#1)(2009-12#1)
The Norwegian Government has##2##4##(1992-11#1)(1992-5#1)
The Norwegian study##2##3##(1991-9#2)
The Norwegian##15##2##(1990-11#1)(1991-9#2)(1992-11#1)(1992-5#1)(1993-3#1)(1995-6#1)(1996-11#1)(1997-6#2)(1997-8#2)(2007-10#1)(2009-10#1)(2012-3#1)
The Notch##2##2##(2007-12#1)(2010-3#1)
The Nuclear##2##2##(2008-10#1)(2009-12#1)
The Nucleus##2##2##(2008-9#1)(2012-2#1)
The Nurse##2##2##(2011-1#2)
The Nursing Diagnosis Accuracy Scale##2##5##(2013-1#2)
The Nursing##3##2##(1996-12#1)(2013-1#2)
The O-buffer##2##2##(2008-6#2)
The OH##2##2##(2007-12#1)(2008-2#1)
The OHA##2##2##(1992-6#2)
The OHS##3##2##(2012-12#3)
The OIE##3##2##(2011-2#3)
The OPO is based on periodically poled lithium niobate##2##9##(2007-12#1)(2008-3#1)
The OPO is##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
The OPO threshold##3##3##(2007-12#2)(2008-2#1)
The OPO##13##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#4)
The OR for##2##3##(2008-3#1)(2011-2#1)
The OR value for the##4##5##(2011-1#4)
The OR value for##5##4##(2011-1#5)
The OR value##6##3##(2011-1#6)
The OR##8##2##(2008-3#1)(2011-1#6)(2011-2#1)
The ORF is##2##3##(1994-12#1)(1997-3#1)
The ORF##5##2##(1994-12#1)(1995-8#1)(1997-3#1)(2008-10#2)
The ORFs##2##2##(1993-2#1)(1994-12#1)
The Ontario##2##2##(1992-3#1)(1995-2#1)
The Oregon Medicaid##3##3##(1992-2#2)(1992-9#1)
The Oregon##4##2##(1992-2#3)(1992-9#1)
The OsMADS7 and 8##3##4##(1997-8#3)
The Ottawa Hospital##2##3##(2007-12#1)(2013-1#1)
The Ottawa##4##2##(1995-12#1)(2007-12#1)(2008-11#1)(2013-1#1)
The Oxford##2##2##(1996-1#1)(2011-2#1)
The P##3##2##(2008-10#2)(2008-6#1)
The P(V) of the##2##4##(2008-11#2)
The P-450##2##2##(1993-8#1)(2008-11#1)
The P1##2##2##(1993-12#1)(2008-10#1)
The P2##2##2##(1995-11#1)(1995-8#1)
The P2Y(1) receptor##2##3##(2008-4#2)
The PAHs##2##2##(2008-10#2)
The PBD##2##2##(1992-12#2)
The PCA##5##2##(1996-5#1)(2008-10#3)(2011-1#1)
The PCCC##2##2##(2010-6#2)
The PCR products are then displayed on an appropriate gel and examined for yield and specificity##2##16##(2008-2#1)(2008-9#1)
The PCR products of##2##4##(1992-8#1)(2009-5#1)
The PCR products##6##3##(1992-8#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)
The PCR##14##2##(1991-5#1)(1992-8#1)(1993-3#1)(1995-6#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-12#1)
The PD nurse is##2##4##(2007-12#2)
The PD##5##2##(2007-12#3)(2008-10#1)(2011-2#1)
The PDA##2##2##(1994-3#1)(2008-12#1)
The PDL##2##2##(2008-11#1)(2013-1#1)
The PDSI##2##2##(2008-7#2)
The PEG hydrogel dural sealant##2##5##(2012-3#2)
The PI##5##2##(1992-6#1)(1996-2#1)(2008-10#1)(2008-2#1)(2009-3#1)
The PKC##3##2##(1992-9#1)(1993-3#1)(1995-11#1)
The PLS-1##3##2##(2008-10#3)
The PP and CP viruses were most##2##7##(2008-10#2)
The PP##3##2##(2008-10#2)(2008-11#1)
The PPI##2##2##(1991-1#1)(2008-7#1)
The PRL profile##2##3##(2008-7#2)
The PS##2##2##(2008-10#1)(2008-3#1)
The Pacific##4##2##(1993-3#1)(2008-1#1)(2012-12#2)
The Palau##3##2##(2008-1#3)
The Pavlik harness##2##3##(2007-8#2)
The Pb concentration in the##2##5##(1992-3#1)(2008-1#1)
The Pb concentration##3##3##(1992-3#2)(2008-1#1)
The Pb##4##2##(1992-3#2)(2008-1#1)(2008-10#1)
The Pennsylvania##2##2##(1992-1#1)(1995-12#1)
The Phazyme##2##2##(2012-2#2)
The Philippines is##2##3##(1990-6#1)(2011-2#1)
The Phytophthora##2##2##(2008-10#2)
The Pi-ta##2##2##(2008-10#2)
The Pi34 locus##2##3##(2008-10#2)
The Place##2##2##(1995-11#1)(2009-8#1)
The Plan##2##2##(1994-2#1)(2011-1#1)
The Plant Ontology Consortium##2##4##(2008-7#2)
The Plant##3##2##(2008-7#2)(2009-8#1)
The Plasmodium##2##2##(2012-2#1)(2012-3#1)
The Poisson-Boltzmann equation##2##3##(2009-5#1)(2013-1#1)
The Portuguese##2##2##(2012-1#2)
The Positive##2##2##(1995-8#1)(2013-8#1)
The Proteomics Standards Initiative (PSI) aims to define community standards for data representation in proteomics and to facilitate data comparison##2##20##(2008-7#2)
The Public Health##2##3##(1995-12#1)(1996-2#1)
The Publisher apologizes for any inconvenience this may cause##5##9##(2008-10#1)(2008-11#4)
The Publisher regrets that this article is an accidental duplication of an article that has already been published in##4##19##(2008-11#3)(2008-7#1)
The Publisher regrets that this article is an accidental duplication of an article that has already been published##5##18##(2008-11#3)(2008-7#1)(2012-3#1)
The Publisher regrets that this article##6##6##(2008-11#4)(2008-7#1)(2012-3#1)
The Publisher##11##2##(2008-10#1)(2008-11#8)(2008-7#1)(2012-3#1)
The QOL Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD)##2##11##(1994-12#1)(1995-4#1)
The QOL##3##2##(1994-12#2)(1995-4#1)
The QTL on LG2##2##4##(2008-10#2)
The QTL on##5##3##(2008-10#5)
The QTL##6##2##(2008-10#5)(2012-3#1)
The QTc##2##2##(2011-1#2)
The QWB##2##2##(1996-7#2)
The Quality##2##2##(1996-12#1)(2010-9#1)
The Queen Elizabeth Hospital##3##4##(1994-3#3)
The QuickVue##2##2##(2011-2#2)
The R##19##2##(2008-10#19)
The RB##3##2##(1992-8#1)(1996-2#1)(2013-1#1)
The RBC##3##2##(2008-3#1)(2013-1#2)
The RDS##2##2##(2009-9#2)
The RH##3##2##(1994-12#2)(2007-11#1)
The RI##2##2##(2008-10#2)
The RILs were##2##3##(2008-10#2)
The RNA genome of##2##4##(2008-9#1)(2013-1#1)
The RNA##10##2##(1990-7#1)(1992-3#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2013-1#1)
The RNN is trained##2##4##(2010-8#2)
The RPL17B##2##2##(1995-6#2)
The RRS##2##2##(2008-10#2)
The RSD is##2##3##(2008-10#2)
The RSD of the##2##4##(2008-10#2)
The RSD was 1##2##4##(2008-10#2)
The RSD was##4##3##(2008-10#3)(2013-8#1)
The RSD##9##2##(2008-10#8)(2013-8#1)
The RT-PCR##3##2##(2008-10#1)(2008-5#2)
The RXR##2##2##(1993-3#2)
The RabMabs##2##2##(2012-12#2)
The Rainbow Families Scale (RFS)##2##5##(2012-2#2)
The Raman spectra of##2##4##(1996-2#1)(2008-10#1)
The Raman spectra##4##3##(1996-2#1)(2007-12#1)(2008-10#2)
The Raman##10##2##(1996-2#2)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#1)(2009-12#1)
The Red##2##2##(2007-12#1)(2009-2#1)
The Regional##2##2##(1994-3#1)(2012-12#1)
The Relationship Between##2##3##(2008-10#1)(2013-8#1)
The Relationship between##2##3##(1996-6#1)(2012-3#1)
The Relationship##5##2##(1996-6#1)(2008-10#2)(2012-3#1)(2013-8#1)
The Relative##2##2##(2008-5#1)(2012-2#1)
The Republic of##2##3##(2008-1#2)
The Resilience Scale##2##3##(2011-1#2)
The Ritz-Carlton Hotel Company (Part##2##5##(1994-2#1)(1994-3#1)
The Ritz-Carlton Hotel Company won the Malcolm##2##7##(1994-2#1)(1994-3#1)
The Ritz-Carlton Hotel Company##4##4##(1994-2#2)(1994-3#2)
The Role of##19##3##(1994-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#2)
The Royal##3##2##(1992-1#1)(1997-8#1)(2008-5#1)
The S##9##2##(1995-3#1)(1997-7#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
The S1##2##2##(1995-6#1)(2008-10#1)
The SBCH##2##2##(2008-2#2)
The SBS##2##2##(2008-2#2)
The SEM##3##2##(2008-10#3)
The SERS of HA##2##4##(2013-8#2)
The SERS of##3##3##(2013-8#3)
The SERS##5##2##(2008-2#1)(2013-1#1)(2013-8#3)
The SGA##2##2##(2013-1#1)(2013-8#1)
The SHG##2##2##(2007-11#1)(2007-12#1)
The SI system was##2##4##(2008-10#2)
The SI##4##2##(2008-10#4)
The SIA##2##2##(2008-10#2)
The SIP##2##2##(2008-3#2)
The SIR was##2##3##(1993-9#2)
The SIR##3##2##(1993-9#3)
The SLM##2##2##(2007-12#1)(2008-10#1)
The SNP module##2##3##(2012-3#2)
The SNP##3##2##(2012-12#1)(2012-3#2)
The SO(2)##2##2##(2008-10#1)(2011-1#1)
The SPE##3##2##(2008-10#3)
The SPME method##2##3##(2008-10#2)
The SPR sensor##2##3##(2008-10#2)
The SPR##4##2##(2008-10#4)
The SRM##2##2##(2008-10#2)
The SSU##2##2##(2013-1#2)
The SSXII##2##2##(2011-1#2)
The STLCV##2##2##(2008-10#2)
The STS markers##3##3##(2008-10#3)
The SWS##2##2##(2007-12#2)
The Saccharomyces cerevisiae##2##3##(1990-5#1)(1995-8#1)
The San##4##2##(1990-9#1)(1993-12#1)(1996-4#1)(2013-7#1)
The Scandinavian##3##2##(2010-3#1)(2013-1#2)
The Schiff##2##2##(1991-5#1)(2008-10#1)
The School of Nursing at the University of##2##8##(2008-12#1)(2010-3#1)
The School of Nursing##4##4##(2008-11#2)(2008-12#1)(2010-3#1)
The Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##2##6##(2008-2#1)(2008-3#1)
The Second##2##2##(1994-11#1)(2008-7#1)
The Sellmeier##3##2##(2008-2#3)
The Senate##2##2##(1996-5#1)(1997-2#1)
The Severe Chronic Neutropenia International Registry##2##6##(2008-7#2)
The Short-Form 36##2##3##(2010-10#1)(2013-1#1)
The Sisters##3##2##(1991-2#2)(1994-2#1)
The Society of##2##3##(2008-5#1)(2011-1#1)
The Southeast Florida AIDS Information Network##2##6##(1995-1#2)
The Southern##2##2##(1995-11#1)(2008-9#1)
The Spanish##2##2##(1994-12#1)(2008-10#1)
The Spearman##2##2##(2008-7#2)
The State##4##2##(1991-3#1)(1996-5#1)(1997-5#1)(2010-12#1)
The Stern-Volmer##2##2##(2008-10#2)
The Stokes parameters of the incident beam are determined by Fourier analysis of the space-variant intensity transmitted through the grating##2##20##(2007-11#1)(2007-12#1)
The Stokes##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
The Study##2##2##(1991-2#1)(2011-2#1)
The Subjective Exercise Experiences Scale##2##5##(2010-6#2)
The Support Protocol##2##3##(2008-4#2)
The Support##3##2##(2008-4#2)(2009-9#1)
The Supreme Court of##2##4##(1991-7#1)(1993-9#1)
The Supreme Court##5##3##(1991-7#1)(1993-9#1)(1994-2#2)(1997-5#1)
The T##11##2##(1993-1#1)(1993-8#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
The TALF isolates##2##3##(2008-10#2)
The TCD-MCA##2##2##(2008-7#2)
The TEM##2##2##(2009-7#1)(2009-9#1)
The TFGS##2##2##(2013-1#2)
The TG##3##2##(2008-10#1)(2009-12#2)
The TGF-beta##2##2##(1990-8#1)(2008-9#1)
The TGF-beta1/SMAD signaling pathway##2##4##(2011-2#2)
The TNF##2##2##(1991-6#1)(1994-2#1)
The TPLO##2##2##(2012-3#2)
The TRA##2##2##(2011-1#1)(2011-2#1)
The TSPO##2##2##(2012-2#2)
The Tca DNA polymerase##2##4##(1997-4#2)
The Theory of##2##3##(1993-3#1)(2011-1#1)
The Third##2##2##(1991-12#1)(1994-11#1)
The Tm##2##2##(2007-11#1)(2007-12#1)
The Toronto##2##2##(1993-12#1)(2008-6#1)
The Truth about Hospital Formularies##2##5##(2009-9#2)
The Trx##2##2##(1991-6#1)(2009-3#1)
The U##17##2##(1992-12#1)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
The UK has##2##3##(1990-6#1)(2008-11#1)
The UK##3##2##(1990-6#1)(2008-11#2)
The UKCC Commission for Nursing and Midwifery Education##2##8##(2008-11#2)
The UMLS##2##2##(2008-7#2)
The UN##2##2##(1990-2#1)(1994-9#1)
The US##5##2##(1992-5#1)(2008-3#1)(2010-1#1)(2010-7#1)(2012-2#1)
The UV absorption##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
The UV##6##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-5#1)
The UV-vis##3##2##(2008-10#1)(2008-6#2)
The UV-visible##2##2##(1996-2#1)(2008-3#1)
The UVA protection##2##3##(2008-5#2)
The United Kingdom Central Council##2##5##(2008-11#2)
The United Kingdom##3##3##(1995-3#1)(2008-11#2)
The United States has##2##4##(1995-2#1)(2009-3#1)
The United States##7##3##(1995-2#1)(1996-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-9#1)
The United##13##2##(1993-12#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-9#1)(2012-3#1)
The University of##9##3##(1991-1#1)(1992-1#1)(1994-2#2)(1997-2#1)(2008-11#3)(2008-5#1)
The University##10##2##(1991-1#1)(1992-1#1)(1994-2#2)(1997-2#2)(2008-11#3)(2008-5#1)
The Use of##4##3##(2008-10#2)(2010-6#1)(2013-1#1)
The V(c)##2##2##(2008-10#2)
The VAS##2##2##(1996-3#1)(2012-1#1)
The VCG##2##2##(2008-10#1)(2010-8#1)
The VI##2##2##(2008-10#2)
The VLDL receptor##2##3##(1995-6#2)
The VLDL##3##2##(1995-6#2)(2007-7#1)
The Veterans##2##2##(1991-12#2)
The WHO##9##2##(1993-3#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)(2013-7#1)
The WHOQOL-BREF##2##2##(2011-2#2)
The WRAP##5##2##(2008-11#5)
The Weibull distribution##2##3##(2008-10#2)
The Weibull model##2##3##(2008-10#1)(2011-2#1)
The Weibull##5##2##(2008-10#4)(2011-2#1)
The Wickbold decomposition method##2##4##(2008-10#2)
The Wiener##2##2##(2008-3#2)
The Working Group##2##3##(1993-5#1)(1997-5#1)
The World Anti-Doping##2##3##(2010-7#2)
The World Health Organization (WHO)##3##5##(1995-3#1)(2011-1#1)(2013-1#1)
The World Health Organization##7##4##(1993-11#1)(1995-3#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#1)
The World Health##8##3##(1993-11#1)(1995-3#1)(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
The World##16##2##(1993-11#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-7#2)(2009-8#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
The X##3##2##(2008-10#3)
The X-linked##2##2##(2008-11#1)(2008-12#1)
The X-ray crystal##2##3##(1992-8#1)(1995-3#1)
The X-ray structure##2##3##(1995-5#1)(1997-7#1)
The X-ray##6##2##(1992-8#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-11#1)(2013-8#1)
The XRD##2##2##(2012-2#1)(2013-8#1)
The YAP+##2##2##(2008-9#2)
The [(triisopropylsilyl)oxy]methyl (TOM) group is a useful protecting group for the 2'-OH of ribonucleosides to be used for oligoribonucleotide synthesis by the phosphoramidite method##2##24##(2008-4#2)
The [Ca2+]i##2##2##(1994-5#1)(1996-2#1)
The [SiO(2)]/[Al(2)O(3)] ratio##2##3##(2008-10#2)
The aa sequence of##2##4##(1990-11#1)(1993-9#1)
The aa##3##2##(1990-11#1)(1993-9#1)(2008-10#1)
The abdominal##6##2##(1991-12#1)(1991-2#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
The aberration##3##2##(2008-3#3)
The abilities##2##2##(2008-6#1)(2009-8#1)
The ability of M##2##4##(2008-10#1)(2010-10#1)
The ability of a##2##4##(2008-5#1)(2012-12#1)
The ability of the new##3##5##(2008-10#1)(2008-3#1)(2009-5#1)
The ability of the##24##4##(1991-2#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2009-5#1)(2010-11#1)(2012-3#1)
The ability of these##2##4##(2008-10#1)(2008-6#1)
The ability of##87##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-2#1)(1997-3#1)(2007-11#2)(2007-2#1)(2008-10#26)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
The ability to construct##2##4##(2008-10#1)(2008-4#1)
The ability to create and##2##5##(2008-11#1)(2008-7#1)
The ability to detect##4##4##(1992-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
The ability to discriminate##2##4##(2008-9#1)(2009-12#1)
The ability to identify##4##4##(2008-10#2)(2009-3#1)(2012-12#1)
The ability to predict##2##4##(2007-12#1)(2008-10#1)
The ability to produce##3##4##(1994-2#1)(1996-3#1)(2008-10#1)
The ability to rapidly##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
The ability to##77##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2010-1#2)(2010-6#3)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#1)
The ability##166##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#39)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)
The abnormal##2##2##(1997-2#1)(2010-8#1)
The above data##2##3##(2008-6#1)(2008-7#1)
The above factors##2##3##(2008-12#1)(2012-3#1)
The above results suggest that##2##5##(1994-6#1)(2008-9#1)
The above results##8##3##(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)(2013-1#2)
The above##28##2##(1990-5#1)(1993-3#1)(1994-6#1)(1996-8#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-3#1)(2013-1#2)
The above-mentioned##4##2##(2008-10#1)(2009-11#1)(2009-6#1)(2011-3#1)
The absence of a##5##4##(1996-5#1)(1997-4#1)(2008-8#1)(2009-10#1)(2010-4#1)
The absence of normal##2##4##(1994-6#1)(2008-6#1)
The absence of the##3##4##(2008-3#1)(2008-9#1)(2009-6#1)
The absence of##31##3##(1991-1#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
The absolute EC50/IC50##2##3##(2012-2#2)
The absolute configuration of the##2##5##(1992-8#1)(1995-3#1)
The absolute configuration##3##3##(1992-8#1)(1995-3#1)(2008-11#1)
The absolute heart##2##3##(2008-9#2)
The absolute liver weight of 100 mg/kg females was##2##9##(2008-9#2)
The absolute liver##3##3##(2008-9#3)
The absolute stereochemistry of##2##4##(1992-8#1)(2010-2#1)
The absolute values of##2##4##(2008-8#2)
The absolute##26##2##(1992-8#2)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#7)(2010-2#1)(2012-2#2)(2013-1#1)
The absorbance at##3##3##(2008-10#3)
The absorbance intensity was##2##4##(2008-10#2)
The absorbance of the##13##4##(2008-10#13)
The absorbance of##14##3##(2008-10#14)
The absorbance##24##2##(2008-10#23)(2008-4#1)
The absorption intensity of the##2##5##(2008-10#1)(2009-11#1)
The absorption maxima##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
The absorption occurred in the postflame region##2##7##(2008-2#1)(2008-3#1)
The absorption of##2##3##(2008-1#1)(2011-3#1)
The absorption properties of##2##4##(2008-10#1)(2008-3#1)
The absorption spectra of##4##4##(1992-8#1)(1994-11#1)(2008-10#1)(2008-3#1)
The absorption spectra were##2##4##(2008-10#1)(2008-3#1)
The absorption spectra##7##3##(1992-8#1)(1994-11#1)(2008-10#2)(2008-3#2)(2009-9#1)
The absorption spectrum##3##3##(1993-11#1)(2008-2#1)(2008-3#1)
The absorption##30##2##(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#6)(2009-11#1)(2009-9#1)(2011-3#1)
The abstract is##2##3##(2009-4#2)
The abundance and diversity of##2##5##(2008-10#1)(2008-5#1)
The abundance and##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
The abundance of##7##3##(1990-5#1)(1990-8#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-11#1)
The abundance##11##2##(1990-5#1)(1990-8#1)(1995-2#1)(2008-10#3)(2008-5#2)(2009-10#1)(2010-11#1)(2011-2#1)
The academic##2##2##(1992-2#1)(2012-1#1)
The accelerated##2##2##(1991-3#1)(2008-7#1)
The acceleration##3##2##(1994-9#1)(2008-2#1)(2013-1#1)
The acceptability##2##2##(1993-2#1)(2009-11#1)
The acceptance of##2##3##(2007-12#1)(2008-10#1)
The acceptance##3##2##(2007-10#1)(2007-12#1)(2008-10#1)
The access##3##2##(1994-1#1)(1995-12#1)(2013-1#1)
The accessory##5##2##(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
The accompanying paper##2##3##(1995-11#1)(2008-4#1)
The accompanying##3##2##(1992-2#1)(1995-11#1)(2008-4#1)
The accumulated evidence##2##3##(1995-5#1)(2008-6#1)
The accumulated##4##2##(1995-5#1)(2008-10#1)(2008-6#1)(2010-9#1)
The accumulation of##15##3##(1991-5#1)(1994-12#1)(1995-11#1)(1997-7#2)(2007-2#1)(2008-10#5)(2008-11#2)(2008-9#1)(2013-8#1)
The accumulation##18##2##(1991-5#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-7#2)(2007-2#1)(2008-10#6)(2008-11#2)(2008-9#1)(2013-8#1)
The accumulation-export trade-off##2##3##(2008-8#2)
The accuracy and precision are##3##5##(2008-10#2)(2008-3#1)
The accuracy and precision of the method##2##7##(1990-8#1)(2008-10#1)
The accuracy and precision of the##5##6##(1990-8#1)(2008-10#3)(2008-2#1)
The accuracy and precision of##6##5##(1990-8#1)(2008-10#4)(2008-2#1)
The accuracy and precision##10##4##(1990-8#1)(2008-10#7)(2008-2#1)(2008-3#1)
The accuracy and the##2##4##(2008-10#1)(2008-2#1)
The accuracy and##16##3##(1990-8#1)(1997-7#1)(2008-10#10)(2008-2#2)(2008-3#1)(2009-8#1)
The accuracy has##2##3##(2008-10#1)(2008-2#1)
The accuracy is##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
The accuracy of both##2##4##(2008-10#1)(2008-3#1)
The accuracy of our##2##4##(2007-11#1)(2008-3#1)
The accuracy of procedure was confirmed by##2##7##(2008-10#2)
The accuracy of the developed method was sufficient and evaluated by the analysis of##2##14##(2008-10#2)
The accuracy of the developed method was##3##7##(2008-10#3)
The accuracy of the developed procedure was##2##7##(2008-10#2)
The accuracy of the developed procedure##3##6##(2008-10#3)
The accuracy of the developed##10##5##(2008-10#10)
The accuracy of the method is##2##6##(2008-10#2)
The accuracy of the method was demonstrated by##2##8##(2008-10#2)
The accuracy of the method was evaluated##2##7##(2008-10#2)
The accuracy of the method was tested##2##7##(2008-10#2)
The accuracy of the method was##11##6##(2008-10#11)
The accuracy of the method##14##5##(2008-10#14)
The accuracy of the methods was##2##6##(2008-10#2)
The accuracy of the overall##2##5##(2008-10#2)
The accuracy of the proposed method was evaluated by##3##9##(2008-10#3)
The accuracy of the proposed method was##4##7##(2008-10#4)
The accuracy of the proposed method##5##6##(2008-10#5)
The accuracy of the proposed##6##5##(2008-10#6)
The accuracy of the##61##4##(1996-6#1)(2007-11#1)(2008-10#42)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2009-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
The accuracy of this diagnosis has been underexplored in the literature##2##11##(2013-1#2)
The accuracy of this##4##4##(1994-8#1)(2008-6#1)(2013-1#2)
The accuracy of##88##3##(1994-3#1)(1994-8#1)(1996-6#1)(2007-11#2)(2008-10#48)(2008-2#4)(2008-3#13)(2008-5#1)(2008-6#4)(2009-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
The accuracy was assessed through recovery experiments of##2##8##(2008-10#2)
The accuracy was assessed through recovery experiments##4##7##(2008-10#4)
The accuracy was assessed##6##4##(2008-10#6)
The accuracy was checked for arsenic determination in##2##8##(2008-10#2)
The accuracy was checked for##3##5##(2008-10#3)
The accuracy was checked##4##4##(2008-10#4)
The accuracy was confirmed by analysis of##3##7##(2008-10#3)
The accuracy was measured##2##4##(2008-2#2)
The accuracy was##20##3##(1997-8#1)(2008-10#15)(2008-2#2)(2008-7#1)(2013-8#1)
The accuracy##139##2##(1990-8#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#80)(2008-2#10)(2008-3#17)(2008-5#1)(2008-6#4)(2008-7#1)(2009-11#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
The accurate diagnosis##3##3##(1994-1#1)(2007-8#1)(2012-3#1)
The accurate##9##2##(1994-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-3#1)
The achieved detection limits were##2##5##(2008-10#1)(2011-2#1)
The achieved limits of detection##2##5##(2008-10#2)
The achieved results##2##3##(2008-10#2)
The achieved##11##2##(2007-10#1)(2008-10#9)(2011-2#1)
The achievement of##3##3##(1995-8#1)(2008-5#1)(2009-7#1)
The achievements of##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
The acid dissociation##2##3##(1990-5#1)(2008-10#1)
The acid##7##2##(1990-5#1)(1996-3#2)(1997-4#1)(2008-10#3)
The acid-base##4##2##(2008-10#4)
The acidic protease##2##3##(1993-12#2)
The acidic##7##2##(1990-7#1)(1993-12#2)(1994-5#1)(1995-6#1)(1997-2#1)(2008-10#1)
The acidity##2##2##(2008-10#2)
The acids##2##2##(2008-10#2)
The acoustic##5##2##(1996-5#1)(2007-7#1)(2009-2#1)(2013-7#2)
The acoustically##2##2##(2008-3#2)
The acquired##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
The acquisition of##4##3##(1992-9#1)(2008-12#1)(2008-7#1)(2008-9#1)
The acrosome is##2##3##(2008-7#1)(2012-2#1)
The acrosome##3##2##(2008-7#2)(2012-2#1)
The actin filaments##2##3##(2008-11#2)
The actin##4##2##(2008-11#3)(2009-12#1)
The action of##13##3##(1991-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-12#1)(2011-2#1)(2012-2#1)
The action##15##2##(1991-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#1)(2012-2#1)
The actions of##5##3##(1991-1#1)(1991-6#1)(2008-1#1)(2008-4#1)(2010-5#1)
The actions##6##2##(1991-1#1)(1991-6#1)(2008-1#1)(2008-4#1)(2010-5#1)(2013-1#1)
The activated##6##2##(1993-8#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-4#1)(2013-8#1)
The activating effect##2##3##(1990-5#2)
The activation and##2##3##(2008-4#1)(2008-9#1)
The activation energy of the##2##5##(1991-5#1)(2007-11#1)
The activation energy##5##3##(1991-5#1)(2007-11#1)(2008-10#2)(2009-7#1)
The activation of the##2##4##(1994-6#1)(2010-7#1)
The activation of##16##3##(1990-7#1)(1992-6#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-11#3)(2008-7#2)(2010-7#1)(2012-12#1)(2013-7#1)
The activation parameters and##2##4##(1996-2#1)(1996-7#1)
The activation was##2##3##(2008-5#1)(2008-7#1)
The activation##31##2##(1990-7#1)(1991-5#1)(1992-6#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-6#1)(2009-7#1)(2010-7#1)(2012-12#1)(2013-7#1)
The active component of##2##4##(1995-12#1)(2008-11#1)
The active metabolite of vitamin D##2##6##(1992-1#1)(1995-2#1)
The active site of##3##4##(1992-4#1)(1995-5#1)(1995-8#1)
The active site##4##3##(1992-4#1)(1995-5#1)(1995-8#1)(2008-4#1)
The active substance##2##3##(1994-2#1)(2008-11#1)
The active##28##2##(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-9#1)
The activities documented in this case study arose as a result of a decision by hospital administration that it would be more cost effective to provide services with in-house departments rather than through outside vendors##2##35##(1994-1#2)
The activities of these##2##4##(2008-10#1)(2008-11#1)
The activities of##12##3##(1994-3#1)(1994-5#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
The activities##16##2##(1990-8#1)(1994-1#2)(1994-3#1)(1994-5#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-5#1)(2011-2#2)(2013-1#1)
The activity of a##2##4##(1990-5#1)(2013-1#1)
The activity of the##17##4##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#1)(1992-6#2)(1993-8#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2012-1#1)
The activity of these enzymes##2##5##(2008-10#1)(2008-11#1)
The activity of this##3##4##(1993-8#1)(1997-3#1)(2008-8#1)
The activity of##50##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-5#2)(2008-8#2)(2009-8#1)(2012-1#1)(2013-1#2)
The activity to##2##3##(1992-8#1)(2008-10#1)
The activity was##3##3##(1990-7#1)(1991-2#1)(2008-10#1)
The activity##61##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#3)(1991-12#2)(1991-2#2)(1991-5#2)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#1)(2012-1#1)(2013-1#2)
The actual##9##2##(1991-2#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
The actuarial overall survival##2##4##(1991-8#1)(1994-12#1)
The actuarial patient##2##3##(1992-5#1)(2008-1#1)
The actuarial survival rate##2##4##(1991-6#1)(2007-8#1)
The actuarial##7##2##(1991-6#1)(1991-8#1)(1992-5#1)(1994-12#1)(2007-8#2)(2008-1#1)
The acute##11##2##(1992-11#1)(1994-12#1)(1995-3#1)(1996-9#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-1#1)(2010-2#1)(2010-4#1)
The acyl##2##2##(1990-5#1)(2007-11#1)
The adaptation##2##2##(2008-10#1)(2008-3#1)
The adapted##2##2##(2008-11#1)(2008-12#1)
The adaptive remodeling##2##3##(2007-11#2)
The adaptive##6##2##(1997-2#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-8#1)
The added value of Catholic health care##2##7##(1993-12#1)(1995-2#1)
The added value of##3##4##(1993-12#1)(1995-2#1)(2007-4#1)
The added##4##2##(1993-12#1)(1995-2#1)(2007-4#1)(2008-10#1)
The addition of 0##2##4##(2008-10#2)
The addition of a##11##4##(1993-1#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-4#1)
The addition of either##2##4##(1995-6#1)(2008-10#1)
The addition of flaxseed flour##2##5##(2010-4#2)
The addition of small##2##4##(1994-2#1)(2008-10#1)
The addition of sodium##2##4##(2008-10#1)(2011-2#1)
The addition of the signal sequence##2##6##(2008-11#2)
The addition of the##8##4##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-4#1)
The addition of##91##3##(1990-9#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-4#7)(2011-1#2)(2011-2#5)(2012-2#2)(2013-1#4)
The addition##92##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-4#7)(2011-1#2)(2011-2#5)(2012-2#2)(2013-1#4)
The additional##13##2##(1993-8#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2010-6#1)(2012-2#1)
The address is##2##3##(1996-8#2)
The adenosine##2##2##(1997-1#1)(2010-1#1)
The adenovirus##2##2##(1997-7#1)(2010-1#1)
The adenylyl cyclase##3##3##(1992-3#1)(1995-11#1)(2008-9#1)
The adequate##2##2##(2008-10#1)(2011-2#1)
The adhesion of##3##3##(1997-7#1)(2009-7#1)(2013-1#1)
The adhesion##4##2##(1994-9#1)(1997-7#1)(2009-7#1)(2013-1#1)
The adhesive##4##2##(1994-9#1)(2008-11#1)(2008-5#1)(2010-4#1)
The adjusted average per capita cost (AAPCC)##2##7##(1991-3#1)(1993-3#1)
The adjusted odds ratios##2##4##(1993-9#1)(2008-11#1)
The adjusted odds##3##3##(1993-9#1)(2008-11#1)(2008-6#1)
The adjusted relative risk of##2##5##(2008-6#2)
The adjusted##12##2##(1991-3#1)(1991-6#1)(1993-3#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-6#3)(2010-12#1)(2010-8#1)(2012-12#1)
The adjustment##4##2##(1992-12#1)(1997-7#1)(2010-7#1)(2013-8#1)
The administration of the##4##4##(1996-12#1)(1997-7#1)(2008-7#2)
The administration of##19##3##(1990-6#1)(1991-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2011-2#1)(2012-2#1)(2013-8#1)
The administration##22##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2011-2#2)(2012-2#1)(2013-8#1)
The administrative##2##2##(1993-2#1)(2008-11#1)
The adoption of##2##3##(2008-1#1)(2011-2#1)
The adoption##3##2##(1991-12#1)(2008-1#1)(2011-2#1)
The adrenal##2##2##(1990-7#1)(1992-3#1)
The adsorbed complex##2##3##(2008-10#2)
The adsorbed complexes##2##3##(2008-10#2)
The adsorbed##9##2##(1990-8#1)(2008-10#8)
The adsorbents##2##2##(1997-2#1)(2008-10#1)
The adsorption and##2##3##(2008-10#2)
The adsorption behavior of##3##4##(2008-10#3)
The adsorption capacity of the##2##5##(2008-10#2)
The adsorption capacity of##4##4##(2008-10#4)
The adsorption mechanism of the##2##5##(2008-10#1)(2011-2#1)
The adsorption of Cu(II) and##2##5##(2008-10#1)(2013-1#1)
The adsorption of heavy metal ions##2##6##(2008-10#2)
The adsorption of heavy metal##3##5##(2008-10#2)(2013-1#1)
The adsorption of vanadium##2##4##(2008-10#2)
The adsorption of##21##3##(2008-10#17)(2008-3#2)(2013-1#2)
The adsorption##42##2##(1992-5#1)(2008-10#34)(2008-3#2)(2011-2#2)(2013-1#2)(2013-8#1)
The adsorptive##5##2##(2008-10#5)
The adult##3##2##(1996-12#1)(2009-4#1)(2012-12#1)
The advanced##3##2##(1991-1#1)(2008-10#1)(2008-7#1)
The advancement of##2##3##(2010-6#2)
The advances in the##2##4##(2012-2#1)(2013-8#1)
The advances in##4##3##(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
The advantage of the##4##4##(2008-10#1)(2008-4#1)(2008-8#1)(2012-1#1)
The advantage of this method is that##3##7##(2008-10#2)(2008-3#1)
The advantage of this technique compared with##2##7##(2008-2#1)(2008-3#1)
The advantage of this##7##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)
The advantage of using##2##4##(2008-10#1)(2012-12#1)
The advantage of##23##3##(1995-1#1)(1997-7#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)
The advantage##24##2##(1995-1#1)(1997-7#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)
The advantages and disadvantages of##8##5##(1997-2#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-7#1)(2010-5#1)
The advantages and drawbacks of##3##5##(2008-10#2)(2012-12#1)
The advantages and drawbacks##4##4##(2008-10#2)(2009-12#1)(2012-12#1)
The advantages and limitations of##2##5##(2008-10#2)
The advantages and##15##3##(1997-2#1)(2007-10#1)(2007-8#2)(2008-10#5)(2008-9#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)
The advantages of a##2##4##(2008-3#2)
The advantages of the method are##2##6##(1990-11#1)(2007-11#1)
The advantages of the proposed##2##5##(2008-10#1)(2008-3#1)
The advantages of the##9##4##(1990-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
The advantages of these##2##4##(1995-1#1)(2007-12#1)
The advantages of this amperometric detector are##2##7##(2008-10#2)
The advantages of this method are##2##6##(1997-2#1)(2008-3#1)
The advantages of this method##4##5##(1990-7#1)(1994-8#1)(1997-2#1)(2008-3#1)
The advantages of this##13##4##(1990-7#1)(1991-6#1)(1994-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2013-1#1)
The advantages of using##3##4##(2008-10#3)
The advantages of##34##3##(1990-11#1)(1990-7#1)(1991-6#1)(1994-8#1)(1995-1#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2010-6#1)(2013-1#1)
The advantages##54##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-6#1)(1994-8#1)(1995-1#1)(1997-2#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#19)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-5#2)(2010-6#1)(2012-12#1)(2013-1#1)
The advent of the##3##4##(1994-12#1)(2008-10#1)(2010-12#1)
The advent of##21##3##(1994-12#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
The advent##22##2##(1994-12#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
The adverse effect of##3##4##(2008-10#1)(2008-11#2)
The adverse effects of##2##4##(2011-2#1)(2013-1#1)
The adverse effects##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
The adverse##6##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)
The advertisement call##2##3##(2013-7#2)
The aerosol optical##2##3##(2008-2#1)(2008-3#1)
The aerosol##6##2##(2008-10#1)(2008-2#2)(2008-3#3)
The aerosols##2##2##(2008-10#2)
The aetiology of the##2##4##(1997-8#1)(2007-11#1)
The aetiology of this##2##4##(2008-12#1)(2008-9#1)
The aetiology of##5##3##(1997-8#1)(2007-11#1)(2008-12#1)(2008-9#1)(2010-12#1)
The aetiology##8##2##(1992-5#1)(1993-6#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2013-1#1)
The affected##3##2##(1991-9#1)(1994-9#1)(2010-11#1)
The affinities of##2##3##(1990-8#1)(1996-5#1)
The affinity constant##2##3##(2008-10#2)
The affinity of##6##3##(1993-3#1)(1993-8#2)(2008-10#1)(2008-5#1)(2008-8#1)
The affinity##11##2##(1992-6#1)(1993-3#1)(1993-8#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)
The aforementioned##3##2##(2008-10#2)(2012-12#1)
The agar diffusion##2##3##(2008-5#2)
The agarose##2##2##(1993-8#1)(2008-10#1)
The age at##2##3##(1993-3#1)(2013-1#1)
The age distribution of##2##4##(1990-6#1)(2010-8#1)
The age group##2##3##(1991-2#1)(2007-7#1)
The age of the patients ranged from##3##7##(2008-1#1)(2012-12#1)(2013-1#1)
The age of the patients##4##5##(2007-8#1)(2008-1#1)(2012-12#1)(2013-1#1)
The age of the##7##4##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
The age of##13##3##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#1)
The age##25##2##(1990-6#2)(1991-12#1)(1991-2#1)(1993-3#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#4)
The age-specific##4##2##(1994-12#1)(1997-7#1)(2008-7#1)(2008-8#1)
The agency##2##2##(1992-8#1)(1996-3#1)
The agenda##2##2##(2008-12#1)(2011-1#1)
The agent##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
The agents##5##2##(2007-11#1)(2010-3#2)(2012-1#1)(2012-2#1)
The aggregates##2##2##(1994-12#1)(2008-11#1)
The aggregation##2##2##(1994-12#1)(2008-10#1)
The aggressiveness of##4##3##(2008-10#4)
The aggressiveness##5##2##(2008-10#5)
The aging of the population##2##5##(2008-2#1)(2013-8#1)
The aging##4##2##(1991-3#1)(2008-2#1)(2009-12#1)(2013-8#1)
The agonist##2##2##(1993-12#1)(1997-7#1)
The agr##2##2##(1995-8#2)
The agreement between the##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
The agreement between##6##3##(2008-10#1)(2008-3#4)(2008-4#1)
The agreement was##2##3##(2008-10#1)(2008-5#1)
The agreement##11##2##(1994-1#1)(1997-5#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-5#2)
The aim is to provide##2##5##(1997-7#1)(2008-11#1)
The aim is to##11##4##(1994-9#1)(1996-9#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
The aim of our investigation was to##3##7##(2008-11#1)(2008-7#1)(2009-8#1)
The aim of our study is to##5##7##(2007-11#1)(2008-11#1)(2009-3#1)(2011-2#1)(2011-7#1)
The aim of our study was to assess the##2##9##(2007-8#1)(2013-1#1)
The aim of our study was to assess##3##8##(2007-8#2)(2013-1#1)
The aim of our study was to compare##2##8##(2007-8#1)(2013-8#1)
The aim of our study was to determine##2##8##(2007-8#1)(2012-6#1)
The aim of our study was to evaluate the##3##9##(1997-8#1)(2011-2#1)(2012-3#1)
The aim of our study was to evaluate##4##8##(1997-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
The aim of our study was to explore##2##8##(2011-1#1)(2011-2#1)
The aim of our study was to investigate##2##8##(2008-4#1)(2013-7#1)
The aim of our study was to##23##7##(1997-8#1)(2007-8#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
The aim of our study was##24##6##(1990-5#1)(1997-8#1)(2007-8#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
The aim of our study##29##5##(1990-5#1)(1997-8#1)(2007-11#1)(2007-8#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
The aim of our##35##4##(1990-5#1)(1997-8#1)(2007-11#1)(2007-8#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
The aim of present study is##2##6##(2008-12#2)
The aim of present study##3##5##(2008-12#3)
The aim of the current study was to##4##8##(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The aim of the current study##5##6##(2007-8#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The aim of the current##7##5##(2007-8#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
The aim of the following##2##5##(2011-1#1)(2013-1#1)
The aim of the paper is to present the##2##9##(2011-2#1)(2013-1#1)
The aim of the paper is to##3##7##(2011-2#1)(2012-3#1)(2013-1#1)
The aim of the paper is##4##6##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
The aim of the present study is to##7##8##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-7#1)
The aim of the present study is##8##7##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-5#1)(2013-1#1)(2013-7#1)
The aim of the present study was to analyze the##2##10##(1995-8#1)(2008-7#1)
The aim of the present study was to analyze##3##9##(1995-8#1)(2008-7#1)(2012-2#1)
The aim of the present study was to assess##2##9##(2009-2#1)(2012-2#1)
The aim of the present study was to characterize##2##9##(1993-1#1)(2008-5#1)
The aim of the present study was to determine the##2##10##(2008-10#1)(2011-1#1)
The aim of the present study was to establish##2##9##(2010-5#1)(2012-3#1)
The aim of the present study was to estimate the##2##10##(2008-12#1)(2013-8#1)
The aim of the present study was to evaluate the##8##10##(2007-7#1)(2007-8#1)(2008-5#2)(2010-3#1)(2013-1#3)
The aim of the present study was to examine the##3##10##(1992-2#1)(2007-11#1)(2010-6#1)
The aim of the present study was to examine##5##9##(1992-2#1)(2007-11#1)(2010-10#1)(2010-6#1)(2013-1#1)
The aim of the present study was to investigate the effect of##2##12##(2008-12#1)(2010-2#1)
The aim of the present study was to investigate the##10##10##(1990-9#1)(1995-12#1)(1997-2#1)(2008-12#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
The aim of the present study was to investigate whether##2##10##(2008-11#1)(2011-2#1)
The aim of the present study was to investigate##14##9##(1990-9#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
The aim of the present study was to##53##8##(1990-9#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-5#4)(2008-7#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
The aim of the present study was##55##7##(1990-9#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-5#4)(2008-7#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
The aim of the present study##63##6##(1990-9#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-5#6)(2008-7#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#4)
The aim of the present work is to##4##8##(1997-2#1)(2008-1#1)(2008-8#1)(2009-12#1)
The aim of the present work is##5##7##(1997-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)
The aim of the present work was to evaluate the##2##10##(1993-11#1)(2012-2#1)
The aim of the present work was to##6##8##(1990-12#1)(1993-11#1)(1994-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
The aim of the present work##11##6##(1990-12#1)(1993-11#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
The aim of the present##77##5##(1990-12#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-5#7)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#4)
The aim of the study is to investigate##2##8##(2010-1#1)(2012-3#1)
The aim of the study is to##9##7##(1997-3#1)(2008-10#1)(2010-1#1)(2010-9#1)(2011-3#1)(2012-3#2)(2013-1#2)
The aim of the study is##11##6##(1997-3#1)(2007-11#1)(2008-10#1)(2010-1#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
The aim of the study was the assessment of##2##9##(2007-11#2)
The aim of the study was the##4##7##(1994-7#1)(2007-11#2)(2007-8#1)
The aim of the study was to analyse the##2##9##(2008-5#1)(2011-1#1)
The aim of the study was to analyse##3##8##(2008-5#1)(2011-1#1)(2012-3#1)
The aim of the study was to analyze##2##8##(2007-8#1)(2008-12#1)
The aim of the study was to assess the##2##9##(2008-5#1)(2008-7#1)
The aim of the study was to assess##3##8##(2008-5#1)(2008-7#1)(2011-2#1)
The aim of the study was to compare the##3##9##(1997-8#1)(2013-1#2)
The aim of the study was to compare##5##8##(1997-8#1)(2012-12#1)(2013-1#3)
The aim of the study was to describe the##2##9##(2008-11#1)(2010-10#1)
The aim of the study was to describe##3##8##(1996-9#1)(2008-11#1)(2010-10#1)
The aim of the study was to determine the##2##9##(2008-12#1)(2012-2#1)
The aim of the study was to determine##4##8##(1994-12#1)(2008-12#1)(2008-9#1)(2012-2#1)
The aim of the study was to evaluate the##5##9##(2007-11#1)(2007-7#1)(2008-7#1)(2010-10#1)(2013-1#1)
The aim of the study was to evaluate##8##8##(2007-11#2)(2007-7#1)(2008-7#1)(2010-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
The aim of the study was to examine the##3##9##(2008-11#2)(2011-2#1)
The aim of the study was to identify##2##8##(2009-7#1)(2013-1#1)
The aim of the study was to investigate the##2##9##(1994-6#1)(2009-6#1)
The aim of the study was to investigate##4##8##(1994-6#1)(2007-12#1)(2008-9#1)(2009-6#1)
The aim of the study was to##52##7##(1991-12#1)(1991-5#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#3)(2008-11#3)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
The aim of the study was##62##6##(1991-12#1)(1991-5#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#8)(2007-12#1)(2007-7#1)(2007-8#4)(2008-11#3)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
The aim of the study##75##5##(1991-12#1)(1991-5#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#9)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#1)(2008-11#3)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
The aim of the work was to##2##7##(2008-10#1)(2010-2#1)
The aim of the work##3##5##(2007-11#1)(2008-10#1)(2010-2#1)
The aim of the##178##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#19)(2013-7#2)(2013-8#7)
The aim of these##2##4##(2008-10#1)(2009-8#1)
The aim of this article is to describe the##2##9##(2008-5#1)(2011-2#1)
The aim of this article is to determine##2##8##(2007-11#1)(2013-1#1)
The aim of this article is to present##3##8##(1997-8#1)(2007-7#1)(2013-1#1)
The aim of this article is to provide a review of the##2##12##(2011-1#1)(2012-2#1)
The aim of this article is to##16##7##(1995-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
The aim of this article##17##5##(1995-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
The aim of this brief##2##5##(2006-6#1)(2008-7#1)
The aim of this paper is to evaluate the##2##9##(2011-2#1)(2013-1#1)
The aim of this paper is to investigate##2##8##(2009-2#1)(2010-8#1)
The aim of this paper is to present##3##8##(2007-7#1)(2011-2#2)
The aim of this paper is to report on##2##9##(2008-11#1)(2010-3#1)
The aim of this paper is to report##3##8##(2008-11#1)(2010-3#1)(2013-1#1)
The aim of this paper is to review the##2##9##(1993-5#1)(2013-1#1)
The aim of this paper is to review##3##8##(1993-5#1)(2008-10#1)(2013-1#1)
The aim of this paper is to##25##7##(1993-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-5#2)(2009-10#2)(2009-2#1)(2010-3#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#4)
The aim of this paper was to##5##7##(2008-11#1)(2009-8#2)(2010-3#1)(2011-2#1)
The aim of this paper##30##5##(1993-5#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-5#2)(2009-10#2)(2009-2#1)(2009-8#2)(2010-3#3)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#4)
The aim of this pictorial essay is to##2##8##(1997-8#1)(2012-2#1)
The aim of this pictorial##3##5##(1997-8#1)(2012-2#2)
The aim of this preliminary##2##5##(2008-12#1)(2013-1#1)
The aim of this project was to develop##2##8##(1991-9#1)(2008-1#1)
The aim of this prospective##3##5##(1997-3#1)(2010-5#1)(2011-2#1)
The aim of this qualitative##3##5##(2010-10#2)(2012-12#1)
The aim of this report is to##3##7##(2008-10#1)(2009-10#1)(2010-5#1)
The aim of this research was the development##2##8##(2008-10#1)(2008-5#1)
The aim of this research was to study the##2##9##(1990-9#1)(2011-2#1)
The aim of this research was to##6##7##(1990-9#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
The aim of this research was##9##6##(1990-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
The aim of this research##11##5##(1990-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
The aim of this retrospective study was to compare##2##9##(2007-8#1)(2011-2#1)
The aim of this retrospective study was to##3##8##(2007-8#1)(2011-2#2)
The aim of this retrospective##5##5##(2007-8#1)(2011-2#3)(2012-2#1)
The aim of this review article is to##2##8##(2007-4#1)(2010-6#1)
The aim of this review article##3##6##(2007-4#1)(2010-6#1)(2012-2#1)
The aim of this review is to discuss the##2##9##(2008-7#1)(2008-8#1)
The aim of this review is to##10##7##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-5#1)(2011-3#1)(2013-1#1)
The aim of this review was##2##6##(2012-3#1)(2013-1#1)
The aim of this review##16##5##(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-5#1)(2010-6#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
The aim of this study is the##2##7##(2007-8#1)(2008-3#1)
The aim of this study is to analyze##2##8##(2007-8#1)(2009-2#1)
The aim of this study is to clarify##2##8##(2008-4#1)(2011-2#1)
The aim of this study is to compare##2##8##(2007-8#1)(2008-10#1)
The aim of this study is to evaluate the##6##9##(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#2)
The aim of this study is to evaluate##9##8##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#3)(2013-1#1)
The aim of this study is to explore##2##8##(2010-10#1)(2012-1#1)
The aim of this study is to investigate the##3##9##(2008-9#1)(2010-12#1)(2011-3#1)
The aim of this study is to show##2##8##(2008-10#1)(2011-2#1)
The aim of this study is to##36##7##(1992-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
The aim of this study is##40##6##(1992-12#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
The aim of this study was to analyze the##3##9##(2009-3#1)(2011-2#2)
The aim of this study was to analyze##4##8##(2009-3#1)(2009-4#1)(2011-2#2)
The aim of this study was to assess the##12##9##(1990-6#1)(1992-10#1)(1997-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
The aim of this study was to assess##17##8##(1990-6#1)(1992-10#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)
The aim of this study was to compare the##4##9##(1992-10#1)(2008-12#2)(2008-5#1)
The aim of this study was to compare##8##8##(1992-10#1)(2007-8#2)(2008-12#2)(2008-5#2)(2011-2#1)
The aim of this study was to describe the##3##9##(2009-3#1)(2010-5#1)(2012-12#1)
The aim of this study was to describe##4##8##(2009-3#1)(2009-5#1)(2010-5#1)(2012-12#1)
The aim of this study was to determine the effects of##3##11##(2008-5#1)(2013-1#1)(2013-8#1)
The aim of this study was to determine the##16##9##(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-3#1)(2013-8#2)
The aim of this study was to determine whether##7##9##(2007-10#2)(2008-10#1)(2010-7#1)(2012-3#2)(2013-1#1)
The aim of this study was to determine##25##8##(2007-10#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-3#1)(2013-8#2)
The aim of this study was to develop and##2##9##(2011-2#1)(2012-1#1)
The aim of this study was to develop optimal conditions for selective adhesion and isolation of mesenchymal progenitor cells##2##19##(2008-11#2)
The aim of this study was to develop##8##8##(2008-11#2)(2008-5#3)(2011-2#2)(2012-1#1)
The aim of this study was to establish the##2##9##(2007-11#1)(2013-7#1)
The aim of this study was to establish##3##8##(2007-11#1)(2013-1#1)(2013-7#1)
The aim of this study was to estimate the##2##9##(2008-7#1)(2008-8#1)
The aim of this study was to evaluate the effectivness of##2##11##(2007-11#2)
The aim of this study was to evaluate the influence of##2##11##(2008-12#1)(2013-1#1)
The aim of this study was to evaluate the prevalence of##2##11##(2008-7#1)(2012-3#1)
The aim of this study was to evaluate the##27##9##(1992-3#1)(2007-11#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#8)
The aim of this study was to evaluate whether##2##9##(2008-11#1)(2013-8#1)
The aim of this study was to evaluate##37##8##(1992-3#1)(1994-5#1)(2007-11#2)(2007-8#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
The aim of this study was to examine the##6##9##(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
The aim of this study was to examine##8##8##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
The aim of this study was to explore the##4##9##(2007-7#1)(2008-7#1)(2013-1#1)(2013-8#1)
The aim of this study was to explore##7##8##(2007-7#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
The aim of this study was to further##2##8##(2008-10#1)(2008-11#1)
The aim of this study was to identify the##2##9##(2008-5#1)(2010-10#1)
The aim of this study was to identify##5##8##(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)
The aim of this study was to investigate how##3##9##(1997-8#1)(2008-9#1)(2013-7#1)
The aim of this study was to investigate the effect of##3##11##(2008-5#1)(2011-1#1)(2012-2#1)
The aim of this study was to investigate the effects of##2##11##(2008-5#1)(2013-1#1)
The aim of this study was to investigate the##17##9##(1992-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#4)(2009-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#5)
The aim of this study was to investigate whether##6##9##(1997-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
The aim of this study was to investigate##30##8##(1992-8#1)(1997-7#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)
The aim of this study was to know the##2##9##(2007-7#1)(2008-9#1)
The aim of this study was to present##3##8##(2008-10#2)(2008-6#1)
The aim of this study was to search for the##2##10##(2008-4#1)(2008-7#1)
The aim of this study was to search for##3##9##(2008-12#1)(2008-4#1)(2008-7#1)
The aim of this study was to use##5##8##(1993-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
The aim of this study was to verify the##2##9##(2008-7#2)
The aim of this study was to verify##3##8##(1996-3#1)(2008-7#2)
The aim of this study was to##207##7##(1990-6#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#5)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#9)(2008-3#2)(2008-4#3)(2008-5#22)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#23)(2013-3#1)(2013-7#3)(2013-8#5)
The aim of this study was##211##6##(1990-6#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#6)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#9)(2008-3#2)(2008-4#3)(2008-5#22)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#23)(2013-3#1)(2013-7#3)(2013-8#5)
The aim of this study##253##5##(1990-6#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#6)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#12)(2008-1#2)(2008-10#15)(2008-11#12)(2008-12#10)(2008-3#3)(2008-4#4)(2008-5#24)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#7)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#23)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#24)(2013-3#1)(2013-7#3)(2013-8#8)
The aim of this survey was to##2##7##(1993-5#1)(2011-2#1)
The aim of this systematic review was to##2##8##(2008-10#1)(2012-3#1)
The aim of this work is the##2##7##(2008-10#2)
The aim of this work is to evaluate##2##8##(2007-11#2)
The aim of this work is to##12##7##(2007-11#3)(2008-10#4)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
The aim of this work is##14##6##(2007-11#3)(2008-10#6)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
The aim of this work was to determine the##3##9##(2007-5#1)(2008-12#1)(2010-5#1)
The aim of this work was to evaluate the##2##9##(2008-5#2)
The aim of this work was to evaluate##3##8##(2008-5#3)
The aim of this work was to investigate##2##8##(2007-12#1)(2008-5#1)
The aim of this work was to study the##3##9##(2008-10#1)(2008-5#1)(2013-7#1)
The aim of this work was to study##4##8##(2008-10#1)(2008-5#1)(2008-7#1)(2013-7#1)
The aim of this work was to##22##7##(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-5#9)(2008-7#1)(2009-8#1)(2010-5#1)(2013-7#2)
The aim of this work was##24##6##(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-5#10)(2008-7#1)(2009-8#1)(2010-5#1)(2013-7#2)
The aim of this work##39##5##(1997-2#1)(2007-11#4)(2007-12#1)(2007-5#1)(2008-10#10)(2008-12#1)(2008-5#12)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#3)
The aim of this##410##4##(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#2)(1994-1#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#5)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#14)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#14)(2008-1#3)(2008-10#34)(2008-11#16)(2008-12#14)(2008-3#3)(2008-4#5)(2008-5#41)(2008-6#3)(2008-7#18)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#39)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#7)(2012-2#12)(2012-3#11)(2013-1#38)(2013-3#1)(2013-7#6)(2013-8#9)
The aim of##640##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#2)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-7#1)(1997-8#7)(2006-6#1)(2006-8#1)(2007-10#5)(2007-11#27)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#28)(2008-1#4)(2008-10#48)(2008-11#26)(2008-12#25)(2008-3#4)(2008-4#7)(2008-5#54)(2008-6#4)(2008-7#25)(2008-8#9)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#9)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#8)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#12)(2011-2#57)(2011-3#3)(2011-7#2)(2012-1#9)(2012-12#10)(2012-2#19)(2012-3#19)(2012-5#1)(2012-6#1)(2013-1#62)(2013-3#1)(2013-7#9)(2013-8#18)
The aim was to compare the##2##6##(1996-2#1)(2013-1#1)
The aim was to determine the##2##6##(1990-11#1)(2013-1#1)
The aim was to evaluate the##2##6##(2012-12#1)(2013-8#1)
The aim was to explore##2##5##(2008-11#1)(2011-2#1)
The aim was to investigate whether##2##6##(2008-7#1)(2011-2#1)
The aim was to obtain##2##5##(1994-5#1)(1995-6#1)
The aim was to##23##4##(1990-11#1)(1990-5#1)(1991-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
The aim was##24##3##(1990-11#1)(1990-5#1)(1991-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
The aim##677##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#2)(1994-1#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#2)(1997-2#4)(1997-3#2)(1997-7#2)(1997-8#7)(2006-6#1)(2006-8#1)(2007-10#7)(2007-11#27)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#29)(2008-1#4)(2008-10#51)(2008-11#30)(2008-12#25)(2008-3#4)(2008-4#7)(2008-5#55)(2008-6#5)(2008-7#27)(2008-8#9)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#9)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#8)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#12)(2011-2#60)(2011-3#3)(2011-7#2)(2012-1#9)(2012-12#13)(2012-2#20)(2012-3#19)(2012-5#1)(2012-6#1)(2013-1#65)(2013-3#1)(2013-7#9)(2013-8#19)
The aims of the present study were to##2##8##(2007-12#1)(2012-2#1)
The aims of the present study were##3##7##(2007-12#1)(2008-10#1)(2012-2#1)
The aims of the study were to##2##7##(2008-8#1)(2012-3#1)
The aims of the study were##3##6##(1992-12#1)(2008-8#1)(2012-3#1)
The aims of the study##4##5##(1992-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
The aims of the##10##4##(1992-12#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
The aims of this paper##2##5##(2007-12#1)(2008-2#1)
The aims of this review are to##2##7##(1990-11#1)(2008-8#1)
The aims of this review##4##5##(1990-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
The aims of this study were to describe##2##8##(2008-6#1)(2009-5#1)
The aims of this study were to determine the##2##9##(2008-12#1)(2011-2#1)
The aims of this study were to determine##4##8##(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
The aims of this study were to##12##7##(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#3)
The aims of this study were##15##6##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#3)
The aims of this study##16##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#3)
The aims of this##24##4##(1990-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#4)
The aims of##35##3##(1990-11#1)(1992-12#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
The aims were##2##3##(1991-6#1)(2008-9#1)
The aims##37##2##(1990-11#1)(1991-6#1)(1992-12#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
The air##5##2##(1997-3#1)(2008-10#3)(2008-6#1)
The airborne##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
The airway##2##2##(2008-8#1)(2013-1#1)
The albumin##2##2##(2008-11#1)(2008-8#1)
The albumin-fixed##2##2##(2008-5#2)
The alcohol##4##2##(1992-6#2)(1997-8#1)(2008-10#1)
The alcohols##4##2##(1991-5#1)(2008-10#1)(2008-5#2)
The algorithm can be##2##4##(2007-11#1)(2008-2#1)
The algorithm described##2##3##(2008-9#1)(2013-8#1)
The algorithm does not require##2##5##(2007-12#1)(2008-2#1)
The algorithm for##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
The algorithm has##3##3##(2008-2#1)(2010-4#1)(2010-8#1)
The algorithm is applied to##2##5##(2008-2#2)
The algorithm is based on a##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
The algorithm is based on the##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
The algorithm is based on##7##5##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
The algorithm is used##2##4##(2008-3#1)(2008-6#1)
The algorithm is##16##3##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#6)(2008-6#1)(2009-9#1)(2013-8#1)
The algorithm of##2##3##(2008-10#1)(2013-1#1)
The algorithm permits##2##3##(2008-2#2)
The algorithm then##2##3##(2008-2#1)(2008-3#1)
The algorithm uses##5##3##(2008-2#3)(2008-3#2)
The algorithm was##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
The algorithm##62##2##(2007-11#5)(2007-12#1)(2008-10#4)(2008-2#18)(2008-3#18)(2008-6#2)(2008-9#1)(2009-9#2)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#3)
The algorithms##3##2##(2008-3#2)(2008-6#1)
The alignment of##4##3##(1991-6#1)(1997-8#1)(2007-11#1)(2008-10#1)
The alkyl##2##2##(2007-11#1)(2008-10#1)
The all-optical##3##2##(2007-11#2)(2013-8#1)
The allelic##3##2##(1990-3#1)(2008-10#1)(2008-12#1)
The alloys##2##2##(2012-2#1)(2013-1#1)
The alpha subunit of the##2##5##(1992-11#1)(1994-8#1)
The alpha subunit##4##3##(1990-7#1)(1992-11#1)(1992-9#1)(1994-8#1)
The alpha##6##2##(1990-7#1)(1992-11#1)(1992-9#1)(1994-8#1)(1995-5#1)(2008-10#1)
The alpha-helical##2##2##(1993-11#2)
The alpha-subunit##2##2##(1990-5#1)(1995-2#1)
The alpha-thiocarbocation generated from the Pummerer reaction of##2##8##(1996-5#2)
The alteration of##3##3##(1995-5#1)(1996-12#1)(2008-10#1)
The alteration##4##2##(1995-5#1)(1996-12#1)(2008-10#1)(2012-1#1)
The alterations in##2##3##(1994-2#1)(1996-7#1)
The alterations##3##2##(1994-2#1)(1996-7#1)(2008-7#1)
The altered PFK had##2##4##(1995-2#2)
The altered##7##2##(1991-10#1)(1995-2#2)(1997-2#1)(2007-10#1)(2008-4#1)(2010-12#1)
The alternative##11##2##(1990-12#1)(1991-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-8#1)(2013-1#1)
The altitude##3##2##(2008-3#3)
The aluminium##2##2##(2008-10#2)
The aluminum##3##2##(2007-8#2)(2009-5#1)
The american phytopathological society elected and appointed officers##8##8##(2008-10#8)
The american phytopathological society##10##4##(2008-10#10)
The american##11##2##(2008-10#10)(2012-3#1)
The amide##2##2##(1995-2#1)(2008-5#1)
The amine##2##2##(2008-10#2)
The amino acid (aa) sequence##2##5##(1990-11#1)(1994-12#1)
The amino acid (aa)##3##4##(1990-11#1)(1991-6#1)(1994-12#1)
The amino acid composition##2##4##(1990-7#1)(1991-9#1)
The amino acid sequence deduced##2##5##(1993-9#1)(1995-6#1)
The amino acid sequence of human##2##6##(1993-11#1)(1996-2#1)
The amino acid sequence of the##5##6##(1990-5#1)(1990-7#1)(1992-8#1)(1994-12#1)(1996-12#1)
The amino acid sequence of##11##5##(1990-5#1)(1990-7#1)(1992-8#2)(1993-11#1)(1994-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(2009-8#1)
The amino acid sequence##17##4##(1990-12#1)(1990-5#1)(1990-7#2)(1992-8#2)(1993-11#1)(1993-9#1)(1994-12#2)(1995-6#2)(1996-12#1)(1996-2#1)(2008-10#2)(2009-8#1)
The amino acid sequences of the##3##6##(1993-12#1)(1996-8#1)(2008-5#1)
The amino acid sequences of##6##5##(1990-11#1)(1992-8#2)(1993-12#1)(1996-8#1)(2008-5#1)
The amino acid sequences##8##4##(1990-11#1)(1992-3#1)(1992-8#2)(1993-12#1)(1996-8#1)(1997-7#1)(2008-5#1)
The amino acid##32##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#3)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#4)(2008-5#1)(2009-8#1)
The amino acids##2##3##(1995-12#1)(2008-10#1)
The amino##38##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#3)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#4)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#7)(2008-5#1)(2009-10#1)(2009-8#1)
The amino-acid sequence of##3##4##(1990-5#3)
The amino-acid sequence##5##3##(1990-5#5)
The amino-terminal sequence of lobster##2##5##(1990-2#2)
The amino-terminal sequence of##3##4##(1990-2#2)(1992-9#1)
The amino-terminal##6##2##(1990-2#2)(1992-9#1)(1994-8#1)(1997-4#1)(1997-8#1)
The ammonia##2##2##(1992-11#1)(2008-11#1)
The amorphous##2##2##(2008-10#2)
The amount of energy##2##4##(2007-11#1)(2008-8#1)
The amount of formaldehyde in##2##5##(2008-10#2)
The amount of the##3##4##(1993-8#1)(1995-3#1)(2008-10#1)
The amount of##64##3##(1990-2#1)(1991-11#1)(1991-9#1)(1993-6#1)(1993-8#3)(1994-12#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#2)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#19)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#2)(2009-11#1)(2010-5#1)(2013-1#1)
The amount##65##2##(1990-2#1)(1991-11#1)(1991-9#1)(1993-6#1)(1993-8#4)(1994-12#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#2)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#19)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#2)(2009-11#1)(2010-5#1)(2013-1#1)
The amounts of##17##3##(1990-11#1)(1990-8#1)(1993-6#1)(1994-5#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-2#1)
The amperometric response of##2##4##(2008-10#2)
The amperometric##5##2##(2008-10#5)
The amplification of##2##3##(2007-10#1)(2008-10#1)
The amplification##5##2##(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)
The amplified DNA is##2##4##(1995-8#1)(2008-2#1)
The amplified DNA##3##3##(1995-8#1)(1997-2#1)(2008-2#1)
The amplified fragments were cloned##2##5##(2008-10#1)(2008-8#1)
The amplified##12##2##(1990-7#1)(1992-8#1)(1993-8#1)(1995-8#1)(1997-2#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
The amplifier##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
The amplifying effect of beta-amyloid##2##5##(1995-5#2)
The amplifying##3##2##(1995-5#2)(2007-12#1)
The amplitude and phase##2##4##(2007-9#1)(2008-3#1)
The amplitude and the phase of##2##6##(2007-11#1)(2008-2#1)
The amplitude and the##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
The amplitude and##6##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
The amplitude of the##6##4##(1991-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
The amplitude of##8##3##(1991-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
The amplitude##16##2##(1991-10#1)(1992-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
The amplitudes of##2##3##(1990-7#1)(2008-10#1)
The amygdala was##2##3##(2008-11#2)
The amygdala##4##2##(1991-1#1)(2008-11#3)
The amyloid##2##2##(1992-12#1)(1992-3#1)
The anaerobic##2##2##(2008-6#1)(2011-2#1)
The analgesic effect##2##3##(2011-2#1)(2013-7#1)
The analgesic##5##2##(1995-6#1)(2007-8#1)(2011-2#2)(2013-7#1)
The analog##4##2##(1993-8#1)(1994-12#1)(1995-3#1)(1997-6#1)
The analogous##2##2##(1992-1#1)(1996-8#1)
The analogs##4##2##(1992-8#1)(1994-5#1)(2011-2#1)(2013-1#1)
The analysed##3##2##(2008-10#2)(2009-7#1)
The analyses of the##2##4##(1994-9#1)(2009-7#1)
The analyses of##6##3##(1994-9#1)(2008-10#3)(2009-7#1)(2012-2#1)
The analyses revealed##3##3##(1993-11#1)(2008-10#1)(2009-7#1)
The analyses##16##2##(1992-2#1)(1993-11#1)(1994-9#1)(1997-8#1)(2008-10#6)(2008-3#1)(2009-7#2)(2010-4#1)(2011-2#1)(2012-2#1)
The analysis can##2##3##(2007-12#1)(2008-2#1)
The analysis focuses on the##2##5##(2009-10#1)(2011-2#1)
The analysis focuses on##3##4##(1991-1#1)(2009-10#1)(2011-2#1)
The analysis includes##4##3##(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#1)
The analysis indicates that##2##4##(1993-12#1)(1996-2#1)
The analysis is based on a##3##6##(1996-2#1)(2008-11#1)(2008-3#1)
The analysis is based on##6##5##(1996-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#1)
The analysis is performed##2##4##(2008-2#1)(2008-3#1)
The analysis is##15##3##(1996-2#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
The analysis of molecular variance##2##5##(2008-10#2)
The analysis of our case##2##5##(2007-10#1)(2009-3#1)
The analysis of the##19##4##(1991-9#1)(1993-3#1)(1993-6#1)(1994-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-6#2)(2012-3#1)(2013-1#1)
The analysis of these##2##4##(2008-10#1)(2009-10#1)
The analysis of##78##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-1#1)(1995-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#3)(2008-2#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
The analysis revealed that##2##4##(1992-12#1)(2010-1#1)
The analysis reveals##2##3##(1995-2#1)(2008-2#1)
The analysis shows that##3##4##(2008-2#1)(2008-3#2)
The analysis shows##4##3##(2008-11#1)(2008-2#1)(2008-3#2)
The analysis suggested##2##3##(2008-10#1)(2011-2#1)
The analysis time was##2##4##(2008-10#1)(2011-1#1)
The analysis time##3##3##(2008-10#2)(2011-1#1)
The analysis was completed##2##4##(2008-10#2)
The analysis was made##2##4##(2009-8#1)(2011-2#1)
The analysis was performed by##2##5##(2008-10#1)(2008-3#1)
The analysis was performed##4##4##(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)
The analysis was##16##3##(1991-1#1)(1993-11#1)(1995-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
The analysis##176##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#3)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#46)(2008-11#7)(2008-12#2)(2008-2#11)(2008-3#15)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
The analyte is##2##3##(2008-10#2)
The analyte was##3##3##(2008-10#2)(2011-1#1)
The analyte##11##2##(2008-10#10)(2011-1#1)
The analytes are##4##3##(1992-11#1)(2008-10#3)
The analytes in##2##3##(2008-10#2)
The analytes were detected using a##2##6##(2008-10#2)
The analytes were determined##3##4##(2008-10#3)
The analytes were extracted##2##4##(2008-10#2)
The analytes were resolved by elution with supercritical fluid carbon dioxide doped with##2##13##(2008-10#2)
The analytes were##15##3##(2008-10#15)
The analytes##25##2##(1992-11#1)(2008-10#24)
The analytic##2##2##(2008-9#1)(2013-1#1)
The analytical and##3##3##(2008-10#3)
The analytical applicability of the##2##5##(2008-10#2)
The analytical applications of the evolved gas analysis (EGA) performed by##2##11##(2008-10#2)
The analytical characteristics of the method such as##2##8##(2008-10#2)
The analytical characteristics of the##4##5##(2008-10#4)
The analytical characteristics of##7##4##(2008-10#7)
The analytical characteristics##9##3##(2008-10#9)
The analytical conditions for##2##4##(2008-10#1)(2010-4#1)
The analytical conditions##3##3##(2008-10#2)(2010-4#1)
The analytical curve was linear in the##2##7##(2008-10#2)
The analytical curve was rectilinear##2##5##(2008-10#2)
The analytical curve was##4##4##(2008-10#4)
The analytical curve##6##3##(2008-10#6)
The analytical curves##2##3##(2008-10#2)
The analytical data##4##3##(2008-10#4)
The analytical expression for the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
The analytical figures of merit##5##5##(2008-10#5)
The analytical figures of##6##4##(2008-10#6)
The analytical formulas##2##3##(2007-11#1)(2008-3#1)
The analytical frequency##3##3##(2008-10#3)
The analytical method is based on the detection of##2##9##(2008-10#2)
The analytical method is based on the##3##7##(2008-10#3)
The analytical method##8##3##(2008-10#7)(2009-8#1)
The analytical parameters for##3##4##(2008-10#3)
The analytical parameters have been##2##5##(2008-10#2)
The analytical parameters##6##3##(2008-10#5)(2013-8#1)
The analytical performance of the proposed method##2##7##(2008-10#2)
The analytical performance of the##3##5##(2008-10#3)
The analytical performance of##6##4##(2008-10#6)
The analytical performance was##2##4##(2008-10#1)(2008-2#1)
The analytical performance##8##3##(2008-10#7)(2008-2#1)
The analytical procedure was verified by the##2##7##(2008-10#2)
The analytical procedure was##4##4##(2008-10#4)
The analytical procedure##7##3##(1996-5#1)(2008-10#6)
The analytical process##2##3##(2008-10#1)(2008-11#1)
The analytical properties of##3##4##(2008-10#3)
The analytical range##2##3##(2008-10#2)
The analytical reagents##2##3##(2008-10#2)
The analytical recoveries obtained by applying the##2##7##(2008-10#2)
The analytical recoveries##3##3##(2008-10#3)
The analytical results obtained by##2##5##(2008-10#2)
The analytical results obtained##5##4##(2008-10#5)
The analytical results##12##3##(2007-11#1)(2008-10#10)(2013-8#1)
The analytical signals##3##3##(2007-11#1)(2008-10#2)
The analytical throughput##2##3##(2008-10#2)
The analytical usefulness of the##2##5##(2008-10#2)
The analytical utility of the##3##5##(2008-10#3)
The analytical##140##2##(1995-12#1)(1996-12#2)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#120)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-7#1)(2013-8#2)
The analyzed ions can be quantitatively concentrated by the##2##9##(2008-10#2)
The analyzed##9##2##(2007-8#2)(2008-10#3)(2008-3#1)(2009-3#1)(2013-1#1)(2013-7#1)
The anatomic##2##2##(1991-10#1)(2012-3#1)
The anatomical and##3##3##(1990-6#1)(2007-8#1)(2013-1#1)
The anatomical##11##2##(1990-6#1)(1991-3#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-8#1)(2013-1#1)
The anatomy and##4##3##(1997-1#1)(2007-11#1)(2008-1#1)(2012-2#1)
The anatomy of the##4##4##(1994-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
The anatomy of##7##3##(1994-9#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
The anatomy##11##2##(1994-9#1)(1997-1#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
The anchor cell##2##3##(2007-12#2)
The aneurysm was##3##3##(1997-6#1)(2008-12#1)(2008-7#1)
The aneurysm##5##2##(1997-6#1)(2008-12#1)(2008-7#2)(2013-8#1)
The angle of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
The angle-impact Wigner function##2##4##(2007-11#2)
The angular dependence##2##3##(2007-12#1)(2008-2#1)
The angular distribution of##2##4##(2008-2#2)
The angular resolution of##2##4##(2008-2#2)
The angular##15##2##(2007-11#1)(2007-12#3)(2008-2#8)(2008-3#3)
The animal was##2##3##(1997-6#1)(2012-2#1)
The animal##4##2##(1997-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
The animals were##12##3##(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
The animals##19##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
The anion has##2##3##(1996-2#2)
The anions##3##2##(1990-5#1)(2008-10#2)
The annetocin-secretory cells##2##3##(2008-5#2)
The annual incidence##3##3##(1996-11#1)(2007-7#1)(2011-2#1)
The annual##16##2##(1992-1#1)(1995-6#1)(1996-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#4)(2013-8#1)
The anodic oxidation of##2##4##(2008-10#2)
The anodic peak potential##2##4##(2008-10#2)
The anodic peak##3##3##(2008-10#3)
The anodic stripping##3##3##(2008-10#3)
The anodic##10##2##(2008-10#10)
The anomalous##2##2##(2007-12#1)(2013-2#1)
The anomaly##2##2##(1990-5#1)(1993-9#1)
The answer lies in the##2##5##(2011-1#2)
The answer##7##2##(1991-12#1)(1996-12#1)(1997-1#1)(2007-7#1)(2008-8#1)(2011-1#2)
The answers##4##2##(1995-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
The antagonist for##2##3##(1993-12#1)(2010-8#1)
The antagonist##6##2##(1993-12#2)(1995-12#1)(2008-10#2)(2010-8#1)
The antagonistic##2##2##(2008-10#2)
The anterior##3##2##(1992-12#2)(2007-8#1)
The anterolateral##2##2##(2011-2#2)
The anti-Stokes##3##2##(2007-1#2)(2008-2#1)
The anti-apoptotic##2##2##(2008-1#1)(2011-2#1)
The anti-heart##2##2##(2008-7#2)
The anti-inflammatory##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
The antibacterial activity of the##2##5##(2008-5#1)(2008-8#1)
The antibacterial activity of##3##4##(2008-5#1)(2008-8#1)(2010-5#1)
The antibacterial##5##2##(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
The antibiotic##8##2##(2008-10#2)(2008-6#3)(2010-5#1)(2012-12#1)(2013-1#1)
The antibodies##6##2##(1994-5#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-7#1)
The antibody immobilized##3##3##(1991-5#2)(2008-10#1)
The antibody on##2##3##(1991-5#2)
The antibody response to##2##4##(1995-5#1)(2008-10#1)
The antibody response##4##3##(1994-8#1)(1995-5#1)(2008-10#1)(2008-4#1)
The antibody titre##2##3##(1997-6#1)(2008-11#1)
The antibody was##2##3##(1994-9#1)(2008-10#1)
The antibody##23##2##(1990-12#1)(1991-12#1)(1991-5#4)(1991-9#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-6#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)
The anticonvulsant effects##2##3##(1994-2#1)(1995-12#1)
The anticonvulsant##3##2##(1992-3#1)(1994-2#1)(1995-12#1)
The antifungal activity of##2##4##(2008-10#1)(2013-1#1)
The antifungal activity##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
The antigen##4##2##(1994-8#1)(1997-2#1)(2008-11#1)(2008-8#1)
The antigenic##4##2##(1996-6#1)(2008-10#1)(2008-5#2)
The antigenicity##2##2##(1994-11#1)(2008-8#1)
The antigens##3##2##(1990-5#1)(1994-3#1)(2013-1#1)
The antimicrobial activity of##2##4##(2008-11#1)(2008-5#1)
The antimicrobial activity##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
The antimicrobial##5##2##(2007-12#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
The antinociceptive effects##2##3##(1992-3#1)(2010-5#1)
The antinociceptive##4##2##(1992-3#1)(1995-12#1)(2010-5#1)(2011-1#1)
The antioxidant activities of##3##4##(2008-10#2)(2013-1#1)
The antioxidant activity in##2##4##(2008-10#1)(2008-11#1)
The antioxidant activity of##2##4##(2008-10#2)
The antioxidant activity##5##3##(2008-10#4)(2008-11#1)
The antioxidant and prooxidant##2##4##(1995-6#2)
The antioxidant capacities of##2##4##(2008-7#1)(2013-1#1)
The antioxidant##21##2##(1995-6#2)(1995-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#3)(2013-7#1)(2013-8#1)
The antiproliferative effects of##2##4##(1992-5#1)(2012-3#1)
The antiproliferative##3##2##(1992-5#2)(2012-3#1)
The antisense##3##2##(1992-12#1)(2008-11#1)(2008-8#1)
The antisera##3##2##(2008-10#3)
The antiserum##2##2##(1990-11#1)(2008-10#1)
The antitumor##3##2##(1990-2#1)(1991-8#1)(1992-5#1)
The antiviral##2##2##(1997-5#1)(2008-10#1)
The ants##2##2##(2007-12#1)(2008-6#1)
The aphid##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
The apical##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
The apoptosis linked##2##3##(2009-4#2)
The apoptosis##3##2##(2008-5#1)(2009-4#2)
The apoptotic##3##2##(1995-6#1)(2008-9#1)(2013-1#1)
The apparatus consists of##2##4##(2008-10#1)(2008-8#1)
The apparatus##9##2##(1993-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-8#1)
The apparent K(m)##2##3##(1997-2#1)(2008-7#1)
The apparent Km for##3##4##(1990-11#1)(1990-2#1)(1992-3#1)
The apparent Km value##2##4##(1994-12#1)(2008-8#1)
The apparent Km values for##2##5##(1991-11#1)(1992-3#1)
The apparent Km##7##3##(1990-11#1)(1990-2#1)(1991-11#1)(1992-3#2)(1994-12#1)(2008-8#1)
The apparent Michaelis-Menten constant##3##4##(2008-10#3)
The apparent degree of##2##4##(1991-12#1)(2008-3#1)
The apparent dissociation constant##3##4##(1990-11#1)(1993-8#1)(1996-3#1)
The apparent formation##2##3##(2008-10#2)
The apparent molar absorptivities##2##4##(2008-10#2)
The apparent molar absorptivity is##4##5##(2008-10#4)
The apparent molar absorptivity##5##4##(2008-10#5)
The apparent molar##8##3##(2008-10#8)
The apparent molecular weight of##2##5##(1992-6#1)(1994-9#1)
The apparent molecular weight##3##4##(1992-11#1)(1992-6#1)(1994-9#1)
The apparent molecular##4##3##(1992-11#1)(1992-6#1)(1994-9#1)(1997-7#1)
The apparent permeability##2##3##(1990-11#1)(2008-5#1)
The apparent##62##2##(1990-11#3)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-7#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-3#1)
The appeals court##4##3##(1995-12#1)(1995-6#3)
The appearance and##2##3##(1996-4#1)(2008-10#1)
The appearance of new##2##4##(2008-10#2)
The appearance of the##5##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
The appearance of##17##3##(1991-2#1)(1992-2#1)(1993-6#1)(1993-8#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
The appearance##20##2##(1991-2#1)(1992-2#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
The appendix##2##2##(1991-2#1)(2009-7#1)
The applicability of the method for##2##6##(2008-10#2)
The applicability of the method was demonstrated by the determination of##2##11##(2008-10#2)
The applicability of the method was demonstrated by##3##8##(2008-10#3)
The applicability of the method was##4##6##(2008-10#4)
The applicability of the method##7##5##(2008-10#6)(2008-3#1)
The applicability of the proposed##3##5##(2008-10#3)
The applicability of the##19##4##(2008-10#14)(2008-3#3)(2008-7#1)(2009-12#1)
The applicability of this method##2##5##(2008-10#2)
The applicability of this##5##4##(2008-10#4)(2011-1#1)
The applicability of##41##3##(1993-12#1)(1996-12#1)(2008-10#30)(2008-2#1)(2008-3#4)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
The applicability##42##2##(1993-12#1)(1996-12#1)(2008-10#31)(2008-2#1)(2008-3#4)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
The applicable##2##2##(2008-10#1)(2008-3#1)
The application of a##8##4##(1997-3#1)(2008-10#5)(2008-3#1)(2008-7#1)
The application of an##4##4##(2008-10#2)(2008-7#1)(2009-10#1)
The application of both methods##2##5##(2008-10#2)
The application of spline wavelet##2##5##(2008-10#2)
The application of such##3##4##(1994-12#1)(2008-2#1)(2012-2#1)
The application of the method to##2##6##(2008-10#1)(2008-2#1)
The application of the method##6##5##(1997-2#1)(2008-10#4)(2008-2#1)
The application of the methodology to the##2##7##(2008-10#1)(2009-10#1)
The application of the##25##4##(1991-5#1)(1997-2#1)(2008-10#17)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)
The application of these techniques to##2##6##(2008-3#2)
The application of these##3##4##(2008-3#2)(2008-4#1)
The application of this method was demonstrated by analyzing##2##9##(2008-10#2)
The application of this method was##4##6##(2008-10#3)(2008-8#1)
The application of this method##5##5##(2008-10#4)(2008-8#1)
The application of this methodology##3##5##(2008-10#2)(2009-11#1)
The application of this newly developed method was demonstrated by analyzing various beef##2##13##(2008-10#2)
The application of this##18##4##(2007-11#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)
The application of##122##3##(1990-8#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#59)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
The application##131##2##(1990-8#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#60)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
The applications of##2##3##(2007-11#1)(2008-8#1)
The applications##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
The applied artificial neural network is composed of three layers##2##10##(2010-8#2)
The applied##10##2##(2008-10#5)(2008-3#1)(2009-8#1)(2010-8#2)(2011-2#1)
The approach allowed##2##3##(1996-2#1)(2011-2#1)
The approach can be##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
The approach has been##2##4##(2008-10#2)
The approach has##3##3##(1997-3#1)(2008-10#2)
The approach involves##2##3##(2011-1#1)(2013-1#1)
The approach is applicable to##2##5##(1997-2#1)(2008-4#1)
The approach is based on##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
The approach is illustrated with##2##5##(1995-12#1)(2009-9#1)
The approach is illustrated##3##4##(1995-12#1)(2009-9#1)(2012-1#1)
The approach is used##2##4##(2008-10#1)(2008-9#1)
The approach is##21##3##(1994-11#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#2)(2008-9#3)(2009-9#1)(2012-1#1)
The approach of##4##3##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)
The approach presented##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
The approach provides##2##3##(2007-12#1)(2008-2#1)
The approach to##8##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#3)
The approach used##2##3##(2008-10#1)(2012-2#1)
The approach uses##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
The approach was##6##3##(2007-5#1)(2008-10#3)(2010-5#2)
The approach##86##2##(1990-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1995-12#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#17)(2008-11#6)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-2#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
The approaches##6##2##(1992-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-10#1)(2011-2#1)
The appropriate use of##2##4##(1996-2#1)(2010-8#1)
The appropriate##9##2##(1995-5#1)(1996-2#1)(2008-2#1)(2008-9#2)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
The approximate##2##2##(1992-3#1)(2010-11#1)
The approximately##2##2##(1994-2#1)(2008-2#1)
The approximation##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The aquatic##2##2##(2008-10#1)(2008-7#1)
The aqueous extracts##2##3##(2008-10#1)(2008-12#1)
The aqueous solution##2##3##(1991-8#1)(2008-11#1)
The aqueous##12##2##(1991-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)
The architecture of##2##3##(1990-8#1)(2007-12#1)
The architecture##3##2##(1990-8#1)(2007-12#1)(2008-3#1)
The architectures##2##2##(1990-11#1)(2008-3#1)
The arduous##2##2##(1993-3#1)(2008-6#1)
The area of##4##3##(1995-9#1)(1996-12#1)(2008-10#1)(2008-8#1)
The area under the disease progress curve (AUDPC) was##2##9##(2008-10#2)
The area under the disease progress curve (AUDPC)##3##8##(2008-10#3)
The area under the##4##4##(2008-10#3)(2010-8#1)
The area##12##2##(1990-9#1)(1995-9#1)(1996-12#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)
The areas##2##2##(1991-1#1)(2013-1#1)
The argon##2##2##(1994-3#1)(2008-10#1)
The argument##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
The arguments are supported by##2##5##(2008-11#1)(2013-1#1)
The arguments are##3##3##(1996-6#1)(2008-11#1)(2013-1#1)
The arguments##4##2##(1996-6#1)(1997-4#1)(2008-11#1)(2013-1#1)
The armed##2##2##(2008-10#1)(2012-12#1)
The arrangement of the##3##4##(1990-5#1)(1996-2#1)(2010-2#1)
The arrangement of##4##3##(1990-5#1)(1996-2#1)(2008-5#1)(2010-2#1)
The arrangement##5##2##(1990-5#1)(1992-3#1)(1996-2#1)(2008-5#1)(2010-2#1)
The array##3##2##(1990-8#1)(2008-10#1)(2008-2#1)
The arrays of##2##3##(2007-5#1)(2008-10#1)
The arsenic##2##2##(2008-10#1)(2008-2#1)
The arsine##2##2##(2008-10#2)
The art of##6##3##(1992-12#1)(2008-12#2)(2010-8#1)(2012-12#1)(2012-2#1)
The art##9##2##(1992-12#1)(1993-3#1)(1995-1#1)(2008-11#1)(2008-12#2)(2010-8#1)(2012-12#1)(2012-2#1)
The arterial##4##2##(1997-7#1)(2007-8#1)(2008-3#1)(2009-6#1)
The article also includes##3##4##(1994-12#1)(1996-12#1)(2008-9#1)
The article also##9##3##(1991-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
The article concludes by##7##4##(1993-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
The article concludes that the##2##5##(1996-9#1)(2008-2#1)
The article concludes that##4##4##(1995-12#1)(1996-9#1)(1997-2#1)(2008-2#1)
The article concludes with a discussion of##3##7##(1992-3#1)(2008-11#1)(2008-8#1)
The article concludes with a##4##5##(1992-3#1)(2008-11#1)(2008-8#1)(2011-1#1)
The article concludes with the##2##5##(2008-12#1)(2008-4#1)
The article concludes with##9##4##(1992-3#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)
The article concludes##20##3##(1992-3#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)
The article considers the##3##4##(2009-4#1)(2013-1#2)
The article considers##4##3##(2009-4#1)(2013-1#3)
The article describes the##8##4##(1990-11#1)(1992-3#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)
The article describes##15##3##(1990-11#3)(1991-2#1)(1992-11#1)(1992-3#1)(1994-12#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
The article discusses the role##2##5##(2009-10#1)(2013-1#1)
The article discusses the##10##4##(1991-12#1)(1991-8#1)(1994-11#1)(1994-2#1)(1995-6#1)(2009-10#1)(2013-1#4)
The article discusses##15##3##(1991-12#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#4)
The article elaborates##2##3##(1994-3#1)(2008-5#1)
The article examines the##2##4##(1991-12#1)(1996-12#1)
The article explores the##2##4##(2008-11#1)(2011-2#1)
The article explores##6##3##(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#2)(2013-8#1)
The article focuses on the##2##5##(1991-6#1)(2007-4#1)
The article focuses on##3##4##(1991-6#1)(2007-4#1)(2008-4#1)
The article goes on to##2##5##(2008-12#1)(2013-7#1)
The article has##2##3##(2008-1#1)(2013-1#1)
The article highlights##2##3##(2008-11#1)(2013-1#1)
The article includes a##2##4##(1991-11#1)(1997-6#1)
The article includes##4##3##(1991-11#1)(1991-6#1)(1994-1#1)(1997-6#1)
The article is devoted to##3##5##(1990-8#1)(2011-1#1)(2012-3#1)
The article is##6##3##(1990-8#1)(1994-12#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)
The article presents a##4##4##(1991-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
The article presents the##5##4##(1995-6#1)(1996-2#1)(2009-5#1)(2011-1#1)(2013-1#1)
The article presents##11##3##(1991-9#1)(1994-2#1)(1995-6#1)(1996-2#1)(2009-5#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#1)
The article reviews the##4##4##(1990-2#1)(1996-12#1)(2008-1#1)(2012-2#1)
The article reviews##8##3##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1996-12#1)(1996-9#1)(2008-1#1)(2012-2#1)
The article suggests##2##3##(2007-11#1)(2013-1#1)
The article summarizes##2##3##(1990-11#1)(2008-7#1)
The article##147##2##(1990-11#4)(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#4)(1994-6#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1996-12#5)(1996-2#3)(1996-3#2)(1996-9#2)(1997-2#2)(1997-3#4)(1997-6#1)(2007-11#2)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#6)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#5)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#2)
The articles were##2##3##(2008-12#1)(2011-2#1)
The articles##4##2##(1993-2#1)(1995-1#1)(2008-12#1)(2011-2#1)
The as-prepared##6##2##(2008-10#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#2)
The asparagine-linked##2##2##(1992-10#1)(1993-11#1)
The aspect##2##2##(2008-5#1)(2011-2#1)
The assay also##3##3##(1992-3#1)(2008-10#2)
The assay can be##2##4##(2008-4#2)
The assay detected##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
The assay for##2##3##(2008-10#2)
The assay has a##3##4##(1991-2#1)(1992-12#1)(2008-10#1)
The assay has##4##3##(1990-2#1)(1991-2#1)(1992-12#1)(2008-10#1)
The assay is based on the##4##6##(1990-12#2)(2008-10#2)
The assay is based on##5##5##(1990-12#2)(2008-10#3)
The assay is performed##2##4##(2008-10#1)(2008-9#1)
The assay is##12##3##(1990-12#3)(1993-12#1)(1993-9#1)(1996-12#1)(2008-10#4)(2008-9#2)
The assay procedure##2##3##(1991-5#1)(1993-9#1)
The assay utilizes##2##3##(2008-10#1)(2008-11#1)
The assay was linear from##2##5##(2008-10#2)
The assay was linear over a##2##6##(1993-9#1)(1996-5#1)
The assay was linear##4##4##(1993-9#1)(1996-5#1)(2008-10#2)
The assay was used to##2##5##(1992-3#1)(2008-10#1)
The assay was##17##3##(1991-12#1)(1992-3#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-5#1)(2008-10#7)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
The assay##66##2##(1990-12#3)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#2)(1993-9#3)(1994-2#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#3)(2008-10#25)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
The assays were##2##3##(2008-10#1)(2012-3#1)
The assays##12##2##(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
The assembly of##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
The assembly##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
The assertion##2##2##(1994-6#1)(2008-12#1)
The assessed##2##2##(1992-12#1)(2008-12#1)
The assessment of a##2##4##(2008-7#1)(2012-1#1)
The assessment of the##7##4##(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
The assessment of##30##3##(1992-5#1)(1992-9#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
The assessment##38##2##(1992-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
The assignment of##5##3##(1994-5#1)(2008-10#2)(2012-2#1)(2013-1#1)
The associated##5##2##(2007-12#1)(2007-8#1)(2008-7#2)(2011-2#1)
The association among##2##3##(2011-2#1)(2013-7#1)
The association between migraine##2##4##(2008-9#2)
The association between the##3##4##(2009-2#1)(2011-2#1)(2013-1#1)
The association between##28##3##(1990-3#1)(1992-2#1)(1992-9#1)(1993-9#1)(1996-7#1)(2008-10#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
The association constants of##2##4##(2008-10#2)
The association constants##4##3##(2008-10#4)
The association of cis isomers of a carotenoid with reaction centers and trans isomers of the same carotenoid with light-harvesting pigment-protein complexes has led to the hypothesis that the stereoisomers play distinctly different physiological roles##2##35##(2010-2#2)
The association of hyperhomocysteinemia##2##4##(2008-3#2)
The association of these##2##4##(1991-3#1)(2008-3#1)
The association of##24##3##(1991-3#1)(1991-8#1)(1993-8#1)(1995-2#1)(1995-9#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-5#1)(2009-9#1)(2010-2#2)(2011-2#1)(2012-12#1)
The association was##4##3##(1990-7#1)(2007-7#1)(2011-1#1)(2011-2#1)
The association with##3##3##(1993-9#1)(2008-10#1)(2012-12#1)
The association##72##2##(1990-3#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-5#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-5#1)(2006-6#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-2#2)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
The associations between the##3##4##(2008-6#1)(2008-8#1)(2011-1#1)
The associations between##4##3##(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)
The associations of##4##3##(1990-3#1)(2008-10#1)(2009-9#1)(2012-2#1)
The associations##8##2##(1990-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
The assumed##2##2##(1991-3#1)(2008-3#1)
The assumption of##2##3##(2008-11#1)(2008-7#1)
The assumption that##3##3##(2008-12#1)(2008-3#2)
The assumption##5##2##(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)
The asthmatic##2##2##(2007-6#1)(2008-10#1)
The asymmetric unit##2##3##(1992-4#1)(1997-7#1)
The asymmetric##3##2##(1992-4#1)(1997-7#1)(2007-11#1)
The asymmetry of the##2##4##(1997-6#1)(2008-3#1)
The asymmetry##3##2##(1997-6#1)(2008-2#1)(2008-3#1)
The asymptotic##6##2##(1994-9#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-11#1)(2012-1#1)
The atomic force##2##3##(2008-4#1)(2008-5#1)
The atomic##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)
The atrthroscopic Bankart procedure by suture and MITEK technique was performed in 102 patients (1992-2003) with acute anterior shoulder dislocations##2##20##(2007-11#2)
The attachment of##4##3##(1993-9#1)(2008-10#1)(2009-10#1)(2012-2#1)
The attachment##5##2##(1993-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
The attendance##2##2##(1991-6#2)
The attention##2##2##(1996-2#1)(2008-8#1)
The attenuation of##2##3##(2008-10#1)(2008-2#1)
The attenuation properties##3##3##(2007-11#2)(2008-3#1)
The attenuation##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
The attitudes of older##2##4##(1996-1#1)(2008-7#1)
The attitudes of##5##3##(1994-1#2)(1996-1#1)(2008-12#1)(2008-7#1)
The attractive##2##2##(2007-11#1)(2008-10#1)
The attractiveness##2##2##(1995-12#1)(2013-8#1)
The attributes##2##2##(2008-4#1)(2012-2#1)
The audit results##2##3##(2013-1#1)(2013-8#1)
The audit##5##2##(2007-11#1)(2010-4#1)(2013-1#1)(2013-8#2)
The augmentation of##2##3##(1995-3#1)(2010-6#1)
The authenticity of the##2##4##(1991-12#1)(1996-6#1)
The author addresses the##3##4##(1994-3#1)(1996-12#1)(2008-10#1)
The author also points out##2##5##(1993-6#1)(2011-2#1)
The author also##6##3##(1991-12#1)(1992-3#1)(1993-6#1)(1994-6#1)(1996-3#1)(2011-2#1)
The author analyzes##2##3##(1990-11#1)(1991-3#1)
The author argues that##3##4##(1991-2#1)(1993-2#1)(2008-11#1)
The author argues##4##3##(1991-2#1)(1993-2#1)(2008-11#1)(2011-2#1)
The author begins with##2##4##(1992-3#1)(2012-2#1)
The author believes that##2##4##(1992-2#1)(1993-3#1)
The author believes##3##3##(1992-2#1)(1993-3#1)(1996-1#1)
The author briefly##3##3##(1990-2#1)(1995-6#1)(1995-8#1)
The author concludes with##2##4##(2010-11#1)(2011-2#1)
The author concludes##4##3##(1992-1#1)(1993-12#1)(2010-11#1)(2011-2#1)
The author considers##2##3##(1990-11#1)(1993-6#1)
The author describes a##2##4##(1991-1#1)(2008-2#1)
The author describes the##6##4##(1993-3#1)(1996-12#1)(1996-2#1)(2008-7#1)(2010-3#1)(2011-2#1)
The author describes##16##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2011-3#2)
The author discusses how the##2##5##(1993-12#1)(2010-3#1)
The author discusses how##6##4##(1991-3#1)(1993-12#2)(1993-2#1)(1994-12#1)(2010-3#1)
The author discusses the general##2##5##(1996-8#1)(2008-4#1)
The author discusses the use of##2##6##(1994-2#1)(1995-2#1)
The author discusses the##18##4##(1990-8#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)
The author discusses why##3##4##(1992-12#1)(1993-2#1)(1996-12#1)
The author discusses##33##3##(1990-8#1)(1990-9#2)(1991-1#1)(1991-3#1)(1992-12#2)(1992-2#2)(1993-12#3)(1993-2#2)(1994-12#1)(1994-2#2)(1995-2#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-3#2)
The author emphasizes##2##3##(1991-6#1)(1992-1#1)
The author examines the##2##4##(1992-1#1)(1995-2#1)
The author explores##2##3##(1994-2#1)(2009-6#1)
The author expresses his##2##4##(1995-2#1)(1996-12#1)
The author focuses on##3##4##(1991-1#1)(1995-2#1)(2008-4#1)
The author gives the##2##4##(1994-2#1)(1995-2#1)
The author makes##2##3##(1990-12#1)(1993-2#1)
The author mentions##2##3##(1990-8#1)(1995-5#1)
The author offers a##2##4##(1992-12#1)(2010-10#1)
The author offers##5##3##(1991-12#1)(1992-12#2)(1993-1#1)(2010-10#1)
The author presents a##7##4##(1991-3#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-5#1)(2008-9#1)
The author presents##13##3##(1991-3#1)(1991-6#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#1)(2012-12#1)
The author proposes##2##3##(1993-2#1)(2011-2#1)
The author provides a##3##4##(1993-2#1)(1995-2#1)(2008-9#1)
The author provides##5##3##(1993-2#1)(1995-2#1)(1997-2#1)(2008-9#2)
The author reports##2##3##(1995-1#1)(2008-2#1)
The author shows why##2##4##(1991-3#1)(1992-2#1)
The author suggests that the##2##5##(1996-12#1)(2007-11#1)
The author suggests that##4##4##(1991-11#1)(1993-2#1)(1996-12#1)(2007-11#1)
The author suggests##6##3##(1991-11#1)(1993-2#1)(1996-12#1)(1997-7#2)(2007-11#1)
The author##183##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-6#2)(1991-8#1)(1992-1#6)(1992-12#5)(1992-2#4)(1992-3#3)(1993-1#1)(1993-12#5)(1993-2#9)(1993-3#3)(1993-6#4)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#8)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(2007-11#2)(2007-8#14)(2008-1#4)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#7)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#4)(2011-2#9)(2011-3#2)(2012-12#3)(2012-2#1)
The author's##3##2##(1994-3#1)(2008-1#1)(2012-12#1)
The authors advocate##2##3##(1996-8#1)(2007-12#1)
The authors also describe##2##4##(2010-8#1)(2012-1#1)
The authors also provide##2##4##(1992-12#1)(2008-9#1)
The authors also##10##3##(1990-11#1)(1992-12#2)(1994-3#1)(2008-11#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-1#1)
The authors analyse the##3##4##(1991-3#1)(1991-6#1)(1993-9#1)
The authors analyze in##2##4##(1991-6#1)(1995-5#1)
The authors analyze##4##3##(1991-6#1)(1992-2#1)(1995-5#1)(1996-3#1)
The authors are presenting##3##4##(1996-7#1)(2007-8#1)(2011-2#1)
The authors argue that the##3##5##(1991-12#1)(1993-6#1)(1997-3#1)
The authors argue that##6##4##(1991-12#1)(1993-6#1)(1997-3#1)(2007-8#1)(2008-11#2)
The authors believe that the##2##5##(2008-5#1)(2008-9#1)
The authors believe that##4##4##(1993-9#1)(2007-11#1)(2008-5#1)(2008-9#1)
The authors believe the##2##4##(1990-6#1)(2008-6#1)
The authors believe##6##3##(1990-6#1)(1993-9#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-9#1)
The authors briefly##2##3##(1996-9#1)(2013-8#1)
The authors conclude that##9##4##(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(2008-10#2)
The authors conclude##13##3##(1990-6#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-8#1)
The authors concluded that##2##4##(2009-3#1)(2010-10#1)
The authors conducted a##4##4##(1994-2#1)(1995-2#1)(1996-3#1)(2013-8#1)
The authors consider##2##3##(1995-2#1)(2013-8#1)
The authors deal##2##3##(1990-11#1)(1993-2#1)
The authors describe a case of primary##2##7##(1991-6#1)(1992-8#1)
The authors describe a case of##3##6##(1991-6#1)(1992-8#1)(2008-12#1)
The authors describe a rare case of##2##7##(1993-5#1)(2011-2#1)
The authors describe a##19##4##(1991-2#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-5#1)(1995-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)
The authors describe the case of a##3##7##(2008-7#1)(2010-1#1)(2011-1#1)
The authors describe the case of##4##6##(1994-9#1)(2008-7#1)(2010-1#1)(2011-1#1)
The authors describe the##21##4##(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#1)(2013-1#1)
The authors describe their experience with##2##6##(1990-8#1)(1991-2#1)
The authors describe two cases of##4##6##(1990-10#1)(1993-6#1)(1997-6#1)(2007-8#1)
The authors describe two cases##5##5##(1990-10#1)(1993-6#1)(1997-6#1)(2007-8#1)(2011-2#1)
The authors describe##54##3##(1990-10#1)(1990-8#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-5#2)(1993-6#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#2)(2010-1#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
The authors determined##2##3##(1990-9#1)(2010-10#1)
The authors developed a##2##4##(1992-3#1)(2011-1#1)
The authors developed an##2##4##(1995-6#1)(2012-1#1)
The authors developed##5##3##(1992-3#1)(1994-3#1)(1995-6#1)(2011-1#1)(2012-1#1)
The authors discuss the##14##4##(1991-12#1)(1991-4#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-6#1)(2007-11#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-3#1)
The authors discuss##27##3##(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-6#1)(2006-7#1)(2007-11#1)(2008-9#3)(2011-2#1)(2011-7#1)(2012-3#1)
The authors emphasize the importance of##2##6##(1990-10#1)(1991-8#1)
The authors emphasize the##3##4##(1990-10#1)(1991-8#1)(2011-2#1)
The authors evaluate##2##3##(1990-3#1)(2011-3#1)
The authors evaluated the##2##4##(1991-2#1)(2011-2#1)
The authors evaluated##3##3##(1991-12#1)(1991-2#1)(2011-2#1)
The authors examine the##4##4##(1990-6#1)(1994-2#1)(1996-2#1)(2010-8#1)
The authors examine##5##3##(1990-6#1)(1991-2#1)(1994-2#1)(1996-2#1)(2010-8#1)
The authors examined##5##3##(1990-10#1)(1993-12#1)(1997-3#1)(2009-5#1)(2010-5#1)
The authors explore the##2##4##(1994-12#1)(1995-1#1)
The authors explore##3##3##(1994-12#1)(1994-2#1)(1995-1#1)
The authors found that##3##4##(1992-5#1)(1996-1#1)(2011-2#1)
The authors found##4##3##(1992-5#1)(1996-1#1)(2011-2#1)(2013-8#1)
The authors have developed##3##4##(2008-4#1)(2008-9#1)(2011-2#1)
The authors have studied##2##4##(2011-1#2)
The authors have##16##3##(1992-5#1)(1993-11#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-3#1)
The authors hypothesize that##2##4##(1995-12#1)(2008-11#1)
The authors identify##2##3##(1996-2#1)(2008-2#1)
The authors investigate the##4##4##(1995-3#1)(1996-2#1)(1996-3#1)(2008-9#1)
The authors of the present##2##5##(2009-10#1)(2012-3#1)
The authors of this Roundtable##2##5##(2013-1#2)
The authors of this article##2##5##(1993-3#1)(1997-4#1)
The authors of this##6##4##(1993-3#1)(1996-12#1)(1997-4#1)(2012-3#1)(2013-1#2)
The authors of##8##3##(1993-3#1)(1996-12#1)(1997-4#1)(2009-10#1)(2012-3#2)(2013-1#2)
The authors performed##2##3##(1993-3#1)(2009-10#1)
The authors present a case of##6##6##(1991-6#1)(1993-5#1)(2008-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
The authors present a case##7##5##(1991-6#1)(1993-5#1)(2007-10#1)(2008-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
The authors present a##15##4##(1991-6#1)(1993-1#1)(1993-5#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
The authors present an##4##4##(1997-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
The authors present the case of a##4##7##(2008-1#1)(2008-10#1)(2011-2#2)
The authors present the case of##5##6##(2008-1#1)(2008-10#1)(2011-2#2)(2012-3#1)
The authors present the results of##2##6##(1991-12#1)(2007-11#1)
The authors present the##11##4##(1991-12#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#2)(2012-3#1)
The authors present##38##3##(1991-12#1)(1991-6#1)(1993-1#1)(1993-5#1)(1993-9#1)(1994-2#2)(1995-5#1)(1997-1#1)(2007-10#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-3#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-3#2)
The authors presented##2##3##(2011-1#1)(2012-3#1)
The authors propose a definition of CS inclusive of the multifarious uses that were revealed in the literature##2##18##(2013-1#2)
The authors propose a##5##4##(1996-1#1)(1996-3#1)(2007-11#1)(2013-1#2)
The authors propose that##2##4##(1993-12#1)(2008-7#1)
The authors propose##10##3##(1993-12#1)(1995-11#1)(1996-1#1)(1996-3#1)(2007-11#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#2)
The authors provide##4##3##(1992-2#1)(1997-1#1)(2008-9#2)
The authors recommend that##3##4##(1993-12#1)(1996-9#1)(2006-10#1)
The authors recommend##8##3##(1993-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
The authors report a case of a##5##7##(1992-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
The authors report a case of primary##2##7##(1992-2#1)(2008-1#1)
The authors report a case of severe##2##7##(1990-10#1)(2013-8#1)
The authors report a case of##16##6##(1990-10#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-6#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#2)
The authors report a case##17##5##(1990-10#1)(1990-2#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-6#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#2)
The authors report a new case##2##6##(1991-11#1)(2010-8#1)
The authors report a new##3##5##(1991-11#1)(1994-3#1)(2010-8#1)
The authors report a rare case of##2##7##(1991-12#1)(2008-12#1)
The authors report a retrospective##2##5##(1993-5#1)(2011-2#1)
The authors report a##31##4##(1990-10#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-5#2)(1993-9#1)(1994-3#1)(1994-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#4)(2009-2#1)(2010-12#1)(2010-8#2)(2011-1#4)(2011-2#2)(2013-8#3)
The authors report an unusual##2##5##(2009-10#1)(2012-3#1)
The authors report an##4##4##(2007-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
The authors report on a consecutive series of##2##8##(1990-8#1)(1991-8#1)
The authors report on a consecutive##3##6##(1990-12#1)(1990-8#1)(1991-8#1)
The authors report on a##7##5##(1990-12#1)(1990-8#1)(1991-8#1)(1992-8#1)(1996-2#1)(1996-3#1)(2006-12#1)
The authors report on##11##4##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-9#1)(1996-2#1)(1996-3#1)(2006-12#2)
The authors report the case of a##4##7##(1991-11#2)(2008-7#1)(2011-2#1)
The authors report the##12##4##(1991-11#2)(1993-12#1)(1993-9#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)
The authors report their experience of##3##6##(1990-3#1)(1993-5#1)(1993-9#1)
The authors report their experience##7##5##(1990-3#1)(1991-3#1)(1992-5#2)(1993-5#1)(1993-9#2)
The authors report their own experience with percutaneous vertebroplasty##2##9##(2007-11#1)(2007-8#1)
The authors report their##10##4##(1990-3#1)(1991-3#1)(1992-5#2)(1993-5#1)(1993-9#3)(2007-11#1)(2007-8#1)
The authors report##80##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#5)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-5#4)(1992-8#1)(1993-12#1)(1993-5#3)(1993-9#6)(1994-2#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#2)(1997-3#1)(2006-12#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-12#1)(2012-3#1)(2013-8#3)
The authors reports##2##3##(1992-5#1)(2010-12#1)
The authors respond##2##3##(2008-11#2)
The authors review the published##2##5##(1995-2#1)(2008-12#1)
The authors review the##12##4##(1992-10#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)
The authors review##18##3##(1991-2#1)(1992-10#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-12#2)(2009-5#1)(2011-2#2)
The authors reviewed##4##3##(1991-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
The authors studied the##4##4##(1990-12#1)(1991-4#1)(1992-5#1)(2008-10#1)
The authors studied##5##3##(1990-12#1)(1990-3#1)(1991-4#1)(1992-5#1)(2008-10#1)
The authors suggest that##6##4##(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
The authors suggest ways##2##4##(1994-3#1)(1996-12#1)
The authors suggest##9##3##(1991-3#1)(1994-3#1)(1996-12#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
The authors tested##2##3##(1990-3#1)(1995-3#1)
The authors then##3##3##(1997-2#1)(2011-2#1)(2012-3#1)
The authors underline##2##3##(1996-3#1)(1997-6#1)
The authors use a##2##4##(2008-3#1)(2009-11#1)
The authors use##3##3##(1994-3#1)(2008-3#1)(2009-11#1)
The authors used##3##3##(1992-2#1)(1992-3#1)(1995-1#1)
The authors##479##2##(1990-10#4)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#5)(1990-6#4)(1990-8#2)(1990-9#2)(1991-11#8)(1991-12#6)(1991-2#7)(1991-3#5)(1991-4#3)(1991-6#8)(1991-8#2)(1992-1#1)(1992-10#3)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#9)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#13)(1993-2#3)(1993-3#5)(1993-5#8)(1993-6#9)(1993-9#10)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#8)(1994-6#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#6)(1995-5#2)(1995-6#1)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#11)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#3)(2006-10#1)(2006-12#3)(2006-7#2)(2007-10#1)(2007-11#11)(2007-12#2)(2007-8#12)(2008-1#4)(2008-10#8)(2008-11#12)(2008-12#6)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#11)(2008-9#20)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2010-1#2)(2010-10#6)(2010-12#5)(2010-3#5)(2010-4#4)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#14)(2011-2#29)(2011-3#2)(2011-7#4)(2012-1#3)(2012-12#7)(2012-2#1)(2012-3#12)(2013-1#6)(2013-8#8)
The authors' own experience]##2##4##(1992-3#2)
The authors'##11##2##(1992-3#2)(1993-12#2)(1993-9#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-3#1)
The autocorrelation function of the##2##5##(2008-3#2)
The autocorrelation function##3##3##(2007-11#1)(2008-3#2)
The automated##3##2##(2008-10#2)(2010-8#1)
The automatic##7##2##(2008-10#3)(2008-2#1)(2009-10#1)(2010-4#1)(2013-8#1)
The automation of the##2##4##(2008-10#2)
The availability of complete##2##4##(2008-7#1)(2008-9#1)
The availability of new##2##4##(2008-3#1)(2008-9#1)
The availability of recombinant human##2##5##(1996-11#1)(1997-8#1)
The availability of the##6##4##(1991-12#1)(1992-11#1)(1994-6#1)(1997-7#1)(2008-7#1)(2008-9#1)
The availability of these##2##4##(1993-2#1)(2008-10#1)
The availability of this##2##4##(1992-10#1)(1993-11#1)
The availability of##41##3##(1991-12#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#5)(2008-9#5)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
The availability##42##2##(1991-12#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#5)(2008-9#5)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
The available data##2##3##(1991-12#1)(2007-2#1)
The available evidence suggests that##2##5##(1991-12#1)(2013-1#1)
The available evidence suggests##3##4##(1991-12#1)(2011-1#1)(2013-1#1)
The available evidence##5##3##(1991-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
The available knowledge##2##3##(1991-12#1)(2013-1#1)
The available##13##2##(1991-12#3)(2007-2#1)(2008-10#2)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
The average DAS for##2##4##(2008-1#2)
The average accuracies##2##3##(2008-10#1)(2012-2#1)
The average age at which##2##5##(1991-8#2)
The average age at##6##4##(1991-8#2)(1997-7#1)(2007-8#1)(2009-10#1)(2011-2#1)
The average age of patients##2##5##(2008-9#1)(2013-1#1)
The average age of the patients was##2##7##(2007-7#1)(2011-1#1)
The average age of##5##4##(2007-2#1)(2007-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
The average age was##6##4##(2007-8#1)(2008-5#1)(2011-2#2)(2013-1#2)
The average age##19##3##(1991-8#2)(1997-7#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#3)(2013-1#5)
The average annual##3##3##(1996-8#1)(2011-2#2)
The average cell##2##3##(2008-10#1)(2008-9#1)
The average concentrations##2##3##(2008-10#2)
The average cost of##2##4##(1994-5#1)(2010-5#1)
The average distance between##2##4##(1991-5#1)(1997-5#1)
The average distance of##2##4##(2008-10#2)
The average distance##4##3##(1991-5#1)(1997-5#1)(2008-10#2)
The average duration of a time series was##2##8##(2009-9#2)
The average duration of care##2##5##(1991-12#2)
The average duration of the##2##5##(1994-11#1)(2013-8#1)
The average duration of##9##4##(1990-2#1)(1991-12#3)(1994-11#1)(2009-9#2)(2013-1#1)(2013-8#1)
The average follow-up period was##2##5##(2007-11#2)
The average follow-up was 10##2##5##(1996-9#1)(2008-9#1)
The average follow-up was##3##4##(1996-9#1)(2008-9#1)(2009-10#1)
The average follow-up##8##3##(1996-9#1)(2007-11#3)(2007-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
The average hospital stay was##2##5##(2007-7#1)(2007-8#1)
The average intensity##2##3##(2007-11#1)(2013-8#1)
The average length of##3##4##(1992-2#1)(2008-10#1)(2008-5#1)
The average length##4##3##(1992-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
The average molar absorption coefficient and Sandell's sensitivity were found to be 4##2##13##(2008-10#2)
The average molar##3##3##(2008-10#2)(2013-1#1)
The average number of##6##4##(1990-9#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-9#1)(2011-2#1)
The average number##7##3##(1990-9#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
The average output power##2##4##(2008-3#2)
The average patient##3##3##(1995-3#1)(2007-12#1)(2008-6#1)
The average rate of albumin secretion for the initial##2##9##(2008-11#2)
The average recoveries of##6##4##(2008-10#2)(2008-5#1)(2011-1#3)
The average recoveries##11##3##(2008-10#6)(2008-5#1)(2011-1#4)
The average recovery for these samples was##2##7##(2008-10#2)
The average recovery for##4##4##(2008-10#3)(2008-5#1)
The average recovery of##2##4##(2008-10#2)
The average recovery##7##3##(2008-10#6)(2008-5#1)
The average roughness##2##3##(2007-12#1)(2008-3#1)
The average signal##2##3##(2008-10#1)(2008-3#1)
The average size of the##2##5##(1996-10#1)(1996-2#1)
The average size of##3##4##(1996-10#1)(1996-2#1)(2013-7#1)
The average survival of##2##4##(1990-2#1)(1994-6#1)
The average survival time##2##4##(1997-4#1)(2013-1#1)
The average survival##4##3##(1990-2#1)(1994-6#1)(1997-4#1)(2013-1#1)
The average time to##3##4##(2008-8#2)(2013-8#1)
The average time##4##3##(1996-9#1)(2008-8#2)(2013-8#1)
The average total##2##3##(1996-12#1)(2011-2#1)
The average values##2##3##(2008-10#1)(2008-7#1)
The average volume of procedures per full-time-equivalent staff is provided for technologists##2##12##(1994-1#1)(1994-2#1)
The average##202##2##(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-8#2)(1992-2#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-3#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#2)(1997-4#2)(1997-5#3)(1997-7#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#11)(2008-1#3)(2008-10#32)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#8)(2009-10#2)(2009-11#1)(2009-2#1)(2009-9#2)(2010-5#2)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-2#4)(2013-1#12)(2013-7#1)(2013-8#6)
The averages of##2##3##(2012-12#1)(2013-8#1)
The averages##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
The axial##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
The axon##2##2##(2008-5#1)(2009-7#1)
The axoneme##2##2##(2008-7#2)
The azo##2##2##(2008-10#2)
The baby##3##2##(1992-4#1)(1995-4#1)(2008-10#1)
The backbone and side chain##2##5##(2009-7#2)
The backbone##3##2##(2009-7#3)
The background##4##2##(1994-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
The backscattering##2##2##(2008-2#1)(2008-3#1)
The backward##3##2##(2007-12#2)(2008-3#1)
The bacteria are##2##3##(1991-2#1)(2007-12#1)
The bacteria##5##2##(1991-2#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#1)
The bacterial##5##2##(1992-3#1)(2008-10#1)(2008-5#2)(2011-2#1)
The bacterially expressed##2##3##(1994-8#1)(2010-4#1)
The bacterium multiplied##2##3##(2008-10#2)
The bacterium was##3##3##(2008-10#2)(2011-2#1)
The bacterium##10##2##(2008-10#5)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#1)
The baculovirus expression system was used##2##6##(1991-2#1)(1997-4#1)
The baculovirus expression system##3##4##(1991-2#1)(1997-4#2)
The baculovirus expression vector##2##4##(1997-4#2)
The baculovirus expression##5##3##(1991-2#1)(1997-4#4)
The baculovirus##7##2##(1991-2#2)(1997-4#4)(2008-11#1)
The balance between##2##3##(2007-5#1)(2010-10#1)
The balance of##2##3##(2009-10#1)(2012-2#1)
The balance##4##2##(2007-5#1)(2009-10#1)(2010-10#1)(2012-2#1)
The balancing act of##2##4##(1994-2#1)(2008-8#1)
The balloon was##3##3##(1997-6#3)
The band##2##2##(2008-2#1)(2013-8#1)
The banding##2##2##(2008-10#1)(2008-5#1)
The bandwidth of the##2##4##(2008-2#1)(2008-3#1)
The bandwidth of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
The bandwidth##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
The barley cv##2##3##(2008-10#2)
The barley##5##2##(1995-6#1)(2008-10#3)(2008-8#1)
The barrier to##2##3##(1996-2#1)(2008-10#1)
The barrier##6##2##(1992-3#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-7#1)
The basal and##2##3##(2007-8#1)(2011-2#1)
The basal rate of hepatic glucose##2##6##(1991-7#2)
The basal##15##2##(1990-8#1)(1991-2#1)(1991-7#2)(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
The base##5##2##(2008-10#2)(2008-5#2)(2011-2#1)
The baseline##4##2##(1992-2#1)(2008-1#1)(2008-10#1)(2008-12#1)
The basic calponin##2##3##(2008-6#2)
The basic idea of the##2##5##(2008-10#1)(2008-3#1)
The basic idea##4##3##(1997-2#1)(2008-10#1)(2008-3#2)
The basic principle##2##3##(2007-12#1)(2007-8#1)
The basic principles of##2##4##(2008-10#1)(2011-2#1)
The basic procedure##2##3##(1990-12#1)(1995-8#1)
The basic protocol describes a##2##5##(2008-4#2)
The basic protocol describes the##2##5##(2008-4#1)(2008-9#1)
The basic protocol describes##5##4##(2008-4#4)(2008-9#1)
The basic protocol in this unit##3##6##(2008-4#3)
The basic protocol is##4##4##(2008-1#1)(2008-4#3)
The basic protocol##17##3##(2008-1#1)(2008-4#13)(2008-9#3)
The basic##73##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#16)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2010-10#1)(2010-11#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
The basics of searching NLM's AIDS databases##2##7##(1995-3#1)(1996-1#1)
The basics of##4##3##(1995-3#1)(1996-1#1)(2008-2#1)(2011-2#1)
The basics##5##2##(1995-3#1)(1996-1#1)(2008-2#1)(2009-12#1)(2011-2#1)
The basis for the##5##4##(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
The basis for this##2##4##(1992-9#1)(2010-5#1)
The basis for##10##3##(1992-9#1)(1997-3#1)(2007-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
The basis of the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
The basis of##7##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
The basis##18##2##(1992-9#1)(1994-11#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
The basolateral membrane##2##3##(1990-2#1)(1994-6#1)
The batch##2##2##(2008-10#2)
The battle##2##2##(2007-12#1)(2008-4#1)
The beads##3##2##(2008-10#2)(2008-7#1)
The beam divergence##2##3##(1995-2#1)(2008-3#1)
The beam quality of##2##4##(2008-2#1)(2008-3#1)
The beam quality##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
The beam##10##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
The bean population##2##3##(2008-8#2)
The bean##3##2##(2008-10#1)(2008-8#2)
The beating##2##2##(1994-11#1)(2008-2#1)
The beginning of the##2##4##(1996-7#1)(2008-10#1)
The behavior of a##2##4##(1992-6#1)(2008-10#1)
The behavior of the##9##4##(1991-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2012-12#1)
The behavior of this##3##4##(1990-6#1)(1996-4#1)(2007-11#1)
The behavior of##20##3##(1990-6#1)(1990-7#1)(1991-2#1)(1992-6#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)
The behavior##22##2##(1990-6#1)(1990-7#1)(1991-2#1)(1992-6#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)
The behavioral##7##2##(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
The behaviour of the##2##4##(1990-12#1)(2008-10#1)
The behaviour of##6##3##(1990-12#1)(2008-10#5)
The behavioural##3##2##(1994-8#1)(1995-12#1)(2007-12#1)
The belief that screening is useless##2##6##(1991-6#1)(1992-2#1)
The belief that##3##3##(1991-6#1)(1992-2#1)(1993-12#1)
The belief##4##2##(1991-6#1)(1992-2#1)(1993-12#1)(2012-12#1)
The bending##3##2##(2007-11#1)(2007-12#1)(2009-7#1)
The beneficial effects##2##3##(1990-5#1)(2008-5#1)
The beneficial##5##2##(1990-5#1)(1991-2#1)(1995-5#1)(2008-5#1)(2012-12#1)
The benefit of##6##3##(1990-10#1)(1995-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
The benefits and##2##3##(2008-3#1)(2013-1#1)
The benefits from##2##3##(1992-8#1)(2008-3#1)
The benefits of the##2##4##(2008-11#1)(2008-7#1)
The benefits of these##3##4##(1990-3#1)(1990-9#1)(2011-2#1)
The benefits of this##2##4##(2007-12#1)(2008-7#1)
The benefits of##23##3##(1990-3#1)(1990-9#1)(1993-10#1)(1994-1#1)(1995-1#1)(1995-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)
The benefits##32##2##(1990-3#1)(1990-9#1)(1992-8#1)(1993-10#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#6)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
The benign##3##2##(1990-3#1)(2009-12#1)(2009-5#1)
The benthic##2##2##(2008-5#1)(2011-2#1)
The best agreement##2##3##(2008-12#1)(2008-3#1)
The best analytical##2##3##(2008-10#2)
The best approach##2##3##(1991-12#1)(2008-10#1)
The best conditions for##3##4##(1996-12#1)(2008-10#2)
The best conditions##4##3##(1996-12#1)(2008-10#3)
The best formulation (F4c)##2##4##(2012-2#2)
The best formulation##3##3##(2009-10#1)(2012-2#2)
The best known##2##3##(1995-5#1)(2008-8#1)
The best models##2##3##(2008-10#2)
The best of##2##3##(1991-6#1)(1993-2#1)
The best option##2##3##(2008-11#1)(2012-12#1)
The best osteogenic differentiation was observed in MPCs cultured in osteogenic medium containing##2##13##(2008-11#2)
The best overall##2##3##(2008-10#2)
The best performance was##5##4##(2008-10#5)
The best response##2##3##(1991-3#1)(1991-8#1)
The best result##4##3##(2007-10#1)(2007-11#1)(2008-10#2)
The best results for the##2##5##(2008-10#1)(2008-5#1)
The best results for##3##4##(2008-10#2)(2008-5#1)
The best results were obtained using##4##6##(2008-10#1)(2008-5#1)(2008-7#2)
The best results were obtained with##2##6##(2008-10#1)(2008-5#1)
The best results were obtained##9##5##(2008-10#4)(2008-5#2)(2008-7#2)(2012-1#1)
The best results were##12##4##(2007-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#2)(2010-4#1)(2012-1#1)
The best results##21##3##(1996-5#1)(2007-11#2)(2008-10#10)(2008-5#3)(2008-6#1)(2008-7#2)(2010-4#1)(2012-1#1)
The best values##2##3##(2008-10#1)(2008-3#1)
The best##128##2##(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-5#2)(2007-10#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#55)(2008-11#3)(2008-12#4)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
The beta##6##2##(1990-7#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-5#1)
The beta-amyloid peptide##2##3##(1992-12#1)(1995-12#1)
The beta-binomial distribution##2##3##(2008-10#2)
The beta-binomial##3##2##(2008-10#3)
The beta-subunit of##3##3##(1990-11#1)(1993-11#1)(1996-12#1)
The better##3##2##(1994-6#1)(2008-10#1)(2011-3#1)
The bias##5##2##(1994-2#2)(1995-12#1)(2008-10#1)(2008-3#1)
The bidirectional##2##2##(2008-3#1)(2008-7#1)
The bilateral nature of##2##4##(2008-5#1)(2012-2#1)
The bilateral##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
The bilayer##3##2##(1994-3#1)(1997-6#1)(2008-10#1)
The bill##2##2##(1996-5#1)(1997-5#1)
The binary##4##2##(2008-10#2)(2008-3#2)
The binding affinity of the##2##5##(1992-6#1)(1995-2#1)
The binding affinity of##3##4##(1992-6#1)(1995-2#1)(1995-5#1)
The binding and##3##3##(1992-9#1)(1994-5#1)(2008-10#1)
The binding assay##2##3##(1993-12#1)(2010-12#1)
The binding capacities##2##3##(1996-5#1)(2008-10#1)
The binding capacity and##2##4##(1997-6#1)(2008-10#1)
The binding characteristics##2##3##(1990-11#1)(1993-1#1)
The binding constant of the##2##5##(1993-8#1)(2008-10#1)
The binding constant of##3##4##(1993-8#1)(2008-10#2)
The binding constant##6##3##(1993-8#1)(1994-8#1)(2008-10#4)
The binding of [125I]IL-8##2##4##(1993-6#2)
The binding of the##2##4##(1994-5#1)(2008-7#1)
The binding of##30##3##(1990-5#1)(1990-7#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-2#2)(1995-5#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)
The binding site for##2##4##(1993-8#1)(1995-12#1)
The binding site##4##3##(1993-8#1)(1995-12#1)(2008-10#1)(2013-7#1)
The binding sites##2##3##(1990-11#1)(2008-10#1)
The binding to the##2##4##(1992-6#1)(2008-10#1)
The binding was inhibited##2##4##(1993-6#1)(1993-9#1)
The binding was##4##3##(1993-6#1)(1993-9#2)(2008-10#1)
The binding##78##2##(1990-11#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#4)(1996-5#1)(1997-6#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2013-7#1)(2013-8#1)
The binomial##2##2##(2008-10#2)
The bioactivity##2##2##(2008-10#1)(2008-5#1)
The bioassay##4##2##(2008-10#2)(2008-4#2)
The bioavailability##2##2##(2008-11#1)(2011-2#1)
The biochemical analysis##2##3##(2008-10#1)(2010-4#1)
The biochemical##9##2##(1991-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-4#1)(2013-1#1)
The biocontrol agent##2##3##(2008-10#2)
The biocontrol##3##2##(2008-10#3)
The biologic##5##2##(1991-2#1)(1991-3#2)(1991-6#1)(2007-8#1)
The biological activity of the##4##5##(1990-12#1)(1994-2#1)(1996-5#1)(2009-6#1)
The biological activity of##7##4##(1990-12#1)(1992-6#1)(1994-2#1)(1996-5#1)(2008-12#1)(2009-6#1)(2010-4#1)
The biological and##3##3##(1995-5#1)(2008-10#2)
The biological behavior of##2##4##(1990-6#1)(2008-8#1)
The biological effects##2##3##(1992-11#1)(2009-3#1)
The biological properties of##2##4##(2008-5#1)(2009-7#1)
The biological properties##3##3##(1992-6#1)(2008-5#1)(2009-7#1)
The biological relevance of##2##4##(1995-2#1)(1997-1#1)
The biological role of##2##4##(1991-2#1)(2013-7#1)
The biological significance of##2##4##(1990-12#1)(1994-11#1)
The biological##35##2##(1990-12#2)(1990-6#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-7#2)
The biology and##2##3##(2008-2#1)(2008-5#1)
The biology of##3##3##(1994-12#1)(2008-5#2)
The biology##5##2##(1994-12#1)(2008-2#1)(2008-5#3)
The biomass concentration##2##3##(2008-5#1)(2008-7#1)
The biomass of##3##3##(2008-10#1)(2008-5#2)
The biomass##7##2##(2008-10#2)(2008-5#3)(2008-7#2)
The bioprocess QbD##2##3##(2012-2#2)
The bioprocess##3##2##(2008-6#1)(2012-2#2)
The bioreactor##2##2##(2008-11#2)
The biosensor can##2##3##(2008-10#2)
The biosensor is based on##2##5##(2008-10#2)
The biosensor is##4##3##(2008-10#4)
The biosensor response depends linearly on##4##6##(2008-10#4)
The biosensor showed##2##3##(2008-10#2)
The biosensor was##3##3##(2008-10#2)(2010-5#1)
The biosensor##31##2##(2008-10#30)(2010-5#1)
The biosensors were##3##3##(2008-10#3)
The biosensors##9##2##(2008-10#9)
The biosynthesis of##4##3##(1993-12#1)(1994-8#1)(2011-1#1)(2012-2#1)
The biosynthesis##5##2##(1990-5#1)(1993-12#1)(1994-8#1)(2011-1#1)(2012-2#1)
The biotherapy##2##2##(2013-1#2)
The biotinylated##2##2##(1995-6#1)(2008-10#1)
The biphasic##2##2##(1992-9#1)(1994-5#1)
The birds were##4##3##(1995-12#1)(1997-3#1)(2008-5#1)(2010-4#1)
The birds##8##2##(1995-12#1)(1997-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#2)
The birefringence of a##2##4##(2007-12#1)(2008-3#1)
The birefringence of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
The birefringence##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
The birth##3##2##(1994-3#1)(2007-12#1)(2008-10#1)
The bisphosphonate##3##2##(2007-11#1)(2008-11#1)(2008-8#1)
The bit-error rate##2##3##(2008-2#2)
The bladder##2##2##(1992-11#1)(1992-3#1)
The blank##2##2##(2008-10#2)
The bleeding##2##2##(2008-7#1)(2008-9#1)
The block of##2##3##(1993-9#1)(2008-4#1)
The block##3##2##(1993-9#1)(2008-4#1)(2008-7#1)
The blood film##2##3##(1995-3#1)(2007-7#1)
The blood flow of the##2##5##(2007-10#1)(2008-10#1)
The blood flow##4##3##(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)
The blood glucose##2##3##(2008-12#1)(2011-3#1)
The blood pressure##5##3##(1996-6#1)(2008-1#1)(2008-3#1)(2010-5#1)(2013-1#1)
The blood##20##2##(1990-11#1)(1990-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-1#1)
The blood-brain barrier##2##3##(2008-5#1)(2008-7#1)
The blue shift of the##2##5##(1991-12#1)(2008-2#1)
The blue##5##2##(1991-12#1)(1994-5#1)(2008-10#2)(2008-2#1)
The blueprint##2##2##(1995-12#1)(1997-3#1)
The blur caused by##2##4##(2008-3#2)
The body length of##2##4##(2013-1#2)
The body of##2##3##(2007-12#1)(2008-10#1)
The body weight##2##3##(2008-12#1)(2008-5#1)
The body##13##2##(1996-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#2)(2009-7#1)(2013-1#2)
The bolometer array demonstrates##3##4##(2008-3#3)
The bolus##3##2##(2008-10#1)(2013-8#2)
The bone marrow##2##3##(2010-8#1)(2013-8#1)
The bone mineral##2##3##(1990-11#1)(2007-11#1)
The bone##10##2##(1990-11#1)(1995-6#1)(2006-10#1)(2007-11#3)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
The boron##2##2##(1990-3#1)(2008-10#1)
The bound##2##2##(1990-12#1)(2007-11#1)
The boundary between##2##3##(2008-10#1)(2008-12#1)
The boundary##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
The bovine##5##2##(1993-2#1)(1994-5#1)(1997-2#1)(2008-10#1)(2010-4#1)
The brain##11##2##(1993-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-8#1)
The brains##2##2##(2008-5#1)(2008-7#1)
The branching patterns##2##3##(1997-3#1)(2010-8#1)
The branching##4##2##(1997-3#1)(2008-3#1)(2010-10#1)(2010-8#1)
The brave new world of##2##5##(1991-3#1)(1997-2#1)
The breakthrough capacity was##2##4##(2008-10#2)
The breakthrough capacity##3##3##(2008-10#3)
The breakthrough##4##2##(2008-10#4)
The breast##2##2##(2010-8#1)(2012-12#1)
The breathing##2##2##(1991-3#1)(1996-2#1)
The breeding##2##2##(1995-2#1)(2008-9#1)
The bright##2##2##(1991-5#1)(2013-1#1)
The broad##4##2##(2007-11#1)(2008-11#1)(2009-5#1)(2013-8#1)
The broadband##3##2##(2008-2#1)(2008-3#2)
The broader##2##2##(2008-10#1)(2013-1#1)
The broken##2##2##(2008-11#1)(2010-9#1)
The bronchial##2##2##(1992-3#1)(2008-6#1)
The budget##3##2##(1996-5#1)(1997-3#1)(2008-6#1)
The buffer solution used##2##4##(2008-10#2)
The buffer##3##2##(2008-10#3)
The bulk of##2##3##(1996-5#1)(2008-8#1)
The bulk##4##2##(1996-5#1)(2008-10#2)(2008-8#1)
The bundle##2##2##(2008-2#1)(2008-3#1)
The burden of##8##3##(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-12#3)
The burden##9##2##(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#3)
The buried##2##2##(1991-8#1)(2008-2#1)
The burst##2##2##(1996-2#1)(2007-12#1)
The business of##2##3##(2007-4#1)(2008-4#1)
The business##4##2##(1994-12#1)(2007-4#1)(2008-1#1)(2008-4#1)
The c-erbA alpha##2##3##(1993-3#2)
The c-myc##3##2##(1992-9#1)(1993-2#1)(1993-3#1)
The cAMP##2##2##(1995-8#1)(2008-11#1)
The cDNA clone##2##3##(1991-11#1)(1997-2#1)
The cDNA clones##3##3##(1997-2#1)(2008-11#1)(2010-4#1)
The cDNA coding for##2##4##(1993-6#1)(1995-2#1)
The cDNA encodes a##2##4##(1994-12#1)(2008-6#1)
The cDNA encoding##4##3##(1990-8#2)(2008-10#1)(2008-9#1)
The cDNA for the##2##4##(1995-2#1)(1997-9#1)
The cDNA for##5##3##(1993-6#1)(1995-2#1)(1997-9#1)(2008-8#1)(2010-5#1)
The cDNA insert##3##3##(1990-7#1)(1991-12#1)(1994-8#1)
The cDNA of##2##3##(1990-12#1)(1994-11#1)
The cDNA sequence##6##3##(1991-6#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-6#2)
The cDNA##37##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-6#2)(1997-2#3)(1997-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#3)
The cDNAs of##2##3##(2008-10#1)(2008-8#1)
The cDNAs##5##2##(1992-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
The cTR##2##2##(1991-6#2)
The cadmium##2##2##(2008-10#2)
The calanolides##2##2##(1992-8#2)
The calculated and measured##2##4##(2008-2#2)
The calculated and##3##3##(2008-2#3)
The calculated detection limits##2##4##(2008-10#2)
The calculated detection##3##3##(2008-10#3)
The calculated rates of##2##4##(1991-3#1)(2008-11#1)
The calculated relative energies of these geometries are compared to those calculated by various wave function and density functional methods##2##20##(2012-12#2)
The calculated results show##2##4##(2008-10#1)(2009-11#1)
The calculated##42##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#3)(2008-5#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
The calculation of##6##3##(1994-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2013-1#1)
The calculation yields high##2##4##(2007-12#2)
The calculation##10##2##(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-7#1)(2013-1#1)
The calculations indicate that the electronic coupling terms are significantly higher for the cis isomer##2##15##(2010-2#2)
The calculations indicate that the##3##5##(2008-2#1)(2010-2#2)
The calculations show##2##3##(2007-11#1)(2007-12#1)
The calculations##14##2##(1991-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-2#2)(2010-4#1)
The calibration curve for##4##4##(2008-10#4)
The calibration curve is linear over the concentration range 0##2##10##(2008-10#2)
The calibration curve is linear over the##3##7##(2008-10#3)
The calibration curve is linear over##4##6##(2008-10#4)
The calibration curve is linear##8##5##(2008-10#8)
The calibration curve is##10##4##(2008-10#10)
The calibration curve of##2##4##(2008-10#2)
The calibration curve was found to be linear##2##8##(2008-10#1)(2012-2#1)
The calibration curve was linear from##2##6##(2008-10#2)
The calibration curve was linear in the range##2##8##(2008-10#2)
The calibration curve was linear in the##3##7##(2008-10#3)
The calibration curve was linear over the concentration range##2##9##(2008-10#2)
The calibration curve was linear over the range##3##8##(2008-10#3)
The calibration curve was linear over the##5##7##(2008-10#5)
The calibration curve was linear over##6##6##(2008-10#5)(2011-2#1)
The calibration curve was linear up to##3##7##(2008-10#3)
The calibration curve was linear##14##5##(2008-10#13)(2011-2#1)
The calibration curve was##17##4##(2008-10#15)(2011-2#1)(2012-2#1)
The calibration curve##36##3##(1991-5#1)(2008-10#33)(2011-2#1)(2012-2#1)
The calibration curves for##3##4##(1990-8#1)(2008-10#2)
The calibration curves of##3##4##(2008-10#2)(2012-1#1)
The calibration curves showed good##2##5##(2008-10#1)(2011-1#1)
The calibration curves showed##3##4##(2008-10#2)(2011-1#1)
The calibration curves were linear in the range of##2##9##(2008-10#2)
The calibration curves were linear in the##3##7##(2008-10#3)
The calibration curves were linear over the range##2##8##(2008-10#2)
The calibration curves were linear over the##3##7##(2008-10#3)
The calibration curves were linear over##4##6##(2008-10#4)
The calibration curves were linear##7##5##(2008-10#7)
The calibration curves were##8##4##(2008-10#8)
The calibration curves##19##3##(1990-8#1)(2008-10#16)(2011-1#1)(2012-1#1)
The calibration equation##2##3##(2008-2#2)
The calibration function##2##3##(2008-10#2)
The calibration graph for##4##4##(2008-10#4)
The calibration graph is linear in the range of##3##9##(2008-10#3)
The calibration graph is linear in the range##4##8##(2008-10#4)
The calibration graph is linear over the range 0##2##9##(2008-10#2)
The calibration graph is linear over the##3##7##(2008-10#3)
The calibration graph is linear##8##5##(2008-10#8)
The calibration graph of##3##4##(2008-10#3)
The calibration graph using the preconcentration system for##3##8##(2008-10#3)
The calibration graph using the##4##5##(2008-10#4)
The calibration graph was linear from##3##6##(2008-10#3)
The calibration graph was linear in the range 0##2##9##(2008-10#2)
The calibration graph was linear in the range of##3##9##(2008-10#3)
The calibration graph was linear in the range##8##8##(2008-10#8)
The calibration graph was linear in the##10##7##(2008-10#10)
The calibration graph was linear over the range 0##2##9##(2008-10#2)
The calibration graph was linear over the range##3##8##(2008-10#3)
The calibration graph was linear over##5##6##(2008-10#5)
The calibration graph was linear up to##3##7##(2008-10#3)
The calibration graph was linear##22##5##(2008-10#22)
The calibration graph was##23##4##(2008-10#23)
The calibration graph##47##3##(2008-10#47)
The calibration graphs are linear##2##5##(2008-10#2)
The calibration graphs for##3##4##(2008-10#3)
The calibration graphs of##2##4##(2008-10#2)
The calibration graphs were linear in the concentration##2##8##(2008-10#2)
The calibration graphs were linear in the range of##2##9##(2008-10#2)
The calibration graphs were linear in the##4##7##(2008-10#4)
The calibration graphs were linear##8##5##(2008-10#8)
The calibration graphs were##10##4##(2008-10#10)
The calibration graphs##21##3##(2008-10#21)
The calibration of##2##3##(2008-10#1)(2008-3#1)
The calibration plot was linear##2##5##(2008-10#2)
The calibration plot##5##3##(2008-10#5)
The calibration plots for##2##4##(2008-10#2)
The calibration plots##4##3##(2008-10#4)
The calibration range##2##3##(2008-10#2)
The calibration set was##3##4##(2008-10#3)
The calibration set##4##3##(2008-10#4)
The calibration was##2##3##(2008-10#2)
The calibration##157##2##(1990-8#1)(1991-5#1)(2008-10#146)(2008-2#2)(2008-3#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
The callus##2##2##(2008-12#1)(2008-8#1)
The calorimetric##2##2##(2008-10#1)(2008-8#1)
The camera##3##2##(1994-5#1)(2008-3#2)
The campaign##4##2##(1991-9#1)(1992-2#1)(1996-8#1)(1997-6#1)
The candidate##2##2##(1994-12#1)(2008-10#1)
The canine##2##2##(2008-9#1)(2010-3#1)
The cannabinoid##2##2##(1996-2#1)(2009-8#1)
The capabilities of##4##3##(2008-10#4)
The capabilities##5##2##(2008-10#4)(2008-2#1)
The capability of the method##2##5##(2008-10#1)(2012-2#1)
The capability of the##7##4##(1996-12#1)(2008-10#3)(2008-3#2)(2012-2#1)
The capability of##10##3##(1996-12#1)(2008-10#5)(2008-3#2)(2008-4#1)(2012-2#1)
The capability##11##2##(1993-8#1)(1996-12#1)(2008-10#5)(2008-3#2)(2008-4#1)(2012-2#1)
The capacitance measurement##2##3##(2008-10#2)
The capacitance##3##2##(2008-10#3)
The capacities of the##2##4##(2008-10#2)
The capacity of the##8##4##(1994-5#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-4#1)
The capacity of##16##3##(1994-5#1)(1995-5#1)(2008-10#8)(2008-11#4)(2008-4#1)(2011-1#1)
The capacity to##2##3##(1997-3#1)(2008-2#1)
The capacity##20##2##(1994-5#1)(1995-5#1)(1997-3#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-4#1)(2011-1#1)
The capillary##2##2##(1997-2#1)(2008-10#1)
The capture of##2##3##(1997-4#1)(2008-5#1)
The carbohydrate##2##2##(1991-12#1)(1992-8#1)
The carbon##7##2##(1992-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-7#1)
The carboxy-terminal##3##2##(1991-9#1)(1997-4#1)(2009-7#1)
The carboxyl##2##2##(1996-12#1)(2008-10#1)
The carboxyl-terminal##2##2##(1992-11#1)(1995-6#1)
The carcinogenic##2##2##(1990-7#1)(1990-8#1)
The cardiac##2##2##(1990-2#1)(1991-5#1)
The cardinal##2##2##(1994-8#1)(2009-4#1)
The cardiovascular diseases are##2##4##(2008-10#2)
The cardiovascular##5##2##(1990-5#1)(2008-10#3)(2012-2#1)
The care##3##2##(1991-12#1)(1993-3#1)(2008-9#1)
The carotid duplex scanning results##2##5##(2008-7#2)
The carpal tunnel anatomy and##2##5##(2008-9#2)
The carpal##3##2##(2008-9#2)(2012-1#1)
The carrier stream##2##3##(2008-10#2)
The carrier##7##2##(1994-5#2)(2007-12#1)(2008-10#3)(2008-7#1)
The case against##4##3##(1997-3#1)(2007-12#1)(2007-2#1)(2008-2#1)
The case for pet wellness and routine monitoring - A##2##10##(2013-8#2)
The case for risk-based##2##4##(2008-7#2)
The case for##10##3##(1995-3#1)(1997-2#2)(2008-11#2)(2008-7#2)(2009-5#1)(2013-8#2)
The case is described of##2##5##(2008-2#1)(2008-4#1)
The case is presented##2##4##(2008-10#1)(2012-2#1)
The case is reported of a##2##6##(1990-6#1)(1991-3#1)
The case is reported##5##4##(1990-6#1)(1991-3#1)(1992-6#1)(2008-2#1)(2010-5#1)
The case is##11##3##(1990-6#1)(1991-3#1)(1992-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-5#1)(2012-2#1)
The case of a patient with##2##6##(1990-8#1)(1991-11#1)
The case of a##15##4##(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-2#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#4)
The case of an##2##4##(2008-11#1)(2013-8#1)
The case of the##2##4##(1997-3#1)(2008-11#1)
The case of##31##3##(1990-8#2)(1991-11#1)(1991-12#1)(1991-6#2)(1991-8#1)(1993-2#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#5)(2013-8#1)
The case presented here##2##4##(2011-2#1)(2013-1#1)
The case presented##3##3##(2011-2#1)(2013-1#2)
The case report##5##3##(1997-8#1)(2007-12#1)(2008-11#2)(2012-3#1)
The case study is##2##4##(1994-12#1)(2008-1#1)
The case study##8##3##(1994-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)
The case was##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
The case##95##2##(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-5#2)(1996-3#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#3)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
The cases suggest that##2##4##(1991-1#1)(1995-6#1)
The cases were##4##3##(1993-9#2)(1996-6#1)(2012-3#1)
The cases##15##2##(1991-1#1)(1993-9#2)(1995-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
The catalytic action of##2##4##(2008-10#2)
The catalytic activities of##2##4##(1993-2#1)(1994-5#1)
The catalytic activity of##4##4##(1997-8#1)(2008-10#3)
The catalytic current##2##3##(2008-10#2)
The catalytic domain##2##3##(1994-8#1)(1997-2#1)
The catalytic effect of##2##4##(2008-10#2)
The catalytic rate constant of the modified##2##7##(2008-10#2)
The catalytic rate constant##4##4##(1995-2#1)(2008-10#3)
The catalytic rate##5##3##(1995-2#1)(2008-10#4)
The catalytic site##2##3##(1990-7#1)(1993-11#1)
The catalytic##30##2##(1990-7#2)(1990-8#1)(1993-11#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#19)(2009-10#1)
The categories of##3##3##(2008-11#1)(2009-11#1)(2010-4#1)
The categories##4##2##(2008-11#2)(2009-11#1)(2010-4#1)
The catheter##4##2##(2007-7#1)(2008-7#1)(2011-2#2)
The cathodic peak##2##3##(2008-10#2)
The cathodic##4##2##(2008-10#4)
The cation uptake and release##2##5##(2008-10#2)
The causal agent of##3##4##(2008-10#2)(2012-2#1)
The causal agent##5##3##(2008-10#4)(2012-2#1)
The causal relationship between malignant mesothelioma and##2##7##(1991-12#1)(1995-2#1)
The causal##10##2##(1991-12#1)(1995-2#1)(2008-10#6)(2008-8#1)(2012-2#1)
The causative organism was not suspected##2##6##(2007-7#2)
The causative organism was##4##4##(1990-2#1)(1992-5#1)(2007-7#2)
The causative##10##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-5#1)(2007-7#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
The cause for##4##3##(1997-3#1)(2008-10#2)(2013-8#1)
The cause is##2##3##(1991-2#1)(2013-1#1)
The cause of the##5##4##(1992-11#1)(1992-5#1)(1995-9#1)(1997-7#1)(2011-3#1)
The cause of##11##3##(1992-11#1)(1992-5#1)(1993-6#1)(1995-11#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-3#1)
The cause was##3##3##(1992-5#1)(1995-5#1)(2007-8#1)
The cause##22##2##(1991-2#1)(1992-11#1)(1992-5#2)(1993-6#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-3#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
The causes of death##3##4##(1994-11#1)(2012-2#1)(2013-1#1)
The causes of the##2##4##(2008-8#2)
The causes of this##2##4##(2008-1#1)(2011-2#1)
The causes of##13##3##(1994-11#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-2#2)(2013-1#1)
The causes##16##2##(1992-3#1)(1994-11#1)(1996-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-2#2)(2013-1#1)
The caustic##2##2##(2008-2#2)
The cavity##4##2##(2007-12#4)
The cell biological##3##3##(1994-8#1)(2008-5#1)(2008-8#1)
The cell body##2##3##(2008-7#2)
The cell density##3##3##(2008-11#2)(2012-1#1)
The cell growth inhibitory factor##2##5##(1992-9#2)
The cell growth##6##3##(1992-3#1)(1992-9#2)(2008-11#3)
The cell is##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
The cell line##3##3##(2008-11#3)
The cell lines##5##3##(1993-3#1)(2008-10#1)(2008-11#2)(2010-3#1)
The cell number increased##2##4##(2008-11#1)(2010-11#1)
The cell surface##2##3##(1994-9#1)(2008-11#1)
The cell wall of##2##4##(2008-5#1)(2009-2#1)
The cell##63##2##(1990-5#1)(1990-7#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-7#2)(2007-12#1)(2008-10#5)(2008-11#19)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-2#1)(2010-11#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
The cell-free culture##2##3##(2008-10#1)(2008-6#1)
The cell-free##5##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)
The cells also##2##3##(1996-2#1)(1996-5#1)
The cells are##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
The cells of this##2##4##(2007-12#1)(2008-9#1)
The cells of##4##3##(2007-12#2)(2008-9#1)(2013-8#1)
The cells showed a fibroblast-like morphology##2##6##(2008-11#2)
The cells were cultured##2##4##(2008-11#2)
The cells were exposed##2##4##(1993-12#1)(2011-2#1)
The cells were grown##2##4##(2008-10#1)(2008-11#1)
The cells were immobilized in##2##5##(2008-11#2)
The cells were##20##3##(1993-12#1)(1994-5#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#6)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#3)
The cells with positive reaction to##2##6##(2012-1#2)
The cells##54##2##(1990-12#1)(1990-5#1)(1992-6#2)(1993-12#1)(1994-5#2)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#14)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#3)(2012-1#3)(2013-1#4)(2013-8#2)
The cells'##2##2##(2008-8#2)
The cellular response##2##3##(1995-12#1)(2011-2#1)
The cellular##24##2##(1990-6#1)(1991-10#1)(1991-9#1)(1992-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-8#1)
The center##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
The central nervous system (CNS)##2##5##(2008-8#1)(2012-3#1)
The central##26##2##(1990-3#1)(1991-2#1)(1993-12#1)(1993-8#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2012-3#1)
The centroid##3##2##(2007-11#1)(2008-3#1)(2010-8#1)
The centroids of##2##3##(2008-3#2)
The ceramide##2##2##(1994-3#1)(2008-5#1)
The cereal##2##2##(2012-2#2)
The cerebellar##2##2##(2011-2#1)(2013-8#1)
The cerebellum##2##2##(1992-9#1)(2008-4#1)
The cerebral metabolic##2##3##(1994-2#1)(1996-5#1)
The cerebral##3##2##(1994-2#1)(1994-3#1)(1996-5#1)
The cerebrum##2##2##(2008-9#2)
The cervical##2##2##(2007-11#1)(2011-2#1)
The cervicofacial flap##2##3##(2007-12#2)
The cessation of##3##3##(1995-6#1)(2006-10#1)(2008-7#1)
The chain##2##2##(1992-8#1)(2008-12#1)
The challenge for clinicians is##2##5##(2008-3#1)(2010-4#1)
The challenge for##8##3##(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2013-8#1)
The challenge in##2##3##(2008-10#1)(2009-12#1)
The challenge is to##5##4##(1991-11#1)(1992-8#1)(1994-2#1)(1997-1#1)(2009-12#1)
The challenge is##7##3##(1991-11#1)(1992-8#1)(1994-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2009-12#1)
The challenge of providing##2##4##(1991-12#1)(2010-10#1)
The challenge of##16##3##(1991-12#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)
The challenge to the##2##4##(2008-10#1)(2008-6#1)
The challenge to##3##3##(2008-10#1)(2008-6#2)
The challenge##40##2##(1991-11#1)(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-4#1)(2013-8#2)
The challenges facing##4##3##(1996-1#1)(1996-12#1)(2008-10#1)(2013-1#1)
The challenges of##6##3##(1994-12#1)(1995-12#1)(1997-1#1)(2008-6#1)(2009-3#1)(2012-2#1)
The challenges##17##2##(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
The change from##2##3##(2008-3#1)(2009-8#1)
The change in the##7##4##(1991-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-3#1)
The change in##17##3##(1991-1#1)(1991-12#1)(1995-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#5)(2008-7#1)(2009-11#1)(2012-3#1)
The change of the##3##4##(2008-10#1)(2008-3#2)
The change of##10##3##(1990-5#1)(1995-5#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-8#1)
The change process##2##3##(1997-2#1)(2008-11#1)
The change##37##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-2#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#9)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2012-3#1)
The changes are##3##3##(1990-2#1)(2007-12#1)(2008-3#1)
The changes in pH##2##4##(2008-10#2)
The changes in the##9##4##(1994-3#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)
The changes in##24##3##(1991-2#1)(1991-5#1)(1991-6#1)(1994-3#1)(1996-3#1)(1996-9#1)(1997-7#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2009-11#1)(2011-2#1)(2013-8#1)
The changes induced by##2##4##(1992-8#1)(1997-7#1)
The changes of the##3##4##(1993-8#1)(1996-2#1)(2008-7#1)
The changes of##8##3##(1990-5#1)(1992-3#1)(1993-8#1)(1996-2#1)(2007-10#2)(2008-7#1)(2008-9#1)
The changes were##6##3##(1990-7#1)(1995-8#1)(2007-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
The changes##51##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#3)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The changing face of##3##4##(1992-3#1)(1994-2#1)(2008-8#1)
The changing landscape of##2##4##(1993-2#1)(2008-11#1)
The changing pattern of nontuberculous mycobacterial disease##2##7##(2007-12#2)
The changing role of##3##4##(1991-3#2)(2008-11#1)
The changing##21##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-8#1)(2007-12#3)(2008-11#2)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
The channel##3##2##(1993-3#2)(2008-2#1)
The channels##5##2##(1990-7#1)(1994-12#1)(1994-2#1)(2008-10#2)
The character of the##2##4##(1996-4#1)(2013-1#1)
The character of##4##3##(1996-4#1)(2008-10#1)(2012-1#1)(2013-1#1)
The character##5##2##(1996-4#1)(2008-10#1)(2012-1#1)(2013-1#2)
The characteristic concentration##2##3##(2008-10#2)
The characteristic ions##2##3##(2008-10#2)
The characteristic mass of##2##4##(2008-10#2)
The characteristic mass was##2##4##(2008-10#2)
The characteristic mass##9##3##(2008-10#9)
The characteristic masses for##2##4##(2008-10#2)
The characteristic time##2##3##(2008-3#2)
The characteristic##27##2##(1992-2#1)(1994-12#1)(1997-3#1)(2008-10#19)(2008-3#3)(2010-6#1)(2013-8#1)
The characteristics and##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
The characteristics of a##3##4##(2008-3#1)(2008-5#1)(2013-8#1)
The characteristics of the##11##4##(1991-2#1)(1992-6#1)(1994-7#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-3#1)
The characteristics of these##2##4##(2008-1#1)(2008-10#1)
The characteristics of this##4##4##(1996-2#1)(2008-10#1)(2008-3#2)
The characteristics of##36##3##(1990-12#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-7#1)(1996-11#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
The characteristics##45##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-7#1)(1996-11#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
The characterization of a##3##4##(2007-12#1)(2008-10#2)
The characterization of the##5##4##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
The characterization of these##2##4##(1990-5#1)(2010-2#1)
The characterization of##26##3##(1990-2#1)(1990-5#1)(1994-9#1)(2007-12#3)(2008-10#9)(2008-3#5)(2008-5#2)(2008-7#1)(2009-5#1)(2010-2#1)(2013-8#1)
The characterization##27##2##(1990-2#1)(1990-5#1)(1994-9#1)(2007-12#3)(2008-10#9)(2008-3#5)(2008-5#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-2#1)(2013-8#1)
The charge##4##2##(1991-5#1)(2008-10#2)(2010-5#1)
The charts of##3##3##(2008-4#1)(2010-6#1)(2013-8#1)
The chelates were##4##3##(2008-10#4)
The chelating polymer##2##3##(2008-10#2)
The chelating resin##3##3##(2008-10#3)
The chelating##8##2##(1990-5#1)(2008-10#7)
The chemical and FI variables##2##5##(2008-10#2)
The chemical and##4##3##(2008-10#4)
The chemical composition of the##2##5##(1990-5#1)(2008-11#1)
The chemical composition of##4##4##(1990-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
The chemical reactivity##2##3##(2008-10#2)
The chemical shift##3##3##(1992-12#1)(2008-10#1)(2012-12#1)
The chemical shifts for##2##4##(1995-5#2)
The chemical shifts##3##3##(1995-5#2)(2008-10#1)
The chemical stability##2##3##(2008-10#2)
The chemical structure of##2##4##(1993-11#1)(1994-2#1)
The chemical structure was encoded by##2##6##(2007-11#2)
The chemical structure##4##3##(1993-11#1)(1994-2#1)(2007-11#2)
The chemical structures of the##3##5##(1990-7#1)(2007-11#1)(2011-3#1)
The chemical variables affecting the##3##5##(2008-10#3)
The chemical##50##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-12#1)(1993-11#2)(1994-2#1)(1995-5#2)(1995-6#1)(2007-11#3)(2008-10#25)(2008-11#4)(2008-9#1)(2009-3#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
The chemically##2##2##(2008-1#1)(2008-10#1)
The chemicals##4##2##(2008-10#3)(2008-5#1)
The chemiluminescence intensity is##2##4##(2008-10#2)
The chemiluminescence intensity was##2##4##(2008-10#2)
The chemiluminescence intensity##5##3##(2008-10#5)
The chemiluminescence##9##2##(2008-10#9)
The chemiluminescent##2##2##(2008-10#2)
The chemistry of##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
The chemistry##6##2##(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#2)
The chemometric##5##2##(2008-1#1)(2008-10#4)
The chest wall##2##3##(2007-12#1)(2012-2#1)
The chest x-ray##2##3##(2010-12#1)(2012-3#1)
The chest##8##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
The chick chorioallantoic membrane##2##4##(2008-1#2)
The chick##3##2##(1990-5#1)(2008-1#2)
The chicken##4##2##(1990-12#1)(1990-8#1)(2008-1#1)(2008-11#1)
The chief##4##2##(1993-2#1)(1995-6#1)(1997-8#1)(2008-6#1)
The child presented with##2##4##(2007-12#1)(2008-10#1)
The child was##6##3##(1992-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
The child##10##2##(1992-3#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
The childbirth##2##2##(2007-2#2)
The children of##2##3##(2009-7#1)(2011-1#1)
The children showed##2##3##(1991-6#1)(1995-6#1)
The children were##5##3##(1991-8#1)(1995-5#1)(1996-11#1)(2008-9#1)(2011-1#1)
The children##16##2##(1991-6#1)(1991-8#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-3#1)(2008-9#2)(2009-7#1)(2010-11#1)(2011-1#3)(2012-12#2)
The children's##3##2##(1991-2#1)(2012-12#1)(2013-1#1)
The chimeric##3##2##(1994-3#1)(2008-11#2)
The chip##2##2##(2008-10#2)
The chiral separation of##3##4##(1990-8#2)(2008-10#1)
The chiral##4##2##(1990-8#2)(2008-10#2)
The chitosan##2##2##(2008-10#1)(2008-5#1)
The chloride conductance##2##3##(1995-11#2)
The chloride##4##2##(1995-11#2)(2008-10#2)
The chlorosis##2##2##(2008-10#2)
The choice of a##2##4##(1994-11#1)(2010-12#1)
The choice of an##2##4##(2008-8#1)(2009-11#1)
The choice of medical##2##4##(2011-2#1)(2013-1#1)
The choice of the##2##4##(2007-11#2)
The choice of therapy for the operative treatment of endometriosis is endoscopic laser surgery##2##14##(1992-2#2)
The choice of these##2##4##(2008-3#1)(2008-9#1)
The choice of##37##3##(1992-2#3)(1994-11#1)(1995-2#1)(1996-2#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
The choice##40##2##(1992-2#3)(1992-3#1)(1994-11#1)(1995-2#1)(1996-2#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
The cholera##2##2##(1992-6#1)(1993-3#1)
The cholesterol##3##2##(1995-5#1)(2007-11#1)(2008-11#1)
The choline##2##2##(1990-11#1)(2008-10#1)
The chorion consists of##2##4##(2007-12#1)(2008-12#1)
The chorion##3##2##(2007-12#1)(2008-12#2)
The chosen##2##2##(2008-10#1)(2008-5#1)
The chromatograms obtained##2##3##(2008-10#2)
The chromatographic analysis##3##3##(2006-6#1)(2008-10#2)
The chromatographic behaviour of##2##4##(2008-10#2)
The chromatographic conditions##2##3##(1994-12#1)(2011-1#1)
The chromatographic method was##3##4##(2008-10#2)(2010-3#1)
The chromatographic method##5##3##(2008-10#4)(2010-3#1)
The chromatographic profiles##2##3##(2008-10#2)
The chromatographic resolution between##2##4##(2008-10#2)
The chromatographic separation was##2##4##(1990-8#1)(2008-10#1)
The chromatographic separation##4##3##(1990-8#1)(2008-10#3)
The chromatographic##29##2##(1990-8#1)(1994-12#1)(2006-6#1)(2008-10#24)(2010-3#1)(2011-1#1)
The chromatography##2##2##(2008-10#2)
The chromatomembrane##2##2##(2008-10#2)
The chromium was##2##3##(2008-10#2)
The chromium##5##2##(2008-10#5)
The chromogen##2##2##(2008-10#2)
The chromophore of##2##3##(2008-10#2)
The chromosomal locations of the##2##5##(2008-10#2)
The chromosomal##9##2##(1991-7#1)(1991-9#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#3)(2010-3#1)
The chromosome complement of##2##4##(2008-12#1)(2008-5#1)
The chromosome##5##2##(1993-9#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-9#1)
The chronic##4##2##(1995-12#1)(2007-11#1)(2007-8#1)(2011-2#1)
The circadian##2##2##(1994-2#1)(2009-8#1)
The circuit##2##2##(1997-6#1)(2008-11#1)
The circular dichroism spectrum in##2##5##(1993-11#2)
The circular dichroism spectrum##3##4##(1993-11#2)(2008-10#1)
The circular dichroism##4##3##(1990-5#1)(1993-11#2)(2008-10#1)
The circular##5##2##(1990-5#1)(1993-11#2)(2008-10#2)
The circulating##2##2##(2007-12#1)(2008-1#1)
The circulatory##3##2##(2007-12#2)(2011-2#1)
The circumstances##2##2##(2011-1#1)(2011-2#1)
The citrus##2##2##(2008-10#1)(2011-2#1)
The city##2##2##(1997-6#1)(2008-12#1)
The class of##2##3##(1995-2#1)(2008-3#1)
The class##7##2##(1992-6#1)(1994-2#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-12#1)
The classic##5##2##(2006-10#1)(2008-10#2)(2008-3#1)(2008-7#1)
The classical##8##2##(1990-6#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
The classification of##5##3##(1993-1#1)(2008-1#1)(2008-10#3)
The classification##14##2##(1993-1#1)(1995-6#1)(1997-3#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-7#1)(2009-10#1)(2011-2#1)(2011-3#1)
The clearance of##2##3##(2007-11#1)(2008-5#1)
The clearance##3##2##(1997-1#1)(2007-11#1)(2008-5#1)
The clearest##2##2##(2008-11#1)(2008-3#1)
The cleavage##6##2##(1991-12#1)(1991-5#1)(1991-9#1)(2008-9#3)
The climate##2##2##(2012-12#1)(2012-9#1)
The clinic administrator was charged with coordinating the implementation of these services in the clinics by the hospital support departments##2##20##(1994-1#2)
The clinic##3##2##(1994-1#2)(2008-5#1)
The clinical and histological features of##2##6##(2008-7#1)(2010-8#1)
The clinical and laboratory##2##4##(1997-7#1)(2008-7#1)
The clinical and pathologic features of##2##6##(1990-6#1)(1992-2#1)
The clinical and radiological##2##4##(1995-9#1)(2008-7#1)
The clinical and##18##3##(1990-6#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#5)(2008-8#1)(2010-8#1)(2013-1#1)
The clinical course is##3##4##(1996-11#1)(2007-7#1)(2012-2#1)
The clinical course of##6##4##(1991-4#1)(2007-2#1)(2008-7#1)(2011-2#1)(2013-1#2)
The clinical course##11##3##(1991-4#1)(1996-11#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
The clinical data##3##3##(1993-9#1)(1996-11#1)(2013-1#1)
The clinical diagnosis of##2##4##(2008-8#1)(2010-8#1)
The clinical diagnosis##3##3##(2008-8#1)(2009-2#1)(2010-8#1)
The clinical efficacy of##2##4##(2007-7#1)(2011-2#1)
The clinical efficacy##4##3##(1993-12#1)(1994-6#1)(2007-7#1)(2011-2#1)
The clinical examination##2##3##(1992-9#1)(1996-9#1)
The clinical feature##2##3##(1990-12#1)(1990-6#1)
The clinical features and##2##4##(2007-7#1)(2008-7#1)
The clinical features of##5##4##(1991-11#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-7#1)
The clinical features were##2##4##(2007-1#1)(2008-12#1)
The clinical features##9##3##(1991-11#1)(1997-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#2)
The clinical findings##2##3##(2008-10#1)(2012-3#1)
The clinical implications of##2##4##(1995-2#1)(2008-6#1)
The clinical management of##2##4##(2008-11#1)(2011-2#1)
The clinical manifestations of##3##4##(2009-4#1)(2011-2#1)(2012-3#1)
The clinical manifestations##5##3##(2006-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-3#1)
The clinical observation##2##3##(1990-10#1)(1991-4#1)
The clinical outcome was##3##4##(1997-3#1)(2007-11#1)(2007-9#1)
The clinical outcome##4##3##(1997-3#1)(2007-11#1)(2007-9#1)(2008-7#1)
The clinical picture is##2##4##(1990-8#1)(1995-11#1)
The clinical picture##4##3##(1990-8#1)(1993-8#1)(1995-11#1)(2007-7#1)
The clinical presentation of##3##4##(1990-12#1)(2008-1#1)(2012-2#1)
The clinical presentation##6##3##(1990-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2012-2#2)
The clinical presentations##2##3##(2008-1#1)(2008-5#1)
The clinical relevance of##2##4##(1991-12#1)(1994-11#1)
The clinical responses##2##3##(1991-3#1)(2008-5#1)
The clinical significance of##3##4##(1990-12#1)(1994-2#1)(2013-1#1)
The clinical significance##4##3##(1990-12#1)(1994-2#1)(2008-10#1)(2013-1#1)
The clinical signs included##2##4##(1997-5#1)(2011-1#1)
The clinical signs##4##3##(1990-3#1)(1997-5#1)(2011-1#2)
The clinical spectrum##2##3##(2010-9#1)(2013-1#1)
The clinical symptoms of##2##4##(1992-2#1)(2010-8#1)
The clinical symptoms##3##3##(1992-2#1)(2010-8#1)(2011-2#1)
The clinical use of##2##4##(2008-8#1)(2010-6#1)
The clinical usefulness of##2##4##(1992-9#1)(2008-11#1)
The clinical value of##3##4##(2008-5#1)(2008-6#1)(2011-1#1)
The clinical##165##2##(1990-10#1)(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1992-2#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#16)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#9)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#3)
The clinician##3##2##(1990-8#1)(2007-12#1)(2010-1#1)
The clinicians##2##2##(1993-8#1)(1994-9#1)
The clinicopathologic features##2##3##(1990-8#1)(1991-2#1)
The clone##3##2##(1993-12#1)(1993-2#1)(1995-8#1)
The cloned gene was##2##4##(1997-2#1)(1997-7#1)
The cloned##10##2##(1990-2#1)(1990-5#1)(1993-12#1)(1997-2#1)(1997-7#2)(2008-10#3)(2008-11#1)
The cloning and characterization of##2##5##(1994-12#1)(1995-8#1)
The cloning and expression of##2##5##(1992-8#1)(1993-2#1)
The cloning and expression##3##4##(1992-8#1)(1993-2#1)(2008-9#1)
The cloning and##6##3##(1992-8#1)(1993-2#2)(1994-12#1)(1995-8#1)(2008-9#1)
The cloning of a##2##4##(1993-8#1)(2008-9#1)
The cloning of##4##3##(1993-3#1)(1993-8#1)(2008-8#1)(2008-9#1)
The cloning##12##2##(1992-8#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-4#2)(2008-8#1)(2008-9#2)
The close relation between##2##4##(1996-12#1)(2008-7#1)
The close##7##2##(1996-12#2)(1996-5#1)(1996-8#1)(2008-7#2)(2012-3#1)
The closed Mariotte system was used as a bioassay method to analyze quantitatively the biological action of these volatiles on##2##20##(2008-10#2)
The closed##3##2##(2008-10#3)
The closest##4##2##(2008-10#3)(2008-12#1)
The closing##2##2##(1992-3#1)(2009-8#1)
The closure of the##2##4##(1995-6#1)(2009-8#1)
The closure of##5##3##(1995-6#1)(1997-8#1)(2007-8#1)(2009-8#1)(2013-1#1)
The cloud point extraction##3##4##(2008-10#3)
The cloud##4##2##(2008-10#3)(2008-2#1)
The cluster of##2##3##(2008-3#1)(2008-4#1)
The cluster##7##2##(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-8#1)(2011-2#1)(2013-7#1)
The clustering of##3##3##(1992-8#1)(2009-5#1)(2009-8#1)
The clustering with##2##3##(2012-1#2)
The clustering##6##2##(1992-8#1)(2008-10#1)(2009-5#1)(2009-8#1)(2012-1#2)
The clusters##2##2##(1990-5#1)(1997-6#1)
The co-existence of##3##3##(1991-5#1)(1995-12#1)(2010-11#1)
The co-occurrence##2##2##(1997-5#1)(2008-10#1)
The coat protein (CP) gene##2##5##(1997-6#1)(2008-10#1)
The coat protein (CP)##4##4##(1997-6#1)(2008-10#3)
The coat protein##6##3##(1997-2#1)(1997-6#1)(2008-10#4)
The coat##7##2##(1997-2#1)(1997-6#1)(2008-10#5)
The coating##4##2##(2008-10#2)(2008-2#1)(2009-7#1)
The coatings##4##2##(2008-2#1)(2008-3#3)
The cobalt##3##2##(2008-10#3)
The cochlear##2##2##(2008-9#1)(2013-8#1)
The coculture##2##2##(1994-6#1)(2008-7#1)
The code##3##2##(1992-11#1)(2008-2#2)
The coding region of the##4##5##(1990-7#1)(1992-8#1)(1997-6#1)(1997-8#1)
The coding region of##7##4##(1990-12#1)(1990-7#1)(1992-8#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-7#1)
The coding region##8##3##(1990-12#1)(1990-7#1)(1992-8#1)(1993-6#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-7#1)
The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1##2##19##(1996-2#2)
The coding sequences of 40 new genes##3##7##(1995-8#1)(1996-2#2)
The coding sequences of##4##4##(1995-8#1)(1996-10#1)(1996-2#2)
The coding##13##2##(1990-12#1)(1990-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1997-6#1)(1997-8#1)(2008-7#1)
The codon usage##2##3##(1993-9#1)(1997-4#1)
The coefficient of variation##4##4##(1993-8#1)(1996-3#1)(2008-10#1)(2010-8#1)
The coefficient of##5##3##(1993-8#1)(1996-3#1)(2008-10#1)(2008-5#1)(2010-8#1)
The coefficient variations of the method are less than##2##9##(2008-10#2)
The coefficient variations of##3##4##(2008-10#3)
The coefficient variations##4##3##(2008-10#4)
The coefficient##9##2##(1993-8#1)(1996-3#1)(2008-10#5)(2008-5#1)(2010-8#1)
The coefficients of variation##2##4##(2008-10#2)
The coefficients of##3##3##(2008-10#2)(2008-3#1)
The coefficients##5##2##(2008-10#2)(2008-3#2)(2008-5#1)
The coenospermia##2##2##(2007-12#2)
The coexistence of##10##3##(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
The cognitive state##2##3##(2008-7#2)
The cognitive##5##2##(1991-5#1)(2008-11#1)(2008-7#2)(2010-4#1)
The coherence of##2##3##(1991-7#1)(2008-3#1)
The coherence##5##2##(1991-7#1)(2007-11#1)(2008-2#1)(2008-3#2)
The coherent##2##2##(2007-12#1)(2008-10#1)
The cohort##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
The coincidence##2##2##(2007-10#1)(2008-4#1)
The collagen##5##2##(1992-6#2)(1993-12#1)(1994-12#1)(2008-5#1)
The collapse of##3##3##(1994-8#1)(1995-11#1)(2008-5#1)
The collapse##4##2##(1994-8#1)(1995-11#1)(2008-11#1)(2008-5#1)
The collected data are also presented in##2##7##(2008-10#2)
The collected data##4##3##(2008-10#3)(2008-11#1)
The collected##7##2##(2008-10#6)(2008-11#1)
The collection and analysis of##2##5##(1995-12#1)(2008-10#1)
The collection of##3##3##(2008-10#2)(2009-10#1)
The collection##7##2##(1995-12#1)(2008-10#4)(2008-5#1)(2009-10#1)
The collections##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
The collective##3##2##(2008-10#1)(2008-9#1)(2009-11#1)
The college##3##2##(2008-4#2)(2008-6#1)
The collimated##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
The collision of##2##3##(1994-1#1)(2010-5#1)
The collision-induced dissociation of protonated molecular ion formed##2##8##(2008-10#2)
The collision-induced##3##2##(2008-10#2)(2008-3#1)
The colonic##2##2##(2012-2#1)(2012-3#1)
The colonization of##2##3##(2008-10#1)(2013-1#1)
The color reaction##2##3##(2008-10#2)
The color system obeys Beer's law in the range 0##2##10##(2008-10#2)
The color##12##2##(1993-11#1)(1993-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-2#1)
The colour of the##4##4##(1995-6#1)(2008-10#2)(2010-4#1)
The colour##10##2##(1995-6#1)(2008-10#7)(2008-5#1)(2010-4#1)
The colt##2##2##(2012-3#2)
The column used was##2##4##(2008-10#2)
The column##8##2##(2008-10#7)(2011-1#1)
The combination of NTG with##2##5##(1991-9#2)
The combination of a##4##4##(2008-10#1)(2008-3#2)(2011-3#1)
The combination of aspirin##2##4##(2008-8#2)
The combination of both##4##4##(2007-10#1)(2007-12#1)(2007-8#1)(2008-8#1)
The combination of high##2##4##(1995-3#1)(2012-3#1)
The combination of the##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
The combination of these##4##4##(2008-10#1)(2010-11#1)(2010-3#1)(2013-7#1)
The combination of##86##3##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-8#1)(2006-4#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-8#4)(2008-9#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
The combination##91##2##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-4#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-8#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#4)(2008-9#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
The combined MP and PE for all 15 loci are##2##10##(2008-12#2)
The combined action of these##2##5##(2007-12#1)(2008-10#1)
The combined action of##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
The combined effects of##4##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
The combined results of this##2##5##(2008-10#1)(2008-5#1)
The combined results of##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
The combined results##7##3##(1990-3#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
The combined treatment##2##3##(1990-2#1)(2008-8#1)
The combined use of##5##4##(1993-2#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
The combined##49##2##(1990-2#2)(1990-3#1)(1990-5#1)(1992-5#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-12#4)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
The comments were##2##3##(2008-11#2)
The commercial##7##2##(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)
The commercially available##5##3##(1992-2#1)(2007-11#1)(2008-10#3)
The committee##3##2##(1996-2#1)(1996-3#1)(2008-4#1)
The common excipients used as additives##2##6##(2008-10#2)
The common wheat##2##3##(2008-10#2)
The common##31##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-12#1)(1994-6#1)(1995-8#1)(1995-9#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
The commonest##6##2##(1993-9#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#1)
The commonly used##4##3##(1994-11#1)(2008-10#2)(2008-3#1)
The community##4##2##(1996-11#1)(2008-1#1)(2009-5#1)(2010-10#1)
The compact##5##2##(2008-2#1)(2008-3#3)(2011-2#1)
The companies##3##2##(1996-5#1)(2008-5#2)
The company has also##2##4##(2008-5#2)
The company has##5##3##(2008-5#4)(2010-9#1)
The company##10##2##(1992-11#1)(2008-5#8)(2010-9#1)
The comparative analysis of##2##4##(2008-10#1)(2010-7#1)
The comparative study of##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
The comparative study##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
The comparative##10##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)
The compared##2##2##(2008-3#1)(2011-2#1)
The comparison between##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)(2013-7#1)
The comparison of the##12##4##(1991-12#1)(1993-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)
The comparison of##30##3##(1991-12#1)(1991-6#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-9#1)(2013-1#2)
The comparison with##5##3##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-6#1)
The comparison##50##2##(1991-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
The comparisons##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
The compatibility##2##2##(2008-10#1)(2011-2#1)
The compelling##2##2##(2009-5#1)(2012-1#1)
The compensation##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
The competition##2##2##(2008-4#1)(2012-2#1)
The competitive##3##2##(1991-1#1)(2008-11#1)(2008-8#1)
The complementary##4##2##(1991-2#1)(2008-10#1)(2008-3#1)(2008-6#1)
The complete CYSDV CP gene##2##5##(2008-10#2)
The complete absence of##2##4##(2007-12#1)(2008-10#1)
The complete amino acid sequence of##3##6##(1995-5#1)(1995-6#1)(2008-8#1)
The complete amino acid sequence##4##5##(1992-8#1)(1995-5#1)(1995-6#1)(2008-8#1)
The complete cycle##2##3##(2008-10#1)(2008-3#1)
The complete genome sequence##2##4##(2008-7#1)(2013-8#1)
The complete genome##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
The complete nucleotide (nt) sequence of the##2##7##(1991-6#1)(1993-12#1)
The complete nucleotide (nt)##3##4##(1991-6#1)(1993-12#1)(2008-10#1)
The complete nucleotide sequence of a##2##6##(1996-6#1)(2008-10#1)
The complete nucleotide sequence of the genomic##2##7##(2008-10#2)
The complete nucleotide sequence of the##8##6##(1992-3#1)(1993-2#1)(1995-6#1)(2008-10#5)
The complete nucleotide sequence of##17##5##(1992-3#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#9)(2008-8#1)
The complete nucleotide sequence##18##4##(1992-3#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#9)(2008-8#1)
The complete nucleotide sequences of the##2##6##(2008-10#2)
The complete nucleotide sequences of##3##5##(2008-10#3)
The complete nucleotide##24##3##(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#13)(2008-8#1)
The complete primary##2##3##(1992-3#1)(1992-8#1)
The complete separation##2##3##(1990-8#1)(2008-10#1)
The complete sequence of a##3##5##(1997-4#1)(2008-9#2)
The complete sequence of the##3##5##(2008-10#2)(2008-8#1)
The complete sequence of##9##4##(1997-4#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)
The complete sequence##10##3##(1997-4#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#3)
The complete##77##2##(1990-8#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#26)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
The complex amplitude##2##3##(2007-12#1)(2008-3#1)
The complex formation between##3##4##(2008-10#3)
The complex formation constants of##3##5##(2008-10#3)
The complex formation##7##3##(2008-10#7)
The complex formed between##2##4##(2008-10#2)
The complex formed##3##3##(2008-10#3)
The complex is##5##3##(1991-3#1)(2008-10#4)
The complex nature of##2##4##(2008-10#1)(2008-8#1)
The complex obeys Beer's law from 0##2##7##(2008-10#2)
The complex of##3##3##(1991-3#1)(1993-8#1)(2008-10#1)
The complex refractive index##2##4##(2008-3#2)
The complex was##5##3##(1994-11#1)(2008-10#3)(2008-5#1)
The complex##62##2##(1990-11#1)(1991-3#2)(1993-8#2)(1994-11#2)(1994-2#1)(1996-2#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#33)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
The complexant##2##2##(2008-10#2)
The complexation equilibria##2##3##(2008-10#2)
The complexation of##3##3##(2008-10#2)(2009-7#1)
The complexation##10##2##(2008-10#9)(2009-7#1)
The complexes formed##2##3##(1990-8#1)(2008-10#1)
The complexes of##2##3##(1997-3#1)(2008-10#1)
The complexes were##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
The complexes##10##2##(1990-8#1)(1994-2#1)(1994-8#1)(1997-3#1)(2008-10#4)(2008-5#2)
The complexing properties##2##3##(2008-10#2)
The complexing##6##2##(2008-10#6)
The complexity of the##6##4##(1992-1#1)(2007-12#1)(2007-6#1)(2008-7#1)(2010-3#1)(2010-8#1)
The complexity of##13##3##(1992-1#1)(1994-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-3#1)
The complexity##16##2##(1992-1#1)(1994-2#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
The compliance of##2##3##(1993-11#1)(1994-8#1)
The compliance##4##2##(1993-11#1)(1994-8#1)(1997-2#2)
The complication rate of##2##4##(1996-9#1)(2008-1#1)
The complication rate was##2##4##(1993-6#1)(2011-2#1)
The complication rate##5##3##(1993-6#1)(1996-9#1)(2008-1#1)(2011-2#1)(2012-3#1)
The complication##6##2##(1993-6#1)(1996-9#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The complications observed##2##3##(2007-8#1)(2012-2#1)
The complications of##2##3##(2007-8#1)(2011-2#1)
The complications##8##2##(2007-8#2)(2008-1#1)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
The component##3##2##(2008-9#2)(2010-12#1)
The components of##4##3##(1990-11#1)(1995-1#1)(1997-4#1)(2009-6#1)
The components##7##2##(1990-11#1)(1995-1#1)(1997-4#1)(2007-11#2)(2008-8#1)(2009-6#1)
The composite##10##2##(2008-10#6)(2008-12#1)(2009-4#1)(2009-7#2)
The composites##3##2##(2008-2#1)(2009-11#1)(2010-4#1)
The composition and##2##3##(2008-10#1)(2008-7#1)
The composition of different##2##4##(2008-11#1)(2008-7#1)
The composition of the complex##2##5##(2008-10#2)
The composition of the##10##4##(1990-11#1)(1990-7#1)(2008-10#5)(2008-11#1)(2010-3#1)(2010-4#1)
The composition of##16##3##(1990-11#1)(1990-7#1)(1991-12#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-7#2)(2010-3#1)(2010-4#1)
The composition##20##2##(1990-11#1)(1990-7#1)(1991-12#1)(1995-8#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-7#3)(2010-3#1)(2010-4#1)
The compositions of the##2##4##(2008-10#1)(2010-4#1)
The compositions##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
The compound crystallizes in the##2##5##(1997-7#1)(2007-11#1)
The compound has##2##3##(1992-12#1)(2008-5#1)
The compound is in phase II clinical##2##7##(2008-5#2)
The compound is##6##3##(1997-6#2)(2008-5#4)
The compound was##3##3##(1990-7#1)(1992-12#1)(2008-10#1)
The compound##27##2##(1990-7#1)(1990-8#1)(1992-12#2)(1992-6#1)(1996-2#1)(1997-6#2)(1997-7#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-5#6)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
The compounds of interest##2##4##(1991-5#1)(2008-10#1)
The compounds showed##2##3##(2008-10#1)(2008-11#1)
The compounds were evaluated##2##4##(2008-8#1)(2010-5#1)
The compounds were##8##3##(1992-10#1)(1992-8#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-5#1)
The compounds##21##2##(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)
The comprehensive##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
The compression##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
The computation##2##2##(2008-3#2)
The computational##4##2##(2008-3#2)(2008-7#1)(2009-9#1)
The computations##2##2##(2008-10#1)(2008-11#1)
The computed##2##2##(2007-11#1)(2008-7#1)
The computer program##2##3##(2008-4#1)(2009-4#1)
The computer##9##2##(1992-4#1)(1997-2#1)(1997-3#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-4#1)
The computer-aided facial reconstruction##2##4##(1995-6#2)
The computer-aided##3##2##(1995-6#2)(2008-2#1)
The computer-based journal provides accurate information on the number and kind of contacts##2##13##(1994-6#2)
The computerized##4##2##(1992-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
The concave##2##2##(2008-2#1)(2008-3#1)
The concentrated##3##2##(1990-2#1)(1993-3#1)(2008-10#1)
The concentration and##5##3##(2008-10#3)(2008-11#1)(2008-2#1)
The concentration dependence of the##2##5##(1992-6#2)
The concentration dependent##2##3##(2008-10#2)
The concentration distribution of##3##4##(2008-10#3)
The concentration factor##3##3##(2008-10#3)
The concentration gradient##2##3##(2008-10#1)(2012-2#1)
The concentration measurements are reproducible within a##2##7##(2008-10#2)
The concentration measurements##3##3##(2008-10#3)
The concentration of H(2)O(2)##2##4##(2008-10#2)
The concentration of potassium##2##4##(2008-10#1)(2008-2#1)
The concentration of the analyte##2##5##(2008-10#2)
The concentration of the##11##4##(1995-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)
The concentration of trace##2##4##(2008-10#2)
The concentration of##72##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#32)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
The concentration profile of##2##4##(2008-10#2)
The concentration range in##2##4##(2008-10#2)
The concentration range##9##3##(2008-10#9)
The concentration ranges##5##3##(2008-10#4)(2008-7#1)
The concentration ratio##2##3##(2008-10#2)
The concentration response##2##3##(1990-12#1)(2008-5#1)
The concentration##122##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#73)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
The concentrations for##2##3##(2008-10#2)
The concentrations of the elements##2##5##(2008-10#2)
The concentrations of the other##2##5##(2008-10#2)
The concentrations of the##9##4##(1991-3#1)(1996-12#1)(2008-10#5)(2008-7#1)(2012-1#1)
The concentrations of##38##3##(1990-5#2)(1991-3#1)(1992-3#1)(1994-9#1)(1996-12#1)(1997-3#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-7#3)(2010-5#2)(2011-1#1)(2011-3#2)(2012-1#2)
The concentrations were##2##3##(2008-10#1)(2011-2#1)
The concentrations##43##2##(1990-5#2)(1991-3#1)(1992-3#1)(1994-9#1)(1996-12#1)(1997-3#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#2)
The concept is based on the##2##6##(2008-10#1)(2008-3#1)
The concept is based on##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
The concept is##6##3##(1992-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
The concept of &quot##2##4##(1992-3#1)(1995-5#1)
The concept of a##4##4##(1995-6#1)(2007-12#2)(2008-10#1)
The concept of the##5##4##(1992-12#1)(1993-1#1)(1994-2#1)(1996-9#1)(2008-3#1)
The concept of##48##3##(1990-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
The concept that##4##3##(1990-6#1)(1995-6#1)(2008-10#2)
The concept##63##2##(1990-2#1)(1990-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-1#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
The concepts of##3##3##(1993-12#1)(2008-10#1)(2008-2#1)
The concepts##4##2##(1993-12#1)(1993-6#1)(2008-10#1)(2008-2#1)
The conceptual applications employed in this technology set are provided by way of illustration##2##14##(2010-8#2)
The conceptual##3##2##(1997-3#1)(2010-8#2)
The conclusion from the##2##4##(2008-10#1)(2010-12#1)
The conclusion from##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
The conclusion is that the##5##5##(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-3#1)
The conclusion is that##12##4##(1990-2#1)(1992-6#1)(1993-12#1)(1994-3#1)(2008-2#1)(2008-7#2)(2008-8#2)(2009-7#1)(2012-3#2)
The conclusion of the##2##4##(1992-3#1)(2013-8#1)
The conclusion of this##2##4##(1990-7#1)(2008-12#1)
The conclusion of##4##3##(1990-7#1)(1992-3#1)(2008-12#1)(2013-8#1)
The conclusion that##2##3##(2008-10#1)(2008-3#1)
The conclusion##25##2##(1990-2#1)(1990-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-3#2)(2013-8#2)
The conclusions of##2##3##(1994-12#1)(2008-12#1)
The conclusions##7##2##(1991-6#1)(1994-12#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
The concomitant##2##2##(2008-5#1)(2008-9#1)
The condensed##3##2##(2008-10#1)(2008-8#1)(2009-11#1)
The condition for##2##3##(2008-10#2)
The condition is##5##3##(1990-9#1)(2008-10#1)(2011-1#2)(2012-3#1)
The condition may be due to##2##6##(1996-3#1)(2007-2#1)
The condition may be##3##4##(1990-6#1)(1996-3#1)(2007-2#1)
The condition of the##3##4##(1997-5#1)(2007-7#1)(2007-8#1)
The condition of##5##3##(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-7#1)
The condition was treated##2##4##(2008-2#1)(2012-12#1)
The condition was##5##3##(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
The condition##24##2##(1990-6#1)(1990-9#1)(1991-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#3)(2012-12#1)(2012-3#1)
The conditional stability constants##2##4##(2008-10#2)
The conditional##4##2##(2008-10#3)(2011-2#1)
The conditioned##2##2##(1990-2#1)(1996-2#1)
The conditions for the##2##4##(2008-10#2)
The conditions for##9##3##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)
The conditions of##6##3##(1991-2#1)(2008-10#5)
The conditions under which##2##4##(1994-12#1)(1995-2#1)
The conditions were##2##3##(2008-9#1)(2011-2#1)
The conditions##24##2##(1991-2#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
The conducted##2##2##(1994-3#1)(2011-2#1)
The conductivity of##2##3##(2008-10#2)
The conductivity##4##2##(2008-10#3)(2012-2#1)
The conference provided##2##3##(2007-5#1)(2010-4#1)
The conference was##2##3##(1995-3#1)(2008-3#1)
The conference##10##2##(1995-3#1)(2007-12#2)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)
The confidence intervals##2##3##(2008-10#1)(2008-8#1)
The configuration of##2##3##(2007-11#1)(2008-9#1)
The configuration##5##2##(1997-7#1)(2007-11#2)(2008-2#1)(2008-9#1)
The confinement##2##2##(2008-3#1)(2008-5#1)
The confirmation##2##2##(2008-10#1)(2013-1#1)
The conformation of the##3##4##(1992-3#1)(1993-3#1)(2008-10#1)
The conformation of##6##3##(1991-12#1)(1991-8#1)(1992-3#1)(1993-3#1)(1995-6#1)(2008-10#1)
The conformation##8##2##(1991-12#1)(1991-8#1)(1992-3#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-12#1)(2010-12#1)
The conformational##2##2##(1990-5#1)(2008-6#1)
The conformations of##2##3##(1993-11#1)(1993-3#1)
The conformations##3##2##(1993-11#1)(1993-3#1)(1995-3#1)
The congenital##4##2##(1995-12#1)(2007-7#1)(2012-3#2)
The conglutinin##2##2##(1992-9#2)
The conjugate##3##2##(2008-7#2)(2010-8#1)
The conjugated##2##2##(2008-10#1)(2009-5#1)
The conjugates##3##2##(1991-5#1)(1992-3#1)(2008-10#1)
The conjugation of##2##3##(1993-8#1)(2008-4#1)
The connection between##5##3##(1995-3#1)(2007-11#2)(2008-1#1)(2008-2#1)
The connection##7##2##(1993-3#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)
The consensus##3##2##(2007-4#1)(2007-6#1)(2008-10#1)
The consequence of##3##3##(1992-10#1)(2008-7#1)(2009-11#1)
The consequence##4##2##(1992-10#1)(2008-7#1)(2009-11#1)(2013-7#1)
The consequences of the##3##4##(1991-6#1)(1991-9#1)(2013-7#1)
The consequences of these##2##4##(1990-2#1)(2012-12#1)
The consequences of this##2##4##(2008-11#1)(2008-3#1)
The consequences of##11##3##(1990-2#1)(1991-6#1)(1991-9#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
The consequences##12##2##(1990-2#1)(1991-6#1)(1991-9#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
The consequent##3##2##(1991-6#1)(2008-10#1)(2013-1#1)
The conservation of##2##3##(1991-7#1)(1993-2#1)
The conservation##3##2##(1991-7#1)(1993-2#1)(2008-10#1)
The conservative##3##2##(1995-2#1)(2007-11#1)(2008-1#1)
The conserved##4##2##(1992-9#1)(2008-8#1)(2009-5#1)(2009-6#1)
The considerable##3##2##(1994-5#1)(2007-6#1)(2008-10#1)
The considerations##4##2##(1990-12#1)(1993-11#1)(2008-12#1)(2008-3#1)
The considered##2##2##(2012-3#2)
The consistency of the##4##4##(1992-9#1)(2008-10#1)(2008-6#1)(2010-3#1)
The consistency##5##2##(1992-9#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-2#1)
The consistent##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
The consolidation##2##2##(1994-12#1)(2008-11#1)
The conspicuous##2##2##(2008-10#2)
The constant##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
The constants##3##2##(2008-10#3)
The constitutive expression##2##3##(1990-11#1)(1995-11#1)
The constitutive##4##2##(1990-11#1)(1995-11#1)(1996-4#1)(2009-4#1)
The construct of##2##3##(1991-12#1)(1993-3#1)
The construct##3##2##(1991-12#1)(1993-3#1)(2013-1#1)
The constructed##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
The construction and##5##3##(1993-9#1)(2008-10#4)
The construction of a##4##4##(2008-10#3)(2008-2#1)
The construction of the##4##4##(2007-10#1)(2008-10#1)(2008-8#1)(2011-1#1)
The construction of##11##3##(1991-6#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#2)(2011-1#1)
The construction##21##2##(1991-6#1)(1993-9#1)(1995-9#1)(1997-2#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-1#1)
The consumer##3##2##(1994-3#1)(1996-1#1)(2008-5#1)
The consumption of##4##3##(1990-8#2)(2011-1#1)(2013-7#1)
The contact##2##2##(2007-12#1)(2008-11#1)
The contamination of##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
The contamination##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
The contemporary##3##2##(1990-11#1)(2008-1#1)(2009-10#1)
The content of the##5##4##(1994-11#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-8#1)
The content of total##2##4##(2008-12#1)(2012-1#1)
The content of vanadium in##2##5##(2008-10#2)
The content of##27##3##(1990-5#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1996-2#1)(1997-3#1)(2007-1#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-5#2)(2008-7#1)(2012-1#2)(2013-8#1)
The content##29##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1996-2#1)(1996-3#1)(1997-3#1)(2007-1#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-5#2)(2008-7#1)(2012-1#2)(2013-8#1)
The contents are##2##3##(2008-3#1)(2013-1#1)
The contents of##14##3##(1990-11#1)(1991-2#1)(1994-6#2)(2008-10#10)
The contents##18##2##(1990-11#1)(1991-2#1)(1993-1#1)(1994-6#2)(2008-10#10)(2008-3#1)(2013-1#2)
The context is##2##3##(2008-1#1)(2009-10#1)
The context of##2##3##(1997-1#1)(1997-2#1)
The context##4##2##(1997-1#1)(1997-2#1)(2008-1#1)(2009-10#1)
The continued##8##2##(1991-12#1)(1996-1#1)(2007-12#2)(2007-2#1)(2008-10#2)(2013-1#1)
The continuing##8##2##(1990-6#1)(1993-3#1)(1995-2#1)(2007-8#1)(2008-11#1)(2008-8#2)(2011-2#1)
The continuity##2##2##(1993-1#1)(2008-3#1)
The continuous analysis using the##2##5##(2008-10#2)
The continuous##10##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
The continuum##2##2##(1994-12#1)(2008-9#1)
The contractile##2##2##(1997-6#1)(2008-12#1)
The contraction of##2##3##(1995-6#1)(2008-10#1)
The contraction##3##2##(1993-3#1)(1995-6#1)(2008-10#1)
The contralateral##4##2##(1990-12#1)(1992-3#1)(2008-10#1)(2011-2#1)
The contrast ratio##2##3##(2008-2#2)
The contrast##4##2##(1991-5#1)(2008-2#3)
The contribution of the##4##4##(1993-3#1)(2008-2#1)(2008-3#2)
The contribution of##25##3##(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
The contribution##26##2##(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
The contributions of##6##3##(1994-5#1)(1995-2#1)(1995-9#1)(1997-8#1)(2008-10#1)(2008-2#1)
The control group comprised##3##4##(2007-7#1)(2008-12#1)(2008-7#1)
The control group consisted of##5##5##(1990-2#1)(2007-8#1)(2008-7#2)(2011-2#1)
The control group included##2##4##(2011-2#1)(2013-1#1)
The control group of##2##4##(1996-3#1)(2007-10#1)
The control group was##2##4##(2008-12#1)(2010-12#1)
The control group##18##3##(1990-2#1)(1991-5#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
The control of##9##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)
The control region was amplified in one piece and sequenced with different sequencing primers##2##14##(2008-12#2)
The control##39##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-3#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-5#3)(2008-7#4)(2008-8#1)(2009-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2013-1#1)
The controlled##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
The controller##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
The controls##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
The controversial##2##2##(1991-3#1)(2008-10#1)
The controversy##3##2##(2008-11#1)(2008-3#1)(2009-7#1)
The conventional method##2##3##(2008-10#2)
The conventional##15##2##(2007-4#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-7#1)(2013-1#1)(2013-8#1)
The convergence of##2##3##(2012-3#1)(2013-8#1)
The convergence##4##2##(2008-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
The converse##2##2##(1990-8#1)(2012-3#1)
The conversion efficiency##3##3##(2007-12#1)(2008-2#1)(2008-6#1)
The conversion of##7##3##(1991-12#1)(1992-12#1)(2008-10#2)(2008-6#2)(2009-12#1)
The conversion##16##2##(1990-7#1)(1991-12#1)(1992-12#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-6#3)(2008-7#1)(2009-12#1)(2009-2#1)
The cooling##2##2##(1994-2#1)(2008-10#1)
The cooperative free energy value of the##2##7##(1990-8#2)
The cooperative##4##2##(1990-8#3)(1994-6#1)
The coordinates of##2##3##(2008-3#1)(2009-2#1)
The coordination geometry##2##3##(1995-5#1)(1996-2#1)
The coordination of##2##3##(2011-2#1)(2012-3#1)
The coordination##9##2##(1994-8#1)(1995-5#1)(1996-2#2)(1997-7#1)(2008-10#1)(2011-2#2)(2012-3#1)
The copper complex##2##3##(2008-10#2)
The copper##10##2##(1990-5#1)(1993-2#1)(1997-7#1)(2008-10#6)(2010-11#1)
The coral reefs##2##3##(2008-5#1)(2011-2#1)
The coral##3##2##(2008-5#2)(2011-2#1)
The core category##2##3##(2008-11#1)(2013-1#1)
The core of##2##3##(2008-6#1)(2012-2#1)
The core##11##2##(1991-11#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-2#1)(2013-1#1)
The corn##2##2##(2008-11#1)(2008-6#1)
The cornerstone of##2##3##(2008-4#1)(2010-1#1)
The cornified cell envelope##2##4##(2008-5#2)
The cornified##3##2##(2008-5#3)
The coronary##2##2##(1994-11#1)(2008-10#1)
The correct diagnosis of##2##4##(2009-6#1)(2010-10#1)
The correct structure##2##3##(2008-4#2)
The correct##9##2##(2007-11#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)
The correction##6##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2013-8#1)
The correlated##2##2##(2008-2#1)(2008-8#1)
The correlation among##2##3##(2008-12#1)(2008-7#1)
The correlation between the##9##4##(1994-11#1)(1995-5#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
The correlation between##22##3##(1990-4#1)(1990-5#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-1#1)(2011-2#2)
The correlation coefficient between##3##4##(1992-6#1)(1993-3#1)(2008-2#1)
The correlation coefficient was 0##3##5##(2008-10#3)
The correlation coefficient##8##3##(1992-6#1)(1993-3#1)(2008-10#5)(2008-2#1)
The correlation coefficients were##2##4##(2008-10#2)
The correlation coefficients##5##3##(1991-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
The correlation of the##2##4##(1993-8#1)(2013-1#1)
The correlation of##7##3##(1990-5#1)(1993-8#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)
The correlation##55##2##(1990-4#1)(1990-5#2)(1991-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
The correlations between##3##3##(1995-11#1)(2008-5#1)(2011-1#1)
The correlations##7##2##(1991-5#1)(1992-3#1)(1995-11#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
The correlator is##2##3##(2008-2#1)(2008-3#1)
The correspondence##3##2##(2008-3#1)(2009-8#1)(2012-12#1)
The corresponding data##2##3##(1990-7#1)(2006-10#1)
The corresponding gene##2##3##(1997-2#1)(1997-7#1)
The corresponding values for##3##4##(1993-8#1)(2008-10#1)(2008-7#1)
The corresponding##42##2##(1990-7#1)(1990-8#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(1997-2#1)(1997-7#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2013-8#3)
The corrosion##2##2##(2013-1#2)
The cortical##3##2##(1993-3#1)(2007-12#1)(2008-1#1)
The cosmetic##7##2##(1991-2#1)(1991-6#1)(2006-12#1)(2008-10#1)(2008-5#2)(2008-9#1)
The cosmid##2##2##(1996-2#1)(1997-9#1)
The cost is##2##3##(1991-8#1)(2008-8#1)
The cost of the##3##4##(1992-12#2)(2008-10#1)
The cost of##16##3##(1991-2#1)(1992-12#3)(1995-1#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
The cost to##2##3##(1991-2#1)(2008-3#1)
The cost##26##2##(1991-2#2)(1991-8#1)(1992-12#3)(1992-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-8#1)(2012-12#2)
The cost-effectiveness of##3##3##(2011-2#1)(2012-12#2)
The costs of##4##3##(1990-9#1)(1991-12#1)(1993-2#1)(1995-12#1)
The costs##5##2##(1990-9#1)(1991-12#1)(1993-2#1)(1995-12#1)(2007-12#1)
The cotton##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
The coulometric##3##2##(2008-10#3)
The countries##3##2##(2011-1#1)(2011-4#1)(2012-2#1)
The country##3##2##(1997-6#2)(2007-7#1)
The coupled##2##2##(1996-8#1)(2007-11#1)
The coupled-mode##2##2##(2007-11#1)(2008-3#1)
The coupling of an##2##4##(2007-12#1)(2008-10#1)
The coupling of the##2##4##(2008-10#1)(2008-3#1)
The coupling of##10##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
The coupling##11##2##(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
The course of pregnancy##2##4##(2012-3#2)
The course of the##4##4##(1991-12#1)(1996-5#1)(1996-6#1)(2008-10#1)
The course of##10##3##(1990-8#1)(1991-12#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#2)(2012-3#2)(2013-8#1)
The course##17##2##(1990-8#1)(1991-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2012-3#2)(2013-8#1)
The court found that##2##4##(1991-7#1)(1997-5#1)
The court found##3##3##(1991-7#1)(1995-2#1)(1997-5#1)
The court is##2##3##(1996-5#1)(1997-5#1)
The court##16##2##(1990-11#2)(1990-2#1)(1991-7#1)(1992-12#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-5#3)(1996-9#1)(1997-5#2)
The covalent immobilization of##2##4##(2008-10#2)
The covalent##6##2##(1991-12#1)(2008-10#4)(2008-4#1)
The covalently##2##2##(2008-10#2)
The covariance##2##2##(2008-2#1)(2008-3#1)
The coverage of##2##3##(2007-11#1)(2011-2#1)
The coverage##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
The cpDNA of Korean##2##4##(1997-2#2)
The cpDNA##3##2##(1996-4#1)(1997-2#2)
The crack##2##2##(2008-3#1)(2009-7#1)
The cranial nerves##2##3##(2008-1#1)(2011-2#1)
The creatinine##2##2##(2008-10#2)
The creation of a##3##4##(1992-1#1)(2008-9#1)(2011-2#1)
The creation of##7##3##(1992-1#1)(1996-2#1)(1996-3#2)(2008-9#2)(2011-2#1)
The creation##8##2##(1992-1#2)(1996-2#1)(1996-3#2)(2008-9#2)(2011-2#1)
The crisis centre for children in Prague 4-Michle##2##8##(1995-5#2)
The crisis##4##2##(1994-12#1)(1995-1#1)(1995-5#2)
The criteria for##2##3##(1990-6#1)(2008-4#1)
The criteria used##2##3##(2012-2#1)(2013-1#1)
The criteria##7##2##(1990-6#1)(1997-8#1)(2008-4#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
The criterion##3##2##(2008-3#1)(2008-6#1)(2010-2#1)
The critical##19##2##(1991-3#1)(1991-6#1)(1993-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-8#1)
The cross sensitivity of##2##4##(2008-10#1)(2008-3#1)
The cross##5##2##(2008-10#2)(2008-3#1)(2009-7#1)(2009-8#1)
The cross-linked##2##2##(1991-2#1)(2008-4#1)
The cross-linking##2##2##(1994-5#1)(2007-12#1)
The cross-reaction of##2##3##(2008-11#2)
The cross-reactivity##2##2##(2008-10#1)(2008-4#1)
The cross-sectional area of the##2##5##(2008-2#1)(2013-8#1)
The cross-sectional##4##2##(1991-5#1)(1997-3#1)(2008-2#1)(2013-8#1)
The cross-sensitivity##2##2##(1995-5#1)(2008-10#1)
The cross-talk##2##2##(2008-2#1)(2008-4#1)
The cross-validation method was used to select the number of factors##3##11##(2008-10#3)
The cross-validation method was used##4##5##(2008-10#4)
The crown##3##2##(2008-10#2)(2011-2#1)
The crucial##4##2##(2007-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
The crude extract##2##3##(2008-10#1)(2008-11#1)
The crude##12##2##(1990-6#1)(1994-6#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)
The crystal is monoclinic##2##4##(1996-5#1)(1997-7#1)
The crystal is##3##3##(1996-5#1)(1997-7#1)(2007-11#1)
The crystal structure of a##3##5##(1991-5#1)(2010-10#1)(2013-8#1)
The crystal structure of the##7##5##(1994-12#1)(1995-11#1)(1995-2#1)(1997-7#1)(2007-11#1)(2012-2#1)(2013-8#1)
The crystal structure of##19##4##(1991-5#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-7#1)(2007-11#1)(2009-11#1)(2010-10#4)(2012-2#1)(2013-8#2)
The crystal structure reveals##2##4##(1996-2#1)(2010-10#1)
The crystal structure was solved by##2##6##(1992-12#1)(2008-8#1)
The crystal structure##24##3##(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#5)(2012-2#1)(2013-8#2)
The crystal structures of##3##4##(1996-2#1)(1997-7#1)(2008-10#1)
The crystal structures##4##3##(1996-2#1)(1997-7#2)(2008-10#1)
The crystal##35##2##(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-7#4)(2007-11#3)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-10#5)(2012-2#1)(2013-8#2)
The crystalline##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
The crystals##5##2##(1992-11#1)(1992-8#1)(1992-9#1)(2008-8#1)(2008-9#1)
The cubic##2##2##(2008-2#1)(2008-5#1)
The cultivars##4##2##(2008-10#3)(2008-12#1)
The cultural##3##2##(1997-3#1)(2012-2#1)(2013-1#1)
The culture conditions##2##3##(1996-12#1)(2010-5#1)
The culture medium##2##3##(2008-11#1)(2008-7#1)
The culture of##2##3##(1996-2#1)(2009-12#1)
The culture##9##2##(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-5#1)
The cultured cells##2##3##(1997-6#1)(2008-11#1)
The cultures##2##2##(1992-5#1)(1996-5#1)
The cumulative risk of##2##4##(1993-9#2)
The cumulative survival rate was##2##5##(1993-11#1)(2008-7#1)
The cumulative##20##2##(1993-11#2)(1993-9#2)(1996-7#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
The cure rate##2##3##(2012-3#1)(2013-1#1)
The curious##2##2##(2007-12#1)(2008-6#1)
The current article##2##3##(2011-2#1)(2012-2#1)
The current challenge in##2##4##(2007-6#1)(2012-3#1)
The current data##3##3##(1990-11#1)(2010-6#1)(2012-12#1)
The current guidelines##3##3##(2007-12#1)(2009-10#1)(2010-8#1)
The current investigation##4##3##(1993-1#1)(2007-10#1)(2008-12#1)(2008-2#1)
The current knowledge##2##3##(2011-3#1)(2013-8#1)
The current literature is##2##4##(2008-5#1)(2010-8#1)
The current literature##6##3##(2007-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#2)
The current management##3##3##(2008-7#1)(2010-6#1)(2013-1#1)
The current method##2##3##(2008-10#2)
The current model##3##3##(2008-3#1)(2008-4#2)
The current paper reviews##2##4##(2012-2#1)(2013-1#1)
The current paper##5##3##(1993-12#1)(2008-9#1)(2012-2#2)(2013-1#1)
The current practice##3##3##(2008-8#2)(2009-4#1)
The current report describes##2##4##(2012-2#1)(2012-3#1)
The current report gives a brief overview into the##2##9##(2008-10#2)
The current report gives##3##4##(2008-10#3)
The current report##6##3##(2008-10#3)(2008-7#1)(2012-2#1)(2012-3#1)
The current research investigated how##2##5##(2009-4#1)(2009-8#1)
The current research investigated##3##4##(2007-12#1)(2009-4#1)(2009-8#1)
The current research##5##3##(2007-12#1)(2008-12#2)(2009-4#1)(2009-8#1)
The current results##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
The current review##4##3##(2008-3#1)(2010-1#1)(2012-1#1)(2012-2#1)
The current state of##2##4##(2013-8#2)
The current status of##4##4##(1996-4#1)(1997-3#1)(2012-12#1)(2013-1#1)
The current studies were##2##4##(1990-11#1)(2008-10#1)
The current studies##9##3##(1990-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)
The current study describes##2##4##(2012-12#1)(2012-3#1)
The current study evaluated##2##4##(2012-2#2)
The current study examined the##2##5##(2008-11#1)(2010-1#1)
The current study examined##4##4##(2008-11#1)(2009-5#1)(2010-1#1)(2012-3#1)
The current study has##2##4##(2008-10#1)(2012-3#1)
The current study investigated##2##4##(2010-1#1)(2011-2#1)
The current study shows##2##4##(2008-3#1)(2012-12#1)
The current study was conducted to##3##6##(2007-7#1)(2011-2#1)(2012-2#1)
The current study was##8##4##(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)
The current study##48##3##(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#1)
The current work presents##2##4##(2008-10#1)(2008-4#1)
The current work##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#1)
The current##190##2##(1990-11#2)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-4#1)(1997-3#1)(2007-10#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#6)(2008-12#6)(2008-2#4)(2008-3#11)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#8)(2013-1#13)(2013-8#4)
The currently##4##2##(2008-12#1)(2008-7#1)(2010-6#1)(2012-12#1)
The curriculum##3##2##(1997-3#1)(2008-11#1)(2012-3#1)
The curves of##2##3##(2008-10#2)
The curves were##2##3##(2011-2#1)(2013-8#1)
The curves##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
The cut##2##2##(2009-6#1)(2012-3#1)
The cut-off##4##2##(1992-1#1)(2007-12#1)(2010-5#1)(2013-1#1)
The cutaneous##5##2##(1991-4#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
The cuticle##2##2##(2008-10#1)(2008-5#1)
The cutoff##2##2##(2006-10#1)(2008-10#1)
The cw##2##2##(2007-12#1)(2008-2#1)
The cycle##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
The cyclic peptide##2##3##(1990-12#1)(1992-3#1)
The cyclic peptides##2##3##(1994-6#2)
The cyclic voltammograms of##2##4##(1996-5#1)(2008-10#1)
The cyclic voltammograms##3##3##(1996-5#1)(2008-10#2)
The cyclic##16##2##(1990-12#1)(1992-3#1)(1994-6#2)(1996-12#1)(1996-5#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-2#1)(2009-9#2)
The cyclotron saga##2##3##(1990-6#1)(1991-6#1)
The cylindrical##2##2##(2008-3#2)
The cyst##4##2##(1997-8#2)(2007-12#1)(2008-7#1)
The cysteine##2##2##(1991-9#1)(1997-6#1)
The cysteinyl leukotrienes##2##3##(1993-6#1)(1993-9#1)
The cystic lesion##2##3##(2008-10#1)(2008-5#1)
The cystic##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2013-8#1)
The cysts were##3##3##(2008-7#1)(2010-11#1)(2010-12#1)
The cysts##5##2##(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
The cytochrome##2##2##(1992-12#1)(2013-1#1)
The cytologic##2##2##(1992-8#1)(2008-10#1)
The cytological grading##2##3##(2013-8#2)
The cytological##4##2##(2013-8#4)
The cytology##3##2##(2012-2#2)(2013-1#1)
The cytoplasm of##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
The cytoplasm##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
The cytoplasmic domain##2##3##(1991-6#1)(2008-5#1)
The cytoplasmic##6##2##(1991-2#1)(1991-6#1)(1994-6#2)(2008-5#1)(2008-7#1)
The cytosolic##3##2##(1992-12#1)(1994-11#1)(1994-6#1)
The cytotoxic effect of##2##4##(2008-11#1)(2013-1#1)
The cytotoxic effect##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
The cytotoxic effects of##4##4##(1990-5#1)(2008-11#1)(2010-1#1)(2011-1#1)
The cytotoxic##8##2##(1990-2#1)(1990-5#1)(2008-11#3)(2010-1#1)(2011-1#1)(2013-1#1)
The cytotoxicity of##2##3##(2008-11#2)
The cytotoxicity##5##2##(2008-11#2)(2008-8#2)(2011-2#1)
The dAVS##2##2##(1996-9#2)
The daily##5##2##(2008-10#1)(2008-12#1)(2008-6#1)(2009-11#1)(2011-2#1)
The damage##8##2##(2007-10#1)(2008-10#1)(2008-3#4)(2008-5#1)(2011-2#1)
The damaging##2##2##(1995-6#1)(2010-5#1)
The danger##2##2##(2010-5#1)(2011-2#1)
The dansyl hydrazones##2##3##(1990-8#2)
The dark##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
The data about##2##3##(2012-3#2)
The data also demonstrate that##2##5##(1992-3#1)(2008-10#1)
The data also demonstrate##4##4##(1992-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
The data also showed that##3##5##(1992-9#1)(2008-10#1)(2013-8#1)
The data also suggest that the##3##6##(1991-12#1)(1992-9#1)(2007-12#1)
The data also suggest that##4##5##(1991-12#1)(1992-9#1)(2007-12#1)(2009-5#1)
The data also##14##3##(1991-12#1)(1992-3#1)(1992-9#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2013-8#1)
The data analysis##5##3##(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-11#1)
The data are consistent with the hypothesis that##2##8##(2008-10#1)(2013-1#1)
The data are consistent with the##3##6##(1994-8#1)(2008-10#1)(2013-1#1)
The data are consistent with##8##5##(1993-12#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-2#1)(2013-1#1)
The data are consistent##9##4##(1993-12#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
The data are discussed in##2##5##(1994-2#1)(2011-2#1)
The data are discussed##3##4##(1994-2#1)(1996-2#1)(2011-2#1)
The data are then##2##4##(2008-10#1)(2009-5#1)
The data are##27##3##(1992-3#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2009-5#1)(2011-2#2)(2013-1#3)
The data collected##4##3##(1990-12#1)(2007-11#1)(2008-12#1)(2012-3#1)
The data collection was conducted##2##5##(1990-12#1)(2011-2#1)
The data collection##3##3##(1990-12#1)(2011-2#1)(2012-2#1)
The data demonstrate that##5##4##(1992-5#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
The data demonstrate##7##3##(1992-5#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
The data demonstrated that##2##4##(2008-10#1)(2011-3#1)
The data do not##2##4##(1997-6#1)(2013-1#1)
The data for##3##3##(1993-1#1)(1993-9#1)(2008-3#1)
The data from the##3##4##(1994-6#1)(2008-12#1)(2008-2#1)
The data from this study##2##5##(2007-10#1)(2008-10#1)
The data from##7##3##(1994-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#2)
The data generated from this study##2##6##(2008-10#2)
The data generated##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
The data have been processed by a recently developed##2##9##(2008-10#2)
The data have been processed##3##5##(2008-10#2)(2008-2#1)
The data have been##4##4##(2008-10#3)(2008-2#1)
The data have##5##3##(2008-10#3)(2008-2#1)(2010-6#1)
The data implicate##2##3##(1991-5#1)(2008-6#1)
The data in##2##3##(2008-10#1)(2010-5#1)
The data included##2##3##(1997-3#1)(1997-8#1)
The data indicate a##2##4##(2008-9#1)(2012-1#1)
The data indicate that the##6##5##(1990-12#1)(1993-11#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-7#1)
The data indicate that##22##4##(1990-12#1)(1990-5#1)(1991-12#2)(1992-12#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-12#3)(1997-7#1)(2008-10#5)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
The data indicate##26##3##(1990-12#1)(1990-5#1)(1991-12#2)(1992-12#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-12#3)(1997-7#1)(2007-2#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
The data indicated that##3##4##(1995-12#1)(2008-11#1)(2010-8#1)
The data is##2##3##(1993-3#1)(2008-11#1)
The data obtained by the present##2##6##(2008-10#2)
The data obtained by this method were in good agreement with those obtained by##2##14##(2008-10#2)
The data obtained by##5##4##(2008-10#5)
The data obtained from this##2##5##(2008-10#1)(2011-1#1)
The data obtained from##5##4##(1995-6#1)(2008-10#3)(2011-1#1)
The data obtained were##2##4##(2008-12#1)(2010-6#1)
The data obtained##18##3##(1995-6#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
The data of##5##3##(1991-3#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
The data on the##3##4##(1991-3#1)(2008-10#1)(2011-2#1)
The data on##9##3##(1991-3#1)(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
The data presented here support##2##5##(2008-10#1)(2012-3#1)
The data presented here##5##4##(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
The data presented##9##3##(1994-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)
The data provide##2##3##(1992-1#1)(2008-10#1)
The data reported##2##3##(1992-9#1)(2008-1#1)
The data reveal##2##3##(2008-10#1)(2009-9#1)
The data set##5##3##(2008-10#4)(2008-3#1)
The data sets##3##3##(1997-8#1)(2008-3#1)(2008-8#1)
The data show that the##3##5##(1991-2#1)(1996-2#1)(2008-10#1)
The data show that##12##4##(1990-5#1)(1991-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-5#1)
The data show##14##3##(1990-5#1)(1991-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
The data showed that##5##4##(1991-6#1)(1996-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
The data showed##6##3##(1991-6#1)(1994-12#1)(1996-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
The data suggest a##2##4##(1991-2#1)(1995-2#1)
The data suggest that a##2##5##(1992-6#1)(1993-12#1)
The data suggest that the##11##5##(1990-2#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)
The data suggest that##35##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
The data suggest##41##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
The data suggests##2##3##(1994-2#1)(2008-10#1)
The data support the hypothesis that##2##6##(1997-3#1)(2007-12#1)
The data support the##5##4##(1997-3#1)(2007-12#1)(2008-6#1)(2009-9#1)(2012-12#1)
The data support##6##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-9#1)(2012-12#1)
The data thus##3##3##(1990-5#1)(1997-6#1)(2008-10#1)
The data was analyzed by##2##5##(2008-12#1)(2013-8#1)
The data was analyzed##3##4##(2008-12#1)(2011-1#1)(2013-8#1)
The data was collected from##2##5##(1991-2#1)(2008-9#1)
The data was collected##3##4##(1991-2#1)(2008-12#1)(2008-9#1)
The data was statistically##2##4##(2012-3#1)(2013-1#1)
The data was##13##3##(1991-2#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
The data were analysed##5##4##(2007-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-6#1)
The data were analyzed by##2##5##(1990-2#1)(1993-9#1)
The data were analyzed using##2##5##(2010-2#1)(2011-2#1)
The data were analyzed##7##4##(1990-2#1)(1990-6#1)(1993-9#1)(2006-12#1)(2008-10#1)(2010-2#1)(2011-2#1)
The data were collected by##2##5##(2009-12#1)(2011-2#1)
The data were collected##6##4##(1991-6#1)(2008-5#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
The data were interpreted in##2##5##(1990-7#1)(2012-3#1)
The data were interpreted##3##4##(1990-7#1)(2008-10#1)(2012-3#1)
The data were obtained from the##2##6##(1991-6#1)(2011-1#1)
The data were obtained from##4##5##(1990-2#1)(1991-6#1)(1995-12#1)(2011-1#1)
The data were obtained##6##4##(1990-2#1)(1991-6#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
The data were subjected to##2##5##(1995-6#1)(2013-1#1)
The data were taken##2##4##(2008-3#1)(2008-9#1)
The data were then fitted##2##5##(2008-3#1)(2009-12#1)
The data were##44##3##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-6#2)(1993-9#1)(1995-12#1)(1995-6#2)(1996-8#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
The data##352##2##(1990-12#3)(1990-2#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#5)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#1)(2008-1#3)(2008-10#66)(2008-11#10)(2008-12#13)(2008-2#12)(2008-3#14)(2008-4#2)(2008-5#8)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#4)(2009-6#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#14)(2013-7#4)(2013-8#3)
The data-acquisition##2##2##(2008-10#1)(2008-3#1)
The database is##3##3##(1991-12#1)(2009-2#2)
The database##9##2##(1991-12#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-7#3)(2009-2#2)
The databases##2##2##(2009-10#1)(2012-3#1)
The day##2##2##(1994-2#1)(2008-7#1)
The death of##2##3##(1994-3#1)(1997-2#1)
The debate over##2##3##(1994-3#1)(1995-2#1)
The debate##4##2##(1990-6#1)(1994-3#1)(1995-2#1)(2008-11#1)
The decay of##3##3##(1992-12#1)(1995-2#1)(2012-3#1)
The decay##4##2##(1992-12#1)(1995-2#1)(2008-3#1)(2012-3#1)
The decimal reduction time##2##4##(2008-10#1)(2011-2#1)
The decision to operate is##2##5##(1996-6#1)(2007-11#1)
The decision to##10##3##(1995-3#1)(1996-6#1)(2007-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-3#3)
The decision##22##2##(1993-1#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-5#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
The decline in##4##3##(1993-11#1)(1995-8#1)(2007-12#1)(2008-11#1)
The decline of##2##3##(2008-3#1)(2012-1#1)
The decline##6##2##(1993-11#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-1#1)
The decrease in absorbance of##2##5##(2008-10#2)
The decrease in the##3##4##(1990-3#1)(1990-7#1)(2008-10#1)
The decrease in##25##3##(1990-3#1)(1990-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-5#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
The decrease of the##4##4##(1993-12#1)(1996-6#1)(1997-7#1)(2008-10#1)
The decrease of##10##3##(1993-12#1)(1994-5#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-7#1)
The decrease was##2##3##(1991-5#1)(2008-11#1)
The decrease##40##2##(1990-3#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
The decreased##12##2##(1990-5#1)(1995-11#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
The deduced aa sequence of##2##5##(1993-12#1)(1995-8#1)
The deduced aa sequence##9##4##(1990-11#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-12#2)(1995-8#2)(1997-4#1)
The deduced amino acid (aa) sequence of##2##7##(1991-6#1)(1993-12#1)
The deduced amino acid sequence consists of##2##7##(1997-6#1)(2008-8#1)
The deduced amino acid sequence of the##4##7##(1992-3#1)(1992-9#1)(1993-2#1)(1997-4#1)
The deduced amino acid sequence of##7##6##(1990-5#1)(1992-3#1)(1992-9#1)(1993-2#1)(1997-4#2)(2008-8#1)
The deduced amino acid sequence shows a##2##7##(1993-2#1)(1994-8#1)
The deduced amino acid sequence shows##3##6##(1993-12#1)(1993-2#1)(1994-8#1)
The deduced amino acid sequence was##2##6##(1992-3#1)(1996-12#1)
The deduced amino acid sequence##21##5##(1990-5#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-4#3)(1997-6#1)(2008-10#1)(2008-8#2)
The deduced amino acid sequences of##3##6##(1992-9#1)(1993-6#1)(2008-7#1)
The deduced amino acid sequences##5##5##(1990-5#2)(1992-9#1)(1993-6#1)(2008-7#1)
The deduced amino acid##29##4##(1990-5#3)(1991-6#1)(1992-12#1)(1992-3#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-4#3)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#2)
The deduced primary##2##3##(1992-3#1)(1993-9#1)
The deduced protein has##2##4##(2008-8#2)
The deduced protein##6##3##(1993-2#1)(1994-6#1)(2008-8#3)(2013-1#1)
The deduced sequence of##2##4##(1993-3#1)(1994-12#1)
The deduced##58##2##(1990-11#1)(1990-5#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#3)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#6)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1997-2#2)(1997-4#4)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#5)(2013-1#1)
The deep##6##2##(1991-9#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#1)
The default##2##2##(2008-4#1)(2013-1#1)
The defect was repaired##2##4##(2008-12#1)(2012-3#1)
The defect was##3##3##(2008-12#1)(2010-3#1)(2012-3#1)
The defect##4##2##(2008-12#1)(2008-7#1)(2010-3#1)(2012-3#1)
The definition of##6##3##(1996-6#1)(1997-1#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)
The definitions of##2##3##(1996-11#1)(1996-6#1)
The definitive##3##2##(1996-12#1)(2008-6#1)(2010-12#1)
The defocusing##2##2##(2008-2#1)(2008-3#1)
The deformation##2##2##(2008-10#1)(2008-3#1)
The degradation of##4##3##(1992-12#1)(2008-6#1)(2011-1#1)(2012-3#1)
The degradation rate of reactive brilliant blue X-BR##2##8##(2009-8#2)
The degradation rate##3##3##(2007-12#1)(2009-8#2)
The degradation##14##2##(1992-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-3#1)
The degree of deacetylation##2##4##(2008-10#2)
The degree of genetic##2##4##(2008-10#2)
The degree of interference from##2##5##(2008-10#2)
The degree of##39##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-6#1)(1994-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-5#4)(2008-7#2)(2009-10#1)(2012-12#2)(2013-1#2)
The degree to which##3##4##(1992-12#1)(1992-3#1)(2008-5#1)
The degree##42##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-5#5)(2008-7#2)(2009-10#1)(2012-12#2)(2013-1#2)
The degree-day intercept of##2##4##(2008-10#2)
The dehydrogenase##2##2##(1990-11#1)(1992-9#1)
The delay in diagnosis of##2##5##(2008-8#1)(2013-1#1)
The delay in##5##3##(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
The delay line##2##3##(2008-3#2)
The delay##15##2##(1991-2#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
The deleted##2##2##(1991-9#1)(2008-10#1)
The deleterious##2##2##(2008-11#1)(2011-2#1)
The deletion mutant##2##3##(1995-8#1)(2008-8#1)
The deletion of##3##3##(1991-6#1)(1992-6#1)(1997-2#1)
The deletion##5##2##(1991-6#1)(1992-6#1)(1995-8#1)(1997-2#1)(2008-8#1)
The delivery of##4##3##(1995-1#1)(1996-3#1)(2008-3#1)(2008-4#1)
The delivery##5##2##(1995-1#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-5#1)
The delta##3##2##(1991-1#1)(1993-8#1)(2010-4#1)
The demand for##6##3##(1993-12#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2012-2#1)
The demand##7##2##(1993-12#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
The demands on##3##3##(1992-2#1)(1996-1#1)(2012-1#1)
The demands##4##2##(1992-2#1)(1996-1#1)(2011-2#1)(2012-1#1)
The dementia##2##2##(2008-5#1)(2008-7#1)
The demographic variables##2##3##(1995-1#2)
The demographic##6##2##(1994-12#1)(1995-1#2)(2008-8#1)(2008-9#1)(2012-2#1)
The demonstrated##2##2##(2007-11#1)(2012-3#1)
The demonstration of##4##3##(1995-12#1)(2007-11#1)(2007-12#1)(2008-7#1)
The demonstration##5##2##(1995-12#1)(2007-11#1)(2007-12#2)(2008-7#1)
The densities and polarities of the mobile phase were optimised from the effects of pressure##2##15##(2008-10#2)
The density of##16##3##(1990-12#1)(1994-6#2)(1997-7#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
The density##18##2##(1990-12#1)(1994-6#2)(1997-7#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
The dental##4##2##(1995-3#1)(1996-9#1)(2013-1#1)(2013-8#1)
The deoxygenation of the##2##4##(2008-10#2)
The deoxygenation##3##2##(2008-10#3)
The dependence of fluorescence##2##4##(2008-2#1)(2008-3#1)
The dependence of optical##2##4##(2007-11#1)(2007-12#1)
The dependence of the##13##4##(1990-2#1)(1991-8#1)(1993-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)
The dependence of##38##3##(1990-2#1)(1990-8#1)(1991-10#1)(1991-8#1)(1993-8#1)(1995-11#1)(2007-11#3)(2007-12#7)(2008-10#11)(2008-2#4)(2008-3#6)(2008-8#1)
The dependence on##2##3##(2008-10#1)(2008-3#1)
The dependence##40##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-8#1)(1993-8#1)(1995-11#1)(2007-11#3)(2007-12#7)(2008-10#12)(2008-2#4)(2008-3#7)(2008-8#1)
The dependences of the##2##4##(2007-11#1)(2008-10#1)
The dependencies of the##2##4##(1996-5#1)(2008-3#1)
The depletion##2##2##(2008-11#1)(2010-3#1)
The deposition of##3##3##(1995-3#1)(2008-10#2)
The deposition##4##2##(1995-3#1)(2008-10#2)(2009-11#1)
The deposits##2##2##(1994-5#2)
The depression##3##2##(1997-3#1)(1997-7#1)(2008-9#1)
The depressive##2##2##(1993-12#1)(2011-2#1)
The depth of invasion was##2##5##(1990-9#1)(2008-5#1)
The depth of the##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
The depth of##10##3##(1990-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2013-1#2)
The depth resolution##3##3##(2007-12#2)(2008-3#1)
The depth##16##2##(1990-9#1)(2007-12#4)(2008-10#3)(2008-3#3)(2008-5#1)(2008-8#2)(2013-1#2)
The derivation of##2##3##(2008-11#1)(2008-3#1)
The derivative was##3##3##(2008-10#2)(2011-1#1)
The derivative##5##2##(2008-10#4)(2011-1#1)
The derivatives showed an intense protonated molecular ion corresponding m/z##2##10##(2008-10#2)
The derivatives##4##2##(1995-2#1)(2008-10#2)(2011-1#1)
The derivatization reagent##2##3##(2008-10#2)
The derivatization##6##2##(1993-9#1)(2008-10#5)
The derived amino acid sequence##2##5##(1990-8#1)(1996-3#1)
The derived##10##2##(1990-8#1)(1991-2#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
The described method##3##3##(2007-8#1)(2008-10#1)(2009-8#1)
The described##9##2##(1995-3#1)(2007-8#1)(2008-10#4)(2009-10#1)(2009-8#1)(2013-7#1)
The description of##4##3##(1991-2#1)(1994-3#1)(2008-10#1)(2013-1#1)
The descriptions of the##2##4##(2008-5#2)
The design and evaluation of a##2##6##(2008-2#1)(2008-3#1)
The design and operation of a##2##6##(2008-10#1)(2008-2#1)
The design and the##2##4##(2008-3#2)
The design and##17##3##(1996-3#1)(2008-10#1)(2008-2#4)(2008-3#10)(2009-9#1)
The design concept##2##3##(2008-2#2)
The design is##3##3##(2008-3#3)
The design of a##10##4##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#7)
The design of the##11##4##(1990-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-3#1)
The design of##31##3##(1990-2#1)(1992-3#1)(1994-11#1)(1997-3#1)(2007-11#3)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#15)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
The design##79##2##(1990-2#1)(1992-3#1)(1994-11#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-12#2)(2008-2#8)(2008-3#40)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
The designed##6##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-3#1)
The desire to##2##3##(2008-7#1)(2013-8#1)
The desired##5##2##(2007-11#1)(2008-11#1)(2010-6#1)(2012-8#1)(2013-7#1)
The desorption was##2##3##(2008-10#2)
The desorption##4##2##(1994-3#1)(2008-10#3)
The detailed study of various interferences confirmed the high selectivity of the##2##12##(2008-10#2)
The detailed study of##3##4##(2008-10#2)(2008-12#1)
The detailed##10##2##(2008-10#3)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#1)
The details of the##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
The details of##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-2#1)
The detected##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
The detection and quantification limits were##2##6##(2008-10#2)
The detection and quantification limits##4##5##(2008-10#4)
The detection and##9##3##(2008-10#5)(2008-2#1)(2008-3#1)(2010-5#1)(2010-7#1)
The detection chemistry is based on the##2##7##(2008-10#2)
The detection frequency of P##2##5##(2008-10#2)
The detection is based##2##4##(2008-10#1)(2008-9#1)
The detection is##4##3##(1990-8#1)(2008-10#2)(2008-9#1)
The detection limit (3##2##4##(1991-12#1)(2008-10#1)
The detection limit (3sigma) was 0##3##6##(2008-10#3)
The detection limit (3sigma)##6##4##(2008-10#6)
The detection limit (DL) value for the preconcentration method proposed was##2##11##(2008-10#2)
The detection limit (DL)##3##4##(2008-10#3)
The detection limit (S/N=3) is##2##5##(2008-10#2)
The detection limit (S/N=3) was##2##5##(2008-10#2)
The detection limit (S/N=3)##6##4##(2008-10#6)
The detection limit (signal-to-noise##2##4##(2008-10#2)
The detection limit and linear##2##5##(2008-10#2)
The detection limit and the variation coefficient were found to be 2##2##12##(2008-10#2)
The detection limit and the##4##5##(2008-10#4)
The detection limit and##9##4##(2008-10#9)
The detection limit based on a signal-to-noise ratio of three was 0##2##12##(2008-10#2)
The detection limit corresponding to three times the standard deviation of the blank was found to be 0##2##18##(2008-10#2)
The detection limit corresponding to three times the standard deviation of the blank was found to be##5##17##(2008-10#5)
The detection limit for dichlorvos##2##5##(2008-10#2)
The detection limit for the##4##5##(2008-10#4)
The detection limit for##25##4##(1990-8#2)(2008-10#21)(2008-12#1)(2012-3#1)
The detection limit found##2##4##(2008-10#2)
The detection limit in##2##4##(2008-10#2)
The detection limit is 0##16##5##(2008-10#16)
The detection limit is 1##2##5##(2008-10#2)
The detection limit is 2##3##5##(2008-10#3)
The detection limit is 5##4##5##(2008-10#4)
The detection limit is 8##3##5##(2008-10#3)
The detection limit is about 0##2##6##(1996-5#1)(2008-10#1)
The detection limit is found to be##2##7##(2008-10#2)
The detection limit is##46##4##(1996-5#1)(2008-10#44)(2008-2#1)
The detection limit obtained##2##4##(2008-10#2)
The detection limit of Cr(VI)##2##5##(2008-10#2)
The detection limit of each##2##5##(2008-10#1)(2008-11#1)
The detection limit of the method is 0##4##8##(2008-10#4)
The detection limit of the method is##6##7##(2008-10#6)
The detection limit of the method##10##6##(1995-6#1)(2008-10#9)
The detection limit of the proposed method is##2##8##(2008-10#2)
The detection limit of the proposed method##3##7##(2008-10#3)
The detection limit of the proposed##5##6##(2008-10#5)
The detection limit of the##22##5##(1995-6#1)(2008-10#19)(2008-12#1)(2013-8#1)
The detection limit of this assay##2##6##(1991-2#1)(1995-11#1)
The detection limit of this method is##2##7##(2008-10#2)
The detection limit of this method was##3##7##(1990-2#1)(2008-10#2)
The detection limit of this method##6##6##(1990-2#1)(2008-10#5)
The detection limit of this##9##5##(1990-2#1)(1991-2#1)(1995-11#1)(2008-10#6)
The detection limit of##50##4##(1990-2#1)(1991-2#1)(1995-11#1)(1995-6#1)(2008-10#42)(2008-11#1)(2008-12#1)(2013-8#2)
The detection limit was 0##10##5##(1994-9#1)(2008-10#9)
The detection limit was 1##3##5##(2008-10#3)
The detection limit was 2##3##5##(2008-10#3)
The detection limit was 3##2##5##(2008-10#2)
The detection limit was 5##2##5##(2008-10#2)
The detection limit was 8##3##5##(1990-8#1)(2008-10#2)
The detection limit was c(L)=0##2##5##(2008-10#2)
The detection limit was determined as##2##6##(2008-10#2)
The detection limit was determined##3##5##(2008-10#3)
The detection limit was estimated to be##3##7##(2008-10#2)(2008-3#1)
The detection limit was found to be##3##7##(2008-10#3)
The detection limit was##50##4##(1990-8#1)(1994-9#1)(2008-10#46)(2008-3#1)(2013-8#1)
The detection limit##249##3##(1990-2#1)(1990-8#3)(1991-12#1)(1991-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-10#230)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2012-3#1)(2013-8#3)
The detection limits (3sigma##2##4##(2008-10#2)
The detection limits (3sigma) are##2##5##(2008-10#2)
The detection limits (3sigma) were##2##5##(2008-10#2)
The detection limits (3sigma)##6##4##(2008-10#6)
The detection limits (DL)##2##4##(2008-10#1)(2013-8#1)
The detection limits (LOD)##2##4##(2008-10#2)
The detection limits (S/N=3) are##3##5##(2008-10#3)
The detection limits (S/N=3) for##2##5##(2008-10#2)
The detection limits (S/N=3) of##3##5##(2008-10#3)
The detection limits (S/N=3)##11##4##(2008-10#11)
The detection limits achieved (3sigma) were##2##6##(2008-10#2)
The detection limits achieved##3##4##(2008-10#3)
The detection limits and##3##4##(2008-10#3)
The detection limits are 0##4##5##(2008-10#4)
The detection limits are##8##4##(2008-10#8)
The detection limits at##2##4##(2008-10#2)
The detection limits for the##2##5##(2008-10#2)
The detection limits for##18##4##(1990-8#1)(1997-2#1)(2008-10#15)(2011-1#1)
The detection limits observed##2##4##(2008-10#2)
The detection limits obtained##5##4##(2008-10#5)
The detection limits of Cd##2##5##(2008-10#2)
The detection limits of ETAAS followed by##2##7##(2008-10#2)
The detection limits of the method are##2##7##(2008-10#2)
The detection limits of the method##3##6##(2008-10#2)(2012-1#1)
The detection limits of the proposed electrodes were##2##8##(2008-10#2)
The detection limits of the##8##5##(2008-10#7)(2012-1#1)
The detection limits of##16##4##(1997-2#1)(2008-10#14)(2012-1#1)
The detection limits were 0##8##5##(2008-10#8)
The detection limits were 2##2##5##(2008-10#2)
The detection limits were 3##2##5##(2008-10#2)
The detection limits were 5##2##5##(2008-10#2)
The detection limits were found to be 0##2##8##(2008-10#2)
The detection limits were found to be##3##7##(2008-10#3)
The detection limits were##29##4##(2008-10#29)
The detection limits##130##3##(1990-8#2)(1997-2#2)(2008-10#122)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
The detection method##2##3##(2008-10#2)
The detection of the##4##4##(1997-3#1)(2008-10#2)(2012-2#1)
The detection of##27##3##(1990-9#1)(1992-6#1)(1997-3#1)(2008-10#13)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
The detection rate of##3##4##(1995-4#2)(2010-12#1)
The detection sensitivity##2##3##(2008-10#1)(2008-2#1)
The detection system consists##2##4##(2008-10#2)
The detection system##5##3##(2007-12#1)(2008-10#4)
The detection was based on the##2##6##(2008-10#2)
The detection was##7##3##(2008-10#7)
The detection wavelength##2##3##(2008-10#1)(2011-1#1)
The detection##456##2##(1990-2#1)(1990-8#6)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-4#2)(1995-6#1)(1996-5#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#396)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
The detector is##2##3##(2008-10#2)
The detector##4##2##(2008-10#3)(2008-3#1)
The determinants of##3##3##(2008-7#1)(2010-10#1)(2011-2#1)
The determination is based on the precipitation reaction of##2##9##(2008-10#2)
The determination is based on the reaction of##2##8##(2008-10#2)
The determination is based on the##6##6##(2008-10#6)
The determination is based on##8##5##(2008-10#8)
The determination is carried out without any derivatization reaction##2##9##(2008-10#2)
The determination is##11##3##(2008-10#11)
The determination limit was##5##4##(2008-10#5)
The determination limit##8##3##(2008-10#8)
The determination of chloride##2##4##(2008-10#2)
The determination of the##12##4##(1991-11#1)(1995-12#1)(2008-10#9)(2008-5#1)
The determination of total##2##4##(2008-10#2)
The determination of trace amounts of##2##6##(2008-10#2)
The determination of trace levels of aluminum##2##7##(2008-10#2)
The determination of trace levels of##3##6##(2008-10#3)
The determination of trace##6##4##(2008-10#6)
The determination of water##2##4##(2008-10#1)(2012-1#1)
The determination of##83##3##(1990-8#1)(1991-11#1)(1992-11#1)(1995-12#1)(2008-10#71)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2012-1#1)
The determination results##2##3##(2008-10#2)
The determination was##3##3##(1991-5#1)(2008-10#2)
The determination##116##2##(1990-8#2)(1991-11#1)(1991-5#1)(1992-11#1)(1995-12#1)(2008-10#101)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#1)(2012-1#1)
The determined##2##2##(2008-10#1)(2011-2#1)
The detrimental effects of a##2##5##(2008-3#1)(2011-1#1)
The detrimental##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
The developed analytical method was##2##5##(2008-10#2)
The developed analytical##3##3##(2008-10#3)
The developed approach##2##3##(2007-11#1)(2010-8#1)
The developed grafted##2##3##(2008-10#2)
The developed method allows##2##4##(2008-10#2)
The developed method has been successfully##2##6##(2008-10#2)
The developed method has been##4##5##(2008-10#4)
The developed method is##6##4##(2008-10#6)
The developed method was applied for##3##6##(2008-10#3)
The developed method was applied to the determination of##3##9##(2008-10#3)
The developed method was applied to the##6##7##(2008-10#6)
The developed method was applied to##12##6##(2008-10#12)
The developed method was applied##15##5##(2008-10#15)
The developed method was successfully applied to the##2##8##(2008-10#1)(2011-2#1)
The developed method was successfully applied to##4##7##(2008-10#2)(2008-11#1)(2011-2#1)
The developed method was##25##4##(2008-10#22)(2008-11#1)(2011-2#1)(2012-12#1)
The developed method##46##3##(2008-10#41)(2008-11#2)(2011-2#2)(2012-12#1)
The developed methodology was##2##4##(2008-10#2)
The developed methodology##9##3##(2008-10#8)(2011-2#1)
The developed methods were applied to the determination of##2##9##(2008-10#2)
The developed methods were applied to##3##6##(2008-10#3)
The developed methods were applied##4##5##(2008-10#4)
The developed methods were##5##4##(2008-10#5)
The developed procedure has been successfully utilized for the estimation of##2##11##(2008-10#2)
The developed procedure provided##2##4##(2008-10#2)
The developed procedure was##3##4##(2008-10#3)
The developed procedure##9##3##(2008-10#9)
The developed sensor was applied for the##2##7##(2008-10#2)
The developed sensor was##3##4##(2008-10#3)
The developed system was##2##4##(2008-10#2)
The developed system##4##3##(2008-10#4)
The developed technology##2##3##(2008-4#1)(2008-6#1)
The developed##117##2##(1990-2#1)(1995-2#1)(2007-11#3)(2008-10#92)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-1#4)
The developing##2##2##(2008-11#1)(2008-9#1)
The development and##13##3##(1992-3#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2012-2#1)
The development of a women's health center in an academic health center##2##12##(1994-3#2)
The development of a##22##4##(1991-9#1)(1992-1#1)(1994-3#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)
The development of an##4##4##(2007-12#1)(2008-10#2)(2009-10#1)
The development of new##3##4##(2008-6#1)(2008-8#1)(2009-1#1)
The development of reliable##2##4##(1993-6#1)(2008-7#1)
The development of specific##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
The development of the serious mental illness physical Health Improvement##2##10##(2009-6#2)
The development of the##19##4##(1991-3#1)(1991-9#1)(1992-1#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#2)(2010-8#1)(2012-3#1)
The development of these##3##4##(1992-9#1)(2008-5#1)(2009-8#1)
The development of this##4##4##(1995-2#1)(2008-11#1)(2009-5#1)(2012-12#1)
The development of##164##3##(1990-3#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-1#3)(1992-9#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#36)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#2)(2009-1#2)(2009-10#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
The development##181##2##(1990-3#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-1#3)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#2)(1995-2#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#40)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#2)(2009-1#2)(2009-10#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
The developmental time##2##3##(1990-5#1)(2011-2#1)
The developmental##11##2##(1990-5#1)(1991-2#1)(1993-12#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
The deviation from##4##3##(1992-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
The deviation##6##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
The device can be used##2##5##(2007-11#1)(2007-12#1)
The device can be##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
The device can modulate##2##4##(2008-2#1)(2008-3#1)
The device can##7##3##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
The device consists of a##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
The device consists of two##2##5##(2007-11#1)(2008-2#1)
The device consists of##7##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
The device has a##5##4##(2007-11#2)(2008-3#3)
The device has the##2##4##(2007-12#1)(2008-2#1)
The device has##8##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
The device is based on##2##5##(2007-11#1)(2008-2#1)
The device is##8##3##(1992-11#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2012-1#1)
The device was##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
The device##44##2##(1992-11#1)(1993-2#1)(2007-11#8)(2007-12#6)(2008-10#4)(2008-2#5)(2008-3#13)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-1#1)(2013-1#1)
The devices are##2##3##(2007-11#1)(2008-7#1)
The devices##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)
The diabetes##5##2##(1993-9#1)(1996-12#1)(1997-8#1)(2008-10#1)(2010-7#1)
The diabetic##4##2##(1994-12#1)(2007-10#1)(2007-11#1)(2011-2#1)
The diagnoses were based upon##2##5##(1990-8#1)(1992-4#1)
The diagnoses were##4##3##(1990-2#1)(1990-8#1)(1992-4#1)(1994-3#1)
The diagnoses##6##2##(1990-2#1)(1990-8#1)(1992-4#1)(1994-3#1)(2008-10#1)(2011-2#1)
The diagnosis and management of##2##5##(2008-10#1)(2009-12#1)
The diagnosis and treatment of##2##5##(2008-10#1)(2011-2#1)
The diagnosis and treatment##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
The diagnosis and##7##3##(1990-6#1)(1993-2#1)(2008-10#2)(2008-12#1)(2009-12#1)(2011-2#1)
The diagnosis is based##2##4##(1993-2#1)(2013-1#1)
The diagnosis is difficult##2##4##(1996-9#1)(2012-12#1)
The diagnosis is made##2##4##(2011-1#1)(2013-1#1)
The diagnosis is usually##2##4##(2010-4#1)(2012-3#1)
The diagnosis is##10##3##(1993-2#1)(1996-9#1)(2007-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
The diagnosis may be##2##4##(2008-1#1)(2010-11#1)
The diagnosis of TB##2##4##(2008-1#1)(2010-5#1)
The diagnosis of drug-induced liver injury##2##6##(2008-8#2)
The diagnosis of drug-induced liver##3##5##(2008-8#3)
The diagnosis of primary##2##4##(1995-12#1)(2008-12#1)
The diagnosis of tuberculosis##2##4##(1990-6#1)(1990-9#1)
The diagnosis of##50##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1993-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
The diagnosis should##2##3##(1990-3#1)(2008-9#1)
The diagnosis was based on##3##5##(2010-12#1)(2012-12#1)(2012-3#1)
The diagnosis was confirmed by##8##5##(1990-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#1)
The diagnosis was confirmed on##2##5##(2012-2#1)(2013-8#1)
The diagnosis was confirmed##10##4##(1990-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
The diagnosis was made##3##4##(2007-10#1)(2007-12#1)(2012-3#1)
The diagnosis was obtained##2##4##(1990-10#1)(2009-1#1)
The diagnosis was suspected##2##4##(2008-7#2)
The diagnosis was##26##3##(1990-10#1)(1990-12#1)(1990-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#3)(2009-1#1)(2009-11#1)(2009-5#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
The diagnosis##106##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-6#2)(1990-9#1)(1991-3#1)(1992-5#1)(1993-2#3)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#2)
The diagnostic and therapeutic##2##4##(2010-8#1)(2012-3#1)
The diagnostic and##4##3##(2007-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
The diagnostic criteria##3##3##(1990-9#1)(1995-8#1)(2008-7#1)
The diagnostic features of the##2##5##(2011-2#2)
The diagnostic features##3##3##(2008-8#1)(2011-2#2)
The diagnostic value of##6##4##(1991-4#1)(1994-7#1)(1995-4#1)(1996-12#1)(2007-11#1)(2012-2#1)
The diagnostic##41##2##(1990-9#1)(1991-4#1)(1992-5#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-12#2)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
The dialysate collected in##2##4##(2008-10#2)
The dialysis##5##2##(1993-12#1)(1994-6#1)(2008-10#3)
The diameter and##2##3##(2008-11#1)(2009-7#1)
The diameter of the##4##4##(1997-4#1)(1997-5#1)(2008-3#1)(2008-7#1)
The diameter of##7##3##(1997-4#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
The diameter##9##2##(1997-4#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
The diameters of the##2##4##(2008-7#1)(2011-2#1)
The dielectric##3##2##(1997-2#1)(2007-12#2)
The diet##6##2##(1997-3#2)(2008-3#1)(2008-5#2)(2012-3#1)
The dietary##6##2##(1990-8#1)(1991-12#1)(1997-3#1)(2008-3#1)(2008-7#1)(2010-2#1)
The diets of##2##3##(1991-12#1)(2008-7#1)
The diets##3##2##(1991-12#1)(2008-3#1)(2008-7#1)
The dif##2##2##(1995-2#2)
The difference between the results##2##5##(2007-8#1)(2011-2#1)
The difference between the##13##4##(1991-2#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#2)
The difference between##24##3##(1991-2#1)(1993-12#1)(1994-3#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
The difference in mean##2##4##(2008-10#1)(2008-6#1)
The difference in the##6##4##(1995-5#1)(2008-10#3)(2008-3#1)(2013-1#1)
The difference in their##2##4##(2008-5#1)(2012-3#1)
The difference in##27##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-8#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
The difference is##2##3##(2008-8#1)(2013-8#1)
The difference lies in the##2##5##(2008-1#1)(2009-4#1)
The difference of##2##3##(2007-7#1)(2008-10#1)
The difference was significant##2##4##(2008-9#2)
The difference was statistically significant##5##5##(1996-12#1)(2009-6#1)(2011-2#1)(2013-1#2)
The difference was##9##3##(1995-6#1)(1996-12#1)(1997-5#1)(2008-9#2)(2009-6#1)(2011-2#1)(2013-1#2)
The difference##72##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
The differences are##2##3##(1993-12#1)(2008-3#1)
The differences between the##7##4##(1991-6#1)(1992-6#1)(1994-8#1)(2008-1#1)(2008-10#3)
The differences between##18##3##(1991-6#1)(1992-6#1)(1994-12#1)(1994-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#2)
The differences found##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
The differences in the##3##4##(2008-10#2)(2011-1#1)
The differences in these##3##4##(2010-7#1)(2012-1#1)(2012-12#1)
The differences in##16##3##(1996-12#1)(2008-10#7)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
The differences of##3##3##(2007-8#1)(2008-8#1)(2011-1#1)
The differences were##2##3##(2008-11#1)(2011-2#1)
The differences##51##2##(1991-6#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-12#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-5#1)(2013-1#2)(2013-8#1)
The different experimental parameters##2##4##(2008-10#2)
The different genotypes were##2##4##(2008-10#2)
The different##59##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-7#1)
The differential diagnosis for##2##4##(2012-12#1)(2012-2#1)
The differential diagnosis included##2##4##(2006-10#1)(2008-11#1)
The differential diagnosis includes##3##4##(2006-12#1)(2008-7#1)(2010-3#1)
The differential diagnosis of##6##4##(1990-9#1)(1991-8#1)(2007-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
The differential diagnosis##14##3##(1990-9#1)(1991-8#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
The differential effect of##2##4##(1994-5#1)(2013-1#1)
The differential expression of##2##4##(1991-9#1)(1997-2#1)
The differential pulse##3##3##(2008-10#3)
The differential##33##2##(1990-9#1)(1991-8#2)(1991-9#1)(1994-5#1)(1995-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
The differentially expressed##2##3##(2008-9#1)(2011-3#1)
The differentiation##2##2##(2008-9#1)(2013-1#1)
The difficulties in##2##3##(1992-11#1)(2008-6#1)
The difficulties##8##2##(1992-11#1)(1995-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)
The difficulty in##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
The difficulty of##3##3##(1992-8#1)(1995-2#1)(2012-1#1)
The difficulty##10##2##(1992-2#1)(1992-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2012-1#1)(2012-3#1)
The diffracted##2##2##(2007-12#1)(2008-3#1)
The diffraction efficiency of##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
The diffraction efficiency##9##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#2)
The diffraction##17##2##(2007-11#4)(2007-12#4)(2008-2#5)(2008-3#4)
The diffractive##2##2##(2008-2#1)(2008-3#1)
The diffuse##3##2##(1991-12#1)(2008-11#1)(2008-3#1)
The diffusion coefficient is##2##4##(2007-11#1)(2007-12#1)
The diffusion coefficient##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
The diffusion coefficients##2##3##(2008-10#1)(2008-5#1)
The diffusion##11##2##(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-7#1)(2013-8#1)
The diffusive##2##2##(2008-10#1)(2010-5#1)
The digested##2##2##(1995-5#1)(1995-8#1)
The digestion##3##2##(2008-10#3)
The digests were##2##3##(1997-3#1)(2008-10#1)
The digests##3##2##(1997-3#1)(2008-10#2)
The digital##6##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)
The dilemma of##2##3##(1995-12#1)(2013-1#1)
The dilemma##3##2##(1995-12#1)(2010-11#1)(2013-1#1)
The dilution##2##2##(2008-10#2)
The dimensions of the ICU##2##5##(1992-2#2)
The dimensions of the##4##4##(1992-2#2)(1996-5#1)(2009-11#1)
The dimensions of##5##3##(1992-2#2)(1996-5#1)(2008-3#1)(2009-11#1)
The dimensions##8##2##(1992-2#2)(1994-12#1)(1996-5#1)(2008-3#1)(2009-1#1)(2009-11#1)(2013-1#1)
The dimeric##2##2##(2008-10#1)(2010-2#1)
The dimers##3##2##(2008-8#1)(2009-9#1)(2010-7#1)
The diode laser##3##3##(2008-2#3)
The diode##4##2##(2007-11#1)(2008-2#3)
The diode-laser##2##2##(2007-12#1)(2008-2#1)
The diode-pumped##2##2##(2007-11#2)
The diphenylamido complexes##2##3##(2008-11#2)
The diploid##2##2##(2008-12#1)(2008-9#1)
The direct antiglobulin test was##2##5##(1992-9#1)(1994-12#1)
The direct antiglobulin test##3##4##(1992-9#1)(1994-12#2)
The direct determination of trace##2##5##(2008-10#2)
The direct determination of##4##4##(2008-10#4)
The direct effect of##2##4##(1995-3#1)(2008-6#1)
The direct##33##2##(1990-11#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-4#1)
The direction of the##2##4##(1996-2#1)(2008-6#1)
The direction of##9##3##(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-4#1)
The direction##11##2##(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-7#1)(2010-4#1)
The directional##3##2##(2007-9#1)(2008-3#1)(2008-8#1)
The directions of##2##3##(2007-12#1)(2008-5#1)
The directions##3##2##(2007-12#1)(2008-5#1)(2010-8#1)
The disability##2##2##(2008-7#1)(2010-12#1)
The disappearance of##3##3##(1992-12#1)(1996-3#1)(2008-7#1)
The discharge##2##2##(1993-12#1)(2008-10#1)
The discipline##3##2##(2008-12#1)(2008-2#1)(2012-3#1)
The discontinuity##2##2##(2008-3#1)(2008-5#1)
The discovery and##4##3##(2008-10#1)(2008-9#1)(2011-3#1)(2013-8#1)
The discovery of novel##2##4##(2008-5#1)(2010-5#1)
The discovery of the##6##4##(1993-5#1)(1996-9#1)(2006-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
The discovery of##24##3##(1991-2#1)(1993-3#1)(1993-5#1)(1995-11#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
The discovery##33##2##(1990-8#1)(1991-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-11#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)(2013-8#2)
The discrepancy between the##2##4##(1991-12#1)(2008-3#1)
The discrepancy between##5##3##(1991-12#1)(1995-1#1)(2008-10#1)(2008-3#1)(2009-6#1)
The discrepancy##6##2##(1991-12#1)(1995-1#1)(1996-8#1)(2008-10#1)(2008-3#1)(2009-6#1)
The discrete##2##2##(1996-4#1)(2008-10#1)
The discriminating##2##2##(2011-2#1)(2012-1#1)
The discriminatory##2##2##(1997-5#1)(2008-12#1)
The discussed##2##2##(2007-11#1)(2009-7#1)
The discussion focuses on##2##4##(2008-3#1)(2010-10#1)
The discussion highlights the##2##4##(2008-12#1)(2008-2#1)
The discussion includes##2##3##(2008-4#1)(2013-8#1)
The discussion is based on##3##5##(1991-6#1)(2008-12#1)(2008-8#1)
The discussion is##6##3##(1991-3#1)(1991-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
The discussion of##2##3##(1991-1#1)(2008-9#1)
The discussion will##2##3##(2008-10#1)(2008-11#1)
The discussion##25##2##(1991-1#1)(1991-3#1)(1991-6#1)(1995-1#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2013-8#1)
The discussions##2##2##(1995-1#1)(2008-8#1)
The disease has##4##3##(2008-10#3)(2008-9#1)
The disease is caused by##4##5##(2008-10#2)(2011-2#1)(2012-1#1)
The disease is characterized by##3##5##(1991-11#1)(2008-10#1)(2011-1#1)
The disease is predominantly##2##4##(2008-10#1)(2012-3#1)
The disease is##14##3##(1991-11#1)(1997-6#1)(2008-1#1)(2008-10#5)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
The disease was##8##3##(1993-5#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-5#1)
The disease##46##2##(1991-11#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-5#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-5#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
The diseases##3##2##(1993-11#1)(1994-6#1)(2011-1#1)
The disks##2##2##(2008-2#1)(2008-3#1)
The disorder can##2##3##(2008-10#1)(2008-4#1)
The disorder is##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
The disorder##7##2##(1997-5#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-1#1)
The disorders##2##2##(1991-5#1)(2012-2#1)
The dispersal of##2##3##(2008-10#2)
The dispersal##3##2##(2008-10#3)
The dispersion##8##2##(1991-12#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2011-1#1)
The displaced women##2##3##(2013-1#2)
The displacement##2##2##(1996-2#1)(2008-3#1)
The display##2##2##(1995-2#1)(2008-3#1)
The disruption of##4##3##(1993-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
The disruption##5##2##(1993-1#1)(2008-10#1)(2008-7#2)(2008-9#1)
The dissection##2##2##(2008-10#2)
The dissemination of##2##3##(2009-12#1)(2011-2#1)
The dissociated##2##2##(2008-4#1)(2008-8#1)
The dissociation constant##2##3##(2008-10#1)(2008-11#1)
The dissociation constants##3##3##(1993-6#1)(1995-6#1)(2008-10#1)
The dissociation##7##2##(1993-6#1)(1995-6#1)(2008-10#3)(2008-11#2)
The dissolution profiles of isoniazid fast-release##2##6##(2008-10#2)
The dissolution rates##2##3##(2008-5#2)
The dissolution##8##2##(2008-10#5)(2008-5#2)(2012-2#1)
The distal##9##2##(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)
The distance between##3##3##(1997-6#1)(2008-11#1)(2011-2#1)
The distance##7##2##(1991-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
The distances between##2##3##(1994-5#1)(1996-2#1)
The distilled water##2##3##(2008-10#1)(2009-6#1)
The distilled##3##2##(2008-10#2)(2009-6#1)
The distinct##9##2##(1990-5#1)(1995-11#1)(1996-9#1)(1997-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
The distinctive##2##2##(1997-1#1)(2012-2#1)
The distribution and##3##3##(1996-5#1)(1997-3#1)(2008-10#1)
The distribution behavior of##4##4##(2008-10#4)
The distribution coefficient##4##3##(2008-10#4)
The distribution constants of##2##4##(2008-10#2)
The distribution constants##3##3##(2008-10#3)
The distribution of the##9##4##(1990-8#1)(1991-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)
The distribution of##65##3##(1990-5#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-9#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
The distribution##85##2##(1990-5#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-9#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#2)(1997-4#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
The distributions of##2##3##(2008-3#1)(2010-8#1)
The distributions##3##2##(2008-3#1)(2010-8#1)(2012-2#1)
The disturbance##2##2##(1990-2#1)(1994-9#1)
The disulfide##3##2##(1992-6#1)(1993-8#2)
The dithizone-anchored##2##2##(2008-10#2)
The divalent##2##2##(1990-5#1)(1995-11#1)
The divergence of##3##3##(1991-6#1)(2008-8#1)(2009-2#1)
The divergence##5##2##(1991-5#1)(1991-6#1)(2008-6#1)(2008-8#1)(2009-2#1)
The diverse##5##2##(1994-9#1)(1996-12#1)(2008-4#2)(2009-6#1)
The diversity and##4##3##(2008-10#1)(2008-12#1)(2009-10#1)(2012-3#1)
The diversity of the##2##4##(2008-10#1)(2011-2#1)
The diversity of##6##3##(2008-10#4)(2008-5#1)(2011-2#1)
The diversity##14##2##(2008-10#6)(2008-12#1)(2008-5#3)(2009-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
The division of##2##3##(2007-12#1)(2008-8#1)
The division##4##2##(1992-5#1)(2007-12#1)(2008-8#1)(2009-10#1)
The dlt operon##2##3##(1995-6#2)
The doctor##3##2##(1993-11#1)(1996-8#1)(1996-9#1)
The document##2##2##(2012-2#1)(2013-1#1)
The dogs were evaluated##2##4##(2008-10#2)
The dogs were##3##3##(1996-6#1)(2008-10#2)
The dogs##4##2##(1996-6#1)(2008-10#2)(2011-1#1)
The dollar##2##2##(1995-3#1)(2008-10#1)
The domain##2##2##(1990-7#1)(2008-3#1)
The dominance of##2##3##(1991-12#1)(2013-1#1)
The dominant##16##2##(1990-5#1)(1991-8#1)(1994-3#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-6#1)
The dominantly inherited##2##3##(1990-12#1)(2008-6#1)
The donor must##2##3##(2011-2#2)
The donor##7##2##(1991-3#1)(2008-11#1)(2008-7#1)(2011-2#4)
The dopamine receptor antagonist##2##4##(1996-2#2)
The dopamine##5##2##(1993-9#1)(1996-2#3)(2008-10#1)
The dopaminergic##2##2##(1997-3#1)(2009-7#1)
The dorsal##3##2##(1996-5#1)(2007-12#1)(2011-2#1)
The dosage of##2##3##(2006-10#1)(2008-5#1)
The dosage##5##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2012-2#1)
The dose of the##2##4##(2008-1#1)(2008-3#1)
The dose of##6##3##(1991-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
The dose was##2##3##(1992-10#1)(2008-7#1)
The dose##13##2##(1991-6#1)(1992-10#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-11#2)(2009-2#1)(2013-8#1)
The dose-dependent##2##2##(1993-12#1)(1994-9#1)
The dose-response##3##2##(1993-12#1)(1993-6#1)(2008-5#1)
The doses of##6##3##(1992-3#1)(1993-6#1)(1994-7#1)(1996-2#1)(2008-10#2)
The double##6##2##(1991-12#1)(1994-12#1)(2008-10#3)(2010-8#1)
The double-stranded##2##2##(1994-8#1)(2008-10#1)
The doubling time##2##3##(2008-5#1)(2008-9#1)
The doubly##2##2##(1996-7#1)(1997-7#1)
The down-regulation##2##2##(1993-9#1)(2013-1#1)
The downstream##2##2##(1997-3#1)(2008-10#1)
The dramatic growth##2##3##(1994-1#1)(1994-10#1)
The dramatic##6##2##(1990-5#1)(1991-3#1)(1994-1#1)(1994-10#1)(2008-10#1)(2008-4#1)
The dried##2##2##(2008-10#1)(2011-2#1)
The driving force##2##3##(2008-10#1)(2010-5#1)
The driving##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
The drop##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
The drug is##3##3##(1996-2#1)(2008-3#1)(2008-5#1)
The drug release##2##3##(2010-5#1)(2012-2#1)
The drug undergoes degradation under acidic##2##6##(2008-10#2)
The drug was accumulated##2##4##(2008-10#2)
The drug was administered##2##4##(1990-2#1)(2008-10#1)
The drug was##11##3##(1990-2#1)(1993-6#1)(1994-8#1)(2006-10#1)(2008-10#4)(2008-5#1)(2010-12#1)(2012-12#1)
The drug##34##2##(1990-2#1)(1990-7#1)(1991-1#1)(1992-11#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The drug-induced##2##2##(1992-7#1)(1997-2#1)
The drugs were##2##3##(2008-10#2)
The drugs##4##2##(1994-12#1)(2008-10#2)(2008-7#1)
The dry##5##2##(2008-10#3)(2008-5#2)
The dual##9##2##(1994-1#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-2#1)(2009-12#1)(2011-1#1)
The duplex##3##2##(1992-6#1)(1993-11#1)(2013-8#1)
The duplicate article has therefore been withdrawn##8##7##(2008-11#6)(2008-7#1)(2012-3#1)
The duplication of##2##3##(2007-11#1)(2008-1#1)
The dural##2##2##(2008-12#1)(2012-3#1)
The duration of the##8##4##(1994-7#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)
The duration of##22##3##(1991-12#1)(1993-11#1)(1993-3#1)(1994-7#1)(1994-8#1)(1995-5#2)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-2#1)
The duration time##2##3##(1994-2#1)(2008-10#1)
The duration##27##2##(1991-12#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-5#2)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)
The dye was##2##3##(1994-12#1)(2008-10#1)
The dye##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
The dynamic behavior of##3##4##(2007-12#2)(2008-2#1)
The dynamic range of the calibration graph##2##7##(2008-10#2)
The dynamic range of the##4##5##(2008-10#3)(2008-5#1)
The dynamic range was##2##4##(2008-10#2)
The dynamic range##9##3##(2007-11#1)(2008-10#7)(2008-5#1)
The dynamic##33##2##(1992-6#1)(1993-11#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
The dynamics of the##10##4##(1990-8#1)(1992-9#1)(1993-11#1)(2007-11#1)(2008-10#3)(2008-3#2)(2009-8#1)
The dynamics of##26##3##(1990-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#1)(1996-3#1)(1996-8#1)(1997-6#2)(2007-11#2)(2008-10#8)(2008-3#2)(2009-11#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
The dynamics##28##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#1)(1996-3#1)(1996-8#1)(1997-6#2)(2007-11#2)(2008-10#8)(2008-3#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
The earlier##3##2##(1995-6#1)(2008-10#1)(2009-8#1)
The earliest##2##2##(1991-5#1)(2008-12#1)
The early detection of##2##4##(1993-12#1)(2010-12#1)
The early development##2##3##(1993-12#1)(2008-11#1)
The early##24##2##(1992-5#1)(1992-6#1)(1993-12#3)(1995-5#1)(1996-11#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
The ease of use##2##4##(1992-12#1)(2009-12#1)
The ease of##5##3##(1992-12#1)(2008-10#1)(2009-12#1)(2010-7#1)(2013-1#1)
The easier##2##2##(1991-9#1)(2008-11#1)
The ecological##6##2##(2008-11#2)(2008-6#1)(2008-8#2)(2010-11#1)
The ecology and##2##3##(2008-8#2)
The economic burden##2##3##(2008-7#1)(2011-1#1)
The economic impact of##2##4##(1994-2#1)(2007-12#1)
The economic##11##2##(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The economics of##2##3##(2008-11#1)(2009-8#1)
The edge##3##2##(1992-12#1)(2008-2#1)(2008-3#1)
The editors##2##2##(1994-1#1)(1995-1#1)
The education and training##2##4##(2008-11#1)(2008-12#1)
The education##5##2##(2007-10#1)(2008-11#2)(2008-12#1)(2008-5#1)
The educational##3##2##(2008-12#1)(2010-9#1)(2012-12#1)
The efe##2##2##(2008-10#2)
The effect is demonstrated##2##4##(2007-11#1)(2012-2#1)
The effect is##10##3##(1990-12#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-3#2)(2012-2#1)
The effect of CO2##2##4##(1995-2#1)(1996-12#1)
The effect of a single##2##5##(1994-8#1)(2008-10#1)
The effect of a##12##4##(1990-7#1)(1994-8#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-2#1)(2012-8#1)
The effect of acetyl-L-carnitine##2##4##(1992-7#1)(1997-2#1)
The effect of activin A##2##5##(1992-6#1)(1995-8#1)
The effect of activin##3##4##(1992-6#1)(1993-8#1)(1995-8#1)
The effect of adding##2##4##(2008-10#1)(2012-2#1)
The effect of addition of##2##5##(2008-10#2)
The effect of aging and##2##5##(1990-7#1)(1994-6#1)
The effect of an##4##4##(2008-10#1)(2009-6#2)(2011-1#1)
The effect of analytical and##2##5##(2008-10#2)
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy##3##8##(1994-3#3)
The effect of cervical spine isometric contract-relax technique on hamstring extensibility##2##11##(2007-11#2)
The effect of chemical modification of##2##6##(1990-8#1)(1995-2#1)
The effect of clustering##2##4##(2008-10#1)(2008-3#1)
The effect of concentration of##2##5##(2008-10#2)
The effect of concentration##3##4##(2008-10#2)(2009-8#1)
The effect of cultivar##2##4##(2008-10#2)
The effect of different factors such as##2##7##(2008-10#2)
The effect of different parameters##2##5##(2008-10#2)
The effect of different variables##2##5##(2008-10#2)
The effect of different##15##4##(2008-10#11)(2008-12#2)(2008-5#1)(2011-1#1)
The effect of diverse ions on the##2##7##(2008-10#2)
The effect of diverse ions##3##5##(2008-10#3)
The effect of early##2##4##(1993-12#2)
The effect of evidence-based drug coverage policies on pharmaceutical r&amp##2##10##(2009-3#2)
The effect of experimental parameters##2##5##(2008-10#2)
The effect of experimental##3##4##(1991-8#1)(2008-10#2)
The effect of facet##2##4##(2008-3#2)
The effect of high##2##4##(2008-10#1)(2010-2#1)
The effect of imagery perspectives##2##5##(1992-12#2)
The effect of increased##2##4##(2008-10#1)(2008-7#1)
The effect of interferences was studied##2##6##(2008-10#2)
The effect of interferences##4##4##(2008-10#4)
The effect of interfering ions##3##5##(2008-10#3)
The effect of long-term##2##4##(1996-12#1)(2007-12#1)
The effect of low##2##4##(2008-11#1)(2010-12#1)
The effect of membrane##2##4##(1990-8#1)(2008-10#1)
The effect of mobile phase variables such as##2##8##(2008-10#2)
The effect of mobile phase variables##3##6##(2008-10#3)
The effect of other ions##2##5##(2008-10#2)
The effect of other##3##4##(2008-10#3)
The effect of pH on##3##5##(1991-5#1)(2008-10#1)(2008-5#1)
The effect of pH##8##4##(1991-5#1)(2008-10#6)(2008-5#1)
The effect of palladium##2##4##(1991-12#2)
The effect of polymer composition upon bulk adhesion was examined##2##10##(2013-1#2)
The effect of polymeric##2##4##(2008-10#1)(2008-5#1)
The effect of postoperative immobilization on the##2##7##(2009-3#2)
The effect of random##2##4##(2008-10#1)(2008-7#1)
The effect of several##2##4##(2008-10#2)
The effect of sodium##3##4##(1994-5#1)(2008-10#1)(2013-7#1)
The effect of some##2##4##(2008-7#1)(2013-1#1)
The effect of surgical glove##2##5##(1995-3#2)
The effect of temperature and relative humidity##2##7##(1996-12#1)(2010-10#1)
The effect of temperature on the##3##6##(1990-8#1)(2008-10#1)(2008-3#1)
The effect of temperature on##5##5##(1990-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
The effect of temperature was##2##5##(2008-6#1)(2010-4#1)
The effect of temperature##10##4##(1990-8#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-6#2)(2010-10#1)(2010-4#1)
The effect of the composition of the##2##7##(2008-10#2)
The effect of the presence of##2##6##(2008-10#2)
The effect of the##60##4##(1990-5#1)(1990-9#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-2#3)(1997-7#1)(2007-12#3)(2008-10#26)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-4#3)(2011-2#2)(2013-1#1)(2013-8#1)
The effect of these##2##4##(1991-12#1)(1995-6#1)
The effect of this##4##4##(1990-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
The effect of treating##2##4##(1992-6#1)(2012-12#1)
The effect of treatments##2##4##(2008-10#2)
The effect of two##5##4##(1990-12#1)(2008-11#2)(2009-7#1)(2011-2#1)
The effect of variable##3##4##(2008-10#2)(2012-3#1)
The effect of various experimental parameters##2##6##(2008-10#2)
The effect of various parameters##2##5##(2008-10#1)(2013-1#1)
The effect of various##10##4##(1993-2#1)(2008-10#7)(2008-2#1)(2013-1#1)
The effect of vitamin E##2##5##(1990-2#1)(1993-6#1)
The effect of vitamin##6##4##(1990-2#1)(1991-12#1)(1993-6#1)(1996-12#1)(2010-1#1)(2011-1#1)
The effect of water##2##4##(2008-7#2)
The effect of##559##3##(1990-12#6)(1990-2#2)(1990-5#4)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#2)(1991-12#10)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#5)(1996-3#2)(1996-5#4)(1997-1#1)(1997-2#10)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-11#1)(2007-10#3)(2007-11#7)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#170)(2008-11#13)(2008-12#11)(2008-2#17)(2008-3#14)(2008-4#1)(2008-5#17)(2008-6#4)(2008-7#10)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#4)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-4#8)(2010-8#1)(2010-9#3)(2011-1#6)(2011-2#12)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#8)(2012-7#1)(2012-8#1)(2013-1#11)(2013-7#4)(2013-8#5)
The effect on the##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
The effect on##11##3##(1993-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2012-3#1)
The effect was also##2##4##(1996-5#1)(2011-1#1)
The effect was##11##3##(1992-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-3#1)
The effect##607##2##(1990-12#7)(1990-2#2)(1990-5#4)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#2)(1991-12#10)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-2#3)(1994-3#7)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#6)(1996-3#2)(1996-5#6)(1997-1#1)(1997-2#10)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-11#1)(2007-10#3)(2007-11#11)(2007-12#12)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#175)(2008-11#14)(2008-12#11)(2008-2#17)(2008-3#20)(2008-4#1)(2008-5#22)(2008-6#4)(2008-7#12)(2008-8#15)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#4)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-4#8)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#12)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#10)(2012-7#1)(2012-8#1)(2013-1#12)(2013-7#4)(2013-8#5)
The effective concentration##2##3##(1995-5#1)(2008-10#1)
The effective dose##2##3##(2008-10#2)
The effective molar absorptivity##2##4##(2008-10#2)
The effective size of##2##4##(2008-8#2)
The effective##24##2##(1991-5#1)(1995-5#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-3#5)(2008-8#4)(2009-7#1)
The effectiveness of a##2##4##(1992-1#1)(2008-7#1)
The effectiveness of the##9##4##(1993-12#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-4#1)
The effectiveness of this approach##2##5##(1996-12#1)(2008-7#1)
The effectiveness of this##5##4##(1990-11#1)(1996-12#1)(2008-3#2)(2008-7#1)
The effectiveness of##44##3##(1990-11#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
The effectiveness##45##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
The effects are##2##3##(1997-1#1)(2008-3#1)
The effects of 5-HT##2##4##(1990-5#1)(1993-12#1)
The effects of PDT##2##4##(1992-9#1)(2008-5#1)
The effects of a##14##4##(1992-4#1)(1993-12#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-4#1)(2010-7#1)(2013-1#1)
The effects of an arbitrary small inclination between##2##8##(2008-3#2)
The effects of an##6##4##(1991-9#1)(1992-3#1)(2008-10#1)(2008-3#2)(2011-2#1)
The effects of areca catechu L extract on##2##8##(2008-5#2)
The effects of both##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
The effects of caffeine on##2##5##(1995-11#2)
The effects of chemical##2##4##(2008-10#1)(2008-12#1)
The effects of chlordiazepoxide on K(+)-evoked##2##6##(1992-7#2)
The effects of chronic##2##4##(1991-4#1)(1997-2#1)
The effects of cognitive##2##4##(2012-2#1)(2012-3#1)
The effects of composition##2##4##(2008-10#1)(2010-4#1)
The effects of dietary##4##4##(1992-11#1)(1994-3#1)(2008-7#2)
The effects of different##7##4##(1990-7#1)(1993-12#1)(2008-10#4)(2008-3#1)
The effects of electrolytes##2##4##(2008-10#2)
The effects of endothelin-1##2##4##(1991-5#1)(1992-3#1)
The effects of experimental##3##4##(2008-10#3)
The effects of food##2##4##(1997-1#1)(2010-8#1)
The effects of foreign ions were##2##6##(2008-10#2)
The effects of foreign ions##3##5##(2008-10#3)
The effects of histamine##2##4##(1991-5#1)(1996-5#1)
The effects of host diversity##2##5##(2008-10#2)
The effects of host##4##4##(2008-10#4)
The effects of increasing##2##4##(1997-6#1)(2010-3#1)
The effects of lesions of the##2##6##(1994-3#2)
The effects of lesions of##3##5##(1992-11#1)(1994-3#2)
The effects of metal ion##2##5##(2008-10#2)
The effects of muscle##2##4##(1995-2#2)
The effects of noise##2##4##(2008-2#1)(2008-3#1)
The effects of pH and##2##5##(1996-5#1)(2008-10#1)
The effects of pH of##3##5##(2008-10#3)
The effects of pH##10##4##(1996-5#1)(2008-10#9)
The effects of postwar appraisals were not carried forward through psychological adjustment or midlife health##2##15##(2013-1#2)
The effects of protein kinase C##2##6##(1995-11#2)
The effects of reaction##2##4##(2008-10#2)
The effects of rust##2##4##(2008-10#2)
The effects of saturation on the line-center signal intensity and the resonance linewidth are investigated##2##15##(2008-3#2)
The effects of several important factors were investigated to find optimum conditions##3##12##(2008-10#3)
The effects of several##8##4##(1996-5#1)(2008-10#6)(2008-11#1)
The effects of sleep and touch therapy on symptoms of fibromyalgia and depression##2##13##(2013-1#2)
The effects of sodium##2##4##(1992-3#1)(2008-10#1)
The effects of solution concentration##2##5##(2008-10#2)
The effects of solution pH##2##5##(2008-10#2)
The effects of solution##4##4##(2008-10#4)
The effects of some##6##4##(2008-10#4)(2008-11#1)(2008-8#1)
The effects of temperature and##7##5##(2008-10#4)(2008-5#1)(2010-8#1)(2011-2#1)
The effects of temperature##11##4##(2008-10#8)(2008-5#1)(2010-8#1)(2011-2#1)
The effects of the concentration of##4##6##(1996-5#1)(2008-10#3)
The effects of the different##2##5##(2008-10#1)(2008-3#1)
The effects of the electrode##2##5##(2008-10#1)(2008-2#1)
The effects of the mobile phase##2##6##(2008-10#2)
The effects of the number of##3##6##(1991-2#1)(2008-10#2)
The effects of the two##2##5##(2008-11#1)(2008-2#1)
The effects of the##39##4##(1991-2#1)(1992-12#1)(1994-11#1)(1995-11#2)(1996-5#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)
The effects of these##5##4##(1990-5#1)(1993-11#1)(1993-3#1)(1996-11#1)(2008-5#1)
The effects of this##3##4##(1994-8#1)(1997-7#1)(2008-3#1)
The effects of three##4##4##(1994-3#1)(2008-10#1)(2008-7#2)
The effects of total##2##4##(1993-11#1)(2007-4#1)
The effects of two##4##4##(1990-7#1)(1994-8#1)(1997-4#1)(2008-10#1)
The effects of various cationic interferences on the percent recovery of copper in binary mixtures were studied##2##17##(2008-10#2)
The effects of various cationic interferences on the##3##8##(2008-10#3)
The effects of various cationic interferences on##4##7##(2008-10#4)
The effects of various parameters##2##5##(2008-10#2)
The effects of various##10##4##(1994-5#1)(2008-10#7)(2008-3#1)(2009-2#1)
The effects of varying##4##4##(2007-11#1)(2008-2#1)(2008-9#1)(2012-4#1)
The effects of vitamin##2##4##(1993-12#1)(2011-1#1)
The effects of##481##3##(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-11#4)(1992-12#1)(1992-3#6)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#6)(1993-3#6)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-2#4)(1994-3#8)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#8)(1995-12#6)(1995-2#3)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-5#4)(1997-1#4)(1997-2#5)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#144)(2008-11#21)(2008-12#4)(2008-2#20)(2008-3#22)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#6)(2009-11#2)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#14)(2013-8#3)
The effects on the##3##4##(2008-10#3)
The effects on##7##3##(2008-10#4)(2008-11#2)(2013-1#1)
The effects were##6##3##(1991-5#1)(1992-3#1)(1995-12#1)(2008-10#2)(2013-1#1)
The effects##502##2##(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#4)(1991-9#2)(1992-11#4)(1992-12#1)(1992-3#7)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#6)(1993-3#6)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-2#4)(1994-3#8)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#8)(1995-12#7)(1995-2#3)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-5#4)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#150)(2008-11#24)(2008-12#4)(2008-2#20)(2008-3#23)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#6)(2009-11#2)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#16)(2013-8#3)
The efficacy analysis##2##3##(2007-11#2)
The efficacy and safety of##2##5##(1991-11#1)(2007-9#1)
The efficacy and tolerability of##3##5##(1991-2#1)(1994-12#1)(2012-3#1)
The efficacy and##9##3##(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-12#1)(2007-9#1)(2011-3#1)(2012-3#1)
The efficacy of a##3##4##(2009-9#1)(2010-8#1)(2010-9#1)
The efficacy of chemical##2##4##(2008-10#2)
The efficacy of such##2##4##(1997-7#1)(2008-5#1)
The efficacy of the##7##4##(1991-11#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)
The efficacy of this##2##4##(1994-5#1)(2008-10#1)
The efficacy of##50##3##(1991-11#2)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#7)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
The efficacy##63##2##(1991-11#3)(1991-2#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#8)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
The efficiencies for##2##3##(2008-3#2)
The efficiencies of##4##3##(1992-9#1)(2008-2#2)(2008-3#1)
The efficiencies##7##2##(1992-9#1)(2008-2#3)(2008-3#3)
The efficiency and##2##3##(1990-5#1)(2008-6#1)
The efficiency in the##2##4##(2007-11#1)(2008-2#1)
The efficiency of direct##2##4##(1997-4#1)(2008-2#1)
The efficiency of gene transfer##2##5##(1994-11#1)(1995-12#1)
The efficiency of the##12##4##(1990-5#1)(2008-10#8)(2008-3#2)(2008-9#1)
The efficiency of this##4##4##(1993-12#1)(1994-9#1)(2008-10#1)(2013-1#1)
The efficiency of##44##3##(1990-5#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
The efficiency##56##2##(1990-5#2)(1991-7#1)(1992-2#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-2#1)(1997-4#2)(2007-11#2)(2007-12#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
The efficient##7##2##(1994-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)
The effluent##2##2##(2008-10#1)(2008-6#1)
The effort##2##2##(1996-2#2)
The efforts to##2##3##(1997-3#1)(2011-2#1)
The egg capsule##3##3##(2007-12#1)(2008-12#2)
The egg##7##2##(1994-9#1)(1996-12#1)(2007-12#3)(2008-12#2)
The eggs of##3##3##(2007-12#1)(2008-12#2)
The eight##3##2##(1990-7#1)(2008-10#2)
The elasticity##2##2##(1994-3#1)(2008-1#1)
The elderly##7##2##(1990-2#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
The eldest##2##2##(2007-7#1)(2008-10#1)
The elective##2##2##(1993-3#1)(1996-12#1)
The electric field##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
The electric##7##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#3)(2009-8#1)
The electrical##3##2##(2007-11#1)(2009-11#2)
The electroanalytical##2##2##(2008-10#2)
The electrocardiogram##2##2##(1993-1#1)(2010-8#1)
The electrocatalytic behavior is further exploited as a sensitive detection scheme for##2##12##(2008-10#2)
The electrocatalytic detection of##2##4##(1990-12#1)(2008-10#1)
The electrocatalytic reduction##2##3##(2008-10#2)
The electrocatalytic##10##2##(1990-12#1)(2008-10#9)
The electrochemical behavior of the##2##5##(2008-10#2)
The electrochemical behavior of##10##4##(2008-10#10)
The electrochemical behaviors of##3##4##(2008-10#3)
The electrochemical behaviour##3##3##(2008-10#3)
The electrochemical characteristics of##3##4##(2008-10#3)
The electrochemical characteristics##4##3##(2008-10#4)
The electrochemical copolymerization of 3##2##5##(2008-10#2)
The electrochemical detection of##2##4##(2008-10#2)
The electrochemical oxidation of the##2##5##(2008-10#2)
The electrochemical oxidation of##6##4##(2008-10#6)
The electrochemical properties of##2##4##(2008-10#2)
The electrochemical redox##2##3##(2008-10#2)
The electrochemical reduction of##3##4##(2008-10#3)
The electrochemical reduction##4##3##(2008-10#4)
The electrochemical response##2##3##(2008-10#2)
The electrochemical##50##2##(1996-2#1)(2008-10#49)
The electrochemistry of dopamine##2##4##(2008-10#2)
The electrochemistry of##6##3##(2008-10#5)(2009-5#1)
The electrode E2##2##3##(2008-10#2)
The electrode based on##3##4##(2008-10#3)
The electrode can be used in the pH range from##3##10##(2008-10#3)
The electrode can be used in the pH range##4##9##(2008-10#4)
The electrode can be##5##4##(2008-10#5)
The electrode could be##2##4##(2008-10#2)
The electrode exhibited a linear response with a##2##8##(2008-10#2)
The electrode exhibited a##3##4##(2008-10#3)
The electrode exhibited##5##3##(2008-10#5)
The electrode exhibits a Nernstian response for##3##7##(2008-10#3)
The electrode exhibits a Nernstian slope of##2##7##(2008-10#2)
The electrode exhibits a Nernstian##6##5##(2008-10#6)
The electrode exhibits a linear response##3##6##(2008-10#3)
The electrode exhibits a##11##4##(2008-10#11)
The electrode exhibits linear response to##2##6##(2008-10#2)
The electrode exhibits##16##3##(2008-10#16)
The electrode had##2##3##(2008-10#2)
The electrode has a linear dynamic range##2##7##(2008-10#2)
The electrode has a linear##3##5##(2008-10#3)
The electrode has a##4##4##(2008-10#4)
The electrode has been##2##4##(2008-10#2)
The electrode has##9##3##(2008-10#9)
The electrode is##8##3##(2008-10#8)
The electrode posses a##2##4##(2008-10#2)
The electrode response is##2##4##(2008-10#2)
The electrode response was stable over##2##6##(2008-10#2)
The electrode response was##4##4##(2008-10#4)
The electrode response##7##3##(2008-10#7)
The electrode showed high##2##4##(2008-10#2)
The electrode showed##4##3##(2008-10#4)
The electrode shows a linear##2##5##(2008-10#2)
The electrode shows a##6##4##(2008-10#6)
The electrode shows##11##3##(2008-10#11)
The electrode surface##2##3##(2008-10#2)
The electrode was prepared by##2##5##(2008-10#2)
The electrode was successfully applied for##2##6##(2008-10#2)
The electrode was used for##2##5##(2008-10#2)
The electrode was used in the direct determination of##2##9##(2008-10#2)
The electrode was used in##3##5##(2008-10#3)
The electrode was used##6##4##(2008-10#6)
The electrode was##17##3##(2008-10#17)
The electrode works##2##3##(2008-10#2)
The electrode##116##2##(2008-10#116)
The electrodes based on##2##4##(2008-10#2)
The electrodes exhibit##2##3##(2008-10#2)
The electrodes have##2##3##(2008-10#2)
The electrodes possess##2##3##(2008-10#2)
The electrodes were successfully##2##4##(2008-10#2)
The electrodes were##5##3##(2008-10#5)
The electrodes##18##2##(2008-10#18)
The electrogenerated chemiluminescent##2##3##(2008-10#2)
The electrolyte##2##2##(2008-12#1)(2010-7#1)
The electrolytic cell##2##3##(2008-10#2)
The electromagnetic field##2##3##(2008-2#1)(2008-3#1)
The electromagnetic##3##2##(2008-2#2)(2008-3#1)
The electromyographic##2##2##(2010-6#1)(2010-9#1)
The electron density##2##3##(1992-9#1)(2006-4#1)
The electron microscopical##2##3##(2008-7#2)
The electron transfer##2##3##(1990-5#1)(2008-10#1)
The electron##13##2##(1990-5#1)(1992-9#1)(1993-11#1)(1994-3#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2012-2#1)(2012-3#1)
The electronic effects more than offset the decrease in coupling efficiencies associated with the higher system origin energies and explain the observed shorter cis isomer lifetimes##2##26##(2010-2#2)
The electronic nose##2##3##(2008-10#1)(2012-2#1)
The electronic##14##2##(1991-5#1)(1993-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-2#2)(2012-2#1)(2012-3#1)
The electrophoretic##4##2##(2008-10#3)(2008-5#1)
The electropolymerization##2##2##(2008-10#2)
The electrostatic##2##2##(1994-8#1)(2007-11#1)
The electrothermal atomic absorption##2##4##(2008-10#2)
The electrothermal##3##2##(2008-10#3)
The element was##2##3##(2008-3#2)
The element##3##2##(2008-10#1)(2008-3#2)
The elemental##5##2##(2008-10#2)(2008-5#2)(2010-11#1)
The elements were determined##2##4##(2008-10#2)
The elements were##3##3##(2007-11#1)(2008-10#2)
The elements##9##2##(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#1)
The elevated##5##2##(1996-11#1)(1997-5#1)(1997-8#1)(2008-10#1)(2012-12#1)
The elicitation of##2##3##(1993-6#1)(2008-10#1)
The elimination of##2##3##(1992-12#1)(2008-10#1)
The elimination##5##2##(1992-12#1)(2008-10#4)
The ellipsometric##2##2##(2008-3#2)
The elongated##2##2##(2007-11#1)(2007-12#1)
The elongation##2##2##(2007-12#1)(2008-5#1)
The eluate was##3##3##(1993-2#1)(2008-10#2)
The eluate##6##2##(1993-2#1)(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
The eluent was##2##3##(2008-10#2)
The eluent##3##2##(2008-10#3)
The eluted##4##2##(2008-10#4)
The elution is##2##3##(2008-10#2)
The elution order##2##3##(1995-3#1)(2008-10#1)
The elution##6##2##(1995-3#1)(2008-10#5)
The embedded##2##2##(2007-11#1)(2008-3#1)
The embryonic##3##2##(1995-2#1)(1997-1#1)(2008-8#1)
The emergence of new##3##4##(1994-1#1)(2008-8#1)(2010-12#1)
The emergence of resistance##2##4##(2008-11#2)
The emergence of##17##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-8#3)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)
The emergence##19##2##(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)
The emergencies##2##2##(2011-2#1)(2012-2#1)
The emergency physician##2##3##(2009-6#1)(2012-3#1)
The emergency##3##2##(2009-6#1)(2012-12#1)(2012-3#1)
The emerging role of##2##4##(2008-7#1)(2012-2#1)
The emerging##14##2##(1990-8#1)(1992-1#1)(1992-5#1)(1994-3#1)(2007-12#1)(2007-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
The emission intensity is greatly enhanced##3##6##(2008-10#3)
The emission intensity is##4##4##(2008-10#4)
The emission of##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
The emission spectra##2##3##(2008-10#1)(2008-2#1)
The emission wavelengths##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The emission##19##2##(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)
The emissivity##2##2##(2008-3#2)
The emitted light##2##3##(2007-11#1)(2008-10#1)
The emitted##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
The emitter is##2##3##(2007-12#1)(2008-3#1)
The emotional##2##2##(2008-11#1)(2008-5#1)
The emphasis is on the##2##5##(1997-8#1)(2007-11#1)
The emphasis is on##5##4##(1991-2#1)(1997-8#1)(2007-11#1)(2008-4#2)
The emphasis is##6##3##(1991-2#1)(1997-8#1)(2007-11#1)(2008-4#2)(2010-9#1)
The emphasis##10##2##(1991-2#1)(1993-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2010-9#1)
The empirical##8##2##(1990-6#1)(1993-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-8#1)(2011-3#2)
The employed methodology##2##3##(2008-10#2)
The employed##4##2##(1990-12#1)(2008-10#3)
The employee##2##2##(1995-6#1)(1996-5#1)
The employer##2##2##(1994-12#1)(2008-5#1)
The employment of##2##3##(2007-8#1)(2008-10#1)
The employment##3##2##(1993-3#1)(2007-8#1)(2008-10#1)
The empowerment##2##2##(1993-1#1)(1996-12#1)
The emulsion##4##2##(2008-10#3)(2008-5#1)
The enantioselective##3##2##(1995-6#1)(2008-10#2)
The enantioselectivity was determined over##3##5##(2008-10#3)
The enantioselectivity##4##2##(2008-10#4)
The encoded##3##2##(1992-8#1)(1994-12#1)(2009-2#1)
The encoding##2##2##(2007-12#1)(2008-2#1)
The end of the##2##4##(2007-12#1)(2008-4#1)
The end point##2##3##(2008-10#1)(2008-11#1)
The end##9##2##(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)
The end-point of the titration is detected as the##2##9##(2008-10#2)
The end-point##3##2##(2008-10#3)
The endocrine##2##2##(1991-11#1)(2012-2#1)
The endogenous##9##2##(1992-11#1)(1992-3#1)(1994-2#1)(1994-6#1)(1997-6#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-1#1)
The endometrial##4##2##(1994-9#2)(1995-3#1)(2013-7#1)
The endoplasmic reticulum (ER)##2##4##(2009-10#1)(2012-2#1)
The endoplasmic reticulum##3##3##(2008-8#1)(2009-10#1)(2012-2#1)
The endoplasmic##4##2##(1994-11#1)(2008-8#1)(2009-10#1)(2012-2#1)
The endoscopy##2##2##(1992-5#1)(1992-6#1)
The endothelial##2##2##(2011-2#2)
The endotoxin##3##2##(1992-3#1)(1996-12#2)
The endovascular##2##2##(2007-10#1)(2008-10#1)
The endpoint##2##2##(2008-10#1)(2008-7#1)
The energetics##2##2##(1990-8#1)(2008-8#1)
The energy absorption and##2##4##(2008-1#2)
The energy of##2##3##(1997-7#1)(2008-6#1)
The energy##14##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#1)
The engineered##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
The enhanced backscattering##3##3##(2007-12#1)(2008-3#2)
The enhanced cytotoxicity##2##3##(1993-3#1)(2012-12#1)
The enhanced##26##2##(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-10#8)(2008-3#4)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
The enhancement in##2##3##(1994-6#1)(2008-10#1)
The enhancement is##2##3##(2007-12#1)(2009-4#1)
The enhancement of the##4##4##(1993-12#1)(1997-8#1)(2008-10#1)(2008-7#1)
The enhancement of##11##3##(1990-12#1)(1993-12#1)(1993-8#1)(1994-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)
The enhancement was##2##3##(1991-3#1)(1994-6#1)
The enhancement##21##2##(1990-12#1)(1991-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-6#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)
The enormous##2##2##(2007-11#1)(2008-7#1)
The enquiry##2##2##(2008-10#2)
The enriched rats##2##3##(1992-8#2)
The enriched##3##2##(1992-8#2)(2008-10#1)
The enrichment factor for##2##4##(2008-10#2)
The enrichment factor##4##3##(2008-10#4)
The enrichment factors for Cu(II)##2##5##(2008-10#2)
The enrichment factors##3##3##(2008-10#3)
The enrichment of##3##3##(2008-10#1)(2008-11#1)(2010-11#1)
The enrichment##13##2##(2008-10#10)(2008-11#1)(2008-6#1)(2010-11#1)
The ensuing##4##2##(1994-12#1)(2008-10#3)
The enteric nervous system in##2##5##(2008-8#2)
The enthusiasm##2##2##(2008-11#1)(2009-5#1)
The entire procedure##2##3##(1991-12#1)(2008-9#1)
The entire##16##2##(1991-12#1)(1992-1#1)(1992-2#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-9#2)(2009-9#1)(2010-8#1)(2013-8#1)
The environment of##2##3##(1990-5#1)(2011-2#1)
The environment##4##2##(1990-5#1)(1997-7#1)(2008-3#1)(2011-2#1)
The environmental conditions##2##3##(2008-10#1)(2008-12#1)
The environmental##7##2##(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2012-12#1)
The enzymatic activities##2##3##(1993-2#1)(2008-10#1)
The enzymatic activity##3##3##(1990-11#1)(1993-3#1)(1996-5#1)
The enzymatic reaction##3##3##(2008-10#2)(2008-6#1)
The enzymatic##20##2##(1990-11#1)(1990-2#1)(1990-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-5#1)(2008-10#8)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
The enzyme activity was##2##4##(1990-5#1)(1994-11#1)
The enzyme activity##5##3##(1990-5#1)(1992-8#1)(1994-11#1)(2008-12#1)(2008-8#1)
The enzyme can##2##3##(2008-10#1)(2008-8#1)
The enzyme did not##2##4##(1990-2#1)(2008-10#1)
The enzyme electrode##4##3##(2008-10#4)
The enzyme had##2##3##(1990-11#1)(2008-10#1)
The enzyme has##2##3##(2008-10#1)(2009-2#1)
The enzyme inactivation##2##3##(1990-5#1)(1993-8#1)
The enzyme is a##2##4##(1993-11#1)(1993-8#1)
The enzyme is an##2##4##(1992-6#1)(1994-8#1)
The enzyme is##8##3##(1990-7#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-8#1)(2008-4#1)
The enzyme telomerase##2##3##(2008-11#2)
The enzyme was entrapped##2##4##(2008-10#2)
The enzyme was purified##2##4##(1997-2#2)
The enzyme was##18##3##(1990-11#1)(1991-12#3)(1991-9#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)
The enzyme##84##2##(1990-11#3)(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#3)(1991-5#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#2)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#3)(2009-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
The enzyme-linked immunosorbent assay (ELISA)##3##5##(1994-3#1)(2008-4#2)
The enzyme-linked##4##2##(1994-3#1)(2008-4#3)
The enzymes are##2##3##(2008-10#1)(2008-4#1)
The enzymes were##2##3##(1994-11#1)(2008-10#1)
The enzymes##9##2##(1994-11#1)(2008-10#2)(2008-4#3)(2008-5#2)(2011-1#1)
The epidemic dynamics##2##3##(1992-9#1)(2008-10#1)
The epidemic##7##2##(1990-6#1)(1991-12#1)(1992-9#1)(2008-10#3)(2009-2#1)
The epidemiological##8##2##(1990-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-12#2)(2013-7#1)
The epidemiology of##7##3##(1990-9#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-3#1)(2011-2#1)
The epidemiology##8##2##(1990-9#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-3#1)(2011-2#1)
The epidermal##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
The epigenetic##2##2##(1994-5#1)(2009-3#1)
The epithelial lining##2##3##(1992-1#1)(2008-7#1)
The epithelial##5##2##(1991-2#1)(1992-1#1)(1995-11#1)(2008-11#1)(2008-7#1)
The epithelium##2##2##(2007-12#1)(2013-8#1)
The epitopes##2##2##(1996-12#1)(2008-10#1)
The equation for##3##3##(2008-10#1)(2008-3#1)(2012-7#1)
The equation##9##2##(1996-12#1)(2008-1#1)(2008-10#3)(2008-3#3)(2012-7#1)
The equations are##2##3##(2008-3#2)
The equations##9##2##(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-4#1)
The equilibria##2##2##(1990-8#1)(2008-10#1)
The equilibrium constant for##2##4##(2008-10#2)
The equilibrium constant##3##3##(2008-10#3)
The equilibrium constants of the##2##5##(2008-10#2)
The equilibrium constants##3##3##(2008-10#3)
The equilibrium##16##2##(1990-7#1)(1993-6#2)(1994-9#1)(1996-2#2)(2008-10#9)(2013-1#1)
The equipment##2##2##(2008-11#1)(2008-3#1)
The equivalence between##2##3##(2008-10#2)
The equivalence##3##2##(1992-11#1)(2008-10#2)
The equivalent average daily doses were approximately##2##7##(2008-9#2)
The equivalent##5##2##(1994-6#1)(2007-11#1)(2008-10#1)(2008-9#2)
The eradication of##2##3##(2008-4#1)(2010-6#1)
The error analysis##2##3##(2008-3#2)
The error in##2##3##(2007-12#1)(2008-3#1)
The error of##2##3##(2008-3#2)
The error##16##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#11)(2013-1#1)
The errors in the##3##4##(2008-2#2)(2008-3#1)
The errors in##4##3##(2008-2#3)(2008-3#1)
The errors##9##2##(2008-2#4)(2008-3#5)
The essence of the##5##4##(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
The essence of##9##3##(1992-3#1)(1992-9#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
The essential oil effectively##2##4##(2013-1#2)
The essential oil of##3##4##(2008-11#3)
The essential oil##8##3##(2008-10#1)(2008-11#3)(2008-12#1)(2012-12#1)(2013-1#2)
The essential##22##2##(1990-12#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
The established method is##2##4##(2008-10#1)(2011-1#1)
The established method was##3##4##(2008-10#2)(2013-1#1)
The established method##5##3##(2008-10#3)(2011-1#1)(2013-1#1)
The established##15##2##(1994-9#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-11#1)(2011-1#1)(2013-1#3)
The establishment of a##2##4##(1993-2#1)(2013-1#1)
The establishment of the##2##4##(2007-12#1)(2013-8#1)
The establishment of##11##3##(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
The esterified product##2##3##(2008-5#2)
The estimate of##4##3##(1990-11#2)(1996-6#1)(2008-10#1)
The estimated 5- and 10-year Overall Survival (OS) rates for##2##10##(2010-3#2)
The estimated 5- and 10-year##3##5##(2010-3#3)
The estimated detection##2##3##(2008-10#1)(2012-1#1)
The estimated rate of##2##4##(1991-8#1)(1992-6#1)
The estimated##44##2##(1991-8#2)(1992-12#1)(1992-4#1)(1992-6#2)(1995-1#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2010-3#4)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
The estimates of##3##3##(1992-6#1)(1996-4#1)(2008-9#1)
The estimates##4##2##(1992-6#1)(1996-4#1)(2008-9#1)(2011-2#1)
The estimation of the##3##4##(2008-10#2)(2008-11#1)
The estimation of##5##3##(2008-10#4)(2008-11#1)
The estimation##7##2##(2008-10#5)(2008-11#1)(2008-6#1)
The estimator##3##2##(1992-9#1)(1997-4#1)(2008-10#1)
The ethanol extract of##2##4##(2008-10#1)(2010-3#1)
The ethanol##4##2##(2008-10#3)(2010-3#1)
The ethanolic extract of##3##4##(2008-10#1)(2011-1#2)
The ether-type##2##2##(2008-10#2)
The ethical##9##2##(1996-12#1)(2007-2#1)(2008-11#4)(2008-5#1)(2008-9#1)(2009-11#1)
The ethics of##3##3##(1995-5#1)(1996-1#1)(2010-3#1)
The ethnic##2##2##(2008-5#1)(2011-2#1)
The ethyl acetate##2##3##(2008-10#1)(2011-1#1)
The etiologic##3##2##(1991-6#1)(1997-4#1)(2008-10#1)
The etiological##2##2##(1990-6#1)(2010-4#1)
The etiology is unknown##2##4##(1991-9#1)(2011-2#1)
The etiology is##3##3##(1991-9#1)(2008-1#1)(2011-2#1)
The etiology of halo nevi##2##5##(2011-2#2)
The etiology of the##2##4##(1991-11#1)(2008-10#1)
The etiology of these##2##4##(2008-6#1)(2008-7#1)
The etiology of this condition##2##5##(2009-3#1)(2013-1#1)
The etiology of this##8##4##(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)(2013-1#1)(2013-8#1)
The etiology of##21##3##(1991-11#1)(1992-9#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2009-3#1)(2010-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
The etiology##31##2##(1990-6#1)(1991-11#1)(1991-9#1)(1992-6#1)(1992-9#1)(1996-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
The eukaryotic##3##2##(2008-4#1)(2009-2#1)(2012-2#1)
The evaluated##6##2##(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#1)
The evaluation of a##3##4##(1996-2#1)(2008-5#1)(2010-7#1)
The evaluation of the##11##4##(1994-6#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-2#1)(2013-8#1)
The evaluation of##32##3##(1990-2#1)(1990-6#1)(1994-6#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-8#1)
The evaluation process was##2##4##(1993-12#1)(2008-11#1)
The evaluation##47##2##(1990-2#1)(1990-6#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-11#5)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
The evaporation##2##2##(2008-10#1)(2008-5#1)
The event##2##2##(2012-1#1)(2013-1#1)
The events##2##2##(2008-1#1)(2013-7#1)
The eventual##2##2##(2008-11#1)(2011-1#1)
The evidence base for##2##4##(2012-12#1)(2013-1#1)
The evidence base##4##3##(2008-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
The evidence for an##2##4##(2009-5#1)(2010-4#1)
The evidence for the##2##4##(2010-3#1)(2011-2#1)
The evidence for##6##3##(2008-7#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#2)
The evidence indicates that##2##4##(2008-10#2)
The evidence of the##2##4##(2011-2#2)
The evidence of##4##3##(1991-12#1)(1995-11#1)(2011-2#2)
The evidence##33##2##(1991-12#2)(1992-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#1)
The evolution of the##8##4##(1992-2#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-7#1)
The evolution of these##2##4##(2008-8#1)(2010-3#1)
The evolution of##54##3##(1991-3#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#2)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
The evolution was##2##3##(2007-8#1)(2013-1#1)
The evolution##61##2##(1991-3#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#2)(2010-12#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
The evolutionary origin of##2##4##(2008-5#1)(2008-7#1)
The evolutionary relationships##2##3##(1994-11#1)(2008-10#1)
The evolutionary##16##2##(1990-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)(2013-1#1)
The evolving role of##2##4##(1997-3#1)(2009-2#1)
The evolving##6##2##(1992-3#1)(1997-3#1)(2008-11#1)(2009-2#1)(2010-12#1)(2011-2#1)
The ex vivo##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
The exacerbation of##2##3##(1997-7#1)(2006-10#1)
The exact mechanism by which##2##5##(2008-7#1)(2013-1#1)
The exact mechanism of the##2##5##(2008-10#1)(2008-6#1)
The exact mechanism##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
The exact mechanisms##2##3##(1990-3#1)(1991-4#1)
The exact##25##2##(1990-10#1)(1990-3#1)(1991-11#2)(1991-4#1)(1994-8#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
The examination of##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
The examination was##2##3##(1996-6#1)(2007-12#1)
The examination##8##2##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
The examinations##2##2##(1996-5#1)(2007-8#1)
The examined samples##2##3##(2008-10#1)(2008-3#1)
The examined##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
The example of the##2##4##(1993-3#1)(2008-3#1)
The example of##4##3##(1993-3#1)(1994-11#1)(2008-12#1)(2008-3#1)
The example##7##2##(1993-3#1)(1994-11#1)(2007-12#1)(2008-12#1)(2008-3#2)(2009-11#1)
The examples presented##2##3##(2008-7#1)(2012-3#1)
The examples##4##2##(1992-9#1)(1994-12#1)(2008-7#1)(2012-3#1)
The excellent performance of the##2##5##(2007-11#1)(2013-1#1)
The excellent##8##2##(2007-11#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#2)
The exception was##2##3##(2008-10#2)
The exceptional##2##2##(1991-8#1)(2008-1#1)
The exceptionally##2##2##(2006-4#1)(2007-8#1)
The excess of##2##3##(1991-6#1)(2008-10#1)
The excess##4##2##(1991-6#1)(2008-10#2)(2013-1#1)
The excessive##2##2##(1997-7#1)(2012-1#1)
The exchange capacity##2##3##(2008-10#2)
The exchange of##2##3##(1997-6#1)(2011-2#1)
The exchange##4##2##(1997-6#1)(2008-10#2)(2011-2#1)
The excipients##2##2##(2008-5#1)(2011-2#1)
The excitation and emission wavelengths are##2##6##(2008-10#2)
The excitation and emission wavelengths##3##5##(2008-10#3)
The excitation source was a##2##5##(2007-12#1)(2008-3#1)
The excitation spectra##2##3##(2008-10#1)(2013-8#1)
The excitation wavelength##3##3##(2008-10#3)
The excitation##12##2##(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-8#1)(2013-8#1)
The excitation-emission spectra of these compounds are##2##7##(2008-10#2)
The exclusion of##3##3##(2008-10#2)(2009-10#1)
The exclusive##2##2##(2008-7#1)(2012-3#1)
The executive##2##2##(1995-3#1)(2008-11#1)
The exercise consisted##2##3##(1991-10#1)(2008-3#1)
The exercise was##2##3##(1994-7#1)(2008-12#1)
The exercise##8##2##(1991-10#1)(1991-3#1)(1994-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)
The existence of a##7##4##(1993-12#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
The existence of such##2##4##(1996-4#1)(2008-4#1)
The existence of the##2##4##(2008-11#1)(2008-8#1)
The existence of this##3##4##(1990-8#1)(1992-6#1)(1996-3#1)
The existence of##29##3##(1990-11#1)(1990-8#1)(1992-11#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2012-3#1)
The existing##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
The expanded##3##2##(2007-11#1)(2012-2#2)
The expanding##4##2##(1994-5#1)(1996-2#1)(2008-2#1)(2008-9#1)
The expansion of##3##3##(1996-3#1)(2008-10#1)(2010-1#1)
The expansion##6##2##(1994-11#1)(1996-3#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-2#1)
The expectations##3##2##(1997-1#1)(2008-11#1)(2009-11#1)
The expected changes##2##3##(1991-1#1)(2008-1#1)
The expected number of##2##4##(1990-9#1)(2008-10#1)
The expected##13##2##(1990-9#1)(1991-1#1)(1991-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#2)(2012-1#1)(2013-8#1)
The experience gained with##2##4##(1992-5#1)(2008-10#1)
The experience of the##3##4##(1993-11#1)(1993-12#1)(2008-10#1)
The experience of##9##3##(1993-11#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-3#1)
The experience##16##2##(1992-5#1)(1993-11#1)(1993-12#1)(1994-12#2)(1995-1#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-3#1)(2010-9#1)(2012-12#1)
The experiences of##2##3##(1994-2#1)(2008-11#1)
The experiences##5##2##(1994-2#1)(1997-6#1)(2008-11#1)(2010-11#1)(2010-8#1)
The experiment for##2##3##(1996-12#1)(2013-8#1)
The experiment is based on a##2##6##(2007-12#1)(2012-2#1)
The experiment verifies##2##3##(2008-3#2)
The experiment was carried out in##2##6##(2008-11#1)(2008-6#1)
The experiment was carried out##3##5##(2008-11#1)(2008-12#1)(2008-6#1)
The experiment was conducted in##2##5##(2008-12#2)
The experiment was conducted##5##4##(2008-12#2)(2009-12#1)(2012-2#1)(2012-6#1)
The experiment was laid in a##2##6##(2008-12#2)
The experiment was##16##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-6#1)
The experiment##42##2##(1992-2#1)(1992-3#1)(1992-8#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#9)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#2)(2013-1#1)(2013-8#3)
The experimental and theoretical##2##4##(2007-12#1)(2013-1#1)
The experimental and##6##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
The experimental calibration set was composed of##2##7##(2008-10#2)
The experimental calibration##3##3##(2008-10#3)
The experimental conditions were optimized##2##5##(2008-10#2)
The experimental conditions##8##3##(2008-10#7)(2011-1#1)
The experimental data and##2##4##(2008-3#1)(2008-6#1)
The experimental data are##2##4##(2008-10#1)(2008-3#1)
The experimental data obtained##2##4##(2008-10#2)
The experimental data show that the##2##6##(2008-3#1)(2013-8#1)
The experimental data show that##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
The experimental data were##3##4##(1995-2#1)(2008-10#1)(2008-3#1)
The experimental data##23##3##(1993-6#1)(1995-2#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-8#2)
The experimental demonstration of##2##4##(2007-11#2)
The experimental design was##2##4##(2008-3#1)(2013-7#1)
The experimental design##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
The experimental findings##2##3##(1995-9#1)(2008-3#1)
The experimental group##9##3##(1991-12#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#2)(2010-4#1)
The experimental groups##2##3##(2008-12#1)(2013-7#1)
The experimental host range was limited to Nicotiana##2##8##(2008-10#2)
The experimental host range was limited to##3##7##(2008-10#3)
The experimental host range##4##4##(2008-10#4)
The experimental minimum and maximum WSS at##2##7##(2011-2#2)
The experimental observations are##2##4##(2008-3#2)
The experimental parameters##4##3##(1995-5#1)(2008-10#3)
The experimental result##2##3##(2007-11#1)(2008-9#1)
The experimental results are compared with a##2##7##(2007-12#1)(2008-3#1)
The experimental results are compared with##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
The experimental results are consistent with##2##6##(2007-12#1)(2008-3#1)
The experimental results are in good agreement with the##2##9##(2008-2#1)(2008-3#1)
The experimental results are in good agreement with##4##8##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
The experimental results are##13##4##(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)
The experimental results for##3##4##(2008-10#2)(2008-3#1)
The experimental results indicate that the##5##6##(2008-10#3)(2008-3#1)(2012-3#1)
The experimental results indicate##6##4##(2007-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
The experimental results indicated that##2##5##(2008-10#1)(2009-8#1)
The experimental results obtained##2##4##(2008-10#2)
The experimental results of a##2##5##(2008-2#1)(2008-3#1)
The experimental results reveal##2##4##(2007-11#1)(2008-10#1)
The experimental results show good##2##5##(2008-2#2)
The experimental results show that the##6##6##(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#2)
The experimental results show that##12##5##(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2013-8#5)
The experimental results show##15##4##(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#5)
The experimental results showed that the##4##6##(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
The experimental results showed that##6##5##(2008-10#2)(2008-3#1)(2008-8#2)(2013-8#1)
The experimental results were compared##2##5##(2008-10#1)(2008-2#1)
The experimental results were fitted to##2##6##(2008-10#1)(2011-2#1)
The experimental results were##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2011-2#1)
The experimental results##68##3##(1995-3#1)(2007-11#3)(2007-12#5)(2008-10#19)(2008-11#1)(2008-2#10)(2008-3#15)(2008-8#3)(2009-8#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#6)
The experimental setup is##2##4##(2008-3#2)
The experimental setup##4##3##(2008-3#4)
The experimental studies##2##3##(2008-2#1)(2011-2#1)
The experimental study##2##3##(2008-10#1)(2008-3#1)
The experimental variables##3##3##(2008-10#3)
The experimental##180##2##(1991-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-6#1)(2007-11#11)(2007-12#6)(2008-10#60)(2008-11#4)(2008-12#3)(2008-2#15)(2008-3#34)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-2#5)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#9)
The experimentally measured##2##3##(2007-11#1)(2008-3#1)
The experimentally obtained##2##3##(2008-3#2)
The experimentally##5##2##(2007-10#1)(2007-11#1)(2008-3#3)
The experiments also##2##3##(1990-7#1)(2008-3#1)
The experiments are##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
The experiments carried out##2##4##(2008-10#1)(2008-5#1)
The experiments indicate that under##2##5##(2008-10#2)
The experiments indicated that##2##4##(2008-10#2)
The experiments presented here##2##4##(1996-6#1)(2010-11#1)
The experiments reported here##2##4##(1990-5#1)(1993-6#1)
The experiments revealed that##2##4##(2008-10#1)(2008-8#1)
The experiments showed that##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
The experiments showed##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
The experiments were carried out in##3##6##(2008-4#1)(2008-6#1)(2013-1#1)
The experiments were carried out##6##5##(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#2)
The experiments were conducted in a##2##6##(2008-10#1)(2011-2#1)
The experiments were conducted##6##4##(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)
The experiments were performed in##2##5##(1993-12#1)(2008-11#1)
The experiments were performed on##2##5##(1992-6#1)(2008-8#1)
The experiments were performed with a##2##6##(1990-12#1)(2008-10#1)
The experiments were performed with##3##5##(1990-12#1)(2008-10#1)(2008-6#1)
The experiments were performed##9##4##(1990-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#1)
The experiments were##23##3##(1990-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#2)
The experiments##53##2##(1990-12#1)(1990-5#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1996-6#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
The expert system##2##3##(2008-10#2)
The expert##3##2##(2008-10#2)(2008-5#1)
The experts##2##2##(2008-8#1)(2010-12#1)
The explanation for this##2##4##(2007-11#1)(2010-12#1)
The explanation for##4##3##(2007-11#2)(2010-1#1)(2010-12#1)
The explanation##6##2##(1991-6#1)(1996-9#1)(2007-11#2)(2010-1#1)(2010-12#1)
The explicit##2##2##(2008-10#1)(2008-7#1)
The exploitation of##2##3##(2008-10#1)(2011-1#1)
The exponential##2##2##(2008-10#2)
The exposure of##5##3##(1996-5#1)(1997-4#1)(1997-8#1)(2008-5#1)(2008-8#1)
The exposure time##2##3##(1996-12#1)(2008-3#1)
The exposure to##3##3##(1993-3#1)(2007-12#1)(2008-10#1)
The exposure##11##2##(1993-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
The expressed protein is##2##4##(1993-6#1)(1997-4#1)
The expressed protein was##2##4##(1992-12#1)(2008-8#1)
The expressed protein##6##3##(1992-12#1)(1993-6#1)(1994-11#1)(1997-4#2)(2008-8#1)
The expressed##16##2##(1991-5#1)(1992-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-4#3)(2008-10#1)(2008-11#1)(2008-8#2)
The expression and##4##3##(1994-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
The expression level of##3##4##(2008-11#1)(2010-12#1)(2010-5#1)
The expression level was##2##4##(1997-2#1)(2009-3#1)
The expression level##6##3##(1997-2#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)
The expression levels of##2##4##(2008-11#2)
The expression of Bcl-2 and Bax##2##6##(2008-9#2)
The expression of CYP1A1##2##4##(1995-11#1)(2008-11#1)
The expression of Glu-1##2##4##(2008-10#2)
The expression of a##6##4##(1992-12#1)(1995-12#1)(1995-6#2)(2008-10#1)(2010-10#1)
The expression of c-myc##2##4##(1993-11#1)(2008-8#1)
The expression of the gene##2##5##(1993-8#2)
The expression of the##20##4##(1990-11#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-2#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
The expression of this##3##4##(1991-5#1)(1994-8#1)(2008-10#1)
The expression of##113##3##(1990-11#1)(1990-12#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#4)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#9)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#10)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
The expression pattern of##3##4##(1996-12#1)(1997-4#1)(2007-12#1)
The expression##142##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#4)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(2007-12#2)(2008-1#4)(2008-10#9)(2008-11#12)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#13)(2009-12#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
The expressions of##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
The expressions##4##2##(1991-12#1)(2007-12#1)(2008-8#1)(2008-9#1)
The extended##6##2##(1996-5#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
The extension of a##2##4##(2007-8#1)(2008-3#1)
The extension of the##3##4##(1990-3#1)(2008-10#1)(2010-1#1)
The extension of these##2##4##(2007-11#1)(2011-2#1)
The extension of##10##3##(1990-3#1)(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2011-1#1)(2011-2#1)
The extension##11##2##(1990-3#1)(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
The extensive##8##2##(1994-6#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-8#1)(2012-3#1)
The extent and##2##3##(1993-8#1)(2008-11#1)
The extent of agreement##2##4##(1993-1#1)(1996-2#1)
The extent of inhibition##2##4##(1992-3#2)
The extent of the##9##4##(1993-8#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
The extent of this##3##4##(1992-9#1)(1996-2#1)(2007-2#1)
The extent of##45##3##(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#1)(1996-2#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
The extent to which##3##4##(1994-3#1)(2008-10#1)(2012-3#1)
The extent##51##2##(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The extinction##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
The extracellular domain of the##2##5##(1992-12#1)(1995-2#1)
The extracellular domain of##4##4##(1992-12#2)(1995-2#1)(2008-11#1)
The extracellular##7##2##(1992-12#2)(1993-2#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
The extract is also##2##4##(2008-10#1)(2008-5#1)
The extract is##5##3##(2008-10#3)(2008-5#2)
The extract of##3##3##(2008-5#1)(2010-5#1)(2012-2#1)
The extract showed##2##3##(2008-10#1)(2011-1#1)
The extract was evaporated##2##4##(2008-10#1)(2008-11#1)
The extract was##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)
The extract##24##2##(1990-5#1)(1992-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#5)(2010-3#1)(2010-5#2)(2011-1#2)(2012-2#2)(2013-7#1)
The extractability of##3##3##(2008-10#3)
The extractability with##2##3##(2008-10#2)
The extractability##6##2##(2008-10#6)
The extracted species##2##3##(2008-10#2)
The extracted##13##2##(2008-10#9)(2008-12#1)(2008-4#1)(2012-12#1)(2012-2#1)
The extracting##2##2##(2008-10#2)
The extraction ability##2##3##(2008-10#2)
The extraction behaviour of##3##4##(2008-10#3)
The extraction constant##5##3##(2008-10#5)
The extraction efficiency and##2##4##(2008-10#2)
The extraction efficiency of##2##4##(2008-10#1)(2012-1#1)
The extraction efficiency was##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
The extraction efficiency##9##3##(2007-12#1)(2008-10#6)(2008-2#1)(2012-1#1)
The extraction is carried out##2##5##(2008-10#2)
The extraction mechanism of##2##4##(2008-10#2)
The extraction mechanism##3##3##(2008-10#3)
The extraction of the##3##4##(2008-10#2)(2008-3#1)
The extraction of uranium by##2##5##(2008-10#2)
The extraction of##22##3##(1994-6#1)(1997-2#1)(2008-10#17)(2008-3#1)(2008-6#1)(2010-8#1)
The extraction procedure was##4##4##(2008-10#4)
The extraction procedure##5##3##(2008-10#5)
The extraction process was##2##4##(2008-10#2)
The extraction rate of platinum(II)##2##5##(2008-10#2)
The extraction rate##3##3##(2008-10#3)
The extraction recoveries##2##3##(2008-10#1)(2011-2#1)
The extraction selectivity##2##3##(2008-10#2)
The extraction step##2##3##(2008-10#2)
The extraction time##2##3##(2008-10#2)
The extraction was##3##3##(2008-10#3)
The extraction yield of##2##4##(2008-10#1)(2008-7#1)
The extraction##84##2##(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#72)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
The extractor system##2##3##(2008-10#2)
The extractor##4##2##(2008-10#4)
The extracts of##4##3##(1996-2#1)(2008-10#3)
The extracts were evaluated directly by derivative spectrophotometric measurement##2##9##(2008-10#2)
The extracts were##5##3##(2008-10#4)(2008-5#1)
The extracts##12##2##(1992-3#1)(1996-2#1)(2008-10#8)(2008-5#1)(2010-3#1)
The extraordinary##3##2##(2008-3#3)
The extreme##4##2##(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#1)
The extremely##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
The eye##5##2##(2007-12#2)(2010-1#1)(2010-8#1)(2011-1#1)
The fabricated##7##2##(2007-11#1)(2008-10#3)(2008-3#2)(2009-5#1)
The fabrication and characterization of##2##5##(2007-12#1)(2009-9#1)
The fabrication and##7##3##(2007-12#2)(2008-10#2)(2008-3#1)(2009-9#1)(2010-5#1)
The fabrication of##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
The fabrication##15##2##(2007-11#2)(2007-12#2)(2008-10#6)(2008-3#2)(2008-7#1)(2009-9#1)(2010-5#1)
The face##4##2##(2007-4#1)(2007-8#1)(2008-5#1)(2010-6#1)
The facets##2##2##(2007-12#1)(2012-1#1)
The facial##4##2##(1996-3#1)(1996-5#1)(2007-8#1)(2008-9#1)
The facilitation##2##2##(1991-2#1)(1995-5#1)
The facility master plan##2##4##(1992-2#2)
The facility##3##2##(1992-2#2)(2008-3#1)
The fact that the##7##4##(1992-3#1)(1992-5#1)(1993-3#2)(1994-8#1)(1996-6#1)(2008-9#1)
The fact that there##2##4##(2008-10#1)(2008-2#1)
The fact that this##4##4##(1995-12#1)(2008-11#1)(2008-3#1)(2009-3#1)
The fact that##28##3##(1992-3#1)(1992-5#1)(1993-3#2)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-1#1)
The fact##29##2##(1992-3#1)(1992-5#1)(1993-3#2)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-1#1)
The factor is##3##3##(1990-7#1)(1995-2#1)(2008-3#1)
The factor##8##2##(1990-7#1)(1995-2#1)(1995-6#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-11#1)
The factors affecting the##3##4##(2008-10#2)(2008-12#1)
The factors associated with##2##4##(2008-10#1)(2011-2#1)
The factors influencing the##2##4##(2008-10#2)
The factors influencing##3##3##(1991-6#1)(2008-10#2)
The factors that influenced the##2##5##(2008-10#1)(2008-11#1)
The factors that might##2##4##(1993-12#1)(2007-7#1)
The factors that##8##3##(1993-12#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
The factors which##2##3##(2008-10#1)(2010-8#1)
The factors##33##2##(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-3#1)(1995-5#1)(1997-4#2)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)
The facts##2##2##(2008-11#1)(2008-9#1)
The failure of##6##3##(1990-6#1)(1990-7#1)(1991-3#1)(1993-6#1)(2008-7#1)(2011-2#1)
The failure##10##2##(1990-6#1)(1990-7#1)(1991-3#1)(1993-6#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
The fall##2##2##(1993-3#1)(2010-7#1)
The false##2##2##(2008-10#1)(2008-7#1)
The familial##2##2##(1991-3#1)(2007-10#1)
The families##6##2##(1990-2#1)(1997-2#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
The family history##3##3##(1993-1#1)(2008-10#1)(2008-7#1)
The family of##4##3##(1994-11#2)(2008-3#1)(2009-5#1)
The family##12##2##(1993-1#1)(1993-6#1)(1994-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-1#1)(2012-12#1)
The fast##8##2##(1991-12#2)(1992-1#1)(1992-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2009-9#1)
The fastest##3##2##(2008-10#2)(2011-2#1)
The fate of the##3##4##(2007-11#1)(2008-11#1)(2010-11#1)
The fate of##9##3##(1994-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-11#1)
The fate##10##2##(1994-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-11#1)(2011-1#1)
The fatty acid composition of##2##5##(2008-11#1)(2008-7#1)
The fatty acid release##2##4##(1991-12#2)
The fatty acid##6##3##(1991-12#2)(2008-10#1)(2008-11#1)(2008-7#2)
The fatty acids##3##3##(1990-8#1)(2008-5#2)
The fatty##9##2##(1990-8#1)(1991-12#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)
The favorable##3##2##(2007-10#1)(2008-8#1)(2012-1#1)
The favourable##2##2##(1992-11#1)(2012-2#1)
The feasibility of employing##2##4##(2008-10#1)(2008-2#1)
The feasibility of our##2##4##(2007-11#1)(2007-12#1)
The feasibility of simultaneous##2##4##(2007-12#1)(2008-3#1)
The feasibility of the system was##3##6##(2008-10#3)
The feasibility of the##10##4##(1991-5#1)(2008-10#7)(2008-5#1)(2010-7#1)
The feasibility of this method is demonstrated##2##7##(2007-11#2)
The feasibility of this method is##3##6##(2007-11#2)(2008-3#1)
The feasibility of this method##4##5##(2007-11#2)(2008-10#1)(2008-3#1)
The feasibility of this##5##4##(2007-11#2)(2008-10#2)(2008-3#1)
The feasibility of using##5##4##(2008-10#2)(2008-3#2)(2011-2#1)
The feasibility of##42##3##(1991-5#1)(2007-11#4)(2007-12#4)(2008-10#19)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#1)
The feasibility##46##2##(1990-9#1)(1991-5#1)(1994-2#1)(2007-11#4)(2007-12#4)(2008-10#20)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#2)
The features are##2##3##(2008-5#1)(2010-8#1)
The features of the##2##4##(1991-12#1)(2008-10#1)
The features of##5##3##(1991-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
The features that##2##3##(2007-12#2)
The features##10##2##(1990-9#1)(1991-12#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#2)(2010-8#1)
The fecundity of##2##3##(2010-8#1)(2012-12#1)
The fecundity##3##2##(2010-8#1)(2012-12#2)
The feed##2##2##(2008-6#1)(2010-8#1)
The feedback##6##2##(2007-11#1)(2007-12#1)(2008-12#1)(2012-2#1)(2013-8#2)
The feeding##4##2##(1996-9#1)(2008-10#1)(2008-5#2)
The feet##2##2##(1997-5#1)(2008-7#1)
The female##5##2##(1995-6#1)(1997-6#2)(2007-7#1)(2013-8#1)
The females##3##2##(2008-1#1)(2008-5#1)(2013-7#1)
The femoral##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
The fermentation process##2##3##(2008-10#1)(2008-6#1)
The fermentation##7##2##(2008-10#1)(2008-6#4)(2008-7#1)(2009-6#1)
The fermentative##2##2##(2008-6#1)(2013-1#1)
The fetal origins of adult disease##2##6##(2013-1#2)
The fetal origins of adult##3##5##(2012-2#1)(2013-1#2)
The fetal##6##2##(1996-3#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#2)
The few studies##2##3##(2008-1#1)(2008-2#1)
The few##4##2##(1990-6#1)(2008-1#1)(2008-10#1)(2008-2#1)
The fiber is##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
The fiber laser##2##3##(2007-12#1)(2008-2#1)
The fiber##16##2##(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#2)(2008-7#1)
The fiber-optic##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
The fibers##3##2##(2007-12#1)(2008-10#1)(2009-7#1)
The fibres##2##2##(1997-3#1)(2008-10#1)
The fibrinogen-mediated##2##2##(1995-2#1)(1996-2#1)
The field of view is##2##5##(2008-3#2)
The field of##15##3##(1992-1#1)(1992-3#1)(1993-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
The field strain and##2##4##(2011-2#2)
The field strain##3##3##(2011-2#3)
The field##29##2##(1992-1#1)(1992-3#2)(1993-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-8#1)
The fields of##3##3##(1996-1#1)(2008-12#1)(2009-8#1)
The fifth##8##2##(1990-12#1)(1992-8#1)(1993-8#1)(2007-11#1)(2008-12#1)(2010-11#1)(2011-1#1)(2011-2#1)
The figure of merit##3##4##(2007-11#2)(2007-12#1)
The figures for##2##3##(2013-1#2)
The figures of merit of the proposed method##2##8##(2008-10#2)
The figures of merit of the##3##6##(2008-10#3)
The figures of merit##4##4##(2008-10#4)
The figures##9##2##(1990-6#1)(1997-1#1)(1997-6#1)(2008-10#4)(2013-1#2)
The filamentous fungus##2##3##(1993-2#1)(2010-10#1)
The filamentous##3##2##(1993-2#1)(2008-10#1)(2010-10#1)
The files of##3##3##(1995-12#1)(1997-2#1)(2012-2#1)
The files##4##2##(1992-1#1)(1995-12#1)(1997-2#1)(2012-2#1)
The film is##2##3##(2008-10#2)
The film modified##2##3##(2008-10#2)
The film properties##2##3##(2008-3#1)(2009-7#1)
The film thickness##2##3##(2008-2#1)(2008-3#1)
The film##10##2##(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2009-7#1)
The films were characterized using X-ray diffraction and X-ray photoelectron spectroscopy##2##11##(2008-10#2)
The films were##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
The films##6##2##(2007-12#2)(2008-10#3)(2008-3#1)
The filter is##3##3##(2008-2#3)
The filter##7##2##(1993-8#1)(2007-11#1)(2008-2#4)(2008-3#1)
The filtrate##2##2##(2008-10#1)(2008-5#1)
The final R value for##2##5##(1993-8#1)(1996-5#1)
The final R##3##3##(1993-8#1)(1996-5#1)(2008-8#1)
The final analysis##2##3##(2012-2#1)(2013-8#1)
The final cleavage occurs quantitatively without concomitant destruction of the RNA product##2##12##(2008-4#2)
The final concentrations of##2##4##(2008-10#1)(2008-11#1)
The final diagnosis##2##3##(1993-12#1)(2007-7#1)
The final mean body weight##2##5##(2008-9#2)
The final model##4##3##(1997-4#1)(2008-10#1)(2008-9#1)(2009-7#1)
The final product##3##3##(1994-6#1)(2008-10#1)(2013-1#1)
The final result##2##3##(1993-5#1)(2008-2#1)
The final sample##2##3##(2011-1#1)(2013-1#1)
The final section offers advice on database construction##2##8##(2008-4#2)
The final section offers##3##4##(1990-12#1)(2008-4#2)
The final section##4##3##(1990-12#1)(2008-10#1)(2008-4#2)
The final sections of this article discuss new excipients##2##9##(2012-2#2)
The final specific activity##2##4##(1997-6#2)
The final steps##2##3##(1991-6#1)(2008-4#1)
The final two##2##3##(2008-2#1)(2008-4#1)
The final version##2##3##(2008-9#1)(2013-1#1)
The final##76##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#2)(1997-4#1)(1997-6#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
The financial##3##2##(2008-11#2)(2008-9#1)
The finding of this##2##4##(2008-5#1)(2011-1#1)
The finding of two##2##4##(2008-10#1)(2011-2#1)
The finding of##13##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#1)(1993-2#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
The finding suggests that##2##4##(2008-4#1)(2010-10#1)
The finding that the##2##4##(1990-2#1)(2008-5#1)
The finding that##12##3##(1990-2#1)(1990-7#1)(1993-6#2)(1995-6#1)(1997-4#1)(2006-11#1)(2008-1#1)(2008-5#2)(2010-11#1)(2013-7#1)
The finding##29##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1993-2#1)(1993-6#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#2)
The findings also suggest that##3##5##(1993-1#1)(2008-8#1)(2009-7#1)
The findings also##7##3##(1993-1#1)(1994-12#1)(2008-8#1)(2009-2#1)(2009-7#2)(2013-8#1)
The findings are discussed in terms of the##2##8##(1992-5#1)(2009-12#1)
The findings are discussed in terms of##3##7##(1992-5#1)(2007-12#1)(2009-12#1)
The findings are discussed in the context of##2##8##(2009-11#1)(2012-2#1)
The findings are discussed in the##3##6##(2008-3#1)(2009-11#1)(2012-2#1)
The findings are discussed in##8##5##(1992-5#1)(1993-11#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
The findings are discussed##10##4##(1992-5#1)(1993-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
The findings are##13##3##(1992-5#1)(1993-11#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
The findings demonstrate##3##3##(2007-1#1)(2008-7#1)(2010-7#1)
The findings emphasize the##2##4##(2007-6#1)(2008-10#1)
The findings focus on##2##4##(2010-10#1)(2011-1#1)
The findings from this##3##4##(2008-6#1)(2009-3#1)(2012-1#1)
The findings from##8##3##(1990-6#1)(1993-12#1)(1995-1#1)(2007-12#1)(2008-6#1)(2009-3#1)(2010-2#1)(2012-1#1)
The findings have##3##3##(1992-2#1)(1994-12#1)(2011-1#1)
The findings highlight the need for##2##6##(2011-2#1)(2013-1#1)
The findings illustrate##2##3##(1993-12#1)(2008-9#1)
The findings indicate a need##2##5##(1996-6#1)(2008-1#1)
The findings indicate a##5##4##(1996-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
The findings indicate that the##3##5##(1993-12#1)(1994-2#1)(2010-11#1)
The findings indicate that##10##4##(1993-12#2)(1994-2#1)(1995-12#1)(1996-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-11#1)(2013-8#1)
The findings indicate##16##3##(1993-12#2)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2013-8#2)
The findings indicated that##6##4##(1994-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2012-1#1)
The findings may##3##3##(1991-2#1)(2008-4#1)(2009-5#1)
The findings obtained##2##3##(1990-8#1)(2008-10#1)
The findings of the present study##2##6##(2008-5#1)(2011-2#1)
The findings of the present##3##5##(2008-5#1)(2011-2#1)(2013-1#1)
The findings of the study demonstrate##2##6##(2008-5#1)(2008-7#1)
The findings of the study##3##5##(2007-10#1)(2008-5#1)(2008-7#1)
The findings of the##8##4##(1996-3#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
The findings of this study are##2##6##(2008-11#1)(2008-7#1)
The findings of this study demonstrate##2##6##(1994-6#1)(2008-8#1)
The findings of this study show immunologic bases for most patients with valvular heart diseases candidate for surgery##2##18##(2013-1#2)
The findings of this study suggest that##3##7##(1994-2#1)(2008-11#1)(2008-3#1)
The findings of this study suggest##4##6##(1994-2#1)(2008-11#1)(2008-3#1)(2012-3#1)
The findings of this study suggested##2##6##(1995-4#1)(2009-5#1)
The findings of this study##19##5##(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#2)
The findings of this##22##4##(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
The findings of##36##3##(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#3)
The findings point to the need for##2##7##(1991-3#1)(2008-10#1)
The findings point to##3##4##(1991-3#1)(2008-10#1)(2008-12#1)
The findings presented in this paper##2##6##(1993-3#1)(2008-11#1)
The findings presented##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
The findings provide##4##3##(1993-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
The findings reported in##2##4##(2008-12#1)(2011-3#1)
The findings revealed that##2##4##(2008-12#1)(2010-3#1)
The findings revealed##7##3##(2008-12#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
The findings show that##5##4##(1993-9#1)(2008-9#2)(2011-2#1)(2012-12#1)
The findings show##7##3##(1990-8#1)(1991-2#1)(1993-9#1)(2008-9#2)(2011-2#1)(2012-12#1)
The findings showed a##2##4##(1991-11#1)(1994-12#1)
The findings showed that##2##4##(2008-12#1)(2011-2#1)
The findings showed##6##3##(1991-11#1)(1994-12#1)(1994-3#1)(2008-12#1)(2011-2#1)(2012-1#1)
The findings suggest a##2##4##(1990-5#1)(2010-4#1)
The findings suggest that the##5##5##(1992-8#1)(2008-11#1)(2009-12#1)(2009-5#1)(2012-3#1)
The findings suggest that##23##4##(1990-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
The findings suggest the##3##4##(1992-2#1)(1994-3#1)(2010-4#1)
The findings suggest##30##3##(1990-3#1)(1990-5#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
The findings suggested that##2##4##(1991-12#1)(2008-11#1)
The findings suggested##3##3##(1990-7#1)(1991-12#1)(2008-11#1)
The findings support the##2##4##(2009-8#1)(2013-1#1)
The findings were##4##3##(1990-10#1)(2010-10#1)(2011-1#1)(2013-1#1)
The findings##206##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#3)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#14)(2008-12#9)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#2)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#4)
The fine structure of the##3##5##(2007-12#1)(2008-7#1)(2008-8#1)
The fine structure of##6##4##(2007-12#3)(2008-7#2)(2008-8#1)
The fine##7##2##(2007-12#3)(2008-7#2)(2008-8#1)(2009-5#1)
The first 22##2##3##(2007-8#1)(2013-1#1)
The first ORF##2##3##(1996-6#1)(2008-10#1)
The first and second##2##4##(2008-10#1)(2012-12#1)
The first and the last##2##5##(1990-3#1)(2008-7#1)
The first and##4##3##(1990-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
The first attempt##2##3##(2008-10#1)(2013-1#1)
The first basic protocol describes##2##5##(2008-4#2)
The first basic protocol##3##4##(2008-4#3)
The first basic##4##3##(2008-4#4)
The first case of##3##4##(2008-1#1)(2012-3#1)(2013-1#1)
The first case was##2##4##(2008-8#1)(2013-1#1)
The first case##7##3##(2007-10#1)(2008-1#1)(2008-8#2)(2012-3#1)(2013-1#2)
The first cohort##2##3##(2011-2#1)(2013-7#1)
The first data##2##3##(1995-9#1)(2007-5#1)
The first describes the##2##4##(2006-10#1)(2008-2#1)
The first design##3##3##(2008-2#2)(2012-2#1)
The first domain##2##3##(1995-6#1)(1997-4#1)
The first group consisted of 30##2##6##(2007-8#2)
The first group consisted of##3##5##(2007-8#2)(2008-7#1)
The first group of##4##4##(1992-8#1)(2007-8#1)(2012-3#2)
The first group##13##3##(1990-2#1)(1992-8#1)(2007-8#3)(2008-10#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-3#2)
The first half of this unit discusses the two main approaches to developing genetically engineered mouse models of human disease##2##20##(2008-4#2)
The first hypothesis##2##3##(1994-3#1)(2008-8#1)
The first intron##4##3##(1993-2#1)(1994-12#1)(2008-9#2)
The first is a##6##4##(1992-11#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#2)
The first is based on the##3##6##(2008-3#2)(2008-4#1)
The first is related to##2##5##(1996-6#1)(2008-10#1)
The first is the##4##4##(2008-2#4)
The first is to##3##4##(1996-2#1)(2008-8#1)(2012-2#1)
The first is##23##3##(1992-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-8#1)(2012-2#2)(2012-3#1)
The first issue of World Journal of##3##7##(2010-12#3)
The first issue of##4##4##(2010-12#3)(2013-1#1)
The first issue##5##3##(2008-1#1)(2010-12#3)(2013-1#1)
The first known##2##3##(2007-11#1)(2007-12#1)
The first method was based on##2##6##(2008-10#1)(2010-4#1)
The first method was##3##4##(2008-10#2)(2010-4#1)
The first method##7##3##(2008-10#3)(2008-3#1)(2010-4#1)(2010-8#1)(2012-2#1)
The first of the##2##4##(2008-3#1)(2008-9#1)
The first of these##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
The first of##7##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2013-1#1)
The first one is##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
The first one##11##3##(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
The first part is##2##4##(2008-11#1)(2008-3#1)
The first part of the article##2##6##(1993-6#1)(1995-3#1)
The first part of the##3##5##(1993-6#1)(1995-3#1)(2009-6#1)
The first part of this unit compares general and locus-specific mutation databases##2##12##(2008-4#2)
The first part of this##4##5##(1992-1#1)(2008-4#2)(2012-12#1)
The first part of##7##4##(1992-1#1)(1993-6#1)(1995-3#1)(2008-4#2)(2009-6#1)(2012-12#1)
The first part##12##3##(1992-1#1)(1993-6#1)(1995-3#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)
The first patient##7##3##(1992-10#1)(1996-6#1)(1997-3#1)(2007-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
The first peak##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#1)
The first population##2##3##(2008-10#2)
The first protocol in this unit describes the##2##8##(2008-2#2)
The first protocol uses##2##4##(2008-4#2)
The first protocol##7##3##(2008-2#3)(2008-4#4)
The first reported case of##2##5##(2007-2#1)(2012-12#1)
The first reported##4##3##(2007-2#1)(2008-10#2)(2012-12#1)
The first results##3##3##(1997-2#1)(2008-1#1)(2008-10#1)
The first section##6##3##(1991-3#1)(2008-10#2)(2008-4#3)
The first series of##2##4##(1997-7#1)(2008-10#1)
The first set of##2##4##(2012-2#1)(2013-1#1)
The first set##4##3##(2008-10#1)(2009-9#1)(2012-2#1)(2013-1#1)
The first stage of the##2##5##(2008-5#1)(2010-8#1)
The first stage##3##3##(2008-12#1)(2008-5#1)(2010-8#1)
The first step in the##2##5##(1995-2#1)(2008-7#1)
The first step in##5##4##(1995-2#1)(1997-7#1)(2008-5#1)(2008-7#1)(2012-2#1)
The first step is##2##4##(2007-11#1)(2008-4#1)
The first step of PCR simply entails mixing template DNA##2##10##(2008-2#1)(2008-9#1)
The first step of##3##4##(1996-2#1)(2008-2#1)(2008-9#1)
The first step##14##3##(1995-2#1)(1995-5#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
The first study##5##3##(1992-8#1)(2008-5#2)(2009-11#1)(2011-1#1)
The first system##4##3##(2008-10#2)(2008-3#2)
The first three##2##3##(1992-10#1)(2008-10#1)
The first two##11##3##(1993-12#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#1)(2013-1#1)
The first type of##2##4##(1997-3#1)(2008-10#1)
The first type##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
The first was##5##3##(1995-5#1)(2008-1#1)(2010-5#1)(2010-6#1)(2013-1#1)
The first##358##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1995-9#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#3)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#9)(2008-10#61)(2008-11#10)(2008-12#5)(2008-2#14)(2008-3#16)(2008-4#23)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#5)(2011-4#1)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#12)(2013-7#2)(2013-8#3)
The first-derivative##2##2##(2008-10#2)
The fish samples##2##3##(2008-12#2)
The fish##6##2##(2008-10#1)(2008-12#2)(2008-5#1)(2013-7#2)
The fishery##3##2##(2007-5#2)(2008-5#1)
The fishes were collected##2##4##(2008-5#1)(2012-2#1)
The fission yeast Schizosaccharomyces pombe has##2##6##(2008-7#1)(2012-3#1)
The fission yeast Schizosaccharomyces pombe##3##5##(1995-2#1)(2008-7#1)(2012-3#1)
The fission yeast##5##3##(1991-2#1)(1995-2#1)(2008-2#1)(2008-7#1)(2012-3#1)
The fistulas##2##2##(1995-11#1)(2007-7#1)
The fitness##2##2##(2008-10#1)(2008-8#1)
The five##7##2##(1994-12#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-4#1)(2012-2#1)
The five-year survival##2##3##(2012-1#1)(2013-1#1)
The fixed##4##2##(1990-12#1)(2007-7#1)(2008-10#1)(2008-3#1)
The flagellum##5##2##(2007-12#2)(2008-7#3)
The flame##2##2##(2008-10#2)
The flap was##2##3##(2013-1#2)
The flash##2##2##(2008-10#1)(2008-3#1)
The flavonoids##2##2##(2008-10#1)(2013-1#1)
The flexibility of the##2##4##(1995-6#1)(2008-10#1)
The flexibility of##3##3##(1995-6#1)(1997-8#1)(2008-10#1)
The flow cell##2##3##(2008-10#2)
The flow cytometry##2##3##(2008-9#2)
The flow injection analysis##3##4##(2008-10#3)
The flow injection system##2##4##(2008-10#2)
The flow injection##9##3##(2008-10#9)
The flow manifold was designed##2##5##(2008-10#2)
The flow manifold was##3##4##(2008-10#3)
The flow manifold##4##3##(2008-10#4)
The flow network##2##3##(2008-10#2)
The flow of##2##3##(1995-8#1)(2008-10#1)
The flow rate of the##3##5##(1991-9#1)(2008-10#2)
The flow rate of##4##4##(1991-9#1)(2008-10#3)
The flow rate was##2##4##(2008-10#1)(2012-3#1)
The flow rate##9##3##(1991-9#1)(2008-10#6)(2008-8#1)(2012-3#1)
The flow system was successfully applied to the analysis of##2##10##(2008-10#2)
The flow system was##3##4##(2008-10#3)
The flow system##11##3##(2008-10#11)
The flow##55##2##(1991-9#1)(1995-3#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
The flow-rate##2##2##(1997-2#1)(2008-10#1)
The flow-through coulometric titration##2##4##(2008-10#2)
The flower##3##2##(2007-11#1)(2013-1#2)
The flowing##2##2##(2008-10#2)
The fluctuations of the##2##4##(2008-2#1)(2008-3#1)
The fluctuations##4##2##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
The fluid##2##2##(2008-11#1)(2013-1#1)
The fluorescence emission##4##3##(1995-2#1)(2008-1#1)(2008-10#2)
The fluorescence energy transfer##2##4##(2008-10#2)
The fluorescence enhancement of the##2##5##(2008-10#2)
The fluorescence enhancement##3##3##(2008-10#3)
The fluorescence from##2##3##(2008-10#1)(2008-3#1)
The fluorescence increase is linearly related to the concentration of##2##10##(2008-10#2)
The fluorescence intensities##3##3##(2008-10#3)
The fluorescence intensity is##3##4##(2008-10#3)
The fluorescence intensity of the##2##5##(1992-3#1)(2008-10#1)
The fluorescence intensity of##3##4##(1992-3#1)(2008-10#2)
The fluorescence intensity was##2##4##(2008-10#2)
The fluorescence intensity##10##3##(1992-3#1)(2008-10#8)(2008-3#1)
The fluorescence measurements to quantify##2##5##(2008-10#2)
The fluorescence of the##5##4##(1990-11#1)(1992-9#1)(2008-10#3)
The fluorescence of##10##3##(1990-11#1)(1991-5#1)(1992-9#1)(2008-10#6)(2008-4#1)
The fluorescence properties of##2##4##(2007-11#1)(2008-10#1)
The fluorescence quenching##2##3##(2008-10#2)
The fluorescence spectra of##2##4##(2008-10#1)(2008-2#1)
The fluorescence spectra##3##3##(2008-10#2)(2008-2#1)
The fluorescence spectrum of##2##4##(2008-10#2)
The fluorescence was##2##3##(2007-12#1)(2008-10#1)
The fluorescence##61##2##(1990-11#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
The fluorescent##6##2##(1991-12#1)(2008-10#5)
The fluoride##3##2##(2008-10#2)(2008-2#1)
The fluorimetric determination##2##3##(2008-10#2)
The fluorimetric method allows the determination of##2##7##(2008-10#2)
The fluorimetric method##3##3##(2008-10#3)
The fluorimetric##8##2##(2008-10#8)
The flux of##3##3##(2008-10#2)(2008-11#1)
The flux##8##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
The fly##2##2##(2008-10#2)
The foam##2##2##(1992-5#1)(2008-6#1)
The focal##2##2##(1996-5#1)(2008-2#1)
The focus is on##5##4##(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
The focus of attention##2##4##(2008-12#1)(2008-4#1)
The focus of the##5##4##(1991-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-9#1)
The focus of this article is##4##6##(1996-2#1)(2008-1#1)(2010-2#1)(2012-2#1)
The focus of this paper is##2##6##(2008-12#1)(2012-12#1)
The focus of this paper##3##5##(2008-11#1)(2008-12#1)(2012-12#1)
The focus of this review is to##2##7##(2008-1#1)(2012-2#1)
The focus of this review is##4##6##(2008-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
The focus of this review##6##5##(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2012-2#1)
The focus of this study is##2##6##(1992-2#1)(2010-10#1)
The focus of this study##3##5##(1992-2#1)(2008-11#1)(2010-10#1)
The focus of this unit is##2##6##(2008-4#2)
The focus of this##21##4##(1992-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
The focus of##29##3##(1991-2#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#3)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
The focus##40##2##(1991-2#1)(1992-2#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#3)(2008-6#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
The focused##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
The focusing of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
The focusing##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
The fold of##2##3##(1995-5#1)(1995-8#1)
The follicle cells##2##3##(2007-12#1)(2008-6#1)
The follicular unit-like wigs##2##4##(2012-3#2)
The follicular##3##2##(2008-6#1)(2012-3#2)
The follow up##3##3##(2011-2#2)(2013-1#1)
The follow-up of##2##3##(1993-11#1)(1997-8#1)
The follow-up period ranged from 1 to##2##7##(2008-7#1)(2013-1#1)
The follow-up period ranged from 1##3##6##(2007-8#1)(2008-7#1)(2013-1#1)
The follow-up period##5##3##(1994-11#1)(2007-8#1)(2008-7#1)(2013-1#2)
The follow-up was##2##3##(1993-9#1)(2013-1#1)
The follow-up##16##2##(1990-3#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-11#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#3)(2013-7#1)
The following article presents##2##4##(1993-12#1)(2007-11#1)
The following article reviews the##2##5##(2006-10#1)(2008-4#1)
The following article##8##3##(1993-12#1)(1993-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#2)(2013-1#1)
The following case##3##3##(1991-1#1)(2013-1#2)
The following characteristics##2##3##(2013-1#2)
The following conclusions##4##3##(1992-3#1)(1993-12#1)(2007-11#1)(2008-8#1)
The following day##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
The following findings##2##3##(1996-4#1)(2012-3#1)
The following formation of##2##4##(1992-12#1)(2008-10#1)
The following is a##2##4##(2012-12#1)(2013-8#1)
The following is##4##3##(1996-2#2)(2012-12#1)(2013-8#1)
The following parameters were##4##4##(2007-11#1)(2008-10#2)(2013-8#1)
The following sequence##2##3##(1992-12#1)(2008-10#1)
The following three criteria##2##4##(2008-4#1)(2010-3#1)
The following variables were associated with##2##6##(2011-2#2)
The following variables were##5##4##(2008-11#1)(2011-2#2)(2013-1#1)(2013-7#1)
The following##98##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-4#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#3)
The food##4##2##(1994-3#1)(1995-2#1)(2008-12#1)(2011-2#1)
The force##4##2##(1997-7#1)(2007-11#1)(2007-12#1)(2013-1#1)
The foregoing##4##2##(1990-7#1)(1994-8#1)(1994-9#1)(2008-8#1)
The forest ecosystem##2##3##(2008-9#2)
The forest##4##2##(1995-12#1)(2008-10#1)(2008-9#2)
The forgotten##2##2##(1991-12#1)(2009-11#1)
The form of the##2##4##(2008-3#1)(2013-8#1)
The form##4##2##(1991-1#1)(1996-3#1)(2008-3#1)(2013-8#1)
The formal potential of##2##4##(2008-10#2)
The formal potential##3##3##(2008-10#3)
The formal##4##2##(2008-10#4)
The formalism is##3##3##(2008-2#1)(2008-3#2)
The formation and stability of protonated##2##6##(2008-10#2)
The formation and stability of##4##5##(1992-6#1)(2008-10#3)
The formation and##5##3##(1992-6#1)(2007-12#1)(2008-10#3)
The formation constant##3##3##(2008-10#3)
The formation constants of the resulting##2##6##(2008-10#2)
The formation constants of the##3##5##(2008-10#3)
The formation constants of##5##4##(2008-10#5)
The formation constants##7##3##(2008-10#7)
The formation mechanism##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
The formation of a##2##4##(1994-12#1)(2008-10#1)
The formation of the##11##4##(1994-3#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
The formation of these novel inclusions##2##6##(2008-10#2)
The formation of these##4##4##(1993-11#1)(1996-5#1)(2008-10#2)
The formation of##50##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-3#2)(1993-11#2)(1994-12#1)(1994-3#2)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#2)(2009-8#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-2#1)
The formation##74##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-3#2)(1992-6#1)(1993-11#2)(1994-12#1)(1994-3#2)(1995-5#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-10#35)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-10#2)(2009-8#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
The formed##7##2##(1991-2#1)(1994-3#1)(1994-6#1)(2008-10#2)(2008-11#1)(2013-1#1)
The former is##4##3##(1997-3#1)(2007-12#1)(2008-2#1)(2008-8#1)
The former two##2##3##(1993-11#1)(1993-12#1)
The former was##3##3##(1991-9#1)(1996-3#1)(2008-10#1)
The former##39##2##(1990-8#2)(1991-2#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The formula##4##2##(1996-3#1)(2007-11#1)(2008-3#1)(2013-8#1)
The formulas##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
The formulation was##2##3##(2011-2#1)(2013-1#1)
The formulation##6##2##(2008-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
The formulations were##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
The forward##5##2##(1990-7#1)(2008-10#2)(2009-11#1)(2009-3#1)
The foundations of##2##3##(2008-10#1)(2010-4#1)
The founding##2##2##(2008-1#1)(2008-9#1)
The four traditional##2##3##(2010-8#1)(2011-2#1)
The four##27##2##(1993-3#1)(1993-8#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
The fourth##12##2##(1990-8#1)(1992-3#1)(1993-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
The fraction of##6##3##(1991-11#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2012-1#1)
The fraction##8##2##(1991-11#1)(1992-8#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-7#1)(2012-1#1)
The fractional Fourier transform (FRT) is##2##6##(2007-11#1)(2008-2#1)
The fractional##6##2##(1990-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
The fractionation##2##2##(2008-10#1)(2008-6#1)
The fractions of##2##3##(1994-3#1)(2008-10#1)
The fractions were##2##3##(1994-6#1)(2008-11#1)
The fractions##5##2##(1994-3#1)(1994-6#1)(2008-10#2)(2008-11#1)
The fracture##5##2##(2007-11#1)(2008-8#3)(2010-5#1)
The fractures were##2##3##(1991-9#1)(2009-4#1)
The fractures##5##2##(1991-9#1)(2007-11#2)(2008-8#1)(2009-4#1)
The fragment of##2##3##(2008-8#1)(2008-9#1)
The fragment##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
The fragments were##2##3##(2008-10#1)(2008-7#1)
The fragments##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
The framework##6##2##(1993-12#1)(1994-12#1)(1994-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
The free radical scavenging##2##4##(2008-10#1)(2010-5#1)
The free radical theory of aging##2##6##(2013-8#2)
The free radical##4##3##(2008-10#1)(2010-5#1)(2013-8#2)
The free##10##2##(1991-4#1)(1992-3#1)(1996-2#1)(2008-10#3)(2010-4#1)(2010-5#1)(2013-8#2)
The frequencies of the##3##4##(1993-3#1)(2007-12#1)(2008-10#1)
The frequencies of##16##3##(1993-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
The frequency and severity of##2##5##(1992-11#1)(2012-3#1)
The frequency and##7##3##(1992-11#1)(1995-5#1)(2007-11#1)(2007-8#1)(2009-2#1)(2011-2#1)(2012-3#1)
The frequency distribution was##2##4##(2008-10#1)(2008-7#1)
The frequency distribution##3##3##(2008-10#2)(2008-7#1)
The frequency distributions of##3##4##(1996-7#1)(2008-10#2)
The frequency noise##2##3##(2007-11#2)
The frequency of HLA class I and II##2##8##(2011-2#1)(2012-12#1)
The frequency of local##2##4##(1990-3#1)(1991-9#1)
The frequency of the flashes is directly proportional to the concentration of particles in the colloidal suspension##2##17##(2008-10#2)
The frequency of the##11##4##(1993-9#1)(1995-1#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2011-2#3)
The frequency of these##2##4##(2007-8#1)(2012-12#1)
The frequency of##67##3##(1990-12#2)(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-1#1)(1996-3#2)(1997-3#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2011-1#2)(2011-2#7)(2012-12#4)(2013-1#4)
The frequency shift##2##3##(2008-10#1)(2008-2#1)
The frequency shifts##2##3##(2007-11#1)(2008-10#1)
The frequency##96##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-3#2)(1996-7#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-3#2)(2013-1#4)(2013-7#1)
The frequency-domain##2##2##(2007-12#1)(2010-7#1)
The frequent##5##2##(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
The frequently##3##2##(1996-3#1)(2008-1#1)(2012-12#1)
The friction##2##2##(1996-4#1)(2008-5#1)
The fringe##6##2##(2007-12#1)(2008-3#5)
The fruit##2##2##(1992-3#1)(2008-10#1)
The fruits##2##2##(2013-1#1)(2013-7#1)
The full##13##2##(1994-6#2)(2007-11#1)(2008-10#1)(2008-11#4)(2008-3#2)(2009-4#1)(2009-5#1)(2011-1#1)
The full-length cDNA of##2##4##(2008-10#1)(2008-8#1)
The full-length cDNA##4##3##(1995-12#1)(2008-10#1)(2008-8#2)
The full-length##11##2##(1994-12#2)(1995-12#1)(2008-10#5)(2008-7#1)(2008-8#2)
The fully##6##2##(1995-3#1)(2007-12#1)(2008-10#2)(2010-3#1)(2010-4#1)
The function of the##9##4##(1990-5#2)(1991-3#1)(1991-5#1)(1992-2#1)(1996-12#1)(1996-5#1)(2008-5#1)(2009-8#1)
The function of##23##3##(1990-5#2)(1991-3#1)(1991-5#1)(1992-2#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)
The function##24##2##(1990-5#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)
The functional and##3##3##(1991-3#1)(2008-10#1)(2013-8#1)
The functional properties of##4##4##(1993-11#1)(1995-2#1)(1997-7#1)(2008-5#1)
The functional relevance of##2##4##(1994-6#1)(1995-2#1)
The functional role of##3##4##(1994-8#1)(1995-12#1)(2013-1#1)
The functional significance of##2##4##(1993-12#1)(1996-5#1)
The functional##42##2##(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The functions of##6##3##(1997-6#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-4#1)
The functions##8##2##(1995-2#1)(1997-6#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)
The fundamental##13##2##(1993-3#1)(1993-9#1)(1994-12#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
The fungal##8##2##(1995-2#1)(2008-10#4)(2008-5#2)(2013-8#1)
The fungi were##2##3##(2008-10#2)
The fungi##6##2##(1996-6#1)(2008-1#1)(2008-10#3)(2008-8#1)
The fungicide##4##2##(2008-10#4)
The fungus was##4##3##(2008-10#3)(2008-5#1)
The fungus##15##2##(2008-10#12)(2008-5#1)(2008-8#2)
The further##2##2##(1990-2#1)(2007-8#1)
The fused##2##2##(2008-2#1)(2013-1#1)
The fusion gene##2##3##(2008-8#2)
The fusion protein##6##3##(1990-11#1)(1990-8#1)(1991-7#1)(1997-4#1)(1997-6#1)(2008-1#1)
The fusion proteins##2##3##(2008-10#2)
The fusion##14##2##(1990-11#1)(1990-8#1)(1991-7#1)(1994-12#2)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-6#1)
The future is##2##3##(1994-1#1)(1996-2#1)
The future of Britain's high security hospitals##2##7##(1997-5#2)
The future of nursing##2##4##(1996-3#1)(2012-3#1)
The future of the##2##4##(1993-2#1)(2013-8#1)
The future of##24##3##(1992-12#1)(1993-1#2)(1993-2#2)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
The future##44##2##(1991-6#1)(1992-12#2)(1993-1#2)(1993-2#3)(1994-1#2)(1994-12#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#2)(1997-5#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
The gain##4##2##(1996-6#1)(2007-11#1)(2008-3#1)(2011-2#1)
The gains##2##2##(1993-3#1)(2007-11#1)
The ganglion##4##2##(2007-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
The gas##9##2##(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#3)
The gaseous phase is separated from the liquid##2##8##(2008-10#2)
The gaseous phase##3##3##(2008-10#3)
The gaseous##8##2##(2008-10#8)
The gases##3##2##(2007-12#3)
The gastric##2##2##(1992-8#1)(1997-1#1)
The gastrointestinal##2##2##(2008-5#1)(2012-12#1)
The gel test##2##3##(2011-1#2)
The gel##7##2##(1996-9#2)(2008-10#1)(2008-11#2)(2011-1#2)
The gene (or allele)##2##4##(2008-10#2)
The gene coding for##3##4##(1992-8#1)(1994-5#1)(1994-9#1)
The gene contains##3##3##(1993-2#1)(1995-8#1)(2008-7#1)
The gene encodes a##2##4##(1992-8#1)(1994-12#1)
The gene encoding Escherichia coli acyl carrier protein##2##8##(1992-4#2)
The gene encoding the##2##4##(1991-9#1)(1995-6#1)
The gene encoding##12##3##(1990-11#1)(1991-7#1)(1991-9#1)(1992-4#2)(1993-2#2)(1995-6#2)(1997-4#1)(2007-8#1)(2008-10#1)
The gene expression of##2##4##(2012-3#1)(2013-1#1)
The gene expression##5##3##(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
The gene for human##2##4##(1990-8#1)(1992-8#1)
The gene for the##2##4##(1997-4#1)(2008-11#1)
The gene for##6##3##(1990-8#1)(1992-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
The gene identified##2##3##(2008-10#2)
The gene is composed of##2##5##(1990-12#1)(1993-3#1)
The gene is##11##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1995-8#1)(1995-9#1)(2008-8#1)(2008-9#2)
The gene of##3##3##(1990-12#1)(1997-4#1)(2008-10#1)
The gene responsible for##3##4##(1990-8#1)(2007-7#1)(2008-4#1)
The gene was##8##3##(1990-5#1)(1993-2#1)(1994-9#1)(1997-2#1)(2008-10#3)(2008-7#1)
The gene##100##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-8#3)(1991-6#1)(1991-7#2)(1991-9#3)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#6)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#2)(1994-9#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#3)(1997-7#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
The general application of##2##4##(1994-1#1)(2008-1#1)
The general form of##2##4##(2008-8#2)
The general methodology##2##3##(2008-8#2)
The general##33##2##(1991-6#1)(1992-2#1)(1992-6#1)(1994-1#2)(1994-6#1)(1996-1#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
The generalist##2##2##(1991-4#1)(2009-8#1)
The generalization##2##2##(2008-3#1)(2010-3#1)
The generalized##9##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2012-3#1)
The generated##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
The generation and##3##3##(1993-12#1)(2008-9#1)(2010-9#1)
The generation of multiple##2##4##(2007-11#1)(2012-2#1)
The generation of these##2##4##(2007-12#1)(2008-9#1)
The generation of##17##3##(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-12#1)(2012-2#1)
The generation##20##2##(1993-12#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#3)(2009-12#1)(2010-9#1)(2012-2#1)
The generic##3##2##(1992-9#1)(1994-3#1)(2008-1#1)
The genes are##4##3##(1994-12#2)(2008-10#1)(2008-6#1)
The genes encoding the##3##4##(1992-9#1)(2008-10#1)(2013-1#1)
The genes encoding##6##3##(1991-6#1)(1992-9#1)(1994-12#2)(2008-10#1)(2013-1#1)
The genes for##2##3##(1994-6#1)(1994-8#1)
The genes##19##2##(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#1)(1997-3#1)(2008-10#5)(2008-6#1)(2009-4#1)(2012-3#1)(2013-1#1)
The genesis##2##2##(2007-11#1)(2011-2#1)
The genetic and##3##3##(1995-8#1)(2008-10#2)
The genetic architecture of##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
The genetic basis of the##2##5##(2008-10#1)(2012-3#1)
The genetic basis of##7##4##(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2012-3#1)
The genetic characteristics##2##3##(2011-2#1)(2013-8#1)
The genetic correlation between##2##4##(2008-9#2)
The genetic diagnosis of##2##4##(2007-7#1)(2008-6#1)
The genetic differences##2##3##(2008-10#1)(2010-4#1)
The genetic differentiation of##2##4##(2008-10#1)(2008-6#1)
The genetic differentiation##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
The genetic distance between##2##4##(2008-10#1)(2008-6#1)
The genetic distance##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
The genetic diversity of##5##4##(2008-10#4)(2013-8#1)
The genetic diversity##9##3##(2008-10#8)(2013-8#1)
The genetic information##2##3##(2008-10#1)(2008-4#1)
The genetic polymorphisms##2##3##(2008-12#1)(2008-9#1)
The genetic structure of field populations of##3##7##(2008-10#3)
The genetic structure of populations of##3##6##(2008-10#2)(2011-2#1)
The genetic structure of##9##4##(2008-10#8)(2011-2#1)
The genetic structure##11##3##(1993-2#1)(2008-10#8)(2011-2#1)(2013-1#1)
The genetic##78##2##(1990-3#1)(1992-3#1)(1993-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-7#1)(2008-1#2)(2008-10#37)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-6#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
The genetics of cerebrovascular##2##4##(2007-10#2)
The genetics of##5##3##(2007-10#2)(2008-1#1)(2008-10#1)(2008-8#1)
The genetics##6##2##(2007-10#2)(2008-1#1)(2008-10#1)(2008-8#1)(2012-3#1)
The genome of##10##3##(1991-6#1)(2008-10#7)(2008-7#1)(2013-8#1)
The genome sizes of##2##4##(1997-2#1)(2008-10#1)
The genome##22##2##(1991-6#1)(1997-2#2)(2008-10#12)(2008-5#1)(2008-7#3)(2012-3#1)(2013-7#1)(2013-8#1)
The genomes of two##2##4##(2008-10#2)
The genomes of##3##3##(2008-10#3)
The genomic DNA of##2##4##(2008-8#1)(2010-7#1)
The genomic DNA##6##3##(1994-11#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-7#1)
The genomic organization##3##3##(1992-3#1)(1993-12#1)(2012-2#1)
The genomic##22##2##(1991-9#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
The genotoxic effect of##2##4##(1992-5#1)(1996-2#1)
The genotoxicity##2##2##(1997-4#1)(2008-11#1)
The genotype and##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
The genotype frequencies of A/A##2##5##(2011-1#2)
The genotype##11##2##(1990-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#3)(2012-2#1)(2013-1#1)
The genotypes##5##2##(2008-10#1)(2008-12#1)(2011-1#2)(2012-12#1)
The genotypic##3##2##(1990-3#1)(2008-10#2)
The genus##18##2##(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-10#2)(2010-3#1)(2011-2#5)(2013-7#1)
The geographic##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
The geography of##2##3##(1996-6#1)(2008-7#1)
The geometrical##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
The geometries##2##2##(1997-6#1)(2013-8#1)
The geometry of the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
The geometry of##4##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
The geometry##6##2##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)
The germination and##2##3##(2008-10#1)(2011-2#1)
The germination##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
The ghost##2##2##(2007-12#1)(2008-9#1)
The giant panda##3##3##(2008-8#1)(2008-9#2)
The giant##4##2##(2007-7#1)(2008-8#1)(2008-9#2)
The girl##2##2##(2007-7#1)(2008-10#1)
The girls##2##2##(1996-6#1)(2008-11#1)
The given##2##2##(2008-3#2)
The gland cell cytoplasm##2##4##(2007-12#2)
The gland##3##2##(2007-12#3)
The glass##5##2##(2008-10#4)(2008-5#1)
The global analysis of##2##4##(2008-7#1)(2008-9#1)
The global##20##2##(1990-12#1)(1991-12#1)(1993-9#1)(1994-5#1)(1996-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-7#1)(2013-7#1)
The globalization of##2##3##(1996-12#1)(2008-7#1)
The gloves are off##2##4##(2008-4#2)
The glucose biosensor##2##3##(2008-10#2)
The glucose content in##2##4##(2008-10#2)
The glucose##15##2##(1991-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
The glue##2##2##(2010-2#1)(2012-2#1)
The glutamine##2##2##(1991-12#1)(2008-11#1)
The glycemic index##2##3##(2008-1#2)
The glycosylation##3##2##(1992-12#1)(2008-11#1)(2008-7#1)
The goal is to##4##4##(1995-3#1)(2007-12#1)(2008-8#1)(2012-1#1)
The goal of our##4##4##(1997-8#1)(2007-8#1)(2011-2#1)(2012-3#1)
The goal of surgical treatment is##2##6##(1993-3#1)(2007-11#1)
The goal of the present##4##5##(1993-12#1)(2008-11#1)(2011-2#1)(2012-12#1)
The goal of the study was to##2##7##(2008-7#1)(2013-1#1)
The goal of the study##3##5##(1993-3#1)(2008-7#1)(2013-1#1)
The goal of the##16##4##(1992-12#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
The goal of this article is##3##6##(2008-10#1)(2011-2#1)(2013-1#1)
The goal of this article##4##5##(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
The goal of this research was to##2##7##(2008-10#2)
The goal of this research##4##5##(1994-8#1)(2008-10#2)(2008-3#1)
The goal of this review is to##5##7##(2008-6#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-3#1)
The goal of this study is to##6##7##(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#2)(2013-8#1)
The goal of this study was to compare##2##8##(1994-2#1)(2007-8#1)
The goal of this study was to determine the##3##9##(2008-10#2)(2013-8#1)
The goal of this study was to determine##6##8##(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
The goal of this study was to develop a method##2##10##(2008-6#1)(2012-4#1)
The goal of this study was to develop an##2##9##(2008-10#1)(2013-1#1)
The goal of this study was to develop##4##8##(2008-10#1)(2008-6#1)(2012-4#1)(2013-1#1)
The goal of this study was to evaluate the##4##9##(1992-8#1)(2007-11#1)(2007-8#1)(2008-12#1)
The goal of this study was to evaluate##6##8##(1992-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-8#1)(2013-8#1)
The goal of this study was to investigate the##4##9##(1996-3#1)(2007-10#1)(2009-7#1)(2012-2#1)
The goal of this study was to##26##7##(1992-8#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#2)(2010-8#1)(2011-1#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#2)
The goal of this study##32##5##(1992-8#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#3)
The goal of this unit is to provide##2##8##(2008-4#1)(2008-9#1)
The goal of this unit is to##4##7##(2008-4#3)(2008-9#1)
The goal of this work was to##2##7##(2008-10#1)(2008-11#1)
The goal of this work##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
The goal of this##67##4##(1992-8#1)(1994-2#1)(1994-8#1)(1996-3#2)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#5)(2012-4#1)(2013-1#4)(2013-8#3)
The goal of##107##3##(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#10)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#6)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#6)(2013-8#3)
The goal should be##2##4##(1993-12#1)(2011-2#1)
The goal was to##3##4##(1996-12#1)(2008-2#1)(2012-3#1)
The goal##118##2##(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#4)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#5)(2012-4#1)(2013-1#6)(2013-8#3)
The goals are to##2##4##(1993-1#1)(2008-10#1)
The goals of our##3##4##(2008-3#1)(2012-3#1)(2013-1#1)
The goals of the##9##4##(1991-12#1)(1996-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
The goals of this##3##4##(2007-5#1)(2008-10#1)(2008-11#1)
The goals of##22##3##(1991-12#1)(1995-3#1)(1996-1#1)(2007-12#4)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The goals##24##2##(1991-12#1)(1993-1#1)(1995-3#1)(1996-1#1)(2007-12#4)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The gold##3##2##(2008-10#2)(2013-7#1)
The gonads##2##2##(2008-11#2)
The good agreement between##3##4##(2007-11#1)(2008-10#1)(2010-2#1)
The good agreement##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-2#1)
The good##18##2##(1990-9#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-7#1)(2010-2#1)(2012-3#1)(2013-8#1)
The governing##2##2##(2008-6#1)(2010-10#1)
The government is##2##3##(1997-6#2)
The government of##2##3##(2008-10#1)(2008-7#1)
The government##6##2##(1992-2#1)(1997-6#2)(2008-10#1)(2008-7#1)(2009-10#1)
The government's##3##2##(1991-3#1)(2008-11#2)
The grade of##2##3##(2010-12#1)(2013-8#1)
The grade##3##2##(2010-12#1)(2012-2#1)(2013-8#1)
The gradient##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
The gradual##6##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)
The graduate##2##2##(2008-11#1)(2012-3#1)
The graft##2##2##(2007-7#1)(2008-6#1)
The grafted##3##2##(2008-10#2)(2012-12#1)
The grafts##2##2##(2007-8#1)(2008-1#1)
The graphical##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
The graphite paste is impregnated with##2##6##(2008-10#2)
The graphite##4##2##(2008-10#4)
The grating##13##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#10)
The gratings are##3##3##(2007-11#1)(2008-3#2)
The gratings##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
The gravimetric##2##2##(1994-3#2)
The graying of##2##3##(1991-5#1)(2008-4#1)
The great majority of##3##4##(1991-6#1)(1995-12#1)(2010-12#1)
The great majority##5##3##(1991-6#1)(1995-12#1)(2008-10#2)(2010-12#1)
The great##15##2##(1990-6#1)(1991-6#1)(1992-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
The greater##10##2##(1990-9#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-1#1)(1997-6#1)(2006-8#1)(2008-4#1)(2012-2#2)
The greatest decrease##2##3##(1995-9#1)(2008-10#1)
The greatest difference##2##3##(2008-10#1)(2008-3#1)
The greatest genetic distance##2##4##(2008-10#2)
The greatest number of##2##4##(2011-1#1)(2012-12#1)
The greatest##33##2##(1990-2#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-9#1)(2007-10#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
The green alga##2##3##(1994-11#1)(2010-10#1)
The green fluorescent protein (GFP)##2##5##(1996-6#1)(2008-8#1)
The green##7##2##(1994-11#1)(1996-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)
The greenhouse seedling##2##3##(2008-10#2)
The greenhouse##3##2##(1991-6#1)(2008-10#2)
The gross and##2##3##(2008-5#2)
The gross##5##2##(1990-12#1)(2007-12#1)(2008-4#1)(2008-5#2)
The ground-state##2##2##(2008-3#1)(2012-2#1)
The grounded##2##2##(2007-10#1)(2013-7#1)
The group has##4##3##(1995-12#1)(2008-12#1)(2010-3#2)
The group included##2##3##(2008-1#1)(2008-9#1)
The group index##2##3##(2007-12#1)(2008-3#1)
The group of patients with##2##5##(2012-3#1)(2013-1#1)
The group of patients##3##4##(1996-9#1)(2012-3#1)(2013-1#1)
The group of##9##3##(1995-5#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
The group receiving##2##3##(2008-10#2)
The group##37##2##(1991-12#1)(1991-6#1)(1993-12#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#3)(2008-6#1)(2008-9#1)(2010-3#3)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
The groups were##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
The groups##9##2##(1992-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)
The growing interest in the##2##5##(2010-11#1)(2011-2#1)
The growing##11##2##(1991-3#1)(1995-1#1)(1996-12#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-8#1)
The growth and##3##3##(2008-11#1)(2008-6#1)(2009-6#1)
The growth factor##2##3##(1994-10#1)(2008-8#1)
The growth in##2##3##(1995-3#1)(1997-1#1)
The growth increment and##2##4##(2008-9#2)
The growth inhibitory##2##3##(1996-2#1)(2008-12#1)
The growth of the##3##4##(1993-12#1)(1993-8#1)(2013-1#1)
The growth of##11##3##(1990-8#1)(1991-6#1)(1993-12#1)(1993-8#1)(1995-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2013-1#1)
The growth parameters##2##3##(2008-5#1)(2013-7#1)
The growth rate of cells##2##5##(1992-3#1)(1995-2#1)
The growth rate of##4##4##(1992-3#1)(1995-2#1)(2008-9#1)(2013-1#1)
The growth rate##8##3##(1991-11#1)(1992-3#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-9#2)(2013-1#1)
The growth##41##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#6)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
The guide##3##2##(1993-12#1)(1996-2#1)(2008-10#1)
The guidelines for##2##3##(2008-11#1)(2009-5#1)
The guidelines##7##2##(2008-11#1)(2008-7#3)(2009-5#1)(2010-3#1)(2012-2#1)
The gyrotron##2##2##(2011-1#2)
The hAT2R##2##2##(1994-11#2)
The hCNTF gene##2##3##(1991-6#2)
The haematological##3##2##(1997-6#1)(2008-5#1)(2008-7#1)
The hair##2##2##(2008-5#2)
The half-life of##3##3##(1990-7#1)(2008-10#1)(2011-2#1)
The half-life##4##2##(1990-7#1)(2008-10#2)(2011-2#1)
The half-maximal##5##2##(1990-12#1)(1992-11#1)(1994-5#1)(1994-6#1)(1995-5#1)
The hallmark of the##2##4##(2008-7#1)(2008-9#1)
The hand##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
The haplotypes##3##2##(1997-5#1)(2012-12#2)
The hardness of the##2##4##(2008-12#1)(2008-5#1)
The hardness##4##2##(2008-12#2)(2008-5#1)(2010-4#1)
The harmful##2##2##(1992-3#1)(2011-2#1)
The harmony of##2##3##(2008-5#1)(2012-3#1)
The hazards##2##2##(1995-11#1)(2013-1#1)
The head and neck##3##4##(1993-9#1)(2011-2#1)(2013-8#1)
The head##5##2##(1993-9#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
The health care environment##2##4##(1995-3#1)(1997-3#1)
The health care industry##2##4##(2008-11#2)
The health care worker shortage##2##5##(2007-3#2)
The health care##14##3##(1990-6#1)(1991-12#1)(1992-12#1)(1993-12#1)(1995-3#1)(1997-1#1)(1997-3#2)(2007-3#2)(2007-7#1)(2008-11#3)
The health maintenance organization##2##4##(1994-12#2)
The health of adult women in accra##2##7##(2013-1#2)
The health of##4##3##(1991-8#1)(2011-2#1)(2013-1#2)
The health service delivery organisations##2##5##(2010-3#2)
The health status##2##3##(1993-1#1)(1994-3#1)
The health##40##2##(1990-6#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-4#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-1#3)(1997-3#2)(1997-6#1)(2007-3#2)(2007-7#1)(2008-11#4)(2008-5#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
The healthcare##3##2##(1996-12#1)(1997-5#1)(2008-7#1)
The heart of##2##3##(1995-5#1)(2010-8#1)
The heart rate##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
The heart##10##2##(1992-2#1)(1993-2#1)(1995-5#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#2)(2013-1#1)
The heat shock response##2##4##(1994-11#1)(2008-7#1)
The heat shock##5##3##(1994-11#3)(2008-7#1)(2012-1#1)
The heat##11##2##(1994-11#3)(1995-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)
The heating##3##2##(1990-7#1)(2007-10#1)(2008-10#1)
The heavy##5##2##(1994-11#1)(1997-4#1)(2008-10#1)(2008-9#2)
The height of the##2##4##(2007-11#1)(2008-11#1)
The height of##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
The height##7##2##(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
The helical##2##2##(2009-8#1)(2011-2#1)
The helper-dependent adenovirus (HDAd) is a recently developed adenovirus-based vector with an improved safety profile and long-term transgene expression##2##19##(2008-2#1)(2008-4#1)
The hematologic##2##2##(2008-7#2)
The hematological##2##2##(1992-9#1)(2013-8#1)
The heme##4##2##(1993-8#2)(1994-9#1)(2011-2#1)
The hemodynamic##2##2##(1992-9#1)(2012-3#1)
The hemoglobin##5##2##(1994-3#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
The heparin-binding##2##2##(1992-10#1)(2008-7#1)
The hepatic uptake of##2##4##(1992-3#2)
The hepatic##7##2##(1990-2#1)(1992-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(2008-3#1)
The hepatitis B##3##3##(1995-5#1)(2012-12#1)(2013-8#1)
The hepatitis##5##2##(1995-5#2)(2012-12#1)(2013-8#2)
The herbicide##2##2##(2008-10#1)(2011-1#1)
The hereditary##2##2##(2008-10#1)(2009-12#1)
The heritability of##3##3##(1997-7#1)(2008-10#2)
The heterogeneity of##6##3##(1995-11#1)(1995-6#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
The heterogeneity##7##2##(1995-11#1)(1995-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
The heterologous##2##2##(1993-9#1)(2008-10#1)
The heteropoly##2##2##(2008-10#2)
The hexapeptide##2##2##(2008-10#1)(2008-5#1)
The hh##2##2##(1993-2#2)
The hierarchical##3##2##(2008-10#2)(2009-7#1)
The hierarchy of##2##3##(2008-11#1)(2012-12#1)
The high affinity##4##3##(1991-2#2)(2008-1#1)(2008-10#1)
The high conservation of##2##4##(1992-8#1)(2013-8#1)
The high cost##2##3##(2007-2#1)(2013-1#1)
The high degree of conservation of##2##6##(1990-2#1)(1993-12#1)
The high degree of##3##4##(1990-2#1)(1993-12#1)(2007-12#1)
The high diversity of##2##4##(2010-3#1)(2010-8#1)
The high efficiency of##2##4##(2008-3#1)(2008-7#1)
The high frequency of##2##4##(1994-11#1)(1997-9#1)
The high incidence of##3##4##(2010-12#1)(2010-8#1)(2011-2#1)
The high initial##2##3##(2008-10#2)
The high level of##4##4##(1997-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
The high levels of##2##4##(2008-12#1)(2008-8#1)
The high number of##3##4##(2008-12#1)(2012-3#1)(2013-7#1)
The high prevalence of##3##4##(1992-8#1)(2008-4#1)(2012-12#1)
The high prevalence##4##3##(1992-8#1)(2008-4#1)(2010-1#1)(2012-12#1)
The high rate of##4##4##(1993-3#1)(2008-11#1)(2008-3#1)(2013-1#1)
The high resolution##2##3##(1993-12#1)(2008-3#1)
The high retention##2##3##(2008-10#1)(2008-12#1)
The high selectivity##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
The high sensitivity of the##2##5##(2008-10#1)(2008-3#1)
The high sensitivity of##3##4##(2008-10#1)(2008-3#1)(2010-1#1)
The high sensitivity that can be attained using an enzymatic system and mediated by##3##14##(2008-10#3)
The high sensitivity##8##3##(1996-2#1)(2008-10#5)(2008-3#1)(2010-1#1)
The high success rate##2##4##(1995-11#1)(2009-7#1)
The high values for the##2##5##(2008-10#1)(2013-1#1)
The high values##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
The high vapour pressure of##2##5##(2008-5#2)
The high##123##2##(1990-11#1)(1990-2#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-3#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-5#1)(1997-9#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#5)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#7)(2013-7#1)(2013-8#1)
The high-performance##2##2##(1991-5#1)(2008-10#1)
The high-resolution##3##2##(1997-7#1)(2008-10#1)(2009-10#1)
The high-risk##2##2##(1992-3#1)(2009-8#1)
The higher the##6##3##(1991-2#1)(1991-5#1)(2008-10#2)(2013-8#2)
The higher##33##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-8#1)(1995-11#1)(2007-10#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
The highest activity##2##3##(1994-7#1)(2008-12#1)
The highest concentration of##4##4##(1990-3#1)(2008-11#1)(2008-12#1)(2012-1#1)
The highest concentration##5##3##(1990-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-1#1)
The highest concentrations of##2##4##(1994-9#1)(2009-5#1)
The highest concentrations##3##3##(1994-9#1)(2009-5#1)(2013-1#1)
The highest content of##2##4##(2008-5#2)
The highest densities##2##3##(1994-2#1)(2011-2#1)
The highest dose##3##3##(1992-10#1)(2008-10#1)(2008-12#1)
The highest incidence of##3##4##(2008-11#2)(2013-1#1)
The highest increase in##2##4##(2008-12#1)(2008-3#1)
The highest level of##2##4##(1997-4#1)(2008-5#1)
The highest levels of##2##4##(1994-7#1)(2008-10#1)
The highest levels##3##3##(1994-7#1)(2008-10#1)(2009-3#1)
The highest maximum##2##3##(2008-12#2)
The highest mean##4##3##(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
The highest number of##3##4##(2008-12#1)(2010-12#1)(2011-1#1)
The highest numbers of##2##4##(1996-12#1)(2008-10#1)
The highest percentage of##3##4##(1994-11#1)(2007-10#1)(2008-6#1)
The highest prevalence##2##3##(1996-7#1)(2013-8#1)
The highest production of##4##4##(2008-11#3)(2008-8#1)
The highest response for##3##4##(2008-10#3)
The highest risk of##2##4##(2008-7#1)(2012-3#1)
The highest sensitivity was obtained##2##5##(2008-10#2)
The highest sensitivity was##3##4##(2008-10#3)
The highest sensitivity##5##3##(2008-10#5)
The highest sensitization to##2##4##(2013-1#2)
The highest value##2##3##(2008-3#1)(2008-7#1)
The highest values##2##3##(2008-5#1)(2008-7#1)
The highest##131##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-4#1)(1992-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#25)(2008-11#8)(2008-12#12)(2008-3#6)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#3)
The highly sensitive##2##3##(2008-10#2)
The highly##17##2##(1990-5#1)(1993-12#1)(1994-2#1)(1995-5#1)(2006-12#1)(2008-1#1)(2008-10#7)(2008-2#1)(2009-11#1)(2009-7#1)(2012-3#1)
The hip##2##2##(2011-2#1)(2013-8#1)
The histologic and##2##3##(2006-12#1)(2009-3#1)
The histologic features of##2##4##(1994-12#1)(2008-1#1)
The histologic response##2##3##(1990-12#1)(1992-6#1)
The histologic##10##2##(1990-12#1)(1991-8#2)(1992-6#1)(1994-12#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-3#1)(2013-7#1)
The histological and ultrastructural features of##2##6##(2008-5#1)(2008-7#1)
The histological and##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
The histological diagnosis was##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
The histological diagnosis##4##3##(2008-7#2)(2011-2#1)(2013-1#1)
The histological##14##2##(1997-3#1)(1997-6#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#3)(2011-2#2)(2012-2#1)(2013-1#2)
The histology##2##2##(2009-12#1)(2009-7#1)
The histopathologic findings showed##2##4##(2010-6#2)
The histopathologic findings##3##3##(1995-3#1)(2010-6#2)
The histopathologic study showed##2##4##(2008-5#1)(2010-6#1)
The histopathologic##8##2##(1995-3#1)(2008-10#1)(2008-5#1)(2010-6#4)(2013-8#1)
The histopathological diagnosis##3##3##(2008-10#1)(2009-5#1)(2009-8#1)
The histopathological study revealed##2##4##(2008-10#1)(2008-7#1)
The histopathological##9##2##(1996-12#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)
The histopathology of##2##3##(2012-1#1)(2012-3#1)
The histopathology##4##2##(2008-1#2)(2012-1#1)(2012-3#1)
The historical##5##2##(1991-3#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-6#1)
The history and##2##3##(1991-5#1)(2009-6#1)
The history of the##5##4##(1992-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
The history of##19##3##(1990-9#1)(1992-2#1)(1993-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
The history##24##2##(1990-9#1)(1991-5#1)(1992-2#1)(1993-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#1)
The hit-miss transform##2##3##(2008-3#2)
The hollow##2##2##(2008-11#1)(2008-3#1)
The holograms##3##2##(2007-11#1)(2008-3#2)
The holographic##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
The home##3##2##(1991-3#1)(1995-3#1)(2010-10#1)
The homeless##2##2##(1992-2#1)(2008-4#1)
The homeopathic##2##2##(2008-10#2)
The homocysteine##2##2##(2007-10#1)(2008-10#1)
The homogeneity##3##2##(2008-10#2)(2013-1#1)
The homogeneous##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
The homogenized##2##2##(2008-2#1)(2009-7#1)
The homologies of##2##3##(1996-10#1)(2008-6#1)
The homologous##3##2##(1990-5#1)(1993-6#1)(2008-9#1)
The homozygous##2##2##(2008-10#1)(2008-6#1)
The hope is that this will##2##6##(2008-12#1)(2013-8#1)
The horizontal##4##2##(1990-11#1)(1993-3#1)(2008-5#1)(2012-12#1)
The hormonal##3##2##(1993-2#1)(2008-1#1)(2008-4#1)
The hormone##3##2##(1992-9#1)(1997-7#1)(2008-3#1)
The horse##2##2##(2009-1#1)(2013-8#1)
The hospital##13##2##(1991-12#1)(1991-7#1)(1992-12#1)(1992-2#1)(1994-1#2)(1994-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2010-11#1)(2011-1#1)
The hospitals##3##2##(1991-9#1)(1995-1#1)(2008-5#1)
The host range of the virus##2##6##(2008-10#2)
The host range of the##3##5##(2008-10#3)
The host range of##5##4##(2008-10#5)
The host range##7##3##(2008-10#6)(2008-11#1)
The host##12##2##(1996-2#1)(2008-10#9)(2008-11#1)(2008-8#1)
The hot##3##2##(2008-11#2)(2009-5#1)
The household##3##2##(1994-2#1)(2008-1#1)(2011-2#1)
The hoxG gene##2##3##(1990-11#2)
The hoxK##2##2##(1990-11#2)
The human MUC2##2##3##(1992-11#2)
The human immunodeficiency virus (HIV)##2##5##(1992-6#1)(2007-7#1)
The human##63##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-10#1)(1992-11#3)(1992-2#1)(1992-6#1)(1992-9#2)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#3)(1995-6#1)(1997-3#2)(1997-5#1)(1997-7#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-9#5)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
The humerus##2##2##(2007-11#2)
The humoral and cellular immune##2##5##(1991-12#2)
The humoral##3##2##(1991-12#2)(2008-5#1)
The hybrid##11##2##(1993-8#1)(2008-10#2)(2008-3#6)(2008-5#1)(2010-4#1)
The hybridization##2##2##(1993-12#1)(2008-10#1)
The hybridoma##2##2##(2008-11#2)
The hybrids had##2##3##(2008-5#2)
The hybrids##3##2##(2008-11#1)(2008-5#2)
The hydration##3##2##(1992-8#1)(1995-11#1)(2008-5#1)
The hydride generated in a##2##5##(2008-10#2)
The hydride generated is collected in a liquid nitrogen cryogenic trap##2##11##(2008-10#2)
The hydride generated##4##3##(2008-10#4)
The hydride generation##2##3##(2008-10#2)
The hydride##7##2##(2008-10#7)
The hydroalcoholic extract##2##3##(2010-3#1)(2010-5#1)
The hydroalcoholic##3##2##(2008-5#1)(2010-3#1)(2010-5#1)
The hydrodynamic##3##2##(2008-10#2)(2008-3#1)
The hydrogel membrane was##2##4##(2008-5#2)
The hydrogel##6##2##(2008-5#6)
The hydrogen exchange mass spectrometry data##2##6##(2012-1#2)
The hydrogen peroxide##6##3##(2008-10#6)
The hydrogen##11##2##(1990-5#1)(2008-10#8)(2012-1#2)
The hydrolysis of the##3##4##(1991-9#1)(1996-12#1)(2008-10#1)
The hydrolysis of##6##3##(1991-9#1)(1995-3#1)(1996-12#1)(2008-10#3)
The hydrolysis rate of CMC##2##5##(2008-10#2)
The hydrolysis##9##2##(1991-9#1)(1995-3#1)(1996-12#1)(2008-10#6)
The hydropathy##3##2##(1993-3#1)(1995-6#1)(1997-2#1)
The hydrophilic##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
The hydrophobic##2##2##(2008-10#1)(2010-8#1)
The hydroxyl group##2##3##(1991-5#1)(2011-3#1)
The hydroxyl##4##2##(1991-5#1)(2008-3#1)(2008-4#1)(2011-3#1)
The hydroxyl-terminated##2##2##(2008-10#1)(2011-1#1)
The hypertensive##2##2##(1993-11#1)(2013-8#1)
The hypothesis of##4##3##(1993-9#1)(2008-10#2)(2011-2#1)
The hypothesis tested in this##2##5##(1995-3#1)(2013-1#1)
The hypothesis that a##3##4##(1990-7#1)(1997-4#1)(2008-10#1)
The hypothesis that the##2##4##(2008-5#1)(2010-1#1)
The hypothesis that##15##3##(1990-7#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-1#1)(2012-2#1)
The hypothesis was tested##2##4##(1994-8#1)(2008-11#1)
The hypothesis was that##2##4##(2009-11#1)(2012-12#1)
The hypothesis was##5##3##(1994-8#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-12#1)
The hypothesis##30##2##(1990-7#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
The i##2##2##(1992-12#1)(1994-8#1)
The ibotenate##2##2##(1992-10#2)
The ice##2##2##(2008-2#2)
The idea is to##2##4##(2010-5#2)
The idea of##6##3##(1992-11#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#2)
The idea that##2##3##(2008-7#1)(2008-8#1)
The idea##10##2##(1992-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#2)(2011-1#1)(2011-2#2)
The ideal approach##2##3##(1993-12#1)(2008-10#1)
The ideal##12##2##(1991-12#1)(1993-11#1)(1993-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
The identification and characterization of##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
The identification and##11##3##(1990-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2013-8#1)
The identification of NO##2##4##(1994-6#1)(2011-2#1)
The identification of a##4##4##(1991-6#1)(1995-8#1)(2008-10#2)
The identification of the##7##4##(1995-6#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
The identification of these##2##4##(1993-12#1)(1993-6#1)
The identification of##35##3##(1990-11#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
The identification##48##2##(1990-11#1)(1990-5#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
The identified pigments were##2##4##(2008-10#2)
The identified##8##2##(1991-12#1)(1996-12#1)(2007-8#1)(2008-10#4)(2013-7#1)
The identities of the##3##4##(1994-12#1)(2008-10#2)
The identities of##4##3##(1994-12#1)(2007-12#1)(2008-10#2)
The identity of the##5##4##(1990-5#1)(1992-9#1)(1993-6#1)(1994-5#1)(2011-1#1)
The identity of##13##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-2#2)(2008-10#2)(2011-1#1)(2011-2#1)
The identity##14##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-2#2)(2008-10#3)(2011-1#1)(2011-2#1)
The image is##2##3##(2008-3#2)
The image quality is##2##4##(2008-3#2)
The image quality##5##3##(2007-9#1)(2008-3#3)(2008-7#1)
The image##23##2##(1995-6#1)(2007-9#1)(2008-2#3)(2008-3#13)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)
The imager##2##2##(2008-2#1)(2008-3#1)
The images clearly##2##3##(2008-2#1)(2008-3#1)
The images of##2##3##(2008-10#1)(2008-9#1)
The images were##4##3##(2008-12#2)(2008-3#1)(2013-1#1)
The images##12##2##(1997-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2013-1#1)
The imaging of##2##3##(2008-7#1)(2008-8#1)
The imaging properties##2##3##(2007-11#1)(2008-3#1)
The imaging system##2##3##(2008-3#1)(2010-5#1)
The imaging##14##2##(1991-2#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)
The immature##2##2##(1996-5#1)(2012-2#1)
The immediate##11##2##(1991-6#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)
The immersion##2##2##(1995-3#1)(2008-3#1)
The immobilization of the##2##4##(2008-10#1)(2008-2#1)
The immobilization of##6##3##(2008-10#4)(2008-2#1)(2008-7#1)
The immobilization procedure##2##3##(2008-10#2)
The immobilization##9##2##(2008-10#7)(2008-2#1)(2008-7#1)
The immobilized##7##2##(1994-11#1)(1997-2#1)(2008-10#4)(2008-7#1)
The immune reconstitution inflammatory syndrome (IRIS)##2##6##(2009-7#1)(2012-2#1)
The immune response##3##3##(1995-12#1)(1996-3#1)(2006-10#1)
The immune system##2##3##(2010-3#1)(2011-1#1)
The immune##10##2##(1995-12#2)(1996-3#1)(1997-9#1)(2006-10#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
The immunoassay was based on##2##5##(2008-10#2)
The immunoassay was##3##3##(2008-10#3)
The immunoassay##8##2##(1994-2#1)(2008-10#6)(2008-5#1)
The immunochemical##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
The immunoconjugate##2##2##(1997-7#2)
The immunogenicity and protective efficacy of##2##6##(1995-12#1)(2008-3#1)
The immunogenicity and##3##3##(1995-12#2)(2008-3#1)
The immunogenicity of##2##3##(2007-11#2)
The immunogenicity##5##2##(1995-12#2)(2007-11#2)(2008-3#1)
The immunoglobulin production-stimulating##2##3##(2008-11#2)
The immunoglobulin##3##2##(2008-11#3)
The immunohistochemical##6##2##(1991-8#1)(1994-7#1)(2006-6#1)(2008-11#1)(2008-6#1)(2012-3#1)
The immunologic markers##2##3##(2013-1#2)
The immunologic##4##2##(1990-2#2)(2013-1#2)
The immunological and##2##3##(1992-6#1)(2007-7#1)
The immunological##4##2##(1992-6#1)(2007-7#2)(2009-5#1)
The immunoreactive##2##2##(1993-12#1)(1994-6#1)
The immunoreactivity of the antibody in the##3##7##(2008-7#3)
The immunoreactivity of##4##3##(1993-11#1)(2008-7#3)
The immunoreactivity##5##2##(1993-11#1)(1996-5#1)(2008-7#3)
The immunosensor can be##2##4##(2008-10#2)
The immunosensor has##2##3##(2008-10#2)
The immunosensor##7##2##(2008-10#7)
The immunosuppressive activity of##2##4##(1991-1#2)
The immunosuppressive##5##2##(1990-12#1)(1991-1#2)(2008-10#1)(2011-3#1)
The impact and##2##3##(2011-1#1)(2011-2#1)
The impact of Medicaid##2##4##(1994-1#1)(1995-12#1)
The impact of a##2##4##(1991-2#1)(2008-11#1)
The impact of clinical biochemistry on##2##6##(1994-12#2)
The impact of cost containment##2##5##(1991-3#2)
The impact of health care##2##5##(1995-12#1)(2007-12#1)
The impact of health##3##4##(1995-12#1)(2007-12#1)(2013-1#1)
The impact of managed care on##3##6##(1992-3#1)(1994-3#1)(1997-1#1)
The impact of managed care##4##5##(1992-3#1)(1994-3#1)(1995-2#1)(1997-1#1)
The impact of managed##5##4##(1992-3#1)(1994-3#2)(1995-2#1)(1997-1#1)
The impact of patient##2##4##(1996-3#1)(2013-1#1)
The impact of poverty on##2##5##(2008-11#2)
The impact of state##2##4##(1993-1#1)(1994-2#1)
The impact of the##11##4##(1991-12#1)(1993-1#1)(1995-1#1)(1995-3#1)(2007-10#1)(2008-11#2)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#1)
The impact of these##2##4##(1992-1#1)(2012-12#1)
The impact of##105##3##(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#4)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#12)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-11#3)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#2)
The impact##112##2##(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#5)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#13)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#3)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#2)
The impairment of##3##3##(1995-12#1)(2008-7#1)(2008-8#1)
The impairment##5##2##(1993-12#1)(1995-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
The impending##2##2##(2008-10#1)(2008-7#1)
The imperative to##2##3##(2013-1#2)
The impetus##2##2##(1996-2#1)(2008-7#1)
The implant was##2##3##(2008-9#1)(2009-7#1)
The implant##3##2##(2008-1#1)(2008-9#1)(2009-7#1)
The implantation of##3##3##(1993-8#1)(2011-2#2)
The implementation of a##4##4##(2008-10#1)(2008-3#2)(2010-7#1)
The implementation of the##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
The implementation of##18##3##(1995-2#1)(2008-10#3)(2008-2#1)(2008-3#6)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
The implementation##23##2##(1995-2#1)(2008-10#4)(2008-2#2)(2008-3#7)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
The implemented##2##2##(2007-12#1)(2012-2#1)
The implication is that##3##4##(1993-2#1)(1993-9#1)(2008-10#1)
The implication of##4##3##(1995-11#1)(2008-12#1)(2008-3#1)(2009-8#1)
The implication##7##2##(1993-2#1)(1993-9#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)
The implications for##11##3##(1990-7#1)(1991-3#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-2#1)
The implications of our results are discussed in##2##8##(1997-8#1)(2008-2#1)
The implications of the results for##4##6##(1993-12#1)(2008-6#1)(2009-7#1)(2011-2#1)
The implications of the results##5##5##(1993-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2011-2#1)
The implications of the##11##4##(1993-11#1)(1993-12#1)(1996-2#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
The implications of these findings are discussed##5##7##(1991-2#1)(1993-1#1)(1994-2#1)(2010-9#1)(2012-1#1)
The implications of these findings for##5##6##(1992-3#1)(2008-10#1)(2009-7#1)(2012-1#1)(2012-2#1)
The implications of these findings in##2##6##(1996-3#1)(2008-10#1)
The implications of these findings##17##5##(1991-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1996-3#1)(2008-10#3)(2008-11#3)(2009-7#1)(2010-1#1)(2010-9#1)(2012-1#2)(2012-2#1)
The implications of these observations for##3##6##(2008-10#1)(2009-9#1)(2010-9#1)
The implications of these observations##4##5##(2008-10#1)(2008-8#1)(2009-9#1)(2010-9#1)
The implications of these results for##5##6##(1991-5#1)(2007-12#1)(2008-10#2)(2008-8#1)
The implications of these results##8##5##(1991-5#2)(1993-12#1)(2007-12#1)(2008-10#3)(2008-8#1)
The implications of these##33##4##(1991-2#1)(1991-5#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1996-3#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-8#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-9#2)(2012-1#2)(2012-2#1)
The implications of this##7##4##(1993-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-11#1)
The implications of##65##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
The implications##80##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#4)(2007-7#1)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
The importance and##3##3##(2008-1#1)(2008-12#1)(2011-1#1)
The importance is stressed of##2##5##(1991-2#1)(1992-6#1)
The importance of a##2##4##(2007-11#1)(2012-12#1)
The importance of an##2##4##(1991-11#1)(1992-2#1)
The importance of collaboration##2##4##(1993-3#1)(2008-11#1)
The importance of involving family members in the care of individuals with schizophrenia or other psychotic illnesses has received increasing attention within psychiatric healthcare services##2##25##(2011-2#2)
The importance of involving##3##4##(1997-7#1)(2011-2#2)
The importance of patient##2##4##(1993-11#1)(2008-7#1)
The importance of the laboratory##2##5##(2008-10#2)
The importance of the##15##4##(1991-6#1)(1992-3#1)(1993-8#1)(1997-1#1)(2007-11#2)(2007-5#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)
The importance of these##3##4##(1995-1#1)(2008-10#1)(2013-8#1)
The importance of this##3##4##(1995-12#1)(2011-2#1)(2013-1#1)
The importance of##112##3##(1990-2#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#4)(2012-4#1)(2013-1#4)(2013-8#3)
The importance to##2##3##(2008-10#1)(2013-8#1)
The importance##119##2##(1990-2#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#4)(2012-4#1)(2013-1#4)(2013-8#4)
The important question##2##3##(1996-6#1)(2007-12#1)
The important role of##2##4##(2007-12#1)(2010-11#1)
The important role##4##3##(2007-12#1)(2008-12#1)(2008-9#1)(2010-11#1)
The important##13##2##(1990-6#1)(1996-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)
The impossible##2##2##(1997-1#1)(2008-8#1)
The imprecision of##2##3##(1992-3#1)(2008-10#1)
The imprecision##3##2##(1992-3#1)(2008-10#2)
The imprinted##2##2##(2008-10#1)(2008-7#1)
The improved CRP method##2##4##(2008-10#2)
The improved Sellmeier equations##2##4##(2008-2#2)
The improved method##2##3##(2008-10#2)
The improved stability##2##3##(1994-12#1)(1994-8#1)
The improved##22##2##(1991-5#1)(1994-12#2)(1994-8#1)(2007-11#1)(2008-10#7)(2008-2#3)(2008-3#4)(2011-2#3)
The improvement in##11##3##(1995-6#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-1#1)
The improvement is##2##3##(2007-11#1)(2008-2#1)
The improvement of the##2##4##(1995-2#1)(2009-7#1)
The improvement of##7##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-7#1)(2011-2#2)
The improvement##21##2##(1995-2#1)(1995-6#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-7#1)(2011-2#2)(2013-1#1)
The improvements##2##2##(2008-1#1)(2008-3#1)
The in situ##7##3##(2006-4#1)(2008-10#3)(2008-3#1)(2010-5#1)(2013-8#1)
The in vitro effects of##2##5##(1995-12#1)(1997-4#1)
The in vitro studies##2##4##(1997-8#1)(2009-12#1)
The in vitro system##2##4##(1991-9#1)(2008-10#1)
The in vitro##33##3##(1990-3#1)(1990-6#1)(1991-9#2)(1993-6#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#4)(2008-9#1)(2009-12#2)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
The in vivo##15##3##(1990-5#1)(1991-10#1)(1992-12#1)(1992-8#1)(1995-9#1)(2008-4#2)(2008-5#2)(2008-9#3)(2009-11#1)(2012-2#2)
The in##57##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-9#4)(2009-11#1)(2009-12#2)(2010-5#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#1)(2013-8#1)
The in-plane##2##2##(2008-3#1)(2009-6#1)
The inability to##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
The inability##4##2##(1994-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
The inactivation of##4##3##(1992-8#1)(1995-12#1)(2008-3#1)(2008-7#1)
The inactivation##7##2##(1992-6#1)(1992-8#1)(1995-12#1)(1996-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
The inactive##2##2##(1992-4#1)(1992-8#1)
The incidence and prevalence of##3##5##(2007-12#1)(2007-7#2)
The incidence and##5##3##(2007-12#1)(2007-7#2)(2008-6#1)(2013-1#1)
The incidence density of##2##4##(2008-11#1)(2011-1#1)
The incidence in##2##3##(2011-2#1)(2012-3#1)
The incidence is##2##3##(2012-1#1)(2013-1#1)
The incidence of V (Rh10)##2##5##(1994-12#2)
The incidence of acute##2##4##(1994-6#1)(2012-12#1)
The incidence of brown stem rot was##2##7##(2008-10#2)
The incidence of complications was##2##5##(1991-8#1)(2008-9#1)
The incidence of complications##4##4##(1991-8#1)(2008-1#1)(2008-9#2)
The incidence of congenital##2##4##(1990-9#1)(2011-1#1)
The incidence of different##2##4##(2008-10#1)(2008-3#1)
The incidence of hepatocellular carcinoma (HCC)##2##6##(2006-10#1)(2013-7#1)
The incidence of injuries##2##4##(1992-6#1)(2007-8#1)
The incidence of latent##2##4##(2008-10#2)
The incidence of malignant##2##4##(1995-2#1)(2010-12#1)
The incidence of melanoma##2##4##(2011-2#2)
The incidence of obesity##2##4##(2008-10#1)(2009-11#1)
The incidence of peritonitis##2##4##(1992-5#1)(2011-2#1)
The incidence of this##2##4##(1990-6#1)(1991-3#1)
The incidence of##130##3##(1990-3#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#4)(2007-7#4)(2007-8#6)(2008-1#5)(2008-10#15)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
The incidence rate of##2##4##(2007-12#1)(2012-2#1)
The incidence rates##2##3##(2010-3#2)
The incidence was##3##3##(1991-8#1)(2007-7#1)(2012-3#1)
The incidence##157##2##(1990-3#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#6)(2007-7#7)(2007-8#6)(2008-1#6)(2008-10#16)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#3)(2011-1#5)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#1)
The incidences and/or severities of##2##5##(2008-9#2)
The incidences and/or##3##3##(2008-9#3)
The incidences of hepatocyte fatty change in all##2##8##(2008-9#2)
The incidences of hepatocyte fatty change in##3##7##(2008-9#3)
The incidences of hepatocyte fatty change##4##6##(2008-9#4)
The incidences of hepatocyte##5##4##(2008-9#5)
The incidences of renal tubule##3##5##(2008-9#3)
The incidences of##19##3##(1997-7#1)(2008-8#1)(2008-9#15)(2012-1#1)(2012-3#1)
The incidences##23##2##(1997-7#1)(2008-8#1)(2008-9#19)(2012-1#1)(2012-3#1)
The incident##4##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
The included##2##2##(2011-2#2)
The inclusion criteria were##3##4##(1996-11#1)(2010-10#1)(2013-1#1)
The inclusion criterion was##2##4##(2010-8#1)(2013-8#1)
The inclusion of a##2##4##(2008-10#1)(2008-3#1)
The inclusion of the##2##4##(2007-11#1)(2013-8#1)
The inclusion of these##2##4##(1992-9#1)(2008-8#1)
The inclusion of##9##3##(1991-6#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-4#1)(2013-8#1)
The inclusion##18##2##(1991-6#1)(1992-9#1)(1996-11#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-8#2)(2010-10#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#2)
The incorporation of these##2##4##(1990-2#1)(2010-4#1)
The incorporation of##21##3##(1990-2#2)(1990-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-4#1)(2013-8#1)
The incorporation##22##2##(1990-2#2)(1990-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-4#1)(2013-8#1)
The increase in Na+/K(+)-ATPase activity##2##5##(1994-6#2)
The increase in the##11##4##(1991-4#1)(1992-8#1)(1994-6#1)(1997-2#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-3#1)(2009-6#1)
The increase in##50##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-6#4)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-8#1)
The increase of the##3##4##(2008-2#1)(2008-5#1)(2012-2#1)
The increase of##15##3##(1992-8#2)(1993-12#2)(1994-11#1)(1995-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
The increase was##8##3##(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#2)(1997-1#1)(2008-10#1)(2008-3#1)
The increase##78##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#3)(1993-12#3)(1993-9#1)(1994-11#1)(1994-6#4)(1994-9#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
The increased activity##2##3##(1992-5#1)(1993-12#1)
The increased bioavailability of##2##4##(2012-2#2)
The increased expression of##2##4##(2013-8#2)
The increased incidence of##2##4##(1997-2#1)(2008-5#1)
The increased use of##5##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
The increased##49##2##(1990-2#1)(1991-12#2)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
The increases in##2##3##(1993-9#1)(1996-12#1)
The increasing incidence of##2##4##(1990-11#1)(1997-6#1)
The increasing number of##6##4##(2008-11#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
The increasing prevalence of##2##4##(2008-1#1)(2008-12#1)
The increasing##26##2##(1990-11#1)(1991-12#2)(1993-9#1)(1994-8#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
The incremental cost-effectiveness ratio##2##4##(2011-2#1)(2012-12#1)
The incubation of##2##3##(1990-12#1)(2008-11#1)
The incubation period##3##3##(1996-8#2)(2008-10#1)
The incubation temperature##2##3##(2008-11#1)(2011-2#1)
The incubation##10##2##(1990-12#1)(1993-11#1)(1996-8#2)(2008-10#2)(2008-11#2)(2011-2#1)(2011-3#1)
The independent variables##3##3##(2009-8#1)(2010-6#1)(2013-1#1)
The independent##8##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-6#2)(2013-1#1)
The index is##2##3##(2008-6#1)(2009-5#1)
The index of##2##3##(2008-10#2)
The index##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2009-5#1)
The indexes of##2##3##(2008-5#1)(2011-3#1)
The indexes##4##2##(1993-3#2)(2008-5#1)(2011-3#1)
The indicated##2##2##(2008-7#2)
The indication for surgical treatment##2##5##(1990-8#1)(2007-11#1)
The indication for##6##3##(1990-8#1)(1993-8#1)(2007-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
The indication##9##2##(1990-8#1)(1991-6#1)(1993-8#1)(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
The indications and##3##3##(1990-9#1)(2008-10#2)
The indications for the##2##4##(1994-3#1)(2010-6#1)
The indications for##8##3##(1990-3#1)(1991-5#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-2#1)
The indications of the##2##4##(2008-10#2)
The indications##15##2##(1990-3#1)(1990-9#1)(1991-5#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)
The indicator##4##2##(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
The indicators of##2##3##(1996-2#1)(2011-1#1)
The indicators##6##2##(1994-3#1)(1994-5#1)(1996-2#1)(2008-9#1)(2011-1#1)(2012-4#1)
The indices##2##2##(2008-11#1)(2008-6#1)
The indirect##6##2##(1990-12#1)(2008-10#3)(2009-7#1)(2010-7#1)
The individual##13##2##(1990-2#1)(1990-8#1)(1993-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-1#2)(2012-3#1)
The indoor##2##2##(1995-6#1)(2008-10#1)
The induced refractive-index##2##3##(2007-12#2)
The induced##7##2##(1992-8#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
The induction of pathogen resistance##2##5##(2008-10#2)
The induction of##26##3##(1994-11#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
The induction##30##2##(1994-11#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
The industry##2##2##(1994-3#1)(2008-11#1)
The infant##4##2##(1990-12#1)(2007-8#1)(2009-9#1)(2011-1#1)
The infants##2##2##(2010-5#2)
The infected##7##2##(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-3#1)
The infection of##7##3##(1991-2#1)(1992-12#1)(2008-10#3)(2008-11#1)(2010-10#1)
The infection rate was highest##2##5##(2008-10#2)
The infection rate##5##3##(2007-7#1)(2008-10#3)(2012-3#1)
The infection##23##2##(1991-11#1)(1991-2#1)(1992-12#1)(1997-1#1)(2007-7#2)(2008-10#11)(2008-11#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The infectivity##2##2##(2008-10#2)
The inference of##2##3##(2008-7#1)(2008-9#1)
The inferred##4##2##(1993-2#1)(2008-10#1)(2009-10#1)(2010-10#1)
The infestation##2##2##(2011-2#1)(2012-12#1)
The inflammatory##8##2##(1992-12#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
The influence exerted by##2##4##(2008-10#2)
The influence of a##6##4##(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
The influence of age on##2##5##(1990-3#1)(1995-8#1)
The influence of age##3##4##(1990-3#1)(1995-8#1)(2010-9#1)
The influence of body##2##4##(2008-7#1)(2008-8#1)
The influence of common##3##4##(2008-10#2)(2008-5#1)
The influence of complex##2##4##(2008-10#1)(2008-2#1)
The influence of diabetes on the##2##6##(2008-1#1)(2011-2#1)
The influence of different##8##4##(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)
The influence of electrolyte##2##4##(2008-10#2)
The influence of flow rates of eluent and sample solution##2##10##(2008-10#2)
The influence of foreign ions##2##5##(2008-10#2)
The influence of foreign##3##4##(2008-10#3)
The influence of moisture##2##4##(2008-10#2)
The influence of pH##2##4##(2008-10#2)
The influence of potential interfering ions was studied##2##8##(2008-10#2)
The influence of potential interfering ions##3##6##(2008-10#3)
The influence of potential interfering##4##5##(2008-10#4)
The influence of reagent##2##4##(2008-10#2)
The influence of root infection##2##5##(2008-10#2)
The influence of several##5##4##(2008-10#5)
The influence of some experimental parameters##2##6##(2008-10#2)
The influence of some##5##4##(2008-10#5)
The influence of spirituality##2##4##(2008-4#2)
The influence of temperature and##2##5##(1992-5#1)(2008-3#1)
The influence of temperature##4##4##(1992-5#1)(2008-10#1)(2008-3#2)
The influence of the plasticizer##2##5##(2008-10#2)
The influence of the##40##4##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#20)(2008-2#6)(2008-3#7)(2008-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
The influence of these##2##4##(2008-3#1)(2008-4#1)
The influence of various parameters##2##5##(2008-10#2)
The influence of various##6##4##(2008-10#6)
The influence of##256##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-3#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#106)(2008-11#6)(2008-2#13)(2008-3#23)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
The influence##259##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-3#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#108)(2008-11#6)(2008-2#13)(2008-3#23)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
The influences of pH##2##4##(2008-10#2)
The influences of the##5##4##(2008-10#4)(2008-2#1)
The influences of##16##3##(1994-9#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
The influences##17##2##(1994-9#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
The influenza##3##2##(2009-5#1)(2011-1#1)(2011-2#1)
The influx of##2##3##(1994-6#1)(1996-12#1)
The information about the##2##4##(2008-11#1)(2008-5#1)
The information about##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
The information gathered##2##3##(1996-2#1)(2008-10#1)
The information gleaned from##2##4##(2009-9#1)(2010-2#1)
The information includes##2##3##(1994-3#1)(2008-10#1)
The information is##4##3##(1995-6#1)(1996-11#1)(2008-2#1)(2011-2#1)
The information may##2##3##(1992-5#1)(2012-2#1)
The information obtained##3##3##(2008-4#1)(2011-2#1)(2012-12#1)
The information on##2##3##(1991-6#1)(2007-11#1)
The information provided##2##3##(1997-1#1)(2008-11#1)
The information was##4##3##(1992-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
The information##45##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
The informed consent##2##3##(2008-4#1)(2011-2#1)
The infrared evolved gas analysis was##2##6##(2008-10#2)
The infrared##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
The infrequent##2##2##(1991-5#1)(1995-5#1)
The inherent##7##2##(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
The inheritance of resistance to##4##5##(2008-10#4)
The inheritance of##10##3##(2008-10#9)(2008-9#1)
The inheritance##11##2##(2007-7#1)(2008-10#9)(2008-9#1)
The inhibition by##5##3##(1992-3#1)(1992-8#1)(1995-12#1)(2008-10#1)(2008-8#1)
The inhibition is##2##3##(1992-3#1)(1994-11#1)
The inhibition of the##5##4##(2006-6#1)(2008-10#2)(2009-11#1)(2009-12#1)
The inhibition of##20##3##(1990-5#1)(1990-8#1)(1991-8#1)(1992-3#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-4#1)
The inhibition was not##2##4##(1995-2#1)(2008-6#1)
The inhibition was##5##3##(1990-5#1)(1992-3#1)(1995-2#1)(2008-10#1)(2008-6#1)
The inhibition##37##2##(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#4)(1992-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-4#1)
The inhibitor##4##2##(1990-5#1)(1993-3#1)(1996-12#1)(2008-10#1)
The inhibitors##2##2##(1992-8#1)(1994-6#1)
The inhibitory action of##2##4##(1992-12#1)(1995-3#1)
The inhibitory action##3##3##(1992-12#1)(1995-3#1)(2008-10#1)
The inhibitory activity of##2##4##(2008-10#1)(2012-2#1)
The inhibitory activity##4##3##(1990-5#1)(1993-3#1)(2008-10#1)(2012-2#1)
The inhibitory effect of##13##4##(1990-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1994-8#1)(1995-11#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)
The inhibitory effect##14##3##(1990-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1994-8#1)(1995-11#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)
The inhibitory effects of##9##4##(1990-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-12#2)(2008-10#1)(2008-5#2)
The inhibitory##34##2##(1990-11#2)(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#2)(2010-5#1)(2012-2#1)
The initial agglutination rates##2##4##(1990-12#2)
The initial rate of the##2##5##(2008-10#2)
The initial rate of##3##4##(2008-10#3)
The initial rate##5##3##(2008-10#5)
The initial rates of##2##4##(1990-12#1)(1992-6#1)
The initial studies have##2##4##(1997-4#1)(2008-10#1)
The initial studies##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
The initial##63##2##(1990-12#3)(1990-3#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-6#2)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#2)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#2)
The initially##3##2##(1994-11#1)(1996-5#1)(2010-4#1)
The initiating##2##2##(2008-10#1)(2009-8#1)
The initiation of##2##3##(1992-12#1)(2012-2#1)
The initiative##3##2##(1993-3#1)(2011-2#1)(2011-9#1)
The injection of##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
The injury##4##2##(1990-6#1)(1992-6#1)(2008-10#1)(2010-1#1)
The innate immune##2##3##(2009-6#1)(2013-7#1)
The inner##6##2##(2007-12#2)(2008-10#2)(2011-2#1)(2013-1#1)
The inositol##2##2##(2008-8#1)(2010-4#1)
The input to##2##3##(2008-3#1)(2008-9#1)
The input##7##2##(1992-1#1)(2008-3#4)(2008-9#1)(2010-8#1)
The inputs to the##2##4##(2008-2#2)
The inquiry##2##2##(1991-8#1)(2010-11#1)
The ins and outs of##3##5##(2008-11#1)(2011-2#1)(2012-12#1)
The insect mushroom bodies##2##4##(2007-12#2)
The insect##3##2##(2007-12#2)(2008-9#1)
The insert##2##2##(1990-11#1)(2008-8#1)
The insertion of the##2##4##(1995-8#1)(2007-11#1)
The insertion of##6##3##(1995-8#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-8#1)(2012-3#1)
The insertion##9##2##(1990-11#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
The insights##2##2##(1992-3#1)(2012-2#1)
The inspiratory flow##2##3##(1992-3#1)(1997-2#1)
The instability of##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
The instability##4##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
The installation of##2##3##(2008-10#1)(2008-11#1)
The instantaneous baroreflex gain is estimated in the feedback loop with a point process filter##2##15##(2009-9#1)(2010-5#1)
The instantaneous##5##2##(2007-11#1)(2007-12#1)(2009-9#1)(2010-5#1)(2013-1#1)
The instrument and##2##3##(2008-3#2)
The instrument is based on##2##5##(2008-3#2)
The instrument is designed##2##4##(2008-2#1)(2008-3#1)
The instrument is##10##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-9#1)
The instrument matrix A##2##4##(2008-3#2)
The instrument was##5##3##(1993-3#1)(2008-10#2)(2008-2#2)
The instrument##36##2##(1993-2#1)(1993-3#1)(1994-3#1)(2007-11#1)(2008-10#11)(2008-2#4)(2008-3#14)(2008-9#1)(2009-12#1)(2012-2#1)
The instrumental analysis##2##3##(2008-10#1)(2008-5#1)
The instrumental##6##2##(2008-10#4)(2008-3#1)(2008-5#1)
The instrumentation has##2##3##(2008-10#1)(2008-3#1)
The instrumentation##5##2##(2008-10#4)(2008-3#1)
The instruments##7##2##(2008-11#1)(2008-3#4)(2010-11#1)(2011-2#1)
The insulin receptor##2##3##(1993-8#1)(1995-8#1)
The insulin resistance##2##3##(2012-3#1)(2013-1#1)
The insulin sensitivity##2##3##(1997-7#1)(2008-3#1)
The insulin##8##2##(1993-8#2)(1995-8#1)(1997-7#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
The insulin-like##2##2##(1990-5#1)(2008-5#1)
The insurance industry##2##3##(1992-3#1)(2008-7#1)
The insurance##4##2##(1992-3#1)(1993-3#1)(1995-1#1)(2008-7#1)
The integral##4##2##(1994-12#1)(2008-3#3)
The integrated##7##2##(1996-12#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
The integration of the##2##4##(2008-10#1)(2011-2#1)
The integration of##15##3##(1991-6#1)(1993-2#1)(1995-2#1)(1996-3#2)(1997-3#2)(2008-10#3)(2008-11#1)(2008-7#2)(2011-2#1)(2013-8#1)
The integration##16##2##(1991-6#1)(1993-2#1)(1995-2#1)(1996-3#2)(1997-3#2)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
The integrity of the##2##4##(2008-7#1)(2013-1#1)
The integrity of##6##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
The intense##2##2##(2008-11#1)(2012-2#1)
The intensities of the##2##4##(2008-10#1)(2013-8#1)
The intensities of##3##3##(2008-10#2)(2013-8#1)
The intensity and##2##3##(2008-3#2)
The intensity distribution in the##3##5##(2008-2#1)(2008-3#2)
The intensity distribution of##3##4##(2007-11#1)(2008-2#2)
The intensity distribution##7##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
The intensity of the##9##4##(1995-8#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2009-7#1)
The intensity of##21##3##(1995-8#2)(2007-10#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)(2013-1#1)
The intensity##36##2##(1995-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)(2013-1#1)
The intensive use of##2##4##(2008-10#1)(2008-3#1)
The intent is to##4##4##(1994-2#2)(2008-6#1)(2011-2#1)
The intent##5##2##(1994-2#2)(1996-2#1)(2008-6#1)(2011-2#1)
The intention of this##2##4##(2008-10#1)(2009-9#1)
The intention of##3##3##(1997-4#1)(2008-10#1)(2009-9#1)
The inter-rater reliability of##2##4##(2008-11#1)(2011-2#1)
The inter-rater reliability##4##3##(2008-11#1)(2010-10#2)(2011-2#1)
The interaction between the##4##4##(1996-5#1)(2008-10#2)(2008-8#1)
The interaction between##28##3##(1992-1#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
The interaction of cyclodextrins##2##4##(2008-10#2)
The interaction of the##7##4##(1990-2#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-8#1)
The interaction of##39##3##(1990-2#2)(1990-8#1)(1991-6#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#15)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2012-1#1)(2012-3#1)
The interaction was##2##3##(2008-10#2)
The interaction with##3##3##(1995-12#1)(1997-4#1)(2008-10#1)
The interaction##77##2##(1990-2#2)(1990-8#1)(1991-6#1)(1992-1#1)(1992-3#3)(1992-9#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
The interactions between the##2##4##(2008-10#1)(2010-12#1)
The interactions between##10##3##(2008-10#7)(2008-8#1)(2010-12#1)(2010-9#1)
The interactions of##8##3##(1990-8#1)(1991-9#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-11#1)
The interactions##21##2##(1990-8#1)(1991-9#1)(1994-5#1)(1995-5#2)(2008-10#8)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-9#1)
The intercellular##3##2##(2008-4#1)(2008-5#1)(2009-7#1)
The interconversion of##2##3##(1992-11#1)(2008-10#1)
The interdisciplinary team##2##3##(1994-12#1)(1995-5#1)
The interdisciplinary##3##2##(1994-12#1)(1995-5#1)(2009-7#1)
The interest in##3##3##(1990-5#1)(2008-7#1)(2013-1#1)
The interest of##2##3##(2008-5#1)(2013-1#1)
The interest##8##2##(1990-5#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2013-1#2)
The interface##4##2##(2007-12#1)(2008-10#2)(2009-9#1)
The interfacial##3##2##(1991-3#1)(1991-8#1)(2008-10#1)
The interfacing of##2##3##(2008-10#2)
The interference by##2##3##(2008-10#2)
The interference caused by Ca(II) and Ba(II) can be easily eliminated by prior extraction with potassium iodide-methylisobutylketone##3##17##(2008-10#3)
The interference effect##2##3##(2008-10#2)
The interference effects of##2##4##(2008-10#2)
The interference from over 50 cations##2##6##(2008-10#2)
The interference from transition and heavy metal ions was masked by##2##11##(2008-10#2)
The interference from##5##3##(2008-10#5)
The interference has##2##3##(2007-12#1)(2008-10#1)
The interference of a large number of anions and cations has been studied##2##13##(2008-10#2)
The interference of a large number of anions and cations##3##10##(2008-10#3)
The interference of the##2##4##(2008-10#2)
The interference of##18##3##(2007-11#1)(2008-1#1)(2008-10#16)
The interference pattern##2##3##(2007-11#1)(2008-2#1)
The interference##40##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#33)(2008-2#1)
The interferences from##2##3##(2008-10#2)
The interferences of some metal ions and##2##7##(2008-10#2)
The interferences of some##3##4##(2008-10#3)
The interferences of##9##3##(2008-10#9)
The interferences##11##2##(2008-10#11)
The interfering effect of##2##4##(2008-10#2)
The interfering effects of##3##4##(2008-10#3)
The interfering effects##5##3##(2008-10#5)
The interfering##9##2##(1997-2#1)(2008-10#8)
The interferometer is##3##3##(2008-3#3)
The interferometer##12##2##(2007-12#3)(2008-3#9)
The interferometric##4##2##(2007-11#2)(2008-3#2)
The intergenic##2##2##(1993-2#1)(1996-6#1)
The intermediate and##2##3##(2008-7#1)(2010-11#1)
The intermediate##11##2##(1993-11#1)(1994-6#1)(1995-5#2)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)
The intermolecular##2##2##(1995-2#1)(2012-2#1)
The internal barriers of rotation for the 209 polychlorinated biphenyls##2##10##(2008-11#2)
The internal consistency##2##3##(1996-3#1)(2007-12#1)
The internal standard##2##3##(2008-10#2)
The internal transcribed spacer (ITS)##2##5##(2008-10#2)
The internal transcribed spacer##3##4##(2008-10#3)
The internal##20##2##(1991-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-5#1)(2011-2#1)
The internalization##2##2##(1990-11#1)(2011-1#1)
The internally##3##2##(1990-11#1)(2007-11#1)(2008-10#1)
The international##4##2##(1991-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
The interplay between##8##3##(2007-11#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)
The interplay##9##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)
The interpretation of the##3##4##(1993-6#1)(1994-3#1)(2008-3#1)
The interpretation of##9##3##(1993-6#1)(1994-3#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-3#3)(2012-2#1)
The interrelationship between##2##3##(2008-12#1)(2013-1#1)
The interrelationship##3##2##(2008-12#1)(2013-1#2)
The interspecific##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
The interval between##4##3##(1992-5#1)(1994-7#1)(2007-7#1)(2008-11#1)
The interval##5##2##(1992-5#1)(1994-7#1)(2007-7#1)(2008-10#1)(2008-11#1)
The intervals##3##2##(2008-10#2)(2008-5#1)
The intervened##2##2##(2013-1#2)
The intervention was##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
The intervention##10##2##(1994-1#2)(2008-12#1)(2008-4#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
The interventional radiology in the##2##5##(2008-1#2)
The interventional radiology##3##3##(2008-1#3)
The interventional##4##2##(2008-1#3)(2008-3#1)
The interview##3##2##(1994-12#1)(2008-7#1)(2010-6#1)
The interviews focused on each measurement instrument collected##2##8##(2013-1#2)
The interviews were analysed##2##4##(2008-12#1)(2012-1#1)
The interviews were##6##3##(2008-11#1)(2008-12#1)(2010-10#1)(2012-1#1)(2013-1#2)
The interviews##9##2##(2008-11#1)(2008-12#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#4)
The intestinal##5##2##(1995-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
The intra- and inter-assay coefficients of variation were##2##8##(1990-12#1)(2008-10#1)
The intra- and inter-assay##3##4##(1990-12#1)(2008-10#1)(2011-3#1)
The intra- and##5##3##(1990-12#1)(2008-10#2)(2011-3#2)
The intra-class correlation##2##3##(2008-10#1)(2008-9#1)
The intracellular##15##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
The intraclass correlation##2##3##(2008-12#2)
The intravesical##2##2##(1993-11#1)(2008-10#1)
The intrinsic##11##2##(1990-5#1)(1992-6#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#2)
The introduction and##2##3##(1994-12#1)(2007-5#1)
The introduction of a##4##4##(2007-11#1)(2008-4#1)(2008-6#1)(2013-1#1)
The introduction of highly##2##4##(1991-5#1)(2008-3#1)
The introduction of new##2##4##(2008-7#1)(2011-2#1)
The introduction of the##6##4##(1994-6#1)(1995-6#1)(1997-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
The introduction of##41##3##(1991-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2010-3#2)(2011-2#5)(2012-2#1)(2013-1#6)
The introduction##46##2##(1991-5#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2010-3#2)(2011-2#5)(2012-2#1)(2013-1#6)
The introductory##2##2##(1992-1#1)(2011-1#1)
The intron##2##2##(1997-2#1)(2008-10#1)
The invasion##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
The inverse##2##2##(1995-2#1)(2012-12#1)
The inversion##3##2##(2008-3#3)
The inverted and##2##3##(2008-12#1)(2008-2#1)
The inverted##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
The investigated metal##2##3##(2008-10#2)
The investigated##11##2##(1996-2#1)(1997-4#1)(2008-10#6)(2011-2#1)(2012-3#1)(2013-1#1)
The investigation included##2##3##(2008-10#1)(2008-2#1)
The investigation of the##4##4##(1990-5#1)(1992-5#1)(2008-10#1)(2008-7#1)
The investigation of##12##3##(1990-5#1)(1992-5#1)(1995-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
The investigation shows that##2##4##(1993-6#1)(2007-11#1)
The investigation shows##4##3##(1993-6#1)(1995-2#1)(2007-11#1)(2007-12#1)
The investigation was##3##3##(2007-11#1)(2008-6#1)(2012-1#1)
The investigation##30##2##(1990-12#1)(1990-5#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
The investigations were carried out##2##5##(2008-5#1)(2011-2#1)
The investigations were##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
The investigations##7##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
The involvement in##2##3##(2008-10#1)(2013-7#1)
The involvement of the##3##4##(1992-6#1)(1994-2#1)(2008-12#1)
The involvement of##21##3##(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-9#1)(1994-11#2)(1994-2#1)(1997-2#2)(2008-10#2)(2008-12#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
The involvement##24##2##(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-9#1)(1994-11#2)(1994-2#1)(1997-2#2)(2008-10#3)(2008-12#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
The inward##2##2##(1996-2#1)(2008-8#1)
The ion adsorption##2##3##(2008-10#2)
The ion association##2##3##(2008-10#2)
The ion exchange##2##3##(2008-10#2)
The ion##11##2##(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)
The ion-associate##2##2##(2008-10#2)
The ion-exchange##2##2##(2008-10#2)
The ion-pair##3##2##(2008-10#3)
The ionic liquids##2##3##(2012-1#2)
The ionic product of water##2##5##(2008-10#2)
The ionic##7##2##(1995-5#1)(2008-10#3)(2012-1#2)(2012-2#1)
The ionization constants##2##3##(2008-10#1)(2008-9#1)
The ionization##3##2##(2008-10#2)(2008-9#1)
The ionophores##2##2##(2008-10#2)
The ions were##2##3##(2008-10#1)(2008-3#1)
The ions##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
The iron##4##2##(1991-6#1)(2008-10#3)
The irreversible##2##2##(1990-7#1)(2008-10#1)
The isocitrate dehydrogenase of Escherichia coli is##2##7##(1990-8#2)
The isoelectric point##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
The isoelectric##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
The isolate from##2##3##(2008-10#1)(2008-5#1)
The isolate##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
The isolated##22##2##(1990-12#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-10#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#1)
The isolates from##2##3##(2008-10#2)
The isolates were characterized by##3##5##(2008-10#3)
The isolates were characterized##4##4##(2008-10#4)
The isolates were##10##3##(2008-10#6)(2008-12#2)(2008-6#1)(2012-2#1)
The isolates##22##2##(1997-6#1)(2007-7#1)(2008-10#14)(2008-12#3)(2008-6#1)(2011-2#1)(2012-2#1)
The isolation and characterization of##2##5##(1991-9#1)(1993-5#1)
The isolation and##8##3##(1991-9#1)(1993-5#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-9#1)(2011-3#1)
The isolation of the##2##4##(2008-12#1)(2009-7#1)
The isolation of##6##3##(1991-2#1)(1995-6#1)(1996-6#1)(2008-12#1)(2008-2#1)(2009-7#1)
The isolation##16##2##(1991-2#1)(1991-9#1)(1993-5#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-3#1)
The isolator##4##2##(2008-3#4)
The isomerized C*I##2##3##(1992-6#2)
The isosmotic##2##2##(2008-5#2)
The isotherms##2##2##(1994-5#2)
The isotope##4##2##(1992-3#1)(1995-2#1)(2007-11#1)(2008-10#1)
The isotopic composition of lead##2##5##(1992-3#2)
The isotopic##4##2##(1992-3#2)(2008-10#2)
The issue is##2##3##(1991-2#1)(1996-2#1)
The issue of##7##3##(1991-12#1)(1992-12#1)(1997-7#1)(2008-11#2)(2008-7#1)(2010-11#1)
The issue##12##2##(1991-12#1)(1991-2#1)(1992-12#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#1)(2010-11#1)
The issues and##4##3##(1996-3#1)(1997-1#1)(2008-1#1)(2008-5#1)
The issues of##2##3##(1994-8#1)(2008-12#1)
The issues##9##2##(1993-12#1)(1994-8#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)
The items##2##2##(1994-9#1)(2010-2#1)
The job##3##2##(1993-1#1)(1997-1#1)(2008-11#1)
The joint##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
The journal##2##2##(1993-6#1)(2013-1#1)
The journey is##2##3##(2008-1#1)(2008-9#1)
The journey of##2##3##(2008-12#1)(2010-12#1)
The journey##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)
The judge##7##2##(1995-12#1)(1995-6#1)(1996-5#2)(1997-5#3)
The judgement##2##2##(1997-2#1)(2012-12#1)
The junctions##2##2##(1991-5#1)(1996-4#1)
The juxtaposition of##2##3##(1990-7#1)(2008-7#1)
The k##2##2##(2008-3#2)
The kappa##3##2##(1991-1#1)(1992-8#1)(2009-8#1)
The karyotype##3##2##(2008-10#1)(2008-12#1)(2010-3#1)
The kcat##3##2##(1991-5#1)(1992-3#1)(1995-2#1)
The key factors##4##3##(1990-6#1)(1995-3#1)(2007-8#1)(2008-10#1)
The key is to##2##4##(1993-2#1)(1994-12#1)
The key is##4##3##(1993-2#1)(1994-12#1)(2008-3#1)(2011-2#1)
The key result of##2##4##(2011-2#1)(2012-2#1)
The key result##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
The key step in the##2##5##(1992-3#1)(2008-10#1)
The key step in##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
The key step##4##3##(1992-3#1)(1996-5#1)(2008-10#1)(2008-11#1)
The key terms##2##3##(2008-12#1)(2009-8#1)
The key to the##2##4##(1990-3#1)(1994-2#1)
The key to##17##3##(1990-3#1)(1993-1#1)(1994-2#1)(1995-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2010-3#1)(2013-1#3)
The key##58##2##(1990-11#1)(1990-3#1)(1990-6#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-8#3)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)
The keys to##2##3##(1995-1#1)(2008-1#1)
The kidney##3##2##(1990-7#1)(1996-5#1)(2009-3#1)
The kind of##2##3##(1994-1#1)(2012-2#1)
The kinetic analysis indicated##2##4##(1993-3#1)(1994-8#1)
The kinetic and##2##3##(1991-6#1)(1993-8#1)
The kinetic data reveal that the lifetime of the lowest excited singlet state of a cis-isomer is consistently shorter than that of its corresponding all-trans counterpart despite the fact that the excited state energy of the cis molecule is typically higher than that of the trans molecule##2##47##(2010-2#2)
The kinetic of##2##3##(2008-10#2)
The kinetic parameters of the mutant##2##6##(1995-5#2)
The kinetic parameters of##4##4##(1990-3#1)(1995-5#2)(2008-10#1)
The kinetic parameters##10##3##(1990-3#1)(1992-11#1)(1995-5#3)(1997-4#1)(2008-10#3)(2011-2#1)
The kinetic results##3##3##(1990-8#1)(2007-11#1)(2009-12#1)
The kinetic##32##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#2)(1994-8#2)(1995-5#3)(1997-4#1)(2007-11#2)(2008-10#10)(2008-8#1)(2009-12#1)(2010-2#2)(2011-2#1)
The kinetics and thermodynamics of the##2##6##(1993-3#1)(2008-10#1)
The kinetics and thermodynamics of##3##5##(1993-3#1)(2008-10#1)(2008-8#1)
The kinetics and##8##3##(1993-3#1)(1993-6#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)
The kinetics of the##12##4##(1991-12#1)(1992-9#1)(2008-10#6)(2008-6#1)(2010-5#1)(2011-2#2)
The kinetics of##31##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-6#1)(2009-11#1)(2010-5#1)(2011-2#2)
The kinetics##42##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#2)
The knowledge of##5##3##(1994-11#1)(2007-11#1)(2008-11#1)(2012-3#2)
The knowledge##12##2##(1991-2#1)(1994-11#1)(2007-11#1)(2008-11#2)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#2)
The known##7##2##(1991-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
The lab##2##2##(1992-1#1)(2008-2#1)
The labeled##4##2##(1990-11#1)(1993-11#1)(1994-5#1)(1997-2#1)
The labeling##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
The labelled##2##2##(1990-8#1)(2008-10#1)
The labial##2##2##(2007-12#2)
The laboratory findings##2##3##(1990-9#1)(2010-6#1)
The laboratory##15##2##(1990-9#1)(2007-7#2)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)
The lack of a##4##4##(1990-11#1)(2008-10#1)(2008-7#1)(2010-1#1)
The lack of correlation between##2##5##(1991-12#1)(2010-6#1)
The lack of detection of##2##5##(2008-10#1)(2012-2#1)
The lack of inhibition##2##4##(1992-5#1)(1995-6#1)
The lack of typical##3##4##(2007-12#1)(2008-5#1)(2013-8#1)
The lack of##57##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
The lactate##3##2##(1991-5#2)(2008-10#1)
The lactic acid##3##3##(1997-4#1)(2008-6#1)(2008-7#1)
The lag phase##2##3##(2008-5#1)(2011-1#1)
The lag time##2##3##(1995-12#1)(2013-1#1)
The lag##5##2##(1995-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
The lambda(max)##2##2##(2008-10#2)
The lambs##2##2##(1996-12#1)(2008-12#1)
The lamellar##2##2##(1997-2#1)(2012-2#1)
The lamin##2##2##(2011-2#2)
The language of birth##2##4##(2013-1#2)
The language of##4##3##(2008-7#1)(2011-2#1)(2013-1#2)
The laparoscopic##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
The large amount of##3##4##(2007-11#1)(2008-5#1)(2010-3#1)
The large majority of##2##4##(2008-10#1)(2013-8#1)
The large number of##5##4##(2008-3#1)(2008-4#1)(2008-7#2)(2012-3#1)
The large##30##2##(1992-11#1)(1994-11#1)(1996-4#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
The larger size##2##3##(2007-11#1)(2011-2#1)
The larger the##3##3##(2008-10#1)(2008-3#2)
The larger##17##2##(1994-2#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-9#1)(2011-2#1)
The largest##27##2##(1990-7#1)(1990-8#2)(1993-8#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#2)
The larvae##4##2##(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
The larval##2##2##(2007-12#1)(2010-8#1)
The laryngeal mask##4##3##(1993-2#4)
The laser beam##2##3##(2007-11#1)(2008-3#1)
The laser can be##2##4##(2007-12#1)(2008-3#1)
The laser can##3##3##(2007-12#2)(2008-3#1)
The laser design incorporates a##2##5##(2007-11#1)(2007-12#1)
The laser diode##2##3##(2007-12#1)(2008-2#1)
The laser efficiency##2##3##(2007-12#1)(2008-3#1)
The laser generates##2##3##(2007-11#1)(2008-2#1)
The laser is based on##2##5##(2007-12#2)
The laser is##3##3##(2007-11#1)(2007-12#2)
The laser linewidth##3##3##(2007-12#1)(2008-3#2)
The laser operates##2##3##(2007-11#1)(2008-2#1)
The laser performance of##2##4##(2007-11#1)(2007-12#1)
The laser produces##2##3##(2007-11#1)(2007-12#1)
The laser radiation##2##3##(2007-11#1)(2008-2#1)
The laser was##8##3##(1992-12#1)(2007-12#3)(2008-2#2)(2012-3#2)
The laser##57##2##(1991-3#1)(1992-12#1)(2007-11#13)(2007-12#15)(2008-11#1)(2008-2#9)(2008-3#13)(2008-9#1)(2009-7#1)(2012-3#2)
The lasers are##2##3##(2007-12#2)
The lasing##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
The last few years have##2##5##(1992-12#1)(2009-3#1)
The last step##2##3##(1994-2#1)(2007-11#1)
The last two##3##3##(1993-2#1)(2009-8#1)(2013-1#1)
The last##23##2##(1992-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2011-2#2)(2013-1#1)
The late phase##2##3##(1993-8#1)(1995-6#1)
The late##7##2##(1991-6#1)(1993-8#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-9#1)(2011-3#1)
The latency##2##2##(1997-6#1)(2008-7#1)
The latent##3##2##(2008-10#3)
The later##3##2##(1997-7#1)(2008-1#1)(2011-2#1)
The lateral##11##2##(1991-10#1)(1993-3#1)(1997-8#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
The latest research##2##3##(2008-5#1)(2010-6#1)
The latest##15##2##(1990-3#1)(1991-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
The latex##2##2##(2007-10#1)(2008-5#1)
The latter are the##2##4##(2008-11#1)(2008-5#1)
The latter are##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)
The latter data##2##3##(1997-7#1)(2008-10#1)
The latter effect##3##3##(1991-12#1)(1995-12#1)(1997-4#1)
The latter group##2##3##(1991-12#1)(2011-1#1)
The latter has##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
The latter includes the##2##4##(1993-11#1)(2008-2#1)
The latter includes##3##3##(1993-11#1)(1996-9#1)(2008-2#1)
The latter is more##2##4##(1991-5#1)(2012-12#1)
The latter is the##3##4##(1990-7#1)(1991-3#1)(2008-10#1)
The latter is##19##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1995-5#1)(1997-7#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-5#1)(2009-4#1)(2012-12#1)(2012-2#1)
The latter may be##2##4##(1997-8#1)(2008-7#1)
The latter may##4##3##(1993-11#1)(1995-3#1)(1997-8#1)(2008-7#1)
The latter method##2##3##(2008-10#1)(2008-7#1)
The latter samples##2##3##(2010-8#1)(2013-1#1)
The latter shows##2##3##(1996-8#1)(2008-10#1)
The latter two##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
The latter was##6##3##(1991-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
The latter were##3##3##(1991-4#1)(1994-9#1)(2013-1#1)
The latter##115##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-11#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#4)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#5)
The law##7##2##(1994-1#1)(1996-5#1)(1997-6#1)(2008-3#1)(2008-8#1)(2010-4#2)
The lawsuits##2##2##(1997-5#1)(2012-12#1)
The layout##3##2##(2008-2#1)(2008-3#2)
The leaching factor were determined as##2##6##(2008-12#2)
The leaching method##2##3##(2008-10#2)
The leaching##8##2##(2008-10#6)(2008-12#2)
The lead and nickel##2##4##(2008-10#2)
The lead was##2##3##(2012-2#2)
The lead##8##2##(2008-10#4)(2008-11#1)(2008-5#1)(2012-2#2)
The leader##2##2##(1992-5#1)(2008-1#1)
The leaders##2##2##(1992-2#1)(1996-5#1)
The leading causes of death include heart disease##3##8##(2013-8#3)
The leading causes of death include##5##6##(2013-8#5)
The leading causes of death##7##5##(2013-8#7)
The leading causes of##9##4##(1995-12#1)(2008-1#1)(2013-8#7)
The leading##13##2##(1992-9#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-8#7)
The leaf##6##2##(2008-10#2)(2008-12#1)(2008-5#3)
The learning and##2##3##(2008-11#1)(2012-2#1)
The learning##6##2##(1992-6#1)(2008-11#1)(2012-2#2)(2013-8#2)
The least##5##2##(1993-11#1)(1994-12#1)(2008-12#1)(2009-4#1)(2013-1#1)
The leaves of##2##3##(1995-2#1)(2008-12#1)
The leaves##4##2##(1995-2#1)(2007-1#1)(2008-12#1)(2011-1#1)
The lectin (Mr 140##2##4##(1990-5#2)
The lectin##3##2##(1990-5#2)(1994-12#1)
The left ventricular ejection fraction##2##5##(1997-5#2)
The left ventricular##7##3##(1995-3#1)(1997-5#2)(2008-12#2)(2012-2#2)
The left##17##2##(1993-9#1)(1995-3#1)(1996-2#1)(1997-5#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#2)
The legal##2##2##(1996-2#1)(2008-11#1)
The length and width of##2##5##(2008-10#1)(2008-5#1)
The length and##4##3##(1993-12#1)(2008-10#2)(2008-5#1)
The length of the##10##4##(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2013-8#1)
The length of##13##3##(1992-3#1)(1992-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2013-8#1)
The length##21##2##(1992-3#1)(1992-5#1)(1993-12#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
The lens was##2##3##(2007-12#1)(2008-2#1)
The lens##5##2##(1993-9#1)(2007-12#2)(2008-2#1)(2011-1#1)
The lesion had##2##3##(2008-7#1)(2012-3#1)
The lesion in the##2##4##(2007-8#1)(2008-10#1)
The lesion of##2##3##(2008-8#2)
The lesion was surgically excised##2##5##(2012-2#1)(2013-1#1)
The lesion was##14##3##(1995-11#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-5#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
The lesion##29##2##(1995-11#1)(1997-8#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-1#4)
The lesions are##2##3##(2010-12#2)
The lesions caused by##2##4##(1995-11#1)(2008-10#1)
The lesions caused##3##3##(1993-12#1)(1995-11#1)(2008-10#1)
The lesions were##6##3##(1990-12#1)(2007-12#1)(2008-12#1)(2011-2#2)(2013-1#1)
The lesions##21##2##(1990-12#1)(1991-2#3)(1993-12#1)(1995-11#1)(1997-8#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-12#2)(2010-6#2)(2011-2#2)(2013-1#1)(2013-8#1)
The less##4##2##(1990-12#1)(2008-10#2)(2008-5#1)
The lessons##4##2##(2007-5#1)(2008-11#1)(2009-2#1)(2012-2#1)
The lethal##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
The lethality of##2##3##(1994-5#1)(1994-8#1)
The leukocyte differential obtained with the##2##6##(2008-10#2)
The leukocyte##3##2##(1993-11#1)(2008-10#2)
The level in##2##3##(1993-3#1)(2008-12#1)
The level of activity of the##2##6##(1994-2#2)
The level of agreement##2##4##(2008-10#1)(2009-5#1)
The level of appropriateness and usefulness of the instruments##2##9##(2013-1#2)
The level of detection##2##4##(2008-10#1)(2008-5#1)
The level of plasma##2##4##(2007-10#1)(2011-2#1)
The level of recombinant##2##4##(1993-6#1)(2008-7#1)
The level of serum##2##4##(1990-6#1)(2013-1#1)
The level of the##2##4##(1992-6#1)(1995-6#1)
The level of##76##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-2#3)(1994-7#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
The level##79##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#3)(1994-7#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
The levels of these##2##4##(2008-12#1)(2013-8#1)
The levels of urinary factor H##2##6##(2009-6#2)
The levels of##36##3##(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#3)(1992-4#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#2)(2013-1#2)(2013-8#1)
The levels##43##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#3)(1992-4#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#2)(2013-1#2)(2013-8#2)
The liability##2##2##(1994-12#1)(1995-3#1)
The libraries##2##2##(1992-1#1)(1997-6#1)
The library was screened##2##4##(1992-3#1)(1995-2#1)
The library was##4##3##(1992-3#1)(1995-2#1)(2008-5#1)(2008-7#1)
The lidar measurements##2##3##(2008-10#1)(2008-2#1)
The lidar uses##2##3##(2008-3#2)
The lidar##9##2##(2008-10#2)(2008-2#2)(2008-3#5)
The life cycle of##4##4##(2007-6#1)(2008-9#1)(2011-2#2)
The life cycle##6##3##(2007-6#1)(2008-12#2)(2008-9#1)(2011-2#2)
The life history##2##3##(2008-12#1)(2010-8#1)
The life span of##2##4##(1993-8#1)(2008-10#1)
The life##13##2##(1993-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)
The lifetime of the sensor is##2##6##(2008-10#2)
The lifetime of the##5##4##(2007-12#1)(2008-10#4)
The lifetime of##6##3##(2007-12#1)(2008-10#5)
The lifetime##11##2##(2007-12#1)(2008-10#8)(2008-4#1)(2013-1#1)
The ligand binding##2##3##(1990-5#1)(1995-11#1)
The ligand##6##2##(1990-5#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
The ligands##4##2##(1990-7#1)(1995-5#1)(2008-10#2)
The ligation##3##2##(1990-7#1)(1993-11#1)(2008-2#1)
The light chain##3##3##(1994-11#2)(1995-6#1)
The light microscope is a basic tool for the cell biologist##3##11##(2008-4#2)(2008-9#1)
The light source##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
The light##26##2##(1994-11#2)(1995-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
The light-scattering##2##2##(2008-10#1)(2008-3#1)
The likelihood of##7##3##(1991-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
The likelihood ratio##2##3##(2008-12#1)(2012-2#1)
The likelihood that##2##3##(1997-8#1)(2008-10#1)
The likelihood##12##2##(1991-12#1)(1994-11#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
The likely##4##2##(1990-5#1)(2008-10#2)(2012-2#1)
The limbic system has##2##4##(1992-12#2)
The limbic system##5##3##(1992-12#5)
The limit of detection (3sigma) was##2##6##(2008-10#2)
The limit of detection (3sigma)##4##5##(2008-10#4)
The limit of detection (LOD##3##5##(2008-10#2)(2010-4#1)
The limit of detection (LOD) of the##2##7##(2008-10#2)
The limit of detection (LOD) of##3##6##(2008-10#3)
The limit of detection (LOD)##8##5##(2008-10#8)
The limit of detection achieved##2##5##(2008-10#2)
The limit of detection and limit of quantification##2##8##(2008-10#1)(2012-2#1)
The limit of detection and the limit of quantification##2##9##(2008-10#2)
The limit of detection and the limit of##3##8##(2008-10#2)(2010-3#1)
The limit of detection and the##4##6##(2008-10#3)(2010-3#1)
The limit of detection and##7##5##(2008-10#5)(2010-3#1)(2012-2#1)
The limit of detection for the determination of##2##8##(2008-10#2)
The limit of detection for##13##5##(1990-8#1)(1995-2#1)(2008-10#11)
The limit of detection is 0##2##6##(2008-10#2)
The limit of detection is 1##2##6##(2008-10#2)
The limit of detection is 2##3##6##(2008-10#3)
The limit of detection is##10##5##(2008-10#10)
The limit of detection obtained##2##5##(2008-10#2)
The limit of detection of the method was##3##8##(2008-10#3)
The limit of detection of the proposed method is 0##4##10##(2008-10#4)
The limit of detection of the proposed method is##5##9##(2008-10#5)
The limit of detection of the##10##6##(2008-10#10)
The limit of detection of##15##5##(2008-10#14)(2011-2#1)
The limit of detection provided##2##5##(2008-10#2)
The limit of detection values##2##5##(2008-10#2)
The limit of detection was 0##8##6##(2008-10#8)
The limit of detection was 4##2##6##(2008-10#2)
The limit of detection was 7##2##6##(2008-10#2)
The limit of detection was estimated##2##6##(2008-10#2)
The limit of detection was found to be##2##8##(2008-10#2)
The limit of detection was##25##5##(1991-5#1)(2008-10#24)
The limit of detection##105##4##(1990-8#1)(1991-5#1)(1995-2#1)(2008-10#97)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
The limit of detections##2##4##(2008-10#2)
The limit of quantification (LOQ)##2##5##(2008-10#2)
The limit of quantification##6##4##(2008-10#6)
The limit of quantitation##4##4##(1996-5#1)(2008-10#3)
The limit of##123##3##(1990-8#1)(1991-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#111)(2008-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
The limit##124##2##(1990-8#1)(1991-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#111)(2008-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
The limitations of##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
The limitations##5##2##(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)
The limited##8##2##(1991-6#1)(2008-11#2)(2008-9#2)(2010-11#2)(2013-1#1)
The limiting factors in##2##4##(2008-2#1)(2012-1#1)
The limiting##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
The limits of ECH detection##2##5##(2008-10#2)
The limits of detection (LOD) and quantification (LOQ)##2##8##(2008-10#2)
The limits of detection (LOD) for the##2##7##(2008-10#1)(2010-5#1)
The limits of detection (LOD)##5##5##(2008-10#4)(2010-5#1)
The limits of detection (LODs) ranged from 0##2##8##(2008-10#2)
The limits of detection (LODs)##4##5##(2008-10#4)
The limits of detection and quantification##2##6##(2008-10#2)
The limits of detection and##3##5##(2008-10#3)
The limits of detection are 0##2##6##(2008-10#2)
The limits of detection are##4##5##(2008-10#4)
The limits of detection for##6##5##(1990-8#1)(2008-10#5)
The limits of detection in urine##2##6##(2008-10#2)
The limits of detection of##5##5##(2008-10#3)(2008-3#1)(2011-1#1)
The limits of detection were 0##2##6##(2008-10#2)
The limits of detection were 2##2##6##(2008-10#1)(2011-1#1)
The limits of detection were##9##5##(2008-10#8)(2011-1#1)
The limits of detection##49##4##(1990-8#1)(2008-10#44)(2008-3#1)(2010-5#1)(2011-1#2)
The limits of quantification (LOQ)##2##5##(2008-10#2)
The limits of quantification##6##4##(2008-10#5)(2011-1#1)
The limits of quantitation##3##4##(2008-10#2)(2013-1#1)
The limits of##67##3##(1990-8#1)(2008-10#57)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#3)(2013-1#1)
The limits##69##2##(1990-8#1)(2008-10#58)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#3)(2013-1#1)
The line##2##2##(1997-5#1)(2008-3#1)
The lineal interval was##2##4##(2008-10#2)
The linear calibration range of##2##5##(2008-10#2)
The linear calibration range was##4##5##(2008-10#4)
The linear calibration range##7##4##(2008-10#7)
The linear calibration ranges##2##4##(2008-10#2)
The linear calibration##13##3##(2008-10#13)
The linear concentration range of##3##5##(2008-10#2)(2013-1#1)
The linear concentration range was##2##5##(2008-10#2)
The linear concentration range##6##4##(2008-10#5)(2013-1#1)
The linear concentration ranges for the proposed enantioselective membrane electrodes were##2##11##(2008-10#2)
The linear concentration ranges for the proposed##3##7##(2008-10#3)
The linear concentration ranges##6##4##(2008-10#6)
The linear concentration##12##3##(2008-10#11)(2013-1#1)
The linear domain range of##2##5##(2008-10#2)
The linear dynamic range##6##4##(2008-10#6)
The linear dynamic ranges of the calibration##2##7##(2008-10#2)
The linear dynamic ranges of##4##5##(2008-10#4)
The linear dynamic ranges##6##4##(2008-10#6)
The linear dynamic##12##3##(2008-10#12)
The linear model##2##3##(2007-11#2)
The linear range for the determination of##2##7##(2008-10#2)
The linear range for##5##4##(2008-10#5)
The linear range is 0##2##5##(2008-10#2)
The linear range is##3##4##(2008-10#3)
The linear range of calibration##2##5##(2008-10#2)
The linear range of the assay in##2##7##(2008-10#1)(2008-11#1)
The linear range of the calibration curve##2##7##(2008-10#2)
The linear range of the determination was##2##7##(2008-10#2)
The linear range of the method for##3##7##(2008-10#3)
The linear range of the method##5##6##(2008-10#5)
The linear range of the##17##5##(2008-10#16)(2008-11#1)
The linear range of this method was##2##7##(2008-10#2)
The linear range of this method##3##6##(2008-10#3)
The linear range of##29##4##(2008-10#28)(2008-11#1)
The linear range was 0##2##5##(2008-10#1)(2011-1#1)
The linear range was##5##4##(2008-10#4)(2011-1#1)
The linear range##49##3##(2008-10#47)(2008-11#1)(2011-1#1)
The linear ranges were##4##4##(2008-10#4)
The linear ranges##7##3##(2008-10#7)
The linear regression analysis##2##4##(2008-10#2)
The linear regression equation of the calibration graph is C=0##2##10##(2008-10#2)
The linear regression equation of the calibration graph is##3##9##(2008-10#3)
The linear regression equation##4##4##(2008-10#4)
The linear regression##9##3##(2008-10#8)(2013-8#1)
The linear relationship between the##3##5##(2008-10#3)
The linear relationship between##5##4##(2008-10#4)(2010-5#1)
The linear relationship##6##3##(1990-7#1)(2008-10#4)(2010-5#1)
The linear response of the##2##5##(2008-10#2)
The linear response range of##2##5##(2008-10#2)
The linear response##7##3##(2008-10#7)
The linear working range##2##4##(2008-10#2)
The linear##135##2##(1990-7#1)(1995-8#1)(2007-11#3)(2007-12#1)(2008-10#119)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
The linearity of the##3##4##(2008-10#3)
The linearity of##8##3##(2008-10#7)(2010-3#1)
The linearity range##2##3##(2008-10#2)
The linearity was good from 0##2##6##(2008-10#2)
The linearity was obtained for##2##5##(2008-10#2)
The linearity was obtained##3##4##(2008-10#2)(2010-5#1)
The linearity was##6##3##(2008-10#4)(2010-5#2)
The linearity##23##2##(1994-9#1)(2008-10#16)(2008-3#2)(2010-3#1)(2010-5#2)(2011-1#1)
The lines##2##2##(2008-10#1)(2008-9#1)
The linewidth of##2##3##(2008-2#1)(2008-3#1)
The link between##5##3##(2007-12#1)(2008-3#2)(2009-7#1)(2010-3#1)
The linkage between##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
The linkage##4##2##(2008-10#2)(2008-3#1)(2009-11#1)
The linked markers##2##3##(2008-10#2)
The links between##3##3##(1996-12#1)(2009-7#1)(2013-8#1)
The lipase activity##2##3##(2008-10#1)(2012-2#1)
The lipid##4##2##(1995-5#1)(2008-5#1)(2008-7#1)(2011-2#1)
The lipid-soluble##2##2##(1993-8#1)(2008-10#1)
The lipofuscin##2##2##(1995-3#2)
The lipophilic##4##2##(1990-11#1)(1994-3#1)(2008-10#1)(2008-9#1)
The lipoprotein fractions##2##3##(1990-8#1)(2008-7#1)
The lipoprotein lipase (LPL) activity and mass from postheparin plasma of the##2##12##(1993-3#1)(1994-11#1)
The lipoprotein##5##2##(1990-8#1)(1993-3#1)(1994-11#1)(2008-6#1)(2008-7#1)
The liquid##8##2##(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
The liquid-crystal##4##2##(2007-11#1)(2008-3#3)
The liquid-liquid extraction of##2##4##(2008-10#2)
The list of##3##3##(1997-4#1)(2009-4#1)(2011-2#1)
The list##4##2##(1991-3#1)(1997-4#1)(2009-4#1)(2011-2#1)
The literature has##2##3##(1996-3#1)(2013-1#1)
The literature is reviewed and the##2##6##(1993-8#1)(2008-7#1)
The literature is reviewed and##3##5##(1993-8#1)(2008-12#1)(2008-7#1)
The literature is reviewed regarding##2##5##(1994-12#1)(2008-9#1)
The literature is reviewed##8##4##(1990-9#1)(1991-3#1)(1993-8#1)(1994-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
The literature is##10##3##(1990-9#1)(1991-3#1)(1993-8#1)(1994-12#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
The literature on the##4##4##(1994-11#1)(1996-11#1)(2011-2#1)(2013-1#1)
The literature on##10##3##(1991-6#1)(1992-2#1)(1994-11#1)(1995-8#1)(1996-11#1)(1997-8#1)(2007-11#1)(2009-1#1)(2011-2#1)(2013-1#1)
The literature regarding##2##3##(2011-2#2)
The literature reveals that##2##4##(2008-1#1)(2008-11#1)
The literature review##2##3##(2009-8#1)(2013-1#1)
The literature search##4##3##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The literature was reviewed and##2##5##(1992-3#1)(2007-12#1)
The literature was reviewed##3##4##(1992-3#1)(2007-12#2)
The literature was##4##3##(1992-3#1)(2007-12#2)(2011-1#1)
The literature##52##2##(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
The lithium##3##2##(1992-9#1)(2008-10#1)(2012-2#1)
The little##2##2##(2011-1#1)(2013-1#1)
The lived##2##2##(2008-12#1)(2009-5#1)
The liver and##3##3##(2008-11#1)(2008-5#1)(2010-11#1)
The liver##10##2##(1996-12#2)(2008-10#2)(2008-11#3)(2008-5#1)(2010-11#1)(2012-12#1)
The living donor##3##3##(2011-2#2)(2013-8#1)
The living##4##2##(2008-12#1)(2011-2#2)(2013-8#1)
The loaded##3##2##(1991-5#1)(2008-10#2)
The loading##5##2##(2008-10#4)(2008-5#1)
The local density##2##3##(1996-2#1)(2013-1#1)
The local doctor##2##3##(1993-3#1)(1993-6#1)
The local health authorities launched a##2##6##(1991-6#1)(1994-11#1)
The local health##3##3##(1991-6#1)(1994-11#1)(1995-6#1)
The local##24##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-6#2)(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#5)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)
The localization of##6##3##(1990-7#1)(1992-3#1)(1994-2#1)(1994-8#1)(2008-8#1)(2012-2#1)
The localization##10##2##(1990-7#1)(1991-5#1)(1992-3#1)(1994-2#1)(1994-8#1)(1996-2#1)(2007-11#2)(2008-8#1)(2012-2#1)
The location of the##7##4##(1994-1#1)(1994-11#1)(1997-4#1)(1997-9#1)(2008-3#1)(2008-5#1)(2013-8#1)
The location of##10##3##(1994-1#1)(1994-11#1)(1995-6#1)(1997-4#1)(1997-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-8#1)
The location##13##2##(1991-6#1)(1994-1#1)(1994-11#1)(1995-6#1)(1997-4#1)(1997-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
The locations of##2##3##(2007-12#1)(2008-9#1)
The locations##4##2##(1992-5#1)(1997-3#1)(2007-12#1)(2008-9#1)
The locomotor##2##2##(1993-12#2)
The locus##4##2##(2007-7#1)(2008-10#3)
The log##2##2##(2008-10#2)
The logK##2##2##(2008-10#2)
The logarithm of the##4##4##(2008-10#3)(2008-3#1)
The logarithmic##3##2##(2008-10#3)
The logic##2##2##(2008-3#1)(2008-8#1)
The logistic model##3##3##(2008-10#3)
The logistic regression model##2##4##(2008-8#1)(2012-12#1)
The logistic regression##3##3##(2008-8#1)(2010-7#1)(2012-12#1)
The logistic##9##2##(2007-8#1)(2008-10#5)(2008-8#1)(2010-7#1)(2012-12#1)
The long and##2##3##(2008-1#1)(2008-11#1)
The long arm of##2##4##(2010-7#1)(2012-12#1)
The long##15##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
The long-period##2##2##(2007-11#2)
The long-term effect##2##3##(1991-8#1)(2008-10#1)
The long-term follow-up##2##3##(2009-5#2)
The long-term stability of##4##4##(2008-10#2)(2008-11#1)(2010-3#1)
The long-term##25##2##(1991-8#1)(1994-8#1)(1995-5#1)(1997-3#1)(2007-4#1)(2007-8#2)(2008-10#7)(2008-11#3)(2008-4#1)(2008-7#1)(2009-5#2)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#1)
The longer the##2##3##(2008-8#1)(2011-2#1)
The longer##4##2##(1990-12#1)(2007-10#1)(2008-8#1)(2011-2#1)
The longest cDNA##2##3##(1991-5#1)(2008-11#1)
The longest##9##2##(1991-1#1)(1991-5#1)(1994-12#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-9#2)(2011-2#1)
The longitudinal##6##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
The loop between##2##3##(1992-4#1)(1995-5#1)
The loop##3##2##(1992-4#1)(1995-1#1)(1995-5#1)
The loss of##11##3##(1990-5#1)(1992-12#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
The loss rate of wigs was##2##6##(2012-3#2)
The loss##14##2##(1990-5#1)(1992-12#1)(1993-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
The low detection limits##2##4##(2008-10#1)(2008-5#1)
The low frequency##2##3##(1990-8#1)(1991-11#1)
The low incidence of##2##4##(2008-8#1)(2010-1#1)
The low level of##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
The low limit of##2##4##(2008-10#2)
The low##33##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-12#1)(1993-3#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#3)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
The low-CHO diet##2##3##(2013-8#2)
The low-density lipoprotein (LDL) receptor##2##5##(1990-7#1)(1995-6#1)
The lower detection limit of##2##5##(2008-10#2)
The lower detection limit was##2##5##(1990-12#1)(2008-10#1)
The lower detection limit##7##4##(1990-12#1)(2008-10#6)
The lower detection##8##3##(1990-12#1)(2008-10#7)
The lower levels of##2##4##(1997-6#2)
The lower limit of detection (LOD) obtained under the optimal conditions was##2##12##(2008-10#2)
The lower limit of detection (LOD)##3##6##(2008-10#3)
The lower limit of detection was##2##6##(2008-10#1)(2010-5#1)
The lower limit of detection##7##5##(2008-10#6)(2010-5#1)
The lower limit of quantification was##2##6##(2011-2#2)
The lower limit of quantitation was##2##6##(2008-10#2)
The lower limit of##12##4##(2008-10#8)(2008-2#1)(2010-5#1)(2011-2#2)
The lower limits of##2##4##(2008-10#1)(2011-3#1)
The lower limits##3##3##(2008-10#2)(2011-3#1)
The lower phase was used as the mobile phase and the upper phase was used as the stationary phase##2##19##(2011-1#2)
The lower the##2##3##(2011-2#1)(2013-1#1)
The lower##42##2##(1990-12#1)(1993-1#1)(1996-3#1)(1997-4#1)(1997-6#2)(2007-8#1)(2008-10#20)(2008-2#1)(2008-6#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2013-1#2)
The lowest concentration of metal##2##5##(2008-10#2)
The lowest concentration##4##3##(2008-10#3)(2012-1#1)
The lowest##24##2##(1993-12#1)(1993-8#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
The lumbar##2##2##(1991-11#1)(1996-3#1)
The luminal##2##2##(2008-9#1)(2010-3#1)
The luminescence of silver bromide crystals##2##6##(2008-2#2)
The luminescence of##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
The luminescence##7##2##(2008-10#3)(2008-2#2)(2008-3#1)(2013-1#1)
The lung##4##2##(2008-5#1)(2008-9#1)(2010-7#1)(2011-3#1)
The lungs and##2##3##(2009-9#1)(2010-12#1)
The lungs##4##2##(1992-9#1)(1996-3#1)(2009-9#1)(2010-12#1)
The lymphocyte proliferation##2##3##(2007-2#1)(2011-2#1)
The lymphocyte##3##2##(2007-2#1)(2009-12#1)(2011-2#1)
The lyophylized sample##3##3##(1992-8#3)
The lyophylized##4##2##(1992-8#4)
The mRNA and protein levels of##2##6##(2011-3#2)
The mRNA and protein##3##4##(2009-12#1)(2011-3#2)
The mRNA expression of CaM##2##5##(2011-3#2)
The mRNA expression##3##3##(2008-9#1)(2011-3#2)
The mRNA for the rat cognate of##2##7##(1996-12#2)
The mRNA for the##4##4##(1992-8#1)(1996-12#2)(1997-4#1)
The mRNA for##5##3##(1990-7#1)(1992-8#1)(1996-12#2)(1997-4#1)
The mRNA##18##2##(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-12#2)(1997-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-3#4)(2013-1#1)
The magnesium##4##2##(2008-10#4)
The magnetic properties of##2##4##(1997-7#2)
The magnetic##6##2##(1997-7#2)(2007-11#1)(2008-10#2)(2010-4#1)
The magnitude and direction##2##4##(2008-10#1)(2010-5#1)
The magnitude and##3##3##(1997-2#1)(2008-10#1)(2010-5#1)
The magnitude of K(ex)##2##4##(2008-10#2)
The magnitude of the##18##4##(1990-8#1)(1992-12#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-4#1)(2007-11#3)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)
The magnitude of this##5##4##(1990-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
The magnitude of##40##3##(1990-2#1)(1990-8#1)(1992-12#1)(1993-6#1)(1994-6#2)(1995-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-3#2)(2007-10#1)(2007-11#5)(2007-12#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#2)(2012-12#1)(2012-2#1)
The magnitude##45##2##(1990-2#1)(1990-8#1)(1992-12#1)(1993-6#1)(1994-6#2)(1995-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-11#5)(2007-12#1)(2008-10#12)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#2)(2010-5#1)(2012-12#1)(2012-2#1)
The magnitudes of the##2##4##(2008-2#1)(2009-2#1)
The magnitudes of##4##3##(1997-2#1)(2008-2#1)(2009-2#1)(2012-12#1)
The magnitudes##5##2##(1997-2#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-12#1)
The main advantage of the proposed##2##6##(2008-10#2)
The main advantage of the##4##5##(2008-10#3)(2008-3#1)
The main advantage of this##4##5##(2007-12#1)(2008-10#2)(2008-2#1)
The main advantage of##14##4##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
The main advantage##15##3##(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
The main advantages of this##3##5##(2007-11#1)(2008-11#1)(2011-2#1)
The main advantages of##6##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#1)
The main advantages##8##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#1)
The main aim is##2##4##(2007-8#1)(2008-10#1)
The main aim of the study was to##3##8##(1993-2#1)(2008-11#1)(2010-3#1)
The main aim of the##4##5##(1993-2#1)(1997-7#1)(2008-11#1)(2010-3#1)
The main aim of##7##4##(1993-2#1)(1997-7#1)(2008-11#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
The main aim##9##3##(1993-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
The main aims of##2##4##(2008-10#1)(2012-1#1)
The main analytical##2##3##(2008-10#2)
The main barriers##2##3##(2011-2#2)
The main cause of##4##4##(1991-6#1)(2007-10#1)(2007-12#1)(2012-2#1)
The main cause##6##3##(1991-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
The main causes of##3##4##(1990-9#1)(2008-1#1)(2008-8#1)
The main causes##5##3##(1990-9#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-8#1)
The main characteristics of the##3##5##(1991-12#1)(2008-10#2)
The main clinical##2##3##(2008-1#1)(2013-1#1)
The main complications##2##3##(1991-3#1)(1994-3#1)
The main component of the##2##5##(2007-12#1)(2011-1#1)
The main components of##2##4##(2008-10#1)(2008-5#1)
The main components##3##3##(1990-11#1)(2008-10#1)(2008-5#1)
The main conclusion##2##3##(2008-5#1)(2008-7#1)
The main degradation products##2##4##(2008-10#2)
The main difference between the##2##5##(2008-10#2)
The main difference between##3##4##(2008-10#3)
The main difference##6##3##(2008-10#4)(2011-2#1)(2012-3#1)
The main drawback##2##3##(2008-2#1)(2008-3#1)
The main effects of##2##4##(2008-10#2)
The main factor##3##3##(1993-12#1)(1997-3#1)(2008-5#1)
The main features of the##3##5##(1990-3#1)(1991-12#1)(1992-1#1)
The main features of##5##4##(1990-3#1)(1991-12#1)(1992-1#1)(2007-11#1)(2008-2#1)
The main finding##2##3##(1995-6#1)(2008-8#1)
The main findings are##2##4##(2008-6#1)(2008-8#1)
The main findings revealed a significant improvement##2##7##(2011-2#2)
The main findings##5##3##(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#2)
The main focus of this review is##2##7##(2008-7#1)(2011-1#1)
The main focus of this review##3##6##(2008-7#1)(2011-1#2)
The main focus of this##5##5##(1992-12#1)(2008-10#1)(2008-7#1)(2011-1#2)
The main focus##9##3##(1992-12#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2011-1#2)
The main fractions##2##3##(2008-6#2)
The main goal of this##3##5##(2007-11#1)(2008-6#1)(2013-1#1)
The main goal of##4##4##(2007-11#1)(2008-10#1)(2008-6#1)(2013-1#1)
The main goal##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
The main idea is to##2##5##(2008-2#1)(2009-8#1)
The main indication##2##3##(1992-6#1)(2008-1#1)
The main indications for##2##4##(1992-9#1)(2008-1#1)
The main limitation of##2##4##(2008-11#1)(2010-5#1)
The main limitations of the##2##5##(2008-10#1)(2009-1#1)
The main limitations##4##3##(2008-10#1)(2008-3#2)(2009-1#1)
The main objective of the##3##5##(2008-11#1)(2008-12#1)(2012-2#1)
The main objective of this study was to##2##8##(1992-12#1)(2008-12#1)
The main objective of this study##3##6##(1992-12#1)(2008-12#1)(2008-7#1)
The main objective of this work##2##6##(2008-5#1)(2009-6#1)
The main objective of this##5##5##(1992-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)
The main objective of##8##4##(1992-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)
The main objectives of this study were to##2##8##(2008-11#1)(2013-1#1)
The main objectives of this##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
The main outcome measure was##3##5##(2008-7#1)(2011-2#2)
The main outcome measures were##3##5##(2008-8#1)(2011-2#1)(2013-1#1)
The main outcome##9##3##(1993-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#3)(2013-1#1)
The main part##2##3##(1991-2#1)(1993-6#1)
The main problem##4##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)
The main purpose of the##2##5##(2008-3#1)(2008-8#1)
The main purpose of this study was to##3##8##(1997-3#1)(2007-11#1)(2009-9#1)
The main purpose of this study##4##6##(1997-3#1)(2007-11#1)(2008-5#1)(2009-9#1)
The main purpose of this##8##5##(1997-3#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
The main purpose of##10##4##(1997-3#1)(2007-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
The main purpose##12##3##(1997-3#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
The main questions##2##3##(2009-4#1)(2011-2#1)
The main reason for the##2##5##(1991-9#1)(1994-6#1)
The main reason for##3##4##(1991-9#1)(1994-6#1)(2007-11#1)
The main reason##4##3##(1991-9#1)(1994-6#1)(2007-11#1)(2008-5#1)
The main reasons##2##3##(1990-12#1)(2008-9#1)
The main result is##2##4##(2008-3#1)(2010-1#1)
The main result##4##3##(1993-3#1)(2008-2#1)(2008-3#1)(2010-1#1)
The main results of these##2##5##(2008-3#1)(2008-7#1)
The main results were##2##4##(1991-6#1)(1993-8#1)
The main results##7##3##(1991-6#1)(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
The main risk factors##2##4##(1992-4#1)(2013-1#1)
The main source##2##3##(1993-1#1)(1994-12#1)
The main thrust##2##3##(1994-9#1)(1997-7#1)
The main uncertainty##2##3##(2008-10#2)
The main##271##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#2)(1997-7#2)(2007-10#1)(2007-11#10)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#48)(2008-11#12)(2008-12#6)(2008-2#7)(2008-3#15)(2008-5#11)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#3)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#4)(2011-2#19)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#12)(2013-8#6)
The mainstay of treatment##2##4##(2010-5#1)(2010-6#1)
The mainstay of##3##3##(2008-8#1)(2010-5#1)(2010-6#1)
The maintenance of the##2##4##(2008-7#1)(2011-2#1)
The maintenance of##9##3##(1990-11#1)(1996-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
The maintenance##10##2##(1990-11#1)(1995-3#1)(1996-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
The major advantage of##4##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
The major cause of##2##4##(1990-11#1)(1991-2#1)
The major cause##3##3##(1990-11#1)(1991-2#1)(2008-3#1)
The major characteristics##3##3##(1994-8#1)(2008-10#2)
The major components of the##2##5##(1996-1#1)(2008-10#1)
The major components of##3##4##(1996-1#1)(2008-10#1)(2012-3#1)
The major constituents##3##3##(1990-8#1)(2008-11#1)(2008-12#1)
The major factor##2##3##(1995-3#1)(2008-11#1)
The major findings##2##3##(1995-9#1)(1997-3#1)
The major focus is on efficacy of such dietary supplements to enhance exercise or sport performance##2##16##(2008-5#2)
The major focus is on efficacy of such dietary supplements to enhance exercise or##3##14##(2008-5#3)
The major focus##5##3##(2008-11#1)(2008-5#3)(2010-11#1)
The major form of the##2##5##(2008-10#2)
The major gene##2##3##(2008-8#1)(2013-1#1)
The major limitation##2##3##(2013-1#1)(2013-8#1)
The major problem##2##3##(2008-10#1)(2012-12#1)
The major problems##2##3##(2007-11#1)(2008-12#1)
The major protein##2##3##(2008-5#1)(2008-8#1)
The major reason for##2##4##(2009-5#1)(2012-1#1)
The major reduction##2##3##(1990-11#1)(1995-3#1)
The major significant##2##3##(1992-6#1)(2007-12#1)
The major##130##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
The majority (88%) of##2##4##(1993-12#1)(2011-1#1)
The majority of GPs did not##2##6##(2007-2#2)
The majority of cases of##3##5##(2007-7#1)(2008-7#1)(2012-3#1)
The majority of cases##6##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-3#1)
The majority of children##3##4##(1996-12#1)(2008-11#1)(2011-2#1)
The majority of deaths##2##4##(2007-2#1)(2011-2#1)
The majority of isolates##3##4##(2008-10#3)
The majority of participants##2##4##(2008-4#1)(2008-9#1)
The majority of patients who##2##5##(2008-1#1)(2008-3#1)
The majority of patients with##2##5##(1992-3#1)(1992-8#1)
The majority of patients##8##4##(1992-3#1)(1992-8#1)(1993-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2011-1#1)
The majority of respondents##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
The majority of studies##3##4##(1997-6#1)(2008-2#1)(2012-2#1)
The majority of the interventions##2##5##(2012-2#2)
The majority of the patients##3##5##(2007-11#1)(2008-4#1)(2011-1#1)
The majority of the##27##4##(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#2)(1996-1#1)(1997-3#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#3)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
The majority of them##3##4##(2007-6#1)(2011-1#1)(2011-2#1)
The majority of these patients##2##5##(2008-1#1)(2010-3#1)
The majority of these##8##4##(1993-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)
The majority of women##3##4##(1996-6#1)(2009-3#1)(2011-2#1)
The majority of##130##3##(1991-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
The majority##159##2##(1991-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-11#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#3)(1997-6#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#18)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#3)(2010-12#1)(2010-3#3)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
The making of##2##3##(2008-7#1)(2012-12#1)
The malaria##2##2##(2012-2#2)
The male to female sex ratio##2##6##(1997-7#1)(2008-7#1)
The male to female##3##4##(1997-7#1)(2008-1#1)(2008-7#1)
The male##11##2##(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#2)(2008-5#2)(2008-7#2)
The male-to-female ratio##2##3##(2008-9#2)
The malformation##2##2##(2008-10#1)(2008-11#1)
The mammalian brain##2##3##(2008-11#1)(2008-4#1)
The mammalian##9##2##(1990-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-4#1)(2011-2#1)
The mammary##2##2##(1991-11#1)(1995-9#1)
The man##3##2##(1991-1#1)(1994-2#1)(2009-1#1)
The managed care##3##3##(1994-3#1)(1995-12#1)(2006-10#1)
The management and##2##3##(2008-5#1)(2011-2#1)
The management of patients with##4##5##(2007-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
The management of patients##6##4##(2007-11#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
The management of the##2##4##(2008-12#1)(2009-12#1)
The management of this##2##4##(2008-12#1)(2012-12#1)
The management of##43##3##(1991-8#1)(1993-11#1)(1993-9#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)
The management##53##2##(1991-8#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-3#2)(2013-1#5)
The managers##2##2##(1994-3#2)
The mandate##2##2##(2007-5#1)(2008-10#1)
The mandible##2##2##(2008-12#1)(2008-6#1)
The maneuver##2##2##(2008-1#1)(2008-7#1)
The manganese##2##2##(2008-10#2)
The mangrove forest##2##3##(2007-5#1)(2011-2#1)
The mangrove##3##2##(2007-5#1)(2008-5#1)(2011-2#1)
The manifold was##2##3##(2008-10#2)
The manifold##4##2##(2008-10#4)
The manipulation of##2##3##(2011-2#1)(2013-8#1)
The manner##3##2##(1993-2#1)(1995-3#1)(2008-10#1)
The manufacture and##2##3##(2008-3#1)(2008-7#1)
The manufacturing process##3##3##(1996-2#1)(2008-2#1)(2008-3#1)
The many##5##2##(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#2)
The map has##2##3##(1994-9#1)(2008-10#1)
The map##6##2##(1994-9#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
The mapping##3##2##(1995-6#1)(1997-6#1)(1997-9#1)
The maps##2##2##(2007-5#1)(2008-3#1)
The marginal sinus is##2##4##(1996-9#2)
The marginal sinus##4##3##(1996-9#4)
The marginal##6##2##(1992-1#1)(1996-9#5)
The marine##4##2##(1997-6#1)(2007-5#1)(2008-8#1)(2011-1#1)
The marked increase##2##3##(1990-12#1)(1996-12#1)
The marked##9##2##(1990-12#1)(1990-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#3)
The marker##2##2##(2008-10#1)(2008-12#1)
The markers##5##2##(2008-10#5)
The mask##2##2##(2008-2#1)(2008-3#1)
The mass of##3##3##(1991-12#1)(1992-3#1)(1996-2#1)
The mass transfer coefficient##2##4##(2008-6#1)(2008-7#1)
The mass transfer##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
The mass was##6##3##(1992-2#1)(2006-12#1)(2010-11#1)(2012-12#2)(2013-1#1)
The mass##33##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-12#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
The massive##2##2##(1994-11#1)(1996-2#1)
The material and##2##3##(1995-11#1)(2007-11#1)
The material has been##2##4##(2008-10#1)(2013-1#1)
The material##15##2##(1990-5#1)(1990-7#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#2)(2013-8#1)
The materials were##2##3##(2008-10#1)(2010-4#1)
The materials##5##2##(2008-10#2)(2008-3#1)(2010-4#1)(2013-1#1)
The maternal##3##2##(1993-6#1)(1995-12#1)(2010-3#1)
The mathematical explanation of the procedure is illustrated##2##8##(2008-10#2)
The mathematical model##2##3##(2008-10#2)
The mathematical##13##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#3)
The matrix##10##2##(1994-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-7#1)
The maturation of##3##3##(1993-6#1)(2007-12#1)(2012-2#1)
The mature protein##2##3##(1993-9#1)(1995-2#1)
The mature##11##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-9#1)(1995-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-10#1)
The maximal effect##2##3##(1993-12#1)(1997-1#1)
The maximal##17##2##(1990-3#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)
The maximum absorbance##2##3##(2008-10#2)
The maximum absorption wavelength was##2##5##(2008-10#1)(2008-3#1)
The maximum amount of##2##4##(2008-10#1)(2009-7#1)
The maximum and minimum##2##4##(2008-3#1)(2011-2#1)
The maximum capacity of the membrane disks modified##2##8##(2008-10#2)
The maximum concentration##2##3##(2008-10#1)(2012-3#1)
The maximum concentrations##2##3##(2008-10#1)(2008-5#1)
The maximum conversion##2##3##(2007-12#1)(2008-3#1)
The maximum excitation and emission wavelengths are##2##7##(2008-10#2)
The maximum excitation and emission wavelengths##4##6##(2008-10#4)
The maximum excitation##5##3##(2008-10#5)
The maximum growth rate##2##4##(2008-11#1)(2008-8#1)
The maximum number of##2##4##(2008-10#2)
The maximum output##3##3##(2007-11#2)(2007-12#1)
The maximum sorption##2##3##(2008-10#2)
The maximum specific##2##3##(2008-6#1)(2010-11#1)
The maximum temperature##4##3##(2008-10#1)(2008-3#2)(2011-1#1)
The maximum##93##2##(1990-11#1)(1990-5#1)(1995-3#1)(1995-6#1)(2007-11#4)(2007-12#6)(2008-10#33)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#12)(2008-5#2)(2008-6#7)(2008-7#1)(2008-8#2)(2009-11#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The mean (+/-##2##3##(1991-5#1)(1994-7#1)
The mean (+/-SD)##2##3##(1994-12#1)(2008-3#1)
The mean QTc##2##3##(2008-8#2)
The mean absolute##2##3##(1991-10#1)(2008-10#1)
The mean activity of##2##4##(1991-5#1)(2008-8#1)
The mean activity##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
The mean age and##3##4##(1991-12#1)(1997-8#1)(2007-7#1)
The mean age at diagnosis was##2##6##(2008-7#1)(2011-1#1)
The mean age at##6##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
The mean age of onset was##2##6##(2007-8#1)(2008-8#1)
The mean age of onset##3##5##(2007-8#1)(2008-7#1)(2008-8#1)
The mean age of patients was##3##6##(2007-2#1)(2007-8#1)(2011-2#1)
The mean age of patients##4##5##(2007-2#1)(2007-8#1)(2011-2#1)(2012-12#1)
The mean age of the GPs was 46##2##8##(2007-2#2)
The mean age of the patients was 39##2##8##(1991-8#1)(2008-1#1)
The mean age of the patients was 49##2##8##(2008-1#1)(2012-3#1)
The mean age of the patients was 54##2##8##(2008-1#1)(2010-6#1)
The mean age of the patients was##10##7##(1991-8#1)(1993-2#1)(1995-4#1)(2008-1#4)(2010-6#1)(2011-3#1)(2012-3#1)
The mean age of the##15##5##(1991-8#1)(1993-2#1)(1995-4#1)(2007-2#2)(2008-1#5)(2008-11#1)(2010-6#1)(2011-3#1)(2012-12#1)(2012-3#1)
The mean age of##28##4##(1991-8#1)(1993-2#1)(1995-4#1)(2007-10#1)(2007-2#3)(2007-8#2)(2008-1#5)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
The mean age was 43##2##5##(2007-7#1)(2008-6#1)
The mean age was##14##4##(1991-3#1)(1991-6#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
The mean age##54##3##(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-2#1)(1995-4#1)(1997-8#2)(2007-10#1)(2007-2#3)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-8#2)
The mean angle##2##3##(2008-9#1)(2009-12#1)
The mean anteroposterior diameter of normal##2##6##(2013-1#2)
The mean blood flow##2##4##(2008-10#1)(2008-4#1)
The mean body weights of##2##5##(2008-8#1)(2008-9#1)
The mean body##3##3##(2007-10#1)(2008-8#1)(2008-9#1)
The mean change in##2##4##(2008-7#1)(2013-1#1)
The mean concentration##2##3##(1995-12#1)(1996-8#1)
The mean concentrations of##2##4##(2008-10#1)(2008-4#1)
The mean diameter of the##2##5##(2007-8#1)(2008-7#1)
The mean diameter of##3##4##(1994-7#1)(2007-8#1)(2008-7#1)
The mean differences in##2##4##(2008-12#2)
The mean dose##2##3##(1992-10#1)(2009-2#1)
The mean duration of follow up##2##6##(2008-4#1)(2010-3#1)
The mean duration of##10##4##(1994-8#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
The mean duration##11##3##(1994-8#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
The mean follow-up period was##2##5##(1990-9#1)(2008-1#1)
The mean follow-up period##3##4##(1990-9#1)(2008-1#2)
The mean follow-up time was##2##5##(2010-3#1)(2011-2#1)
The mean follow-up was##5##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
The mean follow-up##10##3##(1990-9#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#2)
The mean free##2##3##(2007-8#1)(2008-10#1)
The mean haemoglobin##2##3##(1996-9#1)(2009-10#1)
The mean hemoglobin##3##3##(2007-7#1)(2008-1#1)(2008-3#1)
The mean interday##2##3##(2008-10#2)
The mean left ventricular##3##4##(1995-3#2)(2008-12#1)
The mean length of the##2##5##(2007-8#1)(2013-8#1)
The mean length of##4##4##(2007-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
The mean levels##2##3##(2008-12#2)
The mean number of##12##4##(1990-2#1)(1990-6#1)(1992-6#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
The mean of the##3##4##(1992-3#1)(2008-10#2)
The mean of##6##3##(1992-3#1)(2008-10#3)(2011-2#2)
The mean operative time was##2##5##(2008-10#2)
The mean percentage of##4##4##(1991-5#1)(2008-10#2)(2013-1#1)
The mean percentage recoveries obtained using##2##6##(2008-10#2)
The mean percentage recoveries##3##4##(2008-10#3)
The mean percentage##7##3##(1991-5#1)(2008-10#5)(2013-1#1)
The mean plasma##2##3##(1992-6#1)(2008-1#1)
The mean ratio##2##3##(2008-12#2)
The mean recoveries##4##3##(2008-10#4)
The mean recovery was##2##4##(2008-10#2)
The mean recovery##3##3##(1993-3#1)(2008-10#2)
The mean relative##2##3##(2008-10#1)(2008-2#1)
The mean score for perception of##2##6##(1991-2#2)
The mean score##4##3##(1991-2#2)(2011-2#1)(2013-8#1)
The mean scores of##3##4##(1995-4#1)(2008-7#1)(2009-10#1)
The mean serum##2##3##(2008-1#1)(2011-2#1)
The mean size of the##2##5##(1995-4#1)(2013-8#1)
The mean survival##4##3##(1990-2#1)(1991-8#1)(2007-11#1)(2008-7#1)
The mean thickness##2##3##(1996-2#1)(2008-10#1)
The mean time of##3##4##(2007-11#1)(2008-11#1)(2009-3#1)
The mean time to##4##4##(2007-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
The mean time##10##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
The mean total##3##3##(1994-2#1)(2007-7#1)(2011-2#1)
The mean urea##2##3##(2008-4#2)
The mean value of##6##4##(2008-10#2)(2008-11#2)(2008-4#1)(2009-6#1)
The mean value##8##3##(1993-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-6#1)
The mean values of##4##4##(2008-10#2)(2008-7#1)(2010-1#1)
The mean values##8##3##(1994-12#1)(2008-10#5)(2008-7#1)(2010-1#1)
The mean was##2##3##(2007-11#1)(2011-2#1)
The mean##341##2##(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-8#2)(2006-4#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-2#3)(2007-7#13)(2007-8#18)(2008-1#16)(2008-10#56)(2008-11#6)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#10)(2008-9#9)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#4)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#21)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#9)(2013-1#17)(2013-8#12)
The meaning of##2##3##(2008-11#1)(2010-10#1)
The means of##3##3##(2008-12#1)(2008-3#1)(2010-8#1)
The means##4##2##(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)
The measure of multilocus correlation##2##5##(2008-10#2)
The measure of##3##3##(2008-10#2)(2011-2#1)
The measure##6##2##(1996-1#1)(2008-10#2)(2010-10#1)(2011-2#1)(2013-1#1)
The measured data##3##3##(2007-11#3)
The measured optical##2##3##(2008-3#2)
The measured results##2##3##(2008-3#2)
The measured scattering##2##3##(2007-11#1)(2008-3#1)
The measured spectral##2##3##(2007-12#1)(2008-3#1)
The measured##74##2##(1991-6#1)(1993-2#2)(2007-11#9)(2007-12#8)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#32)(2008-7#1)(2009-11#1)(2009-5#1)(2009-7#2)(2012-12#1)
The measurement conditions were##2##4##(2008-10#2)
The measurement error##3##3##(2008-3#3)
The measurement is##2##3##(2008-10#1)(2008-3#1)
The measurement method##3##3##(2007-11#1)(2008-3#2)
The measurement of the##8##4##(1990-11#1)(1990-7#1)(1992-12#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-3#2)
The measurement of##23##3##(1990-11#1)(1990-7#1)(1991-11#1)(1992-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)
The measurement results##2##3##(2008-3#1)(2012-3#1)
The measurement system##2##3##(2008-2#1)(2008-3#1)
The measurement technique##2##3##(2008-3#2)
The measurement uncertainty##2##3##(2008-2#1)(2008-3#1)
The measurement was##4##3##(2007-11#1)(2008-5#1)(2013-8#2)
The measurement##56##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1992-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-3#1)(2007-11#3)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#17)(2008-5#3)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#2)
The measurements are in good agreement with##2##7##(2007-12#2)
The measurements are##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
The measurements indicate that##2##4##(2008-2#1)(2012-2#1)
The measurements indicate##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
The measurements of the##2##4##(2008-10#1)(2008-3#1)
The measurements of##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
The measurements were made##2##4##(2008-10#1)(2008-3#1)
The measurements were performed in a##2##6##(2008-10#1)(2008-2#1)
The measurements were performed in##3##5##(2008-10#1)(2008-2#2)
The measurements were performed with##2##5##(2007-12#1)(2008-2#1)
The measurements were performed##6##4##(2007-12#1)(2008-10#2)(2008-2#3)
The measurements were##14##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2012-5#1)
The measurements##36##2##(1996-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#9)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-5#1)
The measures of##2##3##(2008-10#1)(2012-3#1)
The measuring range of##2##4##(2008-10#2)
The measuring range##4##3##(2008-10#4)
The measuring##10##2##(2008-10#8)(2008-11#1)(2008-3#1)
The mechanical properties of the##2##5##(2008-5#1)(2009-7#1)
The mechanical properties of##7##4##(2008-5#2)(2009-7#3)(2009-9#1)(2012-2#1)
The mechanical properties##9##3##(2008-5#2)(2009-7#5)(2009-9#1)(2012-2#1)
The mechanical removal of##2##4##(2012-2#1)(2012-3#1)
The mechanical stability of##2##4##(2008-10#1)(2008-7#1)
The mechanical##19##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#6)(2009-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
The mechanics of##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
The mechanism by which the##3##5##(1992-3#1)(1994-12#1)(1994-8#1)
The mechanism by which##7##4##(1990-5#1)(1990-7#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-5#1)
The mechanism causing##2##3##(2008-2#1)(2008-7#1)
The mechanism for the interaction of##2##6##(2008-10#2)
The mechanism for the##5##4##(2008-10#4)(2008-3#1)
The mechanism for##7##3##(2007-11#1)(2008-10#4)(2008-3#2)
The mechanism is##4##3##(1992-6#1)(1996-8#1)(2008-2#1)(2009-11#1)
The mechanism of action of##2##5##(2008-11#1)(2013-7#1)
The mechanism of action##4##4##(1992-3#1)(2008-11#1)(2008-5#1)(2013-7#1)
The mechanism of the inhibition##2##5##(2008-10#2)
The mechanism of the##15##4##(1990-5#1)(1996-2#1)(1997-7#1)(2008-10#10)(2008-9#1)(2009-10#1)
The mechanism of this effect##2##5##(1990-3#1)(1995-8#1)
The mechanism of this##10##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-3#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-7#2)(2010-11#1)
The mechanism of##67##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#3)(1991-3#2)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
The mechanism underlying##2##3##(1990-3#1)(1992-9#1)
The mechanism whereby##2##3##(1990-2#1)(1995-2#1)
The mechanism##99##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#4)(1990-7#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#36)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
The mechanisms by which the##2##5##(2008-10#1)(2011-1#1)
The mechanisms by which##9##4##(1994-11#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-8#2)(2011-1#1)
The mechanisms for##4##3##(1992-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
The mechanisms of the##2##4##(2008-10#1)(2009-10#1)
The mechanisms of##11##3##(1993-8#1)(2007-12#2)(2008-10#3)(2008-4#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
The mechanisms responsible for##3##4##(1990-12#1)(1996-5#1)(2009-11#1)
The mechanisms that##2##3##(1993-12#1)(2009-7#1)
The mechanisms underlying the##3##4##(2008-3#1)(2008-4#1)(2012-2#1)
The mechanisms underlying these effects##2##5##(2008-7#1)(2008-8#1)
The mechanisms underlying these##4##4##(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
The mechanisms underlying##9##3##(1993-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)
The mechanisms##45##2##(1990-12#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#3)
The mechanistic##4##2##(2008-4#2)(2009-12#1)(2010-12#1)
The media##5##2##(2008-11#2)(2008-12#1)(2008-3#1)(2010-8#1)
The medial##4##2##(1993-12#1)(1994-2#1)(2009-4#1)(2012-2#1)
The median age was##5##4##(1990-9#1)(2007-7#1)(2010-3#1)(2013-1#2)
The median age##7##3##(1990-9#1)(1997-8#1)(2007-7#1)(2010-3#1)(2013-1#3)
The median cost##2##3##(1992-1#1)(1995-2#1)
The median dose##2##3##(2010-3#1)(2013-1#1)
The median duration of response was##2##6##(1992-8#1)(1994-8#1)
The median duration of##8##4##(1990-12#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-8#1)(2007-2#1)(2013-8#1)
The median follow-up duration was##2##5##(2008-10#2)
The median follow-up##3##3##(2008-10#2)(2010-3#1)
The median number of##2##4##(2010-12#1)(2011-2#1)
The median survival of##2##4##(2008-7#1)(2012-3#1)
The median survival time was##2##5##(1994-8#1)(2012-1#1)
The median survival time##4##4##(1990-9#1)(1994-8#1)(2007-11#1)(2012-1#1)
The median survival was##4##4##(1990-12#1)(1992-12#1)(2008-10#1)(2008-6#1)
The median survival##12##3##(1990-12#1)(1990-9#1)(1992-12#1)(1994-8#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-1#1)(2012-3#1)
The median time to progression was##2##6##(1990-10#1)(1990-2#1)
The median time to##4##4##(1990-10#1)(1990-2#1)(2012-3#1)(2013-8#1)
The median time##6##3##(1990-10#1)(1990-2#1)(1993-2#1)(2007-8#1)(2012-3#1)(2013-8#1)
The median##75##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-9#2)(1991-11#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-6#5)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#2)
The medical and##2##3##(1995-1#1)(2010-8#1)
The medical director and company liability beyond the insurance policy##2##10##(1993-12#2)
The medical literature##3##3##(1997-1#1)(2007-7#1)(2008-11#1)
The medical records of##5##4##(1991-4#1)(1996-3#1)(2007-7#1)(2008-7#1)(2013-1#1)
The medical records##6##3##(1991-4#1)(1992-3#1)(1996-3#1)(2007-7#1)(2008-7#1)(2013-1#1)
The medical##25##2##(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1994-2#1)(1995-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
The medication##3##2##(1993-3#1)(1997-2#1)(2008-10#1)
The medium##5##2##(2007-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
The meeting was##4##3##(2008-10#1)(2008-5#3)
The meeting##10##2##(2008-10#1)(2008-5#4)(2008-7#2)(2008-8#2)(2010-5#1)
The melanin##2##2##(2008-10#1)(2008-5#1)
The members of the##3##4##(1990-5#1)(2008-7#1)(2012-12#1)
The membrane attack complex of complement##2##6##(1994-2#2)
The membrane having##2##3##(2008-10#2)
The membrane is##2##3##(2008-10#2)
The membrane##25##2##(1990-12#1)(1993-9#1)(1994-2#2)(1995-6#1)(1997-7#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)(2011-2#1)
The membranes were##4##3##(2008-10#3)(2008-5#1)
The membranes##7##2##(2008-10#6)(2008-5#1)
The memory##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
The mental health##2##3##(1990-6#1)(2011-1#1)
The mental##3##2##(1990-6#1)(2008-11#1)(2011-1#1)
The mentioned##2##2##(2008-10#1)(2009-10#1)
The mercury##2##2##(2008-10#2)
The merit of##2##3##(2008-10#1)(2012-12#1)
The message##4##2##(1992-5#1)(1995-9#1)(2008-12#1)(2010-4#1)
The messenger RNA##2##3##(1997-8#1)(2012-2#1)
The meta-analysis##5##2##(2008-2#1)(2010-11#2)(2010-2#1)(2013-1#1)
The metabolic syndrome (MS)##2##4##(2008-3#2)
The metabolic syndrome and##2##4##(2008-1#1)(2008-3#1)
The metabolic syndrome is##2##4##(2008-1#1)(2008-3#1)
The metabolic syndrome##14##3##(2007-7#1)(2008-1#2)(2008-3#7)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
The metabolic##27##2##(1990-11#2)(1991-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#8)(2008-7#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#2)
The metabolism of##4##3##(1990-11#1)(1992-11#1)(1992-3#1)(2008-11#1)
The metabolites##3##2##(1995-11#1)(1996-5#1)(2008-10#1)
The metal ions in the##3##5##(2008-10#3)
The metal ions were##3##4##(2008-10#3)
The metal ions##8##3##(2008-10#8)
The metal sorption##2##3##(2008-10#2)
The metal##26##2##(1997-7#1)(2007-11#1)(2008-10#22)(2008-12#1)(2008-6#1)
The metallic##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
The metals##3##2##(2008-10#3)
The metapopulation##3##2##(2008-10#1)(2008-8#2)
The method affords binary separation of##3##6##(2008-10#3)
The method allowed##4##3##(2008-10#3)(2009-8#1)
The method allows a##2##4##(2008-10#1)(2008-11#1)
The method allows determination of##2##5##(2008-10#2)
The method allows immediate control of the##2##7##(2008-10#2)
The method allows the determination of##6##6##(2008-10#6)
The method allows the##11##4##(1990-11#1)(2008-10#9)(2009-12#1)
The method allows##20##3##(1990-11#1)(2008-10#15)(2008-11#1)(2008-3#1)(2009-12#1)(2013-1#1)
The method also##3##3##(2007-11#1)(2008-10#1)(2009-6#1)
The method appeared##2##3##(2008-10#1)(2012-1#1)
The method appears##2##3##(2008-10#2)
The method assumes that##2##4##(1994-1#1)(2007-12#1)
The method based on##3##4##(2008-10#3)
The method can be applied##3##5##(2008-10#3)
The method can be used to##5##6##(2008-10#3)(2008-3#1)(2008-5#1)
The method can be used##6##5##(1993-9#1)(2008-10#3)(2008-3#1)(2008-5#1)
The method can be##13##4##(1993-9#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2013-1#1)
The method can##14##3##(1993-9#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#2)(2013-1#1)
The method combines##2##3##(2007-12#1)(2008-6#1)
The method consists of##6##4##(2007-11#1)(2008-10#3)(2008-3#2)
The method could be##2##4##(2008-10#2)
The method could##3##3##(2008-10#3)
The method described here##3##4##(1991-12#1)(2008-4#1)(2008-9#1)
The method described in this##2##5##(2007-12#1)(2012-12#1)
The method described is a##2##5##(1996-5#1)(2008-9#1)
The method described is##6##4##(1990-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
The method described was##2##4##(2008-10#2)
The method described##16##3##(1990-2#1)(1991-12#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#2)(2009-3#1)(2012-12#1)
The method detection limit (MDL)##3##5##(2008-10#3)
The method detection limit for##2##5##(2008-10#2)
The method detection limit##7##4##(2008-10#7)
The method detection##8##3##(2008-10#8)
The method detects##2##3##(2008-10#1)(2010-5#1)
The method developed was##2##4##(2008-10#2)
The method developed##12##3##(2008-10#12)
The method does not##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
The method does##5##3##(2008-10#2)(2008-2#2)(2008-3#1)
The method employs##2##3##(2008-10#1)(2008-3#1)
The method exhibits a##2##4##(2008-10#1)(2008-3#1)
The method exhibits##3##3##(2008-10#2)(2008-3#1)
The method exploits the##4##4##(2008-10#2)(2008-2#1)(2008-4#1)
The method exploits##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
The method for##6##3##(2008-10#4)(2008-3#1)(2008-5#1)
The method gives the detection limit of##2##7##(2008-10#2)
The method gives##3##3##(2008-10#3)
The method had##2##3##(2008-5#1)(2011-2#1)
The method has a detection limit of 0##2##8##(2008-10#2)
The method has a detection limit##3##6##(2008-10#3)
The method has a##10##4##(1990-2#1)(2008-10#9)
The method has also been##3##5##(2008-10#3)
The method has applications in##2##5##(2008-3#1)(2008-4#1)
The method has been applied for quantifying##2##7##(2008-10#2)
The method has been applied for the##2##7##(2008-10#2)
The method has been applied for##5##6##(2008-10#5)
The method has been applied successfully to the##2##8##(2008-10#2)
The method has been applied successfully to##3##7##(2008-10#3)
The method has been applied successfully##4##6##(2008-10#4)
The method has been applied to determine##2##7##(2008-10#2)
The method has been applied to the determination of lead in##4##11##(2008-10#4)
The method has been applied to the determination of these##2##10##(2008-10#2)
The method has been applied to the determination of total##2##10##(2008-10#2)
The method has been applied to the determination of trace##2##10##(2008-10#2)
The method has been applied to the determination of##19##9##(2008-10#19)
The method has been applied to the##22##7##(2008-10#22)
The method has been applied to##33##6##(2008-10#32)(2010-8#1)
The method has been applied##43##5##(2008-10#42)(2010-8#1)
The method has been employed to##2##6##(2008-10#2)
The method has been fully validated##3##6##(2008-10#3)
The method has been satisfactorily applied to the determination of##6##10##(2008-10#6)
The method has been satisfactorily applied to the direct determination of the total protein in human serum##2##17##(2008-10#2)
The method has been satisfactorily applied to the##8##8##(2008-10#8)
The method has been successfully applied for the##3##8##(2008-10#3)
The method has been successfully applied for##6##7##(2008-10#6)
The method has been successfully applied to determine##2##8##(2008-10#2)
The method has been successfully applied to the determination of##9##10##(2008-10#9)
The method has been successfully applied to##13##7##(2008-10#13)
The method has been successfully applied##19##6##(2008-10#19)
The method has been successfully##20##5##(2008-10#20)
The method has been tested##2##5##(2007-11#1)(2008-10#1)
The method has been used for the determination##2##8##(2008-10#2)
The method has been used to##2##6##(2008-10#2)
The method has been used##4##5##(2008-10#4)
The method has been##85##4##(2007-11#1)(2008-10#83)(2010-8#1)
The method has high precision and accuracy##2##7##(2008-10#2)
The method has potential##2##4##(2008-10#1)(2008-9#1)
The method has##110##3##(1990-2#1)(2007-11#1)(2008-10#104)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)
The method here##2##3##(2008-10#2)
The method includes a##2##4##(2007-12#1)(2008-3#1)
The method includes##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
The method involved##4##3##(2008-10#4)
The method involves a sequential injection analysis (SIA) system equipped with a chemiluminescence detector and a##2##16##(2008-10#2)
The method involves a sequential##3##5##(2008-10#3)
The method involves a##9##4##(2008-10#7)(2008-3#1)(2011-2#1)
The method involves measuring the##2##5##(2008-10#1)(2008-3#1)
The method involves the##14##4##(1990-2#1)(1996-5#1)(2008-10#12)
The method involves##34##3##(1990-2#1)(1991-5#1)(1993-8#1)(1996-5#1)(2008-10#25)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
The method is a##2##4##(2008-10#1)(2008-2#1)
The method is accurate and##2##5##(2008-10#2)
The method is accurate##6##4##(1997-2#1)(2008-10#2)(2010-5#1)(2011-1#2)
The method is also##3##4##(1992-9#1)(2008-10#1)(2008-3#1)
The method is an extension of##2##6##(2008-10#1)(2008-2#1)
The method is an##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
The method is applicable for##2##5##(2008-10#2)
The method is applicable to the##2##6##(2008-10#2)
The method is applicable to##5##5##(2008-10#3)(2008-2#1)(2008-5#1)
The method is applicable##7##4##(2008-10#5)(2008-2#1)(2008-5#1)
The method is applied for##2##5##(2008-10#2)
The method is applied to the analysis of##2##8##(2008-10#2)
The method is applied to the determination of##2##8##(2008-10#2)
The method is applied to the##10##6##(2008-10#7)(2008-3#2)(2008-7#1)
The method is applied to##18##5##(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
The method is applied##22##4##(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-7#1)
The method is based on a##12##6##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)
The method is based on an##2##6##(2007-11#1)(2008-10#1)
The method is based on its catalytic effect on the oxidation of##2##12##(2008-10#2)
The method is based on the CL reaction of##2##9##(2008-10#2)
The method is based on the catalytic effect of vanadium(V) on##2##11##(2008-10#2)
The method is based on the catalytic effect of##9##9##(2008-10#9)
The method is based on the catalytic##10##7##(2008-10#10)
The method is based on the chemical##2##7##(2008-10#2)
The method is based on the chemiluminescence reaction of##2##9##(2008-10#2)
The method is based on the condensation reaction##2##8##(2008-10#2)
The method is based on the condensation##3##7##(2008-10#3)
The method is based on the derivatization reaction of the primary amine group with o-phthalaldehyde in the presence of 2-mercaptoethanol##2##20##(2008-10#2)
The method is based on the difference in the rate of##2##11##(2008-10#2)
The method is based on the enhancing effect##2##8##(2008-10#2)
The method is based on the extraction of##2##8##(2008-10#2)
The method is based on the fact that##2##8##(1997-2#1)(2008-10#1)
The method is based on the fluorescence##2##7##(2008-10#2)
The method is based on the formation of##4##8##(2008-10#4)
The method is based on the interaction of##2##8##(2008-10#2)
The method is based on the measurement of##2##8##(2008-10#2)
The method is based on the on-line##2##7##(2008-10#2)
The method is based on the oxidation of rhodamine##2##9##(2008-10#2)
The method is based on the oxidation of##6##8##(2008-10#6)
The method is based on the oxidation##7##7##(2008-10#7)
The method is based on the reaction between the##2##9##(2008-10#2)
The method is based on the reaction between##6##8##(2008-10#6)
The method is based on the reaction of##5##8##(2008-10#5)
The method is based on the reaction##12##7##(2008-10#12)
The method is based on the reduction of##3##8##(2008-10#3)
The method is based on the separation##2##7##(2008-10#2)
The method is based on the sorption of##2##8##(2008-10#2)
The method is based on the use of##4##8##(2008-10#1)(2008-3#3)
The method is based on the##122##6##(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#109)(2008-11#1)(2008-3#6)(2011-2#1)
The method is based on##177##5##(1990-8#1)(1997-2#1)(1997-3#1)(2007-11#8)(2007-12#5)(2008-10#138)(2008-11#1)(2008-2#4)(2008-3#17)(2011-2#1)
The method is based upon the##2##6##(2008-10#2)
The method is based upon##4##5##(2008-10#4)
The method is based##182##4##(1990-8#1)(1997-2#1)(1997-3#1)(2007-11#8)(2007-12#5)(2008-10#143)(2008-11#1)(2008-2#4)(2008-3#17)(2011-2#1)
The method is capable of detecting##2##6##(1995-3#1)(2008-10#1)
The method is capable of##3##5##(1995-3#1)(2008-10#2)
The method is demonstrated by the##2##6##(2007-12#1)(2008-5#1)
The method is demonstrated##3##4##(2007-12#1)(2008-5#1)(2008-8#1)
The method is developed by the use of a##2##9##(2008-10#2)
The method is developed by##3##5##(2008-10#3)
The method is developed##4##4##(2008-10#3)(2008-2#1)
The method is easy##2##4##(1991-11#1)(2008-10#1)
The method is fast##2##4##(2008-10#2)
The method is free from##4##5##(2008-10#4)
The method is highly selective and the determination is little affected by the presence of other substances##2##17##(2008-10#2)
The method is highly##5##4##(2008-10#4)(2008-7#1)
The method is illustrated using##3##5##(1992-9#1)(1994-11#1)(2012-1#1)
The method is illustrated##6##4##(1992-9#1)(1994-11#1)(2007-11#1)(2010-1#1)(2010-6#1)(2012-1#1)
The method is not##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
The method is particularly##4##4##(1991-5#1)(2008-3#1)(2008-4#1)(2008-6#1)
The method is rapid##4##4##(2008-10#3)(2008-9#1)
The method is sensitive and##4##5##(1995-11#1)(2008-10#2)(2008-3#1)
The method is sensitive##10##4##(1995-11#1)(1996-2#1)(2008-10#7)(2008-3#1)
The method is simple and##11##5##(1992-3#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-3#2)
The method is simple##25##4##(1990-2#1)(1992-3#1)(1996-2#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)
The method is successfully applied to##4##6##(2008-10#4)
The method is successfully applied##5##5##(2008-10#5)
The method is suitable for the determination of##2##8##(2008-10#2)
The method is suitable for the##3##6##(2008-10#3)
The method is suitable for##6##5##(2008-10#6)
The method is tested##2##4##(2008-10#1)(2008-3#1)
The method is used to##2##5##(2008-3#1)(2010-2#1)
The method is used##3##4##(2008-10#1)(2008-3#1)(2010-2#1)
The method is validated##2##4##(2008-10#1)(2008-5#1)
The method is very##4##4##(2008-10#3)(2008-11#1)
The method is##364##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-3#2)(1992-9#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#4)(1997-3#2)(2007-11#12)(2007-12#10)(2008-10#245)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#32)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)
The method makes use of##3##5##(2008-10#1)(2008-3#2)
The method of analysis##2##4##(2008-10#2)
The method of choice##3##4##(2007-11#1)(2008-4#1)(2010-3#1)
The method of cumulants##2##4##(2008-3#2)
The method of##37##3##(1990-8#2)(1992-11#1)(1994-12#1)(1996-6#1)(1997-3#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)
The method offered the##2##4##(2008-10#2)
The method offers##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
The method performance was evaluated##2##5##(2008-10#2)
The method permits rapid and precise individual separation of gallium (III)##2##11##(2008-10#2)
The method permits the##4##4##(2008-10#2)(2008-3#2)
The method permits##9##3##(2008-10#5)(2008-3#4)
The method presented here##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
The method presented##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
The method proposed for##2##4##(2008-10#2)
The method proposed here is##2##5##(1991-5#1)(2008-10#1)
The method proposed is##2##4##(2008-10#2)
The method proposed was applied##4##5##(2008-10#4)
The method proposed##14##3##(1991-5#1)(1993-6#1)(2008-10#12)
The method proved to be##2##5##(2008-10#1)(2008-2#1)
The method provided##4##3##(1995-2#1)(2008-10#3)
The method provides a dynamic range from##2##7##(2008-10#2)
The method provides a##6##4##(2008-10#4)(2008-3#1)(2008-4#1)
The method provides##11##3##(1992-11#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-4#1)
The method relies on the linear relationship between the##2##9##(2008-10#2)
The method relies on the##6##5##(2007-12#1)(2008-10#3)(2008-3#2)
The method relies on##9##4##(2007-12#2)(2008-10#3)(2008-3#4)
The method relies##10##3##(2007-12#2)(2008-10#4)(2008-3#4)
The method requires a##2##4##(2008-10#1)(2008-7#1)
The method requires only##2##4##(2008-3#2)
The method requires##6##3##(1994-7#1)(2008-10#2)(2008-3#2)(2008-7#1)
The method showed a good##2##5##(2008-10#1)(2011-3#1)
The method showed a##3##4##(2008-10#2)(2011-3#1)
The method showed good linearity##2##5##(1993-8#1)(1996-5#1)
The method showed good##3##4##(1993-8#1)(1996-5#1)(2011-2#1)
The method showed linear##2##4##(2008-10#2)
The method showed##9##3##(1993-8#1)(1996-5#1)(2008-10#5)(2011-2#1)(2011-3#1)
The method shows a linear range between##2##7##(2008-10#2)
The method shows a##3##4##(2008-10#3)
The method shows good##5##4##(2008-10#4)(2013-8#1)
The method shows##9##3##(2008-10#7)(2012-12#1)(2013-8#1)
The method takes advantage of##2##5##(2008-2#2)
The method takes##3##3##(2008-2#2)(2008-3#1)
The method to##2##3##(2008-11#2)
The method used a##2##4##(2008-10#2)
The method used is##2##4##(1997-1#1)(2008-3#1)
The method used##6##3##(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)
The method uses a##6##4##(2008-10#3)(2008-3#2)(2012-3#1)
The method uses##12##3##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-9#1)(2012-3#1)
The method utilizes##2##3##(1991-2#1)(2008-2#1)
The method was also##6##4##(2008-10#6)
The method was applied for the determination of##11##8##(2008-10#11)
The method was applied for the direct##2##7##(2008-10#2)
The method was applied for the evaluation of##2##8##(2008-10#2)
The method was applied for the##19##6##(2008-10#19)
The method was applied for##24##5##(2008-10#24)
The method was applied in##2##5##(2008-10#1)(2011-3#1)
The method was applied on##3##5##(2008-10#3)
The method was applied satisfactorily to##2##6##(2008-10#2)
The method was applied successfully to the determination of these##2##10##(2008-10#2)
The method was applied successfully to the determination of##6##9##(2008-10#6)
The method was applied successfully to##7##6##(1991-5#1)(2008-10#6)
The method was applied to 1##2##6##(2008-10#2)
The method was applied to determine##5##6##(2008-10#5)
The method was applied to different##3##6##(2008-10#3)
The method was applied to samples of##2##7##(2008-10#2)
The method was applied to the analysis of##7##8##(2008-10#7)
The method was applied to the determination of##28##8##(1996-5#1)(1997-2#1)(2008-10#26)
The method was applied to the recovery and determination of##2##10##(2008-10#2)
The method was applied to the recovery of##2##8##(2008-10#2)
The method was applied to the recovery##4##7##(2008-10#4)
The method was applied to the##43##6##(1996-5#1)(1997-2#1)(2008-10#41)
The method was applied to two##2##6##(2008-10#1)(2008-3#1)
The method was applied to##72##5##(1996-5#1)(1997-2#1)(2008-10#66)(2008-3#2)(2011-2#1)(2013-8#1)
The method was applied##111##4##(1991-5#1)(1996-5#1)(1997-2#1)(2008-10#103)(2008-3#2)(2011-2#1)(2011-3#1)(2013-8#1)
The method was based on the competitive reaction of##2##9##(2008-10#2)
The method was based on the formation of##2##8##(2008-10#2)
The method was based on the##12##6##(2008-10#12)
The method was based on##13##5##(2008-10#13)
The method was based##14##4##(2008-10#14)
The method was carried out##2##5##(2008-10#2)
The method was compared with the##2##6##(2008-10#2)
The method was compared with##4##5##(2008-10#4)
The method was developed##2##4##(2008-10#2)
The method was employed for the determination of##2##8##(2008-10#1)(2011-1#1)
The method was employed for the##3##6##(2008-10#2)(2011-1#1)
The method was evaluated by##2##5##(2008-10#2)
The method was evaluated##5##4##(2008-10#5)
The method was extended for##2##5##(2008-10#2)
The method was finally applied##2##5##(2008-10#2)
The method was found to be accurate and##2##8##(2008-10#1)(2012-2#1)
The method was found to be applicable##2##7##(2008-10#2)
The method was found to be relatively selective and was applied successfully to##2##13##(2008-10#2)
The method was found to be suitable for the##2##9##(2008-10#1)(2011-1#1)
The method was found to be very precise [s(r)=0##2##9##(2008-10#2)
The method was found to be##12##6##(2008-10#8)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#1)
The method was further##2##4##(2008-10#2)
The method was highly sensitive##2##5##(1994-11#1)(2008-10#1)
The method was linear over the##2##6##(2008-10#2)
The method was linear##3##4##(2008-10#3)
The method was optimized##3##4##(2008-10#3)
The method was satisfactorily applied to the determination of##3##9##(2008-10#3)
The method was satisfactorily applied to the##4##7##(2008-10#4)
The method was satisfactorily applied##5##5##(2008-10#5)
The method was satisfactorily##6##4##(2008-10#6)
The method was successfully applied for the analysis of##2##9##(2008-10#2)
The method was successfully applied for the determination of##2##9##(2008-10#2)
The method was successfully applied for the##6##7##(2008-10#6)
The method was successfully applied in##2##6##(2008-10#1)(2011-3#1)
The method was successfully applied to determine##2##7##(2008-10#2)
The method was successfully applied to the analysis of##6##9##(2008-10#5)(2013-1#1)
The method was successfully applied to the determination of lead in##2##11##(2008-10#2)
The method was successfully applied to the determination of low levels of##2##12##(2008-10#2)
The method was successfully applied to the determination of##26##9##(1994-9#1)(1996-5#1)(2008-10#24)
The method was successfully applied to the extraction and determination of bismuth in natural water##2##15##(2008-10#2)
The method was successfully applied to the##37##7##(1994-9#1)(1996-5#1)(2008-10#34)(2013-1#1)
The method was successfully applied to##39##6##(1994-9#1)(1996-5#1)(2008-10#36)(2013-1#1)
The method was successfully applied##47##5##(1994-9#1)(1996-5#1)(2008-10#43)(2011-3#1)(2013-1#1)
The method was successfully used##2##5##(2008-10#2)
The method was successfully##51##4##(1994-9#1)(1996-5#1)(2008-10#46)(2008-2#1)(2011-3#1)(2013-1#1)
The method was tested by##3##5##(2008-10#3)
The method was tested with##2##5##(2008-10#2)
The method was tested##8##4##(2008-10#6)(2008-12#1)(2008-3#1)
The method was then applied to the##2##7##(2008-10#2)
The method was used for the determination of##3##8##(2008-10#3)
The method was used for the##5##6##(2008-10#5)
The method was used to determine the concentration-time profiles of##2##10##(2008-10#2)
The method was used to determine the##3##7##(2008-10#3)
The method was used to determine##4##6##(2008-10#4)
The method was used to screen##2##6##(2008-10#1)(2008-9#1)
The method was used to##11##5##(1990-11#1)(2008-10#8)(2008-6#1)(2008-9#1)
The method was used##19##4##(1990-11#1)(2008-10#16)(2008-6#1)(2008-9#1)
The method was validated and##4##5##(1996-5#1)(2008-10#2)(2010-3#1)
The method was validated by the##2##6##(2008-10#2)
The method was validated by##7##5##(1996-3#1)(2008-10#6)
The method was validated for precision##2##6##(2008-10#2)
The method was validated for##5##5##(2008-10#5)
The method was validated in terms of linearity##2##8##(2010-3#1)(2012-2#1)
The method was validated in terms of##3##7##(2008-10#1)(2010-3#1)(2012-2#1)
The method was validated using a##2##6##(2008-10#2)
The method was validated using##3##5##(2008-10#3)
The method was validated##25##4##(1996-3#1)(1996-5#1)(2008-10#19)(2010-3#2)(2011-3#1)(2012-2#1)
The method was##300##3##(1990-11#1)(1990-8#1)(1991-5#1)(1994-11#2)(1994-9#1)(1996-3#1)(1996-5#3)(1997-2#2)(2007-12#1)(2008-10#264)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#2)(2010-3#3)(2011-1#2)(2011-2#1)(2011-3#3)(2012-2#3)(2013-1#1)(2013-8#1)
The method with##2##3##(2008-10#1)(2008-3#1)
The method works well##2##4##(2008-2#1)(2008-3#1)
The method works##3##3##(2008-2#2)(2008-3#1)
The method yields##2##3##(1991-5#1)(2008-2#1)
The method##1174##2##(1990-11#2)(1990-12#1)(1990-2#5)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#5)(1992-11#2)(1992-3#2)(1992-9#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#4)(2006-4#1)(2007-11#19)(2007-12#22)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#831)(2008-11#14)(2008-12#2)(2008-2#31)(2008-3#86)(2008-4#13)(2008-5#10)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#9)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#5)(2011-3#4)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
The method's##3##2##(2008-10#2)(2013-1#1)
The methodological quality was assessed##2##5##(2008-10#1)(2011-2#1)
The methodological quality was##3##4##(2008-10#2)(2011-2#1)
The methodological quality##4##3##(2008-10#3)(2011-2#1)
The methodological##9##2##(1995-11#1)(2008-10#5)(2008-12#1)(2011-2#1)(2012-3#1)
The methodologies##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
The methodology developed is##2##4##(2008-10#2)
The methodology developed##4##3##(2008-10#3)(2009-10#1)
The methodology has been##2##4##(2008-2#1)(2009-10#1)
The methodology has##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
The methodology involves##2##3##(2007-11#1)(2008-10#1)
The methodology is applied to the##2##6##(1992-3#1)(2008-10#1)
The methodology is based on the##2##6##(2008-10#2)
The methodology is##9##3##(1992-3#1)(1996-5#1)(2008-10#5)(2012-12#1)(2012-2#1)
The methodology of##2##3##(1991-11#1)(2008-10#1)
The methodology used to##2##4##(1996-1#1)(2008-2#1)
The methodology used##5##3##(1991-6#1)(1996-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
The methodology##37##2##(1991-11#1)(1991-6#1)(1992-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#19)(2008-2#2)(2008-4#1)(2009-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
The methodology's##2##2##(1994-2#1)(2011-1#1)
The methods are applied to##3##5##(1997-4#2)(2008-10#1)
The methods are applied##4##4##(1997-4#2)(2008-10#1)(2012-1#1)
The methods are based on the reaction of these drugs as n-electron donors with the sigma-acceptor iodine##2##17##(2008-10#2)
The methods are based on the##3##6##(2008-10#3)
The methods are based on##4##5##(2008-10#3)(2008-3#1)
The methods are##11##3##(1997-4#2)(2008-10#6)(2008-3#1)(2008-4#1)(2012-1#1)
The methods covered##2##3##(2008-10#1)(2008-9#1)
The methods described##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
The methods developed##2##3##(2008-10#2)
The methods employed##2##3##(1991-11#1)(2013-8#1)
The methods have been successfully applied to the##2##8##(2008-10#2)
The methods have been successfully applied to##3##7##(2008-10#3)
The methods have been##5##4##(2008-10#3)(2008-9#1)(2009-8#1)
The methods have##6##3##(2008-10#4)(2008-9#1)(2009-8#1)
The methods included##2##3##(2008-10#1)(2013-8#1)
The methods of##5##3##(1996-5#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-2#1)
The methods proposed##2##3##(2008-10#1)(2012-3#1)
The methods require##2##3##(1994-8#1)(2008-10#1)
The methods used included##2##4##(1996-8#1)(2008-12#1)
The methods used to##2##4##(2008-1#1)(2008-9#1)
The methods used##7##3##(1996-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
The methods were applied to##4##5##(2008-10#4)
The methods were applied##5##4##(2008-10#5)
The methods were##16##3##(2008-10#13)(2008-3#1)(2008-6#1)(2008-9#1)
The methods##73##2##(1991-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-4#2)(2008-1#2)(2008-10#35)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-8#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
The mice##3##2##(1990-6#1)(2008-8#1)(2012-2#1)
The micellar##2##2##(2008-10#2)
The micro-volume ByT-FAS##2##3##(2008-10#2)
The microarray##2##2##(2011-1#1)(2013-1#1)
The microbial community resident in##2##5##(2008-10#2)
The microbial##10##2##(1992-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
The microbiological##4##2##(1990-6#1)(2007-8#1)(2011-2#1)(2013-1#1)
The microcirculation##2##2##(2009-10#1)(2010-7#1)
The microfluidic##2##2##(2009-12#2)
The microsatellite##5##2##(2008-10#4)(2008-5#1)
The microscope achieves##2##3##(2008-2#2)
The microscope##5##2##(2008-2#4)(2008-5#1)
The microscopic##3##2##(1995-3#1)(2008-5#1)(2011-2#1)
The microsomal##2##2##(1997-3#1)(1997-7#1)
The microstructure and##2##3##(2009-7#1)(2011-2#1)
The microstructure of##2##3##(2008-10#1)(2008-2#1)
The microstructure##5##2##(2008-10#1)(2008-2#1)(2009-7#2)(2011-2#1)
The microvascular##3##2##(1995-12#1)(2011-2#2)
The microvilli##2##2##(2007-12#2)
The microwave##3##2##(2008-10#2)(2013-8#1)
The mid-century revolution in thoracic and cardiovascular surgery##2##8##(2007-8#2)
The middle##3##2##(1995-12#1)(2008-1#1)(2011-2#1)
The midgut##3##2##(2007-12#3)
The midpoint##5##2##(1990-7#1)(1991-8#1)(1995-5#2)(2008-10#1)
The migration of##2##3##(1994-8#1)(2008-7#1)
The migration##6##2##(1994-8#1)(2008-1#1)(2008-10#3)(2008-7#1)
The mild##2##2##(1995-12#1)(1996-5#1)
The milk##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
The millennium##3##2##(1996-12#1)(2008-1#1)(2009-10#1)
The mineralogical##2##2##(2008-10#2)
The miniaturized##3##2##(2008-10#1)(2009-12#1)(2011-1#1)
The minigenes##2##2##(2008-8#2)
The minimal##8##2##(1995-11#1)(1995-2#1)(1996-5#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-5#1)
The minimally invasive##2##3##(2008-10#1)(2013-1#1)
The minimum detectable##4##3##(2008-10#2)(2008-3#2)
The minimum follow-up was 1 year##2##6##(2007-11#2)
The minimum##26##2##(1991-11#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-3#4)(2008-5#1)(2008-6#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
The minor##5##2##(1992-4#1)(1993-12#1)(1994-8#1)(2008-11#1)(2011-2#1)
The minority of##2##3##(2008-10#1)(2008-4#1)
The mirror##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
The mirrors##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
The missing##4##2##(1991-6#1)(1993-6#1)(1996-12#1)(2012-2#1)
The mission of the##2##4##(2008-5#1)(2009-10#1)
The mission of##3##3##(1997-1#1)(2008-5#1)(2009-10#1)
The mission##6##2##(1993-2#1)(1993-3#1)(1997-1#1)(2008-5#1)(2009-10#1)(2010-6#1)
The mitochondrial cytidylyltransferase##2##3##(1991-11#2)
The mitochondrial##11##2##(1991-11#3)(1994-8#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-3#1)(2012-2#1)
The mitogen-activated protein##2##3##(2008-4#1)(2008-9#1)
The mitogenic##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
The mixed##7##2##(2008-10#4)(2008-3#1)(2009-10#1)(2012-2#1)
The mixing##2##2##(2008-10#1)(2008-5#1)
The mixture of##6##3##(1996-5#1)(1997-7#1)(2008-10#4)
The mixture##10##2##(1996-5#1)(1997-7#1)(2008-10#8)
The mobile phase consisted of##2##5##(2008-10#1)(2011-2#1)
The mobile phase consisting of##2##5##(2010-3#1)(2012-12#1)
The mobile phase is a##2##5##(2008-10#2)
The mobile phase used was phosphate buffer##2##7##(2008-10#2)
The mobile phase used was##7##5##(1997-2#1)(2008-10#4)(2010-5#1)(2012-2#1)
The mobile phase was##2##4##(1990-8#1)(2010-3#1)
The mobile phase##16##3##(1990-8#1)(1997-2#1)(2008-10#7)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
The mobile phases##2##3##(1990-8#1)(2008-10#1)
The mobile##21##2##(1990-8#2)(1995-6#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-3#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
The mobility of##5##3##(1991-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2013-1#1)
The modal##2##2##(2008-3#2)
The mode of action of##3##5##(2008-10#2)(2008-4#1)
The mode of action##4##4##(1990-12#1)(2008-10#2)(2008-4#1)
The mode of##12##3##(1990-12#1)(1992-6#1)(1995-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-9#1)
The mode##18##2##(1990-12#1)(1992-6#1)(1993-3#1)(1995-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-7#1)
The mode-locked##2##2##(2007-11#1)(2008-3#1)
The model accounts for##3##4##(2008-3#2)(2013-8#1)
The model also##7##3##(1995-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
The model assumes that##2##4##(1994-5#1)(1995-12#1)
The model assumes##3##3##(1994-5#1)(1995-12#1)(2008-3#1)
The model can be used to##3##6##(2008-10#1)(2008-3#1)(2010-8#1)
The model can be##6##4##(1997-4#1)(2008-10#3)(2008-3#1)(2010-8#1)
The model can##8##3##(1997-4#1)(2008-10#3)(2008-3#3)(2010-8#1)
The model considers##2##3##(2008-10#1)(2009-8#1)
The model describes the##2##4##(2008-1#1)(2008-11#1)
The model describes##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
The model for##2##3##(1992-2#1)(2008-9#1)
The model gives##2##3##(1996-4#1)(2008-10#1)
The model has been##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
The model has##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
The model includes the##4##4##(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
The model includes##7##3##(1993-8#1)(1995-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
The model incorporates a##2##4##(1992-6#1)(2008-7#1)
The model incorporates##5##3##(1992-6#1)(2008-10#1)(2008-7#2)(2013-8#1)
The model is based on the##5##6##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
The model is based on##8##5##(1990-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
The model is used to##2##5##(2008-11#1)(2008-4#1)
The model is useful for##3##5##(2008-2#1)(2008-3#1)(2013-1#1)
The model is validated##2##4##(2008-7#2)
The model is##37##3##(1990-8#1)(1992-6#1)(1995-9#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-7#3)(2008-8#2)(2009-11#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
The model of##3##3##(1992-6#1)(2011-1#2)
The model predicted##2##3##(2008-3#1)(2008-7#1)
The model predictions##2##3##(2008-7#1)(2013-8#1)
The model predicts a##2##4##(2008-10#1)(2008-5#1)
The model predicts that##8##4##(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-1#1)
The model predicts the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
The model predicts##14##3##(1992-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#1)(2013-1#1)
The model provides a##2##4##(2008-11#1)(2011-2#1)
The model provides##6##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
The model results##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
The model shows that##3##4##(2008-8#2)(2008-9#1)
The model shows##4##3##(2007-11#1)(2008-8#2)(2008-9#1)
The model simulates##2##3##(2008-10#1)(2013-8#1)
The model suggests that##2##4##(2008-4#1)(2008-8#1)
The model suggests##3##3##(2007-12#1)(2008-4#1)(2008-8#1)
The model system##2##3##(2007-11#2)
The model uses##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
The model utilized##2##3##(2008-7#1)(2013-1#1)
The model was able to##3##5##(2008-10#1)(2008-6#1)(2013-1#1)
The model was applied to##2##5##(2008-10#1)(2008-7#1)
The model was expanded##2##4##(2008-10#1)(2008-8#1)
The model was tested##2##4##(2008-10#1)(2008-7#1)
The model was validated with##3##5##(2008-10#2)(2008-11#1)
The model was##27##3##(1992-2#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
The model with##2##3##(2011-2#2)
The model##230##2##(1990-8#1)(1992-2#3)(1992-4#1)(1992-6#4)(1992-9#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-8#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#37)(2008-11#11)(2008-2#8)(2008-3#28)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#22)(2008-8#17)(2008-9#9)(2009-11#2)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#7)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#6)
The model's##3##2##(2007-11#1)(2008-3#1)(2011-3#1)
The model-predicted##2##2##(2008-8#1)(2008-9#1)
The modeling of the##2##4##(1995-2#1)(2007-12#1)
The modeling of##3##3##(1995-2#1)(2007-12#1)(2009-8#1)
The modeling##8##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-8#1)
The modelling##3##2##(2008-10#3)
The models are##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
The models were##4##3##(2008-10#2)(2010-6#1)(2011-2#1)
The models##30##2##(1992-6#1)(1994-1#1)(1996-3#1)(1996-4#1)(1997-1#2)(2007-11#1)(2007-7#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#4)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-8#2)
The moderating effect of##2##4##(2010-6#1)(2010-7#1)
The modern treatment##2##3##(1995-5#1)(2012-3#1)
The modern##5##2##(1994-12#1)(1995-5#1)(2007-8#1)(2009-5#1)(2012-3#1)
The modes of action##2##4##(2008-10#2)
The modes of##4##3##(2007-12#1)(2007-4#1)(2008-10#2)
The modes##6##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2011-2#1)
The modification of the##4##4##(2008-10#4)
The modification of##7##3##(1993-6#1)(2008-10#4)(2008-2#1)(2008-3#1)
The modification##12##2##(1990-8#1)(1993-3#1)(1993-6#1)(1995-6#1)(2008-10#5)(2008-2#1)(2008-3#2)
The modifications##6##2##(1990-12#1)(1991-9#1)(1996-12#1)(2008-10#2)(2008-4#1)
The modified electrode can be used for##2##7##(2008-10#2)
The modified electrode showed excellent##2##5##(2008-10#2)
The modified electrode showed##4##4##(2008-10#4)
The modified electrode shows a##2##5##(2008-10#2)
The modified electrode shows##4##4##(2008-10#4)
The modified electrode was characterized by alternating current impedance and electrochemical probe##2##12##(2008-10#2)
The modified electrode was##5##4##(2008-10#5)
The modified electrode##22##3##(2008-10#22)
The modified electrodes were##2##4##(2008-10#2)
The modified electrodes##5##3##(2008-10#5)
The modified silica gels##2##4##(2008-10#2)
The modified silica##3##3##(2008-10#3)
The modified technique##2##3##(2008-10#1)(2008-7#1)
The modified##66##2##(1990-7#1)(1997-7#1)(2007-10#1)(2008-10#47)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
The modifier##2##2##(2008-10#2)
The modular##2##2##(2008-11#1)(2011-2#1)
The modulation depth##2##3##(2008-2#1)(2008-3#1)
The modulation of the##2##4##(2008-7#1)(2011-1#1)
The modulation of##5##3##(1992-9#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
The modulation##8##2##(1992-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
The modulator##2##2##(2007-12#1)(2008-2#1)
The module is##2##3##(2007-12#1)(2008-12#1)
The module##7##2##(1996-1#2)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)
The molar absorption coefficient##2##4##(2008-10#2)
The molar absorptivities of##2##4##(2008-10#2)
The molar absorptivity and Sandell's sensitivity are 1##2##8##(2008-10#2)
The molar absorptivity and Sandell's sensitivity are##3##7##(2008-10#3)
The molar absorptivity and Sandell's sensitivity were found to be##2##10##(2008-10#2)
The molar absorptivity and Sandell's sensitivity##5##6##(2008-10#5)
The molar absorptivity and##7##4##(2008-10#7)
The molar absorptivity is##3##4##(2008-10#3)
The molar absorptivity of the complex is##2##7##(2008-10#2)
The molar absorptivity of the##5##5##(2008-10#5)
The molar absorptivity of##6##4##(2008-10#6)
The molar absorptivity##20##3##(2008-10#20)
The molar ratio of the##3##5##(2008-10#3)
The molar##30##2##(2008-10#30)
The molecular and##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
The molecular basis for##3##4##(1997-2#1)(2008-8#1)(2011-2#1)
The molecular basis of the##2##5##(2008-3#1)(2008-9#1)
The molecular basis of##5##4##(1992-5#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-9#1)
The molecular basis##8##3##(1992-5#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
The molecular characterization of##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
The molecular genetic##2##3##(2008-7#1)(2011-2#1)
The molecular mass of the##4##5##(1991-8#1)(1992-9#1)(1997-4#1)(2008-10#1)
The molecular mass of##9##4##(1990-5#2)(1991-8#1)(1992-12#1)(1992-9#1)(1995-2#1)(1997-4#1)(2008-10#2)
The molecular mass##10##3##(1990-5#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-2#1)(1997-4#1)(2008-10#2)
The molecular mechanism##3##3##(1990-2#1)(2010-7#1)(2012-12#1)
The molecular mechanisms that##2##4##(1996-2#1)(1997-6#1)
The molecular mechanisms underlying the##2##5##(1992-3#1)(2011-2#1)
The molecular mechanisms##8##3##(1992-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-6#1)(2011-10#1)(2011-2#1)(2013-1#1)
The molecular size##2##3##(1997-1#1)(2008-10#1)
The molecular species##2##3##(1995-8#1)(2008-1#1)
The molecular structure is##2##4##(1992-12#1)(1997-7#1)
The molecular structure of##3##4##(1996-2#1)(1996-5#1)(1997-7#1)
The molecular structure##5##3##(1992-12#1)(1996-2#1)(1996-5#1)(1997-7#2)
The molecular weight of the enzyme##3##6##(1991-12#1)(1997-6#1)(2008-11#1)
The molecular weight of the native enzyme##2##7##(1992-11#1)(1997-6#1)
The molecular weight of the##9##5##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1997-6#2)(2008-11#1)(2008-8#1)(2010-4#1)
The molecular weight of##10##4##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1997-6#2)(2008-11#1)(2008-8#2)(2010-4#1)
The molecular weight was##3##4##(1990-11#1)(1992-9#2)
The molecular weight##16##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1997-6#2)(2008-10#1)(2008-11#2)(2008-8#2)(2010-4#1)
The molecular weights of##2##4##(1993-6#1)(2008-5#1)
The molecular##105##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-8#2)(1996-2#2)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#2)(2006-10#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
The molecule is##2##3##(1992-8#1)(2008-11#1)
The molecule##6##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
The molecules are neurosporene##2##4##(2010-2#2)
The molecules##3##2##(1990-3#1)(2010-2#2)
The monitoring of##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2013-1#1)
The monitoring##7##2##(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#1)(2013-1#1)
The monkeys treated with##2##4##(2008-5#1)(2008-7#1)
The monkeys##3##2##(2008-5#1)(2008-7#2)
The monoclonal antibody was##2##4##(2008-10#1)(2008-8#1)
The monoclonal antibody##6##3##(1993-9#1)(1994-12#1)(1994-5#1)(2008-10#2)(2008-8#1)
The monoclonal##8##2##(1993-9#1)(1994-12#1)(1994-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
The monodisperse##2##2##(2008-10#1)(2013-1#1)
The monomer##2##2##(1992-4#1)(2013-1#1)
The monomer-dimer equilibrium##2##3##(2008-10#2)
The monomeric##3##2##(1992-3#1)(1995-12#1)(2013-1#1)
The monophyletic##2##2##(2008-10#1)(2010-8#1)
The moral##2##2##(1997-8#1)(2008-1#1)
The morbidity##2##2##(1992-9#1)(2007-2#1)
The more aggressive##2##3##(1993-11#1)(2008-10#1)
The more common##2##3##(1997-8#1)(2008-5#1)
The more complex##2##3##(1994-1#1)(2008-6#1)
The more detailed##3##3##(1990-6#1)(1991-9#1)(2008-5#1)
The more the##2##3##(2011-1#1)(2013-8#1)
The more##33##2##(1990-10#1)(1990-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The morphologic##2##2##(1992-10#1)(2010-12#1)
The morphological changes in##2##4##(2007-12#1)(2008-12#1)
The morphological characters##2##3##(1996-12#1)(2008-5#1)
The morphological##13##2##(1991-3#1)(1996-12#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-9#1)(2013-1#1)
The morphologies##2##2##(2008-5#1)(2008-8#1)
The morphology and the##2##4##(2007-12#1)(2008-2#1)
The morphology and##3##3##(2007-12#2)(2008-2#1)
The morphology of the films##2##5##(2008-10#1)(2009-11#1)
The morphology of the##13##4##(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#3)
The morphology of##20##3##(1995-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-3#1)(2011-2#3)
The morphology##26##2##(1995-12#1)(1997-1#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2010-3#1)(2011-2#3)
The morphometric##2##2##(2007-12#1)(2013-7#1)
The mortality and morbidity##2##4##(2008-7#1)(2012-3#1)
The mortality in##3##3##(1990-2#1)(1990-6#1)(1992-5#1)
The mortality rate was##2##4##(2007-7#1)(2008-1#1)
The mortality rate##5##3##(1992-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)
The mortality was##3##3##(1997-8#1)(2007-7#1)(2008-5#1)
The mortality##22##2##(1990-2#1)(1990-6#1)(1992-5#2)(1994-12#1)(1994-3#1)(1996-7#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#4)(2012-3#1)
The most abundant species were##4##5##(2008-5#3)(2013-7#1)
The most abundant##9##3##(1994-2#1)(1995-12#1)(2008-5#4)(2008-6#1)(2010-4#1)(2013-7#1)
The most accurate##2##3##(1994-9#1)(2007-11#1)
The most characteristic##3##3##(2008-10#2)(2008-7#1)
The most common adverse##2##4##(2010-12#1)(2011-2#1)
The most common cause of##3##5##(1997-8#1)(2007-7#1)(2008-3#1)
The most common cause##5##4##(1990-6#1)(1997-8#1)(2007-7#1)(2008-3#1)(2009-10#1)
The most common causes of##2##5##(1990-3#1)(2013-1#1)
The most common clinical##2##4##(1991-8#1)(2010-4#1)
The most common complication of##2##5##(2007-11#1)(2008-6#1)
The most common indications##2##4##(1992-5#1)(2010-8#1)
The most common localization##2##4##(1990-9#1)(2011-2#1)
The most common operative##2##4##(2008-3#1)(2008-9#1)
The most common primary##2##4##(2008-12#1)(2008-6#1)
The most common problems##3##4##(2007-11#1)(2010-12#1)(2011-2#1)
The most common reason for##2##5##(2010-8#1)(2013-1#1)
The most common side effect##2##5##(2007-10#1)(2011-1#1)
The most common side effects of##2##6##(1994-11#1)(2013-1#1)
The most common side effects##3##5##(1994-11#1)(1996-8#1)(2013-1#1)
The most common side##5##4##(1994-11#1)(1996-8#1)(2007-10#1)(2011-1#1)(2013-1#1)
The most common symptom was##2##5##(1990-9#1)(2007-2#1)
The most common type of##5##5##(2008-6#1)(2010-9#1)(2011-1#2)(2012-1#1)
The most common type##6##4##(2008-6#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-8#1)
The most common types are##2##5##(2012-3#1)(2013-1#1)
The most common types##4##4##(2012-3#1)(2013-1#3)
The most common##105##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-8#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#5)(2008-7#3)(2008-9#4)(2009-10#2)(2009-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#3)
The most commonly used##6##4##(1990-6#1)(1994-11#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-4#1)
The most commonly##14##3##(1990-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
The most consistent##2##3##(2008-10#2)
The most dangerous##2##3##(1991-8#1)(2009-3#1)
The most difficult##4##3##(1992-1#1)(1994-3#1)(1994-9#1)(2007-11#1)
The most dramatic##2##3##(1995-12#1)(2008-10#1)
The most effective treatment##2##4##(2007-7#1)(2008-12#1)
The most effective##13##3##(1995-3#1)(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
The most efficient separation##2##4##(1996-12#1)(2008-10#1)
The most efficient##4##3##(1996-12#1)(1997-1#1)(2008-10#2)
The most expensive hysterectomy##2##4##(1992-12#1)(1993-2#1)
The most frequent complication##2##4##(2008-7#1)(2011-2#1)
The most frequent isolated##2##4##(2008-12#1)(2011-1#1)
The most frequent##39##3##(1990-6#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-8#1)(1996-9#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#5)(2012-2#1)(2013-1#1)
The most frequently found##2##4##(1996-8#1)(2008-10#1)
The most frequently mentioned##2##4##(1991-8#1)(2011-1#1)
The most frequently observed##3##4##(2008-10#1)(2008-5#1)(2010-1#1)
The most frequently prescribed##2##4##(2008-11#1)(2008-7#1)
The most frequently reported##2##4##(2008-11#1)(2008-6#1)
The most frequently used##4##4##(1990-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
The most frequently##24##3##(1990-10#1)(1991-8#1)(1992-2#1)(1995-1#2)(1995-12#1)(1996-8#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)
The most important and##2##4##(1994-8#1)(2008-5#1)
The most important are##2##4##(1991-11#1)(2008-6#1)
The most important factors##3##4##(1993-1#1)(2007-11#1)(2008-3#1)
The most important feature of##2##5##(2008-3#2)
The most important finding##2##4##(2008-10#1)(2011-1#1)
The most important in##2##4##(1990-11#1)(2008-10#1)
The most important reasons##2##4##(1992-5#1)(2013-1#1)
The most important##55##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-3#1)(1997-2#2)(1997-3#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
The most intense##2##3##(1996-5#1)(2013-8#1)
The most likely explanation for##2##5##(1991-8#1)(2012-3#1)
The most likely explanation##3##4##(1991-8#1)(1997-1#1)(2012-3#1)
The most likely##5##3##(1991-8#1)(1997-1#1)(1997-3#1)(2008-8#1)(2012-3#1)
The most marked##2##3##(1995-11#1)(1997-2#1)
The most notable##2##3##(1997-7#1)(2008-4#1)
The most numerous##2##3##(2008-8#1)(2011-1#1)
The most obvious##5##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)
The most popular##4##3##(1995-3#1)(2007-8#1)(2008-4#1)(2012-3#1)
The most potent##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
The most powerful##3##3##(1994-3#1)(2008-7#1)(2010-5#1)
The most prevalent##5##3##(1990-6#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)
The most probable##2##3##(1991-10#1)(2008-10#1)
The most prominent##6##3##(1994-3#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
The most promising of these##2##5##(2008-1#1)(2008-7#1)
The most promising##5##3##(2007-11#1)(2008-1#1)(2008-7#1)(2011-3#1)(2013-1#1)
The most recent##10##3##(1994-12#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-2#1)
The most relevant##4##3##(2008-10#2)(2010-12#1)(2011-1#1)
The most remarkable##2##3##(1993-8#1)(2009-7#1)
The most representative##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
The most robust##2##3##(2008-9#1)(2010-1#1)
The most sensitive screening serologic tests were also assayed##2##9##(2013-1#2)
The most sensitive##6##3##(1996-12#1)(2008-10#3)(2013-1#2)
The most serious##2##3##(2008-7#1)(2012-12#1)
The most severe##6##3##(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2012-12#1)
The most significant finding##2##4##(1997-6#1)(2008-12#1)
The most significant##11##3##(1990-11#1)(1990-6#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)(2012-12#1)
The most striking difference##2##4##(2008-10#1)(2011-1#1)
The most striking finding was##2##5##(1992-5#1)(2008-7#1)
The most striking##9##3##(1992-3#1)(1992-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
The most successful##2##3##(2008-10#1)(2008-8#1)
The most suitable##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
The most surprising##2##3##(1990-8#1)(2008-3#1)
The most useful predictor variables were##2##6##(2008-10#2)
The most useful##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
The most widely##4##3##(1991-3#1)(1996-2#1)(2008-1#1)(2012-12#1)
The most##467##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#6)(1990-8#3)(1990-9#5)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#16)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#13)(2008-10#50)(2008-11#17)(2008-12#9)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#19)(2008-6#11)(2008-7#15)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#15)(2011-2#23)(2011-3#4)(2012-1#2)(2012-12#14)(2012-2#6)(2012-3#7)(2013-1#23)(2013-7#2)(2013-8#7)
The mother was##2##3##(2008-7#1)(2011-1#1)
The mother##6##2##(1992-4#1)(1995-8#1)(1997-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
The mothers##4##2##(1997-3#1)(2009-5#1)(2011-2#2)
The motion of##2##3##(2007-12#1)(2012-1#1)
The motion##4##2##(2007-12#1)(2008-11#2)(2012-1#1)
The motivation for##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
The motor activity of the points evaluated according to ECOG scale##2##11##(2007-11#2)
The motor activity of the##3##5##(1990-5#1)(2007-11#2)
The motor##4##2##(1990-5#2)(2007-11#2)
The mouse##12##2##(1993-12#1)(1993-3#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-12#1)
The move towards##2##3##(1996-7#1)(2011-3#1)
The move##4##2##(1996-7#1)(2008-11#2)(2011-3#1)
The movement of##5##3##(1992-3#1)(1996-3#1)(2008-1#2)(2010-11#1)
The movement##6##2##(1991-3#1)(1992-3#1)(1996-3#1)(2008-1#2)(2010-11#1)
The much higher##2##3##(1995-12#1)(2008-10#1)
The mucosal##4##2##(1995-6#1)(2008-5#2)(2012-12#1)
The multidisciplinary##2##2##(2007-11#1)(2009-2#1)
The multilayer##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)
The multilayers were##2##3##(2008-2#2)
The multiple regression analysis##2##4##(2010-2#1)(2013-1#1)
The multiple regression##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
The multiple scattering##3##3##(2008-2#2)(2008-3#1)
The multiple##22##2##(1993-11#1)(1994-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2013-1#1)
The multiresolution##2##2##(2008-10#1)(2008-6#1)
The multivariate##5##2##(1997-4#1)(2008-10#3)(2008-11#1)
The murine##8##2##(1990-5#1)(1993-2#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
The muscle##6##2##(1992-11#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-12#1)
The mutant enzyme##2##3##(1990-10#2)
The mutant has##2##3##(2008-8#1)(2008-9#1)
The mutant protein was##2##4##(1993-11#1)(1995-5#1)
The mutant protein##4##3##(1991-5#1)(1993-11#1)(1995-5#1)(2009-2#1)
The mutant strain##5##3##(1997-2#1)(2008-10#2)(2008-6#2)
The mutant##30##2##(1990-10#2)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#5)(2008-6#2)(2008-8#3)(2008-9#2)(2009-2#1)(2011-1#1)
The mutants were##4##3##(1992-12#1)(1992-8#1)(1995-2#1)(1996-3#1)
The mutants##9##2##(1992-12#1)(1992-8#1)(1995-2#2)(1995-6#1)(1996-3#1)(2008-10#2)(2011-1#1)
The mutated##2##2##(1991-2#1)(1995-2#1)
The mutation Pro115Gln##2##3##(2006-8#2)
The mutation of##2##3##(2008-10#1)(2011-3#1)
The mutation##15##2##(1990-7#1)(1991-7#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-8#2)(2008-10#3)(2008-8#1)(2010-4#1)(2011-3#1)(2012-12#1)
The mutations##7##2##(1993-11#2)(1995-12#1)(1997-6#1)(2008-8#1)(2011-3#1)(2013-1#1)
The mutual##2##2##(2007-12#1)(2008-10#1)
The myocardial##2##2##(1996-9#1)(2012-12#1)
The myogenic##2##2##(1996-2#1)(2008-5#1)
The myosin##3##2##(1991-5#1)(2008-5#2)
The n-alcohols##2##2##(1990-11#2)
The name of P##2##4##(2008-10#2)
The name of##3##3##(2008-10#2)(2008-11#1)
The name##8##2##(2007-11#1)(2008-10#5)(2008-11#1)(2011-2#1)
The nanoparticles exhibit##2##3##(2008-10#2)
The nanoparticles were##2##3##(2008-10#2)
The nanoparticles##6##2##(2008-10#5)(2013-8#1)
The nanosheet colloids with##2##4##(2008-10#2)
The narratives##2##2##(1996-3#1)(2013-1#1)
The narrow spectral response##2##4##(2007-12#2)
The narrow##6##2##(1997-3#1)(2007-12#3)(2008-2#1)(2008-3#1)
The nasal##2##2##(1991-3#1)(2012-3#1)
The nasolabial flap##2##3##(2007-12#2)
The national health##3##3##(1991-5#1)(1992-3#1)(1993-2#1)
The national##9##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
The native enzyme##2##3##(1994-6#1)(2008-8#1)
The native##4##2##(1993-11#1)(1994-6#1)(2007-7#1)(2008-8#1)
The natural history and##2##4##(1992-8#1)(2012-12#1)
The natural history of##3##4##(1992-12#1)(2008-7#1)(2011-2#1)
The natural history##7##3##(1992-12#1)(1992-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
The natural##19##2##(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#2)
The nature and composition of the##2##6##(2008-10#2)
The nature and##11##3##(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)
The nature of the genetic##2##5##(2008-10#2)
The nature of the##14##4##(1991-2#1)(1991-5#2)(1995-3#1)(1996-5#1)(2007-10#1)(2008-10#6)(2008-2#1)(2012-2#1)
The nature of these##2##4##(1990-2#1)(2011-2#1)
The nature of this##2##4##(1994-6#1)(2009-9#1)
The nature of##33##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#2)(1994-5#1)(1994-6#1)(1995-3#2)(1995-5#1)(1996-5#1)(2007-10#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
The nature##45##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-3#2)(1995-5#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
The near##3##2##(1996-5#1)(2008-10#2)
The near-infrared absorption##2##3##(2008-3#2)
The nearly##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
The nebulizer##2##2##(1992-3#1)(1994-12#1)
The necessary##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
The necessity of##4##3##(1991-2#1)(2007-7#1)(2008-10#2)
The necessity to##3##3##(2008-11#1)(2010-6#1)(2012-12#1)
The necessity##7##2##(1991-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-12#1)
The necrosis was##3##3##(1994-5#1)(2008-10#2)
The necrosis##4##2##(1994-5#1)(2008-10#3)
The need for a continuous##2##5##(2008-11#1)(2008-3#1)
The need for a systematic approach##2##6##(1994-2#1)(2008-10#1)
The need for a##7##4##(1994-2#1)(2008-10#4)(2008-11#1)(2008-3#1)
The need for accurate##2##4##(1995-2#1)(2008-6#1)
The need for guidelines##2##4##(2008-1#1)(2012-12#1)
The need for the##3##4##(1992-2#1)(2008-10#1)(2012-2#1)
The need for treatment of##2##5##(2008-10#1)(2008-4#1)
The need for##45##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-9#1)(1997-3#1)(2007-5#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-2#2)(2013-8#1)
The need to analyze rare cells is based on the nature of tissue differentiation and regeneration##2##16##(2008-2#1)(2008-4#1)
The need to##17##3##(1991-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
The need##64##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-9#1)(1997-3#1)(2007-5#1)(2008-1#2)(2008-10#12)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
The negative effect of##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
The negative symptoms##2##3##(2008-6#1)(2011-2#1)
The negative##19##2##(1991-3#1)(1992-5#1)(1993-3#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2011-2#3)(2013-1#1)
The negatively charged##2##3##(1990-8#1)(2008-10#1)
The neglected##2##2##(1993-11#1)(2008-8#1)
The nematode##6##2##(1990-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
The neoplasm##3##2##(1991-12#1)(2008-7#1)(2009-5#1)
The nerve##4##2##(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
The nervous##2##2##(1991-3#1)(2008-7#1)
The nested##3##2##(1997-2#1)(2008-10#1)(2008-12#1)
The nested-PCR##2##2##(2008-10#1)(2008-12#1)
The net effect of##2##4##(2008-10#2)
The net effect##3##3##(1997-1#1)(2008-10#2)
The net result of##2##4##(2008-10#1)(2008-5#1)
The net result##3##3##(2008-10#2)(2008-5#1)
The net##13##2##(1990-3#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#2)(2011-1#1)
The network architecture##2##3##(2008-10#2)
The network is##2##3##(2008-7#1)(2010-2#1)
The network##10##2##(1993-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2010-2#1)
The networks were##2##3##(2008-10#2)
The networks##3##2##(2008-10#2)(2008-6#1)
The neural##10##2##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
The neurobiology of##3##3##(2008-6#2)(2011-2#1)
The neuroendocrine##2##2##(2007-7#1)(2008-11#1)
The neuronal##4##2##(1990-7#1)(1996-5#1)(2008-1#1)(2013-1#1)
The neurons##3##2##(1990-7#1)(1993-6#1)(2010-11#1)
The neuropeptide##5##2##(1991-2#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-5#1)
The neuropsychological##2##2##(2008-10#1)(2008-11#1)
The neurotoxic effect of##2##4##(1995-11#1)(2008-7#1)
The neurotrophic##2##2##(1996-2#1)(2013-1#1)
The neutral##4##2##(1993-11#1)(1994-12#1)(2008-11#2)
The new Mennen 3 PeriPro plate##2##6##(2008-7#2)
The new NHS##2##3##(1991-3#2)
The new algorithm is##2##4##(2008-3#1)(2008-6#1)
The new algorithm##5##3##(2008-3#3)(2008-6#2)
The new approach##4##3##(2007-8#1)(2008-10#2)(2008-2#1)
The new concept##2##3##(2007-12#1)(2007-8#1)
The new convexity measure##2##4##(2008-6#2)
The new design##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
The new electrode##2##3##(2008-10#2)
The new genus##2##3##(1997-4#2)
The new information##2##3##(1994-12#2)
The new laser##2##3##(1992-12#1)(2008-10#1)
The new method has##2##4##(2008-10#1)(2008-2#1)
The new method is superior to##2##6##(2008-10#2)
The new method is##6##4##(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)
The new method of##2##4##(2008-10#2)
The new method was##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
The new method##20##3##(1990-8#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#1)
The new model##2##3##(1994-5#1)(2008-7#1)
The new packing##2##3##(2008-10#2)
The new procedure##2##3##(2008-10#2)
The new protocol##3##3##(2008-10#3)
The new reagent##2##3##(2008-10#2)
The new system##2##3##(2007-11#1)(2010-8#1)
The new techniques##2##3##(2008-10#1)(2011-2#1)
The new##202##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1993-6#1)(1994-12#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#60)(2008-11#6)(2008-2#8)(2008-3#17)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
The newer##2##2##(2008-4#1)(2008-7#1)
The newest##2##2##(2008-4#1)(2008-7#1)
The newly developed##11##3##(1997-4#1)(2008-10#7)(2009-10#1)(2012-12#1)(2012-3#1)
The newly##21##2##(1991-2#1)(1991-5#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-8#2)(2009-10#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-8#2)
The next decade will##2##4##(1992-1#1)(2009-4#1)
The next era of HCV antiviral therapy finally begins##2##9##(2011-2#2)
The next generation##2##3##(1994-3#1)(1996-2#1)
The next step in##2##4##(2007-8#1)(2008-10#1)
The next step##5##3##(1996-3#1)(2007-8#1)(2008-10#2)(2009-2#1)
The next##24##2##(1991-6#1)(1992-1#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-2#3)(2012-12#1)
The nickel##3##2##(1995-3#1)(2008-10#2)
The nidation index was calculated##2##5##(1992-3#2)
The nine##4##2##(1996-7#1)(2008-10#3)
The nitrate##2##2##(2008-10#2)
The nitric oxide##5##3##(1997-4#1)(2008-10#1)(2010-12#1)(2012-8#1)(2013-1#1)
The nitric##6##2##(1997-4#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-8#1)(2013-1#1)
The nitrogen and##2##3##(2008-10#1)(2008-5#1)
The nitrogen contents##2##3##(2008-12#2)
The nitrogen##7##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)
The nodal##2##2##(1990-8#1)(2013-1#1)
The noise of##2##3##(2007-11#2)
The noise##9##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#3)
The non##2##2##(2007-8#1)(2008-10#1)
The non-helical##2##2##(1991-2#1)(1995-3#1)
The non-invasive##2##2##(2009-1#1)(2012-2#1)
The non-linear##2##2##(2008-5#2)
The non-specific##2##2##(1992-3#1)(2008-10#1)
The nonapeptide##2##2##(1990-5#1)(1994-3#1)
The nonlinear absorption##2##3##(2008-3#2)
The nonlinear activation function sigmoid (sigmoid function) has been used in the hidden layer and the output layer##2##18##(2010-8#2)
The nonlinear optical##2##3##(2007-11#2)
The nonlinear phase##2##3##(2007-12#1)(2008-2#1)
The nonlinear refractive index##2##4##(2007-11#2)
The nonlinear refractive##3##3##(2007-11#2)(2007-12#1)
The nonlinear##19##2##(2007-11#6)(2007-12#3)(2008-2#3)(2008-3#5)(2010-8#2)
The nonlinearity##3##2##(2008-2#1)(2008-3#2)
The nonreciprocal##3##2##(2008-3#3)
The nonspecific##2##2##(1995-2#1)(2011-2#1)
The normal##9##2##(1991-5#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-8#1)
The normalized##2##2##(2008-10#1)(2008-3#1)
The notion of##3##3##(1992-1#1)(2011-2#1)(2012-2#1)
The notion that##2##3##(1992-9#1)(1997-3#1)
The notion##5##2##(1992-1#1)(1992-9#1)(1997-3#1)(2011-2#1)(2012-2#1)
The novel approach##3##3##(2007-6#1)(2008-10#2)
The novel##22##2##(1992-5#1)(1993-3#1)(1994-8#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
The novelty of this##2##4##(2008-2#2)
The novelty of##3##3##(2008-2#2)(2008-8#1)
The novelty##4##2##(2008-2#2)(2008-8#1)(2012-12#1)
The nozzle##2##2##(1994-2#1)(2008-3#1)
The nt sequence of##2##4##(1990-5#1)(1995-8#1)
The nt sequence##4##3##(1990-5#1)(1991-6#1)(1994-12#1)(1995-8#1)
The nuclear and##2##3##(1996-2#2)
The nuclear pore complex (NPC)##2##5##(2011-2#2)
The nuclear##11##2##(1992-2#1)(1994-5#1)(1995-8#1)(1996-2#3)(2008-10#1)(2011-2#4)
The nucleic acid##2##3##(1995-5#1)(1996-12#1)
The nucleic##3##2##(1995-5#1)(1996-12#1)(2008-10#1)
The nucleolar##3##2##(1991-2#1)(2008-12#1)(2008-7#1)
The nucleotide (nt) sequence of the##3##6##(1991-6#1)(1994-12#1)(1997-4#1)
The nucleotide (nt) sequence of##4##5##(1991-6#1)(1991-7#1)(1994-12#1)(1997-4#1)
The nucleotide (nt) sequence##5##4##(1991-6#1)(1991-7#1)(1994-12#1)(1997-4#2)
The nucleotide (nt)##6##3##(1991-6#1)(1991-7#1)(1994-12#2)(1997-4#2)
The nucleotide and deduced amino-acid sequences of a cDNA encoding##2##10##(1994-11#2)
The nucleotide and deduced##3##4##(1994-11#3)
The nucleotide and##5##3##(1990-12#1)(1991-5#1)(1994-11#3)
The nucleotide sequence encoding the##3##5##(1992-12#1)(1997-6#1)(2008-10#1)
The nucleotide sequence of a cDNA##2##6##(1992-11#1)(1996-2#1)
The nucleotide sequence of a##8##5##(1992-11#1)(1996-2#1)(1996-3#2)(1996-8#2)(2008-10#1)(2009-3#1)
The nucleotide sequence of the cloned DNA##2##7##(1991-9#1)(1997-4#1)
The nucleotide sequence of the##19##5##(1990-7#1)(1991-5#1)(1991-7#1)(1991-9#3)(1993-12#1)(1993-9#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-8#1)
The nucleotide sequence of this##3##5##(1990-12#1)(1993-2#1)(1993-3#1)
The nucleotide sequence of##37##4##(1990-11#2)(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-8#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-7#1)(2008-8#2)(2009-3#1)
The nucleotide sequence revealed##2##4##(1997-2#1)(1997-4#1)
The nucleotide sequence##47##3##(1990-11#4)(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-8#2)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2008-10#9)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)
The nucleotide sequences of the##8##5##(1991-6#1)(1991-9#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-6#1)
The nucleotide sequences of##12##4##(1991-6#2)(1991-9#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
The nucleotide sequences##13##3##(1991-6#2)(1991-9#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
The nucleotide##75##2##(1990-11#4)(1990-12#2)(1990-7#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#4)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-8#3)(1995-8#1)(1996-2#2)(1996-3#2)(1996-8#2)(1997-2#2)(1997-4#4)(1997-6#2)(1997-8#1)(2007-10#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2013-8#1)
The nucleus accumbens##4##3##(1994-3#1)(1996-5#1)(2007-8#2)
The nucleus##9##2##(1994-3#1)(1996-5#1)(2007-12#1)(2007-8#2)(2008-7#3)(2011-2#1)
The number and type##2##4##(1996-3#1)(2008-10#1)
The number and##6##3##(1996-3#1)(2008-10#3)(2008-6#1)(2012-1#1)
The number of airborne conidia##2##5##(2008-10#2)
The number of cases##2##4##(2011-2#1)(2012-2#1)
The number of channels##2##4##(2007-12#1)(2008-9#1)
The number of children##2##4##(2009-7#1)(2011-2#1)
The number of conidia##3##4##(2008-10#3)
The number of deaths##2##4##(1997-7#1)(2008-8#1)
The number of electrons##2##4##(2008-10#2)
The number of false##2##4##(2008-10#1)(2010-3#1)
The number of genes##2##4##(2008-10#1)(2008-7#1)
The number of graduates from##2##5##(1991-2#1)(1991-8#1)
The number of immunoreactive##2##4##(2007-12#2)
The number of individuals##3##4##(1996-3#1)(2008-4#1)(2012-2#1)
The number of infested##2##4##(2008-12#1)(2011-2#1)
The number of live##2##4##(1991-3#1)(2011-1#1)
The number of older##2##4##(2010-10#1)(2010-11#1)
The number of patients undergoing##2##5##(2007-8#1)(2013-8#1)
The number of patients with##7##5##(2007-11#2)(2008-1#1)(2011-1#3)(2011-2#1)
The number of patients##10##4##(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2011-1#3)(2011-2#1)(2013-8#1)
The number of polymorphic loci varied from##2##7##(2008-10#2)
The number of species found##2##5##(2008-5#1)(2013-7#1)
The number of species##4##4##(2008-5#2)(2008-8#1)(2013-7#1)
The number of women##2##4##(1993-6#1)(2012-2#1)
The number of##189##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-8#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-8#3)(2008-1#1)(2008-10#40)(2008-11#3)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#10)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#4)
The number##201##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-12#3)(1995-2#1)(1995-8#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-8#3)(2008-1#1)(2008-10#44)(2008-11#3)(2008-12#6)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
The numbers of##5##3##(1997-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)
The numbers##6##2##(1997-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2010-9#1)
The numerical results##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
The numerical##18##2##(1996-2#1)(2007-12#1)(2008-2#7)(2008-3#7)(2008-9#1)(2013-8#1)
The numerous##4##2##(1992-6#1)(2006-12#1)(2008-1#1)(2008-2#1)
The nurse##7##2##(1992-4#1)(1993-2#1)(1995-3#1)(2008-11#3)(2010-3#1)
The nurses were##2##3##(1992-2#1)(2008-11#1)
The nurses##5##2##(1992-2#1)(2008-11#2)(2013-1#2)
The nursing staff##2##3##(2008-7#1)(2010-10#1)
The nursing##8##2##(1990-10#1)(1991-2#1)(2007-10#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-5#1)
The nutrient##3##2##(1994-12#1)(2008-7#1)(2013-8#1)
The nymphal##3##2##(2007-12#1)(2011-2#2)
The obese##2##2##(1996-12#1)(2013-8#1)
The obesity epidemic##3##3##(2008-3#1)(2013-7#1)(2013-8#1)
The object is##3##3##(2007-11#1)(2008-3#2)
The object of our research was to examine the##2##9##(1990-5#1)(1990-6#1)
The object of our##3##4##(1990-5#1)(1990-6#1)(1997-8#1)
The object of the##2##4##(2008-7#1)(2011-2#1)
The object of this study was to assess##2##8##(1991-6#1)(1992-12#1)
The object of this study was to##4##7##(1991-6#1)(1992-12#1)(2008-10#1)(2008-5#1)
The object of this study##5##5##(1991-6#1)(1992-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
The object of this##6##4##(1991-6#1)(1992-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
The object of##11##3##(1990-5#1)(1990-6#1)(1991-6#1)(1992-12#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
The object##16##2##(1990-5#1)(1990-6#1)(1991-6#1)(1992-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
The objective for##3##3##(2010-8#1)(2012-12#1)(2012-2#1)
The objective is to allow##2##5##(1995-12#1)(2012-12#1)
The objective is to##7##4##(1995-12#2)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
The objective is##8##3##(1995-12#2)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)
The objective of our study was to##2##7##(1997-8#1)(2008-10#1)
The objective of our##3##4##(1997-8#1)(2008-10#1)(2010-8#1)
The objective of the paper was to##2##7##(2007-8#1)(2008-10#1)
The objective of the present paper##2##6##(1991-9#1)(2007-12#1)
The objective of the present study is to##2##8##(2008-8#1)(2009-11#1)
The objective of the present study was to determine##2##9##(1996-5#1)(2011-2#1)
The objective of the present study was to examine the##2##10##(2011-2#2)
The objective of the present study was to##10##8##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2010-2#1)(2011-2#4)
The objective of the present study was##11##7##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2010-2#1)(2011-2#4)(2012-2#1)
The objective of the present study##13##6##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#4)(2012-2#1)
The objective of the present work was to##3##8##(2008-5#1)(2010-3#1)(2013-1#1)
The objective of the present##20##5##(1991-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#1)
The objective of the program##2##5##(1993-12#2)
The objective of the study was to##3##7##(1990-2#1)(2008-5#1)(2010-8#1)
The objective of the study##4##5##(1990-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
The objective of the##34##4##(1990-2#1)(1991-9#2)(1993-12#2)(1995-3#1)(1996-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#1)
The objective of this article is to##3##7##(2007-11#1)(2012-12#1)(2013-1#1)
The objective of this article is##4##6##(2007-11#1)(2012-12#2)(2013-1#1)
The objective of this cross-sectional study was to##2##8##(2010-2#1)(2012-12#1)
The objective of this paper is to provide an overview of##2##11##(2007-4#1)(2011-2#1)
The objective of this paper is to provide##3##8##(1992-3#1)(2007-4#1)(2011-2#1)
The objective of this paper is to##8##7##(1992-3#1)(1993-1#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
The objective of this paper is##11##6##(1992-3#1)(1993-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
The objective of this paper##12##5##(1992-3#1)(1993-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
The objective of this prospective##2##5##(1997-3#1)(2007-10#1)
The objective of this research was to##5##7##(2008-10#3)(2008-5#1)(2008-7#1)
The objective of this research was##7##6##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
The objective of this research##8##5##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
The objective of this review is to##6##7##(2007-4#1)(2008-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
The objective of this review was to##3##7##(2010-6#1)(2013-1#2)
The objective of this review##9##5##(2007-4#1)(2008-8#1)(2009-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#3)
The objective of this study is to##6##7##(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
The objective of this study was to analyze##2##8##(2009-4#1)(2012-3#1)
The objective of this study was to apply##2##8##(2008-5#1)(2013-1#1)
The objective of this study was to assess the##5##9##(2007-7#1)(2008-5#2)(2011-1#1)(2013-8#1)
The objective of this study was to assess##6##8##(2007-7#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
The objective of this study was to compare##5##8##(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
The objective of this study was to define the##2##9##(1995-2#1)(2011-2#1)
The objective of this study was to describe the##2##9##(2007-2#1)(2013-7#1)
The objective of this study was to determine the effect of##2##11##(1991-8#1)(2008-10#1)
The objective of this study was to determine the species##2##10##(2011-1#1)(2013-8#1)
The objective of this study was to determine the##12##9##(1991-8#1)(2008-1#1)(2008-10#4)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
The objective of this study was to determine whether##4##9##(1994-11#1)(1995-3#1)(2008-4#1)(2011-2#1)
The objective of this study was to determine##18##8##(1991-8#1)(1994-11#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
The objective of this study was to develop##3##8##(2008-10#1)(2008-5#1)(2010-3#1)
The objective of this study was to evaluate the effect of##3##11##(2008-1#1)(2008-5#1)(2012-2#1)
The objective of this study was to evaluate the##12##9##(1996-1#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
The objective of this study was to evaluate##17##8##(1996-1#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
The objective of this study was to examine the##4##9##(1997-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
The objective of this study was to identify##3##8##(2008-10#1)(2008-6#1)(2008-9#1)
The objective of this study was to investigate the effect of##2##11##(2007-8#1)(2008-7#1)
The objective of this study was to investigate the##12##9##(1994-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)
The objective of this study was to investigate##16##8##(1994-12#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2013-1#1)
The objective of this study was to measure the##2##9##(2010-10#1)(2011-2#1)
The objective of this study was to##97##7##(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1997-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-3#3)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
The objective of this study was##99##6##(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1997-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-3#3)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
The objective of this study##106##5##(1991-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1997-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-3#3)(2010-8#3)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
The objective of this work is to##2##7##(2008-7#1)(2011-2#1)
The objective of this work is##3##6##(2008-10#1)(2008-7#1)(2011-2#1)
The objective of this work was to assess##2##8##(2009-7#1)(2010-4#1)
The objective of this work was to evaluate##2##8##(2013-1#1)(2013-8#1)
The objective of this work was to##10##7##(1993-12#1)(1995-12#1)(1995-5#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
The objective of this work##14##5##(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
The objective of this##166##4##(1991-5#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1997-3#2)(1997-8#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#5)
The objective of##207##3##(1990-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-3#2)(1997-5#1)(1997-8#3)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#25)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#5)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#5)
The objective was to analyze##2##5##(2008-11#1)(2012-3#1)
The objective was to determine##2##5##(2008-10#1)(2008-11#1)
The objective was to study the##2##6##(2008-2#1)(2008-7#1)
The objective was to##13##4##(1994-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#2)
The objective##233##2##(1990-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-3#2)(1997-5#1)(1997-8#3)(2006-10#1)(2006-8#1)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#7)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#5)
The objectives of our study were to##3##7##(2008-10#1)(2008-11#1)(2011-2#1)
The objectives of the##7##4##(1996-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2012-3#1)
The objectives of this article##2##5##(1997-1#1)(2013-1#1)
The objectives of this research were to determine the##2##9##(2008-1#1)(2008-10#1)
The objectives of this research were to##5##7##(2008-1#1)(2008-10#3)(2010-3#1)
The objectives of this study are to##3##7##(2008-5#1)(2012-2#1)(2013-1#1)
The objectives of this study are##4##6##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
The objectives of this study were to (i)##3##8##(2008-10#2)(2010-12#1)
The objectives of this study were to determine the prevalence of##2##11##(2008-3#1)(2008-8#1)
The objectives of this study were to determine the##5##9##(1996-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
The objectives of this study were to evaluate the##2##9##(2008-12#1)(2008-5#1)
The objectives of this study were to evaluate##3##8##(2008-10#1)(2008-12#1)(2008-5#1)
The objectives of this study were to use##2##8##(2008-10#1)(2008-6#1)
The objectives of this study were to##21##7##(1996-1#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
The objectives of this study were##22##6##(1996-1#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
The objectives of this study##26##5##(1996-1#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
The objectives of this work were to study the##2##9##(2008-10#2)
The objectives of this##37##4##(1996-1#1)(1997-1#1)(2007-4#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
The objectives of##47##3##(1996-1#2)(1997-1#1)(2007-4#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
The objectives were to study the##2##6##(2013-1#2)
The objectives were##3##3##(2008-7#1)(2013-1#2)
The objectives##53##2##(1996-1#2)(1997-1#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#5)
The observable##2##2##(2007-12#1)(2008-1#1)
The observation and##2##3##(2008-11#1)(2012-12#1)
The observation of##7##3##(1990-6#1)(1991-12#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-12#1)(2010-8#1)
The observation that##6##3##(1990-12#1)(1990-5#1)(1993-6#1)(1995-12#1)(2008-10#1)(2012-3#1)
The observation##20##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1993-6#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
The observations showed##2##3##(2008-7#1)(2008-8#1)
The observations##9##2##(1997-8#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#1)(2013-1#1)
The observed changes in##2##4##(1991-2#1)(1994-9#1)
The observed differences##2##3##(2007-12#1)(2008-3#1)
The observed increase in##2##4##(1997-1#1)(2013-8#1)
The observed phenomenon##2##3##(2007-11#1)(2007-12#1)
The observed response##2##3##(2008-3#1)(2009-8#1)
The observed##66##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-7#1)(2007-11#2)(2007-12#7)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#2)
The obtained accuracy##2##3##(2008-10#1)(2010-7#1)
The obtained concentration##2##3##(2008-10#1)(2012-1#1)
The obtained data allow##2##4##(1990-5#1)(2008-2#1)
The obtained data##4##3##(1990-5#1)(2008-12#1)(2008-2#1)(2008-5#1)
The obtained detection##2##3##(2008-10#2)
The obtained models##2##3##(2008-10#1)(2009-3#1)
The obtained results are##2##4##(2010-8#1)(2012-3#1)
The obtained results indicated##2##4##(2008-5#1)(2013-8#1)
The obtained results show that##2##5##(2008-10#1)(2008-5#1)
The obtained results show##3##4##(2008-10#1)(2008-5#1)(2009-10#1)
The obtained results showed that the##2##6##(2008-5#1)(2011-1#1)
The obtained results showed##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
The obtained results suggest that the##2##6##(2007-12#1)(2008-10#1)
The obtained results were compared to##2##6##(2008-10#1)(2008-7#1)
The obtained results were compared##4##5##(2008-10#3)(2008-7#1)
The obtained results were##8##4##(2008-10#5)(2008-12#2)(2008-7#1)
The obtained results##32##3##(2007-11#1)(2007-12#1)(2008-10#16)(2008-12#2)(2008-5#3)(2008-7#1)(2009-10#1)(2010-8#3)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
The obtained values##2##3##(2008-10#2)
The obtained##80##2##(1990-5#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#42)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#1)(2009-10#1)(2009-3#1)(2010-7#1)(2010-8#4)(2011-1#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
The occlusion##3##2##(1997-3#1)(2008-12#1)(2008-2#1)
The occurrence and##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
The occurrence of A##2##4##(2008-10#1)(2008-6#1)
The occurrence of hypotensive episodes did not differ##2##8##(2007-7#1)(2008-1#1)
The occurrence of such##2##4##(1991-12#1)(1994-9#1)
The occurrence of the##2##4##(2008-11#1)(2008-6#1)
The occurrence of##38##3##(1990-12#1)(1990-8#1)(1991-12#2)(1991-9#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
The occurrence##43##2##(1990-12#1)(1990-8#2)(1991-12#2)(1991-9#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
The ocular##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
The odds of##2##3##(2008-8#1)(2011-2#1)
The odds ratio for##4##4##(1991-11#1)(2008-12#1)(2008-8#1)(2009-5#1)
The odds ratio relating breastfeeding to##2##6##(1991-8#2)
The odds ratio##11##3##(1990-8#1)(1991-11#2)(1991-8#2)(2008-12#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-12#2)
The odds ratios##2##3##(1990-9#1)(2008-10#1)
The odds##17##2##(1990-8#1)(1990-9#1)(1991-11#2)(1991-8#2)(1994-7#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#2)
The odds-ratios##2##2##(2008-11#1)(2008-3#1)
The odour##2##2##(2008-10#1)(2008-5#1)
The off-axis##2##2##(2008-3#2)
The official##2##2##(1993-8#1)(2008-10#1)
The offset computed from##2##4##(2008-3#2)
The offspring##2##2##(2011-1#1)(2012-12#1)
The oil of Adenanthera pavonina L##2##6##(2008-11#2)
The oil##12##2##(2008-11#3)(2008-5#6)(2008-8#1)(2009-10#1)(2010-5#1)
The oils were analyzed by GC and##2##7##(2008-12#1)(2012-2#1)
The oils were##4##3##(2008-11#1)(2008-12#2)(2012-2#1)
The oils##6##2##(2008-11#1)(2008-12#3)(2012-2#2)
The oily##2##2##(2008-10#2)
The old of##2##3##(2008-12#2)
The old##4##2##(1990-6#1)(2008-12#2)(2013-1#1)
The older people's##2##3##(2010-10#2)
The older##4##2##(2008-10#1)(2008-11#1)(2010-10#2)
The olfactory bulb##2##3##(2009-12#1)(2012-2#1)
The olfactory##4##2##(1991-2#1)(2009-12#2)(2012-2#1)
The oligonucleotide##2##2##(1993-1#1)(1997-7#1)
The omentum##2##2##(1995-11#1)(2012-2#1)
The on line##2##3##(2008-10#2)
The on-axis##2##2##(2008-3#2)
The on-line##11##2##(2008-1#1)(2008-10#8)(2008-7#2)
The oncology##2##2##(2008-6#1)(2010-9#1)
The one##2##2##(2008-1#2)
The ongoing##2##2##(2008-11#1)(2009-11#1)
The online version of this article (doi##17##7##(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
The only absolute##2##3##(2007-8#1)(2010-6#1)
The only difference between##3##4##(1990-12#1)(1990-7#1)(2012-3#1)
The only difference##4##3##(1990-12#1)(1990-7#1)(1996-12#1)(2012-3#1)
The only exception##2##3##(1996-5#1)(2013-1#1)
The only significant difference##2##4##(1994-2#1)(2013-1#1)
The only significant##3##3##(1994-2#1)(1997-1#1)(2013-1#1)
The only way to##2##4##(2008-11#1)(2008-6#1)
The only##42##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
The onset of##11##3##(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1995-3#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-7#1)
The onset##12##2##(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1995-3#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2013-7#1)
The ontogeny of##2##3##(1992-12#1)(2012-2#1)
The oocytes##2##2##(1990-7#1)(2008-8#1)
The open reading frame encodes a protein##2##7##(1991-2#1)(2008-8#1)
The open reading frame of##3##5##(1994-12#1)(1994-6#1)(2008-6#1)
The open reading frame##8##4##(1991-2#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
The open##14##2##(1991-2#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-3#1)
The opening##5##2##(1994-3#1)(1997-2#1)(2008-10#1)(2011-1#1)(2013-1#1)
The operating parameters##2##3##(2008-10#1)(2008-9#1)
The operating##9##2##(1996-1#1)(2008-10#4)(2008-3#3)(2008-9#1)
The operation conditions##2##3##(2008-10#2)
The operation is##6##3##(1993-6#1)(2007-11#2)(2008-10#2)(2011-2#1)
The operation of the##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
The operation of##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
The operation##22##2##(1993-6#1)(1996-12#1)(1996-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#5)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
The operational stability of the##2##5##(2008-10#2)
The operational stability##3##3##(2008-10#3)
The operational##6##2##(1995-3#1)(2008-10#4)(2012-2#1)
The operations of the##2##4##(2008-10#1)(2008-4#1)
The operations##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
The operative mortality and##2##4##(2008-10#1)(2008-7#1)
The operative mortality##3##3##(1994-11#1)(2008-10#1)(2008-7#1)
The operative##10##2##(1990-8#1)(1992-9#1)(1994-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
The opinions##2##2##(2008-1#1)(2012-3#1)
The opioid##2##2##(1995-3#1)(2008-6#1)
The opportunity for##3##3##(2007-3#1)(2008-8#1)(2013-1#1)
The opportunity##4##2##(1994-6#1)(2007-3#1)(2008-8#1)(2013-1#1)
The opposite was##2##3##(1994-3#1)(2011-1#1)
The opposite##5##2##(1991-9#1)(1994-3#1)(1994-6#1)(2008-12#1)(2011-1#1)
The optical absorption of##2##4##(2007-11#1)(2008-2#1)
The optical absorption##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
The optical arrangement##2##3##(2008-10#1)(2008-3#1)
The optical configuration##2##3##(2007-11#1)(2008-3#1)
The optical constants are##2##4##(2008-3#2)
The optical constants of##3##4##(2008-3#3)
The optical constants were##2##4##(2008-2#1)(2008-3#1)
The optical constants##7##3##(2008-2#1)(2008-3#6)
The optical data##2##3##(2008-3#2)
The optical design##2##3##(2008-2#1)(2008-3#1)
The optical disk##2##3##(2008-3#2)
The optical implementation##2##3##(2008-3#2)
The optical limiting##2##3##(2007-11#2)
The optical loss##2##3##(2008-2#2)
The optical network unit##2##4##(2008-2#2)
The optical path difference##2##4##(2008-3#2)
The optical path length##2##4##(2008-2#1)(2008-3#1)
The optical path##5##3##(2008-2#1)(2008-3#4)
The optical phase##2##3##(2008-3#2)
The optical properties of the##4##5##(2008-2#1)(2008-3#3)
The optical properties of##8##4##(2007-11#1)(2008-2#3)(2008-3#4)
The optical properties##12##3##(2007-11#1)(2008-2#5)(2008-3#6)
The optical purity of##2##4##(2008-6#2)
The optical setup is##3##4##(2008-2#1)(2008-3#2)
The optical signal##2##3##(2008-3#2)
The optical system##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
The optical##98##2##(1994-8#1)(1997-6#1)(2007-11#8)(2007-12#5)(2008-10#4)(2008-2#25)(2008-3#44)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#2)
The optically##2##2##(1996-2#1)(2008-3#1)
The optimal behavior##2##3##(2008-8#1)(2008-9#1)
The optimal concentrations of the##3##5##(2008-10#2)(2008-11#1)
The optimal conditions for the detection of##2##7##(2008-10#2)
The optimal conditions for the##4##5##(1992-3#1)(2008-10#3)
The optimal conditions for##5##4##(1992-3#1)(2008-10#4)
The optimal conditions of##2##4##(2008-10#2)
The optimal conditions were##2##4##(2008-10#2)
The optimal conditions##10##3##(1992-3#1)(2008-10#8)(2008-12#1)
The optimal dosage##2##3##(2012-12#1)(2013-1#1)
The optimal immersing time was##2##5##(2008-10#2)
The optimal immersing##3##3##(2008-10#2)(2009-7#1)
The optimal incubation times##2##4##(2008-10#2)
The optimal level of##2##4##(2008-8#1)(2013-1#1)
The optimal pH for the##2##5##(1991-5#1)(1997-2#1)
The optimal pH for##5##4##(1991-5#2)(1994-11#1)(1997-2#1)(2009-3#1)
The optimal pH of##2##4##(1993-3#1)(2008-10#1)
The optimal pH##8##3##(1991-5#2)(1993-3#1)(1994-11#1)(1997-2#1)(2008-10#1)(2009-3#1)(2011-2#1)
The optimal temperature for##2##4##(2008-10#1)(2008-6#1)
The optimal temperature##3##3##(1997-2#1)(2008-10#1)(2008-6#1)
The optimal treatment##2##3##(2008-7#1)(2010-9#1)
The optimal##69##2##(1990-7#1)(1991-5#2)(1992-3#1)(1992-9#2)(1993-3#1)(1994-11#2)(1994-2#1)(1994-6#1)(1996-5#1)(1997-2#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
The optimisation of the##2##4##(2008-10#2)
The optimisation of##4##3##(2008-10#4)
The optimisation process was carried out##2##6##(2008-10#2)
The optimisation##6##2##(2008-10#6)
The optimised conditions##3##3##(2008-10#2)(2008-8#1)
The optimised##7##2##(2008-10#6)(2008-8#1)
The optimization of a##2##4##(2008-10#1)(2008-2#1)
The optimization of the system was##2##6##(2008-10#2)
The optimization of the##11##4##(2008-10#7)(2008-2#1)(2008-3#1)(2011-3#1)(2013-1#1)
The optimization of##17##3##(2008-10#12)(2008-2#2)(2008-3#1)(2011-3#1)(2013-1#1)
The optimization process was##2##4##(2008-10#2)
The optimization step was carried out using##2##7##(2008-10#2)
The optimization step was##3##4##(2008-10#3)
The optimization##27##2##(2008-10#21)(2008-2#2)(2008-3#2)(2011-3#1)(2013-1#1)
The optimized PAD waveform##2##4##(2008-10#2)
The optimized conditions were##4##4##(2008-10#4)
The optimized conditions##6##3##(2008-10#6)
The optimized method was##3##4##(2008-10#3)
The optimized method##4##3##(2008-10#4)
The optimized procedure##2##3##(2008-10#2)
The optimized pulsed conditions of##2##5##(2008-10#2)
The optimized system##2##3##(2008-10#2)
The optimized##35##2##(2008-10#26)(2008-3#2)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The optimum analytical conditions##3##4##(2008-10#3)
The optimum condition##2##3##(2008-10#2)
The optimum conditions are##2##4##(2008-10#2)
The optimum conditions for the##9##5##(2008-10#9)
The optimum conditions for##14##4##(2008-10#12)(2008-12#1)(2008-3#1)
The optimum conditions obtained##2##4##(2008-10#2)
The optimum conditions were##3##4##(2008-10#3)
The optimum conditions##23##3##(2008-10#21)(2008-12#1)(2008-3#1)
The optimum experimental conditions were investigated by##2##7##(2008-10#2)
The optimum experimental conditions were##4##5##(2008-10#4)
The optimum experimental conditions##6##4##(2008-10#6)
The optimum extraction conditions are evaluated and described##2##8##(2008-10#2)
The optimum extraction conditions##3##4##(2008-10#3)
The optimum flow rate##2##4##(2008-10#2)
The optimum pH and temperature were##2##6##(1991-12#1)(1992-11#1)
The optimum pH for the##3##5##(1990-7#1)(2008-10#2)
The optimum pH range for the##2##6##(2008-10#2)
The optimum pH range##4##4##(2008-10#4)
The optimum pH ranges for quantitative sorption are##2##8##(2008-10#2)
The optimum pH value for quantitative sorption##2##7##(2008-10#2)
The optimum pH values for##2##5##(2008-10#2)
The optimum pH##20##3##(1990-7#2)(1991-12#1)(1992-11#1)(1997-2#1)(2008-10#15)
The optimum parameters##2##3##(2008-10#2)
The optimum reaction conditions and the analytical characteristics##2##8##(2008-10#2)
The optimum reaction conditions and##3##5##(2008-10#3)
The optimum reaction conditions were##5##5##(2008-10#5)
The optimum reaction conditions##8##4##(2008-10#8)
The optimum separation##2##3##(2008-10#2)
The optimum values of##2##4##(2008-10#2)
The optimum##117##2##(1990-7#2)(1991-12#1)(1992-11#1)(1997-2#1)(1997-3#1)(2007-10#2)(2008-10#88)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#1)(2013-7#1)
The oral cavity##2##3##(2008-5#1)(2008-7#1)
The oral##13##2##(2006-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
The order of the##3##4##(1990-5#1)(1996-5#1)(2008-10#1)
The order of##13##3##(1990-5#1)(1991-12#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)
The ordinary and##2##3##(2008-2#1)(2008-3#1)
The ordinary##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The organic and inorganic##2##4##(2008-10#1)(2009-7#1)
The organic phase##4##3##(2008-10#3)(2013-1#1)
The organic##14##2##(1994-9#1)(1996-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#1)
The organisation of##3##3##(1991-7#1)(2007-10#1)(2008-11#1)
The organisms##2##2##(1994-3#1)(2008-5#1)
The organization and##4##3##(1991-12#1)(1994-12#1)(1996-12#1)(2008-12#1)
The organization of the##2##4##(1991-6#1)(1996-2#1)
The organization of##9##3##(1990-5#1)(1991-6#1)(1994-3#2)(1996-2#1)(1996-4#1)(2008-8#2)(2011-2#1)
The organization##15##2##(1990-5#1)(1991-12#1)(1991-6#1)(1993-1#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(2008-12#1)(2008-8#2)(2011-2#1)
The orientation of##3##3##(1990-11#1)(1993-3#1)(2008-7#1)
The orientation##5##2##(1990-11#1)(1993-3#1)(1995-3#2)(2008-7#1)
The origin and##5##3##(1997-1#1)(2008-7#3)(2010-1#1)
The origin of the##12##4##(1991-11#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)
The origin of##18##3##(1991-11#1)(1992-3#1)(1994-5#1)(1995-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#2)
The origin##24##2##(1991-11#1)(1992-3#1)(1994-5#1)(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#4)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#2)(2013-8#1)
The original data was##2##4##(2008-10#1)(2010-8#1)
The original##14##2##(1990-2#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-3#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
The origins of the##2##4##(2008-1#1)(2010-4#1)
The origins of##7##3##(1995-1#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-4#1)
The origins##8##2##(1995-1#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2010-4#1)
The orthogonality##2##2##(2008-2#1)(2008-3#1)
The oscillation##2##2##(2008-2#2)
The ossicle##2##2##(2007-12#1)(2008-9#1)
The osteogenic potential##2##3##(2008-11#2)
The other G##2##3##(1993-11#1)(2010-3#1)
The other area##2##3##(2008-9#1)(2010-6#1)
The other case##2##3##(1992-4#1)(1996-5#1)
The other experimental parameters##2##4##(2008-10#2)
The other group##2##3##(1995-1#1)(2007-8#1)
The other is a##2##4##(1993-3#1)(2008-3#1)
The other is that##2##4##(1992-3#1)(2007-11#1)
The other is the##2##4##(2008-11#1)(2008-2#1)
The other is##8##3##(1992-3#1)(1993-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
The other locus##2##3##(2008-10#2)
The other mutant##3##3##(1992-3#1)(1993-3#1)(1997-4#1)
The other patient##2##3##(1996-6#1)(2008-1#1)
The other stream was passed through##2##6##(2008-10#2)
The other three##2##3##(2008-10#1)(2012-3#1)
The other two##5##3##(1990-7#1)(1994-12#1)(1995-2#1)(1996-5#1)(2012-2#1)
The other type##2##3##(2008-3#1)(2008-4#1)
The other was##3##3##(1991-3#1)(2008-3#1)(2008-5#1)
The other##95##2##(1990-12#2)(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#3)(2008-9#5)(2009-7#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
The others##3##2##(1993-6#1)(1997-8#1)(2008-10#1)
The outcome measure##2##3##(2011-2#1)(2013-1#1)
The outcome of the##3##4##(2008-11#1)(2008-7#1)(2011-1#1)
The outcome of##9##3##(1991-3#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#2)
The outcome was##4##3##(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#1)
The outcome##23##2##(1991-11#1)(1991-3#1)(1996-1#1)(1996-9#1)(2007-10#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
The outcomes of the##2##4##(2008-11#1)(2013-1#1)
The outcomes of##6##3##(2008-11#2)(2008-3#1)(2008-8#1)(2010-1#1)(2013-1#1)
The outcomes were##4##3##(2007-8#1)(2008-3#1)(2008-7#1)(2009-11#1)
The outcomes##17##2##(1994-11#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-1#2)(2010-12#1)(2013-1#1)
The outer membrane##2##3##(2008-8#1)(2013-1#1)
The outer##6##2##(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
The outermost##2##2##(2007-12#1)(2008-5#1)
The output beam##3##3##(2007-11#1)(2008-3#2)
The output energy was##2##4##(2008-2#1)(2008-3#1)
The output is##2##3##(2007-12#1)(2008-3#1)
The output of a##2##4##(2007-12#1)(2008-2#1)
The output of the##2##4##(2007-11#1)(2008-2#1)
The output of##7##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)
The output power was##2##4##(2008-2#1)(2008-3#1)
The output power##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
The output signal##2##3##(2007-12#1)(2008-3#1)
The output##30##2##(1995-11#1)(1995-3#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#9)(2008-4#1)(2011-2#1)
The outputs of the##2##4##(2008-2#2)
The outputs of these##2##4##(2008-10#2)
The outputs of##4##3##(2008-10#2)(2008-2#2)
The outputs##5##2##(2007-12#1)(2008-10#2)(2008-2#2)
The ovarian##3##2##(1990-10#1)(2008-12#1)(2008-5#1)
The overall 5-year survival##2##4##(2010-3#1)(2011-1#1)
The overall accuracy##2##3##(1990-6#1)(2008-2#1)
The overall aim##2##3##(2008-11#1)(2012-2#1)
The overall approach##2##3##(2008-10#1)(2008-9#1)
The overall average##2##3##(2008-4#1)(2009-4#1)
The overall complication##2##3##(2012-3#2)
The overall efficiency of##2##4##(2007-12#1)(2008-10#1)
The overall efficiency##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The overall estimated##2##3##(2008-10#1)(2013-1#1)
The overall extraction equilibrium constants (K(ex))##2##6##(2008-10#2)
The overall formation##2##3##(2008-10#2)
The overall frequency##2##3##(2008-10#1)(2012-2#1)
The overall incidence of##6##4##(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#1)
The overall incidence##8##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)
The overall mean##2##3##(2008-10#2)
The overall method##2##3##(2008-10#2)
The overall mortality rate was##2##5##(1994-11#1)(2007-7#1)
The overall mortality rate##3##4##(1993-9#1)(1994-11#1)(2007-7#1)
The overall mortality was##3##4##(2007-10#1)(2008-4#1)(2008-8#1)
The overall mortality##6##3##(1993-9#1)(1994-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-8#1)
The overall objective of##2##4##(2008-11#1)(2012-2#1)
The overall operative mortality##2##4##(1990-3#1)(2007-8#1)
The overall performance of the##2##5##(2008-10#1)(2008-3#1)
The overall performance of##3##4##(2008-10#1)(2008-3#2)
The overall prevalence of hypertension##2##5##(2008-11#1)(2008-7#1)
The overall prevalence of##11##4##(1990-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
The overall prevalence##13##3##(1990-2#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
The overall rate of##3##4##(1991-2#1)(1993-11#1)(1994-2#1)
The overall reduction process##2##4##(2008-10#2)
The overall reduction##3##3##(2008-10#3)
The overall response rate was##4##5##(1991-4#1)(1992-10#1)(1993-1#1)(2012-2#1)
The overall results of our study thus##2##7##(2008-10#2)
The overall results of our##3##5##(2008-10#3)
The overall results of##4##4##(2008-10#3)(2008-3#1)
The overall results##9##3##(1994-8#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-8#1)
The overall score of##2##4##(2009-11#2)
The overall sensitivity of##2##4##(1996-12#1)(1997-8#1)
The overall structure##2##3##(1993-8#1)(2008-3#1)
The overall success rate##2##4##(2008-12#1)(2012-2#1)
The overall survival rate##2##4##(2007-8#1)(2010-3#1)
The overall survival##4##3##(1990-12#1)(2007-8#1)(2008-10#1)(2010-3#1)
The overall system##2##3##(2008-10#1)(2013-1#1)
The overall##168##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#2)(1997-8#2)(2007-10#1)(2007-12#3)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#32)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#10)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-3#3)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#6)(2013-8#1)
The overarching goal##2##3##(2007-8#1)(2009-12#1)
The overarching##3##2##(2007-8#1)(2009-12#1)(2012-3#1)
The overestimation of##2##3##(1994-3#1)(2008-10#1)
The overexpressed##3##2##(1995-2#1)(2008-10#2)
The overexpression of##5##3##(1994-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
The overlapping##3##2##(2008-10#3)
The own##2##2##(2007-11#2)
The oxidant##2##2##(2008-10#2)
The oxidation mechanism##2##3##(2008-10#2)
The oxidation of##13##3##(1992-3#1)(1992-9#1)(1994-5#1)(1995-6#1)(2007-11#1)(2008-10#8)
The oxidation peak current##2##4##(2008-10#2)
The oxidation peak##5##3##(2008-10#5)
The oxidation reaction##2##3##(2008-10#2)
The oxidation##25##2##(1992-3#1)(1992-9#1)(1994-5#1)(1995-6#1)(2007-11#1)(2008-10#20)
The oxidative##6##2##(2008-10#4)(2008-5#1)(2009-5#1)
The oxidized##3##2##(1992-1#1)(1994-9#1)(2008-5#1)
The oxygen##5##2##(1991-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
The oxygen-binding##2##2##(1990-8#2)
The ozone therapy##2##3##(2007-8#1)(2012-2#1)
The ozone##3##2##(2007-8#1)(2008-3#1)(2012-2#1)
The p101##2##2##(1996-2#2)
The p120##2##2##(1990-11#1)(1996-2#1)
The p53 tumor suppressor##2##4##(2009-5#1)(2011-2#1)
The p53##5##2##(1991-2#1)(1992-3#1)(2008-5#1)(2009-5#1)(2011-2#1)
The pH dependence of the##3##5##(1991-8#1)(1991-9#1)(1996-12#1)
The pH dependence of##4##4##(1991-8#2)(1991-9#1)(1996-12#1)
The pH of the mixed solution was##2##7##(2008-10#2)
The pH of the##6##4##(2008-10#4)(2012-2#1)(2013-1#1)
The pH range##3##3##(1997-2#1)(2008-10#1)(2008-6#1)
The pH values##4##3##(2008-10#3)(2013-1#1)
The pH##36##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-8#2)(1991-9#1)(1993-8#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#17)(2008-12#1)(2008-6#2)(2009-12#1)(2012-2#2)(2013-1#2)
The pH-independent##2##2##(1990-8#1)(1991-9#1)
The pK##3##2##(1991-9#1)(1994-5#1)(1995-2#1)
The pK(00)##2##2##(2008-10#2)
The pK(a) values of##3##4##(2008-10#2)(2008-4#1)
The pK(a)##4##2##(2008-10#3)(2008-4#1)
The pKZ1##2##2##(2008-7#2)
The pKa values##2##3##(1997-2#1)(2009-9#1)
The pace##2##2##(1991-12#1)(2008-12#1)
The packing##2##2##(2008-10#1)(2008-3#1)
The pain level##2##3##(2007-11#1)(2012-3#1)
The pain##9##2##(2007-11#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
The paired ovaries of##2##4##(2007-12#2)
The paired##4##2##(1996-3#1)(2007-12#2)(2010-9#1)
The pairing of##2##3##(1994-5#1)(2009-6#1)
The pairing##3##2##(1994-5#1)(2009-5#1)(2009-6#1)
The palladium##2##2##(2007-11#1)(2008-10#1)
The pancreas##2##2##(2012-2#2)
The panel of##2##3##(1996-12#1)(2011-2#1)
The panel##5##2##(1996-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
The panelists also##2##3##(2008-5#1)(2008-6#1)
The paper also discusses the##2##5##(1990-6#1)(2009-10#1)
The paper also discusses##3##4##(1990-6#1)(2009-10#1)(2013-8#1)
The paper also##9##3##(1990-6#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2010-1#1)(2013-8#1)
The paper begins##2##3##(1992-1#1)(1996-1#1)
The paper concludes by##6##4##(1991-3#1)(1992-12#1)(2008-11#3)(2008-12#1)
The paper concludes that##2##4##(1992-5#1)(2012-1#1)
The paper concludes with a discussion of the##2##8##(2008-12#2)
The paper concludes with some##2##5##(2008-2#1)(2008-5#1)
The paper concludes with##4##4##(2008-12#2)(2008-2#1)(2008-5#1)
The paper concludes##12##3##(1991-3#1)(1992-12#1)(1992-5#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2012-1#1)
The paper describes a case of##2##6##(1990-9#1)(2012-3#1)
The paper describes a##10##4##(1990-9#2)(1992-6#2)(1995-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)(2012-3#1)
The paper describes an##3##4##(2008-10#3)
The paper describes the##6##4##(1990-6#1)(1991-5#2)(2008-1#1)(2008-10#1)(2008-11#1)
The paper describes##20##3##(1990-6#1)(1990-9#2)(1991-5#2)(1992-6#2)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2009-11#1)(2009-8#1)(2012-3#1)
The paper discusses the##5##4##(1995-6#1)(2008-10#1)(2008-11#2)(2012-1#1)
The paper discusses##8##3##(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2009-6#1)(2012-1#1)
The paper emphasizes the##2##4##(2008-11#1)(2010-4#1)
The paper examines##3##3##(2008-1#1)(2010-12#1)(2010-8#1)
The paper focuses on the##2##5##(1991-2#1)(2008-12#1)
The paper highlights the##2##4##(2008-11#1)(2009-7#1)
The paper highlights##3##3##(2008-11#1)(2009-7#1)(2012-2#1)
The paper illustrates the##2##4##(1990-9#1)(1991-3#1)
The paper indicates##2##3##(1991-9#1)(2011-2#1)
The paper is based on##2##5##(2010-10#1)(2011-2#1)
The paper is based##3##4##(2010-10#1)(2011-2#1)(2012-3#1)
The paper is##5##3##(1997-2#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
The paper outlines##3##3##(2008-11#3)
The paper presents the results of##3##6##(2008-10#1)(2009-4#2)
The paper presents the##7##4##(2007-11#1)(2008-10#1)(2009-4#2)(2010-8#1)(2012-12#1)(2013-7#1)
The paper presents##13##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-4#3)(2009-8#1)(2010-8#1)(2012-12#1)(2013-7#2)
The paper proposes##2##3##(2007-12#1)(2010-8#1)
The paper provides a##2##4##(2007-5#1)(2009-6#1)
The paper provides##3##3##(2007-5#1)(2008-10#1)(2009-6#1)
The paper reports a case of##4##6##(1990-6#2)(1991-5#1)(1992-6#1)
The paper reports a##6##4##(1990-6#3)(1991-5#2)(1992-6#1)
The paper reports the results of a##2##7##(1991-6#1)(1993-3#1)
The paper reports the results of##3##6##(1990-6#1)(1991-6#1)(1993-3#1)
The paper reports the results##4##5##(1990-6#2)(1991-6#1)(1993-3#1)
The paper reports the##8##4##(1990-6#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-3#1)(2010-4#1)
The paper reports##20##3##(1990-5#2)(1990-6#5)(1991-3#1)(1991-5#3)(1991-6#1)(1992-6#3)(1993-3#2)(2008-12#1)(2009-4#1)(2010-4#1)
The paper suggests##3##3##(1991-3#1)(1991-9#1)(2008-12#1)
The paper summarises##2##3##(2008-10#2)
The paper##138##2##(1990-5#2)(1990-6#9)(1990-9#3)(1991-2#1)(1991-3#5)(1991-5#5)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#5)(1993-3#2)(1995-2#1)(1995-6#1)(1996-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#17)(2008-12#10)(2008-2#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#5)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
The paradigm##3##2##(2008-4#1)(2008-9#1)(2009-10#1)
The paradox##2##2##(1995-9#1)(2012-3#1)
The parallel##3##2##(1996-5#1)(2008-11#1)(2008-3#1)
The parameter estimates##3##3##(2008-10#3)
The parameter##5##2##(1996-9#1)(2008-10#4)
The parameters affecting the##3##4##(2008-10#3)
The parameters affecting##5##3##(2008-10#5)
The parameters for the##2##4##(2008-10#1)(2008-3#1)
The parameters for##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
The parameters investigated were##3##4##(1991-1#1)(2008-10#1)(2008-3#1)
The parameters investigated##4##3##(1991-1#1)(2008-10#2)(2008-3#1)
The parameters of the##7##4##(1991-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)
The parameters of##11##3##(1991-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
The parameters related to the electrochemical hydride generation were investigated##2##10##(2008-10#2)
The parameters used##3##3##(1990-5#1)(2008-3#1)(2013-1#1)
The parameters which##2##3##(2008-10#2)
The parameters##42##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-9#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
The parametric##2##2##(2007-12#1)(2008-3#1)
The parasite##3##2##(1990-9#1)(2007-2#1)(2012-2#1)
The parasites##3##2##(1996-12#1)(1997-7#1)(2012-2#1)
The parent##3##2##(1995-3#1)(2008-12#2)
The parental##2##2##(1991-12#1)(2008-8#1)
The parents of##2##3##(1991-11#1)(1994-12#1)
The parents were##4##3##(1991-11#1)(1995-12#1)(1997-8#1)(2007-7#1)
The parents##9##2##(1991-11#2)(1994-12#1)(1995-1#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-10#2)
The parietal cells##2##3##(2007-12#1)(2012-1#1)
The partial##11##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-5#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-7#1)(2013-1#1)
The partially purified##2##3##(1990-5#1)(2008-10#1)
The participants in##2##3##(1996-3#1)(2011-2#1)
The participants of the study were##2##6##(2010-1#1)(2012-3#1)
The participants were asked to##2##5##(2007-7#1)(2012-3#1)
The participants were##8##3##(1995-5#1)(2007-7#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
The participants##22##2##(1992-1#1)(1995-5#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
The participation of##10##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1996-12#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
The particle size##2##3##(2008-3#1)(2008-5#1)
The particle##8##2##(1995-2#1)(1997-2#1)(1997-6#1)(2008-2#1)(2008-3#3)(2008-5#1)
The particles have##2##3##(2008-11#1)(2009-8#1)
The particles##8##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
The particular##3##2##(1994-3#1)(1995-3#1)(2007-12#1)
The particulate##2##2##(1992-11#1)(1994-8#1)
The partition coefficients of##2##4##(2008-5#1)(2008-7#1)
The partition##7##2##(1993-8#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
The partnership##2##2##(1994-1#1)(2010-4#1)
The passage of the##2##4##(1997-1#1)(2008-10#1)
The passage of##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
The passive sampler##2##3##(2008-10#2)
The passive##4##2##(1993-3#1)(2008-10#2)(2008-12#1)
The past decade has witnessed##2##5##(2008-8#1)(2011-2#1)
The past decade has##5##4##(1993-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)
The past##12##2##(1993-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
The patch of##2##3##(2008-5#1)(2010-12#1)
The patch##4##2##(1995-12#1)(2008-5#1)(2009-6#1)(2010-12#1)
The path##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
The pathogen also##3##3##(2008-10#3)
The pathogen##12##2##(2008-10#11)(2011-2#1)
The pathogenesis and##2##3##(2007-8#1)(2008-5#1)
The pathogenesis of the##2##4##(1997-6#1)(2011-1#1)
The pathogenesis of##17##3##(1991-2#1)(1995-5#1)(1997-6#2)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
The pathogenesis##20##2##(1991-2#1)(1991-9#1)(1995-5#1)(1997-6#2)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
The pathogenic##3##2##(1997-3#1)(1997-8#1)(2008-5#1)
The pathogenicity of##5##3##(2008-10#4)(2012-3#1)
The pathogens##3##2##(2008-10#3)
The pathologic##5##2##(1992-12#1)(1992-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
The pathological changes##2##3##(1991-3#1)(2007-11#1)
The pathological diagnosis##2##3##(1994-8#1)(2012-2#1)
The pathological findings##3##3##(1995-11#1)(2007-8#1)(2008-12#1)
The pathological##11##2##(1991-3#1)(1994-8#1)(1995-11#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-12#2)(2008-7#1)(2012-2#1)
The pathology of##2##3##(2008-7#1)(2011-2#1)
The pathology##3##2##(1995-2#1)(2008-7#1)(2011-2#1)
The pathomechanism of##3##3##(2007-11#3)
The pathophysiological mechanisms##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
The pathophysiological role of##2##4##(2008-12#1)(2009-10#1)
The pathophysiological##6##2##(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)
The pathophysiology and##2##3##(1992-5#1)(2008-7#1)
The pathophysiology of##6##3##(1996-12#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-2#1)
The pathophysiology##8##2##(1992-5#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-2#1)
The pathway of##2##3##(1990-7#1)(1992-3#1)
The pathway##4##2##(1990-7#1)(1992-3#1)(2008-3#1)(2009-6#1)
The pathways##3##2##(1992-12#1)(2008-3#2)
The patient also##4##3##(2008-6#1)(2009-4#1)(2010-4#1)(2012-2#1)
The patient arrived##2##3##(2007-12#1)(2010-1#1)
The patient continues to##2##4##(2007-7#1)(2008-9#1)
The patient developed##5##3##(1994-3#1)(2006-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
The patient did not have##2##5##(2007-5#1)(2008-1#1)
The patient did not##4##4##(1991-11#1)(2007-5#1)(2008-1#1)(2011-2#1)
The patient died at##2##4##(2007-7#1)(2009-10#1)
The patient died in##2##4##(2011-2#1)(2012-12#1)
The patient died of##4##4##(1990-2#1)(2007-10#1)(2008-1#1)(2010-12#1)
The patient died##15##3##(1990-2#1)(1990-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#2)
The patient group##2##3##(2007-8#1)(2011-2#1)
The patient had a history of##5##6##(1992-9#1)(1996-6#1)(2010-6#1)(2012-12#1)(2013-1#1)
The patient had a##10##4##(1992-9#1)(1995-3#1)(1996-6#1)(2007-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
The patient had an uneventful recovery##4##6##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
The patient had an uneventful##5##5##(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
The patient had an##7##4##(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
The patient had been##4##4##(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
The patient had no history of##2##6##(2006-10#1)(2007-12#1)
The patient had no##10##4##(1996-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#2)
The patient had undergone##2##4##(1993-6#1)(2008-2#1)
The patient had##53##3##(1990-6#1)(1992-9#1)(1993-6#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
The patient has been followed##2##5##(2008-6#1)(2012-2#1)
The patient has been##4##4##(2007-8#1)(2008-6#1)(2011-2#1)(2012-2#1)
The patient has##9##3##(2007-8#1)(2008-12#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-2#2)
The patient is a##2##4##(1993-3#1)(2012-3#1)
The patient is currently##2##4##(2010-3#1)(2011-2#1)
The patient is in good health##2##6##(2008-5#1)(2012-1#1)
The patient is##14##3##(1990-2#1)(1990-6#1)(1991-2#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-3#1)
The patient left the##2##4##(2008-12#1)(2013-1#1)
The patient left##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
The patient made a good##2##5##(1997-6#1)(2010-5#1)
The patient made a##3##4##(1997-6#1)(2007-12#1)(2010-5#1)
The patient made an uneventful recovery##2##6##(1993-9#1)(1997-3#1)
The patient made an##3##4##(1993-9#1)(1997-3#1)(2012-3#1)
The patient made##7##3##(1993-9#1)(1997-3#1)(1997-6#1)(2007-12#1)(2010-5#1)(2012-3#2)
The patient presented with a history of##2##7##(2008-11#1)(2008-7#1)
The patient presented with##10##4##(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
The patient presented##14##3##(1994-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
The patient received##4##3##(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)
The patient recovered from##4##4##(1990-12#1)(2011-2#2)(2012-12#1)
The patient recovered uneventfully##2##4##(2007-8#1)(2013-1#1)
The patient recovered##11##3##(1990-12#1)(1991-3#1)(1991-8#1)(1997-3#1)(2007-8#2)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
The patient refused##3##3##(2007-8#1)(2008-9#1)(2009-6#1)
The patient remained##5##3##(1993-1#1)(1997-5#1)(2009-4#1)(2011-2#2)
The patient required##3##3##(2008-1#1)(2010-5#1)(2013-1#1)
The patient responded favourably to##2##5##(2007-12#1)(2007-7#1)
The patient responded to##2##4##(2010-12#1)(2012-2#1)
The patient responded well to##3##5##(2007-7#2)(2011-1#1)
The patient responded##9##3##(1995-8#1)(2007-12#1)(2007-7#4)(2010-12#1)(2011-1#1)(2012-2#1)
The patient returned to##2##4##(2008-7#1)(2010-3#1)
The patient satisfaction##2##3##(1994-2#1)(1996-3#1)
The patient showed##5##3##(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#2)
The patient subsequently##3##3##(1994-12#1)(2007-5#1)(2009-6#1)
The patient suffered from##2##4##(1990-9#1)(2011-1#1)
The patient suffered##3##3##(1990-9#1)(2008-8#1)(2011-1#1)
The patient underwent a left lateral##2##6##(2008-6#1)(2008-7#1)
The patient underwent a total##2##5##(2009-3#1)(2013-1#1)
The patient underwent a##10##4##(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
The patient underwent partial##2##4##(2011-2#1)(2012-3#1)
The patient underwent##23##3##(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)
The patient was a 40-year-old woman##2##6##(2008-12#1)(2008-7#1)
The patient was a 63-year-old##2##5##(2006-10#1)(2013-8#1)
The patient was a##13##4##(1994-11#1)(1994-12#1)(1994-6#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-8#1)(2011-2#1)(2013-8#1)
The patient was admitted in the##2##6##(2013-1#2)
The patient was admitted to our##2##6##(2011-2#1)(2012-3#1)
The patient was admitted##5##4##(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
The patient was diagnosed with##4##5##(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
The patient was discharged after##2##5##(1995-3#1)(2013-8#1)
The patient was discharged home##2##5##(2007-8#1)(2010-7#1)
The patient was discharged on the##2##6##(2012-12#1)(2013-1#1)
The patient was discharged on##3##5##(2012-12#1)(2013-1#2)
The patient was discharged##9##4##(1995-3#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
The patient was first##2##4##(2008-7#1)(2009-8#1)
The patient was followed up##2##5##(2011-1#1)(2013-1#1)
The patient was free of##2##5##(2011-2#2)
The patient was managed##2##4##(2008-12#1)(2013-8#1)
The patient was placed on##2##5##(2008-7#1)(2011-2#1)
The patient was referred##2##4##(1995-5#1)(2011-2#1)
The patient was successfully treated##2##5##(2008-7#1)(2013-1#1)
The patient was then##2##4##(1994-3#1)(2011-2#1)
The patient was transferred to the##3##6##(2011-2#1)(2013-1#2)
The patient was treated by##2##5##(2008-10#1)(2011-2#1)
The patient was treated with##17##5##(1994-12#1)(1996-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
The patient was treated##22##4##(1994-12#1)(1996-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#2)
The patient was urgently##2##4##(2010-1#1)(2011-3#1)
The patient was##103##3##(1990-8#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-7#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#9)(2009-11#2)(2009-3#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#16)(2013-8#6)
The patient with##2##3##(1992-10#2)
The patient##363##2##(1990-12#1)(1990-2#4)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-4#3)(2007-5#2)(2007-7#8)(2007-8#15)(2008-1#14)(2008-10#6)(2008-11#3)(2008-12#10)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#8)(2008-7#26)(2008-8#1)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#2)(2009-3#8)(2009-4#3)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#4)(2010-12#2)(2010-3#6)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-2#39)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#7)(2012-3#11)(2013-1#39)(2013-7#1)(2013-8#8)
The patient's RBCs##2##3##(1994-12#1)(1994-9#1)
The patient's clinical##2##3##(2008-7#1)(2011-2#1)
The patient's postoperative course was uneventful##2##6##(2006-12#1)(2008-1#1)
The patient's presentation##2##3##(2010-8#1)(2011-2#1)
The patient's serum##2##3##(1992-9#1)(1994-6#1)
The patient's##30##2##(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-9#1)(1995-4#1)(1996-3#2)(2006-12#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
The patients do not##2##4##(1994-12#1)(2008-12#1)
The patients had been diagnosed with##2##6##(2011-2#1)(2013-1#1)
The patients had##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
The patients in the##2##4##(1991-2#1)(2013-1#1)
The patients in##3##3##(1991-2#1)(2007-7#1)(2013-1#1)
The patients received a##2##4##(2008-10#2)
The patients received##5##3##(1990-6#1)(1991-11#1)(2008-10#2)(2008-5#1)
The patients underwent##4##3##(1991-3#1)(2007-11#2)(2013-1#1)
The patients were divided into four groups##3##7##(2007-7#1)(2008-7#1)(2011-2#1)
The patients were divided into##5##5##(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
The patients were divided##6##4##(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#2)
The patients were examined##2##4##(2007-8#2)
The patients were followed up##2##5##(2007-11#1)(2007-8#1)
The patients were followed##3##4##(2007-11#1)(2007-8#1)(2009-7#1)
The patients were grouped according to##2##6##(1997-8#1)(2008-1#1)
The patients were selected##2##4##(2008-1#1)(2008-8#1)
The patients were stratified##2##4##(1995-11#1)(2011-2#1)
The patients were treated##3##4##(1992-12#1)(1997-3#1)(2012-3#1)
The patients were##43##3##(1990-5#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-6#1)(1995-11#1)(1995-2#1)(1996-7#2)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#2)
The patients who developed##2##4##(2008-7#1)(2013-1#1)
The patients who##7##3##(1997-2#1)(2007-10#1)(2007-8#1)(2008-7#2)(2012-3#1)(2013-1#1)
The patients with##12##3##(1990-3#1)(1991-5#1)(1994-12#1)(1994-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-1#1)(2013-1#2)
The patients##104##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#3)(1994-3#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#5)(2007-4#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#10)
The patients'##8##2##(1990-3#1)(1990-6#1)(1996-3#2)(1996-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
The pattern is##2##3##(1993-6#1)(2008-5#1)
The pattern of neuronal##2##4##(1991-12#1)(2008-4#1)
The pattern of##33##3##(1991-12#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#2)(1994-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
The pattern##39##2##(1991-12#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
The patterns of##8##3##(1991-8#1)(1994-7#1)(1996-4#1)(1996-6#1)(2008-10#1)(2008-5#1)(2011-3#1)(2013-1#1)
The patterns##12##2##(1991-8#1)(1994-7#1)(1996-4#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-3#1)(2013-1#1)
The payment##2##2##(1993-1#1)(1997-1#1)
The peak age##2##3##(2007-10#1)(2011-1#1)
The peak at##2##3##(1990-5#1)(2008-10#1)
The peak current is##3##4##(2008-10#3)
The peak current##7##3##(2008-10#7)
The peak currents##2##3##(2008-10#2)
The peak efficiency##2##3##(2008-3#2)
The peak intensity##2##3##(2007-12#1)(2008-3#1)
The peak of##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
The peak potential is##2##4##(2008-10#2)
The peak potential##3##3##(2008-10#3)
The peak power of the##2##5##(2008-3#2)
The peak power of##3##4##(2007-11#1)(2008-3#2)
The peak##39##2##(1990-5#1)(1991-9#1)(1993-9#1)(1995-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#15)(2008-2#1)(2008-3#8)(2008-5#1)(2011-1#1)(2011-2#1)
The peaks##2##2##(2008-10#2)
The pectoralis##2##2##(2007-12#1)(2013-1#1)
The pediatric##3##2##(1991-11#1)(2008-10#1)(2011-2#1)
The penetration##3##2##(1992-6#1)(2008-5#2)
The peptide had##2##3##(1993-11#1)(1993-3#1)
The peptide is##2##3##(1991-5#1)(2008-3#1)
The peptide was found to have##2##6##(1991-12#1)(1993-6#1)
The peptide was##4##3##(1991-12#2)(1993-6#1)(1993-8#1)
The peptide##26##2##(1990-12#1)(1990-7#1)(1991-12#3)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
The peptides##4##2##(1992-9#1)(1996-5#1)(2008-10#1)(2008-9#1)
The percent of##2##3##(2008-10#1)(2010-3#1)
The percent rebound of##2##4##(2008-4#2)
The percent##11##2##(1995-12#1)(1996-9#1)(2008-10#3)(2008-4#2)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)
The percentage of correct##2##4##(1993-12#1)(2008-9#1)
The percentage of infected##2##4##(2008-10#2)
The percentage of nematodes##3##4##(2008-10#3)
The percentage of the##2##4##(2011-2#1)(2012-3#1)
The percentage of##51##3##(1990-9#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-7#1)(1994-8#1)(1995-8#1)(1997-3#2)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
The percentage recoveries for##2##4##(2008-10#1)(2010-3#1)
The percentage recoveries of##2##4##(2008-10#2)
The percentage recoveries##5##3##(2008-10#4)(2010-3#1)
The percentage##65##2##(1990-9#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#2)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-6#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
The percentages of##9##3##(1993-6#1)(1997-8#1)(2008-10#3)(2008-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
The percentages##10##2##(1993-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
The perception of the##2##4##(2008-12#1)(2012-3#1)
The perception of##6##3##(2008-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The perception##11##2##(1991-12#1)(1991-2#1)(1991-3#1)(1997-1#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The perceptions of##2##3##(2008-11#1)(2010-8#1)
The performance characteristics of an##2##5##(2008-10#2)
The performance characteristics of the##2##5##(2008-10#1)(2008-3#1)
The performance characteristics of##5##4##(2008-10#4)(2008-3#1)
The performance is##4##3##(2008-2#2)(2008-3#1)(2008-6#1)
The performance of a##15##4##(1992-9#1)(1993-3#1)(2007-12#1)(2008-10#4)(2008-2#5)(2008-3#3)
The performance of an##4##4##(2007-11#2)(2008-3#2)
The performance of commercially available##2##5##(2008-10#1)(2008-3#1)
The performance of our##2##4##(2008-2#1)(2011-2#1)
The performance of such##2##4##(2007-12#1)(2008-3#1)
The performance of the device##2##5##(2007-11#1)(2008-10#1)
The performance of the method has been##2##7##(2008-10#2)
The performance of the method is##2##6##(2008-3#2)
The performance of the method##7##5##(2008-10#4)(2008-3#3)
The performance of the new algorithm is demonstrated##2##8##(2008-3#2)
The performance of the proposed method is##2##7##(2008-10#1)(2008-2#1)
The performance of the proposed method was##2##7##(2008-10#2)
The performance of the proposed method##4##6##(2008-10#3)(2008-2#1)
The performance of the proposed##9##5##(2008-10#5)(2008-2#2)(2008-6#1)(2011-1#1)
The performance of the sensor is geometrically analyzed##2##8##(2008-2#1)(2008-3#1)
The performance of the sensor##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
The performance of the system was demonstrated in the##2##9##(2008-10#2)
The performance of the system was##4##6##(2008-10#4)
The performance of the system##5##5##(2008-10#4)(2008-2#1)
The performance of the##62##4##(1991-6#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#28)(2008-11#1)(2008-2#6)(2008-3#15)(2008-6#1)(2010-10#1)(2011-1#1)
The performance of these two##2##5##(1997-2#1)(2008-10#1)
The performance of these##7##4##(1997-2#1)(2008-10#5)(2010-7#1)
The performance of this##8##4##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)
The performance of##134##3##(1991-6#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-11#4)(2007-12#7)(2007-7#1)(2008-10#50)(2008-11#3)(2008-2#18)(2008-3#30)(2008-6#1)(2008-7#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
The performance##150##2##(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-11#4)(2007-12#7)(2007-7#1)(2008-10#56)(2008-11#3)(2008-2#21)(2008-3#32)(2008-5#1)(2008-6#2)(2008-7#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
The performances of the##2##4##(2008-2#1)(2008-3#1)
The performances of these##2##4##(2007-11#1)(2008-3#1)
The performances of this##2##4##(2008-10#2)
The performances of##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
The performances##7##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
The perfusion##3##2##(2008-11#1)(2009-11#1)(2012-3#1)
The perinatal##2##2##(1994-3#1)(2011-2#1)
The period of##6##3##(1990-5#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-7#1)
The period##10##2##(1990-5#1)(1991-11#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#2)(2013-1#1)
The periodic##3##2##(2008-3#2)(2008-8#1)
The periods##2##2##(2008-3#1)(2008-6#1)
The perioperative##4##2##(1995-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
The peripheral##4##2##(1991-6#1)(2007-12#1)(2008-7#1)(2012-2#1)
The peritoneal##4##2##(1994-9#1)(2007-7#1)(2008-1#2)
The permanent##2##2##(2008-10#1)(2008-12#1)
The permeability of the##2##4##(1991-5#1)(2008-5#1)
The permeability of##3##3##(1991-5#1)(2008-11#1)(2008-5#1)
The permeability##6##2##(1991-5#1)(1992-6#2)(1994-5#1)(2008-11#1)(2008-5#1)
The peroxidase##2##2##(2008-10#1)(2008-5#1)
The peroxidative activity of human Cu##2##6##(1997-2#2)
The peroxidative activity##4##3##(1997-2#4)
The peroxide##2##2##(1990-5#1)(2008-10#1)
The peroxisome proliferator-activated##2##3##(1995-6#1)(2008-7#1)
The peroxisome##3##2##(1992-11#1)(1995-6#1)(2008-7#1)
The persistence of##4##3##(1994-3#1)(1996-4#1)(2012-3#1)(2013-1#1)
The persistence##5##2##(1993-8#1)(1994-3#1)(1996-4#1)(2012-3#1)(2013-1#1)
The persistent##2##2##(2007-12#1)(2012-3#1)
The personal##5##2##(1990-12#1)(1990-9#1)(1992-6#1)(2008-11#2)
The perspective##3##2##(1995-12#1)(1995-2#1)(2008-3#1)
The pertussis toxin##2##3##(1993-9#2)
The pesticides##4##2##(2008-10#3)(2008-6#1)
The pfhsp86##2##2##(1994-12#2)
The phantom##2##2##(2009-11#1)(2011-1#1)
The pharmaceutical##8##2##(1996-1#1)(1996-2#1)(2008-10#2)(2009-9#1)(2011-2#2)(2011-3#1)
The pharmacokinetic parameters of the##2##5##(2008-10#1)(2008-11#1)
The pharmacokinetic parameters##3##3##(2008-10#2)(2008-11#1)
The pharmacokinetic##5##2##(2008-10#2)(2008-11#1)(2010-11#1)(2011-1#1)
The pharmacokinetics of##2##3##(1994-3#1)(2008-11#1)
The pharmacologic##2##2##(1996-7#1)(2008-10#1)
The pharmacological##7##2##(1990-7#1)(1996-5#1)(1996-9#1)(2008-4#2)(2009-9#1)(2012-2#1)
The pharmacology of the##3##4##(1993-12#1)(1995-11#1)(2008-7#1)
The phase and##2##3##(2007-11#1)(2007-12#1)
The phase diagrams of##2##4##(1993-8#1)(2008-5#1)
The phase diagrams##3##3##(1993-8#1)(2008-5#2)
The phase difference between##2##4##(2008-3#2)
The phase distribution##2##3##(2008-2#1)(2008-3#1)
The phase exchange##2##3##(2008-10#2)
The phase of the##2##4##(2008-2#1)(2008-5#1)
The phase of##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
The phase space##2##3##(2009-11#1)(2012-2#1)
The phase##38##2##(1993-8#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#3)(2008-2#5)(2008-3#11)(2008-5#6)(2009-11#1)(2010-5#1)(2012-2#3)(2013-8#1)
The phase-boundary##2##2##(2008-10#2)
The phase-shifting##4##2##(2008-2#1)(2008-3#3)
The phases##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
The phenolic##3##2##(2008-10#2)(2008-5#1)
The phenomena##2##2##(2007-12#1)(2008-10#1)
The phenomenological##2##2##(2009-5#1)(2012-3#1)
The phenomenon of##9##3##(1993-2#1)(1996-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
The phenomenon##13##2##(1993-2#1)(1996-4#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#2)
The phenotype of##3##3##(1997-3#1)(2008-6#1)(2012-3#1)
The phenotype##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)
The phenotypes of##2##3##(2008-9#1)(2011-1#1)
The phenotypes##4##2##(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
The phenotypic##7##2##(1996-5#1)(2007-7#1)(2008-10#3)(2012-3#1)(2013-1#1)
The phenytoin##2##2##(2008-11#2)
The phorbol ester##3##3##(1993-6#1)(1994-6#1)(1995-11#1)
The phosphate##4##2##(1992-6#1)(1994-11#1)(2008-10#2)
The phospholipase D activity##3##4##(1993-3#3)
The phospholipase##4##2##(1993-11#1)(1993-3#3)
The phosphopeptide##2##2##(1990-11#1)(1992-6#1)
The phosphorescence##3##2##(2008-10#3)
The phosphorus##4##2##(1997-7#1)(2008-10#2)(2013-1#1)
The phosphorylated##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
The phosphorylating reagent##2##3##(2008-4#2)
The phosphorylation of##3##3##(1993-3#1)(2011-2#1)(2013-1#1)
The phosphorylation##6##2##(1993-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
The photocatalytic##6##2##(1994-3#2)(2008-10#2)(2009-8#1)(2013-8#1)
The photochemical##4##2##(1996-2#1)(2008-11#1)(2008-3#1)(2009-8#1)
The photocurrent##3##2##(2007-11#2)(2008-10#1)
The photodiode##2##2##(2008-11#1)(2008-3#1)
The photoinduced##2##2##(2007-12#2)
The photoluminescence##2##2##(2013-8#2)
The photon flux density of PAR##2##6##(2008-10#2)
The photon##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
The photorefractive##2##2##(2007-11#1)(2008-3#1)
The phylogenetic tree##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
The phylogenetic##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)
The physical and##2##3##(1994-12#1)(2008-10#1)
The physical principles of##2##4##(1994-5#1)(2008-4#1)
The physical properties of the##2##5##(1997-3#1)(2010-6#1)
The physical properties of##3##4##(1997-3#1)(2008-5#1)(2010-6#1)
The physical state of##2##4##(1990-12#1)(1994-8#1)
The physical##27##2##(1990-12#1)(1991-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#2)(2010-6#1)(2012-2#1)
The physician##5##2##(1992-1#1)(1993-11#1)(1994-2#1)(1995-3#1)(1997-4#1)
The physicians were##2##3##(1997-4#1)(2009-2#1)
The physicians##6##2##(1990-2#1)(1993-6#1)(1994-11#1)(1997-4#1)(2007-11#1)(2009-2#1)
The physicochemical properties of##2##4##(2008-11#1)(2010-4#1)
The physicochemical##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
The physiological function of##3##4##(1994-2#1)(1997-2#1)(2009-5#1)
The physiological role of##2##4##(1990-11#1)(2008-1#1)
The physiological role##3##3##(1990-11#1)(1993-5#1)(2008-1#1)
The physiological##16##2##(1990-11#2)(1991-9#1)(1993-11#1)(1993-5#1)(1994-2#1)(1997-2#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-4#1)(2009-5#1)(2010-8#1)(2012-6#1)
The physiology and##2##3##(2008-10#1)(2008-7#1)
The physiology of##4##3##(1992-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
The physiology##6##2##(1992-6#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
The phytopathogenic##2##2##(2008-10#1)(2008-11#1)
The phytotoxic##2##2##(2008-10#2)
The picture is##2##3##(2008-1#1)(2012-3#1)
The picture##3##2##(2008-1#1)(2009-6#1)(2012-3#1)
The piezoelectric##3##2##(2008-10#2)(2013-1#1)
The pilot study##2##3##(2008-10#1)(2008-5#1)
The pilot##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
The pineal gland##2##3##(1994-5#1)(2008-12#1)
The pineal hormone melatonin##2##4##(1990-5#1)(2013-7#1)
The pineal organ##2##3##(1994-5#2)
The pineal##7##2##(1990-5#1)(1994-5#4)(2008-12#1)(2013-7#1)
The pinless navigation##2##3##(2013-1#2)
The pituitary##2##2##(1993-2#1)(1993-9#1)
The place of##4##3##(1991-12#1)(1995-3#1)(2008-10#1)(2008-12#1)
The place##6##2##(1991-12#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
The placement of a##2##4##(2007-7#1)(2012-12#1)
The placement of##4##3##(2007-7#1)(2007-8#1)(2012-12#1)(2013-8#1)
The placement##6##2##(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
The placenta##2##2##(1990-5#1)(1995-12#1)
The plan is##2##3##(1992-11#1)(2011-1#1)
The plan##8##2##(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1995-12#2)(1996-3#1)(2011-1#1)
The plane##2##2##(2008-3#2)
The planning and##2##3##(1995-3#1)(2008-10#1)
The planning##3##2##(1991-3#1)(1995-3#1)(2008-10#1)
The plant material##2##3##(2008-10#1)(2008-11#1)
The plant##8##2##(1994-7#1)(2008-10#4)(2008-11#1)(2012-5#1)(2013-7#1)
The plants##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
The plasma CCK##2##3##(2008-7#2)
The plasma concentration##2##3##(1994-12#1)(2008-11#1)
The plasma membrane##2##3##(2008-5#1)(2008-7#1)
The plasma samples were##2##4##(1990-12#1)(1996-5#1)
The plasma was deproteinized with acetonitrile##2##6##(2008-10#2)
The plasma##22##2##(1990-12#1)(1990-3#2)(1993-2#1)(1994-12#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
The plasmid was##2##3##(1994-8#1)(2008-7#1)
The plasmid##4##2##(1991-6#1)(1994-8#1)(2008-7#2)
The plastic##2##2##(2008-8#1)(2009-7#1)
The plasticizer##2##2##(2008-10#2)
The plastid##2##2##(1995-8#1)(2011-2#1)
The plate##2##2##(1997-7#1)(2007-11#1)
The platelet lysate was##2##4##(2008-11#2)
The platelet lysate##3##3##(2008-11#3)
The platelet##7##2##(1992-8#1)(2008-11#3)(2008-9#1)(2011-2#2)
The play##2##2##(2008-11#2)
The pleiotropic phenotypes##2##3##(1995-8#1)(2009-8#1)
The pleural effusion##2##3##(1991-12#1)(2008-1#1)
The pleural fluid##2##3##(2007-12#1)(2007-6#1)
The pleural##4##2##(1991-12#1)(2007-12#1)(2007-6#1)(2008-1#1)
The plot of##2##3##(2008-5#1)(2009-11#1)
The plot##3##2##(2008-10#1)(2008-5#1)(2009-11#1)
The plug##3##2##(2009-6#1)(2013-1#2)
The point mutation##2##3##(1991-8#1)(1996-2#1)
The point of##3##3##(2007-5#1)(2008-11#1)(2008-7#1)
The point##8##2##(1991-8#1)(1996-2#1)(1997-6#1)(2007-5#1)(2008-11#2)(2008-7#1)(2011-1#1)
The points##2##2##(2008-3#1)(2009-8#1)
The polar##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2013-8#1)
The polarimetric##2##2##(2008-3#2)
The polarised##2##2##(1994-6#2)
The polarity##2##2##(1990-5#1)(1991-5#1)
The polarization dependence of##2##4##(2007-11#1)(2008-3#1)
The polarization properties of##4##4##(2007-12#1)(2008-3#3)
The polarization state##2##3##(2007-12#1)(2008-2#1)
The polarization##17##2##(1997-6#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#8)
The polarization-dependent##2##2##(2007-11#2)
The polarized##2##2##(2008-3#2)
The polarographic##2##2##(2008-10#2)
The policy##4##2##(1994-2#1)(1994-7#1)(1995-3#1)(1997-7#1)
The political##3##2##(1994-7#1)(1995-12#1)(1996-2#1)
The politics and economics of health care finance##2##8##(1991-2#1)(1994-3#1)
The politics and economics of##3##5##(1991-2#1)(1994-3#2)
The politics of Medicare and##2##5##(1996-12#1)(1996-3#1)
The politics of##3##3##(1994-9#1)(1996-12#1)(1996-3#1)
The politics##6##2##(1991-2#1)(1994-3#2)(1994-9#1)(1996-12#1)(1996-3#1)
The pollen##2##2##(2008-5#1)(2013-8#1)
The polyamine portions of##2##4##(1990-5#2)
The polyamines##2##2##(1992-11#1)(2008-10#1)
The polyclonal antibody showed specific recognition of##2##7##(2008-10#2)
The polyclonal antibody##4##3##(1993-9#1)(2007-12#1)(2008-10#2)
The polycondensation of##2##3##(1992-12#1)(2007-11#1)
The polycystic ovary syndrome (PCOS)##2##5##(2008-4#2)
The polymer##9##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)
The polymerase chain reaction (PCR)##3##5##(1993-12#1)(2008-4#1)(2011-2#1)
The polymerase chain reaction was used to amplify the##2##9##(1991-7#1)(1996-5#1)
The polymerase chain reaction was used to amplify##4##8##(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)
The polymerase chain reaction was##5##5##(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1996-5#1)
The polymerase chain reaction##11##4##(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1996-5#1)(1997-7#1)(2008-4#2)(2011-2#1)
The polymeric##4##2##(2008-10#3)(2012-1#1)
The polymers were##3##3##(2008-10#2)(2008-11#1)
The polymers##7##2##(2008-10#5)(2008-11#1)(2008-2#1)
The polymorphic markers were##2##4##(2008-10#2)
The polymorphic##3##2##(1995-6#1)(2008-10#2)
The polymorphism of the##2##4##(2008-10#1)(2011-1#1)
The polymorphism of##4##3##(2008-10#1)(2011-1#2)(2013-8#1)
The polypeptide was##2##3##(1997-6#1)(2008-9#1)
The polypeptide##6##2##(1992-12#1)(1993-11#1)(1994-8#1)(1995-2#1)(1997-6#1)(2008-9#1)
The polyprotein##2##2##(2008-10#1)(2008-9#1)
The pooled##3##2##(1990-12#1)(2008-6#1)(2012-3#1)
The poor are##2##3##(1992-5#1)(2008-11#1)
The poor quality of##2##4##(1995-9#1)(2008-3#1)
The poor##11##2##(1990-10#1)(1990-6#1)(1992-5#1)(1995-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2010-4#1)
The popliteal##2##2##(1991-3#1)(2008-10#1)
The popularity of##3##3##(1994-9#1)(2010-8#1)(2011-2#1)
The population density of##3##4##(2008-10#3)
The population dynamics of the##2##5##(2008-10#1)(2008-5#1)
The population dynamics of##4##4##(2008-10#2)(2008-5#2)
The population genetic structure of the##2##6##(2008-10#1)(2013-8#1)
The population genetic structure of##4##5##(2008-10#3)(2013-8#1)
The population genetic structure##6##4##(2008-10#4)(2010-8#1)(2013-8#1)
The population of##6##3##(2008-10#2)(2008-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
The population size of##2##4##(2008-10#1)(2010-8#1)
The population size##3##3##(2008-10#1)(2010-7#1)(2010-8#1)
The population structure of##7##4##(2008-10#6)(2008-5#1)
The population structure##9##3##(2008-10#7)(2008-5#2)
The population##44##2##(1990-6#1)(2008-10#25)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#3)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
The populations of the##3##4##(1990-8#1)(1994-9#1)(2008-10#1)
The populations of##5##3##(1990-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-5#1)
The populations##6##2##(1990-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
The porcine##3##2##(1991-6#1)(2008-11#1)(2008-7#1)
The porphyrins##2##2##(2008-10#1)(2009-12#1)
The portable##4##2##(1995-5#1)(2008-10#3)
The position of the##8##4##(1990-12#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-3#2)(2008-5#1)
The position of##9##3##(1990-12#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-3#2)(2008-5#2)
The position##13##2##(1990-12#1)(1995-2#1)(1996-1#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#2)
The positioning##2##2##(1991-5#1)(2008-3#1)
The positions of exons which do not exhibit##2##8##(1997-6#1)(1997-8#1)
The positions of the##3##4##(1990-5#2)(2008-3#1)
The positions of##7##3##(1990-5#2)(1997-6#1)(1997-8#1)(2008-3#1)(2008-5#1)(2008-8#1)
The positive and negative##3##4##(1991-6#1)(2008-11#1)(2008-8#1)
The positive effect##2##3##(1997-7#1)(2008-10#1)
The positive influence of##2##4##(2007-8#1)(2011-2#1)
The positive predictive##2##3##(2011-2#2)
The positive rate of##2##4##(1994-12#1)(2011-1#1)
The positive rate##3##3##(1994-12#1)(2011-1#1)(2013-8#1)
The positive##22##2##(1991-6#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-8#1)
The positivity##3##2##(1990-6#1)(1991-8#1)(2007-7#1)
The possibilities of the##3##4##(2008-10#2)(2008-3#1)
The possibilities of##5##3##(2008-10#3)(2008-3#1)(2012-12#1)
The possibilities##6##2##(1992-9#1)(2008-10#3)(2008-3#1)(2012-12#1)
The possibility for##2##3##(1996-3#1)(2013-1#1)
The possibility of a##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
The possibility of applying##3##4##(2008-10#3)
The possibility of compensating##2##4##(2007-12#1)(2008-10#1)
The possibility of the##3##4##(2008-10#1)(2008-3#1)(2010-10#1)
The possibility of using##5##4##(1991-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
The possibility of##55##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1994-2#1)(1995-6#1)(1996-1#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-7#2)(2008-8#2)(2009-6#1)(2010-10#1)(2011-1#1)(2012-3#2)(2013-1#2)
The possibility that the##2##4##(1991-5#1)(2010-4#1)
The possibility that##15##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-2#1)(2010-4#1)(2010-8#1)(2012-3#1)
The possibility to use##2##4##(2008-10#2)
The possibility to##6##3##(2008-10#4)(2008-8#1)(2012-2#1)
The possibility##80##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-7#2)(2008-8#3)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#3)
The possible extension of this##2##5##(2007-12#1)(2008-10#1)
The possible impact of##2##4##(1991-2#1)(2013-8#1)
The possible implications of these##2##5##(1991-5#1)(1991-6#1)
The possible interferences of the most common ions have been investigated##2##11##(2008-10#2)
The possible mechanism for the##2##5##(2008-10#2)
The possible mechanism for##3##4##(1994-8#1)(2008-10#2)
The possible mechanism of##5##4##(2008-10#4)(2008-8#1)
The possible mechanism##11##3##(1994-8#1)(2008-10#8)(2008-8#2)
The possible mechanisms##3##3##(2008-10#2)(2012-12#1)
The possible reaction mechanism was##2##5##(2008-10#2)
The possible reasons for##3##4##(1996-12#1)(2007-12#1)(2008-1#1)
The possible role of these##2##5##(1992-8#1)(2008-10#1)
The possible role of##7##4##(1992-3#1)(1992-8#1)(2007-10#1)(2008-10#3)(2010-12#1)
The possible roles of these##2##5##(1991-11#1)(1991-9#1)
The possible roles of this##2##5##(1993-9#1)(2010-8#1)
The possible roles of##6##4##(1991-11#1)(1991-9#1)(1993-9#1)(2008-1#1)(2008-10#1)(2010-8#1)
The possible underlying pathophysiological##2##4##(2009-11#1)(2011-2#1)
The possible use of##3##4##(1991-9#1)(1992-3#1)(2008-10#1)
The possible##83##2##(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#31)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
The post##2##2##(2010-5#1)(2010-7#1)
The post-operative##2##2##(2007-7#1)(2012-2#1)
The post-translational processing and intracellular sorting of##2##7##(1995-8#2)
The post-translational##3##2##(1995-12#1)(1995-8#2)
The posterior##7##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)
The postoperative course was favorable##2##5##(2013-1#1)(2013-8#1)
The postoperative course was uneventful and##2##6##(2008-10#1)(2012-3#1)
The postoperative course was uneventful##6##5##(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
The postoperative course was##10##4##(1992-9#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The postoperative course##11##3##(1992-9#1)(2007-8#2)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The postoperative morbidity was##2##4##(1994-3#1)(2008-10#1)
The postoperative mortality was##2##4##(1992-11#1)(2008-10#1)
The postoperative period was##2##4##(1991-11#1)(2008-10#1)
The postoperative period##3##3##(1991-11#1)(2008-10#1)(2011-3#1)
The postoperative survival##2##3##(1992-9#1)(1993-5#1)
The postoperative##22##2##(1990-9#1)(1991-11#1)(1992-11#1)(1992-9#2)(1993-5#1)(1994-3#1)(2007-8#2)(2008-10#4)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The potassium##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
The potency of the##2##4##(1994-8#1)(1995-12#1)
The potency of these##2##4##(1990-12#1)(1992-12#1)
The potency of##7##3##(1990-12#1)(1991-12#1)(1992-12#1)(1994-8#1)(1995-12#1)(2008-10#2)
The potent##4##2##(1991-12#1)(1993-8#1)(1994-6#1)(2012-2#1)
The potential application of##4##4##(1995-9#1)(2008-10#2)(2013-7#1)
The potential application##5##3##(1995-9#1)(2008-10#2)(2008-3#1)(2013-7#1)
The potential applications of##2##4##(2008-10#1)(2008-7#1)
The potential benefit of##3##4##(2008-10#1)(2008-6#1)(2010-8#1)
The potential benefits of##2##4##(2008-6#1)(2008-7#1)
The potential benefits##4##3##(1996-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
The potential effect of##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
The potential effects of##3##4##(1991-5#1)(2007-12#1)(2008-10#1)
The potential for##13##3##(1991-5#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
The potential impact of##3##4##(1995-12#1)(2008-7#1)(2011-1#1)
The potential involvement of##2##4##(1994-11#1)(1996-5#1)
The potential of a##3##4##(1993-9#1)(2008-10#1)(2008-3#1)
The potential of the##5##4##(1993-12#1)(2008-10#3)(2008-2#1)
The potential of these##4##4##(1990-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
The potential of this electrode##2##5##(2008-10#2)
The potential of this##4##4##(2007-11#1)(2007-12#1)(2008-10#2)
The potential of##35##3##(1990-5#1)(1993-12#1)(1993-5#1)(1993-9#1)(2007-11#1)(2007-12#3)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
The potential role of##7##4##(1992-1#1)(2008-1#1)(2008-5#1)(2009-1#1)(2009-11#1)(2010-3#1)(2011-2#1)
The potential use of##4##4##(1993-6#1)(2008-6#1)(2008-7#1)(2010-12#1)
The potential utility of##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
The potential##135##2##(1990-5#1)(1991-5#2)(1992-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#41)(2008-11#7)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
The potentiality of##2##3##(2008-10#2)
The potentials of##2##3##(2008-10#2)
The potentials##3##2##(1996-6#1)(2008-10#2)
The potentiating effect of##2##4##(1990-5#1)(1997-4#1)
The potentiation##2##2##(1993-6#1)(1996-2#1)
The potentiometric response characteristics of##3##5##(2008-10#3)
The potentiometric response is independent of##2##6##(2008-10#2)
The potentiometric response##6##3##(2008-10#6)
The potentiometric selectivity coefficient values as determined by match potential method (MPM) indicate##2##13##(2008-10#2)
The potentiometric selectivity coefficient values as determined by##3##8##(2008-10#3)
The potentiometric selectivity##4##3##(2008-10#4)
The potentiometric##15##2##(2008-10#15)
The powder##3##2##(1997-7#1)(2012-2#1)(2013-8#1)
The powdery mildew resistance##2##4##(2008-10#2)
The power and##2##3##(2008-11#1)(2010-4#1)
The power law model##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
The power law##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
The power of the##4##4##(1992-9#1)(1993-12#1)(2008-7#1)(2008-8#1)
The power of##10##3##(1992-9#1)(1993-12#1)(1994-2#1)(1996-2#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)
The power##27##2##(1992-1#1)(1992-9#1)(1993-12#1)(1994-2#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#1)(2013-1#1)
The practical applicability of the##2##5##(2008-10#2)
The practical application of##2##4##(2008-5#1)(2008-7#1)
The practical utility of the##3##5##(2008-10#3)
The practical##17##2##(1991-3#1)(1991-6#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)
The practice of##7##3##(1993-7#1)(1994-12#2)(1994-6#1)(2007-2#1)(2010-11#1)(2011-2#1)
The practice##9##2##(1993-7#1)(1994-12#2)(1994-6#1)(1996-1#2)(2007-2#1)(2010-11#1)(2011-2#1)
The practitioners##2##2##(2008-1#1)(2008-10#1)
The pre-concentration##3##2##(2008-10#3)
The pre-operative##2##2##(2007-7#1)(2008-9#1)
The preceding##5##2##(1992-1#1)(1995-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
The precipitate is##2##3##(2008-10#2)
The precipitate was dissolved with##3##5##(2008-10#3)
The precipitate was separated by##2##5##(2008-10#2)
The precipitate was##5##3##(2008-10#5)
The precipitate##7##2##(2008-10#7)
The precipitation of##3##3##(2008-10#2)(2008-6#1)
The precipitation##5##2##(1993-8#1)(2008-10#3)(2008-6#1)
The precise function of##2##4##(1995-8#1)(1997-3#1)
The precise##9##2##(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-12#1)
The precision (R##6##3##(2008-10#6)
The precision and accuracy of the##4##6##(1991-5#1)(2008-10#2)(2008-3#1)
The precision and accuracy of##6##5##(1991-5#1)(2008-10#4)(2008-3#1)
The precision and##8##3##(1991-5#1)(2008-10#6)(2008-3#1)
The precision at##2##3##(2008-10#2)
The precision characteristics##2##3##(2008-10#2)
The precision expressed as relative standard deviation##3##7##(2008-10#3)
The precision expressed as##4##4##(2008-10#4)
The precision for 10 replicate determinations at the##2##8##(2008-10#2)
The precision for 10 replicate determinations at##4##7##(2008-10#4)
The precision for##9##3##(2008-10#9)
The precision is##2##3##(2008-10#2)
The precision obtained for##2##4##(2008-10#2)
The precision obtained##3##3##(2008-10#3)
The precision of the method was 2##2##7##(2008-10#2)
The precision of the method was estimated##2##7##(2008-10#2)
The precision of the method was tested##2##7##(2008-10#2)
The precision of the method was##7##6##(2008-10#7)
The precision of the method##17##5##(2008-10#17)
The precision of the proposed method was##2##7##(2008-10#2)
The precision of the proposed method##4##6##(2008-10#4)
The precision of the##32##4##(1993-12#1)(1996-5#1)(2008-10#29)(2008-3#1)
The precision of##36##3##(1993-12#1)(1996-5#1)(2008-10#33)(2008-3#1)
The precision was assessed from##2##5##(2008-10#2)
The precision was##9##3##(1990-8#1)(2008-10#8)
The precision##98##2##(1990-8#1)(1991-5#1)(1993-12#1)(1996-5#1)(2008-10#91)(2008-2#1)(2008-3#2)
The precisions##3##2##(2008-10#3)
The preconcentrated##2##2##(2008-10#2)
The preconcentration factor obtained##2##4##(2008-10#2)
The preconcentration factor was##2##4##(2008-10#2)
The preconcentration factor##8##3##(2008-10#8)
The preconcentration factors are##2##4##(2008-10#2)
The preconcentration factors##3##3##(2008-10#3)
The preconcentration was carried out##2##5##(2008-10#2)
The preconcentration##18##2##(2008-10#17)(2009-6#1)
The precursor and##2##3##(1993-12#1)(1994-6#1)
The precursor to##2##3##(1996-2#1)(2008-11#1)
The precursor##7##2##(1993-12#1)(1994-6#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-3#1)
The predator##2##2##(2008-6#1)(2008-8#1)
The predicted amino acid sequence of the##2##7##(1993-8#1)(1994-6#1)
The predicted amino acid sequence of##4##6##(1993-3#1)(1993-8#1)(1994-6#1)(1995-6#1)
The predicted amino acid sequence was##3##6##(1991-9#1)(1993-12#1)(1993-9#1)
The predicted amino acid sequence##8##5##(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-6#2)
The predicted amino acid sequences of##3##6##(1991-9#1)(1997-2#1)(2008-7#1)
The predicted amino acid##12##4##(1991-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-6#2)(1997-2#1)(2008-7#1)
The predicted open reading##2##4##(1994-11#2)
The predicted protein of##2##4##(1993-2#1)(1996-6#1)
The predicted protein##5##3##(1993-12#1)(1993-2#1)(1996-12#1)(1996-6#1)(1997-7#1)
The predicted slopes of plots of log(range size) versus##2##9##(2008-8#2)
The predicted##47##2##(1990-11#1)(1991-2#1)(1991-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-7#3)(2008-8#3)(2009-6#1)(2012-2#1)
The predicting##2##2##(2008-10#1)(2008-9#1)
The prediction errors of##2##4##(2008-10#1)(2008-3#1)
The prediction for gas chromatographic retention##2##6##(2008-10#2)
The prediction of##3##3##(2008-10#2)(2008-7#1)
The prediction result##2##3##(2007-12#2)
The prediction##18##2##(1997-6#1)(2007-12#2)(2007-6#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
The predictions of##2##3##(2007-11#1)(2008-2#1)
The predictions##6##2##(1994-3#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
The predictive power of##2##4##(2010-1#1)(2012-2#1)
The predictive value of##3##4##(1990-10#1)(1994-2#1)(2008-10#1)
The predictive##10##2##(1990-10#1)(1994-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2012-2#1)(2013-1#1)
The predictors##2##2##(2008-8#1)(2013-1#1)
The predominance of##7##3##(1992-9#1)(1993-2#1)(2008-10#2)(2008-7#1)(2008-8#2)
The predominant clinical pathology changes suggest a secondary##2##8##(2008-9#2)
The predominant##18##2##(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)
The predominantly inattentive##2##3##(2008-2#2)
The predominantly##3##2##(2008-2#2)(2008-9#1)
The preferential##2##2##(1993-8#1)(2007-12#1)
The preferred##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
The prefrontal cortex##2##3##(1994-8#1)(1996-5#1)
The pregnancy##2##2##(1992-1#1)(2013-1#1)
The pregnant women##2##3##(1995-6#2)
The pregnant##5##2##(1990-11#1)(1993-10#1)(1993-12#1)(1995-6#2)
The preliminary results##5##3##(1992-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-3#1)
The preliminary##12##2##(1992-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-3#1)(2009-6#1)(2012-3#1)(2013-1#1)
The premise##3##2##(1997-3#2)(2008-1#1)
The prenatal diagnosis##2##3##(1992-6#1)(2013-1#1)
The preoperative##11##2##(1991-6#1)(1992-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The preparation and characterization of##2##5##(2008-10#2)
The preparation and##6##3##(2008-10#3)(2008-11#1)(2008-4#1)(2009-9#1)
The preparation of a##2##4##(2008-10#1)(2010-4#1)
The preparation of the##2##4##(2008-10#1)(2008-4#1)
The preparation of##10##3##(2008-10#3)(2008-11#1)(2008-4#3)(2008-9#1)(2010-4#1)(2010-6#1)
The preparation##23##2##(1995-2#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#4)(2008-9#1)(2009-9#1)(2010-4#1)(2010-6#1)
The preparatory##2##2##(1995-12#1)(2009-7#1)
The prepared batches of tablets were evaluated for hardness##2##9##(2010-3#2)
The prepared tablets were characterized##2##5##(2012-2#2)
The prepared##12##2##(2007-11#1)(2008-10#5)(2008-5#1)(2010-3#2)(2010-5#1)(2012-2#2)
The preponderance of##2##3##(1996-5#1)(2006-10#1)
The prerequisite for##2##3##(1991-9#1)(1994-2#1)
The prescription##5##2##(1995-12#1)(2007-9#1)(2008-11#1)(2012-3#2)
The presence and##3##3##(1994-11#1)(2007-8#1)(2008-10#1)
The presence of EDTA##2##4##(2008-10#2)
The presence of PPV-D##2##4##(2008-10#2)
The presence of Pi-ta##2##4##(2008-10#2)
The presence of T##2##4##(1997-8#1)(2008-8#1)
The presence of a##20##4##(1990-5#1)(1993-11#1)(1994-8#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-8#1)
The presence of active##2##4##(1994-6#1)(2008-7#1)
The presence of an##6##4##(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#1)
The presence of both##3##4##(1991-12#1)(1991-8#1)(2008-10#1)
The presence of concomitant##2##4##(2008-10#1)(2012-12#1)
The presence of high##2##4##(1990-12#1)(1991-8#1)
The presence of proteins##2##4##(1992-12#1)(2013-8#1)
The presence of residual##2##4##(1992-10#1)(2009-7#1)
The presence of the##20##4##(1990-2#1)(1991-5#1)(1992-12#2)(1992-6#1)(1994-11#1)(1995-12#2)(1995-2#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2013-1#1)
The presence of these##5##4##(1994-8#1)(1995-12#1)(2008-1#1)(2008-2#1)(2012-2#1)
The presence of this##5##4##(1990-12#1)(1990-5#1)(1991-5#1)(1994-5#1)(2008-3#1)
The presence of two##6##4##(1996-10#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-7#1)(2010-8#1)
The presence of##244##3##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#4)(1991-12#6)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#3)(1992-6#3)(1992-8#1)(1993-11#4)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-8#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#5)(2008-1#3)(2008-10#67)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#2)
The presence##248##2##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#4)(1991-12#6)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#3)(1992-6#3)(1992-8#1)(1993-11#4)(1993-12#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-8#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#69)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#2)
The present FIA system##3##4##(2008-10#3)
The present approach##2##3##(1995-8#1)(2008-10#1)
The present article describes the##4##5##(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)
The present article describes##6##4##(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-9#1)
The present article examines##2##4##(2008-10#1)(2009-4#1)
The present article focuses on the##2##6##(2008-11#1)(2009-8#1)
The present article highlights##2##4##(2008-10#1)(2008-11#1)
The present article is intended##2##5##(1994-6#1)(2008-11#1)
The present article provides an overview of##2##7##(2008-11#1)(2009-2#1)
The present article provides##4##4##(2008-11#2)(2009-2#1)(2011-2#1)
The present article reports##4##4##(1992-1#1)(1996-7#1)(2007-12#1)(2008-7#1)
The present article reviews the##6##5##(2008-11#3)(2010-6#1)(2011-2#1)(2012-1#1)
The present article reviews##11##4##(2008-11#5)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
The present article##44##3##(1990-12#1)(1992-1#1)(1994-6#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#16)(2008-5#1)(2008-7#4)(2009-2#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
The present case involves##2##4##(2009-7#1)(2012-3#1)
The present case report is a##2##6##(2013-1#2)
The present case report##7##4##(1990-8#1)(2007-12#2)(2008-7#1)(2009-8#1)(2013-1#2)
The present case##15##3##(1990-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
The present clinical##2##3##(2007-12#1)(2013-1#1)
The present commentary##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
The present communication##3##3##(1990-12#1)(1991-12#1)(1993-8#1)
The present data indicate##2##4##(1990-7#1)(2008-8#1)
The present data show##2##4##(1993-1#1)(2007-8#1)
The present data suggest that##2##5##(1994-3#1)(2008-12#1)
The present data suggest##3##4##(1992-3#1)(1994-3#1)(2008-12#1)
The present data##15##3##(1990-7#2)(1992-3#2)(1993-1#1)(1993-8#1)(1994-3#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#2)
The present document is##2##4##(2007-12#1)(2008-10#1)
The present document##3##3##(2007-12#1)(2008-10#1)(2009-5#1)
The present experiment compared the##2##5##(2009-11#1)(2011-2#1)
The present experiment has##2##4##(2008-6#1)(2008-9#1)
The present experiment was designed to##2##6##(1997-8#1)(2008-11#1)
The present experiment##8##3##(1997-8#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-11#1)(2011-2#2)
The present experimental##2##3##(1993-1#1)(2007-12#1)
The present experiments were##2##4##(1993-3#1)(1994-2#1)
The present experiments##6##3##(1990-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(2008-11#1)
The present findings suggest that##2##5##(1995-5#1)(1997-2#1)
The present findings##7##3##(1991-5#1)(1993-3#2)(1995-5#1)(1997-2#2)(2011-2#1)
The present investigation explores##2##4##(1995-3#1)(2012-2#1)
The present investigation##8##3##(1993-12#1)(1995-12#1)(1995-3#1)(2008-2#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#1)
The present method allows the determination of##2##7##(2008-10#2)
The present method can be##3##5##(2008-10#2)(2009-9#1)
The present method is##2##4##(1990-7#1)(2008-10#1)
The present method was applied to##2##6##(2008-10#2)
The present method was successfully applied to##2##7##(2008-10#2)
The present method was##7##4##(2008-10#7)
The present method##24##3##(1990-7#1)(1991-3#1)(1993-8#1)(2008-10#19)(2008-4#1)(2009-9#1)
The present methods##2##3##(1997-7#1)(2010-12#1)
The present paper aims to##3##5##(1993-3#1)(2009-7#1)(2012-3#1)
The present paper aims##4##4##(1991-6#1)(1993-3#1)(2009-7#1)(2012-3#1)
The present paper deals with the##2##6##(2008-10#1)(2013-8#1)
The present paper deals with##4##5##(2008-10#3)(2013-8#1)
The present paper describes a procedure that##2##7##(2008-10#2)
The present paper describes a procedure##3##6##(2008-10#3)
The present paper describes a##6##5##(2008-10#5)(2013-1#1)
The present paper describes the##2##5##(2008-10#2)
The present paper describes##10##4##(2008-10#7)(2008-11#1)(2012-2#1)(2013-1#1)
The present paper discusses the##3##5##(2008-11#3)
The present paper focuses on the##2##6##(2008-5#2)
The present paper is the##2##5##(1990-7#1)(2008-10#1)
The present paper is##3##4##(1990-7#1)(2008-10#2)
The present paper proposes a##2##5##(2008-10#1)(2012-2#1)
The present paper provides##2##4##(2008-11#1)(2008-7#1)
The present paper reports##2##4##(2007-12#1)(2008-2#1)
The present paper##45##3##(1990-7#1)(1991-6#1)(1993-11#1)(1993-3#1)(1994-6#1)(2007-12#2)(2007-4#1)(2008-10#14)(2008-11#6)(2008-2#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-7#1)(2010-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
The present report describes a case of a##2##8##(1994-12#1)(2008-11#1)
The present report describes a case of##6##7##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)
The present report describes a##8##5##(1994-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)
The present report describes the##4##5##(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
The present report describes##17##4##(1990-12#1)(1994-12#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#2)
The present report is##2##4##(2007-12#1)(2007-7#1)
The present report##28##3##(1990-12#1)(1994-12#1)(1994-3#1)(1995-5#1)(2007-12#4)(2007-7#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#2)(2013-1#2)
The present research##8##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-9#1)(2013-8#2)
The present results are##3##4##(1991-2#1)(2008-5#1)(2012-2#1)
The present results demonstrate that##3##5##(1991-12#1)(2008-8#1)(2013-1#1)
The present results demonstrate##4##4##(1991-12#1)(1997-4#1)(2008-8#1)(2013-1#1)
The present results indicate that##2##5##(1990-8#1)(2010-1#1)
The present results show that##2##5##(1995-12#1)(1996-12#1)
The present results showed that the##2##6##(1996-2#1)(2012-1#1)
The present results showed that##3##5##(1996-2#1)(2008-8#1)(2012-1#1)
The present results strongly suggest##2##5##(1991-2#1)(2012-12#1)
The present results suggest that the##3##6##(1990-2#1)(2008-10#1)(2008-6#1)
The present results suggest that##10##5##(1990-2#1)(1991-12#1)(1991-9#1)(1993-3#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-6#1)
The present results##33##3##(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-9#1)(1993-12#2)(1993-3#1)(1994-5#1)(1995-12#3)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#2)(2010-1#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
The present review addresses##2##4##(2008-11#1)(2008-6#1)
The present review discusses Avicenna's opinion about protective role of exercise against some diseases through a comparison with modern medical views and also emphasizes aspects that need further investigation for these opinions to be useful in clinic in the future##2##40##(2013-1#2)
The present review discusses##3##4##(2011-2#1)(2013-1#2)
The present review focuses on the##7##6##(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#2)(2012-3#1)
The present review focuses##8##4##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#2)(2012-3#1)
The present review is##2##4##(1992-6#1)(2008-10#1)
The present review provides##2##4##(2008-7#1)(2012-2#1)
The present review summarizes the##3##5##(2008-7#2)(2012-12#1)
The present review summarizes##6##4##(2008-1#1)(2008-4#1)(2008-7#2)(2012-12#1)(2012-2#1)
The present review##33##3##(1992-6#1)(1993-12#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
The present sensor##2##3##(2008-10#2)
The present statement##2##3##(2008-11#1)(2010-10#1)
The present status of##2##4##(1990-11#1)(2008-3#1)
The present studies were undertaken to##2##6##(1994-6#1)(1997-7#1)
The present studies were##3##4##(1994-6#1)(1995-11#1)(1997-7#1)
The present studies##6##3##(1994-10#1)(1994-6#2)(1995-11#1)(1997-2#1)(1997-7#1)
The present study aimed to##7##5##(1991-5#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-6#1)(2013-7#1)
The present study aims to##5##5##(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
The present study aims##6##4##(2008-11#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
The present study also##4##4##(2008-10#1)(2008-12#1)(2011-3#1)(2013-1#1)
The present study analyses##2##4##(1990-11#1)(2009-12#1)
The present study characterizes##2##4##(1993-6#1)(2008-10#1)
The present study compared the##4##5##(1993-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
The present study compared##6##4##(1993-3#1)(1994-3#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
The present study concerns##2##4##(1994-6#1)(2008-11#1)
The present study deals with the##2##6##(2012-2#1)(2013-1#1)
The present study deals with##3##5##(2012-2#2)(2013-1#1)
The present study demonstrates that exposure of human thyroid slices##2##10##(1994-11#1)(1994-6#1)
The present study demonstrates that##7##5##(1991-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(2011-1#1)
The present study demonstrates the##2##5##(1990-5#1)(2011-2#1)
The present study demonstrates##9##4##(1990-5#1)(1991-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(2011-1#1)(2011-2#1)
The present study describes a##3##5##(2008-10#1)(2008-11#1)(2012-3#1)
The present study describes##6##4##(1990-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
The present study determined##3##4##(1997-7#1)(2012-5#1)(2013-1#1)
The present study does not support##2##6##(1991-8#1)(1993-3#1)
The present study established##2##4##(2008-11#1)(2012-3#1)
The present study evaluated the##7##5##(1991-2#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
The present study evaluated##8##4##(1991-2#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
The present study evaluates the##2##5##(2008-10#1)(2008-7#1)
The present study examined possible##2##5##(1996-2#1)(2009-9#1)
The present study examined the effects of##2##7##(1996-12#1)(1997-6#1)
The present study examined the##13##5##(1991-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-1#2)(2010-10#1)(2011-2#1)(2013-1#1)
The present study examined whether the##2##6##(1992-12#1)(1996-5#1)
The present study examined whether##5##5##(1992-12#1)(1996-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
The present study examined##26##4##(1991-8#1)(1992-12#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
The present study examines the##3##5##(1991-5#1)(1994-2#1)(2008-5#1)
The present study examines##5##4##(1991-5#1)(1993-3#1)(1994-2#1)(2008-5#1)(2010-4#1)
The present study explores##2##4##(2010-4#1)(2013-8#1)
The present study extends##3##4##(1993-12#1)(2008-10#1)(2010-2#1)
The present study focuses on the##2##6##(1990-6#1)(2008-3#1)
The present study has been##2##5##(2008-12#1)(2013-1#1)
The present study has##5##4##(1997-8#1)(2007-10#1)(2008-12#1)(2013-1#2)
The present study highlights##2##4##(2008-7#1)(2013-1#1)
The present study indicates that##2##5##(1993-9#1)(2008-5#1)
The present study investigated the effects of##2##7##(1991-9#1)(2011-2#1)
The present study investigated the##8##5##(1991-9#1)(1995-12#2)(2008-12#1)(2008-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
The present study investigated##10##4##(1991-7#1)(1991-9#1)(1995-12#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
The present study investigates the##3##5##(1991-12#1)(2008-12#1)(2011-2#1)
The present study investigates whether##2##5##(1995-12#1)(2011-2#1)
The present study investigates##6##4##(1991-12#1)(1995-12#1)(2008-12#2)(2011-2#2)
The present study is a retrospective##2##6##(2007-8#1)(2008-7#1)
The present study is a##4##5##(2007-11#1)(2007-8#1)(2008-7#1)(2010-8#1)
The present study is an##2##5##(1990-8#1)(2008-10#1)
The present study is the first to##2##7##(2009-12#1)(2013-3#1)
The present study is the first##3##6##(1997-7#1)(2009-12#1)(2013-3#1)
The present study is##15##4##(1990-8#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-3#1)
The present study opens##2##4##(2008-5#1)(2011-2#1)
The present study replicates##2##4##(1993-6#1)(1994-2#1)
The present study reports on the##2##6##(1993-1#1)(1994-2#1)
The present study reports on##3##5##(1993-1#2)(1994-2#1)
The present study reports##7##4##(1993-1#2)(1994-2#1)(2007-12#1)(2007-7#1)(2013-1#2)
The present study revealed that##3##5##(1991-2#1)(2008-10#1)(2008-7#1)
The present study revealed##5##4##(1991-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-7#1)
The present study reveals that##2##5##(2012-2#1)(2013-1#1)
The present study reveals##3##4##(2007-7#1)(2012-2#1)(2013-1#1)
The present study shows##4##4##(1992-3#1)(2008-5#2)(2013-7#1)
The present study suggests that the##2##6##(1995-12#1)(2008-10#1)
The present study suggests that##3##5##(1995-12#2)(2008-10#1)
The present study suggests##4##4##(1992-12#1)(1995-12#2)(2008-10#1)
The present study tested##3##4##(2007-12#1)(2008-5#1)(2009-11#1)
The present study used##2##4##(1993-12#1)(2008-12#1)
The present study was aimed at investigating##2##7##(1990-6#1)(2012-12#1)
The present study was aimed at##4##6##(1990-6#1)(1994-2#1)(1995-5#1)(2012-12#1)
The present study was aimed to##4##6##(2008-12#1)(2009-12#1)(2010-5#1)(2012-12#1)
The present study was aimed##8##5##(1990-6#1)(1994-2#1)(1995-5#1)(2008-12#1)(2009-12#1)(2010-5#1)(2012-12#2)
The present study was based on##2##6##(1990-9#1)(1992-12#1)
The present study was carried out to investigate##2##8##(1991-6#1)(2008-11#1)
The present study was carried out to##6##7##(1990-7#1)(1991-6#1)(1995-12#1)(2007-7#1)(2008-11#1)(2008-7#1)
The present study was carried out##8##6##(1990-7#1)(1991-6#1)(1994-6#1)(1995-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2013-8#1)
The present study was carried##9##5##(1990-7#1)(1991-6#1)(1994-6#1)(1995-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
The present study was conducted in##3##6##(2008-5#1)(2008-7#1)(2013-7#1)
The present study was conducted on##2##6##(2008-10#1)(2012-12#1)
The present study was conducted to determine##2##7##(1995-8#1)(2008-11#1)
The present study was conducted to evaluate##2##7##(2008-7#1)(2013-8#1)
The present study was conducted to##10##6##(1995-10#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
The present study was conducted##15##5##(1995-10#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
The present study was designed to assess##2##7##(1994-6#1)(2007-10#1)
The present study was designed to compare##2##7##(2012-2#1)(2012-3#1)
The present study was designed to determine##2##7##(1990-5#1)(1994-2#1)
The present study was designed to evaluate the##2##8##(2009-12#1)(2011-1#1)
The present study was designed to evaluate##4##7##(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
The present study was designed to examine the effect of##2##10##(1993-12#1)(1994-11#1)
The present study was designed to examine the##3##8##(1992-8#1)(1993-12#1)(1994-11#1)
The present study was designed to examine##4##7##(1992-8#1)(1993-12#2)(1994-11#1)
The present study was designed to investigate the effect of##2##10##(2010-5#1)(2012-12#1)
The present study was designed to investigate the##4##8##(1997-6#1)(2009-8#1)(2010-5#1)(2012-12#1)
The present study was designed to##21##6##(1990-5#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
The present study was performed in##2##6##(1996-5#1)(2007-12#1)
The present study was performed to##2##6##(1992-8#1)(1994-9#1)
The present study was performed##6##5##(1991-6#1)(1992-8#1)(1994-9#1)(1996-5#1)(2007-12#1)(2013-1#1)
The present study was to investigate##2##6##(2008-8#1)(2010-5#1)
The present study was undertaken to determine whether##2##8##(1993-6#1)(2008-6#1)
The present study was undertaken to establish##2##7##(2012-2#2)
The present study was undertaken to examine whether##2##8##(2008-5#1)(2011-2#1)
The present study was undertaken to examine##3##7##(2008-5#1)(2011-2#2)
The present study was undertaken to investigate the##3##8##(1994-12#1)(2008-7#1)(2012-2#1)
The present study was undertaken to##12##6##(1992-3#1)(1993-6#1)(1994-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#3)
The present study was undertaken##13##5##(1992-3#2)(1993-6#1)(1994-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#3)
The present study was##79##4##(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-6#2)(1992-12#1)(1992-3#2)(1992-8#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-12#2)(2009-8#1)(2010-3#1)(2010-5#4)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
The present study##295##3##(1990-11#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#3)(1992-3#3)(1992-8#3)(1993-1#3)(1993-12#7)(1993-3#3)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#9)(1994-3#3)(1994-6#4)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#6)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#5)(2007-8#4)(2008-10#20)(2008-11#7)(2008-12#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#8)(2009-11#3)(2009-12#5)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#13)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#17)(2013-3#1)(2013-7#4)(2013-8#5)
The present system was##2##4##(1992-4#1)(2008-10#1)
The present system##7##3##(1992-4#1)(1995-6#1)(2008-10#4)(2008-8#1)
The present work also##2##4##(1992-8#1)(2008-10#1)
The present work deals with the##2##6##(2008-10#1)(2013-1#1)
The present work describes a##2##5##(2008-10#2)
The present work describes the##5##5##(2008-10#3)(2008-11#1)(2011-1#1)
The present work describes##9##4##(2007-12#1)(2008-10#6)(2008-11#1)(2011-1#1)
The present work has##2##4##(2008-10#2)
The present work reports a##2##5##(2008-10#1)(2010-5#1)
The present work reports the##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
The present work reports##5##4##(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)
The present work shows the##2##5##(1996-5#1)(2008-10#1)
The present work was##3##4##(1994-3#1)(2008-10#1)(2013-1#1)
The present work##43##3##(1990-7#1)(1992-8#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#16)(2008-11#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
The present##703##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#7)(1990-8#4)(1990-9#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#6)(1992-4#1)(1992-6#2)(1992-8#5)(1993-1#5)(1993-11#2)(1993-12#11)(1993-3#8)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#10)(1994-3#6)(1994-5#1)(1994-6#9)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#10)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#5)(1996-2#3)(1996-5#5)(1996-6#1)(1996-7#3)(1997-2#3)(1997-4#4)(1997-6#2)(1997-7#4)(1997-8#2)(2007-10#3)(2007-11#6)(2007-12#20)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#7)(2008-1#3)(2008-10#107)(2008-11#48)(2008-12#14)(2008-2#6)(2008-3#5)(2008-4#5)(2008-5#24)(2008-6#9)(2008-7#27)(2008-8#8)(2008-9#12)(2009-11#6)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-7#6)(2009-8#5)(2009-9#3)(2010-1#5)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#27)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#29)(2012-3#9)(2012-5#1)(2012-6#1)(2013-1#31)(2013-3#1)(2013-7#5)(2013-8#14)
The presentation of##4##3##(1990-6#1)(2008-12#1)(2008-2#1)(2009-2#1)
The presentation##13##2##(1990-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
The presented case##2##3##(2012-12#2)
The presented data##2##3##(1990-9#1)(2008-5#1)
The presented method##2##3##(2008-10#1)(2011-2#1)
The presented report##3##3##(2011-2#3)
The presented results##2##3##(1991-2#1)(2007-11#1)
The presented system has been applied successfully to##2##8##(2008-10#2)
The presented##22##2##(1990-9#1)(1991-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)
The presenting clinical features##2##4##(2007-2#1)(2008-1#1)
The presenting##3##2##(1993-2#1)(2007-2#1)(2008-1#1)
The preservation of the##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
The preservation of##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
The president's report##2##3##(1991-12#1)(1992-3#1)
The pressure##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
The pressures for##4##3##(1993-3#2)(1996-3#1)(1997-3#1)
The pressures##5##2##(1993-3#2)(1996-3#2)(1997-3#1)
The presumed##2##2##(1993-8#1)(2008-9#1)
The presynaptic##2##2##(1995-2#1)(1996-12#1)
The preterm##2##2##(1993-3#1)(1994-9#1)
The pretreated##2##2##(2008-6#1)(2013-1#1)
The pretreatments##2##2##(2008-10#1)(2013-1#1)
The prevalence and##7##3##(1992-1#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
The prevalence for##2##3##(2012-12#1)(2013-1#1)
The prevalence in##2##3##(1990-6#2)
The prevalence of abnormal##2##4##(2007-2#1)(2011-2#1)
The prevalence of and##2##4##(2009-2#1)(2010-4#1)
The prevalence of antibodies to B##2##6##(1991-11#2)
The prevalence of antibodies##3##4##(1991-11#2)(1994-7#1)
The prevalence of brown stem rot##2##6##(2008-10#2)
The prevalence of cavities##2##4##(2008-9#2)
The prevalence of circumportal pancreas##2##5##(2012-2#2)
The prevalence of dementia##2##4##(2008-7#2)
The prevalence of diabetes##4##4##(2008-7#1)(2010-10#3)
The prevalence of hepatitis##2##4##(1996-3#1)(2007-12#1)
The prevalence of infection and antibiotic susceptibility was##2##8##(2012-12#2)
The prevalence of infection##3##4##(2012-12#3)
The prevalence of obesity##3##4##(2008-1#1)(2010-6#1)(2013-1#1)
The prevalence of overweight##2##4##(2008-3#1)(2012-12#1)
The prevalence of smoking##3##4##(1991-11#1)(2009-5#1)(2011-2#1)
The prevalence of the##11##4##(1990-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#2)(2011-7#1)(2012-2#1)
The prevalence of this##4##4##(1991-8#1)(1991-9#1)(2008-12#1)(2008-7#1)
The prevalence of##130##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-7#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#4)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#3)(2008-3#4)(2008-5#2)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#7)(2011-2#11)(2011-7#1)(2012-12#11)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#2)
The prevalence rate of##2##4##(2008-12#1)(2008-7#1)
The prevalence rate##3##3##(2008-12#1)(2008-7#2)
The prevalence rates of##3##4##(2011-1#3)
The prevalence rates##4##3##(2011-1#3)(2012-3#1)
The prevalence##154##2##(1990-12#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-11#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-7#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#5)(2008-1#7)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#10)(2011-2#11)(2011-7#1)(2012-12#12)(2012-2#9)(2012-3#3)(2013-1#4)(2013-8#2)
The prevention of##6##3##(1995-3#1)(2006-10#1)(2008-2#1)(2009-4#1)(2013-1#2)
The prevention##7##2##(1995-3#1)(1997-4#1)(2006-10#1)(2008-2#1)(2009-4#1)(2013-1#2)
The previous treatment of spores with lipase activity inhibitor##2##9##(2010-10#2)
The previous##14##2##(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-10#2)(2010-11#1)(2011-1#1)(2013-8#1)
The previously reported##2##3##(1990-7#1)(2008-1#1)
The previously##7##2##(1990-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
The primary advantages of this##2##5##(2008-2#1)(2012-3#1)
The primary aim of this study was to##3##8##(2008-1#1)(2008-11#1)(2008-7#1)
The primary care##2##3##(1990-10#1)(2013-8#1)
The primary cause of##2##4##(2009-10#1)(2011-2#1)
The primary effect of##2##4##(2008-11#1)(2010-1#1)
The primary efficacy##3##3##(2007-10#1)(2008-7#1)(2012-2#1)
The primary end-point was the##2##5##(2011-1#1)(2012-2#1)
The primary endpoint was##2##4##(2008-10#1)(2010-8#1)
The primary endpoint##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2010-8#1)
The primary focus##3##3##(1990-3#1)(2008-11#1)(2013-1#1)
The primary function of the##3##5##(1997-1#1)(2008-2#1)(2008-9#1)
The primary goal of##3##4##(1995-2#1)(2007-7#1)(2007-8#1)
The primary objective of the study was to##2##8##(1996-9#1)(2011-2#1)
The primary objective of this study was to##2##8##(2008-10#2)
The primary objective of this##4##5##(2008-10#2)(2010-4#1)(2011-1#1)
The primary objective of##6##4##(1996-9#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)
The primary objective##7##3##(1996-9#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
The primary outcome measure##2##4##(2008-4#1)(2011-2#1)
The primary outcome was##3##4##(2007-10#1)(2008-11#1)(2008-9#1)
The primary outcome##6##3##(2007-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
The primary purpose of##2##4##(1992-11#1)(2010-3#1)
The primary role##2##3##(1995-12#1)(2008-7#1)
The primary statistical##2##3##(2008-5#1)(2013-8#1)
The primary structure of the##2##5##(1994-9#1)(1997-4#1)
The primary structure of##7##4##(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#1)(1994-9#1)(1997-4#1)
The primary structures##2##3##(1990-5#1)(1997-2#1)
The primary##110##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
The prime##3##2##(1992-2#1)(1996-12#1)(2006-10#1)
The primer##3##2##(1997-6#1)(2008-10#1)(2008-4#1)
The primers were##2##3##(2008-10#2)
The primers##6##2##(2008-10#5)(2008-5#1)
The priming##2##2##(1992-3#1)(2008-4#1)
The primordial##2##2##(2007-12#2)
The principal component analysis##2##4##(2008-10#2)
The principal findings of this study are##2##7##(1992-8#1)(2011-1#1)
The principal findings##3##3##(1992-8#1)(1997-2#1)(2011-1#1)
The principal technique##2##3##(2008-9#2)
The principal##32##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(2007-10#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#3)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2013-1#1)
The principle behind##2##3##(2008-9#1)(2011-7#1)
The principle is demonstrated##2##4##(2007-12#1)(2008-3#1)
The principle is to##2##4##(2008-10#1)(2008-4#1)
The principle is##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
The principle of operation##2##4##(2007-11#1)(2008-3#1)
The principle of the method is##2##6##(2008-10#1)(2008-2#1)
The principle of the##5##4##(2008-10#3)(2008-2#2)
The principle of this##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
The principle of##20##3##(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#6)(2008-7#1)(2009-5#1)(2009-6#1)
The principle##37##2##(1992-1#1)(2007-11#3)(2007-12#3)(2008-10#8)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-7#1)(2012-2#1)
The principles and##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
The principles are##2##3##(2007-11#1)(2008-3#1)
The principles of microscopy and step-by-step alignment and adjustment procedures are described in this unit##3##15##(2008-4#2)(2008-9#1)
The principles of##11##3##(1992-4#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-9#1)(2011-2#1)
The principles underlying the##3##4##(1992-12#1)(2007-12#1)(2008-9#1)
The principles underlying##4##3##(1992-12#1)(2007-12#1)(2008-4#1)(2008-9#1)
The principles##23##2##(1992-12#1)(1992-4#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-9#2)(2011-2#1)(2013-8#1)
The pro-inflammatory##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
The probability of a##4##4##(1990-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
The probability of##12##3##(1990-6#2)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
The probability##15##2##(1990-6#2)(1991-4#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
The probable##8##2##(1994-12#1)(2007-7#1)(2008-10#4)(2008-6#1)(2008-7#1)
The probe##4##2##(2008-10#2)(2008-2#1)(2013-1#1)
The probes##5##2##(2008-10#1)(2008-3#2)(2009-11#2)
The problem is##8##3##(1995-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-6#1)(2010-12#1)
The problem of the##6##4##(1990-12#1)(2008-10#3)(2008-2#2)
The problem of##31##3##(1990-12#1)(1991-2#1)(1992-9#2)(1996-12#1)(1996-2#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#7)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)(2013-8#1)
The problem##48##2##(1990-12#1)(1991-2#1)(1992-6#1)(1992-9#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-2#6)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
The problematic##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
The problems associated with##2##4##(1991-3#1)(1996-12#1)
The problems encountered##2##3##(2008-2#1)(2008-3#1)
The problems in##2##3##(1992-3#1)(2008-10#1)
The problems##11##2##(1990-10#1)(1991-3#1)(1992-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-11#1)
The procedure allowed the detection of the enzyme activity expressed by##2##11##(1992-6#1)(1993-9#1)
The procedure can also be##2##5##(2008-2#1)(2008-4#1)
The procedure can##3##3##(2008-2#2)(2008-4#1)
The procedure consists of##3##4##(2008-10#2)(2008-3#1)
The procedure consists##4##3##(2008-10#3)(2008-3#1)
The procedure described##2##3##(2008-10#1)(2008-3#1)
The procedure developed allows the##2##5##(2008-10#2)
The procedure developed##4##3##(2008-10#4)
The procedure does not##2##4##(1991-4#1)(2008-7#1)
The procedure for inoculating overnight (starter) cultures of E##2##9##(2008-2#1)(2008-9#1)
The procedure for##6##3##(2008-10#2)(2008-2#2)(2008-4#1)(2008-9#1)
The procedure has a##2##4##(1994-12#1)(2009-5#1)
The procedure has been##3##4##(2008-10#3)
The procedure has##6##3##(1992-9#1)(1994-12#1)(2008-10#3)(2009-5#1)
The procedure is based on the##7##6##(2008-10#7)
The procedure is based on##9##5##(2008-10#9)
The procedure is carried out##2##5##(1996-5#1)(2008-10#1)
The procedure is described in##2##5##(2008-10#1)(2011-2#1)
The procedure is suitable for##2##5##(2008-10#1)(2008-5#1)
The procedure is##29##3##(1994-9#1)(1996-5#1)(2007-11#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-3#1)
The procedure may##2##3##(1996-12#1)(2008-2#1)
The procedure of##2##3##(2008-10#2)
The procedure offers##2##3##(2008-10#2)
The procedure proposed allowed the determination of##2##7##(2008-10#2)
The procedure provided##2##3##(2008-10#1)(2009-3#1)
The procedure used##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
The procedure was also##2##4##(2008-10#2)
The procedure was applied successfully to the determination of##2##9##(2008-10#2)
The procedure was applied to a##3##6##(2008-10#2)(2008-3#1)
The procedure was applied to the analysis of##3##8##(2008-10#3)
The procedure was applied to the determination of##2##8##(2008-10#2)
The procedure was applied to the##5##6##(2008-10#5)
The procedure was applied to##12##5##(2008-10#11)(2008-3#1)
The procedure was applied##16##4##(2008-10#15)(2008-3#1)
The procedure was based on the##3##6##(2008-10#3)
The procedure was based on##5##5##(1995-12#1)(2007-8#1)(2008-10#3)
The procedure was successful##2##4##(2012-12#1)(2012-2#1)
The procedure was successfully applied for the##2##7##(2008-10#2)
The procedure was successfully applied to the determination of##2##9##(2008-10#2)
The procedure was successfully applied to the##3##7##(2008-10#3)
The procedure was successfully applied##5##5##(2008-10#5)
The procedure was tested##2##4##(2008-10#2)
The procedure was validated by analysis##2##6##(2008-10#2)
The procedure was validated by##4##5##(2008-10#4)
The procedure was validated##5##4##(2008-10#5)
The procedure was##45##3##(1991-2#1)(1995-12#1)(2007-8#2)(2008-10#36)(2008-12#1)(2008-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
The procedure##137##2##(1991-2#3)(1991-4#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-8#2)(2008-10#86)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
The procedures are based on##2##5##(2008-10#2)
The procedures##13##2##(2007-11#1)(2008-10#6)(2008-11#1)(2008-4#4)(2008-9#1)
The process by which##2##4##(2008-10#1)(2008-7#1)
The process can be##4##4##(1994-12#1)(2007-12#1)(2008-4#1)(2011-2#1)
The process is##14##3##(1993-2#1)(1996-3#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
The process of learning##2##4##(1996-2#1)(2008-9#1)
The process of the##2##4##(1992-1#1)(2008-10#1)
The process of##37##3##(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1994-11#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-3#2)(2011-1#2)(2012-3#1)(2013-8#1)
The process was##4##3##(1993-2#2)(2008-10#1)(2008-6#1)
The process##82##2##(1990-11#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-2#3)(1994-11#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-1#3)(2011-2#2)(2011-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
The process-parameter-dependent optical and structural properties of##2##7##(2008-2#2)
The processes of the##2##4##(2008-10#2)
The processes of##4##3##(2008-10#3)(2008-3#1)
The processes##7##2##(1996-5#1)(1997-1#1)(2007-10#1)(2008-10#3)(2008-3#1)
The processing of##3##3##(1991-2#1)(1991-9#1)(1992-12#1)
The processing##6##2##(1991-2#1)(1991-9#1)(1992-12#1)(2008-2#1)(2008-6#1)(2008-8#1)
The produced##3##2##(2008-10#3)
The product is##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
The product of reaction##3##4##(2008-10#3)
The product of the##8##4##(1993-2#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
The product of this gene is a##2##7##(1994-5#1)(1995-6#1)
The product of##14##3##(1993-2#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
The product##26##2##(1991-5#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#7)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#2)
The production and##2##3##(1992-2#1)(2008-6#1)
The production of##34##3##(1991-11#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#7)(2008-7#1)(2012-2#1)(2012-3#1)
The production##40##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#8)(2008-7#1)(2012-2#2)(2012-3#1)
The products of the##2##4##(2008-10#1)(2008-7#1)
The products of##6##3##(1991-12#1)(1994-8#1)(2008-10#2)(2008-7#1)(2009-8#1)
The products were##4##3##(1992-8#1)(2008-10#1)(2008-8#2)
The products##13##2##(1991-12#1)(1992-8#1)(1994-12#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#2)(2009-8#1)
The profession of##2##3##(1994-12#1)(2008-10#1)
The profession##4##2##(1994-12#1)(2008-10#2)(2012-3#1)
The professional##4##2##(2007-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
The profile of##5##3##(1992-12#1)(1995-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
The profile##8##2##(1992-12#1)(1995-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
The profiles are##2##3##(1994-2#1)(2008-10#1)
The profiles of##2##3##(1996-12#1)(2008-11#1)
The profiles##5##2##(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#1)
The progeny##3##2##(1995-12#1)(2008-10#2)
The prognosis for##2##3##(2008-7#1)(2011-2#1)
The prognosis is##3##3##(1996-9#1)(2008-6#1)(2009-10#1)
The prognosis of the##2##4##(2008-1#1)(2012-3#1)
The prognosis of##12##3##(1993-8#1)(1996-6#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
The prognosis##20##2##(1990-11#2)(1993-8#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-6#2)(2008-7#2)(2009-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
The prognostic significance of##5##4##(1990-9#1)(1991-12#1)(1993-9#1)(2008-7#2)
The prognostic value of quantitative##2##5##(1996-9#1)(1997-7#1)
The prognostic value of##4##4##(1991-6#1)(1996-9#1)(1997-7#1)(2008-10#1)
The prognostic##15##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1993-9#1)(1996-9#1)(1997-7#1)(2007-8#3)(2008-10#2)(2008-7#2)(2011-2#1)
The program also##2##3##(1991-12#1)(1996-2#1)
The program consisted of##3##4##(1994-9#1)(2008-12#1)(2008-8#1)
The program has been##2##4##(2008-11#1)(2008-4#1)
The program includes##2##3##(1992-1#1)(2008-12#1)
The program is##2##3##(1997-3#1)(2007-12#1)
The program was##3##3##(1997-4#1)(2008-9#1)(2012-1#1)
The program##37##2##(1991-12#1)(1991-2#1)(1992-1#3)(1993-12#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-2#2)(2012-1#1)
The program's##3##2##(1994-3#1)(2007-2#1)(2012-12#1)
The programme##6##2##(1993-6#2)(1994-11#1)(1997-3#1)(2009-1#1)(2010-1#1)
The programmes##2##2##(2008-10#1)(2011-2#1)
The progress of##3##3##(1994-5#1)(2008-10#1)(2010-6#1)
The progress##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-6#1)
The progression of the##2##4##(2008-10#1)(2008-7#1)
The progression of##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
The progression##4##2##(2007-5#1)(2008-10#1)(2008-7#1)(2009-5#1)
The progressive##14##2##(1992-11#1)(1994-2#1)(1996-5#1)(2008-1#1)(2008-3#3)(2008-9#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
The project was initiated##2##4##(1993-3#1)(2008-12#1)
The project was##7##3##(1993-3#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-9#1)(2012-12#1)(2013-1#1)
The project##19##2##(1992-1#1)(1993-3#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-8#1)(2011-9#1)(2012-12#2)(2012-2#1)(2013-1#2)
The projected##3##2##(1994-12#1)(2007-12#1)(2009-7#1)
The projection##4##2##(1993-9#1)(2007-12#1)(2008-4#1)(2011-1#1)
The projections##2##2##(1993-3#1)(2008-2#1)
The proliferation of##2##3##(2008-11#1)(2011-3#1)
The proliferation##4##2##(2008-11#2)(2008-9#1)(2011-3#1)
The proliferative activity of##2##4##(1994-9#1)(1997-7#1)
The proliferative response of##2##4##(1991-12#1)(1995-8#1)
The proliferative##4##2##(1991-12#1)(1994-9#1)(1995-8#1)(1997-7#1)
The promise of##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
The promoter region of##2##4##(1993-3#1)(2009-8#1)
The promoter region##3##3##(1993-3#1)(1993-6#1)(2009-8#1)
The promoter regions##2##3##(1992-9#1)(1997-2#1)
The promoter sequence##2##3##(1993-12#1)(1997-7#1)
The promoter##10##2##(1990-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1997-2#1)(1997-7#2)(2009-8#1)
The promotion of##2##3##(1995-3#1)(2011-2#1)
The propagation loss of the waveguide##2##6##(2007-11#2)
The propagation of##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
The propagation##9##2##(2007-11#4)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)
The proper##9##2##(1991-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
The properties of a##4##4##(1990-8#1)(1991-5#1)(2008-2#2)
The properties of the##6##4##(1994-12#1)(1994-8#1)(2008-10#2)(2008-3#2)
The properties of this##3##4##(1995-9#1)(2008-6#1)(2008-9#1)
The properties of##26##3##(1990-8#1)(1991-5#1)(1994-12#2)(1994-8#1)(1995-9#1)(1996-3#1)(2006-4#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-8#1)
The properties##32##2##(1990-8#1)(1991-5#1)(1994-12#2)(1994-8#1)(1995-9#1)(1996-3#1)(2006-4#1)(2008-10#8)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-3#1)(2012-8#1)
The property of##4##3##(1994-5#1)(2007-11#1)(2008-10#2)
The property##6##2##(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
The prophylactic effect of##2##4##(1997-3#1)(1997-4#1)
The prophylactic##4##2##(1997-3#1)(1997-4#1)(2008-10#1)(2010-7#1)
The proportion of cases##2##4##(2013-8#2)
The proportion of embryos##2##4##(1996-8#1)(2008-11#1)
The proportion of patients with##3##5##(2010-8#2)(2013-1#1)
The proportion of patients##5##4##(2010-8#3)(2012-3#1)(2013-1#1)
The proportion of the##3##4##(1991-3#1)(1995-3#1)(2010-1#1)
The proportion of##56##3##(1990-2#1)(1990-3#1)(1991-12#2)(1991-3#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
The proportion##58##2##(1990-2#1)(1990-3#1)(1991-12#2)(1991-3#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
The proportional hazard model##2##4##(2012-2#2)
The proportional##3##2##(2007-12#1)(2012-2#2)
The proportions of##6##3##(1992-11#1)(1992-6#1)(2008-3#1)(2012-2#1)(2013-8#2)
The proposal is##2##3##(1993-12#1)(1997-8#1)
The proposal##5##2##(1993-12#1)(1995-3#1)(1997-8#1)(2007-5#1)(2008-7#1)
The proposed FI##3##3##(2008-10#3)
The proposed SIA system##2##4##(2008-10#2)
The proposed algorithm is##4##4##(2008-3#1)(2008-6#1)(2011-3#1)(2012-1#1)
The proposed algorithm##5##3##(2008-2#1)(2008-3#1)(2008-6#1)(2011-3#1)(2012-1#1)
The proposed analytical method##2##4##(2008-10#1)(2012-3#1)
The proposed analytical##3##3##(2008-10#2)(2012-3#1)
The proposed approach is##3##4##(2008-2#1)(2009-7#1)(2011-2#1)
The proposed approach may be##2##5##(2008-7#1)(2009-10#1)
The proposed approach##7##3##(1994-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-1#1)
The proposed electrode revealed good selectivities##2##6##(2008-10#2)
The proposed electrode revealed good selectivity##2##6##(2008-10#2)
The proposed electrode revealed good sensitivities for##2##7##(2008-10#2)
The proposed electrode revealed good##6##5##(2008-10#6)
The proposed electrode revealed##7##4##(2008-10#7)
The proposed electrode shows a##2##5##(2008-10#2)
The proposed electrode was##2##4##(2008-10#2)
The proposed electrode##13##3##(2008-10#13)
The proposed electrodes could be##2##5##(2008-10#2)
The proposed electrodes##3##3##(2008-10#3)
The proposed final model##2##4##(2008-10#2)
The proposed immunosensor##2##3##(2008-10#2)
The proposed mechanism##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
The proposed membrane sensor##2##4##(2008-10#2)
The proposed membrane##3##3##(2008-10#3)
The proposed method allowed the determination of##2##7##(2008-10#2)
The proposed method allows the determination of##2##7##(2008-10#2)
The proposed method allows the##3##5##(2008-10#3)
The proposed method allows##6##4##(2008-10#6)
The proposed method can be successfully used to determine the drug##2##11##(2010-5#1)(2012-2#1)
The proposed method can be##5##5##(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
The proposed method can##6##4##(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
The proposed method depends upon the##2##6##(2008-10#2)
The proposed method employs##3##4##(2008-10#2)(2008-3#1)
The proposed method for##2##4##(2008-10#1)(2010-8#1)
The proposed method had a##2##5##(1992-11#1)(2008-10#1)
The proposed method had been##2##5##(2008-10#2)
The proposed method had##4##4##(1992-11#1)(2008-10#3)
The proposed method has a linear calibration range##2##8##(2008-10#2)
The proposed method has a##4##5##(2008-10#4)
The proposed method has been applied satisfactorily##2##7##(2008-10#2)
The proposed method has been applied to the AAS determination of##2##11##(2008-10#2)
The proposed method has been applied to the determination of nickel in##2##12##(2008-10#2)
The proposed method has been applied to the determination of trace##4##11##(2008-10#4)
The proposed method has been applied to the determination of##14##10##(2008-10#14)
The proposed method has been applied to the##18##8##(2008-10#18)
The proposed method has been applied to##22##7##(2008-10#22)
The proposed method has been applied##25##6##(2008-10#25)
The proposed method has been satisfactorily applied to##2##8##(2008-10#2)
The proposed method has been satisfactorily applied##3##7##(2008-10#3)
The proposed method has been successfully applied to the determination of##2##11##(2008-10#2)
The proposed method has been successfully applied to the##5##9##(2008-10#5)
The proposed method has been successfully applied to##8##8##(2008-10#8)
The proposed method has been successfully applied##9##7##(2008-10#9)
The proposed method has been used to##2##7##(2008-10#2)
The proposed method has been used##3##6##(2008-10#3)
The proposed method has been##42##5##(2008-10#42)
The proposed method has##48##4##(2007-12#1)(2008-10#47)
The proposed method is applied to the##2##7##(2008-10#2)
The proposed method is applied to##3##6##(2008-10#3)
The proposed method is based on the##3##7##(2008-10#3)
The proposed method is based on##5##6##(2008-10#4)(2008-2#1)
The proposed method is fast##3##5##(2008-10#3)
The proposed method is of##2##5##(2008-10#2)
The proposed method is one of the most sensitive fluoremetries of##2##11##(2008-10#2)
The proposed method is rapid##2##5##(2008-10#2)
The proposed method is simple and##5##6##(2008-10#5)
The proposed method is simple##11##5##(2008-10#11)
The proposed method is suitable for automatic and continuous analysis##2##10##(2008-10#2)
The proposed method is very##2##5##(2008-10#2)
The proposed method is##47##4##(2008-10#43)(2008-2#2)(2008-3#1)(2012-3#1)
The proposed method permitted large enrichment factors of about 100##2##10##(2008-10#2)
The proposed method permitted large enrichment factors of about##3##9##(2008-10#3)
The proposed method permitted the##2##5##(2008-10#2)
The proposed method permitted##5##4##(2008-10#5)
The proposed method presented a##2##5##(2008-10#2)
The proposed method presented##3##4##(2008-10#3)
The proposed method provides a##3##5##(2008-3#2)(2008-7#1)
The proposed method showed##3##4##(2008-10#3)
The proposed method was also applied satisfactorily to the determination of considered metal ions in##2##15##(2008-10#2)
The proposed method was also##3##5##(2008-10#2)(2010-5#1)
The proposed method was applied successfully to the determination of##2##10##(2008-10#2)
The proposed method was applied successfully to##3##7##(2008-10#3)
The proposed method was applied successfully##4##6##(2008-10#4)
The proposed method was applied to determination of##2##8##(2008-10#2)
The proposed method was applied to determine##4##7##(2008-10#4)
The proposed method was applied to tap water##2##8##(2008-10#2)
The proposed method was applied to the analysis of##3##9##(2008-10#2)(2010-4#1)
The proposed method was applied to the determination of both analytes in##2##12##(2008-10#2)
The proposed method was applied to the determination of these##2##10##(2008-10#2)
The proposed method was applied to the determination of trace##3##10##(2008-10#3)
The proposed method was applied to the determination of##19##9##(2008-10#19)
The proposed method was applied to the##25##7##(2008-10#24)(2010-4#1)
The proposed method was applied to##36##6##(2008-10#35)(2010-4#1)
The proposed method was applied##44##5##(2008-10#43)(2010-4#1)
The proposed method was compared with##3##6##(2008-10#3)
The proposed method was evaluated by analyzing##2##7##(2008-10#2)
The proposed method was evaluated##3##5##(2008-10#3)
The proposed method was sensitive##2##5##(2008-10#2)
The proposed method was simple##2##5##(2008-10#2)
The proposed method was successfully applied for the determination of##3##10##(2008-10#3)
The proposed method was successfully applied for the##4##8##(2008-10#4)
The proposed method was successfully applied for##7##7##(2008-10#7)
The proposed method was successfully applied to determine##2##8##(2008-10#2)
The proposed method was successfully applied to the determination of vanadium in##2##12##(2008-10#2)
The proposed method was successfully applied to the determination of##13##10##(2008-10#13)
The proposed method was successfully applied to the simultaneous determination of##7##11##(2008-10#7)
The proposed method was successfully applied to the##21##8##(2008-10#21)
The proposed method was successfully applied to##24##7##(2008-10#24)
The proposed method was successfully applied##32##6##(2008-10#32)
The proposed method was successfully used for the determination of##2##10##(2008-10#2)
The proposed method was successfully##36##5##(2008-10#36)
The proposed method was used to##2##6##(2008-10#2)
The proposed method was validated##2##5##(2008-10#1)(2011-1#1)
The proposed method was##107##4##(2008-10#103)(2008-3#1)(2010-4#1)(2010-5#1)(2011-1#1)
The proposed method##267##3##(1992-11#1)(2007-11#4)(2007-12#2)(2008-10#238)(2008-2#2)(2008-3#8)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
The proposed methodology was##3##4##(2008-10#3)
The proposed methodology##6##3##(2008-10#6)
The proposed methods have##2##4##(2008-10#2)
The proposed methods were successfully applied to the##2##8##(2008-10#2)
The proposed methods were##6##4##(2008-10#6)
The proposed methods##10##3##(1994-11#1)(2008-10#9)
The proposed model is##2##4##(2008-1#1)(2011-2#1)
The proposed model was##2##4##(2008-10#1)(2008-7#1)
The proposed model##9##3##(1994-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)
The proposed optical##2##3##(2008-10#1)(2008-3#1)
The proposed optosensor##2##3##(2008-10#2)
The proposed procedure allowed the determination of##2##7##(2008-10#2)
The proposed procedure allows##2##4##(2008-10#2)
The proposed procedure has been tested first on synthetic samples prepared in##2##12##(2008-10#2)
The proposed procedure has been tested first##3##7##(2008-10#3)
The proposed procedure has been tested##4##6##(2008-10#4)
The proposed procedure has been##6##5##(2008-10#6)
The proposed procedure has##7##4##(2008-10#7)
The proposed procedure is##3##4##(1997-8#1)(2007-12#1)(2008-10#1)
The proposed procedure was applied for##3##6##(2008-10#3)
The proposed procedure was applied to##2##6##(2008-10#2)
The proposed procedure was applied##6##5##(2008-10#6)
The proposed procedure was successfully applied##2##6##(2008-10#2)
The proposed procedure was successfully##3##5##(2008-10#3)
The proposed procedure was##10##4##(2008-10#10)
The proposed procedure##27##3##(1997-8#1)(2007-12#1)(2008-10#24)(2010-1#1)
The proposed procedures have been##2##5##(2008-10#2)
The proposed procedures were##2##4##(2008-10#2)
The proposed procedures##6##3##(2008-10#6)
The proposed sensor displayed good selectivity for##2##7##(2008-10#2)
The proposed sensor is##2##4##(2008-10#2)
The proposed sensor shows fairly good discriminating ability towards##2##9##(2008-10#2)
The proposed sensor shows fairly##3##5##(2008-10#3)
The proposed sensor was successfully##2##5##(2008-10#2)
The proposed sensor was##4##4##(2008-10#4)
The proposed sensor##16##3##(2008-10#15)(2008-2#1)
The proposed system is##3##4##(2008-10#2)(2008-2#1)
The proposed system was applied to the##2##7##(2008-10#2)
The proposed system was##5##4##(2008-10#5)
The proposed system##15##3##(2007-11#1)(2008-10#11)(2008-2#1)(2008-3#1)(2010-8#1)
The proposed technique is##3##4##(2008-10#3)
The proposed technique##8##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)
The proposed test##2##3##(1997-7#1)(2012-3#1)
The proposed##497##2##(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-8#1)(1997-7#1)(1997-8#2)(2007-11#7)(2007-12#6)(2008-1#1)(2008-10#389)(2008-2#14)(2008-3#19)(2008-6#4)(2008-7#6)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#4)(2012-2#1)(2012-3#3)(2013-1#2)
The prospective##4##2##(1990-6#1)(1993-1#1)(1997-8#1)(2007-11#1)
The prospects for further improvement in performance##2##7##(2007-11#2)
The prospects for further##3##4##(2007-11#2)(2008-3#1)
The prospects##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
The prosthesis was##2##3##(2007-8#2)
The prosthetic group##2##3##(1993-8#1)(2007-11#1)
The protease inhibitor##2##3##(1991-2#1)(1992-12#1)
The protease##3##2##(1991-2#1)(1992-12#1)(1992-6#1)
The protection of##2##3##(1990-12#1)(2008-5#1)
The protection##4##2##(1990-12#1)(1990-5#1)(1996-12#1)(2008-5#1)
The protective effect of the##2##5##(2008-10#1)(2013-1#1)
The protective effect of##8##4##(1995-12#2)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
The protective effect##9##3##(1995-12#2)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)
The protective effects of##3##4##(1995-12#1)(1995-6#1)(2012-2#1)
The protective##20##2##(1995-12#3)(1995-6#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
The protein composition of##3##4##(2008-8#2)(2009-6#1)
The protein contains##3##3##(1994-12#1)(1995-2#1)(2008-10#1)
The protein is stabilized##2##4##(1997-2#1)(2009-12#1)
The protein is##8##3##(1993-8#1)(1994-8#1)(1997-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-8#1)
The protein kinase C##2##4##(1997-1#1)(2008-4#1)
The protein sequence##3##3##(1992-8#1)(1995-8#1)(2013-1#1)
The protein was##6##3##(1991-9#1)(1993-12#1)(1994-11#1)(1995-12#1)(1997-3#1)(2009-9#1)
The protein##53##2##(1990-7#1)(1991-6#1)(1991-9#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#2)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
The protein-free##2##2##(1993-12#1)(2008-11#1)
The proteins are##3##3##(1992-6#1)(2008-4#1)(2009-9#1)
The proteins encoded by##2##4##(1990-8#1)(1994-12#1)
The proteins were separated##2##4##(1992-8#1)(2008-11#1)
The proteins were##3##3##(1992-8#1)(1994-5#1)(2008-11#1)
The proteins##22##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)
The proteoglycans##2##2##(1991-9#2)
The prothrombotic##2##2##(1997-7#1)(2008-3#1)
The protocol also##2##3##(2008-4#2)
The protocol described in this unit##2##6##(2008-2#1)(2008-4#1)
The protocol described in this##3##5##(1994-9#1)(2008-2#1)(2008-4#1)
The protocol described##4##3##(1994-9#1)(2008-2#2)(2008-4#1)
The protocol is based on a global molecular dynamics search (GMDS) of the configuration space of the helical bundle##2##19##(2008-4#2)
The protocol is simple and##2##5##(2008-4#1)(2012-2#1)
The protocol is##7##3##(2008-1#1)(2008-4#4)(2008-5#1)(2012-2#1)
The protocol was##2##3##(2007-8#1)(2008-7#1)
The protocol##31##2##(1994-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
The protocols are##3##3##(2008-4#1)(2008-9#2)
The protocols described here##2##4##(2008-4#2)
The protocols described herein##2##4##(2008-4#2)
The protocols described##5##3##(2008-4#5)
The protocols in this unit describe the##2##7##(2008-2#1)(2008-9#1)
The protocols in this unit describe##3##6##(2008-2#1)(2008-4#1)(2008-9#1)
The protocols in this unit##10##5##(2008-2#1)(2008-4#4)(2008-9#5)
The protocols##28##2##(2008-2#1)(2008-4#16)(2008-9#10)(2012-12#1)
The protolytic##2##2##(2008-10#2)
The proton NMR##2##3##(1992-3#1)(2008-9#1)
The proton##3##2##(1992-3#1)(2008-8#1)(2008-9#1)
The protonation constants of##3##4##(2008-10#3)
The protonation##4##2##(2008-10#4)
The prototype of##2##3##(2008-10#1)(2008-9#1)
The prototype##8##2##(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)
The protozoa##2##2##(2008-5#1)(2013-1#1)
The provision of##5##3##(1993-12#1)(1996-1#1)(2010-12#1)(2011-1#1)(2012-12#1)
The proximal##11##2##(1994-5#2)(1997-4#1)(1997-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-9#1)(2010-11#1)
The psychiatric##4##2##(1992-11#1)(2008-1#1)(2010-3#1)(2013-1#1)
The psychological impact of##2##4##(1997-5#1)(2008-5#1)
The psychological##7##2##(1990-10#1)(1995-6#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)
The psychometric##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
The psychosocial##3##2##(1991-2#1)(2008-11#1)(2013-1#1)
The public health##2##3##(1997-1#1)(1997-5#1)
The public##6##2##(1993-12#1)(1997-1#1)(1997-5#1)(1997-6#2)(2008-11#1)
The published##4##2##(1991-6#1)(2008-1#1)(2008-11#1)(2012-2#1)
The publisher regrets that this article is an accidental duplication of an article that has already been published in##2##19##(2008-11#2)
The pulmonary##7##2##(1991-2#1)(1992-11#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#2)
The pulse width of##2##4##(2008-2#2)
The pulse width##4##3##(2008-2#3)(2008-3#1)
The pulse##10##2##(1992-11#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#1)
The pulse-to-pulse##2##2##(2008-2#1)(2008-3#1)
The pulsed##3##2##(1990-2#1)(2007-12#1)(2008-3#1)
The pump source##3##3##(2007-12#2)(2008-3#1)
The pump##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
The pumping efficiency##2##3##(2007-12#1)(2008-2#1)
The pungency##2##2##(2008-10#2)
The pure##2##2##(2008-3#1)(2013-8#1)
The purification and##2##3##(1990-8#1)(2008-8#1)
The purification##6##2##(1990-12#1)(1990-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
The purified enzyme had##2##4##(1991-5#1)(1995-2#1)
The purified enzyme##5##3##(1990-11#1)(1990-7#1)(1991-5#1)(1995-2#1)(2008-11#1)
The purified peptides were##2##4##(1990-7#1)(1995-11#1)
The purified preparation##2##3##(1990-7#1)(2008-8#1)
The purified protein##6##3##(1990-8#1)(1992-7#2)(1992-8#1)(1995-11#1)(1997-4#1)
The purified sample was##2##4##(2008-10#1)(2008-9#1)
The purified##46##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-5#3)(1992-3#1)(1992-7#2)(1992-8#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#5)(1995-11#2)(1995-2#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)(2013-8#1)
The purity##4##2##(1994-8#1)(2008-10#2)(2008-11#1)
The purple##2##2##(1994-5#1)(2008-10#1)
The purpose is to identify the priority nursing diagnoses##2##9##(2013-1#2)
The purpose is to identify##3##5##(2008-2#1)(2013-1#2)
The purpose is to show that CS terminology is inconsistent in the nursing literature##2##14##(2013-1#2)
The purpose is to##8##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2013-1#4)
The purpose is##9##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#4)
The purpose of our research was to evaluate the##2##9##(2007-11#1)(2007-8#1)
The purpose of our study was to evaluate##2##8##(2007-8#2)
The purpose of our study was to##3##7##(2007-8#2)(2008-9#1)
The purpose of our study was##4##6##(2007-8#3)(2008-9#1)
The purpose of our##7##4##(2007-11#1)(2007-8#4)(2008-5#1)(2008-9#1)
The purpose of such##2##4##(1992-12#1)(2008-10#1)
The purpose of the current study was to examine##2##9##(2007-12#1)(2009-5#1)
The purpose of the current study was to##3##8##(2007-12#1)(2009-5#1)(2011-2#1)
The purpose of the current##4##5##(2007-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
The purpose of the paper is to##2##7##(1996-9#1)(2007-11#1)
The purpose of the paper##3##5##(1996-9#1)(2007-10#1)(2007-11#1)
The purpose of the present review is to##2##8##(2009-7#1)(2010-1#1)
The purpose of the present review##3##6##(2008-11#1)(2009-7#1)(2010-1#1)
The purpose of the present study is to investigate##2##9##(2007-10#1)(2008-10#1)
The purpose of the present study is to##4##8##(2007-10#1)(2008-10#1)(2012-2#1)(2012-3#1)
The purpose of the present study was to determine##2##9##(1995-12#1)(2008-10#1)
The purpose of the present study was to examine the##2##10##(2008-7#1)(2013-8#1)
The purpose of the present study was to examine##3##9##(2008-7#1)(2009-8#1)(2013-8#1)
The purpose of the present study was to identify the##2##10##(1994-5#1)(2011-2#1)
The purpose of the present study was to investigate the##4##10##(2007-10#1)(2008-5#1)(2009-1#1)(2013-1#1)
The purpose of the present study was to test##2##9##(1990-8#1)(1995-3#1)
The purpose of the present study was to##15##8##(1990-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The purpose of the present study##19##6##(1990-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(2007-10#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
The purpose of the present work was to##2##8##(1992-12#1)(2010-5#1)
The purpose of the present work##3##6##(1992-12#1)(1995-6#1)(2010-5#1)
The purpose of the present##30##5##(1990-5#1)(1990-8#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
The purpose of the program##2##5##(1992-1#1)(2008-4#1)
The purpose of the study is to##4##7##(2007-10#1)(2007-11#1)(2007-8#1)(2011-1#1)
The purpose of the study was to determine the##2##9##(2007-10#1)(2013-8#1)
The purpose of the study was to determine##5##8##(1990-8#1)(2007-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
The purpose of the study was to evaluate the##3##9##(2008-1#1)(2008-9#1)(2009-8#1)
The purpose of the study was to evaluate##4##8##(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)
The purpose of the study was to identify the##2##9##(1996-12#1)(2010-1#1)
The purpose of the study was to##16##7##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-8#1)
The purpose of the study was##17##6##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-8#1)
The purpose of the study##21##5##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
The purpose of the survey was to##2##7##(2008-10#1)(2008-11#1)
The purpose of the##72##4##(1990-5#1)(1990-8#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(2007-10#5)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
The purpose of this article is to describe the structure##2##10##(1994-1#1)(2008-12#1)
The purpose of this article is to describe the##3##9##(1994-1#1)(2007-11#1)(2008-12#1)
The purpose of this article is to describe##7##8##(1994-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-12#2)(2012-2#1)
The purpose of this article is to illustrate the##2##9##(2011-2#1)(2012-2#1)
The purpose of this article is to present##2##8##(1993-12#1)(2012-3#1)
The purpose of this article is to provide a##3##9##(1997-3#1)(2010-11#1)(2012-3#1)
The purpose of this article is to provide##7##8##(1994-3#1)(1997-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-8#1)
The purpose of this article is to review recent##2##9##(2008-8#1)(2010-12#1)
The purpose of this article is to review the##8##9##(1994-11#1)(1994-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-8#1)
The purpose of this article is to review##12##8##(1994-11#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2013-8#1)
The purpose of this article is to##44##7##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-8#2)
The purpose of this article was to review##3##8##(2008-8#1)(2011-1#1)(2012-2#1)
The purpose of this article was to##5##7##(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
The purpose of this article##50##5##(1992-1#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-8#2)
The purpose of this case study##2##6##(1993-1#1)(2010-5#1)
The purpose of this case##3##5##(1993-1#1)(2010-5#1)(2010-9#1)
The purpose of this document is to provide##2##8##(2008-3#1)(2008-7#1)
The purpose of this investigation was to##3##7##(2006-6#1)(2009-3#1)(2013-8#1)
The purpose of this investigation##4##5##(2006-6#1)(2009-3#1)(2012-2#1)(2013-8#1)
The purpose of this manuscript is to##2##7##(2010-3#1)(2011-2#1)
The purpose of this paper is to describe the##4##9##(1992-1#1)(1992-2#1)(2008-11#2)
The purpose of this paper is to describe##6##8##(1992-1#1)(1992-2#1)(2008-11#2)(2008-9#1)(2010-11#1)
The purpose of this paper is to discuss##2##8##(2008-11#1)(2012-3#1)
The purpose of this paper is to present##3##8##(2008-4#1)(2010-12#1)(2012-3#1)
The purpose of this paper is to##22##7##(1991-4#1)(1992-1#1)(1992-2#1)(1997-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
The purpose of this paper##23##5##(1991-4#1)(1992-1#1)(1992-2#2)(1997-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
The purpose of this pictorial essay is to review##2##9##(2012-2#2)
The purpose of this pictorial##3##5##(2012-2#3)
The purpose of this pilot study was to examine the##2##10##(1995-3#1)(2008-12#1)
The purpose of this pilot study was to##5##8##(1995-3#1)(2008-12#3)(2013-1#1)
The purpose of this presentation is to##2##7##(2011-1#1)(2012-2#1)
The purpose of this project was to examine##2##8##(1995-3#1)(2007-4#1)
The purpose of this project was to##4##7##(1995-3#2)(2007-4#1)(2008-12#1)
The purpose of this project##5##5##(1995-3#2)(2007-4#1)(2008-12#1)(2010-7#1)
The purpose of this qualitative study was to explore##2##9##(2008-12#1)(2009-9#1)
The purpose of this qualitative study was to##3##8##(2008-12#1)(2009-9#1)(2011-2#1)
The purpose of this report is to review the##2##9##(2007-10#1)(2012-12#1)
The purpose of this report is to review##3##8##(2007-10#1)(2008-1#1)(2012-12#1)
The purpose of this report is to##7##7##(1992-12#1)(2007-10#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
The purpose of this report was to##3##7##(2008-6#1)(2011-1#1)(2011-2#1)
The purpose of this report##10##5##(1992-12#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
The purpose of this research is##2##6##(1995-6#1)(2008-3#1)
The purpose of this research was to evaluate##2##8##(2011-2#1)(2013-7#1)
The purpose of this research was to##6##7##(1994-3#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this research##8##5##(1994-3#1)(1995-6#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this retrospective study was to##2##8##(2007-7#1)(2012-1#1)
The purpose of this review is to evaluate##2##8##(2007-8#1)(2008-3#1)
The purpose of this review is to##6##7##(2007-8#1)(2008-3#2)(2009-6#1)(2012-2#1)(2013-1#1)
The purpose of this review is##7##6##(2007-8#1)(2008-3#2)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
The purpose of this review was to##2##7##(1996-6#1)(2008-5#1)
The purpose of this review##9##5##(1996-6#1)(2007-8#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
The purpose of this study is to compare##2##8##(2007-7#1)(2011-2#1)
The purpose of this study is to describe the##2##9##(1995-4#1)(2010-7#1)
The purpose of this study is to determine whether##3##9##(2008-5#1)(2011-2#1)(2013-1#1)
The purpose of this study is to evaluate the##3##9##(2007-10#1)(2010-8#2)
The purpose of this study is to evaluate##4##8##(2007-10#1)(2008-7#1)(2010-8#2)
The purpose of this study is to examine##2##8##(2008-10#1)(2011-2#1)
The purpose of this study is to investigate##3##8##(2008-7#1)(2010-8#1)(2012-2#1)
The purpose of this study is to present a case of##2##11##(2011-2#1)(2012-12#1)
The purpose of this study is to present##4##8##(1996-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
The purpose of this study is to##29##7##(1995-4#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
The purpose of this study is##30##6##(1995-4#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
The purpose of this study was to analyse the##2##9##(2008-6#1)(2013-8#1)
The purpose of this study was to analyze the##2##9##(2007-6#1)(2008-9#1)
The purpose of this study was to analyze##5##8##(2007-6#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
The purpose of this study was to ascertain##2##8##(1992-3#1)(2008-9#1)
The purpose of this study was to assess the##5##9##(2007-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-3#1)
The purpose of this study was to assess##7##8##(1994-3#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2012-3#1)
The purpose of this study was to compare the##8##9##(2007-10#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
The purpose of this study was to compare##11##8##(1994-12#1)(2007-10#2)(2008-12#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
The purpose of this study was to determine if##4##9##(1995-2#1)(1996-5#1)(2008-9#1)(2010-6#1)
The purpose of this study was to determine the effects of##4##11##(2008-5#2)(2010-4#1)(2010-6#1)
The purpose of this study was to determine the prevalence of##3##11##(2008-12#2)(2013-1#1)
The purpose of this study was to determine the relationship between##2##11##(2008-12#1)(2012-2#1)
The purpose of this study was to determine the relationship##3##10##(2008-12#1)(2009-5#1)(2012-2#1)
The purpose of this study was to determine the##24##9##(1990-12#1)(1991-11#1)(1994-2#1)(1994-5#1)(1997-6#1)(2007-2#1)(2007-8#1)(2008-12#3)(2008-5#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#3)(2013-1#2)
The purpose of this study was to determine whether##6##9##(1990-10#1)(1993-9#1)(1997-8#1)(2007-10#1)(2008-5#1)(2008-7#1)
The purpose of this study was to determine##34##8##(1990-10#1)(1990-12#1)(1991-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#3)(2011-2#1)(2012-2#3)(2013-1#2)
The purpose of this study was to develop an##2##9##(2008-10#1)(2008-11#1)
The purpose of this study was to develop and##3##9##(2008-10#1)(2010-9#1)(2012-1#1)
The purpose of this study was to develop##7##8##(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2012-1#1)
The purpose of this study was to establish##2##8##(1994-2#1)(2008-11#1)
The purpose of this study was to evaluate the effects of##2##11##(1993-12#1)(2008-12#1)
The purpose of this study was to evaluate the efficacy of##2##11##(2009-8#1)(2013-1#1)
The purpose of this study was to evaluate the##18##9##(1990-11#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-12#4)(2008-4#1)(2008-9#2)(2009-11#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
The purpose of this study was to evaluate##24##8##(1990-11#1)(1993-12#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#4)(2008-4#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
The purpose of this study was to examine the effects of music on##2##13##(1991-12#1)(2008-5#1)
The purpose of this study was to examine the effects of##3##11##(1991-12#1)(2008-5#1)(2013-8#1)
The purpose of this study was to examine the##10##9##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2008-5#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
The purpose of this study was to examine##17##8##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-6#2)(2008-12#1)(2008-5#2)(2009-12#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The purpose of this study was to explore##4##8##(2007-12#1)(2007-2#1)(2011-2#1)(2013-7#1)
The purpose of this study was to identify##4##8##(1990-2#1)(2008-12#1)(2008-9#1)(2010-11#1)
The purpose of this study was to investigate the effect of##3##11##(1995-3#1)(2008-12#1)(2010-12#1)
The purpose of this study was to investigate the##19##9##(1992-11#1)(1995-3#1)(2007-10#2)(2007-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this study was to investigate##22##8##(1992-11#1)(1992-3#1)(1993-2#1)(1995-3#1)(1996-6#1)(2007-10#2)(2007-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this study was to obtain##2##8##(1993-1#1)(2008-10#1)
The purpose of this study was to test a##2##9##(1993-12#1)(2012-3#1)
The purpose of this study was to test the##3##9##(1993-12#1)(2008-8#1)(2010-3#1)
The purpose of this study was to test##6##8##(1993-12#2)(2007-10#1)(2008-8#1)(2010-3#1)(2012-3#1)
The purpose of this study was to validate##2##8##(2008-12#1)(2008-8#1)
The purpose of this study was to##176##7##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-10#9)(2007-12#2)(2007-2#2)(2007-6#4)(2007-8#6)(2008-10#9)(2008-11#3)(2008-12#13)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#3)
The purpose of this study was##181##6##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#2)(1997-8#2)(2007-10#9)(2007-12#2)(2007-2#2)(2007-6#5)(2007-7#1)(2007-8#6)(2008-10#9)(2008-11#3)(2008-12#13)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#3)
The purpose of this study##212##5##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#3)(1993-1#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#2)(1997-8#2)(2007-10#10)(2007-12#2)(2007-2#2)(2007-6#5)(2007-7#2)(2007-8#6)(2008-10#12)(2008-11#4)(2008-12#13)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#4)
The purpose of this survey##2##5##(1991-12#1)(2008-9#1)
The purpose of this unit is not##2##7##(2008-4#1)(2008-9#1)
The purpose of this unit is to##3##7##(2008-4#1)(2008-9#2)
The purpose of this unit is##6##6##(2008-4#3)(2008-9#3)
The purpose of this work is to##2##7##(2008-5#1)(2008-6#1)
The purpose of this work was to evaluate the##2##9##(1997-8#1)(2008-10#1)
The purpose of this work was to study the##2##9##(2010-5#1)(2011-2#1)
The purpose of this work was to study##3##8##(2007-8#1)(2010-5#1)(2011-2#1)
The purpose of this work was to##7##7##(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
The purpose of this work was##8##6##(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-2#1)
The purpose of this work##10##5##(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
The purpose of this##383##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-4#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1993-1#3)(1993-12#8)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#3)(2006-6#1)(2007-10#11)(2007-11#2)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#3)(2007-8#9)(2008-1#2)(2008-10#15)(2008-11#10)(2008-12#23)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#12)(2008-6#8)(2008-7#11)(2008-8#6)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#8)(2011-2#20)(2012-1#2)(2012-12#5)(2012-2#18)(2012-3#9)(2013-1#15)(2013-7#4)(2013-8#8)
The purpose of##470##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-7#1)(1993-1#4)(1993-12#9)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#3)(2006-6#1)(2007-10#16)(2007-11#6)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#3)(2007-8#14)(2008-1#6)(2008-10#20)(2008-11#13)(2008-12#25)(2008-2#1)(2008-3#6)(2008-4#8)(2008-5#15)(2008-6#8)(2008-7#14)(2008-8#6)(2008-9#23)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#9)(2011-2#23)(2012-1#2)(2012-12#5)(2012-2#20)(2012-3#11)(2013-1#17)(2013-7#4)(2013-8#13)
The purpose was to##3##4##(1991-6#1)(2008-3#1)(2009-7#1)
The purpose##483##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-7#1)(1993-1#4)(1993-12#9)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#3)(2006-6#1)(2007-10#16)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#3)(2007-8#14)(2008-1#6)(2008-10#21)(2008-11#13)(2008-12#26)(2008-2#2)(2008-3#7)(2008-4#8)(2008-5#15)(2008-6#9)(2008-7#14)(2008-8#7)(2008-9#23)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#9)(2011-2#23)(2012-1#2)(2012-12#5)(2012-2#20)(2012-3#11)(2013-1#21)(2013-7#4)(2013-8#13)
The purposes of the##2##4##(1996-3#1)(2008-6#1)
The purposes of this article##2##5##(2010-9#1)(2011-1#1)
The purposes of this study were to##3##7##(2008-12#1)(2010-11#1)(2010-3#1)
The purposes of this study##4##5##(2008-12#1)(2008-6#1)(2010-11#1)(2010-3#1)
The purposes of this##10##4##(2008-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
The purposes of##12##3##(1996-3#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-1#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
The putative##20##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-6#1)(1997-4#1)(2008-10#4)(2012-2#1)
The pyrolysis and atomization temperatures##2##5##(2008-10#2)
The pyrolysis##3##2##(2008-10#3)
The qcr1##2##2##(2012-3#2)
The quadratic##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
The qualitative features##2##3##(1992-9#1)(2008-8#1)
The qualitative##8##2##(1992-9#1)(1993-1#1)(1995-5#1)(2007-12#1)(2008-8#2)(2008-9#1)(2013-1#1)
The quality and the##2##4##(2007-2#1)(2008-10#1)
The quality assurance program##2##4##(1997-4#1)(2008-6#1)
The quality of care##2##4##(1993-1#1)(2008-1#1)
The quality of life##3##4##(1995-4#1)(2007-11#1)(2009-10#1)
The quality of the##9##4##(1995-5#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
The quality of##31##3##(1993-1#1)(1993-12#1)(1993-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
The quality##41##2##(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
The quantification limit##3##3##(2008-10#3)
The quantification of fluoxetine##2##4##(2008-10#2)
The quantification of##7##3##(2008-10#7)
The quantification##13##2##(2008-10#12)(2013-1#1)
The quantitative analysis of the##3##5##(2008-10#3)
The quantitative analysis of##5##4##(2008-10#5)
The quantitative analysis##6##3##(2008-10#6)
The quantitative determination of##2##4##(2008-10#2)
The quantitative relationships between##2##4##(1996-2#1)(2008-10#1)
The quantitative trait loci##2##4##(2008-10#1)(2008-8#1)
The quantitative##27##2##(1993-12#1)(1993-9#1)(1996-2#1)(1997-5#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)
The quantity of DNA required for separation is in the nanogram range##2##12##(2008-2#1)(2008-4#1)
The quantity of##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)
The quantum##2##2##(2007-12#1)(2008-2#1)
The quartz crystal##2##3##(2008-10#2)
The quenching of##2##3##(1992-6#1)(2008-10#1)
The quenching##8##2##(1992-12#1)(1992-6#1)(1994-5#1)(2008-10#5)
The quest for##4##3##(1992-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
The quest##5##2##(1992-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
The question addressed was whether the##2##6##(2007-8#2)
The question addressed was whether##9##5##(2007-8#9)
The question addressed was which##2##5##(2007-8#2)
The question addressed was##11##4##(2007-8#11)
The question addressed##12##3##(2007-8#12)
The question arises##2##3##(2011-2#2)
The question is##4##3##(1996-9#1)(2007-12#1)(2008-10#1)(2008-8#1)
The question of whether##2##4##(1992-12#1)(2008-7#1)
The question of##7##3##(1992-12#1)(1995-9#1)(1996-6#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
The question##30##2##(1992-12#1)(1993-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-9#1)(2007-11#1)(2007-12#2)(2007-8#12)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
The questionnaire consisted of##2##4##(2008-1#1)(2011-2#1)
The questionnaire contained##2##3##(2007-12#1)(2012-2#1)
The questionnaire was administered to##2##5##(2008-10#1)(2012-12#1)
The questionnaire was designed to##2##5##(1991-1#1)(2007-7#1)
The questionnaire was##7##3##(1991-1#1)(1993-2#2)(2007-7#1)(2008-10#1)(2012-12#1)(2013-1#1)
The questionnaire##15##2##(1991-1#1)(1993-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
The questionnaires##2##2##(2009-12#1)(2010-1#1)
The questions##7##2##(1996-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
The quotient##2##2##(1994-5#1)(2008-3#1)
The r(m)##2##2##(2011-2#2)
The rH##2##2##(2013-8#2)
The rabbit##4##2##(1991-12#1)(1992-6#1)(2008-10#1)(2013-1#1)
The rachis##2##2##(2008-10#2)
The radar##2##2##(2008-3#2)
The radial artery##2##3##(1990-8#1)(2011-2#1)
The radial distribution##2##3##(1992-9#1)(2008-10#1)
The radial##7##2##(1990-8#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
The radiation burden##2##3##(2012-2#2)
The radiation##9##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)(2012-2#2)(2013-1#1)
The radiative properties of##2##4##(2008-2#1)(2008-3#1)
The radical scavenging##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
The radical##4##2##(1996-2#1)(2008-11#1)(2008-5#1)(2009-10#1)
The radiobiological##2##2##(1993-9#1)(2007-4#1)
The radiolabeled##2##2##(1990-12#1)(2009-9#1)
The radiologic findings##2##3##(2006-12#1)(2008-7#1)
The radiological##7##2##(1992-5#1)(2007-11#2)(2007-8#1)(2012-2#1)(2013-8#2)
The radiologist##2##2##(2007-11#1)(2007-12#1)
The radiology department##3##3##(1996-1#2)(2008-3#1)
The radiology##4##2##(1995-3#1)(1996-1#2)(2008-3#1)
The radiometric##2##2##(2007-11#1)(2008-2#1)
The radius##2##2##(2008-2#1)(2008-3#1)
The random amplified polymorphic DNA##3##5##(2007-10#1)(2008-10#2)
The random##7##2##(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)
The randomized##2##2##(1996-6#2)
The range of linearity using the##2##6##(2008-10#2)
The range of linearity##3##4##(2008-10#3)
The range of the##4##4##(2008-10#3)(2008-3#1)
The range of##21##3##(1994-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)
The range##25##2##(1994-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)
The ranges##2##2##(2008-10#2)
The rank order of potency##2##5##(1995-12#2)
The rank order of##4##4##(1993-8#1)(1995-12#2)(1995-8#1)
The rank##5##2##(1993-8#1)(1995-12#2)(1995-8#1)(2010-3#1)
The rapid and##2##3##(2008-10#1)(2008-5#1)
The rapid development of##2##4##(1994-12#1)(2012-2#1)
The rapid development##3##3##(1994-12#1)(2012-2#1)(2013-8#1)
The rapid expansion of##2##4##(2007-4#1)(2008-8#1)
The rapid growth of##2##4##(2008-10#1)(2012-3#1)
The rapid##26##2##(1990-12#1)(1990-7#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-4#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
The rapidity of##3##3##(1992-9#1)(1995-3#1)(2008-10#1)
The rapidly##3##2##(1990-8#1)(2008-12#1)(2010-1#1)
The rare earth##2##3##(2008-10#1)(2012-2#1)
The rare##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
The rarity and##2##3##(1990-12#1)(2008-12#1)
The rarity of this##2##4##(1990-9#1)(2009-5#1)
The rarity of##4##3##(1990-9#1)(2008-7#1)(2009-3#1)(2009-5#1)
The rarity##8##2##(1990-12#1)(1990-9#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-5#1)(2013-1#1)
The rat##22##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-3#5)(1994-12#1)(1994-6#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2011-3#1)
The rate and##2##3##(1992-6#1)(2013-1#1)
The rate constant for the##3##5##(1991-5#1)(1994-5#1)(2008-10#1)
The rate constant for##4##4##(1990-7#1)(1991-5#1)(1994-5#1)(2008-10#1)
The rate constant##5##3##(1990-7#1)(1991-5#1)(1994-3#1)(1994-5#1)(2008-10#1)
The rate constants of the repair##2##6##(2008-8#1)(2008-9#1)
The rate constants##5##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
The rate of change in##2##5##(2008-10#2)
The rate of change##3##4##(2008-1#1)(2008-10#2)
The rate of complications##2##4##(1991-3#1)(2007-7#1)
The rate of growth##2##4##(1997-1#1)(2008-7#1)
The rate of increase##5##4##(1990-7#1)(1992-6#1)(1993-3#1)(2008-10#2)
The rate of multiple##2##4##(1995-6#1)(2008-11#1)
The rate of oxygen##2##4##(1997-1#1)(2008-6#1)
The rate of temporal increase in disease##2##7##(2008-10#2)
The rate of the reaction##2##5##(2008-10#2)
The rate of the##8##4##(1991-12#1)(1992-6#1)(1995-2#1)(2008-10#4)(2010-12#1)
The rate of##89##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-11#2)(1993-3#3)(1994-5#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#1)
The rate##104##2##(1990-11#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1993-11#2)(1993-3#3)(1994-3#1)(1994-5#2)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#2)
The raters##2##2##(1997-3#1)(2008-12#1)
The rates of##14##3##(1990-11#1)(1990-5#1)(1993-1#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
The rates##17##2##(1990-11#1)(1990-5#1)(1993-1#1)(1994-3#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
The rather##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
The ratio between##2##3##(2008-2#1)(2012-12#1)
The ratio of hapten##2##4##(2008-11#2)
The ratio of male to female##2##6##(2007-2#1)(2011-2#1)
The ratio of signal intensity##2##5##(2009-11#2)
The ratio of the##12##4##(1993-6#1)(1996-2#1)(1996-5#1)(2008-10#4)(2008-2#2)(2008-3#3)
The ratio of##45##3##(1990-5#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2011-1#1)(2011-2#1)
The ratio##55##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#13)(2008-11#3)(2008-2#5)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2011-1#1)(2011-2#2)(2012-12#1)
The rational##4##2##(1990-3#1)(1992-5#1)(2008-11#1)(2010-12#1)
The rationale behind the##2##4##(2008-12#1)(2008-9#1)
The rationale behind##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
The rationale for the##3##4##(2007-11#1)(2008-11#1)(2008-3#1)
The rationale for this##2##4##(1992-9#1)(2011-2#1)
The rationale for##13##3##(1992-3#2)(1992-9#1)(1993-1#1)(1994-9#1)(2007-11#1)(2008-11#2)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#2)
The rationale of##2##3##(2008-7#1)(2009-8#1)
The rationale##19##2##(1992-3#2)(1992-9#1)(1993-1#1)(1994-9#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
The ratios of##9##3##(1993-3#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#2)(2011-2#1)
The ratios##13##2##(1993-3#1)(1996-3#2)(1997-3#1)(2008-10#5)(2008-11#2)(2011-2#1)(2013-8#1)
The rats in##2##3##(2008-10#1)(2013-1#1)
The rats treated with##2##4##(2012-2#1)(2013-8#1)
The rats were##4##3##(1990-7#1)(1993-11#1)(1993-3#1)(2013-1#1)
The rats##12##2##(1990-6#1)(1990-7#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(2008-10#2)(2012-2#1)(2013-1#2)(2013-8#1)
The raw##2##2##(1993-12#1)(2013-1#1)
The ray##2##2##(2008-3#2)
The re-alpha-sarcin was##2##3##(1997-4#2)
The reactants##2##2##(1995-6#1)(2010-12#1)
The reaction between##3##3##(2008-10#3)
The reaction can be##2##4##(2008-10#2)
The reaction can##3##3##(2008-10#3)
The reaction is instantaneous and absorbance##2##6##(2008-10#2)
The reaction is##10##3##(1996-2#1)(1996-5#1)(2008-10#7)(2010-5#1)
The reaction mechanism for##2##4##(2008-10#2)
The reaction mechanism##4##3##(2008-10#2)(2008-12#2)
The reaction mixture##2##3##(1991-5#1)(2007-11#1)
The reaction of 2##2##4##(1996-5#1)(1997-7#1)
The reaction of 3##2##4##(2008-10#2)
The reaction of aluminium chloride with##2##6##(2008-10#2)
The reaction of##28##3##(1993-3#1)(1995-9#1)(1996-2#3)(1996-5#1)(1997-7#1)(2007-11#4)(2008-10#14)(2008-8#1)(2008-9#1)(2009-10#1)
The reaction proceeds##2##3##(1996-5#1)(2009-10#1)
The reaction product##5##3##(1991-5#1)(2008-10#4)
The reaction rate constants##2##4##(2008-10#1)(2008-9#1)
The reaction rate##3##3##(2008-10#2)(2008-9#1)
The reaction was monitored spectrophotometrically by measuring the decrease in absorbance of carminic acid at##2##15##(2008-10#2)
The reaction was monitored spectrophotometrically by measuring the increase in absorbance of##2##12##(2008-10#2)
The reaction was monitored spectrophotometrically by measuring the##4##8##(2008-10#4)
The reaction was monitored##5##4##(2008-10#5)
The reaction was##8##3##(2008-10#8)
The reaction##88##2##(1991-5#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-5#2)(1995-9#1)(1996-2#4)(1996-5#3)(1997-7#1)(2007-11#5)(2008-10#52)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#2)(2010-5#1)(2013-1#2)
The reactions between##2##3##(2008-10#2)
The reactions of##3##3##(2007-11#1)(2008-10#1)(2009-8#1)
The reactions were carried out in##2##6##(2007-11#1)(2008-6#1)
The reactions were##3##3##(2007-11#1)(2008-5#1)(2008-6#1)
The reactions##13##2##(1990-11#1)(1996-3#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-5#2)(2008-6#1)(2009-8#1)
The reactive##5##2##(1990-7#1)(1993-8#1)(1995-6#1)(2008-10#2)
The reactivity of the##2##4##(1996-2#1)(2008-10#1)
The reactivity of##7##3##(1990-12#1)(1992-2#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)
The reactivity##13##2##(1990-12#1)(1992-2#1)(1992-6#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
The reactor using DAO from##2##5##(2008-10#2)
The reactor##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
The readability##2##2##(2011-1#2)
The readout##2##2##(2007-11#1)(2008-3#1)
The reagent gives##2##3##(2008-10#2)
The reagent##8##2##(1990-8#1)(2008-10#7)
The reagents are dispensed##2##4##(2008-10#2)
The reagents are##3##3##(2008-10#3)
The reagents##4##2##(2008-10#4)
The real part of the refractive index##2##7##(2008-3#2)
The real part of the##3##5##(2008-3#3)
The real samples were##2##4##(2008-10#2)
The real world experience##4##4##(1994-1#4)
The real##20##2##(1994-1#4)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2012-3#1)(2013-8#1)
The real-time PCR assay##2##4##(2008-10#2)
The real-time PCR##4##3##(2008-10#4)
The real-time##10##2##(2008-10#6)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
The reality of##2##3##(2008-11#1)(2013-1#1)
The reality##3##2##(2008-11#1)(2010-8#1)(2013-1#1)
The realization of##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
The reason for the##2##4##(1996-6#1)(2007-7#1)
The reason for this is that##2##6##(2009-8#1)(2010-12#1)
The reason for this is the##2##6##(2008-3#1)(2009-7#1)
The reason for this is##4##5##(2008-3#1)(2009-7#1)(2009-8#1)(2010-12#1)
The reason for this##10##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-3#1)
The reason for##15##3##(1996-12#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-3#1)
The reason is the##2##4##(1993-8#1)(2010-7#1)
The reason is##3##3##(1993-8#1)(2006-10#1)(2010-7#1)
The reason##22##2##(1993-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
The reasonable##2##2##(1993-8#1)(2007-12#1)
The reasons for the##3##4##(1997-7#1)(2007-10#1)(2012-3#1)
The reasons for this##5##4##(1991-4#1)(2007-2#1)(2008-10#1)(2010-12#1)(2012-2#1)
The reasons for##16##3##(1991-4#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-6#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#2)(2012-3#1)
The reasons why##2##3##(2010-11#1)(2011-2#1)
The reasons##25##2##(1991-4#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
The receiver is##2##3##(2008-2#1)(2008-3#1)
The receiver operating characteristic##3##4##(2008-3#1)(2012-1#1)(2013-7#1)
The receiver##6##2##(2008-2#1)(2008-3#2)(2012-1#1)(2012-12#1)(2013-7#1)
The receiver-stimulator##2##2##(2008-9#1)(2012-2#1)
The recent advances##2##3##(2007-7#1)(2010-12#1)
The recent advent of##2##4##(2008-3#1)(2010-8#1)
The recent cloning of##2##4##(1994-11#1)(2009-8#1)
The recent development of a##3##5##(1990-2#1)(1997-2#1)(2008-4#1)
The recent development of##10##4##(1990-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-8#1)
The recent discovery of##3##4##(1993-5#1)(1996-4#1)(2007-10#1)
The recent discovery##4##3##(1993-5#1)(1996-4#1)(2007-10#1)(2008-4#1)
The recent identification of##4##4##(1996-2#2)(2008-7#1)(2011-2#1)
The recent introduction of##4##4##(1993-12#1)(1997-8#1)(2008-3#1)(2011-2#1)
The recent proliferation of##2##4##(2009-6#1)(2013-1#1)
The recent##62##2##(1990-2#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)
The recently##9##2##(1990-11#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
The receptor##9##2##(1992-12#1)(1992-8#1)(1995-11#1)(2008-11#2)(2008-4#2)(2008-9#1)(2010-8#1)
The receptors##3##2##(1993-2#1)(2008-4#1)(2008-7#1)
The recessive mouse mutant##2##4##(1996-2#2)
The reciprocal##2##2##(1992-9#1)(1997-3#1)
The recognition of##12##3##(1990-9#1)(1992-12#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-7#1)
The recognition##16##2##(1990-9#1)(1992-12#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-7#1)
The recombinant enzyme displayed##2##4##(1992-8#1)(2011-1#1)
The recombinant enzyme##3##3##(1992-8#2)(2011-1#1)
The recombinant human NGF was##2##5##(1990-8#2)
The recombinant human##3##3##(1990-12#1)(1990-8#2)
The recombinant protein is##3##4##(1994-8#1)(2008-8#2)
The recombinant protein was##3##4##(1990-11#1)(1990-8#1)(1994-3#1)
The recombinant protein##8##3##(1990-11#1)(1990-8#1)(1994-3#1)(1994-8#1)(1997-4#1)(2008-8#2)(2010-12#1)
The recombinant proteins were##2##4##(1990-11#1)(1997-4#1)
The recombinant proteins##3##3##(1990-11#1)(1993-8#1)(1997-4#1)
The recombinant royalisin##2##3##(2011-2#2)
The recombinant scTcr##2##3##(1994-6#2)
The recombinant##45##2##(1990-11#2)(1990-12#1)(1990-8#4)(1991-9#1)(1992-8#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#2)(1994-6#2)(1994-8#2)(1997-2#1)(1997-4#5)(2008-10#1)(2008-11#3)(2008-8#5)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#4)
The recombination##2##2##(2009-3#1)(2013-8#1)
The recommendations apply to patients##2##5##(2008-6#2)
The recommendations##10##2##(1990-2#1)(1993-6#1)(1997-2#1)(2008-11#1)(2008-6#2)(2008-7#1)(2011-2#2)(2013-1#1)
The recommended method has been applied to the##2##8##(2008-10#2)
The recommended method has been applied##3##6##(2008-10#3)
The recommended method was##2##4##(2008-10#2)
The recommended method##5##3##(2008-10#5)
The recommended##12##2##(1994-2#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-4#1)(2009-3#1)(2013-1#1)
The reconstructed images are##2##4##(2008-3#2)
The reconstructed images##3##3##(2008-3#2)(2010-8#1)
The reconstructed##8##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-8#1)
The reconstruction is##2##3##(2008-2#1)(2008-3#1)
The reconstruction method##2##3##(2008-2#2)
The reconstruction of a##2##4##(2008-2#1)(2008-3#1)
The reconstruction of##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
The reconstruction##14##2##(2007-11#1)(2008-2#4)(2008-3#7)(2008-9#1)(2011-2#1)
The recorded signal##2##3##(1997-6#1)(2008-10#1)
The recorded##7##2##(1990-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
The recording of##2##3##(2008-2#1)(2008-4#1)
The recording##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
The records of##6##3##(2007-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#1)
The records##7##2##(2007-10#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-5#1)(2008-7#1)
The recovered##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
The recoveries are##3##3##(2008-10#3)
The recoveries for the##4##4##(1997-2#1)(2008-10#3)
The recoveries for##8##3##(1997-2#1)(2008-10#7)
The recoveries of a standard added in real solution samples are between##2##12##(2008-10#2)
The recoveries of the##6##4##(2008-10#5)(2011-1#1)
The recoveries of##28##3##(1992-11#1)(1997-6#1)(2008-10#25)(2011-1#1)
The recoveries ranged##2##3##(2008-10#2)
The recoveries were &gt##2##4##(2008-10#2)
The recoveries were##5##3##(2008-10#3)(2011-1#2)
The recoveries##51##2##(1992-11#1)(1997-2#1)(1997-6#1)(2008-10#44)(2011-1#3)(2012-3#1)
The recovery obtained##2##3##(2008-10#2)
The recovery of Cr(VI) was##2##5##(2008-10#2)
The recovery of Cr(VI)##3##4##(2008-10#3)
The recovery of added##2##4##(1995-2#1)(2008-10#1)
The recovery of spiked water samples was from##2##8##(2008-10#2)
The recovery of spiked##4##4##(2008-10#4)
The recovery of the assay was##2##6##(1992-6#1)(2008-10#1)
The recovery of the##5##4##(1992-6#1)(2008-10#2)(2009-8#1)(2013-1#1)
The recovery of##37##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-6#1)(1995-11#1)(1995-2#1)(2008-10#26)(2008-11#1)(2008-3#1)(2009-8#1)(2013-1#1)
The recovery range##2##3##(2008-10#1)(2008-5#1)
The recovery rate was##2##4##(2008-10#1)(2008-11#1)
The recovery rate##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
The recovery studies##2##3##(2008-10#2)
The recovery values obtained##3##4##(2008-10#3)
The recovery values##6##3##(2008-10#6)
The recovery was##5##3##(2008-10#4)(2013-8#1)
The recovery##72##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-6#1)(1995-11#1)(1995-2#1)(2008-10#52)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
The recurrence rate was##2##4##(1995-5#1)(1996-9#1)
The recurrence rate##4##3##(1992-11#1)(1992-6#1)(1995-5#1)(1996-9#1)
The recurrence##7##2##(1992-11#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-9#1)(2007-12#1)(2013-1#1)
The red##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
The redox reaction##3##3##(2008-10#3)
The redox##7##2##(2008-10#6)(2008-11#1)
The reduced expression of##2##4##(1992-1#1)(1997-6#1)
The reduced##18##2##(1991-3#1)(1992-1#1)(1993-8#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The reducing##3##2##(1992-5#1)(2008-11#2)
The reduction current of##2##4##(2008-10#2)
The reduction current##4##3##(2008-10#4)
The reduction in the##3##4##(1993-11#1)(2008-10#1)(2008-2#1)
The reduction in transfusions##2##4##(1990-2#2)
The reduction in##18##3##(1990-2#2)(1990-5#2)(1991-5#1)(1993-11#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#3)(2011-2#1)(2012-2#1)(2013-8#1)
The reduction is##2##3##(1991-5#1)(2009-6#1)
The reduction of Hg(II)##2##4##(2008-10#2)
The reduction of the##3##4##(2008-10#2)(2008-3#1)
The reduction of##19##3##(1990-3#1)(1993-12#1)(1996-6#1)(2007-11#1)(2008-10#12)(2008-12#1)(2008-3#1)(2011-2#1)
The reduction peak potential##2##4##(2008-10#2)
The reduction peak##3##3##(2008-10#3)
The reduction potentials##2##3##(1991-8#1)(1995-5#1)
The reduction was##3##3##(1990-11#1)(1990-2#1)(2008-5#1)
The reduction##55##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#2)(1991-8#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
The reductionist theory##2##3##(1997-6#2)
The reductive charge##2##3##(2008-10#2)
The reference is##2##3##(2008-10#1)(2010-11#1)
The reference##11##2##(1992-9#1)(2008-10#4)(2008-2#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
The references##3##2##(2007-5#2)(2013-1#1)
The refinement of##2##3##(2008-10#1)(2009-7#1)
The reflected##3##2##(2008-2#1)(2008-3#2)
The reflectivity of the##3##4##(2007-11#1)(2008-3#2)
The reflectivity of##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
The reflectivity was##2##3##(2007-12#1)(2008-2#1)
The reflectivity##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
The refractive index of##2##4##(2008-3#2)
The refractive index##3##3##(2008-2#1)(2008-3#2)
The refractive indices are##2##4##(2008-2#1)(2008-3#1)
The refractive indices##3##3##(2008-2#1)(2008-3#2)
The refractive##6##2##(2008-2#2)(2008-3#4)
The refractive-index modulation##3##3##(2007-11#2)(2007-12#1)
The refractive-index##9##2##(2007-11#2)(2007-12#4)(2008-3#3)
The regenerated##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
The regeneration##2##2##(2008-10#1)(2008-5#1)
The regimen was##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
The regimen##4##2##(1990-6#1)(2008-10#1)(2008-6#1)(2013-8#1)
The region from##2##3##(1994-6#1)(2008-2#1)
The region of the##3##4##(1990-5#1)(1991-6#1)(1993-6#1)
The region of##5##3##(1990-5#1)(1991-6#1)(1993-6#2)(1993-9#1)
The region##15##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-7#1)(1993-6#2)(1993-9#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-3#1)
The regional##10##2##(1990-7#1)(1991-2#1)(1992-12#1)(1993-9#2)(1994-12#1)(2008-10#1)(2009-10#1)(2011-1#1)(2013-3#1)
The regions##5##2##(1991-6#1)(1997-8#2)(2008-10#1)(2011-2#1)
The registered##2##2##(1995-3#1)(2011-2#1)
The regression equation for##2##4##(2008-10#2)
The regression equation##3##3##(2008-10#3)
The regression line##2##3##(1990-8#1)(2008-10#1)
The regression method##2##3##(2008-10#2)
The regression models were subsequently##2##5##(2008-10#2)
The regression models##3##3##(2008-10#2)(2008-11#1)
The regression of##2##3##(1994-9#1)(2008-6#1)
The regression##16##2##(1990-8#1)(1994-9#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
The regular##3##2##(1997-3#1)(2008-1#1)(2008-10#1)
The regulated##2##2##(1993-3#1)(2008-4#1)
The regulation of the##3##4##(1992-12#1)(1995-3#1)(2011-2#1)
The regulation of##12##3##(1992-12#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-2#1)
The regulation was##2##3##(2008-11#1)(2008-9#1)
The regulation##15##2##(1992-12#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2011-2#1)
The regulatory##5##2##(1990-2#1)(1995-2#1)(1996-5#1)(2012-2#1)(2013-1#1)
The relapse##3##2##(1990-6#1)(2008-1#1)(2012-3#1)
The related##4##2##(1994-6#1)(2008-10#1)(2012-3#1)(2013-8#1)
The relation between sample concentration and reflectance is described by the Kubelka-Munk equation##2##13##(2008-10#2)
The relation between the##8##4##(1992-6#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
The relation between##26##3##(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-3#1)(2012-1#1)(2012-12#1)
The relation of blood##2##4##(2010-4#1)(2013-8#1)
The relation of##7##3##(2008-2#1)(2008-4#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
The relation##34##2##(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#2)(2010-3#1)(2010-4#1)(2012-1#2)(2012-12#2)(2013-8#1)
The relations between the##2##4##(1993-6#1)(2008-3#1)
The relations of##2##3##(2008-4#1)(2009-10#1)
The relations##6##2##(1993-6#1)(2007-11#1)(2008-3#2)(2008-4#1)(2009-10#1)
The relationship among the##2##4##(2007-11#1)(2008-10#1)
The relationship among##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
The relationship between a##2##4##(1996-12#1)(2009-3#1)
The relationship between cancer##2##4##(1991-3#1)(2008-7#1)
The relationship between erythrocyte sodium-lithium counter-transport activity##2##7##(1992-6#2)
The relationship between genetic and cytogenetic maps of pea##2##9##(2008-5#2)
The relationship between incidence##2##4##(2008-10#2)
The relationship between local##2##4##(1994-8#1)(2008-7#1)
The relationship between peak##3##4##(2008-10#3)
The relationship between the structure##2##5##(2008-10#1)(2008-8#1)
The relationship between the##28##4##(1990-2#1)(1991-11#1)(1992-10#1)(1992-12#1)(1995-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The relationship between##128##3##(1990-2#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
The relationship is##2##3##(2008-3#1)(2013-1#1)
The relationship of the##4##4##(2007-12#1)(2008-10#1)(2009-12#1)(2013-8#1)
The relationship of these##2##4##(1990-2#1)(1995-3#1)
The relationship of##16##3##(1990-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
The relationship with##2##3##(2010-3#1)(2013-1#1)
The relationship##158##2##(1990-2#3)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#3)
The relationships among these##2##4##(2008-7#1)(2008-9#1)
The relationships among##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
The relationships between##6##3##(2007-12#1)(2008-10#3)(2008-2#1)(2013-1#1)
The relationships of##2##3##(2007-6#1)(2009-7#1)
The relationships##13##2##(2007-12#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#1)
The relative EC50/IC50##2##3##(2012-2#2)
The relative abundance of##4##4##(1992-12#1)(1997-2#1)(2008-9#1)(2012-6#1)
The relative abundance##5##3##(1992-12#1)(1997-2#1)(2008-9#1)(2010-8#1)(2012-6#1)
The relative affinities of##2##4##(2008-9#1)(2011-2#1)
The relative amounts of the##2##5##(1991-5#1)(1996-9#1)
The relative amounts of##3##4##(1991-5#1)(1992-12#1)(1996-9#1)
The relative binding##2##3##(1990-11#1)(2010-1#1)
The relative contributions of##3##4##(2007-12#1)(2008-7#1)(2009-9#1)
The relative ease##2##3##(2009-12#1)(2011-1#1)
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults##2##15##(2011-2#2)
The relative efficacy of##3##4##(2011-2#3)
The relative error of##2##4##(2008-10#1)(2008-2#1)
The relative error##4##3##(2008-10#3)(2008-2#1)
The relative errors##4##3##(2008-10#3)(2008-3#1)
The relative fluorescence intensity of##2##5##(2008-10#2)
The relative fluorescence intensity##3##4##(2008-10#3)
The relative frequency of##2##4##(2007-12#1)(2012-3#1)
The relative merits and##2##4##(2008-10#1)(2008-11#1)
The relative rates of##2##4##(1995-3#1)(2009-2#1)
The relative risk of##3##4##(1995-6#1)(2006-10#1)(2013-1#1)
The relative risk##4##3##(1995-6#1)(2006-10#2)(2013-1#1)
The relative risks##2##3##(1990-6#1)(1996-11#1)
The relative roles of##2##4##(2008-8#2)
The relative standard deviation (&lt##2##5##(2008-10#2)
The relative standard deviation (R##17##5##(2008-10#17)
The relative standard deviation (n=10) was 0##2##7##(2008-10#2)
The relative standard deviation (n=11)##2##5##(2008-10#2)
The relative standard deviation (n=6)##2##5##(2008-10#2)
The relative standard deviation for 10##5##6##(2008-10#5)
The relative standard deviation for 11 replicate##3##7##(2008-10#3)
The relative standard deviation for five##2##6##(2008-10#2)
The relative standard deviation for the analysis of##2##8##(2008-10#2)
The relative standard deviation for the##4##6##(2008-10#4)
The relative standard deviation for##26##5##(2008-10#26)
The relative standard deviation is 3##2##6##(2008-10#2)
The relative standard deviation is##6##5##(2008-10#6)
The relative standard deviation of 11##2##6##(2008-10#2)
The relative standard deviation of the method##2##7##(2008-10#2)
The relative standard deviation of the proposed method##2##8##(2008-10#2)
The relative standard deviation of the proposed technique was##2##9##(2008-10#2)
The relative standard deviation of the proposed##4##7##(2008-10#4)
The relative standard deviation of the##9##6##(2008-10#9)
The relative standard deviation of##23##5##(1994-9#1)(2008-10#22)
The relative standard deviation values for##2##6##(2008-10#2)
The relative standard deviation values##3##5##(2008-10#3)
The relative standard deviation was 0##3##6##(2008-10#3)
The relative standard deviation was 1##4##6##(2008-10#4)
The relative standard deviation was 2##4##6##(2008-10#4)
The relative standard deviation was 3##2##6##(2008-10#2)
The relative standard deviation was found to be##2##8##(2008-10#2)
The relative standard deviation was##20##5##(2008-10#20)
The relative standard deviation##113##4##(1994-9#1)(2008-10#111)(2010-4#1)
The relative standard deviations (R##9##5##(2008-10#9)
The relative standard deviations (RSD)##2##5##(2008-5#1)(2012-1#1)
The relative standard deviations (n =##2##6##(2008-10#1)(2011-1#1)
The relative standard deviations for ten successive##2##7##(2008-10#2)
The relative standard deviations for ten##4##6##(2008-10#4)
The relative standard deviations for##13##5##(2008-10#12)(2008-5#1)
The relative standard deviations obtained##2##5##(2008-10#1)(2008-5#1)
The relative standard deviations of repeated measurements of##2##8##(2008-10#2)
The relative standard deviations of the determinations were below 9%##2##10##(2008-10#2)
The relative standard deviations of the results were##2##8##(2008-10#1)(2008-5#1)
The relative standard deviations of the##10##6##(2008-10#9)(2008-5#1)
The relative standard deviations of##16##5##(2008-10#15)(2008-5#1)
The relative standard deviations were in all instances less than##2##10##(2008-10#2)
The relative standard deviations were##7##5##(2008-10#5)(2011-1#2)
The relative standard deviations##59##4##(2008-10#51)(2008-5#4)(2011-1#3)(2012-1#1)
The relative standard##177##3##(1994-9#1)(2008-10#167)(2008-5#4)(2010-4#1)(2011-1#3)(2012-1#1)
The relative strength of##2##4##(1996-5#1)(2007-12#1)
The relative##268##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-3#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#2)(2006-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#187)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#1)
The relatively high##2##3##(1996-11#1)(2007-12#1)
The relatively low##4##3##(1991-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
The relatively slow##2##3##(1994-5#1)(2006-6#1)
The relatively##21##2##(1991-1#2)(1994-1#1)(1994-5#1)(1995-11#1)(1996-11#1)(1996-3#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-1#1)
The relaxation time of##2##4##(1990-7#1)(2008-3#1)
The relaxation##4##2##(1990-7#1)(1991-12#1)(1995-11#1)(2008-3#1)
The release of ascospores##2##4##(2008-10#2)
The release of##17##3##(1990-8#1)(1992-11#2)(1992-3#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)(2010-5#1)(2012-6#1)
The release##24##2##(1990-8#1)(1992-11#2)(1992-3#3)(1994-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#5)(2009-11#1)(2009-12#1)(2010-5#1)(2012-6#1)
The released##2##2##(2008-4#1)(2008-7#1)
The relevance of the##5##4##(1994-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-12#1)
The relevance of these findings to##2##6##(2008-10#2)
The relevance of these results##2##5##(1993-11#1)(2008-10#1)
The relevance of these##7##4##(1993-11#1)(2008-10#3)(2008-7#2)(2012-4#1)
The relevance of this##2##4##(2008-1#1)(2010-8#1)
The relevance of##22##3##(1993-11#1)(1994-3#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-4#1)
The relevance##23##2##(1991-2#1)(1993-11#1)(1994-3#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-4#1)
The relevant literature##2##3##(2013-1#2)
The relevant parameters##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
The relevant##11##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2013-1#2)
The reliability of the entire procedure was checked with the analysis of##2##12##(2008-10#2)
The reliability of the method##4##5##(2008-10#4)
The reliability of the procedures is##2##6##(2008-10#2)
The reliability of the##14##4##(1994-3#1)(2008-10#13)
The reliability of##20##3##(1990-2#1)(1994-3#1)(1995-12#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-8#1)
The reliability was##2##3##(2008-10#1)(2013-1#1)
The reliability##27##2##(1990-2#1)(1991-9#1)(1994-3#1)(1995-12#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#1)
The remainder of the##3##4##(1993-12#1)(1994-3#1)(2010-10#1)
The remainder##7##2##(1990-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(2008-7#1)(2008-9#1)(2010-10#1)
The remaining 13##2##3##(2008-10#1)(2008-7#1)
The remaining 25%##2##3##(1992-12#1)(2010-3#1)
The remaining 3##2##3##(1993-2#1)(2008-7#1)
The remaining isolates##3##3##(2008-10#3)
The remaining patients were##2##4##(1992-5#1)(2011-1#1)
The remaining patients##3##3##(1990-11#1)(1992-5#1)(2011-1#1)
The remaining##60##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
The remarkable##9##2##(1990-11#1)(1991-6#1)(1993-8#1)(2007-12#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#1)
The remission##2##2##(2008-1#1)(2008-10#1)
The remodeling of the##2##4##(2007-8#2)
The remodeling of##3##3##(2007-8#3)
The removal of the##2##4##(2008-12#1)(2008-7#1)
The removal of##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
The removal process should not##2##5##(2011-1#1)(2011-2#1)
The removal process##3##3##(2008-2#1)(2011-1#1)(2011-2#1)
The removal##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
The renal##9##2##(2007-8#1)(2008-1#4)(2008-5#2)(2009-11#1)(2013-1#1)
The reorientation of##2##3##(2007-12#1)(2008-3#1)
The rep-PCR fingerprints##2##3##(2008-10#2)
The rep-PCR##4##2##(2008-10#4)
The repair of##3##3##(2006-12#1)(2009-5#1)(2011-2#1)
The repair##5##2##(2006-12#2)(2008-8#1)(2009-5#1)(2011-2#1)
The repeat##2##2##(2008-10#1)(2010-11#1)
The repeatability and reproducibility of the##2##6##(2008-10#1)(2008-5#1)
The repeatability and##3##3##(2008-10#2)(2008-5#1)
The repeatability for##3##3##(2008-10#3)
The repeatability of the method##2##5##(2008-10#2)
The repeatability of the proposed sensor##2##6##(2008-10#2)
The repeatability of the##10##4##(2007-11#1)(2008-10#9)
The repeatability of##11##3##(2007-11#1)(2008-10#10)
The repeatability was##3##3##(2008-10#3)
The repeatability##28##2##(2007-11#1)(2008-10#26)(2008-5#1)
The repeated##4##2##(1997-2#1)(2007-12#1)(2012-2#1)(2013-1#1)
The repetition##3##2##(1996-4#1)(2007-11#2)
The repetitive##3##2##(1993-8#1)(2007-8#1)(2011-2#1)
The replacement of##7##3##(1991-12#1)(1992-6#1)(1995-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2012-12#1)
The replication of##4##3##(1990-11#1)(2009-7#2)(2012-3#1)
The replication##6##2##(1990-11#2)(2008-3#1)(2009-7#2)(2012-3#1)
The report is##2##3##(2008-7#1)(2013-1#1)
The report of##2##3##(2007-7#1)(2013-8#1)
The report recommended##2##3##(1993-12#1)(2008-11#1)
The report##23##2##(1991-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#2)(1996-5#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
The reported case##2##3##(2008-7#1)(2012-2#1)
The reported incidence of##2##4##(2007-12#1)(2008-7#1)
The reported values##2##3##(2008-10#2)
The reported##18##2##(1991-2#1)(1993-6#1)(1994-12#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-9#1)(2012-2#2)
The reporting##3##2##(1990-3#1)(2008-10#1)(2008-6#1)
The reports on##2##3##(1996-11#1)(1996-8#1)
The reports##4##2##(1990-3#1)(1991-1#1)(1996-11#1)(1996-8#1)
The reproducibilities were s(r##2##4##(2008-10#2)
The reproducibilities##3##2##(2008-10#3)
The reproducibility between##2##3##(2008-10#2)
The reproducibility is##2##3##(2008-10#2)
The reproducibility of the##6##4##(2007-10#1)(2008-10#3)(2010-7#1)(2012-2#1)
The reproducibility of##9##3##(2007-10#1)(2008-10#6)(2010-7#1)(2012-2#1)
The reproducibility was##5##3##(2008-10#4)(2009-11#1)
The reproducibility##21##2##(2007-10#1)(2008-10#17)(2009-11#1)(2010-7#1)(2012-2#1)
The reproducible##3##2##(2008-10#2)(2008-7#1)
The reproductive success of##2##4##(2008-6#1)(2008-9#1)
The reproductive##5##2##(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)
The required relations##2##3##(2008-2#1)(2008-3#1)
The required##12##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2012-12#1)
The requirement for##3##3##(1992-3#1)(2010-5#1)(2012-1#1)
The requirement of##2##3##(1995-5#1)(2008-3#1)
The requirement##6##2##(1992-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-1#1)
The requirements for##3##3##(2008-10#2)(2008-2#1)
The requirements##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
The research described here##2##4##(2007-8#1)(2012-1#1)
The research design##2##3##(2010-3#1)(2013-1#1)
The research highlights##2##3##(1996-1#1)(2008-12#1)
The research involved##4##3##(2007-11#1)(2007-8#3)
The research material##2##3##(2007-11#1)(2012-2#1)
The research on##2##3##(1990-12#1)(2013-1#1)
The research presented##2##3##(2007-12#1)(2008-3#1)
The research reported##2##3##(2007-10#1)(2010-5#1)
The research results##2##3##(1993-1#1)(2007-11#1)
The research was conducted at##2##5##(2011-2#1)(2013-1#1)
The research was conducted##3##4##(1997-6#1)(2011-2#1)(2013-1#1)
The research was performed##2##4##(2008-7#1)(2011-1#1)
The research was##7##3##(1997-6#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
The research##51##2##(1990-10#1)(1990-12#1)(1993-1#2)(1995-3#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#5)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
The researchers##3##2##(1993-2#2)(2011-2#1)
The resected##2##2##(2008-7#1)(2013-1#1)
The resection of##2##3##(2010-12#1)(2013-1#1)
The residual##8##2##(1996-8#1)(2007-11#2)(2008-10#4)(2008-8#1)
The residue##5##2##(1995-2#1)(2008-10#3)(2008-4#1)
The resin exhibits no affinity for alkali or alkaline earth metals##2##11##(2008-10#2)
The resin was used##2##4##(2008-10#2)
The resin was##5##3##(2008-10#5)
The resin##13##2##(2008-10#12)(2008-12#1)
The resins##2##2##(2008-10#2)
The resistance gene in##2##4##(2008-10#2)
The resistance gene##6##3##(2008-10#6)
The resistance genes##2##3##(2008-10#2)
The resistance in##2##3##(2008-10#1)(2009-11#1)
The resistance is##3##3##(2008-10#2)(2011-2#1)
The resistance of##4##3##(1997-5#1)(2007-7#1)(2008-10#1)(2008-2#1)
The resistance rates##2##3##(2007-7#2)
The resistance to##2##3##(2007-10#1)(2008-10#1)
The resistance##26##2##(1997-5#1)(2007-10#1)(2007-7#3)(2008-10#17)(2008-12#1)(2008-2#1)(2009-11#1)(2011-2#1)
The resistant and##2##3##(2008-10#1)(2008-5#1)
The resistant##10##2##(2007-8#1)(2008-10#8)(2008-5#1)
The resistive##3##2##(1995-3#1)(1996-5#1)(2013-1#1)
The resolution of binary mixtures of##2##6##(2008-10#2)
The resolution of the##8##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
The resolution of##15##3##(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#5)
The resolution##27##2##(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#7)(2008-2#2)(2008-3#8)(2008-5#1)(2009-11#1)(2009-9#1)
The resolved##2##2##(2008-10#1)(2010-4#1)
The resonance assignments##2##3##(2009-7#2)
The resonance##4##2##(2007-11#1)(2008-3#1)(2009-7#2)
The resonant##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
The resonator##3##2##(2007-12#2)(2008-3#1)
The respective##5##2##(1990-5#1)(1994-9#1)(1996-2#1)(2008-10#1)(2009-6#1)
The respiratory##3##2##(2007-12#1)(2009-12#1)(2013-8#1)
The respondents showed##2##3##(2011-2#2)
The respondents were asked to##2##5##(1995-11#1)(2011-2#1)
The respondents were##4##3##(1995-11#1)(1996-2#1)(2010-8#1)(2011-2#1)
The respondents##11##2##(1995-1#1)(1995-11#1)(1996-2#1)(1996-9#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)
The response behavior of##2##4##(2008-10#2)
The response characteristics of the##2##5##(2008-10#2)
The response characteristics of##4##4##(2008-10#4)
The response characteristics##6##3##(2008-10#6)
The response current##2##3##(2008-10#2)
The response is##4##3##(2008-10#4)
The response mechanism##3##3##(2008-10#3)
The response of a##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
The response of the electrode detector as a peak-shape signal was obtained for injected##2##14##(2008-10#2)
The response of the electrode##3##5##(2008-10#3)
The response of the sensor to##2##6##(2008-10#2)
The response of the sensor##4##5##(2008-10#4)
The response of the system##2##5##(2007-12#1)(2008-10#1)
The response of the##15##4##(2007-12#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-5#1)
The response of these##2##4##(2007-11#1)(2008-10#1)
The response of##35##3##(1991-5#1)(1992-12#1)(1994-6#1)(2007-11#1)(2007-12#4)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)
The response patterns##2##3##(2008-10#1)(2008-11#1)
The response range of##2##4##(2008-10#2)
The response rate was##13##4##(1990-9#1)(1991-3#1)(1994-7#1)(1995-4#1)(1995-8#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
The response rate##17##3##(1990-9#1)(1991-3#1)(1991-8#1)(1994-7#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
The response time for##3##4##(2008-10#2)(2010-5#1)
The response time of electrode##2##5##(2008-10#2)
The response time of the electrode is less than##2##9##(2008-10#2)
The response time of the electrode is##3##7##(2008-10#3)
The response time of the electrode was##2##7##(2008-10#2)
The response time of the electrode##5##6##(2008-10#5)
The response time of the sensor is##2##7##(2008-10#2)
The response time of the##9##5##(2008-10#9)
The response time of##12##4##(2008-10#12)
The response time##19##3##(2008-10#17)(2010-5#1)(2013-1#1)
The response times were##2##4##(2008-10#1)(2008-2#1)
The response to the inquiry was 67% (non-responders did not otherwise differ from responders)##2##14##(1991-8#2)
The response to the##3##4##(1990-12#1)(1991-8#2)
The response to treatment##2##4##(1996-6#1)(2010-3#1)
The response to##21##3##(1990-12#1)(1991-3#1)(1991-8#2)(1992-11#1)(1993-3#1)(1995-12#2)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-7#2)(2010-3#1)(2012-3#1)
The response was linear over##3##5##(2008-10#3)
The response was linear##6##4##(1996-12#1)(1997-2#1)(2008-10#4)
The response was##10##3##(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#7)
The response##137##2##(1990-12#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-8#3)(1992-11#1)(1992-12#1)(1993-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#72)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-3#2)(2013-1#1)
The responses of the##2##4##(2008-10#1)(2008-9#1)
The responses of##11##3##(1990-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-9#1)(2012-3#1)(2012-5#1)
The responses to##4##3##(1990-7#1)(2008-8#2)(2009-2#1)
The responses were##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
The responses##19##2##(1990-12#1)(1990-7#1)(1992-4#1)(1995-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-3#1)(2012-5#1)
The responsible##2##2##(2007-12#1)(2011-2#1)
The responsivity##2##2##(2007-12#1)(2008-3#1)
The rest of the##3##4##(1991-5#1)(2010-2#1)(2010-8#1)
The rest##6##2##(1991-5#1)(1992-2#1)(1995-5#1)(2008-10#1)(2010-2#1)(2010-8#1)
The resting##2##2##(1994-3#1)(2008-4#1)
The restoration of##4##3##(2007-11#1)(2007-8#1)(2008-11#1)(2013-7#1)
The restoration##5##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2013-7#1)
The restricted##2##2##(2008-10#2)
The restriction endonuclease##2##3##(1991-2#1)(2012-3#1)
The restriction##3##2##(1991-2#1)(1997-2#1)(2012-3#1)
The result demonstrated that the##2##5##(2008-8#1)(2013-8#1)
The result demonstrated that##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
The result demonstrates##2##3##(2007-11#1)(2012-2#1)
The result indicated that the##2##5##(2008-1#1)(2008-8#1)
The result indicated that##6##4##(2008-1#1)(2008-8#4)(2008-9#1)
The result indicates that##5##4##(1992-5#1)(1994-11#1)(2008-5#1)(2009-9#1)(2012-2#1)
The result is a##8##4##(1991-1#1)(2006-7#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-3#1)
The result is that##3##4##(1991-12#1)(2008-10#1)(2008-3#1)
The result is the##2##4##(1996-12#1)(2008-3#1)
The result is##17##3##(1991-1#1)(1991-12#1)(1992-3#1)(1996-12#1)(1996-3#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2010-3#1)
The result obtained##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
The result of SDS-PAGE##2##4##(2008-4#1)(2008-8#1)
The result of the study##2##5##(1990-2#1)(2010-4#1)
The result of the##7##4##(1990-2#1)(1993-12#1)(1995-8#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-4#1)
The result of this study showed that 53##2##8##(2013-1#2)
The result of this study shows##2##6##(1995-6#1)(2008-7#1)
The result of this study##4##5##(1995-6#1)(2008-7#1)(2013-1#2)
The result of this##5##4##(1995-6#1)(2008-7#1)(2010-8#1)(2013-1#2)
The result of##26##3##(1990-2#1)(1991-7#1)(1993-12#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
The result reveals##2##3##(2010-11#1)(2010-8#1)
The result showed that the##4##5##(1997-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
The result showed that##13##4##(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
The result shows that##4##4##(2008-10#3)(2013-8#1)
The result shows##7##3##(2007-11#1)(2008-10#4)(2010-5#1)(2013-8#1)
The result suggests that the##2##5##(1997-3#1)(2008-10#1)
The result suggests that##5##4##(1997-3#1)(2008-10#1)(2010-7#1)(2012-12#1)(2013-1#1)
The result was a##2##4##(1996-12#1)(2008-12#1)
The result was##4##3##(1994-2#1)(1996-12#1)(2008-12#1)(2011-2#1)
The result##109##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-11#4)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#14)(2008-9#5)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#4)
The resultant spatial##2##3##(2008-10#1)(2011-2#1)
The resultant##35##2##(1990-5#1)(1991-10#1)(1991-11#1)(1994-12#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#2)(2008-8#1)(2009-11#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#3)(2013-1#1)
The resulting blots are studied by hybridization analysis with labeled DNA or RNA probes##2##14##(2008-4#2)
The resulting chelating resin##2##4##(2008-10#2)
The resulting clones were##2##4##(1994-12#1)(2008-10#1)
The resulting complex##2##3##(2007-11#1)(2008-10#1)
The resulting data##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
The resulting derivative##2##3##(2008-10#1)(2008-9#1)
The resulting dynamic##2##3##(2007-11#1)(2009-10#1)
The resulting equation##2##3##(2008-2#2)
The resulting equations##3##3##(2008-10#2)(2008-2#1)
The resulting expression##2##3##(1990-5#1)(2010-7#1)
The resulting fusion protein was##2##5##(1994-8#1)(2008-10#1)
The resulting fusion protein##3##4##(1994-8#1)(2008-10#1)(2008-4#1)
The resulting high##2##3##(1995-12#1)(2008-3#1)
The resulting hybrid##3##3##(1990-11#1)(2007-11#1)(2012-3#1)
The resulting image##2##3##(1995-6#1)(2012-1#1)
The resulting mass##2##3##(1993-8#1)(2008-9#1)
The resulting membrane##2##3##(2008-10#1)(2010-12#1)
The resulting method##2##3##(2008-10#2)
The resulting mutant##2##3##(1990-7#1)(1994-5#1)
The resulting recombinant##2##3##(2008-6#1)(2008-8#1)
The resulting resin has been characterized by##2##7##(2008-10#2)
The resulting solution##2##3##(2008-10#2)
The resulting solutions##2##3##(1995-1#1)(2007-10#1)
The resulting##173##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#2)(1991-6#3)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#1)(2008-1#2)(2008-10#47)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#19)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)
The results above##2##3##(2008-8#2)
The results add to##2##4##(1994-11#1)(1995-5#1)
The results agree with those##2##5##(2008-10#2)
The results agree##3##3##(2008-10#3)
The results also indicate that the##2##6##(1990-8#1)(1995-6#1)
The results also indicate that##6##5##(1990-8#1)(1992-8#1)(1995-6#1)(2007-12#1)(2008-7#1)(2013-1#1)
The results also indicate##8##4##(1990-8#1)(1992-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#2)
The results also revealed##2##4##(1992-3#1)(2008-9#1)
The results also show that##3##5##(1990-12#1)(1991-12#1)(2008-3#1)
The results also show##6##4##(1990-12#1)(1991-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
The results also showed that##4##5##(2007-12#1)(2008-7#1)(2008-9#1)(2012-1#1)
The results also suggest that the##2##6##(2008-6#1)(2008-8#1)
The results also suggest that##6##5##(1993-3#1)(2008-10#3)(2008-6#1)(2008-8#1)
The results also suggest##7##4##(1993-3#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-8#1)
The results also##37##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-6#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
The results and##5##3##(1992-3#1)(2007-11#1)(2008-11#1)(2008-3#2)
The results are applicable to##2##5##(2008-3#2)
The results are as follows##2##5##(1992-10#1)(1994-5#1)
The results are compared to##3##5##(1991-8#1)(2008-10#1)(2008-8#1)
The results are compared with the##4##6##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
The results are compared with those obtained from##3##8##(2008-10#2)(2008-2#1)
The results are compared with those obtained with##2##8##(2008-10#1)(2008-3#1)
The results are compared with those obtained##7##7##(2008-10#3)(2008-2#1)(2008-3#3)
The results are compared with those##9##6##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#4)
The results are compared with##17##5##(1992-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#7)
The results are compared##21##4##(1991-8#1)(1992-2#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#7)(2008-8#1)
The results are consistent with the hypothesis that##3##8##(1992-12#1)(1993-8#1)(1995-2#1)
The results are consistent with the##9##6##(1991-1#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#1)
The results are consistent with##11##5##(1991-1#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-10#2)
The results are discussed and compared##2##6##(1993-11#1)(2010-3#1)
The results are discussed in light of##2##7##(2008-10#1)(2008-8#1)
The results are discussed in relation to the##3##8##(1990-12#1)(1992-12#1)(2008-7#1)
The results are discussed in relation to##4##7##(1990-12#1)(1992-12#1)(1993-6#1)(2008-7#1)
The results are discussed in terms of the##6##8##(1990-11#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#1)(2012-1#1)
The results are discussed in terms of##13##7##(1990-11#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-5#2)(2012-1#1)
The results are discussed in the context of##2##8##(1996-5#1)(2008-9#1)
The results are discussed in the##3##6##(1996-5#1)(2008-10#1)(2008-9#1)
The results are discussed in##22##5##(1990-11#1)(1990-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#2)(1995-11#1)(1995-12#1)(1996-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
The results are discussed with##2##5##(1995-12#1)(2011-1#1)
The results are discussed##30##4##(1990-11#1)(1990-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#2)(1995-11#1)(1995-12#2)(1996-5#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)
The results are evaluated##2##4##(2008-10#1)(2010-8#1)
The results are in accord with##2##6##(2007-12#1)(2008-3#1)
The results are in good agreement with a##2##8##(2007-12#1)(2008-3#1)
The results are in good agreement with those obtained##2##9##(2008-10#1)(2008-3#1)
The results are in good agreement with those##3##8##(2008-10#1)(2008-2#1)(2008-3#1)
The results are in good agreement with##5##7##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
The results are in good##6##5##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
The results are in##11##4##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)
The results are intended to##2##5##(2009-7#1)(2010-9#1)
The results are interpreted in terms of##3##7##(2007-12#1)(2008-2#1)(2009-10#1)
The results are not##2##4##(2008-10#1)(2008-5#1)
The results are presented as an interpretation of the participants' perceptions of their spirituality and spiritual experiences##2##17##(2013-1#2)
The results are presented in the form of##3##8##(2007-11#1)(2008-10#1)(2008-4#1)
The results are presented##8##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#3)
The results are shown##2##4##(2008-3#2)
The results are##128##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#9)(2007-12#7)(2008-10#20)(2008-12#1)(2008-2#11)(2008-3#19)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-1#1)(2013-1#4)(2013-8#1)
The results can be explained##2##5##(1994-5#1)(2008-7#1)
The results can be used to##2##6##(2008-2#1)(2010-5#1)
The results can be##5##4##(1990-12#1)(1994-5#1)(2008-2#1)(2008-7#1)(2010-5#1)
The results can##6##3##(1990-12#1)(1994-5#1)(1997-2#1)(2008-2#1)(2008-7#1)(2010-5#1)
The results clearly demonstrate that##2##5##(1994-6#1)(2008-5#1)
The results clearly indicate that##2##5##(2008-4#1)(2013-1#1)
The results clearly show that##3##5##(1990-5#1)(1991-9#1)(2008-7#1)
The results clearly show##4##4##(1990-2#1)(1990-5#1)(1991-9#1)(2008-7#1)
The results clearly showed that##2##5##(1993-11#1)(2008-5#1)
The results clearly##11##3##(1990-2#1)(1990-5#1)(1991-9#1)(1993-11#1)(1994-6#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)
The results confirm that the##2##5##(2008-10#1)(2008-8#1)
The results confirm that##7##4##(1994-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2013-1#1)
The results confirm the##3##4##(2008-11#2)(2008-3#1)
The results confirm##11##3##(1994-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2012-3#1)(2013-1#1)
The results confirmed##2##3##(1994-8#1)(2010-6#1)
The results could be##2##4##(2008-3#1)(2008-5#1)
The results demonstrate a##2##4##(1993-3#1)(1996-5#1)
The results demonstrate that the##10##5##(1991-12#1)(1991-5#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)
The results demonstrate that these metal ions are extracted into##2##10##(2008-10#2)
The results demonstrate that these##3##5##(2008-10#3)
The results demonstrate that##37##4##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-2#2)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
The results demonstrate the##10##4##(1990-9#1)(1993-9#1)(1995-11#1)(1995-9#1)(2007-12#2)(2008-10#2)(2008-3#2)
The results demonstrate##53##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
The results demonstrated a##2##4##(2008-7#1)(2009-9#1)
The results demonstrated that the##7##5##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)
The results demonstrated that##22##4##(1990-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1995-4#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#3)
The results demonstrated the##2##4##(2008-10#1)(2008-8#1)
The results demonstrated##31##3##(1990-6#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#1)(1995-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
The results depend on three parameters##2##6##(2008-10#2)
The results determined##2##3##(2008-10#1)(2013-1#1)
The results do not support the##2##6##(1990-2#1)(2008-8#1)
The results do not support##3##5##(1990-2#1)(2007-12#1)(2008-8#1)
The results emphasize the importance of##2##6##(1991-12#1)(1997-2#1)
The results emphasize the##3##4##(1991-12#1)(1997-2#1)(2008-5#1)
The results emphasize##4##3##(1991-12#1)(1997-2#1)(2008-12#1)(2008-5#1)
The results enable##2##3##(2008-2#1)(2011-2#1)
The results exemplify##2##3##(2008-10#1)(2008-9#1)
The results exhibited##2##3##(2008-10#1)(2013-8#1)
The results for the##2##4##(2008-10#1)(2012-1#1)
The results for##15##3##(1997-1#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
The results found##2##3##(2008-10#1)(2009-7#1)
The results from the present study##2##6##(1992-8#1)(2008-10#1)
The results from the##11##4##(1992-6#1)(1992-8#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#2)
The results from these studies demonstrate that yeast is a viable trace metal enrichment##2##14##(2008-10#2)
The results from these##3##4##(1992-10#1)(2008-10#2)
The results from this study##6##5##(2008-10#3)(2008-5#1)(2010-7#1)(2010-8#1)
The results from this##10##4##(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2010-7#1)(2010-8#1)(2012-1#1)
The results from##35##3##(1992-10#1)(1992-6#1)(1992-8#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
The results further##2##3##(1991-1#1)(2008-7#1)
The results give##2##3##(2007-12#1)(2008-3#1)
The results has been##2##4##(1990-3#1)(1995-2#1)
The results have been discussed in##2##6##(2008-10#2)
The results have been##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
The results have implications for##2##5##(1994-6#1)(2008-8#1)
The results have shown that##2##5##(2008-3#1)(2013-1#1)
The results have shown##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
The results have##17##3##(1994-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-3#1)(2013-1#1)
The results here##2##3##(1995-3#1)(2008-10#1)
The results herein presented prove##2##5##(2010-10#2)
The results highlight the##3##4##(2008-5#1)(2012-12#1)(2012-2#1)
The results highlight##4##3##(1993-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
The results hold##2##3##(2008-10#1)(2008-3#1)
The results illustrate the##4##4##(1994-9#1)(2007-12#1)(2008-3#1)(2011-2#1)
The results illustrate##5##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
The results imply that##6##4##(1995-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
The results imply##7##3##(1992-2#1)(1995-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
The results in this##2##4##(1995-11#1)(2007-7#1)
The results in##5##3##(1992-2#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-6#1)
The results indicate a##7##4##(1995-11#2)(1995-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
The results indicate that both##2##5##(1996-12#1)(1997-4#1)
The results indicate that in the##2##6##(1994-3#1)(1997-1#1)
The results indicate that in##4##5##(1994-3#1)(1997-1#1)(2008-10#1)(2008-8#1)
The results indicate that it##3##5##(2008-3#2)(2008-4#1)
The results indicate that some##2##5##(1995-12#1)(2008-5#1)
The results indicate that the stationary phase behaves as a##2##10##(2008-10#2)
The results indicate that the##47##5##(1990-11#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-2#2)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The results indicate that there##3##5##(1992-12#1)(2008-5#2)
The results indicate that these##2##5##(1994-5#1)(2008-10#1)
The results indicate that this##2##5##(1993-6#1)(2008-10#1)
The results indicate that##139##4##(1990-11#2)(1990-8#1)(1990-9#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
The results indicate the##4##4##(1992-3#1)(1994-3#1)(2008-10#1)(2008-3#1)
The results indicate##157##3##(1990-11#2)(1990-8#1)(1990-9#1)(1991-3#1)(1992-12#2)(1992-3#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
The results indicated a significantly##2##5##(2008-11#1)(2008-12#1)
The results indicated a##8##4##(1992-2#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)
The results indicated for##2##4##(1997-7#1)(2009-2#1)
The results indicated that a##3##5##(1993-3#1)(1996-2#1)(2008-5#1)
The results indicated that the##33##5##(1994-3#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-3#3)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
The results indicated that there was a##2##7##(2008-10#2)
The results indicated that there was##3##6##(1996-5#1)(2008-10#2)
The results indicated that##77##4##(1990-12#1)(1992-12#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-5#2)(1996-6#2)(2007-11#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
The results indicated##96##3##(1990-11#1)(1990-12#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-7#1)(2007-11#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#3)
The results may##2##3##(2008-3#1)(2010-8#1)
The results obtained agree##2##4##(2008-10#2)
The results obtained analysing##2##4##(2008-10#2)
The results obtained are compared with those##2##7##(1997-8#1)(2008-3#1)
The results obtained are compared with##3##6##(1997-8#1)(2008-3#2)
The results obtained are compared##4##5##(1997-8#1)(2008-11#1)(2008-3#2)
The results obtained are consistent with##2##6##(2008-10#2)
The results obtained are discussed in terms of##2##8##(2008-10#1)(2009-9#1)
The results obtained are in##2##5##(2008-10#2)
The results obtained are##15##4##(1997-8#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)
The results obtained by the proposed method were##2##8##(2008-10#2)
The results obtained by the proposed##4##6##(2008-10#4)
The results obtained by the##9##5##(1996-5#1)(2008-10#8)
The results obtained by this method agreed with those by the official method##2##13##(2008-10#2)
The results obtained by this method##3##6##(2008-10#3)
The results obtained by this##4##5##(2008-10#4)
The results obtained by##18##4##(1996-5#1)(2008-10#17)
The results obtained can##2##4##(2008-10#1)(2013-1#1)
The results obtained confirm that the##2##6##(2008-10#1)(2008-7#1)
The results obtained demonstrate the##2##5##(2008-10#2)
The results obtained demonstrate##3##4##(2008-10#3)
The results obtained demonstrated that##2##5##(1996-12#1)(1997-7#1)
The results obtained for the determination of##2##7##(2008-10#2)
The results obtained for the##6##5##(2008-10#6)
The results obtained for##24##4##(1996-2#1)(2008-10#22)(2008-3#1)
The results obtained from the##3##5##(2008-10#2)(2008-5#1)
The results obtained from this##2##5##(2008-2#1)(2010-8#1)
The results obtained from##9##4##(2008-10#6)(2008-2#1)(2008-5#1)(2010-8#1)
The results obtained here##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
The results obtained in the##7##5##(1992-9#1)(2008-10#4)(2008-5#1)(2009-12#1)
The results obtained in this##2##5##(2008-10#1)(2008-7#1)
The results obtained in##13##4##(1992-9#2)(2008-10#7)(2008-5#2)(2008-7#1)(2009-12#1)
The results obtained indicate that the##2##6##(2008-10#1)(2008-5#1)
The results obtained indicate that##6##5##(1991-9#1)(1992-8#1)(2008-10#3)(2008-5#1)
The results obtained indicate##9##4##(1991-9#1)(1992-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
The results obtained indicated##3##4##(1991-5#1)(2008-10#2)
The results obtained provide##2##4##(2008-10#1)(2008-5#1)
The results obtained show that the##4##6##(1990-8#1)(1991-12#1)(2008-10#1)(2008-2#1)
The results obtained show that##7##5##(1990-8#1)(1991-12#1)(2008-10#4)(2008-2#1)
The results obtained show##10##4##(1990-8#1)(1991-12#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-5#1)
The results obtained showed that##4##5##(1993-3#1)(2008-10#2)(2013-7#1)
The results obtained showed##5##4##(1993-3#1)(2008-10#3)(2013-7#1)
The results obtained suggest that the##2##6##(2008-10#1)(2008-5#1)
The results obtained suggest that##4##5##(1990-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
The results obtained using this method were##2##7##(2008-10#2)
The results obtained using this##3##5##(2008-10#3)
The results obtained using##5##4##(2008-10#4)(2008-6#1)
The results obtained were compared to##2##6##(2008-4#1)(2010-4#1)
The results obtained were compared with the##3##7##(2008-10#1)(2008-5#1)(2012-3#1)
The results obtained were compared with those achieved by##2##9##(2008-10#2)
The results obtained were compared with those##3##7##(2008-10#3)
The results obtained were compared with##6##6##(2008-10#4)(2008-5#1)(2012-3#1)
The results obtained were compared##9##5##(2008-10#5)(2008-4#1)(2008-5#1)(2010-4#1)(2012-3#1)
The results obtained were used to##2##6##(2007-11#1)(2010-5#1)
The results obtained were validated by##2##6##(2008-10#2)
The results obtained were##16##4##(2007-11#1)(2008-10#10)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-3#1)
The results obtained with the##8##5##(2008-10#4)(2008-3#1)(2011-2#2)(2012-1#1)
The results obtained with this##3##5##(2008-10#3)
The results obtained with##19##4##(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-1#1)(2012-12#1)
The results obtained##188##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#120)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
The results of a series of##2##6##(2008-3#1)(2008-4#1)
The results of a##14##4##(1990-8#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-8#1)(1997-2#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)
The results of an open##2##5##(1990-12#1)(1991-8#1)
The results of an##8##4##(1990-12#1)(1991-8#1)(1997-2#1)(2007-11#1)(2008-3#2)(2010-4#1)(2013-8#1)
The results of analysis##2##4##(2010-5#1)(2013-1#1)
The results of applying the H-point standard addition method showed that##2##11##(2008-10#2)
The results of applying the##3##5##(2008-10#2)(2008-2#1)
The results of applying##4##4##(2008-10#2)(2008-2#1)(2012-2#1)
The results of both the##2##5##(1996-6#1)(2008-7#1)
The results of both##5##4##(1992-12#1)(1996-6#1)(2008-3#1)(2008-7#2)
The results of clinical trials##2##5##(1993-12#1)(2008-7#1)
The results of determination for three human serum samples##2##9##(2008-10#2)
The results of determination for##3##5##(2008-10#3)
The results of determination of##2##5##(2008-10#2)
The results of determination##5##4##(2008-10#5)
The results of investigation##2##4##(2007-11#1)(2008-10#1)
The results of method detection limit and accuracy and precision studies are reported##2##13##(2008-10#2)
The results of our current study##2##6##(2013-8#2)
The results of our study show##2##6##(2008-1#1)(2008-3#1)
The results of our study##5##5##(1992-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
The results of our##13##4##(1992-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
The results of preliminary##3##4##(1997-2#1)(2007-11#2)
The results of several##2##4##(2008-10#1)(2008-5#1)
The results of studies##2##4##(2008-10#1)(2008-8#1)
The results of such##2##4##(1994-12#1)(1996-12#1)
The results of tests##2##4##(2008-10#1)(2008-3#1)
The results of the analysis of##2##6##(2008-10#2)
The results of the analysis##5##5##(1995-12#1)(2008-10#2)(2008-3#1)(2010-5#1)
The results of the current study##2##6##(2008-10#1)(2011-2#1)
The results of the experiments##2##5##(2008-3#1)(2008-7#1)
The results of the present study indicate that##3##8##(2008-10#1)(2008-12#1)(2010-2#1)
The results of the present study strongly support the##2##9##(1994-3#1)(2008-10#1)
The results of the present study suggest that##3##8##(2007-12#1)(2008-2#1)(2012-5#1)
The results of the present study##14##6##(1994-3#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#2)(2010-2#1)(2011-7#1)(2012-5#1)
The results of the present##18##5##(1992-11#1)(1994-3#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#2)(2010-2#1)(2011-7#1)(2012-5#1)(2013-8#1)
The results of the research##2##5##(1990-12#1)(2008-10#1)
The results of the study demonstrated that##2##7##(1996-1#1)(2012-12#1)
The results of the study show that##2##7##(1991-5#1)(2008-7#1)
The results of the study were##2##6##(1990-10#1)(1992-3#1)
The results of the study##13##5##(1990-10#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-1#1)(1996-1#2)(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-12#1)
The results of the survey showed that##2##7##(2008-10#1)(2008-12#1)
The results of the survey##3##5##(2008-10#2)(2008-12#1)
The results of the##91##4##(1990-10#1)(1990-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-7#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#8)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
The results of these analyses##2##5##(2008-10#1)(2008-2#1)
The results of these experiments indicated that##2##7##(2008-10#1)(2008-6#1)
The results of these experiments##4##5##(1994-3#1)(2008-10#2)(2008-6#1)
The results of these studies are##3##6##(1991-9#1)(2007-8#1)(2012-1#1)
The results of these studies provide new understanding##2##8##(2008-5#2)
The results of these studies provide##3##6##(1992-11#1)(2008-5#2)
The results of these studies##11##5##(1991-9#1)(1992-11#1)(1996-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-1#1)
The results of these tests##2##5##(2007-11#1)(2008-5#1)
The results of these##28##4##(1991-9#1)(1992-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2012-1#1)(2013-1#1)
The results of this analysis##7##5##(1991-9#1)(1994-11#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)
The results of this case##2##5##(2008-12#1)(2012-12#1)
The results of this research show that##2##7##(1991-2#1)(2010-10#1)
The results of this research show##3##6##(1991-2#1)(2008-10#1)(2010-10#1)
The results of this research##5##5##(1991-2#1)(1995-2#1)(1997-1#1)(2008-10#1)(2010-10#1)
The results of this review##2##5##(2011-2#1)(2012-2#1)
The results of this study are##3##6##(1994-3#1)(2008-3#1)(2008-7#1)
The results of this study demonstrate that##3##7##(2008-10#2)(2008-5#1)
The results of this study demonstrate the##2##7##(1997-3#1)(2006-12#1)
The results of this study demonstrate##5##6##(1997-3#1)(2006-12#1)(2008-10#2)(2008-5#1)
The results of this study demonstrated that##3##7##(1992-9#1)(2008-7#1)(2008-9#1)
The results of this study highlight##2##6##(1995-1#1)(2008-12#1)
The results of this study indicate that in##2##8##(1990-5#1)(1991-11#1)
The results of this study indicate that the##2##8##(1996-3#1)(2009-7#1)
The results of this study indicate that##12##7##(1990-5#1)(1991-11#1)(1995-1#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-6#2)(2009-7#1)(2011-2#1)
The results of this study indicate##13##6##(1990-5#1)(1991-11#1)(1995-1#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-7#1)(2011-2#1)
The results of this study indicated that##3##7##(1993-12#1)(2008-11#1)(2008-12#1)
The results of this study revealed that##2##7##(2007-12#1)(2008-5#1)
The results of this study show that##3##7##(2008-10#1)(2010-2#1)(2011-2#1)
The results of this study show##4##6##(2008-10#1)(2010-2#1)(2010-3#1)(2011-2#1)
The results of this study showed that##2##7##(2008-12#2)
The results of this study showed##3##6##(2007-2#1)(2008-12#2)
The results of this study strongly##2##6##(2008-10#1)(2008-7#1)
The results of this study suggest that##6##7##(1990-2#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
The results of this study suggest##7##6##(1990-2#1)(1991-3#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
The results of this study were##2##6##(1991-2#1)(2008-11#1)
The results of this study will##2##6##(2008-10#1)(2008-5#1)
The results of this study##67##5##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-11#3)(2008-12#6)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2013-1#2)
The results of this survey indicate##2##6##(1990-3#1)(2008-12#1)
The results of this survey##4##5##(1990-3#1)(1996-1#1)(2008-1#1)(2008-12#1)
The results of this work show##2##6##(2008-12#1)(2010-8#1)
The results of this##102##4##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#13)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
The results of treatment of##2##5##(1995-5#1)(2011-1#1)
The results of treatment##5##4##(1992-2#1)(1995-5#1)(2007-11#1)(2008-7#1)(2011-1#1)
The results of##405##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-5#5)(1997-8#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-8#2)(2008-1#4)(2008-10#73)(2008-11#8)(2008-12#23)(2008-2#11)(2008-3#25)(2008-4#3)(2008-5#19)(2008-6#6)(2008-7#13)(2008-8#8)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#5)
The results on##4##3##(1990-12#1)(1997-5#1)(1997-8#1)(2013-8#1)
The results point to the##2##5##(1990-6#1)(1995-3#1)
The results point to##4##4##(1990-6#1)(1991-10#1)(1994-2#1)(1995-3#1)
The results point##5##3##(1990-6#1)(1991-10#1)(1994-2#1)(1995-3#1)(2008-10#1)
The results presented here also##2##5##(2007-12#1)(2008-8#1)
The results presented here suggest that##2##6##(2008-10#1)(2008-7#1)
The results presented here##11##4##(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)
The results presented in this paper##2##6##(1991-9#1)(1993-6#1)
The results presented in this study##2##6##(2008-10#1)(2008-7#1)
The results presented in this##4##5##(1991-9#1)(1993-6#1)(2008-10#1)(2008-7#1)
The results presented in##5##4##(1991-9#1)(1993-6#1)(2008-10#2)(2008-7#1)
The results presented indicate that##2##5##(1990-12#1)(2008-10#1)
The results presented##23##3##(1990-12#1)(1991-9#1)(1993-6#1)(1995-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-8#1)
The results provide a##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
The results provide evidence that##3##5##(1993-12#1)(2008-10#2)
The results provide evidence##4##4##(1993-12#1)(2008-10#2)(2009-7#1)
The results provide##14##3##(1990-7#1)(1992-2#1)(1993-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
The results provided##2##3##(2008-10#2)
The results reported##2##3##(2008-10#1)(2009-5#1)
The results reveal that the##3##5##(1994-1#1)(2011-2#1)(2012-2#1)
The results reveal that##8##4##(1993-12#1)(1994-1#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
The results reveal##10##3##(1993-12#1)(1994-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)
The results revealed a##2##4##(2007-7#1)(2008-8#1)
The results revealed significant##2##4##(2008-12#1)(2009-7#1)
The results revealed that the##2##5##(2008-10#1)(2008-5#1)
The results revealed that there##2##5##(2007-10#1)(2008-12#1)
The results revealed that##17##4##(1991-6#1)(1992-2#1)(1994-12#1)(1994-2#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2013-1#1)
The results revealed the##2##4##(1991-2#1)(2008-10#1)
The results revealed##27##3##(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-12#1)(1994-2#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#2)(2013-1#1)
The results seem to indicate##2##5##(1997-8#1)(2008-7#1)
The results seem to##4##4##(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)
The results seem##5##3##(1990-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)
The results should##2##3##(2010-4#1)(2011-2#1)
The results show a clear##2##5##(2008-5#1)(2008-6#1)
The results show a high##2##5##(1993-8#1)(2008-5#1)
The results show a##14##4##(1990-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
The results show an##2##4##(2008-10#1)(2008-2#1)
The results show that Bi2WO6 sample##2##6##(2013-8#2)
The results show that a##6##5##(1990-12#1)(1994-2#1)(2006-6#1)(2008-3#1)(2008-7#1)(2013-8#1)
The results show that all##2##5##(1992-3#1)(1995-9#1)
The results show that although##3##5##(2008-3#1)(2008-5#1)(2013-7#1)
The results show that at##2##5##(2008-10#1)(2011-1#1)
The results show that both the##2##6##(1997-2#1)(2008-10#1)
The results show that both##5##5##(1993-3#1)(1997-2#1)(2008-10#2)(2008-2#1)
The results show that in the##2##6##(1994-8#1)(2008-3#1)
The results show that in##4##5##(1994-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
The results show that many##2##5##(1992-6#1)(1997-4#1)
The results show that our##2##5##(2008-5#1)(2011-2#1)
The results show that the average##2##6##(2008-2#1)(2011-2#1)
The results show that the calix[8]arene-bonded phase exhibits high##2##9##(2008-10#2)
The results show that the calix[8]arene-bonded phase exhibits##3##8##(2008-10#3)
The results show that the surface##2##6##(2008-10#1)(2008-2#1)
The results show that the##72##5##(1991-12#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#22)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-6#2)(2008-8#8)(2008-9#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#7)
The results show that there is##4##6##(1991-9#1)(1992-8#1)(2008-10#1)(2008-2#1)
The results show that there##5##5##(1991-9#1)(1992-8#1)(1994-9#1)(2008-10#1)(2008-2#1)
The results show that this##4##5##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
The results show that##189##4##(1990-11#1)(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#45)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#15)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#13)
The results show the effectiveness of##2##6##(1996-12#1)(2010-4#1)
The results show the##7##4##(1990-12#1)(1996-12#1)(2007-12#1)(2008-10#3)(2010-4#1)
The results show##227##3##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#2)(1997-2#1)(1997-4#1)(2006-6#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#54)(2008-11#2)(2008-12#2)(2008-2#12)(2008-3#18)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#4)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#15)
The results showed a significant##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
The results showed a statistically significant##3##6##(2008-12#1)(2012-3#1)(2013-1#1)
The results showed a##15##4##(1991-9#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
The results showed an##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
The results showed high##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
The results showed no##2##4##(1991-4#1)(2012-12#1)
The results showed significant##2##4##(2010-3#1)(2010-8#1)
The results showed that (i) the##2##6##(2008-9#2)
The results showed that (i)##3##5##(2008-8#1)(2008-9#2)
The results showed that a##2##5##(2009-5#1)(2010-12#1)
The results showed that after##2##5##(2008-12#1)(2013-8#1)
The results showed that in##5##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
The results showed that neither##2##5##(2007-11#1)(2008-6#1)
The results showed that nurses##2##5##(2012-3#2)
The results showed that simultaneous##2##5##(2008-10#2)
The results showed that the method##2##6##(2008-10#2)
The results showed that the proposed method is simple##2##9##(2008-10#2)
The results showed that the proposed method##3##7##(2008-10#2)(2008-5#1)
The results showed that the proposed##4##6##(2008-10#3)(2008-5#1)
The results showed that the##59##5##(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#7)(2008-9#6)(2009-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#3)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
The results showed that there were##2##6##(2008-12#2)
The results showed that there##4##5##(2008-12#2)(2008-8#1)(2011-2#1)
The results showed that these##3##5##(1996-1#1)(2008-10#1)(2008-9#1)
The results showed that trace enrichment of the metals under study with yeast##2##13##(2008-10#2)
The results showed that##167##4##(1990-12#2)(1990-8#1)(1991-5#1)(1993-6#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#36)(2008-11#12)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#4)(2008-8#16)(2008-9#17)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#4)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#8)
The results showed the##10##4##(1993-1#1)(2008-10#2)(2008-5#3)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
The results showed##212##3##(1990-12#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-6#1)(1994-9#1)(1995-12#4)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#44)(2008-11#12)(2008-12#10)(2008-3#2)(2008-4#2)(2008-5#13)(2008-6#4)(2008-8#18)(2008-9#18)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2011-3#4)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#9)
The results strongly##2##3##(1994-6#1)(2008-5#1)
The results suggest a possible##2##5##(1991-5#1)(1993-6#1)
The results suggest a##7##4##(1991-12#1)(1991-5#2)(1992-11#1)(1993-6#2)(1994-3#1)
The results suggest that 5-HT##2##5##(1990-5#1)(1993-12#1)
The results suggest that a##4##5##(2008-10#2)(2008-7#1)(2008-8#1)
The results suggest that although##2##5##(1991-4#1)(1997-3#1)
The results suggest that for##2##5##(1992-11#1)(2008-7#1)
The results suggest that in##3##5##(1990-2#1)(1993-3#2)
The results suggest that the effect of##2##7##(1994-3#1)(1996-12#1)
The results suggest that the##43##5##(1990-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#3)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The results suggest that there may be##2##7##(2008-12#1)(2011-2#1)
The results suggest that this##2##5##(1993-9#1)(2008-3#1)
The results suggest that##147##4##(1990-11#1)(1990-2#2)(1990-5#4)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#3)(1992-12#3)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-3#3)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#23)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#5)(2009-10#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#2)
The results suggest the need for##2##6##(1995-1#1)(2008-9#1)
The results suggest the##8##4##(1993-12#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-9#1)
The results suggest##173##3##(1990-11#1)(1990-2#2)(1990-5#4)(1991-12#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#4)(1992-12#3)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#2)(1993-3#3)(1993-6#5)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#2)
The results suggested that the##6##5##(1997-8#1)(2008-10#1)(2008-8#2)(2010-4#1)(2011-3#1)
The results suggested that##14##4##(1996-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-4#1)(2011-3#1)(2012-1#1)(2013-1#1)
The results suggested##15##3##(1996-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)(2013-1#1)
The results support a##3##4##(1993-11#1)(2008-5#1)(2008-7#1)
The results support the hypothesis that the##2##7##(1994-9#1)(2008-10#1)
The results support the hypothesis that##5##6##(1992-7#1)(1994-9#1)(1996-12#1)(2008-10#2)
The results support the##12##4##(1992-12#1)(1992-7#1)(1994-9#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-8#3)(2009-12#1)(2010-3#1)
The results support##21##3##(1992-12#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2010-3#1)(2010-8#1)(2013-1#1)
The results taken together##2##4##(1990-12#1)(2008-11#1)
The results thus obtained##2##4##(1990-3#1)(2008-10#1)
The results thus##3##3##(1990-3#1)(1997-6#1)(2008-10#1)
The results were also##2##4##(2008-10#1)(2010-8#1)
The results were analyzed##2##4##(2008-3#1)(2013-7#1)
The results were as follows##2##5##(1990-2#1)(1995-2#1)
The results were checked##2##4##(2008-10#2)
The results were compared to those##2##6##(2008-10#2)
The results were compared with the##3##6##(2007-11#1)(2008-10#1)(2008-2#1)
The results were compared with those obtained by##3##8##(2008-10#3)
The results were compared with those obtained using a##2##9##(2008-10#2)
The results were compared with those obtained using##3##8##(2008-10#3)
The results were compared with those obtained##8##7##(1996-5#1)(2008-10#7)
The results were compared with those##9##6##(1996-5#1)(2008-10#8)
The results were compared with##23##5##(1991-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
The results were compared##28##4##(1991-8#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
The results were correlated##2##4##(2008-10#1)(2008-7#1)
The results were found to be in good agreement with the##2##11##(2008-10#2)
The results were found to be##3##6##(2007-7#1)(2008-10#2)
The results were in good agreement with those##2##8##(2008-10#2)
The results were in good agreement with##3##7##(2007-12#1)(2008-10#2)
The results were in##4##4##(2007-12#1)(2008-10#3)
The results were interpreted as##2##5##(2008-5#2)
The results were interpreted##3##4##(1993-8#1)(2008-5#2)
The results were similar##2##4##(1994-12#1)(2008-8#1)
The results were then compared with##2##6##(2008-3#1)(2012-2#1)
The results were used to##3##5##(2007-8#1)(2008-10#1)(2008-3#1)
The results were used##5##4##(2007-8#1)(2008-10#3)(2008-3#1)
The results were##91##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#41)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#4)(2008-7#1)(2008-8#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
The results will##4##3##(2008-11#1)(2008-8#2)(2008-9#1)
The results##2176##2##(1990-10#1)(1990-11#7)(1990-12#14)(1990-2#6)(1990-3#3)(1990-5#11)(1990-6#2)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#8)(1991-6#2)(1991-8#6)(1991-9#10)(1992-1#1)(1992-10#2)(1992-11#7)(1992-12#14)(1992-2#10)(1992-3#11)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#13)(1992-9#4)(1993-1#5)(1993-11#7)(1993-12#20)(1993-2#7)(1993-3#9)(1993-5#1)(1993-6#16)(1993-8#7)(1993-9#5)(1994-1#3)(1994-11#10)(1994-12#9)(1994-2#8)(1994-3#13)(1994-5#4)(1994-6#9)(1994-8#6)(1994-9#6)(1995-1#3)(1995-11#9)(1995-12#15)(1995-2#9)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#6)(1995-8#4)(1995-9#3)(1996-1#8)(1996-11#2)(1996-12#13)(1996-2#11)(1996-3#2)(1996-5#11)(1996-6#4)(1996-7#2)(1996-9#1)(1997-1#6)(1997-2#9)(1997-3#7)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#8)(1997-8#6)(2006-12#2)(2006-6#2)(2006-8#1)(2007-10#7)(2007-11#39)(2007-12#43)(2007-2#3)(2007-7#5)(2007-8#4)(2008-1#10)(2008-10#532)(2008-11#56)(2008-12#63)(2008-2#62)(2008-3#118)(2008-4#13)(2008-5#93)(2008-6#24)(2008-7#53)(2008-8#86)(2008-9#56)(2009-10#8)(2009-11#4)(2009-12#3)(2009-2#5)(2009-3#3)(2009-4#3)(2009-5#6)(2009-7#9)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#8)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#11)(2010-4#10)(2010-5#10)(2010-6#4)(2010-7#4)(2010-8#19)(2010-9#6)(2011-1#26)(2011-2#41)(2011-3#11)(2011-7#1)(2012-1#14)(2012-12#11)(2012-2#20)(2012-3#24)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#59)(2013-7#10)(2013-8#45)
The resuscitation##2##2##(1996-6#1)(2011-2#1)
The retained Cr(VI)##2##3##(2008-10#2)
The retained analyte##2##3##(2008-10#2)
The retained##10##2##(2008-10#10)
The retardance##2##2##(2008-2#2)
The retention and##4##3##(1990-8#1)(2008-10#3)
The retention characteristics of##2##4##(1996-5#1)(2008-10#1)
The retention mechanism##2##3##(2008-10#2)
The retention of##5##3##(1990-8#1)(1996-5#3)(2008-10#1)
The retention times of##3##4##(1990-8#1)(2008-10#1)(2009-8#1)
The retention times##4##3##(1990-8#1)(2008-10#2)(2009-8#1)
The retention##24##2##(1990-8#4)(1996-5#4)(2008-10#15)(2009-8#1)
The retinal##2##2##(1993-9#1)(2012-12#1)
The retrieval of##2##3##(2008-3#1)(2013-8#1)
The retrieval##6##2##(2008-2#1)(2008-3#4)(2013-8#1)
The retrieved##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
The retrospective##3##2##(1996-6#1)(2007-11#1)(2008-11#1)
The return of##2##3##(2008-10#1)(2012-12#1)
The return##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
The reversal##3##2##(1992-6#1)(1995-12#1)(1997-2#1)
The reverse##11##2##(1991-9#1)(1992-3#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)
The reversed-phase##2##2##(1995-3#1)(1997-2#1)
The reversibility of these##2##4##(2008-10#1)(2008-8#1)
The reversibility of##4##3##(2008-10#3)(2008-8#1)
The reversible##4##2##(1990-5#1)(1993-11#1)(2008-10#2)
The review concludes with some##2##5##(2010-11#1)(2012-2#1)
The review concludes with##3##4##(2010-11#1)(2010-5#1)(2012-2#1)
The review concludes##4##3##(2008-11#1)(2010-11#1)(2010-5#1)(2012-2#1)
The review includes##2##3##(1997-4#1)(2008-7#1)
The review is devoted to##2##5##(2011-1#1)(2012-1#1)
The review is##5##3##(2008-10#2)(2008-11#1)(2011-1#1)(2012-1#1)
The review of literature regarding##2##5##(2012-2#2)
The review of literature##3##4##(1990-10#1)(2012-2#2)
The review of##6##3##(1990-10#1)(2007-11#1)(2008-8#1)(2012-2#2)(2013-1#1)
The review will##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
The review##36##2##(1990-10#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-7#2)(2008-8#4)(2009-3#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
The reviewed##2##2##(1992-1#1)(2013-1#1)
The reviews##2##2##(2011-2#2)
The revised##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)
The rheological behavior##2##3##(2008-10#1)(2008-8#1)
The rheological##5##2##(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)
The rho##2##2##(1994-11#2)
The rhythms##2##2##(1990-8#1)(1995-12#1)
The ribosomal##2##2##(1997-7#1)(2008-10#1)
The ribozyme##2##2##(1993-9#1)(1997-6#1)
The rice##5##2##(2008-10#2)(2008-12#1)(2009-10#1)(2013-8#1)
The riddle of##2##3##(1993-12#1)(2008-5#1)
The ridge##2##2##(2007-12#1)(2012-12#1)
The right to##3##3##(1990-12#1)(1997-5#1)(1997-8#1)
The right##10##2##(1990-12#1)(1990-6#1)(1992-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-11#1)(2013-1#1)(2013-7#1)
The right-hemisphere##2##2##(2008-11#2)
The ring sinus##2##3##(2011-2#2)
The ring##4##2##(2008-2#2)(2011-2#2)
The ring-disc electrode was##2##4##(2008-10#2)
The rise##2##2##(1990-12#1)(1997-1#1)
The rising prevalence of obesity##2##5##(2011-1#1)(2012-1#1)
The rising##4##2##(2010-11#1)(2011-1#2)(2012-1#1)
The risk associated with##2##4##(1991-12#1)(2011-1#1)
The risk associated##3##3##(1991-12#1)(2009-10#1)(2011-1#1)
The risk factor##2##3##(1991-6#1)(2008-12#1)
The risk factors and quality of life in children with allergic rhinitis in relation to seasonal attack patterns##2##18##(2012-2#2)
The risk factors and##3##4##(2008-7#1)(2012-2#2)
The risk factors for##3##4##(2007-8#1)(2008-8#1)(2012-3#1)
The risk factors##9##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-2#2)(2012-3#1)
The risk for##2##3##(2008-7#1)(2012-3#1)
The risk is##2##3##(2007-10#1)(2012-2#1)
The risk of adverse effects##2##5##(2007-12#1)(2008-10#1)
The risk of cancer##2##4##(1994-9#1)(2012-12#1)
The risk of complications##2##4##(1990-3#1)(2013-1#1)
The risk of developing##3##4##(1991-2#1)(2008-12#1)(2008-7#1)
The risk of iatrogenic##2##4##(1996-3#1)(2007-10#1)
The risk of infection##2##4##(1994-6#1)(2007-2#1)
The risk of spinal cord compression is##2##7##(2007-11#2)
The risk of##47##3##(1990-3#1)(1991-2#2)(1991-8#1)(1992-5#1)(1993-6#2)(1994-6#1)(1994-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#2)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The risk##75##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-5#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-2#2)(1994-6#1)(1994-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#2)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#7)(2008-8#5)(2009-10#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
The risks of##7##3##(1991-8#2)(1994-6#1)(2008-10#1)(2009-8#1)(2010-8#1)(2013-1#1)
The risks##12##2##(1991-8#2)(1994-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
The rms##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
The road##2##2##(1992-5#1)(2006-12#1)
The robust##3##2##(2008-10#1)(2008-4#1)(2010-12#1)
The robustness of the proposed##2##5##(2008-10#2)
The robustness of the##3##4##(2008-10#3)
The robustness of this##3##4##(2007-12#1)(2008-10#1)(2010-10#1)
The robustness of##7##3##(2007-12#1)(2008-10#4)(2009-8#1)(2010-10#1)
The role and##2##3##(2008-11#1)(2010-11#1)
The role of HIV##2##4##(1994-11#1)(2008-8#1)
The role of a##5##4##(1990-12#1)(1993-2#1)(2007-12#1)(2008-1#1)(2008-10#1)
The role of an emergency department observation unit in a clinical pathway for atrial##2##14##(2008-3#2)
The role of an##3##4##(2008-10#1)(2008-3#2)
The role of bisphosphonates in##2##5##(1993-11#1)(2010-4#1)
The role of clinical##3##4##(1996-2#1)(2008-4#1)(2013-7#1)
The role of cyclic AMP##2##5##(1994-6#2)
The role of cyclic##3##4##(1994-11#1)(1994-6#2)
The role of dietary protein##2##5##(1994-3#1)(2008-5#1)
The role of distraction osteogenesis in##2##6##(2007-12#2)
The role of endoscopic ultrasound##2##5##(2008-2#1)(2013-1#1)
The role of estrogen in##2##5##(1995-9#1)(2010-6#1)
The role of genetic##2##4##(2008-1#1)(2008-7#1)
The role of health##2##4##(1992-12#1)(1997-2#1)
The role of imaging##2##4##(1997-6#1)(2009-4#1)
The role of lipids and##2##5##(1995-8#1)(2008-3#1)
The role of metabolic##2##4##(2011-2#1)(2012-2#1)
The role of nicotine##2##4##(1991-1#1)(2011-2#1)
The role of nursing##2##4##(2008-1#1)(2012-3#1)
The role of protein kinase C##2##6##(1994-5#1)(1996-9#1)
The role of protein##3##4##(1994-5#1)(1996-9#1)(2008-11#1)
The role of public relations##2##5##(2008-12#2)
The role of radiotherapy in the management of##2##8##(1995-9#1)(2007-10#1)
The role of radiotherapy in the##3##6##(1994-8#1)(1995-9#1)(2007-10#1)
The role of radiotherapy in##4##5##(1994-8#1)(1995-9#1)(2007-10#1)(2010-3#1)
The role of radiotherapy##6##4##(1994-8#1)(1995-9#1)(2007-10#1)(2009-1#1)(2010-3#1)(2013-1#1)
The role of released##2##4##(2008-4#2)
The role of risk##2##4##(1993-2#1)(1995-3#1)
The role of serum##2##4##(2011-2#1)(2012-12#1)
The role of surgery in##3##5##(2007-8#2)(2008-6#1)
The role of the lecturer##2##5##(2008-11#1)(2008-12#1)
The role of the nurse##2##5##(2008-11#2)
The role of the##63##4##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-2#2)(1994-10#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
The role of these##5##4##(1993-9#1)(2008-10#2)(2008-11#1)(2008-4#1)
The role of this##5##4##(1993-11#1)(2007-7#1)(2008-3#1)(2012-2#1)(2013-1#1)
The role of three dimensional##2##5##(1995-8#1)(2012-2#1)
The role of vascular##2##4##(1990-12#1)(2008-7#1)
The role of##341##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#10)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#11)(2008-10#34)(2008-11#13)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#9)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-12#1)(2010-3#6)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#6)
The role played by##2##4##(1992-2#1)(2008-1#1)
The role##351##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#10)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#12)(2008-10#34)(2008-11#16)(2008-12#4)(2008-2#8)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#9)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#6)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#6)
The roles and responsibilities of##2##5##(1994-1#1)(2008-3#1)
The roles and##3##3##(1991-1#1)(1994-1#1)(2008-3#1)
The roles of##12##3##(1995-9#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#1)(2013-1#1)
The roles##17##2##(1991-1#1)(1994-1#1)(1995-9#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-8#1)(2013-1#2)
The root mean square error of prediction##2##7##(2008-10#2)
The root mean square##5##4##(2008-10#2)(2008-3#1)(2008-9#1)(2010-9#1)
The root of##2##3##(1994-12#1)(2008-8#1)
The root##13##2##(1990-5#1)(1994-12#1)(1995-3#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)
The root-mean-square##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
The rotation##3##2##(1993-1#1)(2008-3#1)(2010-12#1)
The roughness##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
The route of##3##3##(1996-2#1)(2008-10#2)
The routine##5##2##(1990-6#1)(1994-9#1)(2008-7#1)(2008-9#2)
The rubidium content of##2##4##(2008-10#2)
The rule of##2##3##(2008-10#1)(2011-1#1)
The rule##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
The rules##2##2##(2008-3#1)(2008-8#1)
The running buffer##2##3##(2008-10#2)
The running##3##2##(2008-10#3)
The rust##4##2##(2008-10#4)
The sIL-6R##2##2##(1997-7#2)
The safe##3##2##(1993-1#1)(2008-10#1)(2013-8#1)
The safety and efficacy of##2##5##(1992-8#1)(2008-2#1)
The safety and##4##3##(1990-12#1)(1992-8#1)(2008-2#1)(2010-3#1)
The safety of the##3##4##(1996-9#1)(2008-8#2)
The safety of##9##3##(1996-9#1)(2008-10#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#1)
The safety##16##2##(1990-12#1)(1992-8#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#5)(2008-9#1)(2010-3#1)(2011-2#1)
The sale of##3##3##(1996-11#1)(2008-1#2)
The salient features of the##2##5##(1993-8#1)(2009-11#1)
The salient features of##3##4##(1993-8#1)(2007-12#1)(2009-11#1)
The salient##5##2##(1993-2#1)(1993-8#1)(2007-12#1)(2008-7#1)(2009-11#1)
The same applies to##2##4##(1990-9#1)(1994-9#1)
The same approach##2##3##(2008-6#1)(2011-2#1)
The same compounds##2##3##(1992-5#1)(2008-4#1)
The same mutation##2##3##(1994-11#1)(2008-10#1)
The same pattern was##2##4##(2007-10#1)(2008-10#1)
The same pattern##3##3##(1990-6#1)(2007-10#1)(2008-10#1)
The same procedure was##2##4##(1993-12#1)(2008-10#1)
The same rats##2##3##(1993-6#2)
The same results were##2##4##(2008-10#1)(2010-6#1)
The same samples were##2##4##(2008-10#2)
The same trend##2##3##(2008-11#1)(2010-4#1)
The same trends were##2##4##(2008-10#1)(2010-4#1)
The same was##2##3##(2008-10#1)(2008-11#1)
The same wheat##2##3##(2008-10#2)
The same##98##2##(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#2)(1993-6#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-2#1)(1997-7#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
The sample consisted of 3##2##5##(2008-9#1)(2013-8#1)
The sample consisted of##16##4##(1994-1#1)(1995-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
The sample extraction##2##3##(2008-10#2)
The sample included##5##3##(1991-2#1)(1993-2#1)(2008-11#1)(2008-4#1)(2010-7#1)
The sample is initially mixed on-line with##2##7##(2008-10#2)
The sample is##13##3##(1991-1#1)(1994-11#1)(2007-12#1)(2008-10#8)(2008-5#2)
The sample preparation##4##3##(2008-10#4)
The sample size##2##3##(2008-8#1)(2012-12#1)
The sample solution##3##3##(2008-10#3)
The sample throughput is##2##4##(2008-10#2)
The sample throughput rate is##2##5##(2008-10#2)
The sample throughput was##9##4##(2008-10#9)
The sample throughput##14##3##(2008-10#14)
The sample volume##3##3##(2008-10#2)(2012-1#1)
The sample was divided##3##4##(2011-2#1)(2013-1#2)
The sample was##18##3##(1995-1#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)
The sample##113##2##(1990-9#1)(1991-1#1)(1991-2#1)(1993-2#1)(1994-1#1)(1994-11#1)(1995-1#2)(1995-6#1)(1996-1#1)(1997-5#1)(2007-12#1)(2008-10#57)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
The sampled##2##2##(2008-10#1)(2008-3#1)
The samples are##5##3##(2008-10#5)
The samples of##2##3##(2008-10#2)
The samples were analyzed##2##4##(2008-10#1)(2010-3#1)
The samples were collected from##2##5##(2008-7#2)
The samples were digested##2##4##(2008-10#2)
The samples were##22##3##(1997-2#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
The samples##42##2##(1997-2#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
The sampling frequency is##2##4##(2008-10#2)
The sampling frequency was##4##4##(2008-10#4)
The sampling frequency##7##3##(2008-10#7)
The sampling included##2##3##(2013-1#2)
The sampling rate and relative standard deviation##2##7##(2008-10#2)
The sampling rate and##3##4##(2008-10#3)
The sampling rate is##3##4##(2008-10#3)
The sampling rate was##6##4##(2008-10#5)(2010-5#1)
The sampling rate##12##3##(2008-10#11)(2010-5#1)
The sampling was performed##2##4##(2008-5#2)
The sampling was##3##3##(2008-5#2)(2013-1#1)
The sampling##32##2##(2008-10#24)(2008-11#1)(2008-5#2)(2010-5#1)(2011-2#1)(2013-1#3)
The samplings were##2##3##(2013-7#2)
The satellite pointing##2##3##(2008-3#2)
The satisfaction##2##2##(1991-2#1)(2013-8#1)
The satisfactory##3##2##(1991-11#1)(2008-10#1)(2008-5#1)
The saturated##3##2##(1992-6#1)(2008-3#2)
The saturation##7##2##(1990-8#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)
The scFv##2##2##(2008-10#2)
The scale##5##2##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#2)
The scaled##2##2##(2008-2#1)(2008-3#1)
The scaling##3##2##(2007-11#1)(2008-2#2)
The scan##2##2##(2008-10#1)(2008-7#1)
The scanner##2##2##(2008-2#1)(2008-3#1)
The scanning electron##4##3##(2008-10#2)(2008-5#1)(2012-1#1)
The scanning tunneling microscope##2##4##(1990-11#1)(2010-7#1)
The scanning##8##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-1#1)
The scarcity of##2##3##(2007-12#1)(2011-2#1)
The scarcity##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
The scatter##3##2##(1990-8#1)(2008-3#1)(2011-1#1)
The scattering and absorption##2##4##(2008-3#2)
The scattering and##3##3##(2008-2#1)(2008-3#2)
The scattering by##2##3##(2007-11#2)
The scattering##16##2##(2007-11#2)(2007-12#2)(2008-2#6)(2008-3#5)(2011-1#1)
The scavenging##3##2##(1993-6#1)(2008-10#1)(2008-4#1)
The scheme is##4##3##(2008-2#2)(2008-3#2)
The scheme##8##2##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)
The school is a##2##4##(1991-2#1)(2013-1#1)
The school##3##2##(1991-2#1)(2008-7#1)(2013-1#1)
The science and##2##3##(1993-2#1)(2010-10#1)
The science of##3##3##(1993-12#1)(1995-5#1)(2008-7#1)
The science##5##2##(1993-12#1)(1993-2#1)(1995-5#1)(2008-7#1)(2010-10#1)
The scientific and##2##3##(1991-3#1)(2008-10#1)
The scientific##8##2##(1991-3#1)(1995-11#1)(2008-10#3)(2008-11#2)(2010-11#1)
The scientists##2##2##(1996-9#1)(2010-3#1)
The scintillation##2##2##(2008-3#2)
The scope and##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
The scope of the reaction##2##5##(1996-5#1)(2009-10#1)
The scope of the##3##4##(1996-5#1)(2008-4#1)(2009-10#1)
The scope of this##2##4##(2008-5#2)
The scope of##7##3##(1996-5#1)(2007-10#1)(2007-5#1)(2008-4#1)(2008-5#2)(2009-10#1)
The scope##11##2##(1996-5#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)
The score of##2##3##(1991-12#1)(2008-1#1)
The score##4##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
The scores related to##2##4##(2008-10#1)(2010-10#1)
The scores##4##2##(2008-10#2)(2008-3#1)(2010-10#1)
The screen was##2##3##(1992-12#1)(2008-9#1)
The screen-printed##2##2##(2008-10#2)
The screening##5##2##(1991-6#1)(2008-5#2)(2011-2#1)(2011-3#1)
The search for##8##3##(1993-9#1)(1994-12#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
The search##18##2##(1993-9#1)(1994-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
The seasonal##5##2##(2007-10#1)(2008-10#1)(2008-5#2)(2013-7#1)
The second ORF##2##3##(1996-6#2)
The second and third##2##4##(2008-12#1)(2008-7#1)
The second and##3##3##(2007-7#1)(2008-12#1)(2008-7#1)
The second approach##4##3##(1993-3#1)(2008-10#2)(2008-3#1)
The second basic protocol describes##2##5##(2008-4#2)
The second basic##3##3##(2008-4#3)
The second case is##2##4##(2007-10#1)(2007-2#1)
The second case was##2##4##(1996-6#1)(2007-7#1)
The second case##6##3##(1996-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-8#1)
The second derivative##2##3##(2008-10#2)
The second goal##2##3##(1997-4#2)
The second group of##2##4##(1992-8#1)(2011-2#1)
The second group##5##3##(1990-2#1)(1992-8#1)(2008-10#2)(2011-2#1)
The second harmonic##2##3##(2007-11#1)(2008-3#1)
The second is a##4##4##(2008-2#2)(2008-3#1)(2012-2#1)
The second is##12##3##(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#2)(2012-3#1)
The second main##2##3##(2012-12#1)(2013-8#1)
The second method is##2##4##(2008-10#1)(2012-2#1)
The second method utilizes##2##4##(2008-3#1)(2010-8#1)
The second method was##3##4##(2008-10#2)(2010-4#1)
The second method##12##3##(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-2#1)
The second most##2##3##(1996-8#1)(2012-2#1)
The second one##4##3##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
The second part of##2##4##(2008-7#1)(2013-8#1)
The second part reviews##2##4##(1995-6#1)(2008-8#1)
The second part##6##3##(1995-6#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-8#1)
The second patient presented##2##4##(2008-1#1)(2008-6#1)
The second patient was##3##4##(2009-1#1)(2012-12#1)(2013-1#1)
The second patient##9##3##(1992-10#1)(2007-11#1)(2008-1#1)(2008-6#1)(2009-1#1)(2009-10#1)(2012-12#1)(2013-1#2)
The second phase of a##2##5##(1993-1#1)(1995-3#1)
The second phase##3##3##(1993-1#1)(1995-3#1)(2009-7#1)
The second protocol##3##3##(2008-2#2)(2008-4#1)
The second prototype##2##3##(2008-10#2)
The second section deals with submitting data##2##7##(2008-4#2)
The second section deals with##3##5##(2008-10#1)(2008-4#2)
The second section##5##3##(2008-10#2)(2008-4#3)
The second stage##2##3##(2008-5#1)(2012-3#1)
The second step##4##3##(1995-12#1)(2008-6#1)(2009-12#1)(2009-5#1)
The second study##6##3##(1992-8#1)(2008-5#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
The second system##4##3##(2008-10#2)(2008-3#2)
The second type##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
The second was##2##3##(1994-2#1)(2008-8#1)
The second##191##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-4#4)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#33)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#10)(2008-4#13)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#2)
The second-harmonic generation##2##3##(2007-11#1)(2007-12#1)
The second-harmonic output##2##3##(2008-2#2)
The second-harmonic signal##2##3##(2007-11#1)(2007-12#1)
The second-harmonic##10##2##(2007-11#3)(2007-12#4)(2008-2#3)
The second-order##4##2##(1992-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
The secondary structure of##3##4##(1992-12#1)(1994-11#1)(2008-9#1)
The secondary structure##4##3##(1991-5#1)(1992-12#1)(1994-11#1)(2008-9#1)
The secondary##13##2##(1990-12#1)(1991-5#1)(1992-12#1)(1994-11#1)(1995-3#1)(2007-12#1)(2007-7#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
The secreted##2##2##(1997-4#1)(2008-10#1)
The secretion of##5##3##(1991-5#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#1)
The secretion##6##2##(1991-5#1)(1991-6#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#1)
The secretory##2##2##(2007-12#1)(2011-2#1)
The secured##2##2##(1991-2#2)
The security##5##2##(1991-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2010-8#1)
The seed treatment##2##3##(2008-10#2)
The seed##5##2##(2007-11#1)(2008-10#3)(2013-8#1)
The seedling##2##2##(2008-12#2)
The seeds of the##2##4##(2008-11#1)(2008-5#1)
The seeds##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)
The segmental##2##2##(2008-10#1)(2009-10#1)
The segregation of##4##3##(2008-10#3)(2008-5#1)
The segregation##5##2##(2008-10#4)(2008-5#1)
The seizures were##2##3##(1995-12#1)(2011-1#1)
The selected##14##2##(1997-3#1)(2007-6#1)(2008-10#5)(2008-5#1)(2008-8#2)(2009-6#1)(2010-3#2)(2012-3#1)
The selection of the##5##4##(2008-10#5)
The selection of##16##3##(1990-9#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
The selection##22##2##(1990-8#1)(1990-9#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The selective##18##2##(1991-8#1)(1992-10#1)(1994-6#1)(1995-12#2)(1997-2#1)(2008-10#8)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
The selectivity and##3##3##(2008-10#3)
The selectivity coefficient values for mono-##2##6##(2008-10#2)
The selectivity coefficient values##3##4##(2008-10#3)
The selectivity coefficient##4##3##(2008-10#4)
The selectivity coefficients for##2##4##(2008-10#2)
The selectivity coefficients##3##3##(2008-10#3)
The selectivity for##2##3##(2008-10#2)
The selectivity of the reaction##2##5##(2008-10#2)
The selectivity of the##5##4##(2008-10#4)(2009-11#1)
The selectivity of this##4##4##(1994-9#1)(2008-10#3)
The selectivity of##12##3##(1994-9#1)(2008-10#10)(2009-11#1)
The selectivity##34##2##(1994-9#1)(2007-12#1)(2008-10#31)(2009-11#1)
The selenium##3##2##(2008-10#3)
The self-diffusion behavior of##2##4##(2008-3#2)
The self-diffusion##3##2##(2008-3#3)
The semantic network##2##3##(1996-7#1)(2008-7#1)
The semantic##3##2##(1996-7#1)(2008-7#2)
The sensing characteristics##2##3##(2008-10#2)
The sensing element consists of a##2##6##(2008-3#2)
The sensing element##3##3##(2008-3#3)
The sensing film##2##3##(2008-10#2)
The sensing membrane of the electrode was##2##7##(2008-10#2)
The sensing membrane##4##3##(2008-10#4)
The sensing##18##2##(2008-10#12)(2008-2#1)(2008-3#5)
The sensitive##5##2##(1993-9#1)(2008-10#4)
The sensitivities of##4##3##(2008-10#2)(2008-3#2)
The sensitivities to##2##3##(2008-10#1)(2008-3#1)
The sensitivities##9##2##(2008-10#3)(2008-12#1)(2008-3#4)(2011-1#1)
The sensitivity analysis##2##3##(2008-11#2)
The sensitivity and positive predictive values##2##6##(1994-3#1)(2012-12#1)
The sensitivity and selectivity of the##2##6##(2008-10#2)
The sensitivity and specificity of the##2##6##(1990-7#1)(2008-11#1)
The sensitivity and specificity of##8##5##(1990-7#1)(1991-2#1)(1992-9#1)(2008-11#1)(2010-8#2)(2011-2#1)(2012-3#1)
The sensitivity and specificity##11##4##(1990-7#1)(1991-2#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-3#1)
The sensitivity and##19##3##(1990-7#1)(1991-2#1)(1992-9#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#2)
The sensitivity for the determination of##2##6##(2008-10#2)
The sensitivity for the##3##4##(2008-10#3)
The sensitivity for##7##3##(1992-3#1)(2008-10#5)(2013-1#1)
The sensitivity in##3##3##(1996-12#1)(1997-3#1)(2008-5#1)
The sensitivity of a##2##4##(1996-12#1)(2008-10#1)
The sensitivity of the method is##5##6##(1990-8#1)(2008-10#3)(2008-2#1)
The sensitivity of the method##9##5##(1990-8#1)(2008-10#7)(2008-2#1)
The sensitivity of the##39##4##(1990-11#1)(1990-2#1)(1990-8#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#24)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-1#1)
The sensitivity of thermal lensing##2##5##(2008-10#2)
The sensitivity of this method was##2##6##(2008-10#1)(2008-7#1)
The sensitivity of this method##3##5##(2008-10#2)(2008-7#1)
The sensitivity of this##7##4##(2008-10#4)(2008-2#1)(2008-7#1)(2011-2#1)
The sensitivity of##70##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)
The sensitivity to##2##3##(1992-9#1)(2008-2#1)
The sensitivity was improved##2##4##(2008-10#2)
The sensitivity was of##2##4##(2008-10#2)
The sensitivity was##9##3##(1990-2#1)(2008-10#7)(2013-8#1)
The sensitivity##130##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#2)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-9#2)(1994-3#1)(1995-11#1)(1996-12#2)(1996-2#1)(1997-3#2)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#58)(2008-11#6)(2008-2#5)(2008-3#8)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
The sensitizing##2##2##(2008-10#1)(2008-4#1)
The sensor can be##2##4##(2008-10#2)
The sensor can##3##3##(2008-10#2)(2008-2#1)
The sensor characteristics##2##3##(2008-10#2)
The sensor could be##2##4##(2008-10#2)
The sensor exhibited##2##3##(2008-10#2)
The sensor exhibits a Nernstian response for##2##7##(2008-10#2)
The sensor exhibits a linear##2##5##(2008-10#2)
The sensor exhibits a##5##4##(2008-10#5)
The sensor exhibits adequate shelf life ( approximately##2##8##(2008-10#2)
The sensor exhibits adequate##3##4##(2008-10#3)
The sensor exhibits##10##3##(2008-10#10)
The sensor has a##2##4##(2008-10#2)
The sensor has been used in the potentiometric titration of##2##10##(2008-10#2)
The sensor has been used##4##5##(2008-10#4)
The sensor has been##8##4##(2008-10#8)
The sensor has##13##3##(2008-10#11)(2008-3#2)
The sensor is based on a##4##6##(2008-10#2)(2008-2#1)(2008-3#1)
The sensor is based on the##3##6##(2008-10#2)(2008-3#1)
The sensor is based on##10##5##(2008-10#5)(2008-2#3)(2008-3#2)
The sensor is fully reversible##2##5##(2008-10#2)
The sensor is stable##2##4##(2008-10#2)
The sensor is used for##2##5##(2008-10#2)
The sensor is##26##3##(2008-10#21)(2008-2#3)(2008-3#2)
The sensor performance was##2##4##(2008-10#2)
The sensor responds to##3##4##(2008-10#3)
The sensor response##4##3##(2008-10#4)
The sensor showed##2##3##(2008-10#2)
The sensor shows a linear##2##5##(2008-10#2)
The sensor shows good selectivity for##2##6##(2008-10#2)
The sensor shows good selectivity##3##5##(2008-10#3)
The sensor shows good##4##4##(2008-10#4)
The sensor shows##8##3##(2008-10#8)
The sensor signals##2##3##(2008-10#2)
The sensor system is##2##4##(2008-10#2)
The sensor system##5##3##(2008-10#4)(2008-2#1)
The sensor was also used##3##5##(2008-10#3)
The sensor was also##4##4##(2008-10#4)
The sensor was applied to##2##5##(2008-10#2)
The sensor was developed in conjunction with a monochannel flow-injection analysis system with fluorimetric##2##14##(2008-10#2)
The sensor was fabricated##2##4##(2008-10#1)(2013-1#1)
The sensor was found to have##2##6##(2008-10#2)
The sensor was found to##3##5##(2008-10#3)
The sensor was tested in##2##5##(2008-3#1)(2008-7#1)
The sensor was##23##3##(2008-10#18)(2008-3#1)(2008-7#2)(2010-5#1)(2013-1#1)
The sensor works satisfactorily in the concentration range##2##8##(2008-10#2)
The sensor works well in the##2##6##(2008-10#2)
The sensor works##4##3##(2008-10#4)
The sensor##142##2##(1994-12#1)(2007-12#2)(2008-10#116)(2008-2#6)(2008-3#11)(2008-7#3)(2010-2#1)(2010-5#1)(2013-1#1)
The sensors are used for direct##2##6##(2008-10#2)
The sensors are##3##3##(2008-10#3)
The sensors display##2##3##(2008-10#2)
The sensors exhibit a##2##4##(2008-10#1)(2008-3#1)
The sensors exhibit##5##3##(2008-10#3)(2008-3#1)(2009-9#1)
The sensors were prepared by##2##5##(2008-10#2)
The sensors were##4##3##(2008-10#4)
The sensors##19##2##(2008-10#17)(2008-3#1)(2009-9#1)
The sensory cells of##2##4##(1997-6#1)(2008-7#1)
The sensory##9##2##(1992-6#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
The separate##2##2##(2008-10#2)
The separated##6##2##(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
The separation and detection of##3##5##(2008-10#3)
The separation and determination of##4##5##(1990-8#1)(2008-10#3)
The separation and preconcentration of##2##5##(2008-10#2)
The separation and preconcentration##3##4##(2008-10#3)
The separation and quantitative determination was##2##6##(2008-5#2)
The separation and##13##3##(1990-8#1)(2008-10#10)(2008-5#2)
The separation between##2##3##(2008-7#1)(2008-9#1)
The separation factor##2##3##(2008-10#2)
The separation factors##2##3##(2008-10#2)
The separation is performed##2##4##(2008-10#2)
The separation is##5##3##(2008-10#4)(2012-2#1)
The separation of anions was achieved##2##6##(2008-10#2)
The separation of arsenic##2##4##(2008-10#2)
The separation of the##6##4##(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
The separation of##26##3##(1990-8#2)(1994-9#1)(1996-5#1)(2008-10#18)(2008-2#1)(2008-3#2)(2011-1#1)
The separation was achieved##2##4##(2008-10#2)
The separation was carried out by##2##6##(2008-10#2)
The separation was carried out##4##5##(2008-10#4)
The separation was completed##2##4##(2008-10#2)
The separation was performed on##2##5##(2011-1#2)
The separation was performed##4##4##(2008-10#2)(2011-1#2)
The separation was##14##3##(2008-10#11)(2008-5#1)(2011-1#2)
The separation##76##2##(1990-8#3)(1994-12#1)(1994-9#1)(1996-5#1)(1997-2#1)(2008-10#56)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2011-1#3)(2012-2#1)(2013-1#1)
The separations##3##2##(2008-10#2)(2008-7#1)
The sequence analysis of a##2##5##(1993-3#1)(2007-6#1)
The sequence analysis of##3##4##(1993-3#1)(1997-6#1)(2007-6#1)
The sequence analysis##6##3##(1991-9#1)(1993-3#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-9#1)
The sequence contains##3##3##(1990-5#1)(1991-12#1)(1996-3#1)
The sequence data and gene information are available through the World Wide Web at http##2##15##(1997-6#1)(1997-8#1)
The sequence encodes##2##3##(1993-6#1)(1995-9#1)
The sequence information##2##3##(1993-2#1)(2008-4#1)
The sequence of a##5##4##(1990-11#1)(1994-12#1)(1996-3#1)(1997-3#2)
The sequence of operations##2##4##(2008-10#2)
The sequence of the##9##4##(1991-2#1)(1993-2#1)(1993-9#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-7#1)
The sequence of##33##3##(1990-11#1)(1990-3#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-6#2)(1995-6#1)(1995-9#2)(1996-3#1)(1997-2#1)(1997-3#3)(1997-7#1)(2008-10#9)(2008-7#1)(2008-8#1)(2010-5#1)
The sequence was##2##3##(1995-6#1)(1996-6#1)
The sequence##69##2##(1990-11#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#3)(1993-9#1)(1994-12#3)(1994-6#2)(1995-6#2)(1995-9#4)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#4)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
The sequenced##3##2##(2008-10#2)(2013-1#1)
The sequences of the##5##4##(1992-12#1)(1997-6#1)(2008-10#3)
The sequences of##12##3##(1990-7#1)(1990-8#2)(1992-12#1)(1997-6#1)(2008-10#6)(2008-8#1)
The sequences were##2##3##(1994-12#1)(2008-10#1)
The sequences##19##2##(1990-7#1)(1990-8#2)(1992-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-8#1)
The sequencing of the##2##4##(2008-4#1)(2008-7#1)
The sequencing of##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
The sequencing##6##2##(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
The sequential extraction##5##3##(2008-10#5)
The sequential injection (SIA) technique was applied##2##7##(2008-10#2)
The sequential injection##5##3##(2008-10#5)
The sequential##18##2##(1991-8#1)(2008-10#14)(2008-11#1)(2008-4#1)(2012-2#1)
The serial##3##2##(1997-6#1)(2011-2#2)
The series includes##2##3##(2011-2#2)
The series of papers##2##4##(2008-10#1)(2008-2#1)
The series##9##2##(1990-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2010-5#1)(2011-2#2)
The serine##2##2##(1994-5#1)(2008-8#1)
The serious##5##2##(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
The seroconversion##2##2##(1997-8#1)(2013-1#1)
The serological##3##2##(2007-6#1)(2008-10#2)
The seroprevalence of##2##3##(2011-2#2)
The seroprevalence##3##2##(2011-2#3)
The serum EC-SOD##2##3##(1992-11#2)
The serum thyroxine##2##3##(2008-11#2)
The serum##26##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-11#2)(1993-6#1)(1994-12#1)(1995-11#1)(1996-12#2)(2006-6#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#3)(2011-2#1)(2013-8#1)
The serum-free##2##2##(2008-11#2)
The service##3##2##(1995-2#1)(2008-1#1)(2008-9#1)
The set of##5##3##(1993-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
The set##8##2##(1993-11#1)(1997-2#1)(2008-10#3)(2008-4#1)(2013-1#1)(2013-8#1)
The setting up of##3##4##(2008-11#1)(2010-3#1)(2012-12#1)
The setting##4##2##(2008-11#1)(2008-7#1)(2010-3#1)(2012-12#1)
The settlement##2##2##(1995-12#1)(1997-5#1)
The setup is##4##3##(2008-2#1)(2008-3#2)(2010-12#1)
The setup##12##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#3)(2010-12#2)
The seven management and planning tools are##2##7##(1994-1#1)(1994-2#1)
The seven##9##2##(1992-8#1)(1994-1#2)(1994-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2011-1#1)
The several##2##2##(2008-3#1)(2010-8#1)
The severe##4##2##(2008-10#1)(2008-9#1)(2009-12#1)(2009-7#1)
The severity of illness##2##4##(1993-12#1)(2007-1#1)
The severity of the disease##2##5##(2008-10#1)(2010-6#1)
The severity of the##5##4##(1990-11#1)(1991-12#1)(1992-11#1)(2008-10#1)(2010-6#1)
The severity of these##2##4##(2008-7#1)(2012-7#1)
The severity of this##2##4##(2010-8#1)(2013-1#1)
The severity of##22##3##(1990-11#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-12#1)(1996-6#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2009-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-7#1)(2013-1#1)
The sex##6##2##(1990-3#1)(1994-7#1)(2007-12#1)(2008-7#1)(2011-2#2)
The sexual##3##2##(1996-3#1)(1996-8#1)(2008-10#1)
The sham##2##2##(2009-12#1)(2011-2#1)
The shape and size of the##2##6##(2007-8#1)(2010-8#1)
The shape of the##8##4##(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)
The shape of##10##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#2)
The shape##19##2##(1992-9#1)(1995-9#1)(1996-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-8#1)
The shapes of the##3##4##(1994-6#1)(2008-3#1)(2008-9#1)
The share of##2##3##(1995-3#1)(2011-2#1)
The share##3##2##(1994-1#1)(1995-3#1)(2011-2#1)
The shared##2##2##(1996-2#1)(1997-7#1)
The shear##2##2##(1993-11#1)(2009-5#1)
The shear-force value of raw pork correlated significantly with##2##9##(2010-2#2)
The shift##6##2##(1992-6#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
The shoot##3##2##(2008-12#1)(2008-5#1)(2013-1#1)
The short##12##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
The short-term effects of##4##4##(1994-6#1)(2008-9#1)(2013-1#2)
The short-term##6##2##(1994-6#1)(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#2)
The shortage of##2##3##(2007-4#1)(2012-12#1)
The shortest##5##2##(1995-12#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-5#1)
The shot-to-shot##2##2##(2008-2#1)(2008-3#1)
The siblings##2##2##(1993-12#1)(2011-1#1)
The side chain of##2##4##(1992-3#1)(2008-8#1)
The side chains of##2##4##(2008-10#1)(2008-3#1)
The side effects of##3##4##(2008-1#1)(2011-2#2)
The side##7##2##(1992-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)
The side-effects of##2##3##(1993-12#1)(2008-5#1)
The side-pumping##2##2##(2007-12#2)
The sieving coefficient of##2##4##(2010-5#1)(2011-1#1)
The sieving##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
The sign##3##2##(1995-2#1)(2007-11#1)(2008-3#1)
The signal was##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
The signal##28##2##(1992-12#1)(1993-6#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2010-6#1)(2010-7#1)
The signal-processing##2##2##(2008-3#2)
The signal-to-noise ratio (SNR)##2##4##(2007-12#1)(2008-3#1)
The signal-to-noise ratio##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
The signal-to-noise##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
The signaling##2##2##(2008-4#1)(2011-2#1)
The signals may be##2##4##(2008-7#1)(2012-2#1)
The signals##6##2##(2008-10#4)(2008-7#1)(2012-2#1)
The significance level##2##3##(2007-11#1)(2013-8#1)
The significance of breastfeeding to incarcerated pregnant women##2##8##(2013-1#2)
The significance of differences##2##4##(2007-10#1)(2008-10#1)
The significance of the##2##4##(2008-7#1)(2008-9#1)
The significance of these findings for##2##6##(2008-3#1)(2009-9#1)
The significance of these results##2##5##(1996-2#1)(2008-10#1)
The significance of these##7##4##(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
The significance of this##5##4##(1990-11#1)(1990-5#1)(1993-6#1)(2008-9#2)
The significance of##31##3##(1990-11#1)(1990-5#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#2)
The significance##35##2##(1990-11#1)(1990-5#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
The significant##23##2##(1992-12#1)(1992-6#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
The significantly##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
The signs were##2##3##(2011-1#1)(2012-3#1)
The signs##4##2##(2007-11#1)(2007-7#1)(2011-1#1)(2012-3#1)
The silencing##2##2##(2008-9#1)(2011-1#1)
The silica gel modified with##2##5##(2008-10#2)
The silica gel##4##3##(2008-10#4)
The silica##7##2##(2008-10#5)(2008-12#1)(2008-5#1)
The similar##4##2##(2007-11#1)(2008-10#1)(2010-8#1)(2013-1#1)
The similarities##4##2##(1992-1#1)(1993-3#1)(2008-3#1)(2010-12#1)
The similarity between##2##3##(1990-11#1)(2008-5#1)
The similarity of the##3##4##(2007-11#1)(2012-2#1)(2013-7#1)
The similarity of##6##3##(1995-2#1)(1995-3#1)(2007-11#1)(2008-3#1)(2012-2#1)(2013-7#1)
The similarity##10##2##(1990-11#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-2#1)(2013-7#1)
The simple and##2##3##(2008-10#1)(2008-3#1)
The simple##22##2##(1992-3#1)(1996-4#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
The simplest##7##2##(1995-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-5#1)
The simplex##2##2##(2008-10#1)(2010-5#1)
The simplicity and##2##3##(2008-11#1)(2013-7#1)
The simplicity of the##3##4##(2008-10#1)(2010-5#1)(2011-2#1)
The simplicity of##5##3##(2008-10#3)(2010-5#1)(2011-2#1)
The simplicity##8##2##(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
The simulated##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)
The simulation model##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
The simulation of##3##3##(2008-10#2)(2013-1#1)
The simulation results show that the##2##6##(2008-3#1)(2012-3#1)
The simulation results##8##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2012-3#1)
The simulation shows that##2##4##(2008-2#1)(2011-1#1)
The simulation##25##2##(1997-3#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#6)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The simulations show that the##2##5##(2007-12#1)(2008-2#1)
The simulations show that##3##4##(2007-12#2)(2008-2#1)
The simulations##9##2##(1995-3#1)(2007-12#3)(2008-11#2)(2008-2#1)(2008-3#2)
The simultaneous detection of##2##4##(2007-12#1)(2008-10#1)
The simultaneous detection##3##3##(2007-12#1)(2008-10#2)
The simultaneous determination of##12##4##(2008-10#12)
The simultaneous determination##13##3##(2008-10#13)
The simultaneous enrichment and determination of all the metals##2##9##(2008-10#2)
The simultaneous occurrence of##2##4##(1992-10#1)(2008-2#1)
The simultaneous presence of##2##4##(1991-12#1)(1991-8#1)
The simultaneous##34##2##(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-6#1)(1994-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-2#2)(2008-3#1)
The single most important factor##2##5##(1990-8#1)(2008-9#1)
The single##15##2##(1990-8#1)(1994-3#1)(1995-2#1)(2007-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-12#1)
The single-mode##3##2##(2008-2#1)(2008-3#2)
The single-scatter albedo was 0##2##5##(2008-3#2)
The single-sideband method##2##3##(2008-3#2)
The singly resonant OPO##3##4##(2007-11#2)(2007-12#1)
The site of interaction##2##4##(1993-3#1)(2012-1#1)
The site of the##2##4##(1994-5#1)(2008-7#1)
The site of##9##3##(1990-8#1)(1993-3#1)(1994-5#2)(1995-5#1)(1996-2#1)(2007-7#1)(2008-7#1)(2012-1#1)
The site##12##2##(1990-8#1)(1991-6#1)(1993-3#1)(1994-5#2)(1995-5#1)(1995-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-1#1)
The sites of##2##3##(1996-5#1)(1997-4#1)
The sites##4##2##(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#1)
The situation is##3##3##(2008-11#1)(2008-3#1)(2009-7#1)
The situation##6##2##(1990-12#1)(1997-5#1)(2008-11#1)(2008-3#2)(2009-7#1)
The six##8##2##(1994-5#1)(2007-12#1)(2008-12#1)(2008-4#1)(2009-2#1)(2011-2#2)(2013-1#1)
The size and##8##3##(1993-11#1)(1993-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
The size of the##12##4##(1990-7#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-11#2)(2008-10#3)(2008-5#2)(2010-9#1)
The size of##18##3##(1990-7#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-11#2)(1997-3#1)(2008-10#4)(2008-5#2)(2010-9#1)(2011-1#1)(2013-1#2)
The size parameter of##2##4##(2008-2#1)(2008-3#1)
The size##34##2##(1990-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-11#2)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#3)
The skeletal##2##2##(2008-3#1)(2008-9#1)
The skeleton##2##2##(2007-11#1)(2012-2#1)
The skewness##2##2##(2008-10#2)
The skills##2##2##(1996-3#1)(2008-11#1)
The skin and##3##3##(2008-9#1)(2012-3#1)(2013-8#1)
The skin biopsy##2##3##(1992-5#1)(2013-1#1)
The skin lesions##4##3##(2010-6#1)(2012-3#2)(2013-8#1)
The skin##25##2##(1991-8#1)(1992-5#1)(2008-12#1)(2008-3#1)(2008-5#9)(2008-9#1)(2009-4#1)(2010-11#1)(2010-6#1)(2010-9#1)(2012-3#4)(2013-1#1)(2013-8#2)
The slight##3##2##(2008-10#2)(2012-2#1)
The slope is##2##3##(2007-11#1)(2008-2#1)
The slope of the##8##4##(1996-5#1)(2008-10#5)(2008-2#1)(2008-3#1)
The slope of##13##3##(1991-2#1)(1993-12#1)(1996-5#1)(2008-10#8)(2008-2#1)(2008-3#1)
The slope##20##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-12#1)(1996-5#1)(2007-11#2)(2008-10#8)(2008-2#2)(2008-3#3)
The slopes of the electrodes were##3##6##(2008-10#3)
The slopes of the##4##4##(1990-11#1)(2008-10#3)
The slopes of##5##3##(1990-11#1)(2008-10#3)(2008-3#1)
The slow##7##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
The sludge##4##2##(2008-12#2)(2012-12#2)
The slurries were prepared by##2##5##(2008-10#2)
The slurry was##2##3##(2008-10#2)
The slurry##3##2##(2008-10#3)
The small size of##2##4##(1992-12#1)(2008-9#1)
The small##20##2##(1992-11#1)(1992-12#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2013-1#1)
The small-angle##2##2##(2008-3#2)
The smaller##7##2##(1993-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
The smallest##7##2##(1997-2#1)(2008-10#3)(2008-2#1)(2010-4#1)(2013-1#1)
The smoking##3##2##(1993-2#1)(2008-1#1)(2009-5#1)
The smoothing##2##2##(2008-2#1)(2008-3#1)
The snakes were##2##3##(1996-12#1)(2008-7#1)
The so-called##3##2##(2007-12#1)(2008-7#1)(2010-8#1)
The social##4##2##(1992-1#1)(1997-1#1)(2008-9#1)(2012-12#1)
The sodium##3##2##(1991-8#1)(2008-10#2)
The software is designed##2##4##(2008-7#1)(2012-3#1)
The software is##4##3##(1996-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
The software##10##2##(1992-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
The soil samples were##3##4##(2008-10#2)(2008-12#1)
The soil##12##2##(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#1)(2009-3#1)(2012-9#1)
The soilborne fungus##2##3##(2008-10#2)
The sol-gel##4##2##(2008-10#4)
The solar##4##2##(2008-10#1)(2008-3#3)
The sole##4##2##(1990-3#1)(1994-5#1)(1997-3#1)(2011-2#1)
The solid mass##2##3##(2008-10#2)
The solid mixture consisting of the##2##6##(2008-10#2)
The solid phase##2##3##(1995-6#1)(2008-10#1)
The solid##8##2##(1995-6#1)(2008-10#6)(2012-2#1)
The solid-phase##2##2##(2008-10#2)
The solid-state##2##2##(2008-2#1)(2008-7#1)
The soliton##2##2##(2007-12#2)
The solubility of toluene##2##4##(2008-10#2)
The solubility of##6##3##(1995-2#1)(2008-10#4)(2008-11#1)
The solubility##10##2##(1995-2#1)(2008-10#8)(2008-11#1)
The soluble##5##2##(1992-3#1)(1995-2#1)(1995-5#1)(2008-10#1)(2013-1#1)
The solution equilibria of##2##4##(2008-10#2)
The solution is##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
The solution of##3##3##(2008-10#1)(2008-7#2)
The solution was##5##3##(2008-10#2)(2008-11#1)(2009-9#1)(2011-3#1)
The solution##23##2##(1992-4#1)(1994-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-3#1)
The solutions are##2##3##(2007-12#1)(2013-8#1)
The solutions were##2##3##(2008-10#1)(2010-3#1)
The solutions##8##2##(1990-2#1)(1990-7#1)(2007-12#2)(2008-10#2)(2010-3#1)(2013-8#1)
The solvent extraction of##4##4##(2008-10#4)
The solvent extraction##5##3##(2008-10#5)
The solvent system consisted of##2##5##(2008-10#2)
The solvent##13##2##(1994-3#1)(1996-2#1)(2008-10#10)(2009-6#1)
The sorbed elements##2##3##(2008-10#2)
The sorbed##3##2##(2008-10#3)
The sorbent##2##2##(2008-10#2)
The sorption capacity of the matrix##2##6##(2008-10#2)
The sorption capacity of the##4##5##(2008-10#4)
The sorption capacity of##5##4##(2008-10#5)
The sorption capacity##9##3##(2008-10#9)
The sorption data##2##3##(2008-10#2)
The sorption isotherms##2##3##(2008-6#1)(2010-4#1)
The sorption kinetics##2##3##(2008-10#2)
The sorption of##4##3##(2008-10#4)
The sorption##26##2##(2008-10#24)(2008-6#1)(2010-4#1)
The source of##4##3##(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
The source##13##2##(1993-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
The sources of##4##3##(2008-3#2)(2009-11#1)(2010-5#1)
The sources##7##2##(2008-10#1)(2008-3#3)(2009-11#1)(2009-7#1)(2010-5#1)
The southern##2##2##(2008-10#1)(2008-8#1)
The soybean##2##2##(2008-10#1)(2008-12#1)
The space-time##2##2##(2007-11#1)(2009-2#1)
The spaces##2##2##(2008-5#1)(2009-5#1)
The spacing##2##2##(2007-12#1)(2008-3#1)
The spatial and temporal##4##4##(2008-10#1)(2008-5#2)(2008-7#1)
The spatial and##6##3##(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)
The spatial coherence of##2##4##(2008-3#2)
The spatial distribution of the##2##5##(2008-10#1)(2008-3#1)
The spatial distribution of##5##4##(2007-5#1)(2008-10#1)(2008-3#2)(2008-8#1)
The spatial distribution##6##3##(2007-5#1)(2008-10#2)(2008-3#2)(2008-8#1)
The spatial dynamics of##2##4##(1995-5#1)(2011-2#1)
The spatial pattern of##3##4##(2008-10#3)
The spatial pattern##4##3##(2008-10#4)
The spatial resolution of##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
The spatial resolution##5##3##(2007-12#2)(2008-3#2)(2008-4#1)
The spatial scale of##2##4##(2008-8#2)
The spatial spread of disease was simulated using a half-Cauchy distribution with median dispersal distance mu (units of distance)##2##19##(2008-10#2)
The spatial##49##2##(1995-5#1)(1996-12#1)(1997-3#1)(2007-11#4)(2007-12#5)(2007-5#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)
The spatially resolved##2##3##(2008-10#1)(2008-3#1)
The spatially##5##2##(2008-10#1)(2008-11#1)(2008-3#3)
The spatiotemporal##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
The spawning##2##2##(2008-12#1)(2013-7#1)
The special##5##2##(1996-6#1)(1997-8#1)(2008-3#2)(2011-2#1)
The speciation of##4##3##(2008-10#4)
The speciation performance of##2##4##(2008-10#2)
The speciation was then repeated on##2##6##(2008-10#2)
The speciation##15##2##(1996-6#1)(2008-10#14)
The species is a Gram-positive##2##5##(2011-2#2)
The species is a##3##4##(2011-2#3)
The species is compared with##2##5##(2008-5#2)
The species is of interest because it is##2##8##(2011-2#2)
The species is of interest##3##5##(2011-2#3)
The species is##12##3##(2008-10#1)(2008-12#1)(2008-5#3)(2011-2#7)
The species##27##2##(2008-10#7)(2008-12#3)(2008-5#7)(2011-2#9)(2013-7#1)
The species-specific##4##2##(2008-10#4)
The specific activity of##4##4##(1993-11#1)(1994-8#2)(1995-6#1)
The specific binding of##5##4##(1990-2#1)(1992-3#1)(1996-5#2)(2009-5#1)
The specific binding##8##3##(1990-2#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-5#2)(2008-9#1)(2009-5#1)
The specific glucose uptake rate##2##5##(1994-5#2)
The specific glucose##3##3##(1994-5#2)(2008-11#1)
The specific growth##4##3##(2008-11#4)
The specific objective##2##3##(1993-11#1)(2008-5#1)
The specific primers were##2##4##(2008-10#2)
The specific primers##3##3##(2008-10#2)(2013-8#1)
The specific role of##2##4##(1993-6#1)(2008-1#1)
The specific##63##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-7#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-5#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
The specifications are##2##3##(2008-2#1)(2008-3#1)
The specifications##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
The specificity and##2##3##(2008-11#1)(2013-8#1)
The specificity of a##2##4##(1992-9#1)(2008-10#1)
The specificity of the technique was##2##6##(1991-2#1)(2008-10#1)
The specificity of the##7##4##(1991-2#1)(1992-6#1)(1994-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
The specificity of these##2##4##(2008-10#1)(2008-7#1)
The specificity of this##2##4##(1996-3#1)(2008-10#1)
The specificity of##22##3##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
The specificity##26##2##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
The specimens were##8##3##(2007-7#1)(2008-12#3)(2008-3#1)(2012-2#1)(2013-1#2)
The specimens##9##2##(2007-7#1)(2008-12#3)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#2)
The speckle##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
The spectra obtained##3##3##(1990-7#1)(2008-10#2)
The spectra of the##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
The spectra of##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
The spectra were##2##3##(2008-10#1)(2008-3#1)
The spectra##15##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)
The spectral broadening is##2##4##(2007-12#2)
The spectral characteristics of the##2##5##(2008-10#1)(2008-3#1)
The spectral characteristics of##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
The spectral data taken at 77 K provide a high resolution view of the spectroscopic differences between geometric isomers##2##19##(2010-2#2)
The spectral data##4##3##(2008-10#1)(2009-2#1)(2010-2#2)
The spectral performance##2##3##(2008-2#1)(2008-3#1)
The spectral properties of##2##4##(1992-1#1)(2008-3#1)
The spectral resolution##3##3##(2008-3#3)
The spectral shape##2##3##(2008-2#1)(2008-3#1)
The spectral spacing of##2##4##(2008-3#2)
The spectral##52##2##(1992-1#1)(2007-11#5)(2007-12#7)(2008-10#7)(2008-2#7)(2008-3#18)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-2#2)
The spectrofluorimetric determination of##2##4##(2008-10#2)
The spectrometer##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
The spectrometer's responsivity##2##3##(2008-3#2)
The spectrometer's##3##2##(2008-3#3)
The spectrophotometric##8##2##(2008-10#7)(2011-1#1)
The spectroscopic experiments were carried out on geometric isomers of the carotenoids purified by high performance liquid chromatography (HPLC) and then frozen to 77 K to inhibit isomerization##2##28##(2010-2#2)
The spectroscopic results indicate that##2##5##(1994-6#1)(2008-3#1)
The spectroscopic results##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
The spectroscopic##8##2##(1990-7#1)(1994-6#1)(2008-10#3)(2008-3#1)(2010-2#2)
The spectrum of glomerulonephritis in##2##5##(2008-1#2)
The spectrum of##12##3##(1992-12#2)(1992-5#1)(1994-3#1)(1995-9#1)(2008-1#3)(2008-7#1)(2009-12#1)(2009-4#1)(2011-2#1)
The spectrum was##2##3##(2008-10#2)
The spectrum##19##2##(1992-12#2)(1992-5#1)(1994-3#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
The speed of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The speed##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
The sperm##5##2##(1997-6#1)(2007-12#2)(2008-4#1)(2008-7#1)
The spermatozoa of all the species##2##6##(2007-12#2)
The spermatozoa of##4##3##(2007-12#2)(2008-7#2)
The spermatozoa##8##2##(2007-12#3)(2008-7#5)
The spermatozoon##2##2##(2007-12#1)(2008-7#1)
The spiked recoveries##2##3##(2008-10#2)
The spiked##3##2##(2008-10#3)
The spinal cord##2##3##(1996-5#1)(2009-12#1)
The spinal##4##2##(1995-12#1)(1996-5#1)(2009-12#1)(2011-2#1)
The spirochetes were##2##3##(1997-4#2)
The spirometric parameters##2##3##(2008-1#1)(2008-7#1)
The splitting##2##2##(1997-7#1)(2007-11#1)
The spontaneous##3##2##(1990-2#1)(1994-3#1)(2008-10#1)
The spore##2##2##(2008-10#2)
The spores##2##2##(2008-10#1)(2008-5#1)
The spread of##6##3##(2008-10#4)(2013-1#2)
The spreading##2##2##(1990-7#1)(1994-6#1)
The square of##2##3##(2008-10#1)(2012-3#1)
The square root of the##2##5##(2008-2#2)
The square##5##2##(2008-10#2)(2008-2#2)(2012-3#1)
The stability and##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
The stability constant##2##3##(2008-10#2)
The stability constants for##2##4##(2008-10#1)(2008-5#1)
The stability constants of the##3##5##(2008-10#3)
The stability constants of these##2##5##(1992-9#1)(2008-10#1)
The stability constants of##9##4##(1992-9#1)(2008-10#8)
The stability constants##12##3##(1992-9#1)(2008-10#10)(2008-5#1)
The stability of the##12##4##(1993-11#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-2#1)
The stability of these##2##4##(2008-10#1)(2008-8#1)
The stability of##26##3##(1990-8#1)(1993-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)
The stability##51##2##(1990-8#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)
The stabilization of##2##3##(1996-3#1)(1997-2#1)
The stabilization##6##2##(1994-11#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
The stabilizing effect##2##3##(1997-2#1)(2008-4#1)
The stabilizing##3##2##(1997-2#1)(2007-11#1)(2008-4#1)
The stable##9##2##(1996-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-9#1)
The staff##2##2##(2010-10#1)(2010-8#1)
The stage of##2##3##(1995-4#1)(2008-12#1)
The stalled##2##2##(1991-9#1)(1993-3#1)
The standard addition method##4##4##(2008-10#4)
The standard addition technique##3##4##(2008-10#3)
The standard addition##8##3##(2008-10#8)
The standard curve##2##3##(2008-10#2)
The standard deviation of the##2##5##(2008-10#2)
The standard deviation##7##3##(2008-10#6)(2008-3#1)
The standard management of OP poisoning includes decontamination##2##8##(2013-1#2)
The standard treatment##2##3##(1997-5#1)(2013-8#1)
The standard##55##2##(1992-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-10#1)(1996-12#1)(1997-5#1)(2007-11#3)(2008-10#27)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#2)
The standardization of##2##3##(1992-5#1)(2008-10#1)
The standards##2##2##(1994-3#1)(2008-10#1)
The staphylococcal##2##2##(1991-9#1)(1994-6#1)
The starch##2##2##(1993-6#1)(2008-5#1)
The starting dose##2##3##(1992-10#1)(2008-6#1)
The starting##3##2##(1992-10#1)(2008-6#1)(2008-9#1)
The state of##8##3##(1993-12#1)(1994-12#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
The state##13##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#2)
The static##6##2##(2008-10#2)(2008-3#3)(2008-5#1)
The stationary##2##2##(1990-8#1)(2012-2#1)
The statistical analysis of##4##4##(1990-9#1)(1995-5#1)(2011-2#1)(2012-2#1)
The statistical analysis showed##2##4##(2008-10#1)(2008-7#1)
The statistical analysis was##2##4##(2008-11#1)(2013-8#1)
The statistical analysis##10##3##(1990-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The statistical properties of the##2##5##(2007-12#1)(2008-11#1)
The statistical properties of##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
The statistical##24##2##(1990-6#1)(1990-9#1)(1995-5#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The status of the##3##4##(1993-3#1)(2007-11#1)(2013-1#1)
The status of##10##3##(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
The status##11##2##(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)
The stay in hospital##2##4##(1997-4#1)(1997-8#1)
The steady state levels of##2##5##(1991-5#1)(2008-11#1)
The steady state##7##3##(1991-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)
The steady-state level of##2##4##(1990-11#1)(2007-8#1)
The steady-state##10##2##(1990-11#1)(1991-9#1)(1992-11#1)(1992-9#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
The stem cell##3##3##(2008-11#1)(2012-2#1)(2012-7#1)
The stem##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-7#1)
The stents##2##2##(1990-8#2)
The steps to produce an effective antibody include##2##8##(2008-4#2)
The steps##5##2##(1996-2#1)(2008-4#2)(2008-7#1)(2011-2#1)
The stepwise##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
The stereochemical course of the##2##5##(1990-7#1)(1996-5#1)
The stereochemical##3##2##(1990-7#1)(1996-5#1)(2008-9#1)
The stereochemistry of##4##3##(1990-12#1)(1992-11#1)(2008-10#1)(2009-7#1)
The steric##4##2##(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
The sterile insect technique (SIT) is##2##6##(2011-2#1)(2012-12#1)
The steroid##2##2##(1992-12#1)(2008-5#1)
The steroid-binding##2##2##(1990-11#2)
The stigma##2##2##(2008-10#1)(2012-1#1)
The stimulated group##2##3##(2007-10#2)
The stimulated##5##2##(1993-11#1)(2007-10#2)(2008-3#1)(2008-4#1)
The stimulating effect of##3##4##(1993-5#1)(1994-8#1)(1996-2#1)
The stimulation of##7##3##(1990-2#1)(1990-5#1)(1992-12#1)(1994-3#1)(1995-2#1)(1997-6#1)(2008-7#1)
The stimulation##8##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-2#1)(1997-6#1)(2008-7#1)
The stimulatory effect of##3##4##(1992-6#1)(1994-2#1)(1995-6#1)
The stimuli##4##2##(1992-11#1)(1996-5#1)(2008-8#2)
The stimulus##2##2##(2008-9#1)(2013-8#1)
The stoichiometric##5##2##(1992-3#1)(1994-3#2)(2007-12#1)(2008-10#1)
The stoichiometry and##2##3##(1995-2#1)(2008-10#1)
The stoichiometry of the extracted##2##5##(2008-10#2)
The stoichiometry of the##4##4##(2008-10#4)
The stoichiometry of##7##3##(1997-2#1)(2007-11#1)(2008-10#5)
The stoichiometry##11##2##(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#8)
The storage process involves selecting the records from inactive status##2##10##(1994-3#2)
The storage stability##3##3##(2008-10#3)
The storage##7##2##(1994-3#2)(2008-10#4)(2008-3#1)
The story##2##2##(2010-1#1)(2012-2#1)
The strain described in this study was isolated from##3##9##(2011-2#3)
The strain described in this study##4##6##(2011-2#4)
The strain described in this##5##5##(2011-2#5)
The strain was##2##3##(2011-2#1)(2013-1#1)
The strain##17##2##(2007-6#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-7#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)
The strains could be##2##4##(1993-2#1)(2008-10#1)
The strains from##2##3##(2008-10#2)
The strains##11##2##(1993-2#1)(1997-4#1)(2007-10#2)(2008-10#6)(2008-5#1)
The strategic##4##2##(1991-8#1)(1994-3#1)(2012-2#1)(2012-3#1)
The strategies used to##2##4##(2007-12#1)(2013-1#1)
The strategies##9##2##(1993-2#1)(1994-1#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2012-12#2)(2013-1#1)
The strategy has##2##3##(2008-7#2)
The strategy is##2##3##(1991-6#1)(2008-10#1)
The strategy of##3##3##(2008-10#1)(2008-4#1)(2010-8#1)
The strategy##17##2##(1990-6#1)(1991-6#1)(1995-11#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2010-7#1)(2010-8#1)
The stratum corneum##5##3##(2008-5#4)(2012-2#1)
The stream##2##2##(2008-10#2)
The strength of the##3##4##(1997-8#1)(2008-10#1)(2008-3#1)
The strength of##5##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
The strength##6##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)
The strengths and##2##3##(1993-1#1)(2008-11#1)
The strengths of##2##3##(1995-9#1)(1996-1#1)
The strengths##6##2##(1993-1#1)(1995-9#1)(1996-1#1)(2008-11#1)(2008-3#1)(2008-6#1)
The stress##9##2##(1992-5#1)(1994-5#1)(1995-1#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
The striatal##3##2##(1994-5#1)(1995-8#1)(1997-2#1)
The striatum##2##2##(1991-6#1)(2013-8#1)
The striking##2##2##(1993-8#1)(1997-3#1)
The stripping step was carried out by##2##7##(2008-10#2)
The stripping##6##2##(2008-10#6)
The stromal##2##2##(2012-1#1)(2013-1#1)
The strong influence of##2##4##(2008-3#2)
The strong##12##2##(1993-11#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)
The stronger##2##2##(2008-4#1)(2012-5#1)
The strongest correlations were##2##4##(2008-10#1)(2008-12#1)
The strongest##15##2##(1990-7#1)(1992-12#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
The strongly##2##2##(2008-11#1)(2011-1#1)
The structural changes##5##3##(1990-7#1)(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)
The structural composition##2##3##(2008-10#2)
The structural gene##2##3##(1992-3#1)(1993-2#1)
The structural model##2##3##(1992-9#1)(2011-1#1)
The structural modifications##2##3##(2008-3#1)(2008-7#1)
The structural##32##2##(1990-7#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
The structure and##10##3##(1993-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(1996-7#1)(2007-5#1)(2008-12#1)(2010-4#1)(2010-8#1)(2013-8#1)
The structure has been refined to a##2##7##(1995-3#1)(1997-4#1)
The structure has been##3##4##(1995-3#1)(1996-2#1)(1997-4#1)
The structure is##3##3##(1991-5#1)(1995-11#1)(2007-11#1)
The structure of the first representative of Pfam family##2##9##(2010-10#2)
The structure of the major lipooligosaccharide##2##6##(1993-11#2)
The structure of the##24##4##(1990-2#1)(1990-5#1)(1992-12#1)(1992-4#1)(1993-11#2)(1994-8#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-8#1)(2007-12#2)(2008-10#4)(2008-5#2)(2009-6#1)(2010-10#2)(2012-2#1)(2012-3#1)
The structure of##45##3##(1990-2#1)(1990-5#1)(1992-12#1)(1992-4#1)(1993-11#3)(1993-8#1)(1994-8#1)(1995-11#3)(1995-5#1)(1996-2#2)(1996-8#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-5#2)(2009-6#1)(2010-10#5)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
The structure was determined by##3##5##(1990-5#1)(2008-8#1)(2009-10#1)
The structure was refined##2##4##(1993-8#1)(2008-8#1)
The structure was##7##3##(1990-5#1)(1993-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)
The structure##80##2##(1990-2#1)(1990-5#2)(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#4)(1993-3#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-11#6)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#4)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#2)(2010-10#5)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
The structure-activity relationship of##2##4##(2008-11#1)(2011-3#1)
The structure-activity relationships##2##3##(1995-3#1)(1995-6#1)
The structure-activity##4##2##(1995-3#1)(1995-6#1)(2008-11#1)(2011-3#1)
The structures are##2##3##(1990-11#1)(1990-5#1)
The structures of a number of stereoisomers of carotenoids have been revealed in three-dimensional X-ray crystallographic investigations of pigment-protein complexes from photosynthetic organisms##2##23##(2010-2#2)
The structures of all the##2##5##(1996-2#1)(2007-11#1)
The structures of all##4##4##(1996-2#1)(2007-11#2)(2012-2#1)
The structures of the new compounds were elucidated on the basis of##2##12##(2008-8#1)(2013-1#1)
The structures of the##11##4##(1990-7#1)(1990-9#1)(1991-12#1)(1994-5#1)(1995-11#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-8#1)(2013-1#1)
The structures of these compounds##2##5##(2007-11#1)(2011-1#1)
The structures of these##5##4##(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
The structures of##30##3##(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-8#2)(1994-5#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-11#5)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
The structures thus##2##3##(1994-5#1)(2008-3#1)
The structures##41##2##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-8#2)(1993-11#1)(1994-5#2)(1995-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-11#5)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
The student##2##2##(2008-12#1)(2010-3#1)
The students were##6##3##(2008-11#2)(2008-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
The students##17##2##(1992-1#1)(1992-6#1)(1993-3#1)(2008-11#6)(2008-12#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
The students'##2##2##(2008-12#1)(2009-12#1)
The studied parameters##2##3##(2008-10#1)(2008-7#1)
The studied##13##2##(2008-10#10)(2008-7#1)(2010-8#1)(2011-2#1)
The studies of the##2##4##(2008-10#2)
The studies of##3##3##(2008-10#3)
The studies reported here##2##4##(1995-8#1)(2009-2#1)
The studies show##2##3##(1996-3#1)(2011-1#1)
The studies##29##2##(1991-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
The study aimed to understand##2##5##(2012-3#2)
The study aimed to##3##4##(2010-3#1)(2012-3#2)
The study aimed##4##3##(2010-3#1)(2012-3#3)
The study aims to##3##4##(2012-2#1)(2013-1#2)
The study also demonstrates that##2##5##(2008-3#1)(2009-4#1)
The study also examined the##2##5##(2008-11#1)(2008-12#1)
The study also found that##2##5##(1997-3#1)(2010-3#1)
The study also##21##3##(1992-3#2)(1995-2#1)(1996-1#1)(1997-3#2)(1997-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#2)(2011-1#1)
The study and##2##3##(1993-2#1)(2008-10#1)
The study attempted to##2##4##(1990-2#1)(1994-3#1)
The study concluded that##4##4##(2008-11#2)(2011-1#2)
The study concludes that the##3##5##(1991-2#1)(1996-1#1)(2008-11#1)
The study concludes that##4##4##(1991-2#1)(1996-1#2)(2008-11#1)
The study confirms##4##3##(1992-8#1)(1996-1#1)(1996-7#1)(2008-7#1)
The study consisted of##3##4##(2008-6#1)(2011-2#1)(2013-8#1)
The study demonstrated that##2##4##(2008-10#1)(2008-9#1)
The study demonstrated##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
The study described here##3##4##(1993-3#1)(2007-2#1)(2008-11#1)
The study described##4##3##(1993-3#1)(1996-3#1)(2007-2#1)(2008-11#1)
The study design##4##3##(1994-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
The study evaluates##2##3##(2008-5#1)(2008-7#1)
The study examined the##2##4##(2008-11#1)(2011-2#1)
The study examined##4##3##(2008-11#1)(2008-12#1)(2011-2#2)
The study findings##3##3##(1991-2#1)(1995-1#1)(2009-5#1)
The study focused on##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
The study focuses on##2##4##(1994-12#1)(2008-11#1)
The study for##2##3##(2008-10#1)(2010-6#1)
The study found that the##2##5##(2008-11#1)(2012-12#1)
The study found that##4##4##(2008-11#1)(2010-10#1)(2012-12#1)(2013-8#1)
The study found##7##3##(1997-5#1)(2008-11#2)(2008-7#1)(2010-10#1)(2012-12#1)(2013-8#1)
The study group comprised##2##4##(2009-6#1)(2013-1#1)
The study group consisted of##6##5##(1994-3#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The study group included##4##4##(1996-7#1)(2008-7#1)(2009-10#1)(2011-2#1)
The study group was##2##4##(2007-7#1)(2008-10#1)
The study group##15##3##(1994-3#1)(1996-7#1)(2007-7#2)(2008-10#1)(2008-7#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The study has shown that##2##5##(2008-10#1)(2011-1#1)
The study has shown##3##4##(2008-10#1)(2011-1#2)
The study has##8##3##(1997-4#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)(2011-1#2)
The study highlights##2##3##(2008-10#1)(2008-11#1)
The study identified a##2##4##(2008-9#1)(2011-2#1)
The study identified##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
The study included 14##2##4##(1990-2#1)(2010-3#1)
The study included 42##2##4##(1990-2#1)(2011-2#1)
The study included 61 patients (34 women##2##7##(2008-12#2)
The study included##22##3##(1990-2#2)(1994-6#1)(2007-11#3)(2008-10#1)(2008-11#2)(2008-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
The study includes a successful attempt at##2##7##(2008-10#2)
The study includes##6##3##(2007-1#1)(2008-10#3)(2008-12#1)(2008-3#1)
The study indicates that##5##4##(1993-2#1)(1994-2#2)(2008-10#1)(2011-2#1)
The study indicates##6##3##(1993-2#1)(1994-2#2)(1995-2#1)(2008-10#1)(2011-2#1)
The study investigated##2##3##(2008-9#1)(2013-8#1)
The study involved##12##3##(1995-1#1)(1996-1#1)(1996-9#1)(1997-4#1)(2008-11#3)(2008-2#1)(2011-2#2)(2012-12#1)(2012-4#1)
The study is a##2##4##(2011-2#1)(2012-3#1)
The study is aimed at##2##5##(2009-1#1)(2012-3#1)
The study is based on data##2##6##(1991-12#1)(2011-2#1)
The study is based on##3##5##(1991-12#1)(1997-3#1)(2011-2#1)
The study is##15##3##(1991-12#1)(1991-3#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#2)(2013-1#2)
The study lasted for##2##4##(1993-2#1)(2008-5#1)
The study objective was##2##4##(2007-11#1)(2009-5#1)
The study of the relationship between##2##6##(2008-10#1)(2011-10#1)
The study of the##18##4##(1993-1#1)(1994-11#1)(1997-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#1)(2011-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
The study of##51##3##(1990-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-6#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
The study patients were##2##4##(2007-7#1)(2008-1#1)
The study period##3##3##(1993-3#1)(2006-8#1)(2008-4#1)
The study population consisted of##5##5##(1996-7#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#1)
The study population##8##3##(1996-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-12#2)
The study presents##2##3##(2010-10#1)(2013-8#1)
The study provided##2##3##(2008-7#1)(2010-1#1)
The study provides a##3##4##(2007-7#1)(2008-10#1)(2010-5#1)
The study provides##6##3##(2007-11#1)(2007-7#1)(2008-10#1)(2010-5#1)(2013-1#2)
The study recommends##2##3##(2008-11#1)(2011-1#1)
The study reported here was##2##5##(2008-12#1)(2008-5#1)
The study reported here##4##4##(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#1)
The study reported##5##3##(2008-12#1)(2008-5#1)(2010-3#1)(2010-5#1)(2011-2#1)
The study results will##2##4##(2008-9#1)(2010-6#1)
The study results##5##3##(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#2)
The study revealed that##4##4##(1996-1#1)(2007-11#1)(2007-8#1)(2013-1#1)
The study revealed the##2##4##(2007-7#1)(2012-3#1)
The study revealed##10##3##(1994-12#2)(1996-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
The study reveals##2##3##(2008-11#1)(2011-1#1)
The study sample consisted of##3##5##(2008-12#1)(2010-6#1)(2012-3#1)
The study sample##6##3##(1995-1#1)(1996-9#1)(2007-10#1)(2008-12#1)(2010-6#1)(2012-3#1)
The study showed that the##5##5##(1990-11#1)(2008-1#1)(2008-10#2)(2011-2#1)
The study showed that##12##4##(1990-11#1)(1990-2#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
The study showed##15##3##(1990-11#1)(1990-2#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#2)
The study shows that the##3##5##(2008-1#1)(2008-7#1)(2013-1#1)
The study shows that##17##4##(1991-12#1)(1993-2#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-5#1)(2013-1#2)(2013-8#1)
The study shows##19##3##(1991-12#1)(1993-2#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-5#1)(2013-1#2)(2013-8#1)
The study suggests that##3##4##(1990-8#1)(1996-9#1)(2008-9#1)
The study suggests##4##3##(1990-8#1)(1996-9#1)(2008-5#1)(2008-9#1)
The study took place##2##4##(2010-3#1)(2011-2#1)
The study used a qualitative##2##5##(2009-4#1)(2013-1#1)
The study used a##5##4##(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#2)
The study used##6##3##(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#3)
The study uses##3##3##(1997-3#1)(2008-2#1)(2010-7#1)
The study was a##3##4##(2008-9#1)(2010-10#1)(2011-2#1)
The study was also##3##4##(2008-10#2)(2011-2#1)
The study was carried out at##2##6##(2011-2#1)(2013-8#1)
The study was carried out on##4##6##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
The study was carried out##12##5##(1995-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The study was conducted by##2##5##(2007-11#1)(2010-5#1)
The study was conducted in a##2##6##(2009-12#1)(2012-2#1)
The study was conducted in##6##5##(2008-1#1)(2009-12#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
The study was conducted on##2##5##(2007-7#1)(2008-5#1)
The study was conducted to evaluate the##3##7##(2008-10#1)(2010-8#1)(2011-2#1)
The study was conducted to##6##5##(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
The study was conducted##21##4##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-5#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
The study was designed as a##2##6##(2010-3#1)(2011-2#1)
The study was designed##6##4##(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#3)
The study was guided by##2##5##(2010-11#1)(2010-3#1)
The study was performed in##3##5##(2008-5#1)(2008-7#1)(2010-5#1)
The study was performed on##3##5##(2008-12#1)(2008-4#1)(2013-8#1)
The study was performed with##2##5##(2008-10#2)
The study was performed##11##4##(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-5#1)(2013-8#1)
The study was planned##2##4##(1990-6#1)(2013-8#1)
The study was undertaken in##3##5##(2007-10#1)(2008-10#1)(2009-6#1)
The study was undertaken to##2##5##(2007-7#1)(2008-12#1)
The study was undertaken##6##4##(2007-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2009-6#1)
The study was##82##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-6#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#3)(2010-8#3)(2011-2#9)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
The study will##2##3##(2007-8#1)(2008-5#1)
The study##477##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#6)(1993-3#3)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-6#1)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#7)(1996-12#4)(1996-2#1)(1996-3#1)(1996-7#3)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#9)(2007-8#3)(2008-1#8)(2008-10#50)(2008-11#32)(2008-12#17)(2008-2#2)(2008-3#9)(2008-4#6)(2008-5#15)(2008-6#1)(2008-7#16)(2008-8#6)(2008-9#9)(2009-1#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#12)(2010-5#7)(2010-6#5)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#11)(2011-10#1)(2011-2#29)(2011-3#1)(2012-12#11)(2012-2#6)(2012-3#14)(2012-4#1)(2012-6#1)(2013-1#31)(2013-7#3)(2013-8#12)
The study's##6##2##(1993-2#1)(2007-10#1)(2007-12#2)(2008-11#1)(2011-2#1)
The subcellular localization##2##3##(1992-11#1)(1993-5#1)
The subcellular##5##2##(1992-11#1)(1993-5#1)(1996-2#1)(2008-11#1)(2008-7#1)
The subgroup##3##2##(1990-2#1)(2007-8#1)(2011-2#1)
The subject##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
The subjective##3##2##(1991-6#3)
The subjects completed##2##3##(2007-7#1)(2009-3#1)
The subjects covered include##2##4##(2008-10#1)(2012-3#1)
The subjects in##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
The subjects of the study were##3##6##(1990-10#1)(1991-1#1)(2007-10#1)
The subjects of##6##3##(1990-10#1)(1991-1#1)(2007-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
The subjects were divided into##2##5##(2008-6#1)(2008-7#1)
The subjects were divided##3##4##(2008-6#1)(2008-7#2)
The subjects were##23##3##(1990-12#1)(1991-2#1)(1992-2#1)(1993-12#2)(1993-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
The subjects##44##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(2007-10#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
The subperitoneal space##2##3##(2008-1#2)
The subsequent elution of##2##4##(2008-10#2)
The subsequent##16##2##(1990-11#1)(1993-12#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
The substance inhibited##2##3##(1995-12#1)(1997-6#1)
The substance##5##2##(1995-12#1)(1997-6#2)(2010-11#1)(2010-8#1)
The substances##2##2##(2008-7#1)(2013-1#1)
The substantial##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
The substitution of##3##3##(1990-12#1)(1996-2#1)(2008-9#1)
The substrate is##3##3##(1992-3#2)(2008-3#1)
The substrate specificity of the##2##5##(1992-8#1)(1995-2#1)
The substrate specificity of##3##4##(1990-8#1)(1992-8#1)(1995-2#1)
The substrate##10##2##(1990-8#1)(1991-12#1)(1992-3#2)(1992-8#1)(1994-5#1)(1995-2#1)(2008-3#1)(2008-6#2)
The substrates##2##2##(1994-11#1)(1997-2#1)
The subunit##2##2##(1990-5#1)(1990-7#1)
The success of PTCA in patients with##2##7##(1992-9#2)
The success of a##2##4##(1994-2#1)(2013-1#1)
The success of the method##2##5##(1991-5#1)(1996-5#1)
The success of the##8##4##(1991-5#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-5#1)(2009-8#1)(2012-2#1)
The success of this##7##4##(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-1#1)
The success of##30##3##(1991-5#1)(1992-9#2)(1994-2#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#2)
The success rate for##3##4##(2007-11#1)(2007-8#1)(2008-12#1)
The success rate of##3##4##(2010-12#1)(2010-7#1)(2012-2#1)
The success rate##9##3##(1994-6#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-12#1)(2010-7#2)(2012-2#1)
The success##40##2##(1991-5#1)(1992-9#2)(1994-2#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#2)
The successful application of##2##4##(1995-1#1)(2008-2#1)
The successful defense of##2##4##(1991-1#1)(1992-2#1)
The successful health##2##3##(1994-3#1)(1996-3#1)
The successful treatment of##2##4##(2006-10#1)(2010-3#1)
The successful use of##2##4##(2008-10#1)(2008-11#1)
The successful##25##2##(1991-1#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-3#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
The successive##5##2##(1990-7#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
The sudden##2##2##(1995-3#1)(2013-1#1)
The sugar##5##2##(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
The suggested method##2##3##(2008-10#1)(2008-2#1)
The suggested##6##2##(1993-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)
The suggestion##2##2##(1992-12#1)(2009-10#1)
The suit##4##2##(1995-12#1)(1995-6#3)
The suitability for##2##3##(2008-10#1)(2008-3#1)
The suitability of the##3##4##(2008-10#3)
The suitability of##11##3##(1994-12#1)(1997-2#1)(2008-10#7)(2010-3#1)(2013-1#1)
The suitability##14##2##(1994-12#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-3#1)(2010-3#1)(2013-1#1)
The sulfated##2##2##(1991-2#1)(1992-10#1)
The sulfur##2##2##(2008-10#2)
The sum of the##3##4##(1990-12#1)(1996-6#1)(2008-10#1)
The sum of##10##3##(1990-12#3)(1996-6#1)(1997-6#1)(2008-10#3)(2008-3#1)(2013-8#1)
The sum##12##2##(1990-12#3)(1996-6#1)(1997-6#1)(2008-10#3)(2008-3#2)(2010-3#1)(2013-8#1)
The sun protection factors (SPFs) of##2##6##(2008-5#2)
The sun protection factors##3##4##(2008-5#3)
The sun protection##4##3##(2008-5#4)
The sun##7##2##(2008-10#1)(2008-3#1)(2008-5#5)
The sunscreen##2##2##(2008-5#2)
The super##2##2##(1992-10#1)(2008-10#1)
The supercritical fluid##2##3##(2008-10#2)
The superficial##2##2##(2008-5#1)(2008-7#1)
The superior vena cava##2##4##(2008-1#2)
The superior##5##2##(1995-3#1)(2008-1#2)(2008-3#1)(2008-7#1)
The superiority of the##2##4##(1997-2#1)(2010-2#1)
The superiority of##3##3##(1997-2#1)(2010-2#1)(2012-2#1)
The supernatant##2##2##(2012-2#1)(2013-8#1)
The superoxide anion##2##3##(1992-11#1)(2012-2#1)
The superoxide##4##2##(1990-11#1)(1992-11#1)(2012-2#1)(2013-1#1)
The supervisor must be##2##4##(1992-11#2)
The supply of##6##3##(1991-2#1)(1992-3#1)(1993-1#1)(1994-3#1)(2008-7#1)(2010-2#1)
The support of##2##3##(1991-1#1)(2011-2#1)
The support##7##2##(1990-8#1)(1991-1#1)(2008-10#2)(2009-5#2)(2011-2#1)
The supporting##2##2##(2008-10#1)(2008-8#1)
The suppression of##5##3##(1997-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
The suppression##7##2##(1997-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#1)
The suppressive effect of##2##4##(2008-5#1)(2008-9#1)
The suppressive##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
The suprameatal approach##2##3##(2008-9#2)
The supramolecular interaction of##2##4##(2008-10#2)
The supramolecular##4##2##(2008-10#4)
The supraoptic (SON) and paraventricular##2##5##(1993-12#1)(2008-7#1)
The surface area of##2##4##(2008-10#2)
The surface characteristics of##2##4##(2008-10#2)
The surface charge##2##3##(2008-5#1)(2009-11#1)
The surface concentration##2##3##(2008-10#2)
The surface of the electrode can##2##6##(2008-10#2)
The surface of the##10##4##(2008-10#5)(2008-11#1)(2008-12#2)(2011-1#1)(2012-2#1)
The surface of##13##3##(1991-5#1)(1995-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-1#1)(2012-2#1)
The surface profile is##3##4##(2008-3#3)
The surface roughness of##2##4##(2008-2#1)(2008-3#1)
The surface roughness##4##3##(2008-2#1)(2008-3#3)
The surface velocity of##2##4##(2008-2#1)(2008-3#1)
The surface##51##2##(1990-2#1)(1991-5#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#10)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
The surfaces of the electrodes are easily renewable by simply polishing on an alumina paper##2##15##(2008-10#2)
The surfaces of the electrodes are stable and easily renewable by polishing on alumina paper##3##15##(2008-10#3)
The surfaces of the electrodes are##5##6##(2008-10#5)
The surfaces of##6##3##(2008-10#5)(2012-2#1)
The surfaces##8##2##(1991-2#1)(2008-10#5)(2008-2#1)(2012-2#1)
The surgeon should##2##3##(2012-12#1)(2013-8#1)
The surgeon##4##2##(1992-1#1)(2007-12#1)(2012-12#1)(2013-8#1)
The surgeon's##2##2##(2011-2#1)(2012-12#1)
The surgery was##2##3##(2007-8#1)(2010-5#1)
The surgery##6##2##(2007-11#1)(2007-8#2)(2010-5#1)(2012-12#1)(2012-2#1)
The surgical approach##2##3##(1990-5#1)(1993-8#1)
The surgical management##2##3##(2007-8#1)(2013-1#1)
The surgical procedure##4##3##(2008-10#1)(2009-3#1)(2010-7#1)(2011-2#1)
The surgical procedures##2##3##(2008-4#1)(2012-3#1)
The surgical technique of##2##4##(1992-9#1)(2010-11#1)
The surgical technique##7##3##(1990-9#1)(1992-9#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
The surgical treatment of##3##4##(2007-11#1)(2007-12#1)(2007-8#1)
The surgical treatment##8##3##(1990-12#1)(2007-11#3)(2007-12#1)(2007-8#2)(2009-4#1)
The surgical##39##2##(1990-12#2)(1990-5#1)(1990-9#1)(1992-9#1)(1993-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#4)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)
The surgically##3##2##(2008-11#1)(2008-6#1)(2013-7#1)
The surveillance of schistosomiasis in##3##5##(2012-3#3)
The surveillance of##4##3##(2012-3#4)
The surveillance##6##2##(1996-11#1)(2007-12#1)(2012-3#4)
The survey findings indicate weaknesses warranting further exploration to identify changes needed to improve care planning documentation##2##17##(2013-1#2)
The survey identified several problematic areas related to nurses and care planning##2##12##(2013-1#2)
The survey identified##3##3##(1994-3#1)(2013-1#2)
The survey of##4##3##(1993-12#1)(2008-10#1)(2008-6#1)(2009-7#1)
The survey showed that##2##4##(1993-6#1)(2008-10#1)
The survey was conducted in##2##5##(1996-1#1)(2008-10#1)
The survey was conducted##6##4##(1993-2#1)(1996-1#1)(2008-10#1)(2011-2#1)(2013-1#2)
The survey was##11##3##(1993-2#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
The survey##39##2##(1991-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#3)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#6)
The surveys##3##2##(1991-9#1)(1992-12#1)(2013-8#1)
The survival and##2##3##(2008-9#2)
The survival curves##3##3##(1995-1#1)(2007-8#2)
The survival of dosed males and females was similar to that of the vehicle control groups##3##16##(2008-9#3)
The survival of dosed males and females was similar to that of the##4##13##(2008-9#4)
The survival of exposed males and females was similar to that of the control groups##3##15##(2008-9#3)
The survival of exposed males and females was similar to that##4##11##(2008-9#4)
The survival of##13##3##(1992-4#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-9#8)
The survival rate of##3##4##(2008-11#2)(2008-9#1)
The survival rate##4##3##(2008-11#2)(2008-6#1)(2008-9#1)
The survival time of##2##4##(2008-7#1)(2013-1#1)
The survival time##5##3##(1992-10#1)(1995-12#1)(2007-11#1)(2008-7#1)(2013-1#1)
The survival##31##2##(1992-10#1)(1992-4#1)(1995-1#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#11)(2012-2#1)(2013-1#1)
The susceptibility of##5##3##(1994-8#1)(2007-6#1)(2008-10#2)(2012-12#1)
The susceptibility##7##2##(1994-8#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#1)
The susceptible##2##2##(2008-10#2)
The suspension##3##2##(2008-10#2)(2008-11#1)
The sustained##5##2##(1990-12#1)(1991-12#2)(1994-2#1)(1997-2#1)
The sweat volume of the##3##5##(2009-12#3)
The swelling##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
The switch##4##2##(2008-3#2)(2012-1#1)(2013-8#1)
The switching##3##2##(2007-11#2)(2008-3#1)
The symmetry##2##2##(2007-10#1)(2007-11#1)
The symptom##6##2##(1997-8#1)(2008-10#2)(2008-7#2)(2013-1#1)
The symptoms are##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
The symptoms of the##2##4##(1990-10#1)(1997-3#1)
The symptoms of##6##3##(1990-10#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)
The symptoms##14##2##(1990-10#1)(1993-6#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-1#1)
The synchronous luminescence##2##3##(2008-10#2)
The synchronous##4##2##(2008-10#3)(2008-11#1)
The syndrome can##2##3##(2008-4#1)(2011-2#1)
The syndrome is##4##3##(1992-5#1)(1996-6#1)(2010-4#1)(2012-3#1)
The syndrome of##3##3##(1995-5#1)(2008-12#1)(2013-1#1)
The syndrome##14##2##(1992-5#2)(1995-5#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
The synergistic effect of##2##4##(2008-10#1)(2013-1#1)
The synergistic##5##2##(2008-10#3)(2009-4#1)(2013-1#1)
The syntheses are described of##2##5##(1992-12#2)
The syntheses##4##2##(1992-12#2)(1996-2#2)
The synthesis and characterization of##2##5##(1994-8#1)(2009-11#1)
The synthesis and##11##3##(1992-9#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)
The synthesis of [4##2##4##(1996-5#2)
The synthesis of a##2##4##(2008-10#1)(2008-4#1)
The synthesis of the##4##4##(1997-4#1)(2008-10#2)(2008-5#1)
The synthesis of##38##3##(1991-8#1)(1992-12#2)(1992-8#1)(1993-1#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#5)(1997-4#2)(2007-11#4)(2007-12#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
The synthesis##52##2##(1991-8#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#5)(1997-4#2)(2007-11#4)(2007-12#1)(2008-10#10)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
The synthesized compounds were##3##4##(2008-11#1)(2008-5#1)(2010-5#1)
The synthesized##9##2##(1994-12#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2012-2#1)
The synthetic route##2##3##(1996-5#1)(2009-11#1)
The synthetic##16##2##(1993-11#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-3#3)(2008-4#1)(2009-11#1)(2009-4#1)(2012-3#1)
The system allowed##2##3##(2008-10#1)(2009-9#1)
The system also##2##3##(2007-11#1)(2008-3#1)
The system can also##2##4##(1992-12#1)(2008-3#1)
The system can be used to##2##6##(2008-10#1)(2008-3#1)
The system can be used##3##5##(2008-10#1)(2008-3#2)
The system can be##7##4##(1992-11#1)(2008-10#2)(2008-11#1)(2008-3#3)
The system can##11##3##(1992-11#1)(1992-12#1)(2008-10#3)(2008-11#1)(2008-3#5)
The system combines##2##3##(2007-11#1)(2007-12#1)
The system consisted of##2##4##(1996-5#1)(2008-10#1)
The system consists of a##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
The system consists of##11##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2012-12#1)
The system described here##2##4##(1994-2#1)(2008-5#1)
The system described##3##3##(1994-2#1)(2008-3#1)(2008-5#1)
The system employs##2##3##(2007-11#1)(2008-3#1)
The system exhibited##2##3##(2008-10#2)
The system for##2##3##(1992-2#1)(2008-10#1)
The system had a##2##4##(2008-10#1)(2008-11#1)
The system handles about##2##4##(2008-10#2)
The system handles##3##3##(2008-10#3)
The system has a##5##4##(2008-10#3)(2008-2#1)(2008-3#1)
The system has been evaluated for##2##6##(2008-10#2)
The system has been tested for##2##6##(2008-10#2)
The system has been tested on##2##6##(2008-10#1)(2008-3#1)
The system has been tested##4##5##(2008-10#3)(2008-3#1)
The system has been used##2##5##(1992-4#1)(2008-10#1)
The system has been##16##4##(1992-4#1)(1992-6#1)(1993-9#1)(2008-10#7)(2008-2#1)(2008-3#2)(2010-6#1)(2010-8#1)(2012-7#1)
The system has##27##3##(1992-4#1)(1992-6#1)(1993-9#1)(1994-5#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#3)(2010-6#1)(2010-8#1)(2012-7#1)
The system is able to##4##5##(2008-10#2)(2008-3#1)(2009-8#1)
The system is based on a##5##6##(2007-11#1)(2008-2#1)(2008-3#3)
The system is based on##8##5##(1992-4#1)(2007-11#1)(2008-2#2)(2008-3#3)(2008-9#1)
The system is capable of##2##5##(2007-12#1)(2008-3#1)
The system is compact at only 10 in##2##8##(2008-3#2)
The system is compact##3##4##(2008-3#3)
The system is designed to##2##5##(2008-3#1)(2011-2#1)
The system is designed##3##4##(1991-1#1)(2008-3#1)(2011-2#1)
The system is shown to##2##5##(2007-12#1)(2008-3#1)
The system is##37##3##(1991-1#1)(1992-4#1)(2007-11#1)(2007-12#4)(2008-10#8)(2008-2#4)(2008-3#13)(2008-4#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)
The system obeys Beer's law##2##5##(2008-10#2)
The system offered##2##3##(2008-10#2)
The system offers##2##3##(2007-12#1)(2008-10#1)
The system parameters##2##3##(2007-12#1)(2008-3#1)
The system performance##4##3##(2008-3#4)
The system presented##3##3##(2008-10#2)(2008-11#1)
The system produces##2##3##(2007-12#1)(2008-3#1)
The system provides a##2##4##(2007-11#1)(2008-10#1)
The system provides##4##3##(1992-2#1)(2007-11#1)(2008-10#2)
The system shows##2##3##(2008-10#1)(2008-3#1)
The system uses a##3##4##(2008-10#1)(2008-3#2)
The system uses an##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
The system uses##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
The system utilizes##5##3##(2008-10#3)(2008-3#2)
The system was applied to the determination of##3##8##(2008-10#3)
The system was applied to##4##5##(2008-10#4)
The system was calibrated##2##4##(2007-11#1)(2008-10#1)
The system was evaluated for##2##5##(2008-10#2)
The system was evaluated##3##4##(2008-10#2)(2008-2#1)
The system was optimized and offered good performance characteristics with##2##10##(2008-10#2)
The system was tested##3##4##(2008-10#2)(2008-3#1)
The system was used##2##4##(2007-11#1)(2008-10#1)
The system was##32##3##(2007-11#2)(2007-12#1)(2008-10#24)(2008-12#1)(2008-2#2)(2008-3#1)(2012-2#1)
The system works##2##3##(2008-3#1)(2010-12#1)
The system##244##2##(1991-1#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#9)(2007-12#16)(2008-10#94)(2008-11#9)(2008-12#1)(2008-2#16)(2008-3#52)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-8#1)
The system's##2##2##(2008-3#2)
The systematic use of##2##4##(1990-10#1)(1997-1#1)
The systematic##10##2##(1990-10#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
The systems were##2##3##(2008-10#2)
The systems##3##2##(2008-10#2)(2008-3#1)
The t##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
The t-test##2##2##(2008-10#2)
The t1/2 for##2##3##(1992-5#2)
The tablets were##2##3##(2010-5#1)(2012-2#1)
The tablets##3##2##(2010-5#1)(2012-2#2)
The tagged##2##2##(2008-10#1)(2008-8#1)
The tandem##2##2##(2008-10#2)
The taper##2##2##(2007-11#1)(2008-3#1)
The target DNA##2##3##(1995-8#1)(2008-5#1)
The target compounds were##2##4##(2008-10#1)(2011-3#1)
The target of##2##3##(2007-11#1)(2008-10#1)
The target##23##2##(1990-12#1)(1991-2#1)(1995-12#1)(1995-8#1)(1996-1#1)(2007-11#2)(2008-10#5)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
The targeted##3##2##(2008-10#2)(2010-7#1)
The targets##2##2##(2008-10#1)(2013-7#1)
The task##5##2##(1993-6#1)(1994-2#1)(1997-6#1)(2008-4#1)(2008-6#1)
The tau##2##2##(1995-2#1)(1997-4#1)
The taxonomic##3##2##(2010-10#1)(2013-7#1)(2013-8#1)
The taxonomy of the##2##4##(2008-5#2)
The taxonomy##3##2##(2008-5#2)(2010-8#1)
The teaching##2##2##(1993-12#1)(2009-2#1)
The team must##2##3##(1995-3#1)(2008-11#1)
The team##7##2##(1991-6#1)(1995-3#2)(1996-1#2)(2008-11#1)(2013-1#1)
The team's##2##2##(1990-4#1)(1994-1#1)
The technical details of the##2##5##(1994-9#1)(2008-10#1)
The technical##8##2##(1993-12#1)(1994-9#1)(1996-12#1)(2007-12#2)(2008-10#2)(2012-2#1)
The technique also##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
The technique and##2##3##(2006-12#1)(2008-3#1)
The technique can also##2##4##(2008-3#1)(2008-4#1)
The technique can be used##2##5##(2008-3#2)
The technique can be##4##4##(2008-3#4)
The technique can##8##3##(2007-12#1)(2008-3#6)(2008-4#1)
The technique could be##2##4##(2008-3#2)
The technique could##3##3##(2008-3#3)
The technique described here##2##4##(2010-4#1)(2011-2#1)
The technique described in this##2##5##(2008-10#1)(2008-9#1)
The technique described##4##3##(2008-10#1)(2008-9#1)(2010-4#1)(2011-2#1)
The technique enables##2##3##(2008-10#1)(2011-1#1)
The technique has been applied##2##5##(2008-10#1)(2008-2#1)
The technique has been##4##4##(2007-12#2)(2008-10#1)(2008-2#1)
The technique has##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)
The technique includes##2##3##(2007-12#1)(2007-8#1)
The technique involves the##2##4##(2008-10#1)(2008-4#1)
The technique involves##7##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
The technique is applied to##2##5##(2008-3#2)
The technique is based on the##3##6##(2007-11#2)(2008-3#1)
The technique is based on##14##5##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#5)(2008-5#1)(2008-6#1)(2011-2#1)
The technique is based##16##4##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#6)(2008-5#2)(2008-6#1)(2011-2#1)
The technique is demonstrated##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
The technique is##47##3##(1992-12#1)(1994-11#1)(2007-11#6)(2007-12#4)(2008-1#1)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-1#1)(2010-3#1)(2010-4#1)(2011-2#2)
The technique may##2##3##(1994-2#1)(2008-9#1)
The technique of##11##3##(1990-8#1)(1991-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#2)(2011-2#1)
The technique permits##2##3##(2007-12#1)(2008-3#1)
The technique presented##2##3##(2008-2#1)(2008-5#1)
The technique provides a##2##4##(2007-11#1)(2008-3#1)
The technique relies on##2##4##(2008-3#1)(2008-4#1)
The technique represents##2##3##(1990-2#1)(2008-6#1)
The technique requires##3##3##(2007-12#1)(2008-3#2)
The technique used##2##3##(2008-2#1)(2008-7#1)
The technique uses a##3##4##(2007-12#1)(2008-3#2)
The technique uses##7##3##(2007-12#1)(2008-3#6)
The technique utilizes##2##3##(2007-11#1)(2008-5#1)
The technique was applied to a##2##6##(1990-5#1)(2008-10#1)
The technique was applied to##7##5##(1990-5#1)(2008-10#3)(2008-3#2)(2010-3#1)
The technique was applied##8##4##(1990-5#1)(2008-10#3)(2008-3#3)(2010-3#1)
The technique was##15##3##(1990-5#1)(2007-12#1)(2008-10#8)(2008-3#4)(2010-3#1)
The technique##172##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#2)(1992-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-11#11)(2007-12#18)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-2#15)(2008-3#53)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-1#1)(2009-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#6)(2013-1#1)
The techniques of##2##3##(2007-11#1)(2009-7#1)
The techniques used for##2##4##(2008-6#1)(2011-2#1)
The techniques used##5##3##(1997-7#1)(2008-10#2)(2008-6#1)(2011-2#1)
The techniques##18##2##(1992-3#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-9#3)(2009-7#1)(2011-2#1)(2012-3#1)
The technology is##4##3##(1994-2#1)(1996-12#1)(2008-3#1)(2008-7#1)
The technology##6##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
The teeth were##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
The teeth##6##2##(1990-2#1)(1997-4#2)(2008-11#1)(2013-1#2)
The temozolomide is##2##3##(2008-8#2)
The temperature and##2##3##(2008-3#2)
The temperature dependence of the##7##5##(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
The temperature dependence of##10##4##(1992-7#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
The temperature dependence##13##3##(1992-7#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)
The temperature difference between the##2##5##(1990-7#1)(2008-5#1)
The temperature of the##3##4##(2008-10#3)
The temperature of##4##3##(2008-10#3)(2011-2#1)
The temperature##40##2##(1990-7#1)(1992-2#1)(1992-7#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-2#3)(2008-3#8)(2008-5#2)(2008-6#1)(2011-2#2)
The temporal and spatial##3##4##(2008-10#2)(2008-3#1)
The temporal characteristics##2##3##(2008-8#1)(2013-1#1)
The temporal pattern of##3##4##(1994-12#1)(2010-11#1)(2011-1#1)
The temporal##25##2##(1994-10#1)(1994-12#1)(1996-4#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-7#1)
The temporoparietal galea flap##2##4##(2007-12#2)
The ten##4##2##(1993-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
The tendency of##2##3##(1990-8#1)(2012-1#1)
The tendency##6##2##(1990-2#1)(1990-8#1)(1994-2#1)(1995-5#1)(2010-12#1)(2012-1#1)
The tensile##2##2##(2008-5#1)(2012-2#1)
The tension##3##2##(1990-8#1)(1991-12#1)(2008-8#1)
The terahertz##4##2##(2007-11#1)(2010-5#2)(2012-12#1)
The term &quot##8##3##(1991-12#1)(1994-1#1)(1997-6#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
The term##22##2##(1990-9#1)(1991-12#1)(1992-8#1)(1994-1#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#1)
The terminal##7##2##(1992-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-6#1)(2008-8#2)
The ternary complex##2##3##(2008-10#2)
The ternary complexes of##2##4##(2008-10#2)
The ternary complexes##3##3##(2008-10#2)(2008-5#1)
The ternary##7##2##(2008-10#6)(2008-5#1)
The terrestrial##2##2##(1996-6#1)(1997-5#1)
The tertiary##2##2##(2008-2#1)(2008-4#1)
The test is##4##3##(1990-2#1)(2008-8#2)(2012-3#1)
The test statistics##2##3##(1997-3#2)
The test system##2##3##(2008-11#2)
The test was##8##3##(1997-2#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
The test##43##2##(1990-2#1)(1995-6#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-3#4)(2013-1#1)
The tested materials##2##3##(2008-10#1)(2013-1#1)
The tested##4##2##(2008-10#1)(2013-1#3)
The testicular##3##2##(2007-12#1)(2008-5#1)(2009-11#1)
The testing##5##2##(1993-11#1)(1995-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
The tests##9##2##(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-12#1)(2009-7#1)(2013-8#1)
The text##3##2##(1991-8#1)(2009-10#1)(2010-12#1)
The theme of##3##3##(1993-3#1)(1995-3#1)(2008-5#1)
The themes##2##2##(2008-1#1)(2009-5#1)
The theoretical analyses are proved by experimental results##2##8##(2008-3#2)
The theoretical analyses##3##3##(2008-3#3)
The theoretical analysis of the##3##5##(2008-2#1)(2008-3#2)
The theoretical analysis##4##3##(2008-2#1)(2008-3#2)(2013-8#1)
The theoretical background of##2##4##(2008-1#1)(2008-10#1)
The theoretical background##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
The theoretical model is##2##4##(2007-11#1)(2008-3#1)
The theoretical predictions##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
The theoretical results of##2##4##(2008-2#1)(2008-3#1)
The theoretical results##4##3##(2008-2#2)(2008-3#2)
The theoretical##43##2##(1994-9#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
The theory and the##2##4##(2008-3#2)
The theory and##4##3##(2007-12#1)(2008-3#3)
The theory is used to##2##5##(2008-3#2)
The theory is##7##3##(1990-8#1)(2008-3#6)
The theory of the##6##4##(2008-2#1)(2008-3#4)(2011-2#1)
The theory of this##3##4##(1990-8#1)(2007-12#1)(2008-3#1)
The theory of##14##3##(1990-8#1)(1992-3#1)(2007-12#2)(2008-2#2)(2008-3#7)(2011-2#1)
The theory##35##2##(1990-5#1)(1990-8#2)(1992-3#1)(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#17)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
The therapeutic approach to##2##4##(2008-6#1)(2009-6#1)
The therapeutic effect##3##3##(1996-3#1)(2010-6#1)(2012-3#1)
The therapeutic efficacy of##2##4##(1990-5#1)(2008-5#1)
The therapeutic potential of##2##4##(2008-11#1)(2012-12#1)
The therapeutic use of##2##4##(2008-7#1)(2013-8#1)
The therapeutic value of##2##4##(1997-4#1)(2007-7#1)
The therapeutic##23##2##(1990-5#1)(1990-6#1)(1994-8#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The therapy for##2##3##(1996-6#1)(1997-4#1)
The therapy is##2##3##(1993-6#1)(2008-5#1)
The therapy of choice##2##4##(1992-9#1)(2013-1#1)
The therapy of##4##3##(1990-6#1)(1992-9#1)(1993-6#1)(2013-1#1)
The therapy was##2##3##(2008-5#2)
The therapy##10##2##(1990-6#1)(1992-9#1)(1993-6#2)(1996-6#1)(1997-4#1)(2008-5#3)(2013-1#1)
The thermal analysis##2##3##(2008-10#2)
The thermal expansion coefficient##2##4##(2008-3#2)
The thermal##17##2##(1994-3#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#4)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
The thermo-optic##2##2##(2007-11#1)(2008-3#1)
The thermodynamic data##2##3##(2008-10#2)
The thermodynamic dissociation constant##2##4##(2008-10#2)
The thermodynamic dissociation##3##3##(2008-10#3)
The thermodynamic model of inorganic arsenic##2##6##(2008-10#2)
The thermodynamic parameters##5##3##(1996-2#1)(2008-10#4)
The thermodynamic##20##2##(1996-2#1)(1997-2#1)(2008-10#15)(2008-9#1)(2009-6#1)(2010-5#1)
The thermodynamics##2##2##(1990-8#1)(2008-10#1)
The thick##2##2##(2008-10#2)
The thickness and##2##3##(2007-11#1)(2008-3#1)
The thickness of the##8##4##(1991-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)
The thickness of##11##3##(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-2#1)
The thickness##17##2##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-9#1)(2009-7#1)(2010-2#1)
The thin##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
The thin-film##2##2##(2008-10#1)(2008-3#1)
The thin-layer##2##2##(1994-3#1)(2012-3#1)
The third ORF##2##3##(1996-6#1)(2008-10#1)
The third case##2##3##(2007-10#1)(2008-8#1)
The third group included##2##4##(2007-11#1)(2008-10#1)
The third group##3##3##(2007-11#1)(2008-10#2)
The third method was##2##4##(2008-10#2)
The third method##6##3##(1995-2#1)(2008-10#4)(2010-4#1)
The third part provides guidance for accessing mutation data##2##9##(2008-4#2)
The third patient##5##3##(1997-6#1)(2008-1#1)(2009-1#1)(2012-12#1)(2013-1#1)
The third phase##2##3##(1993-12#1)(2008-10#1)
The third##45##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1993-12#2)(1995-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-2#2)(2008-4#6)(2008-8#1)(2009-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
The third-order nonlinear optical##2##4##(2007-11#2)
The third-order##3##2##(2007-11#2)(2008-10#1)
The thoracic drainage system is##2##5##(2010-8#2)
The thoracic##5##2##(1991-3#1)(2010-8#2)(2011-2#1)(2013-1#1)
The threat of##2##3##(1991-3#1)(1995-12#1)
The threat##3##2##(1991-3#1)(1995-12#1)(2008-10#1)
The three analytes could be##2##5##(2008-10#2)
The three anthropometric indicators##2##4##(2010-6#2)
The three compounds##3##3##(1990-8#1)(2008-10#1)(2011-1#1)
The three groups##2##3##(1995-5#1)(2010-7#1)
The three isoforms of##2##4##(1991-12#1)(1995-2#1)
The three isolates##3##3##(2008-10#3)
The three main##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
The three methods##2##3##(1994-12#1)(2008-6#1)
The three other##2##3##(1991-8#1)(2008-10#1)
The three species##2##3##(2008-10#1)(2010-2#1)
The three##68##2##(1990-12#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
The three-dimensional (3-D)##2##3##(2008-2#2)
The three-dimensional structure of##6##4##(1991-12#1)(1992-12#1)(1993-11#1)(1997-4#1)(1997-6#1)(2008-7#1)
The three-dimensional structure##7##3##(1991-12#1)(1992-12#1)(1993-11#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-8#1)
The three-dimensional##18##2##(1991-12#1)(1992-12#1)(1993-11#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2011-3#1)(2013-1#1)
The threshold concentrations##2##3##(1993-12#1)(2008-10#1)
The threshold pump##2##3##(2008-2#1)(2008-3#1)
The threshold##13##2##(1993-12#3)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)
The thresholds##2##2##(1996-3#1)(2008-4#1)
The thrombosed##2##2##(1997-3#1)(2007-8#1)
The throughput of the##2##4##(2008-10#2)
The throughput of##3##3##(2008-10#2)(2008-2#1)
The throughput was##2##3##(2008-10#2)
The throughput##5##2##(2008-10#4)(2008-2#1)
The thymine##3##2##(1992-6#2)(2008-11#1)
The thyroid gland##2##3##(1996-3#1)(2008-11#1)
The thyroid hormone receptor##2##4##(1994-11#1)(2008-4#1)
The thyroid hormone##3##3##(1994-11#2)(2008-4#1)
The thyroid##7##2##(1994-11#2)(1996-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-3#1)
The tibial##2##2##(2007-12#1)(2013-8#1)
The tight##3##2##(1990-8#1)(2007-11#1)(2008-8#1)
The tilt##3##2##(2008-3#3)
The time constants##2##3##(2008-2#2)
The time course for##2##4##(1993-6#1)(1995-6#1)
The time course of##6##4##(1993-11#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)
The time course##9##3##(1990-8#1)(1993-11#1)(1993-6#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)
The time courses of##3##4##(1992-11#1)(1995-6#1)(2008-10#1)
The time for##2##3##(2008-10#1)(2009-9#1)
The time from##2##3##(1994-7#1)(2011-2#1)
The time length##2##3##(2008-11#2)
The time of the##3##4##(2007-11#2)(2008-10#1)
The time of##7##3##(2007-11#3)(2008-10#3)(2008-5#1)
The time required for the coprecipitation##2##6##(2008-10#2)
The time required for the##3##5##(2008-10#3)
The time required for##8##4##(2008-10#5)(2008-3#1)(2010-7#1)(2011-2#1)
The time required to reach the##2##6##(1996-5#1)(2008-10#1)
The time required to##5##4##(1996-5#1)(2008-10#2)(2008-9#1)(2011-2#1)
The time required##13##3##(1996-5#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#2)
The time resolution is##2##4##(2008-3#2)
The time resolution##3##3##(2007-12#1)(2008-3#2)
The time series##2##3##(2008-11#1)(2013-1#1)
The time taken##2##3##(1992-12#1)(2010-6#1)
The time##67##2##(1990-8#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-7#1)(1995-11#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#17)(2008-11#5)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
The time-course of the##2##4##(1994-11#1)(2008-8#1)
The time-course of##3##3##(1994-11#1)(2008-8#1)(2013-8#1)
The time-course##4##2##(1994-11#1)(1995-2#1)(2008-8#1)(2013-8#1)
The time-dependent##5##2##(2008-2#3)(2008-3#2)
The time-resolved##4##2##(1992-6#1)(2007-12#1)(2008-3#1)(2009-3#1)
The timing and##3##3##(1997-4#1)(2007-12#1)(2009-12#1)
The timing of##4##3##(2008-10#1)(2010-10#1)(2010-8#1)(2013-1#1)
The timing##9##2##(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2009-12#1)(2010-10#1)(2010-8#1)(2013-1#1)
The tin##2##2##(2008-10#2)
The tissue##9##2##(1990-12#1)(1993-6#1)(1994-5#1)(2008-12#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
The tissues##3##2##(1991-2#1)(2008-7#1)(2010-8#1)
The titanium##3##2##(2008-10#2)(2008-8#1)
The titer of##2##3##(1994-9#1)(2008-10#1)
The titer##4##2##(1993-3#1)(1994-9#1)(2008-10#1)(2010-1#1)
The title compounds##2##3##(2011-1#2)
The title##4##2##(2008-10#2)(2011-1#2)
The titrant##2##2##(2008-10#2)
The titration is##2##3##(2008-10#2)
The titration##7##2##(2008-10#7)
The tolerability##2##2##(2007-11#1)(2013-1#1)
The tolerance limit##2##3##(2008-10#2)
The tolerance limits for##2##4##(2008-10#2)
The tolerance limits of electrolytes##2##5##(2008-10#2)
The tolerance limits of##5##4##(2008-10#5)
The tolerance limits##7##3##(2008-10#7)
The tolerance of the##2##4##(1990-11#1)(2008-10#1)
The tolerance of##4##3##(1990-11#1)(1993-11#1)(2007-12#1)(2008-10#1)
The tolerance##15##2##(1990-11#1)(1993-11#1)(2007-12#1)(2008-10#12)
The tomato##3##2##(2008-10#2)(2008-8#1)
The tomographic##2##2##(1990-3#1)(2012-12#1)
The tool was##2##3##(2008-11#2)
The tool##4##2##(2008-1#2)(2008-11#2)
The tools and##2##3##(2008-8#1)(2010-12#1)
The tools used to##2##4##(1992-2#1)(2008-7#1)
The tools used##3##3##(1990-10#1)(1992-2#1)(2008-7#1)
The tools##7##2##(1990-10#1)(1992-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
The top##3##2##(1992-8#1)(2008-1#1)(2010-12#1)
The topic of the##2##4##(2008-12#1)(2011-2#1)
The topic of##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
The topic##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
The topical##2##2##(2008-2#1)(2009-6#1)
The topics##6##2##(1993-12#1)(1997-2#1)(2008-3#1)(2008-7#2)(2010-11#1)
The total RNA##2##3##(1992-3#1)(2008-9#1)
The total amount of##4##4##(1993-1#1)(1997-3#1)(2008-10#2)
The total analysis time was##2##5##(2008-10#2)
The total cholesterol was lower than normal in TT##2##9##(2007-7#2)
The total cholesterol##3##3##(2007-7#2)(2008-1#1)
The total concentration##2##3##(2008-10#1)(2011-10#1)
The total content of##2##4##(2008-10#2)
The total cost of##3##4##(1990-12#1)(1996-11#1)(2009-12#1)
The total energy##2##3##(2008-2#1)(2008-7#1)
The total error##2##3##(2008-3#2)
The total length of the sequenced regions##2##7##(1997-6#1)(1997-8#1)
The total length of the##4##5##(1996-6#1)(1997-6#1)(1997-8#1)(2012-12#1)
The total number of##16##4##(1993-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
The total of##4##3##(2007-10#1)(2008-6#3)
The total optical##2##3##(2008-2#1)(2008-3#1)
The total phenolic content was##2##5##(2008-10#1)(2009-6#1)
The total phenolic content##3##4##(2008-10#2)(2009-6#1)
The total phenolic##4##3##(2008-10#2)(2009-6#1)(2012-2#1)
The total sorption capacity of the resin was##2##8##(2008-10#2)
The total sorption capacity##3##4##(2008-10#3)
The total time of##2##4##(2008-10#2)
The total time required for##3##5##(2008-10#3)
The total time##6##3##(2008-10#6)
The total treatment##2##3##(1993-9#1)(1996-11#1)
The total##143##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#39)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#11)(2008-5#5)(2008-6#6)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
The town of Cabar##2##4##(2011-2#2)
The toxic##5##2##(1990-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
The toxicity of this##2##4##(2008-10#1)(2008-12#1)
The toxicity of##17##3##(1995-8#1)(1996-3#1)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#3)(2011-2#1)
The toxicity tests##3##3##(2008-10#3)
The toxicity##29##2##(1990-12#1)(1991-3#2)(1992-8#1)(1995-8#2)(1996-3#1)(2007-11#1)(2008-10#9)(2008-11#5)(2008-12#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
The toxin##4##2##(2008-10#4)
The trace element##4##3##(1993-2#2)(2008-10#2)
The trace##8##2##(1993-2#2)(2008-10#6)
The tracer##2##2##(1994-2#1)(2009-12#1)
The tracheal system##2##3##(2007-12#2)
The tracheal##4##2##(1991-9#1)(1997-1#1)(2007-12#2)
The track##3##2##(2008-2#3)
The trade-off between##3##3##(1995-2#1)(2008-3#2)
The trade-off##5##2##(1995-2#1)(2008-3#3)(2008-8#1)
The tradition of##2##3##(1995-1#1)(2013-8#1)
The traditional method##2##3##(2008-10#1)(2008-9#1)
The traditional##20##2##(1991-12#1)(1992-6#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-8#1)(2013-1#1)
The trafficking##2##2##(2008-11#1)(2009-8#1)
The training of##5##3##(1994-12#3)(2007-8#1)(2011-2#1)
The training##11##2##(1991-3#1)(1994-12#3)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-2#2)(2013-1#1)
The trans-sinusal frontal approach##3##4##(2006-12#3)
The transcript of##2##3##(1995-8#1)(2008-8#1)
The transcript##6##2##(1994-12#1)(1995-8#1)(1996-10#1)(2008-2#1)(2008-8#2)
The transcription factor##4##3##(1994-11#1)(2007-8#1)(2009-8#1)(2013-1#1)
The transcription level of the predicted genes##2##7##(1997-6#1)(1997-8#1)
The transcription start point##2##4##(1991-9#1)(1993-9#1)
The transcription start##3##3##(1991-9#1)(1993-9#1)(2008-9#1)
The transcription##11##2##(1991-9#2)(1993-9#1)(1994-11#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
The transcriptional activity of##2##4##(1996-5#1)(2010-4#1)
The transcriptional start##2##3##(1994-11#2)
The transcriptional##12##2##(1991-10#1)(1993-11#1)(1993-2#1)(1994-11#2)(1996-12#1)(1996-5#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-12#1)
The transcriptome##2##2##(2009-10#2)
The transcripts of##2##3##(1991-12#2)
The transduced##2##2##(1997-4#2)
The transduction did not affect the expression of Fas##2##9##(2008-8#2)
The transfected cells were##2##4##(1991-2#1)(1994-8#1)
The transfected cells##3##3##(1991-2#1)(1994-8#1)(2008-11#1)
The transfection activity of the lipopolylysine##2##6##(1991-5#2)
The transfection of##2##3##(1995-2#1)(2008-11#1)
The transfection##8##2##(1991-5#2)(1995-2#1)(2008-11#4)(2011-1#1)
The transfer of##8##3##(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
The transfer##16##2##(1993-12#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)
The transferred proteins are bound to the surface of the membrane##2##11##(2008-4#2)
The transformants##3##2##(1993-12#1)(2008-10#2)
The transformation of##4##3##(1995-2#1)(2007-10#1)(2008-5#1)(2008-9#1)
The transformation##11##2##(1991-2#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2013-1#1)
The transformed##5##2##(1990-5#1)(2008-10#3)(2008-2#1)
The transfusion##2##2##(1996-9#1)(2008-12#1)
The transgene##2##2##(1996-12#1)(2008-10#1)
The transgenic##5##2##(1992-8#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-8#1)
The transient expression##2##3##(2008-11#1)(2008-9#1)
The transient##8##2##(1990-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#2)
The transition between the##2##4##(1991-6#1)(2007-12#1)
The transition from##5##3##(1994-2#1)(1994-3#1)(1997-3#1)(2007-12#1)(2013-1#1)
The transition##14##2##(1991-6#1)(1992-10#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
The translated##2##2##(1993-6#1)(1997-3#1)
The translation function##2##3##(1992-9#1)(2008-8#1)
The translation##5##2##(1992-9#1)(1997-3#1)(2008-8#1)(2008-9#1)(2009-12#1)
The translational##2##2##(1991-9#1)(2008-9#1)
The translocation of##2##3##(1993-8#1)(2008-11#1)
The translocation##5##2##(1991-2#1)(1993-8#1)(1996-6#1)(2008-11#1)(2008-8#1)
The translocator protein (TSPO) is a##2##6##(2012-2#2)
The translocator protein (TSPO)##3##4##(2012-2#3)
The translocator protein##4##3##(1995-2#1)(2012-2#3)
The translucency##2##2##(2012-2#2)
The transmission characteristics of Ge-coated##2##5##(2008-3#2)
The transmission of##5##3##(1994-12#1)(2007-11#2)(2008-3#2)
The transmission spectrum of##2##4##(2007-12#1)(2008-2#1)
The transmission##17##2##(1994-12#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#6)(2009-7#1)
The transmittance of the##2##4##(2007-12#1)(2008-2#1)
The transmittance of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
The transmittance##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
The transmitter##2##2##(2007-11#1)(2008-3#1)
The transparent##2##2##(2008-3#1)(2013-8#1)
The transport of the##3##4##(1992-3#1)(2008-10#2)
The transport of##10##3##(1990-2#1)(1992-3#2)(1994-6#1)(1994-8#1)(2008-10#3)(2008-7#1)(2008-9#1)
The transport##16##2##(1990-2#1)(1992-3#2)(1994-6#1)(1994-8#2)(1995-6#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
The transportation of##2##3##(2008-10#1)(2009-10#1)
The transporters##2##2##(1993-3#2)
The transradial approach for##2##4##(2011-2#2)
The transradial approach##3##3##(2011-2#3)
The transverse and##2##3##(2007-12#1)(2008-2#1)
The transverse##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
The trapped##5##2##(1994-11#1)(2007-11#1)(2008-10#3)
The traumatic lung pseudocyst is a rare complication of##2##9##(2013-1#2)
The treated##2##2##(2008-11#1)(2008-8#1)
The treatment and##2##3##(2008-6#1)(2013-1#1)
The treatment consists##3##3##(1990-6#1)(1991-6#1)(2012-12#1)
The treatment for##5##3##(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
The treatment group##2##3##(2008-12#1)(2008-9#1)
The treatment had##2##3##(1994-6#1)(2013-1#1)
The treatment is##6##3##(1990-9#1)(1993-2#1)(1996-11#1)(1997-3#1)(2010-1#1)(2013-1#1)
The treatment may##2##3##(2010-10#1)(2013-1#1)
The treatment of acute##2##4##(1994-11#1)(2013-1#1)
The treatment of choice for##2##5##(2008-4#1)(2010-12#1)
The treatment of choice is##3##5##(1990-2#1)(1994-5#1)(2013-1#1)
The treatment of choice##5##4##(1990-2#1)(1994-5#1)(2008-4#1)(2010-12#1)(2013-1#1)
The treatment of chronic##2##4##(1997-1#1)(2012-3#1)
The treatment of mice with MPTP##2##6##(2008-7#2)
The treatment of pathological fractures with##2##6##(2007-11#2)
The treatment of the##2##4##(1992-7#1)(1993-3#1)
The treatment of##55##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)
The treatment strategy##3##3##(1996-3#1)(1997-8#1)(2008-7#1)
The treatment was administered##2##4##(1993-2#1)(2008-5#1)
The treatment was continued##2##4##(1991-3#1)(2008-10#1)
The treatment was well tolerated##2##5##(1992-12#1)(2012-3#1)
The treatment was##16##3##(1990-3#1)(1991-3#2)(1992-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The treatment##128##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#5)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#1)
The treatments available for##2##4##(2008-2#1)(2010-7#1)
The treatments were##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
The treatments##9##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#2)
The trees##2##2##(2008-10#1)(2011-2#1)
The tremendous##3##2##(2007-10#1)(2009-12#1)(2010-6#1)
The trend in##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
The trend of the##2##4##(2008-10#1)(2012-7#1)
The trend of##3##3##(2008-10#1)(2008-12#1)(2012-7#1)
The trend toward##2##3##(1996-2#1)(1997-2#1)
The trend was##2##3##(2008-5#1)(2012-12#1)
The trend##12##2##(1992-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2012-12#2)(2012-7#1)(2013-1#1)
The trends##2##2##(2007-10#1)(2008-7#1)
The trial will be conducted##2##5##(2008-5#2)
The trial will##4##3##(2008-5#4)
The trial##10##2##(1992-3#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2011-2#1)
The trials##4##2##(1995-5#1)(1997-1#1)(2007-8#1)(2008-5#1)
The triglycerides##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
The trinuclear##2##2##(1997-7#2)
The triple##2##2##(2009-8#1)(2013-1#1)
The trout##2##2##(2008-5#2)
The true incidence##2##3##(2010-6#1)(2011-2#1)
The true linear wear rate was##2##6##(2008-8#2)
The true##12##2##(1990-6#1)(1992-2#1)(1997-3#1)(2007-8#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-3#1)(2010-6#1)(2011-2#1)
The truth##3##2##(1992-6#1)(1994-2#1)(2008-6#1)
The tube was##2##3##(1991-5#2)
The tube##5##2##(1991-5#2)(2008-10#1)(2008-9#1)(2011-1#1)
The tumor arose from the##2##5##(2007-8#1)(2013-1#1)
The tumor arose##3##3##(1991-2#1)(2007-8#1)(2013-1#1)
The tumor microenvironment##2##3##(2011-1#2)
The tumor necrosis factor##2##4##(2008-4#1)(2012-2#1)
The tumor necrosis##3##3##(1994-11#1)(2008-4#1)(2012-2#1)
The tumor suppressor##4##3##(1990-12#1)(1995-6#1)(2009-4#1)(2011-2#1)
The tumor was##10##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-2#1)(2013-1#1)(2013-8#1)
The tumor##38##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-9#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#4)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
The tumor-specific##2##2##(1994-3#1)(2008-6#1)
The tumors in##2##3##(1990-9#1)(2013-1#1)
The tumors were##2##3##(1996-5#1)(2006-12#1)
The tumors##9##2##(1990-9#1)(1991-8#1)(1996-5#1)(2006-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
The tumour was diagnosed##2##4##(2007-8#1)(2012-2#1)
The tumour was resected##3##4##(2008-6#1)(2008-7#2)
The tumour was##12##3##(1991-6#1)(2007-8#1)(2008-6#2)(2008-7#5)(2012-12#1)(2012-2#1)(2013-8#1)
The tumour##16##2##(1991-6#1)(1997-6#1)(2007-8#1)(2008-6#3)(2008-7#7)(2012-12#1)(2012-2#1)(2013-8#1)
The tunable##2##2##(2008-2#1)(2008-3#1)
The tungsten##2##2##(2008-10#2)
The tuning range##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
The tuning##8##2##(1996-2#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
The tunnel##2##2##(1996-2#1)(2008-3#1)
The twentieth anniversary of##2##4##(1995-1#1)(2013-1#1)
The two Category##2##3##(2012-2#2)
The two cases were##2##4##(1997-8#1)(2010-3#1)
The two cases##3##3##(1997-8#1)(2008-7#1)(2010-3#1)
The two cell##2##3##(2008-11#2)
The two clones had##2##4##(1993-8#1)(2008-11#1)
The two clones##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
The two compounds##2##3##(1997-7#2)
The two cultivars were crossed with##2##6##(2008-10#2)
The two different##2##3##(2008-10#2)
The two distinct##2##3##(1997-7#1)(2008-10#1)
The two groups of patients##2##5##(1995-6#1)(2013-1#1)
The two groups of##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
The two groups were comparable##3##5##(1992-5#1)(2008-6#1)(2011-2#1)
The two groups were compared with respect to##2##8##(2011-1#1)(2011-2#1)
The two groups were compared##3##5##(2011-1#1)(2011-2#2)
The two groups were##8##4##(1990-5#1)(1992-5#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#3)
The two groups##14##3##(1990-5#1)(1992-5#1)(1995-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
The two largest##4##3##(2008-10#4)
The two laser beams are##2##5##(2008-3#2)
The two latter##2##3##(1990-11#1)(2008-10#1)
The two main##5##3##(1996-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-8#1)
The two major##6##3##(1990-7#1)(1993-12#1)(1996-12#1)(1996-4#1)(2008-5#1)(2012-2#1)
The two methods are##2##4##(2008-10#2)
The two methods##3##3##(1997-2#1)(2008-10#2)
The two most common##3##4##(2007-12#2)(2007-6#1)
The two most important##2##4##(1993-1#1)(1993-11#1)
The two most##6##3##(1992-6#1)(1993-1#1)(1993-11#1)(2007-12#2)(2007-6#1)
The two other##4##3##(1994-3#1)(1996-2#1)(2008-5#1)(2012-12#1)
The two pathogens##2##3##(2008-10#2)
The two proteins##2##3##(1992-6#1)(2008-12#1)
The two species are##2##4##(2008-3#1)(2008-7#1)
The two species##4##3##(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)
The two subunits in##2##4##(1991-12#1)(2008-9#1)
The two techniques##2##3##(2008-10#2)
The two treatment groups##2##4##(2007-8#1)(2008-5#1)
The two types of##2##4##(2008-10#1)(2008-2#1)
The two##202##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#2)(1991-11#2)(1991-12#2)(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-10#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2007-11#3)(2007-12#7)(2007-6#1)(2007-8#3)(2008-10#51)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-11#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
The two-bounce##2##2##(2008-2#2)
The two-color##2##2##(2008-2#1)(2008-3#1)
The two-dimensional##6##2##(1996-5#1)(2008-2#2)(2008-3#3)
The two-photon absorption coefficient##2##4##(2007-11#1)(2007-12#1)
The two-photon fluorescence##2##3##(2008-2#1)(2008-3#1)
The two-photon##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
The two-stage##2##2##(2008-1#1)(2008-6#1)
The two-step##4##2##(1990-7#1)(2008-10#2)(2008-3#1)
The type II##3##3##(1995-11#1)(1995-2#1)(1997-7#1)
The type of surgical procedure##2##5##(2012-2#2)
The type of##14##3##(1990-6#1)(1993-3#1)(1995-12#1)(2007-11#2)(2008-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
The type strain##4##3##(2011-2#4)
The type##25##2##(1990-6#1)(1991-5#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-11#3)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#3)
The types of##10##3##(1992-3#1)(1995-2#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-2#1)
The types##11##2##(1992-3#1)(1995-2#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-12#1)
The typical approach##2##3##(2008-3#1)(2009-5#1)
The typical##17##2##(1996-2#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#2)(2010-6#1)(2011-1#1)
The tyrosine kinase inhibitor##4##4##(1996-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
The tyrosine phosphorylation of##2##4##(1997-2#1)(2008-8#1)
The tyrosine##8##2##(1994-8#1)(1996-12#1)(1997-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
The ubiquitous##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
The ultimate goal of##2##4##(2009-6#1)(2010-12#1)
The ultimate goal##3##3##(2008-11#1)(2009-6#1)(2010-12#1)
The ultimate goals##2##3##(2008-10#1)(2008-7#1)
The ultimate##19##2##(1993-8#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-6#2)(2010-12#1)(2012-3#1)
The ultrasonic##3##2##(1990-9#1)(2008-4#1)(2009-12#1)
The ultrasound examination##3##3##(1991-6#1)(1996-11#1)(2007-11#1)
The ultrasound-modulated laser light reflects the local optical and mechanical properties in the ultrasonic beam and##2##16##(2007-12#1)(2008-3#1)
The ultrastructural##7##2##(2007-12#3)(2008-5#1)(2008-7#2)(2011-2#1)
The ultrastructure and function of the silk-producing basitarsus##2##8##(2007-12#2)
The ultrastructure and##3##3##(2007-12#3)
The ultrastructure of Sorubim lima##2##5##(2008-7#2)
The ultrastructure of##9##3##(2007-12#2)(2008-5#1)(2008-7#4)(2009-10#2)
The ultrastructure##12##2##(2007-12#5)(2008-5#1)(2008-7#4)(2009-10#2)
The ultraviolet##2##2##(2008-3#1)(2011-2#1)
The unbiased##2##2##(1991-3#1)(2008-10#1)
The uncertainties##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
The uncertainty budget##2##3##(2008-10#2)
The uncertainty is##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
The uncertainty of##2##3##(2008-3#2)
The uncertainty##12##2##(2008-10#4)(2008-2#2)(2008-3#5)(2012-12#1)
The underlying mechanism for the##2##5##(2008-7#1)(2011-1#1)
The underlying mechanism##5##3##(2007-11#2)(2008-1#1)(2008-7#1)(2011-1#1)
The underlying mechanisms##2##3##(1990-2#1)(2008-11#1)
The underlying pathology##2##3##(1992-6#1)(2008-12#1)
The underlying##22##2##(1990-2#1)(1992-6#1)(1996-3#1)(1997-4#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
The understanding of the##3##4##(1993-8#1)(1995-5#1)(2007-12#1)
The understanding of##5##3##(1993-8#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-9#1)
The understanding##6##2##(1993-8#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-9#2)
The uneven##2##2##(1993-6#1)(2008-3#1)
The unexpected##4##2##(1991-12#1)(1992-2#1)(2008-7#1)(2009-6#1)
The unfolding of##2##3##(1995-5#2)
The unfolding##6##2##(1995-2#1)(1995-3#1)(1995-5#4)
The unique characteristics##2##3##(1992-1#1)(2007-11#1)
The unique feature of the##2##5##(2008-10#1)(2008-2#1)
The unique feature of##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
The unique features of##2##4##(2008-10#1)(2011-2#1)
The unique structure of this##2##5##(1997-3#1)(2009-3#1)
The unique##23##2##(1990-8#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)
The unit also contains##2##4##(2008-1#1)(2008-4#1)
The unit also includes##2##4##(2008-1#1)(2008-4#1)
The unit also presents##2##4##(2008-4#1)(2008-9#1)
The unit also##9##3##(2008-1#2)(2008-4#6)(2008-9#1)
The unit can be##2##4##(2008-11#1)(2008-2#1)
The unit describes the##3##4##(2008-4#2)(2008-9#1)
The unit describes##5##3##(2008-4#4)(2008-9#1)
The unit details##2##3##(2008-9#2)
The unit discusses##4##3##(2008-4#1)(2008-9#3)
The unit includes##3##3##(2008-4#2)(2008-9#1)
The unit presents##2##3##(2008-9#2)
The unit provides##3##3##(2008-9#3)
The unit##41##2##(1996-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#17)(2008-8#1)(2008-9#17)(2012-12#1)
The university##2##2##(2011-2#2)
The unknown##2##2##(1995-6#1)(2008-10#1)
The unraveling of a joint venture##2##6##(1994-3#2)
The unstable##4##2##(2008-10#2)(2008-9#1)(2009-4#1)
The unusual##8##2##(1990-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-5#1)(2013-1#1)
The upper frequency range##2##4##(2007-12#2)
The upper##9##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
The upregulation of##2##3##(2012-2#1)(2013-8#1)
The upstream region of##2##4##(1994-6#1)(1996-3#1)
The upstream region##3##3##(1994-6#1)(1996-3#1)(1997-2#1)
The uptake and##3##3##(1992-9#1)(2008-10#1)(2010-12#1)
The uptake of##9##3##(1990-8#1)(1992-3#1)(1995-11#1)(1997-2#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-11#1)
The uptake##16##2##(1990-8#1)(1992-3#2)(1992-9#1)(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)
The urea reduction ratio##2##4##(1993-9#1)(2008-1#1)
The urethral##2##2##(2008-10#2)
The urgent##2##2##(2007-8#1)(2008-11#1)
The uric acid##2##3##(1990-11#1)(2008-5#1)
The urinary##4##2##(2008-1#2)(2008-10#1)(2009-12#1)
The urine##6##2##(1995-3#1)(2008-10#5)
The usage of##3##3##(2008-1#1)(2008-10#1)(2008-6#1)
The use and##4##3##(1990-2#1)(1992-12#1)(2008-10#1)(2009-8#1)
The use of SPME##2##4##(2008-10#2)
The use of X-ray##2##4##(2008-10#1)(2008-4#1)
The use of a large##2##5##(2008-10#1)(2008-11#1)
The use of a##44##4##(1990-3#1)(1990-8#1)(1991-2#1)(1993-2#1)(1994-11#1)(1994-12#2)(2007-11#4)(2007-8#2)(2008-10#14)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
The use of alternative##2##4##(2008-10#1)(2010-4#1)
The use of an##9##4##(1993-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)
The use of antibiotics##2##4##(2011-2#1)(2012-2#1)
The use of appropriate##3##4##(1993-2#1)(2008-5#1)(2009-8#1)
The use of both##2##4##(2010-10#1)(2013-1#1)
The use of cell##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
The use of composite##2##4##(1990-5#1)(2008-10#1)
The use of contrast-enhanced US##2##5##(2008-7#1)(2010-12#1)
The use of contrast-enhanced##3##4##(2008-7#1)(2010-12#2)
The use of different##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
The use of diffractive##2##4##(2008-3#2)
The use of flow cytometry##3##5##(2008-9#3)
The use of gating technology##2##5##(2008-11#2)
The use of genetic##2##4##(2008-10#1)(2011-2#1)
The use of highly##2##4##(2007-12#1)(2010-4#1)
The use of human skin##2##5##(2008-5#1)(2012-3#1)
The use of human##3##4##(2008-11#1)(2008-5#1)(2012-3#1)
The use of laser##2##4##(1991-1#1)(2008-10#1)
The use of medicines##2##4##(2008-11#2)
The use of modified##2##4##(2008-10#1)(2008-4#1)
The use of molecular##2##4##(1997-7#1)(2008-11#1)
The use of monoclonal antibodies##2##5##(2008-11#2)
The use of multiple databases often helps researchers understand the structure and function of proteins##2##15##(2008-2#1)(2008-4#1)
The use of multiple##3##4##(2008-2#1)(2008-4#1)(2010-9#1)
The use of multivariate spectrophotometric calibration for the simultaneous determination of##2##11##(2008-10#2)
The use of optical coherence tomography##2##6##(2011-7#2)
The use of optical##4##4##(2007-11#1)(2008-3#1)(2011-7#2)
The use of oral##3##4##(1991-4#1)(1996-3#1)(1997-4#1)
The use of order patterns##2##5##(2008-11#2)
The use of phase##2##4##(2008-2#1)(2008-3#1)
The use of propensity scores in pharmacoepidemiologic research##2##8##(2008-11#2)
The use of prophylactic antibiotics##2##5##(2007-12#1)(2008-7#1)
The use of recombinant human##2##5##(2008-1#1)(2008-7#1)
The use of reflection##2##4##(2008-11#1)(2008-12#1)
The use of scanning##2##4##(2008-10#1)(2008-7#1)
The use of sodium##2##4##(1990-2#1)(2010-8#1)
The use of structured##2##4##(2007-10#1)(2008-11#1)
The use of such##2##4##(2008-10#1)(2008-11#1)
The use of synthetic##2##4##(2007-8#1)(2013-7#1)
The use of the generalized Lorenz-Mie theory##2##7##(2008-2#1)(2008-3#1)
The use of the##40##4##(1990-6#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
The use of these##7##4##(1991-3#1)(2008-10#4)(2008-5#1)(2008-7#1)
The use of this##7##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-9#1)
The use of##504##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-7#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#5)(2007-11#17)(2007-12#10)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2008-1#5)(2008-10#125)(2008-11#44)(2008-12#11)(2008-2#11)(2008-3#18)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#23)(2008-8#7)(2008-9#12)(2009-1#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#19)(2011-3#1)(2011-7#3)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#4)
The use##508##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#5)(1992-7#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#5)(2007-11#17)(2007-12#10)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2008-1#5)(2008-10#126)(2008-11#44)(2008-12#11)(2008-2#11)(2008-3#18)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#23)(2008-8#7)(2008-9#12)(2009-1#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#19)(2011-3#1)(2011-7#3)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#4)
The used techniques##2##3##(2008-10#1)(2013-1#1)
The useful lifetime of the##2##5##(2008-10#2)
The useful##4##2##(2008-10#4)
The usefulness of the proposed##2##5##(2007-11#1)(2008-10#1)
The usefulness of the##12##4##(2007-11#1)(2008-10#7)(2008-3#2)(2008-5#1)(2012-3#1)
The usefulness of these##2##4##(1992-6#1)(2008-4#1)
The usefulness of this approach was##2##6##(2008-10#2)
The usefulness of this##6##4##(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
The usefulness of##39##3##(1991-8#1)(1992-10#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
The user##2##2##(2008-2#1)(2010-8#1)
The usual methods##2##3##(2008-10#1)(2008-5#1)
The usual##8##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#3)
The utilisation of##2##3##(2008-10#1)(2012-12#1)
The utility and##2##3##(2008-10#1)(2008-9#1)
The utility of the##9##4##(1994-9#1)(1995-3#1)(2008-10#4)(2008-3#2)(2011-2#1)
The utility of this##3##4##(2008-10#2)(2008-8#1)
The utility of##23##3##(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
The utility##26##2##(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
The utilization of##10##3##(1992-12#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-7#2)(2011-2#1)(2013-7#1)
The vaccine is immunogenic##2##4##(2007-11#1)(2011-2#1)
The vaccine##5##2##(1993-3#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
The vaccinia##3##2##(2008-2#2)(2008-8#1)
The vaginal route was##2##4##(1994-2#1)(1995-12#1)
The vaginal##3##2##(1994-2#1)(1995-12#1)(2008-11#1)
The validated##2##2##(2008-10#1)(2011-2#1)
The validation of the method##2##5##(2008-10#2)
The validation of the procedure was##3##6##(2008-10#3)
The validation of the##7##4##(2008-10#7)
The validation of##11##3##(2008-10#9)(2008-11#2)
The validation parameters have shown good results##2##7##(2008-10#2)
The validation results##2##3##(2008-3#1)(2012-2#1)
The validation##19##2##(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
The validity and reliability of##2##5##(1994-6#1)(2013-8#1)
The validity of the analysis##2##5##(2008-2#1)(2008-3#1)
The validity of the method##3##5##(1990-8#1)(2008-10#2)
The validity of the proposed method was checked##2##8##(2008-10#2)
The validity of the proposed method##3##6##(2008-10#2)(2008-3#1)
The validity of the theoretical##2##5##(2008-3#2)
The validity of the##21##4##(1990-5#1)(1990-8#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#9)(2008-9#1)(2011-1#2)
The validity of these##2##4##(1993-12#1)(2010-12#1)
The validity of this method is demonstrated##2##7##(2008-10#1)(2008-3#1)
The validity of this##3##4##(2008-10#2)(2008-3#1)
The validity of##32##3##(1990-5#1)(1990-8#1)(1993-12#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#11)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#2)
The validity##34##2##(1990-5#1)(1990-8#1)(1993-12#1)(1994-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#11)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#2)(2013-8#1)
The value of Km##2##4##(1990-3#1)(1990-7#1)
The value of a##2##4##(1991-6#1)(1992-1#1)
The value of the##4##4##(1994-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
The value of##43##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The value##46##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The values are##2##3##(1997-7#1)(2008-10#1)
The values for##3##3##(1991-9#1)(1995-2#1)(2008-10#1)
The values obtained by##4##4##(2008-10#4)
The values obtained for##2##4##(2008-10#1)(2012-12#1)
The values obtained##11##3##(1991-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-3#1)(2012-12#1)
The values of the##11##4##(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
The values of##30##3##(1991-12#2)(1995-5#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
The values were##3##3##(1993-8#1)(2008-10#1)(2009-4#1)
The values##55##2##(1991-11#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-5#1)(1993-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
The valve##3##2##(2007-8#1)(2008-3#1)(2010-8#1)
The vanadium##2##2##(2008-10#2)
The variability in##2##3##(2008-10#1)(2012-2#1)
The variability of##5##3##(1992-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
The variability##9##2##(1992-5#2)(2008-10#4)(2008-12#1)(2008-9#1)(2012-2#1)
The variable##6##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2013-1#1)
The variable-region peptide sequence##2##4##(1995-2#2)
The variables selected##2##3##(2008-10#1)(2008-9#1)
The variables that##3##3##(2008-10#2)(2011-2#1)
The variables##11##2##(2008-10#6)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)
The variance in the##2##4##(2008-10#1)(2008-8#1)
The variance of##3##3##(1997-3#1)(2008-3#1)(2011-1#1)
The variance##6##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
The variant##2##2##(1994-12#1)(1995-5#1)
The variants##2##2##(1996-6#1)(2010-3#1)
The variation coefficient##2##3##(2008-10#2)
The variation in the##2##4##(2009-5#1)(2010-8#1)
The variation in##12##3##(1993-9#1)(1994-8#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2009-5#1)(2009-9#1)(2010-8#2)(2013-8#1)
The variation of sorption with temperature yields##2##7##(2008-10#2)
The variation of sorption with temperature##3##6##(2008-10#3)
The variation of the##3##4##(2008-10#1)(2008-3#2)
The variation of##15##3##(1992-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#1)
The variation##31##2##(1992-11#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-5#1)(2009-9#1)(2010-8#2)(2013-1#1)(2013-8#1)
The variations in the##2##4##(2008-3#1)(2008-9#1)
The variations in##4##3##(2008-3#2)(2008-5#1)(2008-9#1)
The variations of the##2##4##(1992-8#1)(2008-10#1)
The variations of##5##3##(1992-8#1)(2008-10#3)(2008-2#1)
The variations##10##2##(1990-8#1)(1992-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)
The variety of##4##3##(1993-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
The various methods##2##3##(1995-9#1)(1997-4#1)
The various##24##2##(1990-3#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#1)(2010-7#1)
The varying##3##2##(1996-2#1)(2008-2#1)(2008-7#1)
The vascular##2##2##(2006-10#1)(2008-6#1)
The vast majority of patients##2##5##(2007-7#1)(2012-2#1)
The vast majority of##11##4##(1994-12#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-9#1)(2009-8#2)(2010-9#1)(2011-2#2)(2012-2#1)
The vast##12##2##(1994-12#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-9#1)(2011-2#2)(2012-2#1)
The vector##2##2##(2008-11#1)(2008-9#1)
The vectors are##3##3##(1991-7#1)(1993-12#1)(1994-12#1)
The vectors##7##2##(1990-5#1)(1991-7#1)(1993-12#2)(1994-12#1)(1994-5#1)(1997-4#1)
The velocimeter was##2##3##(2008-3#2)
The velocity of##2##3##(2008-10#1)(2008-3#1)
The velocity##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
The venous##2##2##(1996-9#1)(2012-3#1)
The versatility of the##6##4##(1996-5#1)(2008-10#3)(2008-4#2)
The versatility of##9##3##(1996-5#1)(2008-10#5)(2008-4#2)(2010-7#1)
The vertebral##4##2##(2007-8#2)(2011-2#1)(2012-2#1)
The vertebrate##3##2##(2008-4#1)(2009-11#1)(2011-2#1)
The vertical##5##2##(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)
The very high##3##3##(1992-12#1)(2008-10#2)
The very low##3##3##(1995-3#1)(2008-10#2)
The very##16##2##(1992-12#1)(1992-2#1)(1993-2#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-7#2)(2008-9#1)(2010-6#1)
The vesicle sensor was##2##4##(2008-10#2)
The viability of the##2##4##(2008-10#1)(2011-1#1)
The viability of##6##3##(2008-10#4)(2011-1#1)(2013-1#1)
The viable##2##2##(2008-11#2)
The vibration##2##2##(2008-3#1)(2012-2#1)
The vibrational spectra##2##3##(1993-11#1)(1996-2#1)
The vibrational##4##2##(1993-11#2)(1996-2#1)(2008-10#1)
The vibrations##2##2##(2008-2#1)(2010-2#1)
The vibrissal##2##2##(2011-2#2)
The view of##3##3##(1994-6#2)(1995-2#1)
The view##5##2##(1994-6#2)(1995-2#1)(1996-7#1)(2009-7#1)
The views of##3##3##(2008-12#2)(2012-2#1)
The viral RNA##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
The viral##9##2##(1990-2#1)(1993-6#1)(1994-1#1)(1994-7#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
The virtual##6##2##(1996-1#1)(1996-2#1)(2007-11#1)(2008-11#1)(2010-8#1)(2011-2#1)
The virulence of##6##3##(2008-10#4)(2008-11#1)(2009-6#1)
The virulence##7##2##(2008-10#5)(2008-11#1)(2009-6#1)
The virus is##2##3##(2008-10#1)(2011-2#1)
The virus was transmitted by##4##5##(2008-10#4)
The virus was##14##3##(2008-10#12)(2008-8#1)(2013-8#1)
The virus##29##2##(1990-11#1)(1991-6#1)(1993-11#1)(2007-12#1)(2008-10#22)(2008-8#1)(2011-2#1)(2013-8#1)
The viruses were##2##3##(2008-10#1)(2013-8#1)
The viruses##6##2##(2007-6#1)(2008-10#2)(2008-8#1)(2013-1#1)(2013-8#1)
The visceral cells##2##3##(2012-1#2)
The visibility of the##2##4##(2008-3#1)(2009-11#1)
The visibility of##3##3##(1994-3#1)(2008-3#1)(2009-11#1)
The visible##2##2##(2008-1#1)(2008-2#1)
The vision of##2##3##(2008-11#1)(2008-8#1)
The vision##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)
The visual##5##2##(1993-12#1)(2007-7#1)(2011-2#1)(2013-8#2)
The vitamin D endocrine system plays a##2##7##(2008-4#1)(2008-7#1)
The vitamin##5##2##(1990-3#1)(2008-11#1)(2008-4#2)(2008-7#1)
The volatile##4##2##(2008-10#4)
The voltage##4##2##(2008-10#3)(2009-12#1)
The voltammetric behavior of##3##4##(2008-10#3)
The voltammetric behaviour of##4##4##(2008-10#4)
The voltammetric##16##2##(2008-10#16)
The voltammograms##2##2##(2008-10#2)
The volume density##2##3##(1995-8#1)(2009-11#1)
The volume of the##6##4##(1997-8#1)(2007-10#2)(2008-10#2)(2008-9#1)
The volume of##14##3##(1991-11#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-10#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
The volume##21##2##(1991-11#2)(1991-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-10#2)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
The volumes of the##2##4##(1994-3#1)(2008-2#1)
The volumes of##3##3##(1994-3#1)(2008-2#1)(2012-12#1)
The volunteer##2##2##(1992-1#1)(1992-3#1)
The volunteers##3##2##(1992-1#1)(2008-3#1)(2012-2#1)
The vomeronasal##2##2##(1994-2#1)(2012-2#1)
The von Bertalanffy growth##2##4##(2010-8#1)(2013-7#1)
The von Hippel-Lindau##2##3##(2011-1#2)
The von##4##2##(2010-8#1)(2011-1#2)(2013-7#1)
The waiting##2##2##(1997-5#1)(2008-5#1)
The waiver##2##2##(1997-2#2)
The walking##2##2##(2009-4#1)(2013-1#1)
The wall##2##2##(2008-3#1)(2009-11#1)
The walls of the##2##4##(2008-6#1)(2012-2#1)
The war##3##2##(1992-9#1)(2007-11#1)(2008-11#1)
The water sac##3##3##(2007-12#3)
The water##12##2##(1990-2#1)(1993-2#1)(1993-9#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)
The water-soluble##2##2##(1992-9#1)(2008-10#1)
The wave front##4##3##(2008-2#1)(2008-3#3)
The wave##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
The wave-front##2##2##(2008-3#2)
The waveforms##2##2##(2007-11#1)(2008-2#1)
The waveguide##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
The wavelength and##2##3##(2007-11#1)(2007-12#1)
The wavelength dependence of the##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
The wavelength dependence##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
The wavelength modulation##2##3##(2008-10#1)(2008-3#1)
The wavelength of the##3##4##(2006-4#1)(2008-10#1)(2008-2#1)
The wavelength of##5##3##(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#2)
The wavelength range##2##3##(2008-10#1)(2008-3#1)
The wavelength##22##2##(2006-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#6)
The wavelength-dependent##2##2##(2008-2#1)(2008-3#1)
The wavelengths of excitation and emission were##3##7##(2008-10#3)
The wavelengths of excitation and emission##4##6##(2008-10#4)
The wavelengths of the##2##4##(2007-11#1)(2007-12#1)
The wavelengths of##7##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)
The wavelengths##8##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)
The wavelet transform can be##2##5##(2008-2#1)(2010-4#1)
The way of##2##3##(2009-4#1)(2012-2#1)
The way##7##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-2#1)
The ways in which##3##4##(1992-2#1)(2012-2#1)(2013-1#1)
The weak##5##2##(1994-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
The wealth of##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
The web##2##2##(2007-6#1)(2008-10#1)
The weight average molecular weight of##2##6##(1995-11#2)
The weight##6##2##(1995-11#2)(2008-10#1)(2010-4#1)(2012-12#1)(2012-3#1)
The weights of##2##3##(1994-8#1)(2008-5#1)
The well##2##2##(1991-5#1)(2007-12#1)
The well-known mechanism of OP toxicity is the inhibition of acetyl cholinesterase##2##12##(2013-1#2)
The well-known##5##2##(1990-5#1)(1993-8#1)(2008-10#1)(2013-1#2)
The west##2##2##(2008-10#1)(2010-8#1)
The wet##4##2##(1997-2#1)(2008-10#2)(2013-8#1)
The wheat##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
The whole S1##2##3##(2008-5#2)
The whole procedure##2##3##(1996-11#1)(2008-10#1)
The whole process could be completed in 1 min##2##9##(2008-10#2)
The whole process##3##3##(2008-10#3)
The whole##25##2##(1994-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#11)(2008-3#3)(2008-5#2)(2010-8#1)(2011-1#1)(2012-2#1)
The wide range of##2##4##(1994-12#1)(1997-6#1)
The wide variation##2##3##(1997-3#1)(2007-11#1)
The wide##11##2##(1992-5#1)(1993-6#1)(1994-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
The wide-spread use of##2##4##(2009-10#1)(2012-1#1)
The widely##2##2##(1993-8#1)(2008-6#1)
The widespread distribution of##4##4##(1992-8#1)(1993-6#1)(2008-10#1)(2012-3#1)
The widespread occurrence of##3##4##(1996-12#1)(1997-7#1)(2008-10#1)
The widespread use of##2##4##(2008-3#1)(2012-2#1)
The widespread##12##2##(1992-8#1)(1993-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-2#1)(2012-3#1)
The width of##2##3##(2008-10#1)(2008-7#1)
The width##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
The wild type##2##3##(2008-10#1)(2013-1#1)
The wild-type and mutant##2##4##(1993-8#1)(1997-3#1)
The wild-type##3##2##(1993-8#1)(1997-3#1)(2008-10#1)
The withdrawal##2##2##(1994-9#1)(2009-12#1)
The within-day and between-day##2##4##(1991-2#1)(2008-10#1)
The within-day##3##2##(1991-2#1)(2008-10#2)
The within-run and between-run##2##4##(2008-10#2)
The within-run##4##2##(2008-10#4)
The women had##2##3##(2008-11#2)
The women with##2##3##(2008-11#1)(2011-1#1)
The women##7##2##(1992-4#1)(1996-1#1)(2008-11#4)(2011-1#1)
The wood##3##2##(2008-10#1)(2009-11#1)(2013-8#1)
The work described##2##3##(1997-3#1)(2007-12#1)
The work is a##2##4##(2007-11#2)
The work is##4##3##(2007-11#2)(2008-10#1)(2013-7#1)
The work of##4##3##(1997-2#1)(1997-7#1)(2007-8#1)(2012-2#1)
The work presented in this##2##5##(1991-12#1)(1997-3#1)
The work presented##4##3##(1991-12#1)(1997-3#1)(2008-10#1)(2008-7#1)
The work presents##2##3##(2007-11#1)(2008-10#1)
The work was carried out in##2##6##(2008-12#1)(2013-7#1)
The work was##4##3##(2008-10#1)(2008-12#1)(2011-1#1)(2013-7#1)
The work##36##2##(1991-12#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
The workers##2##2##(2011-2#2)
The working conditions##3##3##(2008-10#2)(2009-12#1)
The working electrode was a##5##5##(2008-10#5)
The working electrode##7##3##(2008-10#7)
The working pH range is 2##2##6##(2008-10#2)
The working pH range is##3##5##(2008-10#3)
The working pH range##4##4##(2008-10#4)
The working pH##5##3##(2008-10#5)
The working principle##2##3##(2008-10#2)
The working range##2##3##(2008-10#2)
The working##25##2##(2008-10#21)(2008-2#1)(2009-12#1)(2013-8#2)
The workshop included##2##3##(1996-2#1)(2008-10#1)
The workshop was##5##3##(1996-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
The workshop##14##2##(1992-12#1)(1995-3#1)(1996-2#1)(1996-4#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#2)(2013-8#1)
The world is##2##3##(2007-7#1)(2009-3#1)
The world##6##2##(1992-2#1)(2006-12#1)(2007-7#1)(2008-7#1)(2009-3#1)(2012-2#1)
The worldwide prevalence of##2##4##(2008-3#1)(2013-1#1)
The worldwide##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-3#1)(2010-5#1)(2013-1#1)
The worsening##2##2##(2006-10#1)(2012-12#1)
The worst##3##2##(1993-3#1)(2007-8#1)(2007-9#1)
The yeast Candida##2##3##(1996-12#1)(2008-10#1)
The yeast Saccharomyces cerevisiae has##2##5##(2008-4#1)(2008-6#1)
The yeast Saccharomyces cerevisiae##3##4##(2008-4#1)(2008-6#1)(2011-2#1)
The yeast two-hybrid system##2##4##(2008-2#1)(2008-8#1)
The yeast##9##2##(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2011-2#1)
The yield of##8##3##(1990-12#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-2#1)
The yield##11##2##(1990-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-2#2)
The yields obtained##2##3##(2008-10#1)(2008-11#1)
The yields of##5##3##(1993-6#1)(2008-10#2)(2008-11#1)(2012-1#1)
The yields##8##2##(1993-6#1)(2008-10#3)(2008-11#2)(2008-8#1)(2012-1#1)
The young##2##2##(2007-12#1)(2008-4#1)
The younger##3##2##(1996-11#1)(2008-3#1)(2008-4#1)
The youngest##2##2##(1992-6#1)(2008-7#1)
The zebrafish##2##2##(2008-4#1)(2012-3#1)
The zero-birefringence##2##2##(2008-3#2)
The zinc finger##2##3##(1991-9#1)(1992-8#1)
The zinc##5##2##(1991-9#1)(1992-8#1)(2008-10#2)(2009-12#1)
The zone of##3##3##(1993-12#1)(2008-8#1)(2013-1#1)
The zone##4##2##(1993-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
The zwitterionic##2##2##(1994-9#1)(1996-5#1)
The##62682##1##(1990-10#40)(1990-11#220)(1990-12#226)(1990-2#182)(1990-3#105)(1990-4#5)(1990-5#277)(1990-6#143)(1990-7#174)(1990-8#266)(1990-9#105)(1991-1#93)(1991-10#24)(1991-11#109)(1991-12#314)(1991-2#251)(1991-3#185)(1991-4#33)(1991-5#239)(1991-6#210)(1991-7#38)(1991-8#128)(1991-9#169)(1992-1#123)(1992-10#56)(1992-11#135)(1992-12#287)(1992-2#165)(1992-3#336)(1992-4#48)(1992-5#122)(1992-6#250)(1992-7#17)(1992-8#207)(1992-9#193)(1993-1#118)(1993-10#7)(1993-11#213)(1993-12#389)(1993-2#216)(1993-3#250)(1993-5#41)(1993-6#229)(1993-7#1)(1993-8#219)(1993-9#182)(1994-1#102)(1994-10#12)(1994-11#238)(1994-12#377)(1994-2#243)(1994-3#289)(1994-5#194)(1994-6#203)(1994-7#42)(1994-8#214)(1994-9#172)(1995-1#99)(1995-10#3)(1995-11#175)(1995-12#334)(1995-2#353)(1995-3#278)(1995-4#20)(1995-5#226)(1995-6#273)(1995-8#170)(1995-9#52)(1996-1#152)(1996-10#21)(1996-11#65)(1996-12#323)(1996-2#382)(1996-3#229)(1996-4#37)(1996-5#297)(1996-6#136)(1996-7#42)(1996-8#61)(1996-9#95)(1997-1#132)(1997-2#338)(1997-3#300)(1997-4#282)(1997-5#116)(1997-6#225)(1997-7#258)(1997-8#192)(1997-9#11)(2006-10#60)(2006-11#2)(2006-12#40)(2006-4#14)(2006-5#2)(2006-6#20)(2006-7#5)(2006-8#15)(2006-9#2)(2007-1#11)(2007-10#259)(2007-11#1203)(2007-12#1369)(2007-2#86)(2007-3#5)(2007-4#49)(2007-5#81)(2007-6#47)(2007-7#319)(2007-8#509)(2007-9#23)(2008-1#600)(2008-10#15535)(2008-11#2077)(2008-12#981)(2008-2#1570)(2008-3#3232)(2008-4#846)(2008-5#1603)(2008-6#692)(2008-7#1768)(2008-8#1211)(2008-9#1159)(2009-1#45)(2009-10#222)(2009-11#194)(2009-12#170)(2009-2#84)(2009-3#119)(2009-4#135)(2009-5#204)(2009-6#153)(2009-7#247)(2009-8#229)(2009-9#136)(2010-1#107)(2010-10#169)(2010-11#170)(2010-12#212)(2010-2#119)(2010-3#289)(2010-4#251)(2010-5#255)(2010-6#157)(2010-7#117)(2010-8#366)(2010-9#84)(2011-1#706)(2011-10#7)(2011-2#1875)(2011-3#127)(2011-4#7)(2011-7#17)(2011-8#2)(2011-9#4)(2012-1#245)(2012-12#600)(2012-2#935)(2012-3#718)(2012-4#7)(2012-5#13)(2012-6#9)(2012-7#11)(2012-8#6)(2012-9#7)(2013-1#1663)(2013-2#1)(2013-3#3)(2013-7#214)(2013-8#773)
Theaim of this study was to##2##6##(2009-8#2)
Theatre##3##1##(2008-11#2)(2013-1#1)
Thecaphora solani##2##2##(2008-10#2)
Thecaphora##3##1##(2008-10#3)
ThegdhA genes of##2##3##(2008-8#2)
Theil's method##2##2##(2008-10#2)
Theileria##3##1##(1997-5#1)(2007-2#1)(2008-9#1)
Thein vivo##2##2##(2008-11#1)(2008-8#1)
Thein##3##1##(2008-11#1)(2008-8#2)
Their Roles in##2##3##(2007-2#1)(2008-10#1)
Their ability to##2##3##(1997-3#1)(2006-10#1)
Their ability##3##2##(1992-9#1)(1997-3#1)(2006-10#1)
Their advantages and limitations are##2##5##(2008-10#1)(2008-3#1)
Their age ranged##2##3##(2007-7#1)(2010-7#1)
Their age##3##2##(1993-3#1)(2007-7#1)(2010-7#1)
Their ages ranged between##2##4##(2008-1#1)(2008-4#1)
Their ages ranged##3##3##(1992-9#1)(2008-1#1)(2008-4#1)
Their application##3##2##(2008-10#1)(2008-7#1)(2010-3#1)
Their capacity to##2##3##(1990-2#1)(2013-7#1)
Their chemical structures were##2##4##(2011-1#1)(2013-1#1)
Their clinical##3##2##(2008-9#1)(2009-5#1)(2012-3#1)
Their concentrations##2##2##(2007-8#1)(2008-10#1)
Their correlation##2##2##(2008-5#1)(2013-1#1)
Their design##2##2##(2008-3#1)(2008-7#1)
Their effectiveness##2##2##(2008-10#1)(2008-5#1)
Their effects on##2##3##(2007-4#1)(2008-10#1)
Their effects##3##2##(2007-4#1)(2008-10#1)(2008-5#1)
Their expression##3##2##(2008-5#1)(2009-3#1)(2010-6#1)
Their function is##2##3##(2007-11#1)(2008-12#1)
Their function##4##2##(2007-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
Their identification##2##2##(2008-10#1)(2008-5#1)
Their incorporation##2##2##(1996-6#1)(2008-5#1)
Their influence on##2##3##(1990-9#1)(1995-5#1)
Their influence##3##2##(1990-9#1)(1995-5#1)(2007-11#1)
Their interaction with##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
Their main##2##2##(1990-10#1)(2008-5#1)
Their mean age was##2##4##(2007-7#1)(2011-2#1)
Their mean##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
Their molecular weights are about##2##5##(2008-8#1)(2008-9#1)
Their molecular weights##3##3##(1991-5#1)(2008-8#1)(2008-9#1)
Their most##4##2##(1993-3#1)(2008-12#1)(2008-4#1)(2008-9#1)
Their phosphatase##2##2##(2008-9#2)
Their poor##2##2##(1995-8#1)(2008-4#1)
Their potency##2##2##(1990-12#1)(2013-1#1)
Their primary##2##2##(1995-3#1)(2008-9#1)
Their relative##3##2##(1990-8#1)(2008-10#1)(2011-1#1)
Their responses were##2##3##(2008-11#1)(2008-7#1)
Their responses##4##2##(1991-3#1)(2008-11#1)(2008-4#1)(2008-7#1)
Their results##3##2##(2008-5#1)(2010-1#1)(2010-5#1)
Their role in the##2##4##(1992-5#1)(2009-3#1)
Their role in##4##3##(1992-5#1)(2008-8#1)(2009-3#1)(2013-7#1)
Their structures were determined##2##4##(1997-7#1)(2010-6#1)
Their structures were elucidated by##2##5##(1995-11#1)(2011-3#1)
Their structures were elucidated##3##4##(1995-11#1)(2011-2#1)(2011-3#1)
Their structures were established by##2##5##(2007-11#1)(2008-11#1)
Their structures were established##4##4##(2007-11#3)(2008-11#1)
Their structures were##10##3##(1995-11#1)(1997-7#1)(2007-11#3)(2008-11#1)(2010-6#1)(2011-2#1)(2011-3#2)
Their study##2##2##(1994-3#1)(1995-3#1)
Their symptoms##2##2##(1996-3#1)(2008-7#1)
Their use##4##2##(1991-12#1)(2008-11#1)(2008-5#1)(2008-6#1)
Their usefulness##2##2##(2008-3#1)(2008-6#1)
Their vast##2##2##(1990-3#1)(2008-10#1)
Their##327##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-5#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#6)(1993-6#2)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#4)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#49)(2008-11#8)(2008-12#7)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#17)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#6)(2010-5#3)(2010-6#2)(2010-7#2)(2011-1#7)(2011-2#15)(2011-3#4)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#15)(2013-7#3)(2013-8#5)
Thelephora##4##1##(2008-11#2)(2013-7#2)
Thematic analysis of the##2##4##(2007-10#1)(2009-5#1)
Thematic analysis##4##2##(2007-10#1)(2009-5#1)(2010-10#1)(2010-11#1)
Thematic##9##1##(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2012-12#1)
Theme##3##1##(2008-11#1)(2010-5#2)
Themes were##2##2##(2008-11#1)(2013-1#1)
Themes##6##1##(1995-12#1)(1995-3#1)(2008-11#1)(2008-4#1)(2010-11#1)(2013-1#1)
Then a##6##2##(2008-10#2)(2008-3#2)(2008-8#2)
Then an##2##2##(2008-3#1)(2011-1#1)
Then both##2##2##(1991-12#1)(2008-10#1)
Then the maximum##2##3##(2008-2#1)(2013-8#1)
Then the##39##2##(1990-8#1)(1993-8#1)(2007-8#1)(2008-10#13)(2008-2#4)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
Then there is##2##3##(2008-9#1)(2009-12#1)
Then these##3##2##(2008-12#1)(2008-3#2)
Then we consider the##2##4##(2008-3#1)(2008-9#1)
Then we show##2##3##(2008-3#2)
Then we##16##2##(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#4)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
Then##171##1##(1990-8#2)(1991-12#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#50)(2008-11#4)(2008-12#7)(2008-2#6)(2008-3#20)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#7)
Theo and Jamie##2##3##(2011-1#2)
Theodor Billroth##3##2##(2007-4#2)(2013-1#1)
Theodor##4##1##(2007-4#2)(2013-1#2)
Theophylline##4##1##(1992-3#1)(2007-10#1)(2008-1#1)(2008-6#1)
Theoretical Studies##2##2##(1996-2#2)
Theoretical analyses##3##2##(2007-12#1)(2008-3#2)
Theoretical analysis of the##3##4##(2008-3#2)(2013-1#1)
Theoretical analysis of##7##3##(1993-3#1)(2008-2#2)(2008-3#3)(2013-1#1)
Theoretical analysis##8##2##(1993-3#1)(2007-11#1)(2008-2#2)(2008-3#3)(2013-1#1)
Theoretical and experimental results are presented##2##6##(2007-12#1)(2008-3#1)
Theoretical and experimental results##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
Theoretical and experimental studies of##2##5##(2008-3#2)
Theoretical and experimental##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
Theoretical and numerical##2##3##(2008-2#2)
Theoretical and practical##2##3##(1991-12#1)(2008-3#1)
Theoretical and##13##2##(1991-12#1)(1996-5#1)(2007-12#1)(2008-2#4)(2008-3#5)(2008-9#1)
Theoretical calculations##4##2##(2007-11#1)(2008-10#2)(2010-6#1)
Theoretical considerations##3##2##(1990-12#1)(1993-11#1)(2008-3#1)
Theoretical investigation of##2##3##(2008-3#2)
Theoretical investigation on##2##3##(2008-8#2)
Theoretical investigation##4##2##(2008-3#2)(2008-8#2)
Theoretical modeling##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Theoretical models##2##2##(1995-2#1)(2008-10#1)
Theoretical predictions are##2##3##(2008-2#1)(2008-3#1)
Theoretical predictions##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Theoretical results##5##2##(2007-12#1)(2008-2#2)(2008-8#1)(2009-11#1)
Theoretical simulations##2##2##(2007-11#1)(2008-2#1)
Theoretical studies##2##2##(1996-2#1)(2007-11#1)
Theoretical study of##2##3##(2007-12#1)(2008-3#1)
Theoretical study##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
Theoretical treatment##2##2##(2008-2#1)(2008-3#1)
Theoretical##94##1##(1990-11#1)(1990-12#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-11#6)(2007-12#8)(2008-10#5)(2008-11#3)(2008-2#14)(2008-3#24)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
Theoretically##8##1##(1992-9#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-1#1)
Theories of##2##2##(2008-10#1)(2010-1#1)
Theories##8##1##(1996-9#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)
Theory and##7##2##(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)
Theory for##3##2##(1996-9#1)(2008-2#1)(2008-3#1)
Theory of Planned Behavior##2##4##(2011-1#1)(2013-1#1)
Theory of Reasoned Action##3##4##(1993-3#1)(2008-4#1)(2011-1#1)
Theory of the double-edge##2##4##(2008-2#1)(2008-3#1)
Theory of the##5##3##(2008-1#1)(2008-2#1)(2008-3#3)
Theory of##18##2##(1993-3#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2009-8#1)(2009-9#1)(2011-1#2)(2013-1#1)
Theory predicts##2##2##(2008-7#1)(2013-1#1)
Theory to##2##2##(2010-10#1)(2013-8#1)
Theory##64##1##(1990-11#1)(1991-2#1)(1993-3#1)(1996-1#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#14)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
Thepatient##4##1##(2013-8#4)
Ther##2##1##(2010-3#2)
Therapeutic Agents##2##2##(2009-10#1)(2010-7#1)
Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrest##2##6##(2011-2#2)
Therapeutic antibody##2##2##(2008-11#1)(2010-11#1)
Therapeutic approaches to##2##3##(1992-9#1)(2008-3#1)
Therapeutic cytapheresis##2##2##(2011-2#2)
Therapeutic effects##2##2##(2008-3#1)(2008-8#1)
Therapeutic hypothermia##2##2##(2008-8#2)
Therapeutic interventions##3##2##(1991-7#1)(2008-9#1)(2013-1#1)
Therapeutic options include##2##3##(2008-7#1)(2011-2#1)
Therapeutic possibilities##3##2##(1990-10#1)(1993-11#1)(1994-5#1)
Therapeutic responses##2##2##(2008-6#1)(2012-3#1)
Therapeutic use of##2##3##(1992-3#1)(2008-7#1)
Therapeutic##65##1##(1990-10#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)
Therapeutics##9##1##(1993-11#1)(1996-9#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#2)
Therapies for##4##2##(2008-1#1)(2008-10#1)(2008-3#2)
Therapies##8##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-12#1)(2010-4#1)(2013-8#1)
Therapist##3##1##(2008-4#1)(2013-1#2)
Therapists##3##1##(1995-2#1)(2008-12#1)(2010-6#1)
Therapy Trial##3##2##(2010-12#2)(2010-9#1)
Therapy consists of##2##3##(1990-9#1)(2011-2#1)
Therapy for Breast Cancer##4##4##(1994-12#1)(1994-7#2)(1997-7#1)
Therapy for Breast##5##3##(1994-12#1)(1994-7#2)(1997-7#2)
Therapy for Early##2##3##(2008-11#1)(2008-5#1)
Therapy for the##2##3##(2009-1#1)(2010-9#1)
Therapy for##23##2##(1994-12#1)(1994-5#1)(1994-7#2)(1997-7#4)(2006-10#1)(2007-8#1)(2008-11#2)(2008-5#2)(2009-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#3)
Therapy in the##2##3##(1994-7#1)(2008-11#1)
Therapy in##6##2##(1994-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
Therapy is##3##2##(1990-9#1)(1991-6#1)(1997-4#1)
Therapy of##7##2##(1991-6#1)(1992-9#1)(1993-11#1)(1995-10#1)(1997-6#2)(2008-6#1)
Therapy that##2##2##(2010-3#1)(2013-1#1)
Therapy was##4##2##(1992-8#1)(1996-3#1)(2007-11#1)(2011-2#1)
Therapy with##10##2##(1990-2#1)(1991-2#1)(1991-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2012-12#1)(2013-8#1)
Therapy##122##1##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#4)(1995-10#1)(1996-3#1)(1997-1#1)(1997-4#3)(1997-6#2)(1997-7#5)(2006-10#4)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2009-1#2)(2009-12#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#12)(2013-7#1)(2013-8#1)
Therapy?##2##1##(2008-10#1)(2011-2#1)
There also was a##3##4##(1990-6#1)(2008-10#1)(2008-9#1)
There also##5##2##(1990-6#1)(2007-12#1)(2008-10#2)(2008-9#1)
There appears to be a##5##5##(1993-11#1)(2007-2#2)(2008-1#1)(2009-9#1)
There appears to be##7##4##(1993-11#1)(2007-2#2)(2008-1#1)(2009-9#1)(2011-1#1)(2013-1#1)
There appears##8##2##(1993-11#1)(2007-2#2)(2008-1#1)(2008-10#1)(2009-9#1)(2011-1#1)(2013-1#1)
There are 2##2##3##(2010-8#1)(2012-2#1)
There are 3##2##3##(2011-1#1)(2011-2#1)
There are a few##2##4##(2010-11#1)(2013-1#1)
There are a limited number of##3##6##(2012-2#2)(2013-1#1)
There are a lot of##2##5##(2007-4#1)(2012-2#1)
There are a number of factors##2##6##(2008-10#1)(2008-5#1)
There are a number of##16##5##(1991-3#1)(1992-9#1)(1995-1#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2013-8#1)
There are a variety of##2##5##(1997-1#1)(2012-3#1)
There are a##30##3##(1991-3#1)(1992-9#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-4#1)(2007-4#1)(2008-10#4)(2008-11#3)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
There are already##3##3##(1992-9#1)(2008-5#2)
There are also indications that##3##5##(1991-9#1)(2008-8#1)(2011-2#1)
There are also some##3##4##(1990-5#1)(2008-12#1)(2008-5#1)
There are also##15##3##(1990-5#1)(1991-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#2)(2011-4#1)(2012-3#1)
There are at least##4##4##(1994-2#1)(2007-10#1)(2008-8#1)(2011-2#1)
There are concerns##2##3##(2009-6#1)(2012-3#1)
There are considerable differences between##2##5##(1997-8#1)(2010-4#1)
There are currently no##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
There are currently##9##3##(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#2)
There are different##3##3##(1991-11#1)(2007-11#1)(2008-7#1)
There are few data##2##4##(1992-3#1)(2009-9#1)
There are few high-quality studies##2##5##(2010-6#1)(2013-1#1)
There are few studies##2##4##(2009-6#1)(2012-3#1)
There are few##15##3##(1992-3#1)(1994-12#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)
There are four##5##3##(1993-8#1)(1995-3#1)(2008-1#1)(2012-2#1)(2012-3#1)
There are good##2##3##(1997-8#1)(2013-1#1)
There are however##2##3##(2009-3#1)(2010-11#1)
There are hundreds of##2##4##(2008-3#1)(2010-2#1)
There are insufficient##2##3##(2011-2#1)(2013-7#1)
There are large##2##3##(1995-3#1)(2013-8#1)
There are many##22##3##(1991-5#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
There are more##2##3##(1992-2#1)(2008-5#1)
There are multiple##2##3##(2008-10#1)(2009-12#1)
There are no definitive diagnostic##2##5##(2008-12#1)(2010-12#1)
There are no reports##2##4##(2008-1#1)(2011-1#1)
There are no specific##2##4##(2008-10#1)(2008-7#1)
There are no##24##3##(1990-11#1)(1990-6#1)(1993-8#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
There are now##3##3##(1997-1#1)(2008-4#2)
There are numerous##7##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
There are only a few studies##2##6##(2008-1#1)(2011-2#1)
There are only a few##3##5##(2008-1#1)(2009-5#1)(2011-2#1)
There are only##7##3##(1993-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
There are pronounced##2##3##(1992-9#1)(2008-11#1)
There are recent##2##3##(2008-2#1)(2008-7#1)
There are reports of##3##4##(1991-2#1)(2008-10#1)(2009-11#1)
There are seven##3##3##(1996-1#1)(2008-1#1)(2011-2#1)
There are several different##2##4##(1994-3#1)(2008-4#1)
There are several methods##3##4##(1997-4#1)(2011-2#2)
There are several new##2##4##(2008-2#1)(2008-7#1)
There are several##27##3##(1991-8#1)(1993-2#1)(1994-3#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)
There are significant challenges##2##4##(1995-12#1)(2007-12#1)
There are significant##4##3##(1995-12#1)(1996-4#1)(2007-12#1)(2008-4#1)
There are some##6##3##(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
There are specific##2##3##(2008-4#1)(2011-2#1)
There are still##2##3##(2008-11#1)(2011-3#1)
There are three types of##3##5##(1997-4#1)(2008-11#1)(2013-7#1)
There are three##8##3##(1992-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-7#1)
There are times##2##3##(1996-3#1)(2008-3#1)
There are two forms of##2##5##(2010-5#1)(2011-2#1)
There are two forms##3##4##(2010-5#1)(2011-2#1)(2013-1#1)
There are two kinds of##2##5##(1993-3#1)(2008-2#1)
There are two main##5##4##(1995-5#1)(1997-6#1)(2008-4#1)(2009-2#1)(2011-2#1)
There are two major##4##4##(1994-11#1)(2008-10#2)(2009-6#1)
There are two types of##6##5##(1991-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
There are two ways##2##4##(2008-2#1)(2010-4#1)
There are two##36##3##(1991-2#2)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-6#2)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
There are usually##2##3##(1997-3#1)(2008-3#1)
There are various##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
There are very few##2##4##(1996-4#1)(2008-9#1)
There are##342##2##(1990-11#1)(1990-5#3)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#7)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-2#3)(1996-3#4)(1996-4#2)(1997-1#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#10)(2008-10#19)(2008-11#17)(2008-12#6)(2008-2#8)(2008-3#5)(2008-4#9)(2008-5#12)(2008-6#1)(2008-7#17)(2008-8#7)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#22)(2011-3#1)(2011-4#1)(2012-12#2)(2012-2#13)(2012-3#8)(2013-1#20)(2013-7#3)(2013-8#4)
There currently are##2##3##(2008-9#1)(2011-2#1)
There exist##2##2##(1995-2#1)(2009-11#1)
There existed##2##2##(2011-1#1)(2013-8#1)
There exists a##4##3##(1990-5#1)(1992-9#1)(2008-7#1)(2012-12#1)
There exists##5##2##(1990-5#1)(1992-9#1)(1995-5#1)(2008-7#1)(2012-12#1)
There has been a large##2##5##(2008-3#1)(2010-8#1)
There has been a recent##5##5##(1996-11#1)(2008-11#3)(2008-5#1)
There has been a##19##4##(1992-1#1)(1996-11#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#5)
There has been an##4##4##(2006-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
There has been much##4##4##(1992-4#1)(2008-9#2)(2012-12#1)
There has been no recurrence##2##5##(2007-11#1)(2013-1#1)
There has been no##3##4##(2007-11#1)(2011-2#1)(2013-1#1)
There has been some##2##4##(2008-5#1)(2008-6#1)
There has been##41##3##(1991-12#1)(1992-1#1)(1992-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-7#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#6)
There has##43##2##(1991-12#1)(1992-1#1)(1992-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#6)
There have also been##3##4##(1992-2#1)(2007-12#1)(2008-11#1)
There have been a number of##2##6##(2008-10#2)
There have been few##2##4##(2007-10#1)(2011-2#1)
There have been many##3##4##(2008-3#1)(2009-2#1)(2009-5#1)
There have been no##3##4##(1997-8#1)(2007-12#1)(2008-7#1)
There have been only two##2##5##(2008-7#1)(2008-9#1)
There have been only##3##4##(2008-7#1)(2008-9#1)(2013-7#1)
There have been several reported##2##5##(1992-2#1)(2008-7#1)
There have been three##2##4##(2008-2#1)(2012-2#1)
There have been##29##3##(1992-2#1)(1994-12#1)(1994-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
There have##32##2##(1992-2#2)(1994-12#1)(1994-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
There is a clear##3##4##(2008-5#1)(2008-7#1)(2009-11#1)
There is a consensus##2##4##(2008-11#1)(2011-2#1)
There is a constant##2##4##(2008-11#1)(2008-9#1)
There is a critical need to##2##6##(2008-4#1)(2010-7#1)
There is a general##3##4##(2008-4#1)(2010-5#1)(2012-2#1)
There is a great##2##4##(2008-12#1)(2008-6#1)
There is a growing##4##4##(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
There is a lack of evidence to##2##7##(1995-2#1)(2013-8#1)
There is a lack of##8##5##(1994-6#1)(1995-2#1)(2007-10#1)(2008-11#2)(2012-2#1)(2013-8#2)
There is a large body of##2##6##(2008-10#1)(2008-5#1)
There is a large##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
There is a need for##14##5##(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
There is a need to develop##2##6##(2008-10#1)(2008-5#1)
There is a need to increase##2##6##(2008-1#1)(2013-1#1)
There is a need to##7##5##(2008-1#2)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
There is a need##22##4##(1997-6#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
There is a paucity of##5##5##(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
There is a pressing need to##2##6##(1990-9#1)(2008-8#1)
There is a significant reduction in the##2##7##(2007-11#1)(2008-7#1)
There is a significant##6##4##(1997-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
There is a strong association##2##5##(2008-6#1)(2013-8#1)
There is a strong##5##4##(1991-9#1)(1997-3#1)(2008-6#1)(2010-10#1)(2013-8#1)
There is a tendency##2##4##(2008-7#1)(2011-2#1)
There is a wide range##2##5##(1991-4#1)(2007-8#1)
There is a wide##5##4##(1991-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)
There is a##119##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#3)(1997-3#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#9)
There is already some##2##4##(2008-9#1)(2011-1#1)
There is already##3##3##(2008-7#1)(2008-9#1)(2011-1#1)
There is also a discussion##2##5##(2008-2#1)(2010-11#1)
There is also a need for##2##6##(2008-1#1)(2008-11#1)
There is also a##12##4##(1991-6#1)(1992-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
There is also evidence that##4##5##(1992-4#1)(1995-5#1)(2008-11#1)(2013-1#1)
There is also evidence##6##4##(1992-4#1)(1995-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2013-1#1)
There is also##27##3##(1991-6#1)(1992-4#1)(1992-8#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#1)(2013-1#1)
There is an increased risk of##2##6##(2007-7#1)(2011-2#1)
There is an increased##3##4##(2007-7#1)(2010-8#1)(2011-2#1)
There is an increasing need for##2##6##(2010-12#1)(2011-1#1)
There is an increasing trend##2##5##(2008-12#1)(2009-6#1)
There is an increasing##8##4##(1991-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)
There is an urgent need to##2##6##(1996-12#1)(2009-5#1)
There is an urgent need##3##5##(1996-12#1)(2009-4#1)(2009-5#1)
There is an##32##3##(1990-2#1)(1991-12#1)(1993-1#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-6#2)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
There is considerable evidence that##2##5##(2008-5#1)(2008-9#1)
There is considerable interest in the##2##6##(1997-7#1)(2008-4#1)
There is considerable##14##3##(1992-9#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
There is currently##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
There is emerging evidence that##2##5##(2009-6#1)(2011-2#1)
There is evidence of##4##4##(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
There is evidence that persons##2##5##(2008-1#1)(2008-10#1)
There is evidence that some##2##5##(1995-11#1)(2008-5#1)
There is evidence that the##2##5##(2010-1#1)(2010-5#1)
There is evidence that##17##4##(1991-12#1)(1995-11#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
There is evidence to suggest that##2##6##(1994-9#1)(2008-9#1)
There is evidence to support a##2##6##(1996-9#1)(2008-2#1)
There is evidence to##4##4##(1994-9#1)(1996-9#1)(2008-2#1)(2008-9#1)
There is evidence##30##3##(1991-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-9#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
There is good agreement##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
There is good evidence that##2##5##(2008-7#1)(2010-12#1)
There is good##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
There is great interest in##2##5##(2007-8#1)(2008-11#1)
There is growing evidence that##6##5##(1991-12#1)(2006-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
There is growing evidence##7##4##(1991-12#1)(2006-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
There is growing interest in##4##5##(1996-3#1)(1997-7#1)(2010-1#1)(2011-3#1)
There is growing##17##3##(1991-12#1)(1993-1#1)(1996-3#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
There is increased##2##3##(2007-7#1)(2013-7#1)
There is increasing concern about##2##5##(2008-10#1)(2010-8#1)
There is increasing evidence that##9##5##(1995-12#1)(1996-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)
There is increasing evidence##10##4##(1995-12#1)(1996-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)
There is increasing interest in##2##5##(2008-11#1)(2008-4#1)
There is increasing recognition that##2##5##(1995-3#1)(2011-2#1)
There is increasing##21##3##(1991-3#1)(1995-12#1)(1995-3#1)(1996-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)
There is insufficient evidence##2##4##(2008-11#1)(2011-2#1)
There is limited##2##3##(2007-11#1)(2011-2#1)
There is little evidence##2##4##(1993-3#1)(2012-3#1)
There is little##9##3##(1993-3#1)(1993-8#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
There is more##2##3##(1997-8#1)(2008-11#1)
There is much##4##3##(1994-2#1)(1997-5#1)(2008-11#1)(2008-5#1)
There is need for##2##4##(2009-6#1)(2010-8#1)
There is no association between serum##2##6##(2011-1#2)
There is no convincing evidence##2##5##(1995-11#1)(2009-5#1)
There is no doubt that##2##5##(1992-6#1)(1995-4#1)
There is no evidence for##3##5##(1991-8#1)(1995-5#1)(2011-2#1)
There is no evidence of##2##5##(2011-1#1)(2012-2#1)
There is no evidence that##2##5##(1993-3#1)(2008-10#1)
There is no evidence##7##4##(1991-8#1)(1993-3#1)(1995-5#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
There is no functional data system that is able to identify##2##11##(2013-8#2)
There is no functional data system that##3##7##(2013-8#3)
There is no functional data system##4##6##(2013-8#4)
There is no overall##2##4##(2013-8#2)
There is no significant##2##4##(1996-6#1)(2007-8#1)
There is no simple##2##4##(1995-3#1)(2008-9#1)
There is no specific treatment##3##5##(1994-9#1)(2007-2#1)(2011-2#1)
There is no strong evidence##2##5##(2008-8#2)
There is no##66##3##(1991-4#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-6#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#8)
There is not##2##3##(1993-3#1)(2011-2#1)
There is now##7##3##(1996-5#1)(1997-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
There is often a##2##4##(2011-2#1)(2012-2#1)
There is often##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
There is one##5##3##(1995-2#1)(2007-12#1)(2008-3#1)(2010-2#1)(2012-12#1)
There is only one##3##4##(2007-8#1)(2008-11#1)(2012-12#1)
There is only##4##3##(2007-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
There is significant##3##3##(2008-3#1)(2010-12#1)(2011-2#1)
There is some evidence of##2##5##(1991-1#1)(1995-5#1)
There is some evidence that##2##5##(1996-6#1)(2008-5#1)
There is some evidence##5##4##(1991-1#1)(1995-5#1)(1996-6#1)(2008-5#1)(2008-7#1)
There is some##9##3##(1990-8#1)(1991-1#1)(1995-5#1)(1996-6#1)(2008-5#2)(2008-7#1)(2013-1#2)
There is still##6##3##(1996-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2013-1#1)
There is strong evidence to##2##5##(2008-8#1)(2012-2#1)
There is strong##5##3##(1995-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#1)
There is substantial evidence##2##4##(2008-11#1)(2008-8#1)
There is substantial##3##3##(1992-12#1)(2008-11#1)(2008-8#1)
There is the##5##3##(1994-8#1)(1996-11#1)(1997-6#1)(2008-10#2)
There is therefore a##2##4##(2008-10#1)(2010-12#1)
There is thus a##2##4##(2008-3#1)(2012-12#1)
There is##479##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#1)(2006-10#6)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#3)(2007-6#1)(2007-7#5)(2007-8#8)(2008-1#12)(2008-10#31)(2008-11#22)(2008-12#3)(2008-2#5)(2008-3#14)(2008-4#12)(2008-5#16)(2008-6#5)(2008-7#25)(2008-8#9)(2008-9#11)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#1)(2009-8#6)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#1)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#8)(2011-2#26)(2011-3#2)(2012-1#3)(2012-12#12)(2012-2#8)(2012-3#9)(2013-1#20)(2013-7#3)(2013-8#20)
There may be##4##3##(1993-9#1)(1996-4#1)(2008-4#1)(2012-12#1)
There must be##4##3##(1995-12#1)(2008-3#3)
There remains##3##2##(2008-3#1)(2008-8#1)(2012-1#1)
There seems to be a##2##5##(2008-11#1)(2011-2#1)
There should be##3##3##(1997-8#1)(2008-1#1)(2008-9#1)
There should##4##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
There was 1##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
There was a consistent##3##4##(1997-8#1)(2008-3#1)(2010-5#1)
There was a correlation between##4##5##(1991-6#1)(2008-10#2)(2008-9#1)
There was a correlation##6##4##(1991-6#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-9#1)
There was a direct##2##4##(1994-5#1)(2011-2#1)
There was a general##2##4##(2008-10#2)
There was a good correlation between the##3##7##(1990-7#1)(1995-12#1)(2007-8#1)
There was a good##5##4##(1990-7#1)(1995-12#1)(2007-8#1)(2008-10#2)
There was a high correlation between##2##6##(2008-10#1)(2008-9#1)
There was a high degree of##2##6##(1995-3#1)(1995-5#1)
There was a high prevalence of##2##6##(1994-6#1)(2013-1#1)
There was a high##8##4##(1994-6#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
There was a higher incidence of##3##6##(1996-3#1)(2007-8#1)(2013-8#1)
There was a higher##7##4##(1996-3#1)(1996-5#1)(1996-6#1)(2007-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
There was a highly significant##2##5##(1994-3#1)(2008-5#1)
There was a linear relationship between the##2##7##(2008-10#1)(2008-11#1)
There was a linear##3##4##(2008-10#2)(2008-11#1)
There was a marked##2##4##(1997-4#1)(1997-6#1)
There was a negative correlation between##2##6##(1991-11#1)(2008-8#1)
There was a positive correlation between##2##6##(2008-10#1)(2013-7#1)
There was a positive##5##4##(2008-10#1)(2008-3#1)(2011-1#1)(2013-7#2)
There was a reduction in##2##5##(1996-2#1)(1997-1#1)
There was a reduction##3##4##(1996-2#1)(1997-1#1)(2007-7#1)
There was a remarkable##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
There was a significant (P &lt##2##6##(2012-2#2)
There was a significant association between##3##6##(2008-10#1)(2011-2#2)
There was a significant correlation between the##3##7##(1992-11#1)(1996-12#1)(2013-1#1)
There was a significant correlation between##9##6##(1992-11#1)(1992-8#1)(1996-12#1)(2007-10#1)(2007-7#2)(2008-6#1)(2013-1#2)
There was a significant correlation##10##5##(1992-11#1)(1992-8#1)(1996-12#1)(2007-10#1)(2007-7#2)(2008-6#1)(2011-2#1)(2013-1#2)
There was a significant decrease in the##2##7##(1993-12#1)(2011-2#1)
There was a significant decrease##4##5##(1993-12#1)(2008-12#1)(2010-4#1)(2011-2#1)
There was a significant difference in##4##6##(1990-10#1)(2007-8#1)(2008-10#1)(2008-9#1)
There was a significant difference##6##5##(1990-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
There was a significant effect of##2##6##(2008-10#1)(2010-7#1)
There was a significant increase in the##2##7##(2007-9#1)(2013-8#1)
There was a significant increase##3##5##(2007-7#1)(2007-9#1)(2013-8#1)
There was a significant negative correlation between the##3##8##(1994-2#1)(2008-10#1)(2008-7#1)
There was a significant negative correlation between##6##7##(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2012-6#1)
There was a significant negative correlation##7##6##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2012-6#1)
There was a significant overall improvement in the incidence of acute intra-dialytic symptoms with the use of vitamin E-modified dialyzers as compared with the other membranes##2##26##(2007-7#1)(2008-1#1)
There was a significant positive##2##5##(2008-8#2)
There was a significant relationship between##3##6##(1995-11#1)(1997-8#1)(2008-10#1)
There was a significant##54##4##(1990-10#1)(1990-12#1)(1992-11#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#2)(1996-12#1)(1997-8#1)(2007-10#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-4#1)(2012-6#1)(2013-1#2)(2013-8#1)
There was a slight##2##4##(1992-6#1)(2010-8#1)
There was a statistical significance##2##5##(1990-12#2)
There was a statistical##3##4##(1990-12#2)(2012-12#1)
There was a statistically significant difference##2##6##(2011-2#1)(2013-1#1)
There was a statistically significant##8##5##(1993-9#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
There was a strong correlation##2##5##(2008-10#2)
There was a strong##6##4##(1997-4#1)(2008-10#4)(2008-8#1)
There was a trend for##3##5##(1990-2#1)(2008-10#1)(2008-11#1)
There was a trend toward##3##5##(1995-11#1)(2008-10#1)(2008-7#1)
There was a trend towards##3##5##(2007-7#1)(2008-10#1)(2008-7#1)
There was a trend##10##4##(1990-2#1)(1995-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#2)
There was a very##2##4##(2008-10#1)(2008-7#1)
There was a weak##2##4##(2008-10#1)(2008-9#1)
There was a##185##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2007-10#1)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#5)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#10)(2012-12#2)(2012-2#4)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#6)(2013-7#2)(2013-8#5)
There was almost##2##3##(1996-12#1)(2009-4#1)
There was also a significant##3##5##(1997-8#1)(2008-5#1)(2012-2#1)
There was also a trend##2##5##(1993-12#1)(1995-12#1)
There was also a##10##4##(1993-12#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-2#1)
There was also an##2##4##(1993-9#1)(2008-10#1)
There was also no evidence of##2##6##(2008-8#1)(2009-10#1)
There was also no evidence##3##5##(2008-8#2)(2009-10#1)
There was also##22##3##(1993-12#1)(1993-9#1)(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
There was an almost equal##2##5##(1997-3#2)
There was an association##2##4##(2007-10#1)(2013-8#1)
There was an average##2##4##(2008-1#1)(2013-7#1)
There was an increase in##3##5##(2008-10#1)(2008-11#1)(2009-8#1)
There was an increase##4##4##(2008-10#2)(2008-11#1)(2009-8#1)
There was an inverse linear relationship between##2##7##(2008-10#2)
There was an inverse relationship between##2##6##(1991-5#1)(2008-10#1)
There was an inverse##4##4##(1991-5#1)(2008-10#3)
There was an overall##2##4##(2007-12#1)(2013-1#1)
There was an##25##3##(1991-5#1)(1997-3#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
There was another##2##3##(2008-5#1)(2010-4#1)
There was evidence of##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
There was evidence##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
There was excellent##2##3##(2012-2#1)(2013-1#1)
There was good agreement between##2##5##(1996-12#1)(2008-7#1)
There was greater than 99%##2##5##(2008-10#2)
There was greater##3##3##(1996-6#1)(2008-10#2)
There was limited##3##3##(2007-10#1)(2008-10#2)
There was little change##2##4##(2008-10#1)(2008-8#1)
There was little##6##3##(1991-4#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
There was no apparent##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
There was no association between##4##5##(1993-1#1)(2008-8#1)(2013-1#1)(2013-8#1)
There was no association with##2##5##(2008-1#1)(2008-9#1)
There was no association##6##4##(1993-1#1)(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
There was no case##2##4##(1995-3#1)(2007-8#1)
There was no change in the##2##6##(1995-2#1)(2008-7#1)
There was no change in##3##5##(1995-2#1)(2008-7#1)(2012-12#1)
There was no consistent##2##4##(1990-12#1)(2008-10#1)
There was no correlation between the##5##6##(1994-6#1)(2008-10#3)(2008-5#1)
There was no correlation between##9##5##(1991-11#1)(1991-8#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-5#1)
There was no correlation##10##4##(1991-11#1)(1991-8#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-5#1)
There was no decrease in##2##5##(2008-10#1)(2008-9#1)
There was no difference between the##2##6##(2008-9#1)(2013-1#1)
There was no difference between##6##5##(1991-11#1)(1994-3#1)(2008-10#1)(2008-9#1)(2010-5#1)(2013-1#1)
There was no difference in HR##2##6##(2013-8#2)
There was no difference in survival between##2##7##(2008-6#1)(2010-3#1)
There was no difference in the##8##6##(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
There was no difference in##24##5##(1990-11#1)(1992-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#4)
There was no difference##33##4##(1990-11#1)(1991-11#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
There was no effect of##3##5##(1995-11#1)(1996-12#1)(2009-3#1)
There was no effect on##2##5##(1992-2#1)(1997-6#1)
There was no effect##6##4##(1992-2#1)(1992-8#1)(1995-11#1)(1996-12#1)(1997-6#1)(2009-3#1)
There was no evidence of excessive##2##6##(1992-5#1)(2010-3#1)
There was no evidence of##14##5##(1992-5#1)(1996-1#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
There was no evidence that##2##5##(1993-9#1)(2008-10#1)
There was no evidence##17##4##(1992-5#1)(1993-9#1)(1996-1#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
There was no family history##3##5##(2008-10#1)(2012-3#1)(2013-1#1)
There was no improvement##2##4##(2008-12#1)(2011-1#1)
There was no increase in##2##5##(1992-6#1)(1995-11#1)
There was no interference from the excipients##2##7##(2008-10#1)(2010-5#1)
There was no interference from##4##5##(2008-10#3)(2010-5#1)
There was no interference##5##4##(1993-2#1)(2008-10#3)(2010-5#1)
There was no marked##2##4##(2011-2#1)(2013-8#1)
There was no mortality and##2##5##(1991-6#1)(2007-8#1)
There was no mortality##3##4##(1991-6#1)(2007-8#1)(2008-5#1)
There was no observed##2##4##(2008-10#1)(2013-1#1)
There was no obvious##2##4##(1997-3#1)(2008-3#1)
There was no relationship between the##2##6##(1990-2#1)(2013-1#1)
There was no relationship between##7##5##(1990-2#1)(1997-2#1)(2008-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
There was no relationship##8##4##(1990-2#1)(1993-12#1)(1997-2#1)(2008-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
There was no significant association between##2##6##(1994-7#1)(2011-1#1)
There was no significant association##3##5##(1994-7#1)(2008-12#1)(2011-1#1)
There was no significant change in##3##6##(1990-3#1)(2008-4#1)(2008-6#1)
There was no significant correlation between the##4##7##(1997-2#1)(1997-8#1)(2008-10#1)(2010-3#1)
There was no significant correlation between##10##6##(1994-12#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-3#1)
There was no significant difference between the##6##7##(1993-8#1)(1997-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
There was no significant difference between##18##6##(1991-11#1)(1991-8#1)(1993-2#1)(1993-8#1)(1997-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
There was no significant difference in response rates##2##8##(1994-7#1)(1995-4#1)
There was no significant difference in the mean##2##8##(2007-7#1)(2008-8#1)
There was no significant difference in the##13##7##(1991-2#1)(1991-8#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
There was no significant difference in##29##6##(1991-2#1)(1991-8#1)(1993-11#1)(1994-7#1)(1995-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-7#1)(2013-1#2)
There was no significant difference##49##5##(1991-11#1)(1991-2#1)(1991-8#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-7#1)(1995-4#1)(1997-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#1)
There was no significant increase##2##5##(2013-1#2)
There was no significant relationship between##2##6##(2008-10#1)(2008-6#1)
There was no significant##78##4##(1990-3#1)(1991-11#1)(1991-2#1)(1991-8#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-7#2)(1995-2#1)(1995-4#1)(1997-2#1)(1997-8#1)(1997-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#5)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#1)
There was no statistical difference between the##2##7##(1996-12#1)(2008-7#1)
There was no statistical difference between##3##6##(1996-12#1)(2008-7#1)(2012-2#1)
There was no statistical difference in##2##6##(1990-12#1)(2011-1#1)
There was no statistical difference##6##5##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#2)(2012-2#1)
There was no statistical##8##4##(1990-12#1)(1996-12#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#2)
There was no statistically significant difference in##2##7##(2010-9#1)(2012-2#1)
There was no statistically significant difference##6##6##(2007-7#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
There was no statistically significant##8##5##(1996-9#1)(2007-10#1)(2007-7#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
There was no statistically##9##4##(1996-9#1)(2007-10#1)(2007-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
There was no##249##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#4)(1991-2#1)(1991-6#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-8#1)(1997-9#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#10)(2008-10#34)(2008-11#9)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#10)(2008-8#4)(2008-9#6)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#12)(2012-12#3)(2012-2#4)(2012-3#6)(2012-7#1)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#7)
There was not a significant##2##5##(2011-2#2)
There was not any##2##4##(2007-2#1)(2008-7#1)
There was not##5##3##(2007-2#1)(2008-7#1)(2009-8#1)(2011-2#2)
There was one death##2##4##(2007-8#1)(2008-7#1)
There was one##7##3##(1993-12#1)(2007-8#2)(2008-7#2)(2011-2#1)(2013-1#1)
There was only one##3##4##(1996-12#1)(2008-4#1)(2011-1#1)
There was only##5##3##(1991-3#1)(1995-3#1)(1996-12#1)(2008-4#1)(2011-1#1)
There was significant correlation##2##4##(2008-10#2)
There was significant difference between##3##5##(2008-9#1)(2011-1#1)(2011-3#1)
There was significant difference##4##4##(2007-7#1)(2008-9#1)(2011-1#1)(2011-3#1)
There was significant##10##3##(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#2)(2011-3#1)
There was significantly##2##3##(1995-3#1)(2008-10#1)
There was some evidence##3##4##(2008-10#2)(2009-6#1)
There was some##5##3##(2008-10#2)(2008-9#1)(2009-5#1)(2009-6#1)
There was strong##2##3##(1994-9#1)(2008-10#1)
There was substantial##3##3##(1995-1#1)(1995-6#1)(2008-7#1)
There was variability##2##3##(1990-7#1)(2012-2#1)
There was##591##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#5)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#4)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#5)(1993-5#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#7)(1995-12#3)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#10)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#2)(1997-6#3)(1997-8#4)(1997-9#1)(2006-8#1)(2007-10#5)(2007-11#4)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#12)(2007-9#1)(2008-1#14)(2008-10#93)(2008-11#18)(2008-12#13)(2008-2#1)(2008-3#9)(2008-4#7)(2008-5#11)(2008-6#7)(2008-7#33)(2008-8#14)(2008-9#18)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#17)(2011-10#1)(2011-2#28)(2011-3#2)(2012-12#6)(2012-2#12)(2012-3#12)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#25)(2013-7#5)(2013-8#14)
There were 1##4##3##(1991-3#1)(2007-7#1)(2008-1#1)(2012-12#1)
There were 10##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
There were 11##2##3##(2008-1#1)(2011-2#1)
There were 119##2##3##(2008-1#1)(2011-1#1)
There were 15##2##3##(1997-6#1)(2008-9#1)
There were 16##2##3##(2007-8#1)(2012-3#1)
There were 17##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
There were 18##2##3##(2007-7#1)(2008-5#1)
There were 19##2##3##(2007-7#1)(2008-6#1)
There were 2 cases##2##4##(2007-8#1)(2012-3#1)
There were 2 deaths##2##4##(2007-8#1)(2008-1#1)
There were 2##7##3##(1991-2#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2012-3#1)
There were 28##2##3##(2007-7#1)(2013-1#1)
There were 3##2##3##(2008-12#1)(2012-12#1)
There were 6##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
There were 69##2##3##(2007-7#1)(2008-4#1)
There were 74##2##3##(2008-1#1)(2011-2#1)
There were 75##2##3##(1993-8#1)(2012-3#1)
There were 79##2##3##(2007-7#1)(2012-3#1)
There were a few##2##4##(2008-12#1)(2008-9#1)
There were a total of##2##5##(2007-10#1)(2013-7#1)
There were a##5##3##(2007-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2013-7#1)
There were about##2##3##(2008-10#1)(2008-5#1)
There were also no differences in##2##6##(2008-5#1)(2012-2#1)
There were also no##4##4##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
There were also##15##3##(1996-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
There were differences in##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2012-8#1)
There were differences##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-8#1)
There were eight##2##3##(1993-12#1)(2008-1#1)
There were few##2##3##(1995-11#1)(2008-10#1)
There were fewer##2##3##(2008-10#1)(2008-3#1)
There were five##3##3##(1996-3#1)(2011-1#1)(2011-2#1)
There were four##6##3##(1992-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-8#1)
There were large differences##3##4##(2008-10#2)(2008-8#1)
There were large##4##3##(2008-10#2)(2008-8#1)(2010-12#1)
There were many##2##3##(1996-10#1)(2007-11#1)
There were minor##3##3##(2008-10#2)(2008-5#1)
There were more##2##3##(2008-3#1)(2008-9#1)
There were nine##2##3##(1993-3#1)(2010-12#1)
There were no cases of##2##5##(1991-2#1)(2011-2#1)
There were no changes##2##4##(2008-11#1)(2009-3#1)
There were no clinically##2##4##(1996-1#1)(2012-2#1)
There were no complications##2##4##(2008-7#1)(2011-2#1)
There were no consistent##2##4##(1993-9#1)(2008-10#1)
There were no deaths##4##4##(1993-9#1)(2007-7#1)(2008-8#1)(2008-9#1)
There were no differences among the##2##6##(1990-3#1)(2008-4#1)
There were no differences between males and females##2##8##(2008-4#1)(2012-3#1)
There were no differences between the##2##6##(2008-6#1)(2010-4#1)
There were no differences between##4##5##(2008-4#1)(2008-6#1)(2010-4#1)(2012-3#1)
There were no differences in the##4##6##(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
There were no differences in##13##5##(1993-1#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
There were no differences##20##4##(1990-3#1)(1993-1#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
There were no increased incidences of neoplasms in male or female Tg##2##12##(2008-9#2)
There were no intraoperative complications##2##5##(1993-12#1)(2012-3#1)
There were no intraoperative##3##4##(1993-12#1)(2007-11#1)(2012-3#1)
There were no major complications##2##5##(1994-2#1)(2008-5#1)
There were no neoplasms or nonneoplastic lesions that were attributed to exposure to acesulfame potassium##2##15##(2008-9#2)
There were no neoplasms or nonneoplastic lesions that were attributed to exposure to##3##13##(2008-8#1)(2008-9#2)
There were no other instances of##2##6##(2011-2#1)(2013-1#1)
There were no perioperative##2##4##(1996-9#1)(2012-12#1)
There were no recurrences##2##4##(2010-3#1)(2012-2#1)
There were no serious##3##4##(1990-2#1)(2008-5#1)(2013-1#1)
There were no significant changes in##4##6##(1993-12#1)(2006-12#1)(2007-8#1)(2008-9#1)
There were no significant changes##5##5##(1993-12#1)(2006-12#1)(2007-8#1)(2008-9#1)(2012-2#1)
There were no significant complications##2##5##(1993-1#1)(2008-9#1)
There were no significant differences among##2##6##(2008-10#1)(2011-2#1)
There were no significant differences between groups##3##7##(1994-5#1)(2013-1#2)
There were no significant differences between the##2##7##(1995-4#1)(2007-8#1)
There were no significant differences between##9##6##(1990-12#1)(1992-1#1)(1994-5#1)(1995-4#1)(1997-7#1)(2007-8#1)(2009-11#1)(2013-1#2)
There were no significant differences for##3##6##(2008-10#1)(2013-8#2)
There were no significant differences in the##8##7##(1991-8#1)(1994-12#1)(1997-2#1)(1997-7#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
There were no significant differences in##16##6##(1991-8#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
There were no significant differences on##2##6##(2008-9#1)(2012-2#1)
There were no significant differences##33##5##(1990-12#1)(1991-8#1)(1992-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-4#1)(1997-2#1)(1997-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
There were no significant##49##4##(1990-12#1)(1990-6#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-4#1)(1997-2#1)(1997-7#2)(2006-12#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
There were no signs of##2##5##(2007-8#1)(2008-10#1)
There were no statistically significant differences between the##2##8##(2009-10#1)(2013-1#1)
There were no statistically significant differences between##3##7##(2009-10#1)(2012-3#1)(2013-1#1)
There were no statistically significant differences in##5##7##(1996-1#1)(1996-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
There were no statistically significant differences##9##6##(1996-1#1)(1996-7#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
There were no statistically##10##4##(1996-1#1)(1996-7#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
There were no##161##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#3)(1993-6#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#3)(1997-7#3)(2006-12#1)(2007-11#3)(2007-7#2)(2007-8#8)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#13)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-3#3)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#11)(2013-8#3)
There were not##2##3##(2008-10#1)(2008-8#1)
There were only three##2##4##(1991-6#1)(2008-1#1)
There were only##5##3##(1991-6#1)(1994-9#1)(2008-1#1)(2008-11#1)(2011-1#1)
There were seven##2##3##(2007-7#1)(2011-2#1)
There were significant associations between##2##5##(2008-3#1)(2011-2#1)
There were significant changes##2##4##(1993-1#1)(2009-7#1)
There were significant correlations between##2##5##(1992-2#1)(2007-2#1)
There were significant differences among##2##5##(2008-10#2)
There were significant differences between the##4##6##(1991-9#1)(1994-9#1)(2008-10#1)(2012-12#1)
There were significant differences between##8##5##(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
There were significant differences in the##4##6##(1996-7#1)(2008-12#1)(2008-7#1)(2011-2#1)
There were significant differences in##9##5##(1996-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
There were significant differences##20##4##(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(1996-7#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
There were significant improvements in##2##5##(2007-2#1)(2013-1#1)
There were significant##33##3##(1991-9#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-9#1)(1995-2#1)(1996-7#1)(2007-2#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
There were significantly##3##3##(1992-2#1)(1996-12#1)(2008-10#1)
There were six##2##3##(2007-8#1)(2008-12#1)
There were some differences in##2##5##(1991-6#1)(2007-6#1)
There were some##5##3##(1991-6#1)(2007-6#1)(2008-11#1)(2010-1#1)(2010-8#1)
There were three##6##3##(2008-11#1)(2008-3#1)(2008-6#2)(2010-11#1)(2013-8#1)
There were trends##2##3##(1994-2#1)(2012-3#1)
There were two minor##2##4##(1994-2#1)(2008-9#1)
There were two##15##3##(1994-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
There were##449##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#4)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#2)(1996-1#3)(1996-10#1)(1996-12#3)(1996-3#5)(1996-5#3)(1996-7#2)(1996-9#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-10#5)(2007-11#12)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#14)(2007-8#21)(2008-1#22)(2008-10#40)(2008-11#9)(2008-12#10)(2008-2#2)(2008-3#7)(2008-4#10)(2008-5#13)(2008-6#6)(2008-7#14)(2008-8#9)(2008-9#24)(2009-1#1)(2009-10#3)(2009-11#2)(2009-3#2)(2009-7#3)(2010-1#2)(2010-11#3)(2010-12#3)(2010-3#3)(2010-4#4)(2010-6#1)(2010-8#4)(2011-1#9)(2011-2#28)(2012-12#6)(2012-2#10)(2012-3#17)(2012-8#1)(2013-1#22)(2013-7#2)(2013-8#9)
There will be##4##3##(1995-8#1)(1996-6#1)(2011-2#1)(2012-12#1)
There will##5##2##(1995-8#1)(1996-6#1)(1997-5#1)(2011-2#1)(2012-12#1)
There##2006##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#4)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#9)(1991-12#7)(1991-2#10)(1991-3#5)(1991-4#4)(1991-5#3)(1991-6#7)(1991-8#8)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#8)(1992-3#4)(1992-4#4)(1992-5#4)(1992-6#5)(1992-8#4)(1992-9#10)(1993-1#6)(1993-11#4)(1993-12#15)(1993-2#8)(1993-3#8)(1993-5#1)(1993-6#4)(1993-8#5)(1993-9#6)(1994-1#1)(1994-11#2)(1994-12#8)(1994-2#8)(1994-3#6)(1994-5#4)(1994-6#6)(1994-7#2)(1994-8#4)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#13)(1995-12#9)(1995-2#10)(1995-3#9)(1995-4#4)(1995-5#7)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#7)(1996-10#1)(1996-11#4)(1996-12#14)(1996-2#8)(1996-3#16)(1996-4#4)(1996-5#6)(1996-6#6)(1996-7#3)(1996-8#1)(1996-9#5)(1997-1#8)(1997-2#7)(1997-3#12)(1997-4#6)(1997-5#4)(1997-6#8)(1997-7#9)(1997-8#10)(1997-9#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#14)(2007-11#33)(2007-12#23)(2007-2#11)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#36)(2007-8#43)(2007-9#2)(2008-1#60)(2008-10#194)(2008-11#75)(2008-12#32)(2008-2#17)(2008-3#42)(2008-4#42)(2008-5#54)(2008-6#21)(2008-7#94)(2008-8#41)(2008-9#69)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#5)(2009-5#12)(2009-6#12)(2009-7#7)(2009-8#8)(2009-9#2)(2010-1#6)(2010-10#2)(2010-11#10)(2010-12#16)(2010-2#3)(2010-3#8)(2010-4#9)(2010-5#15)(2010-6#7)(2010-7#5)(2010-8#17)(2010-9#6)(2011-1#42)(2011-10#1)(2011-2#111)(2011-3#5)(2011-4#1)(2012-1#5)(2012-12#30)(2012-2#47)(2012-3#47)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#2)(2013-1#94)(2013-7#14)(2013-8#54)
There's##3##1##(1993-2#1)(1996-3#1)(2008-4#1)
Thereafter##31##1##(1992-10#1)(1992-12#1)(1992-9#1)(1995-12#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
Thereby##10##1##(1994-3#1)(1997-3#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-3#1)
Therefore a##11##2##(2008-2#2)(2008-3#6)(2008-5#1)(2012-3#1)(2013-8#1)
Therefore an##3##2##(1990-12#1)(2007-11#1)(2008-3#1)
Therefore determination of##2##3##(1992-3#1)(2008-3#1)
Therefore in##3##2##(2007-2#1)(2007-8#1)(2008-10#1)
Therefore it is##7##3##(1994-2#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#1)
Therefore it##8##2##(1994-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#1)
Therefore one##2##2##(2008-2#1)(2012-2#1)
Therefore the aim of##2##4##(2008-7#1)(2011-2#1)
Therefore the aim##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
Therefore the present##2##3##(1993-8#1)(2008-12#1)
Therefore the##39##2##(1990-3#1)(1990-6#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#10)(2008-7#4)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
Therefore this##3##2##(2008-11#2)(2008-3#1)
Therefore we investigated the##2##4##(1994-5#1)(2011-1#1)
Therefore we suggest that##2##4##(2008-11#1)(2009-1#1)
Therefore we##12##2##(1990-11#1)(1991-12#1)(1991-6#1)(1994-5#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-1#1)(2011-1#1)
Therefore##777##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#2)(1991-6#3)(1992-1#1)(1992-11#2)(1992-12#8)(1992-2#2)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#4)(1993-8#4)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#5)(1994-9#4)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#6)(1995-6#5)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#2)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#132)(2008-11#47)(2008-12#18)(2008-2#16)(2008-3#33)(2008-4#12)(2008-5#30)(2008-6#4)(2008-7#34)(2008-8#17)(2008-9#14)(2009-1#2)(2009-11#4)(2009-12#7)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#9)(2011-2#35)(2011-3#3)(2011-7#1)(2012-12#8)(2012-2#14)(2012-3#11)(2013-1#35)(2013-7#3)(2013-8#16)
Theresa##2##1##(1992-3#1)(1994-9#1)
Thermal Emission##2##2##(2008-3#2)
Thermal and##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
Thermal blooming##2##2##(2008-2#2)
Thermal conductivity of##2##3##(1992-8#1)(2008-3#1)
Thermal emission from##2##3##(2008-3#2)
Thermal inactivation##2##2##(1995-2#1)(1995-8#1)
Thermal lensing is used##2##4##(2008-10#2)
Thermal lensing##5##2##(2008-10#2)(2008-3#3)
Thermal luminescence##2##2##(2008-3#2)
Thermal stability of##3##3##(2007-11#1)(2008-11#1)(2008-6#1)
Thermal stability##4##2##(2007-11#1)(2008-11#1)(2008-6#2)
Thermal unfolding of the N-terminal RNA binding domain of##2##9##(1997-2#2)
Thermal##66##1##(1990-2#1)(1992-3#1)(1992-8#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-5#2)(1997-2#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#18)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#2)
Thermally induced##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Thermally##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
Thermo-optical measurements on##2##3##(2008-10#2)
ThermoSENSOR##4##1##(2010-5#4)
Thermoanaerobacter##3##1##(2011-1#2)(2011-2#1)
Thermobispora bispora##2##2##(2011-2#2)
Thermobispora##4##1##(2011-2#4)
Thermocrinis albus##2##2##(2011-2#2)
Thermocrinis##4##1##(2011-2#4)
Thermodynamic analysis of##4##3##(1992-10#1)(1993-11#1)(1997-2#1)(2008-7#1)
Thermodynamic analysis##6##2##(1990-8#1)(1992-10#1)(1993-11#1)(1995-2#1)(1997-2#1)(2008-7#1)
Thermodynamic and##2##2##(1993-8#1)(1995-5#1)
Thermodynamic characterization of##3##3##(2008-10#3)
Thermodynamic data for##2##3##(1992-5#1)(2008-10#1)
Thermodynamic parameters for the##3##4##(2008-10#3)
Thermodynamic parameters for##4##3##(1992-3#1)(2008-10#3)
Thermodynamic##27##1##(1990-8#1)(1990-9#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-5#2)(1996-9#1)(1997-2#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)
Thermodynamics of##3##2##(1990-8#2)(1997-2#1)
Thermodynamics##5##1##(1990-8#2)(1997-2#2)(2008-3#1)
Thermogravimetric analysis##2##2##(2008-10#2)
Thermogravimetric##4##1##(2008-10#3)(2008-6#1)
Thermophilic##2##1##(1990-3#1)(2008-7#1)
Thermoresponsive##2##1##(2008-10#1)(2009-3#1)
Thermosediminibacter oceani##2##2##(2011-2#2)
Thermosediminibacter##4##1##(2011-2#4)
Thermosphaera aggregans##2##2##(2011-2#2)
Thermosphaera##3##1##(2011-2#3)
Thermostable##3##1##(1997-4#2)(2013-1#1)
Thermotoga maritima##6##2##(1995-5#1)(2008-7#1)(2010-10#2)(2011-1#2)
Thermotoga##7##1##(1995-5#1)(2008-6#1)(2008-7#1)(2010-10#2)(2011-1#2)
Thermus aquaticus##3##2##(1997-4#1)(1997-6#1)(1997-8#1)
Thermus caldophilus GK24##2##3##(1997-4#2)
Thermus scotoductus##2##2##(1994-12#2)
Thermus thermophilus HB8##2##3##(1990-7#2)
Thermus##12##1##(1990-7#2)(1994-12#2)(1997-4#4)(1997-6#1)(1997-8#1)(2011-2#2)
Thesaurus is##3##2##(2008-7#3)
These &quot##10##2##(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-6#1)(2012-2#1)
These 2##4##2##(1992-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
These CD4##2##2##(2008-11#1)(2012-2#1)
These DNA##4##2##(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)
These Guidelines##2##2##(2008-9#1)(2013-1#1)
These QTL##2##2##(2008-10#2)
These TGCCA##2##2##(2009-12#2)
These abnormalities##2##2##(2008-4#1)(2008-6#1)
These activities##4##2##(1990-7#1)(1994-2#1)(2007-12#1)(2008-11#1)
These adaptations##3##2##(2010-12#1)(2010-8#1)(2013-7#1)
These adhesives##2##2##(2008-5#2)
These advances##3##2##(2008-4#1)(2009-11#1)(2010-11#1)
These advantages##2##2##(2007-11#1)(2008-2#1)
These agents##8##2##(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-3#1)(2012-1#1)(2012-3#1)
These alterations are##2##3##(1990-2#1)(1992-8#1)
These alterations##4##2##(1990-2#1)(1992-8#1)(2008-10#1)(2012-2#1)
These altered##2##2##(2008-1#1)(2012-3#1)
These amino##2##2##(1993-8#1)(1995-6#1)
These analyses suggest##2##3##(2008-9#2)
These analyses##16##2##(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-6#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2012-3#1)
These analytical##2##2##(2008-10#2)
These and other##6##3##(1994-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
These and previous##2##3##(1995-11#1)(2008-9#1)
These and##10##2##(1994-5#1)(1995-11#1)(1996-2#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
These animals##5##2##(1993-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2013-1#1)
These antibodies##4##2##(2006-6#1)(2007-10#1)(2008-1#1)(2011-2#1)
These applications may##2##3##(2008-10#1)(2008-3#1)
These applications##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
These approaches are based on##2##5##(2007-12#1)(2011-3#1)
These approaches are##4##3##(2007-12#1)(2008-6#1)(2011-3#1)(2012-3#1)
These approaches have##2##3##(2009-11#1)(2009-5#1)
These approaches may##2##3##(1997-3#1)(2008-5#1)
These approaches##13##2##(1994-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-5#1)(2011-3#1)(2012-3#1)(2013-1#1)
These are based on the##3##5##(2008-10#2)(2013-1#1)
These are based##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
These are being##2##3##(2010-3#1)(2012-2#1)
These are discussed##2##3##(1993-2#1)(2012-2#1)
These are important##2##3##(2008-7#2)
These are the first data##2##5##(1995-12#1)(2008-11#1)
These are the first##4##4##(1992-8#1)(1995-12#1)(2007-12#1)(2008-11#1)
These are the##10##3##(1991-12#1)(1992-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-7#1)
These are then reacted to give the ligand-oligonucleotide conjugate##2##9##(2008-4#2)
These are##60##2##(1991-1#1)(1991-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
These areas were##2##3##(1990-8#1)(2008-5#1)
These areas##3##2##(1990-8#1)(2008-5#1)(2012-5#1)
These articles focus on the##2##5##(1994-12#1)(1996-3#1)
These aspects are##3##3##(2006-4#1)(2008-10#1)(2008-9#1)
These aspects##5##2##(2006-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
These assays are##4##3##(2008-1#1)(2008-4#2)(2008-9#1)
These assays can be used to##3##6##(2008-1#3)
These assays provide##2##3##(2008-1#1)(2008-9#1)
These assays##15##2##(2008-1#5)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#3)(2010-4#1)
These associations##4##2##(1990-3#1)(1993-9#1)(2008-10#1)(2013-1#1)
These assumptions##2##2##(1992-6#1)(1996-3#1)
These attributes##2##2##(2007-10#1)(2010-8#1)
These beads were##2##3##(2008-10#1)(2008-11#1)
These beads##3##2##(2008-10#2)(2008-11#1)
These behavioral##2##2##(2007-8#1)(2013-8#1)
These benefits##5##2##(1993-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
These biases##2##2##(2008-1#1)(2008-8#1)
These biochemical##3##2##(1994-2#1)(2011-2#1)(2013-1#1)
These biological##2##2##(2008-10#1)(2011-2#1)
These brain##2##2##(1997-2#1)(1997-8#1)
These calculations##3##2##(2007-11#1)(2008-2#1)(2009-5#1)
These can be##2##3##(1996-12#1)(2012-2#1)
These can##6##2##(1990-5#1)(1996-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2012-2#1)
These case##2##2##(1991-2#1)(2010-7#1)
These cases highlight the##4##4##(2008-10#1)(2008-7#2)(2012-2#1)
These cases illustrate##2##3##(2008-1#1)(2011-2#1)
These cases show##2##3##(1992-10#1)(2007-8#1)
These cases were##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
These cases##18##2##(1990-6#1)(1991-2#1)(1992-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#5)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
These categories##2##2##(2008-10#1)(2008-12#1)
These cattle##2##2##(1997-8#1)(2012-2#1)
These cell lines were##2##4##(1994-6#1)(2008-11#1)
These cell lines##6##3##(1994-6#1)(1995-12#1)(2008-11#3)(2012-2#1)
These cells are##2##3##(2008-1#1)(2008-11#1)
These cells can##2##3##(2008-1#1)(2008-10#1)
These cells expressed the bone-related mRNA##2##6##(2008-11#2)
These cells expressed the##3##4##(1996-5#1)(2008-11#2)
These cells expressed##4##3##(1996-5#1)(2008-11#3)
These cells have been##2##4##(1997-8#1)(2008-11#1)
These cells have##4##3##(1997-8#1)(2008-11#3)
These cells were CD45(+)##2##4##(2008-11#2)
These cells were also##2##4##(1996-5#1)(2009-12#1)
These cells were##10##3##(1991-5#1)(1992-3#1)(1996-5#1)(2008-10#1)(2008-11#4)(2009-1#1)(2009-12#1)
These cells##35##2##(1991-5#2)(1992-3#1)(1996-5#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#15)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-11#1)
These challenges##2##2##(1992-1#1)(1996-2#1)
These changes are##8##3##(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-3#1)(2008-5#1)
These changes can be##2##4##(2008-10#1)(2008-9#1)
These changes can##3##3##(1995-3#1)(2008-10#1)(2008-9#1)
These changes have##2##3##(2010-4#1)(2012-2#1)
These changes in##5##3##(1993-10#1)(1994-8#1)(1994-9#1)(2008-10#2)
These changes include##2##3##(1990-9#1)(1995-1#1)
These changes may be##2##4##(1997-1#1)(2007-12#1)
These changes may contribute to##2##5##(1997-3#1)(1997-8#1)
These changes may##5##3##(1994-1#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)
These changes might##2##3##(2008-12#1)(2008-8#1)
These changes seem to##2##4##(1994-6#1)(2008-7#1)
These changes were associated with##3##5##(1990-5#1)(2008-11#1)(2013-1#1)
These changes were##9##3##(1990-2#1)(1990-5#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(2008-11#1)(2012-12#1)(2013-1#1)
These changes##52##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
These channels##2##2##(1992-11#1)(1994-11#1)
These characteristics and##2##3##(1992-12#1)(2008-3#1)
These characteristics are##2##3##(2008-10#1)(2011-2#1)
These characteristics##9##2##(1990-3#1)(1992-12#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2011-2#2)
These chemical##2##2##(1991-5#1)(1992-8#1)
These children##5##2##(1997-2#1)(1997-6#1)(2007-11#1)(2011-1#2)
These clades##2##2##(2008-10#2)
These clinical trials##2##3##(1994-5#1)(2010-6#1)
These clinical##4##2##(1994-5#1)(1995-12#1)(2008-9#1)(2010-6#1)
These clones were##2##3##(1996-2#1)(2008-10#1)
These clones##4##2##(1996-2#1)(1997-8#1)(2008-10#1)(2008-9#1)
These coatings##2##2##(2008-10#1)(2009-11#1)
These combined data suggest that##2##5##(2008-10#1)(2010-2#1)
These combined##4##2##(1990-8#1)(1992-3#1)(2008-10#1)(2010-2#1)
These common narratives include the narrative of##2##7##(2013-1#2)
These comparisons##2##2##(2008-2#1)(2011-2#1)
These complexes##4##2##(1996-2#1)(2008-10#3)
These complications##4##2##(2007-8#1)(2008-10#1)(2008-7#1)(2011-3#1)
These components are##3##3##(1996-12#1)(2008-8#1)(2013-1#1)
These components##5##2##(1996-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
These compounds also##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2012-3#1)
These compounds are##2##3##(1996-5#1)(2012-12#1)
These compounds do not show##2##5##(2008-10#2)
These compounds have been##3##4##(2008-10#2)(2010-3#1)
These compounds may##2##3##(1991-5#1)(1993-2#1)
These compounds were##7##3##(1992-9#1)(1995-3#2)(1996-2#1)(2007-11#1)(2007-5#1)(2008-10#1)
These compounds##36##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#2)(1995-3#3)(1996-2#1)(1996-5#2)(2007-11#2)(2007-5#1)(2008-10#8)(2008-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
These concentrations were##2##3##(1992-2#1)(2008-10#1)
These concepts##2##2##(2008-10#1)(2008-5#1)
These conclusions are##2##3##(1992-3#1)(2008-7#1)
These conclusions##5##2##(1992-3#1)(1994-12#1)(2008-5#1)(2008-7#2)
These conditions were##2##3##(2008-10#1)(2008-11#1)
These conditions##8##2##(1996-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#2)
These constraints need to be addressed and put into proper perspective in order to attract the interest of potential candidates##2##20##(1994-1#2)
These constraints##6##2##(1994-1#2)(2007-7#2)(2008-3#2)
These constructions##2##2##(2008-2#1)(2008-8#1)
These constructs##2##2##(1993-12#1)(2008-8#1)
These correlations##2##2##(1992-6#1)(2008-8#1)
These could be##3##3##(2008-12#1)(2011-2#2)
These could##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#2)
These criteria##4##2##(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)
These crystals##2##2##(1992-9#1)(2008-8#1)
These cues##2##2##(2011-1#1)(2011-2#1)
These cysts have##2##3##(2013-1#2)
These data also##5##3##(1992-3#1)(1993-6#1)(2008-10#2)(2011-2#1)
These data and##3##3##(1994-9#1)(1995-6#1)(2007-12#1)
These data are consistent with a##2##6##(1991-5#1)(2008-10#1)
These data are consistent with the##3##6##(1994-3#1)(1997-9#1)(2012-3#1)
These data are consistent with##5##5##(1991-5#1)(1994-3#1)(1997-9#1)(2008-10#1)(2012-3#1)
These data are the first##2##5##(1992-12#1)(2009-2#1)
These data are used to##2##5##(2009-11#1)(2013-1#1)
These data are used##3##4##(2008-3#1)(2009-11#1)(2013-1#1)
These data are useful##2##4##(2010-8#1)(2011-2#1)
These data are##18##3##(1991-5#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-9#1)(2008-10#3)(2008-3#2)(2009-11#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
These data clearly##2##3##(1996-12#1)(2009-10#1)
These data confirm that the##3##5##(2008-3#1)(2008-5#1)(2009-8#1)
These data confirm that##7##4##(1990-8#1)(1991-6#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
These data confirm the##2##4##(2008-10#1)(2008-7#1)
These data confirm##10##3##(1990-8#1)(1991-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
These data could##2##3##(2008-6#1)(2008-7#1)
These data demonstrate a##2##4##(1992-7#1)(1997-2#1)
These data demonstrate that a##2##5##(2009-6#1)(2011-2#1)
These data demonstrate that##14##4##(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-5#1)
These data demonstrate the##4##4##(1990-11#1)(2008-10#1)(2011-2#2)
These data demonstrate##23##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#2)(2009-6#1)(2011-2#4)(2012-12#1)(2012-5#1)
These data do not##2##4##(1993-6#1)(2008-7#1)
These data highlight##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
These data imply that##4##4##(1991-1#1)(1995-2#1)(2008-4#1)(2012-12#1)
These data imply##5##3##(1991-1#1)(1995-2#1)(1996-5#1)(2008-4#1)(2012-12#1)
These data indicate that increased##2##5##(1994-8#1)(2013-1#1)
These data indicate that the##10##5##(1990-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1996-3#1)(2007-12#1)(2008-7#1)
These data indicate that there is a##2##7##(1995-11#1)(2008-11#1)
These data indicate that there##3##5##(1990-11#1)(1995-11#1)(2008-11#1)
These data indicate that##46##4##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)
These data indicate##51##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
These data indicated that##2##4##(1996-2#1)(2008-10#1)
These data may##2##3##(1992-8#1)(2011-2#1)
These data point to##2##4##(1995-3#1)(2008-7#1)
These data provide a##2##4##(2012-5#1)(2013-8#1)
These data provide evidence for##2##5##(1993-12#1)(1995-11#1)
These data provide evidence##4##4##(1993-12#1)(1995-11#1)(1995-8#2)
These data provide further evidence##2##5##(1996-2#1)(2008-4#1)
These data provide important information##2##5##(1990-8#1)(2009-6#1)
These data provide the first##3##5##(1994-5#1)(1997-4#1)(2007-7#1)
These data provide##18##3##(1990-8#2)(1992-6#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-4#2)(2008-7#1)(2009-6#1)(2012-5#1)(2013-8#1)
These data provided##2##3##(2008-11#1)(2008-8#1)
These data raise##2##3##(1991-2#1)(1991-9#1)
These data reveal##4##3##(1990-12#1)(1996-1#1)(2011-2#1)(2013-1#1)
These data show that the##2##5##(1996-12#1)(1996-5#1)
These data show that##20##4##(1990-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
These data show##23##3##(1990-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
These data showed that##2##4##(2008-11#1)(2008-9#1)
These data strongly support the##2##5##(1994-8#1)(1997-7#1)
These data suggest a##4##4##(1992-3#1)(1995-12#1)(2012-2#2)
These data suggest that a##3##5##(1995-2#1)(2008-10#1)(2012-3#1)
These data suggest that an##2##5##(1990-9#1)(1991-9#1)
These data suggest that the observed##2##6##(1994-11#1)(2013-7#1)
These data suggest that the##24##5##(1990-2#1)(1990-5#1)(1992-8#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-2#2)(1995-3#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-7#1)
These data suggest that there##2##5##(2008-10#1)(2008-3#1)
These data suggest that##91##4##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#2)(1994-11#4)(1994-2#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
These data suggest the possibility##2##5##(1990-5#1)(2011-1#1)
These data suggest the##3##4##(1990-5#1)(1995-12#1)(2011-1#1)
These data suggest##103##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#4)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
These data suggested that##3##4##(2008-11#1)(2010-11#1)(2012-12#1)
These data suggested##4##3##(1991-5#1)(2008-11#1)(2010-11#1)(2012-12#1)
These data support a##2##4##(1991-12#1)(2013-1#1)
These data support the hypothesis that##2##6##(1992-6#1)(2008-10#1)
These data support the view that##3##6##(1992-8#1)(1996-7#1)(1997-6#1)
These data support the##11##4##(1992-6#1)(1992-8#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-7#2)(1997-6#1)(2008-10#1)(2008-5#2)
These data support##14##3##(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-7#2)(1997-6#1)(2008-10#2)(2008-5#2)(2013-1#1)
These data warrant##2##3##(2007-2#1)(2008-8#1)
These data were analyzed using##2##5##(1994-11#1)(2008-12#1)
These data were compared with##2##5##(2008-10#1)(2008-12#1)
These data were compared##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
These data were confirmed##2##4##(1992-3#1)(2008-5#1)
These data were then##2##4##(2008-10#1)(2011-2#1)
These data were used to calculate##2##6##(2009-8#2)
These data were##15##3##(1992-3#1)(1994-11#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#1)
These data will##3##3##(1995-1#1)(2008-9#1)(2010-8#1)
These data##360##2##(1990-11#3)(1990-12#5)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#5)(1992-3#5)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#7)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#7)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#5)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#6)(1995-8#3)(1996-1#2)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#5)(1996-7#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#38)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#8)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#3)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2012-5#2)(2013-1#8)(2013-7#1)(2013-8#3)
These databases reorganize and annotate the data or provide predictions##2##10##(2008-2#1)(2008-4#1)
These days##2##2##(2008-4#1)(2010-8#1)
These decreases##2##2##(1992-11#1)(2008-9#1)
These defects##3##2##(2007-11#1)(2008-9#1)(2009-4#1)
These deletions##2##2##(1993-6#1)(1997-2#1)
These derivatives are##2##3##(2007-11#1)(2012-12#1)
These developments are##3##3##(1996-11#1)(2008-7#1)(2009-8#1)
These developments##7##2##(1992-1#1)(1996-11#1)(1996-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
These devices were##2##3##(2007-11#1)(2008-12#1)
These devices##5##2##(2007-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
These differences are##8##3##(1992-8#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
These differences between##2##3##(1992-8#1)(1996-12#1)
These differences could be##2##4##(2008-7#1)(2013-7#1)
These differences could##3##3##(2006-10#1)(2008-7#1)(2013-7#1)
These differences in##5##3##(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
These differences may be##4##4##(1997-7#1)(2008-7#1)(2011-1#1)(2013-1#1)
These differences may##5##3##(1995-5#1)(1997-7#1)(2008-7#1)(2011-1#1)(2013-1#1)
These differences were##3##3##(1994-8#1)(2011-2#1)(2013-8#1)
These differences##37##2##(1991-6#1)(1992-8#2)(1993-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
These different##3##2##(2008-10#2)(2012-1#1)
These differential effects of##2##4##(1996-2#1)(2011-2#1)
These differential##3##2##(1996-2#1)(2007-5#1)(2011-2#1)
These discoveries##3##2##(2006-10#1)(2010-3#1)(2012-2#1)
These diseases are##7##3##(1991-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#1)
These dislocations##2##2##(2008-12#1)(2011-2#1)
These disorders are##2##3##(1992-5#1)(2007-12#1)
These distributions are##2##3##(1992-3#1)(2008-6#1)
These divergent##2##2##(2008-3#1)(2008-8#1)
These drawbacks##2##2##(2008-3#1)(2008-9#1)
These drugs are##2##3##(2008-11#1)(2009-7#1)
These drugs##4##2##(2008-11#1)(2009-12#1)(2009-7#1)(2012-12#1)
These dsRNAs##2##2##(2008-10#2)
These early clinical##2##3##(1994-11#1)(1997-3#1)
These early##5##2##(1992-12#1)(1994-11#1)(1997-3#1)(2008-10#1)(2010-6#1)
These effects are##11##3##(1990-7#1)(1991-12#1)(1992-11#1)(1993-3#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
These effects of##7##3##(1991-2#1)(1992-5#1)(1994-8#1)(1995-12#1)(2008-3#1)(2008-7#1)(2009-8#1)
These effects on##2##3##(1992-8#1)(1996-12#1)
These effects were observed##2##4##(1995-12#1)(2008-10#1)
These effects were##12##3##(1990-12#1)(1995-12#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
These effects##43##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#2)(1992-8#1)(1993-3#1)(1994-3#2)(1994-8#2)(1995-12#3)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#2)
These efforts##4##2##(1996-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
These electrochemical##2##2##(2008-10#1)(2009-5#1)
These electrodes have been found to be chemically inert showing a fast response time of##2##15##(2008-10#2)
These electrodes##4##2##(2008-10#4)
These elements are##4##3##(1991-12#1)(1995-8#1)(2008-11#1)(2008-3#1)
These elements were##4##3##(1993-12#1)(2008-10#3)
These elements##12##2##(1991-12#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)
These encouraging results suggest that the##2##6##(2008-10#1)(2010-3#1)
These enzymes are##2##3##(2007-7#1)(2008-10#1)
These enzymes##7##2##(1990-8#1)(1995-5#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
These equations are used##2##4##(2008-3#2)
These equations##5##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)
These errors are##2##3##(2008-2#1)(2008-3#1)
These errors##4##2##(2008-2#3)(2008-3#1)
These estimates are used##2##4##(1994-2#1)(2008-9#1)
These estimates are##3##3##(1994-2#1)(2008-9#1)(2010-10#1)
These estimates##5##2##(1994-2#1)(1995-12#1)(1996-8#1)(2008-9#1)(2010-10#1)
These events are##3##3##(1994-8#1)(2008-11#1)(2013-1#1)
These events##9##2##(1991-12#1)(1991-2#1)(1994-8#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
These examples##3##2##(1992-11#1)(2008-11#1)(2008-3#1)
These expatriated scientists##2##3##(2008-11#2)
These experimental results indicate that adjunctive treatment with mianserin to a typical D(2) antagonist generates an atypical antipsychotic profile##2##19##(2008-6#2)
These experimental results##6##3##(1992-11#1)(2008-3#1)(2008-6#2)(2010-12#1)(2012-12#1)
These experimental##9##2##(1992-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2010-12#1)(2012-1#1)(2012-12#1)
These experiments confirmed##2##3##(2008-10#2)
These experiments demonstrate the##3##4##(1995-2#1)(2008-3#2)
These experiments demonstrate##4##3##(1995-2#1)(2008-10#1)(2008-3#2)
These experiments show that the##2##5##(1990-11#1)(2008-7#1)
These experiments suggest that##2##4##(1991-2#1)(1994-8#1)
These experiments were##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
These experiments##28##2##(1990-11#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-8#3)(1995-2#2)(1997-7#1)(2006-6#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-4#1)(2010-2#1)(2013-7#1)
These experts##2##2##(2008-5#1)(2009-11#1)
These expression##2##2##(1993-12#1)(1997-4#1)
These expressions##3##2##(1995-9#1)(2008-10#1)(2008-2#1)
These extracts##2##2##(1993-6#1)(2008-2#1)
These factors are well##2##4##(1994-11#1)(1996-1#1)
These factors are##5##3##(1994-11#1)(1996-1#1)(2008-11#1)(2009-8#1)(2013-1#1)
These factors can be##2##4##(2008-10#1)(2008-8#1)
These factors include##7##3##(1992-12#1)(1993-1#1)(1993-3#1)(1995-2#1)(2007-7#1)(2008-4#1)(2010-12#1)
These factors##25##2##(1992-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#2)
These facts indicate##2##3##(1990-5#2)
These facts suggest that the##2##5##(1992-3#1)(2008-9#1)
These facts suggest##3##3##(1992-3#1)(2008-8#1)(2008-9#1)
These facts##7##2##(1990-2#1)(1990-5#2)(1992-3#1)(1997-1#1)(2008-8#1)(2008-9#1)
These families##2##2##(2008-4#1)(2008-7#1)
These features are##4##3##(1992-6#1)(1993-2#1)(2007-11#1)(2008-7#1)
These features make##2##3##(2008-6#1)(2009-4#1)
These features suggest that##2##4##(1993-9#1)(2007-11#1)
These features##20##2##(1992-6#1)(1993-2#1)(1993-9#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-6#1)(2010-6#1)(2013-8#1)
These films##2##2##(2008-10#1)(2010-7#1)
These filters##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
These findings add to the##2##5##(1993-9#1)(1995-12#1)
These findings also##3##3##(1995-2#1)(1995-6#1)(2010-2#1)
These findings and##4##3##(1995-5#1)(1995-6#1)(1996-2#1)(2008-10#1)
These findings are additional##2##4##(2006-6#1)(2008-12#1)
These findings are compared##2##4##(2007-12#1)(2008-7#1)
These findings are consistent with the##2##6##(1992-3#1)(2011-2#1)
These findings are consistent with##4##5##(1992-10#1)(1992-3#1)(2008-12#1)(2011-2#1)
These findings are discussed in relation##2##6##(1990-8#1)(2008-12#1)
These findings are discussed in terms of##3##7##(2007-12#1)(2008-10#1)(2010-2#1)
These findings are discussed in##6##5##(1990-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-12#1)
These findings are discussed with respect to##2##7##(1992-3#1)(1993-8#1)
These findings are discussed##8##4##(1990-8#1)(1992-3#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-12#1)
These findings are important##2##4##(2008-10#1)(2012-2#1)
These findings are##35##3##(1990-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-2#1)(1995-9#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
These findings clearly##2##3##(2008-10#1)(2010-6#1)
These findings confirm the##3##4##(2008-11#1)(2012-1#1)(2013-1#1)
These findings confirm##4##3##(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
These findings confirmed##2##3##(1994-8#1)(2008-5#1)
These findings contribute to##2##4##(2009-12#1)(2013-1#1)
These findings demonstrate that##8##4##(1993-12#1)(1993-6#1)(1995-11#1)(1997-4#1)(2007-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
These findings demonstrate the##2##4##(2011-2#1)(2013-1#1)
These findings demonstrate##12##3##(1993-12#1)(1993-6#1)(1995-11#1)(1995-5#1)(1997-4#1)(2007-12#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
These findings do not##2##4##(1991-6#1)(2013-8#1)
These findings emphasize the##3##4##(1991-5#1)(1992-10#1)(1993-6#1)
These findings further##2##3##(2009-4#1)(2009-5#1)
These findings have important implications for##3##6##(2008-10#2)(2012-1#1)
These findings have led##2##4##(2008-11#1)(2008-3#1)
These findings have##13##3##(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
These findings highlight the##3##4##(1995-12#1)(2009-7#1)(2011-2#1)
These findings highlight##4##3##(1995-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
These findings illustrate the potential##2##5##(2008-10#1)(2010-12#1)
These findings illustrate##3##3##(1994-3#1)(2008-10#1)(2010-12#1)
These findings imply that##2##4##(2008-9#1)(2012-2#1)
These findings indicate that the main##2##6##(1995-12#1)(2008-11#1)
These findings indicate that the##10##5##(1992-6#1)(1993-6#1)(1995-12#2)(1995-6#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
These findings indicate that##46##4##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-4#1)(1997-7#1)(2007-10#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
These findings indicate the##3##4##(1993-12#1)(2008-5#1)(2008-7#1)
These findings indicate##53##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-4#1)(1997-7#1)(2007-10#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
These findings indicated that##8##4##(1994-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
These findings may be##3##4##(1990-8#1)(2007-10#1)(2012-2#1)
These findings may have##3##4##(1993-12#1)(2008-7#1)(2012-2#1)
These findings may provide##2##4##(2008-10#1)(2008-6#1)
These findings may represent##2##4##(1990-12#1)(1995-5#1)
These findings may##18##3##(1990-12#1)(1990-8#1)(1993-12#1)(1994-8#1)(1995-5#1)(2006-6#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#3)(2012-3#1)(2013-1#1)
These findings offer##2##3##(1993-8#1)(2011-1#1)
These findings point to the need for##2##7##(1994-2#1)(2009-9#1)
These findings present##2##3##(2008-9#1)(2010-12#1)
These findings provide a##7##4##(1990-3#1)(1991-8#1)(2007-11#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
These findings provide evidence that##3##5##(1991-12#1)(1994-8#1)(1995-2#1)
These findings provide##18##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-8#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
These findings raise the possibility##2##5##(1992-12#1)(1994-8#1)
These findings resolve##2##3##(1993-9#1)(1995-11#1)
These findings reveal##3##3##(1991-11#1)(2009-5#1)(2010-8#1)
These findings revealed##2##3##(2008-5#1)(2010-4#1)
These findings shed light on the##3##6##(2008-11#1)(2012-12#1)(2012-2#1)
These findings shed##4##3##(2008-11#1)(2012-12#1)(2012-2#2)
These findings should be##2##4##(2008-11#1)(2013-1#1)
These findings should##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
These findings show that the##3##5##(1996-5#1)(2010-3#1)(2012-2#1)
These findings show that##5##4##(1995-12#1)(1995-3#1)(1996-5#1)(2010-3#1)(2012-2#1)
These findings show##6##3##(1995-12#1)(1995-3#1)(1996-5#1)(2008-8#1)(2010-3#1)(2012-2#1)
These findings strongly support the##2##5##(1995-12#1)(2008-5#1)
These findings suggest a role for##3##6##(1991-8#1)(1992-9#1)(1994-11#1)
These findings suggest a role##4##5##(1990-7#1)(1991-8#1)(1992-9#1)(1994-11#1)
These findings suggest a##9##4##(1990-7#1)(1991-8#1)(1992-9#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-12#1)
These findings suggest an##3##4##(1994-12#1)(1996-3#1)(1997-8#1)
These findings suggest that a##5##5##(1992-1#1)(1993-8#1)(1995-3#1)(2013-1#1)(2013-8#1)
These findings suggest that the##18##5##(1990-11#1)(1992-2#1)(1994-11#1)(1994-7#1)(1995-12#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
These findings suggest that these##2##5##(1992-12#1)(1993-8#1)
These findings suggest that##113##4##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#4)(1995-3#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2007-12#1)(2007-5#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
These findings suggest the##6##4##(1992-2#1)(1992-6#1)(1993-3#1)(1996-12#1)(2008-4#1)(2010-8#1)
These findings suggest##141##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#2)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#4)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
These findings suggested that the##2##5##(1994-6#1)(2008-10#1)
These findings suggested that##5##4##(1994-11#1)(1994-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
These findings suggested##6##3##(1994-11#1)(1994-6#2)(2008-10#1)(2008-9#1)(2013-1#1)
These findings support a##2##4##(2011-2#1)(2012-2#1)
These findings support the##8##4##(1991-7#1)(1994-11#1)(1994-2#1)(1996-7#1)(2007-11#1)(2008-7#1)(2009-4#1)(2009-9#1)
These findings support##12##3##(1990-8#1)(1991-7#1)(1994-11#1)(1994-2#1)(1996-7#1)(2007-11#1)(2007-2#1)(2008-7#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)
These findings were confirmed##3##4##(1993-12#1)(2008-9#1)(2010-11#1)
These findings were validated##2##4##(2010-12#1)(2010-7#1)
These findings were##10##3##(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
These findings will##3##3##(1993-2#2)(2010-5#1)
These findings##433##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#6)(1992-2#2)(1992-3#5)(1992-6#4)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#4)(1993-9#3)(1994-11#9)(1994-12#4)(1994-2#4)(1994-3#3)(1994-6#5)(1994-7#1)(1994-8#5)(1995-1#1)(1995-11#3)(1995-12#11)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#4)(1997-8#1)(2006-6#2)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#35)(2008-11#19)(2008-12#7)(2008-3#2)(2008-4#10)(2008-5#10)(2008-6#5)(2008-7#11)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-9#4)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#12)(2012-1#5)(2012-12#9)(2012-2#17)(2012-3#2)(2013-1#18)(2013-7#1)(2013-8#6)
These five##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
These flaps##2##2##(2007-12#1)(2008-9#1)
These forms of##3##3##(1994-11#1)(2008-7#1)(2009-9#1)
These forms##5##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
These four##5##2##(2008-1#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-10#1)
These fractions##2##2##(2008-10#1)(2008-11#1)
These fragments were##2##3##(1995-6#1)(2008-8#1)
These fragments##3##2##(1995-6#1)(2008-8#1)(2010-6#1)
These functional##7##2##(1994-12#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
These functions are##2##3##(1991-2#1)(1994-11#1)
These functions##5##2##(1991-2#1)(1994-11#1)(2008-10#1)(2008-7#1)(2010-1#1)
These fungi##3##2##(2008-10#2)(2009-6#1)
These gene##2##2##(1991-5#1)(1995-11#1)
These genes are##5##3##(1994-12#1)(2007-12#1)(2010-10#1)(2010-4#1)(2012-3#1)
These genes were##4##3##(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
These genes##11##2##(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)
These genotypes##2##2##(2008-10#1)(2008-12#1)
These gratings are##2##3##(2008-2#1)(2008-3#1)
These gratings##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
These groups##4##2##(2008-1#1)(2008-10#3)
These have been##3##3##(2008-10#1)(2008-5#1)(2009-2#1)
These have##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)
These high##5##2##(1994-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
These hospitals##2##2##(1991-6#1)(2008-8#1)
These images are##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
These images##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
These improved##3##2##(2008-2#1)(2008-3#2)
These improvements are##3##3##(2008-1#1)(2008-3#1)(2009-11#1)
These improvements##8##2##(1995-3#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#2)(2009-11#1)
These in vitro##3##3##(1994-6#1)(2008-5#1)(2013-1#1)
These in##4##2##(1992-11#1)(1994-6#1)(2008-5#1)(2013-1#1)
These include (1)##2##3##(1991-12#1)(1992-9#1)
These include 1)##2##3##(2008-3#1)(2010-5#1)
These include a##7##3##(1992-6#1)(1994-12#1)(1994-2#1)(2008-2#1)(2008-3#2)(2008-9#1)
These include both##3##3##(2007-12#1)(2009-11#1)(2012-12#1)
These include the three##2##4##(1996-2#1)(2013-1#1)
These include the##15##3##(1992-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
These include##84##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
These included##14##2##(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2013-1#1)
These increases##3##2##(1993-8#1)(1994-8#1)(1995-11#1)
These indicate that the##3##4##(1992-8#1)(1997-2#1)(2008-8#1)
These indicate that##5##3##(1992-8#1)(1997-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
These indicate##6##2##(1992-8#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
These individual##2##2##(1997-7#1)(2008-11#1)
These individuals##2##2##(1992-12#1)(1993-12#1)
These infections are##3##3##(1991-11#1)(2008-11#1)(2011-2#1)
These infections##5##2##(1991-11#1)(2007-7#1)(2008-11#1)(2011-2#2)
These inhibitors##2##2##(1992-8#1)(1995-6#1)
These inhibitory##2##2##(1995-12#1)(2012-12#1)
These initial results##2##3##(2007-11#1)(2008-3#1)
These initial##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
These initiatives may##2##3##(1996-3#1)(1997-2#1)
These injuries##2##2##(2007-8#1)(2010-12#1)
These insights##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
These interactions##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
These interferences##2##2##(2008-10#2)
These intermediates##2##2##(1990-5#1)(2007-11#1)
These investigations##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
These isolates originated from##2##4##(2008-10#2)
These isolates were##5##3##(2007-6#1)(2008-10#3)(2008-6#1)
These isolates##10##2##(2007-6#1)(2008-10#8)(2008-6#1)
These issues are##4##3##(1994-11#1)(1995-9#1)(2008-11#1)(2013-1#1)
These issues##6##2##(1994-11#1)(1995-9#1)(1997-5#1)(2008-11#1)(2010-7#1)(2013-1#1)
These lasers are##2##3##(2008-3#2)
These lasers##4##2##(2007-11#1)(2008-3#3)
These last##2##2##(2008-10#1)(2011-3#1)
These latest##2##2##(2008-4#2)
These latter##5##2##(1991-9#1)(1994-12#1)(1994-8#1)(2010-2#1)(2011-2#1)
These lesions are##2##3##(2012-3#1)(2013-1#1)
These lesions##8##2##(1990-5#1)(2007-10#1)(2007-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
These levels##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
These ligands##2##2##(2008-10#2)
These limitations##2##2##(2009-8#1)(2013-8#1)
These lines are##2##3##(2008-10#1)(2008-2#1)
These lines##3##2##(2008-10#2)(2008-2#1)
These lipids##2##2##(1990-7#1)(2013-1#1)
These localizations##2##2##(1991-9#1)(1994-2#1)
These loci were##2##3##(2008-10#2)
These loci##4##2##(1991-6#1)(2008-10#3)
These longitudinal##2##2##(2010-3#1)(2012-2#1)
These low##2##2##(1993-8#1)(2008-3#1)
These mAbs##2##2##(1993-8#1)(1996-12#1)
These maps were##2##3##(2007-5#1)(2008-3#1)
These markers were##4##3##(1994-7#1)(2008-10#2)(2008-12#1)
These markers##8##2##(1994-7#1)(2008-10#5)(2008-12#1)(2009-5#1)
These materials are##3##3##(2008-10#1)(2010-4#2)
These materials were##2##3##(2008-10#1)(2008-7#1)
These materials##10##2##(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-4#2)
These may be##5##3##(1990-11#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
These may##7##2##(1990-11#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
These measurements are##3##3##(1993-11#1)(2008-2#1)(2008-3#1)
These measurements were performed##2##4##(2008-3#2)
These measurements were##5##3##(1996-4#1)(2008-3#2)(2008-7#1)(2011-1#1)
These measurements##17##2##(1993-11#1)(1996-4#1)(1996-6#1)(2008-2#4)(2008-3#7)(2008-7#1)(2009-7#1)(2011-1#1)
These measures##3##2##(1994-2#1)(2011-2#1)(2012-3#1)
These mechanisms are##4##3##(2007-11#1)(2010-12#1)(2010-3#1)(2012-2#1)
These mechanisms include##3##3##(1991-9#1)(2009-12#1)(2012-12#1)
These mechanisms##12##2##(1990-2#1)(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)
These metals##3##2##(2008-10#3)
These methods allow##2##3##(2008-1#1)(2012-2#1)
These methods are based on##2##5##(2008-11#1)(2011-2#1)
These methods are##12##3##(2008-11#1)(2008-2#1)(2008-4#4)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#1)
These methods can be used##2##5##(2008-10#1)(2008-4#1)
These methods can be##3##4##(2008-10#1)(2008-4#2)
These methods can##5##3##(2008-10#1)(2008-4#3)(2008-9#1)
These methods have been##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
These methods have##5##3##(1995-12#1)(1996-9#1)(2008-10#2)(2008-7#1)
These methods include the##2##4##(1997-3#1)(2008-1#1)
These methods provide an##2##4##(2008-9#2)
These methods provide##3##3##(1991-2#1)(2008-9#2)
These methods were used to##2##5##(1992-11#1)(2008-10#1)
These methods were##7##3##(1992-11#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)
These methods##50##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-3#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-3#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
These mice##3##2##(1993-12#1)(1995-2#2)
These microcapsules##2##2##(2008-5#2)
These models are##2##3##(2007-11#1)(2008-8#1)
These models may prove to be more rapid##2##8##(2008-8#1)(2008-9#1)
These models were##2##3##(1994-9#1)(2007-11#1)
These models##14##2##(1994-9#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#2)(2011-1#1)
These modes##3##2##(1995-3#1)(2007-12#1)(2010-3#1)
These modifications##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
These modified##2##2##(2008-2#1)(2008-4#1)
These modulations##2##2##(2007-8#1)(2008-3#1)
These molecules##5##2##(1997-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2013-1#1)
These more##2##2##(2008-12#1)(2009-5#1)
These multiple##2##2##(1997-7#1)(2012-3#1)
These mutants##7##2##(1992-12#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)
These mutations##5##2##(1990-12#1)(1990-8#2)(2008-8#1)(2011-1#1)
These neurons##4##2##(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
These new formulations##2##3##(2008-11#1)(2008-5#1)
These new##17##2##(1994-12#1)(1995-3#1)(1996-9#1)(1997-1#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-9#1)(2010-2#1)(2011-3#1)
These newly##2##2##(2008-11#1)(2010-3#1)
These novel##6##2##(1996-2#1)(2007-11#2)(2008-10#1)(2012-2#1)(2013-1#1)
These observations are consistent with the##4##6##(1992-10#1)(1993-12#1)(1996-5#1)(2008-2#1)
These observations are consistent with##6##5##(1992-10#1)(1993-12#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-2#1)
These observations are in##3##4##(1990-12#1)(1995-11#1)(2006-6#1)
These observations are##13##3##(1990-12#1)(1992-10#1)(1993-12#2)(1995-11#1)(1996-5#1)(1997-7#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-5#1)
These observations confirm the important##2##5##(1995-12#1)(2008-5#1)
These observations confirm##3##3##(1995-12#1)(2008-5#1)(2008-6#1)
These observations demonstrate that##2##4##(1996-12#1)(2008-10#1)
These observations emphasize##2##3##(1993-1#1)(1994-8#1)
These observations have##2##3##(2007-12#1)(2012-2#1)
These observations indicate that##7##4##(1990-11#1)(1990-2#1)(1991-5#1)(1994-6#1)(1995-2#1)(2010-10#1)(2012-12#1)
These observations indicate##8##3##(1990-11#1)(1990-2#1)(1991-5#1)(1994-11#1)(1994-6#1)(1995-2#1)(2010-10#1)(2012-12#1)
These observations lend##2##3##(1990-11#1)(2012-2#1)
These observations provide##2##3##(1993-2#1)(2012-2#1)
These observations show##2##3##(2008-2#1)(2008-3#1)
These observations suggest a##3##4##(1991-6#1)(1993-3#1)(2011-1#1)
These observations suggest that a##2##5##(1994-6#1)(1996-2#1)
These observations suggest that the##5##5##(1992-10#1)(1994-5#1)(1995-2#1)(1995-6#1)(2012-2#1)
These observations suggest that##30##4##(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2012-2#1)
These observations suggest the existence of a##2##7##(1991-2#1)(1992-8#1)
These observations suggest the##4##4##(1991-2#1)(1992-8#1)(2008-10#1)(2008-11#1)
These observations suggest##39##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
These observations suggested that##2##4##(1995-5#1)(2008-7#1)
These observations suggested##3##3##(1995-5#1)(1997-2#1)(2008-7#1)
These observations support a##2##4##(1992-6#1)(1995-8#1)
These observations support##3##3##(1992-6#1)(1995-8#1)(2008-10#1)
These observations therefore##3##3##(1995-5#1)(2008-3#1)(2009-11#1)
These observations were further confirmed##2##5##(1991-4#1)(2008-10#1)
These observations were##4##3##(1990-11#1)(1991-4#1)(1995-6#1)(2008-10#1)
These observations##114##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#2)(1997-7#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)
These optical##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
These organizations##3##2##(1991-3#1)(1995-12#1)(2008-7#1)
These oscillations##2##2##(2008-10#1)(2011-2#1)
These outcomes##3##2##(1992-11#1)(2011-1#1)(2013-8#1)
These papers##3##2##(1994-11#1)(2008-10#1)(2008-3#1)
These parameters are##6##3##(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)
These parameters can##2##3##(2008-4#1)(2008-6#1)
These parameters could##2##3##(2008-10#1)(2008-3#1)
These parameters were##6##3##(2008-10#2)(2008-5#2)(2012-12#1)(2013-1#1)
These parameters##21##2##(1990-2#1)(1993-8#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
These pathways##5##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
These patients are at##2##4##(2011-2#1)(2012-12#1)
These patients are##4##3##(2011-2#2)(2012-12#1)(2013-1#1)
These patients had##2##3##(1991-11#1)(1994-12#1)
These patients may##2##3##(2010-5#1)(2011-2#1)
These patients should be treated##2##5##(1991-3#1)(2011-2#1)
These patients should##3##3##(1991-3#1)(2011-2#2)
These patients were then##2##4##(1992-9#1)(2010-8#1)
These patients were treated##2##4##(1992-12#1)(2013-7#1)
These patients were##11##3##(1992-12#1)(1992-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-10#1)(2010-8#1)(2013-7#1)
These patients##30##2##(1991-11#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-12#2)(2013-1#1)(2013-7#1)
These patterns are##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
These patterns##10##2##(1993-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
These peaks were##2##3##(2008-10#1)(2009-12#1)
These peaks##3##2##(2007-11#1)(2008-10#1)(2009-12#1)
These people##2##2##(1993-3#1)(1994-12#1)
These peptides##7##2##(1990-5#2)(1990-7#1)(1993-5#1)(1995-2#2)(1996-12#1)
These percentages##2##2##(1996-12#1)(2008-4#1)
These perturbations##2##2##(1996-12#1)(2008-4#1)
These phenomena##3##2##(1990-7#1)(1990-8#1)(2007-11#1)
These physical##2##2##(2008-7#1)(2012-2#1)
These pieces of evidence##2##4##(1996-6#1)(2008-8#1)
These plants##2##2##(2008-10#1)(2012-7#1)
These plasmids##2##2##(2008-9#1)(2012-3#1)
These points##2##2##(1994-11#1)(1996-11#1)
These polarization##2##2##(2008-2#1)(2008-3#1)
These polymers##4##2##(1995-6#1)(1997-7#1)(2008-10#1)(2011-3#1)
These population##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
These positive##2##2##(2008-7#1)(2010-3#1)
These potentially##2##2##(1992-9#1)(2010-1#1)
These predictions were supported##2##4##(1993-12#1)(2008-8#1)
These predictions were##4##3##(1990-2#1)(1993-12#1)(2008-8#2)
These predictions##6##2##(1990-2#1)(1993-12#1)(2008-7#1)(2008-8#2)(2009-5#1)
These preliminary findings##3##3##(1994-11#1)(1996-7#1)(2008-9#1)
These preliminary results indicate that##3##5##(2008-1#1)(2008-10#2)
These preliminary results suggest that##2##5##(1990-5#1)(1997-4#1)
These preliminary results suggest##3##4##(1990-5#1)(1997-4#1)(2012-2#1)
These preliminary results##12##3##(1990-2#1)(1990-5#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
These preliminary##16##2##(1990-2#1)(1990-5#1)(1994-11#1)(1996-1#1)(1996-7#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
These previously unrecognized##2##3##(1995-5#1)(2009-9#1)
These previously##3##2##(1995-5#1)(2009-9#1)(2011-1#1)
These primers amplified##2##3##(2008-10#2)
These primers##5##2##(1993-6#1)(2008-10#3)(2008-12#1)
These principles have##2##3##(1992-2#1)(2009-4#1)
These principles##3##2##(1992-2#1)(2008-11#1)(2009-4#1)
These probes##5##2##(2008-10#5)
These problems are##2##3##(1997-5#1)(2008-10#1)
These problems can be##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
These problems##12##2##(1991-3#1)(1992-2#1)(1997-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#1)
These procedures require##2##3##(2007-12#1)(2012-1#1)
These procedures##10##2##(1991-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(2007-12#2)(2008-4#2)(2012-1#1)(2012-3#1)
These processes are##5##3##(2007-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
These processes##8##2##(2007-12#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
These products are##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
These products##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
These properties and the##2##4##(2008-11#1)(2008-3#1)
These properties are##5##3##(1995-2#1)(1996-2#1)(2007-11#1)(2007-12#2)
These properties make##2##3##(1991-5#1)(2013-1#1)
These properties##20##2##(1991-5#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
These proposed methods##2##3##(2008-10#2)
These proteins are##5##3##(1993-12#1)(1996-5#1)(1996-9#1)(2008-7#1)(2009-9#1)
These proteins can##2##3##(1994-3#1)(1997-2#1)
These proteins have been##2##4##(1995-6#1)(2009-8#1)
These proteins##16##2##(1992-10#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)
These protocols are based on##2##5##(2008-4#2)
These protocols are##5##3##(2007-9#1)(2008-4#2)(2008-9#1)(2011-1#1)
These protocols can be used##2##5##(2008-1#1)(2008-9#1)
These protocols can##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
These protocols describe how to use the FASTA programs to characterize protein and DNA sequences##2##15##(2008-4#2)
These protocols may##2##3##(2008-2#1)(2008-4#1)
These protocols##17##2##(2007-9#1)(2008-1#1)(2008-2#3)(2008-4#7)(2008-9#4)(2011-1#1)
These pulses##2##2##(2007-12#1)(2008-2#1)
These questions are##2##3##(2011-1#1)(2012-2#1)
These questions##6##2##(2009-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
These ranges##2##2##(2008-3#1)(2010-8#1)
These rare##2##2##(1995-8#1)(2006-12#1)
These rates##2##2##(1991-1#1)(2007-7#1)
These ratios were##3##3##(1996-12#2)(2012-12#1)
These reactions##4##2##(1992-6#1)(1997-2#1)(2008-10#1)(2009-11#1)
These reagents##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
These recent##2##2##(2008-3#1)(2012-2#1)
These receptors##4##2##(1991-12#1)(2008-4#2)(2011-1#1)
These recommendations are##2##3##(2007-2#1)(2011-2#1)
These recommendations##6##2##(1992-3#1)(1992-9#1)(2007-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
These regions are##2##3##(2008-10#1)(2008-6#1)
These regions##5##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
These relationships are##2##3##(2007-12#1)(2008-2#1)
These relationships##7##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)
These represent##2##2##(2008-12#1)(2009-12#1)
These responses are##2##3##(1995-5#1)(1996-2#1)
These responses may##2##3##(1994-6#1)(1997-2#1)
These responses##7##2##(1994-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-5#1)(2009-5#1)(2012-12#1)
These results agree with##2##4##(2008-10#1)(2008-3#1)
These results agree##3##3##(2008-10#1)(2008-3#2)
These results also##7##3##(1990-7#1)(1993-3#1)(2008-8#2)(2010-4#1)(2010-8#1)(2013-1#1)
These results and##2##3##(2007-12#1)(2008-10#1)
These results appear to##2##4##(2008-11#1)(2008-2#1)
These results are applicable to##2##5##(2008-2#1)(2008-8#1)
These results are consistent with a model in which##2##9##(1990-2#1)(2008-10#1)
These results are consistent with a model##4##7##(1990-2#1)(1992-6#1)(2007-1#1)(2008-10#1)
These results are consistent with a##10##6##(1990-2#1)(1992-6#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-11#1)
These results are consistent with the hypothesis that the##3##9##(1994-2#1)(1997-3#1)(2012-1#1)
These results are consistent with the hypothesis that##6##8##(1993-12#2)(1994-2#1)(1997-3#1)(2008-10#1)(2012-1#1)
These results are consistent with the previous##2##7##(1991-12#1)(2008-5#1)
These results are consistent with the##18##6##(1990-11#2)(1991-12#1)(1992-3#1)(1993-12#2)(1993-8#1)(1994-2#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-1#1)
These results are consistent with those obtained##2##7##(2008-10#1)(2008-7#1)
These results are consistent with##38##5##(1990-11#2)(1990-2#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-9#1)(2007-1#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-1#1)
These results are discussed in terms of the##4##8##(1990-7#2)(1993-6#1)(2008-10#1)
These results are discussed in terms of##5##7##(1990-7#2)(1993-12#1)(1993-6#1)(2008-10#1)
These results are discussed in##8##5##(1990-11#1)(1990-7#2)(1991-12#1)(1993-12#1)(1993-6#1)(2008-10#2)
These results are discussed with##2##5##(1993-3#1)(1995-8#1)
These results are discussed##11##4##(1990-11#1)(1990-7#2)(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-8#1)(1996-3#1)(2008-10#2)
These results are in agreement with previous findings##2##8##(1994-5#1)(2008-7#1)
These results are in##4##4##(1994-5#1)(1994-8#1)(2008-7#1)(2010-4#1)
These results are interpreted as##2##5##(1991-5#1)(1994-6#1)
These results are interpreted in terms of##2##7##(1994-11#1)(2008-3#1)
These results are interpreted##5##4##(1991-5#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-3#1)
These results are similar to##2##5##(1992-12#1)(1994-12#1)
These results are the first demonstration that##2##7##(1997-2#1)(2012-1#1)
These results are the first demonstration##3##6##(1991-5#1)(1997-2#1)(2012-1#1)
These results are the first##5##5##(1991-5#1)(1997-2#1)(1997-3#1)(2008-3#1)(2012-1#1)
These results are used to##2##5##(2008-3#2)
These results are useful##3##4##(2008-10#1)(2008-3#2)
These results are##97##3##(1990-11#3)(1990-2#1)(1990-7#2)(1991-12#2)(1991-5#2)(1992-12#2)(1992-3#2)(1992-6#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#12)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#5)(2009-9#1)(2010-4#1)(2011-2#1)(2012-1#2)
These results argue##3##3##(1993-11#1)(1993-6#1)(1997-2#1)
These results can be used to##2##6##(2008-10#1)(2010-7#1)
These results can be used##3##5##(2008-10#1)(2010-7#1)(2013-1#1)
These results can be##5##4##(1990-5#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#1)
These results can##7##3##(1990-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2013-1#1)
These results clearly demonstrate that##2##5##(2009-6#1)(2009-8#1)
These results clearly demonstrate##3##4##(2008-10#1)(2009-6#1)(2009-8#1)
These results clearly##4##3##(1990-7#1)(2008-10#1)(2009-6#1)(2009-8#1)
These results confirm previous##2##4##(1991-2#1)(1994-8#1)
These results confirm that##4##4##(1990-12#1)(1991-5#1)(2008-5#1)(2008-9#1)
These results confirm the##4##4##(1992-4#1)(1992-5#1)(1997-6#1)(2008-9#1)
These results confirm##13##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-5#1)(1994-8#1)(1997-6#2)(2008-5#2)(2008-9#2)
These results confirmed that the##4##5##(1997-2#1)(2007-6#1)(2008-10#1)(2010-6#1)
These results confirmed that##6##4##(1997-2#1)(2007-6#1)(2008-10#2)(2008-9#1)(2010-6#1)
These results confirmed##9##3##(1994-3#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-9#1)(2010-2#1)(2010-6#1)(2013-8#1)
These results contribute to a better understanding of the##3##9##(2008-10#3)
These results demonstrate a##4##4##(1994-3#1)(1996-12#1)(2008-11#1)(2012-2#1)
These results demonstrate that both##3##5##(1994-11#1)(2008-10#1)(2008-7#1)
These results demonstrate that exposure##2##5##(1992-8#1)(2013-1#1)
These results demonstrate that the two##2##6##(2008-5#1)(2008-9#1)
These results demonstrate that the##12##5##(1992-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-11#3)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
These results demonstrate that##76##4##(1990-12#2)(1990-5#1)(1990-8#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-11#4)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#3)(1997-2#1)(1997-7#2)(2008-10#12)(2008-11#7)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#4)
These results demonstrate the important role of##2##7##(1995-8#1)(2012-1#1)
These results demonstrate the utility of##2##6##(1990-5#1)(2007-11#1)
These results demonstrate the##11##4##(1990-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
These results demonstrate##100##3##(1990-12#2)(1990-5#2)(1990-8#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#5)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-10#15)(2008-11#8)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#4)
These results demonstrated that##9##4##(1992-11#1)(1992-9#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#2)
These results demonstrated the##3##4##(1994-9#1)(2008-10#1)(2008-9#1)
These results demonstrated##13##3##(1992-11#1)(1992-9#1)(1994-9#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)
These results do not##2##4##(1991-12#1)(1991-8#1)
These results do##3##3##(1991-12#1)(1991-8#1)(2008-7#1)
These results emphasize the##4##4##(1990-5#1)(1993-3#1)(2008-9#1)(2009-10#1)
These results establish that the##2##5##(1993-11#1)(1994-11#1)
These results establish that##5##4##(1990-11#1)(1993-11#1)(1994-11#1)(1995-2#1)(2008-10#1)
These results establish##6##3##(1990-11#1)(1993-11#1)(1994-11#1)(1995-2#1)(2008-10#1)(2013-1#1)
These results extend##2##3##(1994-8#1)(2012-3#1)
These results further##2##3##(1993-12#1)(2008-2#1)
These results have implications for the##2##6##(2008-9#1)(2012-12#1)
These results have implications for##5##5##(1994-8#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)
These results have important implications##2##5##(2007-7#1)(2008-7#1)
These results have important##3##4##(1993-12#1)(2007-7#1)(2008-7#1)
These results have##16##3##(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)
These results highlight the importance of considering##2##7##(2011-2#1)(2012-12#1)
These results highlight the importance of##3##6##(2009-8#1)(2011-2#1)(2012-12#1)
These results highlight the##8##4##(1992-10#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
These results identify##3##3##(1993-12#1)(1994-8#1)(1995-6#1)
These results illustrate the##5##4##(1994-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-1#1)
These results illustrate##6##3##(1994-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
These results implicate##4##3##(1993-11#1)(1995-6#1)(2008-10#1)(2008-11#1)
These results implied##2##3##(1997-3#1)(2008-8#1)
These results imply that a##4##5##(1993-11#1)(1995-2#1)(2008-3#1)(2008-8#1)
These results imply that the##3##5##(1995-12#1)(2008-5#1)(2013-1#1)
These results imply that##14##4##(1993-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-1#1)
These results imply##15##3##(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-1#1)
These results in##2##3##(1995-11#1)(1997-2#1)
These results indicate a##2##4##(2007-2#1)(2008-5#1)
These results indicate that (i)##2##5##(1994-5#1)(2008-10#1)
These results indicate that ANP##2##5##(1993-8#1)(2008-5#1)
These results indicate that a single##2##6##(1997-2#1)(2008-10#1)
These results indicate that a##7##5##(1991-11#1)(1991-12#1)(1992-11#1)(1997-2#1)(2008-10#2)(2008-2#1)
These results indicate that activin##2##5##(1993-8#1)(1995-8#1)
These results indicate that application of##2##6##(2008-10#1)(2008-12#1)
These results indicate that at##2##5##(1994-11#1)(2008-7#1)
These results indicate that both##2##5##(1991-12#1)(2008-6#1)
These results indicate that higher##2##5##(2008-9#1)(2012-3#1)
These results indicate that in the##2##6##(2008-2#1)(2008-5#1)
These results indicate that in##5##5##(1992-5#1)(1997-1#1)(2008-2#1)(2008-5#2)
These results indicate that one##2##5##(1991-8#1)(2008-5#1)
These results indicate that the activation of##2##7##(1997-2#2)
These results indicate that the association of##2##7##(2008-10#1)(2008-12#1)
These results indicate that the expression##2##6##(1993-6#1)(1997-3#1)
These results indicate that the##56##5##(1990-2#1)(1990-7#2)(1991-12#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#4)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
These results indicate that there is##2##6##(1990-2#1)(1997-1#1)
These results indicate that this##2##5##(1992-8#1)(2008-11#1)
These results indicate that##223##4##(1990-12#2)(1990-2#2)(1990-7#6)(1990-8#1)(1991-11#1)(1991-12#6)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#6)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#2)(1994-11#6)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#3)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#6)(1996-5#2)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#31)(2008-11#12)(2008-12#6)(2008-2#2)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#9)(2008-9#4)(2009-7#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
These results indicate the##7##4##(1990-10#1)(1992-6#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
These results indicate##239##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-7#6)(1990-8#1)(1991-11#1)(1991-12#6)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#6)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#3)(1994-11#6)(1994-2#2)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#6)(1996-5#2)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#33)(2008-11#13)(2008-12#6)(2008-2#2)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#5)(2008-8#9)(2008-9#4)(2009-7#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
These results indicated TMSG-1##2##4##(2008-9#2)
These results indicated that the##5##5##(1990-2#1)(2008-10#1)(2008-11#2)(2008-8#1)
These results indicated that##13##4##(1990-2#1)(1992-6#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
These results indicated##18##3##(1990-2#1)(1991-2#1)(1992-6#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-5#1)
These results lead us to conclude that##2##7##(2008-10#2)
These results led us to##2##5##(1994-8#1)(2008-6#1)
These results led##3##3##(1994-8#1)(2008-2#1)(2008-6#1)
These results may be##4##4##(1997-5#1)(1997-6#1)(2007-12#1)(2008-9#1)
These results may help##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
These results may provide##3##4##(1995-12#1)(2008-5#1)(2010-12#1)
These results may reflect##2##4##(2007-10#1)(2008-7#1)
These results may##17##3##(1993-12#1)(1994-1#1)(1994-8#1)(1995-12#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)
These results point to the##4##5##(1993-12#1)(1995-2#1)(1997-4#1)(2008-2#1)
These results point to##6##4##(1990-11#1)(1993-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)
These results point##7##3##(1990-11#1)(1993-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2012-8#1)
These results prove that##2##4##(1992-9#1)(1994-5#1)
These results proved##2##3##(1990-8#1)(2008-10#1)
These results provide direct##2##4##(2008-10#2)
These results provide evidence that##2##5##(1990-7#1)(1992-3#1)
These results provide insights into##2##5##(1997-2#1)(2012-3#1)
These results provide new insights into##2##6##(2008-10#1)(2009-8#1)
These results provide support for##2##5##(1994-8#1)(1994-9#1)
These results provide the first##3##5##(2008-10#1)(2009-2#1)(2013-1#1)
These results provide the##4##4##(1995-2#1)(2008-10#1)(2009-2#1)(2013-1#1)
These results provide##28##3##(1990-7#1)(1992-2#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-2#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-2#1)(2012-3#2)(2013-1#1)
These results provided new##2##4##(2008-10#1)(2008-9#1)
These results provided##4##3##(2008-10#1)(2008-9#2)(2012-12#1)
These results reflect the##2##4##(2008-10#1)(2012-3#1)
These results represent##3##3##(1992-3#1)(2008-2#1)(2008-6#1)
These results reveal that##2##4##(1992-3#1)(1994-9#1)
These results reveal##5##3##(1992-3#1)(1992-9#1)(1994-9#1)(2007-11#1)(2010-12#1)
These results revealed##3##3##(2008-10#2)(2008-6#1)
These results should##3##3##(1992-6#1)(2008-5#1)(2011-3#1)
These results show a##2##4##(2008-10#1)(2008-2#1)
These results show that a##2##5##(1990-11#1)(2008-8#1)
These results show that the##19##5##(1990-7#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-6#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-3#1)
These results show that##55##4##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#2)(2007-12#1)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
These results show the##4##4##(1995-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
These results show##69##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#2)(2007-12#1)(2008-10#15)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
These results showed that the##3##5##(2008-10#2)(2012-2#1)
These results showed that##9##4##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-7#1)
These results showed their sensitivity to growth##2##7##(2008-11#2)
These results showed##12##3##(2008-10#4)(2008-11#3)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-7#1)
These results strongly indicate that##2##5##(1991-12#1)(1993-8#1)
These results strongly suggest that both L-leucine and KIC stimulate protein synthesis in##2##13##(2008-11#2)
These results strongly suggest that both##3##6##(2008-10#1)(2008-11#2)
These results strongly suggest that the##2##6##(1991-12#1)(2008-6#1)
These results strongly suggest that##13##5##(1990-4#1)(1991-12#3)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2010-3#1)
These results strongly suggest##14##4##(1990-4#1)(1991-12#3)(1994-5#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2010-3#1)
These results strongly##16##3##(1990-4#1)(1991-12#4)(1993-8#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2010-3#1)
These results suggest a possible role for##2##7##(1991-1#1)(1992-3#1)
These results suggest a possible##4##5##(1990-8#1)(1991-1#1)(1992-3#1)(1994-3#1)
These results suggest a role for##2##6##(1992-12#1)(2012-3#1)
These results suggest a##14##4##(1990-8#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(2008-10#1)(2012-3#1)
These results suggest an##9##4##(1990-6#1)(1993-12#1)(1994-3#1)(1994-8#2)(1996-9#1)(2007-10#1)(2008-11#1)(2008-5#1)
These results suggest that BF##2##5##(2008-10#1)(2009-3#1)
These results suggest that CaM kinase##2##6##(1990-5#1)(1994-6#1)
These results suggest that a##7##5##(1992-3#1)(1992-6#2)(2008-10#2)(2008-2#1)(2008-7#1)
These results suggest that an##4##5##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
These results suggest that at##2##5##(1995-12#1)(2008-10#1)
These results suggest that both##3##5##(1991-12#1)(1994-5#1)(2008-9#1)
These results suggest that different##5##5##(1990-7#1)(2007-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
These results suggest that factors##2##5##(1993-6#1)(2011-2#1)
These results suggest that human##2##5##(1994-2#1)(2008-8#1)
These results suggest that in##4##5##(1992-9#1)(1993-8#2)(2008-10#1)
These results suggest that interactions##2##5##(1994-8#1)(2008-10#1)
These results suggest that intracellular##2##5##(1995-8#1)(2008-10#1)
These results suggest that one or##2##6##(1991-12#1)(1994-9#1)
These results suggest that our##2##5##(2008-10#1)(2008-11#1)
These results suggest that p53##2##5##(1994-9#1)(2012-2#1)
These results suggest that protein##4##5##(1992-12#1)(1993-8#1)(1994-9#1)(1995-12#1)
These results suggest that some of the##2##7##(1996-6#1)(2008-9#1)
These results suggest that species##2##5##(2008-8#2)
These results suggest that the inhibitory##2##6##(1990-5#1)(1991-12#1)
These results suggest that the mechanisms##2##6##(2008-7#1)(2011-2#1)
These results suggest that the resistance of##2##7##(2008-10#2)
These results suggest that the##103##5##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#4)(1997-6#2)(2007-10#1)(2007-12#1)(2008-10#16)(2008-11#6)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#2)(2009-11#1)(2009-2#1)(2010-5#3)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)
These results suggest that there is a##2##7##(2008-3#1)(2009-8#1)
These results suggest that there is##6##6##(1994-3#1)(2008-10#3)(2008-3#1)(2009-8#1)
These results suggest that there##8##5##(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)
These results suggest that these##3##5##(1992-8#1)(1993-11#1)(1994-12#1)
These results suggest that when##2##5##(1992-10#1)(2009-9#1)
These results suggest that while##2##5##(1994-7#1)(2008-11#1)
These results suggest that##438##4##(1990-11#4)(1990-12#3)(1990-2#5)(1990-5#5)(1990-7#5)(1990-8#2)(1991-11#2)(1991-12#12)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#5)(1992-3#8)(1992-4#1)(1992-6#2)(1992-8#7)(1992-9#6)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#8)(1993-6#5)(1993-8#11)(1993-9#3)(1994-11#6)(1994-12#5)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#5)(1995-11#5)(1995-12#10)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#5)(1996-2#7)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(2007-10#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#58)(2008-11#32)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#18)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#1)
These results suggest the importance of##2##6##(1992-8#1)(1994-8#1)
These results suggest the possibility that##2##6##(1994-11#1)(1996-12#1)
These results suggest the possibility##3##5##(1993-3#1)(1994-11#1)(1996-12#1)
These results suggest the potential usefulness of##2##7##(2008-10#2)
These results suggest the potential##3##5##(1993-11#1)(2008-10#2)
These results suggest the presence of a##4##7##(1991-2#1)(2008-10#1)(2008-6#1)(2008-9#1)
These results suggest the presence of##5##6##(1991-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#1)
These results suggest the usefulness of##2##6##(1990-5#1)(2008-5#1)
These results suggest the##22##4##(1990-5#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-8#1)
These results suggest##492##3##(1990-11#4)(1990-12#3)(1990-2#5)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#3)(1991-1#1)(1991-11#3)(1991-12#12)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#7)(1992-3#9)(1992-4#2)(1992-6#2)(1992-8#8)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#9)(1993-6#5)(1993-8#12)(1993-9#3)(1994-11#7)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#5)(1995-11#5)(1995-12#11)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#6)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(2007-10#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#65)(2008-11#36)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#7)(2008-7#9)(2008-8#18)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#2)
These results suggested a##3##4##(1997-8#1)(2008-6#1)(2008-8#1)
These results suggested that the expression of##2##7##(1997-7#1)(2008-9#1)
These results suggested that the##7##5##(1995-6#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
These results suggested that##23##4##(1991-5#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-8#3)(2008-9#2)(2012-12#1)(2013-1#2)(2013-8#1)
These results suggested##28##3##(1991-5#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#3)(2012-12#1)(2013-1#2)(2013-8#1)
These results support a role for##4##6##(1990-5#1)(1992-5#1)(1995-5#1)(1995-6#1)
These results support previous##2##4##(1996-5#1)(2011-2#1)
These results support that##2##4##(2008-5#1)(2012-1#1)
These results support the hypotheses that##2##6##(2008-7#1)(2010-6#1)
These results support the hypothesis of a##2##7##(1993-5#1)(1994-11#1)
These results support the hypothesis that the##2##7##(1992-7#1)(2008-10#1)
These results support the hypothesis that##11##6##(1992-5#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-6#1)(1997-4#1)(2008-10#4)(2009-5#1)
These results support the hypothesis##14##5##(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-4#1)(2008-10#5)(2009-5#1)
These results support the suggestion##2##5##(1995-8#1)(1996-5#1)
These results support the view that##2##6##(2008-2#1)(2008-5#1)
These results support the##28##4##(1990-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-6#1)(2012-12#1)
These results support##41##3##(1990-10#1)(1990-5#1)(1991-9#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-4#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
These results therefore##2##3##(1997-4#1)(2008-11#1)
These results thus indicate a##2##5##(1994-6#1)(1996-5#1)
These results thus##5##3##(1994-6#1)(1996-5#1)(2007-8#1)(2008-10#1)(2013-1#1)
These results were achieved##2##4##(2007-12#1)(2008-10#1)
These results were also confirmed by##2##6##(1995-6#1)(2008-10#1)
These results were compared with##2##5##(2008-10#2)
These results were confirmed by##2##5##(1994-11#1)(2011-2#1)
These results were confirmed with##2##5##(2008-10#2)
These results were confirmed##6##4##(1994-11#1)(2007-10#1)(2008-10#2)(2008-5#1)(2011-2#1)
These results were consistent##2##4##(1990-5#1)(2008-10#1)
These results were further##2##4##(1997-1#1)(2009-6#1)
These results were in good agreement with##2##7##(1992-9#1)(2008-10#1)
These results were interpreted to mean that##2##7##(2008-10#2)
These results were interpreted##3##4##(1990-11#1)(2008-10#2)
These results were obtained##2##4##(2007-12#1)(2008-3#1)
These results were##37##3##(1990-11#1)(1990-5#1)(1990-7#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-7#1)
These results will be##3##4##(2008-6#1)(2008-8#1)(2013-7#1)
These results will facilitate##2##4##(2008-8#1)(2008-9#1)
These results will##7##3##(1995-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2013-7#1)
These results would##3##3##(1990-2#1)(2008-10#1)(2013-1#1)
These results##1454##2##(1990-10#2)(1990-11#11)(1990-12#9)(1990-2#11)(1990-4#1)(1990-5#13)(1990-6#1)(1990-7#18)(1990-8#8)(1991-1#1)(1991-11#4)(1991-12#26)(1991-2#4)(1991-5#8)(1991-6#2)(1991-8#3)(1991-9#9)(1992-1#2)(1992-10#3)(1992-11#5)(1992-12#12)(1992-2#4)(1992-3#16)(1992-4#3)(1992-5#5)(1992-6#11)(1992-7#2)(1992-8#17)(1992-9#11)(1993-1#2)(1993-11#16)(1993-12#19)(1993-2#2)(1993-3#14)(1993-5#3)(1993-6#13)(1993-8#22)(1993-9#6)(1994-1#2)(1994-11#24)(1994-12#10)(1994-2#11)(1994-3#7)(1994-5#11)(1994-6#9)(1994-7#1)(1994-8#25)(1994-9#11)(1995-1#1)(1995-11#12)(1995-12#30)(1995-2#14)(1995-3#7)(1995-4#1)(1995-5#6)(1995-6#14)(1995-8#11)(1995-9#1)(1996-12#14)(1996-2#18)(1996-3#2)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#11)(1997-2#21)(1997-3#7)(1997-4#6)(1997-5#2)(1997-6#13)(1997-7#9)(1997-8#4)(1997-9#1)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#12)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#221)(2008-11#88)(2008-12#7)(2008-2#17)(2008-3#31)(2008-4#7)(2008-5#44)(2008-6#19)(2008-7#29)(2008-8#57)(2008-9#44)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#4)(2010-1#3)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#7)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#24)(2011-3#2)(2012-1#5)(2012-12#11)(2012-2#19)(2012-3#16)(2012-8#1)(2013-1#28)(2013-7#6)(2013-8#7)
These same##3##2##(1994-3#1)(2008-9#2)
These samples were##3##3##(2008-10#2)(2013-7#1)
These samples##5##2##(1995-6#1)(2008-10#2)(2008-3#1)(2013-7#1)
These sensilla##2##2##(2008-7#1)(2010-11#1)
These sensors##2##2##(2008-10#1)(2008-3#1)
These sequence##2##2##(1997-8#1)(2008-10#1)
These sequences##2##2##(2008-10#2)
These sera##2##2##(2008-11#1)(2010-4#1)
These side effects##3##3##(1992-10#1)(1992-11#1)(2008-8#1)
These signals##2##2##(2008-9#1)(2009-12#1)
These similarities##2##2##(1994-8#1)(2008-5#1)
These simulations show that##2##4##(2008-2#1)(2008-3#1)
These simulations show##3##3##(1997-2#1)(2008-2#1)(2008-3#1)
These simulations##8##2##(1993-11#2)(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-8#1)
These sites were##2##3##(1990-7#1)(1995-2#1)
These sites##4##2##(1990-7#1)(1992-6#1)(1995-2#1)(2008-10#1)
These situations##3##2##(2008-9#1)(2009-7#1)(2013-1#1)
These six##2##2##(1994-1#1)(1997-2#1)
These small##3##2##(2008-2#1)(2008-5#1)(2009-5#1)
These sources##3##2##(2007-5#1)(2008-11#1)(2008-2#1)
These species are##3##3##(1994-9#1)(2008-12#1)(2012-5#1)
These species##7##2##(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#2)(2012-5#1)
These specifications##3##2##(2008-10#1)(2008-2#2)
These spectra##2##2##(2007-11#1)(2008-3#1)
These standards##2##2##(2008-11#1)(2011-1#1)
These statistics##5##2##(1992-2#1)(1993-2#1)(1996-1#1)(1996-3#1)(2008-9#1)
These strains were##4##3##(2008-10#3)(2011-1#1)
These strains##7##2##(1994-8#1)(2007-10#1)(2008-10#4)(2011-1#1)
These strategies##4##2##(2008-12#1)(2008-3#1)(2009-10#1)(2012-2#1)
These structural##2##2##(1990-7#1)(2008-10#1)
These structure-property insights may help the design of new materials for which the properties of OEG and high strength adhesion are both being sought##2##24##(2013-1#2)
These structures are##4##3##(1994-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
These structures##10##2##(1992-6#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
These students##2##2##(2008-12#2)
These studies also##7##3##(1994-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)
These studies are##4##3##(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
These studies confirm##2##3##(2008-3#1)(2008-7#1)
These studies demonstrate that the##2##5##(2008-11#1)(2008-2#1)
These studies demonstrate that##7##4##(1991-12#1)(1992-8#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)
These studies demonstrate the##2##4##(1990-12#1)(1991-8#1)
These studies demonstrate##10##3##(1990-12#1)(1991-12#1)(1991-8#1)(1992-8#1)(1994-6#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)
These studies demonstrated##2##3##(2006-6#1)(2013-7#1)
These studies have##9##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2013-8#1)
These studies indicate that the##3##5##(1990-11#1)(2008-11#1)(2008-5#1)
These studies indicate that##14##4##(1990-11#1)(1990-8#1)(1993-11#1)(1993-8#1)(1995-12#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)
These studies indicate##15##3##(1990-11#1)(1990-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-12#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)
These studies may##3##3##(1994-12#1)(1995-11#1)(2008-11#1)
These studies of##2##3##(1991-9#1)(1995-6#1)
These studies provide a##2##4##(2008-10#1)(2013-8#1)
These studies provide the##2##4##(1992-8#1)(2010-11#1)
These studies provide##5##3##(1992-8#1)(2007-12#1)(2008-10#1)(2010-11#1)(2013-8#1)
These studies reveal##2##3##(1996-2#1)(2010-4#1)
These studies revealed that##2##4##(2012-2#2)
These studies revealed##3##3##(2008-7#1)(2012-2#2)
These studies show that##6##4##(1990-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-12#1)
These studies suggest that##7##4##(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1997-7#1)(2008-10#2)
These studies suggest##8##3##(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-9#1)(1997-7#1)(2008-10#2)
These studies##100##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-6#1)(1996-10#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#6)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#2)
These subjects were##2##3##(1991-3#1)(2008-1#1)
These substances have##2##3##(1997-4#1)(2007-11#1)
These suggest##2##2##(2007-12#1)(2008-11#1)
These suggestions##2##2##(2008-6#1)(2012-2#1)
These surgical##2##2##(1995-4#1)(2008-7#1)
These symptoms may##2##3##(2008-2#1)(2010-12#1)
These symptoms##9##2##(1991-3#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
These systems are##3##3##(2008-3#1)(2010-6#1)(2013-1#1)
These systems have##2##3##(2008-11#1)(2012-2#1)
These systems##12##2##(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
These techniques are very##2##4##(2008-10#1)(2008-9#1)
These techniques are##9##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)
These techniques have been##2##4##(2008-11#1)(2008-9#1)
These techniques have##4##3##(2008-11#2)(2008-4#1)(2008-9#1)
These techniques##25##2##(1990-5#1)(2007-10#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#4)(2009-11#1)(2010-12#2)(2010-7#1)(2011-2#1)
These tests##8##2##(1992-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
These themes##3##2##(1995-3#1)(1996-2#1)(2008-11#1)
These theoretical##2##2##(2008-10#1)(2008-8#1)
These three##15##2##(1992-11#1)(1992-12#1)(1993-6#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-1#1)
These tools were successfully applied for the identification of the presence of relevant modifications occurring on the##2##17##(2008-10#2)
These tools##5##2##(2007-8#1)(2008-10#3)(2008-4#1)
These toxins##2##2##(1994-2#1)(2011-1#1)
These traits can also be assimilated##2##6##(2010-4#2)
These traits##4##2##(2008-4#1)(2010-4#2)(2013-7#1)
These transcriptional##2##2##(2008-9#2)
These transitions##2##2##(1994-3#1)(2011-2#1)
These treatments also##2##3##(1996-5#1)(2008-10#1)
These treatments##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
These trends are##2##3##(1991-3#1)(2008-7#1)
These trends##5##2##(1991-3#1)(1996-3#1)(2007-8#1)(2008-7#1)(2011-2#1)
These tumors are##2##3##(2007-5#1)(2010-3#1)
These tumors##6##2##(2007-5#1)(2008-4#1)(2010-3#3)(2011-2#1)
These two activities##2##3##(1994-8#1)(1996-2#1)
These two compounds##2##3##(2008-11#1)(2008-5#1)
These two elements##2##3##(1993-6#1)(1993-9#1)
These two factors are##2##4##(2008-10#1)(2008-7#1)
These two factors##5##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
These two methods##2##3##(1997-2#1)(2010-6#1)
These two parameters##2##3##(1994-3#1)(2008-10#1)
These two peptides##2##3##(1992-6#1)(1995-12#1)
These two processes are##2##4##(1995-2#1)(2013-1#1)
These two strains##2##3##(2008-10#1)(2012-2#1)
These two subpopulations##2##3##(2008-10#1)(2008-11#1)
These two techniques##2##3##(2008-12#1)(2008-4#1)
These two types of##3##4##(1994-12#1)(1994-5#1)(2008-11#1)
These two##71##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
These unique properties##2##3##(2007-11#1)(2008-11#1)
These unique##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
These values are sufficiently##2##4##(1995-2#1)(2008-3#1)
These values are##9##3##(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-3#2)
These values decreased##2##3##(1995-8#1)(2009-11#1)
These values indicate that##2##4##(1996-2#1)(2008-10#1)
These values were##9##3##(1990-9#1)(1992-3#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-7#1)
These values##33##2##(1990-9#1)(1992-3#2)(1992-6#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#2)(2009-11#1)(2011-2#1)
These variables may##2##3##(2008-5#1)(2013-1#1)
These variables##6##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
These variations in##3##3##(2008-10#2)(2009-11#1)
These variations##6##2##(1996-5#1)(2008-10#2)(2009-11#2)(2011-2#1)
These various##2##2##(1991-9#1)(1997-2#1)
These vectors##9##2##(1990-5#2)(1991-7#1)(1991-9#1)(1993-12#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-7#1)
These were compared with##5##4##(2007-5#1)(2008-7#2)(2010-6#1)(2012-2#1)
These were compared##6##3##(2007-5#1)(2008-7#2)(2010-4#1)(2010-6#1)(2012-2#1)
These were then##2##3##(2008-7#1)(2010-3#1)
These were##44##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-8#2)(2007-11#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
These will be##2##3##(1994-12#1)(2008-10#1)
These##5214##1##(1990-10#3)(1990-11#27)(1990-12#26)(1990-2#30)(1990-3#4)(1990-4#1)(1990-5#34)(1990-6#4)(1990-7#31)(1990-8#29)(1990-9#5)(1991-1#7)(1991-10#2)(1991-11#10)(1991-12#49)(1991-2#24)(1991-3#15)(1991-4#2)(1991-5#26)(1991-6#9)(1991-7#3)(1991-8#11)(1991-9#22)(1992-1#7)(1992-10#12)(1992-11#18)(1992-12#34)(1992-2#13)(1992-3#42)(1992-4#4)(1992-5#12)(1992-6#38)(1992-7#5)(1992-8#43)(1992-9#25)(1993-1#6)(1993-10#1)(1993-11#26)(1993-12#50)(1993-2#12)(1993-3#37)(1993-5#4)(1993-6#38)(1993-8#42)(1993-9#16)(1994-1#7)(1994-10#1)(1994-11#58)(1994-12#36)(1994-2#31)(1994-3#31)(1994-5#25)(1994-6#27)(1994-7#4)(1994-8#52)(1994-9#23)(1995-1#8)(1995-11#27)(1995-12#81)(1995-2#48)(1995-3#36)(1995-4#2)(1995-5#32)(1995-6#42)(1995-8#25)(1995-9#5)(1996-1#11)(1996-10#2)(1996-11#4)(1996-12#43)(1996-2#55)(1996-3#15)(1996-4#5)(1996-5#30)(1996-6#4)(1996-7#9)(1996-8#2)(1996-9#7)(1997-1#23)(1997-2#52)(1997-3#21)(1997-4#21)(1997-5#7)(1997-6#18)(1997-7#27)(1997-8#18)(1997-9#4)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#6)(2007-1#1)(2007-10#19)(2007-11#54)(2007-12#84)(2007-2#6)(2007-5#10)(2007-6#5)(2007-7#15)(2007-8#17)(2007-9#4)(2008-1#48)(2008-10#696)(2008-11#266)(2008-12#64)(2008-2#103)(2008-3#194)(2008-4#105)(2008-5#157)(2008-6#51)(2008-7#160)(2008-8#142)(2008-9#137)(2009-1#2)(2009-10#21)(2009-11#27)(2009-12#25)(2009-2#5)(2009-3#12)(2009-4#9)(2009-5#21)(2009-6#15)(2009-7#17)(2009-8#31)(2009-9#14)(2010-1#7)(2010-10#12)(2010-11#18)(2010-12#31)(2010-2#15)(2010-3#24)(2010-4#29)(2010-5#15)(2010-6#20)(2010-7#15)(2010-8#34)(2010-9#8)(2011-1#40)(2011-10#1)(2011-2#135)(2011-3#10)(2011-7#2)(2012-1#23)(2012-12#56)(2012-2#102)(2012-3#54)(2012-5#4)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#112)(2013-7#19)(2013-8#37)
Theseresults suggest that##2##3##(2008-11#2)
Theseresults suggest##3##2##(2008-11#3)
Thessaloniki##4##1##(2008-3#3)(2011-2#1)
Theta phase##2##2##(2008-11#2)
Theta##7##1##(1991-12#1)(1997-3#2)(2008-11#2)(2013-1#2)
They act on POMC cells in synergism with corticotrophin-releasing hormone##2##10##(2008-4#2)
They act##3##2##(2008-4#3)
They address##2##2##(1993-12#1)(2010-3#1)
They affect##2##2##(1995-6#1)(2012-12#1)
They all##6##2##(1993-3#1)(1996-12#1)(1997-6#1)(2008-4#1)(2011-1#1)(2011-2#1)
They also completed the##2##4##(1994-12#1)(2008-7#1)
They also completed##3##3##(1994-12#1)(2008-11#1)(2008-7#1)
They also demonstrate that##2##4##(1993-5#1)(1995-3#1)
They also developed##2##3##(1997-3#1)(2008-10#1)
They also had##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
They also have##3##3##(1991-12#1)(2008-1#1)(2012-12#1)
They also indicate that##2##4##(1996-2#1)(2009-10#1)
They also serve as##3##4##(1995-3#1)(2008-2#1)(2011-2#1)
They also showed##3##3##(2008-11#1)(2009-9#1)(2011-2#1)
They also suggest that##2##4##(1997-4#1)(2012-3#1)
They also suggest##3##3##(1992-2#1)(1997-4#1)(2012-3#1)
They also##58##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
They analyse the##2##3##(1990-9#1)(1993-5#1)
They analyse##3##2##(1990-9#1)(1993-5#1)(1997-3#1)
They appeared##2##2##(1990-3#1)(2008-5#1)
They are a##2##3##(2008-11#1)(2012-2#1)
They are able to##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
They are about##2##3##(2008-7#2)
They are also the##2##4##(2010-4#1)(2011-1#1)
They are also useful in analyzing the impact of hormones and other physiological stimuli on the function of a specific phosphoprotein##2##21##(2008-2#1)(2008-4#1)
They are also useful in##4##5##(2007-11#1)(2008-2#1)(2008-4#2)
They are also##12##3##(1990-6#1)(1993-12#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)
They are based on the oxidation of##2##7##(2008-10#2)
They are based on the##4##5##(2008-10#3)(2012-12#1)
They are divided##2##3##(2008-10#2)
They are either##2##3##(1993-11#1)(2008-4#1)
They are extremely##2##3##(2008-2#1)(2011-3#1)
They are found in##3##4##(1992-5#1)(1995-12#1)(2008-9#1)
They are found##4##3##(1992-5#1)(1995-12#1)(1997-7#1)(2008-9#1)
They are highly##3##3##(1991-5#1)(2008-4#1)(2008-5#1)
They are more##2##3##(1995-12#1)(2008-10#1)
They are not##3##3##(1992-8#1)(1993-11#1)(2012-2#1)
They are now##2##3##(2008-11#1)(2008-8#1)
They are often##2##3##(1995-5#1)(2006-4#1)
They are particularly##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
They are produced##2##3##(1994-9#1)(2008-2#1)
They are synthesized##2##3##(2008-4#1)(2013-1#1)
They are the most##2##4##(2011-1#1)(2012-3#1)
They are the##7##3##(1992-11#1)(1992-6#1)(1995-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
They are thought to play an important role in##2##9##(2008-4#1)(2010-11#1)
They are thought to##3##4##(2008-4#1)(2010-11#1)(2012-2#1)
They are transcribed##2##3##(2007-12#1)(2009-5#1)
They are usually##2##3##(2013-1#2)
They are##138##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-4#1)(1997-7#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-10#16)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#11)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2011-3#3)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#7)
They argue that##3##3##(1991-12#1)(1993-2#1)(2008-5#1)
They believe that##2##3##(1995-2#1)(1996-2#1)
They both##2##2##(2009-8#1)(2010-1#1)
They can also be##2##4##(1994-12#1)(2009-10#1)
They can also##3##3##(1994-12#1)(2008-8#1)(2009-10#1)
They can be used as##2##5##(2008-10#1)(2008-2#1)
They can be used to##3##5##(2008-10#1)(2008-4#1)(2008-7#1)
They can be used##6##4##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
They can be##15##3##(1991-2#1)(1991-9#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
They can##24##2##(1990-9#1)(1991-2#1)(1991-9#1)(1994-12#1)(2006-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)
They cause##3##2##(2009-4#1)(2011-2#1)(2013-8#1)
They conclude##2##2##(1993-3#1)(2008-11#1)
They consist of##2##3##(2007-11#1)(2008-10#1)
They constitute about##2##3##(1992-4#1)(2013-1#1)
They constitute##3##2##(1992-4#1)(2008-10#1)(2013-1#1)
They contain##3##2##(1993-8#1)(2008-11#1)(2008-9#1)
They contained##2##2##(2008-5#1)(2011-1#1)
They correspond##2##2##(1990-7#1)(1992-12#1)
They could also##2##3##(2011-2#1)(2011-7#1)
They could##5##2##(1996-2#1)(2008-2#1)(2008-7#1)(2011-2#1)(2011-7#1)
They demonstrate##2##2##(2008-11#1)(2008-3#1)
They did not##7##3##(1991-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#2)(2009-5#1)
They differ##2##2##(1992-3#1)(2008-8#1)
They discuss the##2##3##(1993-9#1)(1997-3#1)
They discuss##3##2##(1993-9#1)(1996-12#1)(1997-3#1)
They do not##4##3##(1993-2#1)(1996-2#1)(2008-2#2)
They do##6##2##(1993-2#1)(1995-1#1)(1996-2#1)(2008-2#2)(2008-7#1)
They emphasize##3##2##(1990-9#1)(1992-5#1)(1993-5#1)
They exhibited##2##2##(2008-12#1)(2011-1#1)
They felt that##2##3##(2007-7#2)
They focus on##2##3##(1991-12#1)(1992-6#1)
They focus##3##2##(1991-12#1)(1992-6#1)(1993-6#1)
They form##2##2##(2008-10#1)(2008-4#1)
They found a##2##3##(1990-3#1)(1990-8#1)
They found that##3##3##(1997-4#1)(2007-11#1)(2013-1#1)
They found##6##2##(1990-3#1)(1990-8#1)(1991-6#1)(1997-4#1)(2007-11#1)(2013-1#1)
They further##2##2##(1995-12#1)(2012-12#1)
They had a##2##3##(2009-1#1)(2010-1#1)
They had##6##2##(1991-12#1)(2008-9#1)(2009-1#1)(2010-1#1)(2011-1#1)(2011-2#1)
They have a##2##3##(1997-7#1)(2008-7#1)
They have also##2##3##(1990-11#1)(1991-1#1)
They have been##9##3##(1990-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-9#1)(2010-12#1)(2010-7#1)
They have to be##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
They have##36##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-2#1)(1993-11#1)(1993-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
They include the##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2013-8#1)
They include##12##2##(1990-6#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-3#1)(2012-12#1)(2013-8#1)
They included##3##2##(1995-12#1)(2008-11#1)(2012-12#1)
They involve##2##2##(2007-11#1)(2012-1#1)
They made##2##2##(1990-8#1)(2012-1#1)
They may also be##2##4##(2008-10#1)(2008-8#1)
They may also##4##3##(1994-1#1)(1996-3#1)(2008-10#1)(2008-8#1)
They may be##7##3##(1992-1#1)(1996-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)
They may remain asymptomatic##2##4##(1991-5#1)(2012-12#1)
They may##17##2##(1991-5#1)(1992-1#1)(1994-1#1)(1994-3#2)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)
They must##2##2##(1995-3#1)(1997-5#1)
They need##3##2##(2011-2#3)
They noted less agreement with statements of the care plan offering information on assessment of patient outcomes of nursing care##2##20##(2013-1#2)
They occur##2##2##(1990-6#1)(1996-6#1)
They often##2##2##(2010-12#1)(2011-2#1)
They play a##2##3##(2008-7#1)(2011-2#1)
They play##3##2##(1990-9#1)(2008-7#1)(2011-2#1)
They present##3##2##(1993-3#1)(2010-8#1)(2013-1#1)
They provide a##2##3##(2008-9#1)(2012-2#1)
They provide an##2##3##(1997-6#1)(2008-4#1)
They provide##9##2##(1993-12#1)(1994-2#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-2#1)
They report##3##2##(1993-5#1)(1995-12#1)(1996-3#1)
They reported that##2##3##(2008-10#1)(2011-2#1)
They reported##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
They represent##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
They serve##3##2##(1991-2#1)(2008-11#1)(2012-3#1)
They shared##3##2##(1993-8#1)(2008-10#1)(2010-5#1)
They should also##2##3##(1997-4#1)(2008-12#1)
They should##5##2##(1993-3#1)(1997-4#1)(2008-12#1)(2011-2#1)(2011-3#1)
They show that##2##3##(1992-3#1)(2008-2#1)
They show##9##2##(1990-5#1)(1992-3#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)
They showed that##2##3##(2008-10#1)(2012-2#1)
They showed##5##2##(2007-10#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
They stress##2##2##(1990-12#1)(1993-9#1)
They suggest that##2##3##(1995-2#1)(1996-5#1)
They tend to be##2##4##(2011-2#1)(2012-3#1)
They tend to##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
They then##3##2##(2008-11#1)(2009-4#1)(2012-3#1)
They underline the##2##3##(1990-11#1)(2007-11#1)
They use##2##2##(2008-10#1)(2013-1#1)
They want##2##2##(2008-1#1)(2008-11#1)
They were also##7##3##(1994-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-12#1)(2011-2#1)
They were assessed by##3##4##(1996-7#1)(2011-2#1)(2013-8#1)
They were assessed##4##3##(1996-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
They were compared with##2##4##(2007-8#1)(2008-10#1)
They were divided into two equal groups of low-flux (C15NL##2##10##(2007-7#1)(2008-1#1)
They were divided into two##3##5##(2007-7#1)(2008-1#1)(2008-7#1)
They were divided into##6##4##(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-12#1)
They were evaluated##4##3##(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
They were fed##3##3##(2008-12#1)(2008-6#1)(2009-4#1)
They were followed up##4##4##(1991-9#1)(2007-10#1)(2008-11#1)(2012-3#1)
They were found in all##2##5##(2008-10#1)(2008-6#1)
They were found in##3##4##(1996-5#1)(2008-10#1)(2008-6#1)
They were found##5##3##(1996-5#1)(2008-10#1)(2008-6#1)(2008-7#2)
They were given a##2##4##(1992-4#1)(2012-1#1)
They were given##4##3##(1992-4#1)(1994-6#1)(2009-11#1)(2012-1#1)
They were identified##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
They were killed##2##3##(2008-7#1)(2013-1#1)
They were observed##3##3##(1990-5#1)(1992-5#1)(2008-6#1)
They were prepared##2##3##(2007-11#1)(2008-12#1)
They were randomly##3##3##(2008-5#1)(2010-2#1)(2013-1#1)
They were recruited##2##3##(1995-1#1)(2008-10#1)
They were separated in##2##4##(1994-9#1)(2008-10#1)
They were the##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
They were then##3##3##(2007-11#1)(2012-1#1)(2012-2#1)
They were used##2##3##(2008-10#2)
They were##130##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-5#1)(1997-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
They will##3##2##(1994-1#2)(1996-3#1)
They##746##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#4)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#6)(1993-12#7)(1993-2#5)(1993-3#5)(1993-5#6)(1993-6#3)(1993-8#4)(1993-9#5)(1994-1#3)(1994-12#5)(1994-2#7)(1994-3#7)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#10)(1996-3#3)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#13)(2007-12#11)(2007-2#1)(2007-5#1)(2007-7#10)(2007-8#6)(2008-1#9)(2008-10#69)(2008-11#26)(2008-12#10)(2008-2#15)(2008-3#16)(2008-4#23)(2008-5#23)(2008-6#8)(2008-7#29)(2008-8#16)(2008-9#11)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#5)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#11)(2011-2#42)(2011-3#7)(2011-7#2)(2012-1#6)(2012-12#17)(2012-2#19)(2012-3#15)(2013-1#24)(2013-8#7)
They're doctors##2##2##(1996-3#1)(1997-6#1)
Thi5##2##1##(1990-5#1)(1992-3#1)
Thiamine and benfotiamine##2##3##(2012-4#2)
Thiamine disulfide##3##2##(1994-11#3)
Thiamine##5##1##(1994-11#3)(2012-4#2)
Thiazolidinediones##2##1##(2008-3#1)(2010-8#1)
Thick##5##1##(2008-2#2)(2008-7#1)(2010-3#1)(2012-12#1)
Thickness and##2##2##(2008-11#1)(2010-2#1)
Thickness in##2##2##(2008-2#1)(2011-1#1)
Thickness of the##2##3##(2008-8#1)(2010-8#1)
Thickness##9##1##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
Thielaviopsis basicola to##2##3##(2008-10#2)
Thielaviopsis basicola##10##2##(2008-10#10)
Thielaviopsis##12##1##(2008-10#12)
Thin Films by##2##3##(2008-2#2)
Thin Films##3##2##(2008-2#2)(2008-3#1)
Thin Layer##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
Thin ferroelectric##2##2##(2008-2#2)
Thin film##2##2##(2008-10#2)
Thin films of##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
Thin films##5##2##(2007-11#1)(2008-10#1)(2008-3#2)(2013-8#1)
Thin layer##2##2##(2011-2#2)
Thin sections##2##2##(2008-7#2)
Thin##26##1##(1992-2#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
Thin-Film##3##1##(2008-2#1)(2008-3#2)
Thin-film interference effects##2##3##(2008-2#2)
Thin-film interference##3##2##(2008-2#2)(2008-3#1)
Thin-film##7##1##(1994-9#1)(2008-2#2)(2008-3#4)
Thin-layer chromatography##2##2##(2008-10#2)
ThinPrep##3##1##(2010-8#2)(2013-8#1)
Think##5##1##(1995-2#1)(2009-3#1)(2012-2#1)(2013-1#2)
Thinking about##2##2##(1997-3#1)(2008-11#1)
Thinking##11##1##(1995-1#1)(1997-3#2)(2008-11#4)(2008-2#1)(2012-2#1)(2013-1#2)
Thinopyrum chromosome and##2##3##(2008-5#2)
Thinopyrum distichum##3##2##(2008-5#3)
Thinopyrum intermedium##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
Thinopyrum ponticum##4##2##(2008-10#4)
Thinopyrum##17##1##(2008-10#9)(2008-5#7)(2008-8#1)
Thiobacillus ferrooxidans##4##2##(1990-11#2)(2008-8#2)
Thiobacillus##6##1##(1990-11#3)(2008-6#1)(2008-8#2)
Thiocyanate was##2##2##(2008-10#2)
Thiocyanate##3##1##(2008-10#3)
Thiodicarb##2##1##(2008-10#2)
Thioflavin T fluorescence##3##3##(2009-9#1)(2010-11#1)(2012-1#1)
Thiol##2##1##(1994-11#1)(2010-11#1)
Thiopurine##2##1##(2010-12#1)(2013-1#1)
Thioxanthones##2##1##(2012-3#2)
Third World##2##2##(1992-5#1)(1993-6#1)
Third method##2##2##(2008-8#1)(2010-5#1)
Third##55##1##(1991-12#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#3)(2011-2#4)(2012-3#1)(2013-1#2)
Third-harmonic generation microscopy##2##3##(2008-3#2)
Third-harmonic generation##4##2##(2007-11#1)(2008-3#3)
Third-order##3##1##(2008-1#1)(2008-2#1)(2008-3#1)
Thirdly##7##1##(1990-3#1)(1992-12#1)(1995-12#1)(1997-7#1)(2008-11#2)(2012-7#1)
Thirteen of the##2##3##(1991-4#1)(2008-9#1)
Thirteen of##3##2##(1991-4#1)(2007-10#1)(2008-9#1)
Thirteen patients with##4##3##(1990-2#1)(2007-8#1)(2012-12#1)(2013-1#1)
Thirteen patients##6##2##(1990-2#1)(1991-3#1)(2007-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
Thirteen##36##1##(1990-2#2)(1991-3#1)(1991-4#1)(1992-12#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#2)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Thirteenth##6##1##(2008-10#1)(2011-2#5)
Thirty cases##2##2##(1991-12#1)(2008-10#1)
Thirty five##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
Thirty isolates##2##2##(2008-10#2)
Thirty male##4##2##(1992-12#1)(2007-7#1)(2008-12#1)(2011-1#1)
Thirty minutes after##3##3##(1995-12#1)(2007-10#1)(2008-7#1)
Thirty months after##2##3##(1995-9#1)(2008-5#1)
Thirty patients were##2##3##(1997-6#1)(2008-6#1)
Thirty patients with##2##3##(1994-12#1)(2008-7#1)
Thirty patients##6##2##(1994-12#1)(1997-6#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-1#1)
Thirty seven##3##2##(1990-8#1)(2008-8#1)(2011-2#1)
Thirty six##3##2##(1994-12#1)(2007-2#1)(2008-5#1)
Thirty three##2##2##(2012-12#1)(2013-1#1)
Thirty two HEV71##2##3##(2013-8#2)
Thirty women were##2##3##(1991-3#1)(2011-2#1)
Thirty years of##3##3##(1996-12#2)(2008-2#1)
Thirty##64##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#2)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#3)(2013-8#4)
Thirty-eight patients##2##2##(1997-8#1)(2007-7#1)
Thirty-eight##8##1##(1997-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-8#1)(2013-1#1)
Thirty-five percent##2##2##(1990-6#1)(2008-12#1)
Thirty-five##17##1##(1990-6#1)(1991-4#1)(1992-5#1)(1993-1#1)(1993-12#1)(1996-7#1)(1997-1#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-1#1)
Thirty-four patients##2##2##(1995-12#1)(2008-7#1)
Thirty-four##14##1##(1990-6#1)(1991-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-10#1)(2011-1#2)
Thirty-nine##7##1##(1990-6#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#1)
Thirty-one of##2##2##(2008-2#1)(2008-7#1)
Thirty-one patients had##2##3##(1991-2#1)(1995-12#1)
Thirty-one patients with##2##3##(2008-1#1)(2013-1#1)
Thirty-one patients##5##2##(1991-2#1)(1995-12#1)(2008-1#2)(2013-1#1)
Thirty-one##12##1##(1991-2#1)(1995-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Thirty-seven patients##3##2##(2008-6#2)(2008-7#1)
Thirty-seven##12##1##(1990-5#1)(1997-3#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-4#1)(2011-2#2)
Thirty-six patients were##2##3##(2008-7#1)(2010-12#1)
Thirty-six patients##5##2##(2007-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
Thirty-six percent##2##2##(2009-2#1)(2011-2#1)
Thirty-six##14##1##(1993-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
Thirty-three of the##2##3##(2008-10#1)(2012-2#1)
Thirty-three patients##2##2##(1993-12#1)(2008-7#1)
Thirty-three##12##1##(1993-12#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-3#1)(2012-2#2)
Thirty-two of##2##2##(2008-4#1)(2008-7#1)
Thirty-two patients with advanced##2##4##(1990-2#1)(1997-7#1)
Thirty-two patients with##3##3##(1990-2#1)(1994-3#1)(1997-7#1)
Thirty-two patients##5##2##(1990-2#1)(1992-2#1)(1994-3#1)(1997-7#1)(2008-6#1)
Thirty-two percent##2##2##(1997-5#1)(2012-12#1)
Thirty-two##20##1##(1990-2#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-3#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#3)(2012-12#1)(2013-8#1)
This &quot##4##2##(1990-11#1)(1992-2#1)(2008-8#1)(2009-6#1)
This 3-year##2##2##(2010-10#1)(2012-12#1)
This CL##3##2##(2008-10#3)
This DNA fragment##2##3##(1992-12#1)(2008-8#1)
This DNA##4##2##(1992-12#1)(1993-8#2)(2008-8#1)
This ELISA##2##2##(1995-11#1)(2012-12#1)
This HBV##2##2##(1993-8#1)(2012-12#1)
This ORF##6##2##(1990-11#2)(1996-6#1)(1997-4#1)(2008-10#1)(2008-8#1)
This PCR assay##2##3##(2008-10#2)
This PCR##3##2##(1994-12#1)(2008-10#2)
This Perspective##2##2##(2010-5#2)
This Phase I treatment study##2##5##(2012-3#2)
This QTL##2##2##(2008-10#1)(2012-3#1)
This RNA##2##2##(1990-5#1)(2008-8#1)
This Roundtable Discussion explores the language used in obstetrics and in the interactions between caregivers and women or their families##2##20##(2013-1#2)
This TG##2##2##(2008-3#1)(2009-12#1)
This Week in SCIENCE##2##4##(1991-5#1)(1991-8#1)
This Week in##3##3##(1991-5#1)(1991-8#1)(1995-3#1)
This ability to##2##3##(2011-1#1)(2012-5#1)
This ability##3##2##(2008-10#1)(2011-1#1)(2012-5#1)
This account##5##2##(2007-12#1)(2008-6#1)(2010-11#1)(2010-6#1)(2012-2#1)
This action of##2##3##(1993-3#1)(1995-12#1)
This action##7##2##(1993-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2012-2#1)
This activation was##2##3##(1993-11#1)(1995-2#1)
This activation##3##2##(1993-11#1)(1995-2#1)(1995-6#1)
This activity is##2##3##(1991-2#1)(2012-3#1)
This activity was##3##3##(1997-1#1)(2010-7#1)(2011-2#1)
This activity##9##2##(1990-8#1)(1991-2#1)(1997-1#1)(2007-5#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
This adaptation##2##2##(2008-10#1)(2008-2#1)
This adaptive##2##2##(2008-10#1)(2008-7#1)
This addendum##2##2##(2008-8#1)(2011-2#1)
This adds to the##2##4##(2008-10#1)(2009-12#1)
This adsorption##2##2##(1990-2#1)(2008-10#1)
This advantage##2##2##(1991-5#1)(1997-7#1)
This adverse##2##2##(2013-1#2)
This algorithm is applied to a##2##6##(1995-2#1)(2008-2#1)
This algorithm is##5##3##(1995-2#1)(2008-2#2)(2008-3#1)(2010-8#1)
This algorithm requires##3##3##(2008-3#2)(2013-8#1)
This algorithm##13##2##(1995-2#1)(2007-12#1)(2008-2#3)(2008-3#4)(2010-8#1)(2012-3#2)(2013-8#1)
This allowed a##2##3##(1995-6#1)(2008-10#1)
This allowed us to evaluate##2##5##(1993-8#1)(2008-5#1)
This allowed us to##3##4##(1993-8#1)(2007-12#1)(2008-5#1)
This allowed##8##2##(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
This allows a##2##3##(2008-2#1)(2008-3#1)
This allows application##2##3##(2008-2#1)(2008-3#1)
This allows for##4##3##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
This allows the##10##3##(1996-6#1)(2008-10#1)(2008-3#4)(2008-6#1)(2009-12#1)(2010-8#1)(2012-2#1)
This allows us to##6##4##(1995-5#1)(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#1)
This allows##34##2##(1992-12#1)(1995-5#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
This also applies##2##3##(1992-5#1)(2008-8#1)
This also##9##2##(1992-11#1)(1992-5#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#2)
This alteration##3##2##(1990-12#1)(1997-1#1)(2013-1#1)
This alternative##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
This analysis has been##2##4##(1997-2#1)(2007-11#1)
This analysis has##3##3##(1992-2#1)(1997-2#1)(2007-11#1)
This analysis indicated that##2##4##(1990-2#1)(2009-10#1)
This analysis is##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
This analysis may##2##3##(2007-11#1)(2008-4#1)
This analysis of the##2##4##(2008-9#1)(2013-8#1)
This analysis revealed a##2##4##(1992-8#1)(1993-11#1)
This analysis revealed that##2##4##(1990-11#1)(1995-8#1)
This analysis revealed##5##3##(1990-11#1)(1992-8#1)(1993-11#1)(1995-8#1)(2008-10#1)
This analysis shows##2##3##(1995-3#1)(2008-2#1)
This analysis was##4##3##(1996-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
This analysis##42##2##(1990-11#1)(1990-2#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-11#4)(2008-10#7)(2008-11#1)(2008-2#5)(2008-4#1)(2008-7#2)(2008-9#3)(2009-10#3)(2011-1#1)(2011-2#1)(2012-6#1)(2013-8#1)
This analytical##6##2##(2008-10#6)
This and other##4##3##(1990-12#1)(1995-2#1)(1995-6#1)(2008-10#1)
This and##8##2##(1990-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-11#1)
This animal model##2##3##(1993-2#1)(1994-6#1)
This annual report##2##3##(1996-1#1)(2012-3#1)
This annual##3##2##(1991-12#1)(1996-1#1)(2012-3#1)
This antibody##6##2##(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-8#1)(2012-2#1)
This antiserum##2##2##(2008-10#2)
This apparent paradox##2##3##(2008-5#1)(2008-9#1)
This apparent##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
This appeared to##2##3##(1995-11#1)(2012-12#1)
This appears to be a##2##5##(2008-3#1)(2009-10#1)
This appears to be the first##2##6##(1992-12#1)(1992-8#1)
This appears to be##5##4##(1992-12#1)(1992-8#1)(2006-10#1)(2008-3#1)(2009-10#1)
This appendix describes##2##3##(2008-4#2)
This appendix presents useful basic information##2##6##(2008-2#2)
This appendix presents##4##3##(2008-2#2)(2008-4#1)(2008-9#1)
This appendix provides protocols for some commonly used disposal and decontamination procedures along with analytical techniques that are used to verify that reagents have been decontaminated##2##26##(2008-4#1)(2008-9#1)
This appendix provides##4##3##(2008-4#1)(2008-9#3)
This appendix##14##2##(2008-2#2)(2008-4#7)(2008-9#5)
This applies##2##2##(1994-6#1)(2008-2#1)
This approach accounts for##2##4##(2008-3#1)(2010-3#1)
This approach allowed us to##2##5##(2008-10#1)(2011-2#1)
This approach allowed##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
This approach allows for##2##4##(1996-12#1)(2009-8#1)
This approach allows the##2##4##(2008-10#1)(2008-4#1)
This approach allows##11##3##(1996-12#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
This approach also##3##3##(1992-6#1)(2008-2#1)(2008-8#1)
This approach can be##2##4##(2008-2#2)
This approach can##6##3##(2008-10#1)(2008-2#3)(2008-3#1)(2011-2#1)
This approach does not##2##4##(1991-9#1)(2007-11#1)
This approach enabled the##2##4##(2008-10#1)(2009-10#1)
This approach has been##6##4##(1995-12#1)(2008-10#2)(2008-7#2)(2009-10#1)
This approach has the##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
This approach has##13##3##(1990-7#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2012-2#1)
This approach involves##2##3##(1994-5#1)(2008-7#1)
This approach is based on##3##5##(2008-3#1)(2008-4#1)(2008-7#1)
This approach is not##2##4##(2008-12#1)(2012-2#1)
This approach is particularly useful when there is a limited amount of ligand available##2##14##(2008-4#2)
This approach is particularly useful##3##5##(1997-1#1)(2008-4#2)
This approach is particularly##4##4##(1997-1#1)(2008-10#1)(2008-4#2)
This approach is##27##3##(1990-8#1)(1994-2#2)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-6#1)(2008-7#2)(2008-9#2)(2010-4#1)(2012-2#1)
This approach may##2##3##(1993-3#1)(1997-3#1)
This approach minimizes##2##3##(2008-10#2)
This approach permits##2##3##(2008-2#1)(2011-2#1)
This approach provides a##3##4##(1994-8#1)(2007-12#1)(2011-2#1)
This approach provides##5##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
This approach therefore##2##3##(2012-2#1)(2013-1#1)
This approach to##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
This approach was used##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
This approach was##7##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-9#1)(2012-2#1)
This approach would##2##3##(1996-1#1)(2007-11#1)
This approach yields##2##3##(1996-3#1)(2008-3#1)
This approach##132##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#5)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#23)(2008-11#2)(2008-12#3)(2008-2#10)(2008-3#16)(2008-4#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#7)(2011-3#1)(2011-9#1)(2012-2#4)(2013-1#4)(2013-8#1)
This approximation##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2012-3#1)
This architecture##3##2##(2008-1#1)(2008-11#1)(2010-6#1)
This area##4##2##(2008-5#2)(2013-8#2)
This argues against##2##3##(2008-7#1)(2008-9#1)
This arrangement##3##2##(2008-10#2)(2008-3#1)
This article addresses some of the##2##6##(1991-12#2)
This article addresses the##6##4##(1992-2#1)(1994-3#1)(1995-1#1)(2008-1#1)(2008-2#1)(2008-7#1)
This article addresses##13##3##(1991-12#2)(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-7#1)
This article advocates the##2##4##(1997-3#1)(2008-7#1)
This article aims at##4##4##(1991-6#1)(1997-7#1)(2010-11#1)(2012-12#1)
This article aims to##5##4##(2007-6#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-3#1)
This article aims##9##3##(1991-6#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-3#1)(2012-12#1)
This article also discusses##4##4##(1996-2#1)(2009-5#1)(2013-1#1)(2013-8#1)
This article also##8##3##(1991-12#1)(1996-2#1)(1997-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-1#1)(2013-8#1)
This article analyses the##3##4##(2008-2#1)(2010-4#1)(2013-1#1)
This article analyses##4##3##(2008-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
This article analyzes a##2##4##(1992-12#1)(2008-8#1)
This article analyzes the##10##4##(1991-1#1)(1991-12#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
This article analyzes##14##3##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
This article applies the##2##4##(1996-3#1)(2008-4#1)
This article argues that##3##4##(1991-12#1)(2008-12#1)(2013-8#1)
This article argues##5##3##(1991-12#1)(1996-3#1)(2008-12#1)(2012-12#1)(2013-8#1)
This article assesses##2##3##(1997-2#2)
This article attempts to##5##4##(1996-12#1)(2007-11#1)(2007-7#1)(2008-8#1)(2009-5#1)
This article briefly describes the##4##5##(1991-2#1)(1992-12#1)(2009-9#1)(2013-1#1)
This article briefly describes##5##4##(1991-2#1)(1992-12#1)(2009-9#1)(2010-4#1)(2013-1#1)
This article briefly discusses the##2##5##(1997-2#1)(2008-12#1)
This article briefly##12##3##(1991-2#1)(1992-12#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-9#1)(2010-4#1)(2013-1#2)
This article considers some of the##2##6##(2008-11#1)(2009-7#1)
This article considers the##2##4##(1991-6#1)(2008-10#1)
This article considers##7##3##(1991-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-12#1)
This article contains a##2##4##(2007-8#1)(2008-10#1)
This article contains##6##3##(1991-12#1)(1991-2#1)(1993-1#1)(1997-3#1)(2007-8#1)(2008-10#1)
This article deals with##2##4##(2008-8#1)(2008-9#1)
This article defines##3##3##(1991-1#1)(1996-2#1)(2008-10#1)
This article demonstrates the##2##4##(1996-1#1)(2010-5#1)
This article demonstrates##5##3##(1994-2#1)(1996-1#1)(2008-5#1)(2010-5#1)(2011-1#1)
This article describes a case##2##5##(1996-2#1)(2013-1#1)
This article describes a model##4##5##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)
This article describes a number of##2##6##(1992-1#1)(1994-2#1)
This article describes a study that##2##6##(1996-3#2)
This article describes a system of##2##6##(1992-3#1)(1997-1#1)
This article describes a##26##4##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#4)(1996-3#2)(1996-7#1)(1997-1#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2013-1#1)(2013-7#1)
This article describes an##8##4##(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
This article describes how hospitals##2##5##(1995-1#1)(1995-3#1)
This article describes how the##2##5##(1995-3#1)(1996-12#1)
This article describes how##11##4##(1992-12#1)(1993-12#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
This article describes one##3##4##(1994-2#1)(1997-3#1)(2008-12#1)
This article describes some of the issues##2##7##(1991-3#1)(1992-3#1)
This article describes some of##3##5##(1991-3#1)(1992-3#1)(2010-9#1)
This article describes some##7##4##(1991-3#1)(1992-3#1)(1994-12#1)(1995-1#1)(1997-3#1)(2007-7#1)(2010-9#1)
This article describes the conceptual##2##5##(1993-12#1)(1994-12#1)
This article describes the development of a##4##7##(1996-3#1)(1997-7#1)(2008-10#1)(2012-2#1)
This article describes the development of##7##6##(1994-12#1)(1996-3#1)(1997-7#1)(2007-8#2)(2008-10#1)(2012-2#1)
This article describes the development##8##5##(1994-12#1)(1996-3#1)(1997-7#1)(2007-8#2)(2008-10#2)(2012-2#1)
This article describes the history of the##2##7##(2008-3#1)(2011-2#1)
This article describes the process##2##5##(1995-2#1)(2010-5#1)
This article describes the types of##3##6##(1992-12#1)(1993-1#1)(1995-12#1)
This article describes the use of##3##6##(1996-3#2)(1997-2#1)
This article describes the##72##4##(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1997-1#1)(1997-2#4)(1997-3#3)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#2)
This article describes##158##3##(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#2)(1994-12#4)(1994-2#4)(1994-3#1)(1995-1#5)(1995-12#3)(1995-2#2)(1995-3#6)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#9)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
This article details one##2##4##(1992-1#1)(2008-1#1)
This article details the##3##4##(1994-3#1)(2010-7#1)(2012-12#1)
This article details##5##3##(1992-1#1)(1994-3#1)(2008-1#1)(2010-7#1)(2012-12#1)
This article develops a##2##4##(1991-1#1)(2008-7#1)
This article develops##4##3##(1991-1#1)(1995-2#1)(2008-7#1)(2008-9#1)
This article discusses a##4##4##(1994-1#1)(1996-3#1)(2008-3#1)(2008-7#1)
This article discusses how the##4##5##(1992-1#1)(1993-2#1)(1994-1#1)(1995-12#1)
This article discusses how##6##4##(1992-1#1)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-2#1)
This article discusses medical and##2##5##(1994-9#1)(2007-11#1)
This article discusses some of the##6##6##(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(2008-7#1)
This article discusses the development and##2##6##(1996-3#1)(2012-2#1)
This article discusses the development##3##5##(1996-3#1)(1997-3#1)(2012-2#1)
This article discusses the indications for##2##6##(1990-11#1)(2008-7#1)
This article discusses the role of##2##6##(1990-12#1)(2009-4#1)
This article discusses the use of##2##6##(1996-1#1)(2009-11#1)
This article discusses the##41##4##(1990-11#1)(1990-12#1)(1991-12#3)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#2)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
This article discusses these##2##4##(2008-3#1)(2008-9#1)
This article discusses##86##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#4)(1993-12#2)(1993-2#3)(1993-3#3)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1997-2#3)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
This article enumerates##3##3##(1994-1#1)(2008-6#1)(2008-7#1)
This article evaluates##4##3##(1996-2#1)(2012-2#1)(2013-8#2)
This article examines how##2##4##(1994-1#1)(2009-9#1)
This article examines the impact of##2##6##(1995-12#1)(1996-2#1)
This article examines the relationship##2##5##(2008-11#1)(2013-1#1)
This article examines the##29##4##(1991-1#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-7#1)(2011-2#4)(2012-12#1)(2013-1#1)
This article examines##55##3##(1991-1#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#5)(2012-12#2)(2013-1#2)
This article explains the##4##4##(1991-2#1)(1993-3#1)(1994-12#1)(2008-2#1)
This article explains##7##3##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-2#1)
This article explores the possibility##2##5##(2011-2#2)
This article explores the relationship between##2##6##(1996-2#1)(2011-2#1)
This article explores the##19##4##(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#1)
This article explores##34##3##(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#3)(1995-12#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#2)
This article features##2##3##(1990-11#1)(2008-3#1)
This article focuses on the development of##2##7##(1993-6#1)(2008-11#1)
This article focuses on the relationship##2##6##(1991-2#1)(2008-11#1)
This article focuses on the##11##5##(1991-2#1)(1992-2#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)
This article focuses on##22##4##(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-6#1)(1996-12#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#2)
This article focuses##23##3##(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-6#1)(1996-12#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)
This article gives a brief overview of##2##7##(1994-12#1)(2011-2#1)
This article gives a##3##4##(1994-12#1)(2011-2#1)(2012-2#1)
This article gives an account of##2##6##(2008-11#1)(2008-12#1)
This article gives##6##3##(1991-1#1)(1994-12#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
This article has been retracted at the request of the Editors-in-Chief##3##11##(2008-10#3)
This article has been retracted at the request of the##4##10##(2008-10#4)
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal (http##2##13##(2008-10#1)(2008-11#1)
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal##4##12##(2008-10#1)(2008-11#3)
This article has been##9##4##(2008-10#5)(2008-11#4)
This article has presented##2##4##(1991-12#1)(2012-12#1)
This article has three objectives##2##5##(1993-12#1)(1995-12#1)
This article has##19##3##(1991-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(2006-5#1)(2008-10#5)(2008-11#5)(2012-12#2)
This article highlights some##2##4##(2009-10#1)(2009-11#1)
This article highlights the##5##4##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2009-5#1)
This article highlights##9##3##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2012-3#1)
This article identifies the##2##4##(1996-12#1)(1996-2#1)
This article identifies##3##3##(1991-2#1)(1996-12#1)(1996-2#1)
This article illustrates the##2##4##(1995-3#1)(2007-12#1)
This article illustrates##5##3##(1995-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2011-1#1)
This article includes##2##3##(1992-12#1)(2008-1#1)
This article intends to##2##4##(2009-10#1)(2009-7#1)
This article introduces a new##2##5##(1996-2#1)(2009-5#1)
This article introduces a##4##4##(1996-12#1)(1996-2#1)(2009-5#1)(2013-1#1)
This article introduces the##2##4##(1991-2#1)(1996-3#1)
This article introduces##11##3##(1991-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
This article investigates the effect of##2##6##(1991-2#1)(2011-2#1)
This article investigates the##5##4##(1991-2#1)(2008-10#1)(2008-9#1)(2011-2#2)
This article investigates##6##3##(1991-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
This article is a##8##4##(1992-2#2)(1993-12#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-9#1)
This article is an overview of the##2##7##(2010-12#1)(2012-2#1)
This article is an overview of##3##6##(1997-3#1)(2010-12#1)(2012-2#1)
This article is an update of##2##6##(2012-2#2)
This article is an##7##4##(1990-12#1)(1997-3#1)(2010-12#1)(2012-12#1)(2012-2#3)
This article is based on##2##5##(1996-2#1)(2010-5#1)
This article is open to POST-PUBLICATION REVIEW##6##7##(2012-3#6)
This article is the first in a series##2##8##(1993-2#1)(1993-3#1)
This article is the first##3##5##(1993-2#1)(1993-3#1)(2007-8#1)
This article is the second in a series##2##8##(1993-3#1)(2007-11#1)
This article is the second in a##3##7##(1993-3#1)(2007-11#1)(2008-10#1)
This article is the##9##4##(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-10#1)
This article is##38##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-2#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#6)
This article looks at the##2##5##(1995-2#1)(2013-7#1)
This article looks at##3##4##(1995-2#1)(2013-7#1)(2013-8#1)
This article observes##2##3##(1994-12#1)(1995-12#1)
This article offers a##3##4##(1992-3#1)(2008-1#1)(2010-6#1)
This article offers##5##3##(1992-3#2)(1996-12#1)(2008-1#1)(2010-6#1)
This article on##3##3##(1990-12#1)(1991-1#1)(1993-3#1)
This article outlines some of the##2##6##(1997-2#1)(2010-4#1)
This article outlines the process##2##5##(1994-12#1)(1995-1#1)
This article outlines the##11##4##(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1997-3#1)(2008-11#1)
This article outlines##19##3##(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-4#1)
This article presents a case of a 60-year-old##2##8##(2007-4#1)(2009-3#1)
This article presents a case of a##7##7##(2007-4#1)(2009-3#6)
This article presents a case of##10##6##(2007-4#1)(2009-10#1)(2009-3#8)
This article presents a case report##2##6##(2012-12#1)(2013-1#1)
This article presents a case study##2##6##(1997-2#1)(2009-5#1)
This article presents a case##15##5##(1997-2#1)(2007-4#1)(2009-10#1)(2009-3#8)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
This article presents a methodology for##2##6##(1995-12#2)
This article presents a model of##2##6##(1992-1#1)(1995-2#1)
This article presents a review of##2##6##(2011-7#1)(2013-8#1)
This article presents a survey of##2##6##(1994-3#1)(2013-1#1)
This article presents a##49##4##(1990-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1996-1#2)(1997-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#8)(2009-5#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
This article presents an analysis of##2##6##(1996-2#1)(2011-1#1)
This article presents an overview of the history##2##8##(1997-2#1)(2008-5#1)
This article presents an overview of the##4##7##(1997-2#1)(2008-1#1)(2008-2#1)(2008-5#1)
This article presents an overview of##7##6##(1991-12#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-5#2)(2013-8#1)
This article presents an##12##4##(1991-12#2)(1996-2#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-7#1)(2011-1#1)(2013-8#1)
This article presents data on health care spending for the United States##3##12##(1995-3#1)(1997-1#1)(1997-3#1)
This article presents data on##4##5##(1994-2#1)(1995-3#1)(1997-1#1)(1997-3#1)
This article presents data##6##4##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)
This article presents excerpts from##2##5##(1994-1#1)(2007-11#1)
This article presents results of a study##2##7##(2008-2#2)
This article presents results of a##3##6##(2008-2#2)(2008-9#1)
This article presents results##4##4##(1997-2#1)(2008-2#2)(2008-9#1)
This article presents some##3##4##(1996-7#1)(2007-11#1)(2007-12#1)
This article presents the findings of a##2##7##(1997-7#1)(2013-8#1)
This article presents the findings of##3##6##(1994-2#1)(1997-7#1)(2013-8#1)
This article presents the possibilities of orthotic management##2##8##(2007-11#1)(2007-8#1)
This article presents the results of a##2##7##(1994-3#1)(1997-3#1)
This article presents the results of##5##6##(1994-1#1)(1994-3#1)(1997-3#1)(2007-11#1)(2013-8#1)
This article presents the##22##4##(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-3#2)(1997-7#1)(2007-11#5)(2007-8#5)(2008-10#1)(2013-8#3)
This article presents##114##3##(1990-12#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-7#1)(2007-11#7)(2007-12#1)(2007-4#1)(2007-8#7)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#8)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#5)
This article proposes a##3##4##(1992-3#1)(2008-2#1)(2008-5#1)
This article proposes that##2##4##(2007-10#1)(2008-11#1)
This article proposes##7##3##(1991-12#1)(1992-3#1)(1996-12#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
This article provides a brief overview of the##2##8##(2010-12#1)(2010-8#1)
This article provides a brief##3##5##(2009-5#1)(2010-12#1)(2010-8#1)
This article provides a review of the##3##7##(2008-10#1)(2008-8#1)(2010-12#1)
This article provides a review of##6##6##(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
This article provides a##22##4##(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-1#1)
This article provides an overview of the##13##7##(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
This article provides an overview of##23##6##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-1#2)(1997-2#2)(2007-12#2)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
This article provides an##25##4##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-1#2)(1997-2#2)(2007-12#3)(2008-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
This article provides background information##2##5##(1991-12#1)(2012-2#1)
This article provides the##2##4##(2008-9#1)(2010-9#1)
This article provides##62##3##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-3#2)(1995-12#1)(1996-1#3)(1996-12#2)(1996-3#1)(1997-1#3)(1997-2#4)(1997-3#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
This article questions##2##3##(1991-3#1)(1995-1#1)
This article reports a case of##4##6##(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)
This article reports on a##5##5##(1993-3#1)(1995-1#1)(1996-12#1)(2008-12#1)(2009-5#1)
This article reports on the use of##2##7##(2008-10#1)(2013-8#1)
This article reports on the##4##5##(1995-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
This article reports on##14##4##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
This article reports the findings of##2##6##(1995-1#1)(2008-9#1)
This article reports the results of a##4##7##(1992-3#1)(1996-1#2)(1996-12#1)
This article reports the##8##4##(1992-3#1)(1995-1#1)(1996-1#2)(1996-12#1)(1997-2#1)(2008-9#1)(2013-1#1)
This article reports##33##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#3)(1996-3#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#2)(2009-5#2)(2010-1#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
This article reviews a##2##4##(1993-12#2)
This article reviews important##2##4##(1996-3#1)(1997-2#1)
This article reviews recent developments in the##2##7##(1994-9#1)(2010-4#1)
This article reviews recent studies##2##5##(2008-4#1)(2010-4#1)
This article reviews recent##7##4##(1994-9#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-4#2)(2013-8#1)
This article reviews some of the case law in which##2##10##(1993-1#1)(1993-12#1)
This article reviews some of the##6##6##(1993-1#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)
This article reviews the available data regarding the different aspects of##2##11##(2013-1#2)
This article reviews the available##4##5##(2008-12#1)(2008-4#1)(2013-1#2)
This article reviews the clinical##3##5##(2008-2#2)(2013-1#1)
This article reviews the current##6##5##(2007-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-7#1)
This article reviews the history##2##5##(2008-8#1)(2013-8#1)
This article reviews the literature on the##2##7##(1996-3#1)(2007-11#1)
This article reviews the literature on##3##6##(1996-3#1)(2007-11#1)(2007-12#1)
This article reviews the literature##6##5##(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2010-11#1)(2013-1#1)
This article reviews the pathology##2##5##(2007-12#1)(2008-7#1)
This article reviews the various##4##5##(2007-12#1)(2008-11#1)(2008-6#1)(2010-10#1)
This article reviews the##76##4##(1992-2#1)(1993-12#1)(1994-2#2)(1995-2#3)(1996-2#2)(1996-3#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#6)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2009-12#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#6)(2013-8#3)
This article reviews##118##3##(1992-2#1)(1993-1#1)(1993-12#4)(1994-1#1)(1994-2#3)(1994-9#1)(1995-2#4)(1996-2#5)(1996-3#2)(1997-2#2)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#9)(2008-1#5)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#5)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#2)(2012-2#1)(2013-1#6)(2013-8#7)
This article sets##2##3##(1992-3#1)(2013-8#1)
This article shows how##2##4##(1996-3#1)(1997-2#1)
This article shows the##2##4##(1994-1#1)(2011-2#1)
This article shows##4##3##(1994-1#1)(1996-3#1)(1997-2#1)(2011-2#1)
This article studies##2##3##(1992-3#1)(2008-7#1)
This article suggests##4##3##(1994-12#1)(1996-2#1)(2008-1#1)(2010-8#1)
This article summarises the##2##4##(1997-7#1)(2007-5#1)
This article summarises##3##3##(1997-7#1)(2007-5#2)
This article summarizes a##2##4##(1992-3#1)(2012-2#1)
This article summarizes research##2##4##(1994-1#1)(2008-6#1)
This article summarizes the##15##4##(1992-12#2)(1992-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)
This article summarizes##23##3##(1990-8#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)
This article synthesizes##2##3##(1994-9#1)(1996-2#1)
This article takes a##3##4##(1997-3#1)(2008-8#1)(2013-8#1)
This article takes the##2##4##(2008-10#1)(2008-12#1)
This article takes##7##3##(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2013-8#1)
This article traces the##2##4##(2008-9#1)(2012-2#1)
This article uses a##3##4##(1996-3#1)(2011-2#1)(2012-3#1)
This article uses the##3##4##(1994-12#1)(1995-12#1)(1995-3#1)
This article uses##11##3##(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
This article was##3##3##(2007-2#1)(2011-2#2)
This article will address##3##4##(1993-11#1)(1995-3#1)(2007-10#1)
This article will describe the##3##5##(1994-3#1)(1995-12#1)(2008-9#1)
This article will discuss the##2##5##(1991-1#1)(2012-2#1)
This article will discuss##4##4##(1991-1#1)(2009-9#1)(2011-1#1)(2012-2#1)
This article will explore service delivery problems and resolutions##2##9##(1994-1#2)
This article will explore##3##4##(1991-12#1)(1994-1#2)
This article will introduce##2##4##(1991-12#1)(2010-11#1)
This article will provide an overview of the##2##8##(1991-1#1)(2013-8#1)
This article will provide an overview of##3##7##(1991-1#1)(2012-2#1)(2013-8#1)
This article will provide##7##4##(1991-1#1)(1994-2#1)(1997-3#1)(2010-4#1)(2012-2#2)(2013-8#1)
This article will review the##5##5##(1994-3#1)(1995-2#1)(1997-1#1)(2008-7#1)(2009-12#1)
This article will review##8##4##(1994-3#2)(1995-2#1)(1997-1#1)(2008-7#2)(2009-12#1)(2012-2#1)
This article will##37##3##(1991-1#2)(1991-12#2)(1993-1#1)(1993-11#1)(1994-1#2)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#5)(2013-8#2)
This article##1113##2##(1990-11#2)(1990-12#4)(1990-8#1)(1991-1#12)(1991-12#20)(1991-2#12)(1991-3#2)(1991-6#3)(1991-9#1)(1992-1#5)(1992-12#16)(1992-2#14)(1992-3#16)(1992-4#1)(1992-6#1)(1993-1#13)(1993-11#2)(1993-12#17)(1993-2#9)(1993-3#20)(1993-6#3)(1994-1#16)(1994-12#17)(1994-2#22)(1994-3#14)(1994-9#3)(1995-1#23)(1995-11#1)(1995-12#22)(1995-2#20)(1995-3#17)(1995-5#1)(1995-6#2)(1996-1#17)(1996-11#2)(1996-12#24)(1996-2#33)(1996-3#35)(1996-6#2)(1996-7#2)(1997-1#17)(1997-2#27)(1997-3#25)(1997-7#5)(1997-8#3)(2006-10#1)(2006-5#1)(2007-10#5)(2007-11#15)(2007-12#22)(2007-2#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#14)(2007-9#1)(2008-1#24)(2008-10#35)(2008-11#47)(2008-12#17)(2008-2#16)(2008-3#5)(2008-4#12)(2008-5#10)(2008-6#10)(2008-7#29)(2008-8#13)(2008-9#19)(2009-10#11)(2009-11#6)(2009-12#5)(2009-3#9)(2009-4#2)(2009-5#12)(2009-7#5)(2009-8#1)(2009-9#8)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#6)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#6)(2011-1#11)(2011-2#41)(2011-3#1)(2011-7#3)(2012-1#1)(2012-12#14)(2012-2#24)(2012-3#13)(2013-1#26)(2013-7#3)(2013-8#33)
This article--the##2##2##(1994-1#1)(1994-3#1)
This aspect##2##2##(2008-5#1)(2013-1#1)
This assay can be##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
This assay is##5##3##(1990-12#2)(1995-2#1)(2008-4#1)(2008-9#1)
This assay uses##3##3##(1993-2#1)(1994-11#1)(2008-10#1)
This assay was used to##2##5##(2008-10#1)(2013-1#1)
This assay was##3##3##(1991-2#1)(2008-10#1)(2013-1#1)
This assay##27##2##(1990-12#3)(1990-2#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-9#2)(2011-3#1)(2013-1#1)
This assembly##2##2##(2008-10#2)
This assessment##11##2##(1997-2#1)(2013-8#10)
This assignment##2##2##(1995-6#1)(2009-7#1)
This association is##2##3##(1990-2#1)(2010-12#1)
This association##5##2##(1990-2#1)(1991-12#1)(2008-11#1)(2010-12#1)(2012-12#1)
This assumption##2##2##(1996-5#1)(2008-2#1)
This asymmetry##4##2##(2008-8#1)(2008-9#1)(2009-6#2)
This author##2##2##(2007-10#1)(2009-12#1)
This beam##5##2##(2007-12#1)(2008-3#3)(2009-11#1)
This behavior can be##2##4##(1995-3#1)(2008-3#1)
This behavior was observed##2##4##(1994-5#1)(2008-11#1)
This behavior##8##2##(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-10#1)
This beneficial##2##2##(1993-12#1)(1995-2#1)
This benefit##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
This benign##2##2##(2007-5#1)(2008-2#1)
This bias##2##2##(1996-2#1)(2008-3#1)
This binding was##3##3##(1992-8#1)(1993-6#1)(1997-7#1)
This binding##8##2##(1992-11#1)(1992-8#1)(1993-6#3)(1994-5#1)(1994-8#1)(1997-7#1)
This biosensor##4##2##(2008-10#4)
This bipolar##2##2##(1992-12#1)(2012-2#1)
This boundary##2##2##(2008-2#1)(2008-3#1)
This breed##2##2##(2008-12#1)(2010-4#1)
This brief report##2##3##(1994-1#1)(1996-12#1)
This brief review##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)
This brief##7##2##(1994-1#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)
This broad##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
This cDNA##4##2##(1991-6#1)(1993-11#1)(1997-1#1)(1997-7#1)
This calculation is##2##3##(2007-12#1)(2008-3#1)
This calculation##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
This calibration##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
This can be a##2##4##(1994-12#1)(2012-12#1)
This can be achieved by##2##5##(2007-7#1)(2008-1#1)
This can be achieved##5##4##(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-9#1)
This can be done by##2##5##(2008-10#1)(2008-3#1)
This can be done##3##4##(2008-10#2)(2008-3#1)
This can be useful to identify##2##6##(2008-4#2)
This can be##24##3##(1994-12#1)(1996-2#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-12#2)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
This can lead to##2##4##(1996-12#1)(2008-9#1)
This can##43##2##(1992-6#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
This capability##3##2##(1991-12#1)(2008-3#1)(2009-6#1)
This case adds to##2##4##(2012-3#1)(2013-8#1)
This case also emphasizes the##2##5##(2006-10#1)(2007-8#1)
This case also emphasizes##3##4##(2006-10#1)(2007-8#1)(2009-8#1)
This case also##4##3##(2006-10#1)(2007-8#1)(2009-3#1)(2009-8#1)
This case and review of the literature##2##7##(2008-10#1)(2008-12#1)
This case and##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
This case demonstrates that##2##4##(2008-1#1)(2011-2#1)
This case demonstrates the##2##4##(1994-12#1)(2012-3#1)
This case demonstrates##5##3##(1994-12#1)(2008-1#1)(2010-1#1)(2011-2#1)(2012-3#1)
This case describes a##2##4##(2008-9#1)(2013-1#1)
This case describes##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
This case has##2##3##(1991-3#1)(2012-2#1)
This case highlights the importance of##2##6##(2007-8#1)(2013-1#1)
This case highlights the need##2##5##(2011-1#1)(2013-1#1)
This case highlights the##7##4##(2007-8#2)(2011-1#2)(2012-8#1)(2013-1#2)
This case highlights##9##3##(2006-10#1)(2007-8#2)(2011-1#3)(2012-8#1)(2013-1#2)
This case illustrates that##2##4##(2008-7#1)(2009-8#1)
This case illustrates the##2##4##(2008-7#1)(2011-2#1)
This case illustrates##8##3##(1997-3#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#1)
This case is presented to##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
This case is##9##3##(1990-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
This case presentation##2##3##(2007-1#1)(2012-12#1)
This case report demonstrates the##2##5##(2008-1#1)(2012-2#1)
This case report demonstrates##4##4##(2008-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
This case report describes a##7##5##(2008-7#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
This case report describes the diagnosis and##2##7##(2008-12#2)
This case report describes the##5##5##(2008-12#3)(2008-7#1)(2011-2#1)
This case report describes##12##4##(2008-12#3)(2008-7#2)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
This case report highlights the##3##5##(2010-5#1)(2012-2#1)(2013-1#1)
This case report illustrates the##2##5##(2012-2#1)(2012-3#1)
This case report is##2##4##(2008-1#1)(2009-3#1)
This case report presents a##2##5##(2009-3#1)(2012-12#1)
This case report presents##5##4##(1993-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
This case report##35##3##(1990-3#1)(1993-8#1)(2008-1#2)(2008-10#1)(2008-12#4)(2008-7#2)(2009-3#3)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
This case series##5##3##(2008-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
This case shows that##3##4##(2008-12#1)(2011-1#1)(2011-2#1)
This case study addresses our efforts to educate the candidate regarding the potential foregone##2##14##(1994-1#2)
This case study addresses##3##4##(1992-1#1)(1994-1#2)
This case study analyzes the##2##5##(1993-3#1)(2008-2#1)
This case study describes a##2##5##(2009-6#1)(2012-12#1)
This case study describes the##2##5##(2008-4#1)(2012-12#1)
This case study describes##5##4##(2008-4#1)(2009-6#1)(2010-10#1)(2012-12#2)
This case study details the time##2##6##(1994-3#2)
This case study details the##3##5##(1994-3#2)(1996-1#1)
This case study examines the##3##5##(1991-1#1)(2008-10#1)(2009-10#1)
This case study explains how the##2##6##(1991-1#2)
This case study follows the Ramsey##2##6##(1991-3#2)
This case study suggests that##3##5##(2008-10#1)(2013-1#2)
This case study will show that an optical storage system provides a cost-effective method of archiving medical documents that can be easily indexed and retrieved##2##25##(1994-3#2)
This case study##39##3##(1991-1#3)(1991-3#3)(1992-1#1)(1993-3#2)(1994-1#2)(1994-3#4)(1995-2#1)(1996-1#3)(1996-12#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2012-12#3)(2013-1#6)
This case suggests that##2##4##(2007-10#1)(2013-1#1)
This case suggests the##2##4##(1994-7#1)(2012-12#1)
This case suggests##4##3##(1994-7#1)(2007-10#1)(2012-12#1)(2013-1#1)
This case underlines the##2##4##(2008-11#1)(2010-3#1)
This case underscores the##2##4##(2008-10#1)(2008-9#1)
This case was##4##3##(1992-5#1)(2008-12#1)(2008-7#1)(2013-1#1)
This case##156##2##(1990-3#2)(1991-1#3)(1991-3#4)(1992-1#1)(1992-5#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-3#4)(1994-7#1)(1994-9#1)(1995-2#1)(1996-1#3)(1996-12#1)(1996-3#1)(1997-3#2)(2006-10#2)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#10)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#5)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#17)(2013-8#5)
This causes a##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
This causes##7##2##(1995-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
This cell culture##2##3##(2008-11#1)(2010-3#1)
This cell line is##2##4##(1994-12#1)(2008-11#1)
This cell line##5##3##(1992-9#1)(1994-12#1)(2008-11#1)(2009-4#1)(2011-2#1)
This cell##14##2##(1991-11#1)(1992-9#1)(1994-12#1)(1994-5#1)(1997-1#1)(2007-12#1)(2008-11#3)(2008-7#2)(2009-4#1)(2010-3#1)(2011-2#1)
This cellular##2##2##(1995-2#1)(2008-11#1)
This central##2##2##(1992-5#1)(1997-4#1)
This challenge##2##2##(2011-2#1)(2013-1#1)
This change in##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
This change##8##2##(1992-3#1)(1993-5#1)(1995-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2012-2#1)
This chapter describes##4##3##(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
This chapter discusses the##2##4##(1994-11#1)(2010-8#1)
This chapter provides##2##3##(2008-11#1)(2012-2#1)
This chapter will##2##3##(2008-4#1)(2010-3#1)
This chapter##12##2##(1994-11#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#1)
This characteristic distribution##2##3##(2010-8#1)(2013-1#1)
This characteristic##5##2##(1990-9#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
This chelate##2##2##(2008-10#2)
This chemically modified carbon paste electrode was successfully used for the determination of##2##13##(2008-10#2)
This chemically modified electrode##2##4##(2008-10#2)
This chemically modified##4##3##(2008-10#4)
This clade largely corresponds to individuals with morphological features described as##2##11##(2010-8#2)
This class of##2##3##(1994-9#1)(2007-11#1)
This classification of##2##3##(2008-10#1)(2009-10#1)
This classification##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)
This clinical##5##2##(2007-8#1)(2008-7#1)(2010-7#1)(2013-1#2)
This clone was##2##3##(1990-5#1)(2008-11#1)
This clone##7##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-8#1)(2008-11#1)
This cluster##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
This collateral##2##2##(1993-3#1)(1997-3#1)
This collection of##2##3##(1996-8#1)(2008-7#1)
This collection##4##2##(1996-8#1)(2008-10#2)(2008-7#1)
This column reviews##2##3##(2007-2#2)
This column##4##2##(1995-1#1)(2007-2#2)(2011-2#1)
This combination has##2##3##(2008-4#1)(2009-10#1)
This combination of##7##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2012-2#1)
This combination##16##2##(1992-12#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
This combined procedure##2##3##(2008-11#1)(2009-8#1)
This comment##2##2##(2008-3#1)(2012-3#1)
This commentary discusses some of the reasons##2##7##(1996-2#1)(2009-11#1)
This commentary discusses the##2##4##(2008-4#1)(2013-1#1)
This commentary discusses##4##3##(1996-2#1)(2008-4#1)(2009-11#1)(2013-1#1)
This commentary reviews##2##3##(1996-1#1)(2013-1#1)
This commentary unit discusses##2##4##(2008-9#2)
This commentary unit##3##3##(2008-9#3)
This commentary##16##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
This communication describes##2##3##(2008-10#2)
This communication reports##3##3##(1997-7#1)(2008-10#1)(2013-7#1)
This communication will provide##2##4##(2010-3#2)
This communication##10##2##(1994-12#1)(1997-7#1)(2007-10#1)(2008-10#3)(2010-3#3)(2013-7#1)
This compact##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
This comparison##5##2##(1993-1#1)(2008-2#2)(2008-8#1)(2010-1#1)
This compensation##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
This complex##8##2##(1990-8#1)(2007-12#1)(2008-10#4)(2013-1#1)(2013-7#1)
This complexation##2##2##(2013-1#2)
This complexity##2##2##(2007-8#1)(2008-9#1)
This complication is##4##3##(1997-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
This complication was##2##3##(2007-8#1)(2011-3#1)
This complication##6##2##(1997-8#1)(2007-8#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
This component##3##2##(1995-5#1)(2008-1#1)(2008-11#1)
This compound has##2##3##(1990-8#1)(2008-5#1)
This compound inhibited the##2##4##(2008-10#1)(2008-5#1)
This compound is##2##3##(1995-3#1)(2008-11#1)
This compound reacts##2##3##(2008-10#2)
This compound showed a##2##4##(1990-5#1)(1995-3#1)
This compound was a##3##4##(1990-7#1)(1991-8#1)(1995-3#1)
This compound was##5##3##(1990-7#1)(1991-8#1)(1995-3#2)(2008-10#1)
This compound##20##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1993-11#1)(1995-11#1)(1995-3#4)(2008-10#6)(2008-11#1)(2008-5#2)
This comprehensive##5##2##(1995-1#1)(2008-4#1)(2008-9#3)
This concentration##2##2##(2008-10#1)(2008-6#1)
This concept is##4##3##(1994-9#1)(2008-10#2)(2008-7#1)
This concept##8##2##(1991-6#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-6#1)
This conclusion is based on##2##5##(2008-7#1)(2012-1#1)
This conclusion is confirmed by the##2##6##(1990-11#1)(1993-11#1)
This conclusion is supported##2##4##(1996-4#1)(2008-2#1)
This conclusion is##12##3##(1990-11#1)(1990-7#1)(1993-11#1)(1996-4#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2012-1#1)
This conclusion was supported by##2##5##(1993-9#1)(2008-10#1)
This conclusion was##4##3##(1993-9#1)(1994-3#1)(2008-10#2)
This conclusion##19##2##(1990-11#1)(1990-7#1)(1993-11#1)(1993-9#1)(1994-3#1)(1996-4#1)(1996-6#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-7#1)(2008-8#1)(2012-1#1)
This condition has been##2##4##(2011-1#1)(2012-2#1)
This condition has##3##3##(2008-1#1)(2011-1#1)(2012-2#1)
This condition is most##2##4##(1992-5#1)(1996-12#1)
This condition is##5##3##(1992-5#1)(1996-12#1)(2008-7#1)(2010-7#1)(2012-12#1)
This condition was first##2##4##(1997-8#1)(2013-1#1)
This condition##13##2##(1992-5#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
This conference was##5##3##(2008-5#3)(2010-11#1)(2010-5#1)
This conference##9##2##(1996-6#1)(2008-5#5)(2010-11#1)(2010-4#1)(2010-5#1)
This configuration is a##2##4##(2007-12#1)(2008-3#1)
This configuration is##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
This configuration##9##2##(2007-11#1)(2007-12#3)(2008-3#5)
This confirms that##2##3##(1990-8#1)(1994-1#1)
This confirms##3##2##(1990-8#1)(1994-1#1)(2008-3#1)
This conformational change##2##3##(1994-5#1)(2008-10#1)
This conformational##3##2##(1994-5#1)(1995-2#1)(2008-10#1)
This conservation##2##2##(1990-11#1)(1994-11#1)
This consortium##2##2##(1993-12#1)(1993-2#1)
This constitutes a##2##3##(1996-5#1)(2013-7#1)
This constitutes##4##2##(1994-6#1)(1996-5#1)(2008-10#1)(2013-7#1)
This construct##2##2##(1993-12#1)(2008-10#1)
This continuous##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
This contrast##2##2##(1991-5#1)(2012-12#1)
This contrasts with the##4##4##(1991-5#1)(1993-11#1)(1993-2#1)(2006-6#1)
This contrasts with##10##3##(1991-5#1)(1993-11#1)(1993-2#1)(1995-6#1)(1996-2#1)(2006-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
This contrasts##12##2##(1991-5#1)(1993-11#1)(1993-2#1)(1995-6#1)(1996-2#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
This contribution describes##2##3##(2008-10#1)(2008-11#1)
This contribution reviews##2##3##(1997-1#1)(2009-12#1)
This contribution##7##2##(1994-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2011-2#1)
This conversion##2##2##(1991-9#1)(1994-5#1)
This corrected##2##2##(2008-10#1)(2008-9#1)
This correlation is##2##3##(1992-6#1)(2008-3#1)
This correlation was##2##3##(2006-6#1)(2013-1#1)
This correlation##10##2##(1992-6#1)(1995-3#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
This correlational study##2##3##(2009-5#1)(2010-10#1)
This correlational##3##2##(2009-5#1)(2010-10#1)(2010-11#1)
This correlator is##2##3##(2008-3#2)
This corresponded with##3##3##(1996-12#1)(2008-11#1)(2013-1#1)
This corresponded##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
This correspondence##2##2##(2008-8#1)(2013-1#1)
This corresponds to an##3##4##(2007-2#1)(2008-2#1)(2008-3#1)
This corresponds to##7##3##(1990-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
This corroborates##2##2##(2008-10#1)(2008-8#1)
This could be achieved##3##4##(2008-1#1)(2008-12#1)(2011-2#1)
This could be attributed to##2##5##(2007-11#1)(2007-7#1)
This could be due to##3##5##(1997-4#1)(2008-10#1)(2008-7#1)
This could be the first##2##5##(2012-2#1)(2013-1#1)
This could be the##4##4##(1990-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
This could be##22##3##(1990-2#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
This could have##2##3##(1995-11#1)(2007-6#1)
This could##31##2##(1990-2#1)(1995-11#1)(1996-4#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
This counterintuitive##2##2##(2007-12#1)(2008-10#1)
This coupling##2##2##(2007-11#1)(2007-12#1)
This course##2##2##(2008-11#1)(2010-5#1)
This creates a##2##3##(1990-8#1)(2008-10#1)
This creates##3##2##(1990-8#1)(2008-10#1)(2008-2#1)
This criterion##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
This cross-sectional study examined the##2##5##(2008-5#1)(2013-1#1)
This cross-sectional study was carried out to##2##7##(2010-8#1)(2011-2#1)
This cross-sectional study was carried out##3##6##(2010-8#1)(2011-2#2)
This cross-sectional study was##4##4##(2010-8#1)(2011-2#2)(2013-1#1)
This cross-sectional study##11##3##(2008-5#1)(2010-10#2)(2010-3#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#2)
This cross-sectional##12##2##(1997-2#1)(2008-5#1)(2010-10#2)(2010-3#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#2)
This culture##2##2##(1991-12#1)(2012-2#1)
This current was##3##3##(1992-11#1)(1993-12#1)(1995-11#1)
This data demonstrates##2##3##(1992-3#1)(2008-11#1)
This data suggests that##2##4##(2010-7#1)(2011-1#1)
This data##16##2##(1992-3#1)(1995-12#1)(1997-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
This database##3##2##(2007-12#1)(2008-8#1)(2012-3#1)
This decrease in##2##3##(1992-5#1)(1996-12#1)
This decrease is##2##3##(2008-10#1)(2013-1#1)
This decrease was##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
This decrease##9##2##(1992-5#1)(1994-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
This decrement##2##2##(1993-9#1)(1994-5#1)
This defect##2##2##(1990-5#2)
This deficiency##3##2##(1990-3#1)(1993-3#1)(2008-3#1)
This degradation##2##2##(2008-10#1)(2008-5#1)
This delayed##2##2##(1996-3#1)(2013-8#1)
This demonstrated##3##2##(2008-10#2)(2012-1#1)
This demonstrates a##2##3##(1990-2#1)(1991-2#1)
This demonstrates that the##3##4##(1992-6#1)(1996-7#1)(2008-8#1)
This demonstrates that##10##3##(1992-6#2)(1995-12#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)
This demonstrates##14##2##(1990-2#1)(1991-2#1)(1992-6#2)(1994-6#1)(1995-12#1)(1995-5#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)
This demonstration is##3##3##(2007-11#2)(2008-8#1)
This demonstration##4##2##(2007-11#3)(2008-8#1)
This dependence##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
This dependency##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
This depends##2##2##(2008-10#1)(2008-5#1)
This derivative##2##2##(1990-2#1)(2008-10#1)
This descriptive study##7##3##(1995-1#1)(2008-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
This descriptive##10##2##(1995-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
This deserves further##2##3##(2012-3#2)
This design##8##2##(2007-12#1)(2008-2#1)(2008-3#4)(2008-9#1)(2011-2#1)
This detection##4##2##(2008-10#3)(2008-3#1)
This development##5##2##(1990-2#1)(1995-6#1)(1996-3#1)(1997-7#1)(2010-3#1)
This device allows##2##3##(2007-7#1)(2008-3#1)
This device has##2##3##(2008-3#1)(2008-5#1)
This device is##3##3##(2007-12#1)(2008-3#2)
This device operates##2##3##(2008-2#1)(2008-3#1)
This device was##2##3##(2008-10#1)(2008-2#1)
This device##18##2##(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#7)(2008-5#1)
This diagnosis was##2##3##(1992-12#1)(1996-6#1)
This diagnosis##6##2##(1992-12#1)(1996-6#1)(1997-3#1)(2008-3#1)(2008-4#1)(2012-12#1)
This difference can##2##3##(2008-3#1)(2010-2#1)
This difference in##5##3##(1990-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
This difference is##5##3##(1991-11#1)(1991-8#1)(1993-5#1)(1993-8#1)(2008-6#1)
This difference may##3##3##(1993-12#1)(1994-12#1)(2008-2#1)
This difference was more##2##4##(1995-5#1)(2007-2#1)
This difference was statistically significant##2##5##(1990-3#1)(2013-1#1)
This difference was##8##3##(1990-3#1)(1995-5#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
This difference##29##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-2#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#3)(2009-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
This differential diagnosis##2##3##(1993-2#1)(2010-7#1)
This differential effect##2##3##(1991-5#1)(1992-3#1)
This differential##9##2##(1991-5#1)(1992-3#1)(1993-2#1)(1995-1#1)(2008-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
This direct##2##2##(2008-10#1)(2012-3#1)
This disadvantage##2##2##(2008-10#1)(2008-9#1)
This discrepancy is##4##3##(1993-11#1)(1993-9#1)(2008-8#1)(2012-3#1)
This discrepancy might##2##3##(2008-11#1)(2009-2#1)
This discrepancy##8##2##(1993-11#1)(1993-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-3#1)(2013-1#1)
This discrimination##2##2##(2008-10#1)(2008-7#1)
This discussion##3##2##(1992-12#1)(2008-9#1)(2009-12#1)
This disease is##5##3##(1992-5#1)(1997-8#1)(2008-12#2)(2012-3#1)
This disease##11##2##(1990-9#1)(1992-5#1)(1997-8#1)(2008-10#3)(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
This disorder##2##2##(2010-1#1)(2010-6#1)
This distinct##2##2##(2008-10#1)(2008-5#1)
This distribution##2##2##(1991-5#1)(1993-8#1)
This diurnal##2##2##(2008-10#1)(2008-5#1)
This diversity##2##2##(2008-10#2)
This document provides##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
This document##7##2##(1996-12#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-12#1)
This does not mean##2##4##(2008-10#1)(2008-7#1)
This does not##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
This dosage##2##2##(1994-2#1)(2007-11#1)
This dose##4##2##(1994-6#1)(2007-12#1)(2007-9#1)(2008-10#1)
This dramatic##2##2##(1992-3#1)(2013-1#1)
This drug has been##2##4##(1990-3#1)(1994-6#1)
This drug was##2##3##(1994-8#1)(2008-1#1)
This drug##7##2##(1990-3#1)(1994-6#1)(1994-8#1)(2007-10#1)(2007-5#2)(2008-1#1)
This dual##2##2##(2008-8#1)(2013-8#1)
This ecotype##2##2##(2008-10#2)
This edition of the##2##4##(2011-1#1)(2011-2#1)
This editorial##2##2##(2010-12#2)
This effect appeared##2##3##(1992-8#1)(2011-2#1)
This effect appears to be##3##5##(1991-5#1)(1994-8#1)(2008-8#1)
This effect can be##3##4##(1992-8#1)(2008-10#1)(2008-3#1)
This effect can##5##3##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
This effect did not occur##2##5##(1994-8#1)(2008-10#1)
This effect is mediated by##2##5##(2008-11#1)(2011-2#1)
This effect is##19##3##(1990-7#1)(1991-2#1)(1991-9#1)(1993-8#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
This effect may be##2##4##(2007-11#1)(2008-8#1)
This effect may##4##3##(1992-4#1)(2007-11#1)(2008-8#2)
This effect of##7##3##(1990-12#1)(1992-8#2)(1992-9#1)(1994-2#1)(1995-12#1)(2008-4#1)
This effect was attenuated by##2##5##(1994-5#1)(2009-2#1)
This effect was blocked by##2##5##(1995-12#1)(1996-12#1)
This effect was due to##2##5##(1995-11#1)(1995-12#1)
This effect was more for cuprophane than polysulfone##2##8##(2007-7#1)(2008-1#1)
This effect was more##3##4##(2007-7#1)(2008-1#1)(2011-2#1)
This effect was not##3##4##(1991-1#1)(2008-4#1)(2008-8#1)
This effect was##28##3##(1990-11#1)(1990-6#1)(1991-1#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2011-2#1)(2013-1#1)
This effect##83##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#4)(1992-9#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1996-12#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#4)(2013-1#1)
This efficient##4##2##(1990-2#1)(2007-12#1)(2008-10#2)
This effort##2##2##(1993-12#1)(1996-2#1)
This electrode responds to##2##4##(2008-10#2)
This electrode was##2##3##(2008-10#2)
This electrode##10##2##(2008-10#9)(2012-2#1)
This element##2##2##(1991-2#1)(1993-11#1)
This elevation##2##2##(1990-8#1)(1993-9#1)
This eliminates##2##2##(2008-10#1)(2012-3#1)
This emphasizes the##3##3##(1992-9#1)(1994-9#1)(1995-2#1)
This enables the##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
This enables us to##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
This enables us##4##3##(2008-2#1)(2008-3#1)(2009-7#1)(2012-12#1)
This enables##8##2##(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#1)
This enhanced##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
This enhancement is##3##3##(2007-11#2)(2008-10#1)
This enhancement##6##2##(1993-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)
This ensures##2##2##(2008-10#1)(2008-3#1)
This entity##2##2##(1991-6#1)(1992-2#1)
This enzyme catalyses the oxidation of##2##6##(2008-10#2)
This enzyme is##3##3##(1990-11#1)(1994-8#1)(2008-11#1)
This enzyme was##2##3##(1991-11#1)(1994-11#1)
This enzyme##14##2##(1990-11#1)(1990-5#1)(1991-11#1)(1992-10#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-6#1)
This enzyme-less##2##2##(2008-10#2)
This epigenetic##2##2##(2007-11#1)(2013-8#1)
This equation is based on the average electronic absorption gap##2##10##(2008-2#2)
This equation is##3##3##(2008-10#1)(2008-2#2)
This equation##5##2##(2008-10#2)(2008-2#3)
This error##2##2##(2008-3#2)
This essay##7##2##(2008-1#1)(2008-12#2)(2010-1#2)(2012-12#1)(2012-2#1)
This estimation##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
This ethnographic study##2##3##(2008-5#1)(2010-10#1)
This evaluation##3##2##(1993-3#1)(2008-11#1)(2008-9#1)
This evidence##7##2##(1993-12#1)(1993-3#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
This evolution##3##2##(1992-8#1)(2007-12#1)(2013-1#1)
This exercise##3##2##(1997-4#1)(2008-11#1)(2008-2#1)
This experience##4##2##(1991-6#1)(1992-2#1)(2008-1#1)(2008-7#1)
This experiment was conducted to determine##2##6##(1992-3#1)(2008-12#1)
This experiment was conducted to##3##5##(1992-3#1)(2008-12#2)
This experiment was conducted##4##4##(1992-3#1)(2008-12#3)
This experiment was##6##3##(1992-3#1)(2008-12#4)(2010-10#1)
This experiment##14##2##(1992-3#1)(1993-12#1)(1993-6#1)(2007-12#1)(2008-10#2)(2008-12#5)(2008-2#1)(2010-10#1)(2013-8#1)
This experimental result is##2##4##(2007-12#1)(2008-3#1)
This experimental system##2##3##(1994-2#1)(2008-11#1)
This experimental##8##2##(1994-2#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
This explained##2##2##(2008-7#1)(2010-4#1)
This explains the##2##3##(2008-10#1)(2013-1#1)
This explains why##2##3##(2008-1#1)(2008-8#1)
This explains##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
This explanation##3##2##(1997-4#1)(2007-12#1)(2008-6#1)
This exploratory analysis##2##3##(2008-7#1)(2011-2#1)
This exploratory study##2##3##(2008-11#1)(2008-7#1)
This exploratory##4##2##(2008-11#1)(2008-7#2)(2011-2#1)
This expression system##2##3##(1997-4#1)(2012-2#1)
This expression##10##2##(1991-12#1)(1993-6#1)(1995-12#1)(1997-4#1)(2007-12#2)(2008-3#3)(2012-2#1)
This extended##2##2##(1991-8#1)(2008-3#1)
This extends##2##2##(2007-11#1)(2009-12#1)
This extension of##2##3##(1992-5#1)(2008-4#1)
This extension##3##2##(1992-5#1)(2007-11#1)(2008-4#1)
This extensive##3##2##(2008-5#1)(2008-9#2)
This extraction##2##2##(2008-10#1)(2008-7#1)
This facilitates##2##2##(2008-8#1)(2011-2#1)
This fact is##3##3##(1997-4#1)(2008-10#1)(2013-1#1)
This fact suggests that##2##4##(1993-8#1)(2008-11#1)
This fact suggests##3##3##(1993-8#1)(2008-11#1)(2009-4#1)
This fact##14##2##(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#1)
This factor##5##2##(1990-2#1)(1991-11#1)(2007-11#1)(2008-10#1)(2008-2#1)
This failure##2##2##(2008-9#1)(2011-1#1)
This family is##2##3##(1994-2#1)(2011-2#1)
This family##5##2##(1994-2#1)(1996-2#1)(2009-6#1)(2010-1#1)(2011-2#1)
This feasibility study##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
This feature issue of Applied Optics##2##6##(2008-2#1)(2008-3#1)
This feature issue##3##3##(2008-2#1)(2008-3#2)
This feature makes##2##3##(1997-2#1)(2008-10#1)
This feature##13##2##(1997-2#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2010-11#1)(2010-12#1)(2012-2#1)
This fiber##2##2##(2008-10#1)(2008-3#1)
This field of##2##3##(2008-9#1)(2009-3#1)
This filter##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
This filtering##2##2##(2007-12#1)(2008-3#1)
This final##2##2##(2008-7#1)(2010-9#1)
This finding can##2##3##(2008-5#1)(2011-2#1)
This finding has##5##3##(1994-5#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
This finding in##2##3##(1992-9#1)(2008-12#1)
This finding indicates that the##2##5##(1995-12#1)(2008-3#1)
This finding indicates that##5##4##(1994-12#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-9#1)
This finding is a##2##4##(1992-3#1)(2008-10#1)
This finding is consistent with##3##5##(1993-8#1)(2008-11#1)(2010-2#1)
This finding is of##2##4##(1990-12#1)(2007-12#1)
This finding is##13##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-8#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-1#1)
This finding may##2##3##(2008-5#1)(2008-6#1)
This finding represents a##2##4##(2008-10#1)(2011-2#1)
This finding suggests that the##2##5##(1993-6#1)(2009-8#1)
This finding suggests that##15##4##(1990-7#1)(1992-11#1)(1992-2#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)
This finding suggests the##2##4##(1992-6#1)(2008-3#1)
This finding suggests##19##3##(1990-3#1)(1990-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#2)(2009-8#2)(2010-12#1)(2010-5#1)(2011-1#1)
This finding supports the##2##4##(1990-11#1)(1996-3#1)
This finding supports##4##3##(1990-11#1)(1996-3#1)(2008-10#1)(2008-12#1)
This finding was##4##3##(1994-11#1)(1995-5#1)(2008-6#1)(2010-7#1)
This finding##78##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-3#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-10#10)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
This findings##2##2##(1990-8#1)(2008-4#1)
This first##9##2##(1991-12#1)(1993-12#1)(1994-11#1)(1995-2#1)(2007-7#1)(2008-10#3)(2012-2#1)
This fishery##2##2##(2007-5#1)(2013-7#1)
This flow##3##2##(2008-10#3)
This foam material was found to be##2##7##(2008-10#2)
This focus##2##2##(1991-12#1)(1995-12#1)
This form of##2##3##(1994-11#1)(2008-5#1)
This form##3##2##(1992-12#1)(1994-11#1)(2008-5#1)
This formulation##3##2##(1996-4#1)(2007-11#1)(2008-5#1)
This fourfold path##2##3##(2008-1#2)
This fraction##6##2##(1991-5#1)(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)
This fragment was##2##3##(1995-8#1)(2013-1#1)
This fragment##3##2##(1995-8#1)(1997-3#1)(2013-1#1)
This framework is##3##3##(1992-12#1)(1993-12#1)(2013-1#1)
This framework##6##2##(1992-12#1)(1993-12#1)(2010-3#1)(2012-3#1)(2013-1#2)
This function is##3##3##(1990-11#1)(1997-2#1)(2010-10#1)
This function##5##2##(1990-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2010-10#1)
This functional##2##2##(2007-12#1)(2008-11#1)
This further supports##2##3##(1992-8#1)(2008-9#1)
This further##5##2##(1992-8#1)(2008-10#1)(2008-5#2)(2008-9#1)
This gain##3##2##(2008-2#1)(2008-3#2)
This gap##2##2##(2008-5#1)(2010-5#1)
This gave##4##2##(2008-10#1)(2008-12#1)(2008-7#2)
This gel##2##2##(1993-8#1)(2008-4#1)
This gene consists of##2##4##(1992-12#1)(1995-8#1)
This gene is designated as##2##5##(2008-10#2)
This gene is designated##3##4##(2008-10#3)
This gene is##6##3##(1993-11#1)(1993-2#1)(1993-3#1)(2008-10#3)
This gene was##2##3##(1993-2#1)(2013-1#1)
This gene##21##2##(1991-5#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-8#1)(1997-5#1)(2008-10#8)(2008-8#1)(2013-1#2)
This general approach##2##3##(2007-11#1)(2008-9#1)
This general##4##2##(2007-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
This generalized##2##2##(2008-8#1)(2011-1#1)
This generates##2##2##(2010-12#1)(2010-2#1)
This genetic##2##2##(1990-5#1)(2008-10#1)
This genome##2##2##(1997-3#1)(2011-2#1)
This genus is of##3##4##(2011-2#3)
This geometry##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
This gives rise to a##2##5##(2008-9#1)(2013-8#1)
This gives##5##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)(2013-8#1)
This goal##3##2##(1993-3#1)(2008-10#1)(2010-3#1)
This greatly##2##2##(2008-4#1)(2008-7#1)
This group is##3##3##(1993-8#1)(2010-12#1)(2011-2#1)
This group of##3##3##(2008-9#1)(2009-8#1)(2013-1#1)
This group##11##2##(1993-8#1)(1997-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
This growth##2##2##(2008-9#1)(2013-8#1)
This guide##2##2##(2008-4#1)(2011-2#1)
This handheld##2##2##(2011-7#1)(2012-12#1)
This has been##11##3##(1994-12#1)(1994-5#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-1#1)(2012-3#1)
This has implications for##2##4##(2008-11#1)(2008-3#1)
This has important implications for##3##5##(1991-3#1)(2008-11#1)(2008-2#1)
This has led to the##5##5##(2008-6#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-3#1)
This has led to##9##4##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-3#1)
This has led##10##3##(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-3#1)
This has occurred##2##3##(2008-10#1)(2011-1#1)
This has prompted##2##3##(2008-5#1)(2010-8#1)
This has resulted in the##3##5##(1996-9#1)(2008-11#1)(2008-3#1)
This has resulted in##5##4##(1996-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
This has##59##2##(1991-3#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-9#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2012-1#1)(2012-2#1)(2012-3#2)
This helps##2##2##(2008-3#1)(2008-7#1)
This heterogeneity##2##2##(2008-9#1)(2009-12#1)
This heterogeneous##3##2##(1990-12#1)(2007-12#1)(2008-3#1)
This high stability##2##3##(1993-11#1)(2008-3#1)
This high##11##2##(1990-8#1)(1991-6#1)(1993-11#1)(1993-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)(2012-12#1)
This highlights##2##2##(2009-4#1)(2012-2#1)
This hospital-based##2##2##(2007-10#1)(2008-3#1)
This hypothesis has been##2##4##(1994-2#1)(1994-3#1)
This hypothesis has##3##3##(1994-2#1)(1994-3#1)(2008-8#1)
This hypothesis was tested##3##4##(1996-3#1)(1997-7#1)(2008-9#1)
This hypothesis was##6##3##(1996-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
This hypothesis##11##2##(1992-8#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
This idea##6##2##(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
This illustrates that##2##3##(2008-10#1)(2011-2#1)
This illustrates##3##2##(1992-4#1)(2008-10#1)(2011-2#1)
This imaging##2##2##(2008-2#1)(2011-1#1)
This immunoreactivity was##2##3##(1995-12#1)(2009-8#1)
This impairment##2##2##(1991-7#1)(1994-3#1)
This implicates##2##2##(1991-9#1)(1993-11#1)
This implied##2##2##(1997-8#1)(2008-10#1)
This implies that the##6##4##(1992-8#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
This implies that there##2##4##(2010-10#1)(2010-3#1)
This implies that##22##3##(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-10#1)(2010-3#1)(2010-5#1)
This implies##26##2##(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#1)
This important##2##2##(2008-10#1)(2012-3#1)
This improved##4##2##(1994-6#1)(2007-11#1)(2008-11#1)(2008-7#1)
This improvement is##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
This improvement##6##2##(1990-2#1)(1993-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
This in turn dictates the cellular response to a variety of physiological and environmental stimuli##2##15##(2008-2#1)(2008-4#1)
This in turn##10##3##(1995-3#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
This in vitro study##2##4##(2008-11#1)(2013-1#1)
This in vitro##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
This in##16##2##(1991-5#1)(1995-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
This in-frame##2##2##(1990-8#1)(1991-9#1)
This included##6##2##(1994-3#1)(1994-5#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-9#1)
This includes the##3##3##(2008-7#1)(2009-5#1)(2013-1#1)
This includes##14##2##(1990-8#1)(2008-10#1)(2008-4#2)(2008-7#4)(2009-11#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
This increase in the##3##4##(1992-3#1)(1997-6#1)(2008-10#1)
This increase in##11##3##(1992-3#1)(1993-11#1)(1994-12#1)(1994-8#2)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-8#1)
This increase is shown to##2##5##(1995-2#1)(2008-3#1)
This increase is##6##3##(1995-2#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
This increase was##7##3##(1992-12#1)(1992-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
This increase##30##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-8#1)
This increased##10##2##(1991-7#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
This increases the##2##3##(2007-7#1)(2008-4#1)
This increases##3##2##(2007-7#1)(2008-4#1)(2011-2#1)
This index was##2##3##(1993-9#1)(2012-1#1)
This index##3##2##(1993-9#1)(1994-5#1)(2012-1#1)
This indicated a##2##3##(2008-10#2)
This indicated that the##2##4##(1995-8#1)(2008-10#1)
This indicated that##4##3##(1994-9#1)(1995-8#1)(2008-10#1)(2013-8#1)
This indicated##7##2##(1994-9#1)(1995-8#1)(1997-2#1)(2008-10#3)(2013-8#1)
This indicates a##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2012-3#1)
This indicates that a##2##4##(1994-2#1)(2008-7#1)
This indicates that genes for##2##5##(2008-10#2)
This indicates that the##18##4##(1990-5#1)(1991-5#1)(1992-5#1)(1992-8#1)(1992-9#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
This indicates that##59##3##(1990-2#1)(1990-5#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#1)(1997-3#2)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#3)(2012-2#1)
This indicates the presence of##2##5##(1995-2#1)(2008-10#1)
This indicates the##4##3##(1995-2#1)(2008-10#2)(2011-1#1)
This indicates##71##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
This indicator##2##2##(2008-10#1)(2013-1#1)
This indirect##2##2##(1996-5#1)(2008-10#1)
This induces##2##2##(1997-4#1)(2009-7#1)
This induction of##2##3##(1990-5#1)(1994-11#1)
This information allows us to##2##5##(2007-12#1)(2008-3#1)
This information can##4##3##(1992-9#1)(1996-5#1)(2008-3#1)(2012-3#1)
This information facilitates##2##3##(2008-11#1)(2008-9#1)
This information has##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
This information is crucial##2##4##(2008-9#1)(2013-7#1)
This information is useful##2##4##(1994-3#1)(2013-1#1)
This information is##6##3##(1994-3#1)(2007-11#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-7#1)
This information may##2##3##(2009-4#1)(2010-5#1)
This information should##3##3##(2007-12#1)(2008-10#2)
This information will##3##3##(1994-11#1)(2010-5#1)(2011-2#1)
This information##28##2##(1991-12#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
This informative unit##2##3##(2008-9#2)
This informative##3##2##(1992-2#1)(2008-9#2)
This inhibition may##2##3##(1993-12#1)(2008-8#1)
This inhibition was##5##3##(1991-8#1)(1994-8#1)(2008-10#1)(2008-7#1)(2012-7#1)
This inhibition##10##2##(1991-8#1)(1993-12#1)(1994-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-7#1)
This inhibitor is##2##3##(1993-3#1)(2008-10#1)
This inhibitor##3##2##(1993-3#2)(2008-10#1)
This inhibitory##2##2##(1995-11#2)
This initial##2##2##(1990-2#1)(2008-10#1)
This initiative##2##2##(1991-12#1)(2009-3#1)
This innervation##2##2##(1994-5#2)
This innovative##3##2##(2008-12#1)(2008-8#1)(2009-3#1)
This instrument is##3##3##(2008-3#3)
This instrument measures##2##3##(2007-8#1)(2008-3#1)
This instrument##11##2##(1996-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#6)
This integrated##3##2##(2008-2#1)(2010-8#1)(2012-12#1)
This integration##2##2##(2008-10#1)(2011-1#1)
This interaction is##2##3##(1990-12#1)(1994-12#1)
This interaction##13##2##(1990-12#2)(1994-12#1)(1995-12#1)(1995-2#2)(2008-10#2)(2008-4#1)(2008-9#2)(2011-10#1)(2011-2#1)
This interest##2##2##(2011-2#1)(2013-8#1)
This interference##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)
This intermediate##2##2##(2008-4#1)(2009-10#1)
This interpretation is##2##3##(1997-7#1)(2008-10#1)
This interview##3##2##(1993-12#1)(2010-7#1)(2010-8#1)
This introductory##2##2##(1996-6#1)(2008-4#1)
This investigation has##2##3##(1993-11#1)(1995-11#1)
This investigation was undertaken##2##4##(1990-12#1)(1993-2#1)
This investigation was##4##3##(1990-12#1)(1993-2#1)(2008-12#1)(2008-7#1)
This investigation##19##2##(1990-12#3)(1993-1#1)(1993-11#1)(1993-2#1)(1994-1#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-12#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#1)
This involved a##2##3##(2008-12#1)(2008-9#1)
This involved##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
This involves##3##2##(2008-10#1)(2009-1#1)(2009-12#1)
This ion##2##2##(2008-10#1)(2010-5#1)
This is a case report of a##5##7##(2007-7#1)(2008-12#2)(2008-7#1)(2009-1#1)
This is a case report of##7##6##(2007-7#1)(2008-12#2)(2008-7#2)(2009-1#1)(2011-2#1)
This is a case report##8##5##(2007-7#1)(2008-12#2)(2008-7#2)(2009-1#1)(2011-2#1)(2012-3#1)
This is a case study of##2##6##(1996-9#1)(2008-6#1)
This is a case##10##4##(1996-9#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-1#1)(2011-2#1)(2012-3#1)
This is a clear##2##4##(2008-7#1)(2012-2#1)
This is a description of##2##5##(1992-1#1)(2008-7#1)
This is a descriptive##3##4##(2008-11#1)(2010-10#1)(2013-1#1)
This is a first step toward##2##6##(1997-7#1)(2007-11#1)
This is a first##3##4##(1997-7#1)(2007-11#1)(2013-1#1)
This is a new##3##4##(1993-11#1)(2008-10#1)(2012-2#1)
This is a prospective review of##2##6##(2008-7#1)(2008-8#1)
This is a prospective study##2##5##(1995-2#1)(2008-7#1)
This is a prospective##6##4##(1995-2#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)
This is a qualitative and##2##5##(2012-2#1)(2012-3#1)
This is a qualitative##3##4##(2012-2#1)(2012-3#2)
This is a rare case##2##5##(2010-3#1)(2012-2#1)
This is a rare##5##4##(1992-11#1)(2010-3#1)(2012-2#1)(2013-1#2)
This is a report of a case of##2##8##(2008-10#2)
This is a report of##3##5##(2008-10#2)(2012-12#1)
This is a report on##4##5##(1990-9#1)(1993-2#1)(2008-10#1)(2009-4#1)
This is a report##7##4##(1990-9#1)(1993-2#1)(2008-10#3)(2009-4#1)(2012-12#1)
This is a retrospective analysis of##2##6##(2011-2#1)(2012-2#1)
This is a retrospective study of##2##6##(2008-7#1)(2011-2#1)
This is a retrospective study##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
This is a retrospective##9##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
This is a review of the##2##6##(2008-12#1)(2012-12#1)
This is a review of##4##5##(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
This is a simple and##2##5##(2008-10#1)(2008-2#1)
This is a simple##3##4##(2008-10#1)(2008-2#2)
This is a time to##2##5##(1993-12#2)
This is a unique##2##4##(2007-10#1)(2008-11#1)
This is a very##3##4##(1997-7#1)(2008-7#1)(2011-2#1)
This is a##118##3##(1990-9#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#8)
This is about##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
This is accomplished by##4##4##(1996-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
This is accomplished##5##3##(1996-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)
This is achieved by the##2##5##(1994-3#1)(2008-2#1)
This is achieved by##7##4##(1994-3#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2011-2#1)
This is also supported by##3##5##(2008-1#1)(2008-10#1)(2008-7#1)
This is also true##2##4##(1992-10#1)(1994-3#1)
This is also##9##3##(1991-8#1)(1992-10#1)(1994-3#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)
This is an important##2##4##(1991-12#1)(2009-9#1)
This is an##24##3##(1991-12#1)(1992-6#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
This is associated with an##3##5##(1993-8#1)(2008-10#1)(2008-9#1)
This is associated with##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
This is based on the##2##5##(2008-6#1)(2010-12#1)
This is based on##5##4##(1991-6#1)(2007-11#1)(2008-6#1)(2010-12#1)(2011-2#1)
This is because of##3##4##(1997-6#1)(2007-2#1)(2013-8#1)
This is because the##7##4##(1996-4#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-4#1)(2009-9#1)
This is because##13##3##(1996-4#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-8#1)
This is both##2##3##(1991-3#1)(2007-8#1)
This is called##2##3##(2008-8#1)(2009-1#1)
This is confirmed by##2##4##(2008-10#1)(2012-12#1)
This is confirmed##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
This is consistent with a##2##5##(2008-10#1)(2009-12#1)
This is consistent with the##5##5##(1993-9#1)(1994-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
This is consistent with##12##4##(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
This is discussed in##2##4##(1990-7#1)(2009-8#1)
This is done by##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
This is done##4##3##(1994-1#1)(1997-2#1)(2008-10#1)(2011-2#1)
This is due in##2##4##(2008-10#1)(2008-6#1)
This is due to the##6##5##(1992-4#1)(2008-10#3)(2008-3#2)
This is due to##9##4##(1990-6#1)(1992-4#1)(2008-1#1)(2008-10#3)(2008-3#2)(2010-3#1)
This is due##12##3##(1990-6#1)(1990-8#1)(1992-4#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-6#1)(2010-3#1)
This is equivalent to##2##4##(1992-3#1)(2008-10#1)
This is especially important##2##4##(1991-6#1)(2008-9#1)
This is especially true for##5##5##(1990-12#1)(1994-2#1)(2010-4#1)(2010-7#1)(2011-2#1)
This is especially true in##3##5##(1992-2#1)(2010-10#1)(2010-11#1)
This is especially true##11##4##(1990-12#1)(1992-2#1)(1994-2#1)(2007-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
This is especially##17##3##(1990-12#1)(1991-6#1)(1992-2#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
This is evident##2##3##(2008-7#1)(2012-12#1)
This is exactly what##2##4##(2008-3#1)(2009-10#1)
This is exemplified by##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
This is followed by a discussion of##3##7##(2008-4#1)(2008-9#1)(2009-12#1)
This is followed by a##6##5##(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)
This is followed by##12##4##(1992-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-5#1)
This is followed##13##3##(1992-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-5#1)
This is illustrated##2##3##(2006-4#1)(2008-9#1)
This is important as the##2##5##(2008-10#1)(2008-12#1)
This is important##8##3##(1993-2#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)
This is in contrast to the##3##6##(1992-3#1)(1992-6#1)(1993-3#1)
This is in contrast to##6##5##(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(2008-7#1)(2013-7#1)
This is in contrast with##2##5##(2007-11#1)(2008-2#1)
This is in contrast##8##4##(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(2007-11#1)(2008-2#1)(2008-7#1)(2013-7#1)
This is in line with##2##5##(1997-3#1)(2008-5#1)
This is in part##2##4##(2008-10#2)
This is in sharp contrast with##2##6##(2008-10#1)(2008-5#1)
This is in##17##3##(1992-10#1)(1992-3#2)(1992-6#1)(1993-3#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-7#1)
This is interpreted##2##3##(1994-5#1)(2008-7#1)
This is largely because##2##4##(1994-3#1)(2008-8#1)
This is largely##3##3##(1994-12#1)(1994-3#1)(2008-8#1)
This is likely due to##2##5##(1995-5#1)(2008-10#1)
This is likely to be due to a##2##8##(2008-11#1)(2009-7#1)
This is likely##4##3##(1995-5#1)(2008-10#1)(2008-11#1)(2009-7#1)
This is made possible by##2##5##(2007-11#1)(2012-2#1)
This is mainly due to the##2##6##(1992-1#1)(2009-12#1)
This is mainly due to##3##5##(1992-1#1)(1994-5#1)(2009-12#1)
This is mainly##5##3##(1992-1#1)(1994-5#1)(2008-3#1)(2009-12#1)(2013-1#1)
This is minimally invasive method indicated in treatment of certain spinal lesions affecting the vertebral bodies##2##16##(2007-11#1)(2007-8#1)
This is not a##2##4##(2008-12#1)(2008-7#1)
This is not the case when##2##6##(1991-6#1)(2008-2#1)
This is not the case##3##5##(1991-6#1)(2008-10#1)(2008-2#1)
This is not##9##3##(1991-6#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2012-2#1)
This is notably##2##3##(1997-4#1)(2008-8#1)
This is of importance##2##4##(2008-11#1)(2008-5#1)
This is of particular concern##2##5##(1991-3#1)(2008-3#1)
This is of particular##3##4##(1991-3#1)(2008-11#1)(2008-3#1)
This is of##8##3##(1991-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
This is only the second##2##5##(2008-10#1)(2012-3#1)
This is only the third##2##5##(2011-2#2)
This is only the##4##4##(2008-10#1)(2011-2#2)(2012-3#1)
This is part of##2##4##(1995-6#1)(2008-3#1)
This is particularly important in##2##5##(1992-5#1)(1996-8#1)
This is particularly important##4##4##(1992-5#1)(1996-3#1)(1996-8#1)(2008-9#1)
This is particularly the case for##2##6##(2008-11#1)(2012-2#1)
This is particularly the case##3##5##(1990-6#1)(2008-11#1)(2012-2#1)
This is particularly true in the##2##6##(1992-1#1)(2013-1#1)
This is particularly true in##3##5##(1992-1#1)(2012-3#1)(2013-1#1)
This is particularly true##5##4##(1992-1#1)(2008-10#2)(2012-3#1)(2013-1#1)
This is particularly##17##3##(1990-6#1)(1992-1#1)(1992-5#1)(1996-3#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#2)(2012-2#1)(2012-3#2)(2013-1#1)
This is partly due to##2##5##(2007-2#1)(2013-8#1)
This is partly##3##3##(2007-2#1)(2008-11#1)(2013-8#1)
This is primarily##2##3##(2008-10#1)(2012-12#1)
This is probably the##2##4##(2008-5#1)(2009-8#1)
This is probably##3##3##(1990-6#1)(2008-5#1)(2009-8#1)
This is reflected in##2##4##(2008-10#1)(2008-11#1)
This is revolatilized##2##3##(2008-10#2)
This is similar to the##2##5##(2008-7#1)(2011-1#1)
This is supported by the finding that##2##7##(2008-12#1)(2008-7#1)
This is supported by the##5##5##(1990-2#1)(1997-3#1)(2008-12#1)(2008-7#1)(2013-8#1)
This is supported by##6##4##(1990-2#1)(1997-3#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
This is the case of##2##5##(2008-2#1)(2012-3#1)
This is the case when##2##5##(2008-10#1)(2008-2#1)
This is the case##8##4##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2012-3#1)(2013-1#1)
This is the fifth##2##4##(1997-3#1)(2008-5#1)
This is the first case report of##2##7##(2008-6#1)(2009-2#1)
This is the first case##4##5##(2007-10#1)(2008-5#1)(2008-6#1)(2009-2#1)
This is the first complete genome sequence in the family##2##10##(2011-2#2)
This is the first complete genome sequence of a member of the family##5##13##(2011-2#5)
This is the first complete genome sequence of a member of the##6##12##(2011-2#6)
This is the first complete genome sequence of a##7##9##(2011-2#7)
This is the first complete genome sequence of##8##8##(2011-2#8)
This is the first complete genome sequence##10##7##(2011-2#10)
This is the first completed genome sequence for a##2##9##(2011-2#2)
This is the first completed genome sequence of a member of the genus##2##13##(2011-2#2)
This is the first completed genome sequence of a member of the##3##12##(2011-2#3)
This is the first completed genome sequence of a##4##9##(2011-2#4)
This is the first completed genome sequence of the family##4##10##(2011-2#4)
This is the first completed genome sequence of the genus##3##10##(2011-2#3)
This is the first completed genome sequence of the##7##9##(2011-2#7)
This is the first completed genome sequence of##11##8##(2011-2#11)
This is the first completed genome sequence##14##7##(2011-2#14)
This is the first completed sequence of##2##7##(2011-2#2)
This is the first completed##16##5##(2011-2#16)
This is the first demonstration of a##2##7##(1990-12#1)(2008-2#1)
This is the first demonstration of##4##6##(1990-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
This is the first demonstration##5##5##(1990-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
This is the first description of##2##6##(1997-5#1)(2009-7#1)
This is the first direct##2##5##(1996-12#1)(2011-1#1)
This is the first evidence##3##5##(1994-6#1)(2008-10#1)(2010-6#1)
This is the first example of a##2##7##(1991-2#1)(1996-3#1)
This is the first natural##2##5##(1990-5#1)(1993-3#1)
This is the first of a##2##6##(1994-12#1)(2008-9#1)
This is the first report demonstrating that##2##7##(2008-10#1)(2008-11#1)
This is the first report demonstrating##3##6##(2008-10#1)(2008-11#1)(2008-6#1)
This is the first report describing##2##6##(2008-10#1)(2008-11#1)
This is the first report of a##7##7##(1995-5#1)(1995-9#1)(2008-10#3)(2011-2#1)(2013-1#1)
This is the first report of the##6##7##(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
This is the first report of##39##6##(1990-7#1)(1991-4#1)(1992-10#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-7#1)(2007-8#2)(2008-10#13)(2008-11#3)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
This is the first report on a##2##7##(2007-1#1)(2011-2#1)
This is the first report on the determination of proteins##2##10##(2008-10#2)
This is the first report on the determination of##3##9##(2008-10#3)
This is the first report on the##7##7##(2008-10#6)(2008-9#1)
This is the first report on##13##6##(2007-1#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#2)
This is the first report showing that##3##7##(1995-6#1)(2009-12#1)(2012-12#1)
This is the first report showing##4##6##(1992-8#1)(1995-6#1)(2009-12#1)(2012-12#1)
This is the first report that##9##6##(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
This is the first report to##2##6##(1990-5#1)(2012-2#1)
This is the first report##76##5##(1990-5#1)(1990-7#1)(1991-4#1)(1992-10#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-6#2)(1995-5#1)(1995-6#2)(1995-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#24)(2008-11#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
This is the first reported case of a##2##8##(2008-7#2)
This is the first reported case of##7##7##(2008-7#4)(2010-7#1)(2011-2#1)(2012-3#1)
This is the first reported##9##5##(2008-10#1)(2008-7#4)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
This is the first study in##2##6##(2008-10#1)(2011-2#1)
This is the first study to##4##6##(2008-10#2)(2008-12#1)(2008-8#1)
This is the first study##8##5##(1995-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2011-2#1)
This is the first time that##7##6##(1991-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
This is the first time to##2##6##(2008-2#1)(2008-9#1)
This is the first time##16##5##(1991-11#1)(1991-3#1)(1995-6#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#1)
This is the first##184##4##(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-6#3)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#3)(1997-5#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#2)(2008-10#39)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#6)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#35)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#5)
This is the largest##3##4##(1997-5#1)(2009-10#1)(2011-1#1)
This is the only way##2##5##(1991-11#1)(1994-9#1)
This is the report of##2##5##(2008-10#1)(2012-2#1)
This is the same##2##4##(1995-8#1)(2008-10#1)
This is the second complete genome sequence of the##2##9##(2011-2#2)
This is the second completed genome sequence of a member of the##3##12##(2011-2#3)
This is the second completed genome sequence of a member##4##10##(2011-2#4)
This is the second in a##2##6##(1995-1#1)(1996-12#1)
This is the second part of a two-part article examining the##2##11##(1992-12#1)(1993-2#1)
This is the second##18##4##(1992-12#1)(1993-2#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#6)
This is the third##2##4##(2008-5#1)(2013-1#1)
This is the##236##3##(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#2)(1996-12#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-7#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#3)(2008-10#43)(2008-11#12)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2011-1#4)(2011-2#41)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#7)
This is to our knowledge the##3##6##(2007-11#2)(2007-12#1)
This is to##4##3##(2007-11#3)(2007-12#1)
This is useful##2##3##(2008-10#1)(2008-2#1)
This is why##2##3##(1991-2#1)(2008-4#1)
This is##707##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#5)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#5)(1995-5#4)(1995-6#5)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#9)(2007-2#2)(2007-7#6)(2007-8#7)(2008-1#10)(2008-10#89)(2008-11#35)(2008-12#9)(2008-2#21)(2008-3#27)(2008-4#11)(2008-5#19)(2008-6#8)(2008-7#38)(2008-8#14)(2008-9#19)(2009-1#3)(2009-10#3)(2009-12#4)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2011-1#7)(2011-2#55)(2011-8#1)(2012-1#1)(2012-12#9)(2012-2#25)(2012-3#15)(2013-1#21)(2013-7#2)(2013-8#5)
This isolation##2##2##(2008-4#2)
This issue is##3##3##(1992-1#1)(2009-5#1)(2013-8#1)
This issue of Applied Optics features 16 papers##3##8##(2008-2#1)(2008-3#2)
This issue of Applied Optics features##5##6##(2008-2#1)(2008-3#4)
This issue of##6##3##(1996-2#1)(2008-2#1)(2008-3#4)
This issue##12##2##(1992-1#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2009-5#1)(2013-8#1)
This key##2##2##(1996-12#1)(2008-2#1)
This kind of##8##3##(1990-9#1)(1991-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
This kinetic##2##2##(1991-6#1)(1994-5#1)
This knowledge can be used to##2##6##(2008-2#1)(2008-5#1)
This knowledge##5##2##(1991-5#1)(1993-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
This lack of##8##3##(1993-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2008-11#2)(2008-5#1)(2009-8#1)
This lag##2##2##(2008-5#2)
This large group of##2##4##(2011-1#1)(2012-2#1)
This large##5##2##(1995-12#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-2#1)
This laser is mode locked##2##5##(2007-11#1)(2007-12#1)
This laser is##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
This laser##12##2##(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#2)
This last##4##2##(1992-4#1)(1993-6#1)(2011-2#1)(2012-3#1)
This latter effect was##2##4##(1991-9#1)(1995-2#1)
This latter##10##2##(1991-3#1)(1991-9#1)(1992-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-8#1)
This leads not only to##2##5##(2008-2#1)(2008-7#1)
This leads to a reduction##2##5##(1995-5#1)(2008-7#1)
This leads to a##7##4##(1990-8#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
This leads to exceptionally high-affinity binding to complementary sequences##2##9##(2008-4#2)
This leads to the conclusion that##2##6##(2008-9#2)
This leads to the##6##4##(2008-10#1)(2008-9#2)(2009-2#1)(2009-5#1)(2011-1#1)
This leads to##20##3##(1990-8#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#4)(2008-9#3)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#1)
This leads us to##4##4##(1994-8#1)(2008-3#1)(2008-5#1)(2008-8#1)
This leads##27##2##(1990-8#1)(1994-8#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#1)
This learning##2##2##(1993-12#1)(2008-11#1)
This led to a##2##4##(2009-11#1)(2012-2#1)
This led to the##3##4##(1992-6#2)(1997-8#1)
This led to##10##3##(1992-6#2)(1997-8#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
This led##12##2##(1992-6#2)(1993-3#1)(1997-8#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
This legislation##2##2##(1991-12#1)(1996-1#1)
This lends##2##2##(1993-9#1)(1995-11#1)
This lens##2##2##(2007-11#1)(2008-3#1)
This lesion##2##2##(1990-12#1)(1997-7#1)
This letter##2##2##(2007-10#1)(2008-10#1)
This level of##6##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)
This light##3##2##(1992-8#1)(2008-10#1)(2008-9#1)
This limitation##3##2##(2007-8#1)(2008-3#1)(2009-5#1)
This limited##2##2##(1996-12#1)(2008-10#1)
This limits the##2##3##(2007-12#1)(2012-2#1)
This line##3##2##(1991-6#1)(2008-10#2)
This linear##2##2##(1990-7#1)(2008-10#1)
This literature review explores##2##4##(2008-11#1)(2009-5#1)
This literature review highlights##2##4##(1995-8#1)(2011-2#1)
This literature review##8##3##(1995-8#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
This literature##9##2##(1993-3#1)(1995-8#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
This locus##2##2##(2008-10#2)
This longitudinal study##2##3##(2007-2#1)(2013-1#1)
This longitudinal##3##2##(2007-2#2)(2013-1#1)
This loss is##2##3##(2007-12#2)
This loss of##2##3##(1997-1#1)(2013-1#1)
This loss##4##2##(1997-1#1)(2007-12#2)(2013-1#1)
This lottery provides an opportunity to gauge the effects of expanding access to public health insurance on the health care use##2##21##(2013-1#2)
This low##5##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-12#1)
This low-cost##2##2##(2008-10#1)(2012-2#1)
This lower##2##2##(2008-3#1)(2010-5#1)
This mAb##2##2##(2008-11#1)(2009-8#1)
This makes it possible to##6##5##(1994-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)
This makes it##8##3##(1994-6#1)(1996-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2013-8#1)
This makes the##4##3##(2007-12#1)(2008-12#1)(2008-2#1)(2009-12#1)
This makes##18##2##(1994-6#1)(1996-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-12#1)(2012-12#1)(2013-8#1)
This manner of##2##3##(2008-10#1)(2008-5#1)
This manuscript aims to##2##4##(2010-8#1)(2011-1#1)
This manuscript reports##2##3##(2007-11#1)(2012-3#1)
This manuscript##13##2##(2007-11#1)(2008-10#3)(2008-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
This map##2##2##(1996-3#1)(2008-11#1)
This marker##3##2##(1991-4#1)(2008-10#2)
This marriage##2##2##(1994-6#1)(2008-10#1)
This mass##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
This material was##2##3##(2008-10#2)
This material##9##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#2)
This mathematical model##2##3##(2007-10#1)(2011-3#1)
This may account for##2##4##(2008-11#1)(2008-8#1)
This may also##2##3##(1997-4#1)(2012-12#1)
This may be attributed to##2##5##(2008-10#1)(2008-11#1)
This may be because##3##4##(1990-11#1)(2008-10#1)(2008-11#1)
This may be due to##4##5##(2008-1#1)(2008-10#2)(2008-3#1)
This may be due##7##4##(1992-9#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2013-7#1)
This may be especially##2##4##(2008-10#1)(2008-12#1)
This may be explained by##3##5##(1997-7#1)(2008-3#1)(2012-2#1)
This may be of##2##4##(2007-2#2)
This may be##30##3##(1990-11#1)(1992-9#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-11#2)(2007-2#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
This may explain the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
This may explain##6##3##(1990-11#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-8#2)
This may have been because##2##5##(2008-5#1)(2012-12#1)
This may have##8##3##(1992-8#1)(1994-12#1)(2007-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
This may indicate that##2##4##(2008-10#2)
This may indicate##3##3##(1996-2#1)(2008-10#2)
This may lead to##2##4##(1996-8#1)(2008-8#1)
This may reflect##2##3##(2008-7#1)(2008-8#1)
This may represent a##2##4##(1992-6#1)(2007-10#1)
This may result in##3##4##(2008-11#1)(2008-7#1)(2012-3#1)
This may result##4##3##(2008-11#1)(2008-7#2)(2012-3#1)
This may suggest##2##3##(1996-12#1)(2013-1#1)
This may##88##2##(1990-11#2)(1990-6#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#2)(2007-2#2)(2008-1#5)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#6)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
This means that a##2##4##(1994-3#1)(2009-7#1)
This means that the##8##4##(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)
This means that##22##3##(1990-6#1)(1991-6#1)(1992-5#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
This means##25##2##(1990-6#1)(1991-6#1)(1992-5#1)(1992-8#1)(1994-3#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
This measure##4##2##(1996-4#1)(2008-10#1)(2008-3#1)(2008-9#1)
This measurement is##2##3##(2007-12#1)(2008-3#1)
This measurement##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
This mechanism has been##2##4##(1996-3#1)(2008-4#1)
This mechanism is##4##3##(1990-11#1)(1995-3#1)(2008-11#1)(2010-11#1)
This mechanism##12##2##(1990-11#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-2#1)
This meeting was##2##3##(2008-5#2)
This meeting##5##2##(2008-5#5)
This membrane##2##2##(1990-12#1)(2008-10#1)
This meta-analysis##3##2##(2007-12#1)(2009-9#1)(2011-2#1)
This metabolite##2##2##(1991-8#1)(1994-11#1)
This method allows one to##2##5##(2008-10#1)(2008-2#1)
This method allows##9##3##(2008-10#3)(2008-2#2)(2008-3#2)(2011-2#1)(2012-3#1)
This method also##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
This method can also##2##4##(2008-3#1)(2011-2#1)
This method can be applied to the determination of##2##9##(2008-10#2)
This method can be applied to the determination##3##8##(2008-10#3)
This method can be applied to##6##6##(2007-12#2)(2008-10#4)
This method can be applied##7##5##(2007-12#2)(2008-10#4)(2013-8#1)
This method can be used to##4##6##(2008-10#1)(2008-3#2)(2011-2#1)
This method can be used##8##5##(1994-12#1)(2008-10#3)(2008-3#3)(2011-2#1)
This method can be##19##4##(1994-12#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
This method can##26##3##(1990-3#1)(1994-12#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
This method could be used to determine##4##7##(2008-10#4)
This method could be##8##4##(2008-10#6)(2010-12#1)(2013-1#1)
This method could##10##3##(1991-5#1)(2008-10#7)(2010-12#1)(2013-1#1)
This method does not require##3##5##(1992-3#1)(2008-10#1)(2008-3#1)
This method does not##4##4##(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
This method employs##2##3##(2008-10#2)
This method gives##2##3##(1990-12#1)(2008-2#1)
This method has been applied to the determination of trace mercury in##2##12##(2008-10#2)
This method has been applied to the determination of##4##9##(2008-10#4)
This method has been applied to the##7##7##(2008-10#5)(2009-5#1)(2010-7#1)
This method has been applied to##8##6##(2008-10#6)(2009-5#1)(2010-7#1)
This method has been applied##10##5##(2008-10#8)(2009-5#1)(2010-7#1)
This method has been employed to##2##6##(1995-5#1)(2008-10#1)
This method has been successfully applied to the determination of##2##10##(2008-10#2)
This method has been successfully applied to the##3##8##(2008-10#3)
This method has been successfully applied to##5##7##(2008-10#5)
This method has been successfully used to determine##2##8##(2008-10#2)
This method has been successfully##7##5##(2008-10#7)
This method has been used to determine##3##7##(2008-10#3)
This method has been used##4##5##(2008-10#4)
This method has been##27##4##(1991-6#1)(1993-3#1)(1995-5#1)(2008-10#22)(2009-5#1)(2010-7#1)
This method has the##2##4##(1990-8#1)(2008-10#1)
This method has##37##3##(1990-8#1)(1991-6#1)(1993-3#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#29)(2009-5#1)(2010-7#1)
This method involves a##2##4##(2008-10#2)
This method involves##4##3##(2008-10#3)(2008-4#1)
This method is a##5##4##(1991-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
This method is also##2##4##(2008-10#1)(2010-8#1)
This method is applicable##2##4##(1996-12#1)(2008-11#1)
This method is based on a##2##6##(2007-11#1)(2008-10#1)
This method is based on the difference between the##2##9##(2008-10#2)
This method is based on the difference##3##7##(2008-10#3)
This method is based on the fact that##2##8##(2008-10#2)
This method is based on the##26##6##(1995-6#1)(2007-12#1)(2008-10#20)(2008-11#1)(2008-3#2)(2011-2#1)
This method is based on##38##5##(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#4)(2011-2#1)(2012-3#1)
This method is demonstrated##2##4##(2008-2#1)(2008-7#1)
This method is rapid##3##4##(2008-10#1)(2011-1#2)
This method is simple##4##4##(2008-10#2)(2008-3#1)(2011-1#1)
This method is successfully applied to the##2##7##(2008-10#1)(2008-5#1)
This method is successfully applied to##4##6##(2008-10#2)(2008-3#1)(2008-5#1)
This method is suitable for##2##5##(1991-2#1)(2008-4#1)
This method is suitable##3##4##(1991-2#1)(2007-7#1)(2008-4#1)
This method is very sensitive##2##5##(2008-10#2)
This method is very##4##4##(2008-10#4)
This method is##88##3##(1991-12#1)(1991-2#1)(1992-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#43)(2008-11#3)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#2)(2008-7#2)(2009-12#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)
This method may##2##3##(2008-10#1)(2008-11#1)
This method minimizes##2##3##(2007-11#1)(2008-3#1)
This method of##7##3##(1991-9#1)(1994-9#1)(1995-6#1)(2008-10#2)(2008-7#1)(2009-3#1)
This method permits##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
This method produces##2##3##(2007-11#1)(2008-7#1)
This method provides a new##3##5##(2008-3#1)(2008-8#1)(2013-8#1)
This method provides a##7##4##(1995-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2013-8#1)
This method provides##12##3##(1995-1#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2013-8#1)
This method relies on##2##4##(2008-2#1)(2008-3#1)
This method requires a##2##4##(2008-10#1)(2008-3#1)
This method requires##3##3##(2008-10#1)(2008-3#2)
This method should be##2##4##(2007-11#1)(2012-3#1)
This method should##3##3##(2007-11#1)(2008-6#1)(2012-3#1)
This method takes##2##3##(2008-10#2)
This method uses the##2##4##(2008-11#1)(2008-3#1)
This method uses##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
This method utilizes##2##3##(2008-4#1)(2008-9#1)
This method was applied for the determination of##2##8##(2008-10#2)
This method was applied for the##4##6##(2008-10#4)
This method was applied for##5##5##(2008-10#5)
This method was applied to the determination of##5##8##(2008-10#5)
This method was applied to the##9##6##(2008-10#9)
This method was applied to##14##5##(2008-10#13)(2008-3#1)
This method was applied##19##4##(2008-10#18)(2008-3#1)
This method was based on##2##5##(2008-10#1)(2008-7#1)
This method was compared with##2##5##(2008-10#2)
This method was compared##3##4##(2007-10#1)(2008-10#2)
This method was simple##2##4##(2013-8#2)
This method was successfully applied to the determination of trace amounts of##2##12##(2008-10#2)
This method was successfully applied to the determination of##4##9##(2008-10#4)
This method was successfully applied to the##5##7##(2008-10#5)
This method was successfully applied##7##5##(2008-10#7)
This method was used for##2##5##(1996-1#1)(2008-10#1)
This method was used to##5##5##(2008-10#3)(2008-11#1)(2008-3#1)
This method was used##7##4##(1996-1#1)(2008-10#4)(2008-11#1)(2008-3#1)
This method was##59##3##(1990-12#1)(1996-1#1)(2007-10#1)(2008-10#43)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-3#1)(2013-1#1)(2013-8#2)
This method##335##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#167)(2008-11#10)(2008-2#11)(2008-3#38)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#4)
This methodology has##2##3##(2008-10#1)(2008-2#1)
This methodology is##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
This methodology was##2##3##(2008-10#1)(2012-2#1)
This methodology##16##2##(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
This microassay##2##2##(1990-12#1)(1996-12#1)
This microscope##2##2##(2008-10#1)(2008-3#1)
This might also be##2##4##(1994-8#1)(2011-2#1)
This might be due to##3##5##(1993-1#1)(1997-1#1)(2010-3#1)
This might be one##2##4##(1994-9#1)(2011-1#1)
This might be##11##3##(1992-2#1)(1993-1#1)(1994-9#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#1)
This might##18##2##(1992-2#1)(1993-1#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-7#2)(2008-9#2)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
This mini-review##4##2##(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)
This mode of##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
This mode##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
This model allows##2##3##(2008-8#1)(2010-7#1)
This model assumes that##2##4##(2008-3#1)(2008-8#1)
This model can be##2##4##(2008-10#1)(2008-3#1)
This model can##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
This model has been##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
This model has##5##3##(1991-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
This model is a##2##4##(2010-8#1)(2011-1#1)
This model is applied to##2##5##(2008-3#1)(2013-8#1)
This model is used to##2##5##(1990-7#1)(2008-3#1)
This model is##18##3##(1990-7#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-8#1)(2011-1#2)(2013-8#2)
This model of##4##3##(1995-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
This model provides##3##3##(1997-3#1)(2008-3#2)
This model should be##2##4##(1995-6#1)(2008-5#1)
This model should##3##3##(1995-6#1)(2008-5#1)(2008-8#1)
This model suggests##2##3##(1990-8#1)(1995-1#1)
This model takes into account the##2##6##(2008-10#1)(2008-2#1)
This model was##7##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)
This model##68##2##(1990-7#1)(1990-8#1)(1991-11#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-5#1)(2009-7#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#3)
This modification is##2##3##(1990-8#1)(2008-2#1)
This modification##6##2##(1990-8#1)(1991-2#1)(1996-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
This modified electrode showed##2##4##(2008-10#2)
This modified electrode##4##3##(2008-10#4)
This modified##9##2##(2008-10#6)(2008-3#1)(2008-4#1)(2012-2#1)
This module##2##2##(2008-3#1)(2012-1#1)
This molecule is##2##3##(1994-12#1)(2008-5#1)
This molecule##5##2##(1993-9#1)(1994-12#1)(1995-2#1)(2008-5#2)
This month in wjm##2##4##(2008-8#2)
This morphological change##2##3##(1994-8#1)(2008-11#1)
This morphological##4##2##(1994-8#1)(2008-11#2)(2008-7#1)
This movement##2##2##(1994-3#1)(2007-12#1)
This multipartite genome##2##3##(2011-2#2)
This multiplex RT-PCR##2##3##(2008-10#2)
This must be##3##3##(1990-5#1)(1993-12#1)(1997-8#1)
This mutant enzyme##2##3##(1990-8#1)(1994-5#1)
This mutant##6##2##(1990-8#1)(1993-11#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
This mutation##3##2##(1991-5#1)(1994-12#1)(2008-8#1)
This narrative##2##2##(2012-3#2)
This national##2##2##(1996-9#1)(2007-12#1)
This necessitated##2##2##(1995-9#1)(2008-10#1)
This need##2##2##(1994-2#1)(2008-9#1)
This needs##2##2##(1995-12#1)(2007-10#1)
This new algorithm##2##3##(2007-12#1)(2008-3#1)
This new approach may be##2##5##(2008-7#1)(2010-5#1)
This new approach##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)
This new code##2##3##(2008-3#2)
This new information##2##3##(2007-7#1)(2012-12#1)
This new method##6##3##(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#2)
This new procedure##2##3##(2008-10#1)(2008-5#1)
This new technique##6##3##(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
This new##64##2##(1990-7#2)(1991-11#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#3)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-12#1)
This newly developed##2##3##(2008-10#2)
This newly##7##2##(1994-5#1)(2007-8#1)(2008-10#4)(2011-2#1)
This news brief discusses the##2##5##(1997-6#2)
This news brief##4##3##(1997-6#4)
This noise##2##2##(2008-2#1)(2008-3#1)
This non-randomized##2##2##(2007-8#1)(2013-1#1)
This nonlinear##2##2##(2007-12#1)(2008-3#1)
This normative data##2##3##(2008-12#1)(2011-1#1)
This not only##2##3##(2008-10#1)(2010-5#1)
This novel approach##2##3##(2008-10#1)(2008-7#1)
This novel gene delivery system##2##5##(2008-8#1)(2008-9#1)
This novel method##3##3##(2007-11#1)(2009-11#1)(2010-7#1)
This novel technique##2##3##(2011-1#1)(2012-3#1)
This novel##26##2##(1991-9#1)(1992-11#1)(1994-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2010-7#3)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
This nucleotide##2##2##(1990-12#2)
This numerical##2##2##(2007-11#1)(2008-2#1)
This observation indicates that##4##4##(1992-8#1)(1993-11#1)(2008-7#1)(2013-1#1)
This observation is consistent with##2##5##(1991-2#1)(1991-8#1)
This observation is##5##3##(1991-2#1)(1991-8#1)(1995-11#1)(1997-3#1)(2007-11#1)
This observation suggests that##6##4##(1991-8#1)(1994-11#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-8#1)
This observation##27##2##(1991-2#1)(1991-8#2)(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-11#2)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2013-1#1)
This occurred##2##2##(1994-11#1)(2013-1#1)
This one-step##2##2##(2008-3#1)(2012-2#1)
This ongoing column is dedicated to the challenging clinical interface between psychiatry and primary care-two fields that are inexorably linked##2##20##(2009-9#2)
This opens the way##2##4##(2009-8#1)(2010-7#1)
This optical##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
This order##2##2##(2008-10#1)(2008-11#1)
This overall##2##2##(2008-11#1)(2008-9#1)
This overview describes the##4##4##(2008-1#1)(2008-11#1)(2008-4#2)
This overview discusses articles published in this issue of the Health Care Financing Review##3##14##(1994-12#1)(1996-3#1)(1997-3#1)
This overview discusses the##5##4##(1996-12#1)(1997-2#1)(2008-2#1)(2008-4#2)
This overview discusses##9##3##(1994-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-2#1)(2008-4#3)
This overview presents##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
This overview provides a##2##4##(2008-1#1)(2012-12#1)
This overview provides##3##3##(2008-1#1)(2008-4#1)(2012-12#1)
This overview summarizes##3##3##(1996-1#1)(2008-4#1)(2009-8#1)
This overview unit discusses##2##4##(2008-4#2)
This overview unit##5##3##(2008-2#1)(2008-4#4)
This overview##36##2##(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#15)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
This paper addresses a number of##2##6##(2008-4#1)(2008-7#1)
This paper addresses the##6##4##(2008-11#1)(2008-12#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-2#1)
This paper addresses##13##3##(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-12#1)(2012-2#1)
This paper aims to describe the##2##6##(2008-11#1)(2008-7#1)
This paper aims to##8##4##(1996-3#1)(2008-11#2)(2008-12#2)(2008-7#1)(2011-1#1)(2012-2#1)
This paper also##7##3##(2008-10#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-9#1)(2012-12#2)
This paper analyses the##5##4##(1991-6#1)(2008-12#2)(2008-9#1)(2010-4#1)
This paper analyzes the##3##4##(2012-2#1)(2013-1#2)
This paper analyzes##5##3##(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#2)
This paper argues that##4##4##(2008-11#1)(2010-1#1)(2010-10#1)(2011-2#1)
This paper argues##6##3##(1996-8#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-10#1)(2011-2#1)
This paper attempts to##8##4##(1990-3#1)(1992-3#1)(1993-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)
This paper briefly##3##3##(1997-2#1)(2007-12#1)(2008-5#1)
This paper compares the results of##2##6##(2008-10#1)(2012-2#1)
This paper compares the##6##4##(1991-12#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2012-2#1)
This paper compares these two##2##5##(2008-7#1)(2008-8#1)
This paper compares##11##3##(1991-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
This paper concerns##2##3##(1990-6#1)(1997-3#1)
This paper concludes##2##3##(2008-11#1)(2010-8#1)
This paper considers a##2##4##(1995-9#1)(2008-7#1)
This paper considers the##5##4##(1992-1#1)(1997-3#1)(2008-12#1)(2008-7#1)(2009-6#1)
This paper considers##13##3##(1992-1#1)(1995-9#1)(1997-3#1)(2008-12#2)(2008-7#3)(2009-6#1)(2010-2#1)(2011-1#1)(2013-1#2)
This paper contains##2##3##(1995-6#1)(2008-11#1)
This paper contributes to the##2##5##(1993-1#1)(2008-11#1)
This paper covers##2##3##(2008-10#1)(2008-8#1)
This paper deals with##3##4##(2008-10#2)(2012-3#1)
This paper demonstrates the##3##4##(1997-2#1)(2008-10#1)(2011-1#1)
This paper demonstrates##6##3##(1997-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-1#1)
This paper describes a case##2##5##(2007-7#1)(2008-11#1)
This paper describes a liquid##2##5##(2008-10#2)
This paper describes a new##4##5##(2008-10#2)(2008-5#1)(2008-6#1)
This paper describes a newly developed##3##6##(2008-10#3)
This paper describes a novel##3##5##(1990-11#1)(2008-11#1)(2009-7#1)
This paper describes a simple and##2##6##(2008-10#2)
This paper describes a##46##4##(1990-11#1)(1990-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-7#1)(1997-2#2)(1997-3#1)(2007-7#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
This paper describes an analytical method for##2##7##(2008-10#2)
This paper describes an analytical##3##5##(2008-10#3)
This paper describes an##10##4##(1993-12#1)(2007-10#1)(2008-10#3)(2008-11#3)(2008-12#1)(2013-1#1)
This paper describes how the##3##5##(1991-2#1)(1997-2#1)(2010-3#1)
This paper describes how##6##4##(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#2)(2010-3#1)
This paper describes one##2##4##(1996-2#1)(2008-12#1)
This paper describes our##2##4##(2007-5#1)(2010-8#1)
This paper describes the construction##2##5##(2008-10#2)
This paper describes the design##4##5##(2008-10#4)
This paper describes the development and##2##6##(2008-10#2)
This paper describes the development of a##3##7##(2008-10#1)(2008-11#1)(2010-8#1)
This paper describes the development of##4##6##(2008-10#2)(2008-11#1)(2010-8#1)
This paper describes the development##6##5##(2008-10#4)(2008-11#1)(2010-8#1)
This paper describes the process##3##5##(1994-3#1)(2008-11#2)
This paper describes the use of##5##6##(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
This paper describes the##66##4##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#2)(1995-12#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#23)(2008-11#8)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
This paper describes##156##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(1997-3#2)(1997-4#1)(2007-10#1)(2007-5#2)(2007-7#2)(2008-10#48)(2008-11#19)(2008-12#9)(2008-3#1)(2008-5#6)(2008-6#5)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#3)(2011-2#2)(2012-1#1)(2013-1#6)
This paper develops a##2##4##(2007-12#1)(2012-3#1)
This paper develops##3##3##(2007-12#1)(2008-6#1)(2012-3#1)
This paper discusses a##2##4##(2008-12#1)(2008-7#1)
This paper discusses how##3##4##(1992-12#1)(2008-11#1)(2008-12#1)
This paper discusses the application of##2##6##(1995-9#1)(2008-11#1)
This paper discusses the development of##2##6##(1991-3#1)(2009-7#1)
This paper discusses the issues##2##5##(2008-8#1)(2012-3#1)
This paper discusses the value of##2##6##(2008-11#2)
This paper discusses the##26##4##(1991-3#1)(1993-3#1)(1995-9#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
This paper discusses these##2##4##(2008-1#1)(2008-10#1)
This paper discusses##41##3##(1991-3#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-9#1)(1996-1#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
This paper documents the##3##4##(1994-2#1)(2007-5#1)(2008-11#1)
This paper draws on##2##4##(2008-1#1)(2008-12#1)
This paper emphasizes the##2##4##(1992-1#1)(2008-10#1)
This paper evaluates the##3##4##(1995-2#1)(2008-10#1)(2012-12#1)
This paper examines the##11##4##(1991-6#1)(1992-1#1)(1992-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)
This paper examines##27##3##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
This paper explores some of the##3##6##(2008-1#1)(2008-7#2)
This paper explores the use of##2##6##(1992-9#1)(2008-10#1)
This paper explores the##14##4##(1992-2#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)
This paper explores##22##3##(1992-2#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#3)(2010-10#1)(2011-1#1)(2013-8#1)
This paper focuses on the effect of##2##7##(1995-9#1)(2008-10#1)
This paper focuses on the##14##5##(1992-1#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
This paper focuses on##21##4##(1992-1#1)(1995-9#1)(1997-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
This paper focuses##22##3##(1992-1#1)(1995-9#1)(1997-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
This paper follows##4##3##(1991-3#1)(2007-10#1)(2007-12#1)(2009-6#1)
This paper gives a##2##4##(2008-10#1)(2009-10#1)
This paper gives an overview##2##5##(2008-10#1)(2013-1#1)
This paper gives##5##3##(2008-10#2)(2008-6#1)(2009-10#1)(2013-1#1)
This paper has##4##3##(1991-1#1)(1995-11#1)(1995-5#1)(2008-2#1)
This paper highlights some of the##2##6##(2008-7#1)(2009-6#1)
This paper highlights some##3##4##(2008-7#1)(2009-6#1)(2012-12#1)
This paper highlights the##2##4##(2008-10#1)(2009-3#1)
This paper highlights##9##3##(2007-7#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
This paper illustrates a method to##2##6##(1990-7#1)(2009-10#1)
This paper illustrates##3##3##(1990-7#1)(1994-3#1)(2009-10#1)
This paper intends to encourage debate##2##6##(2008-11#1)(2008-12#1)
This paper introduces a##7##4##(1990-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2010-8#1)
This paper introduces##12##3##(1990-8#1)(1995-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-8#1)(2012-12#1)
This paper investigates the##6##4##(1992-2#1)(1997-1#1)(2008-10#1)(2008-7#2)(2010-8#1)
This paper investigates##10##3##(1992-2#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-7#2)(2010-8#1)(2012-1#1)(2012-12#1)
This paper is a review of the##2##7##(2008-11#1)(2011-2#1)
This paper is a##5##4##(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
This paper is an##3##4##(1992-2#1)(1994-2#1)(2008-12#1)
This paper is based on the##2##6##(2008-12#1)(2008-9#1)
This paper is based on##5##5##(1997-6#1)(2007-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
This paper is intended to##3##5##(2010-8#1)(2013-1#2)
This paper is##24##3##(1992-2#1)(1994-2#1)(1997-6#1)(2007-10#1)(2007-5#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
This paper looks at##2##4##(2008-5#1)(2008-7#1)
This paper offers an##2##4##(2008-10#1)(2010-12#1)
This paper offers##4##3##(2007-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
This paper outlines a##3##4##(2008-11#1)(2008-3#1)(2009-12#1)
This paper outlines how##2##4##(2008-11#1)(2010-9#1)
This paper outlines the development and evaluation of a##2##9##(2008-12#2)
This paper outlines the##7##4##(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)
This paper outlines##16##3##(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-8#1)(2010-9#1)
This paper presents a case of##2##6##(2010-12#1)(2011-2#1)
This paper presents a case##3##5##(2010-12#1)(2011-2#1)(2012-2#1)
This paper presents a method for##2##6##(2008-10#1)(2008-6#1)
This paper presents a method whereby trace elements##2##8##(2008-10#2)
This paper presents a method##4##5##(2008-10#3)(2008-6#1)
This paper presents a methodology##2##5##(1992-3#1)(2008-10#1)
This paper presents a new##2##5##(2008-6#1)(2009-10#1)
This paper presents a short overview of##2##7##(2012-2#2)
This paper presents a simple##4##5##(1997-3#1)(2008-10#2)(2009-8#1)
This paper presents a summary of the##2##7##(2009-10#1)(2013-1#1)
This paper presents a##46##4##(1992-3#1)(1995-12#1)(1997-3#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-6#6)(2008-7#1)(2009-10#3)(2009-8#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
This paper presents an analysis of##2##6##(2007-8#1)(2008-11#1)
This paper presents an evaluation of the##2##7##(2008-10#1)(2010-5#1)
This paper presents an evaluation of##3##6##(1992-12#1)(2008-10#1)(2010-5#1)
This paper presents an overview of##2##6##(1997-4#1)(2007-5#1)
This paper presents an##11##4##(1992-12#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-5#1)
This paper presents and##2##4##(1991-9#1)(2009-3#1)
This paper presents data##2##4##(1997-2#1)(2008-10#1)
This paper presents results##2##4##(1992-5#1)(1997-3#1)
This paper presents the case of##2##6##(1992-1#1)(2012-3#1)
This paper presents the results of a##4##7##(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
This paper presents the results of##6##6##(2007-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)
This paper presents the results##7##5##(2007-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-8#1)(2011-2#1)
This paper presents the use of##3##6##(2007-12#1)(2010-8#2)
This paper presents the##25##4##(1991-6#1)(1992-1#1)(1992-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2009-10#3)(2010-10#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
This paper presents two##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
This paper presents##104##3##(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#7)(2008-7#3)(2008-8#1)(2009-10#6)(2009-11#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-5#1)(2010-8#5)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
This paper proposes a new##2##5##(2008-10#1)(2011-3#1)
This paper proposes a##9##4##(1994-9#1)(2008-10#2)(2008-11#2)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#1)
This paper proposes an optimization##2##5##(2011-1#1)(2012-1#1)
This paper proposes an##4##4##(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
This paper proposes##14##3##(1994-9#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#3)(2013-1#1)
This paper provides a brief description of the##2##8##(2008-11#1)(2008-7#1)
This paper provides a brief introduction##2##6##(2008-9#1)(2013-1#1)
This paper provides a brief overview##2##6##(2008-11#1)(2008-12#1)
This paper provides a brief##8##5##(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
This paper provides a##12##4##(1996-9#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2008-9#1)(2013-1#1)
This paper provides an introduction to##2##6##(2008-10#1)(2008-7#1)
This paper provides an overview of the##3##7##(2008-10#1)(2011-1#1)(2013-1#1)
This paper provides an overview of##5##6##(1992-1#1)(2008-10#2)(2011-1#1)(2013-1#1)
This paper provides an##8##4##(1992-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
This paper provides##23##3##(1992-1#1)(1996-9#1)(1997-3#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#2)
This paper reports a case##2##5##(2008-12#1)(2012-1#1)
This paper reports a study##2##5##(2008-11#1)(2011-1#1)
This paper reports a##9##4##(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#2)(2012-1#1)
This paper reports an investigation##2##5##(2008-10#1)(2008-11#1)
This paper reports an##6##4##(1992-9#1)(1994-1#1)(2008-10#2)(2008-11#1)(2012-3#1)
This paper reports data##2##4##(2009-8#1)(2011-2#1)
This paper reports findings from a##3##6##(1995-11#1)(2008-11#2)
This paper reports findings##4##4##(1995-11#1)(2008-11#2)(2008-4#1)
This paper reports on a##4##5##(2008-10#1)(2008-11#2)(2013-8#1)
This paper reports on an evaluation of the##2##8##(1994-1#1)(2008-10#1)
This paper reports on an evaluation of##3##7##(1994-1#1)(2008-10#1)(2008-12#1)
This paper reports on the use of a##2##8##(2008-10#1)(2008-12#1)
This paper reports on the use of##3##7##(2008-10#2)(2008-12#1)
This paper reports on the##14##5##(1992-5#1)(1994-3#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-7#1)(2012-3#1)
This paper reports on##26##4##(1992-5#1)(1994-1#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
This paper reports the development of a new##2##8##(2008-10#2)
This paper reports the development of##3##6##(1996-12#1)(2008-10#2)
This paper reports the findings##2##5##(2007-12#1)(2008-11#1)
This paper reports the results of a study##2##8##(1992-5#1)(2008-5#1)
This paper reports the results of a##4##7##(1992-5#1)(1994-12#1)(1996-1#1)(2008-5#1)
This paper reports the results of##6##6##(1992-5#1)(1994-12#1)(1996-1#1)(2008-5#1)(2008-6#1)(2013-1#1)
This paper reports the results##7##5##(1992-5#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
This paper reports the study of##2##6##(2008-10#1)(2008-5#1)
This paper reports the use of##4##6##(2008-10#3)(2013-1#1)
This paper reports the##36##4##(1990-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1994-12#1)(1996-1#1)(1996-12#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#3)(2010-10#1)(2011-2#1)(2013-1#4)
This paper reports##86##3##(1990-12#1)(1990-2#1)(1991-5#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#4)(2013-8#1)
This paper reviewed##2##3##(2008-11#1)(2010-11#1)
This paper reviews and##2##4##(1991-12#1)(1992-6#1)
This paper reviews current##2##4##(2008-4#1)(2013-8#1)
This paper reviews our current knowledge of the##2##8##(1997-7#1)(2008-7#1)
This paper reviews recent##5##4##(2008-10#3)(2008-7#1)(2008-9#1)
This paper reviews some of the##3##6##(1992-4#1)(2008-11#1)(2008-12#1)
This paper reviews some##4##4##(1992-4#1)(2008-10#1)(2008-11#1)(2008-12#1)
This paper reviews the available##2##5##(2007-2#1)(2011-2#1)
This paper reviews the current##2##5##(2011-1#1)(2013-1#1)
This paper reviews the literature on the##2##7##(2008-12#1)(2008-7#1)
This paper reviews the literature on##4##6##(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
This paper reviews the major##2##5##(1994-3#1)(2008-7#1)
This paper reviews the##29##4##(1993-3#2)(1994-3#1)(1994-6#1)(1996-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#4)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#3)
This paper reviews##63##3##(1990-6#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-3#2)(1994-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-5#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
This paper seeks to##2##4##(2008-12#1)(2008-7#1)
This paper sets out to##2##5##(2008-11#1)(2009-5#1)
This paper sheds##2##3##(2012-2#1)(2013-1#1)
This paper shows how##3##4##(1996-3#1)(2009-3#1)(2012-12#1)
This paper shows that##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
This paper shows the##4##4##(2008-10#3)(2012-1#1)
This paper shows##10##3##(1995-3#1)(1996-3#1)(2008-10#4)(2008-5#1)(2009-3#1)(2012-1#1)(2012-12#1)
This paper studies the##2##4##(2011-1#1)(2012-12#1)
This paper studies##3##3##(1996-3#1)(2011-1#1)(2012-12#1)
This paper suggests a##3##4##(1996-12#1)(1997-8#1)(2008-10#1)
This paper suggests that##2##4##(1991-2#1)(2008-11#1)
This paper suggests##6##3##(1991-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
This paper summarizes the##6##4##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)
This paper summarizes##12##3##(1991-12#1)(1992-1#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-11#1)(2010-11#1)(2012-3#1)(2013-8#1)
This paper tests the hypothesis that##3##6##(1990-6#1)(2008-7#1)(2008-8#1)
This paper traces##2##3##(2008-10#1)(2008-7#1)
This paper uses##3##3##(1991-3#1)(1994-9#1)(2009-7#1)
This paper will describe the##3##5##(1992-12#1)(1995-3#1)(2010-10#1)
This paper will describe##4##4##(1992-12#1)(1995-3#1)(1997-2#1)(2010-10#1)
This paper will discuss the##4##5##(2008-11#2)(2010-4#1)(2011-2#1)
This paper will discuss##6##4##(1992-3#1)(2008-11#2)(2008-6#1)(2010-4#1)(2011-2#1)
This paper will focus on##2##5##(2008-10#1)(2008-2#1)
This paper will review the current##2##6##(2008-5#1)(2010-12#1)
This paper will review the##5##5##(1992-3#1)(2008-5#2)(2010-12#1)(2011-2#1)
This paper will##29##3##(1991-12#1)(1992-12#1)(1992-3#3)(1994-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-9#1)
This paper##894##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#5)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#3)(1991-9#2)(1992-1#11)(1992-12#6)(1992-2#9)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#3)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#1)(1994-1#4)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#6)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#5)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#7)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#9)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-10#7)(2007-11#3)(2007-12#13)(2007-2#3)(2007-4#1)(2007-5#7)(2007-7#7)(2007-8#2)(2008-1#15)(2008-10#156)(2008-11#90)(2008-12#52)(2008-2#4)(2008-3#7)(2008-4#9)(2008-5#23)(2008-6#23)(2008-7#41)(2008-8#8)(2008-9#11)(2009-10#11)(2009-11#3)(2009-12#2)(2009-3#6)(2009-4#2)(2009-5#5)(2009-6#8)(2009-7#6)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#15)(2010-9#2)(2011-1#16)(2011-2#24)(2011-3#3)(2012-1#9)(2012-12#11)(2012-2#13)(2012-3#16)(2012-9#1)(2013-1#32)(2013-7#1)(2013-8#6)
This parameter is##2##3##(2008-10#1)(2008-3#1)
This parameter was##2##3##(1997-4#1)(2008-5#1)
This parameter##5##2##(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)
This part of##2##3##(1996-2#1)(2008-7#1)
This part##5##2##(1996-2#1)(2008-7#1)(2012-3#3)
This partial##2##2##(1992-11#1)(1995-11#1)
This pathogen##2##2##(2008-10#2)
This pathological##2##2##(1997-6#1)(2009-2#1)
This pathology##3##2##(2007-8#1)(2008-1#1)(2008-9#1)
This pathway is##2##3##(1992-12#1)(2008-1#1)
This pathway##6##2##(1992-12#1)(1992-6#1)(1994-9#1)(2008-1#1)(2008-9#1)(2009-5#1)
This patient developed##2##3##(2008-1#1)(2008-4#1)
This patient died##2##3##(1994-12#1)(2010-5#1)
This patient was##2##3##(1994-9#1)(2007-10#1)
This patient##11##2##(1994-12#1)(1994-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
This pattern can be##2##4##(1994-8#1)(2008-11#1)
This pattern is##2##3##(1991-12#1)(2012-2#1)
This pattern of##14##3##(1990-11#1)(1993-1#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-6#2)(2007-12#1)(2007-7#2)(2008-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
This pattern##22##2##(1990-11#1)(1991-12#1)(1993-1#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-6#2)(2007-12#1)(2007-7#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#2)
This peak is##2##3##(2007-12#1)(2008-10#1)
This peak##6##2##(1991-8#1)(1993-8#1)(2007-12#1)(2008-10#3)
This peptide represents a##2##4##(1995-2#1)(1995-6#1)
This peptide##11##2##(1990-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1994-12#1)(1995-2#1)(1995-6#1)(2008-6#1)
This permits##7##2##(1994-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
This perspective##4##2##(1993-1#1)(2008-1#1)(2008-3#1)(2010-5#1)
This phase is##2##3##(2007-12#1)(2008-3#1)
This phase##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)
This phenomenological study##4##3##(2008-11#2)(2008-12#1)(2012-3#1)
This phenomenon can be##2##4##(2008-3#1)(2008-7#1)
This phenomenon has been##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
This phenomenon is##9##3##(1991-6#1)(1994-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)
This phenomenon may be##2##4##(2008-5#1)(2008-7#1)
This phenomenon occurs##3##3##(1997-2#1)(1997-7#1)(2007-12#1)
This phenomenon was##5##3##(1990-5#1)(1995-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
This phenomenon##43##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-6#1)(1992-2#1)(1992-7#1)(1994-11#2)(1995-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
This phenotype was##2##3##(1995-2#1)(2011-1#1)
This phenotype##9##2##(1990-5#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-5#1)(2011-1#2)(2012-12#1)
This pictorial essay##2##3##(1997-8#1)(2012-2#1)
This pictorial##4##2##(1997-8#1)(2012-2#2)(2012-3#1)
This pilot project##2##3##(1996-2#1)(2008-9#1)
This pilot study used##2##4##(2007-2#1)(2008-4#1)
This pilot study##9##3##(1992-1#1)(2007-10#1)(2007-2#1)(2008-4#2)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
This pilot##13##2##(1992-1#1)(1996-2#1)(2007-10#1)(2007-2#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
This plan##2##2##(2008-7#1)(2013-1#1)
This plant##2##2##(2008-10#1)(2013-1#1)
This plasmid##3##2##(1991-9#1)(1997-6#1)(2011-2#1)
This point##3##2##(2008-9#1)(2009-3#1)(2011-2#1)
This points to the##4##4##(1991-6#1)(1993-9#1)(1994-9#1)(2008-11#1)
This points to##5##3##(1991-6#1)(1993-9#1)(1994-9#1)(2008-11#2)
This polarization##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
This policy##5##2##(1994-1#1)(1996-2#1)(1997-5#1)(2008-7#1)(2012-12#1)
This polymorphism##2##2##(2009-5#1)(2012-1#1)
This population was##2##3##(2008-10#1)(2012-3#1)
This population##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
This portable##2##2##(2008-10#2)
This poses##2##2##(2008-8#1)(2010-12#1)
This position##2##2##(1997-6#1)(2010-3#1)
This positive##3##2##(1995-2#1)(1995-5#1)(2008-8#1)
This possibility was##2##3##(1993-8#1)(2013-1#1)
This possibility##3##2##(1993-8#1)(2007-8#1)(2013-1#1)
This potential##3##2##(1995-6#1)(2007-12#1)(2008-10#1)
This potentially##2##2##(2008-5#1)(2013-1#1)
This potentiation##2##2##(1996-2#1)(2008-4#1)
This powerful##2##2##(1991-12#1)(2008-10#1)
This practice##5##2##(1993-12#1)(2007-10#1)(2008-10#2)(2012-2#1)
This prediction is##2##3##(2008-2#1)(2008-9#1)
This prediction##5##2##(2008-2#1)(2008-8#1)(2008-9#3)
This preference##2##2##(2008-3#1)(2010-3#1)
This preliminary study##4##3##(1991-9#1)(1993-3#1)(2008-7#1)(2012-3#1)
This preliminary##5##2##(1990-8#1)(1991-9#1)(1993-3#1)(2008-7#1)(2012-3#1)
This present##3##2##(1990-2#1)(2008-12#1)(2012-12#1)
This presentation discusses##2##3##(2008-10#2)
This presentation focuses on##2##4##(2008-1#1)(2008-10#1)
This presentation will##2##3##(2008-10#1)(2008-7#1)
This presentation##12##2##(1992-5#1)(1994-12#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-7#2)(2010-1#1)
This presents##2##2##(2008-10#1)(2012-2#1)
This prevalence was##2##3##(2010-3#1)(2013-1#1)
This prevalence##4##2##(2007-7#1)(2009-8#1)(2010-3#1)(2013-1#1)
This primer set##3##3##(2008-10#3)
This principle was##2##3##(2008-10#2)
This principle##5##2##(1992-3#1)(2008-10#3)(2008-12#1)
This probably##2##2##(2008-8#1)(2011-2#1)
This probe##3##2##(1991-2#1)(1997-4#1)(2008-10#1)
This problem could##2##3##(2006-8#1)(2008-3#1)
This problem has been##2##4##(2008-6#1)(2008-9#1)
This problem is##4##3##(1993-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
This problem was##3##3##(2008-10#3)
This problem##14##2##(1993-2#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#3)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#1)
This procedure allows the simultaneous determination of##3##7##(2008-10#3)
This procedure allows the##4##4##(2008-10#4)
This procedure allows##6##3##(2008-10#6)
This procedure avoids the##2##4##(2008-2#2)
This procedure can be##2##4##(1994-8#1)(2008-9#1)
This procedure can##3##3##(1994-8#1)(2007-11#1)(2008-9#1)
This procedure has been##2##4##(2008-10#2)
This procedure has##4##3##(1993-12#1)(2008-10#3)
This procedure is viewed as a relevant model for the study of human drug-taking behavior##2##15##(2008-4#1)(2012-3#1)
This procedure is##11##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#1)(2010-7#1)(2012-3#1)
This procedure may be##2##4##(2011-1#1)(2011-2#1)
This procedure may##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
This procedure reduces##2##3##(2007-12#1)(2011-2#1)
This procedure results in a##2##5##(1994-5#1)(2012-3#1)
This procedure was applied to the determination of cadmium in##2##10##(2008-10#2)
This procedure was applied to the determination of##3##8##(2008-10#3)
This procedure was applied to##4##5##(2008-10#4)
This procedure was applied##5##4##(2008-10#5)
This procedure was repeated##2##4##(1997-6#1)(2011-3#1)
This procedure was##14##3##(1997-6#1)(2008-10#9)(2008-3#1)(2011-1#1)(2011-3#1)(2013-8#1)
This procedure##65##2##(1991-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#27)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-9#2)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
This process can##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
This process has been##3##4##(1992-11#1)(2009-10#1)(2011-2#1)
This process has##8##3##(1992-11#1)(1995-12#1)(1995-3#1)(2008-3#1)(2008-6#2)(2009-10#1)(2011-2#1)
This process involves##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2009-7#1)
This process is not##2##4##(1994-12#1)(2007-12#1)
This process is##11##3##(1991-2#1)(1994-12#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-8#1)(2012-2#1)
This process was##4##3##(1991-2#1)(1991-8#1)(2008-7#1)(2008-9#1)
This process##46##2##(1991-2#2)(1991-8#1)(1992-11#1)(1994-12#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-9#1)(1997-1#1)(2007-12#3)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-10#2)(2009-7#1)(2009-8#2)(2011-2#1)(2012-2#1)
This processing##2##2##(2007-12#1)(2008-3#1)
This produced##3##2##(1991-5#1)(1995-11#1)(1997-5#1)
This produces##2##2##(2008-1#1)(2010-7#1)
This product is##2##3##(2008-10#2)
This product was##2##3##(1992-6#1)(2008-6#1)
This product##4##2##(1992-6#1)(2008-10#2)(2008-6#1)
This professional paper was written in order to investigate the relationship between group size and measures of performance##2##18##(1994-3#2)
This professional paper will address the various elements in designing a women's health center in an academic health setting##2##19##(1994-3#2)
This professional paper will define several ethical theories##2##8##(1994-1#2)
This professional paper will provide a summary reference in the correct design of a &quot##2##15##(1994-3#2)
This professional paper will show that provider expertise and patient care are the most important factors in referral decisions##2##19##(1994-1#2)
This professional paper will show that##3##6##(1994-1#2)(1996-1#1)
This professional paper will##11##4##(1994-1#4)(1994-3#5)(1996-1#2)
This professional paper##18##3##(1991-1#2)(1992-3#1)(1994-1#4)(1994-3#7)(1996-1#2)(1996-3#2)
This profile##2##2##(2008-3#1)(2008-9#1)
This program has##4##3##(1992-3#1)(2008-3#2)(2013-1#1)
This program was developed at##2##5##(1992-2#1)(2008-12#1)
This program was developed##3##4##(1992-2#1)(2008-11#1)(2008-12#1)
This program was##4##3##(1992-2#1)(2008-11#1)(2008-12#2)
This program##15##2##(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2013-1#1)
This programme##2##2##(2012-3#2)
This progress##3##2##(2008-1#1)(2008-7#1)(2010-10#1)
This progressive##2##2##(2008-2#1)(2008-5#1)
This project has##2##3##(2008-10#1)(2013-1#1)
This project is##3##3##(1994-3#1)(1996-2#1)(2008-11#1)
This project was##5##3##(1994-1#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-4#1)
This project##17##2##(1994-1#1)(1994-3#1)(1996-2#1)(1996-7#1)(2007-5#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-12#1)(2013-1#1)
This projection##2##2##(2007-4#1)(2008-7#1)
This projector##2##2##(2008-3#2)
This promoter##4##2##(1990-12#1)(1991-6#1)(2010-5#2)
This prompted##2##2##(1995-12#1)(2008-10#1)
This pronounced##2##2##(1991-2#1)(2010-6#1)
This proof-of-principle##2##2##(2007-12#1)(2010-12#1)
This property has##2##3##(1990-8#1)(2008-12#1)
This property is##5##3##(1990-12#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
This property##14##2##(1990-12#1)(1990-8#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-10#1)(2011-1#1)
This proposed method can be used for the##2##8##(2008-10#2)
This proposed method can be##3##5##(2008-10#2)(2008-6#1)
This proposed method demonstrated##2##4##(2008-10#2)
This proposed method##8##3##(2008-10#7)(2008-6#1)
This proposed##11##2##(1996-1#1)(2008-10#8)(2008-6#1)(2011-1#1)
This prospective study was carried out##2##6##(2007-7#1)(2008-4#1)
This prospective study was##4##4##(2007-7#1)(2008-4#1)(2012-3#1)(2013-8#1)
This prospective study##5##3##(2007-7#1)(2008-4#1)(2009-3#1)(2012-3#1)(2013-8#1)
This prospective##12##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
This protective effect##2##3##(1993-2#1)(1995-2#1)
This protective##3##2##(1993-2#1)(1995-2#1)(2008-11#1)
This protein has##2##3##(1992-3#1)(1994-11#1)
This protein is present in##2##5##(1992-6#1)(2009-8#1)
This protein is##7##3##(1992-12#1)(1992-6#1)(1994-3#1)(1995-6#1)(1996-5#1)(2009-8#1)(2010-10#1)
This protein was##6##3##(1990-11#1)(1991-11#1)(1991-2#1)(1995-6#1)(2008-10#2)
This protein##25##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-6#3)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)
This protocol describes a method##2##5##(2008-4#1)(2008-9#1)
This protocol describes a##4##4##(2008-11#1)(2008-4#2)(2008-9#1)
This protocol describes##6##3##(2008-11#1)(2008-4#4)(2008-9#1)
This protocol offers##2##3##(2008-4#2)
This protocol provides a##2##4##(2008-9#2)
This protocol provides##3##3##(2008-4#1)(2008-9#2)
This protocol##19##2##(2008-10#1)(2008-11#1)(2008-4#12)(2008-9#3)(2012-2#1)(2013-1#1)
This provided a##4##3##(1991-8#1)(1993-9#1)(2008-10#1)(2008-11#1)
This provided##6##2##(1991-5#1)(1991-8#1)(1993-9#1)(2008-10#1)(2008-11#2)
This provides a framework for##2##5##(2007-12#1)(2008-8#1)
This provides a##9##3##(1992-11#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-6#1)(2012-2#1)
This provides an##2##3##(1997-2#1)(2011-1#1)
This provides in##2##3##(1992-10#1)(2012-2#1)
This provides the##3##3##(1992-12#1)(2008-7#2)
This provides##22##2##(1992-10#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#2)
This purified##2##2##(1993-8#1)(1994-5#1)
This putative##4##2##(2008-10#3)(2010-5#1)
This qualitative research##4##3##(1997-3#1)(2008-9#1)(2010-9#1)(2012-12#1)
This qualitative study aimed to describe##2##6##(2010-7#1)(2012-3#1)
This qualitative study aimed to##3##5##(2007-10#1)(2010-7#1)(2012-3#1)
This qualitative study##5##3##(2007-10#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
This qualitative##11##2##(1997-3#1)(2007-10#1)(2008-9#2)(2010-11#1)(2010-7#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
This quantitative research study assesses the##2##6##(2008-11#2)
This quantitative##3##2##(2008-10#1)(2008-11#2)
This quantity##2##2##(2008-10#1)(2013-1#1)
This question is##2##3##(1992-6#1)(1996-1#1)
This raises the##2##3##(1997-1#1)(2008-2#1)
This raises##3##2##(1997-1#1)(2008-2#1)(2013-7#1)
This randomized controlled##2##3##(2008-12#1)(2009-11#1)
This randomized##3##2##(2008-12#1)(2008-5#1)(2009-11#1)
This range is##2##3##(1995-1#1)(2008-8#1)
This range##6##2##(1992-12#1)(1994-11#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
This rapid and##4##3##(2008-10#3)(2009-8#1)
This rapid##6##2##(2007-7#1)(2008-10#4)(2009-8#1)
This rare##6##2##(1991-11#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-7#1)
This rate is##2##3##(1997-5#1)(2009-12#1)
This rate##3##2##(1997-5#1)(2007-12#1)(2009-12#1)
This reaction is##2##3##(2008-10#1)(2008-6#1)
This reaction was##2##3##(2008-10#2)
This reaction##11##2##(1994-2#1)(1994-9#1)(1996-2#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-8#1)
This reagent##2##2##(2008-10#1)(2009-12#1)
This realization##2##2##(2008-3#1)(2013-1#1)
This rearrangement##2##2##(1995-8#1)(1996-5#1)
This receptor##2##2##(1991-2#1)(1992-9#1)
This reconstructed##2##2##(2008-5#2)
This reduces the##2##3##(1996-6#1)(2010-8#1)
This reduction in##6##3##(1992-3#1)(1995-5#1)(1996-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
This reduction was##2##3##(1995-3#1)(2012-5#1)
This reduction##9##2##(1992-3#1)(1995-3#1)(1995-5#1)(1996-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-5#1)
This reflects the##2##3##(1995-9#1)(1997-6#1)
This region contains a##2##4##(1991-11#1)(1992-11#1)
This region contains##7##3##(1991-11#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-6#1)(1996-8#1)
This region has##2##3##(1990-10#1)(1993-2#1)
This region is also##2##4##(2008-10#1)(2012-2#1)
This region is##6##3##(1990-11#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
This region of the genome##2##5##(1996-2#1)(2008-10#1)
This region of the##3##4##(1996-2#1)(2008-10#2)
This region of##4##3##(1995-6#1)(1996-2#1)(2008-10#2)
This region##29##2##(1990-10#1)(1990-11#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#4)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#2)(2008-10#3)(2008-11#1)(2008-4#1)(2012-2#1)
This relation##4##2##(1992-11#1)(2008-3#2)(2008-7#1)
This relationship has##2##3##(2008-1#1)(2010-3#1)
This relationship is##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
This relationship persists after adjusting for traditional risk factors and known cardiovascular disease##2##13##(1993-12#2)
This relationship was found to be##2##6##(2008-10#1)(2013-1#1)
This relationship was##4##3##(2008-10#3)(2013-1#1)
This relationship##18##2##(1993-12#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-2#1)(2010-3#1)(2013-1#1)(2013-8#1)
This remarkable##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
This report deals with##2##4##(2008-11#1)(2008-9#1)
This report demonstrates that##3##4##(1997-6#1)(2008-10#1)(2009-4#1)
This report demonstrates##4##3##(1997-6#1)(2007-8#1)(2008-10#1)(2009-4#1)
This report describes a case of##2##6##(2007-12#1)(2008-11#1)
This report describes a##17##4##(1993-12#1)(1995-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#2)(2013-1#2)
This report describes an##2##4##(2006-10#1)(2008-5#1)
This report describes one##2##4##(1995-3#1)(2008-10#1)
This report describes the results of a##3##7##(1991-5#1)(1997-7#1)(2006-10#1)
This report describes the results##4##5##(1991-5#1)(1997-7#1)(2006-10#1)(2008-5#1)
This report describes the use of a##3##7##(1992-1#1)(1995-8#1)(2013-8#1)
This report describes the use of##5##6##(1992-1#1)(1995-8#1)(1996-9#1)(2007-7#1)(2013-8#1)
This report describes the##23##4##(1991-5#1)(1992-1#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-7#2)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
This report describes##52##3##(1991-5#1)(1992-1#1)(1992-10#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-9#1)(1997-7#2)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
This report discusses the##2##4##(2008-11#1)(2008-12#1)
This report emphasizes the##2##4##(2011-1#1)(2012-12#1)
This report focuses on##2##4##(2006-12#1)(2008-5#1)
This report focuses##3##3##(1992-11#1)(2006-12#1)(2008-5#1)
This report from the##2##4##(2008-1#1)(2008-7#1)
This report highlights the##2##4##(2008-10#2)
This report illustrates the##3##4##(1996-1#1)(2008-12#1)(2013-8#1)
This report is the first to##2##6##(1990-11#1)(2008-6#1)
This report is the first##4##5##(1990-11#1)(2008-11#2)(2008-6#1)
This report is##5##3##(1990-11#1)(2008-11#3)(2008-6#1)
This report of##2##3##(2012-3#1)(2013-8#1)
This report outlines the##2##4##(2008-7#1)(2008-9#1)
This report outlines##3##3##(1994-3#1)(2008-7#1)(2008-9#1)
This report presents the##3##4##(1995-3#1)(2008-11#1)(2012-2#1)
This report presents##7##3##(1991-11#1)(1993-12#1)(1995-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
This report profiles the keynote talks given at##2##8##(2008-7#2)
This report provides##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
This report shows that a##2##5##(1990-12#1)(1994-12#1)
This report shows that##4##4##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)
This report shows##5##3##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(2007-8#1)
This report summarizes the##5##4##(1993-12#1)(1994-9#1)(2007-12#1)(2011-2#2)
This report summarizes##11##3##(1991-5#1)(1993-12#1)(1994-9#3)(1995-6#1)(2007-12#1)(2008-6#1)(2010-4#1)(2011-2#2)
This report will discuss##2##4##(2009-4#1)(2012-3#1)
This report##140##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-5#3)(1992-1#1)(1992-10#1)(1992-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#3)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#7)(2008-1#5)(2008-10#10)(2008-11#10)(2008-12#5)(2008-5#4)(2008-6#3)(2008-7#8)(2008-9#3)(2009-2#1)(2009-4#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#3)
This represents a##9##3##(1991-11#1)(1995-2#1)(2007-11#1)(2007-5#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
This represents the first##2##4##(2008-10#1)(2013-8#1)
This represents##15##2##(1991-11#1)(1991-6#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
This requirement##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
This requires##10##2##(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-8#2)
This research aimed at##3##4##(1991-6#1)(2010-10#1)(2013-1#1)
This research aimed##4##3##(1991-6#1)(1993-6#1)(2010-10#1)(2013-1#1)
This research demonstrates##2##3##(2008-10#1)(2008-2#1)
This research has##5##3##(1995-3#1)(1997-2#1)(2008-10#1)(2013-1#2)
This research is based on##2##5##(1990-12#1)(2009-10#1)
This research is##5##3##(1990-12#2)(2008-12#1)(2008-7#1)(2009-10#1)
This research was##4##3##(2008-12#2)(2008-7#1)(2010-6#1)
This research##48##2##(1990-12#2)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-2#3)(2007-12#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
This residue is##3##3##(1995-2#2)(1995-6#1)
This residue##4##2##(1992-6#1)(1995-2#2)(1995-6#1)
This resistance##4##2##(2007-2#1)(2008-10#3)
This resolution is##2##3##(2008-3#2)
This resonator##2##2##(2008-3#1)(2013-8#1)
This response was not##2##4##(1996-7#1)(1997-4#1)
This response was##4##3##(1990-6#1)(1996-7#1)(1997-4#1)(2008-11#1)
This response##10##2##(1990-6#1)(1990-7#1)(1991-2#1)(1993-6#1)(1995-12#1)(1996-7#1)(1997-4#1)(2008-11#1)(2009-8#1)(2010-4#1)
This result confirms the##2##4##(2008-8#2)
This result confirms##3##3##(2008-10#1)(2008-8#2)
This result could##2##3##(2008-3#1)(2008-5#1)
This result demonstrates that the##2##5##(2008-2#1)(2008-9#1)
This result further##2##3##(1996-2#1)(2008-9#1)
This result has been##2##4##(2007-11#1)(2012-3#1)
This result implies that##6##4##(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
This result implies##7##3##(1990-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
This result indicates that the##4##5##(1991-3#1)(1991-6#1)(2008-10#2)
This result indicates that##8##4##(1990-12#1)(1991-3#1)(1991-6#1)(2007-12#1)(2008-10#4)
This result is in contrast with the##2##7##(1992-12#1)(2008-10#1)
This result is in contrast##3##5##(1992-12#1)(2008-10#1)(2008-8#1)
This result is obtained##2##4##(1992-11#1)(2007-12#1)
This result is of##2##4##(1996-12#1)(2008-10#1)
This result is##15##3##(1992-11#1)(1992-12#1)(1996-12#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)
This result may##4##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
This result represents an##2##4##(2007-11#1)(2007-12#1)
This result represents##3##3##(2007-11#1)(2007-12#2)
This result shows that##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
This result shows##7##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2012-2#1)
This result suggested that the##4##5##(1990-5#1)(2008-10#1)(2008-11#1)(2009-3#1)
This result suggested that##8##4##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#1)
This result suggests that the##3##5##(1991-2#1)(1996-5#1)(2008-10#1)
This result suggests that##12##4##(1991-2#2)(1992-3#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)
This result suggests the##2##4##(2007-12#1)(2012-2#1)
This result suggests##15##3##(1991-2#2)(1992-3#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2012-2#1)
This result supports the hypothesis that the##2##7##(1993-9#1)(1997-1#1)
This result supports the##3##4##(1993-9#1)(1997-1#1)(2008-8#1)
This result supports##4##3##(1993-9#1)(1997-1#1)(2008-8#2)
This result was not##2##4##(2008-10#1)(2008-9#1)
This result was##8##3##(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
This result##120##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#2)(1997-7#2)(1997-8#1)(2007-11#5)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#5)(2008-7#3)(2008-8#9)(2008-9#9)(2009-10#1)(2009-2#2)(2009-3#1)(2010-10#1)(2010-8#1)(2012-2#2)(2012-3#1)
This resulted in a##3##4##(1994-12#1)(1996-7#1)(2008-10#1)
This resulted in the identification of##2##6##(2008-10#1)(2008-7#1)
This resulted in the##4##4##(2008-10#1)(2008-11#2)(2008-7#1)
This resulted in##15##3##(1990-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-7#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
This results from##2##3##(1991-9#1)(2008-5#1)
This results in a##6##4##(1991-11#1)(1994-6#1)(1997-6#1)(2008-3#2)(2008-9#1)
This results in an##3##4##(1991-11#1)(1996-9#1)(2008-10#1)
This results in##16##3##(1991-11#2)(1992-11#1)(1994-6#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)
This results##19##2##(1991-11#2)(1991-9#1)(1992-11#1)(1994-6#1)(1996-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)
This retrospective analysis of##2##4##(2007-8#1)(2008-1#1)
This retrospective review##2##3##(2008-1#1)(2008-6#1)
This retrospective study compared the##2##5##(2009-3#1)(2012-3#1)
This retrospective study was##3##4##(1996-1#1)(2010-3#1)(2011-2#1)
This retrospective study##13##3##(1995-3#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-3#1)
This retrospective##21##2##(1995-3#1)(1996-1#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
This revealed that##2##3##(1995-6#1)(2008-10#1)
This revealed the##2##3##(2008-10#1)(2008-8#1)
This revealed##5##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
This reveals##2##2##(2008-8#1)(2012-3#1)
This review addresses the##4##4##(2008-6#1)(2011-7#1)(2012-12#1)(2013-8#1)
This review addresses##8##3##(2006-10#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-7#1)(2012-12#1)(2013-8#1)
This review aims at providing##2##5##(2008-4#1)(2012-12#1)
This review aims at##3##4##(2008-4#1)(2012-12#1)(2013-8#1)
This review aims to summarize##3##5##(2008-11#1)(2013-1#2)
This review aims to##6##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2013-1#2)
This review aims##9##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
This review article describes the##2##5##(2007-11#1)(2009-9#1)
This review article discusses##2##4##(2008-9#1)(2012-2#1)
This review article focuses on the##2##6##(2010-12#1)(2010-7#1)
This review article is a##2##5##(2012-2#2)
This review article summarizes the##2##5##(2007-10#1)(2011-2#1)
This review article summarizes##3##4##(2007-10#1)(2008-10#1)(2011-2#1)
This review article##16##3##(2007-10#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
This review assesses##3##3##(2008-10#1)(2008-4#1)(2010-5#1)
This review attempts to##5##4##(1997-8#1)(2008-11#1)(2009-5#1)(2009-6#1)(2009-8#1)
This review briefly outlines##2##4##(2008-3#1)(2009-11#1)
This review briefly##3##3##(2008-1#1)(2008-3#1)(2009-11#1)
This review concentrates on##2##4##(2008-10#1)(2010-9#1)
This review considers the##3##4##(2007-6#1)(2008-10#1)(2008-4#1)
This review considers##6##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
This review covers the##4##4##(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
This review covers##9##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-12#1)
This review critically examines##2##4##(1990-5#1)(2010-8#1)
This review deals with the##4##5##(1994-11#1)(1994-2#1)(2008-1#1)(2008-10#1)
This review deals with##6##4##(1994-11#1)(1994-2#1)(2008-1#1)(2008-10#3)
This review demonstrates##2##3##(1997-6#1)(2010-11#1)
This review describes how##2##4##(2008-11#1)(2011-1#1)
This review describes recent##5##4##(2008-10#3)(2008-8#1)(2011-2#1)
This review describes the current##2##5##(2008-2#1)(2008-8#1)
This review describes the##12##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
This review describes##28##3##(1991-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-7#1)(2013-8#2)
This review details the##2##4##(1992-1#1)(2008-10#1)
This review discusses recent progress in the development of##2##9##(2011-2#1)(2011-3#1)
This review discusses recent##4##4##(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
This review discusses some of the##2##6##(2008-8#1)(2009-5#1)
This review discusses the##17##4##(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
This review discusses##33##3##(1993-3#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
This review examines the##4##4##(2008-7#2)(2010-7#1)(2010-9#1)
This review examines##8##3##(2008-10#1)(2008-7#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
This review explores the##4##4##(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)
This review explores##5##3##(2008-10#1)(2008-11#1)(2009-9#1)(2012-12#1)(2012-3#1)
This review focuses mainly on##2##5##(2009-12#1)(2010-5#1)
This review focuses on recent advances##2##6##(2008-10#1)(2008-7#1)
This review focuses on the recent##3##6##(2010-6#1)(2011-2#1)(2012-3#1)
This review focuses on the##25##5##(1991-7#1)(1994-1#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
This review focuses on##38##4##(1991-7#1)(1994-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-11#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)
This review focuses##42##3##(1991-7#1)(1994-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#1)
This review gives a##2##4##(2008-10#1)(2011-1#1)
This review gives##4##3##(2008-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
This review has##2##3##(2008-11#1)(2010-1#1)
This review highlights the##5##4##(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
This review highlights##7##3##(2008-4#1)(2008-7#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-3#1)
This review introduces##2##3##(2008-1#1)(2010-7#1)
This review is aimed at##2##5##(2008-1#1)(2009-3#1)
This review is based on##2##5##(2007-2#1)(2008-7#1)
This review is focused on##4##5##(2007-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
This review is##12##3##(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
This review of the##2##4##(2009-7#1)(2010-8#1)
This review of##8##3##(1993-3#1)(1995-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)
This review outlines general##2##4##(1997-2#1)(2008-7#1)
This review outlines the##2##4##(2008-3#1)(2012-1#1)
This review outlines##6##3##(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)
This review presents a##4##4##(2006-10#1)(2010-7#1)(2011-2#1)(2011-3#1)
This review presents an##2##4##(2008-11#1)(2011-2#1)
This review presents the##4##4##(1995-11#1)(2008-10#1)(2011-2#1)(2011-7#1)
This review presents##12##3##(1995-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#3)(2011-3#1)(2011-7#1)
This review provides a summary of##2##6##(2008-7#1)(2010-3#1)
This review provides a##6##4##(2008-10#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-3#1)(2012-12#1)
This review provides an overview of the##6##7##(2008-12#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
This review provides an##9##4##(2008-10#1)(2008-12#1)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
This review provides##19##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
This review serves to##2##4##(1997-4#1)(2010-6#1)
This review sets##2##3##(2007-12#1)(2008-9#1)
This review shows##2##3##(2008-10#1)(2010-7#1)
This review summarises the##3##4##(2008-10#1)(2011-10#1)(2011-2#1)
This review summarises##6##3##(2008-10#1)(2008-11#1)(2011-10#1)(2011-2#2)(2012-2#1)
This review summarizes current knowledge##2##5##(2008-4#1)(2011-2#1)
This review summarizes our current##2##5##(2008-11#1)(2010-8#1)
This review summarizes recent##3##4##(2006-10#1)(2007-7#1)(2008-10#1)
This review summarizes the current##4##5##(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
This review summarizes the most##2##5##(2006-10#1)(2008-10#1)
This review summarizes the recent##2##5##(2010-11#1)(2012-12#1)
This review summarizes the##20##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#2)(2011-9#1)(2012-12#2)(2012-3#1)(2013-8#1)
This review summarizes##37##3##(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-3#2)(2013-8#2)
This review will address the##2##5##(2008-10#1)(2008-11#1)
This review will address##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
This review will also##2##4##(2008-10#1)(2010-8#1)
This review will discuss the##6##5##(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
This review will discuss##12##4##(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
This review will examine the##3##5##(2008-10#1)(2009-6#1)(2012-2#1)
This review will examine##4##4##(2008-10#1)(2009-4#1)(2009-6#1)(2012-2#1)
This review will focus on the##10##6##(1994-3#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
This review will focus on##19##5##(1994-3#1)(2008-1#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#1)(2009-12#1)(2010-8#2)(2012-12#1)(2012-2#1)
This review will highlight##2##4##(2008-11#1)(2010-5#1)
This review will provide a##2##5##(2008-11#1)(2009-12#1)
This review will provide##3##4##(2008-11#1)(2009-12#1)(2009-4#1)
This review will summarize recent progress##2##6##(2008-1#1)(2011-2#1)
This review will summarize the##3##5##(2007-7#1)(2008-7#1)(2013-1#1)
This review will summarize##5##4##(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
This review will##58##3##(1994-3#1)(2007-7#1)(2008-1#5)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
This review##397##2##(1990-5#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#6)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#4)(2007-8#1)(2008-1#14)(2008-10#40)(2008-11#22)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#12)(2008-5#11)(2008-6#6)(2008-7#27)(2008-8#12)(2008-9#4)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#3)(2010-3#1)(2010-5#5)(2010-6#3)(2010-7#11)(2010-8#9)(2010-9#3)(2011-1#9)(2011-10#1)(2011-2#34)(2011-3#4)(2011-7#2)(2011-9#1)(2012-1#3)(2012-12#13)(2012-2#16)(2012-3#13)(2013-1#11)(2013-7#1)(2013-8#10)
This revised and expanded unit##2##5##(2008-9#2)
This revised##5##2##(2008-9#2)(2009-2#1)(2010-6#1)(2011-2#1)
This risk##2##2##(1996-12#1)(2010-12#1)
This role##3##2##(1995-3#1)(2008-1#1)(2012-2#1)
This route##2##2##(2009-2#1)(2011-2#1)
This rule##2##2##(1994-11#1)(2011-2#1)
This same##4##2##(1991-7#1)(1994-8#1)(2011-2#1)(2012-12#1)
This sample##2##2##(2009-5#1)(2012-12#1)
This sampling##2##2##(2008-10#2)
This scenario##2##2##(2008-7#1)(2012-2#1)
This scheme completely suppresses##2##4##(2007-12#2)
This scheme is##2##3##(2007-11#1)(2008-10#1)
This scheme##14##2##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#3)
This second site was##2##4##(1995-6#1)(2011-2#1)
This second##8##2##(1994-5#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#1)
This secondary##3##2##(1990-8#1)(1993-11#1)(2010-10#1)
This section##5##2##(1991-12#1)(1997-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
This seems to##2##3##(2007-11#1)(2008-5#1)
This seems##3##2##(1994-1#1)(2007-11#1)(2008-5#1)
This segment##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
This selection##4##2##(1996-6#1)(2008-10#2)(2010-5#1)
This selective##2##2##(1994-11#1)(2008-8#1)
This sensing##3##2##(2008-10#3)
This sensitivity##5##2##(1990-2#1)(2008-10#1)(2008-2#2)(2008-7#1)
This sensor can be used##2##5##(2008-10#2)
This sensor exhibited##2##3##(2008-10#2)
This sensor gave a linear calibration##2##6##(1992-11#2)
This sensor is##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
This sensor was##2##3##(2008-10#2)
This sensor##17##2##(1992-11#2)(2007-12#2)(2008-10#12)(2008-2#1)
This separation##2##2##(2008-10#1)(2008-3#1)
This sequence contains##2##3##(1997-3#2)
This sequence has##2##3##(1991-11#2)
This sequence is##4##3##(1994-12#1)(1994-5#1)(1994-6#1)(1997-4#1)
This sequence of##2##3##(1994-8#1)(2010-2#1)
This sequence was##4##3##(1993-9#1)(2008-10#2)(2010-5#1)
This sequence##22##2##(1991-11#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-3#3)(1997-4#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-5#1)
This series of##2##3##(1991-12#1)(2008-9#1)
This series##8##2##(1991-12#1)(1991-2#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
This set of##3##3##(2007-11#1)(2009-10#1)(2013-8#1)
This set##6##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
This sexual##2##2##(2008-9#2)
This shift##2##2##(2008-10#1)(2008-7#1)
This short##2##2##(1997-7#1)(2008-1#1)
This short-term##2##2##(2008-6#1)(2009-7#1)
This should be##2##3##(1996-11#1)(2010-5#1)
This should##6##2##(1992-12#1)(1994-2#1)(1996-11#1)(2007-2#1)(2010-5#1)(2010-8#1)
This showed that##2##3##(2008-11#1)(2008-3#1)
This showed##6##2##(1993-2#1)(1995-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)
This shows that the##2##4##(1990-11#1)(1994-3#1)
This shows that##7##3##(1990-11#1)(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
This shows##10##2##(1990-11#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-6#1)
This sign is##2##3##(2012-12#1)(2013-1#1)
This sign was##2##3##(2013-7#2)
This sign##4##2##(2012-12#1)(2013-1#1)(2013-7#2)
This signal##2##2##(2008-10#1)(2008-7#1)
This significant##2##2##(1995-3#1)(2008-11#1)
This simple and rapid##2##4##(1996-12#1)(2008-10#1)
This simple and##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
This simple method##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
This simple procedure##2##3##(2008-1#1)(2008-3#1)
This simple technique##2##3##(2008-3#1)(2008-4#1)
This simple##18##2##(1992-12#1)(1996-12#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#1)
This situation##9##2##(1990-8#1)(1992-1#1)(1992-6#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#1)
This size##2##2##(2008-10#1)(2008-8#1)
This small##2##2##(2008-11#1)(2010-12#1)
This so-called##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
This solution allows##2##3##(2007-11#1)(2008-3#1)
This solution was##2##3##(2008-10#1)(2008-5#1)
This solution##7##2##(1991-9#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
This source of##2##3##(2008-10#1)(2008-12#1)
This source##5##2##(2007-11#3)(2008-10#1)(2008-12#1)
This spatial##2##2##(2007-11#1)(2008-2#1)
This special issue##2##3##(2008-8#1)(2013-8#1)
This species is##8##3##(1996-2#1)(2008-10#1)(2008-5#2)(2008-6#1)(2011-2#2)(2013-7#1)
This species was##5##3##(2008-10#1)(2008-5#2)(2008-6#1)(2013-7#1)
This species##19##2##(1996-2#1)(2008-10#4)(2008-5#6)(2008-6#2)(2009-8#1)(2011-2#3)(2013-7#2)
This stability##2##2##(2007-8#1)(2008-5#1)
This state of affairs##2##4##(2008-11#1)(2011-2#1)
This state##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
This statement##2##2##(2008-10#1)(2008-5#1)
This statistic##2##2##(1996-3#1)(2008-10#1)
This statistical##2##2##(2009-3#1)(2010-5#1)
This step##2##2##(1996-12#1)(2009-2#1)
This strain was##4##3##(2008-10#2)(2012-12#2)
This strain##5##2##(2008-10#3)(2012-12#2)
This strategy has##3##3##(1996-2#1)(2008-10#1)(2009-10#1)
This strategy is##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
This strategy resulted in##2##4##(2008-10#1)(2012-2#1)
This strategy was##4##3##(1993-8#1)(2007-10#1)(2008-1#1)(2008-10#1)
This strategy##26##2##(1992-6#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-10#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
This strongly suggests that##2##4##(1993-6#1)(2008-10#1)
This strongly suggests##3##3##(1990-5#1)(1993-6#1)(2008-10#1)
This structural##5##2##(1992-3#1)(1992-5#1)(1994-12#1)(2008-4#1)(2013-8#1)
This structure is##2##3##(1991-11#1)(2008-12#1)
This structure##7##2##(1991-11#1)(1992-5#1)(1997-4#1)(2007-12#1)(2008-12#1)(2008-3#1)(2010-10#1)
This study addresses the##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)
This study addresses##5##3##(2008-10#1)(2008-5#2)(2008-9#1)(2009-4#1)
This study aimed at##3##4##(2010-2#1)(2012-12#1)(2012-3#1)
This study aimed to assess the##2##6##(2011-2#1)(2012-3#1)
This study aimed to describe##2##5##(2012-12#1)(2013-1#1)
This study aimed to determine the##2##6##(2007-10#1)(2009-5#1)
This study aimed to determine##4##5##(2007-10#1)(2007-11#1)(2009-5#1)(2011-1#1)
This study aimed to develop a##2##6##(2008-10#1)(2010-1#1)
This study aimed to evaluate the feasibility##2##7##(2011-2#1)(2013-8#1)
This study aimed to evaluate the quality of##2##8##(2008-11#1)(2012-3#1)
This study aimed to evaluate the##6##6##(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
This study aimed to evaluate##7##5##(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
This study aimed to examine the##2##6##(2012-2#1)(2013-1#1)
This study aimed to identify##4##5##(2011-2#2)(2012-3#1)(2012-8#1)
This study aimed to investigate the##4##6##(2008-10#1)(2012-3#2)(2013-7#1)
This study aimed to investigate##5##5##(2008-10#1)(2012-3#2)(2013-7#1)(2013-8#1)
This study aimed to##37##4##(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-5#1)(2010-1#2)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#5)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#3)
This study aimed##40##3##(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-5#1)(2010-1#2)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#6)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#3)
This study aims at##3##4##(1994-6#1)(2009-11#1)(2011-1#1)
This study aims to determine the##2##6##(2011-1#1)(2011-2#1)
This study aims to evaluate##2##5##(2008-10#1)(2012-3#1)
This study aims to identify##2##5##(2010-10#1)(2010-2#1)
This study aims to##13##4##(2008-10#1)(2008-11#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
This study aims##16##3##(1994-6#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
This study also##12##3##(1991-12#1)(1992-12#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#1)
This study analysed##2##3##(2008-12#1)(2012-1#1)
This study analyzed the accuracy of acute pain diagnoses after the implementation of a systematic evaluation of pain (study intervention)##2##20##(2013-1#2)
This study analyzed the##3##4##(2013-1#2)(2013-7#1)
This study analyzed##6##3##(1995-12#1)(2013-1#4)(2013-7#1)
This study analyzes the##4##4##(1992-5#1)(1996-3#1)(2008-2#1)(2013-1#1)
This study analyzes##7##3##(1992-5#1)(1993-6#1)(1995-2#1)(1996-3#2)(2008-2#1)(2013-1#1)
This study assessed the effects of##2##6##(1993-3#1)(2008-7#1)
This study assessed the relationship between##2##6##(2008-12#1)(2011-1#1)
This study assessed the##13##4##(1993-3#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
This study assessed##18##3##(1993-3#1)(1995-2#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
This study assesses the##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
This study assesses##5##3##(1997-3#1)(2008-11#1)(2008-3#1)(2010-3#1)(2012-2#1)
This study attempted to determine the##2##6##(1993-2#1)(2008-9#1)
This study attempted to##3##4##(1993-2#1)(2008-10#1)(2008-9#1)
This study attempts to##3##4##(2008-9#1)(2010-5#1)(2011-2#1)
This study characterized the##2##4##(2010-1#1)(2013-1#1)
This study characterized##3##3##(2008-10#1)(2010-1#1)(2013-1#1)
This study clearly##3##3##(2008-10#1)(2008-11#2)
This study compared the##9##4##(1993-1#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-1#1)(2011-2#3)(2013-1#1)
This study compared two##2##4##(2008-4#1)(2009-3#1)
This study compared##17##3##(1993-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-8#1)
This study compares the##5##4##(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(2012-1#1)
This study compares##9##3##(1992-12#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-7#1)(2012-1#1)(2012-3#1)
This study concludes##2##3##(1995-12#1)(2013-1#1)
This study confirmed that##2##4##(2008-10#1)(2011-2#1)
This study confirmed##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
This study confirms that##4##4##(2008-10#2)(2008-9#1)(2009-2#1)
This study confirms the##3##4##(1995-2#1)(2008-10#2)
This study confirms##8##3##(1994-3#1)(1995-2#1)(2008-10#4)(2008-9#1)(2009-2#1)
This study contributes the##2##4##(2013-1#2)
This study contributes##3##3##(2010-10#1)(2013-1#2)
This study could##2##3##(2011-3#1)(2013-8#1)
This study deals with the##4##5##(2008-10#2)(2008-5#2)
This study deals with##6##4##(1995-12#1)(2007-2#1)(2008-10#2)(2008-5#2)
This study deals##7##3##(1995-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#2)
This study demonstrated that the##2##5##(2011-2#2)
This study demonstrated that##9##4##(2008-10#1)(2008-12#2)(2010-5#1)(2010-9#1)(2011-2#4)
This study demonstrated##11##3##(2008-10#1)(2008-12#2)(2009-1#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#4)
This study demonstrates a##4##4##(1990-11#1)(1995-12#1)(1996-3#1)(2008-10#1)
This study demonstrates that the##2##5##(2008-10#1)(2008-3#1)
This study demonstrates that##15##4##(1992-6#1)(1995-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2012-2#1)(2013-1#1)
This study demonstrates the efficacy of##2##6##(2010-1#1)(2013-1#1)
This study demonstrates the potential##3##5##(1992-1#1)(2008-5#1)(2012-1#1)
This study demonstrates the utility of##2##6##(2008-9#2)
This study demonstrates the##17##4##(1992-1#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
This study demonstrates##41##3##(1990-11#1)(1992-1#1)(1992-3#1)(1992-6#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-8#2)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)
This study describes a##4##4##(2008-10#3)(2008-6#1)
This study describes an##4##4##(1991-12#1)(1994-6#1)(2008-10#1)(2012-2#1)
This study describes how##2##4##(2010-4#1)(2010-9#1)
This study describes the development##3##5##(2008-10#1)(2008-6#1)(2010-10#1)
This study describes the##15##4##(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
This study describes##33##3##(1991-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2008-10#8)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
This study detected##2##3##(2008-12#1)(2012-7#1)
This study determined the##3##4##(1993-2#1)(2012-2#1)(2013-1#1)
This study determined##5##3##(1993-2#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
This study documents##2##3##(1993-9#1)(2008-6#1)
This study does not support the##2##6##(2007-11#1)(2008-9#1)
This study does not##3##4##(1992-12#1)(2007-11#1)(2008-9#1)
This study draws##2##3##(2009-12#1)(2012-2#1)
This study emphasizes the##2##4##(2008-11#1)(2013-8#1)
This study employed##2##3##(2007-8#1)(2013-1#1)
This study establishes the##2##4##(2008-10#1)(2013-1#1)
This study establishes##3##3##(1991-8#1)(2008-10#1)(2013-1#1)
This study estimated the##2##4##(1997-1#1)(2012-12#1)
This study evaluated the effect of##2##6##(2008-12#1)(2011-1#1)
This study evaluated the effectiveness of##2##6##(2008-12#1)(2012-2#1)
This study evaluated the influence of##2##6##(2008-12#1)(2011-2#1)
This study evaluated the##20##4##(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)
This study evaluated##32##3##(1995-11#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)
This study evaluates the##9##4##(1993-2#1)(1993-3#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-2#1)(2013-8#1)
This study evaluates##11##3##(1993-2#1)(1993-3#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-2#1)(2013-8#1)
This study examined the effect of a##2##7##(1991-2#1)(2013-1#1)
This study examined the effect of##4##6##(1991-2#2)(1995-12#1)(2013-1#1)
This study examined the effects of##8##6##(1990-9#1)(1994-8#1)(2008-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)
This study examined the relationship between the##2##7##(2010-6#1)(2011-2#1)
This study examined the relationship between##5##6##(2009-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
This study examined the relationship##6##5##(2009-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
This study examined the relative contribution of##2##7##(2007-12#2)
This study examined the relative##3##5##(1992-11#1)(2007-12#2)
This study examined the role of##2##6##(1991-12#1)(2008-10#1)
This study examined the##43##4##(1990-9#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-12#2)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-5#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
This study examined whether##5##4##(1996-2#1)(2008-5#1)(2009-12#1)(2009-7#1)(2012-3#1)
This study examined##75##3##(1990-2#1)(1990-9#1)(1991-12#2)(1991-2#3)(1992-11#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#6)(2009-9#3)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
This study examines how##2##4##(2008-5#1)(2008-8#1)
This study examines the effects of##2##6##(1993-3#1)(2008-5#1)
This study examines the influence##2##5##(2008-6#1)(2012-3#1)
This study examines the relationship between##2##6##(1995-12#1)(1997-3#1)
This study examines the##26##4##(1992-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#2)(2012-3#1)
This study examines##45##3##(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
This study explored the prevalence##2##5##(2009-7#1)(2012-12#1)
This study explored the##7##4##(1994-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
This study explored##10##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
This study explores the impact of##2##6##(1997-1#1)(2013-8#1)
This study explores the##7##4##(1996-2#1)(1997-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
This study explores##12##3##(1994-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
This study extended##2##3##(2008-9#1)(2010-8#1)
This study extends previous##2##4##(1994-3#1)(2013-8#1)
This study extends##3##3##(1994-3#1)(2008-9#1)(2013-8#1)
This study focuses on the##3##5##(1992-8#1)(2008-10#1)(2008-11#1)
This study found that##2##4##(2008-11#1)(2009-9#1)
This study found##3##3##(2008-11#1)(2008-3#1)(2009-9#1)
This study gave##2##3##(2008-10#1)(2008-11#1)
This study has been##3##4##(2008-10#1)(2011-2#2)
This study has shown that##4##5##(1990-6#1)(2008-7#1)(2008-9#1)(2010-12#1)
This study has##15##3##(1990-2#1)(1990-6#1)(1991-12#1)(1993-2#1)(1997-1#1)(2007-10#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#3)(2013-8#1)
This study highlighted the##2##4##(2008-1#1)(2011-2#1)
This study highlights the##4##4##(2007-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
This study highlights##5##3##(2007-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
This study identified##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
This study identifies##2##3##(1997-2#1)(2008-4#1)
This study illuminates##2##3##(1994-8#1)(2008-1#1)
This study included##9##3##(1991-1#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-1#1)(2008-11#1)(2011-2#1)(2012-3#2)
This study indicated##2##3##(1992-8#1)(2008-9#1)
This study indicates a##2##4##(2007-1#1)(2013-8#1)
This study indicates that the##3##5##(2008-3#1)(2013-1#2)
This study indicates that##14##4##(1996-6#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#3)
This study indicates##19##3##(1996-6#1)(1996-9#1)(2007-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
This study investigated the effect of##4##6##(1993-12#1)(2008-12#1)(2010-9#1)(2011-2#1)
This study investigated the effectiveness of##2##6##(1993-2#1)(2008-7#1)
This study investigated the effects of##3##6##(2008-5#1)(2008-9#1)(2011-1#1)
This study investigated the influence of##2##6##(1994-12#1)(2009-7#1)
This study investigated the possible##2##5##(1994-11#1)(2011-2#1)
This study investigated the presence of the##2##7##(2007-7#1)(2013-1#1)
This study investigated the##34##4##(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1996-2#1)(1997-4#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
This study investigated whether##6##4##(1994-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-2#1)
This study investigated##49##3##(1991-2#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
This study investigates the effect of##3##6##(1996-12#1)(2007-12#1)(2008-11#1)
This study investigates the influence of##2##6##(2008-5#1)(2009-5#1)
This study investigates the relationship##2##5##(2008-7#1)(2008-8#1)
This study investigates the##16##4##(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
This study investigates##20##3##(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#2)
This study is a part of##2##6##(2009-11#1)(2010-6#1)
This study is a##4##4##(2009-11#1)(2010-3#1)(2010-6#1)(2011-2#1)
This study is an##4##4##(2008-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
This study is based on##3##5##(2008-2#2)(2010-10#1)
This study is focused on##2##5##(1994-5#1)(2008-9#1)
This study is part of the##2##6##(2008-7#1)(2010-4#1)
This study is part of##3##5##(1992-1#1)(2008-7#1)(2010-4#1)
This study is the first to##5##6##(1993-1#1)(1994-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
This study is the first##8##5##(1993-1#1)(1994-11#1)(2008-11#1)(2008-6#1)(2010-9#1)(2011-2#1)(2013-8#2)
This study is the##9##4##(1993-1#1)(1994-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#1)(2013-8#2)
This study is to##4##4##(2010-8#1)(2011-3#3)
This study is##39##3##(1992-1#1)(1993-1#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
This study may##3##3##(1997-4#1)(2011-2#1)(2012-2#1)
This study measured the##2##4##(1995-1#1)(1996-2#1)
This study measured##5##3##(1995-1#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-9#1)
This study observed##2##3##(2008-5#1)(2008-7#1)
This study of##5##3##(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-1#1)
This study offers##2##3##(2010-5#1)(2012-2#1)
This study points##2##3##(1994-6#1)(2013-7#1)
This study presents a##7##4##(2007-11#1)(2008-10#3)(2009-8#1)(2010-3#1)(2011-2#1)
This study presents data on##2##5##(1991-6#1)(2007-8#1)
This study presents the##3##4##(2011-1#1)(2011-2#2)
This study presents##17##3##(1991-6#1)(1994-8#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)
This study proposes##2##3##(2008-5#1)(2009-10#1)
This study proved also that very important##2##7##(2007-11#2)
This study proved that##2##4##(2007-11#1)(2008-10#1)
This study proved##4##3##(2007-11#3)(2008-10#1)
This study proves that##2##4##(1990-6#1)(2008-10#1)
This study provided##6##3##(1991-12#1)(2008-1#1)(2008-5#1)(2010-1#1)(2010-11#1)(2013-1#1)
This study provides a basis for##2##6##(2010-12#1)(2010-8#1)
This study provides a##4##4##(2008-10#1)(2010-12#1)(2010-8#1)(2012-12#1)
This study provides evidence for##2##5##(1994-8#1)(2013-8#1)
This study provides evidence that##2##5##(1994-6#1)(2008-9#1)
This study provides evidence##6##4##(1990-3#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
This study provides information on##2##5##(1997-6#1)(2010-8#1)
This study provides information##3##4##(1997-6#1)(2008-10#1)(2010-8#1)
This study provides insights into##2##5##(2012-2#1)(2013-1#1)
This study provides preliminary##2##4##(2008-12#1)(2011-2#1)
This study provides the first##5##5##(1990-7#1)(1993-3#1)(1995-2#1)(2008-10#2)
This study provides##32##3##(1990-3#1)(1990-7#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-10#9)(2008-12#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
This study replicates##2##3##(1996-2#1)(2009-8#1)
This study report##2##3##(2008-1#1)(2008-12#1)
This study reports a##2##4##(2008-10#1)(2008-11#1)
This study reports on the##2##5##(2007-7#1)(2008-7#1)
This study reports on##4##4##(2007-7#1)(2008-1#1)(2008-7#1)(2009-5#1)
This study reports that##2##4##(1995-2#1)(1995-6#1)
This study reports the##9##4##(1997-7#1)(2008-10#4)(2008-11#1)(2010-5#1)(2012-7#1)(2013-1#1)
This study reports##22##3##(1990-12#1)(1991-2#1)(1995-2#1)(1995-6#2)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-7#1)(2013-1#1)
This study represents one of##2##5##(2008-10#1)(2008-8#1)
This study represents the first##3##5##(2008-10#1)(2008-9#1)(2010-3#1)
This study represents##6##3##(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
This study revealed that##3##4##(2007-2#1)(2008-12#1)(2011-2#1)
This study revealed##5##3##(2007-2#1)(2008-12#2)(2011-2#1)(2012-2#1)
This study reveals that the##2##5##(2008-1#1)(2009-5#1)
This study reveals the##2##4##(1997-4#1)(2013-1#1)
This study reveals##6##3##(1997-4#1)(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#2)
This study reviews the##2##4##(2012-2#2)
This study reviews##3##3##(1996-1#1)(2012-2#2)
This study set out to##2##5##(2008-7#1)(2010-12#1)
This study showed a##2##4##(2006-10#1)(2013-1#1)
This study showed that the##3##5##(2007-10#1)(2008-1#1)(2013-8#1)
This study showed that there##2##5##(2012-1#1)(2013-8#1)
This study showed that##13##4##(2007-10#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#2)
This study showed##19##3##(1992-12#1)(1994-9#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
This study shows a##3##4##(1991-8#1)(1993-12#1)(1996-3#1)
This study shows that the##7##5##(1990-7#1)(1995-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
This study shows that this##2##5##(2008-10#1)(2008-5#1)
This study shows that##25##4##(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#2)
This study shows##31##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-12#2)(1995-6#1)(1996-3#1)(1996-5#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-3#2)
This study sought to examine##2##5##(2008-6#1)(2012-2#1)
This study sought to investigate##2##5##(2008-11#1)(2008-5#1)
This study sought to##10##4##(2008-11#2)(2008-5#1)(2008-6#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
This study suggests that a##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
This study suggests that the##5##5##(1990-7#1)(1991-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
This study suggests that##21##4##(1990-12#1)(1990-7#1)(1991-3#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
This study suggests the##2##4##(1990-3#1)(2008-10#1)
This study suggests##24##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-3#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
This study supports the hypothesis that##2##6##(1993-6#1)(2013-1#1)
This study supports the use of##2##6##(2008-11#1)(2012-3#1)
This study supports the##6##4##(1993-6#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
This study supports##10##3##(1993-6#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
This study tested the hypothesis that the##2##7##(1993-6#1)(2008-3#1)
This study tested the hypothesis that##4##6##(1993-6#1)(1995-12#1)(2008-3#2)
This study tested the##6##4##(1993-6#1)(1995-12#1)(1996-5#1)(2008-3#2)(2008-9#1)
This study tested##7##3##(1993-6#1)(1995-12#1)(1996-5#1)(2008-3#2)(2008-9#1)(2009-9#1)
This study tests##3##3##(1995-2#1)(2008-9#1)(2013-8#1)
This study used a##3##4##(2008-9#1)(2009-4#1)(2013-1#1)
This study used the##3##4##(2008-5#1)(2010-7#1)(2011-1#1)
This study used##15##3##(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2013-1#2)
This study uses the##2##4##(2009-12#1)(2009-7#1)
This study uses##6##3##(1995-2#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)
This study was a##2##4##(2010-3#1)(2012-12#1)
This study was aimed at investigating the##2##7##(2010-12#1)(2012-12#1)
This study was aimed at##7##5##(1994-8#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
This study was aimed to##5##5##(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
This study was aimed##12##4##(1994-8#1)(2008-3#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
This study was based on##5##5##(2007-11#1)(2008-11#1)(2008-5#1)(2010-11#1)(2012-12#1)
This study was carried out on##2##6##(2008-2#1)(2008-7#1)
This study was carried out to determine the##4##8##(1994-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
This study was carried out to investigate the##3##8##(2008-12#1)(2009-12#1)(2009-7#1)
This study was carried out to##10##6##(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
This study was carried out##16##5##(1991-12#1)(1994-3#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
This study was conducted at the##3##6##(1994-1#1)(2007-7#1)(2008-9#1)
This study was conducted at##4##5##(1994-1#1)(2007-7#1)(2008-5#1)(2008-9#1)
This study was conducted in order to##2##7##(1997-7#1)(2008-9#1)
This study was conducted in##4##5##(1997-7#1)(2008-1#1)(2008-9#1)(2013-1#1)
This study was conducted over##2##5##(2007-8#1)(2008-10#1)
This study was conducted to determine the##5##7##(1994-6#1)(1995-1#1)(1995-11#1)(2008-4#1)(2010-4#1)
This study was conducted to determine##6##6##(1994-6#1)(1995-1#1)(1995-11#1)(2008-10#1)(2008-4#1)(2010-4#1)
This study was conducted to evaluate the##2##7##(2010-4#1)(2012-2#1)
This study was conducted to evaluate##3##6##(2008-7#1)(2010-4#1)(2012-2#1)
This study was conducted to investigate the effects of##2##9##(2010-2#1)(2011-2#1)
This study was conducted to test##2##6##(2008-10#1)(2012-2#1)
This study was conducted to##21##5##(1990-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-2#2)(2013-8#1)
This study was conducted##35##4##(1990-12#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
This study was designed to assess##2##6##(1994-3#1)(2011-2#1)
This study was designed to compare the##5##7##(1991-12#1)(1994-12#1)(1996-3#1)(2008-5#1)(2013-8#1)
This study was designed to determine the##3##7##(2008-10#1)(2008-6#1)(2012-3#1)
This study was designed to determine##5##6##(1992-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)
This study was designed to evaluate the frequency of rheumatological background in patients candidate for valvular heart surgery in Afshar Cardiovascular Center##2##22##(2013-1#2)
This study was designed to evaluate the##6##7##(1995-8#1)(2007-7#2)(2011-2#1)(2013-1#2)
This study was designed to evaluate##7##6##(1995-8#1)(2007-7#2)(2011-2#1)(2013-1#3)
This study was designed to examine the##2##7##(1992-2#1)(2008-9#1)
This study was designed to explore the##3##7##(2006-10#1)(2008-3#1)(2011-2#1)
This study was designed to investigate the##7##7##(1993-12#1)(1993-3#1)(2008-10#1)(2008-12#1)(2011-2#3)
This study was designed to investigate##9##6##(1993-12#1)(1993-3#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#4)
This study was designed to measure##2##6##(1993-9#1)(1995-2#1)
This study was designed to##47##5##(1991-12#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#8)(2012-3#2)(2013-1#3)(2013-8#1)
This study was designed##48##4##(1991-12#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#8)(2012-3#2)(2013-1#4)(2013-8#1)
This study was done to##3##5##(2007-7#1)(2008-12#1)(2013-8#1)
This study was done##5##4##(1990-10#1)(2007-7#1)(2008-12#1)(2008-7#1)(2013-8#1)
This study was initiated to##2##5##(2008-10#2)
This study was performed to determine##2##6##(2008-3#1)(2008-7#1)
This study was performed to evaluate##2##6##(2008-1#1)(2013-8#1)
This study was performed to##9##5##(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2013-8#1)
This study was performed##12##4##(1996-5#1)(2008-1#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2013-8#1)
This study was to investigate##2##5##(2011-2#1)(2013-1#1)
This study was to##4##4##(2009-1#1)(2009-9#1)(2011-2#1)(2013-1#1)
This study was undertaken to assess the##3##7##(1991-12#1)(1994-6#1)(2008-10#1)
This study was undertaken to assess##4##6##(1991-12#1)(1993-12#1)(1994-6#1)(2008-10#1)
This study was undertaken to compare##2##6##(2008-5#1)(2011-2#1)
This study was undertaken to determine the##5##7##(1996-2#1)(2007-8#1)(2009-3#1)(2010-4#1)(2012-12#1)
This study was undertaken to determine##7##6##(1996-2#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-4#1)(2010-6#1)(2012-12#1)
This study was undertaken to evaluate the##3##7##(1991-4#1)(2008-12#1)(2013-1#1)
This study was undertaken to##23##5##(1991-12#1)(1991-4#1)(1993-12#2)(1994-1#1)(1994-6#1)(1996-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
This study was##170##3##(1990-10#1)(1990-12#1)(1991-12#3)(1991-4#1)(1992-11#1)(1992-2#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#2)(2007-11#3)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#1)(2008-12#9)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#15)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#5)
This study will##6##3##(1994-3#1)(1996-3#1)(2007-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
This study##1159##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#10)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#4)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#6)(1993-11#1)(1993-12#8)(1993-2#7)(1993-3#6)(1993-6#4)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#9)(1994-8#10)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#9)(1995-2#12)(1995-5#3)(1995-6#5)(1995-8#1)(1996-1#4)(1996-12#5)(1996-2#9)(1996-3#7)(1996-5#5)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#7)(1997-4#7)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#3)(2007-1#1)(2007-10#9)(2007-11#13)(2007-12#8)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#5)(2008-1#16)(2008-10#118)(2008-11#40)(2008-12#41)(2008-2#9)(2008-3#22)(2008-4#10)(2008-5#34)(2008-6#19)(2008-7#31)(2008-8#11)(2008-9#40)(2009-1#3)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#10)(2009-4#2)(2009-5#10)(2009-6#3)(2009-7#18)(2009-8#8)(2009-9#8)(2010-1#8)(2010-10#9)(2010-11#5)(2010-12#5)(2010-2#8)(2010-3#7)(2010-4#11)(2010-5#11)(2010-6#7)(2010-7#4)(2010-8#14)(2010-9#6)(2011-1#24)(2011-10#1)(2011-2#77)(2011-3#4)(2012-1#11)(2012-12#12)(2012-2#35)(2012-3#27)(2012-7#2)(2012-8#1)(2013-1#73)(2013-7#8)(2013-8#32)
This study's##2##2##(2010-2#1)(2012-2#1)
This substance##3##2##(1990-7#1)(1993-3#1)(2008-11#1)
This substitution##2##2##(1990-12#1)(2008-10#1)
This substrate##2##2##(1996-12#1)(2008-4#1)
This suggested that the##3##4##(1990-2#1)(2007-12#1)(2008-10#1)
This suggested that##11##3##(1990-2#1)(1994-6#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
This suggested##13##2##(1990-2#1)(1991-3#1)(1994-6#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)
This suggests a potential##2##4##(1996-2#1)(2013-7#1)
This suggests a##6##3##(1994-8#2)(1996-2#1)(2008-10#1)(2010-3#1)(2013-7#1)
This suggests that a##2##4##(2008-3#1)(2008-7#1)
This suggests that natural##2##4##(2008-11#1)(2008-8#1)
This suggests that our##2##4##(1992-8#1)(2008-7#1)
This suggests that the##26##4##(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#1)
This suggests that these##3##4##(1992-11#1)(1992-12#1)(1995-11#1)
This suggests that##94##3##(1990-12#3)(1990-5#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-8#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
This suggests the##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
This suggests##113##2##(1990-12#3)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-8#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-2#3)(1994-8#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
This summary##2##2##(1991-1#1)(2008-10#1)
This supports the##4##3##(1996-5#1)(2007-6#1)(2008-5#1)(2012-1#1)
This supports##6##2##(1992-10#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-1#1)
This supposition##2##2##(2008-11#1)(2008-2#1)
This suppression is##2##3##(1995-3#1)(2008-4#1)
This suppression##3##2##(1995-3#1)(2008-4#2)
This surgical##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
This survey of##2##3##(1996-12#1)(1996-4#1)
This survey was##4##3##(1992-1#1)(1993-3#1)(2008-10#1)(2008-7#1)
This survey##13##2##(1990-12#1)(1992-1#1)(1993-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)
This survival##2##2##(1990-6#1)(1996-12#1)
This susceptibility##3##2##(1991-12#1)(2007-11#1)(2007-8#1)
This switch is##3##3##(2008-10#1)(2008-3#2)
This switch##4##2##(2008-1#1)(2008-10#1)(2008-3#2)
This symposium was##3##3##(2008-5#3)
This symposium##6##2##(2008-5#5)(2010-7#1)
This syndrome is characterized by##2##5##(1991-3#1)(2008-7#1)
This syndrome##4##2##(1991-3#1)(2008-3#1)(2008-7#1)(2013-8#1)
This synthesis##2##2##(2008-2#1)(2010-2#1)
This system allows##3##3##(1990-5#1)(2008-11#1)(2008-2#1)
This system can##4##3##(2008-3#1)(2008-7#1)(2010-6#1)(2010-8#1)
This system consists of a##2##5##(2008-2#2)
This system enables us to##2##5##(1991-9#1)(1996-12#1)
This system enables##3##3##(1991-9#1)(1996-12#1)(2008-10#1)
This system has been##4##4##(1991-12#1)(2007-12#1)(2008-10#1)(2008-6#1)
This system has##9##3##(1991-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-12#1)
This system is##8##3##(1990-11#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#3)
This system offers##2##3##(1995-2#1)(2010-7#1)
This system permits##2##3##(1994-3#1)(2008-2#1)
This system should be useful##2##5##(1992-1#1)(2008-5#1)
This system should##3##3##(1992-1#1)(1994-8#1)(2008-5#1)
This system was applied##2##4##(2008-10#2)
This system was found to give compact spots for##2##9##(2008-10#2)
This system was successfully applied##2##5##(2007-12#1)(2008-10#1)
This system was##9##3##(1990-11#1)(2007-12#1)(2008-10#6)(2008-2#1)
This system##66##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-9#3)(1992-1#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#4)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-6#2)(2010-7#1)(2010-8#2)(2012-12#1)(2013-1#1)
This systematic review is##2##4##(2011-2#1)(2012-3#1)
This systematic review##6##3##(2011-2#1)(2012-3#2)(2013-1#3)
This systematic##7##2##(1990-8#1)(2011-2#1)(2012-3#2)(2013-1#3)
This takes##3##2##(2008-12#1)(2008-3#1)(2009-4#1)
This target##2##2##(2007-11#1)(2012-3#1)
This task is##2##3##(2008-4#2)
This task##3##2##(2008-4#3)
This team##2##2##(1992-5#1)(2013-1#1)
This technically##2##2##(1995-12#1)(2008-11#1)
This technique allows##7##3##(2007-11#2)(2008-10#4)(2008-7#1)
This technique can be##2##4##(2007-9#1)(2008-3#1)
This technique can##8##3##(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
This technique consists of##3##4##(1990-9#1)(2008-3#1)(2010-6#1)
This technique could be##2##4##(2008-10#1)(2008-11#1)
This technique could##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
This technique enabled the##2##4##(1995-6#1)(2007-11#1)
This technique facilitates##2##3##(2008-11#1)(2008-2#1)
This technique gives##2##3##(2007-11#1)(2007-6#1)
This technique has a##2##4##(2008-3#1)(2008-9#1)
This technique has an##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
This technique has been applied##3##5##(1996-8#1)(2007-12#1)(2008-10#1)
This technique has##12##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-9#1)(2012-12#1)
This technique is a##2##4##(2008-3#2)
This technique is based on the##7##6##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)
This technique is based on##10##5##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2010-5#1)(2010-7#1)
This technique is useful for##2##5##(2007-12#1)(2008-3#1)
This technique is##30##3##(1992-6#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#7)(2008-4#3)(2008-9#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
This technique makes it possible to##2##6##(1996-5#1)(2008-11#1)
This technique may be used for##2##6##(2008-3#1)(2008-7#1)
This technique may be##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
This technique may##6##3##(1990-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)
This technique of monitoring the levels of endocrine-disruptors in##2##9##(2008-10#2)
This technique of##3##3##(1991-9#1)(2008-10#2)
This technique offers a##2##4##(2007-11#1)(2007-12#1)
This technique offers##3##3##(2007-11#1)(2007-12#1)(2010-8#1)
This technique permits##3##3##(2007-12#2)(2008-10#1)
This technique provides a##2##4##(2008-10#1)(2008-5#1)
This technique provides##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-10#1)
This technique requires##2##3##(2009-5#1)(2011-2#1)
This technique shows##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
This technique uses##2##3##(2007-12#1)(2008-3#1)
This technique was##6##3##(2008-10#4)(2008-3#1)(2012-2#1)
This technique##129##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-8#1)(2007-11#14)(2007-12#11)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-11#3)(2008-2#7)(2008-3#21)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#6)(2009-2#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
This technological##2##2##(2008-11#1)(2008-8#1)
This technology allows##2##3##(2008-12#1)(2008-2#1)
This technology has##2##3##(2007-11#1)(2008-11#1)
This technology is##2##3##(2008-10#1)(2008-4#1)
This technology##11##2##(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
This tendency to##2##3##(1994-3#1)(2008-10#1)
This tendency was##2##3##(1995-11#1)(2007-6#1)
This tendency##5##2##(1994-3#1)(1995-11#1)(2007-6#1)(2008-10#1)(2008-7#1)
This test is##2##3##(2008-5#1)(2008-9#1)
This test##7##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
This theoretical##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
This theory is##2##3##(2008-1#1)(2008-3#1)
This theory##9##2##(2008-1#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2012-3#1)
This therapy##2##2##(2008-6#1)(2009-5#1)
This threshold##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
This time##3##2##(2008-11#1)(2008-8#1)(2010-6#1)
This tissue##2##2##(1990-11#1)(2008-5#1)
This tool##2##2##(2008-10#1)(2008-3#1)
This toxicity##2##2##(1991-12#1)(1995-5#1)
This transformation##4##2##(1993-8#1)(1995-2#1)(2008-12#1)(2009-11#1)
This transient##2##2##(1994-5#1)(2008-11#1)
This transition##3##2##(1996-8#1)(2008-3#1)(2008-7#1)
This translated into a##2##4##(2008-10#2)
This transport##2##2##(1990-2#1)(2009-8#1)
This treatment##9##2##(1994-2#2)(1996-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
This trend is##2##3##(1992-3#1)(1997-1#1)
This trend##7##2##(1992-3#1)(1992-6#1)(1993-12#1)(1997-1#2)(2007-12#1)(2012-12#1)
This trial was##4##3##(1991-1#1)(2007-10#1)(2013-1#1)(2013-7#1)
This trial##6##2##(1991-1#1)(1996-12#1)(2007-10#1)(2013-1#1)(2013-7#1)(2013-8#1)
This tumor##2##2##(2007-8#2)
This tunable##2##2##(2008-2#1)(2008-3#1)
This tutorial##2##2##(1994-2#1)(1996-2#1)
This two-day meeting##2##3##(2008-5#2)
This two-day##3##2##(2008-5#3)
This two-part article##3##3##(1992-3#1)(1994-1#1)(1994-2#1)
This type of cancer##2##4##(1997-6#1)(2013-8#1)
This type of culture##2##4##(2008-10#1)(2008-11#1)
This type of##32##3##(1992-8#1)(1992-9#1)(1994-1#2)(1995-2#1)(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
This type##33##2##(1991-11#1)(1992-8#1)(1992-9#1)(1994-1#2)(1995-2#1)(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
This uncertainty##2##2##(2011-2#1)(2012-1#1)
This underlines the##2##3##(2007-12#1)(2008-2#1)
This understanding##3##2##(2008-12#1)(2010-6#1)(2013-7#1)
This unique##9##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
This unit addresses all three of these health management practices##2##10##(2008-4#2)
This unit addresses the##2##4##(2008-2#1)(2008-9#1)
This unit addresses##5##3##(2008-2#1)(2008-4#2)(2008-9#2)
This unit also describes##2##4##(2008-1#1)(2008-4#1)
This unit also includes##2##4##(2008-4#2)
This unit also##6##3##(2008-1#2)(2008-4#3)(2008-9#1)
This unit begins with##2##4##(2008-4#2)
This unit briefly##2##3##(2008-4#1)(2008-9#1)
This unit contains a##2##4##(2008-1#1)(2008-4#1)
This unit contains protocols for##4##5##(2008-1#2)(2008-9#2)
This unit contains protocols##5##4##(2008-1#2)(2008-4#1)(2008-9#2)
This unit contains##10##3##(2008-1#3)(2008-4#5)(2008-9#2)
This unit covers steps 1 and 3##2##7##(2008-4#2)
This unit covers the important criteria and methods for appropriately selecting pedigrees for linkage analysis##2##15##(2008-4#2)
This unit covers the##5##4##(2008-4#3)(2008-9#2)
This unit covers##11##3##(2008-2#1)(2008-4#7)(2008-9#3)
This unit deals##2##3##(2008-4#1)(2008-9#1)
This unit demonstrates##2##3##(2008-4#2)
This unit describes a method for amplifying DNA enzymatically by the polymerase chain reaction (PCR)##2##15##(2008-2#1)(2008-9#1)
This unit describes a method for the##2##7##(2008-4#1)(2008-9#1)
This unit describes a method for##13##6##(2008-2#1)(2008-4#7)(2008-9#5)
This unit describes a method to##2##6##(2008-4#1)(2008-9#1)
This unit describes a method##16##5##(2008-2#1)(2008-4#9)(2008-9#6)
This unit describes a number of##2##6##(2008-1#1)(2008-9#1)
This unit describes a procedure for##3##6##(2008-4#2)(2008-9#1)
This unit describes a protocol for##2##6##(2008-1#1)(2008-4#1)
This unit describes a protocol##3##5##(2008-1#1)(2008-4#2)
This unit describes a quantitative##2##5##(2008-1#2)
This unit describes a rapid##2##5##(2008-4#2)
This unit describes a simple and##2##6##(2008-4#1)(2008-9#1)
This unit describes a system##2##5##(2008-9#2)
This unit describes a##50##4##(2008-1#6)(2008-2#1)(2008-4#23)(2008-9#20)
This unit describes an assay##2##5##(2008-4#2)
This unit describes an##7##4##(2008-1#1)(2008-4#4)(2008-9#2)
This unit describes basic##3##4##(2008-4#2)(2008-9#1)
This unit describes functional assays##2##5##(2008-4#2)
This unit describes how to use the##2##7##(2008-4#2)
This unit describes how to use##3##6##(2008-4#3)
This unit describes how to##5##5##(2008-2#1)(2008-4#4)
This unit describes how##6##4##(2008-2#2)(2008-4#4)
This unit describes in detail the##2##6##(2008-4#1)(2008-9#1)
This unit describes in detail##4##5##(2008-4#2)(2008-9#2)
This unit describes in##5##4##(2008-4#2)(2008-9#3)
This unit describes methods for preparation##2##6##(2008-1#1)(2008-9#1)
This unit describes methods for the##4##6##(2008-1#1)(2008-2#1)(2008-4#2)
This unit describes methods for##14##5##(2008-1#2)(2008-2#2)(2008-4#9)(2008-9#1)
This unit describes methods##17##4##(2008-1#2)(2008-2#2)(2008-4#10)(2008-9#3)
This unit describes one##2##4##(2008-4#1)(2008-9#1)
This unit describes procedures for measuring the##2##7##(2008-4#2)
This unit describes procedures for measuring##3##6##(2008-4#3)
This unit describes procedures for the##2##6##(2008-4#1)(2008-9#1)
This unit describes procedures for##11##5##(2008-4#8)(2008-9#3)
This unit describes protocols for detecting protein in a gel by either Coomassie blue##2##14##(2008-2#1)(2008-4#1)
This unit describes protocols for inhibiting##2##6##(2008-2#1)(2008-4#1)
This unit describes protocols for the##3##6##(2008-4#3)
This unit describes protocols for##10##5##(2008-1#2)(2008-2#2)(2008-4#5)(2008-9#1)
This unit describes protocols##13##4##(2008-1#2)(2008-2#2)(2008-4#6)(2008-9#3)
This unit describes strategies##3##4##(2008-2#1)(2008-4#2)
This unit describes technical##2##4##(2008-9#2)
This unit describes techniques##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
This unit describes the analysis of##2##6##(2008-1#1)(2008-9#1)
This unit describes the basic##2##5##(2008-4#1)(2008-9#1)
This unit describes the isolation of##4##6##(2008-4#3)(2008-9#1)
This unit describes the isolation##5##5##(2008-4#4)(2008-9#1)
This unit describes the methods##2##5##(2008-1#1)(2008-9#1)
This unit describes the preparation of##6##6##(2008-2#1)(2008-4#3)(2008-9#2)
This unit describes the production of##2##6##(2008-1#1)(2008-9#1)
This unit describes the purification of##2##6##(2008-1#1)(2008-4#1)
This unit describes the synthesis##3##5##(2008-4#3)
This unit describes the techniques##2##5##(2008-4#1)(2008-9#1)
This unit describes the use of the##4##7##(2008-4#4)
This unit describes the use of##13##6##(2008-1#1)(2008-2#1)(2008-4#8)(2008-9#3)
This unit describes the##81##4##(2008-1#8)(2008-2#6)(2008-4#46)(2008-9#21)
This unit describes three##2##4##(2008-9#2)
This unit describes two protocols that can be used to quantitate##2##11##(2008-4#2)
This unit describes two protocols##3##5##(2008-2#1)(2008-4#2)
This unit describes two##9##4##(2008-1#1)(2008-2#1)(2008-4#5)(2008-9#2)
This unit describes##249##3##(2008-1#25)(2008-2#17)(2008-4#137)(2008-9#70)
This unit details the##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
This unit details##6##3##(2008-2#2)(2008-4#3)(2008-9#1)
This unit discusses the optics and other components of the fluorescence microscope##2##12##(2008-1#1)(2008-4#1)
This unit discusses the##11##4##(2008-1#1)(2008-4#3)(2008-9#7)
This unit discusses##25##3##(2008-1#2)(2008-4#8)(2008-9#15)
This unit explains the##2##4##(2008-4#1)(2008-9#1)
This unit explains##3##3##(2008-4#2)(2008-9#1)
This unit focuses on the##2##5##(2008-4#2)
This unit focuses on##10##4##(2008-1#1)(2008-4#5)(2008-9#4)
This unit gives an overview of the##2##7##(2008-2#1)(2008-9#1)
This unit gives an overview of##3##6##(2008-2#1)(2008-9#2)
This unit identifies##2##3##(2008-2#1)(2008-4#1)
This unit illustrates##2##3##(2008-4#1)(2008-9#1)
This unit includes protocols for the##3##6##(2008-9#3)
This unit includes##4##3##(2008-9#4)
This unit introduces readers to some of the more commonly used techniques for gene identification##2##15##(2008-4#2)
This unit introduces the##2##4##(2008-9#2)
This unit introduces##4##3##(2008-4#2)(2008-9#2)
This unit is intended to##2##5##(2008-2#1)(2008-4#1)
This unit is##7##3##(2008-2#1)(2008-4#4)(2008-9#2)
This unit offers a##2##4##(2008-4#2)
This unit offers##4##3##(2008-4#4)
This unit on##3##3##(2008-9#3)
This unit outlines the##2##4##(2008-4#2)
This unit outlines##5##3##(2008-4#4)(2008-9#1)
This unit presents a general##2##5##(2008-1#1)(2008-4#1)
This unit presents a protocol for semi-quantitative analysis of gene expression of a single cell and quantitative representation of expressed genes from &gt##2##23##(2008-2#1)(2008-4#1)
This unit presents a protocol for##5##6##(2008-2#1)(2008-4#3)(2008-9#1)
This unit presents a protocol##7##5##(2008-2#2)(2008-4#4)(2008-9#1)
This unit presents a representative##2##5##(2008-4#2)
This unit presents a##22##4##(2008-1#1)(2008-2#2)(2008-4#10)(2008-9#9)
This unit presents an alternative to differential display that allows the quantification of transcripts##2##14##(2008-2#2)
This unit presents an overview of the##2##7##(2008-4#1)(2008-9#1)
This unit presents an overview of##4##6##(2008-4#2)(2008-9#2)
This unit presents an##6##4##(2008-2#2)(2008-4#2)(2008-9#2)
This unit presents basic##2##4##(2008-2#1)(2008-9#1)
This unit presents methods for##3##5##(2008-4#1)(2008-9#2)
This unit presents methods##4##4##(2008-4#1)(2008-9#3)
This unit presents procedures for##3##5##(2008-4#2)(2008-9#1)
This unit presents protocols for the##3##6##(2008-4#2)(2008-9#1)
This unit presents protocols for##14##5##(2008-2#1)(2008-4#5)(2008-9#8)
This unit presents protocols##17##4##(2008-2#2)(2008-4#6)(2008-9#9)
This unit presents the##6##4##(2008-4#3)(2008-9#3)
This unit presents two methods of calcium phosphate-based eukaryotic cell transfection that can be used for both transient and stable transfections##2##21##(2008-1#1)(2008-2#1)
This unit presents two protocols for##2##6##(2008-9#2)
This unit presents two##6##4##(2008-1#1)(2008-2#2)(2008-4#1)(2008-9#2)
This unit presents##80##3##(2008-1#2)(2008-2#11)(2008-4#30)(2008-9#37)
This unit provides a brief##2##5##(2008-4#2)
This unit provides a detailed##2##5##(2008-9#2)
This unit provides a general##2##5##(2008-4#2)
This unit provides a protocol##3##5##(2008-4#3)
This unit provides a set of protocols for introducing##2##9##(2008-4#2)
This unit provides a starting point for readers to explore the potential of protein databases on the Internet##2##18##(2008-2#1)(2008-4#1)
This unit provides a summary of some of the issues that researchers face when attempting to store purified proteins##2##19##(2008-4#2)
This unit provides a##21##4##(2008-1#2)(2008-2#1)(2008-4#13)(2008-9#5)
This unit provides an excellent overview##2##6##(2008-9#2)
This unit provides an excellent##3##5##(2008-9#3)
This unit provides an introduction to clinical cytogenetics##2##8##(2008-4#2)
This unit provides an introduction to##4##6##(2008-1#1)(2008-4#3)
This unit provides an overview of the field of synthetic peptides and proteins##2##13##(2008-4#2)
This unit provides an overview of the##3##7##(2008-2#1)(2008-4#2)
This unit provides an overview of##11##6##(2008-2#1)(2008-4#9)(2008-9#1)
This unit provides an##18##4##(2008-1#1)(2008-2#1)(2008-4#12)(2008-9#4)
This unit provides detailed instructions##2##5##(2008-4#1)(2008-9#1)
This unit provides detailed##4##4##(2008-4#2)(2008-9#2)
This unit provides guidelines##2##4##(2008-1#1)(2008-4#1)
This unit provides information##2##4##(2008-2#2)
This unit provides methods for the##2##6##(2008-2#1)(2008-4#1)
This unit provides methods for##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
This unit provides protocols for##7##5##(2008-1#1)(2008-4#3)(2008-9#3)
This unit provides protocols##8##4##(2008-1#1)(2008-4#4)(2008-9#3)
This unit provides the##3##4##(2008-4#2)(2008-9#1)
This unit provides##72##3##(2008-1#5)(2008-2#6)(2008-4#39)(2008-8#1)(2008-9#21)
This unit reports##2##3##(2008-4#2)
This unit reviews the##3##4##(2008-4#3)
This unit reviews##6##3##(2008-4#5)(2008-9#1)
This unit should be required reading for##2##7##(2008-9#2)
This unit summarizes the##2##4##(2008-4#1)(2008-9#1)
This unit summarizes##3##3##(2008-4#2)(2008-9#1)
This unit will describe the use of##2##7##(2008-1#1)(2008-4#1)
This unit will describe the##4##5##(2008-1#2)(2008-4#1)(2008-9#1)
This unit will##7##3##(2008-1#2)(2008-4#2)(2008-9#3)
This unit##564##2##(1997-4#1)(2008-1#42)(2008-2#42)(2008-3#1)(2008-4#283)(2008-8#1)(2008-9#194)
This unusual presentation of##2##4##(2008-7#1)(2013-7#1)
This unusual##6##2##(2008-11#1)(2008-3#1)(2008-7#2)(2009-10#1)(2013-7#1)
This value increased##2##3##(1995-5#1)(2008-11#1)
This value is##5##3##(1994-3#1)(1994-5#1)(1995-5#1)(2007-12#1)(2011-2#1)
This value##12##2##(1994-3#1)(1994-5#1)(1995-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
This variability##2##2##(2008-2#1)(2012-3#1)
This variation in##2##3##(1994-5#1)(2008-10#1)
This variation##5##2##(1994-5#1)(2008-10#2)(2008-7#1)(2012-2#1)
This vector##3##2##(1993-8#1)(1993-9#1)(2007-11#1)
This very##2##2##(2008-3#1)(2008-9#1)
This view##3##2##(2009-10#1)(2010-3#1)(2013-1#1)
This virus has##2##3##(2008-10#1)(2008-9#1)
This virus##4##2##(2008-10#3)(2008-9#1)
This volume##2##2##(2008-11#1)(2009-5#1)
This was a cross-sectional descriptive##2##5##(2011-2#1)(2013-1#1)
This was a cross-sectional study using##2##6##(2011-2#1)(2013-1#1)
This was a cross-sectional study##5##5##(2011-2#2)(2012-12#2)(2013-1#1)
This was a cross-sectional##8##4##(2011-2#3)(2012-12#3)(2013-1#2)
This was a descriptive study which##2##6##(2012-12#1)(2013-1#1)
This was a descriptive study##3##5##(2012-12#2)(2013-1#1)
This was a descriptive##5##4##(2011-2#1)(2012-12#3)(2013-1#1)
This was a prospective##3##4##(2009-6#1)(2012-12#1)(2013-8#1)
This was a retrospective##3##4##(2008-3#1)(2012-12#1)(2013-1#1)
This was a##33##3##(1991-12#1)(1992-10#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-6#1)(2010-8#1)(2011-2#8)(2012-12#10)(2013-1#5)(2013-8#2)
This was accompanied by##2##4##(1990-11#1)(2013-7#1)
This was accompanied##3##3##(1990-11#1)(2008-6#1)(2013-7#1)
This was accomplished by##2##4##(1993-9#1)(2008-10#1)
This was accomplished##3##3##(1993-9#1)(2008-10#1)(2008-5#1)
This was achieved by##6##4##(1993-1#1)(1994-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#1)
This was achieved##9##3##(1993-1#1)(1994-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
This was an##5##3##(1994-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
This was analyzed##2##3##(2008-8#1)(2013-7#1)
This was associated with##4##4##(1995-12#1)(2010-11#2)(2012-2#1)
This was attributed to##3##4##(2008-10#2)(2008-5#1)
This was based##2##3##(1994-12#1)(2011-3#1)
This was because##3##3##(2008-10#2)(2008-3#1)
This was confirmed by the##2##5##(1995-2#1)(1995-6#1)
This was confirmed by##5##4##(1993-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2011-1#1)
This was confirmed in##2##4##(1991-5#1)(2008-10#1)
This was confirmed##10##3##(1991-5#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)
This was corroborated by##3##4##(1995-12#1)(1997-3#1)(2008-10#1)
This was demonstrated by##4##4##(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
This was done by##6##4##(1992-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#1)
This was done##9##3##(1990-10#1)(1992-6#1)(1994-2#1)(2008-10#2)(2008-11#1)(2010-1#1)(2012-12#2)
This was due to##2##4##(2008-9#1)(2011-2#1)
This was due##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
This was followed by##6##4##(1990-10#1)(1996-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
This was in##4##3##(1997-2#1)(2008-10#1)(2008-11#2)
This was interpreted##2##3##(2008-10#1)(2012-7#1)
This was most##2##3##(2008-10#1)(2009-2#1)
This was not##6##3##(1990-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-7#1)(2013-1#1)
This was of##2##3##(1992-8#1)(2011-1#1)
This was part of##2##4##(1996-12#1)(2008-7#1)
This was particularly##5##3##(1994-12#1)(1994-2#1)(2008-10#3)
This was performed##2##3##(1997-6#1)(2008-10#1)
This was probably due to##2##5##(1996-6#1)(2008-11#1)
This was probably##4##3##(1990-6#1)(1994-8#1)(1996-6#1)(2008-11#1)
This was reflected in##3##4##(2008-5#1)(2009-8#1)(2010-8#1)
This was shown by##2##4##(1996-12#1)(2008-10#1)
This was shown##4##3##(1996-12#1)(2008-10#1)(2008-7#1)(2009-2#1)
This was substantiated by##2##4##(1994-2#1)(2008-10#1)
This was successfully##2##3##(2008-10#1)(2010-5#1)
This was the first##2##4##(1992-5#1)(2013-8#1)
This was the##4##3##(1992-5#1)(2008-10#1)(2009-10#1)(2013-8#1)
This was then followed by##2##5##(2008-10#1)(2008-11#1)
This was treated##2##3##(1996-5#1)(2008-1#1)
This was##195##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#5)(1994-2#3)(1994-8#1)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#3)(1996-12#5)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#4)(2008-10#34)(2008-11#10)(2008-12#1)(2008-3#2)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#15)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#5)
This water##2##2##(2008-5#1)(2011-2#1)
This way##7##2##(1991-12#1)(1995-6#1)(2008-10#4)(2008-7#1)
This weak##3##2##(1990-2#1)(1995-12#1)(2008-10#1)
This week in science##5##4##(1990-11#1)(1990-8#1)(1994-9#1)(1995-3#1)(1995-6#1)
This weight##3##2##(1994-11#1)(1997-4#1)(2013-8#1)
This will allow the##3##4##(2008-10#1)(2009-7#1)(2011-2#1)
This will be illustrated##2##4##(2008-11#1)(2008-7#1)
This will be##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
This will help##2##3##(2008-3#1)(2008-7#1)
This will probably##2##3##(1993-2#1)(2010-8#1)
This will require a##2##4##(1997-7#1)(2011-2#1)
This will require international##2##4##(2007-7#1)(2010-5#1)
This will require##5##3##(1994-9#1)(1997-7#1)(2007-7#1)(2010-5#1)(2011-2#1)
This will##31##2##(1993-2#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#3)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
This work aimed##2##3##(1997-4#1)(2008-6#1)
This work approaches##2##3##(2010-8#1)(2013-1#1)
This work assesses##2##3##(2008-10#2)
This work could##2##3##(2008-12#1)(2008-7#1)
This work deals with the##2##5##(2008-10#1)(2009-7#1)
This work demonstrates a##2##4##(1997-7#1)(2008-10#1)
This work demonstrates that an##2##5##(1995-2#1)(2008-7#1)
This work demonstrates that##4##4##(1995-2#1)(2008-10#1)(2008-7#2)
This work demonstrates the##2##4##(2008-7#1)(2009-12#1)
This work demonstrates##8##3##(1995-2#1)(1997-7#1)(2008-10#2)(2008-7#3)(2009-12#1)
This work describes a##3##4##(2008-10#2)(2008-11#1)
This work describes the application of##2##6##(2008-10#2)
This work describes the##5##4##(2008-10#4)(2013-1#1)
This work describes##12##3##(2008-10#7)(2008-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
This work focuses on##2##4##(2007-8#1)(2008-10#1)
This work has been##2##4##(1997-4#1)(2008-10#1)
This work has##7##3##(1997-4#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-8#1)
This work investigates##2##3##(2008-12#1)(2008-5#1)
This work is an##2##4##(2008-10#2)
This work is the##2##4##(2008-10#2)
This work is##11##3##(2007-12#1)(2008-1#1)(2008-10#5)(2008-6#1)(2009-3#1)(2011-2#1)(2013-8#1)
This work outlines##2##3##(2008-1#1)(2008-10#1)
This work presents a##6##4##(2008-10#5)(2009-5#1)
This work presents the##2##4##(2010-10#1)(2011-2#1)
This work presents##10##3##(2008-10#6)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)
This work proposes##2##3##(2008-10#2)
This work provides a##2##4##(2008-10#2)
This work provides new##2##4##(1995-5#1)(2013-8#1)
This work provides##7##3##(1993-9#1)(1995-5#1)(2008-10#4)(2013-8#1)
This work reports a##2##4##(2008-10#2)
This work reports the##5##4##(2008-10#3)(2008-5#1)(2010-4#1)
This work reports##8##3##(2008-10#6)(2008-5#1)(2010-4#1)
This work studies the##2##4##(2008-10#1)(2012-1#1)
This work suggests that##2##4##(2008-8#1)(2011-1#1)
This work suggests##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
This work therefore##2##3##(2006-6#1)(2008-5#1)
This work was##4##3##(1997-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
This work##130##2##(1992-7#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#54)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
This would allow##2##3##(2008-5#1)(2012-2#1)
This would be##3##3##(1996-1#1)(2008-7#1)(2008-9#1)
This would##17##2##(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2012-2#2)(2013-1#1)
This year##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)
This year's##3##2##(2006-10#1)(2010-11#1)(2011-2#1)
This##11763##1##(1990-10#4)(1990-11#38)(1990-12#55)(1990-2#28)(1990-3#13)(1990-5#34)(1990-6#20)(1990-7#22)(1990-8#33)(1990-9#8)(1991-1#26)(1991-10#1)(1991-11#24)(1991-12#73)(1991-2#51)(1991-3#24)(1991-4#3)(1991-5#30)(1991-6#31)(1991-7#5)(1991-8#15)(1991-9#30)(1992-1#34)(1992-10#9)(1992-11#25)(1992-12#57)(1992-2#38)(1992-3#58)(1992-4#9)(1992-5#23)(1992-6#28)(1992-7#3)(1992-8#32)(1992-9#23)(1993-1#29)(1993-11#28)(1993-12#71)(1993-2#45)(1993-3#70)(1993-5#2)(1993-6#25)(1993-8#31)(1993-9#26)(1994-1#45)(1994-10#1)(1994-11#42)(1994-12#78)(1994-2#67)(1994-3#69)(1994-5#37)(1994-6#31)(1994-7#2)(1994-8#48)(1994-9#33)(1995-1#39)(1995-11#31)(1995-12#77)(1995-2#98)(1995-3#56)(1995-5#43)(1995-6#64)(1995-8#23)(1995-9#10)(1996-1#48)(1996-10#3)(1996-11#6)(1996-12#92)(1996-2#86)(1996-3#79)(1996-4#10)(1996-5#27)(1996-6#20)(1996-7#8)(1996-8#8)(1996-9#12)(1997-1#48)(1997-2#80)(1997-3#84)(1997-4#45)(1997-5#12)(1997-6#29)(1997-7#43)(1997-8#25)(2006-10#19)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#1)(2007-1#3)(2007-10#50)(2007-11#208)(2007-12#241)(2007-2#25)(2007-3#1)(2007-4#5)(2007-5#28)(2007-6#11)(2007-7#54)(2007-8#82)(2007-9#3)(2008-1#203)(2008-10#1598)(2008-11#494)(2008-12#228)(2008-2#296)(2008-3#485)(2008-4#480)(2008-5#282)(2008-6#132)(2008-7#416)(2008-8#213)(2008-9#463)(2009-1#12)(2009-10#69)(2009-11#35)(2009-12#44)(2009-2#22)(2009-3#47)(2009-4#31)(2009-5#61)(2009-6#35)(2009-7#59)(2009-8#65)(2009-9#34)(2010-1#28)(2010-10#48)(2010-11#40)(2010-12#52)(2010-2#35)(2010-3#58)(2010-4#43)(2010-5#65)(2010-6#35)(2010-7#50)(2010-8#88)(2010-9#26)(2011-1#148)(2011-10#3)(2011-2#426)(2011-3#19)(2011-7#8)(2011-8#1)(2011-9#2)(2012-1#43)(2012-12#145)(2012-2#232)(2012-3#175)(2012-5#3)(2012-6#2)(2012-7#4)(2012-8#3)(2012-9#1)(2013-1#338)(2013-7#37)(2013-8#167)
Thomas D##2##2##(1993-12#1)(1994-1#1)
Thomas##17##1##(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#2)(2006-10#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
Thomas' Hospital##2##2##(2007-9#1)(2008-5#1)
Thomas'##4##1##(2007-8#2)(2007-9#1)(2008-5#1)
Thominx neopulchra##2##2##(2011-2#2)
Thompson##7##1##(1995-12#1)(2007-10#2)(2008-12#1)(2011-2#2)(2013-1#1)
Thomson##2##1##(1996-12#1)(2010-12#1)
Thorac Surg##2##2##(2007-8#2)
Thoracic Society##7##2##(1990-9#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#1)
Thoracic and##2##2##(2010-9#1)(2013-1#1)
Thoracic aortic##4##2##(2008-12#1)(2009-8#1)(2010-8#1)(2012-2#1)
Thoracic kidney is a rare##2##5##(2011-2#2)
Thoracic outlet syndrome##3##3##(2008-3#3)
Thoracic##35##1##(1990-12#1)(1990-6#1)(1990-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
Thoracoscopic thymectomy##3##2##(2007-8#1)(2012-12#2)
Thoracoscopic##8##1##(2007-8#3)(2008-1#1)(2010-8#2)(2012-12#2)
Thoracoscopy##3##1##(2007-8#1)(2008-5#1)(2012-12#1)
Thoracotomy##4##1##(1991-9#1)(2007-12#1)(2008-1#1)(2011-2#1)
Thorium colloid analysis##2##3##(2008-10#2)
Thorium##3##1##(2008-10#3)
Thorne##3##1##(1995-1#2)(2008-11#1)
Thorough##5##1##(1997-4#1)(2008-10#2)(2009-6#1)(2013-1#1)
Thoroughbred colt##2##2##(2012-3#2)
Those are##2##2##(1992-11#1)(1997-8#1)
Those changes##2##2##(1996-2#1)(2007-11#1)
Those data##4##2##(1994-2#1)(1995-2#1)(2008-8#1)(2008-9#1)
Those for the##2##3##(1994-7#1)(1996-2#1)
Those in the##2##3##(1990-5#1)(2007-11#1)
Those in##5##2##(1990-5#1)(2007-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
Those of the##4##3##(1993-12#1)(2008-10#2)(2008-3#1)
Those of##8##2##(1993-12#1)(1994-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)
Those results##3##2##(1991-8#1)(2008-5#1)(2008-8#1)
Those studies##2##2##(1996-12#1)(2008-10#1)
Those which##2##2##(1994-7#1)(2013-8#1)
Those who had##4##3##(1993-3#1)(2006-10#1)(2008-12#1)(2013-1#1)
Those who have##2##3##(1996-3#1)(2008-12#1)
Those who##17##2##(1993-3#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-12#2)(2008-8#1)(2009-4#1)(2013-1#1)(2013-8#1)
Those with a##2##3##(1995-12#1)(2008-9#1)
Those with##7##2##(1990-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
Those##93##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-7#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#4)(1996-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#4)(2007-2#3)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#5)(2013-8#5)
Though the radial artery is##2##5##(2008-11#1)(2011-2#1)
Though the##15##2##(1992-3#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#1)(2013-8#1)
Though there##2##2##(2008-9#1)(2012-3#1)
Though these##2##2##(2008-7#1)(2012-3#1)
Though this##6##2##(2008-1#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
Though##69##1##(1991-7#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#5)
Thought Suppression Inventory##2##3##(2012-3#2)
Thought##4##1##(2009-11#1)(2012-3#3)
Thousand Oaks##2##2##(2008-12#2)
Thousands of##6##2##(2008-10#2)(2008-2#1)(2009-7#1)(2010-12#1)(2010-8#1)
Thousands##8##1##(2008-10#3)(2008-2#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#1)
Thr and##2##2##(1992-11#1)(1993-11#1)
Thr for##2##2##(1991-9#1)(1993-3#1)
Thr substitution##2##2##(1993-6#2)
Thr##19##1##(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-8#3)(1994-8#2)(2006-12#1)(2008-2#1)(2008-8#1)(2012-2#1)
Thr)##3##1##(1993-3#1)(1993-8#2)
Thr-197##2##1##(1995-2#2)
Thr-290##2##1##(2008-9#2)
Thr147##3##1##(2012-2#3)
Thr348##2##1##(1993-11#2)
Thr399Ile##4##1##(2008-3#3)(2012-3#1)
Thr46##2##1##(1995-5#2)
Thr46--&gt##2##1##(1995-5#2)
Thrace##3##1##(2008-10#1)(2008-12#2)
Threat##2##1##(2008-2#1)(2009-9#1)
Threats to##2##2##(2008-12#1)(2010-10#1)
Threats##3##1##(2008-12#1)(2008-6#1)(2010-10#1)
Three Cases##2##2##(2011-2#1)(2013-1#1)
Three Clonal Lineages of Phytophthora##2##5##(2008-10#2)
Three F(2) populations##2##3##(2008-10#2)
Three QTL on##3##3##(2008-10#3)
Three QTL##4##2##(2008-10#4)
Three alternate##2##2##(1993-12#1)(2008-9#1)
Three approaches to##2##3##(1996-1#1)(2008-11#1)
Three aspects##2##2##(2008-7#1)(2010-12#1)
Three binary##2##2##(2008-10#1)(2012-2#1)
Three cases of##13##3##(1990-12#1)(1990-9#1)(1991-6#1)(1994-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
Three cases##17##2##(1990-12#1)(1990-9#1)(1991-6#1)(1992-5#1)(1994-2#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
Three categories of##2##3##(1997-3#1)(2011-2#1)
Three categories##3##2##(1997-3#1)(2011-2#1)(2013-1#1)
Three children##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
Three cholesterol##2##2##(2008-10#1)(2012-2#1)
Three classes of##2##3##(1992-9#1)(2009-2#1)
Three cultivars have##2##3##(2008-10#2)
Three cultivars##3##2##(2008-10#3)
Three cycles of##2##3##(2008-11#1)(2013-1#1)
Three days after##5##3##(1997-6#1)(2008-10#1)(2012-3#1)(2013-1#2)
Three days##9##2##(1992-6#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-6#1)(2012-3#1)(2013-1#2)
Three deaths and##2##3##(2007-2#2)
Three different genes##2##3##(1991-12#1)(1997-7#1)
Three different methods for the##2##5##(2008-10#2)
Three different methods##3##3##(2008-10#3)
Three different##32##2##(1990-5#1)(1991-12#1)(1994-12#1)(1994-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-6#1)(2012-1#1)(2012-2#1)
Three digestion procedures##2##3##(2008-10#2)
Three distinct##3##2##(1991-12#1)(1994-12#1)(2010-1#1)
Three dogs##2##2##(2008-6#2)
Three enantioselective##2##2##(2008-10#2)
Three examples##2##2##(1990-2#1)(2008-10#1)
Three experiments were carried out to##2##6##(2008-10#1)(2008-6#1)
Three experiments##4##2##(2008-10#2)(2008-6#1)(2009-11#1)
Three factors##2##2##(2007-12#1)(2008-10#1)
Three focus##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
Three forms of##2##3##(1993-3#1)(2008-10#1)
Three forms##3##2##(1993-3#1)(1995-3#1)(2008-10#1)
Three groups of animals were##2##5##(2006-6#1)(2008-11#1)
Three groups of##9##3##(1994-2#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-2#1)
Three groups##10##2##(1994-2#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-2#1)(2010-4#1)
Three hours after##2##3##(1992-12#1)(2009-12#1)
Three hours##3##2##(1992-12#1)(2008-5#1)(2009-12#1)
Three hundred and##5##3##(1991-6#1)(1992-1#1)(2007-10#1)(2007-7#1)(2008-4#1)
Three hundred##12##2##(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-4#1)(2012-3#1)
Three hypotheses##2##2##(2007-8#1)(2010-8#1)
Three independent##2##2##(1997-7#1)(2008-10#1)
Three isolates of##4##3##(2008-10#4)
Three isolates##5##2##(2008-10#5)
Three kinds of##3##3##(1992-9#1)(1993-2#1)(1996-11#1)
Three layers##2##2##(2008-12#1)(2009-4#1)
Three levels of##3##3##(2008-10#3)
Three main##7##2##(1995-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)
Three major##4##2##(1996-4#1)(2008-1#1)(2008-10#1)(2009-4#1)
Three methods are##2##3##(2008-10#1)(2012-3#1)
Three methods of##4##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
Three methods##9##2##(1990-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#1)
Three minor##2##2##(2008-10#1)(2013-1#1)
Three models##2##2##(2008-12#1)(2011-2#1)
Three months after##4##3##(1991-6#1)(1992-12#1)(2008-12#1)(2013-1#1)
Three months later##2##3##(2011-1#1)(2011-2#1)
Three months##7##2##(1991-6#1)(1992-12#1)(1997-7#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
Three new##8##2##(1997-7#1)(1997-9#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
Three of the patients##3##4##(2007-11#1)(2007-8#1)(2008-10#1)
Three of the##19##3##(1990-6#1)(1990-8#1)(1991-6#1)(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
Three of them##4##3##(1991-11#1)(1995-6#1)(2007-7#1)(2011-2#1)
Three of these##4##3##(1990-8#1)(1995-2#1)(1995-6#1)(2008-1#1)
Three of##31##2##(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-6#1)(1993-12#1)(1995-2#1)(1995-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#1)
Three other##5##2##(1991-12#1)(2007-11#1)(2008-10#2)(2008-4#1)
Three out of##5##3##(1992-4#1)(1992-6#1)(1994-11#1)(1996-12#1)(2011-2#1)
Three patients died of breast cancer##2##6##(1990-12#1)(1992-8#1)
Three patients died of##3##4##(1990-12#1)(1992-8#1)(1994-3#1)
Three patients died##4##3##(1990-12#1)(1992-8#1)(1994-3#1)(2013-8#1)
Three patients had##11##3##(1990-9#1)(1991-2#1)(1991-4#1)(1992-9#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#2)
Three patients were##3##3##(1997-8#1)(2008-5#1)(2013-1#1)
Three patients who##2##3##(2006-12#1)(2008-7#1)
Three patients with##2##3##(1991-6#1)(2013-1#1)
Three patients##27##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#4)(2011-2#1)(2013-1#2)(2013-8#1)
Three patterns of##2##3##(1994-9#1)(2010-4#1)
Three peptides were##2##3##(1992-12#1)(1993-11#1)
Three peptides##3##2##(1992-12#1)(1992-8#1)(1993-11#1)
Three percent##2##2##(1996-6#1)(2010-8#1)
Three plant##2##2##(2008-11#1)(2008-8#1)
Three populations##2##2##(1997-2#1)(2008-10#1)
Three presidents##2##2##(1995-3#2)
Three principal##2##2##(1994-8#1)(2008-9#1)
Three problems##2##2##(1994-2#1)(2010-8#1)
Three putative##2##2##(1993-3#1)(2008-10#1)
Three recent legal cases##4##4##(2008-11#4)
Three recent##7##2##(1994-2#1)(2008-11#5)(2008-7#1)
Three regions of##2##3##(1997-5#1)(2008-5#1)
Three regions##4##2##(1993-8#1)(1995-6#1)(1997-5#1)(2008-5#1)
Three research##2##2##(1996-12#1)(2009-5#1)
Three separate##2##2##(2008-4#1)(2008-9#1)
Three sets of##3##3##(2008-10#2)(2009-9#1)
Three simple and sensitive visible spectrophotometric methods##2##7##(2008-10#2)
Three simple##5##2##(2008-10#4)(2010-5#1)
Three species of##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
Three stories##2##2##(2008-11#1)(2008-12#1)
Three strains of##2##3##(2008-7#1)(2008-8#1)
Three strains##3##2##(1993-9#1)(2008-7#1)(2008-8#1)
Three strategies##2##2##(2008-10#2)
Three studies##5##2##(1994-2#1)(2008-10#1)(2009-9#1)(2010-10#1)(2011-2#1)
Three support protocols##2##3##(2008-2#1)(2008-4#1)
Three thousand##2##2##(1995-6#1)(2011-3#1)
Three to##2##2##(1997-6#1)(2008-9#1)
Three types of##18##3##(1990-5#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-1#1)
Three types##19##2##(1990-5#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-1#1)
Three variables##3##2##(1994-1#1)(2008-10#2)
Three women had##2##3##(1990-9#1)(1994-12#1)
Three years later##2##3##(2007-4#1)(2008-1#1)
Three years of##2##3##(2010-8#1)(2012-2#1)
Three years##5##2##(1997-8#1)(2007-4#1)(2008-1#1)(2010-8#1)(2012-2#1)
Three##608##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#7)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#6)(1994-2#7)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#8)(1995-6#8)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#2)(1997-9#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#11)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#5)(2008-1#7)(2008-10#163)(2008-11#26)(2008-12#9)(2008-2#9)(2008-3#11)(2008-4#13)(2008-5#17)(2008-6#7)(2008-7#17)(2008-8#12)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#17)(2011-3#2)(2012-1#4)(2012-2#7)(2012-3#8)(2012-9#1)(2013-1#18)(2013-8#5)
Three-Dimensional Reconstruction##3##2##(2008-2#1)(2010-8#1)(2012-3#1)
Three-Dimensional##6##1##(1996-9#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-3#1)
Three-dimensional (3-D)##2##2##(1994-3#1)(2008-11#1)
Three-dimensional (3D)##2##2##(2008-3#1)(2008-7#1)
Three-dimensional holographic##2##2##(2007-12#1)(2008-3#1)
Three-dimensional image##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
Three-dimensional images of##2##3##(2008-3#1)(2012-3#1)
Three-dimensional imaging of##2##3##(2008-3#2)
Three-dimensional imaging##5##2##(2008-2#1)(2008-3#4)
Three-dimensional object recognition by##2##4##(2007-12#1)(2008-3#1)
Three-dimensional objects##2##2##(2008-2#1)(2008-3#1)
Three-dimensional optical##4##2##(2008-3#4)
Three-dimensional structure of the##3##4##(1995-8#1)(2008-8#2)
Three-dimensional structure of##4##3##(1992-4#1)(1995-8#1)(2008-8#2)
Three-dimensional structure##5##2##(1992-4#1)(1995-8#1)(2008-8#3)
Three-dimensional structures of the##2##4##(1991-12#1)(1992-3#1)
Three-dimensional visualization of##2##3##(2008-9#2)
Three-dimensional##88##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-11#5)(2007-12#8)(2007-8#2)(2008-11#7)(2008-2#7)(2008-3#32)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
Three-way##3##1##(2008-10#2)(2008-12#1)
Three-year follow-up of##2##3##(2007-12#1)(2008-9#1)
Three-year follow-up##3##2##(1996-2#1)(2007-12#1)(2008-9#1)
Three-year##5##1##(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)
Threonine 246##2##2##(1993-11#2)
Threshold bootstrap##2##2##(2008-10#2)
Threshold##13##1##(1995-2#1)(1996-9#1)(1997-4#1)(2006-12#2)(2008-10#4)(2008-3#2)(2010-7#1)(2011-1#1)
Thresholds and##2##2##(1994-5#1)(2008-1#1)
Thresholds##5##1##(1994-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)
Thripidae)##3##1##(2008-10#1)(2011-2#2)
Thrips setosus##2##2##(2008-10#2)
Thrips tabaci##3##2##(2008-10#3)
Thrips##14##1##(2008-10#14)
Thriving##2##1##(2010-5#2)
Throat##3##1##(1991-11#1)(1997-2#1)(2012-12#1)
Thrombin stimulation##2##2##(1992-6#1)(1994-6#1)
Thrombin##8##1##(1991-9#2)(1992-6#2)(1994-6#2)(2008-5#1)(2008-7#1)
Thrombin-induced##2##1##(1992-8#1)(2009-12#1)
Thromboangiitis obliterans##3##2##(1996-8#1)(1997-8#1)(2006-10#1)
Thrombocytopenia##5##1##(1990-10#1)(1991-8#1)(1997-3#1)(2013-1#2)
Thromboembolic complications##3##2##(1997-2#1)(2007-8#2)
Thromboembolic event##2##2##(2008-7#2)
Thromboembolic##7##1##(1997-2#1)(2007-11#1)(2007-8#2)(2008-7#2)(2012-2#1)
Thrombolysis and the general practitioner##2##5##(1990-3#2)
Thrombolysis and##4##2##(1990-3#2)(2008-8#2)
Thrombolysis for##3##2##(2007-10#1)(2008-8#2)
Thrombolysis##8##1##(1990-3#2)(2007-10#1)(2008-3#1)(2008-8#4)
Thrombolytic therapy##3##2##(1990-12#1)(1994-6#1)(2008-7#1)
Thrombolytic treatment##2##2##(1991-3#1)(2008-7#1)
Thrombolytic##7##1##(1990-12#1)(1991-3#1)(1994-6#1)(2008-11#1)(2008-7#2)(2010-8#1)
Thrombomodulin##2##1##(1990-5#2)
Thrombopoietin (TPO) is##2##3##(2008-8#2)
Thrombopoietin (TPO)##3##2##(2008-8#3)
Thrombosis and##3##2##(1997-6#1)(1997-8#1)(2011-2#1)
Thrombosis of the##2##3##(1994-11#1)(1997-3#1)
Thrombosis of##3##2##(1994-11#1)(1997-3#1)(2011-2#1)
Thrombosis##15##1##(1993-9#1)(1994-11#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#2)(2008-11#4)(2011-2#2)(2012-3#1)
Thrombotic##4##1##(1991-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
Thromboxane##4##1##(1990-3#2)(1990-5#1)(1991-5#1)
Through Southern##2##2##(1997-4#1)(2008-8#1)
Through a series of##3##4##(2008-10#1)(2010-3#1)(2010-8#1)
Through a simple##2##3##(2007-12#1)(2008-3#1)
Through a##17##2##(1993-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)
Through an##2##2##(1990-6#1)(2008-5#1)
Through controlled##2##2##(2008-8#1)(2010-12#1)
Through five experiments##2##3##(2008-3#1)(2012-3#1)
Through its##2##2##(1990-8#1)(1996-8#1)
Through review of##2##3##(1993-1#1)(2012-12#1)
Through the development of##3##4##(1992-12#1)(2009-4#1)(2012-12#1)
Through the use of the##2##5##(1994-3#1)(1995-1#1)
Through the use of##6##4##(1991-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(2008-3#1)
Through the##27##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
Through these##4##2##(2008-10#1)(2008-8#1)(2009-11#1)(2012-2#1)
Through this##4##2##(2007-10#1)(2008-3#1)(2010-11#1)(2013-8#1)
Through##130##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-5#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#1)(2013-8#2)
Throughout the entire##2##3##(2011-2#1)(2012-9#1)
Throughout the##11##2##(1991-3#1)(1997-1#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-9#1)
Throughout this article##2##3##(2008-4#1)(2012-3#1)
Throughout this##4##2##(1990-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
Throughout##23##1##(1990-8#1)(1991-3#1)(1997-1#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#3)(2012-3#1)(2012-9#1)
Throughput##4##1##(2008-2#1)(2009-6#2)(2013-8#1)
Thuja##2##1##(2008-10#2)
Thurgau was##2##2##(1996-11#2)
Thurgau##10##1##(1996-11#10)
Thurman##2##1##(1991-12#1)(1995-6#1)
Thus a novel##2##3##(2008-10#1)(2008-2#1)
Thus a##15##2##(1992-3#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)
Thus an##4##2##(1992-7#1)(1993-2#1)(2008-2#1)(2008-3#1)
Thus far##5##2##(1990-8#1)(1996-5#1)(2010-6#1)(2010-8#1)(2011-1#1)
Thus for##2##2##(2007-7#1)(2008-11#1)
Thus in##3##2##(2007-7#1)(2008-9#1)(2012-1#1)
Thus it appears that##3##4##(1990-11#1)(1996-12#1)(2008-5#1)
Thus it is concluded that##2##5##(1992-6#1)(1997-6#1)
Thus it is##6##3##(1992-6#1)(1994-3#1)(1996-9#1)(1997-6#1)(2008-2#1)(2008-3#1)
Thus it##12##2##(1990-11#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-9#1)(1997-6#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
Thus its##2##2##(2008-3#1)(2010-8#1)
Thus nicotinamide##2##2##(2008-5#2)
Thus obtained##2##2##(2008-10#1)(2008-6#1)
Thus only##2##2##(1991-12#1)(2007-8#1)
Thus the##60##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#4)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#8)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Thus there is##3##3##(2007-2#1)(2008-1#1)(2008-6#1)
Thus there##4##2##(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#1)
Thus they##2##2##(1996-9#1)(2008-8#1)
Thus this##5##2##(1990-2#1)(1991-5#1)(2008-12#2)(2012-12#1)
Thus to##2##2##(1990-5#1)(2008-3#1)
Thus we conclude that##2##4##(1990-8#1)(1997-8#1)
Thus we##8##2##(1990-6#1)(1990-8#1)(1993-1#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-9#1)
Thus##1126##1##(1990-11#8)(1990-12#7)(1990-2#9)(1990-3#2)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#10)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#9)(1991-2#8)(1991-3#3)(1991-5#8)(1991-6#3)(1991-8#2)(1991-9#8)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#7)(1992-9#9)(1993-1#3)(1993-11#9)(1993-12#8)(1993-2#4)(1993-3#5)(1993-6#8)(1993-8#8)(1993-9#2)(1994-10#1)(1994-11#12)(1994-12#9)(1994-2#9)(1994-3#6)(1994-5#6)(1994-6#7)(1994-7#2)(1994-8#12)(1994-9#7)(1995-1#3)(1995-11#8)(1995-12#15)(1995-2#12)(1995-3#5)(1995-4#1)(1995-5#7)(1995-6#6)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#13)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#10)(1997-5#2)(1997-6#9)(1997-7#13)(1997-8#3)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#6)(2008-1#9)(2008-10#178)(2008-11#46)(2008-12#7)(2008-2#11)(2008-3#33)(2008-4#15)(2008-5#25)(2008-6#8)(2008-7#35)(2008-8#33)(2008-9#24)(2009-10#4)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#16)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#7)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#11)(2011-2#30)(2011-3#3)(2012-1#7)(2012-12#16)(2012-2#24)(2012-3#20)(2012-5#1)(2012-8#1)(2013-1#19)(2013-7#3)(2013-8#13)
Thy##4##1##(1993-12#4)
Thy-1##5##1##(1996-2#3)(2009-8#1)(2010-3#1)
Thymic##6##1##(1991-12#1)(1993-12#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-7#1)
Thymol##2##1##(2007-7#1)(2008-10#1)
Thymus eriocalyx##3##2##(2008-12#3)
Thymus serpyllum L##2##3##(2012-2#2)
Thymus weights of males administered 50 mg/kg or greater##2##9##(2008-9#2)
Thymus weights of males administered##3##5##(2008-9#3)
Thymus weights of##4##3##(2008-9#4)
Thymus##20##1##(1991-12#1)(1995-12#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-9#4)(2012-2#2)(2012-3#1)
Thyroid disease##2##2##(2008-7#1)(2011-2#1)
Thyroid dysfunction##2##2##(2008-7#1)(2011-1#1)
Thyroid function##5##2##(2008-4#1)(2008-7#2)(2012-12#2)
Thyroid gland##2##2##(2008-9#1)(2013-1#1)
Thyroid hormone##6##2##(1991-2#1)(1991-9#1)(1993-3#1)(2008-4#1)(2009-12#1)(2011-1#1)
Thyroid hormones##2##2##(2009-12#1)(2013-8#1)
Thyroid##38##1##(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-8#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-3#2)(2013-1#5)(2013-8#1)
Thyrotropin##2##1##(1994-11#1)(1994-2#1)
Thyrotropin-releasing Hormone##2##2##(2008-5#2)
Thyrotropin-releasing##4##1##(1994-2#1)(2008-5#2)(2013-7#1)
Thysanoptera##4##1##(2007-12#1)(2011-2#3)
ThzID1-M3 was##3##2##(2008-10#3)
ThzID1-M3##8##1##(2008-10#8)
Ti and##4##2##(2008-10#4)
Ti film##4##2##(2009-7#4)
Ti in##2##2##(1997-7#1)(2008-10#1)
Ti plasmid##6##2##(1990-11#2)(2006-12#1)(2008-10#3)
Ti##173##1##(1990-11#2)(1997-7#4)(2006-12#1)(2007-11#42)(2007-12#45)(2008-10#24)(2008-12#1)(2008-2#11)(2008-3#32)(2009-6#1)(2009-7#5)(2013-8#5)
Ti(3+) and##2##2##(2008-2#1)(2008-8#1)
Ti(3+)##3##1##(2007-12#1)(2008-2#1)(2008-8#1)
Ti(IV)##10##1##(2008-10#10)
Ti-6 Al-4V##2##2##(2009-7#2)
Ti-6Al-4V##8##1##(2008-10#1)(2009-7#4)(2012-2#3)
Ti-Cl##2##1##(1997-7#2)
Ti-N##2##1##(1997-7#2)
Ti-O##2##1##(1997-7#2)
Ti3+##2##1##(2008-3#2)
TiCl(3)##2##1##(2008-10#2)
TiN alloys##2##2##(2008-2#2)
TiNi alloy foams##2##3##(2009-7#2)
TiNi##4##1##(2009-7#4)
TiO _ 2 was found##3##5##(2008-5#3)
TiO _ 2##8##3##(2008-5#8)
TiO(2) and In(2)O(3)) and doped with noble metals (Au##2##9##(2008-10#2)
TiO(2) and##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
TiO(2) as##3##2##(2008-10#2)(2008-5#1)
TiO(2) film##2##2##(2008-10#2)
TiO(2) nanoparticles in##3##3##(2009-11#3)
TiO(2) nanoparticles##5##2##(2009-11#4)(2010-6#1)
TiO(2) suspensions##2##2##(2007-12#2)
TiO(2) thin##2##2##(2008-10#1)(2008-2#1)
TiO(2)##70##1##(2007-12#2)(2008-10#30)(2008-2#4)(2008-3#11)(2008-5#6)(2009-11#8)(2010-5#1)(2010-6#2)(2012-2#1)(2013-1#5)
TiO(2)/PEDOT##2##1##(2009-11#2)
TiO2 band gap##2##3##(2007-12#2)
TiO2 film##2##2##(2007-12#1)(2008-3#1)
TiO2 films deposited on##2##4##(2007-12#2)
TiO2 films deposited##3##3##(2007-12#2)(2008-3#1)
TiO2 films##9##2##(2007-12#4)(2008-10#1)(2008-3#3)(2008-5#1)
TiO2##31##1##(1994-3#1)(2007-12#10)(2008-10#10)(2008-3#5)(2008-5#4)(2010-5#1)
Tianjin##5##1##(2008-10#1)(2011-1#2)(2012-2#1)(2013-8#1)
Tianshan##2##1##(2012-3#1)(2013-8#1)
Tibial##3##1##(1991-3#1)(2012-2#1)(2013-1#1)
Tick##2##1##(1997-7#1)(2013-1#1)
Tick-borne encephalitis (TBE)##2##3##(1996-11#1)(2007-2#1)
Ticks##4##1##(1994-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
Ticlopidine##2##1##(1993-9#1)(1994-9#1)
Tid1##6##1##(2011-2#6)
Tidal##3##1##(2007-5#2)(2013-1#1)
Tierra Del Fuego##2##3##(2008-3#2)
Tift 23DB##2##2##(2008-10#2)
Tift##5##1##(2008-10#5)
Tifton##2##1##(2008-10#2)
Tight##3##1##(1994-12#1)(1995-5#1)(2008-1#1)
Tightly##3##1##(1990-5#1)(1995-2#1)(2010-8#1)
Tikhonov regularization##3##2##(2008-10#1)(2008-3#2)
Tikhonov##8##1##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2013-8#1)
Tilburg##2##1##(1991-6#1)(1992-2#1)
Till Uwe Keil]##2##3##(1996-9#1)(1997-8#1)
Till now##2##2##(2012-1#1)(2013-1#1)
Till##6##1##(1996-9#1)(1997-8#1)(2007-7#1)(2008-7#1)(2012-1#1)(2013-1#1)
Tillage and##2##2##(2008-10#2)
Tillage##7##1##(2008-10#6)(2008-12#1)
Tilletia controversa and T##3##4##(2008-10#3)
Tilletia indica##8##2##(2008-10#8)
Tilletia tritici##2##2##(2008-10#2)
Tilletia##17##1##(2008-10#17)
Tilly's##2##1##(2011-1#2)
Tilt##9##1##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#5)(2013-1#1)
Tilting##3##1##(1990-11#1)(2008-10#1)(2008-3#1)
Tim##4##1##(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Time 1##9##2##(2007-12#4)(2008-12#4)(2010-4#1)
Time 2##9##2##(2007-12#2)(2008-12#3)(2009-9#2)(2010-4#2)
Time 3##2##2##(2009-9#2)
Time and##6##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)
Time course of##3##3##(1995-12#1)(1995-3#1)(2013-1#1)
Time course##5##2##(1993-8#1)(1995-12#1)(1995-3#1)(2009-6#1)(2013-1#1)
Time for##6##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-3#2)
Time in the##2##3##(2008-10#1)(2008-9#1)
Time in##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
Time is##2##2##(1992-5#1)(2010-12#1)
Time management##2##2##(1992-2#1)(2009-12#1)
Time of Flight##3##3##(2008-10#1)(2009-12#1)(2012-12#1)
Time of##8##2##(1995-6#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-12#1)(2012-12#1)
Time to get##2##3##(2008-11#1)(2013-8#1)
Time to##16##2##(1996-11#1)(1996-2#1)(1996-8#1)(2008-11#1)(2008-3#3)(2008-6#2)(2008-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Time trends##4##2##(2013-1#4)
Time##117##1##(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#7)(2008-10#10)(2008-11#2)(2008-12#10)(2008-3#5)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#2)(2009-6#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#1)
Time-course##3##1##(1991-12#1)(1994-8#1)(2008-7#1)
Time-dependent##6##1##(1992-8#1)(1992-9#1)(1994-2#1)(1995-6#1)(2007-12#1)(2008-3#1)
Time-division multiplexing of##2##3##(2007-11#1)(2008-3#1)
Time-division multiplexing##3##2##(2007-11#1)(2008-3#2)
Time-domain optical##2##2##(2007-11#1)(2008-3#1)
Time-domain##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
Time-lapse microscopy##3##2##(2008-9#2)(2009-7#1)
Time-lapse##5##1##(1994-9#1)(2008-9#2)(2009-12#1)(2009-7#1)
Time-resolved fluorescence experiments were performed##2##5##(1995-5#2)
Time-resolved fluorescence##6##2##(1995-5#3)(1997-2#1)(2008-10#1)(2008-9#1)
Time-resolved##24##1##(1992-6#1)(1992-8#1)(1995-5#3)(1997-2#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-9#1)(2010-2#1)(2012-2#1)
Timely reporting##2##2##(2011-2#1)(2013-8#1)
Timely##11##1##(1994-12#1)(2007-12#1)(2008-7#3)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#1)
Times of##2##2##(1993-5#1)(2007-2#1)
Times##6##1##(1990-11#1)(1993-5#1)(1997-3#1)(2007-2#1)(2008-10#1)(2009-3#1)
Timing and##3##2##(2007-5#1)(2008-10#1)(2008-7#1)
Timing jitter##2##2##(2007-11#1)(2007-12#1)
Timing of surgery##2##3##(2011-2#2)
Timing of##17##2##(1991-6#1)(1995-9#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-4#1)(2009-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
Timing##22##1##(1991-6#1)(1995-9#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
Timopentina##2##1##(1990-5#2)
Timothy##2##1##(2008-5#1)(2012-2#1)
Tin protein inhibits##2##3##(1997-3#2)
Tin protein##7##2##(1997-3#7)
Tin##9##1##(1997-3#7)(2008-10#2)
Tin(IV) was##2##2##(2008-10#2)
Tin(IV)##3##1##(2008-10#3)
Tinnitus is##2##2##(1996-6#1)(2010-7#1)
Tiny##2##1##(2009-5#1)(2010-5#1)
Tiopronin##2##1##(1994-5#2)
Tiotriazoline have##2##2##(2011-1#2)
Tiotriazoline##3##1##(2011-1#3)
Tiotropium bromide##2##2##(2010-5#2)
Tiotropium is##2##2##(2010-5#2)
Tiotropium##4##1##(2010-5#4)
Tip##2##1##(1997-6#1)(2007-11#1)
Tip-SP CD34-KSL cells##2##3##(2008-4#2)
Tips for##3##2##(1991-1#1)(1995-12#1)(2013-8#1)
Tips##8##1##(1991-1#1)(1993-1#1)(1995-12#2)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
Tir##4##1##(2011-2#4)
Tiron##9##1##(1990-5#4)(2008-10#5)
Tissue Doppler##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
Tissue and##3##2##(1991-2#1)(2008-10#1)(2008-6#1)
Tissue culture##5##2##(2008-10#2)(2008-11#1)(2008-9#2)
Tissue distribution##2##2##(1990-11#1)(1992-11#1)
Tissue engineering##5##2##(2008-11#1)(2009-9#1)(2010-10#1)(2012-3#2)
Tissue expansion##2##2##(1992-5#2)
Tissue plasminogen activator##2##3##(2007-10#1)(2008-8#1)
Tissue samples contain many different cell types in variable amounts##2##10##(2008-2#1)(2008-4#1)
Tissue samples were##2##3##(2011-2#1)(2012-3#1)
Tissue samples##6##2##(1994-9#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
Tissue viability##5##2##(1996-7#5)
Tissue##88##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-2#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#2)(1993-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-7#5)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-4#3)(2008-6#9)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#2)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
Tissue-specific expression of##2##3##(1990-12#1)(1990-8#1)
Tissue-specific##4##1##(1990-12#1)(1990-8#1)(1991-1#1)(1992-9#1)
Tissues in##3##2##(2008-10#2)(2013-1#1)
Tissues##12##1##(1992-8#1)(1993-12#1)(1994-7#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-8#1)(2013-1#1)
Titanium##9##1##(1997-7#1)(2008-10#4)(2008-5#3)(2008-8#1)
Titanium-nickel##2##1##(2009-7#2)
Tithonia diversifolia##4##2##(2008-10#2)(2008-5#2)
Title I of the Americans with Disabilities Act##2##8##(1993-3#1)(1994-2#1)
Title I of the##3##4##(1993-3#1)(1994-1#1)(1994-2#1)
Title III of the Americans with Disabilities Act##2##8##(1992-12#1)(1995-6#1)
Title III of the Americans##3##5##(1992-12#1)(1995-1#1)(1995-6#1)
Title III of the##4##4##(1992-12#1)(1995-1#1)(1995-6#1)(1997-5#1)
Title III of##5##3##(1991-1#1)(1992-12#1)(1995-1#1)(1995-6#1)(1997-5#1)
Title III##7##2##(1991-1#1)(1992-12#1)(1995-1#1)(1995-6#1)(1997-5#3)
Title V children with special health care needs##2##8##(1995-12#2)
Title V##3##2##(1995-12#3)
Title X##6##2##(1991-1#5)(1991-3#1)
Title##23##1##(1991-1#7)(1991-3#3)(1992-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#1)(1997-5#3)
Titration of##2##2##(1992-6#1)(1997-7#1)
Titration with##2##2##(1995-5#1)(1997-2#1)
Titration##6##1##(1992-6#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#2)
Titrimetric##3##1##(2008-10#3)
Tityus##3##1##(2008-5#2)(2008-8#1)
Tl and##3##2##(2008-10#3)
Tl##23##1##(2008-10#20)(2010-5#1)(2011-1#1)(2013-8#1)
Tl(I) and Tl(III) were separated##2##5##(2008-10#2)
Tl(I) and Tl(III)##4##3##(2008-10#4)
Tl(I) and##6##2##(2008-10#6)
Tl(I) ions##2##2##(2008-10#2)
Tl(I)##10##1##(2008-10#10)
Tl(III)##7##1##(2008-10#7)
Tl-N bond distances##2##3##(1996-2#2)
TlNO(3)##2##1##(2008-10#2)
TlPF(6)##2##1##(1996-2#2)
Tm for##2##2##(1997-2#1)(1997-7#1)
Tm of##2##2##(1990-8#1)(1993-11#1)
Tm values##3##2##(1990-7#1)(1992-6#1)(1995-5#1)
Tm##53##1##(1990-7#3)(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-5#3)(1997-2#1)(1997-7#3)(2007-11#2)(2007-12#11)(2008-10#2)(2008-2#15)(2008-3#8)
Tm(3+)##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Tm(3+)-doped##2##1##(2008-3#2)
Tm-Ho##2##1##(2007-12#2)
Tm-doped silica fiber laser##2##4##(2007-11#2)
TmDOTP(5)(-)##5##1##(1997-7#5)
Tn antigen glycoproteins##2##3##(1992-8#2)
Tn antigen##6##2##(1992-8#6)
Tn##7##1##(1990-7#1)(1992-8#6)
Tn3 transposase##2##2##(1996-12#2)
Tn3##7##1##(1990-11#2)(1996-12#5)
Tn4001##5##1##(1993-12#5)
Tn4001lac derivative##2##2##(1993-12#2)
Tn4001lac##3##1##(1993-12#3)
Tn5 insertion occurred##2##3##(2008-10#2)
Tn5 insertion##4##2##(1993-9#1)(2008-10#3)
Tn5 inversion##2##2##(1995-8#2)
Tn5 mutant of##2##3##(2008-10#2)
Tn5##13##1##(1990-5#1)(1993-9#1)(1995-8#4)(1997-2#1)(2008-10#6)
Tn5-induced##2##1##(2008-10#2)
Tn552##2##1##(1995-8#2)
TnC##9##1##(1995-5#4)(1995-6#5)
TnI##10##1##(1995-6#4)(2007-8#3)(2010-12#3)
TnOA##2##1##(2008-10#2)
TnT and TnI##2##3##(2007-8#2)
TnT and##3##2##(2007-8#2)(2008-7#1)
TnT##10##1##(1995-6#3)(2007-8#3)(2008-7#4)
To a large extent##3##4##(1996-6#1)(1997-4#1)(2013-8#1)
To a##5##2##(1990-9#1)(1996-6#1)(1997-4#1)(2008-10#1)(2013-8#1)
To accelerate the##2##3##(2007-7#1)(2008-11#1)
To accelerate##3##2##(2007-7#1)(2008-10#1)(2008-11#1)
To accomplish this objective##2##4##(2008-10#1)(2008-5#1)
To accomplish this##7##3##(1992-12#1)(1992-3#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-5#1)
To accomplish##9##2##(1992-12#1)(1992-3#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2013-1#1)
To account for the##2##4##(2009-9#1)(2011-2#1)
To account for##5##3##(1992-9#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
To accurately##2##2##(2008-3#1)(2009-7#1)
To achieve a##4##3##(2007-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
To achieve an##2##3##(2008-10#1)(2008-2#1)
To achieve optimum##2##3##(2008-10#1)(2013-1#1)
To achieve the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
To achieve these##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
To achieve this##8##3##(2006-6#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
To achieve##37##2##(1995-2#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
To address the issue of##3##5##(1995-8#1)(1996-12#1)(2010-10#1)
To address the##16##3##(1995-8#1)(1996-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
To address these issues##2##4##(2008-11#1)(2008-5#1)
To address these##5##3##(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
To address this issue##9##4##(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2011-1#1)(2013-1#1)
To address this problem##2##4##(2009-6#1)(2011-1#1)
To address this question we##2##5##(1994-11#1)(2013-8#1)
To address this question##6##4##(1994-11#1)(2008-11#2)(2008-9#1)(2012-1#1)(2013-8#1)
To address this##26##3##(1992-6#1)(1994-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
To address whether##2##3##(1993-12#1)(1997-6#1)
To address##51##2##(1992-10#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
To advance##2##2##(2008-11#1)(2010-10#1)
To aid##4##2##(1993-1#1)(1995-2#1)(2008-10#1)(2008-11#1)
To allow##4##2##(1994-5#1)(2008-12#1)(2008-3#1)(2008-7#1)
To alter##2##2##(1992-11#1)(2008-10#1)
To an##2##2##(1992-2#1)(2008-3#1)
To analyse the##2##3##(1993-6#1)(2012-2#1)
To analyze the evolutionary##2##4##(1993-2#1)(2008-8#1)
To analyze the##19##3##(1993-2#1)(1993-3#2)(1997-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
To analyze##24##2##(1993-2#1)(1993-3#2)(1994-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
To answer##3##2##(1997-6#1)(2009-7#1)(2012-12#1)
To apply##2##2##(1995-5#1)(2012-2#1)
To ascertain the##3##3##(1996-12#1)(2008-3#1)(2011-2#1)
To ascertain whether##3##3##(1993-3#2)(2006-6#1)
To ascertain##7##2##(1993-3#2)(1996-12#1)(2006-6#1)(2008-3#1)(2011-2#1)(2012-3#1)
To assess the efficacy of a##2##6##(2012-3#1)(2013-1#1)
To assess the efficacy of##3##5##(2012-3#1)(2013-1#2)
To assess the extent##2##4##(1993-12#1)(2008-8#1)
To assess the functional##2##4##(1995-2#1)(1996-5#1)
To assess the genetic##2##4##(2008-10#2)
To assess the prevalence##2##4##(2011-1#1)(2011-2#1)
To assess the role of##3##5##(1990-7#1)(2008-7#1)(2011-1#1)
To assess the technical efficiency##2##5##(2013-8#2)
To assess the##63##3##(1990-7#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#3)
To assess this##3##3##(2008-11#1)(2013-7#2)
To assess whether the##3##4##(2007-10#1)(2008-7#1)(2010-12#1)
To assess whether##5##3##(1994-11#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
To assess##88##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#13)(2013-7#2)(2013-8#4)
To assist in##3##3##(2008-10#2)(2008-2#1)
To assist##5##2##(2008-10#3)(2008-2#1)(2010-3#1)
To assure##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
To avoid possible##2##3##(2008-10#2)
To avoid the risk of##2##5##(1994-9#1)(2008-5#1)
To avoid the##6##3##(1994-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
To avoid these##2##3##(2011-2#1)(2013-7#1)
To avoid##28##2##(1993-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
To be effective##4##3##(1990-2#1)(1992-12#1)(1993-2#1)(1995-12#1)
To be successful##2##3##(1993-2#1)(1993-3#1)
To be##18##2##(1990-2#1)(1992-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-9#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
To begin to##2##3##(2008-8#1)(2011-2#1)
To begin##3##2##(1995-3#1)(2008-8#1)(2011-2#1)
To better understand how##2##4##(1995-5#1)(2008-8#1)
To better understand the mechanism##2##5##(1992-6#1)(2008-2#1)
To better understand the##18##4##(1991-12#1)(1992-6#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
To better understand this##2##4##(2008-7#1)(2009-10#1)
To better understand##25##3##(1991-12#1)(1992-6#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
To better##32##2##(1991-12#1)(1991-5#1)(1992-6#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
To calculate the##3##3##(2008-2#1)(2008-3#2)
To capture##2##2##(2012-3#1)(2013-1#1)
To carry out##2##3##(2008-12#1)(2008-4#1)
To characterize the##15##3##(1991-5#2)(1992-3#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
To characterize these##2##3##(1997-3#1)(2008-3#1)
To characterize this##5##3##(1991-9#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-3#1)
To characterize##32##2##(1991-5#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-8#2)(1996-8#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-5#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
To check the accuracy of the proposed method##2##8##(2008-10#2)
To check the##3##3##(2008-10#2)(2008-5#1)
To circumvent the difficulty of regeneration of##2##7##(2008-10#2)
To circumvent these problems##2##4##(1997-8#1)(2008-4#1)
To circumvent these##4##3##(1994-12#1)(1997-8#1)(2008-3#1)(2008-4#1)
To circumvent##8##2##(1994-12#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)
To clarify effects of##2##4##(1990-12#1)(2013-1#1)
To clarify the molecular mechanisms##2##5##(2008-6#1)(2010-12#1)
To clarify the serological relationship##2##5##(2008-10#2)
To clarify the##13##3##(1992-6#1)(1993-6#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-7#2)(2009-6#1)(2010-12#1)
To clarify##20##2##(1990-12#1)(1990-2#1)(1992-6#1)(1993-6#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
To compare the levels of##2##5##(2013-8#2)
To compare the outcome of##2##5##(2013-1#2)
To compare the results of##2##5##(1996-1#1)(2013-1#1)
To compare the##19##3##(1993-1#1)(1995-4#1)(1996-1#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#2)(2013-1#5)(2013-8#2)
To compare with##2##3##(2008-10#1)(2008-11#1)
To compare##26##2##(1993-1#1)(1995-4#1)(1996-1#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#3)(2012-1#1)(2013-1#5)(2013-8#3)
To compensate for the##3##4##(2008-2#1)(2011-2#1)(2012-3#1)
To compensate for##4##3##(2007-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
To complement##2##2##(2008-10#1)(2010-8#1)
To comprehensively##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
To conclude##5##2##(1991-6#1)(2008-5#2)(2008-7#1)(2010-7#1)
To conduct a##2##3##(2013-1#1)(2013-8#1)
To conduct##4##2##(1995-2#1)(2007-12#1)(2013-1#1)(2013-8#1)
To confirm that##2##3##(1997-8#1)(2008-8#1)
To confirm the##7##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)
To confirm these##2##3##(1996-12#1)(2008-11#1)
To confirm this##3##3##(1994-11#1)(1997-6#1)(2009-6#1)
To confirm##18##2##(1994-11#1)(1994-3#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
To consider the##2##3##(1993-12#1)(2009-8#1)
To consider##3##2##(1993-12#1)(2009-8#1)(2010-10#1)
To construct##3##2##(2008-10#2)(2008-11#1)
To control##3##2##(1993-12#1)(1996-1#1)(2009-6#1)
To cope with##2##3##(2008-2#1)(2012-1#1)
To counter this##3##3##(1994-5#1)(2008-2#1)(2008-5#1)
To counter##4##2##(1994-5#1)(2008-2#1)(2008-5#1)(2010-4#1)
To create a##3##3##(1996-6#1)(2008-3#1)(2013-1#1)
To create##6##2##(1994-2#1)(1996-6#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
To date most##3##3##(1992-3#1)(2010-8#1)(2011-2#1)
To date the##2##3##(2010-7#1)(2013-8#1)
To date there##4##3##(1992-2#1)(2007-8#2)(2008-9#1)
To date##76##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-6#1)(1994-7#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-8#1)
To decrease##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
To define the role of##2##5##(2008-10#1)(2008-11#1)
To define the##7##3##(1992-8#1)(1992-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)
To define##12##2##(1991-11#1)(1992-8#1)(1992-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-2#1)(2010-1#1)(2012-2#1)
To delineate the##4##3##(1994-5#1)(1995-2#1)(1995-5#1)(2011-2#1)
To deliver##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
To demonstrate that##2##3##(1994-11#1)(2012-3#1)
To demonstrate the feasibility of the##2##6##(2008-10#2)
To demonstrate the feasibility of##3##5##(2008-10#3)
To demonstrate the potential##2##4##(2008-3#1)(2008-8#1)
To demonstrate the##21##3##(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-8#1)(2009-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
To demonstrate##27##2##(1994-11#1)(1995-3#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-8#1)(2009-12#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
To depict the##2##3##(2010-12#1)(2012-3#1)
To describe an##2##3##(2007-2#1)(2012-12#1)
To describe the##16##3##(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
To describe##27##2##(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
To detect and##2##3##(2008-9#1)(2009-2#1)
To detect the##2##3##(2008-10#1)(2008-11#1)
To detect##14##2##(1991-11#1)(1992-6#1)(1994-2#1)(1995-11#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)
To determine how##3##3##(1990-5#1)(2008-10#2)
To determine if the##4##4##(1990-8#1)(1994-6#1)(2008-10#2)
To determine if this##4##4##(1992-12#1)(1994-8#1)(2009-9#1)(2012-7#1)
To determine if##21##3##(1990-7#1)(1990-8#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-7#1)
To determine its##2##3##(1993-6#1)(2008-5#1)
To determine the association##2##4##(2008-1#1)(2013-8#1)
To determine the correlation between the##2##6##(2013-8#2)
To determine the effect of##5##5##(1995-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
To determine the effects of##5##5##(1994-11#1)(1994-8#1)(1996-5#1)(2008-9#1)(2013-1#1)
To determine the frequency of##2##5##(2008-11#1)(2008-12#1)
To determine the impact of##2##5##(1994-3#1)(2011-2#1)
To determine the incidence of##2##5##(2012-3#1)(2013-1#1)
To determine the incidence##3##4##(2008-1#1)(2012-3#1)(2013-1#1)
To determine the mechanism##2##4##(2008-5#1)(2013-1#1)
To determine the prevalence of##4##5##(2008-1#1)(2011-1#1)(2013-1#2)
To determine the prevalence##5##4##(2008-1#1)(2011-1#2)(2013-1#2)
To determine the relationship between##2##5##(2008-10#1)(2008-12#1)
To determine the##77##3##(1991-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#6)
To determine this##2##3##(1993-12#1)(2008-7#1)
To determine whether a##2##4##(1996-5#1)(2008-11#1)
To determine whether the P2Y(1) receptor##2##6##(2008-4#2)
To determine whether the##10##4##(1990-5#1)(1993-6#1)(1993-9#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)
To determine whether##34##3##(1990-5#2)(1990-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#4)
To determine which##5##3##(1991-12#1)(1992-2#1)(1995-5#1)(1997-6#1)(2013-1#1)
To determine##170##2##(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#32)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#4)(2011-2#8)(2012-12#4)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#17)(2013-8#7)
To develop a##7##3##(1990-8#1)(1994-3#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)(2013-8#1)
To develop##15##2##(1990-8#1)(1993-3#1)(1994-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
To differentiate##4##2##(2008-10#4)
To discover##2##2##(2008-1#1)(2008-12#1)
To discuss the##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
To discuss##4##2##(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
To distinguish##2##2##(2008-4#1)(2010-11#1)
To do so##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
To do this##3##3##(2007-12#1)(2008-3#1)(2009-10#1)
To do##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-12#1)
To document the##2##3##(2007-11#1)(2007-7#1)
To draw##2##2##(1991-1#1)(1991-11#1)
To ease##2##2##(1992-1#2)
To effectively##3##2##(1994-3#1)(2008-3#1)(2010-8#1)
To eliminate the##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
To eliminate##7##2##(2008-10#3)(2011-2#2)(2013-1#1)(2013-8#1)
To elucidate the mechanism of##2##5##(1993-11#1)(1995-11#1)
To elucidate the molecular mechanism##2##5##(2008-9#1)(2009-8#1)
To elucidate the molecular##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
To elucidate the role of##3##5##(1990-2#1)(1991-5#1)(2013-7#1)
To elucidate the##27##3##(1990-12#1)(1990-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2012-3#1)(2013-7#1)
To elucidate##28##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2012-3#1)(2013-7#1)
To enable the##2##3##(1993-6#1)(1994-11#1)
To enable##6##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-10#1)
To encode##2##2##(2008-3#1)(2008-8#1)
To enhance the##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
To enhance##9##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#2)
To ensure adequate##2##3##(1996-1#1)(2008-7#1)
To ensure that##2##3##(1991-8#1)(2008-2#1)
To ensure the##3##3##(2008-8#1)(2010-4#1)(2011-2#1)
To ensure##17##2##(1991-8#1)(1993-12#1)(1996-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
To establish a##8##3##(1991-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-3#1)(2012-3#1)
To establish an##2##3##(2007-10#1)(2008-10#1)
To establish optical communication between any two satellites##2##8##(2008-2#1)(2008-3#1)
To establish the##3##3##(2007-10#1)(2010-5#1)(2011-2#1)
To establish##24##2##(1991-5#1)(1992-2#1)(1996-5#1)(1997-2#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
To estimate the##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
To estimate##8##2##(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
To evaluate a##2##3##(2008-10#1)(2011-2#1)
To evaluate the effect of##6##5##(2008-1#1)(2008-10#2)(2008-9#2)(2010-4#1)
To evaluate the effectiveness of##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
To evaluate the effects of##3##5##(2008-10#1)(2012-12#1)(2012-3#1)
To evaluate the efficacy and##2##5##(2008-10#1)(2008-3#1)
To evaluate the efficacy##5##4##(2008-10#3)(2008-3#1)(2008-8#1)
To evaluate the impact of##2##5##(1991-1#1)(2008-11#1)
To evaluate the outcome##2##4##(2008-6#1)(2013-1#1)
To evaluate the patterns of glomerular##2##6##(2007-7#1)(2008-1#1)
To evaluate the performance of the##2##6##(2008-3#1)(2010-8#1)
To evaluate the possibility of##3##5##(1992-2#1)(1994-5#1)(2008-11#1)
To evaluate the prevalence of##3##5##(2007-8#1)(2012-2#1)(2013-1#1)
To evaluate the prevalence##4##4##(2007-8#1)(2008-1#1)(2012-2#1)(2013-1#1)
To evaluate the role of##2##5##(1992-8#1)(2013-8#1)
To evaluate the significance of##2##5##(2008-7#1)(2013-1#1)
To evaluate the##88##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#17)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#11)(2013-8#4)
To evaluate these##2##3##(1991-3#1)(1995-2#1)
To evaluate this##3##3##(1994-8#1)(2011-2#1)(2013-7#1)
To evaluate total##2##3##(1991-6#1)(2011-1#1)
To evaluate##115##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#20)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#5)
To examine if##2##3##(2008-10#1)(2009-10#1)
To examine the consequences of##2##5##(1995-2#1)(2008-11#1)
To examine the effects of##3##5##(1993-3#1)(1995-5#1)(2008-11#1)
To examine the expression of##2##5##(1993-8#1)(1995-2#1)
To examine the influence of the##2##6##(2008-11#1)(2008-3#1)
To examine the influence of##3##5##(1994-9#1)(2008-11#1)(2008-3#1)
To examine the role of##3##5##(1994-8#1)(1995-2#1)(1997-7#1)
To examine the##38##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#5)(1995-5#1)(1997-7#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
To examine these##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
To examine this##4##3##(1990-5#1)(1993-1#1)(2008-11#1)(2008-8#1)
To examine whether or not the brain Epo protects the in vitro cultured neurons from glutamate-induced cell death##2##18##(2008-11#2)
To examine whether the##4##4##(1990-12#1)(2008-11#1)(2008-6#2)
To examine whether##13##3##(1990-12#1)(1991-12#1)(1993-8#1)(1994-8#2)(1997-6#1)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#1)
To examine##78##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-8#4)(1994-9#1)(1995-2#5)(1995-5#1)(1996-9#1)(1997-6#1)(1997-7#2)(2006-8#1)(2007-2#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
To exclude the influence of##2##5##(2008-10#2)
To explain the##5##3##(1992-8#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
To explain##9##2##(1992-8#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
To explore the association between##3##5##(2011-1#2)(2012-12#1)
To explore the relationship##2##4##(2011-1#1)(2013-8#1)
To explore the##22##3##(1992-12#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-4#1)(2011-1#9)(2012-12#1)(2013-1#1)(2013-8#2)
To explore this possibility##3##4##(1993-6#1)(2008-9#1)(2013-8#1)
To explore this##4##3##(1993-6#1)(1997-3#1)(2008-9#1)(2013-8#1)
To explore whether##2##3##(2008-10#1)(2008-11#1)
To explore##37##2##(1992-12#1)(1993-6#1)(1995-11#1)(1995-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#4)(2010-10#1)(2010-4#1)(2011-1#11)(2012-12#2)(2013-1#3)(2013-8#4)
To extend##2##2##(2008-10#1)(2011-2#1)
To extract##2##2##(2008-3#2)
To fabricate##2##2##(2008-10#1)(2008-3#1)
To facilitate functional##2##3##(2008-7#1)(2009-10#1)
To facilitate the##3##3##(1993-3#1)(2009-8#1)(2010-2#1)
To facilitate##16##2##(1993-3#1)(1995-8#1)(1996-3#1)(2007-5#1)(2008-10#5)(2008-7#3)(2009-10#1)(2009-8#1)(2010-2#1)(2013-1#1)
To fill##2##2##(2008-11#1)(2010-2#1)
To find a possible##2##4##(2007-10#1)(2008-5#1)
To find a##5##3##(1990-8#1)(1993-12#1)(1995-1#1)(2007-10#1)(2008-5#1)
To find out##2##3##(1990-2#1)(2008-7#1)
To find the relationship between the##2##6##(2013-8#2)
To find the##4##3##(2012-3#1)(2013-1#1)(2013-8#2)
To find##14##2##(1990-2#1)(1990-8#1)(1993-12#1)(1995-1#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
To focus##2##2##(1993-3#1)(2007-12#1)
To follow the##3##3##(2008-10#3)
To fulfill this##2##3##(2008-10#2)
To fully##3##2##(2008-7#1)(2009-4#1)(2012-2#1)
To further characterize the##6##4##(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#3)
To further characterize##8##3##(1994-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#4)
To further confirm this##2##4##(2008-11#1)(2008-3#1)
To further elucidate##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
To further examine the##2##4##(2008-11#1)(2008-3#1)
To further explore##4##3##(1992-9#1)(1996-2#1)(2008-10#1)(2013-8#1)
To further investigate the##3##4##(2008-10#1)(2008-9#2)
To further investigate##6##3##(2008-10#2)(2008-9#2)(2009-5#1)(2010-3#1)
To further understand the##2##4##(2008-10#1)(2012-12#1)
To further understand##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
To further##39##2##(1992-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-9#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#2)(2012-12#1)(2013-1#1)(2013-8#2)
To gain a better understanding of the##2##7##(1995-12#1)(2008-3#1)
To gain a better understanding of##3##6##(1995-12#1)(2008-3#1)(2012-3#1)
To gain a better understanding##4##5##(1995-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
To gain further insight into how##2##6##(2008-11#2)
To gain further insight into the##2##6##(1997-9#1)(2008-11#1)
To gain further insight into##4##5##(1997-9#1)(2008-11#3)
To gain insight into the mechanism by which##2##8##(1990-5#1)(2008-10#1)
To gain insight into the mechanism##3##6##(1990-5#1)(2008-10#2)
To gain insight into the##7##5##(1990-5#1)(1990-7#1)(2007-12#1)(2008-10#3)(2008-8#1)
To gain more insight into the##2##6##(1991-6#1)(1994-8#1)
To gain##23##2##(1990-5#1)(1990-7#1)(1991-6#1)(1993-6#1)(1994-8#1)(1995-12#2)(1997-9#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
To generate##5##2##(1990-12#1)(1990-5#1)(2008-3#1)(2013-1#1)(2013-8#1)
To get an##2##3##(1995-2#1)(2007-9#1)
To get more##2##3##(2008-10#1)(2008-5#1)
To get##6##2##(1994-1#1)(1995-2#1)(2007-9#1)(2008-10#2)(2008-5#1)
To give a##2##3##(1997-3#1)(2009-8#1)
To give##3##2##(1997-3#1)(2008-3#1)(2009-8#1)
To guarantee##2##2##(2008-12#1)(2013-1#1)
To have##3##2##(1993-12#1)(1994-7#1)(2008-10#1)
To help elucidate##2##3##(1994-8#1)(2008-1#1)
To help##12##2##(1992-11#1)(1994-8#1)(1996-3#1)(1996-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#1)(2013-8#1)
To identify factors that##2##4##(1994-12#1)(2013-1#1)
To identify novel##2##3##(2008-7#1)(2012-3#1)
To identify the characteristics of##2##5##(1994-7#1)(2011-2#1)
To identify the risk factors##2##5##(2011-2#1)(2013-1#1)
To identify the##20##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-12#2)(1992-6#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
To identify which##2##3##(1992-6#1)(2008-8#1)
To identify##52##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-12#3)(1992-6#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#6)
To illuminate the function of EDRF1 in K562 cells##2##9##(2008-8#1)(2008-9#1)
To illuminate##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
To illustrate the method##2##4##(1997-3#1)(2008-2#1)
To illustrate the##10##3##(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)
To illustrate this##3##3##(2008-10#2)(2012-2#1)
To illustrate##15##2##(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
To impact##2##2##(1997-1#1)(2012-12#1)
To implement##4##2##(1993-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
To improve our understanding of##2##5##(2007-8#1)(2008-10#1)
To improve the quality##2##4##(2007-4#1)(2008-3#1)
To improve the##21##3##(1996-11#1)(1996-5#1)(2007-4#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)
To improve##36##2##(1992-4#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)
To increase the sensitivity##2##4##(2008-10#2)
To increase the##12##3##(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-7#1)
To increase their##2##3##(2008-2#1)(2011-2#1)
To increase##20##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
To induce##3##2##(2008-10#2)(2008-4#1)
To inform##3##2##(1994-2#1)(2009-5#1)(2010-8#1)
To insure##2##2##(1994-12#1)(2008-8#1)
To investigate further the##3##4##(1995-6#1)(1996-2#1)(2008-5#1)
To investigate further##4##3##(1995-6#1)(1996-2#1)(2008-5#1)(2010-2#1)
To investigate how##3##3##(1993-6#1)(2010-12#1)(2012-12#1)
To investigate if##2##3##(2008-2#1)(2013-1#1)
To investigate the association##2##4##(2011-1#1)(2013-1#1)
To investigate the distribution of##2##5##(1993-12#1)(2011-1#1)
To investigate the effect of##3##5##(1992-2#1)(1997-7#1)(2013-8#1)
To investigate the effects of##4##5##(1995-8#1)(2008-11#1)(2008-12#1)(2010-2#1)
To investigate the mechanism##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
To investigate the molecular##2##4##(1990-5#1)(1997-7#1)
To investigate the nature of##2##5##(1992-9#1)(1993-9#1)
To investigate the possible##3##4##(1992-9#1)(1994-5#1)(2011-1#1)
To investigate the potential##2##4##(1995-2#1)(2008-9#1)
To investigate the prevalence##2##4##(2007-2#1)(2011-1#1)
To investigate the relationship between##2##5##(1993-8#1)(2008-9#1)
To investigate the relationship##3##4##(1990-8#1)(1993-8#1)(2008-9#1)
To investigate the role of##9##5##(1990-11#1)(1993-11#1)(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#1)(2009-7#1)(2011-10#1)(2011-2#1)
To investigate the##79##3##(1990-11#1)(1990-5#2)(1990-8#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#2)(1996-6#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-10#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
To investigate this phenomenon##2##4##(2008-11#1)(2013-8#1)
To investigate this possibility##2##4##(1992-2#1)(1994-3#1)
To investigate this##10##3##(1992-2#1)(1994-3#1)(1997-7#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2013-8#1)
To investigate whether a##2##4##(2008-11#1)(2008-5#1)
To investigate whether##10##3##(1990-5#1)(1991-8#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2013-8#1)
To investigate##124##2##(1990-11#1)(1990-5#3)(1990-8#1)(1991-8#2)(1992-2#2)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#7)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#5)
To isolate the##2##3##(2008-10#1)(2008-8#1)
To isolate##9##2##(1992-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
To know the##2##3##(2008-9#1)(2012-12#1)
To learn##2##2##(1991-1#1)(1997-3#1)
To localize##3##2##(1991-6#1)(1995-6#1)(2008-5#1)
To maintain##4##2##(1994-1#1)(2012-1#1)(2012-2#2)
To make a distinction between##2##5##(2010-12#2)
To make a##6##3##(2008-10#1)(2008-3#2)(2009-11#1)(2010-12#2)
To make the##6##3##(1991-3#1)(1997-4#1)(2008-2#2)(2008-7#1)(2012-2#1)
To make this##2##3##(2008-10#1)(2011-2#1)
To make##19##2##(1991-3#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
To manage the##2##3##(1996-12#1)(2007-12#1)
To manage##3##2##(1996-12#1)(2007-12#1)(2008-8#1)
To map the##2##3##(1994-8#1)(1997-8#1)
To map##4##2##(1994-8#1)(1997-8#1)(2008-10#2)
To maximize##3##2##(1995-12#1)(2007-12#1)(2008-3#1)
To measure the##4##3##(2007-7#1)(2008-3#1)(2010-8#1)(2013-1#1)
To measure##11##2##(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-8#1)(2013-1#2)(2013-8#1)
To meet the##3##3##(1994-12#1)(1996-12#1)(2008-6#1)
To meet##4##2##(1994-12#1)(1996-12#1)(2008-6#1)(2008-8#1)
To minimize the##5##3##(1992-2#1)(1997-3#1)(2008-5#1)(2008-6#1)(2012-12#1)
To minimize##9##2##(1992-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#2)(2012-12#1)
To mitigate the##2##3##(2008-3#1)(2011-2#1)
To molecularly##2##2##(1997-7#1)(2009-8#1)
To monitor the##2##3##(2011-2#1)(2013-8#1)
To monitor##5##2##(1994-12#1)(1995-6#1)(2007-7#1)(2011-2#1)(2013-8#1)
To obtain a##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
To obtain information about the##2##5##(1990-8#1)(2008-5#1)
To obtain more##3##3##(1991-6#1)(1996-11#1)(1997-8#1)
To obtain reliable##2##3##(1992-9#1)(2013-7#1)
To obtain the##5##3##(1996-2#1)(2008-3#2)(2010-2#1)(2013-8#1)
To obtain##33##2##(1990-8#1)(1991-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
To optimize##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-12#1)
To our knowledge only##2##4##(2008-2#1)(2008-7#1)
To our knowledge this is the first report of##2##9##(2007-8#1)(2009-8#1)
To our knowledge this is the first report##3##8##(2007-8#1)(2008-5#1)(2009-8#1)
To our knowledge this is the first reported case##2##9##(1991-9#1)(2010-11#1)
To our knowledge this is the first##7##7##(1991-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-11#1)
To our knowledge this is the##9##6##(1991-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2013-1#1)
To our knowledge this##11##4##(1991-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2013-1#1)
To our knowledge##98##3##(1991-9#1)(1995-4#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-3#2)(2010-5#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#2)
To our##100##2##(1991-9#1)(1992-11#1)(1995-4#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-3#2)(2010-5#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#2)
To overcome the##5##3##(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2012-3#1)
To overcome these difficulties##2##4##(2007-8#1)(2008-7#1)
To overcome these##6##3##(1996-2#1)(2007-8#1)(2008-3#1)(2008-7#2)(2012-3#1)
To overcome this limitation##2##4##(2008-9#1)(2009-10#1)
To overcome this problem##5##4##(1995-2#1)(1997-4#2)(2008-10#1)(2008-11#1)
To overcome this##9##3##(1995-2#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2012-3#1)
To overcome##23##2##(1995-2#1)(1996-2#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2012-3#3)
To perform a##2##3##(2012-3#1)(2013-1#1)
To perform##7##2##(1991-9#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
To pilot##2##2##(1994-3#2)
To play##2##2##(1994-1#1)(2008-3#1)
To predict##4##2##(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)
To prepare##2##2##(1996-2#1)(2012-12#1)
To present a case##2##4##(2008-6#1)(2011-2#1)
To present##3##2##(1992-3#1)(2008-6#1)(2011-2#1)
To prevent the##2##3##(2008-2#1)(2012-2#1)
To prevent##15##2##(1990-6#1)(1995-9#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
To produce##6##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
To promote##10##2##(1991-6#1)(1992-6#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-12#1)(2009-12#1)(2010-10#1)(2011-1#2)
To prove the##2##3##(2008-10#1)(2008-5#1)
To provide a##5##3##(1993-11#1)(2007-12#1)(2010-5#1)(2011-2#2)
To provide an##2##3##(1995-2#1)(2012-2#1)
To provide the##2##3##(1990-2#1)(1996-3#1)
To provide##18##2##(1990-2#1)(1993-11#1)(1995-2#1)(1996-3#2)(1997-1#1)(2007-12#1)(2007-8#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
To pursue##2##2##(1995-2#1)(2008-8#1)
To quantify the##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
To quantify##5##2##(1990-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-3#1)
To raise##2##2##(2008-10#1)(2011-2#1)
To reach these aims##2##4##(2010-8#1)(2012-2#1)
To reach##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
To realise##2##2##(1997-8#1)(2010-3#1)
To realize a##2##3##(2008-3#2)
To realize##4##2##(1994-3#1)(2008-11#1)(2008-3#2)
To reduce the##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)
To reduce##17##2##(1991-1#1)(1993-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-1#2)(2012-1#1)
To relate##2##2##(2008-3#1)(2013-8#1)
To remove##2##2##(2008-10#1)(2013-8#1)
To report a##4##3##(2009-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
To report or not to report##2##6##(1991-2#1)(2011-2#1)
To report the##5##3##(2007-8#1)(2008-6#1)(2013-8#3)
To report##11##2##(1991-2#1)(2007-8#1)(2008-6#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
To retrospectively##2##2##(2011-1#1)(2012-2#1)
To reveal the##2##3##(2009-2#1)(2013-1#1)
To reveal##3##2##(2008-6#1)(2009-2#1)(2013-1#1)
To review the##11##3##(2007-2#3)(2008-1#1)(2008-11#1)(2008-6#1)(2011-1#2)(2012-12#1)(2012-2#2)
To review##14##2##(2007-12#1)(2007-2#3)(2008-1#1)(2008-11#1)(2008-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
To screen##2##2##(1990-7#1)(2008-7#1)
To search for##4##3##(1991-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
To see whether##3##3##(1991-11#1)(1995-11#1)(1995-12#1)
To select the##2##3##(1995-11#1)(2013-8#1)
To show that##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
To show the##4##3##(2007-11#1)(2008-5#1)(2009-10#1)(2010-8#1)
To show##9##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-8#1)
To simplify the##3##3##(1995-6#1)(1997-3#1)(2008-11#1)
To simulate##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
To solve the problem##3##4##(1992-9#1)(2008-2#1)(2008-3#1)
To solve the##4##3##(1992-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
To solve this problem##2##4##(2007-12#1)(2013-8#1)
To solve##7##2##(1992-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
To some extent##2##3##(1994-2#1)(2009-9#1)
To strengthen the##2##3##(1995-12#1)(1995-2#1)
To study the association##2##4##(2008-5#1)(2011-1#1)
To study the effect of##7##5##(1996-12#1)(1996-3#1)(2008-10#3)(2008-4#1)(2008-9#1)
To study the effects of##5##5##(1996-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-3#1)
To study the evolution of##2##5##(2008-6#1)(2008-8#1)
To study the expression##2##4##(2008-9#1)(2013-8#1)
To study the function of##3##5##(1995-8#1)(2008-8#1)(2008-9#1)
To study the functions of the##2##6##(1997-2#1)(1997-8#1)
To study the functions of##3##5##(1997-2#1)(1997-8#1)(2008-11#1)
To study the molecular##2##4##(1991-6#1)(1997-6#1)
To study the role of the##2##6##(1993-8#2)
To study the role of##4##5##(1993-8#2)(2012-12#1)(2013-8#1)
To study the##57##3##(1991-6#1)(1991-9#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#6)
To study this##5##3##(1997-7#1)(2008-3#1)(2009-12#1)(2012-1#1)(2013-1#1)
To study##72##2##(1990-8#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#2)(2009-2#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#7)
To successfully##4##2##(1991-1#1)(1994-2#1)(1997-2#1)(2008-2#1)
To summarize the##2##3##(1993-12#1)(2013-1#1)
To summarize##3##2##(1993-12#1)(2013-1#1)(2013-8#1)
To supplement##3##2##(1997-4#1)(2008-5#1)(2013-1#1)
To support##4##2##(1993-3#1)(2007-8#1)(2008-11#1)(2008-12#1)
To systematically##2##2##(2011-2#2)
To take advantage of##2##4##(1991-5#1)(1993-12#1)
To take##4##2##(1991-5#1)(1993-12#1)(2008-11#1)(2008-2#1)
To test for the##2##4##(1994-5#1)(1995-2#1)
To test for##3##3##(1994-5#1)(1995-2#2)
To test the hypothesis that##10##5##(1990-11#1)(1990-8#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-9#1)(2009-3#1)(2010-11#1)
To test the hypothesis##12##4##(1990-11#1)(1990-8#1)(1993-12#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)
To test the method##3##4##(1990-11#1)(2008-10#1)(2010-12#1)
To test the##33##3##(1990-11#3)(1990-8#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-7#1)
To test this hypothesis##8##4##(1991-12#1)(1992-8#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-3#1)(2013-1#1)
To test this idea##3##4##(2008-7#1)(2010-12#1)(2011-1#1)
To test this##21##3##(1991-12#1)(1991-5#1)(1992-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
To test whether the##2##4##(2008-2#1)(2008-8#1)
To test whether##6##3##(1995-2#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
To test##69##2##(1990-11#3)(1990-8#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#4)(1996-12#1)(2007-10#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)
To that end##6##3##(1992-8#1)(1994-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
To the author's knowledge##3##4##(2008-10#1)(2008-2#2)
To the authors' knowledge##8##4##(2007-12#2)(2008-10#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-3#1)
To the best of our knowledge this is the##2##9##(2011-2#1)(2012-3#1)
To the best of our knowledge this##4##7##(2008-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
To the best of our knowledge##30##6##(1991-9#1)(1994-12#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
To the best of##32##4##(1991-9#1)(1994-12#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2009-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
To the extent that##3##4##(1991-8#1)(1992-1#1)(1997-4#1)
To the##55##2##(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-12#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
To this end the##4##4##(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
To this end##38##3##(1993-11#1)(1993-8#1)(1995-1#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
To this purpose##7##3##(1991-3#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)
To this##49##2##(1991-3#1)(1992-2#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-1#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
To trace##2##2##(1996-2#1)(2011-1#1)
To treat##2##2##(2008-4#1)(2010-12#1)
To try to##2##3##(2008-10#1)(2011-2#1)
To understand how##4##3##(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
To understand its##2##3##(2010-2#1)(2010-7#1)
To understand the function of##2##5##(1996-12#1)(2011-2#1)
To understand the genetic##2##4##(1994-9#1)(2013-8#1)
To understand the mechanism of##2##5##(2008-10#1)(2008-11#1)
To understand the mechanism##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
To understand the mechanisms##2##4##(2007-12#1)(2008-11#1)
To understand the molecular mechanism of##3##6##(1992-8#1)(1993-8#1)(1995-2#1)
To understand the##37##3##(1991-12#1)(1992-8#1)(1993-8#2)(1994-3#1)(1994-9#1)(1995-2#3)(1996-12#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
To understand##54##2##(1991-12#1)(1991-3#1)(1992-8#1)(1993-8#2)(1994-3#1)(1994-9#1)(1995-2#3)(1996-1#1)(1996-12#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
To use##2##2##(2008-10#1)(2008-3#1)
To validate our##2##3##(2008-3#1)(2009-12#1)
To validate the##7##3##(2008-10#3)(2008-2#1)(2008-3#2)(2012-1#1)
To validate##12##2##(1992-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-10#1)(2009-12#1)(2012-1#1)
To verify the##4##3##(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
To verify##9##2##(1997-8#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-8#1)(2012-3#1)
To what extent##4##3##(1992-5#1)(1994-3#1)(2009-8#1)(2013-1#1)
To##2573##1##(1990-11#6)(1990-12#5)(1990-2#6)(1990-5#9)(1990-6#2)(1990-7#5)(1990-8#9)(1990-9#1)(1991-1#5)(1991-11#5)(1991-12#10)(1991-2#3)(1991-3#7)(1991-5#12)(1991-6#10)(1991-8#6)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#12)(1992-2#10)(1992-3#10)(1992-4#1)(1992-5#3)(1992-6#13)(1992-8#9)(1992-9#10)(1993-1#6)(1993-11#8)(1993-12#19)(1993-2#5)(1993-3#14)(1993-5#2)(1993-6#11)(1993-8#13)(1993-9#3)(1994-1#4)(1994-11#9)(1994-12#11)(1994-2#13)(1994-3#13)(1994-5#7)(1994-6#3)(1994-7#4)(1994-8#15)(1994-9#6)(1995-1#3)(1995-11#8)(1995-12#14)(1995-2#32)(1995-3#6)(1995-4#2)(1995-5#9)(1995-6#8)(1995-8#5)(1995-9#3)(1996-1#8)(1996-11#2)(1996-12#13)(1996-2#11)(1996-3#13)(1996-5#8)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#11)(1997-3#16)(1997-4#16)(1997-5#1)(1997-6#7)(1997-7#9)(1997-8#16)(1997-9#2)(2006-10#2)(2006-6#2)(2006-8#1)(2007-10#15)(2007-11#23)(2007-12#32)(2007-2#7)(2007-4#1)(2007-5#4)(2007-7#14)(2007-8#25)(2007-9#2)(2008-1#34)(2008-10#365)(2008-11#111)(2008-12#42)(2008-2#62)(2008-3#119)(2008-4#30)(2008-5#63)(2008-6#35)(2008-7#67)(2008-8#63)(2008-9#51)(2009-1#3)(2009-10#17)(2009-11#7)(2009-12#14)(2009-2#5)(2009-3#7)(2009-4#7)(2009-5#7)(2009-6#5)(2009-7#8)(2009-8#24)(2009-9#8)(2010-1#4)(2010-10#12)(2010-11#14)(2010-12#18)(2010-2#9)(2010-3#11)(2010-4#10)(2010-5#13)(2010-6#1)(2010-7#6)(2010-8#15)(2010-9#3)(2011-1#70)(2011-10#1)(2011-2#102)(2011-3#4)(2011-7#1)(2012-1#13)(2012-12#45)(2012-2#52)(2012-3#66)(2012-7#2)(2013-1#145)(2013-7#11)(2013-8#78)
ToCMoV##2##1##(2008-10#2)
ToCMoV-[BA-Se1] DNA-A##2##2##(2008-10#2)
ToCMoV-[BA-Se1]##3##1##(2008-10#3)
ToCV is##3##2##(2008-10#3)
ToCV##10##1##(2008-10#10)
ToF-SIMS##3##1##(2009-12#1)(2009-2#2)
ToLCBV##2##1##(2008-10#2)
ToLCGV-[Var] could##2##2##(2008-10#2)
ToLCGV-[Var] shares##3##2##(2008-10#3)
ToLCGV-[Var]##6##1##(2008-10#6)
ToLCJAV##3##1##(2008-10#3)
ToLCJV-Mld was##2##2##(2008-10#2)
ToLCNDV-Svr[Jes]##2##1##(2008-10#2)
ToLCNDV-[Lucknow]##2##1##(2008-10#2)
ToLCV is##3##2##(2008-10#3)
ToLCV##5##1##(2008-10#5)
ToLCVs##3##1##(2008-10#3)
ToM tasks##2##2##(2013-1#2)
ToM##7##1##(2008-12#4)(2013-1#3)
ToMoV##4##1##(2008-10#4)
Toad##3##1##(2008-5#1)(2008-6#1)(2013-1#1)
Tobacco Plants##3##2##(2008-10#3)
Tobacco chewing##2##2##(1996-6#1)(2013-1#1)
Tobacco curly shoot virus##2##4##(2008-10#2)
Tobacco exposure##3##2##(1991-12#1)(2013-1#2)
Tobacco mosaic virus (TMV)##3##4##(2008-10#3)
Tobacco mosaic virus and##2##4##(2008-10#2)
Tobacco mosaic virus##7##3##(2008-10#7)
Tobacco mosaic##8##2##(2008-10#8)
Tobacco plants##2##2##(2008-10#2)
Tobacco smoking##2##2##(2008-7#1)(2011-1#1)
Tobacco##53##1##(1991-12#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-10#32)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#3)(2013-1#4)(2013-7#1)
Tobago##13##1##(2007-5#8)(2007-8#1)(2008-10#2)(2009-7#1)(2011-2#1)
Tobamovirus##6##1##(2008-10#6)
Tobin##3##1##(1995-5#1)(1996-5#2)
Toborinone##3##1##(2008-5#3)
Tocantins##3##1##(2008-6#2)(2010-3#1)
Tocopherols are##3##2##(1992-9#1)(2008-5#1)(2008-6#1)
Tocopherols##4##1##(1992-9#2)(2008-5#1)(2008-6#1)
Today the##3##2##(1997-5#1)(2008-10#2)
Today there is##2##3##(2008-7#1)(2010-11#1)
Today there##3##2##(1995-2#1)(2008-7#1)(2010-11#1)
Today this##3##2##(1997-6#1)(2009-6#1)(2013-1#1)
Today##54##1##(1991-11#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-4#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
Today's successful##2##2##(1995-3#1)(1997-2#1)
Today's##10##1##(1992-5#1)(1993-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-5#2)(2010-8#1)
Todd##2##1##(2008-5#1)(2008-7#1)
Toddler##2##1##(2009-10#1)(2012-12#1)
Together our##2##2##(2008-11#1)(2010-3#1)
Together these findings##2##3##(1990-5#1)(2008-3#1)
Together these results suggest that##2##5##(1990-2#1)(2008-8#1)
Together these results##5##3##(1990-2#1)(1993-12#1)(2008-4#1)(2008-8#1)(2010-8#1)
Together these studies provide##2##4##(2010-11#1)(2010-4#1)
Together these studies##4##3##(1994-3#1)(2008-5#1)(2010-11#1)(2010-4#1)
Together these##15##2##(1990-2#1)(1990-5#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-8#1)
Together they##2##2##(1993-2#1)(2008-1#1)
Together with a##2##3##(2008-1#1)(2008-3#1)
Together with other##2##3##(1992-6#1)(1995-5#1)
Together with the previously##2##4##(1994-12#1)(1995-11#1)
Together with the##13##3##(1993-1#1)(1994-12#1)(1995-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)
Together with##31##2##(1990-10#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#3)(2009-4#1)(2009-9#1)(2012-3#2)(2013-1#1)
Together##115##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)
Tohoku University##2##2##(2008-3#2)
Tohoku##3##1##(1994-7#1)(2008-3#2)
Toiletry and Perfumery Association##2##4##(2008-5#2)
Toiletry and Perfumery##3##3##(2008-5#3)
Toki's criteria##2##2##(2013-1#2)
Toki's##4##1##(2013-1#4)
Tokushima##2##1##(1995-4#2)
Tokyo Dental College##2##3##(2013-1#2)
Tokyo##10##1##(1993-8#1)(1994-12#1)(1997-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#2)
Tolerability##4##1##(1995-6#1)(2008-10#1)(2008-3#2)
Tolerance limits for##3##3##(2008-10#3)
Tolerance of the##2##3##(1991-6#1)(2008-12#1)
Tolerance of##10##2##(1991-6#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
Tolerance to##3##2##(2008-10#2)(2011-2#1)
Tolerance was##2##2##(2008-10#2)
Tolerance##30##1##(1991-6#1)(1992-3#1)(1993-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-3#2)
Tolerant##2##1##(2008-10#2)
Toll##4##1##(1991-5#2)(2008-9#1)(2010-11#1)
Toll-like receptor 4 (TLR4)##2##4##(2008-3#1)(2010-8#1)
Toll-like receptor##7##2##(2008-10#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
Toll-like receptors (TLRs) are##2##4##(2009-3#1)(2013-1#1)
Toll-like receptors and##2##3##(2008-2#1)(2010-8#1)
Toll-like receptors##4##2##(2008-2#1)(2009-3#1)(2010-8#1)(2013-1#1)
Toll-like##12##1##(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-5#2)(2010-8#2)(2012-1#1)(2012-3#1)(2013-1#2)
Tolman length##2##2##(2010-2#2)
Toluca valley##3##2##(2008-10#2)(2008-5#1)
Toluca##11##1##(2008-10#10)(2008-5#1)
Toluene##3##1##(2008-10#2)(2008-7#1)
Tom Yum herbs##2##3##(2011-2#2)
Tom##9##1##(1990-8#1)(1993-3#2)(1995-2#1)(2008-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
Tom-6##3##1##(2008-10#3)
Tom40##5##1##(2012-2#5)
TomRSV##3##1##(2008-10#3)
Tomato Leaf##2##2##(2008-10#2)
Tomato Plants##2##2##(2008-10#2)
Tomato Race 3##2##3##(2008-10#2)
Tomato Resistance##2##2##(2008-10#2)
Tomato Spotted Wilt Tospovirus##2##4##(2008-10#2)
Tomato Spotted Wilt##4##3##(2008-10#4)
Tomato Yellow Leaf Curl Virus##2##5##(2008-10#2)
Tomato and Potato in the Del Fuerte Valley##2##8##(2008-10#2)
Tomato and Potato in##4##4##(2008-10#4)
Tomato and##5##2##(2008-10#5)
Tomato bushy stunt virus (TBSV)##3##5##(2008-10#3)
Tomato by##6##2##(2008-10#6)
Tomato chlorosis virus (ToCV)##2##4##(2008-10#2)
Tomato chlorosis virus##4##3##(2008-10#4)
Tomato chlorotic mottle virus##2##4##(2008-10#2)
Tomato in##5##2##(2008-10#5)
Tomato leaf curl Gujarat virus##3##5##(2008-10#3)
Tomato leaf curl Gujarat##4##4##(2008-10#4)
Tomato leaf curl Karnataka virus (ToLCKV)##2##6##(2008-10#2)
Tomato leaf curl Karnataka virus##3##5##(2008-10#3)
Tomato leaf curl New Delhi virus-Severe (ToLCNDV-Svr)##2##7##(2008-10#2)
Tomato leaf curl New Delhi virus-Severe##3##6##(2008-10#3)
Tomato leaf curl virus##2##4##(2008-10#2)
Tomato leaf curl##17##3##(2008-10#17)
Tomato leaf##19##2##(2008-10#19)
Tomato spotted wilt tospovirus (TSWV)##2##5##(2008-10#2)
Tomato spotted wilt virus (TSWV) and##3##6##(2008-10#3)
Tomato spotted wilt virus (TSWV)##14##5##(2008-10#14)
Tomato spotted wilt virus##27##4##(2008-10#27)
Tomato spotted wilt##30##3##(2008-10#30)
Tomato yellow leaf curl Sardinia virus (TYLCSV)##2##7##(2008-10#2)
Tomato yellow leaf curl Sardinia virus##4##6##(2008-10#4)
Tomato yellow leaf curl virus (TYLCV) and##2##7##(2008-10#2)
Tomato yellow leaf curl virus (TYLCV)##9##6##(2008-10#9)
Tomato yellow leaf curl virus##17##5##(2008-10#17)
Tomato yellow leaf curl##23##4##(2008-10#23)
Tomato yellow##24##2##(2008-10#24)
Tomato##145##1##(2008-10#143)(2011-2#2)
Tomatoes##2##1##(2008-10#2)
Tomographic reconstruction of##2##3##(2008-2#2)
Tomographic##8##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
Tomography##18##1##(2007-8#1)(2008-12#1)(2008-2#3)(2009-12#1)(2009-5#1)(2009-8#2)(2011-1#5)(2012-12#2)(2012-3#1)(2013-8#1)
Tomorrow##3##1##(1993-11#1)(2008-11#2)
Tomorrow's##2##1##(1991-1#1)(2012-2#1)
Tongan diabetes patients##2##3##(2008-1#2)
Tongan##5##1##(2008-1#5)
Tongans##5##1##(2008-1#5)
Tongue##2##1##(2007-12#1)(2012-12#1)
Tonic##3##1##(1991-12#1)(1995-11#1)(2011-2#1)
Too many##5##2##(1992-5#1)(2008-11#3)(2011-2#1)
Too often##2##2##(1993-12#1)(2008-11#1)
Too##11##1##(1992-5#1)(1993-12#1)(1996-3#1)(2007-2#1)(2008-11#4)(2008-8#1)(2009-6#1)(2011-2#1)
Tool for##9##2##(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)
Tool##23##1##(1996-3#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#3)(2009-4#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
Toolbox##4##1##(2008-8#4)
Toolkit##3##1##(2008-3#2)(2009-12#1)
Tools for##4##2##(2008-3#1)(2010-2#1)(2012-1#1)(2013-1#1)
Tools to##3##2##(2008-10#2)(2011-1#1)
Tools##14##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Tooth##2##1##(2008-12#2)
Top 10##3##2##(2011-2#1)(2012-12#1)(2013-7#1)
Top##13##1##(1990-12#1)(1991-2#2)(1996-3#2)(1997-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
Topic##2##1##(2008-6#1)(2008-8#1)
Topical Meeting##4##2##(2008-2#2)(2008-3#2)
Topical application of##2##3##(2009-5#1)(2011-2#1)
Topical lincomycin gel in acne vulgaris##2##6##(2007-7#2)
Topical sprays with##2##3##(2008-10#2)
Topical treatment##2##2##(2008-10#1)(2008-5#1)
Topical##29##1##(1993-8#1)(2007-11#2)(2007-7#4)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-2#3)(2013-1#1)
Topically applied##2##2##(1994-2#1)(2008-5#1)
Topically##4##1##(1994-2#1)(2007-7#1)(2008-5#2)
Topics covered include##2##3##(2008-7#1)(2011-2#1)
Topics covered##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
Topics discussed include routine precautions when working with biohazards##2##9##(2008-4#1)(2008-9#1)
Topics discussed include##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
Topics include##3##2##(2008-2#1)(2008-4#1)(2009-6#1)
Topics##15##1##(1996-2#1)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#2)(2013-8#1)
Topiramate##2##1##(2008-7#2)
Topo I##4##2##(1994-8#4)
Topo##7##1##(1994-8#7)
Topographic analysis of the##2##4##(2008-7#2)
Topographic##3##1##(2007-11#1)(2008-7#2)
Topographical##2##1##(1995-11#1)(2008-3#1)
Topography of##2##2##(1991-12#1)(2008-11#1)
Topography##5##1##(1991-12#1)(1992-10#1)(2008-11#2)(2013-7#1)
Topoisomerase I##3##2##(1990-7#2)(2008-11#1)
Topological##2##1##(1996-9#1)(2007-11#1)
Topologies##2##1##(2008-3#1)(2010-4#1)
Topology##2##1##(1997-7#1)(2008-11#1)
Topper and Steptoe##2##3##(2008-10#2)
Topsiturvitrema verticalia##2##2##(2008-5#2)
Topsiturvitrema##3##1##(2008-5#3)
Tor Vergata##2##2##(2011-7#1)(2013-1#1)
Tor##7##1##(1992-5#2)(2007-7#1)(2011-7#1)(2012-3#2)(2013-1#1)
Torch##4##1##(2008-10#4)
Torenia fournieri##4##2##(2008-11#2)(2008-9#2)
Torenia##5##1##(2008-11#3)(2008-9#2)
Torino##2##1##(1990-6#1)(1992-8#1)
Toronto Clearinghouse##4##2##(1996-3#4)
Toronto Extremity Salvage Score##2##4##(2008-6#2)
Toronto Hospital##2##2##(1993-12#1)(1996-3#1)
Toronto and##2##2##(1991-12#1)(2007-12#1)
Toronto during##2##2##(1994-3#1)(2008-3#1)
Toronto##52##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1992-1#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-3#2)(1994-1#5)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#7)(1997-3#2)(2007-12#4)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#4)(2008-7#1)(2008-9#1)(2011-2#1)
Toronto's##2##1##(1994-2#1)(1996-2#1)
Torpedo##5##1##(1992-12#1)(1993-3#1)(1994-5#2)(1995-12#1)
Torque##5##1##(1997-3#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-7#1)
Torr of##6##2##(2007-12#1)(2008-10#4)(2008-3#1)
Torr##12##1##(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#5)
Torr) and##2##2##(1997-7#1)(2008-3#1)
Torr)##4##1##(1997-7#2)(2008-10#1)(2008-3#1)
Torre-Muir syndrome##3##2##(2008-8#3)
Torsade de##2##2##(2010-8#1)(2013-1#1)
Torsion of the##2##3##(2008-10#1)(2011-1#1)
Torsion of##4##2##(2007-2#1)(2008-10#1)(2008-12#1)(2011-1#1)
Torsional##2##1##(2008-10#1)(2008-7#1)
Tort reform##2##2##(1994-1#1)(2007-4#1)
Tort##3##1##(1994-1#1)(1995-3#1)(2007-4#1)
Tortricidae)##2##1##(2011-2#2)
Torture##3##1##(1996-3#1)(1996-6#1)(2013-1#1)
Tosflex##2##1##(2008-10#2)
Tospovirus and##2##2##(2008-10#2)
Tospovirus##15##1##(2008-10#15)
Tospoviruses##2##1##(2008-10#2)
Total Dry Matter (TDM)##3##4##(2008-12#3)
Total Knee Arthroplasty##5##3##(2013-1#5)
Total Knee Replacement##6##3##(1995-3#2)(2009-4#2)(2013-1#2)
Total Knee##11##2##(1995-3#2)(2009-4#2)(2013-1#7)
Total N##2##2##(2008-5#2)
Total Ozone##2##2##(2008-2#1)(2008-3#1)
Total PKC activity##2##3##(1992-11#1)(1994-11#1)
Total Quality Management (TQM)##4##4##(1992-2#1)(1994-2#1)(1996-2#1)(1996-3#1)
Total Quality##5##2##(1992-2#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#1)
Total Synthesis of##4##3##(1996-5#2)(2008-6#1)(2008-8#1)
Total amount of##2##3##(2008-10#1)(2010-7#1)
Total amount##3##2##(2007-11#1)(2008-10#1)(2010-7#1)
Total analysis time##2##3##(1993-9#1)(2008-10#1)
Total and##4##2##(1995-3#1)(2008-10#1)(2008-7#1)(2009-4#1)
Total anomalous pulmonary venous connection to##2##6##(2008-11#2)
Total arsenic##3##2##(2008-10#3)
Total bilirubin of##2##3##(2012-3#2)
Total body irradiation##2##3##(1995-9#1)(2007-4#1)
Total body##3##2##(1995-9#1)(2007-4#1)(2013-1#1)
Total cholesterol##2##2##(2008-10#1)(2009-7#1)
Total chromium was determined by##2##5##(2008-10#2)
Total chromium##4##2##(2008-10#4)
Total hip arthroplasty in##2##4##(2007-8#1)(2009-3#1)
Total hip arthroplasty##7##3##(2007-11#2)(2007-8#2)(2008-7#1)(2009-3#1)(2011-2#1)
Total hip replacement is##3##4##(1996-6#1)(2009-4#1)(2010-10#1)
Total hip replacement##5##3##(1996-6#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-10#1)
Total hip##12##2##(1996-6#1)(2007-11#2)(2007-8#3)(2008-7#2)(2009-3#1)(2009-4#1)(2010-10#1)(2011-2#1)
Total inorganic##2##2##(2008-10#2)
Total internal reflection##2##3##(2008-1#1)(2008-3#1)
Total internal##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
Total knee arthroplasty##2##3##(2007-8#2)
Total knee##3##2##(2007-8#3)
Total leaf##2##2##(2008-10#2)
Total mercury##2##2##(2008-10#2)
Total metal concentrations##2##3##(2008-10#2)
Total number of##2##3##(2008-11#1)(2011-2#1)
Total operative time was##2##4##(2007-8#1)(2008-10#1)
Total population size##2##3##(2008-10#2)
Total protein##2##2##(2008-10#1)(2013-1#1)
Total quality management (TQM)##2##4##(1994-2#1)(1995-1#1)
Total quality management in health care##3##6##(1994-12#1)(1994-2#1)(1995-1#1)
Total quality management##8##3##(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-12#2)
Total quality##9##2##(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-12#3)
Total removal of##3##3##(2008-7#3)
Total serum##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
Total synthesis of##3##3##(1996-5#1)(2008-7#1)(2009-5#1)
Total thyroidectomy##3##2##(1992-2#1)(2010-11#1)(2011-2#1)
Total##247##1##(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#2)(1993-12#1)(1993-3#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#2)(1997-7#1)(2007-1#1)(2007-11#4)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#9)(2008-1#3)(2008-10#62)(2008-11#7)(2008-12#11)(2008-2#3)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#7)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#18)(2013-8#1)
Total/HDL cholesterol ratio was##2##4##(2013-1#2)
Totally##6##1##(2007-8#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
Totowa##3##1##(2008-4#3)
Touch##2##1##(2008-10#1)(2012-2#1)
Touching##2##1##(1991-2#1)(1996-2#1)
Toulouse##2##1##(2008-11#1)(2013-1#1)
Tourette syndrome##2##2##(1997-5#2)
Tours##2##1##(1992-12#1)(2011-2#1)
Toward Wheat##2##2##(2008-10#2)
Toward a##10##2##(1991-1#1)(1993-1#1)(1994-2#1)(1996-2#1)(1997-1#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
Toward an##4##2##(1993-1#1)(1993-2#1)(1997-3#1)(2011-2#1)
Toward making##2##2##(2008-3#1)(2012-2#1)
Toward the##4##2##(1993-2#1)(1993-5#1)(1994-12#1)(1996-3#1)
Toward this end##5##3##(1993-8#1)(1994-2#1)(2008-12#1)(2008-3#2)
Toward##50##1##(1991-1#1)(1993-1#2)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1995-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
Towards a##8##2##(1993-12#1)(1994-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
Towards advanced chemical##2##3##(2008-10#2)
Towards an##2##2##(1997-1#1)(2008-12#1)
Towards the##3##2##(1994-11#1)(2009-12#1)(2010-5#1)
Towards##32##1##(1991-9#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-7#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Town##9##1##(2007-2#1)(2007-7#1)(2008-8#3)(2010-3#2)(2012-2#1)(2012-3#1)
Tox(+)##4##1##(2008-10#4)
ToxA and##4##2##(2008-10#4)
ToxA##19##1##(2008-10#19)
ToxB##9##1##(2008-10#9)
Toxic concentrations of##2##3##(2008-11#1)(2013-7#1)
Toxic##11##1##(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-7#1)
Toxicity Testing##2##2##(2011-1#2)
Toxicity and##2##2##(2008-7#1)(2011-2#1)
Toxicity in##2##2##(2008-10#2)
Toxicity of##3##2##(2007-2#1)(2008-7#1)(2011-2#1)
Toxicity was##8##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-10#1)(2007-10#2)(2008-11#1)(2013-1#1)
Toxicity##33##1##(1990-12#1)(1990-2#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1996-12#2)(1997-3#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#2)(2011-2#3)(2013-1#1)
Toxicological##4##1##(2008-10#1)(2008-11#2)(2012-12#1)
Toxicology studies of##4##3##(2008-9#4)
Toxicology##20##1##(1995-11#1)(1996-12#2)(1997-4#2)(2007-10#1)(2008-10#5)(2008-9#5)(2009-8#1)(2011-2#2)(2012-1#1)
Toxin from##2##2##(2008-10#2)
Toxin##14##1##(1994-2#1)(2007-12#1)(2008-10#9)(2009-2#1)(2009-8#2)
Toxins##5##1##(2008-10#2)(2008-5#2)(2011-2#1)
Toxocara canis and##2##3##(2011-1#1)(2013-1#1)
Toxocara canis##3##2##(2011-1#2)(2013-1#1)
Toxocara##6##1##(2008-8#1)(2011-1#2)(2013-1#3)
Toxoplasma gondii antibodies##2##3##(2008-5#2)
Toxoplasma gondii##17##2##(1990-9#1)(1992-8#2)(1993-9#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-5#2)(2009-6#1)(2009-7#2)(2012-2#2)(2012-3#1)
Toxoplasma infection##2##2##(2007-7#1)(2012-2#1)
Toxoplasma##24##1##(1990-9#1)(1992-2#1)(1992-8#2)(1993-9#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#6)(2008-10#1)(2008-5#2)(2009-6#1)(2009-7#2)(2012-2#3)(2012-3#1)
Toxoplasmosis##5##1##(1990-9#1)(1995-9#1)(1996-3#1)(2007-7#1)(2011-2#1)
Toxoptera citricida##7##2##(2008-10#7)
Toya##2##1##(2008-5#2)
Toyopearl##3##1##(1992-8#1)(2008-10#2)
Toyota Production System##5##3##(2012-2#5)
Toyota##8##1##(2008-9#1)(2012-2#5)(2013-8#2)
TrPs was##2##2##(2010-9#2)
TrPs were##2##2##(2010-9#2)
TrPs##10##1##(2010-9#10)
TraD##3##1##(1992-7#3)
Trace DNA##2##2##(2008-12#2)
Trace Elements in Serum##2##4##(2008-10#2)
Trace Elements in Urine##2##4##(2008-10#2)
Trace Elements in##7##3##(2008-10#7)
Trace Elements##8##2##(2008-10#8)
Trace amounts of##7##3##(2008-10#7)
Trace analysis of##4##3##(2008-10#4)
Trace concentrations of##3##3##(2008-11#1)(2008-3#2)
Trace element##2##2##(1993-2#1)(2008-10#1)
Trace enrichment of metal ions##2##5##(2008-10#2)
Trace enrichment##3##2##(2008-10#3)
Trace levels of##2##3##(2008-10#2)
Trace metal ions in##2##4##(2008-10#2)
Trace metal##3##2##(2008-10#3)
Trace metals##2##2##(2008-10#2)
Trace##50##1##(1993-2#1)(2008-10#40)(2008-11#1)(2008-12#3)(2008-3#4)(2009-8#1)
Tracer##3##1##(1994-3#1)(2008-5#1)(2012-2#1)
Traces of##2##2##(1996-1#1)(2008-2#1)
Tracheal and##2##2##(2010-7#2)
Tracheal compression##2##2##(2007-8#1)(2013-1#1)
Tracheal##8##1##(1990-3#1)(2007-8#1)(2008-10#1)(2010-7#2)(2012-3#1)(2013-1#2)
Tracheostomy##6##1##(2008-6#2)(2012-2#2)(2013-1#2)
Trachoma##5##1##(2010-8#5)
Tracing the##4##2##(1994-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
Tracing##5##1##(1994-3#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
Track##4##1##(2007-9#3)(2010-5#1)
Tracking of the##2##3##(2008-2#1)(2008-5#1)
Tracking of##3##2##(2008-2#2)(2008-5#1)
Tracking##13##1##(1992-11#1)(1996-2#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-9#1)(2012-2#1)
Tract Infections##3##2##(2010-3#1)(2011-2#2)
Tract##7##1##(1992-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2013-8#1)
Tractography and##2##2##(2010-6#1)(2011-2#1)
Trade Agreement##2##2##(2008-1#1)(2011-2#1)
Trade##7##1##(1990-4#1)(1993-1#2)(2007-2#1)(2008-1#1)(2011-2#2)
Trade-off between##2##2##(2008-3#1)(2008-9#1)
Trade-off##3##1##(2008-3#1)(2008-7#1)(2008-9#1)
Trade-offs between##2##2##(2008-9#1)(2009-12#1)
Trade-offs##4##1##(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
Tradescantia zebrina leaves##2##3##(1994-11#2)
Traditional Birth Attendants##2##3##(2008-7#1)(2011-1#1)
Traditional Chinese##4##2##(2008-10#3)(2013-1#1)
Traditional Uighur##3##2##(2009-5#3)
Traditional and##2##2##(1990-9#1)(2011-2#1)
Traditional approaches to##2##3##(1995-12#1)(2008-8#1)
Traditional methods of##4##3##(1994-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
Traditional methods##5##2##(1994-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)
Traditional open##3##2##(2009-12#1)(2011-2#2)
Traditional practices##2##2##(1997-7#1)(2013-7#1)
Traditional treatment##2##2##(1994-2#1)(1997-3#1)
Traditional##66##1##(1990-9#1)(1994-2#2)(1994-8#1)(1995-12#2)(1996-1#1)(1997-3#2)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)
Traditionally##24##1##(1995-1#1)(1996-12#1)(1997-1#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
Traffic##5##1##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
Trail Making Test##3##3##(2008-5#2)(2012-12#1)
Trail-making Part B##2##3##(1995-11#2)
Trail-making Part##3##2##(1995-11#3)
Trail-making##4##1##(1995-11#4)
Trained##4##1##(1992-2#1)(2007-2#1)(2010-8#2)
Trainee##2##1##(2008-11#1)(2012-3#1)
Training Center##2##2##(2010-11#1)(2013-1#1)
Training Program##2##2##(2010-12#1)(2012-12#1)
Training Programs##2##2##(1992-1#1)(1992-12#1)
Training and##5##2##(1994-12#2)(2008-1#1)(2008-10#1)(2010-8#1)
Training for##3##2##(1996-8#1)(2009-12#1)(2012-2#1)
Training in##7##2##(1991-2#1)(1992-6#1)(1994-12#2)(2008-10#1)(2011-2#1)(2013-8#1)
Training of##5##2##(1994-12#1)(1994-3#1)(2007-12#1)(2008-3#1)(2012-12#1)
Training volunteers##2##2##(1992-12#1)(1996-2#1)
Training##67##1##(1991-1#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1994-12#6)(1994-3#1)(1996-12#1)(1996-2#2)(1996-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
Trait##14##1##(2008-10#10)(2008-7#2)(2009-8#1)(2012-3#1)
Traits##5##1##(2008-10#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-3#1)
Trajectories of##4##2##(2009-7#2)(2009-8#1)(2012-12#1)
Trajectories##8##1##(2007-9#1)(2008-12#2)(2009-7#2)(2009-8#1)(2012-12#1)(2013-8#1)
Tramadol et de##3##3##(2013-1#3)
Tramadol et##5##2##(2013-1#5)
Tramadol##13##1##(1996-5#1)(2008-10#1)(2013-1#11)
Trametes multicolor##2##2##(2008-6#2)
Trametes versicolor##2##2##(2008-6#2)
Trametes##4##1##(2008-6#4)
Tranilast##3##1##(1995-11#2)(2008-5#1)
Trans##4##1##(2008-2#2)(2012-3#2)
Trans-tamoxifen (1 muM)##2##3##(2008-11#2)
Trans-tympanic electric auditory brainstem response (TT-EABR)##2##6##(2008-9#2)
Transaction##3##1##(1994-12#2)(2012-12#1)
Transanal endoscopic microsurgery##2##3##(2008-4#1)(2011-2#1)
Transanal##4##1##(1993-9#2)(2008-4#1)(2011-2#1)
Transarterial##5##1##(1997-3#1)(1997-6#1)(2008-7#1)(2013-1#2)
Transbronchial##3##1##(2008-1#1)(2010-12#1)(2011-2#1)
Transcatheter closure of##2##3##(2008-11#2)
Transcatheter##4##1##(1997-8#1)(2008-11#2)(2009-12#1)
Transcervical osteotomy##2##2##(2012-2#2)
Transcervical##4##1##(2012-2#2)(2012-3#1)(2013-1#1)
Transcranial Doppler monitoring##2##3##(2007-10#2)
Transcranial Doppler##6##2##(1996-3#1)(2007-10#2)(2008-7#1)(2008-8#1)(2012-1#1)
Transcranial Magnetic Stimulation (rTMS)##2##4##(2008-12#1)(2011-2#1)
Transcranial Magnetic Stimulation##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
Transcranial magnetic stimulation (TMS)##2##4##(2010-7#2)
Transcranial magnetic stimulation##4##3##(2008-2#1)(2009-10#1)(2010-7#2)
Transcranial magnetic##5##2##(1996-6#1)(2008-2#1)(2009-10#1)(2010-7#2)
Transcranial##15##1##(1996-3#1)(1996-6#1)(2007-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
Transcribed Spacer##7##2##(2008-10#6)(2012-2#1)
Transcribed##10##1##(2008-10#9)(2012-2#1)
Transcript levels##2##2##(2008-10#2)
Transcript##7##1##(1994-8#1)(1996-8#1)(2007-11#1)(2008-10#2)(2010-12#1)(2010-4#1)
Transcriptase##4##1##(2008-10#2)(2009-9#1)(2012-2#1)
Transcription by##2##2##(1994-3#1)(2011-2#1)
Transcription factor##2##2##(1995-2#1)(2012-3#1)
Transcription factors (TFs)##2##3##(2008-7#1)(2010-7#1)
Transcription factors##5##2##(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Transcription in##2##2##(2008-11#1)(2012-3#1)
Transcription is##2##2##(1994-12#1)(2011-2#1)
Transcription of a##2##3##(1995-8#1)(1997-2#1)
Transcription of the##5##3##(1990-11#1)(1991-9#1)(1995-5#1)(1997-2#1)(2013-1#1)
Transcription of##7##2##(1990-11#1)(1991-9#1)(1995-5#1)(1995-8#1)(1997-2#2)(2013-1#1)
Transcription##29##1##(1990-11#2)(1991-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-1#2)
Transcriptional activation##2##2##(1994-12#1)(2009-8#1)
Transcriptional control of##2##3##(1990-11#1)(1993-12#1)
Transcriptional control##3##2##(1990-11#1)(1990-5#1)(1993-12#1)
Transcriptional fusions##2##2##(1993-9#1)(1995-8#1)
Transcriptional regulation of##4##3##(1993-12#1)(1997-7#1)(2008-11#2)
Transcriptional##24##1##(1990-11#1)(1990-5#1)(1991-10#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#2)(1997-7#2)(2008-11#2)(2008-9#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
Transcriptome analysis revealed##2##3##(2011-2#1)(2012-2#1)
Transcriptome analysis##3##2##(2010-6#1)(2011-2#1)(2012-2#1)
Transcriptome##8##1##(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
Transcriptomic##2##1##(2010-4#1)(2010-6#1)
Transcripts of the##2##3##(1993-2#1)(1995-8#1)
Transcripts of##4##2##(1993-2#1)(1995-8#1)(2008-10#2)
Transcripts were##2##2##(2008-12#1)(2011-1#1)
Transcripts##13##1##(1993-2#1)(1993-6#1)(1994-12#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
Transcultural##3##1##(1991-12#1)(2008-11#2)
Transcutaneous##3##1##(2007-8#1)(2007-9#1)(2008-11#1)
Transdermal##2##1##(2008-11#1)(2008-5#1)
Transduction##2##1##(1994-5#1)(2010-8#1)
Transepidermal water loss##2##3##(2008-5#2)
Transepidermal##3##1##(2008-5#3)
Transesophageal echocardiography##3##2##(2007-10#1)(2007-8#1)(2013-7#1)
Transfected cells##2##2##(1993-3#1)(2010-11#1)
Transfection by electroporation##2##3##(2008-1#1)(2008-2#1)
Transfection of a##2##3##(2008-11#1)(2010-4#1)
Transfection of cultured##2##3##(2008-1#2)
Transfection of the##2##3##(1992-8#1)(1997-2#1)
Transfection of##15##2##(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1995-5#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-11#3)(2008-9#2)(2010-4#1)
Transfection studies##2##2##(1994-12#1)(2008-1#1)
Transfection##28##1##(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(2008-1#6)(2008-11#7)(2008-2#1)(2008-6#1)(2008-9#2)(2010-4#1)
Transfer of the##3##3##(1994-12#1)(1996-2#1)(2009-5#1)
Transfer of##16##2##(1993-8#1)(1994-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
Transfer pricing##2##2##(1996-1#1)(1996-12#1)
Transfer##56##1##(1991-2#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
Transfer-matrix##2##1##(2008-3#2)
Transferred##2##1##(1990-2#1)(2008-10#1)
Transferrin##7##1##(1990-11#1)(1990-3#1)(1993-11#3)(2008-11#2)
Transferring##2##1##(2008-11#1)(2008-12#1)
Transform##15##1##(2008-10#5)(2008-2#4)(2008-3#1)(2009-12#2)(2010-8#1)(2011-1#1)(2011-2#1)
Transform-limited##2##1##(2007-12#1)(2008-3#1)
Transformants of##3##2##(2008-10#3)
Transformants##10##1##(1991-7#1)(1991-9#1)(2008-10#7)(2011-2#1)
Transformation of the moss Physcomitrella patens using##2##7##(2010-2#2)
Transformation of the##3##3##(2008-7#1)(2010-2#2)
Transformation of##17##2##(1990-12#1)(1990-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-7#1)(2010-2#3)(2013-1#1)
Transformation##29##1##(1990-12#1)(1990-5#1)(1990-8#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-7#2)(2008-8#1)(2010-2#3)(2012-12#1)(2013-1#1)
Transformed with the##2##3##(2008-10#2)
Transformed##9##1##(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1997-7#1)(2008-10#4)
Transformer##2##1##(2008-10#2)
Transforming Growth Factor-beta##2##3##(2008-6#1)(2011-2#1)
Transforming a##2##2##(1995-3#1)(1997-2#1)
Transforming growth factor beta (TGF-beta)##3##5##(1993-12#1)(1993-8#1)(1995-2#1)
Transforming growth factor beta##8##4##(1992-8#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-2#1)(2008-10#1)(2011-2#1)
Transforming growth factor##10##3##(1992-8#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-2#1)(1997-4#1)(2008-10#2)(2011-2#1)
Transforming growth##12##2##(1992-8#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-2#1)(1997-4#1)(2008-10#2)(2009-12#1)(2011-2#1)(2013-1#1)
Transforming the##2##2##(1993-8#1)(2009-9#1)
Transforming##22##1##(1992-8#1)(1993-12#1)(1993-8#3)(1995-12#2)(1995-2#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-6#1)(2009-12#1)(2009-9#1)(2011-2#2)(2013-1#1)
Transfusion Medicine##3##2##(2008-10#1)(2013-1#2)
Transfusion and risk of infection in Canada##3##7##(2007-12#3)
Transfusion##10##1##(1994-12#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#3)
Transfusions##2##1##(2009-4#1)(2013-8#1)
Transgene expression##2##2##(1994-3#1)(1995-2#1)
Transgene##4##1##(1994-3#1)(1995-2#1)(2008-10#1)(2011-2#1)
Transgenerational##3##1##(2008-8#2)(2010-8#1)
Transgenesis in##2##2##(2012-3#2)
Transgenesis##4##1##(2008-11#1)(2008-2#1)(2012-3#2)
Transgenic Arabidopsis##3##2##(2008-10#3)
Transgenic Mouse##2##2##(2010-7#1)(2012-12#1)
Transgenic Nicotiana occidentalis##2##3##(2008-10#2)
Transgenic Nicotiana##3##2##(2008-10#3)
Transgenic mice##2##2##(1992-11#1)(2008-1#1)
Transgenic mouse##2##2##(2008-2#2)
Transgenic plants##6##2##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#2)(2011-2#1)
Transgenic rabbits##2##2##(2008-11#1)(2008-12#1)
Transgenic soybean##2##2##(2008-10#2)
Transgenic tobacco plants##2##3##(2008-10#1)(2009-8#1)
Transgenic##45##1##(1992-11#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#2)(2009-6#1)(2009-8#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
Transglutaminase##2##1##(1994-11#1)(2008-10#1)
Transgressive segregation##2##2##(2008-10#2)
Transient Receptor Potential (TRP)##2##4##(2008-7#1)(2009-12#1)
Transient abnormal myelopoeisis##2##3##(2008-12#2)
Transient absorption##2##2##(2008-10#1)(2008-3#1)
Transient and##2##2##(1991-2#1)(2008-8#1)
Transient deformation measurement with electronic speckle pattern interferometry##2##8##(2008-2#1)(2008-3#1)
Transient expression of##3##3##(2008-2#1)(2008-8#2)
Transient expression##8##2##(1993-8#2)(1994-11#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-8#2)
Transient gene expression in##2##4##(2008-11#2)
Transient gene expression##3##3##(2008-11#3)
Transient ischaemic attacks##2##3##(2009-7#1)(2011-2#1)
Transient left ventricular##2##3##(2010-5#2)
Transient optical modulation##2##3##(2008-3#2)
Transient signals##2##2##(2008-10#2)
Transient transfection assays##2##3##(1993-6#1)(1995-8#1)
Transient transfection##4##2##(1993-6#1)(1995-8#1)(2008-11#1)(2011-2#1)
Transient visual##2##2##(2008-7#1)(2010-3#1)
Transient##66##1##(1991-2#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#6)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
Transit##3##1##(2007-11#1)(2009-7#1)(2013-1#1)
Transition Zone A##2##3##(2008-7#2)
Transition Zone B##3##3##(2008-7#3)
Transition Zone##5##2##(2008-7#5)
Transition in##3##2##(1996-9#1)(1997-7#1)(2008-3#1)
Transition to##3##2##(1992-11#1)(2008-11#1)(2012-2#1)
Transition##28##1##(1992-11#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-7#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
Transitional Cell Carcinoma##2##3##(2007-10#1)(2008-10#1)
Transitional cell carcinoma##2##3##(2007-7#1)(2012-3#1)
Transitional cell##4##2##(2007-7#1)(2008-10#2)(2012-3#1)
Transitional funding##2##2##(1993-1#2)
Transitional##9##1##(1993-1#2)(1994-1#1)(2007-10#1)(2007-7#1)(2008-10#3)(2012-3#1)
Transitions between##2##2##(2012-1#1)(2013-1#1)
Transitions##8##1##(1996-12#1)(2008-11#2)(2008-3#2)(2008-6#1)(2012-1#1)(2013-1#1)
Transitive##2##1##(2009-8#2)
Translating the##2##2##(1991-1#1)(1996-3#1)
Translating##3##1##(1991-1#1)(1996-3#1)(2009-11#1)
Translation and validation of the##2##5##(2009-3#1)(2012-2#1)
Translation and##3##2##(2009-3#1)(2012-2#1)(2012-3#1)
Translation of the##2##3##(1994-8#1)(2013-8#1)
Translation of##4##2##(1994-8#1)(2008-3#1)(2012-12#1)(2013-8#1)
Translation##10##1##(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Translational control of##2##3##(2007-12#2)
Translational##8##1##(2007-12#2)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
Translocation of the##2##3##(1995-2#1)(1997-7#1)
Translocation of##12##2##(1990-5#1)(1990-7#1)(1992-12#1)(1994-12#1)(1995-2#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-8#1)
Translocation##18##1##(1990-5#1)(1990-7#1)(1991-10#1)(1992-12#1)(1994-12#1)(1995-2#2)(1997-7#1)(2007-12#1)(2008-10#5)(2008-8#1)(2009-2#1)(2009-8#1)(2012-1#1)
Translocator Protein (TSPO) in##3##4##(2012-2#3)
Translocator Protein (TSPO)##9##3##(2012-2#9)
Translocator Protein##11##2##(2012-2#11)
Translocator##12##1##(2012-2#12)
Translucency of##3##2##(2012-2#3)
Transmembrane##2##1##(1993-1#1)(1994-12#1)
Transmissible##4##1##(1990-3#1)(1997-5#1)(2008-10#1)(2008-11#1)
Transmission Electron Microscopy##2##3##(2008-12#1)(2009-9#1)
Transmission and reflection##2##3##(2008-2#1)(2008-3#1)
Transmission and##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2010-8#1)
Transmission by##3##2##(2008-10#3)
Transmission efficiency##2##2##(2008-10#2)
Transmission electron microscopic##2##3##(2007-12#1)(2008-10#1)
Transmission electron microscopy (TEM)##2##4##(2008-10#1)(2008-11#1)
Transmission electron microscopy and##2##4##(2007-11#1)(2009-8#1)
Transmission electron microscopy of##2##4##(2008-10#1)(2008-8#1)
Transmission electron microscopy reveals that##2##5##(2008-10#1)(2008-3#1)
Transmission electron microscopy was used to##3##6##(2007-12#1)(2008-10#1)(2008-5#1)
Transmission electron microscopy##18##3##(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
Transmission electron##21##2##(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#1)
Transmission from##2##2##(2008-10#1)(2013-1#1)
Transmission in##2##2##(2008-10#1)(2009-12#1)
Transmission is##2##2##(2007-12#1)(2008-2#1)
Transmission of hepatitis C virus##2##5##(1996-2#1)(2007-7#1)
Transmission of hepatitis##3##3##(1996-2#2)(2007-7#1)
Transmission of##26##2##(1990-3#1)(1996-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-6#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Transmission rates##2##2##(2008-10#1)(2008-3#1)
Transmission scattering##2##2##(2008-3#2)
Transmission to##2##2##(2008-10#2)
Transmission##96##1##(1990-3#1)(1996-2#2)(1997-7#1)(2007-11#3)(2007-12#6)(2007-7#1)(2008-10#39)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#13)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
Transmittance##4##1##(2008-3#4)
Transmitted by##3##2##(2008-10#2)(2010-1#1)
Transmitted##7##1##(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#2)(2013-1#1)
Transparency##3##1##(1996-12#1)(2007-12#1)(2013-8#1)
Transparent##2##1##(2008-10#2)
Transparent-scaled variant##2##2##(2008-5#2)
Transpedicular##3##1##(2007-11#1)(2007-8#2)
Transplant Recipients##2##2##(2008-1#2)
Transplant##13##1##(1991-2#1)(1994-3#1)(1996-6#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
Transplantation in##2##2##(2012-12#1)(2012-3#1)
Transplantation of pancreatic islets##2##4##(2009-3#1)(2010-11#1)
Transplantation of##11##2##(2007-5#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
Transplantation##29##1##(1992-12#1)(1995-12#1)(1996-6#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#3)(2008-9#3)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)
Transplanted##5##1##(1990-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-8#1)
Transplants##3##1##(1997-3#1)(2008-9#1)(2013-1#1)
Transport across the##2##3##(2008-5#1)(2013-1#1)
Transport is inhibited by##2##4##(1994-12#2)
Transport is##3##2##(1994-12#3)
Transport of glutathione##2##3##(1990-2#2)
Transport of##17##2##(1990-2#3)(1990-9#1)(1992-3#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#6)(2009-10#1)(2011-2#1)(2012-2#1)
Transport##35##1##(1990-2#3)(1990-9#1)(1991-3#1)(1992-3#1)(1993-8#1)(1994-12#3)(1994-8#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
Transportation##3##1##(1995-6#1)(2013-1#2)
Transporter##2##1##(2008-11#1)(2011-2#1)
Transporting patients(3##2##2##(1991-2#2)
Transporting##3##1##(1991-2#2)(1995-2#1)
Transposable elements##2##2##(2010-3#2)
Transposable##3##1##(2008-10#1)(2010-3#2)
Transposition of##4##2##(1995-8#1)(2008-10#2)(2009-5#1)
Transposon##2##1##(1997-2#1)(2008-10#1)
Transradial interventions##2##2##(2011-2#2)
Transradial percutaneous coronary interventions##2##4##(2011-2#2)
Transradial procedure failures can sometimes be due to##2##8##(2011-2#2)
Transradial##12##1##(2011-2#12)
Transrectal##3##1##(2011-2#2)(2013-1#1)
Transtheoretical##3##1##(2008-12#1)(2008-4#1)(2013-1#1)
Transthoracic and transesophageal##2##3##(2009-3#1)(2011-2#1)
Transthoracic echocardiography##2##2##(2007-8#1)(2011-2#1)
Transthoracic##5##1##(2007-8#1)(2009-3#1)(2011-2#2)(2011-6#1)
Transthyretin##3##1##(1993-12#1)(1994-8#1)(2008-12#1)
Transtympanic##2##1##(2008-4#2)
Transvaginal##3##1##(1994-3#1)(1995-3#1)(1996-1#1)
Transverse and##2##2##(1997-8#1)(2008-2#1)
Transverse myelitis##3##2##(2007-7#1)(2012-3#2)
Transverse##15##1##(1995-6#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-3#2)
Transverse-sigmoid##2##1##(2006-12#1)(2012-2#1)
Transversely##2##1##(2008-10#2)
Transwomen##2##1##(2008-12#2)
Trap plants##2##2##(2008-10#2)
Trap##7##1##(2008-10#2)(2008-2#1)(2012-12#1)(2013-8#3)
Trapping forces##2##2##(2008-2#2)
Trapping of##2##2##(1997-7#1)(2008-10#1)
Trapping##6##1##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
Traska##2##1##(1995-3#1)(1996-2#1)
Trastuzumab##3##1##(2012-12#1)(2012-3#1)(2013-1#1)
Trauma Surgery##2##2##(2010-9#2)
Trauma##26##1##(1990-3#1)(1990-9#1)(1992-1#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-12#3)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-9#2)(2011-2#4)(2012-12#1)(2013-8#1)
Traumatic Brain Injury##2##3##(2008-10#1)(2010-2#1)
Traumatic brachial plexus##2##3##(2008-9#2)
Traumatic brain injury (TBI)##2##4##(2008-6#1)(2012-2#1)
Traumatic brain injury##3##3##(1995-12#1)(2008-6#1)(2012-2#1)
Traumatic lumbar##2##2##(2008-12#2)
Traumatic rupture of##2##3##(2007-8#1)(2010-8#1)
Traumatic##32##1##(1993-12#1)(1993-6#1)(1995-12#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Traumatology Clinic##2##2##(2007-11#2)
Traumatology in##2##2##(2007-8#1)(2012-12#1)
Traumatology of##6##2##(2007-11#3)(2007-8#2)(2008-12#1)
Traumatology##18##1##(2007-11#8)(2007-8#5)(2008-12#1)(2009-4#1)(2012-12#1)(2013-1#2)
Travel Health##2##2##(2007-2#2)
Travel Medicine##2##2##(2007-2#2)
Travel##17##1##(1995-2#1)(1995-8#3)(1996-8#1)(2007-2#9)(2008-4#1)(2012-2#1)(2013-8#1)
Travellers to##3##2##(2007-2#3)
Travellers'##2##1##(1993-7#1)(1994-7#1)
Treacher Collins syndrome##4##3##(2007-12#4)
Treadmill##3##1##(2008-3#1)(2008-7#1)(2012-3#1)
Treat##3##1##(2008-11#1)(2012-3#1)(2013-1#1)
Treated by##2##2##(1995-11#1)(1997-6#1)
Treated mice##2##2##(1995-11#1)(2010-7#1)
Treated with##9##2##(1994-12#1)(1995-4#1)(1996-6#1)(2008-10#1)(2008-8#2)(2010-6#2)(2013-1#1)
Treated##20##1##(1994-12#1)(1995-11#2)(1995-4#1)(1996-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-6#2)(2010-7#1)(2013-1#1)
Treating CS gas injuries to the eye##3##7##(1995-9#3)
Treating temporarily incompetent patients##3##4##(1995-9#3)
Treating the##2##2##(2007-11#1)(2010-6#1)
Treating##29##1##(1990-8#1)(1993-2#1)(1995-8#1)(1995-9#6)(1996-1#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2013-8#2)
Treatment Group##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
Treatment I##2##2##(2008-7#2)
Treatment II##2##2##(2008-7#2)
Treatment Panel III##4##3##(2008-11#1)(2008-3#3)
Treatment Study##2##2##(1991-8#1)(1995-11#1)
Treatment and##9##2##(1990-9#1)(1995-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#2)(2012-3#1)
Treatment at##2##2##(2007-7#1)(2013-8#1)
Treatment based on##2##3##(2008-11#1)(2011-3#1)
Treatment by##2##2##(2007-8#1)(2008-10#1)
Treatment comparisons##2##2##(1997-4#1)(2008-10#1)
Treatment consisted of##7##3##(1990-2#1)(1991-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
Treatment consists of oral##2##4##(1997-8#1)(2013-8#1)
Treatment decisions##3##2##(2008-7#1)(2009-10#1)(2012-2#1)
Treatment efficacy##2##2##(1994-11#1)(2008-7#1)
Treatment for##7##2##(1992-5#1)(2008-1#1)(2008-6#3)(2012-3#2)
Treatment has##2##2##(1996-11#1)(2012-3#1)
Treatment in##4##2##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Treatment included##2##2##(1992-6#1)(2011-1#1)
Treatment interruption##2##2##(2008-6#1)(2009-4#1)
Treatment is by##2##3##(2009-3#1)(2009-5#1)
Treatment is##5##2##(1996-6#1)(2009-3#1)(2009-5#1)(2010-5#1)(2013-8#1)
Treatment of Adolescent Suicide Attempters (TASA)##2##6##(2010-9#2)
Treatment of Elderly##2##3##(2009-9#1)(2010-8#1)
Treatment of Patients with##2##4##(2010-8#1)(2013-8#1)
Treatment of a##4##3##(1997-3#1)(1997-6#1)(2008-1#1)(2013-8#1)
Treatment of an##2##3##(1997-5#1)(2008-7#1)
Treatment of cells with##6##4##(1990-2#1)(1992-6#1)(1994-9#1)(2008-11#1)(2008-4#1)(2008-9#1)
Treatment of chronic##2##3##(2008-7#1)(2010-1#1)
Treatment of cytotrophoblasts with##2##4##(1994-9#2)
Treatment of human##2##3##(1992-8#1)(1992-9#1)
Treatment of hypertension in##2##4##(2008-1#1)(2010-4#1)
Treatment of hypertension##4##3##(1991-11#1)(2008-1#2)(2010-4#1)
Treatment of membranes##2##3##(1992-7#1)(1993-6#1)
Treatment of mice with##2##4##(1993-9#1)(2011-2#1)
Treatment of neutrophils with##2##4##(2008-4#2)
Treatment of osteoporotic##2##3##(2007-11#1)(2007-8#1)
Treatment of pemphigus##2##3##(2007-7#2)
Treatment of persistent otitis media##2##5##(1996-11#2)
Treatment of relapsed##3##3##(2008-5#2)(2010-4#1)
Treatment of resistant##2##3##(2006-10#1)(2011-2#1)
Treatment of the##15##3##(1990-2#1)(1992-1#2)(1992-5#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2012-3#1)
Treatment of these##2##3##(1992-7#1)(1995-6#1)
Treatment of##224##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#2)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1996-11#3)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#2)(2006-10#2)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#2)(2008-1#6)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#2)(2009-3#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#4)(2011-1#2)(2011-10#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#3)
Treatment options for##5##3##(2007-12#2)(2008-1#1)(2008-10#1)(2010-4#1)
Treatment options include##2##3##(2008-9#1)(2010-5#1)
Treatment options##14##2##(1991-6#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
Treatment outcome was##2##3##(1993-2#1)(2007-8#1)
Treatment outcome##4##2##(1993-12#1)(1993-2#1)(2007-11#1)(2007-8#1)
Treatment patterns##2##2##(1991-4#1)(2012-3#1)
Treatment planning##5##2##(1995-8#1)(1995-9#1)(2008-11#1)(2012-12#1)(2013-1#1)
Treatment should be##2##3##(1991-7#1)(1997-3#1)
Treatment should##3##2##(1991-7#1)(1997-3#1)(2008-6#1)
Treatment was started with##2##4##(1990-11#1)(2011-1#1)
Treatment was##15##2##(1990-11#1)(1990-6#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-3#1)(1997-3#2)(2007-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
Treatment with CoQ10##2##3##(2013-1#2)
Treatment with a##2##3##(1990-7#1)(2012-1#1)
Treatment with high-dose##2##3##(2008-1#1)(2010-10#1)
Treatment with the##8##3##(1994-2#1)(1995-12#1)(1997-4#1)(2008-10#3)(2008-5#1)(2013-1#1)
Treatment with##88##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-6#1)(1997-4#2)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)
Treatment##524##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-9#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#9)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#5)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#4)(1996-3#1)(1996-5#5)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#2)(2006-10#4)(2007-10#6)(2007-11#6)(2007-12#8)(2007-2#1)(2007-7#11)(2007-8#10)(2008-1#13)(2008-10#43)(2008-11#11)(2008-12#8)(2008-2#2)(2008-3#16)(2008-4#9)(2008-5#10)(2008-6#10)(2008-7#26)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#5)(2010-6#6)(2010-8#7)(2010-9#4)(2011-1#7)(2011-10#1)(2011-2#28)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#8)(2012-3#22)(2012-7#1)(2013-1#21)(2013-7#2)(2013-8#8)
Treatment-related clinical findings included papillomas at the site of application in##2##11##(2008-9#2)
Treatment-related squamous cell carcinomas occurred at the site of application in##2##11##(2008-9#2)
Treatment-related##6##1##(2008-6#1)(2008-7#1)(2008-9#4)
Treatments for##4##2##(2007-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
Treatments included##3##2##(2008-10#3)
Treatments of##3##2##(1993-3#1)(2008-10#1)(2008-5#1)
Treatments that##2##2##(2008-10#1)(2008-5#1)
Treatments were##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
Treatments with##2##2##(1995-11#1)(2008-10#1)
Treatments##24##1##(1993-11#1)(1993-3#1)(1995-11#1)(2007-12#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#5)(2011-2#2)(2012-12#1)(2013-8#2)
Treaty##2##1##(2009-5#1)(2011-2#1)
Tree##8##1##(1992-2#1)(1993-3#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
TreeView##4##1##(2008-9#4)
Trees infected with##2##3##(2008-10#2)
Trees of##2##2##(2008-10#2)
Trees were##2##2##(2008-10#2)
Trees##19##1##(2008-10#16)(2008-6#1)(2009-10#1)(2010-8#1)
Treg quantification##2##2##(2013-8#2)
Treg subsets##3##2##(2013-8#3)
Treg##14##1##(2008-4#2)(2013-8#12)
Tregs##3##1##(2013-8#3)
Trehalose##2##1##(1993-8#1)(2009-10#1)
Trematoda##2##1##(2010-9#1)(2011-2#1)
Tremor##6##1##(2008-7#4)(2012-3#1)(2013-1#1)
Trend##4##1##(1991-2#1)(2008-12#1)(2009-7#1)(2012-3#1)
Trends Survey##2##2##(1991-1#1)(2010-2#1)
Trends Surveys##2##2##(1991-1#1)(1996-1#1)
Trends and##4##2##(1991-3#1)(1993-12#1)(2008-11#1)(2008-3#1)
Trends in Endocrinology and Metabolism##2##5##(2008-4#2)
Trends in Medicare##2##3##(1994-3#1)(2008-6#1)
Trends in radiology##3##3##(1991-1#1)(1992-12#1)(1996-1#1)
Trends in the##4##3##(1997-4#1)(2009-12#1)(2009-4#1)(2009-7#1)
Trends in##39##2##(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1996-1#1)(1996-3#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Trends of##2##2##(2008-11#1)(2012-1#1)
Trends##58##1##(1990-11#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#2)(1996-1#2)(1996-3#2)(1997-4#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
Treponema denticola##5##2##(2008-9#4)(2010-11#1)
Treponema pallidum##2##2##(1997-5#1)(2012-12#1)
Treponema##9##1##(1997-5#1)(2008-9#4)(2010-11#1)(2012-12#1)(2013-8#2)
Treuman##2##1##(2008-6#2)
Trevor##2##1##(1990-3#1)(2008-4#1)
Tri-Calciphor##2##1##(1994-6#2)
Tri-nucleotide##2##1##(2008-4#2)
Triage##4##1##(2008-3#2)(2009-4#1)(2013-1#1)
Trial (SALT)##2##2##(1991-11#2)
Trial Research##2##2##(1993-9#1)(2013-1#1)
Trial and##2##2##(2008-7#1)(2011-1#1)
Trial for##2##2##(1991-5#1)(2008-11#1)
Trial in##2##2##(2009-10#1)(2010-12#1)
Trial of##5##2##(2007-10#1)(2007-8#2)(2008-5#1)(2012-12#1)
Trial##44##1##(1991-11#2)(1991-5#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-9#1)(1997-5#2)(2006-7#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
Trial</PublicationType>##2##1##(1994-5#2)
Trialeurodes vaporariorum##2##2##(2008-10#2)
Trialists'##5##1##(1993-11#1)(1993-12#2)(1995-11#1)(2007-5#1)
Trials of##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
Trials##22##1##(2007-8#1)(2008-10#3)(2008-5#2)(2009-10#1)(2009-6#1)(2009-9#3)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#2)
Triamcinolone acetonide##2##2##(1990-11#1)(1991-9#1)
Triamcinolone##3##1##(1990-11#1)(1991-9#1)(1997-7#1)
Triangle##5##1##(1994-3#1)(1997-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
Triangular##3##1##(2008-2#1)(2008-3#1)(2011-2#1)
Triangulating##2##1##(2008-2#1)(2010-10#1)
Triangulation##2##1##(2008-11#1)(2008-3#1)
Triassic##3##1##(1990-8#3)
Triatoma infestans##2##2##(2007-12#2)
Triatoma##3##1##(2007-12#2)(2008-8#1)
Triazine##2##1##(2008-10#1)(2010-8#1)
Triazolam##2##1##(1991-11#1)(1993-7#1)
Tribes##2##1##(1997-1#1)(2008-10#1)
Tribolium castaneum##4##2##(2008-12#2)(2008-9#1)(2012-2#1)
Trichinella infection##2##2##(1996-12#2)
Trichinella##5##1##(1990-12#2)(1996-12#3)
Trichlorfon##2##1##(2008-10#1)(2013-1#1)
Trichloroethylene (TCE) is a##2##4##(2008-10#2)
Trichloroethylene##5##1##(2008-10#4)(2010-4#1)
Trichoderma and##3##2##(2008-10#3)
Trichoderma atroviride P1##2##3##(2008-10#2)
Trichoderma atroviride##4##2##(2008-10#4)
Trichoderma conidia##2##2##(2008-10#2)
Trichoderma hamatum 382 (T(382))##2##4##(2008-10#2)
Trichoderma hamatum 382##4##3##(2008-10#4)
Trichoderma hamatum strain##2##3##(2008-10#1)(2013-8#1)
Trichoderma hamatum##7##2##(2008-10#5)(2013-8#2)
Trichoderma harzianum (atroviride) P1##2##4##(2008-10#2)
Trichoderma harzianum Strain##2##3##(2008-10#2)
Trichoderma harzianum and##2##3##(2008-10#1)(2008-5#1)
Trichoderma harzianum in##2##3##(2008-10#2)
Trichoderma harzianum strain##3##3##(2008-10#3)
Trichoderma harzianum##21##2##(2008-10#20)(2008-5#1)
Trichoderma have been##2##3##(2008-10#2)
Trichoderma koningii##3##2##(2008-10#2)(2008-5#1)
Trichoderma reesei##10##2##(1991-9#2)(1993-8#2)(2008-10#1)(2008-6#2)(2008-9#2)(2011-2#1)
Trichoderma sp##7##2##(2008-10#5)(2008-5#1)(2008-6#1)
Trichoderma species##4##2##(2008-10#4)
Trichoderma spp##18##2##(2008-10#18)
Trichoderma strains##3##2##(2008-10#3)
Trichoderma stromaticum##4##2##(2008-10#4)
Trichoderma virens to##2##3##(2008-10#2)
Trichoderma virens##5##2##(2008-10#5)
Trichoderma viride##3##2##(1992-3#1)(2008-10#2)
Trichoderma##124##1##(1991-9#2)(1992-3#1)(1993-8#2)(2008-10#106)(2008-5#3)(2008-6#4)(2008-9#2)(2011-2#1)(2013-8#3)
Trichodiene synthase##3##2##(1995-2#2)(2008-10#1)
Trichodiene##4##1##(1995-2#2)(2008-10#1)(2008-11#1)
Trichogramma pratissolii Querino &amp##2##4##(2008-6#2)
Trichogramma##5##1##(2008-6#2)(2008-8#3)
Trichomonas tenax##3##2##(2007-6#3)
Trichomonas vaginalis##7##2##(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2012-2#1)
Trichomonas##13##1##(1996-8#1)(2007-6#4)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2012-2#1)
Trichophyton mentagrophytes##6##2##(2008-5#5)(2012-3#1)
Trichophyton rubrum var##3##3##(2009-2#3)
Trichophyton rubrum##9##2##(2008-5#6)(2009-2#3)
Trichophyton species##2##2##(2008-8#2)
Trichophyton spp##6##2##(2009-2#2)(2011-2#4)
Trichophyton tonsurans##5##2##(2008-5#4)(2012-3#1)
Trichophyton##32##1##(2008-5#17)(2008-8#3)(2009-2#5)(2011-2#5)(2012-3#2)
Trichoplusia ni BTI-Tn-5B1-4##3##3##(2008-7#3)
Trichoplusia ni larvae##2##3##(1995-12#2)
Trichoplusia ni##11##2##(1990-8#1)(1995-12#2)(2008-11#4)(2008-7#4)
Trichoplusia##12##1##(1990-8#1)(1995-12#2)(2008-11#4)(2008-7#5)
Trichosporon cutaneum##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
Trichosporon pullulans##2##2##(2008-10#2)
Trichosporon##10##1##(2008-10#3)(2008-5#2)(2009-4#3)(2013-1#2)
Trichostrongylus##6##1##(1996-12#5)(2008-5#1)
Trichovirus and a##2##3##(2008-10#2)
Trichovirus##7##1##(2008-10#7)
Trichuris##4##1##(1996-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
Tricuspid atresia##2##2##(2007-8#2)
Tricyclic##6##1##(1996-5#2)(2008-11#1)(2008-6#1)(2010-1#1)(2013-1#1)
Tridacna##3##1##(2008-5#3)
Tridentate##2##1##(1997-7#2)
Trieste##3##1##(2008-10#2)(2008-2#1)
Trifluoroacetic acid was##2##3##(1997-2#1)(2008-10#1)
Trifolium (clover) species##2##3##(2011-2#2)
Trifolium polymorphum##2##2##(2011-2#2)
Trifolium##6##1##(2008-10#1)(2010-3#1)(2011-2#4)
Trigeminal##3##1##(1993-1#1)(2009-12#1)(2011-2#1)
Triggered by##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
Triggered##4##1##(2007-12#1)(2008-2#1)(2008-8#1)(2012-2#1)
Triggering##4##1##(1994-11#1)(2007-11#1)(2011-2#1)(2013-1#1)
Triglycerides and##2##2##(1992-9#1)(2010-8#1)
Triglycerides##4##1##(1992-9#1)(2008-3#1)(2010-4#1)(2010-8#1)
Trigonella foenum graecum (L##2##4##(2013-1#2)
Trimeresurus##3##1##(1993-3#1)(2008-6#2)
Trimeserusus##2##1##(1990-5#2)
Trimethylolpropane triacrylate##2##2##(2008-9#2)
Trinidad and Tobago were##2##4##(2008-10#2)
Trinidad and Tobago##7##3##(2007-5#2)(2007-8#1)(2008-10#2)(2009-7#1)(2011-2#1)
Trinidad##19##1##(1992-5#1)(2007-5#6)(2007-8#1)(2008-10#4)(2008-4#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
Trinidadian##3##1##(2008-9#2)(2012-3#1)
Trinity Inlet##2##2##(2010-8#2)
Trinity##3##1##(2008-11#1)(2010-8#2)
Trinuclear##2##1##(1997-7#2)
Triops longicaudatus##2##2##(2008-5#2)
Triploid##3##1##(2008-5#2)(2010-5#1)
Tripterygium wilfordii##2##2##(2008-11#2)
Tris buffer (pH##2##3##(1995-6#1)(2008-10#1)
Tris buffer##9##2##(1992-10#1)(1995-6#1)(2008-10#6)(2008-2#1)
Tris##21##1##(1992-10#2)(1992-9#1)(1993-9#1)(1995-6#1)(2008-10#13)(2008-2#1)(2008-4#1)(2008-5#1)
Tris(2##4##1##(2008-10#4)
Tris-HCl buffer at##2##3##(2008-10#2)
Tris-HCl buffer solution##2##3##(2008-10#2)
Tris-HCl buffer##7##2##(1990-8#1)(2008-10#6)
Tris-HCl##9##1##(1990-2#1)(1990-8#1)(2008-10#6)(2008-7#1)
Tris-boric acid##2##2##(2008-10#2)
Tris-buffer##2##1##(2008-10#2)
Tris/HCl##2##1##(2008-10#2)
Tristar)##3##1##(2008-10#3)
Tristeza##3##1##(2008-10#3)
Trisubstituted##2##1##(1996-5#1)(2008-2#1)
Triterpenic derivatives##2##2##(2008-5#2)
Triterpenoid##2##1##(2012-2#1)(2013-1#1)
Tritiated##2##1##(1990-11#1)(1992-3#1)
Triticeae##5##1##(2008-10#3)(2008-5#2)
Triticum aestivum L##4##3##(2008-12#1)(2008-8#1)(2011-2#2)
Triticum aestivum##5##2##(2008-12#2)(2008-8#1)(2011-2#2)
Triticum isolate (pathogenic on wheat) of Magnaporthe##2##7##(2008-10#2)
Triticum isolate (pathogenic on wheat)##4##5##(2008-10#4)
Triticum isolate##5##2##(2008-10#5)
Triticum##17##1##(2008-10#8)(2008-12#3)(2008-5#2)(2008-8#2)(2011-2#2)
Triton X-100 and##10##3##(1990-2#1)(2008-10#9)
Triton X-100 as##2##3##(2008-10#2)
Triton X-100 at##2##3##(1994-3#1)(2008-10#1)
Triton X-100 for##3##3##(1993-9#1)(2008-10#1)(2008-4#1)
Triton X-100 in the##3##4##(1990-11#1)(2008-10#2)
Triton X-100 were##2##3##(2008-10#2)
Triton X-100##58##2##(1990-11#3)(1990-2#2)(1990-7#1)(1991-8#1)(1992-3#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-8#1)(2008-10#34)(2008-12#2)(2008-4#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
Triton X-100)##2##2##(1990-2#1)(2008-10#1)
Triton X-100/phosphatidylinositol-mixed micelles##2##3##(1991-8#2)
Triton X-114##7##2##(1992-3#2)(1995-5#1)(2008-10#4)
Triton X-I00##2##2##(2008-10#2)
Triton and##2##2##(1992-3#1)(2008-10#1)
Triton##79##1##(1990-11#3)(1990-2#3)(1990-7#1)(1991-8#4)(1992-3#5)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-5#1)(1997-8#1)(2008-10#44)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
Tritrichomonas sp##2##2##(2012-3#2)
Triturus##5##1##(2008-10#1)(2008-7#4)
Triumph/I91-533-va##2##1##(2008-10#2)
TrkB##6##1##(2008-5#1)(2008-7#1)(2008-9#4)
Trolox C had no influence on##2##6##(2008-11#2)
Trolox C##8##2##(2008-11#8)
Trolox##15##1##(2008-10#6)(2008-11#9)
Tromsø University Hospital##2##3##(1991-9#2)
Tromsø University##3##2##(1991-9#2)(1993-3#1)
Tromsø##11##1##(1991-9#2)(1992-5#1)(1993-3#3)(1993-6#2)(1995-5#2)(1996-9#1)
Trondheim##5##1##(1990-2#1)(1991-2#1)(1992-6#1)(1995-5#1)(1995-6#1)
Tropheryma##3##1##(1996-8#2)(2011-2#1)
Tropical Medicine##8##2##(1995-2#1)(1995-8#2)(1996-8#1)(2007-10#1)(2009-2#1)(2010-1#1)(2011-2#1)
Tropical Premontane##2##2##(2008-5#2)
Tropical medicine##2##2##(1995-9#2)
Tropical##25##1##(1995-2#1)(1995-8#2)(1995-9#2)(1996-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
Tropidurus semitaeniatus and##2##3##(2008-7#2)
Tropidurus##3##1##(2008-7#3)
Troponin I and cardiac enzymes##2##5##(2008-12#2)
Troponin I##7##2##(2008-12#6)(2011-2#1)
Troponin##8##1##(2007-8#1)(2008-12#6)(2011-2#1)
Tropospheric and##2##2##(2008-2#1)(2008-3#1)
Tropospheric##4##1##(2008-2#1)(2008-3#3)
Trospium chloride##3##2##(2008-3#3)
Trouble##2##1##(1990-3#1)(2012-2#1)
Trp and##2##2##(1994-12#1)(2008-10#1)
Trp residue##3##2##(1992-12#2)(1994-12#1)
Trp residues of##2##3##(1990-5#1)(1994-5#1)
Trp residues with##2##3##(1990-2#1)(1995-2#1)
Trp residues##8##2##(1990-2#1)(1990-5#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)
Trp##30##1##(1990-2#2)(1990-5#1)(1991-12#2)(1991-7#1)(1992-12#2)(1993-11#2)(1993-9#1)(1994-12#4)(1994-5#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-4#1)
Trp-147##3##1##(2008-8#3)
Trp-37 beta is##2##3##(1992-3#2)
Trp-37 beta##3##2##(1992-3#3)
Trp132##2##1##(1995-2#2)
Trp21-Val22##2##1##(1990-12#2)
Trp38##2##1##(1992-6#2)
Trp7##2##1##(1994-8#2)
TruHARP##2##1##(2010-6#2)
True giant##2##2##(2008-12#1)(2013-1#1)
True##10##1##(1990-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
Trujillo##3##1##(2008-9#3)
Trumpf##2##1##(2008-10#2)
Trumping science in BSE##2##4##(1996-11#2)
Truncated##3##1##(1994-8#1)(1996-12#1)(2008-3#1)
Truncation of##2##2##(1992-9#1)(2008-11#1)
Trunk muscle activity##2##3##(2012-12#2)
Trunk##5##1##(2012-12#3)(2012-2#2)
Trust and##2##2##(2008-11#2)
Trust##17##1##(1994-12#1)(1994-3#1)(1996-11#1)(1996-3#1)(2007-5#1)(2008-11#9)(2008-7#2)(2013-8#1)
Trustees##2##1##(1992-2#1)(1993-5#1)
Trusts##5##1##(2008-11#5)
Truth##5##1##(1997-1#1)(2009-3#1)(2009-9#2)(2010-12#1)
Trx##4##1##(1991-6#2)(2009-3#2)
Try to##2##2##(1990-8#1)(2013-8#1)
Trying##2##1##(2007-1#1)(2008-10#1)
Trypan Blue dye##2##3##(2008-8#2)
Trypan Blue##3##2##(2008-11#1)(2008-8#2)
Trypan blue##2##2##(2008-11#2)
Trypan##5##1##(2008-11#3)(2008-8#2)
Trypanosoma brucei and T##2##4##(1994-12#2)
Trypanosoma brucei##9##2##(1993-9#2)(1994-12#2)(2009-7#3)(2010-2#1)(2011-2#1)
Trypanosoma congolense##2##2##(1997-4#2)
Trypanosoma cruzi##4##2##(1992-9#2)(2012-12#2)
Trypanosoma##16##1##(1992-9#2)(1993-9#2)(1994-12#2)(1997-4#2)(2009-7#3)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
Trypanosomatidae##2##1##(2012-2#2)
Trypsin was##2##2##(1997-2#2)
Trypsin##8##1##(1990-2#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)
Ts##5##1##(2008-3#2)(2008-9#2)(2013-1#1)
Ts1##2##1##(2008-8#2)
Ts65Dn mice##4##2##(1997-2#4)
Ts65Dn mouse model of DS##2##5##(2012-2#2)
Ts65Dn mouse model of##3##4##(2012-2#3)
Ts65Dn mouse##4##2##(1997-2#1)(2012-2#3)
Ts65Dn##9##1##(1997-2#6)(2012-2#3)
Tsu-0##6##1##(2008-10#6)
Tsuda##2##1##(2008-11#2)
Tsukada##2##1##(2008-11#2)
Tsukuba and Chiba##3##3##(2008-10#3)
Tsukuba##9##1##(2008-10#6)(2008-2#2)(2012-12#1)
Tsx##5##1##(1990-11#5)
TtEST##2##1##(2011-1#2)
TuMV isolates with##2##3##(2008-10#2)
TuMV isolates##4##2##(2008-10#4)
TuMV##14##1##(2008-10#14)
Tubal ligation##2##2##(1996-8#2)
Tubal##4##1##(1991-3#1)(1996-8#3)
Tube##8##1##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)
Tuber##2##1##(2008-10#2)
Tubercular##2##1##(1997-8#1)(2008-7#1)
Tuberculosis (TB) is##2##3##(2011-1#1)(2011-2#1)
Tuberculosis (TB)##6##2##(2007-2#1)(2011-1#1)(2011-2#3)(2013-1#1)
Tuberculosis Control##2##2##(2008-1#1)(2013-7#1)
Tuberculosis and##10##2##(1991-6#1)(2007-7#1)(2008-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-5#2)(2011-2#2)
Tuberculosis in##4##2##(1990-6#1)(1995-10#1)(2007-2#1)(2008-12#1)
Tuberculosis is a##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
Tuberculosis is##7##2##(1996-6#1)(1996-8#1)(2007-8#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
Tuberculosis of##2##2##(2007-8#1)(2011-2#1)
Tuberculosis remains a##2##3##(1995-9#1)(2008-9#1)
Tuberculosis surveillance using a hidden markov model##2##7##(2013-1#2)
Tuberculosis was##3##2##(1990-9#1)(1991-6#1)(2009-7#1)
Tuberculosis##55##1##(1990-6#1)(1990-9#1)(1991-6#2)(1995-10#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-8#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-5#3)(2010-8#3)(2011-1#2)(2011-2#7)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
Tuberculous peritonitis##2##2##(2008-1#2)
Tuberculous##7##1##(2007-7#1)(2008-1#3)(2008-7#1)(2011-2#1)(2012-2#1)
Tubiana's##2##1##(2008-9#2)
Tubular##6##1##(1993-2#1)(1995-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#1)
Tubularized incised plate##3##3##(2008-10#2)(2009-5#1)
Tubulo-Interstitial##2##1##(2008-1#2)
Tucson B1 and CVB1Nm strain##2##5##(2013-8#2)
Tucson##6##1##(1990-8#2)(2008-2#1)(2011-2#1)(2013-8#2)
Tukey##3##1##(2008-10#1)(2008-12#1)(2009-8#1)
Tukey's post-hoc##3##2##(2008-11#1)(2008-12#1)(2009-3#1)
Tukey's test (α=0##2##3##(2013-1#2)
Tukey's test##6##2##(2008-12#2)(2013-1#3)(2013-8#1)
Tukey's##13##1##(2008-10#1)(2008-11#1)(2008-12#4)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Tulasnein##2##1##(2008-11#2)
Tulipa##4##1##(2009-12#4)
Tumor Angiogenesis##2##2##(1994-12#1)(2011-1#1)
Tumor Cells##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
Tumor Growth##3##2##(2010-7#1)(2011-2#1)(2013-7#1)
Tumor Necrosis Factor-alpha##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
Tumor Necrosis##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
Tumor Society##2##2##(2008-6#1)(2011-2#1)
Tumor Suppressor##2##2##(2011-1#1)(2013-1#1)
Tumor burden##2##2##(1992-2#2)
Tumor cell##3##2##(1995-2#1)(2008-5#1)(2009-10#1)
Tumor cells##4##2##(1992-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
Tumor lysis syndrome (TLS)##2##4##(2008-7#2)
Tumor lysis syndrome##4##3##(2008-7#3)(2012-12#1)
Tumor markers##4##2##(1994-2#1)(1997-7#1)(2008-10#1)(2008-6#1)
Tumor necrosis factor (TNF) is##2##5##(1990-12#1)(2008-9#1)
Tumor necrosis factor (TNF)##4##4##(1990-12#1)(1992-3#1)(2008-9#1)(2011-2#1)
Tumor necrosis factor alpha##3##4##(1994-12#1)(1995-2#2)
Tumor necrosis factor##10##3##(1990-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(2008-9#1)(2011-2#2)(2013-1#1)
Tumor necrosis##13##2##(1990-12#1)(1992-3#1)(1994-12#1)(1995-12#2)(1995-2#2)(1996-9#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#1)
Tumor resection##2##2##(2013-1#1)(2013-8#1)
Tumor suppressor genes##2##3##(2013-1#2)
Tumor##102##1##(1990-12#1)(1990-6#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-7#3)(1995-12#2)(1995-2#3)(1995-4#1)(1996-9#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#3)(2008-6#7)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#4)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#11)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
Tumor-associated##3##1##(1994-12#1)(2009-9#1)(2011-2#1)
Tumors are##2##2##(2009-3#1)(2013-1#1)
Tumors in##2##2##(2013-1#2)
Tumors were##3##2##(1992-5#1)(2007-11#1)(2008-3#1)
Tumors##26##1##(1992-2#1)(1992-5#1)(1993-9#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#3)
Tumour cells##2##2##(1995-12#1)(2009-4#1)
Tumour necrosis##2##2##(2010-12#1)(2011-1#1)
Tumour##13##1##(1995-12#1)(2007-10#1)(2007-11#1)(2008-6#4)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#3)
Tumours##6##1##(1991-9#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
Tunable Continuous-Wave##3##2##(2008-2#2)(2008-3#1)
Tunable ultraviolet##2##2##(2007-11#1)(2008-2#1)
Tunable##39##1##(1996-5#1)(2007-11#2)(2007-12#11)(2008-12#1)(2008-2#12)(2008-3#9)(2008-7#1)(2009-6#1)(2012-2#1)
Tungiasis##3##1##(2007-2#3)
Tungsten##3##1##(2008-10#2)(2009-11#1)
Tuning the##4##2##(2007-12#1)(2008-7#1)(2010-2#1)(2013-8#1)
Tuning##13##1##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2010-2#1)(2013-8#2)
Tunisia##16##1##(1992-5#1)(2007-11#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#2)(2013-8#1)
Tunisia]##2##1##(2007-8#1)(2013-1#1)
Tunisian##14##1##(1996-6#1)(2007-8#1)(2008-10#3)(2008-12#3)(2008-5#1)(2009-1#2)(2009-10#1)(2009-5#1)(2009-9#1)
Tunja##2##1##(2013-1#2)
Tunneling##7##1##(1990-11#1)(1996-9#3)(2008-3#1)(2009-9#1)(2011-1#1)
Turbid Media##2##2##(2008-2#2)
Turbid##3##1##(2008-2#3)
Turbidity##2##1##(2008-10#2)
Turbo Pascal##2##2##(2008-10#2)
TurboSEQUEST##3##1##(2008-4#3)
Turbuhaler##4##1##(1992-3#3)(1996-2#1)
Turbulence##2##1##(1996-12#1)(2008-2#1)
Turimiquire##2##1##(2008-5#2)
Turin##2##1##(2008-7#1)(2011-3#1)
Turing##2##1##(2009-5#1)(2009-8#1)
Turkey by##2##2##(2008-10#2)
Turkey##56##1##(1991-3#1)(1995-12#1)(1996-12#1)(1997-3#4)(1997-5#3)(1997-8#3)(2008-10#10)(2008-11#1)(2008-12#14)(2008-2#1)(2008-3#3)(2008-8#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-7#1)(2013-8#3)
Turkey)##3##1##(2008-10#1)(2008-8#1)(2013-8#1)
Turkish adolescents##2##2##(2011-1#2)
Turkish and Dutch##2##3##(1992-5#2)
Turkish and##4##2##(1992-5#3)(2011-10#1)
Turkish boys##4##2##(2008-10#1)(2011-1#3)
Turkish families##2##2##(2008-2#1)(2008-7#1)
Turkish freshwater systems##2##3##(2008-12#2)
Turkish men##2##2##(2010-10#2)
Turkish newborns##2##2##(2011-1#2)
Turkish patients with##3##3##(2008-2#1)(2009-12#1)(2011-2#1)
Turkish patients##8##2##(2008-12#1)(2008-2#5)(2009-12#1)(2011-2#1)
Turkish population with##2##3##(2008-2#1)(2011-2#1)
Turkish population##7##2##(2008-2#3)(2011-2#2)(2012-12#1)(2012-2#1)
Turkish respondents##3##2##(1992-5#3)
Turkish woman##2##2##(1997-5#2)
Turkish##69##1##(1991-12#2)(1992-5#8)(1995-12#1)(1996-11#2)(1996-5#2)(1997-5#3)(2008-1#2)(2008-10#1)(2008-12#3)(2008-2#9)(2008-7#2)(2008-9#1)(2009-12#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#12)(2011-10#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-8#1)
Turks##2##1##(2007-7#1)(2011-2#1)
Turner syndrome mosaic##2##3##(2008-6#2)
Turner syndrome##6##2##(1995-8#1)(2008-6#2)(2008-7#1)(2013-1#2)
Turner##11##1##(1991-8#2)(1995-8#1)(2007-12#1)(2008-6#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
Turning##8##1##(1990-8#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-7#1)(2009-11#1)(2012-12#1)
Turnip mosaic virus (TuMV)##2##4##(2008-10#2)
Turnip mosaic virus##4##3##(2008-10#4)
Turnip yellow mosaic virus##2##4##(2008-10#2)
Turnip##6##1##(2008-10#6)
Turnover##4##1##(1992-1#1)(2007-12#1)(2008-8#1)(2011-2#1)
Tuscany (Italy)##3##2##(2008-12#1)(2013-8#2)
Tuscany##7##1##(2008-10#1)(2008-12#2)(2008-8#1)(2011-2#1)(2013-8#2)
Tutorial##11##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)
Tutotest##6##1##(2008-10#6)
Tutotest-C##2##1##(2008-10#2)
Tuzla##3##1##(2011-1#3)
Tween 20 to##2##3##(1991-5#1)(2008-7#1)
Tween 20##8##2##(1991-5#1)(1994-9#2)(2008-7#5)
Tween 80##10##2##(2008-10#9)(2013-1#1)
Tween##21##1##(1991-5#1)(1992-5#1)(1994-9#2)(2008-10#10)(2008-7#6)(2013-1#1)
Tween-40##2##1##(2008-10#2)
Tween-80##3##1##(2008-6#2)(2012-2#1)
Twelve (60%)##2##2##(2011-2#1)(2013-8#1)
Twelve animals died or were sacrificed moribund prior to the end of the study##2##14##(2008-9#2)
Twelve healthy##2##2##(2013-1#1)(2013-8#1)
Twelve isolates of##2##3##(2008-10#2)
Twelve months after##2##3##(2008-11#1)(2012-12#1)
Twelve months##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
Twelve new##2##2##(2008-5#1)(2011-3#1)
Twelve of the##3##3##(1992-6#1)(1997-3#1)(2008-10#1)
Twelve of these##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
Twelve of##8##2##(1992-6#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
Twelve patients had##2##3##(1990-2#1)(2008-7#1)
Twelve patients showed##2##3##(1991-4#1)(1997-7#1)
Twelve patients underwent##3##3##(1997-8#1)(2007-8#1)(2008-7#1)
Twelve patients with##5##3##(1992-12#1)(1993-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
Twelve patients##15##2##(1990-2#1)(1991-4#1)(1992-12#1)(1993-12#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2011-1#1)(2013-1#1)(2013-8#1)
Twelve percent of##2##3##(1995-11#1)(2007-2#1)
Twelve studies were##2##3##(2007-12#1)(2011-2#1)
Twelve studies##3##2##(2007-12#1)(2011-2#2)
Twelve volunteers##2##2##(1993-12#1)(2013-1#1)
Twelve##76##1##(1990-11#1)(1990-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#3)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#3)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#7)(2013-7#1)(2013-8#4)
Twenty children##2##2##(2008-9#1)(2010-9#1)
Twenty eight##4##2##(2008-12#1)(2012-12#1)(2013-1#2)
Twenty five##5##2##(1991-8#1)(1996-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
Twenty four##2##2##(2007-2#1)(2008-7#1)
Twenty healthy##3##2##(1993-10#1)(1994-12#1)(2013-8#1)
Twenty patients on hemodialysis were studied##2##6##(2007-7#1)(2008-1#1)
Twenty patients were randomly divided into##2##6##(2007-8#1)(2009-7#1)
Twenty patients were##3##3##(2007-8#1)(2009-7#1)(2012-3#1)
Twenty patients with##3##3##(1992-12#1)(2007-7#1)(2013-1#1)
Twenty patients##16##2##(1990-6#1)(1991-4#1)(1992-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
Twenty percent of the##2##4##(1994-9#1)(1995-3#1)
Twenty percent of##3##3##(1994-9#1)(1995-3#1)(2008-10#1)
Twenty percent##4##2##(1994-9#1)(1995-3#1)(2008-10#2)
Twenty rats were##2##3##(1993-3#1)(2008-12#1)
Twenty six##2##2##(2007-2#1)(2008-10#1)
Twenty three##2##2##(2007-7#1)(2008-8#1)
Twenty two patients##2##3##(2007-8#1)(2008-12#1)
Twenty two##4##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
Twenty years##2##2##(1994-5#1)(2008-12#1)
Twenty##76##1##(1990-6#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#6)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
Twenty-eight patients with##2##3##(2008-7#1)(2008-9#1)
Twenty-eight patients##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
Twenty-eight##16##1##(1990-11#1)(1995-1#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
Twenty-first##2##1##(2010-3#1)(2010-8#1)
Twenty-five novel mutations including duplications in the ATP7A gene##2##9##(2011-1#2)
Twenty-five patients with##2##3##(1991-2#1)(2012-2#1)
Twenty-five patients##3##2##(1990-5#1)(1991-2#1)(2012-2#1)
Twenty-five years of##2##3##(2008-8#1)(2013-1#1)
Twenty-five years##4##2##(2008-1#2)(2008-8#1)(2013-1#1)
Twenty-five##28##1##(1990-2#1)(1990-5#1)(1991-2#1)(1994-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Twenty-four hour ambulatory blood pressure monitoring##2##6##(2009-11#2)
Twenty-four hour##3##2##(2007-10#1)(2009-11#2)
Twenty-four hours later##2##3##(1996-9#1)(2008-6#1)
Twenty-four hours##5##2##(1991-11#1)(1992-11#1)(1996-9#1)(2008-6#1)(2010-8#1)
Twenty-four patients##2##2##(2008-10#1)(2009-11#1)
Twenty-four percent##3##2##(1991-12#1)(1994-2#1)(2010-7#1)
Twenty-four##25##1##(1991-11#1)(1991-12#2)(1992-11#1)(1993-12#1)(1994-2#1)(1996-9#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#3)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
Twenty-nine of the##2##3##(1994-12#1)(2008-8#1)
Twenty-nine##9##1##(1992-12#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-1#1)
Twenty-one cases##2##2##(1992-6#1)(2013-1#1)
Twenty-one patients##7##2##(1990-2#1)(1994-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)
Twenty-one##22##1##(1990-2#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Twenty-seven patients were##2##3##(1990-5#1)(2008-1#1)
Twenty-seven patients with##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
Twenty-seven patients##10##2##(1990-2#1)(1990-5#1)(1993-2#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
Twenty-seven##21##1##(1990-2#1)(1990-5#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1996-7#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
Twenty-six patients##5##2##(1991-6#1)(1994-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
Twenty-six##20##1##(1991-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
Twenty-three of the##3##3##(1992-11#1)(1995-6#1)(2011-2#1)
Twenty-three of these##2##3##(1990-5#1)(2008-10#1)
Twenty-three of##6##2##(1990-5#1)(1991-12#1)(1992-11#1)(1995-6#1)(2008-10#1)(2011-2#1)
Twenty-three patients##4##2##(1990-6#1)(1991-3#1)(2007-8#1)(2012-2#1)
Twenty-three##22##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-11#1)(1995-6#1)(1996-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-5#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
Twenty-two patients with##2##3##(2008-7#1)(2012-2#1)
Twenty-two patients##6##2##(1990-3#1)(1992-9#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
Twenty-two##22##1##(1990-3#1)(1992-2#1)(1992-9#1)(1995-12#1)(1996-8#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#2)
Twice daily##2##2##(1997-2#1)(2007-11#1)
Twig##2##1##(2008-10#2)
Twin 2##2##2##(2010-1#2)
Twin Cities##3##2##(1991-9#1)(1997-1#1)(2011-2#1)
Twin##11##1##(1991-9#1)(1995-2#2)(1997-1#1)(2008-7#1)(2010-1#3)(2010-8#1)(2011-2#1)(2013-1#1)
Twin-image elimination##2##2##(2007-12#2)
Twisting##3##1##(2007-8#1)(2008-2#1)(2011-2#1)
Two Cases##2##2##(2013-1#2)
Two Cultivars of##2##3##(2008-10#2)
Two Decades##2##2##(2008-10#1)(2011-1#1)
Two Different##2##2##(2008-10#1)(2012-3#1)
Two Dimensions##2##2##(1996-9#1)(2009-8#1)
Two QTL##3##2##(2008-10#3)
Two QTLs##2##2##(2008-10#1)(2008-9#1)
Two Races of##2##3##(2008-10#2)
Two additional##6##2##(2008-2#1)(2008-4#1)(2010-10#1)(2010-12#1)(2012-3#2)
Two adult##4##2##(1996-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
Two alternative##3##2##(1996-1#1)(1997-1#1)(2008-4#1)
Two and##3##2##(1994-9#1)(1995-3#1)(2008-1#1)
Two animals##2##2##(1992-5#1)(2008-7#1)
Two bands##2##2##(1996-9#1)(2013-1#1)
Two biological##2##2##(2008-10#2)
Two case reports##5##3##(1990-9#1)(2007-10#1)(2008-6#1)(2009-5#1)(2012-3#1)
Two case studies##2##3##(1997-3#1)(2009-10#1)
Two case##9##2##(1990-9#1)(1995-11#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-5#1)(2012-3#1)
Two cases are described##2##4##(1992-4#1)(1995-11#1)
Two cases are##5##3##(1992-4#1)(1995-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
Two cases of anomalous origins of##2##6##(2007-8#2)
Two cases of##23##3##(1990-5#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-2#1)(1993-9#1)(1994-6#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#2)
Two cases##30##2##(1990-5#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-6#1)(1995-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
Two cell##3##2##(1992-9#1)(2008-11#1)(2008-7#1)
Two children##2##2##(2010-8#1)(2013-1#1)
Two classes of##3##3##(1990-8#1)(1991-2#1)(2008-5#1)
Two clean-up procedures##2##3##(1990-8#1)(2008-10#1)
Two clinical##5##2##(1993-3#1)(1993-6#1)(2010-11#1)(2010-8#1)(2012-12#1)
Two clones##3##2##(2008-10#1)(2008-11#2)
Two closely related##2##3##(1995-8#1)(2008-10#1)
Two commercial formulations##2##3##(2008-10#2)
Two commercially available##3##3##(2008-5#3)
Two common##2##2##(1997-3#1)(2009-9#1)
Two concepts##2##2##(1996-2#1)(2008-7#1)
Two consecutive##2##2##(2008-10#1)(2009-5#1)
Two contrasting##2##2##(2008-5#1)(2008-9#1)
Two critical##2##2##(1992-3#1)(1997-1#1)
Two days after the##2##4##(1993-12#1)(2010-12#1)
Two days after##8##3##(1993-12#1)(1994-12#1)(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
Two days before##2##3##(1995-3#1)(2007-12#1)
Two days##12##2##(1991-12#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
Two different approaches##2##3##(1991-6#1)(2008-10#1)
Two different methods##3##3##(2008-12#1)(2008-4#1)(2008-8#1)
Two different programs were##2##4##(2008-10#1)(2008-9#1)
Two different types of##3##4##(1996-2#1)(2008-1#1)(2009-2#1)
Two different##60##2##(1990-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1996-2#2)(1997-2#2)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
Two distinct##9##2##(1990-5#1)(1991-10#1)(1994-2#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
Two distinctive##2##2##(1992-6#1)(2008-6#1)
Two enzyme##2##2##(1993-2#1)(2008-10#1)
Two examples of##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
Two examples##6##2##(1997-7#1)(2008-2#1)(2008-3#3)(2008-9#1)
Two experimental##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
Two experiments were carried out##2##5##(2007-12#1)(2010-8#1)
Two experiments were##3##3##(2007-12#1)(2008-12#1)(2010-8#1)
Two experiments##4##2##(2007-12#1)(2008-12#1)(2008-3#1)(2010-8#1)
Two faces##3##2##(2008-11#1)(2008-7#1)(2010-11#1)
Two field##3##2##(2008-10#3)
Two flanking##2##2##(2008-10#2)
Two fluorescent##2##2##(1997-2#1)(2008-11#1)
Two forms of##5##3##(1991-12#1)(1992-8#1)(1997-3#1)(2008-10#1)(2010-5#1)
Two forms##6##2##(1991-12#1)(1992-8#1)(1997-3#1)(2008-10#2)(2010-5#1)
Two fractures##2##2##(2011-2#1)(2012-2#1)
Two further##5##2##(1991-3#1)(1996-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
Two general##2##2##(1992-3#1)(1994-5#1)
Two genes##4##2##(1996-6#1)(2007-7#1)(2008-10#1)(2008-7#1)
Two genetically distinct##2##3##(2008-10#2)
Two genomic##2##2##(1992-11#1)(2008-5#1)
Two geometries##2##2##(2008-2#1)(2008-3#1)
Two gratings##2##2##(2008-3#2)
Two groups of rats were##2##5##(1990-5#1)(1991-12#1)
Two groups of rats##3##4##(1990-5#1)(1991-12#1)(1996-12#1)
Two groups of##10##3##(1990-5#1)(1991-12#1)(1991-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-8#1)
Two groups were studied##2##4##(2007-8#1)(2012-3#1)
Two groups were##4##3##(2007-8#1)(2012-3#2)(2013-1#1)
Two groups##19##2##(1990-5#1)(1991-12#1)(1991-3#1)(1993-5#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Two highly##3##2##(1990-2#1)(2008-10#1)(2008-8#1)
Two histologically##2##2##(2008-10#1)(2012-3#1)
Two hours##2##2##(1995-12#1)(2011-1#1)
Two human##3##2##(1990-8#1)(2008-11#1)(2008-4#1)
Two hundred and eight##2##4##(2007-8#1)(2011-1#1)
Two hundred and thirteen questionnaires##2##5##(2007-2#2)
Two hundred and##17##3##(1993-12#1)(1997-3#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2010-3#1)(2011-1#1)(2012-1#2)(2013-8#1)
Two hundred##31##2##(1992-2#1)(1993-12#1)(1997-3#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-8#1)(2010-3#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#3)
Two hypotheses##2##2##(1994-3#1)(2008-10#1)
Two identical##2##2##(2008-10#1)(2008-5#1)
Two important##9##2##(1996-2#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#2)
Two independent reviewers assessed the strength of evidence using the GRADE criteria and disagreements were resolved by consensus##3##18##(2012-12#3)
Two independent reviewers##4##3##(2012-12#4)
Two independent##8##2##(2008-10#2)(2008-2#1)(2008-5#1)(2012-12#4)
Two indicators##2##2##(2007-7#1)(2008-10#1)
Two individuals##3##2##(1992-6#1)(2007-6#1)(2012-12#1)
Two injections##2##2##(1992-8#1)(2008-10#1)
Two isoforms of##2##3##(1996-12#1)(2008-6#1)
Two isolates of##2##3##(2008-10#1)(2008-12#1)
Two isolates were##2##3##(2008-10#2)
Two isolates##7##2##(2008-10#5)(2008-12#1)(2011-2#1)
Two kinds of##8##3##(1995-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)
Two large##3##2##(1992-8#1)(2008-10#1)(2008-5#1)
Two lines##2##2##(2008-10#1)(2008-8#1)
Two main##10##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
Two major##14##2##(1990-11#1)(1990-5#1)(1991-8#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-1#1)
Two mathematical##2##2##(2008-3#1)(2008-7#1)
Two mechanisms for##2##3##(1996-4#1)(2007-12#1)
Two mechanisms##4##2##(1994-5#1)(1996-4#1)(2007-12#1)(2008-10#1)
Two members of##2##3##(2008-10#1)(2009-9#1)
Two methods are described##2##4##(2008-10#1)(2008-2#1)
Two methods are used##2##4##(2008-3#2)
Two methods are##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
Two methods for the##2##4##(1992-11#1)(2008-10#1)
Two methods for##7##3##(1992-11#1)(2008-10#1)(2008-3#2)(2008-4#2)(2013-1#1)
Two methods of##5##3##(2008-10#2)(2008-7#1)(2012-3#2)
Two methods were used##2##4##(2008-10#1)(2008-5#1)
Two methods were##3##3##(2008-10#2)(2008-5#1)
Two methods##22##2##(1992-11#1)(1993-9#1)(1995-2#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
Two models for##2##3##(2008-10#1)(2009-8#1)
Two models of##2##3##(1991-2#1)(1996-12#1)
Two models##8##2##(1991-2#1)(1996-12#1)(1996-4#1)(2008-10#3)(2008-11#1)(2009-8#1)
Two months after surgery##2##4##(2013-1#1)(2013-8#1)
Two months after##6##3##(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
Two months later##5##3##(2007-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)
Two months##12##2##(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
Two multivariate calibration methods##2##4##(2008-10#1)(2013-8#1)
Two mutant##3##2##(1990-5#1)(1994-6#1)(2008-10#1)
Two new species##2##3##(2008-5#1)(2013-8#1)
Two new##14##2##(1993-9#1)(1996-5#1)(1997-7#2)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-8#1)
Two novel##12##2##(1991-12#1)(1994-11#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-12#1)(2012-3#1)
Two of the most##2##4##(1997-2#1)(2008-10#1)
Two of the patients##3##4##(1993-3#1)(2008-1#1)(2012-3#1)
Two of the three##2##4##(1992-6#1)(2008-11#1)
Two of the##42##3##(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)
Two of them##3##3##(1991-11#1)(1995-12#1)(2008-4#1)
Two of these patients##2##4##(1990-9#1)(2013-1#1)
Two of these##12##3##(1990-9#1)(1997-3#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2013-1#2)
Two of those##2##3##(1990-7#1)(2012-12#1)
Two of##63##2##(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
Two oligonucleotide primers##3##3##(2008-10#2)(2008-5#1)
Two optical##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Two or three##2##3##(1990-8#1)(2008-9#1)
Two or##3##2##(1990-8#1)(2006-4#1)(2008-9#1)
Two other##12##2##(1993-11#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-5#2)(2012-1#1)
Two out of##2##3##(1990-6#1)(1992-9#1)
Two pairs of##2##3##(2007-12#1)(2008-9#1)
Two pairs##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
Two particular##2##2##(1995-3#1)(2009-1#1)
Two patients died##3##3##(1990-9#1)(2007-8#1)(2008-6#1)
Two patients experienced##2##3##(1991-11#1)(2008-7#1)
Two patients had a##2##4##(1991-5#1)(2011-2#1)
Two patients had##8##3##(1991-5#1)(1992-4#1)(1992-9#1)(1993-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
Two patients presented##2##3##(2008-7#1)(2011-1#1)
Two patients underwent##2##3##(1990-6#1)(2008-9#1)
Two patients were##6##3##(1993-2#1)(1993-3#1)(1997-6#1)(2008-7#2)(2011-2#1)
Two patients with this##2##4##(1991-5#1)(1992-2#1)
Two patients with##8##3##(1990-9#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-8#1)(2007-10#1)(2008-7#1)
Two patients##52##2##(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-6#2)(2008-7#6)(2008-9#1)(2011-1#1)(2011-2#5)(2012-3#2)
Two peptides##2##2##(1996-12#1)(2008-4#1)
Two percent##4##2##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
Two polypeptides of##2##3##(1993-6#1)(1997-4#1)
Two populations of##2##3##(1992-8#1)(2007-10#1)
Two populations##3##2##(1992-8#1)(2007-10#1)(2010-8#1)
Two possible##2##2##(1997-4#1)(2008-3#1)
Two potential##2##2##(1991-8#1)(1997-4#1)
Two previously##2##2##(1992-8#1)(1993-6#1)
Two procedures##2##2##(2008-10#2)
Two programs##2##2##(2008-10#2)
Two protein kinase C##2##4##(1993-3#1)(2008-8#1)
Two protein##4##2##(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
Two proteins##5##2##(1992-3#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-12#1)
Two randomized##2##2##(2008-8#1)(2010-12#1)
Two rare##2##2##(2008-7#1)(2012-3#1)
Two recent developments##2##3##(2008-8#1)(2010-12#1)
Two recent##7##2##(1994-5#1)(1996-1#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-12#1)
Two recently##2##2##(2008-2#1)(2008-3#1)
Two regions##4##2##(1991-12#1)(1994-12#1)(1996-2#1)(2008-4#1)
Two related##2##2##(1993-6#1)(2007-2#1)
Two representative##3##2##(2008-3#1)(2008-9#1)(2012-7#1)
Two resistant##2##2##(1992-9#1)(2012-3#1)
Two sample##3##2##(1996-12#1)(2008-10#2)
Two samples were##2##3##(2008-10#1)(2008-3#1)
Two samples##6##2##(1991-12#1)(1994-11#1)(2008-10#1)(2008-3#2)(2012-1#1)
Two separate##2##2##(1996-12#1)(2008-2#1)
Two sequential injection##2##3##(2008-10#2)
Two series of##4##3##(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
Two sets of##7##3##(1993-8#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#3)
Two simple##3##2##(2008-10#3)
Two small##2##2##(2008-10#1)(2008-6#1)
Two solutions are##2##3##(2007-12#1)(2008-2#1)
Two solutions##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
Two species of##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
Two species##8##2##(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-1#1)
Two specific##3##2##(1996-3#2)(2008-10#1)
Two strains of##4##3##(2007-6#1)(2008-10#3)
Two strains##6##2##(2007-6#1)(2008-10#4)(2009-6#1)
Two studies examined musculoskeletal injuries##2##5##(2013-1#2)
Two studies examined##3##3##(2007-12#1)(2013-1#2)
Two studies##9##2##(1995-12#1)(2007-12#1)(2008-12#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Two subgroups##2##2##(2008-10#2)
Two such##2##2##(1997-3#1)(2008-5#1)
Two surveys##2##2##(1992-12#1)(2011-2#1)
Two systems##2##2##(2008-12#1)(2008-3#1)
Two techniques##2##2##(1991-5#1)(2008-2#1)
Two thirds of the##2##4##(1996-6#1)(1997-6#1)
Two thirds of##3##3##(1996-6#1)(1997-6#1)(2013-1#1)
Two thirds##4##2##(1995-6#1)(1996-6#1)(1997-6#1)(2013-1#1)
Two thousand##2##2##(2007-7#1)(2011-2#1)
Two topological indices for the##2##5##(2008-10#2)
Two types of##29##3##(1990-12#1)(1990-6#1)(1991-12#1)(1993-3#1)(1993-6#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-7#1)
Two types##31##2##(1990-12#1)(1990-6#1)(1991-12#1)(1993-3#1)(1993-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-7#1)
Two unknown##2##2##(2008-10#2)
Two unusual##2##2##(2008-12#1)(2008-2#1)
Two weeks after the##2##4##(2008-7#1)(2009-8#1)
Two weeks after##7##3##(1997-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2013-1#1)
Two weeks later##3##3##(1994-12#1)(1996-5#1)(2012-3#1)
Two weeks##11##2##(1994-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
Two women##3##2##(1991-2#1)(1992-4#1)(2007-7#1)
Two years after the##3##4##(2008-6#1)(2012-12#2)
Two years after##4##3##(2008-6#1)(2012-12#2)(2013-1#1)
Two years later##2##3##(2008-10#2)
Two years##10##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2012-12#2)(2013-1#2)
Two##1335##1##(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#10)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#8)(1991-3#8)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#5)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#4)(1992-8#10)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#7)(1993-5#4)(1993-6#8)(1993-8#4)(1993-9#3)(1994-1#2)(1994-11#8)(1994-12#7)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#6)(1995-11#6)(1995-12#5)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#7)(1995-8#3)(1996-1#5)(1996-10#1)(1996-12#13)(1996-2#9)(1996-3#3)(1996-4#3)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#12)(1997-4#6)(1997-6#4)(1997-7#11)(1997-8#3)(1997-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#24)(2007-2#6)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#16)(2007-8#12)(2007-9#1)(2008-1#11)(2008-10#315)(2008-11#35)(2008-12#20)(2008-2#31)(2008-3#58)(2008-4#23)(2008-5#37)(2008-6#21)(2008-7#37)(2008-8#26)(2008-9#26)(2009-1#1)(2009-10#2)(2009-11#4)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#6)(2010-10#3)(2010-11#4)(2010-12#9)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#19)(2011-2#44)(2012-1#5)(2012-12#17)(2012-2#17)(2012-3#26)(2012-7#1)(2013-1#41)(2013-7#2)(2013-8#13)
Two- and three-dimensional##2##3##(1995-2#1)(2008-3#1)
Two- and##3##2##(1995-2#1)(2008-3#1)(2008-6#1)
Two-##4##1##(1991-5#1)(1995-2#1)(2008-3#1)(2008-6#1)
Two-Color##2##1##(2008-3#2)
Two-Dimensional##11##1##(1991-12#1)(1996-9#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#5)
Two-Level##2##1##(1996-9#1)(2012-3#1)
Two-Photon##2##1##(1996-5#1)(2008-3#1)
Two-Wave Coupling in a##2##4##(2008-3#2)
Two-beam##2##1##(2008-3#2)
Two-color##7##1##(1996-5#1)(2008-2#3)(2008-3#3)
Two-dimensional affinity resolution electrophoresis##2##4##(1995-2#2)
Two-dimensional binary##2##2##(2008-3#2)
Two-dimensional gel electrophoresis##5##3##(1990-11#1)(1993-9#1)(2008-4#2)(2011-3#1)
Two-dimensional images of biological##2##4##(2007-12#1)(2008-3#1)
Two-dimensional images of##3##3##(2007-12#2)(2008-3#1)
Two-dimensional measurement technique for birefringence vector distributions##2##7##(2008-3#2)
Two-dimensional phase retrieval##2##3##(2007-11#2)
Two-dimensional phase##3##2##(2007-11#2)(2008-3#1)
Two-dimensional polyacrylamide gel##2##3##(1991-9#1)(2008-10#1)
Two-dimensional temperature##2##2##(2008-2#1)(2008-3#1)
Two-dimensional##55##1##(1990-11#1)(1991-9#1)(1993-11#2)(1993-9#1)(1994-5#1)(1995-2#2)(1995-6#1)(2007-11#6)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#24)(2008-4#4)(2008-9#1)(2011-3#1)
Two-electron##2##1##(1993-11#1)(2012-2#1)
Two-hybrid##3##1##(2008-2#1)(2008-4#1)(2008-7#1)
Two-modulator generalized ellipsometry##2##3##(2008-2#2)
Two-photon excitation microscopy##2##3##(2008-1#2)
Two-photon excitation##3##2##(2007-11#1)(2008-1#2)
Two-photon imaging##2##2##(2008-4#2)
Two-photon##11##1##(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2009-2#1)(2010-1#1)
Two-point##2##1##(1994-8#1)(2008-3#1)
Two-stage##7##1##(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#2)(2012-3#1)
Two-step##4##1##(1992-5#1)(2008-3#1)(2010-11#1)(2012-3#1)
Two-thirds of the##6##3##(1991-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-11#1)
Two-thirds##7##1##(1991-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-11#1)(2013-1#1)
Two-wave mixing of phase-modulated##2##4##(2007-11#2)
Two-wavelength interferometry that##2##3##(2008-2#2)
Two-wavelength lidar inversion algorithm##2##4##(2008-2#2)
Two-wavelength##4##1##(2008-2#4)
Two-way text paging##2##3##(2010-8#2)
Two-way##4##1##(2009-8#1)(2010-8#2)(2012-3#1)
Two-week##2##1##(2008-10#1)(2012-2#1)
Two-week-old##2##1##(1997-6#1)(2008-5#1)
Two-year##2##1##(2008-6#1)(2008-8#1)
Twyman-Green interferometer##4##2##(2008-3#4)
Twyman-Green##6##1##(2008-3#6)
Twyman-Green-type##2##1##(2008-2#2)
TxA(2)##7##1##(2006-6#7)
TxD##4##1##(2008-10#4)
Ty1##4##1##(1995-9#4)
Ty3##5##1##(1997-7#5)
Tyco Healthcare##2##2##(2007-8#1)(2010-8#1)
Tylenchulus semipenetrans##2##2##(2008-10#2)
Tyler##2##1##(1991-12#1)(1997-3#1)
Tymovirus##4##1##(2008-10#4)
Type 1 Diabetes##3##3##(2008-1#1)(2009-3#1)(2013-1#1)
Type 1 and##2##3##(2010-8#1)(2013-1#1)
Type 1 diabetes (T1D)##2##4##(2010-5#2)
Type 1 diabetes is associated with##2##6##(2010-10#1)(2013-1#1)
Type 1 diabetes is##3##4##(2010-10#1)(2010-5#1)(2013-1#1)
Type 1 diabetes mellitus##4##4##(2008-1#1)(2010-12#1)(2010-5#1)(2011-1#1)
Type 1 diabetes##22##3##(1994-12#2)(2008-1#2)(2008-3#1)(2008-9#1)(2010-10#5)(2010-12#1)(2010-5#5)(2010-9#2)(2011-1#1)(2013-1#2)
Type 1##32##2##(1994-12#2)(1997-1#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#6)(2010-12#1)(2010-5#5)(2010-8#1)(2010-9#2)(2011-1#1)(2013-1#5)
Type 2 DM##2##3##(2007-7#1)(2008-3#1)
Type 2 Diabetes Mellitus##4##4##(1994-12#1)(2008-3#2)(2013-1#1)
Type 2 Diabetes##7##3##(1994-12#1)(2008-3#2)(2009-3#1)(2013-1#2)(2013-7#1)
Type 2 diabetes is##3##4##(2008-1#2)(2008-7#1)
Type 2 diabetes mellitus and##3##5##(2007-5#1)(2008-1#1)(2013-1#1)
Type 2 diabetes mellitus##7##4##(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-10#1)(2012-3#1)(2013-1#1)
Type 2 diabetes patients##2##4##(2008-8#2)
Type 2 diabetes##25##3##(1994-12#2)(2007-5#1)(2007-7#1)(2008-1#5)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#4)(2011-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
Type 2 diabetic patients##2##4##(2008-1#1)(2010-10#1)
Type 2 diabetic##4##3##(1994-12#1)(2008-1#1)(2008-3#1)(2010-10#1)
Type 2##48##2##(1993-6#1)(1994-12#4)(1997-1#1)(2007-5#1)(2007-7#2)(2008-1#7)(2008-10#1)(2008-3#7)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#5)(2010-8#1)(2011-2#1)(2012-3#4)(2012-5#1)(2013-1#4)(2013-7#1)
Type 3##3##2##(1997-1#1)(2012-12#2)
Type A##4##2##(1991-8#1)(1994-2#1)(2008-8#1)(2011-2#1)
Type C Niemann-Pick disease##2##4##(1990-8#2)
Type I and Type II##2##5##(1994-2#1)(2008-9#1)
Type I collagen mRNA##2##4##(1991-5#1)(1994-12#1)
Type I error rate is##2##5##(2012-2#2)
Type I error rate##5##4##(2012-2#5)
Type I error##7##3##(2008-8#1)(2012-2#5)(2013-1#1)
Type I is##2##3##(1994-9#1)(2010-8#1)
Type I##25##2##(1991-5#1)(1992-12#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-2#5)(2013-1#1)
Type II collagen##2##3##(1992-2#1)(2008-11#1)
Type II is##2##3##(1996-6#1)(2010-8#1)
Type II tracheal agenesis##2##4##(2012-3#2)
Type II##22##2##(1992-2#1)(1994-2#4)(1994-9#1)(1995-2#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#2)
Type III##6##2##(1996-6#1)(1997-8#2)(2007-12#1)(2010-8#1)(2013-1#1)
Type III)##2##2##(2008-8#2)
Type IV##4##2##(1997-8#1)(2007-7#1)(2008-10#1)(2012-12#1)
Type V##2##2##(1992-12#1)(1997-8#1)
Type of##8##2##(1991-3#1)(2007-11#1)(2008-10#3)(2010-12#1)(2011-2#1)(2013-8#1)
Type##177##1##(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-12#7)(1994-2#8)(1994-7#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(1996-6#3)(1997-1#4)(1997-8#6)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#3)(2008-1#10)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#9)(2008-9#4)(2009-12#1)(2009-3#2)(2010-10#11)(2010-12#2)(2010-5#5)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#6)(2012-3#6)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#1)
Type-2 diabetes##2##2##(2008-7#1)(2012-2#1)
Type-2 diabetic patients##2##3##(2012-2#2)
Type-2##4##1##(2008-7#1)(2012-2#3)
Types and##2##2##(2008-10#2)
Types in##2##2##(2008-10#1)(2009-9#1)
Types of##7##2##(1993-12#1)(1996-12#1)(1997-1#1)(2008-10#3)(2013-1#1)
Types##13##1##(1993-12#1)(1996-12#1)(1997-1#1)(2008-10#7)(2008-7#1)(2009-9#1)(2013-1#1)
Typhi##4##1##(2012-3#4)
Typhimurium##6##1##(2008-10#2)(2008-11#2)(2009-5#1)(2011-2#1)
Typhlichthys##2##1##(2012-3#2)
Typhoid##4##1##(1992-2#1)(2007-7#1)(2011-2#1)(2013-8#1)
Typhula spp##3##2##(2008-10#3)
Typhula##7##1##(2008-10#7)
Typical disease symptoms##2##3##(2008-10#2)
Typical symptoms of##2##3##(1997-6#1)(2008-10#1)
Typical##23##1##(1990-6#1)(1991-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
Typically##21##1##(1992-1#1)(1993-12#1)(1994-11#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
Tyr 60##3##2##(1995-5#3)
Tyr mutant##2##2##(1993-11#2)
Tyr residues##3##2##(1994-5#1)(1995-6#1)(2008-10#1)
Tyr tubulin##2##2##(1992-6#2)
Tyr##27##1##(1991-3#2)(1991-5#1)(1992-6#2)(1993-11#3)(1994-5#4)(1994-6#1)(1995-5#3)(1995-6#1)(2006-12#1)(2008-10#8)(2008-4#1)
Tyr(701)##2##1##(2011-2#2)
Tyr-##5##1##(1991-5#5)
Tyr-165-Phe##3##1##(1990-8#3)
Tyr-240-Phe##2##1##(1990-8#2)
Tyr-Gly##2##1##(1991-3#2)
Tyr-Gly-Gly##3##1##(1991-3#2)(2008-10#1)
Tyr1##3##1##(1992-3#2)(1993-3#1)
Tyr10##2##1##(1995-6#2)
Tyr1150##2##1##(1995-6#2)
Tyr38p##2##1##(1995-3#2)
Tyr7##2##1##(1995-6#2)
Tyr75##2##1##(1995-3#2)
Tyr83##3##1##(1990-5#3)
Tyramine##3##1##(2008-10#2)(2008-7#1)
Tyrode solution##3##2##(2008-12#2)(2011-1#1)
Tyrol##2##1##(2008-10#2)
Tyrosinase was##2##2##(2008-10#2)
Tyrosinase##5##1##(1994-12#1)(2008-10#3)(2008-5#1)
Tyrosine kinase inhibitors##2##3##(1992-12#1)(2011-2#1)
Tyrosine kinase##4##2##(1992-12#1)(2009-8#1)(2010-4#1)(2011-2#1)
Tyrosine phosphorylation of##2##3##(1992-8#1)(1997-6#1)
Tyrosine##14##1##(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1996-5#1)(1997-6#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Táchira##3##1##(2008-9#3)
Tübingen##2##1##(2012-3#2)
Tükrös)##2##1##(2008-10#2)
U = 1##2##3##(2008-7#2)
U =##3##2##(2008-7#3)
U about the results##2##4##(2008-10#2)
U and B in waters by##2##6##(2008-10#2)
U and Pu##2##3##(2008-10#2)
U and##10##2##(1991-8#1)(2008-10#9)
U cm(-2) for##2##3##(2008-10#2)
U conversion##2##2##(1992-11#1)(1994-8#1)
U mismatches in##2##3##(1991-8#2)
U mismatches##3##2##(1991-8#3)
U ml(-1) of##2##3##(2008-10#2)
U ml(-1)##9##2##(2008-10#6)(2008-11#3)
U ml-1 of beads##2##4##(1997-2#2)
U ml-1 of##3##3##(1997-2#3)
U ml-1##5##2##(1995-11#1)(1996-2#1)(1997-2#3)
U to##3##2##(2009-12#2)(2010-10#1)
U##500##1##(1990-10#1)(1990-11#2)(1990-4#1)(1990-6#1)(1990-8#6)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#11)(1991-9#1)(1992-1#4)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#5)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#4)(1993-8#2)(1994-1#7)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#3)(1996-1#3)(1996-12#9)(1996-2#7)(1996-3#7)(1996-5#4)(1996-6#3)(1996-8#1)(1997-1#12)(1997-2#7)(1997-3#1)(1997-5#6)(1997-6#2)(1997-7#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-5#4)(2007-8#2)(2008-1#5)(2008-10#149)(2008-11#7)(2008-12#12)(2008-2#5)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#20)(2008-8#4)(2008-9#7)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#9)(2010-10#2)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2011-9#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#7)(2013-8#11)
U(VI) and Th(IV) from##4##4##(2008-10#4)
U(VI) and Th(IV)##16##3##(2008-10#16)
U(VI) from##4##2##(2008-10#4)
U(VI) over Th(IV)##3##3##(2008-10#3)
U(VI) over##5##2##(2008-10#5)
U(VI) was found to be##2##5##(2008-10#2)
U(VI) was##3##2##(2008-10#3)
U(VI)##50##1##(2008-10#50)
U)##8##1##(1990-6#1)(1990-8#1)(1993-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
U-373##5##1##(1994-11#5)
U-50##9##1##(1993-12#4)(1997-2#5)
U-937 cells##4##2##(1993-12#2)(1994-2#2)
U-937##7##1##(1993-12#4)(1994-2#3)
U-ARF##5##1##(2008-8#5)
U-CLIP devices##2##2##(2007-7#2)
U-CLIP##3##1##(2007-7#3)
U-CLIPTM Anastomotic Device##2##3##(2007-7#2)
U-Cr##3##1##(1994-5#3)
U-G units##4##2##(1997-3#4)
U-G##5##1##(1997-3#5)
U-LDL##2##1##(1991-5#2)
U-box proteins from the##2##4##(2009-10#2)
U-box proteins were##2##3##(2009-10#2)
U-box proteins##7##2##(2009-10#7)
U-box##10##1##(2009-10#10)
U-clipped##3##1##(2007-8#3)
U-clips##2##1##(2007-8#2)
U-rich 3' tail##3##3##(1997-2#3)
U-rich##4##1##(1997-2#3)(2008-10#1)
U-shaped reaction norms##2##3##(2008-8#2)
U-shaped relationship between##2##3##(2008-7#2)
U-shaped##17##1##(1990-7#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2012-12#1)
U-test##4##1##(2007-10#1)(2010-9#1)(2013-8#2)
U/L and##2##2##(2007-12#2)
U/L##9##1##(2007-12#4)(2008-4#1)(2008-6#2)(2011-2#2)
U/g of##3##2##(2008-5#2)(2008-6#1)
U/kg##6##1##(1992-11#1)(2008-7#1)(2010-2#4)
U/l =##2##2##(1991-5#2)
U/l of##2##2##(2008-5#2)
U/l##8##1##(1990-2#1)(1991-5#3)(1992-9#1)(1995-3#1)(2008-5#2)
U/l) and##2##2##(1992-11#1)(1995-3#1)
U/mL##2##1##(2008-4#2)
U/mg protein##3##2##(1992-11#1)(1994-12#1)(1995-8#1)
U/mg##12##1##(1990-12#2)(1992-11#1)(1994-12#1)(1994-6#2)(1995-8#5)(1996-9#1)
U/ml (0%) in##2##3##(1993-1#2)
U/ml of SOD##2##3##(2008-10#2)
U/ml of##3##2##(1996-12#1)(2008-10#2)
U/ml vs##3##2##(1992-9#1)(2008-7#2)
U/ml##25##1##(1991-4#2)(1992-12#1)(1992-9#3)(1993-1#6)(1994-8#4)(1996-12#1)(2008-10#3)(2008-7#4)(2013-1#1)
U/ml)##5##1##(1991-9#2)(1992-3#1)(1994-8#1)(2008-10#1)
U0126##3##1##(2008-11#1)(2008-4#2)
U1 and U2 snRNPs##2##4##(1995-6#2)
U1 and U2##3##3##(1995-6#3)
U1##8##1##(1991-5#1)(1991-6#3)(1995-6#4)
U1-A##6##1##(1991-6#6)
U17##2##1##(1993-11#2)
U2 RNA##2##2##(1993-8#1)(1995-6#1)
U2 RNAs##4##2##(1993-8#4)
U2 small nuclear##2##3##(1993-8#2)
U2 snRNPs##5##2##(1993-8#3)(1995-6#2)
U2##20##1##(1991-6#1)(1993-6#1)(1993-8#10)(1995-6#6)(2007-12#1)(2013-8#1)
U2-B&quot##2##1##(1991-6#2)
U251 cells]##2##2##(2011-2#1)(2013-1#1)
U266 cells##2##2##(2008-3#2)
U266##4##1##(2008-3#4)
U3 promoter region of##2##4##(1995-2#2)
U3##4##1##(1995-2#2)(2008-9#2)
U4##3##1##(1995-6#1)(2007-12#1)(2013-8#1)
U41##2##1##(2008-11#2)
U44069 stimulation##2##2##(1993-11#2)
U44069##4##1##(1993-11#4)
U46619##5##1##(1992-9#3)(1994-9#1)(2008-8#1)
U5##4##1##(1995-6#1)(2007-12#1)(2008-9#1)(2013-8#1)
U50##4##1##(1991-1#4)
U5P##2##1##(2013-7#2)
U6##4##1##(1995-6#1)(2008-9#3)
U6)##3##1##(1995-6#1)(2007-12#1)(2013-8#1)
U6atac##7##1##(2013-8#7)
U73122##3##1##(2008-4#2)(2013-1#1)
U74500A##2##1##(1992-5#2)
U937 cells were treated with 1 muM indirubin-3'-monoxime or carrier control for 24 hrs##3##14##(2008-10#3)
U937 cells were treated##4##4##(2008-10#4)
U937 cells##15##2##(1990-2#1)(1993-3#2)(1993-6#1)(1995-3#1)(2008-10#5)(2012-12#4)(2012-2#1)
U937##30##1##(1990-2#3)(1992-12#1)(1992-3#1)(1993-3#4)(1993-6#1)(1994-8#1)(1995-3#5)(1995-6#1)(2008-10#8)(2012-12#4)(2012-2#1)
U937)##2##1##(1992-6#1)(1993-11#1)
UA and##2##2##(2008-10#2)
UA is##2##2##(1994-8#1)(2008-10#1)
UA##14##1##(1994-8#3)(2008-10#10)(2013-1#1)
UAE and SPME##2##3##(2008-10#2)
UAE##8##1##(2008-1#5)(2008-10#3)
UAS##2##1##(1990-5#1)(1991-9#1)
UASB reactor##4##2##(2013-1#4)
UASRPG##4##1##(1990-5#3)(1995-6#1)
UBR1##3##1##(1995-6#2)(1997-3#1)
UC 27##2##2##(2008-10#2)
UC and CD##2##3##(2009-12#1)(2013-8#1)
UC and##3##2##(2008-9#1)(2009-12#1)(2013-8#1)
UC was##3##2##(2008-9#1)(2011-2#2)
UC##30##1##(1991-8#1)(2008-10#3)(2008-11#1)(2008-9#6)(2009-12#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-2#4)(2013-8#6)
UCB units were##2##3##(2011-2#2)
UCB##3##1##(2011-2#2)(2013-1#1)
UCB-derived CD14(+)##2##2##(2012-2#2)
UCBI##3##1##(2008-10#3)
UCLA##6##1##(2007-11#2)(2008-10#1)(2008-8#1)(2011-1#2)
UCOE vectors##2##2##(2008-11#2)
UCP2 and UCP3##3##3##(2008-1#3)
UCP2 and age (p&lt##2##4##(2008-10#2)
UCP2 and##7##2##(2008-1#3)(2008-10#4)
UCP2##10##1##(2008-1#6)(2008-10#4)
UCP3##7##1##(2008-1#7)
UCP3p and##2##2##(2008-10#2)
UCS is not##2##3##(2008-11#1)(2011-2#1)
UCS##11##1##(1995-12#1)(2008-11#8)(2011-2#2)
UCSF##2##1##(2008-6#2)
UCSs##5##1##(2011-2#5)
UDCA##6##1##(2008-8#6)
UDMA and##2##2##(2013-1#2)
UDMA##6##1##(2013-1#6)
UDP glucuronosyl transferase##2##3##(1991-2#2)
UDP##10##1##(1991-2#2)(1992-3#1)(1992-8#3)(2008-4#4)
UDP-N-acetylmuramyl-L-alanine##3##1##(1995-2#3)
UDP-glucose dolichyl-phosphate glucosyltransferase##2##3##(1990-5#2)
UDP-glucose##3##1##(1990-5#2)(2009-10#1)
UDP-glucuronosyl transferase##2##2##(1990-12#2)
UDP-glucuronosyl##3##1##(1990-12#2)(2008-8#1)
UDP-glucuronosyltransferase##9##1##(1992-8#2)(1995-9#1)(2008-11#6)
UDPGT##4##1##(1990-12#3)(2008-11#1)
UDPGTh1 and UDPGTh2##2##3##(2008-11#2)
UDPGTh1##3##1##(2008-11#3)
UDPGTh2 encoded a 529 amino acid protein with an amino terminus membrane-insertion signal peptide and a carboxyl terminus membrane-spanning region##2##20##(2008-11#2)
UDPGTh2##12##1##(2008-11#12)
UDPGTm1##2##1##(2008-11#2)
UDPglucuronosyltransferase activity##2##2##(1991-5#2)
UDPglucuronosyltransferase##3##1##(1991-5#3)
UER##3##1##(2008-5#1)(2011-2#2)
UES##3##1##(2013-8#3)
UESEs##2##1##(2010-10#2)
UF for##2##2##(1994-2#2)
UF supplemented medium##2##3##(1994-2#2)
UF##10##1##(1994-2#8)(2008-7#1)(2010-5#1)
UFC##6##1##(2011-2#4)(2013-1#2)
UFH for##2##2##(2008-1#1)(2008-10#1)
UFH##13##1##(2007-7#2)(2008-1#4)(2008-10#3)(2013-8#4)
UFL-AG-286 cells##3##2##(2008-11#3)
UFL-AG-286##4##1##(2008-11#4)
UFN level##2##2##(1993-8#2)
UFN levels##2##2##(1993-8#2)
UFN##7##1##(1993-8#6)(2013-1#1)
UG reflex##5##2##(1994-2#5)
UG##6##1##(1994-2#5)(2007-11#1)
UG-FNAB##6##1##(2012-3#6)
UGA##4##1##(2008-10#1)(2012-2#3)
UGI symptoms##2##2##(2008-1#2)
UGI##3##1##(2008-1#2)(2011-2#1)
UGID group##2##2##(2008-1#2)
UGID##5##1##(2008-1#5)
UGT##5##1##(1991-2#3)(1992-8#2)
UGT2B17 genotype##6##2##(2013-8#6)
UGT2B17##10##1##(2013-8#10)
UGT8##5##1##(2013-8#5)
UHMWPE cable##4##2##(2009-3#4)
UHMWPE##6##1##(2008-5#2)(2009-3#4)
UI and##3##2##(1997-3#1)(2010-10#1)(2011-1#1)
UI in##3##2##(2011-1#3)
UI was##2##2##(2011-1#2)
UI##14##1##(1997-3#1)(2008-10#1)(2010-10#1)(2011-1#11)
UK Biobank##2##2##(2010-8#2)
UK DURG##2##2##(2008-11#2)
UK Drug Utilization Research##2##4##(2008-11#2)
UK aircraft##2##2##(2007-2#2)
UK and its##3##3##(2008-10#2)(2010-3#1)
UK and##17##2##(1991-4#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2010-2#1)(2010-3#1)(2010-4#1)(2013-8#1)
UK government##2##2##(1996-8#1)(2008-11#1)
UK have##2##2##(2008-11#1)(2008-12#1)
UK in##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
UK patients##2##2##(1996-1#1)(2012-12#1)
UK physiotherapy##2##2##(2012-12#1)(2012-3#1)
UK registered##4##2##(2007-2#2)(2008-11#2)
UK##166##1##(1990-6#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-2#1)(1992-5#1)(1994-7#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#3)(1996-8#2)(1997-4#4)(1997-8#2)(2007-2#11)(2008-10#10)(2008-11#33)(2008-12#11)(2008-2#1)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-4#3)(2010-1#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#11)(2012-3#2)(2013-1#6)(2013-8#8)
UK)##9##1##(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#1)(2010-7#1)
UK/6/82##3##1##(1997-3#3)
UKCC##7##1##(2008-11#7)
UKM lecturers##2##2##(2008-10#2)
UKM##6##1##(2008-10#4)(2013-1#2)
UKPCD##2##1##(2008-11#2)
UL##3##1##(1993-9#1)(2008-12#1)(2013-1#1)
UL-VWFM##2##1##(2009-7#2)
UL9 gene##3##2##(1994-11#3)
UL9##7##1##(1994-11#7)
ULF##2##1##(2008-7#1)(2008-9#1)
UM methods##2##2##(1997-2#2)
UM programs##3##2##(1992-1#3)
UM##9##1##(1992-1#4)(1997-2#3)(2008-10#2)
UMLS coverage##2##2##(2008-7#2)
UMLS##10##1##(2008-7#10)
UMP synthase##4##2##(1993-2#4)
UMP synthases of##2##3##(1993-2#2)
UMP##8##1##(1993-2#7)(1996-5#1)
UMPS##2##1##(1993-2#2)
UN##11##1##(1990-2#2)(1994-9#1)(1996-5#2)(2008-10#3)(2009-2#3)
UNATI##2##1##(2011-2#1)(2013-1#1)
UNICEF##10##1##(1990-2#1)(1994-3#2)(2008-11#2)(2010-3#2)(2010-5#3)
UNIT 8##2##2##(2008-4#2)
UNIT##6##1##(2008-2#2)(2008-4#4)
UNITS 16D##2##2##(2008-9#2)
UNITS##3##1##(2008-4#1)(2008-9#2)
UNOTM##2##1##(2008-11#2)
UO(2)(2+) ion##2##2##(2008-10#2)
UO(2)(2+)##13##1##(2008-10#13)
UO(2)(II)##3##1##(2008-10#3)
UOS evaluation##4##2##(2012-3#4)
UOS function in people with dysphagia##2##6##(2012-3#2)
UOS function##3##2##(2012-3#3)
UOS##8##1##(2012-3#8)
UOx layers##2##2##(2008-10#2)
UOx##6##1##(2008-10#6)
UP##6##1##(1997-7#4)(2008-3#2)
UPDRS motor score##2##3##(2008-7#2)
UPDRS motor##3##2##(2008-7#3)
UPDRS scores##2##2##(2008-7#2)
UPDRS##9##1##(2008-7#9)
UPDRS-III score##2##2##(2008-7#2)
UPDRS-III##4##1##(2008-7#3)(2013-8#1)
UPGMA##2##1##(2008-12#1)(2008-5#1)
UPLC BEH##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
UPLC system##2##2##(2008-10#2)
UPLC##13##1##(2008-10#9)(2011-1#2)(2012-3#2)
UR cells##2##2##(2008-11#2)
UR##7##1##(2008-11#4)(2008-2#1)(2011-1#2)
URA2##2##1##(1996-6#2)
URA3 gene##3##2##(1991-7#2)(2008-10#1)
URA3##7##1##(1991-7#4)(1994-12#1)(2008-10#2)
URC##2##1##(1990-3#2)
URD##3##1##(2013-8#3)
URM faculty##4##2##(2012-3#4)
URM students##2##2##(2012-3#2)
URM##6##1##(2012-3#6)
URMs##3##1##(2012-3#3)
US Census##2##2##(2008-8#1)(2010-7#1)
US Dietary Guidelines##2##3##(2010-1#2)
US FDA##8##2##(2008-5#5)(2008-8#1)(2010-5#1)(2011-2#1)
US Food and Drug Administration (FDA)##8##6##(1997-4#1)(2008-7#1)(2008-9#2)(2012-12#3)(2013-1#1)
US Food and Drug Administration##15##5##(1995-8#1)(1997-4#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2012-12#5)(2012-3#1)(2013-1#1)
US Food and Drug##16##4##(1995-8#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2012-12#5)(2012-3#1)(2013-1#1)
US National##7##2##(1996-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-7#1)
US Veterans##2##2##(2007-10#1)(2008-7#1)
US and Europe##2##3##(2012-1#1)(2012-12#1)
US and##17##2##(1992-5#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-2#1)(2010-12#3)(2011-2#2)(2012-1#1)(2012-12#1)
US can##4##2##(1994-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
US corn price volatility##3##4##(2012-12#3)
US examination##2##2##(2011-2#1)(2013-8#1)
US for##4##2##(2008-5#3)(2012-2#1)
US government##4##2##(2008-11#2)(2008-8#1)(2009-3#1)
US hospitals that##2##3##(2008-11#1)(2008-3#1)
US hospitals##6##2##(2008-11#5)(2008-3#1)
US imaging##2##2##(2010-12#1)(2013-1#1)
US in##5##2##(1994-6#1)(2008-7#1)(2010-12#2)(2012-2#1)
US is##2##2##(2008-1#1)(2008-5#1)
US population##5##2##(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
US##239##1##(1990-12#1)(1990-2#1)(1990-9#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#1)(1996-8#2)(1996-9#5)(1997-2#5)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2008-1#9)(2008-10#16)(2008-11#17)(2008-12#2)(2008-3#3)(2008-5#24)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#18)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#6)(2011-2#7)(2012-1#1)(2012-12#11)(2012-2#8)(2012-3#4)(2013-1#9)(2013-8#4)
US$##5##1##(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#2)
US$1##2##1##(2007-5#1)(2008-12#1)
US)##3##1##(1996-11#1)(2008-10#1)(2013-1#1)
US-02##2##1##(2008-10#2)
US-03##2##1##(2008-10#2)
US-1 and US-8 isolates##3##4##(2008-10#3)
US-1 and US-8##6##3##(2008-10#6)
US-1 and##8##2##(2008-10#8)
US-1 genotype##4##2##(2008-10#4)
US-1 isolate##2##2##(2008-10#2)
US-1 isolates##4##2##(2008-10#4)
US-1 lineage##2##2##(2008-10#2)
US-1##37##1##(2008-10#37)
US-11 isolates##3##2##(2008-10#3)
US-11##8##1##(2008-10#8)
US-17##2##1##(2008-10#2)
US-6##5##1##(2008-10#5)
US-7 and -8##2##3##(2008-10#2)
US-7 and US-8##3##3##(2008-10#3)
US-7 and##6##2##(2008-10#6)
US-7##14##1##(2008-10#14)
US-8 and US-11##3##3##(2008-10#3)
US-8 and##5##2##(2008-10#5)
US-8 clonal##4##2##(2008-10#4)
US-8 genotype##6##2##(2008-10#6)
US-8 in##2##2##(2008-10#2)
US-8 isolates##9##2##(2008-10#9)
US-8##38##1##(2008-10#38)
US-8)##3##1##(2008-10#3)
US-SA##2##1##(2013-8#2)
US1 and##2##2##(2008-10#2)
US1##3##1##(2008-10#3)
US2##2##1##(2008-10#2)
US8##2##1##(2008-10#2)
USA 86 (1989)##2##3##(1990-11#1)(1990-5#1)
USA 88##3##2##(1991-12#1)(1994-12#1)(1995-2#1)
USA 90 (1993) 2150-2154]##2##4##(1993-12#2)
USA 90##3##2##(1993-12#2)(1994-8#1)
USA and the##2##3##(2008-11#1)(2008-5#1)
USA and##10##2##(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
USA to##2##2##(2013-1#1)(2013-8#1)
USA##110##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-6#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#2)(1997-8#1)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-4#4)(2008-5#9)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#5)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#2)
USA) and##6##2##(2008-1#1)(2008-10#1)(2008-5#4)
USA) to##2##2##(2007-5#1)(2012-12#1)
USA)##41##1##(2007-10#1)(2007-5#3)(2007-8#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#21)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
USAPI##2##1##(2013-8#2)
USC atrophy##3##2##(2010-12#3)
USC##5##1##(1992-12#1)(2010-12#4)
USDA##6##1##(2008-7#5)(2010-4#1)
USE##3##1##(1994-9#1)(2010-12#1)(2011-2#1)
USEPA method 218##3##3##(2008-10#3)
USEPA##7##1##(2008-10#7)
USG##2##1##(2009-9#1)(2011-1#1)
USING##5##1##(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
USM and UKM##3##3##(2008-10#3)
USM##4##1##(2008-10#4)
USMLE steps 1 and 2##3##5##(2008-12#1)(2012-3#2)
USN and##2##2##(2008-10#2)
USO1##2##1##(1995-3#1)(1996-3#1)
USP and##3##2##(1995-8#1)(2008-5#1)(2012-2#1)
USP units heparin/horn##2##3##(1992-1#2)
USP##13##1##(1992-1#2)(1995-8#2)(2008-10#4)(2008-5#1)(2012-2#4)
USQA Health Profile Database##2##4##(1997-1#2)
USS##4##1##(2008-1#3)(2012-2#1)
USSR##5##1##(1990-2#1)(1990-3#2)(1991-11#1)(1992-6#1)
UT##2##1##(1992-6#1)(2008-10#1)
UTI and##3##2##(2007-7#2)(2008-7#1)
UTI in##2##2##(2009-5#1)(2012-3#1)
UTI##16##1##(1994-3#1)(2007-10#2)(2007-7#2)(2008-7#2)(2009-5#3)(2010-8#3)(2011-2#2)(2012-3#1)
UTII concentration##3##2##(2008-7#3)
UTII##6##1##(2008-7#6)
UTIs caused by MDR-Enterococcus##2##4##(2011-2#2)
UTIs caused by##3##3##(2011-2#3)
UTIs##4##1##(2008-10#1)(2011-2#3)
UTP activates##2##2##(1993-8#2)
UTP and##3##2##(1992-6#1)(2008-11#1)(2008-4#1)
UTP was##2##2##(2008-4#2)
UTP with##2##2##(2008-4#2)
UTP##34##1##(1992-6#1)(1993-8#8)(1994-8#1)(1995-11#2)(1995-12#2)(1995-8#2)(1997-7#1)(2008-11#2)(2008-4#15)
UTP-induced##4##1##(1993-8#1)(1995-12#2)(2008-4#1)
UTR and##2##2##(1993-12#1)(2008-8#1)
UTR of##6##2##(1996-12#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#2)
UTR##19##1##(1993-12#2)(1996-12#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#2)(2010-11#1)(2010-5#2)(2011-2#1)(2012-3#2)
UTRs##3##1##(2008-7#3)
UV Laser##2##2##(2008-1#1)(2012-2#1)
UV Microstereolithography##2##2##(2008-2#1)(2008-3#1)
UV absorbance at##3##3##(1995-2#1)(2008-4#2)
UV absorbance detection at##2##4##(1996-5#1)(2008-10#1)
UV absorbance detection##3##3##(1996-5#1)(2008-10#2)
UV absorbance##14##2##(1995-2#1)(1996-5#1)(2008-10#7)(2008-4#3)(2008-5#1)(2009-5#1)
UV absorption spectra of##2##4##(2008-10#2)
UV absorption spectra##3##3##(2008-10#2)(2008-5#1)
UV absorption spectroscopy##2##3##(2008-2#2)
UV absorption##26##2##(1994-9#1)(1996-12#1)(2007-12#3)(2008-10#11)(2008-2#4)(2008-4#1)(2008-5#5)
UV and the##2##3##(1995-8#1)(2008-10#1)
UV and visible##3##3##(2008-10#2)(2009-12#1)
UV and##18##2##(1990-7#1)(1995-8#1)(2008-10#12)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)
UV assay of##2##3##(2008-10#2)
UV assay##3##2##(2008-10#3)
UV at##6##2##(1996-5#1)(2008-10#3)(2008-5#1)(2008-9#1)
UV cross-linking##4##2##(1993-11#1)(1995-2#1)(1995-6#1)(2008-2#1)
UV crosslinking##2##2##(2008-10#1)(2008-2#1)
UV damage##3##2##(2008-11#2)(2009-6#1)
UV detection at##11##3##(2008-10#8)(2008-5#2)(2010-3#1)
UV detection for##3##3##(1991-7#1)(1997-2#1)(2008-10#1)
UV detection was at##3##4##(2008-10#3)
UV detection was performed##2##4##(2008-10#2)
UV detection was##7##3##(2008-10#7)
UV detection##60##2##(1991-7#2)(1994-9#1)(1997-2#3)(2008-10#48)(2008-5#3)(2010-3#1)(2011-1#2)
UV detector is##2##3##(2008-10#2)
UV detector was used##2##4##(2008-10#2)
UV detector##13##2##(2008-10#13)
UV exposure and##2##3##(2007-12#1)(2011-2#1)
UV exposure to##2##3##(1995-3#1)(2008-2#1)
UV exposure##13##2##(1995-3#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2011-2#3)
UV filter in##2##3##(2008-5#2)
UV filter##7##2##(2008-5#7)
UV filters##4##2##(2008-5#4)
UV global irradiances##2##3##(2008-3#2)
UV intensity##2##2##(2007-11#1)(2007-12#1)
UV irradiances##2##2##(2008-3#2)
UV irradiated##2##2##(1994-8#2)
UV irradiation and##2##3##(1995-2#1)(2008-10#1)
UV irradiation are##2##3##(2008-10#1)(2008-3#1)
UV irradiation time##3##3##(2008-10#3)
UV irradiation to produce##2##4##(2008-10#2)
UV irradiation to##3##3##(2008-10#3)
UV irradiation##33##2##(1992-11#1)(1995-11#1)(1995-2#2)(2008-10#14)(2008-12#1)(2008-3#2)(2008-5#9)(2009-7#1)(2010-4#1)(2012-2#1)
UV lamp##5##2##(2008-10#5)
UV laser light##2##3##(2008-2#1)(2012-2#1)
UV laser pulses##2##3##(2007-12#1)(2008-3#1)
UV laser was##2##3##(2008-3#1)(2012-2#1)
UV laser##12##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#3)(2013-8#1)
UV light absorption responses##2##4##(2008-10#2)
UV light and##2##3##(2008-10#1)(2008-11#1)
UV light for##3##3##(1994-6#1)(2007-12#1)(2008-11#1)
UV light in##2##3##(2007-12#1)(2008-10#1)
UV light irradiation##2##3##(2008-4#1)(2009-11#1)
UV light to##2##3##(2008-10#2)
UV light##42##2##(1993-3#1)(1994-6#2)(1995-3#1)(1995-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#5)(2008-10#13)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#1)(2009-11#1)(2009-12#1)
UV mutagenesis of##3##3##(2008-10#2)(2010-2#1)
UV optical##2##2##(2007-12#1)(2008-2#1)
UV or##2##2##(2008-4#1)(2008-9#1)
UV photo-oxidation##4##2##(2008-10#4)
UV photobleaching##4##2##(2008-2#4)
UV photoreduction##3##2##(2008-10#3)
UV photosensitivity##2##2##(2007-11#1)(2007-12#1)
UV protection of##2##3##(2008-5#2)
UV protection##5##2##(2008-5#5)
UV radiation has been##2##4##(2008-10#1)(2008-3#1)
UV radiation has##5##3##(2008-10#2)(2008-3#1)(2011-2#2)
UV radiation in the range##2##5##(2008-5#1)(2010-4#1)
UV radiation in##3##3##(2008-5#2)(2010-4#1)
UV radiation is##2##3##(2008-2#1)(2008-5#1)
UV radiation of a He-Cd laser at 325 nm##2##9##(2007-12#1)(2008-2#1)
UV radiation on##2##3##(2011-2#2)
UV radiation was##2##3##(2007-11#1)(2008-3#1)
UV radiation##44##2##(1993-3#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-2#2)(2008-3#5)(2008-5#8)(2010-4#1)(2011-2#8)(2013-8#1)
UV response##2##2##(2008-10#1)(2009-4#1)
UV source##2##2##(2008-10#1)(2008-5#1)
UV spectra##5##2##(1996-5#2)(1997-2#1)(2008-10#1)(2008-3#1)
UV spectral##6##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
UV spectrophotometric determination of##2##4##(2008-10#2)
UV spectrophotometric determination##3##3##(2008-10#3)
UV spectrophotometric method##2##3##(2008-10#1)(2010-5#1)
UV spectrophotometric##8##2##(1996-5#1)(2008-10#4)(2010-5#1)(2011-1#2)
UV spectrophotometry##9##2##(1995-2#1)(2008-10#8)
UV spectroscopic##3##2##(2008-10#3)
UV spectroscopy and##2##3##(2008-10#1)(2008-5#1)
UV spectroscopy##5##2##(1990-7#1)(2008-10#1)(2008-5#2)(2013-1#1)
UV spectrum##8##2##(2008-10#6)(2008-2#1)(2008-5#1)
UV therapy##2##2##(1995-5#2)
UV wavelengths##2##2##(2008-3#1)(2011-2#1)
UV##516##1##(1990-7#3)(1991-12#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-11#1)(1993-11#1)(1993-3#3)(1994-6#2)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#6)(1996-9#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#16)(2007-12#25)(2008-1#2)(2008-10#206)(2008-11#12)(2008-12#1)(2008-2#37)(2008-3#39)(2008-4#6)(2008-5#67)(2008-7#1)(2008-9#2)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#16)(2012-2#6)(2013-1#1)(2013-7#2)(2013-8#2)
UV- and##2##2##(2008-10#2)
UV-##3##1##(2007-11#1)(2008-10#2)
UV-A and##2##2##(2008-2#1)(2011-2#1)
UV-A irradiation##2##2##(2008-5#2)
UV-A light##2##2##(2008-11#2)
UV-A sun beds##3##3##(1991-6#3)
UV-A##13##1##(1991-6#6)(2008-11#3)(2008-2#1)(2008-5#2)(2011-2#1)
UV-B radiation##2##2##(1991-5#1)(2012-3#1)
UV-B##11##1##(1991-5#2)(1991-6#2)(2008-2#4)(2011-2#1)(2012-3#1)(2013-1#1)
UV-C radiation##3##2##(2008-12#3)
UV-C treatment##4##2##(2008-10#3)(2009-10#1)
UV-C##15##1##(1995-12#1)(2008-10#6)(2008-12#4)(2009-10#2)(2011-2#2)
UV-C-treated fruit##3##2##(2008-10#3)
UV-IP##2##1##(2008-5#2)
UV-MFRSR##5##1##(2008-2#5)
UV-VIS absorbance method##2##3##(2010-11#2)
UV-VIS absorbance##3##2##(2010-11#3)
UV-VIS absorption##2##2##(1990-12#1)(2008-10#1)
UV-VIS##10##1##(1990-12#1)(2008-10#5)(2008-5#1)(2010-11#3)
UV-Vis absorption spectrometry##2##3##(2008-10#2)
UV-Vis absorption##3##2##(2008-10#3)
UV-Vis spectra of##2##3##(2008-10#2)
UV-Vis spectra##4##2##(2008-10#3)(2013-8#1)
UV-Vis spectrophotometer##2##2##(2008-10#2)
UV-Vis spectrophotometry##3##2##(2008-10#3)
UV-Vis spectroscopy##7##2##(2008-10#6)(2009-8#1)
UV-Vis##31##1##(2007-11#1)(2008-10#24)(2008-9#1)(2009-8#1)(2009-9#1)(2013-8#3)
UV-Visible##2##1##(2008-10#1)(2013-8#1)
UV-absorbing molecule##2##2##(1994-8#1)(2008-10#1)
UV-absorbing##6##1##(1994-6#1)(1994-8#1)(2008-10#2)(2008-5#2)
UV-blocking##4##1##(2008-5#4)
UV-crosslinking##2##1##(1992-8#1)(2008-9#1)
UV-damage recognition protein##2##3##(1993-3#2)
UV-exposed##2##1##(2008-3#1)(2008-5#1)
UV-exposure##2##1##(2009-4#1)(2011-2#1)
UV-filter##2##1##(2008-10#1)(2011-2#1)
UV-filters##2##1##(2008-5#2)
UV-grade fused silica##2##3##(2007-11#1)(2008-2#1)
UV-induced generation of##2##3##(1991-2#1)(2011-2#1)
UV-induced immunomodulation##2##2##(2008-10#2)
UV-induced index changes of##2##4##(2007-12#1)(2008-3#1)
UV-induced##20##1##(1991-2#2)(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#5)(2011-2#1)
UV-initiated##3##1##(1995-2#1)(2008-10#1)(2010-6#1)
UV-irradiated##2##1##(1992-8#1)(2008-2#1)
UV-irradiation##4##1##(1993-11#1)(1997-3#1)(2008-10#1)(2008-5#1)
UV-light##6##1##(1991-6#2)(1992-11#1)(2007-12#1)(2008-9#1)(2009-10#1)
UV-lithography##2##1##(2007-12#1)(2008-10#1)
UV-melting measurements##2##2##(1995-5#2)
UV-melting##3##1##(1995-5#3)
UV-protection##3##1##(2008-5#3)
UV-spectrophotometric determination of##2##3##(2008-10#2)
UV-spectrophotometric##5##1##(2008-10#5)
UV-treated and preinoculated roots##2##4##(2008-10#2)
UV-treated##3##1##(2008-10#2)(2008-9#1)
UV-vis absorption##3##2##(2008-10#3)
UV-vis and##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
UV-vis detection at##2##3##(2008-10#2)
UV-vis measurements##2##2##(2008-10#2)
UV-vis spectra of##3##3##(2008-10#2)(2009-3#1)
UV-vis spectra##5##2##(2008-10#4)(2009-3#1)
UV-vis spectrophotometric method for the##2##5##(2008-10#2)
UV-vis spectrophotometric##3##2##(2008-10#2)(2008-6#1)
UV-vis spectrophotometry##2##2##(2008-10#2)
UV-vis spectroscopy and##2##3##(2008-10#1)(2009-9#1)
UV-vis spectroscopy##10##2##(2007-11#1)(2008-10#6)(2009-11#1)(2009-3#1)(2009-9#1)
UV-vis spectrum of##2##3##(1995-2#1)(2008-10#1)
UV-vis##46##1##(1995-2#1)(2007-11#1)(2008-10#37)(2008-6#2)(2009-11#1)(2009-3#2)(2009-9#1)(2010-4#1)
UV-vis-NIR spectroscopy##2##2##(2008-10#2)
UV-vis-NIR##3##1##(2008-10#3)
UV-visible absorption spectra##2##3##(2008-10#2)
UV-visible absorption##3##2##(2008-10#2)(2008-11#1)
UV-visible differential optical absorption spectroscopy##2##5##(2008-3#2)
UV-visible spectra of##2##3##(1996-2#1)(2008-10#1)
UV-visible spectra##3##2##(1996-2#1)(1996-5#1)(2008-10#1)
UV-visible spectrophotometry##5##2##(2008-10#5)
UV-visible spectroscopy##3##2##(2008-10#2)(2009-10#1)
UV-visible spectrum##2##2##(1992-3#1)(1997-7#1)
UV-visible##26##1##(1992-3#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#4)(2009-10#1)(2009-11#1)
UV-written##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
UV/CD##3##1##(2008-10#3)
UV/UV-visible method##2##2##(2008-10#2)
UV/VIS##4##1##(2008-10#4)
UV/Vis##6##1##(2008-10#4)(2008-11#1)(2009-9#1)
UV/vis##3##1##(1992-8#1)(2008-10#2)
UVA could##2##2##(2008-5#2)
UVA filter##3##2##(2008-5#3)
UVA filters##2##2##(2008-5#2)
UVA protection in##2##3##(2008-5#2)
UVA protection##16##2##(2008-5#16)
UVA radiation##2##2##(2008-5#1)(2009-6#1)
UVA rays##2##2##(2008-5#2)
UVA##48##1##(1993-8#1)(2008-10#2)(2008-11#3)(2008-5#38)(2009-6#2)(2011-2#1)(2012-2#1)
UVA)##2##1##(2008-11#1)(2008-5#1)
UVA-caused##2##1##(2009-6#2)
UVA-filter##5##1##(2008-5#5)
UVA-induced oxidative stress in##2##4##(2008-5#1)(2009-6#1)
UVA-induced##5##1##(2008-5#4)(2009-6#1)
UVA/UVB ratio and##2##3##(2008-5#2)
UVA/UVB ratio##6##2##(2008-5#6)
UVA/UVB##9##1##(2008-5#9)
UVB and UVA##4##3##(2008-5#4)
UVB and##5##2##(2008-5#4)(2010-4#1)
UVB exposure##3##2##(2008-10#3)
UVB radiation##6##2##(2008-10#1)(2008-11#4)(2008-5#1)
UVB##36##1##(1995-5#1)(2008-10#6)(2008-11#8)(2008-5#17)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
UVB-absorbing sunscreens in##2##3##(2008-5#2)
UVB-induced##5##1##(2008-10#1)(2008-5#2)(2012-2#2)
UVC-induced##2##1##(2008-11#2)
UVC-irradiation##2##1##(2008-11#2)
UVR is a##2##3##(2011-2#2)
UVR##5##1##(2011-2#5)
UVRR##2##1##(2008-3#2)
UVS112##3##1##(1995-9#3)
UW551##2##1##(2008-10#2)
Ub##4##1##(1993-6#2)(1994-11#1)(2008-4#1)
Uba1##4##1##(2008-9#4)
UbcH7##3##1##(2009-7#3)
Uberlândia##3##1##(2008-6#3)
Ubiquitin##7##1##(1992-12#1)(1994-11#4)(2009-10#1)(2011-3#1)
Ubiquitin-C-terminal hydrolase activity##2##3##(1994-11#2)
Ubiquitous##2##1##(1992-6#1)(2008-10#1)
Ubx##5##1##(2012-2#5)
Uf##8##1##(1991-8#8)
Ufo##2##1##(1991-8#2)
Uganda and##2##2##(2008-10#2)
Uganda were##2##2##(1993-6#1)(2008-10#1)
Uganda##34##1##(1993-3#1)(1993-6#1)(1995-9#2)(2008-10#7)(2008-5#3)(2008-8#5)(2009-4#5)(2010-4#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-1#4)
Ugandan success story##3##3##(2009-4#3)
Ugandan##7##1##(1995-9#1)(2008-10#2)(2009-4#3)(2011-2#1)
Uighur Medicine##3##2##(2009-5#3)
Uighur##4##1##(2009-5#4)
Ukraine##6##1##(2010-4#2)(2011-1#1)(2013-1#3)
Ukrainian##3##1##(2008-7#1)(2011-1#2)
Ulcerative Colitis##3##2##(2010-11#1)(2010-12#1)(2012-12#1)
Ulcerative colitis (UC)##3##3##(2009-12#1)(2012-2#1)(2013-8#1)
Ulcerative colitis##4##2##(2009-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
Ulcerative##7##1##(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
Ullevål Hospital##2##2##(1991-9#1)(1997-2#1)
Ullevål##6##1##(1990-9#1)(1991-9#1)(1992-4#1)(1995-2#1)(1997-2#2)
Ulocladium atrum and Gliocladium roseum##2##5##(2008-10#2)
Ulocladium atrum was##2##3##(2008-10#2)
Ulocladium atrum##10##2##(2008-10#10)
Ulocladium##12##1##(2008-10#11)(2013-1#1)
Ultimate##3##1##(2010-12#1)(2011-1#1)(2011-2#1)
Ultimately##23##1##(1992-12#1)(1993-1#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2013-1#3)
Ultra Hybrid##3##2##(2008-10#3)
Ultra##7##1##(2007-8#1)(2008-10#5)(2012-2#1)
Ultra-low##2##1##(2008-10#1)(2013-1#1)
Ultra-pure##2##1##(2008-10#2)
Ultrafast electron crystallography##2##3##(2008-7#2)
Ultrafast time-resolved##2##2##(2009-9#1)(2010-2#1)
Ultrafast##21##1##(1994-2#1)(1996-12#1)(1996-2#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#1)(2010-2#2)(2012-8#1)
Ultrafiltration and##2##2##(2008-10#1)(2011-2#1)
Ultrafiltration##6##1##(1991-3#1)(2008-1#2)(2008-10#2)(2011-2#1)
Ultrahigh-resolution##2##1##(2007-12#2)
Ultralow##2##1##(2007-11#1)(2008-3#1)
Ultrapure dialysate##2##2##(2008-1#2)
Ultrasensitive##5##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
Ultrashort##3##1##(2007-11#1)(2007-12#2)
Ultrasonic slurry##2##2##(2008-10#2)
Ultrasonic##17##1##(1994-8#1)(1995-12#3)(1997-6#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
Ultrasonically guided##2##2##(2007-8#2)
Ultrasonically##3##1##(2007-8#2)(2012-12#1)
Ultrasonographic##5##1##(1990-10#1)(1994-7#1)(2008-10#1)(2010-11#1)(2013-8#1)
Ultrasonography and##2##2##(1993-3#1)(2008-7#1)
Ultrasonography is##2##2##(1996-8#1)(2009-7#1)
Ultrasonography revealed a##2##3##(2007-10#1)(2011-2#1)
Ultrasonography revealed##4##2##(1997-8#1)(2007-10#1)(2011-2#1)(2013-1#1)
Ultrasonography showed##2##2##(1993-2#1)(2013-1#1)
Ultrasonography##12##1##(1993-2#1)(1993-3#1)(1996-8#1)(1997-8#1)(2007-10#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
Ultrasound (US)##2##2##(2008-7#1)(2011-2#1)
Ultrasound and##4##2##(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#1)
Ultrasound can be##2##3##(2011-2#2)
Ultrasound examination revealed a##2##4##(2007-7#1)(2011-2#1)
Ultrasound examination##3##2##(1990-10#1)(2007-7#1)(2011-2#1)
Ultrasound in##2##2##(2008-7#1)(2012-3#1)
Ultrasound is the##2##3##(2008-7#1)(2012-2#1)
Ultrasound is##3##2##(2008-7#1)(2012-2#2)
Ultrasound of##2##2##(2007-11#2)
Ultrasound screening##2##2##(1996-12#2)
Ultrasound##45##1##(1990-10#1)(1990-11#1)(1990-2#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-12#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-7#5)(2008-8#1)(2010-8#2)(2011-2#4)(2011-5#1)(2011-6#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
Ultrasound-assisted extraction##3##2##(2008-10#2)(2013-1#1)
Ultrasound-assisted##4##1##(2008-10#3)(2013-1#1)
Ultrasound-guided##7##1##(2007-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2012-2#2)(2012-3#1)
Ultrastructural Characteristics of##2##3##(2008-10#1)(2008-5#1)
Ultrastructural analysis##2##2##(2007-12#2)
Ultrastructural and Cytochemical Aspects of the##2##6##(2008-10#2)
Ultrastructural and Cytochemical##3##3##(2008-10#3)
Ultrastructural and cytochemical aspects of##2##5##(2008-10#1)(2008-7#1)
Ultrastructural and##8##2##(1990-10#1)(2008-10#5)(2008-7#2)
Ultrastructural examination of##3##3##(2007-12#1)(2008-5#1)(2010-11#1)
Ultrastructural investigations of##3##3##(2007-12#1)(2008-10#2)
Ultrastructural localization of##2##3##(2008-7#1)(2011-2#1)
Ultrastructural studies##3##2##(2008-10#2)(2008-12#1)
Ultrastructural study of##2##3##(2008-7#1)(2012-1#1)
Ultrastructural##44##1##(1990-10#1)(1991-12#1)(1994-5#1)(1995-3#1)(2007-12#7)(2008-10#14)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#8)(2010-11#2)(2011-2#1)(2012-1#3)
Ultrastructurally##2##1##(1996-5#1)(2012-1#1)
Ultrastructure and motility pattern of##2##5##(2007-12#2)
Ultrastructure and##5##2##(2007-12#5)
Ultrastructure of the male##2##4##(2007-12#1)(2008-7#1)
Ultrastructure of the##7##3##(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#2)
Ultrastructure of##12##2##(2007-12#4)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)
Ultrastructure##17##1##(2007-12#9)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)
Ultraviolet light##2##2##(2008-10#1)(2008-3#1)
Ultraviolet radiation##3##2##(2008-5#3)
Ultraviolet##23##1##(1992-8#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-2#5)(2008-3#8)(2008-5#3)(2008-9#1)
Ultraviolet-induced##2##1##(2007-12#1)(2008-9#1)
Ultraviolet-visible##4##1##(2008-10#3)(2008-3#1)
Ultroser G##2##2##(2007-11#2)
Ulva##2##1##(2008-10#2)
Ulysses##2##1##(1994-1#1)(2008-11#1)
Umbellularia##2##1##(2008-10#2)
Umbilical cord clamping in preterm infants##3##6##(1993-2#3)
Umbilical cord##5##2##(1993-2#3)(2008-11#1)(2012-2#1)
Umbilical##15##1##(1991-8#1)(1993-2#3)(1994-3#2)(2008-10#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Uml(-1) The##2##2##(2008-10#2)
Uml(-1)##3##1##(2008-10#3)
Un##4##1##(2008-5#1)(2013-1#3)
Unambiguous##2##1##(2008-3#2)
Unbalanced##2##1##(2007-12#1)(2008-10#1)
Unbiased##2##1##(2008-10#1)(2008-7#1)
Uncapping##2##1##(2008-6#1)(2008-7#1)
Uncertain##3##1##(1992-2#1)(1997-5#1)(2012-3#1)
Uncertainties##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Uncertainty about##2##2##(1996-3#1)(2012-12#1)
Uncertainty and##2##2##(2008-2#1)(2009-5#1)
Uncertainty in##3##2##(2008-10#1)(2010-10#2)
Uncertainty##15##1##(1990-8#1)(1996-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2010-10#3)(2012-1#1)(2012-12#1)
Uncinula necator on##3##3##(2008-10#3)
Uncinula necator##8##2##(2008-10#8)
Uncommon##4##1##(1997-8#1)(2012-12#1)(2012-2#2)
Uncomplicated##2##1##(2012-2#1)(2012-3#1)
Unconjugated##2##1##(1991-5#1)(1992-3#1)
Uncontrollable##2##1##(2007-8#1)(2011-2#1)
Uncontrolled##3##1##(2008-7#1)(2010-10#1)(2010-11#1)
Unconventional##2##1##(2008-11#1)(2012-12#1)
Uncoupling proteins##2##2##(2008-1#2)
Uncoupling##4##1##(2008-1#2)(2009-8#1)(2010-4#1)
Uncovering the complex relationship between pre-eclampsia##2##6##(2011-2#2)
Uncovering the##3##2##(2011-2#2)(2012-2#1)
Uncovering##6##1##(1996-3#1)(2007-2#1)(2011-2#2)(2012-2#2)
Under Greenhouse##2##2##(2008-10#2)
Under Medicare##2##2##(1991-1#2)
Under Option##2##2##(1995-1#2)
Under a##7##2##(1990-7#1)(1997-3#1)(2008-10#2)(2008-7#1)(2009-6#1)(2013-8#1)
Under all conditions##2##3##(1994-5#1)(1996-2#1)
Under all##4##2##(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#1)
Under appropriate conditions##2##3##(2008-10#1)(2008-9#1)
Under both##2##2##(2008-10#2)
Under certain circumstances##2##3##(1996-9#1)(2011-2#1)
Under certain conditions##7##3##(1994-6#1)(1997-7#2)(2008-10#1)(2010-2#1)(2010-9#1)(2011-2#1)
Under certain##10##2##(1994-6#1)(1996-9#1)(1997-7#2)(2008-10#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#2)
Under circumstances##2##2##(1990-2#1)(1991-12#1)
Under conditions of##8##3##(1990-5#1)(1993-3#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
Under conditions##13##2##(1990-12#1)(1990-5#1)(1993-3#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
Under constant##2##2##(2008-5#2)
Under continuous##2##2##(2008-10#1)(2010-8#1)
Under controlled##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2012-8#1)
Under current##2##2##(1991-2#1)(1994-7#1)
Under drought##2##2##(2008-12#1)(2008-5#1)
Under experimental conditions##2##3##(2008-10#1)(2008-5#1)
Under favorable conditions##2##3##(2007-10#1)(2008-6#1)
Under favorable##3##2##(2007-10#1)(2008-4#1)(2008-6#1)
Under field conditions##5##3##(2008-10#4)(2008-9#1)
Under high##2##2##(2008-11#1)(2010-8#1)
Under identical conditions##2##3##(2008-10#1)(2010-7#1)
Under identical##3##2##(1994-11#1)(2008-10#1)(2010-7#1)
Under laboratory conditions##2##3##(2008-3#1)(2008-9#1)
Under managed care##2##3##(1996-12#1)(1997-2#1)
Under normal physiological##2##3##(2008-7#1)(2008-9#1)
Under normal##5##2##(1990-12#1)(1996-5#1)(2008-5#1)(2008-7#1)(2008-9#1)
Under optimal analytical##2##3##(2008-10#2)
Under optimal conditions the linear##2##5##(2008-10#2)
Under optimal conditions##17##3##(1995-5#1)(2008-10#15)(2008-6#1)
Under optimal##22##2##(1995-5#1)(2008-10#20)(2008-6#1)
Under optimised conditions##5##3##(2008-10#5)
Under optimized conditions##13##3##(2008-10#13)
Under optimized##16##2##(2008-10#16)
Under optimum conditions##15##3##(2007-12#1)(2008-10#13)(2008-3#1)
Under optimum##17##2##(2007-12#1)(2008-10#15)(2008-3#1)
Under pressure##2##2##(2007-5#1)(2010-3#1)
Under proper experimental conditions##2##4##(2008-10#2)
Under selected conditions##2##3##(2008-10#2)
Under selected##3##2##(2008-10#3)
Under similar conditions##2##3##(1997-4#1)(1997-7#1)
Under specific##2##2##(1996-7#1)(2008-3#1)
Under stoichiometric##2##2##(2008-11#2)
Under such conditions##5##3##(1994-12#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-8#1)
Under such##7##2##(1994-12#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-8#1)(2013-8#1)
Under suitable##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
Under the assumption##2##3##(1993-12#1)(2008-3#1)
Under the best##2##3##(2008-10#1)(2013-8#1)
Under the condition of##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
Under the conditions employed##2##4##(2008-10#2)
Under the conditions of these drinking water studies##3##8##(2008-9#3)
Under the conditions of these##4##5##(2008-9#4)
Under the conditions of this 27-week##2##6##(2008-9#2)
Under the conditions of this 9-month feed study##2##8##(2008-8#1)(2008-9#1)
Under the conditions of this##4##5##(2008-8#1)(2008-9#3)
Under the conditions of##10##4##(2008-6#1)(2008-8#1)(2008-9#7)(2010-7#1)
Under the conditions##15##3##(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#7)(2010-7#1)
Under the effect of##2##4##(2007-12#1)(2013-8#1)
Under the experimental conditions##6##4##(1992-4#1)(2008-10#5)
Under the new##2##3##(1992-12#1)(1994-1#1)
Under the optimal conditions##16##4##(2008-10#15)(2013-8#1)
Under the optimal experimental conditions##4##5##(2008-10#4)
Under the optimal##23##3##(2008-10#22)(2013-8#1)
Under the optimised conditions##3##4##(2008-10#3)
Under the optimised##4##3##(2008-10#4)
Under the optimized conditions##15##4##(2008-10#11)(2008-12#1)(2011-1#3)
Under the optimized experimental conditions##2##5##(2008-10#2)
Under the optimized working conditions##2##5##(2008-10#2)
Under the optimized##24##3##(2008-10#19)(2008-12#1)(2011-1#4)
Under the optimum condition##5##4##(2008-10#5)
Under the optimum conditions##36##4##(2008-10#36)
Under the optimum experimental conditions##4##5##(2008-10#4)
Under the optimum##49##3##(2007-11#1)(2008-10#48)
Under the same conditions##7##4##(1990-5#1)(1992-6#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
Under the same experimental conditions##2##5##(1995-12#1)(2007-11#1)
Under the same##11##3##(1990-5#1)(1992-6#1)(1993-8#1)(1995-12#2)(2007-11#1)(2008-10#2)(2008-11#2)(2011-2#1)
Under the selected conditions (i##2##5##(2008-10#2)
Under the selected conditions##5##4##(2008-10#5)
Under the selected##8##3##(2008-10#8)
Under the usual##2##3##(2008-2#1)(2008-3#1)
Under the##184##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#120)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#8)(2009-11#1)(2010-7#1)(2011-1#5)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
Under these circumstances##3##3##(1990-8#1)(1996-3#1)(2008-8#1)
Under these conditions it is##2##5##(2008-3#1)(2008-7#1)
Under these conditions the##4##4##(1993-3#1)(2008-10#3)
Under these conditions##36##3##(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-1#1)
Under these optimized##2##3##(2008-10#1)(2008-6#1)
Under these##48##2##(1990-8#2)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Under this condition##2##3##(2008-11#1)(2008-2#1)
Under this##12##2##(1991-5#1)(1992-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-8#1)(2012-3#1)(2013-1#2)
Under those##2##2##(2008-10#2)
Under##509##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#8)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#6)(2007-10#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#264)(2008-11#16)(2008-12#3)(2008-2#6)(2008-3#15)(2008-4#2)(2008-5#9)(2008-6#8)(2008-7#13)(2008-8#5)(2008-9#14)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#8)(2013-8#8)
Undergo##2##1##(2008-6#1)(2013-8#1)
Undergraduate and graduate##2##3##(2010-10#1)(2010-9#1)
Undergraduate health administration education##2##4##(1991-1#2)
Undergraduate health administration##3##3##(1991-1#3)
Undergraduate##8##1##(1991-1#3)(2008-11#1)(2008-12#1)(2010-10#1)(2010-9#1)(2012-2#1)
Undergraduates in##2##2##(2011-1#1)(2012-3#1)
Underinsurance##3##1##(2011-1#3)
Underivatized##2##1##(1996-5#1)(2008-10#1)
Underlying##6##1##(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)
Understand the##2##2##(2008-7#1)(2010-12#1)
Understand##4##1##(1996-3#1)(2008-7#2)(2010-12#1)
Understanding and##8##2##(1996-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
Understanding how##9##2##(1995-2#1)(2008-10#2)(2008-5#1)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
Understanding mortality in the 1918-1919 influenza pandemic in England and Wales##2##11##(2011-2#2)
Understanding of the##4##3##(1992-12#1)(2007-11#1)(2009-4#1)(2009-8#1)
Understanding of##7##2##(1992-12#1)(2007-11#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-3#1)(2013-8#1)
Understanding some##2##2##(2008-12#1)(2009-10#1)
Understanding the mechanisms##2##3##(2008-7#1)(2008-9#1)
Understanding the relationship between##3##4##(2008-7#1)(2009-7#1)(2013-8#1)
Understanding the spatial##2##3##(2009-10#1)(2009-2#1)
Understanding the specificity of##2##4##(2008-11#1)(2009-8#1)
Understanding the##52##2##(1993-11#1)(1995-6#1)(1996-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
Understanding these##4##2##(1993-12#1)(2010-11#1)(2011-2#2)
Understanding this##2##2##(2008-9#1)(2009-6#1)
Understanding##129##1##(1990-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#2)(1995-6#1)(1996-12#3)(1996-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#10)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#4)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#5)
Underwater##3##1##(2007-12#1)(2008-3#1)(2008-7#1)
Underwent##3##1##(1994-12#1)(2008-10#1)(2008-11#1)
Underwriting psychiatric impairments##3##3##(1995-1#1)(1995-2#1)(1995-3#1)
Underwriting##6##1##(1992-1#1)(1992-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)
Undesirable##2##1##(1993-2#1)(1997-3#1)
Undiagnosed##3##1##(2010-12#1)(2010-4#1)(2012-2#1)
Undifferentiated connective tissue diseases may play an important role in the pathophysiology of valvular damage##2##15##(2013-1#2)
Undifferentiated##11##1##(1992-12#2)(2007-2#1)(2007-5#3)(2008-4#1)(2010-12#2)(2013-1#2)
Undistorted##2##1##(2007-11#2)
Undoped##3##1##(1996-12#1)(2008-10#1)(2008-2#1)
Undoubtedly##3##1##(2008-5#1)(2009-5#1)(2009-9#1)
Une##4##1##(2008-5#1)(2009-10#1)(2013-1#2)
Unemployment and##3##2##(2011-2#1)(2013-1#2)
Unemployment##6##1##(1997-2#1)(2011-2#2)(2013-1#3)
Unequal##4##1##(1997-2#1)(2007-7#1)(2012-1#1)(2013-1#1)
Uneven##2##1##(2008-10#1)(2012-2#1)
Unexpected##8##1##(1991-8#1)(1992-2#1)(1992-3#2)(2007-1#1)(2007-11#1)(2012-3#1)(2013-1#1)
Unexpectedly##22##1##(1990-5#1)(1991-10#1)(1991-5#1)(1992-2#1)(1993-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Unexplained##4##1##(1993-2#1)(2008-12#1)(2008-8#1)(2009-6#1)
Unfolding of##2##2##(1997-2#1)(2007-12#1)
Unfortunately##77##1##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Unfractionated##3##1##(1995-2#1)(2008-1#1)(2010-6#1)
Unicem##5##1##(2009-8#5)
Unidirectional single-mode##2##2##(2008-3#2)
Unidirectional##4##1##(1993-3#1)(2008-3#3)
Unified Health System##2##3##(2012-3#2)
Unified##18##1##(1994-3#1)(2007-12#1)(2008-3#4)(2008-7#5)(2010-8#2)(2012-2#2)(2012-3#2)(2013-8#1)
Uniform##13##1##(1991-3#1)(1992-3#1)(1993-2#3)(1994-2#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-8#1)
Uniformity##4##1##(2008-10#2)(2008-2#2)
Unilamellar##2##1##(1991-5#1)(2008-10#1)
Unilateral and bilateral##2##3##(2008-7#2)
Unilateral dopamine##2##2##(1992-10#1)(1995-2#1)
Unilateral##17##1##(1991-8#1)(1992-10#1)(1992-8#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2012-2#1)
Uninsured##2##1##(1996-6#1)(2012-3#1)
Unintentional##3##1##(1997-7#1)(2009-10#1)(2013-1#1)
Union and the##3##3##(2008-10#2)(2011-2#1)
Union and##6##2##(2007-5#1)(2008-10#3)(2008-12#1)(2011-2#1)
Union to##2##2##(2008-10#1)(2008-12#1)
Union##38##1##(1990-3#1)(1991-12#2)(1994-12#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-5#2)(2011-2#5)(2013-8#1)
Union's##2##1##(1990-3#1)(2008-10#1)
Unique to this study##2##4##(2009-10#1)(2010-8#1)
Unique to##4##2##(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
Unique##22##1##(1993-8#1)(1996-2#2)(1997-8#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#1)
Unit and##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
Unit at the##2##3##(1994-3#1)(2012-12#1)
Unit directors##2##2##(1992-12#2)
Unit in the##2##3##(2008-10#1)(2010-10#1)
Unit in##3##2##(2008-10#1)(2010-10#1)(2012-3#1)
Unit of the Department##2##4##(1991-6#1)(1997-8#1)
Unit of the##5##3##(1990-9#1)(1991-6#1)(1992-6#1)(1996-8#1)(1997-8#1)
Unit of##8##2##(1990-9#1)(1991-6#1)(1992-6#1)(1996-8#1)(1997-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
Unit##63##1##(1990-9#1)(1991-2#1)(1991-6#1)(1992-12#5)(1992-2#1)(1992-6#1)(1994-2#1)(1994-3#2)(1996-2#1)(1996-8#1)(1997-8#1)(2007-10#2)(2007-11#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)
Unit)##2##1##(2011-2#1)(2012-3#1)
United Airlines##3##2##(1997-5#3)
United Arab Emirates##7##3##(2008-1#1)(2008-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
United Health##2##2##(1995-12#1)(2008-11#1)
United HealthCare##3##2##(1991-9#1)(1993-5#1)(1996-12#1)
United Kingdom Central Council for Nursing##4##6##(2008-11#4)
United Kingdom Central Council##5##4##(2008-11#5)
United Kingdom##75##2##(1991-2#1)(1991-3#2)(1991-8#2)(1992-1#1)(1993-2#1)(1994-12#2)(1994-7#2)(1995-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-12#3)(2007-2#3)(2008-10#12)(2008-11#14)(2008-12#6)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
United Kingdom?##2##2##(2008-12#1)(2008-7#1)
United Nations##12##2##(1990-3#1)(1992-6#1)(1994-7#1)(1996-1#1)(2008-11#2)(2008-9#1)(2010-12#3)(2011-2#1)(2012-12#1)
United State##3##2##(1992-1#1)(2008-10#1)(2013-8#1)
United States District Court for the##2##6##(1996-12#1)(1996-9#1)
United States Supreme Court##2##4##(1991-12#1)(1992-2#1)
United States and Canada##16##4##(1991-12#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-8#1)(2012-2#2)
United States and elsewhere##2##4##(1992-2#1)(2008-10#1)
United States and in##2##4##(2008-10#1)(2009-11#1)
United States and subsequently##2##4##(2008-10#2)
United States and##71##3##(1990-10#1)(1991-12#2)(1991-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(2007-12#3)(2007-2#2)(2008-1#1)(2008-10#33)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#3)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
United States are##6##3##(1991-2#1)(1993-1#1)(2008-10#1)(2009-6#1)(2010-6#1)(2011-2#1)
United States has##6##3##(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2009-3#1)(2010-3#1)
United States health care system##2##5##(1995-1#1)(2008-12#1)
United States in 1989##2##4##(2008-10#2)
United States in##14##3##(1993-2#1)(1994-1#1)(1994-2#2)(1995-8#1)(2008-10#8)(2011-2#1)
United States is a##2##4##(1991-5#1)(2011-2#1)
United States is##9##3##(1991-5#1)(1992-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
United States may##2##3##(2007-2#1)(2008-10#1)
United States or##2##3##(2008-10#2)
United States over the##2##4##(1993-3#1)(2008-5#1)
United States since the##3##4##(2007-7#1)(2008-10#2)
United States since##8##3##(1992-8#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2012-3#1)
United States to##5##3##(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
United States was##4##3##(2008-10#3)(2011-2#1)
United States were characterized##3##4##(2008-10#3)
United States were##14##3##(2007-12#1)(2008-10#12)(2008-5#1)
United States will##5##3##(1993-3#1)(1995-12#1)(1995-2#1)(2008-10#1)(2012-12#1)
United States##597##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#4)(1993-2#6)(1993-3#7)(1993-6#1)(1994-1#2)(1994-12#5)(1994-2#4)(1994-3#3)(1995-1#10)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#1)(1996-9#1)(1997-1#8)(1997-2#4)(1997-3#9)(1997-5#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#11)(2007-2#7)(2007-3#1)(2007-7#2)(2008-1#7)(2008-10#195)(2008-11#15)(2008-12#9)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#8)(2008-9#6)(2009-11#11)(2009-12#1)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#6)(2011-2#39)(2012-1#1)(2012-12#14)(2012-2#9)(2012-3#12)(2013-1#17)(2013-7#1)(2013-8#9)
United States-Mexico border##3##3##(2006-10#3)
United##731##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#1)(1992-1#3)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#5)(1993-2#8)(1993-3#8)(1993-5#1)(1993-6#1)(1994-1#2)(1994-12#7)(1994-2#4)(1994-3#4)(1994-7#3)(1995-1#12)(1995-12#3)(1995-2#3)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#3)(1996-4#1)(1996-9#1)(1997-1#8)(1997-2#5)(1997-3#9)(1997-5#7)(1997-8#1)(2006-10#4)(2007-10#2)(2007-11#1)(2007-12#14)(2007-2#11)(2007-3#1)(2007-7#2)(2008-1#9)(2008-10#211)(2008-11#33)(2008-12#18)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#10)(2009-11#12)(2009-12#1)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#6)(2011-2#43)(2012-1#2)(2012-12#16)(2012-2#11)(2012-3#14)(2013-1#20)(2013-7#2)(2013-8#12)
Uniting##2##1##(1997-3#2)
Units in##3##2##(2008-11#1)(2010-4#1)(2012-2#1)
Units of##2##2##(2010-8#1)(2012-3#1)
Units##26##1##(1995-12#1)(1996-5#1)(2007-11#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#5)(2009-3#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
Univariate analysis##2##2##(2012-2#1)(2013-1#1)
Univariate and multivariate analyses were performed##2##6##(2007-10#1)(2011-2#1)
Univariate and multivariate##4##3##(2007-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
Univariate and##7##2##(1995-4#1)(2007-10#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-3#1)
Univariate##12##1##(1995-4#1)(2007-10#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Universal health insurance##4##3##(1991-2#3)(1995-2#1)
Universal health##5##2##(1991-2#3)(1995-2#1)(2009-9#1)
Universal##19##1##(1991-12#1)(1991-2#3)(1994-2#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Universidad##2##1##(2008-3#1)(2013-7#1)
Universita degli Studi di Genova##2##5##(2008-4#2)
Universitario##2##1##(2008-5#1)(2011-2#1)
Universiti Kebangsaan Malaysia##6##3##(2008-10#2)(2008-12#1)(2008-8#1)(2011-1#2)
Universiti Sains Malaysia##2##3##(2008-10#2)
Universiti##8##1##(2008-10#4)(2008-12#1)(2008-8#1)(2011-1#2)
Universities and##2##2##(2008-10#1)(2008-11#1)
Universities##5##1##(2008-10#1)(2008-11#3)(2013-1#1)
University Clinic##5##2##(1991-11#1)(1995-5#1)(2008-12#1)(2013-1#2)
University College##2##2##(2008-11#1)(2010-10#1)
University Department of##2##3##(1991-12#1)(2008-2#1)
University Hospital in##7##3##(1992-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#2)(2011-2#1)
University Hospital of Tromsø##2##4##(1993-3#1)(1995-5#1)
University Hospital of the West Indies##6##6##(2011-2#6)
University Hospital of the##7##4##(2011-2#6)(2013-8#1)
University Hospital of##14##3##(1991-3#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(2008-10#1)(2009-5#1)(2011-2#6)(2013-8#1)
University Hospital##50##2##(1991-3#1)(1991-9#2)(1992-2#3)(1993-3#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#5)(2008-10#1)(2008-12#1)(2009-5#1)(2009-7#1)(2011-2#13)(2012-12#1)(2013-1#2)(2013-8#4)
University Medical Center##11##3##(1992-12#1)(1993-12#1)(1993-2#1)(1996-1#3)(1996-12#1)(1996-2#2)(2008-5#1)(2011-2#1)
University Medical School##2##3##(1991-6#1)(2008-5#1)
University Medical##13##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1996-1#3)(1996-12#1)(1996-2#2)(2008-5#2)(2011-2#1)
University Press##11##2##(1990-11#2)(1990-3#1)(1990-8#1)(1997-6#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)
University School of Medicine##4##4##(1991-3#1)(1996-9#1)(2006-12#1)(2008-1#1)
University Teaching Hospital##9##3##(2008-7#2)(2010-5#1)(2010-9#3)(2013-1#3)
University and NHS##2##3##(2008-11#2)
University and the##2##3##(1992-2#1)(2009-5#1)
University and##6##2##(1992-2#1)(2008-11#2)(2008-4#1)(2009-5#1)(2010-5#1)
University from##2##2##(1990-2#1)(2008-10#1)
University has been##2##3##(1996-9#1)(2008-3#1)
University hospital##3##2##(1992-5#1)(1995-12#1)(2013-1#1)
University hospitals##4##2##(1990-9#1)(2008-10#3)
University in##15##2##(1994-2#1)(1997-6#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
University is##2##2##(2008-2#1)(2008-3#1)
University of Alabama##3##3##(2008-12#2)(2009-8#1)
University of Alberta##6##3##(1992-12#1)(1995-12#1)(1995-3#2)(1996-3#1)(1997-2#1)
University of Arizona##3##3##(1990-8#1)(1997-5#1)(2008-2#1)
University of British Columbia##4##4##(1993-3#2)(2008-12#1)(2013-8#1)
University of Chicago##2##3##(1990-11#1)(2008-5#1)
University of Cologne##2##3##(1995-3#2)
University of Durham##2##3##(2008-11#2)
University of Edinburgh##2##3##(1997-8#1)(2008-10#1)
University of Florida##2##3##(1992-1#2)
University of Glasgow##2##3##(1997-8#1)(2012-1#1)
University of Guelph##4##3##(1992-2#1)(2013-8#3)
University of Health Sciences##2##4##(1994-3#1)(2010-11#1)
University of Hertfordshire##2##3##(2008-11#1)(2008-12#1)
University of London##3##3##(1997-8#1)(2007-12#1)(2009-10#1)
University of Manchester##3##3##(2008-11#1)(2008-7#2)
University of Massachusetts Medical Center##2##5##(1995-1#1)(1997-2#1)
University of Massachusetts##4##3##(1995-1#1)(1997-2#2)(2008-11#1)
University of Medical Sciences##5##4##(2007-11#1)(2007-7#1)(2008-3#1)(2011-2#2)
University of Medical##6##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-2#2)
University of Michigan Medical Center##2##5##(1991-1#1)(1995-3#1)
University of Michigan##7##3##(1991-1#1)(1991-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-11#1)
University of New##5##3##(1991-12#1)(1993-1#1)(1994-11#1)(1996-1#1)(2008-2#1)
University of Oslo##4##3##(1990-9#1)(1992-6#2)(1995-2#1)
University of Pennsylvania##5##3##(1993-2#1)(1996-12#1)(2008-2#1)(2008-5#1)(2012-12#1)
University of Pittsburgh##4##3##(2008-1#1)(2008-5#2)(2009-5#1)
University of Queensland##2##3##(2012-12#1)(2013-8#1)
University of Rome##3##3##(1990-8#1)(2011-7#1)(2013-1#1)
University of São##2##3##(2008-10#1)(2008-12#1)
University of Technology##2##3##(2008-10#1)(2012-12#1)
University of Texas##4##3##(1990-11#2)(2007-12#1)(2011-2#1)
University of Vienna##3##3##(1990-10#1)(1995-11#1)(1996-3#1)
University of Wales##2##3##(1996-7#1)(2008-11#1)
University of Wisconsin##4##3##(1995-2#1)(2007-8#1)(2010-11#2)
University of the Third Age##2##5##(2011-2#2)
University of the##5##3##(2010-1#1)(2011-2#4)
University of##228##2##(1990-10#1)(1990-11#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-6#4)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#6)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#7)(2008-11#17)(2008-12#17)(2008-2#3)(2008-3#6)(2008-5#8)(2008-7#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#14)
University on##3##2##(1990-3#1)(2009-5#2)
University##497##1##(1990-10#3)(1990-11#6)(1990-2#1)(1990-3#2)(1990-8#3)(1990-9#3)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#3)(1992-12#3)(1992-2#7)(1992-5#2)(1992-6#4)(1993-1#2)(1993-12#6)(1993-2#5)(1993-3#4)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#5)(1994-3#4)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#2)(1996-1#9)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#7)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#5)(2008-1#11)(2008-10#29)(2008-11#38)(2008-12#33)(2008-2#6)(2008-3#13)(2008-4#3)(2008-5#17)(2008-7#11)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#5)(2010-3#3)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#33)(2011-7#1)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#21)(2013-7#2)(2013-8#28)
University's##3##1##(2008-12#1)(2008-5#2)
University-based##2##1##(2008-11#1)(2008-9#1)
Université de##3##2##(1996-1#1)(2008-2#1)(2008-3#1)
Unix##3##1##(2008-4#1)(2008-9#2)
Unknown##3##1##(2008-10#1)(2010-5#1)(2010-6#1)
Unlabeled##2##1##(1993-3#1)(2008-9#1)
Unlabelled##2##1##(2008-10#1)(2011-2#1)
Unless the##3##2##(1996-2#1)(2007-11#1)(2008-8#1)
Unless##10##1##(1992-9#1)(1994-2#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
Unlike a##2##2##(2008-2#1)(2012-3#1)
Unlike conventional##6##2##(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
Unlike for##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
Unlike in the##2##3##(2006-12#1)(2008-8#1)
Unlike in##5##2##(2006-12#1)(2008-2#2)(2008-8#1)(2009-10#1)
Unlike most of the##2##4##(1995-2#1)(2013-1#1)
Unlike most other##2##3##(1991-10#1)(2008-10#1)
Unlike most##7##2##(1991-10#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
Unlike other##20##2##(1992-3#1)(1996-12#2)(1997-2#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-1#1)
Unlike previous##5##2##(1990-8#1)(1992-9#1)(2007-12#1)(2008-8#1)(2012-2#1)
Unlike previously described##2##3##(1992-6#1)(2008-10#1)
Unlike previously##3##2##(1992-6#1)(1997-4#1)(2008-10#1)
Unlike the##22##2##(1990-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Unlike their##2##2##(2007-11#1)(2008-7#1)
Unlike##128##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-10#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#5)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#8)(2008-1#5)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
Unmasking##2##1##(1997-7#1)(2008-9#1)
Unmodified and##2##2##(2008-10#2)
Unmodified##3##1##(1995-12#1)(2008-10#2)
Unnecessary##2##1##(1992-2#1)(2012-12#1)
Unoperated##2##1##(1993-3#1)(2012-3#1)
Unprecedented##3##1##(2008-10#1)(2011-2#1)(2012-3#1)
Unraveling the##2##2##(2008-4#1)(2010-3#1)
Unraveling##5##1##(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2013-8#1)
Unravelling the##2##2##(2008-11#1)(2008-7#1)
Unravelling##3##1##(2008-11#2)(2008-7#1)
Unresolved##2##1##(1995-1#1)(2010-6#1)
Unsaturated##3##1##(1990-7#1)(2007-11#1)(2008-11#1)
Unsolved##2##1##(2007-8#1)(2008-10#1)
Unstable##8##1##(1992-8#1)(2008-2#2)(2008-3#2)(2009-5#1)(2012-3#1)(2013-1#1)
Unstructured##2##1##(2010-5#1)(2012-3#1)
Unsymmetrical##3##1##(2008-10#1)(2008-4#1)(2012-2#1)
Until now only##2##3##(1995-6#1)(2010-12#1)
Until now there##2##3##(2009-10#1)(2012-12#1)
Until now##18##2##(1990-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
Until recent years##2##3##(1995-1#1)(2008-10#1)
Until recently##28##2##(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
Until such##2##2##(2011-1#1)(2011-2#1)
Until the end of##3##4##(1995-2#1)(2007-12#1)(2009-7#1)
Until the##11##2##(1994-12#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#2)(2011-2#2)
Until then##3##2##(2007-10#1)(2007-7#1)(2008-3#1)
Until today##2##2##(2008-11#1)(2009-5#1)
Until we##2##2##(1991-12#1)(1997-1#1)
Until##79##1##(1990-11#1)(1990-6#1)(1991-12#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-5#2)(1995-6#1)(1997-1#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#7)(2008-11#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Untreated patients##2##2##(1996-11#1)(2011-2#1)
Untreated##8##1##(1996-11#1)(2007-12#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#3)
Unusual metastasis of##2##3##(2007-4#1)(2008-10#1)
Unusual presentation of##2##3##(2007-12#1)(2012-3#1)
Unusual presentation##3##2##(2007-12#1)(2010-10#1)(2012-3#1)
Unusual##33##1##(1990-5#1)(1992-9#1)(1993-5#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
Unveiling##2##1##(1994-2#1)(2008-5#1)
Unwrapping##2##1##(2008-2#1)(2008-3#1)
Up to 1996##3##3##(1996-11#3)
Up to days##2##3##(2007-11#2)
Up to now##9##3##(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1996-11#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
Up to the present##2##4##(2011-2#1)(2013-1#1)
Up to the##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
Up to##47##2##(1990-10#1)(1990-3#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-1#2)(1996-11#4)(1996-3#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#15)(2008-11#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
Up until##2##2##(1991-4#1)(2008-9#1)
Up##55##1##(1990-10#1)(1990-2#1)(1990-3#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-1#2)(1996-11#4)(1996-3#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#16)(2008-11#2)(2008-7#2)(2008-9#2)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Up-Draft II##2##2##(1995-3#2)
Up-Draft##3##1##(1995-3#3)
Up-regulation of##5##2##(1990-11#1)(2009-6#1)(2010-4#2)(2012-3#1)
Up1##2##1##(2009-8#2)
Upcoming##2##1##(2008-1#1)(2008-5#1)
Upconversion##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
Update in##2##2##(2007-12#1)(2008-11#1)
Update on the##3##3##(2008-2#1)(2008-8#1)(2009-4#1)
Update on##18##2##(2006-10#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
Update##33##1##(1991-1#1)(1994-9#1)(1995-6#2)(2006-10#1)(2006-7#1)(2007-12#4)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)
Updated##5##1##(1995-1#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
Updates in##3##2##(2009-3#1)(2009-8#1)(2012-3#1)
Updating##2##1##(1993-2#1)(1993-3#1)
Upon addition of##3##3##(1990-2#1)(1992-8#1)(2008-11#1)
Upon analysis of##2##3##(1995-12#1)(2009-4#1)
Upon analysis##3##2##(1995-12#1)(2009-4#1)(2012-1#1)
Upon binding##2##2##(2008-10#1)(2011-2#1)
Upon exposure to##2##3##(1995-11#1)(2008-5#1)
Upon expression##2##2##(1991-9#1)(1995-11#1)
Upon further##2##2##(1995-5#1)(2008-11#1)
Upon induction##2##2##(1993-9#1)(1997-4#1)
Upon infection##2##2##(1994-12#1)(2008-11#1)
Upon oxidation##2##2##(1992-9#1)(1997-7#1)
Upon publication##3##2##(2008-12#3)
Upon reading this article##3##4##(2008-7#3)
Upon reduction##2##2##(1991-9#1)(2008-4#1)
Upon release##2##2##(1995-2#1)(2013-1#1)
Upon removal of##2##3##(1993-3#1)(1995-12#1)
Upon stimulation##2##2##(1991-5#1)(2008-5#1)
Upon the##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
Upon treatment of##2##3##(1991-2#1)(2009-10#1)
Upon using##2##2##(1991-6#1)(2008-10#1)
Upon##105##1##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-7#1)(2006-8#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
Upper Coast region##2##3##(2008-10#2)
Upper Coast##4##2##(2008-10#4)
Upper Gastrointestinal##4##2##(2006-10#1)(2008-1#1)(2013-1#2)
Upper Silesia##2##2##(2008-10#2)
Upper extremity surgery in younger children under ultrasound-guided supraclavicular brachial plexus block##2##12##(2012-2#2)
Upper extremity##5##2##(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#2)
Upper gastrointestinal bleeding##2##3##(2010-2#1)(2012-2#1)
Upper gastrointestinal endoscopy##2##3##(2008-5#1)(2011-2#1)
Upper gastrointestinal##7##2##(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Upper respiratory##2##2##(1997-3#1)(2013-8#1)
Upper##47##1##(1991-12#1)(1993-6#2)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
Uppsala##5##1##(2008-10#1)(2008-11#3)(2008-8#1)
Upregulation of##5##2##(1994-6#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)
Upregulation##6##1##(1994-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-2#1)
Upstream - news in genomics##2##5##(2008-7#2)
Upstream of the##2##3##(1994-12#2)
Upstream##7##1##(1994-12#2)(2008-7#2)(2008-8#2)(2010-8#1)
Uptake and##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
Uptake of##3##2##(1992-3#1)(2008-5#1)(2011-1#1)
Uptake##13##1##(1991-5#1)(1992-12#1)(1992-3#2)(1993-11#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
Urabe##2##1##(2007-2#2)
Urachal##3##1##(2008-10#1)(2008-6#2)
Uranium dosed [Fe(-)U(+)]##2##3##(2013-1#2)
Uranium##9##1##(2008-10#6)(2013-1#3)
Uranium(VI)##2##1##(2008-10#2)
Urban##14##1##(1996-3#1)(1996-5#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
Urbana##5##1##(2008-10#5)
Urea cycle enzymes##2##3##(2008-7#2)
Urea##11##1##(1993-3#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#2)
Ureaplasma urealyticum and##2##3##(1997-3#2)
Ureaplasma urealyticum##7##2##(1997-3#3)(2008-12#2)(2011-2#1)(2013-1#1)
Ureaplasma##9##1##(1997-3#3)(2008-12#2)(2011-2#2)(2012-3#1)(2013-1#1)
Urediniospores##2##1##(2008-10#2)
Ureteral##4##1##(1993-12#1)(2007-10#1)(2008-10#1)(2013-1#1)
Ureteric##2##1##(1996-8#1)(2008-7#1)
Ureteropelvic junction obstruction##2##3##(1990-8#1)(2008-10#1)
Ureteroscopy##2##1##(2008-10#1)(2008-7#1)
Urethral inflammation was##2##3##(1990-7#2)
Urethral##12##1##(1990-7#2)(1992-1#1)(1996-11#1)(2008-1#1)(2008-10#2)(2009-5#2)(2012-12#1)(2013-1#1)(2013-8#1)
Urgent##3##1##(2011-2#2)(2012-2#1)
Uric acid##5##2##(1994-6#1)(1996-9#1)(1997-2#1)(2008-5#2)
Uric##6##1##(1994-6#1)(1996-9#1)(1997-2#1)(2008-5#2)(2011-1#1)
Uricase##2##1##(1990-11#1)(2008-10#1)
Urinary Bladder##7##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-1#2)(2013-1#1)
Urinary Tract Infections##2##3##(2010-3#1)(2011-2#1)
Urinary Tract##3##2##(2010-3#1)(2011-2#1)(2013-8#1)
Urinary albumin##2##2##(2008-7#1)(2013-1#1)
Urinary bladder sonography##2##3##(2012-12#2)
Urinary excretion of##3##3##(1990-3#1)(1995-12#1)(2012-2#1)
Urinary excretion rates of##2##4##(1993-12#1)(1997-8#1)
Urinary excretion##6##2##(1990-3#1)(1993-12#1)(1993-8#1)(1995-12#1)(1997-8#1)(2012-2#1)
Urinary incontinence in##2##3##(1997-5#1)(2012-12#1)
Urinary levels of##2##3##(1990-2#1)(1992-3#1)
Urinary mercury##2##2##(1993-8#1)(1995-3#1)
Urinary neopterin##2##2##(2008-10#2)
Urinary tract infection (UTI) was##2##5##(2007-7#1)(2008-7#1)
Urinary tract infection (UTI)##3##4##(2007-7#1)(2008-7#1)(2009-5#1)
Urinary tract infection##5##3##(2007-7#1)(2008-7#2)(2009-5#1)(2012-3#1)
Urinary tract infections##3##3##(1993-2#1)(2010-4#1)(2010-8#1)
Urinary tract##9##2##(1990-8#1)(1993-2#1)(2007-7#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-8#1)(2012-3#1)
Urinary##60##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-8#3)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#4)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Urine analysis##2##2##(1991-12#1)(2007-7#1)
Urine and serum neopterin concentrations##2##5##(1990-2#2)
Urine and##3##2##(1990-2#2)(2009-6#1)
Urine samples##3##2##(1990-2#1)(1990-8#1)(2008-10#1)
Urine##23##1##(1990-2#3)(1990-8#1)(1991-12#2)(1996-12#2)(1996-2#1)(2007-7#2)(2008-10#7)(2008-7#1)(2009-12#1)(2009-6#2)(2010-4#1)
Urine)##2##1##(2008-10#2)
Urinoma##3##1##(1993-12#1)(2008-10#2)
Urm1##3##1##(2009-7#3)
Urmia##4##1##(2008-12#3)(2013-1#1)
Urodynamic##3##1##(2008-10#2)(2013-8#1)
Urogenital##2##1##(2008-5#2)
Urokinase##2##1##(1997-3#1)(2008-7#1)
Urology##8##1##(2007-5#1)(2007-7#1)(2008-10#3)(2008-8#2)(2011-2#1)
Uromyces appendiculatus##3##2##(2008-10#3)
Uromyces striatus##2##2##(2008-10#2)
Uromyces##7##1##(2008-10#7)
Ursodeoxycholic acid is##2##3##(1997-6#1)(2010-12#1)
Ursodeoxycholic acid##4##2##(1995-10#1)(1997-6#1)(2008-8#1)(2010-12#1)
Urtica dioica##5##2##(2008-10#1)(2008-12#4)
Urtica##6##1##(2008-10#1)(2008-12#4)(2008-5#1)
Urticaria##3##1##(1990-9#1)(2007-7#1)(2009-7#1)
Urticarial vasculitis##3##2##(2007-7#3)
Uruguay##6##1##(1992-5#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#2)
Uruguayan##2##1##(2010-8#2)
Usability##2##1##(2010-4#1)(2012-2#1)
Usage##2##1##(2008-10#1)(2008-11#1)
Use Among##2##2##(2012-12#1)(2013-1#1)
Use among##2##2##(2008-10#1)(2010-4#1)
Use and##11##2##(1991-1#1)(1991-11#1)(1991-3#1)(2007-12#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Use in##8##2##(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#2)
Use of Green Fluorescent##3##4##(2008-10#3)
Use of a new##2##4##(2007-7#1)(2008-10#1)
Use of a##37##3##(1992-3#2)(1993-6#1)(1994-3#1)(1996-2#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#10)(2008-5#2)(2009-9#1)(2010-6#1)(2012-2#1)(2012-3#3)(2013-1#2)
Use of adjuvant##2##3##(1991-5#1)(2008-6#1)
Use of an##6##3##(2008-10#1)(2008-2#2)(2008-3#2)(2009-9#1)
Use of caffeine and nicotine##2##5##(2009-7#2)
Use of chemical modification##2##4##(2008-10#1)(2008-4#1)
Use of computerized##2##3##(2008-3#1)(2008-8#1)
Use of data from the EDP medical records in general practice]##2##11##(1994-6#2)
Use of immobilized##2##3##(1992-11#1)(2008-4#1)
Use of intravenous##2##3##(1993-6#1)(2008-3#1)
Use of low##2##3##(2007-7#1)(2008-4#1)
Use of monoclonal##2##3##(1994-3#1)(2008-2#1)
Use of protein phosphatase inhibitors##2##5##(2008-2#1)(2008-4#1)
Use of statistical##2##3##(1992-2#1)(2008-3#1)
Use of such##2##3##(2008-3#1)(2008-7#1)
Use of thalidomide in leprosy##2##5##(1991-11#1)(1991-6#1)
Use of the##34##3##(1991-1#1)(1992-1#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-12#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
Use of these##6##3##(1992-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-7#1)
Use of this system##2##4##(2008-11#1)(2008-7#1)
Use of this##8##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-8#1)
Use of ultrasound in##2##4##(1994-6#1)(2012-2#1)
Use of##322##2##(1990-12#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-2#2)(1992-3#6)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#2)(1996-2#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#3)(2007-11#6)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#53)(2008-11#12)(2008-12#6)(2008-2#13)(2008-3#33)(2008-4#16)(2008-5#3)(2008-6#4)(2008-7#13)(2008-8#2)(2008-9#5)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#5)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#12)(2013-1#13)(2013-7#1)(2013-8#2)
Use the##4##2##(1995-2#2)(2007-8#1)(2011-1#1)
Use to##3##2##(2008-10#1)(2012-12#2)
Use##380##1##(1990-12#1)(1991-1#4)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-2#3)(1992-3#6)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1996-11#2)(1996-2#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#3)(2007-11#6)(2007-12#7)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#59)(2008-11#13)(2008-12#8)(2008-2#13)(2008-3#34)(2008-4#16)(2008-5#5)(2008-6#5)(2008-7#13)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#5)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#11)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#15)(2013-1#21)(2013-7#2)(2013-8#6)
Used to##3##2##(1996-3#1)(2008-10#1)(2012-2#1)
Used##12##1##(1996-3#1)(2007-10#1)(2007-5#1)(2008-10#5)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
Useful##12##1##(1990-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2009-9#1)(2010-6#1)(2011-2#1)
Usefulness and##2##2##(2008-12#1)(2008-4#1)
Usefulness of##13##2##(1996-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
Usefulness##16##1##(1996-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
User experience network##2##3##(2011-2#2)
User##6##1##(1991-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
Users and##2##2##(2008-6#1)(2010-8#1)
Users can##3##2##(2008-7#2)(2011-2#1)
Users of the##2##3##(2008-9#1)(2012-12#1)
Users of##5##2##(2008-11#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
Users##23##1##(1991-3#1)(1993-3#1)(1994-12#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2010-4#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Uses and##2##2##(2011-1#1)(2013-7#1)
Uses of##2##2##(1990-3#1)(2008-10#1)
Uses##6##1##(1990-3#1)(2008-10#1)(2008-2#2)(2011-1#1)(2013-7#1)
Ush##4##1##(2012-12#4)
Usher syndrome associated with a variant of##2##7##(2011-1#2)
Usher syndrome##4##2##(2011-1#4)
Ushuaia##4##1##(2008-2#1)(2008-3#3)
Using 1##2##2##(1997-8#1)(2009-10#1)
Using Bayesian##2##2##(2008-7#1)(2010-8#1)
Using DNA##4##2##(1991-2#1)(2008-10#2)(2009-6#1)
Using ELISA##2##2##(2008-10#1)(2011-1#1)
Using Geographic##2##2##(2010-5#1)(2012-12#1)
Using Northern blot analysis##2##4##(1996-12#1)(1997-2#1)
Using PCR##4##2##(1994-12#1)(1995-12#1)(2008-10#2)
Using RAPD##2##2##(2008-10#2)
Using Real-Time Polymerase Chain Reaction and##2##6##(2008-10#2)
Using Real-Time Polymerase Chain Reaction##3##5##(2008-10#3)
Using TaqMan##3##2##(2008-10#3)
Using a Genetic Cross Between Isolates from Wheat and Foxtail Millet##2##11##(2008-10#2)
Using a Real-Time Polymerase Chain Reaction Assay##2##7##(2008-10#2)
Using a calibration##2##3##(2008-10#2)
Using a case study##3##4##(1992-12#1)(1994-12#1)(1996-1#1)
Using a combination of##8##4##(1991-9#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2009-8#1)(2013-8#1)
Using a community-based participatory##2##4##(2009-12#1)(2011-2#1)
Using a four-mirror ring##2##4##(2007-12#2)
Using a highly##2##3##(1992-6#1)(1997-3#1)
Using a human##2##3##(1990-2#1)(1991-9#1)
Using a known##2##3##(2008-10#1)(2008-8#1)
Using a large##2##3##(1993-1#1)(2008-10#1)
Using a linear##2##3##(2007-11#1)(2008-10#1)
Using a mathematical model##2##4##(2008-11#1)(2011-3#1)
Using a model##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
Using a modification of the##2##5##(1994-12#1)(2008-4#1)
Using a monoclonal antibody##2##4##(1992-3#1)(1992-8#1)
Using a mouse##2##3##(2008-7#1)(2008-8#1)
Using a national sample##3##4##(1994-3#1)(1995-12#1)(2009-7#1)
Using a national##4##3##(1993-12#1)(1994-3#1)(1995-12#1)(2009-7#1)
Using a nationally representative##2##4##(1997-1#1)(2007-12#1)
Using a novel##8##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#1)
Using a quantitative##2##3##(1997-5#1)(2008-10#1)
Using a real-time##2##3##(2007-11#1)(2009-8#1)
Using a recently##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
Using a sample volume of##3##5##(2008-10#3)
Using a sample##6##3##(1992-12#1)(2008-10#3)(2008-3#1)(2009-5#1)
Using a set of##2##4##(1990-5#1)(2008-6#1)
Using a simple##5##3##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
Using a simulation##2##3##(2008-12#1)(2012-12#1)
Using a spatially##2##3##(2008-10#1)(2008-8#1)
Using a standard##3##3##(1992-2#1)(1996-12#1)(2008-11#1)
Using a survey##2##3##(1997-2#1)(2008-12#1)
Using a##274##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1991-5#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#3)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(2007-10#1)(2007-11#8)(2007-12#11)(2008-10#40)(2008-11#9)(2008-12#12)(2008-2#13)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#12)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#5)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
Using an adapted##2##3##(2008-10#1)(2013-1#1)
Using an asymptotic analysis##2##4##(2007-11#1)(2007-12#1)
Using an enzyme-linked immunosorbent assay##2##5##(1993-8#1)(2013-7#1)
Using an in vitro##2##4##(1990-2#1)(1995-6#1)
Using an individual-based##2##3##(2008-8#1)(2008-9#1)
Using an##52##2##(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2010-10#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
Using antibodies##2##2##(1990-11#1)(2008-10#1)
Using bacterial##2##2##(1997-4#1)(2008-8#1)
Using behavioral##2##2##(2008-3#1)(2008-6#1)
Using both a##2##3##(2007-11#1)(2008-3#1)
Using both##6##2##(1992-6#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
Using bulked segregant analysis##2##4##(2008-10#1)(2008-5#1)
Using case##2##2##(2008-1#1)(2009-12#1)
Using cell##3##2##(1995-6#1)(2008-11#2)
Using clinical data##2##3##(1997-2#1)(2007-10#1)
Using clinical##3##2##(1997-2#1)(2007-10#1)(2008-5#1)
Using computer##3##2##(1997-3#1)(2008-2#1)(2008-9#1)
Using confocal##3##2##(2007-12#1)(2009-8#1)(2010-10#1)
Using cyclic voltammetry (CV) and##2##5##(2008-10#2)
Using data from a##4##4##(1992-1#1)(1994-3#1)(1997-4#1)(2011-2#1)
Using data from the##5##4##(1994-3#1)(1997-1#1)(2007-9#1)(2011-2#1)(2012-2#1)
Using data from two##2##4##(1992-2#1)(2008-8#1)
Using data from##20##3##(1992-1#1)(1992-2#1)(1993-1#1)(1994-3#2)(1997-1#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Using data on veterans from the longitudinal Harvard Study of Adult Development (N=241)##2##13##(2013-1#2)
Using data on##3##3##(2012-12#1)(2013-1#2)
Using data to##2##3##(1997-1#1)(1997-2#1)
Using data##26##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-3#2)(1997-1#2)(1997-2#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
Using deletion##2##2##(1995-8#1)(1997-4#1)
Using detailed##2##2##(1990-11#1)(1997-1#1)
Using differential##2##2##(1993-6#1)(2008-10#1)
Using domain##2##2##(2009-10#1)(2011-2#1)
Using electrical##2##2##(2008-1#1)(2012-2#1)
Using electron microscopy##2##3##(2008-7#1)(2012-2#1)
Using electron##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
Using evidence to teach##2##4##(1993-12#2)
Using evidence##4##2##(1993-12#4)
Using experimental##2##2##(2007-12#1)(2008-2#1)
Using field data and computer simulation##2##6##(2008-10#2)
Using flow cytometric##2##3##(2008-11#1)(2012-3#1)
Using flow cytometry##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
Using flow##5##2##(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)
Using functional magnetic resonance imaging##2##5##(2008-10#1)(2008-11#1)
Using functional##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
Using gel retardation##2##3##(1992-6#1)(1995-6#1)
Using gel##3##2##(1992-6#1)(1995-6#2)
Using genomic##2##2##(2008-8#1)(2010-11#1)
Using health##2##2##(1992-12#1)(2009-3#1)
Using human##3##2##(1991-8#1)(2008-8#2)
Using immunocytochemical##2##2##(2007-12#1)(2009-5#1)
Using immunofluorescent##3##2##(1995-12#1)(2008-11#1)(2008-5#1)
Using immunohistochemistry##3##2##(2008-9#1)(2009-4#1)(2012-2#1)
Using in situ hybridization##2##4##(1995-12#1)(1997-3#1)
Using in situ##3##3##(1995-12#1)(1997-3#1)(2007-12#1)
Using in##4##2##(1995-12#1)(1997-3#1)(2007-12#1)(2012-2#1)
Using information##3##2##(1996-12#1)(1996-3#1)(2011-2#1)
Using linear##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
Using logistic regression##2##3##(1996-7#1)(2009-7#1)
Using measurements of##2##3##(1997-1#1)(2008-3#1)
Using mobility shift##2##3##(1991-11#1)(1994-12#1)
Using models##2##2##(2008-2#1)(2008-3#1)
Using modified##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
Using molecular##3##2##(2007-12#1)(2008-10#1)(2010-2#1)
Using more##2##2##(2007-9#1)(2013-8#1)
Using mouse##2##2##(1990-2#1)(1995-12#1)
Using multiple##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
Using native##2##2##(1992-11#1)(2009-11#1)
Using nested##2##2##(2008-10#2)
Using numerical##2##2##(1997-2#1)(2007-11#1)
Using oligonucleotide##2##2##(1995-11#1)(1996-12#1)
Using one of the##2##4##(1996-10#1)(1997-2#1)
Using one of##3##3##(1994-8#1)(1996-10#1)(1997-2#1)
Using optical##2##2##(1994-11#1)(2007-11#1)
Using our##9##2##(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
Using patient##3##2##(1994-3#1)(1996-12#1)(1996-3#1)
Using phage display##2##3##(2008-11#1)(2008-4#1)
Using phage##3##2##(1991-9#1)(2008-11#1)(2008-4#1)
Using polyclonal##2##2##(1992-8#1)(2008-10#1)
Using polymerase chain reaction##2##4##(1997-4#1)(2008-10#1)
Using protein##2##2##(1991-12#1)(2008-10#1)
Using purified##2##2##(2008-10#1)(2012-2#1)
Using quality##2##2##(1994-2#1)(1994-3#1)
Using real-time##2##2##(2010-5#2)
Using realistic##2##2##(2008-3#1)(2009-8#1)
Using research##3##2##(1997-3#1)(2007-12#1)(2008-11#1)
Using restriction##2##2##(2008-5#1)(2012-3#1)
Using reverse##2##2##(1995-12#1)(2008-10#1)
Using several##3##2##(1996-3#1)(2008-2#1)(2008-7#1)
Using simple##2##2##(2008-3#1)(2011-1#1)
Using simulated##2##2##(2008-2#1)(2009-7#1)
Using simulations##2##2##(1997-7#1)(2008-8#1)
Using single##2##2##(2008-8#1)(2013-1#1)
Using specific##4##2##(1992-2#1)(1992-7#1)(1993-6#1)(2008-10#1)
Using such a##2##3##(1990-11#1)(2007-11#1)
Using such techniques##2##3##(2007-9#1)(2008-2#1)
Using such##7##2##(1990-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-4#1)
Using survey data##2##3##(2009-11#1)(2010-12#1)
Using survey##3##2##(2009-11#1)(2010-12#1)(2013-7#1)
Using synthetic##2##2##(1990-8#1)(1994-12#1)
Using technology to##2##3##(1996-3#1)(1997-1#1)
Using the Polymerase Chain Reaction##2##5##(2008-10#2)
Using the cDNA##2##3##(1992-3#1)(1995-8#1)
Using the computer##2##3##(1992-12#1)(1995-12#1)
Using the experimental conditions##2##4##(2008-10#2)
Using the full spectral capacity (six channels) of a real-time PCR instrument can simplify diagnostic laboratory screening and typing protocols for pandemic H1N1 influenza##2##24##(2011-2#2)
Using the full##4##3##(2008-2#1)(2008-3#1)(2011-2#2)
Using the gel##2##3##(1990-7#1)(2008-11#1)
Using the genetic##2##3##(2008-10#1)(2008-9#1)
Using the highly sensitive##2##4##(1995-8#1)(2010-12#1)
Using the latter##2##3##(1992-2#1)(2006-6#1)
Using the method of##2##4##(2008-9#2)
Using the model of##2##4##(2008-10#1)(2008-3#1)
Using the present##2##3##(2008-10#1)(2008-2#1)
Using the proposed method##2##4##(2008-10#2)
Using the recently##2##3##(2007-12#1)(2008-3#1)
Using the same##7##3##(1993-6#1)(1995-2#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-4#1)
Using the second##2##3##(2008-10#1)(2008-6#1)
Using the selected conditions##2##4##(2008-10#2)
Using the sensor##2##3##(2008-10#2)
Using the survey##2##3##(1992-12#1)(1993-1#1)
Using the technique of##2##4##(1995-12#1)(2007-12#1)
Using the technique##3##3##(1995-12#1)(2007-12#1)(2008-10#1)
Using the unique properties of##2##5##(2007-12#1)(2008-3#1)
Using the##215##2##(1990-2#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1993-1#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#3)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#57)(2008-11#8)(2008-2#4)(2008-3#12)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#6)
Using these methods##2##3##(1992-9#1)(2008-4#1)
Using these primers##2##3##(1993-12#1)(2008-10#1)
Using these techniques##4##3##(2008-7#2)(2009-12#1)(2011-1#1)
Using these tools##2##3##(1997-1#1)(2008-8#1)
Using these##32##2##(1991-7#1)(1992-9#2)(1993-12#1)(1995-2#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
Using this approach an##2##4##(2008-10#1)(2008-7#1)
Using this approach we##2##4##(2008-3#1)(2008-5#1)
Using this approach##14##3##(1991-5#1)(1994-9#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-7#1)(2012-2#1)
Using this assay##5##3##(1990-12#1)(1991-2#1)(1991-9#1)(2008-5#2)
Using this flow##2##3##(1990-12#1)(2008-10#1)
Using this method##17##3##(1990-12#1)(1990-8#1)(1994-11#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#4)(2008-8#1)(2010-10#1)(2010-12#1)(2010-8#1)
Using this model##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
Using this new##3##3##(2008-11#1)(2008-3#2)
Using this strategy##2##3##(2007-11#1)(2009-8#1)
Using this system##6##3##(1992-9#1)(1994-6#1)(2008-11#4)
Using this technique##8##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
Using this##104##2##(1990-12#4)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-3#2)(2007-11#5)(2007-12#4)(2008-10#17)(2008-11#11)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
Using three##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
Using two different##6##3##(1990-12#1)(1990-5#1)(1992-3#1)(1995-6#1)(2007-10#1)(2008-10#1)
Using two##9##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-3#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
Using univariate##2##2##(2010-8#1)(2013-8#1)
Using various##2##2##(1990-9#1)(2012-12#1)
Using yeast##2##2##(1990-11#1)(2008-8#1)
Using##1450##1##(1990-11#7)(1990-12#8)(1990-2#6)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#2)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#9)(1992-1#2)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#7)(1992-3#5)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#4)(1993-11#5)(1993-12#11)(1993-2#5)(1993-3#4)(1993-6#6)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#13)(1994-2#6)(1994-3#9)(1994-5#1)(1994-6#3)(1994-8#8)(1994-9#6)(1995-1#4)(1995-11#4)(1995-12#17)(1995-2#12)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#11)(1995-8#5)(1996-1#5)(1996-10#1)(1996-12#12)(1996-2#11)(1996-3#8)(1996-5#11)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#12)(1997-2#23)(1997-3#9)(1997-4#8)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#3)(2006-5#1)(2006-6#1)(2007-10#4)(2007-11#28)(2007-12#43)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#261)(2008-11#65)(2008-12#24)(2008-2#40)(2008-3#52)(2008-4#22)(2008-5#30)(2008-6#7)(2008-7#30)(2008-8#56)(2008-9#38)(2009-10#10)(2009-11#10)(2009-12#7)(2009-2#4)(2009-3#5)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#14)(2009-9#3)(2010-1#5)(2010-10#7)(2010-11#6)(2010-12#8)(2010-2#4)(2010-3#5)(2010-4#8)(2010-5#9)(2010-6#4)(2010-7#2)(2010-8#10)(2010-9#3)(2011-1#19)(2011-2#35)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#17)(2012-2#38)(2012-3#20)(2013-1#38)(2013-3#1)(2013-7#5)(2013-8#19)
Ustilago hordei##6##2##(2008-10#6)
Ustilago maydis##9##2##(1996-6#2)(2008-10#4)(2009-8#2)(2010-7#1)
Ustilago spp##3##2##(2008-10#3)
Ustilago violacea##2##2##(1993-12#2)
Ustilago##28##1##(1993-12#2)(1996-6#4)(2008-10#17)(2008-5#2)(2009-8#2)(2010-7#1)
Usual##3##1##(1997-1#1)(1997-4#1)(2008-10#1)
Usually the symptoms##2##3##(1990-6#1)(1997-6#1)
Usually the##3##2##(1990-6#1)(1997-6#1)(2008-5#1)
Usually these##2##2##(1997-4#1)(2011-2#1)
Usually##29##1##(1990-6#1)(1993-6#2)(1994-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#1)
Utah##11##1##(1993-8#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2013-1#2)
Uterine##16##1##(1990-10#1)(1991-2#1)(1992-6#1)(1994-9#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Uterus##2##1##(1991-11#1)(2012-3#1)
Utilisation of##2##2##(2008-7#1)(2013-1#1)
Utilisation##3##1##(2008-5#1)(2008-7#1)(2013-1#1)
Utilising##3##1##(1997-2#1)(2007-11#1)(2012-8#1)
Utility of the##2##3##(1991-1#1)(2012-3#1)
Utility of##14##2##(1991-1#1)(1995-5#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
Utility##16##1##(1991-1#1)(1995-5#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
Utilization Group##2##2##(1994-12#2)
Utilization Groups##6##2##(1993-12#1)(1993-2#1)(1994-12#2)(1997-1#1)(2008-7#1)
Utilization management##5##2##(1991-3#1)(1992-1#2)(1994-12#1)(2009-4#1)
Utilization of the##3##3##(2008-12#1)(2008-2#1)(2008-8#1)
Utilization of##22##2##(1992-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
Utilization##52##1##(1991-3#1)(1992-1#2)(1992-12#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#5)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Utilizing an##2##2##(1995-2#1)(2008-2#1)
Utilizing the##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)
Utilizing this##4##2##(2007-12#1)(2008-11#2)(2008-12#1)
Utilizing##34##1##(1992-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2012-12#1)(2013-8#1)
Utrogestan is##2##2##(2008-11#2)
Utrogestan##8##1##(2008-11#8)
Uttar Pradesh##2##2##(1997-8#1)(2009-5#1)
Uttar##3##1##(1997-8#1)(2009-5#1)(2011-1#1)
Uyghur##2##1##(2011-2#2)
Uzbekistan##3##1##(2008-10#3)
V (for##4##2##(2009-9#4)
V (versus SCE)##2##3##(2008-10#2)
V (versus##5##2##(2008-10#5)
V (vs##19##2##(2008-10#19)
V =##23##2##(1996-2#13)(1997-7#5)(2007-11#2)(2008-10#1)(2008-3#2)
V alpha and##2##3##(1994-6#2)
V and I##2##3##(1994-6#1)(2008-2#1)
V and VI##5##3##(1990-5#1)(1994-2#1)(1997-2#1)(2007-12#1)(2012-2#1)
V and Zn##3##3##(2008-10#3)
V and a##2##3##(2008-10#1)(2008-2#1)
V and the##4##3##(2008-10#4)
V and##32##2##(1990-5#1)(1991-9#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
V as##3##2##(1992-12#1)(2008-10#2)
V at##4##2##(1990-5#1)(2008-10#1)(2008-2#1)(2010-12#1)
V beta##2##2##(1994-12#1)(1994-6#1)
V cm(-1)##5##2##(2008-10#4)(2008-11#1)
V content decreased##2##3##(2011-2#2)
V content##6##2##(2011-2#6)
V cyclic##2##2##(1992-12#2)
V for a##2##3##(2007-12#1)(2008-10#1)
V for##6##2##(2007-12#1)(2008-10#5)
V in the presence of##2##5##(2008-10#2)
V in the##4##3##(2008-10#3)(2012-2#1)
V in##12##2##(1994-6#2)(2008-10#9)(2012-2#1)
V is##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2010-3#1)(2010-8#1)
V level##6##2##(2008-10#1)(2011-2#5)
V loss increased##2##3##(2011-2#2)
V loss##6##2##(2011-2#6)
V of the##2##3##(1996-5#1)(2008-11#1)
V of##3##2##(1992-3#1)(1996-5#1)(2008-11#1)
V on##2##2##(2008-10#2)
V or##2##2##(2008-10#1)(2008-11#1)
V regions##3##2##(2008-4#3)
V to##5##2##(1994-9#1)(2008-10#1)(2008-11#2)(2008-4#1)
V under##2##2##(2007-11#1)(2010-3#1)
V using a##2##3##(2008-10#2)
V versus Ag/AgCl##8##3##(2008-10#8)
V versus SCE##4##3##(2008-10#4)
V versus##14##2##(2008-10#14)
V vs Ag/AgCl)##2##3##(2008-10#1)(2010-4#1)
V vs##18##2##(1990-8#1)(1991-9#1)(1996-5#1)(2008-10#14)(2010-4#1)
V was obtained##2##3##(2007-12#1)(2008-10#1)
V was##11##2##(1991-9#2)(1992-12#1)(2007-12#1)(2008-10#6)(2008-2#1)
V were##5##2##(1990-9#1)(1992-3#1)(2006-6#1)(2008-10#1)(2010-1#1)
V with##4##2##(2008-10#3)(2008-3#1)
V##643##1##(1990-12#2)(1990-2#1)(1990-5#4)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#1)(1991-9#4)(1992-11#2)(1992-12#6)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-5#2)(1994-6#12)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#16)(1996-3#2)(1996-5#7)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#6)(1997-8#5)(2006-6#4)(2007-11#8)(2007-12#6)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#356)(2008-11#11)(2008-12#7)(2008-2#8)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#2)(2009-6#4)(2009-8#4)(2009-9#10)(2010-1#3)(2010-12#1)(2010-3#5)(2010-4#1)(2010-8#1)(2011-1#7)(2011-2#30)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#9)(2013-1#2)(2013-8#2)
V(-1)##3##1##(2008-10#1)(2008-7#1)(2012-12#1)
V(0) (lambda)##2##2##(2008-2#2)
V(0)##4##1##(2008-2#4)
V(2)O(5)##2##1##(2008-10#2)
V(5+)##2##1##(2008-10#2)
V(D)J recombination and##2##3##(1997-7#2)
V(D)J recombination reaction##2##3##(1997-7#2)
V(D)J recombination##14##2##(1996-2#2)(1997-7#9)(2013-1#3)
V(D)J##18##1##(1996-2#2)(1997-7#9)(2008-7#4)(2013-1#3)
V(E)##3##1##(2008-10#3)
V(H)##3##1##(2008-10#1)(2008-11#2)
V(H)-gp130 and##3##2##(2008-11#3)
V(IV) and Co(II)##4##3##(2008-10#4)
V(IV) and##6##2##(2008-10#6)
V(IV) with##2##2##(2008-10#2)
V(IV)##21##1##(2008-10#21)
V(L)##3##1##(2008-10#1)(2008-11#2)
V(V) and Al(III)##3##3##(2008-10#3)
V(V) and Ti(IV)##2##3##(2008-10#2)
V(V) and V(IV) are##2##4##(2008-10#2)
V(V) and V(IV)##3##3##(2008-10#3)
V(V) and Zn##2##3##(2008-10#2)
V(V) and##15##2##(2008-10#15)
V(V) species##2##2##(2008-10#2)
V(V)##37##1##(2008-10#37)
V(c) that gives##2##3##(2008-10#2)
V(c) was##4##2##(2008-10#4)
V(c)##13##1##(2008-10#13)
V(eq)##3##1##(2008-10#3)
V(gamma##2##1##(2008-10#2)
V(max) =##2##2##(2008-11#2)
V(max)##10##1##(2008-10#3)(2008-11#2)(2008-7#3)(2010-11#1)(2011-3#1)
V(t) andrhoV (alt)##4##3##(2008-9#4)
V) and##5##2##(1990-9#1)(1996-5#1)(2008-10#2)(2009-6#1)
V) of##2##2##(2008-10#2)
V) was##2##2##(2008-10#2)
V)##27##1##(1990-9#1)(1994-6#1)(1994-8#1)(1996-5#3)(2008-10#17)(2009-6#2)(2011-2#1)(2012-2#1)
V-ATPase activity##6##2##(1995-6#2)(2008-9#4)
V-ATPase by##2##2##(1994-8#1)(1995-6#1)
V-ATPase possesses##2##2##(1995-6#2)
V-ATPase##18##1##(1993-11#2)(1994-8#1)(1995-6#11)(2008-9#4)
V-ATPases##2##1##(1993-11#1)(1994-8#1)
V-FITC/PI staining##3##2##(2008-11#3)
V-PPase proteins##2##2##(2008-11#2)
V-PPase##5##1##(2008-11#5)
V-VI##3##1##(1997-2#1)(2009-12#2)
V-number##2##1##(2008-3#2)
V-shaped##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
V-type##2##1##(1993-6#1)(1994-6#1)
V/##2##1##(2007-12#1)(2013-1#1)
V/K for##2##2##(1992-3#1)(1993-8#1)
V/K##6##1##(1991-9#2)(1992-3#3)(1993-8#1)
V/cm##7##1##(1996-12#3)(2008-10#1)(2008-3#3)
V0 =##2##2##(2008-6#2)
V1 and##2##2##(2011-2#1)(2012-2#1)
V1 neurons##2##2##(2008-11#2)
V1 receptor##4##2##(1995-12#3)(2008-6#1)
V1 vasopressin receptors##2##3##(1994-2#1)(1994-9#1)
V1 vasopressin##3##2##(1994-2#1)(1994-9#2)
V1##21##1##(1994-2#1)(1994-8#2)(1994-9#2)(1995-12#4)(1996-2#1)(2008-11#6)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#1)
V1-V3##3##1##(2008-12#1)(2012-12#1)(2013-1#1)
V10##2##1##(2013-1#2)
V108LRUH1##6##1##(2008-10#6)
V12##2##1##(2008-10#2)
V15##2##1##(2013-1#2)
V2##5##1##(1994-11#2)(1997-6#1)(2008-12#1)(2012-3#1)
V281L mutation in the##2##4##(2008-1#2)
V281L mutation##5##2##(2008-1#5)
V2R##5##1##(1993-6#2)(1994-8#3)
V3 and V7)##2##3##(1997-6#2)
V3 cells##2##2##(1996-2#2)
V3##12##1##(1990-11#4)(1993-1#1)(1995-5#1)(1996-2#2)(1997-6#2)(2008-10#1)(2008-12#1)
V3+##4##1##(2008-3#4)
V3-VLPs##2##1##(1995-5#2)
V380M##2##1##(1997-7#2)
V4 and##2##2##(2008-10#1)(2011-2#1)
V4##10##1##(1992-11#5)(2008-10#1)(2008-11#2)(2011-2#2)
V5##2##1##(1993-12#1)(2009-5#1)
V6 regions##3##2##(2011-2#3)
V6##6##1##(1997-6#1)(2011-2#4)(2013-1#1)
V762##2##1##(2010-5#2)
V765##2##1##(2010-5#2)
V79 cells##6##2##(1992-3#1)(1992-8#1)(1997-3#3)(2008-10#1)
V79##10##1##(1992-3#1)(1992-8#1)(1995-2#1)(1997-3#3)(1997-4#2)(2008-10#1)(2011-1#1)
V8 agar##3##2##(2008-10#3)
V8 protease##2##2##(1991-2#1)(1992-3#1)
V8##11##1##(1990-5#2)(1991-2#1)(1992-3#1)(1992-8#1)(2008-10#6)
V94-5152##2##1##(2008-10#2)
VA and c9##3##3##(2012-2#3)
VA and##5##2##(2011-2#2)(2012-2#3)
VA in##2##2##(2012-2#1)(2013-1#1)
VA is a##2##3##(2012-2#1)(2012-3#1)
VA is##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
VA medical centers##2##3##(1991-12#1)(2013-1#1)
VA medical##3##2##(1991-12#1)(2012-1#1)(2013-1#1)
VA##31##1##(1991-12#2)(1992-11#1)(1993-12#1)(1997-3#1)(2008-11#1)(2011-2#7)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#4)
VA)##2##1##(2012-2#2)
VAA##5##1##(2008-10#5)
VAC##2##1##(2007-8#1)(2008-11#1)
VACC##3##1##(2008-8#3)
VACCs##2##1##(2008-8#2)
VACVase was##2##2##(1995-6#2)
VACVase##4##1##(1995-6#4)
VAChT##2##1##(1996-12#2)
VAD and##2##2##(2010-8#2)
VAD##13##1##(2008-9#4)(2010-6#3)(2010-8#2)(2012-1#1)(2012-3#2)(2013-8#1)
VADs are##2##2##(2010-8#1)(2011-2#1)
VADs##5##1##(2010-8#1)(2011-2#2)(2012-3#2)
VAF##2##1##(1992-9#2)
VAM plants##2##2##(2008-10#2)
VAM resistance##2##2##(2008-10#2)
VAM##7##1##(2008-10#7)
VAM7##2##1##(1996-6#2)
VARK##2##1##(2013-8#2)
VAS and##2##2##(1996-3#2)
VAS scores for pain##2##4##(2012-2#2)
VAS##20##1##(1996-3#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-7#1)(2009-3#6)(2011-2#1)(2012-1#1)(2012-2#3)
VAS-I and VAS-U during##2##4##(2008-10#2)
VASobs##3##1##(2012-2#3)
VAT maps##2##2##(2008-7#2)
VAT under LA##3##3##(2008-5#3)
VAT under##4##2##(2008-5#4)
VAT##19##1##(2008-12#1)(2008-5#10)(2008-7#2)(2013-1#6)
VATER/VACTERL##2##1##(2008-8#2)
VATS for##2##2##(2008-10#1)(2010-8#1)
VATS in##3##2##(2007-8#1)(2008-10#1)(2010-8#1)
VATS was##2##2##(2007-8#1)(2010-8#1)
VATS##19##1##(2007-8#7)(2008-1#1)(2008-10#4)(2010-8#7)
VB##7##1##(2008-10#1)(2008-12#5)(2013-1#1)
VB)##2##1##(2008-12#2)
VBBO##4##1##(2008-11#4)
VBI##3##1##(2008-12#3)
VBP##2##1##(1992-9#2)
VC types##3##2##(2008-10#3)
VC##7##1##(2008-10#3)(2009-1#4)
VCA##3##1##(2007-2#1)(2008-3#2)
VCAM-1##2##1##(2008-4#1)(2008-5#1)
VCD##3##1##(2010-10#3)
VCD-treated mice##2##2##(2010-10#2)
VCG 0035##2##2##(2008-10#2)
VCG 0083##2##2##(2008-10#2)
VCG 0094 isolates##3##3##(2008-10#3)
VCG 0094##6##2##(2008-10#6)
VCG diversity may##2##3##(2008-10#2)
VCG diversity##4##2##(2008-10#4)
VCG##50##1##(2008-10#49)(2010-8#1)
VCG1A##9##1##(2008-10#9)
VCG2A##6##1##(2008-10#6)
VCG2B and##2##2##(2008-10#2)
VCG2B isolates##2##2##(2008-10#2)
VCG2B##11##1##(2008-10#11)
VCG4##3##1##(2008-10#3)
VCGs US-01##2##2##(2008-10#2)
VCGs and##5##2##(2008-10#5)
VCGs of##2##2##(2008-10#2)
VCGs were identified among 74 and##2##6##(2008-10#2)
VCGs were identified among##3##4##(2008-10#3)
VCGs were identified##4##3##(2008-10#4)
VCGs##37##1##(2008-10#37)
VCO##5##1##(2013-1#5)
VCP##3##1##(1993-9#3)
VCR##5##1##(2012-2#5)
VCSEL array##2##2##(2008-3#2)
VCSEL##13##1##(2007-12#1)(2008-2#1)(2008-3#11)
VCSEL's##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
VCSEL-based##2##1##(2008-3#2)
VCSELs##2##1##(2007-11#2)
VCT##7##1##(2013-1#7)
VCUG##3##1##(2008-10#3)
VCZ at##3##2##(2008-10#3)
VCZ##7##1##(2008-10#7)
VD##4##1##(1996-5#2)(2007-7#1)(2008-7#1)
VDAC2##2##1##(2011-3#2)
VDC##2##1##(1996-12#2)
VDCC beta 3 cDNA##2##4##(1997-4#2)
VDCC beta 3##10##3##(1997-4#10)
VDCC currents##2##2##(2008-8#2)
VDCC##14##1##(1997-4#12)(2008-8#2)
VDD was##3##2##(2011-1#3)
VDD##6##1##(2011-1#6)
VDJ junctions##3##2##(1997-9#3)
VDJ##4##1##(1997-9#4)
VDR and##2##2##(1995-2#1)(1995-8#1)
VDR gene##4##2##(1997-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
VDR##18##1##(1992-12#5)(1995-2#4)(1995-8#1)(1997-7#1)(2008-1#4)(2008-4#2)(2013-1#1)
VDRE##3##1##(1995-8#2)(2012-12#1)
VDREs##2##1##(1995-8#2)
VDRL reactivity##2##2##(2007-7#2)
VDRL test##2##2##(2007-7#2)
VDRL##9##1##(2007-7#8)(2008-12#1)
VDS##2##1##(1992-12#2)
VE##4##1##(2010-8#2)(2011-1#1)(2012-2#1)
VE-cadherin in##3##2##(2011-1#3)
VE-cadherin##7##1##(2011-1#7)
VED##5##1##(2011-1#5)
VEGF Trap##3##2##(2013-8#3)
VEGF and##6##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-1#2)
VEGF expression in##4##3##(2008-9#2)(2010-12#1)(2012-1#1)
VEGF expression was##2##3##(2008-9#1)(2012-1#1)
VEGF expression##11##2##(2008-9#3)(2009-8#4)(2010-12#1)(2011-1#1)(2012-1#2)
VEGF in##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
VEGF protein##5##2##(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#1)
VEGF secretion##2##2##(2013-8#2)
VEGF##59##1##(1992-3#1)(1992-9#2)(1994-11#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#11)(2009-11#1)(2009-8#8)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#4)(2013-1#3)(2013-8#12)
VEGF)##2##1##(1992-9#1)(2009-8#1)
VEGF-A##3##1##(2013-1#3)
VEGF-induced angiogenesis##2##2##(2008-10#2)
VEGF-induced##4##1##(2008-10#4)
VEGF/VPF levels in the sera##2##5##(1994-3#2)
VEGF/VPF levels in##3##3##(1994-3#3)
VEGF/VPF##4##1##(1994-3#3)(2008-9#1)
VEGFC##3##1##(2012-3#3)
VEGFR-2##2##1##(2009-11#1)(2011-1#1)
VEGFR-3##2##1##(2011-1#1)(2011-2#1)
VEGFR2##3##1##(2009-5#1)(2012-1#2)
VEP latency##3##2##(1995-12#3)
VEP##8##1##(1990-9#1)(1995-12#5)(1996-2#2)
VER and##2##2##(2008-10#2)
VET##3##1##(2008-2#3)
VF##2##1##(2013-8#2)
VF(5)##2##1##(1996-2#2)
VFA##7##1##(2008-10#2)(2008-3#4)(2008-5#1)
VFAs in##2##2##(2008-10#2)
VFAs were##2##2##(2008-10#2)
VFAs##10##1##(2008-10#6)(2008-5#4)
VFC##3##1##(1996-12#3)
VGA liquid-crystal##2##2##(2008-3#2)
VH##7##1##(1994-12#2)(1995-1#2)(1997-2#1)(1997-9#1)(2008-11#1)
VHA##3##1##(1993-8#1)(2008-7#2)
VHF##3##1##(1995-6#2)(2010-8#1)
VHL##9##1##(1995-10#1)(2011-1#8)
VHM##2##1##(2008-2#1)(2011-2#1)
VHN of##2##2##(2008-12#2)
VI and##4##2##(1990-5#1)(1994-2#1)(1997-2#1)(2013-1#1)
VI collagen##8##2##(1993-3#7)(2013-8#1)
VI of##5##2##(1990-5#1)(1991-3#1)(1997-6#3)
VI segment##2##2##(1991-6#1)(2013-1#1)
VI was##2##2##(1993-8#1)(2008-10#1)
VI##58##1##(1990-5#2)(1991-3#1)(1991-6#2)(1993-12#2)(1993-3#7)(1993-8#1)(1994-2#5)(1994-7#3)(1995-11#1)(1995-12#2)(1996-10#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#5)(2007-12#2)(2008-10#10)(2008-5#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
VI) at##2##2##(2008-10#1)(2008-12#1)
VI)##12##1##(1994-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2012-3#1)
VIC and##2##2##(1990-2#2)
VIC##5##1##(1990-2#3)(2008-10#2)
VIGS##4##1##(2008-9#4)
VII and VIII##2##3##(2009-10#1)(2012-2#1)
VII and##4##2##(1991-6#1)(2008-5#1)(2009-10#1)(2012-2#1)
VII collagen##4##2##(1992-3#4)
VII deficiency##2##2##(2008-7#2)
VII of##6##2##(1995-6#2)(1995-9#1)(1996-3#1)(1997-3#2)
VII##53##1##(1991-11#1)(1991-6#1)(1992-3#4)(1994-2#4)(1995-12#2)(1995-6#5)(1995-9#2)(1996-3#3)(1996-6#3)(1997-3#11)(2008-10#3)(2008-5#4)(2008-7#4)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#2)
VII) and Pb(II)##2##3##(2008-10#2)
VII) and##3##2##(1994-8#1)(2008-10#2)
VII)##5##1##(1994-8#1)(2008-10#4)
VII-VIII##3##1##(1996-5#1)(2009-10#1)(2012-3#1)
VIII and IX##4##3##(2008-10#1)(2011-2#3)
VIII and##10##2##(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#2)(2010-6#1)(2011-2#3)(2012-2#1)
VIII of##3##2##(1995-6#1)(2009-10#1)(2012-2#1)
VIII##44##1##(1990-8#4)(1991-3#1)(1993-6#3)(1994-12#2)(1994-8#2)(1994-9#2)(1995-2#2)(1995-6#6)(1996-3#1)(2008-10#2)(2008-12#5)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2010-6#1)(2011-2#4)(2012-2#2)
VIII)##2##1##(1991-5#1)(1994-8#1)
VIIa##16##1##(1995-6#9)(2007-8#3)(2008-8#2)(2008-9#1)(2011-2#1)
VIN##2##1##(1993-9#2)
VIP = PACAP-27##2##3##(1994-3#2)
VIP had no effect on the##2##6##(1995-11#1)(2008-4#1)
VIP in##2##2##(1993-9#1)(2012-3#1)
VIP interview##8##2##(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)
VIP##47##1##(1990-5#4)(1990-7#2)(1993-12#1)(1993-9#3)(1994-1#1)(1994-2#1)(1994-3#5)(1995-1#2)(1995-11#6)(1995-2#1)(1995-3#1)(1995-5#6)(1996-2#1)(2008-4#6)(2012-3#6)(2013-8#1)
VIP-receptor antagonist##2##2##(1995-11#2)
VIP-receptor##3##1##(1994-3#1)(1995-11#2)
VIP/NPY or VIP/C-PON IR##2##4##(1990-5#2)
VIS has##2##2##(1997-4#2)
VIS##9##1##(1997-4#9)
VISION 2020##3##2##(2011-2#3)
VK210##2##1##(2012-12#2)
VKC##2##1##(2012-3#2)
VKORC1##4##1##(2011-1#4)
VL and VH sequences##2##4##(1994-12#2)
VL##10##1##(1994-12#2)(1996-5#2)(2008-12#1)(2008-3#1)(2008-8#4)
VLA-4##2##1##(2008-5#2)
VLCAD##2##1##(1993-3#2)
VLDL and##6##2##(1992-12#1)(1993-6#1)(1993-8#2)(1995-6#1)(2012-2#1)
VLDL cholesterol##3##2##(1993-6#1)(2007-7#1)(2013-1#1)
VLDL from##4##2##(1991-12#2)(1993-8#1)(1995-6#1)
VLDL receptor##10##2##(1995-6#10)
VLDL to##2##2##(1991-12#1)(1995-6#1)
VLDL was##4##2##(1991-12#1)(1992-12#1)(1993-6#1)(1995-6#1)
VLDL were##4##2##(1990-8#1)(1991-12#1)(1993-8#1)(2013-1#1)
VLDL##64##1##(1990-8#7)(1991-12#10)(1992-12#4)(1993-12#1)(1993-6#6)(1993-8#10)(1994-3#1)(1994-6#1)(1995-6#16)(1995-8#1)(1997-7#2)(2007-7#1)(2008-3#1)(2012-2#1)(2013-1#2)
VLE##2##1##(2008-12#2)
VLM##2##1##(2012-2#2)
VLO##9##1##(1994-3#9)
VLP preparations##3##2##(2008-10#3)
VLP##8##1##(1993-3#3)(2008-10#5)
VLPs carrying the##2##3##(1995-5#2)
VLPs carrying##3##2##(1995-5#3)
VLS##2##1##(2008-7#1)(2008-9#1)
VLSI chips##2##2##(2008-3#2)
VLSI implementation##2##2##(2008-2#2)
VLSI##10##1##(2007-12#1)(2008-2#3)(2008-3#6)
VM ratios for cyst##2##4##(2008-10#2)
VM##5##1##(2008-10#2)(2012-3#3)
VM-A##2##1##(1996-9#2)
VMA and VAA##2##3##(2008-10#2)
VMA or VAA##2##3##(2008-10#2)
VMA##6##1##(2008-10#6)
VME inhibited VEGF-A-induced##2##3##(2008-10#2)
VME inhibited##4##2##(2008-10#4)
VME##10##1##(2008-10#7)(2008-2#1)(2009-6#2)
VMT##8##1##(2013-1#8)
VN##2##1##(1997-3#2)
VNC##2##1##(2008-5#2)
VNO##2##1##(1994-2#2)
VNS is##2##2##(2008-1#1)(2008-7#1)
VNS##5##1##(2008-1#2)(2008-7#3)
VNTR hypervariable region##2##3##(1992-3#2)
VNTR##6##1##(1990-12#1)(1992-3#3)(2008-10#1)(2008-12#1)
VO##4##1##(2007-11#1)(2008-11#2)(2011-2#1)
VO(2) nanoparticles##2##2##(2007-11#2)
VO(2)##4##1##(2007-11#4)
VO(2+) ions##2##2##(2008-10#2)
VO(2+)##9##1##(2008-10#9)
VO2##3##1##(2008-10#1)(2008-5#2)
VO2/kg x min(-1)##4##3##(2008-3#4)
VO2max and Time##2##3##(2008-5#2)
VO2max and##3##2##(2008-5#3)
VO2max tests were##2##3##(2008-5#2)
VO2max##13##1##(2008-5#6)(2012-2#3)(2013-1#4)
VO2max/kg##2##1##(2012-2#2)
VO613Y##2##1##(2008-10#2)
VOC##5##1##(2008-10#2)(2008-11#2)(2011-10#1)
VOCl(2) and NH(4)VO(3)##2##3##(2008-10#2)
VOCl(2)##4##1##(2008-10#4)
VOCs in soils##2##3##(2008-10#2)
VOCs in##6##2##(2008-10#5)(2011-1#1)
VOCs were##2##2##(2008-10#1)(2008-11#1)
VOCs##13##1##(2008-10#11)(2008-11#1)(2011-1#1)
VOHC##3##1##(2008-10#3)
VOX##3##1##(2008-10#3)
VP and##4##2##(2007-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
VP shunt in a patient with##2##6##(2008-7#2)
VP shunt##4##2##(2008-7#2)(2012-12#2)
VP##18##1##(1994-9#2)(1996-5#2)(2007-10#6)(2008-4#2)(2008-5#1)(2008-7#2)(2012-12#3)
VP-16 sensitivity##2##2##(1993-9#2)
VP-16##9##1##(1992-12#3)(1992-6#1)(1993-9#2)(1994-10#3)
VP-SFM##3##1##(2008-11#3)
VP/FK mediated F-actin depolymerization##2##4##(2012-12#2)
VP/FK mediated##3##2##(2012-12#3)
VP/FK treatment##3##2##(2012-12#3)
VP/FK##7##1##(2012-12#7)
VP1 coding##3##2##(2013-8#3)
VP1 gene sequences##3##3##(2008-12#3)
VP1 gene##5##2##(1997-8#1)(2008-12#3)(2011-1#1)
VP1 is##3##2##(1994-8#3)
VP1##18##1##(1994-8#5)(1997-8#3)(2008-12#3)(2011-1#1)(2013-8#6)
VP2##5##1##(1994-8#3)(1997-4#2)
VP3##5##1##(1995-5#1)(1997-4#4)
VP4 and##2##2##(1997-4#1)(2013-8#1)
VP4/VP2##2##1##(2013-8#2)
VP5##2##1##(1997-4#2)
VP6 mRNA##2##2##(2008-5#2)
VP6 protein##2##2##(2008-5#2)
VP6##5##1##(2008-5#5)
VP7 and VP3##3##3##(1997-4#3)
VP7##5##1##(1997-4#5)
VPA (300 mg/kg##2##3##(2011-2#2)
VPA and 4-en-VPA##2##3##(1996-5#2)
VPA and PH##2##3##(2011-1#2)
VPA and##6##2##(1996-5#3)(2010-7#1)(2011-1#2)
VPA is##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
VPA treatment##2##2##(2008-7#1)(2011-2#1)
VPA##26##1##(1996-5#4)(2008-7#4)(2010-7#1)(2011-1#3)(2011-2#12)(2013-1#2)
VPD##3##1##(2008-10#3)
VPF##2##1##(1991-2#2)
VPS##2##1##(1993-12#2)
VR can##2##2##(1992-3#1)(2009-11#1)
VR group##2##2##(2010-4#2)
VR##12##1##(1992-3#2)(2009-11#3)(2010-4#6)(2013-1#1)
VR1-like protein##2##2##(2008-11#2)
VRCs##8##1##(2008-11#8)
VRE##10##1##(2007-12#10)
VRN1##2##1##(2009-8#1)(2012-3#1)
VRN2##3##1##(2009-8#3)
VS cells##4##2##(2008-11#4)
VS##6##1##(2008-11#5)(2011-2#1)
VSCs##3##1##(2008-10#3)
VSD##7##1##(2007-8#3)(2008-3#1)(2010-6#1)(2012-1#2)
VSG expression##2##2##(2011-2#2)
VSG##4##1##(2011-2#4)
VSGs##2##1##(2011-2#2)
VSM##7##1##(1993-8#5)(2012-2#1)(2013-1#1)
VSMC and GMC##2##3##(2008-1#2)
VSMC##17##1##(1990-12#3)(1992-9#1)(1993-2#1)(1994-9#4)(2008-1#2)(2008-5#1)(2008-8#3)(2008-9#2)
VSMCs##3##1##(1994-6#2)(2012-12#1)
VSV##2##1##(2008-11#1)(2008-4#1)
VT and##2##2##(2008-10#1)(2011-2#1)
VT##11##1##(1991-2#1)(2008-10#7)(2011-2#3)
VTA##8##1##(1993-12#5)(1996-12#2)(1996-5#1)
VTE after##3##2##(2007-10#1)(2012-3#2)
VTE in patients##3##3##(2007-10#1)(2008-7#1)(2012-3#1)
VTE prophylaxis##2##2##(2011-2#2)
VTE##17##1##(2007-10#5)(2007-2#1)(2008-7#2)(2011-2#2)(2012-3#7)
VU##4##1##(1994-12#4)
VUMC##2##1##(1996-1#2)
VUR##5##1##(2008-10#4)(2009-5#1)
VUV light or Ar##3##4##(2010-4#3)
VUV light##6##2##(2010-4#6)
VUV radiation##2##2##(2008-2#1)(2010-4#1)
VUV##13##1##(2007-11#1)(2008-2#5)(2010-4#7)
VV##5##1##(2008-10#3)(2013-1#2)
VVC##2##1##(2008-5#2)
VVIR##2##1##(1992-5#1)(2008-3#1)
VWA STR##3##2##(2008-12#3)
VWA##6##1##(2008-12#6)
VWF##2##1##(2009-7#1)(2013-1#1)
VZ##5##1##(1996-5#5)
VZV##5##1##(2008-4#2)(2011-1#3)
Va and##2##2##(1993-11#1)(1994-5#1)
Va##15##1##(1993-11#5)(1994-5#7)(1997-3#1)(2008-3#1)(2008-9#1)
Vaccinated##2##1##(2010-4#1)(2012-2#1)
Vaccination of##3##2##(1990-3#1)(1997-6#1)(2009-5#1)
Vaccination##13##1##(1990-3#1)(1995-3#1)(1996-1#1)(1997-6#1)(2007-2#1)(2008-5#2)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#3)
Vaccine development##2##2##(2011-1#2)
Vaccine in##2##2##(2012-3#1)(2013-1#1)
Vaccine schedules##2##2##(2007-12#1)(2009-4#1)
Vaccine strategies##2##2##(1995-5#2)
Vaccine##24##1##(1990-12#1)(1995-5#4)(1996-9#1)(1997-6#1)(2007-12#1)(2008-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Vaccines for##2##2##(1996-12#1)(2009-4#1)
Vaccines in the##2##3##(2007-2#1)(2008-8#1)
Vaccines in##3##2##(2007-2#1)(2008-5#1)(2008-8#1)
Vaccines##9##1##(1995-5#1)(1996-12#2)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
Vaccinium myrtillus (Bilberry)##2##3##(2008-10#2)
Vaccinium##3##1##(2008-10#2)(2011-1#1)
Vacuolar##3##1##(1992-8#1)(1994-8#1)(2009-10#1)
Vacuum temperature-dependent ellipsometric studies on##2##5##(2008-3#2)
Vacuum##7##1##(1996-9#2)(2007-8#1)(2008-2#1)(2008-3#3)
Vaejovidae##2##1##(2007-12#2)
Vaejovis spinigerus (Wood##4##3##(2007-12#4)
Vaginal hysterectomy##5##2##(1994-2#2)(1995-1#1)(1995-12#2)
Vaginal##12##1##(1992-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(2008-12#1)(2009-2#1)(2011-2#2)(2011-5#1)
Vagus nerve stimulation##4##3##(2008-1#1)(2008-7#3)
Vaisala H-Humicap##2##2##(2008-3#2)
Val for##2##2##(1990-7#1)(1991-9#1)
Val substitution##2##2##(1994-5#1)(1995-5#1)
Val##12##1##(1990-7#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1994-5#1)(1995-5#1)(2008-9#1)(2009-5#1)
Valence topological charge-transfer##2##3##(2007-11#2)
Valence##4##1##(1996-9#1)(1997-7#1)(2007-11#2)
Valencia (Spain)##3##2##(2008-10#3)
Valencia##8##1##(1996-2#1)(2008-10#7)
Valencia]##2##1##(1993-2#1)(1995-3#1)
Valid##2##1##(1992-6#1)(2013-1#1)
Validation and##3##2##(1997-3#1)(2010-10#1)(2012-3#1)
Validation of a high performance liquid chromatography##2##7##(2008-10#1)(2008-5#1)
Validation of a##9##3##(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#2)
Validation of an##2##3##(2008-10#1)(2012-12#1)
Validation of reducing-difference procedure##2##4##(2008-10#2)
Validation of the method according to the quality assurance standards##2##10##(2008-10#2)
Validation of the method##4##4##(2008-10#4)
Validation of the##16##3##(2008-10#10)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)(2012-3#1)
Validation of##44##2##(1991-3#1)(1995-12#1)(1996-3#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
Validation on##3##2##(2008-10#2)(2009-11#1)
Validation was carried out##3##4##(2008-10#2)(2008-3#1)
Validation was##6##2##(2008-10#4)(2008-3#1)(2011-1#1)
Validation##65##1##(1991-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)
Validations of the##2##3##(2008-2#1)(2008-3#1)
Validations##3##1##(2008-2#1)(2008-3#1)(2010-8#1)
Validity and reliability of##2##4##(2011-1#1)(2013-1#1)
Validity and reliability##3##3##(2010-10#1)(2011-1#1)(2013-1#1)
Validity of evaluation approaches for outbreak detection methods in syndromic surveillance systems##2##12##(2013-1#2)
Validity of the##6##3##(1995-12#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-3#1)
Validity of##11##2##(1995-12#1)(1996-7#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-1#2)
Validity##16##1##(1995-12#1)(1996-7#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#2)(2011-1#1)(2012-1#1)(2013-1#3)
Valine##2##1##(1995-8#1)(1997-4#1)
Valinomycin##2##1##(1992-12#2)
Valle##2##1##(2008-12#1)(2011-2#1)
Valley Regional##2##2##(1992-12#1)(2008-9#1)
Valley in##4##2##(2008-10#4)
Valley of California##2##3##(2008-10#2)
Valley of##6##2##(2008-10#6)
Valley##44##1##(1990-12#1)(1991-2#1)(1992-12#1)(1994-9#2)(2007-10#1)(2008-10#33)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Valley)##2##1##(2008-10#1)(2013-1#1)
Valleys##2##1##(2008-10#2)
Valproic##2##1##(2011-2#1)(2013-1#1)
Valsalva maneuver##4##2##(2008-7#1)(2012-3#3)
Valsalva max##3##2##(2008-7#3)
Valsalva ratio##2##2##(2012-3#2)
Valsalva##20##1##(1990-9#1)(1994-3#1)(1997-5#3)(2007-8#2)(2008-7#4)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#5)
Valsalva's manoeuvre##2##2##(2008-9#2)
Valsalva's or Toynbee's manoeuvres##2##4##(2012-2#2)
Valsalva's##4##1##(2008-9#2)(2012-2#2)
Valsartan##5##1##(2008-10#3)(2010-3#1)(2011-1#1)
Valtrex##2##1##(2007-1#2)
Value for##3##2##(2009-9#1)(2013-1#2)
Value of the##4##3##(1993-2#1)(1997-5#1)(2007-11#1)(2008-3#1)
Value of##16##2##(1992-5#1)(1993-2#1)(1993-8#1)(1996-6#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-6#1)(2012-3#1)(2013-1#3)
Value##28##1##(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#2)(1996-3#1)(1996-6#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2011-6#1)(2012-2#1)(2012-3#1)(2013-1#5)
Values and##2##2##(2008-10#1)(2009-8#1)
Values for##8##2##(1990-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
Values in##2##2##(1997-3#1)(2010-12#1)
Values of the##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
Values of##20##2##(1990-8#2)(2008-10#11)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
Values##38##1##(1990-8#2)(1990-9#1)(1992-3#1)(1995-12#1)(1997-3#2)(1997-7#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Valve##7##1##(1990-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
Valvular heart diseases are among the frequent causes of cardiac surgery##2##11##(2013-1#2)
Valvular heart##3##2##(2010-12#1)(2013-1#2)
Valvular##4##1##(2008-11#1)(2010-12#1)(2013-1#2)
Van Gieson's##2##2##(2008-5#1)(2012-3#1)
Van Handel##2##2##(2008-10#2)
Van der##3##2##(1994-12#1)(2007-11#1)(2009-6#1)
Van##19##1##(1992-2#1)(1992-6#1)(1994-12#1)(1994-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#3)(2009-6#1)(2012-3#1)(2013-8#4)
Van't Hoff##3##2##(1997-2#1)(2008-10#2)
VanX##7##1##(1995-2#7)
Vanadate##5##1##(1990-5#3)(1994-11#1)(1994-6#1)
Vanadium and##2##2##(2008-10#2)
Vanadium##7##1##(1990-2#1)(1996-2#2)(2008-10#3)(2011-2#1)
Vanadium(IV)##3##1##(2008-10#3)
Vanadium(V)##4##1##(2008-10#4)
Vancomycin##5##1##(1991-3#1)(1991-8#1)(1995-2#1)(2007-7#1)(2010-6#1)
Vancouver Island##5##2##(2008-10#5)
Vancouver##15##1##(2008-10#5)(2008-12#3)(2008-6#1)(2011-2#2)(2013-1#2)(2013-8#2)
VanderLugt correlator##3##2##(2007-12#1)(2008-3#2)
VanderLugt##6##1##(2007-12#1)(2008-3#5)
Vanderbilt University Medical Center (VUMC)##2##5##(1996-1#1)(1996-2#1)
Vanderbilt University Medical Center##4##4##(1996-1#1)(1996-2#2)(2008-5#1)
Vanderbilt University##5##2##(1996-1#1)(1996-2#2)(2008-3#1)(2008-5#1)
Vanderbilt##6##1##(1996-1#2)(1996-2#2)(2008-3#1)(2008-5#1)
Vanuatu in##2##2##(1992-7#1)(2012-12#1)
Vanuatu##7##1##(1992-7#1)(2008-1#5)(2012-12#1)
Vapor##2##1##(1996-2#1)(2008-2#1)
Vapour##4##1##(2008-10#2)(2008-5#2)
Varanasi##3##1##(2008-10#2)(2012-2#1)
Varenicline is##2##2##(2011-2#2)
Varenicline##3##1##(2011-2#3)
Varese##3##1##(1992-10#2)(1992-8#1)
Vargas##3##1##(2008-2#1)(2008-9#2)
Vargula luciferase##3##2##(1995-2#3)
Variability Within and Among##2##4##(2008-10#2)
Variability Within##3##2##(2008-10#3)
Variability in the##3##3##(2008-10#3)
Variability in##15##2##(1991-12#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)
Variability of##9##2##(1993-2#1)(2008-10#5)(2008-9#1)(2009-2#1)(2012-1#1)
Variability##37##1##(1990-11#1)(1991-12#1)(1993-2#1)(2008-10#21)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-7#2)(2013-8#1)
Variable temperature##3##2##(1994-11#1)(1997-7#1)(2007-11#1)
Variable##32##1##(1992-6#1)(1993-11#2)(1994-11#1)(1994-3#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#3)(2010-1#1)(2011-2#1)(2012-3#1)
Variables affecting the##3##3##(2008-10#3)
Variables such as sonication time##2##5##(2008-10#2)
Variables such as##4##3##(2008-10#3)(2013-8#1)
Variables that##2##2##(1992-3#1)(2008-10#1)
Variables##19##1##(1992-3#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
Variamine##2##1##(2008-10#1)(2012-3#1)
Varian##5##1##(2008-10#4)(2009-11#1)
Variance##4##1##(1995-12#1)(2008-10#1)(2009-1#1)(2013-1#1)
Variant##7##1##(1993-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
Variants in##2##2##(2009-7#1)(2013-1#1)
Variants of##3##2##(1994-2#1)(1997-3#1)(2009-12#1)
Variants##15##1##(1994-12#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-3#3)(2012-2#1)(2012-3#1)(2013-1#1)
Variation Among##3##2##(2008-10#3)
Variation and##3##2##(2008-10#3)
Variation at the##2##3##(2008-10#2)
Variation in Pathogenicity##2##3##(2008-10#2)
Variation in the##8##3##(1993-9#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)
Variation in##37##2##(1993-3#1)(1993-9#1)(1994-1#1)(1995-8#1)(1996-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Variation of the##2##3##(2007-11#1)(2008-10#1)
Variation of##14##2##(1995-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
Variation over the range of the standard curve was less than##2##11##(2008-10#2)
Variation was##2##2##(2008-10#1)(2008-5#1)
Variation##70##1##(1993-3#1)(1993-9#1)(1994-1#1)(1995-8#1)(1995-9#1)(1996-11#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Variational##5##1##(1996-12#1)(1996-9#1)(2009-9#1)(2010-2#1)(2013-8#1)
Variations and##2##2##(1992-8#1)(1996-3#1)
Variations in the##8##3##(1991-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
Variations in##31##2##(1990-7#1)(1991-12#1)(1992-4#1)(1993-12#1)(1994-11#2)(1995-12#1)(1996-3#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
Variations of##4##2##(1990-12#1)(2008-10#2)(2010-8#1)
Variations##41##1##(1990-12#1)(1990-7#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-11#2)(1995-12#1)(1996-3#3)(1997-2#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
Varied levels of##2##3##(2008-10#1)(2008-11#1)
Varied##3##1##(2008-10#1)(2008-11#1)(2009-5#1)
Varieties##4##1##(1994-1#1)(2008-10#3)
Variograms##2##1##(2008-10#2)
Various aspects of##3##3##(2008-10#2)(2012-3#1)
Various clinical##2##2##(2008-4#1)(2008-8#1)
Various combinations of the##2##4##(2008-10#1)(2008-11#1)
Various combinations of##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
Various conditions were optimized for practical application##2##7##(2008-10#2)
Various conditions##3##2##(2008-10#3)
Various experimental conditions##2##3##(2008-10#2)
Various factors##4##2##(1997-1#1)(2008-10#3)
Various imaging##2##2##(2010-7#1)(2011-2#1)
Various issues##3##2##(1990-6#1)(2008-4#1)(2011-2#1)
Various measures##2##2##(1993-6#1)(2013-8#1)
Various methods##5##2##(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
Various models##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
Various new##2##2##(1994-9#1)(2008-7#1)
Various other##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
Various parameters such as the effect of pH##6##8##(2008-10#6)
Various parameters such as the##7##5##(2008-10#7)
Various parameters such as##8##4##(2008-10#8)
Various parameters##16##2##(2008-10#16)
Various physio-chemical parameters##3##3##(2008-10#3)
Various physio-chemical##4##2##(2008-10#4)
Various possible##2##2##(2008-10#1)(2008-3#1)
Various procedures##2##2##(2009-9#1)(2010-7#1)
Various studies##2##2##(2008-5#1)(2013-8#1)
Various surgical approaches have been##2##5##(2007-8#1)(2013-1#1)
Various surgical##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
Various techniques of##2##3##(2012-3#1)(2013-8#1)
Various techniques##4##2##(2008-9#1)(2012-3#2)(2013-8#1)
Various types of##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
Various variables##2##2##(2007-11#1)(2008-10#1)
Various##196##1##(1990-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#63)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#1)(2013-8#4)
Varroa destructor##4##2##(2008-6#2)(2013-1#2)
Varroa##10##1##(2008-6#3)(2013-1#7)
Varunda##2##1##(2008-10#2)
Varying degrees of##2##3##(2008-7#1)(2009-5#1)
Varying##11##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#1)
Vasc##3##1##(2007-8#1)(2008-4#1)(2010-9#1)
Vascular Access##2##2##(2007-7#1)(2008-1#1)
Vascular Endothelial##2##2##(2011-1#1)(2012-3#1)
Vascular access##2##2##(2007-7#2)
Vascular complications are##2##3##(2010-10#1)(2010-7#1)
Vascular endothelial cells##2##3##(1996-12#1)(2010-1#1)
Vascular endothelial growth factor (VEGF) is a##3##7##(1994-11#1)(2008-11#1)(2008-7#1)
Vascular endothelial growth factor (VEGF) is##4##6##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
Vascular endothelial growth factor (VEGF)##5##5##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
Vascular endothelial growth factor##6##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
Vascular endothelial growth##7##3##(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
Vascular endothelial##10##2##(1992-9#1)(1994-11#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-1#1)
Vascular remodeling##2##2##(1996-8#1)(2009-1#1)
Vascular smooth muscle cells##3##4##(1992-8#1)(1995-11#1)(2009-7#1)
Vascular##55##1##(1991-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-10#2)(2007-7#5)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Vascularization was##2##2##(1997-6#1)(2011-2#1)
Vascularization##3##1##(1994-9#1)(1997-6#1)(2011-2#1)
Vasculitic##2##1##(2012-3#1)(2013-1#1)
Vasculorama##4##1##(2007-7#4)
Vasoactive intestinal contractor##2##3##(1990-2#2)
Vasoactive intestinal peptide (VIP)##2##4##(1995-5#1)(2012-3#1)
Vasoactive intestinal##4##2##(1990-2#2)(1995-5#1)(2012-3#1)
Vasoactive##6##1##(1990-2#2)(1990-5#1)(1995-5#1)(1996-2#1)(2012-3#1)
Vasodilation##2##1##(1991-9#1)(2012-3#1)
Vasodilatory shock##2##2##(2007-9#1)(2008-10#1)
Vasonat##4##1##(2011-1#4)
Vasopressin##5##1##(1990-12#1)(1994-2#2)(2007-9#1)(2009-7#1)
Vasospasm##9##1##(1996-9#1)(1997-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
Vast##3##1##(2012-12#1)(2013-1#2)
Vb##3##1##(1991-11#3)
Vcyto##6##1##(1991-11#6)
Vector Circulifer##2##2##(2008-10#2)
Vector System##3##2##(2008-11#1)(2008-2#1)(2008-7#1)
Vector diffraction##3##2##(2008-2#1)(2008-3#2)
Vector##35##1##(1997-7#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#3)(2011-2#1)(2013-8#1)
Vectors for##3##2##(1990-5#1)(2008-10#1)(2008-4#1)
Vectors##9##1##(1990-5#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#1)
Vectra Graft for immediate##2##4##(2007-7#2)
Vectra Graft##4##2##(2007-7#4)
Vegard's law##2##2##(2008-10#2)
Vegas##4##1##(1997-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
Vegetable##2##1##(2011-1#1)(2013-8#1)
Vegetation##6##1##(2007-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
Vegetative Compatibility Groups in##3##4##(2008-10#3)
Vegetative Compatibility Groups##5##3##(2008-10#5)
Vegetative Compatibility##10##2##(2008-10#10)
Vegetative compatibility##4##2##(2008-10#4)
Vegetative growth##2##2##(2008-10#1)(2008-8#1)
Vegetative indices calculated from##2##4##(2008-10#2)
Vegetative##19##1##(2008-10#18)(2008-8#1)
Veggie- CHO##2##2##(2008-11#2)
Veggie-CHO##3##1##(2008-11#3)
Vehicle##3##1##(2008-5#1)(2013-8#2)
Vein of Galen##2##3##(1996-3#2)
Vein##9##1##(1996-2#1)(1996-3#2)(2008-1#1)(2008-12#2)(2012-12#1)(2013-1#1)(2013-8#1)
Veins##3##1##(2010-8#1)(2011-2#2)
Velocities for the synthesis of##2##5##(2009-8#2)
Velocities##3##1##(2008-8#1)(2009-8#2)
Velocity of spread##2##3##(2008-10#2)
Velocity##8##1##(1990-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)(2009-5#1)
Vena##3##1##(2008-12#1)(2008-7#1)(2011-2#1)
Venezuela##39##1##(1992-5#1)(2007-10#1)(2007-5#1)(2008-10#8)(2008-5#14)(2008-8#1)(2008-9#2)(2011-2#5)(2012-12#2)(2013-7#4)
Venezuela)##2##1##(2011-2#2)
Venezuela]##14##1##(1994-2#1)(2007-10#1)(2007-5#1)(2008-5#3)(2011-2#5)(2013-7#3)
Venezuelan &quot##2##2##(2008-5#1)(2011-2#1)
Venezuelan crude##3##2##(2008-10#3)
Venezuelan patients with##2##3##(2009-10#1)(2011-2#1)
Venezuelan patients##3##2##(2009-10#1)(2011-2#2)
Venezuelan patients]##2##2##(2011-2#2)
Venezuelan##24##1##(2008-10#7)(2008-5#7)(2008-9#2)(2009-10#1)(2011-2#7)
Venice##5##1##(1991-3#1)(2008-11#3)(2011-2#1)
Venocuff##2##1##(2013-1#2)
Venous Thromboembolism##2##2##(2008-3#1)(2012-3#1)
Venous blood samples were##2##4##(1991-6#1)(1997-3#1)
Venous blood##3##2##(1991-6#1)(1997-3#1)(2013-1#1)
Venous pathologies##2##2##(2012-3#2)
Venous thromboembolism (VTE)##2##3##(2008-7#1)(2012-3#1)
Venous thromboembolism##5##2##(2008-3#1)(2008-7#2)(2012-3#1)(2013-8#1)
Venous##23##1##(1990-3#1)(1991-6#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#2)(2011-2#2)(2012-3#6)(2013-1#3)(2013-8#2)
Ventilation##3##1##(1996-12#1)(2007-8#1)(2010-7#1)
Ventilator##3##1##(1994-12#1)(1995-5#1)(2010-7#1)
Ventilatory##2##1##(2008-10#1)(2013-7#1)
Ventricular Septal##2##2##(2012-1#2)
Ventricular assist devices##5##3##(2006-10#1)(2010-5#1)(2010-6#1)(2011-2#2)
Ventricular fibrillation##2##2##(1990-12#1)(1992-5#1)
Ventricular intramyocardial electrograms##2##3##(2009-3#2)
Ventricular##16##1##(1990-12#1)(1992-5#1)(2006-10#1)(2007-8#1)(2008-3#1)(2009-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#3)
Venturia inaequalis and##5##3##(2008-10#5)
Venturia inaequalis was##3##3##(2008-10#3)
Venturia inaequalis##33##2##(2008-10#33)
Venturia nashicola##5##2##(2008-10#5)
Venturia pirina##2##2##(2008-10#2)
Venturia species##2##2##(2008-10#2)
Venturia##47##1##(2008-10#47)
Venus flytrap##4##2##(2009-8#4)
Venus##15##1##(1991-5#2)(1991-8#2)(1992-7#2)(1997-5#1)(2008-11#1)(2008-3#3)(2009-8#4)
VeraBond##2##1##(2013-1#2)
Veracruz##3##1##(2008-5#1)(2013-7#2)
Verapamil##2##1##(1990-3#1)(1992-12#1)
Verbal feedback##2##2##(2007-11#1)(2008-11#1)
Verbal##6##1##(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
Verdelho##2##1##(2008-10#2)
Verification of##5##2##(1993-9#1)(2008-10#2)(2011-2#1)(2012-2#1)
Verification##9##1##(1993-9#1)(2008-10#3)(2008-3#3)(2011-2#1)(2012-2#1)
Verisyse##4##1##(2011-2#4)
Vermont##8##1##(1992-2#1)(1994-2#2)(1995-12#1)(1996-12#1)(2007-5#1)(2010-8#2)
Vermont's##3##1##(1994-2#1)(1997-1#2)
Vernix##3##1##(2008-5#3)
Vero and##5##2##(2007-10#1)(2008-11#3)(2008-8#1)
Vero cell##6##2##(2007-10#2)(2008-11#3)(2008-9#1)
Vero cells##13##2##(2007-10#1)(2008-11#9)(2008-9#2)(2011-2#1)
Vero##31##1##(1994-3#1)(2007-10#4)(2008-11#20)(2008-8#1)(2008-9#3)(2011-2#1)(2012-2#1)
Verona##3##1##(1990-3#1)(1994-8#1)(1997-5#1)
Verrucous carcinoma##2##2##(2009-10#2)
Versatile##5##1##(1993-2#1)(1997-4#1)(2008-11#1)(2008-3#1)(2011-2#1)
Version##15##1##(1994-12#4)(1996-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
Versus##7##1##(2008-7#1)(2009-9#1)(2012-12#1)(2012-3#2)(2013-1#2)
Vertebral artery dissection##2##3##(2008-7#1)(2013-8#1)
Vertebral##12##1##(1991-8#1)(2007-11#1)(2007-8#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#1)(2013-8#2)
Vertebrate##3##1##(1990-3#1)(1995-12#1)(2012-3#1)
Vertebrates##3##1##(1995-2#1)(2008-5#1)(2010-9#1)
Vertebrobasilar##2##1##(2007-11#1)(2012-3#1)
Vertebroplasty and kyphoplasty are##2##4##(2008-7#2)
Vertebroplasty and kyphoplasty##3##3##(2008-7#3)
Vertebroplasty##4##1##(2008-7#4)
Vertical profiles of##4##3##(2008-2#2)(2008-3#2)
Vertical##22##1##(1991-3#1)(1993-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#6)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#2)
Vertically coupled##2##2##(2007-11#2)
Vertically##3##1##(2007-11#2)(2008-8#1)
Verticillium dahliae Populations##2##3##(2008-10#2)
Verticillium dahliae and##2##3##(2008-10#1)(2008-12#1)
Verticillium dahliae by##2##3##(2008-10#2)
Verticillium dahliae in##3##3##(2008-10#3)
Verticillium dahliae isolates from##2##4##(2008-10#2)
Verticillium dahliae isolates##3##3##(2008-10#3)
Verticillium dahliae on##2##3##(2008-10#1)(2011-1#1)
Verticillium dahliae##38##2##(2008-10#34)(2008-12#2)(2011-1#2)
Verticillium isolates##2##2##(2008-10#2)
Verticillium lecanii and##2##3##(2008-10#2)
Verticillium lecanii##6##2##(2008-10#4)(2008-5#2)
Verticillium spp##4##2##(2008-10#4)
Verticillium wilt and##3##3##(2008-10#3)
Verticillium wilt development##3##3##(2008-10#3)
Verticillium wilt on cauliflower##2##4##(2008-10#2)
Verticillium wilt##20##2##(2008-10#19)(2011-1#1)
Verticillium##85##1##(2008-10#78)(2008-12#2)(2008-5#2)(2011-1#3)
Very Large##2##2##(1995-6#1)(2008-3#1)
Very few cases have been reported##2##6##(2009-5#1)(2012-12#1)
Very few cases of##2##4##(2010-4#1)(2013-1#1)
Very few cases##5##3##(1991-4#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
Very few studies##2##3##(2009-10#1)(2012-3#1)
Very few##16##2##(1990-2#1)(1991-4#1)(1992-3#1)(1993-10#1)(1997-6#1)(2008-10#2)(2009-10#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Very good agreement##2##3##(2007-12#1)(2008-2#1)
Very good##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Very high##3##2##(1992-2#1)(2008-10#1)(2011-1#1)
Very little is known##2##4##(1990-7#1)(2009-8#1)
Very little##6##2##(1990-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-8#1)(2009-9#1)
Very low##2##2##(2008-10#1)(2008-6#1)
Very recent##2##2##(2008-10#1)(2008-7#1)
Very recently##3##2##(1991-10#1)(2008-4#1)(2010-8#1)
Very similar##2##2##(2008-10#1)(2008-11#1)
Very##58##1##(1990-2#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-10#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#3)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
Vesalius##3##1##(2009-7#2)(2012-2#1)
Vesicles containing##2##2##(1992-6#1)(1994-12#1)
Vesicles##5##1##(1992-6#1)(1994-12#1)(2008-10#2)(2008-11#1)
Vesicoureteral reflux (VUR) is##2##4##(2008-10#2)
Vesicoureteral reflux##3##2##(2007-7#1)(2008-10#2)
Vesicoureteric reflux##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
Vessel##6##1##(1990-12#1)(2007-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-5#1)
Vest-Agder##3##1##(1997-4#1)(1997-8#2)
Vestfold##2##1##(1995-5#2)
Vestibular##4##1##(1991-2#1)(1996-5#1)(1997-2#1)(2008-9#1)
Vesuvius##2##1##(2008-8#2)
Veterans Administration##5##2##(1991-12#1)(2006-10#1)(2009-11#1)(2012-1#1)(2012-12#1)
Veterans Affairs Medical Center##4##4##(1990-11#1)(1992-2#1)(1995-2#1)(2007-10#1)
Veterans Affairs##13##2##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(2007-10#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
Veterans Health Administration##3##3##(2008-7#3)
Veterans and##2##2##(2013-1#2)
Veterans who##2##2##(2013-1#2)
Veterans##33##1##(1990-11#1)(1991-12#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-6#1)(2008-7#3)(2009-11#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)
Veterinary College##6##2##(1997-8#1)(2013-8#5)
Veterinary Medicine##4##2##(1997-8#1)(2010-1#1)(2013-8#2)
Veterinary Sciences##2##2##(1996-12#1)(2011-2#1)
Veterinary Services##2##2##(2011-2#2)
Veterinary manpower and 24-hour service##3##5##(1995-9#3)
Veterinary medical ethics##2##3##(2012-3#1)(2013-8#1)
Veterinary##40##1##(1991-8#1)(1992-2#1)(1995-3#1)(1995-9#4)(1996-12#2)(1997-6#1)(1997-7#1)(1997-8#7)(2008-11#1)(2010-1#2)(2010-4#2)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#10)
Vf resistance##2##2##(2008-10#2)
Vf##20##1##(2008-10#18)(2008-5#2)
Vfe##3##1##(2008-5#3)
Vg and##2##2##(2008-10#2)
Vg##17##1##(2008-10#17)
Via a##2##2##(1993-11#1)(2012-3#1)
Via##7##1##(1993-11#1)(1994-9#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
Viability in##2##2##(2008-10#1)(2008-11#1)
Viability of the adherent cells was determined by alamarBlue(R) assay after 2##2##12##(2008-11#2)
Viability of the##6##3##(1996-12#1)(2008-10#2)(2008-11#2)(2013-7#1)
Viability of##11##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2013-7#1)
Viability##18##1##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-7#1)
Viable##11##1##(2008-10#7)(2008-11#2)(2008-9#1)(2012-12#1)
Viagra##2##1##(2008-1#1)(2008-6#1)
Viana do Castelo##2##3##(2009-7#2)
Vibration##6##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)
Vibrational Spectra##2##2##(1996-2#2)
Vibrational spectra##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
Vibrational##15##1##(1992-11#1)(1996-2#3)(2007-1#1)(2008-10#4)(2008-3#3)(2008-8#1)(2009-6#1)(2013-1#1)
Vibrio anguillarum##2##2##(2011-2#2)
Vibrio cholerae##21##2##(1990-5#2)(1991-3#1)(1992-5#1)(1993-9#2)(1994-11#1)(2007-10#2)(2007-7#2)(2008-10#1)(2008-8#2)(2008-9#3)(2009-8#2)(2012-3#2)
Vibrio fischeri##11##2##(1994-11#1)(2008-10#8)(2012-3#1)(2013-8#1)
Vibrio harveyi##4##2##(1990-7#1)(1991-9#1)(2008-9#1)(2009-6#1)
Vibrio splendidus and a V##2##5##(2009-6#2)
Vibrio spp##2##2##(2007-7#2)
Vibrio##48##1##(1990-5#2)(1990-7#1)(1991-3#1)(1991-9#1)(1992-5#1)(1993-9#2)(1994-11#2)(1997-8#2)(2007-10#3)(2007-7#4)(2008-10#11)(2008-8#2)(2008-9#4)(2009-6#3)(2009-8#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
Vibrionaceae from cases of acute diarrhoea##2##6##(2007-7#2)
Vibrionaceae##3##1##(2007-7#3)
Vicarious##3##1##(2007-3#1)(2008-3#2)
Vice##4##1##(1994-1#1)(1995-2#1)(2008-8#1)(2009-5#1)
Vicente##3##1##(1993-3#1)(2012-12#2)
Vichada##3##1##(2012-12#3)
Vicia faba L##2##3##(2008-12#1)(2012-2#1)
Vicia faba##15##2##(2008-10#4)(2008-12#4)(2008-8#6)(2012-2#1)
Vicia##17##1##(1990-7#1)(2008-10#5)(2008-12#4)(2008-8#6)(2012-2#1)
Vickers hardness##6##2##(2008-12#3)(2011-2#2)(2013-1#1)
Vickers##11##1##(1995-3#1)(2008-12#4)(2009-7#1)(2011-2#2)(2013-1#3)
Victimization##4##1##(2010-1#1)(2012-12#2)(2013-1#1)
Victims##6##1##(1993-12#1)(1996-11#1)(2008-2#1)(2009-6#1)(2012-12#1)(2013-1#1)
Victor##2##1##(1993-2#1)(2008-10#1)
Victoria Harbor##3##2##(2010-5#3)
Victoria Hospital Corporation##2##3##(1991-1#1)(1994-3#1)
Victoria Hospital##6##2##(1991-1#1)(1994-1#1)(1994-3#1)(1996-2#2)(1996-3#1)
Victoria and##2##2##(2008-10#2)
Victoria blue derivatives##2##3##(2008-11#2)
Victoria blue##5##2##(2008-10#2)(2008-11#3)
Victoria##31##1##(1991-1#1)(1992-2#2)(1994-1#2)(1994-3#1)(1996-2#3)(1996-3#1)(1996-6#1)(2008-10#4)(2008-11#7)(2008-5#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
Victorian##4##1##(1995-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
Vident)##2##1##(2009-8#2)
Video##9##1##(1990-7#1)(1994-3#1)(2007-12#1)(2008-1#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
Video-assisted hemithyroidectomy was##2##3##(2012-12#2)
Video-assisted##6##1##(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#3)
Video-rate##2##1##(2008-2#1)(2008-3#1)
Vienna##11##1##(1990-10#2)(1995-11#1)(1996-3#1)(2007-4#1)(2008-4#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Vietnam##14##1##(1993-2#1)(1994-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#3)(2011-2#2)
Vietnamese women was##2##3##(2010-3#2)
Vietnamese women##6##2##(2010-3#6)
Vietnamese##7##1##(1995-12#1)(2010-3#6)
View##9##1##(2007-5#1)(2007-8#1)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)
Viewed##2##1##(1993-12#1)(1994-5#1)
Viewer##3##1##(2008-4#1)(2008-5#2)
Viewing##6##1##(2008-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2010-7#1)
Viewpoint##2##1##(2008-7#1)(2013-8#1)
Views of##2##2##(2008-12#1)(2013-1#1)
Views##6##1##(1991-8#1)(1994-1#1)(2007-12#1)(2008-12#1)(2013-1#1)(2013-8#1)
Vigilance##2##1##(1993-8#1)(2008-6#1)
Vigna radiata##5##2##(1995-2#1)(2008-12#4)
Vignette##2##1##(1994-9#1)(2012-3#1)
Vignettes##4##1##(1992-2#1)(1995-3#1)(1995-6#1)(1996-12#1)
Vigorous##2##1##(2008-7#1)(2011-2#1)
Village##8##1##(1994-1#1)(2008-4#1)(2008-6#2)(2012-3#4)
Vim DBS##5##2##(2012-3#5)
Vim##6##1##(2012-3#6)
Vimentin and S-100##2##3##(2008-4#1)(2012-2#1)
Vinblastine##2##1##(1990-2#1)(2013-1#1)
Vinca site agents##2##3##(1995-5#2)
Vinca##6##1##(1995-5#2)(1997-4#1)(2008-10#3)
Vincent van Gogh's##2##3##(1992-2#1)(1996-3#1)
Vincent van##4##2##(1992-2#1)(1996-3#3)
Vincent##6##1##(1992-2#1)(1996-3#3)(1997-5#1)(2007-2#1)
Vincent's Hospital##2##2##(1993-2#1)(2008-7#1)
Vinci surgical##2##2##(2007-8#1)(2008-10#1)
Vinci##3##1##(1991-3#1)(2007-8#1)(2008-10#1)
Vinclozolin##2##1##(2008-10#2)
Vines inoculated##2##2##(2008-10#2)
Vines##4##1##(2008-10#3)(2013-1#1)
Vineyards##2##1##(2008-10#2)
Vinorelbine##3##1##(1994-8#3)
Vinyl##2##1##(1996-5#1)(2009-5#1)
Violence Prevention##2##2##(2008-8#1)(2012-12#1)
Violence and##2##2##(1995-3#1)(2008-11#1)
Violence in the##2##3##(1991-12#1)(1996-2#1)
Violence in##3##2##(1991-12#1)(1995-2#1)(1996-2#1)
Violence##17##1##(1991-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#2)
Vip3Aa tolerance##2##2##(2011-2#2)
Vip3Aa##4##1##(2011-2#4)
Viper##2##1##(2008-5#1)(2013-1#1)
Vipera ammodytes##2##2##(1995-8#2)
Viperidae)##2##1##(2008-5#1)(2013-1#1)
VirE1##2##1##(2008-10#2)
VirE2 from##2##2##(2008-10#2)
VirE2##4##1##(2008-10#4)
ViraType##3##1##(1994-1#3)
Viral Accumulation##2##2##(2008-10#2)
Viral DNA##2##2##(2008-10#2)
Viral detection##2##2##(2008-5#1)(2010-5#1)
Viral hepatitis in##2##3##(2007-12#1)(2008-1#1)
Viral hepatitis##5##2##(2006-10#2)(2007-12#1)(2008-1#2)
Viral load##2##2##(2008-5#1)(2011-2#1)
Viral transformation of T cells is an effective method for obtaining large numbers of T cells that are easily maintained in the laboratory##2##23##(2008-4#2)
Viral transformation of##3##3##(1997-7#1)(2008-4#2)
Viral##54##1##(1991-2#1)(1994-1#1)(1994-12#1)(1997-3#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#17)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#3)
Virgil##3##1##(2008-8#3)
Virgin Islands##2##2##(2007-5#2)
Virgin##5##1##(1991-3#1)(2007-5#2)(2008-10#1)(2013-1#1)
Virginia##25##1##(1990-8#1)(1991-1#1)(1992-3#1)(1995-1#4)(1995-12#1)(1995-6#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-7#2)(2011-1#1)(2011-2#2)
Virginia's##3##1##(1997-2#1)(1997-6#2)
Virions were##2##2##(2008-10#2)
Virions##4##1##(2008-10#4)
Viroid interactions##2##2##(2008-10#2)
Virol##2##1##(1997-4#1)(2011-2#1)
Virological##2##1##(2009-5#1)(2013-1#1)
Virosomes##2##1##(1990-2#2)
Virtual lesion extension##2##3##(2008-10#2)
Virtual source for##2##3##(2007-11#2)
Virtual##19##1##(2007-11#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#2)(2010-8#1)(2011-2#2)(2011-7#1)
Virtually all##6##2##(1994-11#1)(1995-12#2)(2008-5#1)(2009-5#1)(2010-4#1)
Virtually every biochemical process within eukaryotic cells is controlled by the covalent modification of key regulatory proteins##2##17##(2008-2#1)(2008-4#1)
Virtually every##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
Virtually##11##1##(1994-11#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)
Virulence Diversity##3##2##(2008-10#3)
Virulence and Molecular Diversity in##2##5##(2008-10#2)
Virulence and Molecular##3##3##(2008-10#3)
Virulence and##7##2##(2008-10#7)
Virulence assays##2##2##(2008-10#2)
Virulence in the##2##3##(2008-10#2)
Virulence in##8##2##(2008-10#7)(2011-2#1)
Virulence of##7##2##(1997-3#1)(2008-10#6)
Virulence on##3##2##(2008-10#3)
Virulence to##2##2##(2008-10#2)
Virulence##47##1##(1997-3#1)(2008-10#44)(2011-1#1)(2011-2#1)
Virulences##2##1##(2008-10#2)
Virulent Strain of##2##3##(2008-10#2)
Virulent Strain##3##2##(2008-10#3)
Virulent##6##1##(2008-10#6)
Viruliferous##3##1##(2008-10#3)
Virus Accumulation##2##2##(2008-10#2)
Virus Infection##4##2##(2011-2#2)(2013-8#2)
Virus accumulation##2##2##(2008-10#2)
Virus from##2##2##(1994-12#1)(2008-10#1)
Virus infection##2##2##(2008-10#1)(2008-9#1)
Virus production##2##2##(2008-11#2)
Virus titres##3##2##(1997-6#2)(2008-11#1)
Virus##89##1##(1990-2#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-12#1)(1997-6#4)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#36)(2008-11#12)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#6)
Virus-Infected##3##1##(2008-10#3)
Virus-induced gene silencing##2##3##(2008-9#1)(2010-2#1)
Virus-like particles##2##2##(1997-8#1)(2008-10#1)
Virus-transfected strains##3##2##(2008-10#3)
Viruses in the##3##3##(2008-10#3)
Viruses##24##1##(1996-5#2)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#9)(2012-3#1)
Vis-NIR##6##1##(2010-4#6)
VisANT##4##1##(2008-4#4)
Visceral Leishmaniasis##2##2##(2008-12#1)(2012-2#1)
Visceral##9##1##(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#3)(2013-1#2)
Viscoelastic##2##1##(2009-3#1)(2009-7#1)
Viscometric##2##1##(1992-11#1)(2010-5#1)
Viscosity##2##1##(1995-2#1)(2008-10#1)
Viscum album&quot##4##2##(1993-2#4)
Viscum##5##1##(1992-9#1)(1993-2#4)
Visibility##2##1##(2008-3#1)(2009-5#1)
Visible and near-ultraviolet absorption spectrum of liquid water##2##8##(2008-2#1)(2008-3#1)
Visible and##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
Visible##19##1##(1991-2#1)(1992-1#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#5)
Vision##7##1##(1994-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2011-1#2)(2012-2#1)
Visit##2##1##(1990-2#1)(1995-1#1)
Visiting Nurse##2##2##(1997-2#1)(2008-1#1)
Visiting##13##1##(1997-2#1)(2008-1#1)(2008-11#11)
Visitors##2##1##(1992-2#1)(2008-1#1)
Vista Hill##2##2##(1993-2#2)
Vista##4##1##(1991-12#2)(1993-2#2)
Vistula##4##1##(2008-11#4)
Visual Analog##4##2##(2008-12#1)(2008-6#1)(2012-3#2)
Visual Analogue Scale (VAS)##2##4##(2007-8#1)(2013-1#1)
Visual Analogue Scale##4##3##(1991-2#1)(2007-8#1)(2012-1#1)(2013-1#1)
Visual Basic##3##2##(2008-10#3)
Visual Commentary##5##2##(2008-8#5)
Visual acuity and##2##3##(2008-7#2)
Visual acuity was##2##3##(1991-2#1)(2009-3#1)
Visual acuity##5##2##(1991-2#1)(2008-7#2)(2009-3#1)(2011-1#1)
Visual communication with retinex coding##2##5##(2008-3#2)
Visual inspection of##2##3##(2008-11#1)(2010-7#1)
Visual inspection##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
Visual stress is##2##3##(2013-1#2)
Visual stress##3##2##(2013-1#3)
Visual test scales for##2##4##(2008-10#2)
Visual##57##1##(1990-8#1)(1991-2#2)(1991-5#1)(1993-7#1)(1995-11#1)(1996-12#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-3#4)(2013-1#5)(2013-8#1)
Visualization of the##2##3##(2008-10#1)(2008-8#1)
Visualization of these##2##3##(2008-10#1)(2012-2#1)
Visualization of##15##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#4)
Visualization##19##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#4)(2013-1#2)(2013-8#1)
Visualizing the##3##2##(2007-12#1)(2010-2#1)(2011-2#1)
Visualizing##4##1##(2007-12#1)(2008-9#1)(2010-2#1)(2011-2#1)
Vit##4##1##(2008-11#1)(2013-1#3)
VitC##6##1##(1997-4#1)(2008-5#5)
VitE##6##1##(2011-1#6)
Vita##3##1##(2009-8#3)
Vital Capacity##2##2##(2011-2#2)
Vital capacity##2##2##(2012-3#2)
Vital##9##1##(1990-2#1)(1997-7#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
Vitality##2##1##(2008-10#1)(2013-1#1)
Vitamin A is##2##3##(2008-5#1)(2012-1#1)
Vitamin A supplementation##2##3##(1991-8#1)(2007-11#1)
Vitamin A##8##2##(1991-8#1)(1992-6#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)
Vitamin B(12) from milk##2##4##(2008-10#2)
Vitamin B(12)##4##2##(2008-10#3)(2008-11#1)
Vitamin B12##2##2##(1993-12#1)(2010-1#1)
Vitamin B6 metabolism influences the##2##5##(2013-1#2)
Vitamin B6##3##2##(1992-9#1)(2013-1#2)
Vitamin C determination##2##3##(2008-10#2)
Vitamin C is##2##3##(1992-9#1)(2011-1#1)
Vitamin C levels in the##2##5##(2011-1#2)
Vitamin C status##2##3##(1992-9#1)(2008-7#1)
Vitamin C was##2##3##(2008-10#1)(2011-1#1)
Vitamin C##24##2##(1992-9#2)(1996-12#1)(2008-10#9)(2008-5#4)(2008-7#1)(2010-7#1)(2011-1#5)(2012-2#1)
Vitamin D Levels##2##3##(2012-12#1)(2012-3#1)
Vitamin D deficiency has been##2##5##(2013-1#2)
Vitamin D deficiency has##3##4##(2012-2#1)(2013-1#2)
Vitamin D deficiency is associated with##2##6##(2011-2#1)(2012-3#1)
Vitamin D deficiency##9##3##(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#2)
Vitamin D in##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
Vitamin D is##2##3##(2012-2#1)(2013-1#1)
Vitamin D receptor##4##3##(1995-9#1)(2008-1#3)
Vitamin D##33##2##(1994-3#1)(1995-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-7#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#5)
Vitamin D(2)##2##2##(2008-10#2)
Vitamin D(3) and 25-OH-D(3)##3##4##(2008-10#3)
Vitamin D(3) and##5##3##(2008-10#5)
Vitamin E (alpha-tocopherol)##2##3##(1995-12#1)(1996-3#1)
Vitamin E and##2##3##(1992-9#2)
Vitamin E##18##2##(1991-12#1)(1992-9#5)(1993-6#1)(1994-5#1)(1995-12#1)(1996-3#1)(2008-10#3)(2008-5#1)(2011-1#2)(2013-1#2)
Vitamin K-dependent##2##2##(1990-5#1)(1992-12#1)
Vitamin K3##2##2##(1991-12#2)
Vitamin a##2##2##(2008-10#1)(2012-1#1)
Vitamin and##2##2##(1990-3#1)(2010-5#1)
Vitamin d##4##2##(2011-1#1)(2012-2#2)(2013-1#1)
Vitamin##126##1##(1990-3#1)(1990-5#1)(1991-12#3)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#8)(1993-12#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(2007-11#1)(2007-7#1)(2008-1#6)(2008-10#27)(2008-11#2)(2008-3#1)(2008-5#7)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#12)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#10)(2013-7#3)
Vitamins##4##1##(1992-9#1)(2008-10#1)(2008-5#2)
Viterbi decoders##2##2##(2008-3#2)
Viterbi##3##1##(2008-3#3)
Vitiligo##4##1##(2007-8#2)(2010-6#1)(2013-1#1)
Vitis vinifera L##3##3##(2008-5#1)(2009-8#2)
Vitis vinifera cultivars##2##3##(2008-10#2)
Vitis vinifera##13##2##(2008-10#9)(2008-5#2)(2009-8#2)
Vitis##17##1##(2008-10#13)(2008-5#2)(2009-8#2)
Vitreoscilla filiformis##2##2##(2008-5#2)
Vitreoscilla##6##1##(1990-11#2)(2008-5#2)(2008-9#2)
Vitronectin##3##1##(2008-11#2)(2009-12#1)
Vkorc1 gene##3##2##(2009-11#3)
Vkorc1 mutant##2##2##(2009-11#2)
Vkorc1##6##1##(2009-11#6)
Vkorc1(+/+)##2##1##(2009-11#2)
Vkorc1(Y-&gt##6##1##(2009-11#6)
Vl##2##1##(2008-10#1)(2008-8#1)
Vm and Km##2##3##(1991-9#2)
Vmax =##3##2##(1991-5#1)(1992-3#1)(1996-12#1)
Vmax and K(m) values##2##4##(1996-7#1)(2009-2#1)
Vmax and Km##2##3##(1991-12#1)(1995-2#1)
Vmax and##5##2##(1990-5#1)(1991-12#1)(1995-2#1)(1996-7#1)(2009-2#1)
Vmax by##2##2##(1994-8#2)
Vmax for the formation of##2##5##(2011-2#2)
Vmax for##4##2##(1997-6#2)(2011-2#2)
Vmax in##2##2##(1990-3#1)(1994-6#1)
Vmax levels were##2##3##(1995-8#2)
Vmax levels##6##2##(1995-8#6)
Vmax of 0##3##3##(1992-3#1)(1994-6#1)(1995-2#1)
Vmax of##14##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-3#3)(1993-6#1)(1993-8#1)(1994-5#2)(1994-6#2)(1995-2#2)
Vmax values for##2##3##(1990-10#1)(1994-6#1)
Vmax values were##2##3##(1990-2#1)(1996-7#1)
Vmax values##12##2##(1990-10#1)(1990-2#1)(1994-5#1)(1994-6#1)(1995-8#2)(1996-7#6)
Vmax was##2##2##(1991-5#1)(1993-6#1)
Vmax##64##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-5#4)(1992-3#4)(1992-6#2)(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-5#3)(1994-6#4)(1994-8#3)(1995-11#1)(1995-2#5)(1995-5#1)(1995-8#8)(1996-12#1)(1996-7#7)(1997-6#2)(2009-2#1)(2011-2#2)
Vocabulary##3##1##(1995-11#1)(2008-7#1)(2008-9#1)
Vocal cord##2##2##(2008-11#1)(2009-7#1)
Vocal##5##1##(2008-11#2)(2008-9#1)(2009-7#1)(2009-9#1)
Vocational##2##1##(1991-8#1)(1992-3#1)
Vogelsang##3##1##(1995-12#3)
Voice of##2##2##(2008-12#1)(2010-4#1)
Voice##5##1##(1997-3#1)(2008-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
Voices from the##2##3##(2008-1#1)(2010-11#1)
Voices##3##1##(2008-1#1)(2009-7#1)(2010-11#1)
Voigt##3##1##(2008-2#2)(2008-3#1)
Vol##5##1##(1990-11#1)(1990-3#1)(2008-11#2)(2008-5#1)
Volar##2##1##(2008-9#2)
Volatile components##2##2##(2008-10#1)(2013-8#1)
Volatile compounds##2##2##(1995-6#1)(2008-10#1)
Volatile##15##1##(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-8#1)
Volatiles##3##1##(2008-10#3)
Volatilization##3##1##(2008-10#3)
Voltage##5##1##(1990-8#1)(1995-11#2)(1997-4#1)(2011-1#1)
Voltage-activated and spontaneous##2##3##(1995-11#2)
Voltage-activated##3##1##(1995-11#2)(1996-5#1)
Voltage-dependent##3##1##(1993-3#1)(1995-12#1)(2009-12#1)
Voltage-gated##4##1##(1993-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
Voltammetric and##2##2##(2008-10#2)
Voltammetric behavior of##4##3##(2008-10#4)
Voltammetric behavior##5##2##(2008-10#5)
Voltammetric behaviour##2##2##(2008-10#2)
Voltammetric determination of 4-nitrophenol at a##2##6##(2008-10#2)
Voltammetric determination of##19##3##(2008-10#19)
Voltammetric peak##2##2##(2008-10#2)
Voltammetric##44##1##(2008-10#44)
Voltammetry of##4##2##(2008-10#4)
Voltammetry##6##1##(2008-10#6)
Volterra series##2##2##(2008-2#2)
Volume 1##2##2##(2008-4#2)
Volume 5##2##2##(2012-3#2)
Volume 63 is##7##3##(2012-1#7)
Volume 8##2##2##(2008-5#2)
Volume effects##3##2##(2009-7#3)
Volume holographic##2##2##(2007-11#2)
Volume overlap##2##2##(2009-2#2)
Volume##66##1##(1991-2#1)(1992-2#1)(1993-12#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-2#2)(2009-7#3)(2010-11#1)(2011-1#15)(2011-2#10)(2012-1#10)(2012-2#1)(2012-3#2)
Volumes##2##1##(2008-6#1)(2012-12#1)
Volumetric analysis##2##2##(1995-8#1)(2008-10#1)
Volumetric##8##1##(1995-8#1)(1996-7#2)(2008-10#1)(2008-6#2)(2011-2#1)(2011-7#1)
Voluntary##9##1##(1993-1#2)(1994-2#2)(1995-2#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-1#1)
Volunteer Administration##5##2##(1992-1#1)(1994-3#2)(1995-12#1)(1996-12#1)
Volunteer##25##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#3)(1992-3#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-3#3)(1995-12#3)(1995-3#1)(1996-12#2)(1996-2#2)(2013-1#1)
Volunteerism##3##1##(1991-2#1)(1992-3#1)(1997-2#1)
Volunteers and##2##2##(1992-12#1)(1993-12#1)
Volunteers are##2##2##(1993-2#1)(1994-12#1)
Volunteers in##2##2##(1994-8#1)(1995-12#1)
Volunteers were##2##2##(1992-3#1)(2013-1#1)
Volunteers##20##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#2)(1996-12#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
Volvulus##2##1##(1991-6#1)(2013-1#1)
Von Recklinghausen's disease##3##3##(1994-6#1)(2007-8#2)
Von Recklinghausen's##4##2##(1994-6#1)(2007-8#2)(2008-10#1)
Von##6##1##(1994-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2013-1#1)
Voriconazole##6##1##(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#3)
Vortex##4##1##(1996-9#1)(2007-12#3)
Voting##2##1##(1996-5#1)(2010-8#1)
Voyager##2##1##(1991-8#2)
Vpr and Vpx in##2##4##(1997-3#2)
Vpr and Vpx##6##3##(1997-3#6)
Vpr##13##1##(1997-3#13)
Vpu##4##1##(2013-1#4)
Vpx of HIV-1##2##3##(1997-3#2)
Vpx##9##1##(1997-3#9)
Vrn-A1##2##1##(2012-3#2)
Vrn-B1 allele##2##2##(2012-3#2)
Vrn-B1 alleles##2##2##(2012-3#2)
Vrn-B1##6##1##(2012-3#6)
Vs##7##1##(2007-7#1)(2008-10#5)(2008-4#1)
Vtg##4##1##(2010-5#4)
Vulcan##3##1##(2008-3#3)
Vulcanisaeta distributa##2##2##(2011-2#2)
Vulcanisaeta##4##1##(2011-2#4)
Vulgaris##3##1##(2007-7#1)(2010-6#1)(2013-1#1)
Vulnerability to##2##2##(2010-1#1)(2012-3#1)
Vulnerability##3##1##(2008-8#1)(2010-1#1)(2012-3#1)
Vulnerable##2##1##(2009-4#1)(2013-8#1)
Vélez and Thatcher 1990##2##4##(2008-5#2)
W (-1)##2##2##(2007-11#2)
W (VI)##7##2##(2008-10#7)
W = 0##2##3##(2008-9#2)
W =##3##2##(2008-3#1)(2008-9#2)
W I##2##2##(2013-8#2)
W and a peak power of##2##6##(2007-11#1)(2007-12#1)
W and a pulse##2##4##(2007-12#1)(2008-3#1)
W and a##7##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)
W and pulse##2##3##(2007-11#1)(2008-3#1)
W and##16##2##(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#4)(2009-12#2)
W at 1##2##3##(2007-12#1)(2008-2#1)
W at a##4##3##(2007-11#2)(2007-12#1)(2008-10#1)
W at the##3##3##(2007-11#3)
W at##15##2##(2007-11#8)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
W chromosome##2##2##(2010-3#1)(2010-5#1)
W for##2##2##(2007-12#1)(2008-10#1)
W in a##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
W in##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-9#2)(2010-8#1)(2013-1#1)
W is demonstrated##2##3##(2007-11#1)(2008-10#1)
W is##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
W m(-2)##3##2##(2008-10#1)(2008-3#2)
W microwave power##2##3##(2008-10#2)
W of UV radiation##2##4##(2007-12#1)(2008-3#1)
W of UV##3##3##(2007-12#2)(2008-3#1)
W of average output power##4##5##(2007-11#2)(2007-12#2)
W of average power##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
W of average##10##3##(2007-11#5)(2007-12#3)(2008-2#2)
W of cw##2##3##(2007-12#2)
W of incident##3##3##(2007-11#2)(2008-3#1)
W of output power with##2##5##(2007-11#1)(2011-1#1)
W of output power##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
W of power##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
W of signal power##2##4##(2007-11#2)
W of single-frequency##2##3##(2007-12#2)
W of single-mode##2##3##(2008-2#2)
W of total##2##3##(2007-11#1)(2008-3#1)
W of##52##2##(2007-11#20)(2007-12#15)(2008-2#7)(2008-3#8)(2011-1#1)(2011-2#1)
W strains##2##2##(2008-10#2)
W was demonstrated##2##3##(2007-12#1)(2008-3#1)
W was##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
W were##2##2##(2007-12#1)(2008-10#1)
W##298##1##(1990-11#1)(1990-6#4)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-6#8)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1993-8#4)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-6#3)(2007-11#46)(2007-12#43)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#52)(2008-11#4)(2008-12#3)(2008-2#22)(2008-3#36)(2008-5#4)(2008-9#4)(2009-12#2)(2009-8#1)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2013-1#2)(2013-8#4)
W(18)O(49) rods##2##2##(2009-11#2)
W(VI)##10##1##(2008-10#10)
W) in##2##2##(2008-10#1)(2008-5#1)
W)##18##1##(1993-1#1)(1996-2#2)(2007-11#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#4)(2011-2#1)
W-135##3##1##(2007-12#1)(2011-1#1)(2013-1#1)
W-7##4##1##(1994-9#1)(1996-2#2)(2008-8#1)
W-7976/Trenton##2##1##(2008-10#2)
W-7984##2##1##(2008-10#2)
W-7984/Opata 85##2##2##(2008-10#2)
W-CI##4##1##(2008-10#4)
W-Ir##3##1##(2008-10#3)
W-Rh permanent modifier was##2##4##(2008-10#2)
W-Rh permanent modifier##4##3##(2008-10#4)
W-Rh##7##1##(2008-10#7)
W-Ru##2##1##(2008-10#2)
W-coat##2##1##(2008-3#2)
W/ radicalHz##2##2##(2007-11#1)(2008-3#1)
W/##3##1##(2007-11#1)(2008-3#2)
W/O##2##1##(2008-5#2)
W/O-emulsions##2##1##(2008-5#2)
W/O/W emulsion##2##2##(2008-5#2)
W/O/W emulsions with low concentrations##2##5##(2008-5#2)
W/O/W multiple emulsion##4##3##(2008-5#4)
W/O/W multiple emulsions##2##3##(2008-5#2)
W/O/W multiple##6##2##(2008-5#6)
W/O/W##10##1##(2008-5#10)
W/Si##2##1##(2008-3#2)
W/W is achieved##2##3##(2007-11#2)
W/W with a peak optical-optical conversion efficiency of 0##2##9##(2007-11#2)
W/W##4##1##(2007-11#4)
W/cm (2)##2##2##(2007-11#1)(2007-12#1)
W/cm##3##1##(1992-1#1)(2007-11#1)(2007-12#1)
W/cm(2) at##2##2##(2008-3#2)
W/cm(2)##9##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)(2008-8#1)
W/m(2))##2##1##(2008-10#2)
W0##3##1##(2011-1#3)
W1##2##1##(2008-7#1)(2011-3#1)
W120F##2##1##(1995-2#2)
W135 in##2##2##(2007-2#1)(2010-10#1)
W135##9##1##(2007-12#1)(2007-2#4)(2008-12#1)(2010-10#3)
W19##2##1##(2008-8#2)
W2##2##1##(2008-7#1)(2011-3#1)
W2-6##2##1##(2008-10#2)
W22##3##1##(2012-3#3)
W260##5##1##(2008-10#5)
W276C##2##1##(1994-12#2)
W3##2##1##(2008-7#1)(2011-3#1)
W3110##4##1##(1994-11#2)(2008-7#2)
W3110[pGEc47]##2##1##(1994-12#2)
W370##5##1##(2008-10#5)
W370dsRNA##3##1##(2008-10#3)
W370dsRNA-containing strains##2##2##(2008-10#2)
W4##2##1##(2011-3#2)
W54S mutant##2##2##(1997-2#2)
W54S tetramer##2##2##(1997-2#2)
W54S##5##1##(1997-2#5)
W60d##2##1##(1997-2#2)
W7##6##1##(1994-11#1)(1994-3#5)
WA##10##1##(2008-10#7)(2008-5#3)
WAC##2##1##(2008-10#2)
WAF##4##1##(2008-11#4)
WAG/Rij##3##1##(1990-2#3)
WAPH-1##2##1##(2008-10#2)
WB and PS##3##3##(1993-11#3)
WB and##5##2##(1993-11#3)(2008-10#2)
WB disease on pods and##2##5##(2008-10#2)
WB on pods##2##3##(2008-10#2)
WB on##4##2##(1993-11#1)(2008-10#3)
WB##21##1##(1993-11#7)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#1)(2010-1#1)
WB4101##4##1##(1995-12#4)
WB4101-treated##3##1##(1995-12#3)
WBC count##6##2##(1991-2#1)(2008-10#2)(2011-2#1)(2013-1#2)
WBC##11##1##(1991-2#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
WBC)##2##1##(2008-7#1)(2013-8#1)
WBCs##2##1##(2009-11#2)
WBI##8##1##(2008-1#3)(2011-2#5)
WBV##2##1##(2013-8#2)
WC##7##1##(2011-1#2)(2011-2#3)(2012-2#2)
WCC##2##1##(2010-8#2)
WCR##3##1##(2007-12#3)
WCS##4##1##(1995-5#4)
WCS358 and RE8##2##3##(2008-10#2)
WCS358 on##2##2##(2008-10#2)
WCS358##13##1##(2008-10#13)
WCS374r##7##1##(2008-10#7)
WCS417r and##2##2##(2008-10#2)
WCS417r##5##1##(2008-10#5)
WCX resin##2##2##(2008-10#2)
WCX##4##1##(2008-10#4)
WD domains##3##2##(2008-7#1)(2008-8#2)
WD leading to##4##3##(2008-10#4)
WD was##2##2##(2008-10#1)(2010-12#1)
WD##18##1##(2007-3#1)(2008-10#13)(2008-7#1)(2008-8#2)(2010-12#1)
WDDM##2##1##(2008-3#2)
WDM filters##2##2##(2008-2#1)(2008-3#1)
WDM##9##1##(2007-11#1)(2008-2#6)(2008-3#2)
WDNC##4##1##(1991-6#4)
WDNM1##4##1##(1997-6#4)
WE##2##1##(2008-1#1)(2008-11#1)
WEC##3##1##(1993-12#3)
WEDI##2##1##(1994-12#2)
WEHI 231 cells##5##3##(1994-10#5)
WEHI 231##6##2##(1994-10#6)
WEHI##7##1##(1992-7#1)(1994-10#6)
WEHI-3B D+##2##2##(1992-3#1)(1994-11#1)
WEHI-3B cells##2##2##(1992-3#2)
WEHI-3B##5##1##(1992-3#4)(1994-11#1)
WEIGHBOR##2##1##(2008-4#2)
WEP##5##1##(2008-11#5)
WFT##4##1##(2008-10#4)
WG##6##1##(1992-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2013-7#1)
WGA was##2##2##(2008-7#2)
WGA##7##1##(2008-7#6)(2008-8#1)
WGA-fed larvae was##2##3##(2008-7#2)
WGA-fed larvae##4##2##(2008-7#4)
WGM##2##1##(2007-11#2)
WGMs##2##1##(2009-6#2)
WGP##4##1##(2008-5#4)
WHAT##2##1##(2010-5#2)
WHC##8##1##(1997-3#4)(2010-2#1)(2011-2#1)(2012-2#2)
WHHL##2##1##(1994-11#1)(1995-6#1)
WHITE##3##1##(2009-6#1)(2009-9#1)(2013-1#1)
WHO Global##2##2##(1997-8#1)(2013-7#1)
WHO and##6##2##(1996-11#1)(1996-3#1)(2008-3#1)(2010-5#2)(2012-2#1)
WHO classification##3##2##(2008-9#1)(2011-2#1)(2013-7#1)
WHO criteria##9##2##(2007-10#1)(2008-11#1)(2008-3#4)(2008-6#1)(2008-9#1)(2011-1#1)
WHO definition##2##2##(2007-10#1)(2011-2#1)
WHO for##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
WHO grade##2##2##(2008-5#1)(2008-7#1)
WHO is##2##2##(1993-3#1)(1994-9#1)
WHO##91##1##(1990-12#3)(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-2#4)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#3)(2010-6#2)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#2)
WHO)##3##1##(1997-3#2)(2008-10#1)
WHO-TEQ##4##1##(2008-10#4)
WHONET software##2##2##(2007-7#2)
WHONET##3##1##(2007-7#3)
WHOQOL-BREF##3##1##(2011-2#3)
WHR##8##1##(2007-12#7)(2011-1#1)
WI##3##1##(1992-6#1)(2010-11#1)(2010-3#1)
WI-38##3##1##(1995-8#3)
WI38##3##1##(1995-6#2)(2011-2#1)
WIC and AFDC##2##3##(1996-12#2)
WIC participation##4##2##(1993-3#4)
WIC##8##1##(1993-3#5)(1996-12#3)
WICE and the##2##3##(1994-7#2)
WICE and##4##2##(1994-7#4)
WICE##5##1##(1994-7#5)
WILD20##5##1##(1995-12#5)
WILMA##2##1##(2008-10#2)
WIN 35##2##2##(1991-12#2)
WIPK##6##1##(2009-8#6)
WITH##8##1##(2009-11#1)(2009-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
WITHDRAWN##22##1##(2007-7#9)(2008-10#1)(2008-11#9)(2008-4#1)(2008-7#1)(2012-3#1)
WJC##2##1##(2010-12#2)
WJGS##2##1##(2010-12#2)
WJR##2##1##(2010-12#2)
WK isolates##2##2##(2008-10#2)
WKY and SD##3##3##(1997-6#3)
WKY and##4##2##(1997-6#3)(2008-2#1)
WKY rats##5##2##(1993-12#4)(1996-5#1)
WKY##17##1##(1993-12#5)(1994-2#2)(1996-5#1)(1997-6#3)(2008-2#3)(2011-1#3)
WLANs##3##1##(2008-7#3)
WLW for##2##2##(1997-4#2)
WM capacity enhancement##2##3##(2012-2#2)
WM integrity in the medial temporal lobe##2##7##(2010-7#2)
WM integrity in the##3##4##(2010-7#3)
WM signals##2##2##(2008-3#2)
WM##15##1##(1994-8#1)(2008-3#7)(2010-7#4)(2012-2#3)
WMS##4##1##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
WMS-PCR and##2##2##(2008-5#2)
WMS-PCR##3##1##(2008-5#3)
WMSA and##2##2##(2009-10#2)
WMSA in the##2##3##(2009-10#2)
WMSA##7##1##(2009-10#7)
WMV##3##1##(2008-10#3)
WNIN/GR-Ob##2##1##(2012-3#2)
WNK kinase##2##2##(2012-12#2)
WNK##3##1##(2012-12#3)
WNK1##2##1##(2012-12#2)
WNK3 knockout mice##4##3##(2012-12#4)
WNK3 knockout##5##2##(2012-12#5)
WNK3##10##1##(2012-12#10)
WNK4##2##1##(2012-12#2)
WNN model##4##2##(2008-10#4)
WNPs were##2##2##(2009-11#2)
WNT pathway##2##2##(2013-1#2)
WNT signaling##3##2##(2007-12#3)
WNT##9##1##(1995-9#1)(2007-12#3)(2013-1#5)
WNV##7##1##(2007-12#4)(2009-10#2)(2010-8#1)
WO media for##2##3##(2008-3#2)
WO optical data-storage media##2##4##(2008-3#2)
WO##4##1##(2008-3#4)
WO&gt##2##1##(2007-12#2)
WO(3)##3##1##(2008-3#2)(2009-11#1)
WO(3)-based mixed with different metal oxides (SnO(2)##2##7##(2008-10#2)
WO(3)-based mixed with##4##3##(2008-10#4)
WO(3)-based##6##1##(2008-10#6)
WO(x) species##2##2##(2010-12#2)
WORDS)##201##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#13)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#10)(1993-9#4)(1994-1#1)(1994-12#4)(1994-2#11)(1994-3#4)(1994-5#19)(1994-8#4)(1994-9#1)(1995-2#14)(1995-3#4)(1995-5#16)(1995-6#2)(1996-1#1)(1996-2#4)
WOX##2##1##(2009-8#1)(2012-1#1)
WP##6##1##(2008-7#5)(2009-2#1)
WP2 strains##3##2##(2008-9#3)
WP2##4##1##(2008-9#4)
WPA##4##1##(2006-9#2)(2008-10#2)
WPC##4##1##(2013-1#4)
WR##7##1##(2008-6#6)(2008-7#1)
WR302##3##1##(1993-9#3)
WRAP##8##1##(2008-11#8)
WRN helicase##2##2##(2010-2#2)
WRN##10##1##(2009-12#1)(2010-2#9)
WRP-LC##4##1##(2008-10#4)
WRS 1906##2##2##(2008-10#2)
WRS##3##1##(2008-10#3)
WS presented##2##2##(2013-1#2)
WS##7##1##(1992-9#1)(1996-8#1)(2010-2#1)(2013-1#4)
WS-1##2##1##(2008-10#2)
WS3-10##4##1##(1992-9#4)
WSM1325 is##2##2##(2011-2#2)
WSM1325##3##1##(2011-2#3)
WSM2304##3##1##(2011-2#3)
WSMV HC-Pro##5##2##(2008-10#5)
WSMV and##3##2##(2008-10#3)
WSMV cDNA##2##2##(2008-10#2)
WSMV has##2##2##(2008-10#2)
WSMV shares##2##2##(2008-10#2)
WSMV##28##1##(2008-10#28)
WSMoV NP##2##2##(2008-10#2)
WSMoV##12##1##(2008-10#12)
WSS magnitudes##2##2##(2011-2#2)
WSS##9##1##(2011-2#7)(2013-1#2)
WSSMV##5##1##(2008-10#4)(2008-8#1)
WT Sham tissues##2##3##(2013-8#2)
WT and##3##2##(2008-9#1)(2012-3#1)(2013-8#1)
WT andfl ovules##2##3##(2008-8#2)
WT in##2##2##(2008-10#1)(2008-9#1)
WT is##2##2##(2008-2#2)
WT mice##6##2##(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
WT##37##1##(1995-5#2)(1995-6#3)(2008-10#4)(2008-2#4)(2008-8#3)(2008-9#5)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#6)
WT-DOCA##2##1##(2013-8#2)
WT1##8##1##(1991-10#4)(2008-4#1)(2011-2#3)
WTA##4##1##(1995-6#4)
WTGs##3##1##(2008-10#3)
WTH slices##3##2##(1996-5#3)
WTORS disuse and misuse##2##4##(2013-1#2)
WTORS##4##1##(2013-1#4)
WTP##3##1##(2008-10#3)
WTV##2##1##(2008-10#2)
WU-virus##2##1##(2009-3#2)
WUV##2##1##(2009-3#2)
WW domain##3##2##(2008-11#3)
WW domains##3##2##(2008-11#3)
WW##10##1##(2008-11#10)
WWP trees##2##2##(2008-10#2)
WWP##4##1##(2008-10#4)
WWTP effluent##2##2##(2008-10#1)(2013-1#1)
WWTP##7##1##(2008-10#6)(2013-1#1)
WWTPs##2##1##(2008-10#2)
WY##4##1##(2013-7#4)
WY-14643##2##1##(2013-7#2)
WYMV##2##1##(2008-8#2)
Waardenburg syndrome##7##2##(2008-7#1)(2008-9#6)
Waardenburg##8##1##(2008-7#2)(2008-9#6)
Wackenheim line##3##2##(2012-12#3)
Waco bodies##2##2##(1995-11#2)
Waco##3##1##(1995-11#3)
Wadden Sea##2##2##(2008-10#1)(2011-2#1)
Wadi Ara##2##2##(2008-6#2)
Waist##2##1##(2011-1#1)(2012-2#1)
Wait##2##1##(2009-3#1)(2011-2#1)
Waiting in##2##2##(1994-2#1)(2012-3#1)
Waiting##9##1##(1991-11#4)(1994-2#1)(1994-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
Waiànae##2##1##(2008-1#2)
Wake##3##1##(1992-1#1)(1993-9#1)(2008-11#1)
Wales##36##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1995-3#3)(1995-6#1)(1996-1#2)(1996-7#2)(1996-8#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#5)(2012-6#1)(2013-1#1)
Walker##5##1##(2007-2#1)(2008-11#1)(2010-11#2)(2013-8#1)
Walking in##2##2##(2007-12#1)(2013-1#1)
Walking##8##1##(1991-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
Wall and the##2##3##(1994-7#1)(2013-8#1)
Wall appositions##2##2##(2008-10#2)
Wall##10##1##(1994-7#1)(1994-9#1)(1995-1#1)(2008-10#5)(2012-1#1)(2013-8#1)
Wallenberg's syndrome##2##2##(1992-5#2)
Wallenberg's##3##1##(1992-5#3)
Wallerian degeneration##8##2##(1997-3#4)(2007-10#2)(2008-7#2)
Walp##2##1##(2008-12#2)
Walsh##5##1##(2008-11#3)(2008-3#2)
Walter and##2##2##(1995-12#1)(2008-10#1)
Walter##6##1##(1990-11#1)(1990-2#1)(1990-3#1)(1995-12#1)(2008-10#1)(2013-8#1)
Wand##2##1##(2010-12#1)(2011-2#1)
Wang et al##2##3##(2011-2#1)(2012-12#1)
Wang##4##1##(1995-5#1)(2008-2#1)(2011-2#1)(2012-12#1)
Wangiella dermatitidis##2##2##(2008-5#2)
Want to be taken for granted?##2##6##(1994-12#1)(1995-3#1)
Want to##4##2##(1994-12#1)(1994-3#1)(1995-3#1)(2009-3#1)
Wanted##2##1##(1994-6#1)(1995-2#1)
War##49##1##(1990-11#1)(1990-6#2)(1991-11#1)(1992-12#2)(1996-1#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#3)(2010-1#2)(2011-1#1)(2011-2#7)(2011-4#2)(2012-12#1)(2013-1#7)(2013-8#1)
Warburg##5##1##(2010-12#5)
Ward##11##1##(1992-12#2)(1996-5#1)(2007-11#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
Ward&quot##2##1##(2013-1#2)
Warfarin in##2##2##(2007-10#1)(2011-2#1)
Warfarin##5##1##(2007-10#1)(2010-8#1)(2011-2#2)(2012-12#1)
Warfarin-Aspirin##2##1##(2008-8#2)
Warm##3##1##(1996-9#1)(2008-10#1)(2008-7#1)
Warner Bratzler##2##2##(2013-1#2)
Warner##3##1##(1995-6#1)(2013-1#2)
Warner-Bratzler##2##1##(2010-4#1)(2013-1#1)
Warning##2##1##(2008-10#1)(2009-11#1)
Warren##3##1##(1992-7#1)(2008-3#1)(2009-4#1)
Wars##3##1##(1996-5#1)(2008-4#1)(2012-12#1)
Warsaw##20##1##(1991-1#1)(2007-11#5)(2007-8#5)(2008-10#1)(2008-9#3)(2009-5#2)(2011-2#1)(2013-1#2)
Was##2##1##(1994-9#1)(1997-2#1)
Washing with##2##2##(1990-11#1)(1994-8#1)
Washing##5##1##(1990-11#1)(1991-11#1)(1993-11#1)(1994-8#1)(2008-10#1)
Washington State##16##2##(1996-1#3)(1996-2#1)(1996-5#1)(1997-2#2)(2008-10#6)(2010-12#1)(2013-8#2)
Washington and##3##2##(1997-2#1)(2008-10#2)
Washington in the##2##3##(2008-10#2)
Washington in##3##2##(2008-10#3)
Washington is##2##2##(1995-3#1)(1997-6#1)
Washington state##3##2##(2008-10#3)
Washington##69##1##(1990-2#1)(1990-4#1)(1992-1#1)(1992-12#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#4)(1996-2#2)(1996-5#1)(1997-2#4)(1997-6#1)(2007-12#1)(2008-10#30)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
Washington)##2##1##(1996-2#1)(2008-10#1)
Waste Management##2##2##(2008-10#2)
Waste##11##1##(1991-11#1)(1995-12#1)(2008-10#5)(2008-12#1)(2010-5#1)(2013-1#2)
Wastewater##3##1##(2008-10#2)(2008-12#1)
Watch##2##1##(2009-6#1)(2012-3#1)
Water Framework Directive##4##3##(2008-10#4)
Water and##3##2##(2008-10#2)(2008-12#1)
Water at the ice point##2##5##(2008-3#2)
Water consumption by exposed females was##2##6##(2008-9#2)
Water consumption by exposed mice was generally similar to that by control groups##2##13##(2008-9#2)
Water consumption by exposed##5##4##(2008-9#5)
Water consumption by##7##3##(2008-9#7)
Water consumption##8##2##(2008-10#1)(2008-9#7)
Water in the##2##3##(2008-10#1)(2008-2#1)
Water in##4##2##(1996-9#1)(2008-10#2)(2008-2#1)
Water is##3##2##(2008-7#1)(2011-2#1)(2012-5#1)
Water quality##3##2##(1994-3#1)(2007-5#2)
Water stress##2##2##(2008-12#2)
Water vapor##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
Water##86##1##(1993-1#1)(1994-3#1)(1995-5#1)(1995-9#1)(1996-9#2)(1997-8#1)(2007-12#1)(2007-5#2)(2008-10#35)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#1)(2011-2#4)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
Water)##2##1##(2008-10#2)
Water-Vapor##3##1##(2008-3#3)
Water-insoluble##2##1##(2008-10#2)
Water-soluble##9##1##(2008-10#5)(2008-11#2)(2008-7#1)(2009-1#1)
Water-vapor##3##1##(2007-12#1)(2008-3#2)
Watermelon chlorotic stunt virus##2##4##(2008-10#2)
Watermelon mosaic virus##3##3##(2008-10#3)
Watermelon silver mottle virus (WSMoV)##4##5##(2008-10#4)
Watermelon silver mottle virus Serogroup##2##5##(2008-10#2)
Watermelon silver mottle virus##8##4##(2008-10#8)
Watermelon##18##1##(2008-10#18)
Waters Oasis##2##2##(2008-10#1)(2011-1#1)
Waters Porapak(R) Sep-Park C(18) disk##2##5##(2008-10#2)
Waters##12##1##(2008-10#7)(2008-5#1)(2011-1#3)(2012-2#1)
Watson##2##1##(1990-5#1)(2008-12#1)
Watson-Crick base##3##2##(1994-5#1)(1995-6#1)(2008-4#1)
Watson-Crick##8##1##(1993-11#4)(1994-5#1)(1995-6#1)(2008-4#1)(2008-7#1)
Wave 1##4##2##(2013-8#4)
Wave amplitudes##2##2##(1990-11#2)
Wave##23##1##(1990-11#2)(1991-12#1)(1996-12#2)(1996-9#1)(2007-11#1)(2008-11#4)(2008-2#2)(2008-3#3)(2011-2#1)(2012-2#1)(2013-8#5)
Wave-front control##2##2##(2007-12#1)(2008-3#1)
Wave-front##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
Waveform##2##1##(2008-3#1)(2010-1#1)
Waveguide Laser##2##2##(2008-2#1)(2008-3#1)
Waveguide grating##2##2##(2007-11#1)(2007-12#1)
Waveguide##14##1##(2007-11#3)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#6)
Waveguides in##2##2##(2008-3#1)(2010-8#1)
Waveguides##7##1##(2007-12#3)(2008-2#2)(2008-3#1)(2010-8#1)
Wavelength Dependence of##2##3##(2008-2#1)(2008-3#1)
Wavelength conversion##2##2##(2007-11#1)(2007-12#1)
Wavelength modulation##2##2##(2008-10#1)(2008-3#1)
Wavelength selection##2##2##(1991-2#1)(2008-10#1)
Wavelength tunability##2##2##(2007-12#1)(2008-2#1)
Wavelength tuning##2##2##(2008-2#1)(2008-3#1)
Wavelength##24##1##(1991-2#1)(1993-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#8)(2008-3#9)
Wavelength-Modulation##2##1##(2008-3#2)
Wavelength-dependent##2##1##(2008-2#1)(2008-3#1)
Wavelength-division multiplexing##2##2##(2008-2#2)
Wavelength-modulation##2##1##(2008-2#1)(2008-3#1)
Wavelengths##2##1##(2007-12#1)(2008-10#1)
Wavelet##4##1##(2008-10#2)(2008-2#1)(2009-3#1)
Waves##2##1##(1996-9#2)
Way to##2##2##(2008-3#1)(2011-2#1)
Way##7##1##(1996-5#1)(1997-5#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
Wayne##2##1##(1996-1#1)(2008-10#1)
Ways of Coping##3##3##(1990-10#1)(1994-12#1)(2011-2#1)
Ways of##7##2##(1990-10#1)(1994-12#1)(1994-6#1)(1995-3#1)(2008-1#1)(2011-2#2)
Ways to##2##2##(2008-11#1)(2010-8#1)
Ways##12##1##(1990-10#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#2)
We accept the##2##3##(2008-10#2)
We achieve##9##2##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)(2008-7#1)
We achieved a##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
We achieved an##3##3##(2007-11#1)(2008-3#2)
We achieved these##2##3##(2007-12#1)(2008-2#1)
We achieved this##2##3##(2007-11#1)(2008-2#1)
We achieved##22##2##(2007-11#5)(2007-12#4)(2008-2#4)(2008-3#6)(2008-7#1)(2008-9#1)(2012-7#1)
We address the problem of##2##5##(2007-12#2)
We address the##11##3##(1995-1#1)(1995-5#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)
We address this##2##3##(2008-12#1)(2008-8#1)
We address##21##2##(1995-1#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2012-2#1)
We addressed##2##2##(2008-10#1)(2008-8#1)
We administered##4##2##(1991-6#1)(1997-4#1)(2008-11#1)(2012-12#1)
We advocate that##2##3##(2009-6#1)(2009-7#1)
We advocate##7##2##(1991-6#1)(1997-8#1)(2008-11#1)(2009-6#1)(2009-7#1)(2013-1#2)
We agree with##2##3##(1991-6#1)(2008-10#1)
We aim to investigate##2##4##(2008-6#1)(2011-2#1)
We aim to##6##3##(2008-3#2)(2008-6#1)(2011-2#2)(2012-12#1)
We aim##7##2##(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#1)
We aimed at##3##3##(2010-7#1)(2012-4#1)(2013-1#1)
We aimed to assess##2##4##(1997-4#1)(2013-1#1)
We aimed to identify the##2##5##(2009-12#1)(2012-3#1)
We aimed to investigate the##2##5##(2011-1#1)(2012-1#1)
We aimed to##10##3##(1997-4#1)(2009-12#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
We aimed##13##2##(1997-4#1)(2009-12#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#2)(2012-4#1)(2013-1#3)
We also analyze##3##3##(2008-3#1)(2008-6#1)(2011-1#1)
We also analyzed the##3##4##(1992-6#1)(2008-5#1)(2008-8#1)
We also analyzed##4##3##(1992-6#1)(2008-5#1)(2008-8#1)(2013-1#1)
We also apply##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
We also assessed the##2##4##(2008-9#1)(2009-5#1)
We also briefly discuss##2##4##(2008-3#1)(2010-9#1)
We also briefly##3##3##(2008-11#1)(2008-3#1)(2010-9#1)
We also calculated the##2##4##(2008-10#1)(2008-12#1)
We also compare the##5##4##(1995-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
We also compare##6##3##(1995-2#1)(2007-11#1)(2008-2#2)(2008-3#2)
We also conducted##2##3##(2008-3#1)(2012-3#1)
We also consider##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
We also cover##2##3##(2010-4#1)(2012-2#1)
We also demonstrate a##4##4##(1991-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
We also demonstrate that##5##4##(1994-6#1)(1995-8#1)(2008-11#1)(2008-8#2)
We also demonstrate the use of this##2##7##(2007-12#1)(2008-2#1)
We also demonstrate the##5##4##(2007-12#1)(2008-11#1)(2008-2#3)
We also demonstrate##19##3##(1991-8#1)(1992-11#1)(1994-6#1)(1995-8#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-11#2)(2008-2#5)(2008-8#2)
We also demonstrated that##4##4##(2008-10#1)(2008-2#1)(2012-2#1)(2012-3#1)
We also demonstrated##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
We also derive the##2##4##(2008-3#2)
We also derive##4##3##(2008-2#1)(2008-3#2)(2009-9#1)
We also describe a##3##4##(2008-1#1)(2008-3#1)(2012-2#1)
We also describe how##3##4##(2007-12#1)(2008-4#1)(2010-11#1)
We also describe the##4##4##(1995-1#1)(2008-2#1)(2008-8#1)(2009-2#1)
We also describe##14##3##(1995-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-7#1)(2012-2#1)
We also detected##2##3##(2011-2#1)(2012-3#1)
We also determine the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
We also determined the##3##4##(1992-2#1)(1993-8#1)(2008-11#1)
We also determined##4##3##(1992-2#1)(1993-8#1)(2008-10#1)(2008-11#1)
We also developed##2##3##(2007-10#1)(2008-10#1)
We also discuss how##2##4##(2008-3#1)(2010-8#1)
We also discuss our##3##4##(1992-4#1)(2008-12#1)(2008-8#1)
We also discuss the effect of##2##6##(1995-5#1)(2008-3#1)
We also discuss the possibility##2##5##(2009-8#1)(2013-8#1)
We also discuss the##24##4##(1990-11#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-8#2)
We also discuss##44##3##(1990-11#1)(1992-4#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
We also discussed##2##3##(2008-1#1)(2008-10#1)
We also evaluate the##2##4##(2008-7#1)(2011-2#1)
We also evaluate##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
We also evaluated the##2##4##(2013-7#2)
We also evaluated##3##3##(2008-8#1)(2013-7#2)
We also examine the##2##4##(2008-11#1)(2008-3#1)
We also examine##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
We also examined the genetic##2##5##(2009-5#1)(2011-2#1)
We also examined the##8##4##(1992-5#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-5#1)(2011-2#1)
We also examined##11##3##(1992-5#1)(1992-8#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-5#1)(2011-2#2)
We also explored the##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
We also find a##2##4##(2008-10#1)(2009-7#1)
We also find that the##4##5##(1992-2#1)(1995-11#1)(2008-10#1)(2013-1#1)
We also find that##6##4##(1992-2#1)(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
We also find##8##3##(1992-2#1)(1995-11#1)(2008-10#2)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
We also found evidence##2##4##(2008-10#1)(2008-8#1)
We also found no##2##4##(2008-5#1)(2013-1#1)
We also found that a##2##5##(2008-2#1)(2009-8#1)
We also found that the##6##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
We also found that##29##4##(1991-2#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
We also found##38##3##(1991-2#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
We also give##4##3##(1997-4#1)(1997-7#1)(2008-3#1)(2009-5#1)
We also have##2##3##(1996-4#1)(2008-10#1)
We also highlight the##3##4##(2008-3#1)(2010-5#1)(2012-2#1)
We also highlight##5##3##(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#1)
We also identified##4##3##(1993-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
We also illustrate the##2##4##(2007-12#1)(2008-2#1)
We also illustrate##3##3##(2007-12#1)(2008-2#2)
We also introduce##3##3##(2008-3#2)(2008-7#1)
We also investigate the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
We also investigate##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-2#1)(2013-7#1)
We also investigated the##6##4##(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)
We also investigated##9##3##(1992-3#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)
We also measured##4##3##(1994-3#1)(2006-6#1)(2007-12#1)(2011-2#1)
We also observe##2##3##(2007-11#1)(2007-12#1)
We also observed that##4##4##(1995-6#1)(2008-11#1)(2011-2#1)(2012-3#1)
We also observed##6##3##(1993-3#1)(1995-6#1)(2008-11#2)(2011-2#1)(2012-3#1)
We also obtained##4##3##(2007-11#3)(2007-12#1)
We also performed##3##3##(1991-6#1)(2008-3#1)(2012-2#1)
We also present a strategy for integration of results from different protocols##2##12##(2008-2#1)(2008-4#1)
We also present a strategy for##3##6##(2008-2#2)(2008-4#1)
We also present a##7##4##(1991-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-7#1)
We also present an example of##2##6##(2007-12#1)(2008-10#1)
We also present an##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
We also present some##2##4##(2009-12#1)(2013-1#1)
We also present##25##3##(1991-11#1)(1994-3#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-7#1)(2013-1#1)
We also propose##3##3##(2008-3#1)(2008-8#1)(2012-1#1)
We also provide the##2##4##(2008-3#1)(2010-8#1)
We also provide##7##3##(2008-3#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
We also quantify the##2##4##(2008-3#1)(2008-7#1)
We also quantify##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
We also report here##2##4##(1992-11#1)(2008-10#1)
We also report the##3##4##(1995-6#1)(2007-12#1)(2008-10#1)
We also report##11##3##(1992-11#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)
We also review the##4##4##(1994-12#1)(2007-8#1)(2009-11#1)(2010-12#1)
We also review##8##3##(1994-12#1)(1997-2#1)(2007-8#2)(2008-12#1)(2009-10#1)(2009-11#1)(2010-12#1)
We also reviewed the##2##4##(2008-10#1)(2009-5#1)
We also reviewed##3##3##(2006-10#1)(2008-10#1)(2009-5#1)
We also screened##2##3##(2012-3#2)
We also show how a##2##5##(2008-2#1)(2008-8#1)
We also show how##6##4##(2008-2#2)(2008-3#1)(2008-8#2)(2013-1#1)
We also show that the modulation frequency can be tuned by##2##11##(2007-11#1)(2012-2#1)
We also show that the##15##5##(1992-6#1)(1992-9#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#4)(2012-2#3)(2013-1#1)
We also show that##41##4##(1990-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(1997-7#1)(1997-9#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#9)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
We also show the##3##4##(2007-12#2)(2008-3#1)
We also show##53##3##(1990-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-7#1)(1997-9#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#11)(2008-6#1)(2008-8#6)(2008-9#1)(2009-12#2)(2009-3#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
We also showed that##4##4##(1994-11#1)(1996-5#1)(2008-5#1)(2009-6#1)
We also showed##6##3##(1994-11#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-5#1)(2009-6#1)
We also speculate##2##3##(1994-1#1)(2008-10#1)
We also studied the##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2012-3#1)
We also studied##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-3#1)
We also study##2##3##(2008-2#1)(2008-6#1)
We also surveyed##2##3##(2009-8#1)(2012-3#1)
We also tested for##2##4##(1995-2#1)(2008-9#1)
We also tested the##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
We also tested##5##3##(1995-2#1)(2008-3#1)(2008-9#2)(2011-2#1)
We also use##4##3##(1992-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
We also used##2##3##(1990-9#1)(2007-12#1)
We also wanted to determine##2##5##(2008-4#1)(2013-7#1)
We also##456##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#2)(1995-5#3)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#18)(2007-12#27)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#32)(2008-11#20)(2008-12#5)(2008-2#33)(2008-3#56)(2008-4#5)(2008-5#9)(2008-6#6)(2008-7#14)(2008-8#24)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#14)(2012-7#1)(2013-1#11)(2013-7#4)(2013-8#4)
We analyse the##2##3##(2008-7#1)(2012-2#1)
We analyse##3##2##(1997-8#1)(2008-7#1)(2012-2#1)
We analysed a##2##3##(2010-11#1)(2010-12#1)
We analysed data##2##3##(2010-3#2)
We analysed the association##2##4##(2012-12#1)(2012-2#1)
We analysed the##10##3##(1996-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-7#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
We analysed##17##2##(1995-11#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
We analyze a##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
We analyze and demonstrate##2##4##(2008-2#1)(2008-3#1)
We analyze and##3##3##(2008-2#1)(2008-3#2)
We analyze the effect of##2##5##(2008-2#2)
We analyze the influence of##2##5##(2007-11#1)(2008-3#1)
We analyze the phase-matching##2##4##(2008-2#1)(2008-3#1)
We analyze the##24##3##(1990-6#1)(1996-1#1)(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#8)(2008-8#2)(2008-9#1)(2012-2#1)
We analyze##45##2##(1990-6#1)(1994-12#1)(1996-1#1)(2007-11#4)(2007-12#8)(2008-2#9)(2008-3#14)(2008-6#1)(2008-8#3)(2008-9#1)(2012-2#1)(2013-7#1)
We analyzed a group of##2##5##(2007-11#1)(2011-2#1)
We analyzed a##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
We analyzed data from##3##4##(2010-12#1)(2013-1#1)(2013-7#1)
We analyzed nine##2##3##(1996-5#1)(1997-2#1)
We analyzed the data##2##4##(2008-3#1)(2012-3#1)
We analyzed the results##2##4##(2008-1#1)(2011-2#1)
We analyzed the temporal##2##4##(2009-8#1)(2013-1#1)
We analyzed the##24##3##(1992-2#1)(1994-11#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
We analyzed##55##2##(1990-9#1)(1992-2#1)(1994-11#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
We and others have previously##2##5##(1997-2#1)(2008-1#1)
We and others have##6##4##(1992-3#1)(1997-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)
We anticipate that##3##3##(2008-3#1)(2008-9#1)(2012-2#1)
We applied a##3##3##(2008-2#1)(2010-6#1)(2013-1#1)
We applied our##2##3##(2010-10#2)
We applied selected methods for the determination of total##2##9##(2008-10#2)
We applied the##5##3##(2008-10#2)(2008-5#1)(2012-12#1)(2013-7#1)
We applied these##2##3##(2008-3#1)(2010-8#1)
We applied this technique to a##2##6##(2008-2#1)(2008-3#1)
We applied this technique to##5##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
We applied this##8##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)
We applied##26##2##(1992-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#4)(2008-5#1)(2009-9#1)(2010-10#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
We apply the method to##2##5##(1995-12#1)(1997-3#1)
We apply the model to##2##5##(2008-8#2)
We apply the results to##2##5##(2008-3#2)
We apply the##14##3##(1995-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2009-5#1)(2009-8#1)(2013-1#1)
We apply these##2##3##(2008-3#2)
We apply this method##2##4##(2008-2#1)(2012-2#1)
We apply this technique to##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
We apply this technique##4##4##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
We apply this##8##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
We apply##32##2##(1995-12#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#7)(2008-7#2)(2008-8#3)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
We are currently##3##3##(1994-6#1)(1997-5#1)(2008-7#1)
We are developing##2##3##(2008-3#1)(2008-7#1)
We are hereby##2##3##(2011-1#1)(2012-12#1)
We are in##2##3##(1997-4#1)(2012-3#1)
We are not aware of any##2##6##(2007-11#1)(2008-6#1)
We are not aware of##4##5##(1991-3#1)(2007-11#1)(2008-3#1)(2008-6#1)
We are not##6##3##(1991-3#1)(2007-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
We are presenting a##2##4##(2008-10#1)(2012-3#1)
We are presenting the case of a##2##7##(2008-4#1)(2008-5#1)
We are presenting##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
We are reporting a case of##5##6##(2008-12#1)(2009-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
We are reporting a##7##4##(2007-7#1)(2007-8#1)(2008-12#1)(2009-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
We are reporting an##2##4##(1995-2#1)(2009-3#1)
We are reporting on##2##4##(2010-7#1)(2012-12#1)
We are reporting this##2##4##(2007-11#1)(2008-7#1)
We are reporting two cases of##2##6##(2010-2#1)(2013-8#1)
We are reporting two##3##4##(2007-8#1)(2010-2#1)(2013-8#1)
We are reporting##18##3##(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#2)(2013-1#1)(2013-8#2)
We are##66##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#8)(2008-9#1)(2009-3#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#3)
We argue that a##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
We argue that the##10##4##(1991-2#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
We argue that these##2##4##(2011-2#1)(2013-8#1)
We argue that##32##3##(1991-2#1)(1995-11#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
We argue##33##2##(1991-2#1)(1993-1#1)(1995-11#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
We ask whether the##2##4##(2008-12#1)(2012-2#1)
We asked##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
We assayed the##2##3##(1991-5#1)(2008-10#1)
We assess the##4##3##(1990-8#1)(2008-2#2)(2008-3#1)
We assessed immune function in##2##5##(2008-10#1)(2008-8#1)
We assessed the effect of##3##5##(1992-3#1)(2007-8#1)(2008-10#1)
We assessed the effects of##3##5##(2007-10#1)(2010-9#1)(2011-2#1)
We assessed the efficacy of##2##5##(2008-10#1)(2008-3#1)
We assessed the prevalence##2##4##(2008-12#1)(2008-9#1)
We assessed the##21##3##(1990-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1995-2#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-7#1)(2010-9#1)(2011-2#3)
We assessed whether##2##3##(2010-11#1)(2013-7#1)
We assessed##44##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#4)(2013-7#1)
We assume that the##2##4##(2008-3#1)(2008-9#1)
We assume that##7##3##(1996-2#1)(2008-3#3)(2008-7#1)(2008-9#2)
We assume##9##2##(1996-2#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#2)
We assumed that##2##3##(2008-2#1)(2010-8#1)
We assumed##3##2##(2008-2#1)(2009-7#1)(2010-8#1)
We attempt in this study to##2##6##(2007-7#1)(2008-1#1)
We attempt##4##2##(1992-3#1)(2007-7#1)(2008-1#1)(2008-3#1)
We attempted to elucidate the##2##5##(1990-7#1)(2008-10#1)
We attempted to identify##2##4##(1995-2#1)(2008-11#1)
We attempted to##12##3##(1990-7#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
We attempted##13##2##(1990-7#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
We attribute this to##2##4##(2008-11#1)(2008-2#1)
We attribute##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
We attributed the##2##3##(2008-2#1)(2008-8#1)
We begin by##3##3##(2008-6#1)(2010-4#1)(2013-8#1)
We begin with a##2##4##(2008-11#1)(2008-2#1)
We begin##6##2##(2008-11#1)(2008-2#1)(2008-6#2)(2010-4#1)(2013-8#1)
We believe hospitals should remove these cords-which are supplied with equipment from a variety of medical device manufacturers-from service##2##19##(2011-1#1)(2011-2#1)
We believe it##2##3##(1997-2#1)(2008-10#1)
We believe that arthroscopic surgical intervention after the initial shoulder dislocations can dramatically lower the recurrence rate and should be considered as a treatment option in young patients##2##28##(2007-11#2)
We believe that in##3##4##(2007-10#1)(2010-3#1)(2010-8#1)
We believe that our##4##4##(1992-1#1)(1995-2#1)(2008-3#1)(2013-1#1)
We believe that the##16##4##(1995-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-1#1)(2010-2#1)(2013-1#1)
We believe that this is the first##3##7##(2007-11#1)(2007-12#1)(2010-3#1)
We believe that this is##4##5##(2007-11#1)(2007-12#1)(2009-1#1)(2010-3#1)
We believe that this##8##4##(1992-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#1)(2009-1#1)(2010-3#1)
We believe that##57##3##(1990-3#2)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1995-2#1)(1995-3#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#2)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2012-7#1)(2013-1#2)
We believe the##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
We believe this is the first report of##2##8##(2007-7#1)(2008-2#1)
We believe this is the first##4##6##(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)
We believe this is##5##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
We believe this##7##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
We believe##78##2##(1990-3#2)(1991-1#1)(1991-12#3)(1992-1#1)(1992-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)
We briefly##2##2##(2008-8#1)(2013-2#1)
We bring##2##2##(2008-7#2)
We built a##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
We built##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
We calculate the##10##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#3)
We calculate##11##2##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#3)
We calculated a##2##3##(2008-3#1)(2008-9#1)
We calculated the##6##3##(1990-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)
We calculated##13##2##(1990-9#1)(1997-5#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)
We call##3##2##(1994-2#1)(2008-12#1)(2008-7#1)
We can also##4##3##(1995-9#2)(1997-3#1)(2008-2#1)
We can conclude that##2##4##(1994-8#1)(2011-2#1)
We can consider that for a direct measurement of the intensity of reflectance##2##13##(2008-10#2)
We can##22##2##(1991-12#1)(1992-2#1)(1994-2#1)(1994-8#1)(1995-9#2)(1997-3#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
We cannot conclude##2##3##(2008-10#1)(2011-2#1)
We cannot##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
We carried out a##6##4##(1994-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-7#1)
We carried out the##2##4##(2008-2#1)(2008-3#1)
We carried out##14##3##(1991-3#1)(1994-12#1)(1997-2#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-2#3)(2013-1#1)(2013-7#1)
We carry out##5##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-3#1)
We characterize the##6##3##(2007-11#2)(2007-12#1)(2008-3#1)(2009-5#1)(2012-2#1)
We characterize##9##2##(2007-11#2)(2007-12#3)(2008-11#1)(2008-3#1)(2009-5#1)(2012-2#1)
We characterized four##2##3##(1990-5#1)(2008-10#1)
We characterized the##4##3##(1992-8#1)(2008-11#1)(2009-8#1)(2013-1#1)
We characterized##11##2##(1990-11#1)(1990-5#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
We checked##2##2##(2008-3#1)(2008-4#1)
We chose##4##2##(1997-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
We claim that the##2##4##(2008-2#1)(2008-8#1)
We classified##3##2##(2008-7#1)(2010-2#1)(2013-7#1)
We clearly##2##2##(1992-12#1)(2007-11#1)
We cloned and sequenced the##4##5##(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#1)
We cloned the##4##3##(1994-12#1)(1995-2#1)(2008-8#1)(2008-9#1)
We cloned##11##2##(1991-12#1)(1994-11#1)(1994-12#2)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
We close with##2##3##(2011-2#1)(2013-8#1)
We close##3##2##(2009-8#1)(2011-2#1)(2013-8#1)
We collected##9##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
We combine##4##2##(2007-11#1)(2008-3#2)(2008-6#1)
We combined##8##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
We compare experimentally##2##3##(2007-11#1)(2007-12#1)
We compare our experimental##2##4##(2007-12#1)(2008-2#1)
We compare several##2##3##(2010-2#1)(2012-3#1)
We compare the performance of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
We compare the results of##4##5##(1995-3#1)(1997-8#1)(2008-3#1)(2008-5#1)
We compare the results##6##4##(1995-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
We compare the##28##3##(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#6)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
We compare this##2##3##(2008-2#1)(2008-3#1)
We compare various##2##3##(2007-12#1)(2008-11#1)
We compare##57##2##(1995-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#12)(2008-3#13)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-2#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
We compared a##2##3##(2007-12#1)(2008-1#1)
We compared our##3##3##(2008-3#3)
We compared the effects of##3##5##(1991-12#1)(1995-12#1)(2012-2#1)
We compared the results##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
We compared the##31##3##(1990-6#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
We compared this##2##3##(1995-5#1)(2008-10#1)
We compared##71##2##(1990-6#1)(1990-8#1)(1991-12#1)(1992-12#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-1#2)(1997-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#5)(2008-3#9)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#2)
We compute the##2##3##(2007-11#1)(2008-3#1)
We compute##3##2##(1995-9#1)(2007-11#1)(2008-3#1)
We conclude by discussing the##2##5##(2008-8#1)(2010-3#1)
We conclude by discussing##4##4##(2008-8#2)(2010-3#1)(2012-2#1)
We conclude by noting that##2##5##(2010-11#1)(2012-2#1)
We conclude by offering an agenda for future research##2##9##(2013-1#2)
We conclude by##9##3##(2008-8#2)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#2)
We conclude from the##2##4##(1992-7#1)(2008-1#1)
We conclude from this##2##4##(1991-8#1)(2007-10#1)
We conclude from##5##3##(1991-8#1)(1992-7#1)(2007-10#1)(2008-1#1)(2008-10#1)
We conclude that D##2##4##(2008-10#1)(2008-8#1)
We conclude that a large##2##5##(1997-7#1)(2008-5#1)
We conclude that a##10##4##(1994-12#1)(1994-2#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)
We conclude that acute##2##4##(1994-11#1)(2008-3#1)
We conclude that although##4##4##(1992-2#1)(1995-2#1)(2008-3#1)(2013-1#1)
We conclude that both##3##4##(1990-12#1)(1993-8#1)(2009-10#1)
We conclude that endoscopic##2##4##(2008-10#1)(2008-5#1)
We conclude that for##2##4##(1991-6#1)(2007-8#1)
We conclude that high##2##4##(1990-6#1)(2008-1#1)
We conclude that hypertension##2##4##(2007-7#1)(2008-1#1)
We conclude that in addition to##3##6##(1994-5#1)(2009-11#1)(2012-2#1)
We conclude that in##11##4##(1991-5#1)(1994-5#1)(1995-10#1)(2008-11#3)(2008-5#1)(2009-11#1)(2009-2#1)(2009-6#1)(2012-2#1)
We conclude that it is##3##5##(1991-9#1)(2008-3#1)(2008-7#1)
We conclude that our##4##4##(1995-6#1)(1996-12#1)(2007-7#1)(2008-10#1)
We conclude that routine##2##4##(1997-8#1)(2007-7#1)
We conclude that some##2##4##(1991-9#1)(2012-3#1)
We conclude that the most important##2##6##(2008-10#1)(2008-9#1)
We conclude that the use of##4##6##(2007-9#1)(2008-7#3)
We conclude that the##67##4##(1990-12#1)(1990-5#3)(1991-12#2)(1992-12#3)(1993-2#1)(1993-9#1)(1994-12#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
We conclude that there are##3##5##(2007-7#1)(2008-10#1)(2008-9#1)
We conclude that there is##5##5##(2007-10#1)(2007-7#1)(2007-8#2)(2008-4#1)
We conclude that there##9##4##(1996-7#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)
We conclude that these##3##4##(1997-2#1)(2008-10#1)(2010-8#1)
We conclude that this##3##4##(1990-2#1)(2008-11#1)(2008-6#1)
We conclude that##342##3##(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#4)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#11)(2007-8#14)(2007-9#2)(2008-1#13)(2008-10#25)(2008-11#14)(2008-12#1)(2008-2#2)(2008-3#12)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#17)(2008-8#12)(2008-9#14)(2009-10#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#5)
We conclude with a discussion of##2##6##(1992-3#1)(2010-4#1)
We conclude with a##5##4##(1992-3#1)(2008-6#1)(2010-4#1)(2011-2#2)
We conclude with suggestions for##2##5##(2007-12#1)(2008-2#1)
We conclude with suggestions##3##4##(2007-12#1)(2008-2#1)(2008-8#1)
We conclude with##12##3##(1992-3#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-4#1)(2011-2#3)(2012-2#2)
We conclude##376##2##(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#4)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#6)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#11)(2007-8#14)(2007-9#2)(2008-1#14)(2008-10#27)(2008-11#14)(2008-12#1)(2008-2#3)(2008-3#12)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#17)(2008-8#16)(2008-9#14)(2009-10#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#5)
We concluded that the cause of death##2##7##(2011-2#2)
We concluded that the##16##4##(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
We concluded that there is##2##5##(2007-8#1)(2008-10#1)
We concluded that##50##3##(1991-12#1)(1991-6#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-10#7)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#4)(2008-5#2)(2008-7#3)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
We concluded##51##2##(1991-12#1)(1991-6#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-10#7)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#4)(2008-5#2)(2008-7#3)(2008-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
We conducted a meta-analysis##2##4##(2008-4#1)(2008-9#1)
We conducted a quantitative##2##4##(2008-10#2)
We conducted a randomized##3##4##(1990-5#1)(2008-7#1)(2008-8#1)
We conducted a retrospective review of##2##6##(2012-2#1)(2013-8#1)
We conducted a retrospective##4##4##(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
We conducted a review of the##2##6##(2008-8#1)(2011-2#1)
We conducted a review of##3##5##(2008-8#1)(2009-5#1)(2011-2#1)
We conducted a systematic review##2##5##(2008-10#1)(2013-1#1)
We conducted a systematic search of##2##6##(2008-6#1)(2013-8#1)
We conducted a systematic##5##4##(2007-10#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
We conducted a##35##3##(1990-5#1)(1996-12#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
We conducted semistructured interviews with##2##5##(2010-8#1)(2013-1#1)
We conducted the##2##3##(2008-9#1)(2013-8#1)
We conducted this study to##3##5##(2007-7#1)(2008-1#1)(2010-7#1)
We conducted##58##2##(1990-5#1)(1996-12#1)(2007-10#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#3)
We confirm the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
We confirm##10##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#3)(2012-3#1)(2013-1#1)
We confirmed that##2##3##(2008-5#1)(2010-1#1)
We confirmed the##5##3##(1990-5#1)(1992-6#1)(2008-10#1)(2008-2#1)(2012-3#1)
We confirmed these findings##2##4##(2008-3#1)(2010-3#1)
We confirmed##10##2##(1990-5#1)(1992-6#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-3#1)(2012-3#1)
We consider a##9##3##(1990-8#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-10#1)(2013-8#2)
We consider data with high signal energy that produces negligible random outliers##2##12##(2008-2#2)
We consider that##8##3##(1992-6#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-2#1)(2012-2#1)
We consider the problem of##4##5##(1994-11#1)(2007-11#1)(2008-2#1)(2009-9#1)
We consider the use of##2##5##(2012-2#1)(2012-3#1)
We consider the##23##3##(1994-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#10)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
We consider this##3##3##(1994-5#1)(2008-7#1)(2009-11#1)
We consider##65##2##(1990-8#1)(1992-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-4#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#7)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-2#2)(2012-3#4)(2013-8#3)
We considered##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)
We construct a##2##3##(2008-2#1)(2010-2#1)
We construct##4##2##(2008-2#1)(2008-8#1)(2009-9#1)(2010-2#1)
We constructed a new##2##4##(1996-2#1)(2008-8#1)
We constructed a series of##2##5##(1990-12#1)(1991-6#1)
We constructed a##11##3##(1990-12#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-3#1)
We constructed##16##2##(1990-11#1)(1990-12#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
We contend that##2##3##(2007-10#1)(2008-1#1)
We continue to##2##3##(1995-1#1)(2010-9#1)
We continue##3##2##(1995-1#1)(2008-6#1)(2010-9#1)
We contrast##2##2##(1994-1#1)(2009-9#1)
We controlled##2##2##(2007-11#1)(2008-11#1)
We correct the##2##3##(2007-11#1)(2008-3#1)
We could demonstrate that##2##4##(1995-12#1)(2011-1#1)
We could demonstrate##3##3##(1995-12#1)(2008-11#1)(2011-1#1)
We could not find##2##4##(2012-3#1)(2013-8#1)
We could not reveal primary focus of the##2##8##(2007-11#2)
We could not##7##3##(1990-12#1)(2007-11#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
We could##17##2##(1990-12#1)(1995-12#1)(1997-2#1)(1997-6#1)(2007-11#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
We coupled##2##2##(2007-11#1)(2008-3#1)
We created##4##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
We decided to##2##3##(2008-8#1)(2009-8#1)
We decided##3##2##(2008-8#1)(2009-8#1)(2011-2#1)
We define a##2##3##(2008-3#1)(2013-8#1)
We define each##2##3##(2008-2#1)(2012-12#1)
We define the##3##3##(1997-3#1)(2010-4#1)(2013-1#1)
We define##11##2##(1997-3#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
We defined##6##2##(1992-9#1)(1993-12#1)(1995-5#1)(2007-10#1)(2008-5#1)(2009-11#1)
We definitely need##2##3##(2011-1#1)(2013-1#1)
We demonstrate a fiber-optic##2##4##(2007-11#1)(2008-3#1)
We demonstrate a new design for a##3##7##(2008-2#2)(2008-3#1)
We demonstrate a new method for##2##6##(2007-11#1)(2007-12#1)
We demonstrate a new method##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
We demonstrate a new##15##4##(2007-11#3)(2007-12#5)(2008-2#5)(2008-3#2)
We demonstrate a novel##10##4##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#1)
We demonstrate a passively##2##4##(2007-11#1)(2007-12#1)
We demonstrate a scheme for##2##5##(2007-11#1)(2007-12#1)
We demonstrate a simple##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
We demonstrate a simplified##2##4##(2007-11#2)
We demonstrate a##69##3##(1990-12#1)(2007-11#23)(2007-12#25)(2008-2#8)(2008-3#11)(2008-9#1)
We demonstrate an##8##3##(2007-11#1)(2008-2#1)(2008-3#5)(2011-1#1)
We demonstrate efficient##3##3##(2007-11#1)(2007-12#2)
We demonstrate experimentally##8##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
We demonstrate for the first time##2##6##(2008-2#1)(2013-1#1)
We demonstrate for##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
We demonstrate generation##2##3##(2007-11#2)
We demonstrate here that##10##4##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-8#1)
We demonstrate here##15##3##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
We demonstrate how##2##3##(2008-3#2)
We demonstrate improved##2##3##(2007-11#1)(2008-3#1)
We demonstrate in##2##3##(2007-11#1)(2007-12#1)
We demonstrate optical trapping##2##4##(2007-11#1)(2007-12#1)
We demonstrate optical##3##3##(2007-11#1)(2007-12#2)
We demonstrate that a##7##4##(1997-3#1)(2007-12#3)(2008-3#2)(2009-5#1)
We demonstrate that during##2##4##(1990-11#1)(2008-11#1)
We demonstrate that one can##2##5##(2007-11#1)(2007-12#1)
We demonstrate that the##23##4##(1990-4#1)(1993-8#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-2#1)(2008-3#8)(2009-5#1)(2009-8#2)(2010-8#1)(2012-2#1)
We demonstrate that this##3##4##(1995-8#1)(2008-3#1)(2013-1#1)
We demonstrate that##85##3##(1990-11#1)(1990-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-11#10)(2007-12#16)(2008-11#4)(2008-2#2)(2008-3#18)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
We demonstrate the effectiveness of##2##5##(2008-3#1)(2008-6#1)
We demonstrate the efficiency##2##4##(2007-12#2)
We demonstrate the existence of##2##5##(1990-8#1)(2007-12#1)
We demonstrate the feasibility of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
We demonstrate the first##2##4##(2008-3#1)(2010-5#1)
We demonstrate the formation##2##4##(2007-11#1)(2008-3#1)
We demonstrate the generation of##5##5##(2007-11#5)
We demonstrate the measurement of##2##5##(2007-11#1)(2011-1#1)
We demonstrate the performance of the##2##6##(2008-3#1)(2012-1#1)
We demonstrate the possibility of##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
We demonstrate the suitability of##2##5##(2007-11#2)
We demonstrate the use of a##6##6##(2007-11#1)(2007-12#3)(2008-3#1)(2010-5#1)
We demonstrate the use of this##2##6##(2007-12#1)(2008-3#1)
We demonstrate the use of##14##5##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#4)(2010-5#1)
We demonstrate the utility of##2##5##(2008-11#1)(2011-1#1)
We demonstrate the validity##2##4##(2007-12#1)(2008-2#1)
We demonstrate the##77##3##(1990-8#1)(1995-8#1)(2007-11#16)(2007-12#17)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#19)(2008-5#1)(2008-6#3)(2008-7#1)(2009-11#1)(2010-5#2)(2011-1#2)(2012-1#1)(2012-2#1)
We demonstrate theoretically##2##3##(2007-12#1)(2008-3#1)
We demonstrate this effect##2##4##(2007-12#1)(2008-2#1)
We demonstrate this method##2##4##(2007-11#1)(2008-3#1)
We demonstrate this technique##2##4##(2008-2#1)(2012-2#1)
We demonstrate this##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-3#1)(2012-2#1)
We demonstrate what is to our knowledge the first##5##9##(2007-11#3)(2007-12#2)
We demonstrate what we believe is##2##6##(2008-3#2)
We demonstrate what##7##3##(2007-11#3)(2007-12#2)(2008-3#2)
We demonstrate##373##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1997-2#1)(1997-3#1)(2007-11#86)(2007-12#96)(2008-10#7)(2008-11#8)(2008-2#26)(2008-3#77)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-1#4)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#1)
We demonstrated a##2##3##(1994-7#1)(2011-2#1)
We demonstrated that in##2##4##(1994-11#1)(2007-12#1)
We demonstrated that the##2##4##(1992-9#1)(2008-10#1)
We demonstrated that##10##3##(1990-5#1)(1992-9#1)(1994-11#1)(2007-12#1)(2008-10#3)(2010-3#1)(2011-2#1)(2013-1#1)
We demonstrated##21##2##(1990-5#1)(1992-9#1)(1994-11#1)(1994-7#1)(2007-12#3)(2008-10#5)(2008-3#2)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
We derive a relationship between the##2##6##(2007-12#1)(2008-3#1)
We derive a##9##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2011-3#1)
We derive an analytical##2##4##(2007-11#1)(2008-8#1)
We derive an##5##3##(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#2)
We derive expressions for the##2##5##(2008-3#2)
We derive the##6##3##(1992-9#1)(2008-2#2)(2008-3#1)(2009-5#1)(2013-8#1)
We derive##35##2##(1992-9#1)(1994-2#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-2#7)(2008-3#10)(2008-7#1)(2008-8#4)(2009-5#1)(2010-8#1)(2011-3#1)(2013-8#1)
We derived the##4##3##(2008-2#1)(2008-3#3)
We derived##8##2##(1995-8#1)(1997-7#1)(2008-2#1)(2008-3#4)(2013-1#1)
We describe 2 patients with##2##5##(1997-3#1)(2006-10#1)
We describe 2 patients##3##4##(1997-3#1)(2006-10#1)(2011-2#1)
We describe a case of a##8##6##(1991-2#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
We describe a case of an##2##6##(2010-6#1)(2013-7#1)
We describe a case of##26##5##(1990-2#2)(1991-2#1)(1991-6#1)(1992-4#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
We describe a case with##2##5##(1991-9#1)(2008-6#1)
We describe a case##30##4##(1990-2#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
We describe a device that##2##5##(2008-2#1)(2008-3#1)
We describe a fast##2##4##(2007-11#1)(2008-3#1)
We describe a general##2##4##(2008-2#1)(2008-3#1)
We describe a label-free##2##4##(2008-10#1)(2012-2#1)
We describe a method for##10##5##(1991-11#1)(1993-8#1)(2007-11#2)(2008-2#3)(2008-3#3)
We describe a method that##4##5##(2008-2#1)(2008-3#3)
We describe a method to##3##5##(2008-10#1)(2008-3#1)(2012-2#1)
We describe a method##19##4##(1991-11#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#8)(2012-2#1)
We describe a miniature##2##4##(2007-12#2)
We describe a modified##3##4##(2007-12#1)(2008-7#1)(2011-1#1)
We describe a new method for##2##6##(1996-12#1)(2007-12#1)
We describe a new method##3##5##(1996-12#1)(2007-12#1)(2008-2#1)
We describe a new##18##4##(1994-8#1)(1996-12#1)(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)
We describe a novel method##2##5##(2007-12#1)(2008-2#1)
We describe a novel type of##2##6##(2007-11#2)
We describe a novel##19##4##(2007-11#4)(2007-12#6)(2008-11#1)(2008-2#3)(2008-3#4)(2010-11#1)
We describe a patient who##3##5##(2006-10#1)(2008-6#1)(2012-2#1)
We describe a patient with a##3##6##(1996-5#1)(1997-2#1)(2008-7#1)
We describe a patient with##12##5##(1990-9#1)(1992-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#3)
We describe a patient##15##4##(1990-9#1)(1992-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-10#2)(2007-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
We describe a rare case##2##5##(2007-7#1)(2012-12#1)
We describe a rare##3##4##(2007-7#1)(2012-12#1)(2013-1#1)
We describe a simple method for##2##6##(2008-2#1)(2008-3#1)
We describe a simple method##4##5##(2008-2#1)(2008-3#2)(2009-5#1)
We describe a simple##10##4##(2007-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-5#1)(2010-7#1)
We describe a system##2##4##(1994-12#1)(2008-3#1)
We describe a technique##6##4##(1992-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
We describe a##220##3##(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#2)(1993-10#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#15)(2007-12#22)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#23)(2008-3#48)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
We describe active##2##3##(2007-12#1)(2008-2#1)
We describe an unusual case of##2##6##(2011-2#1)(2013-1#1)
We describe an##23##3##(1991-6#1)(1992-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#7)(2011-2#2)(2013-1#1)
We describe and discuss##2##4##(1996-3#1)(2010-8#1)
We describe and##5##3##(1996-3#1)(2008-3#3)(2010-8#1)
We describe five##2##3##(2007-8#1)(2011-2#1)
We describe four patients##2##4##(1991-11#1)(2007-7#1)
We describe four##3##3##(1991-11#1)(1991-2#1)(2007-7#1)
We describe here a new##2##5##(2008-10#2)
We describe here a##10##4##(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#3)(2009-11#1)(2011-2#1)
We describe here an##2##4##(2008-2#1)(2010-10#1)
We describe here the##9##4##(1993-6#3)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#1)
We describe here##25##3##(1993-6#3)(1995-2#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#4)(2009-11#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
We describe how a##3##4##(1995-12#1)(2008-3#1)(2009-12#1)
We describe how##10##3##(1994-12#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-12#2)(2009-3#1)(2010-10#1)(2011-2#1)
We describe in this paper##2##5##(1994-12#1)(1995-1#1)
We describe in this report##3##5##(2008-10#2)(2013-1#1)
We describe in this##6##4##(1994-12#1)(1995-1#1)(2008-10#2)(2012-3#1)(2013-1#1)
We describe one such##2##4##(2008-11#1)(2008-7#1)
We describe our experience##2##4##(1997-3#1)(2010-11#1)
We describe our experimental##2##4##(2008-2#1)(2008-3#1)
We describe our##8##3##(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-7#1)
We describe some##2##3##(2008-3#2)
We describe the analysis of##2##5##(1994-11#1)(2008-3#1)
We describe the application of##2##5##(2008-3#2)
We describe the basic##2##4##(2007-12#1)(2008-2#1)
We describe the case of a patient##2##7##(1993-8#1)(2008-5#1)
We describe the case of a##6##6##(1990-8#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-5#1)(2011-2#1)
We describe the case of an##2##6##(2008-7#1)(2011-2#1)
We describe the case of##9##5##(1990-8#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-7#1)
We describe the case##10##4##(1990-8#1)(1991-8#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-7#1)
We describe the cases of##2##5##(2008-7#1)(2011-2#1)
We describe the characteristics of##2##5##(2007-11#2)
We describe the clinical and##2##5##(1991-8#1)(2006-10#1)
We describe the clinical##9##4##(1991-8#1)(2006-10#2)(2007-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
We describe the construction of a##2##6##(2008-5#1)(2012-3#1)
We describe the construction##3##4##(1995-8#1)(2008-5#1)(2012-3#1)
We describe the design and##2##5##(2008-3#1)(2008-7#1)
We describe the design of a##3##6##(2008-2#2)(2008-3#1)
We describe the design of##6##5##(2008-2#3)(2008-3#2)(2008-7#1)
We describe the design##12##4##(2008-2#5)(2008-3#5)(2008-7#2)
We describe the development and##3##5##(2008-10#1)(2008-3#2)
We describe the development of a##3##6##(2008-2#2)(2008-3#1)
We describe the development of##6##5##(1996-11#1)(1996-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
We describe the development##10##4##(1996-11#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)
We describe the experimental##3##4##(2007-11#1)(2008-3#2)
We describe the first case of##2##6##(1996-8#1)(2012-12#1)
We describe the first##3##4##(1996-8#1)(2009-5#1)(2012-12#1)
We describe the isolation##2##4##(1993-12#1)(1994-8#1)
We describe the management of##2##5##(2010-7#1)(2010-8#1)
We describe the management##4##4##(1993-1#1)(2007-10#1)(2010-7#1)(2010-8#1)
We describe the successful##2##4##(2008-2#1)(2012-12#1)
We describe the surgical technique##2##5##(2009-3#1)(2013-1#1)
We describe the use of a##4##6##(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
We describe the use of##10##5##(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)
We describe the##142##3##(1990-8#1)(1991-8#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#3)(2007-10#2)(2007-11#5)(2007-12#7)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#22)(2008-3#31)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
We describe their##2##3##(1997-7#1)(2012-3#1)
We describe this##2##3##(2008-7#2)
We describe three##2##3##(2007-7#1)(2008-3#1)
We describe two cases of##3##5##(2008-3#1)(2009-3#1)(2013-1#1)
We describe two cases that##2##5##(1995-8#1)(2013-1#1)
We describe two cases##5##4##(1995-8#1)(2008-3#1)(2009-3#1)(2013-1#2)
We describe two patients with##3##5##(1991-11#1)(1995-11#1)(2008-7#1)
We describe two patients##4##4##(1991-11#1)(1995-11#1)(2008-7#1)(2012-2#1)
We describe two##15##3##(1991-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
We describe what##2##3##(2007-11#1)(2007-12#1)
We describe##520##2##(1990-2#2)(1990-5#2)(1990-8#2)(1990-9#1)(1991-11#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#3)(1992-6#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-6#3)(1993-8#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#3)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#2)(2006-10#8)(2007-10#5)(2007-11#26)(2007-12#35)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#8)(2008-1#3)(2008-10#19)(2008-11#8)(2008-12#1)(2008-2#59)(2008-3#104)(2008-4#2)(2008-5#6)(2008-6#11)(2008-7#30)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#4)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#3)(2011-1#6)(2011-2#15)(2012-12#9)(2012-2#13)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#3)
We described a##2##3##(1991-8#1)(2013-7#1)
We described##3##2##(1991-8#1)(2012-12#1)(2013-7#1)
We designated##2##2##(2008-10#2)
We designed a new##2##4##(2008-2#1)(2008-5#1)
We designed a##6##3##(2007-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
We designed and implemented##2##4##(2008-3#1)(2013-1#1)
We designed and##4##3##(2008-2#1)(2008-3#2)(2013-1#1)
We designed this study to##2##5##(2007-10#1)(2013-7#1)
We designed##16##2##(2007-10#1)(2007-12#3)(2008-2#2)(2008-3#2)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
We detected a##2##3##(1992-8#1)(2008-7#1)
We detected the##4##3##(1993-3#2)(2008-10#1)(2008-8#1)
We detected##11##2##(1991-11#1)(1991-12#1)(1992-8#1)(1993-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
We determine the##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
We determine##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
We determined that the##2##4##(2008-10#1)(2008-3#1)
We determined that##4##3##(2008-10#1)(2008-3#2)(2011-2#1)
We determined the##21##3##(1992-3#1)(1993-12#2)(1994-8#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#2)
We determined whether the##2##4##(1994-8#1)(2008-8#1)
We determined whether##6##3##(1994-8#2)(1995-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
We determined##38##2##(1992-3#1)(1993-12#2)(1994-6#1)(1994-8#3)(1995-12#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-7#1)
We develop a general##2##4##(2008-3#2)
We develop a model##5##4##(1993-2#1)(2007-12#1)(2007-7#1)(2008-8#2)
We develop a novel##2##4##(2009-12#1)(2012-3#1)
We develop a theory of##3##5##(2008-3#3)
We develop a theory##4##4##(2008-3#4)
We develop a##28##3##(1993-2#1)(1994-11#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-2#5)(2008-3#8)(2008-8#6)(2008-9#1)(2009-12#1)(2012-3#1)
We develop an##3##3##(2008-2#1)(2008-8#2)
We develop the##2##3##(2008-3#1)(2012-3#1)
We develop##40##2##(1993-2#1)(1994-11#1)(1994-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-2#6)(2008-3#10)(2008-8#10)(2008-9#3)(2009-12#1)(2012-3#3)
We developed a method to##3##5##(1992-11#1)(2007-10#1)(2007-12#1)
We developed a method##6##4##(1992-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2012-1#1)
We developed a nondestructive##2##4##(2008-10#1)(2008-3#1)
We developed a novel##4##4##(2007-10#1)(2008-10#1)(2008-11#1)(2013-1#1)
We developed a simple##2##4##(2008-10#1)(2008-2#1)
We developed a##41##3##(1990-7#1)(1991-9#1)(1992-11#1)(1995-12#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
We developed an##6##3##(1994-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)
We developed and tested##2##4##(2008-10#2)
We developed and##3##3##(2008-10#2)(2008-5#1)
We developed the##2##3##(2008-3#1)(2009-6#1)
We developed##58##2##(1990-7#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
We devised a##2##3##(2007-12#1)(2008-10#1)
We diagnosed this##2##3##(2007-8#1)(2011-2#1)
We diagnosed##4##2##(2007-8#1)(2009-1#1)(2011-2#2)
We did a##2##3##(2007-11#1)(2013-7#1)
We did not detect any##2##5##(2008-10#1)(2008-7#1)
We did not detect##4##4##(2008-10#2)(2008-3#1)(2008-7#1)
We did not find a##3##5##(1990-3#1)(2008-5#1)(2008-7#1)
We did not find any significant##2##6##(2008-5#1)(2009-10#1)
We did not find##10##4##(1990-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#1)
We did not observe##2##4##(2009-9#1)(2013-1#1)
We did not##22##3##(1990-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
We did##27##2##(1990-3#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
We discovered a##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
We discovered that##2##3##(2007-12#1)(2011-2#1)
We discovered##7##2##(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
We discriminated##2##2##(1990-3#1)(2008-8#1)
We discuss a##9##3##(1997-2#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-6#1)
We discuss an##2##3##(2008-2#1)(2008-3#1)
We discuss different##2##3##(1991-11#1)(1992-9#1)
We discuss here##2##3##(2010-11#1)(2011-1#1)
We discuss how the##3##4##(2007-12#1)(2008-2#1)(2013-8#1)
We discuss how this##2##4##(2008-3#2)
We discuss how##9##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-8#2)
We discuss in##2##3##(2008-2#1)(2012-2#1)
We discuss issues##2##3##(2007-11#1)(2011-2#1)
We discuss our##5##3##(2008-2#1)(2008-8#1)(2008-9#2)(2009-6#1)
We discuss possible##3##3##(1991-11#1)(1994-8#1)(2007-12#1)
We discuss several##2##3##(2008-10#1)(2008-7#1)
We discuss some##2##3##(2007-12#1)(2008-3#1)
We discuss that##2##3##(2008-7#1)(2009-6#1)
We discuss the accuracy##2##4##(2008-2#1)(2008-3#1)
We discuss the application of##2##5##(2008-2#1)(2008-8#1)
We discuss the association of##2##5##(2008-8#1)(2011-1#1)
We discuss the case of a##2##6##(1992-12#1)(2008-9#1)
We discuss the case of##3##5##(1991-2#1)(1992-12#1)(2008-9#1)
We discuss the design and realization of such##2##8##(2007-11#1)(2007-12#1)
We discuss the design and##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
We discuss the design##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
We discuss the effects of##2##5##(2008-3#2)
We discuss the implications of our##3##6##(2008-12#1)(2008-9#1)(2010-9#1)
We discuss the implications of##5##5##(2007-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2010-9#1)
We discuss the optical configuration of the system##2##8##(2008-2#1)(2008-3#1)
We discuss the optical##3##4##(2008-2#1)(2008-3#2)
We discuss the possibility##2##4##(1993-12#1)(2008-2#1)
We discuss the possible##5##4##(1992-8#1)(1995-11#1)(2008-9#1)(2012-12#1)(2013-1#1)
We discuss the regions of##2##5##(2008-3#1)(2008-9#1)
We discuss the relationship between the##2##6##(2010-12#1)(2011-2#1)
We discuss the results in##2##5##(2007-12#1)(2008-10#1)
We discuss the results##3##4##(2007-12#1)(2008-10#1)(2013-8#1)
We discuss the role of##2##5##(2013-8#2)
We discuss the use of##2##5##(2007-11#1)(2008-3#1)
We discuss the##108##3##(1990-9#2)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#17)(2008-3#21)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#3)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
We discuss these findings##2##4##(2008-3#1)(2008-8#1)
We discuss these##8##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)
We discuss this##4##3##(1990-9#1)(2008-4#1)(2008-8#1)(2009-6#1)
We discuss two##2##3##(2008-8#1)(2009-10#1)
We discuss whether##2##3##(1990-2#1)(2008-8#1)
We discuss##195##2##(1990-2#1)(1990-9#3)(1991-11#2)(1991-2#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#2)(1997-2#2)(2007-11#5)(2007-12#13)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#25)(2008-3#35)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#13)(2008-9#10)(2009-10#2)(2009-5#1)(2009-6#5)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#3)(2011-1#6)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
We discussed the##4##3##(1995-8#1)(2008-8#1)(2008-9#1)(2013-1#1)
We discussed##7##2##(1995-8#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
We distinguish##3##2##(1997-1#1)(2008-8#1)(2012-2#1)
We divide##2##2##(2007-11#1)(2008-3#1)
We divided##2##2##(2009-2#1)(2011-2#1)
We do not##4##3##(1991-3#1)(1996-6#1)(1997-1#1)(2008-11#1)
We do##5##2##(1991-3#1)(1996-6#1)(1997-1#1)(2008-11#1)(2011-2#1)
We document##2##2##(2011-1#1)(2012-12#1)
We documented##2##2##(2007-12#1)(2010-4#1)
We draw##2##2##(1997-1#1)(2010-12#1)
We earlier##2##2##(2010-5#1)(2012-2#1)
We elaborate##2##2##(2008-3#1)(2008-8#1)
We emphasize that##3##3##(1996-6#1)(2008-8#1)(2010-10#1)
We emphasize the importance of##4##5##(1991-9#1)(1997-8#1)(2008-10#1)(2011-1#1)
We emphasize the##7##3##(1991-2#1)(1991-9#1)(1997-8#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
We emphasize##12##2##(1991-2#1)(1991-9#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
We employ a##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-8#1)
We employ##7##2##(2007-11#2)(2007-12#1)(2008-3#2)(2008-8#1)(2010-8#1)
We employed a##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
We employed the##2##3##(2008-5#1)(2009-4#1)
We employed##10##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-4#1)(2009-5#1)(2013-1#1)
We encountered a##3##3##(2009-8#1)(2011-2#2)
We encountered##7##2##(1994-12#1)(1996-9#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#2)
We envision##2##2##(1994-12#1)(2008-11#1)
We establish a##2##3##(2008-2#1)(2008-3#1)
We establish the##3##3##(2007-11#1)(2008-2#1)(2012-12#1)
We establish##9##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-3#1)
We established a##8##3##(1994-6#1)(2007-12#1)(2008-11#2)(2011-2#2)(2013-1#1)(2013-7#1)
We established that##3##3##(2008-4#1)(2008-7#1)(2010-8#1)
We established the##2##3##(2007-8#1)(2012-12#1)
We established##19##2##(1992-12#1)(1993-6#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
We estimate that the##2##4##(1996-11#1)(2008-10#1)
We estimate the##6##3##(1992-12#1)(1994-2#1)(2008-11#1)(2008-2#1)(2008-3#2)
We estimate##12##2##(1992-12#1)(1994-2#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#2)
We estimated the##5##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)(2013-8#1)
We estimated##10##2##(2008-10#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
We evaluate the effect of##2##5##(2008-3#1)(2011-2#1)
We evaluate the##11##3##(1995-2#1)(2008-2#2)(2008-3#5)(2011-1#1)(2011-2#1)(2012-3#1)
We evaluate two##2##3##(2011-2#1)(2012-3#1)
We evaluate##24##2##(1995-2#1)(2007-11#2)(2008-1#1)(2008-2#3)(2008-3#6)(2008-6#1)(2009-12#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#4)
We evaluated 22 patients with##2##5##(2008-1#1)(2011-2#1)
We evaluated both##2##3##(2010-7#1)(2012-3#1)
We evaluated the accuracy of##2##5##(1994-3#1)(2007-12#1)
We evaluated the clinical##2##4##(2010-6#1)(2013-1#1)
We evaluated the effect of##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
We evaluated the performance of the##2##6##(1994-6#1)(2008-2#1)
We evaluated the performance of##3##5##(1994-6#1)(2008-2#1)(2011-1#1)
We evaluated the role of##3##5##(1995-8#1)(2009-8#1)(2013-1#1)
We evaluated the utility of a##2##6##(1996-7#1)(2011-2#1)
We evaluated the##40##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
We evaluated whether##2##3##(2008-7#1)(2012-12#1)
We evaluated##76##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
We examine a##4##3##(1995-3#1)(2008-2#1)(2008-3#1)(2011-1#1)
We examine the impact of##2##5##(2008-2#1)(2008-3#1)
We examine the performance of##2##5##(2008-3#2)
We examine the##21##3##(1992-6#1)(1997-1#1)(2007-12#2)(2008-2#5)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
We examine##34##2##(1992-6#1)(1995-3#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)
We examined 16 patients with##2##5##(2007-8#1)(2011-2#1)
We examined how veterans of World War II appraised specific dimensions of military service directly after the war and over 40 years later##2##23##(2013-1#2)
We examined how##5##3##(2008-10#2)(2013-1#2)(2013-8#1)
We examined one##2##3##(1991-6#1)(2012-12#1)
We examined the characteristics of##2##5##(1994-12#1)(2008-11#1)
We examined the correlation between##2##5##(1996-11#1)(2013-8#1)
We examined the effect of##11##5##(1992-8#1)(1993-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
We examined the effects of##13##5##(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)
We examined the effects##14##4##(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
We examined the influence of##2##5##(1994-11#1)(2008-1#1)
We examined the molecular##2##4##(1994-11#1)(1997-7#1)
We examined the relationship between##6##5##(1995-2#1)(1995-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-1#1)
We examined the role of##2##5##(2008-10#1)(2009-9#1)
We examined the##75##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
We examined whether the##2##4##(1995-3#1)(2013-1#1)
We examined whether##11##3##(1995-3#1)(1997-3#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
We examined##134##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
We excite##2##2##(2007-11#2)
We expect that##6##3##(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)
We expect##11##2##(1996-11#1)(2007-12#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-2#1)
We expected##2##2##(1994-12#1)(2013-7#1)
We experienced a case of##2##5##(2008-12#1)(2010-6#1)
We experienced a##4##3##(2008-12#1)(2009-3#1)(2010-6#1)(2011-2#1)
We experienced##5##2##(2008-12#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
We experimentally demonstrate a new##2##5##(2007-11#2)
We experimentally demonstrate a##3##4##(2007-11#3)
We experimentally demonstrate that a##2##5##(2007-11#2)
We experimentally demonstrate that##3##4##(2007-11#2)(2007-12#1)
We experimentally demonstrate the generation of##2##6##(2007-12#2)
We experimentally demonstrate the##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
We experimentally demonstrate##15##3##(2007-11#7)(2007-12#4)(2008-2#1)(2008-3#3)
We experimentally##28##2##(2007-11#10)(2007-12#5)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#2)(2012-2#1)
We explain the##4##3##(1997-3#1)(2007-11#1)(2008-3#1)(2009-6#1)
We explain##6##2##(1997-3#1)(2007-11#1)(2008-3#2)(2009-6#1)(2009-8#1)
We exploit the##3##3##(2007-12#2)(2010-12#1)
We exploit##4##2##(2007-12#2)(2008-3#1)(2010-12#1)
We exploited##4##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)
We explore how##3##3##(2008-8#2)(2013-1#1)
We explore the effects of##2##5##(2008-3#1)(2008-8#1)
We explore the##10##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-5#1)(2010-3#1)(2010-8#1)
We explore##15##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
We explored the interaction##2##4##(2008-4#1)(2011-3#1)
We explored the possibility##2##4##(1993-12#1)(2008-2#1)
We explored the##11##3##(1993-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#1)
We explored##18##2##(1993-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
We exposed##2##2##(2008-10#1)(2008-11#1)
We expressed##4##2##(1992-12#1)(1994-11#1)(1994-12#1)(2008-10#1)
We extend the method##2##4##(2008-2#1)(2009-9#1)
We extend the##7##3##(1994-9#1)(1997-2#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#2)
We extend these##2##3##(2008-9#2)
We extend this##3##3##(2007-12#1)(2008-3#2)
We extend##16##2##(1994-9#1)(1997-2#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#2)(2012-3#1)
We extended##2##2##(2008-7#1)(2009-8#1)
We extracted##4##2##(2007-10#1)(2008-5#1)(2011-2#2)
We fabricated a##2##3##(2007-12#1)(2008-2#1)
We fabricated an##2##3##(2008-2#2)
We fabricated##9##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
We failed to##2##3##(2008-5#1)(2008-9#1)
We feel that##2##3##(2008-8#1)(2009-6#1)
We feel##3##2##(2008-8#2)(2009-6#1)
We finally show that##2##4##(2007-11#1)(2008-3#1)
We finally##7##2##(1994-2#1)(2007-11#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-3#2)
We find a##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
We find an##2##3##(2007-12#1)(2009-10#1)
We find evidence##2##3##(2012-2#1)(2012-3#1)
We find good##2##3##(2007-12#1)(2008-3#1)
We find no##3##3##(1990-7#1)(2008-11#1)(2009-10#1)
We find striking##2##3##(2008-7#1)(2013-1#1)
We find strong##2##3##(1994-1#1)(2009-11#1)
We find that in this first year##2##7##(2013-1#2)
We find that in##3##4##(2008-3#1)(2013-1#2)
We find that nonlinear##2##4##(2007-11#1)(2008-8#1)
We find that the maximum##2##5##(2008-10#1)(2012-2#1)
We find that the##29##4##(1992-2#1)(1993-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
We find that there##2##4##(1991-3#1)(2008-3#1)
We find that two##2##4##(2008-8#1)(2008-9#1)
We find that##94##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#12)(2008-5#2)(2008-7#6)(2008-8#9)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
We find the##7##3##(1990-6#1)(1994-11#1)(1994-9#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
We find##130##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-11#8)(2007-12#8)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#15)(2008-5#4)(2008-7#8)(2008-8#11)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#1)
We first describe how##2##4##(2008-10#1)(2009-11#1)
We first describe##3##3##(2008-10#2)(2009-11#1)
We first discuss the##3##4##(1996-2#1)(2008-2#1)(2008-3#1)
We first discuss##5##3##(1996-2#1)(2008-2#2)(2008-3#1)(2008-8#1)
We first give##2##3##(2008-3#1)(2008-6#1)
We first report##2##3##(2008-8#1)(2009-9#1)
We first show##2##3##(2008-10#1)(2008-3#1)
We first study##2##3##(2008-7#1)(2008-8#1)
We first##31##2##(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#5)(2009-11#1)(2009-9#1)(2010-11#1)
We firstly##2##2##(2008-11#1)(2009-6#1)
We fit##2##2##(1997-8#1)(2007-12#1)
We focus on the##8##4##(2008-10#1)(2008-3#3)(2008-8#1)(2012-12#1)(2013-8#2)
We focus on##14##3##(2008-10#1)(2008-3#5)(2008-8#1)(2009-9#1)(2010-3#1)(2012-12#2)(2013-8#3)
We focused on the##2##4##(2008-10#1)(2008-3#1)
We focused on##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-3#1)
We foresee##2##2##(1991-6#1)(2008-7#1)
We formed##2##2##(1992-12#1)(2008-3#1)
We formulate the##2##3##(2008-3#2)
We formulate##5##2##(2008-2#1)(2008-3#2)(2008-6#1)(2011-2#1)
We found a significant##2##4##(2008-7#1)(2011-1#1)
We found a##11##3##(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#3)
We found evidence##2##3##(2008-5#1)(2008-8#1)
We found good##2##3##(1992-5#1)(2011-2#1)
We found high levels of##2##5##(1991-3#1)(2011-1#1)
We found in##2##3##(1990-11#1)(2008-11#1)
We found increased##2##3##(1994-2#1)(1996-3#1)
We found it##2##3##(1995-2#1)(1997-3#1)
We found no effect of##2##5##(1991-11#1)(2008-8#1)
We found no evidence##3##4##(1991-8#1)(2008-3#1)(2011-2#1)
We found no significant##2##4##(2008-1#1)(2011-2#1)
We found no statistically significant##3##5##(1994-3#1)(2008-4#1)(2011-2#1)
We found no##18##3##(1991-11#1)(1991-8#1)(1992-11#1)(1994-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2010-7#1)(2011-2#4)
We found significant differences##2##4##(2011-1#1)(2011-3#1)
We found significant##3##3##(2011-1#1)(2011-3#1)(2012-2#1)
We found substantial##2##3##(2008-12#1)(2010-12#1)
We found that a##7##4##(1994-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-9#1)(2012-2#1)
We found that all##2##4##(1992-5#1)(2008-10#1)
We found that as the##2##5##(2009-8#1)(2010-2#1)
We found that both##3##4##(2008-5#1)(2009-8#1)(2012-2#1)
We found that for##3##4##(2008-2#2)(2008-8#1)
We found that in the##2##5##(1993-8#1)(2008-10#1)
We found that in##5##4##(1993-8#1)(1995-6#1)(2008-10#1)(2008-8#2)
We found that many##2##4##(1995-5#1)(2012-3#1)
We found that most##2##4##(2008-3#1)(2008-7#1)
We found that response##2##4##(2012-1#1)(2013-8#1)
We found that the SCC-DFTB and PMO methods (the latter available so far only for molecules consisting of only O and H and therefore only for the first of the three model systems) give results that are##2##37##(2012-12#2)
We found that the order of##2##6##(1995-11#1)(2008-3#1)
We found that the##62##4##(1990-12#2)(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#2)(1995-11#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-2#1)(2009-8#2)(2010-2#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
We found that there##2##4##(1997-2#1)(2007-11#1)
We found that these##2##4##(1996-2#1)(2013-1#1)
We found that this##4##4##(1997-1#1)(2008-8#1)(2009-10#1)(2012-2#1)
We found that treatment with##2##5##(2009-8#1)(2011-2#1)
We found that two##2##4##(2009-10#1)(2011-2#1)
We found that##209##3##(1990-12#2)(1990-5#3)(1990-9#2)(1991-2#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#1)(2008-10#16)(2008-11#12)(2008-12#1)(2008-2#11)(2008-3#20)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#6)(2009-10#2)(2009-2#3)(2009-4#2)(2009-7#2)(2009-8#7)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
We found the highest##2##4##(2008-10#2)
We found the##9##3##(1991-3#1)(1992-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#1)(2013-8#1)
We found two##2##3##(2007-12#1)(2008-10#1)
We found##309##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-9#3)(1991-11#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#2)(1992-12#2)(1992-5#2)(1992-6#1)(1992-8#2)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#6)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#23)(2008-11#16)(2008-12#3)(2008-2#13)(2008-3#23)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#17)(2008-9#8)(2009-10#2)(2009-2#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#8)(2010-12#3)(2010-2#5)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#9)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#11)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#5)
We further characterize the##2##4##(2008-2#1)(2013-8#1)
We further demonstrate##2##3##(2008-10#1)(2013-8#1)
We further demonstrated that##2##4##(2008-10#1)(2012-2#1)
We further investigated the##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
We further investigated##4##3##(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
We further propose a##2##4##(2009-10#1)(2012-3#1)
We further show that the##2##5##(2008-10#1)(2008-3#1)
We further show that##6##4##(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
We further show##7##3##(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-12#1)
We further##38##2##(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-9#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-8#2)
We furthermore discuss the##2##4##(2008-1#1)(2008-3#1)
We generalize the##3##3##(1997-7#1)(2008-2#1)(2008-3#1)
We generalize##6##2##(1997-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)
We generate our##2##3##(2007-12#2)
We generate##3##2##(2007-12#2)(2013-1#1)
We generated a##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
We generated the##2##3##(2007-11#1)(2007-12#1)
We generated##12##2##(1993-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
We genotyped##4##2##(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
We give a##6##3##(1996-8#1)(2007-12#2)(2008-2#1)(2008-3#2)
We give an##3##3##(2007-12#1)(2008-2#2)
We give the##2##3##(2008-2#1)(2008-3#1)
We give##19##2##(1992-11#1)(1996-8#1)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#4)(2012-3#1)(2013-8#2)
We grew##2##2##(2007-12#1)(2008-10#1)
We had##9##2##(1992-2#1)(1993-9#1)(1994-12#1)(1997-4#1)(2007-11#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)
We have achieved##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
We have addressed the##2##4##(1994-6#1)(2009-3#1)
We have addressed this##2##4##(1995-11#1)(2012-2#1)
We have addressed##4##3##(1994-6#1)(1995-11#1)(2009-3#1)(2012-2#1)
We have already reported that##2##5##(1997-4#1)(2008-11#1)
We have already##4##3##(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
We have also characterized##2##4##(1991-8#1)(1993-11#1)
We have also demonstrated that##4##5##(1994-12#1)(2008-10#2)(2008-4#1)
We have also demonstrated the utility of##2##7##(2007-12#1)(2008-10#1)
We have also demonstrated##7##4##(1994-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)
We have also developed##2##4##(2008-10#1)(2009-6#1)
We have also found that##3##5##(1994-6#1)(2008-9#1)(2013-8#1)
We have also observed##2##4##(2008-10#1)(2009-1#1)
We have also shown that the##2##6##(2008-4#1)(2009-11#1)
We have also shown that##3##5##(2008-10#1)(2008-4#1)(2009-11#1)
We have also##34##3##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-3#1)(2013-8#1)
We have amplified##2##3##(1990-3#1)(1992-8#1)
We have analysed the##5##4##(1994-12#1)(1995-11#1)(1997-7#1)(2009-12#1)(2012-1#1)
We have analysed##6##3##(1994-12#1)(1995-11#1)(1997-7#2)(2009-12#1)(2012-1#1)
We have analyzed the effects of##2##6##(1990-5#1)(2008-3#1)
We have analyzed the expression##2##5##(1992-12#1)(1992-3#1)
We have analyzed the##10##4##(1990-5#1)(1992-12#1)(1992-3#2)(1992-9#1)(1994-11#1)(2008-2#1)(2008-3#2)(2009-4#1)
We have analyzed##14##3##(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-9#1)(1994-11#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-4#1)
We have applied the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
We have applied##8##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
We have assessed##2##3##(1993-2#1)(2011-2#1)
We have attempted to##3##4##(1990-5#1)(1991-12#1)(1994-6#1)
We have attempted##4##3##(1990-5#1)(1991-12#1)(1994-11#1)(1994-6#1)
We have been working##2##4##(1994-3#1)(2008-10#1)
We have been##7##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
We have built a##4##4##(2007-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
We have carried out##2##4##(1993-2#1)(2012-2#1)
We have characterized a##2##4##(1997-2#1)(2008-10#1)
We have characterized the##3##4##(1996-12#1)(1997-2#1)(2011-1#1)
We have characterized##10##3##(1994-12#1)(1996-12#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-2#1)
We have chosen##2##3##(2009-5#1)(2009-7#1)
We have cloned a##6##4##(1991-7#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-7#1)
We have cloned and sequenced a##3##6##(1991-6#1)(1993-3#1)(1993-6#1)
We have cloned and sequenced##6##5##(1991-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(2008-10#1)
We have cloned and##8##4##(1991-6#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(2008-10#1)
We have cloned the gene##3##5##(1991-6#1)(1991-9#1)(1995-11#1)
We have cloned the##7##4##(1990-11#1)(1991-6#1)(1991-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)
We have cloned##25##3##(1990-11#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#2)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#1)
We have combined##2##3##(2008-10#1)(2010-10#1)
We have come##2##3##(1991-1#1)(2008-2#1)
We have compared the##5##4##(1995-2#2)(1997-2#1)(2007-11#1)(2008-7#1)
We have compared##13##3##(1993-12#1)(1995-2#2)(1997-2#1)(2007-11#2)(2008-11#2)(2008-3#2)(2008-7#3)
We have completed##2##3##(1990-7#1)(1996-12#1)
We have conducted a##2##4##(1994-2#1)(2009-10#1)
We have conducted##4##3##(1994-2#1)(2008-3#1)(2009-10#1)(2009-5#1)
We have confirmed that##2##4##(2008-3#1)(2008-5#1)
We have confirmed##4##3##(2008-11#1)(2008-3#1)(2008-5#2)
We have considered the##2##4##(1994-3#1)(2007-12#1)
We have considered##4##3##(1990-7#1)(1994-3#1)(2007-12#1)(2008-10#1)
We have constructed a##12##4##(1995-6#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-9#1)(2010-10#1)(2012-2#1)
We have constructed an##4##4##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
We have constructed and##3##4##(1995-2#1)(2007-12#1)(2008-3#1)
We have constructed two##3##4##(1991-5#1)(1993-12#1)(1994-12#1)
We have constructed##28##3##(1991-5#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#8)(2008-9#1)(2010-10#1)(2012-2#1)
We have created a##2##4##(1993-12#1)(2007-12#1)
We have created##3##3##(1993-12#1)(2007-12#1)(2008-3#1)
We have demonstrated a##8##4##(1994-3#1)(1995-12#1)(2007-11#3)(2008-2#1)(2008-3#1)(2013-8#1)
We have demonstrated previously that##2##5##(1990-11#1)(2008-4#1)
We have demonstrated that the##4##5##(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
We have demonstrated that##11##4##(1994-6#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
We have demonstrated the use of##2##6##(2008-3#2)
We have demonstrated the##7##4##(2007-11#1)(2007-12#1)(2008-3#3)(2010-8#1)(2013-1#1)
We have demonstrated this##2##4##(1995-11#1)(2007-11#1)
We have demonstrated##46##3##(1990-11#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(2007-11#10)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We have derived##2##3##(2008-3#1)(2008-7#1)
We have described a##2##4##(1994-5#1)(2008-7#1)
We have described the##2##4##(1994-5#2)
We have described##5##3##(1994-5#3)(2008-7#1)(2011-2#1)
We have designed a##3##4##(2007-7#1)(2008-2#2)
We have designed and built a##3##6##(2008-3#2)(2009-8#1)
We have designed and##7##4##(2007-12#1)(2008-2#1)(2008-3#4)(2009-8#1)
We have designed##12##3##(1995-5#1)(2007-12#1)(2007-7#1)(2008-2#3)(2008-3#5)(2009-8#1)
We have detected##2##3##(1993-12#1)(1993-9#1)
We have determined that##2##4##(1992-10#1)(1997-2#1)
We have determined the complete##2##5##(1993-2#1)(1995-9#1)
We have determined the nucleotide sequence of##2##7##(1990-5#1)(1997-3#1)
We have determined the##9##4##(1990-5#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-9#1)(1997-3#1)(2007-5#1)(2008-10#1)(2011-2#1)
We have determined##13##3##(1990-5#1)(1992-10#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-9#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
We have developed a diode-pumped##2##5##(2007-11#1)(2008-3#1)
We have developed a facile##2##5##(1994-12#1)(2010-12#1)
We have developed a fast and##2##6##(2008-11#1)(2012-2#1)
We have developed a highly parallelized QM/MM implementation in the NAMD and OpenAtom simulation packages##2##15##(2013-1#2)
We have developed a method##3##5##(2008-5#1)(2008-7#1)(2009-11#1)
We have developed a model##3##5##(1997-3#1)(2008-2#1)(2008-7#1)
We have developed a new method for##2##7##(2008-10#1)(2008-2#1)
We have developed a new##10##5##(1990-8#1)(1991-12#1)(1993-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
We have developed a novel##4##5##(2007-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
We have developed a sensitive and##2##6##(1997-7#1)(2008-5#1)
We have developed a sensitive##3##5##(1992-9#1)(1997-7#1)(2008-5#1)
We have developed a simple##6##5##(1993-12#1)(1994-11#1)(2007-11#1)(2008-11#2)(2008-3#1)
We have developed a stabilized##2##5##(2008-3#1)(2010-5#1)
We have developed a technique##2##5##(2008-11#1)(2008-3#1)
We have developed a##90##4##(1990-11#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#8)(2007-12#5)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#15)(2008-5#6)(2008-7#4)(2008-9#2)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
We have developed an efficient##2##5##(1991-9#1)(2008-11#1)
We have developed an optical##2##5##(2007-11#1)(2007-12#1)
We have developed an##15##4##(1990-12#1)(1991-9#1)(1993-8#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-9#1)(2011-3#1)(2012-1#1)
We have developed and##3##4##(2008-10#1)(2008-11#1)(2009-6#1)
We have developed several##2##4##(2008-10#1)(2008-2#1)
We have developed the##3##4##(1994-6#1)(2007-10#1)(2013-1#1)
We have developed##120##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#10)(2007-12#8)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#20)(2008-5#7)(2008-7#4)(2008-9#2)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
We have directly##3##3##(1994-8#1)(1995-2#1)(2008-3#1)
We have discovered a novel##2##5##(2008-7#1)(2013-1#1)
We have discovered##3##3##(2008-7#1)(2010-4#1)(2013-1#1)
We have done##2##3##(2007-12#1)(2008-5#1)
We have employed##5##3##(1990-6#1)(1993-9#1)(1994-12#1)(2008-2#1)(2008-9#1)
We have established a new##2##5##(2008-11#1)(2008-9#1)
We have established a##7##4##(1995-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
We have established##10##3##(1994-8#1)(1995-3#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
We have evaluated the##7##4##(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#4)
We have evaluated##10##3##(1990-12#1)(1994-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#4)
We have examined the effect of##4##6##(1992-9#1)(1993-12#1)(1995-5#1)(1997-4#1)
We have examined the effects of##3##6##(1990-8#1)(1992-1#1)(1995-5#1)
We have examined the possibility of##2##6##(1991-12#1)(2008-2#1)
We have examined the##19##4##(1990-5#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-6#1)(1995-5#3)(1995-6#1)(1996-12#1)(1997-4#1)(2008-2#1)(2008-3#2)(2009-5#1)
We have examined##30##3##(1990-5#2)(1990-8#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-5#1)(2010-11#1)
We have experimentally observed##2##4##(2007-12#1)(2008-2#1)
We have experimentally##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
We have exploited the##2##4##(1992-4#1)(1994-2#1)
We have exploited##3##3##(1992-4#1)(1994-2#1)(2008-8#1)
We have explored the##2##4##(1991-9#1)(2008-7#1)
We have explored##3##3##(1991-9#1)(2008-7#1)(2008-9#1)
We have expressed the##2##4##(1994-8#1)(1997-4#1)
We have expressed##5##3##(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#1)(1997-4#1)
We have extended the##2##4##(1995-11#1)(2008-2#1)
We have extended##3##3##(1995-11#1)(2008-11#1)(2008-2#1)
We have fabricated a##2##4##(2007-11#1)(2007-12#1)
We have fabricated##10##3##(2007-11#3)(2007-12#4)(2008-3#3)
We have focused##2##3##(1997-1#1)(2008-7#1)
We have found a##2##4##(2007-12#1)(2011-1#1)
We have found that the##3##5##(1991-5#1)(1993-3#1)(2007-11#1)
We have found that##31##4##(1990-5#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-5#1)(2009-12#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
We have found the##2##4##(2010-8#1)(2012-3#1)
We have found##41##3##(1990-5#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
We have further##3##3##(1991-2#1)(1996-12#1)(2008-2#1)
We have generated##5##3##(1993-12#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#1)
We have identified a##11##4##(1990-5#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-6#1)(1995-9#1)(2008-7#1)(2010-11#1)
We have identified an##2##4##(1990-2#1)(1991-5#1)
We have identified and##2##4##(1995-2#1)(2008-10#1)
We have identified the##4##4##(1991-12#1)(1993-3#1)(2008-8#1)(2010-11#1)
We have identified##31##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#2)(2010-3#2)(2011-2#1)(2013-7#1)
We have implemented##4##3##(1995-12#1)(2008-3#2)(2009-6#1)
We have improved the##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
We have investigated how##4##4##(1994-8#1)(1996-2#1)(2008-7#1)(2009-8#1)
We have investigated the effect of the##2##7##(1994-11#1)(1996-2#1)
We have investigated the effect of##5##6##(1992-3#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-7#1)
We have investigated the effects of##3##6##(1996-2#1)(1996-5#1)(2008-7#1)
We have investigated the effects##4##5##(1996-2#1)(1996-3#1)(1996-5#1)(2008-7#1)
We have investigated the influence of##3##6##(2008-11#2)(2008-2#1)
We have investigated the relationship##2##5##(1994-6#1)(1996-12#1)
We have investigated the use of##3##6##(2008-10#1)(2008-12#1)(2008-7#1)
We have investigated the##38##4##(1990-3#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(2007-11#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#5)(2009-10#1)(2012-2#1)
We have investigated whether##3##4##(1994-9#1)(1995-12#1)(1995-2#1)
We have investigated##53##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2009-10#1)(2009-8#1)(2012-2#1)
We have isolated a##6##4##(1990-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(2008-11#1)(2008-6#1)
We have isolated and characterized##2##5##(1992-9#1)(1997-6#1)
We have isolated and sequenced##2##5##(1990-7#1)(1993-6#1)
We have isolated and##8##4##(1990-11#1)(1990-12#1)(1990-7#1)(1992-9#1)(1993-6#1)(1994-9#1)(1997-6#1)(2008-11#1)
We have isolated##20##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#3)(1994-12#2)(1994-9#1)(1997-6#1)(2008-11#2)(2008-6#1)
We have learned a great deal##2##6##(1991-12#1)(2008-11#1)
We have learned##5##3##(1991-12#3)(2008-11#1)(2008-3#1)
We have made##2##3##(2008-10#1)(2009-8#1)
We have measured serum##2##4##(1992-2#1)(2008-6#1)
We have measured the##9##4##(1991-5#1)(1995-2#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
We have measured##16##3##(1991-5#2)(1991-8#1)(1992-2#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)(2008-6#1)
We have modeled the##2##4##(2008-3#2)
We have modeled##4##3##(2008-11#1)(2008-3#3)
We have modified##2##3##(2008-11#1)(2008-2#1)
We have not##5##3##(2008-10#2)(2008-6#1)(2009-3#1)(2010-12#1)
We have now examined##2##4##(1990-12#1)(2008-8#1)
We have now studied the##2##5##(1994-5#1)(1995-3#1)
We have now##13##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
We have observed that the analgesic requirments decreased to##2##9##(2007-11#2)
We have observed that##7##4##(1995-6#1)(1996-2#1)(2007-11#2)(2008-11#1)(2010-5#1)(2013-1#1)
We have observed##21##3##(1992-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#4)(2007-12#7)(2008-11#1)(2008-7#2)(2009-9#1)(2010-5#1)(2013-1#1)
We have obtained for##2##4##(2008-10#2)
We have obtained the##2##4##(1993-8#1)(2008-2#1)
We have obtained##8##3##(1990-5#1)(1993-8#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
We have partially##2##3##(2008-10#1)(2012-3#1)
We have performed##7##3##(1990-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)
We have prepared##4##3##(1991-12#1)(1995-2#1)(2008-10#1)(2009-9#1)
We have previously constructed##2##4##(1995-6#1)(1996-12#1)
We have previously demonstrated that the##3##6##(1992-12#1)(1994-11#1)(2008-11#1)
We have previously demonstrated that##5##5##(1992-12#1)(1994-11#1)(1994-6#1)(2008-11#1)(2013-8#1)
We have previously demonstrated##7##4##(1992-12#1)(1993-11#1)(1994-11#1)(1994-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
We have previously identified##2##4##(1994-11#1)(1994-8#1)
We have previously reported that##4##5##(1992-8#1)(1995-5#1)(1996-12#1)(2008-4#1)
We have previously reported the##2##5##(1994-8#1)(2010-3#1)
We have previously reported##8##4##(1991-2#1)(1992-8#1)(1994-8#1)(1995-5#1)(1996-12#1)(2008-4#1)(2010-3#1)(2011-1#1)
We have previously shown that a##3##6##(1994-11#1)(2008-5#1)(2012-3#1)
We have previously shown that the##6##6##(1993-6#1)(1995-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
We have previously shown that##22##5##(1991-12#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
We have previously shown##24##4##(1991-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
We have previously##54##3##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We have produced a##3##4##(1994-3#2)(2008-11#1)
We have produced rabbit antibodies##2##5##(1991-12#1)(1991-9#1)
We have produced##8##3##(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-3#2)(1997-7#1)(2008-11#1)
We have proposed a##2##4##(1996-5#1)(2007-11#1)
We have proposed that##3##4##(1995-2#1)(1996-9#1)(2012-2#1)
We have proposed##5##3##(1995-2#1)(1996-5#1)(1996-9#1)(2007-11#1)(2012-2#1)
We have purified##4##3##(1991-2#1)(1992-8#1)(1993-9#1)(1996-2#1)
We have recently demonstrated that the##4##6##(1994-2#1)(2009-8#2)(2010-11#1)
We have recently demonstrated that##5##5##(1994-2#1)(2008-7#1)(2009-8#2)(2010-11#1)
We have recently demonstrated##7##4##(1994-2#1)(2008-7#1)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)
We have recently described an##2##5##(1994-5#1)(2011-2#1)
We have recently described##3##4##(1991-12#1)(1994-5#1)(2011-2#1)
We have recently developed a##2##5##(1996-7#1)(2008-11#1)
We have recently developed##4##4##(1996-7#1)(2008-11#1)(2008-3#2)
We have recently identified##2##4##(1990-8#1)(1991-5#1)
We have recently proposed that##2##5##(2008-11#1)(2009-8#1)
We have recently proposed##3##4##(1995-12#1)(2008-11#1)(2009-8#1)
We have recently purified##2##4##(1991-2#1)(1992-12#1)
We have recently reported that##3##5##(1995-6#1)(2009-8#1)(2012-2#1)
We have recently reported the##2##5##(1991-2#1)(1991-8#1)
We have recently reported##6##4##(1991-2#1)(1991-8#1)(1995-6#1)(2008-11#1)(2009-8#1)(2012-2#1)
We have recently shown that human##2##6##(1990-5#1)(1994-5#1)
We have recently shown that##12##5##(1990-5#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-1#2)(2008-10#1)(2009-8#4)(2011-2#1)
We have recently##51##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-3#3)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#9)(2010-11#1)(2011-2#4)(2012-2#1)
We have reconstituted this##2##4##(1992-12#1)(1995-12#1)
We have reported a##2##4##(1993-3#1)(2012-12#1)
We have reported that##2##4##(1995-11#1)(2008-10#1)
We have reported the##4##4##(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)
We have reported##10##3##(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-6#1)
We have reviewed the literature##2##5##(2008-5#1)(2012-12#1)
We have reviewed the##5##4##(1990-2#1)(1991-9#1)(2008-5#1)(2008-8#1)(2012-12#1)
We have reviewed##6##3##(1990-2#1)(1991-9#1)(1992-12#1)(2008-5#1)(2008-8#1)(2012-12#1)
We have selected one or two primary protocols for tasks such as domain detection##2##14##(2008-2#1)(2008-4#1)
We have sequenced a##2##4##(1995-6#1)(2008-5#1)
We have sequenced##4##3##(1990-5#2)(1995-6#1)(2008-5#1)
We have shown previously that##3##5##(1992-9#1)(1995-11#1)(2009-8#1)
We have shown that this##2##5##(2007-12#1)(2008-10#1)
We have shown that##14##4##(1992-11#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#2)(2010-7#1)(2012-3#1)(2013-8#1)
We have shown##20##3##(1991-12#1)(1992-11#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#2)(2010-7#1)(2012-3#1)(2013-8#1)
We have studied a##3##4##(1997-3#1)(2008-1#1)(2008-2#1)
We have studied the effect of##5##6##(1990-2#1)(1993-12#1)(1994-11#1)(1995-6#1)(1997-7#1)
We have studied the effects of##2##6##(1994-8#1)(1995-12#1)
We have studied the optical##2##5##(2008-2#1)(2008-3#1)
We have studied the##29##4##(1990-12#1)(1990-2#1)(1990-7#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2009-9#1)(2012-2#1)
We have studied##42##3##(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1991-2#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#4)(2009-9#1)(2012-2#1)(2012-3#1)
We have succeeded in##2##4##(2008-11#1)(2008-7#1)
We have successfully##5##3##(1997-4#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-7#1)
We have synthesized three##2##4##(1991-12#1)(2013-1#1)
We have synthesized##5##3##(1991-12#2)(2009-7#1)(2012-2#1)(2013-1#1)
We have systematically##2##3##(2008-2#1)(2008-9#1)
We have tested the##3##4##(1995-2#1)(2007-12#1)(2008-11#1)
We have tested this##3##4##(1991-9#1)(1992-11#1)(2009-2#1)
We have tested##9##3##(1991-9#1)(1992-11#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-2#1)
We have therefore##3##3##(1995-8#1)(2008-6#1)(2008-9#1)
We have treated##3##3##(1997-2#1)(2008-6#1)(2012-2#1)
We have tried##2##3##(1992-4#1)(2007-8#1)
We have undertaken##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
We have used DNA##2##4##(2008-7#1)(2010-5#1)
We have used a combination of##2##6##(1994-9#1)(2008-11#1)
We have used a##11##4##(1990-11#1)(1990-2#1)(1992-3#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
We have used in##2##4##(1995-12#1)(1995-2#1)
We have used relative##2##4##(1997-5#1)(2008-7#1)
We have used the##7##4##(1991-12#1)(1995-6#1)(1997-4#2)(2008-10#1)(2008-3#1)(2008-7#1)
We have used this technique to##2##6##(2008-10#1)(2008-11#1)
We have used this##5##4##(1991-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
We have used##55##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-9#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-7#3)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#2)
We have utilized##3##3##(1994-8#1)(1997-7#1)(2008-4#1)
We have verified the##2##4##(2007-11#1)(2008-3#1)
We have##1126##2##(1990-11#8)(1990-12#7)(1990-2#5)(1990-3#2)(1990-5#16)(1990-6#1)(1990-7#7)(1990-8#7)(1991-1#1)(1991-12#23)(1991-2#8)(1991-3#2)(1991-5#11)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#16)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#11)(1992-2#2)(1992-3#9)(1992-4#2)(1992-6#4)(1992-8#11)(1992-9#12)(1993-10#1)(1993-11#10)(1993-12#17)(1993-2#6)(1993-3#6)(1993-5#1)(1993-6#12)(1993-8#6)(1993-9#7)(1994-1#1)(1994-11#9)(1994-12#16)(1994-2#4)(1994-3#6)(1994-5#6)(1994-6#9)(1994-8#13)(1994-9#7)(1995-11#12)(1995-12#12)(1995-2#22)(1995-3#5)(1995-5#9)(1995-6#14)(1995-8#6)(1995-9#2)(1996-10#1)(1996-12#11)(1996-2#13)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#11)(1997-3#4)(1997-4#10)(1997-5#2)(1997-6#2)(1997-7#11)(1997-8#3)(2006-6#1)(2007-10#1)(2007-11#54)(2007-12#52)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#72)(2008-11#54)(2008-12#4)(2008-2#38)(2008-3#103)(2008-4#9)(2008-5#20)(2008-6#7)(2008-7#37)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#16)(2009-9#5)(2010-10#2)(2010-11#4)(2010-12#3)(2010-3#8)(2010-4#3)(2010-5#5)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#21)(2012-3#9)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#6)
We here report a case of##2##6##(2009-5#1)(2011-1#1)
We here report the##3##4##(1991-12#1)(2011-2#1)(2013-1#1)
We here report##5##3##(1991-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
We here review the##2##4##(1996-6#1)(2013-1#1)
We here##16##2##(1990-12#1)(1991-12#1)(1993-11#1)(1996-6#1)(2007-7#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
We hereby present a patient with a##2##7##(2009-11#1)(2009-8#1)
We hereby present##4##3##(2009-11#1)(2009-8#1)(2013-1#2)
We hereby report a##2##4##(2007-7#1)(2012-12#1)
We hereby report the case##2##5##(2013-1#2)
We hereby report##5##3##(2007-7#1)(2008-7#1)(2012-12#1)(2013-1#2)
We hereby##11##2##(2007-7#1)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#5)
We herein present##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
We herein report a case of##2##6##(1990-6#1)(2010-4#1)
We herein report a case##3##5##(1990-6#1)(2010-4#1)(2012-2#1)
We herein report a##5##4##(1990-6#1)(1992-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
We herein report the##2##4##(1993-8#1)(1997-2#1)
We herein report##9##3##(1990-6#1)(1992-12#1)(1993-8#1)(1997-2#1)(2010-4#1)(2010-6#2)(2012-2#1)(2013-1#1)
We herein review the##2##4##(2007-10#1)(2013-8#1)
We herein##17##2##(1990-6#1)(1992-12#1)(1993-8#1)(1997-2#1)(2007-10#1)(2009-12#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#3)
We herewith report##2##3##(2008-1#2)
We highlight##3##2##(2008-8#1)(2011-2#2)
We hope that the##2##4##(2010-3#1)(2013-8#1)
We hope that this##2##4##(2008-10#1)(2011-1#1)
We hope that##8##3##(1993-11#1)(2008-10#2)(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
We hope to##2##3##(1996-2#1)(2007-10#1)
We hope##12##2##(1992-4#1)(1993-11#1)(1996-2#1)(2007-10#1)(2008-10#2)(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
We hypothesize that the##6##4##(1991-9#1)(1997-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
We hypothesize that##28##3##(1991-9#1)(1992-6#2)(1993-9#1)(1994-6#1)(1997-3#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#2)(2012-1#1)(2012-12#1)(2013-1#1)
We hypothesized that a##2##4##(1990-2#1)(1995-5#1)
We hypothesized that the##5##4##(1991-9#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-5#1)
We hypothesized that this##3##4##(2008-8#1)(2009-4#1)(2011-2#1)
We hypothesized that##23##3##(1990-2#1)(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#2)(2011-2#3)(2012-1#1)(2012-12#1)
We identified a region on##2##5##(2010-3#2)
We identified a##11##3##(1991-2#1)(1992-3#1)(1993-6#1)(2008-10#3)(2009-10#1)(2010-12#1)(2010-3#3)
We identified the##7##3##(1990-11#1)(1991-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
We identified three##3##3##(2007-10#1)(2012-12#1)(2012-3#1)
We identified##43##2##(1990-11#1)(1991-2#2)(1991-6#1)(1992-3#1)(1993-6#1)(1994-12#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#3)(2011-2#1)(2012-12#4)(2012-3#4)(2013-1#2)
We identify a##2##3##(2007-11#1)(2008-3#1)
We identify the##6##3##(1993-2#1)(2008-2#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
We identify##18##2##(1993-2#1)(1994-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
We illustrate the method##2##4##(1994-9#1)(2007-11#1)
We illustrate the##13##3##(1994-9#1)(1995-2#2)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2011-2#1)
We illustrate them##2##3##(2008-7#1)(2013-1#1)
We illustrate this##6##3##(1994-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)
We illustrate##26##2##(1994-2#2)(1994-9#1)(1995-2#2)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
We implement a##2##3##(2007-11#2)
We implement##6##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
We implemented a##2##3##(2008-3#2)
We implemented the##2##3##(2008-3#2)
We implemented##5##2##(2007-12#1)(2008-3#4)
We improve##2##2##(2008-2#1)(2008-3#1)
We included all##2##3##(2007-10#1)(2007-7#1)
We included##6##2##(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2013-1#2)
We incorporate##2##2##(2008-10#1)(2008-3#1)
We induced##2##2##(1994-11#1)(2007-10#1)
We infected two##2##3##(2008-11#1)(2008-9#1)
We infer##3##2##(1991-5#1)(1993-12#1)(1996-5#1)
We inferred##2##2##(2008-7#1)(2009-2#1)
We initiated##2##2##(2008-11#1)(2008-3#1)
We injected##2##2##(1995-12#1)(2010-1#1)
We inoculated##2##2##(2008-10#2)
We inserted##2##2##(1992-3#1)(2013-1#1)
We intend to##4##3##(2007-12#1)(2008-7#1)(2009-8#1)(2012-12#1)
We interpret##3##2##(1993-8#1)(2008-3#2)
We interviewed##2##2##(2012-12#1)(2013-1#1)
We introduce a new##7##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
We introduce a novel##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
We introduce a simple##2##4##(2007-12#1)(2013-1#1)
We introduce a technique##2##4##(2008-3#1)(2008-6#1)
We introduce a##26##3##(2007-11#4)(2007-12#6)(2008-2#4)(2008-3#6)(2008-6#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
We introduce an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
We introduce the##6##3##(1995-12#1)(2007-11#1)(2008-3#3)(2013-1#1)
We introduce##43##2##(1995-12#1)(2007-11#7)(2007-12#7)(2007-8#1)(2008-1#1)(2008-2#6)(2008-3#12)(2008-6#2)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
We introduced##3##2##(1993-3#1)(2008-7#1)(2008-8#1)
We investigate coupling##2##3##(2007-11#1)(2008-3#1)
We investigate experimentally##2##3##(2007-11#1)(2007-12#1)
We investigate how##4##3##(2008-2#1)(2008-8#3)
We investigate the accuracy of##2##5##(2008-3#2)
We investigate the characteristics of##2##5##(2008-2#1)(2008-3#1)
We investigate the dynamics of a##2##6##(2007-11#1)(2007-12#1)
We investigate the effect of##4##5##(2007-11#1)(2008-3#3)
We investigate the effects of##2##5##(2008-2#1)(2009-12#1)
We investigate the evolution of##2##5##(2008-8#1)(2008-9#1)
We investigate the feasibility of##2##5##(2008-2#2)
We investigate the influence of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
We investigate the performance of the##2##6##(1997-3#1)(2008-2#1)
We investigate the sensitivity of##2##5##(2007-12#1)(2013-1#1)
We investigate the use of##3##5##(2007-12#1)(2008-2#2)
We investigate the##57##3##(1995-9#1)(1997-3#1)(2007-11#8)(2007-12#8)(2008-2#15)(2008-3#17)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#1)
We investigate theoretically##2##3##(2008-3#1)(2008-8#1)
We investigate##88##2##(1995-2#1)(1995-9#1)(1997-3#2)(1997-8#1)(2007-11#17)(2007-12#10)(2008-10#1)(2008-11#1)(2008-2#17)(2008-3#22)(2008-6#1)(2008-8#6)(2008-9#2)(2009-12#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
We investigated by##2##3##(2006-6#1)(2010-7#1)
We investigated genetic##2##3##(2008-5#1)(2013-1#1)
We investigated how##2##3##(2007-11#1)(2008-6#1)
We investigated the attractiveness of##2##5##(2008-10#1)(2011-2#1)
We investigated the correlation between##2##5##(2008-4#1)(2008-7#1)
We investigated the correlation##3##4##(2008-3#1)(2008-4#1)(2008-7#1)
We investigated the dependence of##2##5##(2008-3#1)(2008-4#1)
We investigated the effect of##7##5##(1993-11#1)(1994-8#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-3#1)
We investigated the effects of##10##5##(1993-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-11#1)(2012-7#1)(2013-1#1)
We investigated the efficacy of##2##5##(2007-11#1)(2007-8#1)
We investigated the expression pattern of##2##6##(2008-8#1)(2011-2#1)
We investigated the expression pattern##3##5##(2008-8#1)(2008-9#1)(2011-2#1)
We investigated the expression##5##4##(1996-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
We investigated the feasibility of##2##5##(1996-2#1)(2008-11#1)
We investigated the importance of##2##5##(2008-1#1)(2008-10#1)
We investigated the influence of##5##5##(1991-6#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
We investigated the interaction##2##4##(2008-10#1)(2008-11#1)
We investigated the mechanism##3##4##(1993-6#1)(2008-2#1)(2008-4#1)
We investigated the properties of##2##5##(2008-10#1)(2012-2#1)
We investigated the relationship between##2##5##(2008-10#2)
We investigated the relationship##3##4##(2008-10#2)(2008-5#1)
We investigated the role of##7##5##(1993-3#1)(1994-9#1)(1997-8#1)(2008-11#1)(2011-2#1)(2013-1#2)
We investigated the use of##3##5##(1997-3#1)(2007-9#1)(2008-10#1)
We investigated the##103##3##(1991-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#4)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#2)(2009-8#2)(2010-11#1)(2010-2#1)(2011-2#4)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)
We investigated this##5##3##(1990-11#1)(1995-2#1)(2008-4#1)(2008-7#1)(2009-10#1)
We investigated two##3##3##(2008-12#1)(2008-8#1)(2012-3#1)
We investigated whether a##2##4##(1992-6#1)(2007-4#1)
We investigated whether the##3##4##(1994-3#1)(1996-2#1)(2008-6#1)
We investigated whether##20##3##(1992-6#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-3#1)
We investigated which##2##3##(1993-12#1)(2008-8#1)
We investigated##167##2##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#3)(2006-6#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#10)(2008-12#4)(2008-2#5)(2008-3#12)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#3)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#3)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#5)
We isolated a##4##3##(1993-3#1)(1995-6#1)(1997-4#2)
We isolated##13##2##(1991-7#1)(1993-3#2)(1993-8#2)(1995-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-10#2)
We know##5##2##(1997-2#1)(2007-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
We linked##2##2##(1997-1#1)(2008-7#1)
We list##2##2##(2011-1#1)(2013-8#1)
We live in##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
We localized##2##2##(1994-12#1)(1997-4#1)
We locked##2##2##(2008-3#2)
We made a##4##3##(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
We made an##2##3##(2008-3#1)(2013-1#1)
We made##12##2##(1994-8#1)(2007-12#1)(2008-3#2)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
We mainly##2##2##(2013-8#2)
We make recommendations##2##3##(1995-2#1)(2009-6#1)
We make##6##2##(1995-12#1)(1995-2#1)(1997-1#1)(2008-2#1)(2009-6#1)(2013-1#1)
We managed##2##2##(2008-1#1)(2008-3#1)
We mapped the##2##3##(2008-7#1)(2012-3#1)
We mapped##4##2##(2008-10#1)(2008-7#1)(2012-3#2)
We measure the##9##3##(2007-12#4)(2008-2#1)(2008-3#3)(2008-8#1)
We measure##10##2##(2007-12#4)(2008-2#1)(2008-3#3)(2008-8#1)(2011-2#1)
We measured a##2##3##(1996-3#1)(2007-11#1)
We measured an##2##3##(2008-2#1)(2011-2#1)
We measured serum##2##3##(2008-1#1)(2011-1#1)
We measured the absorption##2##4##(2007-12#1)(2008-2#1)
We measured the modulation transfer function##2##6##(2008-2#1)(2008-3#1)
We measured the##35##3##(1994-11#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
We measured total##2##3##(1990-12#1)(2008-12#1)
We measured##67##2##(1990-11#1)(1990-12#1)(1992-9#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#15)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#2)
We microinjected##2##2##(1994-11#1)(1996-5#1)
We model the##3##3##(2008-3#2)(2012-2#1)
We model##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
We modeled the##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
We modified a##2##3##(1996-2#1)(2008-3#1)
We modified##4##2##(1996-2#1)(2007-8#1)(2008-2#1)(2008-3#1)
We modify##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
We monitored##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
We must##4##2##(1994-1#1)(2009-10#1)(2012-3#1)(2013-8#1)
We need a##2##3##(1991-1#1)(1994-1#1)
We need to##8##3##(1991-12#3)(1992-12#1)(1993-1#1)(1994-2#1)(2008-1#1)(2010-4#1)
We need##10##2##(1991-1#1)(1991-12#3)(1992-12#1)(1993-1#1)(1994-1#1)(1994-2#1)(2008-1#1)(2010-4#1)
We note that##5##3##(1994-9#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
We note##7##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)
We noted##3##2##(1994-5#1)(2010-4#1)(2013-8#1)
We now demonstrate that##3##4##(1991-9#1)(1992-12#1)(1993-11#1)
We now demonstrate##4##3##(1991-9#1)(1992-12#1)(1993-11#1)(2008-3#1)
We now describe##2##3##(1995-2#1)(2011-2#1)
We now have##5##3##(1990-9#1)(1993-3#1)(1994-9#1)(2008-3#2)
We now know##4##3##(1991-12#1)(1997-1#1)(2011-2#1)(2013-8#1)
We now present##2##3##(1991-5#1)(1997-7#1)
We now report on the##2##5##(1990-8#1)(1992-6#1)
We now report on##3##4##(1990-8#1)(1992-6#1)(2008-10#1)
We now report that##5##4##(1990-2#1)(1991-12#1)(1991-2#1)(2008-7#1)(2009-10#1)
We now report the full##2##5##(1990-12#1)(1994-6#1)
We now report the results of##2##6##(2008-10#2)
We now report the##7##4##(1990-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(2008-10#2)
We now report##19##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(1997-5#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-8#1)
We now show that a##2##5##(1993-8#1)(2012-2#1)
We now show that##7##4##(1992-6#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(2008-7#1)(2012-2#1)
We now##51##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-9#3)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-3#4)(2008-7#2)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
We numerically##5##2##(2008-2#1)(2008-3#4)
We observe##8##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-6#1)(2009-8#1)(2012-2#1)
We observed a##13##3##(1990-12#1)(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
We observed an improvement##2##4##(1997-6#1)(2008-3#1)
We observed an##5##3##(1997-6#1)(2008-3#2)(2011-2#1)(2012-12#1)
We observed and##2##3##(2007-11#1)(2008-8#1)
We observed no##2##3##(1996-6#1)(2011-2#1)
We observed that the##7##4##(1994-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-6#1)(2012-2#1)(2012-3#1)
We observed that##21##3##(1992-8#1)(1993-2#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
We observed the##6##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
We observed two##4##3##(2007-11#2)(2011-2#1)(2013-1#1)
We observed##76##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#2)(1996-6#1)(1997-6#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
We obtain a##3##3##(1992-9#1)(2007-12#1)(2009-5#1)
We obtain the##4##3##(2008-2#1)(2008-3#3)
We obtain##15##2##(1992-9#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#4)(2009-5#1)
We obtained Q-switched pulses##2##4##(2008-3#2)
We obtained a##6##3##(1990-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
We obtained evidence for##3##4##(1990-5#1)(1991-2#1)(2012-3#1)
We obtained more##2##3##(2007-12#1)(2008-3#1)
We obtained the##3##3##(2007-11#1)(2008-2#1)(2008-9#1)
We obtained three##2##3##(2008-11#1)(2009-3#1)
We obtained##40##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-8#1)(2007-11#6)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#9)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
We offer##4##2##(1994-9#1)(1995-4#1)(2008-3#1)(2009-8#1)
We optimized##2##2##(2008-3#2)
We outline the##6##3##(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
We outline##9##2##(2008-2#2)(2008-3#3)(2008-8#1)(2011-2#1)(2012-2#2)
We parameterize##2##2##(2008-8#1)(2010-3#1)
We perform measurements##2##3##(2007-12#1)(2008-3#1)
We perform##8##2##(1992-6#1)(2007-12#3)(2008-3#1)(2008-6#1)(2010-12#1)(2012-3#1)
We performed a crossover study to compare the effect of vitamin E-modified dialyzers on acute intra-dialytic symptoms##2##17##(2007-7#1)(2008-1#1)
We performed a genome-wide##2##4##(2012-3#2)
We performed a retrospective chart review of##2##7##(2007-10#1)(2008-10#1)
We performed a retrospective##9##4##(2007-10#2)(2008-10#1)(2008-9#1)(2011-2#5)
We performed a systematic review of##2##6##(2007-10#1)(2009-2#1)
We performed a systematic review##3##5##(2007-10#1)(2009-2#1)(2013-8#1)
We performed a systematic##4##4##(2007-10#1)(2009-2#1)(2012-2#1)(2013-8#1)
We performed a##38##3##(1994-2#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#3)
We performed an analysis##2##4##(2008-5#1)(2010-2#1)
We performed an##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-2#1)
We performed experiments##2##3##(2008-3#2)
We performed the##5##3##(2008-12#1)(2008-3#2)(2011-2#1)(2013-1#1)
We performed this##2##3##(1990-8#1)(2008-1#1)
We performed two##2##3##(2008-11#2)
We performed##88##2##(1990-8#1)(1991-8#1)(1994-10#1)(1994-2#1)(1996-12#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#5)
We plan to##2##3##(1994-5#1)(2008-1#1)
We point out that##2##4##(2007-11#1)(2008-2#1)
We point out##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2013-1#1)
We point##8##2##(1991-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We postulate that defects in the human##2##7##(1994-12#2)
We postulate that the##5##4##(1992-3#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
We postulate that##16##3##(1992-12#2)(1992-3#1)(1994-12#2)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
We postulate##17##2##(1992-12#2)(1992-3#1)(1994-12#2)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
We postulated that##3##3##(1990-7#1)(2008-4#1)(2009-12#1)
We postulated##4##2##(1990-7#1)(2008-4#1)(2008-8#1)(2009-12#1)
We predict that##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)
We predict the##3##3##(2007-11#1)(2007-12#2)
We predict##13##2##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2012-2#1)
We prepared several##2##3##(2007-7#1)(2008-3#1)
We prepared##6##2##(1991-9#1)(1995-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)
We present 3 cases##2##4##(2007-4#1)(2011-2#1)
We present a Bayesian##2##4##(1995-2#1)(1997-8#1)
We present a case in which##3##6##(2008-11#1)(2008-7#1)(2010-7#1)
We present a case of a##19##6##(2007-5#2)(2007-8#4)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
We present a case of an##3##6##(2012-1#1)(2012-2#1)(2013-1#1)
We present a case of bilateral##2##6##(2008-9#1)(2013-1#1)
We present a case of pulmonary##2##6##(2013-1#2)
We present a case of##70##5##(1997-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#5)(2008-10#4)(2008-11#1)(2008-12#5)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#4)(2013-1#8)(2013-8#2)
We present a case report of a##3##7##(2007-8#1)(2008-12#1)(2012-12#1)
We present a case report of##4##6##(2007-8#1)(2008-12#1)(2010-7#1)(2012-12#1)
We present a case report##6##5##(1990-3#1)(2007-8#1)(2008-12#1)(2009-8#1)(2010-7#1)(2012-12#1)
We present a case where##2##5##(2007-8#1)(2012-12#1)
We present a case##88##4##(1990-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#7)(2008-10#4)(2008-11#2)(2008-12#7)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-2#9)(2012-1#1)(2012-12#9)(2012-2#5)(2013-1#10)(2013-8#2)
We present a compact##3##4##(2007-12#2)(2008-3#1)
We present a design for##2##5##(2007-12#1)(2008-3#1)
We present a detailed description of##2##6##(2008-3#2)
We present a detailed experimental##2##5##(2008-3#2)
We present a detailed##6##4##(2008-2#2)(2008-3#4)
We present a digital##2##4##(2007-11#1)(2008-3#1)
We present a diode-pumped##2##4##(2007-11#1)(2007-12#1)
We present a general##4##4##(1990-8#1)(1995-2#1)(2007-12#1)(2008-3#1)
We present a mathematical model##3##5##(2008-2#1)(2008-7#1)(2013-7#1)
We present a mathematical##5##4##(2008-2#1)(2008-3#2)(2008-7#1)(2013-7#1)
We present a method for compensating##2##6##(2007-11#1)(2008-3#1)
We present a method for obtaining a##2##7##(2007-12#1)(2008-2#1)
We present a method for obtaining##3##6##(2007-12#2)(2008-2#1)
We present a method for##9##5##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#2)
We present a method of##7##5##(2007-11#5)(2007-12#1)(2008-3#1)
We present a method##19##4##(2007-11#6)(2007-12#6)(2008-2#3)(2008-3#4)
We present a methodology for##2##5##(2008-2#1)(2008-3#1)
We present a model for the##3##6##(2007-12#1)(2008-8#1)(2008-9#1)
We present a model for##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
We present a model to##2##5##(2008-2#1)(2008-8#1)
We present a model##9##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-8#2)(2008-9#3)
We present a new approach to##3##6##(2007-11#2)(2012-12#1)
We present a new approach##4##5##(2007-11#2)(2008-3#1)(2012-12#1)
We present a new method for##2##6##(2008-2#1)(2008-3#1)
We present a new method of##4##6##(1994-9#1)(2007-11#1)(2007-12#2)
We present a new method##7##5##(1994-9#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
We present a new technique for the##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
We present a new technique for##5##6##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
We present a new technique##6##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
We present a new##40##4##(1990-12#1)(1994-9#1)(2007-11#6)(2007-12#7)(2008-2#5)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
We present a novel algorithm for##2##6##(2007-11#1)(2008-2#1)
We present a novel method##2##5##(2007-11#1)(2007-12#1)
We present a novel scheme##2##5##(2007-11#2)
We present a novel technique for##3##6##(2007-11#3)
We present a novel##27##4##(1992-3#1)(1994-12#1)(2007-11#12)(2007-12#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-9#1)
We present a numerical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
We present a one-dimensional##2##4##(2008-3#1)(2008-7#1)
We present a patient with##7##5##(1993-8#1)(2007-8#2)(2008-12#2)(2008-9#1)(2013-1#1)
We present a patient##8##4##(1993-8#1)(2007-8#2)(2008-12#2)(2008-9#1)(2011-1#1)(2013-1#1)
We present a performance##2##4##(2008-3#2)
We present a rare case of##4##6##(2008-10#1)(2008-6#1)(2008-9#1)(2012-12#1)
We present a rare##5##4##(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)
We present a retrospective study##2##5##(2010-11#1)(2013-1#1)
We present a retrospective##4##4##(2008-6#1)(2008-9#1)(2010-11#1)(2013-1#1)
We present a review of the##2##6##(2008-10#1)(2008-9#1)
We present a series of 130##2##6##(2007-8#1)(2008-11#1)
We present a series of##3##5##(1990-9#1)(2007-8#1)(2008-11#1)
We present a simple model##2##5##(2008-7#1)(2008-9#1)
We present a simple##17##4##(2007-11#3)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#2)(2009-5#1)(2011-1#1)(2012-2#1)
We present a solution##2##4##(2007-11#1)(2008-3#1)
We present a spectrum of##2##5##(2009-5#1)(2012-2#1)
We present a statistical##2##4##(2008-12#1)(2008-2#1)
We present a straightforward##2##4##(1997-8#1)(2008-2#1)
We present a system##2##4##(2008-3#2)
We present a systematic##2##4##(2008-2#1)(2011-2#1)
We present a technique for##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
We present a technique to##2##5##(2008-2#1)(2008-3#1)
We present a technique##7##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
We present a theoretical analysis and experimentally demonstrate##2##8##(2007-11#2)
We present a theoretical analysis of##2##6##(2007-11#1)(2008-3#1)
We present a theoretical analysis##5##5##(2007-11#3)(2008-3#2)
We present a theoretical study of##3##6##(2007-11#1)(2008-2#1)(2008-8#1)
We present a theoretical##14##4##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#6)(2008-8#1)(2009-9#1)
We present a three-dimensional (3D)##2##5##(2008-2#1)(2008-3#1)
We present a three-dimensional##4##4##(2007-8#1)(2008-2#1)(2008-3#2)
We present a##399##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-9#1)(1997-4#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#48)(2007-12#38)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#15)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#10)(2008-2#42)(2008-3#82)(2008-5#1)(2008-6#6)(2008-7#12)(2008-8#12)(2008-9#11)(2009-1#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#12)(2012-2#8)(2012-3#1)(2013-1#13)(2013-7#2)(2013-8#4)
We present an algorithm that##3##5##(2008-2#1)(2008-3#2)
We present an algorithm##5##4##(2008-2#3)(2008-3#2)
We present an analysis of the##2##6##(2008-2#1)(2008-3#1)
We present an analysis of##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
We present an analytical##2##4##(2008-2#2)
We present an approach to##3##5##(2007-12#1)(2007-8#1)(2008-3#1)
We present an approach##5##4##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
We present an experimental study of the##3##7##(2007-12#2)(2008-2#1)
We present an experimental technique##2##5##(2007-11#1)(2008-2#1)
We present an experimental##6##4##(2007-11#1)(2007-12#3)(2008-2#2)
We present an inexpensive##2##4##(2007-11#1)(2010-5#1)
We present an investigation##2##4##(2007-11#1)(2008-2#1)
We present an optical technique for##2##6##(2008-2#1)(2008-3#1)
We present an optical##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
We present an optoelectronic##2##4##(2008-3#2)
We present an original##2##4##(2007-11#1)(2007-12#1)
We present an overview of the##4##6##(2008-3#2)(2008-5#1)(2009-6#1)
We present an overview of##7##5##(2008-3#2)(2008-5#1)(2009-11#1)(2009-6#1)(2010-9#1)(2011-2#1)
We present an unusual case of##3##6##(2008-10#1)(2008-9#1)(2011-1#1)
We present an##78##3##(1993-8#1)(1994-12#1)(1997-3#1)(2006-10#1)(2007-11#8)(2007-12#7)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#17)(2008-3#18)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)
We present analytical results for the##2##6##(2008-2#2)
We present analytical##3##3##(2007-12#1)(2008-2#2)
We present and evaluate##2##4##(2008-3#1)(2008-9#1)
We present and##6##3##(2008-2#1)(2008-3#3)(2008-9#1)(2009-5#1)
We present another##2##3##(2008-5#1)(2008-7#1)
We present benchmark calculations of nine selected points on potential energy surfaces describing proton transfer process in three model systems##2##20##(2012-12#2)
We present both##3##3##(1994-9#1)(2008-3#2)
We present calculations##2##3##(2008-3#2)
We present data that##2##4##(2008-11#1)(2008-2#1)
We present data##4##3##(1992-11#1)(1994-9#1)(2008-11#1)(2008-2#1)
We present evidence##2##3##(1993-8#1)(1994-9#1)
We present experimental and##2##4##(2007-11#1)(2008-3#1)
We present experimental data for##2##5##(2008-2#1)(2008-3#1)
We present experimental data##3##4##(1995-3#1)(2008-2#1)(2008-3#1)
We present experimental evidence##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
We present experimental observations of##2##5##(2007-11#1)(2007-12#1)
We present experimental results of##2##5##(2007-11#1)(2007-12#1)
We present experimental results##8##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2013-1#1)
We present experimental##20##3##(1995-3#1)(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#7)(2013-1#1)
We present experiments##3##3##(2007-11#2)(2008-2#1)
We present four##3##3##(1997-3#1)(2008-3#1)(2012-2#1)
We present here a simple##2##5##(2008-2#1)(2008-8#1)
We present here a##15##4##(1994-12#1)(1995-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
We present here the##9##4##(1990-3#1)(1993-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-7#1)(2013-1#1)
We present here##32##3##(1990-11#1)(1990-3#1)(1993-12#1)(1994-12#1)(1995-5#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
We present herein two synthetic strategies for accessing chiral polyamines##2##10##(2009-10#2)
We present herein##3##3##(2009-10#2)(2012-3#1)
We present in this##2##4##(2007-10#1)(2009-8#1)
We present in##4##3##(2007-10#1)(2008-3#2)(2009-8#1)
We present laboratory##2##3##(2008-2#1)(2008-3#1)
We present measurements of the##2##5##(2007-11#1)(2007-12#1)
We present measurements of##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
We present measurements##7##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
We present novel##3##3##(2008-1#1)(2008-2#1)(2012-2#1)
We present numerical simulations of##2##5##(2007-12#1)(2008-3#1)
We present numerical simulations##4##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
We present numerical##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
We present one##2##3##(2008-8#1)(2011-1#1)
We present our experience of##2##5##(2008-10#1)(2012-2#1)
We present our experience##3##4##(2008-10#1)(2012-2#1)(2013-8#1)
We present our preliminary##2##4##(2007-8#1)(2008-3#1)
We present our results##2##4##(2008-2#1)(2008-3#1)
We present our##14##3##(1992-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#2)(2013-8#1)
We present quantitative##2##3##(2011-1#1)(2012-2#1)
We present recent##2##3##(2008-3#1)(2012-3#1)
We present results from a##2##5##(2008-3#2)
We present results from##4##4##(2008-12#1)(2008-3#3)
We present results of##7##4##(2007-12#1)(2008-2#2)(2008-3#2)(2009-11#1)(2012-1#1)
We present results that demonstrate##2##5##(2008-3#2)
We present results that##3##4##(2007-12#1)(2008-3#2)
We present results##19##3##(1996-9#1)(2007-11#1)(2007-12#5)(2008-12#1)(2008-2#2)(2008-3#7)(2009-11#1)(2012-1#1)
We present several##3##3##(1992-12#1)(1997-2#1)(2008-8#1)
We present six##2##3##(2008-9#1)(2012-2#1)
We present spatially resolved measurements of the##2##7##(2007-12#1)(2008-3#1)
We present the case of a 30-year-old##2##7##(2008-11#1)(2013-8#1)
We present the case of a child##2##7##(2012-12#1)(2013-1#1)
We present the case of a man who##2##8##(2008-11#1)(2008-8#1)
We present the case of a patient with##3##8##(2006-10#1)(2006-12#1)(2007-10#1)
We present the case of a patient##4##7##(2006-10#1)(2006-12#1)(2007-10#1)(2008-5#1)
We present the case of a##23##6##(1991-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
We present the case of##28##5##(1991-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#4)
We present the case##30##4##(1991-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#4)
We present the design and##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
We present the design of a##2##6##(2008-3#2)
We present the design of##3##5##(2008-2#1)(2008-3#2)
We present the design##6##4##(2007-11#1)(2008-2#2)(2008-3#3)
We present the experimental##2##4##(2007-11#1)(2008-3#1)
We present the first##5##4##(1993-2#1)(1993-3#1)(1995-5#1)(2007-12#1)(2008-3#1)
We present the implementation of##2##5##(2007-11#1)(2008-3#1)
We present the operational##2##4##(2007-12#1)(2008-2#1)
We present the principles of the##2##6##(2008-3#1)(2010-9#1)
We present the results of a##4##6##(1996-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
We present the results of an experiment##3##7##(2007-11#1)(2008-2#1)(2008-3#1)
We present the results of an##4##6##(2007-11#1)(2008-2#1)(2008-3#2)
We present the results of our##2##6##(2007-12#1)(2008-3#1)
We present the results of the##2##6##(2008-2#1)(2008-3#1)
We present the results of##18##5##(1990-6#1)(1994-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#7)(2008-9#1)
We present the results##19##4##(1990-6#1)(1994-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#7)(2008-9#1)
We present the##101##3##(1990-12#1)(1990-6#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-12#1)(1997-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#26)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
We present theoretical results##2##4##(2007-11#1)(2007-12#1)
We present theoretical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
We present this case##2##4##(2009-3#1)(2012-3#1)
We present three##2##3##(1991-11#1)(1997-8#1)
We present two cases of##9##5##(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
We present two cases##11##4##(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
We present two such##2##4##(2007-7#1)(2008-10#1)
We present two##20##3##(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
We present what are##2##4##(2007-11#2)
We present what is to our knowledge the first experimental study of##2##12##(2007-11#1)(2007-12#1)
We present what is to our knowledge the first experimental##3##10##(2007-11#1)(2007-12#1)(2008-3#1)
We present what is to our knowledge the first##7##9##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
We present what to our knowledge is a##2##8##(2008-3#2)
We present what we believe is a new##2##8##(2008-3#2)
We present what we believe is a##3##7##(2008-3#3)
We present what we believe to be the first##2##9##(2007-11#1)(2007-12#1)
We present what we believe to be##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
We present what we believe##7##5##(2007-11#1)(2007-12#2)(2008-3#4)
We present what##18##3##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#8)
We present##825##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#3)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#4)(1995-2#3)(1995-3#1)(1995-5#3)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-8#4)(1997-9#1)(2006-10#3)(2006-12#1)(2007-10#4)(2007-11#79)(2007-12#71)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#20)(2008-1#4)(2008-10#26)(2008-11#10)(2008-12#14)(2008-2#100)(2008-3#180)(2008-5#5)(2008-6#11)(2008-7#20)(2008-8#20)(2008-9#17)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#7)(2011-2#25)(2012-1#4)(2012-12#17)(2012-2#16)(2012-3#9)(2013-1#24)(2013-7#2)(2013-8#11)
We presented##4##2##(2009-9#1)(2010-2#1)(2012-3#2)
We presume##2##2##(2011-2#1)(2013-1#1)
We previously demonstrated that the##2##5##(1993-6#1)(2008-8#1)
We previously demonstrated that##10##4##(1990-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-2#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
We previously described that an##2##5##(2008-10#2)
We previously described##3##3##(1990-11#1)(2008-10#2)
We previously developed a##2##4##(2008-11#1)(2012-2#1)
We previously developed##3##3##(2008-11#2)(2012-2#1)
We previously established##2##3##(2008-11#2)
We previously found##2##3##(1993-6#1)(2012-2#1)
We previously reported that the##2##5##(1990-7#1)(2011-2#1)
We previously reported that##10##4##(1990-11#1)(1990-7#1)(1994-11#1)(1994-2#1)(2008-10#1)(2009-12#2)(2011-2#1)(2013-1#2)
We previously reported##13##3##(1990-11#1)(1990-7#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-2#1)(2008-10#2)(2009-12#2)(2011-2#1)(2013-1#2)
We previously showed that##5##4##(1992-3#2)(2006-6#1)(2011-2#1)(2012-3#1)
We previously##44##2##(1990-11#2)(1990-12#1)(1990-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1996-2#1)(2006-6#1)(2008-10#6)(2008-11#5)(2008-8#1)(2009-12#2)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
We proceed##2##2##(1992-2#1)(2008-2#1)
We produced##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
We propose a mechanism##2##4##(1995-11#1)(2008-7#1)
We propose a method for designing a##2##7##(2007-11#1)(2008-2#1)
We propose a method for##10##5##(2007-11#3)(2008-10#2)(2008-2#1)(2008-3#4)
We propose a method of##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
We propose a method to##3##5##(2007-11#1)(2008-3#2)
We propose a method##19##4##(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#8)
We propose a model for##2##5##(1996-2#1)(2009-3#1)
We propose a model##3##4##(1996-2#1)(2008-11#1)(2009-3#1)
We propose a modified##2##4##(1997-3#1)(2008-3#1)
We propose a new approach to##2##6##(2008-3#1)(2008-6#1)
We propose a new approach##3##5##(2008-10#1)(2008-3#1)(2008-6#1)
We propose a new method of##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
We propose a new method##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
We propose a new technique##2##5##(2008-2#2)
We propose a new##28##4##(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#6)(2008-3#10)(2008-6#1)(2009-9#1)(2011-1#1)(2013-1#1)
We propose a novel approach##2##5##(2008-3#1)(2010-10#1)
We propose a novel##17##4##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#7)(2010-10#2)(2012-1#1)
We propose a procedure##2##4##(2008-10#1)(2008-3#1)
We propose a simple##6##4##(2007-11#2)(2008-3#2)(2009-2#1)(2013-1#1)
We propose a technique for##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
We propose a unified##2##4##(2007-12#1)(2008-3#1)
We propose a##121##3##(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-11#15)(2007-12#14)(2007-7#1)(2008-10#7)(2008-11#2)(2008-2#12)(2008-3#42)(2008-6#2)(2008-7#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-3#2)(2013-1#4)
We propose an adaptive##2##4##(2007-12#1)(2008-3#1)
We propose an algorithm##2##4##(1995-2#1)(2008-3#1)
We propose an alternative##2##4##(2007-11#2)
We propose an optical##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
We propose an##23##3##(1995-2#1)(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#6)(2008-6#1)(2009-6#1)(2010-3#1)(2012-2#2)
We propose and analyze a##2##5##(2007-11#1)(2008-3#1)
We propose and demonstrate a novel##3##6##(2007-12#2)(2008-3#1)
We propose and demonstrate a##7##5##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
We propose and demonstrate the##2##5##(2008-2#1)(2008-3#1)
We propose and demonstrate##10##4##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#3)
We propose and experimentally demonstrate##2##5##(2007-12#1)(2008-3#1)
We propose and experimentally##3##4##(2007-12#1)(2008-3#2)
We propose and##17##3##(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#7)
We propose recommendations for##2##4##(1995-2#1)(2011-1#1)
We propose that a##2##4##(2008-2#1)(2008-5#1)
We propose that in##4##4##(1995-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
We propose that the##30##4##(1990-7#1)(1991-2#1)(1991-5#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-11#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
We propose that these##3##4##(1995-2#1)(2008-11#2)
We propose that this##5##4##(2007-12#1)(2008-10#1)(2008-12#1)(2009-2#1)(2011-2#1)
We propose that##70##3##(1990-11#2)(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#2)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-7#1)(2006-12#1)(2007-12#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2011-2#2)(2012-12#6)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
We propose the use of a##2##6##(2007-12#1)(2008-3#1)
We propose the use of##9##5##(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
We propose the##16##3##(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2011-2#1)(2013-8#1)
We propose to adapt##2##4##(2007-11#1)(2011-1#1)
We propose to use a##3##5##(2007-12#1)(2008-3#2)
We propose to use the##2##5##(2007-12#1)(2008-3#1)
We propose to use##9##4##(2007-12#3)(2008-3#6)
We propose to##19##3##(2007-11#2)(2007-12#3)(2008-3#11)(2011-1#1)(2011-3#1)(2012-1#1)
We propose two##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)
We propose using the##2##4##(2008-3#2)
We propose using##4##3##(2007-12#1)(2008-3#3)
We propose what is##2##4##(2007-12#1)(2008-3#1)
We propose what we believe to be a novel##2##9##(2008-3#2)
We propose what we believe##3##5##(2008-3#3)
We propose what##6##3##(2007-12#1)(2008-3#5)
We propose##313##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#29)(2007-12#35)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#26)(2008-3#80)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#2)
We proposed a##2##3##(1990-5#1)(2008-8#1)
We proposed that##2##3##(2009-8#2)
We proposed##6##2##(1990-5#1)(2008-8#1)(2009-8#2)(2010-8#1)(2013-7#1)
We prospectively studied##3##3##(2008-7#3)
We prospectively##9##2##(1992-2#1)(1997-8#1)(2007-8#1)(2008-7#3)(2011-2#2)(2013-1#1)
We prove that the##2##4##(2008-3#2)
We prove that##4##3##(2008-3#3)(2009-12#1)
We prove##6##2##(2007-11#2)(2008-3#3)(2009-12#1)
We provide a brief##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
We provide a complete##2##4##(2008-3#1)(2009-11#1)
We provide a comprehensive##2##4##(2008-3#1)(2011-2#1)
We provide a general##2##4##(2008-3#1)(2012-2#1)
We provide a simple##2##4##(2008-3#1)(2010-7#1)
We provide a##19##3##(1992-6#1)(1996-3#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)
We provide an##7##3##(1992-9#1)(1996-3#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-2#1)
We provide direct##2##3##(2007-11#1)(2007-12#1)
We provide evidence suggesting that##2##5##(1992-12#1)(2012-3#1)
We provide evidence that##3##4##(1994-11#1)(2009-11#1)(2012-3#1)
We provide evidence##8##3##(1992-12#1)(1994-11#1)(1994-12#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#2)
We provide##55##2##(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(2007-11#1)(2007-12#4)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-6#1)(2008-9#1)(2009-11#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#1)
We purified the##3##3##(1992-12#1)(1995-6#1)(2012-2#1)
We purified##6##2##(1992-12#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(2012-2#1)
We quantified##6##2##(1996-12#1)(2007-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
We quantify the##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
We question the##2##3##(1992-3#1)(1995-5#1)
We question##4##2##(1992-3#1)(1995-5#1)(2008-9#1)(2009-6#1)
We randomized##3##2##(2008-8#1)(2013-1#2)
We recently discovered that the##2##5##(2011-2#2)
We recently identified##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
We recently isolated##2##3##(1994-12#1)(1995-12#1)
We recently mapped##2##3##(1994-12#1)(1996-8#1)
We recently observed that##2##4##(1990-5#1)(1997-7#1)
We recently reported that##4##4##(1992-6#1)(1993-6#1)(1995-2#1)(2009-8#1)
We recently reported the##2##4##(2009-8#1)(2013-1#1)
We recently reported##6##3##(1992-6#1)(1993-6#1)(1995-2#1)(2009-8#2)(2013-1#1)
We recently##33##2##(1990-5#1)(1990-8#1)(1992-6#2)(1993-6#1)(1994-12#3)(1995-12#1)(1995-2#1)(1995-4#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-6#3)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
We recognize that the##2##4##(1992-6#1)(2008-2#1)
We recognize that##3##3##(1992-6#1)(2007-11#1)(2008-2#1)
We recognize##4##2##(1992-6#1)(2007-11#1)(2008-2#1)(2008-6#1)
We recommend a##2##3##(2007-7#1)(2009-9#1)
We recommend that##7##3##(1993-3#1)(2008-10#2)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
We recommend##20##2##(1993-3#1)(1995-8#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-7#3)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
We recommended##2##2##(1995-4#1)(2011-2#1)
We reconstruct##2##2##(2010-4#1)(2012-3#1)
We reconstructed##2##2##(2007-11#1)(2011-2#1)
We recorded the##2##3##(2008-2#1)(2008-3#1)
We recorded##9##2##(1990-9#1)(1994-8#1)(1995-5#1)(2008-2#2)(2008-3#1)(2008-5#2)(2013-1#1)
We recovered##2##2##(2008-10#2)
We recruited##4##2##(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
We refer to##2##3##(1990-6#1)(1995-5#1)
We referred to##2##3##(1991-2#1)(2012-12#1)
We regard##2##2##(2008-10#1)(2012-3#1)
We reject the##2##3##(2008-10#2)
We relate these##2##3##(2007-12#1)(2009-5#1)
We relate##3##2##(2007-12#1)(2008-2#1)(2009-5#1)
We related##2##2##(1993-12#1)(2009-9#1)
We report 2##3##3##(1996-11#1)(2006-10#1)(2010-11#1)
We report a 14-year-old##2##4##(2006-12#1)(2012-12#1)
We report a 26-year-old##2##4##(1990-3#1)(2007-7#1)
We report a 32-year-old##2##4##(2008-1#1)(2008-6#1)
We report a 42-year-old##2##4##(2008-12#1)(2011-1#1)
We report a 51-year-old##3##4##(2008-6#1)(2013-1#1)(2013-8#1)
We report a case in which the##2##7##(2007-7#1)(2012-2#1)
We report a case in which##3##6##(1992-2#1)(2007-7#1)(2012-2#1)
We report a case involving##2##5##(2009-2#1)(2010-8#1)
We report a case of a female patient##2##8##(2012-12#2)
We report a case of a patient with##2##8##(2012-2#1)(2012-3#1)
We report a case of a young male##2##8##(2007-8#1)(2012-2#1)
We report a case of a young man who##2##9##(2007-7#1)(2008-8#1)
We report a case of a young##7##7##(2007-7#1)(2007-8#1)(2008-8#2)(2011-1#1)(2012-2#1)(2013-8#1)
We report a case of a##36##6##(1991-11#1)(1997-6#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
We report a case of acute##4##6##(1992-6#1)(2008-10#1)(2010-4#1)(2013-1#1)
We report a case of an##7##6##(2007-5#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
We report a case of bilateral##2##6##(1994-12#1)(2011-1#1)
We report a case of breast##2##6##(1992-8#1)(1993-12#1)
We report a case of cutaneous##2##6##(2007-7#1)(2010-11#1)
We report a case of diffuse##2##6##(2009-1#1)(2011-2#1)
We report a case of metastatic##2##6##(2007-6#1)(2011-2#1)
We report a case of primary##3##6##(2008-10#1)(2008-11#1)(2013-8#1)
We report a case of##153##5##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-8#1)(1997-6#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#7)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#12)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#9)(2012-12#11)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#3)
We report a case where a##2##6##(1991-11#1)(2012-12#1)
We report a case where##3##5##(1991-11#1)(2008-9#1)(2012-12#1)
We report a case##167##4##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#2)(1992-2#3)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-10#1)(1997-6#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#7)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#13)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#7)(2011-2#9)(2012-12#12)(2012-2#7)(2012-3#5)(2013-1#9)(2013-8#3)
We report a continuous-wave##2##4##(2007-12#2)
We report a facile##2##4##(2009-9#1)(2010-6#1)
We report a further case##2##5##(2008-11#1)(2008-7#1)
We report a method##2##4##(2007-12#1)(2007-8#1)
We report a new approach##2##5##(2007-12#1)(2008-10#1)
We report a new method for##2##6##(2008-2#1)(2010-8#1)
We report a new##10##4##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-8#1)
We report a novel method for##2##6##(2007-12#1)(2010-12#1)
We report a novel method##4##5##(2007-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
We report a novel technique for##2##6##(2007-12#1)(2011-2#1)
We report a novel##11##4##(2007-11#1)(2007-12#5)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
We report a patient who developed##3##6##(2007-7#1)(2008-12#1)(2010-12#1)
We report a patient who##4##5##(2007-10#1)(2007-7#1)(2008-12#1)(2010-12#1)
We report a patient with a##4##6##(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#1)
We report a patient with##7##5##(2008-7#2)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
We report a patient##13##4##(2007-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
We report a rare case of a##4##7##(2007-8#1)(2010-5#1)(2012-3#1)(2013-2#1)
We report a rare case of##14##6##(2007-8#1)(2008-12#3)(2008-7#2)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-2#1)
We report a rare##18##4##(2007-8#1)(2008-12#3)(2008-7#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-2#1)
We report a simple##3##4##(1990-7#1)(2007-11#2)
We report a study of##2##5##(2007-11#1)(2007-12#1)
We report a successful##3##4##(2007-11#1)(2007-8#1)(2013-1#1)
We report a very##2##4##(2007-8#1)(2008-7#1)
We report a young male##3##5##(2008-7#1)(2010-5#1)(2010-7#1)
We report a##325##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-9#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-8#1)(1995-10#1)(1995-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-12#1)(2007-10#6)(2007-11#16)(2007-12#20)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#18)(2008-1#5)(2008-10#14)(2008-11#6)(2008-12#19)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#7)(2008-7#19)(2008-8#6)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#9)(2011-2#14)(2012-12#14)(2012-2#13)(2012-3#8)(2013-1#24)(2013-2#1)(2013-8#8)
We report an adult##2##4##(2007-7#1)(2008-7#1)
We report an efficient##3##4##(2007-11#1)(2007-12#2)
We report an exceptional case of##2##6##(1997-8#1)(2008-9#1)
We report an experimental##2##4##(2007-11#1)(2007-12#1)
We report an unusual case of a##2##7##(2006-10#1)(2008-10#1)
We report an unusual case of##10##6##(2006-10#1)(2007-8#1)(2008-10#2)(2012-12#2)(2012-2#2)(2013-1#2)
We report an unusual case##11##5##(2006-10#1)(2007-8#1)(2008-10#2)(2012-12#2)(2012-2#2)(2013-1#3)
We report an##37##3##(1995-2#1)(1997-8#1)(2006-10#2)(2007-11#5)(2007-12#4)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
We report analytical##2##3##(2008-10#1)(2008-8#1)
We report and##2##3##(1992-8#1)(2008-10#1)
We report complete NMR chemical shift assignments of##2##8##(2009-7#2)
We report complete##3##3##(2009-7#2)(2013-1#1)
We report continuous-wave##2##3##(2007-11#1)(2007-12#1)
We report efficient##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
We report experimental and##2##4##(2007-12#2)
We report experimental results##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
We report experimental##10##3##(2007-11#1)(2007-12#6)(2008-3#3)
We report experiments##2##3##(2008-8#1)(2010-9#1)
We report for the first time##3##6##(1992-6#1)(1996-3#1)(2010-12#1)
We report for##4##3##(1992-6#1)(1996-3#1)(2007-11#1)(2010-12#1)
We report frequency##2##3##(2008-2#2)
We report here a case of##8##6##(2007-7#5)(2007-8#1)(2009-2#1)(2010-1#1)
We report here a##14##4##(1997-7#2)(2007-7#5)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-1#1)
We report here on a rare case of##2##8##(2010-6#1)(2012-3#1)
We report here on a##5##5##(2008-1#1)(2010-6#2)(2012-1#1)(2012-3#1)
We report here on the##4##5##(1993-12#1)(1994-12#1)(2008-10#1)(2011-2#1)
We report here on##9##4##(1993-12#1)(1994-12#1)(2008-1#1)(2008-10#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-3#1)
We report here our##2##4##(1990-12#1)(2008-7#1)
We report here that the##10##5##(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-7#1)
We report here that this##2##5##(1993-8#1)(1995-2#1)
We report here that##31##4##(1990-5#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-8#2)(1995-11#2)(1995-2#2)(1996-2#2)(1997-4#1)(1997-7#2)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
We report here the development of an##2##7##(2008-10#2)
We report here the development of##3##6##(2008-10#3)
We report here the development##4##5##(2008-10#3)(2011-8#1)
We report here the isolation##2##5##(1993-11#1)(1994-8#1)
We report here the results of##2##6##(1997-5#2)
We report here the##27##4##(1990-12#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-5#2)(1997-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#2)(2011-2#1)(2011-8#1)
We report here##94##3##(1990-12#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#4)(1995-11#4)(1995-2#3)(1996-2#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#4)(1997-9#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-6#2)(2011-2#4)(2011-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
We report herein a case of##3##6##(2008-7#1)(2013-1#1)(2013-7#1)
We report herein a##4##4##(2008-11#1)(2008-7#1)(2013-1#1)(2013-7#1)
We report herein the##4##4##(1991-11#1)(2007-11#1)(2008-10#1)(2009-8#1)
We report herein##10##3##(1991-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
We report in this paper##2##5##(2008-10#1)(2013-1#1)
We report in this##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
We report measurements of the##2##5##(2007-11#1)(2008-2#1)
We report measurements of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
We report observations##2##3##(1996-2#1)(2007-11#1)
We report on 2##3##4##(1992-10#1)(1992-12#1)(1996-11#1)
We report on a 4-year-old##2##5##(2008-10#1)(2013-1#1)
We report on a case of##3##6##(2007-10#1)(2007-9#1)(2013-1#1)
We report on a case##4##5##(2007-10#1)(2007-9#1)(2008-10#1)(2013-1#1)
We report on a new##5##5##(2007-11#3)(2007-12#1)(2008-3#1)
We report on a novel##2##5##(2007-12#1)(2008-2#1)
We report on a patient##3##5##(1997-3#1)(2011-2#1)(2011-3#1)
We report on a technique for##2##6##(2008-3#2)
We report on a##47##4##(1991-3#1)(1992-10#1)(1993-12#1)(1996-5#1)(1997-3#4)(1997-5#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#10)(2008-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
We report on an experimental investigation of##2##7##(2007-11#1)(2008-2#1)
We report on an##11##4##(1993-12#1)(1997-5#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
We report on one##2##4##(2008-7#2)
We report on our experience with##2##6##(1996-8#1)(2007-6#1)
We report on our##3##4##(1996-8#1)(2007-6#1)(2008-2#1)
We report on the calculation of##2##6##(2007-11#1)(2008-2#1)
We report on the development and##2##6##(2007-11#1)(2012-2#1)
We report on the development##3##5##(2007-11#2)(2012-2#1)
We report on the experimental##2##5##(2007-11#1)(2008-3#1)
We report on the fabrication and##2##6##(2007-12#2)
We report on the fabrication##3##5##(2007-12#2)(2008-2#1)
We report on the generation of##3##6##(2007-11#2)(2008-2#1)
We report on the implementation of##2##6##(2008-3#2)
We report on the laser##2##5##(2007-12#2)
We report on the use of##2##6##(2008-3#2)
We report on the##39##4##(1991-5#1)(1993-8#1)(2007-11#10)(2007-12#7)(2008-10#2)(2008-2#4)(2008-3#10)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
We report on three-dimensional##2##4##(2008-2#1)(2008-3#1)
We report on two##2##4##(2008-10#1)(2008-7#1)
We report on what is believed to be the first##2##10##(2007-11#1)(2007-12#1)
We report on what is##3##5##(2007-11#2)(2007-12#1)
We report on what we believe##2##6##(2008-3#2)
We report on what##6##4##(2007-11#2)(2007-12#1)(2008-3#2)(2009-3#1)
We report on##143##3##(1990-8#1)(1991-3#1)(1991-5#1)(1992-10#2)(1992-12#1)(1992-9#1)(1993-12#2)(1993-8#1)(1996-11#2)(1996-5#1)(1996-8#1)(1997-3#5)(1997-5#3)(2007-10#1)(2007-11#23)(2007-12#18)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#11)(2008-3#36)(2008-7#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
We report one case of##2##5##(2008-5#1)(2009-5#1)
We report one such case##3##5##(2007-7#2)(2012-12#1)
We report one such##4##4##(2007-7#2)(2011-1#1)(2012-12#1)
We report one##6##3##(2007-7#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)
We report our experience with##3##5##(1995-3#1)(2008-10#1)(2008-11#1)
We report our experience##5##4##(1995-10#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
We report our##12##3##(1995-10#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
We report preliminary results##2##4##(2008-3#1)(2012-1#1)
We report results from##2##4##(2007-12#1)(2008-3#1)
We report results##4##3##(2007-12#2)(2008-3#1)(2008-9#1)
We report seven cases##2##4##(2008-7#1)(2011-1#1)
We report seven##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
We report simulation##2##3##(1997-3#1)(2007-11#1)
We report that a##2##4##(1994-12#1)(2010-5#1)
We report that the##6##4##(1993-3#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
We report that##25##3##(1990-7#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#2)(1994-12#1)(1995-8#1)(1997-1#1)(1997-2#2)(2007-11#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)
We report the anaesthetic##2##4##(2010-7#1)(2011-1#1)
We report the application of##2##5##(2008-3#1)(2010-6#1)
We report the case of a 20-year-old##2##7##(2008-6#1)(2010-6#1)
We report the case of a 33-year-old man##2##8##(2007-8#1)(2012-12#1)
We report the case of a 35-year-old##2##7##(2011-2#1)(2013-1#1)
We report the case of a 45-year-old man##2##8##(2010-5#1)(2013-8#1)
We report the case of a 66-year-old##2##7##(2008-6#1)(2013-1#1)
We report the case of a 72-year-old woman##2##8##(2008-7#1)(2012-12#1)
We report the case of a newborn presenting with##2##9##(2008-10#2)
We report the case of a patient##4##7##(1993-6#1)(2011-2#1)(2013-1#2)
We report the case of a##50##6##(1993-6#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#5)(2009-1#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
We report the case of an##2##6##(1990-6#1)(2008-10#1)
We report the case of##57##5##(1990-6#1)(1993-6#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#6)(2009-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
We report the case##58##4##(1990-6#1)(1993-6#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#6)(2009-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
We report the clinical##2##4##(2013-1#2)
We report the cloning and##3##5##(1991-12#1)(1995-8#1)(2008-4#1)
We report the cloning of a##2##6##(1991-2#1)(1995-8#1)
We report the cloning of##3##5##(1990-11#1)(1991-2#1)(1995-8#1)
We report the cloning##6##4##(1990-11#1)(1991-12#1)(1991-2#1)(1995-8#2)(2008-4#1)
We report the demonstration of##3##5##(2007-12#3)
We report the design##2##4##(2007-12#1)(2008-3#1)
We report the development and##2##5##(2008-10#1)(2008-3#1)
We report the development of a##2##6##(2007-11#1)(2008-3#1)
We report the development of##4##5##(1990-12#1)(2006-10#1)(2007-11#1)(2008-3#1)
We report the development##6##4##(1990-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)
We report the experimental observation of##2##6##(2007-11#1)(2007-12#1)
We report the experimental##8##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
We report the first case of a##4##7##(2008-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
We report the first case of##9##6##(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
We report the first case##10##5##(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
We report the first observation of##2##6##(2007-12#1)(2008-7#1)
We report the first##18##4##(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#2)
We report the generation and##2##5##(2007-11#1)(2007-12#1)
We report the generation of##2##5##(2007-11#1)(2007-12#1)
We report the generation##4##4##(2007-11#2)(2007-12#2)
We report the identification of##3##5##(1993-6#2)(2012-3#1)
We report the implementation##2##4##(2007-12#2)
We report the isolation and characterization of a##2##8##(1990-12#1)(1994-6#1)
We report the isolation and characterization of##3##7##(1990-12#1)(1994-6#1)(1995-8#1)
We report the isolation and##5##5##(1990-12#1)(1991-6#1)(1994-6#1)(1995-8#1)(1997-7#1)
We report the isolation of a##2##6##(1994-8#1)(2008-8#1)
We report the isolation of##3##5##(1990-5#1)(1994-8#1)(2008-8#1)
We report the isolation##8##4##(1990-12#1)(1990-5#1)(1991-6#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-8#1)
We report the measurement of##2##5##(2007-11#1)(2008-2#1)
We report the observation of a##2##6##(2007-12#1)(2013-1#1)
We report the observation of##11##5##(2007-11#3)(2007-12#6)(2008-3#1)(2013-1#1)
We report the occurrence##2##4##(1993-11#1)(2012-2#1)
We report the operation of a##2##6##(2007-11#1)(2007-12#1)
We report the results of a##3##6##(1994-10#1)(2007-11#2)
We report the results of the##2##6##(1996-6#1)(2008-12#1)
We report the results of##11##5##(1994-10#1)(1996-11#1)(1996-6#1)(2007-11#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-9#1)
We report the second##3##4##(2008-6#1)(2010-3#1)(2012-2#1)
We report the sequence of a##3##6##(1995-6#1)(1997-3#2)
We report the sequence of##4##5##(1995-6#1)(1995-9#1)(1997-3#2)
We report the sequence##5##4##(1995-6#1)(1995-9#1)(1997-3#3)
We report the successful##3##4##(1994-6#1)(2007-8#1)(2008-7#1)
We report the synthesis of##2##5##(2009-10#1)(2009-11#1)
We report the synthesis##3##4##(2008-10#1)(2009-10#1)(2009-11#1)
We report the use of a##2##6##(1992-3#1)(2008-7#1)
We report the use of the##4##6##(2007-12#1)(2007-8#1)(2010-5#1)(2011-2#1)
We report the use of##10##5##(1992-3#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#2)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#1)
We report the##230##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#4)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#4)(1997-7#2)(2006-10#1)(2007-11#17)(2007-12#24)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#4)(2008-2#10)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#14)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#3)(2010-6#3)(2010-7#1)(2011-1#3)(2011-2#13)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#1)
We report this case##4##4##(1996-3#1)(2007-8#1)(2008-12#1)(2009-3#1)
We report this rare case##2##5##(2008-12#1)(2008-7#1)
We report this##6##3##(1996-3#1)(2007-8#1)(2008-12#2)(2008-7#1)(2009-3#1)
We report three cases##2##4##(2008-7#1)(2012-12#1)
We report three patients with##2##5##(2010-10#1)(2013-1#1)
We report three##4##3##(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
We report two cases of cerebral##2##6##(2007-10#1)(2009-9#1)
We report two cases of##19##5##(1996-6#1)(2006-10#1)(2007-10#1)(2007-8#5)(2008-10#2)(2008-4#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
We report two cases##22##4##(1996-6#1)(2006-10#1)(2007-10#1)(2007-8#5)(2008-10#2)(2008-4#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
We report two females##2##4##(2008-7#1)(2013-1#1)
We report two patients with##3##5##(1990-3#1)(2008-7#1)(2013-1#1)
We report two patients##5##4##(1990-3#1)(2008-1#1)(2008-7#1)(2013-1#2)
We report two##32##3##(1990-3#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#6)(2013-7#1)
We report what is believed to be the first experimental##2##10##(2007-11#1)(2007-12#1)
We report what is believed to be the first observation of##3##11##(2007-12#3)
We report what is believed to be the first##8##9##(2007-11#3)(2007-12#5)
We report what is to our knowledge the first observation of##2##11##(2007-11#2)
We report what is to our knowledge the first##9##9##(2007-11#4)(2007-12#4)(2008-2#1)
We report what is to our knowledge the##10##8##(2007-11#5)(2007-12#4)(2008-2#1)
We report what is to our knowledge##11##7##(2007-11#5)(2007-12#5)(2008-2#1)
We report what is##19##4##(2007-11#8)(2007-12#10)(2008-2#1)
We report what we believe to be the first##6##9##(2007-12#3)(2008-2#1)(2008-3#2)
We report what we believe to be##7##7##(2007-12#3)(2008-2#1)(2008-3#3)
We report what we believe##9##5##(2007-12#4)(2008-2#2)(2008-3#3)
We report what##29##3##(2007-11#8)(2007-12#15)(2008-2#3)(2008-3#3)
We report##1067##2##(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#4)(1993-11#7)(1993-12#6)(1993-2#1)(1993-3#3)(1993-6#8)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#6)(1995-10#2)(1995-11#4)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-11#4)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#10)(1997-4#2)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#2)(1997-9#1)(2006-10#8)(2006-12#2)(2007-10#8)(2007-11#89)(2007-12#110)(2007-2#3)(2007-5#6)(2007-6#3)(2007-7#24)(2007-8#34)(2007-9#1)(2008-1#12)(2008-10#48)(2008-11#15)(2008-12#25)(2008-2#36)(2008-3#60)(2008-4#2)(2008-5#8)(2008-6#20)(2008-7#52)(2008-8#9)(2008-9#6)(2009-1#5)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#8)(2009-4#3)(2009-5#8)(2009-6#7)(2009-7#10)(2009-8#2)(2009-9#7)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#6)(2010-3#5)(2010-4#2)(2010-5#8)(2010-6#7)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#16)(2011-2#41)(2011-3#1)(2011-8#1)(2012-1#3)(2012-12#25)(2012-2#27)(2012-3#18)(2013-1#54)(2013-2#1)(2013-7#4)(2013-8#10)
We reported a 28-year-old##2##4##(2013-1#2)
We reported a case of##3##5##(2008-1#1)(2008-5#1)(2011-1#1)
We reported a##5##3##(2008-1#1)(2008-5#1)(2011-1#1)(2013-1#2)
We reported previously that the##2##5##(1994-8#1)(2008-7#1)
We reported previously that##4##4##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
We reported previously##5##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
We reported that##3##3##(1992-12#1)(1994-6#1)(2010-6#1)
We reported##18##2##(1992-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
We researched##2##2##(2008-10#2)
We retrospectively analysed##3##3##(1991-3#1)(2008-7#1)(2013-1#1)
We retrospectively analyzed the##2##4##(1993-2#1)(2012-12#1)
We retrospectively analyzed##4##3##(1993-2#1)(2012-12#1)(2012-3#2)
We retrospectively studied##2##3##(2007-7#1)(2010-8#1)
We retrospectively##12##2##(1991-3#1)(1993-2#1)(2007-7#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
We reveal that its genome size is##2##7##(2011-2#2)
We reveal##3##2##(2008-3#1)(2011-2#2)
We review a##2##3##(2008-7#1)(2013-8#1)
We review and##2##3##(1994-2#1)(2008-9#1)
We review different##2##3##(2012-3#1)(2013-1#1)
We review here the##2##4##(2008-11#1)(2012-12#1)
We review here##4##3##(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
We review recent##2##3##(2008-7#1)(2013-8#1)
We review the case of##2##5##(2009-4#1)(2012-12#1)
We review the current##2##4##(2010-4#1)(2010-5#1)
We review the literature on##2##5##(2010-4#1)(2011-2#1)
We review the literature##3##4##(2008-6#1)(2010-4#1)(2011-2#1)
We review the main##2##4##(2008-1#1)(2008-2#1)
We review the possible##2##4##(2008-7#2)
We review the theories of these approaches and their potential applications to molecular simulations##2##14##(2013-1#2)
We review the##28##3##(1991-6#1)(1993-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
We review##58##2##(1990-6#1)(1991-6#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-6#1)(1996-9#1)(1997-2#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
We reviewed our##3##3##(2007-7#1)(2007-8#1)(2012-3#1)
We reviewed published##2##3##(2008-7#1)(2012-3#1)
We reviewed studies##3##3##(2009-7#1)(2012-2#1)(2012-3#1)
We reviewed the clinical and##2##5##(1996-6#1)(1997-6#1)
We reviewed the literature##2##4##(2008-8#1)(2013-1#1)
We reviewed the medical records of patients with##2##8##(2012-12#1)(2012-2#1)
We reviewed the medical records of##3##6##(2008-8#1)(2012-12#1)(2012-2#1)
We reviewed the medical##4##4##(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
We reviewed the##23##3##(1990-2#1)(1995-2#1)(1995-4#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We reviewed##44##2##(1990-2#1)(1995-2#1)(1995-4#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-2#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
We revisit##2##2##(2008-3#1)(2009-11#1)
We sampled##7##2##(1995-11#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-2#1)
We screened##5##2##(1993-2#1)(1994-8#1)(1996-10#1)(2008-10#1)(2008-11#1)
We searched##10##2##(1995-12#1)(1996-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
We select##2##2##(2008-3#2)
We selected a##2##3##(1995-12#1)(1997-2#1)
We selected for##2##3##(1990-10#1)(2008-11#1)
We selected##9##2##(1990-10#1)(1992-9#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
We separated the##2##3##(2008-10#1)(2008-8#1)
We set out to##2##4##(2012-3#1)(2012-5#1)
We set##3##2##(2008-12#1)(2012-3#1)(2012-5#1)
We shall##2##2##(2008-10#1)(2013-1#1)
We share the##2##3##(2008-12#1)(2011-2#1)
We show a##3##3##(2007-12#2)(2008-10#1)
We show both theoretically and experimentally##2##6##(2007-12#2)
We show both##3##3##(2007-11#1)(2007-12#2)
We show by##5##3##(1994-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
We show experimentally that##2##4##(2007-11#1)(2009-11#1)
We show experimentally##3##3##(2007-11#1)(2007-12#1)(2009-11#1)
We show here that a##2##5##(1994-8#1)(2008-7#1)
We show here that the##3##5##(1991-5#1)(1993-8#1)(2007-12#1)
We show here that this##3##5##(1995-11#1)(1997-3#1)(2008-10#1)
We show here that##19##4##(1990-12#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)
We show here##20##3##(1990-12#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-12#2)(2012-2#1)
We show how a##2##4##(1996-3#1)(2007-11#1)
We show how the##7##4##(2007-12#3)(2008-2#1)(2008-3#3)
We show how these##2##4##(2008-3#1)(2008-8#1)
We show how to##9##4##(2007-12#1)(2008-3#7)(2008-6#1)
We show how##29##3##(1996-3#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#12)(2008-6#2)(2008-8#2)(2009-5#1)(2010-11#1)(2011-1#1)
We show images of a##2##5##(2007-11#1)(2008-3#1)
We show in this##3##4##(1991-9#1)(2007-11#1)(2010-8#1)
We show that a##19##4##(1990-11#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#4)(2008-8#2)(2009-10#1)(2009-12#1)(2010-7#1)(2013-8#1)
We show that an##4##4##(2007-11#2)(2008-11#1)(2008-2#1)
We show that by##2##4##(2008-12#1)(2008-3#1)
We show that for##3##4##(2007-12#1)(2008-2#1)(2008-9#1)
We show that if the##2##5##(2008-2#1)(2008-3#1)
We show that in this##2##5##(2008-2#1)(2008-3#1)
We show that in##10##4##(1995-8#1)(2008-2#3)(2008-3#3)(2008-8#1)(2010-9#1)(2013-1#1)
We show that it is possible to##2##7##(2008-2#1)(2008-3#1)
We show that it is possible##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
We show that it##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
We show that many of the##3##6##(2008-3#3)
We show that migration##2##4##(2008-8#1)(2013-8#1)
We show that spatial##3##4##(2008-10#1)(2008-8#2)
We show that the experimental##2##5##(2008-2#1)(2008-3#1)
We show that the method##2##5##(2007-11#1)(2008-3#1)
We show that the nonlinear##2##5##(2007-11#1)(2008-3#1)
We show that the number##2##5##(2008-3#2)
We show that the sensor##2##5##(2007-11#1)(2008-10#1)
We show that the spectral##2##5##(2007-12#2)
We show that the##94##4##(1990-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#9)(2007-12#9)(2008-10#4)(2008-11#2)(2008-2#8)(2008-3#35)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-6#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
We show that there is##3##5##(2007-11#1)(2008-3#1)(2012-3#1)
We show that there##4##4##(2007-11#1)(2008-3#1)(2011-3#1)(2012-3#1)
We show that these##4##4##(1993-8#1)(1995-2#1)(1995-5#1)(1997-2#1)
We show that this approach##2##5##(1992-9#1)(2008-6#1)
We show that this technique##3##5##(2007-11#1)(2008-3#1)(2012-2#1)
We show that this##21##4##(1992-9#1)(1994-9#1)(1995-6#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-2#2)
We show that when##2##4##(2008-3#2)
We show that with##3##4##(2008-6#1)(2008-8#1)(2013-1#1)
We show that##292##3##(1990-11#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#30)(2007-12#30)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#25)(2008-3#83)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#19)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#6)
We show the##12##3##(1995-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-3#1)(2013-8#1)
We show##401##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#5)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(2007-11#42)(2007-12#48)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#32)(2008-3#106)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#26)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#1)(2013-1#4)(2013-8#7)
We showed that after##2##4##(2008-11#2)
We showed that the##4##4##(2008-10#3)(2012-2#1)
We showed that##19##3##(1992-12#1)(1994-11#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
We showed##20##2##(1992-12#1)(1994-11#1)(1997-6#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
We simulate the##2##3##(2008-2#1)(2008-3#1)
We simulate##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
We simulated##3##2##(2008-8#1)(2010-9#1)(2011-2#1)
We simultaneously##2##2##(1996-9#1)(2008-3#1)
We solve##3##2##(2008-3#2)(2008-6#1)
We sought to determine the##2##5##(2007-10#1)(2008-6#1)
We sought to determine##5##4##(2007-10#1)(2008-11#1)(2008-6#1)(2010-2#1)(2012-2#1)
We sought to evaluate the##2##5##(2007-10#1)(2012-3#1)
We sought to##16##3##(1997-5#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
We sought##17##2##(1993-9#1)(1997-5#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
We specifically##2##2##(2008-11#1)(2012-2#1)
We speculate that in##2##4##(2008-10#1)(2011-2#1)
We speculate that the##4##4##(1990-11#1)(2007-12#1)(2008-10#2)
We speculate that##14##3##(1990-11#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
We speculate##15##2##(1990-11#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
We speculated that##3##3##(2008-1#2)(2008-12#1)
We standardized##2##2##(2008-11#1)(2012-4#1)
We start with a##2##4##(2008-3#1)(2008-7#1)
We start##3##2##(2008-3#1)(2008-7#1)(2009-8#1)
We stimulated##2##2##(1994-2#1)(1996-5#1)
We stress the importance of##2##5##(1990-9#1)(2008-9#1)
We stress the##4##3##(1990-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
We stress##5##2##(1990-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
We strongly##3##2##(1994-9#1)(1997-8#1)(2012-3#1)
We studied 186 patients##2##4##(2007-11#1)(2007-8#1)
We studied 32##2##3##(2007-8#1)(2013-1#1)
We studied a##5##3##(1992-8#1)(1997-5#1)(2008-1#1)(2008-8#1)(2009-6#1)
We studied its##2##3##(2008-5#2)
We studied the changes in##2##5##(2009-8#1)(2013-8#1)
We studied the changes##3##4##(2009-8#1)(2011-2#1)(2013-8#1)
We studied the effect of##15##5##(1990-5#1)(1990-8#1)(1994-11#2)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2012-1#1)
We studied the effects of##6##5##(1995-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-10#1)(2013-8#1)
We studied the effects##7##4##(1995-12#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-10#1)(2013-8#1)
We studied the influence of##3##5##(2008-3#2)(2008-5#1)
We studied the##64##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#2)(1995-12#4)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-2#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#3)
We studied two##2##3##(1995-5#1)(2008-5#1)
We studied##139##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-12#4)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#5)(2012-1#3)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#3)
We study a##5##3##(1995-5#1)(1996-4#1)(2007-12#1)(2008-3#1)(2008-8#1)
We study the influence of##2##5##(2008-2#2)
We study the##20##3##(2007-11#3)(2007-12#2)(2008-2#7)(2008-3#3)(2008-8#3)(2009-9#1)(2012-2#1)
We study this##2##3##(2008-11#1)(2008-2#1)
We study##43##2##(1995-5#1)(1996-4#1)(2007-11#8)(2007-12#7)(2008-11#3)(2008-2#8)(2008-3#5)(2008-7#1)(2008-8#5)(2009-5#1)(2009-9#1)(2012-2#2)
We succeeded in##3##3##(1993-8#1)(2007-11#1)(2008-7#1)
We succeeded##5##2##(1993-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
We successfully##11##2##(1990-11#1)(2008-3#2)(2009-3#1)(2010-11#1)(2010-7#2)(2012-2#1)(2012-3#2)(2013-1#1)
We suggest a new##3##4##(2007-12#1)(2012-3#1)(2013-8#1)
We suggest a novel##3##4##(2007-11#3)
We suggest a role of##2##5##(1992-6#1)(1993-11#1)
We suggest a##11##3##(1992-6#1)(1993-11#1)(1995-2#1)(2007-11#3)(2007-12#2)(2008-3#1)(2012-3#1)(2013-8#1)
We suggest an##2##3##(2008-3#2)
We suggest that a##5##4##(1990-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-2#1)
We suggest that in##2##4##(1994-6#1)(2008-12#1)
We suggest that the large##2##5##(2007-11#1)(2010-3#1)
We suggest that the##30##4##(1990-7#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-7#1)
We suggest that these##2##4##(1997-7#1)(2012-1#1)
We suggest that this##7##4##(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)
We suggest that##97##3##(1990-2#1)(1990-7#1)(1991-12#4)(1991-9#1)(1992-10#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
We suggest##124##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#4)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#4)
We summarize the current##2##4##(2008-8#1)(2010-12#1)
We summarize the##6##3##(1996-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
We summarize##12##2##(1996-4#3)(1997-2#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
We support the##2##3##(2007-10#1)(2009-8#1)
We support##3##2##(2007-10#1)(2009-8#1)(2012-2#1)
We surveyed##4##2##(1994-9#1)(1996-2#1)(2008-10#1)(2008-7#1)
We suspect##2##2##(2008-10#1)(2012-2#1)
We synthesized##7##2##(1992-5#1)(1992-9#1)(1994-8#1)(1995-11#1)(2007-12#1)(2009-10#1)(2009-5#1)
We systematically##2##2##(1992-3#1)(2013-1#1)
We take##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2013-7#1)
We targeted##2##2##(2008-6#1)(2012-12#1)
We term this##2##3##(1991-2#1)(2007-12#1)
We test the##4##3##(2008-2#1)(2008-3#2)(2010-3#1)
We test this hypothesis by##2##5##(2008-2#1)(2009-7#1)
We test this hypothesis##3##4##(2008-10#1)(2008-2#1)(2009-7#1)
We test this##4##3##(1997-1#1)(2008-10#1)(2008-2#1)(2009-7#1)
We test whether##2##3##(1997-3#1)(2008-7#1)
We test##15##2##(1997-1#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-3#1)(2012-2#1)
We tested 19##2##3##(2008-7#1)(2010-2#1)
We tested the effect of##3##5##(1992-3#1)(1995-12#1)(2012-1#1)
We tested the hypotheses that##3##5##(2007-10#1)(2008-8#1)(2012-3#1)
We tested the hypothesis that the##3##6##(1995-8#1)(2007-10#1)(2008-10#1)
We tested the hypothesis that##10##5##(1990-5#1)(1995-8#1)(2007-10#1)(2008-10#3)(2008-3#1)(2009-11#1)(2009-9#1)(2013-7#1)
We tested the performance of the##2##6##(2008-2#1)(2008-3#1)
We tested the performance of##3##5##(2008-2#1)(2008-3#1)(2012-2#1)
We tested the##28##3##(1990-10#1)(1990-5#1)(1991-2#1)(1992-3#1)(1995-12#1)(1995-8#1)(2007-10#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
We tested this##4##3##(1993-6#1)(2008-8#2)(2009-8#1)
We tested whether##3##3##(2009-9#1)(2012-1#1)(2012-12#1)
We tested##53##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(2007-10#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#2)(2008-8#7)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#2)(2010-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
We then assess the##2##4##(2008-3#1)(2009-3#1)
We then assessed the##2##4##(1997-5#1)(2013-1#1)
We then describe the##2##4##(2008-3#1)(2010-12#1)
We then describe##4##3##(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
We then discuss the##3##4##(2008-11#1)(2008-9#1)(2011-1#1)
We then discuss##5##3##(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)
We then examined##2##3##(2008-6#1)(2013-1#1)
We then measured the##2##4##(2008-3#1)(2008-5#1)
We then performed##2##3##(2011-2#1)(2012-3#1)
We then present##2##3##(2008-10#1)(2008-6#1)
We then show that the##3##5##(2008-3#1)(2010-3#1)(2013-8#1)
We then show##6##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)(2013-8#1)
We then test##2##3##(2008-8#1)(2013-1#1)
We then used these##2##4##(1997-7#1)(2008-11#1)
We then used##3##3##(1997-6#1)(1997-7#1)(2008-11#1)
We then##78##2##(1994-2#2)(1994-8#1)(1995-3#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-2#5)(2008-3#11)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-3#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
We theoretically analyze the##2##4##(2008-3#2)
We theoretically analyze##3##3##(2007-11#1)(2008-3#2)
We theoretically##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
We therefore conducted##2##3##(2011-2#1)(2013-1#1)
We therefore investigated##3##3##(1990-3#1)(1992-2#1)(2008-7#1)
We therefore propose that##4##4##(1995-2#2)(1995-8#1)(2012-2#1)
We therefore studied the##2##4##(1992-8#1)(1994-8#1)
We therefore studied##3##3##(1992-8#1)(1994-8#1)(2008-10#1)
We therefore suggest that##3##4##(1990-5#1)(2008-5#1)(2008-9#1)
We therefore used##2##3##(1994-6#1)(1995-11#1)
We therefore##35##2##(1990-3#1)(1990-5#2)(1990-8#1)(1992-2#1)(1992-8#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
We think that the##2##4##(2011-2#1)(2013-7#1)
We think that##3##3##(2008-5#1)(2011-2#1)(2013-7#1)
We think##4##2##(1997-8#1)(2008-5#1)(2011-2#1)(2013-7#1)
We thus extend##2##3##(2007-12#1)(2011-3#1)
We thus##11##2##(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
We took advantage of##4##4##(1994-2#1)(2008-4#1)(2009-10#1)(2011-1#1)
We took##6##2##(1994-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)
We trained##2##2##(2010-7#1)(2012-2#1)
We transferred the##2##3##(1994-5#1)(2008-3#1)
We treated a##2##3##(2010-3#1)(2011-2#1)
We treated##8##2##(1990-12#1)(1991-6#2)(2007-11#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
We tried to##5##3##(1990-9#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
We tried##6##2##(1990-9#1)(2007-10#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
We try to##2##3##(2008-2#1)(2009-10#1)
We undertook a##3##3##(1992-3#1)(2008-8#1)(2013-1#1)
We undertook##4##2##(1992-3#1)(2008-1#1)(2008-8#1)(2013-1#1)
We use a combination of##2##5##(2008-10#2)
We use a mathematical model of##2##6##(2008-3#1)(2008-7#1)
We use a novel##2##4##(2007-11#1)(2012-3#1)
We use a##28##3##(1995-2#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
We use an##6##3##(2008-2#2)(2008-8#1)(2008-9#1)(2010-3#1)(2013-8#1)
We use both low (perturbative) and high (saturating)##2##8##(2008-3#2)
We use data from##2##4##(2011-2#1)(2013-1#1)
We use optical##2##3##(2008-3#2)
We use our##2##3##(2008-3#1)(2012-3#1)
We use the##19##3##(1994-2#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
We use this property##2##4##(2008-11#1)(2008-2#1)
We use this##6##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
We use three##2##3##(2008-2#1)(2008-5#1)
We use##104##2##(1993-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1996-3#1)(1997-8#2)(2007-11#6)(2007-12#8)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#17)(2008-3#23)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#2)
We used a novel##3##4##(2007-12#1)(2012-3#1)(2013-1#1)
We used a##40##3##(1990-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-12#4)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#6)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
We used an##8##3##(1993-12#1)(1995-12#1)(2007-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-2#1)
We used data from a##2##5##(2008-8#1)(2013-1#1)
We used data from##4##4##(1995-12#1)(2008-11#1)(2008-8#1)(2013-1#1)
We used four##2##3##(2008-10#1)(2010-6#1)
We used in##2##3##(1990-12#1)(2008-6#1)
We used one##2##3##(2008-10#1)(2011-2#1)
We used published##2##3##(2008-11#1)(2012-3#1)
We used reverse##2##3##(1994-11#1)(1994-6#1)
We used the##24##3##(1990-7#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-8#1)(1995-8#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
We used these##2##3##(2008-3#1)(2008-8#1)
We used this algorithm to##2##5##(2007-11#1)(2008-2#1)
We used this approach to##3##5##(2008-10#1)(2009-12#1)(2012-2#1)
We used this system to##2##5##(2008-3#1)(2009-2#1)
We used this technique to##2##5##(2008-2#1)(2008-3#1)
We used this##15##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2009-12#1)(2009-2#1)(2012-2#2)(2013-1#1)
We used time-resolved##2##3##(1997-2#1)(2008-3#1)
We used two##2##3##(2008-4#1)(2008-7#1)
We used##191##2##(1990-12#1)(1990-7#2)(1990-8#1)(1992-2#1)(1992-8#1)(1993-12#4)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#16)(2007-7#2)(2007-8#2)(2008-10#16)(2008-11#13)(2008-12#2)(2008-2#6)(2008-3#16)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#6)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-5#3)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#2)
We utilize##2##2##(2007-12#1)(2011-1#1)
We utilized a##2##3##(2007-11#1)(2008-9#1)
We utilized the##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
We utilized this technique for##2##5##(2008-11#1)(2008-3#1)
We utilized this##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
We utilized##12##2##(1994-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-11#1)
We validate##2##2##(2009-9#1)(2011-1#1)
We validated our##2##3##(2010-11#1)(2010-8#1)
We validated the##3##3##(1997-2#1)(2008-3#1)(2009-12#1)
We validated##7##2##(1997-2#1)(2007-12#1)(2008-3#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-8#1)
We vary the##2##3##(2008-3#2)
We verified the##3##3##(2008-2#1)(2008-3#2)
We verified##6##2##(2008-2#1)(2008-3#3)(2008-9#1)(2009-12#1)
We verify##2##2##(2007-11#1)(2008-6#1)
We want to##2##3##(2012-2#2)
We wanted to##5##3##(1992-11#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
We were able to show that##3##6##(2008-5#1)(2008-7#1)(2011-1#1)
We were able to##16##4##(1990-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-7#1)(2011-1#1)(2012-7#1)(2013-1#1)
We were also##3##3##(2008-1#1)(2008-12#1)(2008-3#1)
We were unable to##4##4##(1996-3#1)(2008-11#1)(2008-8#1)(2010-12#1)
We were##28##2##(1990-9#2)(1992-11#1)(1992-9#1)(1993-3#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#1)
We will also discuss the##2##5##(1993-12#1)(2010-6#1)
We will also##9##3##(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-2#1)
We will briefly##2##3##(2008-10#1)(2008-7#1)
We will continue to##2##4##(1997-8#1)(2013-8#1)
We will demonstrate##2##3##(1995-12#1)(2008-10#1)
We will discuss the##2##4##(2010-5#1)(2012-3#1)
We will discuss##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
We will review the current##2##5##(2008-5#1)(2008-9#1)
We will review the##7##4##(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-8#2)
We will review##8##3##(1995-1#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-8#2)
We will then##3##3##(1993-3#1)(2008-10#1)(2013-8#1)
We will use the##2##4##(2008-4#1)(2008-7#1)
We will##45##2##(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
We would like to##5##4##(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
We would##7##2##(1990-2#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
We##11018##1##(1990-10#2)(1990-11#29)(1990-12#38)(1990-2#19)(1990-3#17)(1990-4#1)(1990-5#46)(1990-6#15)(1990-7#25)(1990-8#28)(1990-9#21)(1991-1#5)(1991-10#1)(1991-11#15)(1991-12#54)(1991-2#35)(1991-3#14)(1991-4#1)(1991-5#29)(1991-6#25)(1991-7#4)(1991-8#16)(1991-9#34)(1992-1#3)(1992-10#5)(1992-11#23)(1992-12#47)(1992-2#20)(1992-3#36)(1992-4#9)(1992-5#8)(1992-6#29)(1992-7#1)(1992-8#30)(1992-9#44)(1993-1#5)(1993-10#2)(1993-11#29)(1993-12#55)(1993-2#17)(1993-3#33)(1993-5#1)(1993-6#38)(1993-8#34)(1993-9#20)(1994-1#8)(1994-10#4)(1994-11#55)(1994-12#60)(1994-2#30)(1994-3#22)(1994-5#15)(1994-6#32)(1994-7#2)(1994-8#68)(1994-9#29)(1995-1#5)(1995-10#3)(1995-11#37)(1995-12#56)(1995-2#82)(1995-3#20)(1995-4#6)(1995-5#37)(1995-6#36)(1995-8#31)(1995-9#7)(1996-1#6)(1996-10#2)(1996-11#10)(1996-12#34)(1996-2#43)(1996-3#15)(1996-4#8)(1996-5#22)(1996-6#16)(1996-7#6)(1996-8#5)(1996-9#8)(1997-1#24)(1997-2#53)(1997-3#54)(1997-4#36)(1997-5#16)(1997-6#17)(1997-7#47)(1997-8#38)(1997-9#3)(2006-10#25)(2006-12#5)(2006-6#8)(2006-8#4)(2007-10#73)(2007-11#638)(2007-12#720)(2007-2#7)(2007-4#7)(2007-5#13)(2007-6#4)(2007-7#78)(2007-8#135)(2007-9#8)(2008-1#112)(2008-10#638)(2008-11#332)(2008-12#104)(2008-2#683)(2008-3#1390)(2008-4#62)(2008-5#175)(2008-6#140)(2008-7#393)(2008-8#357)(2008-9#196)(2009-1#14)(2009-10#49)(2009-11#37)(2009-12#42)(2009-2#28)(2009-3#31)(2009-4#24)(2009-5#51)(2009-6#45)(2009-7#35)(2009-8#91)(2009-9#50)(2010-1#14)(2010-10#20)(2010-11#41)(2010-12#49)(2010-2#32)(2010-3#51)(2010-4#31)(2010-5#43)(2010-6#35)(2010-7#34)(2010-8#53)(2010-9#20)(2011-1#132)(2011-10#3)(2011-2#341)(2011-3#12)(2011-8#1)(2012-1#44)(2012-12#140)(2012-2#272)(2012-3#218)(2012-4#2)(2012-5#2)(2012-6#1)(2012-7#6)(2012-8#1)(2012-9#1)(2013-1#337)(2013-2#2)(2013-7#50)(2013-8#155)
We'll##2##1##(2009-10#1)(2011-2#1)
We've established that##2##3##(2012-3#2)
We've##5##1##(2009-9#1)(2011-2#1)(2012-3#3)
Weak##17##1##(1993-2#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
Weakly##3##1##(1996-9#1)(2009-8#1)(2011-2#1)
Weakness##2##1##(2007-8#1)(2010-11#1)
Weapons##3##1##(1992-12#1)(1996-3#1)(2011-2#1)
Wear properties##2##2##(2008-5#1)(2012-12#1)
Weather##4##1##(1995-6#1)(2008-10#3)
Web Sites##2##2##(2007-2#2)
Web and##2##2##(1996-12#1)(2008-11#1)
Web at http##3##3##(1997-6#1)(1997-8#1)(2008-3#1)
Web of Knowledge##3##3##(2013-1#3)
Web of Science##2##3##(2011-2#1)(2013-8#1)
Web of##5##2##(2011-2#1)(2013-1#3)(2013-8#1)
Web pages##3##2##(1996-12#1)(2007-11#1)(2008-3#1)
Web resource##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
Web resources##2##2##(1996-12#1)(2008-7#1)
Web server##4##2##(2008-10#1)(2008-4#2)(2008-9#1)
Web site##10##2##(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#3)(2011-1#1)(2012-3#1)(2013-1#1)
Web sites that address##2##4##(2007-2#2)
Web sites that##3##3##(2007-2#3)
Web sites was##2##3##(2011-1#2)
Web sites##9##2##(2007-2#3)(2008-11#1)(2009-5#1)(2011-1#4)
Web top 10##2##3##(2008-7#2)
Web##75##1##(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-2#6)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#12)(2008-6#1)(2008-7#7)(2008-9#5)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Web-Based##2##1##(2010-12#1)(2013-1#1)
Web-based computer##2##2##(2010-3#1)(2013-1#1)
Web-based search##2##2##(2008-4#1)(2010-3#1)
Web-based##19##1##(2007-12#2)(2008-1#1)(2008-12#2)(2008-4#4)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-8#1)(2012-12#1)(2013-1#2)
WebMILL##2##1##(2013-1#2)
Webb##3##1##(1990-7#1)(1991-8#1)(2008-11#1)
Weber Christian disease##2##3##(2008-7#2)
Weber##5##1##(2007-7#1)(2008-3#1)(2008-7#2)(2010-1#1)
Website##2##1##(2008-7#2)
Webster##3##1##(1994-2#1)(2008-4#1)(2008-7#1)
Wechsler Adult Intelligence##3##3##(1994-6#2)(2008-10#1)
Wechsler Memory Scale##3##3##(1994-6#2)(2008-7#1)
Wechsler##7##1##(1994-6#4)(1995-11#1)(2008-10#1)(2008-7#1)
Weed Orobanche##2##2##(2008-10#2)
Weed##8##1##(2008-10#4)(2010-8#4)
Weeder##2##1##(2008-4#2)
Weeds in Central##2##3##(2008-10#2)
Weeds##3##1##(2008-10#3)
Week 4##3##2##(2012-2#3)
Week##11##1##(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1995-3#1)(2008-11#1)(2012-2#4)(2012-3#1)
Weekly clinicopathological exercises##10##3##(1990-5#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)
Weekly##21##1##(1990-5#1)(1991-2#1)(1992-10#3)(1992-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)
Weeks##4##1##(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Wegener's granulomatosis in##2##3##(2008-7#1)(2010-11#1)
Wegener's granulomatosis##7##2##(1993-2#1)(2008-1#1)(2008-7#1)(2010-11#3)(2012-3#1)
Wegener's##10##1##(1991-3#1)(1993-2#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-11#3)(2012-3#1)
Wei and##3##2##(1992-6#2)(2010-7#1)
Wei et Y##2##3##(2013-1#2)
Wei##7##1##(1992-6#2)(1997-3#1)(2008-11#1)(2010-7#1)(2013-1#2)
Weibull distribution##4##2##(2007-12#1)(2008-10#2)(2009-7#1)
Weibull distributions##2##2##(2009-11#1)(2011-2#1)
Weibull model##9##2##(1995-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-4#2)(2011-2#2)
Weibull##22##1##(1995-9#1)(2007-12#1)(2008-10#8)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#2)(2011-2#3)(2012-2#1)
Weight Gain in##2##3##(2013-1#2)
Weight Loss##5##2##(2008-3#4)(2010-8#1)
Weight and##2##2##(2011-1#1)(2012-2#1)
Weight increase from age 20 to 40##2##7##(2009-9#2)
Weight loss was##2##3##(1992-8#1)(2008-4#1)
Weight loss##10##2##(1990-9#1)(1992-8#2)(1993-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
Weight##46##1##(1990-9#1)(1992-8#2)(1993-12#1)(1993-2#3)(1994-3#1)(1995-3#1)(2007-12#1)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
Weighted##4##1##(2008-11#1)(2011-2#2)(2013-1#1)
Weights##5##1##(1991-12#1)(1992-12#1)(1995-1#1)(2008-12#1)(2009-5#1)
Weil osteotomy##3##2##(2010-11#3)
Weinberg##2##1##(1992-3#1)(1997-2#1)
Weiss##3##1##(1991-1#1)(2008-5#1)(2008-8#1)
Weissberger##2##1##(2011-1#2)
Weissella##3##1##(1997-4#3)
Welcome Bay and##2##3##(2007-5#2)
Welcome a New Resident&quot##2##4##(1992-1#2)
Welcome to the##3##3##(2008-10#3)
Welcome to##4##2##(1991-8#1)(2008-10#3)
Welcome##8##1##(1991-8#1)(1992-1#2)(2007-5#2)(2008-10#3)
Welfare and##2##2##(2011-2#1)(2013-8#1)
Welfare##22##1##(1990-12#1)(1991-1#1)(1991-3#3)(1994-7#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#3)(2013-8#3)
Well##7##1##(1994-3#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)
Well-Being##6##1##(1996-7#1)(2008-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)
Well-being##5##1##(1991-6#3)(2008-10#1)(2009-11#1)
Well-constructed##2##1##(1992-3#1)(1994-3#1)
Well-controlled##2##1##(2008-5#1)(2011-2#1)
Well-defined##4##1##(2008-10#3)(2008-12#1)
Well-designed##2##1##(1994-3#1)(2011-2#1)
Well-differentiated neuroendocrine carcinoma##2##3##(1991-6#2)
Well-differentiated##3##1##(1991-6#2)(2009-8#1)
Wellcome Trust##2##2##(2008-7#2)
Wellcome##9##1##(1990-9#1)(2008-10#2)(2008-5#3)(2008-7#3)
Wellington##2##1##(2008-1#2)
Wellness##5##1##(1992-12#1)(1994-3#1)(1996-1#1)(2012-12#2)
Wells##2##1##(1996-9#1)(1997-5#1)
Welsh onion##2##2##(2008-10#2)
Welsh##6##1##(1992-3#1)(1996-7#1)(2008-10#4)
Wenchuan earthquake##3##2##(2011-1#1)(2012-1#2)
Wenchuan##5##1##(2011-1#2)(2012-1#3)
Wendan##4##1##(2008-10#4)
Wentz's##2##1##(1997-5#2)
Were the##2##2##(1991-2#1)(2009-10#1)
Were##5##1##(1991-2#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-8#1)
Werner syndrome and##2##3##(2009-12#1)(2010-1#1)
Werner syndrome##7##2##(1992-9#1)(2009-12#2)(2010-1#1)(2010-2#2)(2012-8#1)
Werner##8##1##(1992-9#1)(2009-12#3)(2010-1#1)(2010-2#2)(2012-8#1)
Werner's syndrome is##2##3##(1994-12#2)
Werner's syndrome##6##2##(1994-12#6)
Wesley##2##1##(2008-12#2)
Wesley's##4##1##(2008-12#4)
Wesleyan##2##1##(1995-1#1)(2008-12#1)
West Africa##9##2##(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-7#1)
West African##4##2##(2007-7#1)(2008-10#1)(2008-9#1)(2010-10#1)
West Ap strains##2##3##(2008-12#2)
West Bank##3##2##(2008-9#1)(2009-2#2)
West Bengal##9##2##(1994-3#1)(2008-10#1)(2009-5#1)(2010-10#1)(2010-4#2)(2011-1#2)(2012-2#1)
West Germany##2##2##(1990-3#1)(1997-8#1)
West Indies##9##2##(2008-7#1)(2011-2#8)
West Nile virus (WNV)##3##4##(2007-12#1)(2009-10#1)(2010-8#1)
West Nile virus in the context of climate change##2##9##(2009-5#2)
West Nile virus is##2##4##(2007-2#2)
West Nile virus##15##3##(2007-12#5)(2007-2#3)(2008-10#1)(2009-10#2)(2009-5#3)(2010-8#1)
West Nile##16##2##(2007-12#5)(2007-2#3)(2008-10#1)(2009-10#2)(2009-5#3)(2010-8#1)(2013-8#1)
West O1##2##2##(2008-12#2)
West Pacific##2##2##(2008-5#1)(2011-2#1)
West Park Hospital##2##3##(1995-2#2)
West Virginia##6##2##(1995-1#4)(2008-10#1)(2008-4#1)
West##103##1##(1990-3#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-1#7)(1995-2#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-10#3)(2007-12#5)(2007-2#3)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#3)(2009-2#2)(2009-4#4)(2009-5#4)(2010-10#2)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#11)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
West-Center region##2##2##(2008-10#2)
Westerbork##2##1##(2008-7#2)
Western Atlantic##3##2##(2007-5#1)(2008-5#1)(2013-7#1)
Western Australia##18##2##(2007-10#1)(2008-10#12)(2008-11#2)(2010-3#3)
Western Australian##2##2##(1994-12#1)(2008-10#1)
Western Azerbaijan province##2##3##(2008-12#2)
Western Blot##2##2##(2007-7#1)(2009-6#1)
Western Canada##2##2##(2008-10#1)(2008-11#1)
Western Europe##9##2##(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)
Western Hemisphere##8##2##(2008-10#7)(2013-7#1)
Western Pacific##2##2##(2008-3#1)(2008-6#1)
Western Pomerania##2##2##(2008-12#2)
Western Region##2##2##(1996-2#1)(1996-3#1)
Western United States##3##3##(2008-10#3)
Western Washington##2##2##(2008-10#2)
Western analyses##2##2##(1993-8#1)(2008-10#1)
Western analysis of the##2##4##(1995-6#1)(1997-7#1)
Western analysis of##3##3##(1995-6#1)(1995-8#1)(1997-7#1)
Western analysis##6##2##(1993-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-7#2)
Western and##5##2##(1992-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2012-2#1)
Western blot analyses revealed##2##4##(2006-12#1)(2008-10#1)
Western blot analyses with##2##4##(1996-12#1)(2012-12#1)
Western blot analyses##9##3##(1991-10#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-12#1)(2006-12#1)(2008-10#1)(2012-12#1)
Western blot analysis and##4##4##(1997-8#1)(2008-11#1)(2009-12#1)(2010-12#1)
Western blot analysis demonstrated##2##4##(2008-10#1)(2008-8#1)
Western blot analysis of##6##4##(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(2011-2#1)
Western blot analysis revealed that both##2##6##(1996-2#1)(2009-3#1)
Western blot analysis revealed that##6##5##(1994-6#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-3#1)(2012-2#1)
Western blot analysis showed that##2##5##(2008-11#1)(2008-6#1)
Western blot analysis showed##5##4##(1997-7#1)(2008-11#2)(2008-6#1)(2011-2#1)
Western blot analysis using##2##4##(1990-8#1)(1992-11#1)
Western blot analysis with##2##4##(1991-9#1)(1993-11#1)
Western blot analysis##46##3##(1990-8#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#4)(2009-12#1)(2009-3#1)(2010-12#2)(2011-2#3)(2012-2#1)(2013-1#1)
Western blot and##10##3##(1990-7#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2013-8#1)
Western blot showed a##2##4##(2008-8#1)(2008-9#1)
Western blot##101##2##(1990-3#1)(1990-7#2)(1990-8#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#6)(1996-2#1)(1997-1#1)(1997-4#3)(1997-7#2)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#6)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Western blots and##3##3##(1995-6#1)(2008-10#1)(2012-12#1)
Western blots of##2##3##(1992-3#2)
Western blots with##3##3##(1992-8#1)(1994-6#1)(1995-12#1)
Western blots##17##2##(1991-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-6#1)(1995-8#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-12#1)
Western blotting also##2##3##(2008-8#1)(2008-9#1)
Western blotting and##2##3##(1990-5#1)(1994-9#1)
Western blotting of##3##3##(1994-11#1)(2008-11#1)(2008-9#1)
Western blotting revealed that##2##4##(1992-9#1)(1993-8#1)
Western blotting showed that##2##4##(2008-4#1)(2008-8#1)
Western blotting using##3##3##(1992-12#1)(1993-11#1)(1997-1#1)
Western blotting with##7##3##(1991-12#1)(1991-8#1)(1992-3#1)(1994-11#1)(1997-1#1)(2008-8#1)(2010-12#1)
Western blotting##53##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-2#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#6)(2010-12#3)(2011-1#2)(2011-3#3)(2012-3#2)(2013-1#1)
Western countries has##2##3##(1992-1#1)(2012-2#1)
Western countries##23##2##(1990-6#2)(1992-1#1)(1992-10#1)(1993-11#1)(1993-9#1)(1995-11#1)(1996-8#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
Western diamondback rattlesnake##3##3##(1992-8#2)(1994-6#1)
Western immunoblot##2##2##(1992-9#1)(2008-10#1)
Western medical ointments##2##3##(1997-2#2)
Western medicine##2##2##(2012-2#2)
Western moral theory##2##3##(2011-2#2)
Western nations##2##2##(1992-1#1)(2010-2#1)
Western patients##3##2##(2007-12#2)(2012-2#1)
Western populations##3##2##(2007-12#1)(2008-1#1)(2011-2#1)
Western societies##5##2##(2009-2#2)(2011-1#1)(2012-3#1)(2013-8#1)
Western society##4##2##(2007-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
Western white pine##2##3##(2008-10#2)
Western##368##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#6)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#1)(1995-6#5)(1995-8#3)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#4)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#3)(2006-12#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-5#3)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#50)(2008-11#17)(2008-12#8)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#16)(2008-9#15)(2009-10#1)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#5)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#20)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#11)(2013-8#3)
Westerners##2##1##(2008-5#2)
Westernized##3##1##(2008-7#1)(2010-5#1)(2010-8#1)
Weston##3##1##(1994-2#1)(2008-10#2)
Wet##3##1##(2008-10#3)
Wetness Duration on Infection of##2##5##(2008-10#2)
Wetness Duration on##3##3##(2008-10#3)
Wetness##6##1##(2008-10#6)
Weymouth##3##1##(2008-10#3)
What Do You Think##2##4##(2013-1#2)
What Do##3##2##(2009-3#1)(2013-1#2)
What Have##2##2##(2012-3#2)
What I##3##2##(1992-3#1)(2008-6#1)(2011-2#1)
What Is##2##2##(2012-3#2)
What a##4##2##(1993-1#1)(1997-3#1)(2008-11#1)(2010-3#1)
What about##2##2##(1994-1#1)(2009-5#1)
What affects##2##2##(1992-12#1)(1995-3#1)
What are the##16##3##(1992-11#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-12#1)(2012-3#1)
What are##27##2##(1992-11#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(1997-1#2)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#3)(2012-3#1)
What can be done to##3##5##(1992-11#1)(2008-1#1)(2008-10#1)
What can be##4##3##(1990-9#1)(1992-11#1)(2008-1#1)(2008-10#1)
What can the##2##3##(2008-9#1)(2009-5#1)
What can we learn##3##4##(2008-7#1)(2009-8#1)(2011-2#1)
What can we##6##3##(1993-2#1)(2007-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-7#1)
What can##15##2##(1990-9#1)(1992-11#1)(1993-2#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-7#1)
What causes##2##2##(1995-8#1)(2008-9#1)
What do practitioners say to mothers and families during labor? At birth? In consultations? To describe what is happening? To encourage a woman's efforts? To lighten the atmosphere? When advising about possible interventions? Medical terminology in perinatal care can often be deceptive or confusing##2##44##(2013-1#2)
What do we##3##3##(1992-3#1)(1994-3#1)(2007-12#1)
What do you##2##3##(1994-3#1)(1995-12#1)
What do##17##2##(1992-3#1)(1994-2#1)(1994-3#3)(1995-12#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#3)
What does it##2##3##(1997-3#1)(2007-12#1)
What does##4##2##(1993-1#1)(1995-2#1)(1997-3#1)(2007-12#1)
What evidence is available from##2##5##(2012-12#2)
What evidence##3##2##(1994-1#1)(2012-12#2)
What follows is##2##3##(2008-7#1)(2010-7#1)
What happens in##2##3##(2008-11#1)(2012-12#1)
What happens when the private sector plans hospital services for the NHS##5##12##(1997-5#5)
What happens when##6##3##(1997-5#5)(2008-11#1)
What happens##9##2##(1993-1#1)(1997-5#5)(2008-11#2)(2012-12#1)
What has##5##2##(1994-1#1)(1994-12#1)(2008-6#1)(2010-12#1)(2012-12#1)
What have we learned##2##4##(2007-12#1)(2008-7#1)
What have##3##2##(1995-12#1)(2007-12#1)(2008-7#1)
What if I##2##3##(2008-4#1)(2008-8#1)
What if##5##2##(2007-12#1)(2008-4#1)(2008-8#1)(2012-2#2)
What impact##2##2##(1995-3#1)(2008-4#1)
What is a##4##3##(1991-3#1)(1996-1#1)(2008-8#1)(2013-8#1)
What is believed to be the first##3##7##(2007-12#2)(2008-3#1)
What is believed to be##4##5##(2007-12#2)(2008-3#2)
What is it##2##3##(1997-3#1)(2008-8#1)
What is needed is##2##4##(1992-3#1)(1994-2#1)
What is needed##3##3##(1992-3#1)(1994-2#1)(2007-8#1)
What is now##2##3##(2008-12#1)(2008-7#1)
What is required##2##3##(1996-2#1)(2008-5#1)
What is the future##2##4##(2008-11#2)
What is the optimal##3##4##(2007-8#2)(2008-3#1)
What is the purpose of launching World Journal of##2##9##(2010-12#2)
What is the purpose of launching##3##6##(2010-12#3)
What is the risk of##2##5##(2007-5#1)(2008-11#1)
What is the role of##5##5##(1993-11#1)(1995-12#1)(2008-11#1)(2008-8#1)(2012-2#1)
What is the##39##3##(1992-12#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-6#2)(1997-8#1)(2007-5#1)(2007-8#2)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
What is your diagnosis?##2##4##(1992-6#1)(2007-12#1)
What is##84##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-1#3)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#4)(2007-5#1)(2007-8#3)(2008-11#7)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#1)(2010-10#1)(2010-12#4)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
What it##2##2##(1997-1#1)(2012-3#1)
What lessons have##2##3##(2008-10#2)
What really##2##2##(2008-4#1)(2009-5#1)
What should be##2##3##(1994-12#1)(2012-1#1)
What should we##2##3##(1993-2#1)(2008-8#1)
What should##5##2##(1993-2#1)(1994-12#1)(2008-8#1)(2010-10#1)(2012-1#1)
What the##7##2##(1990-8#1)(1992-2#1)(1995-1#1)(1996-3#1)(2008-1#1)(2008-5#1)(2012-2#1)
What this##2##2##(2008-1#1)(2011-2#1)
What to do##4##3##(2008-4#1)(2009-5#1)(2009-9#1)(2010-12#1)
What to##6##2##(1992-12#1)(2007-7#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-12#1)
What was##2##2##(1996-3#1)(2007-12#1)
What we know about##2##4##(2008-4#1)(2013-1#1)
What we##4##2##(1990-9#1)(1995-1#1)(2008-4#1)(2013-1#1)
What##294##1##(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#3)(1992-6#2)(1993-1#4)(1993-11#2)(1993-2#2)(1993-3#2)(1994-1#4)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#8)(1996-12#1)(1996-2#2)(1996-3#4)(1996-4#1)(1996-8#1)(1997-1#7)(1997-3#5)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#12)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#17)(2008-12#6)(2008-3#6)(2008-4#11)(2008-5#5)(2008-6#5)(2008-7#11)(2008-8#10)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#8)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#12)(2012-1#3)(2012-12#13)(2012-2#8)(2012-3#14)(2013-1#7)(2013-7#1)(2013-8#6)
What's New in##2##3##(2008-4#1)(2012-3#1)
What's hot##2##2##(2007-12#1)(2008-8#1)
What's in a name##2##4##(1993-1#1)(2008-5#1)
What's in a name?##3##4##(1992-12#1)(1993-9#1)(2010-8#1)
What's in a##5##3##(1992-12#1)(1993-1#1)(1993-9#1)(2008-5#1)(2010-8#1)
What's in the Literature?##2##4##(2012-3#2)
What's in##9##2##(1991-8#1)(1992-12#1)(1993-1#1)(1993-9#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-3#2)
What's more##2##2##(2011-2#1)(2011-3#1)
What's new in ACS Surgery##2##5##(2008-4#2)
What's new in ACS##3##4##(2008-4#3)
What's next##2##2##(1993-5#1)(2009-1#1)
What's the##3##2##(2008-2#1)(2009-5#1)(2009-8#1)
What's wrong with##3##3##(1994-12#1)(2007-11#1)(2008-4#1)
What's wrong##4##2##(1994-12#1)(1996-11#1)(2007-11#1)(2008-4#1)
What's your diagnosis?##2##3##(2007-2#2)
What's##40##1##(1990-11#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-1#2)(1996-11#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-2#2)(2008-4#7)(2008-5#1)(2008-8#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#3)
Whatever the##7##2##(1991-1#1)(1991-6#1)(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
Whatever##8##1##(1991-1#1)(1991-6#1)(1992-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
Whatman 1PS paper and##2##4##(2008-10#2)
Whatman 1PS paper##3##3##(2008-10#3)
Whatman 1PS##5##2##(2008-10#5)
Whatman##6##1##(2008-10#6)
Wheat (Triticum aestivum)##3##3##(2008-10#3)
Wheat (Triticum##5##2##(2008-10#3)(2008-12#1)(2012-3#1)
Wheat Cultivars##5##2##(2008-10#5)
Wheat Fields##2##2##(2008-10#2)
Wheat Genotypes##3##2##(2008-10#3)
Wheat Leaf Rust##2##3##(2008-10#2)
Wheat Seedlings##3##2##(2008-10#3)
Wheat and chaff in alternative medicine##2##6##(1997-5#2)
Wheat and##6##2##(1997-5#2)(2008-10#4)
Wheat by##3##2##(2008-10#3)
Wheat cultivars that##2##3##(2008-10#2)
Wheat genotypes##2##2##(2008-10#2)
Wheat germ##2##2##(2008-10#1)(2008-4#1)
Wheat leaf rust##2##3##(2008-10#2)
Wheat spindle streak mosaic virus (WSSMV)##2##6##(2008-10#2)
Wheat streak mosaic virus##2##4##(2008-10#2)
Wheat to##4##2##(2008-10#4)
Wheat was##2##2##(2008-10#2)
Wheat##105##1##(1991-12#1)(1997-5#2)(1997-8#1)(2008-10#94)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
When 1##2##2##(2008-10#2)
When 50##2##2##(1993-3#1)(2007-12#1)
When DNA##2##2##(1990-5#1)(2008-5#1)
When RH decreased##2##3##(2008-10#2)
When a##52##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-3#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
When added to##2##3##(1994-11#1)(1995-12#1)
When administered##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
When all##3##2##(1996-12#1)(2008-10#2)
When an##9##2##(1991-12#1)(1995-2#1)(1996-3#1)(2008-2#2)(2008-4#1)(2009-2#1)(2012-2#2)
When analyzed by##2##3##(1990-8#1)(2008-10#1)
When analyzing##2##2##(1995-2#1)(2008-10#1)
When and why##3##3##(1990-2#1)(1990-3#1)(1990-5#1)
When and##5##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#1)(2008-11#1)
When any of these##2##4##(2009-9#1)(2010-10#1)
When applied at##3##3##(2008-10#2)(2008-8#1)
When applied to the##6##4##(1990-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
When applied to##16##3##(1990-12#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-8#1)
When applied##23##2##(1990-12#1)(1997-8#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)
When are##2##2##(1996-12#1)(2008-11#1)
When asked##2##2##(2007-5#1)(2012-3#1)
When assayed##2##2##(1990-7#1)(1995-6#1)
When both##9##2##(1991-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(2008-10#1)(2008-7#2)(2011-2#1)
When bound to##2##3##(1992-3#1)(1997-2#1)
When calcium##2##2##(1996-6#1)(2008-10#1)
When cells were##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
When cells##5##2##(1991-12#1)(1993-9#1)(2008-1#1)(2008-11#1)(2008-7#1)
When challenged##2##2##(2008-10#2)
When changed##2##2##(2008-10#2)
When changes##2##2##(2008-6#1)(2008-9#1)
When chicks were##2##3##(2008-6#2)
When choosing##2##2##(1997-5#1)(2009-5#1)
When combined with##6##3##(2008-10#1)(2008-2#2)(2009-4#1)(2012-2#1)(2013-1#1)
When combined##8##2##(1992-6#1)(2008-10#1)(2008-2#2)(2009-4#1)(2012-2#1)(2012-6#1)(2013-1#1)
When common##2##2##(2008-10#1)(2012-2#1)
When compared to the##5##4##(1990-12#1)(2008-10#1)(2009-7#1)(2010-8#1)(2011-2#1)
When compared to##15##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1997-2#1)(2007-10#2)(2008-10#3)(2008-3#1)(2009-7#1)(2010-8#1)(2011-2#1)
When compared with other##2##4##(2008-1#1)(2012-3#1)
When compared with the##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
When compared with##16##3##(1991-9#1)(1994-10#1)(1996-7#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#2)
When compared##32##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-10#1)(1996-7#1)(1997-2#1)(2007-10#2)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
When comparing##5##2##(1997-6#2)(2008-10#2)(2009-9#1)
When considering##4##2##(1997-6#1)(2008-11#1)(2008-7#1)(2012-2#1)
When coupled with a##2##4##(2008-10#1)(2008-3#1)
When coupled with##3##3##(2008-10#2)(2008-3#1)
When coupled##4##2##(2008-10#3)(2008-3#1)
When cultured##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
When cultures##2##2##(1990-7#1)(2007-9#1)
When data are##2##3##(1992-9#1)(2008-9#1)
When data##4##2##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
When designing##2##2##(1995-9#1)(2008-3#1)
When developing##2##2##(2008-10#1)(2012-3#1)
When discussing##2##2##(1997-2#1)(2008-1#1)
When does##2##2##(2008-11#1)(2008-4#1)
When each##2##2##(1992-12#1)(2008-11#1)
When either##2##2##(2008-10#2)
When evaluating##2##2##(1994-6#1)(2013-1#1)
When examined##3##2##(2008-8#1)(2009-12#1)(2011-1#1)
When expressed in COS##2##4##(1991-9#1)(2008-11#1)
When expressed in##4##3##(1991-9#1)(1993-9#1)(2008-11#1)(2009-10#1)
When fed a diet##2##4##(1990-11#1)(1995-2#1)
When fed a##3##3##(1990-11#1)(1995-2#1)(2008-4#1)
When females##2##2##(2008-11#1)(2008-9#1)
When given a##2##3##(2008-10#2)
When given##3##2##(1992-12#1)(2008-10#2)
When goldfish were##2##3##(2008-6#2)
When ground forces are##2##4##(1995-2#2)
When grown##4##2##(1990-5#1)(2008-10#3)
When heads were inoculated at the##2##6##(2008-10#2)
When hepatocytes were loaded##2##4##(1992-5#2)
When hepatocytes were##3##3##(1990-5#1)(1992-5#2)
When human##5##2##(1990-12#1)(1991-12#1)(1994-8#1)(1995-11#1)(2008-4#1)
When illuminated##2##2##(2008-3#1)(2009-6#1)
When incorporated into##2##3##(2008-10#2)
When incubated##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
When injected##2##2##(1997-4#1)(2008-4#1)
When inoculated##4##2##(2008-10#4)
When intact##2##2##(1990-2#1)(2008-10#1)
When iron##2##2##(2008-11#2)
When isolated##2##2##(1994-9#1)(1996-5#1)
When it comes to##4##4##(1994-12#1)(1996-3#1)(1997-6#1)(2007-7#1)
When it is not##2##4##(2008-10#1)(2008-9#1)
When it is##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#1)
When it##10##2##(1994-12#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#1)
When kept in##2##3##(1991-2#1)(2008-5#1)
When larger##2##2##(2008-8#1)(2009-2#1)
When local##2##2##(1996-5#1)(2008-8#1)
When management##2##2##(1997-3#1)(2008-11#1)
When mice##2##2##(1994-3#1)(2008-11#1)
When mitochondria were##2##3##(1991-2#1)(1995-12#1)
When mixed with##2##3##(2008-10#2)
When more than one##3##4##(1995-2#1)(2008-11#1)(2013-8#1)
When multiple##2##2##(2007-12#1)(2013-1#1)
When one is##2##3##(2007-12#1)(2009-9#1)
When one##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)
When only##5##2##(1992-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
When other##2##2##(2008-8#2)
When patients##2##2##(1992-3#1)(2008-1#1)
When performed##3##2##(1992-3#1)(1993-11#1)(2010-6#1)
When perfusion##2##2##(1994-5#1)(1997-1#1)
When plants were##3##3##(1995-2#1)(2008-10#2)
When plants##6##2##(1995-2#1)(2008-10#4)(2009-8#1)
When preparing##2##2##(1991-5#1)(2008-9#1)
When primary##2##2##(1992-3#1)(2012-1#1)
When properly applied##2##3##(1994-3#1)(2012-12#1)
When properly##3##2##(1994-3#1)(2008-7#1)(2012-12#1)
When protein##2##2##(1993-12#1)(2008-11#1)
When pumped by a##2##4##(2008-2#2)
When purified##2##2##(1997-6#1)(2008-11#1)
When rat##2##2##(1994-11#1)(2008-11#1)
When serum##2##2##(1991-8#1)(2008-9#1)
When she##2##2##(1996-5#1)(2012-12#1)
When small##2##2##(1993-12#1)(1994-12#1)
When soil was##2##3##(2008-10#2)
When soil##3##2##(2008-10#3)
When sperm were##2##3##(2008-12#1)(2008-4#1)
When stimulated##2##2##(1991-9#1)(1995-11#1)
When such##4##2##(2008-11#1)(2008-3#1)(2013-1#2)
When tested against##2##3##(2008-10#2)
When tested in##3##3##(1990-7#1)(1994-11#1)(2008-10#1)
When tested on##2##3##(2008-10#2)
When tested##12##2##(1990-7#1)(1993-3#1)(1994-11#1)(2008-10#6)(2008-8#1)(2010-8#1)(2012-2#1)
When testing##2##2##(1990-12#1)(1994-11#1)
When the analysis was##2##4##(1993-12#1)(2008-10#1)
When the bladder##2##3##(1997-7#2)
When the cell##2##3##(1991-2#1)(2008-11#1)
When the cells were cultured##2##5##(1997-2#1)(2008-6#1)
When the cells were##5##4##(1992-6#1)(1997-2#1)(2008-11#2)(2008-6#1)
When the data were##2##4##(1993-12#1)(1994-1#1)
When the data##3##3##(1993-12#1)(1994-1#1)(1994-3#1)
When the enzyme##2##3##(1996-5#1)(2011-2#1)
When the expression##2##3##(1996-10#1)(2008-11#1)
When the fiber was##2##4##(2007-11#1)(2008-10#1)
When the frontal##2##3##(2006-12#1)(2008-5#1)
When the function of##2##4##(2008-11#1)(2012-12#1)
When the grating##2##3##(2008-2#1)(2008-3#1)
When the incubation##3##3##(1990-2#1)(2008-10#2)
When the initial##2##3##(2008-10#1)(2008-3#1)
When the inoculum density was##2##5##(2008-10#2)
When the intensity of##2##4##(1994-2#1)(2007-11#1)
When the larvae##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
When the nucleotide sequence of the##2##6##(1997-2#1)(1997-4#1)
When the number of subjects##2##5##(1995-9#2)
When the number of##3##4##(1995-9#2)(2008-3#1)
When the object##2##3##(2007-12#1)(2008-2#1)
When the patients##2##3##(2008-4#1)(2012-12#1)
When the ratio of##2##4##(2008-5#2)
When the ratio##3##3##(2008-5#2)(2008-8#1)
When the reaction##2##3##(2008-10#1)(2008-5#1)
When the sample##4##3##(2007-12#1)(2008-10#3)
When the samples##2##3##(2008-3#1)(2010-6#1)
When the solution was##2##4##(2008-10#1)(2008-2#1)
When the subjects were##2##4##(2012-12#2)
When the true GMR##2##4##(2012-3#2)
When the two##2##3##(2008-10#1)(2008-5#1)
When the##293##2##(1990-2#3)(1990-3#2)(1990-5#3)(1990-7#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#5)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-12#1)(2007-11#7)(2007-12#9)(2007-7#1)(2007-9#2)(2008-10#54)(2008-11#17)(2008-12#4)(2008-2#13)(2008-3#21)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#5)(2012-3#3)(2012-6#1)(2012-7#1)(2013-1#5)(2013-8#2)
When there are##2##3##(1997-7#1)(2010-6#1)
When there is no evidence of##2##6##(1990-2#1)(2008-10#1)
When there is no##3##4##(1990-2#1)(2008-10#1)(2008-3#1)
When there is##7##3##(1990-2#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-1#1)
When there##9##2##(1990-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-6#1)(2013-1#1)
When these cells were##3##4##(2008-11#1)(2008-5#1)(2010-1#1)
When these data were##2##4##(1991-12#1)(2008-9#1)
When these two##2##3##(1992-8#1)(2008-3#1)
When these##17##2##(1991-12#1)(1991-5#1)(1992-8#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#1)(2010-1#1)
When they were##2##3##(2008-10#1)(2008-5#1)
When they##4##2##(1991-5#1)(2007-11#1)(2008-10#1)(2008-5#1)
When this occurs##2##3##(2007-4#1)(2011-2#1)
When this##11##2##(1992-8#1)(1993-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#2)
When time##2##2##(1993-11#1)(2008-9#1)
When to##2##2##(1993-7#1)(2008-8#1)
When total##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
When two or more fluorochromes are measured simultaneously##2##8##(2008-9#2)
When two##4##2##(2008-10#1)(2008-2#1)(2008-9#2)
When used in##2##3##(1994-12#1)(2011-1#1)
When used##8##2##(1990-5#1)(1994-12#1)(1995-1#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
When using the##3##3##(2006-4#1)(2008-9#1)(2010-7#1)
When using##6##2##(2006-4#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-7#1)
When was the last time you##2##6##(1991-3#2)
When we used##2##3##(2008-2#1)(2011-2#1)
When we##17##2##(1994-12#1)(1994-8#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#2)(2012-12#1)
When whole##2##2##(1995-3#1)(2008-10#1)
When your##2##2##(2007-12#1)(2010-4#1)
When##1258##1##(1990-11#4)(1990-12#11)(1990-2#9)(1990-3#4)(1990-5#10)(1990-6#2)(1990-7#6)(1990-8#5)(1991-10#1)(1991-12#11)(1991-2#8)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#16)(1992-5#4)(1992-6#9)(1992-8#6)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#8)(1993-2#4)(1993-3#11)(1993-6#5)(1993-7#1)(1993-8#6)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#6)(1994-12#10)(1994-2#6)(1994-3#5)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#9)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#9)(1995-2#11)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#5)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#7)(1996-3#6)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#9)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#6)(2006-12#1)(2006-4#1)(2007-10#4)(2007-11#17)(2007-12#23)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#281)(2008-11#67)(2008-12#12)(2008-2#34)(2008-3#63)(2008-4#13)(2008-5#31)(2008-6#17)(2008-7#30)(2008-8#49)(2008-9#29)(2009-10#3)(2009-11#3)(2009-12#6)(2009-2#4)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#4)(2010-11#2)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#6)(2011-1#12)(2011-10#1)(2011-2#27)(2011-3#2)(2012-1#1)(2012-12#11)(2012-2#13)(2012-3#13)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#27)(2013-7#1)(2013-8#11)
Whenever possible##4##2##(1993-11#1)(1993-6#1)(1994-2#1)(2007-12#1)
Whenever##6##1##(1993-11#1)(1993-6#1)(1994-2#1)(2007-12#1)(2007-8#1)(2013-8#1)
Where a##2##2##(1993-12#1)(2008-2#1)
Where are all the##2##4##(2007-12#1)(2008-10#1)
Where are##6##2##(1990-12#1)(1992-12#1)(1994-2#1)(2007-12#1)(2008-10#1)(2010-4#1)
Where asymmetry was indicated##2##4##(2008-10#2)
Where can I##2##3##(2007-2#1)(2008-8#1)
Where do we##2##3##(2008-11#1)(2012-12#1)
Where do##4##2##(1993-12#1)(2008-11#1)(2012-12#1)(2013-1#1)
Where does##3##2##(1995-12#1)(2008-10#1)(2008-2#1)
Where possible##4##2##(2008-2#1)(2011-2#1)(2012-2#2)
Where the##3##2##(1995-3#1)(1997-8#1)(2008-10#1)
Where they##2##2##(2008-8#1)(2010-11#1)
Where##54##1##(1990-12#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-8#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-6#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
Where's the##3##2##(2008-12#2)(2012-2#1)
Whereas both##2##2##(1994-11#1)(2011-2#1)
Whereas in##7##2##(1990-6#1)(1995-5#1)(2007-11#1)(2008-3#1)(2009-7#1)(2010-3#1)(2011-1#1)
Whereas most##2##2##(2009-5#1)(2010-6#1)
Whereas previous##2##2##(2006-10#1)(2008-3#1)
Whereas the##19##2##(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-9#1)(1995-2#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
Whereas their##2##2##(1996-2#1)(2008-10#1)
Whereas this##2##2##(2010-8#1)(2013-1#1)
Whereas##101##1##(1990-2#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
Whether a##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
Whether it##2##2##(2008-9#1)(2011-2#1)
Whether such##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
Whether the##8##2##(1990-12#1)(1990-5#1)(1992-6#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-8#1)
Whether these##7##2##(1990-12#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
Whether this##7##2##(1993-1#1)(2007-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)
Whether##52##1##(1990-12#3)(1990-5#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-5#2)(1994-8#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-8#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
Whey##3##1##(2008-11#1)(2008-7#1)(2012-2#1)
WhiA##6##1##(2012-2#6)
WhiG##3##1##(2012-2#3)
Which is##2##2##(1995-8#1)(2010-11#1)
Which medications used in paediatric practice have demonstrated natural health product-drug interactions?##2##12##(2008-11#2)
Which of these##2##3##(2008-8#1)(2010-9#1)
Which of##3##2##(2008-8#1)(2010-9#1)(2011-2#1)
Which species##2##2##(2008-8#2)
Which way##2##2##(2008-8#1)(2013-1#1)
Which##25##1##(1990-12#1)(1992-2#1)(1994-7#1)(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#2)(2010-11#1)(2010-9#1)(2011-2#2)(2013-1#2)
While a few##2##3##(2008-3#1)(2011-2#1)
While a number of##2##4##(1996-12#1)(2012-3#1)
While a##12##2##(1996-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
While all##7##2##(1990-2#1)(1995-12#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-11#1)(2011-1#1)
While an##2##2##(2008-11#1)(2010-8#1)
While at##2##2##(2008-10#1)(2008-8#1)
While being##2##2##(2007-12#1)(2008-12#1)
While both##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
While characterizing the##2##3##(1996-12#1)(2008-10#1)
While current##2##2##(2008-12#1)(2012-2#1)
While dry##2##2##(2008-12#1)(2013-1#1)
While each##2##2##(1996-2#1)(2008-8#1)
While further research##2##3##(2008-11#2)
While high##2##2##(1995-8#1)(2010-8#1)
While in##10##2##(1993-8#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2013-1#1)
While individual##2##2##(2008-1#1)(2008-8#1)
While it has been##2##4##(2012-12#1)(2012-2#1)
While it has##3##3##(2008-4#1)(2012-12#1)(2012-2#1)
While it is##5##3##(1992-12#1)(1994-8#1)(2008-10#1)(2008-11#2)
While it##10##2##(1990-11#1)(1992-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
While many of the##2##4##(1994-2#1)(2008-1#1)
While many##14##2##(1991-9#1)(1993-3#1)(1994-2#1)(1995-1#1)(2008-1#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#2)(2012-12#1)(2013-8#1)
While more than##2##3##(2009-4#2)
While more##5##2##(2007-4#1)(2008-2#1)(2009-4#2)(2009-7#1)
While most of us had courses in financial and operations management##2##11##(1994-1#2)
While most of##3##3##(1993-12#1)(1994-1#2)
While most##8##2##(1991-12#1)(1993-12#1)(1994-1#3)(2008-10#1)(2008-9#1)(2011-1#1)
While much##2##2##(2009-7#1)(2013-8#1)
While native##2##2##(2007-7#1)(2008-10#1)
While no##7##2##(1995-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2013-1#1)
While not##6##2##(1994-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
While on##2##2##(2008-12#1)(2011-2#1)
While one##2##2##(2007-7#1)(2011-2#1)
While our##2##2##(1992-3#1)(2008-7#1)
While previous studies have##3##4##(1995-12#1)(2009-9#1)(2010-8#1)
While previous##6##2##(1995-12#1)(1996-5#1)(2009-10#1)(2009-9#1)(2010-8#1)(2013-8#1)
While research##3##2##(2007-12#1)(2008-12#1)(2008-4#1)
While several of##2##3##(2008-10#1)(2012-2#1)
While several##6##2##(1994-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)
While significant##2##2##(2008-11#1)(2009-12#1)
While some of##2##3##(2011-2#1)(2013-1#1)
While some states administer their own occupational safety and health programs##3##11##(1993-12#1)(1993-2#1)(1993-3#1)
While some studies##2##3##(2008-12#1)(2009-12#1)
While some##18##2##(1991-3#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
While such##4##2##(1993-5#1)(2008-2#1)(2008-6#1)(2009-5#1)
While survival##2##2##(1991-6#1)(2010-3#1)
While the alternate method is particularly efficient for stable transformation of cells with circular plasmid DNA##2##16##(2008-1#1)(2008-2#1)
While the conceptual applications employed in this technology set are provided by way of illustration##2##15##(2010-8#2)
While the data##2##3##(1997-5#1)(2007-11#1)
While the effects of##2##4##(1995-12#1)(2008-1#1)
While the incidence of##2##4##(1990-2#1)(1995-5#1)
While the long-term##2##3##(1991-3#1)(2008-10#1)
While the major##2##3##(1997-1#1)(2008-4#1)
While the majority of##4##4##(1993-1#1)(1994-2#1)(1995-2#1)(2008-11#1)
While the methods##2##3##(2008-4#1)(2010-2#1)
While the number of##3##4##(1996-5#1)(2007-4#1)(2008-11#1)
While the results##2##3##(1996-12#1)(2011-2#1)
While the use of##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
While the##141##2##(1990-2#2)(1991-12#2)(1991-3#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2007-10#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-2#2)(2010-7#1)(2010-8#3)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
While their##2##2##(1995-1#1)(2009-10#1)
While there are no##2##4##(1993-8#1)(2008-1#1)
While there are##6##3##(1993-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-1#1)
While there have been##2##4##(2008-11#1)(2008-6#1)
While there is a##6##4##(1990-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-5#1)
While there is no##2##4##(2008-12#1)(2008-6#1)
While there is##13##3##(1990-11#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)
While there was##2##3##(2008-12#1)(2008-9#1)
While there##28##2##(1990-11#1)(1993-8#1)(1994-1#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2012-2#1)(2012-3#1)
While these approaches##2##3##(2008-11#1)(2010-5#1)
While these##11##2##(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2013-8#1)
While this approach##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
While this is##2##3##(2008-12#1)(2009-6#1)
While this study##2##3##(2008-10#1)(2008-7#1)
While this##20##2##(1993-2#1)(1993-9#1)(1995-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#2)(2013-1#2)
While total##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
While we##3##2##(1995-1#1)(1996-2#1)(2010-2#1)
While##610##1##(1990-11#4)(1990-2#4)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#4)(1991-3#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#8)(1995-2#6)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#7)(1996-3#1)(1996-5#4)(1997-1#6)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#13)(2008-10#57)(2008-11#34)(2008-12#21)(2008-2#8)(2008-3#5)(2008-4#16)(2008-5#13)(2008-6#13)(2008-7#18)(2008-8#13)(2008-9#13)(2009-10#8)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#6)(2010-10#4)(2010-11#4)(2010-12#3)(2010-2#5)(2010-3#5)(2010-4#1)(2010-5#4)(2010-7#4)(2010-8#10)(2011-1#7)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#16)(2012-2#15)(2012-3#4)(2013-1#18)(2013-7#2)(2013-8#11)
Whilst the##3##2##(2010-11#1)(2012-2#1)(2013-1#1)
Whilst there##2##2##(2012-2#1)(2013-1#1)
Whilst##21##1##(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2009-7#1)(2010-11#2)(2010-3#1)(2012-2#2)(2013-1#2)
Whipple##5##1##(1990-9#1)(2013-1#4)
Whipple's disease in##2##3##(1996-8#1)(2008-7#1)
Whipple's disease##4##2##(1996-8#2)(2008-7#1)(2009-5#1)
Whipple's operation##3##2##(1991-3#1)(1994-3#2)
Whipple's##10##1##(1991-3#1)(1992-8#1)(1994-3#2)(1996-8#3)(2008-7#1)(2009-5#1)(2013-1#1)
Whispering-gallery##2##1##(2007-11#1)(2007-12#1)
Whistler##2##1##(2008-3#1)(2008-7#1)
White Deaf##2##2##(2011-2#2)
White House Conference on##2##4##(1995-12#1)(1996-1#1)
White House##5##2##(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-1#1)
White Leghorn##2##2##(2008-10#1)(2008-12#1)
White Liqueur Wine##2##3##(2008-10#2)
White Liqueur##3##2##(2008-10#3)
White Matter Integrity##2##3##(2010-6#1)(2010-7#1)
White Matter##3##2##(2009-10#1)(2010-6#1)(2010-7#1)
White Pine (Pinus##2##3##(2008-10#2)
White Pine##3##2##(2008-10#3)
White adolescents##2##2##(2009-7#2)
White and##3##2##(2011-2#2)(2012-12#1)
White blood##2##2##(1991-6#1)(1991-8#1)
White faces##3##2##(2008-11#2)(2009-9#1)
White participants##5##2##(2008-11#3)(2009-9#1)(2012-2#1)
White targets##2##2##(2008-11#2)
White women##3##2##(2011-2#2)(2012-2#1)
White##99##1##(1991-6#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-6#3)(1996-1#1)(1996-2#1)(1996-5#1)(2007-7#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#5)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
White)##2##1##(2009-7#1)(2013-1#1)
White-American Indian##2##2##(2013-8#2)
White-light##7##1##(2007-12#2)(2008-2#1)(2008-3#4)
Whiteflies##2##1##(2008-10#2)
Whitefly##3##1##(2008-10#3)
Whites and##3##2##(1991-2#1)(1993-3#1)(1995-6#1)
Whites than##2##2##(2010-2#1)(2012-12#1)
Whites##20##1##(1991-2#1)(1993-3#2)(1995-6#1)(2009-11#1)(2010-10#4)(2010-2#3)(2011-2#3)(2012-12#4)(2012-2#1)
Whither##3##1##(1993-3#2)(2008-10#1)
Whitman##3##1##(1996-5#3)
Who Inject Drugs##2##3##(2013-1#2)
Who Stutter##2##2##(2008-2#2)
Who Underwent##2##2##(1994-12#1)(2008-11#1)
Who are##3##2##(1994-12#1)(2009-4#1)(2009-5#1)
Who cares##2##2##(1995-1#1)(1995-12#1)
Who is##5##2##(1994-2#1)(1995-1#1)(1995-9#1)(2008-7#1)(2010-2#1)
Who should##4##2##(1993-11#1)(1993-7#1)(1994-12#1)(1994-9#1)
Who was Robert Hurlbut?##2##4##(2008-6#2)
Who will##2##2##(1991-12#1)(1995-12#1)
Who##40##1##(1991-12#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-7#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-9#1)(1997-3#1)(1997-8#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#3)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-3#1)(2013-1#2)
Who's the##3##2##(1993-2#1)(1997-6#1)(2007-9#1)
Who's##8##1##(1991-12#1)(1992-11#1)(1993-1#1)(1993-2#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-9#1)
Whole Genome##2##2##(2008-7#1)(2012-3#1)
Whole blood##6##2##(1996-12#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)
Whole body##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
Whole cell##2##2##(2008-1#1)(2012-2#1)
Whole genome##2##2##(2008-7#1)(2012-3#1)
Whole mount in situ hybridization##2##5##(1997-7#1)(2008-6#1)
Whole##30##1##(1995-2#1)(1996-12#1)(1997-7#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
Whole-cell##6##1##(1995-11#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
Whole-field##3##1##(2007-11#1)(2007-12#2)
Whose##3##1##(1993-2#1)(1993-9#1)(1997-3#1)
Why are##4##2##(1995-1#1)(2007-11#1)(2008-11#1)(2008-9#1)
Why did##2##2##(2007-9#1)(2012-2#1)
Why do individuals##2##3##(2009-6#1)(2012-3#1)
Why do people##3##3##(1993-2#1)(2008-8#1)(2009-6#1)
Why do young##2##3##(2010-2#1)(2011-2#1)
Why do##20##2##(1991-12#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Why don't we##2##3##(2008-11#1)(2013-8#1)
Why don't##3##2##(2007-4#1)(2008-11#1)(2013-8#1)
Why has##2##2##(1997-5#1)(2011-2#1)
Why is##4##2##(1996-9#1)(2010-9#1)(2013-1#1)(2013-7#1)
Why outcomes##2##2##(1996-1#1)(1996-2#1)
Why study##2##2##(2007-4#1)(2008-8#1)
Why the##5##2##(1991-3#2)(1994-3#1)(2008-10#1)(2010-8#1)
Why we need##2##3##(1994-12#1)(1997-1#1)
Why we##3##2##(1994-12#1)(1997-1#1)(2008-10#1)
Why##89##1##(1990-9#1)(1991-12#1)(1991-3#4)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#3)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
Why?##2##1##(2008-4#1)(2010-9#1)
Wichita##4##1##(1996-1#3)(2008-10#1)
Wickbold decomposition method##3##3##(2008-10#3)
Wide Field-of-View Sensor (SeaWiFS)##2##4##(2008-3#2)
Wide Field-of-View Sensor##3##3##(2008-3#3)
Wide Field-of-view Sensor (SeaWiFS)##6##4##(2008-2#1)(2008-3#5)
Wide excision##2##2##(1992-9#1)(2009-5#1)
Wide range##2##2##(2008-10#1)(2010-5#1)
Wide resection of##2##3##(2008-9#2)
Wide surgical excision was##2##4##(2007-7#1)(2011-1#1)
Wide surgical excision##3##3##(2007-7#1)(2008-6#1)(2011-1#1)
Wide##45##1##(1992-9#1)(1994-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#2)(2009-6#1)(2010-5#1)(2011-1#2)
Wide-angle##3##1##(2008-3#2)(2008-8#1)
Wide-range##2##1##(2007-11#1)(2007-12#1)
Wideband##3##1##(2007-12#3)
Widely Tunable Continuous-Wave##2##3##(2008-2#2)
Widely tunable##4##2##(2007-11#2)(2007-12#2)
Widely##6##1##(2007-11#2)(2007-12#2)(2008-2#2)
Widespread##14##1##(1990-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
Wiener filter##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
Wiener##13##1##(2007-11#2)(2008-2#1)(2008-3#10)
Wiener-kernel##2##1##(2009-5#2)
Wierzejewski##2##1##(2007-8#2)
Wigner distribution function##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
Wigner distribution of the##2##4##(2007-12#2)
Wigner distribution##7##2##(2007-12#3)(2008-2#3)(2008-3#1)
Wigner function for highly convergent three-dimensional##2##6##(2007-11#2)
Wigner function##5##2##(2007-11#4)(2007-12#1)
Wigner##19##1##(1996-9#1)(2007-11#5)(2007-12#9)(2008-2#3)(2008-3#1)
Wiktor Dega##4##2##(2007-8#1)(2013-1#3)
Wilbur-Collins hypothesis##2##2##(2008-8#2)
Wilcoxon rank-sum test##2##3##(1996-3#1)(2013-1#1)
Wilcoxon rank-sum##5##2##(1996-3#1)(2012-1#2)(2013-1#2)
Wilcoxon signed##3##2##(1997-8#1)(2008-10#1)(2010-6#1)
Wilcoxon statistic##2##2##(1996-3#2)
Wilcoxon test with##2##3##(1992-6#1)(1996-3#1)
Wilcoxon test##4##2##(1992-6#1)(1996-3#2)(2013-1#1)
Wilcoxon##19##1##(1992-6#1)(1996-3#5)(1997-8#1)(2008-10#2)(2008-6#1)(2009-2#1)(2010-6#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
Wild Solanum##2##2##(2008-10#2)
Wild type##4##2##(1997-7#1)(2008-11#2)(2013-1#1)
Wild##21##1##(1994-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(2008-10#10)(2008-11#2)(2010-8#1)(2012-12#2)(2013-1#1)(2013-7#1)
Wild-type##8##1##(1995-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)
Wildlife##9##1##(1996-3#1)(1997-7#1)(2008-5#4)(2011-1#1)(2011-2#1)(2013-7#1)
Wiley Periodicals##5##2##(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
Wiley##150##1##(2008-11#37)(2008-4#1)(2008-7#62)(2008-9#2)(2011-1#1)(2011-2#14)(2012-1#1)(2012-2#8)(2012-3#5)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#11)
Wiley-Liss##33##1##(2009-4#8)(2011-2#25)
Wilkins##3##1##(1997-6#1)(2008-10#1)(2008-7#1)
Will the US##2##3##(2008-11#2)
Will the##5##2##(2008-11#3)(2009-6#1)(2013-7#1)
Will this##2##2##(2012-12#1)(2013-7#1)
Will##24##1##(1993-1#1)(1993-12#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-11#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-7#2)(2013-8#1)
Willamette Valley##2##2##(2008-10#2)
Willd##3##1##(2008-6#1)(2011-2#1)(2013-1#1)
Willebrand##19##1##(1990-5#2)(1992-11#1)(1993-3#2)(1994-11#2)(1997-7#1)(2007-10#2)(2008-10#2)(2008-11#2)(2008-12#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
William##13##1##(1990-4#1)(1991-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-3#1)(2010-4#1)
Williams and Wilkins##2##3##(1997-6#1)(2008-7#1)
Williams and##4##2##(1997-6#1)(2008-10#2)(2008-7#1)
Williams syndrome are##2##3##(2008-11#2)
Williams syndrome##4##2##(2008-11#3)(2010-6#1)
Williams##20##1##(1992-1#1)(1993-8#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)
Williams's##2##1##(2008-8#2)
Willingness to pay##2##3##(2007-7#2)
Willingness##3##1##(2007-10#1)(2007-7#2)
Willis##5##1##(1993-12#1)(1995-11#1)(2007-10#1)(2008-7#2)
Willis'##2##1##(2007-10#2)
Wilms tumor (WT)##2##3##(1991-10#1)(2013-1#1)
Wilms tumor##5##2##(1991-10#2)(2008-10#1)(2010-3#1)(2013-1#1)
Wilms' tumor and##2##3##(1990-2#1)(2008-10#1)
Wilms' tumor locus##2##3##(1990-11#2)
Wilms' tumor##8##2##(1990-11#3)(1990-2#1)(1994-2#2)(2008-10#2)
Wilms' tumour##4##2##(2008-10#4)
Wilms'##12##1##(1990-11#3)(1990-2#1)(1994-2#2)(2008-10#6)
Wilson disease##7##2##(1993-11#4)(2006-10#1)(2012-2#2)
Wilson##18##1##(1991-8#2)(1992-1#1)(1993-11#5)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2012-2#3)
Wilson's disease is##2##3##(2008-9#2)
Wilson's disease##10##2##(2008-9#10)
Wilson's##12##1##(2008-7#1)(2008-9#11)
Wilt in##3##2##(2008-10#3)
Wilt##31##1##(2008-10#31)
Wind Imaging Interferometer (WINDII)##2##4##(2008-2#2)
Wind##6##1##(2008-10#1)(2008-2#3)(2008-3#1)(2012-2#1)
Windhoek##2##1##(2010-4#2)
Window of##2##2##(2012-1#2)
Window##4##1##(1994-12#1)(2008-3#1)(2012-1#2)
Windows##10##1##(1995-9#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
Wine##6##1##(2008-10#5)(2012-3#1)
Wine&quot##3##1##(2008-10#3)
Wines##2##1##(2008-10#2)
Wing##2##1##(1991-6#1)(1995-12#1)
Winkler's##2##1##(2008-10#2)
Winnipeg##2##1##(1995-12#1)(2008-10#1)
Winsor Index##2##2##(1990-5#2)
Winter Garden##2##2##(2008-10#2)
Winter School##3##2##(2008-7#3)
Winter Wheat to##2##3##(2008-10#2)
Winter Wheat##9##2##(2008-10#9)
Winter##24##1##(1991-8#1)(1996-3#1)(2008-10#16)(2008-7#3)(2010-5#1)(2010-8#1)(2012-4#1)
Wire##4##1##(1996-6#1)(2009-6#1)(2009-7#1)(2011-2#1)
Wireless##4##1##(2008-7#2)(2010-2#1)(2013-1#1)
Wisconsin Card Sorting Test (WCST)##2##5##(1995-11#1)(2013-8#1)
Wisconsin Card Sorting Test##3##4##(1995-11#1)(2008-7#1)(2013-8#1)
Wisconsin Card Sorting##6##3##(1995-11#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-8#1)
Wisconsin##34##1##(1991-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-11#2)(2013-8#1)
Wise##3##1##(1993-11#1)(1996-2#1)(2008-10#1)
Wish##2##1##(2010-9#1)(2012-2#1)
Wiskott-Aldrich syndrome##2##2##(2008-3#1)(2012-12#1)
Wistar Albino##3##2##(1996-12#1)(2008-11#1)(2011-1#1)
Wistar Hannover GALAS [BrlHan##2##4##(2012-1#2)
Wistar Hannover GALAS##3##3##(2012-1#3)
Wistar Kyoto (WKY)##2##3##(1996-5#1)(2011-1#1)
Wistar and Buffalo##2##3##(1993-12#2)
Wistar and stroke-prone spontaneously hypertensive rats##3##6##(1995-12#3)
Wistar and##5##2##(1993-12#2)(1995-12#3)
Wistar male rats##2##3##(1994-6#1)(1995-8#1)
Wistar rats of##2##3##(1996-5#1)(2008-10#1)
Wistar rats received##2##3##(1992-9#1)(2012-2#1)
Wistar rats was##2##3##(1993-12#1)(1996-5#1)
Wistar rats were divided into##2##5##(2007-10#1)(2011-2#1)
Wistar rats were treated##2##4##(1997-7#1)(2008-7#1)
Wistar rats were##12##3##(1991-2#1)(1996-12#1)(1997-7#1)(2007-10#1)(2008-12#1)(2008-7#2)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
Wistar rats with##2##3##(1994-2#1)(2008-11#1)
Wistar rats##54##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#5)(1994-11#2)(1994-2#1)(1994-6#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-7#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#2)(2009-5#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)
Wistar strain##2##2##(1990-2#1)(2011-2#1)
Wistar##80##1##(1990-2#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#7)(1994-11#2)(1994-2#1)(1994-6#3)(1995-12#5)(1995-3#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-5#3)(1997-7#2)(2007-10#2)(2008-10#4)(2008-11#4)(2008-12#3)(2008-7#4)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)
Wistar-Kyoto (WKY) and##2##3##(1997-6#1)(2008-2#1)
Wistar-Kyoto (WKY)##3##2##(1993-12#1)(1997-6#1)(2008-2#1)
Wistar-Kyoto rats in the##2##4##(1991-5#1)(1993-12#1)
Wistar-Kyoto rats##3##2##(1991-5#1)(1993-12#1)(1994-2#1)
Wistar-Kyoto##6##1##(1991-5#1)(1993-12#2)(1994-2#1)(1997-6#1)(2008-2#1)
Witches'-Broom##2##1##(2008-10#2)
With 1##2##2##(2008-10#2)
With 10##3##2##(1992-12#1)(2007-11#1)(2008-6#1)
With Cancer##2##2##(2010-10#1)(2010-7#1)
With a first##2##3##(2008-2#1)(2008-3#1)
With a good##2##3##(2008-10#1)(2008-3#1)
With a high##2##3##(2008-10#1)(2008-9#1)
With a mean follow-up of##2##5##(2007-8#1)(2008-3#1)
With a new##2##3##(2008-10#1)(2008-5#1)
With a sample##3##3##(2008-10#3)
With a sampling##2##3##(2008-10#2)
With a single##2##3##(2007-12#2)
With a typical##2##3##(2007-11#1)(2008-3#1)
With a view to##3##4##(2008-10#1)(2010-2#1)(2012-12#1)
With a view##4##3##(2008-10#1)(2008-2#1)(2010-2#1)(2012-12#1)
With a##106##2##(1990-3#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#9)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#4)(2008-2#10)(2008-3#24)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)
With all##3##2##(1992-2#1)(2008-9#1)(2012-3#1)
With almost##2##2##(2011-1#1)(2012-3#1)
With an aging##2##3##(2008-1#1)(2012-12#1)
With an appropriate##2##3##(2007-11#1)(2010-5#1)
With an emphasis##2##3##(1992-12#1)(1992-3#1)
With an##21##2##(1992-12#2)(1992-3#1)(1994-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#2)(2009-11#2)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
With appropriate##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-3#1)
With both##6##2##(1994-3#1)(1997-3#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-8#1)
With constant##2##2##(2008-5#1)(2008-9#1)
With extended##2##2##(1996-5#1)(2007-8#1)
With few exceptions##4##3##(1992-9#1)(2008-10#3)
With further##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
With high##2##2##(1996-12#1)(2008-7#1)
With increasing##10##2##(1992-11#1)(1993-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-2#2)
With its##3##2##(2008-7#1)(2011-2#1)(2011-7#1)
With limited##2##2##(1997-7#1)(2007-2#1)
With little##2##2##(1992-1#1)(2012-3#1)
With lower##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
With many##2##2##(2008-12#1)(2008-4#1)
With modification##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
With more than##2##3##(2008-7#1)(2010-7#1)
With more##5##2##(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2012-2#1)
With new##2##2##(2010-2#1)(2013-8#1)
With no##5##2##(1990-10#1)(1992-4#1)(2007-10#1)(2009-4#1)(2013-1#1)
With one exception##2##3##(1994-2#1)(1995-12#1)
With one##3##2##(1994-2#1)(1995-12#1)(2011-1#1)
With only one##2##3##(1996-3#1)(2008-7#1)
With only two##2##3##(2008-3#1)(2012-2#1)
With only##4##2##(1996-3#1)(2008-3#1)(2008-7#1)(2012-2#1)
With optimized##3##2##(2008-10#1)(2011-1#2)
With our##6##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2013-1#1)
With over##2##2##(1996-12#1)(2008-11#1)
With proper##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#2)
With reference to the##4##4##(1990-12#1)(1991-8#1)(2008-11#1)(2008-3#1)
With reference to##6##3##(1990-12#1)(1991-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
With regard to the##7##4##(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)
With regard to##18##3##(1990-2#1)(1991-4#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
With regards to##2##3##(2011-2#1)(2013-1#1)
With respect to the##7##4##(1990-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
With respect to##25##3##(1990-7#1)(1991-2#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
With some##6##2##(1990-11#1)(1992-5#1)(2008-10#2)(2008-7#1)(2012-12#1)
With such##2##2##(1996-11#1)(2008-10#1)
With ten##2##2##(1992-5#1)(2009-11#1)
With the addition of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
With the advances in##2##4##(2008-6#1)(2012-2#1)
With the advent of##6##4##(1993-2#1)(1994-2#1)(1996-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
With the aging population and##2##5##(2011-2#2)
With the aid of an##2##5##(2008-3#1)(2010-5#1)
With the aid of the##2##5##(1991-6#1)(2008-2#1)
With the aid of##8##4##(1991-11#1)(1991-6#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)
With the aim of reducing##2##5##(2008-3#1)(2012-12#1)
With the aim of##9##4##(1993-11#1)(1995-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-12#1)
With the aim to##4##4##(2009-12#1)(2009-4#1)(2009-5#1)(2013-7#1)
With the aim##13##3##(1993-11#1)(1995-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-7#1)
With the assistance of##2##4##(1993-1#1)(1993-3#1)
With the combination of##2##4##(2008-8#1)(2012-2#1)
With the continuing##2##3##(2008-9#1)(2012-3#1)
With the current##2##3##(2009-7#1)(2012-12#1)
With the developed##2##3##(2008-10#2)
With the development of the##2##5##(1995-5#1)(2012-3#1)
With the development of##4##4##(1995-5#1)(2008-10#1)(2012-3#1)(2013-1#1)
With the emergence of##3##4##(2008-10#1)(2009-6#1)(2011-9#1)
With the exception of one##4##5##(2008-10#3)(2008-5#1)
With the exception of the 3##2##6##(2008-9#1)(2011-2#1)
With the exception of the##7##5##(1996-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
With the exception of##22##4##(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
With the first##2##3##(1996-4#1)(2008-3#1)
With the generalized##2##3##(2008-10#1)(2008-2#1)
With the growing##3##3##(1993-12#1)(1996-2#1)(2010-3#1)
With the help of a##2##5##(2008-3#1)(2013-1#1)
With the help of##8##4##(1995-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#1)
With the identification of##2##4##(2007-11#1)(2008-10#1)
With the improved method##2##4##(2008-10#2)
With the improved##3##3##(2008-10#2)(2010-8#1)
With the increase in##2##4##(2008-11#1)(2011-2#1)
With the increase of the##2##5##(2008-3#1)(2008-8#1)
With the increase##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
With the increased##4##3##(1996-3#2)(1997-3#1)(2009-12#1)
With the increasing number of##2##5##(2008-10#1)(2010-10#1)
With the increasing##8##3##(1993-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
With the increasingly competitive##2##4##(1994-2#1)(2008-11#1)
With the initiation of##2##4##(1996-3#1)(2012-3#1)
With the intention of##2##4##(2008-10#1)(2008-5#1)
With the introduction of effective##2##5##(2008-7#1)(2010-3#1)
With the introduction of##11##4##(1990-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-3#2)(2011-2#1)
With the latter##2##3##(2008-7#1)(2011-1#1)
With the method##4##3##(1990-3#1)(2008-10#2)(2008-3#1)
With the model##2##3##(1996-1#1)(2008-3#1)
With the new##4##3##(1995-1#1)(2008-2#2)(2010-3#1)
With the optimal##2##3##(2008-10#1)(2013-1#1)
With the phase##2##3##(2007-11#1)(2008-2#1)
With the proper##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
With the proposed##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2012-12#1)
With the purpose of##2##4##(1993-6#1)(2008-10#1)
With the rapid development of##2##5##(2008-10#1)(2009-5#1)
With the rapid##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
With the recent development of##2##5##(2010-12#2)
With the recent##7##3##(1994-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#2)
With the results##2##3##(1991-5#1)(2008-10#1)
With the same##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
With the shift##2##3##(1996-2#1)(1997-2#1)
With the use of##7##4##(1991-3#1)(1996-9#1)(2007-8#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
With the##297##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#56)(2008-11#11)(2008-12#3)(2008-2#10)(2008-3#22)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#9)(2008-9#5)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-3#5)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#15)(2011-9#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#4)
With these data##3##3##(2008-1#1)(2008-3#1)(2013-1#1)
With these results we##2##4##(1992-6#1)(2013-1#1)
With these two##2##3##(2008-10#1)(2008-5#1)
With these##22##2##(1991-2#1)(1992-3#1)(1992-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-10#1)(2010-3#1)(2013-1#2)
With this apparatus##2##3##(2008-3#1)(2008-5#1)
With this approach##5##3##(1995-2#1)(1996-3#1)(2008-2#1)(2012-2#2)
With this background##2##3##(2010-3#2)
With this device##2##3##(2008-3#2)
With this goal in mind##2##5##(1996-1#1)(2010-3#1)
With this in mind##4##4##(1990-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
With this method the##2##4##(2007-11#1)(2008-3#1)
With this method##16##3##(1990-2#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-8#1)(2010-8#1)
With this model##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
With this modification##2##3##(2008-10#2)
With this new##2##3##(2007-12#1)(2008-10#1)
With this novel##2##3##(1996-6#1)(2012-1#1)
With this procedure##2##3##(2008-10#1)(2008-2#1)
With this report##2##3##(2010-12#1)(2012-3#1)
With this technique##11##3##(1993-8#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-7#1)(2012-3#1)
With this##104##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-2#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-8#2)(2008-10#21)(2008-11#5)(2008-2#7)(2008-3#12)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
With time##2##2##(2010-10#1)(2011-2#1)
With traditional##2##2##(1995-1#1)(2008-2#1)
With training and##2##3##(2009-3#1)(2009-5#1)
With two##5##2##(2008-3#3)(2011-2#1)(2012-1#1)
With##978##1##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#6)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#2)(1993-6#1)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#8)(1994-3#4)(1994-5#1)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#11)(1995-2#8)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#9)(1996-4#2)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#7)(1997-4#3)(1997-6#1)(1997-7#5)(1997-8#3)(2006-10#4)(2007-10#3)(2007-11#26)(2007-12#28)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#156)(2008-11#36)(2008-12#13)(2008-2#42)(2008-3#97)(2008-4#9)(2008-5#18)(2008-6#9)(2008-7#28)(2008-8#19)(2008-9#15)(2009-10#5)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#3)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#5)(2010-2#2)(2010-3#14)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#9)(2010-9#2)(2011-1#15)(2011-2#30)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#3)(2012-12#7)(2012-2#24)(2012-3#18)(2013-1#28)(2013-7#3)(2013-8#13)
Withdrawal of##3##2##(1993-6#1)(1995-2#1)(2008-5#1)
Withdrawal##14##1##(1991-1#1)(1991-12#1)(1993-6#1)(1995-2#1)(2008-10#4)(2008-11#4)(2008-5#1)(2011-2#1)
Within Populations of##3##3##(2008-10#3)
Within a population##2##3##(2008-8#1)(2008-9#1)
Within a##12##2##(2007-11#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
Within an##4##2##(2008-9#1)(2009-7#1)(2012-2#2)
Within and##3##2##(2008-10#3)
Within each group##3##3##(2007-7#1)(2008-1#1)(2009-7#1)
Within each##8##2##(1990-9#1)(1993-12#1)(2007-12#1)(2007-7#1)(2008-1#2)(2009-7#1)(2012-2#1)
Within experimental error##2##3##(1991-5#1)(1993-11#1)
Within the conserved##2##3##(1995-5#1)(1995-6#1)
Within the context of##2##4##(2008-11#1)(2008-12#1)
Within the framework of##5##4##(1990-3#1)(1995-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
Within the group of patients##2##5##(2011-2#1)(2012-3#1)
Within the group of##4##4##(1995-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
Within the group##5##3##(1995-3#1)(2008-6#2)(2011-2#1)(2012-3#1)
Within the last##2##3##(2008-4#1)(2008-7#1)
Within the limitations of this study##2##6##(2013-1#2)
Within the limitations of this##3##5##(2013-1#3)
Within the limitations of##4##4##(2011-2#1)(2013-1#3)
Within the range of##2##4##(1990-3#1)(2008-9#1)
Within the range##3##3##(1990-3#1)(2008-2#1)(2008-9#1)
Within the same##2##3##(1996-2#1)(2008-2#1)
Within the##69##2##(1990-11#1)(1990-3#2)(1991-12#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#5)(2013-7#1)
Within these two##2##3##(1995-3#1)(2008-5#1)
Within these##6##2##(1995-3#1)(1997-2#1)(1997-4#1)(2008-5#1)(2010-1#1)(2011-2#1)
Within this framework##3##3##(1990-6#1)(1991-2#1)(2013-1#1)
Within this##15##2##(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-10#1)(2010-9#1)(2013-1#1)
Within##180##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#8)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
Within- and between-assay##2##3##(1995-12#1)(2008-10#1)
Within- and##3##2##(1993-9#1)(1995-12#1)(2008-10#1)
Within-group comparisons##2##2##(2009-2#1)(2009-7#1)
Within-group##3##1##(2008-3#1)(2009-2#1)(2009-7#1)
Within-plant##2##1##(2008-10#1)(2009-8#1)
Without any##5##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
Without exception##2##2##(1994-12#1)(2008-10#1)
Without the##5##2##(1992-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)
Without these##2##2##(1994-2#1)(1994-8#1)
Without this##5##2##(1991-8#1)(1993-3#1)(2008-10#1)(2008-6#1)(2008-9#1)
Without##52##1##(1990-11#1)(1990-8#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
Witnesses##7##1##(1996-9#2)(2007-12#1)(2013-8#4)
Wittig reaction##2##2##(1996-5#1)(2010-12#1)
Wittig reactions##2##2##(1996-5#1)(2009-10#1)
Wittig##4##1##(1996-5#2)(2009-10#1)(2010-12#1)
WmCSV##3##1##(2008-10#3)
Wnt binding##2##2##(2007-12#2)
Wnt ligands##2##2##(2007-12#2)
Wnt signal##2##2##(2007-12#1)(2008-10#1)
Wnt signaling and##2##3##(2007-12#2)
Wnt signaling##10##2##(2007-12#7)(2008-7#1)(2012-12#1)(2013-1#1)
Wnt signalling##3##2##(2012-12#3)
Wnt##29##1##(2007-12#14)(2008-10#1)(2008-7#1)(2012-12#8)(2013-1#4)(2013-8#1)
Wnt/beta-catenin signaling##2##2##(2009-8#2)
Wnt/β-catenin signaling plays a key##2##5##(2013-1#2)
Wnt/β-catenin signaling##4##2##(2013-1#4)
Wnt/β-catenin##5##1##(2013-1#4)(2013-8#1)
Wnt3a##2##1##(2009-8#2)
Woc##2##1##(2012-3#2)
Wolbachia are##3##2##(2008-8#1)(2008-9#2)
Wolbachia can##2##2##(2008-8#1)(2012-3#1)
Wolbachia differences##2##2##(2008-8#2)
Wolbachia pipientis##2##2##(2008-9#2)
Wolbachia transfection##2##2##(2008-9#2)
Wolbachia##29##1##(2008-10#1)(2008-8#13)(2008-9#12)(2012-3#3)
Wolbachia-infected females##2##2##(2012-3#2)
Wolf##6##1##(1990-11#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)
Wolf-Hirschhorn syndrome##2##2##(2010-3#2)
Wollaston prism group##2##3##(2013-8#2)
Wollaston prism##7##2##(2008-3#4)(2013-8#3)
Wollaston prisms##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
Wollaston##11##1##(2008-2#1)(2008-3#6)(2013-8#4)
Wolter##2##1##(2008-3#2)
Wolven Pole##3##2##(2008-10#3)
Woman##3##1##(2007-2#1)(2010-3#1)(2013-1#1)
Women and men##3##3##(1995-9#1)(2008-12#1)(2010-6#1)
Women and the##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
Women and##11##2##(1991-6#1)(1993-3#1)(1995-12#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2010-6#1)
Women had a higher##2##4##(2012-1#1)(2012-2#1)
Women had##3##2##(1996-6#1)(2012-1#1)(2012-2#1)
Women in##6##2##(1991-2#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
Women were more likely##2##4##(2008-12#1)(2012-2#1)
Women were more##3##3##(2008-12#1)(2010-5#1)(2012-2#1)
Women were##5##2##(1990-8#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
Women who##6##2##(1995-3#1)(1997-3#1)(2007-12#1)(2009-5#1)(2012-3#1)(2013-1#1)
Women with PCOS had##2##4##(2008-3#2)
Women with##17##2##(1992-2#2)(1993-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#3)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
Women##106##1##(1990-8#1)(1991-2#2)(1991-6#1)(1992-2#2)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#6)(2007-2#4)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-5#2)(2010-6#2)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#1)
Women's Caucus is##2##3##(1996-5#2)
Women's College##2##2##(1993-12#1)(2008-7#1)
Women's Health##4##2##(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
Women's Hospital##8##2##(1990-10#1)(1993-3#2)(1994-3#1)(2008-3#1)(2008-4#1)(2010-5#2)
Women's Preferences for##2##3##(2007-2#1)(2013-1#1)
Women's health needs have been a special focus of health care for more than a century##2##16##(1994-3#2)
Women's health##5##2##(1994-3#2)(1995-2#1)(1996-9#1)(1997-3#1)
Women's##37##1##(1990-10#1)(1993-12#1)(1993-3#2)(1994-3#3)(1995-2#1)(1995-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(2007-12#2)(2007-2#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
Wongan Hills##2##2##(2008-10#2)
Wood##16##1##(1993-2#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-5#1)(2013-1#2)
Wood's##3##1##(2007-12#1)(2007-7#1)(2008-2#1)
Woodall v##2##2##(1995-6#2)
Woodcock-Johnson##2##1##(2008-12#2)
Woodward's##2##1##(1993-3#1)(1993-6#1)
Woody##4##1##(1992-1#1)(2008-10#1)(2008-11#1)(2012-7#1)
Word##4##1##(1993-3#1)(2008-10#1)(2008-9#1)(2010-12#1)
Words##11##1##(2008-10#9)(2012-3#1)(2013-1#1)
Work and##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
Work in##2##2##(2008-7#1)(2011-2#1)
Work with##2##2##(2008-10#2)
Work##37##1##(1992-1#1)(1992-3#1)(1993-2#3)(1994-1#1)(1995-1#1)(1996-3#3)(1996-6#2)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#2)(2009-8#2)(2010-5#1)(2010-7#3)(2011-2#9)
Work-based learning##2##2##(2008-11#2)
Work-related##2##1##(2011-2#1)(2012-1#1)
Work-up##2##1##(2008-10#1)(2009-12#1)
Worker##3##1##(1991-12#1)(1994-1#1)(2009-9#1)
Workers Compensation cases##2##3##(1991-12#2)
Workers Compensation##3##2##(1991-12#3)
Workers in##2##2##(2011-2#2)
Workers of the world##2##4##(1994-1#2)
Workers##14##1##(1991-12#3)(1994-1#2)(1997-7#1)(2008-6#3)(2011-1#1)(2011-2#3)(2012-3#1)
Workers' compensation##2##2##(1995-1#2)
Workers'##3##1##(1995-1#2)(2011-2#1)
Workforce##7##1##(2008-11#2)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
Working Group in##2##3##(1991-8#1)(2011-2#1)
Working Group of##2##3##(1997-5#1)(2010-5#1)
Working Group on the##2##4##(1993-5#1)(1996-6#1)
Working Group on##6##3##(1993-5#1)(1996-6#1)(2007-9#1)(2008-12#1)(2013-1#2)
Working Group##16##2##(1991-8#1)(1993-5#1)(1996-6#2)(1997-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#2)(2011-2#1)(2013-1#2)
Working Together##2##2##(2008-11#1)(2008-12#1)
Working and##2##2##(2008-11#2)
Working conditions##3##2##(2008-10#2)(2008-3#1)
Working heart##2##2##(2007-8#1)(2008-6#1)
Working in##3##2##(2007-11#1)(2008-10#2)
Working memory performance##2##3##(2009-9#1)(2012-3#1)
Working memory##3##2##(2009-9#1)(2012-2#1)(2012-3#1)
Working on##2##2##(2007-11#1)(2013-1#1)
Working range##2##2##(2008-10#2)
Working together for##2##3##(1996-1#1)(2008-6#1)
Working together##3##2##(1996-1#1)(2008-6#1)(2013-1#1)
Working with an##2##3##(2008-11#1)(2008-9#1)
Working with##13##2##(1991-3#1)(1992-12#1)(1992-3#1)(1994-12#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#2)(2012-3#1)(2013-8#1)
Working##61##1##(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-12#2)(1996-1#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#3)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
Workload##2##1##(1995-3#1)(1997-8#1)
Workplace##8##1##(1995-2#1)(2008-11#2)(2008-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
Works of##2##2##(2008-2#1)(2011-2#1)
Works##4##1##(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
Workshop for Early Career Investigators##2##5##(2012-2#2)
Workshop on##12##2##(1991-8#1)(1996-4#1)(2008-10#1)(2008-4#3)(2008-7#4)(2011-2#1)(2013-8#1)
Workshop##41##1##(1991-3#2)(1991-8#1)(1996-4#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#4)(2008-7#6)(2011-2#4)(2012-2#3)(2012-3#10)(2013-1#1)(2013-8#1)
Workshops##2##1##(2008-4#1)(2011-2#1)
Workstation##2##1##(2008-10#1)(2012-2#1)
Worland strains##3##2##(2008-10#3)
Worland##9##1##(2008-10#9)
World AIDS##3##2##(1990-11#2)(2008-5#1)
World Allergy Organization##3##3##(2012-12#3)
World Anti-Doping##3##2##(2010-4#1)(2010-7#2)
World Bank##5##2##(1990-3#1)(1992-5#1)(1997-8#3)
World Congress##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
World Federation of##3##3##(2008-2#1)(2011-2#1)(2012-3#1)
World Health Day##2##3##(1995-3#2)
World Health Organization (WHO)##23##4##(1994-9#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
World Health Organization and##4##4##(2007-12#1)(2007-2#1)(2008-3#1)(2011-2#1)
World Health Organization has##2##4##(2008-1#1)(2011-2#1)
World Health Organization or Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer toxicity##2##16##(2008-7#2)
World Health Organization##68##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#2)(1993-6#1)(1994-3#1)(1994-9#3)(1995-3#1)(1996-9#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#5)
World Health##82##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#2)(1993-6#1)(1994-3#1)(1994-9#3)(1995-3#4)(1996-9#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#6)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#4)(2012-2#4)(2013-1#6)
World J Orthod 2008##3##4##(2009-7#3)
World Journal of Gastrointestinal##3##4##(2010-12#3)
World Journal of##6##3##(2010-12#6)
World Kidney Day##2##3##(2010-4#1)(2012-2#1)
World Leishmania spp##2##3##(2012-2#2)
World No-Tobacco Day##2##3##(1991-5#2)
World Organisation for Animal Health (OIE)##3##6##(2011-2#3)
World Organisation for Animal Health##6##5##(2011-2#6)
World Radiation Center##2##3##(2008-2#2)
World Sciurus and##3##3##(2008-5#3)
World Sciurus##7##2##(2008-5#7)
World War I##2##3##(2010-1#1)(2011-1#1)
World War II##18##3##(1990-11#1)(1990-6#2)(1996-1#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#7)(2013-8#1)
World War II]##2##3##(1991-11#1)(2012-12#1)
World War##32##2##(1990-11#1)(1990-6#2)(1991-11#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-4#2)(2012-12#1)(2013-1#7)(2013-8#1)
World Wide Web server##2##4##(2008-4#2)
World Wide Web##11##3##(1996-11#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#3)(2011-1#1)
World class##2##2##(1992-12#1)(1994-1#1)
World monkeys and##2##3##(1995-11#2)
World monkeys##4##2##(1995-11#3)(2007-12#1)
World of##2##2##(2008-11#1)(2013-8#1)
World##240##1##(1990-11#4)(1990-3#2)(1990-6#2)(1991-11#1)(1991-12#1)(1991-5#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#2)(1993-11#3)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-11#3)(1995-3#5)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-8#5)(2006-10#1)(2007-12#2)(2007-2#3)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#21)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#7)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#8)(2010-3#1)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#19)(2011-3#1)(2011-4#2)(2011-7#1)(2012-12#8)(2012-2#9)(2012-3#2)(2013-1#14)(2013-8#4)
World&quot##2##1##(2008-1#1)(2008-10#1)
World-Wide Web##7##2##(1996-12#3)(2007-11#2)(2008-3#1)(2008-4#1)
Worldwide##19##1##(1991-11#1)(1994-9#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2013-1#1)
Worm##2##1##(1996-12#1)(2012-2#1)
Wortmannin##4##1##(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#1)
Would near-infrared fluorescence signals propagate through large human organs for clinical studies?##2##12##(2007-11#2)
Would##6##1##(2007-11#2)(2008-9#1)(2013-1#3)
Wound Healing##3##2##(2008-10#1)(2009-12#1)(2013-1#1)
Wound healing##2##2##(2008-7#1)(2012-12#1)
Wound##16##1##(1992-1#1)(1992-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
Wounded##2##1##(2008-10#2)
Wounding##3##1##(2008-10#3)
Wright and##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
Wright##8##1##(2008-6#1)(2008-8#1)(2008-9#4)(2012-2#1)(2013-8#1)
Wright's##2##1##(2008-9#1)(2012-2#1)
Wright-Giemsa##3##1##(2008-11#1)(2008-9#2)
Wrinkles##2##1##(2008-5#2)
Wrist##2##1##(2008-10#1)(2008-9#1)
Writing and##2##2##(1993-2#1)(1994-2#1)
Writing as##2##2##(2013-1#2)
Writing for##3##2##(2008-11#3)
Writing##17##1##(1990-12#2)(1992-8#1)(1993-2#1)(1994-2#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2011-2#1)(2013-1#2)
Written by##3##2##(1996-1#1)(2008-9#2)
Written in##2##2##(2011-2#1)(2012-2#1)
Written##8##1##(1992-11#1)(1996-1#1)(2008-11#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
Wrong##4##1##(1991-11#1)(1996-3#1)(1996-6#1)(2008-6#1)
Wschr##2##1##(1991-6#1)(1993-2#1)
Wt##2##1##(1990-2#1)(2010-3#1)
Wu##2##1##(2008-5#1)(2012-2#1)
Wuyujing-7 and CG-14 were##2##4##(2009-10#2)
Wuyujing-7##5##1##(2009-10#5)
Wx##2##1##(2008-9#2)
Wyeth-Ayerst##3##1##(2008-5#3)
Wyman##5##1##(1990-8#2)(1997-2#3)
Wyoming##4##1##(1994-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
Wölter mirror##4##2##(2008-2#4)
Würzburg##3##1##(1996-5#3)
X 10(-6) M##3##3##(1996-2#3)
X 10(-7)##5##2##(1990-5#5)
X 10(-8)##2##2##(1990-5#1)(1996-2#1)
X = Y =##2##4##(1997-7#2)
X =##9##2##(1992-6#1)(1995-5#1)(1997-7#3)(2008-10#2)(2008-3#1)(2009-7#1)
X and Y chromosome##2##4##(1990-3#1)(2008-7#1)
X and Y chromosomes##3##4##(1990-3#1)(2008-7#1)(2010-5#1)
X and Y##13##3##(1990-3#3)(1994-1#2)(1997-4#1)(2008-11#1)(2008-7#4)(2008-8#1)(2010-5#1)
X and the##2##3##(1991-1#1)(2008-2#1)
X and##18##2##(1990-3#3)(1991-1#1)(1994-1#2)(1996-5#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#1)(2010-5#2)
X are##2##2##(2007-12#1)(2008-7#1)
X chromosome of##2##3##(1994-11#1)(2008-9#1)
X chromosome##24##2##(1991-6#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-5#1)(1996-12#2)(1996-6#2)(1997-5#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-4#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-1#1)
X chromosome-linked dominant inheritance pattern##2##5##(1994-8#2)
X chromosome-linked dominant##3##3##(1994-8#3)
X chromosome-linked##6##2##(1994-8#5)(2008-5#1)
X chromosomes##11##2##(1997-2#1)(2007-11#1)(2007-12#5)(2008-12#1)(2008-4#2)(2013-1#1)
X collagen##3##2##(1992-8#2)(2008-11#1)
X gene##4##2##(1996-8#1)(2008-4#1)(2012-12#2)
X in##3##2##(1994-8#1)(1997-5#1)(2008-10#1)
X inactivation##3##2##(1992-8#1)(1997-2#2)
X is##10##2##(1992-8#1)(1994-8#1)(1995-11#2)(1995-6#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)
X linked##3##2##(2008-11#1)(2008-8#2)
X ray##5##2##(1993-12#1)(2008-1#3)(2013-1#1)
X rays##3##2##(2008-3#1)(2008-7#1)(2013-1#1)
X receptors##6##2##(1993-3#2)(1993-6#1)(1995-8#1)(2008-10#2)
X syndrome##9##2##(1997-8#1)(2007-2#1)(2008-4#3)(2010-4#1)(2011-2#2)(2012-1#1)
X##501##1##(1990-11#1)(1990-12#1)(1990-3#4)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#5)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#4)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#2)(1993-6#10)(1994-1#2)(1994-11#1)(1994-5#1)(1994-8#8)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#3)(1995-9#2)(1996-12#2)(1996-2#5)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2007-11#2)(2007-12#10)(2007-2#2)(2007-7#1)(2008-1#3)(2008-10#249)(2008-11#10)(2008-12#11)(2008-2#2)(2008-3#9)(2008-4#12)(2008-5#6)(2008-7#16)(2008-8#5)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-9#1)(2011-2#12)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
X((2))##4##1##(2007-12#4)
X(+))X(3)(-)##2##1##(2008-10#2)
X(2)##3##1##(2008-10#2)(2012-12#1)
X(v&quot##2##1##(2008-3#2)
X) and##2##2##(1995-12#1)(2011-2#1)
X- and##2##2##(1990-3#1)(2012-3#1)
X-##3##1##(1990-3#1)(1991-5#1)(2012-3#1)
X-100 and##13##2##(1990-2#1)(1991-5#1)(2008-10#11)
X-100 were##3##2##(2008-10#3)
X-100 without##2##2##(2008-10#2)
X-100##68##1##(1990-11#3)(1990-2#2)(1990-7#1)(1991-5#1)(1991-8#1)(1992-3#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#1)(1997-8#1)(2008-10#41)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
X-100)##4##1##(1990-2#1)(2008-10#2)(2008-8#1)
X-8##4##1##(2008-10#1)(2008-12#3)
X-BR in##2##2##(2009-8#2)
X-BR##3##1##(2009-8#3)
X-POL##4##1##(2008-11#4)
X-Ray Fluorescence##2##2##(2008-10#1)(2008-12#1)
X-Ray Image Intensifier (SSXII)##2##4##(2011-1#2)
X-Ray crystallography##2##2##(2013-1#2)
X-Ray##17##1##(1996-12#2)(2008-10#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#2)(2013-1#2)(2013-8#1)
X-box binding##2##2##(2011-2#2)
X-box##3##1##(1992-11#1)(2011-2#2)
X-chromosomal short tandem##2##3##(2008-12#2)
X-chromosomal##5##1##(1994-11#1)(2008-12#4)
X-chromosome inactivation##2##2##(1997-2#1)(1997-4#1)
X-chromosome##9##1##(1990-8#1)(1994-11#1)(1997-2#2)(1997-4#2)(2008-12#3)
X-disease##2##1##(2008-10#2)
X-gal##3##1##(1995-8#1)(1997-6#1)(2009-12#1)
X-inactivation##2##1##(2008-11#1)(2008-4#1)
X-irradiation##3##1##(1992-11#1)(1994-2#1)(2011-2#1)
X-linked and autosomal##2##3##(1992-8#1)(1997-5#1)
X-linked and##3##2##(1992-8#1)(1997-5#1)(2008-7#1)
X-linked dominant##2##2##(2007-7#1)(2012-3#1)
X-linked gene##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
X-linked recessive##5##2##(2007-7#1)(2008-11#2)(2008-4#1)(2011-1#1)
X-linked##30##1##(1990-5#1)(1992-8#4)(1993-3#1)(1993-8#1)(1997-5#1)(2007-12#1)(2007-7#4)(2008-11#4)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
X-organ##2##1##(2007-12#1)(2008-5#1)
X-ray CT##2##2##(2011-1#2)
X-ray Diffraction##4##2##(1996-2#1)(1997-7#1)(2008-7#2)
X-ray Fluorescence##2##2##(2013-8#2)
X-ray absorptiometry (DXA)##5##3##(1997-8#1)(2008-10#1)(2008-7#2)(2011-2#1)
X-ray absorptiometry##12##2##(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#2)
X-ray absorption fine spectroscopy##2##4##(2008-10#2)
X-ray absorption fine structure spectroscopy##3##5##(2008-9#1)(2011-2#2)
X-ray absorption fine structure##6##4##(1996-2#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#2)
X-ray absorption fine##9##3##(1996-2#1)(2008-10#4)(2008-9#1)(2010-11#1)(2011-2#2)
X-ray absorption spectroscopy (XAS)##2##4##(2008-10#1)(2010-11#1)
X-ray absorption spectroscopy##4##3##(2008-10#2)(2010-11#1)(2011-2#1)
X-ray absorption##15##2##(1996-2#1)(2008-10#8)(2008-9#1)(2010-11#2)(2011-2#3)
X-ray analyses##3##2##(1990-7#1)(2007-11#1)(2008-10#1)
X-ray analysis of the##2##4##(1992-3#1)(1996-5#1)
X-ray analysis of##3##3##(1992-3#1)(1995-3#1)(1996-5#1)
X-ray analysis##9##2##(1992-3#1)(1995-3#1)(1996-5#2)(2007-11#2)(2008-10#1)(2008-5#1)(2012-2#1)
X-ray and computed tomographic##2##4##(2008-1#1)(2012-12#1)
X-ray and computed tomography##2##4##(2012-12#1)(2013-8#1)
X-ray and computed##4##3##(2008-1#1)(2012-12#2)(2013-8#1)
X-ray and nuclear medical examinations##2##5##(1997-8#2)
X-ray and##11##2##(1990-6#1)(1993-2#1)(1997-8#2)(2008-1#1)(2010-7#1)(2012-12#2)(2013-1#2)(2013-8#1)
X-ray and/or ultrasonography of breast##2##5##(1994-5#2)
X-ray beam##2##2##(1995-2#1)(2008-4#1)
X-ray chest##2##2##(2008-1#1)(2008-7#1)
X-ray computed tomography##2##3##(1991-11#1)(2011-1#1)
X-ray cross correlation analysis##2##4##(2010-8#2)
X-ray crystal structure of##3##4##(1992-8#1)(2007-11#1)(2013-7#1)
X-ray crystal structure##5##3##(1992-8#1)(1995-11#1)(1996-5#1)(2007-11#1)(2013-7#1)
X-ray crystal structures of##3##4##(1995-3#1)(1996-5#1)(2007-6#1)
X-ray crystal##12##2##(1992-8#2)(1995-11#1)(1995-3#1)(1996-5#2)(2007-11#1)(2007-6#1)(2010-2#1)(2011-2#2)(2013-7#1)
X-ray crystallographic study of the##2##5##(1993-11#1)(1995-3#1)
X-ray crystallographic##7##2##(1990-12#1)(1993-11#1)(1995-3#1)(2008-4#1)(2010-2#2)(2011-2#1)
X-ray crystallography and##3##3##(1993-11#1)(1996-2#1)(2008-4#1)
X-ray crystallography has##2##3##(2008-4#2)
X-ray crystallography##24##2##(1991-11#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1995-3#1)(1996-2#3)(1996-5#1)(1997-4#2)(1997-7#1)(2007-11#1)(2008-10#2)(2008-4#7)
X-ray diffraction (XRD) and##5##4##(2008-10#5)
X-ray diffraction (XRD)##12##3##(2008-10#9)(2009-7#1)(2009-8#1)(2013-8#1)
X-ray diffraction analysis of the##2##5##(1992-11#1)(2011-2#1)
X-ray diffraction analysis##8##3##(1992-11#1)(2007-11#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
X-ray diffraction and scattering##2##4##(2008-10#1)(2008-11#1)
X-ray diffraction and##16##3##(1994-5#1)(1997-4#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-7#1)(2010-12#1)
X-ray diffraction at##2##3##(2007-11#1)(2013-1#1)
X-ray diffraction data##4##3##(1991-5#1)(1992-8#1)(2008-6#1)(2008-8#1)
X-ray diffraction experiments##2##3##(1993-11#1)(2006-4#1)
X-ray diffraction for##4##3##(1996-2#1)(1996-5#1)(2008-5#1)(2008-7#1)
X-ray diffraction of##2##3##(1993-11#1)(2010-4#1)
X-ray diffraction patterns##3##3##(1992-9#1)(1993-11#1)(2008-10#1)
X-ray diffraction showed that##2##4##(2008-8#2)
X-ray diffraction spectrometry##2##3##(2008-10#2)
X-ray diffraction studies##3##3##(2008-5#1)(2010-5#2)
X-ray diffraction study##2##3##(1997-7#1)(2010-5#1)
X-ray diffraction##86##2##(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#4)(1994-5#1)(1996-2#4)(1996-5#1)(1997-4#1)(1997-7#4)(2006-4#2)(2007-11#2)(2007-12#1)(2008-10#26)(2008-11#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#2)
X-ray diffractometry##2##2##(2008-10#2)
X-ray energies##2##2##(2013-1#2)
X-ray energy dispersive spectroscopy##2##4##(2008-10#2)
X-ray energy##4##2##(1997-8#2)(2008-10#2)
X-ray exposure##2##2##(2007-12#1)(2013-8#1)
X-ray film##6##2##(1991-12#2)(1993-6#1)(2008-4#1)(2008-7#1)(2012-3#1)
X-ray films##7##2##(1991-12#1)(2007-11#1)(2008-1#3)(2008-4#1)(2008-9#1)
X-ray fluorescence (EDXRF)##4##3##(2008-10#4)
X-ray fluorescence (XRF) analysis##4##4##(2008-10#3)(2008-5#1)
X-ray fluorescence (XRF)##5##3##(2008-10#4)(2008-5#1)
X-ray fluorescence spectrometry##7##3##(2008-10#7)
X-ray fluorescence spectroscopy##4##3##(2008-10#3)(2013-8#1)
X-ray fluorescence##38##2##(2008-10#32)(2008-5#3)(2013-8#3)
X-ray generator##2##2##(2008-11#2)
X-ray imaging##3##2##(2010-10#1)(2013-8#2)
X-ray lens##3##2##(2008-10#3)
X-ray microanalysis##6##2##(1995-8#1)(2008-10#4)(2013-1#1)
X-ray microanalyzer##2##2##(1992-11#1)(2008-9#1)
X-ray microsource##3##2##(2008-11#3)
X-ray microtomography##4##2##(2012-12#3)(2012-2#1)
X-ray multispectrum imaging based on variable##2##6##(2013-8#2)
X-ray natural circular dichroism##3##4##(2006-4#3)
X-ray of the##3##3##(1990-6#1)(1991-9#1)(2007-11#1)
X-ray optics##3##2##(2006-4#1)(2008-10#2)
X-ray or##4##2##(1990-12#1)(1991-2#1)(2008-4#1)(2013-1#1)
X-ray photoelectron spectra (XPS)##2##4##(2008-10#1)(2013-8#1)
X-ray photoelectron spectrometry and##2##4##(2008-10#2)
X-ray photoelectron spectroscopy (XPS)##6##4##(2008-10#5)(2013-8#1)
X-ray photoelectron spectroscopy and##2##4##(2008-10#1)(2013-8#1)
X-ray photoelectron spectroscopy##17##3##(1996-12#1)(2008-10#12)(2011-2#2)(2013-8#2)
X-ray photoelectron##24##2##(1996-12#1)(2008-10#17)(2010-4#1)(2011-2#2)(2013-8#3)
X-ray powder diffraction (XRD) and Fourier transform infrared spectroscopy##2##9##(2008-10#1)(2012-2#1)
X-ray powder diffraction##6##3##(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2011-3#1)(2012-2#1)
X-ray powder##9##2##(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
X-ray scattering (SAXS)##3##3##(2008-10#3)
X-ray scattering##10##2##(2006-4#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)
X-ray source##2##2##(2008-10#1)(2011-2#1)
X-ray sources##5##2##(2006-4#2)(2008-7#1)(2010-8#1)(2012-2#1)
X-ray spectrometer##3##2##(2008-10#2)(2013-8#1)
X-ray spectrometry##4##2##(2008-10#4)
X-ray structure##6##2##(1993-8#2)(1995-5#1)(1996-5#1)(1997-7#1)(2008-11#1)
X-ray structures of##2##3##(1994-5#1)(1994-8#1)
X-ray structures##3##2##(1994-5#1)(1994-8#1)(2012-1#1)
X-ray telescopes##2##2##(2008-3#2)
X-ray##463##1##(1990-12#2)(1990-6#3)(1990-7#1)(1991-11#3)(1991-12#6)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#7)(1992-9#1)(1993-11#6)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#13)(1996-3#1)(1996-5#8)(1996-6#1)(1997-3#1)(1997-4#4)(1997-7#11)(1997-8#5)(2006-4#12)(2007-10#1)(2007-11#12)(2007-12#6)(2007-6#1)(2007-8#1)(2008-1#7)(2008-10#127)(2008-11#11)(2008-2#1)(2008-3#6)(2008-4#13)(2008-5#11)(2008-6#4)(2008-7#15)(2008-8#5)(2008-9#6)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#9)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#10)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#23)
X-ray-induced##2##1##(1994-2#1)(1997-4#1)
X-rays or##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
X-rays##32##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1995-3#1)(1996-6#1)(2006-4#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#6)(2009-11#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
X1 and##2##2##(1990-3#1)(1995-3#1)
X1##7##1##(1990-3#1)(1992-6#1)(1995-3#3)(1997-7#2)
X2##5##1##(1990-3#1)(1992-6#1)(1993-2#1)(2008-1#1)(2009-8#1)
X2X2 genotype##2##2##(1990-3#2)
X2X2##4##1##(1990-3#4)
XACML which##2##2##(2010-8#2)
XACML##8##1##(2010-8#8)
XAD 8##2##2##(2008-10#2)
XAD##5##1##(2008-10#5)
XAD-1180-PV##2##1##(2008-10#2)
XAD-16 resin and##3##3##(2008-10#3)
XAD-16 resin##5##2##(2008-10#5)
XAD-16##15##1##(2008-10#15)
XAD-2 loaded with##3##3##(2008-10#3)
XAD-2 resin adsorption##2##3##(2008-10#2)
XAD-2 resin##17##2##(2008-10#17)
XAD-2##33##1##(2008-10#33)
XAD-4 and XAD-7##2##3##(2008-10#2)
XAD-4 columns##3##2##(2008-10#3)
XAD-4 resin##7##2##(2008-10#7)
XAD-4##27##1##(2008-10#27)
XAD-7##7##1##(2008-10#7)
XAD-8##7##1##(2008-10#7)
XANES and##2##2##(2008-10#1)(2010-4#1)
XANES spectra##2##2##(2008-10#2)
XANES##6##1##(2006-4#1)(2008-10#4)(2010-4#1)
XAS##2##1##(2010-11#1)(2012-2#1)
XBP1 gene##3##2##(2011-2#3)
XBP1##9##1##(2011-2#9)
XC##4##1##(2008-3#4)
XD##2##1##(2012-3#2)
XDLVO theory##2##2##(2013-1#2)
XDR-TB and HIV##3##3##(2008-10#1)(2010-5#2)
XDR-TB and##5##2##(2008-10#3)(2010-5#2)
XDR-TB##15##1##(2008-10#6)(2010-5#9)
XE-2100 haematology analyser##2##3##(2008-10#2)
XE-2100##7##1##(2008-10#7)
XFGFR-1##4##1##(1993-6#4)
XGP##5##1##(2008-1#2)(2013-1#3)
XGal plates##3##2##(1993-12#1)(1997-4#2)
XGal##5##1##(1993-12#1)(1993-9#1)(1997-4#3)
XI activation##2##2##(1991-9#2)
XI was##2##2##(1993-11#1)(2008-6#1)
XI##19##1##(1991-9#8)(1993-11#3)(1993-9#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#1)(2008-6#1)(2008-7#1)
XIAP##2##1##(2009-9#1)(2010-6#1)
XII##12##1##(1990-2#1)(1991-6#1)(1991-9#1)(1995-11#3)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)
XIII##18##1##(1990-8#2)(1994-2#1)(1994-9#1)(1995-12#2)(1995-9#1)(2008-11#9)(2008-8#1)(2012-3#1)
XIV##13##1##(1991-1#1)(1995-9#2)(1996-3#4)(1996-6#1)(2008-10#1)(2008-3#3)(2012-3#1)
XIX century##3##2##(1991-6#2)(2009-8#1)
XLCT has##2##2##(2012-12#2)
XLCT system##2##2##(2012-12#2)
XLCT##7##1##(2012-12#7)
XLOLR strain of E##2##4##(1997-7#2)
XN4 and##3##2##(2008-10#3)
XN4 x SP##3##3##(2008-10#3)
XN4 x##4##2##(2008-10#4)
XN4##11##1##(2008-10#11)
XO (L)##2##2##(2008-10#2)
XO##5##1##(2008-10#4)(2008-11#1)
XOD##2##1##(2008-10#2)
XOMA has##3##2##(2008-5#3)
XOMA is##3##2##(2008-5#3)
XOMA##11##1##(2008-5#11)
XOMA's##2##1##(2008-5#2)
XOR##3##1##(2007-11#1)(2007-12#1)(2010-8#1)
XP##3##1##(2008-10#2)(2013-1#1)
XPAC##3##1##(1991-12#3)
XPS##7##1##(2008-10#6)(2008-2#1)
XR##4##1##(1995-8#2)(2008-11#2)
XRCC1##2##1##(2010-6#1)(2010-8#1)
XRCC4 and##2##2##(1997-7#2)
XRCC4##7##1##(1997-7#7)
XRD and XRF##2##3##(2013-8#2)
XRD and##8##2##(2008-10#5)(2012-2#1)(2013-8#2)
XRD##23##1##(2008-10#9)(2008-5#4)(2012-2#2)(2013-1#3)(2013-8#5)
XRF trans-rectal probe##2##3##(2008-10#2)
XRF##13##1##(2008-10#9)(2008-5#1)(2013-8#3)
XRT group##3##2##(1991-4#3)
XRT patients##3##2##(1991-4#3)
XRT##9##1##(1991-4#7)(2008-3#2)
XTT reduction##2##2##(2013-1#2)
XTT##4##1##(2008-11#1)(2011-2#1)(2013-1#2)
XUV##2##1##(2007-11#2)
XX##5##1##(1992-11#1)(2008-10#1)(2008-4#1)(2010-10#1)(2011-1#1)
XXIII##2##1##(2008-10#1)(2009-5#1)
XXY##2##1##(1995-8#1)(2012-3#1)
XXth century##2##2##(2007-11#1)(2007-8#1)
XY##8##1##(1997-3#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-3#1)
XY)##2##1##(2007-12#1)(2008-1#1)
XYL1##4##1##(1995-8#4)
XYLA##2##1##(2012-3#2)
XY[9] in case##2##3##(2009-2#2)
XZ113 delta##3##2##(2012-3#3)
XZ113##4##1##(2012-3#4)
Xa##14##1##(1990-7#1)(1991-3#2)(1993-11#2)(1994-5#5)(1994-8#1)(2008-11#1)(2008-5#1)(2012-12#1)
Xa10##5##1##(2008-10#5)
Xa21 gene##2##2##(2008-8#2)
Xa21 was##2##2##(2008-10#1)(2008-8#1)
Xa21##22##1##(2008-10#16)(2008-8#6)
Xa22(t) locus##3##2##(2008-10#3)
Xa22(t)##6##1##(2008-10#6)
Xa4##9##1##(2008-10#7)(2008-8#2)
XadA##2##1##(2008-10#2)
XadA-##2##1##(2008-10#2)
Xanthi##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
Xanthi-nc##2##1##(2008-10#2)
Xanthine oxidase##2##2##(2008-10#2)
Xanthines##3##1##(1997-3#2)(2008-5#1)
Xanthogranulomatous##2##1##(1991-8#1)(2008-1#1)
Xanthoma disseminatum##2##2##(2012-3#2)
Xanthomonad-like bacteria associated with CBB in##2##6##(2008-10#2)
Xanthomonas albilineans##6##2##(2008-10#6)
Xanthomonas arboricola pv##2##3##(2008-10#2)
Xanthomonas axonopodis pv##23##3##(2008-10#23)
Xanthomonas axonopodis##24##2##(2008-10#24)
Xanthomonas campestris pv##40##3##(2008-10#37)(2009-6#1)(2010-10#2)
Xanthomonas campestris##42##2##(2008-10#38)(2009-6#1)(2010-10#2)(2012-2#1)
Xanthomonas isolates##2##2##(2008-10#2)
Xanthomonas oryzae pv##20##3##(1993-9#1)(2008-10#17)(2008-9#1)(2009-10#1)
Xanthomonas oryzae##21##2##(1993-9#2)(2008-10#17)(2008-9#1)(2009-10#1)
Xanthomonas pathovars##3##2##(1993-9#2)(2008-10#1)
Xanthomonas sp##2##2##(2009-6#2)
Xanthomonas spp##3##2##(2008-10#3)
Xanthomonas strains isolated from onion##2##5##(2008-10#2)
Xanthomonas strains isolated from##3##4##(2008-10#3)
Xanthomonas strains##8##2##(2008-10#8)
Xanthomonas translucens##6##2##(2008-10#6)
Xanthomonas##143##1##(1993-6#1)(1993-9#4)(2008-10#129)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#3)(2010-10#2)(2012-2#1)
Xanthosoma/Syngonium group##2##2##(2008-10#2)
Xavier##3##1##(1994-5#2)(2008-10#1)
XbaI and##2##2##(1992-3#1)(2008-10#1)
XbaI##11##1##(1990-3#1)(1991-9#1)(1992-3#3)(1994-12#1)(1997-8#1)(2008-10#3)(2008-5#1)
XcTcmJ##5##1##(2010-10#5)
Xca4##2##1##(2008-10#2)
XcmN##3##1##(2008-10#3)
Xe##3##1##(2007-11#1)(2008-11#1)(2008-3#1)
XeCl laser##2##2##(2008-2#1)(2008-3#1)
XeCl##3##1##(2008-2#1)(2008-3#2)
Xemilofiban is##2##2##(2008-5#2)
Xemilofiban##5##1##(2008-5#5)
Xenoestrogens##2##1##(2008-4#2)
Xenon##2##1##(2008-10#1)(2008-3#1)
Xenopus Gq alpha mRNA##2##4##(1995-2#2)
Xenopus Gq alpha##3##3##(1995-2#3)
Xenopus embryos##3##2##(1993-3#2)(2012-12#1)
Xenopus fibroblast growth factor receptor-1##2##5##(1993-6#2)
Xenopus laevis (Daudin)##2##3##(2011-2#2)
Xenopus laevis and Drosophila melanogaster##2##5##(1991-12#2)
Xenopus laevis and##3##3##(1991-12#2)(1996-2#1)
Xenopus laevis egg extracts##2##4##(2008-8#1)(2008-9#1)
Xenopus laevis egg##5##3##(1993-2#1)(1993-6#1)(2008-8#1)(2008-9#2)
Xenopus laevis melanophores##2##3##(1992-3#2)
Xenopus laevis oocytes##6##3##(1991-12#2)(1992-3#1)(1994-8#2)(2010-2#1)
Xenopus laevis##53##2##(1990-12#2)(1991-12#4)(1991-6#2)(1992-3#3)(1993-12#2)(1993-2#2)(1993-5#6)(1993-6#5)(1994-12#2)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#4)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#1)(2011-2#2)
Xenopus oocyte##3##2##(1995-2#1)(1997-2#2)
Xenopus oocytes injected with##2##4##(1990-7#1)(1997-2#1)
Xenopus oocytes##30##2##(1990-11#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(1995-11#7)(1995-2#2)(1995-5#1)(1997-2#2)(2008-4#3)(2008-5#1)(2012-12#1)
Xenopus##117##1##(1990-11#1)(1990-12#3)(1990-7#2)(1990-8#1)(1991-12#8)(1991-6#2)(1991-9#1)(1992-11#2)(1992-3#3)(1992-6#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#6)(1993-6#8)(1994-11#1)(1994-12#3)(1994-8#3)(1995-11#7)(1995-12#2)(1995-2#9)(1995-3#3)(1995-5#1)(1996-2#2)(1997-2#5)(1997-3#1)(1997-7#8)(1997-9#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-2#1)(2011-2#2)(2012-12#2)(2012-3#1)
Xenotransplantation##3##1##(1995-11#1)(2008-11#1)(2008-8#1)
Xenotropic##2##1##(1990-5#2)
Xeroderma##2##1##(1991-12#1)(2011-2#1)
Xgwm111##2##1##(2008-10#2)
Xgwm295##4##1##(2008-10#4)
Xgwm410##2##1##(2008-10#2)
XhoI##2##1##(2008-5#1)(2008-8#1)
Xian##2##1##(2008-10#2)
Xieyou 63##4##2##(2008-9#4)
Xieyou 9308##4##2##(2008-9#4)
Xieyou##8##1##(2008-9#8)
Xilingang granite##2##2##(2013-8#2)
Xilingang pluton##2##2##(2013-8#2)
Xilingang##5##1##(2013-8#5)
Xingu##2##1##(1991-12#2)
Xinjiang##2##1##(2008-9#1)(2009-5#1)
Xiphinema americanum##7##2##(2008-10#7)
Xiphinema index##5##2##(2008-10#5)
Xiphinema##12##1##(2008-10#12)
Xist expression##4##2##(1994-11#1)(1997-2#3)
Xist##9##1##(1994-11#4)(1997-2#5)
Xi’an##2##1##(2013-1#2)
Xmsx-1 and Xmsx-2B##2##3##(2008-6#2)
Xmsx-1##6##1##(2008-6#6)
Xmsx-2B##12##1##(2008-6#12)
Xoo recA was##2##3##(1993-9#2)
Xoo recA##3##2##(1993-9#3)
Xoo##6##1##(1993-9#4)(2008-8#2)
Xp22##6##1##(1992-10#2)(1997-5#4)
Xpsr680 and##2##2##(2008-8#2)
Xq22##2##1##(2007-7#2)
Xq26-28##3##1##(1997-5#3)
Xq28##13##1##(1993-3#2)(1993-6#3)(1994-8#1)(1996-10#2)(2008-12#3)(2012-3#2)
Xray diffraction##2##2##(2013-8#2)
Xray##3##1##(2008-11#1)(2013-8#2)
Xsfr##2##1##(2008-10#2)
Xu-142##2##1##(2008-8#2)
Xuanwei and Fuyuan##2##3##(2010-5#2)
Xxx##4##1##(1994-6#4)
XylS##7##1##(2011-1#7)
Xylanase recovery##2##2##(2008-6#2)
Xylanase##4##1##(2008-10#1)(2008-6#3)
Xylanases##2##1##(2008-10#1)(2008-6#1)
Xylella fastidiosa strains from##2##4##(2008-10#2)
Xylella fastidiosa strains##4##3##(2008-10#4)
Xylella fastidiosa##33##2##(2008-10#33)
Xylene cyanol FF##3##3##(2008-10#3)
Xylene##4##1##(2008-10#4)
Xylenol orange##2##2##(2008-10#2)
Xylitol##2##1##(2008-6#2)
Xylohypha bantiana##2##2##(2007-12#2)
Xylose##3##1##(2008-6#2)(2012-3#1)
XynA-C##2##1##(2013-1#2)
Y (NPY)##8##2##(1990-5#1)(1992-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-8#1)
Y = -C&amp##2##3##(1997-7#2)
Y = 0##4##3##(1995-6#1)(2008-10#1)(2008-6#1)(2011-1#1)
Y =##12##2##(1995-5#1)(1995-6#1)(1997-7#3)(2008-10#4)(2008-6#1)(2011-1#2)
Y RNA##2##2##(2008-1#2)
Y VO(4)##2##2##(2007-12#2)
Y and W135##4##3##(2007-12#1)(2010-10#3)
Y and##13##2##(1995-12#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-10#3)(2012-3#1)
Y chromosome loss##2##3##(1993-9#2)
Y chromosome sequences##2##3##(1992-11#1)(1993-9#1)
Y chromosome##28##2##(1990-3#1)(1992-11#5)(1993-12#4)(1993-9#6)(1996-12#1)(1996-5#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2012-3#1)
Y chromosomes##9##2##(1990-3#2)(1992-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2010-5#2)
Y in##4##2##(1991-3#1)(2007-12#1)(2008-10#2)
Y is##3##2##(1995-12#1)(2008-7#1)(2012-12#1)
Y junction##2##2##(2008-3#2)
Y junctions##2##2##(2007-11#2)
Y or##2##2##(2008-12#1)(2010-5#1)
Y sequence may##2##3##(1993-6#2)
Y sequence##7##2##(1993-6#7)
Y splitter##3##2##(2007-11#3)
Y to##3##2##(1995-12#1)(2007-12#1)(2008-8#1)
Y transfer set##3##3##(2007-12#3)
Y was##4##2##(2008-10#4)
Y with##5##2##(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#2)
Y##257##1##(1990-11#1)(1990-3#4)(1990-5#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#7)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#4)(1993-5#1)(1993-6#7)(1993-8#1)(1993-9#10)(1994-1#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#26)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#2)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#7)(1997-7#4)(1997-8#1)(2007-11#5)(2007-12#20)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#4)(2008-12#10)(2008-2#2)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#12)(2008-8#9)(2008-9#4)(2009-11#1)(2009-8#1)(2010-10#3)(2010-5#3)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
Y(2)##2##1##(2008-10#1)(2008-2#1)
Y(2)O(3)##3##1##(2007-12#2)(2008-10#1)
Y(2)SiO(5)##2##1##(2007-11#1)(2007-12#1)
Y(3+)##3##1##(2008-10#3)
Y(75)##2##1##(2008-10#2)
Y(III)##3##1##(2008-10#3)
Y(V)##2##1##(2008-7#2)
Y(f)##3##1##(2008-10#3)
Y(t)##2##1##(1990-8#2)
Y)##4##1##(1993-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
Y- and##2##2##(1995-12#1)(2012-2#1)
Y-CPApK##4##1##(2008-10#4)
Y-GATA-H4##2##1##(2008-12#2)
Y-TZP##2##1##(2009-8#1)(2010-12#1)
Y-branch defect waveguides##2##3##(2007-11#2)
Y-branch##7##1##(2007-11#5)(2008-3#2)
Y-chromosome haplotype##2##2##(2008-8#2)
Y-chromosome##5##1##(2008-12#3)(2008-8#2)
Y-junction##2##1##(2007-12#1)(2008-3#1)
Y-maze##5##1##(1993-5#3)(2010-2#2)
Y-shaped##3##1##(2008-10#1)(2008-2#1)(2008-5#1)
Y-type##2##1##(2008-10#2)
Y1 receptors##2##2##(1995-12#2)
Y1##13##1##(1990-12#1)(1992-11#1)(1995-12#7)(1995-3#1)(2013-1#3)
Y14##6##1##(2012-2#6)
Y17##3##1##(1997-3#3)
Y2##7##1##(1992-11#2)(1995-12#3)(1995-3#2)
Y2-receptor##2##1##(1997-4#2)
Y2SiO5 solid-state saturable absorber##2##4##(2008-3#2)
Y2SiO5##4##1##(2008-3#4)
Y5##4##1##(1992-11#4)
Y509##2##1##(1994-6#2)
Y55G TCS##2##2##(2008-10#2)
YAC 872B5##3##2##(1997-8#3)
YAC D142H8##2##2##(1997-8#2)
YAC F136C5##2##2##(1997-8#2)
YAC clone##3##2##(1996-12#1)(1997-8#1)(2008-8#1)
YAC clones from##2##3##(1995-6#1)(2008-5#1)
YAC clones were##2##3##(1996-12#1)(2008-5#1)
YAC clones with##2##3##(1996-12#1)(2008-5#1)
YAC clones##18##2##(1995-6#2)(1996-10#2)(1996-12#7)(1996-8#1)(1997-2#1)(1997-8#1)(2008-5#4)
YAC contigs at##2##3##(1995-6#2)
YAC contigs##6##2##(1995-6#3)(1996-10#3)
YAC libraries##2##2##(1995-6#1)(2008-4#1)
YAC library##3##2##(1996-10#2)(2008-5#1)
YAC##58##1##(1991-9#2)(1993-11#1)(1994-11#1)(1995-6#7)(1996-10#9)(1996-12#10)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#14)(2008-4#3)(2008-5#6)(2008-8#1)
YACs were##6##2##(1996-10#1)(1996-12#1)(1997-2#4)
YACs##19##1##(1993-6#1)(1996-10#6)(1996-12#2)(1997-2#8)(1997-8#1)(2008-4#1)
YAG (2##3##2##(1991-2#3)
YAG Laser Pulses##2##3##(2008-2#1)(2008-3#1)
YAG Laser at##2##3##(2008-2#1)(2008-3#1)
YAG Laser with##4##3##(2008-2#2)(2008-3#2)
YAG Laser##17##2##(2008-2#10)(2008-3#6)(2010-6#1)
YAG Q-switched laser##2##3##(2007-12#1)(2008-2#1)
YAG and Ho##2##3##(2011-1#2)
YAG and Nd##2##3##(2007-11#1)(2008-3#1)
YAG and##11##2##(2007-11#1)(2008-2#5)(2008-3#3)(2011-1#2)
YAG as the##2##3##(2008-3#2)
YAG as##3##2##(2008-2#1)(2008-3#2)
YAG at##4##2##(2007-12#4)
YAG ceramic##2##2##(2007-11#2)
YAG ceramics##4##2##(2007-11#4)
YAG cladding-pumped planar waveguide laser##2##5##(2007-11#2)
YAG crystal with##2##3##(2007-12#1)(2008-2#1)
YAG crystal##10##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#5)
YAG crystals##3##2##(2007-11#1)(2008-3#2)
YAG endometrial ablation##2##3##(1993-1#2)
YAG laser and a##2##4##(2007-12#2)
YAG laser and##8##3##(2007-11#2)(2007-12#4)(2008-3#2)
YAG laser as##2##3##(2007-12#1)(2008-3#1)
YAG laser at 1##2##4##(2008-2#1)(2008-3#1)
YAG laser at 1064 nm##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
YAG laser at 1064##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
YAG laser at 532 nm##2##5##(2007-12#1)(2008-3#1)
YAG laser at##13##3##(1991-3#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)
YAG laser by##5##3##(2007-11#1)(2007-12#4)
YAG laser has been##2##4##(2007-12#1)(2008-2#1)
YAG laser has##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
YAG laser in a##2##4##(2007-12#1)(2008-3#1)
YAG laser in##3##3##(2007-12#1)(2008-3#2)
YAG laser is pumped##2##4##(2007-11#1)(2007-12#1)
YAG laser is##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
YAG laser light##4##3##(2008-2#1)(2008-3#3)
YAG laser on the low-gain 1123-nm##2##6##(2008-3#2)
YAG laser on the##3##4##(2007-12#1)(2008-3#2)
YAG laser operating at a##2##5##(2007-12#2)
YAG laser operating at##6##4##(2007-12#3)(2008-10#1)(2008-2#2)
YAG laser operating in##2##4##(2007-12#1)(2008-10#1)
YAG laser operating##8##3##(2007-12#4)(2008-10#2)(2008-2#2)
YAG laser photocoagulation##2##3##(1993-6#2)
YAG laser pulses##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
YAG laser pumped by a##2##5##(2007-12#1)(2008-2#1)
YAG laser pumped by##3##4##(2007-12#1)(2008-2#2)
YAG laser that operates at##2##5##(2008-2#1)(2008-3#1)
YAG laser that##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
YAG laser wavelength##2##3##(2008-3#1)(2008-7#1)
YAG laser were##2##3##(2007-11#1)(2008-2#1)
YAG laser with a planar semimonolithic ring cavity##2##8##(2008-3#2)
YAG laser with a simple##2##5##(2007-12#1)(2008-3#1)
YAG laser with a##9##4##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)
YAG laser with##13##3##(1991-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#5)
YAG laser##160##2##(1991-2#1)(1991-3#2)(1992-1#1)(1993-6#2)(1994-2#1)(1995-2#3)(2007-11#16)(2007-12#40)(2008-1#1)(2008-10#7)(2008-2#42)(2008-3#37)(2008-5#1)(2008-7#4)(2011-1#2)
YAG lasers at##2##3##(2008-2#1)(2008-3#1)
YAG lasers in##2##3##(2008-2#1)(2008-3#1)
YAG lasers with##2##3##(2008-3#2)
YAG lasers##16##2##(2007-12#4)(2008-2#6)(2008-3#5)(2011-1#1)
YAG microchip laser system for the detection of NO##2##9##(2008-3#2)
YAG microchip laser with##2##4##(2007-12#1)(2008-2#1)
YAG microchip laser##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
YAG microchip lasers##4##3##(2007-11#2)(2008-3#2)
YAG microchip##10##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
YAG or##2##2##(2008-3#1)(2011-1#1)
YAG oscillator##3##2##(2007-12#1)(2008-2#2)
YAG pump laser##3##3##(2008-2#3)
YAG pumped##2##2##(2008-2#1)(2008-3#1)
YAG rod laser with##2##4##(2007-12#1)(2008-2#1)
YAG rod laser##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
YAG rod with undoped ends##2##5##(2008-2#2)
YAG rod with##5##3##(2008-2#5)
YAG rod##15##2##(2007-12#5)(2008-2#9)(2008-3#1)
YAG rods##2##2##(2008-2#1)(2008-3#1)
YAG saturable absorber##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
YAG slab##2##2##(2007-11#2)
YAG transparent ceramic##2##3##(2013-8#2)
YAG transparent##4##2##(2013-8#4)
YAG waveguide laser##2##3##(2007-11#2)
YAG##368##1##(1991-2#4)(1991-3#2)(1992-1#1)(1993-1#2)(1993-6#2)(1994-2#1)(1995-2#3)(2007-11#40)(2007-12#71)(2008-1#1)(2008-10#7)(2008-2#108)(2008-3#98)(2008-5#1)(2008-7#5)(2010-6#1)(2011-1#6)(2013-8#15)
YAG)##2##1##(2008-2#1)(2008-3#1)
YAG-##2##1##(2007-12#1)(2008-3#1)
YAG-OPO Laser##2##2##(2008-5#2)
YAG-OPO laser##3##2##(2008-5#3)
YAG-OPO##5##1##(2008-5#5)
YAG-capsulotomy##3##1##(2011-2#3)
YAG-laser##3##1##(1991-9#3)
YAG-pumped##2##1##(2007-11#1)(2007-12#1)
YAP laser##2##2##(2008-2#2)
YAP##4##1##(2008-2#2)(2008-9#2)
YAP+ frequency##2##2##(2008-9#2)
YAP+##5##1##(2008-9#5)
YAl(3)(BO(3))(4)##3##1##(2007-11#1)(2007-12#2)
YAlO(3) laser##2##2##(2008-3#2)
YAlO(3)##5##1##(2008-3#5)
YBa2Cu3O7##3##1##(1990-12#1)(1993-5#1)(1994-2#1)
YBa2Cu3O7- delta##3##2##(1992-11#1)(1992-8#2)
YBa2Cu3O7-x##3##1##(1996-12#1)(1996-9#1)(2008-3#1)
YCOB##2##1##(2007-11#1)(2007-12#1)
YCa(4)O(BO(3))(3) (YCOB)##2##2##(2007-11#1)(2007-12#1)
YDVs##3##1##(2008-10#3)
YE##2##1##(2008-11#1)(2008-6#1)
YFP and CFP##2##3##(2008-10#2)
YFP##5##1##(2008-10#3)(2008-9#1)(2009-4#1)
YFP-tagged##3##1##(2008-9#3)
YH439##6##1##(2008-11#6)
YK##3##1##(2008-10#3)
YK-4##2##1##(2008-11#2)
YKE2##5##1##(1994-12#5)
YLF Laser##3##2##(2008-2#1)(2008-3#2)
YLF crystals##2##2##(2008-2#1)(2008-3#1)
YLF laser was##2##3##(2008-2#2)
YLF laser##9##2##(2007-12#2)(2008-2#4)(2008-3#3)
YLF rod laser##2##3##(2007-12#2)
YLF##26##1##(2007-11#1)(2007-12#4)(2008-2#10)(2008-3#11)
YM##2##1##(1994-12#1)(2008-10#1)
YM022##2##1##(1995-12#2)
YO-PRO-1##2##1##(2008-11#2)
YPA(4)##6##1##(2008-10#6)
YPD##2##1##(1993-9#1)(2011-1#1)
YPLH##2##1##(2013-1#2)
YRRM sequences##3##2##(1993-12#3)
YS and WR##2##3##(2008-6#2)
YS##5##1##(2008-10#1)(2008-6#4)
YSGG##3##1##(2008-2#1)(2008-3#2)
YUF##5##1##(2008-11#5)
YVO (4) laser##2##3##(2007-11#1)(2007-12#1)
YVO##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
YVO(4) crystal##3##2##(2007-11#2)(2008-3#1)
YVO(4) laser is##2##3##(2007-11#2)
YVO(4) laser##13##2##(2007-11#6)(2007-12#3)(2008-3#4)
YVO(4) microchip##2##2##(2007-12#2)
YVO(4)##32##1##(2007-11#15)(2007-12#6)(2008-2#2)(2008-3#9)
YVO(4)/KTP##2##1##(2008-2#2)
YVO4 laser##2##2##(2007-11#1)(2008-3#1)
YVO4##8##1##(2007-11#1)(2007-12#1)(2008-3#6)
YXRF##5##1##(1990-11#5)
YY1##10##1##(2008-11#8)(2008-7#2)
YY3-36 concentrations##2##2##(2013-8#2)
Yag laser##2##2##(1992-1#1)(2008-10#1)
Yahoo Health##2##2##(2011-1#2)
Yahr stage##4##2##(2008-11#1)(2008-7#2)(2013-8#1)
Yahr staging##2##2##(2008-7#2)
Yahr##8##1##(2008-11#1)(2008-7#6)(2013-8#1)
Yakedake Volcano##2##2##(2008-2#1)(2008-3#1)
Yale University##4##2##(1992-2#1)(1996-1#1)(1996-9#1)(2008-11#1)
Yale##7##1##(1992-2#1)(1996-1#1)(1996-9#3)(2008-11#1)(2008-8#1)
Yale-New Haven Hospital##2##3##(1996-2#1)(2013-8#1)
Yamamoto##2##1##(1995-2#1)(2007-11#1)
Yang##3##1##(1996-3#1)(2008-10#1)(2009-12#1)
Yangtze##2##1##(2008-8#1)(2012-3#1)
Yangxin County##2##2##(2012-3#2)
Yangzhong City##4##2##(2012-3#4)
Yanomámi Indians##2##2##(1991-12#2)
Yanomámi##7##1##(1991-12#7)
Yao##3##1##(1994-12#1)(1995-6#1)(2008-9#1)
Yaoundé##4##1##(2009-10#2)(2011-2#2)
Yap State##3##2##(2008-1#3)
Yap##6##1##(2008-1#3)(2008-10#2)(2013-8#1)
Yazd##2##1##(2013-1#2)
Yb and iodine##2##3##(1997-8#2)
Yb and##4##2##(1997-8#2)(2008-10#2)
Yb##68##1##(1997-8#7)(2007-11#15)(2007-12#14)(2008-10#6)(2008-2#1)(2008-3#21)(2010-4#4)
Yb(3+) -doped##3##2##(2007-11#3)
Yb(3+)##17##1##(2007-11#7)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2010-4#1)(2012-12#1)
Yb(3+))##2##1##(2012-12#2)
Yb(3+)-doped##3##1##(2007-11#2)(2008-2#1)
Yb(3+)/Al (3+) codoped##3##3##(2007-11#3)
Yb(III)##4##1##(2008-10#4)
Yb)##2##1##(1997-7#1)(2008-10#1)
Yb-doped fiber amplifier##3##3##(2007-11#2)(2007-12#1)
Yb-doped fiber##5##2##(2007-11#3)(2007-12#2)
Yb-doped##11##1##(2007-11#6)(2007-12#5)
Yb-fiber chirped-pulse amplification systems##2##4##(2007-11#2)
Yb-fiber##3##1##(2007-11#3)
YeaZ##3##1##(2010-10#3)
Year III##3##2##(2010-3#3)
Year of the##2##3##(2008-2#1)(2008-4#1)
Year of##3##2##(2008-2#1)(2008-4#2)
Year##17##1##(1990-8#1)(1992-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2010-3#3)(2010-5#1)(2011-2#1)
Yearly##2##1##(1994-12#1)(2008-10#1)
Years of##4##2##(1995-11#1)(2006-8#1)(2011-3#1)(2013-1#1)
Years##15##1##(1995-11#2)(2006-8#1)(2008-10#3)(2008-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#1)
Yeast artificial chromosome (YAC) clones##2##5##(1996-12#1)(1997-8#1)
Yeast cells##2##2##(2008-10#1)(2011-2#1)
Yeast##24##1##(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Yeasts##4##1##(2008-10#3)(2008-8#1)
Yeh##2##1##(1995-12#2)
Yellow Stripe Virus##2##3##(2008-10#2)
Yellow and##3##2##(1993-12#1)(2008-10#2)
Yellow pages##2##2##(1997-1#2)
Yellow##31##1##(1993-12#1)(1997-1#2)(2007-2#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-1#1)(2013-8#1)
Yellows Phytoplasma##2##2##(2008-10#2)
Yellows##5##1##(2008-10#5)
Yellowstone National Park##2##3##(2011-2#2)
Yemen##12##1##(2008-1#3)(2008-10#2)(2010-6#7)
Yemeni##2##1##(2008-10#1)(2008-12#1)
Yeq##2##1##(1990-8#2)
Yersinia enterocolitica##8##2##(1992-5#1)(1996-12#2)(1997-4#1)(2008-11#2)(2013-8#2)
Yersinia infections##2##2##(1990-6#2)
Yersinia pestis##2##2##(2008-10#1)(2012-2#1)
Yersinia##19##1##(1990-6#2)(1992-5#1)(1996-12#5)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-4#1)(2012-2#2)(2013-8#3)
Yersinia-induced arthritis##2##2##(1990-6#2)
Yes##6##1##(1991-3#1)(1994-2#1)(2007-10#1)(2010-12#1)(2010-5#1)(2012-2#1)
Yet despite the##2##3##(2008-7#1)(2011-1#1)
Yet despite##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
Yet in##2##2##(1994-1#1)(2012-2#1)
Yet most##2##2##(2008-8#1)(2011-2#1)
Yet the##8##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-1#1)(2013-8#1)
Yet there is##2##3##(1994-9#1)(2008-1#1)
Yet##90##1##(1990-11#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-9#2)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
Yi##2##1##(1995-6#1)(2008-9#1)
YidC##2##1##(2011-2#2)
Yield Loss of##2##3##(2008-10#2)
Yield and##2##2##(2008-10#1)(2008-9#1)
Yield loss##2##2##(2008-10#2)
Yield losses due to##2##4##(2008-10#2)
Yield losses##3##2##(2008-10#3)
Yield##21##1##(2008-10#15)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-8#1)
Yields##3##1##(2008-10#1)(2008-11#1)(2008-4#1)
Yin-Yang##2##1##(2008-7#1)(2008-9#1)
Yixing City from 2008 to##2##5##(2012-3#2)
Yl##3##1##(1995-2#3)
Yoga on##2##2##(2012-2#2)
Yoga##4##1##(2010-12#1)(2012-2#3)
Yolk DNA##2##2##(2008-4#2)
Yolk coelomitis##2##2##(2011-1#2)
Yolk##6##1##(2008-4#3)(2011-1#2)(2012-3#1)
Yolo##3##1##(2008-10#3)
Yonagunijima##2##1##(2010-3#2)
York Heart Association##4##3##(2007-8#1)(2008-3#1)(2010-10#1)(2011-2#1)
York and##7##2##(1992-1#1)(1992-12#2)(1994-2#1)(1995-5#1)(2008-10#1)(2008-7#1)
York##175##1##(1990-11#4)(1990-3#5)(1990-8#2)(1991-1#3)(1991-12#7)(1991-2#1)(1991-3#2)(1992-1#7)(1992-12#4)(1992-3#5)(1992-8#3)(1993-1#1)(1993-2#3)(1993-3#2)(1993-5#1)(1994-12#6)(1994-2#3)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#10)(1996-12#6)(1996-2#4)(1996-3#11)(1996-5#2)(1997-1#4)(1997-2#1)(2007-4#2)(2007-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#6)(2009-3#1)(2009-5#5)(2010-10#1)(2011-1#4)(2011-2#7)(2012-2#2)(2013-1#2)(2013-8#4)
Yorkshire##3##1##(2008-8#1)(2008-9#1)(2012-2#1)
Yoruba##2##1##(2009-10#1)(2011-1#1)
Yoshida AH-130 ascites hepatoma##2##4##(1993-8#2)
Yoshida##3##1##(1993-8#3)
You can##2##2##(1997-3#1)(2008-9#1)
You!##2##1##(2006-12#1)(2010-5#1)
You##17##1##(1992-1#2)(1995-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(2008-11#2)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#4)
Youden##2##1##(2010-4#1)(2012-3#1)
Youden's index##2##2##(2008-10#2)
Young Adult##2##2##(2009-12#1)(2012-12#1)
Young Adults##4##2##(2011-2#1)(2013-1#3)
Young adults##4##2##(2007-12#1)(2013-1#3)
Young children with##2##3##(1991-8#1)(2008-12#1)
Young children##4##2##(1991-8#1)(1994-12#1)(2008-12#1)(2010-12#1)
Young investigator##2##2##(2010-11#1)(2013-8#1)
Young men's##2##2##(2009-5#2)
Young people##3##2##(1997-5#1)(2008-5#1)(2013-1#1)
Young women##3##2##(1996-12#2)(2013-1#1)
Young##52##1##(1990-5#1)(1991-8#1)(1992-6#1)(1994-12#1)(1996-12#2)(1997-5#1)(2006-5#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#3)(2009-5#2)(2010-11#1)(2010-12#2)(2010-5#4)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#10)(2013-8#3)
Young's Modulus##3##2##(2008-5#1)(2008-9#2)
Young's modulus and##2##3##(2007-11#1)(2009-11#1)
Young's modulus change##2##3##(2009-5#2)
Young's modulus of the##2##4##(2008-3#1)(2009-4#1)
Young's modulus of##7##3##(1996-12#1)(2007-12#1)(2008-3#2)(2009-4#2)(2009-7#1)
Young's modulus values##2##3##(2009-4#2)
Young's modulus##25##2##(1996-12#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-5#4)(2009-11#1)(2009-4#5)(2009-5#2)(2009-7#6)(2010-8#1)
Young's relaxation modulus in the##2##5##(2009-7#2)
Young's relaxation modulus##6##3##(2009-7#6)
Young's##41##1##(1996-12#1)(2007-11#3)(2007-12#3)(2008-3#5)(2008-5#5)(2008-9#2)(2009-11#1)(2009-4#5)(2009-5#2)(2009-7#13)(2010-8#1)
Younger age##2##2##(2008-7#1)(2011-1#1)
Younger patients##4##2##(2009-9#1)(2010-12#1)(2011-2#2)
Younger##13##1##(1991-8#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
Your##11##1##(1990-11#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-2#1)(2008-6#1)
Youth Study##2##2##(2008-12#1)(2013-1#1)
Youth were##2##2##(2008-12#1)(2010-10#1)
Youth with##2##2##(2008-3#1)(2009-8#1)
Youth##29##1##(1990-12#1)(1994-2#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Youths##4##1##(2008-6#1)(2008-9#2)(2009-7#1)
Yp##2##1##(1993-9#2)
Ypt1##7##1##(1992-8#7)
Yq heterochromatic sequences##2##3##(1993-9#2)
Yq##3##1##(1992-11#1)(1993-9#2)
YrCN19##2##1##(2008-10#2)
Yrs##2##1##(1991-12#2)
Yrs-Yrs##2##1##(1991-12#2)
Yttrium##3##1##(2008-10#2)(2008-2#1)
Yuan##3##1##(2011-1#2)(2013-1#1)
Yucatan##3##1##(2008-10#1)(2008-5#2)
Yugoslav##2##1##(2007-10#1)(2008-7#1)
Yunnan Province##4##2##(2008-8#2)(2008-9#1)(2013-8#1)
Yunnan and##2##2##(2008-8#1)(2008-9#1)
Yunnan province##7##2##(2010-5#1)(2011-1#5)(2013-1#1)
Yunnan##17##1##(2008-8#3)(2008-9#4)(2010-5#1)(2011-1#5)(2013-1#1)(2013-8#3)
Z = 1##2##3##(1996-2#1)(1997-7#1)
Z = 2##11##3##(1996-2#7)(1997-7#3)(2007-11#1)
Z = 4##30##3##(1992-12#1)(1996-2#19)(1996-5#1)(1997-7#8)(2007-11#1)
Z = 8##5##3##(1996-2#1)(1997-7#4)
Z =##53##2##(1992-12#1)(1996-2#29)(1996-5#1)(1997-7#18)(2007-11#2)(2008-10#2)
Z and##4##2##(2008-12#1)(2008-3#1)(2010-5#1)(2011-2#1)
Z at the##2##3##(2008-5#2)
Z chromosome##4##2##(2008-5#3)(2010-3#1)
Z chromosomes##2##2##(2008-5#1)(2010-5#1)
Z is##3##2##(1992-6#1)(2008-3#1)(2009-12#1)
Z or##2##2##(2008-12#1)(2008-3#1)
Z pinch##2##2##(1992-11#1)(2008-2#1)
Z score##2##2##(1991-11#1)(2012-12#1)
Z##110##1##(1990-5#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-6#1)(1996-2#29)(1996-5#1)(1997-7#18)(2007-11#4)(2007-12#1)(2008-10#5)(2008-12#4)(2008-2#1)(2008-3#6)(2008-5#6)(2008-6#8)(2008-7#4)(2009-12#2)(2010-3#2)(2010-5#2)(2011-2#4)(2012-12#1)
Z(b)##2##1##(2008-3#2)
Z-250 through a 0##2##4##(2008-12#2)
Z-250 through a 1-mm layer of##2##6##(2008-12#2)
Z-250 through a##4##3##(2008-12#4)
Z-250##6##1##(2008-12#6)
Z-D-Phe-L-PheGly##9##1##(1992-3#9)
Z-VAD-fmk##2##1##(2008-10#1)(2008-11#1)
Z-cut##2##1##(2007-12#1)(2008-2#1)
Z-lumirubin##3##1##(1992-4#3)
Z-scan technique##8##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)(2013-1#1)
Z-scan##12##1##(2007-11#5)(2007-12#2)(2008-10#1)(2008-3#3)(2013-1#1)
Z-score##2##1##(2008-10#1)(2008-3#1)
Z-scores##3##1##(2008-10#3)
Z250##4##1##(2008-12#2)(2013-1#2)
Z8 snoRNA gene##2##3##(2008-8#2)
Z8##3##1##(2008-8#3)
ZA##4##1##(2008-7#2)(2013-1#2)
ZAP-70##4##1##(2008-9#4)
ZAPM were##2##2##(2008-7#2)
ZAPM##7##1##(2008-7#7)
ZBL##2##1##(1994-12#2)
ZBLAN fiber##3##2##(2007-12#3)
ZBLAN##6##1##(2007-12#5)(2008-3#1)
ZBP-89##7##1##(2010-8#7)
ZCFIA##4##1##(2008-10#4)
ZDF rats##2##2##(2008-4#1)(2012-1#1)
ZDV and##3##2##(2008-7#3)
ZDV##6##1##(2008-7#6)
ZEMAX##2##1##(2013-8#2)
ZEN and α-ZOL at##2##4##(2013-1#2)
ZEN and α-ZOL##4##3##(2013-1#4)
ZFPOU1##6##1##(1992-9#6)
ZGMMV is##2##2##(2008-10#2)
ZGMMV##3##1##(2008-10#3)
ZIFT##2##1##(1991-11#2)
ZIP##4##1##(2012-3#1)(2013-8#3)
ZIP1##2##1##(2008-9#2)
ZLRS##4##1##(1995-12#4)
ZM##4##1##(1994-12#1)(2008-12#2)(2008-2#1)
ZMA##3##1##(2008-5#3)
ZMR system can##2##3##(2011-2#2)
ZNF179##2##1##(1997-3#2)
ZO##2##1##(2013-1#2)
ZORBAX Eclipse##2##2##(2008-10#1)(2011-3#1)
ZP##7##1##(2008-8#1)(2013-1#6)
ZP3##3##1##(2008-4#3)
ZPT##6##1##(2008-10#2)(2008-5#4)
ZR-75-1##3##1##(1990-11#1)(1997-7#2)
ZW sex chromosome##2##3##(2010-3#1)(2010-8#1)
ZW sex##3##2##(2010-3#2)(2010-8#1)
ZW##4##1##(2010-3#3)(2010-8#1)
ZYMV in##2##2##(2008-10#2)
ZYMV isolates##3##2##(2008-10#3)
ZYMV##13##1##(2008-10#13)
ZYQ8/JX17##2##1##(2008-8#2)
Zagreb##11##1##(2007-11#5)(2008-10#2)(2009-12#2)(2013-1#2)
Zaire##5##1##(1991-11#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-8#1)
Zambia##2##1##(1997-6#1)(2010-4#1)
Zanthoxylum##3##1##(2007-11#2)(2008-5#1)
Zanzibar##6##1##(2008-10#1)(2012-2#5)
Zataria multiflora##2##2##(2008-8#1)(2012-2#1)
Zea mays L##8##3##(2008-12#2)(2008-5#1)(2009-8#1)(2011-2#4)
Zea mays##16##2##(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#3)(2009-8#1)(2011-2#4)(2012-3#1)
Zea##20##1##(1995-12#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2009-8#1)(2011-2#4)(2012-3#1)
Zealand##139##1##(1990-2#9)(1991-2#2)(1992-1#5)(1992-11#2)(1992-3#2)(1993-1#1)(1994-3#3)(1996-12#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2008-1#16)(2008-10#13)(2008-11#5)(2008-12#9)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#13)(2008-9#1)(2009-3#1)(2010-6#2)(2011-1#8)(2011-2#5)(2012-12#9)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#1)
Zebu##2##1##(2008-12#2)
Zeeland##2##1##(1992-12#1)(2008-10#1)
Zeeman background correction##2##3##(2008-10#2)
Zeeman effect background corrector##2##4##(2008-10#2)
Zeeman effect background##4##3##(2008-10#4)
Zeeman effect##6##2##(2008-10#4)(2008-3#2)
Zeeman laser in conjunction with a Glan-Thompson analyzer##3##8##(2007-11#1)(2007-12#1)(2008-2#1)
Zeeman laser##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
Zeeman laser-scanning confocal##2##3##(2007-11#2)
Zeeman##26##1##(2007-11#3)(2007-12#2)(2008-10#11)(2008-2#4)(2008-3#6)
Zeeman-effect background correction##3##3##(2008-10#3)
Zeeman-effect background##4##2##(2008-10#4)
Zeiss##2##1##(2008-1#1)(2010-1#1)
Zempoala National Park##2##3##(2008-5#2)
Zenith##2##1##(2008-10#1)(2008-2#1)
Zeon##2##1##(1995-8#1)(2010-8#1)
Zeon-1##3##1##(1995-8#3)
Zernike modes##2##2##(2008-3#2)
Zernike polynomial modes##2##3##(2008-3#2)
Zernike polynomial##3##2##(2008-3#3)
Zernike polynomials for##2##3##(2008-3#2)
Zernike polynomials to##2##3##(2008-3#2)
Zernike polynomials##9##2##(2008-2#1)(2008-3#8)
Zernike##21##1##(2007-12#2)(2008-2#4)(2008-3#15)
Zero##2##1##(2008-11#1)(2013-1#1)
Zero-##2##1##(2007-11#1)(2011-2#1)
Zerodur substrates##2##2##(2008-3#2)
Zerodur##4##1##(2008-3#4)
Zeus##5##1##(2007-8#3)(2008-6#1)(2011-2#1)
Zfx genes##2##2##(2008-8#2)
Zhan##2##1##(2008-10#2)
Zhang et al##2##3##(2009-5#1)(2012-3#1)
Zhang##3##1##(2008-10#1)(2009-5#1)(2012-3#1)
Zhejiang Province##3##2##(2008-10#2)(2008-9#1)
Zhejiang##10##1##(2008-10#2)(2008-9#2)(2011-1#5)(2013-1#1)
Zhenjiang City##2##2##(2012-3#2)
Zhi et al##2##3##(2011-2#1)(2012-3#1)
Zhuang##3##1##(1995-6#2)(2008-9#1)
Zidovudine##2##1##(1991-11#1)(2012-12#1)
Ziehl-Neelsen##3##1##(1996-12#1)(2012-12#1)(2013-8#1)
Zimbabwe##10##1##(1996-12#1)(1996-3#1)(1997-6#2)(2008-10#1)(2008-11#1)(2011-1#3)(2013-1#1)
Zimowski##2##1##(2007-9#2)
Zinc and##3##2##(1994-6#1)(2008-10#1)(2012-2#1)
Zinc fingers##2##2##(1992-8#1)(1993-2#1)
Zinc ion##2##2##(2008-10#2)
Zinc is an essential##2##4##(2008-10#1)(2013-8#1)
Zinc is##4##2##(2008-10#2)(2013-7#1)(2013-8#1)
Zinc was##3##2##(2008-10#2)(2008-11#1)
Zinc##38##1##(1992-3#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-6#2)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
Zinc(II)##2##1##(1997-7#1)(2008-10#1)
Zincon##3##1##(2008-10#3)
Zineb in##4##2##(2008-10#4)
Zineb##7##1##(2008-10#7)
Zingel asper##3##2##(2010-8#3)
Zip##2##1##(2008-10#2)
Zip4##2##1##(2008-10#2)
Ziprasidone##2##1##(2008-6#2)
Ziram and Zineb##5##3##(2008-10#5)
Ziram and##6##2##(2008-10#6)
Ziram##10##1##(2008-10#10)
Zirconia implants##2##2##(2009-8#2)
Zirconia-based ceramics have##2##3##(2009-8#2)
Zirconium##2##1##(2008-10#1)(2008-6#1)
Zitazonium##2##1##(1993-2#2)
ZmPR-10##2##1##(2008-10#2)
Zmspds2##3##1##(2009-8#3)
Zn alpha 2gp##3##3##(1994-6#3)
Zn and Cd##3##3##(1993-12#1)(2008-10#2)
Zn and Cu##7##3##(1997-4#5)(2008-10#2)
Zn and Cu)##2##3##(2008-10#2)
Zn and Ni##2##3##(2008-10#2)
Zn and Pb##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
Zn and##28##2##(1993-12#1)(1997-4#7)(2008-10#16)(2008-5#2)(2010-2#1)(2011-2#1)
Zn by##5##2##(2008-10#5)
Zn complexes##3##2##(2008-10#3)
Zn concentration and##3##3##(1994-10#1)(2010-2#1)(2013-8#1)
Zn concentration##4##2##(1994-10#1)(2008-10#1)(2010-2#1)(2013-8#1)
Zn concentrations were##2##3##(1997-4#1)(2008-10#1)
Zn concentrations##4##2##(1997-4#2)(2008-10#2)
Zn content was##2##3##(2008-10#1)(2008-5#1)
Zn content##6##2##(2008-10#4)(2008-5#1)(2012-2#1)
Zn deficiency##2##2##(2008-12#1)(2013-8#1)
Zn determination##3##2##(2008-10#3)
Zn did not##2##3##(2008-10#1)(2010-2#1)
Zn for##2##2##(2012-2#2)
Zn homeostasis##2##2##(2010-11#1)(2012-2#1)
Zn in each##2##3##(2008-10#1)(2012-2#1)
Zn in##23##2##(2008-10#19)(2010-2#1)(2012-2#2)(2013-8#1)
Zn ions##2##2##(2008-10#1)(2013-7#1)
Zn is##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
Zn levels were found##2##4##(2008-10#1)(2011-2#1)
Zn levels were##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
Zn levels##6##2##(1997-4#1)(2008-10#2)(2008-5#2)(2011-2#1)
Zn metabolism##3##2##(2012-2#3)
Zn species##2##2##(2008-10#2)
Zn superoxide dismutase##5##3##(1990-12#2)(1991-12#2)(2008-10#1)
Zn than the##2##3##(1997-4#1)(2010-2#1)
Zn to##2##2##(2008-10#1)(2010-11#1)
Zn was found##2##3##(2008-12#1)(2010-11#1)
Zn was##5##2##(2008-10#3)(2008-12#1)(2010-11#1)
Zn##304##1##(1990-12#2)(1991-12#2)(1993-12#8)(1993-2#2)(1994-10#1)(1994-6#3)(1995-3#2)(1997-4#17)(2008-10#189)(2008-11#2)(2008-12#5)(2008-5#10)(2009-11#1)(2010-11#6)(2010-2#11)(2010-5#3)(2011-2#3)(2012-12#3)(2012-2#17)(2013-1#1)(2013-7#1)(2013-8#15)
Zn(1)##2##1##(1997-7#2)
Zn(1)(i)##2##1##(1997-7#2)
Zn(2+) and Cd(2+)##3##3##(2008-10#3)
Zn(2+) and Mn(2+)##3##3##(2008-10#2)(2012-12#1)
Zn(2+) and##10##2##(2008-10#9)(2012-12#1)
Zn(2+) based on the##2##4##(2008-10#2)
Zn(2+) concentration##2##2##(2008-10#2)
Zn(2+) for##2##2##(2010-11#1)(2012-12#1)
Zn(2+) in##5##2##(2008-10#5)
Zn(2+) ions##2##2##(2008-10#2)
Zn(2+) on the##2##3##(2008-10#2)
Zn(2+) or##2##2##(2008-10#1)(2012-12#1)
Zn(2+) sensitivity of the T(in)##2##5##(2008-4#2)
Zn(2+) sensitivity##3##2##(2008-4#3)
Zn(2+)##76##1##(2008-10#60)(2008-4#3)(2008-5#3)(2010-11#2)(2011-2#1)(2012-12#6)(2012-2#1)
Zn(2+)-binding region##2##2##(1993-6#1)(1995-8#1)
Zn(II) and 0##2##3##(2008-10#2)
Zn(II) and Cd(II)##4##3##(2008-10#2)(2008-5#2)
Zn(II) and Pb(II) were##2##4##(2008-10#2)
Zn(II) and Pb(II)##7##3##(2008-10#7)
Zn(II) and##20##2##(2008-10#17)(2008-5#2)(2010-11#1)
Zn(II) has been##2##3##(2008-10#2)
Zn(II) in the##2##3##(1995-5#1)(2008-10#1)
Zn(II) in##7##2##(1995-5#1)(2008-10#5)(2010-11#1)
Zn(II) ions##4##2##(1992-3#2)(2008-10#2)
Zn(II) preconcentration##3##2##(2008-10#3)
Zn(II) was##2##2##(2008-10#2)
Zn(II) were found to be##2##5##(2008-10#2)
Zn(II) were##4##2##(2008-10#4)
Zn(II)##102##1##(1992-3#7)(1992-9#1)(1995-5#1)(2008-10#88)(2008-5#2)(2009-12#1)(2010-11#2)
Zn(ii)-NA##3##1##(2010-11#3)
Zn) in##4##2##(2008-10#4)
Zn)##14##1##(2008-10#14)
Zn+2 is##2##2##(1991-2#2)
Zn+2##6##1##(1991-2#6)
Zn-SOD and catalase##3##3##(1995-6#3)
Zn-SOD and##5##2##(1995-6#3)(1997-8#2)
Zn-SOD by H2O2##2##3##(1997-8#2)
Zn-SOD was##4##2##(1997-2#3)(1997-8#1)
Zn-SOD##13##1##(1995-6#3)(1997-2#4)(1997-8#6)
Zn-alpha 2-glycoprotein##2##2##(1994-6#2)
Zn-metallothioneins##5##1##(2008-10#5)
Zn-superoxide dismutase (SOD)##2##3##(1997-2#1)(1997-8#1)
Zn-superoxide dismutase##5##2##(1997-2#2)(1997-8#2)(2008-10#1)
Zn2+ from the enzyme##2##4##(1992-11#1)(1997-4#1)
Zn2+ ion##2##2##(1995-8#1)(1997-4#1)
Zn2+ ions##4##2##(1992-11#1)(1997-4#3)
Zn2+##27##1##(1991-5#1)(1992-11#5)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#3)(1995-8#1)(1997-4#12)(1997-7#1)(2013-8#1)
Zn2+-reconstituted RNApolII##2##2##(1997-4#2)
ZnCl2##2##1##(1991-9#1)(1995-6#1)
ZnGeP(2)##6##1##(2007-11#2)(2007-12#2)(2008-2#2)
ZnGeP2##2##1##(2008-3#2)
ZnL##2##1##(2008-10#2)
ZnO NCs##2##2##(2009-7#2)
ZnO and##2##2##(2008-10#1)(2008-5#1)
ZnO film##2##2##(2009-5#2)
ZnO nanocrystals##2##2##(2008-10#1)(2009-7#1)
ZnO thin films##2##3##(2008-10#2)
ZnO was##5##2##(2008-5#1)(2009-8#4)
ZnO##34##1##(2007-11#2)(2008-10#10)(2008-5#4)(2008-7#1)(2009-5#4)(2009-7#3)(2009-8#7)(2010-4#2)(2010-7#1)
ZnO/chitosan composite##4##2##(2008-10#4)
ZnPTO shampoo##4##2##(2008-5#4)
ZnPTO##6##1##(2008-5#6)
ZnPc##4##1##(1994-12#4)
ZnPc-binding##2##1##(1994-12#2)
ZnS QDs##2##2##(2008-10#2)
ZnS and Cr(2+)##3##3##(2007-11#3)
ZnS and##5##2##(2007-11#4)(2008-3#1)
ZnS laser##3##2##(2007-11#3)
ZnS##20##1##(2007-11#10)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)
ZnS/MgF(2)##2##1##(2008-3#2)
ZnSO(4) in##2##2##(2008-10#2)
ZnSO(4)##8##1##(2008-10#8)
ZnSO₄##3##1##(2010-11#3)
ZnSe and##2##2##(2007-11#2)
ZnSe crystal##2##2##(2007-11#2)
ZnSe laser##3##2##(2007-11#1)(2007-12#2)
ZnSe saturable absorber##2##3##(2008-3#2)
ZnSe##19##1##(2007-11#11)(2007-12#5)(2008-3#3)
ZnT4##7##1##(2008-10#7)
ZnTCP##7##1##(2008-5#7)
ZnTe##2##1##(2007-12#1)(2008-2#1)
ZnxTe films##2##2##(2013-8#2)
ZnxTe##3##1##(2013-8#3)
Zoledronic Acid##3##2##(2007-11#2)(2010-9#1)
Zoledronic acid##2##2##(2008-7#1)(2013-1#1)
Zoledronic##5##1##(2007-11#2)(2008-7#1)(2010-9#1)(2013-1#1)
Zoll M##2##2##(2010-9#2)
Zollinger-Ellison syndrome and##2##3##(1997-1#2)
Zonal##3##1##(2009-12#1)(2011-1#1)(2012-12#1)
Zone Diet##3##2##(2008-3#3)
Zone of Maximal Protection##3##4##(2008-7#3)
Zone##24##1##(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#9)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
Zones of##3##2##(2008-10#2)(2008-5#1)
Zoo Biol 27##8##3##(2009-4#8)
Zoo##13##1##(1996-12#3)(1997-6#1)(2008-5#1)(2009-4#8)
Zooplankton##2##1##(2010-12#1)(2013-1#1)
Zoospore##2##1##(2008-10#2)
Zoospores##2##1##(2008-10#2)
Zorbax##6##1##(2008-10#5)(2011-1#1)
Zr in##2##2##(2008-10#2)
Zr is##2##2##(2008-10#2)
Zr was##2##2##(2008-10#2)
Zr##31##1##(1997-7#2)(2008-10#24)(2008-12#1)(2008-3#1)(2009-7#3)
Zr(IV) and Hf(IV)##6##3##(2008-10#6)
Zr(IV) porphyrins##3##2##(2008-10#2)(2010-6#1)
Zr(IV)##19##1##(2008-10#16)(2010-6#3)
Zr-Ir##2##1##(2008-10#2)
Zr-WO(x) clusters##2##2##(2010-12#2)
Zr-coating##2##1##(2008-10#2)
ZrO(2) gel films were##2##4##(2008-3#2)
ZrO(2)##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
ZrO2##4##1##(2008-3#1)(2008-5#2)(2010-12#1)
ZrP##2##1##(2008-6#2)
Zucc##2##1##(2008-5#2)
Zucchi##4##1##(2008-6#4)
Zucchini green mottle mosaic virus##2##5##(2008-10#2)
Zucchini yellow mosaic virus (ZYMV##2##5##(2008-10#2)
Zucchini yellow mosaic virus (ZYMV)##3##5##(2008-10#3)
Zucchini yellow mosaic virus##8##4##(2008-10#8)
Zucchini##12##1##(2008-10#12)
Zucker diabetic fatty (ZDF) rats##2##5##(2008-4#1)(2012-1#1)
Zucker diabetic fatty##3##3##(2008-4#2)(2012-1#1)
Zucker obese##2##2##(1994-11#1)(2011-2#1)
Zucker rat##2##2##(1996-12#2)
Zucker rats##8##2##(1994-11#1)(1995-5#4)(1996-12#3)
Zucker##17##1##(1994-11#3)(1995-5#4)(1996-12#5)(2008-4#2)(2011-2#1)(2012-1#2)
Zulia##3##1##(2008-9#1)(2011-2#1)(2012-12#1)
Zung-score##2##1##(2008-7#2)
Zurich and##2##2##(1996-11#1)(2013-1#1)
Zurich##12##1##(1995-5#1)(1996-11#9)(2011-2#1)(2013-1#1)
Zusanli##2##1##(2010-7#2)
Zyginidia scutellaris##2##2##(2011-2#2)
Zygo Pegasus 2000##2##3##(2008-3#2)
Zymark BenchMate##2##2##(2008-10#2)
Zymark##7##1##(2008-10#7)
Zymark's##3##1##(2008-10#3)
Zymate##2##1##(2008-10#2)
Zymography##4##1##(2008-4#2)(2012-2#2)
Zymomonas mobilis and##2##3##(1995-3#1)(2008-6#1)
Zymomonas mobilis under certain operating conditions##2##6##(2008-7#2)
Zymomonas mobilis##20##2##(1995-3#1)(2008-6#12)(2008-7#4)(2009-5#2)(2011-2#1)
Zymomonas##25##1##(1995-3#1)(2008-6#17)(2008-7#4)(2009-5#2)(2011-2#1)
Zymosan##3##1##(1994-6#1)(2008-12#1)(2008-8#1)
[ p##2##2##(2009-3#2)
[##9##1##(1992-6#1)(1997-2#1)(1997-7#2)(2008-8#1)(2009-3#2)(2009-7#1)(2012-12#1)
[&quot##18##1##(1991-2#1)(1991-6#1)(1992-5#1)(1993-11#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-6#1)(2013-1#1)
[(##5##1##(1990-5#1)(1990-7#1)(1991-12#2)(1991-6#1)
[(11)C]raclopride##2##1##(2013-8#2)
[(123)I]MIBG##3##1##(2008-11#1)(2008-7#2)
[(131)I]MIBG##2##1##(2008-7#2)
[(18)F]-fluorodeoxyglucose incorporation##6##2##(2008-11#6)
[(18)F]-fluorodeoxyglucose##8##1##(2008-11#8)
[(3)H]##2##1##(2008-11#1)(2008-8#1)
[(3)H]-thymidine##2##1##(2008-5#1)(2010-3#1)
[(3)H]5-HT##3##1##(2008-7#3)
[(3)H]thymidine##3##1##(2008-11#1)(2008-4#2)
[(35)S]methionine##2##1##(2008-11#1)(2008-4#1)
[(TPP)Ru(NO)(H(2)O)]BF(4)##2##1##(1996-2#2)
[(TPP)Ru(NO)(py)](+)##3##1##(1996-2#3)
[(triisopropylsilyl)oxy]methyl##3##1##(2008-4#3)
[0##16##1##(1990-2#1)(1990-3#3)(1991-8#2)(2008-10#2)(2008-3#2)(2012-2#2)(2012-3#1)(2013-1#3)
[1##37##1##(1990-3#2)(1990-7#1)(1991-3#2)(1992-11#4)(1992-12#1)(1995-12#1)(1995-2#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2011-2#7)(2012-2#1)(2013-1#1)(2013-8#1)
[1-(2-pyridylazo)-2-naphthol]-naphthalene adsorbent##2##2##(2008-10#2)
[1-14C]pyruvate##4##1##(1991-3#2)(1991-5#2)
[1-3]##2##1##(2008-10#1)(2008-4#1)
[111In-DTPA-D-Phe1]-octreotide##3##1##(1997-8#3)
[123I]iodobenzamide (IBZM)##2##2##(1996-12#2)
[125I]##5##1##(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1995-11#1)
[125I]-PSTI was incubated with##2##4##(1990-12#2)
[125I]CGP 42112A##2##2##(1991-12#2)
[125I]D-Trp6-LH-RH##3##1##(1993-1#3)
[125I]ET-1##6##1##(1995-11#6)
[125I]IGF-II##3##1##(1992-3#3)
[125I]IL-8##4##1##(1993-6#4)
[125I]Sar1-angiotensin II binding##2##3##(1991-9#1)(1996-5#1)
[125I]T-98 was##2##2##(1993-1#2)
[125I]T-98##5##1##(1993-1#5)
[125I]VIP##2##1##(1994-3#2)
[125I]VPF##2##1##(1991-2#2)
[125I]apoprotein##2##1##(1992-3#2)
[125I]iodocyanopindolol##2##1##(1993-12#1)(1995-12#1)
[125I]iodomelatonin##2##1##(1990-7#2)
[125I]omega-CTX-MVIIC##2##1##(1993-11#2)
[125I]omega-CgTx##3##1##(1993-9#3)
[125I]thyroxine glucuronide##2##2##(1991-5#2)
[125I]thyroxine##7##1##(1991-5#3)(1993-12#4)
[125]OP-1 binding to TE85##2##4##(1994-6#2)
[125]OP-1 binding to##3##3##(1994-6#3)
[125]OP-1##4##1##(1994-6#4)
[13C]##2##1##(1995-2#2)
[13C]formate##2##1##(1992-10#2)
[14-38]Abu is##2##2##(1997-2#2)
[14-38]Abu##3##1##(1997-2#3)
[14C]##5##1##(1990-12#1)(1991-12#2)(1991-3#1)(1991-9#1)
[14C]-5-HT##3##1##(1992-11#3)
[14C]-GM3##2##1##(1992-12#2)
[14C]-cholesterol##2##1##(1994-11#2)
[14C]-labeled##3##1##(1991-12#1)(1992-9#1)(2008-11#1)
[14C]4HA##2##1##(1995-6#2)
[14C]TCDD##3##1##(1994-5#3)
[14C]aminopyrine accumulation##5##2##(1995-12#5)
[14C]carboxyphospho-enzyme complex##2##2##(1993-11#2)
[14C]isopentenol##2##1##(1991-12#2)
[14C]oxalacetate##5##1##(1993-11#5)
[16-14C]ARM##2##1##(1994-8#2)
[174944]##2##1##(2008-5#2)
[180367]##3##1##(2008-5#3)
[182809]##3##1##(2008-5#3)
[18]##2##1##(2013-8#2)
[198694]##2##1##(2008-5#2)
[1]##22##1##(1993-6#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#5)(2013-1#1)
[2 new##2##2##(1990-6#1)(1995-12#1)
[2 patients with##2##3##(1992-2#1)(1995-12#1)
[2##28##1##(1990-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-4#1)(2010-4#1)(2011-2#3)(2012-12#1)
[2+2] cycloaddition##2##2##(2007-11#1)(2009-5#1)
[2-(4-##3##1##(1991-8#3)
[2-13C]glycine and##2##2##(1992-10#2)
[223964]##2##1##(2008-5#2)
[22]##2##1##(2012-3#1)(2013-8#1)
[24-hour##2##1##(1990-11#1)(1992-2#1)
[243679]##2##1##(2008-5#2)
[260590]##2##1##(2008-5#2)
[260592]##2##1##(2008-5#2)
[264164]##2##1##(2008-5#2)
[265945]##3##1##(2008-5#3)
[272442]##2##1##(2008-5#2)
[272638]##2##1##(2008-5#2)
[275844]##3##1##(2008-5#3)
[275922]##2##1##(2008-5#2)
[276895]##2##1##(2008-5#2)
[282257]##6##1##(2008-5#6)
[284325]##2##1##(2008-5#2)
[287131]##2##1##(2008-5#2)
[293193]##2##1##(2008-5#2)
[2]##6##1##(1993-6#1)(1994-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
[2]rotaxane##4##1##(2007-11#3)(2010-12#1)
[3 +##2##2##(1996-5#1)(2012-3#1)
[3##8##1##(1996-5#1)(2007-11#1)(2008-5#1)(2012-2#1)(2012-3#2)(2013-8#2)
[3+2]##3##1##(2008-7#1)(2009-11#2)
[3-13C]serine##3##1##(1992-10#3)
[32P]##3##1##(1991-12#1)(1992-9#1)(1994-8#1)
[32P]-labeled cells##2##2##(1993-11#2)
[32P]RII##2##1##(1995-11#2)
[32P]phosphate content##2##2##(1990-10#1)(1990-11#1)
[32P]phosphate##3##1##(1990-10#1)(1990-11#2)
[35S]-sulfate##3##1##(1992-12#1)(1994-9#1)(2008-4#1)
[35S]ATP-alpha-S##2##1##(1991-8#2)
[35S]GTP gamma S binding##5##4##(1996-2#5)
[35S]methionine##2##1##(1992-12#1)(1996-2#1)
[35S]methionine-labeled##2##1##(1993-2#1)(1996-2#1)
[35S]sulfate##2##1##(1992-1#1)(1993-12#1)
[3H] uridine##2##2##(1992-11#2)
[3H]##10##1##(1990-12#2)(1991-12#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-12#1)(1994-8#1)(1996-5#1)
[3H]-GM1##2##1##(1992-12#2)
[3H]-staurosporine##6##1##(1990-8#6)
[3H]-thymidine incorporation into DNA of##2##5##(1991-12#2)
[3H]-thymidine incorporation into##3##3##(1991-12#2)(1993-6#1)
[3H]-thymidine incorporation##4##2##(1991-12#3)(1993-6#1)
[3H]-thymidine##8##1##(1991-12#4)(1993-6#2)(1997-7#1)(2008-9#1)
[3H]5##2##1##(1995-11#2)
[3H]5-HT release from##2##3##(1992-7#1)(1995-12#1)
[3H]5-HT release in##4##3##(1995-12#4)
[3H]5-HT release##6##2##(1992-7#1)(1995-12#5)
[3H]5-HT was##2##2##(1994-2#1)(1995-12#1)
[3H]5-HT##15##1##(1992-7#1)(1994-2#6)(1995-12#8)
[3H]ACPC binding were##2##3##(1995-11#2)
[3H]ACPC##6##1##(1995-11#6)
[3H]AMPA binding in##2##3##(1996-5#2)
[3H]AMPA binding##4##2##(1996-5#4)
[3H]CGP39653##2##1##(1996-2#2)
[3H]DHT##3##1##(1990-11#3)
[3H]GABA##2##1##(1993-12#1)(1994-2#1)
[3H]GBR 12935##3##2##(1996-2#3)
[3H]Ins1##5##1##(1993-6#5)
[3H]NE release##3##2##(1992-3#3)
[3H]NE##4##1##(1992-3#4)
[3H]R1881##3##1##(1990-11#3)
[3H]RX821002##2##1##(1997-7#2)
[3H]Ro 15-4513 binding sites##2##4##(1992-3#2)
[3H]Ro 15-4513 binding##3##3##(1992-3#3)
[3H]Ro 15-4513##4##2##(1992-3#4)
[3H]SR 48968##4##2##(1993-3#4)
[3H]SR141716A##3##1##(1996-2#3)
[3H]T##3##1##(1990-11#3)
[3H]arachidonic acid-labelled##2##2##(1994-3#2)
[3H]arachidonic##3##1##(1994-3#2)(1997-1#1)
[3H]cholesteryl ester##2##2##(1992-3#2)
[3H]choline##4##1##(1990-12#1)(1991-2#1)(1991-5#1)(1997-2#1)
[3H]dextrorphan binding##4##2##(1990-7#4)
[3H]dextrorphan##5##1##(1990-7#5)
[3H]dichlorokynurenic acid##2##2##(1996-2#2)
[3H]dizocilpine binding##2##2##(1996-2#2)
[3H]dizocilpine##3##1##(1996-2#3)
[3H]dopamine and [14C]acetylcholine release##2##4##(1995-12#2)
[3H]dopamine release##2##2##(1995-12#2)
[3H]dopamine uptake##2##2##(1996-2#2)
[3H]dopamine##6##1##(1995-12#4)(1996-2#2)
[3H]flunitrazepam binding##4##2##(1994-2#1)(1996-2#3)
[3H]flunitrazepam##6##1##(1994-2#1)(1996-2#5)
[3H]folate##2##1##(1992-3#2)
[3H]glucosamine##2##1##(1990-5#1)(1994-6#1)
[3H]glycerol##3##1##(1990-12#1)(1994-5#2)
[3H]glycine##2##1##(1995-11#2)
[3H]idazoxan binding##2##2##(1996-5#2)
[3H]idazoxan##3##1##(1996-5#3)
[3H]imipramine binding##5##2##(1990-5#4)(1996-7#1)
[3H]inositol##4##1##(1991-12#1)(1993-6#1)(1997-1#2)
[3H]inositol-prelabeled##2##1##(1993-6#2)
[3H]leucine##4##1##(1993-12#3)(1994-8#1)
[3H]leukotriene D4##2##2##(1993-6#2)
[3H]leukotriene D4-specific binding##3##3##(1993-6#3)
[3H]leukotriene##5##1##(1993-6#5)
[3H]mepyramine##3##1##(1992-11#3)
[3H]naloxone##2##1##(1991-5#1)(1992-5#1)
[3H]paroxetine binding##3##2##(1996-5#3)
[3H]paroxetine##5##1##(1996-5#5)
[3H]prazosin and##2##2##(1991-6#2)
[3H]prazosin binding to##2##3##(1991-6#1)(1993-12#1)
[3H]prazosin##6##1##(1991-6#5)(1993-12#1)
[3H]quinuclidinyl benzilate##2##2##(1990-5#1)(1995-11#1)
[3H]raclopride##2##1##(1993-9#1)(1995-12#1)
[3H]thymidine incorporation and##2##3##(1991-12#1)(1991-5#1)
[3H]thymidine incorporation##7##2##(1991-12#1)(1991-5#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#1)
[3H]thymidine##21##1##(1991-12#3)(1991-5#1)(1992-3#1)(1993-11#1)(1994-3#1)(1995-12#2)(1995-2#3)(1996-12#2)(1996-5#4)(1997-1#2)(2008-4#1)
[3]##4##1##(1993-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
[4 + 2] cycloaddition##2##4##(1996-5#2)
[4##14##1##(1993-6#1)(1996-5#8)(1997-7#1)(2008-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
[4-14C]cholesterol##2##1##(1994-8#1)(1995-12#1)
[4Fe-4S]##2##1##(1993-8#2)
[4]##6##1##(2008-10#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
[5##6##1##(1990-7#1)(1994-6#1)(1997-8#1)(2009-8#3)
[57Co]Cbl##5##1##(1990-11#3)(1991-12#2)
[5]##2##1##(2008-4#1)(2008-5#1)
[6##4##1##(1991-5#1)(1992-3#1)(1993-9#1)(2008-3#1)
[6]##4##1##(2008-10#1)(2008-4#1)(2009-12#1)(2009-4#1)
[7##3##1##(1990-9#1)(1996-2#1)(2008-4#1)
[70##2##1##(1994-2#1)(2009-3#1)
[7]##5##1##(1994-3#1)(2008-4#1)(2009-12#1)(2009-4#1)(2012-2#1)
[8]##4##1##(1991-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
[9##2##1##(1997-7#1)(2009-8#1)
[95% CI##7##2##(2007-8#2)(2008-8#2)(2011-2#2)(2012-2#1)
[95% CI]##3##2##(2010-3#1)(2012-2#2)
[95% confidence interval 0##2##4##(1991-8#2)
[95% confidence interval##5##3##(1991-8#2)(2010-4#1)(2012-3#1)(2013-1#1)
[95%##15##1##(1991-8#2)(2007-8#2)(2008-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
[9]##2##1##(2008-4#1)(2010-5#1)
[9]mercuracarborand-3##2##1##(2008-10#2)
[A case from practice##3##4##(1992-6#1)(1993-8#1)(1994-5#1)
[A case of pulmonary##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
[A case of severe##2##4##(1991-11#1)(1991-6#1)
[A case of##15##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-9#1)(1993-2#1)(1996-11#2)(2008-1#2)(2008-10#1)(2008-11#2)(2012-2#1)(2013-8#1)
[A case report of##3##4##(2008-10#1)(2011-3#1)(2012-12#1)
[A case study of##3##4##(1990-12#1)(1990-2#1)(1991-2#1)
[A case##24##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-11#2)(2008-1#2)(2008-10#2)(2008-11#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
[A comparison##2##2##(1997-4#1)(2011-1#1)
[A critical##3##2##(1993-6#1)(1995-8#1)(2011-2#1)
[A health##3##2##(1990-6#1)(1992-5#1)(1996-2#1)
[A meta-analysis##2##2##(2008-9#1)(2013-8#1)
[A new species of fern##2##5##(2008-5#2)
[A new species of##4##4##(2008-5#3)(2013-7#1)
[A new##12##2##(1991-9#1)(1992-9#1)(1993-9#1)(1995-5#1)(2008-5#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
[A patient with##2##3##(1996-9#1)(1997-3#1)
[A pilot study of##2##4##(1990-2#1)(2009-8#1)
[A rare case of##3##4##(1992-5#1)(1992-6#1)(2008-10#1)
[A rare##5##2##(1992-5#1)(1992-6#1)(2008-10#1)(2009-5#1)(2012-2#1)
[A re-evaluation of the##2##4##(1993-11#1)(1993-2#1)
[A study on the##4##4##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)
[A study on##6##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-9#1)(2008-10#1)
[A study##8##2##(1990-10#2)(1990-12#1)(1990-2#1)(1991-2#1)(1992-9#1)(2008-10#1)(2012-2#1)
[A##147##1##(1990-10#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#4)(1991-11#2)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-5#3)(1992-6#2)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#3)(1995-8#3)(1996-11#4)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#1)(1997-8#1)(2006-8#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#5)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#8)
[ACE-inhibitors##2##1##(1990-2#1)(1996-9#1)
[AIDS and##3##2##(1991-5#1)(1991-6#1)(1996-3#1)
[AIDS in##2##2##(1991-6#1)(1993-8#1)
[AIDS##8##1##(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1993-8#1)(1996-3#1)(1996-8#1)
[Abdominal##5##1##(1990-9#1)(1992-6#1)(1993-3#1)(1993-5#1)(2008-10#1)
[About##3##1##(1995-11#1)(1996-10#1)(2012-3#1)
[Abstracts##2##1##(2010-1#1)(2010-3#1)
[Abundance##2##1##(2008-5#1)(2011-2#1)
[Ac-D(2)-Nal1##2##1##(1994-8#2)
[Acetylsalicylic acid##3##2##(1990-9#1)(1994-6#1)(1995-11#1)
[Activity of##3##2##(1991-3#1)(2008-5#1)(2008-7#1)
[Acute pancreatitis##2##2##(1990-9#1)(1992-4#1)
[Acute respiratory##3##2##(1997-3#1)(2009-5#1)(2011-2#1)
[Acute##37##1##(1990-2#1)(1990-9#3)(1991-6#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
[Adenosine##2##1##(2008-1#1)(2013-1#1)
[Adherence to##2##2##(2011-1#1)(2013-8#1)
[Adhesion##2##1##(1990-2#1)(1997-3#1)
[Adjuvant##3##1##(1991-9#1)(1993-2#1)(1997-8#1)
[Adolescents##2##1##(1996-6#1)(2008-9#1)
[Adult##4##1##(1991-9#1)(1992-2#1)(1994-2#1)(2007-8#1)
[Adult-onset##2##1##(1995-11#1)(1996-11#1)
[Advances in the study of##2##5##(2011-3#2)
[Advances in##7##2##(2010-8#1)(2011-3#3)(2012-2#2)(2013-8#1)
[Advances##8##1##(2010-8#2)(2011-3#3)(2012-2#2)(2013-8#1)
[Adverse events##2##2##(2011-2#1)(2012-3#1)
[Adverse reactions to drugs##2##4##(1993-10#1)(1994-9#1)
[Adverse reactions to##3##3##(1993-10#1)(1994-9#1)(2011-1#1)
[Adverse reactions##4##2##(1993-10#1)(1994-9#1)(1996-6#1)(2011-1#1)
[Adverse##6##1##(1993-10#1)(1994-9#1)(1996-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
[After##3##1##(1994-5#1)(2008-4#1)(2012-3#1)
[Age##3##1##(1990-11#1)(2013-1#2)
[Air##2##1##(1993-3#1)(1997-6#1)
[Alarming##2##1##(1994-12#1)(1996-3#1)
[Alcohol and##4##2##(1990-6#1)(1994-2#1)(1995-5#1)(1996-8#1)
[Alcohol consumption##2##2##(1994-5#1)(1997-6#1)
[Alcohol##9##1##(1990-6#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-6#1)(2013-1#1)
[Allergy##2##1##(1993-3#1)(1993-6#1)
[Alpha##3##1##(1990-9#1)(1993-2#2)
[Alveolar##2##1##(2008-7#1)(2013-1#1)
[Ambulatory care##2##2##(1993-3#1)(1996-2#1)
[Ambulatory##4##1##(1991-3#1)(1993-3#1)(1994-3#1)(1996-2#1)
[Amyloidosis##2##1##(1990-3#1)(2008-10#1)
[An analysis of the##7##4##(1990-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1997-5#1)(2013-8#1)
[An analysis of##9##3##(1990-9#1)(1991-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1997-5#1)(2012-2#1)(2013-8#1)
[An epidemiological##2##2##(1994-6#1)(1995-3#1)
[An evaluation of##3##3##(1993-11#1)(1993-5#1)(1994-6#1)
[An overview##2##2##(2011-2#1)(2013-8#1)
[An##44##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-2#1)(1993-3#3)(1993-5#4)(1993-6#1)(1993-9#2)(1994-6#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
[Analysis of the##7##3##(1994-5#1)(2011-2#1)(2012-2#1)(2012-3#4)
[Analysis of##34##2##(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-9#2)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#9)(2013-1#3)(2013-8#3)
[Analysis##36##1##(1993-9#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-9#2)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#9)(2013-1#4)(2013-8#3)
[Analyze##2##1##(2012-3#2)
[Anaphylactic##2##1##(1992-11#1)(1993-2#1)
[Anaplastic large cell lymphoma##2##4##(1997-3#1)(2011-2#1)
[Anesthesia##2##1##(1990-10#1)(2010-8#1)
[Antibiotic prophylaxis##2##2##(1991-3#1)(1992-6#1)
[Antibiotic##3##1##(1991-3#1)(1992-6#2)
[Anticoagulant therapy and##2##3##(1990-9#1)(2008-10#1)
[Antifungal##2##1##(2008-5#2)
[Antimicrobial susceptibility of##2##3##(2012-12#1)(2013-8#1)
[Antimicrobial##3##1##(1990-2#1)(2012-12#1)(2013-8#1)
[Antiphospholipid antibodies##2##2##(1996-6#1)(2008-7#1)
[Anxiety##3##1##(1992-11#1)(1993-3#1)(1996-11#1)
[Aortic valve##2##2##(1992-5#1)(1997-5#1)
[Apo E##2##2##(1996-11#1)(1997-5#1)
[Appl##67##1##(2008-2#20)(2008-3#47)
[Application of the##3##3##(1997-8#1)(2008-7#1)(2013-8#1)
[Application of##9##2##(1990-5#1)(1997-8#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
[Are##6##1##(1993-11#1)(1993-6#1)(1994-6#1)(1995-8#1)(2009-5#1)(2013-8#1)
[Arg8]vasopressin##2##1##(1994-8#1)(1995-12#1)
[Arterial hypertension##3##2##(1991-6#1)(1992-5#1)(1995-11#1)
[Arterial##6##1##(1990-11#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-5#1)(1995-11#1)
[Artificial##2##1##(1995-2#1)(2010-8#1)
[Aspects of##2##2##(1995-5#1)(1996-11#1)
[Assessing the##3##2##(1994-3#1)(2012-12#1)(2013-1#1)
[Assessment and##4##2##(1990-10#2)(1992-6#1)(2011-2#1)
[Assessment of##9##2##(1994-5#1)(1997-3#1)(2007-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
[Assessment##14##1##(1990-10#2)(1992-6#1)(1994-5#1)(1995-5#1)(1997-3#1)(2007-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
[Assisted##2##1##(1994-3#1)(2009-10#1)
[Association between##2##2##(2011-1#1)(2013-8#1)
[Association of##6##2##(1991-11#1)(1992-5#1)(2013-1#4)
[Association##9##1##(1991-11#1)(1992-5#1)(2011-1#1)(2013-1#5)(2013-8#1)
[Asthma##3##1##(2007-6#2)(2008-4#1)
[Asylum##3##1##(1993-3#3)
[Atopic##2##1##(2011-1#1)(2012-2#1)
[Atrial##2##1##(1990-9#1)(1994-11#1)
[Attention deficit/hyperactivity##2##2##(1997-8#2)
[Attention##3##1##(1997-8#2)(2013-1#1)
[Attitude##2##1##(1994-5#1)(2007-8#1)
[Attitudes##3##1##(1993-3#1)(1997-5#1)(1997-6#1)
[Atypical##2##1##(1996-6#1)(2011-3#1)
[Au(2){(PPh(2))(2)C(2)B(9)H(10)}(2)(&amp##2##1##(1996-2#2)
[Autoimmune##2##1##(1997-5#1)(2009-5#1)
[Automated##2##1##(1990-2#1)(1990-8#1)
[Au{(PPh(2))(2)C(2)B(9)H(10)}(PPh(3))]##2##1##(1996-2#2)
[BMIM]Cl##2##1##(2013-1#2)
[Ba##3##1##(2010-8#3)
[Back pain##2##2##(1996-9#2)
[Bacterial##4##1##(1994-2#1)(2008-10#1)(2010-4#1)(2012-3#1)
[Bad##3##1##(1992-9#1)(1995-2#1)(1997-4#1)
[Bajjalieh et al##2##3##(1993-12#2)
[Barriers##2##1##(2012-2#1)(2013-1#1)
[Basic##3##1##(1994-6#1)(2011-2#1)(2013-8#1)
[Bedside##2##1##(1995-5#1)(2013-1#1)
[Behavioral##2##1##(1993-2#1)(2011-1#1)
[Benign##3##1##(1993-5#1)(2009-5#1)(2010-12#1)
[Bilateral##4##1##(1993-5#1)(1997-2#1)(1997-8#1)(2013-1#1)
[Biological and##2##2##(2008-5#2)
[Biological##6##1##(1990-2#1)(1994-9#1)(2008-5#2)(2008-8#1)(2013-1#1)
[Bladder##2##1##(2011-2#2)
[Blood pressure##2##2##(1990-8#1)(2008-4#1)
[Blood transfusion##2##2##(1990-2#1)(1996-9#1)
[Blood##7##1##(1990-2#1)(1990-8#1)(1992-3#1)(1993-11#1)(1993-2#1)(1996-9#1)(2008-4#1)
[Bone density in##2##3##(1991-11#2)
[Bone density##3##2##(1991-11#3)
[Bone##7##1##(1991-11#5)(1993-11#1)(1996-11#1)
[Brain##3##1##(1995-6#1)(1997-2#1)(2010-8#1)
[Brazilian guidelines##2##2##(2008-10#2)
[Brazilian##3##1##(2008-10#2)(2012-3#1)
[Breast feeding##2##2##(1991-11#1)(1991-2#1)
[Breast##5##1##(1991-11#1)(1991-2#1)(1993-2#1)(1996-11#1)(2007-8#1)
[Breast-preserving surgery in breast##2##4##(1991-2#2)
[Bronchial##2##1##(1990-9#1)(2007-6#1)
[Brucellosis##2##1##(1992-5#1)(1996-3#1)
[Burden##2##1##(2012-3#1)(2013-8#1)
[C##3##1##(2008-10#2)(2008-3#1)
[CI] =##3##2##(2010-10#1)(2011-2#2)
[CI]##11##1##(1993-12#1)(2006-10#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-2#3)(2012-2#1)
[Ca(2+)](i) increase##3##2##(2012-2#3)
[Ca(2+)](i)##12##1##(2008-9#5)(2009-12#2)(2012-2#5)
[Ca(2+)](o)##6##1##(2008-8#6)
[Ca++]i in##2##2##(1991-5#1)(1993-3#1)
[Ca++]i##8##1##(1991-5#4)(1993-3#4)
[Ca2+]##7##1##(1990-2#1)(1991-6#3)(1994-6#1)(1995-11#1)(1995-5#1)
[Ca2+]c by##2##2##(1991-12#1)(1995-8#1)
[Ca2+]c##9##1##(1991-12#6)(1995-8#3)
[Ca2+]i after##2##2##(1992-6#1)(1993-3#1)
[Ca2+]i and##8##2##(1990-12#2)(1990-7#2)(1994-3#1)(1994-6#1)(1997-1#1)(2008-5#1)
[Ca2+]i from##2##2##(1994-6#1)(1995-12#1)
[Ca2+]i in a concentration-dependent##2##4##(1992-6#1)(1994-6#1)
[Ca2+]i in##16##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-6#4)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-6#1)(1996-2#1)(1997-2#2)
[Ca2+]i increase with##2##3##(1996-2#2)
[Ca2+]i increase##4##2##(1990-12#1)(1996-2#3)
[Ca2+]i induced by##4##3##(1990-12#1)(1990-7#1)(1991-12#1)(1993-3#1)
[Ca2+]i rise##2##2##(1994-5#1)(1995-11#1)
[Ca2+]i was##9##2##(1991-9#1)(1992-3#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1997-1#1)
[Ca2+]i were measured##2##3##(1994-6#1)(1997-4#1)
[Ca2+]i were##4##2##(1994-6#1)(1994-9#1)(1995-11#1)(1997-4#1)
[Ca2+]i when##2##2##(1990-12#1)(1990-7#1)
[Ca2+]i##104##1##(1990-12#12)(1990-5#1)(1990-7#7)(1991-12#4)(1991-5#2)(1991-9#1)(1992-3#2)(1992-6#12)(1992-9#3)(1993-12#1)(1993-3#7)(1994-11#2)(1994-2#8)(1994-3#3)(1994-5#1)(1994-6#12)(1994-9#3)(1995-11#4)(1995-12#3)(1996-2#4)(1997-1#4)(1997-2#3)(1997-4#1)(2008-5#1)(2011-3#3)
[Ca2+]o##6##1##(1990-12#1)(1990-8#5)
[Calcium##3##1##(1990-3#1)(1990-6#1)(1990-9#1)
[Can we##2##2##(1993-2#1)(1995-8#1)
[Can##12##1##(1990-2#1)(1992-9#2)(1993-11#1)(1993-2#2)(1995-8#2)(1996-3#1)(1997-8#1)(2011-2#2)
[Cancer of##2##2##(1990-9#1)(2013-1#1)
[Cancer##6##1##(1990-9#1)(1991-6#1)(1993-3#2)(1997-5#1)(2013-1#1)
[Carcinoembryonic antigen##2##2##(1991-4#1)(1997-4#1)
[Carcinoma of the##6##3##(1990-6#3)(1992-9#1)(2006-8#1)(2011-2#1)
[Cardiac##4##1##(1991-6#1)(1993-6#1)(1997-6#1)(2008-7#1)
[Cardiopulmonary resuscitation in##2##3##(1990-9#1)(1997-3#1)
[Cardiopulmonary resuscitation##3##2##(1990-9#1)(1997-3#2)
[Cardiovascular screenings in Norwegian counties##2##5##(1991-6#2)
[Cardiovascular##8##1##(1990-10#1)(1991-6#2)(1993-10#1)(1994-11#1)(1996-6#1)(2008-10#1)(2010-12#1)
[Care for##4##2##(1991-2#1)(1993-2#1)(1997-5#1)(2012-12#1)
[Care of##2##2##(1993-3#1)(1997-5#1)
[Care##6##1##(1991-2#1)(1993-2#1)(1993-3#1)(1997-5#2)(2012-12#1)
[Case##2##1##(1990-10#1)(2013-1#1)
[Cataract surgery##2##2##(1993-3#2)
[Catheter treatment of##2##3##(1994-9#1)(1997-8#1)
[Catheter##4##1##(1994-11#1)(1994-9#1)(1996-6#1)(1997-8#1)
[Causes of death in##2##4##(1995-5#1)(1996-11#1)
[Causes of##4##2##(1995-5#1)(1996-11#1)(2009-10#2)
[Causes##5##1##(1991-3#1)(1995-5#1)(1996-11#1)(2009-10#2)
[Ca²⁺ ]i##2##2##(2013-1#2)
[Ca²⁺]i rise##4##2##(2013-1#4)
[Ca²⁺]i##5##1##(2013-1#5)
[Cell##2##1##(1991-11#1)(1994-6#1)
[Cellular##2##1##(1991-2#1)(2013-7#1)
[Center##3##1##(1990-3#1)(1995-5#1)(2008-9#1)
[Central##2##1##(1991-8#1)(2011-2#1)
[Cerebral##4##1##(1990-3#1)(1995-6#1)(1997-4#1)(2009-5#1)
[Cesarean section##2##2##(1991-6#1)(1991-9#1)
[Challenges##2##1##(2008-11#1)(2012-12#1)
[Change of##2##2##(2011-1#1)(2012-2#1)
[Change##5##1##(1995-2#1)(1996-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
[Changes in the##4##3##(1997-3#2)(2011-1#1)(2011-2#1)
[Changes in##6##2##(1997-3#2)(1997-8#2)(2011-1#1)(2011-2#1)
[Changes of##5##2##(2008-7#1)(2010-12#3)(2012-3#1)
[Changes##11##1##(1997-3#2)(1997-8#2)(2008-7#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-3#1)
[Characteristics of the##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
[Characteristics of##6##2##(1996-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
[Characteristics##7##1##(1996-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
[Characterization of the##2##3##(2012-12#1)(2013-8#1)
[Characterization of##6##2##(2008-9#2)(2012-12#1)(2013-1#1)(2013-8#2)
[Characterization##7##1##(2008-9#2)(2012-12#1)(2013-1#2)(2013-8#2)
[Chem##2##1##(2007-12#1)(2008-3#1)
[Chemical constituents from##2##3##(2012-3#1)(2013-8#1)
[Chemical##5##1##(2008-11#1)(2012-3#3)(2013-8#1)
[Chemotherapy in##2##2##(1996-3#1)(2012-3#1)
[Child##3##1##(1992-4#1)(1993-6#1)(2007-3#1)
[Childhood and juvenile ankylosing##2##4##(1993-11#2)
[Childhood##4##1##(1992-3#1)(1993-11#2)(2012-2#1)
[Children and##2##2##(1994-6#1)(2013-8#1)
[Children##6##1##(1990-12#1)(1994-6#1)(1996-10#1)(1997-2#1)(2011-2#1)(2013-8#1)
[Children's##2##1##(1990-2#1)(1995-6#1)
[Chinese##3##1##(2008-11#1)(2013-1#1)(2013-8#1)
[Cholecystectomy##2##1##(1992-3#1)(1993-9#1)
[Cholestatic##2##1##(1992-9#1)(1995-3#1)
[Chronic granulomatous disease##2##3##(1992-5#2)
[Chronic obstructive##2##2##(1991-4#1)(2011-2#1)
[Chronic##21##1##(1990-3#1)(1991-4#1)(1991-6#1)(1992-5#2)(1993-5#1)(1993-8#1)(1995-5#1)(1996-3#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
[Classification of##2##2##(1991-6#1)(2008-10#1)
[Classification##3##1##(1991-6#1)(2008-10#2)
[Clinical and laboratory##2##3##(2012-12#1)(2012-2#1)
[Clinical and therapeutic##2##3##(2009-5#1)(2012-3#1)
[Clinical and##9##2##(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
[Clinical application of##3##3##(2010-8#1)(2012-3#1)(2013-1#1)
[Clinical assessment of##2##3##(2010-6#1)(2012-3#1)
[Clinical course of##2##3##(1990-11#1)(2011-2#1)
[Clinical experience with##3##3##(1990-12#1)(1991-2#1)(2011-3#1)
[Clinical features##2##2##(2011-2#1)(2013-1#1)
[Clinical manifestations of##2##3##(1990-2#1)(1991-2#1)
[Clinical significance of##2##3##(1991-6#1)(2013-1#1)
[Clinical##55##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-5#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-6#2)(2010-8#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#8)(2013-8#2)
[Clinicopathological##2##1##(2010-8#1)(2013-8#1)
[Co(phen)3]3+##2##1##(1990-5#2)
[Cognitive##4##1##(1991-5#1)(2013-1#1)(2013-7#2)
[Combination of##3##2##(1995-5#1)(1995-6#1)(2011-1#1)
[Combination therapy##2##2##(1991-6#1)(2011-1#1)
[Combination##5##1##(1991-6#1)(1995-5#1)(1995-6#1)(2011-1#2)
[Combined##6##1##(1996-8#1)(2010-8#2)(2011-2#1)(2012-3#2)
[Coment on the original article##2##5##(2013-1#2)
[Comments on##2##2##(1997-3#1)(2007-3#1)
[Common##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
[Communication between##2##2##(1993-9#1)(1996-3#1)
[Communication##3##1##(1993-9#1)(1996-3#1)(2008-9#1)
[Comparative study of the##2##4##(2009-8#1)(2012-2#1)
[Comparative study of##5##3##(1996-11#1)(2009-1#1)(2009-8#1)(2012-2#1)(2013-8#1)
[Comparative study##6##2##(1996-11#1)(2007-10#1)(2009-1#1)(2009-8#1)(2012-2#1)(2013-8#1)
[Comparative##7##1##(1996-11#1)(2007-10#1)(2009-1#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
[Comparison of##16##2##(2006-8#1)(2007-10#2)(2007-12#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)
[Comparison##18##1##(2006-8#1)(2007-10#2)(2007-12#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
[Complex##2##1##(1997-4#1)(2011-8#1)
[Compliance to therapy in daily##3##5##(1993-11#3)
[Compliance##4##1##(1993-11#3)(2012-3#1)
[Complications of##4##2##(1990-5#1)(1995-8#1)(1996-3#1)(2011-1#1)
[Complications##6##1##(1990-5#1)(1995-8#1)(1996-3#1)(2008-11#1)(2011-1#1)(2013-8#1)
[Computer technology and##2##3##(1993-11#2)
[Computer##4##1##(1993-11#3)(1995-11#1)
[Concerning##2##1##(1993-2#1)(1993-9#1)
[Concurrent##2##1##(2012-2#1)(2013-8#1)
[Conflict of interest regarding clinical##2##5##(2011-3#2)
[Conflict of interest##4##3##(2011-3#4)
[Congenital##8##1##(1990-9#1)(1992-5#1)(1993-5#1)(1996-11#1)(1997-3#1)(2012-3#2)(2013-1#1)
[Conjugal violence##2##2##(1997-3#1)(2008-2#1)
[Consensus##4##1##(1991-11#1)(2007-3#1)(2007-6#1)(2013-1#1)
[Conservative##3##1##(1993-6#1)(1997-2#1)(2008-4#1)
[Construction and##2##2##(2011-2#1)(2013-8#1)
[Construction of##3##2##(2011-1#1)(2012-3#1)(2013-8#1)
[Construction##5##1##(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
[Contact##2##1##(1990-9#1)(1993-11#1)
[Continued##2##1##(1993-8#1)(2011-2#1)
[Continuing##3##1##(1990-5#1)(1996-8#1)(1997-8#1)
[Continuous##2##1##(1992-5#1)(1994-8#1)
[Contraception##2##1##(1996-6#1)(1997-5#1)
[Contribution of##4##2##(1990-8#1)(1991-11#1)(2007-6#1)(2010-5#1)
[Contribution to the##2##3##(2007-1#1)(2008-5#1)
[Contribution to##3##2##(2007-1#1)(2008-5#1)(2011-3#1)
[Contribution##7##1##(1990-8#1)(1991-11#1)(2007-1#1)(2007-6#1)(2008-5#1)(2010-5#1)(2011-3#1)
[Control of##7##2##(1992-6#1)(1995-11#1)(1997-2#2)(1997-6#1)(2009-10#1)(2009-5#1)
[Convulsive##2##1##(1993-2#1)(2013-1#1)
[Cooperation##2##1##(1992-11#1)(2007-1#1)
[Coordination of##2##2##(1994-9#1)(1997-3#1)
[Coronary##7##1##(1991-5#1)(1992-4#1)(1994-11#1)(1994-3#1)(2008-10#2)(2012-3#1)
[Correction of##2##2##(1990-10#1)(2013-1#1)
[Correlation between##2##2##(2011-8#1)(2013-1#1)
[Correlation of##2##2##(2012-3#1)(2013-8#1)
[Correlation study##2##2##(2013-8#2)
[Correlation##7##1##(2011-8#1)(2012-3#1)(2013-1#1)(2013-8#4)
[Correlations between##2##2##(2008-1#1)(2013-7#1)
[Cost##2##1##(1996-10#1)(1997-2#1)
[Cr(VI)]##2##1##(1994-5#2)
[Crataegus##2##1##(1992-5#1)(1996-8#1)
[Crib death##3##2##(1991-11#2)(1992-4#1)
[Crisis##2##1##(1997-4#1)(2013-1#1)
[Criteria of##2##2##(1992-4#1)(1994-11#1)
[Criteria##3##1##(1992-4#1)(1994-11#1)(1996-3#1)
[Critical##3##1##(1995-6#1)(2012-3#1)(2013-8#1)
[Cu(2)(&amp##2##1##(1997-7#2)
[Cu(2)Cl(4)(bppz)](n)() (3)##2##2##(1997-7#2)
[Cu(2)Zn(Hdmg)(2)(dmg)(2)(H(2)O)]##3##1##(1997-7#3)
[Cu(HIO(6))(2)](5-)##3##1##(2008-10#3)
[Cu(Hdmg)(dmg)](-)##3##1##(1997-7#3)
[Cu4(bpy)4(aspartate)2(H2O)3](ClO4)4##2##1##(2007-11#2)
[Cultural##2##1##(1991-12#1)(2012-12#1)
[Current possibilities in reproduction medicine##2##5##(1991-11#2)
[Current status of##2##3##(1994-3#1)(1997-6#1)
[Current treatment##3##2##(1995-5#1)(1997-3#1)(2008-5#1)
[Current##17##1##(1991-11#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-5#1)(2011-3#1)(2013-8#1)
[Cutaneous##5##1##(1990-9#1)(1991-11#1)(1996-9#1)(2009-5#2)
[Cytomegalovirus##2##1##(1996-3#1)(2012-2#1)
[D-Ala2##5##1##(1995-12#1)(1995-6#1)(1996-2#3)
[D-Arg6]##2##1##(1994-8#2)
[D-Met2]-FMRFamide (DMFa)##2##2##(1991-1#2)
[D-Pen2##3##1##(1992-3#1)(1995-12#1)(1996-2#1)
[D-Trp6]LH-RH##2##1##(1993-1#2)
[D-hArg(Et2)6##2##1##(1994-8#2)
[D-hArg(Et2)6]##2##1##(1994-8#2)
[DAMP (Deficits in Attention##2##4##(1997-8#2)
[Decision##2##1##(1997-5#1)(2013-1#1)
[Definition##2##1##(1997-2#1)(2013-1#1)
[Delayed##2##1##(1994-6#1)(2013-1#1)
[Dental photograph##4##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)
[Dental##7##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-5#1)(1996-3#1)(2013-1#1)
[Department of Health##3##3##(2008-11#3)
[Dermatomycoses##3##1##(1995-11#1)(1995-6#1)(1995-8#1)
[Dermatomyositis##2##1##(1991-3#1)(2013-1#1)
[Dermatophytes##2##1##(2008-5#2)
[Description of the##2##3##(1995-3#1)(2008-6#1)
[Description of##5##2##(1995-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
[Descriptive study of##2##3##(2010-6#1)(2013-1#1)
[Design and##2##2##(2012-3#2)
[Design of##2##2##(2011-1#1)(2013-8#1)
[Design##5##1##(2011-1#1)(2011-3#1)(2012-3#2)(2013-8#1)
[Detection and##5##2##(1994-3#1)(1996-3#1)(2008-10#1)(2010-12#1)(2013-1#1)
[Detection of##4##2##(1990-6#1)(1996-6#1)(2013-1#2)
[Detection##11##1##(1990-6#1)(1994-3#1)(1996-3#1)(1996-6#2)(1997-2#1)(2008-10#1)(2010-12#1)(2013-1#3)
[Determination of##19##2##(1990-11#1)(1991-2#1)(1992-6#1)(2011-1#9)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
[Development and##2##2##(1992-4#1)(2008-6#1)
[Development of a##2##3##(2007-12#1)(2013-8#1)
[Development of##6##2##(1996-11#1)(2007-12#1)(2011-3#1)(2012-2#2)(2013-8#1)
[Development##8##1##(1992-4#1)(1996-11#1)(2007-12#1)(2008-6#1)(2011-3#1)(2012-2#2)(2013-8#1)
[Diabetes mellitus in pregnancy]##2##4##(1996-11#2)
[Diabetes mellitus in##3##3##(1994-6#1)(1996-11#2)
[Diabetes mellitus##4##2##(1991-5#1)(1994-6#1)(1996-11#2)
[Diabetes##6##1##(1990-12#1)(1991-5#1)(1994-6#1)(1995-11#1)(1996-11#2)
[Diagnosis and therapy of##3##4##(1990-6#1)(1994-11#1)(1995-5#1)
[Diagnosis and treatment of##3##4##(1991-11#1)(1996-6#1)(2008-10#1)
[Diagnosis and##9##2##(1990-6#1)(1991-11#1)(1991-2#1)(1994-11#1)(1995-5#1)(1996-6#1)(2008-10#1)(2010-8#1)(2011-2#1)
[Diagnosis in##2##2##(1990-11#1)(1993-2#1)
[Diagnosis of##10##2##(1990-11#1)(1991-6#2)(1991-9#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-9#1)(2009-8#1)
[Diagnosis##23##1##(1990-11#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#2)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#1)
[Diagnostic criteria##2##2##(1991-9#1)(2008-11#1)
[Diagnostic peritoneal lavage in blunt abdominal##2##6##(1990-2#2)
[Diagnostic##12##1##(1990-11#1)(1990-2#2)(1990-9#1)(1991-5#1)(1991-9#1)(1996-9#1)(1997-3#1)(2008-11#1)(2011-2#1)(2011-6#1)(2012-12#1)
[Dialysis##3##1##(1994-5#1)(1995-5#2)
[Diet and##2##2##(1994-2#1)(2008-5#1)
[Differential##2##1##(1997-8#1)(2013-8#1)
[Difficulties in##2##2##(1990-2#1)(1990-3#1)
[Digestive##2##1##(1991-6#1)(2009-10#1)
[Dioxins and sarcomas in Veneto##3##5##(2008-8#3)
[Dioxins##4##1##(1990-3#1)(2008-8#3)
[Discussion of##2##2##(2012-3#2)
[Discussion##3##1##(2012-3#2)(2013-8#1)
[Distal##2##1##(1994-6#1)(2008-10#1)
[Distribution and##2##2##(1991-3#1)(2013-7#1)
[Diversity and##2##2##(2008-5#1)(2013-7#1)
[Diversity##3##1##(2008-5#1)(2012-3#1)(2013-7#1)
[Diving##2##1##(1990-6#1)(1991-6#1)
[Do the##2##2##(1994-3#1)(1995-6#1)
[Do we have##2##3##(1994-11#1)(1995-8#1)
[Do##9##1##(1990-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)
[Doctors and##2##2##(2008-10#1)(2009-7#1)
[Doctors##3##1##(1996-8#1)(2008-10#1)(2009-7#1)
[Does##8##1##(1990-11#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-4#1)(1997-6#1)(2013-1#1)
[Down's syndrome##2##2##(1990-2#1)(1992-5#1)
[Dr##2##1##(2011-2#2)
[Drug##12##1##(1990-6#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
[Drugs and##2##2##(1994-8#1)(1997-6#1)
[Drugs##4##1##(1991-3#1)(1994-8#1)(1997-6#2)
[Dynamic##4##1##(1990-6#1)(2010-6#1)(2011-2#1)(2013-7#1)
[E##3##1##(2008-10#3)
[EC 1##4##2##(1996-6#1)(2008-10#3)
[EC 2##2##2##(1994-8#2)
[EC##7##1##(1994-8#2)(1996-2#1)(1996-6#1)(2008-10#3)
[EMIM][N(Tf)(2)]##2##1##(2008-10#2)
[E]##2##1##(1992-11#2)
[Early##12##1##(1991-11#1)(1991-9#1)(1992-2#1)(1997-3#1)(1997-8#1)(2011-3#1)(2012-2#3)(2013-1#2)(2013-8#1)
[Eating##2##1##(1994-6#1)(2008-4#1)
[Economic##2##1##(2011-3#1)(2013-1#1)
[Editorial]##2##1##(2006-10#2)
[Education of##2##2##(1990-12#1)(2007-6#1)
[Effect of electroacupuncture of##2##4##(2012-3#2)
[Effect of electroacupuncture##3##3##(2012-3#2)(2013-8#1)
[Effect of occupational stress on##3##5##(2010-12#3)
[Effect of##56##2##(1991-3#1)(1992-11#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-7#1)(2008-5#2)(2010-12#11)(2011-1#2)(2011-2#2)(2011-3#4)(2012-3#9)(2013-1#10)(2013-8#10)
[Effective##2##1##(2011-3#1)(2012-3#1)
[Effectiveness of##6##2##(1992-5#1)(1997-2#1)(2008-1#1)(2009-5#1)(2009-8#1)(2012-12#1)
[Effects and##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
[Effects of##41##2##(1990-3#1)(1990-5#1)(1991-8#1)(1992-3#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-6#1)(2010-12#4)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#14)
[Effects##45##1##(1990-3#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-6#1)(2010-12#4)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#14)
[Efficacy and safety of##2##4##(1991-2#1)(2008-4#1)
[Efficacy comparison between##2##3##(2013-1#2)
[Efficacy of##7##2##(1991-3#1)(1991-5#1)(2011-2#1)(2011-3#1)(2013-1#3)
[Efficacy##11##1##(1991-2#1)(1991-3#1)(1991-5#1)(2008-4#1)(2011-2#1)(2011-3#1)(2013-1#5)
[Efficiency of##3##2##(2008-5#1)(2010-4#1)(2011-1#1)
[Elevated serum##2##2##(2012-2#2)
[Emergencies##2##1##(1991-2#1)(1993-10#1)
[Emergency care##2##2##(1995-6#1)(1996-3#1)
[Emergency services in##2##3##(1992-11#1)(1997-8#1)
[Emergency##11##1##(1990-2#1)(1992-11#2)(1993-8#1)(1995-6#1)(1996-3#1)(1997-8#2)(2008-11#1)(2008-4#1)(2012-12#1)
[Endometriosis##2##1##(1993-2#1)(2013-1#1)
[Endoscopic Doppler##2##2##(1992-5#1)(1992-6#1)
[Endoscopic and##3##2##(1990-8#1)(1992-9#1)(2013-1#1)
[Endoscopic##12##1##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1995-3#1)(2010-9#1)(2013-1#2)
[Environmental##5##1##(1991-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Epidemiological study##2##2##(2007-6#1)(2013-8#1)
[Epidemiological##9##1##(2007-6#1)(2007-8#1)(2009-1#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
[Epidemiology of##5##2##(1990-2#1)(1990-3#1)(1990-6#1)(1993-9#1)(2008-8#1)
[Epidemiology##7##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-9#1)(1993-9#1)(2008-10#1)(2008-8#1)
[Episodes of##2##2##(1997-5#1)(1997-6#1)
[Errata]##2##1##(2013-8#2)
[Erythema##2##1##(1992-5#1)(2009-1#1)
[Establish##2##1##(2012-3#1)(2013-8#1)
[Establishment and application of a##2##5##(2011-3#2)
[Establishment and application of##3##4##(2010-12#1)(2011-3#2)
[Establishment and##4##2##(2008-5#1)(2010-12#1)(2011-3#2)
[Establishment##5##1##(2008-5#1)(2010-12#1)(2010-8#1)(2011-3#2)
[Estimation of##3##2##(1996-3#1)(2012-12#1)(2013-7#1)
[Ethical problems in##2##3##(1993-6#1)(1994-2#1)
[Ethical##6##1##(1993-6#1)(1994-2#1)(1995-5#1)(2009-5#1)(2011-2#1)(2011-3#1)
[Ethics and##2##2##(1993-6#1)(1997-4#1)
[Ethics##3##1##(1992-2#1)(1993-6#1)(1997-4#1)
[Etiology of##2##2##(2009-5#1)(2011-1#1)
[Etiology##3##1##(1992-9#1)(2009-5#1)(2011-1#1)
[Euthanasia and assisted suicide by physicians in the home situation##2##10##(1991-8#2)
[Evaluating##4##1##(1990-12#1)(2011-2#1)(2012-12#2)
[Evaluation of a##3##3##(1994-3#1)(1996-11#1)(1996-6#1)
[Evaluation of the effectiveness of##2##5##(1990-2#1)(1995-3#1)
[Evaluation of the quality of##2##5##(1996-6#1)(2013-8#1)
[Evaluation of the safety##2##4##(1990-6#1)(2011-2#1)
[Evaluation of the##24##3##(1990-2#1)(1990-3#1)(1990-6#2)(1991-3#2)(1994-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-10#2)(2008-2#1)(2008-8#1)(2011-2#5)(2013-1#2)(2013-8#1)
[Evaluation of##44##2##(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-3#3)(1992-5#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-2#1)(1996-6#2)(1997-3#1)(2007-10#3)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#7)(2011-3#1)(2013-1#2)(2013-8#4)
[Evaluation on##2##2##(2012-3#1)(2013-8#1)
[Evaluation##49##1##(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-2#1)(1991-3#3)(1992-5#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-2#1)(1996-6#2)(1997-3#1)(2007-10#3)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#6)
[Everyday##2##1##(2008-10#1)(2010-6#1)
[Evolution of##5##2##(1995-11#1)(2009-1#1)(2012-2#1)(2013-1#2)
[Experience in##2##2##(1990-5#1)(1997-3#1)
[Experience##3##1##(1990-5#1)(1997-3#1)(2011-1#1)
[Experiential Learning##2##2##(2008-11#2)
[Experimental study on##2##3##(2012-3#2)
[Experimental study##3##2##(2012-3#2)(2013-8#1)
[Experimental##7##1##(1993-6#1)(2010-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
[Exposure to##3##2##(1990-12#1)(1993-6#1)(2011-2#1)
[Expression and Clinical Significance of##2##5##(2010-8#2)
[Expression and clinical significance of##2##5##(2012-2#1)(2013-1#1)
[Expression and##6##2##(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#2)
[Expression of##5##2##(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
[Expression##11##1##(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
[Extracorporeal##2##1##(1997-6#1)(2010-8#1)
[Extraction##2##1##(2012-3#1)(2013-8#1)
[F (1##2##2##(2013-8#2)
[F##3##1##(2013-8#3)
[Factitious##2##1##(1993-2#1)(1997-5#1)
[Factors associated with the##2##4##(1993-5#1)(2013-1#1)
[Factors associated with##6##3##(1993-5#1)(1996-10#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
[Factors##11##1##(1992-6#1)(1993-5#1)(1993-9#1)(1996-10#1)(1996-3#1)(2007-10#1)(2010-6#1)(2012-12#2)(2013-1#1)(2013-8#1)
[Failure##2##1##(1993-6#1)(2013-1#1)
[Familial##2##1##(1990-3#1)(2011-1#1)
[Family physician##2##2##(1994-12#1)(2008-4#1)
[Family##13##1##(1990-10#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#1)
[Fatal##3##1##(1991-11#1)(1996-6#1)(1996-8#1)
[Fatigue of the respiratory##2##4##(1991-6#1)(1992-2#1)
[Fe(-)U(+)]##3##1##(2013-1#3)
[Fe(BPA)Cl(3)] complex (2)##2##3##(1997-7#2)
[Fe(BPA)Cl(3)]##3##1##(1997-7#3)
[Fe(BPE)Cl(3)]##2##1##(1997-7#2)
[Fe(BPG)Cl(2)] complex##2##2##(1997-7#2)
[Fe(BPG)Cl(2)]##3##1##(1997-7#3)
[Fe(CN)(6)](3-)-[Fe(CN)(6)](4-) potential buffer solution##2##4##(2008-10#2)
[Fe(CN)(6)](3-)-[Fe(CN)(6)](4-) potential buffer##3##3##(2008-10#3)
[Fe(CN)6]3- and##2##2##(1990-5#2)
[Fe(CN)6]3-##3##1##(1990-5#3)
[Fe(CN)6]4-##2##1##(1990-5#2)
[Fe(IV)(O)(N4Py)](2+)##2##1##(2012-12#2)
[Feasibility of##2##2##(2012-2#1)(2013-1#1)
[Feasibility##3##1##(2012-2#1)(2013-1#1)(2013-8#1)
[Features of##2##2##(1990-6#1)(2013-1#1)
[Feeding##2##1##(2008-5#2)
[Female##2##1##(1991-6#1)(1993-6#1)
[Fever##3##1##(1996-6#1)(1997-7#1)(2011-2#1)
[First##3##1##(1990-9#1)(2012-3#1)(2013-1#1)
[Five##3##1##(1996-8#1)(2008-1#1)(2008-5#1)
[Fixed##2##1##(1990-6#1)(1992-6#1)
[Follow up##2##2##(1991-6#1)(1997-8#1)
[Follow-up of##3##2##(1991-6#1)(1993-11#1)(1994-2#1)
[Follow-up##4##1##(1991-6#1)(1993-11#1)(1994-2#1)(2013-8#1)
[Food poisoning##2##2##(1993-2#1)(2007-3#1)
[Food##7##1##(1993-2#1)(1994-6#1)(1996-11#1)(2007-3#1)(2012-2#2)(2013-7#1)
[Foreign##3##1##(1991-6#1)(1993-6#1)(1993-8#1)
[Forensic##2##1##(1997-8#1)(2011-2#1)
[Formula##47##1##(2008-10#19)(2008-11#4)(2008-3#2)(2008-4#1)(2008-8#10)(2012-2#3)(2012-7#1)(2013-1#7)
[Frequency of##2##2##(2012-12#1)(2012-3#1)
[From &quot##2##2##(1995-6#1)(1995-8#1)
[From the##3##2##(1990-6#1)(1995-12#1)(2008-4#1)
[From##14##1##(1990-5#1)(1990-6#1)(1990-9#2)(1995-12#1)(1995-6#1)(1995-8#2)(1997-4#1)(1997-6#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
[Frozen##2##1##(2007-3#1)(2007-8#1)
[Functional##9##1##(1991-2#1)(1991-3#1)(1992-5#1)(1995-2#1)(1995-5#1)(2007-8#1)(2011-2#2)(2013-7#1)
[Future##5##1##(1992-2#1)(1995-2#1)(1996-3#1)(1997-5#1)(2011-3#1)
[G##2##1##(1997-2#1)(2008-10#1)
[Gardens of##2##2##(2010-6#2)
[Gardens##4##1##(2010-6#4)
[Gastric##3##1##(1990-5#1)(1990-9#1)(2013-1#1)
[Gastrointestinal##2##1##(2008-10#1)(2013-1#1)
[Gene##4##1##(1990-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
[General practitioners##3##2##(1994-3#1)(1996-9#1)(2011-2#1)
[General##8##1##(1990-6#1)(1992-9#1)(1994-3#1)(1996-9#2)(1997-3#1)(2011-2#1)(2012-3#1)
[Genetic##5##1##(1990-12#1)(2009-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
[Geriatrics in The Netherlands##2##4##(1996-11#2)
[Geriatrics##3##1##(1994-2#1)(1996-11#2)
[Giant##3##1##(1991-6#1)(2008-10#1)(2013-1#1)
[Good##3##1##(1996-3#1)(1997-8#1)(2008-12#1)
[Grief##2##1##(1993-3#1)(1996-11#1)
[Group##2##1##(1991-6#1)(1995-6#1)
[Growth hormone##2##2##(1993-2#1)(1996-11#1)
[Growth##3##1##(1993-2#1)(1996-11#1)(1997-2#1)
[Guideline##2##1##(1997-3#1)(2008-9#1)
[Guidelines for##2##2##(1993-6#1)(1995-2#1)
[Guidelines##3##1##(1993-6#1)(1995-2#1)(2008-9#1)
[H##2##1##(2008-1#1)(2011-2#1)
[H(+)]##2##1##(2008-10#2)
[HIV##4##1##(1990-6#1)(1992-6#1)(1993-11#1)(1997-3#1)
[HS]##3##1##(2008-10#1)(2009-9#2)
[Haemophilus##2##1##(1992-5#1)(2009-5#1)
[Health and social##2##3##(1993-2#1)(1994-5#1)
[Health and##3##2##(1993-2#1)(1994-5#1)(1995-11#1)
[Health care##2##2##(1990-6#1)(1990-8#1)
[Health education##2##2##(1994-2#1)(2012-3#1)
[Health problems of##2##3##(1992-4#1)(1993-3#1)
[Health problems##3##2##(1992-4#1)(1993-3#1)(1993-5#1)
[Health status during the occupation##3##5##(1990-6#3)
[Health##25##1##(1990-6#5)(1990-8#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-5#1)(2012-3#2)
[Hearing##2##1##(1991-5#1)(2013-1#1)
[Heart##6##1##(1990-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2010-8#1)(2013-1#1)
[Heat##2##1##(1996-3#1)(2010-12#1)
[Helicobacter pylori and##2##3##(1997-4#1)(2013-1#1)
[Helicobacter pylori##3##2##(1990-2#1)(1997-4#1)(2013-1#1)
[Help##2##1##(1993-3#1)(1996-9#1)
[Hemodynamic##3##1##(1992-2#1)(1996-3#1)(2013-8#1)
[Hemophagocytic##2##1##(2011-2#2)
[Hemophilia##2##1##(1991-3#2)
[Hepatitis B##2##2##(1994-7#1)(1997-2#1)
[Hepatitis##8##1##(1992-11#1)(1993-5#1)(1994-2#1)(1994-7#1)(1997-2#3)(1997-3#1)
[High dose##2##2##(1997-3#2)
[High incidence##2##2##(1990-6#1)(1994-9#1)
[High##5##1##(1990-6#1)(1994-9#1)(1997-3#2)(2011-1#1)
[Hill##2##1##(2008-12#1)(2008-4#1)
[Histiocytic necrotizing lymphadenitis##2##3##(1991-3#1)(1991-9#1)
[Historical##2##1##(1990-10#1)(1996-3#1)
[History and##3##2##(1995-8#1)(2008-9#2)
[History of children oncology in Poland##2##6##(2008-9#2)
[History of the Child##2##4##(2008-9#2)
[History of the Department##2##4##(2008-9#2)
[History of the##11##3##(2008-7#1)(2008-9#9)(2013-8#1)
[History of##18##2##(1991-6#1)(2008-5#1)(2008-7#1)(2008-9#14)(2013-8#1)
[History##21##1##(1991-6#1)(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#16)(2013-8#1)
[Hogg##2##1##(1994-5#2)
[Home care##2##2##(1990-2#1)(2012-1#1)
[Home nursing care (I)##2##4##(1991-2#2)
[Home##8##1##(1990-2#1)(1991-2#2)(1993-6#1)(1995-11#1)(1995-3#1)(2008-9#1)(2012-1#1)
[Hormonal##6##1##(1990-2#1)(1990-6#1)(1993-8#1)(1994-8#1)(2008-2#1)(2011-3#1)
[Hospital admission of nursing home patients##2##6##(1994-12#2)
[Hospital readmissions##2##2##(1997-5#2)
[Hospital##9##1##(1991-3#1)(1994-12#2)(1997-3#1)(1997-4#1)(1997-5#2)(2010-6#1)(2013-8#1)
[How can##2##2##(1992-5#1)(1993-11#1)
[How do##3##2##(1992-9#1)(1993-8#1)(2008-4#1)
[How much##2##2##(1991-11#1)(1995-3#1)
[How to evaluate##2##3##(1991-11#1)(1996-2#1)
[How to improve##2##3##(1992-2#1)(1996-10#1)
[How to##7##2##(1991-11#1)(1992-2#1)(1993-6#1)(1996-10#1)(1996-2#1)(2011-3#1)(2012-2#1)
[How##23##1##(1990-6#1)(1991-11#3)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-4#1)(2011-3#1)(2012-2#1)
[Huang and Ackers##2##3##(1997-2#2)
[Human##8##1##(1991-3#1)(1992-3#1)(1993-11#1)(1996-3#3)(1997-3#1)(2008-11#1)
[Hybrid##3##1##(2011-2#2)(2011-3#1)
[Hydatid cyst of the##2##4##(1992-5#1)(1997-3#1)
[Hydatid##3##1##(1991-5#1)(1992-5#1)(1997-3#1)
[Hyperlipidemia##2##1##(1995-11#1)(1996-11#1)
[Hypertension in the##2##3##(1997-3#1)(1997-5#1)
[Hypertension in##4##2##(1990-12#1)(1997-3#1)(1997-4#1)(1997-5#1)
[Hypertension##5##1##(1990-12#1)(1993-11#1)(1997-3#1)(1997-4#1)(1997-5#1)
[Hypertrophic##2##1##(1992-9#1)(2011-2#1)
[Hypoglycemia##2##1##(1997-2#1)(1997-5#1)
[I##2##1##(1993-3#1)(1997-2#1)
[IEEE##2##1##(2008-2#1)(2008-3#1)
[III]##2##1##(2008-10#2)
[II]##4##1##(2008-10#4)
[I] and##4##2##(2008-10#4)
[I]##7##1##(2008-10#7)
[Iatrogenic##2##1##(1996-3#1)(2009-5#1)
[Identification of##2##2##(2008-5#1)(2012-3#1)
[Idiopathic##8##1##(1991-11#1)(1992-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(2007-8#1)(2008-1#1)(2011-1#1)
[Imaging##3##1##(1990-11#1)(2009-5#1)(2010-6#1)
[Immune##3##1##(1995-2#1)(2012-2#1)(2013-1#1)
[Immunization##2##1##(2009-5#1)(2012-3#1)
[Immunologic##3##1##(1990-5#1)(1997-8#1)(2011-2#1)
[Immunological##4##1##(1991-5#1)(1995-6#1)(1996-11#1)(2013-1#1)
[Immunotherapy in##2##2##(1991-2#1)(1992-5#1)
[Impact of##12##2##(1990-3#1)(1996-10#1)(2008-10#1)(2008-5#1)(2009-10#2)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#2)
[Impact##13##1##(1990-3#1)(1996-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#2)
[Implementation##2##1##(2008-2#1)(2009-5#1)
[Importance of##7##2##(1991-3#1)(1994-9#2)(1997-4#1)(1997-7#1)(2008-10#1)(2013-1#1)
[Importance##8##1##(1991-3#1)(1994-9#2)(1997-4#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
[Improvement in##2##2##(1996-3#1)(1997-4#1)
[In Process Citation]##80##3##(1991-12#2)(1991-6#1)(1991-9#2)(1994-7#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-7#4)(2008-8#8)(2009-4#1)(2011-2#3)(2011-3#1)(2012-12#11)(2012-2#15)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#11)
[In vitro comparison of##2##4##(2008-5#1)(2011-3#1)
[In vitro##7##2##(1991-11#1)(1996-11#1)(2008-5#2)(2011-3#3)
[In##94##1##(1991-11#1)(1991-12#2)(1991-6#2)(1991-9#2)(1994-3#1)(1994-7#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#3)(2011-3#4)(2012-12#11)(2012-2#15)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#11)
[Incidence and##2##2##(2013-1#2)
[Incidence of##4##2##(1992-4#1)(1994-7#1)(2008-8#1)(2009-5#1)
[Incidence##6##1##(1992-4#1)(1994-7#1)(2008-8#1)(2009-5#1)(2013-1#2)
[Incidental##2##1##(1990-9#1)(2013-1#1)
[Includes supplementary material]##4##3##(2010-10#4)
[Increased##4##1##(1996-3#1)(1997-4#1)(2007-10#1)(2008-11#1)
[Indications and contraindications##2##3##(2011-2#1)(2011-3#1)
[Indications and##3##2##(1990-3#1)(2011-2#1)(2011-3#1)
[Indications for##9##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-2#1)
[Indications##12##1##(1990-3#2)(1990-9#1)(1991-2#1)(1991-3#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-2#1)(2011-2#1)(2011-3#1)
[Indoor##2##1##(1991-3#1)(1995-6#1)
[Induced abortion##2##2##(1991-6#1)(2013-1#1)
[Infection##3##1##(1990-9#1)(1994-6#1)(1997-2#1)
[Infections##2##1##(1991-2#1)(1996-6#1)
[Infectious##2##1##(1996-3#1)(2009-5#1)
[Influence of##11##2##(1990-9#1)(1996-9#1)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
[Influence##12##1##(1990-9#1)(1996-9#1)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
[Influenza vaccination##2##2##(1994-3#1)(1996-9#1)
[Influenza##3##1##(1990-3#1)(1994-3#1)(1996-9#1)
[Information for##2##2##(1994-6#2)
[Information##4##1##(1992-11#1)(1994-6#2)(2011-1#1)
[Inhaled##2##1##(1995-11#1)(2008-7#1)
[Inhibition of##3##2##(2010-12#2)(2011-3#1)
[Inhibitory effect##2##2##(2011-2#1)(2012-3#1)
[Injuries##3##1##(1992-6#1)(1993-3#1)(1996-6#1)
[Innovations##2##1##(1996-9#1)(1997-7#1)
[Instituto##2##1##(2008-3#1)(2012-3#1)
[Insufficient##2##1##(1991-6#1)(1995-12#1)
[Integrated##2##1##(2008-11#1)(2012-12#1)
[Interest of##3##2##(2009-5#2)(2012-3#1)
[Intermittent##2##1##(1992-4#1)(1995-2#1)
[International##3##1##(1993-11#1)(2009-10#1)(2011-2#1)
[Interpretation of##2##2##(1993-9#1)(1995-11#1)
[Intervention##2##1##(1993-11#1)(1994-11#1)
[Interventional##3##1##(1991-3#1)(1993-2#1)(1994-9#1)
[Interview by##2##2##(2008-4#2)
[Intestinal obstruction##2##2##(1990-6#1)(1992-5#1)
[Intestinal##5##1##(1990-6#1)(1992-5#1)(1993-9#1)(2009-5#1)(2012-3#1)
[Intraoperative##4##1##(1992-3#1)(2008-10#1)(2010-8#1)(2013-1#1)
[Intrauterine growth##2##2##(2011-1#1)(2012-2#1)
[Intrauterine##3##1##(1996-3#1)(2011-1#1)(2012-2#1)
[Introduction of##2##2##(1992-5#1)(1993-11#1)
[Introduction to##2##2##(1996-6#1)(2011-1#1)
[Introduction##5##1##(1992-5#1)(1993-11#1)(1996-6#1)(2010-6#1)(2011-1#1)
[Invasive##2##1##(1992-4#1)(2008-5#1)
[Investigation and##2##2##(1990-11#1)(2013-1#1)
[Investigation of the##2##3##(2012-2#1)(2013-8#1)
[Investigation of##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
[Investigation on##2##2##(2012-3#2)
[Investigation##7##1##(1990-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
[Iron##3##1##(1990-11#1)(1992-11#1)(1994-6#1)
[Is it##2##2##(1990-6#1)(1995-8#1)
[Is primary care management possible from the hospital? The view of##2##11##(1994-6#2)
[Is the##4##2##(1990-3#1)(1991-9#1)(1995-6#1)(1997-4#1)
[Is there##2##2##(1991-8#1)(1995-12#1)
[Is##21##1##(1990-3#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1994-6#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-7#1)(2009-9#1)(2012-3#1)
[Ischemic##3##1##(1990-9#1)(1991-5#1)(1992-5#1)
[Isolated##8##1##(1992-9#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(2007-8#2)
[Isolation and identification of##2##4##(2008-5#1)(2012-3#1)
[Isolation and##4##2##(2008-5#2)(2011-1#1)(2012-3#1)
[Isolation of##2##2##(1990-9#1)(2008-5#1)
[Isolation##6##1##(1990-9#1)(2008-5#3)(2011-1#1)(2012-3#1)
[J##22##1##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#9)(2008-5#1)(2009-2#1)
[Job satisfaction##2##2##(2008-11#1)(2011-2#1)
[Job##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
[K(+)](o) and##2##2##(2008-8#2)
[K(+)](o) promoted##2##2##(2008-8#2)
[K(+)](o)##7##1##(2008-8#7)
[Kidney##4##1##(1992-5#1)(1994-5#1)(1997-4#1)(2013-8#1)
[Knowledge and attitudes of##2##4##(1996-9#1)(2012-3#1)
[Knowledge##3##1##(1991-9#1)(1996-9#1)(2012-3#1)
[Krükenberg tumors##2##2##(1997-3#2)
[L##3##1##(1990-5#1)(2008-10#1)(2011-2#1)
[L]/[M(+)]##3##1##(2008-10#3)
[Laboratory diagnosis##2##2##(1991-6#1)(2013-8#1)
[Laboratory##3##1##(1991-6#1)(2011-2#1)(2013-8#1)
[Laparoscopic##8##1##(1991-6#1)(1992-9#1)(1996-3#1)(1996-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
[Large##2##1##(1991-2#1)(1993-6#1)
[Larval##2##1##(1990-8#1)(2008-5#1)
[Laser in##2##2##(1991-9#2)
[Laser##5##1##(1991-3#1)(1991-9#2)(1997-2#1)(2010-8#1)
[Late##2##1##(1990-9#1)(1992-5#1)
[Lee-Huang##2##1##(1993-12#1)(1993-6#1)
[Legal##2##1##(1990-11#1)(2012-12#1)
[Leiomyoma of the##3##3##(1992-5#1)(1992-6#1)(1992-9#1)
[Leu11]gastrin-(5-17) or##2##2##(1995-12#2)
[Leu11]gastrin-(5-17)##8##1##(1995-12#8)
[Leu31##5##1##(1995-12#2)(1997-4#3)
[Leu]- and [Met]enkephalin##3##3##(1991-3#3)
[Leu]enkephalin##2##1##(1991-3#2)
[Life expectancy##2##2##(1991-3#1)(1996-3#1)
[Life##4##1##(1991-3#1)(1991-6#1)(1996-3#1)(2008-9#1)
[Light##2##1##(1992-4#1)(2010-3#1)
[Lim##2##1##(1995-5#2)
[Lipid##2##1##(1991-4#1)(2008-4#1)
[Listeria monocytogenes##2##2##(1990-3#1)(1993-2#1)
[Liver##2##1##(1992-2#1)(1995-8#1)
[Living##2##1##(1993-8#1)(1996-9#1)
[Local##5##1##(1990-11#1)(1990-3#1)(1991-6#1)(1994-11#1)(2013-1#1)
[Long-term outcome of##2##3##(2011-3#1)(2011-5#1)
[Long-term treatment with##2##3##(1995-12#1)(1995-3#1)
[Long-term treatment##3##2##(1995-12#1)(1995-3#1)(2009-8#1)
[Long-term##9##1##(1990-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(2009-8#1)(2011-2#1)(2011-3#1)(2011-5#1)(2013-8#1)
[Low##2##1##(1990-3#1)(2008-10#1)
[Lp(a)]##3##1##(1996-8#1)(2008-6#1)(2013-7#1)
[Lumbar disk prolapse##2##3##(1997-2#1)(1997-3#1)
[Lumbar##4##1##(1992-5#1)(1993-9#1)(1997-2#1)(1997-3#1)
[Lung##4##1##(1990-3#1)(1991-2#1)(1996-6#1)(2011-3#1)
[Lupus##2##1##(1996-11#1)(2010-12#1)
[Lymphedema##2##1##(1994-9#1)(2011-1#1)
[Lys7]##2##1##(1991-2#2)
[MRI##2##1##(1992-11#1)(2010-12#1)
[Magnetic resonance imaging##2##3##(1991-11#1)(2012-3#1)
[Magnetic resonance##4##2##(1990-10#1)(1991-11#1)(1997-4#1)(2012-3#1)
[Magnetic##6##1##(1990-10#1)(1990-11#1)(1991-11#1)(1997-4#1)(2012-3#1)(2013-1#1)
[Malaria##3##1##(2011-2#1)(2012-12#1)(2012-3#1)
[Male##4##1##(1990-3#1)(1991-11#1)(1993-3#1)(2012-12#1)
[Malignant pleural mesothelioma in##2##4##(1995-2#1)(1997-5#1)
[Malignant##8##1##(1991-11#1)(1991-5#1)(1992-5#1)(1995-2#1)(1997-3#1)(1997-5#1)(2011-3#1)(2013-1#1)
[Man##2##1##(1991-3#1)(2008-10#1)
[Management of##7##2##(2008-10#1)(2008-4#1)(2009-1#1)(2010-9#1)(2011-2#1)(2013-1#2)
[Maternal##3##1##(1995-2#1)(1996-11#1)(2009-10#1)
[Maternity in adolescents##2##3##(1993-3#1)(1997-5#1)
[May##3##1##(1995-2#1)(1996-11#1)(1996-9#1)
[Measurement of##4##2##(2008-10#1)(2008-6#1)(2010-3#1)(2013-8#1)
[Measuring##2##1##(1993-6#1)(1994-3#1)
[Mechanical##3##1##(1994-11#1)(2010-8#1)(2013-8#1)
[Mediastinal##2##1##(1990-8#1)(2008-1#1)
[Medical education##2##2##(1994-11#1)(1997-4#1)
[Medical##18##1##(1990-11#1)(1991-11#1)(1991-2#2)(1992-4#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-5#1)(2010-6#1)(2011-3#1)(2012-3#1)
[Medicine##3##1##(1994-2#1)(1997-5#1)(2013-1#1)
[Mem##4##1##(2007-12#4)
[Mental disorders in##2##3##(1992-5#1)(1997-5#1)
[Mental health##2##2##(1993-6#1)(1996-11#1)
[Mental##4##1##(1992-5#1)(1993-6#1)(1996-11#1)(1997-5#1)
[Met]enkephalin##4##1##(1991-3#4)
[Metabolic##3##1##(2008-7#1)(2012-3#2)
[Metastatic##2##1##(1996-6#1)(1996-9#1)
[Methadone##3##1##(1991-11#1)(1992-4#1)(1992-5#1)
[Methodological##3##1##(1990-3#1)(1991-11#1)(1991-3#1)
[Methodology for##2##2##(2007-10#1)(2011-2#1)
[Methodology##3##1##(1990-3#1)(2007-10#1)(2011-2#1)
[Mg2+]i##7##1##(1993-11#2)(1994-6#5)
[Microalbuminuria##2##1##(1993-2#1)(2013-1#1)
[Minor##2##1##(1991-6#1)(1995-6#1)
[Mn##4##1##(2010-8#4)
[Mo(V)O(OH)](2+)##2##1##(1996-2#2)
[Mo(VI)O(2)](2+) to##2##2##(1996-2#2)
[Mo(VI)O(2)](2+)##3##1##(1996-2#3)
[Modern##3##1##(1996-3#1)(1996-9#1)(2011-1#1)
[Molecular characterization of##2##3##(2008-5#1)(2011-1#1)
[Molecular##3##1##(2008-5#1)(2011-1#1)(2013-1#1)
[Molecular-genetic##2##1##(1995-12#1)(1997-3#1)
[Monitoring of##2##2##(1990-6#1)(2008-5#1)
[Monoclonal antibodies##2##2##(1992-5#1)(2007-10#1)
[Morbidity and##2##2##(1992-5#2)
[Morbidity of##2##2##(2009-5#1)(2011-2#1)
[Morbidity##4##1##(1992-5#2)(2009-5#1)(2011-2#1)
[More##3##1##(1991-2#1)(1996-6#1)(2008-6#1)
[Morphological##2##1##(1990-6#1)(2012-3#1)
[Mortality due to##2##3##(1997-3#1)(2008-8#1)
[Mortality##5##1##(1996-7#1)(1997-3#1)(2008-8#2)(2011-2#1)
[Multicenter##3##1##(1990-5#1)(1997-3#1)(2013-1#1)
[Multiple injuries in##2##3##(1992-4#2)
[Multiple sclerosis##2##2##(1996-3#1)(1996-8#1)
[Multiple##10##1##(1990-12#1)(1992-4#2)(1996-3#1)(1996-8#1)(2008-1#1)(2009-5#1)(2010-12#1)(2011-3#1)(2013-8#1)
[My##3##1##(1997-3#1)(2008-10#1)(2011-2#1)
[Myocardial infarction##2##2##(1991-3#1)(1993-6#1)
[Myocardial##6##1##(1990-8#1)(1991-3#1)(1992-5#1)(1993-6#1)(2011-2#1)(2012-3#1)
[Mäntele##2##1##(1992-6#2)
[N##4##1##(1994-12#1)(1995-5#1)(1997-3#1)(2008-10#1)
[N-MePhe3##2##1##(1996-2#2)
[Na+##3##1##(1991-8#3)
[Na+]o##3##1##(1993-12#3)
[NaCl]##8##1##(1995-5#2)(1997-2#6)
[NaOC(6)H(4)(CH(2)NMe(2))-2](6)##2##1##(1996-2#2)
[NaOH](T)##3##1##(2008-10#3)
[Natural##2##1##(1992-5#1)(2012-12#1)
[Near infrared##2##2##(2013-8#2)
[Necrotizing##2##1##(1991-11#1)(2008-10#1)
[Neoliberalism##2##1##(2013-1#2)
[Neonatal##5##1##(2008-5#1)(2008-8#1)(2009-5#2)(2013-1#1)
[Nephropathy##2##1##(1994-2#1)(1995-11#1)
[Nephrotic syndrome##2##2##(1996-6#1)(2013-8#1)
[Neuroendocrine##2##1##(1991-3#1)(1996-3#1)
[Neurofibromatosis type##2##2##(1997-3#2)
[New therapeutic##2##2##(1995-11#1)(2011-3#1)
[New##28##1##(1990-11#1)(1990-12#1)(1990-6#2)(1993-10#1)(1993-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#2)
[News in##2##2##(1994-6#1)(2008-10#1)
[Ni(acac)2]##2##1##(2007-11#2)
[NiFe]hydrogenase-encoding structural genes##2##3##(1990-11#2)
[No##2##1##(1996-8#1)(2008-4#1)
[Nocturnal##2##1##(2009-1#1)(2013-8#1)
[Norwegian##3##1##(1994-6#1)(1997-6#2)
[Not##2##1##(1990-2#1)(1992-6#1)
[Nuclear medical##2##2##(1991-2#2)
[Nurse##3##1##(1993-3#1)(2008-11#1)(2011-2#1)
[Nursing care for the adolescent (IV)##3##6##(1990-12#3)
[Nursing care##6##2##(1990-12#3)(2012-2#1)(2012-3#2)
[Nursing participation in##2##3##(2008-10#2)
[Nursing##17##1##(1990-12#4)(1990-2#3)(1993-3#3)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#3)
[Nutrition##3##1##(1991-6#1)(1993-9#1)(2007-3#1)
[Nutritional##5##1##(1990-3#1)(1993-10#1)(1995-5#1)(2008-5#1)(2012-2#1)
[OR =##3##2##(2009-7#3)
[OR##6##1##(2008-10#2)(2008-12#1)(2009-7#3)
[OR] =##3##2##(2008-3#1)(2010-10#1)(2011-2#1)
[OR]##4##1##(2008-3#1)(2010-10#1)(2011-2#2)
[Obstructive jaundice##2##2##(1991-3#1)(2007-10#1)
[Obstructive lung disease in##2##4##(1997-4#2)
[Obstructive##4##1##(1991-3#1)(1997-4#2)(2007-10#1)
[Occupational conditions##2##2##(1993-3#1)(1996-3#1)
[Occupational exposure to##2##3##(2011-2#1)(2012-3#1)
[Occupational##10##1##(1991-4#1)(1992-5#2)(1993-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-9#1)(2011-2#1)(2012-3#1)
[Occurrence and##2##2##(2008-6#1)(2011-2#1)
[Occurrence##3##1##(1990-12#1)(2008-6#1)(2011-2#1)
[On the##4##2##(1992-4#1)(1996-10#1)(2008-5#2)
[On##7##1##(1990-3#1)(1992-4#1)(1996-10#1)(2008-5#2)(2009-7#1)(2010-3#1)
[One case of##2##3##(2010-12#1)(2013-1#1)
[One##3##1##(1991-11#1)(2010-12#1)(2013-1#1)
[Only##4##1##(1991-8#1)(1995-8#1)(1997-2#1)(2008-4#1)
[Opt##25##1##(2007-11#7)(2007-12#7)(2008-2#1)(2008-3#9)(2011-1#1)
[Optical biopsy##2##2##(2012-2#2)
[Optimal##2##1##(1991-5#1)(1992-9#1)
[Optimization of##2##2##(2011-1#1)(2012-3#1)
[Oral##7##1##(1990-5#1)(1991-3#1)(1994-2#1)(1995-11#1)(1997-3#1)(2008-5#1)(2008-9#1)
[Organization of##2##2##(1997-8#1)(2008-2#1)
[Os(OEP)](2)##2##1##(1997-7#2)
[Osteoporosis in##2##2##(1990-9#1)(2008-4#1)
[Osteoporosis##4##1##(1990-9#1)(1991-11#1)(1996-6#1)(2008-4#1)
[Our experience in##2##3##(1992-3#1)(2011-2#1)
[Our experience##4##2##(1990-3#1)(1990-9#1)(1992-3#1)(2011-2#1)
[Outcome##3##1##(2007-1#1)(2012-2#1)(2013-1#1)
[Ovarian##2##1##(2008-5#1)(2011-1#1)
[Overview of##2##2##(2008-10#1)(2011-1#1)
[Oxygen##2##1##(1992-11#2)
[P = 0##2##3##(2008-10#2)
[P =##4##2##(2008-10#2)(2010-4#2)
[P##7##1##(2008-10#3)(2008-12#1)(2010-4#2)(2011-2#1)
[P&lt##2##1##(2007-8#2)
[PER]##5##1##(2008-10#5)
[PR(3) =##2##2##(1996-2#2)
[Painful sequelae of##2##3##(1991-4#1)(1992-5#1)
[Painful##3##1##(1991-4#1)(1992-5#1)(2010-11#1)
[Palliative##4##1##(1993-3#1)(1996-8#1)(1997-2#1)(2007-3#1)
[Pancreas##2##1##(1991-9#1)(1995-2#1)
[Pancreatic##2##1##(1990-9#1)(2009-5#1)
[Paraneoplastic##2##1##(1991-11#1)(1997-8#1)
[Parkinson disease##2##2##(1995-2#1)(2013-8#1)
[Parkinson##3##1##(1995-2#1)(1996-3#1)(2013-8#1)
[Paroxysmal##2##1##(1996-8#1)(2013-1#1)
[Pathogenesis of##5##2##(1991-2#1)(1996-9#1)(1997-7#1)(2010-10#1)(2010-4#1)
[Pathogenic##3##1##(2008-5#1)(2012-12#1)(2012-3#1)
[Pathological##2##1##(2012-12#1)(2012-2#1)
[Patient##7##1##(1990-6#1)(1995-5#1)(1995-8#1)(1997-4#1)(2007-8#1)(2011-2#1)(2013-8#1)
[Patients##5##1##(1990-6#1)(1991-6#1)(1994-8#1)(1997-5#1)(1997-6#1)
[Patients'##2##1##(1992-4#1)(1996-8#1)
[Pay##2##1##(2012-2#1)(2013-1#1)
[Pediatric##2##1##(1991-6#1)(1994-3#1)
[Pelvic girdle##2##2##(1990-6#2)
[Pelvic##4##1##(1990-6#2)(1991-2#1)(2013-1#1)
[Perceived##2##1##(1993-6#1)(2008-11#1)
[Perception of the##2##3##(1994-9#1)(1996-3#1)
[Perception of##5##2##(1994-9#1)(1996-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
[Perception##6##1##(1994-9#1)(1996-3#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
[Percutaneous treatment]##2##2##(1997-5#2)
[Percutaneous##6##1##(1990-8#1)(1991-9#1)(1997-5#2)(2008-12#1)(2010-8#1)
[Periodontal##2##1##(1990-5#1)(2012-12#1)
[Perioperative##2##1##(1992-5#1)(2008-10#1)
[Peripheral##4##1##(1990-5#1)(1991-6#1)(1992-6#1)(1995-5#1)
[Peritoneal##2##1##(1990-6#1)(2009-5#1)
[Persistent##2##1##(1991-6#1)(2007-8#1)
[Personal##2##1##(2008-9#1)(2011-2#1)
[Pharmacies' information##2##2##(1990-2#2)
[Pharmaco-morbidity linking##2##2##(1990-9#2)
[Pharmacologic##2##1##(1991-6#1)(2008-10#1)
[Pharmacological##2##1##(2008-10#1)(2013-8#1)
[Philos##2##1##(2008-2#1)(2008-3#1)
[Phototherapy##2##1##(1997-6#2)
[Phys##12##1##(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#1)(2010-2#1)
[Physical activity and##2##3##(1993-2#1)(1995-5#1)
[Physical##5##1##(1993-2#1)(1995-5#1)(1996-9#1)(1997-6#1)(2012-2#1)
[Physician##2##1##(1995-12#1)(1997-2#1)
[Physicians and##2##2##(1992-9#1)(1996-9#1)
[Physicians##4##1##(1991-2#1)(1992-9#1)(1993-3#1)(1996-9#1)
[Physiologic and pathologic age related changes in the##2##8##(1990-11#2)
[Picotamide##3##1##(1990-12#1)(1990-5#1)(1991-6#1)
[Piracetam##2##1##(1995-6#1)(1996-9#1)
[Plants##2##1##(2013-7#1)(2013-8#1)
[Pneumocystis##2##1##(1992-5#1)(2010-12#1)
[Poisoning with##2##2##(1990-6#1)(2011-2#1)
[Polish##3##1##(2008-11#1)(2012-12#1)(2012-3#1)
[Polymorphism##2##1##(2011-2#1)(2013-1#1)
[Population##2##1##(2008-5#2)
[Positive##2##1##(1990-2#1)(1995-8#1)
[Postoperative##3##1##(1993-5#1)(1996-9#1)(2011-3#1)
[Practical##3##1##(1990-6#1)(1994-12#1)(1996-11#1)
[Predictive##3##1##(1996-6#1)(2007-8#1)(2013-1#1)
[Predictors of##2##2##(2012-12#1)(2012-3#1)
[Pregnancy in##3##2##(1996-11#1)(2008-10#1)(2012-3#1)
[Pregnancy##6##1##(1995-6#1)(1996-11#1)(2007-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
[Preliminary##2##1##(2011-2#1)(2013-8#1)
[Premature##2##1##(1994-6#1)(2012-3#1)
[Prenatal##5##1##(1990-2#1)(1995-11#1)(2009-10#1)(2009-5#1)(2011-1#1)
[Preoperative##3##1##(1994-11#1)(1996-6#1)(2009-5#1)
[Preparation and##3##2##(2008-5#1)(2013-8#2)
[Preparation of##2##2##(2010-12#1)(2011-2#1)
[Preparation##7##1##(1991-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#3)
[Prescription of exercise and physical activity##2##6##(1995-2#1)(1995-3#1)
[Prescription of##4##2##(1994-3#1)(1995-2#1)(1995-3#1)(1997-3#1)
[Prescription##5##1##(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-3#1)
[Present##2##1##(1996-11#1)(2011-2#1)
[Prevalence and##2##2##(2009-10#1)(2011-1#1)
[Prevalence of##23##2##(1990-6#2)(1991-11#1)(1993-2#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#3)
[Prevalence##25##1##(1990-6#2)(1991-11#1)(1993-2#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
[Prevention of cardiovascular##2##3##(1991-6#1)(1994-11#1)
[Prevention of congenital##2##3##(1990-9#1)(1991-8#1)
[Prevention of##18##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#2)(1993-3#1)(1994-11#1)(1995-5#1)(1996-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
[Prevention##19##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#2)(1993-3#1)(1994-11#1)(1995-5#1)(1996-9#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
[Primary care##2##2##(1993-9#1)(1997-2#1)
[Primary malignant##2##2##(1991-6#1)(1992-11#1)
[Primary pulmonary hypertension##2##3##(1991-6#1)(1997-5#1)
[Primary pulmonary##4##2##(1990-6#1)(1991-6#1)(1997-5#1)(2009-5#1)
[Primary##24##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-2#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#1)(2009-5#3)(2011-2#1)(2013-1#2)
[Principle and##2##2##(2012-3#1)(2013-1#1)
[Principles##2##1##(1991-11#1)(2013-8#1)
[Priority decisions##2##2##(1994-3#2)
[Problem-based##2##1##(1995-2#1)(1995-6#1)
[Problems in##2##2##(1995-5#1)(2008-10#1)
[Problems of##3##2##(1997-3#1)(1997-8#1)(2013-1#1)
[Problems##6##1##(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
[Proc##5##1##(1990-11#1)(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
[Procedures##2##1##(1990-2#1)(2011-3#1)
[Professor Dr##2##2##(2008-9#2)
[Professor##7##1##(2008-9#5)(2009-5#1)(2011-1#1)
[Profile of##3##2##(1996-6#1)(1996-9#1)(2008-9#1)
[Prognostic value of##2##3##(1990-9#1)(1992-2#1)
[Prognostic##4##1##(1990-9#1)(1992-2#1)(2009-1#1)(2013-1#1)
[Progress in##3##2##(1990-6#1)(2012-2#2)
[Progress##4##1##(1990-6#1)(2012-2#2)(2012-3#1)
[Prostate-specific##2##1##(1990-9#1)(1995-11#1)
[Protective effect of##2##3##(2011-3#1)(2013-8#1)
[Protective##3##1##(2011-3#1)(2012-2#1)(2013-8#1)
[Pseudomonas##2##1##(1992-11#2)
[Psychiatric disorders and somatic diseases]##2##5##(1997-3#2)
[Psychiatric##5##1##(1996-1#1)(1997-3#2)(2007-1#2)
[Psychiatry##2##1##(1992-6#1)(1993-6#1)
[Psychological##5##1##(1991-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
[Psychometric properties##2##2##(2009-10#1)(2013-1#1)
[Psychosocial##2##1##(1990-6#1)(2008-2#1)
[Public health##2##2##(1993-6#1)(2012-12#1)
[Public##4##1##(1993-2#1)(1993-6#2)(2012-12#1)
[Pulmonary thromboembolism##2##2##(1990-9#1)(2008-10#1)
[Pulmonary##14##1##(1990-9#1)(1991-9#1)(1993-2#1)(1995-8#1)(1996-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2009-5#4)(2010-8#1)
[Q##2##1##(2008-2#1)(2008-3#1)
[Qualitative##2##1##(1990-5#1)(2008-12#1)
[Quality assurance in##5##3##(1990-9#1)(1992-9#1)(1996-3#1)(1997-4#1)(2013-1#1)
[Quality assurance of##3##3##(1992-11#1)(1992-9#1)(1997-8#1)
[Quality assurance##8##2##(1990-9#1)(1992-11#1)(1992-9#2)(1996-3#1)(1997-4#1)(1997-8#1)(2013-1#1)
[Quality control of##2##3##(1993-6#1)(2011-3#1)
[Quality control##3##2##(1993-6#1)(2008-10#1)(2011-3#1)
[Quality of care##2##3##(1997-3#2)
[Quality of life##2##3##(2007-1#1)(2013-8#1)
[Quality of nursing##2##3##(1994-9#1)(2012-3#1)
[Quality of##7##2##(1994-9#1)(1997-3#2)(2007-1#1)(2010-12#1)(2012-3#1)(2013-8#1)
[Quality##26##1##(1990-9#1)(1992-11#1)(1992-5#1)(1992-9#3)(1993-6#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#2)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
[Quantitative##3##1##(1991-11#1)(2011-3#1)(2012-3#1)
[Questionnaire##2##1##(2008-11#1)(2011-2#1)
[R##4##1##(1996-2#1)(2008-10#3)
[Radical##2##1##(1990-3#1)(1995-5#1)
[Rapid identification##2##2##(2013-8#2)
[Rare##2##1##(1992-5#1)(2011-2#1)
[Rational##2##1##(1992-5#1)(1997-5#1)
[Reasons##2##1##(1991-6#1)(1995-12#1)
[Recent advance in##2##3##(2013-8#2)
[Recent##9##1##(1990-2#1)(1991-2#1)(1991-3#1)(1997-2#1)(2008-7#1)(2011-3#1)(2012-2#1)(2013-8#2)
[Recommendations for##2##2##(2007-6#1)(2013-1#1)
[Recurrent##3##1##(1994-3#1)(2007-8#1)(2009-5#1)
[Reduced##3##1##(1990-9#1)(1991-6#1)(1994-2#1)
[Referral##2##1##(1996-6#1)(1997-3#1)
[Reflux##2##1##(1991-8#1)(1992-3#1)
[Rehabilitation of##2##2##(1993-3#1)(1995-5#1)
[Rehabilitation##6##1##(1990-9#1)(1993-3#1)(1995-5#2)(1997-3#1)(2012-12#1)
[Relation between##2##2##(1991-6#1)(1996-6#1)
[Relation##3##1##(1991-6#1)(1996-6#1)(2011-1#1)
[Relationship between pseudocroup and air pollutant burden of the inhaled air and##2##12##(1990-8#2)
[Relationship between##7##2##(1990-8#2)(1997-2#1)(2013-1#1)(2013-8#3)
[Renal##4##1##(1990-5#1)(1997-2#1)(1997-7#1)(2009-10#1)
[Report of the##2##3##(1990-12#1)(1994-2#1)
[Report of##3##2##(1990-12#1)(1994-2#1)(2007-10#1)
[Report##4##1##(1990-12#1)(1994-2#1)(2007-10#1)(2008-10#1)
[Reported##2##1##(1990-9#1)(2012-3#1)
[Reproductive outcome##2##2##(2007-10#1)(2011-1#1)
[Research and##2##2##(1993-6#1)(2008-5#1)
[Research on the##3##3##(2012-3#1)(2013-8#2)
[Research on##11##2##(1997-6#1)(2012-1#1)(2012-3#4)(2013-8#5)
[Research##21##1##(1991-9#1)(1992-6#1)(1993-6#1)(1997-6#2)(2008-5#1)(2010-8#1)(2012-1#1)(2012-3#8)(2013-8#5)
[Respiratory tract##2##2##(1994-11#1)(1995-8#1)
[Respiratory##5##1##(1994-11#1)(1995-8#1)(1996-11#1)(2008-1#1)(2008-5#1)
[Responsibility and##2##2##(1991-6#1)(2008-10#1)
[Responsibility##3##1##(1991-6#1)(1995-2#1)(2008-10#1)
[Restless legs##2##2##(1997-4#1)(2008-4#1)
[Results of##6##2##(1994-11#1)(1996-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
[Results##7##1##(1994-11#1)(1996-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
[Resuscitation of##2##2##(1994-6#1)(1996-6#1)
[Resuscitation##3##1##(1992-5#1)(1994-6#1)(1996-6#1)
[Resveratrol##2##1##(2013-1#1)(2013-8#1)
[Retroperitoneal##2##1##(2012-2#1)(2013-1#1)
[Retrospective##2##1##(1996-3#1)(2012-12#1)
[Reversible##2##1##(1991-9#1)(2008-10#1)
[Review of##4##2##(1991-9#1)(1992-2#1)(1992-9#1)(2013-1#1)
[Rheumatoid arthritis##2##2##(1997-2#1)(2008-11#1)
[Rickettsia##2##1##(2010-10#1)(2011-2#1)
[Risk assessment of##2##3##(2011-2#1)(2012-3#1)
[Risk factors and##2##3##(1991-3#1)(2012-2#1)
[Risk factors for##2##3##(2008-1#1)(2013-1#1)
[Risk factors in##2##3##(2008-4#1)(2010-6#1)
[Risk factors of##5##3##(1991-6#1)(1996-3#1)(2012-3#1)(2013-1#2)
[Risk factors##13##2##(1991-3#1)(1991-6#1)(1996-3#1)(2008-1#1)(2008-4#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
[Risk of##2##2##(1992-6#1)(1994-8#1)
[Risk##19##1##(1991-3#1)(1991-6#1)(1992-6#1)(1994-8#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
[Role of mitochondrial##2##3##(2007-8#1)(2010-12#1)
[Role of the##3##3##(1995-11#2)(2011-2#1)
[Role of##18##2##(1990-6#1)(1991-3#1)(1992-6#1)(1995-11#2)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
[Routine##2##1##(1992-9#1)(1997-3#1)
[Ru(OETAP)](2)##2##1##(1997-7#2)
[Ru(bipy)(3)](2+)##2##1##(2008-10#2)
[Ru(bpy)(3)](2+)##4##1##(2008-10#3)(2010-7#1)
[Ru(phend)(2)bpy](2+)##4##1##(2008-6#4)
[S-(R*##3##1##(1993-8#3)
[SD]##5##1##(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
[Safe childbirth as a goal##3##5##(1993-3#3)
[Safety and efficacy of##2##4##(2008-10#1)(2009-5#1)
[Safety##3##1##(1997-6#1)(2008-10#1)(2009-5#1)
[Sarcoidosis and##3##2##(1992-2#1)(2007-6#2)
[Science##4##1##(1990-5#1)(1993-3#1)(2007-11#1)(2009-5#1)
[Scientific##2##1##(1995-11#1)(2009-10#1)
[Screening of##2##2##(1997-3#1)(2012-3#1)
[Screening##4##1##(1994-6#1)(1996-10#1)(1997-3#1)(2012-3#1)
[Scrotal##2##1##(1990-9#1)(2011-5#1)
[Searching for##2##2##(1997-3#1)(1997-6#1)
[Seasonal##3##1##(1991-11#1)(2008-5#1)(2013-7#1)
[Secondary hyperparathyroidism##2##2##(1991-11#1)(1991-5#1)
[Secondary prevention##2##2##(1990-6#1)(1993-2#1)
[Secondary##8##1##(1990-6#1)(1991-11#1)(1991-5#1)(1992-5#1)(1993-2#1)(1996-3#1)(2008-5#1)(2008-7#1)
[Selection of##2##2##(2007-10#1)(2010-8#1)
[Selective##2##1##(1990-9#1)(2013-1#1)
[Self##3##1##(1994-6#1)(1997-3#1)(2008-10#1)
[Self-esteem##2##1##(1991-2#1)(2013-7#1)
[Self-reported##2##1##(1996-6#1)(1997-4#1)
[Sentinel lymph node mapping in##2##5##(2008-10#1)(2010-8#1)
[Sentinel lymph node##3##3##(2008-10#2)(2010-8#1)
[Separation and##2##2##(2011-1#1)(2012-3#1)
[Separation##3##1##(2011-1#1)(2011-2#1)(2012-3#1)
[Sepsis##2##1##(1990-3#1)(1996-6#1)
[Septic arthritis##2##2##(1991-11#1)(1992-5#1)
[Septic##3##1##(1991-11#1)(1992-5#1)(1993-2#1)
[Serological##2##1##(1991-11#1)(2011-2#1)
[Serum##4##1##(1992-5#1)(1993-2#1)(2008-11#1)(2011-2#1)
[Severe##4##1##(1990-3#1)(1991-3#1)(1997-4#1)(2013-1#1)
[Sex disorders##2##2##(1990-6#2)
[Sex##3##1##(1990-6#2)(2008-4#1)
[Sexual abuse of##2##3##(1996-11#2)
[Sexual##3##1##(1995-11#1)(1996-11#2)
[Shibayama##2##1##(1993-8#2)
[Shockwave therapy##2##2##(1994-3#2)
[Shortening of life during adequate##2##5##(1990-2#2)
[Should##9##1##(1991-2#1)(1991-6#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-9#1)(1997-8#1)
[SiO(2)]/[Al(2)O(3)] ratio##3##2##(2008-10#3)
[Sialendoscopy##2##1##(2011-2#1)(2013-1#1)
[Side effects of##2##3##(1997-8#1)(2008-4#1)
[Side effects##4##2##(1996-3#1)(1997-8#1)(2008-4#1)(2008-6#1)
[Significance of##9##2##(1990-8#1)(1991-3#1)(1992-11#1)(1993-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-5#1)(2011-2#1)
[Significance##10##1##(1990-3#1)(1990-8#1)(1991-3#1)(1992-11#1)(1993-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-5#1)(2011-2#1)
[Silicone breast##3##2##(1992-5#1)(1992-6#1)(1994-11#1)
[Simulation of##3##2##(2009-5#1)(2010-8#1)(2011-1#1)
[Simultaneous determination of##7##3##(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-8#1)
[Simultaneous##10##1##(1990-9#1)(1997-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-8#2)
[Single##2##1##(2007-10#1)(2013-1#1)
[Sinusitis in general##2##3##(1993-2#2)
[Sinusitis in##3##2##(1991-6#1)(1993-2#2)
[Size##2##1##(1992-2#1)(2008-5#1)
[Skin##2##1##(1992-3#1)(1992-9#1)
[Sleep##2##1##(1993-2#1)(2013-7#1)
[Small hospitals--future tasks and functions]##2##5##(1991-6#2)
[Small##4##1##(1991-6#2)(1994-11#1)(2010-11#1)
[Smoking and##3##2##(1990-6#1)(1991-9#1)(1992-4#1)
[Smoking##7##1##(1990-6#1)(1991-4#1)(1991-9#1)(1992-4#1)(1993-2#1)(1993-6#1)(1996-6#1)
[Smoking-free##2##1##(1995-6#2)
[So##2##1##(1995-6#1)(2008-4#1)
[Social representations##2##2##(2008-2#1)(2012-12#1)
[Social##6##1##(1990-12#1)(1994-3#1)(1995-2#1)(2008-2#1)(2010-3#1)(2012-12#1)
[Socialization of physician's role during the clinical part of medical education##2##11##(1992-6#2)
[Solitary##3##1##(1991-3#1)(1994-3#1)(1994-5#1)
[Somatic##2##1##(1990-2#1)(1995-8#1)
[Some##5##1##(2008-5#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
[Special##2##1##(1993-6#1)(1996-6#1)
[Spectral##3##1##(1990-6#1)(2013-8#2)
[Spinal##4##1##(1991-3#1)(1994-7#1)(1995-11#1)(2012-3#1)
[Splenic##2##1##(1993-9#1)(1997-3#1)
[Spontaneous bacterial peritonitis##2##3##(1995-3#1)(2009-8#1)
[Spontaneous##9##1##(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#1)(1995-3#1)(1997-7#1)(2009-5#1)(2009-8#1)(2013-1#1)
[State of the##2##3##(2007-10#1)(2010-11#1)
[State of##3##2##(2007-10#1)(2010-11#1)(2012-12#1)
[Statistical##2##1##(1991-3#1)(1997-4#1)
[Status of##3##2##(2011-1#1)(2013-1#1)(2013-8#1)
[Status##4##1##(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
[Sterile##2##1##(1991-6#1)(1993-8#1)
[Strategy##2##1##(1992-9#1)(2012-3#1)
[Strengthening##2##1##(1996-11#1)(2008-11#1)
[Stress and##2##2##(1990-5#1)(1995-2#1)
[Stress##5##1##(1990-5#1)(1992-5#1)(1994-11#1)(1995-2#1)(1996-6#1)
[Structural##2##1##(1995-11#1)(2011-2#1)
[Studies on resistance of Schistosoma to praziquantel##2##7##(2012-3#2)
[Studies on##4##2##(2011-1#1)(2012-3#2)(2013-8#1)
[Study of the##3##3##(1995-6#1)(2009-1#1)(2013-8#1)
[Study of##16##2##(1991-11#2)(1994-9#1)(1995-6#2)(1996-2#2)(1996-9#1)(1997-8#1)(2008-5#2)(2009-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
[Study on chemical constituents of##3##5##(2012-3#1)(2013-8#2)
[Study on the chemical components of##2##6##(2013-8#2)
[Study on the chemical##3##4##(2013-8#3)
[Study on the relationship between##2##5##(2011-1#2)
[Study on the##17##3##(1990-2#1)(1993-9#1)(2011-1#4)(2012-3#6)(2013-8#5)
[Study on##37##2##(1990-2#1)(1993-9#1)(2010-12#3)(2011-1#5)(2012-3#16)(2013-8#11)
[Study##54##1##(1990-2#1)(1990-9#1)(1991-11#2)(1993-9#1)(1994-9#1)(1995-6#2)(1996-2#2)(1996-9#1)(1997-8#1)(2008-5#2)(2009-1#1)(2010-12#3)(2011-1#5)(2012-3#17)(2013-1#1)(2013-8#13)
[Substance##2##1##(1997-4#1)(2008-2#1)
[Successful##3##1##(1990-11#1)(1990-6#1)(2013-1#1)
[Sudden infant death##2##3##(1990-11#1)(1991-11#1)
[Sudden infant##4##2##(1990-11#3)(1991-11#1)
[Sudden##7##1##(1990-11#3)(1991-11#1)(1992-11#1)(1992-6#1)(1994-9#1)
[Suicidal##2##1##(1996-3#1)(2013-1#1)
[Suicide##2##1##(1996-1#1)(2013-1#1)
[Sumatriptan in##2##2##(1991-8#1)(1994-11#1)
[Sumatriptan##3##1##(1991-8#1)(1994-11#2)
[Surgery##2##1##(1990-2#1)(1995-5#1)
[Surgical aspects of##2##3##(1991-3#1)(2011-2#1)
[Surgical treatment of##11##3##(1990-3#1)(1990-5#2)(1990-6#2)(1991-8#1)(1993-6#1)(1997-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
[Surgical treatment##13##2##(1990-3#1)(1990-5#2)(1990-6#2)(1991-8#1)(1993-6#1)(1997-2#1)(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
[Surgical##20##1##(1990-3#1)(1990-5#2)(1990-6#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-6#2)(1995-5#1)(1997-2#1)(2008-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
[Surveillance and##2##2##(1990-9#1)(2012-3#1)
[Surveillance of schistosomiasis in a national##2##6##(2012-3#2)
[Surveillance of schistosomiasis in##3##4##(2012-3#3)
[Surveillance of schistosomiasis##5##3##(2012-3#5)
[Surveillance of##8##2##(1996-11#1)(2012-3#7)
[Surveillance##10##1##(1990-9#1)(1996-11#1)(2012-3#8)
[Survey of##2##2##(1995-8#1)(2008-6#1)
[Survey report on nursing education##2##5##(1990-2#1)(1991-2#1)
[Survey##5##1##(1990-2#1)(1991-2#1)(1994-2#1)(1995-8#1)(2008-6#1)
[Survival of##2##2##(1995-8#1)(2012-12#1)
[Survival##3##1##(1995-8#1)(2008-1#1)(2012-12#1)
[Susceptibility to##2##2##(2008-5#1)(2012-12#1)
[Susceptibility##3##1##(2008-5#1)(2012-12#1)(2012-2#1)
[Suspected##2##1##(1994-3#1)(1997-6#1)
[Symptomatic##2##1##(1990-6#2)
[Synchronous##2##1##(1991-6#1)(2009-5#1)
[Synthesis and##2##2##(2011-3#2)
[Synthesis##3##1##(2011-3#2)(2013-8#1)
[Systemic lupus erythematosus##2##3##(1992-5#1)(2009-5#1)
[Systemic##5##1##(1990-12#1)(1992-5#1)(1995-11#1)(2007-10#1)(2009-5#1)
[Teeth##2##1##(1990-5#1)(2012-3#1)
[Temporal##2##1##(2008-5#1)(2013-7#1)
[Testicular##4##1##(1995-5#2)(1997-3#1)(2007-8#1)
[Testing##2##1##(1992-11#1)(2012-3#1)
[Texas Red DHPE##2##3##(2009-12#2)
[The &quot##4##2##(1994-9#1)(1995-8#1)(1997-2#1)(2011-2#1)
[The Expression##2##2##(2010-8#2)
[The HIV-epidemic among##2##3##(1996-11#2)
[The HIV-epidemic##3##2##(1996-11#3)
[The Norwegian##2##2##(1994-2#1)(1997-8#1)
[The accuracy of portable reflectometers]##2##5##(1994-2#2)
[The accuracy of##3##3##(1993-8#1)(1994-2#2)
[The age of##2##3##(1990-9#1)(1992-5#1)
[The application of##3##3##(1997-4#1)(2013-1#1)(2013-8#1)
[The application##4##2##(1997-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
[The benefit of##2##3##(1992-2#1)(1995-6#1)
[The case##2##2##(1994-5#1)(2013-8#1)
[The changes of##2##3##(1997-4#1)(2012-2#1)
[The characteristics of##3##3##(2013-1#3)
[The classification##2##2##(1991-3#1)(1993-9#1)
[The companion##2##2##(1993-11#1)(1993-3#1)
[The concept of##4##3##(1991-2#1)(1993-3#1)(1993-6#1)(2013-1#1)
[The concept##5##2##(1990-5#1)(1991-2#1)(1993-3#1)(1993-6#1)(2013-1#1)
[The contribution of##2##3##(2008-9#1)(2013-1#1)
[The detection of##2##3##(1990-8#1)(2013-1#1)
[The diagnosis and treatment of##2##5##(1992-5#1)(1993-2#1)
[The diagnosis##3##2##(1992-5#1)(1993-2#1)(1993-5#1)
[The diagnostic value of##2##4##(1991-3#1)(2013-1#1)
[The diagnostic##4##2##(1990-11#1)(1991-3#1)(1993-9#1)(2013-1#1)
[The early detection of##2##4##(1993-11#1)(1993-3#1)
[The early##3##2##(1993-11#1)(1993-3#1)(1993-9#1)
[The effect of##7##3##(1991-5#1)(1992-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
[The effect##8##2##(1991-5#1)(1992-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
[The effectiveness##2##2##(2008-1#1)(2013-8#1)
[The effects of##5##3##(1991-4#1)(2010-12#1)(2011-2#2)(2012-2#1)
[The elderly##2##2##(1996-3#1)(2009-7#1)
[The epidemiology of##3##3##(1993-3#1)(1994-6#1)(2011-2#1)
[The evaluation of a##3##4##(1993-11#1)(1993-3#1)(1993-6#1)
[The evaluation of##6##3##(1993-11#1)(1993-3#1)(1993-6#1)(1997-4#1)(2012-12#1)(2013-1#1)
[The evolution of##2##3##(1993-2#1)(2012-12#1)
[The expression##2##2##(2010-12#1)(2013-1#1)
[The family##2##2##(1993-6#1)(1994-12#1)
[The health##2##2##(1991-12#1)(1993-6#1)
[The impact of##5##3##(1996-6#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
[The importance of##4##3##(1990-11#1)(1993-11#1)(1997-7#1)(2008-11#1)
[The incidence of##2##3##(1994-6#1)(2008-1#1)
[The incidence##3##2##(1990-11#1)(1994-6#1)(2008-1#1)
[The indications##2##2##(1992-3#1)(1993-9#1)
[The influence of##2##3##(2008-7#1)(2012-1#1)
[The introduction of##3##3##(1993-3#1)(1994-6#1)(1996-6#1)
[The medical##3##2##(1992-5#1)(1993-11#2)
[The need##2##2##(1991-11#1)(1997-3#1)
[The new##2##2##(1996-6#1)(2008-2#1)
[The organization of##2##3##(1991-9#1)(1993-3#1)
[The physician##3##2##(1991-6#1)(1992-11#1)(1997-3#1)
[The physician's##2##2##(1990-2#1)(1991-6#1)
[The place of##2##3##(1992-6#1)(2007-8#1)
[The practice##2##2##(1990-9#1)(2013-8#1)
[The prestige of diseases and medical specialties]##2##7##(1991-11#1)(1991-6#1)
[The prevalence of##7##3##(1992-5#1)(1993-11#1)(1993-5#1)(1993-6#1)(1996-7#1)(2009-8#1)(2012-12#1)
[The principles##2##2##(1997-6#1)(2010-8#1)
[The problem of##2##3##(1990-6#1)(2008-10#1)
[The profile of##2##3##(2008-9#1)(2011-2#1)
[The protective##2##2##(2010-12#2)
[The protein##2##2##(1991-11#1)(1994-9#1)
[The quality of##2##3##(1995-8#1)(1997-5#1)
[The relationship between##2##3##(2011-2#1)(2013-8#1)
[The repair##2##2##(1992-3#1)(1993-9#1)
[The research of##2##3##(2012-3#2)
[The research##3##2##(2012-3#2)(2013-8#1)
[The risk of##2##3##(1994-9#1)(2011-2#1)
[The role of the##4##4##(1993-11#1)(2008-11#1)(2008-9#1)(2011-3#1)
[The role of##14##3##(1990-11#1)(1990-3#1)(1991-3#1)(1993-11#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-3#2)(2012-3#1)(2013-1#2)(2013-8#1)
[The role##15##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-9#1)(1993-11#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-3#2)(2012-3#1)(2013-1#2)(2013-8#1)
[The significance of##7##3##(1990-10#2)(1990-9#1)(1991-9#1)(1992-5#1)(2008-11#1)(2013-8#1)
[The surgical treatment of##4##4##(1991-11#1)(1992-3#1)(1992-5#1)(1993-9#1)
[The surgical##6##2##(1991-11#1)(1992-3#3)(1992-5#1)(1993-9#1)
[The telephone##2##2##(1994-6#1)(1997-5#1)
[The treatment of##4##3##(1990-6#1)(1991-6#1)(1991-8#1)(1993-2#1)
[The use of##5##3##(1992-3#1)(1992-5#1)(1993-11#1)(1996-6#1)(2013-1#1)
[The validity of 6 indirect methods for assessing##2##8##(1997-4#1)(1997-5#1)
[The value of##5##3##(1990-6#1)(1990-9#1)(1991-3#1)(2013-1#1)(2013-8#1)
[The##443##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#4)(1990-5#1)(1990-6#6)(1990-8#2)(1990-9#8)(1991-11#7)(1991-12#2)(1991-2#5)(1991-3#9)(1991-4#1)(1991-5#1)(1991-6#9)(1991-8#2)(1991-9#6)(1992-11#3)(1992-2#2)(1992-3#10)(1992-5#11)(1992-6#1)(1992-9#1)(1993-10#3)(1993-11#13)(1993-2#5)(1993-3#16)(1993-5#4)(1993-6#9)(1993-8#2)(1993-9#11)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#11)(1994-8#1)(1994-9#4)(1995-11#2)(1995-2#1)(1995-5#3)(1995-6#5)(1995-8#2)(1996-11#5)(1996-2#1)(1996-3#4)(1996-6#4)(1996-7#1)(1996-9#5)(1997-2#4)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#7)(2009-1#1)(2009-10#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#6)(2010-3#1)(2010-6#3)(2010-8#11)(2010-9#1)(2011-1#2)(2011-2#16)(2011-3#9)(2012-1#2)(2012-12#11)(2012-2#6)(2012-3#13)(2013-1#40)(2013-7#1)(2013-8#18)
[Therapeutic##10##1##(1991-11#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-8#1)(2007-6#1)(2010-3#1)(2012-3#2)(2013-1#1)
[Therapy of##7##2##(1991-11#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(2008-4#1)
[Therapy##10##1##(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-4#1)
[This corrects the article DOI##3##5##(2010-9#1)(2012-2#2)
[This corrects the article on p##16##6##(2008-11#2)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
[This corrects the article##19##4##(2008-11#2)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
[Thoracoscopic lobectomy##2##2##(2011-2#2)
[Thoracoscopic##3##1##(2010-8#1)(2011-2#2)
[Thrombocyte##3##1##(1990-12#1)(1994-9#1)(1996-6#1)
[Thrombocytopenia##2##1##(1993-6#1)(1996-11#1)
[Thyroid##2##1##(1992-5#1)(2013-1#1)
[Time course of##2##3##(2010-12#2)
[Time##3##1##(2008-4#1)(2010-12#2)
[To the##2##2##(1993-2#1)(1994-12#1)
[To##8##1##(1991-2#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-5#1)(1997-6#1)(2010-12#1)
[Tobacco##3##1##(1993-10#1)(1993-9#1)(2009-5#1)
[Topical##4##1##(1990-9#1)(1991-3#1)(1994-2#1)(2008-5#1)
[Topics on reproductive health at the##2##6##(2008-11#2)
[Total##2##1##(2011-2#1)(2013-1#1)
[Towards a##2##2##(1997-4#1)(1997-5#1)
[Towards##3##1##(1997-4#1)(1997-5#1)(1997-6#1)
[Toxoplasma##2##1##(1991-11#1)(2007-7#1)
[Training and professional profile of dentistry in the EEC##5##9##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)
[Training and professional profile of dentistry in the##6##8##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)
[Training and##7##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(2011-2#1)
[Training##9##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1997-3#2)(2011-2#1)
[Transfusion medicine in##2##3##(2008-10#2)
[Transfusion##4##1##(1990-11#1)(1994-8#1)(2008-10#2)
[Transient##3##1##(1991-11#1)(1995-5#1)(2013-8#1)
[Traumatic##3##1##(1991-3#1)(1992-9#1)(2011-2#1)
[Travel##2##1##(2007-2#1)(2011-2#1)
[Treatment of heart failure]##2##4##(1992-9#1)(1996-6#1)
[Treatment of heart##3##3##(1992-6#1)(1992-9#1)(1996-6#1)
[Treatment of hypertension in the elderly--diuretics/atenolol?]##2##6##(1992-6#1)(1992-9#1)
[Treatment of hypertension in the elderly]##2##6##(1992-6#2)
[Treatment of hypertension in the##4##5##(1992-6#3)(1992-9#1)
[Treatment of hypertension in##6##4##(1992-6#3)(1992-9#1)(1994-6#1)(1996-6#1)
[Treatment of##39##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#5)(1992-9#4)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-6#3)(1997-3#1)(1997-5#1)(1997-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#4)
[Treatment results of##2##3##(2011-2#1)(2013-1#1)
[Treatment with##2##2##(1990-2#1)(2008-11#1)
[Treatment##47##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#5)(1992-9#4)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-6#3)(1997-3#1)(1997-5#1)(1997-8#2)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
[Trends in##2##2##(1996-6#1)(1996-7#1)
[Trial##2##1##(1993-6#1)(2007-1#1)
[Triple##3##1##(1991-3#1)(1996-11#1)(2011-2#1)
[Tuberculosis##3##1##(1993-11#1)(1996-11#1)(2008-11#1)
[Tuberculous infection in##2##3##(1992-2#1)(1993-11#1)
[Tuberculous##6##1##(1992-2#1)(1993-11#1)(1996-6#1)(1997-5#1)(2007-8#1)(2013-1#1)
[Tumor##4##1##(1990-11#1)(1995-11#1)(1996-3#1)(2011-2#1)
[Two cases of##3##3##(1993-3#1)(1993-6#1)(2010-12#1)
[Two new species of##2##4##(2008-5#2)
[Two##5##1##(1993-3#1)(1993-6#1)(2008-5#2)(2010-12#1)
[Type##2##1##(1991-11#1)(2011-2#1)
[Ulcerative##3##1##(1992-3#3)
[Ultrasonic##2##1##(1991-6#1)(2010-8#1)
[Ultrasonography##3##1##(1992-5#1)(1996-11#1)(2013-8#1)
[Ultrasound##2##1##(2010-8#1)(2013-1#1)
[Unusual##2##1##(1990-3#1)(2008-5#1)
[Urban##2##1##(2012-12#2)
[Urinary##2##1##(1993-2#1)(2012-2#1)
[Urogenital##2##1##(1990-9#1)(1996-3#1)
[Use of the##3##3##(1990-3#1)(1991-9#1)(2010-12#1)
[Use of##22##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-5#1)(1991-9#1)(1992-6#1)(1996-11#2)(1996-3#2)(1997-6#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
[Usefulness of##10##2##(1996-10#1)(1996-11#2)(1996-9#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
[User satisfaction in##2##3##(1993-11#1)(1997-6#1)
[Using##2##1##(2008-11#1)(2011-2#1)
[Utility of##2##2##(2011-2#1)(2013-1#1)
[Vaccination##3##1##(1990-11#1)(1996-11#1)(1997-8#1)
[Vaccinations in##3##2##(1996-8#1)(1996-9#2)
[Vaccinations##5##1##(1994-5#1)(1996-8#1)(1996-9#2)(2011-2#1)
[Validation of a questionnaire##2##4##(1997-2#1)(2013-1#1)
[Validation of a##3##3##(1994-3#1)(1997-2#1)(2013-1#1)
[Validation of the French version of the##2##7##(2010-9#2)
[Validation of the##3##3##(1994-2#1)(2010-9#2)
[Validation of##8##2##(1991-3#1)(1994-2#1)(1994-3#1)(1997-2#1)(2006-10#1)(2010-9#2)(2013-1#1)
[Value of##4##2##(1990-3#1)(1992-5#1)(1996-3#1)(2013-8#1)
[Variation in##3##2##(1995-12#1)(1996-6#1)(1996-8#1)
[Varicella##2##1##(2008-4#1)(2013-1#1)
[Vascular##4##1##(1991-6#1)(2009-5#2)(2011-3#1)
[Ventricular arrhythmias##2##2##(1990-9#1)(2008-10#1)
[Ventricular##5##1##(1990-9#1)(1992-9#1)(1996-3#1)(2008-10#1)(2010-8#1)
[Violence in##2##2##(1996-6#1)(2013-1#1)
[Violence##3##1##(1996-6#1)(2008-9#1)(2013-1#1)
[Viral##2##1##(1993-11#1)(2013-1#1)
[Virological##2##1##(2013-1#1)(2013-8#1)
[Viruses and##3##2##(1990-6#1)(1994-6#1)(2013-1#1)
[Vitamin A##2##2##(1991-6#1)(2008-9#1)
[Vitamin##3##1##(1990-3#1)(1991-6#1)(2008-9#1)
[Volvulus of the##2##3##(1990-6#1)(1991-6#1)
[W##2##1##(2008-12#2)
[WHO]##2##1##(2006-10#1)(2011-1#1)
[Waiting##2##1##(1991-11#2)
[Was##2##1##(1990-5#1)(1996-7#1)
[Water##3##1##(1990-12#1)(1993-6#1)(2008-3#1)
[We##5##1##(1990-12#1)(1990-2#1)(1991-6#1)(1993-8#1)(2009-10#1)
[Weaning from##2##2##(2007-6#2)
[What happens##2##2##(1992-11#1)(1995-5#1)
[What is the benefit of##2##5##(1992-11#1)(1997-2#1)
[What is the##5##3##(1991-2#1)(1992-11#2)(1993-11#1)(1997-2#1)
[What is your diagnosis?##2##4##(1993-11#1)(1994-5#1)
[What is your##3##3##(1993-11#1)(1993-8#1)(1994-5#1)
[What is##10##2##(1991-2#1)(1992-11#2)(1993-11#2)(1993-8#1)(1994-5#1)(1997-2#1)(2008-9#1)(2009-5#1)
[What##24##1##(1990-2#1)(1990-9#1)(1991-2#1)(1992-11#3)(1992-5#1)(1993-11#2)(1993-6#2)(1993-8#2)(1994-5#1)(1994-9#1)(1995-5#2)(1995-6#2)(1996-8#1)(1997-2#1)(1997-5#1)(2008-9#1)(2009-5#1)
[When##3##1##(1993-11#1)(1993-3#1)(1997-4#1)
[Where does##2##2##(1993-2#1)(1997-4#1)
[Where##4##1##(1993-11#1)(1993-2#1)(1993-3#1)(1997-4#1)
[While##2##1##(1992-11#1)(1995-5#1)
[White##3##1##(1990-10#1)(1990-6#1)(2008-11#1)
[Who is##2##2##(1991-11#1)(1993-10#1)
[Who should perform abortion counseling?]##3##5##(1995-11#3)
[Who should##4##2##(1994-5#1)(1995-11#3)
[Who##9##1##(1990-2#1)(1991-11#1)(1992-2#1)(1993-10#1)(1994-12#1)(1994-5#1)(1995-11#3)
[Whose##2##1##(1991-2#1)(1994-8#1)
[Why do##2##2##(1991-11#1)(1991-9#1)
[Why does##2##2##(1997-3#2)
[Why##8##1##(1991-11#1)(1991-9#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-3#2)
[Will##2##1##(1993-6#1)(2013-7#1)
[Women in##2##2##(1993-6#1)(2013-1#1)
[Women##4##1##(1993-6#1)(2008-11#1)(2009-10#1)(2013-1#1)
[Work##2##1##(2008-8#1)(2010-12#1)
[X##3##1##(1996-5#1)(2008-10#2)
[Zellweger syndrome and other peroxisomal disorders##2##6##(1990-3#2)
[a =##3##2##(1996-2#3)
[a##4##1##(1993-8#1)(1996-2#3)
[acetonitrile##2##1##(2008-5#2)
[additive] and##2##2##(2007-8#2)
[alpha##2##1##(1990-8#1)(1992-11#1)
[alpha-32P]ATP##2##1##(1992-6#1)(1994-5#1)
[also known as##2##3##(1993-8#1)(2008-1#1)
[arrows##2##1##(1992-4#2)
[bis(5'-nucleosyl)-tetraphosphatase##2##1##(2009-2#2)
[cAMP]i##4##1##(1991-3#4)
[cM])##2##1##(2008-10#2)
[controls##4##1##(2013-8#4)
[corrected] nmol/g albumin##2##3##(1990-3#2)
[corrected]##6##1##(1990-10#1)(1990-3#2)(1991-2#1)(1993-8#1)(1994-5#1)
[correction of##3##2##(1992-6#1)(1992-8#1)(1997-4#1)
[d(CTGCAG)2][3FD]##2##1##(1990-7#2)
[during 5 min##2##3##(2009-12#2)
[e##6##1##(2007-12#3)(2008-7#1)(2009-10#1)(2012-2#1)
[electric field##2##2##(2011-2#2)
[formula##7##1##(1992-12#3)(1995-11#3)(1995-6#1)
[gamma##2##1##(1990-10#1)(1990-7#1)
[gamma-32P]ATP##4##1##(1992-6#2)(1993-11#1)(1995-6#1)
[i##5##1##(1991-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-7#1)
[in##3##1##(1993-2#1)(2007-12#1)(2010-4#1)
[ligand]/[metal cation]##2##2##(2008-10#2)
[logistic]##2##1##(2007-8#2)
[m]##2##1##(2007-10#1)(2009-12#1)
[monoclinic P2(1)/c##2##2##(1996-2#2)
[monoclinic P2(1)/n##2##2##(1996-2#2)
[monoclinic##4##1##(1996-2#4)
[n =##2##2##(2012-3#2)
[odds ratio##2##2##(2011-2#1)(2013-8#1)
[oxy/30%##2##1##(1992-8#2)
[p = 0##2##3##(2013-1#2)
[post]##4##1##(2008-5#4)
[pre] to##4##2##(2008-5#4)
[pyH(+)](2)[CuNb(2)(py)(4)O(2)F(10)](2)(-)##3##1##(1996-2#3)
[rho(w)(lambda(NIR))](N)##4##1##(2008-3#4)
[sodium##2##1##(2008-10#1)(2008-5#1)
[standard##2##1##(2008-10#1)(2008-3#1)
[the##4##1##(1995-2#1)(2008-11#1)(2013-1#1)(2013-8#1)
[with##2##1##(1997-1#1)(2008-10#1)
]##331##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#2)(1992-11#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#4)(2006-8#3)(2007-1#1)(2007-12#5)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#17)(2008-4#2)(2008-5#61)(2008-7#5)(2008-8#1)(2009-5#2)(2009-6#1)(2009-8#16)(2010-1#1)(2010-11#4)(2010-12#5)(2010-3#1)(2010-6#1)(2010-8#40)(2010-9#1)(2011-1#43)(2011-2#38)(2011-3#9)(2012-2#4)(2012-3#1)(2013-1#40)
]i##3##1##(2013-1#3)
_ 2 and##4##3##(2008-5#4)
_ 2 stretching##2##3##(2008-5#2)
_ 2##19##2##(2008-5#19)
_ 50##6##2##(2008-5#6)
_##30##1##(2008-5#30)
a $1##2##2##(1996-5#1)(2008-5#1)
a $75##2##2##(1995-12#1)(1996-5#1)
a &gt##3##2##(2007-11#1)(2007-12#1)(2008-6#1)
a &lt##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
a &quot##196##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#3)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#5)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#2)
a '9+9+2' axoneme flanked by two mitochondrial derivatives##2##8##(2007-12#2)
a 'real'##2##2##(2012-3#1)(2013-1#1)
a (-/+) reaction was##2##4##(2007-10#2)
a -lines##2##2##(2007-11#2)
a 0##100##2##(1993-12#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#47)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#11)(2008-5#2)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
a 1 L##2##3##(2008-7#2)
a 1 cm##2##3##(2007-11#1)(2008-10#1)
a 1 degree of freedom test##2##6##(1997-3#2)
a 1 mM##2##3##(1992-8#1)(1994-12#1)
a 1 min##2##3##(2008-10#1)(2008-11#1)
a 1 mm##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
a 1 x##2##3##(2008-3#1)(2011-2#1)
a 1 year##2##3##(2009-7#1)(2012-2#1)
a 1##188##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#3)(2008-10#69)(2008-11#6)(2008-2#6)(2008-3#14)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
a 1%##7##2##(1991-8#1)(2008-3#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
a 1-Hz bandwidth##2##3##(2007-12#2)
a 1-cm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a 1-day##2##2##(2008-10#2)
a 1-h##7##2##(1997-4#3)(2008-10#1)(2008-3#1)(2008-6#2)
a 1-kHz repetition rate##11##4##(2007-11#2)(2007-12#5)(2008-3#4)
a 1-kHz##13##2##(2007-11#3)(2007-12#5)(2008-3#5)
a 1-km##2##2##(2008-2#1)(2008-3#1)
a 1-m path##3##3##(2007-12#1)(2008-3#2)
a 1-m##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
a 1-mm##7##2##(2007-12#1)(2008-10#3)(2008-12#3)
a 1-mm-thick##3##2##(2007-12#1)(2008-3#2)
a 1-month##3##2##(2007-10#1)(2008-10#2)
a 1-mum##3##2##(2007-12#2)(2008-3#1)
a 1-nm##3##2##(2008-2#1)(2008-3#2)
a 1-to-5##2##2##(2008-10#2)
a 1-year follow-up##3##3##(2008-2#1)(2012-5#1)(2013-8#1)
a 1-year period##7##3##(2008-11#2)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
a 1-year##13##2##(1991-6#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#3)
a 1-year-old child##2##3##(1997-8#1)(2011-1#1)
a 1-year-old##6##2##(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
a 1-yr##2##2##(2008-8#1)(2010-10#1)
a 10 cm##3##3##(1995-3#1)(2008-3#1)(2008-8#1)
a 10 min##4##3##(1992-3#1)(1995-12#1)(2008-10#2)
a 10 ml##2##3##(2008-10#2)
a 10 x##2##3##(1994-7#1)(2008-10#1)
a 10 year period##3##4##(1990-2#1)(2007-8#1)(2008-5#1)
a 10 year##5##3##(1990-2#1)(2007-8#1)(2008-5#1)(2008-7#2)
a 10 years period##2##4##(1997-8#1)(2011-2#1)
a 10 years##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
a 10##41##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#2)
a 10%##11##2##(1990-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)
a 10-GHz##2##2##(2007-11#2)
a 10-Hz##4##2##(2007-12#1)(2008-2#3)
a 10-W##2##2##(2008-2#1)(2008-3#1)
a 10-cm##2##2##(2007-12#1)(2008-12#1)
a 10-day##2##2##(2010-5#2)
a 10-fold increase in##3##4##(1990-6#1)(1992-3#1)(2010-1#1)
a 10-fold##10##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-6#1)(1995-3#1)(1995-9#1)(2008-10#1)(2010-1#1)
a 10-item##2##2##(2008-12#1)(2008-9#1)
a 10-kHz##2##2##(2007-12#1)(2008-3#1)
a 10-mm-thick##2##2##(2007-12#1)(2008-2#1)
a 10-month##2##2##(2008-10#1)(2008-7#1)
a 10-month-old##2##2##(1994-12#2)
a 10-mum##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
a 10-week##4##2##(2012-12#2)(2013-1#2)
a 10-year period##8##3##(1990-10#1)(1992-2#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-7#2)
a 10-year##15##2##(1990-10#1)(1991-2#1)(1991-9#1)(1992-2#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#1)
a 10-year-old boy##3##3##(2007-7#1)(2008-7#1)(2013-1#1)
a 10-year-old##5##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
a 100 l stirred tankbioreactor##2##5##(2008-11#2)
a 100 mM##2##3##(2008-10#2)
a 100##13##2##(1991-5#1)(1994-5#1)(2007-12#1)(2008-10#5)(2008-11#3)(2009-8#1)(2010-5#1)
a 100% increase in##2##4##(2007-12#1)(2008-5#1)
a 100% increase##3##3##(1990-6#1)(2007-12#1)(2008-5#1)
a 100% of##2##3##(2008-10#1)(2008-5#1)
a 100% water mobile phase##4##5##(2008-10#4)
a 100%##19##2##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-5#1)(1994-11#1)(2007-12#2)(2008-10#7)(2008-12#1)(2008-5#2)(2013-1#1)
a 100-1000##2##2##(1996-12#1)(2008-10#1)
a 100-Hz##2##2##(2008-3#2)
a 100-fold##2##2##(1991-12#1)(2008-5#1)
a 100-mum##2##2##(2007-11#1)(2007-12#1)
a 1000##3##2##(2008-10#2)(2008-5#1)
a 1000-fold##3##2##(1996-12#1)(2008-10#2)
a 1024-channel##2##2##(2008-2#2)
a 106-residue##2##2##(1994-5#2)
a 1064-nm##2##2##(2008-3#2)
a 10mul##2##2##(2008-10#2)
a 11##2##2##(1994-12#1)(2007-8#1)
a 110##2##2##(1995-5#1)(2009-8#1)
a 12##9##2##(2007-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
a 12%##3##2##(1997-4#1)(2012-1#1)(2013-1#1)
a 12-day##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
a 12-fold##2##2##(1995-2#1)(1996-12#1)
a 12-h##4##2##(1994-8#1)(1995-11#1)(2008-10#2)
a 12-kDa##2##2##(1991-6#1)(1995-6#1)
a 12-lead##2##2##(2009-10#1)(2010-1#1)
a 12-month period##5##3##(1992-1#1)(1994-9#1)(2008-10#1)(2008-12#1)(2010-4#1)
a 12-week strength-training program##2##4##(2007-12#2)
a 12-week##9##2##(2007-12#3)(2008-3#1)(2008-5#4)(2008-7#1)
a 12-year period##2##3##(2008-10#1)(2013-8#1)
a 12-year##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
a 12-year-old boy who##2##4##(2012-12#1)(2013-1#1)
a 12-year-old boy with diffuse##2##5##(2008-10#1)(2008-11#1)
a 12-year-old boy with##3##4##(2008-10#1)(2008-11#2)
a 12-year-old boy##5##3##(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
a 12-year-old girl with##2##4##(2007-12#1)(2007-8#1)
a 12-year-old girl##5##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)
a 12-year-old##10##2##(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
a 120##3##2##(1993-12#1)(2008-10#2)
a 120s##2##2##(2008-10#2)
a 13 year##2##3##(1991-3#1)(1993-6#1)
a 13##9##2##(1991-3#1)(1993-6#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
a 13% increase in##2##4##(2008-10#1)(2008-3#1)
a 13%##4##2##(2008-10#2)(2008-3#2)
a 13-year##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
a 13-year-old boy##4##3##(2007-10#1)(2007-7#1)(2008-10#1)(2013-1#1)
a 13-year-old##6##2##(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
a 130 bp##2##3##(1990-7#2)
a 14##10##2##(1992-11#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#3)
a 14-day##2##2##(1992-10#1)(2010-4#1)
a 14-kDa protein##2##3##(2008-10#1)(2009-5#1)
a 14-kDa##3##2##(2008-10#2)(2009-5#1)
a 14-month-old girl##2##3##(1997-3#1)(2008-9#1)
a 14-year-old boy who##2##4##(2007-5#1)(2012-12#1)
a 14-year-old girl with##2##4##(2006-12#1)(2008-9#1)
a 14-year-old girl##5##3##(2006-12#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
a 14-year-old##10##2##(2006-12#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-5#2)(2012-12#1)(2012-3#1)(2013-1#1)
a 140-kDa protein##2##3##(1992-3#1)(1994-12#1)
a 140-kDa##3##2##(1992-3#1)(1994-12#2)
a 15 bp##2##3##(1994-9#1)(2008-9#1)
a 15 cm##2##3##(2008-10#1)(2008-5#1)
a 15##12##2##(1992-3#1)(1993-2#1)(1994-2#1)(1994-9#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)
a 15% increase in##2##4##(2008-3#1)(2008-4#1)
a 15%##5##2##(2008-10#3)(2008-3#1)(2008-4#1)
a 15-dB##2##2##(2007-12#1)(2008-3#1)
a 15-kb##2##2##(1990-5#1)(1993-9#1)
a 15-month-old##2##2##(2007-8#2)
a 15-year##2##2##(1991-8#1)(2013-1#1)
a 15-year-old boy##2##3##(2009-9#1)(2013-1#1)
a 15-year-old girl with##2##4##(2009-5#1)(2013-8#1)
a 15-year-old girl##6##3##(2007-2#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
a 15-year-old##13##2##(2007-2#1)(2008-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a 150##5##2##(1990-8#1)(2008-10#3)(2008-11#1)
a 150-fold##2##2##(1993-8#1)(2008-10#1)
a 16##5##2##(2008-3#1)(2008-8#2)(2009-10#1)(2013-8#1)
a 16-channel##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
a 16-mW##2##2##(2007-12#2)
a 16-year-old female##2##3##(2012-3#1)(2013-1#1)
a 16-year-old##6##2##(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
a 17##8##2##(1990-12#1)(1990-6#1)(1991-11#1)(1997-3#2)(2007-10#1)(2008-12#1)(2008-5#1)
a 17%##2##2##(2008-3#1)(2013-8#1)
a 17-year##2##2##(2011-2#1)(2012-3#1)
a 17-year-old female##3##3##(2010-10#1)(2012-3#1)(2013-7#1)
a 170##3##2##(1993-3#1)(1994-5#1)(2008-10#1)
a 180 degrees##2##3##(2008-2#1)(2008-3#1)
a 180 kDa##2##3##(1996-5#2)
a 180##5##2##(1996-5#2)(2007-8#1)(2008-2#1)(2008-3#1)
a 181-bp##2##2##(2008-10#1)(2012-3#1)
a 19##3##2##(1994-5#1)(2007-12#2)
a 19%##2##2##(2008-11#1)(2008-2#1)
a 19-year-old##3##2##(2008-7#1)(2011-1#1)(2012-12#1)
a 193-nm##2##2##(2008-3#2)
a 1988##2##2##(1992-2#1)(1995-6#1)
a 1989##2##2##(1992-2#1)(1992-3#1)
a 1990##2##2##(1993-12#1)(1995-12#1)
a 1991##2##2##(1993-1#1)(1994-3#1)
a 1992##2##2##(1995-1#1)(2008-3#1)
a 1995##3##2##(1996-5#1)(2008-2#1)(2009-9#1)
a 1D##4##2##(2008-10#1)(2008-6#1)(2009-11#2)
a 2 1/2-year period##2##4##(1994-1#1)(2007-2#1)
a 2 cm##2##3##(2008-3#1)(2010-12#1)
a 2 h##4##3##(1993-9#1)(1995-5#1)(2007-12#1)(2009-9#1)
a 2 min##2##3##(1991-12#1)(2008-10#1)
a 2 mm##2##3##(2008-3#1)(2009-5#1)
a 2 x 2 factorial design##2##6##(1994-3#1)(2010-2#1)
a 2 x 2##4##4##(1994-3#1)(2008-2#1)(2008-3#1)(2010-2#1)
a 2 x##5##3##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
a 2##90##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-5#2)(2007-11#2)(2007-12#12)(2007-2#1)(2008-10#15)(2008-11#3)(2008-2#5)(2008-3#7)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
a 2% lidocaine##2##3##(1993-1#1)(1993-12#1)
a 2%##4##2##(1991-8#1)(1993-1#1)(1993-12#1)(2008-10#1)
a 2(4-1)##2##2##(2008-10#1)(2011-2#1)
a 2- to##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
a 2-##4##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
a 2-3 fold increase in##2##5##(1991-2#1)(1992-7#1)
a 2-3 fold##3##3##(1991-2#1)(1992-7#1)(2008-11#1)
a 2-3 times##2##3##(1992-6#1)(2008-1#1)
a 2-3##5##2##(1991-2#1)(1992-6#1)(1992-7#1)(2008-1#1)(2008-11#1)
a 2-5##2##2##(1996-5#1)(2008-9#1)
a 2-D##3##2##(2008-3#2)(2008-4#1)
a 2-cm##2##2##(2008-9#1)(2010-3#1)
a 2-fold increase in the##2##5##(1993-3#1)(2010-1#1)
a 2-fold increase in##4##4##(1993-3#1)(1995-2#1)(1995-6#1)(2010-1#1)
a 2-fold##8##2##(1992-4#1)(1993-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(2010-1#1)(2013-7#1)
a 2-h##2##2##(1995-11#1)(2008-10#1)
a 2-m##2##2##(2008-3#2)
a 2-min##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
a 2-month##2##2##(2008-10#1)(2011-2#1)
a 2-month-old boy with##2##4##(2007-5#1)(2008-10#1)
a 2-month-old boy##3##3##(2007-5#2)(2008-10#1)
a 2-month-old##5##2##(2007-5#2)(2008-10#1)(2010-6#2)
a 2-week interval##2##3##(2008-10#1)(2008-7#1)
a 2-week period##5##3##(2007-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)
a 2-week rest##2##3##(1991-2#2)
a 2-week##15##2##(1991-2#2)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-11#1)(2010-2#1)(2013-1#1)
a 2-year period##8##3##(1994-12#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-9#1)(2012-5#1)
a 2-year##15##2##(1991-12#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-9#1)(2012-5#1)
a 2-year-old##4##2##(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
a 20 degrees##2##3##(2008-2#1)(2008-3#1)
a 20 mM##3##3##(1997-2#1)(2008-10#2)
a 20 ml##3##3##(2008-10#3)
a 20 mul##2##3##(2008-10#2)
a 20 year##2##3##(2008-6#1)(2008-7#1)
a 20##25##2##(1990-5#1)(1992-8#1)(1997-2#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)
a 20% increase in##3##4##(2008-5#1)(2011-2#1)(2013-8#1)
a 20%##11##2##(1992-4#1)(1994-12#1)(1994-5#1)(1996-3#1)(2008-10#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-8#1)
a 20-fold##4##2##(1990-8#1)(2008-10#2)(2008-3#1)
a 20-microm##3##2##(2007-11#1)(2008-3#2)
a 20-mul##3##2##(2008-10#3)
a 20-year old man##2##4##(1993-8#1)(2013-1#1)
a 20-year##5##2##(1993-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
a 20-year-old##6##2##(1992-2#1)(1994-11#1)(2008-6#2)(2008-9#1)(2010-6#1)
a 200 kDa##2##3##(1991-5#1)(2008-6#1)
a 200##9##2##(1991-5#1)(1994-2#1)(2008-10#2)(2008-6#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)
a 200-Hz##2##2##(2007-11#1)(2008-2#1)
a 200-bp intron of the##2##5##(2008-10#2)
a 200-fold reduction##2##3##(1995-2#1)(2008-10#1)
a 200-fold##4##2##(1990-7#1)(1995-2#1)(2008-10#2)
a 200mul##2##2##(2008-10#2)
a 21 amino acid##2##4##(1995-11#1)(1995-2#1)
a 21##7##2##(1993-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-2#1)(2011-2#1)
a 21%##2##2##(1994-12#1)(2008-6#1)
a 21-year-old female patient with##2##5##(1991-8#1)(2007-10#1)
a 21-year-old##5##2##(1991-8#1)(2007-10#1)(2008-9#1)(2009-7#1)(2013-1#1)
a 22##10##2##(1990-12#1)(1992-12#1)(1993-5#1)(1994-11#1)(1994-8#1)(2008-11#1)(2008-2#2)(2008-9#1)(2013-8#1)
a 22%##2##2##(2008-10#1)(2008-5#1)
a 22-point##2##2##(2007-11#1)(2008-12#1)
a 22-year-old female##2##3##(2008-7#1)(2011-2#1)
a 22-year-old##3##2##(2008-6#1)(2008-7#1)(2011-2#1)
a 23 kDa##2##3##(1993-6#1)(1993-8#1)
a 23##13##2##(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1997-3#2)(1997-4#1)(2008-11#1)(2008-2#2)(2008-9#1)(2010-11#1)(2012-2#1)
a 23-kb##2##2##(1995-12#2)
a 23-year-old man##2##3##(1990-6#1)(1997-8#1)
a 23-year-old woman##4##3##(2007-8#1)(2008-7#1)(2010-12#1)(2013-8#1)
a 23-year-old##9##2##(1990-6#1)(1994-6#1)(1997-8#1)(2007-8#1)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
a 24 h##5##3##(1990-2#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-5#1)
a 24 year old##2##4##(1990-12#1)(2009-4#1)
a 24##11##2##(1990-12#1)(1990-2#1)(1994-2#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-7#1)(2008-5#2)(2008-7#1)(2009-4#1)
a 24-h##10##2##(1990-12#1)(1992-5#1)(1997-4#3)(2008-10#3)(2008-11#1)(2008-3#1)
a 24-hour##5##2##(1991-2#1)(1992-2#1)(1994-2#1)(1996-8#1)(1996-9#1)
a 24-month##2##2##(2012-12#1)(2013-1#1)
a 24-week##2##2##(2008-4#1)(2008-5#1)
a 24-year-old male##2##3##(2007-7#1)(2012-2#1)
a 24-year-old##5##2##(2007-7#2)(2010-9#1)(2012-2#2)
a 248-nm##2##2##(2007-12#1)(2008-3#1)
a 25 kDa##2##3##(1992-8#2)
a 25##17##2##(1990-12#1)(1992-8#2)(1995-11#1)(1996-5#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)
a 25%##6##2##(1993-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
a 25-fold##2##2##(1993-12#1)(1996-2#1)
a 25-year##4##2##(1995-3#1)(1996-5#1)(2008-10#1)(2012-3#1)
a 25-year-old patient##2##3##(2007-8#1)(2013-1#1)
a 25-year-old##4##2##(2007-8#1)(2008-12#1)(2011-1#1)(2013-1#1)
a 250-fold##3##2##(1991-12#1)(2008-10#1)(2010-3#1)
a 26##3##2##(1992-4#1)(2008-10#1)(2010-12#1)
a 26-year-old woman who##2##4##(1994-12#1)(2007-7#1)
a 26-year-old##4##2##(1990-3#1)(1994-12#1)(2007-7#1)(2010-6#1)
a 27##5##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-4#1)(1996-8#1)
a 27-kDa##3##2##(1994-5#1)(2008-10#1)(2009-2#1)
a 27-year##2##2##(1992-4#1)(2008-6#1)
a 27-year-old man##2##3##(2012-2#1)(2013-1#1)
a 27-year-old##5##2##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
a 28 year old male##2##5##(2007-7#1)(2013-1#1)
a 28##5##2##(1993-6#1)(2007-7#1)(2011-2#1)(2013-1#2)
a 28-day##3##2##(2008-10#2)(2008-7#1)
a 28-kDa##2##2##(1990-5#1)(1994-2#1)
a 28-kb##2##2##(1996-10#1)(2008-8#1)
a 28-year-old male who##2##4##(2007-10#1)(2013-8#1)
a 28-year-old male##3##3##(2007-10#1)(2013-1#1)(2013-8#1)
a 28-year-old##7##2##(2007-10#1)(2008-12#2)(2013-1#3)(2013-8#1)
a 29##3##2##(1990-11#1)(1991-11#1)(1992-4#1)
a 29-amino-acid-long##2##2##(2008-10#2)
a 29-year old##2##3##(2008-11#1)(2011-2#1)
a 29-year-old male##4##3##(1990-3#1)(2008-12#1)(2010-7#1)(2013-1#1)
a 29-year-old##8##2##(1990-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
a 2D##6##2##(2007-12#2)(2008-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
a 2mL##2##2##(2008-10#1)(2008-8#1)
a 2n prime code##2##4##(2008-3#2)
a 2n##3##2##(2008-3#2)(2010-3#1)
a 2nd dose##2##3##(1995-8#2)
a 2pi phase##3##3##(2007-11#1)(2008-3#2)
a 2x2##3##2##(2007-12#1)(2008-1#1)(2010-3#1)
a 3 min##2##3##(1991-2#1)(2008-10#1)
a 3 x##2##3##(2008-3#2)
a 3##68##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-3#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#2)(2009-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
a 3%##3##2##(2008-10#3)
a 3' untranslated region##2##4##(1993-12#1)(1994-11#1)
a 3-4-fold##3##2##(1994-5#1)(1994-8#1)(2008-10#1)
a 3-5##2##2##(1992-6#1)(2008-10#1)
a 3-D object##2##3##(2008-3#2)
a 3-D##9##2##(2008-11#2)(2008-2#1)(2008-3#6)
a 3-Hz##2##2##(2007-12#1)(2008-3#1)
a 3-dB##2##2##(2007-11#1)(2008-2#1)
a 3-day AAP##2##3##(2008-10#2)
a 3-day period##2##3##(1993-12#1)(2008-3#1)
a 3-day##10##2##(1993-12#1)(1996-5#1)(2008-10#4)(2008-3#1)(2011-2#2)(2013-1#1)
a 3-fold increase in##4##4##(1990-7#1)(1994-8#1)(1995-2#1)(2008-3#1)
a 3-fold increase##5##3##(1990-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-3#1)
a 3-fold##10##2##(1990-7#1)(1994-12#1)(1994-8#2)(1995-2#2)(1995-8#1)(1997-7#1)(2008-10#1)(2008-3#1)
a 3-h period##2##3##(1993-6#1)(2008-10#1)
a 3-hour##2##2##(2007-10#1)(2008-11#1)
a 3-min##3##2##(2008-10#2)(2009-1#1)
a 3-month period##5##3##(1997-8#1)(2007-8#1)(2008-10#2)(2012-2#1)
a 3-month##8##2##(1990-9#1)(1997-8#1)(2007-8#1)(2008-10#2)(2010-9#1)(2012-12#1)(2012-2#1)
a 3-week##3##2##(2007-12#1)(2008-5#1)(2013-8#1)
a 3-year period##9##3##(1993-12#1)(2008-1#1)(2008-10#4)(2008-9#2)(2012-2#1)
a 3-year##17##2##(1993-11#1)(1993-12#1)(1994-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
a 3-year-old##4##2##(1994-2#1)(2008-9#1)(2011-1#1)(2012-3#1)
a 30 m##2##3##(2008-10#1)(2013-1#1)
a 30 mM phosphate buffer##2##5##(1996-5#1)(2008-10#1)
a 30 min##3##3##(1994-5#1)(2008-10#2)
a 30 year old##2##4##(1990-9#1)(2012-1#1)
a 30##21##2##(1990-3#1)(1990-9#1)(1991-5#1)(1993-12#1)(1994-5#1)(1996-5#1)(2008-10#7)(2008-2#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
a 30% higher##2##3##(2008-11#1)(2008-3#1)
a 30%##13##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2012-12#1)(2013-1#1)
a 30-day##3##2##(1990-8#1)(1995-2#1)(2008-5#1)
a 30-fold##4##2##(1995-11#1)(1995-3#1)(2007-11#1)(2012-12#1)
a 30-min##4##2##(1991-5#1)(1997-4#1)(2008-2#1)(2010-12#1)
a 30-week cycling experiment in##2##5##(2008-10#2)
a 30-year period##2##3##(2008-10#1)(2008-7#1)
a 30-year-old female##2##3##(2012-12#1)(2013-8#1)
a 30-year-old male patient##2##4##(2010-5#1)(2013-1#1)
a 30-year-old man who##3##4##(1990-8#1)(2007-10#1)(2008-11#1)
a 30-year-old man##4##3##(1990-8#1)(2007-10#1)(2008-11#2)
a 30-year-old##10##2##(1990-8#1)(2007-10#1)(2007-8#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a 300##5##2##(1992-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
a 300-fold##2##2##(1990-8#1)(1995-3#1)
a 300-m##2##2##(2008-3#2)
a 300-mum##2##2##(2008-10#1)(2008-2#1)
a 31##5##2##(1990-2#1)(1991-8#1)(2008-10#1)(2009-1#1)(2013-1#1)
a 31%##2##2##(2007-11#1)(2008-3#1)
a 31-year-old woman##2##3##(1992-10#1)(2011-2#1)
a 31-year-old##4##2##(1992-10#1)(2009-10#1)(2011-2#1)(2012-3#1)
a 32##3##2##(1990-8#1)(2007-8#1)(2008-3#1)
a 32%##3##2##(1992-3#1)(2007-8#1)(2008-1#1)
a 32-year-old female##3##3##(1995-12#1)(2013-1#2)
a 32-year-old man##4##3##(2007-10#1)(2009-1#1)(2010-6#1)(2012-3#1)
a 32-year-old woman with##2##4##(2007-10#1)(2008-7#1)
a 32-year-old##15##2##(1995-12#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-1#3)
a 32P-labeled##2##2##(1990-2#1)(1991-1#1)
a 33%##3##2##(1994-11#1)(1994-8#1)(2013-8#1)
a 33-bp sequence##2##3##(1995-2#2)
a 33-kDa##3##2##(1992-9#1)(2008-10#2)
a 33-year-old##5##2##(2007-8#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
a 34 year old woman##2##5##(1991-8#1)(1993-2#1)
a 34##5##2##(1991-12#1)(1991-8#1)(1993-2#1)(1997-1#1)(2007-12#1)
a 34-year-old female##2##3##(1993-3#1)(2007-7#1)
a 34-year-old##5##2##(1993-3#1)(1996-5#1)(2006-10#1)(2007-7#1)(2007-8#1)
a 340 kDa protein##2##4##(1990-2#2)
a 35 kDa protein##2##4##(1996-6#1)(1997-8#1)
a 35##5##2##(1996-6#1)(1997-7#2)(1997-8#1)(2008-10#1)
a 35%##6##2##(1991-8#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
a 35-fold##2##2##(1992-3#1)(1996-10#1)
a 35-kDa##3##2##(1990-5#1)(1992-9#1)(1995-6#1)
a 35-year old woman##2##4##(2011-1#1)(2011-2#1)
a 35-year old##4##3##(1992-4#1)(2011-1#2)(2011-2#1)
a 35-year-old male##3##3##(2008-7#2)(2011-2#1)
a 35-year-old white woman##2##4##(2007-10#1)(2008-11#1)
a 35-year-old woman##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
a 35-year-old##11##2##(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
a 350##2##2##(1995-12#1)(2008-10#1)
a 355-nm##2##2##(2008-2#1)(2008-3#1)
a 36%##2##2##(1995-2#1)(2010-1#1)
a 36-h period##2##3##(2008-3#1)(2008-7#1)
a 36-h##3##2##(1994-2#1)(2008-3#1)(2008-7#1)
a 36-kDa polypeptide##2##3##(1995-3#1)(2008-10#1)
a 36-kDa##3##2##(1995-3#1)(1995-6#1)(2008-10#1)
a 36-m##2##2##(2008-3#2)
a 36-month##2##2##(2008-7#1)(2010-1#1)
a 36-year-old##3##2##(2009-11#1)(2012-12#1)(2012-3#1)
a 37 degrees C##3##4##(1994-3#1)(2008-11#2)
a 37##6##2##(1991-12#1)(1994-3#1)(2007-8#1)(2008-11#2)(2008-8#1)
a 37-amino acid##2##3##(1992-6#2)
a 37-year-old##4##2##(1991-3#1)(2008-12#1)(2008-7#1)(2013-1#1)
a 38##3##2##(1990-2#1)(2007-11#1)(2008-10#1)
a 38-year-old female##2##3##(2008-7#1)(2013-8#1)
a 38-year-old woman with##3##4##(1992-5#1)(2006-10#1)(2008-6#1)
a 38-year-old woman##4##3##(1992-5#1)(2006-10#1)(2007-7#1)(2008-6#1)
a 38-year-old##10##2##(1992-5#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-6#1)(2008-7#1)(2013-1#3)(2013-8#1)
a 384-well format##2##3##(2010-12#1)(2012-3#1)
a 39 year old##2##4##(1997-6#1)(2010-3#1)
a 39##3##2##(1997-6#1)(2008-3#1)(2010-3#1)
a 39-year old woman##2##4##(1997-6#1)(2013-1#1)
a 39-year-old man##2##3##(1997-5#1)(2010-2#1)
a 39-year-old##4##2##(1997-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
a 3D image##2##3##(2008-9#1)(2010-8#1)
a 3D##18##2##(2007-12#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-8#2)(2011-2#2)(2012-1#3)(2012-2#1)(2013-7#1)(2013-8#1)
a 3sigma##2##2##(2008-10#2)
a 4 week##2##3##(1994-11#1)(1996-1#1)
a 4 x 4##4##4##(2008-2#2)(2008-3#2)
a 4##43##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-2#3)(1996-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#7)(2008-7#1)(2009-10#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#2)
a 4%##3##2##(1991-8#1)(2008-10#1)(2008-2#1)
a 4-f##2##2##(2007-12#1)(2008-3#1)
a 4-fold##2##2##(2008-11#1)(2012-3#1)
a 4-h##3##2##(2008-10#2)(2008-6#1)
a 4-mm-long##2##2##(2007-12#1)(2008-3#1)
a 4-week##8##2##(1992-8#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
a 4-year period##4##3##(1994-12#1)(2008-10#2)(2008-5#1)
a 4-year##13##2##(1991-1#1)(1992-6#1)(1993-12#1)(1994-12#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-6#1)(2012-3#1)
a 4-year-old##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
a 40##18##2##(1992-11#1)(1992-5#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(2007-2#1)(2008-10#3)(2008-3#2)(2009-2#1)(2012-12#2)
a 40% decrease##2##3##(1993-12#1)(2008-3#1)
a 40% reduction##2##3##(2008-7#1)(2012-2#1)
a 40%##8##2##(1993-12#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)
a 40-kDa##2##2##(1993-9#1)(1997-1#1)
a 40-nm##2##2##(2008-2#2)
a 40-year-old woman##4##3##(1991-6#1)(2008-12#1)(2008-7#1)(2010-11#1)
a 40-year-old##7##2##(1991-6#1)(2008-12#2)(2008-7#2)(2010-11#1)(2012-2#1)
a 400##2##2##(1994-11#1)(2012-12#1)
a 41-amino acid##2##3##(1991-12#1)(1995-6#1)
a 41-year-old female##2##3##(2008-12#1)(2012-3#1)
a 41-year-old woman with##2##4##(2008-7#1)(2013-1#1)
a 41-year-old##6##2##(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#2)(2013-1#1)
a 42##5##2##(1994-12#1)(1994-8#1)(1995-6#2)(2008-7#1)
a 42-year-old man##3##3##(1991-5#1)(2008-7#1)(2012-3#1)
a 42-year-old woman##2##3##(1991-6#1)(2008-12#1)
a 42-year-old##7##2##(1991-5#1)(1991-6#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-3#1)
a 425##2##2##(1992-9#1)(2008-3#1)
a 43-year-old female##2##3##(2008-12#1)(2013-8#1)
a 43-year-old##7##2##(1991-6#1)(2007-10#2)(2007-12#1)(2008-12#1)(2008-9#1)(2013-8#1)
a 44-year old##2##3##(1992-4#1)(2008-1#1)
a 44-year-old##2##2##(1994-9#1)(2012-3#1)
a 45 degrees##6##3##(2008-3#6)
a 45##7##2##(2008-3#6)(2008-8#1)
a 45%##2##2##(2008-11#1)(2012-2#1)
a 45-fold##2##2##(1994-5#1)(2011-2#1)
a 45-year-old male##2##3##(2008-11#1)(2010-6#1)
a 45-year-old patient##2##3##(2007-8#1)(2012-2#1)
a 45-year-old##8##2##(2007-8#1)(2008-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a 450-kb##2##2##(1997-2#1)(2010-4#1)
a 46##3##2##(1994-11#1)(2008-2#1)(2013-1#1)
a 46-year-old man##2##3##(1996-6#1)(2008-9#1)
a 46-year-old##8##2##(1996-6#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
a 47%##2##2##(1990-5#1)(2008-3#1)
a 48##4##2##(1993-6#1)(1994-5#1)(1996-6#1)(2008-12#1)
a 48%##3##2##(1990-5#1)(1995-5#1)(2008-11#1)
a 48-kDa##2##2##(1994-12#1)(2008-10#1)
a 48-year-old man##2##3##(2013-1#2)
a 48-year-old woman##4##3##(2009-1#1)(2009-3#1)(2012-12#1)(2012-3#1)
a 48-year-old##8##2##(2008-6#1)(2009-1#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
a 49##2##2##(1994-11#1)(2008-8#1)
a 4f##2##2##(2008-3#2)
a 4g enema##2##3##(2010-12#2)
a 5 L##2##3##(2008-6#1)(2008-8#1)
a 5 min##2##3##(2008-10#2)
a 5 mm##3##3##(1991-12#1)(1993-3#1)(2013-1#1)
a 5 year##3##3##(1993-9#1)(2008-10#2)
a 5##39##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-1#1)(2007-12#3)(2008-10#14)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#3)(2013-1#1)
a 5% (v/v)##2##3##(2008-10#2)
a 5%##15##2##(1990-6#1)(1991-2#1)(1996-12#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-5#1)(2010-9#1)
a 5' region of##2##4##(1990-12#1)(1997-7#1)
a 5' region##4##3##(1990-12#3)(1997-7#1)
a 5'##7##2##(1990-12#3)(1994-11#1)(1997-7#1)(1997-8#1)(2008-10#1)
a 5-##3##2##(1994-3#1)(1994-8#1)(2008-10#1)
a 5-N##2##2##(2009-12#1)(2009-2#1)
a 5-cm-long##2##2##(2007-12#2)
a 5-fold##5##2##(1992-10#1)(1994-8#1)(1996-12#1)(2008-10#1)(2012-12#1)
a 5-hydroxytryptamine (5-HT)(2A/C) receptor antagonist and an alpha(2)- and alpha(1)-adrenoceptor antagonist##2##11##(2008-6#2)
a 5-kb##2##2##(1993-2#1)(1997-7#1)
a 5-min residence time##3##4##(2008-5#3)
a 5-min##7##2##(2008-10#2)(2008-2#2)(2008-5#3)
a 5-ml##3##2##(2008-10#3)
a 5-mm##5##2##(2006-6#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-9#1)
a 5-mm-long##3##2##(2007-12#3)
a 5-year period##7##3##(1991-2#1)(1997-8#1)(2007-2#1)(2007-8#1)(2009-8#1)(2010-1#1)(2011-2#1)
a 5-year##15##2##(1991-2#1)(1996-2#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
a 5-year-old boy##2##3##(1990-6#1)(2013-1#1)
a 5-year-old##9##2##(1990-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
a 50 cm##2##3##(1996-5#1)(2008-10#1)
a 50 mM##2##3##(1996-5#1)(2008-10#1)
a 50##22##2##(1993-3#1)(1994-12#1)(1994-3#1)(1996-5#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-3#1)
a 50% (v/v)##2##3##(2008-10#2)
a 50% competitive##2##3##(1993-3#1)(1995-8#1)
a 50% decrease in##4##4##(1990-7#1)(1991-11#1)(1993-6#1)(2008-11#1)
a 50% decrease##5##3##(1990-11#1)(1990-7#1)(1991-11#1)(1993-6#1)(2008-11#1)
a 50% duty cycle##2##4##(2007-11#1)(2008-3#1)
a 50% improvement##2##3##(2008-11#1)(2008-6#1)
a 50% reduction in##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
a 50% reduction##5##3##(2007-12#1)(2008-10#2)(2008-6#1)(2013-1#1)
a 50%##34##2##(1990-11#1)(1990-7#1)(1991-11#1)(1992-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-11#2)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#3)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
a 50-W##2##2##(2007-11#2)
a 50-fold molar excess##3##4##(1990-11#2)(1997-4#1)
a 50-fold##5##2##(1990-11#2)(1994-8#1)(1997-4#1)(2008-3#1)
a 50-ha##2##2##(2008-8#1)(2008-9#1)
a 50-kDa##3##2##(1993-12#1)(1993-6#2)
a 50-mm-diameter##2##2##(2007-11#1)(2008-2#1)
a 50-year-old man with##2##4##(2008-7#1)(2012-2#1)
a 50-year-old man##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
a 50-year-old woman with a##2##5##(2011-2#1)(2012-12#1)
a 50-year-old##7##2##(2007-8#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
a 50/50##4##2##(1993-12#1)(2007-12#2)(2008-10#1)
a 500##6##2##(1990-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
a 500-fold##4##2##(1994-12#1)(1995-2#1)(2008-1#1)(2008-2#1)
a 500-fs##2##2##(2007-11#2)
a 505##2##2##(1993-8#1)(1995-2#1)
a 51-kDa##2##2##(2008-10#2)
a 51-year-old man##2##3##(2012-12#1)(2013-1#1)
a 51-year-old woman presenting with a##2##6##(2008-5#1)(2013-1#1)
a 51-year-old woman##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
a 51-year-old##10##2##(1994-12#1)(1995-3#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
a 52##2##2##(2012-12#1)(2013-1#1)
a 52-year-old male##2##3##(2011-2#1)(2013-1#1)
a 52-year-old woman who##2##4##(2011-1#1)(2011-2#1)
a 52-year-old##6##2##(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
a 529##3##2##(1992-12#1)(2008-11#2)
a 53 year old##2##4##(1991-5#1)(2009-8#1)
a 53##4##2##(1991-5#1)(1993-11#1)(2009-8#1)(2013-8#1)
a 53%##2##2##(1992-8#1)(1993-6#1)
a 53-kDa##2##2##(1993-8#1)(1995-9#1)
a 53-year-old man##3##3##(1992-6#1)(2007-10#1)(2008-11#1)
a 53-year-old##5##2##(1992-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-11#1)
a 532-nm##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
a 54##4##2##(1997-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
a 54-year-old man##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
a 54-year-old woman##2##3##(2013-1#2)
a 54-year-old##7##2##(2007-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2013-1#2)(2013-7#1)
a 54-years old##2##3##(1992-4#1)(2012-12#1)
a 55##2##2##(1991-3#1)(1992-8#1)
a 55-year-old woman##2##3##(2008-6#1)(2013-1#1)
a 55-year-old##5##2##(1992-12#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
a 56-year-old##3##2##(2007-10#1)(2010-12#1)(2010-9#1)
a 57##3##2##(2007-11#1)(2007-2#1)(2008-10#1)
a 57-year-old man##4##3##(1997-8#1)(2008-12#1)(2011-2#2)
a 57-year-old##6##2##(1997-8#1)(2008-12#1)(2010-5#1)(2011-2#2)(2013-7#1)
a 58-year-old male##2##3##(2007-8#1)(2009-9#1)
a 58-year-old man with##2##4##(2009-3#1)(2011-2#1)
a 58-year-old man##4##3##(1990-2#1)(2008-7#1)(2009-3#1)(2011-2#1)
a 58-year-old patient##3##3##(1991-2#1)(2011-2#1)(2013-1#1)
a 58-year-old##9##2##(1990-2#1)(1991-2#1)(2007-8#1)(2008-7#1)(2009-3#1)(2009-9#1)(2011-2#2)(2013-1#1)
a 59-year-old man##2##3##(2007-8#1)(2009-8#1)
a 59-year-old##5##2##(2007-8#1)(2009-8#1)(2012-12#1)(2013-8#2)
a 5S##2##2##(1997-2#1)(2008-5#1)
a 5x10(-4) M##3##3##(2008-10#3)
a 6 MV##2##3##(1991-2#1)(2008-3#1)
a 6 x##2##3##(1995-8#1)(2008-3#1)
a 6##20##2##(1990-12#1)(1991-2#1)(1993-2#1)(1995-2#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2009-12#1)(2012-2#1)(2013-1#1)
a 6-cm##3##2##(2008-10#1)(2008-6#1)(2009-2#1)
a 6-fold decrease in##2##4##(1993-6#1)(1995-2#1)
a 6-fold increase in##4##4##(1992-11#1)(1993-3#1)(1995-11#1)(2008-3#1)
a 6-fold##6##2##(1992-11#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(2008-3#1)
a 6-h##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
a 6-month period##4##3##(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#1)
a 6-month##11##2##(2008-1#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-1#2)
a 6-month-old##2##2##(2008-12#1)(2012-3#1)
a 6-point##2##2##(2008-12#1)(2008-6#1)
a 6-week##5##2##(1995-3#1)(2007-12#1)(2011-2#2)(2013-1#1)
a 6-year period##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
a 6-year##8##2##(2007-8#2)(2008-10#3)(2010-4#1)(2013-1#2)
a 6-year-old boy##2##3##(2007-8#1)(2010-5#1)
a 6-year-old girl##2##3##(1995-4#1)(2010-3#1)
a 6-year-old##6##2##(1995-4#1)(2007-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-6#1)
a 60 degrees##2##3##(2007-11#2)
a 60 kDa heat shock protein of Helicobacter pylori##2##9##(1996-12#2)
a 60 kDa##4##3##(1996-12#4)
a 60 s preconcentration time##3##5##(2008-10#3)
a 60 s##4##3##(2008-10#4)
a 60##17##2##(1992-11#1)(1996-12#4)(2007-11#2)(2008-10#6)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#1)
a 60% reduction##2##3##(2008-3#1)(2008-7#1)
a 60%##8##2##(1994-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
a 60-day##2##2##(2012-2#1)(2012-8#1)
a 60-kDa##2##2##(1990-12#1)(1994-6#1)
a 60-s##2##2##(2008-10#1)(2008-12#1)
a 60-year-old male##3##3##(1997-2#1)(2012-1#1)(2013-1#1)
a 60-year-old man with##2##4##(1996-6#1)(2007-4#1)
a 60-year-old man##4##3##(1996-6#1)(2007-4#1)(2007-8#1)(2008-7#1)
a 60-year-old woman##4##3##(2008-4#1)(2009-1#1)(2009-3#1)(2012-3#1)
a 60-year-old##11##2##(1996-6#1)(1997-2#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
a 600##2##2##(2008-2#1)(2008-7#1)
a 61##2##2##(2008-10#1)(2011-1#1)
a 61-year-old woman##4##3##(1992-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
a 61-year-old##9##2##(1992-8#1)(1996-3#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-7#1)(2013-8#1)
a 62 kDa##2##3##(1990-11#1)(1990-7#1)
a 62-year-old woman##4##3##(1991-11#1)(1994-6#1)(2008-10#1)(2009-3#1)
a 62-year-old##6##2##(1991-11#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-3#1)
a 63 years old patient##2##5##(2007-8#1)(2010-12#1)
a 63 years old##4##4##(1991-11#1)(2007-8#1)(2010-12#1)(2013-7#1)
a 63##7##2##(1991-11#1)(2007-8#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
a 63-year-old woman who##2##4##(2007-5#1)(2013-8#1)
a 63-year-old woman##3##3##(2007-5#1)(2008-5#1)(2013-8#1)
a 63-year-old##6##2##(2006-10#1)(2007-5#1)(2008-5#1)(2012-12#1)(2013-8#2)
a 635-nm##2##2##(2008-3#2)
a 64-year-old male##2##3##(2012-12#1)(2013-1#1)
a 64-year-old##6##2##(1996-11#1)(2007-10#1)(2012-12#1)(2013-1#3)
a 65##3##2##(1990-2#1)(2008-5#1)(2010-5#1)
a 65%##2##2##(1991-8#1)(2008-10#1)
a 65-year-old woman with##2##4##(2007-10#1)(2012-3#1)
a 65-year-old woman##3##3##(2007-10#1)(2008-11#1)(2012-3#1)
a 65-year-old##5##2##(1992-10#1)(2007-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
a 66 degrees incident angle##2##5##(2008-3#2)
a 66 degrees##3##3##(2008-3#2)(2008-8#1)
a 66##4##2##(1997-2#1)(2008-3#2)(2008-8#1)
a 66-year-old man##4##3##(1994-3#1)(2008-6#1)(2009-1#1)(2012-12#1)
a 66-year-old woman##3##3##(1992-2#1)(2007-8#1)(2012-3#1)
a 66-year-old##8##2##(1992-2#1)(1994-3#1)(2007-8#1)(2008-6#1)(2009-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
a 67##2##2##(2007-8#1)(2008-12#1)
a 67-year-old man##3##3##(1991-8#1)(2008-7#1)(2013-1#1)
a 67-year-old##5##2##(1991-8#1)(2008-7#1)(2012-3#1)(2013-1#2)
a 68-year-old##3##2##(2008-1#1)(2008-12#1)(2010-12#1)
a 69 year-old##2##3##(1990-8#1)(2007-7#1)
a 69##3##2##(1990-8#1)(1992-3#1)(2007-7#1)
a 69-year-old##2##2##(2008-7#1)(2010-6#1)
a 7##17##2##(1990-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#1)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
a 7-##2##2##(1993-6#1)(2008-10#1)
a 7-W##2##2##(2007-12#1)(2008-3#1)
a 7-day##3##2##(1992-12#1)(2008-10#1)(2009-11#1)
a 7-fold##3##2##(1996-5#1)(2007-10#1)(2008-11#1)
a 7-week##3##2##(1994-1#1)(2008-10#1)(2013-7#1)
a 7-year##4##2##(1994-1#1)(2010-6#1)(2011-2#2)
a 7-year-old girl##3##3##(2008-10#2)(2013-1#1)
a 7-year-old##5##2##(2008-10#2)(2010-9#1)(2013-1#2)
a 70%##6##2##(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#3)
a 70-80%##2##2##(1997-2#1)(2008-3#1)
a 70-kDa##2##2##(1993-6#1)(1994-8#1)
a 70-year-old lady##2##3##(2008-12#1)(2013-1#1)
a 70-year-old male##2##3##(1992-2#1)(2013-1#1)
a 70-year-old woman with##2##4##(2011-2#1)(2012-3#1)
a 70-year-old woman##4##3##(1991-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
a 70-year-old##9##2##(1991-12#1)(1992-2#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
a 71-year-old##4##2##(1992-12#1)(1992-2#1)(2007-5#1)(2010-12#1)
a 72##3##2##(1991-12#1)(1991-5#1)(1994-9#1)
a 72-h##2##2##(2008-10#2)
a 72-year-old female##2##3##(2011-2#1)(2012-12#1)
a 72-year-old man who##2##4##(2007-12#1)(2010-6#1)
a 72-year-old woman who##2##4##(2007-8#1)(2008-7#1)
a 72-year-old woman##5##3##(1997-7#1)(2007-8#1)(2008-7#1)(2010-7#1)(2012-12#1)
a 72-year-old##10##2##(1997-7#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)
a 73 kDa##2##3##(1993-6#1)(1993-8#1)
a 73##5##2##(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(2007-11#1)
a 73%##2##2##(2008-3#1)(2008-9#1)
a 73-year-old##3##2##(2007-12#1)(2013-1#2)
a 74##3##2##(1992-10#1)(1996-3#1)(2013-1#1)
a 74%##3##2##(1991-8#1)(1994-12#1)(1997-6#1)
a 74-year-old woman##3##3##(2009-1#1)(2012-12#1)(2013-7#1)
a 74-year-old##5##2##(2009-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
a 75%##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
a 75-year-old male##2##3##(2008-7#1)(2012-2#1)
a 75-year-old woman with##2##4##(1991-11#1)(2007-8#1)
a 75-year-old##5##2##(1991-11#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-2#1)
a 76##2##2##(1990-2#1)(2008-10#1)
a 76-year-old woman##2##3##(1993-12#1)(2011-2#1)
a 76-year-old##3##2##(1993-12#1)(2008-1#1)(2011-2#1)
a 77-year-old##2##2##(2007-10#1)(2009-8#1)
a 78%##3##2##(1991-6#1)(2008-12#1)(2012-2#1)
a 78-kDa##2##2##(1993-12#2)
a 78-year-old woman who##2##4##(2009-3#1)(2010-4#1)
a 78-year-old##5##2##(1990-8#1)(2008-6#1)(2009-3#1)(2010-4#1)(2013-1#1)
a 780-nm##2##2##(2008-2#2)
a 79##3##2##(1997-2#1)(2008-12#2)
a 8##3##2##(1992-11#1)(1997-3#2)
a 83-year-old##2##2##(1991-6#1)(2013-1#1)
a 9##14##2##(1993-6#2)(1995-11#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
a 9%##3##2##(1996-12#1)(2008-3#1)(2010-10#1)
a 9-month##2##2##(1993-12#1)(2010-6#1)
a 9-point##2##2##(2010-12#2)
a 9-year-old boy##4##3##(1994-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
a 9-year-old##7##2##(1991-6#1)(1994-3#1)(1996-6#1)(2008-10#1)(2012-12#2)(2013-1#1)
a 90 degrees phase##2##4##(2008-2#1)(2008-3#1)
a 90 kDa##2##3##(1997-3#1)(2009-8#1)
a 90##4##2##(1997-3#1)(2008-2#1)(2008-3#1)(2009-8#1)
a 90% incidence of tumor-bearing mice with an average of##2##10##(1990-7#2)
a 90%##10##2##(1990-7#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#1)
a 90-microm##2##2##(2008-3#2)
a 91-year-old##2##2##(1996-5#1)(2008-11#1)
a 94##2##2##(1991-9#1)(1993-3#1)
a 94-kDa##3##2##(1992-3#1)(2008-10#2)
a 95% confidence interval##2##4##(1991-7#1)(2008-3#1)
a 95% confidence level with##2##5##(2008-10#2)
a 95% confidence level##11##4##(2008-10#10)(2008-3#1)
a 95% confidence##13##3##(1991-7#1)(2008-10#10)(2008-3#2)
a 95%##16##2##(1990-7#1)(1991-7#1)(2008-10#12)(2008-3#2)
a 96%##2##2##(1997-8#1)(2013-8#1)
a 96-well microtiter plate##3##4##(1997-7#1)(2008-10#1)(2008-9#1)
a 96-well##5##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
a 99 kDa##2##3##(1991-9#2)
a 99##5##2##(1991-9#2)(2008-10#2)(2008-3#1)
a = 10##5##3##(1996-2#4)(1997-7#1)
a = 12##2##3##(1996-2#2)
a = 13##6##3##(1996-2#2)(1997-7#4)
a = 15##2##3##(1996-2#1)(1997-7#1)
a = 18##2##3##(1996-2#2)
a = 21##3##3##(1996-2#2)(1997-7#1)
a = 22##2##3##(1996-2#1)(1997-7#1)
a = 8##7##3##(1996-2#3)(1997-7#4)
a = 9##5##3##(1996-2#2)(1997-7#2)(2007-11#1)
a = b =##2##4##(1992-11#1)(1996-2#1)
a =##56##2##(1992-11#1)(1992-12#1)(1992-9#1)(1996-2#29)(1996-5#1)(1997-7#18)(2007-11#2)(2008-12#1)(2008-8#1)(2013-8#1)
a ?##2##2##(2007-11#2)
a AgGaSe(2) crystal##2##3##(2008-2#2)
a AgGaSe(2)##3##2##(2008-2#3)
a Au(111) single crystal electrode##2##5##(2008-10#2)
a Au(111)##3##2##(2008-10#3)
a B##15##2##(1993-12#1)(1997-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#2)(2012-2#3)
a B-cell##2##2##(2008-10#1)(2009-8#1)
a B2##3##2##(1991-2#1)(1992-3#1)(1996-10#1)
a BAC##4##2##(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
a BCL2 GR##3##3##(2009-8#3)
a BCL2##4##2##(2009-8#4)
a BES-buffered system is used that allows the precipitate to form gradually in the medium and then drop onto the cells##2##21##(2008-1#1)(2008-2#1)
a BLAST search##2##3##(2008-9#1)(2013-1#1)
a BLAST##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
a BMI greater than##2##4##(2008-1#2)
a BMI##4##2##(2006-8#1)(2008-1#2)(2008-3#1)
a BaTiO(3)##2##2##(2007-12#1)(2008-2#1)
a Bachelor of Nursing degree##2##5##(2008-12#2)
a Bachelor of Nursing##3##4##(2008-12#2)(2012-3#1)
a Bacillus##3##2##(1990-11#1)(1991-6#1)(2008-10#1)
a Basic##2##2##(1994-6#1)(2008-2#1)
a Bayesian approach##2##3##(1995-2#1)(2008-8#1)
a Bayesian##13##2##(1994-11#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-4#1)(2011-1#1)(2013-1#1)
a Bessel beam##3##3##(2007-11#1)(2008-2#2)
a Bessel##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
a Bi(12)TiO(20) crystal##2##3##(2007-11#1)(2008-3#1)
a Biocontrol Agent##2##3##(2008-10#2)
a Biocontrol##3##2##(2008-10#3)
a BmNPV##2##2##(1997-3#2)
a Bmax of##3##3##(1990-2#1)(1990-7#1)(1991-5#1)
a Bmax##4##2##(1990-2#1)(1990-7#1)(1991-5#1)(1993-8#1)
a Boeing##2##2##(1996-12#1)(2008-11#1)
a Bragg grating##4##3##(2007-12#2)(2008-3#2)
a Bragg##6##2##(2007-12#4)(2008-3#2)
a Brazilian##2##2##(2011-2#1)(2013-8#1)
a Brewer##2##2##(2008-2#2)
a Brillouin##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a British##6##2##(1993-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)
a Broad##2##2##(2008-10#2)
a Broadband##2##2##(2008-3#2)
a Brownian##2##2##(2008-8#1)(2010-12#1)
a Bruker##2##2##(2008-2#1)(2008-3#1)
a Bulgarian##2##2##(2008-9#1)(2009-10#1)
a Burkard##2##2##(2008-10#2)
a C##11##2##(1994-12#1)(2008-10#8)(2008-7#1)(2008-8#1)
a C(18) column and##3##4##(2008-10#2)(2012-2#1)
a C(18) column##7##3##(2008-10#6)(2012-2#1)
a C(18)##17##2##(2008-10#15)(2009-8#1)(2012-2#1)
a C(4)##2##2##(2008-9#1)(2009-10#1)
a C(60)##2##2##(2009-10#1)(2012-1#1)
a C(8) column##2##3##(2008-10#2)
a C-18##5##2##(2008-10#5)
a C-shaped##2##2##(2011-2#2)
a C-terminal region##2##3##(2008-10#1)(2009-10#1)
a C-terminal##21##2##(1991-5#1)(1992-6#2)(1993-12#1)(1993-6#2)(1993-9#1)(1995-12#1)(1995-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-8#3)(2009-10#2)(2009-6#2)(2009-9#1)(2012-2#1)
a C/EBP binding site##2##4##(1990-5#2)
a C1##2##2##(2008-10#2)
a C18 column with a##2##5##(1990-8#1)(2008-10#1)
a C18 column with##3##4##(1990-8#1)(2008-10#1)(2011-1#1)
a C18 column##8##3##(1990-8#1)(1993-9#1)(1995-6#1)(2008-10#4)(2011-1#1)
a C18##12##2##(1990-8#1)(1993-11#1)(1993-9#1)(1995-6#1)(1996-5#1)(2008-10#4)(2011-1#2)(2011-3#1)
a C20##3##2##(1990-7#1)(1997-1#2)
a C3 ketone##3##3##(1997-1#3)
a C3##4##2##(1997-1#3)(2008-10#1)
a CAAT box##2##3##(1993-6#2)
a CAAT##4##2##(1993-3#1)(1993-6#2)(1997-7#1)
a CAPD##2##2##(2007-12#2)
a CC chemokine##2##3##(2010-5#2)
a CCD array##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
a CCD camera and##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a CCD camera##21##3##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#11)
a CCD detector##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a CCD##44##2##(2007-11#5)(2007-12#3)(2008-10#4)(2008-2#10)(2008-3#22)
a CCI##2##2##(1997-2#1)(2008-11#1)
a CCK##3##2##(1994-2#2)(1995-11#1)
a CCK-B receptor antagonist##2##4##(1995-12#2)
a CD##5##2##(1990-8#3)(2008-12#1)(2008-3#1)
a CD-ROM##2##2##(1993-1#1)(2008-11#1)
a CD4##2##2##(1993-3#1)(2013-1#1)
a CGH##2##2##(2008-3#2)
a CHIN##3##2##(1996-1#3)
a CHO cell line##5##4##(1990-8#1)(2008-11#3)(2011-2#1)
a CHO##8##2##(1990-8#1)(1994-1#2)(2008-11#4)(2011-2#1)
a CI##2##2##(2010-10#1)(2012-2#1)
a CL##2##2##(2008-10#2)
a CL-HPLC##2##2##(2008-5#2)
a CNS##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
a CO##3##2##(1992-3#1)(2008-2#1)(2008-3#1)
a CO(2) laser beam##2##4##(2008-2#2)
a CO(2) laser##7##3##(2007-11#1)(2008-2#3)(2008-3#3)
a CO(2)##13##2##(2007-11#1)(2008-11#1)(2008-2#6)(2008-3#5)
a CPD##2##2##(1994-8#2)
a CPP##2##2##(1993-6#1)(1994-2#1)
a CPU##2##2##(2008-3#2)
a CQI##5##2##(1993-2#3)(1995-12#1)(1996-1#1)
a CRDS##3##2##(2008-2#3)
a CSF##3##2##(1993-8#1)(1994-8#1)(2011-2#1)
a CT scan##5##3##(1990-12#1)(1990-6#1)(1995-11#1)(2007-8#1)(2013-1#1)
a CT##9##2##(1990-12#1)(1990-6#1)(1992-5#1)(1994-12#1)(1995-11#1)(1997-2#1)(2007-8#2)(2013-1#1)
a CWP##3##2##(2008-10#3)
a Ca(2+)##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
a Ca(2+)-activated##2##2##(1992-6#1)(1995-11#1)
a Ca(2+)-dependent##6##2##(1992-6#1)(1992-7#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-4#1)
a Ca(2+)-independent##2##2##(1992-12#1)(1994-11#1)
a Ca2+ channel blocker##3##4##(1991-9#1)(1995-11#1)(1995-12#1)
a Ca2+ channel##4##3##(1991-9#1)(1995-11#1)(1995-12#1)(1997-7#1)
a Ca2+##12##2##(1990-2#1)(1990-8#2)(1991-9#1)(1994-11#2)(1994-2#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-7#1)
a California##6##2##(1992-2#1)(1995-12#2)(1997-5#1)(2008-10#2)
a Canadian experience##2##3##(2008-6#1)(2012-12#1)
a Canadian##17##2##(1992-12#1)(1992-3#1)(1996-12#1)(2007-12#3)(2007-2#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2012-12#1)(2013-1#1)
a Care Map##2##3##(1995-3#2)
a Case##5##2##(1994-7#1)(1996-6#1)(2011-1#2)(2012-2#1)
a Catholic##3##2##(1993-12#1)(1994-1#1)(1997-1#1)
a Cause of##2##3##(1997-6#1)(2008-1#1)
a CdGeAs(2)##2##2##(2008-2#2)
a Ce##5##2##(2007-12#3)(2008-3#1)(2011-2#1)
a Ce(3+)##2##2##(2008-2#2)
a Chiari##2##2##(2008-7#1)(2012-12#1)
a Chilean##5##2##(2012-12#1)(2013-1#4)
a Chinese hamster ovary (CHO) cell##2##6##(2008-11#1)(2008-7#1)
a Chinese hamster ovary##3##4##(2008-11#2)(2008-7#1)
a Chinese##15##2##(1991-6#1)(1994-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#5)(2013-7#1)(2013-8#1)
a Cl-##2##2##(1990-2#2)
a Clinical##3##2##(2007-2#1)(2008-11#1)(2010-3#1)
a Co(2+)##4##2##(2007-11#2)(2008-3#2)
a Colletotrichum##2##2##(2008-10#2)
a Colombian population##2##3##(2012-12#2)
a Combined##2##2##(2008-3#1)(2009-11#1)
a Congressional##2##2##(2009-6#1)(2012-3#1)
a Conserved##2##2##(2008-10#1)(2012-2#1)
a Control##2##2##(2011-1#2)
a CpG island##4##3##(1991-6#1)(1996-10#1)(2007-11#1)(2010-3#1)
a CpG##5##2##(1991-6#1)(1996-10#1)(2007-11#1)(2008-10#1)(2010-3#1)
a Cr##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
a Cr(4+)##8##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#1)
a Cr4+##2##2##(2008-3#2)
a Crataegus##2##2##(1992-5#1)(2008-10#1)
a Critical##2##2##(1995-3#1)(2011-2#1)
a Cs(+)-selective electrode##2##3##(2008-10#2)
a Cu electrode##2##3##(2008-10#2)
a Cu##3##2##(2008-10#2)(2008-3#1)
a Cys##2##2##(1993-11#1)(1994-12#1)
a D-##2##2##(1994-12#1)(1995-2#1)
a DA##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
a DDR2##2##2##(2012-2#2)
a DIAL system##2##3##(2008-3#2)
a DIC##2##2##(2008-4#1)(2010-3#1)
a DNA fragment containing the R##2##6##(1993-6#2)
a DNA fragment containing the##3##5##(1993-6#2)(1995-2#1)
a DNA fragment containing##4##4##(1990-5#1)(1993-6#2)(1995-2#1)
a DNA fragment##10##3##(1990-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-8#1)
a DNA probe##2##3##(1990-5#1)(2008-10#1)
a DNA sample##2##3##(2007-10#1)(2008-12#1)
a DNA sensor##2##3##(2013-7#2)
a DNA sequence##5##3##(1992-8#1)(1993-6#1)(2008-10#2)(2008-8#1)
a DNA##64##2##(1990-5#3)(1990-6#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-8#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-10#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)
a DNA-binding##5##2##(1990-11#1)(1992-8#1)(1993-11#1)(2008-9#1)(2010-10#1)
a DNR order##7##3##(1992-12#3)(1992-3#4)
a DSM-IV##2##2##(2008-1#1)(2008-6#1)
a DVD##4##2##(2007-12#1)(2008-3#3)
a Deflux bleb##2##3##(2008-7#2)
a Difference curriculum##2##3##(2008-11#2)
a Difference##8##2##(2008-11#8)
a Diode-Pumped##4##2##(2008-2#1)(2008-3#3)
a Diploma in##5##3##(2008-1#1)(2008-11#3)(2013-1#1)
a Disordered##2##2##(1996-9#2)
a Distinct##4##2##(2008-10#4)
a Doppler##4##2##(1991-12#1)(2008-2#2)(2008-4#1)
a Drosophila##6##2##(1990-12#1)(1993-2#1)(1995-2#1)(1996-12#1)(2008-8#1)(2008-9#1)
a Dutch##5##2##(2007-12#1)(2009-12#1)(2011-1#2)(2011-2#1)
a European American##3##3##(2009-11#3)
a European##10##2##(1994-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-10#2)(2009-11#3)(2011-2#1)
a FACS##2##2##(2008-11#1)(2008-4#1)
a FDA approved##2##3##(2008-7#1)(2010-11#1)
a FFPI##2##2##(2007-11#2)
a FIA system##3##3##(2008-10#3)
a FIA##7##2##(2008-10#7)
a FRT##2##2##(2007-11#2)
a FWHM of##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
a FWHM##8##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#3)
a Fabry-Perot cavity##4##3##(2008-2#2)(2008-3#2)
a Fabry-Perot interferometer##7##3##(2008-2#1)(2008-3#6)
a Fabry-Perot laser diode##3##4##(2008-2#2)(2008-3#1)
a Fabry-Perot optical cavity##2##4##(2008-2#2)
a Fabry-Perot resonator##2##3##(2007-11#1)(2008-3#1)
a Fabry-Perot##29##2##(2007-11#2)(2007-12#2)(2008-2#12)(2008-3#13)
a Family Health##2##3##(2010-10#1)(2011-2#1)
a Family##3##2##(1992-1#1)(2010-10#1)(2011-2#1)
a Faraday rotator##3##3##(2007-12#1)(2008-3#2)
a Faraday##5##2##(2007-12#1)(2008-3#3)(2008-7#1)
a Fast##2##2##(2007-9#1)(2008-7#1)
a Fe##2##2##(2008-2#1)(2008-3#1)
a Fish##2##2##(2008-10#1)(2008-5#1)
a Fizeau##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a Fourier plane##3##3##(2007-11#1)(2008-2#2)
a Fourier series##2##3##(2008-2#1)(2008-3#1)
a Fourier transform infrared spectrometer##2##5##(2008-10#1)(2008-3#1)
a Fourier transform infrared##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
a Fourier transform spectrometer##4##4##(2008-2#1)(2008-3#3)
a Fourier transform##13##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#5)
a Fourier##21##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#7)(2008-3#8)
a Fourier-transform infrared spectrometer##2##4##(2008-3#2)
a Fourier-transform infrared##4##3##(2008-2#1)(2008-3#3)
a Fourier-transform method##2##3##(2008-2#1)(2008-3#1)
a Fourier-transform##13##2##(1996-7#1)(2007-12#1)(2008-2#3)(2008-3#8)
a French##7##2##(2008-3#2)(2008-7#3)(2010-6#1)(2011-2#1)
a Fresnel lens##2##3##(2008-3#2)
a Fresnel##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
a Frontal##2##2##(2013-8#2)
a Fungal##2##2##(2008-10#2)
a Fusarium##5##2##(2008-10#5)
a G protein##6##3##(1993-6#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-7#2)
a G##13##2##(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#2)(1995-8#2)(1997-7#2)(2008-4#1)(2009-5#1)
a G--&gt##2##2##(1993-3#1)(1994-12#1)
a G-26 in-vivo mouse model##2##5##(1994-11#2)
a G-protein-coupled##2##2##(1995-11#1)(1995-6#1)
a GC##5##2##(2008-10#5)
a GFD##2##2##(2011-2#2)
a GFP reporter gene##2##4##(2008-10#2)
a GFP##4##2##(2008-1#1)(2008-10#3)
a GPL anchor##2##3##(1992-3#2)
a GPU##3##2##(2012-2#3)
a GTP analogue##2##3##(1995-11#1)(1996-5#1)
a GTP##3##2##(1993-12#1)(1995-11#1)(1996-5#1)
a GTP-binding protein##3##3##(1992-8#1)(1993-6#1)(1995-8#1)
a GTPase activating protein##2##4##(1991-12#1)(1991-5#1)
a GaAs##10##2##(2007-11#4)(2008-2#5)(2008-3#1)
a GaAsP photodiode##3##3##(2007-11#1)(2007-12#2)
a Gamma##2##2##(2011-2#1)(2012-12#1)
a Gaussian beam##10##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#5)
a Gaussian distribution##2##3##(2008-2#1)(2008-3#1)
a Gaussian function##2##3##(2008-2#1)(2008-3#1)
a Gaussian intensity profile##2##4##(2008-3#2)
a Gaussian laser beam##3##4##(2007-11#1)(2008-3#1)(2009-6#1)
a Gaussian mixture##2##3##(2012-3#1)(2013-1#1)
a Gaussian##45##2##(2007-11#6)(2007-12#3)(2008-2#11)(2008-3#20)(2008-6#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#1)
a Gaussian-synapse neuron model##2##4##(2008-3#2)
a Gene##5##2##(2008-10#5)
a Genetic##3##2##(2008-10#2)(2008-8#1)
a Geographic Information System##2##4##(2007-5#1)(2009-7#1)
a German population##2##3##(2008-12#2)
a German##5##2##(2008-10#1)(2008-12#2)(2010-4#1)(2012-1#1)
a Global##3##2##(2008-10#2)(2012-12#1)
a Gly##3##2##(1992-8#1)(1994-12#1)(1997-3#1)
a GnRH agonist##2##3##(1996-2#1)(2008-5#1)
a GnRH##5##2##(1993-3#1)(1995-11#1)(1996-2#1)(2008-5#2)
a Gompertzian##2##2##(1991-6#1)(2013-8#1)
a Gram-negative##3##2##(2008-6#1)(2010-10#1)(2011-2#1)
a Gram-positive bacterium##3##3##(2009-5#1)(2011-2#2)
a Gram-positive##9##2##(2007-12#1)(2009-5#1)(2011-2#5)(2012-12#1)(2012-3#1)
a Green##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
a H-H distance of 1##2##5##(1997-7#2)
a HCN laser##2##3##(2008-3#2)
a HNO(3)##2##2##(2008-10#2)
a HPLC method##3##3##(2008-10#2)(2008-5#1)
a HPLC##6##2##(2008-10#5)(2008-5#1)
a He##2##2##(2007-11#1)(2008-2#1)
a He-Ne laser as##2##4##(2008-2#1)(2008-3#1)
a He-Ne laser at##3##4##(2007-12#1)(2008-3#2)
a He-Ne laser beam##2##4##(2008-3#2)
a He-Ne laser##12##3##(2007-12#1)(2008-2#3)(2008-3#8)
a Health Maintenance Organization##2##4##(2010-8#2)
a Health##5##2##(1991-2#2)(1994-12#1)(2010-8#2)
a Henyey-Greenstein phase function##2##4##(2008-3#2)
a Herriott multipass##2##3##(2007-11#1)(2008-3#1)
a Hg(II)##2##2##(2008-10#2)
a Hill##4##2##(1993-12#1)(1994-6#1)(1997-2#1)(2012-2#1)
a Hopf bifurcation##5##3##(2007-11#2)(2007-12#1)(2013-8#2)
a Human##3##2##(2008-11#2)(2012-12#1)
a Hypersensitive Response in##2##4##(2008-10#2)
a Hypersensitive Response##3##3##(2008-10#3)
a JCAHO##2##2##(1996-2#2)
a JTC##2##2##(2008-2#1)(2012-1#1)
a Japanese##15##2##(1990-7#1)(1992-8#1)(1993-12#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
a Joint##3##2##(2008-2#1)(2011-1#2)
a K(i) of##2##3##(2008-11#2)
a K(i)##3##2##(2008-11#2)(2008-4#1)
a K+ channel##2##3##(1992-9#2)
a KBD-affected diet##2##3##(2011-2#2)
a KNbO(3)##2##2##(2007-11#1)(2008-3#1)
a KTP##5##2##(2007-12#3)(2008-2#2)
a KTP-based##2##2##(2007-11#2)
a Kalman filter##3##3##(2008-3#1)(2009-9#1)(2010-5#1)
a Kampo##2##2##(2008-10#2)
a Kd for##2##3##(1991-5#2)
a Kd##11##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-5#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-8#1)
a Kenyan##2##2##(2008-10#1)(2011-2#1)
a Kerr medium##4##3##(2007-11#1)(2007-12#3)
a Kerr##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
a Kerr-lens mode-locked femtosecond laser##2##5##(2007-12#2)
a Kerr-lens mode-locked##9##3##(2007-11#2)(2007-12#7)
a Ki of##6##3##(1991-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-3#1)
a Ki##14##2##(1990-7#1)(1991-12#3)(1991-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-3#5)
a Km of##3##3##(1992-6#1)(1994-6#1)(2008-7#1)
a Km value of##3##4##(1991-12#1)(1995-2#2)
a Km##10##2##(1991-12#1)(1992-3#1)(1992-6#1)(1994-6#2)(1995-2#2)(1995-5#2)(2008-7#1)
a Korean isolate##3##3##(1997-2#1)(2008-10#2)
a Korean##9##2##(1994-11#2)(1997-2#2)(2007-2#1)(2008-10#3)(2011-2#1)
a KrF excimer laser##2##4##(2008-2#2)
a KrF laser##2##3##(1992-8#1)(2007-11#1)
a KrF##4##2##(1992-8#1)(2007-11#1)(2008-2#2)
a LED##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
a LOD of##3##3##(2008-10#3)
a LOD##5##2##(2008-10#5)
a Lactobacillus##2##2##(2012-2#2)
a Lambertian source##2##3##(2008-3#2)
a Lambertian##5##2##(2008-3#5)
a Langmuir##3##2##(2008-10#2)(2010-4#1)
a Latin##2##2##(2008-7#1)(2009-4#1)
a LiNbO(3)##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
a LiTaO(3)##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
a Likert scale##2##3##(1991-2#1)(2008-9#1)
a Linear##2##2##(1996-9#1)(2008-11#1)
a Littrow##3##2##(2008-2#1)(2008-3#2)
a Lloyd texture analyser fitted with a##2##7##(2013-1#2)
a Lloyd##3##2##(2009-7#1)(2013-1#2)
a Long##3##2##(2009-9#1)(2011-2#1)(2012-3#1)
a Lorentz model##2##3##(2008-2#2)
a M##3##2##(2008-10#3)
a M(r) of##2##3##(1993-11#1)(1994-12#1)
a M(r)##3##2##(1993-11#1)(1994-12#1)(1996-3#1)
a MADRS total score less or equal to##2##8##(2012-3#2)
a MADS-box gene##2##3##(2008-8#2)
a MAPK##2##2##(1995-2#1)(2009-10#1)
a MEDLINE search of##2##4##(2006-10#1)(2008-8#1)
a MEDLINE search##6##3##(2006-10#1)(2007-10#1)(2008-3#1)(2008-8#2)(2013-1#1)
a MEDLINE##7##2##(1992-2#1)(2006-10#1)(2007-10#1)(2008-3#1)(2008-8#2)(2013-1#1)
a MEK##3##2##(1995-2#1)(1996-2#1)(2008-10#1)
a MEKK##2##2##(1995-2#2)
a MIG would##2##3##(1992-2#2)
a MIG##3##2##(1992-2#3)
a MIP##2##2##(2008-10#2)
a MOI of##4##3##(2008-11#3)(2008-9#1)
a MOI##5##2##(2008-11#4)(2008-9#1)
a Mach-Zehnder interferometer##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-4#1)
a Mach-Zehnder##9##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)(2010-4#1)
a Mach-Zehnder-type interferometric##2##3##(2008-2#1)(2008-3#1)
a Mach-Zehnder-type##3##2##(2008-2#2)(2008-3#1)
a Magnetic Resonance Imaging (MRI)##2##5##(2006-10#1)(2008-7#1)
a Magnetic##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
a Maize##2##2##(2008-10#1)(2012-3#1)
a Majocchi granuloma##4##3##(2012-3#4)
a Major Gene##2##3##(2008-10#2)
a Major##4##2##(2008-10#3)(2013-1#1)
a Malaysian##3##2##(2008-8#1)(2011-1#1)(2012-12#1)
a Marine##2##2##(2009-10#1)(2010-2#1)
a Markov chain Monte Carlo##2##5##(1997-7#1)(2009-4#1)
a Markov##3##2##(1997-7#1)(2009-4#1)(2013-8#1)
a Med-El##2##2##(2008-9#2)
a Medicaid##4##2##(1991-2#1)(1995-1#1)(1996-3#1)(2009-6#1)
a Medical##4##2##(1991-6#1)(2008-9#1)(2013-1#2)
a Medicare##7##2##(1992-2#2)(1993-12#1)(1994-1#1)(1994-12#2)(1995-1#1)
a Mediterranean##4##2##(2008-10#2)(2013-1#2)
a Mexican##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
a Michaelis##3##2##(1993-8#1)(1994-5#1)(2008-6#1)
a Michaelis-Menten##2##2##(1994-3#1)(2008-10#1)
a Michelson interferometer with a##2##5##(2007-11#1)(2008-3#1)
a Michelson interferometer with##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
a Michelson interferometer##8##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#2)
a Microsoft##3##2##(2008-1#1)(2008-4#1)(2013-1#1)
a Midwestern##2##2##(1997-1#1)(2012-3#1)
a Mie particle##2##3##(2008-3#2)
a Missouri##2##2##(1991-12#1)(1994-2#1)
a Model for##2##3##(2008-11#1)(2012-12#1)
a Model##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
a Monte Carlo code##2##4##(2008-3#2)
a Monte Carlo simulation of##3##5##(2008-2#1)(2008-3#2)
a Monte Carlo simulation##5##4##(2008-2#1)(2008-3#3)(2009-11#1)
a Monte Carlo##17##3##(2008-2#5)(2008-3#10)(2009-11#2)
a Mr of##3##3##(1991-7#1)(1991-9#1)(1994-11#1)
a Mueller matrix##2##3##(2008-2#1)(2008-3#1)
a Mycoparasite of##2##3##(2008-10#2)
a Mycosphaerella teleomorph##2##3##(2008-10#2)
a Mycosphaerella##3##2##(2008-10#3)
a N(2)##2##2##(2008-10#1)(2008-3#1)
a NA##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
a NADP(+) -specific IDH##2##4##(2012-5#2)
a NADPH##2##2##(1995-8#1)(2009-8#1)
a NASA##2##2##(2008-2#1)(2008-3#1)
a NIR##2##2##(2008-10#2)
a NIST##2##2##(2008-10#2)
a NMDA##3##2##(1993-12#1)(1993-5#1)(1997-2#1)
a Na+##2##2##(1997-8#2)
a NaCl##2##2##(1993-12#1)(2012-2#1)
a NaOH##2##2##(2008-10#2)
a Nafion membrane##2##3##(2008-10#2)
a Nafion(R)/lead-ruthenium oxide pyrochlore chemically modified electrode##2##7##(2008-10#2)
a National Environmental Health Action Plan##2##6##(2008-1#2)
a National##7##2##(1991-3#1)(2008-1#3)(2008-3#1)(2008-5#1)(2010-8#1)
a Nd##43##2##(2007-11#4)(2007-12#13)(2008-10#1)(2008-2#14)(2008-3#11)
a Nepalese##2##2##(2008-6#1)(2008-7#1)
a Nernstian response for##10##4##(2008-10#10)
a Nernstian response to##2##4##(2008-10#2)
a Nernstian response##16##3##(2008-10#16)
a Nernstian slope of 19##2##5##(2008-10#2)
a Nernstian slope of 29##4##5##(2008-10#4)
a Nernstian slope of##16##4##(2008-10#16)
a Nernstian##35##2##(2008-10#35)
a New Subgroup##2##3##(2008-10#2)
a New Zealand##2##3##(1992-1#2)
a New##30##2##(1992-1#4)(1996-5#2)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#1)(2011-1#1)(2011-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a Nigerian##6##2##(2009-4#1)(2010-9#1)(2012-12#3)(2013-1#1)
a Nonlinear##2##2##(2008-2#1)(2008-3#1)
a Nordic Journal of Psychiatry##2##5##(2011-4#2)
a Nordic expert group##2##4##(1990-11#1)(2008-10#1)
a Nordic##6##2##(1990-11#1)(2008-10#2)(2011-4#3)
a North American##4##3##(1993-12#1)(2007-2#1)(2008-10#1)(2011-2#1)
a North##7##2##(1993-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)
a Norwegian##5##2##(1992-6#1)(1995-11#1)(1996-3#1)(1997-2#1)(2011-2#1)
a Novel##15##2##(1996-2#1)(1996-5#2)(1997-7#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
a Nucleus Contour##2##3##(2008-9#2)
a Nucleus##6##2##(2008-9#6)
a Nursing undergraduate##2##3##(2012-3#2)
a P##11##2##(1995-12#1)(1995-2#3)(2008-10#6)(2008-7#1)
a P1##3##2##(1997-6#1)(1997-8#1)(2008-2#1)
a P2 receptor##2##3##(1993-8#1)(2008-2#1)
a P2Y receptor##2##3##(2008-4#2)
a P2Y##3##2##(1995-12#1)(2008-4#2)
a PACS##3##2##(1996-2#1)(2008-7#2)
a PBL##2##2##(2008-11#1)(2011-1#1)
a PBN##2##2##(2008-7#2)
a PC##5##2##(2007-12#1)(2008-10#2)(2010-9#1)(2012-1#1)
a PC-based##2##2##(2008-10#1)(2008-3#1)
a PC12##2##2##(2008-10#1)(2013-7#1)
a PCMH##2##2##(2012-3#2)
a PCR assay##2##3##(2008-10#1)(2010-5#1)
a PCR product##2##3##(1993-12#1)(2008-10#1)
a PCR##9##2##(1990-8#1)(1993-12#1)(1997-2#1)(2008-10#4)(2008-8#1)(2010-5#1)
a PCR-amplified DNA fragment##2##4##(1993-12#1)(2008-10#1)
a PCR-amplified##3##2##(1993-12#1)(1997-4#1)(2008-10#1)
a PCR-based assay##3##3##(2008-10#2)(2008-4#1)
a PCR-based##7##2##(1995-11#1)(1997-8#1)(2008-10#4)(2008-4#1)
a PD##3##2##(2007-12#2)(2008-10#1)
a PDA##2##2##(2008-3#1)(2010-2#1)
a PDMS##2##2##(2008-10#2)
a PEP##2##2##(2009-12#2)
a PFO##5##2##(1996-6#1)(2007-10#2)(2008-7#2)
a PKC inhibitor##3##3##(1992-11#1)(1995-11#1)(1997-1#1)
a PKC##5##2##(1992-11#1)(1995-11#1)(1997-1#2)(1997-7#1)
a PM##2##2##(1994-12#1)(2008-7#1)
a POU##2##2##(1990-11#1)(1992-9#1)
a PPO##3##2##(1992-2#2)(1993-12#1)
a PPTA##2##2##(2008-7#2)
a PPV-M##2##2##(2008-10#2)
a PR-5##2##2##(2008-10#2)
a PTFE membrane##4##3##(2008-10#4)
a PTFE##9##2##(2008-10#9)
a PVA##2##2##(2008-10#2)
a PVC##6##2##(2008-10#6)
a Pacific##5##2##(1995-11#1)(1996-3#1)(2008-1#3)
a Paneth cell specific protein from mouse small intestines##2##9##(1993-11#1)(1993-9#1)
a Paneth cell specific##3##4##(1993-11#1)(1993-9#2)
a Pap##2##2##(1991-6#2)
a Parkinson's disease##3##3##(2008-7#1)(2010-11#1)(2012-3#1)
a Patient with##5##3##(1994-12#1)(2008-12#2)(2008-6#1)(2013-1#1)
a Patient##7##2##(1994-12#1)(1995-3#1)(2008-1#1)(2008-12#2)(2008-6#1)(2013-1#1)
a Pediatric##2##2##(1993-9#1)(1995-11#1)
a Pertussis toxin-biotin conjugate##2##4##(1991-9#2)
a Phe residue##2##3##(1990-11#1)(1992-3#1)
a Photorefractive##2##2##(2008-2#1)(2008-3#1)
a Plackett-Burman design##3##3##(2008-10#3)
a Plackett-Burman##4##2##(2008-10#4)
a Plasmodium falciparum##2##3##(1991-5#1)(1994-12#1)
a Pockels cell##5##3##(2008-3#5)
a Pockels readout optical modulator##2##5##(2008-2#2)
a Pockels##7##2##(2008-2#2)(2008-3#5)
a Point##2##2##(2008-10#1)(2010-5#1)
a Poisson##4##2##(2008-10#1)(2008-3#3)
a Possible##2##2##(2008-10#1)(2013-7#1)
a Potential##2##2##(2008-10#2)
a Preliminary##2##2##(1995-11#1)(2008-10#1)
a Primary##2##2##(2008-8#1)(2011-1#1)
a Prospective##2##2##(2008-1#1)(2010-5#1)
a Prussian Blue##2##3##(2008-10#2)
a Pseudomonas putida##2##3##(2008-7#1)(2011-2#1)
a Pseudomonas##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
a Pt electrode##2##3##(2008-10#2)
a Pt##7##2##(2008-10#7)
a Putative##3##2##(2008-10#1)(2010-10#1)(2012-3#1)
a Q -switched##3##3##(2007-11#1)(2007-12#2)
a Q value of##2##4##(2007-12#1)(2008-3#1)
a Q##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
a Q-switched Nd##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-5#1)
a Q-switched diode-pumped Nd##2##4##(2008-3#2)
a Q-switched double-pulsed ruby laser##2##5##(2008-3#2)
a Q-switched laser##3##3##(2008-2#2)(2008-3#1)
a Q-switched##19##2##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#9)(2008-5#1)
a QA program##2##3##(1993-2#2)
a QTL##4##2##(2008-10#3)(2008-8#1)
a QWP##2##2##(2008-2#1)(2008-3#1)
a R##22##2##(1997-2#1)(2008-10#21)
a RA##3##2##(1994-6#1)(2007-8#1)(2008-10#1)
a RAPD##3##2##(2008-10#2)(2008-9#1)
a RR spectrum##2##3##(1995-5#2)
a RR##3##2##(1995-5#2)(2011-1#1)
a Rabbit##2##2##(2012-3#1)(2013-1#1)
a Raman lidar measurement of##3##5##(2008-3#3)
a Raman probe##2##3##(1992-4#1)(2007-12#1)
a Raman##9##2##(1992-4#1)(2007-12#2)(2008-10#2)(2008-3#3)(2013-8#1)
a Randomized##2##2##(2008-12#1)(2013-1#1)
a Rapid##2##2##(2008-10#1)(2009-9#1)
a Recombinant##2##2##(2008-10#2)
a Resistance##2##2##(2008-10#2)
a Retzius cell##2##3##(1991-5#2)
a Rev-dependent##2##2##(1995-2#1)(2011-3#1)
a Rhodamine 6G##3##3##(2008-2#2)(2008-3#1)
a Risk##2##2##(2011-2#1)(2013-1#1)
a Ronchi##3##2##(2008-3#3)
a Ross##2##2##(2007-8#2)
a S##3##2##(1996-6#1)(2008-10#1)(2008-5#1)
a SIA##2##2##(2008-10#2)
a SLM##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
a SNP##2##2##(2013-1#2)
a SNR of##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
a SO compliant##2##3##(2008-7#2)
a SPE##2##2##(2008-10#2)
a SUN##2##2##(2008-9#2)
a Saccharomyces cerevisiae##2##3##(1994-12#1)(2008-7#1)
a Sagnac interferometer##3##3##(2007-12#2)(2008-2#1)
a Sagnac##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
a Saturable Absorber##2##3##(2008-3#2)
a Scanning##2##2##(2008-10#1)(2008-3#1)
a Scatchard##2##2##(1997-2#1)(2008-10#1)
a Schwann##2##2##(1995-2#1)(2008-7#1)
a Second##2##2##(2007-12#1)(2008-10#1)
a Semiconductor##2##2##(2008-2#1)(2008-3#1)
a Sephadex##2##2##(1991-2#1)(1992-12#1)
a Serbian population##2##3##(2008-7#2)
a Setaria isolate (pathogenic on foxtail millet)##2##7##(2008-10#2)
a Shack-Hartmann sensor##2##3##(2008-3#2)
a Shack-Hartmann##5##2##(2008-3#5)
a Shimadzu##2##2##(2008-10#1)(2008-12#1)
a Si prism##2##3##(2008-3#2)
a Si##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
a Simple##2##2##(2008-2#1)(2008-5#1)
a Single##4##2##(1996-9#1)(2008-10#3)
a Small##7##2##(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#2)(2009-10#1)
a Soil##2##2##(2008-10#2)
a South##6##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-5#1)(2012-1#1)
a Southeastern##3##2##(1995-6#1)(1996-1#1)(2012-2#1)
a Southern blot##2##3##(1995-6#1)(1995-8#1)
a Southern##3##2##(1995-6#1)(1995-8#1)(2013-7#1)
a Soxhlet##3##2##(2008-10#3)
a Spanish##2##2##(1997-5#1)(2013-1#1)
a Species##2##2##(2008-10#2)
a Sprague-Dawley##2##2##(1993-5#1)(2008-2#1)
a Stokes##2##2##(1990-11#1)(2007-12#1)
a Strategy##2##2##(2009-8#1)(2011-1#1)
a Strong##2##2##(1994-12#1)(2012-3#1)
a Stroop-type##2##2##(2007-8#1)(2013-8#1)
a Support##2##2##(2008-4#1)(2010-8#1)
a Swedish##6##2##(1993-6#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-12#1)
a Swiss##3##2##(1991-11#1)(1997-3#1)(2008-9#1)
a Syrian##2##2##(1990-7#1)(2011-1#1)
a T cell##5##3##(1990-12#1)(1997-7#1)(2007-5#1)(2008-9#1)(2013-1#1)
a T##9##2##(1990-12#1)(1990-9#1)(1992-8#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
a T(m) of##2##3##(2011-1#2)
a T--&gt##3##2##(1993-6#1)(1994-11#2)
a T-cell acute##2##3##(1994-8#1)(2008-10#1)
a T-cell lymphoma##2##3##(1991-12#1)(1995-1#1)
a T-cell##9##2##(1991-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-6#1)(2008-10#2)(2009-1#1)
a T-dependent##3##2##(1994-5#1)(2008-10#2)
a T-flask##3##2##(2008-11#3)
a T3##2##2##(1992-10#1)(2008-10#1)
a T7 RNA##2##3##(1993-8#1)(2008-10#1)
a T7 promoter##2##3##(1991-9#2)
a T7##5##2##(1991-9#2)(1993-8#1)(1997-4#1)(2008-10#1)
a TACTICS-TIMI 18 substudy##2##4##(2008-3#2)
a TATA box##3##3##(1992-3#2)(1997-2#1)
a TATA##4##2##(1992-3#2)(1993-3#1)(1997-2#1)
a TB clinic##2##3##(2008-7#1)(2013-1#1)
a TB##6##2##(1996-11#1)(1996-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
a TBI##4##2##(2009-10#2)(2012-2#2)
a TEM(00) mode##2##3##(2007-12#1)(2008-2#1)
a TEM(00)##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
a THz##3##2##(2007-12#2)(2011-1#1)
a TNF standard##2##3##(1990-12#2)
a TSH binding##2##3##(1993-3#1)(1994-11#1)
a TSH##3##2##(1992-12#1)(1993-3#1)(1994-11#1)
a TV##3##2##(1996-8#1)(2008-3#1)(2010-11#1)
a Talbot array illuminator##3##4##(2008-2#1)(2008-3#2)
a Talbot##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
a Taylor##2##2##(2011-1#1)(2012-2#1)
a Teflon##3##2##(2008-10#2)(2012-2#1)
a Tertiary Care##2##3##(2011-1#1)(2012-2#1)
a Th1##2##2##(1994-12#1)(1995-12#1)
a Th2##2##2##(1994-8#1)(1995-12#1)
a Ti##30##2##(2007-11#9)(2007-12#11)(2008-10#1)(2008-2#2)(2008-3#6)(2009-6#1)
a Ti-doped##2##2##(2008-2#2)
a Tm##4##2##(1993-11#1)(2007-12#1)(2008-3#2)
a Triticum isolate (pathogenic on wheat)##3##6##(2008-10#3)
a Triticum isolate##4##3##(2008-10#4)
a Trp residue##2##3##(1992-12#1)(1994-12#1)
a Trp##3##2##(1991-12#1)(1992-12#1)(1994-12#1)
a Tunable##2##2##(2008-2#2)
a Tunisian##2##2##(2009-1#1)(2009-9#1)
a U##8##2##(1991-2#1)(1992-1#1)(1992-5#1)(2008-10#1)(2008-2#1)(2010-6#1)(2013-8#2)
a U-shaped##3##2##(1992-8#1)(2008-10#1)(2008-7#1)
a UK##4##2##(1994-7#1)(2007-2#3)
a UV absorption##2##3##(2008-10#2)
a UV detector##6##3##(2008-10#6)
a UV irradiation##2##3##(1995-11#1)(2008-10#1)
a UV laser##2##3##(2007-11#1)(2008-2#1)
a UV##19##2##(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#1)
a United States##2##3##(2008-6#1)(2009-11#1)
a United##5##2##(2006-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)
a University hospital##2##3##(1992-5#1)(1995-12#1)
a University##5##2##(1992-5#1)(1995-12#1)(2007-2#1)(2008-12#2)
a V##3##2##(2009-6#2)(2013-1#1)
a VCG##2##2##(2008-10#2)
a VCSEL##2##2##(2008-3#2)
a VLSI##3##2##(2008-3#3)
a VP shunt##2##3##(2008-7#1)(2012-12#1)
a Venezuelan oil##2##3##(2011-2#2)
a Veterans##2##2##(2006-10#1)(2008-6#1)
a Vibrio##3##2##(2008-10#2)(2009-6#1)
a Virulent Strain##2##3##(2008-10#2)
a Visual Analogue Scale##2##4##(2012-1#1)(2013-1#1)
a WHC##3##2##(1997-3#3)
a Water-Soluble##2##2##(1996-2#1)(1997-7#1)
a Waters##3##2##(2008-10#1)(2011-1#2)
a Watson-Crick##2##2##(1993-11#1)(1995-6#1)
a Web##5##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)
a Web-based##7##2##(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
a Weibull##2##2##(1995-9#1)(2012-2#1)
a Wiener filter that##2##4##(2008-3#2)
a Wiener filter##3##3##(2007-11#1)(2008-3#2)
a Wilcoxon##2##2##(2008-10#1)(2012-1#1)
a Workshop##2##2##(2008-10#2)
a World##3##2##(2008-10#1)(2008-4#1)(2010-4#1)
a Worldwide Collection of##3##4##(2008-10#3)
a Xenopus##2##2##(1993-2#1)(1995-2#1)
a Y##2##2##(2007-12#2)
a Y-maze##3##2##(1993-5#2)(2010-2#1)
a YAC##3##2##(1996-12#1)(1996-6#1)(1997-8#1)
a YAG##2##2##(2008-2#2)
a Yb##2##2##(2007-11#1)(2008-3#1)
a Young's##2##2##(2007-11#1)(2008-3#1)
a Zea##2##2##(1995-12#1)(2012-3#1)
a Zeeman laser in conjunction with a Glan-Thompson analyzer##2##9##(2007-11#1)(2007-12#1)
a Zeeman laser##3##3##(2007-11#1)(2007-12#2)
a Zeeman##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
a Zn(II)##3##2##(1992-3#1)(2008-10#2)
a ZnGeP(2)##2##2##(2007-11#2)
a ZnSe##2##2##(2007-11#1)(2007-12#1)
a Zorbax##2##2##(2008-10#1)(2011-1#1)
a [Ca2+]o##2##2##(1990-8#2)
a a##2##2##(2008-7#2)
a and b##11##3##(1991-3#1)(1995-2#1)(2008-10#4)(2008-12#2)(2008-3#2)(2010-5#1)
a and b(b)##4##3##(2008-2#1)(2008-3#3)
a and the##3##3##(2008-2#2)(2008-3#1)
a and##34##2##(1990-11#1)(1991-3#2)(1993-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-7#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
a approximately##8##2##(1990-8#2)(1992-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
a baby with##3##3##(1996-2#1)(2008-11#2)
a baby##10##2##(1992-2#1)(1994-7#1)(1996-2#1)(1996-6#1)(2007-7#1)(2008-11#3)(2008-5#1)(2011-2#1)
a baccalaureate##2##2##(2008-11#2)
a bachelor's degree##3##3##(1993-2#1)(1994-12#1)(2010-11#1)
a back pain##3##3##(1995-2#1)(2007-11#2)
a back##4##2##(1995-2#1)(1997-7#1)(2007-11#2)
a back-illuminated##2##2##(2007-12#1)(2008-3#1)
a backbone##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)
a background electrolyte##2##3##(2008-10#2)
a background of##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-1#1)
a background##17##2##(1993-2#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-1#1)(2012-3#1)
a backscatter##2##2##(2008-2#1)(2008-3#1)
a backscattering geometry##3##3##(2007-11#2)(2008-3#1)
a backward##5##2##(1994-3#1)(1994-9#1)(2008-10#1)(2008-2#1)(2011-2#1)
a bacterial artificial chromosome##2##4##(2008-10#1)(2008-8#1)
a bacterial expression##3##3##(1992-12#2)(2008-10#1)
a bacterial##24##2##(1990-11#1)(1992-12#2)(1992-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
a bacterium##8##2##(1994-11#1)(1997-1#1)(2008-10#4)(2008-8#2)
a baculovirus expression system##3##4##(1992-10#1)(1993-6#1)(2008-11#1)
a baculovirus expression vector##4##4##(1993-6#1)(1994-9#1)(2008-11#2)
a baculovirus expression##7##3##(1992-10#1)(1993-6#2)(1994-9#1)(2008-11#3)
a baculovirus system##4##3##(1992-10#1)(1992-3#1)(1994-8#2)
a baculovirus##17##2##(1992-10#2)(1992-3#1)(1993-6#2)(1994-8#2)(1994-9#1)(1997-4#1)(2008-11#7)(2008-7#1)
a bad prognostic factor##2##4##(1997-3#1)(2011-1#1)
a bad prognostic##3##3##(1997-3#1)(2010-11#1)(2011-1#1)
a bad##14##2##(1994-6#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
a badge##2##2##(2008-10#1)(2008-8#1)
a bafilomycin A1-sensitive##2##3##(1994-6#2)
a balance between##11##3##(1990-5#1)(1992-6#1)(1993-12#2)(1997-5#1)(2007-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)
a balance in##2##3##(2008-1#1)(2011-2#1)
a balance of##2##3##(1991-8#1)(2013-1#1)
a balance##17##2##(1990-5#1)(1991-8#1)(1992-6#1)(1993-12#2)(1997-5#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
a balanced##12##2##(1991-9#1)(1993-12#1)(1994-1#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#2)(2013-1#1)
a ball lens##2##3##(2011-1#2)
a ball##7##2##(2008-11#2)(2008-3#1)(2011-1#2)(2011-2#1)(2013-1#1)
a balloon##8##2##(1992-3#1)(1996-6#1)(2008-2#1)(2008-3#2)(2010-12#1)(2013-1#2)
a balloonborne spectrometer##2##3##(2008-3#2)
a balloonborne##4##2##(2007-11#1)(2008-3#3)
a bamboo pulp##2##3##(2008-10#2)
a band of##6##3##(1991-12#1)(1994-2#1)(2007-11#2)(2008-10#1)(2013-1#1)
a band##12##2##(1991-12#1)(1994-2#1)(1996-8#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
a bandpass##3##2##(2008-3#3)
a bandwidth of##8##3##(2007-11#3)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)
a bandwidth##9##2##(2007-11#3)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#2)
a bank of##2##3##(1994-12#1)(2008-12#1)
a bar##2##2##(1993-5#1)(2010-8#1)
a bare##14##2##(1997-2#2)(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#2)(2010-5#1)
a barley##6##2##(1995-6#1)(2008-10#4)(2008-8#1)
a barrier of##3##3##(1994-11#1)(1996-2#2)
a barrier to##13##3##(1994-3#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2012-1#3)(2012-12#1)
a barrier##23##2##(1990-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#2)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-1#3)(2012-12#1)
a basal diet##4##3##(1992-9#2)(1997-3#1)(2013-1#1)
a basal level##2##3##(1993-11#1)(2008-6#1)
a basal medium##2##3##(2008-10#2)
a basal##12##2##(1992-8#1)(1992-9#2)(1993-11#2)(1997-3#1)(2008-10#3)(2008-6#1)(2013-1#2)
a base de##2##3##(2008-5#2)
a base for##2##3##(1990-6#1)(2012-12#1)
a base substitution##3##3##(1991-2#2)(2008-10#1)
a base##18##2##(1990-6#1)(1991-2#2)(1993-8#2)(1994-8#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-5#4)(2008-7#1)(2009-1#1)(2012-12#2)
a baseline data set##2##4##(1997-4#2)
a baseline defined at##2##4##(2008-10#2)
a baseline established between##4##4##(2008-10#4)
a baseline for future##2##4##(2008-12#1)(2011-2#1)
a baseline from which##2##4##(2008-10#1)(2008-12#1)
a baseline measure of##2##4##(1996-1#1)(2012-3#1)
a baseline of##2##3##(2008-12#1)(2008-7#1)
a baseline##29##2##(1991-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-12#2)(2008-10#11)(2008-12#3)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
a basement membrane##3##3##(2008-7#2)(2011-2#1)
a basic amino##2##3##(1991-9#1)(1992-8#1)
a basic health##2##3##(1996-9#1)(2011-2#1)
a basic list##2##3##(1996-12#2)
a basic principle##2##3##(1992-1#1)(2008-12#1)
a basic procedure for HDAd production using the Cre-loxP system is presented##2##12##(2008-2#1)(2008-4#1)
a basic procedure for##3##4##(2008-2#1)(2008-4#2)
a basic residue##2##3##(1996-7#1)(2009-8#1)
a basic understanding of##3##4##(1997-1#1)(1997-7#1)(2011-2#1)
a basic##66##2##(1990-8#1)(1991-12#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-6#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a basilar artery##3##3##(1997-6#1)(2011-2#2)
a basilar##4##2##(1997-6#2)(2011-2#2)
a basis for a new##2##5##(2008-10#1)(2009-6#1)
a basis for a##3##4##(1991-6#1)(2008-10#1)(2009-6#1)
a basis for constructing##2##4##(1997-6#1)(2010-8#1)
a basis for discussion on##2##5##(2008-11#1)(2011-1#1)
a basis for discussion##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
a basis for future##2##4##(2008-10#1)(2010-12#1)
a basis for the development of##4##6##(1994-2#1)(2008-11#1)(2009-5#1)(2010-12#1)
a basis for the##9##4##(1992-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-6#1)
a basis for##56##3##(1991-11#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-2#2)(1994-9#2)(1995-12#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a basis in##2##3##(2008-9#1)(2010-7#1)
a basis of##2##3##(2008-10#1)(2008-9#1)
a basis set##2##3##(2008-2#1)(2008-3#1)
a basis##67##2##(1991-11#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-2#2)(1994-9#2)(1995-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#1)(2010-12#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a batch culture##2##3##(2008-11#2)
a batch fermentation##2##3##(2008-6#1)(2008-7#1)
a batch method##3##3##(2008-10#3)
a batch or##2##3##(2008-10#1)(2008-11#1)
a batch##19##2##(1994-11#1)(2008-10#10)(2008-11#3)(2008-6#2)(2008-7#3)
a battery of##8##3##(1990-12#1)(1990-3#1)(1990-6#1)(1995-3#1)(2008-11#1)(2008-2#1)(2009-10#2)
a battery##10##2##(1990-12#1)(1990-3#1)(1990-6#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2009-10#2)
a bcl-2##2##2##(1994-10#1)(1994-3#1)
a bead##2##2##(2008-6#1)(2012-2#1)
a beam is##2##3##(2008-3#2)
a beam quality factor##2##4##(2008-2#1)(2008-3#1)
a beam quality##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a beam splitter##3##3##(2008-2#1)(2008-3#2)
a beam waist##3##3##(2007-12#1)(2008-3#2)
a beam with a##3##4##(2007-12#2)(2008-2#1)
a beam##36##2##(2007-11#4)(2007-12#5)(2008-2#8)(2008-3#18)(2008-9#1)
a beam-splitter##2##2##(2007-12#1)(2008-3#1)
a beat length of##2##4##(2007-11#1)(2007-12#1)
a beat length##3##3##(2007-11#2)(2007-12#1)
a beat note##2##3##(2008-3#2)
a beat##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
a beating##2##2##(2007-11#1)(2009-5#1)
a bed of##2##3##(2008-10#2)
a bed##3##2##(1991-2#1)(2008-10#2)
a bedside##3##2##(2008-1#1)(2009-6#1)(2011-2#1)
a beef##2##2##(1996-8#1)(1997-2#1)
a beef-based raw diet##2##4##(2009-4#2)
a behavior which##2##3##(1990-8#1)(1991-8#1)
a behavior##8##2##(1990-8#1)(1991-8#1)(1992-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#2)
a behavioral model##4##3##(1992-12#2)(2008-4#1)(2011-2#1)
a behavioral trait##2##3##(2008-8#1)(2008-9#1)
a behavioral##15##2##(1991-6#1)(1992-12#2)(1993-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)(2013-8#1)
a behaviour##2##2##(1991-8#1)(2008-10#1)
a behavioural##3##2##(1993-12#1)(1996-5#1)(1997-7#1)
a belief that##2##3##(1996-12#1)(2009-6#1)
a belief##5##2##(1996-12#2)(2009-6#2)(2011-2#1)
a bell-shaped##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
a benchmark for##2##3##(2008-3#1)(2012-2#1)
a benchmark##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-2#1)
a benchmarking##5##2##(1995-12#1)(1996-1#1)(1997-1#2)(2008-11#1)
a bending radius##2##3##(2007-12#1)(2008-3#1)
a bending##6##2##(1997-2#1)(2007-12#2)(2008-3#3)
a beneficial effect of##3##4##(1992-12#1)(2013-1#2)
a beneficial effect on the##3##5##(1991-11#1)(2009-7#1)(2013-8#1)
a beneficial effect on##8##4##(1991-11#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
a beneficial effect##11##3##(1991-11#1)(1992-12#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
a beneficial impact on##2##4##(2008-11#1)(2009-8#1)
a beneficial##24##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-6#1)(1997-1#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
a benefit of##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
a benefit##8##2##(1994-3#1)(1995-1#1)(2006-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
a benign bone##2##3##(2006-10#1)(2010-5#1)
a benign condition##3##3##(2007-5#1)(2008-7#1)(2013-8#1)
a benign course##2##3##(2008-7#1)(2011-2#1)
a benign disease##2##3##(2008-8#1)(2010-5#1)
a benign lesion##4##3##(1990-12#2)(2008-4#1)(2012-3#1)
a benign tumor with##2##4##(2008-10#1)(2012-3#1)
a benign tumor##5##3##(2007-11#1)(2008-10#1)(2008-12#2)(2012-3#1)
a benign##41##2##(1990-12#3)(1990-3#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-5#1)(1994-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-5#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
a bent fiber##2##3##(2007-12#2)
a bent##5##2##(1996-2#1)(2007-12#2)(2008-2#1)(2008-8#1)
a benthic##2##2##(2008-5#1)(2013-1#1)
a benzodiazepine##5##2##(1991-12#1)(1992-7#1)(1994-2#1)(1996-9#1)(2009-9#1)
a bereavement##2##2##(1991-11#1)(2007-11#1)
a best fit##2##3##(2008-3#1)(2011-2#1)
a best practice##3##3##(1995-12#1)(2010-10#2)
a best##9##2##(1995-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#3)(2011-2#1)(2012-2#1)
a beta -barium borate crystal##2##5##(2007-11#1)(2007-12#1)
a beta##7##2##(1991-2#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-6#1)
a beta-adrenergic##3##2##(1991-12#1)(1995-3#1)(2008-2#1)
a beta-binomial distribution##4##3##(2008-10#3)(2010-3#1)
a beta-blocker##2##2##(1995-2#1)(2008-10#1)
a beta-cyclodextrin##5##2##(1996-5#1)(2008-10#2)(2011-1#2)
a beta-galactosidase##3##2##(1990-2#1)(1997-3#1)(2008-11#1)
a beta-lactam antibiotic##3##3##(2008-10#2)(2009-12#1)
a beta-sheet structure##3##3##(1992-11#1)(1994-11#1)(2008-5#1)
a beta-sheet##5##2##(1992-11#1)(1992-6#1)(1994-11#1)(2008-5#1)(2009-7#1)
a beta-tubulin##2##2##(2008-9#2)
a beta-turn##8##2##(1991-10#2)(1991-6#2)(1992-5#1)(1994-11#2)(1994-8#1)
a better ability##2##3##(2011-2#1)(2012-3#1)
a better appreciation of the##2##5##(1993-3#1)(2009-3#1)
a better appreciation of##4##4##(1993-3#1)(2008-10#1)(2008-8#1)(2009-3#1)
a better approach##3##3##(1991-2#1)(1996-1#1)(2013-8#1)
a better awareness of the##2##5##(2010-4#1)(2013-1#1)
a better classification##2##3##(2008-10#1)(2012-12#1)
a better comprehension of##2##4##(2007-8#1)(2008-10#1)
a better cue##2##3##(2013-8#2)
a better definition of the##2##5##(1997-3#1)(2008-10#1)
a better definition of##3##4##(1996-3#1)(1997-3#1)(2008-10#1)
a better description of##2##4##(2008-9#1)(2012-2#1)
a better diagnostic##2##3##(2008-3#1)(2011-2#1)
a better discrimination##2##3##(2008-3#2)
a better estimate##2##3##(1997-7#1)(2011-2#1)
a better fit##5##3##(1995-12#1)(2008-10#3)(2009-8#1)
a better future##2##3##(1991-2#1)(2008-10#1)
a better insight into the##2##5##(2008-1#1)(2008-10#1)
a better insight into##3##4##(2008-1#1)(2008-10#1)(2013-7#1)
a better insight##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2013-7#1)
a better knowledge of the##2##5##(1990-12#1)(1992-12#1)
a better level of##2##4##(2007-12#1)(2008-6#1)
a better option for##2##4##(2007-7#1)(2010-11#1)
a better option##3##3##(2007-7#1)(2010-11#1)(2011-2#1)
a better outcome in##3##4##(2008-11#1)(2008-6#1)(2009-10#1)
a better outcome##5##3##(1992-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)
a better performance in##2##4##(2008-11#1)(2008-2#1)
a better precision##2##3##(2008-10#2)
a better predictor of##2##4##(2010-8#1)(2012-3#1)
a better predictor##3##3##(1991-2#1)(2010-8#1)(2012-3#1)
a better prognosis##6##3##(1992-9#1)(1993-1#1)(1994-6#1)(2011-2#2)(2012-3#1)
a better protection of##2##4##(2007-8#1)(2008-10#1)
a better quality of life##4##5##(1990-10#1)(1991-2#1)(2008-7#1)(2011-2#1)
a better response to##2##4##(1990-9#1)(1991-2#1)
a better selectivity for##2##4##(2008-10#2)
a better survival##3##3##(1996-9#1)(2008-10#1)(2013-1#1)
a better thermal##2##3##(2008-12#1)(2013-8#1)
a better understanding and##2##4##(2008-3#1)(2008-4#1)
a better understanding of how##3##5##(2008-7#1)(2010-3#1)(2010-9#1)
a better understanding of the mechanisms##3##6##(2008-1#1)(2011-2#1)(2012-3#1)
a better understanding of the molecular##2##6##(1996-4#1)(2011-2#1)
a better understanding of the pathogenesis of##2##7##(1990-9#1)(2007-10#1)
a better understanding of the role of##2##7##(1995-12#1)(2009-12#1)
a better understanding of the##40##5##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
a better understanding of##64##4##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-9#2)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
a better understanding##67##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-9#2)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
a better way of##3##4##(1996-3#1)(2008-5#1)(2010-8#1)
a better way to##2##4##(1996-1#1)(2009-5#1)
a better way##8##3##(1994-2#1)(1996-1#1)(1996-3#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)
a better working##3##3##(2008-10#1)(2012-3#2)
a better##247##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#5)(1991-6#2)(1992-11#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-7#1)(2006-12#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#40)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#10)(2013-1#5)(2013-7#2)(2013-8#8)
a beverage##2##2##(2011-2#1)(2012-3#1)
a bi-directional##2##2##(2008-10#1)(2010-8#1)
a bias in size##2##4##(2013-8#2)
a bias in##3##3##(1995-8#1)(2013-8#2)
a bias##8##2##(1995-8#1)(2008-3#2)(2013-1#2)(2013-8#3)
a biased##6##2##(2007-12#1)(2008-8#1)(2009-10#3)(2013-8#1)
a biaxial##3##2##(2007-11#1)(2008-3#2)
a bibliographic database##2##3##(1991-12#1)(1997-1#1)
a bibliographic revision##2##3##(2008-11#1)(2009-10#1)
a bibliographic##8##2##(1991-12#1)(1997-1#1)(2008-11#1)(2009-10#1)(2012-3#4)
a bichromatic##2##2##(2007-12#2)
a bicomponent##3##2##(2008-2#2)(2008-3#1)
a bidentate##2##2##(1997-7#1)(2012-2#1)
a bidirectional##5##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)
a biennial##2##2##(2008-10#1)(2012-12#1)
a bifunctional toxin##2##3##(1990-8#2)
a bifunctional##7##2##(1990-8#2)(2008-10#2)(2008-4#1)(2009-5#1)(2011-1#1)
a bifurcated optical fiber##2##4##(2008-10#1)(2008-7#1)
a bifurcated##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
a big diversity##2##3##(1997-8#2)
a big step##2##3##(1993-6#1)(1994-3#1)
a big##13##2##(1990-6#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-3#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
a bigger##4##2##(1996-2#1)(2008-10#1)(2009-10#2)
a bilateral increase##2##3##(1990-9#1)(1994-8#1)
a bilateral reduction in##2##4##(1990-9#1)(2012-2#1)
a bilateral##14##2##(1990-9#2)(1994-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
a bilaterally##2##2##(2007-12#1)(2008-7#1)
a biliary##2##2##(1991-3#1)(1991-8#1)
a bill that##2##3##(1996-5#2)
a bill to##2##3##(1995-6#1)(1997-5#1)
a bill##6##2##(1995-6#1)(1996-5#2)(1997-5#1)(2008-4#1)(2011-2#1)
a billion##2##2##(1992-6#1)(2011-2#1)
a bimodal distribution of##2##4##(1994-6#1)(2009-7#1)
a bimodal distribution##6##3##(1994-6#1)(2008-10#1)(2008-3#1)(2009-7#3)
a bimodal##14##2##(1993-6#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-3#2)(2009-7#3)(2010-11#1)(2010-3#1)
a binary diffractive##2##3##(2007-12#1)(2008-3#1)
a binary key code##2##4##(2008-3#2)
a binary mixture of##2##4##(2008-10#1)(2008-7#1)
a binary phase##2##3##(2007-11#1)(2008-3#1)
a binary structure##2##3##(2008-3#2)
a binary##46##2##(1992-1#1)(1992-9#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#4)(2008-3#19)(2008-5#1)(2008-7#4)(2009-9#1)(2010-8#1)
a binding capacity of##4##4##(1990-12#1)(1990-5#3)
a binding protein for##2##4##(1990-11#1)(1994-12#1)
a binding protein##5##3##(1990-11#1)(1990-12#2)(1992-6#1)(1994-12#1)
a binding site for the##4##5##(1990-5#1)(1992-8#1)(1995-6#1)(2009-8#1)
a binding site##5##3##(1990-5#1)(1992-11#1)(1992-8#1)(1995-6#1)(2009-8#1)
a binding##25##2##(1990-11#1)(1990-12#3)(1990-5#4)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
a binomial distribution##3##3##(2008-10#2)(2010-3#1)
a binomial##5##2##(2008-10#4)(2010-3#1)
a bioactive##7##2##(1995-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-2#1)
a bioassay##9##2##(1991-6#1)(2008-10#6)(2008-4#1)(2008-5#1)
a biochemical marker for##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
a biochemical##14##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)
a biocontrol agent of##6##4##(2008-10#6)
a biocontrol agent##9##3##(2008-10#8)(2008-12#1)
a biocontrol fungus##2##3##(2008-10#2)
a biocontrol##14##2##(2008-10#13)(2008-12#1)
a biodegradable polymer##3##3##(2008-7#2)(2010-4#1)
a biodegradable##8##2##(2007-8#1)(2008-5#2)(2008-7#2)(2010-4#1)(2012-2#2)
a biofilm##2##2##(2008-7#2)
a biogenic##2##2##(1997-1#1)(2008-3#1)
a bioinformatics approach##2##3##(2008-6#1)(2008-7#1)
a bioinformatics##3##2##(2008-6#1)(2008-7#2)
a biologic basis##2##3##(2007-7#1)(2008-1#1)
a biologic##4##2##(2007-7#1)(2008-1#1)(2008-5#1)(2008-9#1)
a biological assay for##2##4##(1994-5#1)(2008-9#1)
a biological assay##5##3##(1990-12#2)(1994-5#1)(2008-11#1)(2008-9#1)
a biological cell in##2##4##(2008-2#1)(2008-3#1)
a biological continuum##2##3##(2013-1#2)
a biological control agent for##3##5##(2008-10#3)
a biological control agent##5##4##(2008-10#5)
a biological response modifier##2##4##(1997-4#1)(2008-5#1)
a biological response##3##3##(1990-11#1)(1997-4#1)(2008-5#1)
a biological system##4##3##(1995-5#1)(2008-4#1)(2008-9#2)
a biological tissue##2##3##(2007-12#1)(2009-10#1)
a biological##66##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
a biological/genetic marker of##2##4##(1994-2#2)
a biologically active##4##3##(1994-11#1)(1994-5#1)(2008-10#1)(2008-4#1)
a biologically inactive##2##3##(2008-12#1)(2010-6#1)
a biologically relevant##3##3##(1994-8#1)(2007-11#1)(2008-10#1)
a biologically##16##2##(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2010-6#1)(2011-2#1)(2013-1#1)
a bioluminescent##4##2##(1990-8#1)(2008-10#2)(2008-7#1)
a biomarker of##7##3##(1994-5#1)(2008-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
a biomarker##18##2##(1994-5#1)(2008-10#2)(2008-8#2)(2009-11#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-5#2)(2012-2#2)(2012-3#1)(2013-8#3)
a biomass##2##2##(2008-6#1)(2008-7#1)
a biome##2##2##(2008-8#1)(2013-7#1)
a biomechanical study##2##3##(2008-9#1)(2009-3#1)
a biomechanical##3##2##(2008-9#2)(2009-3#1)
a biomimetic##7##2##(1995-3#1)(2007-12#2)(2008-10#2)(2009-9#1)(2010-5#1)
a biomolecular##2##2##(2008-1#1)(2008-2#1)
a biomolecule##2##2##(2007-11#1)(2008-10#1)
a biophysical##2##2##(2008-10#1)(2008-8#1)
a bioprocess##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
a bioprosthesis##3##2##(2007-8#3)
a biopsy for##3##3##(2012-2#3)
a biopsy##11##2##(1991-3#1)(1995-5#1)(2011-2#1)(2012-2#5)(2013-1#1)(2013-8#2)
a biopsychosocial model##2##3##(2008-4#1)(2009-9#1)
a biopsychosocial##3##2##(2008-4#1)(2009-9#1)(2011-2#1)
a biopteroflavoprotein##2##2##(1992-3#2)
a bioreactor with##2##3##(2008-11#2)
a bioreactor##9##2##(2008-10#1)(2008-11#6)(2008-3#1)(2008-7#1)
a biosensor based on##2##4##(2008-10#2)
a biosensor for##2##3##(2008-10#2)
a biosensor method##2##3##(2008-10#2)
a biosensor##19##2##(1991-5#1)(2008-10#18)
a bioterrorist attack##3##3##(2007-12#3)
a biotherapeutic##2##2##(2008-10#1)(2010-11#1)
a biotin##2##2##(2008-4#2)
a biotinylated polypyrrole##2##3##(2008-10#2)
a biotinylated##9##2##(1992-6#1)(1995-6#1)(2008-1#1)(2008-10#4)(2009-12#1)(2012-3#1)
a bipartite genome##3##3##(2008-10#3)
a bipartite structure##2##3##(1992-6#1)(1993-2#1)
a bipartite##6##2##(1992-6#1)(1993-2#1)(2008-10#3)(2009-8#1)
a biphasic change##2##3##(1990-2#1)(2010-5#1)
a biphasic effect##3##3##(1994-3#1)(2008-7#1)(2012-4#1)
a biphasic increase in##2##4##(1990-2#1)(1994-2#1)
a biphasic pattern##2##3##(1993-11#1)(2008-1#1)
a biphasic##27##2##(1990-2#3)(1991-10#2)(1991-2#1)(1991-5#1)(1992-7#1)(1992-9#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-7#4)(2010-5#1)(2012-4#1)
a bipolar##7##2##(1993-8#1)(1994-8#1)(1997-5#1)(2007-8#1)(2008-3#1)(2009-10#1)(2013-1#1)
a biracial population of##2##4##(2007-10#1)(2012-3#1)
a bird##3##2##(1996-8#2)(1997-3#1)
a birefringence vector distribution##3##4##(2008-3#3)
a birefringence##7##2##(2007-11#2)(2008-3#5)
a birefringent blur filter##2##4##(2008-3#2)
a birefringent filter##2##3##(2008-3#2)
a birefringent material##2##3##(2008-3#2)
a birefringent prism##2##3##(2008-3#2)
a birefringent##13##2##(2007-11#1)(2007-7#1)(2008-3#11)
a birth##3##2##(1994-3#1)(1994-8#1)(2007-2#1)
a bit error rate of##2##5##(2007-12#1)(2008-3#1)
a bit error rate##3##4##(2007-12#1)(2008-3#2)
a bit##5##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#2)
a bite by a tick##2##5##(1996-11#2)
a bivariate##4##2##(2008-10#1)(2008-3#1)(2009-9#1)(2011-2#1)
a black##4##2##(1993-5#1)(1994-12#1)(2010-8#1)(2012-3#1)
a black-white discrimination##2##3##(1993-5#1)(1996-5#1)
a blackbody##2##2##(2008-3#2)
a blank of##2##3##(2008-10#2)
a blank solution##2##3##(2008-10#2)
a blank with the##2##4##(2008-10#2)
a blank##10##2##(1992-3#1)(2008-10#8)(2008-5#1)
a blast##2##2##(2008-10#1)(2008-7#1)
a blazed diffraction grating##2##4##(2007-11#1)(2008-3#1)
a blazed##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
a bleaching##4##2##(2007-11#3)(2009-2#1)
a bleeding##4##2##(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
a blend of##2##3##(1993-1#1)(2009-8#1)
a blind##10##2##(1990-5#2)(1991-9#2)(1992-11#1)(1995-11#1)(1997-2#1)(2007-8#1)(2008-5#1)(2008-6#1)
a blinded##3##2##(2007-10#1)(2008-5#1)(2013-8#1)
a block of##2##3##(2008-10#2)
a block##8##2##(2008-10#4)(2008-12#1)(2010-2#1)(2012-12#2)
a blockade of##3##3##(1991-2#1)(1996-5#1)(1997-7#1)
a blocker of##3##3##(1990-12#1)(2009-2#1)(2013-1#1)
a blocking##5##2##(1990-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
a blood pressure measurement##2##4##(2008-12#1)(2013-8#1)
a blood pressure##9##3##(1997-2#1)(1997-7#1)(2008-1#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
a blood sample##2##3##(2006-10#1)(2008-9#1)
a blood transfusion##3##3##(1997-5#1)(2011-2#1)(2012-3#1)
a blood##23##2##(1991-7#1)(1994-11#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-8#1)
a bloom##2##2##(1993-11#1)(2008-8#1)
a blue picosecond##2##3##(2007-11#2)
a blue##16##2##(1990-2#1)(1997-3#2)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#1)(2008-7#1)(2011-1#1)
a blueprint for##7##3##(1994-12#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)
a blueprint##8##2##(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)
a blunt##6##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
a blunted##2##2##(2009-12#1)(2010-11#1)
a board##2##2##(1995-12#1)(1996-3#1)
a body mass index##4##4##(2008-11#2)(2011-2#1)(2012-12#1)
a body mass##5##3##(2008-11#2)(2011-2#2)(2012-12#1)
a body of##2##3##(2008-12#1)(2011-2#1)
a body##14##2##(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#4)(2012-12#1)(2013-8#1)
a bolus##3##2##(1993-1#1)(2007-9#1)(2011-2#1)
a bone graft##5##3##(1995-12#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-7#1)
a bone infarct##4##3##(2008-6#4)
a bone marrow stromal cell line##3##6##(2008-10#1)(2008-11#2)
a bone marrow##4##3##(2008-10#1)(2008-11#3)
a bone##18##2##(1995-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2013-1#1)
a bony##3##2##(2008-7#2)(2013-8#1)
a booklet##2##2##(1996-8#1)(2008-3#1)
a boost##3##2##(2007-11#1)(2010-5#1)(2012-2#1)
a booster dose##3##3##(1990-8#1)(2010-10#1)(2013-1#1)
a booster##4##2##(1990-8#1)(2008-4#1)(2010-10#1)(2013-1#1)
a bootstrap confidence value of##2##5##(2008-10#2)
a borderline##4##2##(1995-4#1)(1996-3#1)(1997-3#1)(2008-12#1)
a boric acid gel column##2##5##(1990-8#2)
a boron##4##2##(1994-3#1)(1996-2#1)(2008-10#2)
a boron-doped diamond thin film##2##5##(2008-10#2)
a boron-doped diamond##3##3##(2008-10#3)
a botanical##2##2##(1993-11#1)(2013-8#1)
a bottleneck##2##2##(2008-10#1)(2008-11#1)
a bottom-up approach##4##3##(1995-3#1)(2011-2#1)(2012-2#2)
a bound##3##2##(1990-5#1)(2008-11#1)(2008-8#1)
a boundary##6##2##(1994-6#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-2#1)
a boundary-element##2##2##(2008-3#2)
a bovine##8##2##(1991-2#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-6#1)
a bow##2##2##(2008-2#2)
a box##2##2##(1997-3#1)(2010-3#1)
a boy affected##2##3##(2008-10#1)(2011-1#1)
a boy##9##2##(1994-3#1)(1995-5#1)(1996-11#1)(1997-3#1)(2007-7#1)(2008-10#2)(2011-1#1)(2012-12#1)
a brachial plexus##2##3##(2008-9#1)(2009-3#1)
a brain area##2##3##(2008-11#1)(2008-7#1)
a brain cell##2##3##(2012-2#2)
a brain##14##2##(1991-11#1)(1992-8#1)(1996-2#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-8#2)
a brain-specific##3##2##(1992-11#1)(1994-12#1)(2012-3#1)
a branch clinic##2##3##(1991-3#2)
a branch##6##2##(1991-3#2)(2007-8#1)(2008-10#1)(2010-8#2)
a branched##5##2##(1990-8#1)(1993-12#2)(2007-12#1)(2008-1#1)
a brand new##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
a breakdown in##4##3##(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
a breakdown product of##2##4##(1995-12#1)(2008-10#1)
a breakdown##7##2##(1995-12#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
a breast cancer screening##2##4##(2011-2#1)(2012-12#1)
a breast cancer##10##3##(1993-3#1)(1994-9#1)(1997-7#1)(2007-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
a breast screening##2##3##(1993-2#1)(2012-12#1)
a breast##20##2##(1990-10#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-5#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
a breeding##5##2##(1997-4#3)(2008-10#2)
a bridge between the two##2##5##(1997-3#1)(2012-3#1)
a bridge between the##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
a bridge between##8##3##(1993-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
a bridge to##9##3##(2008-11#1)(2011-2#6)(2013-1#2)
a bridge##25##2##(1993-2#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#8)(2012-3#1)(2013-1#3)
a brief account of##2##4##(1990-8#1)(1996-9#1)
a brief but intensive##2##4##(2013-1#2)
a brief but##3##3##(2010-9#1)(2013-1#2)
a brief description of the##9##5##(1991-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
a brief description of##12##4##(1991-11#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
a brief discussion of the##4##5##(1990-5#1)(2008-11#1)(2008-4#2)
a brief discussion of##8##4##(1990-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-9#1)(2012-12#1)(2013-1#1)
a brief discussion##10##3##(1990-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-9#1)(2012-12#1)(2013-1#1)
a brief historical perspective##2##4##(1992-1#1)(2008-4#1)
a brief history of the##3##5##(1991-9#1)(1993-12#1)(2008-2#1)
a brief history of##5##4##(1991-9#1)(1993-12#1)(2008-2#1)(2008-8#1)(2012-2#1)
a brief introduction to##7##4##(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
a brief introduction##9##3##(2008-7#1)(2008-9#2)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a brief overview of the##11##5##(1994-12#1)(1995-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
a brief overview of##19##4##(1993-2#1)(1994-12#1)(1995-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
a brief overview##24##3##(1993-2#1)(1994-12#1)(1995-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
a brief review of the literature##3##6##(2008-8#1)(2009-5#1)(2010-8#1)
a brief review of the##10##5##(1990-12#1)(1993-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#3)(2010-8#1)
a brief review of##15##4##(1990-12#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#3)(2010-8#1)(2012-12#1)
a brief review##16##3##(1990-12#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#3)(2010-8#1)(2012-12#1)
a brief summary of the##3##5##(1996-8#1)(1997-3#1)(2012-2#1)
a brief summary of##4##4##(1996-8#1)(1997-3#1)(2008-10#1)(2012-2#1)
a brief survey##2##3##(2006-4#1)(2008-9#1)
a brief##122##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-12#3)(2007-5#2)(2007-7#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#3)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#7)(2009-11#1)(2009-3#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#5)(2013-1#6)(2013-8#1)
a bright future##3##3##(1992-11#1)(2006-10#1)(2011-7#1)
a bright light##2##3##(2008-2#1)(2008-3#1)
a bright##16##2##(1991-5#1)(1992-11#1)(1995-2#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#2)(2011-7#1)
a brilliant##2##2##(1995-3#1)(2008-5#1)
a broad and##4##3##(2008-10#2)(2011-1#1)(2012-3#1)
a broad array of##5##4##(2008-5#1)(2009-5#2)(2012-2#1)(2013-7#1)
a broad band##3##3##(2008-10#2)(2008-3#1)
a broad continuum##2##3##(2007-11#1)(2008-10#1)
a broad distribution of##2##4##(2007-11#1)(2008-3#1)
a broad host range##3##4##(2008-10#2)(2008-9#1)
a broad maximum##2##3##(2008-10#2)
a broad pH range##3##4##(1991-5#1)(2006-6#1)(2013-1#1)
a broad perspective of##2##4##(2008-7#1)(2011-2#1)
a broad perspective##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
a broad range from##2##4##(2008-5#1)(2010-12#1)
a broad range of methods##2##5##(2008-5#1)(2010-5#1)
a broad range of pathogens##2##5##(2008-10#2)
a broad range of##61##4##(1993-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)
a broad range##65##3##(1993-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#14)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)
a broad signal##2##3##(1995-12#1)(2007-12#1)
a broad spectral range from##2##5##(2007-11#2)
a broad spectral range##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
a broad spectrum of biological##3##5##(1994-6#1)(2008-10#1)(2010-4#1)
a broad spectrum of##22##4##(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
a broad spectrum##26##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
a broad temperature range##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
a broad theoretical##2##3##(2009-4#1)(2012-3#1)
a broad variety of##3##4##(2007-12#1)(2008-9#1)(2009-10#1)
a broad##185##2##(1990-11#1)(1990-5#1)(1991-5#1)(1993-1#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#7)(2007-12#10)(2008-1#2)(2008-10#33)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#12)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#1)(2013-7#2)
a broad-area laser##2##3##(2008-3#2)
a broad-area##4##2##(2008-2#1)(2008-3#3)
a broad-spectrum##5##2##(2008-10#4)(2012-2#1)
a broad-stripe##2##2##(2007-12#2)
a broadband light source##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
a broadband source##4##3##(2007-11#2)(2008-2#1)(2012-2#1)
a broadband##17##2##(2007-11#6)(2007-12#1)(2008-2#2)(2008-3#6)(2012-2#2)
a broadening##2##2##(2007-12#1)(2008-2#1)
a broader context##2##3##(1993-2#1)(2010-12#1)
a broader public health##2##4##(2008-1#1)(2011-2#1)
a broader range of##2##4##(1992-12#1)(2008-8#1)
a broader range##3##3##(1992-12#1)(2008-10#1)(2008-8#1)
a broader spectrum of##5##4##(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
a broader understanding of##2##4##(2008-11#1)(2008-7#1)
a broader understanding##3##3##(1995-3#1)(2008-11#1)(2008-7#1)
a broader##40##2##(1992-12#1)(1993-2#2)(1993-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#4)(2013-1#3)
a broadly tunable##3##3##(2008-3#3)
a broadly##10##2##(1991-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)(2011-1#1)(2011-9#1)
a broken##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2013-7#1)
a bromide##2##2##(2008-10#2)
a bronchial##3##2##(2007-8#2)(2009-7#1)
a broth##2##2##(2008-10#1)(2008-12#1)
a brother##3##2##(2007-7#2)(2011-2#1)
a brown##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
a brownish##2##2##(2008-5#1)(2012-2#1)
a bubble##5##2##(2008-2#1)(2008-6#2)(2008-7#1)(2009-11#1)
a budget of##2##3##(1991-1#1)(1997-1#1)
a budget##3##2##(1991-1#1)(1997-1#1)(2012-3#1)
a buffer##14##2##(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
a buffered solution##2##3##(2008-10#2)
a buffered##3##2##(2008-1#1)(2008-10#2)
a buffering##2##2##(1996-8#1)(2008-10#1)
a build-up##2##2##(1992-8#1)(2007-11#1)
a building##3##2##(1991-12#1)(2008-3#2)
a built-in##4##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
a bulk acoustic wave##4##4##(2008-10#4)
a bulk acoustic##5##3##(2008-10#5)
a bulk crystal##2##3##(2007-12#1)(2008-3#1)
a bulk medium##3##3##(2007-11#1)(2007-12#2)
a bulk of##2##3##(2010-1#1)(2010-10#1)
a bulk sample##2##3##(2007-11#1)(2007-12#1)
a bulk##28##2##(2007-11#7)(2007-12#8)(2008-10#10)(2008-3#1)(2010-1#1)(2010-10#1)
a bulky##2##2##(2008-8#1)(2010-11#1)
a bundle of##2##3##(1995-12#1)(2013-1#1)
a bundle##5##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
a buoyant##3##2##(1996-12#1)(2008-10#2)
a burden##2##2##(2008-11#1)(2008-8#1)
a buried##3##2##(1992-3#1)(1993-11#1)(1997-2#1)
a burnout##3##2##(1996-2#2)(2011-2#1)
a burst of##4##3##(1991-9#1)(1994-8#1)(2007-12#1)(2011-2#1)
a business in##2##3##(1994-3#1)(2008-5#1)
a business##10##2##(1992-1#2)(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(2007-10#1)(2008-12#1)(2008-5#1)(2010-7#1)
a butterfly##4##2##(2008-2#2)(2008-8#1)(2013-1#1)
a buttock terotoma##2##3##(2012-12#2)
a by-product of##10##3##(1992-3#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
a by-product##11##2##(1992-3#1)(1994-3#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
a byproduct##2##2##(2008-6#2)
a bystander##2##2##(2008-7#2)
a cAMP##2##2##(1993-5#1)(1995-11#1)
a cDNA clone encoding a##2##5##(1993-9#1)(1994-8#1)
a cDNA clone encoding##6##4##(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)
a cDNA clone##11##3##(1990-12#1)(1990-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-7#1)
a cDNA coding for##3##4##(1991-9#1)(1995-2#1)(1996-2#1)
a cDNA encoding a##7##4##(1992-8#2)(1994-12#2)(1995-11#1)(1997-1#1)(2008-8#1)
a cDNA encoding human##5##4##(1994-12#1)(2008-8#4)
a cDNA encoding the human##2##5##(1991-6#1)(2008-5#1)
a cDNA encoding the##6##4##(1991-6#1)(1992-11#1)(1993-3#2)(1994-12#1)(2008-5#1)
a cDNA encoding##23##3##(1991-6#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-3#2)(1994-11#2)(1994-12#5)(1995-11#1)(1997-1#1)(2008-5#1)(2008-6#1)(2008-8#5)
a cDNA for##6##3##(1990-11#1)(1990-12#1)(1991-9#1)(1993-11#1)(1994-11#1)(1995-6#1)
a cDNA library and##2##4##(2008-8#1)(2011-2#1)
a cDNA library derived from##4##5##(1990-11#1)(1992-9#1)(1993-6#1)(1994-12#1)
a cDNA library from##2##4##(1993-3#1)(1994-8#1)
a cDNA library prepared from##2##5##(1993-3#1)(1994-6#1)
a cDNA library##18##3##(1990-11#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
a cDNA probe##2##3##(1990-2#1)(1992-8#1)
a cDNA##78##2##(1990-11#2)(1990-12#2)(1990-2#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#8)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#3)(2010-4#1)(2011-2#1)
a cable##2##2##(2008-11#1)(2012-12#1)
a cadaver##2##2##(2008-10#1)(2008-12#1)
a cadaveric study##2##3##(2008-7#1)(2008-9#1)
a cadre of##3##3##(1996-3#1)(2012-3#1)(2013-1#1)
a caesarean section##3##3##(1990-12#1)(1992-5#1)(1996-11#1)
a cage##2##2##(2010-5#2)
a calcified mass##3##3##(2007-8#1)(2011-1#1)(2013-8#1)
a calcified##4##2##(2007-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
a calcineurin inhibitor##2##3##(2008-3#1)(2011-3#1)
a calcium channel##2##3##(1992-8#1)(2008-8#1)
a calcium##20##2##(1990-2#3)(1990-5#1)(1990-7#1)(1991-6#1)(1992-6#1)(1992-8#1)(1995-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)
a calcium-binding##2##2##(1993-12#2)
a calcium-dependent##2##2##(1993-11#1)(1994-6#1)
a calcium/calmodulin-dependent protein kinase II##2##5##(1996-2#1)(2008-8#1)
a calculated Mr of##2##4##(1990-11#1)(1990-5#1)
a calculated molecular mass of##3##5##(1993-3#1)(1996-6#1)(2008-4#1)
a calculated molecular weight of##4##5##(1990-12#1)(1990-7#2)(1995-6#1)
a calculated molecular##7##3##(1990-12#1)(1990-7#2)(1993-3#1)(1995-6#1)(1996-6#1)(2008-4#1)
a calculated##21##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-12#1)
a calculation based on##2##4##(2007-11#1)(2010-10#1)
a calculation of the##2##4##(2007-11#1)(2008-2#1)
a calculation of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a calculation##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2010-10#1)
a calculator##3##2##(2008-11#3)
a calibrated##3##2##(1997-2#1)(2008-1#1)(2008-3#1)
a calibration curve by plotting the relative intensity of reflectance versus the##2##12##(2008-10#2)
a calibration curve by plotting the##3##6##(2008-10#3)
a calibration curve by##4##4##(2008-10#3)(2008-9#1)
a calibration curve##12##3##(2008-10#9)(2008-8#1)(2008-9#1)(2013-8#1)
a calibration graph##3##3##(2008-10#3)
a calibration model##4##3##(2007-12#1)(2008-10#3)
a calibration procedure##3##3##(2008-10#1)(2008-3#2)
a calibration set##2##3##(2008-10#2)
a calibration standard##2##3##(2008-10#1)(2008-2#1)
a calibration##39##2##(2007-12#2)(2008-10#28)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2013-8#1)
a call for an international coordinated effort in rice functional genomics##2##11##(2009-10#2)
a call for##7##3##(1996-1#1)(2009-10#2)(2010-2#1)(2011-1#2)(2012-12#1)
a call to action##3##4##(1996-1#1)(2009-5#1)(2011-1#1)
a call to##4##3##(1991-3#1)(1996-1#1)(2009-5#1)(2011-1#1)
a call##11##2##(1991-3#1)(1996-1#2)(2009-10#2)(2009-5#1)(2010-2#1)(2011-1#3)(2012-12#1)
a calorie is##2##3##(2008-3#1)(2008-5#1)
a calorie##4##2##(2008-3#1)(2008-5#3)
a calpain/protein kinase C##2##4##(1992-9#2)
a camera##9##2##(1992-12#1)(2008-2#1)(2008-3#6)(2008-9#1)
a campaign##3##2##(1991-9#1)(2008-5#1)(2012-12#1)
a campus##2##2##(1991-2#1)(1996-12#1)
a canal##2##2##(2007-12#1)(2008-7#1)
a cancer centre##5##3##(2008-6#3)(2011-2#1)(2012-2#1)
a cancer treatment##3##3##(2007-10#1)(2008-11#1)(2011-2#1)
a cancer##21##2##(1992-10#1)(1993-3#1)(1995-9#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-6#3)(2008-7#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
a candidate for use##2##4##(1995-11#1)(2009-9#1)
a candidate for##12##3##(1990-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2012-2#1)
a candidate gene approach##2##4##(2008-10#1)(2009-10#1)
a candidate gene for Wilson disease##2##6##(1993-11#2)
a candidate gene for##3##4##(1993-11#2)(2010-2#1)
a candidate gene##8##3##(1992-3#1)(1993-11#2)(2008-10#1)(2009-10#2)(2010-2#1)(2012-3#1)
a candidate of##2##3##(1992-6#1)(2010-1#1)
a candidate tumor suppressor gene##3##5##(2008-9#1)(2009-9#1)(2012-2#1)
a candidate##48##2##(1990-12#1)(1990-3#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-9#2)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)
a canine model##4##3##(2009-8#3)(2013-1#1)
a canine##11##2##(1994-12#1)(2008-10#1)(2009-8#3)(2010-4#2)(2012-3#2)(2013-1#2)
a cannula##3##2##(1990-7#1)(2008-10#1)(2008-6#1)
a canonical##6##2##(1992-3#1)(1995-6#1)(2008-3#1)(2009-11#1)(2009-6#1)(2012-2#1)
a cap on the##2##4##(2012-3#2)
a cap##6##2##(1992-3#1)(1993-9#1)(2008-11#1)(2011-2#1)(2012-3#2)
a capability for##5##3##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
a capacity for##3##3##(1990-5#1)(2008-12#1)(2009-7#1)
a capacity of##4##3##(2008-10#4)
a capacity to##2##3##(1996-5#1)(2008-8#1)
a capacity##10##2##(1990-5#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#1)(2009-7#1)
a capillary discharge##2##3##(2008-3#2)
a capillary electrophoresis##5##3##(1994-12#1)(2008-10#4)
a capillary electrophoretic##2##3##(2008-10#2)
a capillary ion##2##3##(1997-2#1)(2008-10#1)
a capillary tube##2##3##(2008-2#2)
a capillary##30##2##(1994-12#1)(1994-9#2)(1997-2#3)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)
a capital##2##2##(2008-10#1)(2008-9#1)
a capitated##2##2##(1994-3#1)(1996-2#1)
a capstone course##2##3##(1993-1#2)
a capsule##2##2##(2008-10#1)(2011-2#1)
a captive##2##2##(1993-1#1)(2008-5#1)
a capture##2##2##(2008-11#1)(2008-3#1)
a car##4##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
a carbohydrate##7##2##(1990-5#1)(1992-9#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
a carbohydrate-binding##3##2##(1995-5#1)(2009-3#2)
a carbohydrate-restricted diet##9##3##(2008-3#9)
a carbon ceramic electrode##2##4##(2008-10#2)
a carbon core##2##3##(2008-10#2)
a carbon electrode##3##3##(2008-10#3)
a carbon fiber##5##3##(2008-10#5)
a carbon paste electrode (CPE)##3##5##(2008-10#2)(2008-6#1)
a carbon paste electrode modified by##2##6##(2008-10#2)
a carbon paste electrode modified with organofunctionalized amorphous silica##2##9##(2008-10#2)
a carbon paste electrode modified with##8##6##(2008-10#8)
a carbon paste electrode modified##12##5##(2008-10#12)
a carbon paste electrode##22##4##(2008-10#21)(2008-6#1)
a carbon paste##25##3##(2008-10#24)(2008-6#1)
a carbon source##9##3##(1994-3#1)(1997-2#2)(2008-10#2)(2008-6#2)(2008-7#1)(2011-1#1)
a carbon##55##2##(1994-3#1)(1994-8#1)(1995-8#1)(1997-2#2)(2008-10#42)(2008-3#2)(2008-6#3)(2008-7#2)(2011-1#1)
a carbonyl##4##2##(1990-5#1)(1995-3#2)(2009-5#1)
a carboxylic acid##2##3##(1994-8#1)(2008-10#1)
a carboxylic##4##2##(1994-8#1)(1995-5#1)(2008-10#2)
a carboxymethylated##2##2##(1990-8#1)(2008-10#1)
a carcinogen##2##2##(1994-11#1)(2013-1#1)
a carcinogenic effect##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
a carcinogenic##4##2##(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
a carcinoid##3##2##(1990-2#1)(1992-5#1)(1997-1#1)
a carcinoma of the pancreatic head##2##6##(2008-10#2)
a carcinoma of the##4##4##(1997-8#2)(2008-10#2)
a carcinoma##7##2##(1990-9#1)(1992-2#1)(1994-7#1)(1997-8#2)(2008-10#2)
a card##3##2##(1996-2#1)(2008-11#1)(2008-2#1)
a cardiac##18##2##(1990-9#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-7#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
a cardinal##2##2##(2008-6#1)(2011-1#1)
a cardiologist##2##2##(2008-3#1)(2012-2#1)
a cardiothoracic##2##2##(2007-8#1)(2013-1#1)
a cardiovascular##6##2##(1993-3#1)(2008-4#1)(2009-10#1)(2010-6#1)(2010-8#1)(2013-8#1)
a cardioverter-defibrillator##2##2##(2008-12#1)(2012-2#1)
a care##3##2##(1990-2#1)(1995-12#1)(2008-11#1)
a career in health##2##4##(1992-1#1)(2008-1#1)
a career in##5##3##(1992-1#1)(1993-11#1)(1994-12#1)(1994-2#1)(2008-1#1)
a career ladder##2##3##(1994-12#1)(2008-1#1)
a career##12##2##(1992-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(1996-1#1)(2007-4#2)(2008-1#3)(2008-11#1)
a careful analysis of the##2##5##(2008-2#1)(2008-7#1)
a careful analysis of##3##4##(1994-3#1)(2008-2#1)(2008-7#1)
a careful examination of the##2##5##(1990-10#1)(1993-11#1)
a careful history and##2##4##(1991-12#1)(2010-6#1)
a careful##20##2##(1990-10#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-3#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
a carefully controlled##2##3##(2008-3#1)(2012-7#1)
a carefully crafted##2##3##(2008-10#1)(2008-9#1)
a carefully##6##2##(1992-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-7#1)
a caregiver##2##2##(2008-6#1)(2012-3#1)
a caring environment##3##3##(2008-1#3)
a caring##8##2##(1990-6#1)(1993-12#1)(2008-1#4)(2008-12#1)(2012-3#1)
a carotid artery reconstruction##2##4##(2008-7#2)
a carrier and##3##3##(2008-10#2)(2008-3#1)
a carrier gas flow rate of##2##6##(2008-10#2)
a carrier gas##4##3##(2008-10#4)
a carrier ionophore mechanism##2##4##(1990-2#2)
a carrier ionophore##3##3##(1990-2#3)
a carrier of a##3##4##(1994-12#1)(1997-3#1)(2008-1#1)
a carrier of##6##3##(1994-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
a carrier protein##5##3##(1990-7#1)(1995-11#1)(2008-2#1)(2008-4#2)
a carrier solution##3##3##(2008-10#3)
a carrier state##2##3##(1997-3#1)(2009-5#1)
a carrier stream of##6##4##(2008-10#6)
a carrier stream##10##3##(2008-10#10)
a carrier##60##2##(1990-2#3)(1990-7#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)
a carrier-mediated##2##2##(1994-8#1)(2011-3#1)
a cartilage##2##2##(2008-5#1)(2011-2#1)
a cartridge##3##2##(2008-10#3)
a cascade of events##2##4##(1993-8#1)(2009-9#1)
a cascade of##6##3##(1993-8#1)(1994-6#1)(2007-11#1)(2008-3#2)(2009-9#1)
a cascade##8##2##(1993-8#1)(1994-6#1)(2007-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)
a cascaded##2##2##(2007-12#2)
a case about]##2##3##(2013-1#2)
a case and review##11##4##(1990-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)
a case and##13##3##(1990-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
a case control study##3##4##(2006-10#1)(2007-6#1)(2008-11#1)
a case example of a##2##5##(2008-7#1)(2009-9#1)
a case example##8##3##(1993-12#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)
a case for##13##3##(1992-5#1)(1994-1#1)(1994-2#2)(2008-1#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-9#1)(2012-2#2)
a case history of a##2##5##(1994-12#1)(2012-12#1)
a case history of##4##4##(1994-12#1)(1996-12#1)(1996-3#1)(2012-12#1)
a case history##6##3##(1994-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(2012-12#1)
a case in which the##4##5##(2007-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
a case in which##13##4##(1990-2#1)(1992-2#1)(1993-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
a case in##17##3##(1990-2#1)(1992-2#1)(1993-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a case involving a##2##4##(2009-9#1)(2010-8#1)
a case involving##3##3##(2009-2#1)(2009-9#1)(2010-8#1)
a case mix##3##3##(1991-12#1)(1996-2#1)(1997-1#1)
a case of a 1-year-old##2##5##(2008-10#1)(2008-7#1)
a case of a 10##2##5##(2008-7#1)(2012-2#1)
a case of a 14-year-old##2##5##(2007-5#1)(2008-9#1)
a case of a 16-year-old girl with##2##7##(2011-1#1)(2013-1#1)
a case of a 16-year-old##3##5##(2011-1#1)(2012-3#1)(2013-1#1)
a case of a 55-year-old##2##5##(2013-1#1)(2013-8#1)
a case of a 59-year-old##2##5##(2007-8#1)(2013-8#1)
a case of a 60-year-old woman##2##6##(2009-1#1)(2009-3#1)
a case of a 60-year-old##3##5##(2007-4#1)(2009-1#1)(2009-3#1)
a case of a 61-year-old##2##5##(2010-8#1)(2013-8#1)
a case of a 65-year-old##2##5##(1992-10#1)(2012-2#1)
a case of a 72-year-old##2##5##(2008-12#1)(2010-6#1)
a case of a healthy##2##5##(2006-10#1)(2013-8#1)
a case of a large##2##5##(1992-5#1)(2007-8#1)
a case of a patient with##4##6##(2007-8#1)(2009-3#1)(2012-2#1)(2012-3#1)
a case of a previously##2##5##(2008-8#1)(2009-3#1)
a case of a symptomatic##2##5##(2007-8#1)(2008-10#1)
a case of a young##8##5##(2007-7#1)(2007-8#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
a case of a##105##4##(1991-11#1)(1991-2#1)(1992-10#1)(1992-5#1)(1994-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#10)(2008-10#3)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#2)(2009-1#1)(2009-3#7)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#5)
a case of acute##5##4##(1992-6#1)(2007-12#1)(2008-10#1)(2010-4#1)(2013-1#1)
a case of aggressive##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
a case of an elderly##3##5##(2010-5#1)(2011-1#1)(2012-2#1)
a case of an##20##4##(2007-5#1)(2007-8#1)(2008-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
a case of bilateral##6##4##(1994-12#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
a case of carotid##2##4##(1992-6#1)(2009-7#1)
a case of cervical##2##4##(2012-3#2)
a case of chest wall##2##5##(1992-6#1)(2007-12#1)
a case of chronic##5##4##(2007-7#1)(2008-11#1)(2011-2#2)(2013-1#1)
a case of congenital##4##4##(2008-12#1)(2010-11#1)(2011-1#1)(2012-3#1)
a case of cutaneous sarcoidosis##2##5##(2007-7#1)(2010-6#1)
a case of cutaneous##4##4##(2007-7#1)(2008-10#1)(2010-11#1)(2010-6#1)
a case of fatal##2##4##(2009-4#1)(2011-2#1)
a case of giant##3##4##(1991-6#1)(2008-12#1)(2008-7#1)
a case of hydatid cyst##2##5##(2007-7#1)(2010-11#1)
a case of idiopathic##2##4##(2006-12#1)(2008-10#1)
a case of leiomyosarcoma##3##4##(2008-5#1)(2008-6#2)
a case of lupus nephritis##2##5##(2008-1#2)
a case of massive##2##4##(1992-5#1)(2011-1#1)
a case of metastatic##4##4##(2007-6#1)(2010-6#1)(2011-2#2)
a case of multiple##4##4##(2008-10#1)(2009-3#1)(2013-1#2)
a case of painless##2##4##(2008-12#1)(2013-1#1)
a case of persistent##2##4##(2008-10#1)(2012-2#1)
a case of pleural##2##4##(2007-7#1)(2007-8#1)
a case of pneumocephalus##2##4##(2008-7#1)(2008-9#1)
a case of primary##11##4##(1990-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-8#1)
a case of pulmonary##7##4##(2007-7#1)(2007-8#1)(2008-1#1)(2012-3#1)(2013-1#3)
a case of recurrent##5##4##(1993-1#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
a case of renal##2##4##(2007-7#1)(2008-8#1)
a case of secondary##3##4##(1993-12#1)(2008-12#1)(2010-3#1)
a case of septic##2##4##(2006-10#1)(2012-12#1)
a case of severe##7##4##(1990-10#1)(1991-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2012-3#1)(2013-8#1)
a case of sigmoid##2##4##(2010-12#1)(2012-12#1)
a case of spontaneous splenic rupture in##2##7##(1992-2#1)(1993-9#1)
a case of spontaneous##7##4##(1990-9#1)(1992-2#1)(1993-9#1)(2008-7#1)(2012-12#1)(2013-1#2)
a case of subcutaneous##2##4##(1991-5#1)(2007-7#1)
a case of symptomatic##2##4##(1993-9#1)(2012-12#1)
a case of##504##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#4)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#6)(1991-8#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-12#2)(1994-6#1)(1994-8#3)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#4)(2006-12#1)(2007-10#3)(2007-12#5)(2007-2#3)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#20)(2007-8#21)(2007-9#1)(2008-1#7)(2008-10#19)(2008-11#11)(2008-12#26)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#8)(2008-7#25)(2008-8#10)(2008-9#5)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#9)(2009-4#4)(2009-5#6)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#5)(2010-3#7)(2010-4#5)(2010-5#3)(2010-6#9)(2010-7#2)(2010-8#4)(2011-1#21)(2011-2#35)(2012-1#5)(2012-12#25)(2012-2#19)(2012-3#17)(2013-1#36)(2013-7#2)(2013-8#16)
a case report and a review of literature##2##8##(2008-1#1)(2013-1#1)
a case report and a review of##3##7##(2007-2#1)(2008-1#1)(2013-1#1)
a case report and a##4##5##(2007-2#1)(2008-1#1)(2013-1#2)
a case report and discussion of##2##6##(2008-7#1)(2011-2#1)
a case report and literature review##15##6##(2007-10#2)(2008-1#1)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
a case report and literature##16##5##(2007-10#2)(2008-1#1)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
a case report and review of literature##4##7##(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
a case report and review of the literature of##2##9##(2008-6#1)(2012-3#1)
a case report and review of the literature##15##8##(2007-2#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a case report and review of the##17##7##(2007-2#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
a case report and review of##22##6##(2007-2#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
a case report and##47##4##(2007-10#2)(2007-2#3)(2007-8#1)(2008-1#4)(2008-10#2)(2008-12#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#7)(2013-8#1)
a case report of a patient##2##6##(2007-8#1)(2012-12#1)
a case report of a##14##5##(2007-10#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#3)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a case report of an##2##5##(2008-12#1)(2013-1#1)
a case report of##21##4##(2007-10#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#4)(2008-7#2)(2009-1#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
a case report with##3##4##(2008-6#1)(2013-1#1)(2013-8#1)
a case report##213##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-6#4)(1992-12#1)(1993-6#1)(1994-11#1)(1996-9#1)(2006-10#1)(2007-10#7)(2007-2#3)(2007-5#1)(2007-7#17)(2007-8#4)(2008-1#7)(2008-10#2)(2008-11#2)(2008-12#16)(2008-6#3)(2008-7#16)(2008-8#5)(2008-9#9)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#20)(2011-3#1)(2012-12#12)(2012-2#4)(2012-3#6)(2013-1#27)(2013-7#1)(2013-8#6)
a case report]##8##3##(1994-11#1)(2009-1#1)(2009-5#2)(2012-2#2)(2013-1#1)(2013-7#1)
a case series and review of the##2##7##(1993-5#1)(2009-6#1)
a case series##11##3##(1993-5#1)(2007-11#1)(2007-5#1)(2008-12#2)(2009-10#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#2)
a case study and review##3##5##(2007-7#1)(2013-1#2)
a case study for##3##4##(1992-3#1)(1997-3#1)(2011-1#1)
a case study from british columbia##2##6##(2009-3#2)
a case study from##5##4##(1995-3#1)(2008-8#1)(2009-10#1)(2009-3#2)
a case study in##10##4##(1993-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-8#1)(2012-2#1)
a case study involving the##2##5##(2008-10#1)(2008-6#1)
a case study of a##7##5##(1992-2#1)(1996-3#1)(1997-2#1)(2008-2#1)(2008-6#1)(2010-6#1)(2013-1#1)
a case study of the##6##5##(1995-2#1)(1996-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
a case study of##27##4##(1992-12#1)(1992-2#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-2#3)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
a case study on##3##4##(1994-12#1)(1996-2#1)(2008-12#1)
a case study##99##3##(1991-1#1)(1991-2#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-12#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-9#1)(1997-2#5)(1997-3#1)(2006-5#1)(2007-11#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#3)(2009-5#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
a case that had##2##4##(2008-7#1)(2013-8#1)
a case that##10##3##(2007-6#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
a case where##6##3##(1991-11#1)(2007-8#2)(2008-9#1)(2012-12#2)
a case with a##2##4##(1991-6#1)(2012-3#1)
a case with##17##3##(1991-6#1)(1991-9#1)(1992-5#1)(1993-3#1)(1995-3#1)(2007-10#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-3#2)
a case##974##2##(1990-10#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-6#8)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#11)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#5)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#5)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#8)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#6)(2006-12#1)(2006-5#1)(2007-10#12)(2007-11#2)(2007-12#6)(2007-2#7)(2007-4#1)(2007-5#10)(2007-6#3)(2007-7#40)(2007-8#28)(2007-9#2)(2008-1#18)(2008-10#32)(2008-11#25)(2008-12#54)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#8)(2008-6#14)(2008-7#50)(2008-8#18)(2008-9#20)(2009-1#6)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#13)(2009-4#6)(2009-5#10)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#12)(2010-4#6)(2010-5#5)(2010-6#12)(2010-7#6)(2010-8#10)(2010-9#3)(2011-1#35)(2011-2#60)(2011-3#1)(2012-1#5)(2012-12#44)(2012-2#36)(2012-3#27)(2013-1#75)(2013-7#5)(2013-8#26)
a case-control association study##2##4##(1997-5#1)(2011-2#1)
a case-control study on##2##4##(1990-12#1)(1990-8#1)
a case-control study##11##3##(1990-12#1)(1990-8#1)(1991-8#1)(1993-9#2)(2007-10#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#2)
a case-control##13##2##(1990-12#1)(1990-8#1)(1991-8#1)(1993-9#2)(1997-5#1)(2007-10#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#3)
a case-mix##2##2##(1991-2#1)(1994-3#1)
a case]##9##2##(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1993-9#1)(1996-2#1)(2013-1#2)(2013-8#1)
a cassette##2##2##(2008-6#1)(2008-8#1)
a casual##2##2##(2008-1#1)(2008-10#1)
a cat##6##2##(1992-5#1)(1993-12#1)(1995-1#1)(1997-8#1)(2008-3#1)(2012-3#1)
a catalyst for##3##3##(1995-2#1)(2008-10#2)
a catalyst##13##2##(1995-2#1)(1996-5#1)(2008-10#9)(2008-7#1)(2012-3#1)
a catalytic surface##2##3##(2008-10#2)
a catalytic##19##2##(1997-6#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-6#1)(2009-10#1)(2010-6#1)
a catechol##2##2##(2008-10#2)
a categorical##2##2##(2008-10#1)(2008-7#1)
a categorization##2##2##(2008-1#1)(2013-8#1)
a category##2##2##(1991-3#1)(2008-3#1)
a catheter##6##2##(1993-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-12#1)
a cathode##3##2##(2008-10#2)(2008-11#1)
a cathodic peak at##2##4##(2008-10#2)
a cathodic##4##2##(2008-10#4)
a cation exchange column##3##4##(2008-10#3)
a cation exchange##5##3##(2008-10#5)
a cation##9##2##(1990-7#1)(2008-10#8)
a cation-exchange##2##2##(2008-10#2)
a cationic dye##2##3##(2008-10#2)
a cationic gemini##2##3##(2008-10#2)
a cationic polymer##2##3##(2008-10#1)(2008-5#1)
a cationic resin##2##3##(2008-10#2)
a cationic surfactant##9##3##(2008-10#9)
a cationic##33##2##(1990-7#1)(1994-12#1)(1995-8#1)(2008-10#27)(2008-2#1)(2008-5#1)(2009-12#1)
a causal agent of##2##4##(2008-10#2)
a causal agent##4##3##(1990-2#1)(2008-10#2)(2010-1#1)
a causal factor##3##3##(1995-12#1)(1995-6#1)(2013-7#1)
a causal inference##2##3##(2010-12#1)(2012-12#1)
a causal link##4##3##(2008-10#1)(2009-9#1)(2013-7#2)
a causal relation between##2##4##(1997-3#1)(2012-2#1)
a causal relationship between##4##4##(1990-6#1)(2007-10#1)(2008-7#1)(2010-2#1)
a causal relationship with##2##4##(1992-2#1)(2008-11#1)
a causal relationship##7##3##(1990-6#1)(1992-2#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-2#1)
a causal role in##5##4##(1990-5#1)(1991-12#1)(1995-12#1)(2008-10#1)(2008-6#1)
a causal role##6##3##(1990-5#1)(1991-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-6#1)
a causal##34##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-2#2)(1994-3#1)(1995-12#2)(1995-6#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#3)
a causative role##3##3##(2008-11#2)(2008-7#1)
a causative##11##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
a cause for##4##3##(1997-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
a cause of action for##2##5##(1994-1#1)(2008-3#1)
a cause of action##3##4##(1994-1#1)(1995-6#1)(2008-3#1)
a cause of significant##2##4##(1992-12#1)(2009-5#1)
a cause of the##4##4##(1990-3#1)(1992-8#1)(2008-1#1)(2012-2#1)
a cause of##50##3##(1990-3#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#2)(1992-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a cause or##3##3##(2008-7#2)(2011-1#1)
a cause##57##2##(1990-3#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#2)(1992-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
a cautionary note##5##3##(1994-3#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
a cautionary tale##2##3##(1995-2#1)(2012-2#1)
a cautionary##8##2##(1994-3#1)(1995-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
a cautious##2##2##(1996-11#1)(2011-2#1)
a cavernous##5##2##(1990-7#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
a cavity ringdown##2##3##(2008-2#1)(2008-3#1)
a cavity##15##2##(1990-9#1)(1996-5#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)(2008-7#1)
a ceiling##2##2##(1996-12#1)(2008-11#1)
a cell adhesion molecule##3##4##(1997-6#1)(2008-5#1)(2009-8#1)
a cell adhesion##4##3##(1997-6#1)(2008-11#1)(2008-5#1)(2009-8#1)
a cell can be##2##4##(2008-1#1)(2008-9#1)
a cell containing##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a cell culture model##2##4##(1994-9#1)(2008-7#1)
a cell culture##7##3##(1994-2#1)(1994-9#1)(2008-11#4)(2008-7#1)
a cell death##2##3##(2008-10#1)(2008-5#1)
a cell density-dependent##3##3##(1993-8#2)(1995-2#1)
a cell free system##3##4##(1990-12#1)(1991-2#2)
a cell is##4##3##(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
a cell line from##3##4##(1995-11#2)(2008-11#1)
a cell line##14##3##(1992-9#1)(1994-6#1)(1995-11#2)(1995-6#1)(2008-10#1)(2008-11#6)(2008-6#1)(2011-2#1)
a cell population##4##3##(1991-8#1)(2008-1#1)(2008-3#1)(2008-4#1)
a cell sorter##3##3##(1994-2#1)(2008-9#2)
a cell surface receptor##2##4##(1992-12#1)(1994-11#1)
a cell surface##6##3##(1992-12#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-6#1)
a cell system##2##3##(2008-9#1)(2009-5#1)
a cell that##2##3##(2007-12#2)
a cell type##2##3##(2008-11#1)(2008-7#1)
a cell type-specific marker for##2##5##(1996-5#2)
a cell type-specific##6##3##(1992-9#1)(1993-12#1)(1995-11#1)(1995-8#1)(1996-5#2)
a cell wall##6##3##(2008-10#3)(2009-2#1)(2011-2#1)(2012-1#1)
a cell with##2##3##(2007-12#1)(2008-10#1)
a cell##133##2##(1990-12#2)(1991-2#2)(1991-8#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-8#3)(1994-11#2)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-5#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-1#3)(2008-10#15)(2008-11#24)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#9)(2008-9#10)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#1)
a cell-associated##2##2##(1990-2#1)(1992-10#1)
a cell-based##6##2##(1993-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-12#1)
a cell-cycle##4##2##(1990-2#1)(1993-9#1)(2008-11#1)(2008-9#1)
a cell-free system consisting of##2##5##(1991-5#1)(1993-8#1)
a cell-free system##13##3##(1990-11#1)(1990-5#2)(1991-5#2)(1993-8#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#2)
a cell-free##15##2##(1990-11#1)(1990-5#2)(1991-5#2)(1992-12#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#3)
a cell-specific##4##2##(1994-8#2)(1996-5#1)(2009-8#1)
a cellular adhesion##2##3##(2008-11#2)
a cellular factor##3##3##(1995-2#1)(1995-6#1)(1997-4#1)
a cellular mechanism##2##3##(1997-2#1)(2009-8#1)
a cellular protein##2##3##(1997-1#1)(2008-11#1)
a cellular response to##2##4##(1990-12#1)(2008-7#1)
a cellular response##3##3##(1990-12#1)(2008-7#1)(2011-2#1)
a cellular##38##2##(1990-11#1)(1990-12#2)(1991-6#1)(1991-9#1)(1992-6#1)(1995-2#2)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
a cellulose binding domain##3##4##(2008-7#3)
a cellulose##12##2##(1991-11#1)(2008-10#6)(2008-11#1)(2008-7#3)(2013-1#1)
a cellulose-binding##2##2##(1995-5#1)(2008-11#1)
a cement##4##2##(2008-10#2)(2008-6#2)
a cemented##5##2##(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2013-1#1)
a census##2##2##(2008-7#1)(2010-5#1)
a center for##3##3##(1997-8#1)(2010-7#1)(2012-3#1)
a center frequency##2##3##(2007-12#1)(2008-3#1)
a center wavelength of##9##4##(2007-11#2)(2007-12#5)(2008-3#2)
a center##19##2##(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#6)(2008-10#2)(2008-3#4)(2010-7#1)(2012-3#1)(2013-8#1)
a central action##2##3##(1996-12#1)(2011-2#1)
a central component of##2##4##(1997-4#1)(2008-7#1)
a central component##5##3##(1994-8#1)(1997-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
a central composite design##9##4##(2008-10#9)
a central composite##10##3##(2008-10#9)(2008-11#1)
a central feature##2##3##(1994-11#1)(1994-8#1)
a central focus##2##3##(2008-11#1)(2012-2#1)
a central goal in##2##4##(2008-11#1)(2011-2#1)
a central issue in##2##4##(2008-10#1)(2008-11#1)
a central issue##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a central level##2##3##(2008-4#1)(2012-3#1)
a central mechanism of action##2##5##(1991-2#1)(1995-12#1)
a central mechanism##3##3##(1991-2#2)(1995-12#1)
a central nervous system##3##4##(1991-3#1)(1993-5#1)(2012-2#1)
a central nervous##4##3##(1991-3#1)(1993-5#1)(2012-2#1)(2013-1#1)
a central part of##2##4##(1995-2#1)(2012-1#1)
a central part##3##3##(1995-2#1)(2012-1#1)(2012-2#1)
a central role for the##2##5##(2006-10#1)(2009-4#1)
a central role in determining the##2##6##(2008-8#1)(2009-10#1)
a central role in determining##3##5##(2008-8#1)(2009-10#1)(2013-1#1)
a central role in the pathogenesis of##2##7##(1990-11#1)(1991-9#1)
a central role in the regulation of##2##7##(1994-12#1)(1996-5#1)
a central role in the##11##5##(1990-11#1)(1991-9#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)
a central role in##29##4##(1990-11#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
a central role##37##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
a central theme##4##3##(1995-3#1)(2008-11#2)(2009-7#1)
a central venous catheter##5##4##(1991-5#1)(2007-7#1)(2008-7#2)(2011-2#1)
a central##128##2##(1990-11#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-3#3)(2008-4#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#3)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
a centralized resource##2##3##(2008-10#2)
a centralized##10##2##(1992-10#1)(1992-8#1)(1994-5#1)(1997-1#1)(2008-10#3)(2008-3#1)(2010-8#1)(2011-2#1)
a centrally located##3##3##(1995-2#2)(2008-10#1)
a centrally##5##2##(1995-2#2)(2008-10#1)(2008-2#1)(2008-7#1)
a centre##3##2##(1991-6#1)(2008-10#1)(2008-2#1)
a centrifugal analyser##2##3##(1995-12#2)
a centrifugal field##2##3##(2008-2#2)
a centrifugal##8##2##(1993-8#1)(1995-12#2)(2007-8#1)(2008-2#2)(2010-8#1)(2013-1#1)
a centrifuge##2##2##(2008-10#2)
a centrosymmetric##2##2##(2008-10#1)(2008-3#1)
a century after their clinical introduction##2##6##(2008-6#2)
a century ago##5##3##(1991-2#1)(1997-3#1)(2008-3#1)(2011-2#1)(2012-3#1)
a century##25##2##(1990-5#1)(1991-2#1)(1992-5#1)(1993-6#1)(1994-3#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
a cephalosporin##2##2##(1996-3#1)(2008-11#1)
a ceramic##5##2##(2008-10#2)(2008-3#2)(2008-6#1)
a cerebellar##4##2##(2008-6#1)(2009-1#1)(2012-2#1)(2012-3#1)
a cerebral infarction##5##3##(1997-5#4)(2011-2#1)
a cerebral##15##2##(1992-12#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-6#1)(1997-3#1)(1997-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
a cerebrovascular accident##2##3##(1992-2#1)(2008-4#1)
a cerium-doped potassium sodium strontium barium niobate##5##7##(2007-12#1)(2008-3#4)
a cerium-doped##6##2##(2007-12#1)(2008-3#5)
a certain amount##2##3##(2008-10#1)(2008-3#1)
a certain degree of##2##4##(2008-10#1)(2013-7#1)
a certain degree##4##3##(1990-11#1)(2008-10#1)(2008-12#1)(2013-7#1)
a certain extent##6##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#2)(2013-8#1)
a certain level of##2##4##(1996-3#1)(2009-8#1)
a certain level##3##3##(1996-3#1)(2009-8#1)(2011-2#1)
a certain pH##2##3##(2008-10#1)(2013-1#1)
a certain point##2##3##(2008-3#1)(2010-9#1)
a certain range##3##3##(2008-10#2)(2013-8#1)
a certain role in##4##4##(1992-8#1)(2008-8#3)
a certain threshold##3##3##(1995-8#1)(2007-11#1)(2008-10#1)
a certain trajectory##2##3##(1994-8#1)(2008-11#1)
a certain type of##2##4##(1992-11#1)(2008-3#1)
a certain type##3##3##(1992-11#1)(1994-2#1)(2008-3#1)
a certain##93##2##(1990-11#2)(1991-8#1)(1992-11#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#4)(2007-12#4)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#10)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
a certificate of##2##3##(1991-3#1)(1994-12#1)
a certificate##4##2##(1991-3#1)(1994-12#2)(2008-10#1)
a certified reference material of##4##5##(2008-10#3)(2011-2#1)
a certified reference material##11##4##(2008-10#10)(2011-2#1)
a certified reference##14##3##(2008-10#13)(2011-2#1)
a certified water##2##3##(2008-10#2)
a certified##20##2##(2008-10#19)(2011-2#1)
a cervical##16##2##(1992-5#1)(1993-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
a cesarean section##2##3##(1991-6#1)(2007-7#1)
a chain of##3##3##(1995-2#1)(1997-7#1)(2007-11#1)
a chain##7##2##(1994-11#1)(1995-2#1)(1997-7#3)(2007-11#1)(2009-11#1)
a chair##2##2##(2010-4#1)(2013-8#1)
a challenge and##3##3##(2008-12#1)(2012-12#1)(2013-8#1)
a challenge due to##3##4##(2007-7#1)(2008-11#1)(2009-8#1)
a challenge facing##2##3##(2008-7#1)(2012-12#1)
a challenge for the##9##4##(1991-3#1)(1994-11#1)(2008-11#2)(2008-6#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
a challenge for##17##3##(1991-3#1)(1992-1#1)(1994-11#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
a challenge in the##2##4##(2008-3#1)(2011-2#1)
a challenge in##8##3##(1992-2#1)(1992-5#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)(2013-8#1)
a challenge to the##5##4##(1992-1#1)(1995-6#1)(2008-10#1)(2009-10#1)(2010-3#1)
a challenge to their##2##4##(2008-7#1)(2012-3#1)
a challenge to##26##3##(1992-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-12#1)(2010-3#2)(2012-2#4)(2012-3#1)(2013-1#2)
a challenge##81##2##(1991-12#1)(1991-3#2)(1992-1#2)(1992-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#6)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
a challenging and##2##3##(2009-3#1)(2010-8#1)
a challenging problem for##2##4##(1994-3#1)(2012-1#1)
a challenging problem in the##2##5##(2008-7#1)(2011-1#1)
a challenging problem##9##3##(1994-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
a challenging task for##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
a challenging task##8##3##(1996-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)
a challenging##37##2##(1994-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#2)
a champion##2##2##(2008-7#1)(2013-8#1)
a chance for##3##3##(2008-8#1)(2011-2#2)
a chance to##3##3##(1997-3#1)(2008-12#1)(2013-8#1)
a chance##11##2##(1990-8#1)(1991-1#1)(1994-12#1)(1997-3#1)(2008-12#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
a change from##4##3##(1993-2#1)(1994-12#1)(2008-2#1)(2008-3#1)
a change in diagnostic##2##4##(1991-9#1)(2008-11#1)
a change in practice##2##4##(2008-11#1)(2008-8#1)
a change in the refractive index##3##6##(2007-11#1)(2008-2#2)
a change in the relative##2##5##(2008-10#1)(2008-3#1)
a change in the transcription##2##5##(1991-9#1)(1992-3#1)
a change in the##43##4##(1991-9#1)(1992-12#2)(1992-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-6#1)(1996-8#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#3)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#1)
a change in##98##3##(1990-11#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-2#4)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
a change may be##2##4##(2008-11#1)(2008-3#1)
a change of the##8##4##(1991-5#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-7#1)
a change of treatment##2##4##(1991-11#1)(2011-2#1)
a change of##24##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
a change to##3##3##(2008-9#1)(2009-2#1)(2011-2#1)
a change##143##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#3)(1992-3#3)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#20)(2008-11#8)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
a changing climate##2##3##(2008-8#1)(2012-2#1)
a changing environment##4##3##(1991-2#1)(1996-3#1)(2008-7#1)(2011-2#1)
a changing##14##2##(1991-2#1)(1992-1#1)(1992-11#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)
a channel for##2##3##(2008-5#1)(2012-2#1)
a channel##9##2##(1993-8#1)(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)
a chaotic##10##2##(2006-12#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-9#1)(2012-2#1)
a chaperone##2##2##(2008-7#1)(2009-6#1)
a chapter on the##2##4##(1994-12#1)(2013-8#1)
a chapter##3##2##(1994-12#1)(2008-10#1)(2013-8#1)
a character##2##2##(2007-12#1)(2012-3#1)
a characteristic length##2##3##(1996-4#2)
a characteristic mass##3##3##(2008-10#3)
a characteristic of##6##3##(1990-11#1)(1991-8#1)(2007-12#1)(2008-10#2)(2008-12#1)
a characteristic scale length##2##4##(1996-4#2)
a characteristic##55##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-4#7)(1996-9#1)(1997-7#2)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2009-10#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
a characterization of##2##3##(1993-2#1)(2010-12#1)
a charge##9##2##(1995-11#1)(1996-5#1)(2008-10#3)(2008-7#2)(2009-12#1)(2010-12#1)
a charge-coupled device (CCD)##2##4##(2008-10#1)(2008-3#1)
a charged membrane##2##3##(2008-7#2)
a charged##7##2##(1993-11#1)(1997-2#1)(2008-7#3)(2009-1#1)(2009-6#1)
a chase##2##2##(1992-6#1)(2008-9#1)
a cheap##5##2##(1993-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
a check##2##2##(1996-5#1)(2010-8#1)
a checklist##4##2##(1990-3#1)(1994-1#1)(1995-2#1)(2008-5#1)
a cheese##2##2##(2008-10#2)
a chelate with##2##3##(2008-10#2)
a chelate##5##2##(2008-10#5)
a chelating agent##5##3##(1995-3#1)(2008-10#4)
a chelating resin##5##3##(2008-10#5)
a chelating##17##2##(1995-3#1)(1996-2#1)(2008-10#15)
a chemical approach##2##3##(2008-7#1)(2009-7#1)
a chemical defense##2##3##(2008-10#1)(2008-8#1)
a chemical modifier##6##3##(2008-10#6)
a chemical reaction##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
a chemical scoring and ranking##2##5##(2008-11#2)
a chemical sensor for##2##4##(2008-10#2)
a chemical sensor##4##3##(2008-10#4)
a chemical separation##2##3##(2008-10#1)(2008-2#1)
a chemical##56##2##(1991-9#1)(1992-9#1)(1993-8#1)(2007-11#1)(2007-12#2)(2008-10#23)(2008-11#5)(2008-2#3)(2008-3#4)(2008-5#4)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#2)
a chemically defined##2##3##(2008-11#1)(2008-5#1)
a chemically modified##4##3##(2008-10#4)
a chemically synthesized##3##3##(1990-7#1)(1992-9#1)(1997-2#1)
a chemically##12##2##(1990-7#1)(1992-9#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)
a chemiluminescence##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
a chemiluminescent assay##2##3##(2008-10#1)(2012-12#1)
a chemiluminescent##3##2##(2008-10#2)(2012-12#1)
a chemokine##3##2##(2008-4#2)(2009-12#1)
a chemometric tool for##2##4##(2008-10#2)
a chemometric##3##2##(2008-10#3)
a chemometrical##2##2##(2008-10#2)
a chemotherapeutic agent##2##3##(2012-3#2)
a chemotherapeutic##3##2##(2008-10#1)(2012-3#2)
a chemotherapy##3##2##(1990-2#1)(2008-7#1)(2010-3#1)
a chest pain critical care pathway##2##6##(2008-3#2)
a chest pain##3##3##(2008-3#3)
a chest tube##2##3##(2010-12#1)(2012-2#1)
a chest##10##2##(1990-6#1)(2007-7#1)(2008-1#1)(2008-3#3)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
a chicken##6##2##(1990-12#1)(1997-9#1)(2007-6#1)(2008-10#1)(2008-11#2)
a chief##5##2##(1996-3#1)(2008-12#2)(2011-2#1)(2012-12#1)
a child and adolescent##2##4##(1993-12#1)(2013-1#1)
a child and##4##3##(1993-12#2)(2007-11#1)(2013-1#1)
a child health##2##3##(1991-11#1)(1992-3#1)
a child presenting with##2##4##(2007-8#1)(2008-11#1)
a child under##2##3##(1991-8#1)(2009-5#1)
a child who##4##3##(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
a child with CP##2##4##(2011-2#2)
a child with a cochlear implant##2##6##(2008-9#2)
a child with a##4##4##(2008-10#1)(2008-9#2)(2009-5#1)
a child with##27##3##(1992-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
a child##101##2##(1991-11#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#2)(1994-7#1)(1995-11#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#5)(2008-10#14)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#7)(2009-12#1)(2009-4#2)(2009-5#6)(2009-9#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-12#10)(2012-2#4)(2013-1#5)
a child's language##2##3##(2008-11#2)
a child's##18##2##(1991-8#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(1997-6#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-9#3)(2011-1#1)(2011-2#1)(2012-3#1)
a childbirth educator##2##3##(2007-2#2)
a childhood##2##2##(1996-3#1)(2012-12#1)
a children's hospital##3##3##(1991-1#1)(1993-2#1)(2008-11#1)
a children's##6##2##(1991-1#1)(1991-2#1)(1993-2#1)(1994-3#1)(1995-5#1)(2008-11#1)
a chimeric bispecific antibody##2##4##(1994-3#2)
a chimeric gene##3##3##(1993-12#1)(1994-5#2)
a chimeric##16##2##(1990-8#1)(1993-12#1)(1994-3#2)(1994-5#2)(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2010-12#1)(2012-12#1)(2013-7#1)
a chimpanzee##2##2##(1993-8#1)(1994-12#1)
a chip##7##2##(2008-10#5)(2008-11#1)(2011-1#1)
a chiral solvating agent##2##4##(1995-2#1)(2008-10#1)
a chiral##16##2##(1994-9#1)(1995-2#2)(1996-5#1)(1997-2#1)(2008-10#9)(2008-7#1)(2010-4#1)
a chirp-encoded##2##2##(2007-12#2)
a chirped##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
a chirped-grating distributed-feedback##2##3##(2008-3#2)
a chirped-pulse amplification##2##3##(2007-12#1)(2008-2#1)
a chirped-pulse amplifier##2##3##(2007-12#2)
a chirped-pulse##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
a chitin##3##2##(1997-3#1)(1997-4#1)(2008-10#1)
a chitinase##3##2##(2008-10#2)(2013-1#1)
a chitosan-gelatin matrix##2##3##(2008-5#2)
a chitosan-gelatin##3##2##(2008-5#3)
a chloramphenicol##2##2##(1995-2#1)(1996-8#1)
a chlorate-resistant##2##2##(2008-10#2)
a chloride ion channel##2##4##(1995-12#1)(2011-3#1)
a chloride##4##2##(1995-12#1)(2008-10#1)(2008-9#1)(2011-3#1)
a choice of##4##3##(2008-3#1)(2008-9#2)(2013-8#1)
a choice##15##2##(1992-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#7)(2009-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
a cholera##2##2##(1991-9#1)(1993-3#1)
a cholesteric liquid crystal##2##4##(2007-12#2)
a cholesterol##2##2##(1991-6#1)(2012-2#1)
a cholinergic deficit##2##3##(1994-5#2)
a cholinergic##6##2##(1994-5#2)(1994-8#1)(2008-7#1)(2013-1#2)
a choosy##2##2##(2008-8#1)(2008-9#1)
a chosen##5##2##(2008-1#1)(2008-3#3)(2008-4#1)
a chromatin##2##2##(1990-8#1)(2008-2#1)
a chromatographic separation##2##3##(2008-10#2)
a chromatographic##14##2##(2008-10#13)(2013-1#1)
a chromatomembrane cell##3##3##(2008-10#3)
a chromogenic##8##2##(1993-12#1)(2008-10#5)(2008-5#1)(2010-4#1)
a chromoionophore##2##2##(2008-10#2)
a chromosomal##8##2##(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
a chromosome of size 4##2##5##(2011-2#2)
a chromosome of##3##3##(2008-5#1)(2011-2#2)
a chromosome##8##2##(1994-12#1)(1995-6#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)
a chromotropic acid##2##3##(2008-10#2)
a chronic disease of##2##4##(2008-10#1)(2012-3#1)
a chronic disease##8##3##(1993-11#2)(1994-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
a chronic illness##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
a chronic inflammatory process##3##4##(2008-1#1)(2008-3#1)(2013-1#1)
a chronic inflammatory##11##3##(1994-5#1)(1997-8#1)(2008-1#1)(2008-3#1)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
a chronic relapsing##2##3##(1991-2#1)(2009-7#1)
a chronic rheumatic disease##3##4##(2008-8#1)(2011-2#1)(2012-12#1)
a chronic sensory neuropathy##2##4##(2008-7#2)
a chronic##77##2##(1990-3#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-5#2)(1993-11#2)(1993-9#1)(1994-5#3)(1995-12#1)(1996-3#1)(1997-8#4)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#2)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#1)
a chronically ill##3##3##(1990-10#2)(1991-3#1)
a chronically##7##2##(1990-10#2)(1991-3#1)(1992-12#1)(1992-6#1)(1997-8#1)(2013-1#1)
a chronological##2##2##(2008-9#1)(2012-2#1)
a circadian rhythm in##2##4##(1994-2#1)(2008-5#1)
a circadian rhythm##4##3##(1994-2#1)(1995-11#1)(2008-11#1)(2008-5#1)
a circadian##5##2##(1994-2#1)(1995-11#1)(2008-11#1)(2008-5#2)
a circle##4##2##(2007-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
a circular aperture##9##3##(2007-11#2)(2008-2#4)(2008-3#3)
a circular area of##2##4##(1997-3#1)(2008-10#1)
a circular##37##2##(1991-2#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#12)(2008-3#12)(2009-7#1)
a circulating hormone##2##3##(1991-5#1)(1992-6#1)
a circulating##4##2##(1991-11#1)(1991-5#1)(1992-6#1)(1997-7#1)
a circulatory flow injection method##2##5##(2008-10#2)
a circumscribed##2##2##(1990-11#1)(1994-8#1)
a cirrhotic patient##2##3##(2011-2#1)(2013-8#1)
a cirrhotic##3##2##(2008-1#1)(2011-2#1)(2013-8#1)
a cirrus cloud##2##3##(2008-2#1)(2008-3#1)
a cis##3##2##(1991-11#1)(1995-2#1)(1997-2#1)
a cis-acting element##2##3##(1995-6#1)(2008-8#1)
a cis-acting##6##2##(1990-5#1)(1991-11#1)(1993-3#1)(1994-12#1)(1995-6#1)(2008-8#1)
a citrate synthase##2##3##(1997-4#2)
a citrus##2##2##(2008-10#2)
a city##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
a clade##7##2##(2008-10#1)(2008-8#4)(2009-8#1)(2011-2#1)
a claim##6##2##(1991-12#1)(1992-9#1)(1993-3#1)(1995-12#1)(2007-11#1)(2008-5#1)
a class of people##2##4##(1992-12#1)(1996-1#1)
a class of##37##3##(1992-12#1)(1992-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
a class##46##2##(1990-12#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
a classic CPC##2##3##(2008-3#2)
a classic example of##2##4##(2008-10#1)(2010-3#1)
a classic##19##2##(1991-6#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#2)(2009-11#1)(2009-7#1)(2010-3#1)(2010-7#1)(2012-12#1)
a classical lacunar syndrome##2##4##(2007-10#2)
a classical least-squares##2##3##(2008-10#2)
a classical model##2##3##(2008-9#1)(2013-8#1)
a classical##42##2##(1990-10#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-8#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
a classification model##2##3##(2010-8#1)(2013-8#1)
a classification of##6##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
a classification system##5##3##(1993-1#1)(2008-12#2)(2010-12#1)(2012-1#1)
a classification##23##2##(1991-3#1)(1993-1#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
a clay##4##2##(1993-8#1)(2008-10#3)
a clean##12##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
a clean-up method##2##3##(2008-10#2)
a clean-up step##2##3##(2008-10#2)
a clean-up##5##2##(2008-10#5)
a clear advantage over the##2##5##(2008-3#1)(2008-7#1)
a clear advantage##5##3##(1991-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
a clear dependence on##2##4##(2008-2#1)(2013-8#1)
a clear difference##2##3##(2008-10#1)(2013-1#1)
a clear dose-response##2##3##(1990-6#1)(1996-2#1)
a clear effect##2##3##(2008-10#1)(2008-6#1)
a clear explanation##3##3##(2008-9#1)(2011-2#1)(2012-12#1)
a clear increase in##2##4##(1991-5#1)(2008-5#1)
a clear indication##3##3##(1992-8#1)(2008-10#1)(2008-9#1)
a clear link between##2##4##(2008-7#1)(2013-1#1)
a clear need for more##2##5##(2009-11#1)(2009-2#1)
a clear need for##4##4##(2007-8#1)(2008-10#1)(2009-11#1)(2009-2#1)
a clear relationship between##2##4##(2008-5#2)
a clear relationship##3##3##(2008-5#2)(2008-7#1)
a clear tendency towards##2##4##(1991-2#1)(1995-11#1)
a clear trend##3##3##(2008-12#1)(2010-7#1)(2012-1#1)
a clear understanding of the##3##5##(1996-7#1)(1997-1#1)(2010-3#1)
a clear understanding of##6##4##(1996-7#1)(1997-1#1)(2008-10#1)(2009-9#1)(2010-3#1)(2011-1#1)
a clear##109##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
a clear-cut##6##2##(1995-2#1)(1997-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
a clearer understanding of the##2##5##(2008-9#1)(2012-12#1)
a clearer understanding of##3##4##(2008-9#1)(2012-12#2)
a clearer##12##2##(1991-1#1)(1996-3#1)(2007-6#1)(2008-10#1)(2008-6#2)(2008-9#1)(2009-11#1)(2012-1#1)(2012-12#3)
a clearly defined##3##3##(1995-12#1)(2008-8#1)(2012-2#1)
a clearly different##2##3##(2008-1#1)(2008-10#1)
a clearly##10##2##(1990-11#1)(1992-8#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-2#1)
a cleaved##4##2##(1995-11#1)(2007-12#1)(2008-3#2)
a client##4##2##(1994-1#1)(1996-1#1)(2010-6#1)(2010-8#1)
a climate##9##2##(1992-2#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2011-1#1)
a clinic in##2##3##(1994-2#1)(2012-2#1)
a clinic setting##2##3##(1993-12#1)(2008-9#1)
a clinic##7##2##(1993-12#1)(1994-2#1)(1996-5#1)(1997-3#1)(2008-9#1)(2009-5#1)(2012-2#1)
a clinic-based##2##2##(2006-10#1)(2013-1#1)
a clinical and##8##3##(1994-12#1)(2008-5#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
a clinical assessment##2##3##(1992-12#1)(2006-10#1)
a clinical case of##3##4##(1990-5#1)(2010-12#1)(2013-1#1)
a clinical case##7##3##(1990-5#2)(1993-5#1)(2007-12#1)(2009-9#1)(2010-12#1)(2013-1#1)
a clinical case]##6##3##(1990-3#1)(1990-5#1)(1993-5#1)(1993-6#2)(2012-12#1)
a clinical challenge to##2##4##(2007-8#1)(2008-6#1)
a clinical challenge##4##3##(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)
a clinical chemistry department##2##4##(1995-3#2)
a clinical chemistry##3##3##(1994-12#1)(1995-3#2)
a clinical concern##2##3##(1994-3#1)(2011-2#1)
a clinical condition characterized by a##2##6##(2008-1#1)(2008-5#1)
a clinical condition characterized by##3##5##(2008-1#1)(2008-5#1)(2011-2#1)
a clinical condition##4##3##(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
a clinical decision##2##3##(1991-1#1)(2008-4#1)
a clinical diagnosis and##2##4##(2007-11#1)(2007-2#1)
a clinical diagnosis of##4##4##(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
a clinical diagnosis##8##3##(2007-11#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-3#1)
a clinical diagnostic##2##3##(1992-5#1)(2008-3#1)
a clinical entity##5##3##(1990-3#1)(1991-6#1)(1996-11#1)(2008-12#1)(2013-1#1)
a clinical evaluation unit##2##4##(1997-2#2)
a clinical evaluation##5##3##(1997-2#2)(2008-1#1)(2008-5#1)(2008-9#1)
a clinical guideline##2##3##(1996-1#2)
a clinical intervention##2##3##(1997-2#2)
a clinical laboratory##4##3##(1994-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
a clinical model##2##3##(1997-2#2)
a clinical nurse##3##3##(2013-1#2)(2013-8#1)
a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery##2##15##(2008-8#2)
a clinical pathology conference held by the##3##7##(2008-8#2)(2012-2#1)
a clinical pathway##3##3##(2008-3#2)(2012-3#1)
a clinical picture of##3##4##(1990-3#1)(1992-10#1)(2011-2#1)
a clinical picture##4##3##(1990-3#1)(1992-10#1)(2009-3#1)(2011-2#1)
a clinical population of##2##4##(2010-2#1)(2012-2#1)
a clinical practice##4##3##(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
a clinical problem##4##3##(1997-4#1)(1997-8#1)(2008-7#2)
a clinical reality##3##3##(2010-10#1)(2010-5#1)(2011-2#1)
a clinical review##2##3##(2008-11#1)(2008-7#1)
a clinical role##2##3##(2011-2#1)(2013-1#1)
a clinical sample of##2##4##(1996-7#1)(2007-7#1)
a clinical setting##8##3##(1993-11#1)(2008-3#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
a clinical study##8##3##(1990-5#2)(1992-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-8#1)(2013-1#1)
a clinical syndrome##3##3##(2008-10#1)(2010-9#1)(2012-3#1)
a clinical test##2##3##(2008-5#1)(2008-9#1)
a clinical trial in##2##4##(1994-2#1)(2010-6#1)
a clinical trial of a##2##5##(1994-9#1)(2011-1#1)
a clinical trial of##8##4##(1994-9#1)(2008-5#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a clinical trial that##2##4##(1997-4#1)(2009-6#1)
a clinical trial##24##3##(1992-9#1)(1994-2#2)(1994-9#1)(1996-6#2)(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#3)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-6#3)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a clinical##229##2##(1990-2#1)(1990-3#5)(1990-5#5)(1991-1#3)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#2)(1994-12#5)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#4)(1996-1#3)(1996-11#1)(1996-6#2)(1996-7#1)(1997-2#7)(1997-3#1)(1997-4#3)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#3)(2008-11#7)(2008-12#7)(2008-3#9)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#7)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#12)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#14)(2013-8#7)
a clinically important##2##3##(1996-7#1)(2012-3#1)
a clinically relevant##7##3##(1995-2#1)(1996-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
a clinically useful and##2##4##(2007-8#1)(2008-12#1)
a clinically useful##5##3##(1990-9#1)(1991-12#1)(2007-8#1)(2008-12#1)(2008-7#1)
a clinically##28##2##(1990-9#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#1)
a clinician##6##2##(1996-1#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-2#1)
a clinico-pathologic##2##2##(1991-6#1)(1991-8#1)
a clinicopathologic study of##2##4##(1993-6#1)(2012-1#1)
a clinicopathologic study##3##3##(1993-6#1)(2007-10#1)(2012-1#1)
a clinicopathologic##5##2##(1993-6#1)(2007-10#1)(2009-5#1)(2011-1#1)(2012-1#1)
a clinimetric##2##2##(1991-6#2)
a clip##2##2##(1996-8#1)(2008-12#1)
a clonal population##3##3##(2008-10#3)
a clonal##15##2##(1992-8#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-4#1)(2012-12#1)
a clone from a##2##4##(1992-3#1)(1996-3#1)
a clone from##3##3##(1992-3#1)(1996-3#1)(2008-8#1)
a clone that##2##3##(1996-10#2)
a clone##10##2##(1992-3#1)(1994-11#3)(1996-10#2)(1996-3#1)(1997-7#1)(2008-8#1)(2008-9#1)
a cloned##9##2##(1990-11#2)(1994-8#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-8#2)
a cloning vector##2##3##(1991-9#1)(1995-8#1)
a cloning##4##2##(1991-9#1)(1993-2#1)(1994-12#1)(1995-8#1)
a clonogenic assay##2##3##(1995-3#1)(2008-7#1)
a close association between##2##4##(1993-1#1)(2012-12#1)
a close association of##2##4##(2008-10#1)(2009-10#1)
a close association##5##3##(1993-1#1)(2008-10#2)(2009-10#1)(2012-12#1)
a close correlation between##3##4##(2008-10#2)(2008-12#1)
a close correlation##8##3##(1990-2#1)(1990-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)
a close relation between##2##4##(1992-11#1)(1994-6#1)
a close relationship between the##4##5##(1992-8#1)(2008-10#1)(2008-8#1)(2010-3#1)
a close relationship between##8##4##(1992-8#1)(2008-10#3)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#1)
a close relationship##11##3##(1992-8#1)(2008-10#5)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#2)
a close relative##2##3##(2008-10#1)(2008-8#1)
a close resemblance to those of##2##6##(1993-11#1)(2008-3#1)
a close resemblance to##3##4##(1993-11#1)(2007-5#1)(2008-3#1)
a close##56##2##(1990-2#1)(1990-9#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-3#2)(2008-8#3)(2009-10#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-4#1)(2012-12#3)(2013-8#1)
a closed system##3##3##(2008-10#3)
a closed##22##2##(1993-3#1)(1994-12#1)(1995-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
a closed-form expression for##2##4##(2007-11#1)(2007-12#1)
a closed-form expression##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
a closed-form##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)(2012-1#1)
a closed-fringe pattern##2##3##(2008-3#2)
a closed-loop model of the cardiovascular system##2##7##(2009-9#1)(2010-5#1)
a closed-loop##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-5#1)
a closed-set##2##2##(2008-9#1)(2013-8#1)
a closed-socket approach##2##3##(2007-12#2)
a closely related non-symbiotic clam##2##5##(2008-5#2)
a closely related##4##3##(2007-7#1)(2008-5#2)(2009-2#1)
a closely##5##2##(2007-11#1)(2007-7#1)(2008-5#2)(2009-2#1)
a closer look at##2##4##(1997-6#1)(2008-8#1)
a closer look##4##3##(1997-6#1)(2008-10#1)(2008-8#2)
a closer relationship with##3##4##(2008-10#1)(2008-8#2)
a closer relationship##4##3##(1994-1#1)(2008-10#1)(2008-8#2)
a closer##15##2##(1990-2#1)(1992-3#1)(1994-1#1)(1995-12#1)(1997-6#1)(2008-10#4)(2008-8#4)(2011-2#1)(2012-3#1)
a closing##2##2##(2008-2#1)(2010-3#1)
a closure##2##2##(1996-3#1)(2007-5#1)
a cloud##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
a cloudy##3##2##(2008-10#2)(2008-2#1)
a clue to the##2##4##(2008-8#2)
a clue to##3##3##(2008-10#1)(2008-8#2)
a cluster of genes##2##4##(1996-12#1)(2008-4#1)
a cluster of outbreaks##2##4##(2009-2#2)
a cluster of##22##3##(1992-4#2)(1995-9#1)(1996-12#2)(1996-6#1)(1997-5#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-6#1)(2012-3#1)(2013-1#1)
a cluster##33##2##(1992-4#2)(1995-9#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#4)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#1)
a clustering##2##2##(2008-3#1)(2011-1#1)
a co-culture system of##2##4##(2008-11#2)
a co-factor in##2##3##(2011-2#1)(2013-1#1)
a co-transmitter##2##2##(2008-7#2)
a coagulation##2##2##(2008-7#2)
a coagulopathy##3##2##(2007-10#2)(2008-10#1)
a coalition of##3##3##(1994-12#1)(1996-3#1)(2008-8#1)
a coarse##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)(2012-3#1)
a coastal##2##2##(2008-2#1)(2008-3#1)
a coated cylinder##2##3##(2008-3#2)
a coated graphite##2##3##(2008-10#2)
a coated##4##2##(2008-10#2)(2008-3#2)
a coating##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
a coaxial##5##2##(1992-11#1)(2007-12#1)(2008-3#2)(2013-8#1)
a cobalt phthalocyanine modified##2##4##(2008-10#2)
a cobalt##3##2##(2008-10#3)
a cobalt-wire##2##2##(2008-10#2)
a cocaine##4##2##(1991-12#2)(2010-6#2)
a cochlear implant (CI)##2##4##(2010-10#1)(2011-2#1)
a cochlear implant##17##3##(2008-9#14)(2010-10#1)(2011-2#1)(2012-2#1)
a cocktail of##4##3##(1990-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
a cocktail##5##2##(1990-7#1)(2007-11#1)(2008-10#1)(2009-5#1)(2013-1#1)
a coculture##2##2##(2008-11#1)(2008-7#1)
a code for##2##3##(1990-5#1)(2008-3#1)
a code of##2##3##(1995-12#1)(1997-5#1)
a code##6##2##(1990-5#1)(1995-12#1)(1996-9#1)(1997-5#1)(2008-3#2)
a codebook##2##2##(2008-3#1)(2008-6#1)
a coding##4##2##(1993-11#1)(1997-7#1)(2008-10#1)(2009-3#1)
a codominant##2##2##(2008-10#1)(2008-5#1)
a codon##3##2##(1991-11#1)(2008-10#2)
a coefficient of variation of##4##5##(1995-2#1)(2008-10#3)
a coefficient of variation##5##4##(1995-2#1)(2008-10#4)
a coefficient of##9##3##(1990-2#1)(1995-2#1)(2008-10#6)(2011-2#1)
a coevolutionary##2##2##(2008-8#1)(2013-1#1)
a cofactor in the##2##4##(1993-8#1)(1996-2#1)
a cofactor in##5##3##(1993-8#1)(1996-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
a cofactor of##2##3##(1993-8#1)(2012-2#1)
a cofactor##8##2##(1993-8#2)(1996-2#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
a cognitive##13##2##(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
a cognitive-behavioral##3##2##(2008-4#1)(2009-11#1)(2009-6#1)
a cognitive-motivational theory##2##3##(2007-8#2)
a coherence function##2##3##(2007-12#1)(2008-3#1)
a coherence##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a coherent light source##2##4##(2008-3#2)
a coherent set of##2##4##(1995-12#1)(2010-10#1)
a coherent source##2##3##(2008-2#1)(2008-3#1)
a coherent##38##2##(1993-2#1)(1995-12#1)(1996-1#1)(2007-11#5)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#1)(2008-6#1)(2009-3#1)(2009-9#2)(2010-10#1)(2012-2#3)(2013-1#1)
a cohesive##3##2##(1993-11#1)(2007-11#1)(2008-12#1)
a cohort of individuals##3##4##(1994-12#1)(1997-3#1)(2013-1#1)
a cohort of##34##3##(1990-9#1)(1992-6#1)(1994-12#1)(1995-9#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#2)
a cohort study##5##3##(1994-2#1)(2011-1#1)(2012-2#2)(2013-1#1)
a cohort##42##2##(1990-9#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-9#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-7#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#4)
a coil##3##2##(1997-3#1)(2008-10#2)
a coiled coil##2##3##(1993-11#1)(2011-1#1)
a coiled##5##2##(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
a cold room##2##3##(2008-10#1)(2011-2#1)
a cold##18##2##(1994-9#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#4)
a cold-regulated##2##2##(1992-3#1)(2008-10#1)
a collaborative effort between##2##4##(1994-12#1)(2008-7#1)
a collaborative effort to identify##2##5##(1995-11#2)
a collaborative effort to##3##4##(1995-11#2)(1996-12#1)
a collaborative effort##9##3##(1994-12#2)(1995-11#2)(1996-12#2)(1996-2#1)(2008-10#1)(2008-7#1)
a collaborative group##2##3##(1993-12#1)(2008-1#1)
a collaborative model##3##3##(1991-2#1)(1994-1#1)(2008-11#1)
a collaborative relationship##2##3##(1992-2#1)(2008-4#1)
a collaborative study##2##3##(1995-11#1)(2009-11#1)
a collaborative##34##2##(1991-2#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#2)(1995-11#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2009-11#1)(2011-9#1)(2012-3#1)
a collagen##4##2##(1993-5#1)(1994-8#1)(2007-8#1)(2009-7#1)
a collagenase##2##2##(1993-3#1)(2008-11#1)
a collection of 10##2##4##(2008-10#1)(2008-6#1)
a collection of P##2##4##(2008-10#2)
a collection of isolates##2##4##(2008-10#2)
a collection of##36##3##(1994-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
a collection##39##2##(1994-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
a collective approach##2##3##(2008-12#2)
a collective phenomenon##2##3##(2008-2#1)(2012-2#1)
a collective##10##2##(1995-11#1)(1995-2#1)(2008-11#1)(2008-12#3)(2008-2#2)(2011-2#1)(2012-2#1)
a collector##2##2##(2008-10#2)
a college##6##2##(2007-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)
a college-based programme##2##3##(2012-3#2)
a collimated##8##2##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#5)
a collinear##5##2##(2007-12#4)(2008-3#1)
a colloid cyst of the third ventricle##2##7##(2008-7#2)
a colloid cyst##3##3##(2008-7#3)
a colloid##6##2##(1990-8#1)(1994-2#1)(2008-10#1)(2008-7#3)
a colloidal##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
a colon cancer##2##3##(2008-1#1)(2010-6#1)
a colonic##2##2##(1993-9#1)(2008-3#1)
a colony of##2##3##(1997-8#1)(2008-2#1)
a colony##10##2##(1990-3#1)(1992-1#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
a color CCD##2##3##(2007-11#2)
a color##14##2##(1995-6#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#4)
a color-splitting##2##2##(2008-3#2)
a colored complex##5##3##(2008-10#5)
a colored##16##2##(1990-2#1)(2008-10#13)(2008-3#1)(2008-9#1)
a colorimetric assay##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
a colorimetric method##5##3##(1993-9#1)(2008-10#4)
a colorimetric##12##2##(1993-9#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-12#1)
a colorless##4##2##(2008-10#3)(2009-10#1)
a coloured##3##2##(2008-10#3)
a colourless##4##2##(1993-12#1)(2008-10#3)
a column containing##4##3##(2008-10#4)
a column filled with##2##4##(2008-10#2)
a column of##5##3##(1990-8#1)(2008-10#3)(2008-4#1)
a column packed with##6##4##(1990-8#1)(2008-10#4)(2008-7#1)
a column temperature of##4##4##(2008-10#4)
a column##45##2##(1990-8#3)(2008-10#38)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)
a columnar##2##2##(2008-3#2)
a comb##2##2##(2008-3#2)
a combination aperture##2##3##(2007-12#2)
a combination is##2##3##(2008-3#2)
a combination of a##7##4##(1997-4#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-8#1)
a combination of an##4##4##(1994-11#1)(2008-10#1)(2008-5#1)(2011-10#1)
a combination of analytical##2##4##(2008-8#2)
a combination of asymmetric##2##4##(1990-8#1)(2011-2#1)
a combination of both##11##4##(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)(2013-8#1)
a combination of clinical##3##4##(2008-7#1)(2010-8#1)(2013-1#1)
a combination of conventional##2##4##(2007-12#1)(2008-1#1)
a combination of decreased##2##4##(1991-7#1)(2008-11#1)
a combination of four##2##4##(2008-10#1)(2013-1#1)
a combination of gel##2##4##(2008-11#1)(2008-8#1)
a combination of hydrogen peroxide and##2##6##(2008-10#2)
a combination of low pH and##2##6##(1994-8#2)
a combination of methods##2##4##(2008-11#1)(2008-7#1)
a combination of molecular##3##4##(1993-8#1)(2007-11#1)(2008-8#1)
a combination of monoclonal antibodies##2##5##(2008-10#1)(2008-4#1)
a combination of principal component analysis##2##6##(2008-10#2)
a combination of random##2##4##(2008-10#1)(2008-8#1)
a combination of several##3##4##(1994-6#1)(2008-9#1)(2011-2#1)
a combination of the two##2##5##(2008-8#1)(2012-6#1)
a combination of the##25##4##(1992-3#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)(2012-1#1)(2012-6#1)(2013-8#1)
a combination of these factors##2##5##(2006-10#1)(2009-12#1)
a combination of these treatments##2##5##(2007-8#1)(2010-1#1)
a combination of these##6##4##(1991-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-1#1)
a combination of three enzymes##2##5##(2008-10#2)
a combination of three##3##4##(2008-10#3)
a combination of two##5##4##(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#1)
a combination of various##3##4##(2007-7#1)(2010-9#1)(2011-2#1)
a combination of##313##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-3#3)(1993-12#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#7)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#56)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#26)(2008-4#7)(2008-5#8)(2008-6#6)(2008-7#13)(2008-8#9)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-8#6)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2012-6#1)(2012-9#1)(2013-1#5)(2013-8#4)
a combination with##3##3##(1990-8#1)(1992-11#1)(2008-10#1)
a combination##327##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-3#3)(1993-12#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#9)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#58)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#28)(2008-4#7)(2008-5#8)(2008-6#6)(2008-7#13)(2008-8#9)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-8#6)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2012-6#1)(2012-9#1)(2013-1#5)(2013-8#5)
a combinatorial approach##2##3##(2008-7#1)(2009-8#1)
a combinatorial library##2##3##(2007-12#1)(2008-4#1)
a combinatorial##11##2##(1994-8#2)(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#2)
a combined approach##3##3##(1990-6#1)(2008-10#1)(2008-9#1)
a combined endpoint##2##3##(1992-9#1)(1997-4#1)
a combined molecular##2##3##(2010-11#1)(2012-3#1)
a combined procedure##2##3##(2008-10#1)(2008-11#1)
a combined strategy##2##3##(2008-10#1)(2012-12#1)
a combined treatment##2##3##(1995-8#1)(2008-7#1)
a combined##68##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-9#3)(1994-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-2#1)
a combustion##3##2##(2008-10#2)(2008-2#1)
a comfortable##5##2##(1991-2#1)(1996-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
a commensurate##2##2##(2008-3#2)
a comment by##2##3##(2008-3#1)(2010-6#1)
a comment##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2010-6#1)
a commentary##3##2##(1992-3#1)(2008-2#1)(2008-4#1)
a commercial glucose##2##3##(2008-10#1)(2008-6#1)
a commercial product##2##3##(2008-10#2)
a commercial sample##2##3##(2008-10#1)(2008-7#1)
a commercial static mercury drop electrode##2##6##(2008-10#2)
a commercial##90##2##(1990-3#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#39)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#5)(2012-5#1)(2013-7#1)(2013-8#1)
a commercially available enzyme-linked immunosorbent assay##3##6##(1997-4#1)(2008-10#1)(2010-5#1)
a commercially available flow cell (Hellma 176-QS)##2##7##(2008-10#2)
a commercially available herbal##2##4##(2008-5#1)(2012-3#1)
a commercially available##43##3##(1990-12#1)(1991-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
a commercially##47##2##(1990-12#1)(1991-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
a commitment to##5##3##(1993-2#1)(1994-1#1)(1994-2#2)(2008-7#1)
a commitment##7##2##(1993-2#1)(1994-1#1)(1994-2#2)(1995-12#1)(2008-10#1)(2008-7#1)
a committed##4##2##(1995-6#2)(2007-12#1)(2008-11#1)
a committee to##2##3##(1996-2#1)(1997-6#1)
a committee was constituted by the University to look into these allegations##3##12##(2008-10#3)
a committee was##4##3##(2008-10#3)(2008-4#1)
a committee##7##2##(1996-2#1)(1997-6#1)(2008-10#3)(2008-4#1)(2012-12#1)
a common ancestor##4##3##(1997-4#1)(2008-10#1)(2008-7#1)(2012-3#1)
a common ancestral##3##3##(1997-9#1)(2008-10#2)
a common and##11##3##(1991-8#1)(1993-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-8#1)(2012-2#1)
a common basis##2##3##(1996-1#1)(2008-2#1)
a common cause for##2##4##(1990-11#1)(2007-7#1)
a common cause of##13##4##(1990-6#1)(1997-3#1)(2007-11#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#3)(2013-1#1)
a common cause##16##3##(1990-11#1)(1990-6#1)(1997-3#1)(2007-11#2)(2007-7#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#3)(2013-1#1)
a common cavity##2##3##(1993-9#1)(2008-7#1)
a common cellular##2##3##(1995-12#1)(2008-8#1)
a common clinical##4##3##(1993-10#1)(2007-12#1)(2008-7#1)(2011-2#1)
a common competitor##2##3##(2008-10#1)(2008-9#1)
a common complication in##3##4##(1996-9#1)(2008-1#1)(2008-3#1)
a common complication of##2##4##(1991-6#1)(2008-7#1)
a common complication##5##3##(1991-6#1)(1996-9#1)(2008-1#1)(2008-3#1)(2008-7#1)
a common conceptual definition and##4##5##(2013-1#4)
a common denominator in##2##4##(2007-4#1)(2008-11#1)
a common denominator##3##3##(1990-8#1)(2007-4#1)(2008-11#1)
a common disease##4##3##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
a common evolutionary##3##3##(1990-5#2)(2013-8#1)
a common feature in##2##4##(2008-10#1)(2011-2#1)
a common feature of##12##4##(1991-10#1)(1991-3#1)(1991-9#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)
a common feature##15##3##(1991-10#1)(1991-3#1)(1991-9#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
a common finding in##6##4##(1992-9#1)(1996-6#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
a common finding##8##3##(1992-9#1)(1996-6#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
a common fixed point of##2##5##(2011-2#2)
a common intermediate##3##3##(1990-5#1)(1991-3#1)(2007-12#1)
a common mechanism for##3##4##(1990-2#1)(1995-12#1)(2009-8#1)
a common mechanism##6##3##(1990-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-4#1)(2009-8#1)
a common molecular weight##2##4##(1990-7#2)
a common molecular##3##3##(1990-7#2)(2011-2#1)
a common mutation in##2##4##(1990-8#1)(2008-7#1)
a common occurrence in the##2##5##(2008-6#1)(2012-12#1)
a common occurrence in##3##4##(1993-3#1)(2008-6#1)(2012-12#1)
a common occurrence##7##3##(1993-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
a common origin##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
a common pathophysiology##3##3##(2011-2#1)(2012-12#2)
a common phenomenon##5##3##(1994-11#1)(2008-7#3)(2008-8#1)
a common point##2##3##(2008-3#1)(2008-6#1)
a common problem following##2##4##(2007-11#1)(2011-2#1)
a common problem in##8##4##(1993-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
a common problem##16##3##(1993-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
a common procedure##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
a common property##2##3##(1994-11#1)(1996-12#1)
a common psychiatric##2##3##(2008-4#1)(2011-1#1)
a common reason for##2##4##(2008-5#1)(2012-2#1)
a common receptor##3##3##(1990-2#2)(2008-8#1)
a common site of##2##4##(2008-1#1)(2008-9#1)
a common site##3##3##(1992-3#1)(2008-1#1)(2008-9#1)
a common spatial##2##3##(1993-8#1)(2008-3#1)
a common spectrofluorimeter##2##3##(2008-10#2)
a common spectrofluorometer##6##3##(2008-10#6)
a common step##3##3##(1991-9#1)(1994-2#1)(2007-12#1)
a common structural##4##3##(1990-11#1)(1993-2#1)(1994-12#1)(1995-5#1)
a common system##2##3##(2012-3#1)(2013-8#1)
a common target for##2##4##(1997-4#1)(2013-1#1)
a common target##4##3##(1991-9#2)(1997-4#1)(2013-1#1)
a common treatment##3##3##(1995-12#1)(2007-12#1)(2009-5#1)
a common underlying##2##3##(2008-1#1)(2009-8#1)
a common urologic##2##3##(1992-1#1)(2013-1#1)
a common##418##2##(1990-11#3)(1990-2#4)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#4)(1992-1#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#4)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#3)(1997-9#1)(2007-10#1)(2007-11#10)(2007-12#11)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#2)(2008-1#8)(2008-10#57)(2008-11#9)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#28)(2008-8#13)(2008-9#8)(2009-10#2)(2009-12#3)(2009-5#6)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#19)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#8)
a commonly seen##2##3##(2007-8#1)(2010-6#1)
a commonly used##11##3##(1997-2#1)(2008-10#2)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
a commonly##20##2##(1997-2#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
a communication tool##3##3##(1996-1#2)(2008-11#1)
a communication##8##2##(1990-12#3)(1990-9#1)(1996-1#2)(2008-11#1)(2010-3#1)
a community health center##2##4##(2007-10#1)(2008-1#1)
a community health worker##2##4##(2012-12#1)(2012-2#1)
a community health##6##3##(1996-1#1)(1996-2#1)(2007-10#1)(2008-1#1)(2012-12#1)(2012-2#1)
a community hospital##9##3##(1993-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)
a community of research and practice##2##6##(2010-10#2)
a community of##6##3##(2008-12#1)(2008-8#1)(2009-6#1)(2010-10#2)(2013-1#1)
a community resource##2##3##(2008-7#1)(2012-2#1)
a community sample of##5##4##(1992-1#1)(2007-12#1)(2009-11#1)(2010-11#1)(2011-1#1)
a community sample##7##3##(1992-1#1)(2007-12#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-8#1)
a community with your advisees##2##5##(2010-3#2)
a community with##4##3##(2008-1#1)(2008-8#1)(2010-3#2)
a community##71##2##(1990-5#2)(1991-1#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-3#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#3)
a community's##3##2##(1995-3#1)(1997-1#1)(2008-12#1)
a community-acquired##2##2##(2007-12#1)(2009-5#1)
a community-based approach##2##3##(1994-1#1)(1995-3#1)
a community-based participatory research##2##4##(2011-2#1)(2012-12#1)
a community-based participatory##3##3##(2009-12#1)(2011-2#1)(2012-12#1)
a community-based program##3##3##(1992-1#1)(1994-12#1)(2013-1#1)
a community-based sample of employed Korean women##2##7##(2011-2#2)
a community-based sample of##4##4##(2008-3#1)(2009-8#1)(2011-2#2)
a community-based sample##6##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#2)
a community-based study of##2##4##(2008-3#1)(2008-7#1)
a community-based study##4##3##(2007-12#1)(2008-3#1)(2008-7#2)
a community-based##29##2##(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#2)(2007-12#1)(2008-11#2)(2008-3#3)(2008-7#3)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#1)
a community-partnered##2##2##(2012-2#2)
a compact and portable##2##4##(2008-10#2)
a compact and##5##3##(2008-10#3)(2008-2#1)(2011-1#1)
a compact disc##2##3##(2008-3#2)
a compact discharge device##2##4##(2007-11#2)
a compact disk pickup##2##4##(2008-2#2)
a compact disk##3##3##(2007-12#1)(2008-2#2)
a compact film##3##3##(2008-10#3)
a compact optical##2##3##(2008-2#1)(2008-3#1)
a compact##64##2##(2007-11#10)(2007-12#6)(2008-10#12)(2008-2#9)(2008-3#23)(2008-4#1)(2011-1#2)(2013-1#1)
a companion paper##4##3##(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
a companion##7##2##(1991-2#1)(1992-2#1)(1997-1#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
a company##6##2##(1991-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2008-5#1)(2012-3#1)
a comparable group of##2##4##(1997-2#1)(2008-6#1)
a comparable##16##2##(1992-6#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
a comparative analysis of##2##4##(2008-8#1)(2012-12#1)
a comparative analysis##6##3##(2008-7#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)
a comparative evaluation##2##3##(2008-3#1)(2010-3#1)
a comparative intervention##2##3##(2008-10#1)(2012-2#1)
a comparative method##4##3##(2008-10#3)(2008-7#1)
a comparative perspective##2##3##(1991-12#1)(2009-8#1)
a comparative study in##2##4##(2007-11#1)(2008-10#1)
a comparative study of the##3##5##(2010-2#2)(2012-1#1)
a comparative study of##7##4##(2008-3#1)(2008-7#1)(2008-8#2)(2010-2#2)(2012-1#1)
a comparative study##23##3##(1990-9#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-2#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
a comparative##61##2##(1990-9#1)(1991-12#2)(1994-1#2)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
a comparatively low##2##3##(1997-2#1)(2008-10#1)
a comparatively##7##2##(1993-3#1)(1997-2#1)(2007-8#1)(2008-10#2)(2009-5#1)(2013-1#1)
a comparison between the##7##4##(1992-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
a comparison between two##3##4##(1992-8#1)(2008-8#1)(2010-11#1)
a comparison between##20##3##(1990-2#1)(1992-5#1)(1992-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-1#1)
a comparison group##2##3##(2008-12#1)(2010-3#1)
a comparison is##3##3##(2008-10#2)(2008-5#1)
a comparison of a##2##4##(1994-3#1)(2008-4#1)
a comparison of results##2##4##(2008-10#1)(2008-11#1)
a comparison of the results##4##5##(1997-8#1)(2008-10#1)(2008-3#1)(2009-9#1)
a comparison of the##22##4##(1990-7#1)(1992-2#1)(1992-6#1)(1995-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2009-9#1)(2010-8#1)(2013-1#1)
a comparison of three##2##4##(2010-4#1)(2012-2#1)
a comparison of two##6##4##(1994-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#2)
a comparison of##70##3##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-7#1)(2013-1#1)
a comparison was made between##2##5##(2011-2#1)(2013-7#1)
a comparison was made##3##4##(2008-10#1)(2011-2#1)(2013-7#1)
a comparison was##4##3##(1994-3#1)(2008-10#1)(2011-2#1)(2013-7#1)
a comparison with other##2##4##(2007-12#1)(2008-5#1)
a comparison with the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
a comparison with##20##3##(1991-1#1)(1991-2#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#2)
a comparison##128##2##(1990-2#1)(1990-7#1)(1991-1#3)(1991-12#1)(1991-2#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-1#1)(1994-3#3)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#25)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#4)(2012-7#1)(2013-1#3)(2013-7#1)
a compartmental##4##2##(1992-9#1)(2008-5#1)(2008-7#1)(2010-10#1)
a compatible clinical##2##3##(2008-3#1)(2012-3#1)
a compatible interaction##2##3##(2008-10#2)
a compatible##8##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2012-3#1)
a compelling##2##2##(1997-1#1)(2011-2#1)
a compensator##5##2##(2007-12#1)(2008-3#4)
a compensatory mechanism##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
a compensatory##9##2##(1993-9#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
a competency-based##2##2##(2008-11#2)
a competent##4##2##(1991-12#1)(1991-8#1)(1996-1#1)(2008-5#1)
a competition between##2##3##(1994-2#1)(1996-12#1)
a competition experiment##2##3##(2008-10#1)(2008-8#1)
a competition##9##2##(1990-7#1)(1994-2#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
a competitive advantage##3##3##(1994-2#1)(2008-11#1)(2008-5#1)
a competitive antagonist of the##2##5##(2008-11#1)(2012-3#1)
a competitive antagonist##5##3##(1995-12#1)(1997-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
a competitive assay##2##3##(2008-10#2)
a competitive binding##2##3##(1992-3#1)(2008-10#1)
a competitive disadvantage##2##3##(1995-2#1)(2008-10#1)
a competitive environment##2##3##(1993-1#1)(1993-3#1)
a competitive immunoassay##3##3##(1990-8#1)(2008-10#1)(2010-5#1)
a competitive inhibitor of##3##4##(1993-8#1)(1994-6#1)(1997-7#1)
a competitive inhibitor##5##3##(1991-12#1)(1993-8#1)(1994-6#1)(1997-7#1)(2008-10#1)
a competitive ligand##2##3##(1990-8#1)(2008-10#1)
a competitive type##2##3##(1993-3#1)(1994-9#1)
a competitive##54##2##(1990-8#2)(1991-12#2)(1991-3#1)(1991-9#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#3)
a compilation and##2##3##(1997-3#1)(2008-7#1)
a compilation of##2##3##(2008-11#1)(2008-7#1)
a compilation##4##2##(1997-3#1)(2008-11#1)(2008-7#2)
a complaint##4##2##(1995-12#1)(1996-12#1)(1996-5#1)(2012-3#1)
a complement to##6##3##(1996-3#1)(1996-5#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
a complement##8##2##(1996-3#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
a complementary DNA##2##3##(1991-5#1)(2008-4#1)
a complementary metal-oxide semiconductor pixel##2##5##(2008-3#2)
a complementary metal-oxide##4##3##(2008-2#1)(2008-3#3)
a complementary role to##2##4##(2010-6#1)(2011-2#1)
a complementary role##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
a complementary sequence##2##3##(1993-11#1)(1995-12#1)
a complementary therapy##2##3##(2011-1#1)(2013-8#1)
a complementary##33##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1993-11#1)(1994-12#1)(1995-12#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
a complete absence of##2##4##(1993-12#1)(2008-10#1)
a complete absence##3##3##(1993-12#1)(2008-10#1)(2009-2#1)
a complete and##4##3##(2007-5#1)(2007-8#1)(2008-2#1)(2010-4#1)
a complete description of the##3##5##(2007-12#1)(2008-3#2)
a complete disc##2##3##(2009-4#2)
a complete functional##2##3##(1993-6#1)(2009-5#1)
a complete list of##2##4##(1996-12#1)(2010-3#1)
a complete loss of##4##4##(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#1)
a complete recovery##3##3##(1992-3#1)(2008-11#1)(2008-7#1)
a complete regression of##2##4##(1990-2#1)(1990-6#1)
a complete remission##4##3##(1991-4#1)(1991-6#1)(2008-1#1)(2012-3#1)
a complete resection##3##3##(1990-8#1)(1992-12#1)(2007-8#1)
a complete response to##2##4##(2008-6#1)(2012-3#1)
a complete response##3##3##(2008-6#2)(2012-3#1)
a complete rupture of the anal sphincter##2##7##(2011-2#2)
a complete rupture of the##3##5##(1997-6#1)(2011-2#2)
a complete separation of##2##4##(1997-2#1)(2008-10#1)
a complete set of##5##4##(1994-2#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-3#1)
a complete termination##2##3##(1995-8#1)(1997-2#1)
a complete unilateral##2##3##(1995-12#1)(2011-2#1)
a complete vectorial##2##3##(2007-11#1)(2008-3#1)
a complete##147##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#3)(1992-12#2)(1992-2#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#9)(2012-3#4)(2012-5#1)(2013-1#6)(2013-8#1)
a completely new##3##3##(2008-10#1)(2008-11#2)
a completely randomized##5##3##(2008-10#1)(2008-12#2)(2011-2#1)(2012-2#1)
a completely##19##2##(1990-11#1)(1992-11#1)(1995-8#1)(1996-9#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
a complex and##15##3##(1992-3#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
a complex array of##3##4##(1992-8#1)(2008-4#1)(2010-10#1)
a complex biological##3##3##(2009-10#1)(2010-5#1)(2013-8#1)
a complex but##2##3##(2008-10#1)(2010-11#1)
a complex cascade of##3##4##(2006-10#1)(2008-5#1)(2012-2#1)
a complex case##2##3##(2008-2#1)(2013-1#1)
a complex formation reaction##2##4##(2008-10#2)
a complex formed##2##3##(2008-10#2)
a complex genetic##3##3##(1997-5#1)(2008-8#1)(2009-5#1)
a complex in##4##3##(1994-8#1)(1997-6#1)(2008-10#1)(2012-2#1)
a complex interaction between##5##4##(2007-12#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
a complex interaction##7##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
a complex interplay between##2##4##(2009-12#1)(2009-3#1)
a complex interplay##3##3##(2008-2#1)(2009-12#1)(2009-3#1)
a complex matrix##3##3##(2008-10#2)(2009-10#1)
a complex medical##2##3##(1992-12#1)(1992-9#1)
a complex mixture of proteins##2##5##(1996-12#1)(2008-4#1)
a complex mixture of##7##4##(1992-6#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
a complex mixture##13##3##(1992-6#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)
a complex network of##3##4##(2008-6#1)(2008-7#1)(2009-8#1)
a complex network##6##3##(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-2#2)
a complex of the##2##4##(1995-5#1)(1995-8#1)
a complex of##19##3##(1991-2#1)(1992-12#1)(1992-9#1)(1995-5#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#9)(2008-4#2)(2008-8#1)
a complex pattern of##2##4##(1992-1#1)(2011-2#1)
a complex pattern##5##3##(1992-1#1)(1993-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
a complex phenomenon##2##3##(1995-2#1)(2012-12#1)
a complex problem##4##3##(2008-5#1)(2009-4#1)(2012-12#1)(2012-2#1)
a complex process##13##3##(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
a complex response##2##3##(2010-8#1)(2013-8#1)
a complex set of##4##4##(1994-12#1)(2007-8#1)(2008-7#1)(2011-2#1)
a complex signaling##3##3##(2008-4#1)(2009-8#1)(2011-2#1)
a complex spectral grating##2##4##(2007-12#2)
a complex spectral##3##3##(2007-12#2)(2011-1#1)
a complex system of##2##4##(1991-8#1)(2008-6#1)
a complex system##5##3##(1990-11#1)(1991-8#1)(2008-11#1)(2008-4#1)(2008-6#1)
a complex task##2##3##(1991-6#1)(2012-2#1)
a complex trait##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
a complex undertaking##2##3##(1994-1#1)(1994-3#1)
a complex way##3##3##(1990-3#1)(1997-2#1)(2012-12#1)
a complex web of##2##4##(2008-11#1)(2009-8#1)
a complex with beta gamma subunit##2##6##(1993-3#2)
a complex with##19##3##(1990-2#1)(1990-7#1)(1992-11#1)(1993-3#2)(1995-6#1)(1997-6#2)(2008-10#6)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
a complex##292##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#3)(1997-7#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#9)(2007-8#1)(2008-1#6)(2008-10#43)(2008-11#14)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#11)(2008-5#6)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#5)(2009-10#6)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#9)(2012-12#8)(2012-2#11)(2012-3#5)(2013-1#5)(2013-8#3)
a complex-forming##2##2##(2008-10#2)
a complexing agent##4##3##(2008-10#4)
a complexing##7##2##(2008-10#7)
a complexity##4##2##(1991-6#1)(1992-3#1)(2008-10#1)(2012-12#1)
a complicated##18##2##(1993-12#1)(1993-2#1)(1994-11#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a complication of surgery##2##4##(1990-6#1)(1993-1#1)
a complication of##22##3##(1990-6#1)(1993-1#1)(1993-5#1)(1995-10#1)(1995-11#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
a complication rate##2##3##(2012-3#2)
a complication##29##2##(1990-6#1)(1991-5#1)(1993-1#1)(1993-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-7#3)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
a complimentary metal oxide semiconductor##2##5##(2007-11#2)
a complimentary##3##2##(2007-11#2)(2008-5#1)
a component in##6##3##(1990-12#1)(1993-3#2)(2007-12#1)(2008-11#1)(2011-1#1)
a component of a larger##3##5##(1990-8#1)(2009-9#1)(2010-10#1)
a component of a##6##4##(1990-8#2)(2008-10#1)(2009-9#1)(2010-10#1)(2013-8#1)
a component of the Arp2/3 complex##2##6##(2012-2#2)
a component of the active##2##5##(1991-9#1)(1993-9#1)
a component of the##26##4##(1991-9#1)(1992-6#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-8#1)(2011-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
a component of##56##3##(1990-8#2)(1991-9#1)(1992-11#1)(1992-6#3)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-3#2)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-10#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
a component that##3##3##(1990-3#1)(1992-3#1)(1995-6#1)
a component##71##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-3#2)(1995-6#2)(1997-7#1)(2007-12#3)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
a composed##2##2##(2008-3#2)
a composite B##2##3##(2008-10#2)
a composite graft##4##3##(2007-8#1)(2008-12#1)(2008-9#1)(2012-2#1)
a composite material##3##3##(1991-5#1)(2007-11#1)(2008-10#1)
a composite matrix##2##3##(2008-10#2)
a composite of##4##3##(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
a composite rod##3##3##(2008-2#3)
a composite##44##2##(1991-5#1)(1992-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#4)(2008-2#7)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2012-2#3)(2013-1#1)
a composition of##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
a composition ratio of##2##4##(2008-10#2)
a composition##7##2##(2007-11#1)(2008-10#5)(2008-2#1)
a compound from##2##3##(1991-5#1)(1994-2#1)
a compound that##4##3##(1996-2#1)(2008-10#2)(2012-2#1)
a compound with##3##3##(2008-11#2)(2011-1#1)
a compound##35##2##(1991-5#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
a comprehensive and##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
a comprehensive approach to##3##4##(1992-12#1)(2008-7#1)(2011-2#1)
a comprehensive approach##4##3##(1992-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
a comprehensive assessment of##4##4##(2009-10#2)(2011-2#2)
a comprehensive assessment that##2##4##(2008-6#1)(2013-8#1)
a comprehensive assessment##6##3##(2008-6#1)(2009-10#2)(2011-2#2)(2013-8#1)
a comprehensive description of##2##4##(2008-3#1)(2008-4#1)
a comprehensive experimental##2##3##(1997-7#1)(2008-3#1)
a comprehensive framework##3##3##(1995-12#1)(2008-11#2)
a comprehensive investigation of##2##4##(2008-2#1)(2008-3#1)
a comprehensive list of##3##4##(2008-4#1)(2008-9#1)(2010-2#1)
a comprehensive manner##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
a comprehensive model for##2##4##(1992-9#2)
a comprehensive model of##2##4##(2010-5#1)(2010-8#1)
a comprehensive model##5##3##(1992-9#2)(1994-2#1)(2010-5#1)(2010-8#1)
a comprehensive overview of the##6##5##(1992-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
a comprehensive overview of##9##4##(1992-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a comprehensive overview##10##3##(1992-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a comprehensive review of the literature##3##6##(2006-10#1)(2007-8#1)(2012-2#1)
a comprehensive review of the##4##5##(1995-6#1)(2006-10#1)(2007-8#1)(2012-2#1)
a comprehensive review of##5##4##(1995-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2012-2#1)
a comprehensive review##10##3##(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#2)(2012-2#2)
a comprehensive screening program##3##4##(1996-2#1)(2008-10#1)(2012-12#1)
a comprehensive set of##3##4##(2008-4#2)(2012-2#1)
a comprehensive study of the##2##5##(2008-3#1)(2009-3#1)
a comprehensive study of##3##4##(2008-10#1)(2008-3#1)(2009-3#1)
a comprehensive study##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2009-3#1)
a comprehensive theory of##2##4##(1994-2#1)(1997-6#1)
a comprehensive understanding of the##3##5##(2007-12#1)(2012-3#2)
a comprehensive understanding of##4##4##(2007-12#1)(2009-2#1)(2012-3#2)
a comprehensive##158##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-9#2)(1993-1#3)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-9#2)(1995-12#4)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#8)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#4)(2013-8#4)
a compression ratio of##2##4##(2007-12#1)(2008-3#1)
a compression##5##2##(2007-12#1)(2008-3#2)(2008-9#1)(2011-3#1)
a compressive##4##2##(1991-11#1)(1992-6#1)(2008-3#1)(2011-2#1)
a compromise between##4##3##(1995-3#1)(2008-10#2)(2008-7#1)
a compromise##5##2##(1995-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
a compromised Mlo pathway##2##4##(2008-10#2)
a compromised##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
a computational model based on##2##5##(2008-2#1)(2012-2#1)
a computational model of##2##4##(2008-11#1)(2013-8#1)
a computational model##9##3##(2008-11#3)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
a computational strategy##3##3##(1995-5#1)(2008-10#2)
a computational##21##2##(1994-8#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
a computationally##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
a computed tomography (CT) scan##4##5##(2007-10#1)(2008-12#1)(2008-7#2)
a computed tomography##5##3##(2007-10#1)(2008-12#1)(2008-7#2)(2013-1#1)
a computed##7##2##(2007-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2013-1#1)
a computer and##2##3##(1995-6#1)(2008-4#1)
a computer program for##2##4##(1993-6#1)(1994-9#1)
a computer program##12##3##(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-2#1)
a computer readable##2##3##(2008-10#1)(2008-4#1)
a computer simulation of##2##4##(2008-2#2)
a computer simulation##5##3##(2008-2#3)(2008-3#2)
a computer simulator of sensor errors##2##6##(2009-9#2)
a computer system##3##3##(1995-12#1)(1997-2#1)(2008-3#1)
a computer through##2##3##(2007-12#1)(2008-3#1)
a computer##64##2##(1990-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-2#1)
a computer-aided##3##2##(1990-11#1)(2008-10#2)
a computer-based##9##2##(1992-1#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-12#1)
a computer-controlled environmental chamber##2##4##(2008-10#2)
a computer-controlled##5##2##(2008-10#3)(2008-3#2)
a computer-generated hologram##4##3##(2008-3#4)
a computer-generated##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
a computerised##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
a computerized imaging system##2##4##(2008-2#1)(2008-9#1)
a computerized medical##2##3##(1994-6#1)(2010-8#1)
a computerized##17##2##(1993-12#1)(1994-6#1)(1995-5#1)(1996-3#2)(1997-3#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
a concave diffraction grating##2##4##(2008-3#2)
a concave##8##2##(1995-11#1)(2007-11#2)(2008-3#3)(2008-8#1)(2011-2#1)
a concentrated##6##2##(1990-5#1)(1991-11#1)(1995-2#1)(2008-10#2)(2008-7#1)
a concentration as low as##5##5##(1993-6#1)(1993-8#1)(1994-6#1)(2008-10#2)
a concentration as##6##3##(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(2008-10#2)
a concentration dependent##7##3##(1990-11#1)(1990-5#1)(1993-6#1)(1996-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
a concentration gradient##3##3##(2008-10#2)(2012-2#1)
a concentration level of##5##4##(2008-10#4)(2009-8#1)
a concentration level##6##3##(2008-10#5)(2009-8#1)
a concentration limit of##2##4##(2008-10#2)
a concentration of 0##10##4##(1992-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
a concentration of 1##11##4##(1992-3#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)
a concentration of 10##3##4##(1991-2#1)(1995-5#1)(2008-10#1)
a concentration of 10(-6) M##2##5##(1991-9#1)(1993-12#1)
a concentration of 100##5##4##(1997-4#1)(2008-10#1)(2008-7#1)(2011-1#2)
a concentration of 2##4##4##(2008-10#3)(2008-5#1)
a concentration of 3 X 10(-7) M##2##7##(1990-5#2)
a concentration of 3##6##4##(1990-5#2)(1995-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
a concentration of 4##2##4##(2008-10#2)
a concentration of 50##2##4##(2008-10#1)(2010-3#1)
a concentration of less than##2##5##(2008-10#1)(2008-5#1)
a concentration of##86##3##(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1997-1#1)(1997-4#1)(2008-10#33)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
a concentration range from 0##2##5##(2008-10#1)(2008-2#1)
a concentration range from##4##4##(2008-10#3)(2008-2#1)
a concentration range of 0##3##5##(2008-10#3)
a concentration range of 1##4##5##(2008-10#3)(2011-2#1)
a concentration range of##13##4##(2008-10#10)(2008-2#1)(2011-2#1)(2011-3#1)
a concentration range##20##3##(1997-4#1)(2008-10#15)(2008-2#2)(2011-2#1)(2011-3#1)
a concentration##158##2##(1990-11#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#2)(1995-2#1)(1995-5#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-4#5)(2008-10#66)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
a concentration- and time-dependent##3##4##(1995-2#1)(1997-4#1)(2012-3#1)
a concentration-dependent increase in##2##4##(1997-4#1)(2008-10#1)
a concentration-dependent reduction in##3##4##(1992-1#1)(1993-12#1)(1995-12#1)
a concentration-dependent##57##2##(1990-5#2)(1990-7#3)(1991-1#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#4)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#2)(1995-11#3)(1995-12#6)(1995-5#2)(1996-12#1)(1997-2#1)(1997-4#3)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#2)
a concentric##4##2##(1997-8#1)(2008-8#1)(2011-1#1)(2012-1#1)
a concept of##6##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)
a concept##20##2##(1991-3#1)(1994-3#2)(1995-12#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
a conceptual framework and##2##4##(1993-2#1)(2007-12#1)
a conceptual framework for##3##4##(1994-2#1)(1997-2#1)(2010-8#1)
a conceptual framework of##4##4##(1992-3#1)(2011-1#1)(2013-1#2)
a conceptual framework##12##3##(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
a conceptual##22##2##(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-4#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
a conceptually##2##2##(2011-2#1)(2013-1#1)
a concern for the##2##4##(1993-12#1)(2011-1#1)
a concern for##4##3##(1993-12#1)(2007-11#1)(2008-9#1)(2011-1#1)
a concern to##2##3##(2012-12#1)(2012-3#1)
a concern##17##2##(1991-12#1)(1993-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
a concerted action of##2##4##(2009-8#1)(2011-1#1)
a concerted effort to##2##4##(1991-1#1)(2009-9#1)
a concerted effort##5##3##(1991-1#1)(1991-3#1)(1995-1#1)(2009-9#1)(2012-2#1)
a concerted##11##2##(1991-1#1)(1991-3#1)(1995-1#1)(1995-5#1)(1996-2#2)(2008-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)
a concise and##2##3##(2008-7#1)(2009-11#1)
a concise overview of the##2##5##(1992-3#1)(2008-11#1)
a concise overview##4##3##(1992-3#1)(2008-10#2)(2008-11#1)
a concise review of##2##4##(1997-4#1)(2008-11#1)
a concise review##3##3##(1997-4#1)(2008-11#1)(2013-1#1)
a concise summary of##2##4##(2012-12#2)
a concise##11##2##(1992-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-11#1)(2012-12#2)(2013-1#1)
a conclusion that##3##3##(1995-12#1)(2008-3#1)(2013-8#1)
a conclusion##9##2##(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
a concomitant decrease in##2##4##(1990-7#1)(1992-11#1)
a concomitant decrease##3##3##(1990-7#1)(1992-11#1)(1994-2#1)
a concomitant increase in##2##4##(1992-8#1)(2008-5#1)
a concomitant reduction##2##3##(1990-12#1)(1994-3#1)
a concomitant rise in##3##4##(1995-2#1)(2008-5#1)(2010-8#1)
a concomitant##28##2##(1990-12#1)(1990-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-6#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-8#1)
a concordance of##5##3##(1992-6#1)(2008-7#1)(2013-1#3)
a concordance##6##2##(1992-6#1)(2008-7#2)(2013-1#3)
a concrete##4##2##(2007-12#1)(2007-8#1)(2008-11#1)(2010-1#1)
a concurrent cohort of##2##4##(2012-12#2)
a concurrent##7##2##(1994-12#1)(1995-3#1)(2007-10#1)(2010-10#1)(2011-10#1)(2012-12#2)
a condensation of##2##3##(1994-12#1)(2008-10#1)
a condensation##3##2##(1994-12#1)(2008-10#1)(2010-12#1)
a condensed##2##2##(2007-12#1)(2012-1#1)
a condition for##4##3##(1994-12#1)(1997-5#1)(2008-2#1)(2008-3#1)
a condition in which##4##4##(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)
a condition is##2##3##(2008-10#1)(2008-3#1)
a condition of##4##3##(1991-8#1)(2008-5#1)(2011-1#1)(2012-3#1)
a condition that##3##3##(1997-6#1)(2006-10#1)(2009-3#1)
a condition which##2##3##(1995-12#1)(2008-1#1)
a condition##35##2##(1991-8#2)(1994-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a conditional expression##2##3##(1997-3#1)(2013-1#1)
a conditional##8##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
a conditionally##4##2##(1993-8#2)(2008-5#2)
a conditioned##7##2##(1991-1#1)(1993-6#2)(1994-2#1)(1996-2#1)(2008-5#1)(2009-11#1)
a conditioning##4##2##(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
a condom##2##2##(1993-2#1)(2013-1#1)
a conductance of##2##3##(1994-12#1)(1995-11#1)
a conductance##3##2##(1990-7#1)(1994-12#1)(1995-11#1)
a conducting polymer##5##3##(2008-10#3)(2008-5#1)(2009-11#1)
a conducting polypyrrole##2##3##(2008-10#2)
a conducting##12##2##(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
a conductive##5##2##(1990-2#1)(2008-10#3)(2010-10#1)
a conduit for##2##3##(1992-8#1)(2008-5#1)
a conduit##5##2##(1992-8#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
a cone##2##2##(2007-12#1)(2011-1#1)
a cone-shaped##2##2##(2008-10#1)(2008-12#1)
a conference##17##2##(1990-3#1)(1990-8#1)(1992-12#1)(1992-3#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)
a confidence interval for theta##2##5##(1996-3#2)
a confidence interval for##3##4##(1996-3#3)
a confidence interval of 95%##2##5##(2008-10#1)(2013-1#1)
a confidence interval##7##3##(1995-9#1)(1996-3#3)(2008-10#2)(2013-1#1)
a confidence level of 95%##2##5##(2008-10#2)
a confidence##12##2##(1995-9#1)(1996-3#3)(2008-10#5)(2008-11#1)(2010-5#1)(2013-1#1)
a configuration##3##2##(1996-2#1)(2007-11#1)(2007-12#1)
a confined##3##2##(2008-1#1)(2010-3#1)(2012-1#1)
a confirmatory##8##2##(1997-8#1)(2008-10#5)(2011-2#1)(2012-2#1)
a conflict between##2##3##(2008-8#1)(2013-1#1)
a conflict of##2##3##(2007-4#1)(2008-12#1)
a conflict##5##2##(2007-4#1)(2008-12#1)(2008-8#1)(2013-1#2)
a confluence##2##2##(2008-10#1)(2010-8#1)
a confluent##2##2##(2008-10#1)(2008-7#1)
a confocal image##3##3##(2008-3#3)
a confocal laser scanning microscope##4##5##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
a confocal laser##6##3##(1992-9#1)(1994-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
a confocal microscope##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
a confocal scanning##2##3##(2007-11#1)(2008-3#1)
a confocal unstable resonator##2##4##(2008-2#1)(2008-3#1)
a confocal##29##2##(1992-9#1)(1994-9#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#13)(2008-8#1)(2008-9#1)(2012-2#1)
a conformational change##6##3##(1990-5#2)(1992-9#1)(1993-8#1)(1994-6#1)(2008-5#1)
a conformational epitope##3##3##(1995-2#1)(2009-8#1)(2012-2#1)
a conformational##14##2##(1990-5#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-2#1)
a confusing##3##2##(1991-3#1)(1997-1#1)(2008-10#1)
a congenital##12##2##(1996-11#1)(1997-3#1)(1997-8#3)(2007-8#2)(2008-7#1)(2010-3#1)(2010-5#1)(2012-3#2)
a conical##12##2##(1994-9#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#2)
a conidial suspension of P##2##5##(2008-10#2)
a conidial suspension of##3##4##(2008-10#3)
a conidial suspension##8##3##(2008-10#8)
a conjugate of the##2##4##(2008-2#2)
a conjugate of##5##3##(2008-10#2)(2008-11#1)(2008-2#2)
a conjugate with##2##3##(1993-8#1)(2008-10#1)
a conjugate##11##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)
a conjugated##4##2##(2007-11#1)(2008-9#2)(2009-11#1)
a connecting##2##2##(1992-6#1)(2012-3#1)
a connection between##7##3##(1991-2#1)(1993-3#1)(2007-10#1)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)
a connection with##2##3##(1992-11#1)(1996-6#1)
a connection##12##2##(1991-2#1)(1992-11#1)(1993-3#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
a consecutive series of##6##4##(1990-8#1)(1991-8#1)(2007-8#1)(2010-11#1)(2012-5#1)(2013-1#1)
a consecutive##9##2##(1990-12#1)(1990-8#1)(1991-8#1)(2007-8#1)(2010-11#1)(2012-2#2)(2012-5#1)(2013-1#1)
a consensual##2##2##(2008-11#1)(2011-1#1)
a consensus among##2##3##(2008-10#1)(2011-2#1)
a consensus as to##2##4##(1990-11#1)(1993-1#1)
a consensus sequence of##4##4##(1990-8#1)(1991-12#1)(2008-10#1)(2009-8#1)
a consensus sequence##8##3##(1990-8#1)(1991-12#1)(1991-2#1)(1993-9#1)(1994-12#1)(2008-10#2)(2009-8#1)
a consensus statement##2##3##(1990-2#1)(1993-3#1)
a consensus that##3##3##(1993-11#1)(1993-12#1)(1997-3#1)
a consensus##40##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#2)(1996-1#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-6#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#4)
a consent##2##2##(1995-12#1)(2012-3#1)
a consequence of a##9##4##(1994-8#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
a consequence of different##2##4##(2008-8#1)(2009-2#1)
a consequence of increased##2##4##(1991-1#1)(1995-2#1)
a consequence of its##2##4##(1994-5#1)(1995-2#1)
a consequence of the##21##4##(1990-11#1)(1990-2#1)(1992-6#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
a consequence of their##3##4##(1992-6#1)(2008-3#1)(2010-3#1)
a consequence of this##4##4##(1997-8#1)(2008-11#1)(2008-6#1)(2008-8#1)
a consequence of##92##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-6#3)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#3)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-5#1)(2013-1#6)(2013-7#1)
a consequence##143##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-6#3)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#3)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#26)(2008-11#8)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#1)
a consequent##7##2##(1995-12#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-3#1)
a conservative approach##4##3##(1990-9#1)(1995-8#1)(1996-6#1)(2008-8#1)
a conservative##13##2##(1990-9#1)(1991-12#1)(1992-3#1)(1994-5#1)(1995-8#1)(1996-6#1)(2008-3#1)(2008-8#2)(2011-7#1)(2013-1#3)
a conserved motif##2##3##(1995-6#1)(2008-8#1)
a conserved##27##2##(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
a considerable amount of##5##4##(1991-12#1)(1994-6#1)(2008-4#1)(2008-6#1)(2009-1#1)
a considerable amount##6##3##(1991-12#1)(1994-6#1)(2008-4#1)(2008-6#1)(2009-1#1)(2012-3#1)
a considerable decrease in the##2##5##(2008-6#2)
a considerable decrease in##5##4##(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
a considerable decrease##6##3##(1994-8#1)(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
a considerable degree of##4##4##(1991-6#2)(2008-10#1)(2008-7#1)
a considerable degree##5##3##(1991-6#2)(2008-10#1)(2008-7#1)(2010-3#1)
a considerable heterogeneity##2##3##(2008-10#1)(2008-7#1)
a considerable improvement##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
a considerable increase in##2##4##(2008-2#1)(2008-4#1)
a considerable number##2##3##(2007-5#1)(2008-4#1)
a considerable reduction in##5##4##(1991-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
a considerable reduction##6##3##(1991-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
a considerable time##2##3##(1990-3#1)(1994-2#1)
a considerable variation##2##3##(1995-11#1)(2011-2#1)
a considerable##74##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-6#2)(1993-12#2)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-8#3)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#3)(2008-7#3)(2008-9#1)(2009-1#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)
a considerably##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
a consideration of the##4##4##(1992-2#1)(1995-11#1)(2012-12#1)(2013-1#1)
a consideration of##7##3##(1992-2#1)(1995-11#1)(1996-6#1)(2008-11#1)(2009-7#1)(2012-12#1)(2013-1#1)
a consideration##8##2##(1992-2#1)(1995-11#1)(1996-6#1)(2007-11#1)(2008-11#1)(2009-7#1)(2012-12#1)(2013-1#1)
a consistent and significant##2##4##(2008-10#2)
a consistent and##4##3##(2008-10#2)(2008-5#1)(2010-11#1)
a consistent approach to##2##4##(1993-3#1)(1995-3#1)
a consistent increase in##2##4##(2011-1#1)(2012-2#1)
a consistent increase##3##3##(1992-1#1)(2011-1#1)(2012-2#1)
a consistent pattern of##2##4##(2008-11#1)(2008-7#1)
a consistent pattern##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
a consistent##46##2##(1990-2#1)(1991-1#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)
a consistently##3##2##(1993-3#1)(1995-12#1)(2008-10#1)
a consolidation##2##2##(1994-12#1)(2007-8#1)
a consortium of##3##3##(1991-1#1)(2008-11#1)(2009-11#1)
a conspicuous##6##2##(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#2)
a constant amount of##3##4##(2008-10#2)(2008-5#1)
a constant and##4##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)
a constant component of##2##4##(2007-11#1)(2007-12#1)
a constant current##3##3##(2008-10#2)(2008-4#1)
a constant degree and##2##4##(2008-2#2)
a constant degree##3##3##(1992-11#1)(2008-2#2)
a constant finding in##2##4##(1991-9#1)(2011-1#1)
a constant ionic medium##3##4##(2008-10#3)
a constant ionic##5##3##(2008-10#4)(2008-5#1)
a constant level of##4##4##(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
a constant level##5##3##(1993-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
a constant molecular clock##2##4##(1995-3#2)
a constant net reproductive rate##2##5##(2008-8#2)
a constant potential##3##3##(2008-10#3)
a constant pressure##2##3##(2008-9#1)(2009-6#1)
a constant rate##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
a constant temperature##4##3##(2007-12#1)(2008-10#3)
a constant value for the##2##5##(2008-2#2)
a constant value##6##3##(2008-10#2)(2008-2#2)(2008-3#1)(2009-7#1)
a constant##124##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-3#3)(1996-12#1)(1996-4#1)(2007-11#4)(2007-12#9)(2007-7#1)(2008-10#35)(2008-11#5)(2008-2#12)(2008-3#14)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
a constant-bias##2##2##(2007-12#2)
a constant-start version of the Morris water##2##7##(1993-12#2)
a constellation of##7##3##(1994-2#1)(1995-3#1)(2007-4#1)(2011-1#2)(2012-3#1)(2013-8#1)
a constituent of##2##3##(2008-10#1)(2008-11#1)
a constitutional##2##2##(1992-2#1)(1996-5#1)
a constitutive expression of##2##4##(1995-8#1)(2008-10#1)
a constitutive expression##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
a constitutive##5##2##(1995-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
a constitutively activated##2##3##(2008-7#1)(2009-7#1)
a constitutively photomorphogenic mutant##2##4##(1996-10#2)
a constitutively##6##2##(1995-11#1)(1996-10#2)(2008-7#2)(2009-7#1)
a constrained##4##2##(1996-5#1)(2008-2#3)
a constraint##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
a construct##10##2##(1990-12#1)(1990-5#1)(1993-2#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-12#1)(2010-10#1)(2011-2#1)
a construction of a##2##4##(2008-10#1)(2008-7#1)
a construction worker##2##3##(1995-12#1)(1997-7#1)
a construction##5##2##(1991-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-7#1)
a constructive##4##2##(1995-3#1)(1996-1#1)(2008-11#1)(2008-3#1)
a consultant##2##2##(1990-3#1)(2008-4#1)
a consultation##3##2##(1993-2#1)(1994-11#1)(2007-2#1)
a consulting##2##2##(1993-5#1)(2009-12#1)
a consumer guide on##2##4##(1996-2#2)
a consumer##9##2##(1993-1#1)(1994-1#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-11#2)(2008-2#1)
a consumer's##3##2##(1994-2#1)(1996-1#1)(2008-5#1)
a contact lens##2##3##(2008-10#1)(2008-3#1)
a contact##10##2##(1993-11#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-1#1)(2009-7#1)(2010-8#1)
a containment##2##2##(2008-10#1)(2011-2#1)
a contaminated water##2##3##(2008-10#1)(2012-3#1)
a contaminated##6##2##(2008-10#5)(2012-3#1)
a contamination##2##2##(2008-10#1)(2011-2#1)
a content analysis##5##3##(1993-12#1)(2008-11#2)(2009-5#1)(2012-12#1)
a content of##2##3##(2008-12#1)(2008-5#1)
a content word##2##3##(2008-2#2)
a content##11##2##(1993-12#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-5#1)(2009-5#1)(2012-12#1)
a contentious##2##2##(2008-7#1)(2008-9#1)
a context and##2##3##(2008-7#1)(2010-10#1)
a context for##2##3##(1992-3#1)(2009-6#1)
a context of##7##3##(1991-11#1)(1991-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#2)
a context where##2##3##(2008-2#2)
a context##18##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#2)
a contextual##2##2##(1996-2#1)(2010-10#1)
a contiguous gene##2##3##(1997-3#1)(2008-10#1)
a contiguous##7##2##(1997-3#1)(2007-5#1)(2008-10#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
a continent##3##2##(2008-10#3)
a continuation of##3##3##(1992-2#1)(2008-3#1)(2012-2#1)
a continued##6##2##(1991-6#1)(1997-5#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
a continuing care##2##3##(1991-12#1)(1993-2#1)
a continuing challenge##2##3##(2007-2#1)(2008-3#1)
a continuing##14##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-2#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-6#1)(2013-1#1)
a continuous (168 h) exposure of at least##2##8##(2008-9#2)
a continuous and##3##3##(1997-2#1)(2008-11#1)(2008-5#1)
a continuous filtration/dissolution system##2##4##(2008-10#2)
a continuous flow manifold##2##4##(2008-10#2)
a continuous flow of##3##4##(1991-12#1)(2008-10#2)
a continuous flow system was##2##5##(2008-10#2)
a continuous flow system##7##4##(2008-10#7)
a continuous flow##16##3##(1991-12#1)(2008-10#14)(2011-2#1)
a continuous frequency##2##3##(2007-11#1)(2007-12#1)
a continuous function of##2##4##(1994-11#1)(2008-2#1)
a continuous increase of##2##4##(1996-12#1)(1997-7#1)
a continuous infusion of##3##4##(1992-5#1)(1994-12#1)(2007-10#1)
a continuous mode##4##3##(1997-2#1)(2008-10#3)
a continuous monitoring of the##2##5##(2010-10#1)(2011-2#1)
a continuous monitoring of##3##4##(2008-10#1)(2010-10#1)(2011-2#1)
a continuous phase##2##3##(2007-11#1)(2008-2#1)
a continuous process##3##3##(1992-9#1)(1995-2#1)(1995-3#1)
a continuous quality##2##3##(1993-3#1)(1994-3#1)
a continuous set of##2##4##(2008-2#1)(2008-3#1)
a continuous sound##2##3##(1995-5#2)
a continuous spectrum##2##3##(1992-8#1)(2008-2#1)
a continuous temperature##2##3##(1993-6#1)(2008-10#1)
a continuous twin screw-driven reactor (CTSR)##2##6##(2013-1#2)
a continuous wave##4##3##(1992-1#1)(1996-1#1)(2008-11#1)(2008-2#1)
a continuous##147##2##(1990-2#1)(1991-12#1)(1992-1#3)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#46)(2008-11#7)(2008-2#6)(2008-3#9)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-4#1)(2013-1#4)(2013-8#1)
a continuous-flow system##2##3##(2008-10#2)
a continuous-flow##4##2##(2008-10#4)
a continuous-wave (cw)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a continuous-wave 262-GHz##2##3##(2007-11#2)
a continuous-wave laser##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
a continuous-wave quantum-cascade##2##3##(2007-12#1)(2008-3#1)
a continuous-wave##31##2##(2007-11#4)(2007-12#10)(2008-2#7)(2008-3#9)(2011-1#1)
a continuously flowing##2##3##(2008-10#2)
a continuously tunable##3##3##(2008-2#2)(2008-3#1)
a continuously##15##2##(1996-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2010-11#1)(2012-2#1)
a continuum of##12##3##(1992-1#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2011-2#1)(2012-2#1)
a continuum that##2##3##(1994-9#1)(1997-3#1)
a continuum with##2##3##(2008-1#1)(2010-8#1)
a continuum##26##2##(1992-1#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-3#2)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a contraceptive##4##2##(1996-11#1)(1996-9#1)(2012-12#1)(2013-1#1)
a contract##2##2##(1997-2#1)(2008-5#1)
a contraction##2##2##(1995-12#1)(1997-4#1)
a contradiction##3##2##(1992-8#1)(2007-10#1)(2012-2#1)
a contraindication for surgery##2##4##(1990-8#1)(1993-9#1)
a contraindication for##4##3##(1990-8#1)(1993-9#1)(2013-1#1)(2013-8#1)
a contraindication to##3##3##(1994-3#1)(2008-1#1)(2008-9#1)
a contraindication##10##2##(1990-8#1)(1992-6#1)(1993-9#1)(1994-3#1)(2008-1#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
a contralateral##2##2##(2008-7#1)(2008-9#1)
a contrast ratio of##2##4##(2008-3#2)
a contrast ratio##3##3##(2008-2#1)(2008-3#2)
a contrast to the##2##4##(1992-3#1)(1993-3#1)
a contrast##7##2##(1992-3#1)(1993-3#1)(2008-2#1)(2008-3#3)(2008-5#1)
a contributing factor to##2##4##(1992-6#1)(2011-2#1)
a contributing factor##4##3##(1992-6#1)(1995-8#1)(2009-3#1)(2011-2#1)
a contributing source of##2##4##(1995-3#1)(2013-1#1)
a contributing##7##2##(1992-6#1)(1994-5#1)(1995-3#1)(1995-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
a contribution from##2##3##(1997-4#1)(2010-7#1)
a contribution of##2##3##(1993-12#1)(2013-1#1)
a contribution to the##2##4##(1996-11#1)(2007-12#1)
a contribution to##3##3##(1996-11#1)(2006-12#1)(2007-12#1)
a contribution towards##2##3##(1990-6#1)(2012-12#1)
a contribution##10##2##(1990-6#1)(1993-12#1)(1996-11#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-6#1)(2010-7#1)(2012-12#1)(2013-1#1)
a contributory factor##3##3##(1995-5#1)(2008-11#1)(2008-12#1)
a contributory##5##2##(1993-2#1)(1994-2#1)(1995-5#1)(2008-11#1)(2008-12#1)
a control and##2##3##(2008-11#1)(2008-12#1)
a control cell##2##3##(2009-2#2)
a control compound##2##3##(2008-10#2)
a control condition##3##3##(2008-4#3)
a control diet##2##3##(2008-11#1)(2008-12#1)
a control group of##11##4##(1992-6#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
a control group receiving##2##4##(1991-1#1)(2007-12#1)
a control group were##2##4##(2009-5#1)(2013-8#1)
a control group with##5##4##(1990-6#1)(1992-2#1)(1995-2#1)(2008-5#1)(2008-9#1)
a control group##54##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
a control parameter##2##3##(1996-4#1)(2008-7#1)
a control population##3##3##(1997-7#1)(2008-11#1)(2013-1#1)
a control system##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
a control##132##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#7)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#6)(2008-9#4)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
a controllable donor-acceptor nanohybrid##2##4##(2009-3#2)
a controllable##3##2##(2007-12#1)(2009-3#2)
a controlled vocabulary##2##3##(2008-7#2)
a controlled##50##2##(1990-9#1)(1991-3#1)(1993-1#1)(1993-8#1)(1994-11#1)(1996-1#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-6#1)(2012-8#1)(2013-8#1)
a controller##2##2##(2008-10#2)
a controversial issue##2##3##(2008-11#1)(2008-7#1)
a controversial##8##2##(1990-3#1)(1991-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
a controversy##2##2##(2008-8#1)(2012-12#1)
a convective##4##2##(1992-8#1)(2008-2#1)(2008-6#1)(2013-8#1)
a convenience sample of##10##4##(1990-10#1)(1992-2#1)(1993-3#1)(2008-12#1)(2009-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2013-1#2)
a convenience sample##11##3##(1990-10#1)(1992-2#1)(1993-3#1)(2008-12#1)(2009-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2013-1#2)
a convenience##12##2##(1990-10#1)(1992-2#1)(1993-3#1)(2008-12#1)(2009-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2013-1#2)(2013-8#1)
a convenient and effective##2##4##(2008-4#1)(2012-12#1)
a convenient and##3##3##(2007-8#1)(2008-4#1)(2012-12#1)
a convenient method##3##3##(2007-11#1)(2008-3#1)(2008-9#1)
a convenient##31##2##(1990-8#1)(1994-12#1)(1994-6#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
a conventional CT##2##3##(2008-7#2)
a conventional image##2##3##(2008-3#1)(2008-6#1)
a conventional optical##2##3##(2008-2#2)
a conventional reversed-phase##2##3##(2008-10#2)
a conventional solution##2##3##(2008-5#1)(2011-2#1)
a conventional spectrophotometer##2##3##(2008-10#2)
a conventional##116##2##(1990-12#1)(1990-6#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-5#2)(1994-7#1)(1995-3#1)(2007-11#6)(2007-12#5)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#22)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#4)(2013-1#1)(2013-8#1)
a convergence##2##2##(1991-12#1)(1995-2#1)
a converging##6##2##(2008-2#3)(2008-3#3)
a conversion efficiency of##2##4##(2007-12#1)(2008-2#1)
a conversion efficiency##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
a conversion##8##2##(1991-5#1)(1992-12#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
a convex##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
a convicted##2##2##(1992-9#1)(1996-5#1)
a convincing##2##2##(1994-2#1)(2011-2#1)
a convolution between the##3##4##(2008-2#1)(2008-3#2)
a convolution with##2##3##(2007-11#1)(2008-3#1)
a convolution##7##2##(2007-11#2)(2008-2#2)(2008-3#3)
a cooked##2##2##(1997-4#2)
a cooled##6##2##(2008-10#3)(2008-11#1)(2008-2#2)
a cooling##2##2##(1990-5#1)(2008-10#1)
a cooperative approach##2##3##(1994-3#1)(1996-12#1)
a cooperative##16##2##(1991-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
a coordinated ambulatory care system##2##5##(1992-1#2)
a coordinated##12##2##(1992-1#2)(1994-2#1)(1995-1#1)(1996-12#1)(2007-12#1)(2008-12#2)(2008-4#1)(2011-2#1)(2012-12#2)
a coordinating##2##2##(1995-11#1)(2007-7#1)
a copolymer obtained by##2##4##(2007-11#1)(2008-10#1)
a copolymer##4##2##(2007-11#1)(2008-10#3)
a copper metal vapor laser##2##5##(1992-9#2)
a copper##10##2##(1992-9#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-11#1)
a copper-vapor laser##4##3##(2007-12#3)(2008-2#1)
a copperised cadmium reductor column##2##5##(2008-10#2)
a copperised cadmium##3##3##(2008-10#3)
a copy of the##5##4##(1997-4#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
a copy of##6##3##(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
a copy##7##2##(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
a coral reef##2##3##(2007-5#1)(2011-2#1)
a coral##3##2##(2007-5#1)(2010-5#1)(2011-2#1)
a core curriculum##3##3##(1992-1#1)(2012-2#2)
a core mode and##2##4##(2007-12#1)(2008-3#1)
a core of##3##3##(1990-3#1)(2007-6#1)(2008-10#1)
a core set of##2##4##(2008-10#1)(2011-2#1)
a core##31##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)
a core-doped##2##2##(2008-2#2)
a corn##3##2##(2008-10#2)(2011-2#1)
a corneometer##3##2##(2008-5#3)
a cornerstone of##2##3##(1991-11#1)(2008-8#1)
a cornerstone##3##2##(1991-11#1)(1996-11#1)(2008-8#1)
a coronary artery##4##3##(2008-4#1)(2010-5#1)(2012-3#2)
a coronary stent##3##3##(2008-7#1)(2011-2#2)
a coronary##12##2##(1995-11#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#2)(2012-3#2)
a corporate##3##2##(1992-3#1)(2008-12#1)(2012-2#1)
a corporate-level performance assessment system##2##5##(1996-2#2)
a corpus of##2##3##(2008-11#1)(2009-10#1)
a corpus##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
a correct diagnosis##2##3##(1991-6#1)(2009-6#1)
a correct diagnostic##2##3##(1991-5#1)(2013-1#1)
a correct estimation of the##2##5##(1994-5#1)(2008-3#1)
a correct##28##2##(1990-10#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1992-9#1)(1994-2#1)(1994-5#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
a corrected##3##2##(1997-7#1)(2007-11#1)(2012-3#1)
a correction factor for##2##4##(2008-10#1)(2008-3#1)
a correction factor##7##3##(1995-12#1)(2008-10#2)(2008-3#3)(2008-9#1)
a correction of the##2##4##(1995-9#1)(2008-3#1)
a correction##15##2##(1995-12#1)(1995-9#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-9#1)(2009-8#1)(2013-1#1)
a corrective gene##2##3##(2008-11#2)
a corrective##3##2##(1994-8#1)(2008-11#2)
a correlate of##2##3##(2008-12#2)
a correlated##2##2##(1997-4#1)(2008-8#1)
a correlation (r = 0##2##5##(1994-12#1)(2008-10#1)
a correlation between the##10##4##(1990-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#2)
a correlation between these##2##4##(2008-5#1)(2011-2#1)
a correlation between##29##3##(1990-2#1)(1991-6#1)(1992-9#1)(1997-7#1)(2006-10#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2011-2#3)(2013-1#2)
a correlation coefficient (r)##2##4##(2008-10#2)
a correlation coefficient of 0##28##5##(2008-1#1)(2008-10#24)(2010-2#1)(2010-4#1)(2013-8#1)
a correlation coefficient of##30##4##(2008-1#1)(2008-10#26)(2010-2#1)(2010-4#1)(2013-8#1)
a correlation coefficient##39##3##(1990-8#1)(2008-1#1)(2008-10#33)(2008-8#1)(2010-2#1)(2010-4#1)(2013-8#1)
a correlation was found between the##3##6##(1990-12#1)(1992-3#1)(2008-5#1)
a correlation was##6##3##(1990-12#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
a correlation with##3##3##(2007-11#1)(2008-12#1)(2008-4#1)
a correlation##92##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#49)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
a correlator##2##2##(2008-2#1)(2008-3#1)
a corresponding decrease in##3##4##(1995-12#1)(1995-9#1)(2008-11#1)
a corresponding increase in the##2##5##(1991-3#1)(2011-1#1)
a corresponding increase in##4##4##(1991-3#1)(1993-6#1)(2008-5#1)(2011-1#1)
a corresponding increase##5##3##(1991-3#1)(1993-6#1)(2008-5#1)(2011-1#1)(2011-2#1)
a corresponding##38##2##(1991-3#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-9#1)(1996-4#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
a corrosion##3##2##(1992-11#1)(2007-12#1)(2008-3#1)
a corrugated long-period##2##3##(2008-3#2)
a corrugated##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
a cortical##4##2##(2008-7#1)(2010-7#2)(2011-2#1)
a cosmetic formulation##4##3##(2008-5#4)
a cosmetic##14##2##(2008-10#1)(2008-5#10)(2011-2#1)(2013-1#1)(2013-7#1)
a cosmetically##2##2##(2007-7#1)(2013-1#1)
a cosmid clone##3##3##(1996-2#1)(1996-3#1)(2008-10#1)
a cosmid##6##2##(1993-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#1)
a cost effective##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
a cost for##2##3##(2009-9#1)(2012-3#1)
a cost function that##2##4##(2007-11#1)(2008-2#1)
a cost function##4##3##(2007-11#1)(2008-2#3)
a cost of##7##3##(1994-9#1)(1996-12#1)(2008-10#2)(2008-7#2)(2008-9#1)
a cost##33##2##(1992-2#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#2)(1996-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-9#2)(2012-3#1)
a cost-benefit##3##2##(1991-12#1)(1994-11#1)(1995-3#1)
a cost-effective alternative to##3##4##(1991-1#1)(1993-3#1)(2008-10#1)
a cost-effective and##4##3##(1993-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
a cost-effective method##3##3##(1994-3#2)(2008-10#1)
a cost-effective way##3##3##(1995-2#1)(1997-7#1)(2008-3#1)
a cost-effective##27##2##(1991-1#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-3#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-6#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
a cost-utility analysis##2##3##(2007-8#2)
a costly##2##2##(1991-12#1)(2008-9#1)
a cotton##2##2##(2008-10#1)(2008-9#1)
a coulometric##2##2##(2008-10#2)
a counter anion##2##3##(2008-10#2)
a counter##5##2##(2008-10#4)(2008-5#1)
a counterintuitive##2##2##(2007-11#1)(2008-8#1)
a counterpropagating quasi-phase-matched device##2##4##(2008-2#2)
a counterpropagating quasi-phase-matched##3##3##(2007-12#1)(2008-2#2)
a counterpropagating two-beam fiber-optic trap##2##5##(2008-2#2)
a counterpropagating##8##2##(2007-12#4)(2008-2#4)
a counting##4##2##(2008-7#1)(2009-8#1)(2013-8#2)
a country of##2##3##(1993-6#1)(2008-1#1)
a country were to initiate a biological weapons##2##8##(1992-12#2)
a country were##4##3##(1992-12#3)(2011-2#1)
a country where##3##3##(1997-6#1)(2008-10#1)(2013-8#1)
a country with##2##3##(2008-10#1)(2008-8#1)
a country##16##2##(1992-12#3)(1993-6#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
a county##5##2##(1990-11#1)(1991-3#2)(1996-9#1)(2008-12#1)
a couple of days##2##4##(1995-5#1)(2009-12#1)
a couple of years##2##4##(2007-2#1)(2007-4#1)
a couple of##10##3##(1995-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#2)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
a couple##11##2##(1994-7#1)(1995-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#2)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
a coupled##7##2##(1996-4#1)(2007-12#1)(2008-10#2)(2008-3#3)
a coupler##4##2##(2008-2#3)(2008-8#1)
a coupling efficiency of##4##4##(2007-11#1)(2008-3#2)(2009-9#1)
a coupling of##2##3##(1993-3#1)(1994-11#1)
a coupling##13##2##(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-9#2)
a course for##2##3##(1995-3#1)(2008-11#1)
a course in##4##3##(1993-6#1)(1995-1#2)(2008-12#1)
a course of##7##3##(1993-11#1)(1997-2#1)(2006-10#1)(2007-8#1)(2010-3#1)(2011-2#2)
a course##18##2##(1992-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-3#1)(1997-2#1)(2006-10#1)(2007-8#2)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#2)(2013-8#1)
a court##3##2##(1990-11#1)(1995-12#1)(2008-11#1)
a covalent##3##2##(1990-7#1)(1992-9#1)(1994-5#1)
a covalently attached##2##3##(1992-3#1)(2008-4#1)
a covalently##3##2##(1992-3#1)(2008-2#1)(2008-4#1)
a covariance##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
a covariate##4##2##(1994-8#1)(2009-12#1)(2012-1#1)(2013-8#1)
a cover crop##3##3##(2008-10#3)
a coverage factor k=2##2##4##(2008-10#2)
a covered stent##3##3##(2007-8#1)(2008-12#1)(2010-5#1)
a covered##4##2##(2007-8#1)(2008-10#1)(2008-12#1)(2010-5#1)
a coverslip##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
a cow##2##2##(1990-6#1)(1991-8#1)
a crack##5##2##(2008-2#3)(2009-4#1)(2009-6#1)
a cranial##2##2##(1996-3#1)(2007-12#1)
a craniotomy##2##2##(2012-3#1)(2013-1#1)
a craving for##2##3##(1997-5#1)(1997-6#1)
a cream##3##2##(2008-5#3)
a creatine##3##2##(1990-11#1)(2008-5#2)
a creative##3##2##(1992-2#1)(2008-10#1)(2008-12#1)
a crime##5##2##(1997-7#1)(2007-1#1)(2008-10#2)(2008-12#1)
a criminal##2##2##(1991-2#1)(1994-3#1)
a crisis##9##2##(1993-12#1)(1994-2#1)(1996-3#1)(2008-12#2)(2009-6#2)(2010-8#1)(2012-3#1)
a criterion for##5##3##(1991-9#1)(2008-3#2)(2008-8#1)(2013-7#1)
a criterion of##3##3##(1993-3#1)(1994-12#1)(2008-7#1)
a criterion##11##2##(1991-9#1)(1993-3#1)(1994-12#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2013-7#1)
a critical amino acid for##2##5##(2008-11#1)(2008-8#1)
a critical analysis of the##2##5##(2008-7#1)(2009-10#1)
a critical and##2##3##(1997-2#1)(2009-9#1)
a critical appraisal##2##3##(1995-1#1)(2008-11#1)
a critical approach##2##3##(2008-9#2)
a critical challenge##2##3##(1996-12#1)(2012-2#1)
a critical component in##2##4##(2008-10#1)(2009-3#1)
a critical component##5##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)
a critical degree of##2##4##(2007-12#1)(2008-7#1)
a critical developmental##2##3##(2012-3#1)(2013-1#1)
a critical evaluation of the##4##5##(1990-9#1)(1995-3#1)(2008-3#1)(2013-1#1)
a critical evaluation of##5##4##(1990-9#1)(1995-3#1)(2008-3#1)(2013-1#1)(2013-8#1)
a critical examination of##2##4##(1991-12#1)(2009-4#1)
a critical factor in##3##4##(1993-1#1)(2008-1#1)(2008-10#1)
a critical factor##7##3##(1993-1#1)(1994-2#1)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
a critical length##2##3##(2006-10#1)(2012-2#1)
a critical level##2##3##(2008-9#1)(2010-8#1)
a critical parameter in##2##4##(1991-2#1)(2008-5#1)
a critical parameter##4##3##(1991-2#1)(1997-4#1)(2008-5#1)(2010-7#1)
a critical part##2##3##(1991-12#1)(2009-6#1)
a critical pathway##5##3##(1995-12#1)(2008-3#4)
a critical process##2##3##(2008-1#1)(2013-8#1)
a critical review of the literature##3##6##(1996-12#1)(2008-11#1)(2012-3#1)
a critical review of the##5##5##(1993-3#1)(1996-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
a critical review of##12##4##(1992-3#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
a critical review##17##3##(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
a critical role for##2##4##(2008-9#1)(2010-11#1)
a critical role in mediating the##2##6##(1993-6#1)(2013-1#1)
a critical role in the expression of##2##7##(1992-8#1)(2008-11#1)
a critical role in the maintenance of##2##7##(2008-5#1)(2012-3#1)
a critical role in the regulation of##3##7##(1997-2#1)(2008-8#1)(2013-1#1)
a critical role in the##19##5##(1990-11#1)(1990-5#1)(1992-8#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
a critical role in##55##4##(1990-11#1)(1990-5#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#2)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)
a critical role##62##3##(1990-11#1)(1990-5#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-6#2)(2010-11#1)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)
a critical size##2##3##(1994-5#1)(2008-7#1)
a critical skill##2##3##(1992-2#1)(2008-12#1)
a critical step in the##3##5##(1995-8#1)(2008-10#1)(2008-9#1)
a critical step in##8##4##(1993-9#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2013-1#1)
a critical step##10##3##(1993-9#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2013-1#2)
a critical threshold##4##3##(1997-4#1)(2008-8#2)(2010-10#1)
a critical value##2##3##(2008-1#1)(2008-3#1)
a critical##252##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-12#4)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(2006-10#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-8#1)(2008-1#8)(2008-10#14)(2008-11#14)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#14)(2008-9#8)(2009-10#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#13)(2012-12#1)(2012-2#12)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#3)
a critically##4##2##(1994-5#1)(2007-8#1)(2010-8#1)(2012-12#1)
a critique of##2##3##(2008-1#1)(2008-3#1)
a crop##4##2##(2008-10#3)(2008-11#1)
a cropping##2##2##(2008-10#2)
a cross between a##5##4##(2008-10#4)(2012-3#1)
a cross between cv##2##4##(2008-10#2)
a cross between the##9##4##(2008-10#9)
a cross between##34##3##(2008-10#27)(2008-4#1)(2008-5#2)(2008-9#2)(2012-3#2)
a cross of##6##3##(2008-10#6)
a cross section of the##2##5##(1997-3#1)(2008-3#1)
a cross sectional study in##2##5##(1990-6#1)(2008-12#1)
a cross sectional study##6##4##(1990-6#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-12#1)
a cross sectional##9##3##(1990-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-2#1)(2012-12#1)(2013-8#1)
a cross was made between##2##5##(2008-10#2)
a cross##58##2##(1990-6#1)(1997-3#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
a cross-correlation##3##2##(2008-2#2)(2008-3#1)
a cross-cultural##3##2##(2007-12#1)(2008-1#1)(2010-2#1)
a cross-disciplinary##2##2##(2008-11#1)(2013-8#1)
a cross-linked##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
a cross-linker##3##2##(1990-8#1)(2008-10#1)(2010-4#1)
a cross-linking agent##3##3##(2008-10#3)
a cross-linking##4##2##(2008-10#3)(2008-4#1)
a cross-national##2##2##(1996-2#1)(2008-3#1)
a cross-section of##2##3##(1997-3#1)(2008-7#1)
a cross-section##3##2##(1997-3#1)(2008-7#1)(2011-1#1)
a cross-sectional sample##2##3##(1994-11#1)(2010-3#1)
a cross-sectional study in##2##4##(2008-3#1)(2009-2#1)
a cross-sectional study of##4##4##(1996-1#1)(1996-2#1)(2008-7#1)(2011-2#1)
a cross-sectional study to##2##4##(2010-4#1)(2011-2#1)
a cross-sectional study was##2##4##(2008-12#1)(2009-5#1)
a cross-sectional study##24##3##(1996-1#1)(1996-2#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-1#1)(2013-8#1)
a cross-sectional survey##5##3##(1994-11#1)(2008-11#2)(2008-9#2)
a cross-sectional##45##2##(1994-11#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-4#1)(2011-1#2)(2011-2#7)(2012-12#3)(2013-1#3)(2013-8#3)
a cross-talk##2##2##(1994-12#1)(2008-2#1)
a crosslink##2##2##(2008-10#1)(2010-11#1)
a crosslinked##5##2##(2008-10#3)(2008-11#1)(2010-6#1)
a crossover study##3##3##(2007-7#1)(2008-1#1)(2008-7#1)
a crossover##8##2##(1993-11#1)(1996-2#1)(2007-7#2)(2008-1#2)(2008-3#1)(2008-7#1)
a crossroads##2##2##(1996-3#1)(1997-6#1)
a crosstalk between##3##3##(2011-2#1)(2012-2#2)
a crosstalk##5##2##(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#2)
a crucial component of##2##4##(2007-8#1)(2009-9#1)
a crucial component##3##3##(1994-3#1)(2007-8#1)(2009-9#1)
a crucial decision##2##3##(2013-1#2)
a crucial determinant of##2##4##(2008-5#1)(2013-7#1)
a crucial factor in##3##4##(2008-12#1)(2008-3#1)(2009-12#1)
a crucial factor##6##3##(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2012-3#1)
a crucial parameter##2##3##(2008-7#1)(2008-8#1)
a crucial part of##5##4##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
a crucial role for##3##4##(1994-3#1)(2008-4#1)(2013-8#1)
a crucial role in maintaining##2##5##(2008-7#1)(2012-2#1)
a crucial role in the control of##2##7##(1994-10#1)(2008-7#1)
a crucial role in the development of##2##7##(2008-6#1)(2013-1#1)
a crucial role in the pathogenesis of##3##7##(2008-1#1)(2011-2#2)
a crucial role in the##15##5##(1994-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
a crucial role in##41##4##(1993-8#1)(1994-10#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a crucial role##49##3##(1992-10#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
a crucial##91##2##(1990-12#1)(1991-12#1)(1992-10#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-3#2)(1995-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
a cruciform##2##2##(1997-3#2)
a crude extract of##2##4##(2008-10#2)
a crude oil##2##3##(2008-10#1)(2008-6#1)
a crude##15##2##(1992-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#2)(2012-2#1)
a crush##2##2##(2008-12#1)(2012-7#1)
a crushed##2##2##(2008-10#2)
a crustacean##2##2##(2008-5#1)(2011-2#1)
a cryogenic##3##2##(2008-10#3)
a cryptic##2##2##(1991-2#2)
a crystal with##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
a crystal##19##2##(1996-2#1)(2007-11#6)(2007-12#4)(2008-2#3)(2008-3#3)(2008-9#1)(2013-8#1)
a crystalline##8##2##(1990-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-12#1)(2010-12#1)
a crystallized glass substrate##2##4##(2007-11#2)
a crystallographic##5##2##(1991-12#1)(1992-4#1)(1993-8#1)(1996-2#1)(1997-4#1)
a cubic##7##2##(1995-2#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)
a cue##4##2##(1993-5#1)(1995-5#2)(2009-9#1)
a cueing##2##2##(2008-2#2)
a cuff##3##2##(1991-12#2)(2007-8#1)
a cultivar##3##2##(2008-10#3)
a cultivated##3##2##(2008-11#1)(2013-8#2)
a cultural##4##2##(2007-2#1)(2008-11#1)(2010-8#1)(2012-2#1)
a culturally diverse##2##3##(1997-2#1)(2008-7#1)
a culturally##4##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)
a culture of##8##3##(1990-11#1)(1991-8#1)(1995-1#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-8#1)
a culture system##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
a culture##27##2##(1990-11#1)(1991-8#1)(1995-1#2)(1995-3#1)(1996-7#1)(2008-10#3)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
a cumulative##12##2##(1994-5#1)(1994-9#1)(2007-10#1)(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
a curable##2##2##(1995-6#1)(2008-10#1)
a curative##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
a cure for##4##3##(1995-12#1)(2007-7#1)(2008-10#1)(2012-8#1)
a cure in##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
a cure##12##2##(1995-12#1)(1997-6#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-3#1)(2012-3#1)(2012-8#1)(2013-1#1)
a curing##2##2##(2008-10#1)(2010-4#1)
a current density of##2##4##(2007-12#1)(2008-10#1)
a current issue##2##3##(2008-10#1)(2008-12#1)
a current of##2##3##(2008-10#1)(2012-3#1)
a current perspective##2##3##(2008-7#1)(2008-9#1)
a current##26##2##(1991-8#1)(1992-6#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-12#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
a currently used##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
a currently##4##2##(2008-10#1)(2008-3#1)(2009-10#1)(2010-10#1)
a curriculum##7##2##(1993-1#2)(2007-12#1)(2008-1#1)(2008-12#3)
a curve##5##2##(1992-8#1)(2008-10#2)(2008-2#1)(2009-6#1)
a curve-fitting##2##2##(2008-3#2)
a curved##3##2##(2008-3#2)(2009-5#1)
a curvilinear##3##2##(1991-5#1)(1991-7#1)(2010-6#1)
a custom##10##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
a custom-built##2##2##(2008-10#2)
a custom-designed##2##2##(2009-9#1)(2010-5#1)
a custom-made##3##2##(2008-10#2)(2008-8#1)
a customer##2##2##(1992-3#1)(1996-3#1)
a customizable checklist##2##3##(2013-1#2)
a customizable##3##2##(2013-1#3)
a customized##5##2##(2008-10#1)(2008-5#2)(2010-4#1)(2013-8#1)
a cut##2##2##(1990-2#1)(2007-7#1)
a cut-off value of##3##4##(1992-11#1)(1996-12#1)(1997-3#1)
a cut-off value##4##3##(1992-11#1)(1996-12#1)(1997-3#2)
a cut-off##5##2##(1992-11#1)(1996-12#1)(1997-3#2)(2013-1#1)
a cutaneous myoepithelioma##2##3##(2013-8#2)
a cutaneous##11##2##(1990-7#1)(1990-8#1)(2008-5#1)(2008-9#1)(2010-6#2)(2013-1#1)(2013-8#4)
a cuticle##3##2##(2007-12#2)(2008-7#1)
a cuticular col##2##3##(1994-12#2)
a cuticular##4##2##(1994-12#3)(2007-12#1)
a cutoff point of##3##4##(2012-12#1)(2012-2#2)
a cutoff value of procalcitonin##2##5##(2013-1#2)
a cutoff value##3##3##(1994-11#1)(2013-1#2)
a cutoff##11##2##(1992-6#2)(1994-11#1)(2006-10#1)(2008-3#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
a cw Ti##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
a cw argon-ion laser##2##4##(2007-11#1)(2007-12#1)
a cw laser##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
a cw optical parametric oscillator##2##5##(2007-12#2)
a cw##38##2##(2007-11#6)(2007-12#15)(2008-2#10)(2008-3#7)
a cyanobacterial##2##2##(1994-6#2)
a cyanobacterium##4##2##(1995-6#1)(1997-6#1)(2008-8#2)
a cycle of##6##3##(1992-3#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-7#2)
a cycle##10##2##(1992-3#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#3)
a cyclic##11##2##(1990-8#1)(1992-4#1)(1993-6#1)(1995-11#1)(1995-9#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-4#1)
a cycling##2##2##(2008-10#1)(2013-8#1)
a cyclobutane pyrimidine dimer##2##4##(1994-8#2)
a cyclooxygenase inhibitor##2##3##(1997-1#1)(2008-10#1)
a cylinder with a##2##4##(2007-12#1)(2008-2#1)
a cylinder with##4##3##(2007-12#1)(2008-2#3)
a cylinder##7##2##(1991-12#1)(2007-12#1)(2008-2#4)(2008-3#1)
a cylindrical impactor in the spray chamber##2##7##(2008-10#2)
a cylindrical lens##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
a cylindrical optical##2##3##(2007-12#1)(2008-7#1)
a cylindrical##27##2##(2007-11#3)(2007-12#6)(2008-10#4)(2008-2#5)(2008-3#7)(2008-7#1)(2010-7#1)
a cyst in the right##2##5##(2008-12#1)(2011-2#1)
a cyst in the##3##4##(2008-12#1)(2010-12#1)(2011-2#1)
a cyst##6##2##(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
a cysteine residue##3##3##(1990-12#1)(1993-11#1)(1995-6#1)
a cysteine##9##2##(1990-12#1)(1990-2#1)(1992-9#1)(1993-11#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)
a cysteine-rich##7##2##(1990-5#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-6#1)(1997-7#1)
a cystic##6##2##(1992-2#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
a cytochrome P450##2##3##(1992-8#1)(1994-5#1)
a cytogenetic##2##2##(1991-4#1)(2008-11#1)
a cytokine##6##2##(1993-3#1)(1993-8#1)(1994-11#1)(1995-6#1)(2009-7#2)
a cytological##2##2##(1997-2#1)(2008-7#1)
a cytoplasmic isoform##2##3##(1994-11#2)
a cytoplasmic male##2##3##(1996-10#1)(2008-9#1)
a cytoplasmic##18##2##(1991-12#1)(1991-5#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-11#3)(1996-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#2)
a cytoskeletal protein##3##3##(1995-12#2)(1996-10#1)
a cytoskeletal##6##2##(1990-8#1)(1992-11#1)(1995-11#1)(1995-12#2)(1996-10#1)
a cytosolic protein##2##3##(1992-3#1)(1993-8#1)
a cytosolic##7##2##(1992-3#2)(1993-8#1)(1996-2#1)(2009-10#1)(2010-5#1)(2013-1#1)
a cytotoxic effect##2##3##(1992-8#1)(2008-10#1)
a cytotoxic##8##2##(1992-11#2)(1992-8#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
a daily basis##9##3##(1991-12#1)(1993-9#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)
a daily dose of##3##4##(1990-11#1)(1990-2#1)(2008-10#1)
a daily##28##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2006-12#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-1#3)
a dairy##2##2##(1991-8#1)(1996-12#1)
a dam##2##2##(1990-5#2)
a damage##4##2##(1990-2#1)(2008-2#1)(2008-3#1)(2013-8#1)
a damaged##3##2##(2008-3#1)(2008-6#1)(2010-3#1)
a damaging disease of##3##4##(2008-10#2)(2010-1#1)
a dampening of##2##3##(1992-2#1)(2008-2#1)
a damper##2##2##(1997-3#1)(2008-11#1)
a dangerous##4##2##(1990-6#1)(1992-5#1)(1997-5#1)(2013-1#1)
a dark brown##2##3##(2008-1#1)(2008-10#1)
a dark circle##2##3##(2008-3#2)
a dark##17##2##(1991-12#1)(1991-5#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#1)(2013-7#1)
a data base##3##3##(1993-12#1)(1993-2#1)(1994-2#1)
a data collection##4##3##(1993-3#1)(1995-2#1)(2008-3#1)(2013-1#1)
a data set from##2##4##(1997-4#1)(2008-3#1)
a data set in##2##4##(1997-3#1)(2008-1#1)
a data set##10##3##(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)
a data##29##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
a data-driven##5##2##(1994-2#1)(2008-1#1)(2010-10#1)(2011-8#1)(2013-8#1)
a database for##2##3##(1992-4#1)(1995-12#1)
a database of##10##3##(1992-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-7#1)(2010-8#1)(2013-1#1)
a database system##2##3##(2008-10#1)(2008-7#1)
a database##30##2##(1992-3#3)(1992-4#1)(1994-12#1)(1995-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#3)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
a dataset of##2##3##(2013-1#1)(2013-8#1)
a dataset##5##2##(2008-12#1)(2008-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
a daunting challenge to##2##4##(1995-3#1)(2011-2#1)
a daunting##4##2##(1995-3#1)(2008-9#1)(2011-2#2)
a day and##3##3##(1994-3#1)(2007-12#1)(2008-5#1)
a day care center##2##4##(1992-1#1)(1995-5#1)
a day care##5##3##(1992-1#1)(1994-6#1)(1995-5#1)(1995-6#2)
a day for##8##3##(1990-9#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-5#2)(2009-3#1)(2013-1#1)
a day in##2##3##(2007-11#1)(2012-12#1)
a day of##4##3##(1997-2#1)(2008-12#2)(2013-7#1)
a day##56##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#4)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
a day)##4##2##(1992-11#1)(1995-5#1)(2010-6#1)(2011-1#1)
a dc##6##2##(2007-11#3)(2008-2#2)(2008-3#1)
a ddI- and/or d4T-containing antiretroviral drug regimen##3##7##(2008-11#3)
a de novo mutation##2##4##(1991-12#1)(1994-11#1)
a de novo##5##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-12#1)(2012-12#1)
a deadly##4##2##(1990-6#1)(2007-5#1)(2010-10#1)(2010-5#1)
a dearth of##9##3##(1992-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-3#1)
a death response##2##3##(2008-7#2)
a death##3##2##(2008-4#1)(2008-7#2)
a debate in the##2##4##(1995-11#1)(1995-2#1)
a debate on##2##3##(2008-8#1)(2012-2#1)
a debate##9##2##(1995-11#1)(1995-2#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-8#1)(2012-2#2)(2013-1#1)
a decade ago##4##3##(1992-3#1)(2009-3#1)(2012-2#2)
a decade of research##2##4##(2007-12#1)(2013-1#1)
a decade of##7##3##(1993-1#1)(1994-1#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
a decade since the##3##4##(2008-5#1)(2010-4#1)(2012-12#1)
a decade##33##2##(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#3)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-3#1)(2009-5#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
a decapeptide##2##2##(1992-11#1)(2008-4#1)
a decay##2##2##(2008-10#2)
a deceased##2##2##(2011-1#1)(2011-2#1)
a decentralized##6##2##(1992-1#1)(1994-1#2)(1994-12#1)(2008-10#1)(2013-1#1)
a deceptive##2##2##(2008-9#1)(2011-2#1)
a decision based##2##3##(2008-11#1)(2008-7#1)
a decision by##3##3##(1994-1#2)(1997-5#1)
a decision is##2##3##(1996-6#1)(2012-2#1)
a decision support##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
a decision was made##2##4##(2008-9#1)(2013-1#1)
a decision##27##2##(1994-1#2)(1994-3#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#3)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
a decision-making##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
a decisive factor in the##3##5##(2008-1#1)(2011-2#1)(2013-1#1)
a decisive factor in##4##4##(2008-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
a decisive factor##6##3##(2008-1#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#2)
a decisive role in the##2##5##(2008-10#2)
a decisive role in##4##4##(2008-10#2)(2008-4#1)(2012-2#1)
a decisive##12##2##(1990-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
a decline in susceptibility##2##4##(2008-10#1)(2008-7#1)
a decline in the##5##4##(1991-7#1)(1996-12#1)(1997-2#1)(2007-2#1)(2008-9#1)
a decline in##22##3##(1990-12#1)(1991-7#1)(1992-12#1)(1993-12#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-7#3)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2012-3#1)(2013-1#3)
a decline of##4##3##(1994-12#1)(1995-5#1)(2008-7#1)(2009-12#1)
a decline##32##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-4#1)(2012-3#1)(2013-1#3)
a declining##4##2##(1991-12#1)(1993-2#1)(2012-3#1)(2013-1#1)
a decomposable graph##2##3##(2010-2#2)
a decomposition##2##2##(2008-10#1)(2008-8#1)
a decompressive##2##2##(2006-7#1)(2012-3#1)
a deconvolution##3##2##(2008-10#1)(2008-3#2)
a decoy##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
a decrease in activity##2##4##(2008-10#1)(2008-5#1)
a decrease in body##2##4##(1992-12#1)(2013-8#1)
a decrease in both the##2##5##(2008-4#1)(2008-6#1)
a decrease in cell##3##4##(1993-8#1)(2008-11#2)
a decrease in its##2##4##(1995-12#1)(1995-2#1)
a decrease in length of##2##5##(1995-12#1)(2013-1#1)
a decrease in pain##2##4##(1994-3#1)(2007-11#1)
a decrease in physical##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
a decrease in protein##3##4##(2008-8#1)(2011-2#2)
a decrease in pulmonary##2##4##(1991-6#1)(2008-12#1)
a decrease in the amount of##2##6##(2008-10#1)(2008-5#1)
a decrease in the apparent##2##5##(1997-2#1)(2008-7#1)
a decrease in the enzyme activity##2##6##(1994-8#1)(2008-10#1)
a decrease in the level of##2##6##(1991-9#1)(2009-8#1)
a decrease in the number of##7##6##(1993-8#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
a decrease in the percentage of residents##2##7##(2011-2#2)
a decrease in the percentage of##4##6##(1991-5#1)(2008-10#1)(2011-2#2)
a decrease in the water content##2##6##(2008-10#1)(2008-5#1)
a decrease in the water##3##5##(2008-10#1)(2008-5#1)(2013-7#1)
a decrease in the##86##4##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
a decrease in their##3##4##(2009-11#1)(2012-3#1)(2013-8#1)
a decrease in total##2##4##(2008-11#1)(2009-8#1)
a decrease in##230##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#3)(1990-8#1)(1991-12#2)(1991-2#5)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#3)(1994-8#4)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#6)(2008-7#10)(2008-8#6)(2008-9#2)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#4)(2013-8#5)
a decrease of WBI in##2##5##(2008-1#2)
a decrease of more than##2##5##(2008-7#1)(2008-8#1)
a decrease of the mean velocity##2##6##(1993-12#2)
a decrease of the##13##4##(1990-12#1)(1993-12#3)(1994-5#1)(1996-6#2)(2008-10#5)(2008-3#1)
a decrease of viability##2##4##(2008-11#2)
a decrease of##43##3##(1990-12#1)(1990-3#1)(1992-8#1)(1992-9#1)(1993-12#3)(1994-5#1)(1994-8#2)(1996-6#2)(2008-1#4)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a decrease on the##3##4##(2008-10#1)(2008-5#2)
a decrease on##4##3##(2008-10#1)(2008-5#2)(2011-1#1)
a decrease or##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
a decrease##291##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#6)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#6)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#5)(2008-10#48)(2008-11#12)(2008-12#5)(2008-2#3)(2008-3#11)(2008-4#4)(2008-5#17)(2008-6#8)(2008-7#15)(2008-8#7)(2008-9#2)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#12)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#4)(2013-8#6)
a decreased K+ conductance##2##4##(1990-7#2)
a decreased level of##2##4##(1990-12#1)(1992-9#1)
a decreased likelihood of##4##4##(2010-11#1)(2011-2#1)(2013-1#2)
a decreased maternal age effect##2##5##(1997-3#2)
a decreased number of##3##4##(1996-2#1)(2008-1#1)(2008-11#1)
a decreased response to##3##4##(1990-11#1)(2008-11#2)
a decreased risk of##4##4##(1996-9#1)(2010-1#1)(2011-2#1)(2013-7#1)
a decreased risk##6##3##(1993-12#1)(1996-9#1)(2007-4#1)(2010-1#1)(2011-2#1)(2013-7#1)
a decreased##63##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-4#1)(2008-1#4)(2008-10#5)(2008-11#7)(2008-5#2)(2008-9#1)(2009-12#2)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-7#2)
a decreasing##8##2##(1994-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-4#1)
a dedicated##12##2##(1993-3#1)(1994-1#2)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-8#1)
a deduced protein##2##3##(1997-9#1)(2008-8#1)
a deduced##6##2##(1990-11#1)(1994-12#1)(1997-9#1)(2008-10#1)(2008-8#2)
a deductive##2##2##(1994-5#1)(1997-9#1)
a deep##18##2##(1990-8#1)(1991-5#1)(1992-12#1)(1993-9#1)(1995-12#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-3#1)(2011-2#3)(2013-1#1)
a deeper insight##3##3##(1993-8#1)(2008-10#1)(2012-1#1)
a deeper understanding of how##3##5##(2008-11#1)(2010-9#1)(2012-12#1)
a deeper understanding of the##4##5##(2008-11#1)(2008-8#1)(2010-11#1)(2013-1#1)
a deeper understanding of##9##4##(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
a deeper##21##2##(1993-8#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a deeply rooted##2##3##(1995-5#1)(2008-10#1)
a deeply##3##2##(1995-5#1)(2007-11#1)(2008-10#1)
a defect in the##10##4##(1990-5#2)(1994-11#2)(2008-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
a defect in##19##3##(1990-5#2)(1994-11#2)(1994-12#1)(1995-2#2)(1996-9#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
a defect of a##2##4##(2013-1#2)
a defect of##3##3##(1995-6#1)(2013-1#2)
a defect##25##2##(1990-5#2)(1994-11#2)(1994-12#1)(1995-2#2)(1995-6#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
a defective##17##2##(1991-9#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
a defense response##2##3##(2008-10#2)
a defense##8##2##(1993-12#1)(1996-5#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#1)
a defensive##2##2##(1992-12#1)(2012-12#1)
a deficiency in the##4##4##(1993-3#1)(1996-8#1)(2008-9#1)(2013-1#1)
a deficiency in##8##3##(1993-3#1)(1994-11#1)(1996-12#1)(1996-8#1)(2008-9#1)(2013-1#3)
a deficiency of##8##3##(1990-8#1)(1991-7#2)(2007-7#1)(2009-5#1)(2010-6#1)(2011-2#2)
a deficiency##19##2##(1990-8#1)(1991-7#2)(1993-3#1)(1994-11#1)(1996-12#1)(1996-8#1)(2007-7#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#3)
a deficient##3##2##(1990-8#1)(2008-4#1)(2011-1#1)
a deficit in##5##3##(1997-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2012-1#1)
a deficit of##2##3##(1990-3#1)(2009-2#1)
a deficit##9##2##(1990-3#1)(1993-12#1)(1997-8#1)(2008-9#1)(2009-2#2)(2009-8#1)(2012-1#2)
a defined and##2##3##(2012-12#1)(2012-2#1)
a defined population##4##3##(1991-1#1)(1991-12#1)(1995-1#1)(1996-12#1)
a defined state##2##3##(2008-11#1)(2008-3#1)
a defined##38##2##(1990-8#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
a definite diagnosis##2##3##(2008-12#1)(2008-9#1)
a definite##19##2##(1990-10#1)(1994-8#1)(1995-3#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-9#1)(2012-2#1)(2013-8#1)
a definition of the##4##4##(1996-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
a definition of##9##3##(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
a definition##14##2##(1996-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
a definitive diagnosis of##2##4##(1997-3#1)(1997-8#1)
a definitive diagnosis was##2##4##(1993-6#1)(2011-2#1)
a definitive diagnosis##9##3##(1993-6#1)(1993-8#1)(1997-3#1)(1997-8#3)(2008-1#1)(2011-2#1)(2012-3#1)
a definitive##20##2##(1991-8#2)(1993-6#1)(1993-8#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-8#3)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a deflection##2##2##(2008-2#2)
a defocused##2##2##(2008-2#1)(2008-3#1)
a deformable mirror in##2##4##(2007-11#2)
a deformable mirror##11##3##(2007-11#3)(2008-2#5)(2008-3#3)
a deformable model##2##3##(2009-12#1)(2012-3#1)
a deformable##14##2##(2007-11#3)(2008-2#6)(2008-3#3)(2009-12#1)(2012-3#1)
a deformation of the##2##4##(2007-12#1)(2008-3#1)
a deformation##3##2##(1996-5#1)(2007-12#1)(2008-3#1)
a deformed##4##2##(1996-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
a degenerate four-wave mixing##2##4##(2007-12#1)(2008-3#1)
a degenerate optical parametric##3##4##(2007-11#3)
a degenerate##8##2##(2007-11#4)(2007-12#2)(2008-10#1)(2008-3#1)
a degeneration##2##2##(2008-10#1)(2008-7#1)
a degradation##2##2##(1997-2#1)(2008-10#1)
a degree of##8##3##(1995-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#1)
a degree##12##2##(1991-2#1)(1992-1#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
a delay in the##5##4##(1993-11#1)(1994-6#1)(1996-5#1)(2008-10#1)(2013-8#1)
a delay in##19##3##(1990-12#1)(1993-11#1)(1994-6#1)(1996-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-8#1)
a delay of##7##3##(1991-3#1)(1996-6#1)(2007-7#1)(2008-6#1)(2010-6#1)(2010-8#1)(2012-6#1)
a delay##38##2##(1990-12#1)(1991-3#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-6#1)(2012-7#1)(2013-8#1)
a delayed and prolonged##2##4##(1995-12#1)(2013-8#1)
a delayed and##3##3##(1990-2#1)(1995-12#1)(2013-8#1)
a delayed non-matching to position task##2##6##(1992-11#1)(1994-3#1)
a delayed rectifier##3##3##(1993-3#1)(1996-5#1)(2009-12#1)
a delayed##32##2##(1990-2#1)(1990-7#1)(1991-6#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-5#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
a deleterious##3##2##(1992-9#1)(1997-5#1)(2008-4#1)
a deletion in##3##3##(1991-2#1)(1993-12#1)(1997-3#1)
a deletion mutant of##2##4##(1994-5#1)(2008-8#1)
a deletion mutant##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
a deletion of the##2##4##(1996-6#1)(2008-10#1)
a deletion of##6##3##(1996-6#1)(2008-10#3)(2008-9#1)(2011-1#1)
a deletion##18##2##(1991-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1996-6#1)(1997-3#3)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
a deliberate##2##2##(2008-7#1)(2011-2#1)
a delivery##2##2##(2008-7#1)(2011-2#1)
a delta##6##2##(1991-8#1)(1995-3#1)(1995-6#1)(1996-2#2)(2008-2#1)
a demand for##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
a demand##7##2##(1992-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-3#1)
a demanding##4##2##(1991-2#1)(2008-3#1)(2008-9#2)
a demographic##6##2##(2008-12#2)(2008-8#1)(2008-9#1)(2010-8#2)
a demonstrable##3##2##(1994-12#1)(1995-2#1)(2008-5#1)
a demonstrated##5##2##(1993-2#1)(1996-3#1)(2007-11#2)(2008-3#1)
a demonstration of the##4##4##(1996-1#1)(2008-3#2)(2011-2#1)
a demonstration of##8##3##(1996-1#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
a demonstration##13##2##(1995-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
a denaturation##3##2##(1994-11#1)(2008-10#1)(2008-3#1)
a denaturing##3##2##(1997-4#1)(2008-1#1)(2008-4#1)
a dendrimer##2##2##(2010-5#1)(2010-8#1)
a dendrite##2##2##(2007-12#1)(2012-2#1)
a dendrogram##3##2##(2008-10#2)(2008-5#1)
a denervated##2##2##(2008-8#1)(2008-9#1)
a dense network##3##3##(2008-1#1)(2008-9#1)(2011-1#1)
a dense##17##2##(1996-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#1)
a density of##5##3##(1994-8#1)(2007-5#1)(2008-10#1)(2008-11#2)
a density##8##2##(1994-8#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)
a density-dependent##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
a dental home##2##3##(2011-2#2)
a dental office##2##3##(1994-12#1)(2008-4#1)
a dental##13##2##(1994-12#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-5#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
a dentist##4##2##(1993-12#1)(1995-6#1)(1996-2#1)(2012-2#1)
a department of pulmonary medicine##3##5##(1992-11#1)(1995-2#1)(1997-4#1)
a department of##6##3##(1991-11#2)(1992-11#1)(1995-2#2)(1997-4#1)
a department##7##2##(1991-11#2)(1992-11#1)(1995-2#2)(1997-4#1)(2009-11#1)
a departmental portfolio##3##3##(2008-12#3)
a departmental##6##2##(1991-12#1)(1992-3#1)(1993-2#1)(2008-12#3)
a departure from##3##3##(2008-10#2)(2008-7#1)
a dependence of##2##3##(2007-11#1)(2008-5#1)
a dependence##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
a dependent virus##2##3##(2008-10#2)
a dependent##4##2##(2008-10#2)(2010-2#1)(2010-8#1)
a depolarization##2##2##(1995-3#1)(2008-7#1)
a deposition##2##2##(2008-2#1)(2008-7#1)
a depression of##2##3##(2008-3#1)(2013-1#1)
a depression##6##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
a depressive##3##2##(2008-1#1)(2008-9#1)(2010-5#1)
a depth of approximately##2##4##(2007-12#1)(2008-3#1)
a depth of##14##3##(1990-11#1)(1993-1#1)(1996-2#1)(1996-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2013-7#1)
a depth range##2##3##(2008-3#1)(2008-5#1)
a depth##27##2##(1990-11#1)(1993-1#1)(1996-2#1)(1996-4#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-3#8)(2008-5#2)(2009-2#1)(2011-1#1)(2011-2#2)(2013-7#1)
a dequeened colony##2##3##(2008-6#2)
a derivative of a##2##4##(2008-11#1)(2011-1#1)
a derivative of##10##3##(1990-5#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-1#1)
a derivative##19##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-2#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-3#1)
a derivatization##3##2##(2008-10#2)(2011-1#1)
a derived##3##2##(1991-1#1)(1996-1#1)(2008-8#1)
a dermal##3##2##(2008-5#3)
a dermatological##2##2##(1991-12#1)(2008-5#1)
a dermoid cyst##3##3##(2009-7#1)(2011-2#2)
a description and##2##3##(1996-2#1)(2008-3#1)
a description of a##3##4##(1995-3#1)(2008-7#1)(2008-9#1)
a description of the##23##4##(1990-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
a description of##48##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1993-12#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
a description##51##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-12#1)(1993-12#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
a descriptive analysis of##2##4##(2008-8#1)(2012-12#1)
a descriptive analysis##4##3##(1996-1#1)(2008-2#1)(2008-8#1)(2012-12#1)
a descriptive correlational##2##3##(2010-10#1)(2012-3#1)
a descriptive cross-sectional study##2##4##(2010-9#1)(2013-1#1)
a descriptive cross-sectional##3##3##(2008-4#1)(2010-9#1)(2013-1#1)
a descriptive study of##2##4##(1994-6#1)(2012-12#1)
a descriptive study##6##3##(1994-6#1)(2010-6#1)(2012-12#2)(2013-1#2)
a descriptive##31##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-1#1)(1994-6#1)(1996-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#2)(2009-8#1)(2010-10#3)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#5)(2012-3#3)(2013-1#4)
a desensitization of##2##3##(1994-5#1)(1995-12#1)
a design and##2##3##(1996-12#1)(2008-3#1)
a design##20##2##(1992-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#7)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
a desirable spectral##2##3##(2007-12#1)(2008-10#1)
a desirable##9##2##(1992-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
a desire to##6##3##(1993-12#1)(2008-6#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
a desire##8##2##(1993-12#1)(1996-2#1)(2008-6#1)(2009-4#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
a desired level of##2##4##(1992-9#1)(2008-10#1)
a desired##20##2##(1992-9#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#4)(2012-2#2)
a destabilizing effect on##2##4##(1993-8#1)(2008-8#1)
a destruction of##2##3##(2008-10#1)(2010-12#1)
a destructive disease of##6##4##(2008-10#6)
a destructive disease##8##3##(2008-10#8)
a destructive##10##2##(2008-10#8)(2013-1#1)(2013-8#1)
a detached##2##2##(2008-10#2)
a detailed account of the##2##5##(1992-2#1)(2009-12#1)
a detailed account##3##3##(1992-2#1)(2008-3#1)(2009-12#1)
a detailed analysis of the##5##5##(1992-6#1)(2008-3#4)
a detailed analysis of##9##4##(1992-6#1)(1994-1#1)(2008-3#6)(2010-1#1)
a detailed and##2##3##(2011-2#1)(2013-8#1)
a detailed assessment of##2##4##(2007-11#1)(2008-10#1)
a detailed comparison between##2##4##(1994-5#1)(2008-2#1)
a detailed comparison of##2##4##(1990-11#1)(2007-12#1)
a detailed comparison##5##3##(1990-11#1)(1991-6#1)(1994-5#1)(2007-12#1)(2008-2#1)
a detailed description of a##2##5##(1996-1#1)(2011-1#1)
a detailed description of the##5##5##(1994-11#1)(1996-6#1)(2007-8#1)(2008-3#1)(2008-5#1)
a detailed description of##10##4##(1994-11#1)(1996-1#1)(1996-6#1)(2007-8#1)(2008-3#3)(2008-5#1)(2010-3#1)(2011-1#1)
a detailed discussion of##2##4##(2008-2#1)(2008-9#1)
a detailed evaluation##2##3##(1995-6#1)(2011-2#1)
a detailed experimental investigation##2##4##(2008-2#1)(2008-3#1)
a detailed experimental study##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
a detailed experimental##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
a detailed history##2##3##(2008-4#1)(2009-12#1)
a detailed knowledge of##2##4##(2008-6#1)(2012-2#1)
a detailed knowledge##3##3##(2007-11#1)(2008-6#1)(2012-2#1)
a detailed medical##2##3##(2008-7#1)(2011-2#1)
a detailed model##2##3##(2009-12#1)(2010-10#1)
a detailed physical map of the region##2##7##(1997-8#2)
a detailed physical map of the##3##6##(1997-8#2)(2008-8#1)
a detailed physical##5##3##(1990-6#1)(1997-8#2)(2008-8#1)(2010-4#1)
a detailed protocol##4##3##(2008-1#1)(2008-11#1)(2008-4#1)(2012-3#1)
a detailed review of##3##4##(2007-11#1)(2010-5#1)(2010-8#1)
a detailed review##4##3##(2007-11#1)(2008-9#1)(2010-5#1)(2010-8#1)
a detailed study of the##2##5##(1991-5#1)(2008-10#1)
a detailed study of##6##4##(1991-5#1)(2008-10#3)(2008-3#1)(2011-2#1)
a detailed study##10##3##(1991-12#1)(1991-5#1)(2007-7#1)(2008-10#3)(2008-3#3)(2011-2#1)
a detailed theory##2##3##(2007-11#1)(2008-2#1)
a detailed time##2##3##(2008-11#1)(2009-9#1)
a detailed treatment of##2##4##(1994-3#1)(1995-5#1)
a detailed understanding of the##2##5##(2008-10#1)(2009-7#1)
a detailed understanding of##6##4##(2007-12#1)(2008-10#1)(2008-7#2)(2009-12#1)(2009-7#1)
a detailed##131##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#2)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#5)(2008-3#24)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#9)(2009-11#1)(2009-12#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
a detectable signal##3##3##(2008-10#1)(2008-9#2)
a detectable##5##2##(1990-11#1)(2008-10#2)(2008-9#2)
a detection limit (3sigma) of 0##5##6##(2008-10#5)
a detection limit (3sigma) of##7##5##(2008-10#7)
a detection limit 2##2##4##(1993-8#1)(2008-10#1)
a detection limit for##4##4##(2008-10#2)(2008-2#2)
a detection limit of 0##74##5##(1992-11#1)(2007-12#1)(2008-10#69)(2008-11#1)(2008-2#1)(2010-4#1)
a detection limit of 1 pmol##2##6##(1991-5#1)(1996-5#1)
a detection limit of 1##39##5##(1991-5#1)(1996-5#1)(2008-10#36)(2008-2#1)
a detection limit of 10##3##5##(2008-10#2)(2008-11#1)
a detection limit of 10ppm##2##5##(2008-10#2)
a detection limit of 2##14##5##(2008-10#14)
a detection limit of 20##3##5##(2008-10#3)
a detection limit of 200##2##5##(2008-10#2)
a detection limit of 25##2##5##(2008-10#2)
a detection limit of 3##8##5##(2008-10#8)
a detection limit of 4##10##5##(2008-10#10)
a detection limit of 5##8##5##(2008-10#8)
a detection limit of 6##9##5##(2008-10#7)(2010-5#2)
a detection limit of 7##2##5##(2008-10#2)
a detection limit of 8##6##5##(2008-10#6)
a detection limit of 9##3##5##(2008-10#3)
a detection limit of##220##4##(1990-12#1)(1991-5#1)(1992-11#1)(1996-5#1)(2007-12#2)(2008-10#206)(2008-11#2)(2008-2#2)(2008-3#1)(2010-4#1)(2010-5#2)
a detection limit##258##3##(1990-12#1)(1991-5#1)(1992-11#1)(1993-8#1)(1996-5#1)(2007-12#3)(2008-10#238)(2008-11#2)(2008-2#4)(2008-3#2)(2010-4#1)(2010-5#2)(2012-1#1)
a detection of##4##3##(1997-7#1)(2008-10#3)
a detection range##2##3##(1992-12#1)(2008-10#1)
a detection sensitivity of##5##4##(2008-10#1)(2008-3#3)(2008-7#1)
a detection sensitivity##6##3##(2008-10#1)(2008-3#4)(2008-7#1)
a detection system##4##3##(2008-10#2)(2008-3#2)
a detection##284##2##(1990-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-8#1)(1993-9#1)(1996-5#1)(1997-4#2)(1997-7#1)(2007-12#3)(2008-10#246)(2008-11#2)(2008-2#5)(2008-3#11)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-5#2)(2012-1#1)
a detector array and some postprocessing##2##6##(2008-3#2)
a detector array and##4##4##(2007-11#2)(2008-3#2)
a detector array##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
a detector bin##2##3##(2012-1#2)
a detector in flow injection analysis for##2##7##(2008-10#2)
a detector in##3##3##(2008-10#3)
a detector##35##2##(2007-11#3)(2007-12#3)(2008-10#15)(2008-2#5)(2008-3#6)(2011-1#1)(2012-1#2)
a detergent##6##2##(1990-2#1)(1994-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
a deterioration in##3##3##(2008-7#2)(2009-12#1)
a deterioration of##2##3##(1991-8#1)(2008-6#1)
a deterioration##6##2##(1991-8#1)(2008-6#1)(2008-7#2)(2009-12#1)(2012-3#1)
a determinant of##6##3##(1990-8#1)(1997-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#1)
a determinant##8##2##(1990-8#1)(1991-9#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#1)
a determination in the presence of##2##6##(2008-10#2)
a determination of##3##3##(1996-9#1)(2008-10#2)
a determination##6##2##(1996-9#1)(2008-10#4)(2010-10#1)
a determining##2##2##(2012-2#1)(2013-1#1)
a deterministic##5##2##(2008-2#1)(2008-7#2)(2008-8#1)(2013-1#1)
a deterrent##2##2##(1994-5#1)(2008-10#1)
a detrimental effect on the##4##5##(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
a detrimental effect on##6##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
a detrimental effect##7##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-7#1)
a detrimental##12##2##(1996-12#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)(2012-7#1)
a deuterium##3##2##(1992-6#1)(2008-2#2)
a devastating complication##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
a devastating disease of##3##4##(2008-10#2)(2012-2#1)
a devastating disease##4##3##(2008-10#3)(2012-2#1)
a devastating injury that##2##4##(2008-9#2)
a devastating##12##2##(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
a developed##2##2##(2008-3#1)(2008-7#1)
a developing country##9##3##(1993-9#1)(1994-9#1)(2007-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
a developing##10##2##(1993-9#1)(1994-9#1)(2007-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
a development of a##2##4##(2008-10#2)
a development of##4##3##(2008-10#2)(2008-5#1)(2009-11#1)
a development##7##2##(1993-1#1)(1994-3#1)(2008-10#2)(2008-5#2)(2009-11#1)
a developmental disorder##2##3##(2008-3#1)(2009-4#1)
a developmental toxicity##2##3##(1997-4#1)(2010-1#1)
a developmental##17##2##(1991-5#1)(1992-12#1)(1993-12#2)(1997-4#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a developmentally regulated##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
a developmentally##5##2##(1993-3#1)(1993-6#1)(2008-11#2)(2012-3#1)
a deviation from##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
a deviation##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
a device for##5##3##(1991-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
a device that##3##3##(2008-2#1)(2008-3#2)
a device##23##2##(1991-3#1)(1994-6#1)(1994-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
a diabetes##4##2##(1993-3#1)(1997-8#1)(2010-11#1)(2013-1#1)
a diabetic patient##3##3##(2008-8#1)(2012-3#1)(2013-1#1)
a diabetic##8##2##(1994-12#3)(2008-8#2)(2009-3#1)(2012-3#1)(2013-1#1)
a diabetogenic##2##2##(1995-2#1)(2008-11#1)
a diafiltration technique##2##3##(2008-10#2)
a diagnosis based##2##3##(2008-10#1)(2008-7#1)
a diagnosis by##2##3##(2007-8#1)(2011-2#1)
a diagnosis in##2##3##(1996-11#1)(2007-11#1)
a diagnosis of MS##2##4##(2008-3#1)(2010-12#1)
a diagnosis of a##2##4##(1991-11#1)(2012-2#1)
a diagnosis of##64##3##(1991-11#3)(1991-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-8#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#3)(2008-9#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#5)
a diagnosis or##2##3##(2010-12#1)(2012-2#1)
a diagnosis##86##2##(1990-3#1)(1991-11#3)(1991-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-9#2)(2009-11#2)(2009-2#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#7)
a diagnostic accuracy##2##3##(1995-4#1)(2008-12#1)
a diagnostic algorithm for##2##4##(2008-10#1)(2008-4#1)
a diagnostic algorithm##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
a diagnostic and therapeutic strategy##2##5##(2012-2#2)
a diagnostic and therapeutic##3##4##(1992-6#1)(2012-2#2)
a diagnostic and##5##3##(1990-6#1)(1992-6#1)(2010-12#1)(2012-2#2)
a diagnostic challenge##5##3##(2008-7#1)(2009-10#1)(2011-2#1)(2011-3#1)(2013-1#1)
a diagnostic dilemma##4##3##(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
a diagnostic marker##2##3##(2008-10#1)(2013-8#1)
a diagnostic method##2##3##(1996-11#1)(2008-12#1)
a diagnostic technique##2##3##(2008-2#2)
a diagnostic test##4##3##(1995-3#1)(1996-8#1)(1997-3#1)(2008-4#1)
a diagnostic tool for##3##4##(2008-12#1)(2008-7#1)(2013-8#1)
a diagnostic tool in##5##4##(1991-12#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
a diagnostic tool##13##3##(1991-12#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
a diagnostic##78##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-1#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
a diagonal##2##2##(2007-12#1)(2008-3#1)
a dialogue on##2##3##(1997-3#1)(2011-3#1)
a dialogue with the patient##2##5##(2008-10#1)(2013-8#1)
a dialogue##6##2##(1997-3#1)(2008-10#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-8#1)
a dialyser##2##2##(2008-10#2)
a dialysis membrane##2##3##(2008-10#1)(2008-7#1)
a dialysis unit##2##3##(2008-10#1)(2008-4#1)
a dialysis##12##2##(1993-8#1)(1994-5#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#1)
a diameter of a few##3##5##(2008-10#1)(2008-3#1)(2012-1#1)
a diameter of##18##3##(1990-8#1)(1994-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
a diameter##25##2##(1990-8#1)(1994-2#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#2)(2013-1#1)(2013-8#1)
a diamine##2##2##(2008-10#2)
a diaphragm##2##2##(2008-10#1)(2008-3#1)
a diary##2##2##(2008-11#1)(2008-12#1)
a diastereoselective##2##2##(1996-5#2)
a diblock copolymer##2##3##(2008-10#1)(2008-12#1)
a diblock##3##2##(2008-10#1)(2008-12#2)
a dichotomous##2##2##(1997-8#1)(2012-3#1)
a dichroic##2##2##(2008-2#1)(2008-3#1)
a dicistronic expression##2##3##(2008-7#2)
a dicistronic##4##2##(1997-8#1)(2008-11#1)(2008-7#2)
a dictionary##2##2##(2012-12#2)
a didactic##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
a dielectric interface##2##3##(2007-11#1)(2008-3#1)
a dielectric layer##2##3##(2008-2#2)
a dielectric material##2##3##(2007-11#1)(2007-12#1)
a dielectric sphere##7##3##(2008-2#4)(2008-3#2)(2010-12#1)
a dielectric substrate##2##3##(2007-12#1)(2008-3#1)
a dielectric##28##2##(2007-11#4)(2007-12#6)(2008-11#1)(2008-2#7)(2008-3#9)(2010-12#1)
a diene##2##2##(1990-5#1)(2008-4#1)
a diet based on##3##4##(2008-12#3)
a diet containing##9##3##(1990-11#1)(1991-12#1)(1992-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#2)(2011-1#1)
a diet rich in##2##4##(1995-2#1)(2013-1#1)
a diet##25##2##(1990-11#1)(1991-11#1)(1991-12#1)(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-1#1)(2013-1#2)
a dietary supplement##3##3##(1992-9#1)(2008-10#2)
a dietary##9##2##(1992-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-11#1)(2009-4#1)(2011-2#1)
a dietitian##4##2##(1992-12#1)(1993-12#2)(1995-3#1)
a difference between the##7##4##(1990-6#1)(1991-4#1)(2008-3#3)(2008-7#1)(2009-7#1)
a difference between##8##3##(1990-6#1)(1991-4#1)(2008-3#3)(2008-7#1)(2009-7#1)(2010-11#1)
a difference in the##5##4##(1991-4#1)(1997-6#1)(2007-12#1)(2012-3#2)
a difference in##28##3##(1990-11#1)(1990-2#1)(1991-4#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#4)(2013-8#1)
a difference of less than##2##5##(2008-3#1)(2012-1#1)
a difference of##8##3##(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-3#1)(2012-1#1)
a difference or##2##3##(1995-5#2)
a difference plot##2##3##(1995-2#1)(2008-4#1)
a difference that##2##3##(2008-10#1)(2012-12#1)
a difference to##2##3##(1995-9#1)(2008-11#1)
a difference##73##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-4#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-7#1)(2013-8#1)
a difference?##3##2##(1991-12#1)(1997-3#1)(2013-1#1)
a different approach##5##3##(2008-11#2)(2008-3#1)(2008-7#1)(2012-3#1)
a different form##2##3##(2008-3#1)(2010-10#1)
a different gene##2##3##(1990-11#1)(1992-8#1)
a different genetic##2##3##(2008-10#2)
a different interpretation##3##3##(2007-12#1)(2008-6#1)(2012-12#1)
a different mechanism of##2##4##(1997-6#1)(2008-10#1)
a different mechanism##5##3##(1991-5#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-8#1)
a different mode##2##3##(1995-5#1)(2008-3#1)
a different model##2##3##(2008-10#1)(2010-4#1)
a different molecular pathway##2##4##(2009-12#1)(2012-1#1)
a different pattern was##2##4##(2008-10#1)(2008-11#1)
a different pattern##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2009-5#1)
a different perspective##4##3##(1996-3#1)(2008-3#1)(2008-8#1)(2013-1#1)
a different profile##2##3##(1993-1#1)(2008-10#1)
a different protein##2##3##(1992-12#1)(2008-2#1)
a different risk are related##2##5##(2008-10#2)
a different set of##4##4##(1992-2#1)(2008-9#1)(2010-6#1)(2013-1#1)
a different source##2##3##(2008-10#1)(2008-6#1)
a different species##4##3##(1992-11#1)(2008-10#2)(2008-4#1)
a different stimulus female##2##4##(1994-3#2)
a different time##2##3##(2008-11#1)(2009-5#1)
a different type of##4##4##(1995-6#1)(2008-1#1)(2009-12#1)(2012-2#1)
a different type##5##3##(1993-9#1)(1995-6#1)(2008-1#1)(2009-12#1)(2012-2#1)
a different vector##2##3##(2008-10#2)
a different way for##2##4##(2008-10#1)(2008-3#1)
a different way##3##3##(2008-10#2)(2008-3#1)
a different##209##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#18)(2008-4#8)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#6)(2009-12#3)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)
a differential absorption coefficient of##2##5##(2008-2#2)
a differential absorption lidar##2##4##(2007-12#1)(2008-3#1)
a differential absorption##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
a differential diagnosis for##2##4##(2007-7#1)(2011-2#1)
a differential diagnosis of##2##4##(2008-10#1)(2013-1#1)
a differential diagnosis##10##3##(1990-10#1)(1990-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
a differential equation##2##3##(2008-2#1)(2008-3#1)
a differential increase##2##3##(1990-12#1)(1993-3#1)
a differential response to##2##4##(2008-11#1)(2009-5#1)
a differential##53##2##(1990-10#1)(1990-12#1)(1990-6#1)(1992-11#1)(1992-12#1)(1993-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
a differentiated##4##2##(1991-10#1)(2008-4#1)(2008-8#2)
a differentiation##5##2##(1990-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
a difficult and##3##3##(1993-12#1)(1994-5#1)(2010-5#1)
a difficult clinical problem##2##4##(1994-11#1)(2007-11#1)
a difficult problem in##3##4##(2006-10#1)(2008-10#2)
a difficult problem##7##3##(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-6#1)
a difficult task##8##3##(1990-9#1)(1991-12#1)(1993-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
a difficult temperament##2##3##(1994-2#2)
a difficult##35##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-5#2)(2010-6#1)(2012-2#1)
a difficulty in##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
a diffraction efficiency of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a diffraction efficiency##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
a diffraction grating as a##2##5##(2007-12#2)
a diffraction grating to##2##4##(2007-11#2)
a diffraction grating##11##3##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#1)
a diffraction pattern##4##3##(2008-2#2)(2008-3#2)
a diffraction##23##2##(2007-11#4)(2007-12#9)(2008-2#5)(2008-3#5)
a diffraction-limited##5##2##(2007-12#2)(2008-3#3)
a diffractive element##2##3##(2008-3#2)
a diffractive lens##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a diffractive optical element##10##4##(2007-12#2)(2008-3#8)
a diffractive optical##13##3##(2007-12#2)(2008-3#11)
a diffractive##24##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#18)
a diffuse object##2##3##(2008-2#1)(2008-3#1)
a diffuse target##2##3##(2008-2#1)(2008-3#1)
a diffuse##25##2##(1990-2#1)(1990-6#1)(1991-11#1)(1992-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#1)(2011-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
a diffuser##3##2##(2008-2#3)
a diffusible##5##2##(1992-8#1)(1994-12#3)(2008-10#1)
a diffusing##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
a diffusing-wave spectroscopy experiment##2##4##(2008-3#2)
a diffusion model##2##3##(2008-3#1)(2009-9#1)
a diffusion##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)
a diffusion-bonded##2##2##(2008-2#1)(2008-3#1)
a diffusion-type##2##2##(2008-10#1)(2008-2#1)
a diffusive medium##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
a diffusive##7##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
a digestion##3##2##(2008-10#3)
a digestive##2##2##(1992-9#1)(2008-5#1)
a digital camera##7##3##(2007-11#1)(2008-3#3)(2008-9#1)(2010-8#1)(2012-6#1)
a digital image analysis##2##4##(2008-10#2)
a digital image##3##3##(2007-12#1)(2008-10#2)
a digital imaging##2##3##(1992-6#1)(1993-11#1)
a digital method##2##3##(2008-3#1)(2013-8#1)
a digital versatile disk##2##4##(2008-2#1)(2008-3#1)
a digital versatile##3##3##(2008-2#1)(2008-3#2)
a digital##45##2##(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#19)(2008-7#1)(2008-9#1)(2009-1#1)(2010-8#2)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
a dilatation##3##2##(1993-12#1)(2008-4#1)(2008-7#1)
a dilated hypokinetic cardiomyopathy##2##4##(2008-10#2)
a dilated##7##2##(1997-8#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)
a dilemma##6##2##(1994-1#1)(1996-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
a diligent and industrious plodder##2##5##(2011-1#2)
a diluent with##2##3##(2008-10#2)
a diluent##4##2##(2008-10#4)
a dilute##4##2##(1993-12#1)(2008-10#3)
a diluted##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
a dilution factor of##2##4##(2008-10#2)
a dilution of##2##3##(1992-6#1)(2008-2#1)
a dilution rate of 0##4##5##(2008-6#3)(2008-7#1)
a dilution rate of##5##4##(2008-6#3)(2008-7#2)
a dilution rate##6##3##(2008-6#4)(2008-7#2)
a dilution series of##2##4##(2008-10#2)
a dilution##14##2##(1992-6#1)(2008-10#5)(2008-2#1)(2008-6#4)(2008-7#2)(2012-3#1)
a dimension of##3##3##(1991-2#1)(2008-2#1)(2009-11#1)
a dimension##4##2##(1991-2#1)(2008-2#1)(2009-11#1)(2011-2#1)
a dimer in##3##3##(1992-3#1)(1995-5#1)(1997-7#1)
a dimer of##4##3##(1991-7#1)(1992-3#1)(1997-2#1)(2013-1#1)
a dimer##11##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-3#2)(1994-8#1)(1995-5#1)(1997-2#1)(1997-7#1)(2010-12#1)(2013-1#1)
a dimeric form##2##3##(1993-3#1)(2011-1#1)
a dimeric##12##2##(1992-3#2)(1993-3#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
a dimerization##2##2##(1996-5#1)(2013-8#1)
a diminished##7##2##(1994-8#1)(2008-10#2)(2008-7#2)(2010-4#1)(2012-2#1)
a diminution of##3##3##(2008-10#2)(2008-5#1)
a dinucleoside##2##2##(2008-4#2)
a diode array detector##3##4##(2008-10#3)
a diode array spectrophotometer##4##4##(2008-10#4)
a diode array##8##3##(2008-10#7)(2008-2#1)
a diode laser##18##3##(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#4)
a diode##28##2##(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#8)(2008-2#6)(2008-3#5)
a diode-array##2##2##(2007-12#1)(2008-10#1)
a diode-bar-pumped Nd##2##3##(2007-12#1)(2008-3#1)
a diode-end-pumped##4##2##(2007-11#1)(2008-2#3)
a diode-laser beam##2##3##(2007-11#1)(2008-3#1)
a diode-laser##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
a diode-pumped Cr##2##3##(2007-12#1)(2008-2#1)
a diode-pumped Nd##15##3##(2007-11#1)(2007-12#8)(2008-2#1)(2008-3#5)
a diode-pumped Yb##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
a diode-pumped fiber-coupled##2##3##(2008-3#2)
a diode-pumped monolithic##3##3##(2007-12#2)(2008-2#1)
a diode-pumped##50##2##(2007-11#9)(2007-12#23)(2008-2#6)(2008-3#12)
a dioxin##2##2##(1993-11#1)(2008-10#1)
a dip##2##2##(2007-10#1)(2008-3#1)
a diploid ancestor##2##3##(1993-3#1)(2009-9#1)
a diploid genome##3##3##(2008-4#2)(2009-12#1)
a diploid number##2##3##(2008-12#1)(2010-3#1)
a diploid##8##2##(1993-3#1)(2008-12#1)(2008-2#1)(2008-4#2)(2009-12#1)(2009-9#1)(2010-3#1)
a dipole layer##2##3##(2008-3#2)
a dipole##5##2##(1997-6#1)(2007-12#1)(2008-3#3)
a direct action of the##3##5##(1990-11#1)(1994-2#1)(1994-8#1)
a direct action of##4##4##(1990-11#1)(1994-2#1)(1994-8#1)(1996-5#1)
a direct action##7##3##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-5#1)
a direct activation of##2##4##(1990-5#1)(1995-11#1)
a direct and##6##3##(1996-12#1)(2007-11#2)(2009-7#1)(2012-12#1)(2013-1#1)
a direct approach for##2##4##(1990-5#1)(1994-11#1)
a direct comparison of the##3##5##(1991-11#1)(1992-3#1)(2008-5#1)
a direct comparison of##8##4##(1991-11#1)(1992-3#1)(1995-3#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
a direct consequence of##3##4##(1994-5#1)(1997-7#1)(2008-11#1)
a direct consequence##5##3##(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
a direct correlation between##5##4##(1994-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2011-1#1)
a direct detection##2##3##(2008-10#2)
a direct determination of the##2##5##(2008-2#1)(2008-3#1)
a direct determination of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
a direct effect of##2##4##(1991-3#1)(2011-2#1)
a direct effect on##4##4##(1996-12#1)(1996-6#1)(2007-11#1)(2008-8#1)
a direct effect##6##3##(1991-3#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-8#1)(2011-2#1)
a direct electronic##2##3##(1994-5#2)
a direct function of the##2##5##(2008-10#1)(2008-2#1)
a direct impact on the##2##5##(1993-2#1)(1995-1#1)
a direct impact on##4##4##(1993-2#1)(1995-1#1)(2008-7#1)(2009-10#1)
a direct impact##5##3##(1991-11#1)(1993-2#1)(1995-1#1)(2008-7#1)(2009-10#1)
a direct influence on the##2##5##(1992-11#1)(2012-2#1)
a direct interaction between##2##4##(1995-2#1)(2008-10#1)
a direct interaction with##2##4##(1995-8#1)(1997-2#1)
a direct interaction##4##3##(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#1)
a direct involvement of##3##4##(1995-8#1)(2008-11#1)(2008-4#1)
a direct link between##5##4##(1994-8#1)(1995-3#1)(1996-2#1)(2009-7#1)(2013-1#1)
a direct measure of the##4##5##(1992-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
a direct measure of##8##4##(1992-2#1)(2007-12#1)(2008-10#3)(2008-3#2)(2013-1#1)
a direct measurement of the##5##5##(2008-10#2)(2008-3#2)(2008-7#1)
a direct measurement of##6##4##(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)
a direct measurement##7##3##(2007-12#1)(2008-10#2)(2008-3#3)(2008-7#1)
a direct method##3##3##(1990-5#1)(2008-10#2)
a direct path##2##3##(2011-2#2)
a direct potentiometric method##2##4##(2008-10#2)
a direct proof##3##3##(2009-10#1)(2009-12#2)
a direct relationship between##6##4##(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
a direct relationship##8##3##(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
a direct response to##2##4##(2008-8#2)
a direct result of##6##4##(1991-9#1)(1994-6#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#1)
a direct role for##2##4##(1993-6#1)(1996-8#1)
a direct role in##2##4##(1992-9#1)(2009-8#1)
a direct role##4##3##(1992-9#1)(1993-6#1)(1996-8#1)(2009-8#1)
a direct space-to-time pulse shaper##3##5##(2007-11#1)(2007-12#2)
a direct study of the##2##5##(1995-6#1)(2008-5#1)
a direct visual##2##3##(2008-10#1)(2008-8#1)
a direct visualization##3##3##(2008-3#1)(2008-4#1)(2010-6#1)
a direct way##2##3##(2008-3#1)(2013-1#1)
a direct##208##2##(1990-11#3)(1990-5#4)(1990-8#1)(1991-11#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#5)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#12)(2007-12#6)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#6)(2008-9#8)(2009-10#2)(2009-12#2)(2009-3#1)(2009-7#3)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
a direct-injection##2##2##(2008-10#1)(2008-2#1)
a directed##3##2##(1992-10#1)(2008-11#1)(2011-2#1)
a direction##5##2##(1995-5#1)(2008-3#2)(2009-7#1)(2013-1#1)
a directional##4##2##(2007-9#1)(2008-10#2)(2012-2#1)
a directly observed therapy##2##4##(1996-3#2)
a directly##3##2##(1996-3#2)(2008-2#1)
a disability pension##5##3##(1991-11#1)(1995-5#3)(1997-6#1)
a disability##8##2##(1991-11#1)(1995-12#1)(1995-5#4)(1997-6#1)(2012-12#1)
a disaccharide##2##2##(1993-11#1)(2009-6#1)
a disadvantage##4##2##(1992-3#1)(2007-11#1)(2008-5#1)(2008-8#1)
a disadvantaged community##2##3##(2010-3#1)(2010-9#1)
a disc##2##2##(2008-10#1)(2008-3#1)
a discharge planner##2##3##(2010-11#2)
a discipline##4##2##(1993-3#1)(2008-10#1)(2008-8#1)(2013-8#1)
a disciplined approach to##2##4##(1995-1#1)(2010-8#1)
a discontinuous##4##2##(1996-2#1)(2008-10#2)(2008-7#1)
a discourse of##3##3##(2008-7#2)(2010-10#1)
a discourse##4##2##(2008-7#2)(2010-10#1)(2013-8#1)
a discreet##3##2##(2008-10#1)(2009-3#2)
a discrepancy##3##2##(1996-2#1)(2008-2#1)(2011-2#1)
a discrete model##2##3##(2008-1#1)(2008-8#1)
a discrete spectral##2##3##(2008-1#1)(2008-3#1)
a discrete##20##2##(1993-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
a discriminant analysis##2##3##(1992-1#1)(2010-8#1)
a discriminant##3##2##(1992-1#1)(1995-6#1)(2010-8#1)
a discrimination##4##2##(1992-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
a discussion about##2##3##(2008-10#1)(2008-11#1)
a discussion of data##2##4##(2008-4#1)(2009-8#1)
a discussion of how the##3##5##(2008-11#1)(2008-2#1)(2010-10#1)
a discussion of how##4##4##(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)
a discussion of its##2##4##(1992-1#1)(1994-2#1)
a discussion of possible##2##4##(1991-2#1)(1995-12#1)
a discussion of the##29##4##(1992-3#1)(1992-9#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-9#1)(2012-2#1)
a discussion of their##2##4##(2007-12#1)(2008-10#1)
a discussion of##77##3##(1990-3#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-3#2)(1992-9#1)(1993-2#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#8)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#2)(2013-1#2)(2013-8#1)
a discussion on the##2##4##(2007-11#1)(2008-11#1)
a discussion on##10##3##(1992-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-8#1)(2008-9#1)
a discussion with##2##3##(2008-11#1)(2012-3#1)
a discussion##97##2##(1990-3#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-2#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-3#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#9)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a disease associated with##2##4##(2008-7#1)(2013-7#1)
a disease caused by##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
a disease complex##2##3##(2008-10#2)
a disease frequently##2##3##(1994-11#1)(2006-10#1)
a disease gene##2##3##(2008-1#1)(2008-4#1)
a disease incidence##2##3##(2008-10#2)
a disease management strategy##2##4##(2008-10#1)(2013-1#1)
a disease management##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
a disease of the##2##4##(2008-11#1)(2008-5#1)
a disease of##13##3##(1991-6#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-7#1)
a disease that is##4##4##(2008-10#2)(2008-7#1)(2013-1#1)
a disease that##6##3##(2008-10#2)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
a disease which##3##3##(1992-9#1)(1996-6#1)(1997-8#1)
a disease with##6##3##(1990-3#1)(1993-9#1)(1994-9#1)(2008-10#1)(2008-7#1)(2013-8#1)
a disease##86##2##(1990-3#1)(1991-12#2)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-9#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
a disease-associated##2##2##(1996-12#1)(2008-10#1)
a disease-free interval of##2##4##(1992-10#1)(2008-6#1)
a disease-free survival##2##3##(2008-6#1)(2010-3#1)
a disease-free##5##2##(1992-10#1)(2008-10#1)(2008-6#2)(2010-3#1)
a dish##3##2##(2008-11#2)(2011-2#1)
a disincentive##2##2##(1996-1#1)(2008-12#1)
a disintegrin and metalloprotease domain##2##5##(2008-8#1)(2008-9#1)
a disk##2##2##(2008-2#1)(2008-3#1)
a disk-mounted##2##2##(2008-6#2)
a dislocated##2##2##(1997-6#1)(2010-5#1)
a disorder of##5##3##(2007-10#1)(2008-7#1)(2009-7#1)(2009-9#1)(2012-12#1)
a disorder with##2##3##(1994-8#1)(2008-2#1)
a disorder##14##2##(1994-8#1)(1995-8#1)(1996-7#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
a disordered##3##2##(1990-12#1)(1993-5#1)(1994-9#1)
a disordering##2##2##(2008-10#1)(2008-11#1)
a disparity##3##2##(1990-8#2)(2008-1#1)
a dispersal-competition trade-off##2##3##(2008-8#2)
a disperse-red-1-doped polymer film##2##4##(2008-3#2)
a dispersion of##3##3##(1997-2#1)(2008-3#2)
a dispersion##8##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)
a dispersion-flattened##3##2##(2007-11#2)(2007-12#1)
a dispersion-managed##6##2##(2007-11#1)(2007-12#5)
a dispersive material##2##3##(2007-11#1)(2007-12#1)
a dispersive wave##2##3##(2008-10#1)(2008-3#1)
a dispersive##9##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
a displaced##3##2##(2008-12#1)(2008-3#1)(2013-1#1)
a displacement of##2##3##(2008-10#1)(2010-12#1)
a displacement##6##2##(2007-12#1)(2008-10#2)(2008-3#2)(2010-12#1)
a display##2##2##(1995-2#1)(2012-2#1)
a disposable electrochemical DNA biosensor##5##5##(2008-10#5)
a disposable##11##2##(2008-10#10)(2008-5#1)
a disposition of##2##3##(2010-10#2)
a disposition##3##2##(1991-2#1)(2010-10#2)
a disproportionate share of##2##4##(1997-2#1)(2008-8#1)
a disproportionate##5##2##(1991-12#1)(1995-1#1)(1997-2#1)(2008-8#1)(2011-2#1)
a disrupted##5##2##(2008-10#1)(2009-5#2)(2010-10#1)(2011-2#1)
a disruption of the##2##4##(2008-5#1)(2011-1#1)
a disruption of##4##3##(1995-9#1)(1996-12#1)(2008-5#1)(2011-1#1)
a disruption##5##2##(1995-9#1)(1996-12#1)(2008-5#1)(2010-6#1)(2011-1#1)
a dissecting aneurysm##2##3##(1997-5#1)(2008-7#1)
a dissecting##3##2##(1997-5#1)(2008-5#1)(2008-7#1)
a dissection of the##2##4##(1992-10#1)(2008-9#1)
a dissection of##4##3##(1992-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
a dissection##5##2##(1992-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
a dissipative##2##2##(2007-11#1)(2008-3#1)
a dissociation between the##2##4##(1994-8#1)(2013-8#1)
a dissociation##6##2##(1990-11#1)(1990-8#1)(1994-8#1)(1996-7#1)(2008-10#1)(2013-8#1)
a dissolved oxygen##4##3##(2008-10#4)
a distal radius##2##3##(2008-9#2)
a distal##16##2##(1991-12#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-9#5)(2012-2#1)(2013-1#1)
a distance from the##4##4##(1996-5#1)(2007-11#1)(2008-3#2)
a distance greater than##2##4##(2008-10#1)(2013-7#1)
a distance of 1 cm##2##5##(2007-8#1)(2013-1#1)
a distance of 1##4##4##(2007-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
a distance of##27##3##(1992-1#1)(1992-6#1)(1994-9#1)(2007-11#2)(2007-8#1)(2008-10#10)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
a distance##43##2##(1992-1#1)(1992-6#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-10#13)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#1)(2008-8#3)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
a distant##7##2##(1991-5#1)(1994-8#1)(2008-10#1)(2008-3#2)(2010-10#1)(2011-2#1)
a distended gallbladder containing##2##4##(2013-1#2)
a distinct begomovirus species with##2##5##(2008-10#2)
a distinct begomovirus species##3##4##(2008-10#3)
a distinct bipartite begomovirus##2##4##(2008-10#2)
a distinct clinical and##2##4##(2008-7#1)(2010-4#1)
a distinct entity##6##3##(1997-3#1)(2006-10#1)(2009-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
a distinct group##2##3##(1994-9#1)(2010-10#1)
a distinct pattern of##3##4##(1990-12#1)(2008-10#1)(2008-4#1)
a distinct phylogenetic##2##3##(2008-10#2)
a distinct position##2##3##(2008-9#1)(2012-3#1)
a distinct set of##2##4##(2008-11#1)(2011-2#1)
a distinct species in the genus##2##6##(2008-10#2)
a distinct species##8##3##(2008-10#7)(2008-5#1)
a distinct subgroup##2##3##(2007-12#1)(2008-10#1)
a distinct##108##2##(1990-12#3)(1991-1#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-3#3)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#34)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#2)(2009-3#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a distinction between##12##3##(1990-5#1)(1991-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-8#2)
a distinction to##2##3##(1990-7#1)(2008-6#1)
a distinction##19##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-9#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-8#2)
a distinctive##13##2##(1994-8#1)(1995-6#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-7#2)(2009-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
a distinctly##2##2##(2008-10#1)(2008-5#1)
a distinguishing##2##2##(1997-2#1)(2012-2#1)
a distorted diffraction grating##3##4##(2008-3#3)
a distorted##10##2##(1997-7#2)(2008-2#1)(2008-3#6)(2008-5#1)
a distortion##3##2##(1997-7#1)(2008-2#1)(2010-2#1)
a distraction##2##2##(2008-6#1)(2011-2#1)
a distributed##10##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#3)(2011-9#1)(2012-1#1)
a distributed-feedback laser##4##3##(2007-11#3)(2008-3#1)
a distributed-feedback structure##2##3##(2008-3#2)
a distributed-feedback##13##2##(2007-11#4)(2007-12#2)(2008-3#7)
a distribution of##7##3##(1994-2#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#2)
a distribution##10##2##(1994-2#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-11#1)
a district general hospital##2##4##(1990-3#1)(1997-7#1)
a district##5##2##(1990-3#1)(1990-6#1)(1997-7#1)(2008-10#1)(2008-7#1)
a disturbance in##3##3##(1990-11#1)(1996-7#1)(2008-11#1)
a disturbance of##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2012-3#1)
a disturbance##7##2##(1990-11#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
a disturbed##3##2##(1994-5#1)(2009-5#1)(2012-3#1)
a disturbing##2##2##(2008-1#1)(2008-4#1)
a disulfide##3##2##(1990-8#1)(1992-6#1)(1994-12#1)
a divalent cation##2##3##(1997-3#1)(2008-6#1)
a divalent##4##2##(1990-5#1)(1997-3#1)(2008-10#1)(2008-6#1)
a divergent pattern##2##3##(1997-3#1)(2010-3#1)
a divergent##6##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
a diverging##3##2##(2008-2#2)(2009-6#1)
a diverse array of##4##4##(2008-11#1)(2011-9#1)(2012-2#2)
a diverse collection of##2##4##(1990-8#1)(2011-1#1)
a diverse group of diseases##2##5##(2007-11#1)(2011-2#1)
a diverse group of##8##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#3)(2012-12#1)
a diverse population##2##3##(2007-12#1)(2008-10#1)
a diverse range of##15##4##(1994-8#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
a diverse set of##6##4##(2007-11#1)(2008-10#3)(2012-4#1)(2013-1#1)
a diverse##53##2##(1990-11#1)(1990-8#1)(1994-8#1)(1995-5#1)(1997-2#3)(1997-3#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#1)
a diversified##2##2##(1990-8#1)(1996-12#1)
a diversity of##13##3##(1994-3#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-3#1)
a diversity##14##2##(1994-3#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-9#3)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
a divided##3##2##(1996-5#1)(2008-10#2)
a division of##3##3##(1996-1#1)(2007-8#1)(2008-7#1)
a docking##2##2##(1995-2#1)(2012-2#1)
a doctor and##4##3##(1993-12#1)(1997-6#1)(1997-8#1)(2013-1#1)
a doctor in##3##3##(2009-3#2)(2011-2#1)
a doctor or##3##3##(2009-5#2)(2013-1#1)
a doctor##15##2##(1993-12#1)(1993-8#1)(1994-1#1)(1995-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2009-3#2)(2009-5#2)(2011-2#1)(2013-1#3)
a doctor's##2##2##(2007-2#1)(2009-5#1)
a document##3##2##(1996-3#1)(2008-10#1)(2011-1#1)
a documented##5##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)
a dodecapeptide##2##2##(1992-12#1)(2008-10#1)
a dog##11##2##(1995-9#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#3)(2013-8#2)
a domain at its##2##4##(1997-6#2)
a domain at the##2##4##(1997-8#2)
a domain at##4##3##(1997-6#2)(1997-8#2)
a domain of##4##3##(2008-2#1)(2010-10#2)(2013-1#1)
a domain which##2##3##(2008-11#2)
a domain##26##2##(1990-5#2)(1992-3#1)(1993-3#1)(1993-9#1)(1994-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-12#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2011-1#1)(2012-12#1)(2013-1#1)
a domain-general##2##2##(2012-12#2)
a domain-specific##2##2##(2012-12#2)
a domestic microwave oven##6##4##(2008-10#6)
a domestic##12##2##(1995-3#1)(2008-10#6)(2011-1#1)(2011-2#1)(2013-1#3)
a dominant disorder##2##3##(1992-3#1)(2013-1#1)
a dominant gene for resistance to##2##6##(2008-10#2)
a dominant gene##3##3##(2008-10#3)
a dominant major gene and##2##5##(2007-6#1)(2008-10#1)
a dominant negative##3##3##(1993-11#1)(2013-7#2)
a dominant role in##5##4##(1992-1#1)(2008-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
a dominant role##7##3##(1992-1#1)(2008-1#1)(2008-2#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
a dominant##44##2##(1992-1#1)(1992-3#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#3)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#2)
a dominant-negative##3##2##(2008-6#2)(2012-12#1)
a dominating##2##2##(2008-10#1)(2008-11#1)
a domino##2##2##(2007-11#1)(2009-10#1)
a donor stream##3##3##(2008-10#3)
a donor##15##2##(1992-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)
a donor-acceptor##2##2##(1992-6#1)(2007-11#1)
a dopamine agonist##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
a dopamine##7##2##(1992-3#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-8#1)
a dopamine-##2##2##(1991-10#1)(1993-12#1)
a dopaminergic##3##2##(1990-8#1)(1991-1#1)(1996-5#1)
a dorsal##9##2##(2007-12#3)(2007-8#1)(2008-9#3)(2010-8#1)(2011-2#1)
a dosage of 300##2##4##(1990-9#1)(1991-3#1)
a dosage of##6##3##(1990-9#1)(1991-3#1)(1994-2#1)(1994-6#1)(2008-7#1)(2008-9#1)
a dosage##8##2##(1990-9#1)(1991-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
a dosage-dependent##2##2##(2008-10#1)(2008-3#1)
a dose dependent##9##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1994-11#1)(1994-3#1)(1997-7#1)(2007-10#1)(2007-11#1)
a dose effect##2##3##(1993-6#1)(1995-5#1)
a dose of &gt##2##4##(1994-3#1)(2008-10#1)
a dose of 100##3##4##(1992-2#1)(2011-2#1)(2012-2#1)
a dose of 15##2##4##(2008-11#1)(2012-12#1)
a dose of 20##2##4##(2008-1#1)(2008-6#1)
a dose of 6##2##4##(2007-11#1)(2008-7#1)
a dose of##59##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1993-12#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-12#4)(1995-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)
a dose range of##4##4##(1992-6#1)(1994-5#1)(1996-5#1)(2008-9#1)
a dose rate##2##3##(1990-6#1)(2009-11#1)
a dose reduction##2##3##(1990-8#1)(1990-9#1)
a dose##95##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
a dose- and time-dependent##12##4##(1991-5#1)(1993-6#1)(1994-9#2)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2011-2#3)
a dose- and##13##3##(1991-5#1)(1993-6#1)(1994-9#2)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#3)
a dose-dependent decrease##3##3##(1993-11#1)(1994-8#1)(1995-12#1)
a dose-dependent effect of##2##4##(2011-2#1)(2012-12#1)
a dose-dependent increase in##11##4##(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-5#2)
a dose-dependent increase##13##3##(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-5#2)(2009-12#1)(2011-2#1)
a dose-dependent inhibition of##3##4##(1990-12#1)(1992-5#1)(1993-8#1)
a dose-dependent reduction in##6##4##(1991-12#1)(1992-12#1)(1994-9#1)(1997-2#1)(2008-7#2)
a dose-dependent reduction of##2##4##(1995-12#2)
a dose-dependent reduction##9##3##(1991-12#1)(1992-12#2)(1994-9#1)(1995-12#2)(1997-2#1)(2008-7#2)
a dose-dependent suppression of the##2##5##(1995-12#1)(1997-2#1)
a dose-dependent suppression of##3##4##(1995-12#1)(1995-3#1)(1997-2#1)
a dose-dependent##143##2##(1990-12#2)(1990-2#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#12)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
a dose-related##14##2##(1991-12#1)(1991-8#1)(1994-2#1)(1995-11#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#3)
a dose-response relationship##8##3##(1990-8#1)(1993-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)
a dose-response study##2##3##(1994-8#2)
a dose-response##18##2##(1990-8#1)(1992-10#1)(1993-12#1)(1993-9#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#2)
a dot##4##2##(1994-8#1)(1997-4#1)(2008-10#2)
a double blind randomized##2##4##(2008-1#1)(2011-2#1)
a double blind##8##3##(1990-5#1)(2008-1#1)(2008-5#3)(2008-7#1)(2010-4#1)(2011-2#1)
a double mutant##3##3##(1995-6#1)(2008-7#1)(2012-2#1)
a double##56##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
a double-blind randomized##3##3##(1991-3#1)(1994-6#1)(2012-12#1)
a double-blind##19##2##(1990-9#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-6#1)(1996-1#1)(2008-5#9)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
a double-blinded##2##2##(2007-9#1)(2012-12#1)
a double-clad##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a double-etalon##3##2##(2008-2#3)
a double-labeling immunofluorescence##2##3##(1993-12#2)
a double-layer##2##2##(2008-2#1)(2008-3#1)
a double-pass confocal##2##3##(2008-2#1)(2008-3#1)
a double-pass##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
a double-pulse##2##2##(2008-3#2)
a double-random##2##2##(2007-11#1)(2008-3#1)
a double-stranded##2##2##(1990-11#1)(2008-9#1)
a doubled haploid (DH) population##2##5##(2008-10#1)(2008-9#1)
a doubled haploid population##2##4##(2008-10#1)(2012-3#1)
a doubled haploid##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
a doubled##5##2##(2008-10#2)(2008-9#1)(2010-2#1)(2012-3#1)
a doublet##2##2##(1995-12#1)(2008-3#1)
a doubling of##2##3##(2008-10#1)(2008-11#1)
a doubling##5##2##(2008-10#1)(2008-11#4)
a doubly resonant optical parametric oscillator##2##6##(2007-12#2)
a doubly resonant##4##3##(2007-12#3)(2008-2#1)
a doubly##7##2##(2007-12#5)(2008-2#1)(2008-3#1)
a doughnut##2##2##(2007-11#2)
a down##3##2##(1995-3#1)(2007-7#1)(2008-11#1)
a down-regulation of##4##3##(1992-9#1)(2008-4#1)(2009-3#1)(2012-7#1)
a down-regulation##5##2##(1992-9#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-7#1)
a downsizing process##2##3##(1993-1#1)(1994-3#1)
a downstream effector of##3##4##(1997-2#1)(2008-11#1)(2011-2#1)
a downstream target for##3##4##(1992-12#1)(1995-2#2)
a downstream target##4##3##(1992-12#1)(1995-2#2)(2011-2#1)
a downstream##17##2##(1990-5#1)(1991-9#1)(1992-12#1)(1994-8#1)(1995-2#2)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)
a downward##3##2##(2008-10#2)(2008-7#1)
a dozen##5##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
a drain##2##2##(2011-2#2)
a dramatic change##2##3##(2007-11#1)(2008-10#1)
a dramatic decrease in the##4##5##(1991-2#1)(1992-1#1)(1995-5#1)(2008-10#1)
a dramatic decrease in##11##4##(1990-3#1)(1991-2#1)(1992-1#1)(1995-5#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2012-3#1)
a dramatic improvement in##3##4##(1993-2#1)(1996-12#1)(1997-1#1)
a dramatic improvement##4##3##(1993-2#1)(1996-12#1)(1997-1#1)(2008-12#1)
a dramatic increase in reproductive potential##2##6##(2008-8#2)
a dramatic increase in the number of##4##7##(1994-12#1)(2008-10#1)(2013-1#2)
a dramatic increase in the##5##5##(1994-12#1)(2008-10#2)(2013-1#2)
a dramatic increase in##13##4##(1994-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#3)
a dramatic increase##16##3##(1994-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
a dramatic loss of##2##4##(1997-4#1)(2008-7#1)
a dramatic reduction in the##2##5##(1994-8#1)(1995-11#1)
a dramatic reduction in##4##4##(1994-8#1)(1995-11#1)(2010-10#1)(2013-1#1)
a dramatic reduction##6##3##(1994-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(2010-10#1)(2013-1#1)
a dramatic reorganization##2##3##(2013-1#2)
a dramatic shift##2##3##(2006-10#1)(2007-12#1)
a dramatic##60##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
a dramatically##4##2##(1994-9#1)(1997-2#1)(2008-11#1)(2008-7#1)
a drastic decrease in##2##4##(1992-8#1)(2008-11#1)
a drastic decrease##3##3##(1992-8#1)(1997-5#1)(2008-11#1)
a drastic reduction in##5##4##(1994-12#1)(1994-8#1)(1997-4#1)(2008-8#1)(2011-1#1)
a drastic reduction##6##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-1#1)
a drastic##18##2##(1990-11#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)
a drawback##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
a dream##2##2##(2007-10#1)(2012-2#1)
a drift##2##2##(2008-10#2)
a drink##3##2##(2008-7#1)(2012-1#2)
a drinking water##2##3##(2008-10#1)(2008-9#1)
a drinking##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
a drive##3##2##(1997-1#1)(2008-2#2)
a driven##2##2##(1990-12#1)(2007-11#1)
a driver##2##2##(2008-3#1)(2011-2#1)
a drop in the##3##4##(1996-2#1)(2008-11#1)(2010-3#1)
a drop in##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
a drop of a##2##4##(2008-10#1)(2008-3#1)
a drop of##6##3##(1991-3#1)(2008-10#2)(2008-3#2)(2010-12#1)
a drop##15##2##(1991-3#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
a droplet of##2##3##(2008-10#2)
a droplet##6##2##(1994-9#1)(2007-10#1)(2008-10#2)(2008-3#2)
a drug delivery system that##2##5##(2013-1#2)
a drug delivery##3##3##(2009-11#1)(2013-1#2)
a drug for##2##3##(1990-3#1)(2011-2#1)
a drug has##2##3##(1993-12#1)(1994-5#1)
a drug in##2##3##(2008-1#1)(2008-8#1)
a drug target##2##3##(2008-1#1)(2011-1#1)
a drug that##2##3##(1991-6#1)(2010-11#1)
a drug used as##2##4##(2008-10#2)
a drug used##5##3##(1994-11#1)(1995-11#1)(2006-10#1)(2008-10#2)
a drug with##4##3##(2008-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
a drug##65##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#5)(2009-11#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
a drug's##2##2##(2008-10#1)(2013-8#1)
a drug-eluting##2##2##(2009-11#1)(2013-7#1)
a dry ashing##2##3##(2008-10#2)
a dry gauze##2##3##(2007-7#2)
a dry##24##2##(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
a dry-room##2##2##(2008-10#2)
a drying##2##2##(2008-10#1)(2008-2#1)
a dual action##2##3##(2008-8#1)(2012-2#1)
a dual effect##3##3##(1990-2#1)(1995-6#1)(2008-4#1)
a dual##37##2##(1990-2#1)(1991-5#1)(1993-3#3)(1995-12#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
a dual-beam##2##2##(2008-10#1)(2008-2#1)
a dual-cavity##2##2##(2007-12#2)
a dual-chamber##2##2##(2008-12#1)(2011-2#1)
a dual-channel##2##2##(2007-12#1)(2008-3#1)
a dual-fiber-optic sensor##2##3##(2008-3#2)
a dual-wavelength##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
a dumbbell##3##2##(1997-8#1)(2008-6#1)(2010-12#1)
a dummy##2##2##(2008-2#1)(2009-11#1)
a duplex##6##2##(1993-8#2)(1995-5#1)(2008-12#1)(2008-7#1)(2013-8#1)
a duplicate##2##2##(1995-2#1)(1995-6#1)
a duplicated##2##2##(2008-10#1)(2008-11#1)
a duplication of the##2##4##(1996-6#1)(2008-10#1)
a duplication##3##2##(1996-6#1)(1997-3#1)(2008-10#1)
a durable##5##2##(1997-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
a dural AVF##2##3##(1996-9#2)
a dural##5##2##(1996-9#3)(2008-7#1)(2012-12#1)
a duration of##10##3##(1993-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2013-8#1)
a duration that##2##3##(1993-1#1)(2013-1#1)
a duration##13##2##(1993-1#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
a dye laser##3##3##(2008-2#3)
a dye##13##2##(1990-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
a dye-doped pendant drop##2##4##(2007-12#2)
a dye-doped##4##2##(2007-11#1)(2007-12#3)
a dynamic and##4##3##(2008-10#1)(2010-11#1)(2010-6#1)(2011-9#1)
a dynamic interfacial pressure##2##4##(2008-10#2)
a dynamic linear range from 0##2##6##(2008-10#2)
a dynamic model for##2##4##(2008-10#1)(2008-2#1)
a dynamic model##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
a dynamic modification##2##3##(2008-10#1)(2008-4#1)
a dynamic pH junction##3##4##(2008-10#3)
a dynamic process##3##3##(2008-3#1)(2008-9#1)(2009-8#1)
a dynamic range between##2##4##(2008-10#2)
a dynamic range from##3##4##(2008-10#3)
a dynamic range of##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
a dynamic range##9##3##(2008-10#7)(2008-2#1)(2008-3#1)
a dynamic state##2##3##(2008-3#1)(2013-8#1)
a dynamic##80##2##(1992-12#1)(1997-3#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
a dynamically##2##2##(2008-2#1)(2008-3#1)
a dysfunction##2##2##(2008-6#1)(2013-8#1)
a dysfunctional##3##2##(2008-10#1)(2009-9#1)(2012-2#1)
a dysregulated##4##2##(1992-12#1)(2009-12#1)(2011-2#2)
a ete##2##2##(2008-5#2)
a eukaryotic##6##2##(1992-8#1)(1994-8#1)(1997-4#1)(2008-9#2)(2012-3#1)
a face##4##2##(1995-6#1)(1996-5#1)(2008-2#1)(2008-7#1)
a face-to-face##3##2##(2008-11#1)(2010-10#1)(2013-1#1)
a facial##3##2##(1995-6#2)(2010-3#1)
a facile##9##2##(1994-12#1)(2008-10#2)(2009-11#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
a facilitated##4##2##(1992-3#1)(2007-12#1)(2007-5#1)(2008-11#1)
a facilitative effect of##2##4##(2008-11#1)(2011-2#1)
a facilitative##4##2##(2008-11#2)(2010-2#1)(2011-2#1)
a facilitator##4##2##(1991-2#1)(1996-12#2)(2008-7#1)
a facility##5##2##(1991-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(2008-7#1)
a fact that##6##3##(1990-6#1)(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
a fact##8##2##(1990-6#1)(1991-6#1)(1995-12#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
a factitious##2##2##(1993-2#1)(1997-2#1)
a factor 3##2##3##(1990-8#1)(2008-3#1)
a factor analysis##2##3##(1996-7#1)(2010-6#1)
a factor in##5##3##(1996-4#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-7#1)
a factor of 1##9##4##(1991-8#1)(1992-12#1)(1992-6#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
a factor of 10 since##2##5##(1992-3#2)
a factor of 10##9##4##(1992-3#3)(1994-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-2#1)
a factor of 10(4)##3##4##(1995-2#1)(1996-7#1)(2008-10#1)
a factor of 2 over a range from##2##8##(2008-10#2)
a factor of 2##16##4##(1992-12#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)
a factor of 3##10##4##(1990-11#1)(1997-4#1)(2008-10#4)(2008-3#3)(2009-5#1)
a factor of 4##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
a factor of 40##2##4##(2008-2#1)(2008-3#1)
a factor of 5##5##4##(1996-5#1)(2007-11#2)(2007-12#1)(2008-3#1)
a factor of 6##6##4##(1993-8#1)(2008-10#3)(2008-2#2)
a factor of 8##3##4##(1992-3#1)(2008-10#1)(2008-3#1)
a factor of three##3##4##(1995-12#1)(1995-8#1)(2008-10#1)
a factor of two##2##4##(1996-12#1)(1997-2#1)
a factor of##119##3##(1990-11#1)(1990-8#1)(1991-8#1)(1992-12#2)(1992-3#4)(1992-6#1)(1993-11#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#8)(2007-12#6)(2008-10#25)(2008-2#11)(2008-3#20)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#2)
a factor that##7##3##(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2013-7#1)(2013-8#1)
a factor which##3##3##(1990-7#1)(1996-2#1)(1997-3#1)
a factor##160##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#4)(1991-3#2)(1991-5#1)(1991-8#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-6#1)(1993-11#3)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#2)(2007-11#9)(2007-12#7)(2007-2#1)(2007-8#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#24)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
a factorial design to##2##4##(2008-10#2)
a factorial design##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
a factorial experiment##2##3##(2008-5#1)(2009-10#1)
a factorial##10##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-4#1)
a facultatively sexual##2##3##(2008-10#2)
a faculty##2##2##(1991-12#1)(2012-2#1)
a fad##2##2##(1992-12#1)(2007-5#1)
a failed##3##2##(2010-5#1)(2012-12#1)(2012-2#1)
a failure mode##2##3##(2007-12#1)(2012-2#1)
a failure of##4##3##(1994-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
a failure to##4##3##(1994-12#1)(1994-3#1)(1996-11#1)(2008-5#1)
a failure##15##2##(1994-12#2)(1994-3#1)(1995-2#1)(1995-8#1)(1996-11#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a faint##2##2##(1990-7#1)(2007-11#1)
a fair##6##2##(1990-2#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-6#1)(2013-1#1)
a fairly common##2##3##(1993-6#1)(1996-6#1)
a fairly good##2##3##(1990-10#1)(1991-6#1)
a fairly##19##2##(1990-10#1)(1991-6#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1995-3#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
a fall in##8##3##(1991-12#1)(1995-12#1)(1995-3#1)(1997-1#2)(2007-10#1)(2008-7#1)(2010-12#1)
a fall onto##2##3##(2008-9#1)(2013-1#1)
a fall##15##2##(1991-12#1)(1995-12#1)(1995-3#1)(1997-1#2)(2006-10#1)(2007-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2010-12#1)(2013-1#2)
a fallopian tube carcinoma##2##4##(1993-12#2)
a false lumen##2##3##(1991-2#1)(2008-11#1)
a false positive##2##3##(1990-2#1)(2011-2#1)
a false##9##2##(1990-2#1)(1991-2#1)(2007-10#1)(2007-8#2)(2008-11#2)(2008-2#1)(2011-2#1)
a familial##9##2##(1990-12#1)(1991-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2012-12#1)
a familiar##9##2##(1992-10#2)(1994-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-2#1)(2013-1#1)
a family history of DM2##2##5##(2008-3#2)
a family history of coronary artery disease##2##7##(2008-3#1)(2013-8#1)
a family history of the##2##5##(2008-7#1)(2008-9#1)
a family history of##15##4##(1991-1#1)(1994-2#1)(1995-11#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
a family history##17##3##(1991-1#1)(1994-2#1)(1995-11#1)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
a family member with##2##4##(1992-3#1)(2012-1#1)
a family of cysteine proteases##3##5##(2008-11#1)(2008-4#1)(2008-7#1)
a family of proteins##2##4##(1994-6#1)(1995-2#1)
a family of related##2##4##(1992-6#1)(2010-8#1)
a family of six##2##4##(1993-3#1)(2008-5#1)
a family of##81##3##(1990-8#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
a family practice##3##3##(1990-6#1)(1995-3#1)(2008-1#1)
a family who##2##3##(2007-10#1)(2007-7#1)
a family with autosomal dominant##2##5##(1997-5#1)(1997-8#1)
a family with##6##3##(1992-8#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-8#1)(2008-7#1)
a family##133##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
a family-centered##2##2##(1993-3#1)(2012-12#1)
a famous##3##2##(2008-11#1)(2009-7#1)(2012-3#1)
a fan-out##2##2##(2007-11#1)(2007-12#1)
a fan-structured periodically poled LiTaO(3) crystal##2##6##(2007-11#2)
a far##6##2##(1994-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)
a far-field##2##2##(2007-12#1)(2008-3#1)
a far-infrared##3##2##(2008-3#3)
a farm##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
a fascinating##4##2##(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)
a fashion that##3##3##(1994-12#1)(2008-10#1)(2009-11#1)
a fashion##9##2##(1992-4#1)(1992-6#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)
a fast Fourier##2##3##(1997-6#1)(2008-3#1)
a fast algorithm##3##3##(2007-11#2)(2008-2#1)
a fast and accurate##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
a fast and convenient method##2##5##(2008-10#1)(2008-11#1)
a fast and convenient##3##4##(2008-10#2)(2008-11#1)
a fast and efficient##2##4##(2008-2#1)(2012-1#1)
a fast and reliable method##2##5##(2008-10#1)(2009-12#1)
a fast and reliable##4##4##(2008-10#1)(2009-12#1)(2010-12#1)(2010-8#1)
a fast and reproducible##2##4##(2008-10#2)
a fast and sensitive##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
a fast and simple##2##4##(1995-3#1)(2012-2#1)
a fast and##33##3##(1995-3#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#1)(2008-7#3)(2008-9#3)(2009-12#1)(2010-12#2)(2010-8#1)(2012-1#1)(2012-2#1)
a fast atomization program##2##4##(2008-10#2)
a fast initial##2##3##(2008-11#1)(2012-2#1)
a fast liquid-crystal display##2##4##(2008-3#2)
a fast optical recording##2##4##(1996-5#1)(2007-11#1)
a fast parameterized radiative##2##4##(2008-3#2)
a fast potential response of##2##5##(2008-10#2)
a fast response time of about##5##6##(2008-10#5)
a fast response time of approximately##3##6##(2008-10#3)
a fast response time of##17##5##(2008-10#17)
a fast response time##21##4##(2008-10#21)
a fast response##26##3##(2008-10#26)
a fast##137##2##(1991-12#3)(1991-5#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-10#59)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#18)(2008-6#1)(2008-7#5)(2008-9#4)(2009-12#2)(2009-2#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#4)(2012-3#1)
a faster rate##5##3##(1991-12#1)(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
a faster recovery##2##3##(1993-2#1)(2008-3#1)
a faster##23##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-2#1)(2013-1#1)(2013-8#2)
a fat##2##2##(1997-3#1)(2008-3#1)
a fatal disease##2##3##(2008-2#1)(2009-5#1)
a fatal outcome##5##3##(1995-8#1)(2006-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
a fatal##13##2##(1992-4#1)(1995-2#1)(1995-8#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a fatty acid##3##3##(1994-9#2)(2009-5#1)
a fatty##4##2##(1994-9#2)(2009-5#1)(2011-2#1)
a fault system##3##3##(1996-4#3)
a fault##4##2##(1996-4#4)
a faunal##2##2##(2013-7#2)
a favorable outcome##3##3##(2007-10#1)(2011-2#1)(2012-3#1)
a favorable##27##2##(1991-1#2)(1992-11#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-5#2)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#2)
a favorite##2##2##(2008-10#1)(2008-4#1)
a favourable outcome##3##3##(2008-4#1)(2010-10#1)(2010-3#1)
a favourable##17##2##(1990-11#1)(1991-6#2)(1992-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
a fear of##2##3##(2008-2#1)(2011-2#1)
a fearful##2##2##(2007-4#1)(2008-6#1)
a feasibility study for##2##4##(1994-12#1)(2008-3#1)
a feasibility study on##2##4##(2008-7#1)(2010-7#1)
a feasibility study##8##3##(1994-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-7#1)
a feasibility##12##2##(1994-12#1)(1994-8#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2010-10#1)(2010-7#1)
a feasible and##3##3##(1992-2#1)(2008-12#1)(2012-12#1)
a feasible option##2##3##(2008-10#1)(2012-12#1)
a feasible##15##2##(1991-3#1)(1992-2#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2012-12#2)(2013-1#1)(2013-7#1)
a feather##2##2##(2008-5#1)(2009-7#1)
a feature of the##2##4##(1997-8#1)(2011-2#1)
a feature of##7##3##(1996-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
a feature that##2##3##(2008-2#1)(2008-7#1)
a feature##18##2##(1994-3#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
a featureless##2##2##(2008-8#1)(2009-5#1)
a febrile##2##2##(1994-11#1)(1997-8#1)
a fed##2##2##(2011-2#1)(2012-2#1)
a fed-batch process##2##3##(2008-11#1)(2011-1#1)
a fed-batch##10##2##(1992-11#1)(2008-11#3)(2008-6#4)(2008-7#1)(2011-1#1)
a federal##5##2##(1994-3#1)(1996-2#1)(1997-3#1)(2008-11#2)
a federally##2##2##(2008-12#1)(2013-1#1)
a feed forward##2##3##(2008-10#1)(2008-11#1)
a feed##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
a feedback loop##2##3##(1991-7#1)(2007-12#1)
a feedback##8##2##(1991-7#1)(1995-12#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#1)
a feeding##6##2##(1994-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-9#1)
a feeling of##5##3##(1990-11#1)(2008-1#2)(2008-7#1)(2010-3#1)
a fellow##3##2##(1995-3#1)(2009-11#1)(2011-2#1)
a fellowship##3##2##(2011-2#3)
a female child##4##3##(2008-10#3)(2010-1#1)
a female patient affected by##2##5##(1992-12#1)(2010-7#1)
a female patient who##2##4##(2012-12#1)(2012-3#1)
a female patient with##5##4##(1992-12#1)(2008-1#1)(2012-12#2)(2013-1#1)
a female patient##11##3##(1992-12#2)(2008-1#1)(2008-12#1)(2010-7#1)(2012-12#4)(2012-3#1)(2013-1#1)
a female##41##2##(1990-3#1)(1990-9#1)(1992-12#3)(1994-2#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-7#1)(2012-1#3)(2012-12#5)(2012-3#4)(2013-1#2)(2013-8#1)
a feminist##4##2##(1991-6#1)(1996-1#1)(2007-2#1)(2008-10#1)
a femoral##3##2##(2009-4#2)(2012-2#1)
a femoropopliteal##2##2##(1997-8#1)(2011-2#1)
a femtosecond laser pulse##2##4##(2007-11#2)
a femtosecond laser##8##3##(2007-11#3)(2007-12#4)(2013-8#1)
a femtosecond pulse##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a femtosecond##27##2##(2007-11#8)(2007-12#14)(2008-2#1)(2008-3#3)(2013-8#1)
a fermentation##3##2##(2008-10#2)(2008-6#1)
a ferroelectric liquid-crystal spatial light modulator##4##6##(2007-12#1)(2008-2#1)(2008-3#2)
a ferroelectric liquid-crystal##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
a ferroelectric##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
a ferrofluid##3##2##(2008-2#2)(2008-7#1)
a fertile##3##2##(2008-12#1)(2010-12#1)(2012-2#1)
a fetal##10##2##(1990-2#1)(1990-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#1)
a fetal-maternal hemorrhage##2##3##(1992-9#2)
a fetus with##2##3##(2008-7#1)(2010-4#1)
a fetus##5##2##(1990-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-3#1)
a fever##2##2##(2011-2#1)(2012-12#1)
a few bronchiolar/alveolar##2##3##(2008-9#2)
a few cases have been reported in the literature##2##9##(2011-1#1)(2013-7#1)
a few cases have been reported in##3##7##(1997-8#1)(2011-1#1)(2013-7#1)
a few cases have been reported##4##6##(1997-8#1)(2008-7#1)(2011-1#1)(2013-7#1)
a few cases of##9##4##(1994-3#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
a few cases##23##3##(1994-3#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
a few cells##2##3##(1992-6#1)(2008-10#1)
a few compounds##2##3##(1990-9#1)(2008-10#1)
a few controlled##2##3##(1996-8#1)(2008-10#1)
a few days after##4##4##(1992-4#1)(1995-5#1)(1996-2#1)(2011-2#1)
a few days before##2##4##(1993-1#1)(2008-5#1)
a few days##18##3##(1991-4#1)(1992-4#1)(1993-1#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#2)
a few drugs##2##3##(2008-6#1)(2008-8#1)
a few examples of##4##4##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
a few examples##5##3##(2008-10#2)(2008-9#1)(2010-12#1)(2011-2#1)
a few explanations##2##3##(2008-10#1)(2009-9#1)
a few hertz##2##3##(2007-12#1)(2008-3#1)
a few hours after##4##4##(1990-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
a few hours in##2##4##(1994-3#1)(2008-4#1)
a few hours##15##3##(1990-8#1)(1990-9#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
a few hundred##4##3##(1994-5#1)(2008-11#1)(2008-3#1)(2009-5#1)
a few isolated##2##3##(2008-1#1)(2008-5#1)
a few kilometers##2##3##(2008-2#1)(2008-3#1)
a few large##2##3##(1994-3#1)(2008-5#1)
a few meters##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
a few methods##2##3##(2008-4#1)(2010-6#1)
a few millimeters##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
a few milliseconds##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
a few minutes to##2##4##(2007-12#1)(2008-4#1)
a few minutes##13##3##(1990-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2012-12#1)
a few minutes'##3##3##(1990-8#1)(2012-2#2)
a few modifications##2##3##(2007-12#1)(2008-4#1)
a few molecules##2##3##(2008-2#1)(2008-3#1)
a few months##9##3##(1991-4#1)(1992-8#1)(2007-2#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#1)
a few more##2##3##(1991-6#1)(1996-12#1)
a few nanometers##6##3##(2007-12#1)(2008-10#3)(2008-3#2)
a few notable##3##3##(1994-12#1)(1995-6#1)(2013-1#1)
a few of the##4##4##(1995-1#1)(1996-3#1)(2007-2#1)(2008-10#1)
a few of these##3##4##(1990-2#1)(2008-3#1)(2008-8#1)
a few of##9##3##(1990-2#1)(1992-3#1)(1995-1#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
a few or##2##3##(2010-3#1)(2010-5#1)
a few other##2##3##(2008-11#1)(2008-8#1)
a few parts per##2##4##(2008-2#1)(2008-3#1)
a few parts##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a few percent##10##3##(1992-6#1)(1997-7#1)(2007-12#1)(2008-3#7)
a few picoseconds##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a few possible##2##3##(2010-2#1)(2012-1#1)
a few recent##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
a few reports of##4##4##(2007-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
a few reports##6##3##(2007-10#1)(2007-12#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
a few seconds of##2##4##(2008-10#1)(2008-3#1)
a few seconds##6##3##(1992-8#1)(1997-4#1)(2008-10#3)(2008-3#1)
a few selected##5##3##(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
a few short##2##3##(1993-6#1)(2008-5#1)
a few simple##2##3##(1994-1#1)(2010-7#1)
a few small##3##3##(1994-1#1)(2008-7#1)(2010-5#1)
a few species##2##3##(2007-12#1)(2008-10#1)
a few studies dealing with##2##5##(1996-5#1)(2011-2#1)
a few studies have##2##4##(2007-11#1)(2013-1#1)
a few studies##9##3##(1996-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
a few such cases have currently been reported in the medical literature##2##12##(2010-6#2)
a few tens of nanometers##2##5##(2007-12#1)(2012-1#1)
a few tens of##8##4##(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2012-1#1)
a few times the##2##4##(2008-10#1)(2008-2#1)
a few times##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
a few to##4##3##(1994-9#1)(1996-4#2)(2009-11#1)
a few vacuoles##2##3##(2008-7#2)
a few weeks after##2##4##(1990-3#1)(2007-10#1)
a few weeks of##2##4##(2008-10#1)(2012-2#1)
a few weeks##10##3##(1990-3#1)(1993-11#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-10#3)(2012-2#1)
a few years ago##4##4##(1990-11#1)(1992-9#1)(2008-3#1)(2010-8#1)
a few years##11##3##(1990-11#1)(1991-6#1)(1992-9#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-8#1)(2012-12#1)(2013-1#1)
a few##460##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#5)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-1#2)(1994-12#2)(1994-3#4)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#4)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#5)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#8)(2007-12#27)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#71)(2008-11#11)(2008-12#7)(2008-2#15)(2008-3#52)(2008-4#8)(2008-5#10)(2008-6#2)(2008-7#16)(2008-8#12)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#8)(2010-7#3)(2010-8#2)(2011-1#5)(2011-2#14)(2012-1#5)(2012-12#7)(2012-2#8)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#4)
a fiber Bragg grating##13##4##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#4)
a fiber amplifier##3##3##(2007-12#2)(2008-2#1)
a fiber cell-specific##2##3##(1991-9#2)
a fiber core##2##3##(2007-11#1)(2008-3#1)
a fiber grating##5##3##(2007-11#1)(2007-12#4)
a fiber laser cavity##3##4##(2008-2#2)(2008-3#1)
a fiber laser##4##3##(2008-2#2)(2008-3#2)
a fiber loop polarizer and a wavelength-selective fiber loop reflector##2##10##(2008-2#2)
a fiber loop##4##3##(2007-11#1)(2008-2#3)
a fiber optic liquid waveguide##2##5##(2008-10#2)
a fiber optic sensor##2##4##(2008-10#2)
a fiber optic##9##3##(2008-10#7)(2010-6#1)(2011-1#1)
a fiber probe##2##3##(2007-12#2)
a fiber ring semiconductor laser##2##5##(2008-2#2)
a fiber ring##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
a fiber taper##2##3##(2007-12#1)(2008-3#1)
a fiber with a##2##4##(2007-12#1)(2008-3#1)
a fiber with##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
a fiber##81##2##(1991-9#2)(2007-11#18)(2007-12#19)(2008-10#7)(2008-2#15)(2008-3#18)(2010-6#1)(2011-1#1)
a fiber-based##2##2##(2007-11#1)(2011-1#1)
a fiber-coupled##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
a fiber-optic Fabry-Perot##2##3##(2008-10#1)(2008-3#1)
a fiber-optic sensor##4##3##(2008-3#4)
a fiber-optic##26##2##(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#5)(2008-3#10)(2011-1#1)
a fiber-optic-based##2##2##(2008-2#1)(2008-3#1)
a fiberoptic##3##2##(1990-8#1)(1990-9#1)(1994-12#1)
a fibre##3##2##(2008-10#2)(2008-5#1)
a fibre-optic probe##3##3##(2008-10#2)(2010-4#1)
a fibrin##3##2##(1992-3#1)(1995-6#1)(2009-6#1)
a fibrinogen##3##2##(1997-7#1)(2008-10#2)
a fibroadenoma##4##2##(1990-12#1)(1994-7#2)(2007-7#1)
a fibroblast cell line##2##4##(1996-12#1)(2008-10#1)
a fibroblast##4##2##(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
a fibroblast-like shape##2##3##(2008-11#2)
a fibroblast-like##4##2##(2008-11#4)
a fibroepithelial polyp##2##3##(2008-11#1)(2009-5#1)
a fibrous##4##2##(2008-3#1)(2008-5#1)(2008-7#2)
a field experiment in which##2##5##(1994-2#1)(2008-8#1)
a field experiment in##4##4##(1994-2#1)(2008-10#2)(2008-8#1)
a field experiment##12##3##(1994-2#1)(2008-10#6)(2008-8#4)(2008-9#1)
a field of view##5##4##(2008-2#2)(2008-3#2)(2008-9#1)
a field of##9##3##(1996-2#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-8#1)(2012-12#1)
a field plot##3##3##(2008-10#3)
a field population##4##3##(2008-10#2)(2011-2#2)
a field sample##2##3##(2008-10#2)
a field study##5##3##(2008-10#3)(2008-6#1)(2008-9#1)
a field survey##2##3##(2008-10#1)(2008-12#1)
a field trial in##2##4##(2008-10#2)
a field trial##6##3##(1990-6#1)(2008-10#5)
a field##83##2##(1990-6#1)(1992-6#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#44)(2008-12#2)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#2)
a field-portable##2##2##(2008-3#2)
a field-widened Michelson interferometer##2##4##(2008-3#2)
a fifth of the##2##4##(2011-2#1)(2012-1#1)
a fifth of##3##3##(1996-11#1)(2011-2#1)(2012-1#1)
a fifth##6##2##(1996-11#1)(2007-12#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)
a fight##2##2##(2008-7#1)(2008-9#1)
a figure of merit##3##4##(2007-12#1)(2008-3#2)
a figure of##4##3##(2007-12#1)(2008-3#2)(2009-10#1)
a figure##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2009-10#1)
a filamentous fungus##2##3##(2008-11#1)(2008-5#1)
a filamentous##7##2##(1991-9#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-6#1)(2012-3#1)
a file##2##2##(1992-5#1)(1994-3#1)
a filling##2##2##(2008-12#1)(2008-2#1)
a film of##3##3##(2008-10#3)
a film with a##2##4##(2007-11#1)(2008-3#1)
a film with##3##3##(2007-11#2)(2008-3#1)
a film##17##2##(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)
a filter is##2##3##(2008-2#1)(2008-3#1)
a filter paper##2##3##(2008-10#2)
a filter##16##2##(1995-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-2#6)(2008-3#4)
a filtered##2##2##(2008-10#1)(2011-2#1)
a final R##3##3##(1991-3#1)(1997-7#2)
a final concentration of##3##4##(1990-12#1)(1995-12#1)(2008-10#1)
a final diagnosis and##2##4##(1994-6#1)(2010-12#1)
a final diagnosis of##2##4##(1990-3#1)(2011-1#1)
a final diagnosis##7##3##(1990-3#1)(1991-6#1)(1994-6#1)(2010-12#2)(2011-1#1)(2011-2#1)
a final solution##3##3##(2008-10#3)
a final volume of##2##4##(2008-10#2)
a final##54##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-3#1)(1994-6#3)(1995-12#1)(1997-7#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
a financial##7##2##(1992-12#1)(1993-1#2)(1993-3#1)(1994-9#1)(1996-2#1)(2010-3#1)
a finding consistent with##2##4##(1992-3#1)(1994-6#1)
a finding not##2##3##(1991-3#1)(2008-7#1)
a finding of##2##3##(2011-1#1)(2013-1#1)
a finding that is##2##4##(2007-5#1)(2010-10#1)
a finding that##8##3##(1992-3#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-8#1)(2010-10#1)
a finding which##3##3##(2008-5#1)(2010-7#1)(2011-1#1)
a finding##21##2##(1991-1#1)(1991-3#1)(1992-3#2)(1994-3#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#2)(2013-1#1)
a fine grating##2##3##(2008-3#2)
a fine network##2##3##(2008-8#2)
a fine##12##2##(1994-3#1)(2008-10#2)(2008-3#5)(2008-8#2)(2008-9#1)(2011-2#1)
a fine-grained##2##2##(2008-8#2)
a finger##2##2##(2008-9#2)
a finite element##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
a finite number of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
a finite response time##2##4##(2007-12#1)(2008-3#1)
a finite##32##2##(1990-8#1)(1996-4#2)(1997-3#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-2#4)(2008-3#14)(2008-7#2)(2008-9#1)(2013-1#1)
a finite-difference##2##2##(2007-11#1)(2008-3#1)
a finite-element analysis##2##3##(2008-3#2)
a finite-element##4##2##(2008-3#4)
a finite-size##2##2##(2008-3#1)(2008-8#1)
a fire##5##2##(1993-12#1)(1994-12#1)(1995-6#1)(1996-12#1)(2008-10#1)
a firearm##2##2##(2009-2#2)
a firefly luciferase##2##3##(2008-10#2)
a firing##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
a firm##10##2##(1990-11#1)(1990-6#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
a firm's##2##2##(1994-2#1)(2007-4#1)
a first and##2##3##(1994-1#1)(1995-2#1)
a first application of##2##4##(2007-11#1)(2008-2#1)
a first application##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
a first approach to##2##4##(2008-10#1)(2008-11#1)
a first attempt to##2##4##(2011-2#1)(2012-2#1)
a first attempt##3##3##(2009-11#1)(2011-2#1)(2012-2#1)
a first choice##4##3##(1990-3#1)(1996-3#1)(2008-10#1)(2008-4#1)
a first episode of psychosis##2##5##(1996-7#1)(2011-1#1)
a first line##3##3##(1996-3#1)(2008-1#1)(2011-2#1)
a first order##2##3##(2008-10#1)(2008-5#1)
a first step in the##2##5##(1993-11#1)(1996-6#1)
a first step in##7##4##(1992-6#1)(1993-11#1)(1996-10#1)(1996-6#1)(1997-2#1)(2009-7#1)(2012-2#1)
a first step the##2##4##(2008-10#1)(2008-11#1)
a first step to##3##4##(1993-2#1)(2007-12#1)(2008-10#1)
a first step toward a##3##5##(1992-6#1)(2012-12#1)(2012-3#1)
a first step toward development of##2##6##(1997-7#1)(2007-5#1)
a first step toward the##2##5##(2007-11#1)(2009-7#1)
a first step toward##11##4##(1992-6#1)(1997-7#1)(2007-11#2)(2007-5#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)
a first step towards##3##4##(1994-11#1)(1994-12#1)(2010-12#1)
a first step##38##3##(1991-2#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#2)(2010-12#2)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
a first##103##2##(1990-3#2)(1991-2#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a first-ever##3##2##(2007-10#2)(2009-10#1)
a first-line treatment##4##3##(2008-10#1)(2011-2#2)(2013-7#1)
a first-line##12##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-7#1)
a first-order grating##2##3##(2008-3#2)
a first-order quasi-phase-matched##3##3##(2007-12#3)
a first-order rate constant##2##4##(1995-6#1)(2008-10#1)
a first-order rate##3##3##(1995-6#1)(2008-10#2)
a first-order reaction##2##3##(1994-3#1)(2008-10#1)
a first-order unconditional calculation##2##4##(1992-6#2)
a first-order##19##2##(1992-5#1)(1992-6#2)(1994-2#1)(1994-3#1)(1995-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-3#3)(2008-5#1)
a fish##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
a fistula##6##2##(1991-8#1)(1996-9#1)(1997-3#1)(2007-7#1)(2012-12#1)(2013-8#1)
a fit to##2##3##(2008-3#2)
a fit##5##2##(2008-10#1)(2008-3#2)(2009-5#1)(2012-2#1)
a fitness function##2##3##(2008-10#1)(2010-10#1)
a fitness##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
a fitting##2##2##(1995-1#1)(2008-3#1)
a five year old##3##4##(2008-8#1)(2011-1#1)(2013-1#1)
a five year period##4##4##(2007-7#2)(2011-1#1)(2011-2#1)
a five year##8##3##(2007-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
a five##13##2##(2007-11#1)(2007-7#3)(2008-11#1)(2008-8#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
a five-day##2##2##(1992-2#1)(1997-5#1)
a five-part WMU/AHRA magazine course on ethics##4##7##(1991-12#1)(1992-1#1)(1992-2#2)
a five-year period##6##3##(1991-12#1)(1991-6#1)(1992-1#1)(1994-3#1)(2007-7#1)(2008-12#1)
a five-year study##2##3##(2008-11#1)(2008-7#1)
a five-year##13##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
a five-year-old##3##2##(2008-11#1)(2008-9#2)
a fivefold##2##2##(2007-12#1)(2008-7#1)
a fixation##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
a fixed amount of##4##4##(1991-5#2)(2008-10#2)
a fixed bed bioreactor##3##4##(2008-11#3)
a fixed bed##4##3##(2008-11#4)
a fixed concentration of##3##4##(1992-3#1)(2008-10#2)
a fixed dose##2##3##(2007-7#1)(2008-7#1)
a fixed length of##2##4##(1994-9#1)(2008-3#1)
a fixed number of##6##4##(1994-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-5#1)
a fixed orientation##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
a fixed parameter##2##3##(1997-2#1)(2008-9#1)
a fixed population of neurons##2##5##(1991-2#2)
a fixed position##2##3##(2008-10#1)(2011-1#1)
a fixed pump##2##3##(2007-11#1)(2008-2#1)
a fixed time of 5 min##2##6##(2008-10#2)
a fixed time##4##3##(2008-10#4)
a fixed##100##2##(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-6#2)(1992-3#2)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#18)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
a fixed-bed reactor##2##3##(2008-11#1)(2009-2#1)
a fixed-bed##4##2##(2008-11#2)(2008-12#1)(2009-2#1)
a flame atomic absorption spectrometer##6##5##(2008-10#6)
a flame atomic absorption##7##4##(2008-10#7)
a flame ionization detector (FID)##2##5##(2008-10#2)
a flame ionization detector##4##4##(2008-10#3)(2008-11#1)
a flame##19##2##(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#1)
a flare-like vasodilatation##2##3##(1990-7#2)
a flash-lamp-pumped##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
a flat body posture##2##4##(1991-2#2)
a flat passband##2##3##(2007-11#2)
a flat##28##2##(1991-2#2)(2007-11#4)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2012-2#1)
a flat-plate##2##2##(2008-10#1)(2008-3#1)
a flat-top##2##2##(2007-11#1)(2008-2#1)
a flattening of the curve##2##5##(2011-2#2)
a flattening of the psychophysical curve when##2##7##(2011-2#2)
a flattening of the##5##4##(2008-5#1)(2011-2#4)
a flattening of##6##3##(1995-1#1)(2008-5#1)(2011-2#4)
a flavanone glycoside##2##3##(2007-11#2)
a flavanone##3##2##(2007-11#3)
a flavonol##2##2##(2008-10#2)
a flexible and##2##3##(1995-12#1)(2007-11#1)
a flexible approach to##2##4##(2008-7#1)(2013-1#1)
a flexible framework##2##3##(2008-9#1)(2012-2#1)
a flexible linker##2##3##(1994-5#1)(2009-7#1)
a flexible##34##2##(1990-11#1)(1990-8#1)(1992-1#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#1)(2010-7#1)(2012-2#3)(2013-1#2)
a flight##4##2##(2008-10#1)(2008-2#2)(2012-12#1)
a floating##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
a flock of##2##3##(1993-2#1)(2008-5#1)
a flow analysis##2##3##(2008-10#2)
a flow cell##11##3##(2007-11#1)(2008-10#10)
a flow chart for##2##4##(1992-2#1)(1995-2#1)
a flow cytometer to##3##4##(1994-2#2)(2008-9#1)
a flow cytometer##16##3##(1994-2#2)(2006-6#1)(2008-4#1)(2008-9#12)
a flow cytometric##10##3##(1994-2#1)(1994-6#1)(1997-7#1)(2006-6#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#1)
a flow injection (FI) system##6##5##(2008-10#6)
a flow injection (FI)##7##4##(2008-10#7)
a flow injection analysis (FIA) system##5##6##(2008-10#5)
a flow injection analysis system##2##5##(2008-10#2)
a flow injection analysis##11##4##(2008-10#10)(2008-9#1)
a flow injection approach##3##4##(2008-10#3)
a flow injection manifold##2##4##(2008-10#2)
a flow injection on-line##2##4##(2008-10#2)
a flow injection system and##3##5##(2008-10#3)
a flow injection system coupled to##2##6##(2008-10#2)
a flow injection system coupled##3##5##(2008-10#3)
a flow injection system for the determination of##3##8##(2008-10#3)
a flow injection system for the##5##6##(2008-10#5)
a flow injection system is##2##5##(2008-10#2)
a flow injection system with##6##5##(2008-10#6)
a flow injection system##30##4##(2008-10#30)
a flow injection##65##3##(2008-10#64)(2008-9#1)
a flow manifold##2##3##(2008-10#2)
a flow of##7##3##(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)
a flow program##2##3##(2008-10#2)
a flow rate of 1 ml min(-1)##2##7##(2008-10#2)
a flow rate of 1##19##5##(2008-10#13)(2008-5#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
a flow rate of 2##5##5##(2008-10#5)
a flow rate of##47##4##(1996-12#1)(2008-10#38)(2008-5#2)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
a flow rate##51##3##(1996-12#1)(2008-10#41)(2008-5#2)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)
a flow system##12##3##(2008-10#12)
a flow through cell##2##4##(2008-10#2)
a flow##204##2##(1990-12#1)(1992-2#1)(1994-2#3)(1994-6#1)(1995-2#1)(1996-12#1)(1997-7#1)(2006-6#3)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#152)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#14)(2010-1#1)(2010-3#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
a flow-cell##3##2##(2008-10#3)
a flow-continuous##2##2##(2008-10#2)
a flow-injection system with##4##4##(2008-10#4)
a flow-injection system##14##3##(2008-10#14)
a flow-injection##18##2##(2008-10#18)
a flow-rate of 1##5##4##(1991-5#1)(1996-5#1)(2008-10#2)(2008-5#1)
a flow-rate of##6##3##(1991-5#1)(1996-5#1)(2008-10#3)(2008-5#1)
a flow-through bulk optode##2##4##(2008-10#2)
a flow-through cell##4##3##(2008-10#3)(2013-1#1)
a flow-through type##4##3##(2008-10#4)
a flow-through##25##2##(2008-10#24)(2013-1#1)
a flow-type chemiluminescence##2##3##(2008-10#2)
a flowable composite##2##3##(2008-12#2)
a flowable##4##2##(2008-12#2)(2008-2#1)(2008-4#1)
a flower##5##2##(1996-2#1)(2008-8#1)(2009-6#1)(2012-2#2)
a flowing##11##2##(2008-10#8)(2008-2#2)(2008-9#1)
a fluctuating##4##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-8#1)
a fluctuation##2##2##(2007-12#1)(2012-2#1)
a fluence##3##2##(1995-2#1)(2008-3#2)
a fluid flow##2##3##(1996-4#1)(2008-2#1)
a fluid lamellar signal is##2##5##(1994-5#2)
a fluid##13##2##(1991-9#1)(1994-5#2)(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
a fluidic##2##2##(2009-5#1)(2009-6#1)
a fluorescein##3##2##(2008-10#3)
a fluorescence emission##2##3##(2008-10#1)(2008-9#1)
a fluorescence intensity ratio##2##4##(2008-2#1)(2008-3#1)
a fluorescence microscope##2##3##(1993-11#1)(2008-10#1)
a fluorescence##28##2##(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#4)(2008-4#1)(2008-9#2)(2013-1#1)
a fluorescence-based##2##2##(2008-10#1)(2008-9#1)
a fluorescent dye##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
a fluorescent indicator##2##3##(2008-10#1)(2008-3#1)
a fluorescent marker##3##3##(1994-2#1)(2007-11#1)(2008-11#1)
a fluorescent probe##4##3##(1991-5#2)(1992-6#1)(2008-4#1)
a fluorescent protein##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
a fluorescent signal##2##3##(2008-7#1)(2009-7#1)
a fluorescent##54##2##(1990-2#2)(1991-5#2)(1991-6#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#3)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
a fluorescently labeled##2##3##(1995-5#1)(2008-4#1)
a fluorescently##3##2##(1995-5#1)(2008-4#1)(2009-12#1)
a fluorescing##2##2##(2007-12#2)
a fluoride ion-selective electrode##3##4##(2008-10#3)
a fluoride##5##2##(2008-10#4)(2009-9#1)
a fluoride-selective##3##2##(2008-10#3)
a fluorimetric##5##2##(2008-10#5)
a fluorinated##3##2##(1992-12#1)(2008-10#1)(2008-3#1)
a fluorochrome##4##2##(2008-1#1)(2008-11#1)(2008-9#2)
a fluorogenic##4##2##(1996-12#1)(1997-3#1)(2008-10#2)
a fluorometer##2##2##(2008-10#2)
a fluorometric##3##2##(1992-9#1)(2008-10#2)
a fluorometric-enzymatic method based on##2##5##(2008-10#2)
a fluorometric-enzymatic method##3##3##(2008-10#3)
a fluorophore##4##2##(1992-3#1)(1994-6#1)(2008-10#1)(2008-2#1)
a fluoroquinolone##2##2##(2008-10#1)(2011-2#1)
a fluorous##2##2##(2010-4#2)
a flux##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
a fly##2##2##(2008-3#2)
a foam##2##2##(1992-5#1)(1996-12#1)
a focal neurological deficit##2##4##(1992-6#1)(2007-10#1)
a focal point##2##3##(2008-3#2)
a focal##24##2##(1992-6#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#3)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
a focus group approach##2##4##(2008-11#1)(2012-12#1)
a focus group##5##3##(2008-11#2)(2012-12#2)(2012-3#1)
a focus of##6##3##(1991-1#1)(2007-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
a focus on recent##2##4##(2008-10#1)(2011-2#1)
a focus on the##7##4##(1995-12#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)(2011-10#1)(2013-1#1)
a focus on##40##3##(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a focus##56##2##(1991-1#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
a focused Gaussian##2##3##(2008-2#1)(2008-3#1)
a focused beam##3##3##(2008-2#1)(2008-3#2)
a focused continuous-wave##3##3##(2008-2#1)(2008-3#2)
a focused laser beam##6##4##(2008-2#2)(2008-3#3)(2011-1#1)
a focused laser##7##3##(2008-2#2)(2008-3#4)(2011-1#1)
a focused microwave digestor##2##4##(2008-10#2)
a focused microwave oven##5##4##(2008-10#5)
a focused microwave##8##3##(2008-10#8)
a focused spot##2##3##(2007-11#2)
a focused##40##2##(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-2#6)(2008-3#16)(2011-1#2)(2011-2#1)(2013-1#1)
a focusing##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
a foetal##3##2##(1992-5#1)(1996-3#1)(2008-7#1)
a folded optical system##2##4##(2008-3#2)
a folded##6##2##(2008-2#2)(2008-3#3)(2008-4#1)
a folding##2##2##(2007-11#1)(2008-7#1)
a foliar spray##3##3##(2008-10#2)(2011-2#1)
a foliar##6##2##(2008-10#5)(2011-2#1)
a follicular##5##2##(1992-11#1)(2007-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
a follow up of##3##4##(2007-8#1)(2013-1#1)(2013-8#1)
a follow up##5##3##(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
a follow-up of the##2##4##(1993-6#1)(2008-10#1)
a follow-up of##7##3##(1990-6#1)(1991-6#1)(1993-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
a follow-up study##4##3##(1991-1#1)(1991-3#1)(1992-6#1)(2012-3#1)
a follow-up to the##2##4##(1995-2#1)(1996-8#1)
a follow-up##30##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#2)(2010-6#1)(2011-2#1)(2012-3#1)
a food additive##3##3##(1993-11#1)(2008-6#1)(2009-11#1)
a food source##2##3##(2011-2#2)
a food supplement##3##3##(2008-5#3)
a food##24##2##(1990-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#1)
a foot##3##2##(2006-10#1)(2008-4#1)(2013-8#1)
a for##2##2##(1990-9#1)(2011-2#1)
a forager##2##2##(1992-3#1)(2008-9#1)
a foraging##2##2##(2008-9#2)
a force##6##2##(1991-3#1)(1994-1#1)(1995-12#1)(1995-5#1)(2007-12#1)(2012-2#1)
a forearm##2##2##(2008-5#1)(2008-9#1)
a forecasting system for carpogenic germination##2##6##(2008-10#2)
a forecasting system##3##3##(2008-10#3)
a foreign body##4##3##(1990-3#1)(2011-2#2)(2013-1#1)
a foreign gene##4##3##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#1)
a foreign##12##2##(1990-3#1)(1993-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#2)(2013-1#1)
a foreign-body##2##2##(2011-2#1)(2012-12#1)
a forensic##5##2##(2008-10#2)(2010-5#1)(2011-2#2)
a forest##2##2##(2008-11#1)(2008-6#1)
a forgotten##2##2##(2008-11#2)
a form of##41##3##(1990-8#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#2)(2008-8#4)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
a form that##4##3##(1991-5#1)(1992-8#1)(1996-12#1)(2008-4#1)
a form##47##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-4#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
a formal policy for##2##4##(1991-1#2)
a formal##21##2##(1991-1#2)(1992-2#1)(1994-12#2)(1994-2#1)(1996-2#2)(1996-6#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)
a formalized##3##2##(1995-3#1)(1996-3#1)(2008-10#1)
a formation##2##2##(2008-10#1)(2008-5#1)
a formative##2##2##(2008-11#1)(2008-7#1)
a former industrial sludge basin##2##5##(2008-11#2)
a former##9##2##(1995-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2011-1#1)(2012-2#1)
a formerly##2##2##(2008-5#1)(2008-8#1)
a formidable challenge##4##3##(1991-2#1)(2008-8#2)(2011-2#1)
a formidable##6##2##(1991-2#1)(2008-8#2)(2009-2#1)(2011-2#1)(2012-2#1)
a formula for##3##3##(1992-9#1)(2008-5#1)(2008-8#1)
a formula##4##2##(1992-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
a formulation containing##2##3##(1995-5#1)(2008-5#1)
a formulation##8##2##(1995-5#1)(2008-10#2)(2008-5#4)(2012-2#1)
a fornix##2##2##(2008-10#1)(2011-2#1)
a fortuitous##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
a forum for##5##3##(1995-3#1)(1996-1#1)(2007-5#1)(2008-4#1)(2008-5#1)
a forum to##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
a forum##8##2##(1995-3#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
a forward and##2##3##(2008-10#1)(2008-11#1)
a forward##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
a fossil##2##2##(1992-7#1)(2010-3#1)
a foundation for future##3##4##(1997-4#1)(2011-1#1)(2011-2#1)
a foundation for the##3##4##(1995-12#1)(2008-10#1)(2013-8#1)
a foundation for understanding##2##4##(2008-11#1)(2010-3#1)
a foundation for##18##3##(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a foundation##21##2##(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
a founder effect##3##3##(2008-10#3)
a founder population##2##3##(2008-10#1)(2008-8#1)
a founder##10##2##(1996-6#1)(2008-10#4)(2008-8#1)(2008-9#4)
a four year##2##3##(1995-5#1)(2008-11#1)
a four##9##2##(1991-5#1)(1995-5#1)(2008-10#1)(2008-11#2)(2009-7#1)(2012-2#1)(2012-5#2)
a four-channel##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
a four-color##2##2##(2008-9#2)
a four-day##2##2##(1996-4#1)(2013-8#1)
a four-drug##2##2##(1996-11#1)(2007-8#1)
a four-helix##3##2##(1990-5#1)(1994-3#1)(1995-5#1)
a four-item##2##2##(2008-11#1)(2008-7#1)
a four-level##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
a four-mirror ring cavity##2##4##(2007-11#1)(2007-12#1)
a four-mirror ring##3##3##(2007-11#1)(2007-12#2)
a four-mirror##4##2##(2007-11#1)(2007-12#3)
a four-parameter##2##2##(2008-10#2)
a four-part##2##2##(2008-9#1)(2012-3#1)
a four-pass dye laser amplifier##2##5##(2008-2#2)
a four-pass##3##2##(2007-12#1)(2008-2#2)
a four-port##2##2##(2007-11#1)(2007-9#1)
a four-step##2##2##(1994-11#1)(2008-4#1)
a four-year period##4##3##(1992-10#1)(1995-3#1)(2008-1#1)(2008-7#1)
a four-year##5##2##(1992-10#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-7#1)
a fourfold##2##2##(2008-5#1)(2008-6#1)
a fourth##14##2##(1990-11#3)(1990-7#1)(1993-3#3)(1995-2#1)(2008-10#5)(2008-2#1)
a fourth-order##2##2##(2008-2#1)(2008-6#1)
a fractal aggregate##2##3##(2008-2#2)
a fractal##4##2##(2008-2#4)
a fraction of a##3##4##(2008-2#1)(2008-3#2)
a fraction of the cells##2##5##(1992-3#1)(1995-2#1)
a fraction of the##14##4##(1992-3#1)(1992-5#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
a fraction of##27##3##(1991-9#1)(1992-3#1)(1992-5#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
a fraction##29##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
a fractional effective dose (FED)##2##5##(1996-12#2)
a fractional##9##2##(1996-12#2)(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#3)
a fractionated##2##2##(2008-12#1)(2008-6#1)
a fractionation##2##2##(2008-10#1)(2008-7#1)
a fracture of the##3##4##(2006-10#1)(2009-3#1)(2013-1#1)
a fracture of##4##3##(2006-10#1)(2008-12#1)(2009-3#1)(2013-1#1)
a fracture##10##2##(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-2#1)(2013-1#2)
a fractured##2##2##(1990-3#1)(2011-2#1)
a fragile##3##2##(1992-10#1)(1995-1#1)(2012-2#1)
a fragment of the##2##4##(1995-11#1)(2008-12#1)
a fragment of##11##3##(1991-6#1)(1992-12#1)(1992-5#1)(1995-11#2)(1996-3#1)(2008-12#1)(2009-11#1)(2009-6#1)(2010-4#1)(2013-8#1)
a fragment##20##2##(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1995-11#2)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2010-4#1)(2013-8#1)
a fragmented##6##2##(2008-8#2)(2012-3#1)(2013-7#3)
a frame rate of##2##4##(2008-3#2)
a frame##4##2##(1992-2#1)(2008-3#2)(2008-7#1)
a frame-by-frame##2##2##(2011-2#2)
a frameshift##5##2##(1993-6#1)(1997-4#1)(2008-9#1)(2010-4#1)(2012-2#1)
a framework for describing##2##4##(2008-7#2)
a framework for developing##2##4##(1993-12#1)(2008-12#1)
a framework for examining##2##4##(1992-2#1)(2010-10#1)
a framework for health##2##4##(1997-1#2)
a framework for sample-based graphics##2##5##(2008-6#2)
a framework for the##10##4##(1993-3#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)
a framework for##52##3##(1991-1#1)(1991-12#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a framework in##2##3##(1994-3#1)(2008-10#1)
a framework to explain##2##4##(2012-12#1)(2012-2#1)
a framework to##9##3##(1992-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-12#2)(2012-2#1)
a framework##78##2##(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#3)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
a free energy of##2##4##(1992-3#1)(1995-5#1)
a free energy##3##3##(1990-8#1)(1992-3#1)(1995-5#1)
a free fat##3##3##(1997-3#2)(2011-2#1)
a free flap is##2##4##(2008-4#1)(2012-12#1)
a free flap##3##3##(2008-4#1)(2012-12#2)
a free market##2##3##(1991-3#1)(1994-2#1)
a free radical scavenger##3##4##(1991-9#1)(1994-5#1)(1995-8#1)
a free radical##7##3##(1991-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2012-2#1)
a free spectral range##3##4##(2007-11#2)(2008-3#1)
a free##40##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#2)(2006-12#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)
a free-knot spline shape function##2##5##(1995-9#2)
a free-living##8##2##(1992-9#1)(1995-5#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#3)
a free-running##3##2##(1990-5#1)(2007-11#1)(2008-3#1)
a free-space optical interconnection##3##4##(2008-2#2)(2008-3#1)
a free-space optical##7##3##(2008-2#3)(2008-3#4)
a freely propagating##3##3##(2007-11#1)(2007-12#2)
a freely##5##2##(2007-11#1)(2007-12#2)(2010-5#1)(2011-3#1)
a freeway##2##2##(1996-3#2)
a freezing##2##2##(2008-1#1)(2008-4#1)
a frequency decrease##2##3##(2008-10#2)
a frequency of 0##5##4##(2008-10#2)(2008-8#1)(2011-2#2)
a frequency of about##2##4##(1997-8#1)(2008-8#1)
a frequency of##23##3##(1995-3#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2011-2#2)(2013-1#1)
a frequency range of##3##4##(1996-5#1)(2008-11#1)(2008-2#1)
a frequency standard##2##3##(2007-11#2)
a frequency##45##2##(1993-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#6)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#2)(2010-5#1)(2011-2#2)(2013-1#1)
a frequency-domain optical##2##3##(2007-11#1)(2007-12#1)
a frequency-domain##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
a frequency-doubled Nd##3##3##(2007-12#2)(2008-2#1)
a frequency-doubled##15##2##(2007-11#1)(2007-12#8)(2008-2#3)(2008-3#3)
a frequency-independent##2##2##(2007-12#1)(2008-8#1)
a frequency-modulated continuous-wave technique##2##4##(2008-3#2)
a frequency-modulated continuous-wave##4##3##(2008-3#4)
a frequency-modulated##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
a frequency-resolved optical gating (FROG)##2##5##(2007-11#1)(2007-12#1)
a frequency-resolved optical gating##4##4##(2007-11#3)(2007-12#1)
a frequency-resolved##5##2##(2007-11#4)(2007-12#1)
a frequency-stabilized##2##2##(2008-2#1)(2008-3#1)
a frequent and##4##3##(1993-12#1)(1993-3#1)(1994-2#1)(2013-1#1)
a frequent cause of##7##4##(1990-9#1)(1991-8#1)(1992-4#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
a frequent complication in##3##4##(2008-5#1)(2011-2#1)(2012-3#1)
a frequent complication##6##3##(2008-1#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
a frequent source of mutations in##2##6##(1990-8#2)
a frequent target##2##3##(2008-11#1)(2008-9#1)
a frequent##41##2##(1990-10#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-4#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-10#1)(1996-11#1)(1996-6#2)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a frequently used##3##3##(2008-5#1)(2012-12#1)(2013-8#1)
a frequently##9##2##(2007-11#2)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
a fresh##8##2##(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
a freshly##2##2##(1992-6#1)(1993-3#1)
a freshwater##2##2##(2008-7#2)
a friend's##2##2##(2010-5#1)(2013-8#1)
a friendly and##2##3##(1992-12#1)(1996-8#1)
a friendly##3##2##(1992-12#1)(1996-8#1)(2011-3#1)
a fringe pattern that##2##4##(2008-2#1)(2008-3#1)
a fringe pattern##7##3##(2007-11#1)(2008-2#3)(2008-3#3)
a fringe##10##2##(2007-11#1)(2008-2#5)(2008-3#4)
a froid##3##2##(2008-5#3)
a frontal lobectomy##2##3##(2008-7#2)
a frontal##8##2##(1995-6#1)(2008-10#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-12#1)
a frozen##3##2##(2008-3#2)(2008-8#1)
a fuel##2##2##(2008-3#1)(2008-5#1)
a full agonist##4##3##(1992-8#1)(1995-11#1)(1995-3#1)(2009-8#1)
a full diet##2##3##(1993-2#1)(2013-8#1)
a full factorial design##2##4##(2008-10#2)
a full length cDNA##2##4##(1991-9#1)(1994-6#1)
a full length##7##3##(1991-5#2)(1991-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(2008-9#1)
a full range of##3##4##(1997-3#1)(2008-3#1)(2013-1#1)
a full recovery##8##3##(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
a full set of##2##4##(2008-10#1)(2008-7#1)
a full spectrum of##2##4##(2007-12#1)(2008-5#1)
a full##78##2##(1991-5#2)(1991-9#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#10)(2008-5#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
a full-aperture##2##2##(2008-3#2)
a full-length cDNA clone of##2##5##(1997-3#1)(2008-10#1)
a full-length cDNA clone##3##4##(1997-3#1)(2008-10#2)
a full-length cDNA##11##3##(1991-2#1)(1991-9#1)(1994-12#2)(1996-3#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-8#1)
a full-length functional##2##3##(1993-12#1)(1995-2#1)
a full-length infectious clone of##2##5##(2008-10#1)(2008-9#1)
a full-length infectious clone##3##4##(2008-10#1)(2008-9#2)
a full-length##26##2##(1990-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-12#1)(1994-12#2)(1995-12#1)(1995-2#2)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#6)
a full-mouth rehabilitation##2##3##(2009-8#2)
a full-mouth##3##2##(2009-8#3)
a full-scale clinical##2##3##(2008-1#1)(2008-10#1)
a full-scale##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
a full-term infant##2##3##(1994-12#1)(2011-2#1)
a full-time##2##2##(1994-2#1)(1996-3#1)
a fully automated##11##3##(1994-1#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-11#1)(2010-5#1)(2011-1#1)
a fully continuous wave-front distribution##2##5##(2008-2#2)
a fully developed##3##3##(2008-2#1)(2008-7#1)(2009-8#1)
a fully integrated##4##3##(1990-11#1)(1991-12#1)(2008-1#1)(2008-4#1)
a fully##53##2##(1990-11#1)(1991-12#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
a fully-supervised learning##2##3##(2010-7#2)
a fulminant form##2##3##(2008-5#1)(2009-4#1)
a fulminant##3##2##(2007-7#1)(2008-5#1)(2009-4#1)
a fulminating##2##2##(2008-12#1)(2011-2#1)
a fumigated##2##2##(2008-10#2)
a function for##2##3##(2008-11#1)(2012-2#1)
a function in the##2##4##(2008-10#2)
a function in##4##3##(1995-8#1)(2008-10#2)(2012-2#1)
a function of both the number of##2##7##(2008-10#1)(2008-3#1)
a function of both the##4##5##(2008-10#2)(2008-3#1)(2008-7#1)
a function of both##11##4##(1994-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
a function of disease##2##4##(2008-10#2)
a function of distance##2##4##(2008-5#1)(2008-8#1)
a function of incidence##3##4##(2008-10#2)(2008-2#1)
a function of income##3##4##(2008-8#1)(2010-2#2)
a function of laser##5##4##(2007-11#2)(2008-2#1)(2008-3#2)
a function of modulation##2##4##(2007-12#1)(2008-3#1)
a function of pH##19##4##(1990-5#1)(1990-8#1)(1993-11#1)(1995-5#1)(1996-12#1)(2008-10#13)(2013-1#1)
a function of population##2##4##(2008-9#2)
a function of the angle of incidence##3##7##(2008-2#1)(2008-3#2)
a function of the degree of##4##6##(1991-5#1)(2007-12#2)(2008-3#1)
a function of the extent##2##5##(1994-12#1)(2008-7#1)
a function of the length of the##2##7##(1991-9#1)(1992-8#1)
a function of the length##3##5##(1991-9#1)(1992-8#1)(2007-12#1)
a function of the local##2##5##(2008-9#1)(2009-12#1)
a function of the parameters##2##5##(2008-10#1)(2008-2#1)
a function of the rate of##2##6##(2008-10#1)(2008-11#1)
a function of the scattering##3##5##(2008-2#1)(2008-3#2)
a function of the specific energy dissipation##2##7##(2008-7#2)
a function of the total##3##5##(1991-9#1)(2008-10#1)(2011-1#1)
a function of the##139##4##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-6#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-7#2)(2007-11#5)(2007-12#8)(2008-10#20)(2008-11#2)(2008-2#19)(2008-3#37)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
a function of time##24##4##(1990-8#1)(1991-5#1)(1996-4#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2010-4#1)(2010-7#1)
a function of##452##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1994-12#2)(1994-2#1)(1994-5#4)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#1)(2007-11#19)(2007-12#17)(2007-8#1)(2008-1#2)(2008-10#103)(2008-11#11)(2008-12#2)(2008-2#39)(2008-3#88)(2008-4#2)(2008-5#15)(2008-6#5)(2008-7#9)(2008-8#10)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#8)(2012-4#1)(2013-1#5)(2013-8#3)
a function that##3##3##(2007-8#1)(2008-9#1)(2010-2#1)
a function##477##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1994-12#2)(1994-2#1)(1994-5#4)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#1)(2007-11#21)(2007-12#17)(2007-8#2)(2008-1#2)(2008-10#110)(2008-11#12)(2008-12#2)(2008-2#39)(2008-3#89)(2008-4#2)(2008-5#15)(2008-6#6)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#11)(2012-4#1)(2013-1#5)(2013-8#3)
a functional TSH##2##3##(1993-3#2)
a functional activity##2##3##(2008-4#1)(2008-5#1)
a functional analysis of##2##4##(2008-11#1)(2011-3#1)
a functional assay##2##3##(1994-8#1)(1997-4#1)
a functional coupling##2##3##(1994-6#1)(1995-6#1)
a functional form##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
a functional genomics##2##3##(2008-7#2)
a functional group##2##3##(2008-10#1)(2008-11#1)
a functional ingredient##2##3##(2008-5#1)(2010-4#1)
a functional magnetic resonance imaging (fMRI)##2##6##(2008-11#1)(2009-2#1)
a functional receptor##3##3##(1993-2#1)(1993-8#1)(1995-11#1)
a functional role in##2##4##(1992-3#1)(2010-10#1)
a functional role##8##3##(1992-3#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-11#1)(2009-1#1)(2009-12#1)(2010-10#1)
a functional similarity##3##3##(1994-12#1)(1994-3#1)(2008-8#1)
a functional unit##2##3##(2011-2#1)(2012-3#1)
a functional variation##2##3##(1994-12#2)
a functional##128##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#2)(1992-3#2)(1992-8#5)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#4)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#9)(2008-11#9)(2008-2#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
a functionalized##4##2##(2008-10#3)(2008-2#1)
a functionally redundant role##2##4##(2009-10#2)
a functionally##14##2##(1990-5#1)(1990-8#1)(1993-3#1)(1995-11#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-10#2)(2012-2#1)(2013-1#1)
a functioning##8##2##(1992-3#1)(1995-2#1)(2008-1#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
a fundamental activity of##2##4##(1995-12#1)(2008-9#1)
a fundamental aspect of##2##4##(2008-12#1)(2008-9#1)
a fundamental biological##2##3##(2008-11#1)(2008-8#1)
a fundamental function of the##2##5##(2007-8#1)(2008-4#1)
a fundamental limit##2##3##(2007-11#1)(2012-2#1)
a fundamental part of##2##4##(2010-11#2)
a fundamental problem##3##3##(1991-3#1)(2008-3#1)(2008-6#1)
a fundamental process##2##3##(2012-2#1)(2013-8#1)
a fundamental role in the regulation of##2##7##(2008-4#1)(2013-7#1)
a fundamental role in##4##4##(2008-4#1)(2008-8#2)(2013-7#1)
a fundamental task for##2##4##(2008-11#1)(2008-5#1)
a fundamental tool for##2##4##(2008-4#1)(2011-2#1)
a fundamental##70##2##(1991-1#1)(1991-3#1)(1991-5#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#1)(2008-8#6)(2008-9#5)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#2)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
a fundamentally##2##2##(2008-7#1)(2010-8#1)
a fungal isolate##2##3##(2008-10#2)
a fungal pathogen##2##3##(2008-9#2)
a fungal##18##2##(1990-9#1)(1992-12#1)(1992-3#1)(1995-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-9#3)(2011-2#1)(2012-6#1)
a fungicide##7##2##(2008-10#7)
a fungus##5##2##(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-8#1)
a fur mutation##2##3##(2009-6#2)
a furan##2##2##(2008-6#1)(2009-10#1)
a furnace##2##2##(2008-10#2)
a further 4##2##3##(2008-3#1)(2008-7#1)
a further decrease##2##3##(1991-6#1)(1994-3#1)
a further improvement##2##3##(2008-2#1)(2008-3#1)
a further increase in the##2##5##(1992-6#1)(2008-2#1)
a further increase in##5##4##(1992-6#1)(1994-11#1)(2008-2#1)(2008-5#1)(2013-8#1)
a further increase##7##3##(1992-6#1)(1993-11#1)(1994-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
a further reduction in##2##4##(1991-5#1)(2008-5#1)
a further reduction##3##3##(1991-5#1)(1992-3#1)(2008-5#1)
a further significant##2##3##(2007-11#1)(2007-2#1)
a further step##3##3##(1995-2#1)(1997-3#1)(2008-10#1)
a further study##2##3##(1997-4#1)(2008-5#1)
a further##60##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
a fused##2##2##(2008-2#1)(2008-8#1)
a fused-silica capillary##3##3##(1994-9#1)(1996-5#1)(2008-5#1)
a fused-silica microsphere##4##3##(2007-12#4)
a fused-silica##14##2##(1994-9#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#1)(2008-5#1)
a fusion gene##3##3##(1996-12#1)(2008-8#1)(2010-5#1)
a fusion of two##2##4##(1994-8#1)(2008-10#1)
a fusion of##3##3##(1991-5#1)(1994-8#1)(2008-10#1)
a fusion protein between##3##4##(1991-9#1)(1994-8#1)(2008-8#1)
a fusion protein of##2##4##(1990-8#1)(1996-12#1)
a fusion protein which##2##4##(1991-3#1)(1992-12#1)
a fusion protein##14##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)
a fusion##26##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-8#2)(1996-12#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-5#1)(2012-3#1)
a future in##2##3##(1990-6#1)(2012-2#1)
a future##24##2##(1990-6#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#2)(2012-9#1)
a fuzzy logic##3##3##(2008-10#2)(2008-8#1)
a fuzzy##10##2##(2007-12#3)(2008-1#1)(2008-10#2)(2008-8#1)(2010-8#2)(2011-2#1)
a gain coefficient of##2##4##(2007-11#1)(2008-3#1)
a gain medium##2##3##(2007-12#1)(2008-2#1)
a gain of 1##2##4##(2007-11#1)(2008-2#1)
a gain of##7##3##(2007-11#2)(2008-2#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-8#1)
a gain##16##2##(2007-11#6)(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-8#1)
a gain-switched laser diode##2##4##(2008-2#2)
a galactose-specific##2##2##(1990-12#1)(2008-6#1)
a gallbladder##2##2##(2013-1#1)(2013-8#1)
a gallium/silica interface##2##3##(2007-12#2)
a galvanic detector##2##3##(2008-10#2)
a galvanic##5##2##(2008-10#4)(2008-5#1)
a galvanometer##2##2##(2007-12#1)(2008-3#1)
a gamma##4##2##(1992-10#1)(1993-11#1)(2008-11#1)(2008-5#1)
a gamma-ray microscope##2##3##(2009-6#2)
a ganglion##4##2##(2008-9#4)
a ganglioside##3##2##(1990-5#1)(1994-3#1)(1994-9#1)
a gap between##2##3##(2007-10#1)(2011-2#1)
a gap in the##2##4##(1991-1#1)(2010-3#1)
a gap in##4##3##(1991-1#1)(2008-11#1)(2008-8#1)(2010-3#1)
a gap of##2##3##(2007-11#1)(2013-8#1)
a gap##13##2##(1991-1#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
a gas chromatograph##5##3##(2008-10#4)(2008-11#1)
a gas chromatographic##3##3##(2008-10#2)(2012-2#1)
a gas chromatography-mass spectrometry##2##4##(2007-10#1)(2008-10#1)
a gas chromatography/mass##2##3##(2008-10#1)(2013-1#1)
a gas flow rate of##2##5##(2008-6#1)(2013-8#1)
a gas jet##2##3##(2008-3#2)
a gas##30##2##(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a gas-filled hollow waveguide##2##4##(2007-11#2)
a gas-filled##3##2##(2007-11#3)
a gas-liquid separator##3##3##(2008-10#3)
a gas-liquid##4##2##(2008-10#4)
a gas-permeable##4##2##(2008-10#3)(2008-7#1)
a gaseous##3##2##(2008-10#3)
a gastric##4##2##(1993-12#1)(1996-11#1)(2008-12#1)(2008-9#1)
a gastrin-like##2##2##(1990-7#2)
a gastrointestinal##3##2##(1996-3#1)(2012-12#1)(2012-3#1)
a gate##3##2##(2008-7#1)(2009-11#2)
a gating##4##2##(2008-2#1)(2008-3#2)(2010-12#1)
a gel filtration column##2##4##(1995-3#1)(2010-2#1)
a gel filtration##3##3##(1995-3#1)(1997-4#1)(2010-2#1)
a gel formation##2##3##(1994-3#1)(2011-2#1)
a gel##17##2##(1992-12#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#2)(2011-2#1)
a gelatin##5##2##(1994-5#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
a gelling##2##2##(1993-8#1)(2010-3#1)
a gender perspective##2##3##(2009-10#1)(2009-5#1)
a gender##5##2##(1993-6#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-12#1)
a gene and##2##3##(2008-4#2)
a gene associated with##2##4##(1997-8#1)(2008-12#1)
a gene coding for##3##4##(1992-3#1)(1994-2#1)(1994-3#1)
a gene designated##2##3##(2008-10#1)(2009-8#1)
a gene encoding a##4##4##(1994-12#2)(1994-5#1)(1995-11#1)
a gene encoding the##2##4##(1993-6#1)(1996-6#1)
a gene encoding##10##3##(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-6#1)
a gene expression##2##3##(1993-8#1)(2013-8#1)
a gene family##3##3##(1993-12#1)(2008-8#2)
a gene for##4##3##(1991-2#1)(2007-7#1)(2008-10#2)
a gene from##2##3##(2008-10#1)(2008-7#1)
a gene in the##3##4##(1990-5#1)(2008-4#1)(2008-7#1)
a gene in##5##3##(1990-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
a gene involved in##3##4##(1990-5#1)(2008-8#1)(2008-9#1)
a gene is##2##3##(1997-8#1)(2007-11#1)
a gene of interest##4##4##(1996-6#2)(2008-9#2)
a gene on##2##3##(1995-8#1)(2008-7#1)
a gene other than##2##4##(1994-8#1)(2008-10#1)
a gene product##5##3##(1990-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-4#1)
a gene required for##2##4##(1993-3#1)(2008-10#1)
a gene that encodes a##4##5##(1990-11#1)(1993-2#1)(2008-10#2)
a gene that encodes##5##4##(1990-11#1)(1993-2#1)(2008-10#3)
a gene that##10##3##(1990-11#2)(1993-2#1)(1995-2#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-2#1)
a gene therapy clinical trial for##2##6##(1994-5#1)(2008-5#1)
a gene therapy vector##2##4##(2008-5#2)
a gene therapy##5##3##(1994-5#1)(1995-2#1)(2008-5#3)
a gene##120##2##(1990-11#4)(1990-5#2)(1991-2#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#2)(1995-2#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-3#2)(1996-6#5)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-4#8)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#4)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
a gene-for-gene interaction##2##3##(2008-10#2)
a gene-for-gene model##2##3##(2008-10#2)
a gene-for-gene relationship##4##3##(2008-10#4)
a gene-for-gene##10##2##(2008-10#10)
a gene-specific##2##2##(1997-7#1)(2008-9#1)
a general anaesthetic##3##3##(1994-3#2)(1996-11#1)
a general analytical##2##3##(2008-2#1)(2008-8#1)
a general and##5##3##(1990-11#1)(2008-11#1)(2008-7#2)(2008-9#1)
a general approach is##2##4##(2008-2#1)(2008-4#1)
a general approach##5##3##(1995-2#2)(2008-2#1)(2008-3#1)(2008-4#1)
a general background##2##3##(1993-2#1)(2008-10#1)
a general decline in##2##4##(2008-10#1)(2012-2#1)
a general description of##2##4##(2008-1#1)(2008-4#1)
a general discussion##3##3##(2008-4#2)(2011-2#1)
a general disease model##2##4##(2008-10#2)
a general equation##2##3##(2008-10#2)
a general feature of##4##4##(1995-2#1)(1997-3#1)(1997-7#1)(2011-1#1)
a general framework for##3##4##(2008-10#1)(2008-2#1)(2010-11#1)
a general framework##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-11#1)
a general hospital##7##3##(2007-7#1)(2008-7#1)(2011-2#1)(2013-1#4)
a general hospital]##3##3##(1993-10#1)(2013-1#2)
a general introduction to##3##4##(1997-3#1)(2008-4#2)
a general lack of##3##4##(1991-12#1)(2008-11#1)(2012-3#1)
a general method for the##2##5##(2008-9#1)(2012-2#1)
a general method for##5##4##(1994-8#1)(2008-4#1)(2008-9#2)(2012-2#1)
a general method##6##3##(1994-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-2#1)
a general model of##3##4##(1995-6#1)(2008-3#1)(2013-1#1)
a general model##5##3##(1995-6#1)(2008-3#1)(2008-8#1)(2013-1#2)
a general overview of the##2##5##(2008-11#1)(2011-3#1)
a general overview of##6##4##(2008-11#2)(2008-4#1)(2008-7#1)(2011-3#1)(2012-2#1)
a general phenomenon in##2##4##(2008-10#2)
a general phenomenon##4##3##(1997-3#1)(2007-11#1)(2008-10#2)
a general population##7##3##(1991-1#1)(1995-9#1)(1997-1#1)(2008-11#3)(2009-2#1)
a general practice out of hours cooperative##2##7##(1997-5#2)
a general practice##4##3##(1990-2#1)(1993-12#1)(1997-5#2)
a general practitioner and##2##4##(1995-3#1)(1996-8#1)
a general practitioner##10##3##(1993-2#1)(1993-6#1)(1995-3#1)(1996-11#1)(1996-8#2)(2009-3#2)(2010-1#1)(2011-1#1)
a general principle##3##3##(2009-8#2)(2011-1#1)
a general procedure##2##3##(1990-8#1)(2008-4#1)
a general property of##2##4##(2007-12#1)(2008-7#1)
a general quantitative framework for##2##5##(2009-5#2)
a general relationship between##3##4##(2008-10#2)(2008-9#1)
a general rule##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
a general solution##2##3##(2007-12#1)(2008-3#1)
a general stress protein##2##4##(2009-7#2)
a general stress##3##3##(1997-7#1)(2009-7#2)
a general technique##2##3##(2008-2#1)(2009-11#1)
a general term##2##3##(2008-7#1)(2010-12#1)
a general trend##3##3##(2008-10#2)(2012-3#1)
a general##234##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#3)(1997-7#2)(2007-11#4)(2007-12#7)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#13)(2008-2#8)(2008-3#17)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2011-1#6)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#10)(2013-8#1)
a general-purpose##4##2##(1994-8#1)(2008-3#3)
a generalist##6##2##(2008-8#3)(2008-9#2)(2011-10#1)
a generalization of the##5##4##(2007-11#1)(2008-10#1)(2008-3#2)(2011-1#1)
a generalization of##7##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-1#1)
a generalization##8##2##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-4#1)(2011-1#1)
a generalized Lorenz-Mie theory##2##4##(2007-12#1)(2008-3#1)
a generalized linear model##2##4##(1995-12#1)(2008-10#1)
a generalized stress##2##3##(2008-7#1)(2009-10#1)
a generalized theoretical model for the response of##2##8##(2008-2#2)
a generalized##41##2##(1992-6#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)
a generally##9##2##(1990-11#1)(1993-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-3#1)
a generation of##2##3##(2009-12#1)(2013-1#1)
a generation##5##2##(1993-11#1)(2008-12#1)(2009-12#1)(2011-2#1)(2013-1#1)
a generic drug of##2##4##(2013-8#2)
a generic model##2##3##(2008-11#1)(2008-6#1)
a generic##21##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-10#2)(2010-3#1)(2013-8#3)
a genetic algorithm for##2##4##(2008-3#1)(2010-8#1)
a genetic algorithm##8##3##(2007-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-8#1)
a genetic analysis##2##3##(2008-1#1)(2008-10#1)
a genetic anomaly##2##3##(2008-11#1)(2008-6#1)
a genetic approach to##2##4##(1993-12#1)(1995-2#1)
a genetic basis for##2##4##(2008-11#1)(2008-8#1)
a genetic basis##6##3##(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)
a genetic component in##2##4##(2008-8#1)(2012-2#1)
a genetic component##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
a genetic contribution##2##3##(2007-10#1)(2008-7#1)
a genetic disorder##3##3##(2007-7#1)(2008-2#1)(2013-1#1)
a genetic distance of 2##2##5##(2008-10#1)(2008-9#1)
a genetic distance of##3##4##(2008-10#2)(2008-9#1)
a genetic effect##3##3##(1994-2#3)
a genetic linkage map of##2##5##(1996-8#1)(2008-10#1)
a genetic linkage map##4##4##(1996-8#1)(2008-10#2)(2012-3#1)
a genetic locus##2##3##(1997-7#1)(1997-8#1)
a genetic marker##5##3##(1993-8#1)(1994-12#2)(2008-12#1)(2008-5#1)
a genetic predisposition##5##3##(1994-5#1)(2007-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
a genetic structure##3##3##(2008-10#3)
a genetic##101##2##(1990-5#1)(1991-1#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-5#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-12#3)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
a genetically diverse##3##3##(2008-10#2)(2012-3#1)
a genetically engineered##4##3##(1995-11#1)(1995-2#1)(1997-2#1)(2008-11#1)
a genetically heterogeneous##3##3##(1995-5#1)(2009-10#1)(2013-1#1)
a genetically##22##2##(1990-2#1)(1991-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-4#2)(2009-10#1)(2009-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
a genital##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
a genome##13##2##(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-2#1)
a genome-wide association##2##3##(2009-8#1)(2012-3#1)
a genome-wide##14##2##(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#5)(2013-1#1)
a genomic DNA library##2##4##(1991-9#1)(1993-2#1)
a genomic DNA##3##3##(1990-12#1)(1991-9#1)(1993-2#1)
a genomic clone of the human##2##6##(1992-8#1)(1997-4#1)
a genomic clone##7##3##(1990-12#1)(1991-5#1)(1992-8#1)(1994-12#1)(1997-2#1)(1997-4#1)(1997-6#1)
a genomic region##2##3##(2009-5#1)(2011-1#1)
a genomic##34##2##(1990-12#2)(1990-5#1)(1991-5#1)(1991-9#2)(1992-8#2)(1993-2#2)(1993-6#1)(1994-12#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(2008-10#9)(2008-7#3)(2009-5#1)(2011-1#2)(2013-8#1)
a genotype##3##2##(2008-10#2)(2012-3#1)
a genotype-specific##2##2##(2008-10#1)(2009-5#1)
a gentle##3##2##(1997-6#1)(2008-10#1)(2008-5#1)
a gentleman##2##2##(2013-1#2)
a genuine##2##2##(2008-3#1)(2008-7#1)
a genus of##2##3##(2008-10#1)(2008-9#1)
a genus##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
a genus-specific##2##2##(1996-11#2)
a geographic information system##2##4##(2008-8#2)
a geographic##6##2##(2008-10#4)(2008-8#2)
a geographical##3##2##(2007-7#1)(2008-10#2)
a geographically##3##2##(1995-1#1)(2008-7#1)(2012-3#1)
a geometric##9##2##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#4)
a geometrical model of##2##4##(2008-3#1)(2009-4#1)
a geometrical##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2009-4#1)
a geriatric assessment unit##4##4##(1990-5#2)(1992-12#1)(1992-2#1)
a geriatric patient##2##3##(2013-8#2)
a geriatric##11##2##(1990-3#1)(1990-5#2)(1992-1#1)(1992-12#2)(1992-2#1)(2008-7#1)(2011-2#1)(2013-8#2)
a germ plasm##2##3##(2008-10#2)
a germ##3##2##(2008-10#3)
a germin-like protein##2##3##(2008-10#2)
a germline mutation of the p53##2##6##(2008-6#1)(2010-3#1)
a giant leap towards personalized medicine##2##6##(2010-4#2)
a giant##26##2##(1991-11#1)(1993-6#1)(1997-8#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#4)
a gingival##2##2##(2009-8#1)(2012-3#1)
a girl##5##2##(1991-6#1)(1997-3#1)(2007-7#1)(2008-4#1)(2011-1#1)
a given area##3##3##(2008-2#1)(2008-8#2)
a given cell type##2##4##(2008-11#1)(2008-4#1)
a given cell##5##3##(1996-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)
a given compound##3##3##(1991-5#1)(1993-12#1)(2008-10#1)
a given concentration##2##3##(1991-12#1)(2008-10#1)
a given direction (anisotropy in##2##5##(2008-10#2)
a given direction##3##3##(2008-10#3)
a given gene##4##3##(1991-11#1)(1997-9#1)(2008-8#1)(2011-2#1)
a given hospital##2##3##(1992-2#2)
a given host##3##3##(2008-10#3)
a given laser##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a given level of##2##4##(2008-8#2)
a given location##2##3##(2008-10#1)(2008-9#1)
a given number of##5##4##(1992-9#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)
a given optical##2##3##(2008-3#2)
a given patient##6##3##(1992-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2012-1#1)
a given person##2##3##(2008-11#1)(2010-6#1)
a given point in time##3##5##(2007-2#1)(2008-1#1)(2008-10#1)
a given point in##4##4##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
a given point##5##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)
a given protein##7##3##(1997-2#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-12#1)
a given sample##2##3##(2008-10#1)(2009-10#1)
a given sequence of##2##4##(2008-11#1)(2008-2#1)
a given set of##6##4##(2007-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2011-3#1)
a given size##2##3##(2008-2#1)(2008-3#1)
a given species##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
a given target##3##3##(1995-2#1)(2008-3#1)(2008-7#1)
a given time##3##3##(1995-3#1)(2008-3#1)(2008-9#1)
a given value of the##2##5##(1992-6#1)(2008-10#1)
a given value of##4##4##(1992-6#1)(2008-10#2)(2008-5#1)
a given wavelength##4##3##(2008-10#1)(2008-3#3)
a given##252##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#2)(1997-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#47)(2008-11#12)(2008-12#2)(2008-2#20)(2008-3#35)(2008-4#7)(2008-5#4)(2008-7#6)(2008-8#11)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#3)
a gland##2##2##(2008-7#1)(2009-10#1)
a glandular##2##2##(2007-12#2)
a glass capillary tube##3##4##(2007-12#2)(2008-3#1)
a glass column##4##3##(2008-10#3)(2008-6#1)
a glass electrode as the indicator electrode##2##7##(2008-10#2)
a glass electrode as##3##4##(2008-10#3)
a glass electrode##8##3##(2008-10#8)
a glass plate by##2##4##(2008-2#1)(2008-3#1)
a glass plate##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
a glass slide##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
a glass substrate##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
a glass##56##2##(1991-12#1)(1991-5#1)(1995-12#1)(1995-3#1)(2007-11#5)(2007-12#4)(2008-10#26)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
a glassy carbon (GC) electrode##4##5##(2008-10#4)
a glassy carbon electrode and the##2##6##(2008-10#1)(2013-1#1)
a glassy carbon electrode and##4##5##(2008-10#3)(2013-1#1)
a glassy carbon electrode at##3##5##(2008-10#3)
a glassy carbon electrode in##2##5##(2008-10#2)
a glassy carbon electrode is##2##5##(1990-12#1)(2008-10#1)
a glassy carbon electrode modified with##3##6##(2008-10#3)
a glassy carbon electrode modified##4##5##(2008-10#4)
a glassy carbon electrode surface##3##5##(2008-10#3)
a glassy carbon electrode##42##4##(1990-12#1)(2008-10#40)(2013-1#1)
a glassy carbon##50##3##(1990-12#1)(2008-10#48)(2013-1#1)
a glassy##52##2##(1990-12#1)(2008-10#49)(2010-4#1)(2013-1#1)
a glial##3##2##(2008-11#1)(2008-7#1)(2012-1#1)
a global and##2##3##(2011-1#1)(2013-1#1)
a global approach to dispersion##2##5##(2007-11#2)
a global approach to##3##4##(1996-3#1)(2007-11#2)
a global approach##5##3##(1996-3#1)(1996-4#1)(2007-11#2)(2008-8#1)
a global classification of##2##4##(2008-5#1)(2008-7#1)
a global clinical##2##3##(2008-10#1)(2011-2#1)
a global gene##2##3##(2008-10#1)(2008-7#1)
a global health problem##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
a global level##2##3##(2010-2#1)(2012-12#1)
a global optimizer is used##2##5##(2008-3#2)
a global optimizer is##3##4##(2008-3#3)
a global perspective##4##3##(1993-1#1)(2008-6#1)(2008-9#1)(2011-2#1)
a global scale##4##3##(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
a global strategy##4##3##(1994-9#1)(1997-7#1)(2008-4#1)(2008-7#1)
a global view of the##2##5##(2008-2#1)(2008-7#1)
a global view of##3##4##(2008-2#1)(2008-7#1)(2010-5#1)
a global##81##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-3#2)(1996-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-4#1)(2009-5#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#3)
a globally##6##2##(1990-7#1)(1990-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#1)
a globular##3##2##(1995-3#2)(1997-2#1)
a glove##2##2##(2008-11#1)(2012-2#1)
a glucose biosensor##2##3##(2008-10#2)
a glucose##19##2##(1990-8#1)(1995-11#1)(1995-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#2)(2010-2#2)(2010-8#1)(2011-1#1)
a glutamate receptor##2##3##(2008-8#1)(2012-2#1)
a glutamate##5##2##(1995-2#1)(1995-5#2)(2008-8#1)(2012-2#1)
a glutamic acid##3##3##(1993-8#1)(2008-10#2)
a glutamine##9##2##(1990-7#1)(1992-3#1)(1994-5#1)(1995-5#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
a glutathione S-transferase##2##3##(1994-12#1)(1995-6#1)
a glutathione##3##2##(1994-12#1)(1995-6#2)
a gluten-free diet##7##3##(1991-2#3)(2007-5#2)(2011-2#2)
a glycerol##2##2##(1990-7#1)(2007-11#1)
a glycine to##2##3##(1992-8#1)(1996-5#1)
a glycine##7##2##(1992-8#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-8#3)
a glycolipid sorting defect in hepatocarcinogenesis##2##6##(1990-5#2)
a glycopeptide##2##2##(1990-5#1)(2008-8#1)
a glycoprotein with a##2##4##(1990-5#1)(1993-3#1)
a glycoprotein##12##2##(1990-5#1)(1990-7#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#2)
a glycosaminoglycan##2##2##(1990-5#1)(1993-2#1)
a glycosylated##5##2##(1992-10#2)(1992-12#1)(1993-6#1)(1994-3#1)
a gnotobiotic system##2##3##(2008-10#2)
a go##2##2##(2008-7#1)(2013-8#1)
a goal##8##2##(1993-3#3)(1996-1#1)(2006-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
a goat##5##2##(1990-3#1)(1997-5#1)(1997-7#1)(2008-11#1)(2011-1#1)
a gold electrode modified with decanethiol##2##6##(2008-10#2)
a gold electrode modified with##4##5##(2008-10#4)
a gold electrode##7##3##(2008-10#7)
a gold film##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
a gold standard in##2##4##(2011-2#1)(2012-12#1)
a gold standard##6##3##(1997-8#2)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
a gold##34##2##(1991-7#1)(1997-8#2)(2007-12#5)(2008-10#18)(2008-12#1)(2008-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
a goniometer##4##2##(2006-4#1)(2008-12#1)(2008-9#1)(2009-1#1)
a good abstract##2##3##(2008-12#1)(2009-4#1)
a good accuracy##2##3##(2008-10#2)
a good affinity##2##3##(1993-8#1)(2008-4#1)
a good agreement between the##3##5##(2008-10#3)
a good agreement between##4##4##(2008-10#4)
a good agreement with the certified##2##6##(2008-10#2)
a good agreement with the##8##5##(2007-11#1)(2007-12#1)(2008-10#6)
a good agreement with those##2##5##(2008-10#1)(2012-8#1)
a good agreement with##12##4##(2007-11#1)(2007-12#1)(2008-10#8)(2010-2#1)(2012-8#1)
a good agreement##21##3##(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#1)(2010-2#1)(2012-8#1)
a good alternative for the##2##5##(2007-8#1)(2008-10#1)
a good alternative for##4##4##(2007-8#1)(2008-10#1)(2009-8#1)(2013-7#1)
a good alternative to the##2##5##(2008-10#1)(2013-1#1)
a good alternative to##7##4##(1994-9#1)(1995-6#1)(2008-10#2)(2010-4#1)(2013-1#2)
a good alternative##13##3##(1994-9#1)(1995-6#1)(2007-8#1)(2008-10#3)(2009-8#1)(2010-4#2)(2013-1#3)(2013-7#1)
a good approximation of##2##4##(2008-10#1)(2008-2#1)
a good assessment##2##3##(2011-2#2)
a good behavior##2##3##(2007-11#2)
a good calibration##2##3##(2008-10#1)(2008-3#1)
a good candidate for##11##4##(1992-3#1)(1992-6#1)(1993-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
a good candidate##15##3##(1992-3#1)(1992-6#1)(1993-9#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
a good chance##2##3##(1991-3#1)(2008-10#1)
a good choice##2##3##(1997-6#1)(2007-8#1)
a good clinical outcome##2##4##(2007-8#1)(2013-1#1)
a good clinical##6##3##(2007-8#2)(2008-7#1)(2013-1#2)(2013-8#1)
a good comparability##2##3##(2008-10#2)
a good correlation between the##9##5##(1990-7#2)(1992-3#1)(1994-6#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-5#1)
a good correlation between##11##4##(1990-7#2)(1992-3#1)(1994-6#1)(1995-12#2)(2007-8#1)(2008-10#2)(2008-5#2)
a good correlation was found between the##2##7##(1997-6#1)(2008-10#1)
a good correlation was observed##2##5##(1994-6#1)(2008-3#1)
a good correlation was##4##4##(1994-6#1)(1997-6#1)(2008-10#1)(2008-3#1)
a good correlation##19##3##(1990-7#2)(1990-8#1)(1992-3#1)(1994-6#2)(1995-12#2)(1997-6#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#2)
a good cosmetic##2##3##(2012-12#1)(2013-8#1)
a good deal of##2##4##(1994-3#1)(2011-2#1)
a good diagnostic##2##3##(2008-10#1)(2008-11#1)
a good discriminating ability towards##3##5##(2008-10#3)
a good electrode##2##3##(2008-10#2)
a good estimate of the##2##5##(2008-10#1)(2008-5#1)
a good estimate##3##3##(2008-10#2)(2008-5#1)
a good estimation of the##2##5##(1995-9#1)(2008-10#1)
a good example of##3##4##(2008-2#1)(2009-3#1)(2009-5#1)
a good fit to##2##4##(1994-8#1)(2008-10#1)
a good fit##6##3##(1993-1#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
a good functional outcome##2##4##(2007-8#1)(2008-7#1)
a good functional##3##3##(2007-8#1)(2008-7#2)
a good histocompatibility##2##3##(2012-3#2)
a good in vitro model##3##5##(1993-8#1)(1994-8#1)(1994-9#1)
a good indicator of the##2##5##(2008-10#2)
a good indicator of##6##4##(2007-10#1)(2008-10#3)(2008-12#1)(2010-3#1)
a good indicator##7##3##(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-3#1)
a good linear correlation##2##4##(2008-10#1)(2011-1#1)
a good linear measure of##2##5##(1994-12#2)
a good linear relationship with the##2##6##(2008-10#2)
a good linear response##2##4##(2008-10#2)
a good linear##10##3##(1994-12#2)(2008-10#6)(2008-3#1)(2011-1#1)
a good linearity##4##3##(2008-10#2)(2008-11#1)(2011-3#1)
a good match with##2##4##(2012-2#1)(2013-8#1)
a good match##4##3##(2008-3#2)(2012-2#1)(2013-8#1)
a good model for studying##2##5##(1995-3#1)(2009-2#1)
a good model for the study of##2##7##(1991-12#1)(2008-9#1)
a good model for##6##4##(1991-12#1)(1993-11#1)(1994-5#1)(1995-3#1)(2008-9#1)(2009-2#1)
a good model to study##2##5##(2008-10#1)(2008-11#1)
a good model##9##3##(1991-12#1)(1993-11#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)
a good neurological##2##3##(1997-6#1)(2008-7#1)
a good option for##3##4##(2009-3#1)(2011-2#1)(2013-1#1)
a good option##4##3##(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
a good outcome for##2##4##(2008-7#1)(2009-12#1)
a good outcome##3##3##(2008-7#1)(2009-12#1)(2013-8#1)
a good point##2##3##(2007-11#1)(2008-12#1)
a good precision (R##2##4##(2008-10#2)
a good precision##6##3##(2008-10#6)
a good predictor of future##2##5##(2008-9#1)(2013-7#1)
a good predictor of##9##4##(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#2)(2008-9#2)(2013-1#1)(2013-7#1)
a good predictor##10##3##(2007-10#1)(2007-7#1)(2008-10#2)(2008-8#2)(2008-9#2)(2013-1#1)(2013-7#1)
a good prognosis for##2##4##(1992-5#1)(2011-1#1)
a good prognosis##10##3##(1991-8#1)(1992-5#1)(1995-4#1)(1997-6#1)(2006-10#1)(2008-10#2)(2011-1#1)(2012-3#2)
a good quality of life##3##5##(1992-11#1)(1996-3#1)(2012-3#1)
a good recovery##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
a good reproducibility##5##3##(2008-10#5)
a good response for##2##4##(2008-10#2)
a good response to##3##4##(1992-10#1)(2007-7#1)(2012-3#1)
a good response##7##3##(1992-10#1)(1992-12#1)(2007-7#1)(2008-10#3)(2012-3#1)
a good result in##2##4##(1996-9#1)(2007-11#1)
a good result##3##3##(1996-9#1)(2007-11#1)(2008-2#1)
a good safety##2##3##(2008-7#1)(2009-9#1)
a good security program##2##4##(1991-1#2)
a good selectivity for##4##4##(2008-10#4)
a good selectivity##6##3##(2008-10#6)
a good separation of##2##4##(2008-10#2)
a good separation##3##3##(2008-10#3)
a good source##2##3##(2008-10#1)(2008-11#1)
a good stability##3##3##(2008-10#3)
a good statistical##2##3##(2008-10#1)(2008-3#1)
a good substrate for the##4##5##(1990-5#1)(1991-5#1)(1995-6#1)(2008-10#1)
a good substrate for##5##4##(1990-5#1)(1991-5#1)(1994-11#1)(1995-6#1)(2008-10#1)
a good target for##2##4##(2008-10#1)(2008-9#1)
a good teacher##2##3##(2008-7#1)(2013-1#1)
a good therapeutic##2##3##(2007-7#1)(2013-1#1)
a good tool to##2##4##(2008-1#1)(2008-7#1)
a good tool##4##3##(1992-11#1)(2008-1#1)(2008-7#1)(2009-8#1)
a good understanding of the##2##5##(2008-2#1)(2013-1#1)
a good understanding of##3##4##(2008-2#1)(2008-9#1)(2013-1#1)
a good yield##2##3##(2008-10#1)(2008-11#1)
a good##410##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#4)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#6)(2007-12#2)(2007-7#4)(2007-8#7)(2008-1#3)(2008-10#121)(2008-11#19)(2008-12#6)(2008-2#7)(2008-3#15)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#8)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#10)(2012-7#1)(2012-8#1)(2013-1#17)(2013-7#3)(2013-8#10)
a government health##2##3##(2012-12#1)(2013-8#1)
a government##5##2##(1991-3#1)(1991-4#1)(1995-2#1)(2012-12#1)(2013-8#1)
a government-sponsored##2##2##(1991-5#1)(2007-12#1)
a grade##5##2##(1991-2#1)(1991-6#1)(2008-6#1)(2013-1#2)
a graded##4##2##(1993-6#1)(2007-11#1)(2008-5#2)
a gradient flow##4##3##(2008-10#3)(2008-4#1)
a gradient in##2##3##(2008-9#2)
a gradient of the##2##4##(1994-6#1)(2008-2#1)
a gradient of##6##3##(1994-6#1)(1995-3#1)(2007-12#2)(2008-2#1)(2008-4#1)
a gradient##22##2##(1994-6#1)(1995-3#1)(1997-2#1)(2007-12#3)(2008-10#7)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#2)(2011-1#1)(2012-3#1)
a grading##2##2##(2006-10#1)(2008-10#1)
a gradual and##2##3##(2008-3#1)(2011-2#1)
a gradual change##2##3##(1995-5#1)(2008-2#1)
a gradual decline in responding##2##5##(1993-6#2)
a gradual decline in##3##4##(1993-6#2)(2012-7#1)
a gradual decline##4##3##(1993-6#2)(2008-10#1)(2012-7#1)
a gradual decrease in the##3##5##(1995-6#1)(2008-10#1)(2008-11#1)
a gradual decrease in##7##4##(1990-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
a gradual decrease##9##3##(1990-11#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
a gradual increase in the##2##5##(1994-8#1)(2008-10#1)
a gradual increase in##5##4##(1994-11#1)(1994-8#1)(1996-5#1)(2008-10#2)
a gradual increase of osmotic pressure##3##6##(2008-11#3)
a gradual increase##10##3##(1994-11#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-7#1)(2011-2#1)
a gradual##39##2##(1990-11#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#4)(2012-7#1)(2013-1#1)
a graduate health##2##3##(1991-12#1)(1996-1#1)
a graduate nurse##2##3##(2008-11#2)
a graduate student##2##3##(1996-1#1)(2010-6#1)
a graduate##12##2##(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1996-1#2)(2008-11#2)(2010-6#1)(2012-3#1)(2013-1#2)
a graft##6##2##(1993-1#1)(1995-12#1)(2009-5#1)(2010-3#1)(2011-3#1)(2012-2#1)
a grafted##2##2##(2008-10#1)(2009-5#1)
a grain##2##2##(1991-9#1)(2011-2#1)
a grandchild##3##2##(2010-9#3)
a grant##2##2##(1995-3#1)(1996-1#1)
a granular##2##2##(2008-10#1)(2008-3#1)
a granulomatous##6##2##(1990-9#1)(2007-7#2)(2008-1#1)(2011-2#1)(2013-1#1)
a graphic##3##2##(1996-3#1)(2008-9#2)
a graphical design##2##3##(2011-2#2)
a graphical user interface##2##4##(2008-3#1)(2008-9#1)
a graphical##14##2##(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
a graphics processing unit##2##4##(2009-6#1)(2011-1#1)
a graphics##3##2##(2008-6#1)(2009-6#1)(2011-1#1)
a graphite atomizer##2##3##(2008-10#2)
a graphite furnace atomic absorption##5##5##(2008-10#5)
a graphite furnace##9##3##(2008-10#9)
a graphite tube##2##3##(2008-10#1)(2008-2#1)
a graphite##19##2##(2007-12#1)(2008-10#17)(2008-2#1)
a grass##4##2##(2008-8#1)(2012-2#3)
a grating coupler and##2##4##(2007-11#1)(2008-2#1)
a grating coupler##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a grating interferometer##2##3##(2008-3#2)
a grating is projected onto an##2##6##(2008-3#2)
a grating is##5##3##(2007-11#1)(2008-3#4)
a grating spectrometer##3##3##(2008-3#3)
a grating##34##2##(2007-11#7)(2007-12#1)(2008-2#6)(2008-3#19)(2008-5#1)
a gravid##2##2##(2011-1#1)(2011-2#1)
a gravitational-wave interferometer##2##3##(2007-11#1)(2008-2#1)
a gravitational-wave##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a gray##2##2##(2007-3#1)(2012-2#1)
a grazing##6##2##(1991-12#1)(2008-2#2)(2008-7#1)(2012-2#1)(2013-7#1)
a great challenge##5##3##(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
a great deal about##2##4##(1991-12#1)(2008-11#1)
a great deal has been##2##5##(1993-11#1)(1996-1#1)
a great deal in##3##4##(1991-1#1)(1991-12#1)(1991-2#1)
a great deal of attention##4##5##(1992-2#1)(2009-11#1)(2010-9#1)(2012-3#1)
a great deal of interest##2##5##(1992-9#1)(2010-12#1)
a great deal of work has been##2##7##(1994-11#1)(2008-10#1)
a great deal of work##4##5##(1991-1#1)(1994-11#1)(2007-8#1)(2008-10#1)
a great deal of##26##4##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a great deal##37##3##(1991-1#2)(1991-12#2)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a great diversity of##3##4##(2008-5#1)(2009-10#1)(2009-7#1)
a great effect on the##2##5##(2008-10#2)
a great effect on##3##4##(2007-12#1)(2008-10#2)
a great effect##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
a great impact on##2##4##(2011-2#1)(2012-12#1)
a great improvement on##2##4##(1995-6#1)(2008-10#1)
a great improvement##4##3##(1995-6#1)(2008-10#3)
a great influence on##4##4##(1992-6#1)(2008-10#1)(2008-3#1)(2010-11#1)
a great influence##5##3##(1992-6#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
a great need for##2##4##(1994-9#1)(2008-10#1)
a great need##6##3##(1994-9#1)(2008-10#2)(2008-6#1)(2009-11#1)(2013-1#1)
a great number of##4##4##(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
a great opportunity##2##3##(2010-11#1)(2012-3#1)
a great potential for##4##4##(1997-8#1)(2008-11#1)(2009-10#1)(2011-2#1)
a great potential in##2##4##(2008-11#1)(2008-6#1)
a great potential##8##3##(1994-1#1)(1997-8#1)(2008-11#2)(2008-6#2)(2009-10#1)(2011-2#1)
a great problem##2##3##(2008-12#1)(2010-8#1)
a great variety of##6##4##(1993-11#1)(1997-6#1)(2007-10#1)(2008-6#1)(2008-7#1)(2010-8#1)
a great##141##2##(1990-12#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)
a greater (P &lt##2##4##(2008-10#2)
a greater (P##3##3##(2008-10#2)(2010-12#1)
a greater burden##2##3##(2011-2#1)(2013-8#1)
a greater contribution##2##3##(1994-11#1)(2008-5#1)
a greater degree of##4##4##(1991-2#1)(1995-5#1)(2008-3#1)(2009-8#1)
a greater degree##12##3##(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2011-1#1)
a greater diversity##2##3##(2008-7#1)(2008-8#1)
a greater effect on##2##4##(1992-6#1)(2008-7#1)
a greater effect##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
a greater emphasis on##4##4##(1996-3#1)(2008-11#1)(2010-5#1)(2012-3#1)
a greater emphasis##5##3##(1996-3#1)(2008-11#2)(2010-5#1)(2012-3#1)
a greater focus on##2##4##(2012-3#1)(2013-1#1)
a greater frequency of##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
a greater glucose##2##3##(2010-12#1)(2012-4#1)
a greater growth##2##3##(2008-10#1)(2008-5#1)
a greater impact on##3##4##(2008-10#1)(2013-1#2)
a greater impact##5##3##(2008-10#1)(2008-9#1)(2009-4#1)(2013-1#2)
a greater incidence##2##3##(1990-6#1)(2008-7#1)
a greater increase in##5##4##(1991-3#1)(2008-12#1)(2008-3#1)(2009-11#1)(2011-10#1)
a greater influence on the##2##5##(2008-3#1)(2008-4#1)
a greater influence on##4##4##(1991-8#1)(2008-3#2)(2008-4#1)
a greater inhibitory effect than##3##5##(1990-7#1)(1992-2#1)(2013-1#1)
a greater likelihood of##3##4##(1995-2#1)(2008-8#1)(2012-12#1)
a greater number of##16##4##(1992-9#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)
a greater political##2##3##(1994-1#1)(2012-12#1)
a greater proportion of##8##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#1)(2012-3#1)
a greater reduction in##3##4##(2007-10#1)(2008-3#1)(2010-4#1)
a greater risk of##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
a greater risk##5##3##(1996-11#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)
a greater role in##2##4##(1997-3#1)(2007-12#1)
a greater role##4##3##(1991-11#1)(1997-3#1)(2007-12#1)(2008-10#1)
a greater sensitivity##3##3##(1992-5#1)(2008-10#1)(2013-8#1)
a greater stability##2##3##(2008-10#2)
a greater tendency to##2##4##(2008-9#1)(2009-12#1)
a greater than##6##3##(1991-11#1)(1991-5#1)(1992-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
a greater understanding of the##6##5##(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-1#1)
a greater understanding of these##2##5##(2008-10#1)(2008-7#1)
a greater understanding of##11##4##(1994-2#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
a greater understanding##12##3##(1994-2#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
a greater variety of##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
a greater weight##2##3##(2008-3#1)(2013-7#1)
a greater##219##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#2)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#5)(2012-4#1)(2013-1#9)(2013-7#3)(2013-8#3)
a greatly enhanced##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
a greatly reduced##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
a greatly##8##2##(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)
a green analytical procedure##2##4##(2008-10#1)(2008-5#1)
a green fluorescent protein (GFP)##4##5##(2008-10#4)
a green fluorescent protein##7##4##(2008-10#6)(2008-8#1)
a green fluorescent##8##3##(2008-10#6)(2008-8#1)(2009-2#1)
a green tea##2##3##(1995-9#1)(2009-5#1)
a green##21##2##(1995-9#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-2#1)
a greenhouse experiment##2##3##(2008-10#2)
a greenhouse or##2##3##(2008-10#2)
a greenhouse study##2##3##(2008-10#1)(2008-9#1)
a greenhouse##19##2##(2008-10#17)(2008-5#1)(2008-9#1)
a gregarious ectoparasitoid##2##3##(2007-12#2)
a gregarious##3##2##(2007-12#2)(2011-2#1)
a grid##2##2##(2007-5#1)(2008-10#1)
a groove##4##2##(2008-3#3)(2008-7#1)
a grooved##2##2##(2008-2#2)
a gross##2##2##(1990-5#1)(2009-2#1)
a ground##5##2##(2008-10#2)(2008-3#2)(2009-12#1)
a ground-based##5##2##(2008-3#5)
a ground-glass##2##2##(2007-12#1)(2013-1#1)
a ground-to-satellite##2##2##(2008-3#2)
a grounded theory approach##2##4##(2008-12#1)(2013-1#1)
a grounded theory study##2##4##(2007-10#2)
a grounded theory##7##3##(2007-10#2)(2008-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
a grounded##8##2##(2007-10#2)(2008-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
a groundswell of##2##3##(2013-1#1)(2013-8#1)
a group 7 chromosome from##2##5##(2008-10#1)(2008-5#1)
a group as##3##3##(1997-3#1)(2008-7#1)(2008-8#1)
a group has##2##3##(2009-12#2)
a group of 12##2##4##(2008-7#1)(2011-2#1)
a group of 17##3##4##(2010-3#1)(2013-1#2)
a group of 20 patients##2##5##(1990-6#1)(1996-9#1)
a group of 28##2##4##(2007-8#1)(2008-7#1)
a group of 47##2##4##(1990-11#1)(2007-11#1)
a group of 7##2##4##(1994-2#1)(2011-2#1)
a group of adult##2##4##(2008-9#2)
a group of control##2##4##(1996-7#1)(2012-12#1)
a group of diseases##2##4##(2010-4#1)(2011-1#1)
a group of elderly##2##4##(1994-3#1)(2011-2#1)
a group of genetic##2##4##(2008-7#1)(2010-2#1)
a group of inflammatory##2##4##(2010-12#1)(2012-3#1)
a group of isolates##2##4##(2008-10#2)
a group of patients##4##4##(1990-5#1)(2007-8#1)(2009-4#1)(2010-12#1)
a group of physicians##2##4##(1992-2#1)(2010-1#1)
a group of proteins##2##4##(1994-12#1)(2011-2#1)
a group of related##2##4##(2008-1#1)(2008-9#1)
a group of seven##2##4##(2007-7#1)(2008-11#1)
a group of student##2##4##(2008-11#2)
a group of sulfonamide##2##4##(2009-3#2)
a group of uninsured low-income adults in Oregon was selected by lottery to be given the chance to apply for Medicaid##2##21##(2013-1#2)
a group of women##2##4##(1995-11#1)(2012-3#1)
a group of young##3##4##(2009-10#1)(2013-1#1)(2013-8#1)
a group of##209##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#3)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#3)(1992-5#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-5#3)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#16)(2008-11#12)(2008-12#5)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#2)
a group practice##5##3##(1991-3#1)(1993-1#1)(1993-2#1)(1996-3#1)(2013-7#1)
a group significantly##2##3##(2008-10#1)(2012-3#1)
a group that##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
a group to##3##3##(1994-3#2)(2010-4#1)
a group with##4##3##(1990-8#1)(1994-6#1)(1995-5#1)(2012-3#1)
a group##275##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-5#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#4)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#22)(2008-11#13)(2008-12#6)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#2)
a grouping##2##2##(2008-5#1)(2009-4#1)
a grower##2##2##(2008-10#1)(2011-2#1)
a growing body of data##2##5##(2008-7#1)(2008-8#1)
a growing body of evidence##2##5##(2012-2#1)(2013-8#1)
a growing body of literature##3##5##(2008-12#1)(2009-4#1)(2012-3#1)
a growing body of research##2##5##(2009-5#1)(2013-8#1)
a growing body of##11##4##(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
a growing concern##3##3##(2008-11#1)(2008-12#1)(2010-4#1)
a growing drop##2##3##(2008-10#2)
a growing epidemic##2##3##(2008-1#1)(2008-5#1)
a growing incidence of##2##4##(2009-2#1)(2013-8#1)
a growing interest in##6##4##(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#2)(2013-8#1)
a growing interest##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#2)(2013-8#1)
a growing number of studies##2##5##(2008-4#1)(2013-1#1)
a growing number of##16##4##(1995-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#4)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
a growing population of##2##4##(1994-12#1)(1997-6#1)
a growing population##4##3##(1994-12#1)(1997-6#2)(2008-9#1)
a growing recognition of the##2##5##(1996-7#1)(2007-12#1)
a growing recognition##3##3##(1996-7#1)(2007-12#1)(2008-7#1)
a growing season##4##3##(2008-10#4)
a growing##95##2##(1992-12#1)(1992-5#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#4)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#6)
a growth advantage##3##3##(1991-4#1)(1992-8#1)(1994-8#1)
a growth chamber at##4##4##(2008-10#3)(2011-2#1)
a growth chamber##12##3##(2006-11#1)(2008-10#10)(2011-2#1)
a growth factor and##2##4##(1990-7#1)(1994-9#1)
a growth factor for##2##4##(1994-11#1)(1994-3#1)
a growth factor##9##3##(1990-11#1)(1990-7#3)(1992-2#1)(1994-11#1)(1994-3#1)(1994-9#1)(2008-4#1)
a growth rate of##2##4##(1990-6#1)(2008-7#1)
a growth rate##3##3##(1990-6#1)(2008-7#1)(2010-8#1)
a growth signal in##2##4##(1991-12#1)(2008-11#1)
a growth##48##2##(1990-11#2)(1990-6#1)(1990-7#3)(1991-12#1)(1991-4#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-11#1)(2008-10#12)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a growth-associated##3##2##(1990-9#1)(2008-11#1)(2008-6#1)
a guanine nucleotide binding protein##2##5##(1991-2#2)
a guanine nucleotide##3##3##(1991-2#3)
a guanine##4##2##(1991-2#3)(1993-8#1)
a guarded prognosis##2##3##(2011-1#1)(2012-3#1)
a guest##2##2##(1993-11#1)(2008-10#1)
a guest-host##2##2##(2008-3#2)
a guidance##2##2##(2008-11#1)(2013-8#1)
a guide for clinical##2##4##(2007-2#1)(2009-10#1)
a guide for##12##3##(1991-12#1)(1991-2#1)(1996-2#1)(2007-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a guide to the##3##4##(1994-3#1)(2008-3#1)(2008-4#1)
a guide to##12##3##(1990-8#1)(1993-12#1)(1994-3#1)(1995-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#2)
a guide##38##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-2#3)(1996-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#3)(2008-7#1)(2009-10#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
a guided##2##2##(1995-1#1)(2008-2#1)
a guided-wave##2##2##(2008-2#1)(2008-3#1)
a guideline for the##3##4##(2008-11#1)(2008-6#1)(2012-3#1)
a guideline for##6##3##(2008-11#1)(2008-3#1)(2008-6#2)(2010-9#1)(2012-3#1)
a guideline##7##2##(2008-11#1)(2008-3#2)(2008-6#2)(2010-9#1)(2012-3#1)
a guidewire##5##2##(1997-6#1)(2010-12#3)(2013-7#1)
a guiding##2##2##(2008-2#1)(2011-2#1)
a gut##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
a gynecologist##2##2##(1991-6#1)(2011-2#1)
a gypsum mining leachate##2##4##(2013-1#2)
a habitat##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
a haematological##2##2##(2008-12#1)(2008-9#1)
a haemorrhagic##2##2##(1992-2#1)(2008-7#1)
a hair dye##3##3##(2008-10#1)(2012-3#2)
a hairpin##3##2##(1992-3#1)(1994-8#1)(1997-7#1)
a half maximal value at##2##5##(1990-7#2)
a half million##2##3##(2008-4#1)(2013-1#1)
a half of the##3##4##(1994-3#1)(2008-10#1)(2008-7#1)
a half of##6##3##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
a half##31##2##(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-3#1)(1996-6#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
a half-coupler##2##2##(2008-2#2)
a half-maximal concentration##2##3##(1991-8#1)(1992-11#1)
a half-maximal effect##2##3##(1994-6#1)(1994-8#1)
a half-maximal##5##2##(1991-8#2)(1992-11#1)(1994-6#1)(1994-8#1)
a hallmark feature of##2##4##(2008-11#1)(2013-8#1)
a hallmark of##13##3##(1991-2#1)(1992-12#1)(1992-2#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2012-2#1)(2013-1#2)
a hallmark##17##2##(1991-2#1)(1992-12#1)(1992-2#1)(2008-11#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
a halo##7##2##(1995-5#1)(2008-2#3)(2008-6#1)(2011-2#1)(2012-2#1)
a halogen##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
a hand held computer##2##4##(2010-2#2)
a hand held dynamometer##2##4##(2007-11#1)(2009-3#1)
a hand held##4##3##(2007-11#1)(2009-3#1)(2010-2#2)
a hand##9##2##(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#2)(2011-2#1)
a hand-held calculator##2##3##(2008-11#2)
a hand-held##6##2##(2008-10#3)(2008-11#2)(2012-2#1)
a handful of##5##3##(2007-10#1)(2007-5#1)(2010-7#1)(2011-3#1)(2013-1#1)
a handheld##5##2##(2008-10#2)(2009-10#1)(2011-7#1)(2013-1#1)
a hanging mercury drop electrode (HMDE)##8##6##(2008-10#8)
a hanging mercury drop electrode##24##5##(2008-10#24)
a hanging##26##2##(2008-10#24)(2008-11#1)(2008-8#1)
a haploid strain of##2##4##(1994-6#1)(1996-6#1)
a haploid##3##2##(1994-6#1)(1996-6#1)(2008-10#1)
a hapten##3##2##(1994-8#1)(2008-10#2)
a harbinger of##2##3##(1993-3#1)(2008-6#1)
a hard##8##2##(1990-4#1)(1993-3#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)
a hardware##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
a harmful##2##2##(2009-2#1)(2011-2#1)
a harmless##3##2##(2008-1#1)(2008-5#1)(2012-3#1)
a harmonic##2##2##(2008-3#1)(2012-2#1)
a harmonically mode-locked fiber##2##4##(2007-11#1)(2007-12#1)
a harmonically mode-locked##3##3##(2007-11#2)(2007-12#1)
a hatchery##3##2##(1990-3#1)(2007-5#2)
a hazard of##2##3##(1993-2#1)(2008-11#1)
a hazard##8##2##(1991-12#1)(1993-2#1)(1993-9#1)(1997-4#1)(2007-2#1)(2008-11#1)(2013-1#2)
a hazardous##2##2##(1995-12#1)(2008-8#1)
a head injury##3##3##(2008-12#1)(2008-9#1)(2012-3#1)
a head##9##2##(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#2)
a headache##2##2##(2007-8#1)(2010-9#1)
a headset##2##2##(2010-5#2)
a headspace##3##2##(2008-10#2)(2009-8#1)
a healed##2##2##(2007-12#1)(2007-7#1)
a healing##2##2##(1992-1#1)(2011-2#1)
a health administration curriculum##3##4##(1993-1#1)(1996-1#1)(1996-2#1)
a health administration##4##3##(1993-1#2)(1996-1#1)(1996-2#1)
a health benefit##2##3##(2011-2#1)(2013-8#1)
a health care facility##2##4##(1996-2#1)(2008-12#1)
a health care information system##2##5##(1996-12#1)(1996-3#1)
a health care organization##5##4##(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-1#1)
a health care provider##2##4##(1994-1#2)
a health care provider's##2##4##(1994-1#1)(2007-2#1)
a health care system##6##4##(1994-12#1)(1996-3#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-3#1)
a health care transaction##2##4##(2008-11#2)
a health care##39##3##(1991-1#2)(1991-3#1)(1993-1#1)(1994-1#5)(1994-12#4)(1994-2#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2010-4#1)(2012-3#1)(2013-1#1)
a health center##3##3##(1993-3#1)(1996-3#1)(1997-6#1)
a health center]##12##3##(1991-11#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)
a health education##2##3##(1991-6#1)(2013-1#1)
a health emergency in the US-affiliated Pacific Islands (USAPI)##9##9##(2013-8#9)
a health emergency in the##10##5##(2013-8#10)
a health emergency##11##3##(2008-7#1)(2013-8#10)
a health insurance organization##2##4##(1994-2#2)
a health maintenance organization (HMO)##4##5##(1993-1#1)(1994-12#2)(1994-3#1)
a health maintenance organization##5##4##(1992-2#1)(1993-1#1)(1994-12#2)(1994-3#1)
a health network##2##3##(1995-1#2)
a health risk##3##3##(1992-2#1)(1994-3#1)(2011-2#1)
a health service##2##3##(2007-10#1)(2008-11#1)
a health services research##2##4##(1994-3#1)(2008-7#1)
a health system##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
a health##125##2##(1990-12#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#2)(1992-4#1)(1993-1#4)(1993-10#1)(1993-3#4)(1993-5#1)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#4)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#5)(2009-5#1)(2010-12#2)(2010-4#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#11)
a healthcare environment##2##3##(1993-2#1)(2008-9#1)
a healthcare facility##4##3##(1993-12#1)(1994-12#1)(1996-12#1)(1996-3#1)
a healthcare##15##2##(1993-12#2)(1993-2#2)(1994-12#1)(1995-12#1)(1996-12#3)(1996-3#1)(1997-2#1)(2007-12#2)(2008-9#1)(2010-3#1)
a healthier##3##2##(1995-1#1)(2008-11#1)(2013-1#1)
a healthy diet##4##3##(2008-3#1)(2011-1#2)(2011-2#1)
a healthy man##2##3##(2010-1#1)(2013-8#1)
a healthy sample##2##3##(2010-2#1)(2013-8#1)
a healthy subject##3##3##(1990-8#1)(2008-10#2)
a healthy volunteer##5##3##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
a healthy weight##2##3##(2011-2#2)
a healthy##50##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-3#1)(1993-2#1)(1994-6#1)(1995-1#2)(1995-3#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-1#2)(2010-2#1)(2011-1#5)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#2)
a hearing aid##2##3##(2008-9#2)
a hearing##4##2##(2008-9#2)(2011-1#1)(2012-12#1)
a heart attack##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
a heart##6##2##(1993-3#1)(1994-11#1)(2008-11#1)(2008-3#2)(2009-5#1)
a heat shock##4##3##(1990-11#1)(1991-2#1)(1994-6#1)(2012-12#1)
a heat##7##2##(1990-11#1)(1991-2#1)(1992-6#1)(1993-6#1)(1994-6#1)(1997-2#1)(2012-12#1)
a heat-labile##3##2##(1990-11#1)(1991-2#1)(1993-3#1)
a heat-stable##2##2##(1990-7#1)(1994-11#1)
a heated two-dimensional jet##2##4##(2008-2#1)(2008-3#1)
a heated##13##2##(1993-6#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)
a heating cycle##3##3##(2008-10#3)
a heating##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
a heavier##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
a heavily##6##2##(1990-8#1)(1991-3#1)(1996-2#1)(2009-12#1)(2010-5#1)(2013-8#1)
a heavy atom##2##3##(2008-10#2)
a heavy##15##2##(1993-3#2)(1995-12#1)(1996-12#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
a hedonic representation##2##3##(2008-9#2)
a height of 1##2##4##(2008-10#1)(2011-2#1)
a height of##5##3##(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
a heightened risk of##2##4##(2009-7#1)(2011-2#1)
a heightened##3##2##(1995-12#1)(2009-7#1)(2011-2#1)
a helical##3##2##(1991-8#1)(1994-2#1)(2008-10#1)
a helicase##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
a helix##4##2##(1993-11#1)(2008-10#3)
a help##2##2##(1997-2#1)(2008-6#1)
a helpful tool##2##3##(2007-2#1)(2013-1#1)
a helpful##8##2##(1990-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2012-3#2)(2013-1#2)
a hemacytometer##6##2##(2008-2#1)(2008-4#1)(2008-9#4)
a hemangioma##3##2##(1992-8#1)(1993-1#2)
a hematoma##2##2##(2009-3#2)
a hematopoietic stem cell##2##4##(2010-11#1)(2013-1#1)
a hematopoietic##5##2##(2008-11#1)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#1)
a heme##2##2##(1990-8#1)(1994-9#1)
a hemispherical##2##2##(2008-2#1)(2008-3#1)
a hemodialysis unit##2##3##(1996-2#1)(2007-7#1)
a hemodialysis##6##2##(1996-2#1)(1996-3#1)(2007-12#1)(2007-7#2)(2008-1#1)
a hemoglobin##3##2##(1990-11#1)(1990-2#1)(1990-8#1)
a hemorrhagic##3##2##(1993-9#1)(2012-1#2)
a hepatic##3##2##(1995-2#1)(2008-3#1)(2008-9#1)
a hepatitis B virus##2##4##(1994-11#1)(2013-8#1)
a hepatitis##3##2##(1994-11#1)(2013-8#2)
a herbal medicine##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
a herbal##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-7#1)
a herbicide##2##2##(2008-10#1)(2010-1#1)
a herd of##2##3##(1993-2#1)(1996-12#1)
a herd##4##2##(1992-5#1)(1993-2#1)(1996-12#1)(2008-5#1)
a hereditary##9##2##(1990-11#1)(1991-5#1)(1994-12#3)(2006-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
a heretofore##2##2##(1995-8#1)(2008-8#1)
a heritable##4##2##(2008-8#2)(2012-3#1)(2013-1#1)
a heritage of##2##3##(1993-3#1)(2012-2#1)
a hermaphroditic##2##2##(2008-8#1)(2008-9#1)
a herpesvirus##2##2##(1997-6#1)(2012-3#1)
a heterobifunctional##3##2##(1992-11#1)(2008-10#1)(2008-7#1)
a heterodimer and##2##3##(1990-12#1)(1993-3#1)
a heterodimer##8##2##(1990-12#1)(1993-11#2)(1993-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(2011-2#1)
a heterodimeric##5##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-9#1)(2008-11#1)
a heterodyne interferometer##2##3##(2007-12#1)(2008-3#1)
a heterodyne##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
a heterogeneous and##2##3##(2008-1#1)(2008-9#1)
a heterogeneous clinical##2##3##(2010-3#1)(2012-3#1)
a heterogeneous family##2##3##(1995-11#1)(2008-10#1)
a heterogeneous group of##12##4##(1991-11#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)
a heterogeneous group##14##3##(1991-11#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#2)
a heterogeneous mixture##2##3##(2008-10#1)(2008-4#1)
a heterogeneous population of purinoceptors##2##5##(1995-12#2)
a heterogeneous population of##4##4##(1991-12#1)(1995-12#2)(2008-11#1)
a heterogeneous population##7##3##(1991-12#1)(1995-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2009-3#1)
a heterogeneous set of##2##4##(1997-5#1)(2011-2#1)
a heterogeneous##64##2##(1991-11#1)(1991-12#1)(1992-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-4#1)(1997-3#1)(1997-5#3)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#2)(2009-8#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#4)(2012-3#5)(2013-1#1)(2013-8#1)
a heterogenous##6##2##(1990-7#1)(1991-11#1)(2007-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
a heterologous promoter##3##3##(1996-12#1)(1997-3#2)
a heterologous##12##2##(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
a heteromeric##2##2##(1991-5#1)(1995-2#1)
a heteroscedastic##3##2##(2008-6#2)(2009-9#1)
a heterozygous##6##2##(2008-1#1)(2008-10#3)(2008-4#1)(2012-3#1)
a heuristic##6##2##(2008-10#1)(2008-3#3)(2010-12#1)(2013-1#1)
a hexagonal column##2##3##(2008-3#2)
a hexagonal##7##2##(1995-6#1)(2008-3#6)
a hexamer##4##2##(1990-11#1)(1993-11#1)(1997-2#1)(1997-7#1)
a hexameric##2##2##(1990-11#1)(1994-6#1)
a hexane##2##2##(2008-10#1)(2008-7#1)
a hexapeptide##2##2##(1992-9#1)(2008-4#1)
a hidden##6##2##(1997-1#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
a hierarchical##11##2##(1991-6#1)(2007-11#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
a hierarchically##2##2##(2008-7#1)(2009-10#1)
a hierarchy of##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)
a hierarchy##8##2##(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2009-3#1)(2013-1#1)
a high abundance of##3##4##(1993-12#1)(2007-5#1)(2009-5#1)
a high accuracy##6##3##(2008-3#3)(2011-2#1)(2012-2#1)(2013-8#1)
a high activity##2##3##(1997-8#1)(2007-10#1)
a high affinity for the##4##5##(1992-11#1)(1994-11#1)(1995-11#1)(2008-6#1)
a high affinity for##7##4##(1992-11#1)(1994-11#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-6#1)
a high affinity##18##3##(1990-8#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
a high amount of##4##4##(2008-10#3)(2013-1#1)
a high and##3##3##(1994-6#1)(2008-10#1)(2012-1#1)
a high aspect ratio##2##4##(2007-11#1)(2008-3#1)
a high average##2##3##(1994-11#1)(1994-2#1)
a high background##2##3##(1994-12#1)(2008-10#1)
a high basal##2##3##(1994-11#2)
a high burden of##2##4##(2011-1#1)(2011-2#1)
a high capacity##5##3##(1993-5#1)(2008-10#2)(2008-9#1)(2010-6#1)
a high catalytic activity##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
a high cell viability##2##4##(2008-11#2)
a high cleaning calcium carbonate system and 1450 ppm fluoride##2##10##(2011-2#2)
a high cleaning calcium carbonate system##3##6##(2011-2#3)
a high concentration of##13##4##(1990-11#1)(1992-5#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-4#1)
a high concentration##16##3##(1990-11#1)(1992-5#1)(1994-5#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-4#1)
a high content of##3##4##(1991-2#1)(1996-2#1)(2010-4#1)
a high contrast ratio##2##4##(2007-12#1)(2008-2#1)
a high copy##2##3##(1997-4#1)(2008-11#1)
a high correlation (r = 0##2##6##(1993-12#1)(2011-2#1)
a high correlation between##5##4##(1992-9#1)(2008-10#2)(2008-9#2)
a high correlation coefficient##2##4##(2011-2#1)(2011-3#1)
a high correlation with##2##4##(2008-10#1)(2010-8#1)
a high correlation##13##3##(1992-9#1)(1993-12#1)(2007-11#1)(2008-10#4)(2008-9#2)(2010-8#1)(2011-2#2)(2011-3#1)
a high death rate##2##4##(1990-6#1)(2007-12#1)
a high degree of accuracy##4##5##(2008-12#1)(2008-3#2)(2013-1#1)
a high degree of confidence##3##5##(2008-10#1)(2008-3#2)
a high degree of genetic diversity##4##6##(2008-10#4)
a high degree of genetic##6##5##(2008-10#5)(2008-8#1)
a high degree of homology to##3##6##(1992-8#1)(1993-2#1)(2008-10#1)
a high degree of homology with##2##6##(1990-2#1)(1993-11#1)
a high degree of homology##8##5##(1990-2#1)(1992-8#1)(1993-11#1)(1993-2#2)(1994-11#1)(1997-1#1)(2008-10#1)
a high degree of host specificity##2##6##(2008-10#2)
a high degree of patient satisfaction##2##6##(1997-1#1)(2011-2#1)
a high degree of selectivity##3##5##(1990-5#1)(2008-10#2)
a high degree of sensitivity and selectivity##2##7##(2008-10#2)
a high degree of sensitivity##4##5##(2007-12#1)(2008-10#3)
a high degree of sequence homology##2##6##(1993-3#1)(2008-10#1)
a high degree of sequence##4##5##(1992-8#1)(1993-3#1)(1994-12#1)(2008-10#1)
a high degree of similarity##6##5##(1993-2#2)(1993-9#1)(2008-10#3)
a high degree of##95##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-2#4)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-3#3)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
a high degree##97##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-2#4)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-3#3)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
a high density of inoculum##2##5##(2008-10#2)
a high density of##7##4##(1993-12#1)(2008-10#2)(2008-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
a high density##11##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-5#1)(2010-7#1)(2012-3#1)
a high disease incidence##2##4##(2008-10#2)
a high dose of##6##4##(1995-3#2)(2008-12#2)(2013-1#1)(2013-8#1)
a high dose##8##3##(1995-3#2)(2008-12#2)(2008-7#2)(2013-1#1)(2013-8#1)
a high drop-out rate##2##4##(1990-2#1)(2008-7#1)
a high efficiency##5##3##(1990-5#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)
a high enzyme activity##2##4##(1993-3#1)(1994-11#1)
a high expression of##2##4##(1991-5#1)(1992-12#1)
a high expression##3##3##(1991-5#1)(1992-12#1)(1992-3#1)
a high fat diet##2##4##(2008-3#1)(2013-1#1)
a high frequency of##10##4##(1991-8#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
a high frequency##16##3##(1991-8#1)(1993-8#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2012-2#1)(2012-3#1)(2013-8#1)
a high genetic##2##3##(2008-10#1)(2009-3#1)
a high glucose##2##3##(1992-6#1)(2008-7#1)
a high incidence of##17##4##(1991-12#1)(1992-2#1)(1994-12#1)(1997-1#1)(1997-3#1)(2007-10#3)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
a high incidence##18##3##(1991-12#1)(1992-2#1)(1994-12#1)(1997-1#1)(1997-3#1)(2007-10#3)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2013-1#1)
a high index of suspicion and##3##6##(2010-7#1)(2011-2#1)(2012-3#1)
a high index of suspicion for##2##6##(2006-10#1)(2013-8#1)
a high index of suspicion in##2##6##(2008-9#1)(2010-10#1)
a high index of suspicion is##2##6##(2007-7#1)(2010-1#1)
a high index of suspicion##13##5##(2006-10#1)(2007-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-8#2)
a high intake##2##3##(2010-6#1)(2012-2#1)
a high intensity##2##3##(2007-12#1)(2012-12#1)
a high iodine##2##3##(2008-7#1)(2011-1#1)
a high ionic strength##2##4##(2008-10#1)(2010-5#1)
a high level in the##3##5##(1993-3#1)(1994-5#1)(2009-6#1)
a high level in##4##4##(1993-3#1)(1994-5#1)(1995-11#1)(2009-6#1)
a high level of activity##2##5##(2008-10#1)(2013-1#1)
a high level of agreement##2##5##(2007-5#1)(2008-10#1)
a high level of evidence##2##5##(2011-2#2)
a high level of expression##2##5##(1995-11#1)(1997-4#1)
a high level of genetic##3##5##(2008-10#2)(2012-1#1)
a high level of homogeneity##3##5##(1997-4#1)(2008-10#1)(2012-3#1)
a high level of resistance to barley yellow dwarf virus (BYDV)##2##11##(2008-10#1)(2008-8#1)
a high level of resistance to##6##6##(2008-10#4)(2008-12#1)(2008-8#1)
a high level of resistance##7##5##(2008-10#5)(2008-12#1)(2008-8#1)
a high level of##78##4##(1990-12#1)(1991-6#1)(1992-11#2)(1992-9#2)(1993-6#1)(1993-9#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-4#3)(1997-8#1)(2007-5#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
a high level##93##3##(1990-12#1)(1991-6#1)(1992-11#2)(1992-9#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-3#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-4#3)(1997-8#1)(2007-5#1)(2008-10#22)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
a high likelihood of##2##4##(2008-6#1)(2009-2#1)
a high local recurrence rate##2##5##(1997-7#1)(2010-3#1)
a high local##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2010-3#1)
a high molar##2##3##(1990-12#1)(2008-10#1)
a high molecular weight complex##2##5##(1995-6#1)(2008-12#1)
a high molecular weight##10##4##(1990-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-12#1)
a high molecular##11##3##(1990-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-12#1)
a high mortality rate##14##4##(1992-9#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
a high mortality##16##3##(1991-5#1)(1992-9#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
a high number of##11##4##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#2)(2013-7#2)
a high numerical aperture##3##4##(2007-12#1)(2008-3#1)(2009-12#1)
a high percent of##2##4##(1995-11#1)(2008-12#1)
a high percentage of##8##4##(1990-12#1)(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#1)
a high percentage##9##3##(1990-12#1)(1991-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#1)
a high performance liquid##5##4##(2008-10#2)(2008-5#2)(2012-1#1)
a high performance nebulizer##2##4##(2008-10#2)
a high performance runner##2##4##(2011-2#2)
a high performance##11##3##(2008-10#5)(2008-5#2)(2011-2#3)(2012-1#1)
a high polyunsaturated fatty acid content##2##6##(2008-5#2)
a high potential##3##3##(2007-11#1)(2008-3#1)(2012-3#1)
a high pressure##2##3##(2008-10#2)
a high prevalence of##24##4##(1994-6#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
a high prevalence##27##3##(1990-6#1)(1994-6#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
a high priority for##3##4##(2008-11#1)(2013-1#2)
a high priority##5##3##(1994-2#1)(2008-1#1)(2008-11#1)(2013-1#2)
a high probability of##5##4##(1997-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2013-1#1)
a high probability##7##3##(1990-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
a high proportion of the##2##5##(1995-9#1)(2008-10#1)
a high proportion of##14##4##(1991-9#1)(1992-3#1)(1995-3#1)(1995-9#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)
a high proportion##17##3##(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1995-3#1)(1995-9#1)(2008-10#5)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)
a high quality##5##3##(1995-2#1)(2008-11#1)(2008-12#1)(2009-3#1)(2011-1#1)
a high rate of late##2##5##(1994-11#1)(2010-11#1)
a high rate of##23##4##(1991-6#1)(1991-9#1)(1993-6#1)(1994-1#1)(1994-11#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
a high rate##26##3##(1991-6#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
a high ratio of##2##4##(2010-4#1)(2013-1#1)
a high recurrence rate##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
a high reflectivity##3##3##(2007-11#1)(2008-3#2)
a high repetition rate##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a high resolution##10##3##(1992-3#1)(1993-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#2)(2010-4#1)
a high response##3##3##(1991-12#1)(1991-8#1)(2008-10#1)
a high risk for##3##4##(1991-5#1)(2007-10#1)(2008-1#1)
a high risk intervention##2##4##(1991-6#1)(2007-10#1)
a high risk of hyperacute rejection##2##6##(2011-2#2)
a high risk of##20##4##(1990-3#1)(1992-6#1)(1994-9#2)(1995-5#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-7#1)
a high risk##34##3##(1990-3#1)(1991-5#1)(1991-6#1)(1992-6#1)(1994-5#1)(1994-9#2)(1995-5#1)(1997-6#1)(2007-1#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#2)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
a high salt##2##3##(2008-10#1)(2008-11#1)
a high school##2##3##(2008-5#1)(2011-1#1)
a high selectivity for##3##4##(2008-10#2)(2008-2#1)
a high selectivity##6##3##(2008-10#5)(2008-2#1)
a high sensitivity is##2##4##(2008-10#2)
a high sensitivity##12##3##(1990-2#1)(1992-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
a high signal-to-noise ratio##5##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
a high spatial##2##3##(2008-3#1)(2008-7#1)
a high specific activity##2##4##(1994-11#1)(1994-2#1)
a high specific##3##3##(1994-11#1)(1994-2#1)(2008-5#1)
a high spectral##2##3##(2008-10#1)(2008-3#1)
a high stability##2##3##(1990-5#1)(2011-1#1)
a high success rate##5##4##(1994-12#1)(1996-11#1)(1997-4#1)(2012-12#1)(2013-8#1)
a high susceptibility##2##3##(1993-8#1)(2007-12#1)
a high temperature of##2##4##(2008-10#1)(2012-2#1)
a high temperature##6##3##(1991-5#1)(2008-10#2)(2009-11#1)(2011-2#1)(2012-2#1)
a high throughput method##2##4##(2008-10#1)(2008-7#1)
a high throughput##10##3##(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
a high titer##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
a high titre of##2##4##(1993-9#1)(1996-12#1)
a high tone and a rising tone##2##7##(2013-8#2)
a high tone##3##3##(2013-8#3)
a high value of##3##4##(1995-12#1)(2008-2#1)(2011-1#1)
a high value##5##3##(1995-12#1)(2008-10#1)(2008-2#2)(2011-1#1)
a high volume of##2##4##(2008-11#1)(2013-1#1)
a high volume##5##3##(1991-3#1)(1992-2#1)(2008-11#2)(2013-1#1)
a high yield of##5##4##(1990-3#1)(1994-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
a high yield##9##3##(1990-3#1)(1994-3#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#2)
a high##932##2##(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#5)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#6)(1991-8#2)(1991-9#3)(1992-11#4)(1992-12#5)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#5)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#6)(1993-5#2)(1993-6#3)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#8)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#2)(1995-3#6)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#7)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#2)(2007-1#1)(2007-10#7)(2007-11#17)(2007-12#15)(2007-5#2)(2007-7#7)(2007-8#3)(2008-1#10)(2008-10#159)(2008-11#45)(2008-12#19)(2008-2#16)(2008-3#45)(2008-4#18)(2008-5#27)(2008-6#11)(2008-7#29)(2008-8#19)(2008-9#14)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#5)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#6)(2010-2#2)(2010-3#7)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#13)(2011-2#42)(2011-3#2)(2012-1#5)(2012-12#10)(2012-2#23)(2012-3#14)(2012-6#1)(2013-1#31)(2013-7#5)(2013-8#14)
a high- or##2##3##(2013-8#2)
a high-##5##2##(2007-11#1)(2012-3#1)(2013-7#1)(2013-8#2)
a high-N##2##2##(2007-11#1)(2008-3#1)
a high-affinity##6##2##(1993-6#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
a high-birefringence##2##2##(2008-3#2)
a high-capacity##2##2##(1993-8#1)(2008-3#1)
a high-contrast##3##2##(2007-11#1)(2007-12#2)
a high-copy-number##2##2##(1993-9#1)(1994-12#1)
a high-density##4##2##(2008-3#3)(2008-6#1)
a high-dose##2##2##(1990-9#1)(2010-11#1)
a high-efficiency sample introduction system##2##5##(2008-10#2)
a high-fat##3##2##(2012-2#2)(2013-1#1)
a high-fidelity##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
a high-finesse Fabry-Perot cavity##4##4##(2007-12#2)(2008-3#2)
a high-finesse Fabry-Perot##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
a high-finesse##10##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#5)
a high-flow##2##2##(2008-10#2)
a high-frequency##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
a high-gain##2##2##(2007-11#1)(2007-12#1)
a high-grade pleomorphic sarcoma##2##4##(2008-6#2)
a high-grade##4##2##(1997-1#1)(2008-6#2)(2011-2#1)
a high-impact injury##2##3##(2012-12#2)
a high-index##2##2##(2007-11#1)(2008-3#1)
a high-intensity##4##2##(2007-11#1)(2008-3#2)(2008-5#1)
a high-microbeta chromophore##2##3##(2007-12#2)
a high-numerical-aperture objective##2##3##(2008-2#1)(2008-3#1)
a high-numerical-aperture##3##2##(2008-2#1)(2008-3#2)
a high-performance liquid chromatographic (HPLC)##2##5##(1990-8#1)(2008-5#1)
a high-performance liquid chromatographic##3##4##(1990-8#2)(2008-5#1)
a high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
a high-performance liquid##6##3##(1990-8#2)(2008-10#3)(2008-5#1)
a high-performance##16##2##(1990-8#2)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2009-2#1)(2009-6#1)
a high-poverty urban neighborhood##2##4##(2010-9#2)
a high-power laser##2##3##(2007-12#1)(2008-3#1)
a high-power##21##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#7)(2011-2#1)(2012-2#1)(2013-8#2)
a high-precision##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
a high-pressure##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
a high-quality##4##2##(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
a high-reflectance multilayer##2##3##(2008-3#2)
a high-reflectance##4##2##(2008-2#2)(2008-3#2)
a high-repetition-rate##2##2##(2007-11#1)(2008-3#1)
a high-resolution##18##2##(1996-10#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#6)(2009-6#1)(2012-2#1)(2012-3#2)
a high-risk group for##4##4##(1994-11#1)(2007-10#1)(2007-8#1)(2013-1#1)
a high-risk setting##3##3##(2009-5#1)(2013-1#2)
a high-risk##18##2##(1991-6#1)(1992-3#1)(1994-11#1)(1996-3#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#3)
a high-sensitivity##2##2##(2008-6#1)(2010-12#1)
a high-speed camera##2##3##(2008-2#2)
a high-speed##15##2##(2007-11#3)(2008-1#1)(2008-2#3)(2008-3#5)(2008-9#1)(2011-2#1)(2012-3#1)
a high-stakes##2##2##(2008-5#1)(2011-2#1)
a high-temperature##9##2##(1990-12#1)(1994-9#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-8#1)
a high-throughput##15##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
a high-volume albumin transfusion##2##4##(2013-1#2)
a high-volume##4##2##(2008-10#2)(2013-1#2)
a higher affinity for##2##4##(1990-11#1)(1992-6#1)
a higher affinity than##2##4##(1992-6#1)(2008-1#1)
a higher affinity##5##3##(1990-11#1)(1992-6#2)(1993-8#1)(2008-1#1)
a higher average##3##3##(1992-5#1)(2008-11#2)
a higher bleeding##2##3##(2008-8#2)
a higher cell##2##3##(2008-11#2)
a higher concentration of##4##4##(1991-12#1)(2008-11#3)
a higher concentration##9##3##(1991-12#1)(1996-9#1)(2008-10#3)(2008-11#4)
a higher degradation##2##3##(1991-5#1)(2008-6#1)
a higher degree of##5##4##(1996-3#1)(2008-10#2)(2008-11#1)(2009-5#1)
a higher degree##6##3##(1991-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2009-5#1)
a higher dose of##2##4##(1991-7#1)(1995-5#1)
a higher dose##4##3##(1990-2#1)(1991-6#1)(1991-7#1)(1995-5#1)
a higher education diploma in nursing communication module##2##8##(2008-11#2)
a higher education##3##3##(1994-2#1)(2008-11#2)
a higher frequency of##10##4##(1991-8#1)(1994-12#1)(1997-8#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-7#2)
a higher frequency##13##3##(1991-8#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-8#1)(2011-2#1)(2013-7#2)
a higher genetic##2##3##(1994-2#1)(2008-10#1)
a higher growth rate and##2##5##(1990-8#1)(2008-11#1)
a higher incidence of cyst rupture##2##6##(1996-3#2)
a higher incidence of##18##4##(1990-5#1)(1992-3#1)(1996-3#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a higher incidence##23##3##(1990-5#1)(1991-6#1)(1992-3#1)(1996-3#2)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
a higher initial##2##3##(2008-10#1)(2009-7#1)
a higher intensity of##3##4##(1995-12#1)(2008-7#1)(2013-1#1)
a higher intensity##4##3##(1995-12#1)(2008-7#1)(2013-1#2)
a higher ion##2##3##(2008-10#1)(2008-7#1)
a higher level of functioning##2##5##(1997-8#2)
a higher level of##15##4##(1991-2#1)(1994-3#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
a higher level##20##3##(1991-2#1)(1994-3#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#1)
a higher maximal##2##3##(1991-12#1)(2008-11#1)
a higher mean##2##3##(1991-12#1)(2008-7#1)
a higher molecular weight##2##4##(1991-5#1)(2008-10#1)
a higher morbidity##2##3##(1993-6#1)(2009-12#1)
a higher mortality rate than##3##5##(1995-3#1)(2008-8#1)(2011-2#1)
a higher mortality rate##4##4##(1995-3#1)(2006-10#1)(2008-8#1)(2011-2#1)
a higher mortality##8##3##(1995-3#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#2)
a higher number of##10##4##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-8#1)(2012-12#1)(2012-3#1)
a higher order##3##3##(1990-11#1)(2008-2#1)(2011-1#1)
a higher percent##3##3##(1995-12#1)(2008-10#1)(2008-6#1)
a higher percentage of##6##4##(1992-6#1)(1993-6#1)(1996-6#1)(2009-10#1)(2009-8#1)(2013-8#1)
a higher percentage##7##3##(1992-6#1)(1993-6#1)(1996-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-8#1)
a higher prevalence of##15##4##(1990-12#1)(1996-12#1)(2008-1#1)(2008-12#2)(2008-3#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a higher probability of##4##4##(1994-12#1)(1995-12#1)(2009-12#1)(2012-12#1)
a higher proportion of the##2##5##(1992-2#1)(1997-5#1)
a higher proportion of##13##4##(1992-2#1)(1992-4#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)
a higher proportion##14##3##(1992-2#1)(1992-4#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)
a higher rate of##11##4##(1990-11#1)(1992-10#1)(1994-2#2)(1997-8#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#2)(2012-2#1)
a higher rate##19##3##(1990-11#1)(1990-8#1)(1992-10#1)(1994-2#2)(1995-5#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
a higher resistance to##3##4##(1997-7#1)(2007-10#1)(2008-9#1)
a higher resistance##4##3##(1997-7#1)(2007-10#1)(2008-4#1)(2008-9#1)
a higher resolution##2##3##(2008-10#1)(2012-2#1)
a higher risk for##4##4##(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
a higher risk of death##2##5##(1995-2#1)(2008-9#1)
a higher risk of developing breast cancer##3##7##(2008-12#2)(2008-4#1)
a higher risk of developing##5##5##(2008-12#2)(2008-4#1)(2009-3#1)(2013-1#1)
a higher risk of##22##4##(1995-2#1)(1996-11#1)(1996-9#1)(2007-12#1)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
a higher risk to##2##4##(2011-2#1)(2012-1#1)
a higher risk##30##3##(1995-2#1)(1996-11#1)(1996-9#1)(2007-12#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
a higher sensitivity and##2##4##(2008-10#1)(2011-1#1)
a higher sensitivity##8##3##(1991-6#1)(1997-8#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#2)
a higher signal-to-noise ratio##2##4##(2007-12#1)(2008-3#1)
a higher specific##2##3##(2008-11#1)(2011-2#1)
a higher than##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
a higher threshold##2##3##(2009-5#1)(2011-2#1)
a higher total##2##3##(2008-11#1)(2008-6#1)
a higher value of the##2##5##(1991-12#1)(2008-10#1)
a higher value of##3##4##(1991-12#1)(2008-10#1)(2008-3#1)
a higher value##5##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
a higher##395##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#3)(1993-8#3)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#7)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#51)(2008-11#31)(2008-12#10)(2008-2#7)(2008-3#17)(2008-4#6)(2008-5#14)(2008-6#7)(2008-7#18)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#4)(2009-7#2)(2009-8#5)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#20)(2012-1#3)(2012-12#7)(2012-2#8)(2012-3#4)(2012-6#1)(2013-1#10)(2013-7#4)(2013-8#10)
a higher-order Gaussian beam##2##4##(2008-2#2)
a higher-order##8##2##(1993-11#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#2)
a highest##2##2##(2008-12#1)(2013-8#1)
a highly acceptable##2##3##(1994-12#1)(2008-11#1)
a highly accurate##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
a highly active##3##3##(1990-7#1)(1992-3#1)(2008-5#1)
a highly aggregated state##2##4##(1997-2#2)
a highly aggressive##3##3##(1993-8#1)(2010-12#1)(2013-1#1)
a highly asymmetrical##2##3##(1991-2#1)(1993-3#1)
a highly charged##2##3##(1991-12#1)(1995-6#1)
a highly coherent##2##3##(2007-12#1)(2008-3#1)
a highly complex##4##3##(2009-5#1)(2009-6#1)(2010-7#1)(2012-3#1)
a highly conserved region##3##4##(1994-11#1)(1994-12#1)(2008-10#1)
a highly conserved##29##3##(1990-2#1)(1991-12#2)(1991-9#1)(1992-11#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#1)(1997-4#1)(1997-9#1)(2008-10#4)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2012-12#1)
a highly consistent##3##3##(1994-2#1)(1995-3#1)(2008-8#1)
a highly cross-linked##2##3##(2008-10#1)(2013-1#1)
a highly destructive##2##3##(2008-10#2)
a highly diffuse##2##3##(2008-3#2)
a highly dispersive##2##3##(2007-11#1)(2007-12#1)
a highly diverse##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
a highly dynamic##4##3##(1995-2#1)(2008-5#1)(2009-6#1)(2010-8#1)
a highly effective##5##3##(1995-3#1)(1996-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
a highly efficient##13##3##(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-8#1)
a highly endemic area##2##4##(1994-11#1)(1995-12#1)
a highly favorable##2##3##(1992-8#1)(1994-9#1)
a highly homologous##2##3##(1995-8#1)(1997-7#1)
a highly lethal##2##3##(1994-3#1)(2008-10#1)
a highly lipophilic##2##3##(1993-6#1)(2008-10#1)
a highly localized##2##3##(1995-2#1)(2008-8#1)
a highly metastatic##2##3##(2008-8#1)(2012-1#1)
a highly ordered##2##3##(1992-6#1)(2008-10#1)
a highly polymorphic##2##3##(1997-5#1)(2008-10#1)
a highly promising##4##3##(1991-2#1)(1997-6#1)(2008-10#1)(2012-3#1)
a highly purified##5##3##(1990-11#1)(1992-3#1)(1996-3#1)(2008-2#1)(2008-7#1)
a highly reactive##5##3##(1990-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
a highly regulated##4##3##(1994-9#1)(1997-2#1)(2008-7#1)(2013-1#1)
a highly reliable##2##3##(2008-5#1)(2008-9#1)
a highly repetitive##2##3##(1993-11#2)
a highly reproducible##3##3##(2008-10#2)(2008-5#1)
a highly resistant##3##3##(2008-10#3)
a highly scattering medium##4##4##(2008-3#4)
a highly scattering##7##3##(2007-12#1)(2008-2#1)(2008-3#5)
a highly selective and sensitive##4##5##(2008-10#1)(2008-12#2)(2011-1#1)
a highly selective##12##3##(2007-12#1)(2008-10#5)(2008-12#2)(2008-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
a highly sensitive and##5##4##(1994-11#1)(1996-5#1)(2008-10#3)
a highly sensitive detection##4##4##(2008-10#4)
a highly sensitive method for##2##5##(2008-10#1)(2008-3#1)
a highly sensitive method##5##4##(1991-5#1)(1997-4#1)(2008-10#2)(2008-3#1)
a highly sensitive##33##3##(1991-5#2)(1992-6#1)(1994-11#1)(1996-5#1)(1997-4#1)(2008-10#16)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
a highly significant correlation##2##4##(2008-10#1)(2008-7#1)
a highly significant difference##2##4##(1994-3#1)(2008-5#1)
a highly significant##10##3##(1993-2#1)(1994-3#2)(2008-10#1)(2008-5#2)(2008-7#2)(2008-8#2)
a highly specialized##3##3##(1990-3#1)(1997-4#1)(2008-10#1)
a highly specific and##2##4##(1991-5#1)(1997-3#1)
a highly specific##10##3##(1991-5#1)(1992-11#1)(1993-11#1)(1994-11#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-1#1)
a highly stable##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#1)
a highly structured##2##3##(1992-8#1)(1993-12#1)
a highly susceptible##5##3##(2008-10#5)
a highly variable##4##3##(1997-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
a highly virulent isolate##2##4##(2008-10#2)
a highly virulent##3##3##(2008-10#3)
a highly viscous##2##3##(2007-11#1)(2008-8#1)
a highly##316##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2007-11#10)(2007-12#12)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#69)(2008-11#6)(2008-12#6)(2008-2#6)(2008-3#19)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#3)(2009-10#3)(2009-12#2)(2009-2#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#3)
a hindrance##2##2##(2013-8#2)
a hinge region##3##3##(2013-1#3)
a hinge##4##2##(2009-1#1)(2013-1#3)
a hint##2##2##(2007-2#1)(2011-2#1)
a hip prosthesis##2##3##(2009-3#1)(2009-4#1)
a hip##5##2##(1993-11#1)(2007-11#1)(2009-3#1)(2009-4#1)(2013-7#1)
a hippocampal##4##2##(1993-12#1)(1993-6#1)(1994-3#1)(1997-2#1)
a histidine residue##3##3##(1991-9#1)(1992-8#2)
a histidine tag##2##3##(2008-10#2)
a histidine##7##2##(1991-9#1)(1992-8#2)(2008-10#3)(2010-10#1)
a histochemical##2##2##(2008-7#1)(2009-7#1)
a histogram##2##2##(2008-9#1)(2010-8#1)
a histologic diagnosis##3##3##(1990-10#1)(1992-12#1)(1995-3#1)
a histologic##4##2##(1990-10#1)(1992-12#1)(1992-5#1)(1995-3#1)
a histological diagnosis##3##3##(2007-8#1)(2010-12#1)(2012-1#1)
a histological##6##2##(1996-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-1#1)
a histopathologic##3##2##(1990-8#1)(1997-1#1)(2008-5#1)
a histopathological##2##2##(2007-7#1)(2011-2#1)
a historic##3##2##(1995-5#1)(2008-10#1)(2009-10#1)
a historical and##2##3##(1994-12#1)(1996-1#1)
a historical group of##2##4##(1991-8#1)(2008-10#1)
a historical perspective]##2##3##(1993-11#1)(1993-6#1)
a historical review##3##3##(2009-10#1)(2010-8#1)(2011-2#1)
a historical##23##2##(1991-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-6#2)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#2)
a history of a##2##4##(1996-3#1)(2012-3#1)
a history of childhood conduct disorder##2##6##(1994-2#2)
a history of childhood##3##4##(1994-2#2)(2013-8#1)
a history of depression##3##4##(2010-4#1)(2013-1#1)(2013-8#1)
a history of genital herpes##2##5##(2008-10#2)
a history of ischemic##3##4##(2007-10#2)(2008-8#1)
a history of multiple##3##4##(2007-7#1)(2008-11#1)(2013-8#1)
a history of previous##5##4##(1991-3#1)(1996-7#1)(2008-10#1)(2008-11#1)(2010-6#1)
a history of recent##3##4##(1992-3#1)(1992-9#1)(2012-3#1)
a history of recurrent##2##4##(2008-4#1)(2008-5#1)
a history of sexual##2##4##(2008-12#1)(2009-9#1)
a history of stroke##3##4##(1996-11#1)(2007-10#1)(2007-7#1)
a history of sudden##2##4##(2008-12#1)(2008-5#1)
a history of the##2##4##(2008-10#1)(2011-2#1)
a history of three##2##4##(1996-6#1)(2007-5#1)
a history of tuberculosis##2##4##(2008-7#1)(2012-3#1)
a history of venous##2##4##(2010-6#1)(2010-7#1)
a history of##163##3##(1990-12#1)(1990-3#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-5#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#8)(2008-11#5)(2008-12#4)(2008-4#9)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#15)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#7)
a history##170##2##(1990-12#1)(1990-3#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-10#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-5#1)(2007-10#5)(2007-11#5)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#9)(2008-11#5)(2008-12#4)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#15)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#9)
a hitherto undescribed##3##3##(1995-6#1)(2008-10#1)(2011-1#1)
a hitherto##9##2##(1995-6#2)(2008-10#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
a holding coil##4##3##(2008-10#4)
a holding potential of##2##4##(1995-12#2)
a holding potential##3##3##(1995-12#2)(2008-8#1)
a holding##7##2##(1995-12#2)(2008-10#4)(2008-8#1)
a hole##3##2##(2007-12#1)(2011-2#1)(2012-12#1)
a holey fiber##3##3##(2007-11#1)(2007-12#2)
a holey##4##2##(2007-11#1)(2007-12#3)
a holiday in##2##3##(1995-12#1)(1996-11#1)
a holistic approach##4##3##(1991-2#1)(2008-11#2)(2008-7#1)
a holistic##8##2##(1991-2#1)(1994-3#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
a hollow fiber##8##3##(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)
a hollow needle##2##3##(2008-10#2)
a hollow optical fiber##2##4##(2007-11#2)
a hollow waveguide##5##3##(2007-11#1)(2007-12#3)(2008-7#1)
a hollow##25##2##(1990-7#1)(1993-6#1)(1995-10#1)(2007-11#3)(2007-12#4)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#2)(2013-1#2)
a hollow-core##2##2##(2007-11#1)(2007-12#1)
a hollow-fiber##5##2##(1995-3#1)(2007-12#2)(2008-7#2)
a hologram with##2##3##(2007-12#1)(2008-3#1)
a hologram##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
a holographic grating##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
a holographic optical element##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
a holographic##22##2##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#14)
a holographically##2##2##(2008-3#2)
a home care setting##2##4##(1996-2#1)(1997-2#1)
a home care##4##3##(1991-12#1)(1996-2#1)(1997-2#1)(1997-4#1)
a home health agency##3##4##(1996-3#1)(1997-2#1)(2006-5#1)
a home health##4##3##(1996-3#1)(1997-2#2)(2006-5#1)
a home made##3##3##(2008-10#2)(2008-11#1)
a home visit##2##3##(1994-12#1)(2010-5#1)
a home##24##2##(1991-11#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-11#1)(1994-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-5#1)(2012-12#1)
a home-built##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
a home-made flow cell##2##4##(2008-10#2)
a home-made flow##3##3##(2008-10#3)
a home-made##13##2##(2008-10#11)(2008-7#2)
a homeless##2##2##(2008-6#1)(2012-3#1)
a homemade##2##2##(2008-10#1)(2008-3#1)
a homeobox gene##2##3##(1993-2#1)(2008-8#1)
a homeopathic##3##2##(2008-10#3)
a homeotropically aligned##2##3##(2007-12#1)(2008-3#1)
a homodimer##5##2##(1990-7#1)(1990-8#1)(1994-8#1)(1995-6#1)(2012-2#1)
a homodimeric##2##2##(1992-6#1)(2008-11#1)
a homogeneous PS##2##3##(2008-10#2)
a homogeneous and##2##3##(2008-10#1)(2012-1#1)
a homogeneous group##2##3##(1996-12#1)(2008-10#1)
a homogeneous lesion##2##3##(1990-9#1)(2008-7#1)
a homogeneous population of##2##4##(1995-2#1)(2009-8#1)
a homogeneous population##3##3##(1995-2#1)(2008-9#1)(2009-8#1)
a homogeneous solution##2##3##(2008-5#1)(2008-7#1)
a homogeneous##53##2##(1990-11#1)(1990-9#1)(1991-11#1)(1993-11#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-2#5)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a homogeneously random medium##2##4##(2008-2#2)
a homogenous##7##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-1#1)(2012-2#1)
a homolog of the##2##4##(2008-10#1)(2008-5#1)
a homolog of##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
a homologous sequence##2##3##(1995-8#1)(1996-6#1)
a homologous##12##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-12#1)(1992-11#1)(1995-8#1)(1996-6#1)(1996-9#1)(2008-4#1)(2008-7#1)(2013-8#1)
a homologue of the##2##4##(1997-7#1)(2007-12#1)
a homologue of##7##3##(1993-2#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)
a homologue##8##2##(1993-2#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)
a homology##3##2##(1992-5#1)(2008-11#1)(2008-4#1)
a homozygous deletion##2##3##(1997-2#1)(2011-1#1)
a homozygous##11##2##(1993-3#1)(1993-6#1)(1994-11#1)(1997-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a honeybee##2##2##(2008-10#2)
a horizontal orientation##2##3##(2008-10#1)(2009-5#1)
a horizontal##9##2##(2008-10#2)(2008-2#3)(2008-3#3)(2009-5#1)
a hormetic##4##2##(2008-7#4)
a hormonal##3##2##(1995-11#1)(1995-8#1)(2008-5#1)
a hormonally##2##2##(2008-3#1)(2008-9#1)
a hormone##5##2##(1991-2#1)(1995-2#1)(1996-3#1)(2008-5#1)(2013-8#1)
a horse##3##2##(1996-3#1)(2008-9#1)(2009-4#1)
a horseradish peroxidase (HRP)##2##4##(2008-10#2)
a horseradish peroxidase##3##3##(2008-10#3)
a hospital archives##2##3##(1992-1#2)
a hospital based study##2##4##(2012-3#2)
a hospital based##6##3##(1991-2#1)(2010-11#1)(2012-3#2)(2013-8#2)
a hospital but##2##3##(1995-11#1)(2010-8#1)
a hospital is##2##3##(1993-12#1)(1994-3#1)
a hospital laboratory##2##3##(1994-12#1)(1997-3#1)
a hospital or##3##3##(1993-12#1)(1994-11#1)(2011-2#1)
a hospital preparation program##3##4##(1992-1#3)
a hospital security##2##3##(1991-12#1)(1997-2#1)
a hospital setting##7##3##(1991-5#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-12#2)(2008-9#1)
a hospital system##2##3##(1993-12#1)(1996-3#1)
a hospital to reduce##2##4##(1991-12#1)(1991-3#1)
a hospital to##5##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(2008-11#1)
a hospital where##2##3##(1994-1#1)(1995-3#1)
a hospital with a##2##4##(1992-2#1)(1993-12#1)
a hospital##91##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1992-1#5)(1992-12#1)(1992-2#3)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#7)(1996-5#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-11#1)(2010-8#3)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
a hospital's emergency##3##3##(1993-1#1)(1993-2#1)(1994-2#1)
a hospital's##10##2##(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1997-2#1)(1997-3#1)(2013-8#1)
a hospital-based case-control study##3##4##(1990-8#1)(1993-9#2)
a hospital-based managed mental##2##4##(1991-3#2)
a hospital-based study##2##3##(2007-10#1)(2007-2#1)
a hospital-based##13##2##(1990-8#1)(1991-3#2)(1993-9#2)(1994-1#3)(1996-1#1)(2007-10#2)(2007-2#1)(2012-3#1)
a host factor##2##3##(2008-10#2)
a host for##3##3##(2007-5#1)(2008-10#1)(2008-3#1)
a host genotype##2##3##(2008-10#2)
a host of other##2##4##(1997-5#1)(2008-4#1)
a host of##16##3##(1992-12#1)(1995-1#1)(1995-3#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
a host plant##2##3##(2008-10#1)(2011-2#1)
a host to##2##3##(1991-9#1)(2008-8#1)
a host##46##2##(1991-2#1)(1991-9#1)(1992-12#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#14)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#7)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-7#1)
a host-selective toxin (HST)##3##4##(2008-10#3)
a host-selective toxin##4##3##(2008-10#4)
a host-specific##2##2##(2008-10#2)
a hot##11##2##(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#1)
a house##5##2##(1993-1#1)(1995-11#1)(1995-6#1)(1997-4#1)(2009-7#1)
a household##3##2##(2008-10#1)(2010-5#1)(2012-2#1)
a housekeeping##2##2##(1995-6#2)
a hub-mounted pitched##2##3##(2008-6#2)
a huge amount of##2##4##(2008-9#1)(2011-1#1)
a huge mass##3##3##(2007-8#2)(2011-2#1)
a huge number of##2##4##(2011-1#2)
a huge##30##2##(1995-12#1)(1997-8#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)
a human RNase##2##3##(2009-2#2)
a human alpha-1##3##3##(1992-8#1)(1995-2#2)
a human apolipoprotein B##2##4##(1994-8#1)(1995-2#1)
a human bone marrow##2##4##(2008-11#2)
a human brain##4##3##(1991-9#1)(1992-3#1)(1993-8#2)
a human breast##2##3##(1990-11#1)(1995-10#1)
a human cDNA##5##3##(1991-5#1)(1991-6#1)(1993-9#1)(1994-8#2)
a human cell line##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
a human cervical cancer cell line##2##6##(2008-11#1)(2010-12#1)
a human fetal brain cDNA library##2##6##(1996-2#1)(2008-8#1)
a human fetal##3##3##(1996-2#1)(2008-8#2)
a human gastric##2##3##(1992-8#1)(1997-1#1)
a human gene##4##3##(1990-7#1)(1995-12#1)(1995-8#1)(2008-6#1)
a human genetic##2##3##(2008-7#1)(2012-3#1)
a human genomic##4##3##(1991-6#1)(1994-11#1)(1994-9#1)(1997-4#1)
a human hand##2##3##(2008-3#2)
a human head##2##3##(2008-3#1)(2012-3#1)
a human homologue##2##3##(1993-11#1)(1993-3#1)
a human liver cDNA library##3##5##(1992-8#1)(1993-11#1)(1994-11#1)
a human liver cDNA##4##4##(1992-8#1)(1993-11#2)(1994-11#1)
a human liver##6##3##(1991-5#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-11#1)
a human lung##4##3##(1991-5#1)(1993-11#1)(1997-2#1)(2008-11#1)
a human melanoma cell line##2##5##(1990-11#2)
a human melanoma##3##3##(1990-11#2)(1993-9#1)
a human monocytic##2##3##(1993-12#1)(1994-2#1)
a human neuroblastoma cell line##2##5##(1991-9#1)(1996-10#1)
a human observer##2##3##(2008-11#1)(2012-1#1)
a human ovarian##2##3##(1993-9#1)(2008-8#1)
a human pathogen##3##3##(1990-11#1)(1995-2#1)(2007-12#1)
a human placenta cDNA library##2##5##(1994-11#1)(2008-8#1)
a human prostatic cancer cell line##2##6##(1990-12#2)
a human prostatic carcinoma cell strain##2##6##(1991-2#2)
a human prostatic##4##3##(1990-12#2)(1991-2#2)
a human resource##2##3##(1997-3#1)(2008-1#1)
a human skin##3##3##(2008-3#1)(2012-2#1)(2012-3#1)
a human tRNA gene##2##4##(1997-7#2)
a human testis##2##3##(1990-2#1)(2008-9#1)
a human##202##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#3)(1990-7#2)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#6)(1991-9#2)(1992-12#1)(1992-3#3)(1992-8#3)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#7)(1994-12#5)(1994-2#1)(1994-6#3)(1994-8#8)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#16)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#10)(2008-9#2)(2009-2#6)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#3)
a human/rodent##2##2##(1994-9#1)(1997-8#1)
a humanized monoclonal antibody (MAb)##2##5##(2008-5#1)(2008-7#1)
a humanized##5##2##(1995-2#1)(2008-11#1)(2008-5#2)(2008-7#1)
a humanoid robot##2##3##(2009-5#2)
a humanoid##3##2##(2009-11#1)(2009-5#2)
a humid##2##2##(2008-10#2)
a humidified##2##2##(2008-11#1)(2013-1#1)
a humoral immune response##2##4##(1997-4#1)(2008-10#1)
a humoral##6##2##(1997-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
a hundred years##3##3##(1997-2#1)(2008-2#1)(2012-12#1)
a hundred##6##2##(1993-12#1)(1997-2#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
a hunt##2##2##(2008-9#2)
a hyaluronic##5##2##(2008-5#2)(2013-1#3)
a hybrid PBL curriculum##3##4##(2008-10#3)
a hybrid approach##2##3##(2008-3#1)(2011-2#1)
a hybrid artificial liver##4##4##(2008-11#4)
a hybrid between##2##3##(1994-5#1)(2008-10#1)
a hybrid method##2##3##(2008-3#1)(2008-4#1)
a hybrid of##2##3##(1993-1#1)(2008-10#1)
a hybrid recognition system##2##4##(2008-2#2)
a hybrid strategy##2##3##(2011-2#1)(2012-12#1)
a hybrid##68##2##(1990-12#3)(1991-9#3)(1993-1#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-5#1)(2007-11#8)(2007-12#4)(2008-10#11)(2008-11#5)(2008-2#7)(2008-3#13)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-3#1)
a hybridization##8##2##(1991-9#1)(1992-10#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)
a hybridly mode-locked external linear cavity semiconductor laser##2##8##(2007-11#2)
a hybridoma##5##2##(1994-5#1)(2008-11#4)
a hydatid##2##2##(2011-2#1)(2013-1#1)
a hydraulic##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
a hydrazone##4##2##(1992-8#1)(1997-1#1)(2008-10#1)(2010-4#1)
a hydride generation##3##3##(2008-10#3)
a hydrocarbon##2##2##(2007-12#1)(2013-1#1)
a hydrochloric acid##3##3##(2008-10#3)
a hydrodynamic##3##2##(2008-10#2)(2008-4#1)
a hydrogel##4##2##(2008-5#3)(2010-12#1)
a hydrogen bond between##2##4##(1993-1#1)(1995-2#1)
a hydrogen bond forming ligand##2##5##(2008-10#2)
a hydrogen bond##10##3##(1990-8#2)(1991-8#1)(1992-3#1)(1993-1#1)(1995-2#1)(2008-10#2)(2010-7#2)
a hydrogen peroxide##3##3##(2008-10#3)
a hydrogen##22##2##(1990-7#1)(1990-8#2)(1991-3#1)(1991-8#1)(1992-3#1)(1993-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#6)(2008-3#1)(2008-5#2)(2010-4#1)(2010-7#2)
a hydrogen/entrained air flame##2##4##(2008-10#2)
a hydrolysis##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
a hydrolytic product that##2##4##(1996-12#2)
a hydrophilic matrix##3##3##(1990-8#2)(2008-10#1)
a hydrophilic##8##2##(1990-8#2)(1995-2#2)(2008-10#3)(2008-7#1)
a hydrophobic##21##2##(1990-5#1)(1990-7#1)(1993-11#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#1)
a hydroponic##2##2##(2008-10#2)
a hydrothermal##2##2##(2008-6#1)(2009-11#1)
a hydroxyl group in the##2##5##(1993-11#1)(2008-10#1)
a hydroxyl group##4##3##(1993-11#1)(2008-10#1)(2008-11#2)
a hydroxyl##5##2##(1993-11#1)(2008-10#1)(2008-11#2)(2013-1#1)
a hygromycin##2##2##(2008-10#1)(2011-1#1)
a hyperbolic lens##2##3##(2008-2#2)
a hyperbolic##8##2##(1992-5#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
a hypercoagulability study##2##3##(2007-10#2)
a hypercoagulation abnormality##2##3##(2007-10#2)
a hyperintense##2##2##(1996-5#1)(2011-2#1)
a hyperphosphorylated##2##2##(1996-12#1)(1996-2#1)
a hyperplastic##2##2##(2008-5#1)(2008-8#1)
a hypersensitive reaction##2##3##(2008-10#2)
a hypersensitive response##4##3##(2008-10#4)
a hypersensitive##6##2##(2008-10#6)
a hypersensitivity##2##2##(1996-12#1)(2008-8#1)
a hypertensive##4##2##(1993-11#1)(2008-7#1)(2010-4#2)
a hyperthermophilic##3##2##(2008-7#1)(2011-2#2)
a hypertrophy of##2##3##(1996-3#1)(2007-12#1)
a hypervascular##4##2##(1992-3#1)(2008-1#3)
a hypoplastic right##2##3##(2007-8#2)
a hypoplastic##3##2##(2007-8#2)(2013-1#1)
a hypothesis about##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a hypothesis that the##2##4##(2008-11#1)(2012-3#1)
a hypothesis that##8##3##(2008-11#2)(2008-8#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
a hypothesis##18##2##(1992-3#1)(1992-8#1)(1995-5#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
a hypothesized##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2010-2#1)
a hypothetical country##2##3##(2011-2#2)
a hypothetical model##2##3##(2007-11#1)(2012-2#1)
a hypothetical protein##4##3##(1995-9#1)(1996-3#1)(1997-2#1)(2008-7#1)
a hypothetical##22##2##(1990-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
a hypotonic##6##2##(1990-2#4)(1993-11#1)(2008-11#1)
a hypovirulence-associated##2##2##(2008-10#2)
a hysterectomy##2##2##(1996-2#1)(2013-1#1)
a important##2##2##(1997-4#1)(2008-12#1)
a in##5##2##(1996-12#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
a internal##2##2##(2008-10#2)
a is##2##2##(2007-10#1)(2008-2#1)
a jellyfish sting##2##3##(2012-3#2)
a jellyfish##3##2##(2012-3#3)
a jet ring cell##2##4##(2008-10#2)
a jet ring##3##3##(2008-10#3)
a jet##7##2##(1994-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
a job##12##2##(1990-2#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-12#1)(2007-6#1)(2008-1#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2013-8#1)
a joint effort##3##3##(1991-2#1)(1991-3#1)(2007-12#1)
a joint fractional##3##3##(2008-3#3)
a joint transform correlator is##2##5##(2008-2#1)(2008-3#1)
a joint transform correlator##7##4##(2008-2#3)(2008-3#4)
a joint transform##8##3##(2008-2#3)(2008-3#5)
a joint venture##3##3##(1994-3#2)(2008-5#1)
a joint##27##2##(1991-2#1)(1991-3#1)(1994-3#2)(1995-9#1)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
a journal##3##2##(1991-5#1)(2008-3#1)(2008-7#1)
a journey##2##2##(1994-1#1)(2008-11#1)
a judicious##6##2##(1990-3#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
a jugular##2##2##(2008-7#1)(2011-2#1)
a jump##3##2##(1997-3#1)(2007-12#2)
a jury's##2##2##(1995-12#1)(1995-6#1)
a just##3##2##(1993-11#1)(1994-12#1)(2008-6#1)
a juvenile##4##2##(1995-11#1)(1997-6#1)(2008-8#1)(2013-1#1)
a kappa coefficient of 0##2##5##(2011-2#2)
a kappa-opioid##2##2##(1997-2#2)
a karyotype of##2##3##(2009-2#2)
a karyotype##3##2##(2008-12#1)(2009-2#2)
a kcat##4##2##(1995-2#1)(1995-5#2)(1995-6#1)
a keen interest in##2##4##(1991-1#1)(1996-12#1)
a keen##4##2##(1991-1#1)(1996-12#1)(2007-12#1)(2008-10#1)
a keratoacanthoma##2##2##(2010-8#2)
a kernel##2##2##(2008-10#1)(2008-7#1)
a key component in##3##4##(2008-11#2)(2013-8#1)
a key component of the##3##5##(1995-2#1)(2008-10#1)(2009-11#1)
a key component of##5##4##(1995-2#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-3#1)
a key component##8##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-3#1)(2013-8#1)
a key element##2##3##(1996-8#1)(2009-10#1)
a key enzyme in##5##4##(1990-2#1)(1992-3#1)(1992-8#1)(1995-8#1)(2008-9#1)
a key enzyme of##2##4##(1992-8#1)(1993-6#1)
a key enzyme##10##3##(1990-2#1)(1992-3#1)(1992-8#2)(1993-6#1)(1995-11#1)(1995-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
a key event##2##3##(2008-4#1)(2009-9#1)
a key factor for##3##4##(2008-10#2)(2008-9#1)
a key factor in the biocontrol activity of##2##8##(2008-10#2)
a key factor in the##4##5##(2008-10#2)(2013-1#1)(2013-8#1)
a key factor in this##2##5##(2008-5#1)(2011-2#1)
a key factor in##14##4##(1996-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a key factor that##2##4##(2008-3#1)(2012-2#1)
a key factor##21##3##(1995-2#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a key feature of##3##4##(1991-9#1)(2008-11#1)(2013-1#1)
a key feature##4##3##(1991-9#1)(2008-11#1)(2008-5#1)(2013-1#1)
a key for##3##3##(2008-5#1)(2008-8#1)(2013-7#1)
a key group##2##3##(2011-2#1)(2013-1#1)
a key indicator##2##3##(1997-2#1)(2008-7#1)
a key intermediate in the synthesis of##2##7##(1992-12#1)(2011-1#1)
a key intermediate in the##3##5##(1990-8#1)(1992-12#1)(2011-1#1)
a key intermediate##4##3##(1990-8#1)(1992-12#1)(1996-5#1)(2011-1#1)
a key issue for##2##4##(2008-10#2)
a key issue##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
a key measure of##2##4##(2008-11#1)(2012-3#1)
a key mechanism##3##3##(2008-10#1)(2012-2#2)
a key mediator of##2##4##(1997-7#1)(2010-8#1)
a key molecule##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
a key player in the##2##5##(1994-12#1)(2011-2#1)
a key player in##3##4##(1994-12#1)(2008-4#1)(2011-2#1)
a key protein##2##3##(2008-8#1)(2009-8#1)
a key reaction##3##3##(1990-7#1)(2013-1#2)
a key regulator of the##2##5##(2008-11#1)(2010-8#1)
a key regulator of##7##4##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
a key regulatory role##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
a key regulatory##7##3##(1990-4#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
a key role in suppressing##2##5##(2008-10#1)(2008-9#1)
a key role in the development of##5##7##(1996-1#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-11#1)
a key role in the development##6##6##(1991-12#1)(1996-1#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-11#1)
a key role in the pathogenesis of##4##7##(2008-3#1)(2009-8#1)(2011-1#1)(2013-1#1)
a key role in the regulation of##2##7##(2007-12#1)(2011-2#1)
a key role in the##41##5##(1991-12#1)(1991-5#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#4)(2011-2#4)(2012-3#1)(2013-1#2)
a key role in this##2##5##(1994-2#1)(1997-7#1)
a key role in type##2##5##(2010-11#1)(2013-1#1)
a key role in##79##4##(1990-2#1)(1991-12#1)(1991-5#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-1#5)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)
a key role of##2##4##(2009-8#1)(2013-1#1)
a key role##91##3##(1990-2#2)(1991-12#1)(1991-5#1)(1992-9#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)
a key step in the##2##5##(1990-5#1)(2008-10#1)
a key step in##6##4##(1990-5#1)(1994-11#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)
a key step##9##3##(1990-5#1)(1994-11#1)(2008-10#2)(2008-11#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
a key strategy##2##3##(1994-2#1)(2008-9#1)
a key to the##3##4##(1994-12#1)(2008-3#1)(2012-2#1)
a key to understanding##3##4##(2008-7#1)(2008-8#1)(2010-6#1)
a key to##11##3##(1992-1#1)(1994-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#1)(2012-2#1)
a key##276##2##(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#4)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-8#1)(1996-1#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#5)(2008-10#27)(2008-11#16)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#11)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#5)(2011-1#8)(2011-10#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#13)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#4)
a keyword##2##2##(2010-12#1)(2011-2#1)
a kidney transplant##5##3##(1991-3#1)(1997-4#1)(2008-5#1)(2010-12#2)
a kidney##11##2##(1990-2#1)(1991-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-12#2)(2011-2#1)
a killer##4##2##(1993-12#2)(2012-3#2)
a kilohertz repetition##3##3##(2007-12#2)(2008-3#1)
a kilohertz##5##2##(2007-12#3)(2008-3#2)
a kinase##2##2##(2009-8#1)(2012-12#1)
a kinase-deficient mutant##2##3##(1994-8#1)(1995-2#1)
a kind of##13##3##(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a kinetic model##2##3##(1996-2#1)(2008-7#1)
a kinetic study##2##3##(2008-10#1)(2012-2#1)
a kinetic##16##2##(1991-3#1)(1991-8#1)(1995-2#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
a kinship##2##2##(2008-12#2)
a kit##3##2##(1996-2#1)(2008-5#1)(2012-2#1)
a knee##9##2##(2007-8#1)(2008-5#1)(2008-8#2)(2013-1#5)
a knife-edge##3##2##(2007-12#1)(2008-3#2)
a knotted reactor##3##3##(2008-10#3)
a knotted##8##2##(1995-6#1)(2008-10#7)
a knowledge of the complete oxygenation-linked dimer-tetramer association reaction##2##9##(1990-8#2)
a knowledge of the##7##4##(1990-8#2)(1994-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-9#1)
a knowledge of##8##3##(1990-8#2)(1994-3#1)(1996-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-9#1)
a knowledge##9##2##(1990-8#2)(1994-3#1)(1996-12#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-9#1)
a knowledge-based##2##2##(2010-10#1)(2010-5#1)
a known amount of##3##4##(2008-10#2)(2008-12#1)
a known and##3##3##(1991-1#1)(2008-10#1)(2009-4#1)
a known cause of##2##4##(2008-4#1)(2012-12#1)
a known cause##3##3##(2008-4#1)(2011-1#1)(2012-12#1)
a known concentration##2##3##(2008-10#1)(2010-2#1)
a known temperature##2##3##(2008-2#1)(2008-3#1)
a known##86##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a la fois##2##3##(2008-5#2)
a la##5##2##(2008-5#4)(2013-1#1)
a lab-made##2##2##(2008-10#2)
a lab-on-valve (LOV)##2##3##(2008-10#2)
a label to##2##3##(1996-11#1)(2009-8#1)
a label-free detection##2##3##(2008-10#2)
a label-free##5##2##(2008-10#3)(2010-2#1)(2012-2#1)
a labeled##7##2##(1990-12#1)(1993-11#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
a labeling##5##2##(1993-11#1)(1996-5#1)(2008-1#1)(2008-10#2)
a labile##3##2##(1992-8#1)(1993-8#1)(1995-5#1)
a laboratory colony of##3##4##(1996-6#1)(2008-9#1)(2010-4#1)
a laboratory is able to##2##5##(2009-11#2)
a laboratory population of##2##4##(2008-10#2)
a laboratory population##3##3##(2008-10#3)
a laboratory strain##4##3##(1996-12#1)(2011-2#2)(2012-3#1)
a laboratory##54##2##(1992-3#1)(1993-2#2)(1994-6#1)(1996-12#1)(1996-6#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a laboratory-made##6##2##(1990-8#1)(2008-10#5)
a labyrinth##2##2##(1991-2#1)(2008-7#1)
a lac##2##2##(1990-5#1)(1992-9#1)
a lacZ##3##2##(1992-5#1)(1993-12#1)(1994-12#1)
a lack of a##4##4##(2006-10#1)(2008-1#1)(2008-12#1)(2011-2#1)
a lack of access to##2##5##(1996-8#1)(2008-10#1)
a lack of adequate##4##4##(2008-9#2)(2010-6#1)(2011-3#1)
a lack of awareness##2##4##(2007-10#1)(2007-2#1)
a lack of consensus##4##4##(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
a lack of data##5##4##(2007-11#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)
a lack of equipoise##2##4##(2012-2#2)
a lack of established##2##4##(2008-10#2)
a lack of jobs##2##4##(2009-9#2)
a lack of knowledge of##2##5##(2008-1#1)(2008-11#1)
a lack of knowledge##5##4##(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-6#1)
a lack of tools##2##4##(2010-11#1)(2013-8#1)
a lack of##114##3##(1991-12#1)(1991-2#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-8#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-7#1)(2008-1#3)(2008-10#13)(2008-11#12)(2008-12#7)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#3)(2010-11#1)(2010-6#2)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#6)(2013-1#3)(2013-8#3)
a lacunar##3##2##(2007-10#1)(2009-10#2)
a lady of##2##3##(2007-8#1)(2013-1#1)
a lag phase##2##3##(1997-7#1)(2011-2#1)
a lag##4##2##(1997-7#1)(2008-10#1)(2010-1#1)(2011-2#1)
a lake##4##2##(2008-10#2)(2008-8#1)(2010-8#1)
a lambda gt10##2##3##(1994-8#1)(1997-7#1)
a lambda gt11##2##3##(1991-12#1)(1993-6#1)
a lambda max##2##3##(1993-8#1)(1994-8#1)
a lambda##10##2##(1991-12#1)(1991-6#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#2)(1997-7#1)(2008-11#1)
a lambda(max) of##2##3##(2008-10#2)
a lambda(max)##3##2##(2008-10#3)
a laminar flow##2##3##(2008-11#1)(2008-2#1)
a laminar profile##2##3##(1993-12#1)(2008-3#1)
a laminar##14##2##(1993-12#1)(2008-11#1)(2008-2#5)(2008-3#6)(2008-7#1)
a laminin##2##2##(2008-10#1)(2008-11#1)
a language##6##2##(2008-1#1)(2008-11#2)(2008-2#1)(2009-8#1)(2012-12#1)
a lanthanum-modified lead zirconate titanate##2##5##(2008-2#2)
a laparoscopic##4##2##(1996-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
a laparotomy##6##2##(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(2008-12#1)(2011-1#1)
a lapse##2##2##(2012-2#1)(2013-8#1)
a large (n =##3##4##(1992-8#1)(2009-2#1)(2009-9#1)
a large AVM##2##3##(2008-7#2)
a large Stokes shift##2##4##(2007-12#1)(2008-10#1)
a large academic##2##3##(1995-3#1)(2008-11#1)
a large amount of data##3##5##(2008-10#1)(2008-3#1)(2010-8#1)
a large amount of##20##4##(1991-12#1)(2007-12#3)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
a large amount##22##3##(1991-12#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a large and diverse##2##4##(2008-10#1)(2008-11#1)
a large and##11##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
a large aneurysm of##2##4##(2007-8#1)(2008-8#1)
a large angular range##2##4##(2008-3#2)
a large angular##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a large animal##3##3##(2008-4#1)(2012-12#1)(2012-2#1)
a large arachnoid cyst##2##4##(2012-12#2)
a large area##5##3##(1992-5#1)(2008-10#2)(2008-11#1)(2009-11#1)
a large array of##2##4##(2007-8#1)(2012-2#1)
a large automated database of computerized##2##6##(2008-11#2)
a large bandwidth##3##3##(2008-3#3)
a large bladder##2##3##(2007-10#1)(2008-10#1)
a large body of evidence##2##5##(1992-3#1)(2008-10#1)
a large body of##8##4##(1992-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#2)
a large body##9##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#2)
a large cerebral##2##3##(2007-10#1)(2008-7#1)
a large chromosomal inversion##2##4##(2008-10#1)(2013-1#1)
a large class of##2##4##(2007-11#1)(2013-8#1)
a large cohort of##4##4##(2007-4#1)(2008-3#1)(2009-8#1)(2011-2#1)
a large cohort##6##3##(2007-4#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)
a large collection of##2##4##(2008-10#1)(2013-1#1)
a large complex##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
a large contribution##3##3##(2008-2#1)(2009-4#1)(2013-8#1)
a large cystic##3##3##(1990-6#1)(2008-1#1)(2011-2#1)
a large data set##2##4##(2008-9#1)(2009-9#1)
a large data##3##3##(1994-3#1)(2008-9#1)(2009-9#1)
a large database of##2##4##(2008-6#2)
a large degree##3##3##(2008-10#2)(2008-9#1)
a large depth##2##3##(2007-11#1)(2008-3#1)
a large diameter##2##3##(2008-3#1)(2008-7#1)
a large dispersion##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
a large distance##2##3##(2007-12#1)(2008-8#1)
a large domain##2##3##(1990-12#1)(2008-3#1)
a large effect on the##2##5##(2008-3#1)(2008-7#1)
a large effect on##3##4##(2008-3#1)(2008-7#1)(2012-3#1)
a large enhancement of##4##4##(1995-5#1)(2007-11#1)(2008-6#2)
a large enhancement##5##3##(1990-2#1)(1995-5#1)(2007-11#1)(2008-6#2)
a large excess of##6##4##(1991-11#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-2#1)
a large extent##13##3##(1992-6#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
a large family of##7##4##(1994-2#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-2#1)
a large field of view##3##5##(2008-3#1)(2008-7#1)(2010-12#1)
a large fraction of the##2##5##(1990-9#1)(2008-7#1)
a large fraction of##3##4##(1990-9#1)(2008-7#1)(2013-8#1)
a large group of##11##4##(1991-11#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
a large group##13##3##(1991-11#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
a large hospital##3##3##(1993-2#1)(2010-8#1)(2012-2#1)
a large impact on the##2##5##(1994-12#1)(1995-6#1)
a large impact on##5##4##(1991-3#1)(1994-12#1)(1995-6#1)(2008-3#1)(2009-7#1)
a large impact upon##2##4##(2008-10#1)(2013-1#1)
a large impact##7##3##(1991-3#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
a large improvement in##2##4##(2008-3#1)(2011-1#1)
a large improvement##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
a large increase in fluorescence intensity##2##6##(2008-10#2)
a large increase in the##4##5##(1995-6#1)(2007-12#1)(2008-2#1)(2010-8#1)
a large increase in##11##4##(1990-11#1)(1993-12#1)(1995-6#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2010-8#1)
a large increase##13##3##(1990-11#1)(1993-12#1)(1994-12#1)(1995-6#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2010-8#1)
a large local##2##3##(2008-12#1)(2008-7#1)
a large majority of##2##4##(2008-10#1)(2008-3#1)
a large mass##5##3##(2008-11#2)(2008-6#2)(2011-2#1)
a large molecule##2##3##(1997-3#1)(2008-4#1)
a large municipal public health agency##2##6##(2010-8#2)
a large municipal##3##3##(1991-12#1)(2010-8#2)
a large network of##3##4##(2008-4#1)(2008-8#1)(2008-9#1)
a large number of anions##5##5##(2008-10#5)
a large number of cell##2##5##(2008-11#1)(2008-9#1)
a large number of different##4##5##(1994-2#1)(1995-5#1)(2008-9#1)(2013-1#1)
a large number of diverse##2##5##(2008-10#1)(2008-4#1)
a large number of genes##4##5##(1996-12#1)(1996-6#1)(2011-1#1)(2011-2#1)
a large number of individuals##2##5##(2008-10#1)(2008-8#1)
a large number of patients##5##5##(1993-11#2)(1996-3#1)(2009-4#1)(2010-12#1)
a large number of samples##9##5##(1997-4#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-11#1)
a large number of studies on##2##6##(2008-1#1)(2008-5#1)
a large number of targets##2##5##(2008-2#1)(2009-8#1)
a large number of tissue##2##5##(1994-2#1)(2008-4#1)
a large number of##148##4##(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#39)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
a large number##149##3##(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#40)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
a large open##2##3##(1993-3#1)(1997-3#1)
a large optical##2##3##(2007-12#1)(2008-3#1)
a large part of the##8##5##(1990-7#1)(1992-3#1)(2008-10#1)(2008-5#2)(2008-8#3)
a large part of##10##4##(1990-7#1)(1992-3#1)(1993-2#1)(1996-6#1)(2008-10#1)(2008-5#2)(2008-8#3)
a large pedigree of##2##4##(2008-2#2)
a large percentage of the##5##5##(2008-5#1)(2009-11#1)(2012-12#1)(2013-1#2)
a large percentage of##8##4##(2008-10#1)(2008-5#1)(2009-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
a large pool of##3##4##(1991-2#1)(1997-7#1)(2010-11#1)
a large population of##8##4##(1994-8#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)
a large population##11##3##(1994-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-3#1)(2011-2#2)
a large population-based##2##3##(2008-1#1)(2013-1#1)
a large portion of the##2##5##(1993-2#1)(2012-3#1)
a large portion of##3##4##(1993-2#1)(2008-7#1)(2012-3#1)
a large proportion of the population##2##6##(2007-12#1)(2009-4#1)
a large proportion of the##8##5##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2013-8#1)
a large proportion of##21##4##(1990-3#1)(1991-4#1)(1992-12#2)(1996-2#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
a large public##2##3##(1993-1#1)(2009-9#1)
a large quantity##2##3##(1990-5#1)(2013-1#1)
a large range of##13##4##(1993-9#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)
a large right##2##3##(2007-10#1)(2012-12#1)
a large ring##2##3##(2008-2#1)(2008-3#1)
a large sample of##5##4##(1992-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
a large sample##9##3##(1992-11#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)(2012-2#1)
a large scale##16##3##(1991-2#1)(1994-5#1)(1994-6#1)(1997-3#1)(2008-10#4)(2008-11#3)(2009-12#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
a large series of##4##4##(1993-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
a large set of##9##4##(2008-11#1)(2008-2#2)(2008-3#3)(2009-10#1)(2012-12#1)(2013-8#1)
a large shift in##2##4##(1993-11#1)(2008-7#1)
a large spectrum##2##3##(2007-8#1)(2011-1#1)
a large surface area##2##4##(2008-10#1)(2008-11#1)
a large surface##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
a large transient##2##3##(1990-7#1)(2008-10#1)
a large urban public##2##4##(2007-12#1)(2008-3#1)
a large urban##5##3##(1992-1#1)(1992-12#1)(2007-12#1)(2008-3#1)(2011-2#1)
a large vacuole##2##3##(2008-6#1)(2009-12#1)
a large variability##2##3##(1997-3#1)(2008-11#1)
a large variety of applications##2##5##(2008-7#1)(2008-9#1)
a large variety of##15##4##(1992-9#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2010-8#1)(2011-2#2)
a large volume of HuES media##2##6##(2008-8#2)
a large volume of aqueous##3##5##(2008-10#3)
a large volume of##7##4##(1995-3#1)(2008-10#3)(2008-11#1)(2008-8#2)
a large volume##12##3##(1995-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)
a large##833##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#3)(1992-3#5)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#4)(1993-6#2)(1993-9#5)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#5)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#6)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#9)(1997-4#5)(1997-6#2)(1997-7#4)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#21)(2007-12#34)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#12)(2008-1#5)(2008-10#132)(2008-11#30)(2008-12#11)(2008-2#27)(2008-3#56)(2008-4#13)(2008-5#21)(2008-6#14)(2008-7#41)(2008-8#18)(2008-9#19)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#5)(2010-10#2)(2010-11#5)(2010-12#3)(2010-3#5)(2010-4#2)(2010-5#2)(2010-8#8)(2011-1#12)(2011-2#33)(2012-1#1)(2012-12#13)(2012-2#19)(2012-3#13)(2012-7#1)(2013-1#20)(2013-7#1)(2013-8#11)
a large-aperture##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
a large-area photodetector##2##3##(2008-3#2)
a large-area##6##2##(2007-11#1)(2008-11#1)(2008-3#4)
a large-scale comparison of##2##4##(2008-10#1)(2012-3#1)
a large-scale##24##2##(1993-2#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-12#1)(2010-1#1)(2010-5#2)(2012-2#4)(2012-3#1)(2013-1#1)
a largely##7##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#1)
a larger amount of##4##4##(2008-10#4)
a larger anion##2##3##(2008-10#2)
a larger area##2##3##(1991-6#1)(2008-3#1)
a larger change##2##3##(1994-8#1)(2008-10#1)
a larger collection of##2##4##(1993-12#1)(2008-10#1)
a larger dynamic range and##2##5##(2007-11#1)(2007-12#1)
a larger fraction of##2##4##(1991-11#1)(2013-8#1)
a larger group of patients with##2##6##(2008-6#1)(2011-2#1)
a larger group of patients##3##5##(2008-6#1)(2011-2#1)(2012-1#1)
a larger group##4##3##(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
a larger number of patients##2##5##(1992-2#1)(2008-10#1)
a larger number of##6##4##(1992-2#1)(2008-10#3)(2008-2#1)(2008-7#1)
a larger proportion of the##2##5##(1990-6#1)(1995-5#1)
a larger proportion of##3##4##(1990-6#1)(1995-5#1)(2008-1#1)
a larger range of##2##4##(2008-10#1)(2008-3#1)
a larger sample##2##3##(2008-12#1)(2010-7#1)
a larger scale##3##3##(1992-5#1)(2008-1#1)(2013-8#1)
a larger study##7##3##(1994-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)(2010-7#1)
a larger surface area##3##4##(1994-9#1)(2008-7#1)(2012-12#1)
a larger##111##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
a larval##4##2##(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)
a laryngeal##2##2##(1993-8#1)(2008-2#1)
a laryngotomy approach##2##3##(2012-12#2)
a laser Doppler##2##3##(1990-7#1)(2008-3#1)
a laser beacon##2##3##(2008-2#1)(2008-3#1)
a laser beam by##2##4##(2007-12#1)(2008-3#1)
a laser beam is##2##4##(2008-3#2)
a laser beam##19##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#10)(2009-12#1)
a laser cavity##4##3##(2007-11#1)(2008-3#3)
a laser diode and##2##4##(2007-12#1)(2008-3#1)
a laser diode as##2##4##(2007-12#1)(2008-2#1)
a laser diode for##2##4##(2008-3#2)
a laser diode is##3##4##(2008-2#2)(2008-3#1)
a laser diode with a##2##5##(2008-3#2)
a laser diode with##3##4##(2008-3#3)
a laser diode##31##3##(2007-11#3)(2007-12#5)(2008-2#9)(2008-3#14)
a laser guide star##3##4##(2008-2#1)(2008-3#2)
a laser pulse##2##3##(1995-6#1)(2007-11#1)
a laser source##2##3##(2008-3#2)
a laser system##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a laser wavelength of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
a laser wavelength##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
a laser with##2##3##(2007-12#1)(2008-3#1)
a laser##121##2##(1990-7#1)(1993-2#1)(1995-6#1)(2006-4#1)(2007-11#12)(2007-12#17)(2008-10#2)(2008-2#28)(2008-3#51)(2008-4#1)(2008-9#2)(2009-12#1)(2009-7#1)(2012-3#1)(2013-8#1)
a laser-based##2##2##(2008-10#1)(2008-3#1)
a laser-diode##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
a laser-diode-pumped LiNdP(4)O(12)##3##3##(2007-11#1)(2007-12#2)
a laser-diode-pumped microchip LiNdP(4)O(12) laser##3##5##(2007-12#3)
a laser-diode-pumped microchip##6##3##(2007-11#1)(2007-12#5)
a laser-diode-pumped##12##2##(2007-11#3)(2007-12#9)
a laser-produced##2##2##(2007-11#1)(2008-2#1)
a last resort##3##3##(2008-8#1)(2009-8#1)(2010-10#1)
a last##5##2##(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
a lasting##4##2##(1990-2#1)(2007-12#1)(2008-12#1)(2008-7#1)
a late complication of##7##4##(2007-8#3)(2009-5#2)(2012-2#1)(2013-7#1)
a late onset##2##3##(2008-1#2)
a late##24##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-2#1)(1993-9#1)(1996-6#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-7#1)(2009-5#2)(2009-7#2)(2010-11#2)(2011-2#2)(2012-2#1)(2013-7#1)
a latent variable##4##3##(2008-12#1)(2010-11#1)(2012-12#2)
a latent##8##2##(1991-11#1)(1995-6#1)(2008-12#1)(2009-11#1)(2010-11#1)(2010-12#1)(2012-12#2)
a later age##3##3##(1995-8#1)(1996-9#1)(2008-2#1)
a later stage of the##2##5##(1992-6#1)(2008-11#1)
a later stage of##4##4##(1992-6#1)(2008-11#1)(2010-1#1)(2010-10#1)
a later stage##11##3##(1992-6#1)(2007-11#1)(2008-11#3)(2008-5#1)(2010-1#2)(2010-10#1)(2012-1#1)(2013-8#1)
a later##27##2##(1990-2#1)(1991-12#1)(1992-6#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-1#2)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a lateral resolution of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a lateral resolution##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
a lateral shear##2##3##(2008-3#2)
a lateral shearing interferometer##2##4##(2008-2#2)
a lateral shearing##3##3##(2008-2#2)(2008-3#1)
a lateral##25##2##(1991-2#1)(1991-3#1)(1991-6#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#5)(2008-7#1)(2009-1#3)(2009-10#1)(2012-2#1)(2013-1#1)
a laterally##2##2##(2008-3#1)(2008-9#1)
a latissimus dorsi##3##3##(1992-9#1)(1994-12#1)(2008-9#1)
a lattice##3##2##(2007-8#1)(2008-3#1)(2008-5#1)
a law##2##2##(1997-1#1)(2008-8#1)
a lawsuit##6##2##(1992-2#1)(1995-12#2)(1997-5#3)
a layer of##19##3##(1992-9#1)(2007-11#1)(2008-10#8)(2008-3#7)(2008-5#1)(2009-7#1)
a layer##26##2##(1992-9#3)(1997-3#1)(2007-11#1)(2008-10#9)(2008-2#1)(2008-3#9)(2008-5#1)(2009-7#1)
a layer-by-layer##2##2##(2008-10#1)(2008-7#1)
a layered spheroid##2##3##(2008-3#2)
a layered##8##2##(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2012-2#1)
a lead##7##2##(1996-2#1)(1996-3#1)(2008-10#4)(2008-2#1)
a leader##7##2##(1990-2#1)(1991-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(2008-6#1)
a leadership role##2##3##(1993-3#1)(2008-6#1)
a leading cause of blindness##3##5##(2007-11#1)(2008-1#1)(2010-10#1)
a leading cause of death worldwide##2##6##(2011-2#1)(2012-1#1)
a leading cause of death##5##5##(1995-9#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-1#1)
a leading cause of disability##4##5##(1995-12#1)(2008-1#1)(2010-3#1)(2013-1#1)
a leading cause of morbidity and mortality##3##7##(1993-3#1)(2008-8#1)(2011-2#1)
a leading cause of##27##4##(1993-3#1)(1995-12#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
a leading role##2##3##(1994-9#1)(2011-1#1)
a leading##35##2##(1993-3#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-3#1)(2007-11#2)(2008-1#3)(2008-10#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
a leaf in##2##3##(2008-10#2)
a leaf spot##2##3##(2008-10#2)
a leaf##16##2##(1997-7#1)(2008-10#12)(2009-9#1)(2013-1#1)(2013-8#1)
a lean##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
a learning curve##5##3##(1995-11#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
a learning process##2##3##(1997-6#1)(2006-12#1)
a learning##26##2##(1992-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#11)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)
a learning-based model##2##3##(2008-8#2)
a learning-based##3##2##(2008-8#3)
a least-squares fit##2##3##(2008-2#2)
a least-squares method##6##3##(2008-2#1)(2008-3#5)
a least-squares##12##2##(1990-8#1)(2008-2#4)(2008-3#7)
a leave-on lotion##3##3##(2008-5#3)
a leave-on##6##2##(2008-5#6)
a lectin##6##2##(1990-5#3)(1993-6#1)(2008-10#1)(2008-11#1)
a lecturer##3##2##(2008-11#1)(2008-12#2)
a left lateral thoracotomy and##2##5##(2008-6#1)(2012-3#1)
a left lateral##4##3##(1992-9#1)(2008-6#1)(2008-7#1)(2012-3#1)
a left lower##3##3##(2008-1#2)(2008-7#1)
a left pleural effusion##2##4##(1991-12#1)(2013-1#1)
a left sided subpulmonic effusion##2##5##(2007-8#2)
a left sided##4##3##(2007-8#3)(2011-2#1)
a left##39##2##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-9#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-6#2)(2008-7#5)(2009-3#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
a left-handed##2##2##(1992-6#1)(1992-8#1)
a left-sided##3##2##(1997-7#1)(2010-5#1)(2013-8#1)
a leftward relaxation of the spatial##2##6##(2009-10#2)
a legacy of##2##3##(2008-10#1)(2013-1#1)
a legacy##6##2##(1992-3#1)(1995-3#1)(2008-10#2)(2009-11#1)(2013-1#1)
a legal##6##2##(1991-6#1)(1992-3#1)(1992-4#1)(1997-3#1)(2008-11#1)(2013-8#1)
a legitimate##3##2##(1994-2#1)(2008-6#1)(2010-12#1)
a leiomyosarcoma##3##2##(2008-6#3)
a length of##14##3##(1992-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
a length scale of the order of##2##7##(2010-9#2)
a length##17##2##(1992-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-9#2)
a lengthening of the##2##4##(1994-3#1)(1995-3#1)
a lengthy process##2##3##(1992-2#1)(2008-7#1)
a lengthy##5##2##(1992-12#1)(1992-2#1)(1996-1#1)(2008-10#1)(2008-7#1)
a lens array##2##3##(2007-11#1)(2008-3#1)
a lens duct##2##3##(2008-2#1)(2008-3#1)
a lens is##2##3##(2008-3#2)
a lens made##2##3##(2008-3#1)(2011-1#1)
a lens##23##2##(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#6)(2008-3#9)(2011-1#1)
a lensed fiber integrated with a long-period fiber grating##2##9##(2008-3#2)
a leprosy##2##2##(2009-5#1)(2012-12#1)
a lesion in the##4##4##(1996-3#1)(2007-8#1)(2008-10#1)(2009-11#1)
a lesion of the##4##4##(1993-12#2)(1996-2#1)(2012-12#1)
a lesion of##8##3##(1993-12#2)(1996-2#1)(1996-5#2)(2007-7#1)(2008-7#1)(2012-12#1)
a lesion on##3##3##(2007-10#2)(2013-1#1)
a lesion or##2##3##(2008-4#1)(2008-9#1)
a lesion that##2##3##(2007-8#1)(2008-1#1)
a lesion with##2##3##(1996-3#1)(2010-7#1)
a lesion##35##2##(1990-5#1)(1990-9#1)(1991-6#1)(1993-12#2)(1994-3#1)(1996-2#1)(1996-3#2)(1996-5#2)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
a less common##3##3##(1993-3#1)(1993-6#1)(2008-10#1)
a less dramatic##2##3##(1996-11#1)(2008-9#1)
a less effective##2##3##(1991-11#1)(1993-2#1)
a less expensive##2##3##(2008-5#2)
a less frequent##2##3##(2007-7#1)(2008-10#1)
a less important##2##3##(2009-2#1)(2013-8#1)
a less intense##2##3##(2008-3#1)(2010-3#1)
a less invasive##5##3##(2007-11#1)(2007-7#1)(2011-2#1)(2013-1#2)
a less sensitive##2##3##(2008-10#1)(2011-2#1)
a less than##5##3##(1990-2#1)(1995-11#1)(2008-2#1)(2008-3#2)
a less##61##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2013-1#5)(2013-8#3)
a lesser degree##13##3##(1991-12#1)(1991-5#1)(1992-3#1)(1994-6#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
a lesser effect on##2##4##(1992-8#1)(1997-1#1)
a lesser effect##4##3##(1992-8#1)(1997-1#1)(2008-10#1)(2012-12#1)
a lesser extent##64##3##(1990-12#2)(1990-5#1)(1991-12#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)
a lesser role##2##3##(1995-3#1)(2008-9#1)
a lesser##90##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-2#3)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)
a lesson##5##2##(1996-3#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-1#1)
a lethal##13##2##(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-2#1)
a lethality of##2##3##(1997-8#2)
a letter of##2##3##(2008-5#2)
a letter##6##2##(1996-2#1)(2008-5#2)(2008-9#2)(2011-1#1)
a lettuce##2##2##(2008-10#2)
a leucine zipper structure##2##4##(1992-8#2)
a leucine##7##2##(1992-3#1)(1992-6#1)(1992-8#2)(1993-8#1)(2008-9#1)(2013-8#1)
a level above##2##3##(2008-11#1)(2013-1#1)
a level as##3##3##(1992-6#1)(2007-4#1)(2008-10#1)
a level below##3##3##(1991-6#1)(2008-7#2)
a level of 4##2##4##(1990-8#1)(2008-10#1)
a level of##27##3##(1990-8#1)(1991-12#1)(1991-3#1)(1996-2#2)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-1#1)
a level similar to##2##4##(2008-10#2)
a level that##6##3##(1996-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2009-3#1)
a level##62##2##(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1994-6#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)
a lever to##2##3##(1992-11#1)(2013-8#1)
a library consisting of##2##4##(1990-11#1)(2011-1#1)
a library of##9##3##(1990-11#1)(1990-5#2)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)
a library##12##2##(1990-11#2)(1990-5#2)(1991-9#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)
a licensed##3##2##(1991-3#2)(2011-2#1)
a lidar signal##2##3##(2008-2#1)(2008-3#1)
a lidar system##2##3##(2008-2#1)(2008-3#1)
a lidar##12##2##(2007-12#1)(2008-2#5)(2008-3#6)
a life course##3##3##(2008-12#3)
a life history##2##3##(2008-8#2)
a life of##3##3##(1993-12#1)(2008-12#2)
a life style##2##3##(1990-6#1)(2008-1#1)
a life table approach##2##4##(2011-2#2)
a life table##3##3##(2008-9#1)(2011-2#2)
a life threatening complication##2##4##(2007-8#1)(2011-2#1)
a life threatening##5##3##(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#1)
a life##22##2##(1990-6#1)(1992-4#1)(1993-12#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#5)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#3)
a life-history trait##2##3##(2008-8#1)(2008-9#1)
a life-history##3##2##(2008-8#2)(2008-9#1)
a life-long##3##2##(1991-1#1)(1996-3#1)(2008-11#1)
a life-threatening complication of##4##4##(2007-8#1)(2008-12#1)(2010-10#1)(2011-2#1)
a life-threatening complication##8##3##(1993-8#1)(2006-10#1)(2007-8#1)(2008-12#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
a life-threatening condition##2##3##(2011-2#1)(2011-3#1)
a life-threatening disease##4##3##(1991-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
a life-threatening##23##2##(1990-8#1)(1991-8#1)(1993-2#1)(1993-8#1)(1995-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-12#1)(2010-10#1)(2010-5#1)(2011-2#5)(2011-3#2)(2012-2#1)
a lifelong##2##2##(2010-3#1)(2012-2#1)
a lifetime##9##2##(1994-2#1)(1994-9#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-12#2)
a ligand to##2##3##(1992-3#1)(1996-2#1)
a ligand##26##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)
a ligand-dependent##2##2##(2008-4#1)(2012-2#1)
a ligand-induced##2##2##(1990-12#1)(2012-12#1)
a light beam##5##3##(2007-11#1)(2008-3#4)
a light emitting diode##2##4##(1991-2#1)(2008-10#1)
a light microscope##5##3##(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
a light pulse##3##3##(1994-2#1)(2007-11#2)
a light source in##2##4##(2007-12#1)(2008-2#1)
a light source##11##3##(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#2)(2012-3#1)
a light##50##2##(1991-2#1)(1992-11#1)(1992-3#1)(1994-2#1)(1996-6#1)(2007-11#4)(2007-12#3)(2008-10#8)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#1)(2008-6#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
a light-controlled##2##2##(2008-4#1)(2009-7#1)
a light-scattering##4##2##(2008-2#1)(2008-3#3)
a light-sheet##3##2##(2011-1#3)
a lighter##2##2##(1990-5#1)(1991-5#1)
a lightweight##2##2##(2008-3#2)
a likelihood ratio test##3##4##(2008-10#1)(2008-3#2)
a likelihood ratio##5##3##(2008-10#1)(2008-12#1)(2008-3#2)(2013-1#1)
a likelihood##9##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
a likely explanation for##2##4##(1990-5#1)(2012-3#1)
a likely##13##2##(1990-3#1)(1990-5#1)(1991-9#1)(1993-3#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-3#1)
a limb##2##2##(2007-11#1)(2009-3#1)
a limit of detection (3sigma) of 1##2##7##(2008-10#2)
a limit of detection (LOD) of##2##6##(2008-10#2)
a limit of detection (LOD)##4##5##(2008-10#4)
a limit of detection (S/N=2) of##2##6##(2008-10#2)
a limit of detection of 0##5##6##(2008-10#5)
a limit of detection of 1##3##6##(2008-10#3)
a limit of detection of 6##2##6##(2008-10#2)
a limit of detection of##19##5##(2008-10#18)(2011-1#1)
a limit of detection##40##4##(2008-10#38)(2008-2#1)(2011-1#1)
a limit of quantification##2##4##(2008-10#2)
a limit of quantitation##2##4##(1992-8#1)(2008-10#1)
a limit of##45##3##(1992-3#1)(1992-8#1)(2008-10#41)(2008-2#1)(2011-1#1)
a limit on##3##3##(1993-12#2)(2007-12#1)
a limit to##3##3##(2008-2#1)(2008-9#1)(2010-8#1)
a limit##53##2##(1992-3#1)(1992-8#1)(1993-12#2)(2007-12#1)(2008-1#1)(2008-10#42)(2008-2#2)(2008-9#1)(2010-8#1)(2011-1#1)
a limitation##2##2##(2010-4#1)(2012-12#1)
a limited amount of##10##4##(1993-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#2)
a limited area of##2##4##(2008-10#1)(2008-5#1)
a limited capacity##2##3##(1994-2#1)(2008-10#1)
a limited effect##2##3##(1990-6#1)(2008-6#1)
a limited geographic##2##3##(2008-10#1)(2008-8#1)
a limited involvement##2##3##(2007-12#1)(2008-12#1)
a limited number of genes##4##5##(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)
a limited number of studies##3##5##(2007-11#1)(2008-5#1)(2012-2#1)
a limited number of##34##4##(1990-12#1)(1991-2#1)(1992-10#1)(1993-9#1)(1994-2#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
a limited range of##7##4##(2008-10#1)(2008-3#3)(2008-8#1)(2011-2#1)(2013-1#1)
a limited range##9##3##(1996-2#1)(2008-10#2)(2008-3#3)(2008-8#1)(2011-2#1)(2013-1#1)
a limited region of##2##4##(1994-8#1)(2008-2#1)
a limited region##3##3##(1990-11#1)(1994-8#1)(2008-2#1)
a limited role in##2##4##(2008-10#2)
a limited role##4##3##(1995-10#1)(2008-10#2)(2011-2#1)
a limited set of##4##4##(2008-11#1)(2009-11#1)(2009-5#1)(2011-2#1)
a limited##127##2##(1990-11#1)(1990-12#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#3)(2013-1#2)
a limiting factor for##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
a limiting factor in##2##4##(1996-3#1)(2008-10#1)
a limiting factor##8##3##(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2009-12#1)(2012-3#1)
a limiting step##2##3##(1994-11#2)
a limiting##16##2##(1994-11#2)(1995-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2012-3#1)
a line between##2##3##(1995-8#1)(1996-11#1)
a line of##5##3##(1993-6#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-12#1)
a line scan##2##3##(2007-11#1)(2011-1#1)
a line##24##2##(1993-6#1)(1995-8#1)(1996-11#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a line-by-line##2##2##(2008-3#2)
a lineage from##2##3##(2008-10#1)(2008-9#1)
a lineage##10##2##(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#3)(2010-3#1)
a linear array of##3##4##(2008-2#2)(2008-3#1)
a linear calibration curve##6##4##(2008-10#5)(2011-2#1)
a linear calibration graph was obtained over the range##2##9##(2008-10#2)
a linear calibration graph was obtained##4##6##(2008-10#4)
a linear calibration plot of##2##5##(2008-10#2)
a linear calibration plot##5##4##(1992-11#1)(2008-10#4)
a linear calibration range##4##4##(2008-10#4)
a linear calibration##21##3##(1992-11#2)(2008-10#18)(2011-2#1)
a linear combination of the##3##5##(2008-10#2)(2008-2#1)
a linear combination of##6##4##(2008-10#2)(2008-2#1)(2008-3#2)(2010-2#1)
a linear concentration range of 1##2##6##(2008-10#2)
a linear concentration range of##4##5##(2008-10#4)
a linear correlation between the##2##5##(2008-10#2)
a linear correlation##9##3##(1992-11#1)(1993-1#1)(2008-10#5)(2008-2#1)(2008-3#1)
a linear dependence##2##3##(2008-10#2)
a linear determination range of 0##2##6##(2008-10#2)
a linear determination range##3##4##(2008-10#3)
a linear dynamic range between##3##5##(2008-10#3)
a linear dynamic range from 0##3##6##(2008-10#3)
a linear dynamic range from##6##5##(2008-10#6)
a linear dynamic range of##4##5##(2008-10#4)
a linear dynamic range##14##4##(2008-10#14)
a linear dynamic##15##3##(2008-10#15)
a linear function of the concentration of##2##7##(2008-10#1)(2013-8#1)
a linear function of the##5##5##(1990-11#1)(2008-10#2)(2008-4#1)(2013-8#1)
a linear function of##10##4##(1990-11#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
a linear function##12##3##(1990-11#1)(1990-7#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
a linear gradient##2##3##(2008-10#1)(2013-1#1)
a linear increase in##7##4##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
a linear increase##9##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-2#1)
a linear intensity##2##3##(2008-3#2)
a linear model##4##3##(2008-10#1)(2008-3#1)(2009-6#1)(2010-2#1)
a linear no-threshold (LNT)##2##4##(2008-7#2)
a linear or##2##3##(2008-8#1)(2010-5#1)
a linear polarizer##2##3##(2008-2#2)
a linear potential##2##3##(2008-10#2)
a linear range between 0##3##5##(2008-10#3)
a linear range between 1##3##5##(2008-10#3)
a linear range between##9##4##(2008-10#9)
a linear range from##5##4##(2008-10#5)
a linear range of 0##3##5##(2008-10#3)
a linear range of 5##2##5##(2008-10#2)
a linear range of##17##4##(1991-2#1)(2008-10#16)
a linear range up to##2##5##(2008-10#2)
a linear range##35##3##(1991-2#1)(2008-10#34)
a linear regression model##2##4##(1995-9#1)(2008-10#1)
a linear regression##6##3##(1995-9#1)(2007-11#1)(2008-10#3)(2013-8#1)
a linear relation between##2##4##(2008-3#1)(2009-5#1)
a linear relation##6##3##(2008-10#2)(2008-3#3)(2009-5#1)
a linear relationship between peak height and##2##7##(2008-10#2)
a linear relationship between the##7##5##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
a linear relationship between##16##4##(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
a linear relationship was obtained between the##2##7##(2008-10#2)
a linear relationship was##4##4##(2008-10#2)(2008-2#1)(2009-7#1)
a linear relationship with the##4##5##(2007-12#1)(2008-10#3)
a linear relationship with##5##4##(2007-12#1)(2008-10#4)
a linear relationship##30##3##(1995-8#1)(2007-12#2)(2007-2#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2009-7#1)(2011-2#1)
a linear response for both drugs over the concentration range##2##10##(2008-10#2)
a linear response for##7##4##(2008-10#7)
a linear response from##2##4##(2008-10#2)
a linear response in the##4##5##(1996-12#1)(2008-10#3)
a linear response over a##3##5##(2008-10#2)(2010-3#1)
a linear response over the concentration range##2##7##(2008-10#2)
a linear response over the##4##5##(2008-10#4)
a linear response over##7##4##(2008-10#6)(2010-3#1)
a linear response range##2##4##(2008-10#2)
a linear response to##7##4##(2008-10#7)
a linear response with a##3##5##(2008-10#3)
a linear response with##7##4##(2008-10#5)(2008-3#1)(2008-7#1)
a linear response##43##3##(1992-2#1)(1996-12#1)(2008-10#37)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)
a linear shape##2##3##(2008-3#1)(2010-6#1)
a linear transformation##2##3##(2008-3#1)(2011-2#1)
a linear variation##3##3##(2008-10#2)(2008-3#1)
a linear##296##2##(1990-11#2)(1990-7#1)(1991-11#1)(1991-2#1)(1992-11#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#2)(2007-11#9)(2007-12#5)(2007-2#1)(2008-10#173)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#30)(2008-4#2)(2008-7#10)(2008-8#4)(2008-9#2)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#1)(2013-8#4)
a linearity##6##2##(2007-12#1)(2008-10#5)
a linearized##2##2##(1993-11#1)(2008-8#1)
a linearly chirped##3##3##(2007-12#3)
a linearly polarized##7##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
a linearly tapered##2##3##(2008-2#1)(2008-3#1)
a linearly##16##2##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#7)
a linewidth of 0##2##4##(2007-11#1)(2008-2#1)
a linewidth of##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
a linewidth##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
a link between the##5##4##(1994-8#1)(2007-12#1)(2008-11#1)(2009-7#1)(2010-11#1)
a link between these##2##4##(2008-10#1)(2009-10#1)
a link between##22##3##(1990-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)
a link##27##2##(1990-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)(2012-12#1)
a linkage map##4##3##(2008-10#2)(2008-4#1)(2010-8#1)
a linkage##13##2##(1990-9#1)(1991-2#1)(1997-5#2)(2008-10#4)(2008-4#1)(2008-9#2)(2010-8#1)(2012-3#1)
a linked##3##2##(1991-6#1)(1993-11#1)(2008-10#1)
a linker of##2##3##(1992-6#1)(2011-2#1)
a linker##6##2##(1992-6#1)(1997-4#1)(2008-4#3)(2011-2#1)
a lipase##3##2##(2008-5#1)(2008-7#1)(2011-1#1)
a lipid bilayer##2##3##(1993-11#1)(2009-9#1)
a lipid extract##2##3##(1991-5#1)(2008-10#1)
a lipid membrane##2##3##(1994-11#2)
a lipid peroxidation##2##3##(1994-5#1)(2008-10#1)
a lipid profile##2##3##(2008-4#1)(2013-1#1)
a lipid##22##2##(1990-5#1)(1991-5#1)(1993-11#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
a lipidic##3##2##(1990-2#1)(2007-12#1)(2008-10#1)
a lipoma##4##2##(1993-9#3)(2008-10#1)
a lipophilic acrylate resin##2##4##(2008-10#2)
a lipophilic##14##2##(1995-12#1)(2007-7#1)(2008-10#11)(2008-4#1)
a lipstick##2##2##(2008-5#2)
a liquid chromatographic##3##3##(1990-8#1)(2008-10#2)
a liquid jet##3##3##(2008-2#3)
a liquid meal in MSA-C##2##5##(2008-7#2)
a liquid membrane containing##2##4##(2008-10#2)
a liquid membrane##5##3##(2008-10#5)
a liquid phantom##2##3##(2007-12#1)(2008-2#1)
a liquid sample##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a liquid soap##2##3##(2008-10#1)(2008-5#1)
a liquid surface##3##3##(2008-2#2)(2008-3#1)
a liquid##64##2##(1990-8#1)(1996-1#2)(1996-2#1)(2007-11#3)(2007-12#4)(2008-10#22)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#2)(2010-4#1)(2012-2#1)
a liquid's complex refractive index##2##5##(2008-3#2)
a liquid's##3##2##(2008-3#3)
a liquid-core##3##2##(2008-10#2)(2008-2#1)
a liquid-core-waveguide##2##2##(2008-10#2)
a liquid-crystal display monitor##2##4##(2008-3#1)(2010-9#1)
a liquid-crystal display##6##3##(2008-3#4)(2010-9#2)
a liquid-crystal layer##2##3##(2008-2#1)(2008-3#1)
a liquid-crystal point-diffraction interferometer##2##4##(2007-12#2)
a liquid-crystal spatial light modulator##6##5##(2007-11#1)(2008-2#1)(2008-3#4)
a liquid-crystal##29##2##(2007-11#3)(2007-12#5)(2008-2#6)(2008-3#13)(2010-9#2)
a liquid-lined##2##2##(2009-6#2)
a liquid-liquid extraction procedure##2##4##(2008-10#2)
a liquid-liquid extraction##5##3##(2008-10#4)(2013-1#1)
a liquid-liquid##6##2##(2008-10#5)(2013-1#1)
a liquid-nitrogen-cooled##3##2##(2008-10#1)(2008-2#2)
a liquid-solid##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
a list of the##2##4##(1997-3#1)(2013-1#1)
a list of##19##3##(1991-3#1)(1993-2#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-7#1)
a list##22##2##(1991-3#1)(1993-2#1)(1995-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-7#1)
a literature review and##3##4##(1992-12#1)(2009-8#1)(2012-3#1)
a literature review of the##4##5##(2008-11#1)(2008-8#2)(2010-6#1)
a literature review of##6##4##(2008-11#1)(2008-8#2)(2010-6#1)(2011-1#1)(2012-1#1)
a literature review on##2##4##(2008-2#2)
a literature review##35##3##(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
a literature review]##2##3##(1991-3#1)(2013-1#1)
a literature survey##2##3##(2008-8#1)(2013-1#1)
a literature##43##2##(1991-1#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
a literature-based review##2##3##(2008-3#1)(2008-8#1)
a lithium triborate##3##3##(2007-12#1)(2008-3#2)
a lithium##8##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)
a little bit##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
a little difference##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
a little effect##3##3##(2008-10#2)(2008-11#1)
a little while##2##3##(2011-2#1)(2012-2#1)
a little##38##2##(1990-6#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
a live##14##2##(1995-9#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)
a liver transplant##3##3##(1990-8#1)(2009-2#2)
a liver transplantation##2##3##(2013-1#1)(2013-8#1)
a liver##11##2##(1990-8#1)(2007-12#1)(2008-11#2)(2009-2#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
a livestock##2##2##(1994-7#1)(2011-2#1)
a living donor##2##3##(2011-2#2)
a living##4##2##(1997-6#1)(2010-12#1)(2011-2#2)
a load##6##2##(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-8#1)
a loaded##3##2##(2012-3#1)(2013-1#2)
a loading time of##2##4##(2008-10#2)
a loading##4##2##(2008-10#2)(2008-3#1)(2012-12#1)
a loamy##2##2##(2008-10#1)(2008-11#1)
a lobe##2##2##(2009-8#2)
a local accumulation of##2##4##(2008-10#1)(2008-8#1)
a local anesthetic##5##3##(1993-1#3)(1994-2#1)(1996-1#1)
a local area##4##3##(2008-10#4)
a local blood##2##3##(1996-2#1)(2008-12#1)
a local hospital##2##3##(1993-6#1)(2007-12#1)
a local level##2##3##(1997-7#1)(2013-1#1)
a local minimum##2##3##(2008-3#2)
a local oscillator for##2##4##(2008-2#1)(2008-3#1)
a local recurrence##7##3##(1992-10#1)(2008-6#3)(2009-3#1)(2010-3#1)(2011-2#1)
a local scale##3##3##(2008-10#1)(2008-8#2)
a local##104##2##(1990-11#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#3)(1993-11#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-2#3)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
a locality##2##2##(2008-11#1)(2008-5#1)
a localization##2##2##(2008-3#1)(2012-2#1)
a localized form##2##3##(2012-12#1)(2013-1#1)
a localized##14##2##(1990-6#1)(1991-12#1)(1991-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
a locally aggressive##2##3##(1993-6#1)(2010-3#1)
a locally installable web-based relational microarray database##2##7##(2008-7#2)
a locally##12##2##(1993-6#1)(1993-8#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-3#1)(2012-3#1)
a location from##2##3##(2008-10#1)(2010-2#1)
a location##5##2##(1993-1#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-2#1)
a lock-in amplifier##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
a lock-in##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
a locking plate##4##3##(2008-9#1)(2010-3#3)
a locking##5##2##(2008-8#1)(2008-9#1)(2010-3#3)
a locus##9##2##(1990-5#1)(1992-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-5#2)(2008-8#1)(2009-10#1)
a log##2##2##(2008-2#1)(2008-5#1)
a log-linear##2##2##(1994-2#1)(1997-8#1)
a logarithmic asphere##2##3##(2007-11#2)
a logarithmic scale##2##3##(2008-10#1)(2008-3#1)
a logarithmic##11##2##(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)
a logical treatment##2##3##(2010-8#1)(2013-8#1)
a logical##11##2##(1992-2#1)(1993-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2010-8#1)(2012-1#1)(2013-8#1)
a logistic regression analysis##2##4##(2008-10#2)
a logistic regression model##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)
a logistic regression##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)
a logistic##11##2##(2008-10#6)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2012-2#1)
a long 3' untranslated##2##4##(1993-8#1)(1996-12#1)
a long QT##2##3##(2008-7#1)(2010-8#1)
a long and healthy##2##4##(2008-11#1)(2013-1#1)
a long and##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
a long delay##2##3##(1991-1#1)(2007-12#1)
a long exposure to##2##4##(2008-8#1)(2011-2#1)
a long fiber##2##3##(2007-12#1)(2008-3#1)
a long history of##7##4##(1997-1#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
a long history##10##3##(1997-1#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#2)(2013-8#1)
a long hydrophobic##2##3##(1991-5#1)(1993-2#1)
a long lasting bronchial hyperresponsiveness##2##5##(1992-3#2)
a long lasting##4##3##(1991-6#2)(1992-3#2)
a long period of time##5##5##(2007-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-6#1)
a long period of##6##4##(1990-8#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-6#1)
a long period##13##3##(1990-8#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-6#1)(2010-8#1)
a long process##4##3##(1996-2#1)(1996-3#1)(2008-11#1)(2008-8#1)
a long range##4##3##(2008-3#3)(2009-8#1)
a long term##11##3##(1990-2#1)(1992-12#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-7#1)
a long time after the##2##5##(1997-2#1)(1997-4#1)
a long time after##4##4##(1993-8#1)(1997-2#1)(1997-4#1)(2011-2#1)
a long time##38##3##(1990-5#1)(1991-11#1)(1991-9#1)(1993-2#1)(1993-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#1)
a long way from##2##4##(1994-3#1)(2010-12#1)
a long way in##3##4##(2008-10#1)(2008-7#1)(2010-7#1)
a long way to go##5##5##(1992-12#1)(1995-11#1)(2008-11#1)(2010-8#1)(2012-3#1)
a long way to##9##4##(1991-2#1)(1992-12#1)(1995-11#1)(1995-12#1)(2007-7#1)(2008-11#1)(2010-3#1)(2010-8#1)(2012-3#1)
a long way##18##3##(1991-1#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-3#1)
a long working distance##2##4##(2007-12#1)(2008-2#1)
a long##200##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-6#1)(1993-12#1)(1993-2#2)(1993-8#2)(1994-12#2)(1994-3#3)(1995-11#3)(1995-12#3)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(2006-6#1)(2007-10#2)(2007-11#9)(2007-12#9)(2007-2#2)(2007-7#2)(2008-1#4)(2008-10#14)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#9)(2008-7#9)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#1)
a long-lasting##7##2##(1991-2#1)(1992-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(2008-10#1)(2010-1#1)
a long-lived##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
a long-period fiber grating pair##2##5##(2007-11#1)(2008-3#1)
a long-period fiber grating##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
a long-period grating##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a long-period##11##2##(1997-5#1)(2007-11#3)(2007-12#2)(2008-3#5)
a long-range##2##2##(2008-2#1)(2011-1#1)
a long-standing##9##2##(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#2)
a long-term care hospital##2##4##(1994-12#1)(1995-3#1)
a long-term care##6##3##(1992-1#1)(1994-12#1)(1995-3#2)(1997-3#1)(2009-3#1)
a long-term follow-up##2##3##(2008-7#1)(2012-3#1)
a long-term period##2##3##(1990-12#1)(2011-1#1)
a long-term stability##2##3##(2008-10#2)
a long-term study##2##3##(1992-9#1)(2008-1#1)
a long-term##57##2##(1990-12#1)(1990-6#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#2)(1996-2#1)(1996-3#1)(1996-4#2)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
a long-wavelength infrared##2##3##(2008-3#2)
a longer delay##2##3##(1990-12#1)(1994-3#1)
a longer duration of##5##4##(2008-11#1)(2008-5#2)(2012-2#1)(2012-5#1)
a longer duration##7##3##(2008-11#1)(2008-5#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
a longer follow-up##2##3##(1990-12#1)(1993-11#1)
a longer half-life##2##3##(1995-2#1)(2008-5#1)
a longer period of time##5##5##(1993-3#1)(1995-6#1)(2008-1#1)(2010-12#1)(2013-1#1)
a longer period of##7##4##(1993-3#1)(1995-6#1)(2008-1#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
a longer period##11##3##(1991-9#1)(1993-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
a longer time than##2##4##(1994-12#1)(2008-5#1)
a longer time##5##3##(1991-3#1)(1994-12#1)(2008-10#2)(2008-5#1)
a longer##60##2##(1990-12#2)(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#5)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
a longitudinal intervention##2##3##(2008-5#1)(2010-5#1)
a longitudinal study of##6##4##(1990-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
a longitudinal study##16##3##(1990-2#1)(1996-9#1)(2008-11#2)(2008-5#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#3)(2013-1#2)
a longitudinal##38##2##(1990-2#1)(1993-12#1)(1995-2#1)(1996-7#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#1)
a longtime##2##2##(1995-6#1)(2008-11#1)
a look at the##3##4##(1994-1#1)(1994-3#1)(2011-2#1)
a look at##5##3##(1994-1#1)(1994-2#1)(1994-3#1)(2008-7#1)(2011-2#1)
a look##10##2##(1991-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-2#1)
a loop##11##2##(1990-5#1)(1992-4#1)(1994-8#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-3#1)
a loose##2##2##(2007-8#1)(2009-5#1)
a loosely##2##2##(1995-1#1)(2008-10#1)
a loss in##7##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)(2013-8#1)
a loss of 0##2##4##(2007-12#1)(2008-2#1)
a loss of function##2##4##(2008-9#2)
a loss of the##3##4##(1990-11#1)(1990-12#1)(1992-12#1)
a loss of##44##3##(1990-11#2)(1990-12#1)(1990-5#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#2)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#3)(2013-8#2)
a loss##59##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-12#2)(1997-3#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#3)
a lossless##4##2##(2007-11#1)(2007-12#3)
a lost##2##2##(1994-9#1)(1995-6#1)
a lot of attention##3##4##(2008-10#1)(2009-12#1)(2013-1#1)
a lot of research##2##4##(2008-10#1)(2013-8#1)
a lot of time##2##4##(1995-3#1)(2008-10#1)
a lot of##35##3##(1990-2#1)(1994-2#1)(1995-3#1)(1996-4#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#3)(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
a lot##39##2##(1990-2#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-4#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#4)(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
a low activity##2##3##(1993-12#1)(1995-6#1)
a low and a high##2##5##(2008-10#1)(2011-2#1)
a low and high##2##4##(2008-10#1)(2008-5#1)
a low and##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
a low but##3##3##(1996-8#1)(2008-10#1)(2010-6#1)
a low cell##2##3##(1991-8#1)(2010-11#1)
a low complication rate##5##4##(1993-12#1)(1993-6#1)(2007-7#1)(2011-2#1)(2013-1#1)
a low concentration of##5##4##(1993-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
a low concentration##9##3##(1992-9#1)(1993-1#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-3#1)
a low cost##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
a low degree of##6##4##(1990-12#1)(1991-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(2011-2#1)
a low detection limit (0##2##5##(2008-10#2)
a low detection limit of 0##3##6##(2008-10#3)
a low detection limit of##6##5##(2008-10#5)(2013-1#1)
a low detection limit##12##4##(2008-10#10)(2010-5#1)(2013-1#1)
a low dose of##6##4##(1994-7#1)(1995-11#1)(2008-3#1)(2008-6#2)(2013-1#1)
a low dose##11##3##(1991-11#1)(1994-7#1)(1995-11#1)(2008-3#2)(2008-6#2)(2008-7#3)(2013-1#1)
a low enzymatic activity##2##4##(2013-1#2)
a low frequency of##3##4##(2008-7#2)(2012-3#1)
a low frequency##7##3##(1993-12#1)(2007-12#1)(2008-10#2)(2008-7#2)(2012-3#1)
a low genetic##2##3##(2008-10#1)(2011-3#1)
a low grade##5##3##(1992-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-2#1)
a low immunity##2##3##(2007-10#1)(2007-12#1)
a low incidence of serious##2##5##(1995-5#1)(2011-2#1)
a low incidence of##11##4##(1990-6#1)(1991-4#1)(1993-11#1)(1995-5#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
a low incidence##13##3##(1990-6#1)(1991-4#1)(1993-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
a low initial##2##3##(2008-10#1)(2009-7#1)
a low inoculum##2##3##(2008-10#2)
a low level in the##2##5##(1995-11#1)(2012-3#1)
a low level in##3##4##(1992-12#1)(1995-11#1)(2012-3#1)
a low level of##24##4##(1995-2#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#2)(2011-10#1)(2011-2#3)(2013-1#1)
a low level##40##3##(1990-3#1)(1992-12#1)(1992-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#1)
a low molecular weight##7##4##(1992-9#1)(1993-8#1)(1995-5#1)(1997-2#2)(2008-10#1)(2009-4#1)
a low molecular##8##3##(1992-9#1)(1993-8#1)(1995-5#1)(1995-6#1)(1997-2#2)(2008-10#1)(2009-4#1)
a low number of##6##4##(1990-2#1)(1993-6#1)(2007-12#1)(2008-5#1)(2012-1#1)(2012-12#1)
a low of##2##3##(1996-9#1)(1997-5#1)
a low or##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
a low pH##2##3##(1992-6#1)(2012-2#1)
a low percentage##3##3##(2008-5#2)(2008-7#1)
a low productivity##2##3##(2008-11#2)
a low rate of##8##4##(1990-11#1)(1993-6#1)(1994-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)
a low reactivity##2##3##(1995-8#1)(2012-3#1)
a low risk of postoperative##2##5##(1992-5#1)(2006-12#1)
a low risk of##3##4##(1992-5#1)(2006-12#1)(2008-6#1)
a low risk##4##3##(1992-5#1)(2006-12#1)(2008-6#1)(2009-3#1)
a low sensitivity##4##3##(1992-3#1)(2008-8#2)(2012-12#1)
a low socioeconomic##2##3##(1993-3#1)(2012-2#1)
a low solubility##2##3##(2008-10#2)
a low speed##2##3##(1992-3#1)(2008-7#1)
a low stray-light level##2##4##(2008-2#1)(2008-3#1)
a low temperature##7##3##(2007-12#1)(2008-10#5)(2008-11#1)
a low threshold##2##3##(1993-9#1)(2007-11#1)
a low value of##2##4##(2008-10#1)(2008-3#1)
a low value##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
a low##338##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#3)(1995-5#3)(1995-6#2)(1995-8#2)(1996-2#3)(1996-3#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#13)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#75)(2008-11#13)(2008-12#2)(2008-2#10)(2008-3#13)(2008-4#2)(2008-5#10)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#1)(2010-11#1)(2010-4#4)(2010-5#2)(2010-6#2)(2011-1#2)(2011-10#1)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#12)(2013-8#3)
a low-##2##2##(1994-3#1)(2013-8#1)
a low-barrier hydrogen bond##2##4##(1995-5#2)
a low-coherence interferometric##2##3##(2007-12#1)(2008-3#1)
a low-coherence source##2##3##(2007-11#1)(2008-2#1)
a low-coherence##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a low-cost system##2##3##(2008-10#1)(2009-10#1)
a low-cost##22##2##(1996-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#8)(2009-10#1)(2010-5#1)
a low-density##4##2##(1993-6#1)(2008-2#1)(2012-3#1)(2013-1#1)
a low-dose oral isotretinoin##2##4##(2013-1#2)
a low-finesse##3##2##(2007-11#1)(2008-3#2)
a low-frequency##4##2##(2007-11#1)(2007-12#2)(2008-9#1)
a low-glycemic load##2##3##(2008-3#2)
a low-grade##4##2##(1990-12#1)(1996-6#1)(1997-8#1)(2011-2#1)
a low-income##5##2##(1993-3#1)(1995-3#1)(1997-2#1)(2008-9#1)(2010-5#1)
a low-index##2##2##(2007-11#1)(2008-3#1)
a low-intensity##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
a low-level##2##2##(1995-2#1)(2010-9#1)
a low-loss##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
a low-molecular-weight heparin##2##3##(2008-7#1)(2013-1#1)
a low-molecular-weight##4##2##(2008-10#1)(2008-7#1)(2010-4#1)(2013-1#1)
a low-noise##2##2##(2008-1#1)(2008-10#1)
a low-pass filter that##2##4##(2007-11#1)(2007-12#1)
a low-power laser##2##3##(2008-2#1)(2008-3#1)
a low-power##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
a low-repetition-rate##3##2##(2007-11#2)(2007-12#1)
a low-resolution##3##2##(2008-10#1)(2008-3#2)
a low-risk##6##2##(1993-1#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
a low-serum medium##2##3##(1992-11#1)(2008-11#1)
a low-threshold##2##2##(2008-2#1)(2008-4#1)
a low-velocity##2##2##(1996-4#1)(2007-12#1)
a lower Km##2##3##(1993-8#1)(1995-6#1)
a lower blood##2##3##(1990-3#1)(2013-8#1)
a lower concentration##4##3##(1993-6#1)(1996-2#1)(2008-11#2)
a lower court's##3##3##(1995-6#2)(1996-5#1)
a lower degree of##2##4##(1996-12#1)(2010-3#1)
a lower detection limit of 0##3##6##(2008-10#2)(2008-11#1)
a lower detection limit of 1##2##6##(2008-10#2)
a lower detection limit of##5##5##(2008-10#4)(2008-11#1)
a lower detection limit##8##4##(2008-10#7)(2008-11#1)
a lower dose of##2##4##(1995-5#1)(2008-10#1)
a lower dose##4##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-6#1)
a lower extent##3##3##(1990-12#2)(1993-5#1)
a lower frequency of##4##4##(1991-3#1)(2007-5#1)(2008-10#1)(2012-3#1)
a lower frequency##5##3##(1991-3#1)(2007-5#1)(2008-10#2)(2012-3#1)
a lower incidence of##4##4##(1990-8#1)(1992-3#1)(2008-10#1)(2011-2#1)
a lower level of##6##4##(2008-10#2)(2009-12#1)(2010-11#1)(2013-7#1)(2013-8#1)
a lower level##9##3##(1990-3#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-11#1)(2013-7#1)(2013-8#1)
a lower limit of##4##4##(1991-5#1)(1996-5#1)(2008-10#2)
a lower lung##2##3##(1991-2#1)(1996-3#1)
a lower number of##5##4##(2008-10#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
a lower one##2##3##(1990-9#1)(2009-5#1)
a lower prevalence##2##3##(1992-9#1)(2012-3#1)
a lower proportion of##2##4##(2008-3#1)(2008-9#1)
a lower rate of complications##2##5##(2013-1#2)
a lower rate of##6##4##(2011-2#2)(2012-12#1)(2013-1#3)
a lower rate##7##3##(2007-4#1)(2011-2#2)(2012-12#1)(2013-1#3)
a lower risk of tumour progression##2##6##(2013-1#2)
a lower risk of##8##4##(1990-3#1)(1991-11#1)(1992-6#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#2)
a lower sensitivity##2##3##(1991-6#1)(2008-10#1)
a lower than##2##3##(1991-12#1)(2011-2#1)
a lower total##2##3##(2008-11#1)(2013-8#1)
a lower##188##2##(1990-12#2)(1990-3#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#38)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#11)(2008-9#5)(2009-10#1)(2009-12#2)(2009-5#3)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#4)(2012-5#2)(2013-1#11)(2013-7#1)(2013-8#4)
a lowering of the##2##4##(1991-8#1)(2008-10#1)
a lowering of##5##3##(1991-8#2)(2007-11#1)(2008-10#1)(2008-5#1)
a lowest##2##2##(2008-10#2)
a lowland rain forest with##2##5##(2008-5#2)
a lowland##3##2##(2008-5#2)(2010-8#1)
a luciferase reporter##3##3##(1995-6#1)(2008-9#1)(2011-2#1)
a luciferase##4##2##(1995-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
a lumbar##6##2##(1991-11#1)(1997-4#1)(2012-2#4)
a luminescence##2##2##(2008-10#2)
a luminescent##4##2##(2007-12#1)(2008-10#2)(2008-4#1)
a lump in the##2##4##(1994-7#1)(2007-7#1)
a lump in##3##3##(1994-7#1)(2007-7#1)(2012-3#1)
a lump##4##2##(1994-7#1)(2007-7#1)(2012-12#1)(2012-3#1)
a lung##10##2##(1992-3#1)(1994-5#1)(1997-2#2)(2007-12#1)(2008-11#1)(2010-9#3)(2012-1#1)
a lyophilization##2##2##(2008-10#1)(2009-7#1)
a lysine##2##2##(1990-8#1)(1993-3#1)
a lysosomal aspartyl protease##2##4##(1994-5#1)(1995-8#1)
a lysosomal degradative pathway for APP##2##6##(1992-12#2)
a lysosomal##8##2##(1990-5#1)(1992-10#2)(1992-12#2)(1994-11#1)(1994-5#1)(1995-8#1)
a lytic##2##2##(2008-11#1)(2012-12#1)
a macro segmented flow##2##4##(2008-10#2)
a macro##3##2##(2008-10#2)(2012-2#1)
a macrocyclic##2##2##(2008-10#2)
a macromolecular##2##2##(1995-3#1)(2008-12#1)
a macromolecule##3##2##(1997-2#1)(2008-4#1)(2012-1#1)
a macroporous##4##2##(2008-10#3)(2008-11#1)
a macroscopic##9##2##(1995-3#1)(2008-7#1)(2009-11#3)(2009-7#1)(2010-4#1)(2012-2#2)
a magnet##3##2##(1990-12#2)(2008-10#1)
a magnetic field##9##3##(1995-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#1)(2010-9#1)
a magnetic resonance##2##3##(1996-7#1)(2008-7#1)
a magnetic##20##2##(1990-12#1)(1993-5#1)(1995-11#1)(1996-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#2)(2010-9#1)
a magneto-optic##2##2##(2007-11#1)(2007-12#1)
a magnification##3##2##(2008-3#2)(2008-9#1)
a magnitude##3##2##(2008-10#1)(2008-3#2)
a mail##2##2##(1996-2#1)(2008-1#1)
a mailed questionnaire##3##3##(1993-1#1)(1993-2#1)(2010-10#1)
a main##26##2##(1992-3#1)(1992-6#1)(1993-3#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)(2012-6#1)(2013-1#2)
a mainstay of##2##3##(2008-12#1)(2010-1#1)
a mainstay##4##2##(2008-12#1)(2010-1#1)(2013-1#2)
a maize##7##2##(1994-6#1)(2008-10#3)(2008-7#1)(2008-8#2)
a major abdominal##2##3##(2009-12#2)
a major advance in the##2##5##(1993-11#1)(2008-8#1)
a major advance in##3##4##(1993-11#1)(2008-7#1)(2008-8#1)
a major advance##4##3##(1993-11#1)(2007-12#1)(2008-7#1)(2008-8#1)
a major antioxidant##2##3##(1994-2#2)
a major band of##2##4##(1993-3#1)(1993-6#1)
a major barrier to##2##4##(2008-1#1)(2010-8#1)
a major barrier##3##3##(2008-1#1)(2010-11#1)(2010-8#1)
a major cause of death##4##5##(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
a major cause of end-stage renal##3##6##(2007-12#1)(2008-1#2)
a major cause of morbidity and mortality##9##7##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-3#1)
a major cause of morbidity and##10##6##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
a major cause of morbidity##14##5##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
a major cause of persistent##2##5##(2010-12#1)(2013-1#1)
a major cause of the##2##5##(1990-6#1)(2008-10#1)
a major cause of##48##4##(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1994-2#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a major cause##51##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1994-2#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a major challenge for##2##4##(1991-1#1)(2007-12#1)
a major challenge to##4##4##(2008-10#1)(2008-7#1)(2010-1#1)(2012-3#1)
a major challenge##7##3##(1991-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-3#1)
a major change in##2##4##(1995-3#1)(2008-10#1)
a major change##4##3##(1991-2#1)(1995-3#1)(2008-10#1)(2010-6#1)
a major class of##2##4##(1994-8#1)(2008-11#1)
a major clinical problem##2##4##(1994-7#1)(2010-12#1)
a major clinical##3##3##(1994-7#1)(2010-12#1)(2012-3#1)
a major complication##2##3##(2007-12#1)(2012-12#1)
a major component in##4##4##(1992-6#1)(2008-11#2)(2008-12#1)
a major component of the##9##5##(1990-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
a major component of##19##4##(1990-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2009-4#1)(2013-1#1)
a major component##25##3##(1990-9#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-5#1)(2013-1#1)
a major concern in##6##4##(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#1)(2012-3#1)
a major concern##10##3##(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-3#1)
a major constituent of##4##4##(1990-8#1)(1992-12#1)(1995-6#1)(2009-11#1)
a major constituent##5##3##(1990-8#1)(1992-12#1)(1995-3#1)(1995-6#1)(2009-11#1)
a major constraint on##2##4##(2008-10#2)
a major constraint##3##3##(2008-10#3)
a major contribution to the##2##5##(2008-10#1)(2008-7#1)
a major contribution to##3##4##(2008-10#2)(2008-7#1)
a major contributor to the##4##5##(1994-8#1)(2008-1#1)(2008-8#1)(2010-12#1)
a major contributor to##6##4##(1994-8#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-9#1)(2012-12#1)
a major contributor##7##3##(1994-8#1)(2008-1#2)(2008-8#1)(2010-12#1)(2011-9#1)(2012-12#1)
a major determinant of the##2##5##(1993-11#1)(2008-10#1)
a major determinant of##6##4##(1993-11#1)(1994-8#1)(2008-10#2)(2008-3#1)(2013-1#1)
a major determinant##7##3##(1993-11#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-3#1)(2013-1#1)
a major disease of##3##4##(2008-10#3)
a major disease##6##3##(2008-10#6)
a major economic##3##3##(1992-6#1)(2008-10#2)
a major effect on the##2##5##(2008-9#1)(2013-1#1)
a major factor in the##3##5##(1992-1#1)(1997-7#1)(2008-3#1)
a major factor in##9##4##(1992-1#1)(1993-9#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)
a major factor that##2##4##(1991-9#1)(2008-8#1)
a major factor##17##3##(1991-9#1)(1992-1#1)(1993-9#1)(1994-5#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-5#1)(2011-2#1)
a major fatty acid##2##4##(2008-10#2)
a major feature##2##3##(2008-3#1)(2008-7#1)
a major focus of##5##4##(1995-1#1)(2007-2#1)(2008-7#2)(2011-2#1)
a major focus##6##3##(1995-1#1)(1996-3#1)(2007-2#1)(2008-7#2)(2011-2#1)
a major fraction of##2##4##(1990-4#1)(2008-10#1)
a major fraction##3##3##(1990-4#1)(2007-11#1)(2008-10#1)
a major gap##2##3##(2008-3#1)(2008-7#1)
a major gene for resistance##2##5##(2008-10#2)
a major gene##12##3##(1997-5#1)(2008-10#7)(2008-8#2)(2008-9#1)(2009-6#1)
a major genetic##4##3##(2008-10#1)(2008-7#1)(2009-5#1)(2010-5#1)
a major health problem in the##2##6##(2010-8#1)(2013-8#1)
a major health problem in##5##5##(2007-7#1)(2008-1#1)(2010-8#1)(2013-1#1)(2013-8#1)
a major health problem##10##4##(1991-12#1)(1993-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
a major health##13##3##(1991-12#1)(1993-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
a major impact on the##4##5##(1993-12#1)(1994-12#1)(2008-11#1)(2013-7#1)
a major impact on##12##4##(1993-12#1)(1994-12#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-7#1)
a major impact##14##3##(1993-12#1)(1994-12#1)(1996-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-7#1)
a major issue for the##2##5##(1992-11#1)(2008-10#1)
a major issue##5##3##(1991-2#1)(1992-11#1)(2008-10#1)(2008-3#2)
a major limitation##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
a major mechanism##4##3##(2008-11#1)(2008-2#1)(2008-4#2)
a major mediator of##2##4##(1995-12#1)(2013-1#1)
a major medical problem in##2##5##(2008-1#1)(2010-12#1)
a major medical problem##3##4##(2007-7#1)(2008-1#1)(2010-12#1)
a major medical##4##3##(2007-7#1)(2008-1#2)(2010-12#1)
a major membrane##2##3##(2007-12#1)(2008-10#1)
a major mental##2##3##(2009-9#1)(2011-2#1)
a major molecular##2##3##(1990-7#1)(2007-12#1)
a major new##3##3##(1995-2#1)(1996-11#1)(1997-6#1)
a major obstacle to##2##4##(2012-12#1)(2012-2#1)
a major obstacle##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
a major overhaul of the##2##5##(1992-12#1)(1994-8#1)
a major part of the##8##5##(1992-11#1)(1994-1#2)(1997-4#1)(2008-10#3)(2008-3#1)
a major part##10##3##(1992-11#1)(1993-9#1)(1994-1#2)(1997-4#1)(2008-10#3)(2008-3#1)(2011-2#1)
a major pathogen of##2##4##(2008-10#2)
a major player in##2##4##(2010-11#1)(2010-12#1)
a major population of##2##4##(1996-5#1)(2012-2#1)
a major portion of the##2##5##(2008-10#1)(2008-3#1)
a major portion of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
a major problem for##3##4##(1990-10#1)(2007-7#1)(2008-10#1)
a major problem in##7##4##(1991-9#1)(1994-3#1)(1997-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)
a major problem##21##3##(1990-10#1)(1991-9#1)(1993-3#1)(1994-3#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-8#1)
a major process change##2##4##(1993-2#1)(1995-2#1)
a major protein component with a molecular mass of##2##9##(2008-10#2)
a major protein##3##3##(1990-2#1)(2008-10#2)
a major public health burden##2##5##(2010-12#1)(2011-2#1)
a major public health concern##3##5##(2008-11#1)(2010-6#1)(2013-1#1)
a major public health issue##2##5##(2013-1#1)(2013-8#1)
a major public health problem in##7##6##(1992-9#2)(1993-6#1)(1997-4#1)(2007-11#1)(2009-5#1)(2012-3#1)
a major public health problem##14##5##(1992-9#2)(1993-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#2)(2009-4#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
a major public health threat in##2##6##(2011-1#1)(2011-2#1)
a major public health##24##4##(1992-9#2)(1993-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
a major quantitative trait locus (QTL)##3##6##(2008-10#3)
a major quantitative trait locus##5##5##(2008-10#5)
a major reason for##2##4##(1997-6#1)(2008-10#1)
a major resistance##2##3##(2008-10#1)(2012-2#1)
a major risk factor for coronary artery disease (CAD)##2##9##(1997-8#1)(2008-7#1)
a major risk factor for##6##5##(1997-8#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
a major risk factor##7##4##(1990-6#1)(1997-8#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
a major risk##8##3##(1990-6#1)(1997-8#1)(2008-12#2)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
a major role in determining the##2##6##(2008-10#1)(2008-6#1)
a major role in determining##5##5##(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)
a major role in regulating##4##5##(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
a major role in the regulation of##3##7##(1991-6#1)(1992-8#1)(1995-8#1)
a major role in the##23##5##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-7#1)(2010-4#1)
a major role in##62##4##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
a major role##73##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-12#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
a major shift from##2##4##(2008-11#1)(2010-3#1)
a major site of##4##4##(1994-11#1)(2008-1#1)(2008-7#1)(2012-1#1)
a major site##5##3##(1994-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-1#1)
a major social##2##3##(2008-11#1)(2008-6#1)
a major source of##12##4##(1991-9#1)(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
a major step forward in##3##5##(2008-5#1)(2009-3#1)(2012-2#1)
a major step forward##4##4##(1994-11#1)(2008-5#1)(2009-3#1)(2012-2#1)
a major storage##2##3##(1991-5#1)(2010-11#1)
a major success##2##3##(2008-10#2)
a major target of##2##4##(1992-10#1)(2009-11#1)
a major target##4##3##(1992-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
a major therapeutic challenge##2##4##(2008-1#1)(2010-11#1)
a major threat to human##2##5##(1997-5#1)(2011-3#1)
a major threat to##5##4##(1997-5#1)(2008-10#1)(2011-2#2)(2011-3#1)
a major threat##6##3##(1997-5#1)(2008-10#1)(2009-9#1)(2011-2#2)(2011-3#1)
a major tool in the##2##5##(2008-3#1)(2008-9#1)
a major transition##2##3##(1993-3#1)(2008-11#1)
a major vehicle##2##3##(1993-3#1)(2007-11#1)
a major##639##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#2)(1992-6#3)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#2)(1993-9#2)(1994-1#2)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#2)(1994-5#1)(1994-7#2)(1994-8#6)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#5)(1995-3#7)(1995-5#1)(1995-6#5)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#6)(2006-6#1)(2007-10#4)(2007-11#5)(2007-12#11)(2007-2#5)(2007-7#11)(2007-8#5)(2008-1#17)(2008-10#87)(2008-11#29)(2008-12#6)(2008-2#5)(2008-3#16)(2008-4#9)(2008-5#18)(2008-6#4)(2008-7#27)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#10)(2010-3#5)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#23)(2011-3#2)(2011-9#1)(2012-1#3)(2012-12#12)(2012-2#10)(2012-3#11)(2013-1#17)(2013-7#1)(2013-8#8)
a majority of patients##2##4##(1992-1#1)(1994-3#1)
a majority of the cells##2##5##(1996-2#1)(2008-6#1)
a majority of the##9##4##(1991-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-6#1)(2008-9#1)(2010-12#2)(2013-8#1)
a majority of##30##3##(1990-11#1)(1990-3#1)(1991-12#1)(1992-1#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
a majority##34##2##(1990-11#1)(1990-3#1)(1991-12#1)(1992-1#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-5#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
a malaria##3##2##(1995-5#1)(2007-2#1)(2012-12#1)
a male patient##4##3##(2007-10#1)(2007-12#1)(2008-2#1)(2010-3#1)
a male predominance in the##2##5##(1994-12#1)(2013-8#1)
a male predominance##3##3##(1994-12#1)(2008-1#1)(2013-8#1)
a male pregnancy##2##3##(1996-12#2)
a male with##2##3##(2008-11#1)(2012-12#1)
a male##35##2##(1991-6#2)(1994-12#1)(1994-2#1)(1996-12#2)(1996-9#1)(1997-3#1)(2007-10#2)(2007-12#2)(2008-1#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
a malformation##2##2##(2009-5#1)(2013-1#1)
a malignancy##2##2##(2007-7#1)(2009-1#1)
a malignant disease##2##3##(1993-2#1)(2008-11#1)
a malignant phyllodes tumor of the breast##3##7##(1995-4#3)
a malignant tumor##2##3##(1990-5#1)(2008-12#1)
a malignant##25##2##(1990-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-4#3)(1996-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2009-1#1)(2009-3#1)(2009-5#1)
a malpractice##2##2##(1991-12#1)(1995-12#1)
a mammalian cell line##2##4##(2008-11#1)(2008-8#1)
a mammalian genomic##2##3##(1991-6#1)(1993-2#1)
a mammalian homologue of the yeast##2##6##(1991-9#1)(1992-12#1)
a mammalian##16##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1997-7#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#1)
a mammary##3##2##(1992-10#1)(1993-6#1)(2012-3#1)
a mammogram and##2##3##(1997-1#1)(2013-1#1)
a man who##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
a man with##6##3##(1997-3#1)(2007-7#1)(2009-5#1)(2012-3#2)(2013-1#1)
a man##15##2##(1995-12#2)(1997-3#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#1)
a managed care company##2##4##(1995-1#1)(1996-3#1)
a managed care environment##6##4##(1993-3#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-2#1)
a managed care system##3##4##(1993-12#1)(2006-10#2)
a managed care##22##3##(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)(2006-10#2)
a managed##26##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)(2006-10#2)
a management algorithm##2##3##(2010-8#1)(2011-2#1)
a management information system##4##4##(1992-3#2)(1994-3#1)(1996-12#1)
a management strategy for##2##4##(2012-12#1)(2013-7#1)
a management strategy##3##3##(2008-5#1)(2012-12#1)(2013-7#1)
a management tool##3##3##(1994-3#1)(1996-2#1)(2008-10#1)
a management##17##2##(1992-12#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
a manager##6##2##(1993-2#1)(2007-10#1)(2008-8#1)(2012-12#1)(2012-3#2)
a managerial##4##2##(1992-9#1)(1993-3#1)(1995-3#1)(2008-1#1)
a mandate for##3##3##(1996-3#1)(2008-12#1)(2008-6#1)
a mandate##4##2##(1996-3#1)(2008-12#1)(2008-6#1)(2011-2#1)
a mandatory##4##2##(1994-1#1)(1994-12#1)(2008-10#2)
a mandibular##5##2##(1997-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
a manganese##2##2##(1993-8#1)(1996-6#1)
a manifestation of##5##3##(1990-9#1)(1996-4#1)(2008-11#1)(2013-1#1)(2013-8#1)
a manifestation##6##2##(1990-9#1)(1996-4#1)(2007-7#1)(2008-11#1)(2013-1#1)(2013-8#1)
a manner similar to##15##4##(1990-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
a manner that the##2##4##(2008-11#1)(2010-8#1)
a manner that##12##3##(1991-8#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)
a manner##54##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
a manual##14##2##(1991-12#1)(1994-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
a manufactured##2##2##(2007-11#1)(2008-10#1)
a manufacturing##3##2##(1995-1#1)(2008-3#1)(2010-5#1)
a map of the##2##4##(2008-12#1)(2012-12#1)
a map of##7##3##(1993-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)
a map##8##2##(1993-12#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-12#1)
a mapping##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2012-3#1)
a margin##3##2##(2008-2#2)(2012-12#1)
a marginal effect on##2##4##(1990-12#1)(1990-2#1)
a marginal increase of##2##4##(2008-9#2)
a marginal increase##3##3##(2008-5#1)(2008-9#2)
a marginal##9##2##(1990-12#1)(1990-2#1)(1990-6#1)(1995-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2012-1#1)
a marginally significant##3##3##(1991-8#1)(1994-2#1)(2011-2#1)
a marginally##7##2##(1991-8#1)(1994-2#1)(2008-8#1)(2011-1#2)(2011-2#2)
a marine##13##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#4)(2010-2#1)(2011-2#2)
a mark##2##2##(2008-2#1)(2008-3#1)
a marked and##2##3##(1993-11#1)(1994-12#1)
a marked but##2##3##(1996-12#1)(2010-6#1)
a marked decline##2##3##(2008-7#1)(2013-8#1)
a marked decrease in the number of##2##7##(1992-6#1)(1997-7#1)
a marked decrease in the##7##5##(1992-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-7#1)
a marked decrease in##14##4##(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-7#1)(2008-5#1)(2008-7#3)(2013-8#1)
a marked decrease of##4##4##(1991-12#1)(1995-12#1)(1995-5#1)(2008-10#1)
a marked decrease##20##3##(1991-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#3)(2013-8#1)
a marked difference in the##2##5##(2008-10#1)(2008-11#1)
a marked difference##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
a marked effect on##3##4##(1995-3#1)(1996-3#1)(2008-5#1)
a marked enhancement in##2##4##(2008-10#1)(2012-2#1)
a marked enhancement of the##2##5##(2008-10#2)
a marked enhancement##4##3##(2008-10#3)(2012-2#1)
a marked impact on##2##4##(2012-12#1)(2013-1#1)
a marked improvement in the##2##5##(2008-5#1)(2012-2#1)
a marked improvement in##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
a marked improvement##5##3##(1990-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
a marked increase in the##3##5##(1990-5#1)(1995-5#1)(1997-7#1)
a marked increase in##18##4##(1990-11#1)(1990-5#1)(1990-6#1)(1991-4#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#2)(2007-7#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
a marked increase##19##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-4#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-7#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
a marked inhibition of the##2##5##(1994-8#1)(2012-3#1)
a marked predilection for##2##4##(2009-5#1)(2013-1#1)
a marked reduction in##11##4##(1990-12#1)(1992-3#1)(1993-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-10#1)(2012-2#1)
a marked reduction##12##3##(1990-12#1)(1992-3#1)(1993-8#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-10#1)(2012-2#1)
a marked suppression##2##3##(2008-6#1)(2010-4#1)
a marked variation in##2##4##(1992-11#1)(1993-11#1)
a marked##122##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#2)(1993-11#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
a markedly increased##2##3##(1990-11#1)(1992-3#1)
a markedly##8##2##(1990-11#1)(1992-3#1)(1992-8#1)(1995-8#1)(1996-12#1)(2008-12#1)(2008-7#1)(2010-6#1)
a marker for the##4##4##(1995-6#1)(2008-10#1)(2008-7#1)(2009-2#1)
a marker for##19##3##(1990-5#1)(1994-2#1)(1995-1#1)(1995-6#2)(1996-5#1)(1996-6#1)(1996-7#1)(2008-10#2)(2008-11#2)(2008-7#3)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)
a marker of inflammation##2##4##(2011-2#1)(2012-2#1)
a marker of poor##2##4##(2012-2#1)(2013-1#1)
a marker of renal function##2##5##(2013-1#2)
a marker of the##6##4##(1992-6#1)(1992-9#1)(1996-7#1)(1997-6#1)(2007-10#1)(2009-12#1)
a marker of##50##3##(1990-11#1)(1990-7#1)(1992-10#2)(1992-6#1)(1992-9#2)(1993-2#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#2)(2009-12#1)(2010-5#1)(2011-2#5)(2012-2#6)(2012-3#2)(2012-9#1)(2013-1#5)
a marker##77##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-10#2)(1992-6#1)(1992-9#2)(1993-2#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#6)(2012-2#6)(2012-3#2)(2012-9#1)(2013-1#5)
a market research##2##3##(1994-2#1)(1996-1#1)
a market##7##2##(1991-3#1)(1992-11#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-5#1)
a marketing orientation##2##3##(1992-3#1)(2008-12#1)
a marketing plan##4##3##(1994-3#2)(1995-1#1)(2010-7#1)
a marketing##9##2##(1992-2#1)(1992-3#1)(1994-3#2)(1995-1#1)(1997-3#1)(1997-4#1)(2008-12#1)(2010-7#1)
a mask that##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
a mask##6##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
a masking agent##7##3##(2008-10#7)
a masking##8##2##(2008-10#7)(2008-5#1)
a mass in the left lower##2##6##(2010-11#2)
a mass in the##6##4##(1990-5#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-11#2)
a mass loss##2##3##(2008-10#2)
a mass of##10##3##(1990-7#1)(1992-6#1)(1993-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#2)(2010-12#1)
a mass spectrometer for##2##4##(2008-4#1)(2010-6#1)
a mass spectrometer##9##3##(2008-10#5)(2008-3#1)(2008-4#2)(2010-6#1)
a mass spectrometric##2##3##(2008-10#1)(2010-4#1)
a mass spectrometry##2##3##(2008-10#2)
a mass##54##2##(1990-5#1)(1990-7#1)(1992-6#1)(1993-9#1)(1995-11#4)(1996-3#2)(1997-2#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
a massive amount of##2##4##(2008-6#1)(2009-6#1)
a massive increase##2##3##(1995-3#1)(2012-3#1)
a massive##21##2##(1992-1#1)(1992-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-3#1)
a massively parallel##2##3##(2008-10#1)(2008-3#1)
a massively##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
a mastectomy##2##2##(2012-3#1)(2013-1#1)
a master regulator of##3##4##(2010-11#2)(2013-1#1)
a master regulator##4##3##(2010-11#2)(2012-2#1)(2013-1#1)
a master switch##2##3##(2008-5#1)(2013-8#1)
a master##8##2##(2007-12#1)(2008-5#1)(2010-11#2)(2012-2#1)(2013-1#2)(2013-8#1)
a master's##3##2##(1993-12#1)(1994-12#2)
a master-oscillator##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
a master 2##3##2##(2011-2#3)
a mastocytosis-like disease in mice##2##5##(2011-2#2)
a mastoid fascial flap##2##4##(2009-1#2)
a mastoidectomy##2##2##(2008-7#2)
a match##3##2##(2008-3#1)(2008-9#1)(2009-5#1)
a matched case-control study##2##4##(1992-6#1)(2013-1#1)
a matched case-control##3##3##(1992-6#1)(2009-9#1)(2013-1#1)
a matched control group##2##4##(2008-12#1)(2008-5#1)
a matched group of##2##4##(1992-12#1)(1992-5#1)
a matched##11##2##(1992-12#1)(1992-5#1)(1992-6#1)(1993-8#2)(1997-1#1)(2008-12#1)(2008-5#1)(2009-9#1)(2013-1#1)(2013-8#1)
a mate##5##2##(2008-8#2)(2008-9#1)(2009-5#2)
a material is##2##3##(2008-2#1)(2008-3#1)
a material or product is##2##5##(1996-12#2)
a material that##2##3##(2008-2#1)(2011-2#1)
a material##22##2##(1990-11#1)(1996-12#3)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-5#2)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#2)
a materials##2##2##(2007-8#1)(2010-10#1)
a maternal##5##2##(1990-9#1)(2008-5#1)(2009-7#1)(2010-6#1)(2011-2#1)
a mathematical equation##2##3##(1994-5#1)(2008-10#1)
a mathematical model is##2##4##(2008-3#1)(2008-5#1)
a mathematical model of the##6##5##(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
a mathematical model of##10##4##(1991-2#1)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)
a mathematical model that simulates the effect of weather##2##9##(2008-10#2)
a mathematical model that simulates the##3##6##(2008-10#3)
a mathematical model that##7##4##(1995-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
a mathematical model to yield deconvolution##2##6##(2008-10#2)
a mathematical model to##7##4##(1991-11#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-7#1)
a mathematical model was##2##4##(2008-10#1)(2013-8#1)
a mathematical model which##3##4##(1991-2#1)(2008-10#2)
a mathematical model##48##3##(1991-11#1)(1991-2#2)(1992-2#1)(1995-3#1)(1997-1#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-11#1)(2011-3#2)(2013-7#1)(2013-8#2)
a mathematical##58##2##(1991-11#1)(1991-2#2)(1992-2#1)(1994-5#1)(1995-3#1)(1997-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#5)(2009-11#1)(2011-3#2)(2013-7#1)(2013-8#2)
a mating##5##2##(2008-8#1)(2008-9#3)(2009-9#1)
a matrix effect is detected##2##5##(2008-10#2)
a matrix effect##3##3##(2008-10#3)
a matrix for##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
a matrix metalloproteinase##2##3##(2008-10#1)(2009-3#1)
a matrix of##10##3##(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2013-7#1)
a matrix##36##2##(1991-5#1)(1992-10#1)(1993-5#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-7#1)
a matter of controversy##2##4##(1996-9#1)(2013-1#1)
a matter of debate##7##4##(1990-8#1)(1997-5#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)
a matter of fact##3##4##(1996-7#1)(2008-7#1)(2013-1#1)
a matter of##34##3##(1990-8#1)(1991-3#1)(1993-12#1)(1995-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-5#2)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#2)(2010-11#1)(2010-12#2)(2011-1#1)(2013-1#4)(2013-8#1)
a matter##37##2##(1990-8#1)(1991-3#1)(1993-12#1)(1995-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#2)(2010-11#1)(2010-12#2)(2011-1#1)(2013-1#4)(2013-8#2)
a maturation##3##2##(2008-10#1)(2008-5#2)
a mature protein##2##3##(1992-3#1)(2008-10#1)
a mature##19##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-12#1)(1996-10#1)(1996-9#1)(2008-10#4)(2008-4#1)(2008-9#1)(2011-3#2)(2012-3#3)(2013-1#1)(2013-8#1)
a maxillary##6##2##(1990-3#1)(2012-12#1)(2013-1#4)
a maximal level at##2##4##(1993-6#1)(2008-10#1)
a maximal level##5##3##(1991-9#1)(1993-6#2)(1997-7#1)(2008-10#1)
a maximal viable cell density of##2##6##(2008-11#2)
a maximal viable cell density##3##5##(2008-11#3)
a maximal viable cell##4##4##(2008-11#3)(2008-7#1)
a maximal##27##2##(1991-11#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
a maximum absorption peak at##3##5##(2008-10#3)
a maximum at P30##2##4##(1997-2#2)
a maximum at##14##3##(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1997-2#2)(2008-10#2)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
a maximum average of##3##4##(1996-12#3)
a maximum average output power of##2##6##(2007-12#1)(2008-2#1)
a maximum average##6##3##(1996-12#3)(2007-12#1)(2008-2#1)(2008-3#1)
a maximum concentration of##2##4##(2008-11#1)(2010-5#1)
a maximum conversion efficiency##2##4##(2007-12#1)(2008-2#1)
a maximum depth of##2##4##(2008-2#1)(2013-8#1)
a maximum diameter##3##3##(1993-9#1)(2008-12#1)(2011-2#1)
a maximum during##2##3##(2008-10#1)(2012-2#1)
a maximum effect##2##3##(1992-3#1)(1995-5#1)
a maximum for##2##3##(1992-10#1)(1992-12#1)
a maximum in the##4##4##(2008-10#3)(2008-11#1)
a maximum in##11##3##(1994-9#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2013-7#1)
a maximum level##3##3##(1995-3#1)(1997-2#1)(2008-11#1)
a maximum number##2##3##(2008-10#1)(2008-3#1)
a maximum of 2##4##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
a maximum of##32##3##(1990-3#1)(1990-5#2)(1990-6#1)(1991-6#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-7#2)
a maximum on##2##3##(2008-10#1)(2008-3#1)
a maximum output power of##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
a maximum output##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a maximum response##3##3##(2008-10#1)(2008-2#2)
a maximum score##2##3##(1990-10#1)(1991-2#1)
a maximum temperature##2##3##(2008-10#1)(2008-2#1)
a maximum value of##4##4##(1992-7#1)(2008-10#1)(2008-2#1)(2009-4#1)
a maximum value that##2##4##(2008-5#1)(2008-7#1)
a maximum value##8##3##(1992-7#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)
a maximum within 5##2##4##(1992-3#1)(1997-1#1)
a maximum##181##2##(1990-10#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#3)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-8#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#41)(2008-11#9)(2008-12#1)(2008-2#13)(2008-3#17)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#4)(2013-8#4)
a maximum-likelihood##2##2##(2008-3#1)(2010-3#1)
a maze##3##2##(1997-2#1)(2007-9#1)(2013-8#1)
a meal##2##2##(2006-10#1)(2012-2#1)
a mean (range) of##2##4##(2012-2#1)(2013-1#1)
a mean age of 11##2##5##(2010-1#1)(2013-8#1)
a mean age of 12##2##5##(2007-8#1)(2013-8#1)
a mean age of 14##2##5##(1993-6#1)(2009-8#1)
a mean age of##41##4##(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-10#1)(1996-2#1)(1997-3#3)(2007-7#3)(2007-8#4)(2008-1#6)(2008-12#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
a mean age##42##3##(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-10#1)(1996-2#1)(1997-3#3)(2007-7#3)(2007-8#4)(2008-1#6)(2008-12#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
a mean diameter of##3##4##(2008-10#2)(2009-11#1)
a mean difference##3##3##(2007-10#2)(2008-7#1)
a mean duration of##9##4##(1991-2#1)(2008-1#3)(2008-3#1)(2008-6#1)(2008-7#2)(2012-2#1)
a mean duration##10##3##(1991-2#1)(2008-1#3)(2008-3#1)(2008-6#1)(2008-7#3)(2012-2#1)
a mean follow up##2##4##(1996-3#1)(2007-8#1)
a mean follow-up of 1##3##5##(1996-6#1)(2007-10#1)(2013-1#1)
a mean follow-up of 23##2##5##(1994-2#1)(2008-10#1)
a mean follow-up of##13##4##(1990-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-2#1)(2013-1#1)
a mean follow-up##15##3##(1990-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-6#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-6#2)(2009-10#1)(2012-2#1)(2013-1#1)
a mean free##2##3##(2008-10#1)(2008-3#1)
a mean height of##2##4##(2008-1#1)(2009-1#1)
a mean level of disease reduction of##3##7##(2008-10#3)
a mean maximum##2##3##(1993-12#1)(2008-3#1)
a mean observation period of##2##5##(1991-6#1)(2008-6#1)
a mean of 0##2##4##(2008-7#1)(2013-1#1)
a mean of 1##2##4##(1990-6#1)(2010-6#1)
a mean of 4##3##4##(2008-1#1)(2009-4#1)(2010-6#1)
a mean of 5##2##4##(1993-8#1)(2010-11#1)
a mean of 8##2##4##(2007-7#1)(2008-9#1)
a mean of##38##3##(1990-11#1)(1990-2#2)(1990-6#1)(1991-8#1)(1992-1#2)(1993-1#1)(1993-8#1)(1996-2#1)(1996-7#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
a mean peak##2##3##(1990-6#1)(2008-10#1)
a mean period of##5##4##(1990-2#1)(2007-7#1)(2008-1#2)(2008-7#1)
a mean recovery of 99##2##5##(2008-10#2)
a mean relative##4##3##(2008-10#4)
a mean standard##2##3##(2008-10#2)
a mean survival##3##3##(1990-2#1)(2008-6#1)(2008-7#1)
a mean temperature##3##3##(2008-10#3)
a mean total##2##3##(1991-11#1)(2008-7#1)
a mean value of##3##4##(1991-12#1)(2008-2#1)(2008-5#1)
a mean weight##2##3##(2008-1#1)(2013-8#1)
a mean##221##2##(1990-11#2)(1990-2#4)(1990-3#1)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#4)(1997-5#1)(2007-10#3)(2007-11#2)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#19)(2008-10#39)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#3)
a meaningful and##2##3##(1992-12#1)(2012-2#1)
a meaningful##10##2##(1992-12#1)(1995-3#1)(2007-11#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
a means for##7##3##(1991-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-2#1)
a means of addressing the##2##5##(2007-4#1)(2008-11#1)
a means of assessing##3##4##(2008-1#1)(2008-11#1)(2010-11#1)
a means of determining##2##4##(1996-3#1)(2008-3#1)
a means of establishing##2##4##(1991-11#1)(1993-6#1)
a means of evaluating the##2##5##(1990-8#1)(1994-2#1)
a means of quantifying the##2##5##(2008-10#1)(2008-3#1)
a means of understanding the##2##5##(1990-5#1)(1993-11#1)
a means of understanding##4##4##(1990-5#1)(1993-11#1)(2008-11#1)(2009-12#1)
a means of##71##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-1#2)(1996-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-4#2)(2007-5#2)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)
a means to increase the##2##5##(2008-3#1)(2013-1#1)
a means to increase##4##4##(2008-3#1)(2008-5#1)(2010-11#1)(2013-1#1)
a means to understand##2##4##(2008-11#1)(2009-12#1)
a means to##40##3##(1991-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-2#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-2#2)(2013-1#1)
a means##121##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#4)(2013-1#3)(2013-7#2)
a measurable##13##2##(1994-1#1)(1995-12#1)(1995-2#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)
a measure for##5##3##(1992-10#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-6#1)
a measure of health system##2##5##(1995-12#1)(2008-11#1)
a measure of health##3##4##(1995-12#1)(1996-1#1)(2008-11#1)
a measure of its##2##4##(2008-10#1)(2008-11#1)
a measure of physical##2##4##(2008-6#1)(2012-12#1)
a measure of severity##2##4##(1994-12#2)
a measure of the##24##4##(1994-8#1)(1997-1#1)(1997-2#2)(2006-6#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-3#1)
a measure of treatment group##2##5##(1997-3#2)
a measure of treatment##3##4##(1997-3#2)(2008-9#1)
a measure of##94##3##(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-4#2)(1994-11#1)(1994-12#3)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2006-6#1)(2007-12#3)(2007-7#2)(2008-10#10)(2008-11#5)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#2)(2009-3#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#2)
a measure that##2##3##(2008-9#1)(2011-2#1)
a measure to##3##3##(2008-10#2)(2008-6#1)
a measure##109##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-4#2)(1992-10#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2006-6#1)(2007-12#4)(2007-7#3)(2008-10#12)(2008-11#5)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#3)
a measured##9##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)
a measurement of the##4##4##(2007-11#1)(2008-3#2)(2008-7#1)
a measurement of##7##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-7#1)
a measurement range##2##3##(2008-3#2)
a measurement##27##2##(1990-8#1)(1992-1#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#11)(2008-7#2)(2010-8#1)(2012-2#1)
a measuring cell##2##3##(2008-10#2)
a measuring##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
a mechanical model##2##3##(2009-7#1)(2013-1#1)
a mechanical valve##3##3##(2008-8#1)(2009-12#1)(2013-1#1)
a mechanical##25##2##(1992-9#2)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-8#1)(2013-1#3)(2013-8#1)
a mechanically##5##2##(1994-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
a mechanism by which##5##4##(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)
a mechanism for the##4##4##(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
a mechanism for##25##3##(1990-12#1)(1992-1#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
a mechanism in##2##3##(1991-2#1)(2008-10#1)
a mechanism involving##4##3##(1991-12#1)(1992-3#1)(1992-6#1)(2012-12#1)
a mechanism of activation##2##4##(1995-2#1)(2012-2#1)
a mechanism of the##2##4##(1992-5#1)(2008-3#1)
a mechanism of##17##3##(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
a mechanism other than##4##4##(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
a mechanism that can##2##4##(1991-9#1)(2010-4#1)
a mechanism that##8##3##(1991-9#2)(1994-8#1)(1995-3#1)(1995-8#1)(2008-2#1)(2010-4#1)(2010-9#1)
a mechanism to##3##3##(1995-8#1)(1996-12#2)
a mechanism whereby##4##3##(1990-8#1)(1994-9#1)(2008-9#1)(2013-8#1)
a mechanism which##3##3##(1990-5#1)(1997-7#1)(2008-7#1)
a mechanism##92##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#3)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#3)(1995-9#1)(1996-12#3)(1996-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
a mechanism-based classification##2##3##(2008-12#1)(2008-7#1)
a mechanism-based##7##2##(1992-11#1)(1992-6#1)(1995-2#1)(2008-12#2)(2008-3#1)(2008-7#1)
a mechanistic basis for##2##4##(2008-2#1)(2009-8#1)
a mechanistic model##2##3##(2008-10#1)(2013-1#1)
a mechanistic##13##2##(1993-1#1)(2008-10#3)(2008-2#2)(2008-8#1)(2009-11#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
a mechanistically##2##2##(1994-5#1)(2008-5#1)
a medial##8##2##(1995-2#1)(1996-2#1)(2007-12#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-12#2)
a median age of##7##4##(1992-5#1)(2007-11#1)(2008-6#1)(2009-12#1)(2011-1#2)(2013-1#1)
a median follow-up of##8##4##(1990-12#2)(1990-2#1)(1990-6#1)(1992-12#1)(2008-6#2)(2010-3#1)
a median follow-up period of##3##5##(1990-8#1)(2007-10#1)(2013-1#1)
a median follow-up##11##3##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1992-12#1)(2007-10#1)(2008-6#2)(2010-3#1)(2013-1#1)
a median followup of##2##4##(1991-8#1)(2012-3#1)
a median index to##2##4##(2013-1#2)
a median index##3##3##(2013-1#3)
a median of 21##2##4##(1990-2#1)(2008-10#1)
a median of about##2##4##(1997-3#1)(2008-7#1)
a median of##20##3##(1990-2#2)(1991-2#1)(1991-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-6#2)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#4)
a median sternotomy##2##3##(2007-8#1)(2013-1#1)
a median survival of##3##4##(1991-4#1)(2008-5#1)(2010-12#1)
a median survival##6##3##(1990-9#1)(1991-4#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-1#1)
a median time of##3##4##(2010-3#1)(2013-1#2)
a median time##4##3##(2010-3#2)(2013-1#2)
a median##73##2##(1990-12#2)(1990-2#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-9#2)(1997-2#1)(1997-3#3)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#7)(2008-7#2)(2009-12#2)(2010-12#2)(2010-3#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#13)
a mediastinal##5##2##(1990-12#1)(2007-8#1)(2010-12#2)(2011-2#1)
a mediating##4##2##(1992-3#1)(1994-2#1)(1995-2#1)(2008-10#1)
a mediator of the##3##4##(1994-2#1)(2008-11#1)(2010-1#1)
a mediator of##14##3##(1991-12#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-2#2)(1995-2#2)(2008-11#2)(2010-1#1)(2010-5#1)(2010-8#1)(2012-2#1)
a mediator##26##2##(1991-12#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-2#2)(1995-2#2)(2008-10#9)(2008-11#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
a medical and##2##3##(1994-12#1)(2011-2#1)
a medical center##4##3##(1991-3#1)(1997-2#1)(2007-9#1)(2010-8#1)
a medical college##2##3##(2008-7#1)(2012-12#1)
a medical condition##3##3##(1994-3#1)(1996-5#1)(2012-2#1)
a medical emergency##4##3##(2007-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
a medical geographic##2##3##(2013-8#2)
a medical group##2##3##(1991-1#1)(1993-3#1)
a medical library##2##3##(1990-4#1)(1996-1#1)
a medical manpower plan##2##4##(1991-2#2)
a medical or##2##3##(2008-3#1)(2012-2#1)
a medical school##2##3##(1995-1#1)(2008-7#1)
a medical service##3##3##(2007-2#1)(2008-3#2)
a medical treatment##2##3##(2011-2#1)(2012-3#1)
a medical##79##2##(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1992-11#1)(1992-2#3)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-3#3)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
a medication##4##2##(2009-7#1)(2010-3#2)(2010-8#1)
a medicinal##3##2##(1994-11#1)(2008-11#2)
a medicine##4##2##(1997-6#1)(2008-3#1)(2008-7#1)(2013-1#1)
a medium containing##13##3##(1992-8#1)(1994-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)
a medium in##2##3##(2008-10#1)(2008-2#1)
a medium level of##2##4##(2008-10#2)
a medium of##2##3##(2008-10#1)(2008-3#1)
a medium sized##2##3##(2008-11#1)(2013-1#1)
a medium with##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
a medium##49##2##(1991-3#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-4#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-8#1)(2013-1#1)
a medium-sized##3##2##(2007-9#1)(2010-3#1)(2011-2#1)
a meeting in##2##3##(2008-7#1)(2011-2#1)
a meeting with##3##3##(2008-7#1)(2011-2#2)
a meeting##10##2##(1990-3#1)(1992-3#1)(1996-12#1)(2007-2#1)(2008-7#2)(2011-2#3)(2012-12#1)
a melanoma cell line##2##4##(1994-12#1)(2008-8#1)
a melanoma##4##2##(1994-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
a member of a large##2##5##(1994-2#1)(2008-11#1)
a member of a new##2##5##(1995-8#1)(2009-9#1)
a member of a##13##4##(1991-2#1)(1992-3#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1995-8#2)(1996-12#1)(2008-11#1)(2008-12#1)(2009-9#1)
a member of the RING finger family##2##7##(1997-3#1)(1997-7#1)
a member of the RING finger##3##6##(1997-3#2)(1997-7#1)
a member of the family of##2##6##(1990-8#1)(1996-12#1)
a member of the family##19##5##(1990-8#1)(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#14)
a member of the genus Comovirus##2##6##(2008-10#2)
a member of the genus Potyvirus##4##6##(2008-10#4)
a member of the genus##23##5##(2008-10#11)(2011-2#12)
a member of the glycine-rich RNA-binding protein##2##7##(1997-7#2)
a member of the immunoglobulin##2##5##(1996-12#1)(2008-7#1)
a member of the low density lipoprotein (LDL) receptor family##2##10##(1995-8#2)
a member of the newly##2##5##(2008-10#1)(2008-5#1)
a member of the nuclear##2##5##(1995-2#1)(2008-1#1)
a member of the##110##4##(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#5)(1994-5#1)(1994-9#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#5)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-3#1)(2011-2#33)(2012-3#1)(2013-1#1)(2013-7#1)
a member of this family##2##5##(1991-2#1)(2010-10#1)
a member of##137##3##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-9#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#5)(1996-12#4)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#5)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-3#1)(2011-1#1)(2011-2#33)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
a member##140##2##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-9#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#5)(1996-12#4)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#5)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-3#1)(2011-1#1)(2011-2#34)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
a membrane bioreactor##2##3##(2008-6#1)(2013-1#1)
a membrane bound##2##3##(2009-4#1)(2009-8#1)
a membrane composition of##2##4##(2008-10#2)
a membrane electrode##2##3##(2008-10#2)
a membrane filter##2##3##(2008-10#2)
a membrane of##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
a membrane oxygenator##3##3##(2007-8#3)
a membrane surface##2##3##(2008-10#1)(2008-11#1)
a membrane##51##2##(1990-5#1)(1991-5#1)(1991-8#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-4#3)(2008-6#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
a membrane-associated##3##2##(1991-10#1)(1994-11#1)(1994-12#1)
a membrane-bound enzyme##2##3##(1996-2#1)(2007-11#1)
a membrane-bound##10##2##(1991-2#1)(1992-6#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-7#2)
a membrane-permeable##3##2##(1994-2#1)(1995-8#1)(2008-8#1)
a membranous##2##2##(2007-12#1)(2010-3#1)
a memory##8##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)
a meningioma##6##2##(2006-12#2)(2008-7#3)(2011-2#1)
a mental disorder##3##3##(1992-5#1)(2013-8#2)
a mental health##10##3##(1992-2#1)(1994-1#1)(1995-1#1)(1997-4#1)(2008-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
a mental##21##2##(1992-2#1)(1992-5#1)(1994-1#1)(1995-1#1)(1995-12#1)(1997-4#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-12#1)(2013-8#3)
a mentally##2##2##(1993-1#1)(2008-12#1)
a mentor in##2##3##(2008-11#1)(2008-6#1)
a mentor##7##2##(2008-11#5)(2008-6#1)(2008-7#1)
a mercury concentration##2##3##(1993-6#2)
a mercury electrode##9##3##(1990-5#1)(2008-10#8)
a mercury##19##2##(1990-5#2)(1993-6#2)(1995-3#1)(2007-11#1)(2008-10#13)
a mere##5##2##(2008-10#1)(2008-7#2)(2009-9#1)(2013-1#1)
a merely##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
a merging##3##2##(2008-10#2)(2008-7#1)
a mesh##2##2##(2013-1#1)(2013-7#1)
a mesophilic cellulase##2##3##(2008-9#2)
a mesophilic##3##2##(2008-9#2)(2011-2#1)
a mesoporous##3##2##(2008-10#2)(2009-11#1)
a message##2##2##(1997-6#1)(2010-1#1)
a meta-analysis of the##6##4##(1991-9#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)
a meta-analysis of##16##3##(1991-10#1)(1991-9#1)(1995-2#2)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
a meta-analysis to##2##3##(2007-12#1)(2013-8#1)
a meta-analysis##34##2##(1991-10#1)(1991-9#1)(1995-2#2)(1996-3#1)(1997-7#2)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
a metaanalysis##2##2##(2008-7#1)(2010-12#1)
a metabolic and##2##3##(2008-7#1)(2012-12#1)
a metabolic intermediate of the fatty acid incorporation pathway##2##9##(1990-11#2)
a metabolic##19##2##(1990-11#2)(1990-12#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-11#6)(2008-3#2)(2008-7#3)(2012-12#1)
a metabolically##5##2##(1997-7#1)(2008-10#2)(2008-6#1)(2008-7#1)
a metabolite of the##3##4##(1995-12#1)(1996-12#1)(2008-3#1)
a metabolite of##6##3##(1992-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
a metabolite##10##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)
a metabotropic glutamate receptor##7##4##(1991-2#2)(1992-11#1)(1995-12#2)(1997-2#2)
a metabotropic glutamate##8##3##(1991-2#2)(1992-11#1)(1995-12#2)(1997-2#2)(2008-11#1)
a metabotropic##9##2##(1991-2#2)(1992-11#1)(1995-12#2)(1997-2#2)(2008-11#1)(2008-4#1)
a metal film##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
a metal halide lamp##2##4##(2008-3#2)
a metal ion##3##3##(2008-10#3)
a metal tube##2##3##(2008-10#1)(2013-1#1)
a metal##35##2##(1991-12#1)(1993-5#2)(1996-2#1)(2007-11#3)(2007-12#4)(2008-10#8)(2008-2#4)(2008-3#8)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
a metallic alloy##2##3##(1991-9#1)(2008-7#1)
a metallic particle##3##3##(2007-11#2)(2007-12#1)
a metallic##17##2##(1991-9#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#6)(2008-7#2)(2012-2#2)
a metalloenzyme##2##2##(1991-5#1)(1995-8#1)
a metaphor##2##2##(2008-1#1)(2012-2#1)
a metaplastic##2##2##(2009-3#1)(2009-5#1)
a metapopulation model that##2##4##(2008-8#1)(2012-2#1)
a metapopulation of the American pika##2##6##(2008-9#2)
a metapopulation of##3##3##(2008-8#1)(2008-9#2)
a metapopulation with##2##3##(2008-8#1)(2008-9#1)
a metapopulation##12##2##(2008-10#1)(2008-8#6)(2008-9#4)(2012-2#1)
a metastasis##6##2##(1992-6#1)(1992-9#1)(1993-12#2)(1997-1#1)(2013-1#1)
a metastatic##11##2##(1990-12#2)(1990-2#1)(1992-6#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-11#1)(2013-1#1)(2013-8#1)
a methamphetamine##2##2##(1995-3#2)
a methanol##4##2##(2007-11#1)(2008-10#2)(2011-1#1)
a methanol-water##2##2##(2008-10#2)
a method based on the##3##5##(2008-10#1)(2008-2#2)
a method based on##8##4##(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-5#1)
a method for amplifying DNA enzymatically by the##3##8##(2008-2#1)(2008-4#1)(2008-9#1)
a method for analyzing##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
a method for assessing the##2##5##(2008-4#1)(2013-1#1)
a method for calculating##3##4##(2008-10#1)(2008-3#1)(2010-3#1)
a method for correcting##2##4##(2008-3#2)
a method for designing##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
a method for detecting##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
a method for determination of##3##5##(2008-10#2)(2008-3#1)
a method for determining##3##4##(2008-2#1)(2008-3#2)
a method for direct##2##4##(2008-10#1)(2008-3#1)
a method for efficiently##2##4##(1994-12#1)(2008-2#1)
a method for estimating##4##4##(1992-6#1)(1994-12#1)(2008-2#1)(2013-1#1)
a method for evaluating##2##4##(1994-2#1)(2012-1#1)
a method for finding##2##4##(2007-12#1)(2008-6#1)
a method for generating##2##4##(2007-11#1)(2008-4#1)
a method for increasing##2##4##(2008-3#1)(2012-4#1)
a method for measuring##2##4##(2008-3#1)(2011-2#1)
a method for monitoring##2##4##(2008-10#1)(2008-11#1)
a method for obtaining##4##4##(1996-3#1)(2007-12#2)(2008-2#1)
a method for quantitative##2##4##(2008-10#1)(2008-3#1)
a method for recognizing##2##4##(2008-3#2)
a method for the determination of##7##6##(2008-10#7)
a method for the simultaneous determination of##2##7##(2008-10#2)
a method for the simultaneous##3##5##(2008-10#3)
a method for the##24##4##(1997-2#2)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#2)(2010-8#1)
a method for##147##3##(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1996-3#2)(1997-2#2)(2007-11#8)(2007-12#7)(2008-10#30)(2008-11#5)(2008-2#13)(2008-3#24)(2008-4#18)(2008-5#3)(2008-6#3)(2008-8#1)(2008-9#8)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#2)
a method has##2##3##(2007-8#1)(2008-10#1)
a method in##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
a method is described for##4##5##(1992-8#1)(2008-11#1)(2008-4#2)
a method is described##5##4##(1992-8#1)(2008-11#1)(2008-4#3)
a method is presented for##2##5##(2008-10#2)
a method is##12##3##(1992-8#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)
a method of choice##4##4##(1996-5#1)(2007-8#2)(2011-2#1)
a method of data##2##4##(2008-3#1)(2009-10#1)
a method of identifying##2##4##(2008-4#1)(2008-7#1)
a method of##75##3##(1992-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#12)(2007-12#3)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#4)(2012-12#1)(2012-3#1)
a method that allows##2##4##(2008-11#1)(2008-2#1)
a method that can be used##2##6##(2008-2#1)(2008-4#1)
a method that can be##3##5##(2007-8#1)(2008-2#1)(2008-4#1)
a method that is##2##4##(2008-3#2)
a method that reduces the##2##5##(2008-10#1)(2008-7#1)
a method that##22##3##(1990-12#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#8)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)
a method to correct for the##2##6##(2008-11#1)(2008-3#1)
a method to detect##2##4##(2009-8#1)(2011-1#1)
a method to determine##2##4##(1992-11#1)(2008-2#1)
a method to evaluate the##2##5##(2008-10#1)(2008-9#1)
a method to evaluate##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
a method to improve the##2##5##(2008-3#2)
a method to improve##4##4##(2008-3#3)(2009-3#1)
a method to increase##2##4##(1995-5#1)(2008-3#1)
a method to measure##5##4##(1997-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
a method to obtain##2##4##(2008-2#1)(2008-3#1)
a method to reproducibly immortalize human T cells by##2##9##(2008-11#2)
a method to##53##3##(1990-7#1)(1992-11#1)(1992-9#1)(1993-11#1)(1995-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
a method using##2##3##(1993-2#1)(2008-9#1)
a method was developed for##2##5##(2008-10#2)
a method was##5##3##(1990-8#1)(2008-10#4)
a method whereby##4##3##(1992-11#1)(1993-11#1)(2008-10#2)
a method which##4##3##(1990-12#1)(1993-8#1)(1994-8#1)(2008-10#1)
a method with##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
a method##370##2##(1990-12#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#24)(2007-12#17)(2007-8#5)(2008-1#1)(2008-10#66)(2008-11#18)(2008-12#6)(2008-2#23)(2008-3#52)(2008-4#32)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#13)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#2)(2009-8#2)(2010-2#1)(2010-3#2)(2010-6#3)(2010-8#2)(2011-1#3)(2011-2#7)(2011-7#1)(2012-1#5)(2012-12#2)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#2)(2013-8#1)
a methodological##8##2##(1994-12#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)
a methodology for the##3##4##(2008-10#2)(2008-11#1)
a methodology for##13##3##(1992-1#1)(1992-3#1)(1994-3#1)(1995-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
a methodology to evaluate##2##4##(1990-3#1)(2011-2#1)
a methodology to##6##3##(1990-3#1)(2007-6#1)(2008-10#3)(2011-2#1)
a methodology##28##2##(1990-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-12#3)(1996-1#1)(2007-10#1)(2007-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#2)
a methyl group##5##3##(1991-5#1)(1995-11#1)(1995-3#1)(2008-10#1)(2013-8#1)
a methyl##9##2##(1991-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#3)(2009-9#1)(2013-8#1)
a methylene group##4##3##(1995-3#1)(2008-10#3)
a meticulous##4##2##(1991-2#1)(2008-10#2)(2008-8#1)
a metric for##2##3##(2008-3#1)(2010-11#1)
a metric##4##2##(2008-3#1)(2008-6#1)(2009-10#1)(2010-11#1)
a metropolitan area##2##3##(1993-6#1)(1997-8#1)
a metropolitan##5##2##(1991-3#1)(1993-6#1)(1994-2#1)(1997-8#1)(2008-12#1)
a mica substrate##2##3##(2008-10#2)
a micellar medium of##2##4##(2008-10#2)
a micellar medium##5##3##(2008-10#5)
a micellar system##3##3##(1996-5#2)(2008-10#1)
a micellar##10##2##(1996-5#2)(2008-10#7)(2009-8#1)
a micro##8##2##(1997-3#1)(2008-10#6)(2013-1#1)
a micro-FIA system##2##3##(2008-10#2)
a micro-column##4##2##(2008-10#4)
a micro-optical##3##2##(2008-2#1)(2008-3#2)
a micro-volume##2##2##(2008-10#2)
a microarray format##2##3##(2009-10#2)
a microarray##8##2##(2008-2#1)(2008-7#2)(2009-10#2)(2009-9#1)(2011-2#1)(2012-3#1)
a microbalance##2##2##(2008-10#1)(2008-5#1)
a microbial sensor##2##3##(2008-10#2)
a microbial##6##2##(1992-11#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
a microcarrier culture##2##3##(2008-11#2)
a microcatheter##2##2##(2008-7#2)
a microcavity##3##2##(2007-11#1)(2008-3#2)
a microchannel##2##2##(2008-10#2)
a microchip##5##2##(2007-11#3)(2007-12#1)(2008-10#1)
a microcloning library##2##3##(2008-9#2)
a microcolumn containing##2##3##(2008-10#2)
a microcolumn of##3##3##(2008-10#3)
a microcolumn packed with##6##4##(2008-10#6)
a microcolumn##12##2##(2008-10#12)
a microcomputer##6##2##(1992-2#1)(2008-10#5)
a microcomputer-based##4##2##(1992-2#1)(1992-4#1)(1993-2#1)(2012-2#1)
a microdeletion of##2##3##(1993-11#1)(1997-3#1)
a microdialysis probe##5##3##(1993-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
a microdialysis##6##2##(1993-6#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-7#1)
a microelectrode##3##2##(1992-11#1)(1993-12#1)(2008-10#1)
a microelectromechanical mirror##4##3##(2007-11#2)(2007-12#2)
a microenvironment##2##2##(1990-5#2)
a microfabricated##6##2##(2007-11#1)(2008-10#4)(2008-7#1)
a microfluidic device##2##3##(2008-10#2)
a microfluidic##8##2##(2008-10#5)(2009-12#1)(2011-1#2)
a microlens array and a zigzag grating##2##7##(2007-11#2)
a microlens array scanner##2##4##(2007-11#2)
a microlens array##7##3##(2007-11#5)(2008-3#2)
a microlens fiber##2##3##(2011-1#2)
a microlens##14##2##(2007-11#5)(2007-8#1)(2008-2#1)(2008-3#4)(2011-1#3)
a micromachined##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
a micrometer-size##3##2##(2007-11#1)(2008-3#2)
a micromirror array##4##3##(2007-12#2)(2008-3#2)
a microorganism##2##2##(2008-7#1)(2012-3#1)
a microplate##4##2##(1996-12#1)(1997-4#1)(2008-11#1)(2010-6#1)
a microporous##2##2##(2008-10#1)(2008-7#1)
a micropump##3##2##(2008-10#3)
a microscope and##2##3##(2008-2#1)(2008-9#1)
a microscope objective##3##3##(2007-12#2)(2008-2#1)
a microscope slide##2##3##(2008-10#1)(2011-1#1)
a microscope##18##2##(1992-9#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#4)(2011-1#1)
a microscopic level##3##3##(2008-3#2)(2009-7#1)
a microscopic##15##2##(1992-5#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2009-7#1)(2012-2#2)
a microsomal##3##2##(1995-5#3)
a microsphere resonator##3##3##(2007-12#3)
a microsphere##7##2##(2007-11#2)(2007-12#3)(2008-9#1)(2009-6#1)
a microtiter plate##3##3##(1994-8#1)(2008-1#1)(2008-10#1)
a microtiter##4##2##(1994-8#1)(2008-1#1)(2008-10#1)(2011-1#1)
a microtubule##4##2##(1992-5#1)(1993-6#2)(2008-6#1)
a microtubule-dependent##2##2##(1994-12#2)
a microvascular stapling device##2##4##(1996-2#2)
a microvascular##3##2##(1990-6#1)(1996-2#2)
a microwave oven and##2##4##(2008-10#2)
a microwave oven##8##3##(1993-12#1)(1997-7#1)(2008-10#6)
a microwave##17##2##(1993-12#1)(1997-7#1)(2008-10#11)(2008-2#1)(2008-3#2)(2010-12#1)
a mid-IR##2##2##(2007-12#1)(2008-3#1)
a mid-infrared##4##2##(2007-12#1)(2008-3#3)
a midcarpal injection of lidocaine##3##5##(2008-9#3)
a middle cerebral##2##3##(2007-10#1)(2011-2#1)
a middle class##2##3##(1991-1#1)(1996-9#1)
a middle repetitive##2##3##(1995-2#1)(1995-8#1)
a middle##13##2##(1991-1#1)(1995-2#1)(1995-8#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
a middle-aged##2##2##(2007-7#1)(2008-11#1)
a midline##3##2##(2007-12#1)(2010-6#1)(2011-2#1)
a midpoint of##2##3##(1992-6#2)
a midwave-infrared##2##2##(2008-3#2)
a migrant##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
a migrated##2##2##(2008-12#1)(2008-7#1)
a migration##7##2##(1992-3#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
a migratory##2##2##(1997-4#1)(2013-7#1)
a mild and##2##3##(2012-2#1)(2013-1#1)
a mild but##2##3##(1997-3#1)(2012-12#1)
a mild chronic##2##3##(1990-9#1)(2008-1#1)
a mild head injury##2##4##(2008-7#2)
a mild self-limiting##2##3##(2007-12#1)(2011-1#1)
a mild to moderate##2##4##(1997-8#1)(2013-1#1)
a mild##44##2##(1990-11#1)(1990-9#1)(1992-10#1)(1993-11#1)(1995-3#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
a milder##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
a mildly##4##2##(1993-9#1)(2008-4#1)(2013-1#2)
a military##2##2##(2008-6#1)(2013-1#1)
a milk##2##2##(2008-10#2)
a million##4##2##(1996-12#1)(2008-10#2)(2010-12#1)
a mimicking##2##2##(1994-12#1)(1997-7#1)
a mineral matrix##2##3##(2008-10#2)
a mineral water derived from##2##5##(2008-11#2)
a mineral##7##2##(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)
a mini##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
a mini-column containing##2##3##(2008-10#2)
a mini-column of##2##3##(1990-8#1)(2008-10#1)
a mini-column packed with silica gel modified with zirconium##2##9##(2008-10#2)
a mini-column packed with##5##4##(2008-10#5)
a mini-column##14##2##(1990-8#1)(2008-10#13)
a mini-external##2##2##(2012-2#2)
a mini-gene system##2##3##(1993-8#2)
a miniature mass spectrometer##2##4##(2010-7#2)
a miniature##13##2##(1994-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#2)(2010-7#2)(2011-2#1)(2012-12#1)
a miniaturized##8##2##(2008-10#2)(2008-3#2)(2009-11#1)(2010-5#2)(2010-6#1)
a minicolumn filled with##2##4##(2008-10#2)
a minicolumn packed with a##2##5##(2008-10#2)
a minicolumn packed with silica gel modified with##2##8##(2008-10#2)
a minicolumn packed with##7##4##(2008-10#7)
a minicolumn##19##2##(2008-10#19)
a minimal decrease in##2##4##(2008-9#2)
a minimal effect on##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
a minimal medium containing##2##4##(2008-10#2)
a minimal medium##4##3##(2008-10#4)
a minimal set of##2##4##(2008-6#1)(2009-9#1)
a minimal##47##2##(1990-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#2)(1995-2#2)(1995-5#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
a minimal-risk clinical anesthesia##2##4##(2008-8#2)
a minimally invasive approach to anterior cranial vault##2##8##(2011-2#2)
a minimally invasive approach##3##4##(2011-2#3)
a minimally invasive procedure##2##4##(1996-12#1)(2012-12#1)
a minimally invasive surgical##2##4##(2011-2#1)(2012-2#1)
a minimally invasive technique##2##4##(2011-2#1)(2012-2#1)
a minimally invasive##18##3##(1996-12#1)(2007-11#1)(2008-3#1)(2008-8#2)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#3)
a minimally##19##2##(1996-12#1)(2007-11#1)(2008-3#1)(2008-8#2)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#3)
a minimization##2##2##(2007-11#1)(2008-2#1)
a minimum amount of##4##4##(1994-5#1)(1997-8#1)(2008-10#1)(2008-4#1)
a minimum amount##5##3##(1994-5#1)(1997-8#1)(2008-10#2)(2008-4#1)
a minimum and##2##3##(2007-11#1)(2013-1#1)
a minimum detectable##4##3##(2008-2#1)(2008-3#3)
a minimum during##2##3##(1992-12#1)(2008-10#1)
a minimum number of##4##4##(2008-10#2)(2008-2#2)
a minimum of 12##2##4##(2008-10#2)
a minimum of 3##2##4##(1994-8#1)(2008-9#1)
a minimum of two##3##4##(1992-6#1)(2010-2#1)(2013-8#1)
a minimum of##26##3##(1990-6#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
a minimum risk##2##3##(1992-6#1)(2011-2#1)
a minimum size##2##3##(1990-8#1)(1993-6#1)
a minimum value of##2##4##(2008-2#1)(2008-3#1)
a minimum value##4##3##(1992-11#1)(1995-2#1)(2008-2#1)(2008-3#1)
a minimum##102##2##(1990-11#2)(1990-6#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#3)(1993-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
a minireview##3##2##(1997-4#1)(2008-7#1)(2009-12#1)
a ministry of##2##3##(1992-2#1)(1993-12#1)
a minor component of##2##4##(2008-10#2)
a minor component##3##3##(1994-12#1)(2008-10#2)
a minor contribution##2##3##(2008-10#1)(2012-12#1)
a minor effect on the##3##5##(2008-10#2)(2009-8#1)
a minor effect on##4##4##(2008-10#2)(2008-3#1)(2009-8#1)
a minor effect##7##3##(1993-8#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2009-8#1)
a minor impact on##2##4##(2011-1#1)(2013-8#1)
a minor or major##2##4##(2007-10#1)(2008-1#1)
a minor or##3##3##(2007-10#1)(2008-1#1)(2012-2#1)
a minor pontic stroke resulted in transient hemiparesis in the case with dehiscent dura around the petrous##2##17##(2011-2#2)
a minor population##2##3##(1997-3#1)(2008-2#1)
a minor portion of##2##4##(1995-9#1)(2008-10#1)
a minor role in##5##4##(1992-10#1)(1995-6#1)(2008-10#2)(2008-9#1)
a minor role##9##3##(1992-10#1)(1995-6#1)(2008-10#5)(2008-5#1)(2008-9#1)
a minor species##2##3##(2008-10#2)
a minor##70##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
a minority of patients##4##4##(1990-6#1)(2006-6#1)(2008-8#1)(2011-2#1)
a minority of the##3##4##(1992-8#1)(2008-10#1)(2013-1#1)
a minority of##15##3##(1990-6#1)(1992-8#1)(1994-8#1)(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a minority##23##2##(1990-6#1)(1992-3#1)(1992-8#1)(1994-8#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
a minute##6##2##(2007-12#1)(2008-10#3)(2008-11#1)(2009-8#1)
a miracle##2##2##(1990-10#1)(2007-5#1)
a mirror with a##2##4##(2008-2#2)
a mirror with##3##3##(2008-2#3)
a mirror##21##2##(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#4)(2008-6#2)(2012-3#1)(2013-8#2)
a misleading##3##2##(1992-6#1)(2008-6#1)(2010-5#1)
a mismatch between##4##3##(1996-1#1)(2007-12#1)(2008-3#1)(2009-5#1)
a mismatch##7##2##(1996-1#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-5#2)
a mismatched##2##2##(2008-2#1)(2012-2#1)
a missed##3##2##(1995-8#1)(1996-11#1)(2012-12#1)
a missense mutation in the##2##5##(1996-2#1)(2008-8#1)
a missense mutation##5##3##(1996-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
a missing link##2##3##(2009-8#2)
a missing##4##2##(2008-8#2)(2009-8#2)
a mission##4##2##(1997-1#1)(2008-11#1)(2008-6#1)(2010-5#1)
a misunderstanding of the##2##4##(1995-1#1)(2012-12#1)
a misunderstanding##3##2##(1995-1#1)(2009-10#1)(2012-12#1)
a mitochondrial (mt)##3##3##(1993-12#1)(1995-8#1)(2008-12#1)
a mitochondrial DNA haplotype that##2##5##(1992-9#1)(2008-10#1)
a mitochondrial DNA##3##3##(1992-9#1)(2008-10#1)(2010-11#1)
a mitochondrial enzyme##2##3##(1995-6#1)(2009-8#1)
a mitochondrial##17##2##(1992-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
a mitogenic##2##2##(1990-12#1)(1994-3#1)
a mitotic##4##2##(1994-6#1)(1995-6#2)(2008-10#1)
a mitral valve##2##3##(1992-11#1)(2007-8#1)
a mitral##3##2##(1992-11#1)(1994-3#1)(2007-8#1)
a mitre box##2##3##(2008-7#2)
a mix of##4##3##(1993-3#1)(2008-2#1)(2008-8#1)(2010-5#1)
a mixed disulfide##3##3##(1993-11#2)(1995-3#1)
a mixed echogenic mass##2##4##(2007-7#2)
a mixed effects##3##3##(1997-4#1)(2008-11#2)
a mixed infection##3##3##(2008-10#2)(2008-5#1)
a mixed mating system in##2##5##(2008-9#2)
a mixed meal##3##3##(1994-12#2)(2012-3#1)
a mixed population##4##3##(1992-6#1)(1994-9#1)(1995-5#1)(2008-10#1)
a mixed solution containing##2##4##(2008-10#2)
a mixed solution##3##3##(2008-10#3)
a mixed system##2##3##(1990-2#1)(2013-8#1)
a mixed##60##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-9#1)(1994-12#2)(1994-9#1)(1995-3#1)(1995-5#2)(1997-4#2)(2007-6#1)(2007-7#2)(2008-10#24)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
a mixed-field##2##2##(1992-6#1)(1992-9#1)
a mixing chamber##2##3##(2008-10#2)
a mixing##6##2##(2008-10#6)
a mixture and##2##3##(2008-10#2)
a mixture containing##6##3##(2008-10#5)(2008-3#1)
a mixture of 0##5##4##(2008-10#3)(2010-3#1)(2010-5#1)
a mixture of 1##3##4##(2008-10#2)(2008-2#1)
a mixture of 10##2##4##(2008-10#2)
a mixture of 5##2##4##(2008-10#2)
a mixture of a##3##4##(1990-9#1)(2008-10#1)(2013-1#1)
a mixture of amino acids##3##5##(2008-10#3)
a mixture of free##2##4##(2008-10#2)
a mixture of glucose and##2##5##(2008-7#2)
a mixture of glucose##3##4##(2008-6#1)(2008-7#2)
a mixture of nitric##3##4##(2008-10#3)
a mixture of oils##2##4##(2008-3#1)(2008-5#1)
a mixture of the two##3##5##(2007-6#1)(2008-10#1)(2008-9#1)
a mixture of the##10##4##(1996-3#1)(1996-5#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)
a mixture of trace##2##4##(2008-10#2)
a mixture of water##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
a mixture of##165##3##(1990-12#2)(1990-8#1)(1990-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#97)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
a mixture with##3##3##(1992-6#1)(2008-10#1)(2008-9#1)
a mixture##194##2##(1990-12#3)(1990-8#1)(1990-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#120)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
a mnemonic##3##2##(1991-2#1)(1992-11#1)(1993-9#1)
a mobile epidermoid tumour in the lumbar##2##7##(2008-7#2)
a mobile facility##5##3##(1992-5#5)
a mobile phase consisting of##3##5##(1991-5#1)(2008-10#2)
a mobile phase constituted##2##4##(2008-10#1)(2008-5#1)
a mobile phase containing##5##4##(1990-8#1)(2008-10#4)
a mobile phase of##8##4##(1990-8#1)(1996-5#1)(2008-10#6)
a mobile phase with##2##4##(2008-10#1)(2008-11#1)
a mobile phase##27##3##(1990-8#2)(1991-5#1)(1996-5#1)(2008-10#21)(2008-11#1)(2008-5#1)
a mobile platform##2##3##(2010-11#1)(2013-1#1)
a mobile##45##2##(1990-8#2)(1991-5#1)(1992-5#5)(1993-11#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2010-11#1)(2013-1#1)
a mock security department drill##2##5##(1993-12#2)
a mock##5##2##(1993-12#2)(2007-8#1)(2008-8#1)(2010-7#1)
a mode of##4##3##(2008-1#2)(2008-4#1)(2013-1#1)
a mode##9##2##(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#2)
a mode-locked Cr##5##3##(2007-12#5)
a mode-locked Ti##4##3##(2007-11#1)(2007-12#3)
a mode-locked femtosecond laser##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a mode-locked laser diode##2##4##(2007-11#2)
a mode-locked laser##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
a mode-locked##30##2##(2007-11#8)(2007-12#16)(2008-2#3)(2008-3#3)
a model based on the##7##5##(2007-11#1)(2007-12#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-1#1)
a model based on##10##4##(2007-11#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-1#1)
a model based##11##3##(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-1#1)
a model compound##5##3##(1993-8#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-6#1)
a model derived##2##3##(2008-3#2)
a model describing##2##3##(2007-12#1)(2008-10#1)
a model for Down syndrome##2##5##(1997-2#2)
a model for a##2##4##(1990-8#1)(2008-5#1)
a model for an##2##4##(1993-11#1)(2011-2#1)
a model for health care##2##5##(1994-12#1)(2010-8#1)
a model for health##3##4##(1994-12#1)(2010-8#2)
a model for long-term##2##4##(2007-10#1)(2008-9#1)
a model for predicting##2##4##(2008-10#1)(2008-11#1)
a model for studies##2##4##(1992-8#1)(1995-8#1)
a model for studying##2##4##(1990-5#1)(2008-9#1)
a model for the##29##4##(1990-7#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-5#1)(1996-3#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#1)(2013-7#1)
a model for##110##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#3)(1996-6#1)(1997-2#4)(1997-4#1)(1997-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#6)(2009-2#1)(2009-3#1)(2009-8#2)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
a model in the##2##4##(2008-11#1)(2008-3#1)
a model in vitro##2##4##(1993-3#1)(2008-11#1)
a model in which the##9##5##(1993-11#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-7#1)
a model in which##17##4##(1990-2#1)(1992-2#1)(1993-11#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-7#2)
a model in##22##3##(1990-2#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-7#2)(2010-8#1)
a model incorporating##5##3##(1992-6#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
a model involving##2##3##(1990-11#1)(2007-12#1)
a model is##2##3##(1992-3#1)(1995-9#1)
a model lipase##2##3##(1995-5#2)
a model observer##2##3##(2012-1#2)
a model of human##2##4##(1994-5#1)(2011-2#1)
a model of neural##2##4##(2008-11#1)(2010-1#1)
a model of the##9##4##(1990-8#1)(1992-1#1)(1993-1#1)(1993-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
a model of##74##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-5#2)(2009-7#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
a model organism##5##3##(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)
a model originally##2##3##(1997-2#1)(2008-1#1)
a model parameter##2##3##(2008-2#1)(2010-9#1)
a model peptide##2##3##(1991-9#1)(1993-11#1)
a model plant##3##3##(1996-12#1)(2008-9#1)(2011-2#1)
a model predicting##2##3##(1993-2#1)(2008-10#1)
a model protein##5##3##(1996-12#1)(1997-8#2)(2008-11#1)(2009-9#1)
a model secreted##2##3##(2008-11#1)(2008-7#1)
a model skin lotion with##2##5##(2008-5#2)
a model substrate##3##3##(1997-6#1)(2008-10#1)(2008-4#1)
a model system consisting of##2##5##(2007-12#1)(2008-10#1)
a model system for the##2##5##(2011-1#1)(2012-3#1)
a model system for##11##4##(1992-6#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-3#1)
a model system to##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
a model system##43##3##(1990-12#1)(1992-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-12#3)(2008-10#16)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
a model that allows##2##4##(1992-6#1)(2008-3#1)
a model that assumes a##2##5##(2008-2#1)(2008-3#1)
a model that describes the##2##5##(2007-11#1)(2008-10#1)
a model that included##2##4##(2008-10#1)(2013-1#1)
a model that predicts##2##4##(2008-11#1)(2008-3#1)
a model that##25##3##(1991-5#1)(1992-6#1)(1992-9#1)(1997-1#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
a model to study the##3##5##(1993-9#1)(1994-5#1)(2008-8#1)
a model to study##6##4##(1993-9#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
a model to understand##2##4##(1990-7#1)(2011-10#1)
a model to##16##3##(1990-7#1)(1991-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-10#1)(2012-2#1)(2013-1#1)
a model using##4##3##(1995-5#1)(2008-10#1)(2008-8#2)
a model was##3##3##(2008-10#1)(2008-7#2)
a model where##7##3##(1994-2#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)
a model which##3##3##(1990-7#1)(2008-10#1)(2011-2#1)
a model with a##2##4##(2007-12#1)(2009-8#1)
a model with##5##3##(1995-9#1)(2007-12#1)(2008-9#1)(2009-7#1)(2009-8#1)
a model##470##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#4)(1990-8#2)(1991-1#2)(1991-5#5)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#6)(1995-2#9)(1995-3#1)(1995-5#5)(1995-8#2)(1995-9#2)(1996-1#3)(1996-12#4)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#14)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#74)(2008-11#18)(2008-12#1)(2008-2#12)(2008-3#24)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#21)(2008-8#23)(2008-9#20)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#5)
a model-based approach##3##3##(1994-11#2)(2008-8#1)
a modeled##3##2##(2008-2#1)(2008-6#1)(2009-11#1)
a modeless dye laser##2##4##(2008-2#2)
a modelling##2##2##(2008-10#1)(2008-7#1)
a moderate affinity for the##2##5##(1995-3#1)(2008-10#1)
a moderate degree##2##3##(2008-5#1)(2012-12#1)
a moderate effect##3##3##(1997-6#1)(2008-4#2)
a moderate level of##4##4##(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
a moderate level##6##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#1)
a moderate or##3##3##(1994-2#1)(2009-4#1)(2010-1#1)
a moderate##48##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-4#3)(1997-6#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
a moderately high##2##3##(2008-11#1)(2011-2#1)
a moderately resistant cultivar resulted in##2##6##(2008-10#2)
a moderately resistant##4##3##(2008-10#4)
a moderately##17##2##(1990-11#1)(1990-8#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)
a moderating##2##2##(1996-2#1)(2007-12#1)
a modern##20##2##(1990-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a modest but##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
a modest increase in##3##4##(1993-11#1)(1997-3#1)(2008-9#1)
a modest increase##4##3##(1993-11#1)(1997-3#1)(1997-7#1)(2008-9#1)
a modest##26##2##(1990-11#1)(1991-12#1)(1993-11#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#3)(2011-2#1)(2013-1#1)
a modification in the##3##4##(2008-10#3)
a modification of the method##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
a modification of the##19##4##(1992-9#1)(1994-12#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-1#1)
a modification of##26##3##(1992-9#1)(1994-12#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a modification##35##2##(1990-5#1)(1992-12#1)(1992-9#1)(1994-12#2)(1995-6#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a modified Arnoldi method##2##4##(2007-12#2)
a modified Mach-Zehnder##2##3##(2007-12#1)(2008-3#1)
a modified carbon##2##3##(1995-6#1)(2008-10#1)
a modified electrode##2##3##(1995-6#1)(2008-10#1)
a modified form of##4##4##(2008-10#1)(2009-10#1)(2013-1#2)
a modified form##5##3##(2008-10#2)(2009-10#1)(2013-1#2)
a modified method of##2##4##(1996-3#1)(2013-1#1)
a modified method##3##3##(1996-3#1)(2008-9#1)(2013-1#1)
a modified radical mastoidectomy##2##4##(2008-9#2)
a modified radical##3##3##(1994-12#1)(2008-9#2)
a modified technique##2##3##(2007-8#1)(2011-1#1)
a modified version of the original##2##6##(2008-1#1)(2008-6#1)
a modified version of the##13##5##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)
a modified version of##16##4##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-2#1)
a modified##167##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#6)(2007-12#11)(2007-8#5)(2008-1#2)(2008-10#32)(2008-11#3)(2008-12#4)(2008-2#12)(2008-3#19)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#4)(2009-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
a modifier##7##2##(2008-10#6)(2008-9#1)
a modular##9##2##(1995-2#1)(1996-12#1)(2008-3#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
a modulated laser beam##2##4##(2008-3#2)
a modulated##9##2##(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-5#1)
a modulating##2##2##(1997-7#1)(2007-12#1)
a modulation frequency##2##3##(2008-3#2)
a modulation of##4##3##(1994-3#1)(1995-12#1)(2007-12#1)(2012-12#1)
a modulation##12##2##(1994-3#1)(1995-12#1)(2007-12#2)(2008-3#5)(2009-8#1)(2012-12#1)(2013-8#1)
a modulator of##3##3##(1990-12#1)(1995-12#1)(2008-7#1)
a modulator##4##2##(1990-12#1)(1995-12#1)(2007-12#1)(2008-7#1)
a modulatory role in##2##4##(1993-5#1)(2008-5#1)
a modulatory role##4##3##(1993-12#1)(1993-5#1)(2008-5#1)(2011-2#1)
a modulatory##9##2##(1990-5#1)(1993-12#2)(1993-5#1)(1993-6#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
a module of study##2##4##(2008-11#2)
a module that##2##3##(2008-8#1)(2008-9#1)
a module##8##2##(1996-7#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
a moiré##2##2##(2008-2#1)(2008-3#1)
a moisture##2##2##(2009-8#1)(2010-4#1)
a moisturizer##3##2##(2008-5#3)
a mol##2##2##(1995-12#1)(2008-6#1)
a molar ratio of 5##2##5##(1993-11#1)(2008-10#1)
a molar ratio of##7##4##(1990-5#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(2008-10#2)
a molar ratio##10##3##(1990-5#1)(1992-12#2)(1993-11#1)(1993-6#1)(1994-12#1)(2008-10#4)
a molar##18##2##(1990-5#1)(1992-12#2)(1993-11#1)(1993-6#1)(1994-12#2)(2008-10#8)(2008-6#1)(2011-2#1)(2013-1#1)
a mole fraction##2##3##(2008-10#1)(2008-8#1)
a mole##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
a molecular analysis of##2##4##(2008-10#1)(2013-1#1)
a molecular and##2##3##(1997-7#1)(2008-7#1)
a molecular basis for the##3##5##(1996-12#1)(2008-8#1)(2012-12#1)
a molecular basis for##4##4##(1996-12#1)(2008-8#1)(2011-1#1)(2012-12#1)
a molecular diagnostic##2##3##(2008-10#1)(2011-2#1)
a molecular genetic##2##3##(1991-11#1)(2007-7#1)
a molecular level##7##3##(1990-2#2)(1993-9#1)(2008-8#1)(2010-9#2)(2013-1#1)
a molecular marker for##3##4##(2008-10#2)(2013-8#1)
a molecular marker of##3##4##(2008-4#1)(2013-1#1)(2013-8#1)
a molecular marker##8##3##(2007-10#1)(2008-10#3)(2008-4#1)(2013-1#1)(2013-8#2)
a molecular mass of 35 kDa was##2##7##(2008-10#2)
a molecular mass of 60##2##5##(1990-7#1)(1995-2#1)
a molecular mass of##27##4##(1990-7#2)(1991-8#1)(1992-8#1)(1993-11#1)(1993-6#3)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#9)(2008-11#1)(2009-2#1)(2013-1#1)
a molecular mass##30##3##(1990-7#2)(1991-8#1)(1992-8#1)(1993-11#1)(1993-6#3)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#11)(2008-11#1)(2009-2#1)(2011-1#1)(2013-1#1)
a molecular mechanism##3##3##(1997-3#1)(2008-10#1)(2009-8#1)
a molecular perspective##2##3##(2008-4#1)(2008-6#1)
a molecular switch##3##3##(2008-7#1)(2009-6#1)(2012-2#1)
a molecular tweezer-type##2##3##(2008-10#2)
a molecular weight of about##4##5##(1991-5#1)(1992-3#1)(1993-3#1)(2010-3#1)
a molecular weight of approximately##2##5##(1992-12#1)(2010-2#1)
a molecular weight of##23##4##(1990-11#2)(1990-7#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#3)
a molecular weight##28##3##(1990-11#2)(1990-7#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#3)
a molecular##129##2##(1990-11#2)(1990-2#2)(1990-7#5)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
a molecularly imprinted polymer (MIP)##2##5##(2008-10#2)
a molecularly imprinted polymer##3##4##(2008-10#3)
a molecularly imprinted##4##3##(2008-10#4)
a molecularly##7##2##(1997-2#1)(2007-6#1)(2008-10#4)(2013-1#1)
a molecule of interest##2##4##(2008-10#1)(2008-4#1)
a molecule of##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
a molecule that is##2##4##(1994-5#1)(2008-2#1)
a molecule that##5##3##(1992-3#1)(1994-5#1)(2008-2#1)(2008-4#1)(2008-7#1)
a molecule##17##2##(1991-5#2)(1992-3#1)(1994-5#1)(1995-2#1)(2008-10#3)(2008-2#2)(2008-4#3)(2008-7#2)(2009-12#1)(2010-7#1)
a molluscan##2##2##(1991-1#1)(2013-8#1)
a molten##2##2##(1995-5#1)(2008-10#1)
a moment##2##2##(1996-3#1)(2008-2#1)
a momentum##2##2##(2007-12#1)(2008-10#1)
a monitor##5##2##(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)
a monitoring##8##2##(1994-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)
a monkey##4##2##(1991-9#1)(2008-10#1)(2008-5#1)(2009-5#1)
a monocapillary##2##2##(2008-10#1)(2008-3#1)
a monochromatic##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
a monochromator##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
a monoclonal antibody against the##3##5##(1992-3#1)(1993-8#1)(1993-9#1)
a monoclonal antibody against##6##4##(1991-2#1)(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-12#1)
a monoclonal antibody directed against##2##5##(1993-12#1)(1995-3#1)
a monoclonal antibody specific for the##2##6##(1990-12#1)(1995-2#1)
a monoclonal antibody specific for##5##5##(1990-12#1)(1992-8#1)(1995-2#1)(2008-10#2)
a monoclonal antibody specific##6##4##(1990-12#1)(1992-8#1)(1995-2#1)(2008-10#3)
a monoclonal antibody to the##3##5##(1994-12#1)(1996-2#1)(1997-3#1)
a monoclonal antibody to##9##4##(1992-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-4#1)(2008-8#1)
a monoclonal antibody##40##3##(1990-11#1)(1990-12#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
a monoclonal##49##2##(1990-11#1)(1990-12#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#4)(2008-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
a monocyclic##2##2##(2008-10#1)(2011-2#1)
a monocyte##3##2##(1994-6#1)(2008-11#1)(2012-2#1)
a monolayer in the##2##4##(1992-9#1)(2008-5#1)
a monolayer of##11##3##(1995-2#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)
a monolayer##17##2##(1992-6#1)(1992-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)(2010-4#1)
a monolithic four-beam laser diode##2##5##(2008-3#2)
a monolithic##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2010-4#1)
a monomer of##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
a monomer##17##2##(1990-12#1)(1990-5#1)(1990-7#2)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2013-1#1)
a monomeric##8##2##(1992-6#1)(1993-11#1)(1995-11#1)(1995-2#1)(1997-4#1)(1997-6#2)(2008-11#1)
a monomode##2##2##(2007-11#1)(2007-12#1)
a monomolecular##4##2##(2008-10#3)(2012-2#1)
a mononuclear precursor of##2##4##(1991-11#2)
a monophasic##2##2##(1994-2#1)(2013-1#1)
a monophyletic clade##4##3##(2008-10#2)(2010-3#1)(2010-6#1)
a monophyletic group##5##3##(1996-4#1)(2007-12#1)(2008-6#1)(2010-10#1)(2010-8#1)
a monophyletic lineage##2##3##(2008-10#2)
a monophyletic##15##2##(1996-4#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)
a monosaccharide##3##2##(1993-11#1)(2008-11#1)(2010-11#1)
a monospecific polyclonal antibody##2##4##(1996-2#2)
a monospecific##3##2##(1992-3#1)(1996-2#2)
a monotherapy##2##2##(1990-8#1)(2012-3#1)
a monotone##2##2##(2009-9#1)(2010-2#1)
a monotonic##2##2##(2008-2#1)(2008-3#1)
a monotonically##2##2##(2008-8#2)
a monte carlo##2##3##(2008-2#1)(2008-3#1)
a month after##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
a month in##2##3##(2008-11#1)(2012-12#1)
a month##18##2##(1991-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-7#3)(2012-12#1)(2013-1#2)
a monthly##6##2##(1993-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
a mood disorder##2##3##(2008-11#2)
a mood##3##2##(2008-11#2)(2012-2#1)
a moral##8##2##(1993-2#1)(2008-1#1)(2008-11#3)(2008-8#1)(2010-10#1)(2012-2#1)
a moratorium##2##2##(2008-7#1)(2009-9#1)
a more accurate and##2##4##(2008-10#1)(2008-9#1)
a more accurate estimate of##2##5##(1990-3#1)(2008-11#1)
a more accurate estimate##3##4##(1990-3#1)(2007-12#1)(2008-11#1)
a more accurate##16##3##(1990-3#1)(1990-8#1)(1991-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
a more active role##2##4##(1993-1#1)(1996-2#1)
a more active##3##3##(1993-1#1)(1996-2#2)
a more advanced stage##2##4##(1993-11#1)(1995-2#1)
a more affordable##2##3##(1994-2#1)(2008-10#1)
a more aggressive##5##3##(1990-3#1)(1991-4#1)(2013-1#3)
a more appropriate measure##2##4##(2007-10#1)(2008-10#1)
a more appropriate##8##3##(2007-10#1)(2008-10#3)(2008-11#2)(2008-8#1)(2012-1#1)
a more attractive##2##3##(1994-12#1)(2008-11#1)
a more biologically##2##3##(2008-5#1)(2012-2#1)
a more collaborative##2##3##(2008-11#1)(2009-3#1)
a more compact##2##3##(2008-3#1)(2008-5#1)
a more complete description of the##2##6##(2008-3#1)(2008-8#1)
a more complete picture##2##4##(2009-8#2)
a more complete understanding of the##4##6##(1992-3#1)(1996-12#1)(1996-8#1)(2008-4#1)
a more complete understanding of##5##5##(1992-3#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#1)
a more complete##13##3##(1992-3#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-9#1)
a more complex##7##3##(1995-3#1)(1996-11#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-12#1)
a more comprehensive##6##3##(1994-1#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)
a more conservative##2##3##(1997-8#1)(2009-8#1)
a more convenient##2##3##(2008-10#2)
a more correct##2##3##(1993-5#1)(2010-5#1)
a more detailed examination of##2##5##(1997-8#1)(2008-7#1)
a more detailed picture of the##2##6##(1992-6#1)(2012-12#1)
a more detailed picture of##3##5##(1992-6#1)(2007-12#1)(2012-12#1)
a more detailed##14##3##(1992-6#1)(1992-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#3)(2013-8#1)
a more diversified##2##3##(2011-2#2)
a more effective inducer##2##4##(1993-6#1)(2013-1#1)
a more effective##10##3##(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#2)
a more efficient and##2##4##(2008-11#1)(2012-1#1)
a more efficient##10##3##(1990-11#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-4#1)(2012-1#1)
a more equitable##2##3##(1991-1#1)(1996-1#1)
a more expensive##2##3##(1991-3#1)(1993-12#1)
a more explicit##2##3##(2008-8#1)(2012-3#1)
a more extensive##4##3##(1996-12#1)(2010-2#1)(2010-5#1)(2012-7#1)
a more favorable##5##3##(1990-8#1)(2008-10#1)(2008-3#1)(2013-1#2)
a more favourable##4##3##(2008-11#1)(2008-7#1)(2010-10#1)(2010-4#1)
a more female-biased##2##3##(2008-8#1)(2008-9#1)
a more flexible##2##3##(2008-10#1)(2008-11#1)
a more focused##2##3##(2008-5#1)(2008-7#1)
a more frequent##2##3##(1992-10#1)(1993-2#1)
a more functional##2##3##(2010-8#1)(2011-2#1)
a more fundamental##3##3##(1993-6#1)(2008-3#1)(2009-4#1)
a more general approach##2##4##(1995-8#1)(2008-3#1)
a more general##8##3##(1991-6#1)(1995-8#1)(2008-3#3)(2008-7#1)(2012-3#1)(2013-1#1)
a more global level##2##4##(2009-10#1)(2013-1#1)
a more global##3##3##(2007-6#1)(2009-10#1)(2013-1#1)
a more highly##2##3##(1995-2#1)(1997-1#1)
a more holistic view##2##4##(2010-8#1)(2012-12#1)
a more holistic##4##3##(2008-11#1)(2009-8#1)(2010-8#1)(2012-12#1)
a more hydrophilic##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a more important role in##2##5##(1994-8#1)(2008-10#1)
a more important role##3##4##(1994-8#1)(1995-6#1)(2008-10#1)
a more important##8##3##(1994-8#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
a more individualised approach##2##4##(1995-5#1)(2007-10#1)
a more intense##4##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-4#1)
a more limited##2##3##(1992-3#1)(2008-7#1)
a more minor role##2##4##(2007-12#1)(2008-5#1)
a more negative##2##3##(2008-10#1)(2008-9#1)
a more normal##2##3##(2007-12#1)(2008-7#1)
a more personalized##2##3##(1992-3#1)(2008-10#1)
a more physiological##3##3##(1994-12#2)(2008-4#1)
a more polar metabolite##2##4##(1991-5#2)
a more positive##5##3##(2008-10#1)(2008-12#1)(2010-2#1)(2013-1#2)
a more potent inhibitor of##2##5##(1994-11#1)(1995-3#1)
a more potent##10##3##(1991-12#1)(1991-5#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
a more powerful##2##3##(2007-4#1)(2009-5#1)
a more practical##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
a more precise##5##3##(1994-12#1)(1994-5#1)(2008-7#1)(2009-6#1)(2013-8#1)
a more productive##2##3##(1991-9#1)(1994-5#1)
a more prolonged##2##3##(2007-10#1)(2008-1#1)
a more prominent##3##3##(1997-7#1)(2008-11#1)(2011-1#1)
a more pronounced effect on##2##5##(1994-9#1)(2008-10#1)
a more pronounced##5##3##(1994-9#1)(1996-12#1)(2008-10#2)(2013-1#1)
a more quantitative##2##3##(1991-5#1)(2006-4#1)
a more rapid and##2##4##(2007-7#1)(2008-9#1)
a more rapid##7##3##(1992-1#1)(1992-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
a more rapidly##2##3##(2008-5#1)(2010-6#1)
a more rational##2##3##(1995-3#1)(2010-10#1)
a more realistic##3##3##(1995-11#1)(1996-2#1)(2008-3#1)
a more recent##4##3##(2008-1#1)(2008-2#1)(2009-7#1)(2012-12#1)
a more receptive##2##3##(1994-9#1)(2010-8#1)
a more reliable##6##3##(1993-12#1)(2008-10#4)(2009-11#1)
a more rigid##3##3##(1993-3#1)(2008-4#1)(2008-5#1)
a more rigorous##2##3##(2008-2#1)(2010-5#1)
a more selective##3##3##(1997-6#1)(2008-11#1)(2008-5#1)
a more sensitive and##2##4##(2008-10#2)
a more sensitive##3##3##(2008-10#3)
a more severe##6##3##(1991-12#1)(1991-8#1)(1997-2#1)(1997-7#1)(2008-8#1)(2009-2#1)
a more sophisticated##2##3##(1991-3#1)(2013-1#1)
a more specific##10##3##(1992-6#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
a more stable and##2##4##(1994-11#1)(2008-5#1)
a more stable##7##3##(1991-12#1)(1994-11#1)(2008-10#3)(2008-2#1)(2008-5#1)
a more suitable##3##3##(2008-3#1)(2010-8#1)(2013-1#1)
a more systematic##2##3##(2013-1#2)
a more targeted approach to the##2##6##(1991-2#1)(2008-7#1)
a more than##8##3##(1992-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
a more uniform##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
a more##457##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#6)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#5)(2006-4#1)(2007-10#3)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#58)(2008-11#31)(2008-12#3)(2008-2#9)(2008-3#21)(2008-4#9)(2008-5#16)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#12)(2012-1#2)(2012-12#9)(2012-2#3)(2012-3#6)(2012-5#1)(2012-7#1)(2013-1#25)(2013-7#2)(2013-8#4)
a morphologic##3##2##(2011-2#1)(2012-3#2)
a morphological##7##2##(1991-4#1)(1992-5#1)(1996-5#1)(2008-11#1)(2008-2#2)(2013-7#1)
a morphologically##2##2##(2008-7#1)(2010-3#1)
a morphometric##2##2##(2010-8#1)(2012-3#1)
a mortality##6##2##(1991-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2013-1#1)(2013-7#1)
a mosaic##3##2##(1997-3#1)(2008-10#1)(2012-2#1)
a mosquito##3##2##(2008-5#3)
a most recent common ancestor with the##2##7##(2008-10#2)
a most recent common ancestor with##4##6##(2008-10#4)
a most##9##2##(2008-10#4)(2008-3#1)(2008-5#2)(2008-9#1)(2013-1#1)
a mother and a fetus##2##5##(2011-1#1)(2012-3#1)
a mother and##3##3##(2008-7#1)(2011-1#1)(2012-3#1)
a mother##6##2##(1992-4#1)(1995-1#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
a mother's##2##2##(2007-2#2)
a motif##2##2##(1993-12#1)(1993-9#1)
a motion##4##2##(1995-12#1)(1995-6#1)(2008-3#2)
a motivational approach##2##3##(2008-4#1)(2008-6#1)
a motivational##5##2##(2007-12#1)(2008-12#1)(2008-4#2)(2008-6#1)
a motor imagery task##2##4##(2009-6#2)
a motor##11##2##(1990-12#1)(1995-5#2)(2008-7#1)(2009-4#1)(2009-6#2)(2010-1#1)(2011-2#2)(2013-1#1)
a motorized##3##2##(2008-9#3)
a mounting##2##2##(1991-3#1)(2008-5#1)
a mouse mammary tumour cell line##2##6##(2008-11#2)
a mouse model of##7##4##(1992-8#1)(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#3)
a mouse model##13##3##(1992-8#1)(1994-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
a mouse monoclonal antibody##2##4##(1996-12#1)(2008-7#1)
a mouse monoclonal##3##3##(1994-11#1)(1996-12#1)(2008-7#1)
a mouse##49##2##(1990-8#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#3)(1996-12#2)(1997-4#2)(1997-7#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
a movable##2##2##(2008-2#1)(2008-3#1)
a move to##2##3##(1997-3#1)(2008-5#1)
a move##5##2##(1995-1#1)(1997-3#1)(2008-2#1)(2008-5#1)(2012-3#1)
a movement of the##2##4##(1994-5#1)(1994-6#1)
a movement protein##2##3##(2008-10#2)
a movement##12##2##(1993-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-5#1)(2013-8#2)
a movie##2##2##(2007-11#1)(2008-8#1)
a moving boundary##2##3##(2008-7#2)
a moving object##2##3##(2008-3#1)(2011-2#1)
a moving target##5##3##(2008-11#3)(2008-2#1)(2009-8#1)
a moving##28##2##(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#1)(2009-8#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
a much better##4##3##(2007-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
a much broader context##2##4##(2010-1#1)(2010-3#1)
a much broader##6##3##(1992-10#1)(1994-6#1)(2009-5#1)(2010-1#1)(2010-3#1)(2012-3#1)
a much faster##3##3##(1992-12#1)(2007-11#1)(2008-7#1)
a much greater impact on##2##5##(1992-1#1)(2012-5#1)
a much greater##8##3##(1992-1#1)(1993-8#2)(1995-2#1)(1997-5#1)(2008-7#1)(2008-8#1)(2012-5#1)
a much higher##9##3##(1994-6#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)
a much larger##6##3##(1990-5#1)(1991-2#1)(1997-3#1)(2008-10#1)(2008-2#2)
a much less##3##3##(1993-9#1)(2007-12#1)(2011-2#1)
a much longer##7##3##(1992-8#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-8#1)
a much lower concentration##2##4##(2008-10#1)(2012-2#1)
a much lower level##2##4##(1992-8#1)(2008-10#1)
a much lower##12##3##(1990-5#1)(1992-8#1)(1994-9#1)(1995-5#1)(2008-10#5)(2008-2#1)(2012-2#1)(2012-3#1)
a much more##13##3##(1991-8#1)(1992-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#2)
a much poorer##2##3##(1992-5#1)(1995-2#1)
a much smaller##2##3##(1994-3#1)(2008-3#1)
a much stronger##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)
a much weaker##3##3##(1990-7#1)(1995-12#1)(2007-10#1)
a much wider##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
a much##105##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-5#1)(1992-8#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#4)(2008-2#4)(2008-3#7)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#2)(2013-8#2)
a mucin-like##2##2##(1993-8#1)(2013-1#1)
a mucosal prolapse occupying##2##4##(2013-1#2)
a mucosal prolapse##3##3##(2013-1#3)
a mucosal##6##2##(1991-12#1)(1995-2#1)(2013-1#3)(2013-8#1)
a multi##4##2##(1997-2#1)(2008-11#1)(2009-4#1)(2013-1#1)
a multi-analyte##3##2##(2008-10#2)(2013-1#1)
a multi-center study##2##3##(2007-7#1)(2008-11#1)
a multi-center##3##2##(2007-7#1)(2008-11#1)(2010-11#1)
a multi-channel##3##2##(1994-12#1)(2008-10#2)
a multi-disciplinary team##2##3##(2010-12#1)(2010-3#1)
a multi-disciplinary##5##2##(2007-6#2)(2008-1#1)(2010-12#1)(2010-3#1)
a multi-faceted approach##2##3##(2008-12#1)(2012-12#1)
a multi-faceted##4##2##(2008-12#1)(2008-6#1)(2012-12#1)(2013-8#1)
a multi-factorial##2##2##(2008-2#1)(2011-1#1)
a multi-gene##2##2##(1996-3#1)(2008-10#1)
a multi-institutional health##2##3##(1993-12#1)(1994-2#1)
a multi-institutional##4##2##(1993-12#1)(1994-2#2)(2013-8#1)
a multi-level##2##2##(2009-10#1)(2012-2#1)
a multi-method##2##2##(2008-11#2)
a multi-million##2##2##(2007-5#1)(2010-4#1)
a multi-phased research study##2##4##(2008-12#2)
a multi-professional##2##2##(2008-11#2)
a multi-segment##2##2##(2007-10#2)
a multi-site##8##2##(1995-2#1)(1995-3#3)(1996-3#1)(2009-5#1)(2013-1#2)
a multi-state##3##2##(1995-9#1)(2009-4#1)(2013-1#1)
a multi-step process##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a multi-step##7##2##(1994-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)
a multi-subunit##2##2##(1994-3#1)(2008-11#1)
a multi-syringe##2##2##(2008-10#2)
a multi-well format##2##3##(2008-11#1)(2008-9#1)
a multiaperture##2##2##(2008-2#2)
a multibeam##2##2##(2008-3#2)
a multicellular##4##2##(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
a multicenter educational intervention to##2##5##(2008-3#2)
a multicenter randomized trial comparing##2##5##(1993-1#2)
a multicenter study##3##3##(1990-6#1)(2007-7#1)(2009-10#1)
a multicenter##19##2##(1990-12#2)(1990-6#1)(1991-8#1)(1992-11#1)(1993-1#2)(2007-4#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-3#1)(2013-1#1)
a multicentre study##2##3##(1990-3#1)(2008-5#1)
a multicentre##10##2##(1990-3#1)(1992-2#1)(1996-3#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#3)
a multicentric##4##2##(1993-8#1)(2007-7#2)(2008-8#1)
a multichannel##13##2##(2008-10#3)(2008-2#1)(2008-3#8)(2008-9#1)
a multicomponent##2##2##(2008-10#1)(2013-8#1)
a multicopy plasmid##4##3##(1990-11#1)(1993-9#1)(1997-3#2)
a multicopy##8##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1993-9#1)(1995-6#1)(1997-3#2)
a multicultural##2##2##(1995-3#1)(2013-8#1)
a multicystic##2##2##(2008-10#1)(2011-2#1)
a multidimensional assessment##2##3##(1995-2#1)(2008-9#1)
a multidimensional concept##2##3##(1997-3#1)(2007-7#1)
a multidimensional##18##2##(1992-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a multidisciplinary and##2##3##(2008-8#1)(2011-3#1)
a multidisciplinary approach to management##2##5##(2008-7#1)(2011-2#1)
a multidisciplinary approach to the management of##2##7##(2008-1#1)(2013-1#1)
a multidisciplinary approach to##8##4##(1996-1#1)(2008-1#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-1#1)
a multidisciplinary approach##18##3##(1991-2#1)(1993-1#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)
a multidisciplinary international##4##3##(2010-12#4)
a multidisciplinary team of##3##4##(1990-6#1)(2007-12#1)(2013-1#1)
a multidisciplinary team##13##3##(1990-6#1)(1997-2#2)(2007-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
a multidisciplinary##62##2##(1990-6#1)(1991-2#1)(1992-1#1)(1993-1#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-3#1)(1997-2#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#4)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#1)(2010-12#7)(2010-5#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
a multidomain##3##2##(1994-5#1)(1997-4#1)(2009-6#1)
a multidrug resistance##2##3##(1996-8#1)(2008-11#1)
a multidrug##3##2##(1996-8#1)(1997-4#1)(2008-11#1)
a multielement##2##2##(2008-10#1)(2008-2#1)
a multifaceted approach to the##2##5##(1997-3#1)(2007-12#1)
a multifaceted process##2##3##(2008-10#1)(2009-5#1)
a multifaceted role##2##3##(2009-3#1)(2009-9#1)
a multifaceted##11##2##(1994-1#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
a multifactorial origin##2##3##(1997-7#1)(2013-8#1)
a multifactorial##6##2##(1997-7#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
a multifocal##2##2##(2008-3#1)(2011-2#1)
a multifunctional column##2##3##(2008-10#2)
a multifunctional##19##2##(1994-10#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#4)
a multigene family of##2##4##(1995-2#1)(1996-12#1)
a multigene family##6##3##(1991-6#1)(1993-6#1)(1994-11#2)(1995-2#1)(1996-12#1)
a multigene##7##2##(1991-6#1)(1993-6#1)(1994-11#2)(1995-2#1)(1996-12#2)
a multihospital##3##2##(1993-2#1)(1995-3#1)(1996-1#1)
a multilayer coating##3##3##(2008-2#2)(2008-3#1)
a multilayer stack##3##3##(2008-3#3)
a multilayer structure##2##3##(2007-12#1)(2008-3#1)
a multilayer system##2##3##(2008-3#2)
a multilayer##27##2##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#16)(2008-5#1)(2008-6#1)
a multilayered##4##2##(2008-10#2)(2008-3#1)(2009-9#1)
a multilevel##7##2##(2007-11#1)(2008-12#1)(2008-3#4)(2012-12#1)
a multilocus##2##2##(2008-10#1)(2012-3#1)
a multimeric##3##2##(1990-5#1)(1990-8#1)(2008-10#1)
a multimodal non-invasive##2##3##(2012-3#2)
a multimodal##7##2##(2007-10#1)(2008-12#1)(2010-3#1)(2012-2#2)(2012-3#2)
a multimodality##2##2##(1991-2#1)(1994-6#1)
a multimode fiber##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
a multimode laser##7##3##(1992-11#1)(2008-2#2)(2008-3#4)
a multimode optical fiber##5##4##(2007-12#1)(2008-3#4)
a multimode output##2##3##(2007-11#1)(2008-2#1)
a multimode phase retarder plastic optical fiber##2##7##(2010-4#2)
a multimode waveguide##2##3##(2007-11#1)(2008-3#1)
a multimode##35##2##(1992-11#1)(2007-11#6)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#15)(2010-4#2)
a multinational##4##2##(1994-2#1)(2007-7#1)(2008-2#1)(2011-8#1)
a multinomial##2##2##(2008-8#1)(2012-1#1)
a multiorgan##2##2##(2009-7#1)(2012-1#1)
a multiphase##2##2##(2008-3#1)(2009-10#1)
a multiple choice##2##3##(1991-3#1)(1994-2#1)
a multiple cloning site##3##4##(1991-6#1)(1994-12#2)
a multiple regression analysis##2##4##(2008-5#1)(2010-11#1)
a multiple regression##3##3##(2008-5#1)(2010-11#1)(2012-12#1)
a multiple##27##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-9#1)(1994-12#2)(1994-2#1)(1995-2#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
a multiple-beam fiber-optic##2##3##(2008-2#2)
a multiple-beam##3##2##(2007-11#1)(2008-2#2)
a multiple-pass##2##2##(2007-12#1)(2008-3#1)
a multiplex##7##2##(2008-10#5)(2008-9#1)(2010-4#1)
a multiplexed capillary electrophoresis##2##4##(2008-10#2)
a multiplexed configuration##2##3##(2008-3#2)
a multiplexed##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
a multiplicative effect##2##3##(1996-3#1)(2011-2#1)
a multiplicative##3##2##(1996-3#1)(2011-1#1)(2011-2#1)
a multiplicity of##8##3##(1997-8#1)(2007-12#1)(2008-11#3)(2008-3#2)(2010-9#1)
a multiply##2##2##(2008-2#1)(2008-3#1)
a multipoint##2##2##(1997-5#1)(2008-3#1)
a multiprotein complex##2##3##(1993-12#1)(2010-5#1)
a multiresolution##2##2##(2008-6#2)
a multiscale##3##2##(2009-7#1)(2011-1#1)(2013-1#1)
a multisensor system##2##3##(2008-10#2)
a multisensor##3##2##(2008-10#3)
a multisensory##2##2##(1990-11#1)(1991-2#1)
a multispecialty group##3##3##(1996-1#2)(2008-11#1)
a multispecialty##6##2##(1995-2#1)(1996-1#2)(2008-11#2)(2008-8#1)
a multistage process##2##3##(2009-11#1)(2013-1#1)
a multistage##6##2##(2008-2#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a multistep process##4##3##(1992-2#1)(1993-8#1)(2008-10#1)(2008-12#1)
a multistep##11##2##(1992-2#1)(1993-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-6#2)(2011-2#2)
a multisubunit##2##2##(1991-2#1)(2008-2#1)
a multisyringe flow injection system##2##5##(2008-10#2)
a multisyringe##4##2##(2008-10#4)
a multisystem disease##2##3##(1997-8#1)(2012-3#1)
a multisystem##4##2##(1997-8#1)(2008-9#1)(2012-3#2)
a multisystemic##2##2##(1990-2#1)(2009-11#1)
a multithreaded##2##2##(2008-3#1)(2011-3#1)
a multitude of##15##3##(1992-12#1)(1992-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a multivariate analysis of##4##4##(1995-8#1)(2008-7#1)(2009-7#1)(2013-1#1)
a multivariate analysis##9##3##(1993-1#1)(1995-4#1)(1995-8#1)(2008-7#1)(2009-4#1)(2009-7#1)(2013-1#3)
a multivariate logistic regression##2##4##(2012-12#1)(2012-3#1)
a multivariate technique##2##3##(2007-12#1)(2008-2#1)
a multivariate##33##2##(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1995-4#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
a multiview##2##2##(2008-2#2)
a multiwavelength##8##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#3)
a municipal##2##2##(2008-10#1)(2008-9#1)
a murine genomic library constructed with##2##6##(1997-4#1)(1997-8#1)
a murine megakaryoblastic##2##3##(1991-12#2)
a murine model of##5##4##(2008-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
a murine model##7##3##(2007-11#1)(2008-11#1)(2008-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
a murine##41##2##(1991-12#2)(1991-5#1)(1992-2#1)(1992-8#2)(1993-6#2)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#9)(2008-4#3)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-7#1)
a muscarinic##5##2##(1993-12#1)(1995-12#1)(2006-10#1)(2008-9#1)(2012-12#1)
a muscle##5##2##(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
a muscular##3##2##(1993-3#1)(2007-12#1)(2011-2#1)
a musical##4##2##(2012-12#2)(2013-1#1)(2013-8#1)
a must for##2##3##(1996-11#1)(2008-3#1)
a must##8##2##(1995-11#1)(1996-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
a mutagenic activity##2##3##(1996-2#2)
a mutagenic##5##2##(1996-2#3)(1996-6#1)(2008-10#1)
a mutant of the##2##4##(1995-11#1)(1997-8#1)
a mutant of##9##3##(1993-12#1)(1995-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-12#1)
a mutant strain##4##3##(1995-3#1)(1997-3#1)(2008-7#1)(2009-10#1)
a mutant##31##2##(1990-5#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2012-12#1)
a mutated gene is##2##4##(1997-3#1)(2013-1#1)
a mutated gene##3##3##(1997-3#1)(2012-12#1)(2013-1#1)
a mutated##8##2##(1993-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
a mutation at##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
a mutation in a gene##2##5##(1993-3#1)(2007-8#1)
a mutation in a##3##4##(1993-3#1)(2007-8#1)(2013-1#1)
a mutation in the gene##2##5##(1991-12#1)(2009-10#1)
a mutation in the##14##4##(1991-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
a mutation in##23##3##(1991-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2010-4#1)(2012-3#1)(2013-1#4)
a mutation of the##2##4##(1997-3#1)(2013-1#1)
a mutation that##4##3##(1997-7#1)(2009-8#1)(2010-4#1)(2012-3#1)
a mutation##42##2##(1990-5#1)(1991-12#1)(1993-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-3#3)(2013-1#5)
a mutational##2##2##(1993-8#1)(1995-8#1)
a mutualist##3##2##(2008-8#2)(2008-9#1)
a mutualistic##2##2##(2008-10#1)(2008-8#1)
a mutually##3##2##(1996-1#1)(2008-9#1)(2009-4#1)
a mycelial suspension##2##3##(2008-10#2)
a mycoparasite of##2##3##(2008-10#2)
a mycoparasite##5##2##(2008-10#5)
a myelin##2##2##(1996-12#1)(2008-7#1)
a myeloid##3##2##(1991-9#1)(2010-11#1)(2013-8#1)
a myocardial infarction is a##2##5##(2011-2#1)(2013-1#1)
a myocardial infarction##7##3##(1990-5#1)(2007-10#1)(2008-11#1)(2010-7#1)(2011-2#1)(2013-1#2)
a myriad of##10##3##(1996-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)
a mystery##5##2##(1996-12#1)(2008-5#1)(2008-7#3)
a myxoid##4##2##(1993-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
a nadir-viewing##2##2##(2008-2#1)(2008-3#1)
a nail##2##2##(2013-8#2)
a naive##2##2##(1996-3#1)(2013-1#1)
a nano-crystal layer##3##3##(2009-7#3)
a nanometer##2##2##(2008-3#2)
a nanopore##2##2##(2009-11#1)(2009-7#1)
a nanoporous TiO(2)##2##3##(2008-5#1)(2010-5#1)
a nanoporous##4##2##(2008-5#1)(2010-2#1)(2010-5#2)
a nanoscale##2##2##(2008-10#1)(2009-11#1)
a nanoscopic thin film##3##4##(2007-11#3)
a nanosecond##4##2##(2007-11#2)(2007-12#2)
a nanostructured##2##2##(2008-10#2)
a narrative analysis is used for the interpretation of the difficulty in describing these experiences and the opportunities and challenges the term &quot##2##23##(2013-1#2)
a narrative review##2##3##(2012-1#1)(2013-1#1)
a narrative##8##2##(1996-3#1)(2010-8#1)(2012-1#1)(2013-1#5)
a narrow bandwidth##2##3##(2007-11#1)(2008-3#1)
a narrow internal auditory##2##4##(2008-9#2)
a narrow laser beam##2##4##(2008-2#1)(2008-3#1)
a narrow peak##2##3##(2007-12#1)(2008-10#1)
a narrow range of##2##4##(2008-10#1)(2008-8#1)
a narrow range##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
a narrow size distribution##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
a narrow##45##2##(1994-2#1)(1997-1#1)(2007-11#5)(2007-12#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2011-2#1)(2013-1#1)
a narrow-band##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
a narrow-bandwidth##2##2##(2007-11#1)(2008-3#1)
a narrow-bore##2##2##(2008-4#1)(2008-5#1)
a narrower##3##2##(1994-5#1)(1997-3#1)(2008-10#1)
a narrowing of the##2##4##(1994-2#1)(2008-3#1)
a narrowing##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
a nasal spray##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
a nascent##3##2##(1990-5#1)(1994-1#1)(1995-2#1)
a natal tooth##2##3##(2010-3#2)
a nation-wide study##2##3##(1990-9#1)(1993-6#1)
a nation-wide##6##2##(1990-9#1)(1991-9#1)(1993-6#1)(1994-12#1)(2008-1#1)(2011-2#1)
a national cohort of##2##4##(2008-9#1)(2012-2#1)
a national cohort##4##3##(1991-11#1)(1995-9#1)(2008-9#1)(2012-2#1)
a national crisis##2##3##(2009-5#1)(2011-2#1)
a national health care##5##4##(1993-12#1)(1994-2#2)(1995-12#2)
a national health##9##3##(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#2)(2008-1#2)(2008-7#1)
a national level##3##3##(1994-2#1)(1995-12#1)(2008-3#1)
a national network of##2##4##(1991-1#1)(2008-7#1)
a national perspective##2##3##(1997-2#2)
a national priority##3##3##(1994-7#1)(2009-5#1)(2011-3#1)
a national probability sample of##2##5##(1996-2#1)(2012-12#1)
a national public health surveillance system##2##6##(1997-3#2)
a national sample of##4##4##(1992-12#1)(1993-12#1)(2009-2#1)(2012-1#1)
a national sample##8##3##(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(2009-2#1)(2009-7#1)(2012-1#1)(2012-3#1)
a national schistosomiasis surveillance site##3##5##(2012-3#3)
a national strategy##2##3##(1993-12#1)(2007-8#1)
a national surveillance##2##3##(2008-10#1)(2012-3#1)
a national survey of##7##4##(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(2010-2#1)(2012-12#1)
a national survey##12##3##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
a national telephone##2##3##(1995-6#1)(2008-11#1)
a national##107##2##(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-3#3)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#7)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#4)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#2)
a nationally recognized##2##3##(1992-12#1)(2008-1#1)
a nationally representative sample of##5##5##(1993-1#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
a nationally representative sample##6##4##(1993-1#1)(2010-3#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
a nationally representative##10##3##(1993-1#1)(1997-1#1)(2007-12#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
a nationally##14##2##(1992-12#1)(1993-1#1)(1994-3#2)(1997-1#1)(2007-12#1)(2008-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
a nationwide program##2##3##(1997-1#1)(2012-3#1)
a nationwide survey##2##3##(2007-12#1)(2012-2#1)
a nationwide##16##2##(1990-2#1)(1991-11#2)(1992-12#1)(1995-1#1)(1997-1#2)(2007-12#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
a native protein with##2##4##(1993-8#2)
a native protein##3##3##(1993-8#2)(1997-7#1)
a native##14##2##(1990-2#1)(1991-6#1)(1993-8#2)(1994-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-7#1)(2011-2#1)
a natriuretic peptide##2##3##(1990-12#1)(2008-3#1)
a natriuretic##3##2##(1990-12#1)(1994-2#1)(2008-3#1)
a natural antioxidant##2##3##(2010-4#1)(2013-1#1)
a natural barrier to##2##4##(2008-10#1)(2008-11#1)
a natural disaster##4##3##(1991-2#2)(2008-2#2)
a natural environment##2##3##(1997-7#1)(2007-12#1)
a natural experiment##2##3##(1992-2#1)(1997-3#1)
a natural population of song sparrows (Melospiza melodia)##2##8##(2008-9#2)
a natural population of##4##4##(2008-5#1)(2008-9#3)
a natural population##6##3##(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)
a natural preservative##2##3##(2008-5#1)(2008-8#1)
a natural product##2##3##(2008-5#1)(2011-2#1)
a natural result##2##3##(1993-3#1)(2008-7#1)
a natural system##3##3##(2008-9#3)
a natural##98##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#2)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#5)
a naturalistic##2##2##(2008-4#1)(2012-2#1)
a naturally occurring##15##3##(1990-11#1)(1990-7#1)(1991-5#1)(1993-11#1)(1993-9#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#2)(2011-2#1)
a naturally##20##2##(1990-11#1)(1990-7#1)(1991-5#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-1#2)(2011-2#1)
a navigational##2##2##(1990-11#1)(2007-8#1)
a near Nernstian##2##3##(2008-10#2)
a near complete##2##3##(2008-8#1)(2009-7#1)
a near infrared absorbing dye##2##5##(2008-10#2)
a near infrared##4##3##(2008-10#3)(2011-1#1)
a near neutral##2##3##(2011-2#1)(2012-3#1)
a near##18##2##(1992-9#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
a near-Nernstian response##3##3##(2008-10#3)
a near-Nernstian##6##2##(2008-10#6)
a near-complete##2##2##(2008-6#1)(2012-12#1)
a near-critical##3##2##(2007-12#2)(2008-3#1)
a near-diffraction-limited##3##2##(2007-12#2)(2008-3#1)
a near-field optical##2##3##(2008-2#1)(2008-3#1)
a near-field probe##2##3##(2007-12#2)
a near-field scanning optical microscope##3##5##(2007-12#1)(2008-2#2)
a near-field##14##2##(2007-12#6)(2008-2#4)(2008-3#3)(2009-5#1)
a near-infrared acousto-optic tunable filter##2##5##(2008-2#2)
a near-infrared##9##2##(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)
a near-transform-limited##2##2##(2007-11#1)(2007-12#1)
a nearby##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)
a nearly Gaussian##3##3##(2007-11#2)(2008-2#1)
a nearly elliptical cross section##2##5##(2008-2#2)
a nearly elliptical##3##3##(2008-2#3)
a nearly ideal##3##3##(1991-5#1)(1994-2#1)(2007-12#1)
a nearly linear##2##3##(2007-12#1)(2008-3#1)
a nearly##35##2##(1991-3#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-3#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#8)(2008-7#2)(2009-1#1)(2010-2#1)(2011-3#1)(2013-8#1)
a nebulizer##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
a necessary and sufficient##2##4##(1992-9#1)(1993-8#1)
a necessary and##5##3##(1992-9#1)(1993-8#1)(2007-12#1)(2007-2#1)(2009-8#1)
a necessary condition for the##2##5##(2008-8#1)(2009-8#1)
a necessary condition##3##3##(2008-12#1)(2008-8#1)(2009-8#1)
a necessary step in##2##4##(1993-11#1)(1993-8#1)
a necessary step##5##3##(1993-11#1)(1993-8#1)(1994-1#1)(1994-11#1)(2012-2#1)
a necessary##30##2##(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-1#1)(1994-11#1)(1997-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-8#2)(2010-4#1)(2012-2#2)(2013-1#1)
a necessity for##3##3##(1991-1#1)(1996-2#1)(2011-3#1)
a necessity##9##2##(1990-3#1)(1991-1#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-3#1)
a necrosis##3##2##(1992-5#1)(2008-10#2)
a necrotic##5##2##(1995-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
a necrotrophic fungus##2##3##(2008-10#2)
a necrotrophic##5##2##(2008-10#5)
a need exists for##2##4##(1996-2#1)(2008-9#1)
a need for a##7##4##(1994-1#2)(1997-6#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)
a need for accurate##2##4##(2008-7#1)(2008-9#1)
a need for better##2##4##(2011-1#1)(2013-1#1)
a need for continuing##2##4##(2007-11#1)(2008-1#1)
a need for further##7##4##(1995-1#1)(2007-10#1)(2008-5#1)(2010-10#2)(2010-4#1)(2011-1#1)
a need for more##7##4##(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)
a need for precise and accurate methods that allow trace##2##10##(2008-10#2)
a need for the##2##4##(1994-9#1)(1996-3#1)
a need for##79##3##(1991-1#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#5)(2011-2#2)(2012-12#4)(2013-1#7)(2013-8#3)
a need in##2##3##(2008-10#1)(2013-8#1)
a need to develop##7##4##(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-2#2)
a need to improve the##2##5##(1995-6#1)(2010-5#1)
a need to improve##3##4##(1995-6#1)(2010-5#1)(2011-2#1)
a need to increase the##2##5##(2011-2#1)(2012-3#1)
a need to increase##4##4##(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
a need to protect##2##4##(1992-12#1)(2008-2#1)
a need to##53##3##(1991-3#2)(1992-12#2)(1993-12#2)(1995-1#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
a need##143##2##(1991-1#1)(1991-3#2)(1992-12#2)(1993-1#1)(1993-12#3)(1993-8#1)(1994-1#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#3)(1996-3#1)(1996-6#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#2)(2008-1#8)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#2)(2009-4#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#8)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#11)(2013-8#6)
a needle##3##2##(1990-2#1)(1993-9#1)(1996-5#1)
a needlestick##2##2##(1996-5#1)(2012-12#1)
a needs assessment##4##3##(1994-3#1)(1995-12#1)(2011-2#1)(2013-1#1)
a needs##5##2##(1994-3#1)(1995-12#1)(1997-3#1)(2011-2#1)(2013-1#1)
a needs-based##2##2##(1997-1#1)(2011-2#1)
a negative association##2##3##(1994-2#1)(2008-7#1)
a negative attitude##2##3##(1992-2#1)(2010-12#1)
a negative charge##2##3##(1990-8#1)(2008-5#1)
a negative component##2##3##(1995-5#2)
a negative control##4##3##(1992-11#1)(2008-10#1)(2009-2#1)(2010-2#1)
a negative correlation between the##3##5##(2010-12#1)(2011-2#1)(2013-8#1)
a negative correlation between##7##4##(1991-11#1)(1994-5#1)(2008-8#2)(2010-12#1)(2011-2#1)(2013-8#1)
a negative correlation with##2##4##(1991-11#1)(2011-2#1)
a negative correlation##12##3##(1991-11#2)(1994-5#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
a negative delta##2##3##(1990-8#1)(2008-11#1)
a negative effect on##10##4##(1991-2#1)(1992-5#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)
a negative effect##13##3##(1991-2#1)(1992-5#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)
a negative feedback mechanism##2##4##(2010-10#2)
a negative feedback##5##3##(1990-8#1)(2009-7#1)(2009-8#1)(2010-10#2)
a negative impact on the##2##5##(2008-12#1)(2011-7#1)
a negative impact on##8##4##(1992-1#1)(1992-3#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
a negative impact##9##3##(1992-1#2)(1992-3#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
a negative linear##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
a negative potential (-1##2##4##(2008-10#2)
a negative prognosis##2##3##(1991-6#1)(2008-10#1)
a negative regulator of cell##2##5##(2009-10#1)(2012-3#1)
a negative regulator of##8##4##(1990-11#1)(1995-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-5#1)(2012-3#1)(2013-1#1)
a negative regulator##9##3##(1990-11#1)(1991-12#1)(1995-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-5#1)(2012-3#1)(2013-1#1)
a negative regulatory effect##2##4##(2007-12#1)(2013-1#1)
a negative regulatory##3##3##(1993-8#1)(2007-12#1)(2013-1#1)
a negative relationship between##3##4##(1996-3#1)(2008-8#2)
a negative relationship##5##3##(1996-3#1)(2008-8#2)(2010-4#1)(2010-8#1)
a negative result##2##3##(1997-8#1)(2011-2#1)
a negative role##2##3##(2010-11#1)(2013-1#1)
a negative selection##2##3##(1990-12#1)(2008-4#1)
a negative test##2##3##(1990-3#1)(1996-5#1)
a negative##147##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-3#1)(1995-5#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#6)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#7)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
a negatively charged surface##2##4##(1991-9#1)(2008-11#1)
a negatively charged##5##3##(1991-8#1)(1991-9#1)(1992-6#1)(2008-11#1)(2008-4#1)
a negatively cooperative enzyme##2##4##(1993-11#2)
a negatively cooperative##3##3##(1993-11#3)
a negatively##8##2##(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#3)(2008-11#1)(2008-4#1)
a neglected##6##2##(1991-6#1)(1996-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
a negligible effect on##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
a negligible risk##2##3##(2008-10#1)(2009-10#1)
a negligible##15##2##(1994-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#5)(2009-10#1)(2009-7#1)
a negotiated##2##2##(1995-2#1)(2008-12#1)
a neighborhood in##2##3##(2011-2#1)(2013-1#1)
a neighborhood##6##2##(1996-12#1)(2008-1#1)(2011-2#2)(2013-1#2)
a neighboring##3##2##(2007-11#1)(2008-8#1)(2012-3#1)
a neighbouring##3##2##(1993-9#1)(1995-8#1)(1997-3#1)
a nematic liquid crystal##2##4##(2007-11#1)(2007-12#1)
a nematic liquid-crystal##2##3##(2008-3#2)
a nematic##6##2##(1995-6#1)(2007-11#2)(2007-12#1)(2008-3#2)
a nematode##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
a neoadjuvant##2##2##(2012-3#2)
a neodymium magnet##2##3##(2008-10#2)
a neonatal##10##2##(1991-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-7#1)(2007-12#1)(2008-11#2)(2010-8#1)(2012-3#1)
a neonate with##2##3##(2010-10#1)(2013-1#1)
a neonate##5##2##(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)(2013-1#1)
a neonlike##2##2##(2007-12#2)
a neoplasm##3##2##(1992-2#1)(2008-12#1)(2010-8#1)
a neoplastic##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2011-2#1)
a neotropical##2##2##(2008-5#1)(2010-8#1)
a nephrotic syndrome##2##3##(1997-3#1)(1997-7#1)
a nephrotropic strain of infectious bronchitis virus##2##7##(1997-6#2)
a nerve##3##2##(2008-6#1)(2009-3#1)(2013-1#1)
a nervous system##2##3##(2008-4#1)(2009-8#1)
a nervous##4##2##(1994-2#1)(2008-4#1)(2008-8#1)(2009-8#1)
a nest##2##2##(2008-5#1)(2008-6#1)
a nested PCR##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
a nested case-control study##2##4##(2008-8#1)(2010-6#1)
a nested polymerase chain reaction (PCR)##4##6##(1992-9#1)(2008-10#2)(2011-2#1)
a nested polymerase chain reaction##6##5##(1992-9#1)(2008-10#3)(2011-2#1)(2012-3#1)
a nested##19##2##(1990-7#1)(1992-9#1)(1994-12#1)(1997-2#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
a net analyte##2##3##(2008-10#2)
a net increase##2##3##(2007-12#1)(2008-7#1)
a net loss of##2##4##(1992-1#1)(2008-11#1)
a net##16##2##(1990-11#2)(1992-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-9#1)
a network approach##2##3##(2011-3#1)(2012-2#1)
a network is##2##3##(1996-12#1)(1996-3#1)
a network model of the entorhinal cortex layer II with##2##10##(2008-11#2)
a network model of##3##4##(2008-11#3)
a network of##28##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1992-12#1)(1994-1#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a network##48##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-3#1)(1992-12#1)(1994-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
a neural complex##2##3##(2007-12#2)
a neural diagnostic tree##2##4##(2008-3#2)
a neural network for##2##4##(2008-11#1)(2008-3#1)
a neural network model##2##4##(2008-11#1)(2008-8#1)
a neural network##11##3##(1993-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#2)(2013-8#1)
a neural system##2##3##(1993-6#2)
a neural##29##2##(1992-8#1)(1993-12#1)(1993-6#2)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#2)(2012-1#1)(2013-8#1)
a neural-specific##2##2##(1994-12#1)(1995-2#1)
a neuraminidase inhibitor##2##3##(1990-5#1)(2008-5#1)
a neurobiological##3##2##(2008-11#1)(2008-4#1)(2011-1#1)
a neurochemical##2##2##(1995-11#1)(1995-3#1)
a neurodevelopmental##2##2##(1995-11#1)(2011-2#1)
a neuroendocrine##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
a neurogenic##2##2##(2008-12#1)(2008-9#1)
a neurological deficit was noted in##2##6##(2011-2#2)
a neurological deficit##4##3##(1996-8#1)(2007-10#1)(2011-2#2)
a neurological##17##2##(1991-5#1)(1991-8#1)(1996-8#1)(1997-6#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
a neurology##2##2##(2007-10#1)(2010-5#1)
a neuromodulator##4##2##(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
a neuron##3##2##(1996-12#1)(2008-4#1)(2012-2#1)
a neuronal cell line##2##4##(1991-12#2)
a neuronal##9##2##(1991-12#2)(1993-11#1)(1993-12#1)(1994-10#1)(1996-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
a neuropathic pain##2##3##(2008-9#1)(2011-2#1)
a neuropeptide##9##2##(1990-12#1)(1990-7#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-5#1)
a neuroprotective effect##3##3##(2008-11#2)(2008-7#1)
a neuroprotective factor##2##3##(2008-11#1)(2008-7#1)
a neuroprotective##7##2##(2008-11#4)(2008-4#1)(2008-7#2)
a neurosurgical##2##2##(1995-5#1)(2008-12#1)
a neurotoxic##3##2##(1993-12#1)(1994-2#1)(1995-12#1)
a neurotoxin##2##2##(2008-5#1)(2008-7#1)
a neurotransmitter##6##2##(1991-12#1)(1991-5#1)(1996-12#1)(2008-5#2)(2012-3#1)
a neurotrophic##2##2##(1993-5#1)(1997-2#1)
a neurotrophin##2##2##(1996-5#1)(2013-8#1)
a neutral carrier##5##3##(2008-10#5)
a neutral control##2##3##(2008-7#1)(2009-11#1)
a neutral effect##2##3##(2008-3#1)(2012-9#1)
a neutral face##2##3##(2008-11#1)(2009-4#1)
a neutral neurotoxin##2##3##(2008-9#2)
a neutral##38##2##(1990-5#1)(1994-8#2)(1997-4#1)(2007-12#2)(2007-5#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2012-9#1)(2013-1#1)
a neutrophil##4##2##(1994-12#1)(2008-9#3)
a new &quot##2##3##(1994-9#1)(2010-4#1)
a new Ca(2+)-dependent phospholipid-binding protein##2##5##(2008-9#2)
a new addition to the##2##5##(2008-5#1)(2012-12#1)
a new agent for##2##4##(1994-9#1)(2008-5#1)
a new algorithm for##2##4##(2008-12#1)(2008-2#1)
a new algorithm##8##3##(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-4#1)(2012-12#1)(2013-8#1)
a new alternative##2##3##(2012-1#1)(2013-1#1)
a new analysis##3##3##(2008-3#2)(2010-8#1)
a new analytical formula##2##4##(2007-12#1)(2008-3#1)
a new analytical methodology##2##4##(2008-10#2)
a new analytical##8##3##(2007-12#1)(2008-10#5)(2008-3#2)
a new and different##4##4##(1991-6#1)(2008-1#1)(2008-11#1)(2009-3#1)
a new and distinct##2##4##(2008-10#2)
a new and efficient##2##4##(2007-12#1)(2008-10#1)
a new and more##3##4##(1994-1#1)(2008-3#1)(2011-1#1)
a new and simple method for##2##6##(2008-3#1)(2008-6#1)
a new and simple method##4##5##(1997-7#1)(2007-12#1)(2008-3#1)(2008-6#1)
a new and simple##7##4##(1996-5#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
a new and##39##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-10#2)(1994-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
a new anticoagulant##3##3##(2008-10#2)(2013-1#1)
a new application of##2##4##(2007-12#1)(2008-3#1)
a new application##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a new approach for the##5##5##(2007-12#1)(2008-10#3)(2008-3#1)
a new approach for##15##4##(1996-5#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#2)(2009-7#1)(2012-2#1)
a new approach to the##5##5##(2007-11#1)(2007-12#1)(2008-3#1)(2010-5#1)(2012-3#1)
a new approach to##25##4##(1992-1#1)(1992-2#1)(1993-1#1)(1997-8#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-3#2)(2013-8#1)
a new approach towards##2##4##(2009-10#1)(2012-2#1)
a new approach##54##3##(1992-1#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-6#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#5)(2007-12#4)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
a new aspect of##2##4##(1993-8#1)(1994-3#1)
a new aspect##3##3##(1993-8#1)(1994-3#1)(2013-7#1)
a new assay##4##3##(1991-12#1)(2008-10#3)
a new avenue to##2##4##(1991-1#1)(2007-11#1)
a new basis for##3##4##(1996-2#1)(2008-7#1)(2010-4#1)
a new behavioral##2##3##(1991-1#1)(1994-8#1)
a new biosensor##2##3##(2008-10#1)(2013-8#1)
a new bradykinin receptor antagonist##2##5##(1992-3#2)
a new branch##2##3##(2008-10#1)(2008-11#1)
a new but##2##3##(2012-2#1)(2013-1#1)
a new calibration##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
a new camera##2##3##(1992-12#2)
a new capillary electrophoresis (CE)##2##5##(2008-10#2)
a new case of##3##4##(2007-8#1)(2008-7#1)(2010-8#1)
a new case##6##3##(1991-11#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-1#1)(2010-8#1)
a new category of##4##4##(1991-5#1)(1995-6#1)(1997-3#1)(2008-2#1)
a new cell##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
a new centrally acting muscle relaxant##3##6##(1992-3#2)(1996-2#1)
a new challenge for##2##4##(2008-10#1)(2008-11#1)
a new challenge##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
a new chapter in##2##4##(2007-6#1)(2010-8#1)
a new chelating##3##3##(2008-10#3)
a new chemical##2##3##(2008-10#1)(2009-10#1)
a new chromogenic reagent##3##4##(2008-10#3)
a new chromogenic##4##3##(1996-5#1)(2008-10#3)
a new class of drugs##2##5##(1996-7#1)(2012-12#1)
a new class of non-opiate antinociceptive agents##2##7##(1992-8#2)
a new class of optical##2##5##(2007-11#2)
a new class of small##2##5##(1990-5#1)(2012-3#1)
a new class of##39##4##(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-8#3)(1992-9#1)(1996-7#1)(1997-2#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
a new classification of##3##4##(1991-1#1)(2008-7#1)(2012-3#1)
a new classification##4##3##(1991-1#1)(1997-8#1)(2008-7#1)(2012-3#1)
a new combination##2##3##(1995-5#1)(2007-12#1)
a new compound##2##3##(2007-11#1)(2011-3#1)
a new computational##2##3##(2008-3#1)(2008-7#1)
a new concept for an##2##5##(2007-12#1)(2008-3#1)
a new concept for##5##4##(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a new concept in##3##4##(1991-12#1)(2007-12#1)(2010-7#1)
a new concept of##4##4##(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)
a new concept presented here on how to handle gloves with pinholes##2##12##(2012-2#2)
a new concept##23##3##(1991-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)
a new conceptual##2##3##(1996-12#1)(2008-8#1)
a new configuration of##2##4##(2008-2#1)(2008-3#1)
a new configuration##4##3##(2008-2#2)(2008-3#2)
a new curriculum##2##3##(2007-5#1)(2011-1#1)
a new decade##2##3##(1991-1#1)(1991-3#1)
a new desensitizing dentifrice containing 8##3##6##(2011-2#3)
a new design for a##5##5##(2007-11#1)(2008-2#2)(2008-3#2)
a new design for##7##4##(2007-11#1)(2008-2#3)(2008-3#3)
a new device##7##3##(2008-10#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-3#1)(2013-1#1)
a new diagnosis##2##3##(1994-11#1)(1996-3#1)
a new dimension##3##3##(1991-5#1)(1997-2#1)(2008-2#1)
a new direct##2##3##(2008-10#1)(2008-3#1)
a new disease##2##3##(2008-10#2)
a new drug##7##3##(1991-2#1)(1993-2#1)(1995-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)
a new element in##2##4##(2008-9#1)(2012-2#1)
a new enzymatic assay##2##4##(1990-2#1)(1993-12#1)
a new equol-rich##2##3##(2010-1#2)
a new era for##5##4##(1993-12#1)(2008-1#1)(2008-8#1)(2011-2#2)
a new era in##4##4##(1991-8#1)(1997-2#1)(2008-11#1)(2009-5#1)
a new era of##5##4##(1992-2#1)(2008-6#1)(2008-9#2)(2011-7#1)
a new era##21##3##(1991-8#1)(1992-2#1)(1993-12#1)(1993-6#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)
a new estimator##2##3##(1997-7#1)(2008-10#1)
a new experimental##2##3##(2008-10#1)(2008-11#1)
a new expression##2##3##(2008-3#1)(2008-8#1)
a new family of##7##4##(1991-9#1)(1993-2#1)(2007-11#1)(2008-3#3)(2012-2#1)
a new family##11##3##(1991-9#1)(1993-2#1)(1995-5#1)(2007-11#1)(2008-3#3)(2008-5#2)(2012-2#1)(2013-8#1)
a new field##2##3##(2008-10#1)(2008-12#1)
a new flow##3##3##(1995-9#1)(2008-10#2)
a new fluorescence##2##3##(2008-10#2)
a new focus for##3##4##(1995-3#1)(2008-4#1)(2012-2#1)
a new focus##5##3##(1991-1#1)(1995-3#1)(2007-7#1)(2008-4#1)(2012-2#1)
a new fold with##2##4##(2010-10#2)
a new fold##4##3##(2010-10#4)
a new form of##3##4##(2007-12#1)(2008-1#1)(2008-11#1)
a new form##4##3##(1990-8#1)(2007-12#1)(2008-1#1)(2008-11#1)
a new formulation for##2##4##(2007-12#1)(2009-12#1)
a new formulation of##4##4##(2007-11#1)(2010-12#1)(2012-6#1)(2013-1#1)
a new formulation##6##3##(2007-11#1)(2007-12#1)(2009-12#1)(2010-12#1)(2012-6#1)(2013-1#1)
a new framework for##2##4##(2008-12#1)(2010-6#1)
a new framework##3##3##(2008-12#1)(2008-4#1)(2010-6#1)
a new function##2##3##(2012-12#1)(2012-2#1)
a new gene family##3##4##(1993-3#1)(2008-8#1)(2008-9#1)
a new gene##8##3##(1993-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)
a new generation of##6##4##(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)
a new generation##7##3##(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)
a new genus of##3##4##(2008-10#2)(2010-10#1)
a new genus##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2010-10#1)
a new graphical##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
a new group of##4##4##(1991-6#1)(1997-3#1)(2007-11#1)(2008-10#1)
a new group##5##3##(1991-6#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#1)
a new high##2##3##(2007-7#1)(2008-10#1)
a new highly##3##3##(1992-2#1)(2008-10#1)(2008-2#1)
a new host##5##3##(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
a new human##3##3##(1993-3#1)(1994-12#1)(2008-9#1)
a new hybrid##2##3##(2008-3#2)
a new hypothesis##3##3##(1993-12#1)(2010-4#1)(2012-2#1)
a new idea##2##3##(1994-12#1)(2008-2#1)
a new image##4##3##(1992-1#1)(2007-12#1)(2008-3#1)(2010-9#1)
a new imaging##2##3##(2007-12#1)(2010-8#1)
a new implant##2##3##(2008-9#1)(2009-7#1)
a new implementation of##2##4##(2007-11#1)(2008-2#1)
a new insight into the##2##5##(1997-2#1)(2011-1#1)
a new insight##3##3##(1997-2#1)(2011-1#1)(2013-8#1)
a new instrument##3##3##(1992-3#1)(1997-1#1)(2008-2#1)
a new integrated##2##3##(2007-12#1)(2008-10#1)
a new intracoronary shunt design##2##5##(2007-8#2)
a new isoform##2##3##(1992-3#1)(1993-6#1)
a new jet##2##3##(1996-12#1)(1996-3#1)
a new journal##2##3##(2008-7#1)(2009-4#1)
a new kind of##8##4##(1994-3#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-6#1)
a new level of##4##4##(1993-12#1)(1994-2#1)(1997-3#1)(2008-11#1)
a new lipophilic tetrathiafulvalene-tetracyanoquinodimethane##2##4##(2008-10#2)
a new location##4##3##(1994-3#2)(2008-10#1)(2008-7#1)
a new look##2##3##(1993-2#1)(2008-8#1)
a new material for##2##4##(2008-10#1)(2008-2#1)
a new material##4##3##(2008-10#2)(2008-2#2)
a new mathematical##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
a new means of##2##4##(1990-12#1)(2008-3#1)
a new mechanism for##4##4##(2007-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
a new mechanism of##2##4##(2008-9#1)(2010-9#1)
a new mechanism##6##3##(2007-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-9#1)(2012-3#1)
a new medical##5##3##(1991-3#1)(1992-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
a new medium##2##3##(2007-7#2)
a new member of the genus Mitovirus##2##7##(2008-10#2)
a new member of the genus##5##6##(2008-10#5)
a new member of the##10##5##(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-4#1)(2009-3#1)
a new member of##13##4##(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)
a new method based##2##4##(2007-11#1)(2008-8#1)
a new method called##2##4##(2008-10#1)(2008-5#1)
a new method for measuring##3##5##(1996-12#1)(2008-2#1)(2012-2#1)
a new method for the determination of##4##7##(2008-10#4)
a new method for the##9##5##(2008-10#7)(2008-2#1)(2008-7#1)
a new method for##34##4##(1996-12#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#13)(2008-2#4)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#2)
a new method is##3##4##(2008-10#2)(2011-2#1)
a new method of##15##4##(1990-2#1)(1994-9#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)
a new method that##2##4##(1992-3#1)(2008-11#1)
a new method to evaluate##2##5##(2008-5#1)(2009-11#1)
a new method to measure##2##5##(2008-2#1)(2008-5#1)
a new method to##13##4##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#1)
a new method##85##3##(1990-2#1)(1991-12#1)(1992-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#6)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#3)(2013-8#1)
a new methodology##2##3##(2008-10#1)(2008-3#1)
a new microcalorimetric method##2##4##(2008-10#2)
a new model for##3##4##(1996-9#1)(2008-5#1)(2010-11#1)
a new model of##6##4##(1991-5#1)(1995-3#1)(1996-3#1)(1997-4#1)(2009-8#1)(2010-4#1)
a new model to##2##4##(2008-5#2)
a new model##15##3##(1990-8#1)(1991-5#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-3#1)
a new national##3##3##(1994-9#1)(1997-2#1)(2008-3#1)
a new nonlinear##2##3##(2007-11#1)(2008-3#1)
a new one##2##3##(1992-9#1)(2008-11#1)
a new opportunity to##2##4##(2008-10#2)
a new opportunity##3##3##(2008-10#2)(2008-2#1)
a new optical technique##2##4##(2008-2#1)(2008-3#1)
a new optical##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
a new option##2##3##(2006-10#1)(2011-2#1)
a new or##3##3##(1994-12#1)(1997-3#1)(2007-7#1)
a new orientation program##2##4##(1996-1#2)
a new paradigm for understanding##2##5##(2008-3#1)(2010-4#1)
a new paradigm for##7##4##(1996-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2010-4#1)(2013-1#1)
a new paradigm##11##3##(1996-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
a new parameter##4##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
a new pathway##3##3##(1990-8#1)(1991-12#1)(2008-7#1)
a new perspective on##3##4##(1996-3#1)(2008-3#1)(2009-5#1)
a new perspective##6##3##(1994-1#1)(1996-3#1)(2008-1#1)(2008-3#1)(2009-5#1)(2012-3#1)
a new phase##2##3##(1992-5#1)(2008-10#1)
a new philosophy##2##3##(1996-1#1)(2009-4#1)
a new physician##3##3##(1992-8#1)(1993-2#1)(1994-3#1)
a new phytoplasma##2##3##(2008-10#2)
a new picture##2##3##(2008-2#1)(2008-8#1)
a new place##2##3##(2007-8#1)(2008-8#1)
a new population##2##3##(2008-10#1)(2013-8#1)
a new possibility for##2##4##(1991-2#1)(1993-12#1)
a new possibility##3##3##(1991-2#1)(1993-12#1)(2008-11#1)
a new possible##2##3##(1990-8#1)(2012-2#1)
a new potential##3##3##(1991-2#1)(2008-8#1)(2011-2#1)
a new primary##2##3##(1990-12#1)(2013-7#1)
a new procedure for the##2##5##(2008-10#1)(2008-12#1)
a new procedure for##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
a new procedure##11##3##(1990-3#1)(1992-3#1)(2008-10#5)(2008-12#1)(2009-9#1)(2011-2#2)
a new process##3##3##(1993-12#1)(2008-7#1)(2011-2#1)
a new product##4##3##(1992-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
a new program##3##3##(1995-4#1)(1996-2#1)(2008-2#1)
a new pulse##2##3##(2008-3#1)(2008-5#1)
a new quantitative##3##3##(2008-10#2)(2008-5#1)
a new reagent##2##3##(2008-10#2)
a new receiver for potassium resonance temperature lidars##2##8##(2007-11#2)
a new regimen##2##3##(1990-12#1)(2012-3#1)
a new research area##2##4##(2008-11#1)(2013-7#1)
a new research##3##3##(2008-11#2)(2013-7#1)
a new response##3##3##(1993-6#2)(2008-11#1)
a new risk##3##3##(1994-2#1)(2009-7#1)(2011-2#1)
a new role for##2##4##(1990-11#1)(1996-12#1)
a new route to##4##4##(1991-1#1)(2007-11#1)(2008-5#2)
a new route##5##3##(1991-1#1)(2007-11#1)(2008-5#2)(2012-12#1)
a new sample##3##3##(2008-10#2)(2012-2#1)
a new scheme for##3##4##(2007-12#1)(2008-3#1)(2010-3#1)
a new scheme##8##3##(1997-3#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2010-3#1)
a new screening##2##3##(2008-8#1)(2009-6#1)
a new selective##2##3##(1997-6#1)(2008-10#1)
a new sensitive and selective##2##5##(2008-10#2)
a new set of tools##2##5##(1996-2#1)(2007-12#1)
a new set of##7##4##(1993-2#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-12#1)(2013-1#1)
a new simple and##2##4##(1990-5#1)(2008-10#1)
a new simple##4##3##(1990-5#1)(2008-10#1)(2008-2#1)(2008-9#1)
a new solution to##2##4##(2008-10#1)(2008-11#1)
a new source of##3##4##(2008-10#2)(2012-2#1)
a new source##5##3##(1995-8#1)(2008-10#3)(2012-2#1)
a new species in the##3##5##(2008-10#2)(2010-9#1)
a new species of geminivirus##2##5##(2008-10#1)(2008-8#1)
a new species of##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
a new species##17##3##(2008-10#8)(2008-5#4)(2008-8#1)(2010-3#1)(2010-9#1)(2013-1#1)(2013-7#1)
a new spectrofluorimetric method for the determination of##2##8##(2008-10#2)
a new spectrophotometric method##2##4##(2008-10#2)
a new spectrophotometric##3##3##(2008-10#3)
a new standard##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
a new steady-state##2##3##(1990-2#1)(2008-10#1)
a new straight##2##3##(2007-8#1)(2012-2#1)
a new strain of##2##4##(2008-10#1)(2012-2#1)
a new strain##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
a new strategy for##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
a new strategy##10##3##(1991-1#1)(1993-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
a new subcloning-less method for generating nested deletions##2##8##(1995-8#2)
a new surgical technique##2##4##(2012-2#2)
a new surgical##3##3##(2011-1#1)(2012-2#2)
a new suture technique for fascial closure##2##7##(1991-2#2)
a new system for##2##4##(1992-11#1)(2008-9#1)
a new system of##3##4##(1995-12#1)(1996-2#1)(2008-6#1)
a new system##9##3##(1991-1#1)(1992-11#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-6#1)(2008-9#1)(2010-9#1)
a new target for##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
a new target##6##3##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
a new technique based on##2##5##(2008-3#2)
a new technique for measuring the##2##6##(2008-2#2)
a new technique for the##4##5##(2007-11#2)(2007-12#1)(2008-3#1)
a new technique for##21##4##(1990-3#1)(1991-12#1)(1991-3#1)(1991-9#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-6#1)(2008-9#1)(2010-8#1)
a new technique in##3##4##(2008-10#1)(2008-2#1)(2013-7#1)
a new technique that##3##4##(2007-12#1)(2008-3#1)(2012-2#1)
a new technique to##3##4##(1997-3#1)(2008-2#1)(2008-3#1)
a new technique##43##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-2#1)(1997-3#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#7)(2008-3#8)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
a new technology for##2##4##(2007-8#1)(2008-10#1)
a new technology##5##3##(1994-1#1)(2007-8#1)(2008-10#2)(2008-7#1)
a new test##2##3##(2008-5#1)(2008-9#1)
a new theory##2##3##(2009-3#1)(2012-2#1)
a new therapeutic tool for##2##5##(1994-6#1)(2008-1#1)
a new therapeutic tool##4##4##(1994-6#1)(2008-1#1)(2010-6#1)(2011-2#1)
a new therapeutic##10##3##(1991-3#1)(1993-11#1)(1994-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
a new three-dimensional##2##3##(2008-3#1)(2010-11#1)
a new tool for the##2##5##(1996-12#1)(2007-8#1)
a new tool for##8##4##(1993-3#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-2#1)
a new tool in the##2##5##(1997-7#1)(2013-1#1)
a new tool in##4##4##(1997-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
a new tool to##4##4##(1996-12#1)(2008-11#1)(2008-2#1)(2009-5#1)
a new tool##19##3##(1993-3#1)(1996-12#2)(1996-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
a new toothpaste##2##3##(2011-2#2)
a new treatment##8##3##(1995-9#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a new trial##5##3##(1992-2#1)(1996-6#3)(1997-5#1)
a new tumor##2##3##(1991-8#1)(1994-3#1)
a new type of##24##4##(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)
a new type##27##3##(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
a new understanding of##2##4##(2008-11#1)(2009-5#1)
a new virus##2##3##(2008-10#1)(2008-8#1)
a new wave##2##3##(1993-6#1)(2008-10#1)
a new way of##5##4##(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
a new way to##5##4##(1991-2#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)
a new way##11##3##(1991-2#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#2)(2010-2#1)(2012-2#1)(2012-3#1)
a new whitefly-transmitted##2##3##(2008-10#1)(2008-8#1)
a new##1649##2##(1990-10#1)(1990-11#1)(1990-12#11)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#6)(1990-9#1)(1991-1#9)(1991-11#1)(1991-12#11)(1991-2#9)(1991-3#5)(1991-5#8)(1991-6#3)(1991-8#3)(1991-9#5)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#8)(1992-3#12)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#9)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#10)(1993-2#7)(1993-3#7)(1993-6#12)(1993-8#2)(1993-9#1)(1994-1#7)(1994-10#1)(1994-11#4)(1994-12#10)(1994-2#4)(1994-3#7)(1994-6#4)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#7)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#10)(1995-9#3)(1996-1#7)(1996-11#2)(1996-12#13)(1996-2#14)(1996-3#12)(1996-5#6)(1996-6#5)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#12)(1997-3#13)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#8)(1997-9#1)(2006-10#2)(2006-4#1)(2007-1#2)(2007-10#4)(2007-11#55)(2007-12#53)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#14)(2007-9#1)(2008-1#15)(2008-10#288)(2008-11#46)(2008-12#17)(2008-2#74)(2008-3#113)(2008-4#15)(2008-5#64)(2008-6#23)(2008-7#30)(2008-8#48)(2008-9#35)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#6)(2009-2#2)(2009-3#7)(2009-4#6)(2009-5#9)(2009-6#3)(2009-7#8)(2009-8#6)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#6)(2010-2#5)(2010-3#4)(2010-4#9)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#10)(2010-9#5)(2011-1#15)(2011-2#42)(2011-3#6)(2011-7#2)(2012-1#3)(2012-12#18)(2012-2#40)(2012-3#27)(2012-6#1)(2013-1#32)(2013-7#7)(2013-8#21)
a new-generation##2##2##(2008-3#1)(2013-1#1)
a newborn child##2##3##(2008-11#1)(2011-1#1)
a newborn screening##2##3##(2010-8#2)
a newborn with a##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
a newborn with##5##3##(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
a newborn##24##2##(1991-12#2)(1993-2#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
a newer##4##2##(1995-6#1)(2008-10#1)(2011-2#2)
a newly described species##2##4##(2008-10#2)
a newly described##7##3##(1990-5#1)(2008-10#5)(2011-2#1)
a newly designed##3##3##(2008-10#2)(2008-2#1)
a newly developed method##2##4##(2008-10#2)
a newly developed##26##3##(1994-11#2)(1994-12#2)(1995-4#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2011-1#1)(2012-3#2)
a newly discovered##9##3##(1991-5#1)(1992-8#1)(1994-11#1)(2007-11#1)(2008-10#3)(2009-7#1)(2011-2#1)
a newly established##2##3##(1991-2#1)(2008-6#1)
a newly identified##5##3##(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
a newly isolated strain##2##4##(1994-12#1)(2011-2#1)
a newly isolated##4##3##(1994-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
a newly prescribed antihypertensive##2##4##(2008-11#2)
a newly synthesized##7##3##(1995-11#1)(2008-10#5)(2009-9#1)
a newly##80##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#3)(1994-12#3)(1995-11#1)(1995-2#1)(1995-4#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-10#29)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#3)(2011-2#6)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
a newsletter##2##2##(1994-12#1)(1995-1#1)
a next##2##2##(2008-4#1)(2010-10#1)
a niche##4##2##(1994-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
a nickel phthalocyanine complex##2##4##(2008-10#2)
a nickel##8##2##(1995-3#1)(2008-10#6)(2008-3#1)
a nicotinic##2##2##(1991-6#1)(1994-5#1)
a nightmare##3##2##(1992-3#1)(1996-3#1)(2008-7#1)
a nine##2##2##(1991-11#1)(2008-10#1)
a nitrate##4##2##(2006-8#1)(2008-10#2)(2008-3#1)
a nitric acid##3##3##(2008-10#3)
a nitric oxide synthase inhibitor##2##5##(1996-5#1)(1997-2#1)
a nitric oxide##8##3##(1996-5#2)(1997-2#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
a nitric##12##2##(1992-3#1)(1996-5#2)(1997-2#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
a nitrite concentration##3##3##(2008-10#3)
a nitrocellulose##2##2##(1995-2#1)(2008-4#1)
a nitrogen flow##3##3##(2008-10#2)(2008-2#1)
a nitrogen##7##2##(1994-8#1)(1995-9#1)(2008-10#3)(2008-2#1)(2011-2#1)
a no-treatment##2##2##(1992-8#1)(2008-10#1)
a nodal##3##2##(2007-8#1)(2013-8#2)
a nodular##3##2##(1996-12#1)(2008-1#1)(2010-3#1)
a nodule##4##2##(2007-8#1)(2008-12#1)(2012-12#1)(2012-3#1)
a noise level of##2##4##(2008-10#1)(2009-5#1)
a noise level##4##3##(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#1)
a noise##5##2##(2007-11#2)(2008-10#1)(2009-5#1)(2011-2#1)
a noisy##2##2##(2008-10#1)(2012-12#1)
a nominal##14##2##(1994-9#1)(1995-9#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-8#1)(2009-9#1)(2012-1#2)
a nominally##3##2##(2007-11#1)(2008-2#1)(2010-2#1)
a non traumatic##2##3##(2007-7#2)
a non##17##2##(1991-11#1)(1997-3#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-4#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
a non-Hodgkin lymphoma located in the##2##6##(1990-9#1)(1992-2#1)
a non-adhesive##2##2##(2008-11#1)(2008-7#1)
a non-classical##2##2##(2008-1#1)(2008-5#1)
a non-clinical##3##2##(2008-1#2)(2011-1#1)
a non-competitive NMDA receptor antagonist##2##5##(1990-5#1)(1997-7#1)
a non-competitive##7##2##(1990-5#3)(1992-12#1)(1992-3#2)(1997-7#1)
a non-contact##3##2##(2009-7#1)(2010-12#1)(2013-1#1)
a non-destructive##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
a non-detachable balloon##3##3##(1997-3#3)
a non-displaced hip fracture##2##4##(2008-12#2)
a non-displaced##3##2##(2008-12#2)(2013-1#1)
a non-functioning##4##2##(2008-8#2)(2012-2#1)(2013-1#1)
a non-host-specific##2##2##(2008-10#2)
a non-hydrolysable##3##2##(1994-8#1)(1995-3#2)
a non-hydrolyzable##2##2##(1995-8#1)(2008-4#1)
a non-invasive method to##3##4##(1992-5#1)(2008-5#1)(2008-7#1)
a non-invasive method##4##3##(1992-5#1)(2008-5#1)(2008-7#1)(2010-6#1)
a non-invasive##19##2##(1992-5#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a non-ionic detergent##2##3##(1994-11#1)(1997-7#1)
a non-ionic surfactant##6##3##(1994-9#2)(2008-10#2)(2008-5#2)
a non-ionic##10##2##(1994-11#1)(1994-9#2)(1997-7#1)(2008-10#2)(2008-5#3)(2009-11#1)
a non-linear approach##2##3##(2008-7#1)(2009-8#1)
a non-linear method##3##3##(2008-10#3)
a non-linear##15##2##(1991-6#1)(1996-5#1)(2008-10#5)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-8#1)(2013-8#1)
a non-mammalian##2##2##(1995-11#1)(2013-8#1)
a non-native disulfide bridge##2##4##(1990-12#2)
a non-negative##2##2##(1997-7#1)(2013-1#1)
a non-negligible##6##2##(1990-9#1)(1991-9#1)(1994-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
a non-parametric method##2##3##(1995-12#1)(1997-3#1)
a non-parametric##4##2##(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#1)
a non-pathogenic##2##2##(1997-4#1)(2011-2#1)
a non-peptide##2##2##(1994-9#1)(2008-11#1)
a non-physiological##2##2##(1993-6#1)(2009-1#1)
a non-polar##6##2##(2008-10#5)(2012-1#1)
a non-porous##2##2##(1996-12#1)(2008-10#1)
a non-profit##3##2##(1994-3#1)(1997-2#1)(2008-10#1)
a non-receptor##3##2##(1992-6#1)(1995-8#1)(2012-12#1)
a non-selective##3##2##(1996-12#1)(1997-7#1)(2008-7#1)
a non-significant decrease in##2##4##(1994-3#1)(2007-10#1)
a non-significant##4##2##(1994-3#1)(2007-10#1)(2008-9#1)(2011-2#1)
a non-spatial##2##2##(1992-10#1)(1993-3#1)
a non-specific##13##2##(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-8#1)
a non-steroidal anti-inflammatory drug##2##4##(2008-10#1)(2008-5#1)
a non-steroidal##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
a non-toxic##3##2##(2008-10#2)(2008-5#1)
a non-verbal test##2##3##(1990-3#1)(2008-7#1)
a nonabsorbing##2##2##(2008-2#1)(2008-3#1)
a noncollinear##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
a noncompetitive##4##2##(1991-5#1)(1992-3#1)(1994-11#1)(2008-10#1)
a noncomposite##2##2##(2008-2#2)
a noncontact##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
a nondeformable##2##2##(2008-3#1)(2010-4#1)
a nondegenerate##4##2##(1992-11#1)(2007-11#2)(2008-2#1)
a nondestructive and##2##3##(2008-11#1)(2008-3#1)
a nondestructive method##2##3##(2008-10#1)(2008-2#1)
a nondestructive##9##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)
a nonessential##3##2##(1994-5#1)(2008-5#1)(2009-8#1)
a nonfunctional##6##2##(1991-5#1)(1995-2#1)(1997-8#1)(2008-10#1)(2010-3#1)(2012-2#1)
a nongenomic##3##2##(1994-8#1)(2008-4#2)
a nonhost##3##2##(2008-10#3)
a noninstantaneous self-focusing##2##3##(2007-11#2)
a noninstantaneous##4##2##(2007-11#2)(2007-12#2)
a nonintrusive##2##2##(2008-2#1)(2008-3#1)
a noninvasive method to##2##4##(2008-3#1)(2013-7#1)
a noninvasive##24##2##(1993-1#1)(1993-11#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
a nonionic surfactant##2##3##(2008-10#1)(2008-5#1)
a nonionic##4##2##(2008-10#3)(2008-5#1)
a nonlinear crystal##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
a nonlinear function of##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
a nonlinear function##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
a nonlinear least-squares fit to the##2##6##(2008-3#2)
a nonlinear least-squares fit to##3##5##(2007-12#1)(2008-3#2)
a nonlinear least-squares##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
a nonlinear medium##3##3##(2007-12#1)(2008-3#2)
a nonlinear optical crystal##6##4##(2007-11#1)(2007-12#1)(2008-3#4)
a nonlinear optical loop mirror##5##5##(2007-11#2)(2007-12#2)(2008-3#1)
a nonlinear optical##13##3##(2007-11#3)(2007-12#5)(2008-3#5)
a nonlinear relationship##4##3##(2008-10#1)(2008-5#1)(2009-2#1)(2011-1#1)
a nonlinear response##3##3##(2008-2#1)(2008-3#2)
a nonlinear##78##2##(1990-7#1)(1990-8#1)(1996-2#1)(2007-11#10)(2007-12#20)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#23)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)
a nonlinear-fiber Sagnac interferometer##2##4##(2007-12#2)
a nonmammalian enzyme##2##3##(1994-5#2)
a nonmonotonic##2##2##(2007-12#1)(2008-2#1)
a nonnegative##2##2##(2007-11#1)(2008-3#1)
a nonparametric##2##2##(2008-10#1)(2010-9#1)
a nonpathogenic isolate##2##3##(2008-10#2)
a nonpathogenic##6##2##(2008-10#6)
a nonpolar##2##2##(1991-2#1)(1995-2#1)
a nonprofit##5##2##(1992-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1997-1#1)
a nonrandom pattern##2##3##(2008-8#1)(2008-9#1)
a nonrandom##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
a nonresonant##4##2##(2007-11#1)(2007-12#3)
a nonsignificant##2##2##(1996-3#1)(2008-3#1)
a nonspecific##9##2##(1990-11#2)(1995-2#2)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-12#1)
a nonspherical##3##2##(2008-2#1)(2008-3#2)
a nonsteroidal anti-inflammatory drug##2##4##(1997-4#1)(2008-11#1)
a nonstructural##2##2##(2008-10#2)
a nonsymmetrical##2##2##(2007-12#1)(2008-2#1)
a nontoxic##3##2##(2008-9#1)(2010-4#2)
a nonuniform##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
a nonzero##3##2##(2007-11#2)(2008-3#1)
a normal and##2##3##(1994-8#1)(2008-5#1)
a normal ano-genital examination##2##4##(2010-4#2)
a normal component of##4##4##(2008-10#2)(2008-11#2)
a normal condition##2##3##(2008-12#1)(2008-5#1)
a normal diet##3##3##(1991-2#1)(2011-2#2)
a normal distribution##2##3##(2008-10#2)
a normal karyotype##3##3##(1992-10#2)(1993-9#1)
a normal level##3##3##(1991-5#1)(1991-9#1)(2007-8#1)
a normal one##2##3##(1991-2#1)(2011-1#1)
a normal or##2##3##(2008-7#1)(2009-9#1)
a normal population##2##3##(1990-6#1)(1995-2#1)
a normal process##2##3##(2008-4#1)(2008-8#1)
a normal size##2##3##(2008-1#1)(2008-10#1)
a normal##112##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-5#1)(1992-9#2)(1993-9#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-4#2)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
a normal-incidence grating##2##3##(2008-2#1)(2008-3#1)
a normalization of##2##3##(1994-9#1)(1996-12#1)
a normalized Born##2##3##(2007-11#2)
a normalized##11##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)
a normally illuminated##2##3##(2008-2#2)
a normally##6##2##(1990-11#1)(2008-2#2)(2008-3#3)
a normative##3##2##(1996-7#1)(2008-9#1)(2011-2#1)
a normotensive##2##2##(2008-7#1)(2013-1#1)
a north##3##2##(2008-10#1)(2008-12#2)
a northern Italian##2##3##(1990-6#1)(1992-8#1)
a northern##5##2##(1990-6#1)(1992-8#1)(2008-10#1)(2008-7#1)(2010-8#1)
a nose##2##2##(2008-1#1)(2008-4#1)
a not negligible##2##3##(1990-6#1)(2009-10#1)
a not##3##2##(1990-6#1)(1993-5#1)(2009-10#1)
a notable exception##2##3##(2008-1#1)(2012-3#1)
a notable##9##2##(1992-6#1)(1995-11#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
a note of##2##3##(1991-3#1)(2012-2#1)
a note##5##2##(1991-3#1)(1992-1#1)(1995-6#1)(2012-2#1)(2013-1#1)
a noticeable##5##2##(2007-7#1)(2008-2#1)(2008-5#2)(2010-4#1)
a notifiable disease##2##3##(1994-9#1)(2013-1#1)
a novel DNA-binding protein##2##4##(1992-8#1)(2008-8#1)
a novel alloherpesvirus##2##3##(2012-3#2)
a novel and efficient##2##4##(2007-12#1)(2008-8#1)
a novel and simple##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
a novel and very##2##4##(2007-11#1)(2008-10#1)
a novel and##20##3##(1990-5#2)(1992-11#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
a novel antibiotic##2##3##(1991-12#2)
a novel antihypertensive##3##3##(1990-8#1)(2008-10#1)(2010-4#1)
a novel application of##2##4##(2009-11#1)(2013-1#1)
a novel approach for treating##2##5##(2009-6#1)(2013-1#1)
a novel approach for##11##4##(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-1#4)
a novel approach is##2##4##(2008-10#1)(2008-7#1)
a novel approach to estimate##2##5##(2008-10#1)(2009-2#1)
a novel approach to the##3##5##(1991-11#1)(1991-5#1)(2009-7#1)
a novel approach to##13##4##(1991-11#1)(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2009-2#1)(2009-7#1)(2010-11#1)
a novel approach##32##3##(1991-11#1)(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
a novel architecture for cortical computation##2##6##(2008-11#2)
a novel assay##2##3##(2008-10#1)(2008-11#1)
a novel basis for##2##4##(1994-5#1)(2007-12#1)
a novel cDNA##3##3##(1994-11#1)(1995-6#1)(2008-4#1)
a novel cardiac##2##3##(1990-3#1)(2008-7#1)
a novel cell##4##3##(1994-11#1)(1997-6#1)(2008-11#2)
a novel chemiluminescence##2##3##(2008-10#2)
a novel class of##15##4##(1990-12#2)(1990-7#1)(1991-2#1)(1991-5#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-10#3)(2009-3#2)(2010-11#1)(2012-2#1)
a novel computational method##2##4##(2010-10#1)(2010-2#1)
a novel computational##4##3##(2009-12#1)(2010-10#1)(2010-2#1)(2013-1#1)
a novel concept of##2##4##(2007-11#1)(2007-5#1)
a novel concept##3##3##(2007-11#1)(2007-5#1)(2008-10#1)
a novel configuration##2##3##(2008-2#1)(2008-3#1)
a novel control##2##3##(2008-10#1)(2008-2#1)
a novel design##3##3##(1997-1#1)(2008-2#1)(2008-3#1)
a novel determinant of##2##4##(2011-2#1)(2013-1#1)
a novel device##4##3##(1994-1#1)(2007-11#2)(2008-10#1)
a novel drug##3##3##(2009-10#1)(2009-7#1)(2010-2#1)
a novel effective##2##3##(2008-8#1)(2011-2#1)
a novel electrochemical##4##3##(2007-12#1)(2008-10#3)
a novel evolutionary##2##3##(2008-8#1)(2009-9#1)
a novel experimental##2##3##(2008-3#1)(2012-2#1)
a novel explanation##2##3##(1994-11#1)(2008-7#1)
a novel family of##2##4##(2008-11#1)(2008-6#1)
a novel fiber##3##3##(2008-10#2)(2008-2#1)
a novel finding in##2##4##(2008-10#1)(2011-1#1)
a novel fluorescent##2##3##(2007-12#1)(2008-10#1)
a novel form of##5##4##(1990-7#1)(1993-11#1)(2007-12#1)(2007-5#1)(2009-9#1)
a novel framework##2##3##(2008-11#1)(2012-3#1)
a novel function of##2##4##(2008-8#1)(2012-12#1)
a novel functional##4##3##(1994-12#1)(2008-10#2)(2009-10#1)
a novel gene##9##3##(1995-8#1)(1996-10#2)(1997-7#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)
a novel holographic##2##3##(2007-12#1)(2008-3#1)
a novel host##4##3##(2013-1#4)
a novel human gene##4##4##(1996-2#1)(1997-7#1)(1997-8#1)(2008-7#1)
a novel human##11##3##(1990-8#2)(1992-9#1)(1993-11#1)(1994-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-7#1)
a novel hybrid##4##3##(2007-11#2)(2008-7#2)
a novel imaging technique that##2##5##(2007-11#1)(2008-5#1)
a novel imaging technique##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
a novel imaging##6##3##(2007-11#3)(2007-12#1)(2008-3#1)(2008-5#1)
a novel immunoassay##2##3##(2008-11#1)(2008-7#1)
a novel inhibitor of##3##4##(1995-12#1)(2010-4#1)(2011-2#1)
a novel inhibitor##5##3##(1991-12#1)(1995-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
a novel interferometer##4##3##(2007-11#3)(2007-12#1)
a novel mammalian##2##3##(1992-3#1)(1994-8#1)
a novel means of##2##4##(1996-9#1)(2008-10#1)
a novel mechanism for##3##4##(1990-5#1)(1991-5#1)(1992-12#1)
a novel mechanism of##4##4##(1993-3#1)(1994-3#1)(2008-11#1)(2009-7#1)
a novel mechanism##12##3##(1990-5#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(2008-11#1)(2009-7#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
a novel member of the##8##5##(1990-2#1)(1994-11#1)(1994-12#2)(1995-12#1)(2008-10#2)(2013-1#1)
a novel member of##10##4##(1990-2#1)(1993-11#1)(1994-11#1)(1994-12#2)(1995-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
a novel metabolite##2##3##(1991-12#2)
a novel method based on##2##5##(2008-11#1)(2012-2#1)
a novel method for simultaneous quantification of##2##7##(2010-12#2)
a novel method for the determination of##2##7##(2008-10#2)
a novel method for the##6##5##(1994-2#1)(2008-10#4)(2012-2#1)
a novel method for##22##4##(1990-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2010-12#3)(2011-7#1)(2012-2#2)
a novel method of##9##4##(1997-4#1)(1997-7#1)(2007-12#3)(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
a novel method that##2##4##(2007-12#1)(2013-1#1)
a novel method##42##3##(1990-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#7)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-7#1)(2012-2#4)(2013-1#2)
a novel methodology for##2##4##(2007-12#1)(2008-10#1)
a novel model of##2##4##(2008-2#1)(2012-12#1)
a novel model##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-12#1)
a novel monoclonal antibody##2##4##(1992-8#1)(1996-12#1)
a novel optical system##2##4##(2008-3#1)(2009-2#1)
a novel optical##10##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)(2009-2#1)
a novel peptide##2##3##(1990-2#1)(2008-6#1)
a novel physical##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
a novel population##2##3##(2008-10#1)(2010-2#1)
a novel post-transcriptional##2##3##(2008-9#1)(2013-8#1)
a novel probe for##2##4##(1995-11#1)(2008-8#1)
a novel probe##3##3##(1995-11#1)(2007-12#1)(2008-8#1)
a novel protein kinase-encoding gene##2##5##(1990-5#2)
a novel protein of##2##4##(1993-9#1)(1994-6#1)
a novel protein that##2##4##(1990-5#1)(2007-7#1)
a novel protein##9##3##(1990-5#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(2007-7#1)(2008-4#1)
a novel putative##2##3##(1991-9#1)(2010-10#1)
a novel role for##4##4##(1991-12#1)(2008-1#1)(2011-1#1)(2012-12#1)
a novel role##5##3##(1991-12#1)(1995-12#1)(2008-1#1)(2011-1#1)(2012-12#1)
a novel saponin##2##3##(1997-4#2)
a novel scheme##3##3##(2007-11#3)
a novel sensor##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a novel series of##2##4##(1993-11#1)(1995-3#1)
a novel signaling##3##3##(1993-12#1)(2008-10#1)(2009-8#1)
a novel strategy for##3##4##(2008-10#1)(2010-5#1)(2011-2#1)
a novel strategy##6##3##(1992-3#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
a novel structural##2##3##(1992-3#1)(1995-8#1)
a novel synthesized retinoid##2##4##(1992-9#2)
a novel target for##4##4##(1997-1#1)(2009-6#1)(2011-2#1)(2013-8#1)
a novel technique for the##2##5##(2007-11#1)(2007-12#1)
a novel technique for##11##4##(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#1)
a novel technique of##2##4##(2008-2#1)(2008-3#1)
a novel technique to##2##4##(2008-10#1)(2008-3#1)
a novel technique##18##3##(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#3)(2009-6#1)(2011-2#2)(2012-2#1)
a novel therapeutic target##2##4##(2012-2#2)
a novel therapeutic##6##3##(1990-7#1)(2008-7#1)(2010-6#1)(2012-2#2)(2013-7#1)
a novel tool##3##3##(2008-10#3)
a novel transcription factor##2##4##(1991-9#1)(2009-8#1)
a novel two-dimensional##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a novel type of##10##4##(1990-5#1)(1990-7#1)(1993-5#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#2)
a novel type##11##3##(1990-5#2)(1990-7#1)(1993-5#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#2)
a novel tyrosine##2##3##(1992-12#1)(1997-7#1)
a novel way of##2##4##(2008-2#1)(2008-7#1)
a novel way to##2##4##(2012-3#1)(2013-1#1)
a novel way##5##3##(2008-2#1)(2008-7#2)(2012-3#1)(2013-1#1)
a novel whole-field##2##3##(2007-12#2)
a novel##839##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#12)(1990-7#9)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#6)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#9)(1992-9#7)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#10)(1994-12#12)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#3)(1995-11#4)(1995-12#7)(1995-3#3)(1995-6#5)(1995-8#4)(1996-10#2)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-6#2)(1997-7#10)(1997-8#3)(2007-10#1)(2007-11#50)(2007-12#52)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#124)(2008-11#33)(2008-12#4)(2008-2#31)(2008-3#52)(2008-4#8)(2008-5#8)(2008-6#12)(2008-7#19)(2008-8#26)(2008-9#15)(2009-10#4)(2009-11#7)(2009-12#3)(2009-2#2)(2009-3#5)(2009-5#3)(2009-6#6)(2009-7#6)(2009-8#4)(2009-9#6)(2010-10#6)(2010-11#9)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#8)(2012-2#25)(2012-3#15)(2013-1#28)(2013-7#1)(2013-8#6)
a novice##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
a noxious##2##2##(1996-5#1)(2008-10#1)
a nozzle##2##2##(2007-12#1)(2008-10#1)
a nuclear enzyme##2##3##(2008-1#1)(2008-11#1)
a nuclear gene##4##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-7#1)
a nuclear localization signal##3##4##(1994-11#2)(1994-9#1)
a nuclear localization##4##3##(1994-11#2)(1994-9#1)(1995-2#1)
a nuclear magnetic resonance##2##4##(1991-5#1)(1992-4#1)
a nuclear protein##3##3##(1990-8#1)(2007-12#1)(2012-2#1)
a nuclear receptor##3##3##(1996-12#1)(2008-4#1)(2008-9#1)
a nuclear##36##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-4#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
a nucleic acid##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
a nucleophilic##3##2##(1997-3#1)(2008-10#1)(2011-1#1)
a nucleotide exchange factor##2##4##(2012-12#1)(2013-8#1)
a nucleotide identity greater than 98%##2##6##(2008-10#2)
a nucleotide identity##3##3##(2008-10#3)
a nucleotide sequence##3##3##(1995-2#1)(2008-8#1)(2008-9#1)
a nucleotide##20##2##(1990-7#1)(1991-11#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2013-8#1)
a nucleotide-binding site##2##3##(1991-8#1)(1995-6#1)
a nucleotide-binding##5##2##(1990-7#1)(1991-8#1)(1992-3#1)(1995-6#1)(2009-8#1)
a nucleus and##2##3##(2008-2#2)
a nucleus##5##2##(1992-5#1)(2008-10#1)(2008-2#2)(2009-9#1)
a null hypothesis of##2##4##(1995-9#2)
a null hypothesis##4##3##(1995-9#2)(1996-4#2)
a null##9##2##(1995-9#2)(1996-4#2)(2008-10#1)(2008-3#4)
a number of &quot##2##4##(2008-1#1)(2008-3#1)
a number of additional##2##4##(1997-2#1)(2007-11#1)
a number of advantages over##6##5##(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
a number of advantages##11##4##(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#2)(2012-12#1)(2012-3#1)
a number of amino acids##2##5##(1994-6#1)(2011-2#1)
a number of applications##3##4##(2008-2#1)(2008-7#1)(2009-12#1)
a number of approaches##3##4##(1991-3#1)(2008-11#1)(2012-3#1)
a number of attractive properties##2##5##(2008-10#1)(2008-6#1)
a number of autoimmune diseases##2##5##(1992-5#1)(2008-10#1)
a number of behaviors##2##4##(1992-11#2)
a number of biochemical##2##4##(2008-10#1)(2008-12#1)
a number of biological processes##2##5##(1995-11#1)(1996-6#1)
a number of biological##5##4##(1995-11#1)(1996-6#1)(2008-10#1)(2008-4#1)(2010-3#1)
a number of biotic and abiotic stresses##2##7##(2010-10#2)
a number of broad##2##4##(2008-12#1)(2011-2#1)
a number of case reports##2##5##(1991-12#1)(2013-1#1)
a number of cationic##2##4##(2008-5#1)(2008-9#1)
a number of cell##2##4##(1995-6#1)(2008-11#1)
a number of changes##2##4##(1995-2#1)(2012-3#1)
a number of clinical##4##4##(2007-8#1)(2008-3#1)(2009-3#1)(2010-12#1)
a number of commercially available##2##5##(2008-10#1)(2008-9#1)
a number of common features##2##5##(2008-1#1)(2008-10#1)
a number of common##3##4##(2007-12#1)(2008-1#1)(2008-10#1)
a number of compounds with##2##5##(2007-12#1)(2008-5#1)
a number of compounds##3##4##(1995-12#1)(2007-12#1)(2008-5#1)
a number of critical##2##4##(2008-10#1)(2010-9#1)
a number of different cell##2##5##(2008-11#1)(2008-2#1)
a number of different clinical##2##5##(2008-7#2)
a number of different diseases##2##5##(2008-10#2)
a number of different ways##2##5##(2008-7#1)(2009-11#1)
a number of different##31##4##(1990-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2009-11#1)(2009-9#1)(2010-5#1)(2013-8#1)
a number of disadvantages##3##4##(1991-3#1)(1993-6#1)(2009-5#1)
a number of diseases##3##4##(2008-9#1)(2009-5#1)(2010-5#1)
a number of drugs##5##4##(1993-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-3#1)
a number of dysfunction syndromes which will have predictable consequences##2##10##(2008-12#2)
a number of endogenous##2##4##(1992-3#1)(2008-1#1)
a number of environmental##3##4##(2008-4#1)(2009-8#1)(2012-1#1)
a number of experimental##3##4##(1995-6#1)(1997-3#1)(2012-12#1)
a number of factors that##2##5##(1992-12#1)(2008-10#1)
a number of factors which##2##5##(1994-8#1)(1997-2#1)
a number of factors##11##4##(1992-12#1)(1994-3#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
a number of features##4##4##(1994-2#1)(1995-2#1)(1997-7#1)(2008-3#1)
a number of fluorescent##2##4##(2008-9#2)
a number of functions##2##4##(2008-11#1)(2008-3#1)
a number of genes##7##4##(1992-8#1)(1996-12#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)
a number of genetic##2##4##(2010-5#1)(2013-8#1)
a number of government##2##4##(1994-2#1)(1996-7#1)
a number of groups##3##4##(1991-12#1)(2008-11#1)(2009-1#1)
a number of human##5##4##(1993-3#1)(1993-9#1)(2008-11#1)(2008-4#1)(2009-5#1)
a number of important##10##4##(1991-3#1)(1992-9#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
a number of industrial##2##4##(1996-1#1)(2009-8#1)
a number of issues##6##4##(1995-3#1)(1997-1#1)(2008-11#2)(2008-7#1)(2013-1#1)
a number of key##6##4##(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#2)
a number of metabolites##2##4##(1996-5#1)(2012-1#1)
a number of methods##2##4##(1995-1#1)(2008-7#1)
a number of negative##2##4##(2012-1#1)(2013-8#1)
a number of new##7##4##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-10#1)
a number of nuclear##2##4##(1997-2#1)(2011-2#1)
a number of objective##2##4##(1991-6#1)(2008-10#1)
a number of other performance deficits##2##6##(1992-11#2)
a number of other##20##4##(1991-3#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1995-4#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-2#1)
a number of papers##4##4##(2008-10#3)(2012-2#1)
a number of pathways##2##4##(2009-10#1)(2013-8#1)
a number of pitfalls##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
a number of possible##7##4##(1991-3#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-9#1)
a number of potential##6##4##(1995-5#1)(1996-3#1)(2006-12#1)(2008-7#1)(2010-4#1)(2012-12#1)
a number of potentially##4##4##(1993-11#1)(2006-10#1)(2008-9#1)(2011-3#1)
a number of practical##2##4##(2008-11#1)(2008-9#1)
a number of problems##2##4##(1995-12#1)(2008-11#1)
a number of protein##2##4##(1990-8#1)(1995-2#1)
a number of proteins##2##4##(2008-11#1)(2010-12#1)
a number of psychiatric disorders##3##5##(2008-2#1)(2012-2#1)(2013-1#1)
a number of published##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
a number of reagent##2##4##(2008-10#1)(2012-2#1)
a number of reasons##6##4##(1996-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-11#1)
a number of recent studies##3##5##(1995-12#1)(2009-8#1)(2011-2#1)
a number of recent##5##4##(1992-1#1)(1995-12#1)(2009-2#1)(2009-8#1)(2011-2#1)
a number of recommendations##3##4##(2008-11#2)(2008-9#1)
a number of reports##3##4##(2007-8#1)(2008-11#1)(2008-7#1)
a number of research##2##4##(1992-12#1)(2011-2#1)
a number of samples##2##4##(2008-10#2)
a number of secondary##2##4##(1994-5#1)(2008-3#1)
a number of significant##3##4##(2008-11#1)(2008-4#1)(2008-9#1)
a number of single##2##4##(1994-3#1)(1996-12#1)
a number of small##4##4##(2007-11#1)(2007-12#2)(2008-10#1)
a number of sources##2##4##(1993-12#1)(2008-12#1)
a number of species##4##4##(1993-2#2)(1995-12#1)(2008-2#1)
a number of specific##3##4##(2008-11#1)(2008-3#2)
a number of steps##2##4##(2007-10#1)(2008-10#1)
a number of strategies##2##4##(1997-2#1)(2008-11#1)
a number of studies have##3##5##(2008-11#1)(2008-9#1)(2012-12#1)
a number of studies##8##4##(1995-2#1)(1997-1#1)(2008-11#1)(2008-7#3)(2008-9#1)(2012-12#1)
a number of such##2##4##(2008-11#1)(2011-1#1)
a number of test##2##4##(2008-10#2)
a number of the##6##4##(1993-3#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-8#1)
a number of these issues##2##5##(2008-4#2)
a number of these##4##4##(2008-10#2)(2008-4#2)
a number of tissues including##2##5##(2008-11#2)
a number of tissues##3##4##(1990-11#1)(2008-11#2)
a number of unique##2##4##(1997-4#1)(2008-7#1)
a number of useful##2##4##(2008-2#1)(2008-3#1)
a number of variables##2##4##(2008-10#1)(2008-9#1)
a number of viral##2##4##(1995-2#1)(1997-4#1)
a number of virulence##2##4##(2008-10#1)(2009-2#1)
a number of viruses##2##4##(1995-9#1)(2013-1#1)
a number of wards used no measurement instruments at all##2##10##(2013-1#2)
a number of wards##3##4##(2008-7#1)(2013-1#2)
a number of years##5##4##(1992-1#1)(1992-12#1)(1993-3#1)(2008-2#2)
a number of##702##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-12#7)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#4)(1992-12#8)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#9)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#9)(2008-10#93)(2008-11#56)(2008-12#16)(2008-2#24)(2008-3#27)(2008-4#18)(2008-5#15)(2008-6#6)(2008-7#44)(2008-8#10)(2008-9#19)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-2#13)(2011-3#2)(2012-1#4)(2012-12#11)(2012-2#9)(2012-3#8)(2012-8#1)(2013-1#16)(2013-8#7)
a number##703##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-12#7)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#4)(1992-12#8)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#9)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#9)(2008-10#93)(2008-11#56)(2008-12#16)(2008-2#24)(2008-3#27)(2008-4#18)(2008-5#15)(2008-6#7)(2008-7#44)(2008-8#10)(2008-9#19)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-2#13)(2011-3#2)(2012-1#4)(2012-12#11)(2012-2#9)(2012-3#8)(2012-8#1)(2013-1#16)(2013-8#7)
a numeric##2##2##(1995-12#1)(2008-12#1)
a numerical analysis##3##3##(2007-12#1)(2008-3#2)
a numerical aperture of 0##8##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
a numerical aperture of##10##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
a numerical example##2##3##(1992-6#1)(2008-10#1)
a numerical model that##2##4##(2007-11#1)(2007-12#1)
a numerical model##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
a numerical simulation##5##3##(2007-12#2)(2008-3#3)
a numerical solution for##2##4##(1992-9#1)(2008-3#1)
a numerical solution##5##3##(1992-9#2)(2008-3#2)(2009-10#1)
a numerical##41##2##(1992-6#1)(1992-9#2)(2007-11#3)(2007-12#6)(2008-10#2)(2008-2#5)(2008-3#20)(2009-10#1)(2013-8#1)
a nurse and##3##3##(1991-6#1)(2008-11#1)(2010-7#1)
a nurse leader##2##3##(2008-1#1)(2012-3#1)
a nurse##16##2##(1991-6#1)(1992-3#1)(1997-2#1)(2007-11#1)(2008-1#3)(2008-11#4)(2010-7#1)(2011-1#2)(2012-3#2)
a nurse's##2##2##(1992-2#1)(2007-2#1)
a nursery##4##2##(2008-10#2)(2008-5#2)
a nursing home for the blind##2##6##(2008-7#2)
a nursing home##10##3##(1991-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(2008-7#2)(2010-10#4)
a nursing perspective##2##3##(1996-12#1)(2010-3#1)
a nursing##26##2##(1991-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-11#8)(2008-5#1)(2008-7#3)(2010-10#4)(2010-3#1)(2012-3#1)
a nutrient##6##2##(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2013-8#1)
a nutrient-rich##3##2##(2008-10#2)(2008-5#1)
a nutrition##4##2##(1992-12#1)(1993-2#1)(2012-12#1)(2012-3#1)
a nutritional##4##2##(1991-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
a nutritionally##2##2##(2008-10#1)(2008-11#1)
a nutritionist##2##2##(1991-6#1)(1993-1#1)
a nylon membrane##2##3##(1995-6#1)(2008-10#1)
a nylon##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
a nymph##2##2##(2007-12#1)(2008-8#1)
a one and a##2##4##(2007-7#1)(2008-10#1)
a one step##3##3##(2008-11#1)(2010-11#1)(2012-2#1)
a one week##2##3##(1996-9#1)(2011-1#1)
a one year follow up period##2##6##(1991-2#1)(2013-1#1)
a one year follow-up##3##4##(2013-1#1)(2013-8#2)
a one year period##4##4##(1996-2#1)(1997-4#1)(2008-12#1)(2011-2#1)
a one year##11##3##(1991-2#1)(1996-2#1)(1997-4#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
a one##28##2##(1991-2#1)(1993-12#1)(1994-8#1)(1995-10#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
a one-##2##2##(2008-3#2)
a one-day##2##2##(1994-7#1)(2008-7#1)
a one-dimensional model##3##3##(1996-4#1)(2008-3#2)
a one-dimensional sinusoidal##2##3##(2008-2#1)(2008-3#1)
a one-dimensional##33##2##(1996-4#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#15)(2008-7#1)
a one-layer##2##2##(2007-11#1)(2008-10#1)
a one-month##3##2##(2008-3#1)(2008-5#1)(2013-1#1)
a one-piece##2##2##(2008-2#1)(2008-7#1)
a one-pot##5##2##(1996-5#1)(1997-3#2)(2007-11#1)(2008-10#1)
a one-stage##2##2##(2008-7#1)(2013-8#1)
a one-step method##2##3##(2008-3#2)
a one-step process##2##3##(1995-5#1)(2008-3#1)
a one-step##9##2##(1994-2#1)(1995-5#1)(2008-10#1)(2008-3#4)(2008-4#1)(2011-1#1)
a one-to-one##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
a one-trial##2##2##(1994-3#1)(2008-7#1)
a one-way##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
a one-week##2##2##(1997-7#1)(2009-5#1)
a one-year period##3##3##(1995-3#1)(1997-1#1)(2007-7#1)
a one-year time##2##3##(2010-7#1)(2011-2#1)
a one-year##9##2##(1990-2#1)(1995-2#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-7#2)(2010-7#1)(2011-2#1)
a p##2##2##(2007-11#1)(2008-3#1)
a p120##2##2##(1990-11#1)(1996-2#1)
a p53-independent pathway##2##3##(1993-9#1)(1995-6#1)
a p53-independent##3##2##(1993-9#1)(1995-6#2)
a pH 2##4##3##(1993-8#1)(2008-10#3)
a pH 4##3##3##(2008-10#3)
a pH 5##3##3##(1990-12#1)(2008-10#2)
a pH dependent##2##3##(2008-10#1)(2009-12#1)
a pH gradient##2##3##(1994-6#1)(2008-10#1)
a pH of 8##2##4##(2008-10#1)(2009-4#1)
a pH of##9##3##(2008-10#7)(2008-6#1)(2009-4#1)
a pH optimum##3##3##(1990-2#1)(1994-5#1)(2008-9#1)
a pH range of 3##4##5##(2008-10#4)
a pH range of 5##2##5##(2008-10#2)
a pH range of 6##2##5##(2008-10#1)(2008-7#1)
a pH range of##15##4##(1991-9#1)(2008-10#12)(2008-7#1)(2012-2#1)
a pH range##21##3##(1991-9#1)(2008-10#18)(2008-7#1)(2012-2#1)
a pH sensitive##2##3##(2008-10#1)(2009-12#1)
a pH value##4##3##(2007-10#1)(2008-10#2)(2008-5#1)
a pH##74##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-9#2)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(2007-10#1)(2008-10#49)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
a pH-ISFET##2##2##(2008-10#2)
a pH-dependent##3##2##(1990-5#1)(1997-7#1)(2008-8#1)
a pH-gradient##2##2##(1990-5#1)(2008-10#1)
a pH-metric##2##2##(2008-10#2)
a pH-sensitive##5##2##(2008-10#3)(2008-5#2)
a pI of##4##3##(1990-12#1)(1992-8#1)(1995-6#1)(2008-10#1)
a pI value##3##3##(2008-6#1)(2010-8#2)
a pI##7##2##(1990-12#1)(1992-8#1)(1995-6#1)(2008-10#1)(2008-6#1)(2010-8#2)
a pK of##2##3##(1990-8#1)(1993-8#1)
a pKa value of 6##2##5##(1992-6#1)(2008-10#1)
a pKa##4##2##(1992-6#1)(1995-2#1)(2008-10#2)
a pacemaker##2##2##(1994-11#1)(2010-2#1)
a package of##2##3##(1993-3#1)(1995-6#1)
a package##3##2##(1993-3#1)(1994-8#1)(1995-6#1)
a packed bed##3##3##(2008-11#3)
a packed##9##2##(2008-10#4)(2008-11#3)(2008-7#2)
a paediatric##6##2##(2008-11#3)(2008-9#1)(2011-2#1)(2013-1#1)
a pain##6##2##(1996-12#1)(2008-11#1)(2008-4#1)(2009-12#2)(2013-1#1)
a painful##11##2##(1996-5#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2013-8#2)
a painless##7##2##(2007-7#2)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)
a paint##2##2##(2007-12#1)(2008-10#1)
a painted##2##2##(2007-12#1)(2008-3#1)
a pair of LEDs##2##4##(2008-10#2)
a pair of diffractive##2##4##(2007-11#2)
a pair of monozygotic twins##4##5##(2008-7#3)(2011-1#1)
a pair of small chromosomes##2##5##(2008-8#2)
a pair of##75##3##(1990-11#1)(1990-5#1)(1992-6#1)(1995-2#1)(1997-5#1)(1997-7#1)(2007-11#7)(2007-12#8)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#3)
a pair##76##2##(1990-11#1)(1990-5#1)(1992-6#1)(1995-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#7)(2007-12#8)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#3)
a paired##5##2##(1993-6#1)(1996-3#1)(2008-10#2)(2010-10#1)
a palette of##2##3##(2008-10#1)(2013-1#1)
a palliative care unit##2##4##(2010-2#1)(2011-2#1)
a palliative care##4##3##(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
a palliative operation##3##3##(1990-9#3)
a palliative##10##2##(1990-9#3)(1997-3#1)(2007-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
a pallidal stimulator##2##3##(2008-7#2)
a palpable mass in##2##4##(2010-3#1)(2013-1#1)
a palpable mass##4##3##(2010-3#1)(2013-1#3)
a palpable##8##2##(1990-9#1)(2010-3#1)(2011-2#1)(2013-1#4)(2013-7#1)
a pancreas##2##2##(1995-2#1)(2008-4#1)
a pancreatic##6##2##(1990-12#1)(1990-9#1)(2007-5#1)(2010-1#1)(2013-1#2)
a pandemic##5##2##(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#2)
a panel discussion on the##2##5##(2008-6#1)(2013-1#1)
a panel discussion##3##3##(2008-6#2)(2013-1#1)
a panel of monoclonal antibodies##4##5##(1990-12#1)(1991-2#1)(1993-1#1)(1995-2#1)
a panel of monoclonal##5##4##(1990-12#1)(1991-2#1)(1993-1#1)(1995-2#1)(1997-3#1)
a panel of##39##3##(1990-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#2)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
a panel##44##2##(1990-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-5#1)(1996-6#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
a panoramic##2##2##(2008-6#1)(2012-3#1)
a paper industry##2##3##(2008-10#2)
a paper##7##2##(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2012-2#1)
a papillary##2##2##(2006-12#1)(2008-10#1)
a para-phenyl##2##2##(2007-11#2)
a parabolic trajectory##2##3##(2009-9#1)(2012-12#1)
a parabolic##8##2##(2008-2#3)(2008-3#3)(2009-9#1)(2012-12#1)
a paraboloid##2##2##(2008-2#1)(2008-3#1)
a paracrine##10##2##(1992-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(2008-4#2)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
a paradigm for a##2##4##(2011-2#2)
a paradigm for##4##3##(2011-2#2)(2012-12#1)(2013-8#1)
a paradigm of##3##3##(2008-11#2)(2008-7#1)
a paradigm shift away from##2##5##(2008-9#1)(2010-4#1)
a paradigm shift in the##2##5##(2008-11#1)(2012-12#1)
a paradigm shift in##4##4##(2008-11#2)(2012-12#2)
a paradigm shift##9##3##(2008-11#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-4#1)(2012-12#2)
a paradigm shift-Part##2##3##(2008-12#2)
a paradigm##24##2##(1992-11#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#2)(2010-4#2)(2011-2#2)(2012-12#4)(2013-1#1)(2013-8#1)
a paradigmatic##2##2##(2007-12#1)(2008-7#1)
a paradox that##2##3##(2008-1#1)(2008-11#1)
a paradox##4##2##(2008-1#1)(2008-11#2)(2011-2#1)
a parallel algorithm for the##2##5##(2008-2#1)(2010-8#1)
a parallel algorithm for##3##4##(2008-2#1)(2010-8#1)(2011-2#1)
a parallel and##2##3##(1992-6#1)(1995-12#1)
a parallel comparison of##2##4##(2008-10#1)(2008-11#1)
a parallel flux##2##3##(2008-2#2)
a parallel increase in##3##4##(1994-11#1)(1994-3#1)(1995-2#1)
a parallel joint transform correlator##2##5##(2008-3#2)
a parallel##50##2##(1991-5#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
a parallelized##2##2##(2008-3#1)(2008-4#1)
a parameter for##4##3##(1994-7#1)(2008-5#1)(2008-7#2)
a parameter that##2##3##(2008-2#1)(2008-3#1)
a parameter##22##2##(1990-7#1)(1991-10#1)(1991-2#1)(1992-10#1)(1994-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
a parameterized##2##2##(1992-3#1)(2008-3#1)
a parametric##13##2##(1991-2#1)(2007-12#5)(2008-10#2)(2008-2#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
a paranoid##2##2##(1992-12#1)(1996-7#1)
a parasite of##2##3##(2008-10#2)
a parasite that##2##3##(2008-9#2)
a parasite##10##2##(1991-2#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-8#2)(2008-9#3)
a parasitic##8##2##(1996-6#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
a parasitoid##4##2##(2007-12#2)(2008-8#1)(2008-9#1)
a parathyroid##3##2##(1993-11#1)(2012-1#2)
a paraxial Gaussian##2##3##(2007-11#1)(2007-12#1)
a paraxial##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
a parent compound##2##3##(1990-7#1)(2008-8#1)
a parent in##2##3##(2008-11#1)(2010-5#1)
a parent##11##2##(1990-7#1)(1991-12#1)(1991-2#1)(1994-2#1)(2008-11#2)(2008-8#1)(2009-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
a parietal##2##2##(1992-3#1)(2012-1#1)
a parish nurse faculty practice##2##5##(2008-12#2)
a parish##3##2##(1991-12#1)(2008-12#2)
a parking##2##2##(1992-12#1)(2008-10#1)
a parkinsonian syndrome##2##3##(1991-12#1)(1996-3#1)
a part in##8##3##(1994-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-3#2)(2011-2#1)(2013-8#1)
a part of a##5##4##(1997-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
a part of complex##2##4##(1993-12#1)(2013-1#1)
a part of the##61##4##(1990-12#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#23)(2013-8#1)
a part of this##2##4##(1997-3#1)(2011-1#1)
a part of##104##3##(1990-12#2)(1991-12#3)(1991-6#1)(1992-1#2)(1992-6#1)(1992-9#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#23)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
a part##118##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-6#1)(1992-1#2)(1992-6#1)(1992-9#1)(1993-12#2)(1994-1#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#24)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
a part-time##2##2##(2008-11#1)(2011-2#1)
a partial agonist at##2##4##(1995-11#1)(1995-6#1)
a partial agonist##3##3##(1992-8#1)(1995-11#1)(1995-6#1)
a partial cDNA##5##3##(1993-6#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-6#1)
a partial deficiency##2##3##(2008-1#1)(2011-2#1)
a partial differential equation model##2##5##(2008-8#1)(2013-8#1)
a partial differential equation##3##4##(2008-7#1)(2008-8#1)(2013-8#1)
a partial explanation##2##3##(1992-9#1)(2008-1#1)
a partial hepatectomy##6##3##(1990-12#3)(1991-6#1)(1993-5#1)(1994-6#1)
a partial least squares (PLS)##2##5##(2008-10#2)
a partial least squares##3##4##(2008-10#3)
a partial least##4##3##(2008-10#4)
a partial least-squares##3##3##(2008-10#3)
a partial or##3##3##(1992-3#1)(1995-5#1)(2008-7#1)
a partial remission##5##3##(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)
a partial response##8##3##(1990-12#1)(1990-2#1)(1992-12#1)(2007-8#1)(2008-6#2)(2010-12#1)(2013-8#1)
a partial sequence of##2##4##(1996-8#1)(2010-8#1)
a partial##92##2##(1990-12#5)(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-8#3)(1995-11#1)(1995-2#3)(1995-5#3)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2013-7#1)(2013-8#4)
a partially purified##2##3##(1991-12#2)
a partially resistant cultivar##2##4##(2008-10#2)
a partially resistant##3##3##(2008-10#3)
a partially##21##2##(1991-12#2)(1992-11#1)(1993-11#2)(1994-7#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#1)
a participant##2##2##(1995-11#1)(2008-11#1)
a participatory##3##2##(1997-3#1)(2008-1#1)(2008-11#1)
a particle in##3##3##(2008-2#2)(2008-3#1)
a particle size##3##3##(2008-10#3)
a particle##21##2##(2008-10#4)(2008-2#9)(2008-3#5)(2008-7#1)(2008-8#1)(2009-6#1)
a particles##2##2##(2008-8#2)
a particular DNA##2##3##(2008-2#1)(2008-4#1)
a particular biological##2##3##(2008-4#1)(2011-3#1)
a particular case of a##2##5##(2008-2#2)
a particular case##4##3##(1991-2#1)(2008-2#2)(2008-3#1)
a particular cell##3##3##(1994-11#1)(2008-2#1)(2012-12#1)
a particular chemical##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
a particular cluster##2##3##(2008-1#1)(2008-11#1)
a particular developmental stage##2##4##(1993-9#1)(2008-8#1)
a particular example##2##3##(1995-9#1)(2010-12#1)
a particular focus##6##3##(1996-2#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2012-12#1)
a particular form of##2##4##(1993-12#1)(2008-5#1)
a particular function##2##3##(2008-11#1)(2009-9#1)
a particular gene##3##3##(1997-6#1)(2008-4#2)
a particular patient##4##3##(1992-8#2)(2009-10#1)(2010-6#1)
a particular plant##2##3##(2008-7#1)(2008-8#1)
a particular protein##3##3##(1993-8#1)(2008-1#1)(2008-4#1)
a particular region##2##3##(1994-2#1)(2012-12#1)
a particular set of##5##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
a particular stage##2##3##(1994-9#1)(2008-8#1)
a particular treatment##2##3##(2008-3#1)(2008-8#1)
a particular type of##6##4##(1991-8#1)(1993-6#1)(1994-12#1)(1997-4#1)(2008-2#1)(2012-3#1)
a particular##195##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#7)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#12)(2008-3#8)(2008-4#13)(2008-5#4)(2008-7#9)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#4)
a particularly important role##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
a particularly##22##2##(1992-2#1)(1993-12#1)(1993-5#1)(1995-3#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
a particulate##3##2##(1990-11#1)(1991-12#1)(2008-2#1)
a partir d'une##2##3##(2008-5#2)
a partir##4##2##(2008-5#4)
a partition##2##2##(2008-6#1)(2011-2#1)
a partner and##2##3##(1994-5#1)(2012-12#1)
a partner##10##2##(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a partnership agreement##2##3##(1992-3#2)
a partnership between a##2##4##(1996-3#1)(1997-2#1)
a partnership between the##2##4##(1995-3#1)(1996-3#1)
a partnership between##4##3##(1995-3#1)(1996-3#2)(1997-2#1)
a partnership##12##2##(1992-3#2)(1994-1#1)(1994-12#1)(1995-3#1)(1996-3#2)(1997-2#1)(2008-11#1)(2008-12#2)(2012-12#1)
a passive sampler##3##3##(2008-10#2)(2008-11#1)
a passive##25##2##(1995-11#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#7)(2009-7#1)(2012-12#1)
a passively Q -switched Nd##2##5##(2007-11#2)
a passively Q -switched##3##4##(2007-11#3)
a passively Q-switched##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a passively mode-locked thin-disk Yb##2##5##(2007-11#2)
a passively mode-locked##7##3##(2007-11#6)(2008-3#1)
a passively##13##2##(2007-11#9)(2007-12#1)(2008-2#1)(2008-3#2)
a past history of##3##4##(2006-10#1)(2008-12#1)(2011-2#1)
a past history##4##3##(1993-6#1)(2006-10#1)(2008-12#1)(2011-2#1)
a past##10##2##(1993-6#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
a patch##3##2##(2008-5#2)(2008-8#1)
a patchwork of##2##3##(1997-8#1)(2008-1#1)
a patchwork##3##2##(1995-6#1)(1997-8#1)(2008-1#1)
a patchy##3##2##(1991-11#1)(2008-8#1)(2008-9#1)
a patella##2##2##(2009-3#1)(2013-1#1)
a patency rate##2##3##(2007-7#1)(2007-8#1)
a patent ductus arteriosus##3##4##(1997-8#1)(2007-9#1)(2010-10#1)
a patent foramen ovale (PFO)##4##5##(1996-6#1)(2007-10#1)(2008-7#1)(2011-2#1)
a patent foramen ovale##8##4##(1996-6#1)(2007-10#2)(2007-8#1)(2008-7#2)(2009-10#1)(2011-2#1)
a patent##16##2##(1996-6#1)(1997-8#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2011-2#2)
a paternal##2##2##(1996-12#1)(2010-8#1)
a path to##4##3##(1995-11#1)(2010-11#1)(2010-3#1)(2010-4#1)
a path##7##2##(1995-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)
a pathogen is##3##3##(2008-10#2)(2011-2#1)
a pathogen of##4##3##(2008-10#4)
a pathogen##21##2##(2008-10#17)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
a pathogen's##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
a pathogenetic##4##2##(1990-3#1)(1991-3#1)(2006-12#1)(2010-11#1)
a pathogenic organism##2##3##(2007-7#1)(2013-1#1)
a pathogenic role##2##3##(2008-1#1)(2008-5#1)
a pathogenic##11##2##(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2013-1#1)(2013-8#1)
a pathogenicity factor in##2##4##(2008-10#2)
a pathogenicity factor##3##3##(2008-10#3)
a pathogenicity##4##2##(2008-10#4)
a pathologic##3##2##(1992-9#1)(2007-8#1)(2012-3#1)
a pathological fracture##4##3##(2007-11#3)(2008-12#1)
a pathological##11##2##(1990-6#3)(1995-3#1)(1996-6#1)(2007-11#3)(2008-12#1)(2011-2#1)(2011-3#1)
a pathologically##2##2##(1991-8#1)(2013-1#1)
a pathology##6##2##(1991-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
a pathophysiologic##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
a pathophysiological##2##2##(1994-9#1)(2008-3#1)
a pathway distinct from##2##4##(1993-8#1)(1994-11#1)
a pathway for##4##3##(1990-7#1)(1992-9#1)(1996-12#1)(2011-3#1)
a pathway involving##2##3##(1995-8#1)(2007-12#1)
a pathway of##3##3##(1995-6#1)(1996-12#1)(2008-7#1)
a pathway to##3##3##(1995-2#1)(2008-6#1)(2013-1#1)
a pathway##17##2##(1990-7#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1997-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-3#1)(2013-1#1)
a patient affected by##5##4##(1990-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(2008-5#1)
a patient affected##6##3##(1990-3#1)(1993-12#1)(1993-6#2)(1993-9#1)(2008-5#1)
a patient and##2##3##(1992-11#1)(2008-1#1)
a patient at##2##3##(2007-10#1)(2008-9#1)
a patient care##2##3##(1991-12#1)(1993-3#1)
a patient classification system##3##4##(1994-3#2)(1995-2#1)
a patient diagnosed##2##3##(2008-12#1)(2011-2#1)
a patient from##3##3##(2007-12#1)(2010-8#1)(2013-1#1)
a patient in whom##4##4##(1993-2#1)(1994-11#1)(2007-8#1)(2008-7#1)
a patient in##6##3##(1993-2#1)(1994-11#1)(1994-3#1)(2007-8#1)(2008-4#1)(2008-7#1)
a patient is##4##3##(1992-9#1)(1996-9#1)(2008-9#1)(2012-2#1)
a patient lacking##2##3##(1993-6#1)(1995-6#1)
a patient of##7##3##(1990-12#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
a patient on##4##3##(2008-1#1)(2008-5#1)(2010-5#1)(2013-8#1)
a patient or##2##3##(2007-11#1)(2012-12#1)
a patient pT3##2##3##(2011-2#2)
a patient presenting with##5##4##(2008-12#2)(2008-4#1)(2011-2#2)
a patient presenting##7##3##(2008-12#2)(2008-4#1)(2010-5#1)(2011-2#2)(2012-3#1)
a patient presents##2##3##(2008-7#1)(2009-3#1)
a patient satisfaction survey##2##4##(2008-12#2)
a patient suffering from primary aldosteronism##2##6##(1990-11#2)
a patient suffering from##3##4##(1990-11#2)(2013-8#1)
a patient suffering##4##3##(1990-11#2)(2007-2#1)(2013-8#1)
a patient to##5##3##(1990-6#1)(1992-11#1)(1993-1#1)(1995-3#1)(2012-12#1)
a patient treated##6##3##(1990-6#1)(1991-11#1)(1996-3#1)(2007-2#1)(2008-10#2)
a patient undergoing##2##3##(2007-8#1)(2010-5#1)
a patient who developed a##2##5##(1993-8#1)(2008-12#1)
a patient who developed##10##4##(1993-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
a patient who had##5##4##(1991-3#1)(1993-8#1)(1995-3#1)(2006-10#1)(2011-1#1)
a patient who has##2##4##(2010-5#1)(2011-1#1)
a patient who is##2##4##(2010-5#1)(2013-1#1)
a patient who presented with##3##5##(2008-4#1)(2010-8#1)(2011-2#1)
a patient who underwent##3##4##(2007-8#1)(2008-6#1)(2013-1#1)
a patient who##37##3##(1990-9#1)(1991-3#1)(1993-3#1)(1993-8#2)(1993-9#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
a patient with AIDS and##2##5##(2008-11#1)(2009-2#1)
a patient with AIDS##7##4##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-2#1)
a patient with HIV##2##4##(1995-12#1)(2010-12#1)
a patient with a short##2##5##(1991-12#1)(2012-2#1)
a patient with a##34##4##(1990-3#1)(1991-12#1)(1992-2#1)(1992-9#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#2)
a patient with abdominal##2##4##(2008-7#1)(2011-1#1)
a patient with acute##6##4##(1994-12#1)(2007-4#1)(2008-5#2)(2009-6#1)(2013-1#1)
a patient with an##10##4##(2007-6#1)(2007-8#1)(2008-7#2)(2008-9#1)(2009-11#1)(2013-1#4)
a patient with apolipoprotein##2##4##(1991-12#1)(1993-6#1)
a patient with chronic##9##4##(1991-11#1)(2006-10#1)(2007-10#1)(2008-12#2)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
a patient with elevated##2##4##(2006-10#1)(2007-8#1)
a patient with end-stage renal disease##2##6##(2008-1#2)
a patient with end-stage renal##3##5##(2008-1#2)(2013-1#1)
a patient with essential##2##4##(1992-6#1)(1997-7#1)
a patient with hereditary##3##4##(2008-12#2)(2012-3#1)
a patient with known##2##4##(2008-10#1)(2012-12#1)
a patient with malignant##2##4##(2011-3#1)(2013-7#1)
a patient with multiple endocrine abnormalities##2##6##(2009-4#2)
a patient with multiple##5##4##(1992-12#1)(1993-12#1)(1997-8#1)(2009-4#2)
a patient with no##2##4##(2009-5#1)(2011-2#1)
a patient with recurrent##3##4##(2007-7#1)(2008-9#1)(2013-1#1)
a patient with refractory##2##4##(1990-3#1)(2006-12#1)
a patient with this##2##4##(2007-10#1)(2008-11#1)
a patient with type##2##4##(2008-7#1)(2013-1#1)
a patient with ulcerative colitis##3##5##(2007-10#1)(2010-12#1)(2012-12#1)
a patient with##273##3##(1990-12#3)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#8)(2006-12#2)(2007-10#10)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#8)(2007-8#10)(2008-1#6)(2008-10#6)(2008-11#9)(2008-12#13)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#19)(2008-8#3)(2008-9#3)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#18)(2013-1#20)(2013-7#3)(2013-8#7)
a patient##452##2##(1990-11#2)(1990-12#4)(1990-3#4)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#4)(1991-11#3)(1991-12#3)(1991-3#1)(1991-8#1)(1992-11#4)(1992-12#1)(1992-2#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#5)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#10)(2006-12#2)(2007-10#13)(2007-11#4)(2007-12#5)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#10)(2007-8#19)(2008-1#10)(2008-10#9)(2008-11#13)(2008-12#20)(2008-4#6)(2008-5#5)(2008-6#7)(2008-7#26)(2008-8#5)(2008-9#6)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-5#7)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#26)(2011-3#1)(2012-12#14)(2012-2#9)(2012-3#21)(2013-1#26)(2013-7#3)(2013-8#12)
a patient's clinical##2##3##(2009-5#1)(2012-3#1)
a patient's right to##2##4##(1991-2#1)(1993-3#1)
a patient's risk##2##3##(2008-10#1)(2012-3#1)
a patient's view of##2##4##(1991-1#1)(2008-8#1)
a patient's##42##2##(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#2)(1993-12#3)(1993-3#1)(1994-1#2)(1994-12#1)(1996-7#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#2)(2012-1#1)(2012-3#5)(2013-1#1)(2013-8#1)
a patient-based##3##2##(1993-12#1)(2008-3#1)(2011-2#1)
a patient-specific##2##2##(1995-12#1)(2010-3#1)
a pattern of##17##3##(1991-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-6#1)(2012-12#1)(2013-1#1)
a pattern similar to##3##4##(1996-12#1)(2008-10#2)
a pattern that is##2##4##(2008-10#1)(2008-9#1)
a pattern that##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
a pattern##37##2##(1991-3#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-6#2)(2012-12#2)(2013-1#1)
a pattern-recognition##2##2##(2008-3#1)(2009-11#1)
a patterned##3##2##(2007-12#1)(2008-7#1)(2009-12#1)
a paucity of##17##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
a pause##2##2##(2007-12#1)(2008-7#1)
a payment model##2##3##(1993-12#1)(1994-3#1)
a payment##3##2##(1993-12#1)(1993-3#1)(1994-3#1)
a peak at##7##3##(1990-2#1)(1992-6#1)(1994-6#1)(2008-10#3)(2009-12#1)
a peak in the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
a peak in##6##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
a peak intensity of##2##4##(2007-11#1)(2007-12#1)
a peak intensity##3##3##(2007-11#2)(2007-12#1)
a peak level##2##3##(1994-2#1)(1996-12#1)
a peak of##2##3##(2008-11#1)(2008-7#1)
a peak on PND##2##4##(1993-11#2)
a peak on##3##3##(1993-11#2)(2008-7#1)
a peak power of &gt##2##5##(2007-11#1)(2007-12#1)
a peak power of 3##2##5##(2007-11#1)(2007-12#1)
a peak power of##8##4##(2007-11#4)(2007-12#3)(2008-3#1)
a peak reflectivity##2##3##(2007-12#2)
a peak##59##2##(1990-2#1)(1991-12#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-6#1)(1994-2#1)(1994-6#1)(1996-12#2)(1997-3#1)(2007-10#1)(2007-11#11)(2007-12#7)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#2)(2009-12#1)(2012-12#1)(2013-8#1)
a peanut allergen##2##3##(2008-10#1)(2008-11#1)
a pearlescent##2##2##(2008-5#2)
a peculiar pattern##2##3##(2008-10#1)(2008-6#1)
a peculiar##9##2##(1990-10#1)(1992-8#2)(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-2#1)
a pedagogical##2##2##(2008-11#1)(2008-12#1)
a pedestal-free pulse compressor##2##4##(2007-11#2)
a pediatric hospital##2##3##(1991-9#1)(2010-10#1)
a pediatric patient with##2##4##(2007-8#1)(2011-2#1)
a pediatric patient##4##3##(2007-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
a pediatric##21##2##(1991-11#1)(1991-9#1)(1992-2#1)(1993-2#1)(1995-11#1)(1995-12#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
a pedicled##2##2##(2007-8#1)(2008-9#1)
a pedunculated##2##2##(1993-9#1)(2008-8#1)
a peer review##2##3##(1991-1#1)(2008-12#1)
a peer##4##2##(1991-1#1)(1994-5#1)(2008-12#1)(2009-5#1)
a pelleted ration##2##3##(2011-1#2)
a pelleted##3##2##(2009-4#1)(2011-1#2)
a pelvic bone##2##3##(1991-2#1)(2008-6#1)
a pelvic mass##2##3##(2008-12#1)(2013-1#1)
a pelvic##8##2##(1991-2#1)(2008-12#1)(2008-6#3)(2012-1#1)(2013-1#2)
a pendant##2##2##(2009-10#1)(2010-2#1)
a pending##2##2##(1996-6#1)(2009-4#1)
a penetrating##3##2##(2007-10#1)(2010-12#1)(2013-1#1)
a penetration##2##2##(1996-1#1)(2008-10#1)
a pepper##3##2##(2008-10#3)
a peptide bond##2##3##(1990-12#1)(2008-10#1)
a peptide corresponding to##4##4##(1991-12#1)(1991-5#1)(1992-3#1)(2010-11#1)
a peptide fragment##3##3##(1992-6#1)(1994-11#1)(1997-8#1)
a peptide inhibitor##2##3##(2008-11#1)(2009-6#1)
a peptide is##2##3##(2008-6#1)(2008-8#1)
a peptide of##5##3##(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
a peptide sequence##2##3##(1992-11#1)(2008-10#1)
a peptide that##2##3##(1992-8#1)(2006-6#1)
a peptide with a##2##4##(2008-10#1)(2010-1#1)
a peptide with##3##3##(1994-6#1)(2008-10#1)(2010-1#1)
a peptide##49##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#1)(2012-2#1)
a per cell##2##3##(2008-4#1)(2008-7#1)
a per##11##2##(1992-1#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)
a per-hospital basis##2##3##(1996-12#2)
a perceived##5##2##(1995-1#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
a percent##5##2##(1992-11#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
a percentage of##13##3##(1993-12#1)(1996-2#1)(2008-10#3)(2008-11#4)(2010-8#2)(2011-7#1)(2013-1#1)
a percentage##16##2##(1991-1#1)(1993-12#1)(1996-2#1)(2008-10#3)(2008-11#4)(2010-8#2)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#1)
a perception that##2##3##(1992-2#1)(2009-2#1)
a perception##5##2##(1992-2#1)(1994-3#1)(2008-4#1)(2009-2#1)(2012-12#1)
a perchlorate##2##2##(2008-10#2)
a percutaneous technique##2##3##(2012-3#2)
a percutaneous##9##2##(1993-5#1)(2008-10#1)(2008-4#2)(2010-6#1)(2012-2#2)(2012-3#2)
a perennial canker##2##3##(2008-10#2)
a perennial##6##2##(2008-10#4)(2008-12#1)(2012-7#1)
a perfect conductor##2##3##(2008-3#2)
a perfect match to the##2##5##(1996-6#1)(1996-8#1)
a perfect match to##3##4##(1990-5#1)(1996-6#1)(1996-8#1)
a perfect sinusoidal##2##3##(2008-3#2)
a perfect##22##2##(1990-3#1)(1990-5#1)(1995-3#1)(1996-6#1)(1996-8#2)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#8)(2008-7#1)(2010-4#1)
a perfectly aligned##2##3##(2008-2#2)
a perfectly matched layer absorbing boundary condition##2##7##(2008-3#2)
a perfectly matched layer##3##4##(2008-3#2)(2013-7#1)
a perfectly##8##2##(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2013-7#1)
a perforated##2##2##(2010-4#1)(2011-2#1)
a perforation##3##2##(1991-3#1)(2007-8#1)(2011-2#1)
a performance##14##2##(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#6)(2010-12#1)(2013-1#1)
a perfusion bioreactor##2##3##(2008-11#2)
a perfusion cultivation of a recombinant##2##6##(2008-11#2)
a perfusion##9##2##(1991-12#1)(2008-10#2)(2008-11#6)
a perimesencephalic pattern##2##3##(2007-10#1)(2008-7#1)
a perimesencephalic##5##2##(2007-10#3)(2008-7#2)
a perinatal##4##2##(1994-3#1)(2007-2#1)(2007-4#1)(2011-2#1)
a perineal##2##2##(1992-6#1)(2011-2#1)
a period of 1##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
a period of 10##7##4##(1994-12#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
a period of 11##2##4##(2008-10#1)(2008-7#1)
a period of 14 days##2##5##(1990-9#1)(2008-10#1)
a period of 15 years##2##5##(1990-8#1)(1992-12#1)
a period of 15##3##4##(1990-8#1)(1992-12#1)(2012-2#1)
a period of 16 years##2##5##(1991-6#1)(1997-8#1)
a period of 2 years##2##5##(2008-10#1)(2008-7#1)
a period of 2##3##4##(1991-2#1)(2008-10#1)(2008-7#1)
a period of 20 years##2##5##(1995-11#1)(1997-8#1)
a period of 20##3##4##(1995-11#1)(1997-8#1)(2008-3#1)
a period of 24 h##4##5##(1997-2#1)(2008-10#2)(2010-11#1)
a period of 3 months with good reproducibility##2##8##(2008-10#2)
a period of 3 months##3##5##(2008-10#2)(2009-8#1)
a period of 3 years##2##5##(2008-10#1)(2008-2#1)
a period of 3##7##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-8#1)
a period of 30##4##4##(1994-8#1)(1997-8#1)(2008-10#1)(2013-1#1)
a period of 4##4##4##(1991-3#1)(2008-10#3)
a period of 5 months##3##5##(1991-2#1)(2008-10#2)
a period of 5##5##4##(1991-2#1)(1997-2#1)(2008-10#2)(2008-7#1)
a period of 6 months##2##5##(2008-10#2)
a period of 6##6##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)
a period of 7##2##4##(1992-3#1)(1995-3#1)
a period of about##2##4##(1991-2#1)(2008-6#1)
a period of approximately 8 months##2##6##(1991-2#1)(2008-11#1)
a period of at least##3##5##(1990-12#2)(2008-10#1)
a period of five years##3##5##(1997-5#1)(2008-1#1)(2009-2#1)
a period of five##4##4##(1995-1#1)(1997-5#1)(2008-1#1)(2009-2#1)
a period of four months##3##5##(1997-5#1)(2007-8#1)(2011-2#1)
a period of four##4##4##(1991-6#1)(1997-5#1)(2007-8#1)(2011-2#1)
a period of growth##2##4##(1996-3#1)(2008-10#1)
a period of less than##2##5##(1997-2#1)(2008-2#1)
a period of nine months##2##5##(2007-7#1)(2008-9#1)
a period of one month##5##5##(1993-6#1)(2008-10#2)(2008-9#1)(2013-1#1)
a period of one year##5##5##(1997-6#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-3#1)
a period of one##10##4##(1993-6#1)(1997-6#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
a period of six months##4##5##(1990-12#1)(2007-7#1)(2008-4#1)(2008-6#1)
a period of six##6##4##(1990-12#1)(1991-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2013-7#1)
a period of stable disease##2##5##(2008-6#2)
a period of ten years##2##5##(1992-11#1)(1996-9#1)
a period of three months##2##5##(2008-1#1)(2008-11#1)
a period of three##4##4##(1990-6#1)(1996-6#1)(2008-1#1)(2008-11#1)
a period of time##11##4##(1990-8#1)(1993-8#1)(1996-1#1)(1997-4#1)(2008-11#5)(2009-11#1)(2013-8#1)
a period of two months##3##5##(2008-10#1)(2008-2#1)(2009-11#1)
a period of two weeks##2##5##(2008-4#1)(2008-8#1)
a period of two years##3##5##(1991-12#1)(2007-8#1)(2008-1#1)
a period of two##8##4##(1991-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)
a period of##173##3##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#30)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#7)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
a period##188##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#4)(1995-5#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#30)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#7)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
a periodic cycle##2##3##(2008-10#2)
a periodic structure##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a periodic##17##2##(1996-12#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-2#2)(2008-3#3)(2011-1#1)
a periodically interrupted##2##3##(1996-12#1)(2008-10#1)
a periodically poled LiNbO(3) crystal##2##5##(2007-11#1)(2007-12#1)
a periodically poled LiNbO(3)##4##4##(2007-11#1)(2007-12#3)
a periodically poled lithium niobate (PPLN)##2##6##(2007-12#2)
a periodically poled lithium niobate##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
a periodically poled##16##3##(2007-11#5)(2007-12#10)(2008-3#1)
a periodically##23##2##(1996-12#1)(2007-11#6)(2007-12#12)(2008-10#2)(2008-3#2)
a peripheral halo of##2##4##(2006-10#2)
a peripheral neuropathy##3##3##(1991-12#1)(2008-7#2)
a peripheral##17##2##(1990-8#3)(1991-12#1)(1992-11#1)(1993-11#1)(1996-12#1)(2006-10#2)(2007-10#1)(2008-4#1)(2008-7#3)(2010-5#1)(2011-2#2)
a peripherally inserted##2##3##(2007-7#1)(2009-4#1)
a peristaltic pump##7##3##(2008-10#6)(2008-11#1)
a peristaltic##8##2##(2008-10#7)(2008-11#1)
a peritoneal dialysis##3##3##(2007-12#2)(2007-7#1)
a peritoneal##6##2##(1991-8#1)(2007-12#2)(2007-7#1)(2011-2#1)(2012-12#1)
a permanent access site##2##4##(2007-7#2)
a permanent chemical##4##3##(2008-10#4)
a permanent increase in##2##4##(1993-2#1)(2008-7#1)
a permanent##39##2##(1992-4#2)(1992-5#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-7#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#3)(2008-9#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)
a permeabilizing agent##2##3##(1994-11#2)
a permeable membrane##2##3##(2006-6#1)(2008-11#1)
a permis une##2##3##(2013-1#2)
a permis##3##2##(2013-1#3)
a permissive##5##2##(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
a permutation##2##2##(2008-10#1)(2012-1#1)
a peroxidase##2##2##(1994-5#1)(2008-10#1)
a peroxisomal##2##2##(1990-12#1)(1991-12#1)
a perpendicular##3##2##(1997-7#1)(2008-3#1)(2008-6#1)
a persistent increase##2##3##(1996-12#1)(2008-8#1)
a persistent##28##2##(1990-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-10#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2013-1#1)
a persistently##3##2##(1992-9#1)(1997-8#1)(2011-1#1)
a person who##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2012-12#1)
a person with##6##3##(1993-6#1)(1996-8#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-12#1)
a person##27##2##(1991-12#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2013-8#2)
a person's##11##2##(1991-6#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
a personal computer##10##3##(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2010-8#1)
a personal or##2##3##(1991-2#1)(2007-10#1)
a personal perspective##3##3##(2008-12#1)(2008-4#1)(2013-1#1)
a personal reflection on##2##4##(1996-12#1)(2008-11#1)
a personal reflection##3##3##(1996-12#1)(2008-1#1)(2008-11#1)
a personal##39##2##(1990-2#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#3)(2013-1#1)
a personalised##2##2##(2007-6#1)(2012-12#1)
a personalized##3##2##(2008-6#1)(2008-8#1)(2010-12#1)
a personnel##2##2##(1994-1#1)(1995-3#1)
a perspective from##2##3##(2008-11#1)(2008-7#1)
a perspective of the##2##4##(2010-3#1)(2010-5#1)
a perspective of##6##3##(1994-3#1)(2007-12#1)(2008-1#1)(2010-3#1)(2010-5#1)(2010-7#1)
a perspective on##4##3##(2008-10#1)(2010-10#1)(2010-11#1)(2011-2#1)
a perspective##19##2##(1994-3#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)
a pertinent##3##2##(1997-2#1)(2008-7#1)(2010-3#1)
a perturbation of##3##3##(1994-5#1)(1994-8#1)(2009-8#1)
a perturbation##8##2##(1991-8#1)(1994-5#1)(1994-8#1)(2008-2#1)(2008-3#3)(2009-8#1)
a perturbed##2##2##(2008-3#1)(2009-8#1)
a pervasive##7##2##(1995-2#1)(2008-12#1)(2008-3#1)(2009-8#1)(2012-3#1)(2013-1#2)
a pesticide##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
a pet##2##2##(1993-2#1)(2010-4#1)
a petrous##2##2##(2010-3#2)
a phage lambda genomic DNA library##2##6##(1994-12#1)(1997-2#1)
a phage##5##2##(1994-12#2)(1997-2#1)(2008-4#1)(2010-12#1)
a phagocytic##2##2##(1996-12#1)(2008-7#1)
a phantom tissue##2##3##(2009-11#2)
a phantom##9##2##(1994-3#1)(2008-10#1)(2008-3#2)(2009-11#3)(2011-1#1)(2012-12#1)
a pharmaceutical safety culture##2##4##(2008-8#2)
a pharmaceutical##11##2##(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#2)
a pharmacodynamic##4##2##(2008-5#2)(2008-7#1)(2011-2#1)
a pharmacokinetic##5##2##(2007-11#1)(2008-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
a pharmacological treatment##2##3##(2008-1#1)(2012-3#1)
a pharmacological##7##2##(1990-9#1)(1993-6#1)(1995-12#1)(2008-1#1)(2008-4#1)(2012-3#2)
a pharmacy##3##2##(1993-11#1)(1993-3#1)(2013-1#1)
a phase I##3##3##(2008-5#2)(2011-2#1)
a phase II study##6##4##(1991-2#1)(1991-4#1)(1993-6#1)(1994-2#1)(1995-10#1)(2008-6#1)
a phase II trial of##2##5##(1992-10#1)(2008-5#1)
a phase II trial##3##4##(1992-10#1)(2008-5#2)
a phase II##14##3##(1990-12#1)(1991-2#2)(1991-4#1)(1992-10#1)(1993-6#1)(1994-2#1)(1995-10#1)(2007-7#1)(2008-5#2)(2008-6#2)(2008-7#1)
a phase III##4##3##(2007-7#1)(2008-3#1)(2008-5#2)
a phase change##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
a phase grating##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a phase mask##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
a phase modulator##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
a phase object##2##3##(2008-3#2)
a phase of##3##3##(2008-3#1)(2012-2#1)(2012-9#1)
a phase plate##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
a phase separation##3##3##(2008-10#2)(2008-5#1)
a phase shift##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a phase shifter##2##3##(2008-3#2)
a phase##86##2##(1990-12#1)(1991-2#2)(1991-4#1)(1992-10#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-10#1)(1997-4#1)(1997-6#3)(2007-11#11)(2007-12#6)(2007-7#3)(2008-10#3)(2008-2#12)(2008-3#21)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)
a phase-coherent##2##2##(2007-12#1)(2008-2#1)
a phase-conjugate mirror##4##3##(2007-12#1)(2008-2#3)
a phase-conjugate##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
a phase-conjugated##2##2##(2008-2#1)(2008-3#1)
a phase-error##2##2##(2007-12#1)(2008-2#1)
a phase-locked loop##2##3##(2007-12#1)(2008-3#1)
a phase-matched##2##2##(2007-11#1)(2007-12#1)
a phase-modulated##3##2##(2008-2#1)(2008-3#2)
a phase-only filter##2##3##(2008-3#2)
a phase-only liquid-crystal spatial light modulator##2##6##(2008-3#2)
a phase-only##9##2##(2008-2#1)(2008-3#8)
a phase-resolved functional optical coherence tomography##2##6##(2007-11#2)
a phase-resolved##3##2##(2007-11#2)(2011-1#1)
a phase-retrieval##2##2##(2008-3#2)
a phase-shift##3##2##(1993-12#1)(2008-2#1)(2008-3#1)
a phase-shifting technique##3##3##(2008-3#3)
a phase-shifting##12##2##(2008-2#3)(2008-3#9)
a phase-stepping##4##2##(2008-2#2)(2008-3#2)
a phase-unwrapping##2##2##(2008-3#2)
a phased##2##2##(1995-3#1)(2008-3#1)
a phenol##2##2##(1990-12#1)(2008-10#1)
a phenolic##3##2##(1996-5#1)(2008-5#1)(2012-2#1)
a phenomenological approach##3##3##(2007-11#1)(2008-2#2)
a phenomenological##9##2##(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#1)
a phenomenon called##2##3##(1994-11#1)(2008-7#1)
a phenomenon known as##3##4##(1996-7#1)(2008-10#1)(2011-2#1)
a phenomenon not##2##3##(1994-8#1)(2011-2#1)
a phenomenon that has##2##4##(2008-8#1)(2012-2#1)
a phenomenon that is##3##4##(2008-3#1)(2011-2#2)
a phenomenon that##8##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
a phenomenon##28##2##(1994-11#1)(1994-8#2)(1996-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-7#1)
a phenotype that##2##3##(2007-12#1)(2012-3#1)
a phenotype##12##2##(1992-10#1)(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-3#2)
a phenotypic assay##2##3##(2008-10#2)
a phenotypic##7##2##(1996-12#1)(2008-10#4)(2008-8#1)(2008-9#1)
a phenyl group##3##3##(1995-3#1)(2008-10#2)
a phenyl##6##2##(1995-3#1)(1996-5#1)(2008-10#3)(2008-4#1)
a philosophical##2##2##(2008-10#1)(2008-7#1)
a phloem-limited##2##2##(2008-10#2)
a phonological##3##2##(2008-4#1)(2010-1#1)(2012-12#1)
a phosphatase##2##2##(1994-11#1)(1995-6#1)
a phosphate buffer at##2##4##(2008-10#2)
a phosphate buffer##7##3##(2008-10#7)
a phosphate oxygen##2##3##(1993-11#1)(1993-8#1)
a phosphate##11##2##(1993-11#1)(1993-8#1)(2008-10#9)
a phosphodiesterase inhibitor##3##3##(1992-3#1)(2008-5#2)
a phosphodiesterase##4##2##(1992-3#1)(1997-7#1)(2008-5#2)
a phospholipase C##3##3##(1990-12#1)(1993-3#1)(1994-11#1)
a phospholipase##5##2##(1990-12#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)
a phospholipid##3##2##(1990-5#1)(1992-11#1)(2008-11#1)
a phosphor##3##2##(2008-10#2)(2008-4#1)
a phosphorothioate##2##2##(2008-10#1)(2008-4#1)
a phosphorylation event##2##3##(1992-8#1)(2008-8#1)
a photo-diode##5##2##(2008-10#5)
a photoacoustic##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
a photochemical reaction##4##3##(2008-10#3)(2008-3#1)
a photochemical##5##2##(1992-3#1)(2008-10#3)(2008-3#1)
a photoconductive##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a photodetector##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
a photodiode array detector was##2##5##(2008-10#2)
a photodiode array detector##6##4##(2008-10#6)
a photodiode array##7##3##(2008-10#7)
a photodiode##12##2##(2008-10#10)(2008-3#2)
a photoelastic##2##2##(2007-12#1)(2008-3#1)
a photograph##2##2##(2012-2#2)
a photographic##9##2##(2008-10#8)(2008-3#1)
a photolithographic technique##2##3##(2007-12#1)(2008-10#1)
a photolithographic##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
a photometric##6##2##(2008-10#5)(2008-3#1)
a photomultiplier tube##2##3##(2008-10#1)(2008-7#1)
a photomultiplier##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)
a photon counting##2##3##(2008-10#1)(2013-1#1)
a photon flux##2##3##(2008-10#1)(2008-3#1)
a photon##12##2##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#1)
a photon-counting##2##2##(2008-10#1)(2008-3#1)
a photonic bandgap##4##3##(2007-11#1)(2007-12#3)
a photonic crystal fiber##3##4##(2007-12#3)
a photonic crystal##7##3##(2007-11#2)(2007-12#5)
a photonic##17##2##(2007-11#5)(2007-12#8)(2008-2#1)(2008-3#3)
a photonic-crystal##3##2##(2007-11#3)
a photoperiod of##4##3##(2008-11#1)(2011-2#3)
a photoperiod##5##2##(2008-11#1)(2010-8#1)(2011-2#3)
a photopolymer film##2##3##(2007-12#2)
a photopolymer##6##2##(2007-12#3)(2008-3#3)
a photoreactive##3##2##(1990-11#1)(1993-11#1)(1994-8#1)
a photorefractive GaP crystal##2##4##(2007-11#2)
a photorefractive LiNbO(3)##2##3##(2007-12#1)(2008-3#1)
a photorefractive crystal##16##3##(2007-11#1)(2007-12#7)(2008-2#3)(2008-3#5)
a photorefractive material##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a photorefractive medium##3##3##(2008-2#2)(2008-3#1)
a photorefractive polymer##3##3##(2007-11#2)(2008-3#1)
a photorefractive##43##2##(2007-11#7)(2007-12#15)(2008-2#7)(2008-3#14)
a photoresist##3##2##(2008-2#2)(2008-7#1)
a photosensitive##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
a photosensitivity disorder##2##3##(2008-5#1)(2010-6#1)
a photosensitizer##4##2##(2008-8#2)(2012-3#2)
a photosynthetic##2##2##(1994-5#1)(2008-6#1)
a photothermal##2##2##(2008-2#1)(2008-3#1)
a photothermorefractive##2##2##(2007-12#1)(2008-2#1)
a phylogenetic analysis of##2##4##(1996-6#1)(2007-12#1)
a phylogenetic analysis##4##3##(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#1)
a phylogenetic approach##2##3##(2008-8#1)(2010-3#1)
a phylogenetic perspective##2##3##(1993-5#1)(2007-12#1)
a phylogenetic tree##10##3##(1991-5#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-10#1)(2010-6#1)(2013-1#1)
a phylogenetic##24##2##(1991-5#1)(1993-5#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-12#3)(2007-6#1)(2008-10#4)(2008-4#2)(2008-8#3)(2009-10#1)(2009-2#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)
a phylogenetically##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
a phylogenomic##3##2##(2009-10#1)(2012-3#2)
a phylogeny##3##2##(2008-10#1)(2008-9#2)
a physical activity##2##3##(2008-11#1)(2012-12#1)
a physical examination##2##3##(1990-6#1)(2012-3#1)
a physical map of the##2##5##(2008-10#1)(2011-2#1)
a physical map of##4##4##(1996-10#1)(1997-2#1)(2008-10#1)(2011-2#1)
a physical map##5##3##(1996-10#2)(1997-2#1)(2008-10#1)(2011-2#1)
a physical model##4##3##(1996-4#1)(2007-12#2)(2008-3#1)
a physical stimulus##2##3##(1996-12#1)(1997-2#1)
a physical therapy##2##3##(2008-12#2)
a physical##40##2##(1990-6#1)(1990-7#1)(1992-3#1)(1992-6#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-4#1)(1997-2#2)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#6)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#3)(2012-3#1)
a physically##5##2##(1992-12#1)(2007-12#1)(2008-3#1)(2009-12#1)(2009-8#1)
a physician and##7##3##(1995-6#1)(1996-12#1)(2007-7#1)(2008-1#1)(2009-6#1)(2010-1#1)(2012-3#1)
a physician or hospital##2##4##(1991-3#1)(1995-12#1)
a physician##31##2##(1990-6#1)(1991-1#2)(1991-3#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#2)(2012-3#1)(2013-1#1)
a physician's office##2##3##(1990-11#1)(1994-3#1)
a physician's##6##2##(1990-11#1)(1992-12#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-2#1)
a physicians'##2##2##(1993-1#1)(2008-10#1)
a physiologic role in##2##4##(1993-8#1)(1995-2#1)
a physiologic role##4##3##(1993-8#1)(1995-2#1)(2008-4#2)
a physiologic##7##2##(1990-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2008-4#2)(2011-2#1)
a physiological response to##2##4##(1990-11#1)(1995-2#1)
a physiological response##3##3##(1990-11#1)(1995-2#1)(2011-2#1)
a physiological role for##3##4##(1990-12#1)(1993-8#1)(1994-11#1)
a physiological role in the##2##5##(1997-4#1)(2008-4#1)
a physiological role in##4##4##(1994-8#1)(1997-4#1)(2008-4#1)(2009-8#1)
a physiological role##9##3##(1990-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)
a physiological##28##2##(1990-11#1)(1990-12#2)(1991-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
a physiologically compatible pH of approximately 7##2##7##(2011-2#2)
a physiologically inert##2##3##(1995-2#1)(2008-5#1)
a physiologically##6##2##(1990-8#1)(1995-2#1)(1996-5#1)(2008-5#1)(2011-2#2)
a physiotherapist##3##2##(2007-8#1)(2009-3#1)(2013-1#1)
a phytoalexin##2##2##(2008-10#2)
a phytoplasma##2##2##(2008-10#2)
a pi phase shift##2##4##(2008-2#2)
a pi phase##3##3##(2007-12#1)(2008-2#2)
a pi##4##2##(2007-12#2)(2008-2#2)
a pi/2##2##2##(2007-11#1)(2008-2#1)
a picosecond##7##2##(2007-11#3)(2007-12#3)(2008-2#1)
a picosecond-laser-irradiated##2##2##(2007-11#1)(2007-12#1)
a picrate##2##2##(2008-10#2)
a pictorial essay##2##3##(2012-2#2)
a pictorial review##5##3##(2011-2#1)(2012-2#4)
a pictorial##8##2##(2009-9#1)(2011-2#1)(2012-2#6)
a picture of the##4##4##(1993-8#1)(1996-3#1)(2008-1#1)(2008-7#1)
a picture of##11##3##(1993-8#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-8#1)(2012-1#1)(2013-8#1)
a picture##12##2##(1993-8#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
a piece of##9##3##(1993-6#1)(1997-3#3)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#2)
a piecewise##2##2##(1991-5#1)(1995-12#1)
a piezoelectric crystal##2##3##(2008-10#2)
a piezoelectric quartz crystal is##2##5##(2008-10#2)
a piezoelectric quartz##3##3##(2008-10#3)
a piezoelectric transducer##8##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
a piezoelectric##24##2##(1990-8#1)(2007-12#3)(2008-10#9)(2008-2#2)(2008-3#7)(2009-5#2)
a pig##7##2##(1993-6#1)(1996-2#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
a pill##2##2##(2008-5#1)(2011-1#1)
a piloleiomyoma##2##2##(2010-6#2)
a pilot of##2##3##(1994-3#1)(2013-8#1)
a pilot project of##2##4##(2008-12#1)(2012-12#1)
a pilot project that##2##4##(2008-11#1)(2010-11#1)
a pilot project##9##3##(1993-3#1)(1994-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-11#1)(2012-12#1)
a pilot study in##2##4##(2007-5#1)(2008-3#1)
a pilot study of its##2##5##(1990-9#1)(2008-5#1)
a pilot study of relationships in a graduate population##2##9##(2013-1#2)
a pilot study of the##2##5##(1996-2#1)(2010-9#1)
a pilot study of##10##4##(1990-6#1)(1990-9#1)(1993-3#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-9#1)(2013-1#2)
a pilot study to##2##4##(2008-12#1)(2009-12#1)
a pilot study was##2##4##(1992-2#1)(2010-3#1)
a pilot study##57##3##(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-1#2)(2013-1#5)
a pilot toxicity study##2##4##(1994-11#2)
a pilot##92##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#3)(1995-12#1)(1995-8#1)(1996-2#2)(2007-10#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#1)(2013-1#5)(2013-8#1)
a pineal germinoma##2##3##(2008-7#2)
a pineal##3##2##(2008-7#3)
a pinhole in##2##3##(2007-12#1)(2012-2#1)
a pinhole##6##2##(2007-11#1)(2007-12#2)(2008-3#2)(2012-2#1)
a pink colored##2##3##(2008-10#2)
a pink##5##2##(2008-10#5)
a pioneer in the fight against malaria##2##7##(2011-2#2)
a pioneer in the##4##4##(2008-8#1)(2008-9#1)(2011-2#2)
a pioneer in##5##3##(2008-8#1)(2008-9#1)(2011-2#3)
a pioneer of##3##3##(2007-5#1)(2008-10#1)(2009-1#1)
a pioneer##9##2##(1991-5#1)(2007-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#3)
a pioneering effort by the Health Care Financing Administration (HCFA) to measure interstate border crossing for services used by##2##19##(1995-12#1)(1997-3#1)
a pioneering##3##2##(1995-12#1)(1997-3#1)(2008-6#1)
a pipe##2##2##(2008-3#1)(2010-3#1)
a pipeline##2##2##(2008-8#1)(2010-5#1)
a pitfall##2##2##(2009-6#1)(2011-2#1)
a pituitary##6##2##(1990-12#1)(1991-6#1)(1993-11#1)(1996-2#1)(1997-7#1)(2006-12#1)
a pivot##3##2##(1995-2#1)(2008-11#1)(2008-3#1)
a pivotal position##2##3##(2006-10#1)(2010-10#1)
a pivotal role as##2##4##(2008-6#1)(2009-8#1)
a pivotal role in many##2##5##(1991-9#1)(2008-8#1)
a pivotal role in regulating##2##5##(1996-5#1)(1997-8#1)
a pivotal role in the pathogenesis of##2##7##(1997-8#1)(2008-1#1)
a pivotal role in the##13##5##(1994-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#2)(2012-2#1)(2013-7#1)
a pivotal role in##33##4##(1991-2#1)(1991-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
a pivotal role##39##3##(1991-2#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#2)
a pivotal trial##2##3##(2008-5#1)(2010-4#1)
a pivotal##52##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-2#3)(2013-7#3)
a pixel##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2012-12#1)
a pixel-matched##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
a pixelated lens##2##3##(2008-3#2)
a pixelated##4##2##(2007-11#2)(2008-3#2)
a place for##6##3##(1995-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)
a place in the##3##4##(1996-9#1)(2007-11#1)(2008-7#1)
a place##16##2##(1992-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-1#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)
a placebo##18##2##(1992-5#1)(1993-3#1)(1995-5#1)(2008-10#1)(2008-5#9)(2008-7#2)(2010-11#1)(2012-2#2)
a placebo-controlled##5##2##(1993-3#1)(1994-8#1)(2008-5#1)(2008-7#1)(2010-5#1)
a placement##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
a plain##3##2##(2008-10#3)
a plan for##6##3##(1993-2#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
a plan of##2##3##(1991-1#1)(2008-11#1)
a plan to##4##3##(1992-1#1)(1994-1#1)(2008-11#1)(2013-1#1)
a plan##18##2##(1991-1#2)(1991-3#1)(1992-1#2)(1993-1#1)(1993-2#1)(1994-1#2)(2008-10#2)(2008-11#3)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
a planar optical waveguide##2##4##(2007-12#1)(2008-10#1)
a planar waveguide##2##3##(2007-12#1)(2010-5#1)
a planar##22##2##(1990-8#1)(2007-11#1)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#8)(2010-5#1)
a planar-integrated##3##2##(2007-11#2)(2008-3#1)
a plane multimode deformable mirror (MDM)##2##6##(2008-3#2)
a plane perpendicular to the##2##5##(2008-3#2)
a plane wave##11##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#7)
a plane##35##2##(2007-11#2)(2007-12#3)(2008-2#5)(2008-3#21)(2008-6#2)(2008-7#1)(2009-11#1)
a plane-parallel medium##2##3##(2008-2#1)(2008-3#1)
a plane-parallel##6##2##(2008-2#3)(2008-3#3)
a planned##6##2##(1990-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#1)
a planning scheme based##2##4##(2009-11#2)
a planning##5##2##(1993-6#1)(1997-3#1)(2008-2#1)(2009-11#2)
a plant RNA##2##3##(2008-10#2)
a plant expression vector##2##4##(1997-6#1)(2008-9#1)
a plant host##2##3##(2008-10#2)
a plant virus##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
a plant##43##2##(1991-6#1)(1993-2#1)(1993-8#1)(1995-2#1)(1997-6#1)(2008-10#20)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)
a plant-pathogenic##2##2##(2008-10#2)
a plantation of##2##3##(2008-10#1)(2008-5#1)
a plantation##3##2##(2008-10#2)(2008-5#1)
a planting##2##2##(2008-10#2)
a plasma membrane##4##3##(1990-5#2)(1995-2#1)(2009-7#1)
a plasma##21##2##(1990-5#2)(1990-8#2)(1991-9#1)(1993-12#1)(1995-2#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2012-2#2)
a plasmid encoding a##2##4##(1991-3#1)(2008-2#1)
a plasmid encoding##6##3##(1991-3#1)(1994-8#1)(1997-4#1)(2008-2#1)(2010-11#1)(2010-6#1)
a plasmid of##2##3##(1997-3#1)(2008-10#1)
a plasmid vector##4##3##(1994-12#1)(2008-10#2)(2010-8#1)
a plasmid##29##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-2#2)(1995-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2010-11#1)(2010-6#1)(2010-8#1)
a plasminogen##3##2##(1992-8#1)(1997-2#1)(2008-9#1)
a plastic scintillating fiber##2##4##(2008-2#2)
a plastic surgeon##2##3##(2007-8#1)(2013-1#1)
a plastic##18##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1994-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#2)(2013-7#1)
a plasticized poly(vinyl chloride) membrane##3##5##(2008-10#3)
a plasticized poly(vinyl chloride)##5##4##(2008-10#5)
a plasticized##10##2##(2008-10#10)
a plasticizer and##2##3##(2008-10#2)
a plasticizer##4##2##(2008-10#4)
a plate and##2##3##(2008-3#1)(2008-7#1)
a plate diagram sheet for estimation of energy and protein##2##10##(2013-1#2)
a plate diagram sheet##3##4##(2013-1#3)
a plate with##2##3##(2007-12#1)(2008-3#1)
a plate##12##2##(1991-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#3)
a plateau at##2##3##(2011-2#1)(2012-2#1)
a plateau in##4##3##(1995-4#1)(2008-10#1)(2008-7#1)(2010-3#1)
a plateau##18##2##(1990-12#1)(1990-7#1)(1994-11#1)(1995-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#2)(2011-2#1)(2012-2#1)
a platelet##5##2##(1990-12#1)(1991-2#1)(1992-8#1)(1993-6#1)(2008-11#1)
a platelet-derived growth factor##2##4##(1994-9#1)(2013-1#1)
a platform for the##4##4##(2008-10#2)(2010-12#1)(2012-12#1)
a platform for##16##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#4)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)
a platform to##2##3##(2008-11#1)(2008-7#1)
a platform##20##2##(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2010-10#1)(2010-12#4)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#3)
a platinum electrode##8##3##(1991-5#2)(2008-10#6)
a platinum wire##2##3##(2008-10#2)
a platinum##20##2##(1991-5#2)(1997-3#1)(2008-10#16)(2010-12#1)
a plausible mechanism##2##3##(2008-10#1)(2008-3#1)
a plausible##17##2##(1990-8#1)(1992-9#1)(1996-2#1)(1997-6#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
a plea##2##2##(2007-6#1)(2007-8#1)
a pleiotropic##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
a plethora of##15##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2012-3#1)(2013-1#2)
a plexiform##3##2##(2007-8#3)
a plot of##2##3##(2008-10#1)(2008-3#1)
a plug flow##2##3##(2008-7#2)
a plug of##2##3##(2008-10#1)(2013-1#1)
a plug##8##2##(2008-10#2)(2008-7#2)(2009-6#1)(2011-2#1)(2013-1#2)
a pluralistic##2##2##(1994-2#1)(2008-7#1)
a pluripotent##2##2##(2008-11#1)(2008-4#1)
a point in time##2##4##(2008-11#1)(2008-9#1)
a point in##5##3##(1997-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)
a point mutation in the##4##5##(1991-2#1)(1992-8#1)(2008-10#2)
a point mutation of the##2##5##(1994-12#1)(1995-8#1)
a point mutation##9##3##(1991-2#2)(1992-8#2)(1993-9#1)(1994-12#1)(1995-8#1)(2008-10#2)
a point of##6##3##(1990-5#1)(1993-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
a point prevalence##2##3##(1990-6#1)(2008-7#1)
a point process##4##3##(2009-9#2)(2010-5#2)
a point source in the##2##5##(2008-10#1)(2008-3#1)
a point source of##2##4##(2008-10#1)(2008-2#1)
a point source##10##3##(2008-10#4)(2008-2#1)(2008-3#5)
a point where##3##3##(1996-3#1)(2007-11#1)(2010-3#1)
a point##48##2##(1990-5#1)(1990-6#1)(1991-2#2)(1992-8#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#8)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)
a point-diffraction interferometer##2##3##(2008-3#2)
a point-diffraction##3##2##(2008-3#3)
a point-measurement method##2##3##(2008-3#2)
a pointlike##4##2##(2007-12#1)(2008-3#3)
a points##2##2##(1991-6#1)(2011-2#1)
a polar##16##2##(1995-2#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-12#1)(2012-1#1)
a polarimeter##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
a polarimetric pressure##2##3##(2008-2#1)(2010-4#1)
a polarimetric##4##2##(2007-11#1)(2008-2#2)(2010-4#1)
a polarity##3##2##(1994-6#1)(2008-10#1)(2009-3#1)
a polarization beam splitter##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a polarization extinction ratio of##2##5##(2007-12#1)(2008-3#1)
a polarization##18##2##(2007-11#3)(2007-12#6)(2008-2#2)(2008-3#7)
a polarization-independent##3##2##(2008-3#3)
a polarization-insensitive##2##2##(2008-2#1)(2008-3#1)
a polarization-maintaining##3##2##(2007-11#3)
a polarization-modulated##2##2##(2007-12#2)
a polarization-sensitive##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
a polarized laser beam##3##4##(2008-2#1)(2008-3#2)
a polarized microenvironment in human endometrium##2##6##(1994-9#2)
a polarized##8##2##(1991-12#1)(1994-9#2)(2007-12#1)(2008-2#1)(2008-3#3)
a polarizer##4##2##(2007-12#3)(2008-2#1)
a polarizing beam splitter##7##4##(2008-10#1)(2008-2#3)(2008-3#3)
a polarizing##9##2##(2008-10#1)(2008-2#4)(2008-3#4)
a police##3##2##(1992-2#1)(1997-5#1)(2012-3#1)
a policy is##2##3##(1990-12#1)(1993-3#1)
a policy##19##2##(1990-12#1)(1990-2#1)(1991-1#2)(1992-12#3)(1993-3#2)(1996-1#2)(1996-2#1)(1996-3#2)(2008-1#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-8#1)
a polished##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
a political##3##2##(1994-2#1)(2008-1#1)(2008-11#1)
a pollutant##2##2##(2008-11#1)(2013-1#1)
a poly##2##2##(1994-11#1)(2008-5#1)
a poly(A) tail##4##3##(1991-2#1)(2008-10#3)
a poly(A)##5##2##(1990-11#1)(1991-2#1)(2008-10#3)
a poly(methyl methacrylate)##2##3##(2007-11#1)(2008-3#1)
a polyacrylamide-coated tube at neutral pH##2##6##(2008-10#2)
a polyacrylamide-coated##3##2##(2008-10#2)(2008-4#1)
a polyadenylation##3##2##(1991-2#1)(1991-9#1)(2010-4#1)
a polyamine##4##2##(1990-12#1)(1991-5#1)(1997-7#1)(2008-10#1)
a polyamine-deficient##2##2##(2009-6#2)
a polyaniline##2##2##(2008-10#2)
a polycarbonate##4##2##(2008-10#3)(2008-3#1)
a polycistronic##2##2##(2007-12#1)(2008-8#1)
a polyclonal antibody##4##3##(1991-2#1)(1992-11#1)(1993-12#1)(2008-10#1)
a polyclonal antiserum against##4##4##(1993-12#1)(1997-1#1)(2008-10#2)
a polyclonal antiserum##5##3##(1993-12#1)(1997-1#1)(2008-10#3)
a polyclonal##15##2##(1991-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-7#1)(1997-1#2)(2008-10#5)(2008-5#1)
a polycrystalline##2##2##(2007-12#1)(2008-10#1)
a polydisperse##2##2##(1995-2#1)(2008-2#1)
a polyester##2##2##(2008-11#2)
a polyether type polyurethane foam##2##5##(2008-10#2)
a polyethylene glycol##2##3##(1994-3#1)(2012-3#1)
a polyethylene##5##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
a polygenic##3##2##(2009-12#1)(2010-5#1)(2012-3#1)
a polygonal##5##2##(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
a polyherbal formulation##2##3##(2013-1#2)
a polyketide synthase##2##3##(2008-10#2)
a polylinker##3##2##(1991-7#1)(2008-11#1)(2008-2#1)
a polymer film##3##3##(2007-12#1)(2009-11#1)(2010-5#1)
a polymer matrix and##2##4##(2008-10#1)(2008-7#1)
a polymer matrix##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
a polymer##28##2##(1995-3#1)(1996-12#1)(2007-12#4)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#4)(2009-11#1)(2010-4#1)(2010-5#1)(2012-2#1)
a polymer-supported##2##2##(2008-10#1)(2008-4#1)
a polymerase chain reaction (PCR)##3##5##(2008-10#1)(2008-2#1)(2013-1#1)
a polymerase chain reaction##9##4##(1993-9#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-2#2)(2013-1#1)
a polymerase chain##14##3##(1993-9#1)(1996-12#1)(1997-3#1)(2008-10#6)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
a polymerase##16##2##(1990-5#1)(1993-9#1)(1996-12#1)(1997-3#1)(2008-10#7)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
a polymeric gain medium##2##4##(2008-2#2)
a polymeric##16##2##(1990-7#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2012-1#1)
a polymorphic##7##2##(1990-6#1)(1990-8#1)(1995-12#1)(2010-8#2)(2013-1#2)
a polymorphism for##2##3##(2008-12#1)(2008-9#1)
a polymorphism##6##2##(1992-8#1)(2008-12#3)(2008-9#1)(2012-12#1)
a polynomial##2##2##(2007-12#1)(2012-2#1)
a polypeptide chain##2##3##(2008-11#1)(2008-8#1)
a polypeptide of approximately##3##4##(1996-2#1)(1997-7#1)(2008-10#1)
a polypeptide of##18##3##(1990-11#1)(1990-5#2)(1991-12#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-8#1)(2013-1#1)
a polypeptide that##3##3##(1994-12#1)(1995-2#1)(1997-3#1)
a polypeptide with an##2##4##(1990-2#1)(1995-9#1)
a polypeptide with##3##3##(1990-2#1)(1995-9#1)(2008-10#1)
a polypeptide##38##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-12#2)(1995-2#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#5)(2010-7#1)(2013-1#1)
a polyphasic approach##2##3##(2008-10#1)(2010-3#1)
a polyphenolic##2##2##(2008-11#1)(2011-2#1)
a polypoid##4##2##(1992-6#1)(1993-9#1)(2008-11#1)(2010-2#1)
a polypropylene mesh##2##3##(1996-9#1)(2008-12#1)
a polypropylene vessel##2##3##(2008-10#2)
a polypropylene##4##2##(1996-9#1)(2008-10#2)(2008-12#1)
a polyprotein of##2##3##(2008-10#1)(2008-8#1)
a polyprotein##3##2##(2008-10#1)(2008-8#2)
a polypyrrole (PPy)##2##3##(2008-10#2)
a polypyrrole##5##2##(2008-10#5)
a polysaccharide##2##2##(1994-9#1)(2007-10#1)
a polysiloxane##2##2##(2008-10#1)(2008-3#1)
a polystyrene matrix##2##3##(1996-12#1)(2008-11#1)
a polystyrene##6##2##(1996-12#1)(2008-11#2)(2008-2#1)(2008-3#2)
a polystyrene-based##2##2##(2008-11#2)
a polystyrene-divinylbenzene##2##2##(1997-2#1)(2008-10#1)
a polytetrafluoroethylene (PTFE) graft##2##4##(2007-7#2)
a polytetrafluoroethylene (PTFE)##3##3##(2007-7#2)(2008-10#1)
a polyurethane foam##3##3##(2008-10#2)(2008-11#1)
a polyurethane##9##2##(1996-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-7#1)
a polyvinyl alcohol##4##3##(2008-10#2)(2008-2#1)(2009-11#1)
a polyvinyl##7##2##(2008-10#3)(2008-2#1)(2008-5#1)(2009-11#1)(2013-1#1)
a polyvinylidene difluoride##2##3##(1992-8#1)(2008-11#1)
a pool of##17##3##(1990-11#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-2#1)
a pooled##2##2##(1997-2#1)(2008-8#1)
a poor compliance##2##3##(1993-11#2)
a poor correlation##2##3##(1991-9#1)(2008-9#1)
a poor development of##2##4##(2009-5#1)(2011-1#1)
a poor outcome##7##3##(1990-9#1)(2007-10#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-3#1)
a poor prognosis because of##2##5##(1996-11#1)(2012-1#1)
a poor prognosis##28##3##(1990-8#1)(1990-9#1)(1991-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-5#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
a poor quality##2##3##(2008-3#1)(2013-1#1)
a poor recovery##2##3##(2008-10#2)
a poor response to##2##4##(1990-10#1)(2010-6#1)
a poor response##4##3##(1990-10#1)(2008-10#2)(2010-6#1)
a poor substrate for##3##4##(1991-5#1)(1994-11#1)(1997-3#1)
a poor##73##2##(1990-10#1)(1990-8#1)(1990-9#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-11#4)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
a poorer##5##2##(1993-11#1)(2007-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
a poorly differentiated adenocarcinoma##2##4##(1990-2#1)(2011-2#1)
a poorly differentiated##4##3##(1990-2#1)(1990-3#1)(2008-6#1)(2011-2#1)
a poorly understood##2##3##(2008-12#1)(2012-3#1)
a poorly##11##2##(1990-2#1)(1990-3#1)(1995-6#1)(2008-12#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a popular alternative to traditional staining procedures##2##7##(2008-2#1)(2008-4#1)
a popular form of##2##4##(2008-11#1)(2008-5#1)
a popular##22##2##(1992-8#1)(1994-3#1)(1996-3#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-3#1)(2009-4#1)(2009-9#1)
a population at##2##3##(2008-1#1)(2012-12#1)
a population from##2##3##(2008-10#2)
a population genetic##2##3##(2008-10#1)(2008-12#1)
a population in the##2##4##(2008-8#1)(2012-3#1)
a population in##3##3##(2008-8#2)(2012-3#1)
a population is##4##3##(1996-6#1)(2009-2#1)(2012-2#2)
a population of 1##2##4##(1997-3#1)(1997-6#1)
a population of cells##2##4##(2008-9#1)(2010-10#1)
a population of patients##3##4##(2008-11#1)(2008-5#1)(2012-12#1)
a population of plants##2##4##(2008-10#2)
a population of young adults##2##5##(2010-5#1)(2012-12#1)
a population of##71##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-6#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
a population sample of##3##4##(1990-8#1)(1992-2#1)(1993-3#1)
a population sample##6##3##(1990-8#1)(1992-2#1)(1993-3#1)(2008-12#2)(2013-1#1)
a population that##3##3##(1996-2#1)(1997-5#1)(2008-8#1)
a population to be##2##4##(2008-10#1)(2008-9#1)
a population with high##2##4##(1990-3#1)(1992-3#1)
a population with##4##3##(1990-3#1)(1992-3#1)(1994-12#1)(2007-10#1)
a population##149##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#3)(1995-6#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#9)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#4)
a population's##5##2##(1997-7#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-7#1)
a population-based sample of##3##4##(2008-7#2)(2012-2#1)
a population-based sample##4##3##(2008-7#2)(2012-2#1)(2012-3#1)
a population-based study of##2##4##(2008-12#1)(2008-7#1)
a population-based study##7##3##(2008-12#1)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a population-based##28##2##(1991-6#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
a porcine model##4##3##(2007-8#1)(2008-4#1)(2012-2#1)(2013-1#1)
a porcine##9##2##(1991-6#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-2#1)(2013-1#1)
a pore##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
a porous membrane##2##3##(2010-2#1)(2012-4#1)
a porous##21##2##(1996-5#2)(1997-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#3)(2008-7#1)(2009-12#1)(2010-2#1)(2012-2#1)(2012-4#1)
a port city##2##3##(1997-6#2)
a port##6##2##(1997-1#1)(1997-6#2)(2007-11#1)(2007-7#1)(2008-10#1)
a portable and##2##3##(2008-3#1)(2008-4#1)
a portable forceplate##2##3##(2009-1#2)
a portable##21##2##(1992-11#1)(1996-2#1)(1997-4#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#1)(2009-1#2)(2009-10#2)(2013-1#1)
a portal##2##2##(2008-9#1)(2010-8#1)
a portion of the##27##4##(1991-3#1)(1991-9#1)(1992-3#4)(1995-8#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-5#1)(2012-2#1)
a portion of these##2##4##(1993-9#1)(2008-3#1)
a portion of##34##3##(1991-1#1)(1991-3#1)(1991-9#1)(1992-3#4)(1993-9#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-5#1)(2012-2#1)
a portion##36##2##(1991-1#1)(1991-3#1)(1991-9#1)(1992-3#4)(1993-9#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-5#2)(2012-2#1)
a position equivalent to##2##4##(1990-5#1)(2008-5#1)
a position in##2##3##(2008-10#1)(2008-8#1)
a position of##2##3##(1994-12#1)(2011-2#1)
a position sensitive detector (PSD)##2##5##(2008-10#2)
a position##26##2##(1990-5#1)(1991-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a position-sensitive detector##2##3##(2007-11#2)
a position-sensitive##3##2##(2007-11#2)(2008-3#1)
a positional##4##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
a positive OCT##3##3##(2011-2#3)
a positive allosteric##2##3##(1995-11#2)
a positive and a negative##3##5##(1990-3#1)(1994-5#1)(2009-2#1)
a positive and##7##3##(1990-3#1)(1992-3#1)(1994-5#1)(1996-3#1)(2008-11#1)(2009-2#1)(2012-1#1)
a positive association between##5##4##(1990-8#1)(1992-4#1)(1993-12#1)(2010-6#1)(2013-1#1)
a positive association with##2##4##(2012-2#1)(2013-1#1)
a positive association##8##3##(1990-8#1)(1992-4#1)(1993-12#1)(2008-7#1)(2010-6#1)(2012-2#1)(2013-1#2)
a positive attitude##2##3##(1996-11#1)(2007-8#1)
a positive contribution##2##3##(1992-12#1)(1997-4#1)
a positive control##7##3##(1992-12#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)
a positive correlation between the level of##2##7##(1990-10#1)(2011-1#1)
a positive correlation between the##5##5##(1990-10#1)(1993-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
a positive correlation between##8##4##(1990-10#1)(1993-11#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
a positive correlation of##3##4##(1995-9#1)(2008-10#1)(2011-1#1)
a positive correlation with the##2##5##(1991-11#1)(2008-12#1)
a positive correlation with##3##4##(1991-11#1)(2008-12#1)(2013-1#1)
a positive correlation##16##3##(1990-10#1)(1991-11#1)(1993-11#1)(1995-9#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a positive diagnosis##2##3##(1997-2#2)
a positive direct antiglobulin test##3##5##(1992-3#1)(1992-9#1)(1994-3#1)
a positive discography##4##3##(2012-12#4)
a positive effect on the##3##5##(2008-12#1)(2009-10#1)(2013-1#1)
a positive effect on##11##4##(1990-9#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
a positive effect##14##3##(1990-9#1)(1993-3#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
a positive electric##2##3##(1997-6#1)(2008-5#1)
a positive emotional##3##3##(2008-5#1)(2010-10#2)
a positive factor##2##3##(1993-6#1)(1995-2#1)
a positive family history##4##4##(1997-5#1)(1997-6#1)(2008-9#1)(2011-2#1)
a positive herd##2##3##(1992-5#2)
a positive history of##2##4##(1991-4#1)(2013-7#1)
a positive impact on the##7##5##(1995-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
a positive impact on##12##4##(1995-5#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
a positive impact##13##3##(1995-5#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#4)(2013-1#1)(2013-8#1)
a positive influence on the##2##5##(2008-7#1)(2013-8#1)
a positive influence on##4##4##(2008-11#1)(2008-7#2)(2013-8#1)
a positive influence##5##3##(2008-11#1)(2008-7#2)(2009-8#1)(2013-8#1)
a positive interaction##2##3##(1993-3#1)(2008-6#1)
a positive linear##2##3##(1997-6#1)(2008-3#1)
a positive net##2##3##(1995-3#1)(2008-10#1)
a positive or##4##3##(1992-6#1)(1993-5#1)(1995-11#1)(1997-8#1)
a positive predictive value of##2##5##(1993-2#1)(1993-5#1)
a positive reaction##2##3##(1997-6#1)(2010-4#1)
a positive relationship between##4##4##(1995-3#1)(1996-12#1)(2011-1#1)(2013-7#1)
a positive relationship##5##3##(1995-3#1)(1996-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
a positive response in##2##4##(2008-10#2)
a positive role in##4##4##(1993-6#1)(1995-12#1)(2009-8#1)(2011-2#1)
a positive role##5##3##(1993-6#1)(1995-12#1)(1995-2#1)(2009-8#1)(2011-2#1)
a positive test##3##3##(1991-12#1)(1994-1#1)(1994-2#1)
a positive tuberculin##2##3##(1990-6#1)(2013-1#1)
a positive working relationship##2##4##(1993-1#2)
a positive##237##2##(1990-10#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#13)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#3)(2011-1#10)(2011-2#17)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#5)(2013-8#4)
a positively charged##6##3##(1990-5#1)(1991-8#1)(1992-8#1)(2008-11#3)
a positively##7##2##(1990-5#1)(1991-8#1)(1992-8#1)(2008-11#4)
a positivistic##2##2##(1993-2#1)(1993-6#1)
a positivity##2##2##(2007-7#1)(2013-8#1)
a possibility of##10##3##(1994-2#1)(1995-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a possibility that##2##3##(2007-6#1)(2008-11#1)
a possibility to##6##3##(1996-12#1)(1996-4#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-2#1)
a possibility##25##2##(1994-2#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-3#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
a possible &quot##2##3##(1994-11#1)(2009-3#1)
a possible alternative##2##3##(2008-10#1)(2011-2#1)
a possible application##2##3##(2008-10#1)(2008-2#1)
a possible approach##2##3##(2008-10#1)(2011-2#1)
a possible association between##2##4##(2006-10#1)(2013-1#1)
a possible association of##2##4##(1997-3#1)(2011-2#1)
a possible association##4##3##(1997-3#1)(2006-10#1)(2011-2#1)(2013-1#1)
a possible autosomal recessive##2##4##(2007-7#1)(2007-8#1)
a possible candidate##2##3##(1996-12#1)(2008-11#1)
a possible case of##2##4##(1991-9#1)(2010-3#1)
a possible cause##8##3##(1992-11#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
a possible connection between##2##4##(1992-11#1)(2006-10#1)
a possible correlation between##3##4##(1997-7#1)(2008-5#1)(2013-1#1)
a possible diagnosis##3##3##(2010-12#1)(2010-3#1)(2012-12#1)
a possible explanation for the##3##5##(1992-3#1)(1997-1#1)(2008-10#1)
a possible explanation for##4##4##(1992-3#1)(1997-1#1)(2008-10#1)(2008-8#1)
a possible explanation##5##3##(1992-3#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-8#1)
a possible impact##2##3##(1993-9#1)(2011-2#1)
a possible inhibitory effect on##2##5##(1995-11#1)(2008-6#1)
a possible involvement of##5##4##(1996-12#1)(1997-2#2)(2008-10#1)(2008-11#1)
a possible link between##2##4##(2009-12#1)(2013-1#1)
a possible means of##2##4##(2008-10#1)(2013-1#1)
a possible means##3##3##(2008-10#2)(2013-1#1)
a possible mechanism by which##2##5##(1993-6#1)(2008-5#1)
a possible mechanism for the##2##5##(2008-10#1)(2010-6#1)
a possible mechanism for##5##4##(1997-4#1)(2008-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
a possible mechanism of##2##4##(1993-6#1)(2008-10#1)
a possible mechanism##12##3##(1993-6#2)(1997-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#1)
a possible member of the##2##5##(2008-10#1)(2009-9#1)
a possible method of##2##4##(2010-12#1)(2011-2#1)
a possible model##2##3##(2009-10#1)(2012-2#1)
a possible molecular mechanism##2##4##(2008-11#1)(2008-8#1)
a possible new##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
a possible protective##2##3##(2008-1#1)(2013-1#1)
a possible relationship between the##2##5##(2008-9#1)(2012-2#1)
a possible relationship between##3##4##(2007-10#1)(2008-9#1)(2012-2#1)
a possible relationship##4##3##(1990-6#1)(2007-10#1)(2008-9#1)(2012-2#1)
a possible role for this##2##5##(1991-1#1)(1994-8#1)
a possible role for##9##4##(1991-1#1)(1992-3#1)(1993-12#1)(1994-8#1)(2008-10#2)(2009-12#1)(2011-2#1)(2012-2#1)
a possible role in the##4##5##(1993-9#1)(1995-12#1)(1996-3#1)(2008-7#1)
a possible role in##5##4##(1993-12#1)(1993-9#1)(1995-12#1)(1996-3#1)(2008-7#1)
a possible role of the##2##5##(1992-6#1)(1997-4#1)
a possible role of##5##4##(1990-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1997-4#1)
a possible role##19##3##(1990-11#1)(1991-1#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
a possible solution##5##3##(1991-9#1)(1992-1#1)(1993-3#1)(2007-5#1)(2009-10#1)
a possible use of##2##4##(1992-9#1)(2013-1#1)
a possible##223##2##(1990-11#2)(1990-5#2)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(2006-10#4)(2006-12#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#29)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
a post##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
a post-acute##2##2##(1995-3#1)(2008-10#1)
a post-hoc##2##2##(2012-2#1)(2012-3#1)
a post-mortem##3##2##(1991-11#1)(2009-3#2)
a post-operative##3##2##(1992-9#1)(2008-6#2)
a post-registration##2##2##(2008-11#2)
a post-transcriptional##5##2##(1992-1#2)(1992-12#1)(2008-10#1)(2010-11#1)
a post-translational modification##2##3##(2008-1#1)(2013-1#1)
a postal questionnaire##3##3##(1993-10#1)(2011-1#1)(2011-2#1)
a postal##4##2##(1993-10#1)(1997-8#1)(2011-1#1)(2011-2#1)
a posterior fossa##2##3##(2008-12#2)
a posterior mediastinal##2##3##(2007-8#1)(2012-3#1)
a posterior urethral valve##2##4##(2011-2#2)
a posterior##25##2##(1991-6#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-2#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#1)
a posteriori##2##2##(2008-2#1)(2008-9#1)
a posterolateral thoracotomy##3##3##(2007-12#1)(2007-8#1)(2010-12#1)
a posterolateral##5##2##(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-3#1)
a postgraduate##2##2##(1993-2#1)(2008-11#1)
a postharvest##5##2##(2008-10#5)
a postinfection##2##2##(2008-10#2)
a postnatal##2##2##(2009-3#1)(2012-12#1)
a postoperative hemorrhage##3##3##(1991-8#1)(2013-1#2)
a postoperative##7##2##(1991-8#1)(2007-8#2)(2009-3#1)(2012-2#1)(2013-1#2)
a postpartum checkup##3##3##(2013-1#3)
a postpartum##4##2##(1996-8#1)(2013-1#3)
a postsynaptic##2##2##(1996-12#1)(2009-9#1)
a posttranscriptional##3##2##(1990-11#1)(1991-5#1)(1994-8#1)
a posttranslational##2##2##(1993-12#1)(2010-4#1)
a potassium##11##2##(1990-2#1)(1992-3#1)(1996-2#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-2#1)
a potato##6##2##(2008-10#2)(2008-12#1)(2008-5#2)(2009-6#1)
a potent activation##2##3##(1992-12#1)(1995-6#1)
a potent activator of##4##4##(1990-2#1)(1994-11#1)(2008-4#1)(2010-6#1)
a potent and selective##3##4##(1990-8#1)(1992-8#1)(1994-2#1)
a potent and specific##2##4##(1991-9#1)(1994-11#1)
a potent and##7##3##(1990-8#1)(1991-9#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#1)
a potent angiogenic factor##4##4##(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)
a potent antioxidant and##2##4##(2008-10#1)(2009-12#1)
a potent antioxidant##4##3##(1996-3#1)(2008-10#1)(2009-12#2)
a potent cell growth##2##4##(1992-9#1)(1993-8#1)
a potent free radical scavenger##3##5##(1995-8#1)(2012-2#2)
a potent growth inhibitor##2##4##(1990-2#1)(2010-6#1)
a potent inducer of##7##4##(1990-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
a potent inhibitor of HIV-1 protease##2##6##(1991-12#2)
a potent inhibitor of protein kinase##2##6##(1996-12#2)
a potent inhibitor of protein##3##5##(1994-11#1)(1996-12#2)
a potent inhibitor of the##2##5##(2008-11#1)(2012-12#1)
a potent inhibitor of##26##4##(1990-5#1)(1991-12#2)(1992-12#2)(1993-8#2)(1994-11#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-4#2)(2006-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)
a potent ligand for##2##4##(1991-9#2)
a potent mechanism-based inhibitor##2##4##(1991-3#1)(2012-12#1)
a potent mediator##2##3##(1992-6#1)(1993-11#1)
a potent mitogen##2##3##(1995-6#1)(2009-2#1)
a potent non-competitive##2##3##(1990-5#1)(1991-5#1)
a potent reversible##2##3##(1994-8#1)(2008-7#1)
a potent selective##2##3##(1997-6#1)(2008-10#1)
a potent stimulator of##4##4##(1992-3#1)(1993-12#1)(1995-12#1)(2008-6#1)
a potent##160##2##(1990-2#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-12#5)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#5)(1992-11#1)(1992-12#4)(1992-3#2)(1992-6#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#5)(1993-8#5)(1994-11#9)(1994-12#1)(1994-2#2)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#2)
a potential alternative to##2##4##(2006-10#1)(2008-2#1)
a potential alternative##7##3##(1996-1#1)(2006-10#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-8#1)
a potential anticancer drug##2##4##(2008-5#1)(2013-1#1)
a potential application of##2##4##(2008-10#2)
a potential application##3##3##(2008-10#3)
a potential benefit of##2##4##(2008-10#1)(2008-6#1)
a potential candidate for##3##4##(1994-6#1)(2008-5#1)(2012-2#1)
a potential candidate##4##3##(1994-6#1)(1997-5#1)(2008-5#1)(2012-2#1)
a potential carcinogen##2##3##(1990-8#1)(2008-7#1)
a potential drug##2##3##(2010-11#1)(2012-2#1)
a potential explanation for the##2##5##(2008-5#1)(2008-7#1)
a potential for##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
a potential hazard##3##3##(1994-11#1)(2007-5#1)(2007-7#1)
a potential health risk##2##4##(2007-5#1)(2008-5#1)
a potential health##3##3##(2007-5#1)(2008-5#1)(2008-7#1)
a potential indicator##2##3##(1993-3#1)(2011-1#1)
a potential inoculum source for##2##5##(2008-10#2)
a potential marker for##3##4##(2008-7#1)(2010-4#1)(2010-5#1)
a potential mechanism##5##3##(1990-8#1)(2008-10#2)(2011-1#1)(2012-2#1)
a potential method##2##3##(2008-10#2)
a potential new##4##3##(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#1)
a potential of##9##3##(2008-10#8)(2012-2#1)
a potential problem##2##3##(2007-12#1)(2008-10#1)
a potential protective##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2009-11#1)
a potential risk of##2##4##(2007-8#1)(2013-1#1)
a potential risk##4##3##(1994-12#1)(2007-8#1)(2012-12#1)(2013-1#1)
a potential role for##11##4##(1992-3#2)(1993-3#1)(1993-9#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
a potential role in##3##4##(1995-12#1)(2009-6#1)(2011-2#1)
a potential role of the##2##5##(2008-7#1)(2013-7#1)
a potential role of##5##4##(1994-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-7#1)
a potential role##20##3##(1992-3#2)(1993-3#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#2)(2011-2#2)(2013-1#2)(2013-7#1)
a potential solution##4##3##(1992-12#1)(2008-2#1)(2008-8#2)
a potential source for##2##4##(2011-2#1)(2012-2#1)
a potential source of error##2##5##(2008-10#2)
a potential source of##5##4##(2008-10#4)(2008-5#1)
a potential source##7##3##(2008-10#4)(2008-5#1)(2011-2#1)(2012-2#1)
a potential target for##11##4##(1993-8#1)(1995-9#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
a potential target##12##3##(1993-8#1)(1995-9#1)(2008-1#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
a potential therapeutic target for##3##5##(2008-1#1)(2011-2#1)(2012-2#1)
a potential therapeutic target##4##4##(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
a potential therapeutic##11##3##(2008-1#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-7#1)
a potential threat to##2##4##(2008-10#1)(2008-7#1)
a potential threat##4##3##(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)
a potential to be##2##4##(2008-2#1)(2008-8#1)
a potential to##8##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
a potential tool for##4##4##(2008-10#4)
a potential use##2##3##(2008-2#1)(2008-3#1)
a potential value##2##3##(2012-3#1)(2013-8#1)
a potential##294##2##(1990-12#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#2)(1997-5#2)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#57)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#17)(2008-6#2)(2008-7#15)(2008-8#11)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#3)(2009-7#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#16)(2012-1#1)(2012-12#5)(2012-2#15)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#3)(2013-8#5)
a potentially critical##2##3##(1994-5#1)(2011-2#1)
a potentially fatal##5##3##(2008-1#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
a potentially important##8##3##(1993-11#2)(1993-8#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)
a potentially increased##2##3##(1996-6#1)(2013-1#1)
a potentially lethal##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
a potentially life-threatening##3##3##(2007-5#1)(2009-7#1)(2013-1#1)
a potentially safe##2##3##(1997-4#1)(2008-10#1)
a potentially serious##3##3##(2010-1#1)(2010-8#1)(2011-2#1)
a potentially severe and##2##4##(1995-3#1)(2008-11#1)
a potentially useful##7##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)
a potentially valuable##2##3##(1996-2#1)(2009-12#1)
a potentially##67##2##(1990-2#1)(1991-12#1)(1992-11#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
a potentiation of##2##3##(1993-6#1)(2008-10#1)
a potentiometric method##3##3##(2008-10#3)
a potentiometric sensor for##2##4##(2008-10#2)
a potentiometric sensor##9##3##(2008-10#9)
a potentiometric##25##2##(2008-10#25)
a potentized homeopathic drug##2##4##(2008-10#2)
a potyvirus##3##2##(2008-10#2)(2008-9#1)
a powder##3##2##(2008-5#1)(2010-5#1)(2012-2#1)
a powdery mildew resistance gene in##2##6##(2008-10#2)
a power function##3##3##(1995-8#1)(2008-6#1)(2008-7#1)
a power law##3##3##(2008-3#1)(2008-6#1)(2008-8#1)
a power of##6##3##(1991-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
a power##26##2##(1991-3#1)(1992-1#1)(1992-9#1)(1995-8#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2013-1#1)
a power-law relationship##2##3##(2008-10#1)(2008-5#1)
a power-law##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
a powerful alternative for##2##4##(2008-10#1)(2008-3#1)
a powerful alternative to##2##4##(1991-5#1)(2008-3#1)
a powerful alternative##4##3##(1991-5#1)(2008-10#1)(2008-3#2)
a powerful analytical tool for##2##5##(2008-10#1)(2008-7#1)
a powerful analytical tool##4##4##(2008-10#3)(2008-7#1)
a powerful and##9##3##(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-10#1)(2010-12#1)(2011-2#1)
a powerful device for##2##4##(1996-12#1)(2007-12#1)
a powerful inhibitor of##2##4##(1994-6#1)(2008-5#1)
a powerful method for##2##4##(1993-8#1)(1995-2#1)
a powerful method##3##3##(1993-8#1)(1995-2#2)
a powerful methodology##2##3##(1997-3#1)(2008-2#1)
a powerful new##2##3##(2008-10#2)
a powerful predictor of##2##4##(1994-2#1)(2008-12#1)
a powerful predictor##3##3##(1994-2#1)(2008-12#1)(2012-2#1)
a powerful research##3##3##(2008-4#1)(2008-9#2)
a powerful resource##2##3##(2008-9#1)(2011-1#1)
a powerful technique for##6##4##(1993-3#1)(1994-2#1)(1994-9#1)(2008-2#1)(2008-6#1)(2008-7#1)
a powerful technique##11##3##(1991-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
a powerful tool for analyzing##2##5##(1997-3#1)(2007-11#1)
a powerful tool for studying##2##5##(2007-12#1)(2008-4#1)
a powerful tool for the study of##3##7##(2007-11#1)(2007-12#1)(2008-4#1)
a powerful tool for the##8##5##(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#1)
a powerful tool for##36##4##(1991-8#1)(1996-10#2)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)
a powerful tool in the analysis of##2##7##(2008-1#1)(2008-10#1)
a powerful tool in the##7##5##(1993-11#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)
a powerful tool in##13##4##(1993-11#1)(1994-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2013-8#1)
a powerful tool to help##2##5##(1995-12#1)(2011-1#1)
a powerful tool to investigate##2##5##(2008-7#1)(2012-3#1)
a powerful tool to##14##4##(1995-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2011-1#2)(2012-2#1)(2012-3#1)
a powerful tool##70##3##(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-10#2)(1997-3#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-1#4)(2012-2#1)(2012-3#1)(2013-8#1)
a powerful way##2##3##(2008-10#1)(2012-12#1)
a powerful##155##2##(1991-3#1)(1991-5#2)(1991-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-10#2)(1996-12#1)(1997-3#2)(1997-8#1)(2006-4#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#19)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#15)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#3)(2011-1#7)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
a practicable##3##2##(1990-5#1)(2008-2#1)(2008-3#1)
a practical analysis##2##3##(1994-3#1)(1997-2#1)
a practical and##6##3##(1993-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)
a practical application##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
a practical approach for##2##4##(1990-5#1)(2012-2#1)
a practical approach to##3##4##(2008-5#1)(2008-7#1)(2010-12#1)
a practical approach##7##3##(1990-5#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
a practical example##3##3##(1990-7#1)(2007-12#1)(2012-3#1)
a practical guide for##3##4##(1993-6#1)(2008-10#1)(2012-12#1)
a practical guide##6##3##(1993-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-12#1)
a practical level##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
a practical method for##2##4##(2007-11#1)(2008-3#1)
a practical method##4##3##(1991-12#1)(2007-11#1)(2008-11#1)(2008-3#1)
a practical option##3##3##(1996-8#2)(2008-1#1)
a practical perspective##2##3##(1993-1#1)(1994-2#1)
a practical review##2##3##(2008-10#1)(2008-12#1)
a practical way for##2##4##(2012-3#1)(2013-8#1)
a practical way##4##3##(2007-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a practical##94##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-8#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#7)(2008-12#5)(2008-2#6)(2008-3#13)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#6)(2012-5#1)(2013-1#2)(2013-8#2)
a practically##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
a practice placement##2##3##(2008-11#2)
a practice which##2##3##(2007-7#1)(2008-5#1)
a practice##14##2##(1991-3#1)(1993-2#1)(1996-12#1)(2007-4#1)(2007-7#1)(2008-11#5)(2008-5#1)(2008-9#2)(2009-9#1)
a practice's##2##2##(1996-12#1)(2007-4#1)
a practicing##2##2##(1995-2#1)(2010-9#1)
a practitioner##4##2##(1997-4#2)(2008-11#2)
a practitioner's##4##2##(1990-9#1)(1991-1#1)(1996-3#1)(2008-11#1)
a pragmatic approach##2##3##(2011-2#1)(2012-3#1)
a pragmatic##5##2##(2008-11#1)(2010-1#1)(2011-2#1)(2012-3#2)
a pre- and##2##3##(1994-1#1)(2008-12#1)
a pre-concentration factor##2##3##(2008-10#2)
a pre-concentration##4##2##(2008-10#4)
a pre-determined##3##2##(1995-6#1)(1995-9#1)(2007-6#1)
a pre-existing##10##2##(1991-5#1)(1992-12#2)(1997-8#1)(2007-10#2)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
a pre-registration##4##2##(2008-11#4)
a pre-selected##2##2##(1997-3#1)(2008-10#1)
a pre-treatment##2##2##(1992-9#1)(2008-10#1)
a preadapted##2##2##(2008-11#2)
a preadmission telephone call on the day before surgery##2##9##(2008-8#2)
a precarious##2##2##(2011-2#1)(2012-12#1)
a precious##2##2##(1994-8#1)(2009-2#1)
a precipitate of##2##3##(2008-10#2)
a precipitate##7##2##(2008-1#1)(2008-10#5)(2008-2#1)
a precipitation of##2##3##(1994-6#1)(2008-10#1)
a precipitation##4##2##(1994-6#1)(2008-10#2)(2008-8#1)
a precipitation/dissolution##3##2##(2008-10#3)
a precipitous##2##2##(1995-2#1)(2013-1#1)
a precise analysis of the##2##5##(2007-11#1)(2008-2#1)
a precise diagnosis##3##3##(1992-5#1)(1993-9#1)(2012-3#1)
a precise technique##2##3##(1994-9#1)(1997-2#1)
a precise##25##2##(1990-7#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-9#2)(1994-2#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#3)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)(2010-3#1)(2012-3#1)
a precisely##4##2##(2008-10#1)(2008-7#2)(2008-9#1)
a precision of 1##5##4##(2008-10#5)
a precision of 2##3##4##(2008-10#3)
a precision of##21##3##(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#6)(2012-1#1)
a precision##44##2##(2007-11#1)(2007-12#1)(2008-10#25)(2008-2#3)(2008-3#11)(2010-12#1)(2012-1#1)(2012-2#1)
a preclinical test of antipsychotic efficacy with high predictive validity##2##10##(2008-6#2)
a preclinical test of extrapyramidal side effect liability##2##8##(2008-6#2)
a preclinical test of##4##4##(2008-6#4)
a preclinical##7##2##(2008-10#1)(2008-6#4)(2010-6#1)(2011-2#1)
a preconcentration column##3##3##(2008-10#3)
a preconcentration factor of##3##4##(2008-10#3)
a preconcentration factor##4##3##(2008-10#4)
a preconcentration step##5##3##(2008-10#5)
a preconcentration time of 3##2##5##(2008-10#2)
a preconcentration time of 3min##2##5##(2008-10#2)
a preconcentration time of 90s##3##5##(2008-10#3)
a preconcentration time of##14##4##(2008-10#14)
a preconcentration##29##2##(2008-10#29)
a preconditioned conjugate-gradient algorithm##2##4##(2008-2#2)
a preconditioned conjugate-gradient##3##3##(2008-2#3)
a preconditioned expert culture##2##4##(2008-3#2)
a preconditioned##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
a precursor for##2##3##(1993-12#1)(1997-2#1)
a precursor of the##2##4##(2007-11#1)(2008-11#1)
a precursor of##13##3##(1990-7#1)(1992-11#1)(1993-2#1)(1994-5#1)(1997-2#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-5#1)(2011-2#1)
a precursor to the##3##4##(1992-6#1)(2009-8#1)(2013-1#1)
a precursor to##8##3##(1992-6#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2009-8#1)(2010-4#1)(2013-1#1)
a precursor##29##2##(1990-7#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1996-6#1)(1997-2#3)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#4)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
a predation##2##2##(2012-12#2)
a predator##8##2##(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#1)(2012-3#1)
a predefined quality-rating scheme##2##4##(2012-12#2)
a predefined##6##2##(1993-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-12#2)
a predetermined spatial##2##3##(2007-11#1)(2013-1#1)
a predetermined##8##2##(1993-12#1)(1996-3#1)(2007-11#1)(2008-3#2)(2009-7#1)(2012-2#1)(2013-1#1)
a predictable##10##2##(1993-3#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-2#1)
a predicted M(r) of##3##4##(1994-12#2)(1994-8#1)
a predicted molecular mass of##3##5##(1994-12#1)(2008-10#2)
a predicted molecular##4##3##(1994-12#1)(2008-10#3)
a predicted##20##2##(1990-12#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-12#4)(1994-6#1)(1994-8#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-3#2)(2011-2#1)
a prediction model##2##3##(2007-11#1)(2008-10#1)
a prediction of##3##3##(1992-3#1)(1993-2#1)(1996-4#1)
a prediction##6##2##(1992-3#1)(1993-2#1)(1996-4#1)(2007-11#1)(2008-10#2)
a predictive marker for##2##4##(2010-12#2)
a predictive model##5##3##(2008-11#1)(2008-5#1)(2009-3#1)(2010-7#1)(2010-8#1)
a predictive test##2##3##(1997-6#1)(2013-8#1)
a predictive value of##2##4##(1993-2#1)(1994-7#1)
a predictive##22##2##(1993-2#1)(1993-8#1)(1994-7#1)(1996-12#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-7#2)(2010-8#1)(2012-3#1)(2013-8#1)
a predictor for##3##3##(2010-10#1)(2013-1#2)
a predictor of the##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
a predictor of##22##3##(1990-2#1)(1992-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
a predictor##26##2##(1990-2#1)(1992-4#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)
a predisposing factor##2##3##(1991-8#1)(1992-4#1)
a predisposing##4##2##(1991-8#1)(1992-4#1)(1994-11#1)(1994-2#1)
a predisposition to##4##3##(1990-5#1)(2007-10#1)(2010-12#1)(2011-2#1)
a predominance of##6##3##(1993-1#1)(1993-6#1)(2007-8#1)(2008-7#1)(2012-3#1)(2013-8#1)
a predominant role in the##2##5##(2008-5#1)(2011-2#1)
a predominant role in##3##4##(2008-11#1)(2008-5#1)(2011-2#1)
a predominant##14##2##(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)
a predominantly nuclear##2##3##(1991-5#1)(2009-7#1)
a predominantly##18##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
a preexisting##2##2##(2007-10#1)(2012-3#1)
a preferable##3##2##(1994-12#1)(2008-11#1)(2008-3#1)
a preference for individuals with##3##5##(1994-12#3)
a preference for the##2##4##(1995-6#1)(2010-8#1)
a preference for##10##3##(1994-12#3)(1995-6#1)(2007-5#1)(2008-11#3)(2009-5#1)(2010-8#1)
a preference##14##2##(1994-12#3)(1995-6#1)(2007-5#1)(2007-7#1)(2008-11#3)(2009-5#1)(2010-2#3)(2010-8#1)
a preferential##9##2##(1992-11#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
a preferentially##2##2##(1997-6#1)(2008-5#1)
a preferred method##2##3##(2008-7#1)(2011-1#1)
a preferred transfollicular route##2##4##(2008-5#2)
a preferred##12##2##(1990-7#1)(1994-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)
a preformed##2##2##(2008-10#2)
a pregnancy complicated by##2##4##(2006-10#1)(2013-1#1)
a pregnancy in##2##3##(2011-1#2)
a pregnancy##12##2##(1991-11#1)(1995-8#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2009-3#1)(2011-1#2)(2012-3#1)(2013-1#2)
a pregnant woman##5##3##(1990-6#1)(1991-9#1)(1997-7#1)(2008-7#1)(2010-8#1)
a pregnant women##2##3##(1990-6#1)(1997-4#1)
a pregnant##13##2##(1990-6#2)(1991-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-1#2)(2013-1#1)
a preheated##2##2##(2008-10#1)(2008-2#1)
a preliminary analysis##5##3##(2008-3#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-8#1)
a preliminary evaluation##3##3##(1993-1#1)(2008-10#1)(2008-12#1)
a preliminary investigation of##2##4##(1990-2#1)(2008-10#1)
a preliminary investigation##6##3##(1990-2#1)(1990-6#1)(1991-1#1)(2008-10#1)(2008-9#1)(2010-3#1)
a preliminary report##10##3##(1992-12#1)(1993-12#1)(1994-3#1)(1997-5#1)(2007-7#3)(2008-10#1)(2008-9#1)(2009-5#1)
a preliminary step##3##3##(1990-5#1)(2008-10#1)(2008-4#1)
a preliminary structural##2##3##(1993-11#1)(2008-10#1)
a preliminary study##15##3##(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a preliminary##68##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
a prelude to##2##3##(2007-3#1)(2008-10#1)
a premature aging##2##3##(1995-12#1)(2010-2#1)
a premature infant##2##3##(2007-12#1)(2011-2#1)
a premature##10##2##(1990-8#1)(1991-1#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-12#1)
a premise##2##2##(1992-3#1)(1996-9#1)
a premium##2##2##(1994-12#1)(1995-12#1)
a premixed##3##2##(2008-2#3)
a prenatal##5##2##(1991-12#1)(1992-2#1)(1996-12#1)(2008-11#1)(2013-1#1)
a preoperative diagnosis of##2##4##(1991-3#1)(2008-7#1)
a preoperative diagnosis##3##3##(1991-3#1)(2008-7#2)
a preoperative##14##2##(1990-11#1)(1990-9#2)(1991-3#1)(1992-11#1)(1993-1#1)(1994-7#1)(2007-11#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#1)
a preparation of##2##3##(1990-2#1)(1992-6#1)
a preparation that##2##3##(2009-9#2)
a preparation##7##2##(1990-2#1)(1992-6#1)(2008-10#1)(2008-7#1)(2009-9#2)(2012-2#1)
a preparative##3##2##(1992-3#1)(1997-2#1)(2011-1#1)
a preplated##2##2##(2008-10#2)
a preprocessing##3##2##(2008-10#2)(2008-6#1)
a prerequisite for successful##2##4##(2007-8#1)(2009-7#1)
a prerequisite for the##2##4##(1990-2#1)(1996-5#1)
a prerequisite for##20##3##(1990-2#1)(1991-11#1)(1991-8#1)(1994-11#1)(1995-11#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2012-2#1)
a prerequisite of##2##3##(1991-9#1)(2009-2#1)
a prerequisite to##4##3##(1990-5#1)(1995-6#1)(2008-11#1)(2008-5#1)
a prerequisite##28##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2012-2#1)
a prescribed level##2##3##(2008-7#1)(2009-9#1)
a prescribed##5##2##(2007-12#1)(2008-3#2)(2008-7#1)(2009-9#1)
a prescription drug##3##3##(2008-11#1)(2013-8#2)
a prescription for##4##3##(1991-3#1)(1994-12#1)(1995-2#1)(2009-6#1)
a prescription##11##2##(1991-3#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(2008-11#2)(2009-6#1)(2013-8#2)
a presentation of the##2##4##(2007-11#1)(2008-10#1)
a presentation of##6##3##(1991-1#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
a presentation##11##2##(1991-1#1)(1993-2#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-8#1)
a presenting feature of##5##4##(2007-5#1)(2007-7#1)(2007-8#1)(2008-9#2)
a presenting##6##2##(2007-5#1)(2007-7#1)(2007-8#1)(2008-9#2)(2011-2#1)
a preservation##3##2##(2008-10#3)
a preservative in##2##3##(1990-2#1)(2008-5#1)
a preservative##6##2##(1990-2#1)(2008-10#1)(2008-5#3)(2011-2#1)
a preset##2##2##(2008-10#2)
a prespecified##4##2##(1995-5#1)(2008-3#1)(2008-7#1)(2009-9#1)
a pressing need for##3##4##(2008-12#1)(2010-12#1)(2013-1#1)
a pressing need to##3##4##(1990-9#1)(1995-1#1)(2008-8#1)
a pressing need##6##3##(1990-9#1)(1995-1#1)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#1)
a pressing##7##2##(1990-9#1)(1995-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#1)
a pressure cooker##2##3##(2011-1#2)
a pressure of##4##3##(2007-8#1)(2008-10#2)(2008-6#1)
a pressure##15##2##(1996-4#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#2)
a pressurized##2##2##(2008-10#2)
a presumptive##4##2##(1993-8#1)(1993-9#1)(2008-10#1)(2008-7#1)
a presynaptic##5##2##(1990-12#1)(1995-12#1)(1995-6#1)(1997-2#2)
a preterm infant##3##3##(1994-3#2)(2012-2#1)
a preterm##4##2##(1994-3#2)(2012-12#1)(2012-2#1)
a pretreatment##4##2##(1996-9#1)(2008-10#3)
a pretty##3##2##(1993-2#1)(2009-4#1)(2010-12#1)
a prevalence of##12##3##(1990-2#1)(1991-4#1)(1991-9#1)(1994-11#1)(1997-7#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
a prevalence rate of##6##4##(2006-10#2)(2008-1#2)(2008-7#1)(2013-8#1)
a prevalence##20##2##(1990-2#1)(1991-4#1)(1991-9#1)(1994-11#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
a prevalent##10##2##(1994-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
a preventative##2##2##(2011-1#1)(2012-2#1)
a prevention program for##2##4##(1995-3#1)(2008-12#1)
a prevention program##3##3##(1990-3#1)(1995-3#1)(2008-12#1)
a prevention##7##2##(1990-3#1)(1991-6#2)(1995-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
a preventive and##4##3##(1994-11#1)(2007-12#1)(2009-3#1)(2011-2#1)
a preventive effect on the##2##5##(2008-10#1)(2008-11#1)
a preventive effect on##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
a preventive measure##2##3##(1994-9#1)(2008-4#1)
a preventive##17##2##(1990-6#1)(1992-5#1)(1994-11#1)(1994-9#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#1)
a previous diagnosis of##2##4##(2007-8#1)(2012-3#1)
a previous experiment##2##3##(2008-11#1)(2008-3#1)
a previous history##4##3##(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
a previous manuscript##2##3##(2008-10#1)(2008-5#1)
a previous paper##7##3##(1991-12#1)(2008-10#3)(2008-2#2)(2008-3#1)
a previous report##5##3##(1990-4#1)(1990-5#1)(1990-7#1)(1995-2#2)
a previous study of##2##4##(2008-10#2)
a previous study that##2##4##(2008-10#1)(2008-2#1)
a previous study##24##3##(1991-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
a previous work##3##3##(2009-6#1)(2010-10#1)(2010-4#1)
a previous##107##2##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-6#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#5)(2008-6#3)(2008-7#4)(2008-9#4)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
a previously described##10##3##(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)
a previously developed##3##3##(1990-8#1)(2008-10#1)(2009-11#1)
a previously healthy##6##3##(2007-12#1)(2009-3#2)(2009-8#3)
a previously identified##3##3##(1992-9#2)(1995-6#1)
a previously implanted##3##3##(1993-12#1)(2008-10#2)
a previously published##9##3##(1992-11#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-2#1)(2011-1#1)
a previously reported##17##3##(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a previously undescribed##3##3##(2008-10#2)(2012-3#1)
a previously undiagnosed##3##3##(2010-5#1)(2013-8#2)
a previously unidentified##3##3##(1993-8#1)(1997-7#1)(2011-2#1)
a previously unknown role##2##4##(2008-10#1)(2009-10#1)
a previously unknown##8##3##(1995-2#1)(2008-10#1)(2009-10#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a previously unrecognized##9##3##(1995-2#1)(1995-5#1)(2008-10#4)(2008-2#1)(2009-12#1)(2012-2#1)
a previously unreported##5##3##(1990-9#1)(1994-12#1)(2008-10#1)(2008-8#1)(2010-5#1)
a previously unsuspected##3##3##(1992-3#1)(1994-3#1)(2012-3#1)
a previously##117##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-7#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#2)
a prey##4##2##(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)
a price##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
a primarily cellular##2##3##(2006-10#2)
a primarily##5##2##(1995-3#1)(2006-10#2)(2008-2#1)(2008-3#1)
a primary care clinic##4##4##(1993-12#1)(1996-3#1)(2008-8#1)(2013-1#1)
a primary care setting##4##4##(2008-4#1)(2008-8#2)(2010-2#1)
a primary care##19##3##(1993-10#1)(1993-12#1)(1994-3#2)(1994-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-5#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-2#1)(2013-1#1)
a primary defense barrier##2##4##(1997-2#2)
a primary diagnosis of##3##4##(2007-10#1)(2008-1#1)(2008-3#1)
a primary diagnosis##5##3##(1995-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)
a primary diagnostic##2##3##(1990-6#1)(2008-2#1)
a primary factor##3##3##(2008-10#2)(2010-3#1)
a primary immunodeficiency##2##3##(1990-10#1)(2013-1#1)
a primary lung##2##3##(1993-2#1)(2013-1#1)
a primary malignant##3##3##(1992-11#1)(2008-6#1)(2010-3#1)
a primary mediastinal##2##3##(2007-8#2)
a primary repair##2##3##(2010-12#1)(2011-2#1)
a primary role in##5##4##(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)
a primary source of##3##4##(1995-1#1)(2008-10#2)
a primary structure##2##3##(1992-3#1)(1993-6#1)
a primary tumor in##2##4##(2008-1#1)(2010-3#1)
a primary tumor##5##3##(1992-9#1)(2008-1#1)(2008-6#1)(2010-3#1)(2010-8#1)
a primary##160##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-10#1)(1993-12#4)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#19)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#4)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#2)(2011-1#5)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#8)(2013-8#2)
a prime candidate##2##3##(2008-7#2)
a prime##8##2##(1990-4#1)(1990-5#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)
a primer for##3##3##(2008-11#1)(2008-4#1)(2010-1#1)
a primer on the schemes and the tools to fight health care fraud##2##13##(1993-12#2)
a primer on the##3##4##(1993-12#2)(2013-1#1)
a primer pair##4##3##(1992-2#1)(2008-10#3)
a primer##17##2##(1992-2#1)(1993-12#3)(1993-3#1)(1994-1#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2010-1#1)(2013-1#1)
a primitive##3##2##(1995-6#1)(2008-6#1)(2013-1#1)
a principal component analysis (PCA)##3##5##(1996-5#1)(2008-10#2)
a principal component analysis##8##4##(1996-5#1)(2008-10#3)(2008-2#1)(2010-8#1)(2013-7#1)(2013-8#1)
a principal component of##2##4##(1995-2#1)(1995-6#1)
a principal component##11##3##(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-2#1)(2010-8#1)(2013-7#1)(2013-8#1)
a principal components analysis##2##4##(2008-10#1)(2008-8#1)
a principal diagnosis of##2##4##(2008-3#1)(2013-8#1)
a principal##21##2##(1992-12#1)(1994-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
a principle of##2##3##(1992-3#2)
a principle##4##2##(1992-3#2)(2008-10#1)(2008-5#1)
a printed##2##2##(2008-3#2)
a prior history of##3##4##(2007-7#1)(2008-3#1)(2013-8#1)
a prior low dose##2##4##(2008-7#2)
a prior##24##2##(1991-12#1)(1993-3#1)(1997-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2012-3#1)(2013-7#1)(2013-8#1)
a priori assumption##2##3##(1997-6#1)(2008-2#1)
a priori information##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
a priori knowledge of the##4##5##(2007-12#1)(2008-3#3)
a priori knowledge##8##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
a priori selection of##2##4##(2008-2#1)(2008-7#1)
a priori uncertainties##2##3##(2008-3#2)
a priori unknown##2##3##(2008-3#2)
a priori##54##2##(1990-8#2)(1997-6#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#10)(2008-3#17)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
a prioritized list of##2##4##(2008-10#1)(2008-7#1)
a priority and##2##3##(1992-5#1)(2012-12#1)
a priority for##3##3##(1994-3#1)(2008-6#1)(2010-5#1)
a priority in##4##3##(1993-11#1)(1996-12#1)(2008-11#1)(2008-9#1)
a priority##21##2##(1992-5#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#4)
a priority-setting process##2##3##(2008-7#2)
a prism and##2##3##(2008-3#2)
a prism pair##2##3##(2008-2#1)(2008-3#1)
a prism##10##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)
a prison practice##2##3##(1992-2#2)
a prison-based##2##2##(2009-11#2)
a private laboratory##3##3##(1994-12#1)(1997-4#2)
a private practice##2##3##(1997-5#1)(2008-8#1)
a private##22##2##(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#2)(1997-4#2)(1997-5#1)(2006-10#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
a pro-apoptotic##4##2##(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
a pro-inflammatory effect##2##3##(2008-3#1)(2008-5#1)
a pro-oxidant##2##2##(1991-9#1)(2008-7#1)
a proactive##4##2##(1991-12#1)(1996-1#1)(2007-10#1)(2008-10#1)
a probabilistic framework##2##3##(2009-12#1)(2009-7#1)
a probabilistic##5##2##(2008-1#1)(2008-7#1)(2009-12#1)(2009-7#1)(2013-8#1)
a probability distribution##2##3##(2008-10#2)
a probability of##3##3##(1992-6#1)(2009-4#1)(2012-3#1)
a probability sample of##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
a probability##12##2##(1992-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
a probable##10##2##(1990-3#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-1#1)
a probably##2##2##(1990-9#1)(1991-11#1)
a probe containing##2##3##(1991-2#1)(2008-10#1)
a probe for the##4##4##(1990-8#1)(1995-11#1)(1995-5#1)(1997-7#1)
a probe for##6##3##(1990-8#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-7#1)(2008-10#1)
a probe##73##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#3)(1991-6#3)(1991-9#2)(1992-11#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-6#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#2)(2008-8#5)(2009-6#1)(2013-1#1)
a probit model##2##3##(2008-10#1)(2011-2#1)
a problem and##2##3##(1994-12#1)(1995-9#1)
a problem for the##2##4##(1996-8#1)(2007-2#1)
a problem for##7##3##(1991-2#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
a problem in some##2##4##(1993-3#1)(2011-2#1)
a problem in the##3##4##(1997-1#1)(2008-11#1)(2013-8#1)
a problem in##11##3##(1993-3#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
a problem of##9##3##(1995-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
a problem that##3##3##(2008-11#1)(2009-5#1)(2009-7#1)
a problem with##4##3##(1995-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
a problem##60##2##(1991-2#1)(1991-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-11#2)(1995-12#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
a problem-based learning##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
a problem-solving##3##2##(1992-3#1)(1993-2#2)
a problematic##2##2##(2008-8#1)(2009-12#1)
a procedure based on the##2##5##(2008-10#1)(2008-5#1)
a procedure for preparing##2##4##(2008-4#1)(2008-9#1)
a procedure for the##6##4##(2008-10#2)(2008-3#2)(2010-5#1)(2010-6#1)
a procedure for##31##3##(1992-8#1)(1993-9#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-6#1)(2013-1#1)
a procedure in which##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
a procedure is described for##2##5##(2008-4#1)(2008-8#1)
a procedure is##5##3##(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)
a procedure of##2##3##(2007-11#1)(2008-10#1)
a procedure similar to##2##4##(2008-10#1)(2008-5#1)
a procedure that can##2##4##(1994-11#1)(2011-2#1)
a procedure that uses##2##4##(2008-2#1)(2009-12#1)
a procedure that##9##3##(1990-9#1)(1994-11#1)(2008-10#3)(2008-2#1)(2009-12#1)(2010-8#1)(2011-2#1)
a procedure to measure##2##4##(2008-10#1)(2012-2#1)
a procedure to##5##3##(2008-10#3)(2008-12#1)(2012-2#1)
a procedure with a##2##4##(1994-3#1)(2008-7#1)
a procedure with##3##3##(1994-3#1)(2008-7#1)(2013-7#1)
a procedure##76##2##(1990-7#1)(1990-9#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#9)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
a process by which##2##4##(1996-2#1)(2013-8#1)
a process called##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
a process development##2##3##(2008-11#2)
a process for##5##3##(1993-1#1)(1994-1#1)(2007-12#1)(2008-11#1)(2008-3#1)
a process in##2##3##(1994-8#1)(2011-1#1)
a process indicator##2##3##(2011-1#2)
a process known as##3##4##(2012-2#2)(2012-3#1)
a process of##14##3##(1991-9#1)(1995-8#1)(1997-1#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-3#1)
a process termed##2##3##(2008-4#1)(2010-5#1)
a process that eliminates##2##4##(2008-10#1)(2008-12#1)
a process that involves##4##4##(1997-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
a process that was##2##4##(2008-10#1)(2009-3#1)
a process that##18##3##(1994-11#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)
a process to##6##3##(1992-12#1)(1995-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
a process which is##3##4##(1991-12#2)(1996-2#1)
a process which##8##3##(1991-12#2)(1995-2#1)(1996-12#1)(1996-2#2)(2008-5#1)(2011-2#1)
a process##97##2##(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#5)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#2)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#2)
a processed pseudogene for##2##4##(1997-4#2)
a processed pseudogene##3##3##(1991-6#1)(1997-4#2)
a processed##5##2##(1990-12#1)(1991-6#1)(1993-2#1)(1997-4#2)
a processing scheme##2##3##(2008-2#1)(2008-3#1)
a processing##7##2##(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)
a prodrug##2##2##(1991-8#1)(2012-12#1)
a producer of##2##3##(2008-8#1)(2011-2#1)
a product may##3##3##(2008-5#2)(2008-6#1)
a product of a##2##4##(1993-3#1)(1997-4#1)
a product of the##6##4##(1990-2#1)(1990-8#1)(1995-2#1)(1995-6#1)(2009-10#1)(2012-7#1)
a product of two##2##4##(1990-11#1)(2008-3#1)
a product of##21##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-4#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-7#1)
a product that##2##3##(2008-12#1)(2010-5#1)
a product##47##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#10)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-7#1)
a product's##2##2##(2012-2#1)(2013-1#1)
a production process##2##3##(2008-11#1)(2012-2#1)
a production system##2##3##(2008-11#1)(2013-1#1)
a production##11##2##(1992-11#1)(2008-11#6)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
a productive way to##2##4##(1992-12#1)(1993-2#1)
a productive##7##2##(1992-12#1)(1992-6#1)(1993-2#1)(1995-3#1)(2007-2#1)(2008-10#1)(2013-1#1)
a productivity##4##2##(2008-11#1)(2008-8#1)(2008-9#2)
a profession##7##2##(1991-3#1)(1996-3#1)(2008-1#1)(2008-12#2)(2008-5#1)(2012-2#1)
a professional and human service##2##5##(2011-2#2)
a professional and##4##3##(1994-1#1)(1996-12#1)(2011-2#2)
a professional liability##2##3##(1993-3#1)(1994-1#1)
a professional##23##2##(1991-6#1)(1992-3#1)(1993-3#1)(1994-1#3)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
a professor##2##2##(2009-10#1)(2010-7#1)
a proficient mentor##2##3##(2008-7#2)
a profile of##11##3##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-2#2)(1995-3#1)(1997-3#1)(2008-5#1)(2012-1#1)(2013-1#1)
a profile##14##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-2#2)(1995-3#1)(1997-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
a profit##2##2##(1994-2#1)(1995-2#1)
a profound effect on the##4##5##(2008-10#1)(2008-3#1)(2008-9#1)(2010-6#1)
a profound effect on##6##4##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)(2010-6#1)
a profound impact on##3##4##(1994-12#1)(2010-11#1)(2011-1#1)
a profound influence on##3##4##(2008-11#2)(2010-7#1)
a profound##22##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-7#1)
a profoundly##2##2##(1991-3#1)(2008-7#1)
a progeny##3##2##(2008-10#3)
a prognosis of##2##3##(1996-6#1)(2008-10#1)
a prognostic factor##8##3##(1994-5#1)(1996-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)
a prognostic indicator of##2##4##(2008-7#1)(2009-9#1)
a prognostic indicator##7##3##(1993-11#1)(1994-10#1)(1994-12#1)(1997-4#1)(2008-7#1)(2009-9#1)(2013-1#1)
a prognostic##22##2##(1992-10#1)(1993-11#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-4#1)(1995-9#2)(1996-8#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#1)
a program based##2##3##(2008-10#1)(2013-8#1)
a program for##6##3##(1995-3#1)(1996-9#1)(2008-10#1)(2008-12#2)(2008-4#1)
a program of preventive##3##4##(1993-11#1)(1993-2#1)(1993-3#1)
a program of research##2##4##(2008-11#1)(2012-3#1)
a program of##15##3##(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
a program that is##2##4##(1997-1#1)(2012-3#1)
a program that##4##3##(1997-1#1)(2008-4#1)(2008-7#1)(2012-3#1)
a program to##6##3##(1993-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(2008-3#1)(2012-12#1)
a program was##2##3##(1991-5#1)(2007-11#1)
a program written in##2##4##(2008-10#2)
a program written##3##3##(2008-10#3)
a program##55##2##(1991-12#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
a programmable pulse##3##3##(2007-12#3)
a programmable##8##2##(2007-11#1)(2007-12#3)(2008-3#3)(2009-10#1)
a programmatic##2##2##(2008-10#1)(2010-8#1)
a programme for##2##3##(1993-6#1)(2008-7#1)
a programme of##2##3##(1997-7#1)(2008-7#1)
a programme##7##2##(1993-6#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-10#1)
a programmed##5##2##(2008-10#4)(2011-1#1)
a progress##2##2##(2008-7#1)(2012-3#1)
a progression##4##2##(1991-12#1)(1992-6#1)(1993-8#1)(2008-5#1)
a progression-free survival##2##3##(2011-2#1)(2013-1#1)
a progressive decline in##2##4##(2009-12#1)(2013-7#1)
a progressive decline##3##3##(2009-12#1)(2013-1#1)(2013-7#1)
a progressive decrease in##2##4##(1991-2#1)(2008-5#1)
a progressive decrease##3##3##(1991-2#1)(1995-8#1)(2008-5#1)
a progressive deterioration of##3##4##(2008-7#1)(2009-12#1)(2012-2#1)
a progressive deterioration##4##3##(2006-7#1)(2008-7#1)(2009-12#1)(2012-2#1)
a progressive increase in the##5##5##(1990-7#1)(1991-9#1)(1995-2#1)(2008-11#1)(2010-10#1)
a progressive increase in##6##4##(1990-7#1)(1991-9#1)(1995-2#1)(2008-11#1)(2010-10#1)(2011-1#1)
a progressive increase##7##3##(1990-7#1)(1991-9#1)(1995-2#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-1#1)
a progressive neurodegenerative##2##3##(2008-4#1)(2009-6#1)
a progressive neurological##4##3##(2008-4#1)(2008-9#2)(2013-8#1)
a progressive reduction##2##3##(2008-10#2)
a progressive##59##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
a progressively##2##2##(2007-7#1)(2008-6#1)
a proinflammatory response##2##3##(2012-3#2)
a proinflammatory##4##2##(1995-12#1)(2008-12#1)(2012-3#2)
a project aimed##2##3##(2008-10#1)(2012-12#1)
a project of##2##3##(1990-3#1)(2013-1#1)
a project plan##2##3##(1995-12#1)(1995-2#1)
a project##15##2##(1990-3#1)(1991-12#1)(1995-12#1)(1995-2#1)(2006-5#1)(2008-10#1)(2008-12#4)(2009-10#1)(2010-8#1)(2012-12#2)(2013-1#1)
a projected##5##2##(1994-3#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-2#1)
a projection##5##2##(1990-5#2)(1996-9#1)(2008-2#1)(2008-3#1)
a prokaryote##2##2##(2008-10#2)
a proliferation of##8##3##(1997-7#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-6#3)
a proliferation##9##2##(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-6#3)
a proliferative##6##2##(1990-12#2)(1994-12#1)(1995-11#2)(2013-1#1)
a proline##4##2##(1991-12#1)(1992-6#1)(1994-3#1)(1994-5#1)
a prolongation of the##2##4##(1994-8#1)(2008-7#1)
a prolongation of##5##3##(1994-8#1)(2008-11#1)(2008-7#1)(2013-1#2)
a prolonged QT##2##3##(2009-4#1)(2012-2#1)
a prolonged period of##2##4##(2008-9#2)
a prolonged period##4##3##(2008-7#2)(2008-9#2)
a prolonged##26##2##(1992-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-6#1)(2011-2#2)(2012-2#2)
a prominent feature of##2##4##(1990-5#1)(1997-3#1)
a prominent feature##4##3##(1990-5#1)(1994-11#2)(1997-3#1)
a prominent position##2##3##(2008-9#1)(2009-8#1)
a prominent role in the##2##5##(1990-5#1)(2008-9#1)
a prominent role in##8##4##(1990-5#1)(1992-6#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
a prominent role##9##3##(1990-5#1)(1992-6#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-1#1)
a prominent##39##2##(1990-11#2)(1990-12#1)(1990-5#2)(1991-12#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
a promising advance##2##3##(2008-8#1)(2012-2#1)
a promising alternative to##2##4##(2008-10#1)(2010-8#1)
a promising alternative##3##3##(2008-10#1)(2010-11#1)(2010-8#1)
a promising and##2##3##(2008-10#1)(2010-8#1)
a promising approach for the##5##5##(1992-8#1)(2010-4#1)(2010-5#1)(2012-2#2)
a promising approach for##9##4##(1992-8#1)(2008-10#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-7#1)
a promising approach to##3##4##(2009-10#1)(2010-5#1)(2012-2#1)
a promising approach##15##3##(1992-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#3)(2012-7#1)
a promising candidate as##2##4##(1991-12#1)(2010-6#1)
a promising candidate for##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
a promising candidate##5##3##(1991-12#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-2#1)
a promising drug##2##3##(2008-8#1)(2011-3#1)
a promising means##2##3##(1997-3#1)(2009-10#1)
a promising new##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
a promising novel##2##3##(2010-11#1)(2011-7#1)
a promising potential of##2##4##(2009-3#1)(2012-1#1)
a promising potential##3##3##(2008-5#1)(2009-3#1)(2012-1#1)
a promising result for further##2##5##(2008-9#2)
a promising strategy to##2##4##(1991-2#1)(2008-11#1)
a promising target for##4##4##(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
a promising technique for the##2##5##(1990-11#1)(2011-1#1)
a promising technique for##8##4##(1990-11#1)(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-1#1)(2013-1#1)
a promising technique##11##3##(1990-11#1)(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-3#1)(2011-1#2)(2013-1#1)
a promising therapeutic approach##2##4##(2008-5#1)(2013-1#1)
a promising therapeutic##5##3##(1995-2#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
a promising therapy##2##3##(2007-8#1)(2011-2#1)
a promising tool for##6##4##(1994-12#1)(2008-10#3)(2008-3#1)(2009-11#1)
a promising tool##9##3##(1994-12#1)(1997-4#1)(2008-10#5)(2008-3#1)(2009-11#1)
a promising treatment##3##3##(2006-7#1)(2008-11#1)(2012-3#1)
a promising vector##2##3##(2008-4#1)(2008-5#1)
a promising way##2##3##(2009-10#1)(2012-1#1)
a promising##143##2##(1990-11#2)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-10#1)(1995-2#1)(1997-3#1)(1997-4#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#20)(2008-11#9)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#2)(2012-2#9)(2012-3#3)(2012-7#1)(2013-1#8)(2013-8#1)
a promoter in##2##3##(1995-9#1)(1997-2#1)
a promoter of##3##3##(1996-6#1)(2008-9#1)(2009-2#1)
a promoter that##2##3##(1990-12#1)(2008-2#1)
a promoter##16##2##(1990-12#2)(1991-6#1)(1993-12#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)
a promoterless lacZ##2##3##(1994-12#1)(1997-4#1)
a promoterless##4##2##(1994-12#2)(1997-4#1)(2008-10#1)
a prompt treatment##3##3##(1993-12#1)(2011-1#1)(2013-1#1)
a prompt##6##2##(1991-12#1)(1991-8#1)(1993-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
a pronounced decrease in##2##4##(1993-12#1)(1995-12#1)
a pronounced effect on the##3##5##(2008-5#1)(2008-7#1)(2010-4#1)
a pronounced effect##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
a pronounced increase##2##3##(1997-7#1)(2008-7#1)
a pronounced reduction##2##3##(1996-12#1)(2008-7#1)
a pronounced##21##2##(1990-2#1)(1990-5#1)(1992-9#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-2#1)(2010-4#1)(2012-2#1)
a proof of concept##4##4##(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
a proof-of-concept##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
a propagating##2##2##(2007-11#1)(2008-3#1)
a propagation##4##2##(2007-11#2)(2008-3#2)
a propensity for##2##3##(2008-10#1)(2012-12#1)
a propensity to##3##3##(2008-7#1)(2008-9#1)(2009-5#1)
a propensity##7##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)
a propeptide##2##2##(1991-9#1)(1993-12#1)
a proper initial##2##3##(2007-12#1)(2008-3#1)
a proper##36##2##(1990-2#1)(1991-11#1)(1991-6#1)(1994-2#1)(1996-11#2)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
a properly performed##2##3##(2007-11#1)(2008-6#1)
a properly##8##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-6#1)(2012-3#1)
a property of the##3##4##(1992-5#1)(2008-5#1)(2008-7#1)
a property of##6##3##(1992-5#1)(1994-8#1)(1995-8#1)(2008-5#1)(2008-7#1)(2009-10#1)
a property which##2##3##(1997-2#1)(2008-10#1)
a property##12##2##(1991-5#1)(1992-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)
a prophylactic##6##2##(1990-12#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
a proportion of patients##3##4##(2007-7#2)(2013-1#1)
a proportion of the##4##4##(1996-9#1)(2008-10#2)(2008-7#1)
a proportion of##17##3##(1995-11#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-7#2)(2008-10#6)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
a proportion##20##2##(1995-11#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-7#2)(2008-10#8)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
a proportional##8##2##(1994-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
a proposal for a##3##4##(1994-6#1)(2008-6#1)(2011-2#1)
a proposal to##3##3##(1995-5#1)(1995-6#1)(2008-5#1)
a proposal##9##2##(1991-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)
a proposed mechanism for##2##4##(2008-10#1)(2008-3#1)
a proposed model for##3##4##(1996-12#1)(2010-8#2)
a proposed model##6##3##(1996-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-8#2)
a proposed##34##2##(1991-12#1)(1991-5#1)(1993-1#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#2)
a proprietary##4##2##(1992-12#1)(1993-3#1)(2008-10#1)(2008-6#1)
a prospective analysis##2##3##(2008-7#1)(2011-2#1)
a prospective cohort of##2##4##(2008-9#1)(2013-1#1)
a prospective cohort study of##2##5##(2008-7#1)(2012-1#1)
a prospective cohort study##6##4##(1996-11#1)(2007-10#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-8#1)
a prospective cohort##9##3##(1996-11#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
a prospective evaluation##2##3##(2008-7#1)(2008-8#1)
a prospective investigation##2##3##(1996-9#1)(2008-7#1)
a prospective mentor##2##3##(2008-7#2)
a prospective observational study##3##4##(2008-3#1)(2013-1#1)(2013-8#1)
a prospective payment system (PPS)##2##5##(1992-2#1)(1994-3#1)
a prospective payment system for ambulatory surgery##2##7##(1991-1#2)
a prospective payment system##8##4##(1991-1#3)(1992-12#1)(1992-2#1)(1994-3#2)(1995-2#1)
a prospective payment##9##3##(1991-1#3)(1992-12#1)(1992-2#1)(1994-3#3)(1995-2#1)
a prospective randomised clinical##2##4##(1995-6#1)(2013-1#1)
a prospective randomised##3##3##(1995-6#1)(2012-2#1)(2013-1#1)
a prospective randomized study##2##4##(2007-8#1)(2012-3#1)
a prospective randomized trial##2##4##(1993-9#1)(2008-6#1)
a prospective randomized##5##3##(1993-9#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-3#1)
a prospective study from##2##4##(2007-10#1)(2007-7#1)
a prospective study of##9##4##(1990-2#2)(1990-5#1)(1995-2#1)(2007-11#1)(2008-7#3)(2012-12#1)
a prospective study##30##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1993-2#1)(1995-2#1)(1995-9#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
a prospective##114##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#5)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-9#2)(1997-3#1)(1997-8#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-7#5)(2007-8#3)(2008-10#1)(2008-11#2)(2008-3#4)(2008-4#1)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
a prospectively##4##2##(1995-3#1)(2008-6#1)(2012-3#1)(2013-1#1)
a prosthesis##3##2##(2008-2#1)(2009-4#1)(2010-8#1)
a prosthetic joint##2##3##(2006-10#1)(2012-12#1)
a prosthetic##4##2##(2006-10#1)(2012-12#1)(2013-1#2)
a protease involved in##2##4##(2008-6#1)(2008-7#1)
a protease##5##2##(1991-12#1)(1992-8#1)(1995-6#1)(2008-6#1)(2008-7#1)
a protease-resistant##3##2##(1995-2#1)(1995-6#1)(1996-5#1)
a proteasome inhibitor##2##3##(2010-8#1)(2012-12#1)
a protected##5##2##(2008-4#1)(2008-5#1)(2008-7#1)(2013-7#2)
a protecting##4##2##(1997-6#1)(2008-10#3)
a protection against##2##3##(1991-12#1)(2008-10#1)
a protection##4##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
a protective effect against##2##4##(2008-10#1)(2008-11#1)
a protective effect of##3##4##(1994-9#1)(2011-1#1)(2012-12#1)
a protective effect on the##2##5##(2008-12#1)(2008-9#1)
a protective effect on##4##4##(1992-12#1)(2008-12#1)(2008-7#1)(2008-9#1)
a protective effect##17##3##(1992-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
a protective factor against##5##4##(1995-12#1)(2009-11#1)(2009-7#1)(2011-1#1)(2013-1#1)
a protective factor for##4##4##(2009-12#1)(2009-7#1)(2011-2#1)(2013-8#1)
a protective factor in##2##4##(2009-11#1)(2011-1#1)
a protective factor##12##3##(1995-12#1)(2009-11#2)(2009-12#1)(2009-7#2)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
a protective medium##2##3##(2008-10#2)
a protective role for##2##4##(1993-5#1)(1997-2#1)
a protective role of##2##4##(1995-12#1)(2010-11#1)
a protective role##7##3##(1993-5#1)(1995-12#1)(1996-12#1)(1997-2#1)(2009-6#1)(2010-11#1)(2011-2#1)
a protective##53##2##(1992-1#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-12#3)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-3#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
a protein and##2##3##(1991-5#1)(1992-9#1)
a protein antigen-antibody interaction##2##4##(1997-2#2)
a protein binding assay system##2##5##(1990-12#2)
a protein complex that##2##4##(1995-2#1)(2007-12#1)
a protein complex##3##3##(1995-2#1)(2007-12#1)(2009-9#1)
a protein consisting of##2##4##(1995-8#1)(2008-9#1)
a protein encoded##2##3##(1995-5#1)(1995-8#1)
a protein fraction##2##3##(1991-5#1)(2008-6#1)
a protein homologous to##2##4##(1990-5#1)(2013-1#1)
a protein in the##2##4##(2008-4#1)(2008-5#1)
a protein in##5##3##(1995-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
a protein inhibitor of##2##4##(1994-6#1)(2008-7#1)
a protein inhibitor##3##3##(1993-3#1)(1994-6#1)(2008-7#1)
a protein involved in the##2##5##(2009-12#1)(2012-2#1)
a protein involved in##3##4##(2009-12#1)(2011-2#1)(2012-2#1)
a protein is##5##3##(1993-11#1)(1995-12#1)(1997-2#1)(2008-4#1)(2008-9#1)
a protein kinase A##2##4##(1995-11#1)(2009-12#1)
a protein kinase C (PKC)##2##5##(1994-11#1)(1997-1#1)
a protein kinase C inhibitor##2##5##(1990-2#1)(2008-11#1)
a protein kinase C##7##4##(1990-11#1)(1990-2#1)(1991-12#1)(1994-11#1)(1996-6#1)(1997-1#1)(2008-11#1)
a protein kinase inhibitor##4##4##(1990-12#2)(1995-12#1)(1995-2#1)
a protein kinase##19##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-6#1)(1997-1#1)(2008-11#1)(2009-12#1)(2009-7#1)
a protein ligand##2##3##(1992-6#1)(2008-10#1)
a protein of 1##2##4##(1990-8#1)(2008-10#1)
a protein of 386 amino##2##5##(1994-8#1)(1997-2#1)
a protein of approximately##2##4##(1995-2#1)(1996-10#1)
a protein of interest##2##4##(2008-4#1)(2012-2#1)
a protein of##64##3##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-7#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#5)(1994-12#4)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-6#4)(1997-2#2)(1997-3#1)(1997-7#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2012-2#1)
a protein or protein complex##2##5##(1991-11#1)(2008-4#1)
a protein or##6##3##(1991-11#1)(1995-5#1)(2008-4#3)(2008-9#1)
a protein phosphatase##2##3##(1997-4#1)(2008-10#1)
a protein precursor##2##3##(1993-12#2)
a protein sequence##2##3##(2008-4#1)(2008-9#1)
a protein that is##4##4##(1995-12#1)(2007-7#1)(2008-4#2)
a protein that##10##3##(1990-12#1)(1992-3#1)(1993-12#1)(1995-12#1)(1995-2#1)(2007-7#1)(2008-4#2)(2008-8#1)(2012-12#1)
a protein to##3##3##(1993-11#1)(2008-11#1)(2008-4#1)
a protein tyrosine phosphatase##3##4##(1993-11#1)(1995-9#1)(2009-7#1)
a protein which##5##3##(1991-12#1)(1991-2#1)(1992-3#1)(1995-8#1)(1997-3#1)
a protein with a molecular weight of##2##7##(1990-7#1)(1993-6#1)
a protein with a molecular##3##5##(1990-7#1)(1993-6#1)(2008-10#1)
a protein with a##4##4##(1990-7#1)(1993-6#1)(1995-12#1)(2008-10#1)
a protein with an##4##4##(1991-2#1)(1995-5#1)(2008-6#1)(2010-4#1)
a protein with##22##3##(1990-5#1)(1990-7#1)(1991-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-6#2)(2008-8#4)(2009-10#1)(2010-2#1)(2010-4#1)(2011-2#1)
a protein##261##2##(1990-11#6)(1990-12#5)(1990-2#2)(1990-5#5)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-7#1)(1991-9#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#9)(1994-12#7)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#8)(1995-9#1)(1996-10#1)(1996-12#1)(1996-6#5)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#5)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#23)(2008-11#8)(2008-2#2)(2008-4#23)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#12)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)(2013-8#3)
a protein's##3##2##(1994-11#1)(2008-2#1)(2011-1#1)
a protein)##2##2##(2008-4#2)
a protein-DNA complex##2##3##(1995-2#1)(1997-7#1)
a protein-free medium##4##3##(2008-11#4)
a protein-free##7##2##(1993-12#2)(1993-9#1)(2008-11#4)
a protein-synthesis-independent##2##2##(1993-6#1)(2008-7#1)
a proteinaceous##5##2##(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
a proteinase##2##2##(2008-10#1)(2008-11#1)
a proteolytic activity##2##3##(1990-2#1)(1991-12#1)
a proteolytic##3##2##(1990-2#1)(1991-12#1)(2008-11#1)
a proteolytically##2##2##(1992-6#1)(2009-7#1)
a proteomic##3##2##(2008-7#1)(2010-12#2)
a proteomics##2##2##(2008-10#1)(2008-7#1)
a protocol and##3##3##(2007-11#1)(2008-5#1)(2012-3#1)
a protocol for management of##2##5##(2007-8#1)(2012-2#1)
a protocol for obtaining cryosections is given##2##7##(2008-2#1)(2008-4#1)
a protocol for the##4##4##(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
a protocol for##29##3##(1997-2#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#10)(2008-7#1)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#1)
a protocol in which##4##4##(1993-11#1)(2008-1#1)(2008-4#2)
a protocol is given##2##4##(2008-2#1)(2008-4#1)
a protocol is provided##2##4##(2008-4#2)
a protocol is##7##3##(2008-2#1)(2008-4#5)(2008-9#1)
a protocol of##3##3##(1996-2#1)(2008-9#1)(2012-1#1)
a protocol that##5##3##(2008-11#1)(2008-2#1)(2008-4#2)(2012-12#1)
a protocol to##4##3##(2007-7#1)(2008-4#3)
a protocol##64##2##(1991-4#1)(1993-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#4)(2008-2#5)(2008-4#22)(2008-5#3)(2008-7#1)(2008-9#7)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
a proton from##2##3##(1992-10#1)(2008-10#1)
a proton gradient##2##3##(1990-2#1)(1995-2#1)
a proton transfer##2##3##(2008-10#1)(2010-2#1)
a proton##14##2##(1990-2#2)(1990-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1995-2#1)(2007-11#1)(2008-10#3)(2010-2#1)(2012-2#2)
a proton-pump inhibitor##2##3##(2010-12#1)(2013-1#1)
a protonation constants determination##2##4##(2008-10#2)
a prototype for##3##3##(1992-2#1)(2008-12#1)(2009-11#1)
a prototype laboratory##2##3##(2007-6#1)(2008-3#1)
a prototype of##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)
a prototype##36##2##(1991-9#1)(1992-2#1)(1992-3#1)(1994-5#1)(1994-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-6#2)(2008-9#1)(2009-11#2)(2009-3#1)(2010-11#1)(2011-2#1)
a prototypical##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
a protracted##3##2##(2008-10#2)(2008-12#1)
a proven##5##2##(1992-11#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-5#1)
a provider##6##2##(1992-3#1)(1994-3#2)(1995-12#1)(1995-3#1)(2012-12#1)
a province##3##2##(1992-1#1)(1993-2#1)(2009-6#1)
a provisional##5##2##(1992-6#1)(1995-3#1)(2007-1#1)(2009-7#1)(2011-1#1)
a provocative##2##2##(1994-2#1)(1996-3#1)
a proximal##12##2##(1992-6#1)(1994-2#2)(1997-3#1)(1997-8#1)(2008-10#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-3#1)(2013-7#1)
a proxy measure##2##3##(1997-7#1)(2009-4#1)
a proxy##8##2##(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
a prozoning anti-Fya##2##3##(1992-6#2)
a prozoning##3##2##(1992-6#3)
a pruritic##3##2##(2007-2#2)(2010-6#1)
a pseudo##3##2##(2008-10#2)(2009-3#1)
a pseudo-first order##2##3##(1990-11#1)(2008-10#1)
a pseudoaneurysm##2##2##(2008-12#1)(2012-12#1)
a pseudogene##4##2##(1993-12#1)(1993-2#1)(1994-6#1)(2008-1#1)
a pseudorandom##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
a psychiatric hospital##4##3##(1991-2#1)(1993-2#2)(2012-12#1)
a psychiatric mental health##2##4##(2008-1#1)(2008-12#1)
a psychiatric patient##3##3##(1996-12#1)(1997-8#1)(2012-12#1)
a psychiatric ward##2##3##(2011-2#1)(2012-3#1)
a psychiatric##22##2##(1991-2#2)(1992-11#1)(1993-12#1)(1993-2#2)(1995-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#3)(2012-3#2)
a psychiatrist##2##2##(1996-11#1)(2009-9#1)
a psychoanalytical##3##2##(1991-2#1)(2008-12#1)(2010-6#1)
a psychological##4##2##(1993-3#1)(2008-2#1)(2008-6#1)(2011-3#1)
a psychologist##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
a psychophysical##2##2##(2008-10#1)(2013-8#1)
a psychosocial##5##2##(1991-1#1)(1992-3#1)(1996-1#1)(2008-10#1)(2011-2#1)
a psychotherapeutic##3##2##(2010-9#1)(2012-3#1)(2013-1#1)
a psychotic disorder##3##3##(2008-4#2)(2008-9#1)
a public charity may##2##4##(1996-3#2)
a public health care##3##4##(1991-3#1)(1994-9#2)
a public health issue##3##4##(2008-9#2)(2010-7#1)
a public health perspective##2##4##(1995-12#1)(2008-7#1)
a public health problem in the##2##6##(2008-10#1)(2012-12#1)
a public health problem in##3##5##(2008-10#1)(2008-11#1)(2012-12#1)
a public health problem##8##4##(1995-6#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-9#1)(2012-12#1)(2013-1#2)
a public health##33##3##(1991-3#2)(1992-1#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-1#2)
a public hospital in Santiago##2##5##(2013-1#2)
a public hospital in##6##4##(2013-1#5)(2013-8#1)
a public hospital##8##3##(2008-7#1)(2013-1#6)(2013-8#1)
a public##68##2##(1991-12#1)(1991-3#2)(1991-8#1)(1992-1#1)(1993-1#2)(1993-2#1)(1993-5#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#5)(2012-3#4)(2013-1#8)(2013-8#1)
a publicity plan##2##3##(1992-12#2)
a publicly##4##2##(1992-2#1)(1994-2#1)(2008-5#1)(2008-6#1)
a published##6##2##(1993-2#1)(1996-3#1)(2008-10#2)(2008-7#1)(2009-2#1)
a pulmonary##9##2##(1990-6#2)(1993-3#1)(1996-3#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-8#1)
a pulsatile##4##2##(1997-2#2)(2007-8#1)(2008-7#1)
a pulsating##2##2##(1997-3#1)(2009-7#1)
a pulse compressor##2##3##(2007-12#1)(2008-2#1)
a pulse duration of##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
a pulse energy of##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
a pulse in the##2##4##(2007-11#1)(2007-12#1)
a pulse in##3##3##(2007-11#2)(2007-12#1)
a pulse of##2##3##(2008-1#1)(2008-7#1)
a pulse propagating down##2##4##(2007-11#1)(2007-12#1)
a pulse quality factor##2##4##(2007-11#2)
a pulse repetition rate of##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
a pulse shaper##2##3##(2007-11#1)(2007-12#1)
a pulse width of##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
a pulse width##7##3##(2007-11#1)(2007-12#3)(2008-3#3)
a pulse##39##2##(2007-11#11)(2007-12#10)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)
a pulse-repetition rate##2##3##(2007-11#1)(2008-3#1)
a pulsed Nd##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
a pulsed flow##2##3##(2008-10#2)
a pulsed laser beam##2##4##(2008-3#1)(2012-2#1)
a pulsed laser##6##3##(2007-12#1)(2008-10#1)(2008-3#3)(2012-2#1)
a pulsed optical parametric oscillator##2##5##(2008-3#2)
a pulsed quench-flow apparatus##2##4##(1990-2#2)
a pulsed top-hat beam thermal lens##2##6##(2008-3#2)
a pulsed top-hat beam##3##4##(2008-3#3)
a pulsed##52##2##(1990-2#2)(1992-1#2)(1995-12#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-2#9)(2008-3#24)(2008-7#1)(2009-11#1)(2012-2#1)
a pump energy of##2##4##(2007-11#2)
a pump power of##4##4##(2007-11#1)(2007-12#3)
a pump pulse##2##3##(2007-11#1)(2007-12#1)
a pump source##4##3##(2007-11#2)(2007-12#2)
a pump wavelength of##2##4##(2007-12#2)
a pump##27##2##(2007-11#10)(2007-12#16)(2008-3#1)
a pump-and-signal-resonant optical parametric oscillator##2##5##(2007-12#2)
a pumping##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a punctate##2##2##(2008-8#1)(2009-8#1)
a pupil##4##2##(2007-11#3)(2008-2#1)
a puppy##2##2##(2012-12#1)(2012-2#1)
a pure amount effect##2##4##(2008-8#2)
a pure culture of##2##4##(2008-6#1)(2008-7#1)
a pure culture##4##3##(2008-6#1)(2008-7#2)(2010-4#1)
a pure##33##2##(1992-3#1)(1993-11#1)(1994-11#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#2)(2009-7#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
a purely##5##2##(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
a purge-and-trap##3##2##(2008-10#3)
a purification##2##2##(2008-11#1)(2008-4#1)
a purified##14##2##(1991-5#1)(1992-11#1)(1992-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-4#4)(2011-2#1)(2012-2#1)
a purity higher than##2##4##(1994-3#1)(1997-2#1)
a purity##4##2##(1994-3#1)(1994-6#1)(1997-2#1)(2009-3#1)
a purpose to##2##3##(2008-10#1)(2012-2#1)
a purpose##5##2##(2008-10#2)(2008-9#1)(2012-2#2)
a purposeful##2##2##(2013-1#1)(2013-8#1)
a purposive sample of##3##4##(2008-12#1)(2010-10#1)(2011-1#1)
a puréed diet##3##3##(1995-3#3)
a putative DNA##2##3##(1995-5#1)(2012-2#1)
a putative animal model##2##4##(2008-4#1)(2008-6#1)
a putative beta-galactosidase-binding##2##3##(1995-2#2)
a putative binding site for the##2##6##(1993-12#1)(1993-3#1)
a putative inhibitor of##2##4##(1993-3#1)(1995-12#1)
a putative member of the##3##5##(1995-8#1)(2008-10#1)(2009-7#1)
a putative member of##4##4##(1995-8#1)(2008-10#1)(2009-7#2)
a putative metabolite of##2##4##(1990-7#1)(1994-5#1)
a putative new##4##3##(1994-8#1)(1997-3#1)(1997-8#1)(2011-2#1)
a putative protein kinase##2##4##(1991-7#1)(2008-10#1)
a putative protein of##3##4##(1997-4#1)(2008-10#1)(2010-5#1)
a putative protein##6##3##(1991-7#1)(1995-6#1)(1997-4#1)(2008-10#2)(2010-5#1)
a putative role for##2##4##(1990-11#1)(1996-5#1)
a putative role##4##3##(1990-11#1)(1994-6#1)(1996-5#1)(2009-8#1)
a putative signal peptide##2##4##(1990-12#1)(2009-2#1)
a putative signal##3##3##(1990-12#1)(1993-3#1)(2009-2#1)
a putative target protein for Rab3A##3##6##(1994-11#1)(1994-9#2)
a putative##115##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1991-10#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#10)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-7#4)(1997-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#4)(2009-11#2)(2009-2#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
a pyramidal silicon probe##2##4##(2007-12#2)
a pyramidal silicon##3##3##(2007-12#3)
a pyramidal##4##2##(2007-12#3)(2008-7#1)
a pyrimidine##2##2##(1994-8#1)(1997-2#1)
a pyroelectric##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2011-1#1)
a pyrrole##2##2##(1994-9#1)(2008-10#1)
a pyruvate##2##2##(1990-5#1)(2008-10#1)
a quadrat##4##2##(2008-10#3)(2008-8#1)
a quadratic cost##2##3##(2008-2#1)(2012-12#1)
a quadratic equation##2##3##(2008-10#2)
a quadratic function##2##3##(2008-3#1)(2013-8#1)
a quadratic phase##2##3##(2007-12#1)(2008-3#1)
a quadratic##18##2##(2007-11#1)(2007-12#3)(2008-10#7)(2008-2#2)(2008-3#2)(2008-7#1)(2012-12#1)(2013-8#1)
a quadrivalent##2##2##(2013-1#2)
a quadrupole mass spectrometer##2##4##(2008-10#2)
a quadrupole mass##3##3##(2008-10#3)
a quadrupole##6##2##(2007-12#1)(2008-10#5)
a qualitative analysis of the##2##5##(2008-2#1)(2009-5#1)
a qualitative analysis of##4##4##(1996-1#2)(2008-2#1)(2009-5#1)
a qualitative analysis##5##3##(1996-1#2)(2008-2#1)(2009-5#1)(2013-1#1)
a qualitative and quantitative##3##4##(2008-11#1)(2013-1#1)(2013-7#1)
a qualitative and##5##3##(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a qualitative approach##2##3##(2008-9#1)(2009-5#1)
a qualitative descriptive study exploring##2##5##(2008-11#1)(2013-8#1)
a qualitative descriptive##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
a qualitative evaluation##2##3##(2008-1#1)(2008-11#1)
a qualitative index of##2##4##(1997-4#1)(2008-10#1)
a qualitative meta-analysis##2##3##(2008-7#1)(2008-9#1)
a qualitative research methodology##2##4##(1995-3#1)(2008-11#1)
a qualitative research##3##3##(1995-12#1)(1995-3#1)(2008-11#1)
a qualitative study of the##2##5##(2008-12#1)(2008-9#1)
a qualitative study of##3##4##(2008-12#1)(2008-9#1)(2009-4#1)
a qualitative study##18##3##(1995-6#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
a qualitative##74##2##(1990-8#1)(1994-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-1#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#2)(2009-5#3)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
a quality and##3##3##(1993-3#1)(1995-3#1)(2008-4#1)
a quality control##5##3##(1994-12#1)(1996-12#1)(2008-10#3)
a quality factor##2##3##(2008-3#1)(2009-5#1)
a quality improvement culture##2##4##(2009-3#2)
a quality improvement tool##3##4##(1997-1#3)
a quality improvement##13##3##(1993-3#2)(1994-12#2)(1994-3#1)(1995-6#1)(1997-1#3)(1997-3#1)(2009-3#2)(2013-1#1)
a quality indicator##2##3##(1993-12#1)(2013-1#1)
a quality orientation##2##3##(1997-3#2)
a quality planning##2##3##(1993-12#2)
a quality that is##2##4##(1992-1#1)(2008-1#1)
a quality volunteer##2##3##(1992-3#1)(1995-12#1)
a quality work environment##2##4##(2012-3#2)
a quality work##3##3##(2008-11#1)(2012-3#2)
a quality##54##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-3#3)(1994-12#4)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#4)(1997-3#4)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#2)(2009-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
a quantification limit of##2##4##(2008-10#2)
a quantified##2##2##(1992-3#1)(2008-10#1)
a quantile##2##2##(2012-1#2)
a quantitation limit##2##3##(2008-10#2)
a quantitative analysis of the##3##5##(2008-7#1)(2008-9#1)(2012-3#1)
a quantitative analysis##4##3##(1994-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
a quantitative and##2##3##(2009-6#1)(2010-3#1)
a quantitative approach##3##3##(2008-10#2)(2008-9#1)
a quantitative assay##2##3##(2008-1#1)(2008-10#1)
a quantitative assessment of##2##4##(2008-3#1)(2009-9#1)
a quantitative comparison##2##3##(2008-7#1)(2012-2#1)
a quantitative description of the##3##5##(1997-6#1)(2010-5#1)(2011-1#1)
a quantitative description of##5##4##(1996-1#1)(1997-6#1)(2008-3#1)(2010-5#1)(2011-1#1)
a quantitative descriptive analysis (QDA)##2##5##(2008-10#1)(2011-2#1)
a quantitative descriptive##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
a quantitative evaluation of the##2##5##(2008-10#1)(2013-1#1)
a quantitative genetics##2##3##(1997-5#1)(2008-8#1)
a quantitative in vitro##2##4##(1993-1#1)(2008-1#1)
a quantitative measure of the##2##5##(2008-4#1)(2010-10#1)
a quantitative measure of##5##4##(1996-6#1)(2008-3#1)(2008-4#1)(2010-10#1)(2013-7#1)
a quantitative method for##2##4##(2008-3#1)(2012-2#1)
a quantitative method##5##3##(2008-10#1)(2008-3#1)(2008-5#2)(2012-2#1)
a quantitative model##5##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#2)
a quantitative study##2##3##(2008-1#1)(2008-5#1)
a quantitative trait locus (QTL) analysis##2##6##(2008-10#1)(2008-8#1)
a quantitative trait locus##3##4##(2008-10#1)(2008-8#1)(2010-4#1)
a quantitative trait##12##3##(2008-10#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#4)
a quantitative##103##2##(1992-5#2)(1993-1#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#18)(2008-3#10)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#8)(2008-9#6)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#2)
a quantum cascade laser##2##4##(2007-11#2)
a quantum yield##2##3##(1992-4#1)(2008-10#1)
a quantum##13##2##(1990-12#1)(1992-4#1)(1993-5#1)(2007-11#4)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
a quantum-dot microcavity##2##3##(2007-12#2)
a quarantine##2##2##(2008-10#1)(2011-2#1)
a quarter of the##5##4##(1996-9#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
a quarter of##7##3##(1992-3#1)(1992-6#1)(1996-9#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
a quarter##10##2##(1992-3#1)(1992-6#2)(1993-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
a quarter-wave plate##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
a quarter-wave##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
a quartz crystal microbalance##4##4##(2008-10#4)
a quartz crystal##8##3##(2008-10#6)(2009-5#2)
a quartz##21##2##(2007-12#2)(2007-9#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)
a quasi##2##2##(2008-3#1)(2008-7#1)
a quasi-cw##2##2##(2008-3#2)
a quasi-experimental##3##2##(1995-1#1)(1996-3#1)(2008-11#1)
a quasi-monochromatic##5##2##(2007-12#1)(2008-3#4)
a quasi-phase-matching##2##2##(2007-12#2)
a quaternary ammonium##3##3##(2008-10#2)(2008-3#1)
a quaternary##7##2##(1997-2#1)(2008-10#4)(2008-3#2)
a quencher##2##2##(1994-3#1)(1994-5#1)
a quenching##2##2##(2008-10#2)
a query##3##2##(2008-10#1)(2008-9#2)
a question about##3##3##(1992-4#1)(1992-5#1)(1994-5#1)
a question of##3##3##(1993-12#1)(2008-9#1)(2010-8#1)
a question##11##2##(1990-2#1)(1991-1#1)(1992-4#1)(1992-5#1)(1993-12#1)(1994-5#1)(2008-11#1)(2008-9#1)(2010-8#2)(2013-1#1)
a questionnaire about##3##3##(1994-12#1)(1997-2#1)(2008-1#1)
a questionnaire during##2##3##(1990-2#1)(2010-10#1)
a questionnaire for##2##3##(1997-2#1)(2013-1#1)
a questionnaire on##2##3##(2011-1#1)(2013-1#1)
a questionnaire study##2##3##(1997-3#1)(2010-10#1)
a questionnaire survey of##2##4##(1995-2#1)(1997-5#1)
a questionnaire survey##6##3##(1995-2#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-6#1)(2011-1#1)
a questionnaire that##4##3##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
a questionnaire to##6##3##(1992-12#1)(1995-11#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
a questionnaire was given to##2##5##(2008-12#1)(2013-1#1)
a questionnaire was mailed to##2##5##(2008-4#2)
a questionnaire was sent to##2##5##(1997-2#1)(2007-2#1)
a questionnaire was##7##3##(1996-9#1)(1997-2#1)(2007-2#1)(2008-12#1)(2008-4#2)(2013-1#1)
a questionnaire with##2##3##(2011-2#1)(2013-1#1)
a questionnaire##81##2##(1990-2#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#2)(1993-12#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#2)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#7)
a questionnaire-based##3##2##(2010-5#1)(2012-2#1)(2013-1#1)
a quick and effective##3##4##(2007-11#1)(2008-10#1)(2009-8#1)
a quick and##9##3##(1990-8#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-8#1)
a quick response##2##3##(2008-10#1)(2008-12#1)
a quick##23##2##(1990-8#1)(1990-9#1)(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-3#1)(2009-8#1)(2013-8#1)
a quicker##3##2##(1997-8#1)(2010-1#1)(2011-2#1)
a quiescent state##2##3##(2008-10#1)(2008-7#1)
a quiescent##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
a quite different##2##3##(1994-3#1)(2008-7#1)
a quite large##2##3##(2008-10#1)(2013-8#1)
a quite##9##2##(1994-3#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
a rabbit reticulocyte lysate##2##4##(1990-11#1)(1991-10#1)
a rabbit##13##2##(1990-11#1)(1991-10#1)(1993-6#1)(1997-6#2)(2007-8#1)(2008-10#3)(2009-3#2)(2012-1#1)(2012-3#1)
a race 2 isolate##3##4##(2008-10#3)
a race##4##2##(2008-10#4)
a radial artery perforator##2##4##(2008-9#2)
a radial artery##3##3##(2007-8#1)(2008-9#2)
a radial laser array##2##4##(2008-2#2)
a radial##12##2##(1991-8#1)(1993-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
a radially symmetric##2##3##(1994-2#1)(2008-3#1)
a radially##3##2##(1994-2#1)(2008-2#1)(2008-3#1)
a radiation oncology##2##3##(1994-3#2)
a radiation##11##2##(1994-12#1)(1994-3#2)(1995-8#1)(1997-8#1)(2007-11#1)(2008-11#3)(2008-3#1)(2008-7#1)
a radiative transfer model##2##4##(2008-2#2)
a radiative transfer##3##3##(2008-2#2)(2008-3#1)
a radical operation##3##3##(1990-3#1)(1990-9#1)(1993-11#1)
a radical vulvar##2##3##(1992-3#2)
a radical##21##2##(1990-2#1)(1990-3#1)(1990-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-6#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#3)(2013-1#1)(2013-8#1)
a radically##3##2##(1994-12#1)(2007-11#1)(2007-12#1)
a radio##2##2##(2008-3#1)(2010-3#1)
a radio-opaque##2##2##(2008-7#1)(2012-2#1)
a radioactive##5##2##(1991-5#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-4#1)
a radiofrequency##2##2##(2007-8#1)(2008-6#1)
a radiographic##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
a radioimmunoassay (RIA)##2##3##(1990-2#1)(2008-4#1)
a radioimmunoassay##6##2##(1990-2#1)(1990-7#1)(1990-8#1)(1993-12#1)(2008-3#1)(2008-4#1)
a radiolabeled antigen##2##3##(2008-4#2)
a radiolabeled##10##2##(1993-3#1)(1993-8#2)(1994-5#1)(1995-3#1)(1996-3#1)(1997-7#1)(2008-4#2)(2009-12#1)
a radioligand##3##2##(1990-11#1)(1992-11#1)(1994-8#1)
a radiologic##3##2##(1994-1#1)(2008-10#1)(2011-2#1)
a radiological##5##2##(1992-5#1)(1993-3#1)(1996-8#1)(2008-9#1)(2013-1#1)
a radiologist##3##2##(2011-2#1)(2013-1#2)
a radiology department##2##3##(2007-4#1)(2012-2#1)
a radiology information system##5##4##(1991-1#1)(1992-12#2)(1994-2#1)(2007-4#1)
a radiology information##6##3##(1991-1#1)(1992-12#2)(1992-2#1)(1994-2#1)(2007-4#1)
a radiology##10##2##(1991-1#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(2007-4#2)(2012-2#1)
a radiolucent##2##2##(2010-5#2)
a radiometric##3##2##(2008-2#1)(2008-3#2)
a radioprotective##2##2##(2008-7#1)(2011-2#1)
a radiosensitizer##3##2##(1990-6#1)(1991-2#1)(2008-9#1)
a radius of##3##3##(2007-11#1)(2008-10#2)
a radius##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
a rain##5##2##(2008-10#4)(2008-2#1)
a rainbow##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
a raise##3##2##(1991-12#2)(2008-2#1)
a raised##3##2##(1997-4#1)(2007-7#1)(2011-2#1)
a ramified##2##2##(2007-12#1)(2008-12#1)
a ramp-hold-fire##2##2##(2008-3#2)
a random coil##2##3##(1996-2#1)(2008-7#1)
a random digit##2##3##(2012-12#1)(2013-1#1)
a random distribution of##3##4##(2007-11#1)(2008-12#1)(2008-3#1)
a random distribution##4##3##(1995-9#1)(2007-11#1)(2008-12#1)(2008-3#1)
a random orientation##2##3##(2008-2#1)(2008-3#1)
a random pattern##2##3##(1995-1#1)(2008-10#1)
a random process##2##3##(1997-2#1)(2008-10#1)
a random sample from##2##4##(2008-7#2)
a random sample of 1##4##5##(1990-9#1)(1992-8#1)(1993-2#1)(1996-6#1)
a random sample of##25##4##(1990-9#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#1)
a random sample##31##3##(1990-9#1)(1991-3#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#2)
a random sampling of##2##4##(2007-12#1)(2008-11#1)
a random spatial##2##3##(1991-6#1)(2008-10#1)
a random walk##2##3##(2008-2#1)(2012-3#1)
a random##93##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#2)
a random-effects##2##2##(1995-12#1)(1995-2#1)
a randomised clinical trial##2##4##(1990-6#1)(2013-1#1)
a randomised controlled trial##3##4##(1990-3#1)(2011-1#1)(2013-1#1)
a randomised controlled##4##3##(1990-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
a randomised trial of##3##4##(1990-2#1)(1997-5#1)(2008-8#1)
a randomised trial##4##3##(1990-2#1)(1991-8#1)(1997-5#1)(2008-8#1)
a randomised##15##2##(1990-2#1)(1990-3#2)(1990-6#1)(1991-8#1)(1997-5#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-1#3)
a randomized clinical trial##9##4##(1991-12#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
a randomized complete block design with##2##6##(2008-10#1)(2008-12#1)
a randomized complete block design##5##5##(2008-10#4)(2008-12#1)
a randomized control trial##2##4##(2008-10#1)(2010-7#1)
a randomized control##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
a randomized controlled clinical##2##4##(2010-12#1)(2013-1#1)
a randomized controlled study##6##4##(2008-12#2)(2008-8#2)(2012-2#1)(2012-3#1)
a randomized controlled trial of##2##5##(2008-8#1)(2013-1#1)
a randomized controlled trial##12##4##(1997-2#1)(1997-4#1)(2008-7#2)(2008-8#3)(2009-12#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
a randomized controlled##24##3##(1997-2#1)(1997-4#1)(2008-12#2)(2008-7#2)(2008-8#5)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
a randomized double-blind##3##3##(2008-5#2)(2008-7#1)
a randomized study with##2##4##(1991-8#1)(1993-8#1)
a randomized study##4##3##(1991-8#1)(1993-8#1)(2008-11#1)(2008-3#1)
a randomized trial comparing##2##4##(1993-11#1)(1995-12#1)
a randomized trial in##3##4##(1990-5#1)(1992-12#1)(1994-8#1)
a randomized trial##14##3##(1990-5#1)(1990-6#1)(1992-12#1)(1993-11#1)(1994-8#2)(1995-12#1)(1995-3#1)(2007-10#1)(2008-4#2)(2012-12#1)(2012-2#1)(2012-3#1)
a randomized##97##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#2)(2007-10#2)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#6)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
a randomly selected sample of##3##5##(1990-5#1)(1994-12#1)(2012-12#1)
a randomly##10##2##(1990-5#1)(1991-6#1)(1994-12#1)(2007-11#2)(2008-3#4)(2012-12#1)
a range between##2##3##(2008-10#2)
a range from 0 to##2##5##(2010-4#1)(2013-1#1)
a range from 0##4##4##(2008-10#2)(2010-4#1)(2013-1#1)
a range from##9##3##(1993-9#1)(1995-3#1)(2008-10#4)(2008-8#1)(2010-4#1)(2013-1#1)
a range of 0##10##4##(1992-11#1)(1993-12#1)(2008-10#4)(2008-11#1)(2011-2#2)(2013-1#1)
a range of 10##4##4##(1993-9#1)(2007-12#2)(2008-3#1)
a range of Medicago species##2##5##(2008-5#2)
a range of applications##2##4##(2008-7#1)(2012-2#1)
a range of approximately##2##4##(2008-2#1)(2008-3#1)
a range of densities##2##4##(1997-3#1)(2008-10#1)
a range of different##2##4##(2008-11#1)(2009-6#1)
a range of diseases##2##4##(2008-5#1)(2012-2#1)
a range of environments##3##4##(2007-12#1)(2011-2#2)
a range of frequencies##2##4##(2008-10#1)(2013-8#1)
a range of host plants##3##5##(2008-10#2)(2010-10#1)
a range of inoculum##3##4##(2008-10#3)
a range of molecular##2##4##(2008-10#1)(2009-10#1)
a range of other##2##4##(2008-10#2)
a range of physical and##2##5##(1994-5#1)(2008-10#1)
a range of physical##3##4##(1994-5#1)(2007-12#1)(2008-10#1)
a range of services##2##4##(1992-12#1)(2008-1#1)
a range of simple organic##2##5##(2008-10#2)
a range of temperatures and##2##5##(2008-10#1)(2008-3#1)
a range of temperatures##8##4##(2008-10#3)(2008-3#3)(2008-4#1)(2008-8#1)
a range of the##2##4##(2007-11#1)(2008-3#1)
a range of wavelengths and##2##5##(2007-11#1)(2008-2#1)
a range of wavelengths##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
a range of winter barley cultivars##2##6##(2008-10#2)
a range of##318##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#74)(2008-11#15)(2008-12#8)(2008-2#12)(2008-3#18)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#6)(2011-2#12)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#14)(2013-8#5)
a range##346##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#3)(1994-1#2)(1994-12#2)(1994-2#2)(1994-5#2)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#82)(2008-11#15)(2008-12#8)(2008-2#14)(2008-3#24)(2008-4#3)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#6)(2011-2#12)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#15)(2013-8#5)
a rank##3##2##(1992-9#1)(1994-8#1)(1997-3#1)
a rapeseed protein hydrolysate##2##4##(2008-11#2)
a rapid analysis of##2##4##(2008-10#1)(2008-11#1)
a rapid and accurate##3##4##(2008-10#2)(2010-5#1)
a rapid and efficient approach for##2##6##(1991-12#1)(2008-10#1)
a rapid and efficient means of##2##6##(2007-12#2)
a rapid and efficient means##3##5##(2007-12#2)(2008-10#1)
a rapid and efficient##8##4##(1991-12#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-4#1)
a rapid and reliable##2##4##(2007-12#1)(2007-2#1)
a rapid and sensitive method for the##2##7##(2008-10#1)(2010-4#1)
a rapid and sensitive method for##3##6##(2008-10#2)(2010-4#1)
a rapid and sensitive method##4##5##(2008-10#2)(2010-4#1)(2011-2#1)
a rapid and sensitive##9##4##(1992-6#1)(1993-8#1)(2008-10#5)(2010-4#1)(2011-2#1)
a rapid and simple method for##2##6##(2008-10#1)(2012-3#1)
a rapid and simple method##3##5##(2008-10#1)(2008-12#1)(2012-3#1)
a rapid and simple##9##4##(2008-10#6)(2008-11#1)(2008-12#1)(2012-3#1)
a rapid and transient rise in##2##6##(1992-6#1)(1997-1#1)
a rapid and transient##5##4##(1990-12#1)(1992-6#1)(1993-3#1)(1996-2#1)(1997-1#1)
a rapid and##51##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#1)(1996-2#2)(1996-5#1)(1997-1#1)(2007-12#3)(2007-2#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
a rapid but##2##3##(1996-12#1)(2011-1#1)
a rapid clinical##2##3##(2011-2#1)(2013-7#1)
a rapid decline in##4##4##(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)
a rapid decline##5##3##(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)
a rapid decrease##3##3##(1990-12#1)(2008-11#1)(2013-1#1)
a rapid diagnosis##2##3##(2010-10#1)(2012-2#1)
a rapid diagnostic##2##3##(2008-10#2)
a rapid growth in the##2##5##(2009-11#1)(2010-11#1)
a rapid growth in##3##4##(1992-1#1)(2009-11#1)(2010-11#1)
a rapid immunochromatographic##2##3##(2008-10#1)(2012-3#1)
a rapid increase in the##5##5##(1990-2#1)(1990-6#1)(1995-6#1)(2008-10#1)(2013-8#1)
a rapid increase in##12##4##(1990-2#1)(1990-6#1)(1991-12#1)(1992-9#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#3)(2011-2#1)(2013-8#1)
a rapid increase of##3##4##(1990-7#1)(2008-4#1)(2013-1#1)
a rapid increase##16##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1992-9#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
a rapid inhibition of##2##4##(1992-3#1)(2008-5#1)
a rapid method for the##3##5##(2008-10#2)(2010-12#1)
a rapid method for##5##4##(2008-10#3)(2008-11#1)(2010-12#1)
a rapid method to##2##4##(2008-10#1)(2008-7#1)
a rapid method##8##3##(2008-10#4)(2008-11#2)(2008-7#1)(2010-12#1)
a rapid plasma membrane##2##4##(2008-4#2)
a rapid polymerase chain##2##4##(2008-10#2)
a rapid return to##2##4##(1991-6#1)(2008-10#1)
a rapid serum##2##3##(1992-12#1)(1995-5#1)
a rapid technique##2##3##(2008-10#2)
a rapid transient##2##3##(1990-12#1)(1991-5#1)
a rapid##214##2##(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#2)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#3)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#70)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
a rapidly changing##6##3##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(2007-7#1)(2008-10#1)
a rapidly developing##2##3##(1992-9#1)(2008-11#1)
a rapidly enlarging##3##3##(1997-6#1)(2008-12#1)(2009-3#1)
a rapidly evolving##2##3##(1994-12#1)(2008-2#1)
a rapidly expanding field##3##4##(1994-9#1)(2008-5#1)(2008-7#1)
a rapidly expanding##4##3##(1994-9#1)(2008-5#1)(2008-7#1)(2008-9#1)
a rapidly growing##7##3##(1993-2#1)(1994-8#1)(2008-12#1)(2010-10#1)(2010-8#1)(2011-1#2)
a rapidly progressing##2##3##(2010-12#1)(2010-5#1)
a rapidly##39##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1992-9#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2013-8#1)
a rare acute##2##3##(1995-11#1)(2013-1#1)
a rare and lethal##2##4##(2011-2#1)(2012-2#1)
a rare and##16##3##(1993-6#1)(2007-5#1)(2007-8#2)(2009-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
a rare association with##2##4##(2012-2#2)
a rare association##3##3##(2012-12#1)(2012-2#2)
a rare autosomal recessive##6##4##(1997-8#1)(2007-7#1)(2007-8#1)(2011-1#2)(2012-2#1)
a rare autosomal##10##3##(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#4)(2012-2#1)(2013-1#1)
a rare benign##7##3##(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-6#1)(2013-8#1)
a rare but##13##3##(1992-12#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
a rare case of a##6##5##(2007-8#1)(2008-11#1)(2008-6#1)(2010-5#1)(2012-3#1)(2013-2#1)
a rare case of primary##3##5##(1991-12#1)(2008-10#1)(2009-8#1)
a rare case of##44##4##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-6#2)(2008-7#2)(2008-9#2)(2009-3#2)(2009-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-2#1)
a rare case report##4##4##(2007-7#1)(2008-7#1)(2012-3#1)(2013-8#1)
a rare case##52##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-5#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-6#2)(2008-7#3)(2008-9#2)(2009-3#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#4)(2013-2#1)(2013-8#1)
a rare cause of##18##4##(2007-12#1)(2008-12#2)(2008-8#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
a rare cause##20##3##(2007-12#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
a rare clinical entity##4##4##(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a rare clinical##6##3##(2008-10#1)(2009-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
a rare combination##3##3##(2007-7#1)(2009-11#1)(2013-1#1)
a rare complication after##4##4##(2007-8#1)(2008-12#1)(2009-3#1)(2012-12#1)
a rare complication in patients with##2##6##(2011-2#1)(2012-1#1)
a rare complication occurring##2##4##(2009-11#1)(2012-3#1)
a rare complication of##25##4##(1990-5#1)(1993-5#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)
a rare complication##35##3##(1990-5#1)(1992-11#1)(1993-5#1)(2006-10#1)(2007-8#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-3#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)
a rare condition##16##3##(1990-12#1)(1992-9#1)(1993-3#1)(2006-10#1)(2007-8#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#3)(2013-8#1)
a rare disease##19##3##(1992-12#1)(1992-4#1)(1993-6#2)(1996-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
a rare disorder##5##3##(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#2)
a rare entity with##3##4##(2007-5#1)(2008-10#1)(2010-12#1)
a rare entity##22##3##(1993-8#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
a rare event##8##3##(2007-7#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-9#1)(2010-10#1)(2011-2#1)
a rare feature##2##3##(1990-6#1)(2013-7#1)
a rare finding##3##3##(1992-12#1)(2011-2#1)(2012-3#1)
a rare form of##6##4##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
a rare form##7##3##(1994-5#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
a rare glimpse into the##2##5##(2010-3#2)
a rare group of##2##4##(2010-12#1)(2011-2#1)
a rare injury##3##3##(2007-8#1)(2009-3#1)(2010-7#1)
a rare neoplasm##7##3##(2007-5#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)
a rare neurological##2##3##(1990-11#1)(1991-11#1)
a rare occurrence##6##3##(2008-10#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
a rare pathological##2##3##(2009-5#1)(2011-2#1)
a rare phenomenon##5##3##(1996-2#1)(2007-5#1)(2008-10#2)(2011-2#1)
a rare presentation##6##3##(2007-7#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
a rare pulmonary##2##3##(2006-10#1)(2007-8#1)
a rare site##2##3##(2008-6#1)(2010-3#1)
a rare subtype of##4##4##(2008-12#1)(2009-12#1)(2012-3#2)
a rare subtype##5##3##(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#2)
a rare tumor##8##3##(2007-5#1)(2008-6#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
a rare tumour##2##3##(2008-8#1)(2012-2#1)
a rare type of##2##4##(2011-2#1)(2012-3#1)
a rare variant of##5##4##(1990-6#1)(2008-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
a rare variant##6##3##(1990-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
a rare##429##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#4)(1992-4#2)(1992-6#1)(1992-9#2)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2006-10#4)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#8)(2007-7#14)(2007-8#16)(2008-1#4)(2008-10#22)(2008-11#8)(2008-12#14)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#8)(2008-7#15)(2008-8#6)(2008-9#4)(2009-1#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#5)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#7)(2010-3#9)(2010-4#1)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#13)(2011-2#35)(2012-1#3)(2012-12#19)(2012-2#24)(2012-3#22)(2013-1#39)(2013-2#1)(2013-7#5)(2013-8#11)
a ras##2##2##(1990-11#1)(1997-4#1)
a rash##3##2##(1995-11#1)(1997-6#1)(2007-2#1)
a rat EFIA cDNA##2##4##(1993-2#2)
a rat airway cDNA##2##4##(1993-8#2)
a rat airway##3##3##(1993-8#3)
a rat ascites##4##3##(2008-11#4)
a rat brain cDNA##2##4##(1991-2#1)(1996-12#1)
a rat genomic DNA##2##4##(1991-5#1)(1991-9#1)
a rat genomic library##4##4##(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)
a rat genomic##6##3##(1991-5#1)(1991-9#2)(1993-12#1)(1993-3#1)(1993-8#1)
a rat liver##3##3##(1991-12#1)(1995-2#1)(1995-6#1)
a rat model of##14##4##(1994-6#2)(1996-5#2)(1997-2#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
a rat model##20##3##(1990-12#1)(1992-9#1)(1994-6#2)(1995-12#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
a rat pheochromocytoma cell line##2##5##(1993-8#1)(1994-11#1)
a rat pituitary##2##3##(1993-3#2)
a rat##75##2##(1990-12#1)(1991-12#5)(1991-2#1)(1991-5#2)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#5)(1994-11#2)(1994-6#4)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#3)(1996-5#2)(1997-2#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
a rate constant##6##3##(1992-6#2)(2008-10#1)(2008-7#2)(2009-8#1)
a rate limiting step in the##2##6##(2008-10#1)(2008-11#1)
a rate of 0##6##4##(1992-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2013-7#1)
a rate of 1##4##4##(1990-9#1)(1992-12#1)(2008-10#1)(2011-1#1)
a rate of##36##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-12#3)(1992-6#1)(1994-6#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
a rate##61##2##(1990-11#1)(1990-9#1)(1991-9#2)(1992-12#3)(1992-6#4)(1993-6#1)(1993-8#2)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a rate-limiting enzyme in##4##4##(1994-12#1)(1994-6#2)(2008-5#1)
a rate-limiting enzyme##5##3##(1994-12#1)(1994-6#2)(2008-11#1)(2008-5#1)
a rate-limiting step in##2##4##(1990-2#1)(1990-5#1)
a rate-limiting step##3##3##(1990-2#1)(1990-5#1)(2011-2#1)
a rate-limiting##11##2##(1990-2#1)(1990-5#1)(1991-9#1)(1994-12#1)(1994-6#2)(1995-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
a rather accurate##2##3##(2008-2#1)(2011-2#1)
a rather high##4##3##(1996-5#1)(2008-10#2)(2008-8#1)
a rather simple##2##3##(1993-6#1)(2008-10#1)
a rather##22##2##(1993-6#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
a rating##2##2##(2013-1#1)(2013-8#1)
a ratio of 1##9##4##(1990-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(2008-10#3)(2013-1#1)
a ratio of 2##2##4##(1994-5#1)(2008-2#1)
a ratio of##23##3##(1990-12#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)(2009-6#1)(2013-1#1)
a ratio##26##2##(1990-12#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
a rational and##3##3##(1996-3#1)(2008-10#1)(2008-9#1)
a rational approach to##5##4##(1996-3#1)(2007-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
a rational approach##9##3##(1994-9#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-3#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
a rational basis for##2##4##(2008-3#1)(2008-9#1)
a rational explanation##2##3##(2008-4#1)(2013-1#1)
a rational target for##2##4##(2011-3#1)(2012-2#1)
a rational##25##2##(1991-11#1)(1994-9#1)(1995-5#2)(1996-3#2)(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
a rationale and##3##3##(2008-3#3)
a rationale for the use of##2##6##(1990-3#1)(2008-11#1)
a rationale for the##4##4##(1990-3#1)(1994-6#1)(2008-11#1)(2013-8#1)
a rationale for##7##3##(1990-3#1)(1991-5#1)(1992-4#1)(1994-6#1)(2008-11#1)(2008-4#1)(2013-8#1)
a rationale##11##2##(1990-3#1)(1991-5#1)(1992-4#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2013-8#1)
a raw##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
a ray optics##2##3##(2008-3#2)
a ray##6##2##(2007-7#1)(2008-3#5)
a ray-optics model##2##3##(2007-11#1)(2008-2#1)
a ray-optics##3##2##(2007-11#1)(2008-2#2)
a ray-tracing code##2##3##(2007-12#1)(2008-2#1)
a ray-tracing method##2##3##(2008-2#2)
a ray-tracing##11##2##(2007-12#1)(2008-2#4)(2008-3#6)
a re-infarction##3##2##(2009-6#3)
a reaction coil##5##3##(2008-10#5)
a reaction component##2##3##(1997-7#1)(2008-6#1)
a reaction field##2##3##(2008-10#1)(2010-12#1)
a reaction of##2##3##(1991-5#1)(2008-10#1)
a reaction that##4##3##(1990-7#1)(2008-2#1)(2008-4#1)(2009-6#1)
a reaction##33##2##(1990-7#1)(1991-5#1)(1993-11#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
a reactive metabolite##2##3##(1991-9#1)(2008-10#1)
a reactive oxygen species##2##4##(1992-3#1)(2008-11#1)
a reactive##18##2##(1990-10#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-11#1)(2010-4#1)(2012-12#1)(2013-1#2)
a reactor##5##2##(2008-10#4)(2008-11#1)
a readily available##4##3##(2007-11#1)(2009-4#1)(2010-7#1)(2013-1#1)
a readily##5##2##(1995-2#1)(2007-11#1)(2009-4#1)(2010-7#1)(2013-1#1)
a reading##4##2##(1997-2#1)(2008-11#1)(2008-3#1)(2010-7#1)
a readout beam##2##3##(2008-2#1)(2008-3#1)
a readout##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2013-8#1)
a ready source of##3##4##(2008-10#1)(2010-12#1)(2013-1#1)
a reagent consumption of##2##4##(2008-10#2)
a reagent for##3##3##(2008-10#2)(2008-9#1)
a reagent##16##2##(1993-11#1)(2008-10#14)(2008-9#1)
a reagent-injection flow injection##2##4##(2008-10#2)
a reagentless##2##2##(2008-10#2)
a real data##2##3##(2008-7#1)(2009-12#1)
a real microscope##2##3##(2008-3#2)
a real or##2##3##(2008-2#1)(2012-3#1)
a real world##2##3##(2011-1#1)(2013-8#1)
a real##40##2##(1993-3#1)(1994-1#1)(1995-12#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
a real-time PCR instrument##3##4##(2008-10#1)(2011-2#2)
a real-time PCR##5##3##(2008-10#2)(2010-6#1)(2011-2#2)
a real-time polymerase chain reaction##2##5##(2008-10#1)(2009-8#1)
a real-time quantitative##3##3##(2008-10#2)(2008-11#1)
a real-time##32##2##(2007-11#6)(2008-10#7)(2008-11#1)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#2)
a realistic simulation##2##3##(2008-3#1)(2010-6#1)
a realistic##23##2##(1990-5#1)(1990-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1997-3#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#2)
a reality for##2##3##(1994-12#1)(1995-2#1)
a reality in##3##3##(1991-3#1)(2008-10#1)(2013-8#1)
a reality within##2##3##(2008-10#1)(2008-9#1)
a reality##15##2##(1991-3#2)(1993-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#2)(2013-8#1)
a realization of the##2##4##(2008-11#1)(2008-3#1)
a reappraisal of##3##3##(1991-12#1)(1995-3#1)(2008-6#1)
a reappraisal##6##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(2008-6#1)
a rearrangement##3##2##(1990-6#1)(1997-3#1)(2008-6#1)
a reason for##4##3##(1991-12#1)(1994-3#1)(2008-10#1)(2012-2#1)
a reason##5##2##(1991-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
a reasonable alternative##2##3##(1994-12#1)(2008-3#1)
a reasonable correlation between##2##4##(1991-9#1)(1992-6#1)
a reasonable number##2##3##(2008-10#1)(2008-8#1)
a reasonable##36##2##(1990-8#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-2#1)(2006-10#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-2#1)(2013-8#1)
a reasonably short##2##3##(2008-10#1)(2008-2#1)
a reasonably##6##2##(1992-2#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
a rebound##2##2##(1991-5#1)(2012-2#1)
a receiver##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
a recent addition to##3##4##(1994-8#1)(2008-4#1)(2008-6#1)
a recent case of##3##4##(1990-9#1)(2007-12#1)(2008-1#1)
a recent case##6##3##(1990-9#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)
a recent development##3##3##(1995-2#1)(2010-6#2)
a recent diagnosis of##2##4##(1992-5#1)(1996-3#1)
a recent experiment##2##3##(2007-11#1)(2007-12#1)
a recent history of##2##4##(2008-11#1)(2013-1#1)
a recent international##2##3##(1990-6#1)(1995-1#1)
a recent paper##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#3)
a recent published##2##3##(1995-12#1)(1995-3#1)
a recent report##5##3##(1992-12#1)(1992-3#1)(1992-9#1)(1997-6#1)(2012-2#1)
a recent study has##2##4##(2008-8#1)(2011-2#1)
a recent study in##2##4##(2008-10#1)(2010-11#1)
a recent study of##2##4##(1991-12#1)(2008-1#1)
a recent study##23##3##(1990-11#1)(1991-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#2)(2009-8#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
a recent surge in##2##4##(2008-1#1)(2008-11#1)
a recent survey of##4##4##(1994-3#1)(1995-1#1)(1995-2#1)(2008-6#1)
a recent survey##6##3##(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-6#1)
a recent trend of##2##4##(2008-11#1)(2009-12#1)
a recent trend##3##3##(2008-11#1)(2008-4#1)(2009-12#1)
a recent##134##2##(1990-11#2)(1990-5#1)(1990-6#2)(1990-9#3)(1991-12#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#6)(2008-10#9)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#6)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
a recently defined##2##3##(2008-2#1)(2008-5#1)
a recently described##7##3##(1991-7#1)(2008-10#1)(2008-11#2)(2009-6#1)(2012-2#1)(2013-1#1)
a recently developed chemometric##2##4##(2008-10#2)
a recently developed method of##2##5##(1997-4#1)(2008-3#1)
a recently developed method##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
a recently developed##19##3##(1991-5#1)(1992-6#1)(1995-11#2)(1997-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#2)
a recently discovered##5##3##(1990-3#2)(1995-12#1)(1995-3#1)(2008-4#1)
a recently established##2##3##(1997-7#1)(2008-10#1)
a recently identified##4##3##(1993-11#1)(1994-6#1)(1997-1#1)(2009-10#1)
a recently introduced##5##3##(2008-10#2)(2008-2#1)(2008-7#1)(2009-7#1)
a recently proposed##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#2)
a recently published algorithm##2##4##(2008-2#1)(2008-3#1)
a recently published##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
a recently reported##3##3##(1992-8#1)(1992-9#1)(2008-8#1)
a recently synthesized Schiff's base##2##5##(2008-10#2)
a recently synthesized mercapto compound##2##5##(2008-10#2)
a recently synthesized##8##3##(2008-10#8)
a recently##77##2##(1990-3#2)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#20)(2008-11#2)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
a receptive##2##2##(2008-11#1)(2012-3#1)
a receptor for##8##3##(1991-12#1)(1992-9#2)(1994-6#1)(1995-2#1)(1995-6#1)(2008-4#2)
a receptor in##2##3##(1992-10#1)(2008-11#1)
a receptor mediated##2##3##(1991-5#1)(1994-8#1)
a receptor protein##2##3##(1997-7#1)(2008-10#1)
a receptor tyrosine kinase##2##4##(2008-7#1)(2010-4#1)
a receptor##27##2##(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-9#2)(1993-8#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-4#1)(2012-2#1)
a receptor-dependent##2##2##(1995-8#1)(2013-1#1)
a receptor-ligand##2##2##(1994-12#1)(2009-10#1)
a receptor-mediated##4##2##(1993-3#2)(1995-11#1)(2008-3#1)
a recessive gene##3##3##(2008-10#3)
a recessive##10##2##(1992-5#1)(1993-12#1)(1994-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2011-2#1)
a reciprocal regulatory loop##2##4##(2011-2#2)
a reciprocal##14##2##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-3#4)(2008-8#1)(2009-8#1)(2011-2#2)(2013-8#1)
a recirculating##5##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)
a recognition motif##2##3##(2010-11#1)(2010-12#1)
a recognition##8##2##(1996-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)
a recognizable##4##2##(1994-8#1)(1995-4#1)(1997-4#2)
a recognized##10##2##(1996-12#1)(2007-10#1)(2008-4#1)(2008-5#2)(2009-7#1)(2009-8#1)(2012-12#1)(2012-3#2)
a recombinant CHO cell line##5##5##(2008-11#5)
a recombinant E##2##3##(2008-6#1)(2011-2#1)
a recombinant adeno-associated##2##3##(2008-8#1)(2008-9#1)
a recombinant baculovirus##7##3##(1992-3#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
a recombinant cutinase##2##3##(1995-3#1)(2008-7#1)
a recombinant form of##4##4##(1993-8#1)(2008-3#1)(2008-6#1)(2009-3#1)
a recombinant human##3##3##(1994-6#1)(2008-11#2)
a recombinant inbred line population##2##5##(2008-10#2)
a recombinant inbred line##3##4##(2008-10#3)
a recombinant inbred##4##3##(2008-10#4)
a recombinant plasmid##3##3##(1992-9#1)(2008-6#1)(2008-9#1)
a recombinant protein##2##3##(2008-11#2)
a recombinant vector##2##3##(2008-9#1)(2011-2#1)
a recombinant virus##3##3##(1994-6#1)(2008-10#2)
a recombinant##77##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-3#1)(1997-2#1)(1997-4#2)(2008-10#13)(2008-11#19)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-3#1)(2010-4#2)(2010-6#1)(2011-2#4)
a recombination##2##2##(2008-10#1)(2013-1#1)
a recommendation##3##2##(1996-11#1)(2008-5#1)(2009-8#1)
a recommended##5##2##(1996-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
a reconsideration of the##2##4##(2008-4#1)(2009-3#1)
a reconsideration of##3##3##(2008-1#1)(2008-4#1)(2009-3#1)
a reconstituted system##2##3##(1996-3#1)(2010-12#1)
a reconstituted##10##2##(1990-8#1)(1992-3#1)(1996-3#1)(2008-4#3)(2008-5#2)(2010-12#1)(2011-2#1)
a reconstitution##3##2##(1991-5#1)(1993-3#1)(2008-7#1)
a reconstructed##4##2##(2008-3#2)(2008-5#2)
a reconstruction##4##2##(1996-4#1)(2007-11#1)(2008-3#2)
a reconstructive##3##2##(1992-3#1)(2011-2#1)(2012-12#1)
a record##4##2##(2007-11#1)(2007-12#1)(2009-6#1)(2011-1#1)
a recordable compact disk##3##4##(2008-2#1)(2008-3#2)
a recorded##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
a recording##6##2##(2007-12#1)(2008-3#3)(2013-1#2)
a recovery experiment##2##3##(2008-5#2)
a recovery of##8##3##(1991-12#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-7#1)(2010-4#1)
a recovery period##2##3##(2012-2#1)(2013-8#1)
a recovery study##2##3##(2008-10#2)
a recovery test##2##3##(2008-10#2)
a recovery##26##2##(1991-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(2008-10#14)(2008-5#3)(2008-7#1)(2010-4#1)(2012-2#2)(2013-8#1)
a recreational##2##2##(2011-2#1)(2013-8#1)
a rectal##5##2##(1990-9#1)(1994-3#1)(2009-12#2)(2013-8#1)
a rectangular##12##2##(1992-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
a recurrence of the##2##4##(2006-10#1)(2013-1#1)
a recurrence##7##2##(2006-10#2)(2007-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-1#1)
a recurrent neural network##5##4##(2008-11#4)(2008-2#1)
a recurrent problem in##2##4##(1990-6#1)(2011-2#1)
a recurrent##18##2##(1990-6#1)(1992-11#1)(1996-6#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)
a recurring and##2##3##(1997-4#2)
a recurring##4##2##(1993-1#1)(1997-4#3)
a recursive##3##2##(2008-2#1)(2008-3#2)
a recycle batch##3##3##(2008-11#1)(2008-7#2)
a red LED as##2##4##(2008-10#2)
a red blood cell##4##4##(1994-12#1)(2008-2#1)(2013-1#2)
a red complex##4##3##(2008-10#4)
a red shift in##2##4##(1990-5#1)(2008-10#1)
a red shift of the##2##5##(1992-12#1)(2007-11#1)
a red shift of##3##4##(1992-12#1)(2007-11#1)(2008-10#1)
a red shift##5##3##(1990-5#1)(1992-12#1)(2007-11#1)(2008-10#2)
a red##32##2##(1990-5#1)(1992-12#1)(1994-12#1)(2007-11#1)(2007-12#3)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-6#1)(2013-1#3)
a red-violet##2##2##(2008-10#2)
a redesigned##2##2##(1997-2#1)(2011-2#1)
a redesigning##2##2##(1992-3#1)(1997-2#1)
a redistribution of##2##3##(1992-11#1)(1993-8#1)
a redox electrode##3##3##(2008-10#3)
a redox mediator##3##3##(2008-10#3)
a redox process##2##3##(1996-2#1)(2008-10#1)
a redox reaction##3##3##(2008-10#3)
a redox##16##2##(1995-2#1)(1996-2#1)(2008-10#13)(2008-11#1)
a redox-active##2##2##(1995-5#1)(2008-10#1)
a reduced ability to##2##4##(1994-11#2)
a reduced ability##3##3##(1991-7#1)(1994-11#2)
a reduced barrier function##2##4##(2008-5#2)
a reduced growth##2##3##(2008-10#1)(2008-11#1)
a reduced level of##4##4##(2007-2#1)(2008-5#1)(2010-1#1)(2012-12#1)
a reduced level##5##3##(2007-2#1)(2008-5#2)(2010-1#1)(2012-12#1)
a reduced model##2##3##(2007-11#1)(2007-12#1)
a reduced multivariate polynomial##2##4##(2008-6#2)
a reduced number of##6##4##(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2012-12#1)(2012-2#1)
a reduced rate of##2##4##(2008-10#1)(2008-9#1)
a reduced risk of##2##4##(2007-2#1)(2008-10#1)
a reduced system##2##3##(2007-11#1)(2007-12#1)
a reduced##85##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-12#2)(1995-2#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(2007-11#3)(2007-12#4)(2007-2#2)(2008-1#4)(2008-10#8)(2008-11#1)(2008-3#8)(2008-5#5)(2008-6#3)(2008-7#10)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-5#1)
a reducing agent##6##3##(2008-10#6)
a reducing##11##2##(2007-11#1)(2008-10#8)(2008-11#1)(2013-1#1)
a reduction below##2##3##(1993-3#2)
a reduction from##2##3##(1993-8#1)(2008-3#1)
a reduction in analgesic requirements and motor activity (ECOG and Karnofsky scale) were evaluated##2##14##(2007-11#2)
a reduction in body##2##4##(2009-6#1)(2012-3#1)
a reduction in disease severity##2##5##(2008-10#1)(2012-2#1)
a reduction in disease##3##4##(2008-10#2)(2012-2#1)
a reduction in drug##2##4##(1992-12#1)(2008-11#1)
a reduction in lesion##2##4##(2008-10#2)
a reduction in reward##2##4##(1993-12#2)
a reduction in serum##2##4##(2008-5#1)(2013-8#1)
a reduction in the incidence of##3##6##(2007-7#1)(2008-1#1)(2011-2#1)
a reduction in the number of##7##6##(1992-1#1)(1995-12#1)(2008-10#3)(2010-8#1)(2013-1#1)
a reduction in the rate of##2##6##(2008-1#1)(2008-10#1)
a reduction in the serum##2##5##(2008-12#1)(2010-4#1)
a reduction in the##42##4##(1990-5#1)(1991-12#1)(1992-1#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#1)(2008-9#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
a reduction in their##4##4##(1990-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
a reduction in total##2##4##(2008-8#1)(2012-2#1)
a reduction in##143##3##(1990-11#2)(1990-12#1)(1990-5#3)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#9)(2009-10#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#12)
a reduction of disease##2##4##(2008-10#2)
a reduction of the##20##4##(1992-6#1)(1992-9#1)(1994-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
a reduction of##67##3##(1990-10#1)(1990-12#2)(1991-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-7#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#7)(2009-7#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#3)
a reduction or##3##3##(1991-12#1)(2008-5#1)(2008-9#1)
a reduction potential of##2##4##(1991-8#1)(2008-10#1)
a reduction rate of##2##4##(2008-2#1)(2008-7#1)
a reduction to##2##3##(1996-6#1)(2007-12#1)
a reduction##230##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-5#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1997-1#1)(1997-7#1)(2006-10#2)(2007-11#5)(2007-12#2)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#36)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#5)(2008-7#15)(2008-8#3)(2008-9#10)(2009-10#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#5)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#8)(2013-8#12)
a reductive##2##2##(1994-9#1)(2013-8#1)
a redundant##2##2##(1991-5#1)(2013-1#1)
a reevaluation of##2##3##(2008-1#1)(2009-6#1)
a reevaluation##3##2##(1992-1#1)(2008-1#1)(2009-6#1)
a reexamination of##2##3##(1993-8#1)(1994-12#1)
a reexamination##3##2##(1993-8#1)(1994-12#1)(2008-3#1)
a reference and##2##3##(2008-10#1)(2008-2#1)
a reference beam##4##3##(2008-2#1)(2008-3#3)
a reference data##2##3##(2007-7#1)(2008-7#1)
a reference drug##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
a reference electrode##5##3##(2008-10#4)(2008-9#1)
a reference for##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
a reference function in the##2##5##(2007-11#1)(2008-3#1)
a reference group##2##3##(2008-10#1)(2012-1#1)
a reference image##3##3##(2008-2#1)(2008-3#2)
a reference material##7##3##(1996-9#1)(2008-10#6)
a reference method##8##3##(2008-10#7)(2013-1#1)
a reference plane##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a reference procedure##3##3##(2008-10#3)
a reference range##2##3##(1990-2#1)(1993-2#1)
a reference standard##2##3##(2008-10#1)(2012-12#1)
a reference strain##3##3##(2008-10#2)(2011-2#1)
a reference surface##3##3##(2008-11#1)(2008-3#2)
a reference to##3##3##(2008-10#1)(2008-2#1)(2009-9#1)
a reference##117##2##(1990-2#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1996-12#1)(1996-9#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#41)(2008-11#5)(2008-12#2)(2008-2#10)(2008-3#24)(2008-4#3)(2008-5#2)(2008-7#5)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
a referral coordinator##2##3##(2013-1#2)
a referral##15##2##(1994-1#2)(1994-6#2)(2007-2#1)(2007-7#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
a refined group mean##2##4##(2011-2#2)
a refined##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)
a reflectance##5##2##(2007-12#2)(2008-2#3)
a reflected##2##2##(2007-12#1)(2008-2#1)
a reflecting##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a reflection confocal##2##3##(2007-12#1)(2008-3#1)
a reflection hologram##2##3##(2008-1#1)(2008-3#1)
a reflection of the##4##4##(1991-5#1)(2008-1#1)(2008-10#1)(2012-12#1)
a reflection of##8##3##(1991-5#1)(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
a reflection on the##3##4##(2013-1#3)
a reflection##22##2##(1991-5#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
a reflection-type##2##2##(2007-11#1)(2008-2#1)
a reflective grating##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a reflective journal##2##3##(2012-12#2)
a reflective process##2##3##(2008-11#2)
a reflective##16##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#1)(2012-12#2)
a reformed health##2##3##(1995-1#1)(1995-12#1)
a reformulation of the##3##4##(1993-1#1)(2008-3#1)(2010-4#1)
a reformulation##4##2##(1993-1#1)(2008-3#2)(2010-4#1)
a refractive index n(D)##2##4##(2008-2#2)
a refractive index##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
a refractive##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
a refractive-index##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a refractometric##2##2##(2008-3#1)(2009-6#1)
a refuge in##2##3##(2008-5#1)(2009-5#1)
a refuge##6##2##(1993-6#2)(2008-5#2)(2009-5#2)
a regenerable##2##2##(2008-10#2)
a regenerative medicine##2##3##(2008-11#1)(2009-9#1)
a regenerative##3##2##(2008-11#1)(2008-3#1)(2009-9#1)
a regime of##2##3##(2008-11#1)(2008-12#1)
a regime##5##2##(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#1)
a regimen of##2##3##(1992-9#1)(2008-5#1)
a regimen##3##2##(1992-9#1)(2008-5#1)(2009-8#1)
a region at the##2##4##(1993-12#1)(2008-10#1)
a region between##2##3##(1994-9#1)(1996-6#1)
a region from##2##3##(1996-4#1)(2008-8#1)
a region in the##3##4##(1995-6#1)(2008-11#1)(2012-3#1)
a region in##6##3##(1993-8#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-3#1)
a region of homology to##2##5##(1993-12#1)(2008-6#1)
a region of the##5##4##(1993-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(2008-10#1)
a region of##28##3##(1990-2#1)(1990-5#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)
a region on chromosome##2##4##(2010-3#2)
a region on##3##3##(2010-3#3)
a region that##5##3##(1990-12#2)(1990-5#1)(1993-6#1)(2008-10#1)
a region with##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
a region##78##2##(1990-12#2)(1990-2#1)(1990-5#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#3)(2011-2#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#2)
a region-specific##2##2##(1993-9#1)(1994-8#1)
a regional health##2##3##(1995-3#1)(1997-1#1)
a regional hospital##3##3##(1993-12#1)(1995-5#2)
a regional scale##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
a regional##31##2##(1993-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#4)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
a registered##4##2##(1995-3#1)(1996-3#1)(2007-10#1)(2010-5#1)
a registry##3##2##(2008-1#1)(2008-10#1)(2010-6#1)
a regression model to##2##4##(1997-8#1)(2010-8#1)
a regression model##5##3##(1997-8#1)(2007-11#1)(2008-10#2)(2010-8#1)
a regression##10##2##(1997-8#1)(2007-11#2)(2008-10#5)(2008-11#1)(2010-8#1)
a regular grid##2##3##(2008-10#1)(2008-6#1)
a regular surface##2##3##(2007-12#1)(2008-3#1)
a regular##44##2##(1990-11#1)(1990-9#1)(1991-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-3#1)(2011-1#1)(2011-2#6)(2012-12#1)
a regularization scheme##2##3##(2008-3#2)
a regularization##4##2##(2008-3#4)
a regularized phase-tracking##4##3##(2008-3#4)
a regularized##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2010-1#1)
a regulated##7##2##(1990-8#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-8#1)
a regulation##3##2##(2008-5#1)(2009-8#1)(2013-8#1)
a regulator of cell##2##4##(1995-12#1)(2008-4#1)
a regulator of##12##3##(1991-9#1)(1992-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
a regulator##13##2##(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
a regulatory role for##2##4##(1993-3#1)(1993-8#1)
a regulatory role in the##2##5##(1993-3#1)(2008-2#1)
a regulatory role in##5##4##(1991-12#1)(1993-3#1)(1994-12#1)(2008-2#1)(2008-4#1)
a regulatory role##8##3##(1991-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1995-2#1)(2008-2#1)(2008-4#1)
a regulatory##31##2##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-9#1)(2010-11#1)(2011-2#1)
a rehabilitation program##3##3##(2007-11#1)(2008-4#1)(2008-7#1)
a rehabilitation##8##2##(1995-3#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-10#1)(2013-1#1)
a rehabilitative programme##2##3##(2008-10#2)
a relapse of##2##3##(2013-1#1)(2013-8#1)
a relapse##7##2##(1993-2#1)(2009-7#1)(2009-9#1)(2013-1#2)(2013-8#2)
a related##11##2##(1992-9#1)(1993-12#1)(1994-11#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
a relation between the##5##4##(1991-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-2#1)
a relation between##10##3##(1990-5#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-7#1)(2012-2#1)
a relation##11##2##(1990-5#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-7#1)(2012-2#1)
a relational approach##2##3##(2008-12#2)
a relational database##2##3##(2008-4#2)
a relational##5##2##(2008-12#2)(2008-4#2)(2012-12#1)
a relationship between the PSP output and##2##7##(2008-3#2)
a relationship between the##9##4##(1992-2#1)(1993-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2010-9#1)
a relationship between##38##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-11#1)(1995-12#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#6)
a relationship exists between##2##4##(2008-11#1)(2009-7#1)
a relationship exists##3##3##(2007-8#1)(2008-11#1)(2009-7#1)
a relationship for##2##3##(2008-11#1)(2008-5#1)
a relationship was##2##3##(1991-2#1)(2008-10#1)
a relationship with##3##3##(1997-3#1)(2008-1#1)(2011-2#1)
a relationship##57##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-11#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#2)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#6)
a relative accuracy error of 0##2##6##(2008-10#2)
a relative accuracy error of##3##5##(2008-10#3)
a relative accuracy##4##3##(2008-10#3)(2008-2#1)
a relative dearth of##2##4##(2008-11#1)(2012-2#1)
a relative deviation of 1##2##5##(2008-10#1)(2008-2#1)
a relative deviation##3##3##(2008-10#2)(2008-2#1)
a relative error of##5##4##(2008-10#5)
a relative error##6##3##(2008-10#6)
a relative humidity##2##3##(1995-3#1)(2008-2#1)
a relative intensity noise##2##4##(2007-11#1)(2007-12#1)
a relative lack of##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
a relative molecular mass of##5##5##(1991-12#2)(1993-8#1)(2008-11#2)
a relative risk of 1##2##5##(1993-9#1)(2008-2#1)
a relative risk of##7##4##(1990-5#1)(1993-9#2)(1994-9#2)(2008-2#1)(2013-1#1)
a relative standard deviation (R##9##5##(2008-10#9)
a relative standard deviation (RSD) of##3##6##(2008-10#3)
a relative standard deviation 1##2##5##(2008-10#2)
a relative standard deviation between##2##5##(2008-10#2)
a relative standard deviation of 0##5##6##(2008-10#5)
a relative standard deviation of 1##14##6##(2008-10#14)
a relative standard deviation of 2##9##6##(2008-10#9)
a relative standard deviation of 3##3##6##(2008-10#3)
a relative standard deviation of 4##3##6##(2008-10#3)
a relative standard deviation of 5##2##6##(2008-10#2)
a relative standard deviation of approximately##2##6##(2008-10#2)
a relative standard deviation of less than 0##3##8##(2008-10#3)
a relative standard deviation of less than##7##7##(2008-10#7)
a relative standard deviation of##55##5##(2008-10#55)
a relative standard deviation##79##4##(2008-10#79)
a relative standard##81##3##(2008-10#80)(2008-2#1)
a relative##160##2##(1990-2#1)(1990-5#1)(1991-12#3)(1991-3#1)(1991-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-9#2)(1995-3#1)(1996-11#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#103)(2008-11#4)(2008-2#7)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
a relatively benign##2##3##(2011-2#1)(2012-3#1)
a relatively broad##2##3##(2008-10#1)(2011-2#1)
a relatively common##7##3##(1991-4#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-3#1)
a relatively consistent##2##3##(2008-10#1)(2008-11#1)
a relatively constant##2##3##(2008-7#1)(2011-2#1)
a relatively fast##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
a relatively frequent##3##3##(1991-12#1)(2010-5#1)(2013-1#1)
a relatively high concentration##3##4##(1992-6#1)(1997-2#1)(2008-8#1)
a relatively high level of##3##5##(1997-4#1)(2008-10#1)(2008-2#1)
a relatively high##20##3##(1991-6#1)(1991-8#1)(1992-6#2)(1993-11#1)(1993-12#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
a relatively higher##3##3##(1990-3#1)(1994-6#1)(1994-8#1)
a relatively homogeneous##2##3##(2008-10#1)(2008-2#1)
a relatively large number of##5##5##(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
a relatively large##12##3##(1990-8#1)(1991-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
a relatively low cost##2##4##(2008-10#1)(2008-3#1)
a relatively low##23##3##(1993-2#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
a relatively minor##3##3##(1993-6#1)(2008-10#1)(2009-9#1)
a relatively modest##2##3##(1991-11#1)(2008-3#1)
a relatively narrow##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)
a relatively new approach##3##4##(1992-8#1)(2007-12#1)(2008-11#1)
a relatively new concept in##2##5##(2008-10#1)(2008-5#1)
a relatively new field##2##4##(1997-7#1)(2010-10#1)
a relatively new##19##3##(1992-5#1)(1992-8#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-2#1)
a relatively poor##2##3##(1992-12#1)(2008-6#1)
a relatively rapid##2##3##(2008-10#1)(2012-12#1)
a relatively rare entity##2##4##(2007-7#1)(2010-12#1)
a relatively rare##11##3##(1991-12#1)(2007-7#1)(2008-3#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a relatively safe##2##3##(2007-2#1)(2012-2#1)
a relatively short time period##2##5##(2007-7#1)(2008-3#1)
a relatively short time##6##4##(1995-11#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
a relatively short##8##3##(1995-11#1)(1996-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
a relatively simple and##2##4##(1990-11#1)(2006-6#1)
a relatively simple##9##3##(1990-11#1)(1993-12#1)(2006-6#1)(2007-11#2)(2008-3#1)(2009-8#1)(2010-9#1)(2011-2#1)
a relatively small effect##2##4##(2008-10#1)(2008-8#1)
a relatively small number of##4##5##(1996-12#1)(1996-3#1)(2007-10#1)(2008-3#1)
a relatively small##17##3##(1995-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#1)
a relatively stable##2##3##(1991-12#1)(1994-6#1)
a relatively thick##2##3##(2007-12#1)(2008-3#1)
a relatively weak##2##3##(2009-9#1)(2010-4#1)
a relatively wide##5##3##(2008-10#4)(2008-2#1)
a relatively young group of patients##2##6##(2007-7#1)(2008-4#1)
a relatively young##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
a relatively##231##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
a relaxation##3##2##(1990-6#1)(1990-7#1)(2008-3#1)
a relaxed##3##2##(1995-6#1)(2007-11#1)(2010-12#1)
a release of LDH##2##4##(1992-11#2)
a release of##8##3##(1990-8#1)(1991-12#1)(1992-11#4)(1994-3#1)(2008-10#1)
a release##10##2##(1990-8#1)(1991-12#1)(1992-11#4)(1992-3#1)(1992-6#1)(1994-3#1)(2008-10#1)
a relevant model for##3##4##(2008-4#1)(2009-12#1)(2012-3#1)
a relevant role in the##2##5##(1993-9#1)(2011-2#1)
a relevant role in##3##4##(1993-9#1)(2008-10#1)(2011-2#1)
a relevant role##4##3##(1992-9#1)(1993-9#1)(2008-10#1)(2011-2#1)
a relevant##23##2##(1990-8#1)(1992-9#1)(1993-3#1)(1993-9#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)
a reliability of##2##3##(2008-10#1)(2012-3#1)
a reliability##4##2##(1996-7#1)(2008-10#1)(2009-12#1)(2012-3#1)
a reliable and efficient##2##4##(1994-6#1)(2008-2#1)
a reliable and##17##3##(1990-12#1)(1991-5#1)(1992-12#1)(1994-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#2)
a reliable determination of##2##4##(2008-10#2)
a reliable diagnosis##2##3##(2008-6#1)(2008-7#1)
a reliable diagnostic##2##3##(1992-3#1)(2011-1#1)
a reliable estimate of the##3##5##(2008-10#1)(2008-3#1)(2008-4#1)
a reliable estimate of##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
a reliable index of##2##4##(1991-9#1)(1994-2#1)
a reliable indicator of##2##4##(1991-12#1)(2013-7#1)
a reliable marker##2##3##(1995-12#1)(2009-11#1)
a reliable means of##3##4##(2008-10#1)(2008-9#1)(2011-7#1)
a reliable method to##3##4##(2006-10#1)(2011-2#1)(2013-7#1)
a reliable method##4##3##(2006-10#1)(2008-10#1)(2011-2#1)(2013-7#1)
a reliable source of##3##4##(2007-12#1)(2008-10#1)(2008-4#1)
a reliable tool to##3##4##(2008-5#1)(2008-9#1)(2010-12#1)
a reliable tool##4##3##(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)
a reliable##81##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
a relict##2##2##(2008-6#1)(2009-6#1)
a relief##2##2##(2007-11#2)
a religious##2##2##(1995-3#1)(2008-12#1)
a remarkable decrease in##2##4##(2008-1#1)(2008-11#1)
a remarkable decrease##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
a remarkable difference##2##3##(2007-12#1)(2011-2#1)
a remarkable example of##2##4##(2009-6#1)(2012-2#1)
a remarkable increase in the##3##5##(1991-2#1)(1993-3#1)(2012-3#1)
a remarkable increase of##5##4##(1992-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
a remarkable increase##8##3##(1991-2#1)(1992-6#1)(1993-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
a remarkable inhibitory##2##3##(2008-12#2)
a remarkable##46##2##(1990-6#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
a remarkably##9##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-3#1)
a remedy##3##2##(1994-12#1)(1996-12#1)(2008-11#1)
a reminder##6##2##(1994-3#1)(1995-2#1)(2008-10#1)(2011-1#1)(2013-1#2)
a reminiscence bump##2##3##(2009-2#2)
a reminiscence##3##2##(2008-11#1)(2009-2#2)
a remission of##2##3##(1995-11#1)(2012-3#1)
a remission##6##2##(1995-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-11#1)(2012-3#1)
a remnant of##2##3##(2008-10#1)(2009-6#1)
a remote##12##2##(1992-1#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)
a remote-sensing##2##2##(2008-2#1)(2008-3#1)
a remotely##2##2##(2007-11#1)(2008-10#1)
a removal##2##2##(2008-10#1)(2008-7#1)
a renal artery##3##3##(2008-12#1)(2010-4#2)
a renal biopsy##3##3##(1995-5#1)(2007-7#1)(2008-1#1)
a renal transplant##7##3##(1995-2#1)(2007-2#1)(2007-7#2)(2008-1#2)(2013-1#1)
a renal##20##2##(1992-6#1)(1993-8#1)(1995-2#1)(1995-5#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#3)(2008-11#2)(2008-12#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
a renewable##3##2##(2008-10#1)(2013-1#2)
a renewed emphasis on##2##4##(1996-12#1)(1996-3#1)
a renewed interest in##4##4##(2009-11#1)(2011-2#2)(2013-8#1)
a renewed sense of##2##4##(1995-1#1)(2007-2#1)
a renewed##11##2##(1991-2#1)(1993-1#1)(1995-1#1)(1996-12#1)(1996-3#1)(2007-2#1)(2008-12#1)(2009-11#1)(2011-2#2)(2013-8#1)
a reorganization of##2##3##(1994-8#1)(2010-10#1)
a reorientation of##3##3##(1993-1#1)(1997-1#1)(2011-2#1)
a repair##2##2##(2009-5#1)(2012-1#1)
a repeat of##2##3##(2008-10#1)(2013-8#1)
a repeat##13##2##(1992-8#1)(1996-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
a repeatability of 2##2##4##(2008-10#2)
a repeatability##4##2##(2008-10#4)
a repeated batch process##2##4##(2008-11#1)(2008-7#1)
a repeated batch##3##3##(1994-5#1)(2008-11#1)(2008-7#1)
a repeated measures design##2##4##(1993-3#1)(2008-10#1)
a repeated measures##3##3##(1993-3#1)(1996-2#1)(2008-10#1)
a repeated##12##2##(1993-3#1)(1994-5#1)(1996-2#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)
a repeating##4##2##(1992-12#1)(2008-7#2)(2008-9#1)
a repetition rate of 1 kHz##2##6##(2008-3#2)
a repetition rate of 2##2##5##(2007-12#2)
a repetition rate of##24##4##(2007-11#5)(2007-12#10)(2008-2#2)(2008-3#7)
a repetition rate##26##3##(2007-11#6)(2007-12#10)(2008-2#2)(2008-3#8)
a repetition##28##2##(2007-11#7)(2007-12#10)(2008-2#2)(2008-3#9)
a repetitive##8##2##(1991-12#1)(1992-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
a replacement for##5##3##(1992-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
a replacement of##6##3##(1990-11#1)(1992-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-6#1)
a replacement##14##2##(1990-11#1)(1991-12#1)(1992-3#1)(1992-8#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#2)(2012-6#1)
a replication and##2##3##(2008-3#1)(2011-2#1)
a replication fork##2##3##(1992-3#1)(2012-2#1)
a replication##8##2##(1992-2#1)(1992-3#1)(1994-11#1)(2008-3#2)(2011-2#2)(2012-2#1)
a replication-competent##2##2##(1995-2#1)(2012-12#1)
a reply to##2##3##(1993-12#1)(1993-6#1)
a reply##3##2##(1993-12#1)(1993-6#1)(2008-10#1)
a report from the##2##4##(2009-12#1)(2013-8#1)
a report from##3##3##(1997-2#1)(2009-12#1)(2013-8#1)
a report of 2 cases##2##5##(2006-10#1)(2013-1#1)
a report of a##4##4##(2008-10#2)(2008-7#1)(2013-1#1)
a report of four cases##2##5##(1991-12#1)(2007-2#1)
a report of four##3##4##(1991-12#1)(2007-2#1)(2011-2#1)
a report of the first experience in##2##7##(2007-10#1)(2007-9#1)
a report of the##4##4##(1996-9#1)(2007-10#1)(2007-9#1)(2012-3#1)
a report of two cases##6##5##(1992-10#1)(2006-10#1)(2007-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a report of two##7##4##(1992-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
a report of##26##3##(1991-12#1)(1992-10#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#2)(2009-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
a report on the##6##4##(1990-9#1)(1995-2#1)(2007-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
a report on##10##3##(1990-9#2)(1993-2#1)(1995-2#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)
a report##52##2##(1990-9#2)(1991-12#1)(1992-10#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-9#1)(1997-2#2)(2006-10#2)(2007-10#1)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
a reported##9##2##(1990-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-2#1)
a reporter gene encoding##2##4##(1994-12#1)(2008-8#1)
a reporter gene under the control of##4##7##(1994-12#1)(1994-5#2)(1995-8#1)
a reporter gene##18##3##(1991-5#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-8#2)(1997-4#2)(1997-6#1)(1997-7#1)(2008-11#1)(2008-8#1)(2010-10#1)
a reporter plasmid##2##3##(1994-12#1)(1996-3#1)
a reporter##37##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-5#2)(1995-2#1)(1995-8#2)(1996-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2011-1#1)
a representation of the##2##4##(2009-10#1)(2013-7#1)
a representation of##5##3##(1990-8#1)(2008-10#1)(2009-10#1)(2009-6#1)(2013-7#1)
a representative example##2##3##(2008-10#1)(2008-9#1)
a representative of a##2##4##(2011-2#2)
a representative of the##5##4##(1990-11#1)(2008-10#1)(2011-1#1)(2011-2#2)
a representative of##9##3##(1990-11#1)(1991-9#1)(2008-10#1)(2011-1#1)(2011-2#4)(2013-1#1)
a representative sample and##2##4##(1995-12#1)(2008-1#1)
a representative sample of the original##2##6##(2008-5#2)
a representative sample of the##3##5##(2008-5#2)(2011-2#1)
a representative sample of##12##4##(1991-12#1)(1991-6#1)(1994-6#1)(1995-8#1)(2008-12#1)(2008-5#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
a representative sample##14##3##(1991-12#1)(1991-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-12#1)(2008-5#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
a representative##61##2##(1990-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#5)(2009-5#1)(2009-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#5)
a repressor of##2##3##(1991-10#1)(2011-2#1)
a repressor##4##2##(1991-10#1)(2008-9#1)(2010-4#1)(2011-2#1)
a reproducible and precise##2##4##(1996-2#1)(2008-3#1)
a reproducible and##3##3##(1991-5#1)(1996-2#1)(2008-3#1)
a reproducible model for##2##4##(2007-6#1)(2008-9#1)
a reproducible model of##2##4##(2007-8#1)(2008-7#1)
a reproducible model##4##3##(2007-6#1)(2007-8#1)(2008-7#1)(2008-9#1)
a reproducible##20##2##(1990-5#1)(1991-3#1)(1991-5#1)(1996-12#1)(1996-2#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
a request for##2##3##(1995-6#1)(2008-1#1)
a request##3##2##(1995-6#1)(1996-3#1)(2008-1#1)
a required##3##2##(2008-3#1)(2008-7#1)(2010-11#1)
a requirement for##10##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#1)(2009-4#1)
a requirement of##2##3##(1993-3#1)(1994-8#1)
a requirement to##2##3##(1995-12#1)(2008-11#1)
a requirement##15##2##(1993-3#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-7#4)(2008-8#2)(2009-4#1)
a rescue##4##2##(2007-8#1)(2012-12#3)
a research agenda##3##3##(1994-12#1)(2008-12#2)
a research field##2##3##(2008-7#1)(2010-11#1)
a research nurse##2##3##(2008-11#2)
a research of##2##3##(2008-10#1)(2008-9#1)
a research program to##2##4##(2008-10#1)(2012-3#1)
a research project that##2##4##(1991-9#1)(2010-10#1)
a research project##5##3##(1991-6#1)(1991-9#1)(2010-10#2)(2013-1#1)
a research study##5##3##(2007-10#1)(2008-4#2)(2012-12#1)(2013-1#1)
a research##51##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-3#1)(1994-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#3)(2008-7#3)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a researcher##2##2##(2006-5#1)(2007-7#1)
a reservoir for##4##3##(1997-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
a reservoir of##3##3##(1995-2#1)(2009-10#1)(2009-12#1)
a reservoir##11##2##(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
a residency program##3##3##(1994-12#2)(1995-1#1)
a residency##4##2##(1993-12#1)(1994-12#2)(1995-1#1)
a residential home##3##3##(2011-1#3)
a residential##4##2##(2011-1#3)(2013-1#1)
a residual##12##2##(1990-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)
a residue##4##2##(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)
a resin##8##2##(1990-5#1)(1992-11#1)(2007-12#1)(2008-10#4)(2013-1#1)
a resistance gene##5##3##(2008-10#5)
a resistance training##2##3##(2008-5#1)(2013-1#1)
a resistance##13##2##(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#1)
a resistance-breaking##2##2##(2008-10#2)
a resistant and susceptible##2##4##(2008-10#2)
a resistant and##3##3##(2007-8#1)(2008-10#2)
a resistant cultivar##4##3##(2008-10#4)
a resistant##18##2##(1997-6#1)(2007-8#1)(2008-10#16)
a resolution chart##2##3##(2007-12#1)(2008-2#1)
a resolution of 0##4##4##(2007-11#3)(2008-3#1)
a resolution of 1##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-10#1)
a resolution of##32##3##(2007-11#5)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#16)(2010-10#1)(2010-3#1)(2011-1#1)
a resolution that is##2##4##(2007-12#1)(2008-3#1)
a resolution to##2##3##(1992-9#1)(1997-2#1)
a resolution##45##2##(1992-9#1)(1997-2#3)(2007-11#5)(2007-12#4)(2008-10#3)(2008-2#6)(2008-3#20)(2010-10#1)(2010-3#1)(2011-1#1)
a resolving power##2##3##(2008-10#1)(2008-3#1)
a resonance##9##2##(1990-8#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-7#1)
a resonance-photoionization-like process##2##3##(2007-11#2)
a resonant##9##2##(1991-8#1)(1996-2#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-3#1)
a resonantly##2##2##(2007-11#1)(2007-12#1)
a resonator##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a resource for##11##3##(1994-9#1)(1995-9#1)(1997-5#1)(2007-5#2)(2008-10#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-3#2)
a resource of##2##3##(2008-4#1)(2008-7#1)
a resource##25##2##(1993-2#1)(1994-9#1)(1995-12#1)(1995-9#1)(1997-5#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
a resource-poor##2##2##(2009-6#1)(2013-1#1)
a respective##3##2##(2008-10#1)(2008-11#1)(2013-7#1)
a respirator##3##2##(1996-2#1)(2008-12#1)(2010-8#1)
a respiratory##5##2##(1996-3#1)(2006-10#1)(2007-8#1)(2008-3#1)(2011-1#1)
a response in##2##3##(1992-3#1)(2008-10#1)
a response on##2##3##(1992-11#2)
a response rate of##5##4##(1992-2#1)(2007-2#1)(2008-11#1)(2010-3#1)(2011-2#1)
a response rate##6##3##(1992-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
a response that##4##3##(1993-8#1)(2007-11#1)(2007-12#1)(2011-2#1)
a response time of &lt##4##5##(2007-11#1)(2008-10#3)
a response time of less than##2##6##(2007-11#1)(2008-10#1)
a response time of##16##4##(2007-11#3)(2007-12#1)(2008-10#11)(2008-2#1)
a response time##18##3##(2007-11#3)(2007-12#1)(2008-10#13)(2008-2#1)
a response to an##2##4##(1994-12#1)(2009-5#1)
a response to##28##3##(1990-2#1)(1992-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#3)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
a response##84##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-2#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-5#3)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
a responsibility##2##2##(1992-1#1)(2008-11#1)
a responsible##2##2##(1993-11#1)(2013-1#1)
a responsivity##2##2##(2007-11#1)(2008-3#1)
a rest##2##2##(1992-4#1)(2008-10#1)
a resting##3##2##(1995-11#1)(1996-2#1)(2008-12#1)
a restoration##3##2##(2008-11#1)(2008-2#1)(2009-8#1)
a restorative##2##2##(1994-6#1)(2008-11#1)
a restricted amount of##2##4##(1993-12#1)(2008-3#1)
a restricted##20##2##(1990-5#1)(1990-7#1)(1990-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(2008-10#2)(2008-3#4)(2008-5#2)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
a restriction enzyme##5##3##(1993-9#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)
a restriction fragment length polymorphism##3##5##(1992-3#1)(2008-10#2)
a restriction of##2##3##(2008-10#2)
a restriction that##2##3##(1994-8#1)(2008-2#1)
a restriction##14##2##(1992-3#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)
a restrictive cardiomyopathy##2##3##(2010-4#1)(2010-8#1)
a restrictive##3##2##(2010-2#1)(2010-4#1)(2010-8#1)
a restructured environment##2##3##(1994-3#1)(1996-3#1)
a restructured##6##2##(1994-12#1)(1994-3#1)(1996-1#1)(1996-3#3)
a restructuring program is##2##4##(1993-3#1)(1995-1#1)
a restructuring##5##2##(1993-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)
a result it##3##3##(1990-8#1)(2008-10#1)(2013-8#1)
a result of a##23##4##(1991-11#1)(1994-1#2)(1995-12#1)(1995-6#3)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
a result of an##9##4##(1993-12#1)(1994-2#1)(1994-5#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-1#2)
a result of changes in##3##5##(1994-5#1)(2008-11#1)(2008-3#1)
a result of different##2##4##(1994-9#1)(1996-3#1)
a result of either##2##4##(1995-3#1)(2008-8#1)
a result of inadequate##2##4##(2008-10#1)(2012-2#1)
a result of interference##2##4##(2008-10#1)(2008-6#1)
a result of the continuous##3##5##(1996-12#1)(2008-10#1)(2008-11#1)
a result of the fact that##2##6##(1994-2#1)(2008-11#1)
a result of the high##2##5##(2008-2#1)(2011-1#1)
a result of the interaction##2##5##(1992-3#1)(2008-10#1)
a result of the rapid##2##5##(1993-8#1)(1994-9#1)
a result of the realization of a##2##7##(2007-11#1)(2008-3#1)
a result of the##94##4##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#21)(2008-11#6)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#6)(2013-1#3)(2013-7#1)
a result of their##8##4##(1992-9#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#1)
a result of these##7##4##(1992-3#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
a result of this##12##4##(1991-12#1)(1995-9#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-3#1)(2010-5#2)(2013-1#1)(2013-8#1)
a result of##394##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#17)(2007-12#19)(2007-8#8)(2008-1#2)(2008-10#47)(2008-11#23)(2008-12#12)(2008-2#10)(2008-3#25)(2008-4#4)(2008-5#9)(2008-6#7)(2008-7#16)(2008-8#10)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-5#2)(2009-7#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#13)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#15)(2013-7#4)(2013-8#8)
a result that is##2##4##(2008-10#2)
a result that##3##3##(2008-10#2)(2013-1#1)
a result we##4##3##(1997-7#1)(2008-3#1)(2008-8#1)(2008-9#1)
a result##579##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#3)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#6)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#5)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#3)(1996-3#5)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-5#2)(1997-7#2)(1997-8#2)(2007-10#3)(2007-11#21)(2007-12#24)(2007-7#1)(2007-8#8)(2008-1#4)(2008-10#73)(2008-11#32)(2008-12#17)(2008-2#18)(2008-3#44)(2008-4#7)(2008-5#12)(2008-6#9)(2008-7#20)(2008-8#13)(2008-9#17)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-5#5)(2009-7#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#7)(2012-5#1)(2013-1#19)(2013-7#6)(2013-8#13)
a resurgence in the##2##4##(2008-11#1)(2009-12#1)
a resurgence of interest in##3##5##(1997-7#1)(2011-2#1)(2013-1#1)
a resurgence of interest##4##4##(1997-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
a resurgence of##6##3##(1992-2#1)(1997-7#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
a resurgence##8##2##(1992-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
a retained##4##2##(2008-12#2)(2012-2#1)(2012-3#1)
a retardation##2##2##(1995-6#1)(2008-5#1)
a retention##5##2##(1990-8#1)(1992-8#1)(2007-10#1)(2008-10#2)
a retina-specific##2##2##(1990-7#1)(1994-9#1)
a retinal##3##2##(1996-5#1)(2007-12#1)(2010-1#1)
a retreat##2##2##(1991-3#1)(1994-1#1)
a retrieval##5##2##(2008-2#2)(2008-3#2)(2013-7#1)
a retrieved##2##2##(2008-2#1)(2008-3#1)
a retrograde##4##2##(1996-2#1)(2008-11#1)(2009-2#1)(2011-1#1)
a retroperitoneal tumor##2##3##(2008-5#1)(2008-6#1)
a retroperitoneal##7##2##(2007-8#2)(2008-5#2)(2008-6#2)(2009-4#1)
a retrospective analysis of##14##4##(1990-9#1)(1991-12#1)(1993-9#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)
a retrospective analysis##18##3##(1990-9#1)(1991-12#1)(1993-9#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)
a retrospective and prospective##2##4##(1992-12#1)(2008-8#1)
a retrospective and##3##3##(1992-12#1)(2008-8#1)(2011-2#1)
a retrospective case series##3##4##(2007-10#1)(2011-2#1)(2013-7#1)
a retrospective case##4##3##(2007-10#1)(2008-9#1)(2011-2#1)(2013-7#1)
a retrospective chart review of##5##5##(1991-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
a retrospective chart review##7##4##(1991-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
a retrospective cohort of##2##4##(2008-9#1)(2010-12#1)
a retrospective cohort study of##2##5##(2007-10#1)(2012-3#1)
a retrospective cohort study##5##4##(2007-10#1)(2008-5#1)(2010-10#1)(2012-3#1)(2013-1#1)
a retrospective cohort##8##3##(2007-10#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a retrospective multicenter study##2##4##(2010-6#1)(2012-2#1)
a retrospective observational##2##3##(2008-3#1)(2013-1#1)
a retrospective review of##11##4##(1994-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a retrospective review##15##3##(1994-8#1)(1996-1#1)(2008-1#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a retrospective series##2##3##(1994-6#1)(2009-5#1)
a retrospective study of patients##2##5##(1993-11#1)(2008-9#1)
a retrospective study of the##2##5##(2011-2#1)(2012-3#1)
a retrospective study of##13##4##(1990-9#1)(1993-11#1)(1993-5#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#1)
a retrospective study that##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
a retrospective study##32##3##(1990-10#1)(1990-9#1)(1991-4#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#2)
a retrospective##117##2##(1990-10#1)(1990-12#1)(1990-9#2)(1991-12#2)(1991-4#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-6#1)(2006-10#1)(2007-10#5)(2007-11#1)(2007-8#5)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
a retrovirus##2##2##(1994-5#1)(2008-11#1)
a return to single-digit inflation##2##5##(1994-12#2)
a return to the##2##4##(2008-7#1)(2012-3#1)
a return to work##2##4##(1992-5#1)(1997-5#1)
a return to##11##3##(1992-5#1)(1994-12#2)(1997-3#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#2)(2012-3#1)
a return##13##2##(1992-5#1)(1994-12#2)(1997-3#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#2)(2012-3#1)
a revascularization procedure##3##3##(1990-9#2)(1995-12#1)
a reversal of the##3##4##(2006-7#1)(2008-10#1)(2010-8#1)
a reversal of##5##3##(1991-12#1)(2006-7#1)(2008-1#1)(2008-10#1)(2010-8#1)
a reversal##10##2##(1990-7#1)(1991-12#1)(1993-1#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-8#1)(2013-8#1)
a reverse fragment to a cDNA encoding human 6A8 alpha-mannosidase##3##10##(2008-8#3)
a reverse phase##4##3##(1991-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
a reverse transcriptase##2##3##(1997-4#1)(2008-10#1)
a reverse##23##2##(1991-12#1)(1991-8#1)(1992-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
a reversed phase##3##3##(2008-10#2)(2008-5#1)
a reversed temporal gradient##2##4##(2009-2#2)
a reversed##12##2##(1992-2#1)(1993-12#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-2#2)
a reversed-phase C(18) column##2##4##(2008-10#2)
a reversed-phase C18 column with##2##5##(2008-10#2)
a reversed-phase C18##3##3##(2008-10#3)
a reversed-phase HPLC##3##3##(1996-5#1)(2008-10#2)
a reversed-phase column and##2##4##(1990-8#1)(2013-1#1)
a reversed-phase column##5##3##(1990-8#3)(1997-2#1)(2013-1#1)
a reversed-phase##19##2##(1990-8#4)(1996-5#1)(1997-2#1)(2008-10#12)(2013-1#1)
a reversible increase in##2##4##(1996-3#1)(2008-3#1)
a reversible redox##3##3##(2008-10#3)
a reversible##29##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2009-11#1)(2011-2#2)(2013-1#2)
a review about##2##3##(1990-10#1)(2012-3#1)
a review and##8##3##(1992-2#1)(1994-8#1)(1995-1#1)(2008-11#2)(2009-11#1)(2012-3#1)(2013-1#1)
a review of current##3##4##(1994-1#1)(2008-11#1)(2008-4#1)
a review of literature##7##4##(1992-5#1)(1993-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
a review of published##3##4##(1995-9#1)(2008-9#1)(2012-12#1)
a review of the available##2##5##(1996-1#1)(2008-8#1)
a review of the clinical##2##5##(1992-9#1)(2008-1#1)
a review of the current literature##4##6##(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
a review of the current##7##5##(2008-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#1)
a review of the evidence##3##5##(1996-12#1)(2013-1#1)(2013-8#1)
a review of the literature and##11##6##(1990-3#1)(1991-1#1)(1991-3#1)(1995-3#1)(2006-5#1)(2007-11#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#2)
a review of the literature on the##4##7##(2008-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
a review of the literature on this##2##7##(1993-6#1)(2008-5#1)
a review of the literature on##10##6##(1993-6#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
a review of the literature##65##5##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-5#1)(1992-6#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-3#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#3)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
a review of the major##2##5##(1991-3#1)(2011-1#1)
a review of the recent##2##5##(1994-3#1)(2011-2#1)
a review of the##117##4##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#12)(2011-7#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#10)(2013-8#3)
a review of their##2##4##(1993-2#1)(2008-11#1)
a review of##187##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#14)(2011-7#2)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
a review on##2##3##(1996-7#1)(2008-7#1)
a review process##2##3##(1993-1#1)(1995-12#1)
a review with##2##3##(2008-7#1)(2013-8#1)
a review##263##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-5#1)(2006-7#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#33)(2008-11#15)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#5)(2009-11#2)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#14)(2011-7#2)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#6)
a review]##2##2##(2008-9#1)(2013-8#1)
a revised model##2##3##(1991-9#1)(2008-10#1)
a revised##11##2##(1991-9#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
a revision of the##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
a revision##4##2##(2008-10#1)(2009-3#2)(2013-1#1)
a revolution in##4##3##(1996-11#1)(1997-8#1)(2008-5#1)(2009-5#1)
a revolution of##2##3##(2008-10#1)(2011-1#1)
a revolution##8##2##(1993-12#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)(2013-1#1)
a revolutionary##4##2##(2008-7#2)(2009-6#1)(2010-7#1)
a reward##5##2##(1991-3#1)(1992-1#1)(1993-12#1)(2008-4#1)(2009-8#1)
a rewarding##3##2##(1993-3#1)(1995-12#1)(2010-2#1)
a rhabdomyosarcoma of the left ventricle##2##6##(2013-1#2)
a rheological##2##2##(2008-5#2)
a rheumatologic##2##2##(1997-8#1)(2011-2#1)
a rhythm##2##2##(2008-5#1)(2008-6#1)
a ribonuclease##2##2##(1990-7#1)(1994-2#1)
a ribonucleolytic##2##2##(1997-4#1)(2008-10#1)
a ribosomal protein##3##3##(1991-7#1)(1996-6#1)(2013-8#1)
a ribosomal##7##2##(1991-7#1)(1996-6#1)(2007-11#1)(2008-10#3)(2013-8#1)
a ribosome binding##2##3##(2008-10#1)(2010-6#1)
a ribosome##3##2##(1991-9#1)(2008-10#1)(2010-6#1)
a ribosome-binding site##2##3##(1993-9#1)(1994-12#1)
a ribozyme##4##2##(1993-9#1)(1995-3#1)(1997-6#1)(2008-11#1)
a rice BAC clone containing##2##5##(2008-8#2)
a rice cDNA##2##3##(2008-10#1)(2008-9#1)
a rice genomic library##2##4##(2008-8#1)(2008-9#1)
a rice genomic##3##3##(1996-12#1)(2008-8#1)(2008-9#1)
a rice##17##2##(1993-9#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)
a rich and##2##3##(2008-12#1)(2008-3#1)
a rich source of##3##4##(2008-5#1)(2008-9#1)(2012-12#1)
a rich##23##2##(1993-1#1)(1995-5#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a richer##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
a richness of##2##3##(2011-2#2)
a right atrial##4##3##(2007-8#4)
a right lung##2##3##(2008-8#1)(2011-1#1)
a right thalamic##2##3##(2007-10#1)(2008-8#1)
a right to##5##3##(1994-8#1)(1995-12#3)(2008-12#1)
a right##45##2##(1991-5#1)(1993-3#1)(1994-8#1)(1995-12#3)(1995-8#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-6#1)(2007-8#7)(2008-1#2)(2008-12#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
a right-sided##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
a righting##2##2##(2007-12#2)
a rigid##15##2##(1991-2#1)(1992-1#1)(1996-3#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-6#1)(2012-2#1)
a rigorous selection process##2##4##(1993-12#1)(2012-2#1)
a rigorous three-dimensional##2##3##(2007-12#1)(2008-3#1)
a rigorous vector theory##2##4##(2008-2#2)
a rigorous##30##2##(1991-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#4)(2008-3#8)(2008-7#2)(2008-8#2)(2010-5#1)(2012-2#1)
a ring cavity##5##3##(2007-12#3)(2008-3#2)
a ring configuration##2##3##(2008-2#1)(2008-3#1)
a ring of##2##3##(1997-5#1)(2012-12#1)
a ring resonator##3##3##(2007-11#2)(2008-3#1)
a ring##25##2##(1993-1#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-11#7)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#4)(2009-11#1)(2012-12#1)
a ring-shaped##3##2##(2007-11#1)(2008-2#1)(2009-2#1)
a ringing##2##2##(2011-1#2)
a rise in [Ca2+]i##2##4##(1994-3#1)(1995-12#1)
a rise in body##3##4##(1992-3#1)(2008-5#2)
a rise in the##5##4##(2008-10#2)(2008-8#1)(2010-3#1)(2011-2#1)
a rise in##17##3##(1990-3#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
a rise of##2##3##(1990-2#1)(2008-10#1)
a rise##21##2##(1990-2#1)(1990-3#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
a rising tone##3##3##(2013-8#3)
a rising##7##2##(1991-5#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-8#3)
a risk analysis##3##3##(2012-2#3)
a risk assessment##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
a risk factor for cardiovascular##2##5##(2011-2#1)(2012-2#1)
a risk factor for coronary##2##5##(1995-6#1)(2008-6#1)
a risk factor for development of##3##6##(1997-3#1)(2007-10#1)(2011-2#1)
a risk factor for many##2##5##(2008-10#1)(2013-7#1)
a risk factor for stroke##2##5##(2007-10#2)
a risk factor for##43##4##(1990-8#1)(1992-4#1)(1993-9#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-10#4)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
a risk factor in##4##4##(1991-4#1)(1992-3#1)(2007-11#1)(2008-3#1)
a risk factor##51##3##(1990-8#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-9#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-10#4)(2007-11#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
a risk for##2##3##(2008-10#1)(2008-12#1)
a risk management perspective##2##4##(1994-3#2)
a risk management plan##2##4##(2008-9#1)(2009-6#1)
a risk management program##2##4##(1993-2#1)(2013-1#1)
a risk management##9##3##(1992-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
a risk manager's##2##3##(1997-1#1)(2007-3#1)
a risk of##20##3##(1990-5#1)(1992-6#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)
a risk to##2##3##(2011-2#1)(2013-8#1)
a risk##116##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-6#1)(1996-12#2)(1996-6#2)(1997-1#2)(1997-3#2)(1997-5#1)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-5#2)(2011-1#4)(2011-2#14)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
a river sediment##2##3##(2008-10#1)(2008-6#1)
a river##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-7#1)
a rms error of##2##4##(2008-3#2)
a rms##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
a road map##3##3##(1992-2#2)(2010-12#1)
a road##6##2##(1992-2#2)(1997-2#1)(2007-7#1)(2010-12#1)(2012-2#1)
a robot##3##2##(2007-12#1)(2009-12#1)(2013-1#1)
a robotic##4##2##(2007-8#1)(2008-10#1)(2010-7#1)(2012-1#1)
a robust and sensitive##2##4##(2008-10#1)(2008-4#1)
a robust and##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
a robust framework for##2##4##(2008-11#1)(2013-1#1)
a robust method of##2##4##(2008-2#1)(2008-4#1)
a robust method##6##3##(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)
a robust##51##2##(1992-9#1)(1995-12#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#4)(2013-1#5)
a rock-solid foundation##2##3##(1993-1#1)(1996-1#1)
a rocket##2##2##(2008-10#1)(2008-3#1)
a rodent model##2##3##(2008-4#1)(2012-12#1)
a rodent##3##2##(1990-7#1)(2008-4#1)(2012-12#1)
a role as##5##3##(1990-11#1)(1992-9#1)(2008-7#1)(2010-10#1)(2011-2#1)
a role at##2##3##(1990-8#1)(1997-1#1)
a role for a##3##4##(1992-6#1)(1994-6#1)(2008-10#1)
a role for an##2##4##(1992-9#1)(1993-3#1)
a role for neurotrophins in##2##5##(1995-8#1)(1996-12#1)
a role for the##4##4##(1992-12#1)(1994-9#1)(2009-10#1)(2009-4#1)
a role for these##3##4##(1990-3#1)(1997-8#1)(2011-2#1)
a role for this##2##4##(1997-1#1)(2008-5#1)
a role for##84##3##(1990-3#1)(1990-5#3)(1990-6#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-12#3)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
a role in cell##2##4##(1992-12#1)(2009-5#1)
a role in controlling the##2##5##(2008-10#1)(2008-9#1)
a role in controlling##3##4##(2008-10#2)(2008-9#1)
a role in host defense##2##5##(2008-10#1)(2009-10#1)
a role in how##2##4##(2008-11#1)(2009-5#1)
a role in maintaining##2##4##(1994-11#1)(2009-10#1)
a role in mediating##4##4##(1996-2#1)(1996-5#1)(2009-6#1)(2011-2#1)
a role in normal##3##4##(1992-8#1)(2008-5#1)(2009-10#1)
a role in public##2##4##(1996-2#1)(2008-11#1)
a role in regulating##4##4##(1995-12#2)(2010-2#1)(2012-12#1)
a role in resistance##4##4##(1992-7#1)(2008-10#3)
a role in the control of##2##6##(1993-3#1)(2013-8#1)
a role in the development and##3##6##(1996-2#1)(2010-3#1)(2012-3#1)
a role in the development of##8##6##(1994-12#1)(2008-1#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#1)(2013-8#1)
a role in the development##11##5##(1994-12#1)(1996-2#1)(2008-1#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
a role in the diagnosis of##2##6##(2008-11#1)(2009-11#1)
a role in the diagnosis##3##5##(2008-11#1)(2009-11#1)(2012-2#1)
a role in the evolution of##3##6##(2008-8#1)(2010-3#1)(2013-1#1)
a role in the growth##2##5##(1995-12#1)(2008-5#1)
a role in the pathogenesis of##8##6##(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(2008-3#2)(2009-1#1)
a role in the process of##2##6##(1993-11#1)(1997-7#1)
a role in the treatment of##2##6##(1991-9#1)(2008-7#1)
a role in the##103##4##(1990-11#1)(1990-5#3)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#4)
a role in this##4##4##(1994-11#1)(2008-1#1)(2008-6#1)(2009-7#1)
a role in##294##3##(1990-11#2)(1990-12#1)(1990-5#4)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#5)(1992-2#1)(1992-6#4)(1992-7#1)(1992-8#3)(1993-11#3)(1993-12#2)(1993-3#4)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#9)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#7)(1996-4#1)(1996-5#6)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#31)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#5)(2009-1#3)(2009-10#4)(2009-11#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#4)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#2)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#4)(2012-7#1)(2013-1#5)(2013-8#8)
a role of the##8##4##(1992-6#2)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-4#1)
a role of these##2##4##(1993-11#1)(1995-3#1)
a role of this##2##4##(1994-8#1)(2008-10#1)
a role of##30##3##(1990-7#1)(1990-8#1)(1991-2#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
a role##438##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#4)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#5)(1994-8#6)(1994-9#4)(1995-12#14)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#3)(1995-9#2)(1996-10#1)(1996-12#4)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#7)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-8#3)(2008-1#3)(2008-10#38)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#12)(2008-5#11)(2008-6#3)(2008-7#22)(2008-8#8)(2008-9#5)(2009-1#3)(2009-10#6)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-10#2)(2011-2#16)(2012-1#2)(2012-12#7)(2012-2#16)(2012-3#6)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#9)
a room-temperature##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
a root##7##2##(2008-1#1)(2008-10#5)(2011-2#1)
a root-dip##2##2##(2008-10#2)
a rotary evaporator##2##3##(2008-10#2)
a rotary##5##2##(2008-10#4)(2008-6#1)
a rotatable##2##2##(2008-7#1)(2010-12#1)
a rotating bioreactor##2##3##(2008-10#2)
a rotating disc##2##3##(2008-10#1)(2008-7#1)
a rotating disk##4##3##(2008-10#3)(2008-3#1)
a rotating polarizer##3##3##(2008-2#2)(2008-3#1)
a rotating##31##2##(1990-12#2)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#7)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
a rotating-parallelogram prism##2##3##(2008-3#2)
a rotation##4##2##(2008-11#1)(2008-8#1)(2011-2#2)
a rotational##7##2##(1990-7#1)(1995-5#2)(2008-2#2)(2008-3#2)
a rotationally symmetric##3##3##(2007-12#1)(2008-3#2)
a rotationally##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
a rotatory##2##2##(2008-10#1)(2008-4#1)
a rough estimate of##2##4##(1994-9#1)(2008-11#1)
a rough estimate##3##3##(1994-9#1)(2008-11#1)(2008-3#1)
a rough surface##9##3##(2007-12#2)(2008-2#2)(2008-3#5)
a rough##22##2##(1994-9#2)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#9)(2008-8#1)(2011-1#1)(2011-2#1)
a roughly##4##2##(1995-5#1)(2007-12#1)(2008-10#2)
a round##11##2##(1991-8#1)(1993-11#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
a rounded##2##2##(2008-10#1)(2008-7#1)
a roundtable discussion##2##3##(2008-3#1)(2008-6#1)
a route for##2##3##(1993-6#1)(2008-10#1)
a route to the##2##4##(1994-9#1)(2008-11#1)
a route to##7##3##(1994-9#1)(2008-11#1)(2008-7#3)(2008-8#1)(2010-12#1)
a route##11##2##(1992-12#1)(1993-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2010-12#1)(2012-12#1)
a router##2##2##(2008-3#2)
a routine EEG##3##3##(2008-7#3)
a routine basis##5##3##(2008-3#3)(2008-4#1)(2008-7#1)
a routine examination##2##3##(1990-2#1)(2008-7#1)
a routine laboratory##4##3##(1990-2#1)(1992-9#1)(1994-1#1)(2008-10#1)
a routine practice##2##3##(2008-10#1)(2011-1#1)
a routine procedure in##3##4##(1994-3#1)(1996-9#1)(2008-9#1)
a routine procedure##5##3##(1990-10#1)(1994-3#1)(1996-9#1)(2008-9#1)(2011-1#1)
a routine##53##2##(1990-10#1)(1990-2#3)(1991-1#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-3#3)(2008-4#2)(2008-7#7)(2008-9#1)(2011-1#3)(2012-12#1)(2013-1#1)
a row of##2##3##(2007-12#2)
a row##4##2##(2007-12#2)(2008-10#1)(2009-9#1)
a rsd##2##2##(2008-10#2)
a rudimentary##4##2##(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
a rule of thumb##4##4##(2008-2#1)(2008-3#3)
a rule of##5##3##(2008-11#1)(2008-2#1)(2008-3#3)
a rule##15##2##(1991-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2009-5#1)
a rule-based##2##2##(2009-5#1)(2013-1#1)
a ruling against##2##3##(1997-5#2)
a ruling##3##2##(1997-5#3)
a run##3##2##(2008-10#2)(2011-2#1)
a running##3##2##(1993-3#1)(2008-10#2)
a rupture of the##5##4##(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-1#1)
a rupture of##6##3##(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)
a rupture##8##2##(1994-3#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)
a ruptured aneurysm##2##3##(1997-8#1)(2013-8#1)
a ruptured dissecting aneurysm##2##4##(2008-7#2)
a ruptured##8##2##(1995-12#1)(1997-8#1)(2007-5#1)(2008-7#4)(2013-8#1)
a rural area##4##3##(1995-3#2)(1997-4#1)(2008-2#1)
a rural community##7##3##(1994-1#1)(1997-2#1)(2008-11#1)(2009-10#1)(2010-6#2)(2012-2#1)
a rural district##2##3##(1994-6#1)(2007-12#1)
a rural health##3##3##(1993-3#1)(1997-3#1)(2012-3#1)
a rural setting##2##3##(2009-6#1)(2012-12#1)
a rural##36##2##(1990-12#1)(1991-1#1)(1991-3#2)(1992-2#1)(1993-10#1)(1993-3#1)(1993-5#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-3#2)(1995-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a rust##2##2##(2008-10#2)
a ruthenium##3##2##(2008-10#2)(2010-5#1)
a rye##2##2##(2008-10#1)(2008-5#1)
a rye-vetch green manure##2##4##(2008-10#2)
a saccular aneurysm##2##3##(2007-8#1)(2008-7#1)
a sacral##2##2##(2008-10#1)(2008-7#1)
a saddle##2##2##(2007-12#1)(2013-8#1)
a safe alternative to##2##4##(2010-4#1)(2011-2#1)
a safe and effective alternative to##2##6##(1995-8#1)(2008-11#1)
a safe and effective alternative##4##5##(1995-8#1)(2008-11#1)(2011-2#2)
a safe and effective technique##2##5##(2007-8#1)(2011-2#1)
a safe and effective treatment##3##5##(2008-2#1)(2008-9#1)(2012-2#1)
a safe and effective##22##4##(1990-8#1)(1993-12#1)(1995-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#3)(2012-12#1)(2012-2#3)
a safe and efficacious##3##4##(1993-1#1)(1996-9#1)(2008-10#1)
a safe and secure##3##4##(1992-3#1)(1995-2#2)
a safe and##45##3##(1990-11#1)(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
a safe drug##2##3##(2010-4#1)(2011-2#1)
a safe procedure with##2##4##(1990-6#1)(2008-10#1)
a safe procedure##4##3##(1990-6#1)(1995-1#1)(2007-8#1)(2008-10#1)
a safe space for##2##4##(2010-4#2)
a safe##81##2##(1990-11#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-9#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
a safe-haven law##2##3##(2007-2#2)
a safeguard##2##2##(1994-9#1)(2011-2#1)
a safer and##2##3##(1997-4#1)(2007-7#1)
a safer##8##2##(1997-4#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
a safety##3##2##(2008-11#1)(2008-7#1)(2010-11#1)
a salient##2##2##(1995-3#1)(2010-5#1)
a salivary##2##2##(2007-12#1)(2008-10#1)
a salt of##2##3##(2008-10#1)(2012-2#1)
a salt##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
a salvage##2##2##(1992-2#1)(2011-2#1)
a samarium-cobalt magnet##2##3##(2008-10#2)
a same##5##2##(1997-7#1)(2008-10#3)(2009-8#1)
a sample and##3##3##(2007-11#1)(2008-10#2)
a sample containing##9##3##(2008-10#9)
a sample diluted##2##3##(2008-10#2)
a sample do##2##3##(1995-3#1)(2007-7#1)
a sample flow rate of 1##3##6##(2008-10#3)
a sample flow rate of##5##5##(2008-10#5)
a sample flow##6##3##(2008-10#6)
a sample frequency of##10##4##(2008-10#10)
a sample from a first settlement of##2##7##(2008-10#2)
a sample from a##3##4##(2008-10#2)(2010-11#1)
a sample from##4##3##(1994-2#1)(2008-10#2)(2010-11#1)
a sample group of##2##4##(1993-11#1)(2008-10#1)
a sample injection valve##2##4##(2008-10#2)
a sample injection volume of##3##5##(2008-10#3)
a sample injection##6##3##(2008-10#6)
a sample introduction##3##3##(2008-10#3)
a sample is##6##3##(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
a sample loading##2##3##(2008-10#2)
a sample loop of##2##4##(2008-10#2)
a sample of 1##2##4##(2008-10#1)(2012-2#1)
a sample of 15##3##4##(1991-2#1)(2008-5#1)(2010-11#1)
a sample of 179##2##4##(1995-2#1)(2009-8#1)
a sample of 18##3##4##(1995-12#1)(1997-5#1)(2008-10#1)
a sample of 2##4##4##(1992-12#1)(1992-3#1)(1993-12#1)(2008-4#1)
a sample of 40##2##4##(2007-11#1)(2009-12#1)
a sample of 5##2##4##(2008-10#2)
a sample of a##2##4##(1992-8#1)(2008-10#1)
a sample of elderly##2##4##(1996-2#1)(2008-7#1)
a sample of the##4##4##(2008-7#2)(2011-1#1)(2012-12#1)
a sample of##135##3##(1990-6#1)(1990-8#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2008-10#18)(2008-11#7)(2008-12#10)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#6)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#5)
a sample plan##2##3##(1993-3#1)(2008-10#1)
a sample preparation##2##3##(2008-10#2)
a sample pretreatment##2##3##(2008-10#2)
a sample size##3##3##(1994-9#1)(1995-5#1)(2012-2#1)
a sample solution was##2##4##(2008-10#2)
a sample solution##9##3##(1994-9#1)(2008-1#1)(2008-10#6)(2008-3#1)
a sample surface##2##3##(2008-3#2)
a sample that was##2##4##(1992-6#1)(2007-12#1)
a sample that##4##3##(1992-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
a sample throughput of##12##4##(2008-10#12)
a sample throughput##13##3##(2008-10#13)
a sample volume of 100 ml##2##6##(2008-10#2)
a sample volume of 100##3##5##(2008-10#3)
a sample volume of 50##2##5##(2008-10#2)
a sample volume of##17##4##(2008-10#17)
a sample volume##18##3##(2008-10#18)
a sample were##2##3##(2008-10#1)(2011-2#1)
a sample with a##2##4##(2008-3#2)
a sample with##7##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
a sample##333##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#3)(1996-1#2)(1996-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#145)(2008-11#7)(2008-12#12)(2008-2#2)(2008-3#18)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#5)
a sampled##2##2##(2007-12#1)(2008-10#1)
a sampling bout##2##3##(2008-10#2)
a sampling flow rate of##2##5##(2008-10#2)
a sampling frequency of 40 samples per hour##2##8##(2008-10#2)
a sampling frequency of##25##4##(2008-10#23)(2010-9#1)(2013-1#1)
a sampling frequency##26##3##(2008-10#24)(2010-9#1)(2013-1#1)
a sampling of##2##3##(2008-10#1)(2008-2#1)
a sampling rate of 15##2##5##(2008-10#2)
a sampling rate of 60##3##5##(2008-10#3)
a sampling rate of##22##4##(2008-10#20)(2008-3#2)
a sampling volume of##3##4##(2008-10#3)
a sampling##74##2##(1996-3#1)(2008-10#63)(2008-2#1)(2008-3#4)(2008-8#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-1#1)
a sandwich type##2##3##(2008-10#2)
a sandwich##5##2##(2008-10#5)
a sandwich-type##3##2##(2008-10#2)(2008-3#1)
a saphenous vein##3##3##(2007-8#3)
a sapphire##5##2##(2008-2#3)(2008-3#2)
a sarco/endoplasmic reticulum-type Ca2(+)-ATPase##2##4##(1990-12#2)
a sarcoma##3##2##(1991-11#1)(2008-2#1)(2008-6#1)
a satellite symposium##2##3##(2008-5#1)(2012-1#1)
a satellite##17##2##(1994-1#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#2)(2010-9#1)(2012-1#1)
a satisfactory clinical##2##3##(1995-11#1)(2011-2#1)
a satisfactory functional##2##3##(2007-8#1)(2011-2#1)
a satisfactory##29##2##(1992-6#1)(1993-11#1)(1995-11#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
a saturable Bragg reflector##2##4##(2007-11#2)
a saturable absorber is##2##4##(2007-11#1)(2008-3#1)
a saturable absorber##10##3##(2007-11#3)(2008-2#2)(2008-3#5)
a saturable##16##2##(1990-8#1)(1992-3#2)(2007-11#5)(2008-2#2)(2008-3#6)
a saturated solution of##2##4##(2008-10#2)
a saturated##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
a saturating concentration of##2##4##(1990-10#1)(1993-6#1)
a saturating concentration##3##3##(1990-10#1)(1993-6#1)(1994-2#1)
a saturating##5##2##(1990-10#1)(1993-6#1)(1994-2#1)(2007-11#1)(2008-8#1)
a saturation level##2##3##(1996-7#1)(2013-8#1)
a saturation##6##2##(1996-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
a scaffold for the##2##4##(2008-8#1)(2012-2#1)
a scaffold for##5##3##(1997-3#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
a scaffold##9##2##(1997-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
a scaffold-free##2##2##(2011-2#2)
a scaffolding##2##2##(1993-2#1)(2009-12#1)
a scalable##5##2##(2008-3#3)(2008-7#1)(2012-2#1)
a scalar##3##2##(1996-4#1)(2007-12#1)(2008-3#1)
a scale for##2##3##(1991-1#1)(2013-1#1)
a scale larger than##2##4##(2008-10#2)
a scale of 0 to##4##5##(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)
a scale of##13##3##(1994-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
a scale to##2##3##(2008-12#1)(2011-1#1)
a scale##28##2##(1991-1#1)(1992-3#1)(1994-3#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2012-3#2)(2013-1#4)
a scaling law##3##3##(2007-12#2)(2008-3#1)
a scaling##5##2##(1996-4#1)(2007-12#2)(2008-2#1)(2008-3#1)
a scan rate of 100 mV s(-1)##2##7##(2008-10#2)
a scan rate of##4##4##(2008-10#4)
a scan##6##2##(2008-10#5)(2013-1#1)
a scanning confocal##3##3##(2007-11#1)(2008-3#1)(2008-9#1)
a scanning electron microscope##4##4##(1992-12#1)(2008-10#2)(2008-3#1)
a scanning electron##5##3##(1992-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
a scanning near-field optical microscope##2##5##(2007-11#1)(2008-3#1)
a scanning optical-fiber interferometer##2##4##(2008-3#2)
a scanning probe##2##3##(2008-7#2)
a scanning##29##2##(1992-12#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#13)(2008-5#1)(2008-7#2)(2008-9#1)(2013-1#1)
a scanning-beam##2##2##(2008-3#2)
a scarcity of##2##3##(1994-12#1)(1994-3#1)
a scattered##2##2##(2008-2#1)(2008-5#1)
a scattering medium is##2##4##(2007-12#1)(2008-2#1)
a scattering medium##25##3##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#13)
a scattering slab is##2##4##(2008-3#2)
a scattering slab##4##3##(2008-3#4)
a scattering##40##2##(2007-11#3)(2007-12#8)(2008-10#1)(2008-2#5)(2008-3#22)(2011-2#1)
a scavenger of##2##3##(1995-2#1)(2008-11#1)
a scenario in which##2##4##(2009-2#1)(2013-1#1)
a scenario of##4##3##(2008-10#4)
a scenario##11##2##(1992-3#1)(2008-10#5)(2008-12#1)(2009-2#1)(2011-3#1)(2013-1#2)
a scene##6##2##(2008-10#1)(2008-3#3)(2008-9#2)
a scheduled##2##2##(1994-3#1)(2013-1#1)
a schematic##2##2##(2008-2#1)(2008-3#1)
a scheme for the##3##4##(1991-5#1)(1995-3#1)(2013-8#1)
a scheme for##8##3##(1990-5#1)(1991-5#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
a scheme of##2##3##(1995-11#1)(2008-6#1)
a scheme to##2##3##(2008-10#1)(2008-2#1)
a scheme##14##2##(1990-5#1)(1991-5#1)(1995-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2013-8#1)
a schizophrenic##3##2##(1993-2#1)(2008-1#1)(2008-9#1)
a school of##2##3##(2008-12#1)(2008-2#1)
a school##12##2##(1990-2#1)(1991-12#1)(1993-1#1)(1994-1#1)(1995-2#1)(1996-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2011-2#2)(2012-2#1)
a school-based##5##2##(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a schwannoma##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
a sciatic nerve##2##3##(1996-5#1)(2008-8#1)
a scid mouse##2##3##(1995-2#2)
a science of##2##3##(1996-11#1)(2010-10#1)
a science##3##2##(1996-11#1)(2008-10#1)(2010-10#1)
a scientific and##2##3##(2009-10#1)(2012-12#1)
a scientific concept##2##3##(1992-12#1)(1997-6#1)
a scientific##18##2##(1992-12#1)(1993-6#1)(1994-12#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#2)
a scientifically##2##2##(1997-6#1)(2008-10#1)
a scientist##3##2##(1996-3#1)(2008-12#1)(2008-4#1)
a sclerosing agent##2##3##(1990-9#1)(1997-8#1)
a score of##9##3##(1992-1#1)(1997-3#1)(1997-5#1)(2008-5#1)(2011-2#2)(2013-1#3)
a score##12##2##(1992-1#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#4)
a scoring matrix##2##3##(2008-9#2)
a scoring system##2##3##(2007-8#1)(2012-12#1)
a scoring##6##2##(2007-8#1)(2008-11#1)(2008-9#2)(2011-3#1)(2012-12#1)
a scrambled##2##2##(2007-12#1)(2010-1#1)
a screen for##5##3##(1996-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
a screen of approximately##2##4##(2008-11#1)(2008-9#1)
a screen of##4##3##(1994-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
a screen with##2##3##(2008-3#2)
a screen##12##2##(1994-8#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-5#1)
a screen-printed carbon electrode##2##4##(2008-10#2)
a screen-printed electrode##2##3##(2008-10#2)
a screen-printed##5##2##(2008-10#5)
a screening program for##2##4##(1991-6#2)
a screening test##2##3##(2007-4#1)(2008-5#1)
a screening tool for##5##4##(1993-12#1)(2008-10#1)(2010-9#1)(2013-1#2)
a screening tool##7##3##(1992-12#1)(1993-12#1)(1997-4#1)(2008-10#1)(2010-9#1)(2013-1#2)
a screening##31##2##(1991-12#1)(1991-6#3)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-12#2)(1996-11#1)(1997-4#1)(2007-10#2)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-9#2)(2011-3#1)(2013-1#2)
a screw and##2##3##(2009-10#1)(2011-2#1)
a screw##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
a scrotal##3##2##(2007-2#1)(2008-10#2)
a sea##2##2##(1995-12#1)(2008-5#1)
a seamless##4##2##(1996-3#1)(2008-11#3)
a search for a##3##4##(1993-9#1)(1997-8#1)(2013-1#1)
a search for the##4##4##(1995-12#1)(1996-8#1)(2008-10#1)(2010-3#1)
a search for##17##3##(1992-1#1)(1992-5#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
a search model##2##3##(2008-8#1)(2010-8#1)
a search of##3##3##(1992-11#1)(1994-2#1)(2008-10#1)
a search##28##2##(1992-1#1)(1992-11#1)(1992-5#1)(1993-2#2)(1993-9#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-5#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
a searchable##2##2##(2008-7#1)(2008-9#1)
a season##6##2##(1991-12#1)(1996-6#1)(2008-10#4)
a seasonal decline in##2##4##(2008-8#1)(2012-5#1)
a seasonal environment##2##3##(2008-9#1)(2011-2#1)
a seasonal pattern##3##3##(1997-3#1)(1997-6#1)(2013-7#1)
a seasonal variation in##2##4##(2007-10#1)(2008-5#1)
a seasonal variation##3##3##(2007-10#2)(2008-5#1)
a seasonal##12##2##(1997-3#1)(1997-6#1)(2007-10#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-5#1)(2013-7#1)
a seat belt##3##3##(1997-6#3)
a seat##5##2##(1997-6#3)(2012-2#1)(2013-1#1)
a seawater sample##2##3##(2008-10#2)
a seaweed-type bioreactor##2##3##(2008-6#2)
a sech(2)##2##2##(2007-11#1)(2008-2#1)
a second antibody##2##3##(2008-10#1)(2008-11#1)
a second case of##2##4##(1991-4#1)(1993-2#1)
a second cluster##3##3##(2008-10#3)
a second course##2##3##(2008-1#1)(2008-11#1)
a second derivative##2##3##(2008-10#2)
a second dose##3##3##(1993-12#1)(2008-7#2)
a second exhaustive##2##3##(2013-1#2)
a second gene##2##3##(1992-6#1)(2008-10#1)
a second generation of##2##4##(1991-5#1)(2012-12#1)
a second group of##2##4##(1990-5#1)(1993-12#1)
a second group##4##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-9#1)
a second independent##3##3##(1991-12#1)(1995-6#1)(2008-12#1)
a second laser##2##3##(2008-2#2)
a second messenger##4##3##(1992-3#2)(1995-11#1)(1996-12#1)
a second operation##2##3##(2006-12#1)(2010-12#1)
a second opinion##3##3##(1996-2#1)(2008-4#1)(2008-8#1)
a second order##2##3##(2008-10#1)(2008-5#1)
a second patient##2##3##(2008-1#1)(2008-9#1)
a second peak##2##3##(1997-3#1)(2008-3#1)
a second phase##4##3##(2007-12#1)(2008-10#1)(2009-7#1)(2011-2#1)
a second prey##2##3##(2008-8#2)
a second primary##2##3##(1990-8#1)(2012-1#1)
a second procedure##2##3##(1994-9#1)(1996-9#1)
a second ring##2##3##(1995-3#1)(2008-2#1)
a second series##2##3##(1992-6#1)(2011-2#1)
a second set of##4##4##(1993-12#1)(1995-12#1)(2008-10#1)(2013-1#1)
a second step##6##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#2)
a second study##5##3##(1991-3#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-2#1)
a second time by##2##4##(1992-12#1)(2008-10#1)
a second time##3##3##(1992-12#1)(1996-12#1)(2008-10#1)
a second unknown##2##3##(1990-11#1)(2008-10#1)
a second##256##2##(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-5#2)(1992-6#4)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#4)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#46)(2008-11#8)(2008-12#3)(2008-2#10)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-4#2)(2009-6#2)(2009-7#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
a second-generation##2##2##(1997-7#1)(2008-12#1)
a second-harmonic##3##2##(2007-12#1)(2008-3#2)
a second-harmonic-generation##2##2##(2007-12#1)(2008-2#1)
a second-line##3##2##(1992-12#2)(2010-12#1)
a second-order digital phase-locked loop##2##5##(2008-3#2)
a second-order nonlinear coefficient##2##4##(2008-2#2)
a second-order nonlinear##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
a second-order polynomial##3##3##(2008-10#2)(2008-3#1)
a second-order reaction##3##3##(1993-8#1)(2008-10#1)(2008-6#1)
a second-order##20##2##(1993-8#1)(1994-5#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#4)(2008-6#1)(2009-7#1)
a secondary analysis of data##2##5##(2007-4#1)(2008-12#1)
a secondary anion binding site##2##5##(1990-5#1)(1993-8#1)
a secondary cleavage##2##3##(1990-8#2)
a secondary operation for cubital tunnel syndrome##2##7##(2008-9#2)
a secondary role in##2##4##(2008-2#1)(2008-7#1)
a secondary role##3##3##(2008-2#1)(2008-7#1)(2009-9#1)
a secondary sexual##2##3##(2008-9#2)
a secondary standard##3##3##(1995-2#1)(2008-3#2)
a secondary##53##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1992-12#2)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#7)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)
a secreted protein##4##3##(1992-8#1)(2008-2#1)(2009-8#1)(2012-12#1)
a secreted##15##2##(1990-11#1)(1992-8#2)(1994-5#1)(1995-2#2)(1997-4#1)(2008-11#3)(2008-2#1)(2009-8#2)(2010-11#1)(2012-12#1)
a secretion##2##2##(1993-2#1)(2008-4#1)
a secretory response##2##3##(1990-12#1)(2012-3#1)
a secretory##8##2##(1990-12#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-11#1)(2007-12#1)(2008-1#1)(2012-3#1)
a section of the##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
a section of##7##3##(1992-12#1)(1996-5#1)(2008-10#3)(2008-3#2)
a section on##4##3##(1991-2#1)(1992-2#1)(1997-2#1)(2012-2#1)
a section##12##2##(1991-2#1)(1992-12#1)(1992-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-3#2)(2012-2#1)
a secure evidence base##2##4##(2008-7#2)
a secure##9##2##(1996-9#1)(2007-12#2)(2008-10#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)
a security department##2##3##(1994-12#1)(1997-2#1)
a security plan##2##3##(1997-2#1)(2008-9#1)
a security##7##2##(1993-2#1)(1994-12#1)(1995-2#1)(1997-2#2)(2008-9#2)
a sedation protocol##3##3##(2007-11#3)
a sediment##3##2##(2008-10#3)
a sedimentation##2##2##(1994-5#1)(2008-10#1)
a seed bank##3##3##(2008-8#3)
a seed lot with##2##4##(2008-10#2)
a seed lot##3##3##(2008-10#3)
a seed##15##2##(1994-11#2)(2007-11#1)(2008-10#7)(2008-8#4)(2009-12#1)
a seeded##2##2##(2007-11#1)(2008-3#1)
a seemingly##5##2##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#2)
a segment of the women's market began seeking changes in the health care system##2##14##(1994-3#2)
a segment of the##6##4##(1991-4#1)(1994-3#2)(1996-6#1)(2008-4#1)(2012-12#1)
a segment of##10##3##(1991-4#1)(1991-6#1)(1994-3#2)(1996-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-10#1)(2012-12#1)
a segment##13##2##(1991-4#1)(1991-6#1)(1992-4#1)(1994-3#2)(1996-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)
a segmental##3##2##(2007-12#2)(2009-10#1)
a segmentation##3##2##(2007-11#1)(2009-11#1)(2010-4#1)
a segmented cladding##2##3##(2007-11#2)
a segmented mirror telescope##2##4##(2008-3#2)
a segmented##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
a segregating population##4##3##(2008-10#3)(2012-3#1)
a select group of##3##4##(1995-2#1)(1995-3#1)(2009-3#1)
a select sample of##2##4##(2011-1#1)(2012-12#1)
a select##7##2##(1995-2#1)(1995-3#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-12#1)
a selectable marker##6##3##(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#2)
a selectable##7##2##(1994-12#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#2)
a selected group of##5##4##(1990-9#1)(1994-6#1)(1996-9#1)(2008-10#1)(2013-1#1)
a selected range of mobile-wireless infrastructure##2##6##(2010-8#2)
a selected##30##2##(1990-9#1)(1991-9#1)(1994-6#1)(1994-8#1)(1996-6#1)(1996-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
a selection marker##3##3##(1997-4#1)(2008-11#2)
a selection of representatives of Metro Toronto##2##7##(1994-1#2)
a selection of##11##3##(1994-1#2)(1996-3#1)(2006-10#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-9#1)
a selection response##2##3##(2008-8#2)
a selection##23##2##(1994-1#2)(1996-3#2)(1997-4#1)(2006-10#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2008-9#1)
a selective P2Y(1) receptor blocker##2##5##(2008-4#2)
a selective advantage##4##3##(1993-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
a selective and##3##3##(1995-11#1)(2008-10#2)
a selective enrichment##2##3##(1994-12#1)(2008-7#1)
a selective fluorescence quenching agent for##2##6##(2008-10#2)
a selective fluorescence quenching##3##4##(2008-10#3)
a selective group I##2##4##(2008-4#2)
a selective inhibitor of##4##4##(1993-6#1)(1994-6#1)(1995-12#1)(2012-1#1)
a selective inhibitor##6##3##(1990-5#1)(1993-6#1)(1994-6#1)(1995-12#1)(2008-10#1)(2012-1#1)
a selective medium and##2##4##(2008-10#2)
a selective medium##8##3##(2008-10#8)
a selective plasma separator##2##4##(2011-1#2)
a selective pressure##2##3##(2008-9#1)(2013-1#1)
a selective probe for##2##4##(1994-8#2)
a selective quencher##2##3##(2008-10#2)
a selective reduction in##2##4##(1994-6#1)(1995-12#1)
a selective##101##2##(1990-12#2)(1990-2#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#4)(1995-11#1)(1995-12#2)(1995-6#1)(1996-5#2)(1997-2#2)(1997-3#1)(1997-7#2)(2007-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#1)
a selectivity##4##2##(2008-10#2)(2008-4#1)(2013-7#1)
a selenoenzyme##3##2##(1990-12#2)(1992-12#1)
a self monitoring blood pressure device##3##6##(2008-10#3)
a self##7##2##(1996-1#1)(2008-10#4)(2008-11#1)(2009-6#1)
a self-administered##2##2##(1992-1#1)(1997-3#1)
a self-amplifying##2##2##(2008-5#1)(2009-8#1)
a self-assembled monolayer (SAM) of##3##5##(2008-10#3)
a self-assembled monolayer##7##3##(2008-10#5)(2008-3#1)(2008-8#1)
a self-assembled##13##2##(1990-4#1)(2008-10#9)(2008-3#1)(2008-7#1)(2008-8#1)
a self-assessment##5##2##(1995-3#1)(2008-11#1)(2008-9#1)(2009-9#1)(2012-2#1)
a self-closing##2##2##(2007-7#2)
a self-consistent##2##2##(2008-2#1)(2008-3#1)
a self-directed learning##2##3##(2008-11#1)(2008-12#1)
a self-expanding metallic stent##2##4##(2007-8#2)
a self-expanding##3##2##(2007-8#3)
a self-insured##2##2##(1993-1#2)
a self-limiting##2##2##(1992-2#1)(2012-3#1)
a self-mixing##2##2##(2007-11#1)(2008-3#1)
a self-mode-locked##3##2##(2007-12#1)(2008-3#2)
a self-organizing##3##2##(2008-3#2)(2009-6#1)
a self-pumped phase-conjugate mirror##5##4##(2008-2#3)(2008-3#2)
a self-renewing##2##2##(1995-11#1)(2013-1#1)
a self-report##4##2##(2007-12#1)(2008-12#1)(2012-1#2)
a self-study##2##2##(1994-9#1)(1996-2#1)
a selfish##2##2##(2008-9#1)(2013-1#1)
a semantic differential##2##3##(1991-2#1)(1993-2#1)
a semantic##3##2##(1991-2#1)(1993-2#1)(2013-8#1)
a semester##2##2##(2009-3#1)(2011-2#1)
a semi-continuous##2##2##(2008-10#1)(2008-7#1)
a semi-empirical##4##2##(1992-4#1)(1994-12#1)(1997-2#1)(2008-7#1)
a semi-infinite turbid medium##2##4##(2008-2#2)
a semi-infinite##6##2##(2008-2#4)(2008-3#2)
a semi-permeable##2##2##(2008-7#1)(2008-9#1)
a semi-quantitative##4##2##(1993-9#1)(2008-10#1)(2009-8#1)(2011-2#1)
a semi-structured##3##2##(2008-10#1)(2011-1#2)
a semi-supervised learning##3##3##(2010-7#3)
a semicircular##3##2##(2008-2#1)(2012-2#1)(2013-1#1)
a semiconductor laser subjected to##2##5##(2007-11#1)(2007-12#1)
a semiconductor laser##14##3##(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#4)
a semiconductor saturable Bragg reflector##2##5##(2007-11#1)(2008-3#1)
a semiconductor saturable##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a semiconductor saturable-absorber mirror##6##4##(2007-11#2)(2007-12#3)(2008-3#1)
a semiconductor tapered amplifier##3##4##(2007-12#1)(2008-2#2)
a semiconductor tapered##4##3##(2007-12#2)(2008-2#2)
a semiconductor##40##2##(2007-11#8)(2007-12#14)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#8)
a semiempirical model##2##3##(2008-3#2)
a seminar##4##2##(1990-2#1)(1995-1#1)(2008-12#1)(2008-4#1)
a semiparametric model##2##3##(1996-2#1)(2010-11#1)
a semiparametric##5##2##(1996-2#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-5#1)
a semipermeable membrane##2##3##(2008-11#1)(2008-7#1)
a semipermeable##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
a semiquantitative##5##2##(1993-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
a semiselective medium##2##3##(2008-10#2)
a semiselective##4##2##(2008-10#4)
a semistructured interview##2##3##(2007-8#1)(2010-9#1)
a semistructured##6##2##(2007-11#1)(2007-8#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
a senior##4##2##(1996-12#1)(2008-1#1)(2008-9#1)(2010-8#1)
a sensation of##2##3##(2006-10#1)(2013-1#1)
a sensation##3##2##(1996-6#1)(2006-10#1)(2013-1#1)
a sense of ownership##2##4##(2008-12#1)(2008-7#1)
a sense of trust in health workers who##2##8##(2009-6#2)
a sense of##23##3##(1992-1#1)(1993-1#1)(1993-12#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2013-1#1)(2013-8#1)
a sense##26##2##(1992-1#1)(1993-1#1)(1993-12#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
a sensing##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)
a sensitive absorption peak at##3##5##(2008-10#3)
a sensitive adsorptive##2##3##(2008-10#2)
a sensitive and convenient##3##4##(2008-10#3)
a sensitive and reliable##4##4##(1991-12#1)(1997-7#1)(2008-10#2)
a sensitive and selective##2##4##(2008-10#1)(2008-5#1)
a sensitive and simple method for##2##6##(2008-10#2)
a sensitive and specific##5##4##(1992-3#1)(1996-12#1)(1997-7#1)(2011-2#1)(2011-3#1)
a sensitive and##23##3##(1990-8#1)(1991-12#1)(1992-3#1)(1994-11#1)(1996-12#1)(1997-7#2)(2008-1#1)(2008-10#11)(2008-4#1)(2008-5#1)(2011-2#1)(2011-3#1)
a sensitive assay for##2##4##(2008-10#1)(2008-7#1)
a sensitive assay##5##3##(1992-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
a sensitive index of##2##4##(1994-8#1)(2008-7#1)
a sensitive indicator of the##2##5##(2008-10#1)(2008-7#1)
a sensitive indicator of##4##4##(1995-3#1)(2008-10#1)(2008-7#2)
a sensitive indicator strain in##2##5##(2008-10#2)
a sensitive indicator##6##3##(1995-3#1)(2008-10#3)(2008-7#2)
a sensitive marker of##2##4##(1993-6#1)(2008-7#1)
a sensitive means to##2##4##(1992-11#1)(1992-6#1)
a sensitive means##3##3##(1992-11#1)(1992-6#1)(2008-10#1)
a sensitive measure##2##3##(2007-11#1)(2008-5#1)
a sensitive method for the##2##5##(1993-2#1)(2008-10#1)
a sensitive method for##4##4##(1993-2#1)(2008-10#2)(2013-8#1)
a sensitive method##5##3##(1993-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
a sensitive parameter for##2##4##(2008-10#1)(2012-3#1)
a sensitive parameter##3##3##(2008-10#2)(2012-3#1)
a sensitive second##2##3##(2008-10#2)
a sensitive spectrophotometric##2##3##(2008-10#2)
a sensitive technique##2##3##(1996-12#1)(2008-10#1)
a sensitive tool for##2##4##(2008-10#1)(2012-2#1)
a sensitive voltammetric##2##3##(2008-10#2)
a sensitive##111##2##(1990-2#3)(1990-6#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-5#2)(1997-7#2)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#60)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#6)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
a sensitivity analysis was##2##4##(2009-9#1)(2011-2#1)
a sensitivity analysis##7##3##(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)
a sensitivity and specificity of 100%##2##6##(2007-7#1)(2007-8#1)
a sensitivity and specificity of##4##5##(1992-6#1)(2007-7#1)(2007-8#1)(2013-1#1)
a sensitivity and##5##3##(1992-6#1)(2007-7#1)(2007-8#1)(2013-1#1)(2013-8#1)
a sensitivity enhancement of##2##4##(2008-10#2)
a sensitivity of 0##7##4##(1993-2#2)(2008-10#3)(2008-3#1)(2013-1#1)
a sensitivity of 1##2##4##(2007-11#1)(2008-10#1)
a sensitivity of 100%##2##4##(2008-6#1)(2010-8#1)
a sensitivity of 3##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
a sensitivity of about##2##4##(1990-8#1)(2008-10#1)
a sensitivity of##41##3##(1990-6#1)(1990-8#1)(1990-9#1)(1993-2#2)(1994-2#1)(1995-4#1)(1997-3#1)(1997-8#4)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#10)(2008-3#7)(2008-6#1)(2010-8#1)(2012-3#1)(2013-1#3)
a sensitivity##64##2##(1990-6#1)(1990-8#1)(1990-9#1)(1992-6#1)(1993-2#2)(1994-2#1)(1995-4#1)(1997-3#1)(1997-8#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#11)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
a sensitization##5##2##(2008-10#3)(2009-8#1)(2013-1#1)
a sensor of##3##3##(2008-2#1)(2008-9#1)(2009-8#1)
a sensor##24##2##(1994-12#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
a sensory##9##2##(1996-5#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-2#1)
a sentence##5##2##(1997-5#2)(1997-8#1)(2007-12#2)
a sentence-span task##2##3##(2012-3#2)
a sentinel##4##2##(1991-12#1)(2008-9#2)(2009-3#1)
a separable##2##2##(2008-2#1)(2012-2#1)
a separate species##2##3##(2008-10#2)
a separate##51##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-5#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-5#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#6)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a separated##5##2##(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#2)
a separation in##2##3##(1995-5#1)(2008-9#1)
a separation length of##2##4##(2008-10#2)
a separation of the##2##4##(2008-10#1)(2011-2#1)
a separation of##7##3##(2007-12#1)(2008-10#3)(2010-5#1)(2011-2#2)
a separation technique##2##3##(2008-10#2)
a separation voltage of##6##4##(2008-10#6)
a separation##27##2##(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#16)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)
a septate bicornuate uterus##2##4##(2013-1#2)
a sequel of##3##3##(2008-7#2)(2012-3#1)
a sequel##4##2##(2008-7#3)(2012-3#1)
a sequence characterized amplified region (SCAR) marker##2##7##(2008-10#1)(2008-5#1)
a sequence characterized amplified region (SCAR)##3##6##(2008-10#2)(2008-5#1)
a sequence encoding##2##3##(1993-8#1)(1994-8#1)
a sequence of 1##2##4##(1997-2#1)(2010-2#1)
a sequence of##30##3##(1990-11#1)(1991-6#1)(1993-12#2)(1994-8#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-2#1)(2007-11#2)(2008-10#5)(2008-2#3)(2008-3#5)(2009-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a sequence on the##2##4##(1995-2#1)(2008-9#1)
a sequence or a##2##4##(2008-4#1)(2008-7#1)
a sequence that##3##3##(1992-6#1)(1995-2#1)(1996-5#1)
a sequence##69##2##(1990-11#2)(1990-5#1)(1991-5#1)(1991-6#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a sequence-##2##2##(2008-8#1)(2008-9#1)
a sequential extraction procedure##2##4##(2008-10#2)
a sequential extraction##4##3##(2008-10#4)
a sequential injection analysis system##4##5##(2008-10#4)
a sequential injection analysis##8##4##(2008-10#8)
a sequential injection system for##2##5##(2008-10#2)
a sequential injection system##7##4##(2008-10#7)
a sequential injection##23##3##(2008-10#23)
a sequential##45##2##(1990-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#36)(2008-2#1)(2008-4#2)(2008-8#1)(2011-2#1)
a serial##3##2##(1994-5#1)(2008-3#2)
a series of 10##3##4##(2007-8#1)(2008-10#2)
a series of 20 patients##2##5##(2008-10#1)(2008-7#1)
a series of 20##5##4##(2008-10#2)(2008-7#2)(2011-2#1)
a series of 30##2##4##(2008-7#1)(2010-8#1)
a series of alternating##2##4##(2008-2#2)
a series of bacterial##2##4##(1992-12#1)(2013-8#1)
a series of biochemical##2##4##(2008-1#1)(2008-4#1)
a series of clinical##2##4##(2008-10#1)(2010-4#1)
a series of compounds##4##4##(1990-8#1)(1991-5#1)(2010-11#1)(2012-12#1)
a series of concentrations##2##4##(2008-10#1)(2010-5#1)
a series of d##2##4##(2008-10#2)
a series of different##3##4##(1990-8#1)(2008-10#1)(2011-4#1)
a series of discoveries##2##4##(2008-2#1)(2010-1#1)
a series of events##4##4##(1992-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
a series of executive function tasks##2##6##(2013-8#2)
a series of experiments##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
a series of five##2##4##(1994-5#1)(2012-2#1)
a series of four##4##4##(2008-10#1)(2008-12#1)(2008-4#2)
a series of genetic##2##4##(2007-10#1)(2008-11#1)
a series of hierarchical##2##4##(2008-4#1)(2012-1#1)
a series of high##2##4##(2007-11#1)(2012-2#1)
a series of highly##2##4##(2007-11#1)(2009-11#1)
a series of images##2##4##(2008-2#1)(2008-3#1)
a series of indicators##2##4##(1995-12#1)(2008-8#1)
a series of investigations##2##4##(2008-10#1)(2008-5#1)
a series of measurements##4##4##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a series of new##2##4##(2008-8#1)(2012-3#1)
a series of predictions##2##4##(1991-5#1)(2008-1#1)
a series of questions##2##4##(1993-1#1)(1993-3#1)
a series of semi-structured##2##4##(1995-1#1)(2008-12#1)
a series of similar##2##4##(2008-8#1)(2011-2#1)
a series of surface##2##4##(2007-12#1)(2008-10#1)
a series of ten##2##4##(1991-2#1)(1991-5#1)
a series of tests##2##4##(2008-10#1)(2008-2#1)
a series of three##3##4##(1996-12#1)(1996-3#1)(1996-5#1)
a series of various##2##4##(1995-5#1)(2008-5#1)
a series of##364##3##(1990-10#1)(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#5)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#3)(1994-5#4)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#2)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#61)(2008-11#14)(2008-12#6)(2008-2#15)(2008-3#16)(2008-4#10)(2008-5#15)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#10)(2009-11#1)(2009-12#4)(2009-4#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#9)(2011-4#2)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#4)(2013-8#5)
a series##381##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#3)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#2)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#61)(2008-11#14)(2008-12#6)(2008-2#15)(2008-3#17)(2008-4#10)(2008-5#15)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#10)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#9)(2011-4#2)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#5)(2013-8#5)
a serine protease##6##3##(1992-6#2)(1995-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
a serine proteinase##3##3##(1992-11#1)(1995-5#1)(2008-10#1)
a serine##16##2##(1991-9#1)(1992-11#1)(1992-6#2)(1994-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
a serine/threonine kinase##3##3##(1994-12#1)(2008-9#1)(2009-8#1)
a serine/threonine##5##2##(1992-12#1)(1994-12#1)(1996-2#1)(2008-9#1)(2009-8#1)
a serious and##4##3##(2007-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
a serious clinical##2##3##(2007-11#2)
a serious complication of##3##4##(2010-5#2)(2013-1#1)
a serious complication##7##3##(1994-6#1)(1995-11#1)(2010-5#2)(2011-2#1)(2013-1#2)
a serious condition##2##3##(2009-3#1)(2010-5#1)
a serious disease of##8##4##(2008-10#8)
a serious disease##11##3##(2008-10#9)(2010-6#1)(2011-2#1)
a serious disorder##2##3##(1991-6#1)(2012-2#1)
a serious health problem##3##4##(1991-6#1)(2013-1#2)
a serious medical treatment##2##4##(1997-6#1)(2011-2#1)
a serious medical##3##3##(1997-6#1)(2011-2#2)
a serious problem for##2##4##(2008-11#1)(2012-12#1)
a serious problem in##4##4##(2008-7#1)(2012-3#1)(2013-1#2)
a serious problem##14##3##(1996-12#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
a serious public health problem##2##5##(2008-12#1)(2012-12#1)
a serious public health##4##4##(2008-12#1)(2009-10#1)(2011-2#1)(2012-12#1)
a serious risk of##3##4##(1994-6#1)(2009-4#1)(2011-2#1)
a serious risk##4##3##(1994-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
a serious threat##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
a serious##109##2##(1990-11#1)(1991-1#1)(1991-6#2)(1993-6#1)(1994-6#2)(1995-11#1)(1996-12#2)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-6#2)(2011-1#2)(2011-2#10)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#1)
a seroepidemiological study##2##3##(1991-11#1)(2011-1#1)
a seroepidemiological##3##2##(1991-11#1)(2011-1#1)(2011-2#1)
a serological##2##2##(1996-12#1)(2010-4#1)
a serosal##2##2##(2008-1#1)(2008-12#1)
a serous##2##2##(2011-2#1)(2013-7#1)
a serum and##2##3##(2008-10#1)(2008-11#1)
a serum creatinine##2##3##(2006-10#1)(2013-8#1)
a serum protein##2##3##(1992-11#1)(2008-10#1)
a serum##17##2##(1990-12#1)(1992-11#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-11#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
a serum-free medium##8##3##(1990-11#1)(1993-6#1)(2008-11#6)
a serum-free suspension##2##3##(2008-11#2)
a serum-free##19##2##(1990-11#1)(1993-6#1)(1996-5#1)(2008-11#13)(2008-7#2)(2012-12#1)
a service quality improvement##2##4##(1996-3#2)
a service quality##3##3##(1992-3#1)(1996-3#2)
a service##20##2##(1991-12#4)(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#1)(2008-2#1)(2011-1#1)(2013-8#1)
a session##2##2##(2008-6#1)(2010-1#1)
a set of 11##2##4##(2008-10#1)(2012-3#1)
a set of 15##2##4##(2008-10#1)(2009-2#1)
a set of 16##2##4##(2008-10#1)(2008-9#1)
a set of 20##2##4##(2008-10#1)(2008-8#1)
a set of concentric##2##4##(2007-12#1)(2008-2#1)
a set of criteria for##2##5##(2008-10#1)(2008-3#1)
a set of criteria##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
a set of equations##2##4##(2008-10#1)(2008-3#1)
a set of experimental##2##4##(2008-3#1)(2013-8#1)
a set of experiments##2##4##(2008-6#1)(2011-3#1)
a set of four##2##4##(2007-12#1)(2008-10#1)
a set of genes##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
a set of human##2##4##(2008-3#1)(2008-7#1)
a set of images##3##4##(2007-12#2)(2008-3#1)
a set of linear equations##2##5##(2008-3#2)
a set of linear##3##4##(2008-3#2)(2008-7#1)
a set of measurements##3##4##(2008-3#2)(2012-2#1)
a set of molecular##2##4##(2008-10#2)
a set of primers##3##4##(1993-6#1)(1995-8#1)(2008-5#1)
a set of protocols for##3##5##(2008-4#3)
a set of recommendations##2##4##(1996-6#1)(2013-8#1)
a set of simple rules for##2##6##(2008-2#1)(2011-2#1)
a set of simple##3##4##(2008-2#1)(2008-8#1)(2011-2#1)
a set of six##2##4##(1994-8#1)(2008-8#1)
a set of specific##2##4##(2008-10#2)
a set of standards##2##4##(2008-10#1)(2008-9#1)
a set of statistical##2##4##(2008-10#1)(2008-3#1)
a set of suprathreshold tests##2##5##(2008-9#2)
a set of three##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
a set of three-way solenoid valves assembled to implement##2##9##(2008-10#2)
a set of three-way solenoid valves##4##6##(2008-10#4)
a set of unique##3##4##(2011-1#2)(2012-2#1)
a set of##273##3##(1990-11#1)(1990-5#2)(1991-2#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#3)(1994-8#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#3)(2008-10#61)(2008-11#8)(2008-12#3)(2008-2#11)(2008-3#38)(2008-4#6)(2008-5#4)(2008-6#6)(2008-7#10)(2008-8#11)(2008-9#14)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#6)(2011-2#3)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#2)(2013-8#4)
a set##281##2##(1990-11#1)(1990-5#2)(1991-2#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#3)(1994-8#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#3)(2008-10#61)(2008-11#8)(2008-12#3)(2008-2#11)(2008-3#38)(2008-4#6)(2008-5#4)(2008-6#8)(2008-7#11)(2008-8#11)(2008-9#14)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#6)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#2)(2013-8#5)
a setting for##2##3##(1994-12#1)(2013-8#1)
a setting##8##2##(1992-1#1)(1993-1#1)(1994-12#1)(1994-2#1)(2007-7#1)(2009-6#1)(2013-1#1)(2013-8#1)
a settlement##2##2##(1995-6#1)(1997-5#1)
a setup that##2##3##(2008-3#2)
a setup##5##2##(2008-3#5)
a seven##4##2##(1996-6#1)(1997-2#1)(2008-12#1)(2012-2#1)
a seven-year period##4##3##(1992-5#1)(1996-12#1)(2011-3#2)
a seven-year##5##2##(1992-5#1)(1996-12#1)(2008-3#1)(2011-3#2)
a several-fold##3##2##(1991-6#1)(1997-4#1)(2008-7#1)
a severalfold increase in##2##4##(1995-2#1)(2008-7#1)
a severe and##2##3##(2012-12#1)(2013-8#1)
a severe clinical##2##3##(1992-5#1)(2008-2#1)
a severe disease of##2##4##(2008-10#1)(2011-2#1)
a severe disease##6##3##(2008-10#4)(2008-4#1)(2011-2#1)
a severe form of##2##4##(2011-1#1)(2012-2#1)
a severe impairment of##2##4##(1996-1#1)(1997-7#1)
a severe injury##2##3##(2009-3#1)(2010-8#1)
a severe loss of##2##4##(2010-12#1)(2011-1#1)
a severe mental illness##3##4##(2008-6#1)(2011-1#2)
a severe preeclampsia##2##3##(2008-11#1)(2009-1#1)
a severe prognosis##2##3##(1990-2#1)(2011-2#1)
a severe##73##2##(1990-2#1)(1992-5#2)(1993-2#1)(1993-6#2)(1994-8#2)(1996-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#6)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a severely##7##2##(1990-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
a severity system##2##3##(1992-3#1)(1995-2#1)
a severity##7##2##(1992-3#2)(1994-9#1)(1995-2#1)(2009-4#2)(2011-1#1)
a sewage##2##2##(2007-5#1)(2008-10#1)
a sex##4##2##(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)
a sexual##10##2##(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-8#1)(2013-1#1)(2013-8#2)
a sexually dimorphic##3##3##(1992-3#3)
a sexually##7##2##(1992-3#3)(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#1)
a shadow moiré system##2##4##(2008-3#2)
a shake-flask##2##2##(2008-11#1)(2008-12#1)
a shallow reef##3##3##(2011-2#3)
a shallow##11##2##(1991-2#1)(2008-10#1)(2008-3#4)(2010-8#1)(2011-2#3)(2013-8#1)
a sham##2##2##(1994-3#1)(2011-2#1)
a shampoo##7##2##(2008-10#1)(2008-5#6)
a shape##4##2##(2008-10#1)(2008-2#2)(2010-5#1)
a shaped##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
a share of##5##3##(1990-4#1)(1992-12#1)(1992-3#1)(1995-3#1)(2009-10#1)
a shared understanding of##2##4##(1997-3#1)(2008-7#1)
a shared vision##3##3##(1993-12#1)(1995-1#1)(1995-2#1)
a shared##15##2##(1993-12#1)(1994-9#2)(1995-1#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)
a sharp decline##2##3##(2008-11#1)(2009-6#1)
a sharp decrease in##2##4##(2008-7#1)(2012-2#1)
a sharp decrease##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
a sharp increase in##2##4##(1993-12#1)(2008-11#1)
a sharp increase##4##3##(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
a sharp rise in##3##4##(1992-1#1)(1992-3#1)(2010-12#1)
a sharp rise##4##3##(1992-1#1)(1992-3#1)(2008-10#1)(2010-12#1)
a sharp##33##2##(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
a sharper##2##2##(2008-10#1)(2008-2#1)
a sharply##3##2##(2007-12#1)(2010-6#1)(2011-2#1)
a shear##7##2##(2008-11#3)(2008-5#1)(2009-12#1)(2010-1#1)(2013-1#1)
a shearing interferometer##4##3##(2008-3#4)
a sheep##6##2##(1996-12#1)(1997-3#1)(1997-4#1)(2011-1#1)(2011-2#2)
a sheet of##2##3##(2006-12#1)(2011-1#1)
a sheet##3##2##(1997-7#1)(2006-12#1)(2011-1#1)
a shelf##2##2##(1992-1#1)(2012-2#1)
a shield##2##2##(2008-11#1)(2009-11#1)
a shift from the##2##4##(1993-1#1)(2012-3#1)
a shift from##11##3##(1993-1#2)(1993-11#1)(1993-12#1)(1995-2#1)(2007-12#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-3#1)
a shift in its##2##4##(1994-9#1)(2008-7#1)
a shift in the##14##4##(1990-7#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#2)(2013-7#1)
a shift in##21##3##(1990-7#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2013-7#1)
a shift of##5##3##(1991-12#1)(1994-11#1)(1994-5#1)(2008-10#2)
a shift to a##2##4##(1992-2#1)(1993-2#1)
a shift to##5##3##(1992-2#1)(1993-2#1)(1994-5#1)(2010-11#1)(2010-12#1)
a shift toward##4##3##(1996-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
a shift##51##2##(1990-7#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a ship in the##3##4##(2008-2#2)(2008-3#1)
a ship##4##2##(1990-6#1)(2008-2#2)(2008-3#1)
a shock##4##2##(1996-2#1)(1996-3#1)(2007-8#1)(2013-1#1)
a shoot##2##2##(2008-10#2)
a short and##3##3##(1991-3#1)(1994-11#1)(2009-11#1)
a short arm##2##3##(2008-9#2)
a short description of the##3##5##(1990-5#1)(2007-12#1)(2008-10#1)
a short distance##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
a short duration##2##3##(2008-6#1)(2012-2#1)
a short history of##3##4##(1993-12#1)(1997-5#1)(2008-7#1)
a short interval##2##3##(2008-6#1)(2010-5#1)
a short length of##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
a short peptide##2##3##(1995-2#1)(2012-12#1)
a short period of time to##2##6##(1996-3#1)(2013-1#1)
a short period of time##12##5##(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
a short period of##18##4##(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#3)
a short period##25##3##(1990-6#1)(1990-8#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#2)(2013-1#3)(2013-8#1)
a short plasma half-life##2##4##(2008-3#1)(2008-5#1)
a short pulse##6##3##(2007-11#1)(2007-12#1)(2008-2#4)
a short response time of less than##2##7##(2008-10#2)
a short response time##4##4##(2008-10#4)
a short response##5##3##(1997-3#1)(2008-10#4)
a short review of##2##4##(2008-6#1)(2012-12#1)
a short review##4##3##(1995-5#1)(2008-6#1)(2009-3#1)(2012-12#1)
a short survival##2##3##(1996-9#1)(2008-9#1)
a short term##2##3##(1993-3#1)(1997-2#1)
a short time after##2##4##(2007-11#1)(2008-3#1)
a short time##18##3##(1990-12#1)(1991-3#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2010-7#1)
a short training program##2##4##(2010-3#2)
a short##175##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-9#1)(2007-11#7)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#6)(2008-12#3)(2008-2#9)(2008-3#11)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#6)(2008-9#6)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#5)(2013-8#1)
a short-cavity##2##2##(2007-12#1)(2008-3#1)
a short-chain##3##2##(1991-5#1)(1995-5#1)(2007-12#1)
a short-lived##3##2##(1991-2#1)(2012-12#1)(2012-3#1)
a short-pulse##3##2##(1993-5#1)(2007-12#1)(2008-2#1)
a short-term effect##2##3##(2008-5#1)(2012-1#1)
a short-term potentiation##2##3##(1995-12#2)
a short-term##18##2##(1990-2#1)(1994-6#1)(1995-12#2)(1997-3#1)(1997-8#1)(2007-12#2)(2007-7#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
a shortage in##2##3##(2007-4#1)(2008-11#1)
a shortage of##9##3##(1991-2#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-8#1)
a shortage##11##2##(1991-2#1)(1993-2#1)(1997-6#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-3#1)(2010-8#1)
a shortened##7##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
a shortening of the##2##4##(1994-3#1)(2012-7#1)
a shortening##3##2##(1994-3#2)(2012-7#1)
a shorter analysis time than##2##5##(2008-10#2)
a shorter analysis time##3##4##(2008-10#3)
a shorter duration##2##3##(2008-8#1)(2008-9#1)
a shorter latency##2##3##(1990-8#1)(1993-3#1)
a shorter period of time##2##5##(1990-5#1)(1992-3#1)
a shorter period##3##3##(1990-5#1)(1992-3#1)(2006-10#1)
a shorter time##6##3##(1990-2#1)(1996-2#1)(1996-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
a shorter wavelength##3##3##(1992-8#1)(2007-11#1)(2008-2#1)
a shorter##43##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)
a shot##2##2##(2008-2#1)(2011-2#1)
a shoulder##5##2##(2008-10#4)(2010-5#1)
a shrub##2##2##(2008-10#1)(2008-12#1)
a shutdown##2##2##(1995-2#1)(1996-12#1)
a shuttle plasmid##2##3##(1990-12#1)(2008-11#1)
a shuttle vector##2##3##(2008-4#1)(2008-6#1)
a shuttle##4##2##(1990-12#1)(2008-11#1)(2008-4#1)(2008-6#1)
a sialic##2##2##(1994-11#1)(2009-2#1)
a sibling##2##2##(1995-3#1)(1995-8#1)
a side chain##2##3##(1992-6#1)(1993-11#1)
a side effect##3##3##(1996-3#1)(2012-12#1)(2013-8#1)
a side##11##2##(1990-9#1)(1992-6#1)(1993-11#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#1)(2013-8#1)
a side-polished##2##2##(2008-3#2)
a side-pumped##2##2##(2007-11#1)(2008-3#1)
a sigma##3##2##(1995-2#1)(1995-6#1)(2007-11#1)
a sigmoid##5##2##(1992-5#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
a sigmoidal##3##2##(1997-6#1)(2008-10#2)
a sign of##12##3##(1990-12#1)(1991-8#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-9#1)(2013-1#1)(2013-8#1)
a sign##14##2##(1990-12#1)(1991-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
a signal at##2##3##(2008-3#2)
a signal beam##2##3##(2007-12#1)(2008-3#1)
a signal can##2##3##(2007-11#1)(2008-8#1)
a signal for##4##3##(2008-10#1)(2008-11#2)(2009-8#1)
a signal in##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
a signal of##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2009-9#1)
a signal peptidase##2##3##(1991-10#1)(1993-12#1)
a signal peptide and the##2##5##(1990-12#1)(2010-6#1)
a signal peptide and##5##4##(1990-12#1)(1992-8#2)(2008-4#1)(2010-6#1)
a signal peptide of##3##4##(1990-2#1)(1992-8#1)(2008-8#1)
a signal peptide##11##3##(1990-12#1)(1990-2#1)(1992-8#4)(1993-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-6#1)
a signal pulse##2##3##(2007-12#2)
a signal sequence##3##3##(1992-8#1)(1994-12#1)(1997-4#1)
a signal to potential conspecific brood##2##6##(2008-8#2)
a signal to##3##3##(2008-10#1)(2008-8#2)
a signal transduction pathway##3##4##(1993-6#1)(1994-11#1)(2008-10#1)
a signal transduction##5##3##(1993-6#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
a signal##70##2##(1990-12#1)(1990-2#1)(1991-10#1)(1992-8#6)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1997-4#2)(2007-11#3)(2007-12#4)(2008-10#14)(2008-11#4)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-8#7)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2012-2#1)
a signal-anchor##3##2##(1991-10#3)
a signal-induced##2##2##(2008-2#1)(2008-3#1)
a signal-to-noise ratio (S/N) of 3##2##6##(2008-10#2)
a signal-to-noise ratio of 3##11##5##(1990-8#1)(1991-5#1)(2007-12#1)(2008-10#6)(2008-3#1)(2013-1#1)
a signal-to-noise ratio of##23##4##(1990-8#1)(1991-5#1)(2007-12#3)(2008-10#10)(2008-3#7)(2013-1#1)
a signal-to-noise ratio##27##3##(1990-8#1)(1991-5#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-3#8)(2013-1#1)
a signal-to-noise##29##2##(1990-8#1)(1991-5#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-3#9)(2013-1#1)
a signaling##5##2##(2008-4#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
a signalling molecule##2##3##(2008-4#1)(2010-10#1)
a signalling##3##2##(1997-7#1)(2008-4#1)(2010-10#1)
a signature##3##2##(2008-4#1)(2008-5#1)(2010-3#1)
a significance##2##2##(2008-10#1)(2012-2#1)
a significant (P &lt##6##4##(1993-12#1)(2008-10#3)(2012-2#2)
a significant (P = 0##2##5##(2008-10#1)(2008-8#1)
a significant (P##8##3##(1993-12#1)(2008-10#4)(2008-8#1)(2012-2#2)
a significant (P&lt##2##3##(2010-4#1)(2010-5#1)
a significant (p &lt##3##4##(2008-12#1)(2008-4#2)
a significant (p&lt##3##3##(2008-12#2)(2013-1#1)
a significant accumulation##2##3##(2008-3#1)(2008-4#1)
a significant additional##2##3##(2008-1#1)(2008-10#1)
a significant advance in##2##4##(1997-7#1)(2011-2#1)
a significant advancement in##2##4##(2008-10#1)(2010-11#1)
a significant advantage in##2##4##(2007-11#1)(2010-9#1)
a significant advantage over##2##4##(2008-10#2)
a significant advantage##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2009-1#1)(2010-9#1)
a significant amount of##11##4##(1991-2#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
a significant and growing##2##4##(2008-5#1)(2010-6#1)
a significant and##13##3##(1990-7#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
a significant association between##8##4##(2008-1#1)(2008-10#1)(2009-6#1)(2011-2#4)(2012-12#1)
a significant association of##2##4##(2008-10#1)(2008-7#1)
a significant association with##5##4##(1992-2#1)(1992-3#1)(2008-12#1)(2009-5#1)(2012-2#1)
a significant association##16##3##(1990-8#1)(1992-2#1)(1992-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#4)(2012-12#1)(2012-2#1)
a significant attenuation##2##3##(2007-10#1)(2008-4#1)
a significant body##2##3##(2008-7#1)(2008-8#1)
a significant cause of morbidity and mortality##2##7##(2008-3#1)(2008-7#1)
a significant cause of morbidity##4##5##(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
a significant cause of##8##4##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#2)
a significant challenge##4##3##(1994-5#1)(2007-11#1)(2007-12#1)(2011-2#1)
a significant change in the##6##5##(1991-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)
a significant change in##16##4##(1991-2#1)(1993-8#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)
a significant change##17##3##(1991-2#1)(1993-8#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
a significant clinical problem in##2##5##(2008-7#1)(2010-12#1)
a significant clinical problem##5##4##(1995-3#1)(2007-11#1)(2008-7#2)(2010-12#1)
a significant clinical##6##3##(1995-3#1)(2007-11#1)(2008-7#2)(2008-8#1)(2010-12#1)
a significant complication##4##3##(2008-6#1)(2011-2#2)(2013-1#1)
a significant component of the##4##5##(2008-10#2)(2008-12#1)(2009-11#1)
a significant component##5##3##(2008-10#2)(2008-12#1)(2009-11#1)(2011-2#1)
a significant contribution to the##3##5##(1993-11#1)(2013-1#2)
a significant contribution to##9##4##(1992-12#1)(1993-11#1)(1994-12#1)(2007-11#1)(2008-11#2)(2011-1#1)(2013-1#2)
a significant contribution##11##3##(1992-12#1)(1993-11#1)(1994-12#1)(2007-11#1)(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
a significant correlation between elevated##2##5##(1997-7#1)(2007-7#1)
a significant correlation between the##4##5##(1992-11#1)(1996-12#1)(2013-1#2)
a significant correlation between##21##4##(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1996-12#1)(1997-7#1)(2007-10#2)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#2)(2010-4#1)(2011-1#1)(2013-1#3)(2013-8#1)
a significant correlation of the##3##5##(1996-7#1)(1997-7#1)(2013-1#1)
a significant correlation of##4##4##(1996-7#1)(1997-7#1)(2011-2#1)(2013-1#1)
a significant correlation was found##2##5##(2010-4#1)(2011-2#1)
a significant correlation was##4##4##(2008-10#2)(2010-4#1)(2011-2#1)
a significant correlation with##4##4##(1991-12#1)(1994-9#1)(2006-8#1)(2013-1#1)
a significant correlation##39##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-7#2)(2006-8#1)(2007-10#2)(2007-7#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#2)(2013-1#5)(2013-8#1)
a significant decrease during##2##4##(2008-5#1)(2013-8#1)
a significant decrease in both##2##5##(1996-2#1)(1997-1#1)
a significant decrease in platelet activation (P =##2##8##(2011-2#2)
a significant decrease in platelet##3##5##(2011-2#3)
a significant decrease in the mean##2##6##(2007-7#1)(2007-9#1)
a significant decrease in the##15##5##(1990-7#1)(1993-12#2)(1994-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
a significant decrease in##55##4##(1990-7#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#5)(2008-3#1)(2008-5#3)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a significant decrease of the##6##5##(1992-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-8#1)
a significant decrease of##12##4##(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-6#1)(2012-3#1)(2013-8#1)
a significant decrease##75##3##(1990-7#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#2)(2009-11#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
a significant degree of##2##4##(1990-5#1)(2011-2#1)
a significant degree##4##3##(1990-5#1)(2008-11#1)(2008-4#1)(2011-2#1)
a significant departure from the##2##5##(2008-10#1)(2012-2#1)
a significant departure from##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
a significant departure##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
a significant difference (P##2##4##(2008-10#1)(2011-1#1)
a significant difference between the##8##5##(1991-9#1)(1992-2#1)(2007-7#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
a significant difference between##13##4##(1991-9#1)(1992-2#1)(1994-1#1)(1995-5#1)(1995-8#1)(2007-7#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
a significant difference in the##8##5##(1994-2#1)(1996-7#1)(2008-10#2)(2008-5#2)(2009-3#1)(2013-1#1)
a significant difference in##20##4##(1990-10#1)(1990-12#1)(1994-2#1)(1994-6#1)(1996-7#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)(2012-6#1)(2013-1#3)
a significant difference of##2##4##(2008-10#1)(2011-2#1)
a significant difference##47##3##(1990-10#1)(1990-12#1)(1991-9#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#4)
a significant diminution in##2##4##(2008-10#2)
a significant disease##2##3##(1996-6#1)(2011-2#1)
a significant dose-dependent increase in##2##5##(1997-4#1)(2012-2#1)
a significant dose-dependent##3##3##(1993-11#1)(1997-4#1)(2012-2#1)
a significant downward trend##2##4##(2008-11#1)(2012-12#1)
a significant drop in##2##4##(1993-3#1)(2007-8#1)
a significant economic##2##3##(2008-1#1)(2008-11#1)
a significant effect in##2##4##(1991-8#1)(2008-11#1)
a significant effect of##7##4##(1990-2#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)
a significant effect on both##2##5##(1995-12#1)(2008-10#1)
a significant effect on the##19##5##(1991-6#1)(1993-12#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#2)(2013-1#1)
a significant effect on##35##4##(1990-6#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-2#2)(2013-1#1)
a significant effect##50##3##(1990-2#1)(1990-6#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
a significant elevation of##2##4##(1996-5#1)(2008-4#1)
a significant enhancement in##2##4##(1997-2#1)(2008-10#1)
a significant enhancement of the##6##5##(2007-12#2)(2008-10#4)
a significant enhancement of##7##4##(2007-12#2)(2008-10#4)(2008-5#1)
a significant enhancement##10##3##(1997-2#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-5#1)
a significant excess of##3##4##(1990-2#1)(1991-11#1)(2008-5#1)
a significant expansion of##2##4##(2007-10#1)(2008-11#1)
a significant extension##2##3##(2008-3#1)(2008-7#1)
a significant factor in determining##2##5##(2008-10#1)(2008-7#1)
a significant factor in##5##4##(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#2)
a significant factor##6##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#2)
a significant fall in##5##4##(1990-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
a significant fraction of the##2##5##(1992-6#1)(1997-6#1)
a significant fraction of##4##4##(1992-4#1)(1992-6#1)(1997-6#1)(2008-9#1)
a significant fraction##7##3##(1992-4#1)(1992-6#1)(1994-2#2)(1997-6#1)(2006-4#1)(2008-9#1)
a significant gene##2##3##(2008-6#1)(2010-5#1)
a significant genetic effect##2##4##(1994-2#2)
a significant genetic##3##3##(1994-2#2)(2012-3#1)
a significant growth##2##3##(2007-12#1)(2013-7#1)
a significant health##4##3##(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
a significant homology##2##3##(1990-5#1)(1997-3#1)
a significant impact on the##14##5##(1992-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
a significant impact on##27##4##(1990-2#1)(1992-1#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a significant impact##30##3##(1990-2#1)(1991-12#1)(1992-1#1)(1997-2#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a significant improvement in the##3##5##(2008-11#1)(2008-3#1)(2013-1#1)
a significant improvement in##18##4##(1990-2#2)(1991-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
a significant improvement of the##4##5##(2007-11#1)(2008-10#2)(2008-3#1)
a significant improvement of##8##4##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-7#1)(2013-1#1)
a significant improvement over##4##4##(1994-1#1)(2008-3#2)(2010-5#1)
a significant improvement was##2##4##(1995-4#1)(2013-1#1)
a significant improvement##37##3##(1990-2#2)(1991-8#1)(1994-1#1)(1995-4#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#6)
a significant increase (p&lt##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
a significant increase in lung##2##5##(1992-3#1)(1992-5#1)
a significant increase in serum##2##5##(1993-12#2)
a significant increase in the levels of##3##7##(1994-2#1)(2008-12#1)(2013-8#1)
a significant increase in the number of##2##7##(2008-10#1)(2008-6#1)
a significant increase in the proportion of##2##7##(1995-11#1)(1995-6#1)
a significant increase in the##26##5##(1992-11#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
a significant increase in##76##4##(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-7#1)(2013-1#4)(2013-7#3)(2013-8#3)
a significant increase of the##6##5##(1994-6#2)(2007-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
a significant increase of##18##4##(1990-9#1)(1994-6#2)(1995-8#1)(1997-1#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#2)(2012-2#2)
a significant increase##109##3##(1990-9#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#4)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#2)(1997-1#2)(1997-2#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#7)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#5)(2013-7#3)(2013-8#3)
a significant increased##2##3##(2008-8#1)(2011-2#1)
a significant independent##2##3##(2009-7#1)(2010-4#1)
a significant influence on the##5##5##(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
a significant influence on##14##4##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
a significant influence##15##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
a significant inhibition of##2##4##(1997-7#1)(2008-7#1)
a significant inhibition##3##3##(1994-8#1)(1997-7#1)(2008-7#1)
a significant interaction between##3##4##(2008-11#1)(2008-3#1)(2012-4#1)
a significant inverse correlation##3##4##(1991-12#1)(2008-7#2)
a significant issue##4##3##(2006-10#1)(2008-12#2)(2008-7#1)
a significant level of##2##4##(1994-8#1)(1996-7#1)
a significant loss of##3##4##(1994-5#1)(2009-12#1)(2012-2#1)
a significant loss##4##3##(1994-5#1)(2008-12#1)(2009-12#1)(2012-2#1)
a significant modification##2##3##(2007-11#1)(2008-10#1)
a significant negative correlation##9##4##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-6#1)
a significant negative##10##3##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-6#1)
a significant number of patients##3##5##(2008-6#1)(2009-5#1)(2011-2#1)
a significant number of##15##4##(1990-5#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)
a significant number##16##3##(1990-5#1)(1993-8#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)
a significant overall##5##3##(1993-3#1)(1994-12#2)(2007-7#1)(2008-1#1)
a significant part in##2##4##(1996-1#1)(2008-3#1)
a significant part of the##3##5##(1992-11#1)(2007-11#1)(2008-5#1)
a significant part##5##3##(1992-11#1)(1996-1#1)(2007-11#1)(2008-3#1)(2008-5#1)
a significant percentage##2##3##(2008-12#1)(2010-4#1)
a significant population of##2##4##(1995-5#1)(2008-11#1)
a significant portion of the##5##5##(1990-5#1)(1992-8#1)(1997-6#1)(2008-10#1)(2010-4#1)
a significant portion of##12##4##(1990-5#1)(1992-8#1)(1997-6#1)(2008-10#2)(2008-11#2)(2010-4#1)(2012-3#3)(2013-1#1)
a significant portion##13##3##(1990-5#1)(1992-8#1)(1997-6#1)(2008-10#2)(2008-11#2)(2009-10#1)(2010-4#1)(2012-3#3)(2013-1#1)
a significant positive association##2##4##(2008-8#1)(2012-2#1)
a significant positive correlation (r=0##2##5##(2008-7#2)
a significant positive correlation between##2##5##(2008-11#1)(2008-8#1)
a significant positive correlation##5##4##(1991-12#1)(2008-11#1)(2008-7#2)(2008-8#1)
a significant positive relationship between##3##5##(2008-10#2)(2010-11#1)
a significant positive relationship##4##4##(2007-5#1)(2008-10#2)(2010-11#1)
a significant positive##15##3##(1991-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#3)(2010-11#1)(2011-1#1)(2012-2#1)
a significant predictor of##7##4##(1991-3#1)(1996-3#1)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
a significant predictor##9##3##(1991-3#1)(1996-3#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
a significant problem for##2##4##(2010-12#1)(2012-12#1)
a significant problem in##3##4##(1996-12#1)(2008-11#1)(2010-11#1)
a significant problem##10##3##(1991-1#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-11#1)(2010-12#1)(2012-12#1)
a significant prognostic##2##3##(1990-6#1)(1994-7#1)
a significant progress##2##3##(2007-11#1)(2008-10#1)
a significant proportion of patients##2##5##(2008-1#1)(2008-9#1)
a significant proportion of the##6##5##(1993-3#1)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)
a significant proportion of##16##4##(1990-2#1)(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
a significant proportion##17##3##(1990-2#1)(1993-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
a significant protection to##2##4##(2008-10#1)(2009-12#1)
a significant protection##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
a significant protective effect of##2##5##(1992-10#1)(2010-6#1)
a significant protective effect##3##4##(1992-10#1)(2010-6#1)(2011-1#1)
a significant protective##5##3##(1992-10#1)(2009-7#2)(2010-6#1)(2011-1#1)
a significant public health problem##4##5##(1997-1#1)(1997-3#1)(2010-8#1)(2011-1#1)
a significant public health##6##4##(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2010-8#1)(2011-1#1)
a significant recovery##2##3##(2008-5#1)(2013-8#1)
a significant reduction in the number of##2##7##(1996-12#1)(2008-11#1)
a significant reduction in the risk of##2##7##(2010-6#1)(2012-2#1)
a significant reduction in the##13##5##(1991-12#1)(1991-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
a significant reduction in##46##4##(1991-12#2)(1991-3#1)(1993-1#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-4#1)(2010-5#1)(2010-6#1)(2011-10#1)(2012-2#3)(2013-1#3)
a significant reduction of the symptom and medication score##2##9##(2011-2#2)
a significant reduction of the symptom and##3##7##(2011-2#3)
a significant reduction of the##7##5##(1992-1#1)(1992-8#1)(1995-12#1)(2007-11#1)(2011-2#3)
a significant reduction of##25##4##(1991-6#1)(1992-1#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-6#1)(2011-10#1)(2011-2#3)(2012-2#3)
a significant reduction##73##3##(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#3)(1996-1#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#2)(2009-4#1)(2010-5#1)(2010-6#1)(2011-10#2)(2011-2#3)(2012-2#6)(2013-1#3)
a significant relation##2##3##(2008-10#1)(2008-4#1)
a significant relationship between##6##4##(1995-11#1)(1995-12#1)(1995-2#1)(1997-8#2)(2008-10#1)
a significant relationship##8##3##(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-8#2)(2008-10#1)(2011-2#1)
a significant response in##2##4##(2008-9#2)
a significant response##3##3##(2008-10#1)(2008-9#2)
a significant result##2##3##(1990-5#1)(1997-5#1)
a significant rise in##6##4##(1996-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-8#1)
a significant rise##7##3##(1996-3#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
a significant risk factor for developing##2##6##(2012-2#1)(2012-5#1)
a significant risk factor for##7##5##(1997-3#1)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
a significant risk of##3##4##(2010-8#1)(2012-2#1)(2013-1#1)
a significant risk##11##3##(1997-3#1)(2008-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
a significant role for##3##4##(1993-12#1)(2008-10#1)(2008-7#1)
a significant role in disease##2##5##(2008-10#2)
a significant role in the##13##5##(1995-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
a significant role in##38##4##(1993-1#1)(1995-2#1)(1995-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#9)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
a significant role##43##3##(1993-1#1)(1993-12#1)(1995-2#1)(1995-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
a significant source of##4##4##(1995-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
a significant threat to##2##4##(1994-1#1)(2013-8#1)
a significant time##3##3##(2008-9#1)(2010-5#1)(2013-8#1)
a significant##1105##2##(1990-10#1)(1990-12#2)(1990-2#7)(1990-5#8)(1990-6#3)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#5)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#6)(1992-9#2)(1993-1#6)(1993-11#3)(1993-12#9)(1993-3#6)(1993-6#1)(1993-8#4)(1994-1#4)(1994-11#4)(1994-12#6)(1994-2#11)(1994-3#7)(1994-5#3)(1994-6#9)(1994-7#3)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#9)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-1#4)(1996-12#9)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#4)(1996-7#4)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2006-10#5)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#12)(2007-11#20)(2007-12#17)(2007-2#2)(2007-5#1)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#13)(2008-10#140)(2008-11#51)(2008-12#36)(2008-2#5)(2008-3#37)(2008-4#20)(2008-5#31)(2008-6#14)(2008-7#47)(2008-8#23)(2008-9#12)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#7)(2009-7#5)(2009-8#12)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#9)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#14)(2011-10#3)(2011-2#59)(2011-3#1)(2012-1#3)(2012-12#13)(2012-2#36)(2012-3#16)(2012-4#1)(2012-5#2)(2012-6#2)(2012-7#2)(2013-1#48)(2013-7#6)(2013-8#27)
a significantly (P &lt##2##4##(2008-10#2)
a significantly better##6##3##(1991-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)
a significantly decreased##2##3##(2008-3#1)(2008-7#1)
a significantly different##2##3##(1992-3#1)(1995-11#1)
a significantly greater degree of##2##5##(1994-11#1)(2008-10#1)
a significantly greater increase in##2##5##(1997-6#1)(2008-12#1)
a significantly greater##14##3##(1994-11#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
a significantly higher frequency of##5##5##(2007-10#1)(2008-7#1)(2011-2#3)
a significantly higher frequency##7##4##(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#3)
a significantly higher incidence##2##4##(1996-8#1)(2008-8#1)
a significantly higher level of##4##5##(1991-5#1)(2008-10#2)(2008-7#1)
a significantly higher number of##3##5##(2008-5#1)(2009-8#1)(2013-1#1)
a significantly higher percentage of##8##5##(1991-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2011-2#1)
a significantly higher prevalence of##2##5##(2009-12#1)(2011-1#1)
a significantly higher proportion of##2##5##(2008-2#1)(2011-2#1)
a significantly higher rate of##2##5##(2007-12#1)(2008-8#1)
a significantly higher risk of##2##5##(1990-2#1)(2013-1#1)
a significantly higher risk##3##4##(1990-2#1)(2008-7#1)(2013-1#1)
a significantly higher##52##3##(1990-2#1)(1991-2#1)(1991-5#1)(1994-6#1)(1996-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#3)(2011-2#7)(2012-2#1)(2013-1#2)
a significantly increased incidence##3##4##(2008-7#1)(2008-9#2)
a significantly increased risk##3##4##(1992-10#1)(1994-2#1)(2008-1#1)
a significantly increased##8##3##(1992-10#1)(1992-11#1)(1994-2#1)(2008-1#1)(2008-7#1)(2008-9#2)(2011-2#1)
a significantly larger##8##3##(1992-3#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
a significantly low##2##3##(2007-12#1)(2008-2#1)
a significantly lower level of##3##5##(1992-11#1)(1997-3#1)(2008-11#1)
a significantly lower##17##3##(1990-8#1)(1991-11#1)(1992-11#1)(1992-6#1)(1994-6#1)(1997-2#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
a significantly more##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
a significantly shorter##4##3##(1996-2#1)(2007-8#1)(2008-2#1)(2008-8#1)
a significantly smaller##2##3##(2008-10#1)(2008-9#1)
a significantly##137##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-9#1)(2007-10#5)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-7#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
a significative##3##2##(1990-9#1)(1996-2#1)(2008-2#1)
a silent##3##2##(1993-3#1)(1994-12#1)(1996-3#1)
a silica gel##3##3##(2008-10#2)(2008-5#1)
a silica##16##2##(2007-11#1)(2007-12#2)(2008-10#10)(2008-3#2)(2008-5#1)
a silicon nanowire resolution of##2##5##(2009-11#2)
a silicon##19##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#7)(2009-11#2)(2012-2#1)
a silicone##7##2##(1995-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
a silk##2##2##(2008-10#1)(2008-5#1)
a silver electrode##3##3##(2008-10#3)
a silver##5##2##(2008-10#3)(2008-3#2)
a silver/silver chloride##3##3##(2008-10#3)
a similar action##2##3##(2010-11#1)(2013-7#1)
a similar affinity for##2##4##(1995-2#1)(2008-5#1)
a similar age##3##3##(1996-5#1)(2009-12#1)(2010-2#1)
a similar approach##3##3##(1993-11#2)(2008-7#1)
a similar arrangement of##2##4##(1996-2#1)(1997-7#1)
a similar assay##2##3##(1990-12#1)(1997-6#1)
a similar but##3##3##(1993-5#1)(2008-10#1)(2012-12#1)
a similar change##2##3##(1990-3#1)(1994-3#1)
a similar clinical##2##3##(2008-7#1)(2011-2#1)
a similar concentration##2##3##(2008-10#1)(2008-12#1)
a similar decrease##2##3##(1990-3#1)(2008-11#1)
a similar degree of##2##4##(1992-10#1)(1992-3#1)
a similar degree##8##3##(1992-10#1)(1992-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
a similar effect in##2##4##(1991-5#1)(1994-3#1)
a similar effect##9##3##(1991-5#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
a similar enhancement##2##3##(2008-10#1)(2008-4#1)
a similar general##2##3##(2007-12#1)(2008-7#1)
a similar increase in##3##4##(1993-12#1)(1994-1#1)(1997-1#1)
a similar level of##2##4##(2008-10#1)(2008-11#1)
a similar light##2##3##(2008-11#1)(2008-9#1)
a similar manner to the##2##5##(1997-2#1)(2008-11#1)
a similar manner##10##3##(1990-11#1)(1990-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-8#1)
a similar mechanism##4##3##(1990-12#1)(2008-6#1)(2008-7#1)(2009-10#1)
a similar pathway##2##3##(1993-6#1)(2007-12#1)
a similar pattern of##5##4##(1993-12#1)(1994-8#1)(1996-12#1)(1997-2#1)(2011-2#1)
a similar pattern to that##2##5##(1994-10#1)(2012-12#1)
a similar pattern##11##3##(1990-12#1)(1990-8#1)(1993-12#1)(1994-10#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2011-2#2)(2012-12#1)
a similar period##2##3##(1994-8#1)(2007-7#1)
a similar phenomenon in##2##4##(1994-8#1)(2010-4#1)
a similar potency to##3##4##(1994-8#1)(1995-12#1)(2008-5#1)
a similar potency##5##3##(1993-8#2)(1994-8#1)(1995-12#1)(2008-5#1)
a similar project##2##3##(1994-1#1)(2008-11#1)
a similar range of##2##4##(2008-3#1)(2009-5#1)
a similar range##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
a similar rate of##2##4##(1991-9#1)(1994-2#1)
a similar rate##3##3##(1990-9#1)(1991-9#1)(1994-2#1)
a similar reduction in##2##4##(1994-8#1)(2008-5#1)
a similar response to##2##4##(2008-10#1)(2008-3#1)
a similar safety profile to##2##5##(1996-1#1)(2012-3#1)
a similar set of##4##4##(1996-1#1)(2009-8#1)(2010-3#1)(2013-1#1)
a similar study##3##3##(1992-5#1)(1996-11#1)(2012-12#1)
a similar survey##3##3##(1994-1#1)(1994-2#1)(1994-3#1)
a similar time course to that##2##6##(1995-2#1)(2013-1#1)
a similar time##3##3##(1995-2#1)(2012-2#1)(2013-1#1)
a similar##285##2##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#5)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-5#5)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#9)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#40)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#16)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
a similarity in the##2##4##(2008-10#2)
a similarity in##7##3##(1992-8#1)(1993-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#1)
a similarity##11##2##(1990-2#1)(1991-5#1)(1992-8#1)(1993-8#1)(1995-5#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-8#1)
a similarly##6##2##(1992-10#1)(1995-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
a simple DNA##2##3##(2008-4#1)(2013-1#1)
a simple algebraic##2##3##(2008-3#2)
a simple algorithm for##2##4##(2010-7#1)(2013-1#1)
a simple algorithm##3##3##(2008-3#1)(2010-7#1)(2013-1#1)
a simple analytical model##2##4##(2007-11#1)(2008-3#1)
a simple analytical##6##3##(2007-11#2)(2008-10#2)(2008-3#2)
a simple and compact##2##4##(2008-2#2)
a simple and cost-effective##3##4##(1997-4#1)(2013-1#2)
a simple and direct##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
a simple and efficient method##2##5##(1990-11#1)(2008-9#1)
a simple and efficient##6##4##(1990-11#1)(2008-10#2)(2008-9#2)(2009-5#1)
a simple and fast##7##4##(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
a simple and general##2##4##(2008-4#1)(2008-8#1)
a simple and inexpensive##2##4##(1991-6#1)(2008-10#1)
a simple and practical method for##2##6##(1993-8#1)(2008-10#1)
a simple and practical##5##4##(1993-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
a simple and rapid method for##2##6##(1995-2#1)(2008-10#1)
a simple and rapid method##5##5##(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
a simple and rapid##7##4##(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
a simple and reliable method for##3##6##(2008-10#1)(2008-2#1)(2008-8#1)
a simple and reliable method##5##5##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
a simple and reliable##6##4##(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
a simple and reproducible method for##2##6##(2008-11#1)(2010-11#1)
a simple and reproducible##3##4##(2008-11#1)(2010-11#1)(2013-8#1)
a simple and scaleable##2##4##(2008-11#1)(2008-8#1)
a simple and sensitive method##2##5##(1991-3#1)(2008-10#1)
a simple and sensitive##4##4##(1991-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
a simple and##79##3##(1990-11#1)(1991-3#1)(1991-6#1)(1993-5#1)(1993-8#1)(1995-12#2)(1995-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-5#1)(2010-11#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
a simple approach for##2##4##(2008-7#1)(2008-9#1)
a simple approach to##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
a simple approach##6##3##(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)
a simple arrangement##2##3##(2007-12#1)(2008-10#1)
a simple assay##2##3##(1996-12#1)(2008-7#1)
a simple but##4##3##(2008-3#2)(2013-1#1)(2013-8#1)
a simple classification##3##3##(2008-2#1)(2008-7#2)
a simple dependence on the##2##5##(2007-11#1)(2008-2#1)
a simple design##4##3##(2008-10#1)(2008-3#3)
a simple device##2##3##(2008-10#1)(2008-3#1)
a simple diffusion##2##3##(2008-9#1)(2009-12#1)
a simple dilution##2##3##(2008-10#2)
a simple example##3##3##(2007-12#2)(2013-8#1)
a simple experiment##2##3##(2007-11#1)(2008-2#1)
a simple experimental method to##2##5##(2008-2#1)(2008-3#1)
a simple experimental##6##3##(2007-12#2)(2008-2#2)(2008-3#1)(2012-2#1)
a simple extension##2##3##(2007-11#1)(2008-3#1)
a simple extraction##2##3##(1996-5#1)(2008-10#1)
a simple genetic circuit##2##4##(2008-11#2)
a simple genetic##4##3##(1991-6#1)(2008-11#2)(2008-5#1)
a simple growth##2##3##(2008-7#1)(2008-9#1)
a simple holographic##2##3##(2008-3#2)
a simple kinetic##2##3##(2008-10#1)(2012-12#1)
a simple linear##5##3##(2008-10#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-5#1)
a simple mathematical expression to##2##5##(2008-3#2)
a simple mathematical model##4##4##(1994-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
a simple mathematical##7##3##(1994-8#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-8#1)(2013-1#1)
a simple method for determining the##2##6##(2008-10#1)(2008-3#1)
a simple method for the##2##5##(2008-10#1)(2008-2#1)
a simple method for##9##4##(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)
a simple method of##6##4##(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
a simple method to##6##4##(1995-3#1)(1997-7#1)(2008-10#2)(2008-2#1)(2009-5#1)
a simple method##27##3##(1995-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#5)(2008-4#2)(2008-8#1)(2009-5#1)(2013-7#1)
a simple model for##5##4##(1990-8#1)(1992-9#1)(1996-2#1)(2007-12#1)(2008-10#1)
a simple model is##2##4##(2008-2#2)
a simple model of a##3##5##(2008-3#1)(2008-5#1)(2008-8#1)
a simple model of the##3##5##(2008-2#2)(2008-7#1)
a simple model of##12##4##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
a simple model that##2##4##(1994-2#1)(2008-7#1)
a simple model to##2##4##(2008-10#1)(2008-9#1)
a simple model##30##3##(1990-8#1)(1992-4#1)(1992-9#1)(1994-2#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
a simple new##2##3##(2007-12#1)(2007-8#1)
a simple one-step process and##2##5##(2008-3#1)(2009-11#1)
a simple one-step process##3##4##(2008-3#1)(2009-11#1)(2013-1#1)
a simple pattern##2##3##(2008-3#1)(2008-4#1)
a simple power law##2##4##(2008-5#1)(2009-12#1)
a simple procedure to prepare the data for statistical analysis is also provided##2##13##(2008-2#1)(2008-4#1)
a simple procedure##6##3##(1990-11#1)(2008-10#2)(2008-2#1)(2008-4#2)
a simple process##2##3##(1992-12#1)(1996-2#1)
a simple protocol##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
a simple relation between##2##4##(2007-12#1)(2008-3#1)
a simple relationship##2##3##(2008-10#1)(2008-3#1)
a simple rule##2##3##(1992-12#1)(2008-8#1)
a simple scheme##2##3##(2007-11#1)(2007-12#1)
a simple sequence##2##3##(1992-6#1)(1996-5#1)
a simple setup##2##3##(2008-2#1)(2008-3#1)
a simple simulation model##2##4##(2008-8#1)(2008-9#1)
a simple spectrophotometric method##2##4##(1990-8#2)
a simple stepwise pattern##2##4##(2008-10#2)
a simple strategy to##2##4##(1990-12#1)(2013-7#1)
a simple strategy##3##3##(1990-12#1)(2008-10#1)(2013-7#1)
a simple system for##3##4##(2007-8#1)(2008-2#1)(2008-3#1)
a simple system##7##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
a simple technique for##4##4##(2007-11#1)(2008-3#3)
a simple technique##6##3##(1994-3#1)(2007-11#1)(2008-3#3)(2009-2#1)
a simple theory##3##3##(2007-11#2)(2008-2#1)
a simple version of##2##4##(1992-12#1)(2008-8#1)
a simple way to##8##4##(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)
a simple way##12##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)
a simple yet##5##3##(1995-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)
a simple##617##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#5)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1992-12#4)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#33)(2007-12#26)(2007-5#1)(2007-8#5)(2008-1#4)(2008-10#131)(2008-11#22)(2008-12#3)(2008-2#44)(2008-3#88)(2008-4#17)(2008-5#18)(2008-6#5)(2008-7#21)(2008-8#21)(2008-9#23)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-5#5)(2009-8#3)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#3)(2011-1#6)(2011-2#3)(2012-12#3)(2012-2#12)(2012-3#4)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#6)
a simpler##10##2##(2007-11#1)(2008-10#5)(2008-3#3)(2011-2#1)
a simplification of##2##3##(1992-6#1)(2008-2#1)
a simplified configuration##2##3##(2007-11#2)
a simplified method##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a simplified model##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
a simplified pulsed##2##3##(2008-10#2)
a simplified version of the##2##5##(2008-2#1)(2008-8#1)
a simplified version##3##3##(2008-2#1)(2008-8#1)(2011-1#1)
a simplified##28##2##(1992-8#1)(1994-2#1)(1996-7#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#7)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
a simulated Class I restoration##2##5##(2013-1#2)
a simulated annealing algorithm##2##4##(2008-2#1)(2008-3#1)
a simulated annealing##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
a simulated ward exercise##3##4##(2008-11#2)(2008-12#1)
a simulated##31##2##(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#4)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2012-1#2)(2012-3#2)(2013-1#3)
a simulation approach to##2##4##(2013-1#2)
a simulation model##5##3##(2008-10#1)(2008-2#1)(2008-8#2)(2012-12#1)
a simulation of the##4##4##(1997-4#3)(2008-3#1)
a simulation of##8##3##(1997-4#4)(2008-10#1)(2008-3#3)
a simulation study##13##3##(1992-9#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-3#2)(2008-10#2)(2008-3#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
a simulation using a##2##4##(1992-6#1)(2008-3#1)
a simulation##37##2##(1992-6#1)(1992-9#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-3#2)(1997-4#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-8#2)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
a simulator##2##2##(2008-2#1)(2008-3#1)
a simultaneous determination##3##3##(2008-10#3)
a simultaneous##24##2##(1990-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1995-11#1)(1996-2#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)
a sine##2##2##(2008-11#1)(2008-2#1)
a single &quot##3##3##(1991-1#1)(2008-8#1)(2009-4#1)
a single (or##2##3##(2008-10#2)
a single 1##4##3##(1994-12#1)(2008-10#2)(2008-5#1)
a single 2##2##3##(1991-2#1)(1995-9#1)
a single 2x2##2##3##(2007-11#1)(2007-12#1)
a single 8-hydroxyguanine##2##3##(1990-7#2)
a single Cys##2##3##(1994-5#1)(1995-6#1)
a single DNA##2##3##(2008-10#1)(2008-12#1)
a single PCR##2##3##(2008-11#2)
a single RNA##2##3##(2007-12#1)(2009-3#1)
a single Raman##3##3##(2007-12#1)(2008-3#2)
a single active##2##3##(2007-12#1)(2010-5#1)
a single administration##4##3##(1995-3#2)(2012-2#1)(2013-1#1)
a single agent##7##3##(1991-6#2)(1994-8#2)(2008-4#1)(2009-12#1)(2010-4#1)
a single aggregate##2##3##(2008-3#2)
a single amino acid change##2##5##(1995-2#1)(1997-2#1)
a single amino acid substitution in the##2##7##(1995-8#1)(2008-10#1)
a single amino acid substitution in##3##6##(1990-11#1)(1995-8#1)(2008-10#1)
a single amino acid substitution##4##5##(1990-11#1)(1991-12#1)(1995-8#1)(2008-10#1)
a single amino acid##10##4##(1990-11#1)(1991-12#1)(1991-8#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)
a single analysis##4##3##(1990-8#1)(1997-3#1)(2009-11#1)(2012-12#1)
a single and##5##3##(1990-5#1)(1991-6#1)(1997-7#1)(2007-12#1)(2012-2#1)
a single aperture##3##3##(2008-2#2)(2008-3#1)
a single application of iprodione##2##5##(2008-10#2)
a single application of propiconazole##2##5##(2008-10#2)
a single application of##5##4##(2008-10#5)
a single application##6##3##(2008-10#6)
a single attack##2##3##(2008-10#1)(2010-8#1)
a single autosomal##2##3##(2008-4#1)(2011-2#1)
a single band at##2##4##(1995-11#1)(2008-10#1)
a single band in##2##4##(1990-11#1)(1993-2#1)
a single band of##3##4##(1991-12#1)(1991-9#1)(1994-11#1)
a single band on##2##4##(1993-3#1)(1997-2#1)
a single band with##3##4##(1990-11#1)(1992-8#2)
a single band##15##3##(1990-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#2)(1997-2#1)(2008-10#1)
a single base deletion##2##4##(1992-8#2)
a single base pair##3##4##(1990-5#1)(2007-10#1)(2008-10#1)
a single base substitution##2##4##(1993-3#1)(2008-1#1)
a single base##9##3##(1990-5#1)(1992-8#2)(1993-3#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)
a single bead string reactor##2##5##(2008-10#2)
a single bead##3##3##(2008-10#2)(2008-11#1)
a single beam##2##3##(2007-12#1)(2008-3#1)
a single brain##2##3##(1990-12#1)(2008-4#1)
a single camera##3##3##(2007-12#1)(2008-3#2)
a single carbon##2##3##(2008-10#1)(2008-8#1)
a single case of##2##4##(2007-10#1)(2009-2#1)
a single case##5##3##(2007-10#1)(2009-2#1)(2009-5#1)(2013-1#2)
a single cell and##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
a single cell##14##3##(1990-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2013-8#1)
a single center experience##5##4##(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-5#1)
a single center##7##3##(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2010-5#1)
a single chain##2##3##(1990-11#1)(2008-11#1)
a single channel and##2##4##(2008-10#1)(2008-2#1)
a single channel##11##3##(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-8#1)(2011-3#2)
a single chromatographic run##3##4##(1990-8#1)(2008-10#2)
a single chromosomal##2##3##(2008-6#1)(2012-3#1)
a single clade##2##3##(2008-10#1)(2008-5#1)
a single class of binding sites with a Kd of##2##10##(1990-2#1)(1993-12#1)
a single class of##5##4##(1990-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(2008-9#1)
a single class##7##3##(1990-2#2)(1993-12#1)(1993-3#1)(1993-9#1)(1997-5#1)(2008-9#1)
a single clinical entity##2##4##(2008-11#1)(2009-10#1)
a single clinical lacunar syndrome##2##5##(2009-10#2)
a single clinical##4##3##(2008-11#1)(2009-10#3)
a single clonal lineage##2##4##(2008-10#2)
a single cluster##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
a single colony-forming unit##2##4##(1993-12#2)
a single component of##3##4##(1992-12#1)(2008-3#2)
a single component##4##3##(1992-12#1)(1993-12#1)(2008-3#2)
a single control##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
a single copy gene and##3##5##(1997-4#1)(2008-8#1)(2009-10#1)
a single copy gene##7##4##(1992-12#1)(1994-11#1)(1997-4#1)(2008-5#1)(2008-8#2)(2009-10#1)
a single copy in the genome##2##6##(1992-11#1)(1997-4#1)
a single copy in the##4##5##(1992-11#1)(1992-3#1)(1995-8#1)(1997-4#1)
a single copy of the##3##5##(1993-3#1)(1997-2#2)
a single copy of##6##4##(1993-3#1)(1997-2#3)(2008-11#1)(2008-8#1)
a single copy##23##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#3)(1997-4#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#1)
a single crystal##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a single curve##2##3##(2008-3#1)(2008-8#1)
a single daily dose of##3##5##(1990-11#2)(2011-2#1)
a single daily dose##4##4##(1990-11#2)(1991-11#1)(2011-2#1)
a single daily##5##3##(1990-11#2)(1991-11#1)(2007-7#1)(2011-2#1)
a single day##4##3##(2008-12#1)(2010-10#2)(2013-8#1)
a single detector##9##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)
a single device##2##3##(2011-2#1)(2011-7#1)
a single digital##2##3##(2008-3#2)
a single disease##5##3##(2008-4#1)(2008-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
a single dominant allele##2##4##(2008-10#2)
a single dominant gene##12##4##(2008-10#11)(2008-5#1)
a single dominant locus##5##4##(2008-10#5)
a single dominant##21##3##(2008-10#20)(2008-5#1)
a single dose of 2##2##5##(1992-12#1)(1997-5#1)
a single dose of the##2##5##(1990-6#1)(2007-11#1)
a single dose of##17##4##(1990-6#2)(1991-2#1)(1992-12#1)(1993-9#1)(1995-11#1)(1996-12#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
a single dose##21##3##(1990-6#2)(1991-2#1)(1992-12#2)(1993-9#1)(1995-11#1)(1996-12#1)(1997-5#1)(2006-6#1)(2007-11#3)(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
a single electronic##2##3##(2008-7#1)(2011-1#1)
a single episode of##2##4##(2011-2#1)(2013-8#1)
a single episode##4##3##(1992-5#1)(2007-4#1)(2011-2#1)(2013-8#1)
a single essential##2##3##(1990-11#1)(1995-6#1)
a single evaluation##2##3##(2010-8#1)(2012-3#1)
a single excitation beam##2##4##(2007-12#1)(2008-9#1)
a single excitation##3##3##(2007-12#1)(2008-9#1)(2011-1#1)
a single exon##2##3##(1991-6#1)(1997-7#1)
a single experiment##5##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
a single exponential##3##3##(1990-7#1)(1991-12#1)(1996-5#1)
a single exposure##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
a single fiber Bragg grating written in an erbium##2##9##(2008-3#2)
a single fiber Bragg grating##3##5##(2008-2#1)(2008-3#2)
a single fiber##10##3##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)
a single field##4##3##(1994-8#1)(2008-10#3)
a single frequency##2##3##(2008-10#1)(2008-2#1)
a single gall##3##3##(2008-10#3)
a single gel##2##3##(2008-11#1)(2010-3#1)
a single gene control of avirulence##2##6##(2008-10#2)
a single gene difference##2##4##(1995-6#1)(2008-10#1)
a single gene encoding the##2##5##(1991-2#1)(1993-2#1)
a single gene##31##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1993-2#1)(1994-9#1)(1995-6#3)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#14)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)
a single generation##2##3##(1991-12#1)(2008-9#1)
a single genetic##2##3##(1990-8#1)(2010-4#1)
a single genotype##3##3##(2008-10#3)
a single grating##2##3##(2008-3#2)
a single holographic##2##3##(2008-2#1)(2008-3#1)
a single homogeneous##2##3##(2008-3#2)
a single hospital##3##3##(1992-2#1)(2007-12#1)(2011-2#1)
a single host plant##2##4##(2008-10#1)(2011-2#1)
a single host##5##3##(2008-10#3)(2011-2#1)(2012-12#1)
a single hybridization##2##3##(2008-10#2)
a single image##8##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)
a single individual##2##3##(2008-10#1)(2013-1#1)
a single infection##2##3##(2008-11#1)(2011-2#1)
a single injection of##3##4##(2008-10#2)(2013-1#1)
a single injection##5##3##(1997-3#1)(2008-10#2)(2010-8#1)(2013-1#1)
a single institution##5##3##(2007-8#2)(2008-6#1)(2011-2#2)
a single interferogram##5##3##(2008-2#1)(2008-3#4)
a single intraperitoneal dose##2##4##(1994-8#1)(2011-1#1)
a single intraperitoneal injection of##3##5##(1992-12#1)(1994-5#1)(2008-10#1)
a single intraperitoneal##6##3##(1992-12#1)(1994-5#2)(1994-8#1)(2008-10#1)(2011-1#1)
a single introduction of the##2##5##(2008-10#2)
a single ion##3##3##(2007-12#2)(2008-7#1)
a single isolate in##2##4##(2008-10#2)
a single isolate##4##3##(2008-10#4)
a single laboratory##2##3##(2008-10#1)(2008-9#1)
a single large##5##3##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
a single laser diode##2##4##(2007-12#1)(2008-2#1)
a single laser pulse##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
a single laser##11##3##(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#4)
a single layer##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)
a single left##3##3##(2008-1#1)(2013-1#1)(2013-2#1)
a single lick##3##3##(2008-11#3)
a single line##4##3##(2008-10#3)(2008-3#1)
a single locus in##2##4##(1995-8#1)(2008-10#1)
a single locus##5##3##(1995-8#1)(2008-10#3)(2008-8#1)
a single long##2##3##(1992-6#1)(2008-9#1)
a single longitudinal mode##2##4##(2007-12#1)(2008-3#1)
a single longitudinal##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
a single low##2##3##(1995-8#1)(2008-7#1)
a single major##5##3##(1995-2#1)(2008-10#4)
a single mass##2##3##(1992-1#1)(2010-6#1)
a single measurement##3##3##(2007-11#2)(2008-2#1)
a single membrane##2##3##(2008-10#2)
a single mirror##2##3##(2008-2#1)(2008-6#1)
a single model##2##3##(1997-5#1)(2008-11#1)
a single modified##2##3##(2008-10#1)(2008-3#1)
a single molecule##3##3##(1992-3#1)(2010-7#1)(2011-1#1)
a single mutant subunit##2##4##(2008-8#2)
a single mutant##5##3##(1995-6#1)(2008-8#2)(2011-2#1)(2013-8#1)
a single neuron##2##3##(1996-12#1)(2008-10#1)
a single nucleotide difference in the##2##6##(1996-12#1)(2008-10#1)
a single nucleotide difference##3##4##(1990-12#1)(1996-12#1)(2008-10#1)
a single nucleotide##6##3##(1990-12#1)(1995-8#1)(1996-12#1)(2007-6#1)(2008-10#2)
a single object##3##3##(2008-2#2)(2011-1#1)
a single one##3##3##(1990-8#1)(1993-8#1)(2008-11#1)
a single open reading frame##4##5##(1990-5#1)(1997-7#1)(2008-10#2)
a single optical fiber##2##4##(2008-3#2)
a single optical##4##3##(2007-12#2)(2008-3#2)
a single or##6##3##(1996-9#1)(1997-6#1)(2006-12#1)(2008-2#1)(2008-4#1)(2009-5#1)
a single oral dose##3##4##(2007-7#1)(2008-10#1)(2008-7#1)
a single oral##4##3##(2007-7#1)(2008-10#2)(2008-7#1)
a single origin##4##3##(1990-11#1)(1994-3#2)(2008-10#1)
a single pair of##2##4##(2007-12#1)(2008-5#1)
a single palatal##2##3##(2013-1#2)
a single parameter##3##3##(1994-9#1)(2008-10#1)(2008-3#1)
a single parasite##2##3##(1991-2#1)(2011-1#1)
a single particle##8##3##(1990-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)
a single pass of##2##4##(2008-10#1)(2008-2#1)
a single pass through a##3##5##(2007-12#1)(2008-12#1)(2008-3#1)
a single pass through##4##4##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)
a single pass##9##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
a single patch##4##3##(2007-8#2)(2008-10#1)(2012-2#1)
a single patient##7##3##(1990-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a single peak##5##3##(1990-8#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
a single phase##2##3##(1992-6#1)(2008-5#1)
a single plane##3##3##(2008-2#3)
a single point mutation##2##4##(2008-10#2)
a single point##8##3##(1995-12#1)(2008-10#5)(2008-2#1)(2008-6#1)
a single polypeptide##3##3##(1995-6#1)(2008-11#1)(2010-5#1)
a single population##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
a single precursor##2##3##(1994-11#1)(1997-7#1)
a single primary##2##3##(2008-4#1)(2013-1#1)
a single prism##2##3##(2007-12#1)(2008-3#1)
a single product##2##3##(2008-10#1)(2008-11#1)
a single protein band with an##2##6##(1995-5#1)(2009-9#1)
a single protein band##3##4##(1993-11#1)(1995-5#1)(2009-9#1)
a single protein from##2##4##(2008-4#2)
a single protein##10##3##(1990-7#1)(1991-2#1)(1993-11#1)(1995-5#1)(2008-2#1)(2008-4#3)(2009-6#1)(2009-9#1)
a single pulse##2##3##(2007-12#1)(2013-7#1)
a single pulsed##3##3##(2008-10#1)(2008-9#2)
a single pump##2##3##(2007-11#1)(2007-12#1)
a single quantitative trait##2##4##(2008-10#2)
a single reaction##4##3##(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#1)
a single recessive gene##6##4##(2008-10#4)(2008-5#1)(2008-9#1)
a single recessive##8##3##(2008-10#6)(2008-5#1)(2008-9#1)
a single reflection##2##3##(2008-10#1)(2008-3#1)
a single resistance gene##4##4##(2008-10#4)
a single resource##2##3##(2008-9#2)
a single response##3##3##(1997-7#1)(2008-10#2)
a single round of##3##4##(1994-12#1)(2008-10#1)(2008-2#1)
a single run##2##3##(2008-10#2)
a single sample##6##3##(2008-10#5)(2008-6#1)
a single session##2##3##(1993-6#1)(2008-7#1)
a single set of##3##4##(1994-12#1)(2008-1#1)(2008-3#1)
a single shot##3##3##(2007-12#2)(2008-3#1)
a single site of##2##4##(1996-6#1)(2008-10#1)
a single site##10##3##(1996-2#1)(1996-6#1)(1997-4#1)(2006-4#2)(2008-10#3)(2008-11#1)(2008-7#1)
a single small##3##3##(1990-2#1)(1993-2#1)(2013-1#1)
a single source##3##3##(1992-1#1)(2008-10#1)(2008-2#1)
a single species##7##3##(1993-12#1)(2007-5#1)(2008-10#4)(2011-2#1)
a single spectrum##2##3##(2008-4#2)
a single spray with C##2##5##(2008-10#2)
a single spray##3##3##(2008-10#3)
a single standard##2##3##(2008-10#1)(2008-7#1)
a single state##2##3##(1995-3#1)(2011-2#1)
a single step##15##3##(1993-6#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2010-5#1)(2013-1#1)(2013-8#1)
a single strain##4##3##(2008-10#1)(2009-6#1)(2012-3#2)
a single structure##2##3##(2007-12#1)(2008-7#1)
a single subject##2##3##(2013-1#1)(2013-8#1)
a single substrate##3##3##(1991-5#1)(2008-3#2)
a single summary##2##3##(1997-3#1)(2008-9#1)
a single surgeon##3##3##(2008-9#1)(2013-1#2)
a single system##2##3##(2008-8#1)(2012-2#1)
a single test##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
a single time point##3##4##(1995-12#1)(2011-2#1)(2012-3#1)
a single transcript of##3##4##(1991-6#1)(1996-6#2)
a single transcript##4##3##(1991-6#1)(1996-6#2)(2008-11#1)
a single transmembrane domain##2##4##(1993-3#1)(2008-4#1)
a single transmembrane region##2##4##(1993-2#1)(2009-8#1)
a single transmembrane##4##3##(1993-2#1)(1993-3#1)(2008-4#1)(2009-8#1)
a single transverse mode##4##4##(2007-12#1)(2008-3#3)
a single treatment##2##3##(2008-12#1)(2010-5#1)
a single trophic level##3##4##(2008-9#3)
a single tube##4##3##(1992-3#1)(2008-10#3)
a single two-dimensional##3##3##(2007-11#2)(2008-3#1)
a single two-electron irreversible##2##4##(2008-10#2)
a single type##2##3##(1994-2#1)(2010-8#1)
a single visit##4##3##(2013-8#4)
a single wavelength##6##3##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
a single well##2##3##(2008-10#1)(2008-9#1)
a single well-defined##2##3##(2008-10#2)
a single##1379##2##(1990-10#1)(1990-11#12)(1990-12#8)(1990-2#5)(1990-5#7)(1990-6#2)(1990-7#9)(1990-8#9)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#6)(1991-5#4)(1991-6#6)(1991-8#1)(1991-9#5)(1992-1#4)(1992-11#5)(1992-12#8)(1992-2#1)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#9)(1992-9#1)(1993-1#1)(1993-11#8)(1993-12#9)(1993-2#8)(1993-3#5)(1993-6#4)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#9)(1994-2#4)(1994-3#6)(1994-5#9)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#2)(1995-11#5)(1995-12#6)(1995-2#10)(1995-3#4)(1995-5#7)(1995-6#11)(1995-8#6)(1995-9#2)(1996-1#1)(1996-12#8)(1996-2#4)(1996-5#3)(1996-6#3)(1996-9#3)(1997-2#7)(1997-3#8)(1997-4#6)(1997-5#4)(1997-6#5)(1997-7#8)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#3)(2006-6#2)(2007-10#3)(2007-11#41)(2007-12#60)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#1)(2008-1#8)(2008-10#305)(2008-11#34)(2008-12#15)(2008-2#65)(2008-3#125)(2008-4#27)(2008-5#20)(2008-6#9)(2008-7#29)(2008-8#30)(2008-9#35)(2009-10#11)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#4)(2010-10#5)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#11)(2011-10#1)(2011-2#36)(2011-3#3)(2011-7#1)(2012-12#8)(2012-2#14)(2012-3#11)(2013-1#29)(2013-2#1)(2013-7#3)(2013-8#15)
a single-beam##2##2##(2008-2#1)(2008-3#1)
a single-center experience##2##3##(2007-12#2)
a single-centre##2##2##(2007-8#1)(2008-11#1)
a single-chain Fv##2##3##(2008-10#1)(2008-8#1)
a single-chain antibody##3##3##(1997-4#1)(2008-8#2)
a single-chain precursor##2##3##(1992-12#2)
a single-chain##9##2##(1992-12#2)(1992-6#1)(1992-8#1)(1997-4#1)(2008-10#1)(2008-8#3)
a single-copy gene and##2##4##(1991-6#1)(1996-6#1)
a single-copy gene##9##3##(1991-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1996-6#1)(2008-8#1)
a single-copy##12##2##(1991-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-5#1)(2008-8#1)
a single-dose##2##2##(2008-10#1)(2011-2#1)
a single-exponential##3##2##(1992-3#1)(1995-2#1)(2008-3#1)
a single-fiber Bragg grating##2##4##(2008-3#2)
a single-fiber##3##2##(2008-3#2)(2010-4#1)
a single-frequency##8##2##(2007-12#4)(2008-2#2)(2008-3#2)
a single-group##2##2##(1993-1#1)(2013-1#1)
a single-image##2##2##(2008-2#1)(2008-3#1)
a single-incision anterior approach##2##4##(2011-2#2)
a single-line-defect photonic-crystal waveguide##3##4##(2007-11#3)
a single-longitudinal-mode##2##2##(2008-2#1)(2008-3#1)
a single-mode continuous-wave##3##3##(2008-2#2)(2008-3#1)
a single-mode fiber with##3##4##(2008-2#2)(2008-3#1)
a single-mode fiber##9##3##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)
a single-mode optical fiber##9##4##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#1)
a single-mode optical##10##3##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#1)
a single-mode##38##2##(2007-11#9)(2007-12#10)(2008-2#12)(2008-3#7)
a single-nucleotide polymorphism##2##3##(2008-10#1)(2011-2#1)
a single-nucleotide##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
a single-order##3##2##(2008-3#3)
a single-pass##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
a single-point##2##2##(2008-3#2)
a single-scattering##2##2##(2008-2#1)(2008-3#1)
a single-shot##6##2##(2007-11#2)(2007-12#2)(2008-3#1)(2011-1#1)
a single-stage##3##2##(2007-11#1)(2008-3#2)
a single-step##5##2##(2008-10#3)(2008-3#1)(2008-6#1)
a single-stranded##8##2##(1992-9#1)(1993-8#1)(1995-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)
a singly resonant##2##3##(2007-12#2)
a singly##4##2##(1995-2#1)(2007-12#2)(2011-2#1)
a sink##3##2##(2008-11#1)(2008-8#2)
a sinus##2##2##(2008-11#1)(2013-8#1)
a sinusoidal##9##2##(2008-10#1)(2008-2#2)(2008-3#5)(2009-4#1)
a sister group##2##3##(2008-10#1)(2010-3#1)
a sister##3##2##(1996-6#1)(2008-10#1)(2010-3#1)
a site of##6##3##(1995-2#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-7#2)
a site that##4##3##(1994-3#1)(1994-5#2)(2013-1#1)
a site which##2##3##(1993-12#1)(1995-3#1)
a site within##3##3##(1995-5#2)(1997-7#1)
a site##36##2##(1990-7#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-6#2)(1993-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
a site-directed##3##2##(1993-8#1)(1995-6#1)(1997-3#1)
a situation in which a##2##5##(2008-5#1)(2008-9#1)
a situation in which##5##4##(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
a situation of##4##3##(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
a situation that##5##3##(2008-10#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-12#1)
a situation##24##2##(1992-3#1)(1992-4#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a six year##3##3##(1990-3#1)(2007-7#1)(2008-10#1)
a six years##2##3##(2008-7#1)(2013-1#1)
a six##8##2##(1990-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
a six-component##2##2##(2008-10#2)
a six-month period##2##3##(1996-11#1)(1997-3#1)
a six-month##3##2##(1996-11#1)(1997-3#1)(2008-5#1)
a six-port##3##2##(2008-10#3)
a six-step##2##2##(1990-5#1)(2011-2#1)
a six-week##2##2##(2010-8#1)(2013-1#1)
a six-year##2##2##(1996-1#1)(2011-2#1)
a sixfold##2##2##(2007-12#1)(2008-3#1)
a sixth-order##2##2##(2008-2#1)(2010-12#1)
a sizable##2##2##(2008-10#1)(2009-9#1)
a size distribution##2##3##(2008-10#1)(2008-2#1)
a size of##8##3##(1994-2#1)(1995-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
a size parameter of##4##4##(2008-2#2)(2008-3#2)
a size range of##3##4##(1997-3#1)(2008-5#1)(2010-12#1)
a size range##5##3##(1997-3#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-7#1)
a size##25##2##(1991-2#1)(1994-2#1)(1995-3#1)(1995-4#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-7#1)
a size-exclusion##2##2##(1995-6#1)(1997-2#1)
a sizeable##3##2##(1996-3#1)(2010-12#1)(2012-2#1)
a sizing##2##2##(1995-3#1)(2008-3#1)
a skeletal muscle##3##3##(1993-11#2)(2011-2#1)
a skeletal##6##2##(1993-11#2)(1995-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
a skeletonized##2##2##(2007-8#2)
a skiing##2##2##(2007-12#1)(2013-1#1)
a skill that##2##3##(1995-1#1)(2008-11#1)
a skilled and##2##3##(1997-3#1)(2008-10#1)
a skilled##3##2##(1992-11#1)(1997-3#1)(2008-10#1)
a skin lotion and##2##4##(2008-5#2)
a skin lotion##3##3##(2008-5#3)
a skin##20##2##(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#3)
a slab or##2##3##(2008-3#1)(2008-4#1)
a slab waveguide##2##3##(2007-12#2)
a slab with##3##3##(2008-3#3)
a slab##13##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#6)(2008-4#1)
a sleep diary##2##3##(2008-10#1)(2013-1#1)
a slender##2##2##(1996-8#1)(2011-1#1)
a slice##2##2##(1997-8#1)(2007-12#1)
a slide##3##2##(1991-5#1)(2007-11#1)(2008-9#1)
a slider##2##2##(2008-3#1)(2009-3#1)
a slight but significant##2##4##(2008-10#1)(2008-7#1)
a slight but##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2010-8#1)
a slight change in the##2##5##(1997-7#1)(2008-3#1)
a slight decrease in the##3##5##(1990-11#1)(1994-12#1)(2008-6#1)
a slight decrease in##6##4##(1990-11#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
a slight decrease##7##3##(1990-11#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)
a slight increase in the##6##5##(1991-12#1)(1992-12#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-5#1)
a slight increase in##12##4##(1991-12#1)(1991-6#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-5#1)(2013-1#2)
a slight increase##17##3##(1991-12#1)(1991-6#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)(2013-1#2)
a slight reduction##2##3##(1997-2#1)(2008-9#1)
a slight shift of##2##4##(1995-12#1)(2009-2#1)
a slight trend##2##3##(2008-10#1)(2008-6#1)
a slight##71##2##(1990-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#1)(2009-2#1)(2009-8#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
a slightly better##3##3##(2008-10#2)(2013-1#1)
a slightly higher risk of developing PD##2##7##(2008-8#2)
a slightly higher risk of##3##5##(2008-8#2)(2012-12#1)
a slightly higher##8##3##(1991-12#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-12#1)
a slightly increased##3##3##(1992-11#1)(2012-3#1)(2012-5#1)
a slightly larger##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
a slightly lesser##2##3##(2008-10#1)(2010-3#1)
a slightly lower##3##3##(1997-4#1)(2008-10#1)(2008-6#1)
a slightly tender##2##3##(1993-8#1)(2013-8#1)
a slightly##45##2##(1991-12#1)(1991-8#1)(1992-11#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#3)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
a slit##7##2##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-9#1)
a slope efficiency of 35% with respect to the absorbed##2##10##(2007-11#1)(2007-12#1)
a slope efficiency of 54%##2##5##(2007-11#1)(2008-2#1)
a slope efficiency of##18##4##(2007-11#6)(2007-12#7)(2008-2#3)(2008-3#2)
a slope of -0##4##4##(1994-12#1)(1996-2#1)(2008-10#2)
a slope of 0##2##4##(2008-10#2)
a slope of 55##2##4##(2008-10#2)
a slope of about##2##4##(2008-10#2)
a slope of##39##3##(1994-12#1)(1996-2#2)(2008-10#36)
a slope##64##2##(1994-12#1)(1996-2#2)(2007-11#6)(2007-12#7)(2008-10#40)(2008-2#4)(2008-3#4)
a slow and##4##3##(1994-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
a slow or##2##3##(2007-12#1)(2008-7#1)
a slow process##4##3##(1991-12#1)(1992-3#1)(1993-11#1)(2008-1#1)
a slow rate of##3##4##(1997-1#1)(2008-10#1)(2008-7#1)
a slow##39##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
a slow-growing##3##2##(1991-12#1)(2010-3#2)
a slow-onset potentiation##2##3##(1995-12#2)
a slower##12##2##(1992-5#1)(1995-2#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
a slowing of the rate of##2##6##(1991-12#1)(2008-11#1)
a slowing of##5##3##(1991-11#1)(1991-12#1)(1994-3#1)(2008-11#1)(2008-7#1)
a slowing##7##2##(1991-11#1)(1991-12#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
a slowly growing##2##3##(1997-2#1)(2011-2#1)
a slowly increasing##2##3##(1996-4#1)(1997-6#1)
a slowly progressive##3##3##(2007-11#1)(2012-3#2)
a slowly##12##2##(1990-5#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#2)
a slum##2##2##(2007-7#1)(2008-7#1)
a slurry of##2##3##(2008-10#2)
a slurry##4##2##(2008-10#2)(2008-3#2)
a small A3##3##3##(1990-8#3)
a small Norwegian##2##3##(1995-11#1)(1996-11#1)
a small amount of TiO(2)##2##5##(2008-3#1)(2009-11#1)
a small amount of##27##4##(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
a small amount##28##3##(1991-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
a small and##2##3##(1992-3#1)(2007-12#1)
a small animal##2##3##(1994-12#1)(2009-8#1)
a small aperture##2##3##(2008-2#1)(2008-3#1)
a small aqueous pore##2##4##(1990-2#2)
a small area##4##3##(1990-8#1)(1991-8#1)(2008-10#1)(2008-5#1)
a small beam##2##3##(2008-3#2)
a small benefit##2##3##(1991-7#1)(1997-8#1)
a small but significant reduction in the raclopride-induced DA output in the NAC##2##13##(2008-6#2)
a small but significant##11##4##(1991-6#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)
a small but statistically significant##3##5##(1992-2#1)(2008-8#1)(2009-2#1)
a small but##18##3##(1991-6#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-5#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)
a small change in the##3##5##(1994-8#1)(2008-3#2)
a small change in##4##4##(1994-8#1)(2007-11#1)(2008-3#2)
a small column##4##3##(2008-10#4)
a small country##3##3##(2008-1#1)(2008-8#1)(2011-1#1)
a small decrease##2##3##(2008-10#2)
a small deletion##2##3##(1990-5#1)(2008-9#1)
a small difference##2##3##(2010-2#1)(2012-3#1)
a small divergence angle##2##4##(2008-10#2)
a small effect on##3##4##(1990-2#1)(1995-3#2)
a small effect##4##3##(1990-2#1)(1995-3#2)(2010-4#1)
a small field##2##3##(2008-2#1)(2011-1#1)
a small fraction of the##6##5##(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2013-1#1)
a small fraction of##13##4##(1991-12#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-11#2)(2010-5#1)(2013-1#1)
a small fraction##14##3##(1991-12#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#2)(2010-11#2)(2010-5#1)(2013-1#1)
a small genomic##2##3##(2008-9#1)(2013-1#1)
a small geographical##2##3##(2008-10#1)(2012-3#1)
a small group of##6##4##(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2013-1#2)
a small group##7##3##(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#2)
a small incision in the##2##5##(1996-8#1)(2009-3#1)
a small increase in the##2##5##(1992-8#1)(1997-8#1)
a small increase in##5##4##(1990-12#1)(1992-8#1)(1997-8#1)(2008-7#1)(2012-1#1)
a small increase##6##3##(1990-12#1)(1992-8#1)(1997-8#1)(2008-7#1)(2008-9#1)(2012-1#1)
a small influence##2##3##(2008-4#1)(2008-5#1)
a small island##2##3##(2008-1#1)(2012-12#1)
a small local##4##3##(2008-2#2)(2008-3#2)
a small minority##2##3##(1995-11#1)(2013-8#1)
a small molecule##5##3##(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)
a small nuclear##2##3##(1996-3#1)(1997-3#1)
a small number of cases##4##5##(1994-9#1)(2008-7#1)(2010-12#1)(2013-1#1)
a small number of genes##2##5##(1997-7#1)(2008-7#1)
a small number of patients##2##5##(2007-10#1)(2007-8#1)
a small number of##45##4##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-9#1)(1995-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
a small number##49##3##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-9#1)(1995-5#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
a small omphalocele##2##3##(2008-10#2)
a small open##2##3##(2008-9#1)(2013-7#1)
a small pH##2##3##(1991-8#1)(2008-7#1)
a small part of the##4##5##(1991-9#1)(1993-6#1)(1994-12#1)(2008-3#1)
a small percent##2##3##(1990-2#1)(2008-5#1)
a small percentage of the##2##5##(1991-3#1)(2007-5#1)
a small percentage of##8##4##(1991-3#1)(1992-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
a small percentage##9##3##(1991-3#1)(1992-12#1)(1992-9#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
a small perturbation##3##3##(2007-12#1)(2008-3#2)
a small population of##4##4##(1991-12#1)(1997-2#1)(2008-10#1)(2008-7#1)
a small population##6##3##(1991-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#2)
a small portion of the##2##5##(1992-3#1)(2009-5#1)
a small portion of##6##4##(1992-3#1)(2007-10#1)(2008-4#2)(2009-5#1)(2010-3#1)
a small proportion of the total##2##6##(1994-8#1)(2008-10#1)
a small proportion of the##6##5##(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
a small proportion of##13##4##(1991-11#1)(1994-8#1)(1995-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
a small proportion##16##3##(1991-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
a small reduction in##2##4##(2008-3#2)
a small role in##3##4##(2008-8#1)(2008-9#1)(2011-1#1)
a small sample of##2##4##(1997-5#1)(2007-4#1)
a small sample size##2##4##(2008-10#1)(2012-12#1)
a small sample##6##3##(1997-5#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-12#1)
a small scale##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
a small source-detector separation##2##4##(2008-3#2)
a small spatial scale##2##4##(2010-6#1)(2010-8#1)
a small spot##2##3##(2007-12#1)(2008-3#1)
a small subset of patients##3##5##(1995-5#1)(1997-1#1)(2012-1#1)
a small subset of##5##4##(1995-5#1)(1997-1#1)(1997-7#1)(2008-6#1)(2012-1#1)
a small variation##2##3##(1990-8#1)(2007-12#1)
a small vessel##2##3##(2011-2#1)(2013-8#1)
a small volume of an##2##5##(2008-10#2)
a small volume of nitric acid##2##6##(2008-10#2)
a small volume of##11##4##(2008-10#10)(2008-8#1)
a small volume##12##3##(2008-10#11)(2008-8#1)
a small##478##2##(1990-11#1)(1990-12#2)(1990-2#5)(1990-5#6)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#6)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-12#4)(1992-2#2)(1992-3#4)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#7)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2007-10#3)(2007-11#6)(2007-12#15)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#64)(2008-11#15)(2008-12#5)(2008-2#20)(2008-3#48)(2008-4#8)(2008-5#14)(2008-6#7)(2008-7#19)(2008-8#9)(2008-9#14)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#5)(2011-2#7)(2012-1#5)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#6)
a small-diameter##2##2##(2008-3#1)(2010-1#1)
a small-scale##2##2##(1994-8#1)(2008-3#1)
a small-signal gain of##2##4##(2007-12#2)
a small-signal##4##2##(2007-11#1)(2007-12#3)
a smaller but##2##3##(1994-2#1)(2011-2#1)
a smaller number of##2##4##(2011-2#1)(2012-2#1)
a smaller size##2##3##(1992-6#1)(2008-9#1)
a smaller##57##2##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-8#3)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
a smart##3##2##(1994-1#1)(2007-8#1)(2010-2#1)
a smoke##2##2##(1996-12#1)(2007-11#1)
a smoker has##2##3##(2012-12#2)
a smoker##5##2##(1996-3#1)(2012-12#2)(2013-1#2)
a smoking##5##2##(1993-1#1)(1996-1#1)(2007-12#1)(2008-7#1)(2009-5#1)
a smooth muscle protein##2##4##(1992-9#2)
a smooth muscle##5##3##(1992-9#2)(2007-8#1)(2008-11#1)(2008-6#1)
a smooth phase distribution##2##4##(2008-2#2)
a smooth surface##3##3##(1994-7#1)(2008-10#1)(2008-8#1)
a smooth##34##2##(1992-9#2)(1994-7#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#4)(2008-6#3)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)
a smoother##2##2##(2008-11#1)(2008-3#1)
a smoothing parameter##2##3##(2009-10#2)
a smoothing##5##2##(1997-3#1)(2008-2#1)(2009-10#2)(2011-2#1)
a snake##4##2##(1992-12#2)(2012-2#2)
a snap bean##2##3##(2008-10#2)
a snap##4##2##(1996-2#1)(2008-10#3)
a snapshot of the##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
a so-called##6##2##(1995-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
a social and##2##3##(2008-2#1)(2008-9#1)
a social context##2##3##(1993-1#1)(2009-6#1)
a social worker##2##3##(1991-6#1)(2013-1#1)
a social##26##2##(1991-6#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
a societal##2##2##(2008-7#1)(2008-8#1)
a society that##2##3##(1993-1#1)(2008-1#1)
a society##8##2##(1991-3#1)(1992-6#2)(1993-1#1)(1994-9#1)(2008-1#2)(2011-1#1)
a sodium##16##2##(1990-6#1)(1992-11#1)(1996-2#2)(2008-10#9)(2008-3#1)(2008-5#1)(2012-2#1)
a soft##15##2##(1991-2#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
a software package##3##3##(2008-4#2)(2008-9#1)
a software program##4##3##(1992-2#1)(1995-6#1)(1996-2#1)(2008-2#1)
a software##18##2##(1992-2#1)(1994-2#1)(1995-6#1)(1996-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
a soil fulvic acid##2##4##(2008-10#2)
a soil with##2##3##(2008-10#2)
a soil##19##2##(1992-3#1)(2008-10#17)(2008-9#1)
a soilborne pathogen causing##2##4##(2008-10#2)
a soilborne pathogen##3##3##(2008-10#3)
a soilborne##5##2##(2008-10#5)
a sol-gel process##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
a sol-gel##11##2##(2008-10#9)(2008-3#1)(2008-5#1)
a solgel##2##2##(2008-2#1)(2008-3#1)
a solid and##2##3##(2010-3#1)(2013-1#1)
a solid angle of##2##4##(2008-2#1)(2008-3#1)
a solid catalyst##5##3##(2008-10#5)
a solid foundation for##5##4##(1995-1#1)(2008-4#1)(2008-9#2)(2010-9#1)
a solid foundation##6##3##(1995-1#1)(2008-4#1)(2008-9#2)(2010-10#1)(2010-9#1)
a solid immersion lens (SIL)##2##5##(2008-3#2)
a solid immersion lens##3##4##(2008-3#3)
a solid matrix##2##3##(2008-10#1)(2008-2#1)
a solid phase extraction (SPE) procedure##3##6##(2008-10#3)
a solid phase extraction (SPE)##5##5##(2008-10#5)
a solid phase extraction##8##4##(2008-10#8)
a solid phase##20##3##(2008-10#16)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
a solid sensing##2##3##(2008-10#2)
a solid sorbent##2##3##(2008-10#2)
a solid state##2##3##(2008-10#1)(2013-8#1)
a solid support and##2##4##(2008-10#2)
a solid support for##2##4##(2008-10#1)(2008-4#1)
a solid support##15##3##(2008-10#10)(2008-4#4)(2009-12#1)
a solid surface##3##3##(2008-10#2)(2008-7#1)
a solid variant of serous cystadenoma##2##6##(2012-2#2)
a solid waste##3##3##(2008-10#2)(2008-6#1)
a solid##112##2##(1990-8#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#3)(2007-7#1)(2008-10#49)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#4)(2013-1#4)(2013-8#3)
a solid-phase extraction (SPE)##3##4##(2008-10#3)
a solid-phase extraction##6##3##(1997-2#1)(2008-10#5)
a solid-phase##21##2##(1990-8#1)(1997-2#2)(2008-1#1)(2008-10#13)(2008-4#3)(2012-12#1)
a solid-state laser##2##3##(2007-12#1)(2008-2#1)
a solid-state##15##2##(1992-1#1)(2007-12#4)(2008-10#4)(2008-2#4)(2008-3#1)(2008-7#1)
a solitary kidney##2##3##(2012-12#2)
a solitary pulmonary nodule##2##4##(2007-8#2)
a solitary##15##2##(1991-9#1)(2007-8#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#4)
a soliton##4##2##(2007-11#1)(2007-12#3)
a solubility##2##2##(2008-10#1)(2013-1#1)
a solubilizing##2##2##(2008-10#1)(2013-1#1)
a soluble form of the##2##5##(1994-8#1)(1997-2#1)
a soluble form of##3##4##(1994-8#1)(1995-2#1)(1997-2#1)
a soluble form##9##3##(1992-6#1)(1994-8#3)(1995-2#1)(1997-2#1)(2008-7#1)(2012-2#2)
a soluble substrate##2##3##(2008-7#2)
a soluble##29##2##(1990-10#1)(1990-11#1)(1991-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#4)(1995-2#2)(1997-2#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#3)(2012-2#2)
a solution containing 0##3##4##(2008-10#3)
a solution containing 2##2##4##(2008-10#2)
a solution containing PLGA##2##4##(2009-11#2)
a solution containing##25##3##(2007-11#1)(2008-10#19)(2008-3#1)(2008-4#1)(2009-11#2)(2009-12#1)
a solution for##2##3##(2007-12#1)(2008-4#1)
a solution hybridization assay##2##4##(1991-9#2)
a solution in##2##3##(2008-10#1)(2011-2#1)
a solution of 2##2##4##(2008-10#2)
a solution of the##4##4##(2008-10#4)
a solution of##33##3##(1990-7#1)(1992-3#1)(1996-2#1)(2007-12#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2010-2#1)
a solution to the problem of##2##6##(2008-10#1)(2008-12#1)
a solution to the problem##3##5##(2008-10#1)(2008-12#1)(2008-2#1)
a solution to the##5##4##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-7#1)
a solution to this problem##2##5##(2007-11#1)(2008-2#1)
a solution to this##3##4##(2007-11#1)(2008-2#1)(2008-4#1)
a solution to##14##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-9#2)(2010-3#1)(2010-7#1)
a solution with##2##3##(2008-10#2)
a solution##103##2##(1990-5#1)(1990-7#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#49)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#3)(2008-6#3)(2008-9#2)(2009-11#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)
a solvent extraction##5##3##(2008-10#5)
a solvent of##3##3##(2008-10#2)(2010-12#1)
a solvent##19##2##(1994-8#1)(2007-11#1)(2008-10#14)(2008-2#1)(2008-5#1)(2010-12#1)
a solvent-free##2##2##(2007-11#1)(2011-2#1)
a somatostatin analogue##3##3##(2007-8#1)(2008-7#1)(2013-8#1)
a somewhat different##2##3##(2008-10#1)(2010-6#1)
a somewhat##14##2##(1992-6#1)(1993-11#1)(1996-9#1)(2007-7#1)(2008-10#4)(2008-6#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-6#1)(2012-2#1)
a sonication##2##2##(1992-9#1)(2008-10#1)
a sophisticated##6##2##(1993-12#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-8#1)(2013-1#1)
a sorbent##4##2##(2008-10#4)
a sorption capacity of 1##2##5##(2008-10#2)
a sort of##2##3##(2008-7#2)
a sound knowledge of the##2##5##(2008-9#1)(2011-2#1)
a sound##8##2##(1995-5#1)(1996-3#1)(1997-2#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
a sounding rocket##5##3##(2008-3#5)
a sounding##6##2##(2008-3#5)(2010-4#1)
a source for##4##3##(2008-10#2)(2008-12#1)(2011-3#1)
a source of concern in##2##5##(2008-12#1)(2010-6#1)
a source of environmental##2##4##(1995-11#1)(2008-5#1)
a source of health##2##4##(2008-10#1)(2012-12#1)
a source of inoculum for##2##5##(2008-10#2)
a source of inoculum##4##4##(2008-10#4)
a source of inspiration##2##4##(2007-12#1)(2008-12#1)
a source of large##2##4##(2008-4#1)(2012-3#1)
a source of significant##2##4##(2008-6#1)(2008-7#1)
a source of the##3##4##(1996-5#1)(2008-10#1)(2011-2#1)
a source of vitamins##2##4##(2010-1#1)(2013-1#1)
a source of##91##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-1#1)(1993-2#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-5#1)(2008-10#24)(2008-11#3)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
a source##107##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-2#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-5#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
a source-sink system##2##3##(2008-8#1)(2008-9#1)
a source-sink##4##2##(2008-8#3)(2008-9#1)
a southern##3##2##(1994-3#1)(2008-10#1)(2010-8#1)
a space vehicle##2##3##(2008-2#2)
a space##9##2##(1991-6#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-7#1)
a space-dependent rate equation##2##4##(2008-3#2)
a space-variant##2##2##(2007-11#2)
a spaceborne##3##2##(2008-2#2)(2008-3#1)
a spacer device##5##3##(1996-1#2)(1996-2#2)(2008-3#1)
a spacer##16##2##(1990-7#1)(1996-1#3)(1996-2#2)(2007-11#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-8#1)(2013-1#1)
a span of##4##3##(1994-12#1)(2008-12#1)(2008-3#1)(2012-3#1)
a spark##2##2##(2008-10#2)
a sparse##4##2##(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#1)
a spatial carrier##2##3##(2008-2#1)(2008-3#1)
a spatial filter##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
a spatial gradient##2##3##(2008-8#2)
a spatial light modulator (SLM) to##2##6##(2007-12#1)(2008-2#1)
a spatial light modulator (SLM)##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
a spatial light modulator##6##4##(2007-12#2)(2008-2#3)(2008-3#1)
a spatial location recognition task##3##5##(1994-3#3)
a spatial resolution of 20##2##5##(2007-11#1)(2008-3#1)
a spatial resolution of##11##4##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#4)(2008-5#1)
a spatial resolution##13##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)
a spatial scale##2##3##(2008-2#1)(2013-7#1)
a spatial task##4##3##(1994-8#3)(1996-5#1)
a spatial working memory task##2##5##(1994-8#2)
a spatial##76##2##(1992-10#1)(1993-3#2)(1993-6#1)(1994-3#4)(1994-8#5)(1995-5#1)(1996-5#1)(2007-11#2)(2007-12#8)(2008-10#3)(2008-11#2)(2008-2#13)(2008-3#16)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#4)
a spatially explicit##5##3##(2008-10#1)(2008-8#3)(2008-9#1)
a spatially homogeneous##2##3##(2007-12#1)(2008-8#1)
a spatially incoherent##2##3##(2007-12#1)(2008-3#1)
a spatially modulated##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
a spatially realistic metapopulation model##2##5##(2008-8#1)(2008-9#1)
a spatially resolved##2##3##(2007-11#1)(2008-3#1)
a spatially uniform##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
a spatially##41##2##(1990-7#1)(1995-5#1)(2007-11#3)(2007-12#5)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#6)(2008-8#7)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)
a spatio-temporal##2##2##(2008-11#1)(2013-8#1)
a spatiotemporal##2##2##(2008-10#1)(2008-3#1)
a speaker##4##2##(2008-2#1)(2009-10#2)(2009-9#1)
a speaker's##2##2##(2008-2#1)(2009-10#1)
a special and##2##3##(2008-10#2)
a special case of the##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
a special case of##6##4##(2007-11#1)(2008-3#3)(2008-8#2)
a special case##10##3##(2007-11#1)(2008-3#4)(2008-8#4)(2012-3#1)
a special class of##4##4##(1994-2#1)(2008-3#1)(2009-4#1)(2013-8#1)
a special custom made##2##4##(2013-1#2)
a special focus##5##3##(1994-3#2)(2008-4#1)(2009-7#1)(2011-2#1)
a special interest in##2##4##(2007-2#1)(2011-1#1)
a special interest##5##3##(2007-2#1)(2008-10#2)(2008-7#1)(2011-1#1)
a special place##2##3##(2008-8#1)(2009-7#1)
a special role##2##3##(1990-11#1)(2009-12#1)
a special sample treatment##2##4##(2008-10#2)
a special sample##3##3##(2008-10#2)(2012-3#1)
a special structure##2##3##(1992-6#1)(2008-10#1)
a special##106##2##(1990-11#1)(1990-6#1)(1990-8#2)(1992-6#1)(1993-3#2)(1993-8#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#5)(2007-12#4)(2007-2#1)(2008-10#19)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#2)
a specialised##5##2##(1994-9#1)(1995-5#1)(1995-9#1)(2007-12#1)(2011-3#1)
a specialist education programme##2##4##(2010-10#2)
a specialist education##3##3##(2010-10#3)
a specialist in##4##3##(1992-2#1)(1995-6#1)(2008-8#1)(2010-12#1)
a specialist##23##2##(1992-1#1)(1992-2#2)(1992-5#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-10#3)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
a specialized region of the##2##5##(1991-9#1)(2008-7#1)
a specialized##21##2##(1990-5#1)(1991-9#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a specially designed intracavity##2##4##(2007-12#1)(2008-2#1)
a specially designed##17##3##(1994-12#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-3#1)
a specially##25##2##(1994-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#1)(2009-8#1)(2010-2#1)(2010-3#1)
a specialty##5##2##(1992-3#1)(1994-12#1)(1997-4#1)(2011-1#1)(2012-2#1)
a species complex##2##3##(2009-9#1)(2010-10#1)
a species previously##2##3##(1993-8#1)(2008-10#1)
a species specific##2##3##(2008-10#2)
a species with##3##3##(2008-9#2)(2013-7#1)
a species##38##2##(1990-11#1)(1992-10#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-2#2)(2008-10#9)(2008-5#1)(2008-8#8)(2008-9#4)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-7#2)
a species'##4##2##(2008-8#2)(2008-9#1)(2013-1#1)
a species-specific##5##2##(2008-10#2)(2009-5#1)(2009-8#1)(2013-7#1)
a specific DNA binding##2##4##(1990-11#1)(1995-8#1)
a specific DNA##6##3##(1990-11#1)(1991-2#1)(1995-8#1)(1997-2#1)(2008-10#2)
a specific GABA(A)##2##3##(2008-7#1)(2008-9#1)
a specific action##2##3##(1992-8#1)(1993-5#1)
a specific activity of##4##4##(1991-12#1)(1992-11#1)(1994-5#1)(2009-9#1)
a specific analyte##2##3##(2008-4#1)(2009-3#1)
a specific and irreversible##2##4##(1990-2#1)(2008-4#1)
a specific and unique##2##4##(1990-12#1)(2007-5#1)
a specific and##8##3##(1990-12#1)(1990-2#1)(1994-8#1)(1996-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
a specific antagonist of the##3##5##(1994-8#1)(2008-7#2)
a specific antagonist of##6##4##(1993-11#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-7#2)
a specific antibody##6##3##(1992-12#1)(1995-12#1)(1997-1#1)(2008-4#2)(2012-2#1)
a specific antigen##2##3##(2008-4#1)(2013-8#1)
a specific band in##2##4##(2008-4#1)(2013-1#1)
a specific behavior##2##3##(2008-4#1)(2008-8#1)
a specific binding##2##3##(1995-11#1)(1995-2#1)
a specific biological activity##2##4##(1990-12#1)(2011-2#1)
a specific brain##2##3##(1993-8#1)(2008-12#1)
a specific cellular##2##3##(1992-11#1)(2012-2#1)
a specific chemical##2##3##(2008-10#1)(2010-7#1)
a specific clinical##3##3##(2007-5#2)(2008-11#1)
a specific design##3##3##(2008-3#3)
a specific diagnosis##4##3##(1996-6#1)(2011-2#1)(2012-2#2)
a specific drug##2##3##(2008-11#1)(2013-8#1)
a specific effect on##2##4##(1996-5#1)(2008-5#1)
a specific environmental##2##3##(2008-11#1)(2010-8#1)
a specific enzyme##2##3##(1992-3#1)(2008-4#1)
a specific event##2##3##(1995-9#1)(1996-5#1)
a specific example##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
a specific function##2##3##(1991-6#1)(2008-8#1)
a specific functional##2##3##(2008-7#1)(2012-1#1)
a specific gene##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
a specific genetic##3##3##(2007-10#1)(2008-4#1)(2011-2#1)
a specific growth rate of 0##2##6##(2008-6#1)(2011-2#1)
a specific growth rate of##3##5##(2008-6#1)(2008-7#1)(2011-2#1)
a specific growth rate##5##4##(1994-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
a specific health##2##3##(2008-7#1)(2012-12#1)
a specific immune##2##3##(1992-12#1)(2011-2#1)
a specific indicator##2##3##(1995-12#1)(2008-7#1)
a specific inhibitor of protein kinase C##2##7##(1990-11#1)(1997-7#1)
a specific inhibitor of the##4##5##(1992-12#1)(1993-3#1)(1994-6#1)(1996-5#1)
a specific inhibitor of##16##4##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-10#1)
a specific inhibitor##17##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-10#1)
a specific location##3##3##(2007-12#1)(2008-8#1)(2009-9#1)
a specific marker##2##3##(1994-8#1)(1995-11#1)
a specific method##2##3##(1996-3#1)(2008-5#1)
a specific molecular##3##3##(1997-2#1)(2008-6#1)(2013-1#1)
a specific monoclonal antibody##3##4##(1993-8#1)(1994-10#1)(2008-10#1)
a specific pathway##2##3##(1994-8#1)(2008-1#1)
a specific pattern of##2##4##(1993-6#1)(2009-1#1)
a specific phase##2##3##(2008-11#1)(2008-3#1)
a specific physiological##3##3##(1995-6#1)(2010-2#2)
a specific polyclonal##2##3##(2008-10#2)
a specific population of##2##4##(1990-7#1)(1995-12#1)
a specific probe for##3##4##(1990-12#1)(1991-12#1)(2008-9#1)
a specific problem##2##3##(1994-2#1)(2012-12#1)
a specific protein##2##3##(1994-8#1)(2008-11#1)
a specific region##3##3##(1993-9#1)(2011-2#1)(2013-8#1)
a specific response##2##3##(1990-5#1)(2008-10#1)
a specific role##4##3##(1996-2#2)(2008-11#1)(2013-1#1)
a specific sequence##2##3##(2008-7#1)(2010-1#1)
a specific set of##2##4##(2008-10#1)(2009-6#1)
a specific situation##2##3##(2009-11#1)(2010-12#1)
a specific test##2##3##(1996-3#1)(2008-2#1)
a specific type of##2##4##(1990-8#1)(1992-2#1)
a specific university##2##3##(1994-12#1)(2010-3#1)
a specific wavelength##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
a specific##419##2##(1990-11#5)(1990-12#5)(1990-2#6)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#6)(1991-6#2)(1991-9#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#14)(1994-9#1)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#3)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#7)(1997-6#1)(1997-7#4)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-5#4)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#40)(2008-11#17)(2008-12#2)(2008-2#13)(2008-3#18)(2008-4#19)(2008-5#5)(2008-6#4)(2008-7#19)(2008-8#11)(2008-9#9)(2009-1#1)(2009-10#6)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#14)(2012-1#1)(2012-12#2)(2012-2#8)(2013-1#10)(2013-8#6)
a specifically##3##2##(1994-9#1)(2008-3#1)(2010-3#1)
a specificity of 0##3##4##(1993-2#2)(2013-1#1)
a specificity of 82##2##4##(1997-8#1)(2012-3#1)
a specificity of##16##3##(1990-6#1)(1990-9#1)(1992-3#1)(1993-2#2)(1994-2#1)(1995-11#1)(1995-4#1)(1997-3#1)(1997-8#1)(2012-3#2)(2013-1#3)(2013-8#1)
a specified benefit##2##3##(1992-12#2)
a specified period of time##3##5##(1993-3#1)(2008-10#1)(2008-11#1)
a specified time##2##3##(2008-10#1)(2008-12#1)
a specified##25##2##(1990-2#1)(1992-12#2)(1992-9#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#8)(2008-7#1)(2012-3#1)
a specimen##7##2##(2007-12#1)(2008-9#2)(2009-7#1)(2010-6#1)(2012-2#2)
a speckle pattern##2##3##(2007-12#1)(2008-2#1)
a speckle##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
a spectral bandwidth##2##3##(2008-2#1)(2008-3#1)
a spectral feature##2##3##(2008-3#2)
a spectral range of##2##4##(2007-12#1)(2008-3#1)
a spectral range##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a spectral resolution of##4##4##(1991-5#1)(2007-12#2)(2008-3#1)
a spectral resolution##5##3##(1991-5#1)(2007-12#2)(2008-2#1)(2008-3#1)
a spectral##33##2##(1991-5#1)(1995-2#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#4)(2008-3#13)(2008-5#1)(2013-8#1)
a spectrally averaged##2##3##(2008-3#2)
a spectrally encoded##2##3##(2008-2#1)(2011-1#1)
a spectrally##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2011-1#1)
a spectrofluorimeter##3##2##(1995-3#1)(2008-10#1)(2008-4#1)
a spectrofluorimetric method for the determination of##2##7##(2008-10#2)
a spectrograph##5##2##(2007-12#1)(2008-10#1)(2008-3#3)
a spectrometer with##2##3##(2008-10#1)(2008-3#1)
a spectrometer##7##2##(2008-10#1)(2008-2#2)(2008-3#4)
a spectrometric##3##2##(2008-10#2)(2008-2#1)
a spectrophotometer and a##2##4##(2008-10#1)(2008-3#1)
a spectrophotometer or a##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
a spectrophotometer##11##2##(2008-10#6)(2008-2#2)(2008-3#2)(2008-9#1)
a spectrophotometric method based on##2##5##(2008-10#2)
a spectrophotometric method for##5##4##(2008-10#3)(2008-5#1)(2013-8#1)
a spectrophotometric method to determine the##2##6##(2008-10#2)
a spectrophotometric method##16##3##(1996-12#1)(2008-10#13)(2008-5#1)(2013-8#1)
a spectrophotometric reference method##3##4##(2008-10#3)
a spectrophotometric##26##2##(1996-12#1)(2008-10#23)(2008-5#1)(2013-8#1)
a spectroscopic##7##2##(1994-12#1)(2008-2#1)(2008-3#4)(2010-4#1)
a spectrum of possible##2##4##(2008-10#1)(2010-3#1)
a spectrum of##19##3##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-2#4)(2013-1#3)
a spectrum ranging from##2##4##(2007-11#1)(2008-5#1)
a spectrum##26##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-2#4)(2013-1#3)(2013-8#1)
a speech##2##2##(1994-1#1)(2009-3#1)
a speed of##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
a speedy##2##2##(2010-8#1)(2012-12#1)
a sperm##3##2##(2008-6#1)(2012-2#2)
a spermine##2##2##(2009-8#2)
a sphere##5##2##(2008-2#2)(2008-3#3)
a spherical interference filter and a##2##6##(2008-3#2)
a spherical mirror##4##3##(2008-2#1)(2008-3#3)
a spherical object##2##3##(2008-2#1)(2008-3#1)
a spherical particle##3##3##(2008-2#1)(2008-3#2)
a spherical primary##2##3##(2008-3#2)
a spherical varied-line-space grating##2##4##(2008-3#2)
a spherical##40##2##(1990-8#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#22)(2008-7#2)(2009-4#1)(2009-7#2)(2010-11#1)(2012-2#1)(2013-1#1)
a spider##3##2##(2008-9#1)(2011-2#2)
a spike##7##2##(1997-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)
a spiked##5##2##(1996-5#1)(2008-10#3)(2008-9#1)
a spiking##2##2##(2008-10#1)(2008-11#1)
a spin coating##2##3##(2008-10#2)
a spin filter##2##3##(2008-10#1)(2008-11#1)
a spin##9##2##(1990-12#2)(2008-10#4)(2008-11#1)(2008-7#1)(2012-2#1)
a spinal cord compression##2##4##(2007-11#1)(2008-6#1)
a spinal cord##3##3##(2007-11#1)(2008-6#1)(2009-12#1)
a spinal epidural##2##3##(2008-7#2)
a spinal subdural haematoma##3##4##(2008-7#3)
a spinal##18##2##(1994-2#1)(1994-7#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#7)(2009-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
a spindle cell##2##3##(2008-10#1)(2010-12#1)
a spindle##3##2##(2008-10#1)(2008-2#1)(2010-12#1)
a spinfilter##2##2##(2008-11#2)
a spinner flask##3##3##(2008-11#3)
a spinner##4##2##(2008-11#4)
a spiral##6##2##(2008-10#2)(2009-1#1)(2011-2#2)(2012-2#1)
a spirit##2##2##(1996-1#1)(2012-3#1)
a spiritual##3##2##(1997-2#1)(2009-7#1)(2011-1#1)
a spirometer##2##2##(2009-11#1)(2012-3#1)
a spiroplasma##2##2##(2008-10#2)
a splenic##3##2##(2007-5#1)(2011-2#2)
a splice##2##2##(1995-12#1)(2010-4#1)
a splicing##3##2##(1991-9#1)(1993-12#1)(1995-6#1)
a split##5##2##(1993-2#1)(2008-12#2)(2008-2#1)(2008-3#1)
a split-mouth design##3##3##(2012-12#1)(2013-1#2)
a split-mouth##4##2##(2012-12#1)(2013-1#3)
a sponsorship to##2##3##(2008-12#2)
a spontaneous reduction##2##3##(2008-5#1)(2008-8#1)
a spontaneous regression##2##3##(1991-12#1)(2007-8#1)
a spontaneous##19##2##(1991-12#1)(1991-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2010-11#1)(2011-2#2)
a sporadic##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
a spore suspension of##2##4##(2008-10#2)
a spore suspension##5##3##(2008-10#5)
a spore##9##2##(2008-10#7)(2008-8#2)
a sport-related concussion##2##3##(2010-1#2)
a spot##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
a spouse##5##2##(1990-2#1)(1994-2#1)(1995-2#1)(1996-11#1)(2012-12#1)
a spray##5##2##(1992-2#1)(2008-10#3)(2008-5#1)
a spread in##2##3##(1991-8#1)(2007-11#1)
a spreading panicle##2##3##(2009-10#2)
a spreading##6##2##(1990-12#1)(2008-2#1)(2008-5#1)(2009-10#2)(2011-2#1)
a spreadsheet##2##2##(1993-1#1)(2008-11#1)
a spur to##2##3##(1992-2#1)(2013-1#1)
a squamous cell carcinoma##3##4##(1991-8#1)(2008-9#1)(2010-5#1)
a square array##3##3##(1994-11#2)(2008-3#1)
a square grid in##2##4##(2008-2#1)(2008-3#1)
a square grid##3##3##(2008-2#2)(2008-3#1)
a square wave##5##3##(2007-12#2)(2008-10#2)(2011-2#1)
a square##17##2##(1994-11#2)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2011-2#2)
a square-wave (SW) potential-time##2##4##(2008-10#2)
a square-wave##7##2##(2007-12#1)(2008-10#5)(2008-3#1)
a stability##4##2##(2008-10#4)
a stabilized##4##2##(2008-3#2)(2010-5#2)
a stabilizing##4##2##(1992-6#1)(1993-8#1)(2008-9#2)
a stable and##5##3##(1994-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
a stable cell##2##3##(2008-2#1)(2008-8#1)
a stable complex##3##3##(1994-8#1)(2008-10#2)
a stable depilatory cream##2##4##(2008-5#2)
a stable environment##4##3##(1997-7#1)(2008-4#2)(2011-2#1)
a stable equilibrium where##2##4##(2008-8#2)
a stable equilibrium##4##3##(2008-8#3)(2008-9#1)
a stable nitroxide radical##2##4##(1996-5#1)(2008-8#1)
a stable solution##3##3##(2007-11#2)(2008-2#1)
a stable stem cell population##2##5##(2010-7#2)
a stable stem##3##3##(2010-7#2)(2011-2#1)
a stable##125##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-11#3)(1993-8#2)(1993-9#1)(1994-5#2)(1994-8#3)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#6)(2007-12#10)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2010-12#2)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
a stack of##4##3##(2007-12#1)(2008-3#3)
a staff##2##2##(1992-3#1)(2008-11#1)
a stage of##4##3##(1994-12#1)(2008-9#1)(2009-10#1)(2013-1#1)
a stage##10##2##(1994-12#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-1#1)(2013-1#1)
a stage-specific##3##2##(1995-12#1)(2009-7#1)(2012-2#1)
a staged##5##2##(1993-12#1)(2009-4#2)(2010-11#1)(2013-1#1)
a staggered##2##2##(1997-7#1)(2009-12#1)
a staggering##2##2##(2008-2#1)(2008-5#1)
a staging##3##2##(1994-12#1)(2008-1#1)(2008-3#1)
a stagnant##2##2##(2008-10#1)(2008-5#1)
a stainless steel##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
a stainless-steel##4##2##(1992-8#1)(2008-2#1)(2008-3#1)(2008-6#1)
a staminate##2##2##(2012-3#2)
a stand-alone##5##2##(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)
a standard VAS##2##3##(2009-3#2)
a standard and a##2##4##(1995-5#1)(2008-5#1)
a standard and##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
a standard approach in##2##4##(2007-8#1)(2008-10#1)
a standard approach##4##3##(1994-1#1)(2007-8#1)(2008-10#1)(2013-1#1)
a standard compound##2##3##(2008-10#2)
a standard curve##3##3##(1996-12#1)(2008-1#1)(2008-10#1)
a standard deviation##9##3##(2008-10#3)(2008-2#1)(2008-3#2)(2009-2#1)(2011-2#1)(2013-1#1)
a standard dose of##3##4##(1990-6#1)(2007-11#1)(2008-7#1)
a standard error of##4##4##(2008-10#3)(2008-2#1)
a standard for##3##3##(2008-7#1)(2010-8#2)
a standard form##2##3##(2007-2#1)(2008-5#1)
a standard market##2##3##(2008-5#2)
a standard method##5##3##(2008-10#3)(2012-2#1)(2013-8#1)
a standard of##3##3##(1995-3#1)(2009-8#1)(2012-3#1)
a standard optical##2##3##(2007-12#1)(2008-3#1)
a standard peritoneal permeability analysis##2##5##(2011-2#2)
a standard procedure in##2##4##(2007-11#2)
a standard procedure##5##3##(2007-11#4)(2008-12#1)
a standard protocol##3##3##(1996-12#1)(2008-10#1)(2012-2#1)
a standard questionnaire##2##3##(2008-7#1)(2009-5#1)
a standard reference material and##2##5##(2008-10#2)
a standard reference material##6##4##(2008-10#6)
a standard reference##10##3##(2008-10#10)
a standard set of##2##4##(2008-10#1)(2012-2#1)
a standard solution of##2##4##(2008-10#2)
a standard solution##6##3##(2008-10#6)
a standard stirred##2##3##(2008-11#2)
a standard tool for##2##4##(2008-9#1)(2012-12#1)
a standard tool##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
a standard treatment##2##3##(2008-11#1)(2008-3#1)
a standard##245##2##(1990-12#1)(1990-6#1)(1990-7#2)(1991-12#6)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#12)(2007-12#5)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#68)(2008-11#11)(2008-12#1)(2008-2#14)(2008-3#20)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-11#2)(2009-2#1)(2009-3#5)(2009-5#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#1)
a standardised questionnaire for the##2##5##(1993-2#2)
a standardised##9##2##(1993-2#2)(2008-10#1)(2008-11#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
a standardized procedure##2##3##(2008-12#1)(2012-3#1)
a standardized protocol for##2##4##(1990-12#1)(2008-11#1)
a standardized questionnaire##7##3##(1993-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#2)
a standardized##44##2##(1990-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-11#1)(1997-5#1)(2007-6#1)(2008-10#7)(2008-11#3)(2008-12#4)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
a standing##8##2##(2007-11#1)(2007-12#3)(2007-5#1)(2008-12#1)(2008-2#1)(2013-1#1)
a stapled##2##2##(2013-1#2)
a star##2##2##(2007-11#1)(2008-3#1)
a starting point for positional##2##5##(2008-10#2)
a starting point for the##4##5##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
a starting point for##12##4##(1994-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
a starting point##17##3##(1994-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
a starting##23##2##(1993-8#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
a state health agency##2##4##(1997-1#1)(1997-2#1)
a state mental##2##3##(1993-1#1)(1996-9#1)
a state of##14##3##(1994-2#1)(1995-3#2)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
a state##38##2##(1990-11#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a state-of-the-art##6##2##(1992-2#1)(1996-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
a statement of the##2##4##(2007-9#2)
a statement of##4##3##(1995-12#1)(1996-4#1)(2007-9#2)
a statement##8##2##(1995-12#1)(1996-3#1)(1996-4#2)(2007-9#2)(2008-12#1)(2011-1#1)
a statewide survey of##2##4##(1994-12#1)(1997-4#1)
a statewide survey##3##3##(1994-12#1)(1997-1#1)(1997-4#1)
a statewide##11##2##(1994-12#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-3#2)(1997-1#1)(1997-4#1)(2008-6#1)(2008-9#1)
a static magnetic field##2##4##(2007-12#2)
a static mercury drop electrode##3##5##(2008-10#3)
a static##18##2##(2007-11#1)(2007-12#4)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)
a statin##2##2##(2009-4#1)(2012-3#1)
a stationary phase at##2##4##(2008-10#1)(2008-11#1)
a stationary phase for affinity chromatography##2##6##(1991-5#2)
a stationary phase of##2##4##(1997-4#1)(2008-10#1)
a stationary phase##10##3##(1990-8#2)(1991-5#2)(1997-4#1)(2008-10#4)(2008-11#1)
a stationary##21##2##(1990-8#2)(1991-5#2)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-2#2)
a statistic##3##2##(1992-9#1)(1996-3#1)(2013-8#1)
a statistical analysis of the##5##5##(1990-3#1)(1997-7#1)(2008-10#2)(2008-3#1)
a statistical analysis of##8##4##(1990-3#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-12#1)
a statistical method##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
a statistical methodology##2##3##(2008-10#1)(2008-12#1)
a statistical model##4##3##(2008-10#1)(2008-11#1)(2009-11#1)(2010-1#1)
a statistical point of view##2##5##(2007-11#1)(2009-11#1)
a statistical significance##4##3##(1990-12#2)(1994-9#1)(2013-8#1)
a statistical study##2##3##(2008-1#1)(2008-6#1)
a statistical##56##2##(1990-12#2)(1990-3#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#4)(2008-9#2)(2009-11#2)(2010-1#1)(2010-3#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#2)
a statistically better##2##3##(2007-7#1)(2008-3#1)
a statistically significant (p##2##4##(1993-9#1)(1995-12#1)
a statistically significant correlation##3##4##(2007-8#1)(2010-8#1)(2013-1#1)
a statistically significant decrease in##3##5##(1991-2#1)(1996-3#1)(2012-2#1)
a statistically significant decrease##4##4##(1991-2#1)(1993-10#1)(1996-3#1)(2012-2#1)
a statistically significant difference between the two##3##7##(2008-12#2)(2009-8#1)
a statistically significant difference between the##5##6##(2007-6#1)(2008-12#2)(2009-8#1)(2011-2#1)
a statistically significant difference between##7##5##(2007-12#1)(2007-6#1)(2008-12#2)(2009-8#1)(2010-12#1)(2011-2#1)
a statistically significant difference##10##4##(2007-12#1)(2007-6#1)(2008-12#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
a statistically significant effect##5##4##(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
a statistically significant improvement##3##4##(2007-8#1)(2008-12#1)(2013-1#1)
a statistically significant increase in the##2##6##(2007-8#1)(2009-8#1)
a statistically significant increase in##6##5##(1992-11#1)(1992-3#1)(1994-3#1)(2007-8#1)(2009-8#2)
a statistically significant increase##8##4##(1992-11#1)(1992-3#1)(1994-3#1)(2007-8#1)(2008-7#1)(2009-8#2)(2013-1#1)
a statistically significant negative correlation##2##5##(2011-2#1)(2013-1#1)
a statistically significant reduction in the##2##6##(1992-9#1)(2007-8#1)
a statistically significant reduction in##3##5##(1992-9#1)(2007-8#2)
a statistically significant reduction##5##4##(1992-9#1)(1996-1#1)(2007-8#2)(2013-1#1)
a statistically significant relationship##2##4##(2009-5#1)(2010-9#1)
a statistically significant##57##3##(1991-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-3#1)(2007-12#1)(2007-6#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#5)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
a statistically##70##2##(1991-2#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-5#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#5)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#1)
a status report##2##3##(1996-12#1)(2009-4#1)
a statute##2##2##(1992-3#1)(1994-3#1)
a statutory##2##2##(1991-7#1)(2013-8#1)
a stay##3##2##(1990-8#1)(1992-12#1)(1997-6#1)
a steadily##2##2##(1996-2#1)(2008-1#1)
a steady increase in##3##4##(2008-12#1)(2009-7#1)(2013-8#1)
a steady increase##4##3##(1997-3#1)(2008-12#1)(2009-7#1)(2013-8#1)
a steady potential##2##3##(2008-10#2)
a steady state##5##3##(1993-12#1)(2008-10#2)(2008-7#1)(2010-11#1)
a steady##28##2##(1990-7#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a steady-state Raman gain##2##4##(2007-12#2)
a steady-state level of##2##4##(1995-6#1)(2008-4#1)
a steady-state##16##2##(1991-7#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2009-5#1)(2012-1#1)
a steam generator tube rupture##2##5##(2009-10#2)
a steam##4##2##(2008-10#2)(2009-10#2)
a steep dispersal gradient##2##4##(2008-10#2)
a steep##8##2##(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#2)
a steeply##2##2##(2008-2#1)(2011-1#1)
a stellar interferometer##3##3##(2007-11#2)(2008-3#1)
a stem cell##2##3##(2008-10#1)(2012-12#1)
a stem##8##2##(2007-11#1)(2008-10#2)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a stem-loop structure##2##3##(1997-6#1)(2008-10#1)
a stem-loop##3##2##(1997-6#1)(2008-10#2)
a step forward in##2##4##(2008-7#1)(2010-11#1)
a step further##3##3##(1994-2#1)(2008-7#1)(2008-9#1)
a step in the##2##4##(1997-5#1)(2008-3#1)
a step in##4##3##(1997-5#1)(2008-3#2)(2008-9#1)
a step toward##6##3##(1991-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-12#2)
a step towards##5##3##(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2012-2#1)
a step##38##2##(1991-12#2)(1991-3#1)(1992-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#7)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
a step-by-step guide to##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
a step-by-step method##2##3##(2008-11#2)
a step-by-step process##3##3##(1992-1#1)(1994-2#1)(1997-1#1)
a step-by-step##14##2##(1992-1#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
a step-index##3##2##(2007-12#2)(2008-3#1)
a step-scan##2##2##(2008-2#2)
a stepwise procedure##2##3##(1996-5#1)(2012-12#1)
a stepwise##11##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)
a stereo##2##2##(2008-11#1)(2008-3#1)
a stereochemical##2##2##(1990-7#2)
a stereotactic##2##2##(2006-10#1)(2008-7#1)
a stereotyped##4##2##(1993-12#1)(1995-12#1)(2007-12#1)(2008-5#1)
a sterile##6##2##(1994-12#2)(2008-10#1)(2008-12#1)(2012-2#2)
a sternotomy##4##2##(2007-8#3)(2008-11#1)
a steroid##2##2##(1996-11#1)(1997-1#1)
a steroidal##2##2##(1992-8#1)(1997-1#1)
a stick##2##2##(1992-12#1)(2008-5#1)
a sticky##2##2##(2008-10#1)(2008-5#1)
a stiff##2##2##(1997-5#1)(2008-5#1)
a still##6##2##(1992-3#1)(2007-8#1)(2008-10#3)(2008-12#1)
a stimulated##3##2##(1990-5#1)(2008-1#1)(2008-2#1)
a stimulating##3##2##(2008-11#1)(2008-4#1)(2010-7#1)
a stimulation index##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
a stimulation of the##2##4##(1994-5#1)(2008-7#1)
a stimulation of##7##3##(1992-3#1)(1994-5#1)(1995-3#1)(2008-11#1)(2008-5#2)(2008-7#1)
a stimulation##13##2##(1992-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-4#1)
a stimulator of##2##3##(1990-11#1)(1997-1#1)
a stimulatory effect on##3##4##(1993-12#1)(1994-2#1)(2008-5#1)
a stimulatory effect##4##3##(1993-12#1)(1994-2#1)(2008-5#1)(2010-11#1)
a stimulatory##6##2##(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(2008-5#1)(2010-11#1)
a stimuli-responsive##2##2##(1995-11#1)(2010-4#1)
a stimulus for##3##3##(1993-1#1)(2008-3#1)(2008-8#1)
a stimulus##10##2##(1993-1#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
a stirred tank reactor##2##4##(2008-7#2)
a stirred tank##6##3##(2008-11#3)(2008-7#3)
a stirred##9##2##(2008-10#1)(2008-11#4)(2008-7#4)
a stochastic approach##2##3##(2008-3#1)(2011-2#1)
a stochastic model##2##3##(2008-10#1)(2008-9#1)
a stochastic simulation##2##3##(1997-3#1)(2010-7#1)
a stochastic##20##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)
a stoichiometric##5##2##(1993-9#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-7#1)
a stomach##3##2##(2008-10#2)(2012-3#1)
a stop codon##5##3##(1990-5#1)(1994-8#1)(1995-2#2)(2008-4#1)
a stop##8##2##(1990-5#1)(1990-8#1)(1994-8#1)(1995-2#2)(1996-11#1)(2008-10#1)(2008-4#1)
a stopped##3##2##(1996-8#1)(2008-10#1)(2012-1#1)
a storage capacity##2##3##(2008-3#2)
a storage medium##2##3##(2008-3#1)(2013-1#1)
a storage##9##2##(2007-12#1)(2008-10#2)(2008-3#5)(2013-1#1)
a store##2##2##(1996-5#1)(2008-9#1)
a storing and##2##3##(1994-3#2)
a story##4##2##(1992-3#1)(2008-4#1)(2008-8#1)(2013-8#1)
a straight line##5##3##(1991-5#1)(2008-10#3)(2008-3#1)
a straight optical fiber##3##4##(2007-12#2)(2008-2#1)
a straight##16##2##(1991-5#1)(1993-12#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#2)(2013-1#1)
a straightforward application of##2##4##(2008-2#1)(2012-3#1)
a straightforward application##3##3##(2008-2#1)(2012-3#1)(2013-7#1)
a straightforward method##3##3##(1997-8#1)(2008-2#1)(2008-4#1)
a straightforward##24##2##(1994-11#1)(1996-12#1)(1997-8#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
a strain deleted for##2##4##(1991-7#1)(1997-3#1)
a strain in which##2##4##(1990-5#1)(1993-9#1)
a strain of Pseudomonas##2##4##(2008-6#1)(2012-2#1)
a strain of##18##3##(1993-12#2)(2007-10#1)(2008-10#5)(2008-12#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
a strain resolution of##2##4##(2007-12#2)
a strain that produces##2##4##(2008-10#1)(2008-6#1)
a strain##39##2##(1990-5#1)(1991-7#1)(1992-10#1)(1993-12#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#3)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
a strain-based##2##2##(2013-1#2)
a strain-specific##2##2##(2008-10#2)
a strand-specific##2##2##(1994-8#1)(2008-10#1)
a strategic plan are##2##4##(1992-3#1)(1993-3#1)
a strategic plan for the##2##5##(1994-2#1)(1995-2#1)
a strategic plan##5##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-2#1)(2011-1#1)
a strategic planning##2##3##(1991-2#1)(1992-2#1)
a strategic weapon##3##3##(1995-2#1)(1996-2#2)
a strategic##25##2##(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#2)(2013-1#1)
a strategy for the##2##4##(2008-10#1)(2008-7#1)
a strategy for##27##3##(1994-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#3)(2013-8#1)
a strategy is##2##3##(2008-10#1)(2012-12#1)
a strategy of##3##3##(1994-2#1)(2008-8#1)(2012-2#1)
a strategy that will##3##4##(1994-3#2)(2012-12#1)
a strategy that##4##3##(1993-2#1)(1994-3#2)(2012-12#1)
a strategy to prevent the##2##5##(2008-1#2)
a strategy to prevent##3##4##(2008-1#2)(2013-8#1)
a strategy to reduce##2##4##(2007-8#1)(2009-4#1)
a strategy to##19##3##(1993-1#1)(1996-12#1)(1997-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
a strategy##70##2##(1993-1#1)(1993-2#1)(1994-2#2)(1994-3#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#2)
a stratified random sample##2##4##(1996-8#1)(1997-3#1)
a stratified random##3##3##(1996-8#1)(1997-3#1)(2008-2#1)
a stratified##12##2##(1993-3#1)(1995-9#1)(1996-8#1)(1997-3#1)(2008-11#1)(2008-2#4)(2008-3#2)(2010-3#1)
a stratospheric##3##2##(2008-2#1)(2008-3#2)
a streak camera and a grating monochromator##2##7##(2008-2#2)
a streak camera and##3##4##(2008-2#3)
a streak camera##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
a stream of##13##3##(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)
a stream##14##2##(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)
a streamlined##2##2##(1997-3#1)(2008-3#1)
a streptavidin##2##2##(2008-10#1)(2008-4#1)
a stress riser##2##3##(2008-9#1)(2009-3#1)
a stress##9##2##(1990-8#1)(1991-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-3#1)(2013-1#1)
a stress-inducible##2##2##(1997-7#1)(2009-6#1)
a stress-related##2##2##(2008-10#2)
a stressed##3##2##(2008-2#2)(2008-7#1)
a stressful##2##2##(2008-5#1)(2011-1#1)
a stretch of##3##3##(1993-6#1)(1996-3#1)(1997-3#1)
a stretched##2##2##(2008-3#1)(2009-3#1)
a strict##15##2##(1990-7#1)(1991-1#1)(1991-5#1)(1992-9#1)(1996-6#1)(1997-6#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#2)
a strictly clonal##2##3##(2008-10#2)
a strictly##11##2##(1993-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
a stricture##2##2##(2013-1#1)(2013-7#1)
a striking difference##2##3##(2008-10#1)(2008-11#1)
a striking increase in##2##4##(1992-8#1)(2008-10#1)
a striking similarity to##2##4##(1993-3#1)(1996-6#1)
a striking similarity##3##3##(1993-3#1)(1996-6#1)(2007-12#1)
a striking##18##2##(1990-11#1)(1991-5#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2012-2#1)
a stringent##2##2##(2008-7#1)(2012-3#1)
a strip##2##2##(2008-2#1)(2008-3#1)
a strip-loaded##2##2##(2007-12#1)(2008-3#1)
a stroke##21##2##(1992-2#1)(1995-5#1)(1996-11#1)(2007-10#6)(2007-9#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)(2013-1#1)
a strokectomy##2##2##(2012-3#2)
a strong acid##5##3##(1990-6#1)(2008-10#4)
a strong activator of##2##4##(1992-9#1)(2012-12#1)
a strong and##4##3##(1994-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
a strong antibody response##2##4##(1995-12#1)(2009-6#1)
a strong association between##7##4##(1990-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
a strong association with##5##4##(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
a strong association##13##3##(1990-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#2)(2011-2#2)(2012-2#1)(2013-8#1)
a strong band at##2##4##(2008-2#1)(2013-8#1)
a strong base##2##3##(2008-10#2)
a strong bias##3##3##(1995-5#1)(1996-2#1)(2008-7#1)
a strong block##2##3##(1994-8#1)(2008-8#1)
a strong candidate##2##3##(2008-10#1)(2013-7#1)
a strong correlation (r = 0##2##6##(2008-10#1)(2008-11#1)
a strong correlation between the##3##5##(1991-6#1)(1997-3#1)(2008-3#1)
a strong correlation between##10##4##(1991-6#1)(1994-6#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-3#2)(2009-10#1)(2011-2#1)
a strong correlation with the##3##5##(2008-10#1)(2008-3#1)(2008-9#1)
a strong correlation with##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
a strong correlation##21##3##(1991-6#1)(1994-6#1)(1994-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
a strong dependence of##3##4##(2007-11#1)(2008-2#1)(2012-2#1)
a strong dependence on the##3##5##(2007-11#1)(2008-10#1)(2008-7#1)
a strong dependence##8##3##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
a strong desire to##2##4##(2010-5#1)(2011-1#1)
a strong effect on the##2##5##(2008-10#1)(2010-10#1)
a strong effect on##6##4##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)
a strong effect##8##3##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-10#1)(2013-8#1)
a strong emphasis on the##3##5##(1993-12#1)(2008-2#1)(2008-7#1)
a strong emphasis##4##3##(1993-12#1)(2008-2#1)(2008-7#1)(2013-8#1)
a strong fluorescence##2##3##(2008-10#2)
a strong function of the##2##5##(2007-12#1)(2008-3#1)
a strong function of##3##4##(2007-12#2)(2008-3#1)
a strong homology with##2##4##(1996-6#1)(1997-4#1)
a strong impact on##2##4##(2010-8#1)(2012-3#1)
a strong increase in##3##4##(1991-9#1)(2008-10#1)(2008-7#1)
a strong increase##4##3##(1991-9#1)(2008-10#1)(2008-7#1)(2009-12#1)
a strong indication that##2##4##(2008-10#1)(2008-12#1)
a strong inflammatory##2##3##(2008-10#1)(2009-11#1)
a strong influence of##2##4##(1990-2#1)(2009-7#1)
a strong influence on the##3##5##(2008-10#2)(2012-8#1)
a strong influence on##6##4##(2008-10#3)(2008-9#1)(2011-2#1)(2012-8#1)
a strong influence##9##3##(1990-2#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-8#1)
a strong inhibition##2##3##(2008-8#1)(2009-10#1)
a strong inhibitor of##2##4##(1993-3#1)(2008-8#1)
a strong inhibitory effect##2##4##(1994-11#1)(2008-10#1)
a strong interaction##2##3##(2008-10#1)(2008-11#1)
a strong inverse##2##3##(2008-11#1)(2008-3#1)
a strong linear correlation##2##4##(1991-6#1)(2008-10#1)
a strong linkage##2##3##(1997-8#1)(2008-12#1)
a strong negative effect on##2##5##(1994-3#1)(2009-8#1)
a strong negative##5##3##(1994-12#1)(1994-3#1)(1997-7#1)(2009-8#1)(2010-6#1)
a strong positive correlation##2##4##(2008-11#1)(2010-8#1)
a strong positive##5##3##(1994-3#1)(1994-9#1)(2008-11#1)(2008-8#1)(2010-8#1)
a strong predictor of##4##4##(2007-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
a strong preference##2##3##(1990-11#1)(1994-12#1)
a strong rationale for##3##4##(2008-5#1)(2009-4#1)(2013-1#1)
a strong reduction##2##3##(2007-11#1)(2010-11#1)
a strong relationship with##2##4##(2008-10#1)(2012-3#1)
a strong relationship##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
a strong similarity##3##3##(1994-8#1)(1997-4#1)(2008-2#1)
a strong tendency to##3##4##(2008-4#1)(2012-1#1)(2013-1#1)
a strong##304##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1997-1#1)(1997-3#2)(1997-4#5)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#61)(2008-11#12)(2008-12#7)(2008-2#6)(2008-3#20)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#9)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-11#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#6)
a stronger effect on##2##4##(2008-4#1)(2008-8#1)
a stronger positive##2##3##(2009-7#1)(2010-10#1)
a stronger preference for feminine characteristics##2##6##(2012-3#2)
a stronger relation##2##3##(2010-2#1)(2010-4#1)
a stronger##27##2##(1991-12#1)(1992-12#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#2)(2012-2#2)(2012-3#2)(2013-1#1)
a strongly absorbing##3##3##(2007-12#1)(2008-3#2)
a strongly acidic##2##3##(2008-10#2)
a strongly decreased##2##3##(1995-8#1)(2008-4#1)
a strongly supported##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
a strongly targeted agent##2##4##(2013-8#2)
a strongly##29##2##(1992-3#1)(1993-11#1)(1995-8#1)(1996-1#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#4)(2013-8#2)
a structural analysis##2##3##(2007-12#1)(2012-2#1)
a structural change##3##3##(1997-1#1)(1997-6#2)
a structural component of##2##4##(1992-3#1)(2008-10#1)
a structural model for the##2##5##(1993-11#1)(1994-5#1)
a structural model for##3##4##(1993-11#1)(1994-5#1)(2010-2#1)
a structural model##4##3##(1993-11#1)(1994-5#1)(2008-4#1)(2010-2#1)
a structural rationale for##2##4##(1993-8#2)
a structural##43##2##(1992-3#2)(1993-11#3)(1993-8#2)(1994-5#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#4)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#3)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
a structurally##10##2##(1991-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a structure consisting of a##2##5##(2007-12#1)(2008-3#1)
a structure consisting of##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
a structure for##4##3##(1996-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
a structure in which##2##4##(1995-6#1)(1996-2#1)
a structure in##3##3##(1995-6#1)(1996-2#1)(2009-7#1)
a structure similar to that of##2##6##(2008-5#1)(2008-6#1)
a structure similar to##3##4##(1990-11#1)(2008-5#1)(2008-6#1)
a structure that##3##3##(2007-12#1)(2009-10#1)(2013-1#1)
a structure with##4##3##(1990-3#1)(1991-5#1)(1996-2#1)(2011-2#1)
a structure##37##2##(1990-11#1)(1990-3#1)(1991-5#2)(1993-8#1)(1994-12#1)(1995-6#2)(1996-2#3)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
a structured interview##5##3##(1993-6#1)(2006-10#1)(2007-11#1)(2010-8#1)(2011-2#1)
a structured questionnaire and##2##4##(2010-3#1)(2012-12#1)
a structured questionnaire##8##3##(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
a structured##39##2##(1993-6#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-8#12)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a student response system##2##4##(2010-3#2)
a student##16##2##(1990-8#1)(1992-6#1)(1995-3#3)(2008-11#1)(2008-12#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#3)(2010-9#1)(2012-12#1)
a student's##3##2##(2008-11#2)(2009-6#1)
a study aiming##2##3##(2008-2#1)(2011-1#1)
a study by##2##3##(2008-10#2)
a study carried out##4##4##(1993-3#1)(2007-11#1)(2008-5#2)
a study comparing##2##3##(1992-3#1)(1994-3#1)
a study conducted in##2##4##(1995-11#1)(2009-10#1)
a study conducted##5##3##(1990-4#1)(1995-11#1)(2008-2#1)(2009-10#1)(2009-5#1)
a study designed to##2##4##(1996-12#1)(2007-12#1)
a study from##2##3##(2008-3#1)(2013-1#1)
a study in which##2##4##(1997-4#1)(2008-7#1)
a study in##11##3##(1995-12#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
a study is##2##3##(2007-7#1)(2008-10#1)
a study of its##2##4##(1992-3#1)(2008-10#1)
a study of the##28##4##(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-3#1)(1995-1#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-12#1)
a study of##94##3##(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-3#2)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
a study on the##7##4##(1994-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-3#1)
a study on##19##3##(1993-12#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
a study sample##2##3##(1997-5#1)(2008-7#1)
a study that##9##3##(1994-3#1)(1996-12#1)(1996-3#2)(2008-11#1)(2008-2#1)(2009-11#1)(2009-5#1)(2011-2#1)
a study to determine##4##4##(1993-12#1)(2008-10#1)(2008-2#1)(2010-3#1)
a study to##8##3##(1993-12#1)(1994-11#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-3#1)(2011-1#1)
a study using##2##3##(1990-11#1)(2008-5#1)
a study was conducted to investigate##2##6##(1991-3#1)(2008-10#1)
a study was conducted##3##4##(1991-3#1)(2008-10#1)(2012-2#1)
a study was made##2##4##(1990-2#1)(2008-3#1)
a study was##8##3##(1990-2#1)(1991-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
a study which was##2##4##(1991-5#1)(1996-1#1)
a study which##4##3##(1991-5#1)(1996-1#1)(1997-3#1)(2008-11#1)
a study with##5##3##(1996-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-7#1)
a study##216##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#4)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#5)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#26)(2008-11#11)(2008-12#4)(2008-2#7)(2008-3#4)(2008-5#10)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#6)(2013-8#1)
a style##2##2##(2010-11#1)(2013-1#1)
a sub##3##2##(2007-8#1)(2012-12#1)(2013-1#1)
a sub-Nernstian##2##2##(2008-10#2)
a sub-population of##2##3##(1992-8#1)(1993-8#1)
a sub-regional##2##2##(2008-11#2)
a sub-sample of##6##3##(2008-10#2)(2008-12#1)(2010-8#1)(2013-1#2)
a sub-sample was collected in##2##5##(2008-10#2)
a sub-sample was##3##3##(2008-10#3)
a sub-sample##9##2##(2008-10#5)(2008-12#1)(2010-8#1)(2013-1#2)
a subacute##4##2##(1993-6#1)(1996-9#1)(2008-12#2)
a subarachnoid##4##2##(1996-9#1)(2008-7#1)(2012-3#1)(2013-8#1)
a subcellular##2##2##(1995-2#1)(2008-4#1)
a subchorionic hemorrhage##2##3##(2009-6#2)
a subcortical##2##2##(1996-3#1)(2008-7#1)
a subcutaneous injection of##2##4##(1994-2#1)(2012-2#1)
a subcutaneous##15##2##(1991-1#1)(1991-3#1)(1994-2#1)(1995-12#2)(1995-5#1)(1997-4#1)(2007-7#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
a subdivision##2##2##(2008-10#1)(2008-6#1)
a subgenomic##2##2##(1994-8#1)(2008-10#1)
a subgroup of patients##4##4##(1992-9#1)(1993-1#1)(2008-6#2)
a subgroup of the##3##4##(1993-11#1)(1997-5#1)(1997-7#1)
a subgroup of##14##3##(1991-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1996-7#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-6#2)(2009-9#1)(2011-2#1)
a subgroup within the##2##4##(2008-10#2)
a subgroup##20##2##(1991-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1996-7#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-6#2)(2009-9#1)(2011-2#1)
a subject of discussion##2##4##(2008-10#1)(2010-11#1)
a subject of##11##3##(1990-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-5#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-1#1)
a subject with##3##3##(1992-9#1)(1995-8#2)
a subject##28##2##(1990-6#1)(1991-1#1)(1991-3#1)(1992-9#1)(1995-6#1)(1995-8#2)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a subject's##2##2##(2008-4#2)
a subjective##11##2##(1991-11#1)(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
a submaximal##3##2##(1993-12#1)(1994-11#1)(1995-8#1)
a submerged##6##2##(1994-3#1)(2007-12#1)(2008-3#3)(2008-7#1)
a submicrometer##2##2##(2008-3#2)
a submicroscopic deletion of 22q11##2##5##(1997-3#2)
a submicroscopic deletion##3##3##(1997-3#2)(2012-12#1)
a submicroscopic##4##2##(1997-3#2)(2008-3#1)(2012-12#1)
a submucosal##2##2##(1993-9#1)(2012-12#1)
a subnanometer##2##2##(2007-12#1)(2008-3#1)
a suboptimal##3##2##(1991-6#1)(2008-5#1)(2009-8#1)
a subordinate##2##2##(2008-6#1)(2008-8#1)
a subpopulation of patients##2##4##(2010-5#1)(2012-3#1)
a subpopulation of##13##3##(1992-3#1)(1992-9#1)(1995-12#1)(2008-11#2)(2008-7#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
a subpopulation##14##2##(1992-3#1)(1992-9#1)(1995-12#1)(2008-11#3)(2008-7#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
a subsample of##4##3##(2008-10#2)(2008-4#1)(2012-3#1)
a subsecond##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a subsensitivity##2##2##(1992-11#1)(1995-11#1)
a subsequent decrease in the##2##5##(1995-12#1)(2009-6#1)
a subsequent decrease##3##3##(1991-9#1)(1995-12#1)(2009-6#1)
a subsequent##40##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(2007-11#2)(2007-12#1)(2008-10#9)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-1#2)
a subset of AG-2##2##4##(2008-10#2)
a subset of cases##2##4##(2008-4#1)(2010-3#1)
a subset of patients with##2##5##(2007-10#1)(2008-7#1)
a subset of patients##5##4##(1997-8#1)(2007-10#2)(2008-7#1)(2008-9#1)
a subset of the##14##4##(1996-7#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
a subset of this##2##4##(2007-12#1)(2008-9#1)
a subset of##69##3##(1990-8#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-8#2)(1996-7#1)(1997-1#1)(1997-4#2)(1997-8#2)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#15)(2008-11#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)
a subset##74##2##(1990-8#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-3#2)(1995-2#2)(1995-8#2)(1996-7#1)(1997-1#1)(1997-4#2)(1997-8#2)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#16)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)
a subsidiary of##3##3##(1990-2#1)(1997-1#1)(2008-5#1)
a subsidy##2##2##(2008-7#2)
a substance abuse##2##3##(2008-6#2)
a substance that##2##3##(1991-9#1)(2008-11#1)
a substance##9##2##(1990-2#1)(1991-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-9#1)
a substantial amount of##3##4##(1995-1#1)(1997-3#1)(2008-8#1)
a substantial burden of##2##4##(2009-5#1)(2010-1#1)
a substantial challenge##2##3##(2008-10#1)(2008-12#1)
a substantial effect##2##3##(2008-11#1)(2008-6#1)
a substantial enhancement of the##2##5##(1997-3#1)(2008-10#1)
a substantial impact##2##3##(1995-1#1)(2008-5#1)
a substantial improvement in the##2##5##(2007-12#1)(2008-10#1)
a substantial improvement##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
a substantial increase in the number of##2##7##(1992-2#1)(2008-10#1)
a substantial increase in the##3##5##(1992-2#1)(2008-10#1)(2011-2#1)
a substantial increase in##8##4##(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
a substantial increase of##3##4##(1991-6#1)(2008-10#2)
a substantial increase##11##3##(1991-6#1)(1992-2#1)(1994-12#1)(2008-10#3)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
a substantial number of##4##4##(1992-2#1)(2008-6#1)(2012-12#1)(2013-1#1)
a substantial part of the##2##5##(1990-5#1)(1995-1#1)
a substantial part of##3##4##(1990-5#1)(1995-1#1)(2011-2#1)
a substantial part##4##3##(1990-5#1)(1995-1#1)(2008-11#1)(2011-2#1)
a substantial problem for##3##4##(1991-12#1)(1997-7#1)(2008-7#1)
a substantial problem##4##3##(1991-12#1)(1997-7#1)(2008-7#1)(2011-1#1)
a substantial proportion of##4##4##(1991-9#1)(2010-1#1)(2010-12#1)(2013-1#1)
a substantial proportion##5##3##(1991-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
a substantial reduction in##3##4##(1991-12#1)(2007-9#1)(2008-10#1)
a substantial reduction##4##3##(1991-12#1)(1991-8#1)(2007-9#1)(2008-10#1)
a substantial risk##2##3##(2008-4#1)(2013-1#1)
a substantial role in##4##4##(1990-2#1)(2007-10#1)(2008-9#1)(2010-3#1)
a substantial##91##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#3)(1996-12#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#1)
a substantially##7##2##(1991-2#1)(1992-2#1)(1994-9#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-7#1)
a substantive theory##2##3##(2007-10#1)(2013-1#1)
a substantive##3##2##(1996-1#1)(2007-10#1)(2013-1#1)
a substitute for##12##3##(1991-1#1)(1995-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
a substitute##15##2##(1991-1#1)(1995-3#1)(1996-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
a substituted##2##2##(1993-8#1)(2009-9#1)
a substitution of a##2##4##(1993-8#1)(2011-2#1)
a substitution of leucine##2##4##(1992-8#1)(1994-11#1)
a substitution of##5##3##(1992-8#1)(1993-8#1)(1994-11#2)(2011-2#1)
a substitution##10##2##(1992-8#1)(1993-8#1)(1994-11#2)(1996-2#1)(1996-5#2)(2008-10#1)(2008-7#1)(2011-2#1)
a substrate and##3##3##(1991-5#1)(1992-3#1)(2008-5#1)
a substrate for the enzyme##2##5##(1991-5#1)(1993-3#1)
a substrate for the##6##4##(1991-5#2)(1993-12#1)(1993-3#1)(2008-10#2)
a substrate for##25##3##(1991-5#2)(1991-9#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-9#1)(2013-1#1)
a substrate in##3##3##(1997-8#1)(2009-2#1)(2011-2#1)
a substrate of protein kinase C##2##6##(1990-11#1)(1992-6#1)
a substrate of##3##3##(1990-11#1)(1992-6#1)(2008-11#1)
a substrate to##3##3##(1996-8#1)(2008-10#1)(2008-4#1)
a substrate##74##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-5#4)(1991-9#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
a subtle##6##2##(1995-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)
a subtotal##2##2##(1990-6#1)(2010-12#1)
a subtype of##5##3##(1997-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
a subungual metastasis##2##3##(2008-9#2)
a subungual##4##2##(2008-9#2)(2010-6#2)
a subunit of the##6##4##(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
a subunit of##8##3##(1993-12#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
a subunit vaccine##3##3##(1995-2#1)(2007-11#2)
a subunit##13##2##(1992-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-8#1)
a success##6##2##(1994-9#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
a successful case management program##2##5##(1997-1#2)
a successful case of##2##4##(2007-8#1)(2012-1#1)
a successful case##4##3##(1997-1#2)(2007-8#1)(2012-1#1)
a successful clinical outcome##2##4##(2007-12#1)(2008-9#1)
a successful outcome##5##3##(1991-9#1)(2007-8#1)(2008-12#1)(2012-2#2)
a successful technique##2##3##(2008-10#1)(2008-3#1)
a successful treatment##2##3##(1993-2#1)(2013-1#1)
a successful##80##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-2#3)(1993-3#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#5)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
a successfully treated##2##3##(2007-12#1)(2010-4#1)
a succession of##3##3##(2008-10#2)(2008-8#1)
a succinate##2##2##(2008-10#1)(2008-4#1)
a succinct overview of##2##4##(2008-6#1)(2013-8#1)
a such##2##2##(1994-1#1)(2008-10#1)
a sucrose density gradient##2##4##(1990-8#1)(1995-2#1)
a sucrose solution##2##3##(1996-2#1)(2008-10#1)
a sucrose##7##2##(1990-8#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#2)
a sudden and##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
a sudden decrease##2##3##(1995-3#1)(2008-10#1)
a sudden onset of##2##4##(2007-12#1)(2009-12#1)
a sudden rise in##2##4##(1994-12#1)(2008-4#1)
a sudden##15##2##(1991-12#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
a sufficient amount of##3##4##(1993-2#1)(2008-10#1)(2008-5#1)
a sufficient amount##5##3##(1990-12#1)(1993-2#1)(1997-7#1)(2008-10#1)(2008-5#1)
a sufficient number of##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
a sufficient##30##2##(1990-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1997-7#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#2)(2009-8#1)(2010-3#1)
a sufficiently negative##2##3##(2008-10#2)
a sufficiently##10##2##(1994-8#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-8#1)
a sugar##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
a suggestion of##3##3##(1995-11#1)(1995-9#2)
a suggestion that##2##3##(1995-12#1)(2010-12#1)
a suggestion##8##2##(1995-11#1)(1995-12#1)(1995-9#2)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)
a suicide attempt##4##3##(1992-1#1)(2009-3#1)(2010-7#1)(2013-1#1)
a suicide##5##2##(1992-1#1)(1996-3#1)(2009-3#1)(2010-7#1)(2013-1#1)
a suitable alternative to##3##4##(1993-1#1)(1996-1#1)(2008-10#1)
a suitable alternative##8##3##(1993-1#1)(1996-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-3#1)
a suitable carrier##2##3##(2008-10#1)(2008-5#1)
a suitable choice of##2##4##(2007-12#1)(2010-2#1)
a suitable combination of##3##4##(1990-12#1)(2008-2#1)(2008-3#1)
a suitable instrumental##2##3##(2008-10#2)
a suitable ligand##2##3##(2008-10#2)
a suitable material for##3##4##(2008-10#2)(2008-2#1)
a suitable method for##3##4##(2008-10#3)
a suitable method to##2##4##(2008-10#1)(2010-4#1)
a suitable method##7##3##(2008-10#5)(2008-5#1)(2010-4#1)
a suitable model for##3##4##(1992-5#1)(2008-1#1)(2008-10#1)
a suitable model to##3##4##(1995-12#1)(2008-5#1)(2013-1#1)
a suitable model##8##3##(1992-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
a suitable pH##2##3##(2008-10#2)
a suitable precursor##2##3##(1997-7#1)(2008-10#1)
a suitable sensitivity##2##3##(2008-10#1)(2008-3#1)
a suitable starting point for##2##5##(2008-11#2)
a suitable technique to##2##4##(2008-10#1)(2009-12#1)
a suitable tool for##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
a suitable tool##4##3##(1993-6#1)(2008-10#2)(2008-8#1)
a suitable vehicle for##2##4##(2008-5#2)
a suitable vehicle##3##3##(2008-5#3)
a suitable##137##2##(1990-12#1)(1990-2#1)(1991-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-1#3)(2008-10#46)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#15)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
a suitably##6##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)
a suite of##14##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-3#1)(2013-1#1)
a sulfhydryl reagent##2##3##(1995-8#2)
a sulfonamide##2##2##(2006-12#1)(2008-10#1)
a sulphate##2##2##(2008-10#1)(2008-7#1)
a sulphuric##2##2##(2008-10#2)
a summary and##2##3##(1991-1#1)(2007-11#1)
a summary of recent##2##4##(1991-2#1)(2011-2#1)
a summary of the##20##4##(1991-3#2)(1992-3#1)(1992-6#1)(1993-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-12#2)(2010-11#1)(2011-2#1)(2011-3#1)(2011-7#1)(2013-1#1)
a summary of##34##3##(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-2#1)(1996-1#2)(2006-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#2)(2009-10#2)(2009-12#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2011-3#1)(2011-7#1)(2013-1#1)
a summary##45##2##(1991-1#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-4#1)(1996-1#2)(1997-3#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#2)(2009-10#2)(2009-12#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2013-1#2)
a summation of##2##3##(2007-11#1)(2013-1#1)
a summation test##4##3##(2008-5#4)
a summation##7##2##(2007-11#1)(2008-3#1)(2008-5#4)(2013-1#1)
a sun##2##2##(2008-3#1)(2008-5#1)
a sunphotometer##3##2##(2008-2#3)
a sunscreen##5##2##(2008-10#1)(2008-5#4)
a super##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
a superconducting##2##2##(1992-8#1)(2010-7#1)
a superfamily of proteins##2##4##(1993-12#1)(1994-9#1)
a superfamily of##5##3##(1993-12#1)(1994-9#1)(2008-11#1)(2009-2#1)(2010-5#1)
a superficial layer##2##3##(2008-2#1)(2008-3#1)
a superficial##10##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-9#1)(2013-8#1)
a superhigh-yield rice##2##3##(2008-9#2)
a superior competitor##3##3##(2008-8#2)(2010-2#1)
a superior efficacy##2##3##(2008-8#1)(2012-3#1)
a superior##26##2##(1993-12#1)(1995-5#1)(1996-12#1)(1997-6#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#4)(2009-12#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-1#2)
a superluminescent diode##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
a superluminescent##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
a supernumerary##4##2##(2008-3#1)(2008-5#1)(2010-3#1)(2012-2#1)
a superorbital##3##2##(2008-2#3)
a superoxide dismutase##2##3##(1995-8#1)(2008-5#1)
a superoxide##3##2##(1995-8#1)(2008-5#2)
a superposition of two##2##4##(2007-12#2)
a superposition of##9##3##(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2011-2#1)
a superresolution##2##2##(2007-11#1)(2008-3#1)
a supersonic flow##2##3##(2007-12#1)(2008-2#1)
a supersonic##4##2##(2007-12#2)(2008-2#1)(2009-11#1)
a superstrate index##2##3##(2007-11#1)(2008-2#1)
a superstructure fiber grating##2##4##(2007-12#2)
a supervised##6##2##(2008-10#2)(2008-11#1)(2009-7#2)(2012-3#1)
a supine##2##2##(1995-12#1)(2011-2#1)
a supplement to##5##3##(1990-9#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-6#1)
a supplement##8##2##(1990-9#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-6#1)(2008-11#1)(2009-7#1)(2010-2#1)
a supplementary##4##2##(1992-4#1)(1996-9#1)(2011-1#1)(2011-2#1)
a supplementation##2##2##(2010-1#1)(2013-1#1)
a supplier##2##2##(1994-12#1)(1994-3#1)
a supply of##2##3##(1994-9#1)(1995-11#1)
a support protocol for##3##4##(2008-1#1)(2008-4#2)
a support protocol##9##3##(2008-1#1)(2008-2#2)(2008-4#6)
a support##22##2##(1990-6#1)(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#6)(2010-5#1)(2011-2#4)
a supported housing project##2##4##(1993-1#2)
a supported liquid membrane##4##4##(2008-10#3)(2012-1#1)
a supported##8##2##(1993-1#2)(2008-10#5)(2012-1#1)
a supporting electrolyte##3##3##(2008-10#3)
a supporting##5##2##(2008-10#4)(2008-7#1)
a supportive environment##2##3##(2007-7#1)(2010-9#1)
a supportive role##2##3##(1992-3#1)(2010-8#1)
a supportive##11##2##(1992-3#2)(1994-6#1)(2007-7#1)(2008-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
a suppression of##4##3##(1993-12#1)(1994-8#1)(1995-12#1)(2008-11#1)
a suppression##5##2##(1993-12#1)(1994-8#1)(1995-12#1)(2008-11#1)(2011-1#1)
a suppressive effect##3##3##(1996-5#1)(2008-11#1)(2012-12#1)
a suppressive##4##2##(1996-5#1)(2008-11#1)(2012-12#1)(2013-1#1)
a suppressor gene##2##3##(2008-10#1)(2010-3#1)
a suppressor of##2##3##(1994-10#1)(2008-10#1)
a suppressor##5##2##(1994-10#1)(2008-10#3)(2010-3#1)
a supramolecular##2##2##(2008-10#1)(2009-10#1)
a suprasellar##2##2##(1993-2#1)(2012-3#1)
a sure##2##2##(1994-6#1)(2013-1#1)
a surface and##2##3##(1992-11#1)(2008-9#1)
a surface of##3##3##(1991-5#1)(2008-2#1)(2008-4#1)
a surface plasmon resonance (SPR) biosensor##3##6##(2008-10#1)(2008-11#1)(2008-4#1)
a surface plasmon resonance (SPR) sensor##2##6##(2008-10#1)(2008-2#1)
a surface plasmon resonance (SPR)##5##5##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
a surface plasmon resonance biosensor##2##5##(2008-10#2)
a surface plasmon resonance##9##4##(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)
a surface plasmon##10##3##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
a surface tension##3##3##(2008-10#2)(2008-3#1)
a surface##60##2##(1990-8#1)(1991-5#1)(1992-11#1)(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
a surface-relief##2##2##(2008-3#2)
a surface-renewable##2##2##(2008-10#2)
a surfactant##12##2##(1992-5#1)(1994-12#1)(2008-10#4)(2008-5#3)(2009-10#1)(2011-1#1)(2013-1#1)
a surgeon##4##2##(1996-2#1)(2008-11#1)(2010-8#1)(2012-2#1)
a surgeon's##2##2##(2011-2#1)(2013-1#1)
a surgical alternative for##2##4##(2008-10#1)(2008-7#1)
a surgical procedure##6##3##(1994-9#1)(2007-7#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
a surgical series##2##3##(1990-6#2)
a surgical specimen##2##3##(2008-11#1)(2013-7#1)
a surgical technique##4##3##(2007-12#1)(2008-7#3)
a surgical##35##2##(1990-6#2)(1993-9#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#5)(2008-9#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#1)
a surgically##3##2##(2007-8#1)(2008-7#1)(2010-6#1)
a surprise##3##2##(2008-11#1)(2010-5#1)(2011-1#1)
a surprising##5##2##(1994-5#1)(2008-11#2)(2009-7#1)(2013-1#1)
a surprisingly high##2##3##(2008-9#1)(2011-2#1)
a surprisingly large##2##3##(2008-7#1)(2008-8#1)
a surprisingly##7##2##(1995-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
a surrogate for##7##3##(1992-8#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-8#1)
a surrogate index of##3##4##(2008-1#1)(2008-6#1)(2011-2#1)
a surrogate marker for##3##4##(2007-10#2)(2009-6#1)
a surrogate marker##4##3##(2007-10#2)(2008-8#1)(2009-6#1)
a surrogate##21##2##(1992-3#1)(1992-8#1)(1995-1#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-8#1)
a surveillance and##2##3##(1990-3#2)
a surveillance##5##2##(1990-3#2)(1996-3#1)(2008-6#1)(2011-2#1)
a survey conducted##5##3##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
a survey designed to##2##4##(1995-12#1)(2010-8#1)
a survey for##4##3##(1991-5#1)(1994-3#1)(1996-3#1)(2010-8#1)
a survey in the##3##4##(1991-6#1)(1992-2#1)(1995-11#1)
a survey in##6##3##(1990-3#1)(1991-6#1)(1992-2#1)(1995-11#1)(2007-2#1)(2008-11#1)
a survey of the##9##4##(1992-10#1)(1994-3#1)(1994-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-1#1)(2013-1#1)
a survey of##50##3##(1991-1#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2007-7#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a survey on##5##3##(1994-2#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#1)
a survey questionnaire##2##3##(1991-8#1)(1993-12#1)
a survey showed##2##3##(2007-11#1)(2013-8#1)
a survey to##3##3##(1997-2#1)(2009-11#1)(2012-12#1)
a survey was conducted##2##4##(1997-1#1)(2013-1#1)
a survey was##3##3##(1997-1#1)(2012-2#1)(2013-1#1)
a survey##110##2##(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#4)(1996-12#2)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#6)(2008-10#11)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-11#3)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a survival analysis##2##3##(2008-6#1)(2008-7#1)
a survival benefit##3##3##(2008-10#1)(2010-8#1)(2011-3#1)
a survival##15##2##(1994-3#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
a susceptibility factor for##2##4##(2008-8#2)
a susceptibility locus for##4##4##(1996-2#1)(1997-5#3)
a susceptibility locus##6##3##(1996-2#1)(1997-5#5)
a susceptibility##10##2##(1993-11#1)(1996-2#1)(1997-5#5)(2008-8#2)(2011-1#1)
a susceptible cultivar of##3##4##(2008-10#3)
a susceptible cultivar##13##3##(2008-10#13)
a susceptible host##3##3##(2008-10#3)
a susceptible line##3##3##(1997-6#1)(2008-10#2)
a susceptible##37##2##(1997-6#1)(2008-10#35)(2011-2#1)
a suspect##2##2##(2008-12#1)(2013-1#1)
a suspected##4##2##(1991-3#1)(1992-12#1)(2007-9#1)(2008-3#1)
a suspended##3##2##(2007-11#1)(2008-3#1)(2009-11#1)
a suspension containing##3##3##(2008-10#2)(2008-5#1)
a suspension culture##4##3##(2008-11#3)(2008-2#1)
a suspension of##10##3##(1990-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
a suspension##18##2##(1990-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
a suspicion of##3##3##(1994-12#1)(1994-7#1)(2011-2#1)
a sustainable##10##2##(1995-12#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-3#2)(2010-7#1)(2011-2#1)(2013-8#1)
a sustained and##3##3##(1994-9#1)(1995-12#1)(2010-5#1)
a sustained increase in##2##4##(1991-9#1)(1992-6#1)
a sustained reduction in##2##4##(1995-12#1)(1995-5#1)
a sustained release of##2##4##(1994-6#1)(2013-1#1)
a sustained##28##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-5#1)(1997-2#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a sustained-release##3##2##(2009-11#2)(2012-2#1)
a suture##3##2##(2007-12#1)(2007-8#1)(2008-1#1)
a sweeping##2##2##(1995-9#1)(2008-10#1)
a sweet-tasting protein##2##3##(1997-4#1)(2008-9#1)
a swelling of##2##3##(2008-6#1)(2011-2#1)
a swelling##5##2##(1991-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
a swine model##2##3##(2008-11#1)(2009-10#1)
a switch between##2##3##(2008-10#1)(2008-3#1)
a switch in##2##3##(1992-12#1)(2008-10#1)
a switch##7##2##(1992-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)
a switching##6##2##(2007-11#1)(2007-12#1)(2008-3#3)(2008-8#1)
a swollen##2##2##(1997-5#1)(2008-5#1)
a symbiosis of##2##3##(1996-2#1)(2009-6#1)
a symbiosis##3##2##(1996-2#1)(2007-12#1)(2009-6#1)
a symbiotic##2##2##(2010-4#1)(2011-2#1)
a symmetric linear multilayer optical waveguide##2##6##(2007-12#2)
a symmetric##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
a symmetrical##6##2##(1990-8#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a symposium##5##2##(1992-2#1)(1992-3#1)(1994-3#1)(2008-12#1)(2013-1#1)
a symptom of##5##3##(1994-2#1)(2007-10#1)(2007-2#1)(2011-2#1)(2013-7#1)
a symptom##9##2##(1990-12#1)(1994-2#1)(1994-6#1)(2007-10#1)(2007-2#1)(2010-12#2)(2011-2#1)(2013-7#1)
a symptomatic patient##2##3##(2008-10#1)(2011-2#1)
a symptomatic##12##2##(1992-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
a symptomless##2##2##(2008-10#2)
a synchronization##2##2##(2008-3#1)(2008-7#1)
a synchronized##2##2##(2008-10#1)(2008-3#1)
a synchronous detection##2##3##(2008-3#2)
a synchronous##4##2##(1993-8#1)(2008-3#2)(2009-6#1)
a synchronously pumped optical parametric oscillator##2##6##(2007-11#1)(2008-3#1)
a synchronously pumped##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a synchrotron radiation##2##3##(2008-3#2)
a synchrotron##4##2##(2008-3#2)(2008-4#1)(2008-5#1)
a syndrome characterized by##4##4##(1997-4#2)(2010-3#1)(2012-3#1)
a syndrome of##4##3##(1997-6#1)(2007-7#1)(2008-11#1)(2008-7#1)
a syndrome that##2##3##(2007-10#1)(2008-11#1)
a syndrome which##2##3##(1997-6#1)(2008-7#1)
a syndrome##21##2##(1997-4#2)(1997-5#1)(1997-6#2)(2007-10#1)(2007-7#1)(2008-11#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#2)(2011-2#1)(2012-3#2)
a synergic##2##2##(2008-10#1)(2012-1#1)
a synergistic effect on##4##4##(1992-2#1)(1993-6#1)(2008-11#2)
a synergistic effect##10##3##(1992-2#1)(1993-6#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-5#1)
a synergistic##24##2##(1990-2#1)(1991-9#2)(1992-10#1)(1992-2#1)(1993-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)
a synonym of##2##3##(2011-2#1)(2013-7#1)
a synoptic##2##2##(1996-12#1)(2008-10#1)
a synthesis of##7##3##(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2010-12#1)(2011-1#1)
a synthesis##10##2##(1990-9#1)(1993-12#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2010-12#2)(2011-1#1)
a synthesized##8##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-5#1)
a synthetic aperture##3##3##(2007-11#2)(2008-3#1)
a synthetic compound that##3##4##(1997-6#1)(2008-2#1)(2012-2#1)
a synthetic compound##4##3##(1992-12#1)(1997-6#1)(2008-2#1)(2012-2#1)
a synthetic graft##2##3##(2008-7#1)(2011-2#1)
a synthetic peptide composed of##2##5##(1995-6#1)(2008-10#1)
a synthetic peptide corresponding to##2##5##(1990-11#1)(1994-6#1)
a synthetic peptide of##2##4##(1995-6#1)(2008-11#1)
a synthetic peptide substrate##2##4##(1990-7#1)(1991-12#1)
a synthetic peptide##15##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#2)(1992-7#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-7#1)
a synthetic sample##3##3##(2008-10#3)
a synthetic solution##2##3##(2008-10#2)
a synthetic##96##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#1)(2007-4#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)
a syringe pump##3##3##(2008-10#3)
a syringe##12##2##(2008-10#10)(2008-11#1)(2008-5#1)
a system built##2##3##(2007-12#1)(2008-7#1)
a system for targeted##2##4##(1997-7#1)(2008-9#1)
a system for the##4##4##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
a system for##14##3##(1991-2#1)(1992-3#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
a system in##3##3##(1991-3#1)(2008-10#1)(2008-7#1)
a system is##5##3##(1992-3#1)(1994-5#1)(2008-10#1)(2008-2#2)
a system of diagnostic##2##4##(1997-1#1)(2007-11#1)
a system of##36##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#3)
a system that##12##3##(1991-2#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-6#1)(2008-9#1)(2011-2#1)
a system to##5##3##(1991-1#1)(1994-12#1)(2008-2#1)(2008-9#1)(2010-2#1)
a system was##3##3##(1993-8#1)(1997-7#1)(2007-12#1)
a system where##2##3##(2008-8#1)(2013-8#1)
a system with##11##3##(1990-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2011-1#1)
a system##133##2##(1990-11#2)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#1)(1992-2#1)(1992-3#4)(1993-11#1)(1993-12#2)(1993-3#4)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#19)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#6)
a systematic and##2##3##(1996-3#1)(2008-4#1)
a systematic approach to##10##4##(1994-2#1)(1995-12#1)(1996-12#2)(2006-5#1)(2008-3#2)(2009-10#1)(2012-2#1)(2013-1#1)
a systematic approach##15##3##(1991-12#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(2006-5#1)(2008-10#1)(2008-3#3)(2009-10#1)(2009-7#1)(2012-2#1)(2013-1#1)
a systematic error##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
a systematic investigation of##3##4##(2008-5#1)(2010-5#1)(2012-2#1)
a systematic literature review##3##4##(2008-11#1)(2012-2#1)(2013-8#1)
a systematic literature##5##3##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a systematic manner##3##3##(1992-3#1)(1995-1#1)(2012-1#1)
a systematic method for##2##4##(2008-3#1)(2008-6#1)
a systematic review and meta-analysis of##2##6##(2012-3#1)(2013-8#1)
a systematic review and meta-analysis##4##5##(2009-11#1)(2010-10#1)(2012-3#1)(2013-8#1)
a systematic review and##8##4##(2008-6#1)(2009-11#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
a systematic review comparing##2##4##(2012-12#2)
a systematic review of the literature##2##6##(2011-2#1)(2013-1#1)
a systematic review of the##5##5##(2007-7#1)(2011-2#3)(2013-1#1)
a systematic review of##9##4##(2007-10#1)(2007-7#1)(2009-2#1)(2009-3#1)(2011-2#4)(2013-1#1)
a systematic review to evaluate##2##5##(2008-10#1)(2013-1#1)
a systematic review##43##3##(2007-10#3)(2007-11#2)(2007-7#2)(2008-10#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2010-10#1)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#5)(2012-3#2)(2013-1#4)(2013-8#3)
a systematic search##3##3##(1996-12#1)(2008-6#1)(2013-8#1)
a systematic study of the##2##5##(1994-10#1)(2008-2#1)
a systematic study of##3##4##(1994-10#1)(2008-2#1)(2010-6#1)
a systematic study##5##3##(1994-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-6#1)
a systematic way##5##3##(1994-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
a systematic##128##2##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-12#3)(1996-2#2)(1996-3#1)(2006-5#1)(2007-10#4)(2007-11#2)(2007-7#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#9)(2011-7#1)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#7)
a systematically designed##2##3##(2012-1#1)(2012-2#1)
a systemic disease with##2##4##(1997-8#1)(2013-1#1)
a systemic disease##10##3##(1991-12#1)(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
a systemic inflammatory response##5##4##(1997-7#1)(2008-10#2)(2010-5#1)(2012-3#1)
a systemic inflammatory##6##3##(1997-7#1)(2008-10#2)(2010-5#1)(2012-2#1)(2012-3#1)
a systemic##40##2##(1990-6#2)(1991-12#1)(1992-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
a systems approach to##4##4##(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)
a systems approach##6##3##(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2010-5#1)
a systems perspective##12##3##(2010-4#1)(2013-1#1)(2013-8#10)
a systems##19##2##(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-6#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#10)
a systemwide##2##2##(1993-3#1)(2008-3#1)
a t(14##3##2##(2009-8#3)
a table of##2##3##(1996-1#1)(2008-12#1)
a table that##3##3##(1996-3#1)(2008-4#1)(2008-6#1)
a table##11##2##(1990-5#1)(1992-9#1)(1994-2#1)(1996-1#2)(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)
a tabletop##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
a taboo##2##2##(1993-6#1)(1996-6#1)
a tactile##3##2##(2008-3#1)(2008-5#1)(2009-8#1)
a tag##2##2##(2008-10#1)(2008-3#1)
a tail##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
a tailored##4##2##(2007-12#1)(2008-8#1)(2013-1#1)(2013-8#1)
a talar body fracture##2##4##(2010-5#2)
a tale of##2##3##(1996-1#1)(2007-8#1)
a tan##2##2##(2008-10#1)(2008-5#1)
a tandem insertion of a Ty1##2##6##(1995-9#2)
a tandem##12##2##(1991-6#1)(1995-6#1)(1995-9#2)(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-12#1)(2011-1#1)
a tangible##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
a tank##4##2##(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
a tap water##2##3##(2008-10#2)
a tapered waveguide##2##3##(2007-11#1)(2007-12#1)
a tapered##12##2##(2007-11#5)(2007-12#2)(2008-2#3)(2008-3#2)
a target adolescent)##2##3##(2009-7#2)
a target analyte##2##3##(2008-10#1)(2009-11#1)
a target for novel##2##4##(2008-5#1)(2010-2#1)
a target for therapeutic##2##4##(2007-10#1)(2007-8#1)
a target for##24##3##(1992-6#1)(1994-8#2)(1995-5#1)(1996-1#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#2)
a target in##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
a target of##7##3##(1991-5#1)(1993-8#1)(1994-8#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
a target organ of the##2##5##(2008-5#1)(2011-1#1)
a target protein##2##3##(2008-10#1)(2008-11#1)
a target site for##2##4##(1991-2#1)(1994-2#1)
a target weight##5##3##(2013-1#5)
a target with##2##3##(2007-12#1)(2008-3#1)
a target##85##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-2#3)(1994-5#1)(1994-8#3)(1995-1#1)(1995-5#1)(1996-1#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#5)(2011-3#1)(2013-1#8)(2013-8#1)
a targeted disruption of the mouse##2##6##(1994-12#2)
a targeted##13##2##(1993-9#2)(1994-12#2)(1994-9#1)(1996-2#1)(2007-11#1)(2009-12#1)(2010-10#1)(2012-12#2)(2013-7#1)(2013-8#1)
a task force##3##3##(1994-1#1)(1997-3#1)(2013-1#1)
a task involving##3##3##(1993-12#1)(1995-2#1)(2008-11#1)
a task that##2##3##(2008-2#1)(2008-8#1)
a task##16##2##(1993-12#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2013-1#2)
a taste aversion##2##3##(1993-12#1)(2008-5#1)
a taste##3##2##(1993-12#1)(2008-5#1)(2013-1#1)
a tautomeric mixture##2##3##(2008-10#2)
a taxing##2##2##(1994-1#1)(2009-9#1)
a taxonomic##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
a tea##2##2##(2008-11#1)(2008-7#1)
a tea-bag formulation of cryptolepis sanguinolenta root##2##7##(2011-2#2)
a teacher##7##2##(1995-3#1)(2009-7#1)(2012-1#5)
a teaching and learning##5##4##(2008-11#4)(2008-12#1)
a teaching and##6##3##(2008-11#4)(2008-12#2)
a teaching file test##2##4##(1990-2#2)
a teaching hospital in Kuala Lumpur##2##6##(2008-10#1)(2008-8#1)
a teaching hospital in##4##4##(2007-2#1)(2008-10#1)(2008-8#1)(2009-1#1)
a teaching hospital##14##3##(1994-2#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-3#2)(2012-3#2)
a teaching method##5##3##(2008-11#4)(2008-12#1)
a teaching module##2##3##(1996-1#2)
a teaching strategy##5##3##(2008-11#1)(2008-12#3)(2010-3#1)
a teaching##38##2##(1990-2#2)(1994-2#1)(1995-12#1)(1996-1#2)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#11)(2008-12#8)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-3#3)(2012-3#2)
a team approach##4##3##(1994-12#2)(2007-10#1)(2011-2#1)
a team of##9##3##(1996-1#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2011-2#2)
a team##29##2##(1992-1#1)(1994-12#3)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-7#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-6#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
a team-based##2##2##(1993-12#1)(1997-2#1)
a teamwork relationship##2##3##(1991-12#2)
a teamwork##3##2##(1991-12#2)(1994-2#1)
a technical report##2##3##(2011-2#1)(2012-3#1)
a technical##11##2##(1990-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
a technically feasible##2##3##(2007-8#1)(2012-3#1)
a technically##6##2##(1991-12#1)(1993-11#1)(1993-3#1)(2007-8#1)(2008-9#1)(2012-3#1)
a technique based on the##2##5##(2007-11#1)(2008-10#1)
a technique called##2##3##(2008-3#1)(2008-4#1)
a technique developed##2##3##(2008-10#1)(2008-7#1)
a technique for laser##2##4##(2008-2#1)(2008-3#1)
a technique for measuring##6##4##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
a technique for performing##2##4##(2007-12#1)(2008-3#1)
a technique for the##8##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
a technique for##38##3##(1990-8#1)(1996-2#1)(2007-11#4)(2007-12#2)(2008-10#6)(2008-2#6)(2008-3#11)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)
a technique in which##2##4##(2008-9#1)(2009-7#1)
a technique of choice in the##2##6##(2007-11#2)
a technique of##11##3##(1992-6#1)(1993-3#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
a technique that allows##2##4##(2007-8#1)(2008-3#1)
a technique that combines##2##4##(2008-10#1)(2008-3#1)
a technique that uses##3##4##(2008-3#2)(2009-10#1)
a technique that##13##3##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#6)(2008-4#1)(2008-6#1)(2009-10#1)
a technique to detect the##2##5##(2008-3#1)(2008-4#1)
a technique to determine##2##4##(2008-2#1)(2011-2#1)
a technique to##13##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-2#1)(2011-3#1)
a technique used to##2##4##(2008-10#1)(2008-7#1)
a technique used##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
a technique using##2##3##(1992-12#2)
a technique which##3##3##(1993-9#1)(2007-11#1)(2010-12#1)
a technique##103##2##(1990-8#1)(1992-12#3)(1992-6#1)(1993-3#2)(1993-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2007-11#8)(2007-12#4)(2007-8#2)(2008-10#15)(2008-11#1)(2008-2#9)(2008-3#21)(2008-4#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
a technological##2##2##(2007-10#1)(2008-7#1)
a technology for##2##3##(2008-9#2)
a technology that##3##3##(1992-11#1)(2008-9#1)(2012-3#1)
a technology##11##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#3)(2011-2#1)(2012-3#1)
a tedious and##2##3##(2008-10#1)(2008-4#1)
a tedious##4##2##(2008-10#3)(2008-4#1)
a teicoplanin##2##2##(2008-10#2)
a telecentric##2##2##(2008-2#1)(2008-3#1)
a teleomorph##2##2##(2008-10#1)(2010-3#1)
a teleost##2##2##(1997-9#1)(2008-7#1)
a telephone##3##2##(1995-3#1)(2008-9#2)
a telescope pupil##2##3##(2008-3#2)
a telescope##6##2##(2007-11#2)(2008-2#1)(2008-3#3)
a temperature change##2##3##(2008-10#1)(2008-3#1)
a temperature gradient along the##2##5##(2007-11#1)(2013-1#1)
a temperature of 38##2##4##(2008-10#1)(2008-11#1)
a temperature of 50 degrees C##2##6##(2008-10#2)
a temperature of##20##3##(1995-2#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-7#2)(2009-7#1)(2013-1#1)
a temperature optimum##2##3##(1991-5#1)(2008-10#1)
a temperature range from##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
a temperature range of##4##4##(1993-8#1)(2008-3#3)
a temperature range##9##3##(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#5)
a temperature reference##2##3##(2008-2#1)(2008-3#1)
a temperature sensitivity of##2##4##(2007-12#1)(2008-3#1)
a temperature##58##2##(1991-5#1)(1993-8#1)(1994-7#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-7#1)(2013-1#2)
a temperature-sensitive mutant##2##3##(1995-2#1)(1995-6#1)
a temperature-sensitive##8##2##(1993-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-8#1)(2008-8#1)
a template and##2##3##(1993-12#1)(2008-11#1)
a template for##7##3##(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
a template##16##2##(1992-6#1)(1993-12#1)(1994-9#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)
a temporal resolution of 1##2##5##(2007-12#1)(2008-10#1)
a temporal resolution of##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
a temporal signal##2##3##(2008-3#2)
a temporal##26##2##(1997-4#1)(2006-6#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)
a temporally##6##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
a temporary##12##2##(1992-5#1)(1993-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
a ten##3##2##(1990-2#1)(1994-2#1)(2008-11#1)
a ten-year period##3##3##(1991-9#1)(2008-4#1)(2012-2#1)
a ten-year##5##2##(1990-2#1)(1991-9#1)(2008-4#1)(2008-9#1)(2012-2#1)
a tendency for##7##3##(1991-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)
a tendency of##2##3##(1996-9#1)(2011-2#1)
a tendency to cluster##2##4##(2008-5#1)(2010-11#1)
a tendency to##21##3##(1991-1#1)(1991-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
a tendency toward##2##3##(2011-2#2)
a tendency##35##2##(1991-1#1)(1991-2#1)(1991-6#1)(1993-3#1)(1993-8#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)
a tenfold increase in##2##4##(1990-12#1)(2007-11#1)
a tenfold##4##2##(1990-12#1)(1997-7#1)(2007-11#1)(2008-2#1)
a tension##2##2##(2010-3#1)(2012-3#1)
a tentative model for##2##4##(1992-9#1)(1994-5#1)
a tentative##7##2##(1992-9#1)(1994-5#1)(1996-2#1)(1996-5#1)(2011-2#2)(2013-8#1)
a terahertz##2##2##(2007-12#2)
a term describing##2##3##(2013-1#1)(2013-8#1)
a term that##3##3##(2007-11#1)(2008-9#1)(2012-2#1)
a term to##2##3##(2008-8#1)(2011-1#1)
a term##13##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
a terminal##15##2##(1990-2#1)(1990-8#1)(1993-11#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#3)
a termination codon##2##3##(1990-7#1)(1992-6#1)
a termination##3##2##(1990-7#1)(1992-6#1)(2013-8#1)
a ternary complex##7##3##(1994-5#3)(2008-10#3)(2012-12#1)
a ternary mixture of##2##4##(2008-10#2)
a ternary##12##2##(1994-2#1)(1994-5#3)(2008-10#6)(2008-3#1)(2012-12#1)
a terrestrial##4##2##(1990-5#1)(2008-12#1)(2008-7#1)(2010-8#1)
a terrorist##2##2##(1996-12#1)(2008-9#1)
a tertiary care center##2##4##(2010-4#1)(2010-5#1)
a tertiary care centre in India##2##6##(2011-2#1)(2013-1#1)
a tertiary care centre##3##4##(2010-5#1)(2011-2#1)(2013-1#1)
a tertiary care hospital in##6##5##(2008-11#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
a tertiary care hospital##20##4##(1997-3#1)(2007-7#2)(2008-11#2)(2008-3#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
a tertiary care teaching hospital##2##5##(2008-7#1)(2013-8#1)
a tertiary care##33##3##(1997-3#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#5)
a tertiary center##2##3##(2012-12#1)(2012-2#1)
a tertiary hospital##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
a tertiary paediatric##2##3##(2008-11#1)(2012-2#1)
a tertiary referral##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
a tertiary##50##2##(1997-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#5)
a test and##2##3##(2008-5#1)(2008-8#1)
a test based on##2##4##(1997-7#1)(2013-1#1)
a test for##4##3##(1994-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
a test of##11##3##(1992-7#1)(1993-3#1)(1993-5#2)(1994-2#2)(2008-10#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
a test pattern##2##3##(2008-3#2)
a test sample##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
a test set of##3##4##(1996-12#1)(2008-10#1)(2009-3#1)
a test set##6##3##(1996-12#1)(2008-10#4)(2009-3#1)
a test that##2##3##(1991-11#1)(2008-10#1)
a test using##2##3##(2008-8#2)
a test##85##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-2#2)(1994-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#7)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)
a testing##2##2##(2009-3#1)(2011-1#1)
a tethered##2##2##(1992-4#1)(2009-5#1)
a tetracycline##4##2##(1993-11#1)(2008-10#2)(2008-7#1)
a tetracycline-repressible##2##2##(2008-11#1)(2008-7#1)
a tetragonal##2##2##(1997-7#1)(2008-9#1)
a tetramer##2##2##(1990-10#1)(1995-2#1)
a tetrameric##2##2##(1993-8#1)(1995-5#1)
a tetrasaccharide##3##2##(1990-9#1)(1992-12#1)(1995-11#1)
a text##2##2##(1995-1#1)(2008-9#1)
a thematic analysis##3##3##(2008-11#2)(2011-2#1)
a thematic content analysis##2##4##(2008-11#1)(2009-3#1)
a thematic##6##2##(2008-11#3)(2009-3#1)(2011-1#1)(2011-2#1)
a theme##3##2##(2008-4#1)(2008-7#1)(2009-10#1)
a theoretical analysis and##3##4##(2007-11#2)(2008-2#1)
a theoretical analysis of the##2##5##(2007-11#1)(2008-2#1)
a theoretical analysis of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
a theoretical analysis##11##3##(2007-11#3)(2008-2#2)(2008-3#6)
a theoretical and experimental investigation of##2##6##(2007-12#1)(2008-3#1)
a theoretical and##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
a theoretical explanation for##2##4##(2008-10#1)(2008-3#1)
a theoretical framework that##2##4##(2007-8#1)(2012-12#1)
a theoretical framework##8##3##(1992-3#1)(2007-8#1)(2008-8#2)(2009-6#1)(2009-9#1)(2012-12#1)(2012-3#1)
a theoretical investigation of the##2##5##(2007-12#1)(2008-9#1)
a theoretical investigation##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
a theoretical model for the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
a theoretical model of##3##4##(1996-3#1)(2008-3#1)(2009-9#1)
a theoretical model that##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a theoretical model##21##3##(1996-3#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#8)(2008-5#1)(2009-9#1)(2011-1#1)
a theoretical point of view##4##5##(2008-2#2)(2008-3#1)(2008-8#1)
a theoretical study##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
a theoretical##82##2##(1992-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(2007-11#8)(2007-12#6)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#8)(2008-3#22)(2008-5#2)(2008-8#7)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
a theory of the##2##4##(2007-11#1)(2008-3#1)
a theory of##4##3##(2007-11#1)(2008-3#3)
a theory##7##2##(1992-3#1)(2007-11#1)(2008-2#1)(2008-3#4)
a theory-based##2##2##(2013-1#2)
a theory-driven##2##2##(2009-8#1)(2011-1#1)
a therapeutic agent##4##3##(2007-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
a therapeutic and##2##3##(1993-5#1)(2013-8#1)
a therapeutic cure##2##3##(2010-6#1)(2011-2#1)
a therapeutic effect##2##3##(1992-3#1)(2008-9#1)
a therapeutic option for##2##4##(2009-9#1)(2013-8#1)
a therapeutic option in patients##2##5##(2010-12#2)
a therapeutic option##5##3##(2009-5#1)(2009-9#1)(2010-12#2)(2013-8#1)
a therapeutic protein##2##3##(2008-11#2)
a therapeutic regimen##2##3##(1991-9#1)(1992-8#1)
a therapeutic strategy for##2##4##(2010-7#1)(2011-2#1)
a therapeutic strategy##4##3##(2008-1#1)(2010-7#1)(2011-2#1)(2012-2#1)
a therapeutic target for the treatment of##2##7##(2008-1#1)(2013-1#1)
a therapeutic target for##3##4##(2008-1#1)(2010-11#1)(2013-1#1)
a therapeutic target##5##3##(2008-1#1)(2008-11#1)(2010-11#1)(2010-3#1)(2013-1#1)
a therapeutic tool##3##3##(2008-6#1)(2008-9#1)(2009-9#1)
a therapeutic##57##2##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
a therapy for##2##3##(1994-5#1)(2012-2#1)
a therapy in##2##3##(2009-10#1)(2010-7#1)
a therapy##10##2##(1993-11#1)(1994-3#1)(1994-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-7#1)(2012-2#1)
a thermal gradient##2##3##(2008-3#1)(2011-2#1)
a thermal##15##2##(1992-8#1)(1993-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#5)(2008-4#1)(2010-4#1)(2011-2#1)
a thermally##5##2##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#2)
a thermoactive##2##2##(1991-5#2)
a thermocouple##2##2##(2008-2#1)(2008-3#1)
a thermodynamic analysis##2##3##(1993-8#1)(2007-12#1)
a thermodynamic##11##2##(1990-8#2)(1992-5#1)(1993-11#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-2#1)
a thermoelectrically cooled##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a thermogenic nutritional supplement##3##4##(2013-8#3)
a thermogenic##4##2##(1994-2#1)(2013-8#3)
a thermophilic##2##2##(2011-2#1)(2013-1#1)
a thermoreversible organic thin film##2##5##(2007-11#2)
a thermoreversible##3##2##(2007-11#2)(2009-12#1)
a thermostable##2##2##(2008-7#1)(2013-1#1)
a thermostatic##2##2##(2008-10#2)
a theta rhythm##3##3##(2008-11#3)
a theta##4##2##(2008-11#4)
a thiazide diuretic##2##3##(2009-9#2)
a thick##17##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#6)(2009-6#1)(2010-5#1)(2011-2#1)
a thick-walled##2##2##(2007-12#1)(2013-1#1)
a thickening of the##2##4##(2008-5#1)(2012-2#1)
a thicker##3##2##(2007-11#1)(2008-5#1)(2010-10#1)
a thickness of##8##3##(1995-6#1)(2007-12#4)(2008-3#1)(2009-7#1)(2011-2#1)
a thickness##11##2##(1995-6#1)(2007-12#4)(2008-3#4)(2009-7#1)(2011-2#1)
a thin Fabry-Perot##2##3##(2008-2#1)(2008-3#1)
a thin and##2##3##(2008-5#1)(2009-6#1)
a thin film of chlorogenic acid##3##6##(2008-10#3)
a thin film of##6##4##(2007-11#1)(2008-10#5)
a thin film##15##3##(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#2)
a thin layer##4##3##(2008-10#4)
a thin lens##4##3##(2008-2#1)(2008-3#3)
a thin liquid film##2##4##(2008-10#1)(2009-6#1)
a thin slice##2##3##(2007-11#1)(2008-3#1)
a thin wall##2##3##(2012-2#1)(2013-8#1)
a thin##81##2##(1991-6#1)(1994-11#1)(1997-4#2)(2007-11#2)(2007-12#7)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#17)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2009-11#3)(2009-6#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
a thin-film##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
a thin-layer##2##2##(1990-5#1)(2008-10#1)
a thinner##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-4#1)(2013-1#1)
a thiol##4##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-8#1)
a third beam##2##3##(2007-12#1)(2008-3#1)
a third class##2##3##(1990-3#1)(2010-6#1)
a third component##2##3##(1994-5#1)(2008-10#1)
a third generation##3##3##(1990-3#1)(2007-7#1)(2008-5#1)
a third group##2##3##(1996-1#1)(2011-2#1)
a third of##5##3##(1991-1#1)(2008-10#1)(2009-4#1)(2010-8#1)(2011-1#1)
a third party##4##3##(2008-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
a third type of##2##4##(1991-1#1)(2010-12#1)
a third type##3##3##(1991-1#1)(2010-12#1)(2011-2#1)
a third##69##2##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#4)(1990-7#1)(1990-8#3)(1991-1#2)(1991-12#1)(1991-4#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
a third-generation cephalosporin##3##3##(2011-2#3)
a third-level##2##2##(1994-5#1)(2012-12#1)
a third-line 'rescue' option##2##4##(2010-12#2)
a third-order##5##2##(1993-8#1)(1996-5#1)(2007-12#1)(2008-3#2)
a thoracic##4##2##(1997-6#1)(2011-2#2)(2013-1#1)
a thoracotomy##3##2##(2007-8#2)(2008-1#1)
a thorough analysis of the##2##5##(2008-3#1)(2008-5#1)
a thorough and##2##3##(1993-3#1)(2011-1#1)
a thorough discussion of##2##4##(2010-5#1)(2010-8#1)
a thorough history and physical examination##3##6##(2008-8#1)(2010-7#1)(2012-2#1)
a thorough history##4##3##(2006-5#1)(2008-8#1)(2010-7#1)(2012-2#1)
a thorough investigation of##2##4##(2008-10#1)(2010-2#1)
a thorough investigation##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
a thorough review of the##2##5##(1993-1#1)(2008-4#1)
a thorough understanding of the##3##5##(2007-12#1)(2008-7#1)(2010-4#1)
a thorough understanding of##10##4##(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)
a thorough##42##2##(1990-9#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a thought##2##2##(2011-2#1)(2012-2#1)
a thoughtful##2##2##(2007-12#1)(2012-2#1)
a thousand times##2##3##(1990-12#1)(2008-10#1)
a thousand##7##2##(1990-12#1)(1992-6#1)(2008-10#2)(2008-7#1)(2010-9#1)(2013-1#1)
a threat to life##2##4##(1990-2#1)(1993-6#1)
a threat to public health##2##5##(2007-2#1)(2010-4#1)
a threat to the##6##4##(1992-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
a threat to##13##3##(1990-2#1)(1992-1#1)(1993-6#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)
a threat##16##2##(1990-2#1)(1992-1#1)(1993-6#1)(1995-11#1)(1996-2#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)
a threatening##2##2##(2007-12#1)(2008-10#1)
a three dimensional structure##2##4##(2008-4#1)(2012-1#1)
a three dimensional##4##3##(2008-4#1)(2009-12#1)(2011-2#1)(2012-1#1)
a three week##4##3##(1992-6#2)(1994-6#1)(2012-12#1)
a three year period##2##4##(2008-5#1)(2012-3#1)
a three year##6##3##(2007-7#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#1)
a three years##3##3##(1990-6#1)(1994-2#1)(2012-2#1)
a three##32##2##(1990-11#1)(1990-6#1)(1990-9#1)(1992-6#2)(1992-9#2)(1994-2#1)(1994-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
a three-aspherical-mirror##2##2##(2008-3#2)
a three-banded pattern with##2##4##(2008-10#2)
a three-channel##2##2##(1995-3#1)(2008-3#1)
a three-component##5##2##(1996-7#1)(2008-10#3)(2008-2#1)
a three-dimensional (3-D)##2##3##(2008-2#1)(2011-2#1)
a three-dimensional (3D)##8##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#2)
a three-dimensional hexagonal ice column##2##5##(2008-3#2)
a three-dimensional imaging##2##3##(2008-10#1)(2008-3#1)
a three-dimensional network##2##3##(2007-11#1)(2008-7#1)
a three-dimensional object##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a three-dimensional space perception##2##4##(2008-2#2)
a three-dimensional space##3##3##(2008-2#2)(2008-3#1)
a three-dimensional tissue construct from human dental##2##7##(2013-1#2)
a three-dimensional tissue construct from##3##5##(2013-1#3)
a three-dimensional volume##2##3##(2008-3#2)
a three-dimensional##75##2##(1991-11#1)(1995-6#1)(1996-2#1)(2006-4#1)(2007-11#5)(2007-12#8)(2007-8#1)(2008-10#4)(2008-11#4)(2008-2#9)(2008-3#21)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-3#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)
a three-drug##2##2##(1996-11#1)(2010-3#1)
a three-factor##2##2##(2008-4#1)(2013-8#1)
a three-fold increase in##2##4##(1993-11#1)(1993-12#1)
a three-fold##5##2##(1993-11#1)(1993-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
a three-generation##3##2##(2008-10#3)
a three-hole##2##2##(2008-10#2)
a three-judge panel##2##3##(1995-6#1)(1997-5#1)
a three-level##7##2##(1992-1#1)(1994-3#1)(2007-11#2)(2007-12#2)(2011-2#1)
a three-mirror##2##2##(2008-3#2)
a three-month##3##2##(1991-6#1)(2012-3#1)(2013-1#1)
a three-part series of articles##3##5##(1994-12#1)(1995-1#1)(1995-2#1)
a three-phase##2##2##(2007-5#1)(2013-1#1)
a three-port##2##2##(2007-11#1)(2007-12#1)
a three-stage##3##2##(1991-6#1)(2008-3#1)(2008-6#1)
a three-state model##2##3##(1993-8#1)(1997-2#1)
a three-state##3##2##(1993-8#1)(1997-2#1)(2008-3#1)
a three-step##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
a three-wavelength##2##2##(2007-11#1)(2008-3#1)
a three-way##6##2##(2008-10#4)(2009-5#1)(2013-1#1)
a three-year period##3##3##(1997-1#1)(2007-7#1)(2012-2#1)
a three-year##11##2##(1994-3#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2007-7#1)(2008-11#3)(2012-12#1)(2012-2#1)
a threefold increase##3##3##(2008-10#2)(2008-3#1)
a threefold##7##2##(2008-10#3)(2008-3#1)(2008-6#1)(2010-1#1)(2011-1#1)
a threonine residue##2##3##(1990-5#1)(1993-6#1)
a threshold at##2##3##(1995-8#1)(1996-6#1)
a threshold concentration of##3##4##(1995-11#1)(2008-10#1)(2008-5#1)
a threshold concentration##5##3##(1990-8#1)(1992-9#1)(1995-11#1)(2008-10#1)(2008-5#1)
a threshold effect for##2##4##(2010-1#2)
a threshold for##3##3##(1990-8#1)(2009-5#1)(2012-2#1)
a threshold level of##2##4##(2008-2#1)(2011-1#1)
a threshold level##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
a threshold of##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
a threshold power of##2##4##(2008-2#2)
a threshold value##5##3##(1996-8#2)(2008-10#3)
a threshold##58##2##(1990-8#2)(1992-9#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-6#2)(1996-8#2)(1997-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
a thrombin##2##2##(1990-5#1)(2006-6#1)
a thrombotic##2##2##(2013-1#1)(2013-8#1)
a thromboxane receptor##2##3##(1990-5#1)(2007-8#1)
a thromboxane##4##2##(1990-5#2)(1992-9#1)(2007-8#1)
a thrombus##4##2##(1997-6#1)(2008-7#2)(2008-8#1)
a throughput of##6##3##(2008-10#6)
a thrust##2##2##(2008-12#1)(2012-2#1)
a thymic##3##2##(1997-9#1)(2007-8#2)
a thymidine##2##2##(1991-5#1)(2008-4#1)
a thyroid##3##2##(1993-5#1)(2007-8#1)(2008-10#1)
a tick##5##2##(1996-11#2)(2013-8#3)
a tidal estuary in##2##4##(2013-1#2)
a tidal##3##2##(1996-2#1)(2013-1#2)
a tight regulation##2##3##(2009-8#1)(2013-8#1)
a tight sensation##2##3##(2008-5#1)(2010-5#1)
a tight##13##2##(1990-11#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2013-8#2)
a tight-binding##2##2##(1991-5#1)(1992-11#1)
a tightly regulated##3##3##(1995-2#1)(2012-2#2)
a tightly##5##2##(1995-2#1)(2007-11#1)(2008-3#1)(2012-2#2)
a tillage##2##2##(2008-10#2)
a tilt of##2##3##(2007-12#1)(2008-2#1)
a tilt##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
a tilted plane-parallel plate##2##4##(2008-2#2)
a tilted##10##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2013-8#1)
a timber##2##2##(2011-2#1)(2013-7#1)
a time and##5##3##(1994-11#1)(1994-9#1)(1996-12#1)(2008-11#1)(2009-8#1)
a time basis##2##3##(1997-2#1)(2007-11#1)
a time course of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
a time course##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
a time dependent##4##3##(1991-9#1)(2007-2#1)(2013-1#1)(2013-8#1)
a time for##3##3##(1994-3#1)(2008-10#2)
a time frame##2##3##(2010-3#1)(2013-1#1)
a time interval##2##3##(1994-3#1)(2008-3#1)
a time lapse##2##3##(2008-10#1)(2009-6#1)
a time of rapid change##2##5##(1997-3#1)(2013-1#1)
a time of##14##3##(1990-3#1)(1993-12#3)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-12#1)(2013-1#1)
a time period of##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
a time resolution of##6##4##(2007-11#1)(2008-2#1)(2008-3#4)
a time resolution##8##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
a time scale of##3##4##(1994-11#1)(1997-2#1)(2008-11#1)
a time scale##4##3##(1994-11#1)(1997-2#1)(2007-12#1)(2008-11#1)
a time series of##3##4##(1992-9#1)(2008-11#1)(2012-3#1)
a time series##5##3##(1992-9#1)(2008-11#1)(2009-9#2)(2012-3#1)
a time to##3##3##(1993-12#2)(2012-12#1)
a time when the##2##4##(1997-2#1)(2008-9#1)
a time when##16##3##(1992-9#1)(1993-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-10#1)(2010-1#1)(2012-3#1)
a time##125##2##(1990-3#1)(1991-9#1)(1992-9#2)(1993-12#6)(1994-11#2)(1994-3#2)(1994-9#1)(1995-5#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#4)(1997-3#2)(1997-7#1)(2006-4#1)(2007-11#3)(2007-12#6)(2007-2#1)(2008-1#1)(2008-10#19)(2008-11#11)(2008-2#1)(2008-3#14)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
a time- and dose-dependent##6##4##(1990-5#1)(1991-5#1)(1992-8#1)(1994-9#1)(1995-8#1)(2010-1#1)
a time- and voltage-dependent##2##4##(1993-3#2)
a time- and##16##3##(1990-5#1)(1991-12#1)(1991-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-8#1)(1997-1#2)(2008-9#1)(2010-1#1)
a time-based flow method##2##4##(2008-10#2)
a time-based##6##2##(2008-10#6)
a time-consuming##3##2##(2008-10#1)(2008-3#1)(2009-8#1)
a time-dependent decrease##2##3##(1993-9#1)(1994-8#1)
a time-dependent polarization pulse##2##4##(2007-11#2)
a time-dependent##24##2##(1990-6#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#2)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#3)(2012-12#1)
a time-domain##4##2##(2007-12#1)(2008-3#3)
a time-gated##2##2##(2007-12#1)(2008-2#1)
a time-keeping##2##2##(2010-8#2)
a time-of-flight mass spectrometer##2##4##(2008-2#1)(2008-3#1)
a time-of-flight mass##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
a time-resolved##8##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
a time-series approach##2##3##(1997-1#1)(2009-9#1)
a time-series##3##2##(1995-12#1)(1997-1#1)(2009-9#1)
a timely##20##2##(1991-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
a timing##5##2##(1995-12#1)(2008-10#1)(2008-3#3)
a tiny##6##2##(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
a tip##5##2##(1995-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
a tissue culture##2##3##(1994-6#1)(2008-9#1)
a tissue##25##2##(1990-12#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-8#1)(1994-6#1)(1995-2#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2010-7#1)(2012-1#1)(2013-1#1)
a tissue-engineered##2##2##(2008-10#1)(2008-5#1)
a tissue-equivalent##2##2##(1993-9#1)(2008-3#1)
a tissue-like##2##2##(2009-12#1)(2010-12#1)
a tissue-specific##9##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-12#1)(2011-2#1)
a tissuelike##4##2##(2008-3#4)
a titanium##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
a titer exceeding##2##3##(2008-10#2)
a titer##4##2##(1992-9#2)(2008-10#2)
a title##3##2##(1993-2#1)(2011-2#2)
a titrant##7##2##(2008-10#7)
a titration##4##2##(1992-8#1)(2008-10#3)
a to##2##2##(1997-7#1)(2008-10#1)
a tobacco##6##2##(1997-2#3)(2008-10#1)(2008-4#1)(2013-1#1)
a toddler##3##2##(2012-2#3)
a tolerance##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
a tomato##6##2##(1997-6#1)(2008-10#5)
a tone##2##2##(2008-11#1)(2008-4#1)
a tonsillectomy##3##2##(1995-11#1)(2013-1#2)
a tool and##2##3##(2008-7#1)(2013-1#1)
a tool for the##6##4##(1995-6#1)(2008-10#2)(2008-2#2)(2010-11#1)
a tool for##48##3##(1990-11#1)(1990-8#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#3)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-8#1)(2011-1#2)(2011-3#1)
a tool that can##2##4##(2008-3#1)(2008-5#1)
a tool that##4##3##(1992-12#1)(1995-2#1)(2008-3#1)(2008-5#1)
a tool to evaluate##2##4##(2008-7#1)(2012-3#1)
a tool to guide##2##4##(2008-3#1)(2009-10#1)
a tool to identify##2##4##(2008-8#1)(2010-9#1)
a tool to study##4##4##(1995-12#1)(1996-6#1)(2010-6#1)(2010-8#1)
a tool to##36##3##(1990-7#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
a tool##102##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-12#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#5)(2008-5#3)(2008-7#10)(2008-8#6)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#2)(2010-11#2)(2010-2#2)(2010-3#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
a tooth with##2##3##(2009-8#1)(2013-1#1)
a tooth##4##2##(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
a top##6##2##(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-7#1)
a top-down##3##2##(1995-2#1)(2011-2#1)(2013-1#1)
a topic of debate in##2##5##(1995-3#1)(2008-11#1)
a topic of##6##3##(1995-3#1)(1996-12#1)(2008-11#1)(2009-10#1)(2010-8#1)(2012-2#1)
a topic##10##2##(1995-3#1)(1996-12#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-8#1)(2012-2#1)
a topical##5##2##(2008-10#1)(2008-5#4)
a topographic##2##2##(1996-2#1)(2008-12#1)
a topoisomerase##2##2##(1993-8#1)(1995-6#1)
a topological##3##2##(1995-3#1)(2007-12#1)(2010-9#1)
a topology##2##2##(1992-4#1)(2010-3#1)
a total amount##2##3##(2008-10#1)(2008-11#1)
a total analysis time of##3##5##(1991-5#1)(2008-10#2)
a total analysis time##4##4##(1991-5#1)(2008-10#2)(2012-1#1)
a total cholesterol##3##3##(1992-11#2)(2007-11#1)
a total cystectomy##2##3##(2011-2#2)
a total dose of##5##4##(1991-2#2)(1992-11#1)(1995-3#1)(2008-6#1)
a total hip##2##3##(2009-3#2)
a total internal reflection##2##4##(2007-11#1)(2008-3#1)
a total knee arthroplasty##2##4##(2012-12#2)
a total length of##4##4##(1997-2#2)(2013-8#2)
a total number of##4##4##(2007-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
a total of 1##5##4##(1990-11#1)(1996-11#1)(2008-10#2)(2011-2#1)
a total of 10 patients##2##5##(2007-7#1)(2007-8#1)
a total of 10##9##4##(1993-12#1)(1993-9#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)
a total of 100##2##4##(1995-2#1)(2013-1#1)
a total of 102##2##4##(1990-6#1)(2013-1#1)
a total of 104##2##4##(1994-2#1)(1997-3#1)
a total of 11##5##4##(1993-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
a total of 12##4##4##(1992-2#1)(2008-10#1)(2008-12#1)(2009-12#1)
a total of 132##2##4##(2007-2#1)(2008-10#1)
a total of 14##3##4##(1992-11#1)(1994-12#1)(1997-6#1)
a total of 15##2##4##(2008-10#1)(2012-2#1)
a total of 186##2##4##(2007-7#2)
a total of 19##3##4##(1991-11#1)(2008-5#1)(2011-2#1)
a total of 2##6##4##(1992-6#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-7#1)
a total of 20##4##4##(1990-8#1)(1992-6#1)(1995-6#1)(2008-12#1)
a total of 21##3##4##(1990-3#1)(2007-11#1)(2010-5#1)
a total of 24##2##4##(2008-12#1)(2013-8#1)
a total of 28##2##4##(1991-12#1)(1996-9#1)
a total of 3##4##4##(1996-6#1)(2008-10#1)(2012-2#2)
a total of 31##2##4##(2008-7#1)(2011-2#1)
a total of 4##3##4##(1994-2#1)(2008-12#1)(2013-1#1)
a total of 5##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
a total of 6##5##4##(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#2)
a total of 60##2##4##(2007-11#1)(2008-6#1)
a total of 7##2##4##(1997-3#1)(2008-6#1)
a total of 72##2##4##(1996-8#1)(2008-10#1)
a total of 8##3##4##(1993-6#1)(2008-6#1)(2013-7#1)
a total of 96##3##4##(2008-10#1)(2010-4#1)(2013-7#1)
a total of eight##2##4##(1994-5#1)(2008-12#1)
a total of four##2##4##(2007-12#1)(2008-10#1)
a total of ten##3##4##(2008-3#1)(2008-6#1)(2011-2#1)
a total of##210##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#32)(2008-11#5)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#17)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#7)(2013-8#3)
a total population of##3##4##(1991-12#1)(1993-6#1)(2008-4#1)
a total pressure of##3##4##(2007-12#2)(2008-2#1)
a total quality management##3##4##(1994-2#1)(1995-3#1)(1996-12#1)
a total quality##6##3##(1994-2#1)(1995-3#2)(1996-12#1)(2007-8#2)
a total size of##2##4##(1996-12#1)(1997-2#1)
a total time of##2##4##(2008-10#2)
a total time##4##3##(1994-3#1)(2008-10#3)
a total writing##2##3##(2008-3#2)
a total##320##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#4)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#1)(1994-5#2)(1994-7#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#2)(2007-10#3)(2007-11#7)(2007-12#10)(2007-2#1)(2007-7#5)(2007-8#5)(2008-1#6)(2008-10#52)(2008-11#7)(2008-12#9)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#7)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#19)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#9)(2013-1#11)(2013-7#7)(2013-8#7)
a totally##5##2##(1996-11#1)(2008-10#2)(2008-9#1)(2009-10#1)
a tourniquet##2##2##(1992-6#1)(2009-3#1)
a town##3##2##(1996-3#1)(2008-11#1)(2008-7#1)
a toxic effect of##2##4##(1991-8#1)(2008-8#1)
a toxic effect##3##3##(1991-8#1)(2008-5#1)(2008-8#1)
a toxic##11##2##(1990-5#1)(1991-8#1)(1993-12#1)(1995-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
a toxicological##2##2##(1991-5#1)(2008-10#1)
a toxin that##2##3##(2008-10#1)(2008-5#1)
a toxin##7##2##(1992-9#1)(1997-2#1)(2008-10#4)(2008-5#1)
a trace amount of sodium sulfide##3##6##(2008-5#2)(2013-1#1)
a trace amount of##8##4##(1991-5#1)(2008-10#3)(2008-5#2)(2008-8#1)(2013-1#1)
a trace##18##2##(1991-5#1)(2008-10#4)(2008-3#3)(2008-5#8)(2008-8#1)(2013-1#1)
a tracer##7##2##(1990-11#1)(1990-5#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
a tracheal##3##2##(1991-11#1)(2008-7#1)(2010-7#1)
a tracheostomy##2##2##(1995-2#1)(2008-2#1)
a track##4##2##(1997-2#1)(2007-12#1)(2010-12#1)(2012-3#1)
a tractable##2##2##(2008-3#1)(2008-4#1)
a trade-off between virulence and vertical transmission##2##7##(2008-9#2)
a trade-off between##18##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#5)(2008-9#4)(2012-2#1)(2013-1#1)
a trade-off##21##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#5)(2008-9#4)(2010-10#1)(2012-2#1)(2013-1#2)
a tradition of##3##3##(1991-2#1)(1994-3#1)(2011-2#1)
a traditional open##2##3##(1997-8#1)(2008-10#1)
a traditional##29##2##(1991-12#1)(1992-12#1)(1994-9#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#3)(2010-7#1)(2012-12#1)(2013-1#2)
a traffic accident##3##3##(1995-3#1)(1997-3#1)(2009-3#1)
a traffic##4##2##(1995-3#1)(1997-3#1)(2009-3#1)(2011-2#1)
a train of##2##3##(2007-12#1)(2008-2#1)
a train##3##2##(1997-2#1)(2007-12#1)(2008-2#1)
a trained##3##2##(1996-2#1)(1997-4#1)(2008-10#1)
a training program##3##3##(1991-12#1)(2008-7#2)
a training programme##2##3##(2011-2#1)(2013-8#1)
a training set of##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
a training set##6##3##(1995-6#2)(1995-9#1)(2008-10#2)(2008-3#1)
a training##23##2##(1990-3#1)(1991-12#1)(1992-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)(2010-9#1)(2011-2#1)(2013-8#1)
a trait of interest##2##4##(2012-3#2)
a trait that##2##3##(2008-8#1)(2012-3#1)
a trait##9##2##(1996-7#1)(2008-4#1)(2008-8#2)(2010-1#1)(2012-3#3)(2013-1#1)
a trajectory##2##2##(1994-2#1)(2008-10#1)
a trans-acting##2##2##(1993-12#1)(2008-9#1)
a transcript map##2##3##(1996-8#1)(1997-2#1)
a transcript of##4##3##(1991-6#1)(1993-2#1)(1996-6#1)(2010-7#1)
a transcript##9##2##(1991-6#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2010-7#1)
a transcription factor for##2##4##(1995-2#1)(2006-8#1)
a transcription factor that##2##4##(1994-11#1)(2013-1#1)
a transcription factor##16##3##(1993-12#1)(1993-2#1)(1994-11#1)(1995-2#1)(2006-8#2)(2008-11#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-1#1)
a transcription##20##2##(1993-12#2)(1993-2#1)(1994-11#1)(1995-2#1)(1997-2#1)(2006-8#2)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#3)(2013-1#1)
a transcriptional activator##4##3##(1997-3#1)(2008-11#1)(2008-9#1)(2009-8#1)
a transcriptional fusion##2##3##(1994-12#1)(2008-10#1)
a transcriptional##17##2##(1991-10#1)(1992-12#1)(1994-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
a transducer of the##2##4##(1995-2#1)(2008-9#1)
a transducer##7##2##(1995-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-9#1)
a transfection##4##2##(1995-4#1)(2008-11#2)(2008-2#1)
a transfer of##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
a transfer##7##2##(1993-11#1)(2007-12#3)(2008-10#2)(2008-2#1)
a transform##2##2##(2007-12#1)(2008-3#1)
a transformation##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
a transformed##3##2##(1993-3#1)(1996-5#1)(2008-8#1)
a transfusion reaction##2##3##(1994-12#1)(1994-9#1)
a transfusion##4##2##(1994-12#1)(1994-9#1)(1995-6#1)(1996-9#1)
a transgene##6##2##(1990-12#1)(1995-2#1)(2007-11#1)(2008-11#2)(2008-4#1)
a transgenic mouse model##2##4##(1995-6#1)(2010-8#1)
a transgenic mouse##3##3##(1994-3#1)(1995-6#1)(2010-8#1)
a transgenic##13##2##(1994-3#1)(1995-2#1)(1995-6#1)(2008-10#5)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
a transient expression assay##2##4##(1992-12#1)(1997-4#1)
a transient expression##4##3##(1992-12#1)(1997-4#1)(2008-11#1)(2010-11#1)
a transient increase in the##4##5##(1993-3#1)(2007-11#1)(2008-8#1)(2010-12#1)
a transient increase in##9##4##(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
a transient increase##10##3##(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
a transient intermediate##3##3##(1996-5#2)(2009-11#1)
a transient phase##2##3##(1994-2#1)(2008-1#1)
a transient response to##2##4##(1996-5#1)(1997-3#1)
a transient##60##2##(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-11#2)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
a transition from the##2##4##(1996-2#1)(2007-12#1)
a transition from##6##3##(1991-1#1)(1993-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2010-6#1)
a transition in##2##3##(2008-2#1)(2012-12#1)
a transition period##3##3##(1992-3#1)(1996-3#1)(2011-2#1)
a transition to##2##3##(1997-7#1)(2008-10#1)
a transition##26##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#1)(2009-1#1)(2010-6#1)(2011-2#1)(2012-12#1)
a transition-state analog##2##3##(1991-5#1)(1995-2#1)
a transition-state##3##2##(1991-5#1)(1995-2#1)(2008-5#1)
a transitional##4##2##(1993-2#1)(2007-10#1)(2007-8#1)(2009-10#1)
a transitory##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
a translated protein##2##3##(1997-2#1)(2008-4#1)
a translation product of##2##4##(1994-8#1)(2008-10#1)
a translation##9##2##(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2010-8#1)(2012-3#1)
a translational##5##2##(1990-7#1)(2008-10#1)(2010-10#1)(2010-8#1)(2012-12#1)
a translocation##5##2##(1996-6#1)(2008-10#2)(2008-5#1)(2008-6#1)
a translucent##2##2##(2007-12#1)(2009-8#1)
a transmastoid##3##2##(2011-2#3)
a transmembrane H+ gradient##2##4##(1994-6#2)
a transmembrane glycoprotein##2##3##(1992-12#1)(1996-12#1)
a transmembrane protein##3##3##(1993-12#1)(2007-7#1)(2008-9#1)
a transmembrane transporter##2##3##(1993-12#2)
a transmembrane##13##2##(1992-12#1)(1993-12#3)(1994-6#2)(1995-6#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)
a transmission##15##2##(1994-8#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#2)
a transmissive##4##2##(2008-3#4)
a transmitted##3##2##(2008-2#2)(2009-11#1)
a transmitter##3##2##(1992-6#1)(2008-3#1)(2008-7#1)
a transparent dressing##2##3##(2007-7#2)
a transparent glass##2##3##(2008-3#2)
a transparent substrate##2##3##(2008-3#1)(2008-5#1)
a transparent thin film##2##4##(2007-11#1)(2008-3#1)
a transparent##24##2##(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2010-3#1)(2013-8#1)
a transplant##3##2##(1994-5#1)(2007-7#1)(2010-5#1)
a transport##4##2##(1990-2#1)(1994-12#1)(2008-11#1)(2008-2#1)
a transportable##2##2##(2008-10#1)(2008-2#1)
a transposable##2##2##(2008-10#1)(2010-8#1)
a transradial##2##2##(2011-2#2)
a transversal##2##2##(2008-12#1)(2012-3#1)
a transverse incision in##2##4##(1992-2#1)(2011-2#1)
a transverse single-mode vertical-cavity surface-emitting laser##2##6##(2007-12#2)
a transverse single-mode##3##3##(2007-12#3)
a transverse##13##2##(1992-2#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)(2012-12#1)
a transversely heated graphite##4##4##(2008-10#4)
a transversely##6##2##(2007-11#1)(2008-10#5)
a trapezoidal##2##2##(2008-10#1)(2008-3#1)
a trauma##3##2##(1991-2#1)(2009-11#1)(2010-12#1)
a traumatic##13##2##(1994-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
a traveling##2##2##(2007-12#1)(2008-10#1)
a traveling-wave##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a travellers' vaccination record##2##4##(2007-2#2)
a treatable##3##2##(2008-1#2)(2010-1#1)
a treatment approach##2##3##(2008-6#1)(2008-7#1)
a treatment complication##2##3##(2008-1#2)
a treatment for##13##3##(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#3)(2013-1#1)
a treatment group receiving videotape training in##2##7##(1991-1#2)
a treatment group##3##3##(1991-1#2)(1996-11#1)
a treatment modality for##2##4##(2007-12#1)(2013-1#1)
a treatment modality##3##3##(2007-12#2)(2013-1#1)
a treatment of##5##3##(1994-7#1)(2008-10#1)(2008-3#2)(2011-1#1)
a treatment option for##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
a treatment option##6##3##(2007-11#2)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
a treatment planning##2##3##(2008-7#1)(2013-1#1)
a treatment strategy##2##3##(2008-7#1)(2010-12#1)
a treatment##67##2##(1990-2#1)(1991-1#3)(1991-8#1)(1993-11#1)(1994-7#1)(1996-11#1)(1996-5#2)(1997-5#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2010-1#1)(2010-12#3)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#3)
a tree species##2##3##(2008-9#1)(2012-6#1)
a tree##12##2##(2007-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2012-6#1)
a tremendous##10##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
a trend of decreasing##2##4##(2008-10#1)(2008-11#1)
a trend of##7##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
a trend to##3##3##(2008-7#2)(2013-8#1)
a trend toward a##3##4##(1992-9#1)(2008-5#1)(2008-7#1)
a trend toward##14##3##(1990-5#1)(1992-9#1)(1993-12#1)(1995-11#1)(1996-11#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2013-1#1)
a trend towards a##3##4##(1990-12#1)(2008-7#2)
a trend towards an##2##4##(2008-10#1)(2008-7#1)
a trend towards improved##2##4##(2008-6#1)(2010-3#1)
a trend towards improvement##2##4##(2009-3#2)
a trend towards##17##3##(1990-12#1)(1990-6#1)(1995-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#3)(2009-3#2)(2010-11#1)(2010-3#2)(2011-2#1)
a trend##51##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-3#3)(2010-11#1)(2010-3#2)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
a tri-colour##2##2##(2008-10#2)
a tri-ethnic sample##2##3##(2007-12#2)
a triad of##2##3##(2008-7#1)(2012-2#1)
a trial of##8##3##(1991-11#1)(1995-4#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
a trial to##2##3##(1995-9#1)(2008-10#1)
a trial##35##2##(1990-11#1)(1990-6#1)(1991-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-9#3)(1996-6#3)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
a triangular waveform##2##3##(2008-10#2)
a triangular##9##2##(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#2)(2010-6#1)
a triangulation##2##2##(2008-3#1)(2013-1#1)
a triaxial##2##2##(2007-12#2)
a trigger for##3##3##(1994-5#1)(2008-11#2)
a trigger of##2##3##(2008-1#1)(2011-2#1)
a trigger##7##2##(1992-3#1)(1994-5#1)(2008-1#1)(2008-11#2)(2011-2#1)(2012-12#1)
a trigonal##2##2##(1996-2#2)
a tripartite##3##2##(1991-5#1)(2008-12#1)(2009-8#1)
a tripeptide##4##2##(1990-7#1)(1992-3#1)(1993-9#1)(2008-5#1)
a triple##7##2##(1993-8#1)(1995-8#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
a triplet##3##2##(1993-3#1)(2008-2#1)(2008-3#1)
a tritiated##2##2##(1992-8#1)(2008-11#1)
a trivalent candidate##2##3##(2008-9#2)
a trivalent##3##2##(2007-2#1)(2008-9#2)
a trivial##2##2##(2007-8#1)(2008-11#1)
a trophic##4##2##(1993-5#1)(1993-6#1)(1996-12#1)(1997-6#1)
a tropical##14##2##(1995-6#1)(1996-12#1)(2008-10#2)(2008-2#2)(2008-5#2)(2008-9#1)(2010-11#1)(2012-3#1)(2013-7#2)(2013-8#1)
a trout liver cell line##2##5##(1990-12#1)(1992-6#1)
a trout##3##2##(1990-12#1)(1990-5#1)(1992-6#1)
a true increase in##2##4##(2008-1#2)
a true stem cell##2##4##(2008-11#1)(2009-3#1)
a true##29##2##(1992-12#1)(1994-5#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-7#1)(2010-6#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
a truly##5##2##(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
a truncated cDNA##2##3##(1990-7#1)(1993-8#1)
a truncated form of##3##4##(1991-12#1)(2008-11#1)(2008-9#1)
a truncated soluble form of furin##2##6##(1992-12#2)
a truncated##16##2##(1990-7#1)(1991-12#2)(1992-12#2)(1992-3#1)(1993-8#1)(1993-9#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
a trustee##3##2##(1993-1#1)(1993-2#1)(1994-1#1)
a tryptophan##3##2##(1991-5#1)(1992-6#1)(2011-2#1)
a tsunami##2##2##(1990-11#1)(2013-1#1)
a tube##7##2##(1990-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)
a tuberculosis##3##2##(1996-3#1)(1997-2#1)(2013-1#1)
a tubular##8##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-1#2)(2013-1#1)
a tubulin##2##2##(2008-7#1)(2009-7#1)
a tumor arising from##2##4##(1992-12#1)(1993-9#1)
a tumor cell##2##3##(2009-12#1)(2009-3#1)
a tumor in##2##3##(2008-3#1)(2008-6#1)
a tumor marker##5##3##(1992-3#1)(1993-1#2)(2008-4#1)(2009-4#1)
a tumor mass in the##2##5##(1990-6#1)(2008-1#1)
a tumor mass in##3##4##(1990-6#1)(2008-1#1)(2013-8#1)
a tumor necrosis factor##2##4##(2012-3#2)
a tumor necrosis##3##3##(2012-3#2)(2013-1#1)
a tumor of##3##3##(1991-4#1)(2011-2#1)(2013-1#1)
a tumor suppressor gene by##2##5##(1995-2#1)(2008-9#1)
a tumor suppressor gene##6##4##(1994-12#1)(1994-6#1)(1995-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
a tumor suppressor##12##3##(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
a tumor with##3##3##(1991-4#1)(1994-12#1)(1994-2#1)
a tumor##63##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-4#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-4#2)(1995-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#4)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
a tumor-associated##2##2##(1994-5#1)(2008-11#1)
a tumor-selective##2##2##(1994-5#1)(2008-5#1)
a tumour in the##2##4##(2007-8#1)(2008-7#1)
a tumour in##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
a tumour##11##2##(1991-11#1)(1997-3#1)(2007-8#1)(2008-2#1)(2008-7#2)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
a tunable cw##2##3##(2007-12#1)(2008-3#1)
a tunable fiber ring depolarizer##2##5##(2008-3#2)
a tunable fiber##3##3##(2007-11#1)(2008-3#2)
a tunable optical##4##3##(2007-11#2)(2008-2#2)
a tunable single-frequency##2##3##(2008-3#2)
a tunable##43##2##(1992-6#1)(2007-11#7)(2007-12#9)(2008-2#5)(2008-3#19)(2009-6#1)(2009-8#1)
a tungsten coil##4##3##(2008-10#4)
a tungsten lamp##2##3##(2008-10#1)(2008-2#1)
a tungsten wire##4##3##(2008-10#4)
a tungsten##15##2##(2007-12#1)(2008-10#13)(2008-2#1)
a tuning range of##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
a tuning range##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
a tuning##8##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
a tunnel diode can be##2##5##(2008-3#2)
a tunnel diode##4##3##(2008-3#4)
a tunnel##5##2##(2008-3#4)(2009-10#1)
a tunneling##2##2##(2007-7#1)(2008-3#1)
a turbid medium by##2##4##(2008-3#2)
a turbid medium such as##2##5##(2008-3#2)
a turbid medium with##2##4##(2008-2#1)(2008-3#1)
a turbid medium##24##3##(2007-11#1)(2007-12#5)(2008-2#6)(2008-3#12)
a turbid phantom##2##3##(2007-12#1)(2008-3#1)
a turbid##29##2##(2007-11#2)(2007-12#7)(2008-2#7)(2008-3#13)
a turbulent flame##3##3##(2008-3#3)
a turbulent##8##2##(2008-2#2)(2008-3#6)
a turn##3##2##(1994-5#1)(1995-2#1)(2008-3#1)
a turning##2##2##(1993-3#1)(2009-7#1)
a tutorial##2##2##(2009-10#1)(2009-2#1)
a twelve-year-old##2##2##(1995-12#1)(2007-8#1)
a twin##5##2##(1990-6#1)(2007-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
a twin-core##2##2##(2007-11#1)(2008-2#1)
a twist##2##2##(2012-2#2)
a twisted##2##2##(2008-2#1)(2008-7#1)
a twisted-nematic liquid-crystal display##3##4##(2007-12#2)(2008-2#1)
a two component model##2##4##(1991-12#1)(2008-10#1)
a two component##3##3##(1991-12#1)(2008-10#1)(2012-1#1)
a two stage##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
a two year##3##3##(1991-9#1)(2008-12#1)(2010-8#1)
a two##26##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
a two- or##2##3##(2008-3#1)(2008-7#1)
a two-##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
a two-angle##2##2##(2008-2#2)
a two-beam##7##2##(2007-12#1)(2008-3#6)
a two-channel##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
a two-color elliptically polarized laser field##2##6##(2007-12#2)
a two-color##5##2##(1997-3#1)(2007-12#2)(2008-2#1)(2008-3#1)
a two-compartment##2##2##(1996-5#1)(2008-1#1)
a two-component atmosphere with variable##2##5##(2008-2#2)
a two-component##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
a two-cycle##2##2##(2008-12#1)(2008-3#1)
a two-dimensional (2D)##4##3##(2007-12#2)(2008-2#1)(2011-1#1)
a two-dimensional array of##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
a two-dimensional laminar counterflow burner (Tsuji burner) with a 60-mm line-of-sight path length##2##13##(2008-2#1)(2008-3#1)
a two-dimensional periodic##3##3##(2008-3#2)(2008-7#1)
a two-dimensional photonic crystal##5##4##(2007-11#3)(2007-12#2)
a two-dimensional photonic-crystal##2##3##(2007-12#2)
a two-dimensional plane from##2##4##(2007-11#2)
a two-dimensional system##2##3##(1992-5#1)(2007-12#1)
a two-dimensional##80##2##(1991-9#1)(1992-5#1)(1993-11#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-11#13)(2007-12#14)(2008-10#2)(2008-11#1)(2008-2#13)(2008-3#26)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)
a two-domain organization##2##3##(2010-10#2)
a two-domain##3##2##(1991-9#1)(2010-10#2)
a two-electron##2##2##(2008-10#2)
a two-factorial##2##2##(1996-12#1)(1997-3#1)
a two-fold##3##2##(1991-12#1)(2008-2#1)(2009-12#1)
a two-generation##2##2##(2008-10#1)(2010-1#1)
a two-laser##2##2##(2008-3#2)
a two-layer structure##3##3##(2007-12#2)(2008-3#1)
a two-layer##11##2##(2007-12#3)(2008-2#2)(2008-3#4)(2010-2#1)(2011-1#1)
a two-level##4##2##(2007-11#2)(2008-10#1)(2008-7#1)
a two-mirror##2##2##(2008-2#1)(2008-3#1)
a two-part series##3##3##(1996-2#1)(2007-5#1)(2008-10#1)
a two-part##8##2##(1992-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(2007-2#1)(2007-5#1)(2008-10#1)(2012-3#1)
a two-phase solvent system composed of##2##6##(2008-10#1)(2011-1#1)
a two-phase##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
a two-photon fluorescence microscope##2##4##(2007-11#1)(2007-12#1)
a two-photon fluorescence##3##3##(2007-11#2)(2007-12#1)
a two-photon process##2##3##(2007-11#1)(2008-3#1)
a two-photon##10##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#4)
a two-scale##2##2##(2008-10#1)(2008-3#1)
a two-site##2##2##(2009-7#1)(2013-8#1)
a two-stage procedure##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
a two-stage process##3##3##(2007-2#1)(2008-11#1)(2008-3#1)
a two-stage##25##2##(1990-11#1)(1991-12#1)(1991-6#1)(1994-12#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#2)(2013-1#2)
a two-staged##2##2##(2008-6#1)(2008-7#1)
a two-state model##5##3##(1990-7#1)(1991-8#1)(1995-5#1)(1995-6#1)(1997-2#1)
a two-state transition##2##3##(1992-10#1)(1993-8#1)
a two-state##11##2##(1990-7#1)(1991-8#1)(1992-10#1)(1993-11#2)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-2#2)
a two-step procedure##2##3##(2008-2#1)(2008-3#1)
a two-step process involving##2##4##(2008-2#1)(2009-4#1)
a two-step process##6##3##(1994-2#1)(1995-5#1)(2007-12#1)(2008-2#1)(2009-4#1)(2012-3#1)
a two-step reaction##2##3##(2008-10#1)(2008-6#1)
a two-step sequence##2##3##(1997-7#1)(2009-5#1)
a two-step##29##2##(1990-2#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#2)(2011-1#1)(2012-3#1)
a two-wave##2##2##(2007-11#1)(2008-3#1)
a two-wavelength lidar##2##3##(2008-2#1)(2008-3#1)
a two-wavelength##8##2##(2008-2#3)(2008-3#5)
a two-way##5##2##(1991-2#1)(1996-5#1)(2008-9#1)(2010-8#1)(2012-2#1)
a two-week##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
a two-wire##2##2##(2008-2#2)
a two-year##6##2##(1991-1#1)(1994-1#1)(1995-1#1)(2007-10#1)(2008-12#1)(2011-2#1)
a twofold increase in##3##4##(2008-2#2)(2008-7#1)
a twofold increase##5##3##(1996-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
a twofold##8##2##(1996-12#1)(1996-5#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-8#1)
a type 1##6##3##(1992-12#1)(1992-3#1)(1993-6#1)(2007-2#1)(2007-7#1)(2013-1#1)
a type 2##2##3##(1990-2#1)(2012-12#1)
a type 3##2##3##(2008-10#1)(2012-12#1)
a type A##2##3##(1994-2#1)(1995-2#1)
a type C##2##3##(1992-3#1)(2008-4#1)
a type I IFN##2##4##(2007-11#2)
a type I##11##3##(1990-11#1)(1991-12#1)(1993-11#2)(1995-2#1)(1997-7#1)(2007-11#2)(2008-2#2)(2012-3#1)
a type II topology##2##4##(1997-7#2)
a type II##11##3##(1991-10#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-2#2)(2008-5#1)(2009-7#1)(2013-7#1)
a type III secretion##2##4##(2008-10#1)(2008-9#1)
a type III##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
a type of##22##3##(1993-12#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
a type##70##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-6#1)(1994-2#2)(1995-2#2)(1995-5#1)(1996-3#1)(1997-7#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a typical Michaelis-Menten##2##3##(1997-2#1)(2012-2#1)
a typical case of##3##4##(1991-9#1)(2008-1#2)
a typical case##5##3##(1991-9#1)(1994-12#1)(2008-1#2)(2008-3#1)
a typical feature of##3##4##(1997-6#1)(2008-10#1)(2008-8#1)
a typical lifetime##2##3##(2011-2#2)
a typical model of##2##4##(2008-3#1)(2013-8#1)
a typical##122##2##(1990-3#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#3)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#24)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#6)(2009-11#1)(2009-5#2)(2009-8#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-2#6)(2013-8#3)
a typology of##2##3##(2008-12#1)(2012-12#1)
a typology that##2##3##(1996-12#1)(2010-12#1)
a typology##4##2##(1996-12#1)(2008-12#1)(2010-12#1)(2012-12#1)
a tyrosinase##3##2##(2008-10#3)
a tyrosine kinase inhibitor##2##4##(1990-11#2)
a tyrosine kinase##6##3##(1990-11#2)(1992-12#1)(1993-3#1)(2008-3#2)
a tyrosine phosphatase##2##3##(1994-11#1)(1995-2#1)
a tyrosine residue responsible for##2##5##(2008-4#2)
a tyrosine residue##4##3##(1992-1#1)(1993-11#1)(2008-4#2)
a tyrosine##16##2##(1990-11#2)(1992-1#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-3#2)(2008-4#2)
a ubiquitous##16##2##(1990-8#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
a ubiquitously expressed##2##3##(1995-8#1)(2009-8#1)
a une##2##2##(2008-5#2)
a uniaxial##2##2##(2008-3#2)
a unidimensional##3##2##(1996-2#1)(2010-2#1)(2012-2#1)
a unidirectional##2##2##(2007-12#1)(2008-2#1)
a unified approach to##2##4##(2008-3#1)(2010-11#1)
a unified approach##3##3##(2007-11#1)(2008-3#1)(2010-11#1)
a unified representation##2##3##(1996-4#1)(2008-6#1)
a unified##23##2##(1992-1#1)(1993-12#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a uniform and##2##3##(2008-4#1)(2008-9#1)
a uniform beam##2##3##(2007-12#1)(2008-2#1)
a uniform set of##2##4##(2008-10#1)(2008-7#1)
a uniform thickness##2##3##(2008-2#1)(2008-3#1)
a uniform##47##2##(1992-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-2#2)(1996-3#1)(1997-4#1)(2007-11#5)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
a uniformity##2##2##(2007-11#1)(2008-2#1)
a uniformly##6##2##(2008-2#2)(2008-3#3)(2012-1#1)
a unifying model##2##3##(1993-12#1)(2008-11#1)
a unifying##6##2##(1993-12#1)(2007-7#1)(2008-11#3)(2010-5#1)
a unilateral##13##2##(1991-5#1)(1995-2#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-1#2)(2011-2#1)
a unimolecular layer##2##3##(1991-5#2)
a union##3##2##(1991-2#1)(1994-8#1)(2011-2#1)
a unique AFLP##2##3##(2008-10#2)
a unique DNA##2##3##(1997-9#1)(2008-2#1)
a unique and##3##3##(1992-1#1)(1993-12#1)(2012-3#1)
a unique approach to##4##4##(1994-3#1)(1996-3#1)(2008-9#1)(2009-8#1)
a unique case of a##2##5##(2008-4#1)(2011-1#1)
a unique case of##4##4##(2007-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
a unique case##6##3##(2007-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
a unique clinical##2##3##(2011-2#1)(2013-8#1)
a unique compound of royal jelly##2##6##(2008-10#2)
a unique contribution##2##3##(1994-2#1)(2011-2#1)
a unique educational##2##3##(1993-1#1)(2008-10#1)
a unique evolutionary##2##3##(2008-10#1)(2012-2#1)
a unique fingerprint##2##3##(1996-12#1)(2008-10#1)
a unique form of##2##4##(2012-2#1)(2013-7#1)
a unique group##2##3##(2008-10#2)
a unique haplotype##2##3##(2008-10#1)(2012-3#1)
a unique insight into the##2##5##(1992-6#1)(2007-8#1)
a unique macronutrient composition##2##4##(2008-3#2)
a unique marker##2##3##(1993-8#1)(2012-12#1)
a unique mechanism##3##3##(1994-2#1)(1995-8#1)(2009-8#1)
a unique member of the##2##5##(1993-2#1)(2008-11#1)
a unique opportunity for##2##4##(1991-2#1)(2008-10#1)
a unique opportunity to test##2##5##(2008-12#1)(2010-3#1)
a unique opportunity to##12##4##(1991-8#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
a unique opportunity##14##3##(1991-2#1)(1991-8#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
a unique phenomenon##2##3##(2007-12#1)(2008-2#1)
a unique platform##2##3##(2008-7#1)(2012-3#1)
a unique position##9##3##(1995-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)
a unique program##2##3##(1993-1#1)(1996-3#1)
a unique role in##2##4##(1994-11#1)(2009-10#1)
a unique role##4##3##(1994-11#1)(1997-4#1)(2009-10#1)(2012-1#1)
a unique sequence##3##3##(1993-12#1)(1993-6#1)(2012-2#1)
a unique set of##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
a unique site in##3##4##(1990-7#1)(1995-2#1)(1995-6#1)
a unique solution##5##3##(1997-8#2)(2008-3#2)(2008-7#1)
a unique system##2##3##(2008-5#1)(2009-8#1)
a unique time-differential##2##3##(2008-2#2)
a unique view into##2##4##(2008-4#1)(2011-7#1)
a unique way##4##3##(1993-1#1)(1995-1#1)(2007-11#1)(2007-12#1)
a unique##255##2##(1990-11#1)(1990-7#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#3)(1997-9#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#32)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#1)(2009-5#2)(2009-6#3)(2009-8#5)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#4)
a uniquely##5##2##(2007-12#1)(2008-11#1)(2008-7#1)(2009-7#1)(2013-8#1)
a unit block##2##3##(2007-11#1)(2009-9#1)
a unit##10##2##(1990-2#1)(1993-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-2#1)
a unitary##2##2##(1994-11#1)(2007-5#1)
a united##3##2##(2008-8#1)(2009-10#1)(2010-5#1)
a univariate or##2##3##(2008-10#2)
a univariate##5##2##(1991-2#1)(2008-10#3)(2009-4#1)
a universal health##2##3##(1991-2#1)(2007-12#1)
a universal testing machine##4##4##(2008-12#2)(2009-8#1)(2013-1#1)
a universal##24##2##(1991-2#1)(1991-5#1)(1993-11#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a university and##3##3##(1996-1#1)(2008-11#1)(2010-10#1)
a university hospital in Santiago##2##5##(2013-1#2)
a university hospital in##3##4##(2011-2#1)(2013-1#2)
a university hospital##9##3##(1996-12#1)(2008-11#1)(2009-1#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
a university teaching##2##3##(2008-12#1)(2008-7#1)
a university##26##2##(1994-12#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-1#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
a university-based##3##2##(1995-2#1)(2008-1#1)(2008-12#1)
a urachal remnant##2##3##(2008-10#2)
a urachal##4##2##(2008-10#2)(2008-6#1)(2009-5#1)
a uracil##2##2##(1991-7#1)(2008-10#1)
a uranium-contaminated aquifer##2##3##(2013-8#2)
a ureteral calculus##2##3##(2008-7#2)
a ureteral stent##2##3##(2008-10#1)(2013-1#1)
a ureteral##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
a urinary tract infection##2##4##(1994-2#1)(2008-7#1)
a urinary##7##2##(1990-12#1)(1991-11#1)(1991-12#1)(1993-6#1)(1994-2#1)(2008-7#1)(2012-12#1)
a urine##7##2##(1996-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2012-12#1)(2013-1#2)
a use of##3##3##(2007-8#2)(2008-3#1)
a use##4##2##(2007-8#2)(2008-3#1)(2010-4#1)
a used##5##2##(1992-12#1)(2008-10#3)(2008-3#1)
a useful addition to##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
a useful adjunct##5##3##(1993-2#1)(2007-8#1)(2008-9#1)(2010-11#1)(2012-3#1)
a useful alternative for##3##4##(2008-10#2)(2012-2#1)
a useful alternative##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
a useful and##7##3##(1993-12#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
a useful approach for the##2##5##(1995-8#1)(2012-3#1)
a useful approach for##4##4##(1995-8#1)(2008-10#2)(2012-3#1)
a useful approach to##2##4##(1990-6#1)(2012-3#1)
a useful approach##8##3##(1990-6#1)(1995-8#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-3#2)
a useful biomarker for##2##4##(1992-9#1)(2010-1#1)
a useful biomarker##4##3##(1992-9#1)(2009-11#1)(2009-6#1)(2010-1#1)
a useful exercise##2##3##(2008-11#1)(2009-4#1)
a useful experimental model for##2##5##(1994-3#1)(2008-10#1)
a useful experimental##3##3##(1994-3#1)(2007-9#1)(2008-10#1)
a useful first-line##2##3##(2008-2#1)(2011-2#1)
a useful framework for##3##4##(2007-4#1)(2007-8#1)(2009-4#1)
a useful framework##5##3##(2007-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-4#1)
a useful guide##2##3##(2008-10#1)(2008-11#1)
a useful in vitro model for##2##6##(2008-11#1)(2008-9#1)
a useful in##3##3##(2008-11#2)(2008-9#1)
a useful marker for predicting##2##5##(2008-4#1)(2010-8#1)
a useful marker for##4##4##(2008-4#2)(2010-8#1)(2011-2#1)
a useful marker of##3##4##(2008-3#1)(2010-5#1)(2013-1#1)
a useful marker##7##3##(2008-3#1)(2008-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
a useful means for##2##4##(2008-10#1)(2008-9#1)
a useful means of##2##4##(2008-4#1)(2012-2#1)
a useful means##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
a useful method for##4##4##(1990-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
a useful method##7##3##(1990-12#1)(1994-5#1)(2007-9#1)(2008-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
a useful model for the study of##2##7##(1997-4#1)(2009-9#1)
a useful model for##6##4##(1990-5#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-9#1)
a useful model##9##3##(1990-5#1)(1990-8#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-9#1)(2011-2#1)
a useful parameter to##2##4##(1992-12#1)(2010-7#1)
a useful predictor of##2##4##(2008-3#1)(2013-1#1)
a useful probe for##3##4##(1995-3#1)(2008-3#1)(2008-4#1)
a useful procedure##3##3##(1992-5#1)(2008-4#1)(2012-3#1)
a useful resource##3##3##(1992-3#1)(1993-2#1)(2008-9#1)
a useful screening tool##2##4##(2008-10#1)(2009-10#1)
a useful technique for##5##4##(1992-12#1)(2008-3#1)(2008-9#2)(2013-8#1)
a useful technique##7##3##(1992-12#1)(2007-12#1)(2008-3#1)(2008-9#2)(2010-7#1)(2013-8#1)
a useful test##3##3##(1991-3#1)(1995-5#1)(2008-2#1)
a useful tool for the##6##5##(1990-2#1)(1992-12#1)(1993-9#1)(2008-10#2)(2008-3#1)
a useful tool for##24##4##(1990-2#1)(1991-3#1)(1992-12#1)(1993-9#1)(1995-11#2)(1996-12#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
a useful tool in the##10##5##(1991-12#1)(1994-3#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#1)
a useful tool in##21##4##(1991-11#1)(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a useful tool to investigate##2##5##(2008-11#1)(2010-3#1)
a useful tool to##9##4##(1993-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#2)
a useful tool##55##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-11#2)(1996-12#2)(1996-4#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
a useful treatment##2##3##(2007-12#1)(2008-1#1)
a useful tumor marker##2##4##(1990-8#1)(2011-2#1)
a useful##251##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#4)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#14)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#13)(2008-5#5)(2008-7#10)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2011-2#13)(2012-12#1)(2012-2#3)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#3)
a user can##2##3##(2008-4#1)(2008-6#1)
a user##11##2##(1991-3#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-2#1)
a user's##2##2##(2008-12#1)(2008-3#1)
a user-defined##3##2##(2008-10#2)(2013-1#1)
a user-friendly##3##2##(2007-8#1)(2008-3#1)(2011-1#1)
a using##2##2##(2008-10#2)
a usual source of care##2##5##(1995-12#1)(2008-10#1)
a usual source of##4##4##(1995-12#1)(2008-10#3)
a usual source##5##3##(1995-12#2)(2008-10#3)
a usual##7##2##(1995-12#2)(2008-10#3)(2008-6#1)(2008-9#1)
a uterine##3##2##(1990-10#1)(1994-9#1)(2012-1#1)
a uterus##3##2##(1993-11#2)(1994-2#1)
a utilization##3##2##(1993-1#1)(1995-1#1)(1996-1#1)
a vaccination policy##3##3##(2007-6#3)
a vaccination##4##2##(1997-3#1)(2007-6#3)
a vaccine adjuvant##2##3##(1996-9#1)(2013-1#1)
a vaccine against##4##3##(1997-7#1)(2008-7#1)(2009-6#1)(2010-1#1)
a vaccine in##2##3##(1991-9#1)(2008-8#1)
a vaccine to##3##3##(1995-12#1)(1997-6#1)(2013-1#1)
a vaccine##30##2##(1990-11#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-9#1)(1997-6#1)(1997-7#2)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
a vacuum##10##2##(1994-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
a vaginal##7##2##(1990-2#1)(1992-1#1)(1992-12#1)(1996-12#1)(1996-9#1)(2007-7#1)(2010-3#1)
a valid alternative to the##2##5##(1990-2#1)(2008-7#1)
a valid alternative to##4##4##(1990-2#1)(1992-5#1)(1995-3#1)(2008-7#1)
a valid alternative##10##3##(1990-2#1)(1992-5#1)(1992-6#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-7#2)
a valid and reliable##3##4##(1993-2#1)(1997-1#1)(2013-1#1)
a valid and##5##3##(1993-2#1)(1997-1#1)(2008-5#1)(2010-4#1)(2013-1#1)
a valid tool for##2##4##(2008-7#1)(2011-1#1)
a valid tool##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
a valid##42##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2010-12#1)(2010-4#1)(2011-1#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#3)
a validated questionnaire##2##3##(2008-11#1)(2012-2#1)
a validated##13##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a validation of the##2##4##(2008-3#1)(2013-1#1)
a validation set##3##3##(1995-9#1)(2008-10#2)
a validation##9##2##(1994-3#1)(1995-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2013-1#1)
a valuable adjunct##2##3##(2006-10#1)(2008-7#1)
a valuable and##2##3##(1990-3#1)(2008-11#1)
a valuable approach to##2##4##(2008-4#1)(2008-8#1)
a valuable method for##2##4##(2009-1#1)(2013-8#1)
a valuable method##3##3##(2007-11#1)(2009-1#1)(2013-8#1)
a valuable option##2##3##(2008-10#1)(2009-9#1)
a valuable resource for##2##4##(2008-12#1)(2012-3#1)
a valuable source for##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
a valuable source of##2##4##(2010-7#1)(2012-3#1)
a valuable source##5##3##(2008-10#1)(2008-9#1)(2010-7#1)(2012-3#2)
a valuable supplement to##3##4##(1990-2#1)(2007-11#1)(2007-8#1)
a valuable therapeutic##2##3##(2011-3#1)(2012-2#1)
a valuable tool for the##4##5##(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
a valuable tool for##21##4##(1991-6#1)(1993-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)
a valuable tool in the##5##5##(2007-12#1)(2008-1#2)(2008-11#1)(2009-11#1)
a valuable tool in##7##4##(1997-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-11#1)
a valuable tool to##8##4##(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
a valuable tool##38##3##(1991-6#1)(1993-2#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)
a valuable way##3##3##(2008-11#1)(2008-3#2)
a valuable##105##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
a value comparable##2##3##(2008-10#1)(2008-3#1)
a value of 0##6##4##(1992-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)
a value of 1##2##4##(2008-11#1)(2008-2#1)
a value of rho approximately 0##2##6##(2008-3#2)
a value of##19##3##(1990-12#1)(1992-8#1)(1994-8#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#4)(2010-12#1)
a value##37##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#5)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)
a value-added service##2##3##(1993-2#2)
a value-added##3##2##(1993-2#2)(1996-3#1)
a values##3##2##(1994-1#2)(2010-4#1)
a van##3##2##(1992-10#1)(2008-10#1)(2008-3#1)
a vaporization temperature of##2##4##(2008-10#2)
a vaporization##3##2##(2008-10#2)(2008-2#1)
a variability##2##2##(1991-12#1)(2008-3#1)
a variable degree of##3##4##(2011-2#2)(2012-3#1)
a variable degree##4##3##(1997-3#1)(2011-2#2)(2012-3#1)
a variable factor##2##3##(1997-3#1)(2008-10#1)
a variable number of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
a variable that##2##3##(2008-9#1)(2013-1#1)
a variable##42##2##(1993-6#1)(1997-3#3)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#3)(2010-6#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
a variant of the##3##4##(2008-10#2)(2010-7#1)
a variant of##15##3##(1990-11#1)(1992-2#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-7#1)(2011-1#2)
a variant##20##2##(1990-11#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#2)
a variation coefficient of##3##4##(1993-9#1)(2008-10#2)
a variation in the##3##4##(1994-6#1)(2007-12#1)(2008-3#1)
a variation in##4##3##(1994-6#1)(2007-12#1)(2008-3#2)
a variation of the##9##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-8#1)
a variation##21##2##(1993-9#1)(1994-6#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-2#2)
a varied group of##2##4##(2012-2#2)
a varied##4##2##(2008-10#1)(2008-5#1)(2012-2#2)
a variety of DNA##2##4##(1994-5#1)(2008-4#1)
a variety of activities##2##4##(1997-3#1)(2007-11#1)
a variety of adverse effects##2##5##(1991-5#1)(2008-2#1)
a variety of adverse##4##4##(1991-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
a variety of agents including##2##5##(2006-10#1)(2008-8#1)
a variety of agents##4##4##(1995-6#1)(2006-10#1)(2008-5#1)(2008-8#1)
a variety of alternative##2##4##(1996-1#1)(1996-6#1)
a variety of animal models##3##5##(2008-8#1)(2012-1#1)(2012-12#1)
a variety of animal##5##4##(1992-6#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-12#1)
a variety of applications##7##4##(1996-1#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)
a variety of approaches to##2##5##(2008-10#1)(2010-11#1)
a variety of approaches##4##4##(2008-10#1)(2008-7#1)(2010-11#1)(2010-8#1)
a variety of behavioral##3##4##(1993-12#1)(2008-4#1)(2008-8#1)
a variety of biochemical##3##4##(2008-2#1)(2008-4#1)(2008-7#1)
a variety of biologic##3##4##(1997-1#1)(2008-4#1)(2012-2#1)
a variety of biological activities##2##5##(1995-2#1)(2008-10#1)
a variety of biological samples##2##5##(2008-10#1)(2008-4#1)
a variety of biological##9##4##(1990-11#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
a variety of brain##2##4##(1994-2#1)(2008-1#1)
a variety of cancers##4##4##(2008-12#1)(2008-4#1)(2010-11#1)(2013-8#1)
a variety of causes##2##4##(2008-6#1)(2011-2#1)
a variety of cell lines##2##5##(1991-6#1)(2008-7#1)
a variety of cell surface receptors##2##6##(1997-4#1)(2012-12#1)
a variety of cell##9##4##(1991-6#1)(1997-4#1)(2008-11#2)(2008-7#2)(2008-9#2)(2012-12#1)
a variety of cells in##2##5##(2008-4#1)(2008-7#1)
a variety of cells##9##4##(1992-7#1)(1994-11#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-2#1)
a variety of cellular processes##3##5##(1994-12#1)(2008-4#1)(2008-7#1)
a variety of cellular##4##4##(1994-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
a variety of clinical and##2##5##(1992-9#1)(2011-1#1)
a variety of clinical##8##4##(1992-9#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-5#1)(2011-1#1)
a variety of clinically##2##4##(1994-11#1)(2013-8#1)
a variety of commercially available##2##5##(2008-4#2)
a variety of complex##2##4##(1992-11#1)(2009-11#1)
a variety of compounds##3##4##(2008-10#2)(2009-4#1)
a variety of conditions##5##4##(1990-2#1)(1990-7#1)(2008-6#1)(2008-9#1)(2013-8#1)
a variety of contexts##2##4##(1991-12#1)(2013-8#1)
a variety of data##2##4##(1991-3#1)(1996-2#1)
a variety of different##10##4##(1997-4#2)(2008-10#2)(2008-5#1)(2008-8#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
a variety of disease##2##4##(2008-10#1)(2008-4#1)
a variety of diseases##6##4##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)
a variety of drugs##3##4##(1990-11#1)(2006-10#1)(2008-11#1)
a variety of environmental##3##4##(2008-10#3)
a variety of experimental conditions##3##5##(2008-4#1)(2008-7#1)(2011-1#1)
a variety of experimental##5##4##(1994-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)
a variety of factors##2##4##(2008-7#1)(2013-8#1)
a variety of fields##2##4##(2010-1#1)(2011-8#1)
a variety of forms##3##4##(1997-3#1)(2008-6#1)(2009-2#1)
a variety of formulations##2##4##(2008-11#1)(2010-8#1)
a variety of functional##2##4##(1992-11#1)(2008-9#1)
a variety of functions##4##4##(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)
a variety of genes##4##4##(1993-3#1)(1995-12#1)(1996-2#1)(2008-10#1)
a variety of heterologous##2##4##(1995-5#1)(1996-12#1)
a variety of human cancers##3##5##(2008-8#1)(2012-12#1)(2013-1#1)
a variety of human##9##4##(1990-11#1)(1994-10#2)(1994-6#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
a variety of laboratory##2##4##(2008-7#1)(2012-12#1)
a variety of lesions##2##4##(1997-3#1)(2010-8#1)
a variety of lidar applications##2##5##(2008-2#1)(2008-3#1)
a variety of materials##3##4##(1995-3#1)(2007-11#1)(2010-4#1)
a variety of matrices##2##4##(2008-10#2)
a variety of mechanisms##6##4##(2007-5#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-12#1)
a variety of medical##7##4##(2007-12#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
a variety of methods to##2##5##(1993-3#1)(1995-1#1)
a variety of methods##5##4##(1993-3#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
a variety of mutations##2##4##(2008-4#2)
a variety of new##3##4##(1995-3#1)(2007-9#1)(2012-3#1)
a variety of normal and##2##5##(1994-5#1)(2008-4#1)
a variety of novel##2##4##(2008-10#1)(2008-11#1)
a variety of optical##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
a variety of organic##2##4##(2008-10#1)(2012-2#1)
a variety of organisms##3##4##(2008-4#1)(2008-7#1)(2012-3#1)
a variety of other anions##2##5##(1990-5#1)(2008-10#1)
a variety of other##14##4##(1990-5#1)(1993-12#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-8#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
a variety of pathologies##2##4##(2006-12#1)(2010-4#1)
a variety of patient##2##4##(2008-11#1)(2008-12#1)
a variety of physiological##4##4##(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
a variety of potential applications##2##5##(2009-10#1)(2010-6#1)
a variety of potential##6##4##(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)
a variety of proteins##2##4##(1994-9#1)(1995-12#1)
a variety of psychiatric##2##4##(1996-12#1)(2012-12#1)
a variety of reasons##4##4##(1993-6#1)(1995-12#1)(2008-9#1)(2011-1#1)
a variety of regulatory proteins##2##5##(2012-1#1)(2012-12#1)
a variety of regulatory##3##4##(2007-12#1)(2012-1#1)(2012-12#1)
a variety of research##2##4##(2008-10#1)(2010-10#1)
a variety of sample##2##4##(2008-10#1)(2008-3#1)
a variety of studies##2##4##(1996-5#1)(2010-11#1)
a variety of substrates##3##4##(1994-8#1)(2008-2#1)(2010-4#1)
a variety of techniques to##2##5##(1991-3#1)(1995-5#1)
a variety of techniques##6##4##(1991-3#1)(1994-1#1)(1995-5#1)(2010-3#1)(2012-2#2)
a variety of tissues##3##4##(1993-3#1)(1994-11#2)
a variety of treatment##2##4##(2008-7#1)(2008-8#1)
a variety of types of##2##5##(2008-11#1)(2009-9#1)
a variety of viral##2##4##(2008-11#1)(2011-2#1)
a variety of##650##3##(1990-11#4)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#6)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#3)(1994-10#2)(1994-11#7)(1994-12#7)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#2)(1995-12#6)(1995-2#4)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#6)(1997-7#5)(1997-8#3)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#62)(2008-11#32)(2008-12#11)(2008-2#17)(2008-3#18)(2008-4#36)(2008-5#19)(2008-6#11)(2008-7#34)(2008-8#21)(2008-9#22)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#7)(2010-6#3)(2010-8#6)(2010-9#2)(2011-1#8)(2011-2#24)(2011-3#1)(2011-8#1)(2012-1#3)(2012-12#11)(2012-2#17)(2012-3#15)(2013-1#6)(2013-7#1)(2013-8#15)
a variety##652##2##(1990-11#4)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#6)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#3)(1994-10#2)(1994-11#7)(1994-12#7)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#2)(1995-12#6)(1995-2#4)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#6)(1997-7#5)(1997-8#3)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#62)(2008-11#33)(2008-12#11)(2008-2#17)(2008-3#18)(2008-4#36)(2008-5#19)(2008-6#11)(2008-7#35)(2008-8#21)(2008-9#22)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#7)(2010-6#3)(2010-8#6)(2010-9#2)(2011-1#8)(2011-2#24)(2011-3#1)(2011-8#1)(2012-1#3)(2012-12#11)(2012-2#17)(2012-3#15)(2013-1#6)(2013-7#1)(2013-8#15)
a various##2##2##(1996-5#1)(2011-7#1)
a varying##6##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)
a vascular access##2##3##(2007-7#1)(2008-1#1)
a vascular disease in##2##4##(2008-10#1)(2011-1#1)
a vascular disease##3##3##(2008-10#2)(2011-1#1)
a vascular disruption sequence##2##4##(1997-3#2)
a vascular tumor##3##3##(2007-8#1)(2009-1#1)(2011-1#1)
a vascular##21##2##(1990-12#1)(1996-11#1)(1997-3#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#1)(2011-1#2)
a vascularized##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
a vasoactive##2##2##(1991-6#1)(2011-2#1)
a vasoconstrictor##3##2##(1993-1#2)(1995-12#1)
a vasodilator##3##2##(1991-3#1)(1997-7#1)(2008-3#1)
a vasopressin##2##2##(1994-8#1)(1995-12#1)
a vast array of##2##4##(2008-5#1)(2011-1#1)
a vast##11##2##(1995-8#1)(1997-1#1)(2007-7#1)(2008-4#1)(2008-5#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
a vastly##2##2##(2008-10#1)(2012-2#1)
a vector for##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
a vector of##2##3##(1997-3#1)(2010-8#1)
a vector system for##2##4##(1991-6#1)(2008-11#1)
a vector theory##2##3##(2007-11#1)(2008-3#1)
a vector##31##2##(1991-6#1)(1994-12#1)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
a vectorial##2##2##(1997-6#1)(2009-10#1)
a vegetative##2##2##(2008-10#1)(2008-11#1)
a vehicle for##8##3##(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(2008-2#1)(2009-10#1)(2009-11#1)(2010-6#1)
a vehicle##19##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-6#1)
a vein of Galen malformation##3##5##(1996-6#3)
a vein of##5##3##(1996-6#4)(2007-8#1)
a vein##7##2##(1996-6#4)(2007-8#1)(2008-9#1)(2010-8#1)
a velocity of##4##3##(2008-3#3)(2008-4#1)
a velocity##6##2##(2008-3#4)(2008-4#1)(2009-5#1)
a venous##3##2##(1994-9#1)(1997-6#1)(2008-7#1)
a ventral##6##2##(1994-12#1)(2007-12#5)
a ventricular septal defect in##2##5##(2012-1#1)(2012-12#1)
a ventricular septal defect##3##4##(2012-1#1)(2012-12#2)
a ventricular##5##2##(1992-6#1)(2010-8#1)(2012-1#1)(2012-12#2)
a verbal##2##2##(1995-8#1)(2012-3#1)
a versatile and##3##3##(2007-12#1)(2008-9#1)(2011-1#1)
a versatile##25##2##(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
a version of the##2##4##(1995-5#1)(2008-3#1)
a version##3##2##(1995-5#1)(2008-3#1)(2008-8#1)
a vertebral artery##2##3##(1996-9#1)(2008-7#1)
a vertebrate##4##2##(1993-12#1)(1994-12#1)(2008-9#1)(2012-12#1)
a vertex##3##2##(2008-6#3)
a vertical resolution of##3##4##(2008-3#3)
a vertical##15##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#1)(2009-5#1)(2013-7#1)
a vertically##5##2##(2008-2#2)(2008-3#2)(2008-7#1)
a very attractive##4##3##(1992-12#1)(1994-5#1)(2008-10#1)(2012-2#1)
a very challenging##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
a very close##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
a very common##7##3##(1996-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
a very compact##3##3##(1996-6#1)(2007-12#2)
a very complex##9##3##(1992-9#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
a very different##7##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)
a very distinct##2##3##(2008-10#1)(2008-5#1)
a very early##3##3##(2009-7#1)(2012-3#1)(2013-8#1)
a very effective and##2##4##(1994-2#1)(2008-3#1)
a very effective##8##3##(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#1)
a very efficient##4##3##(2007-12#1)(2008-11#1)(2008-8#1)(2010-10#1)
a very fast##6##3##(1990-2#1)(2007-12#2)(2008-10#3)
a very flexible##2##3##(1994-12#1)(2008-10#1)
a very general##3##3##(1994-12#1)(2008-2#1)(2008-8#1)
a very good agreement##2##4##(2008-10#2)
a very good outcome##2##4##(2007-8#1)(2008-1#1)
a very good result##2##4##(2007-11#2)
a very good##27##3##(1994-11#1)(1997-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-3#2)
a very high degree of##3##5##(1994-2#1)(2008-11#1)(2012-6#1)
a very high genetic##2##4##(2008-10#2)
a very high level of##4##5##(1990-2#1)(1991-9#1)(2011-1#1)(2013-1#1)
a very high mortality rate##2##5##(1996-3#1)(2013-1#1)
a very high percentage of##2##5##(1997-7#1)(2008-4#1)
a very high rate of##3##5##(2008-1#1)(2008-10#1)(2012-12#1)
a very high##39##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-9#1)(1994-2#1)(1996-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
a very important factor##2##4##(2008-5#1)(2013-1#1)
a very important role in##4##5##(1990-9#1)(2008-9#1)(2009-2#1)(2010-5#1)
a very important role to play in##2##7##(2008-11#1)(2008-3#1)
a very important role##6##4##(1990-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-5#1)
a very important step in##2##5##(2008-11#1)(2008-5#1)
a very important##21##3##(1990-9#1)(1991-2#1)(1991-8#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
a very inexpensive##2##3##(2008-10#2)
a very intense##2##3##(2007-12#1)(2008-10#1)
a very interesting##2##3##(1996-5#1)(2008-10#1)
a very large scale##2##4##(2007-11#1)(2010-4#1)
a very large##12##3##(1992-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#4)(2008-4#1)(2010-1#1)(2010-4#1)
a very limited##6##3##(2008-10#4)(2008-11#1)(2008-5#1)
a very long##4##3##(1997-7#1)(2008-3#1)(2009-12#1)(2009-4#1)
a very low level of##2##5##(2007-8#1)(2008-10#1)
a very low rate of##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
a very low##30##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-10#1)(1995-3#1)(1995-8#1)(1997-8#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
a very modest##3##3##(1994-12#1)(2008-1#1)(2009-4#1)
a very much##2##3##(1994-11#1)(2008-9#1)
a very poor prognosis##2##4##(1991-11#1)(2010-6#1)
a very poor substrate##2##4##(1991-5#1)(1992-3#1)
a very poor##5##3##(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(2010-6#1)
a very powerful tool##4##4##(2008-10#2)(2008-4#1)(2011-2#1)
a very powerful##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
a very promising##8##3##(1990-9#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-7#2)(2012-2#1)
a very rapid##4##3##(1990-2#1)(2008-10#1)(2009-12#1)(2009-6#1)
a very rare case of##4##5##(1994-7#1)(2008-7#1)(2011-2#2)
a very rare condition##3##4##(1997-8#1)(2007-8#1)(2009-7#1)
a very rare entity##3##4##(2010-11#1)(2010-5#1)(2013-1#1)
a very rare location##2##4##(1996-9#1)(2012-12#1)
a very rare occurrence##3##4##(2008-12#2)(2011-2#1)
a very rare##28##3##(1990-10#1)(1992-2#1)(1994-7#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
a very reliable##3##3##(2011-2#1)(2012-2#2)
a very restricted##2##3##(1993-12#1)(2008-8#1)
a very sensitive##7##3##(1993-12#1)(1994-8#1)(2008-10#4)(2012-3#1)
a very severe##2##3##(1996-12#1)(2008-8#1)
a very short period of##2##5##(1992-6#1)(2008-10#1)
a very short time##2##4##(2008-10#1)(2008-11#1)
a very short##6##3##(1992-6#1)(2007-11#1)(2008-10#3)(2008-11#1)
a very significant##4##3##(1990-8#1)(1997-2#1)(2010-12#1)(2013-1#1)
a very similar##8##3##(1990-12#1)(1991-5#1)(1995-11#1)(1995-3#1)(2008-10#3)(2008-11#1)
a very simple##3##3##(2008-10#3)
a very small proportion##2##4##(2008-5#1)(2011-1#1)
a very small volume##3##4##(2008-10#3)
a very small##21##3##(1992-10#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-2#1)
a very stable complex##2##4##(1990-12#1)(1992-3#1)
a very stable##6##3##(1990-12#1)(1991-8#1)(1992-3#1)(1993-11#1)(2008-10#2)
a very strong and##2##4##(2008-3#1)(2012-3#1)
a very strong##6##3##(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-3#1)
a very successful##3##3##(1993-1#1)(1994-9#1)(2008-8#1)
a very suitable##3##3##(2007-12#1)(2008-10#1)(2009-5#1)
a very uncommon##2##3##(2008-7#1)(2012-2#1)
a very unusual case of a##2##6##(2007-8#1)(2008-7#1)
a very unusual case of##3##5##(2007-8#1)(2008-7#1)(2013-1#1)
a very unusual##5##3##(1997-4#1)(1997-7#1)(2007-8#1)(2008-7#1)(2013-1#1)
a very useful tool in the##2##6##(1990-11#1)(2012-12#1)
a very useful tool in##3##5##(1990-11#1)(2012-12#1)(2012-2#1)
a very useful tool##4##4##(1990-11#1)(1991-2#1)(2012-12#1)(2012-2#1)
a very useful##11##3##(1990-11#1)(1991-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
a very valuable##2##3##(2008-10#1)(2008-7#1)
a very weak##6##3##(1996-2#2)(1997-7#1)(2008-10#2)(2008-4#1)
a very wide range##2##4##(2007-11#1)(2010-7#1)
a very wide##7##3##(1992-12#1)(1995-3#1)(2007-11#1)(2008-10#3)(2010-7#1)
a very##439##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#3)(2007-10#1)(2007-11#7)(2007-12#17)(2007-7#1)(2007-8#7)(2008-1#6)(2008-10#93)(2008-11#19)(2008-12#5)(2008-2#4)(2008-3#15)(2008-4#5)(2008-5#15)(2008-6#2)(2008-7#15)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#14)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#8)(2012-6#1)(2013-1#11)(2013-7#3)(2013-8#5)
a vesicular##2##2##(2009-8#1)(2010-8#1)
a vessel##2##2##(2007-12#2)
a vest##2##2##(2008-8#2)
a vested interest in##3##4##(1994-12#1)(1994-2#1)(2008-12#1)
a veterinary##2##2##(1990-9#1)(2011-1#1)
a viable alternative for##4##4##(1992-2#1)(1997-4#1)(2008-7#1)(2009-5#1)
a viable alternative to the##2##5##(1992-5#1)(2009-2#1)
a viable alternative to##6##4##(1992-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-2#1)
a viable alternative##13##3##(1992-2#1)(1992-5#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#1)
a viable and##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
a viable infant##3##3##(1991-2#1)(2008-7#1)(2013-1#1)
a viable method of##2##4##(1995-1#1)(2010-4#1)
a viable option for##5##4##(2008-10#1)(2009-10#1)(2011-2#2)(2012-2#1)
a viable option##7##3##(2008-10#2)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
a viable solution##2##3##(1993-1#1)(2010-11#1)
a viable strategy for##3##4##(1994-6#1)(2008-8#1)(2013-1#1)
a viable technique for the##2##5##(2008-10#1)(2008-4#1)
a viable technique##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
a viable##59##2##(1991-2#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-6#1)(1995-1#1)(1996-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#6)
a vibrant##2##2##(2008-9#1)(2009-10#1)
a vibrating##3##2##(2008-3#3)
a vibrational##3##2##(2007-11#2)(2013-1#1)
a vibratome##2##2##(2008-4#1)(2008-8#1)
a vicious cycle##4##3##(1994-2#1)(2010-5#1)(2012-12#1)(2012-2#1)
a victim of##2##3##(2008-10#1)(2009-5#1)
a victim##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
a video##10##2##(1993-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2012-12#1)(2013-1#3)
a videotape of##2##3##(1994-3#1)(2009-7#1)
a videotape##6##2##(1994-3#1)(2008-7#4)(2009-7#1)
a videotaped##3##2##(2007-9#1)(2008-9#1)(2010-3#1)
a view from the##3##4##(1991-1#1)(1993-1#1)(2008-3#1)
a view from##7##3##(1991-1#1)(1993-1#1)(1994-1#1)(2007-10#1)(2007-4#1)(2008-3#1)(2009-6#1)
a view of the##2##4##(1993-11#1)(2008-10#1)
a view of##6##3##(1993-11#1)(1993-2#1)(1994-12#1)(1996-1#1)(2008-10#1)(2011-2#1)
a view to##21##3##(1991-3#1)(1991-6#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-3#3)(2011-1#1)(2012-12#1)(2012-2#1)
a view toward##2##3##(2008-12#1)(2008-2#1)
a view##37##2##(1991-1#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-4#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
a viewing##2##2##(2008-3#2)
a viewpoint by##4##3##(2007-11#4)
a viewpoint##6##2##(2007-11#4)(2009-7#1)(2013-1#1)
a vigorous##2##2##(1996-12#1)(2008-4#1)
a village##3##2##(1992-12#1)(2008-10#1)(2008-8#1)
a violation of##3##3##(1995-6#1)(2011-2#1)(2012-2#1)
a violent##3##2##(1995-2#1)(1996-5#1)(1997-7#1)
a violet##3##2##(2008-10#3)
a viral genome##2##3##(1990-7#1)(2008-9#1)
a viral vector##2##3##(2008-9#1)(2010-5#1)
a viral##15##2##(1990-7#1)(1992-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#3)(2008-4#1)(2008-9#3)(2010-5#2)(2011-2#1)
a virion##2##2##(1993-12#2)
a virtual camera##2##3##(2008-6#2)
a virtual learning environment##3##4##(2008-12#3)
a virtual lesion##2##3##(2008-10#2)
a virtual reality##3##3##(2008-11#1)(2011-7#2)
a virtual##22##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2011-7#2)(2013-8#2)
a virtually##4##2##(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)
a virulence##5##2##(1996-12#1)(2008-10#4)
a virulent##7##2##(2008-10#5)(2008-9#2)
a virus associated with##2##4##(2008-10#2)
a virus exit process##2##4##(1997-1#2)
a virus to##2##3##(2008-5#2)
a virus with##2##3##(2008-10#1)(2012-12#1)
a virus##25##2##(1997-1#2)(1997-4#1)(2007-6#1)(2008-10#12)(2008-11#5)(2008-5#2)(2011-2#1)(2012-12#1)
a viscoelastic##4##2##(2008-10#1)(2009-12#1)(2012-2#2)
a visible wavelength##2##3##(2007-12#1)(2008-3#1)
a visible##16##2##(2007-11#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2012-12#1)
a vision of the##2##4##(1995-12#1)(2007-12#1)
a vision of##3##3##(1992-12#1)(1995-12#1)(2007-12#1)
a vision##5##2##(1992-12#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)
a visual analog scale##3##4##(2009-3#1)(2012-2#1)(2013-1#1)
a visual analog##4##3##(1996-12#1)(2009-3#1)(2012-2#1)(2013-1#1)
a visual analogue scale##2##4##(2011-1#1)(2012-1#1)
a visual cue##3##3##(2008-8#2)(2010-5#1)
a visual scene##2##3##(1996-2#1)(2009-12#1)
a visual search task##2##4##(2009-2#1)(2012-3#1)
a visual stimulus##2##3##(2007-8#1)(2008-1#1)
a visual##47##2##(1990-12#2)(1991-2#4)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#3)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
a vital part of the##2##5##(1993-2#1)(2013-8#1)
a vital part of##5##4##(1993-2#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
a vital role in the##5##5##(2008-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
a vital role in##13##4##(1990-12#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
a vital role##16##3##(1990-11#1)(1990-12#2)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
a vital##36##2##(1990-11#1)(1990-12#2)(1991-12#1)(1992-1#1)(1993-2#1)(1996-6#1)(1997-3#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
a vitamin B12 deficiency##3##4##(1990-3#3)
a vitamin E-modified dialyzer was compared with another dialyzer in a crossover design over a two-month period##2##17##(2007-7#1)(2008-1#1)
a vitamin##8##2##(1990-3#3)(1991-5#1)(2007-7#1)(2008-1#1)(2008-10#2)
a vitellogenin##2##2##(1995-2#1)(2010-5#1)
a void##2##2##(2007-12#1)(2008-5#1)
a volar##4##2##(2008-9#4)
a volatile##5##2##(2008-10#2)(2008-11#1)(2012-3#2)
a voltage##5##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-10#1)
a voltage-controlled##2##2##(2008-3#2)
a voltage-sensitive dye##2##3##(1996-5#1)(2008-4#1)
a voltammetric method##2##3##(2008-10#2)
a voltammetric##8##2##(2008-10#8)
a voltammogram##2##2##(2008-10#2)
a volume greater than 10 ml##2##6##(2008-10#2)
a volume hologram##2##3##(2007-12#1)(2008-3#1)
a volume holographic##2##3##(2007-12#1)(2008-3#1)
a volume of##9##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-8#1)
a volume##25##2##(1996-2#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2009-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
a volume-equivalent sphere or##2##4##(2008-2#1)(2008-3#1)
a volumetric##3##2##(2008-1#1)(2008-6#2)
a voluntary disclosure##2##3##(1996-12#1)(2008-7#1)
a voluntary##11##2##(1990-6#1)(1994-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2012-12#1)(2013-1#1)
a volunteer##7##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
a vortex##3##2##(2007-11#3)
a vulnerable##6##2##(2007-8#1)(2008-4#1)(2009-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
a wafer by##2##3##(2008-2#1)(2008-3#1)
a waiting list##2##3##(1993-2#1)(2008-5#1)
a waiting##4##2##(1991-11#1)(1993-2#1)(2008-10#1)(2008-5#1)
a walking##2##2##(2007-12#1)(2009-4#1)
a wall##2##2##(2008-10#1)(2011-2#1)
a wall-jet cell##2##3##(2008-10#2)
a wall-jet configuration##2##3##(2008-10#2)
a wall-jet##8##2##(2008-10#8)
a warm and##2##3##(2011-2#1)(2012-6#1)
a warm##5##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-4#1)(2012-6#1)
a warning##3##2##(1996-5#1)(2012-2#1)(2013-1#1)
a wash step##2##3##(2008-11#1)(2008-8#1)
a washing##2##2##(2008-10#2)
a washout##2##2##(2008-1#1)(2008-11#1)
a waste audit##3##3##(1996-12#2)(1996-3#1)
a waste of##2##3##(2010-8#1)(2013-8#1)
a waste##9##2##(1996-12#2)(1996-3#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
a wastewater treatment##3##3##(2008-10#2)(2012-12#1)
a wastewater##4##2##(2008-10#3)(2012-12#1)
a water bath##4##3##(2008-10#4)
a water body##2##3##(2008-10#1)(2008-3#1)
a water carrier stream##3##4##(2008-10#3)
a water droplet##4##3##(2008-10#1)(2008-11#1)(2008-2#2)
a water mist##2##3##(1991-2#2)
a water mobile phase##4##4##(2008-10#4)
a water molecule##4##3##(1995-2#1)(1995-5#1)(1997-7#1)(2009-9#1)
a water sample matrix##2##4##(2008-10#2)
a water sample##6##3##(2008-10#6)
a water soluble polymer##2##4##(2008-10#2)
a water soluble##5##3##(1995-6#1)(2008-10#3)(2008-5#1)
a water surface##2##3##(2008-3#1)(2008-9#1)
a water##51##2##(1991-2#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#28)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2013-1#1)
a water-insoluble##2##2##(1994-3#1)(2008-10#1)
a water-soluble Vitamin E##2##4##(2008-10#2)
a water-soluble cinnamon extract##2##4##(2008-5#2)
a water-soluble phospholipid##2##3##(1990-11#1)(2010-3#1)
a water-soluble polymer##5##3##(2008-10#3)(2008-7#1)(2012-2#1)
a water-soluble##19##2##(1990-11#1)(1990-8#1)(1991-3#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)
a water-vapor##2##2##(2008-2#1)(2008-3#1)
a wave front under test##2##5##(2008-3#2)
a wave front##8##3##(2007-12#1)(2008-3#7)
a wave that##2##3##(2007-11#1)(2008-2#1)
a wave##16##2##(1996-11#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#8)
a wave-front sensor##2##3##(2007-12#1)(2008-3#1)
a wave-front##10##2##(2007-11#1)(2007-12#4)(2008-3#5)
a waveguide hologram##2##3##(2008-3#2)
a waveguide structure##2##3##(2007-11#1)(2008-3#1)
a waveguide##19##2##(2007-11#6)(2007-12#1)(2008-2#2)(2008-3#9)(2010-8#1)
a wavelength near the##2##4##(2007-11#1)(2007-12#1)
a wavelength near##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a wavelength of 1##12##4##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)
a wavelength of 633 nm##3##5##(2008-3#3)
a wavelength of approximately##2##4##(2008-2#1)(2008-3#1)
a wavelength of##66##3##(1990-12#1)(2007-11#14)(2007-12#15)(2008-10#3)(2008-2#13)(2008-3#20)
a wavelength range from##5##4##(2007-11#2)(2007-12#1)(2008-2#2)
a wavelength range of##4##4##(2007-11#1)(2008-3#3)
a wavelength range##10##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#4)
a wavelength selector##2##3##(2007-12#1)(2008-10#1)
a wavelength##103##2##(1990-12#1)(2007-11#20)(2007-12#20)(2008-10#5)(2008-2#17)(2008-3#37)(2010-8#1)(2013-1#2)
a wavelength-division multiplexing##2##3##(2007-12#1)(2008-3#1)
a wavelength-division##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
a wavelength-scanning##4##2##(2007-12#1)(2008-3#3)
a wavelength-selective filter##2##3##(2008-3#2)
a wavelength-selective##4##2##(2008-2#2)(2008-3#2)
a wax-encased peat pot containing##2##5##(2008-10#2)
a way for##4##3##(1994-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
a way forward##2##3##(2008-11#1)(2009-10#1)
a way of life##2##4##(1991-12#1)(1995-1#1)
a way of##20##3##(1991-12#1)(1992-3#1)(1995-1#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2011-1#2)(2012-12#1)
a way that it could##2##5##(2008-11#1)(2008-3#1)
a way that it##4##4##(2008-11#1)(2008-3#2)(2011-2#1)
a way that the##8##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2012-1#1)
a way that##47##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#9)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
a way to make the##2##5##(2008-8#1)(2011-1#1)
a way to make##3##4##(2008-8#1)(2009-7#1)(2011-1#1)
a way to reduce##2##4##(2011-2#1)(2012-12#1)
a way to##33##3##(1990-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
a way##113##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#4)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
a weak D antigen##2##4##(1992-9#2)
a weak D##3##3##(1992-9#2)(1994-6#1)
a weak but##2##3##(2007-12#2)
a weak correlation with the##2##5##(1995-5#1)(1996-4#1)
a weak correlation##5##3##(1995-5#1)(1996-4#1)(2008-10#2)(2009-5#1)
a weak homology##3##3##(1991-12#1)(1992-3#1)(1995-6#1)
a weak or##2##3##(2007-10#1)(2008-11#1)
a weak refractive-index##2##3##(2007-12#1)(2008-3#1)
a weak signal##2##3##(2007-12#1)(2008-3#1)
a weak##84##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-5#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-8#1)
a weakening of the##2##4##(1996-6#1)(2010-12#1)
a weakening##5##2##(1996-4#1)(1996-6#1)(2008-10#2)(2010-12#1)
a weaker association##2##3##(1996-5#1)(2008-8#1)
a weaker##5##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
a weakly acidic cation-exchange resin##2##5##(2008-10#2)
a weakly acidic##4##3##(2008-10#4)
a weakly positive##2##3##(1994-12#1)(2010-3#1)
a weakly##20##2##(1992-9#1)(1994-12#1)(1995-8#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-3#1)(2009-5#1)(2010-3#1)
a wealth of##12##3##(1996-2#1)(1997-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-12#1)
a weapon##3##2##(2008-10#1)(2009-2#1)(2011-1#1)
a web server##2##3##(2007-6#1)(2008-7#1)
a web##6##2##(2007-6#1)(2008-4#1)(2008-7#3)(2008-9#1)
a web-based##11##2##(2008-10#3)(2008-7#1)(2010-10#3)(2010-12#2)(2011-3#1)(2012-3#1)
a website##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
a wedge##4##2##(1990-11#1)(2007-11#1)(2007-12#1)(2011-2#1)
a wedge-shaped##2##2##(2007-11#1)(2008-3#1)
a wedged##2##2##(2007-12#2)
a week after##2##3##(2008-6#1)(2013-1#1)
a week for 4 weeks##2##5##(2008-10#2)
a week for 6 weeks##2##5##(2008-10#1)(2009-1#1)
a week for 6##3##4##(2008-10#1)(2008-5#1)(2009-1#1)
a week for four weeks##3##5##(1991-6#1)(2008-5#2)
a week for three##2##4##(1991-3#1)(2008-9#1)
a week for##20##3##(1990-3#1)(1991-3#1)(1991-6#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#3)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)
a week of##4##3##(1991-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
a week or##2##3##(2008-5#1)(2012-12#1)
a week##56##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#5)(2013-7#1)
a week's##2##2##(1995-11#1)(2010-2#1)
a week)##4##2##(1991-8#1)(1994-6#1)(1996-6#1)(2013-1#1)
a weekly##8##2##(1994-8#2)(1997-4#2)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
a weight loss of##2##4##(1990-11#1)(1992-8#1)
a weight loss##4##3##(1990-11#1)(1992-8#2)(2013-8#1)
a weight yield of##2##4##(2008-6#2)
a weight##9##2##(1990-11#1)(1992-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2013-8#1)
a weight-of-evidence approach##2##3##(2008-10#2)
a weighted##5##2##(2008-8#2)(2012-12#1)(2012-3#2)
a welcome##2##2##(1991-1#1)(2009-6#1)
a well characterized##3##3##(1990-11#1)(2011-1#1)(2013-7#1)
a well conducted##2##3##(2007-2#1)(2007-7#1)
a well defined##5##3##(1990-9#1)(1996-2#1)(2008-10#2)(2011-2#1)
a well developed##3##3##(1994-12#1)(2008-7#1)(2009-9#1)
a well established procedure##2##4##(1995-11#1)(2008-10#1)
a well established##10##3##(1992-3#1)(1994-11#1)(1995-11#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
a well known complication##3##4##(1991-11#1)(2008-7#1)(2012-2#1)
a well known##14##3##(1991-11#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
a well of##2##3##(2008-11#1)(2008-7#1)
a well tolerated##2##3##(1992-10#1)(2010-12#1)
a well validated##2##3##(2008-10#1)(2013-1#1)
a well##63##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)
a well-adapted##2##2##(2008-10#1)(2013-1#1)
a well-balanced##2##2##(1993-12#1)(2008-5#1)
a well-characterized##6##2##(1991-5#1)(1992-1#1)(1996-12#1)(2008-9#1)(2010-6#1)(2011-2#1)
a well-defined##30##2##(1991-9#1)(1993-11#1)(1996-4#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#12)(2008-3#4)(2008-5#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
a well-described##2##2##(2008-10#1)(2011-3#1)
a well-developed##5##2##(2007-2#1)(2008-10#1)(2008-7#2)(2009-7#1)
a well-differentiated liposarcoma##2##3##(2008-6#1)(2013-1#1)
a well-differentiated##5##2##(2007-12#1)(2008-11#1)(2008-6#1)(2010-8#1)(2013-1#1)
a well-documented##6##2##(1990-9#1)(1992-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2010-3#1)
a well-established method##2##3##(2008-3#1)(2013-7#1)
a well-established technique##4##3##(2008-2#1)(2008-3#2)(2010-7#1)
a well-established##17##2##(1994-12#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-9#1)(2010-4#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
a well-known##22##2##(1991-3#1)(1993-3#1)(1995-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a well-ordered and##2##3##(1993-8#1)(2008-10#1)
a well-ordered##3##2##(1993-8#1)(2007-12#1)(2008-10#1)
a well-organized##2##2##(1992-6#1)(2012-1#1)
a wellness##2##2##(1994-3#1)(2008-4#1)
a wet##6##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
a wheat germ##2##3##(2008-10#1)(2008-9#1)
a wheat powdery mildew population##2##5##(2008-10#2)
a wheat##17##2##(1995-2#1)(2008-10#13)(2008-5#1)(2008-9#1)(2012-2#1)
a white##8##2##(1993-5#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
a white-light continuum generated in##2##5##(2007-12#2)
a white-light continuum probe##2##4##(2007-11#1)(2007-12#1)
a white-light continuum##6##3##(2007-11#3)(2007-12#3)
a white-light##11##2##(2007-11#5)(2007-12#3)(2008-3#3)
a whitefly##2##2##(2008-10#2)
a whitefly-transmitted geminivirus##3##3##(2008-10#3)
a whitefly-transmitted##4##2##(2008-10#4)
a whitening##2##2##(2008-5#2)
a whole cell##4##3##(1990-11#1)(1991-12#1)(2008-10#1)(2008-11#1)
a whole genome##4##3##(1997-5#1)(2008-7#2)(2011-1#1)
a whole new##2##3##(2008-10#1)(2008-9#1)
a whole range of##3##4##(2007-12#1)(2008-5#1)(2013-8#1)
a whole virus vaccine for##2##5##(2007-11#2)
a whole-cell##3##2##(1994-11#1)(2008-4#1)(2011-1#1)
a whole-genome##3##2##(2008-7#3)
a wide age##2##3##(2008-7#1)(2010-5#1)
a wide and##2##3##(1991-12#1)(1996-12#1)
a wide array of##9##4##(1997-2#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2013-1#1)
a wide class of nonlinear##2##5##(1996-4#1)(2007-11#1)
a wide class of##3##4##(1996-4#1)(2007-11#1)(2008-7#1)
a wide concentration range from##3##5##(2008-10#3)
a wide concentration range##28##4##(1993-8#1)(2008-10#27)
a wide distribution##3##3##(1996-12#1)(2008-5#1)(2008-9#1)
a wide diversity of##2##4##(2008-10#1)(2010-3#1)
a wide dynamic range##6##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
a wide field of##2##4##(2008-2#1)(2013-1#1)
a wide geographic##3##3##(2007-12#1)(2008-10#2)
a wide geographical##2##3##(2008-10#1)(2012-5#1)
a wide host range##3##4##(2008-10#2)(2008-2#1)
a wide linear range and##2##5##(2008-10#2)
a wide linear range of##2##5##(2008-10#2)
a wide linear range##7##4##(2008-10#6)(2010-4#1)
a wide pH range##13##4##(1993-8#1)(2008-10#11)(2010-2#1)
a wide pH##14##3##(1993-8#1)(2008-10#12)(2010-2#1)
a wide range in##2##4##(1991-4#1)(2008-10#1)
a wide range of ages##2##5##(2006-10#1)(2008-9#1)
a wide range of applications in##2##6##(2008-10#1)(2012-2#1)
a wide range of applications##5##5##(2008-10#1)(2008-3#2)(2010-12#1)(2012-2#1)
a wide range of cellular processes such as##2##8##(2008-8#1)(2011-2#1)
a wide range of cellular##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
a wide range of clinical##2##5##(1990-2#1)(2008-11#1)
a wide range of concentrations##6##5##(2008-10#5)(2008-7#1)
a wide range of conditions##5##5##(1990-8#1)(2008-10#3)(2009-7#1)
a wide range of different##3##5##(2007-12#1)(2009-10#1)(2011-1#1)
a wide range of diseases##3##5##(1992-11#1)(2008-10#1)(2011-2#1)
a wide range of environmental##2##5##(2008-10#1)(2009-9#1)
a wide range of functions##2##5##(1992-1#1)(2008-11#1)
a wide range of human##2##5##(2009-8#1)(2012-3#1)
a wide range of organisms##2##5##(1995-2#1)(2008-10#1)
a wide range of pH##7##5##(1994-3#1)(2008-10#4)(2008-5#1)(2013-1#1)
a wide range of parameter values##4##6##(2008-3#1)(2008-8#2)(2008-9#1)
a wide range of parameters##2##5##(2008-8#1)(2008-9#1)
a wide range of physiological##3##5##(1991-2#1)(2008-11#1)(2011-2#1)
a wide range of plant species##2##6##(2008-10#1)(2008-7#1)
a wide range of plant##4##5##(2008-10#2)(2008-7#1)(2010-10#1)
a wide range of proteins##3##5##(1994-6#1)(1996-12#2)
a wide range of roles##3##5##(2010-11#1)(2012-12#1)(2012-3#1)
a wide range of spatial##2##5##(2008-10#1)(2008-2#1)
a wide range of temperature##2##5##(2008-10#2)
a wide range of wavelengths##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
a wide range of##230##4##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-11#2)(1992-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1997-3#2)(2006-10#1)(2007-11#3)(2007-12#6)(2007-8#3)(2008-1#3)(2008-10#55)(2008-11#14)(2008-12#3)(2008-2#8)(2008-3#19)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
a wide range##243##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-11#2)(1992-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-3#2)(2006-10#1)(2007-11#4)(2007-12#7)(2007-8#3)(2008-1#3)(2008-10#57)(2008-11#14)(2008-12#3)(2008-2#12)(2008-3#22)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
a wide spectral range##10##4##(2007-12#1)(2008-10#1)(2008-3#8)
a wide spectral##11##3##(2007-12#1)(2008-10#1)(2008-3#9)
a wide spectrum of clinical##2##5##(2008-3#1)(2013-1#1)
a wide spectrum of##17##4##(1993-3#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)
a wide spectrum##18##3##(1992-5#1)(1993-3#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)
a wide variability in##2##4##(2007-10#1)(2008-8#1)
a wide variation in the##3##5##(2008-10#1)(2010-1#1)(2010-8#1)
a wide variation in##6##4##(1997-3#1)(2008-10#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-3#1)
a wide variety of applications##3##5##(1995-1#1)(2008-3#1)(2011-1#1)
a wide variety of cell types##4##6##(1992-3#1)(1996-2#1)(2008-1#1)(2008-4#1)
a wide variety of cell##5##5##(1992-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)
a wide variety of clinical##2##5##(2008-1#1)(2010-5#1)
a wide variety of diseases##3##5##(2008-5#1)(2011-1#1)(2012-3#1)
a wide variety of human##2##5##(2011-2#2)
a wide variety of optical##2##5##(2007-12#1)(2008-3#1)
a wide variety of organisms and##2##6##(2008-6#1)(2008-7#1)
a wide variety of organisms##4##5##(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
a wide variety of other cations##3##6##(2008-10#3)
a wide variety of other##11##5##(2008-10#10)(2011-3#1)
a wide variety of plants##2##5##(2008-10#1)(2009-8#1)
a wide variety of##117##4##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
a wide##543##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-3#2)(1992-5#2)(1993-3#1)(1993-8#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#20)(2007-8#5)(2008-1#7)(2008-10#145)(2008-11#20)(2008-12#6)(2008-2#24)(2008-3#45)(2008-4#10)(2008-5#15)(2008-6#10)(2008-7#23)(2008-8#13)(2008-9#12)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#7)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#12)(2013-8#5)
a wide-angle##2##2##(2008-2#1)(2008-3#1)
a wide-field##2##2##(2007-11#1)(2008-3#1)
a wideband##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a widely accepted##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
a widely tunable##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a widely used herbicide##3##4##(1995-8#1)(2008-10#2)
a widely used method##2##4##(1995-2#1)(2013-8#1)
a widely used technique for##2##5##(2008-3#1)(2010-5#1)
a widely used technique##4##4##(1996-8#1)(2008-3#1)(2010-5#1)(2012-12#1)
a widely used tool##2##4##(2006-10#1)(2012-2#1)
a widely used##28##3##(1990-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(1996-8#1)(2006-10#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
a widely##49##2##(1990-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
a wider array of##2##4##(2008-11#1)(2012-12#1)
a wider range of##9##4##(1994-12#2)(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
a wider range##10##3##(1994-12#2)(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
a wider##50##2##(1993-12#1)(1994-1#1)(1994-12#2)(1996-1#1)(1996-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
a widespread disease##3##3##(2008-10#3)
a widespread environmental##2##3##(2008-10#2)
a widespread##23##2##(1992-8#1)(1995-6#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
a width of##3##3##(1996-4#1)(2007-11#1)(2011-2#1)
a width##4##2##(1996-4#1)(2007-11#1)(2008-10#1)(2011-2#1)
a wild##6##2##(1994-2#1)(2007-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2013-8#1)
a wild-type and##2##3##(2010-10#1)(2013-1#1)
a wild-type background##2##3##(2008-9#2)
a wild-type strain##3##3##(2008-10#2)(2008-6#1)
a wild-type##15##2##(1995-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
a win-win##2##2##(1992-1#1)(1993-1#1)
a wind speed of##2##4##(2008-3#2)
a wind##3##2##(2007-11#1)(2008-3#2)
a winding##2##2##(2007-10#1)(2008-3#1)
a window for##2##3##(2009-8#1)(2012-2#1)
a window function##2##3##(2007-11#2)
a window of opportunity for##2##5##(2008-3#1)(2013-1#1)
a window##12##2##(1993-9#1)(1994-5#1)(2007-11#4)(2008-1#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
a winning combination in##2##4##(1993-3#1)(2013-8#1)
a winning combination##3##3##(1993-3#1)(1995-1#1)(2013-8#1)
a winning##5##2##(1991-3#1)(1993-3#1)(1995-1#1)(2008-7#1)(2013-8#1)
a wire##4##2##(2008-11#2)(2008-3#2)
a wireless telephone##2##3##(2010-2#2)
a wireless##4##2##(2008-12#2)(2010-2#2)
a wish##2##2##(1993-3#1)(2012-3#1)
a woman aged##4##3##(1990-6#1)(1991-3#1)(1991-9#1)(1995-12#1)
a woman in##2##3##(1991-12#1)(2012-2#1)
a woman who hemorrhages 24 hours post tonsillectomy##2##7##(2013-1#2)
a woman who##8##3##(1992-2#1)(1995-12#1)(1997-3#1)(2007-6#1)(2010-12#1)(2010-5#1)(2013-1#2)
a woman with##8##3##(1990-10#1)(1993-11#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-4#1)(2012-1#1)(2013-1#1)
a woman##29##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-11#2)(1995-11#1)(1995-12#3)(1995-6#1)(1997-3#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
a woman's prenatal alcohol use##2##5##(2008-11#2)
a woman's risk of##2##4##(2008-4#1)(2012-1#1)
a woman's##14##2##(1994-7#1)(1995-1#1)(1996-8#2)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-1#2)
a women's health center in an academic health##4##8##(1994-3#4)
a women's health center##7##4##(1994-3#6)(1997-3#1)
a women's##9##2##(1994-3#6)(1997-3#1)(2009-12#1)(2011-2#1)
a word of##2##3##(2008-4#1)(2011-1#1)
a word##8##2##(1995-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-3#1)
a work hardening##2##3##(2008-4#1)(2009-7#1)
a work in progress##3##4##(2008-7#1)(2011-1#1)(2012-12#1)
a work rehabilitation center##2##4##(1993-1#2)
a work##12##2##(1993-1#2)(1996-1#1)(1996-3#1)(2008-4#1)(2008-7#1)(2009-7#2)(2011-1#1)(2012-12#1)(2013-1#2)
a workable##2##2##(1994-12#1)(2008-10#1)
a workday##2##2##(2008-10#1)(2010-6#1)
a worker##2##2##(1995-12#1)(1996-5#1)
a workers' compensation##2##3##(1992-2#1)(1996-2#1)
a working electrode##8##3##(2008-10#8)
a working hypothesis##4##3##(2008-12#2)(2008-3#1)(2013-8#1)
a working plan for##2##4##(1994-1#2)
a working potential##2##3##(2008-10#2)
a working range of##2##4##(2008-10#1)(2008-3#1)
a working range##5##3##(2008-10#4)(2008-3#1)
a working##36##2##(1991-12#1)(1992-11#1)(1993-12#2)(1993-8#1)(1994-1#2)(1995-12#1)(1996-2#1)(2008-10#20)(2008-12#2)(2008-2#1)(2008-3#2)(2013-1#1)(2013-8#1)
a workplace##5##2##(2008-12#2)(2012-1#1)(2012-2#1)(2013-8#1)
a workshop on##4##3##(1994-2#1)(2007-12#1)(2008-1#1)(2008-7#1)
a workshop##13##2##(1990-11#1)(1992-12#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#2)
a world##4##2##(1992-3#2)(2008-5#1)(2011-2#1)
a worldwide collection of##4##4##(2008-10#4)
a worldwide##19##2##(1993-12#1)(1994-1#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
a worse prognosis in##2##4##(1990-8#1)(2011-2#1)
a worse prognosis than##2##4##(2008-7#1)(2010-3#1)
a worse prognosis##11##3##(1990-12#1)(1990-8#2)(1991-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#2)
a worse##15##2##(1990-12#1)(1990-8#2)(1991-8#1)(1993-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#4)
a worsening##3##2##(1991-8#1)(1996-9#1)(2013-1#1)
a worst case of##2##4##(2007-12#2)
a wound##10##2##(2008-10#4)(2008-11#1)(2008-5#3)(2011-2#1)(2012-2#1)
a written##11##2##(1992-1#1)(1993-3#1)(1996-3#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2013-1#1)
a wrong##2##2##(1995-8#1)(1997-8#1)
a xenograft##5##2##(1993-9#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
a xenon arc##2##3##(2008-3#1)(2008-5#1)
a xenon##5##2##(2007-11#1)(2008-3#3)(2008-5#1)
a xylem-limited bacterium##2##3##(2008-10#2)
a year after the Wenchuan earthquake##2##6##(2012-1#2)
a year after the second##2##5##(1994-7#1)(2008-6#1)
a year after the##4##4##(1994-7#1)(2008-6#1)(2012-1#2)
a year after##8##3##(1994-7#1)(2007-7#1)(2008-6#1)(2010-1#1)(2010-4#1)(2012-1#2)(2012-3#1)
a year for##2##3##(2008-10#1)(2008-7#1)
a year in the##2##4##(1995-5#1)(2008-5#1)
a year later##2##3##(2008-5#1)(2008-8#1)
a year of##2##3##(2008-10#1)(2008-5#1)
a year with a##2##4##(1994-9#1)(2008-10#1)
a year##53##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#3)(2013-8#5)
a year)##3##2##(1997-8#1)(2008-11#1)(2012-12#1)
a yeast (Pichia guilermondii) and a bacterium (Bacillus mycoides)##2##9##(2008-10#2)
a yeast gene##2##3##(1990-5#1)(1995-9#1)
a yeast nuclear gene##2##4##(1994-12#2)
a yeast of##2##3##(1996-12#1)(2008-5#1)
a yeast strain##2##3##(1997-3#1)(2008-5#1)
a yeast two-hybrid##2##3##(1997-7#1)(2009-10#1)
a yeast##32##2##(1990-5#2)(1991-5#1)(1991-9#1)(1993-9#3)(1994-12#3)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-10#1)(2012-3#1)
a yellow color##2##3##(1997-4#1)(2008-10#1)
a yellow pigment##2##3##(2008-10#1)(2008-11#1)
a yellow##12##2##(1997-4#1)(2008-10#9)(2008-11#1)(2013-1#1)
a yet unknown##2##3##(1994-6#1)(1997-8#1)
a yet##4##2##(1994-6#1)(1997-8#1)(2008-10#1)(2008-5#1)
a yield of##7##3##(1992-8#1)(1997-6#2)(2008-10#1)(2008-6#1)(2013-1#2)
a yield##9##2##(1992-8#1)(1994-6#1)(1997-6#2)(2008-10#2)(2008-6#1)(2013-1#2)
a young adult##5##3##(1990-3#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-12#1)
a young child##9##3##(1993-3#1)(1996-2#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-1#1)
a young female patient##4##4##(2008-6#2)(2012-12#1)(2013-8#1)
a young female##12##3##(2007-7#1)(2008-12#3)(2008-6#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
a young male who presented##2##5##(2008-11#1)(2008-7#1)
a young male with##2##4##(1996-3#1)(2012-2#1)
a young male##10##3##(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-5#1)(2010-7#1)(2012-2#1)
a young man who presented with##2##6##(2008-8#1)(2013-1#1)
a young man who##3##4##(2007-7#1)(2008-8#1)(2013-1#1)
a young man##7##3##(1992-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#1)
a young patient##6##3##(1990-12#1)(2011-2#4)(2013-1#1)
a young woman with##5##4##(1991-3#1)(2006-10#1)(2007-10#1)(2010-12#1)(2011-2#1)
a young woman##8##3##(1991-3#1)(1992-12#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
a young##78##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-12#1)(1992-2#2)(1993-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
a younger age##6##3##(1996-7#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
a younger##10##2##(1994-2#1)(1994-5#1)(1994-8#1)(1996-7#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
a youth development intervention##2##4##(2013-1#2)
a youth##4##2##(2010-11#1)(2010-5#1)(2013-1#2)
a zero##8##2##(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-1#1)
a zero-dispersion##3##2##(2007-11#1)(2008-2#2)
a zigzag##7##2##(2007-11#3)(2008-10#3)(2008-11#1)
a zinc finger-containing protein that##3##5##(1990-11#2)(1991-10#1)
a zinc finger-containing##4##3##(1990-11#2)(1991-10#1)(1994-9#1)
a zinc##12##2##(1990-11#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
a zinc-finger motif##2##3##(1991-12#2)
a zinc-finger##5##2##(1991-12#2)(1994-6#1)(1997-7#1)(2010-8#1)
a zone of##6##3##(1993-12#1)(2008-10#2)(2008-5#2)(2008-7#1)
a zone plate##2##3##(2007-11#1)(2008-2#1)
a zone##8##2##(1993-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)
a zoonosis##3##2##(2007-2#1)(2008-5#1)(2011-2#1)
a zoonotic##4##2##(2007-2#1)(2008-10#1)(2011-2#1)(2013-7#1)
a zwitterionic##2##2##(1994-9#1)(1995-2#1)
a été##8##2##(2011-2#2)(2013-1#6)
a##106130##1##(1990-10#57)(1990-11#380)(1990-12#430)(1990-2#317)(1990-3#171)(1990-4#21)(1990-5#423)(1990-6#210)(1990-7#276)(1990-8#416)(1990-9#167)(1991-1#161)(1991-10#28)(1991-11#183)(1991-12#528)(1991-2#422)(1991-3#279)(1991-4#45)(1991-5#353)(1991-6#314)(1991-7#42)(1991-8#195)(1991-9#313)(1992-1#201)(1992-10#101)(1992-11#266)(1992-12#491)(1992-2#282)(1992-3#590)(1992-4#67)(1992-5#181)(1992-6#433)(1992-7#26)(1992-8#344)(1992-9#334)(1993-1#224)(1993-10#14)(1993-11#386)(1993-12#668)(1993-2#358)(1993-3#463)(1993-5#80)(1993-6#390)(1993-7#1)(1993-8#374)(1993-9#275)(1994-1#192)(1994-10#19)(1994-11#423)(1994-12#745)(1994-2#496)(1994-3#466)(1994-5#315)(1994-6#288)(1994-7#49)(1994-8#496)(1994-9#256)(1995-1#173)(1995-10#14)(1995-11#357)(1995-12#665)(1995-2#756)(1995-3#475)(1995-4#32)(1995-5#386)(1995-6#469)(1995-8#298)(1995-9#119)(1996-1#242)(1996-10#35)(1996-11#117)(1996-12#553)(1996-2#582)(1996-3#468)(1996-4#93)(1996-5#368)(1996-6#231)(1996-7#67)(1996-8#103)(1996-9#136)(1997-1#282)(1997-2#605)(1997-3#612)(1997-4#444)(1997-5#206)(1997-6#319)(1997-7#501)(1997-8#326)(1997-9#16)(2006-10#180)(2006-11#1)(2006-12#45)(2006-4#20)(2006-5#8)(2006-6#33)(2006-7#9)(2006-8#10)(2007-1#21)(2007-10#426)(2007-11#2639)(2007-12#3421)(2007-2#199)(2007-3#5)(2007-4#49)(2007-5#147)(2007-6#69)(2007-7#526)(2007-8#780)(2007-9#63)(2008-1#1041)(2008-10#17658)(2008-11#3901)(2008-12#1439)(2008-2#3754)(2008-3#7456)(2008-4#1633)(2008-5#2437)(2008-6#1231)(2008-7#3462)(2008-8#2160)(2008-9#2156)(2009-1#91)(2009-10#507)(2009-11#360)(2009-12#341)(2009-2#190)(2009-3#330)(2009-4#220)(2009-5#484)(2009-6#311)(2009-7#408)(2009-8#575)(2009-9#325)(2010-1#200)(2010-10#375)(2010-11#360)(2010-12#512)(2010-2#237)(2010-3#449)(2010-4#408)(2010-5#477)(2010-6#327)(2010-7#242)(2010-8#595)(2010-9#148)(2011-1#1173)(2011-10#17)(2011-2#3313)(2011-3#130)(2011-4#7)(2011-6#1)(2011-7#30)(2011-8#3)(2011-9#9)(2012-1#368)(2012-12#1240)(2012-2#1942)(2012-3#1460)(2012-4#12)(2012-5#32)(2012-6#17)(2012-7#30)(2012-8#15)(2012-9#11)(2013-1#3020)(2013-2#3)(2013-3#1)(2013-7#335)(2013-8#1435)
a&quot##4##1##(1992-6#1)(1995-2#2)(2008-10#1)
a( *) and b( *)##3##5##(2010-4#3)
a( *)##6##2##(2010-4#6)
a(2)(chi)##4##1##(1996-2#4)
a(3) ion##4##2##(2012-12#4)
a(3)##8##1##(2012-12#8)
a(w) = 0##6##3##(2008-7#6)
a(w)##9##1##(2008-10#2)(2008-5#1)(2008-7#6)
a(z) and bb(z)##2##3##(2008-3#2)
a(z)##3##1##(2008-3#3)
a) and##2##2##(2007-11#1)(2008-7#1)
a) the##9##2##(1990-6#1)(1991-2#1)(1991-6#1)(1992-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
a)##38##1##(1990-11#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-8#1)(1997-8#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-1#2)(2011-2#3)(2012-2#3)(2013-7#2)(2013-8#1)
a*(ph(z##2##1##(2008-3#2)
a-Si##2##1##(2008-3#2)
a-factor is##2##2##(1991-12#2)
a-factor##4##1##(1991-12#3)(2008-4#1)
a/b##2##1##(2008-4#2)
a1##2##1##(2008-5#2)
a2##2##1##(2008-10#1)(2008-4#1)
a3 and##2##2##(1995-6#1)(1997-7#1)
a3##4##1##(1995-6#1)(1997-7#1)(2008-10#1)(2008-8#1)
aCL##2##1##(2006-10#2)
aDNA##4##1##(2009-8#1)(2012-2#3)
aFGF and/or bFGF##2##3##(1991-12#2)
aFGF##9##1##(1990-8#2)(1991-12#2)(1997-7#4)(2008-7#1)
aI3 alpha##3##2##(1995-6#3)
aMCI##4##1##(2011-2#4)
aMT and MT##2##3##(2008-5#2)
aMT6s levels##2##2##(1996-7#2)
aOR =##3##1##(2013-1#3)
aPS##5##1##(2008-7#5)
aSKa##4##1##(1993-9#4)
aVR##3##1##(2010-1#3)
a[actin]##2##1##(1993-8#2)
a] imidazole]##2##2##(1991-8#2)
aa are##2##2##(1994-12#1)(1996-6#1)
aa identity##2##2##(1994-12#1)(2010-5#1)
aa in##2##2##(1993-12#1)(1993-2#1)
aa levels##2##2##(1991-9#1)(2013-1#1)
aa of##2##2##(1990-11#1)(1994-8#1)
aa replacements##2##2##(1991-6#1)(1991-9#1)
aa sequence identity##2##3##(1991-6#1)(1993-2#1)
aa sequence of CelS##2##4##(1990-5#2)
aa sequence of the##3##4##(1990-11#1)(1993-12#1)(1993-9#1)
aa sequence of##8##3##(1990-11#2)(1990-5#2)(1993-12#1)(1993-9#1)(1994-12#1)(1995-8#1)
aa sequence shows##2##3##(1993-2#2)
aa sequence##33##2##(1990-11#3)(1990-5#2)(1991-6#3)(1991-7#1)(1993-12#4)(1993-2#4)(1993-6#3)(1993-9#1)(1994-12#6)(1994-9#1)(1995-8#3)(1997-4#1)(2008-10#1)
aa sequences of##6##3##(1990-11#2)(1993-12#1)(1993-6#1)(1995-8#1)(1997-7#1)
aa sequences##9##2##(1990-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1995-8#1)(1997-7#1)
aa substitutions##2##2##(1993-2#1)(2008-10#1)
aa which may be##2##4##(1991-6#1)(1993-12#1)
aa with a##2##3##(1990-11#1)(1991-7#1)
aa with##3##2##(1990-11#1)(1991-7#1)(1993-9#1)
aa##100##1##(1990-11#10)(1990-12#1)(1990-5#2)(1991-6#11)(1991-7#2)(1991-9#3)(1993-12#13)(1993-2#10)(1993-6#7)(1993-9#3)(1994-12#12)(1994-8#1)(1994-9#1)(1995-12#2)(1995-8#6)(1996-6#1)(1997-4#1)(1997-7#2)(1997-9#2)(2008-10#3)(2010-5#3)(2011-1#2)(2013-1#1)(2013-8#1)
aaRSs##2##1##(2012-2#2)
ab initio calculations##4##3##(1996-2#2)(1996-5#1)(2007-12#1)
ab initio quantum##2##3##(1996-5#1)(2012-2#1)
ab initio structure##2##3##(1997-7#1)(2006-4#1)
ab initio##19##2##(1991-5#1)(1996-2#3)(1996-5#3)(1997-7#2)(2006-4#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)
ab##20##1##(1991-5#1)(1996-2#3)(1996-5#3)(1997-7#3)(2006-4#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)
ab-initio##2##1##(2008-10#1)(2012-2#1)
abacavir##2##1##(2007-1#2)
abacterial##2##1##(1990-3#1)(1992-2#1)
abamectin resistance##2##2##(2011-2#2)
abamectin##9##1##(2008-6#1)(2011-2#8)
abamectin-resistant strain##2##2##(2011-2#2)
abamectin-resistant##4##1##(2011-2#4)
abandon their##3##2##(1996-6#1)(2008-9#2)
abandon##10##1##(1991-6#1)(1993-1#1)(1993-9#1)(1996-6#1)(2007-11#1)(2007-2#1)(2008-8#1)(2008-9#2)(2011-2#1)
abandoned citrus##2##2##(2011-2#2)
abandoned groves##4##2##(2011-2#4)
abandoned in a##2##3##(1992-3#1)(2007-2#1)
abandoned in##3##2##(1992-3#1)(2007-2#1)(2008-9#1)
abandoned##23##1##(1991-1#2)(1992-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#2)(2011-2#9)(2012-3#1)(2013-1#1)
abandoned?##2##1##(2008-11#1)(2012-3#1)
abandoning of##2##2##(1992-5#1)(2012-12#1)
abandoning the##3##2##(1991-3#1)(1995-2#1)(2008-5#1)
abandoning##10##1##(1990-6#1)(1991-3#1)(1992-5#1)(1995-2#1)(1996-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
abandonment of##4##2##(1991-12#1)(1992-5#1)(1994-2#1)(1995-1#1)
abandonment##7##1##(1991-12#1)(1992-5#1)(1994-2#1)(1995-1#1)(2007-2#3)
abappressorium##4##1##(2008-10#4)
abasic site##4##2##(1991-3#1)(1995-5#2)(2008-10#1)
abatacept in our##2##3##(2012-3#2)
abatacept in##3##2##(2012-3#3)
abatacept##7##1##(2012-1#1)(2012-3#6)
abated##2##1##(2008-5#1)(2008-6#1)
abatement of##2##2##(1990-2#1)(2011-2#1)
abatement##10##1##(1990-2#1)(1991-12#4)(1992-2#2)(2008-10#2)(2011-2#1)
abattoir workers##3##2##(2009-7#1)(2011-2#2)
abattoir##8##1##(2009-7#1)(2010-4#2)(2011-1#2)(2011-2#3)
abattoirs##3##1##(2011-1#3)
abbreviated as##2##2##(1990-7#1)(2008-10#1)
abbreviated courses of##2##3##(2008-7#1)(2011-2#1)
abbreviated##9##1##(1990-7#1)(1995-12#1)(1995-3#2)(2008-10#2)(2008-7#2)(2011-2#1)
abbreviations##8##1##(1992-3#1)(1994-11#1)(2008-2#2)(2008-4#2)(2008-9#2)
abcess of the chest wall##2##5##(2007-8#2)
abcess##5##1##(2007-8#4)(2009-1#1)
abcès##2##1##(2011-2#2)
abdomen and##15##2##(1990-3#1)(1990-9#1)(1991-6#2)(1993-5#1)(1995-10#1)(1997-5#1)(2008-1#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
abdomen at##3##2##(1997-3#1)(2010-5#1)(2011-1#1)
abdomen can##2##2##(1992-4#1)(2012-2#1)
abdomen in##7##2##(1990-8#1)(1991-5#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
abdomen is##2##2##(2007-7#1)(2008-7#1)
abdomen showed a##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
abdomen showed##5##2##(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
abdomen was##5##2##(1993-6#1)(1997-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
abdomen were##3##2##(1997-8#1)(2011-2#2)
abdomen with##3##2##(1995-11#1)(2012-12#1)(2012-3#1)
abdomen##88##1##(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-5#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-3#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
abdominal CT scan##2##3##(1991-6#1)(2008-1#1)
abdominal CT##6##2##(1991-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
abdominal adipose tissue##2##3##(2008-4#2)
abdominal and presternal##2##3##(2011-2#2)
abdominal and thoracic##5##3##(1993-12#2)(2012-1#1)(2012-3#1)(2013-8#1)
abdominal and vaginal##3##3##(1993-12#3)
abdominal and##17##2##(1993-12#6)(1995-3#1)(2008-11#1)(2008-7#2)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
abdominal aorta and/or renal arteries##2##5##(1997-8#2)
abdominal aorta##13##2##(1994-7#2)(1997-8#5)(2008-4#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-3#2)
abdominal aortic aneurysm (AAA)##4##4##(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)
abdominal aortic aneurysm of##2##4##(1992-5#1)(2013-1#1)
abdominal aortic aneurysm repair##2##4##(2008-3#1)(2012-1#1)
abdominal aortic aneurysm##19##3##(1990-6#1)(1992-5#4)(2008-11#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-7#2)(2011-2#3)(2011-3#1)(2012-1#1)(2013-1#1)
abdominal aortic aneurysms##5##3##(1993-5#2)(2008-7#1)(2010-12#1)(2013-1#1)
abdominal aortic##27##2##(1990-6#1)(1992-5#5)(1993-5#2)(1997-8#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-7#1)(2010-12#2)(2010-7#2)(2011-2#3)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
abdominal area##2##2##(2013-1#2)
abdominal areas##2##2##(1996-12#1)(2010-8#1)
abdominal bloating##5##2##(2008-10#4)(2008-6#1)
abdominal catheter##2##2##(2012-12#2)
abdominal catheters##2##2##(2011-2#2)
abdominal cavity##7##2##(1991-12#1)(1991-2#1)(1993-6#1)(1993-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
abdominal chaetigers##2##2##(2008-5#2)
abdominal circumference##6##2##(1996-11#1)(2008-1#1)(2008-3#1)(2009-11#1)(2013-1#2)
abdominal complaints##2##2##(1993-6#1)(1997-8#1)
abdominal computed tomography scan##2##4##(2008-7#1)(2011-2#1)
abdominal computed tomography##3##3##(2008-7#1)(2010-1#1)(2011-2#1)
abdominal contents##2##2##(2009-4#1)(2012-2#1)
abdominal discomfort##2##2##(2008-12#1)(2011-2#1)
abdominal disease##3##2##(1993-6#1)(2011-2#1)(2013-1#1)
abdominal distension##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
abdominal distention##2##2##(2007-12#1)(2008-11#1)
abdominal examination##2##2##(1993-6#1)(1997-3#1)
abdominal fat graft##3##3##(2006-12#1)(2011-2#2)
abdominal fat weight##2##3##(2008-12#1)(2008-8#1)
abdominal fat##12##2##(1997-3#1)(2006-12#1)(2008-11#2)(2008-12#2)(2008-8#4)(2011-2#2)
abdominal focal disease##2##3##(1991-2#2)
abdominal ganglia##2##2##(1994-2#1)(2007-12#1)
abdominal ganglion##5##2##(1990-7#1)(1993-12#1)(1994-2#1)(2008-4#1)(2008-6#1)
abdominal hysterectomy and##4##3##(1993-12#2)(2013-1#2)
abdominal hysterectomy with bilateral##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
abdominal hysterectomy##21##2##(1991-11#1)(1991-12#2)(1991-3#1)(1993-12#2)(1993-3#1)(1994-2#2)(1995-12#1)(1995-3#1)(2008-10#1)(2010-11#1)(2010-3#2)(2011-2#1)(2013-1#4)(2013-8#1)
abdominal imaging##3##2##(2008-7#2)(2012-2#1)
abdominal injuries]##2##2##(1990-2#2)
abdominal mass##5##2##(1993-9#2)(1997-7#1)(2008-7#2)
abdominal metastases##2##2##(1990-6#1)(1991-4#1)
abdominal muscles##3##2##(2008-10#1)(2009-6#1)(2012-1#1)
abdominal obesity and##2##3##(2008-3#2)
abdominal obesity##9##2##(2008-11#1)(2008-3#4)(2009-4#1)(2013-1#1)(2013-8#2)
abdominal open surgery##3##3##(2011-2#3)
abdominal operation##3##2##(1992-6#1)(1994-2#1)(2011-2#1)
abdominal operations##3##2##(2008-10#1)(2012-2#1)(2013-7#1)
abdominal or##3##2##(1992-2#1)(1993-2#1)(1993-3#1)
abdominal organ##2##2##(1993-6#1)(2009-3#1)
abdominal organs##3##2##(2006-10#1)(2010-8#1)(2011-2#1)
abdominal pain and vomiting##2##4##(1997-8#1)(2013-1#1)
abdominal pain and weight loss##3##5##(1997-3#1)(2008-12#1)(2010-12#1)
abdominal pain and##15##3##(1991-2#1)(1991-3#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#2)(2011-1#1)(2013-1#2)
abdominal pain associated with##4##4##(1993-9#2)(1995-2#2)
abdominal pain associated##5##3##(1993-9#2)(1995-2#2)(2010-1#1)
abdominal pain in##5##3##(1992-5#2)(1997-5#1)(2009-8#1)(2011-2#1)
abdominal pain of##2##3##(1993-3#1)(2013-1#1)
abdominal pain was##5##3##(1991-2#2)(2008-7#1)(2013-1#1)(2013-8#1)
abdominal pain which##2##3##(1995-3#1)(2013-1#1)
abdominal pain##96##2##(1990-11#2)(1990-9#1)(1991-2#3)(1991-3#2)(1991-8#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#4)(1995-2#2)(1995-3#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#4)(2009-10#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#13)(2013-8#3)
abdominal pains##2##2##(2008-10#2)
abdominal pedicle flap##3##3##(2011-2#3)
abdominal pregnancy with##2##3##(2011-2#1)(2012-2#1)
abdominal segment X##2##3##(2007-12#1)(2008-5#1)
abdominal segment##3##2##(2007-12#2)(2008-5#1)
abdominal segments##3##2##(2007-12#3)
abdominal sepsis##2##2##(2008-5#1)(2009-8#1)
abdominal spiracles##3##2##(2007-12#2)(2008-5#1)
abdominal sternites##2##2##(2007-12#2)
abdominal surgery##11##2##(1993-2#1)(1995-3#1)(2009-5#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#2)
abdominal surgery]##2##2##(1990-6#1)(1992-6#1)
abdominal surgical emergencies in##3##4##(2011-2#2)(2012-12#1)
abdominal surgical emergencies##4##3##(2011-2#3)(2012-12#1)
abdominal surgical##5##2##(2011-2#4)(2012-12#1)
abdominal symptoms##3##2##(1995-3#1)(2008-12#1)(2013-1#1)
abdominal tergites of##2##3##(2007-12#2)
abdominal tergites##5##2##(2007-12#5)
abdominal to##2##2##(1993-12#1)(2011-2#1)
abdominal trauma and##2##3##(1992-6#1)(2008-7#1)
abdominal trauma##11##2##(1990-2#2)(1992-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-1#2)(2010-12#1)
abdominal tuberculosis##4##2##(2009-5#1)(2011-1#2)(2011-2#1)
abdominal tumor##2##2##(2007-5#1)(2008-10#1)
abdominal tumours##2##2##(2008-7#2)
abdominal ultrasonography and##2##3##(2009-8#1)(2011-1#1)
abdominal ultrasound##7##2##(1997-8#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
abdominal viscera##3##2##(1991-2#1)(2010-6#1)(2012-3#1)
abdominal wall hernias##2##3##(2010-8#1)(2011-2#1)
abdominal wall in##3##3##(1991-1#2)(2008-7#1)
abdominal wall is an##2##4##(1990-5#1)(2008-10#1)
abdominal wall is##3##3##(1990-5#1)(1991-9#1)(2008-10#1)
abdominal wall portion of the##2##5##(2011-2#2)
abdominal wall##38##2##(1990-5#1)(1991-1#2)(1991-12#1)(1991-9#1)(1995-3#2)(1996-3#1)(1996-8#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#13)(2012-12#3)(2012-2#1)(2013-1#1)
abdominal##521##1##(1990-11#2)(1990-2#6)(1990-5#3)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#8)(1991-3#6)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-2#2)(1992-5#8)(1992-6#5)(1992-8#1)(1992-9#1)(1993-12#10)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#8)(1993-8#1)(1993-9#7)(1994-2#7)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#8)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#3)(1996-9#1)(1997-3#3)(1997-5#2)(1997-7#2)(1997-8#14)(2006-10#1)(2006-12#1)(2007-12#27)(2007-2#4)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#26)(2008-11#12)(2008-12#10)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#8)(2008-6#5)(2008-7#26)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#9)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#6)(2011-2#60)(2011-3#3)(2012-1#4)(2012-12#10)(2012-2#17)(2012-3#9)(2013-1#34)(2013-3#2)(2013-7#1)(2013-8#10)
abdominis muscle##3##2##(1993-12#1)(2008-8#1)(2012-2#1)
abdominis##13##1##(1990-9#1)(1991-5#1)(1993-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-12#3)(2012-2#3)(2013-1#1)
abdomino-scrotal hydrocele##2##2##(2008-7#2)
abdominopelvic##2##1##(1990-2#1)(2009-10#1)
abdominoperineal##3##1##(1992-6#1)(1993-6#1)(2011-2#1)
abdominoscrotal hydrocele##2##2##(2008-10#2)
abducens nerve schwannoma##2##3##(2012-3#2)
abducens nerve##4##2##(2012-3#4)
abducens##5##1##(2012-3#5)
abduct##2##1##(2007-11#2)
abduction and##6##2##(1990-2#1)(2007-11#4)(2011-2#1)
abduction##23##1##(1990-2#1)(1993-12#1)(1993-2#1)(1996-12#2)(2007-11#5)(2008-8#2)(2009-11#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#5)
abductive##3##1##(2009-11#3)
abductor##3##1##(2008-12#2)(2008-7#1)
abecarnil##2##1##(1991-1#2)
aberrant activity##2##2##(2008-6#1)(2008-7#1)
aberrant bands##2##2##(1991-12#2)
aberrant cell##2##2##(2009-4#1)(2011-1#1)
aberrant chromosome##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
aberrant expression of##3##3##(1995-12#1)(2008-9#1)(2013-1#1)
aberrant gene expression##2##3##(1995-9#1)(2010-4#1)
aberrant gene##3##2##(1995-9#1)(1996-12#1)(2010-4#1)
aberrant hyperproliferation in##2##3##(1995-9#2)
aberrant hyperproliferation##4##2##(1995-9#4)
aberrant mRNA##2##2##(1993-6#1)(1996-2#1)
aberrant splicing##2##2##(1996-2#1)(2008-8#1)
aberrant##77##1##(1991-12#3)(1991-9#3)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-6#2)(1995-9#5)(1996-12#1)(1996-2#2)(1996-6#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
aberrantly processed fragments##2##3##(1992-9#2)
aberrantly##4##1##(1992-9#2)(2010-12#1)(2012-2#1)
aberrated by##2##2##(2008-2#1)(2008-3#1)
aberrated wave fronts##3##3##(2008-3#3)
aberrated##11##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)
aberration and the##2##3##(2007-12#1)(2008-2#1)
aberration and##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
aberration characteristics of##2##3##(2008-3#2)
aberration coefficients##3##2##(2008-2#2)(2008-3#1)
aberration compensation##2##2##(2008-2#1)(2008-3#1)
aberration correction##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
aberration in##5##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
aberration introduced by##2##3##(2008-3#1)(2009-5#1)
aberration is##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
aberration of a##3##3##(2008-3#3)
aberration of the##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
aberration of##10##2##(2007-12#1)(2008-2#1)(2008-3#8)
aberration on the##4##3##(2008-2#1)(2008-3#3)
aberration on##6##2##(2008-2#2)(2008-3#4)
aberration pattern##2##2##(1993-9#1)(2008-3#1)
aberration targets##2##2##(2008-3#2)
aberration terms##3##2##(2008-2#3)
aberration that##2##2##(2008-3#2)
aberration theory##3##2##(2008-3#2)(2013-8#1)
aberration was##2##2##(2007-12#2)
aberration##111##1##(1992-8#1)(1993-9#1)(2007-11#1)(2007-12#13)(2007-8#1)(2008-10#1)(2008-2#22)(2008-3#65)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#2)(2013-8#1)
aberration-corrected concave##3##2##(2008-3#3)
aberration-corrected##6##1##(2008-2#1)(2008-3#4)(2010-12#1)
aberration-free##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
aberrations (CAs)##3##2##(1996-2#1)(2008-11#1)(2010-1#1)
aberrations and##11##2##(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#2)
aberrations are##11##2##(2007-11#1)(2008-2#1)(2008-3#7)(2010-11#1)(2013-8#1)
aberrations by##3##2##(2008-2#1)(2010-1#1)(2012-1#1)
aberrations can be##4##3##(2007-11#1)(2008-3#3)
aberrations in optical systems##2##4##(2008-3#2)
aberrations in the##4##3##(1995-8#1)(2008-3#2)(2008-9#1)
aberrations in##21##2##(1993-1#1)(1993-9#1)(1995-8#1)(2007-12#1)(2008-2#2)(2008-3#8)(2008-9#4)(2010-1#1)(2012-12#1)(2012-3#1)
aberrations induced##2##2##(1997-3#1)(2008-3#1)
aberrations involved##2##2##(2008-3#1)(2010-1#1)
aberrations is##2##2##(2008-3#2)
aberrations of a##2##3##(2008-2#1)(2008-3#1)
aberrations of an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
aberrations of the##3##3##(2007-11#1)(2008-3#2)
aberrations of##14##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#8)
aberrations on laser-induced plasma formation in water##2##7##(2008-3#2)
aberrations on##4##2##(2007-11#1)(2008-3#3)
aberrations that##5##2##(2008-3#3)(2008-6#1)(2010-3#1)
aberrations the##2##2##(2007-12#1)(2008-3#1)
aberrations to be##2##3##(2008-4#1)(2013-8#1)
aberrations to##3##2##(2008-3#1)(2008-4#1)(2013-8#1)
aberrations with##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
aberrations##151##1##(1991-12#1)(1993-1#1)(1993-9#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(2007-11#7)(2007-12#7)(2008-10#1)(2008-11#4)(2008-2#19)(2008-3#73)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#6)(2010-1#5)(2010-11#1)(2010-3#3)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#4)
abies##3##1##(2008-7#2)(2012-2#1)
abietina and##2##2##(2008-10#2)
abietina epidemic##2##2##(2008-10#2)
abietina var##6##2##(2008-10#6)
abietina##20##1##(2008-10#20)
abilities and the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
abilities and##13##2##(1994-6#1)(1994-8#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-3#1)
abilities are##5##2##(2008-5#1)(2010-10#1)(2010-2#3)
abilities as##3##2##(2008-10#2)(2010-4#1)
abilities at##2##2##(2008-9#1)(2011-2#1)
abilities in##9##2##(1994-8#1)(1997-2#1)(2008-9#3)(2011-1#3)(2012-12#1)
abilities is##5##2##(1993-12#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
abilities of patients##2##3##(2008-7#1)(2008-9#1)
abilities of the##6##3##(1992-8#1)(1995-5#1)(2007-10#2)(2007-12#1)(2009-8#1)
abilities of##33##2##(1992-11#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
abilities that##2##2##(2008-11#1)(2009-2#1)
abilities to inhibit##3##3##(1993-8#1)(2008-10#1)(2009-12#1)
abilities to stimulate##3##3##(1992-10#1)(1994-8#1)(2009-12#1)
abilities to##31##2##(1991-2#1)(1992-10#1)(1993-8#1)(1994-8#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-7#2)(2007-12#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#3)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
abilities##157##1##(1990-8#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-1#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#16)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#11)(2009-12#4)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#1)(2010-12#1)(2010-2#6)(2010-4#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#8)(2012-5#1)(2013-1#5)(2013-8#1)
ability after##2##2##(2008-7#1)(2013-1#1)
ability against##3##2##(2008-10#2)(2008-12#1)
ability and usefulness of##2##4##(1995-12#1)(2008-10#1)
ability and##45##2##(1990-11#1)(1991-6#1)(1991-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(2007-11#2)(2008-10#13)(2008-11#4)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
ability are##3##2##(2008-3#1)(2008-8#2)
ability as more##2##3##(2009-9#2)
ability as##5##2##(1992-2#1)(1992-9#1)(1994-3#1)(2009-9#2)
ability at##2##2##(1995-8#1)(2008-10#1)
ability both##2##2##(1993-11#1)(2008-10#1)
ability depends on##2##3##(1990-11#1)(2008-6#1)
ability due to##2##3##(1995-8#1)(2011-2#1)
ability for the##3##3##(2008-10#3)
ability for##14##2##(1992-8#1)(2008-10#9)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
ability in the##3##3##(1990-2#1)(2008-10#1)(2012-3#1)
ability in##23##2##(1990-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#3)(2009-8#2)(2011-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
ability is##9##2##(1995-6#1)(1997-1#1)(2006-6#1)(2008-10#2)(2008-8#2)(2008-9#1)(2012-1#1)
ability of C##6##3##(2008-10#4)(2008-8#1)(2011-1#1)
ability of P##2##3##(1997-4#1)(2008-10#1)
ability of Phytophthora infestans##2##4##(2008-10#2)
ability of Ras to##2##4##(1996-2#2)
ability of a group of##2##5##(1994-3#1)(2008-12#1)
ability of a##19##3##(1991-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-8#1)
ability of cells to##5##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
ability of cells##6##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
ability of cultured cells##3##4##(1994-11#3)
ability of each##2##3##(2008-5#1)(2008-7#1)
ability of health##3##3##(1994-3#1)(1995-2#1)(2008-11#1)
ability of human##5##3##(1995-5#1)(2008-11#1)(2008-5#2)(2010-2#1)
ability of low##3##3##(1995-11#1)(1995-12#1)(2008-7#1)
ability of mouse##2##3##(2009-6#1)(2012-3#1)
ability of patients to##3##4##(2008-7#2)(2010-9#1)
ability of protein##2##3##(1990-8#1)(2008-10#1)
ability of some##3##3##(2008-10#3)
ability of the human##2##4##(1992-3#1)(1993-9#1)
ability of the liver##2##4##(1995-8#1)(2011-1#1)
ability of the new##4##4##(2008-10#2)(2008-3#1)(2009-5#1)
ability of the purified##2##4##(1995-11#1)(1997-4#1)
ability of the solvent##2##4##(2008-10#2)
ability of the##114##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#3)
ability of these##18##3##(1990-5#1)(1992-12#2)(1992-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-11#1)
ability of this##9##3##(1990-2#1)(1992-12#1)(1993-5#1)(1995-5#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
ability of three##2##3##(2007-6#1)(2008-10#1)
ability of various##2##3##(2008-10#1)(2008-5#1)
ability of##483##2##(1990-11#1)(1990-2#4)(1990-5#5)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#8)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#5)(1995-12#4)(1995-2#5)(1995-5#7)(1995-6#3)(1995-8#4)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#2)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#3)(2006-12#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#119)(2008-11#20)(2008-12#7)(2008-2#6)(2008-3#8)(2008-4#14)(2008-5#24)(2008-6#2)(2008-7#15)(2008-8#15)(2008-9#13)(2009-1#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#4)
ability on##6##2##(2007-8#1)(2008-10#3)(2008-9#1)(2013-8#1)
ability or##3##2##(2008-10#1)(2008-8#2)
ability than##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
ability that##3##2##(1990-11#1)(1995-1#1)(2008-5#1)
ability to accept##3##3##(1994-12#1)(1995-8#1)(2012-3#1)
ability to achieve##4##3##(1994-9#1)(2007-12#1)(2011-1#1)(2013-1#1)
ability to act as a##2##5##(1995-2#1)(2012-8#1)
ability to act as##5##4##(1990-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2012-8#1)
ability to act for reasons##2##5##(2010-12#2)
ability to act##8##3##(1990-11#1)(1995-2#1)(1995-3#1)(2008-10#2)(2010-12#2)(2012-8#1)
ability to activate a##2##4##(1996-3#1)(2009-8#1)
ability to activate##9##3##(1990-5#1)(1991-11#1)(1992-6#1)(1993-8#1)(1996-3#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
ability to adapt##2##3##(1995-3#1)(2008-8#1)
ability to address##2##3##(2008-1#1)(2012-1#1)
ability to adhere to##2##4##(2008-12#1)(2008-9#1)
ability to affect##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
ability to apply##3##3##(1996-3#1)(1997-3#1)(2008-11#1)
ability to be transmitted##2##4##(2008-10#1)(2008-7#1)
ability to be##15##3##(1992-12#1)(1994-5#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
ability to bind##9##3##(1990-2#1)(1990-5#1)(1994-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)
ability to block##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
ability to carry out##3##4##(1990-2#1)(1995-5#1)(2007-2#1)
ability to cause disease on##2##5##(2008-10#2)
ability to cause##11##3##(1995-6#1)(1997-6#1)(2008-10#6)(2008-9#1)(2009-6#1)(2012-2#1)
ability to change the##2##4##(2007-11#1)(2008-11#1)
ability to change##5##3##(2007-11#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#1)
ability to colonize##2##3##(2008-10#2)
ability to communicate##5##3##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
ability to compete##3##3##(1993-3#1)(2008-8#1)(2013-7#1)
ability to conduct##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
ability to control the##4##4##(2007-11#1)(2008-11#1)(2008-7#2)
ability to control##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-11#1)
ability to coordinate##2##3##(1992-3#1)(2007-12#1)
ability to cope with##2##4##(2009-12#1)(2010-11#1)
ability to create##5##3##(1995-5#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
ability to deal with##2##4##(1995-2#1)(2012-1#1)
ability to deal##3##3##(1995-2#1)(2008-12#1)(2012-1#1)
ability to decrease the##2##4##(2008-10#1)(2008-8#1)
ability to decrease##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
ability to degrade##5##3##(2008-10#3)(2011-2#2)
ability to deliver##5##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
ability to detect##21##3##(1991-3#1)(1992-11#1)(1992-2#1)(1995-5#1)(1997-5#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#1)
ability to determine##5##3##(2008-10#1)(2009-8#1)(2011-1#1)(2013-1#2)
ability to detoxify##2##3##(2008-10#1)(2010-5#1)
ability to diagnose##5##3##(1995-3#1)(2008-4#1)(2008-7#2)(2008-8#1)
ability to differentiate into##3##4##(2008-9#2)(2012-4#1)
ability to differentiate##9##3##(1990-5#1)(1991-12#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-4#1)(2012-5#1)
ability to discriminate between##4##4##(1993-9#1)(2009-12#1)(2010-2#2)
ability to discriminate##10##3##(1993-8#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-2#2)(2013-1#1)
ability to distinguish between##2##4##(2008-10#1)(2008-9#1)
ability to distinguish##4##3##(2008-10#2)(2008-9#2)
ability to do##2##3##(2008-11#1)(2010-12#1)
ability to efficiently##2##3##(2009-3#1)(2012-2#1)
ability to elevate##3##3##(1992-8#1)(1993-6#1)(2007-11#1)
ability to elicit##2##3##(1990-12#1)(2008-10#1)
ability to entrap##2##3##(2008-10#1)(2008-11#1)
ability to examine##2##3##(2008-12#1)(2012-2#1)
ability to explain##3##3##(1991-12#1)(1992-12#1)(2009-4#1)
ability to express##4##3##(1994-11#1)(1994-8#1)(1996-12#1)(2012-2#1)
ability to extract##5##3##(2007-8#1)(2008-10#3)(2009-8#1)
ability to fall##2##3##(1990-5#1)(2008-3#1)
ability to ferment##3##3##(1993-12#1)(2008-6#1)(2012-3#1)
ability to form H-bonds##4##4##(1992-10#4)
ability to form a##3##4##(1990-11#1)(2008-10#1)(2008-7#1)
ability to form##15##3##(1990-11#1)(1992-10#4)(1992-2#1)(1995-5#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)
ability to generate##9##3##(1990-2#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-7#1)
ability to grow at##2##4##(2008-10#1)(2011-2#1)
ability to grow in##4##4##(2008-10#2)(2008-11#1)(2010-4#1)
ability to grow on##4##4##(1990-5#1)(2008-10#1)(2008-6#1)(2008-8#1)
ability to grow##13##3##(1990-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#2)(2013-7#1)
ability to handle a large##2##5##(2008-10#1)(2008-11#1)
ability to handle a##3##4##(2008-10#1)(2008-11#2)
ability to handle##6##3##(2008-10#1)(2008-11#2)(2008-4#2)(2009-12#1)
ability to have##2##3##(2010-1#1)(2011-2#1)
ability to hydrolyze##3##3##(1992-9#1)(1993-8#1)(2008-10#1)
ability to identify the##3##4##(1997-2#1)(2008-6#1)(2012-12#1)
ability to identify##13##3##(1991-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#1)
ability to image##2##3##(2008-3#1)(2010-6#1)
ability to implement##2##3##(1993-12#1)(1994-3#1)
ability to improve##3##3##(2008-5#2)(2008-7#1)
ability to increase the##3##4##(1991-12#1)(2009-4#1)(2013-8#1)
ability to increase##4##3##(1991-12#1)(2008-5#1)(2009-4#1)(2013-8#1)
ability to induce resistance##3##4##(2008-10#3)
ability to induce systemic resistance##3##5##(2008-10#3)
ability to induce##24##3##(1990-5#1)(1994-5#1)(1994-8#1)(1996-2#1)(2006-6#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#1)
ability to infect rice##2##4##(2008-10#2)
ability to infect##7##3##(2008-10#6)(2010-10#1)
ability to inhibit the##6##4##(1990-5#1)(1993-8#1)(1995-11#1)(2008-10#2)(2008-11#1)
ability to inhibit##18##3##(1990-4#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)
ability to interact with##8##4##(1992-11#1)(1993-3#1)(1995-5#2)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)
ability to isolate##3##3##(1993-9#1)(2008-10#1)(2009-6#1)
ability to localize##2##3##(1994-9#1)(2011-2#1)
ability to maintain##5##3##(2008-3#2)(2008-8#1)(2012-3#1)(2013-7#1)
ability to make a##2##4##(1992-12#1)(2013-8#1)
ability to make##10##3##(1992-12#1)(2006-10#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-8#1)
ability to measure the##2##4##(2008-3#1)(2008-8#1)
ability to measure##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
ability to mediate##2##3##(1994-5#1)(1995-5#1)
ability to meet##2##3##(1995-1#1)(2012-12#1)
ability to metastasize##2##3##(2009-3#1)(2010-3#1)
ability to modify##2##3##(1997-8#1)(2008-4#1)
ability to modulate##5##3##(1994-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)
ability to move##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
ability to multiply in##2##4##(1995-2#1)(2008-10#1)
ability to multiply##4##3##(1995-2#1)(2008-10#2)(2009-8#1)
ability to obtain##5##3##(1997-2#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#1)
ability to participate in##2##4##(2012-1#1)(2013-1#1)
ability to pay and##2##4##(1992-2#1)(2008-1#1)
ability to pay##7##3##(1992-2#1)(1994-2#2)(2007-7#2)(2008-1#1)(2012-2#1)
ability to penetrate the##2##4##(1997-1#1)(2008-8#1)
ability to penetrate##5##3##(1997-1#1)(2008-10#2)(2008-8#1)(2009-10#1)
ability to perform##8##3##(1996-12#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
ability to play##2##3##(2008-9#1)(2010-3#1)
ability to predict the##3##4##(2007-12#1)(2008-2#2)
ability to predict##10##3##(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-1#1)(2010-7#1)
ability to prevent##8##3##(1992-10#1)(1992-8#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
ability to produce##23##3##(1991-12#1)(1991-2#1)(1993-6#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#12)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
ability to proliferate and heterogeneity##2##5##(2008-11#2)
ability to proliferate##5##3##(2008-11#4)(2012-12#1)
ability to promote##2##3##(1994-12#1)(1995-11#1)
ability to protect against##2##4##(2008-5#1)(2010-8#1)
ability to protect##5##3##(1992-11#1)(1994-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
ability to provide##6##3##(1992-4#1)(2006-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
ability to purify##2##3##(1994-5#1)(2012-12#1)
ability to quantitate##2##3##(1990-12#1)(2008-10#1)
ability to rapidly##5##3##(2008-10#2)(2008-11#1)(2008-9#2)
ability to recognize##7##3##(1991-2#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-1#1)(2011-2#1)
ability to recover##2##3##(2007-5#1)(2013-1#1)
ability to reduce##9##3##(1991-2#1)(1993-11#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2012-3#1)
ability to reflect##2##3##(2007-10#1)(2008-11#1)
ability to reject##2##3##(2008-3#1)(2008-9#1)
ability to release##3##3##(1992-9#1)(2008-5#1)(2012-12#1)
ability to reliably##2##3##(2009-3#1)(2010-6#1)
ability to repair##2##3##(1995-5#1)(2009-3#1)
ability to reproduce##2##3##(2008-10#1)(2010-10#1)
ability to resolve##3##3##(2008-3#2)(2008-9#1)
ability to respond to the##2##5##(1995-1#1)(1997-3#1)
ability to respond to these##2##5##(1991-12#1)(1995-1#1)
ability to respond to##7##4##(1991-12#1)(1994-11#1)(1995-1#2)(1997-3#1)(2008-8#1)(2010-8#1)
ability to secrete##3##3##(1992-3#1)(2008-1#1)(2008-10#1)
ability to segment##5##3##(2012-3#5)
ability to select for##2##4##(1994-5#1)(2008-2#1)
ability to select##3##3##(1994-5#1)(1995-2#1)(2008-2#1)
ability to sequester##2##3##(2008-10#1)(2010-6#1)
ability to serve as##3##4##(1992-9#1)(2008-10#2)
ability to spread##2##3##(2008-10#1)(2011-2#1)
ability to stimulate##6##3##(1992-7#1)(1994-6#1)(1996-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
ability to study##2##3##(2008-9#1)(2010-11#1)
ability to successfully##2##3##(2008-12#1)(2008-9#1)
ability to support##3##3##(2008-2#1)(2009-10#1)(2010-5#1)
ability to suppress##3##3##(1993-2#1)(2008-10#2)
ability to survive##5##3##(2007-6#1)(2008-7#1)(2008-8#1)(2011-2#2)
ability to synthesize##4##3##(1990-5#1)(2007-11#1)(2008-9#1)(2013-1#1)
ability to take##2##3##(2008-11#1)(2008-9#1)
ability to talk##2##3##(2009-7#1)(2012-12#1)
ability to transfer##2##3##(1990-5#1)(2008-4#1)
ability to transmit##8##3##(2008-10#8)
ability to treat##2##3##(2009-10#1)(2010-7#1)
ability to trigger##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
ability to understand and##3##4##(2010-11#1)(2010-7#1)(2013-1#1)
ability to understand##8##3##(1992-3#1)(1993-1#1)(1995-5#1)(2008-12#1)(2010-11#1)(2010-7#1)(2012-12#1)(2013-1#1)
ability to use##6##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)
ability to utilize##3##3##(1995-2#1)(1997-1#1)(2011-1#1)
ability to walk##5##3##(1991-9#1)(1996-9#2)(2007-11#1)(2012-2#1)
ability to withstand##2##3##(2008-2#1)(2008-5#1)
ability to work##4##3##(2008-1#2)(2008-10#1)(2011-2#1)
ability to##856##2##(1990-11#5)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#9)(1990-8#1)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#5)(1992-11#4)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#3)(1994-11#5)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#7)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#5)(1995-11#5)(1995-12#5)(1995-2#10)(1995-3#3)(1995-5#11)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#5)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#7)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#13)(2007-12#9)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#11)(2008-10#147)(2008-11#44)(2008-12#12)(2008-2#10)(2008-3#26)(2008-4#17)(2008-5#17)(2008-6#10)(2008-7#23)(2008-8#17)(2008-9#36)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#7)(2009-4#4)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#6)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#7)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#4)(2011-1#9)(2011-2#30)(2011-7#2)(2012-1#6)(2012-12#16)(2012-2#23)(2012-3#18)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#23)(2013-7#4)(2013-8#4)
ability towards##7##2##(2008-10#6)(2008-11#1)
ability was enhanced##2##3##(2008-8#1)(2013-8#1)
ability was##10##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
ability were##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
ability while##2##2##(1996-9#1)(2013-1#1)
ability with##2##2##(2008-9#1)(2012-2#1)
ability##1610##1##(1990-11#10)(1990-12#3)(1990-2#9)(1990-4#1)(1990-5#14)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#10)(1991-2#8)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#6)(1992-11#4)(1992-12#10)(1992-2#5)(1992-3#9)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#7)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#4)(1993-8#8)(1993-9#6)(1994-11#14)(1994-12#9)(1994-2#6)(1994-3#10)(1994-5#8)(1994-6#7)(1994-8#8)(1994-9#3)(1995-1#7)(1995-11#11)(1995-12#10)(1995-2#17)(1995-3#3)(1995-5#18)(1995-6#6)(1995-8#10)(1996-1#1)(1996-11#1)(1996-12#10)(1996-2#6)(1996-3#9)(1996-5#2)(1996-7#1)(1996-9#5)(1997-1#6)(1997-2#7)(1997-3#10)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#4)(2006-10#2)(2006-12#1)(2006-6#2)(2007-10#4)(2007-11#23)(2007-12#14)(2007-2#4)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#12)(2008-10#332)(2008-11#80)(2008-12#23)(2008-2#17)(2008-3#38)(2008-4#31)(2008-5#48)(2008-6#16)(2008-7#46)(2008-8#57)(2008-9#72)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#8)(2009-2#6)(2009-3#8)(2009-4#7)(2009-5#4)(2009-6#7)(2009-7#4)(2009-8#12)(2009-9#13)(2010-1#5)(2010-10#8)(2010-11#9)(2010-12#7)(2010-2#8)(2010-3#4)(2010-4#8)(2010-5#5)(2010-6#3)(2010-7#7)(2010-8#11)(2010-9#2)(2011-1#18)(2011-2#47)(2011-7#2)(2011-8#1)(2012-1#8)(2012-12#20)(2012-2#34)(2012-3#31)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#39)(2013-7#5)(2013-8#13)
abiotic agents##3##2##(2008-10#2)(2011-2#1)
abiotic and biotic stress##2##4##(2009-10#1)(2009-6#1)
abiotic and biotic##5##3##(2008-10#3)(2009-10#1)(2009-6#1)
abiotic factors affecting##2##3##(2008-10#1)(2008-8#1)
abiotic factors##7##2##(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#1)
abiotic stress##3##2##(2008-10#1)(2009-10#2)
abiotic stresses##7##2##(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#2)(2011-2#1)
abiotic suppression##3##2##(2008-10#3)
abiotic##37##1##(2008-10#16)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#3)(2009-6#1)(2010-10#2)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#2)
abl oncogene family##2##3##(1994-10#2)
abl##5##1##(1994-10#2)(2012-12#3)
ablate the##2##2##(2007-12#1)(2008-3#1)
ablate##7##1##(1991-2#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
ablated by##2##2##(1997-1#1)(2008-3#1)
ablated in##2##2##(2008-10#1)(2008-11#1)
ablated material##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
ablated to##2##2##(1991-2#1)(1993-2#1)
ablated with##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
ablated##18##1##(1991-2#2)(1993-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-7#1)(2013-1#2)
ablating##3##1##(2008-10#1)(2008-2#1)(2011-2#1)
ablation (LA)##2##2##(2008-10#2)
ablation (RFA)##2##2##(2012-2#2)
ablation and division##3##3##(2011-2#3)
ablation and to##2##3##(2008-3#1)(2011-2#1)
ablation and##11##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#5)(2013-1#1)
ablation at##3##2##(1995-11#1)(2007-12#1)(2008-3#1)
ablation by##3##2##(1997-8#1)(2008-11#1)(2008-7#1)
ablation devices##2##2##(2010-8#2)
ablation effect##2##2##(1997-8#1)(2011-1#1)
ablation for##6##2##(2008-10#2)(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)
ablation has##2##2##(2008-3#1)(2011-2#1)
ablation in##7##2##(2007-8#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-8#1)
ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)##2##7##(2010-11#2)
ablation inductively coupled plasma mass spectrometry##4##6##(2008-10#2)(2010-11#2)
ablation inductively coupled plasma##6##4##(2008-10#4)(2010-11#2)
ablation is a##3##3##(2007-8#2)(2010-8#1)
ablation is##10##2##(1993-2#1)(1995-11#1)(2007-8#2)(2008-10#1)(2008-3#3)(2010-12#1)(2010-8#1)
ablation lesions##2##2##(2010-6#2)
ablation of a##3##3##(1995-2#1)(2007-8#1)(2012-2#1)
ablation of atrial fibrillation##3##4##(2007-8#2)(2010-6#1)
ablation of atrial##5##3##(2007-8#4)(2010-6#1)
ablation of the##12##3##(1991-2#1)(1991-3#1)(1991-5#2)(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)
ablation of untolerated##3##3##(2009-10#3)
ablation of##48##2##(1990-11#1)(1991-2#1)(1991-3#3)(1991-5#2)(1993-1#1)(1994-8#1)(1995-11#1)(1995-2#1)(2007-8#7)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-10#5)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
ablation on##2##2##(2007-12#1)(2008-3#1)
ablation procedures##4##2##(2007-12#1)(2007-8#1)(2008-7#1)(2010-8#1)
ablation rates##2##2##(2008-10#2)
ablation showed##2##2##(2008-10#2)
ablation techniques##2##2##(2008-12#1)(2008-3#1)
ablation the##2##2##(2008-3#1)(2008-6#1)
ablation therapies##2##2##(2010-12#2)
ablation therapy for##3##3##(2007-12#1)(2010-12#2)
ablation therapy##6##2##(2007-12#1)(2008-7#1)(2010-12#2)(2010-6#1)(2013-8#1)
ablation threshold##2##2##(2011-1#2)
ablation were##2##2##(1991-2#1)(2010-12#1)
ablation with a##2##3##(2012-2#1)(2013-8#1)
ablation with##5##2##(2007-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
ablation##223##1##(1990-11#1)(1991-2#2)(1991-3#3)(1991-5#2)(1993-1#4)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#5)(1995-2#1)(1996-1#4)(1997-8#4)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#16)(2008-1#7)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#18)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#5)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#3)(2010-12#9)(2010-3#2)(2010-5#1)(2010-6#4)(2010-8#7)(2010-9#2)(2011-1#7)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#9)
ablation-inductively coupled##3##2##(2008-10#3)
ablations##4##1##(1994-12#1)(1995-11#1)(2008-5#1)(2010-8#1)
ablative neurosurgical procedures##3##3##(2011-1#3)
ablative surgery##2##2##(1993-11#1)(2010-9#1)
ablative##14##1##(1993-11#1)(1994-2#1)(2007-12#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#3)
able of##2##2##(1993-11#1)(2007-12#1)
able than##2##2##(2008-5#1)(2009-10#1)
able to access##2##3##(2008-11#1)(2010-8#1)
able to accomplish this##2##4##(1994-2#1)(2013-1#1)
able to accumulate##2##3##(1990-2#1)(2008-10#1)
able to accurately##3##3##(1993-11#1)(2008-7#1)(2013-1#1)
able to achieve its##2##4##(1996-3#1)(2007-4#1)
able to achieve##12##3##(1995-5#1)(1996-3#1)(1996-8#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
able to acquire##2##3##(1994-3#2)
able to activate##2##3##(1995-3#1)(2009-8#1)
able to adhere to##2##4##(1996-12#1)(2008-9#1)
able to adhere##3##3##(1996-12#1)(2008-9#1)(2011-2#1)
able to alter the##2##4##(1994-11#1)(2008-11#1)
able to alter##6##3##(1994-11#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-5#1)(2013-1#1)
able to amplify##2##3##(2008-10#2)
able to analyse##2##3##(2008-10#2)
able to assess the##2##4##(2008-12#1)(2008-5#1)
able to associate##3##3##(1993-6#1)(1993-9#1)(2007-12#1)
able to attend##2##3##(2008-7#1)(2012-3#1)
able to attenuate##2##3##(1994-9#1)(2012-2#1)
able to be applied##2##4##(2008-10#1)(2008-11#1)
able to be used##2##4##(2008-7#1)(2013-7#1)
able to be##14##3##(1992-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
able to bind to##5##4##(1993-8#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)
able to bind##15##3##(1990-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#2)(1997-7#1)(2008-10#3)(2011-2#1)
able to block##2##3##(1995-12#1)(2011-2#1)
able to both##2##3##(2008-7#2)
able to bud##2##3##(2008-10#2)
able to capture##3##3##(1996-3#1)(2007-11#1)(2008-3#1)
able to cause##4##3##(2006-6#1)(2008-10#2)(2011-2#1)
able to change the##2##4##(2008-10#2)
able to collect##2##3##(1997-5#1)(2008-11#1)
able to compensate for##3##4##(2008-2#1)(2008-5#1)(2008-7#1)
able to compete##2##3##(1995-5#1)(2008-11#1)
able to complement##3##3##(1990-5#2)(2008-10#1)
able to consider##2##3##(2008-3#1)(2009-11#1)
able to consume##2##3##(2007-12#1)(2013-1#1)
able to continue##2##3##(1993-2#1)(2012-2#1)
able to control the##2##4##(2007-11#1)(2008-5#1)
able to control##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)
able to convert##3##3##(1990-12#2)(2007-12#1)
able to cope##2##3##(1996-8#1)(1997-8#1)
able to cross the##2##4##(2008-10#1)(2011-2#1)
able to damage##2##3##(1990-5#1)(1992-3#1)
able to deliver##6##3##(2007-12#2)(2008-7#1)(2010-10#2)(2011-1#1)
able to demonstrate##5##3##(1992-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
able to detect and quantify##2##5##(2008-10#1)(2008-7#1)
able to detect and##4##4##(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
able to detect as little as 10##2##7##(2008-10#1)(2013-1#1)
able to detect as little as##3##6##(2008-10#2)(2013-1#1)
able to detect the##2##4##(2007-12#1)(2008-3#1)
able to detect##32##3##(1990-12#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-7#2)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
able to determine##6##3##(1993-8#1)(2008-10#3)(2011-1#1)(2013-1#1)
able to develop a##2##4##(2008-1#1)(2013-1#1)
able to develop and##2##4##(1993-1#1)(2008-4#1)
able to develop##5##3##(1992-3#1)(1993-1#1)(2008-1#1)(2008-4#1)(2013-1#1)
able to diagnose##3##3##(1991-6#1)(2007-11#1)(2010-5#1)
able to differentiate the role of##2##6##(2008-10#2)
able to differentiate##6##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
able to direct##2##3##(1990-2#1)(1991-6#1)
able to directly##3##3##(1991-7#1)(1992-9#1)(2008-11#1)
able to discriminate##4##3##(2008-12#1)(2008-9#2)(2011-2#1)
able to displace##3##3##(2008-10#1)(2008-8#2)
able to distinguish between##3##4##(1990-7#1)(2008-10#1)(2013-8#1)
able to distinguish##11##3##(1990-7#1)(1991-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
able to effectively##3##3##(2008-11#1)(2008-5#1)(2011-3#1)
able to elucidate##2##3##(2008-10#1)(2008-3#1)
able to employ##2##3##(2008-3#1)(2012-12#1)
able to engage##2##3##(2008-11#1)(2012-3#1)
able to enhance the ECL##2##5##(2008-10#2)
able to enhance the##3##4##(1994-5#1)(2008-10#2)
able to enhance##5##3##(1990-2#1)(1994-5#1)(2008-10#3)
able to establish a##2##4##(1995-5#1)(2008-11#1)
able to estimate the##5##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-8#1)
able to examine##2##3##(1993-12#1)(2008-1#1)
able to exhibit##2##3##(1993-12#1)(2008-5#1)
able to explain the##2##4##(2008-10#1)(2008-11#1)
able to explain##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
able to exploit##2##3##(2008-7#1)(2008-9#1)
able to extend the##2##4##(2007-12#1)(2008-10#1)
able to facilitate##2##3##(2008-10#1)(2010-3#1)
able to find##3##3##(2008-10#1)(2010-8#1)(2012-12#1)
able to focus##2##3##(1997-3#1)(2007-12#1)
able to follow the##2##4##(1991-11#1)(2008-5#1)
able to form secondary##2##4##(2008-10#1)(2008-4#1)
able to form##11##3##(1990-2#2)(1994-5#1)(1994-6#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-3#1)
able to generate a##2##4##(2008-10#1)(2008-2#1)
able to generate##10##3##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-7#1)
able to give##2##3##(2011-2#1)(2012-12#1)
able to grow at##2##4##(2011-2#1)(2012-2#1)
able to grow in##4##4##(1991-12#1)(2008-11#2)(2008-7#1)
able to grow on##2##4##(2008-10#2)
able to grow under##2##4##(2008-11#2)
able to grow well##2##4##(2008-10#1)(2013-7#1)
able to grow##13##3##(1991-12#1)(1994-12#1)(2008-10#3)(2008-11#4)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
able to handle##2##3##(2008-10#1)(2008-4#1)
able to identify a##2##4##(1997-7#1)(2011-2#1)
able to identify and##2##4##(2008-12#1)(2008-3#1)
able to identify the##5##4##(1990-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
able to identify##19##3##(1990-7#1)(1991-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-7#1)(2013-7#1)(2013-8#5)
able to improve##5##3##(2008-5#1)(2008-8#2)(2010-3#1)(2010-6#1)
able to increase the##4##4##(2008-5#1)(2009-6#1)(2009-7#1)(2011-1#1)
able to increase##9##3##(1991-3#1)(1993-3#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)
able to induce resistance in##2##5##(2008-10#2)
able to induce the production of##2##6##(2008-1#1)(2013-8#1)
able to induce the##3##4##(2008-1#1)(2008-9#1)(2013-8#1)
able to induce##25##3##(1991-5#1)(1991-9#1)(1994-11#1)(1995-12#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
able to infect the##3##4##(2008-10#2)(2013-1#1)
able to infect##9##3##(2008-10#7)(2013-1#2)
able to influence##2##3##(2008-5#1)(2013-1#1)
able to inhibit the##3##4##(1991-6#1)(2008-4#1)(2010-4#1)
able to inhibit##6##3##(1991-6#1)(1994-6#1)(1995-11#1)(2008-4#1)(2008-5#1)(2010-4#1)
able to interact with##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
able to interact##4##3##(1994-5#1)(2008-10#1)(2008-8#1)(2009-8#1)
able to isolate##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
able to learn the##2##4##(1993-5#1)(1996-5#1)
able to learn##3##3##(1993-5#1)(1996-5#1)(2012-3#1)
able to maintain##7##3##(1991-8#1)(1993-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#2)
able to make##7##3##(1992-2#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-9#1)
able to manipulate the##2##4##(1990-2#1)(2008-12#1)
able to manipulate##4##3##(1990-2#1)(2008-12#1)(2009-8#1)(2012-2#1)
able to measure the##3##4##(1991-1#1)(2007-12#1)(2009-11#1)
able to measure##4##3##(1991-1#1)(2007-12#1)(2008-2#1)(2009-11#1)
able to meet##4##3##(1990-10#1)(2008-11#2)(2008-7#1)
able to modify##4##3##(1995-12#1)(2008-12#1)(2008-7#2)
able to modulate##5##3##(1995-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
able to monitor##3##3##(1997-6#1)(2008-10#2)
able to obtain a##2##4##(2007-12#1)(2008-10#1)
able to obtain##8##3##(1992-2#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
able to offer##5##3##(1991-3#1)(1992-3#1)(1996-9#1)(2008-11#1)(2011-3#1)
able to overcome the##2##4##(2008-8#1)(2013-7#1)
able to overcome##6##3##(2008-10#1)(2008-12#1)(2008-8#2)(2012-1#1)(2013-7#1)
able to perceive##2##3##(2008-7#2)
able to perform a##2##4##(2008-1#1)(2008-9#1)
able to perform##9##3##(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
able to predict the##4##4##(1990-7#1)(2008-5#1)(2008-8#1)(2012-12#1)
able to predict##12##3##(1990-7#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-12#1)
able to prevent##2##3##(1991-9#1)(2013-1#1)
able to produce a##3##4##(1991-3#1)(1997-6#1)(2008-10#1)
able to produce the##2##4##(2008-10#1)(2008-5#1)
able to produce##18##3##(1991-12#1)(1991-3#1)(1992-11#1)(1992-9#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#1)(2013-8#1)
able to proliferate##3##3##(2008-11#2)(2009-5#1)
able to promote the formation of##2##6##(1995-2#2)
able to promote##5##3##(1995-2#2)(1997-3#1)(2008-10#1)(2008-9#1)
able to protect##2##3##(1995-6#1)(2008-5#1)
able to prove##2##3##(2008-10#2)
able to provide better##2##4##(2008-3#1)(2013-8#1)
able to provide##15##3##(1992-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2009-11#1)(2013-8#1)
able to reach the##2##4##(2008-10#1)(2009-12#1)
able to reach##5##3##(1992-3#1)(2008-10#2)(2009-12#1)(2010-5#1)
able to reap##2##3##(2008-10#1)(2008-11#1)
able to recognize##8##3##(1995-8#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
able to recover##3##3##(2008-3#1)(2012-12#1)(2013-1#1)
able to reduce the##5##4##(1992-11#1)(1992-9#1)(1995-3#1)(2007-8#1)(2008-5#1)
able to reduce##15##3##(1991-3#1)(1992-11#1)(1992-9#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2012-2#2)(2012-3#1)
able to regulate##2##3##(2009-8#1)(2011-2#1)
able to release##2##3##(1995-11#1)(2008-5#1)
able to repair##3##3##(1992-9#1)(2008-10#1)(2010-1#1)
able to replace##3##3##(1990-7#2)(2011-7#1)
able to replicate##2##3##(1994-12#1)(2008-9#1)
able to reproduce##10##3##(1992-9#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2013-8#1)
able to rescue the defective##2##5##(2008-10#1)(2008-11#1)
able to rescue the##4##4##(1993-9#1)(1995-11#1)(2008-10#1)(2008-11#1)
able to resolve##2##3##(2008-1#1)(2013-1#1)
able to respond to##4##4##(1992-12#1)(1992-9#1)(2010-12#1)(2011-2#1)
able to respond##5##3##(1992-12#1)(1992-9#1)(2008-12#1)(2010-12#1)(2011-2#1)
able to return to##2##4##(1992-5#1)(2007-11#1)
able to reveal##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
able to reverse the##3##4##(1995-12#1)(1996-9#1)(2012-3#1)
able to save##2##3##(1996-12#1)(2010-8#1)
able to select the##2##4##(1993-11#1)(2009-12#1)
able to select##3##3##(1993-11#1)(2008-8#1)(2009-12#1)
able to separate##2##3##(1996-5#1)(2008-10#1)
able to share##2##3##(2008-9#1)(2013-8#1)
able to shed##2##3##(2008-1#1)(2009-5#1)
able to show that##6##4##(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)
able to show##9##3##(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
able to significantly##7##3##(1990-3#1)(1994-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)
able to solve##2##3##(2008-9#1)(2012-2#1)
able to specifically##3##3##(2008-10#2)(2011-2#1)
able to stimulate the##5##4##(1992-11#1)(1993-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
able to stimulate transcription##2##4##(1993-8#1)(1994-2#1)
able to stimulate##16##3##(1990-2#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-8#2)(1994-2#1)(2008-11#2)(2008-5#4)(2008-9#1)(2012-2#1)(2013-1#1)
able to study##2##3##(1992-8#1)(2009-11#1)
able to substitute for the##2##5##(1993-3#1)(1995-2#1)
able to substitute for##3##4##(1993-3#1)(1995-2#2)
able to successfully##4##3##(1991-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
able to support the##3##4##(2008-10#2)(2008-11#1)
able to support##8##3##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)
able to suppress the##2##4##(1995-12#1)(1995-3#1)
able to suppress##3##3##(1995-12#1)(1995-3#1)(2008-10#1)
able to survive##4##3##(1991-3#1)(1996-12#1)(2008-5#1)(2011-2#1)
able to take##2##3##(2007-11#1)(2008-9#1)
able to tolerate a##2##4##(1993-2#1)(2008-11#1)
able to tolerate##3##3##(1993-2#1)(2007-11#1)(2008-11#1)
able to transduce a##2##4##(2008-11#1)(2008-5#1)
able to transduce##3##3##(1994-5#1)(2008-11#1)(2008-5#1)
able to transfer the##2##4##(2008-11#1)(2008-3#1)
able to transfer##3##3##(1997-8#1)(2008-11#1)(2008-3#1)
able to translocate##2##3##(2007-12#2)
able to transmit##4##3##(2008-10#4)
able to trigger##2##3##(1994-8#1)(2013-8#1)
able to undergo##3##3##(1993-8#2)(2010-5#1)
able to use the##2##4##(1993-11#1)(2007-11#1)
able to use##7##3##(1993-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#2)
able to utilize##2##3##(1992-3#1)(2013-8#1)
able to walk##2##3##(1996-9#1)(2010-12#1)
able to withstand##2##3##(2008-2#1)(2012-3#1)
able to work##2##3##(2009-9#1)(2012-2#1)
able to##909##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#8)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#5)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-3#7)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#9)(1993-1#2)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#7)(1993-5#1)(1993-6#2)(1993-8#8)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#8)(1994-3#3)(1994-5#7)(1994-6#5)(1994-8#2)(1994-9#2)(1995-11#5)(1995-12#6)(1995-2#10)(1995-3#5)(1995-5#6)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#6)(1996-5#2)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#10)(2007-12#16)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#11)(2008-10#142)(2008-11#58)(2008-12#18)(2008-2#15)(2008-3#28)(2008-4#9)(2008-5#41)(2008-6#6)(2008-7#39)(2008-8#23)(2008-9#25)(2009-1#1)(2009-10#1)(2009-11#8)(2009-12#6)(2009-5#5)(2009-6#2)(2009-7#5)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#9)(2010-6#3)(2010-7#2)(2010-8#11)(2011-1#9)(2011-2#29)(2011-3#4)(2011-7#2)(2012-1#2)(2012-12#14)(2012-2#19)(2012-3#15)(2012-6#1)(2012-7#1)(2013-1#29)(2013-7#5)(2013-8#16)
able##919##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#8)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#5)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-3#7)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#9)(1993-1#2)(1993-11#5)(1993-12#4)(1993-2#4)(1993-3#7)(1993-5#1)(1993-6#2)(1993-8#8)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#8)(1994-3#3)(1994-5#7)(1994-6#6)(1994-8#2)(1994-9#2)(1995-11#5)(1995-12#6)(1995-2#10)(1995-3#5)(1995-5#6)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#6)(1996-5#2)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#10)(2007-12#17)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#11)(2008-10#142)(2008-11#62)(2008-12#18)(2008-2#15)(2008-3#28)(2008-4#9)(2008-5#42)(2008-6#6)(2008-7#39)(2008-8#23)(2008-9#25)(2009-1#1)(2009-10#2)(2009-11#8)(2009-12#6)(2009-5#5)(2009-6#2)(2009-7#5)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#9)(2010-6#3)(2010-7#2)(2010-8#11)(2011-1#9)(2011-2#29)(2011-3#4)(2011-7#2)(2012-1#2)(2012-12#14)(2012-2#19)(2012-3#15)(2012-6#1)(2012-7#1)(2013-1#29)(2013-7#5)(2013-8#16)
abnormal ALT levels##3##3##(2013-1#3)
abnormal EABR recordings##2##3##(2008-9#2)
abnormal based on##2##3##(2007-10#1)(2012-2#1)
abnormal cells##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#2)
abnormal changes##3##2##(1997-7#1)(2008-12#1)(2008-3#1)
abnormal cognitive##2##2##(2008-11#1)(2008-7#1)
abnormal communication between##2##3##(2008-11#1)(2012-1#1)
abnormal cytology##3##2##(2012-12#3)
abnormal development of the##3##4##(2009-10#1)(2012-2#1)(2013-1#1)
abnormal development of##5##3##(2008-4#1)(2009-10#1)(2012-2#2)(2013-1#1)
abnormal endometrial growth##3##3##(1994-9#3)
abnormal endometrial##4##2##(1994-9#4)
abnormal expression of##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
abnormal fetal growth##3##3##(2008-10#2)(2013-1#1)
abnormal findings##2##2##(2008-7#1)(2012-2#1)
abnormal glucose##3##2##(2007-11#1)(2008-1#1)(2008-7#1)
abnormal glycosylation##2##2##(1991-9#2)
abnormal growth##3##2##(2007-10#1)(2007-12#1)(2011-2#1)
abnormal head##2##2##(2007-12#2)
abnormal in##7##2##(1991-12#1)(1993-12#1)(1997-3#1)(2008-12#1)(2009-11#1)(2010-11#1)(2013-1#1)
abnormal joint torque coupling##3##4##(2010-7#3)
abnormal levels##3##2##(1997-2#2)(2009-4#1)
abnormal lipid##2##2##(1997-8#1)(2008-7#1)
abnormal liquor volume was##2##4##(2012-12#2)
abnormal liquor volume##5##3##(2012-12#5)
abnormal liver##2##2##(1991-8#1)(1992-6#1)
abnormal lower urinary##3##3##(1991-11#3)
abnormal lung##2##2##(1994-3#1)(2008-1#1)
abnormal mental##2##2##(1996-11#2)
abnormal metabolic pathways##2##3##(2011-2#2)
abnormal methylation##2##2##(1993-11#1)(2008-4#1)
abnormal micro-lesions##6##2##(2012-2#6)
abnormal plasma##2##2##(2008-9#1)(2011-1#1)
abnormal response##2##2##(1990-2#1)(2008-5#1)
abnormal results of##2##3##(2007-2#1)(2012-3#1)
abnormal results##6##2##(1994-12#1)(2007-11#1)(2007-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
abnormal shape##2##2##(2008-10#2)
abnormal sleep##3##2##(1992-11#1)(2007-12#1)(2009-8#1)
abnormal tissue##4##2##(1992-1#1)(2008-3#1)(2008-6#1)(2008-7#1)
abnormal urine and elevated erythrocyte sedimentation rate (ESR) were 34##2##10##(2013-1#2)
abnormal uterine bleeding##2##3##(1991-2#1)(1995-3#1)
abnormal vaginal bleeding##2##3##(1991-2#1)(2007-10#1)
abnormal vaginal##4##2##(1991-2#1)(2007-10#2)(2007-7#1)
abnormal values of creatinine clearance##2##5##(2008-1#2)
abnormal##355##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#6)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#8)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#5)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#3)(1997-3#5)(1997-7#3)(1997-8#2)(2006-5#1)(2007-10#6)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#18)(2008-10#13)(2008-11#7)(2008-12#10)(2008-3#4)(2008-4#10)(2008-5#4)(2008-6#5)(2008-7#20)(2008-8#7)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#3)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#12)(2011-1#7)(2011-2#20)(2012-1#1)(2012-12#11)(2012-2#21)(2012-3#9)(2013-1#21)(2013-8#5)
abnormal&quot##2##1##(2010-1#1)(2010-12#1)
abnormalities and early##2##3##(2008-6#1)(2011-1#1)
abnormalities and in##2##3##(1990-5#1)(2007-8#1)
abnormalities and##34##2##(1990-5#1)(1990-8#1)(1991-12#1)(1993-2#1)(1995-5#1)(1995-9#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
abnormalities are##9##2##(1991-3#1)(1994-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2013-8#1)
abnormalities associated with the##2##4##(2011-2#2)
abnormalities associated with##4##3##(2007-7#1)(2011-2#2)(2012-3#1)
abnormalities by##3##2##(1995-8#1)(1996-5#1)(2009-5#1)
abnormalities detected##2##2##(2008-6#1)(2008-7#1)
abnormalities following##3##2##(1995-3#1)(2007-10#1)(2010-1#1)
abnormalities have been##2##3##(2008-4#1)(2009-11#1)
abnormalities have##3##2##(1996-12#1)(2008-4#1)(2009-11#1)
abnormalities in a patient with##2##5##(1997-7#1)(2008-7#1)
abnormalities in a##3##3##(1991-6#1)(1997-7#1)(2008-7#1)
abnormalities in hypertensive##2##3##(2008-12#1)(2009-1#1)
abnormalities in patients with##2##4##(2007-10#1)(2012-2#1)
abnormalities in the##21##3##(1990-6#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2012-3#1)(2013-1#2)
abnormalities in this##2##3##(1991-12#1)(2008-7#1)
abnormalities in##68##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-6#2)(1992-8#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
abnormalities include##3##2##(1991-12#1)(1997-3#1)(2009-11#1)
abnormalities is##7##2##(1997-7#1)(2008-1#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
abnormalities may be##3##3##(1995-5#1)(2007-12#1)(2008-6#1)
abnormalities may##4##2##(1995-5#1)(2007-12#1)(2008-5#1)(2008-6#1)
abnormalities of lipid##2##3##(1992-10#1)(2008-3#1)
abnormalities of the##12##3##(1995-3#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)
abnormalities of##33##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
abnormalities on chest X-ray consistent with##2##6##(1991-12#2)
abnormalities on##6##2##(1991-12#2)(1996-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
abnormalities or##2##2##(1990-6#1)(2007-5#1)
abnormalities seen##2##2##(1996-5#1)(1997-3#1)
abnormalities such as##6##3##(1994-9#1)(2007-8#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
abnormalities that##6##2##(2008-10#1)(2008-5#1)(2010-1#1)(2012-2#2)(2013-1#1)
abnormalities the##2##2##(1995-8#1)(2008-11#1)
abnormalities were found##2##3##(2007-7#1)(2012-3#1)
abnormalities were observed in##2##4##(1993-12#1)(2008-10#1)
abnormalities were##18##2##(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-5#1)(1997-8#1)(2007-10#4)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#2)(2013-8#1)
abnormalities which##3##2##(1992-8#1)(1994-5#1)(1997-8#1)
abnormalities with##5##2##(1994-11#1)(1997-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
abnormalities without##2##2##(1996-5#1)(2007-10#1)
abnormalities##401##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#2)(1991-12#12)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-8#7)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#7)(1996-6#1)(1996-7#2)(1997-1#2)(1997-3#14)(1997-6#1)(1997-7#5)(1997-8#5)(2006-10#1)(2007-10#16)(2007-11#4)(2007-12#2)(2007-5#2)(2007-7#6)(2007-8#6)(2008-1#6)(2008-10#11)(2008-11#11)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#11)(2008-5#6)(2008-6#11)(2008-7#20)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#4)(2009-2#1)(2009-4#4)(2009-5#3)(2009-7#1)(2010-1#5)(2010-10#1)(2010-12#1)(2010-3#3)(2010-6#3)(2010-8#7)(2011-1#10)(2011-2#18)(2011-7#2)(2012-1#1)(2012-12#5)(2012-2#16)(2012-3#17)(2013-1#19)(2013-7#1)(2013-8#2)
abnormalities]##2##1##(1990-8#1)(2013-8#1)
abnormality and##3##2##(1992-3#1)(2008-12#1)(2011-1#1)
abnormality as##2##2##(1991-12#1)(1992-5#1)
abnormality at##3##2##(2007-10#2)(2008-12#1)
abnormality could##2##2##(2008-7#2)
abnormality detected##2##2##(2008-8#1)(2012-3#1)
abnormality found##2##2##(2007-8#1)(2008-1#1)
abnormality in the##4##3##(1996-12#1)(1996-9#1)(2008-2#1)(2008-4#1)
abnormality in##9##2##(1993-12#1)(1993-6#1)(1996-12#1)(1996-9#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)
abnormality is##2##2##(2008-4#1)(2010-8#1)
abnormality may##2##2##(1992-12#1)(1994-5#1)
abnormality of##6##2##(1993-3#1)(1996-2#1)(1997-7#1)(2008-1#1)(2012-2#1)(2013-1#1)
abnormality on##2##2##(1991-12#1)(2010-6#1)
abnormality was##7##2##(1991-11#1)(1996-12#1)(1997-3#1)(2007-10#3)(2011-2#1)
abnormality##85##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1993-12#2)(1993-3#1)(1993-6#1)(1994-5#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#3)(1997-7#1)(2007-10#9)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#5)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2010-12#1)(2010-6#3)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#1)
abnormally elevated##2##2##(1994-7#1)(1994-8#1)
abnormally high##6##2##(1990-12#1)(1990-8#1)(1995-5#1)(1997-1#1)(2009-8#1)(2012-1#1)
abnormally large##2##2##(2009-2#1)(2013-1#1)
abnormally long##2##2##(2008-10#1)(2008-6#1)
abnormally low##2##2##(1995-3#1)(2008-2#1)
abnormally##30##1##(1990-12#1)(1990-8#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-1#1)(1997-2#1)(1997-5#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-8#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
aboard the##3##2##(1991-8#1)(2008-2#1)(2008-3#1)
aboard##5##1##(1991-12#1)(1991-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
abolish the##8##2##(1990-11#2)(1990-5#1)(1992-12#1)(1992-7#1)(1996-5#1)(2008-10#1)(2013-7#1)
abolish##13##1##(1990-11#2)(1990-5#1)(1990-7#1)(1992-12#1)(1992-7#1)(1994-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#1)(2013-7#1)
abolished after##3##2##(1990-11#1)(2007-8#1)(2008-11#1)
abolished all##2##2##(2008-10#1)(2008-5#1)
abolished at##3##2##(1990-5#1)(1994-5#1)(1995-2#1)
abolished both##5##2##(1990-12#1)(1991-12#1)(1994-6#1)(1997-1#1)(1997-2#1)
abolished by a##2##3##(1991-2#1)(1995-2#1)
abolished by reducing##2##3##(1990-2#1)(1990-8#1)
abolished by the##8##3##(1992-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-4#1)(2008-6#2)(2013-1#1)
abolished by##38##2##(1990-2#2)(1990-8#1)(1991-2#1)(1992-7#2)(1992-8#1)(1993-6#1)(1994-10#1)(1994-3#2)(1994-6#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#2)(1995-8#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-6#2)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#1)
abolished in the presence of##4##5##(1990-5#1)(1991-12#1)(1994-12#1)(2013-7#1)
abolished in the##8##3##(1990-5#1)(1991-12#1)(1992-3#1)(1994-12#1)(1996-12#1)(1997-7#1)(2009-10#1)(2013-7#1)
abolished in##15##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-3#1)(1994-12#1)(1995-11#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#2)(2009-10#1)(2013-7#1)
abolished its##4##2##(1990-11#1)(2008-1#1)(2008-10#1)(2010-2#1)
abolished the effect of##2##4##(1997-2#1)(1997-7#1)
abolished the##36##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#2)(1992-3#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-2#3)(1996-5#1)(1997-2#3)(1997-4#1)(1997-7#2)(2008-4#2)(2008-5#1)(2009-2#1)(2013-1#2)
abolished these##2##2##(1992-3#1)(1995-5#1)
abolished this##2##2##(1991-1#1)(1995-11#1)
abolished when##3##2##(1993-8#1)(2008-5#1)(2008-8#1)
abolished##161##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#6)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#2)(1991-9#2)(1992-3#4)(1992-7#2)(1992-8#2)(1992-9#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#6)(1994-8#1)(1995-11#6)(1995-12#8)(1995-2#3)(1995-3#2)(1995-5#5)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#3)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#2)(2013-1#5)(2013-7#1)
abolishes the ability of##2##4##(1991-2#1)(1995-5#1)
abolishes the##9##2##(1991-2#1)(1991-7#1)(1994-11#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-8#1)(2008-8#1)
abolishes##24##1##(1990-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1994-11#2)(1995-11#3)(1995-2#4)(1995-5#1)(1995-6#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-8#2)(2010-11#1)(2012-12#1)
abolishing##3##1##(1997-4#1)(1997-7#1)(2008-10#1)
abolition of##4##2##(1994-11#1)(1995-12#1)(2012-2#1)(2013-1#1)
abolition##5##1##(1994-11#1)(1995-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
aboriginal##5##1##(1991-11#1)(1996-12#2)(2008-12#2)
aborted##7##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
abortion after##2##2##(1995-8#1)(2008-11#1)
abortion among low income women##2##5##(1991-6#2)
abortion among##3##2##(1991-6#2)(2010-11#1)
abortion and its##2##3##(2008-11#1)(2011-1#1)
abortion and labor activity##2##4##(2013-1#2)
abortion and the##2##3##(1990-8#1)(2008-11#1)
abortion and##19##2##(1990-8#1)(1992-6#1)(1993-2#1)(1994-9#2)(1995-6#1)(1996-12#1)(2008-11#5)(2011-1#3)(2013-1#4)
abortion at##2##2##(1991-2#1)(2008-4#1)
abortion be##2##2##(2008-11#1)(2011-2#1)
abortion care##2##2##(2008-7#1)(2011-2#1)
abortion for##3##2##(1994-2#3)
abortion has been##2##3##(1996-8#1)(2008-11#1)
abortion in##10##2##(1993-2#1)(2007-2#1)(2008-11#3)(2008-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
abortion is legal in Cuba but not in Chile##2##9##(2013-1#2)
abortion is##8##2##(1990-3#1)(1990-9#1)(1991-6#1)(2008-11#1)(2011-1#1)(2013-1#3)
abortion law and practice in Northern Ireland##2##7##(2013-8#2)
abortion law and##3##3##(2013-8#3)
abortion law##5##2##(1993-7#1)(2008-11#1)(2013-8#3)
abortion may##2##2##(2008-8#1)(2013-1#1)
abortion of##8##2##(1997-7#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-1#1)
abortion or##3##2##(1990-8#1)(1991-1#1)(2008-9#1)
abortion rates##2##2##(1994-2#2)
abortion safe and legal##2##4##(2008-11#2)
abortion services##4##2##(1991-1#1)(1993-2#1)(1994-2#1)(1996-5#1)
abortion to##2##2##(1991-1#1)(1994-9#1)
abortion was performed##2##3##(1994-3#1)(2012-3#1)
abortion was##4##2##(1994-3#1)(1995-8#1)(2012-3#2)
abortion without##2##2##(1997-6#1)(2011-2#1)
abortion##161##1##(1990-10#1)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-2#1)(1991-3#1)(1991-6#8)(1991-8#2)(1992-2#2)(1992-6#2)(1993-2#4)(1993-3#1)(1993-7#1)(1994-2#15)(1994-3#3)(1994-9#4)(1995-11#3)(1995-6#1)(1995-8#3)(1996-12#1)(1996-5#2)(1996-8#4)(1997-5#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#18)(2008-4#2)(2008-7#1)(2008-8#8)(2008-9#2)(2009-1#1)(2010-11#1)(2010-12#1)(2011-1#10)(2011-2#7)(2012-12#1)(2012-3#8)(2013-1#12)(2013-8#4)
abortion-inducing##2##1##(1993-2#2)
abortion-related##2##1##(1996-8#1)(2012-3#1)
abortion]##4##1##(1991-3#2)(2008-11#1)(2013-1#1)
abortions and##8##2##(1997-4#1)(2008-11#3)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
abortions at military facilities##3##4##(1996-5#3)
abortions at overseas military hospitals##2##5##(1995-6#2)
abortions at##5##2##(1995-6#2)(1996-5#3)
abortions except##2##2##(1995-6#1)(1996-5#1)
abortions for##2##2##(1994-2#1)(2013-1#1)
abortions in##7##2##(1994-2#3)(1995-6#1)(1996-11#2)(2013-1#1)
abortions or##2##2##(2008-11#1)(2013-1#1)
abortions##56##1##(1990-3#1)(1991-3#2)(1991-6#2)(1993-3#1)(1993-9#1)(1994-2#10)(1995-6#4)(1995-8#3)(1996-11#3)(1996-5#5)(1996-8#2)(1997-2#2)(1997-4#1)(1997-5#1)(2008-11#7)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#7)
abortive synthesis##2##2##(1997-4#2)
abortive##6##1##(1991-5#1)(1991-9#1)(1997-4#2)(2008-10#1)(2013-1#1)
aborts##2##1##(1994-3#1)(2008-11#1)
abortus strain 2308##3##3##(1996-12#3)
abortus strain##5##2##(1996-12#3)(2010-4#2)
abortus##11##1##(1996-12#3)(2008-9#3)(2010-4#2)(2011-2#2)(2012-2#1)
abound##4##1##(1992-2#2)(2008-4#1)(2008-7#1)
abounds##2##1##(2011-2#1)(2012-3#1)
about &quot##7##2##(1992-1#1)(1994-3#1)(2009-10#2)(2010-8#1)(2013-1#1)(2013-8#1)
about 0##45##2##(1990-10#1)(1990-5#1)(1990-7#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-3#1)(2008-10#24)(2008-6#1)(2008-8#3)(2009-5#1)(2013-8#2)
about 1 in##2##3##(1991-8#1)(1997-3#1)
about 1 kb##2##3##(1995-8#1)(2008-8#1)
about 1 mol##3##3##(1990-12#1)(1990-7#1)(1992-3#1)
about 1 month##2##3##(2008-10#2)
about 1##53##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2007-12#3)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
about 1% of all##3##4##(1990-9#1)(1996-12#1)(2008-4#1)
about 1%##6##2##(1990-9#1)(1996-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2010-1#1)
about 1/3 of the##3##4##(1991-6#1)(1995-6#1)(1995-9#1)
about 1/3##4##2##(1991-12#1)(1991-6#1)(1995-6#1)(1995-9#1)
about 10 kb##4##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-8#1)
about 10 min##2##3##(1993-11#1)(2008-10#1)
about 10 mug##2##3##(2008-10#2)
about 10 s and##3##4##(2008-10#3)
about 10 times##2##3##(2008-10#1)(2012-3#1)
about 10##27##2##(1990-11#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-1#2)(2008-10#15)(2008-8#1)(2010-2#1)(2012-12#1)(2012-3#1)
about 10% of the##2##4##(2008-10#1)(2012-3#1)
about 10% of##5##3##(1993-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-3#1)
about 10%##12##2##(1993-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
about 10(3)##2##2##(2008-10#2)
about 10(4)##2##2##(2008-10#2)
about 10-15##2##2##(1992-5#1)(1997-4#1)
about 10-fold##2##2##(1990-6#1)(1997-4#1)
about 100 times##2##3##(2008-10#2)
about 100##15##2##(1991-5#1)(1993-6#1)(1995-11#2)(1995-12#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-7#1)(2010-12#1)
about 100%##3##2##(1990-8#1)(2008-10#2)
about 1000##5##2##(1990-7#1)(1993-2#1)(2007-12#1)(2008-7#2)
about 11##2##2##(1990-7#1)(2008-10#1)
about 12##4##2##(1992-8#1)(1994-11#1)(2008-7#1)(2010-12#1)
about 120##2##2##(1995-8#1)(2008-8#1)
about 13 to##2##3##(1991-4#1)(1992-3#1)
about 13 years##2##3##(2007-12#1)(2010-12#1)
about 13##7##2##(1990-2#1)(1991-4#1)(1992-3#1)(1997-4#1)(2007-12#1)(2010-12#1)(2010-8#1)
about 13-fold##2##2##(2008-11#1)(2012-3#1)
about 130##4##2##(1994-8#1)(1996-6#1)(2007-4#1)(2013-1#1)
about 130%##2##2##(1997-6#1)(2008-10#1)
about 14% of##2##3##(1992-6#1)(1992-8#1)
about 15 years##3##3##(1993-6#1)(1997-5#1)(2008-10#1)
about 15##13##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
about 15% of##2##3##(1992-11#1)(2008-5#1)
about 15%##7##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-3#1)
about 150##5##2##(1996-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
about 15s##2##2##(2008-10#2)
about 16##2##2##(2007-12#1)(2008-10#1)
about 17%##3##2##(1990-6#1)(1993-11#1)(2008-4#1)
about 18##4##2##(1990-2#1)(1997-6#1)(2008-8#1)(2010-5#1)
about 18%##2##2##(1992-5#1)(2008-3#1)
about 180##3##2##(1992-8#1)(1993-6#1)(2008-8#1)
about 2 h##2##3##(1990-7#1)(2008-10#1)
about 2 kb##2##3##(1991-6#1)(2008-9#1)
about 2 months##3##3##(2008-10#3)
about 2 pH units higher than that of##2##8##(1995-5#2)
about 2 times##3##3##(1990-11#1)(2008-11#1)(2008-6#1)
about 2 years##2##3##(1992-8#1)(2008-10#1)
about 2##49##2##(1990-11#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-6#1)(1992-11#1)(1992-8#2)(1993-2#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-8#1)
about 2% of the##3##4##(1994-3#1)(1997-8#1)(2013-1#1)
about 2% of##4##3##(1990-2#1)(1994-3#1)(1997-8#1)(2013-1#1)
about 2%##6##2##(1990-2#1)(1994-3#1)(1997-8#2)(2009-4#1)(2013-1#1)
about 2-fold##3##2##(1990-5#1)(1994-6#1)(2008-11#1)
about 20 min##2##3##(2008-10#2)
about 20 years ago##3##4##(1995-4#1)(2008-4#1)(2008-8#1)
about 20 years##4##3##(1995-4#1)(1996-3#1)(2008-4#1)(2008-8#1)
about 20##21##2##(1990-7#1)(1991-1#1)(1993-3#1)(1994-11#1)(1995-4#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)
about 20% of all##2##4##(1995-3#1)(2013-1#1)
about 20% of patients##5##4##(1996-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2013-1#1)
about 20% of the##3##4##(1991-8#1)(1997-2#1)(2008-8#1)
about 20% of##14##3##(1991-8#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-1#1)(2013-1#2)
about 20%##20##2##(1991-5#1)(1991-8#1)(1992-12#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-3#1)(2012-1#1)(2013-1#2)
about 20-30##2##2##(2007-11#1)(2008-5#1)
about 200 mV##2##3##(2008-10#2)
about 200##5##2##(1994-11#1)(2008-10#2)(2008-11#1)(2008-12#1)
about 200mV##2##2##(2008-10#2)
about 21##2##2##(1992-6#1)(2010-10#1)
about 23##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
about 24##4##2##(1992-8#1)(2008-10#2)(2008-11#1)
about 25##7##2##(1990-10#1)(2007-5#1)(2008-10#3)(2013-1#2)
about 25% of the##4##4##(1993-8#1)(1994-8#1)(2008-10#2)
about 25% of##5##3##(1993-8#1)(1994-8#1)(2008-10#2)(2011-2#1)
about 25%##7##2##(1993-11#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
about 250 times##2##3##(1990-11#1)(2008-8#1)
about 250##5##2##(1990-11#1)(1992-2#1)(1993-1#1)(1993-2#1)(2008-8#1)
about 27##2##2##(1990-9#1)(2008-7#1)
about 27%##2##2##(2010-12#1)(2013-8#1)
about 3 times higher##2##4##(2008-11#1)(2011-2#1)
about 3 times##4##3##(1994-5#1)(2008-11#1)(2008-8#1)(2011-2#1)
about 3##23##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
about 3% of the##2##4##(1990-12#1)(2007-11#1)
about 3% of##3##3##(1990-12#1)(1997-3#1)(2007-11#1)
about 3%##7##2##(1990-12#1)(1997-3#1)(2007-11#1)(2008-10#4)
about 3-4##3##2##(1993-11#1)(1993-12#1)(1994-6#1)
about 3-fold higher##2##3##(1994-12#1)(2008-11#1)
about 3-fold in##2##3##(1990-5#1)(2012-3#1)
about 3-fold##6##2##(1990-11#1)(1990-5#1)(1994-12#1)(1995-8#1)(2008-11#1)(2012-3#1)
about 30 kDa##3##3##(1990-5#1)(1994-11#2)
about 30 min##5##3##(2008-10#5)
about 30##22##2##(1990-5#1)(1992-3#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#9)(2008-4#1)(2009-8#1)(2009-9#1)(2013-1#1)
about 30% of cases##2##4##(1995-4#1)(2007-10#1)
about 30% of the##2##4##(1990-10#1)(1992-8#1)
about 30% of##6##3##(1990-10#1)(1992-6#1)(1992-8#1)(1995-4#1)(1996-5#1)(2007-10#1)
about 30%##12##2##(1990-10#1)(1992-6#1)(1992-8#1)(1993-2#1)(1995-4#1)(1995-6#1)(1996-5#2)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)
about 300##5##2##(1997-6#1)(2008-10#3)(2010-5#1)
about 30min##2##2##(2008-10#2)
about 32##4##2##(1997-6#1)(2008-5#1)(2012-12#1)(2013-8#1)
about 320##2##2##(1991-2#1)(1995-3#1)
about 33%##2##2##(2008-10#1)(2008-11#1)
about 35##7##2##(1991-5#2)(1993-3#1)(2008-10#1)(2008-9#1)(2010-10#1)(2012-12#1)
about 36##2##2##(1995-1#1)(2008-10#1)
about 4 h##2##3##(1991-8#1)(2008-10#1)
about 4##21##2##(1991-6#1)(1991-8#1)(1992-9#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-7#3)(2008-9#1)(2012-12#1)(2012-2#1)
about 4%##3##2##(2008-10#2)(2010-12#1)
about 4-fold##2##2##(1991-12#1)(1994-8#1)
about 40 times##2##3##(2008-10#1)(2008-11#1)
about 40 years ago##2##4##(2008-10#1)(2008-5#1)
about 40##10##2##(1990-2#1)(1993-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
about 40% of the##3##4##(1990-2#1)(1996-6#1)(2009-4#1)
about 40% of##10##3##(1990-2#1)(1994-8#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-5#2)(2009-4#1)(2010-8#1)(2011-3#1)
about 40%##20##2##(1990-2#1)(1991-8#1)(1992-5#2)(1994-8#2)(1995-12#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-3#2)
about 400##5##2##(1990-11#1)(2007-12#1)(2008-10#2)(2012-12#1)
about 42 percent of##2##4##(2008-8#1)(2011-2#1)
about 45##2##2##(2008-10#1)(2012-12#1)
about 45%##2##2##(1997-4#1)(2012-3#1)
about 47%##2##2##(1996-12#1)(2008-11#1)
about 5 min##3##3##(1993-12#1)(2008-10#2)
about 5 s with##2##4##(2008-10#1)(2008-7#1)
about 5##22##2##(1990-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1995-5#1)(1997-6#2)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#3)
about 5% of the##2##4##(1995-2#2)
about 5% of##3##3##(1995-2#2)(1997-2#1)
about 5%##6##2##(1991-5#1)(1995-2#2)(1997-2#1)(2008-10#1)(2008-5#1)
about 5-fold##2##2##(2008-11#2)
about 50 years##2##3##(2010-6#1)(2011-2#1)
about 50##16##2##(1990-7#1)(1995-12#1)(2008-10#6)(2008-12#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#2)
about 50% of the##3##4##(1990-12#1)(1997-2#1)(2007-10#1)
about 50% of##11##3##(1990-12#1)(1990-6#1)(1994-11#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
about 50%##30##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1993-3#1)(1994-11#2)(1996-6#1)(1997-2#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-8#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
about 50%)##3##2##(2009-8#3)
about 6##7##2##(1990-5#1)(1992-1#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-7#1)(2009-11#1)
about 6%##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
about 60 samples##3##3##(2008-10#3)
about 60##9##2##(1990-5#1)(1993-3#1)(1996-5#1)(1997-7#1)(2008-10#4)(2013-8#1)
about 60%##8##2##(1990-3#1)(1992-8#1)(1993-12#1)(1995-5#1)(1997-2#1)(2008-10#1)(2010-4#1)(2011-2#1)
about 62##2##2##(2009-12#1)(2009-5#1)
about 65##3##2##(1992-8#1)(2008-10#2)
about 65% of##3##3##(1994-6#1)(2008-10#2)
about 65%##4##2##(1993-12#1)(1994-6#1)(2008-10#2)
about 66##2##2##(1992-3#1)(1993-8#1)
about 7##9##2##(1990-7#1)(1992-2#1)(1995-2#1)(1996-6#1)(2008-10#3)(2008-7#1)(2011-2#1)
about 7-fold##2##2##(1994-8#1)(1997-4#1)
about 70##7##2##(1990-8#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
about 70% of the##2##4##(1991-12#1)(2013-1#1)
about 70% of##4##3##(1991-12#1)(1991-5#1)(1996-12#1)(2013-1#1)
about 70%##9##2##(1990-12#1)(1991-12#1)(1991-5#1)(1996-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
about 700##3##2##(1991-12#1)(1992-9#1)(2008-10#1)
about 75##2##2##(2008-11#1)(2010-8#1)
about 75% of##2##3##(2011-2#1)(2013-8#1)
about 75%##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
about 8 weeks##2##3##(2008-10#2)
about 8##4##2##(2008-10#3)(2013-1#1)
about 80 percent of##2##4##(1992-12#1)(1994-2#1)
about 80##5##2##(1992-12#1)(1992-2#1)(1994-2#1)(2008-7#1)(2012-3#1)
about 80% of the##7##4##(1990-9#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#1)
about 80% of##10##3##(1990-9#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2009-9#1)(2013-1#1)
about 80%##11##2##(1990-5#1)(1990-9#1)(1991-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2009-9#1)(2013-1#1)
about 80-fold##2##2##(1994-8#1)(1995-5#1)
about 82%##2##2##(1991-6#1)(2008-11#1)
about 9##6##2##(1992-9#1)(1996-6#1)(2008-10#3)(2009-11#1)
about 90 degrees##2##3##(1993-8#2)
about 90##6##2##(1990-2#1)(1991-2#1)(1993-8#2)(1995-11#1)(2008-10#1)
about 90% of the##3##4##(1992-6#1)(1997-6#1)(2008-10#1)
about 90% of##7##3##(1992-6#1)(1993-3#1)(1997-6#1)(2008-10#2)(2010-12#1)(2011-2#1)
about 90%##11##2##(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1996-11#1)(1997-6#1)(2008-10#3)(2010-12#1)(2011-2#1)
about AIDS in the##2##4##(1997-6#1)(2012-3#1)
about AIDS in##3##3##(1997-6#1)(2012-3#2)
about AIDS##12##2##(1991-1#1)(1992-12#1)(1992-2#3)(1993-1#2)(1995-12#1)(1997-6#2)(2012-3#2)
about GAP##2##2##(2013-1#2)
about HIV transmission and##3##4##(1997-6#1)(2011-2#1)(2012-12#1)
about HIV##11##2##(1991-6#1)(1995-6#1)(1996-5#2)(1997-6#1)(2008-1#1)(2009-5#2)(2011-2#1)(2012-12#2)
about HIV/AIDS##4##2##(2007-7#1)(2008-10#3)
about NRT##4##2##(2012-3#4)
about Y##2##2##(2008-7#2)
about a dozen##2##3##(2008-11#1)(2013-1#1)
about a half of the##2##5##(1994-3#1)(2008-7#1)
about a half of##3##4##(1994-3#1)(2008-7#1)(2011-2#1)
about a particular##2##3##(2008-4#1)(2008-7#1)
about a patient##2##3##(1990-3#1)(2008-10#1)
about a point##2##3##(2008-3#2)
about a significant##3##3##(1991-12#1)(2011-2#1)(2012-12#1)
about a third of##2##4##(2009-4#1)(2010-8#1)
about a third##3##3##(2009-4#1)(2010-8#1)(2012-3#1)
about a##69##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
about abortion##2##2##(2008-11#1)(2010-11#1)
about adverse effects##2##3##(1996-9#1)(2011-2#1)
about adverse##3##2##(1995-11#1)(1996-9#1)(2011-2#1)
about alcohol##3##2##(2007-2#1)(2008-1#1)(2010-11#1)
about all##3##2##(1992-11#1)(2008-5#1)(2011-2#1)
about an increase in##2##4##(1994-6#1)(2008-11#1)
about an order of magnitude##2##5##(1990-8#1)(2008-10#1)
about an##16##2##(1990-8#1)(1991-3#1)(1992-3#1)(1994-5#1)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-3#1)
about and##7##2##(1991-12#1)(1992-3#1)(1994-1#1)(1997-3#1)(2009-10#1)(2010-10#1)(2010-3#1)
about any##2##2##(2008-11#1)(2010-3#1)
about appropriate##2##2##(2008-11#1)(2008-3#1)
about appropriateness of##2##3##(1993-1#1)(2007-9#1)
about as##3##2##(1990-5#1)(1992-12#1)(2012-2#1)
about becoming##3##2##(1995-6#1)(2007-12#1)(2013-1#1)
about being##3##2##(1996-5#1)(2010-10#1)(2012-12#1)
about biological##3##2##(2008-4#1)(2010-4#2)
about body size##2##3##(2007-12#2)
about body##4##2##(2007-12#4)
about brain##2##2##(1991-1#1)(2007-11#1)
about bullying##2##2##(2008-12#2)
about cancer##5##2##(1992-2#1)(1997-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
about changes in the##2##4##(1990-6#1)(2012-3#1)
about changes in##6##3##(1990-6#1)(1996-4#1)(2008-1#1)(2009-4#1)(2012-3#2)
about chronic##2##2##(2010-3#1)(2013-8#1)
about clinical##3##2##(1996-6#1)(2011-2#2)
about complex##2##2##(1995-5#1)(2008-7#1)
about confidentiality##2##2##(2008-11#1)(2012-3#1)
about consumer satisfaction##2##3##(1993-12#1)(1996-2#1)
about contraceptive##2##2##(1996-11#2)
about control##2##2##(1994-3#1)(2010-8#1)
about current##2##2##(2011-2#2)
about demographics##2##2##(1995-3#1)(2008-12#1)
about dengue##2##2##(2011-2#1)(2012-12#1)
about dental##2##2##(2008-1#1)(2008-12#1)
about developmental coordination disorder##2##4##(2008-11#2)
about diabetes##6##2##(1993-12#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-1#2)
about different aspects##2##3##(1991-9#1)(1996-11#1)
about different##4##2##(1991-9#1)(1996-11#1)(2010-8#1)(2011-3#1)
about dynamic##2##2##(2008-10#1)(2008-9#1)
about early intervention##2##3##(2009-8#2)
about eightfold##2##2##(1995-2#1)(2008-10#1)
about emotionally challenging situations##2##4##(2008-11#2)
about end-of-life care##2##3##(2010-4#1)(2012-3#1)
about equally##2##2##(1994-12#1)(1995-2#1)
about ethical##2##2##(1992-11#1)(2008-4#1)
about evolutionary##2##2##(2008-8#1)(2010-5#1)
about five##3##2##(1994-9#1)(1997-3#1)(2009-6#1)
about four times##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
about four##4##2##(2007-12#1)(2008-10#2)(2011-1#1)
about future##5##2##(1995-3#2)(2008-7#1)(2009-12#1)(2011-1#1)
about gene regulatory networks from##2##5##(2008-7#2)
about gene##3##2##(2008-10#1)(2008-7#2)
about genes##2##2##(1995-6#1)(2008-4#1)
about genetic##2##2##(2008-7#1)(2011-3#1)
about half of the##7##4##(1990-11#1)(1990-2#1)(1996-10#1)(2009-3#1)(2010-5#1)(2012-1#1)(2012-2#1)
about half of##11##3##(1990-11#1)(1990-2#1)(1991-5#1)(1996-10#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
about half##21##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-6#1)(1995-12#1)(1996-10#1)(1997-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
about health care reform##3##4##(1995-1#1)(1995-12#1)(1996-3#1)
about health care##8##3##(1993-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#1)
about health problems##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
about health##16##2##(1993-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
about heart##2##2##(2008-12#1)(2008-7#1)
about herb and supplement use##2##5##(2008-10#2)
about herbal##2##2##(2008-10#1)(2008-8#1)
about his##4##2##(1996-5#3)(2011-1#1)
about home##2##2##(1994-12#1)(1997-6#1)
about hospitals'##3##2##(1995-2#2)(1995-3#1)
about how occupational##2##3##(2010-9#1)(2011-2#1)
about how they##3##3##(1995-2#1)(1996-1#1)(1997-1#1)
about how to prevent##2##4##(1990-9#1)(1997-1#1)
about how to##11##3##(1990-9#1)(1992-3#1)(1994-2#1)(1996-5#1)(1997-1#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
about how##50##2##(1990-9#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
about important##2##2##(1997-2#1)(2008-7#1)
about in##3##2##(1991-1#1)(2008-12#1)(2012-2#1)
about incest in##2##3##(2008-1#2)
about incidence##2##2##(1995-5#1)(2008-3#1)
about increased##2##2##(2006-10#1)(2008-6#1)
about influenza disease and##2##4##(2012-3#2)
about influenza##3##2##(2012-3#3)
about information##2##2##(1995-1#1)(2008-11#1)
about it##7##2##(1995-11#1)(1996-3#1)(2008-11#2)(2011-1#1)(2012-2#1)(2013-1#1)
about it?##2##2##(2008-1#1)(2012-2#1)
about its biology##2##3##(2008-5#1)(2013-7#1)
about its origin##2##3##(2010-10#1)(2013-8#1)
about its##29##2##(1990-8#1)(1991-9#1)(1992-2#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
about key##2##2##(1994-1#1)(2011-2#1)
about long-term care##3##3##(1991-3#1)(1996-2#1)(1997-3#1)
about management##2##2##(1994-2#1)(1995-1#1)
about mean##2##2##(2008-5#1)(2013-1#1)
about mechanisms##3##2##(1991-1#1)(2008-10#1)(2011-2#1)
about medical##5##2##(1991-2#1)(1997-3#1)(2008-11#1)(2012-3#2)
about mental##4##2##(1993-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
about microbial##2##2##(2008-10#1)(2011-1#1)
about mutation rates##2##3##(2008-10#1)(2008-12#1)
about mutation##3##2##(2008-10#1)(2008-12#2)
about nanotechnology##2##2##(2010-12#2)
about new##3##2##(1996-9#1)(2007-12#1)(2011-2#1)
about normal##2##2##(1991-12#1)(1992-9#1)
about not##2##2##(2008-7#1)(2012-3#1)
about nutrition##2##2##(1995-1#1)(1995-2#1)
about older##3##2##(2010-10#1)(2010-2#1)(2012-12#1)
about one entry every##2##4##(2008-10#2)
about one fifth of##2##4##(1990-11#1)(2008-8#1)
about one month##2##3##(2008-10#1)(2008-11#1)
about one third##2##3##(2008-6#1)(2008-8#1)
about one##18##2##(1990-11#1)(1993-6#2)(1995-5#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)
about one's own##3##3##(1992-11#1)(1993-12#1)(2009-4#1)
about one-half of##2##3##(1991-1#1)(1993-9#1)
about one-third of the##2##4##(2008-1#1)(2008-12#1)
about one-third of##4##3##(1994-8#1)(2008-1#1)(2008-12#1)(2012-12#1)
about one-third##8##2##(1990-8#1)(1994-8#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-12#1)(2009-4#1)(2012-12#1)
about ontologies and##2##3##(2008-7#2)
about osteoporosis##2##2##(1996-6#1)(2008-8#1)
about other##2##2##(2008-11#1)(2010-12#1)
about pain##2##2##(1992-3#1)(2012-2#1)
about patient care##2##3##(1995-3#1)(2011-1#1)
about patient##5##2##(1992-1#1)(1995-3#1)(2008-12#1)(2008-7#1)(2011-1#1)
about patients and##3##3##(1992-4#1)(1997-1#1)(2010-8#1)
about patients##6##2##(1990-3#1)(1992-4#1)(1997-1#1)(1997-3#1)(2010-3#1)(2010-8#1)
about patients'##5##2##(2011-1#1)(2013-8#4)
about people##2##2##(1993-6#1)(2008-11#1)
about physical activity and##3##4##(2009-6#2)(2013-1#1)
about physical activity##4##3##(2009-6#3)(2013-1#1)
about physical and##2##3##(1990-6#1)(1991-8#1)
about physical##8##2##(1990-6#1)(1991-12#1)(1991-8#1)(2009-6#3)(2010-2#1)(2013-1#1)
about possible##8##2##(1990-5#1)(1996-8#1)(2006-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
about potential##3##2##(1991-3#1)(1996-1#1)(2010-11#1)
about practice##2##2##(1997-1#1)(2008-11#1)
about pregnancy##2##2##(2007-2#1)(2010-12#1)
about prostate##2##2##(2008-11#1)(2009-5#1)
about protective role of exercise against##4##6##(2013-1#4)
about psychiatric##2##2##(1996-8#1)(2009-7#1)
about psychiatry##2##2##(1992-6#2)
about quality of##2##3##(1993-1#1)(1994-2#1)
about quality##5##2##(1991-12#1)(1993-1#1)(1993-3#2)(1994-2#1)
about quitting##2##2##(1993-12#1)(2011-2#1)
about rehabilitation and##2##3##(1991-12#1)(2008-4#1)
about research and##2##3##(1992-9#1)(2010-10#1)
about rheumatoid arthritis##2##3##(2012-3#1)(2013-8#1)
about safe##4##2##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
about safety##3##2##(1993-3#1)(2011-1#1)(2012-2#1)
about salt##2##2##(2009-8#1)(2013-1#1)
about sex##3##2##(1992-11#1)(1995-12#1)(2010-5#1)
about sexual concerns##2##3##(2008-7#2)
about sexual##3##2##(1996-11#1)(2008-7#2)
about sexuality with##2##3##(2009-5#1)(2013-1#1)
about shape##2##2##(2007-12#1)(2012-12#1)
about six##3##2##(1991-11#1)(1995-1#1)(2010-4#1)
about sleep##2##2##(1993-1#1)(2013-1#1)
about social##2##2##(2008-6#1)(2011-2#1)
about some##2##2##(1997-4#1)(2008-10#1)
about specific##2##2##(1993-12#1)(2013-7#1)
about stroke##3##2##(2007-10#2)(2010-10#1)
about such##4##2##(1995-1#1)(2008-4#1)(2008-6#2)
about surgical##2##2##(2008-9#1)(2013-1#1)
about survival##2##2##(2008-11#1)(2012-12#1)
about symptoms##2##2##(2007-10#1)(2010-10#1)
about telomerase activity in sarcomas##2##5##(2008-6#2)
about ten##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
about ten-fold##2##2##(1992-12#1)(2008-7#1)
about that##4##2##(1993-11#1)(1995-12#1)(1997-4#1)(2010-8#1)
about the &quot##3##3##(1993-3#1)(2008-10#1)(2010-6#1)
about the actual##2##3##(1994-1#1)(2008-11#1)
about the advantages##2##3##(2008-12#1)(2013-8#1)
about the appropriateness of##3##4##(2008-12#1)(2008-7#1)(2008-9#1)
about the association of##2##4##(1990-8#1)(2008-3#1)
about the availability of##2##4##(2008-9#1)(2010-8#1)
about the availability##3##3##(1992-12#1)(2008-9#1)(2010-8#1)
about the benefits##3##3##(1992-2#1)(1997-2#1)(2013-8#1)
about the best##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
about the biology of##3##4##(2008-10#1)(2008-4#1)(2009-8#1)
about the biology##5##3##(1992-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
about the care##3##3##(2007-10#1)(2013-1#2)
about the clinical##2##3##(1991-2#1)(2008-12#1)
about the collaborative encoding deficit##2##5##(2013-1#2)
about the communication##2##3##(2009-11#2)
about the consequences of##2##4##(2007-12#1)(2008-9#1)
about the costs##3##3##(1992-1#1)(2008-11#1)(2010-9#1)
about the current##4##3##(1991-6#1)(1997-3#1)(2008-9#1)(2010-10#1)
about the dangers of##2##4##(1995-6#1)(1997-6#1)
about the different##2##3##(1997-7#1)(2011-1#1)
about the disease##4##3##(1992-3#1)(1997-8#1)(2009-7#1)(2012-3#1)
about the ecological##2##3##(1996-6#1)(2009-8#1)
about the ecology of##2##4##(2009-4#2)
about the ecology##3##3##(2008-5#1)(2009-4#2)
about the effect of##5##4##(2008-12#2)(2008-9#1)(2012-2#1)(2013-8#1)
about the effectiveness of farm safety##2##6##(2013-1#2)
about the effectiveness of##5##4##(1996-6#1)(2007-12#1)(2012-1#1)(2013-1#2)
about the effectiveness##6##3##(1996-1#1)(1996-6#1)(2007-12#1)(2012-1#1)(2013-1#2)
about the effects of the##2##5##(2008-5#1)(2013-7#1)
about the effects of##17##4##(1991-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
about the effects##18##3##(1990-2#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
about the efficacy##2##3##(1993-12#1)(2012-2#1)
about the elderly##2##3##(2008-11#1)(2008-7#1)
about the etiology and management of orofacial clefts##3##8##(2009-10#3)
about the eventual##2##3##(1994-12#1)(2008-10#1)
about the evolution of##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
about the existence##2##3##(1990-5#1)(2011-2#1)
about the factors that influence the##2##6##(1992-2#1)(2010-10#1)
about the factors that##4##4##(1992-2#1)(2007-7#1)(2008-9#1)(2010-10#1)
about the factors##6##3##(1992-2#1)(1996-11#1)(2007-7#1)(2008-9#1)(2010-10#1)(2012-2#1)
about the function of##2##4##(2006-10#1)(2008-2#1)
about the functional##2##3##(1994-5#1)(2008-7#1)
about the future##6##3##(1992-3#1)(1995-1#2)(1996-3#1)(2007-2#1)(2012-2#1)
about the general##3##3##(1991-2#1)(2008-7#1)(2010-1#1)
about the growth and##2##4##(2008-10#1)(2008-11#1)
about the health##3##3##(1992-3#1)(1997-3#1)(2008-10#1)
about the health-related##2##3##(2008-11#1)(2013-7#1)
about the horizontal##2##3##(2008-11#1)(2008-3#1)
about the impact of##5##4##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
about the importance of##6##4##(1991-12#1)(2007-2#1)(2008-11#2)(2009-11#1)(2013-1#1)
about the incidence of##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
about the incidence##4##3##(1995-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
about the influence of##2##4##(2008-2#1)(2012-3#1)
about the introduction of##2##4##(1993-8#1)(2008-12#1)
about the kappa statistic##2##4##(1995-2#2)
about the latest##2##3##(2008-10#1)(2011-1#1)
about the long term##2##4##(2007-8#1)(2008-10#1)
about the long-term##2##3##(2008-11#1)(2012-2#1)
about the management of##2##4##(1993-12#1)(2013-1#1)
about the mean value##2##4##(2008-3#2)
about the mean##5##3##(1994-5#1)(1995-5#1)(2008-3#3)
about the mechanism of##4##4##(1990-8#1)(1991-12#1)(1995-5#1)(2008-10#1)
about the mechanism that##2##4##(2011-2#2)
about the mechanism##8##3##(1990-8#1)(1991-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
about the mechanisms responsible for##2##5##(2007-12#1)(2012-2#1)
about the mechanisms##5##3##(2007-12#1)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
about the merits of##2##4##(1992-5#1)(2008-11#1)
about the methodology##2##3##(2008-5#1)(2012-2#1)
about the molecular##3##3##(1991-2#1)(2008-4#1)(2012-2#1)
about the most appropriate##2##4##(2008-10#1)(2008-7#1)
about the most##3##3##(2008-10#2)(2008-7#1)
about the natural##3##3##(1992-9#1)(1994-9#1)(2008-7#1)
about the nature and##2##4##(1991-2#1)(2011-2#1)
about the nature of the##4##5##(1992-12#1)(2007-10#1)(2012-2#1)(2013-8#1)
about the nature of##11##4##(1992-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
about the nature##13##3##(1991-2#1)(1992-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
about the necessity of using an SSRI and##2##8##(2011-1#2)
about the necessity##3##3##(2007-7#1)(2011-1#2)
about the need for##4##4##(1991-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
about the need##5##3##(1991-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2012-3#1)
about the new##2##3##(1990-2#1)(1991-11#1)
about the occurrence##2##3##(2007-10#1)(2011-2#1)
about the optical axis##2##4##(2008-2#1)(2008-3#1)
about the optimal##3##3##(2008-2#1)(2008-7#1)(2013-8#1)
about the origin of the##2##5##(2008-7#1)(2009-8#1)
about the origin of##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
about the past##2##3##(2008-10#1)(2012-3#1)
about the pathogenesis of##2##4##(2008-1#1)(2011-2#1)
about the pathophysiology of##3##4##(1996-12#1)(2008-7#1)(2010-11#1)
about the patient's##2##3##(1991-1#1)(1993-11#1)
about the performance of##2##4##(2009-11#1)(2013-1#1)
about the physical##4##3##(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)
about the population##2##3##(2008-10#1)(2011-2#1)
about the possibility of##3##4##(1992-12#1)(2008-11#1)(2011-2#1)
about the possible##6##3##(1992-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
about the potential##5##3##(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
about the practical##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
about the precise##3##3##(2008-9#1)(2010-5#1)(2011-2#1)
about the presence##2##3##(2008-12#1)(2012-12#1)
about the principles of##2##4##(1992-4#1)(2008-8#1)
about the principles##3##3##(1992-4#1)(1995-1#1)(2008-8#1)
about the problems##2##3##(2008-11#1)(2010-4#1)
about the process of##3##4##(1996-2#1)(2012-3#2)
about the processes##2##3##(1996-6#1)(2008-10#1)
about the prognosis##2##3##(2012-2#1)(2012-3#1)
about the proper##2##3##(1995-2#1)(1996-12#1)
about the psychosocial needs of##2##5##(1991-2#1)(2008-9#1)
about the purpose of##2##4##(1991-6#1)(2008-1#1)
about the purpose##3##3##(1991-6#1)(2008-1#1)(2008-11#1)
about the quality of##4##4##(1991-9#1)(1993-3#1)(2008-4#1)(2012-12#1)
about the quality##5##3##(1991-9#1)(1993-3#1)(1996-12#1)(2008-4#1)(2012-12#1)
about the relationship between##6##4##(2008-2#2)(2008-3#1)(2008-4#2)(2013-1#1)
about the relationship of##2##4##(2008-10#1)(2012-2#1)
about the relationship##8##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2012-2#1)(2013-1#1)
about the relationships between##4##4##(1992-3#1)(2008-8#1)(2013-1#1)(2013-7#1)
about the results##3##3##(2008-10#3)
about the risk of##4##4##(1995-6#1)(1995-8#1)(2008-7#1)(2008-8#1)
about the risk##5##3##(1995-6#1)(1995-8#1)(2008-7#1)(2008-8#1)(2012-2#1)
about the risks associated with##2##5##(2007-12#1)(2012-12#1)
about the risks of##2##4##(2007-2#1)(2010-5#1)
about the risks##5##3##(2007-12#1)(2007-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
about the role of##10##4##(1990-7#1)(1992-12#1)(1993-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-1#1)
about the role##12##3##(1990-7#1)(1992-12#1)(1993-6#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-8#1)
about the roles of##3##4##(1993-12#1)(2008-10#1)(2009-5#1)
about the safety##2##3##(1991-11#1)(2008-7#1)
about the same##5##3##(2008-10#2)(2008-11#1)(2010-11#1)(2013-8#1)
about the scientific##2##3##(1996-3#1)(2012-2#1)
about the signaling##2##3##(2010-1#1)(2012-1#1)
about the size##2##3##(1997-7#1)(2008-5#1)
about the social##2##3##(2007-12#1)(2010-1#1)
about the solution##2##3##(2008-2#1)(2010-8#1)
about the source of##2##4##(1992-3#1)(1994-5#1)
about the spatial##2##3##(1994-8#1)(2009-5#1)
about the strength of##2##4##(1997-1#1)(2012-3#1)
about the structure of the##2##5##(1992-5#1)(2010-11#1)
about the structure##4##3##(1992-5#1)(2008-10#1)(2008-4#1)(2010-11#1)
about the time##3##3##(1992-5#1)(1993-3#1)(1995-12#1)
about the treatment##2##3##(1992-1#1)(2007-11#1)
about the trends##2##3##(1991-8#1)(2009-12#1)
about the underlying##4##3##(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
about the use of a##2##5##(2009-2#1)(2013-1#1)
about the use of the##2##5##(1992-5#1)(2013-8#1)
about the use of##11##4##(1991-5#1)(1992-5#1)(2008-5#2)(2009-10#1)(2009-2#1)(2011-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
about the utility of##2##4##(1994-1#1)(2010-8#1)
about the value of##3##4##(2008-12#1)(2008-3#1)(2008-8#1)
about the##808##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#5)(1991-2#7)(1991-5#3)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#6)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#8)(1993-3#8)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#5)(1995-12#6)(1995-2#7)(1995-5#6)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#2)(2006-10#5)(2007-10#6)(2007-11#6)(2007-12#20)(2007-2#7)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#10)(2008-10#78)(2008-11#40)(2008-12#17)(2008-2#15)(2008-3#39)(2008-4#15)(2008-5#14)(2008-6#2)(2008-7#27)(2008-8#18)(2008-9#21)(2009-10#11)(2009-11#9)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#9)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#8)(2010-11#7)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-8#6)(2010-9#4)(2011-1#9)(2011-10#1)(2011-2#31)(2011-3#2)(2012-1#4)(2012-12#10)(2012-2#34)(2012-3#19)(2013-1#28)(2013-7#4)(2013-8#19)
about their actual##2##3##(2009-3#1)(2009-9#1)
about their disease and##3##4##(1990-6#1)(2008-7#1)(2011-1#1)
about their disease##5##3##(1990-6#1)(2008-10#1)(2008-7#2)(2011-1#1)
about their effectiveness##3##3##(1992-1#1)(1994-3#1)(2013-1#1)
about their experiences with##2##4##(2007-7#1)(2009-9#1)
about their experiences##4##3##(1995-12#1)(2007-7#1)(2008-11#1)(2009-9#1)
about their health##3##3##(1996-9#1)(2008-4#1)(2010-10#1)
about their knowledge##2##3##(1996-6#1)(2012-12#1)
about their own##2##3##(1994-9#1)(2009-9#1)
about their relative##2##3##(2008-8#1)(2010-10#1)
about their sexual##2##3##(2008-11#1)(2009-5#1)
about their structure and function##2##5##(1995-2#1)(2008-4#1)
about their##97##2##(1990-11#1)(1990-6#1)(1991-2#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#5)(2010-1#1)(2010-10#4)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
about them and##3##3##(2008-12#1)(2013-1#2)
about them##8##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#2)
about themselves##2##2##(1991-2#1)(1992-3#1)
about these##14##2##(1993-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
about this complex##2##3##(2008-5#1)(2008-8#1)
about this phenomenon##3##3##(1991-8#1)(2008-11#1)(2012-3#1)
about this topic##2##3##(1993-5#1)(2011-3#1)
about this##24##2##(1991-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-3#2)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-7#2)
about those##2##2##(1997-3#1)(2008-11#1)
about three cases]##2##3##(2009-1#1)(2009-5#1)
about three orders of magnitude##4##5##(2008-10#3)(2012-3#1)
about three times##5##3##(1990-12#1)(1990-2#1)(1996-2#1)(1997-2#1)(2008-10#1)
about three##17##2##(1990-12#1)(1990-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-8#1)(2009-1#1)(2009-5#3)(2012-3#1)
about to##7##2##(1990-3#1)(1991-2#1)(1992-9#1)(1995-3#1)(2007-9#1)(2008-5#1)(2010-4#1)
about transmission##2##2##(1992-2#1)(2011-2#1)
about treatment of##2##3##(1992-12#1)(1995-2#1)
about treatment##3##2##(1992-12#1)(1995-2#1)(2009-8#1)
about twice as##3##3##(2008-11#3)
about twice the##2##3##(2007-12#1)(2008-5#1)
about twice##6##2##(1995-12#1)(2007-12#1)(2008-11#3)(2008-5#1)
about two orders of magnitude##4##5##(1990-11#1)(2008-10#3)
about two##14##2##(1990-11#1)(1993-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#2)(2013-1#2)
about two-thirds##2##2##(1994-9#1)(2008-6#1)
about using##3##2##(1997-6#1)(2008-12#1)(2008-3#1)
about what is best##2##4##(1991-3#2)
about what is##4##3##(1991-3#2)(2008-1#1)(2008-11#1)
about what the##2##3##(1990-2#1)(1991-2#1)
about what they##3##3##(1996-11#1)(1996-3#1)(2009-5#1)
about what##18##2##(1990-2#1)(1991-2#1)(1991-3#2)(1996-11#1)(1996-3#1)(1997-1#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#1)(2013-1#2)
about when##2##2##(1992-3#1)(2008-8#1)
about whether there##2##3##(1992-2#1)(1995-2#1)
about whether to##3##3##(1996-1#1)(2008-10#1)(2008-8#1)
about whether##16##2##(1992-2#1)(1992-3#1)(1992-4#1)(1995-11#1)(1995-2#2)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
about which##10##2##(1994-8#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-8#1)
about why##2##2##(1994-2#1)(1996-3#1)
about women##2##2##(1996-12#1)(2009-9#1)
about work##2##2##(2012-1#2)
about work-based learning##2##3##(2008-11#2)
about##3271##1##(1990-10#5)(1990-11#15)(1990-12#8)(1990-2#29)(1990-3#7)(1990-5#21)(1990-6#13)(1990-7#11)(1990-8#15)(1990-9#6)(1991-1#11)(1991-10#1)(1991-11#7)(1991-12#19)(1991-2#20)(1991-3#11)(1991-4#2)(1991-5#14)(1991-6#15)(1991-8#8)(1991-9#5)(1992-1#11)(1992-10#2)(1992-11#13)(1992-12#18)(1992-2#16)(1992-3#28)(1992-4#7)(1992-5#11)(1992-6#17)(1992-7#1)(1992-8#16)(1992-9#12)(1993-1#7)(1993-11#17)(1993-12#35)(1993-2#9)(1993-3#26)(1993-5#3)(1993-6#15)(1993-8#9)(1993-9#4)(1994-1#12)(1994-11#13)(1994-12#13)(1994-2#16)(1994-3#17)(1994-5#9)(1994-6#9)(1994-8#17)(1994-9#6)(1995-1#23)(1995-11#10)(1995-12#28)(1995-2#32)(1995-3#16)(1995-4#2)(1995-5#17)(1995-6#16)(1995-8#8)(1995-9#2)(1996-1#14)(1996-10#2)(1996-11#16)(1996-12#15)(1996-2#15)(1996-3#26)(1996-4#8)(1996-5#23)(1996-6#18)(1996-8#5)(1996-9#4)(1997-1#12)(1997-2#17)(1997-3#23)(1997-4#19)(1997-5#2)(1997-6#22)(1997-7#11)(1997-8#10)(2006-10#10)(2006-12#1)(2007-10#18)(2007-11#24)(2007-12#66)(2007-2#13)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#16)(2007-9#4)(2008-1#43)(2008-10#414)(2008-11#167)(2008-12#51)(2008-2#27)(2008-3#68)(2008-4#46)(2008-5#54)(2008-6#34)(2008-7#120)(2008-8#81)(2008-9#56)(2009-1#2)(2009-10#21)(2009-11#17)(2009-12#10)(2009-2#4)(2009-3#6)(2009-4#11)(2009-5#40)(2009-6#9)(2009-7#10)(2009-8#25)(2009-9#22)(2010-1#9)(2010-10#36)(2010-11#13)(2010-12#19)(2010-2#4)(2010-3#17)(2010-4#16)(2010-5#15)(2010-6#6)(2010-7#3)(2010-8#29)(2010-9#8)(2011-1#33)(2011-10#1)(2011-2#119)(2011-3#9)(2012-1#17)(2012-12#48)(2012-2#68)(2012-3#70)(2013-1#106)(2013-7#11)(2013-8#62)
above 0##11##2##(1990-5#1)(1990-7#1)(1994-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2013-1#1)
above 1##8##2##(1990-5#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
above 10 mg##2##3##(2008-11#1)(2008-9#1)
above 10##8##2##(1993-6#2)(1995-11#1)(1997-1#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#1)
above 100##4##2##(1992-3#1)(1992-9#1)(2008-10#1)(2008-2#1)
above 2##2##2##(1990-6#1)(2008-1#1)
above 200##2##2##(2008-1#1)(2010-10#1)
above 250##4##2##(1990-2#2)(1996-8#1)(2008-10#1)
above 3##2##2##(2007-11#1)(2008-8#1)
above 30##2##2##(1990-5#1)(2013-1#1)
above 300##2##2##(1990-2#1)(2008-1#1)
above 35##4##2##(1990-2#1)(1992-9#1)(2012-3#2)
above 4##4##2##(2008-7#1)(2009-5#2)(2011-2#1)
above 40 km##3##3##(2008-2#1)(2008-3#2)
above 400##2##2##(1990-12#1)(1992-11#1)
above 5 mM##2##3##(1992-3#1)(1995-5#1)
above 5##5##2##(1992-3#2)(1995-5#1)(2007-11#1)(2008-5#1)
above 50##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
above 70%##2##2##(2008-5#1)(2008-9#1)
above 75%##2##2##(2011-3#1)(2012-1#1)
above 8##2##2##(2008-8#1)(2013-7#1)
above 80##4##2##(1995-2#1)(2007-8#1)(2008-10#1)(2012-12#1)
above 80%##2##2##(1994-9#1)(1997-8#1)
above 90%##2##2##(2008-10#1)(2008-8#1)
above T(g)##2##2##(1995-3#1)(2010-4#1)
above a critical##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)
above a threshold##6##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
above a##27##2##(1990-8#1)(1992-3#1)(1994-11#1)(1996-12#2)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#3)(2009-4#1)(2010-10#1)
above all the##3##3##(1990-9#1)(2007-7#1)(2008-10#1)
above all##20##2##(1990-5#1)(1990-9#2)(1992-3#1)(1992-9#1)(1993-2#1)(1995-5#2)(1996-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-2#1)
above an##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
above and below the##6##4##(1992-7#1)(1997-7#1)(2007-12#2)(2008-3#2)
above and beyond##4##3##(2007-12#1)(2008-1#1)(2009-7#1)(2010-5#1)
above and##20##2##(1992-7#1)(1994-2#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#4)(2009-10#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-3#1)
above approximately##2##2##(2008-10#1)(2008-3#1)
above are##4##2##(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
above average to##2##3##(2013-1#2)
above average##4##2##(1994-1#1)(2013-1#3)
above baseline##2##2##(2007-11#1)(2011-2#1)
above chance##2##2##(2008-5#1)(2008-9#1)
above compounds##2##2##(1991-6#1)(2008-10#1)
above control##3##2##(1995-12#2)(1995-2#1)
above control)##2##2##(1995-2#1)(2008-10#1)
above could##2##2##(1994-3#1)(2008-8#1)
above effects##4##2##(1994-1#1)(2008-10#1)(2011-1#1)(2013-7#1)
above factors##3##2##(2008-12#1)(2008-2#1)(2012-3#1)
above five##2##2##(2008-2#1)(2009-7#1)
above for##2##2##(1994-3#1)(2008-10#1)
above four##2##2##(2007-9#1)(2008-10#1)
above growth##2##2##(2008-12#2)
above information##2##2##(2008-6#1)(2009-11#1)
above is##2##2##(1996-1#1)(2008-10#1)
above its##2##2##(2010-11#1)(2010-4#1)
above mentioned metal ions were##2##5##(2008-10#2)
above mentioned##29##2##(1990-9#1)(1993-3#1)(1993-5#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#13)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#1)
above method##2##2##(1990-12#1)(1997-2#1)
above normal##5##2##(1992-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2012-2#1)
above or below the##4##4##(1995-6#1)(1996-12#1)(2007-11#1)(2008-3#1)
above parameters##9##2##(1994-5#1)(1995-9#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-8#1)(2013-1#3)
above results##13##2##(1994-3#1)(1994-6#1)(1994-8#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#2)
above room temperature##2##3##(2008-3#2)
above sea level##3##3##(1990-8#1)(2008-8#2)
above sea level) and##2##4##(1990-8#1)(2007-7#1)
above sea level)##4##3##(1990-8#2)(2007-7#1)(2008-3#1)
above sea##7##2##(1990-8#3)(2007-7#1)(2008-3#1)(2008-8#2)
above some##2##2##(1991-3#1)(2008-9#1)
above suggest##2##2##(2008-10#1)(2008-8#1)
above system##3##2##(2008-10#3)
above that of##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
above that##13##2##(1992-6#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
above the age of##2##4##(2008-11#1)(2013-8#1)
above the burner##3##3##(2008-10#1)(2008-3#2)
above the cloud##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
above the control mean +##2##5##(1996-7#2)
above the control##3##3##(1996-7#2)(2012-1#1)
above the critical##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
above the damage threshold##2##4##(2007-11#1)(2013-8#1)
above the grating##2##3##(2008-3#2)
above the ground##3##3##(2008-10#2)(2008-3#1)
above the level of##2##4##(2008-11#1)(2012-12#1)
above the level##3##3##(2008-11#2)(2012-12#1)
above the limit of quantification##2##5##(2008-5#2)
above the maximum##4##3##(2008-10#3)(2010-4#1)
above the minimum##2##3##(2009-6#1)(2010-5#1)
above the permissible##2##3##(2008-10#1)(2008-7#1)
above the soil surface##2##4##(2008-10#2)
above the source##2##3##(2008-10#2)
above the surface of the##2##5##(2008-10#2)
above the surface of##3##4##(2008-10#2)(2008-3#1)
above the surface##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
above the threshold for##2##4##(2008-10#1)(2008-3#1)
above the threshold##6##3##(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-8#1)
above the values##2##3##(1990-2#1)(2008-10#1)
above the##128##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-3#1)(1996-5#1)(1996-7#2)(2007-11#5)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#38)(2008-11#3)(2008-2#7)(2008-3#19)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#4)
above their##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
above this##8##2##(1994-3#1)(1995-11#1)(2008-10#2)(2008-3#2)(2008-8#2)
above those##3##2##(1990-12#1)(1994-2#1)(2012-12#1)
above threshold##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
above two years##2##3##(1994-9#1)(1996-8#1)
above two##7##2##(1991-5#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-8#1)(2008-4#1)(2012-2#1)
above was##4##2##(1995-12#1)(2008-10#1)(2008-9#2)
above were##3##2##(1993-2#1)(1995-3#1)(2008-7#1)
above wheat##2##2##(2008-10#2)
above which the##3##3##(2008-10#1)(2008-8#2)
above which##9##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-8#3)(2010-3#1)(2010-6#1)
above##727##1##(1990-11#1)(1990-12#5)(1990-2#6)(1990-5#9)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#7)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#8)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#5)(1995-11#4)(1995-12#8)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#5)(1996-5#7)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2007-11#17)(2007-12#12)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#14)(2008-10#159)(2008-11#18)(2008-12#9)(2008-2#29)(2008-3#53)(2008-4#4)(2008-5#13)(2008-6#4)(2008-7#22)(2008-8#25)(2008-9#12)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#5)(2011-2#22)(2011-3#3)(2012-1#4)(2012-12#4)(2012-2#16)(2012-3#9)(2013-1#15)(2013-7#2)(2013-8#9)
above)##4##1##(1990-6#1)(1990-8#1)(1992-12#1)(1992-6#1)
above-ground##3##1##(2007-5#1)(2009-10#1)(2010-11#1)
above-mentioned indexes were##2##3##(2011-3#2)
above-mentioned##25##1##(1997-7#2)(1997-8#2)(2007-12#2)(2007-9#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-6#1)(2011-2#1)(2011-3#2)
above-water measurements of##2##3##(2008-3#2)
above-water measurements##3##2##(2008-3#3)
above-water##5##1##(2008-3#5)
aboveground plant parts##2##3##(2008-10#1)(2008-8#1)
aboveground tissues##2##2##(2008-10#2)
aboveground##8##1##(2008-10#7)(2008-8#1)
abrade faster than those##2##4##(2008-7#2)
abrade faster##3##2##(2008-7#3)
abrasion of##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
abrasion##15##1##(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#5)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
abrasive immobilization of multiwall carbon nanotubes##2##6##(2008-10#2)
abrasive particles##4##2##(2008-3#4)
abrasive##11##1##(2008-10#4)(2008-3#5)(2009-4#1)(2010-12#1)
abrasives##8##1##(2008-2#2)(2008-3#3)(2008-5#3)
abreast of##2##2##(1991-3#1)(1995-2#1)
abridged##4##1##(1994-1#1)(2008-11#1)(2008-12#1)(2010-11#1)
abrin##4##1##(1994-5#4)
abroad the##2##2##(2007-2#1)(2010-7#1)
abroad##33##1##(1991-2#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-6#2)(1997-8#1)(2007-12#1)(2007-2#10)(2008-1#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
abrogate the##2##2##(2008-11#1)(2011-1#1)
abrogate##4##1##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
abrogated by##3##2##(1992-6#1)(1992-9#1)(2011-1#1)
abrogated in##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
abrogated the##6##2##(1992-9#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2011-2#1)
abrogated##19##1##(1992-6#1)(1992-9#2)(1993-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
abrogates##4##1##(2010-11#1)(2010-3#1)(2010-5#1)(2013-1#1)
abrogation of##3##2##(2010-3#1)(2011-2#1)(2012-2#1)
abrotanoides##4##1##(2010-5#4)
abrupt changes in##2##3##(1994-9#1)(1995-11#1)
abrupt changes##3##2##(1994-9#1)(1995-11#1)(2007-11#1)
abrupt decrease of##2##3##(2008-10#1)(2008-11#1)
abrupt transitions in##2##3##(1991-8#1)(2008-7#1)
abrupt##23##1##(1991-1#1)(1991-5#1)(1991-8#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)
abruption of##2##2##(1992-4#1)(2013-1#1)
abruption##3##1##(1992-4#1)(2012-3#1)(2013-1#1)
abruptly and##2##2##(1995-12#1)(2007-7#1)
abruptly##17##1##(1993-12#1)(1993-9#1)(1994-8#1)(1995-12#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#3)(2013-8#1)
abscess and##9##2##(1994-12#1)(2006-10#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-8#2)
abscess caused by##3##3##(1991-3#1)(2013-8#2)
abscess drainage##2##2##(2007-8#1)(2008-10#1)
abscess due to Salmonella typhi##2##5##(2007-7#2)
abscess due to##5##3##(2007-7#3)(2007-8#1)(2013-8#1)
abscess formation and##2##3##(2011-1#1)(2012-2#1)
abscess formation over##2##3##(2006-10#1)(2008-9#1)
abscess formation##7##2##(1995-9#1)(2006-10#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
abscess in a##3##3##(2008-12#1)(2009-5#1)(2012-2#1)
abscess in the##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
abscess in##7##2##(1990-3#1)(2008-12#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
abscess is##5##2##(2006-10#2)(2007-11#1)(2007-7#1)(2012-3#1)
abscess of the##3##3##(1997-3#1)(2008-12#1)(2011-2#1)
abscess of##5##2##(1990-3#1)(1997-3#1)(2008-12#1)(2008-8#1)(2011-2#1)
abscess with##2##2##(2010-11#2)
abscess##108##1##(1990-3#2)(1991-3#2)(1991-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-10#8)(2006-12#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#9)(2007-8#6)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#3)(2010-12#3)(2011-1#5)(2011-2#8)(2012-1#1)(2012-2#8)(2012-3#8)(2012-8#1)(2013-1#2)(2013-8#9)
abscess)##2##1##(1991-3#1)(2008-12#1)
abscesses and fistulas##3##3##(1997-8#3)
abscesses and##8##2##(1990-6#1)(1993-2#1)(1995-11#1)(1997-8#3)(2008-12#1)(2012-2#1)
abscesses in##7##2##(2007-12#2)(2007-7#1)(2012-2#2)(2013-8#2)
abscesses treated##2##2##(2007-12#1)(2008-7#1)
abscesses##41##1##(1990-3#1)(1990-6#1)(1991-8#1)(1993-2#1)(1995-11#1)(1997-8#4)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#3)(2008-8#2)(2010-12#1)(2010-4#2)(2010-8#1)(2012-2#9)(2013-8#4)
abscisic acid (ABA)##2##3##(2009-6#1)(2009-8#1)
abscisic acid##6##2##(2008-10#2)(2008-8#1)(2009-6#1)(2009-8#2)
abscission step##2##2##(2009-8#2)
abscission##3##1##(2008-10#1)(2009-8#2)
absence and in##5##3##(1991-2#1)(1994-6#1)(2008-10#2)(2008-8#1)
absence and##27##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-7#3)(2008-8#1)(2011-2#1)(2012-5#1)
absence in##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2009-2#1)
absence of 16##2##3##(1995-6#1)(2008-8#1)
absence of ATP##4##3##(1993-6#1)(1993-8#1)(1995-2#1)(2008-8#1)
absence of Ca2+##4##3##(1994-12#1)(1995-6#1)(1996-2#1)(2008-8#1)
absence of Cd in##2##4##(1990-5#1)(2008-12#1)
absence of DNA##2##3##(1994-3#2)
absence of DNAbeta##2##3##(2008-10#2)
absence of EDTA##3##3##(1995-6#3)
absence of SDS##2##3##(1990-11#1)(2008-10#1)
absence of a##52##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-4#2)(1997-7#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#5)(2012-12#1)(2013-1#2)
absence of acetyl CoA##3##4##(1993-11#3)
absence of acute##2##3##(1991-1#1)(1994-12#1)
absence of added##4##3##(1990-11#1)(1994-8#1)(1997-1#1)(2008-10#1)
absence of an##14##3##(1990-3#1)(1991-2#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)
absence of antibodies against##2##4##(1993-3#1)(2011-2#1)
absence of any symptom##2##4##(1991-8#1)(2008-9#1)
absence of any##30##3##(1990-12#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-8#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
absence of blood##2##3##(2008-3#1)(2011-2#1)
absence of cholesterol##2##3##(1990-2#1)(1994-5#1)
absence of clinical##2##3##(2008-7#1)(2011-2#1)
absence of compensatory##2##3##(1994-8#1)(2012-3#1)
absence of disease##4##3##(2008-10#3)(2013-1#1)
absence of estrogen##3##3##(1993-9#1)(1997-7#1)(2008-6#1)
absence of external calcium##2##4##(1990-5#1)(1994-2#1)
absence of external##7##3##(1990-5#1)(1990-7#1)(1993-12#2)(1993-3#1)(1994-2#1)(2008-10#1)
absence of extracellular Ca2+##3##4##(1991-6#1)(1992-3#1)(2008-8#1)
absence of extracellular##5##3##(1990-5#1)(1991-6#1)(1992-3#1)(1995-11#1)(2008-8#1)
absence of functional##2##3##(1995-12#1)(2010-11#1)
absence of glucose##4##3##(1992-9#2)(1995-8#2)
absence of glutamine##3##3##(2008-11#3)
absence of hemin##3##3##(1994-5#2)(2008-8#1)
absence of infection##2##3##(2010-8#1)(2012-3#1)
absence of insects##2##3##(2008-8#2)
absence of insulin##2##3##(2008-1#1)(2008-11#1)
absence of interferences##2##3##(2008-10#2)
absence of isthmus##2##3##(2013-1#2)
absence of known##2##3##(1996-2#1)(2008-2#1)
absence of light##6##3##(1991-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#1)(2009-8#1)
absence of matrix##2##3##(2008-10#2)
absence of other herbivores##2##4##(2008-8#2)
absence of other##8##3##(1991-12#1)(2008-4#3)(2008-8#3)(2013-1#1)
absence of posterior##2##3##(1997-8#1)(2008-7#1)
absence of reducing agent##2##4##(1995-11#2)
absence of reducing##4##3##(1990-12#1)(1991-2#1)(1995-11#2)
absence of serum##6##3##(1990-11#1)(2008-11#5)
absence of significant##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
absence of sodium##2##3##(1992-3#1)(1996-5#1)
absence of such##7##3##(1991-12#1)(1991-2#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
absence of symptoms##5##3##(1990-6#3)(1991-6#1)(2008-10#1)
absence of systemic##2##3##(2007-12#2)
absence of the##71##3##(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#3)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#3)(1997-3#4)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
absence of these##7##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)(2012-3#1)
absence of wild-type##2##3##(2008-10#2)
absence of##817##2##(1990-10#2)(1990-11#11)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#7)(1990-6#4)(1990-7#3)(1990-8#8)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#2)(1991-9#6)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#9)(1992-4#2)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#8)(1993-2#1)(1993-3#8)(1993-5#2)(1993-6#7)(1993-8#9)(1993-9#5)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#9)(1994-6#3)(1994-8#5)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#9)(1995-3#4)(1995-5#5)(1995-6#12)(1995-8#6)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#4)(1996-5#10)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#6)(2006-10#5)(2007-10#3)(2007-11#5)(2007-12#10)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#144)(2008-11#46)(2008-12#7)(2008-2#7)(2008-3#15)(2008-4#10)(2008-5#6)(2008-6#10)(2008-7#25)(2008-8#38)(2008-9#25)(2009-1#1)(2009-10#6)(2009-11#4)(2009-2#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-3#3)(2010-4#6)(2010-5#3)(2010-7#2)(2010-8#4)(2011-1#6)(2011-2#36)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#10)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#5)
absence on##2##2##(1996-2#1)(2008-5#1)
absence or the presence of##2##5##(1994-8#1)(1997-7#1)
absence or##13##2##(1990-2#1)(1992-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
absence seizures are##2##3##(1992-3#1)(2009-9#1)
absence seizures in rodent##2##4##(1992-3#2)
absence seizures in##4##3##(1992-3#3)(2009-9#1)
absence seizures##8##2##(1992-3#6)(2009-9#2)
absence##901##1##(1990-10#2)(1990-11#11)(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#4)(1990-7#3)(1990-8#9)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#5)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#2)(1991-9#6)(1992-1#3)(1992-12#1)(1992-2#4)(1992-3#16)(1992-4#3)(1992-5#2)(1992-6#6)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#8)(1993-2#2)(1993-3#8)(1993-5#2)(1993-6#7)(1993-8#10)(1993-9#8)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#9)(1994-6#5)(1994-8#6)(1994-9#1)(1995-11#7)(1995-12#5)(1995-2#10)(1995-3#4)(1995-5#6)(1995-6#14)(1995-8#8)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#5)(1996-5#10)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#8)(1997-8#6)(2006-10#5)(2007-10#3)(2007-11#5)(2007-12#11)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#8)(2008-10#155)(2008-11#52)(2008-12#8)(2008-2#7)(2008-3#16)(2008-4#13)(2008-5#7)(2008-6#10)(2008-7#29)(2008-8#40)(2008-9#28)(2009-1#1)(2009-10#6)(2009-11#4)(2009-2#3)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-3#3)(2010-4#6)(2010-5#3)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#40)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#7)
absence)##2##1##(2008-10#1)(2011-2#1)
absent from the##10##3##(1990-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-1#1)
absent from##24##2##(1990-11#1)(1990-12#1)(1991-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
absent in all##2##3##(1990-3#1)(2012-2#1)
absent in the##11##3##(1993-2#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
absent in##49##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-7#2)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
absent on##2##2##(2011-2#1)(2012-2#1)
absent or present##2##3##(2008-10#2)
absent or##11##2##(1992-9#1)(1994-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-1#2)
absent when the##2##3##(1990-8#1)(2008-4#1)
absent when##4##2##(1990-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
absent##177##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-3#4)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#3)
absenteeism and##5##2##(1995-6#1)(1996-1#1)(1997-5#1)(2012-3#1)(2013-1#1)
absenteeism##14##1##(1992-12#1)(1993-2#3)(1995-6#1)(1996-1#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
absidiomycosis in##2##2##(2008-5#2)
absolute EC50/IC50##4##2##(2012-2#4)
absolute and proportional##3##3##(2008-12#3)
absolute and relative measures##2##4##(1990-2#1)(2008-10#1)
absolute and relative##10##3##(1990-2#1)(2008-10#4)(2008-7#2)(2010-8#1)(2013-1#2)
absolute and##18##2##(1990-2#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-7#2)(2010-8#1)(2012-3#1)(2013-1#2)
absolute bioavailability##2##2##(2010-11#1)(2012-2#1)
absolute calibration##3##2##(2008-2#1)(2008-3#2)
absolute cell counts##2##3##(2008-10#1)(2008-9#1)
absolute cell##4##2##(2008-10#1)(2008-9#3)
absolute concentration##3##2##(2008-10#2)(2008-3#1)
absolute concentrations##2##2##(1990-11#1)(2010-7#1)
absolute configuration of the##5##4##(1991-12#1)(1992-12#1)(1992-8#1)(1995-3#1)(2008-10#1)
absolute configuration of##7##3##(1991-12#1)(1992-12#1)(1992-8#1)(1995-3#1)(2008-10#1)(2009-10#2)
absolute configuration##8##2##(1991-12#1)(1992-12#1)(1992-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-10#2)
absolute configurations of##2##3##(2008-8#1)(2008-9#1)
absolute contraindication to##3##3##(1994-8#1)(2010-6#1)(2011-2#1)
absolute contraindication##5##2##(1991-6#1)(1994-8#1)(2010-6#1)(2011-2#2)
absolute contraindications##3##2##(2007-8#1)(2011-3#1)(2013-1#1)
absolute control##2##2##(1994-12#1)(2008-10#1)
absolute depth range##2##3##(2008-3#2)
absolute detection limit##4##3##(2008-10#4)
absolute detection limits##2##3##(2008-10#2)
absolute detection##7##2##(2008-10#6)(2011-1#1)
absolute difference##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
absolute differences##2##2##(1994-12#1)(2008-10#1)
absolute diffraction efficiency of##2##4##(2007-12#1)(2008-3#1)
absolute displacement##2##2##(2008-3#2)
absolute efficiency of##2##3##(1992-2#1)(2008-3#1)
absolute error of##2##3##(2007-10#1)(2008-3#1)
absolute error##4##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
absolute fitnesses of##2##3##(2013-1#2)
absolute fitnesses##3##2##(2013-1#3)
absolute frequency stabilization##2##3##(2007-12#1)(2008-3#1)
absolute frequency##3##2##(2007-12#2)(2008-3#1)
absolute heart##3##2##(2008-9#3)
absolute humidity##3##2##(1992-2#1)(2008-10#2)
absolute intensity of##2##3##(2008-3#1)(2013-8#1)
absolute intensity##3##2##(2008-3#1)(2013-8#2)
absolute leukocyte##2##2##(2008-9#2)
absolute levels##3##2##(1991-2#1)(1993-12#1)(2007-11#1)
absolute measurement of##3##3##(2007-11#2)(2008-3#1)
absolute measurements of the##2##4##(2008-3#2)
absolute measurements of##3##3##(2008-3#3)
absolute measurements##4##2##(2008-3#4)
absolute minimum##2##2##(2008-8#1)(2009-12#1)
absolute number of##6##3##(1991-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
absolute number##8##2##(1991-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-1#1)
absolute numbers of##3##3##(1995-12#2)(2010-8#1)
absolute numbers##9##2##(1991-3#1)(1995-12#2)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-8#1)(2013-8#1)
absolute phase and##2##3##(2008-3#2)
absolute phase##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#1)
absolute power##2##2##(1991-10#1)(2008-7#1)
absolute radiometric##2##2##(2008-2#1)(2008-3#1)
absolute recoveries of##2##3##(2008-10#1)(2013-1#1)
absolute reduction##2##2##(1994-6#1)(2007-5#1)
absolute requirement for##5##3##(1990-11#1)(1991-9#1)(1994-11#1)(2007-12#1)(2008-10#1)
absolute requirement##10##2##(1990-11#1)(1991-9#1)(1992-1#1)(1994-11#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#3)
absolute right kidney##2##3##(2008-9#2)
absolute risk##2##2##(2008-9#1)(2013-1#1)
absolute stereochemistry##4##2##(1992-8#2)(1995-3#1)(2010-2#1)
absolute temperature##3##2##(2008-2#1)(2008-8#2)
absolute value of##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2012-2#1)
absolute value##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-2#1)
absolute values of the##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
absolute values of##8##3##(1994-8#1)(2007-12#1)(2008-3#3)(2008-6#1)(2008-8#2)
absolute values##11##2##(1994-6#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#2)
absolute volume of syncytiotrophoblast in resorption villi##3##7##(2011-1#3)
absolute wavelength##4##2##(2007-11#2)(2008-3#2)
absolute##326##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-6#3)(1992-8#3)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-11#14)(2007-12#12)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#49)(2008-11#3)(2008-12#6)(2008-2#19)(2008-3#62)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#20)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#5)
absolutely essential##2##2##(1997-1#1)(1997-3#1)
absolutely necessary##2##2##(1997-3#1)(2007-8#1)
absolutely required for##3##3##(1990-8#1)(1995-8#1)(2008-4#1)
absolutely required##5##2##(1990-7#1)(1990-8#1)(1992-9#1)(1995-8#1)(2008-4#1)
absolutely##22##1##(1990-7#1)(1990-8#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-3#2)(2007-8#1)(2008-10#1)(2008-3#4)(2008-4#1)(2009-10#1)(2012-12#2)
absolutes and##2##2##(2008-5#2)
absolutes##3##1##(2008-1#1)(2008-5#2)
absorb a##2##2##(2007-11#1)(2008-11#1)
absorb at the##2##3##(2008-10#2)
absorb the##4##2##(2007-11#1)(2008-3#2)(2009-10#1)
absorb##22##1##(1991-5#1)(1991-6#1)(1993-12#1)(1996-12#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-9#2)(2009-10#1)(2011-1#2)
absorbable suture##4##2##(1991-1#2)(1992-1#1)(2010-3#1)
absorbable##11##1##(1991-1#2)(1992-1#1)(1992-2#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
absorbance and fluorescence maxima##2##4##(1992-8#1)(2008-10#1)
absorbance and fluorescence##6##3##(1992-8#1)(2008-10#3)(2008-12#1)(2008-8#1)
absorbance and the##4##3##(1992-8#1)(2008-10#3)
absorbance and##16##2##(1992-8#2)(2008-10#12)(2008-12#1)(2008-8#1)
absorbance as the##2##3##(2007-12#1)(2008-10#1)
absorbance as##3##2##(2007-12#1)(2008-10#2)
absorbance at 210 nm##2##4##(1991-12#1)(2008-4#1)
absorbance at 280 nm##2##4##(2008-10#1)(2008-7#1)
absorbance at the##3##3##(1995-2#1)(2008-10#2)
absorbance at##38##2##(1991-12#1)(1992-8#1)(1995-2#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#1)
absorbance band##5##2##(1990-11#1)(2008-10#4)
absorbance bands##2##2##(2008-10#2)
absorbance by##2##2##(2008-10#2)
absorbance change at##2##3##(1990-12#1)(1996-4#1)
absorbance change##4##2##(1990-12#1)(1996-4#1)(2008-10#2)
absorbance data##6##2##(1993-3#1)(2008-10#5)
absorbance decrease##2##2##(2008-10#2)
absorbance detection at##4##3##(1996-5#1)(2008-10#3)
absorbance detection is##2##3##(2008-10#1)(2010-7#1)
absorbance detection##16##2##(1996-5#3)(2008-10#10)(2008-3#1)(2010-7#2)
absorbance detector##6##2##(2008-10#6)
absorbance for the##2##3##(2008-10#2)
absorbance for##6##2##(2007-12#1)(2008-10#5)
absorbance in##3##2##(1994-9#1)(2008-10#1)(2009-11#1)
absorbance intensity of##2##3##(2008-10#2)
absorbance intensity##5##2##(2008-10#4)(2008-8#1)
absorbance is measured##2##3##(2008-10#2)
absorbance is##9##2##(2008-10#8)(2008-3#1)
absorbance maxima##3##2##(2008-10#3)
absorbance maximum##4##2##(1991-12#1)(1992-8#1)(2008-10#2)
absorbance measurement at##2##3##(2008-10#2)
absorbance measurement##3##2##(2008-10#3)
absorbance measurements##9##2##(2008-10#8)(2008-3#1)
absorbance method##3##2##(2008-9#1)(2010-11#2)
absorbance mode##3##2##(2008-10#3)
absorbance of 0##8##3##(2008-10#8)
absorbance of MB##3##3##(2008-10#3)
absorbance of the acceptor stream##2##5##(2008-10#2)
absorbance of the blue##2##4##(2008-10#2)
absorbance of the coloured##2##4##(2008-10#2)
absorbance of the complex##2##4##(2008-10#2)
absorbance of the dye##3##4##(2008-10#3)
absorbance of the extracted complex##2##5##(2008-10#2)
absorbance of the formed##3##4##(2008-10#3)
absorbance of the purple##2##4##(2008-10#2)
absorbance of the##41##3##(2008-10#40)(2008-3#1)
absorbance of##77##2##(1994-12#1)(2008-10#70)(2008-2#1)(2008-3#4)(2011-1#1)
absorbance or##2##2##(2008-10#1)(2008-2#1)
absorbance peaks##2##2##(2008-10#2)
absorbance ratio##2##2##(2010-5#1)(2011-1#1)
absorbance sensors##2##2##(2007-12#2)
absorbance signal##2##2##(2008-10#2)
absorbance signals##2##2##(2008-10#2)
absorbance spectra##3##2##(1995-2#1)(2008-10#1)(2013-8#1)
absorbance spectroscopy##5##2##(2008-10#3)(2008-4#1)(2010-11#1)
absorbance spectrum##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
absorbance to##2##2##(2008-10#2)
absorbance unit##2##2##(2008-10#2)
absorbance units##2##2##(2008-10#2)
absorbance values##9##2##(2008-10#8)(2008-5#1)
absorbance versus concentration##2##3##(2008-10#2)
absorbance versus##9##2##(2008-10#9)
absorbance was measured at 610 nm##2##6##(1990-2#1)(2008-10#1)
absorbance was measured at##5##4##(1990-2#1)(2008-10#4)
absorbance was##8##2##(1990-2#1)(2008-10#6)(2008-3#1)
absorbance were##2##2##(2008-10#2)
absorbance##351##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#2)(1992-8#4)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#3)(1996-4#2)(1996-5#4)(2007-11#1)(2007-12#5)(2008-1#3)(2008-10#267)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#4)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
absorbance)##2##1##(2007-12#1)(2008-5#1)
absorbances at##5##2##(1990-12#1)(2008-10#3)(2008-3#1)
absorbances of the##2##3##(2008-10#1)(2008-5#1)
absorbances##16##1##(1990-12#1)(2008-10#12)(2008-3#2)(2008-5#1)
absorbed at the##2##3##(2008-3#1)(2008-7#1)
absorbed at##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
absorbed by the gas##2##4##(2008-3#2)
absorbed by the##10##3##(1990-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#5)(2013-1#1)
absorbed by##19##2##(1990-12#1)(1990-8#1)(1995-12#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#5)(2008-8#1)(2009-12#1)(2010-12#1)(2013-1#1)
absorbed dose##8##2##(1993-9#1)(1994-3#2)(2008-10#1)(2012-1#3)(2013-1#1)
absorbed doses##2##2##(1991-5#1)(2009-11#1)
absorbed energy##2##2##(2008-11#2)
absorbed from##2##2##(1995-3#1)(2012-2#1)
absorbed in the##5##3##(1992-7#1)(2007-2#1)(2008-10#2)(2012-2#1)
absorbed in##10##2##(1992-7#1)(2007-2#1)(2008-10#5)(2009-8#1)(2011-1#1)(2012-2#1)
absorbed into##3##2##(1995-9#1)(2008-10#1)(2008-5#1)
absorbed on microtitration plates##2##4##(2008-8#2)
absorbed on##6##2##(1992-12#1)(2008-10#2)(2008-8#3)
absorbed power slope efficiency##2##4##(2007-12#1)(2008-2#1)
absorbed power##4##2##(1992-3#1)(2007-12#1)(2008-2#2)
absorbed pump power##12##3##(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#3)
absorbed pump##14##2##(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#4)
absorbed quantitatively on##2##3##(2008-10#2)
absorbed radiation dose##2##3##(1994-3#1)(2013-1#1)
absorbed radiation##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
absorbed water##2##2##(2007-12#1)(2012-12#1)
absorbed##110##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-3#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-7#1)(2007-11#7)(2007-12#7)(2007-2#1)(2008-10#21)(2008-11#2)(2008-2#9)(2008-3#15)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-12#2)(2012-2#5)(2013-1#3)(2013-8#1)
absorbent##6##1##(2007-12#2)(2008-10#4)
absorbents##3##1##(2008-10#3)
absorber and##3##2##(2007-11#1)(2007-12#1)(2008-5#1)
absorber concentrations in##4##3##(2007-12#2)(2008-3#2)
absorber concentrations##5##2##(2007-12#3)(2008-3#2)
absorber is##7##2##(2007-11#2)(2007-12#1)(2008-3#4)
absorber with##2##2##(2008-3#1)(2012-2#1)
absorber##60##1##(2007-11#9)(2007-12#11)(2008-2#8)(2008-3#29)(2008-5#1)(2012-2#2)
absorber)##2##1##(2007-11#1)(2008-3#1)
absorbers for##2##2##(2008-2#1)(2008-3#1)
absorbers in##2##2##(2008-3#2)
absorbers##34##1##(2007-11#5)(2007-12#7)(2008-2#5)(2008-3#15)(2008-5#1)(2010-7#1)
absorbing aerosols##5##2##(2008-2#4)(2008-3#1)
absorbing and scattering medium##2##4##(2008-2#1)(2008-3#1)
absorbing and scattering##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
absorbing and##6##2##(2007-11#2)(2008-2#2)(2008-3#1)(2009-6#1)
absorbing area##4##2##(2007-12#4)
absorbing boundary condition##3##3##(2008-3#3)
absorbing cubes##2##2##(2008-3#2)
absorbing features##2##2##(2008-3#2)
absorbing film##2##2##(2008-10#1)(2008-3#1)
absorbing films##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
absorbing inhomogeneities##5##2##(2008-2#1)(2008-3#4)
absorbing layers##3##2##(2007-11#2)(2008-2#1)
absorbing liquids##3##2##(2007-12#1)(2008-3#2)
absorbing material##2##2##(2007-11#1)(2008-2#1)
absorbing materials##2##2##(2007-11#2)
absorbing media##5##2##(2007-11#2)(2008-3#3)
absorbing medium##8##2##(2007-12#1)(2008-3#7)
absorbing object located##2##3##(2007-12#1)(2008-3#1)
absorbing object##3##2##(2007-12#2)(2008-3#1)
absorbing particles##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
absorbing solution##10##2##(2008-10#9)(2008-3#1)
absorbing species##4##2##(2008-3#4)
absorbing structures##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
absorbing##147##1##(1995-9#1)(2006-4#1)(2007-11#15)(2007-12#14)(2008-10#20)(2008-11#1)(2008-2#23)(2008-3#64)(2008-5#1)(2009-12#1)(2009-6#1)(2011-1#2)(2011-2#2)(2013-1#1)
absorbs at##3##2##(2008-10#2)(2010-5#1)
absorbs the##4##2##(2008-3#1)(2008-6#1)(2008-7#2)
absorbs##12##1##(2007-11#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-5#1)
absorptance is##3##2##(2008-3#3)
absorptance of##5##2##(2008-2#2)(2008-3#3)
absorptance##20##1##(2008-1#1)(2008-2#4)(2008-3#15)
absorptances##2##1##(2008-3#2)
absorptiometrically##2##1##(2008-10#2)
absorptiometry (DXA) scan##2##3##(2008-10#1)(2010-1#1)
absorptiometry (DXA)##6##2##(1997-8#1)(2008-10#1)(2008-7#2)(2010-1#1)(2011-2#1)
absorptiometry in##3##2##(1991-11#1)(2008-4#1)(2008-8#1)
absorptiometry of the lumbar spine##2##5##(1991-11#2)
absorptiometry##23##1##(1991-11#6)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-11#1)(2010-1#1)(2011-1#1)(2011-2#2)
absorption (a) and backscattering (b(b))##2##5##(2008-2#1)(2008-3#1)
absorption (mu(a)) and reduced scattering (mu(s)')##2##6##(2008-3#2)
absorption (mu(a))##3##2##(2008-3#3)
absorption a##3##2##(2008-3#3)
absorption ability of##3##3##(2008-10#1)(2008-5#2)
absorption across the##2##3##(2008-5#1)(2008-9#1)
absorption and backscattering coefficients##6##4##(2008-2#4)(2008-3#2)
absorption and emission spectra##2##4##(2008-10#1)(2009-10#1)
absorption and emission spectrometry##3##4##(2008-10#3)
absorption and emission##13##3##(1993-11#1)(2008-10#8)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#1)
absorption and evaporation of##2##4##(2008-5#2)
absorption and fluorescence##7##3##(1990-8#1)(1993-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
absorption and propagation in##2##4##(2008-1#2)
absorption and reduced-scattering##3##3##(2008-2#1)(2008-3#2)
absorption and scattering coefficients and##2##5##(2008-2#1)(2008-3#1)
absorption and scattering coefficients##13##4##(2007-11#1)(2008-2#3)(2008-3#9)
absorption and scattering##26##3##(2007-11#2)(2008-2#4)(2008-3#18)(2008-7#1)(2009-12#1)
absorption and stability##2##3##(2011-2#2)
absorption and the reduced scattering coefficients##3##6##(2008-3#3)
absorption and the##13##3##(2007-12#1)(2008-2#3)(2008-3#8)(2013-8#1)
absorption and##128##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-8#1)(1993-11#2)(1997-7#1)(2007-11#7)(2007-12#6)(2008-1#4)(2008-10#15)(2008-12#1)(2008-2#16)(2008-3#48)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#4)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
absorption are##6##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
absorption as well as the##2##5##(2007-12#1)(2008-3#1)
absorption as well as##3##4##(2007-12#1)(2008-3#2)
absorption as##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
absorption at 185 nm##2##4##(1994-9#2)
absorption at##18##2##(1994-9#2)(2007-11#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-9#1)(2010-3#1)
absorption band at##2##3##(2008-10#1)(2008-3#1)
absorption band of##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
absorption band##18##2##(1993-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#5)
absorption bands at##4##3##(2008-10#3)(2008-3#1)
absorption bands in the##3##4##(1996-5#1)(2008-10#2)
absorption bands of the##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
absorption bands##23##2##(1991-5#1)(1992-4#1)(1994-6#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#7)
absorption but##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
absorption by quantum interference in##2##5##(2007-11#2)
absorption by the##3##3##(2008-1#1)(2008-2#1)(2010-3#1)
absorption by use of##2##4##(2008-3#2)
absorption by water##2##3##(2008-3#1)(2008-7#1)
absorption by##21##2##(1992-8#1)(1997-6#1)(2007-11#3)(2008-1#1)(2008-2#3)(2008-3#9)(2008-7#1)(2010-3#1)(2013-1#1)
absorption can be##2##3##(2007-12#1)(2008-2#1)
absorption can##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
absorption cell##8##2##(2008-10#2)(2008-2#4)(2008-3#2)
absorption changes##2##2##(2008-10#1)(2008-2#1)
absorption characteristics of##2##3##(2008-2#1)(2011-2#1)
absorption coefficient a##4##3##(2008-2#2)(2008-3#2)
absorption coefficient and##11##3##(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#1)
absorption coefficient at##2##3##(2007-12#1)(2008-3#1)
absorption coefficient in##3##3##(2008-2#1)(2008-3#2)
absorption coefficient is##6##3##(2008-2#1)(2008-3#5)
absorption coefficient of 0##2##4##(2008-2#2)
absorption coefficient of 1##2##4##(2008-2#1)(2008-3#1)
absorption coefficient of a##2##4##(2008-2#1)(2008-3#1)
absorption coefficient of phytoplankton##2##4##(2008-3#2)
absorption coefficient of the##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
absorption coefficient of##24##3##(2007-12#1)(2008-10#1)(2008-2#10)(2008-3#11)(2013-8#1)
absorption coefficient was##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
absorption coefficient with##2##3##(2007-11#1)(2008-3#1)
absorption coefficient##107##2##(2007-11#6)(2007-12#6)(2008-10#7)(2008-2#26)(2008-3#57)(2008-4#1)(2008-5#1)(2012-2#2)(2013-8#1)
absorption coefficients between##2##3##(2007-12#1)(2008-2#1)
absorption coefficients by##2##3##(2008-2#1)(2008-3#1)
absorption coefficients from##2##3##(2008-2#1)(2008-3#1)
absorption coefficients of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
absorption coefficients of##12##3##(2007-12#1)(2008-2#3)(2008-3#8)
absorption coefficients##34##2##(2007-12#2)(2008-2#10)(2008-3#21)(2011-1#1)
absorption components of the force##2##5##(2007-11#2)
absorption cross section and##2##4##(2008-2#1)(2008-3#1)
absorption cross section of the##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
absorption cross section of##6##4##(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#1)
absorption cross section##19##3##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#10)(2008-7#1)
absorption cross sections of the##2##5##(2008-3#2)
absorption cross sections of##3##4##(2008-2#1)(2008-3#2)
absorption cross sections##12##3##(2007-11#1)(2008-2#5)(2008-3#6)
absorption cross##31##2##(2007-11#2)(2007-12#3)(2008-2#9)(2008-3#16)(2008-7#1)
absorption cross-sections##2##2##(2008-11#2)
absorption data##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
absorption detection##4##2##(2008-10#4)
absorption detector##2##2##(2008-10#2)
absorption during##2##2##(2008-10#1)(2008-2#1)
absorption edge##2##2##(2007-12#1)(2008-3#1)
absorption edges##2##2##(2006-4#1)(2008-2#1)
absorption effects##2##2##(2008-2#1)(2008-3#1)
absorption efficiencies##3##2##(2008-3#3)
absorption efficiency##10##2##(2008-10#2)(2008-2#2)(2008-3#6)
absorption feature##2##2##(2007-12#1)(2008-2#1)
absorption features in the##2##4##(2008-2#1)(2008-3#1)
absorption features##9##2##(2008-2#3)(2008-3#5)(2012-12#1)
absorption for the##4##3##(1994-5#1)(2008-3#2)(2008-5#1)
absorption for##9##2##(1992-3#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
absorption from the##2##3##(1997-1#1)(2008-3#1)
absorption from##5##2##(1997-1#1)(2008-10#1)(2008-3#2)(2008-5#1)
absorption gap##4##2##(2008-2#4)
absorption gas imaging##2##3##(2008-3#2)
absorption have##2##2##(1990-11#1)(2008-3#1)
absorption in a##8##3##(2007-11#5)(2007-12#1)(2008-2#2)
absorption in the ultraviolet##2##4##(2008-10#2)
absorption in the visible##2##4##(2007-11#1)(2009-11#1)
absorption in the##24##3##(1992-12#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#6)(2008-9#1)(2009-11#1)(2011-7#1)
absorption in##53##2##(1992-11#2)(1992-12#1)(1992-3#2)(1994-9#1)(1997-6#2)(2007-11#10)(2007-12#5)(2008-10#6)(2008-11#2)(2008-2#9)(2008-3#10)(2008-9#1)(2009-11#1)(2011-7#1)
absorption intensities##2##2##(2008-10#1)(2008-11#1)
absorption intensity of##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
absorption into the##4##3##(1992-3#1)(2008-10#1)(2008-3#2)
absorption into##6##2##(1992-3#1)(2008-10#1)(2008-3#3)(2008-7#1)
absorption is described##3##3##(2008-10#3)
absorption is measured##2##3##(2008-3#2)
absorption is##20##2##(2007-11#4)(2008-10#5)(2008-2#2)(2008-3#6)(2008-8#1)(2012-2#1)(2013-8#1)
absorption length##3##2##(2007-12#1)(2008-3#2)
absorption lidar##48##2##(2007-11#1)(2007-12#2)(2008-2#17)(2008-3#28)
absorption limit of##2##3##(2008-3#2)
absorption line of##3##3##(2007-11#1)(2007-12#2)
absorption line shapes##3##3##(2008-2#1)(2008-3#2)
absorption line##10##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#3)
absorption lines of##2##3##(2008-2#1)(2008-3#1)
absorption lines##5##2##(2008-2#2)(2008-3#3)
absorption loss##6##2##(2007-12#2)(2008-3#4)
absorption losses##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
absorption maxima at##3##3##(1994-6#1)(2008-10#1)(2008-11#1)
absorption maxima##8##2##(1994-5#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)
absorption maximum at##13##3##(2008-10#12)(2008-8#1)
absorption maximum of##4##3##(2008-10#2)(2008-8#2)
absorption maximum##23##2##(1994-5#2)(2008-10#17)(2008-3#1)(2008-8#3)
absorption measurement##2##2##(2008-10#1)(2008-3#1)
absorption measurements and##2##3##(2007-12#1)(2008-3#1)
absorption measurements are##2##3##(2008-2#1)(2008-3#1)
absorption measurements in the##2##4##(2008-10#1)(2008-2#1)
absorption measurements of##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
absorption measurements##22##2##(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#10)
absorption minimum##3##2##(2008-2#3)
absorption model##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
absorption modeling##2##2##(2007-11#1)(2008-3#1)
absorption near 2##2##3##(2008-2#1)(2008-3#1)
absorption near##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
absorption occurred##3##2##(2008-2#1)(2008-3#2)
absorption of 2##2##3##(2008-3#2)
absorption of Hct##3##3##(2011-3#3)
absorption of Zn##3##3##(2010-2#3)
absorption of a##3##3##(2008-10#2)(2008-3#1)
absorption of both##2##3##(2008-3#2)
absorption of drugs##3##3##(1992-5#1)(2008-8#1)(2013-1#1)
absorption of light##3##3##(2007-11#1)(2008-3#2)
absorption of nutrients##2##3##(2007-12#1)(2008-7#1)
absorption of pure##2##3##(2008-2#1)(2008-3#1)
absorption of radiation##2##3##(2008-2#1)(2013-1#1)
absorption of the sample##2##4##(2007-11#1)(2008-3#1)
absorption of the substrate##2##4##(2008-10#1)(2008-3#1)
absorption of the##25##3##(1990-11#1)(1993-11#1)(1996-12#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#8)
absorption of two##2##3##(1992-4#1)(2008-3#1)
absorption of##108##2##(1990-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-1#1)(1997-4#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#32)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#3)(2011-1#2)(2011-3#8)(2012-2#2)(2013-1#2)
absorption on the##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
absorption on##7##2##(2007-11#2)(2008-2#1)(2008-3#3)(2012-12#1)
absorption or##8##2##(1991-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
absorption over##2##2##(2007-12#1)(2008-3#1)
absorption path##2##2##(2008-3#2)
absorption peak at##7##3##(2008-10#6)(2013-8#1)
absorption peak of the##2##4##(1994-3#1)(2008-10#1)
absorption peak of##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
absorption peak##14##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-8#1)(2013-8#2)
absorption peaks are##3##3##(2008-1#1)(2009-5#1)(2013-8#1)
absorption peaks at##2##3##(2007-12#1)(2013-8#1)
absorption peaks of##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
absorption peaks##10##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-5#1)(2013-8#4)
absorption produced##2##2##(2007-12#1)(2008-3#1)
absorption profile##2##2##(2008-11#1)(2008-2#1)
absorption profiles##4##2##(2008-10#2)(2008-2#2)
absorption properties at##2##3##(2008-10#1)(2008-3#1)
absorption properties of the##2##4##(2008-2#1)(2008-3#1)
absorption properties of##6##3##(2008-10#2)(2008-2#1)(2008-3#3)
absorption properties##14##2##(2008-10#3)(2008-2#3)(2008-3#7)(2008-5#1)
absorption rates##2##2##(2008-3#1)(2008-5#1)
absorption saturation##3##2##(2008-1#1)(2008-3#2)
absorption signal##4##2##(2008-10#3)(2008-3#1)
absorption signals##2##2##(2008-10#2)
absorption spectra and##3##3##(2008-10#2)(2009-9#1)
absorption spectra by##3##3##(2008-3#3)
absorption spectra from##2##3##(2007-12#1)(2008-2#1)
absorption spectra in the##5##4##(1992-8#1)(2008-10#4)
absorption spectra of aqueous##2##4##(2008-10#2)
absorption spectra of the##11##4##(2007-12#1)(2008-10#7)(2008-3#2)(2008-9#1)
absorption spectra of##29##3##(1992-8#1)(1994-11#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-3#4)(2008-9#3)(2009-8#1)
absorption spectra to##2##3##(2008-3#2)
absorption spectra were##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
absorption spectra with##2##3##(2007-12#1)(2008-2#1)
absorption spectra##78##2##(1990-8#1)(1992-8#2)(1994-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#3)(2008-10#34)(2008-2#8)(2008-3#19)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2009-9#1)
absorption spectrometer based on##2##4##(2008-2#1)(2008-3#1)
absorption spectrometer that uses a##2##5##(2008-3#2)
absorption spectrometer that##3##3##(2008-3#3)
absorption spectrometer##28##2##(2008-10#20)(2008-2#1)(2008-3#7)
absorption spectrometric determination of ultra trace amounts of##2##8##(2008-10#2)
absorption spectrometric determination of##21##4##(2007-12#1)(2008-10#20)
absorption spectrometric determination##23##3##(2007-12#1)(2008-10#22)
absorption spectrometric procedure##3##3##(2008-10#3)
absorption spectrometric##50##2##(2007-12#1)(2008-10#49)
absorption spectrometry (AAS)##14##3##(2008-10#14)
absorption spectrometry (ETAAS) is described##3##5##(2008-10#3)
absorption spectrometry (ETAAS) is##5##4##(2008-10#5)
absorption spectrometry (ETAAS)##33##3##(2008-10#33)
absorption spectrometry (GFAAS)##25##3##(2008-10#25)
absorption spectrometry (HGAAS)##4##3##(2008-10#4)
absorption spectrometry after##13##3##(2008-10#12)(2013-8#1)
absorption spectrometry and##8##3##(2008-10#8)
absorption spectrometry as##5##3##(2008-10#5)
absorption spectrometry for the determination of##2##6##(2008-10#2)
absorption spectrometry for##7##3##(2008-10#7)
absorption spectrometry is described##4##4##(2008-10#4)
absorption spectrometry is##9##3##(2008-10#9)
absorption spectrometry method##3##3##(2008-10#3)
absorption spectrometry using a##3##4##(2008-10#3)
absorption spectrometry using##16##3##(2008-10#16)
absorption spectrometry with##15##3##(2008-10#14)(2009-6#1)
absorption spectrometry##447##2##(1991-12#1)(1994-6#1)(1995-11#1)(1995-6#2)(2007-12#1)(2008-10#436)(2008-5#1)(2009-6#2)(2011-2#1)(2013-8#1)
absorption spectrophotometric determination of##2##4##(1990-12#1)(2008-10#1)
absorption spectrophotometric##8##2##(1990-12#1)(1991-2#1)(2007-11#1)(2008-10#5)
absorption spectrophotometry##25##2##(1997-4#2)(2008-10#23)
absorption spectroscopy (XAS)##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
absorption spectroscopy and##5##3##(1994-11#1)(1994-3#1)(1996-2#1)(2008-2#1)(2010-4#1)
absorption spectroscopy at 1##2##4##(2008-3#2)
absorption spectroscopy at##3##3##(2008-10#1)(2008-3#2)
absorption spectroscopy by use of##2##5##(2008-3#2)
absorption spectroscopy in a##2##4##(2008-10#1)(2008-3#1)
absorption spectroscopy in the##2##4##(2008-11#1)(2008-2#1)
absorption spectroscopy in##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
absorption spectroscopy is demonstrated##2##4##(2007-11#1)(2008-2#1)
absorption spectroscopy of##5##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-2#1)
absorption spectroscopy techniques##2##3##(2008-2#1)(2008-3#1)
absorption spectroscopy with a##2##4##(2007-12#1)(2008-3#1)
absorption spectroscopy with##6##3##(2007-12#3)(2008-3#3)
absorption spectroscopy##79##2##(1991-9#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#6)(2008-10#23)(2008-11#2)(2008-2#7)(2008-3#20)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
absorption spectrum displays##2##3##(2008-10#1)(2008-8#1)
absorption spectrum in the##2##4##(1993-11#1)(2008-11#1)
absorption spectrum of the##3##4##(2008-10#2)(2008-8#1)
absorption spectrum of##15##3##(1993-8#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)
absorption spectrum was##2##3##(2007-11#1)(2008-10#1)
absorption spectrum##35##2##(1993-11#3)(1993-8#1)(1994-6#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#2)(2008-2#7)(2008-3#6)(2008-5#1)(2008-8#3)
absorption studies##5##2##(2008-2#2)(2008-5#2)(2013-1#1)
absorption techniques##2##2##(2008-10#1)(2008-3#1)
absorption than the##2##3##(2008-2#1)(2008-5#1)
absorption than##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
absorption that is##2##3##(2007-12#1)(2008-3#1)
absorption that##4##2##(2007-12#1)(2008-3#3)
absorption to##5##2##(1996-12#1)(2007-12#2)(2008-10#1)(2011-1#1)
absorption transition at##2##3##(2008-3#2)
absorption was##10##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)
absorption wavelength of##3##3##(2008-10#2)(2008-2#1)
absorption wavelength##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
absorption with a##2##3##(2008-2#1)(2008-3#1)
absorption with the##2##3##(2008-3#1)(2012-1#1)
absorption with##5##2##(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)
absorption##2009##1##(1990-11#4)(1990-12#2)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-8#5)(1993-1#2)(1993-11#8)(1993-12#1)(1993-8#1)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#4)(1994-8#1)(1994-9#5)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-4#4)(1997-6#4)(1997-7#3)(2006-4#2)(2007-11#76)(2007-12#90)(2007-2#1)(2008-1#10)(2008-10#811)(2008-11#20)(2008-12#6)(2008-2#224)(2008-3#496)(2008-4#4)(2008-5#35)(2008-6#2)(2008-7#13)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#5)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-11#2)(2010-2#9)(2010-3#2)(2010-4#3)(2010-7#2)(2011-1#8)(2011-2#8)(2011-3#9)(2011-7#1)(2012-1#3)(2012-12#2)(2012-2#15)(2013-1#6)(2013-8#15)
absorption)##5##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
absorption-based##3##1##(2008-10#2)(2012-12#1)
absorption-induced##4##1##(2007-12#1)(2008-3#3)
absorptions in the##3##3##(2007-12#1)(2008-2#2)
absorptions in##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
absorptions of##6##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
absorptions##15##1##(1997-7#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#3)
absorptive##9##1##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)
absorptivities##13##1##(2008-10#13)
absorptivity and##12##2##(2008-10#11)(2008-5#1)
absorptivity at##2##2##(2008-10#2)
absorptivity in##2##2##(2008-10#2)
absorptivity of the##8##3##(2008-10#8)
absorptivity of##18##2##(2008-10#18)
absorptivity##72##1##(2008-1#1)(2008-10#69)(2008-2#1)(2008-5#1)
abstinence and##2##2##(2008-2#1)(2010-4#1)
abstinence during##2##2##(2013-8#2)
abstinence from##2##2##(2008-6#1)(2010-4#1)
abstinence messages##2##2##(2009-5#2)
abstinence rate##2##2##(2008-2#1)(2010-11#1)
abstinence rates##2##2##(2010-11#1)(2011-2#1)
abstinence##42##1##(1991-1#4)(1995-11#2)(1996-5#2)(1996-7#2)(2008-2#5)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#5)(2009-7#3)(2010-11#4)(2010-2#2)(2010-4#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
abstinent##11##1##(1991-1#1)(1995-11#1)(1996-7#4)(2010-4#1)(2013-1#1)(2013-8#3)
abstract and full text##2##4##(2013-1#2)
abstract and##4##2##(1992-1#1)(2011-2#1)(2013-1#2)
abstract are##2##2##(2010-4#2)
abstract is##5##2##(2009-4#3)(2010-4#2)
abstract letter##2##2##(2012-1#2)
abstract shapes##3##2##(2007-12#2)(2008-11#1)
abstract##55##1##(1990-5#2)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#5)(2008-2#3)(2008-5#2)(2008-6#1)(2009-11#1)(2009-4#7)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#7)(2011-1#1)(2011-2#4)(2012-1#2)(2013-1#3)
abstracted from##2##2##(2008-6#1)(2010-8#1)
abstracted independently by##3##3##(2009-9#2)(2010-2#1)
abstracted##9##1##(2007-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-9#2)(2010-2#1)(2010-8#1)
abstracting##2##1##(2007-12#1)(2008-10#1)
abstraction by##2##2##(1993-8#1)(1996-5#1)
abstraction from##2##2##(1991-3#1)(1996-5#1)
abstraction##11##1##(1991-3#1)(1993-8#1)(1995-5#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-12#1)
abstracts and##3##2##(1992-2#1)(1996-12#1)(2010-12#1)
abstracts for##2##2##(1996-3#1)(2007-7#1)
abstracts of the##4##3##(2008-9#1)(2009-9#1)(2013-1#1)(2013-8#1)
abstracts of##5##2##(2008-9#1)(2009-9#1)(2013-1#2)(2013-8#1)
abstracts##26##1##(1992-1#1)(1992-2#1)(1993-12#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#2)
abu##3##1##(2008-7#3)
abundance and distribution of##2##4##(2008-7#1)(2013-7#1)
abundance and distribution##5##3##(2008-10#2)(2008-7#1)(2013-7#2)
abundance and diversity of##3##4##(2008-10#2)(2008-5#1)
abundance and diversity##6##3##(2008-10#2)(2008-5#2)(2013-7#2)
abundance and richness of##3##4##(2011-2#3)
abundance and richness##4##3##(2008-6#1)(2011-2#3)
abundance and species richness##2##4##(2008-5#1)(2013-7#1)
abundance and species##4##3##(2008-5#2)(2013-7#2)
abundance and##40##2##(1992-4#1)(1997-4#1)(2008-10#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-6#4)(2013-1#1)(2013-7#7)
abundance between##2##2##(2010-8#1)(2011-2#1)
abundance by##3##2##(1993-6#1)(2012-3#2)
abundance for##2##2##(2008-7#1)(2010-2#1)
abundance in May##2##3##(2008-10#1)(2013-7#1)
abundance in the##9##3##(2007-11#1)(2008-5#4)(2011-2#2)(2012-2#2)
abundance in##27##2##(1992-6#1)(1994-9#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#5)(2008-8#2)(2010-4#1)(2011-2#3)(2012-2#4)(2012-7#1)(2013-1#1)(2013-7#2)
abundance increased##2##2##(1991-12#1)(2013-7#1)
abundance index##2##2##(2008-5#2)
abundance is##3##2##(1990-5#1)(2009-8#1)(2013-1#1)
abundance of A beta##2##4##(1994-8#1)(1996-5#1)
abundance of A##5##3##(1994-8#1)(1996-5#1)(2007-5#1)(2009-5#2)
abundance of C##3##3##(2012-6#3)
abundance of S##2##3##(2008-5#2)
abundance of natural##2##3##(1995-3#1)(2008-1#1)
abundance of the##6##3##(1990-8#1)(1992-12#1)(1994-6#1)(1996-12#1)(2008-9#1)(2013-7#1)
abundance of##97##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-11#2)(1994-2#3)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#6)(2012-6#3)(2013-7#5)
abundance or##6##2##(1994-5#2)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
abundance patterns##5##2##(2008-8#4)(2011-2#1)
abundance showed##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
abundance was in##2##3##(2011-2#1)(2013-7#1)
abundance was##5##2##(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-7#1)
abundance were##4##2##(1995-2#1)(2008-10#2)(2008-6#1)
abundance with##2##2##(2011-2#2)
abundance##304##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#3)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#32)(2008-6#7)(2008-7#10)(2008-8#29)(2008-9#15)(2009-10#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#8)(2011-2#15)(2012-1#3)(2012-12#2)(2012-2#14)(2012-3#9)(2012-6#7)(2012-7#1)(2012-8#1)(2013-1#3)(2013-7#23)(2013-8#2)
abundances for##2##2##(2008-2#1)(2008-7#1)
abundances may##2##2##(2008-8#1)(2011-2#1)
abundances of##10##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
abundances were##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
abundances##45##1##(1992-3#1)(1994-2#1)(2008-10#4)(2008-2#6)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#12)(2008-9#5)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
abundancies##2##1##(2008-5#2)
abundancy of##2##2##(1994-5#1)(2012-2#1)
abundant (LEA) proteins##2##3##(2008-10#1)(2012-7#1)
abundant and##16##2##(1992-9#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-11#1)(2010-4#1)(2012-2#2)(2013-1#3)
abundant expression##2##2##(1995-2#1)(1996-2#1)
abundant extracellular##2##2##(1995-2#1)(2009-2#1)
abundant genotypes##3##2##(2008-10#1)(2008-8#2)
abundant in autumn##2##3##(2008-5#1)(2013-7#1)
abundant in the##13##3##(1992-8#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-8#1)
abundant in##34##2##(1990-12#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2010-8#1)(2012-2#1)(2013-7#1)
abundant protein in the##2##4##(1994-12#1)(1997-4#1)
abundant protein in##6##3##(1994-12#1)(1994-2#1)(1996-2#1)(1997-4#1)(2011-2#1)(2013-8#1)
abundant protein##9##2##(1991-5#1)(1992-3#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-8#1)(1997-4#1)(2011-2#1)(2013-8#1)
abundant proteins##4##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
abundant species were##5##3##(2008-5#3)(2011-2#1)(2013-7#1)
abundant species##10##2##(2008-12#1)(2008-5#3)(2011-2#4)(2013-1#1)(2013-7#1)
abundant##233##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#4)(1992-3#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-6#1)(2007-12#2)(2008-1#3)(2008-10#38)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#14)(2008-6#6)(2008-7#8)(2008-8#7)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-8#4)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#4)(2012-2#9)(2012-3#4)(2012-7#1)(2013-1#9)(2013-7#6)(2013-8#2)
abundantly expressed##4##2##(1994-11#2)(2008-5#2)
abundantly in##4##2##(1993-3#1)(1993-6#1)(1994-11#1)(2008-10#1)
abundantly produced##2##2##(2008-10#2)
abundantly##22##1##(1991-5#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1996-12#1)(2008-10#10)(2008-5#3)(2009-10#1)
abuse alcohol and##2##3##(2008-11#1)(2009-9#1)
abuse among##2##2##(1990-2#1)(2009-10#1)
abuse and dependence in##2##4##(1992-1#1)(2009-2#1)
abuse and dependence##4##3##(1992-1#1)(2008-4#1)(2008-8#1)(2009-2#1)
abuse and neglect##7##3##(1996-2#1)(2007-12#1)(2009-7#4)(2012-2#1)
abuse and other##2##3##(1991-1#1)(2008-11#1)
abuse and the##2##3##(2008-3#1)(2012-3#1)
abuse and##43##2##(1991-1#1)(1992-1#1)(1993-12#1)(1994-2#2)(1995-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-5#2)(2009-7#5)(2009-9#5)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
abuse are##4##2##(2008-10#1)(2009-7#1)(2009-9#1)(2010-5#1)
abuse as##2##2##(1994-2#1)(2013-8#1)
abuse at##3##2##(1991-1#1)(1992-2#1)(2012-12#1)
abuse by##7##2##(1990-8#1)(1991-1#1)(1992-1#1)(1992-2#1)(1996-4#1)(2007-9#1)(2008-11#1)
abuse cases##2##2##(1991-1#1)(2007-12#1)
abuse histories##3##2##(1992-1#1)(1996-5#2)
abuse in methadone##2##3##(1991-1#1)(2008-10#1)
abuse in pregnancy##2##3##(1994-3#1)(2008-11#1)
abuse in##16##2##(1991-1#2)(1991-12#1)(1992-1#1)(1994-3#1)(1995-6#2)(1996-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-5#1)(2013-1#3)(2013-8#1)
abuse is a##7##3##(1996-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
abuse is##12##2##(1992-1#1)(1996-11#1)(2007-10#1)(2007-7#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-8#1)
abuse liability##4##2##(1991-1#3)(2008-4#1)
abuse of boys##2##3##(1996-11#2)
abuse of human rights##2##4##(1995-11#2)
abuse of prescription##3##3##(1991-1#1)(2008-3#1)(2012-1#1)
abuse of##22##2##(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1995-11#2)(1995-5#2)(1996-11#4)(1996-2#1)(1996-5#1)(2008-3#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2012-1#1)
abuse or dependence##3##3##(1992-1#1)(2008-11#1)(2008-6#1)
abuse or##7##2##(1992-1#1)(2007-12#1)(2008-11#1)(2008-6#2)(2010-4#1)(2010-7#1)
abuse potential##4##2##(1991-1#1)(2008-4#1)(2009-7#1)(2012-3#1)
abuse prevention##5##2##(1991-1#1)(1995-12#1)(2008-6#1)(2009-7#1)(2012-12#1)
abuse services##2##2##(1991-2#1)(1996-12#1)
abuse treatment and##4##3##(2008-6#3)(2010-6#1)
abuse treatment programs##4##3##(2008-6#3)(2009-9#1)
abuse treatment##18##2##(1991-1#1)(2008-6#9)(2009-9#2)(2010-11#3)(2010-4#1)(2010-6#1)(2012-12#1)
abuse was##2##2##(1995-5#1)(1997-2#1)
abuse which##2##2##(1992-1#1)(1996-2#1)
abuse with##2##2##(1996-11#1)(2008-10#1)
abuse##351##1##(1990-2#4)(1990-8#1)(1991-1#29)(1991-12#4)(1991-2#4)(1991-3#1)(1992-1#13)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#10)(1994-3#1)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#8)(1995-6#2)(1996-1#2)(1996-11#8)(1996-12#1)(1996-2#4)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#5)(1997-2#3)(1997-4#1)(1997-7#2)(2007-10#1)(2007-12#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#3)(2008-6#25)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#15)(2009-9#23)(2010-10#6)(2010-11#4)(2010-12#1)(2010-3#7)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#8)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#12)
abuse)##4##1##(1994-2#1)(2007-2#1)(2010-11#1)(2012-3#1)
abuse/dependence##2##1##(2008-6#1)(2013-1#1)
abuse?##2##1##(2008-4#1)(2010-7#1)
abuse]##4##1##(1990-2#1)(1992-9#1)(1995-5#2)
abused and neglected child##3##4##(1995-5#3)
abused and neglected##5##3##(1995-5#5)
abused and##7##2##(1993-12#1)(1995-5#6)
abused child##3##2##(1995-5#3)
abused or##2##2##(2010-3#2)
abused women##3##2##(2010-3#3)
abused##34##1##(1990-11#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-12#1)(1995-5#10)(1996-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#7)(2010-4#2)(2012-3#1)(2013-1#1)
abuser had##2##2##(1990-3#1)(2012-2#1)
abuser was##2##2##(2010-3#2)
abuser##10##1##(1990-3#1)(1991-1#1)(1994-2#1)(1996-11#1)(2008-12#1)(2010-3#4)(2012-2#1)
abusers and##5##2##(1990-3#1)(1994-2#1)(2007-7#1)(2008-12#1)(2008-6#1)
abusers showed##2##2##(1996-5#2)
abusers with##2##2##(1991-1#1)(1996-5#1)
abusers##36##1##(1990-2#1)(1990-3#1)(1991-1#12)(1993-12#1)(1994-2#3)(1996-5#5)(1996-7#1)(2007-7#2)(2008-12#1)(2008-3#2)(2008-6#2)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#2)
abusers'##2##1##(1990-2#1)(2012-1#1)
abuses##3##1##(1993-2#1)(1993-3#1)(1997-3#1)
abusing##5##1##(1991-1#1)(1996-5#2)(2009-9#1)(2013-7#1)
abusive##2##1##(2009-9#1)(2010-3#1)
abutment##4##1##(2013-1#4)
abutments##6##1##(2008-11#1)(2013-1#5)
abyssinica##2##1##(2008-5#2)
abzyme##3##1##(1992-11#1)(1995-3#2)
ac impedance spectroscopy##2##3##(2008-10#2)
ac impedance##4##2##(2008-10#4)
ac##25##1##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#10)(2008-7#5)
acacia##5##1##(2008-10#1)(2008-5#4)
academia and##7##2##(2008-1#1)(2008-5#5)(2012-3#1)
academia##24##1##(1993-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#7)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)
academic achievement and##3##3##(2009-7#1)(2010-1#1)(2010-10#1)
academic achievement in immigrant families##2##5##(2009-7#2)
academic achievement##18##2##(2007-8#1)(2008-11#1)(2009-7#4)(2010-1#9)(2010-10#1)(2012-2#2)
academic activities##4##2##(1993-1#1)(2009-7#2)(2013-8#1)
academic adjustment##4##2##(2008-12#1)(2010-1#3)
academic advising##5##2##(2010-3#5)
academic and clinical##2##3##(1994-3#1)(2008-12#1)
academic and professional##2##3##(1996-12#1)(2008-12#1)
academic and##15##2##(1994-3#1)(1996-12#2)(2008-1#1)(2008-12#3)(2008-5#2)(2009-10#1)(2009-4#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
academic and/or##2##2##(2008-2#1)(2008-9#1)
academic background##2##2##(1991-2#1)(1996-3#1)
academic buoyancy##6##2##(2008-12#6)
academic center##3##2##(2007-10#1)(2008-10#1)(2012-3#1)
academic centres##2##2##(1994-3#1)(2008-11#1)
academic clinical##3##2##(1997-2#1)(2009-4#2)
academic community##4##2##(1990-2#1)(1996-1#1)(2008-10#1)(2012-1#1)
academic development##2##2##(2008-12#1)(2011-2#1)
academic discipline##2##2##(1994-12#1)(2008-1#1)
academic dishonesty##3##2##(2008-12#3)
academic engagement##12##2##(2008-12#7)(2009-7#4)(2010-3#1)
academic environment##2##2##(1995-3#1)(2013-1#1)
academic failure##2##2##(2008-11#2)
academic health center##3##3##(1994-3#2)(1997-2#1)
academic health centers##4##3##(1996-1#1)(1997-2#3)
academic health sciences##3##3##(1995-1#1)(1995-2#1)(1996-12#1)
academic health##14##2##(1994-3#5)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#5)
academic hospital##2##2##(2008-11#1)(2010-8#1)
academic hospitals##2##2##(2008-9#1)(2012-3#1)
academic institution##2##2##(1992-1#1)(2008-11#1)
academic institutions and##3##3##(2010-3#1)(2012-2#1)(2013-8#1)
academic institutions##9##2##(1995-9#1)(1996-1#1)(2009-12#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
academic integrity violations##2##3##(2010-3#2)
academic knowledge##3##2##(1996-3#2)(2011-2#1)
academic medical center##6##3##(1992-2#1)(1995-3#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-3#1)
academic medical centers##6##3##(1994-12#1)(1995-3#1)(1996-1#3)(2011-2#1)
academic medical##15##2##(1991-1#2)(1992-2#1)(1994-12#1)(1995-3#2)(1996-1#3)(1997-1#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
academic medicine##6##2##(1994-3#1)(2007-4#1)(2009-7#1)(2010-4#1)(2012-3#2)
academic outcomes##3##2##(2008-12#1)(2009-7#1)(2011-1#1)
academic performance and##4##3##(2008-11#1)(2012-2#1)(2013-8#2)
academic performance of##3##3##(2011-2#1)(2013-8#2)
academic performance##25##2##(1992-2#2)(2007-8#1)(2008-11#1)(2008-12#1)(2009-7#4)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#9)
academic programs##2##2##(1993-1#1)(2008-11#1)
academic radiology departments##4##3##(2007-4#4)
academic reputation and##2##3##(1996-1#2)
academic research##2##2##(1997-2#1)(2008-11#1)
academic self-competence##2##2##(2009-7#2)
academic setting##3##2##(1992-1#1)(2008-11#1)(2010-1#1)
academic staff##4##2##(2008-11#2)(2008-12#1)(2013-8#1)
academic stress##3##2##(2012-1#3)
academic stressors##3##2##(2012-1#3)
academic support##2##2##(2008-11#1)(2009-5#1)
academic##304##1##(1990-2#2)(1991-1#2)(1991-2#1)(1991-8#1)(1992-1#2)(1992-2#3)(1993-1#3)(1993-6#2)(1994-12#4)(1994-3#8)(1995-1#1)(1995-2#2)(1995-3#4)(1995-9#1)(1996-1#10)(1996-12#4)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#3)(2007-4#6)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#28)(2008-12#34)(2008-2#2)(2008-3#4)(2008-5#4)(2008-7#5)(2008-9#3)(2009-10#2)(2009-11#4)(2009-12#1)(2009-4#4)(2009-5#2)(2009-7#20)(2009-9#1)(2010-1#13)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#13)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#11)(2012-1#11)(2012-12#1)(2012-2#8)(2012-3#12)(2013-1#4)(2013-8#15)
academically##4##1##(2008-11#1)(2008-12#1)(2010-1#2)
academician##4##1##(1992-4#2)(2008-1#1)(2010-10#1)
academicians##3##1##(1994-7#1)(1996-1#1)(1996-3#1)
academics and##4##2##(1993-12#1)(1995-12#1)(2008-11#1)(2008-9#1)
academics in##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
academics to##2##2##(2008-12#1)(2013-1#1)
academics##18##1##(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
academy##3##1##(1991-1#1)(1994-12#1)(1997-4#1)
acalculous cholecystitis in##2##3##(1991-6#2)
acalculous cholecystitis##3##2##(1990-2#1)(1991-6#2)
acamprosate##8##1##(2008-2#8)
acanthosis nigricans##4##2##(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#1)
acanthosis##7##1##(2007-7#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
acarbose##10##1##(1994-12#9)(2010-11#1)
acaricide##4##1##(1997-5#1)(1997-7#1)(2008-6#1)(2011-2#1)
acaricides##2##1##(2010-6#1)(2011-2#1)
acatalasemia##2##1##(1990-12#2)
accelerate the degradation of##2##4##(1994-8#1)(2008-4#1)
accelerate the degradation##3##3##(1994-8#1)(2008-4#2)
accelerate the development of an##2##5##(2007-7#1)(2008-10#1)
accelerate the development of##5##4##(2007-11#1)(2007-7#1)(2008-10#3)
accelerate the##43##2##(1990-11#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-4#2)(1997-2#1)(2007-11#2)(2007-7#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-5#2)(2010-8#1)(2012-3#1)(2013-1#1)
accelerate##65##1##(1990-11#1)(1990-12#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-4#2)(1997-2#2)(2007-11#2)(2007-7#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#1)
accelerated ageing processes##2##3##(2008-10#2)
accelerated ageing##3##2##(2008-10#3)
accelerated aging##2##2##(2008-3#1)(2008-5#1)
accelerated and##3##2##(1994-3#1)(2008-10#1)(2008-3#1)
accelerated atherosclerosis and##2##3##(2008-1#1)(2008-8#1)
accelerated atherosclerosis is##2##3##(1994-6#1)(2008-1#1)
accelerated atherosclerosis##8##2##(1994-6#1)(2008-1#4)(2008-3#1)(2008-7#1)(2008-8#1)
accelerated by##8##2##(1991-9#1)(1993-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#2)(2013-8#1)
accelerated decline##2##2##(2008-10#1)(2010-5#1)
accelerated development of##3##3##(1991-3#1)(1991-5#1)(2010-5#1)
accelerated growth##2##2##(1993-1#1)(2008-7#1)
accelerated in the presence of##3##5##(2008-10#1)(2008-11#1)(2008-9#1)
accelerated in the##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)
accelerated in##7##2##(1993-12#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-6#1)
accelerated loss of##3##3##(2011-1#2)(2011-2#1)
accelerated partial##2##2##(2011-3#1)(2013-1#1)
accelerated process##2##2##(2008-6#1)(2011-2#1)
accelerated silicosis##2##2##(2008-7#2)
accelerated solvent extraction (ASE) followed by##2##6##(2008-10#2)
accelerated solvent extraction (ASE)##4##4##(2008-10#4)
accelerated solvent extraction##6##3##(2008-10#6)
accelerated solvent##7##2##(2008-10#7)
accelerated stability under centrifugation##2##4##(2008-5#2)
accelerated stability##3##2##(2008-5#2)(2011-1#1)
accelerated the development##2##3##(2008-10#1)(2013-1#1)
accelerated the process##2##3##(2008-12#1)(2008-4#1)
accelerated the##19##2##(1992-3#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#1)(2013-1#1)
accelerated##153##1##(1990-12#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-8#2)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#5)(2008-10#26)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-4#4)(2010-5#3)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
accelerates the##11##2##(1990-11#1)(1990-9#1)(1992-3#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2011-3#1)(2013-1#1)
accelerates##23##1##(1990-11#1)(1990-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-2#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-6#1)(2008-8#1)(2009-3#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
accelerating effect##4##2##(2008-10#3)(2008-11#1)
accelerating slip##3##2##(1996-4#3)
accelerating the##7##2##(1990-6#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#2)
accelerating##47##1##(1990-6#1)(1991-1#1)(1993-5#1)(1994-1#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-4#6)(2007-12#2)(2008-1#4)(2008-10#5)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
accelerating&quot##2##1##(2008-1#2)
acceleration and##3##2##(2007-7#2)(2011-1#1)
acceleration c##2##2##(2010-8#2)
acceleration feedback control of##3##4##(2013-1#3)
acceleration feedback##4##2##(2013-1#4)
acceleration in the##2##3##(2008-10#1)(2013-8#1)
acceleration in##5##2##(1996-4#1)(2008-10#1)(2013-1#1)(2013-8#2)
acceleration is##2##2##(2013-1#1)(2013-8#1)
acceleration of the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
acceleration of##16##2##(1991-5#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
acceleration time##2##2##(2008-1#1)(2008-10#1)
acceleration was##3##2##(2008-2#1)(2013-1#2)
acceleration##67##1##(1991-5#1)(1994-9#3)(1996-2#1)(1996-4#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#5)(2008-5#2)(2008-8#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#14)(2013-8#4)
accelerations##6##1##(2007-11#1)(2008-3#1)(2009-9#2)(2010-4#1)(2013-1#1)
accelerator##17##1##(1990-12#1)(1992-12#1)(1993-9#1)(2007-11#1)(2008-2#2)(2008-3#6)(2009-11#4)(2010-11#1)
accelerators##3##1##(2008-3#2)(2010-9#1)
accelerometer##5##1##(2008-2#4)(2013-1#1)
accelerometers##2##1##(2013-1#2)
accent is##2##2##(2011-2#1)(2013-8#1)
accent##4##1##(2011-2#1)(2013-8#3)
accentuate##3##1##(2006-10#1)(2008-10#1)(2011-2#1)
accentuated by##3##2##(1992-12#1)(2008-10#1)(2013-1#1)
accentuated in##2##2##(1991-2#1)(2009-10#1)
accentuated##12##1##(1991-2#1)(1991-9#1)(1992-12#1)(1995-11#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-10#1)(2011-2#1)(2013-1#1)
accentuates the difference##2##3##(1993-9#1)(1995-12#1)
accentuates the##3##2##(1993-9#1)(1995-12#1)(1996-12#1)
accentuates##4##1##(1993-9#1)(1995-12#1)(1996-12#1)(2009-8#1)
accentuating##2##1##(1997-2#1)(2008-1#1)
accentuation of ethanol-induced motor impairment by##2##6##(1997-2#2)
accentuation of##4##2##(1997-2#4)
accentuation##6##1##(1997-2#6)
accept a##2##2##(2008-8#2)
accept and##2##2##(1991-12#1)(1994-3#1)
accept more##2##2##(1995-5#1)(2008-6#1)
accept or##2##2##(1993-11#1)(2010-11#1)
accept the##11##2##(1992-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#1)
accept##50##1##(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
acceptability and representativeness of##2##4##(2009-11#2)
acceptability and representativeness##3##3##(2009-11#3)
acceptability and##8##2##(2009-11#3)(2010-10#1)(2010-4#3)(2013-1#1)
acceptability of the##3##3##(1994-2#1)(1995-3#1)(2010-4#1)
acceptability of##15##2##(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
acceptability##46##1##(1992-1#1)(1992-12#2)(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-11#4)(2009-4#2)(2010-10#1)(2010-2#2)(2010-4#8)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
acceptable (10##2##2##(1991-8#2)
acceptable accuracy##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
acceptable adverse##2##2##(2007-10#1)(2008-7#1)
acceptable agreement with##2##3##(2008-10#2)
acceptable agreement##4##2##(2008-10#4)
acceptable and##9##2##(1994-11#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
acceptable dose##2##2##(2007-10#1)(2011-2#1)
acceptable for clinical##2##3##(2008-10#1)(2008-3#1)
acceptable for the##2##3##(1994-3#1)(2008-8#1)
acceptable for##9##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
acceptable if##2##2##(1996-12#1)(2013-1#1)
acceptable in most##2##3##(2008-10#1)(2013-1#1)
acceptable in##8##2##(1991-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2012-12#2)(2013-1#1)
acceptable levels of haemoglobin##2##4##(2011-1#2)
acceptable levels of##4##3##(1994-11#1)(2008-10#1)(2011-1#2)
acceptable levels##8##2##(1992-10#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#2)
acceptable limits##3##2##(2008-10#2)(2012-3#1)
acceptable means of##2##3##(1996-12#1)(1996-3#1)
acceptable practices##2##2##(2010-11#2)
acceptable range##5##2##(2008-10#4)(2008-11#1)
acceptable recoveries##3##2##(1997-2#1)(2008-10#2)
acceptable results##5##2##(2008-10#2)(2010-5#1)(2011-3#1)(2012-12#1)
acceptable risk##2##2##(2006-10#1)(2010-3#1)
acceptable sensory characteristics##2##3##(2010-3#1)(2010-7#1)
acceptable sensory##3##2##(2010-3#1)(2010-7#1)(2011-2#1)
acceptable solutions##3##2##(1994-1#1)(2008-3#2)
acceptable than##2##2##(2007-8#1)(2008-10#1)
acceptable to clinicians##2##3##(1995-5#1)(1997-3#1)
acceptable to participants##2##3##(2009-11#1)(2013-1#1)
acceptable to patients##2##3##(1990-11#1)(2009-2#1)
acceptable to the##3##3##(1993-3#1)(2007-5#1)(2010-5#1)
acceptable to##10##2##(1990-11#1)(1993-3#1)(1995-5#1)(1997-3#1)(2007-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-5#1)(2013-1#1)
acceptable toxicity##3##2##(1994-12#1)(2008-6#1)(2008-8#1)
acceptable treatment##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
acceptable value##2##2##(2008-9#1)(2012-2#1)
acceptable when##2##2##(1995-2#1)(2013-1#1)
acceptable##225##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-3#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#51)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-3#3)(2010-5#3)(2010-7#3)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#1)
acceptably low##2##2##(2008-1#1)(2011-2#1)
acceptance and use of##2##4##(1996-1#1)(1997-7#1)
acceptance and##13##2##(1992-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-3#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
acceptance by##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
acceptance for##3##2##(1994-11#1)(2008-1#1)(2009-5#1)
acceptance in the##6##3##(1990-10#1)(1993-2#1)(1995-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
acceptance in##7##2##(1990-10#1)(1993-2#1)(1995-12#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
acceptance limits##2##2##(2008-10#2)
acceptance of a##3##3##(1994-7#1)(1995-12#1)(1995-2#1)
acceptance of cosmetic surgery##2##4##(2007-12#2)
acceptance of low prestige##2##4##(2008-10#2)
acceptance of low##3##3##(2008-10#3)
acceptance of the##11##3##(1990-10#1)(1993-11#2)(2008-1#1)(2008-12#3)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
acceptance of this##2##3##(1994-2#1)(2009-5#1)
acceptance of##47##2##(1990-10#2)(1990-6#1)(1992-11#1)(1993-11#2)(1993-12#1)(1994-2#2)(1994-7#1)(1995-12#1)(1995-2#2)(1996-12#2)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#5)(2008-12#5)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
acceptance or rejection of the##2##5##(2008-7#1)(2012-2#1)
acceptance or rejection of##3##4##(2007-10#1)(2008-7#1)(2012-2#1)
acceptance or##6##2##(1990-10#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
acceptance rate##2##2##(2007-10#1)(2012-2#1)
acceptance rates##2##2##(2007-10#1)(2012-3#1)
acceptance that##3##2##(1993-2#1)(2010-5#1)(2011-3#1)
acceptance to##2##2##(2007-11#1)(2007-5#1)
acceptance##132##1##(1990-10#5)(1990-6#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-11#3)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-12#4)(1996-3#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-11#1)(2009-5#2)(2010-1#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#2)(2013-8#2)
accepted and##5##2##(1996-4#1)(2008-4#1)(2008-5#2)(2011-2#1)
accepted as a##11##3##(1990-9#1)(1993-2#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#2)
accepted as an##2##3##(2007-6#1)(2008-9#1)
accepted as the##4##3##(1990-12#1)(1993-12#1)(2008-11#1)(2008-9#1)
accepted as##25##2##(1990-12#1)(1990-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-11#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#3)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#2)
accepted at##4##2##(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
accepted but##2##2##(2008-7#2)
accepted by the##2##3##(1997-2#1)(2008-6#1)
accepted by##18##2##(1990-6#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
accepted criteria##3##2##(1993-8#1)(1997-8#1)(2007-11#1)
accepted for##4##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)
accepted idea##2##2##(2008-10#1)(2009-5#1)
accepted if the##2##3##(2008-10#1)(2011-2#1)
accepted in##7##2##(1990-6#1)(1992-12#1)(2008-10#3)(2008-6#1)(2011-2#1)
accepted medical##2##2##(1991-11#1)(1996-3#1)
accepted method##2##2##(2008-11#1)(2008-5#1)
accepted model##2##2##(1994-3#1)(2008-8#1)
accepted on##2##2##(1992-12#1)(2007-8#1)
accepted or##3##2##(1991-12#1)(2008-11#1)(2008-7#1)
accepted standard##2##2##(2008-5#1)(2012-12#1)
accepted that the##3##3##(2008-11#1)(2008-4#1)(2009-7#1)
accepted that##30##2##(1991-1#1)(1992-3#1)(1994-9#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-8#1)
accepted the##5##2##(1991-6#1)(1995-6#1)(1996-3#1)(2008-9#1)(2009-9#1)
accepted theoretical##2##2##(2008-1#1)(2008-3#1)
accepted theory##3##2##(2008-1#1)(2008-4#1)(2011-1#1)
accepted to be##4##3##(1990-12#1)(2007-8#1)(2008-2#1)(2008-7#1)
accepted to##8##2##(1990-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#2)(2008-9#1)(2012-3#1)
accepted treatment for##2##3##(2008-6#1)(2010-11#1)
accepted with##2##2##(1991-6#1)(1994-2#1)
accepted##219##1##(1990-11#2)(1990-12#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#4)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2006-6#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#20)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#10)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#8)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#3)(2013-8#6)
accepting a##2##2##(1990-2#1)(1993-11#1)
accepting the##4##2##(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
accepting##15##1##(1990-2#1)(1993-11#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)
acceptor and donor##2##3##(1994-11#1)(2009-12#1)
acceptor for the##2##3##(1991-12#1)(1992-11#1)
acceptor guided modes##2##3##(2007-12#2)
acceptor in##5##2##(1990-7#1)(1991-5#1)(1992-6#1)(1995-2#1)(2008-10#1)
acceptor is##2##2##(2008-10#1)(2010-7#1)
acceptor molecules##2##2##(2007-11#1)(2009-10#1)
acceptor phase##3##2##(2008-10#3)
acceptor photobleaching##3##2##(2008-4#1)(2008-9#2)
acceptor site##4##2##(1993-11#1)(1995-12#2)(1995-5#1)
acceptor solution##5##2##(2008-10#3)(2012-1#2)
acceptor stream of##3##3##(2008-10#3)
acceptor stream##16##2##(2008-10#16)
acceptor vesicles##2##2##(1992-3#1)(1994-5#1)
acceptor was##3##2##(1990-7#1)(2008-10#2)
acceptor##115##1##(1990-12#2)(1990-7#4)(1991-12#1)(1991-5#3)(1992-10#1)(1992-11#1)(1992-3#4)(1992-6#2)(1993-11#2)(1994-11#1)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1997-3#1)(1997-4#1)(1997-7#2)(2007-1#2)(2007-11#2)(2007-12#3)(2008-10#42)(2008-11#2)(2008-4#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-1#2)
acceptor)##3##1##(2008-10#2)(2012-2#1)
acceptors and donors##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
acceptors and##5##2##(1992-12#1)(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
acceptors with##2##2##(1994-5#1)(2008-12#1)
acceptors##23##1##(1990-7#1)(1990-9#1)(1992-12#2)(1994-5#2)(1994-7#1)(1995-3#1)(2008-10#5)(2008-12#1)(2009-12#2)(2009-9#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
accepts##4##1##(1991-3#1)(2007-11#1)(2008-2#1)(2013-1#1)
access a##3##2##(1995-2#1)(1996-2#1)(2010-4#1)
access among##2##2##(2007-7#1)(2012-2#1)
access and capacity issues##3##4##(1995-1#3)
access and capacity##4##3##(1995-1#4)
access and quality of care##4##5##(1995-1#1)(1996-1#1)(1997-2#1)(2012-2#1)
access and quality##9##3##(1995-1#1)(1995-12#2)(1996-1#1)(1997-2#4)(2012-2#1)
access and satisfaction##2##3##(1995-12#2)
access and use of##2##4##(2010-8#1)(2013-1#1)
access and utilization##2##3##(1994-1#1)(1994-2#1)
access and##41##2##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#6)(1995-12#4)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#4)(2007-7#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#2)(2009-4#2)(2010-8#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
access by##6##2##(1996-2#1)(1996-3#1)(1997-3#1)(2008-2#1)(2008-3#1)(2011-2#1)
access can be##2##3##(2008-4#1)(2011-2#1)
access can##4##2##(2008-4#1)(2011-2#3)
access control##4##2##(1995-2#1)(2010-8#3)
access failure##3##2##(2007-7#2)(2011-2#1)
access for chronic##2##3##(1991-6#1)(2007-7#1)
access for coronary##2##3##(2008-11#1)(2011-2#1)
access for##24##2##(1991-6#2)(1994-2#1)(1996-1#1)(1997-2#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#3)(2013-8#2)
access from the##2##3##(1995-12#1)(2011-2#1)
access grafts##2##2##(2007-7#2)
access has##2##2##(1995-12#1)(1996-12#1)
access in a##2##3##(2007-7#1)(2009-5#1)
access in##14##2##(1997-2#2)(2007-7#5)(2008-1#1)(2008-12#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
access is a##2##3##(2008-2#1)(2012-2#1)
access is##7##2##(1991-12#1)(1994-2#1)(1995-12#1)(2008-2#1)(2011-2#1)(2012-2#2)
access management##10##2##(1992-12#1)(1993-2#1)(1994-12#2)(1994-2#2)(1996-12#2)(2007-7#2)
access manager##2##2##(1992-2#1)(1996-3#1)
access manager's role in##2##4##(1995-12#1)(1997-1#1)
access managers##3##2##(1993-3#1)(1996-2#1)(1996-3#1)
access neurology##3##2##(2010-12#3)
access node in a##2##4##(2008-3#2)
access node##3##2##(2008-3#3)
access of##11##2##(1993-8#1)(1996-1#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)
access only##2##2##(1993-12#1)(2012-2#1)
access over##2##2##(2007-7#1)(2008-11#1)
access period of##2##3##(2008-10#2)
access period##8##2##(2008-10#8)
access periods##5##2##(2008-10#5)
access placement##2##2##(2007-7#2)
access related##2##2##(1992-2#1)(2007-7#1)
access retroperitoneoscopic adrenalectomy##3##3##(2012-12#3)
access retroperitoneoscopic##5##2##(2012-12#5)
access route##2##2##(1990-9#1)(2011-2#1)
access services##2##2##(1995-2#1)(2010-8#1)
access site complications##5##3##(2011-2#5)
access site##12##2##(2007-7#4)(2011-2#8)
access surgery##3##2##(2008-11#1)(2008-9#1)(2012-12#1)
access system##2##2##(1997-2#1)(2007-8#1)
access technique##2##2##(2008-11#1)(2011-2#1)
access the##11##2##(1996-1#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-1#1)
access through a##2##3##(2007-9#1)(2008-7#1)
access to a doctor or clinic##2##6##(2009-5#2)
access to a range of##2##5##(2008-11#2)
access to a wide##2##4##(1991-12#1)(2006-12#1)
access to a##16##3##(1991-12#1)(1993-12#1)(1993-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#2)
access to affordable##2##3##(1996-8#1)(2008-7#1)
access to and experiences##2##4##(1997-3#1)(2008-12#1)
access to and use of##3##5##(1994-12#1)(1994-2#1)(2008-12#1)
access to and##10##3##(1994-1#1)(1994-12#1)(1994-2#1)(1997-3#2)(2007-10#1)(2008-1#1)(2008-12#2)(2008-3#1)
access to both##3##3##(1991-3#1)(1992-3#1)(2009-12#1)
access to capital##2##3##(1997-6#1)(2008-7#1)
access to care for Medicare beneficiaries##2##6##(1992-12#1)(1995-12#1)
access to care for the uninsured##2##6##(1995-1#1)(1996-1#1)
access to care for the##3##5##(1995-1#1)(1996-1#1)(1997-2#1)
access to care for##7##4##(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(2013-8#1)
access to care##26##3##(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#5)(1996-1#2)(1996-3#3)(1997-2#1)(1997-4#1)(2008-7#1)(2010-3#1)(2011-1#4)(2012-2#2)(2012-3#1)(2013-8#1)
access to clinical##2##3##(1995-12#1)(2008-11#1)
access to electronic##2##3##(2007-12#1)(2008-11#1)
access to emergency##3##3##(1997-8#1)(2008-6#2)
access to essential medicines##2##4##(2009-5#2)
access to essential##3##3##(2009-5#2)(2012-2#1)
access to family##2##3##(1991-6#1)(2008-12#1)
access to health care in rural##2##6##(1995-3#1)(2008-11#1)
access to health care in##3##5##(1995-3#1)(2008-11#1)(2010-4#1)
access to health care##20##4##(1991-3#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(2008-11#2)(2008-6#1)(2008-8#2)(2009-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
access to health services##7##4##(1992-2#2)(2008-11#1)(2008-8#1)(2011-1#2)(2012-12#1)
access to health##30##3##(1991-3#1)(1992-2#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(2008-11#3)(2008-6#2)(2008-8#3)(2009-5#1)(2010-4#1)(2011-1#2)(2012-1#2)(2012-12#3)(2012-2#1)
access to healthcare##2##3##(2008-4#1)(2013-1#1)
access to hospice care by##2##5##(1993-12#2)
access to hospice care##3##4##(1993-12#3)
access to information##2##3##(2008-7#2)
access to insurance##2##3##(1992-2#2)
access to kidney transplantation##2##4##(1995-12#2)
access to large##2##3##(2009-6#1)(2012-2#1)
access to learning resources##2##4##(2008-11#2)
access to learning##3##3##(2008-11#3)
access to medical care##3##4##(1996-5#1)(1997-3#1)(2008-8#1)
access to medical##4##3##(1990-6#1)(1996-5#1)(1997-3#1)(2008-8#1)
access to nursing homes##2##4##(1994-12#1)(1995-1#1)
access to preventive health care##2##5##(2008-4#2)
access to primary##2##3##(1997-2#1)(1997-3#1)
access to resources##2##3##(1992-3#1)(2007-7#1)
access to safe##4##3##(2011-1#2)(2011-2#1)(2013-1#1)
access to scientific##2##3##(1993-1#1)(2010-5#1)
access to services and##4##4##(1993-1#1)(1996-1#1)(1997-5#1)(2007-7#1)
access to services##8##3##(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-5#1)(2007-7#1)(2009-6#1)(2011-1#1)
access to specialty##3##3##(1994-3#1)(1997-2#1)(2006-10#1)
access to the Internet##2##4##(1994-12#1)(1996-2#1)
access to the entire##2##4##(1992-2#1)(2009-2#1)
access to the heart##2##4##(2008-12#1)(2011-2#1)
access to the process##2##4##(2012-2#2)
access to the##53##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-6#1)(2006-12#1)(2007-12#3)(2007-9#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
access to their##2##3##(1993-12#1)(2007-12#1)
access to these##4##3##(1997-2#1)(2007-5#1)(2009-9#1)(2013-1#1)
access to this##2##3##(2008-8#1)(2010-6#1)
access to treatment##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
access to universal##2##3##(2008-11#2)
access to##347##2##(1990-12#1)(1990-2#1)(1990-6#3)(1990-9#2)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#4)(1992-2#6)(1992-3#3)(1992-4#2)(1993-1#2)(1993-12#8)(1993-2#2)(1993-3#3)(1993-6#2)(1994-1#4)(1994-12#6)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#5)(1995-11#2)(1995-12#14)(1995-2#2)(1995-3#3)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#8)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#24)(2008-12#8)(2008-2#2)(2008-3#4)(2008-4#10)(2008-6#4)(2008-7#12)(2008-8#9)(2008-9#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#12)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#5)(2012-8#1)(2013-1#12)(2013-8#4)
access under##2##2##(1994-2#1)(1997-1#1)
access was used##2##3##(1996-6#1)(2007-7#1)
access was##4##2##(1996-6#1)(2007-7#1)(2008-1#1)(2011-2#1)
access were##3##2##(2007-10#1)(2007-7#1)(2010-2#1)
access will##3##2##(1996-3#1)(2008-11#1)(2010-8#1)
access would##2##2##(1996-3#1)(1997-8#1)
access##756##1##(1990-12#1)(1990-2#1)(1990-6#3)(1990-8#1)(1990-9#4)(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-9#2)(1992-12#9)(1992-2#9)(1992-3#5)(1992-4#2)(1993-1#2)(1993-12#12)(1993-2#3)(1993-3#7)(1993-6#2)(1993-8#1)(1994-1#9)(1994-12#9)(1994-2#11)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#14)(1995-11#2)(1995-12#26)(1995-2#6)(1995-3#4)(1995-6#1)(1995-9#1)(1996-1#14)(1996-12#6)(1996-2#7)(1996-3#21)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#6)(1997-2#15)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#61)(2007-8#8)(2007-9#3)(2008-1#14)(2008-10#37)(2008-11#40)(2008-12#17)(2008-2#6)(2008-3#14)(2008-4#18)(2008-6#4)(2008-7#21)(2008-8#12)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#8)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#10)(2011-1#14)(2011-2#49)(2011-3#2)(2012-1#7)(2012-12#19)(2012-2#19)(2012-3#10)(2012-8#1)(2013-1#23)(2013-8#6)
accessed and##2##2##(1995-1#1)(2008-10#1)
accessed by##6##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)
accessed through##2##2##(2008-4#1)(2011-2#1)
accessed##29##1##(1991-12#1)(1991-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#4)(2008-7#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
accesses to the##2##3##(2008-3#1)(2008-7#1)
accesses to##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
accesses##10##1##(1992-2#1)(1996-7#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)
accessibility and##4##2##(1994-6#1)(1996-1#1)(2010-11#1)(2010-8#1)
accessibility in the##2##3##(2008-7#1)(2012-3#1)
accessibility in##4##2##(2008-7#1)(2010-6#1)(2012-2#1)(2012-3#1)
accessibility of community##2##3##(1991-12#1)(2012-2#1)
accessibility of the##9##3##(1990-11#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-11#1)(2012-3#1)
accessibility of##26##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#1)(1995-2#3)(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2010-11#2)(2012-2#2)(2012-3#2)(2013-1#1)
accessibility problems##2##2##(2008-7#1)(2010-8#1)
accessibility to care##2##3##(1997-1#2)
accessibility to the##3##3##(1991-5#1)(1997-2#1)(2008-7#1)
accessibility to##12##2##(1991-5#1)(1992-3#1)(1997-1#2)(1997-2#1)(2007-5#1)(2008-12#1)(2008-7#2)(2013-1#2)(2013-7#1)
accessibility##75##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#3)(1995-8#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-3#2)(2009-5#1)(2010-11#3)(2010-6#1)(2010-8#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)
accessible and##6##2##(1993-11#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)
accessible as##2##2##(2008-4#1)(2011-2#1)
accessible by##3##2##(2008-10#1)(2008-3#2)
accessible for the##2##3##(1997-4#1)(2008-10#1)
accessible for##8##2##(1992-5#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)
accessible from##3##2##(1997-8#1)(2008-3#1)(2008-4#1)
accessible health care##2##3##(1996-12#1)(1997-2#1)
accessible over the##2##3##(1992-2#1)(2009-10#1)
accessible surface area##2##3##(1997-2#1)(2008-7#1)
accessible surface##5##2##(1997-2#3)(2008-11#1)(2008-7#1)
accessible through the##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
accessible through##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
accessible to the##7##3##(1992-12#1)(1992-9#1)(2008-10#2)(2008-7#1)(2013-1#1)(2013-8#1)
accessible to##26##2##(1990-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-2#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2010-3#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
accessible transit vehicles##2##3##(2013-1#2)
accessible via##3##2##(1997-2#1)(2008-2#1)(2008-4#1)
accessible##125##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#5)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#1)(2009-10#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
accessing the##5##2##(1996-5#1)(2008-12#2)(2012-12#1)(2012-3#1)
accessing them##2##2##(1997-2#1)(2011-1#1)
accessing##27##1##(1992-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-11#4)(2008-12#3)(2008-4#4)(2009-10#2)(2009-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
accession number##7##2##(1993-6#1)(1996-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-1#1)
accession were##2##2##(2008-10#2)
accession##26##1##(1993-6#1)(1996-8#1)(2008-10#17)(2008-8#2)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
accessions CIho 14300##2##3##(2008-10#2)
accessions CIho##3##2##(2008-10#3)
accessions from the U##2##4##(2008-10#2)
accessions from the##3##3##(2008-10#3)
accessions from##5##2##(2008-10#5)
accessions in which##2##3##(2008-10#1)(2008-5#1)
accessions of##9##2##(2008-10#5)(2008-5#4)
accessions showed##2##2##(2008-10#2)
accessions was##3##2##(2008-10#3)
accessions were susceptible##2##3##(2008-10#2)
accessions were##8##2##(2008-10#7)(2008-5#1)
accessions##64##1##(2008-10#50)(2008-5#12)(2012-3#2)
accessories for##2##2##(1995-2#1)(2013-8#1)
accessories##5##1##(1995-2#1)(2007-10#1)(2008-9#2)(2013-8#1)
accessory bodies and two mitochondrial derivatives##2##6##(2007-12#1)(2008-7#1)
accessory bodies##5##2##(2007-12#3)(2008-7#2)
accessory cells##2##2##(1995-2#1)(2008-11#1)
accessory channel##2##2##(2013-1#2)
accessory genome##2##2##(2011-2#2)
accessory glands in the##2##4##(2007-12#2)
accessory glands in##3##3##(2007-12#3)
accessory glands ofAllacma##2##3##(2008-7#2)
accessory glands##8##2##(2007-12#4)(2008-7#4)
accessory metatarsal located between the left fourth and fifth metatarsals##2##10##(2010-3#2)
accessory metatarsal##3##2##(2010-3#3)
accessory muscle##2##2##(2012-2#2)
accessory nerve##7##2##(2008-7#6)(2008-9#1)
accessory nuclei##3##2##(2007-12#2)(2008-7#1)
accessory pathway was##4##3##(1993-2#1)(2008-11#3)
accessory pathway##10##2##(1993-2#1)(2008-11#9)
accessory pathways##2##2##(1993-2#1)(2009-10#1)
accessory plantaris muscles##2##3##(2012-2#2)
accessory plantaris##4##2##(2012-2#4)
accessory protein##4##2##(1997-3#3)(2011-1#1)
accessory proteins##3##2##(2008-4#1)(2009-9#1)(2012-2#1)
accessory salivary glands##2##3##(2008-10#2)
accessory salivary##3##2##(2008-10#2)(2008-4#1)
accessory sex##2##2##(1991-5#1)(2008-10#1)
accessory##83##1##(1991-5#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-2#2)(1994-8#1)(1995-2#3)(1997-3#4)(2007-12#12)(2008-10#6)(2008-11#10)(2008-4#2)(2008-7#15)(2008-9#2)(2009-10#1)(2009-9#1)(2010-3#3)(2011-1#1)(2011-2#3)(2012-2#7)(2012-3#1)(2013-1#4)
accident and emergency##3##3##(1991-3#1)(2011-2#1)(2013-1#1)
accident and##7##2##(1991-3#1)(1997-8#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
accident at##2##2##(2008-4#2)
accident databases##2##2##(2009-10#2)
accident in##3##2##(1992-2#1)(2007-2#1)(2013-1#1)
accident or##2##2##(2008-12#1)(2008-7#1)
accident prevention##2##2##(1995-1#1)(2008-11#1)
accident risk##4##2##(1992-6#1)(2008-11#1)(2010-7#2)
accident##79##1##(1990-5#1)(1990-9#3)(1991-12#2)(1991-3#1)(1992-2#2)(1992-4#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#4)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#5)(2008-7#3)(2008-8#1)(2009-10#10)(2009-3#1)(2009-4#1)(2009-5#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)
accident]##2##1##(1991-11#1)(2011-1#1)
accidental and##2##2##(2008-10#1)(2008-11#1)
accidental astemizole##2##2##(1991-8#2)
accidental falls##2##2##(1992-4#1)(2008-11#1)
accidental ingestion of##2##3##(2007-12#1)(2011-2#1)
accidental injuries##2##2##(2008-11#2)
accidental injury##2##2##(2007-7#1)(2013-1#1)
accidental or##2##2##(1992-2#1)(2008-10#1)
accidental pollution##2##2##(1994-3#1)(2008-11#1)
accidental##60##1##(1991-8#2)(1991-9#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-5#1)(1994-3#1)(1995-11#3)(1995-2#1)(1995-3#2)(1996-8#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#4)(2008-10#6)(2008-11#13)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
accidentally##9##1##(1991-3#1)(1991-6#2)(1993-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)
accidents (CVA)##2##2##(1992-2#1)(2007-8#1)
accidents and##10##2##(1990-6#1)(1991-3#1)(1995-8#1)(2008-11#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-1#1)
accidents at work##2##3##(1995-8#1)(2012-1#1)
accidents at##5##2##(1992-2#2)(1995-8#2)(2012-1#1)
accidents in the##3##3##(1995-8#1)(1996-12#1)(2009-10#1)
accidents in##8##2##(1990-9#1)(1995-8#2)(1996-12#1)(2007-7#1)(2009-10#2)(2013-7#1)
accidents involving##2##2##(2009-10#1)(2012-12#1)
accidents was##2##2##(1992-6#1)(2009-10#1)
accidents were##4##2##(1996-12#1)(2008-11#1)(2008-7#1)(2009-10#1)
accidents##92##1##(1990-6#3)(1990-9#3)(1991-3#3)(1991-6#1)(1992-2#3)(1992-6#2)(1994-3#1)(1995-3#2)(1995-8#6)(1996-11#1)(1996-12#4)(1996-2#2)(1996-8#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-7#2)(2007-8#2)(2008-1#2)(2008-11#3)(2008-7#3)(2008-8#1)(2009-10#14)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#6)(2012-1#3)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#4)
accidents]##4##1##(1992-2#1)(1992-9#1)(1993-3#1)(1997-6#1)
acclimated burbot##2##2##(2008-7#2)
acclimated roach##2##2##(2008-7#2)
acclimated to tomato##2##3##(2008-8#2)
acclimated to##4##2##(2008-5#1)(2008-7#1)(2008-8#2)
acclimated##9##1##(2008-5#1)(2008-7#5)(2008-8#2)(2011-2#1)
acclimation of##3##2##(2008-7#1)(2012-5#2)
acclimation##19##1##(1992-3#1)(2008-12#1)(2008-4#1)(2008-7#8)(2008-8#2)(2012-5#3)(2012-9#1)(2013-8#2)
acclimatisation##2##1##(2012-2#2)
acclimatization in July and##4##4##(2009-12#4)
acclimatization in##7##2##(2009-12#7)
acclimatization##10##1##(2008-10#1)(2008-12#1)(2009-12#8)
acclimatized at##2##2##(2011-2#2)
acclimatized##3##1##(2011-2#3)
acclinidens##2##1##(2008-5#2)
accommodate a##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)
accommodate an##2##2##(1997-5#1)(2008-10#1)
accommodate the##10##2##(1990-8#1)(1994-3#2)(2007-12#2)(2009-8#1)(2010-10#1)(2011-3#1)(2013-8#2)
accommodate##64##1##(1990-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-3#1)(1993-8#2)(1994-1#1)(1994-3#3)(1995-2#1)(1995-6#2)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
accommodated by##2##2##(2008-3#1)(2008-7#1)
accommodated in the##2##3##(2008-8#1)(2010-3#1)
accommodated##14##1##(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
accommodates the##3##2##(1996-5#1)(2008-3#1)(2013-1#1)
accommodates##5##1##(1994-3#1)(1996-5#1)(2008-3#1)(2013-1#1)(2013-7#1)
accommodating##5##1##(1996-5#1)(2007-3#1)(2008-11#2)(2012-2#1)
accommodation of the##2##3##(1990-3#1)(2008-11#1)
accommodation of##5##2##(1990-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
accommodation##22##1##(1990-3#2)(1995-12#1)(1995-6#3)(1996-2#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#2)
accommodations##4##1##(1992-12#1)(1993-3#1)(1995-12#1)(2008-9#1)
accompagnée##2##1##(2011-2#1)(2013-1#1)
accompanied by a change in##3##5##(2008-1#1)(2008-2#1)(2008-9#1)
accompanied by a change##4##4##(1997-7#1)(2008-1#1)(2008-2#1)(2008-9#1)
accompanied by a decrease in the##3##6##(1990-11#1)(1991-5#1)(2008-10#1)
accompanied by a decrease in##7##5##(1990-11#1)(1991-5#1)(1992-8#1)(1994-3#1)(2008-10#1)(2009-7#1)(2010-8#1)
accompanied by a decrease##8##4##(1990-11#1)(1991-5#1)(1992-8#1)(1992-9#1)(1994-3#1)(2008-10#1)(2009-7#1)(2010-8#1)
accompanied by a significant##4##4##(1992-3#1)(1994-8#1)(2007-11#1)(2007-12#1)
accompanied by a similar##2##4##(1994-1#1)(2008-11#1)
accompanied by a##58##3##(1990-11#2)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1997-7#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
accompanied by abundant##2##3##(2008-10#1)(2008-5#1)
accompanied by an increase in the##4##6##(1992-6#1)(1992-9#1)(2008-10#1)(2011-2#1)
accompanied by an increase in##11##5##(1990-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
accompanied by an##24##3##(1990-7#1)(1991-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1994-7#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
accompanied by changes in the##2##5##(2008-4#1)(2009-6#1)
accompanied by changes in##9##4##(1993-8#1)(1995-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#2)(2010-4#1)
accompanied by considerable##2##3##(2007-12#1)(2008-10#1)
accompanied by diabetic ketoacidosis##2##4##(2011-1#2)
accompanied by diabetic##3##3##(2011-1#2)(2012-12#1)
accompanied by direct##2##3##(2008-11#2)
accompanied by elevated levels of##2##5##(1996-12#1)(2008-7#1)
accompanied by enhanced##3##3##(2009-2#1)(2011-1#2)
accompanied by impaired##2##3##(2012-12#1)(2012-3#1)
accompanied by improved##2##3##(2008-1#1)(2009-11#1)
accompanied by increased##6##3##(1992-12#1)(1992-6#1)(1994-3#1)(2008-8#1)(2009-9#1)(2012-2#1)
accompanied by increases in##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
accompanied by lower##2##3##(2008-10#1)(2011-1#1)
accompanied by multiple##2##3##(2008-11#1)(2008-8#1)
accompanied by only a##2##4##(2010-3#1)(2012-1#1)
accompanied by other##2##3##(2011-2#1)(2012-12#1)
accompanied by reduced##2##3##(1992-6#1)(1992-7#1)
accompanied by reduction##2##3##(1995-8#1)(2008-1#1)
accompanied by significant##2##3##(2008-3#1)(2008-8#1)
accompanied by the development of##2##5##(2010-3#1)(2012-3#1)
accompanied by the formation of##2##5##(1994-3#1)(2009-8#1)
accompanied by the##16##3##(1990-5#1)(1994-12#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
accompanied by##260##2##(1990-11#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#2)(2007-10#3)(2007-11#3)(2007-12#6)(2007-8#4)(2008-1#3)(2008-10#26)(2008-11#14)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#8)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#7)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#5)
accompanied the##3##2##(1991-5#1)(1991-6#1)(1992-3#1)
accompanied these##2##2##(2007-11#1)(2008-10#1)
accompanied with a##3##3##(1990-8#1)(1997-1#1)(2011-2#1)
accompanied with the##2##3##(1992-6#1)(2008-10#1)
accompanied with##17##2##(1990-8#1)(1991-12#1)(1992-6#1)(1995-8#1)(1997-1#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
accompanied##293##1##(1990-11#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#2)(2007-10#3)(2007-11#5)(2007-12#6)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#32)(2008-11#16)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#9)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#8)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#5)
accompanies the##4##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-12#1)
accompanies these##2##2##(2008-1#1)(2008-10#1)
accompanies##19##1##(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1993-6#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2012-12#1)
accompaniment##2##1##(2008-4#1)(2010-3#1)
accompany the##9##2##(1992-12#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#1)
accompany this##2##2##(1997-1#1)(2009-5#1)
accompany##34##1##(1990-3#1)(1990-9#1)(1992-11#1)(1992-12#1)(1994-5#1)(1994-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
accompanying paper##7##2##(1990-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-3#2)(2008-4#1)
accompanying the##6##2##(1990-11#1)(1992-12#1)(1994-9#1)(1997-3#1)(2008-10#2)
accompanying##76##1##(1990-11#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#4)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-7#1)(2013-8#1)
accomplish that##2##2##(1992-8#1)(1997-7#1)
accomplish the##8##2##(1995-12#1)(2008-10#3)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#1)
accomplish this##17##2##(1992-12#1)(1992-3#2)(1994-2#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
accomplish##48##1##(1991-1#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#2)(2013-1#3)
accomplished at##2##2##(2008-10#1)(2008-12#1)
accomplished by a##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)
accomplished by means of##2##4##(2008-10#1)(2008-2#1)
accomplished by two##2##3##(1994-8#1)(2009-8#1)
accomplished by use of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
accomplished by using##6##3##(2007-12#1)(2008-10#5)
accomplished by##78##2##(1990-9#1)(1993-3#2)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-3#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
accomplished during the##2##3##(2008-11#1)(2013-1#1)
accomplished in a##3##3##(2008-2#2)(2008-3#1)
accomplished in less than##3##4##(2008-10#3)
accomplished in the##4##3##(2006-10#1)(2008-12#1)(2010-4#1)(2011-2#1)
accomplished in##18##2##(2006-10#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2010-4#1)(2011-2#1)(2012-3#1)
accomplished on##2##2##(2006-10#1)(2008-10#1)
accomplished over a##2##3##(1995-3#2)
accomplished the##2##2##(1997-3#1)(2013-1#1)
accomplished through an##2##3##(1994-5#1)(2008-2#1)
accomplished through##5##2##(1994-5#1)(1996-2#1)(2008-2#1)(2008-3#1)(2012-3#1)
accomplished using a##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
accomplished using##17##2##(1993-2#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#1)
accomplished via##2##2##(1993-3#1)(2008-10#1)
accomplished with a##9##3##(1990-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-6#1)
accomplished with low##2##3##(1995-1#1)(2008-10#1)
accomplished with the##2##3##(2008-10#1)(2008-11#1)
accomplished with##25##2##(1990-8#1)(1992-2#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
accomplished##194##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-8#2)(1995-1#1)(1995-3#4)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-8#1)(1997-3#2)(1997-6#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#57)(2008-11#9)(2008-12#3)(2008-2#10)(2008-3#12)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-4#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
accomplishing the##3##2##(1996-1#1)(2008-3#1)(2012-3#1)
accomplishing this##3##2##(1991-3#1)(2008-9#2)
accomplishing##10##1##(1991-3#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2011-2#1)(2012-3#1)
accomplishment of##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)
accomplishment##5##1##(2008-10#2)(2008-9#1)(2009-5#1)(2013-1#1)
accomplishments and##6##2##(1995-12#1)(1997-2#1)(2008-4#4)
accomplishments of##2##2##(1995-12#1)(2013-1#1)
accomplishments##14##1##(1991-1#1)(1994-1#1)(1995-12#2)(1997-2#2)(2007-12#1)(2008-4#4)(2013-1#3)
accord with this##2##3##(2008-7#1)(2010-5#1)
accord with##24##2##(1990-7#1)(1991-6#1)(1991-9#4)(1992-6#2)(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-5#1)(2010-5#1)
accord##27##1##(1990-7#1)(1991-6#1)(1991-9#4)(1992-6#2)(1993-3#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#3)(2009-5#1)(2010-5#1)(2012-2#1)
accordance to the##3##3##(2007-7#1)(2008-11#1)(2013-1#1)
accordance to##6##2##(2007-7#1)(2007-8#2)(2008-11#1)(2012-3#1)(2013-1#1)
accordance with current##2##3##(2008-3#1)(2012-12#1)
accordance with the##41##3##(1993-6#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
accordance with this##2##3##(1995-6#1)(2008-6#1)
accordance with those##2##3##(2008-10#1)(2008-3#1)
accordance with##86##2##(1990-3#2)(1990-5#1)(1993-6#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-6#4)(1996-11#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
accordance##94##1##(1990-3#2)(1990-5#1)(1993-6#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-6#4)(1996-11#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
accorded##4##1##(1994-9#1)(1995-1#1)(2009-12#1)(2013-8#1)
according the results of##2##4##(2010-8#1)(2011-1#1)
according the##3##2##(1991-3#1)(2010-8#1)(2011-1#1)
according to CD127##2##3##(2013-1#2)
according to Clayton##2##3##(2008-10#2)
according to DSM-IV criteria##2##4##(2008-1#1)(2008-7#1)
according to DSM-IV##3##3##(1997-8#1)(2008-1#1)(2008-7#1)
according to Graf##3##3##(2007-11#3)
according to WHO##2##3##(2007-8#1)(2011-2#1)
according to a protocol##2##4##(1993-11#1)(2012-12#1)
according to a split-mouth design##2##5##(2013-1#2)
according to a standardized##2##4##(1990-12#1)(2008-10#1)
according to a##58##3##(1990-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-6#1)(2007-8#12)(2008-1#2)(2008-10#9)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)
according to age##12##3##(1991-9#1)(1992-12#1)(1993-12#1)(1994-9#1)(1996-7#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2013-1#1)
according to an established##2##4##(2008-10#2)
according to an##6##3##(1990-3#1)(2008-10#4)(2013-1#1)
according to approved##2##3##(1993-3#1)(2009-6#1)
according to clinical##2##3##(2008-5#1)(2013-1#1)
according to current##2##3##(1994-9#1)(2009-8#1)
according to demographic context##2##4##(1997-5#1)(1997-6#1)
according to demographic##3##3##(1997-5#1)(1997-6#1)(2009-5#1)
according to different##5##3##(1994-5#1)(2007-11#2)(2009-7#1)(2013-1#1)
according to disease severity##4##4##(2008-7#1)(2009-2#3)
according to disease##5##3##(1994-9#1)(2008-7#1)(2009-2#3)
according to each##2##3##(2010-3#1)(2010-8#1)
according to etiology##2##3##(1992-6#1)(2013-8#1)
according to four##2##3##(2009-1#1)(2013-8#1)
according to gender and##2##4##(2011-1#2)
according to genotype##2##3##(2008-10#1)(2008-8#1)
according to geographic##2##3##(2008-10#1)(2012-12#1)
according to growth##2##3##(2008-7#1)(2008-9#1)
according to guidelines##2##3##(1996-11#1)(2008-8#1)
according to histological##2##3##(2008-7#1)(2010-3#1)
according to indicators of##2##4##(1994-2#1)(2013-1#1)
according to internal##2##3##(2008-11#2)
according to international##2##3##(2011-2#1)(2013-1#1)
according to its##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2013-7#1)
according to literature##2##3##(1991-6#1)(2013-1#1)
according to one##2##3##(1992-5#1)(2008-9#1)
according to our##5##3##(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-7#1)
according to predefined criteria##2##4##(2008-10#1)(2009-11#1)
according to reaction##2##3##(1992-6#1)(1996-5#1)
according to risk factors##2##4##(2010-8#1)(2012-2#1)
according to risk##3##3##(2010-8#2)(2012-2#1)
according to sex##2##3##(2010-5#2)
according to some##2##3##(1992-2#1)(2010-8#1)
according to species##2##3##(1991-3#1)(2008-8#1)
according to specific##5##3##(2008-10#1)(2008-11#1)(2011-2#1)(2011-7#1)(2013-1#1)
according to standard##5##3##(1990-12#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-11#1)
according to the &quot##2##4##(1991-8#1)(2008-5#1)
according to the DSM-IV##2##4##(2007-10#1)(2008-11#1)
according to the International##4##4##(1994-9#1)(2007-5#1)(2008-10#1)(2012-3#1)
according to the National Cancer Institute Common Toxicity Criteria##2##9##(2008-8#1)(2011-2#1)
according to the National##3##4##(2008-8#1)(2010-12#1)(2011-2#1)
according to the New##2##4##(1990-6#1)(2012-1#1)
according to the WHO##2##4##(1990-12#1)(2008-10#1)
according to the World Health Organization (WHO)##3##7##(2008-12#1)(2008-3#1)(2009-8#1)
according to the World Health##4##5##(2008-12#1)(2008-3#1)(2009-8#1)(2010-5#1)
according to the age##2##4##(2008-10#1)(2012-3#1)
according to the amount of##2##5##(2008-10#1)(2008-5#1)
according to the amount##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
according to the body mass index##2##6##(2008-9#1)(2011-1#1)
according to the chemical##2##4##(1991-6#1)(2008-10#1)
according to the classification##2##4##(1990-3#1)(2011-2#1)
according to the compound##2##4##(2008-10#2)
according to the corresponding##2##4##(2008-10#1)(2008-3#1)
according to the criteria##5##4##(1991-11#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
according to the current##2##4##(1990-8#1)(2013-1#1)
according to the definition##2##4##(1992-11#1)(2008-3#1)
according to the degree of##3##5##(1997-1#1)(2008-1#1)(2008-10#1)
according to the detection##3##4##(2008-10#2)(2008-3#1)
according to the different##3##4##(2008-7#1)(2009-10#1)(2012-12#1)
according to the equation##2##4##(2008-10#2)
according to the extent of##2##5##(2008-10#2)
according to the guidelines##2##4##(1991-4#1)(2007-8#1)
according to the health##2##4##(1994-5#2)
according to the latest##2##4##(1991-6#1)(1997-8#1)
according to the level of##3##5##(1996-7#1)(2008-10#1)(2010-5#1)
according to the levels##2##4##(2008-10#1)(2010-8#1)
according to the linear##2##4##(2008-10#1)(2013-7#1)
according to the literature##2##4##(1997-4#1)(2008-9#1)
according to the location of##2##5##(2007-8#1)(2008-7#1)
according to the location##4##4##(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
according to the manufacturer's instructions and##2##6##(2008-12#1)(2009-7#1)
according to the manufacturer's instructions##3##5##(1994-1#1)(2008-12#1)(2009-7#1)
according to the metal##2##4##(2008-10#2)
according to the method of##4##5##(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)
according to the method used##2##5##(2008-10#1)(2013-1#1)
according to the method##6##4##(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2013-1#1)
according to the modified##2##4##(1990-8#1)(2010-10#1)
according to the most##4##4##(1997-3#1)(2006-10#1)(2008-4#1)(2010-8#1)
according to the nature of##3##5##(2008-4#1)(2008-5#1)(2013-1#1)
according to the needs of##2##5##(2007-12#1)(2007-8#1)
according to the patient's##3##4##(1992-12#1)(2008-3#1)(2010-8#1)
according to the presence##2##4##(2008-7#1)(2010-6#1)
according to the principles of##2##5##(1992-6#1)(1994-2#1)
according to the proposed##2##4##(2008-10#1)(2008-2#1)
according to the recommendations of the##2##6##(2009-11#1)(2012-3#1)
according to the results##4##4##(1990-6#2)(2008-7#1)(2011-2#1)
according to the same##2##4##(1992-11#1)(1997-2#1)
according to the sandbar opening and closing?##2##7##(2013-7#2)
according to the schedule##2##4##(1991-6#1)(2013-1#1)
according to the sensitivity##2##4##(1995-11#1)(2008-10#1)
according to the severity of##2##5##(2007-6#1)(2008-6#1)
according to the severity##4##4##(1990-12#1)(2007-6#1)(2008-6#1)(2013-1#1)
according to the size of the##2##6##(2008-10#1)(2011-2#1)
according to the target##2##4##(2008-10#1)(2011-1#1)
according to the theory of##2##5##(2008-10#1)(2013-7#1)
according to the type of##7##5##(1993-11#1)(1993-2#1)(1993-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
according to the##372##3##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#5)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#5)(1991-8#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#4)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#10)(2008-1#7)(2008-10#81)(2008-11#6)(2008-12#6)(2008-2#5)(2008-3#15)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#11)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#3)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#6)(2010-6#1)(2010-8#5)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#11)(2013-1#17)(2013-7#4)(2013-8#10)
according to their age##3##4##(1990-8#1)(1994-3#1)(2011-2#1)
according to their isoelectric##2##4##(2008-12#1)(2008-4#1)
according to their metal content##2##5##(2008-10#2)
according to their mineral content##4##5##(2008-10#4)
according to their##71##3##(1990-8#1)(1990-9#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-3#1)(1997-2#1)(2007-11#1)(2008-10#22)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
according to this##6##3##(1991-12#1)(1991-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2012-1#1)
according to time##4##3##(1992-11#1)(2006-8#1)(2008-5#2)
according to traditional##2##3##(2008-10#1)(2013-8#1)
according to treatment##2##3##(2010-12#1)(2011-2#1)
according to tumour##2##3##(1997-4#1)(2008-6#1)
according to type of##2##4##(2010-6#1)(2011-2#1)
according to type##3##3##(1997-3#1)(2010-6#1)(2011-2#1)
according to various##2##3##(2008-7#1)(2013-1#1)
according to whether##5##3##(1990-6#1)(1996-12#1)(2007-12#1)(2013-1#2)
according to which the##6##4##(1993-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
according to which##10##3##(1990-2#1)(1991-12#1)(1993-11#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
according to##881##2##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#7)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#12)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#2)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#1)(1994-9#8)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#4)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#9)(2006-10#2)(2006-8#3)(2007-10#3)(2007-11#20)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#28)(2008-1#14)(2008-10#168)(2008-11#18)(2008-12#17)(2008-2#13)(2008-3#26)(2008-4#14)(2008-5#39)(2008-6#11)(2008-7#31)(2008-8#13)(2008-9#14)(2009-1#2)(2009-10#2)(2009-11#5)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#9)(2010-6#4)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#8)(2011-2#54)(2011-3#2)(2011-7#2)(2012-1#3)(2012-12#9)(2012-2#9)(2012-3#19)(2013-1#44)(2013-7#9)(2013-8#21)
according with the##2##3##(2008-10#2)
according with##4##2##(1993-2#1)(2008-10#2)(2008-9#1)
according##892##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#7)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#12)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#2)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#1)(1994-9#8)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#4)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#9)(2006-10#2)(2006-8#3)(2007-10#3)(2007-11#20)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#28)(2008-1#14)(2008-10#170)(2008-11#18)(2008-12#17)(2008-2#13)(2008-3#26)(2008-4#14)(2008-5#39)(2008-6#11)(2008-7#31)(2008-8#13)(2008-9#15)(2009-1#2)(2009-10#2)(2009-11#5)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#9)(2010-6#4)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#10)(2011-2#54)(2011-3#2)(2011-7#2)(2012-1#3)(2012-12#9)(2012-2#9)(2012-3#19)(2013-1#47)(2013-7#9)(2013-8#21)
accordingly##36##1##(1991-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#3)(2009-8#2)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
account all##5##2##(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
account and##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
account balance##3##2##(2011-2#3)
account balances##3##2##(2011-2#3)
account can##3##2##(2007-12#1)(2009-10#1)(2012-2#1)
account during##3##2##(2007-7#1)(2008-8#1)(2011-2#1)
account for a significant proportion of##2##6##(1993-3#1)(2010-12#1)
account for a##10##3##(1993-3#1)(1994-9#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
account for about##3##3##(1993-3#1)(1997-6#1)(2008-10#1)
account for all cases##2##4##(2008-11#1)(2008-7#1)
account for any##2##3##(2008-3#1)(2008-9#1)
account for approximately 80 percent of##2##6##(1992-12#1)(2009-9#1)
account for approximately##5##3##(1992-12#1)(2008-12#1)(2008-7#1)(2009-9#1)(2011-2#1)
account for as much as##2##5##(2008-7#2)
account for differences in##3##4##(1991-3#1)(2008-11#1)(2012-2#1)
account for differences##4##3##(1991-3#1)(2007-12#1)(2008-11#1)(2012-2#1)
account for its##2##3##(1994-12#1)(2013-1#1)
account for less than##2##4##(1990-6#1)(2013-7#1)
account for more than##3##4##(1991-12#1)(1994-6#1)(1995-1#1)
account for most##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
account for much of the##3##5##(1993-11#1)(1995-1#1)(2008-11#1)
account for multiple light scattering in##2##6##(2008-3#2)
account for multiple##3##3##(2008-3#3)
account for only##3##3##(1997-5#1)(2008-11#1)(2012-3#1)
account for some of the##3##5##(2007-3#1)(2008-8#1)(2012-12#1)
account for some of these##2##5##(2008-3#1)(2008-4#1)
account for some of##6##4##(1991-12#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
account for the age-related##2##4##(1994-5#1)(2008-7#1)
account for the effects of##3##5##(2008-10#2)(2008-3#1)
account for the influence of##2##5##(2008-10#1)(2011-2#1)
account for the majority of##4##5##(1996-3#1)(2008-7#1)(2009-11#1)(2010-6#1)
account for the reduced##2##4##(1991-11#1)(1996-12#1)
account for the##96##3##(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-12#2)(1996-3#2)(1996-5#2)(1997-4#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-9#2)(2010-1#1)(2010-3#3)(2010-4#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
account for their##3##3##(1992-12#1)(2010-11#1)(2012-12#1)
account for these##3##3##(1991-11#1)(2007-12#1)(2008-5#1)
account for this##4##3##(1992-2#1)(1997-3#1)(2008-8#1)(2012-12#1)
account for trends in##2##4##(1992-9#1)(1996-3#1)
account for##235##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#4)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-9#4)(1993-11#3)(1993-12#2)(1993-3#3)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#3)(2008-10#27)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#20)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
account in the##11##3##(1990-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)
account in##24##2##(1990-6#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#3)(2008-10#5)(2008-2#5)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#2)
account is given of the##2##5##(1997-7#1)(2007-2#1)
account is given of##3##4##(1997-7#1)(2007-2#1)(2008-3#1)
account is##5##2##(1994-3#1)(1997-7#1)(2007-2#1)(2008-3#1)(2013-8#1)
account of a##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
account of its##2##3##(1990-5#1)(1997-4#1)
account of the existing detection protocols for##2##7##(2008-10#2)
account of the##36##3##(1990-3#1)(1990-8#1)(1992-2#1)(1992-5#1)(1993-3#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
account of this##2##3##(2008-5#1)(2011-2#1)
account of##67##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-9#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
account that##2##2##(2008-10#1)(2012-2#1)
account the influence of##2##4##(2008-2#1)(2009-10#1)
account the##85##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-5#2)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#4)(2007-12#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)
account well for##2##3##(2007-12#1)(2008-3#1)
account##614##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#2)(1992-9#6)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(2006-10#1)(2007-11#11)(2007-12#23)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#80)(2008-11#27)(2008-12#6)(2008-2#35)(2008-3#65)(2008-4#6)(2008-5#11)(2008-6#8)(2008-7#23)(2008-8#18)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#3)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#5)(2010-4#3)(2010-6#4)(2010-7#1)(2011-1#6)(2011-2#33)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#5)(2013-8#8)
accountability agreements##2##2##(2011-2#2)
accountability and##6##2##(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(2009-6#1)
accountability for health##3##3##(1996-2#3)
accountability for the##2##3##(1997-3#1)(2008-12#1)
accountability for##14##2##(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#2)(2008-12#1)(2008-6#1)(2008-7#2)
accountability in##2##2##(1995-2#1)(2011-2#1)
accountability systems##2##2##(1996-12#1)(2012-2#1)
accountability##57##1##(1992-1#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#3)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#1)(1997-2#1)(1997-3#3)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-8#1)
accountable health##2##2##(1994-12#1)(1996-1#1)
accountable##8##1##(1993-12#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#2)
accountants##4##1##(1993-1#1)(1994-1#2)(2012-12#1)
accounted by the##2##3##(1997-2#1)(2008-11#1)
accounted for 24##2##3##(2008-10#1)(2010-11#1)
accounted for 4##2##3##(1991-6#1)(2007-7#1)
accounted for 45%##2##3##(1991-6#1)(2009-2#1)
accounted for 85% of##2##4##(1990-8#1)(2008-10#1)
accounted for a large proportion of##2##6##(1997-6#1)(2008-10#1)
accounted for a significant##2##4##(2008-9#1)(2009-9#1)
accounted for a##7##3##(1997-6#1)(2008-10#4)(2008-9#1)(2009-9#1)
accounted for all##2##3##(1991-12#1)(2008-10#1)
accounted for an additional##4##4##(1996-1#1)(2010-10#1)(2010-5#1)(2011-2#1)
accounted for an##6##3##(1991-2#1)(1996-1#1)(2008-12#1)(2010-10#1)(2010-5#1)(2011-2#1)
accounted for approximately##2##3##(1994-2#1)(2008-4#1)
accounted for by electrode discrimination ability##2##6##(2008-9#2)
accounted for by the##5##4##(1992-11#1)(1995-6#1)(2007-7#1)(2008-2#1)(2012-1#1)
accounted for by##28##3##(1990-10#1)(1990-11#1)(1990-5#1)(1992-11#1)(1992-6#3)(1994-3#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-1#2)
accounted for greater than##2##4##(1990-5#1)(1994-8#1)
accounted for in the##3##4##(2008-3#2)(2009-5#1)
accounted for in##9##3##(1990-8#2)(1995-5#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-11#1)(2010-6#1)
accounted for less than##4##4##(1993-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
accounted for more than 70% of the##2##7##(2008-10#1)(2008-8#1)
accounted for more than##3##4##(2008-10#2)(2008-8#1)
accounted for only##4##3##(1992-5#1)(1997-7#1)(2008-2#1)(2010-5#1)
accounted for over##2##3##(1994-3#1)(1997-2#1)
accounted for the highest##2##4##(2008-6#1)(2013-8#1)
accounted for the largest proportion##2##5##(2008-10#1)(2010-8#1)
accounted for the largest##3##4##(2008-10#2)(2010-8#1)
accounted for the##15##3##(1993-3#1)(2007-10#1)(2007-6#1)(2008-10#6)(2008-2#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
accounted for up to##2##4##(2008-10#1)(2008-2#1)
accounted for using##2##3##(2008-10#2)
accounted for##162##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#34)(2008-11#1)(2008-12#6)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#5)
accounted##166##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#34)(2008-11#2)(2008-12#6)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#4)(2008-9#3)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#5)
accounting for 15##2##3##(1996-6#1)(2012-1#1)
accounting for 17##2##3##(1997-2#1)(2011-1#1)
accounting for 98##2##3##(2008-10#2)
accounting for a##2##3##(1995-1#1)(2007-4#1)
accounting for about 50%##2##4##(2008-11#1)(2008-8#1)
accounting for all##2##3##(1996-5#1)(2012-12#1)
accounting for approximately 20% of##2##5##(1995-6#1)(2013-1#1)
accounting for approximately##6##3##(1995-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
accounting for less than##2##4##(2007-5#1)(2009-3#1)
accounting for more than##2##4##(2008-10#1)(2011-2#1)
accounting for over##2##3##(2008-1#1)(2012-2#1)
accounting for the free energy contribution from solvent relaxation##2##9##(2013-1#2)
accounting for the##20##3##(1992-5#1)(1993-6#1)(1996-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
accounting for##92##2##(1991-11#1)(1991-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
accounting is##3##2##(2007-4#2)(2008-11#1)
accounting on##2##2##(1993-2#1)(2008-11#1)
accounting rules##2##2##(1992-3#1)(1997-3#1)
accounting##113##1##(1991-11#1)(1991-2#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#4)(1993-6#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#6)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
accounts for 0##2##3##(1991-6#2)
accounts for 60% of##2##4##(1992-6#1)(2011-2#1)
accounts for 80% of##2##4##(2012-3#1)(2013-1#1)
accounts for 90% of##2##4##(1991-3#1)(2008-12#1)
accounts for a small portion of##2##6##(2008-4#1)(2010-3#1)
accounts for a wide##2##4##(1997-2#1)(2013-8#1)
accounts for a##6##3##(1992-12#1)(1993-3#1)(1997-2#1)(2008-4#1)(2010-3#1)(2013-8#1)
accounts for about##5##3##(2008-10#1)(2008-9#1)(2011-2#1)(2012-1#2)
accounts for an##2##3##(2007-7#1)(2008-2#1)
accounts for approximately##7##3##(2008-1#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
accounts for both##2##3##(2008-3#1)(2008-7#1)
accounts for most of the##2##5##(1994-12#1)(2007-12#1)
accounts for most##3##3##(1994-12#1)(2006-10#1)(2007-12#1)
accounts for only##5##3##(1995-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
accounts for the invariant and dominant property##2##7##(2012-2#2)
accounts for the##33##3##(1990-8#1)(1991-8#1)(1992-10#2)(1992-12#1)(1993-6#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-5#1)(2012-2#3)(2012-3#1)(2013-8#1)
accounts for up to##2##4##(1991-11#1)(2008-1#1)
accounts for##123##2##(1990-8#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-12#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-2#2)(2006-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#3)(2009-5#1)(2009-8#3)(2009-9#2)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#6)
accounts have##2##2##(2008-8#1)(2011-2#1)
accounts of the##2##3##(1991-8#1)(2008-7#1)
accounts of##16##2##(1991-8#1)(1992-3#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-5#2)(2010-2#1)(2010-3#2)(2011-1#1)(2012-12#1)(2013-8#1)
accounts receivable##4##2##(1993-1#1)(1994-2#1)(1996-3#1)(2007-9#1)
accounts##173##1##(1990-8#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-2#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#9)(2008-3#11)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-12#3)(2009-5#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-5#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#7)
accreditation as an##2##3##(1992-1#1)(1995-3#1)
accreditation as##4##2##(1992-1#1)(1995-3#2)(2010-9#1)
accreditation bodies##2##2##(1996-12#1)(1997-3#1)
accreditation in the##3##3##(1995-3#1)(1996-12#2)
accreditation in##4##2##(1995-3#2)(1996-12#2)
accreditation models##2##2##(1993-1#2)
accreditation process##4##2##(1996-12#2)(1997-1#1)(2007-4#1)
accreditation surveys and##2##3##(1993-12#1)(1995-2#1)
accreditation##41##1##(1992-1#2)(1993-1#2)(1993-12#1)(1993-2#3)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#6)(1996-12#10)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-1#1)(2012-2#2)
accredited by the##2##3##(1996-7#1)(1997-3#1)
accredited schools of public health##2##5##(1997-3#2)
accredited##14##1##(1994-12#2)(1996-7#1)(1997-3#3)(2008-11#3)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
accrediting agencies##2##2##(1995-3#1)(2011-2#1)
accrediting local##2##2##(1997-2#2)
accrediting##7##1##(1994-12#1)(1995-3#2)(1997-2#2)(2006-5#1)(2011-2#1)
accretion##2##1##(2007-5#1)(2012-2#1)
accretive##2##1##(2008-5#2)
accrual of##2##2##(2008-9#1)(2011-2#1)
accrual performance##2##2##(1992-12#2)
accrual to##5##2##(1992-12#2)(1995-2#1)(2008-11#1)(2010-10#1)
accrual##15##1##(1992-12#5)(1995-2#1)(2008-11#1)(2008-9#1)(2010-10#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
accrue##6##1##(1992-12#1)(1994-2#2)(1995-1#1)(2010-3#1)(2011-2#1)
accrued##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
accruing##3##1##(1995-2#1)(2010-3#1)(2010-8#1)
acculturation and##3##2##(2007-12#1)(2009-7#2)
acculturation in##2##2##(2008-1#1)(2012-2#1)
acculturation level##3##2##(2007-12#3)
acculturation strategies##2##2##(2010-8#2)
acculturation##25##1##(2007-12#5)(2008-1#1)(2008-4#1)(2008-8#4)(2009-5#1)(2009-7#6)(2010-8#2)(2012-2#5)
accumbens (NAc)##2##2##(2008-7#1)(2009-8#1)
accumbens and##10##2##(1993-12#2)(1993-5#1)(1993-6#3)(1994-2#1)(1997-7#1)(2007-8#1)(2008-7#1)
accumbens was##3##2##(1991-2#1)(1991-5#1)(1993-6#1)
accumbens##81##1##(1991-1#1)(1991-2#6)(1991-5#4)(1993-12#7)(1993-5#1)(1993-6#18)(1994-2#4)(1994-3#2)(1994-8#7)(1995-12#1)(1995-2#2)(1995-5#2)(1996-12#2)(1996-5#2)(1997-2#2)(1997-3#3)(1997-7#6)(2007-8#2)(2008-4#2)(2008-6#2)(2008-7#4)(2009-8#1)
accumulate and##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
accumulate in the##15##3##(1990-2#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
accumulate in##26##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1994-5#1)(1994-8#1)(1997-6#1)(2008-10#4)(2008-11#5)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
accumulate##79##1##(1990-2#2)(1990-5#1)(1991-12#2)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-3#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
accumulated after##3##2##(2008-10#3)
accumulated and the##3##3##(2008-10#3)
accumulated and##5##2##(1995-2#1)(2008-10#3)(2012-2#1)
accumulated at a##2##3##(2008-10#2)
accumulated at##7##2##(2008-10#7)
accumulated by##7##2##(1990-5#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#1)
accumulated during the##5##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
accumulated during##8##2##(1991-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2011-2#1)
accumulated evidence##4##2##(1994-6#1)(1995-5#1)(2008-6#1)(2013-8#1)
accumulated from##2##2##(2008-10#1)(2008-12#1)
accumulated high levels of phytoene##2##5##(1995-2#2)
accumulated high levels of##3##4##(1995-2#3)
accumulated in a##3##3##(1995-8#1)(2007-11#1)(2008-10#1)
accumulated in the##12##3##(1990-12#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2012-8#1)
accumulated in##38##2##(1990-12#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)
accumulated more##6##2##(2008-10#4)(2008-12#1)(2010-4#1)
accumulated on a##2##3##(2008-10#2)
accumulated on the##4##3##(1991-11#1)(1994-5#1)(2008-10#2)
accumulated on##7##2##(1991-11#1)(1994-5#1)(2008-10#4)(2008-2#1)
accumulated over the##2##3##(2008-2#1)(2008-9#1)
accumulated over##4##2##(1994-3#1)(2007-12#1)(2008-2#1)(2008-9#1)
accumulated protein##2##2##(2008-3#1)(2008-7#1)
accumulated rainfall##2##2##(2008-10#2)
accumulated that##2##2##(2008-1#1)(2009-8#1)
accumulated the##3##2##(1992-3#1)(1993-6#1)(2008-10#1)
accumulated to a##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
accumulated to##7##2##(1992-3#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#1)
accumulated##218##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-7#1)(1991-9#2)(1992-12#5)(1992-3#4)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#2)(1994-3#4)(1994-5#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1997-1#4)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#69)(2008-11#7)(2008-12#5)(2008-2#4)(2008-3#3)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#5)(2013-8#2)
accumulates as##2##2##(1993-9#1)(2008-10#1)
accumulates in the##8##3##(1992-12#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-3#1)(2008-5#1)
accumulates in##11##2##(1992-12#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)
accumulates##30##1##(1992-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-3#3)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2013-8#1)
accumulating and##2##2##(2008-7#1)(2012-3#1)
accumulating evidence##5##2##(1994-12#1)(2008-1#1)(2008-7#1)(2009-8#1)(2012-12#1)
accumulating in the##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
accumulating in##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-1#1)
accumulating##35##1##(1992-3#1)(1994-12#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)
accumulation after##2##2##(2008-10#2)
accumulation and antagonistic##2##3##(2008-12#1)(2008-9#1)
accumulation and release of##2##4##(1991-9#1)(1997-2#1)
accumulation and voltammetric##2##3##(2008-10#2)
accumulation and##49##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2012-1#1)(2013-8#1)
accumulation are##2##2##(1994-12#1)(2008-7#1)
accumulation at +0##2##3##(2008-10#2)
accumulation at the##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
accumulation at##12##2##(1992-3#2)(1997-1#1)(2008-10#6)(2008-3#1)(2008-9#1)(2011-2#1)
accumulation by the##2##3##(1995-12#1)(2008-6#1)
accumulation by##10##2##(1990-2#2)(1992-6#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
accumulation can##3##2##(1992-12#1)(1996-12#1)(2008-10#1)
accumulation during the early##2##4##(2008-10#2)
accumulation during##8##2##(2008-10#6)(2008-7#1)(2011-2#1)
accumulation in a##4##3##(2008-10#3)(2008-9#1)
accumulation in grain and##2##4##(2008-10#2)
accumulation in grain##5##3##(2008-10#5)
accumulation in harvested##2##3##(2008-10#2)
accumulation in rabbit##2##3##(1995-12#1)(2008-10#1)
accumulation in response to##2##4##(1993-3#1)(1995-8#1)
accumulation in skeletal muscle##2##4##(2008-1#2)
accumulation in the liver##2##4##(1996-12#1)(2008-10#1)
accumulation in the##16##3##(1992-11#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-12#1)(2012-3#1)(2012-7#1)(2013-8#1)
accumulation in##88##2##(1990-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-9#2)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1997-1#1)(2008-1#3)(2008-10#36)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#3)(2010-5#1)(2011-2#2)(2012-2#3)(2012-3#1)(2012-4#1)(2012-7#1)(2012-8#1)(2013-1#1)(2013-8#2)
accumulation induced by##5##3##(1991-6#2)(1994-11#1)(1997-1#1)(2008-4#1)
accumulation is a##2##3##(1994-11#1)(2008-8#1)
accumulation is the##4##3##(2008-1#1)(2008-8#1)(2011-2#1)(2012-3#1)
accumulation is##12##2##(1992-3#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
accumulation mechanism##2##2##(2008-10#1)(2008-5#1)
accumulation model##2##2##(2013-1#2)
accumulation occurred in resistant##2##4##(1994-8#1)(2008-10#1)
accumulation occurred in##3##3##(1994-8#1)(2008-10#2)
accumulation of ADP##2##3##(2008-4#2)
accumulation of Cr(3+)##2##3##(2008-10#2)
accumulation of PRms##2##3##(2008-10#2)
accumulation of a##8##3##(1994-11#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
accumulation of advanced glycation end products##2##6##(2008-1#2)
accumulation of ammonia##3##3##(2008-10#2)(2008-11#1)
accumulation of cells in##4##4##(1997-7#1)(2008-11#1)(2008-6#1)(2008-9#1)
accumulation of cells##5##3##(1995-2#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-9#1)
accumulation of copper##2##3##(2008-10#1)(2008-9#1)
accumulation of defense##2##3##(2008-10#1)(2011-2#1)
accumulation of deleterious mutations##3##4##(2008-8#1)(2010-3#1)(2013-1#1)
accumulation of genetic##2##3##(2011-2#2)
accumulation of inositol phosphates##2##4##(1990-12#1)(1993-6#1)
accumulation of inositol##4##3##(1990-12#1)(1993-6#2)(1997-1#1)
accumulation of intracellular##3##3##(1990-2#1)(2008-7#1)(2008-9#1)
accumulation of labeled IP4 or##2##5##(1997-1#2)
accumulation of labeled IP4##5##4##(1997-1#5)
accumulation of labeled inositol mono-##2##5##(1997-1#2)
accumulation of labeled##7##3##(1997-1#7)
accumulation of long chain##2##4##(1995-6#2)
accumulation of metal ions##2##4##(2008-10#2)
accumulation of molecular##2##3##(1995-6#1)(2008-7#1)
accumulation of mutations##2##3##(2008-10#1)(2008-7#1)
accumulation of oxidative damage##3##4##(2008-5#1)(2009-12#1)(2013-8#1)
accumulation of p53##3##3##(1997-7#3)
accumulation of phenolic compounds##2##4##(2008-10#2)
accumulation of reactive oxygen species (ROS)##2##6##(2008-5#1)(2009-12#1)
accumulation of repetitive##2##3##(2010-3#2)
accumulation of reverse transcriptase activity##2##5##(1994-6#2)
accumulation of some##3##3##(1997-6#1)(2010-10#1)(2012-3#1)
accumulation of substances##2##3##(2007-7#1)(2008-6#1)
accumulation of the complex##2##4##(2008-10#2)
accumulation of the##27##3##(1990-2#1)(1992-11#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
accumulation of transcripts##2##3##(1992-5#1)(2008-10#1)
accumulation of viral##2##3##(2008-10#1)(2008-9#1)
accumulation of virus##2##3##(2008-10#2)
accumulation of zinc##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
accumulation of##317##2##(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-12#4)(1991-5#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#6)(1994-12#1)(1994-5#3)(1994-6#3)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#9)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#9)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#7)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#92)(2008-11#12)(2008-12#6)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#17)(2008-8#4)(2008-9#8)(2009-10#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#11)(2013-8#5)
accumulation ofcells in##2##3##(2008-11#2)
accumulation on##3##2##(2008-10#1)(2008-7#2)
accumulation or##2##2##(2008-10#2)
accumulation period##4##2##(2008-10#4)
accumulation potential and time##2##4##(2008-10#2)
accumulation potential and##5##3##(2008-10#5)
accumulation potential of -0##7##4##(2008-10#7)
accumulation potential of##9##3##(2008-10#9)
accumulation potential##24##2##(2008-10#24)
accumulation rate##2##2##(2008-11#1)(2009-12#1)
accumulation step##2##2##(2008-10#2)
accumulation than##2##2##(2013-1#2)
accumulation time and potential##4##4##(2008-10#4)
accumulation time of 60 s##2##5##(2008-10#2)
accumulation time of##8##3##(2008-10#8)
accumulation time##33##2##(1992-3#1)(2008-10#32)
accumulation to##3##2##(1994-8#1)(1995-12#1)(2008-10#1)
accumulation under##3##2##(2008-6#1)(2008-8#2)
accumulation via##2##2##(1994-8#1)(1997-1#1)
accumulation was detected##2##3##(2008-10#2)
accumulation was found to be##2##5##(1992-8#1)(2008-7#1)
accumulation was inhibited##2##3##(1994-5#1)(1995-12#1)
accumulation was observed##2##3##(2008-10#1)(2008-8#1)
accumulation was seen##2##3##(1991-12#1)(2008-6#1)
accumulation was##31##2##(1991-12#1)(1992-8#1)(1994-5#2)(1995-12#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#2)(2012-1#1)
accumulation were##2##2##(1997-2#1)(2008-7#1)
accumulation with##2##2##(2008-10#2)
accumulation within##2##2##(1991-12#1)(2012-2#1)
accumulation##786##1##(1990-12#3)(1990-2#8)(1990-3#1)(1990-5#7)(1990-8#4)(1990-9#1)(1991-1#1)(1991-12#7)(1991-3#1)(1991-5#4)(1991-6#2)(1991-9#2)(1992-11#3)(1992-12#3)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#6)(1993-11#1)(1993-12#1)(1993-3#6)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#15)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#8)(1994-6#6)(1994-8#9)(1995-11#4)(1995-12#7)(1995-2#5)(1995-3#3)(1995-6#13)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-4#2)(1996-5#2)(1997-1#16)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#7)(1997-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#9)(2008-10#295)(2008-11#29)(2008-12#14)(2008-2#1)(2008-3#7)(2008-4#11)(2008-5#9)(2008-6#9)(2008-7#35)(2008-8#16)(2008-9#13)(2009-10#6)(2009-12#5)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#3)(2010-5#3)(2010-7#1)(2011-1#4)(2011-2#17)(2012-1#3)(2012-2#8)(2012-3#8)(2012-4#3)(2012-7#1)(2012-8#2)(2013-1#25)(2013-7#1)(2013-8#8)
accumulation)##3##1##(2008-10#2)(2008-7#1)
accumulations in##2##2##(1997-3#1)(2013-1#1)
accumulations of##6##2##(1994-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#1)
accumulations##14##1##(1992-12#2)(1994-8#1)(1995-3#1)(1997-1#1)(1997-3#2)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#2)
accumulative##6##1##(2008-12#1)(2008-3#1)(2008-7#1)(2010-1#1)(2013-1#1)(2013-8#1)
accumulator##2##1##(2009-8#2)
accuracies for the##2##3##(2008-10#1)(2008-3#1)
accuracies of 1##2##3##(2008-3#2)
accuracies of##10##2##(2008-10#3)(2008-3#5)(2012-2#1)(2013-1#1)
accuracies##22##1##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#10)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
accuracy (mean##2##2##(2008-10#1)(2011-2#1)
accuracy 82##2##2##(2010-7#2)
accuracy achieved##2##2##(2008-2#1)(2008-3#1)
accuracy and a##2##3##(2008-2#1)(2008-7#1)
accuracy and efficiency##2##3##(2008-3#1)(2008-6#1)
accuracy and precision are##4##4##(2008-10#2)(2008-3#1)(2011-1#1)
accuracy and precision data in##2##5##(1996-5#1)(2008-10#1)
accuracy and precision for the##2##5##(2008-10#1)(2011-2#1)
accuracy and precision for##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
accuracy and precision of the determination##2##6##(2008-10#2)
accuracy and precision of the method##3##6##(1990-8#1)(2008-10#2)
accuracy and precision of the##9##5##(1990-8#1)(2008-10#6)(2008-2#1)(2008-3#1)
accuracy and precision of this##2##5##(2008-10#1)(2008-2#1)
accuracy and precision of##17##4##(1990-8#1)(1991-3#1)(2008-10#12)(2008-2#2)(2008-3#1)
accuracy and precision was##2##4##(2008-10#2)
accuracy and precision were##4##4##(2008-10#2)(2011-2#1)(2011-3#1)
accuracy and precision##62##3##(1990-8#1)(1991-3#1)(1996-5#1)(2008-10#47)(2008-2#2)(2008-3#5)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)
accuracy and reduce##2##3##(1997-2#1)(2012-3#1)
accuracy and reliability of##3##4##(2008-3#2)(2012-3#1)
accuracy and repeatability##2##3##(2007-11#1)(2008-3#1)
accuracy and reproducibility##5##3##(1995-8#1)(2008-10#3)(2008-9#1)
accuracy and resolution##2##3##(2008-2#1)(2008-3#1)
accuracy and robustness##2##3##(2008-10#1)(2008-6#1)
accuracy and spatial##2##3##(2008-2#1)(2008-3#1)
accuracy and speed##2##3##(2009-12#1)(2010-8#1)
accuracy and the precision of the##2##6##(2008-10#1)(2008-3#1)
accuracy and the precision##3##4##(2008-10#2)(2008-3#1)
accuracy and the reproducibility of the##2##6##(2008-10#1)(2010-7#1)
accuracy and the##16##3##(1990-2#1)(1993-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#5)(2010-7#1)(2010-8#1)
accuracy and##145##2##(1990-2#1)(1990-8#1)(1991-3#2)(1993-12#3)(1994-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#69)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#21)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#4)
accuracy are##7##2##(2008-10#2)(2008-3#2)(2008-7#2)(2012-3#1)
accuracy as##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
accuracy at##3##2##(2007-11#1)(2008-2#1)(2012-3#1)
accuracy better than##4##3##(2008-2#1)(2008-3#3)
accuracy between##3##2##(2008-12#1)(2009-12#1)(2012-3#1)
accuracy by use of a##2##5##(2008-3#2)
accuracy by using##2##3##(2008-3#1)(2012-2#1)
accuracy by##13##2##(1993-2#1)(1995-12#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
accuracy can be obtained##2##4##(2008-10#2)
accuracy can be##3##3##(2007-11#1)(2008-10#2)
accuracy can##4##2##(2007-11#1)(2008-10#2)(2008-8#1)
accuracy compared##2##2##(2008-10#1)(2008-2#1)
accuracy depends##2##2##(2008-10#1)(2008-3#1)
accuracy for a##2##3##(2008-2#1)(2008-3#1)
accuracy for the determination of##2##5##(2008-10#2)
accuracy for the##7##3##(2007-8#1)(2008-10#4)(2008-7#1)(2012-2#1)
accuracy for##21##2##(1992-2#1)(1994-12#1)(2007-8#2)(2008-10#7)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#2)
accuracy from##4##2##(2008-10#2)(2009-8#1)(2010-8#1)
accuracy has##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)
accuracy in a given##2##4##(2008-3#1)(2012-3#1)
accuracy in a##4##3##(2008-10#1)(2008-3#2)(2012-3#1)
accuracy in determining the##2##4##(2008-3#2)
accuracy in the##12##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-9#1)(2009-10#1)
accuracy in##43##2##(1990-5#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-7#1)(1996-2#1)(1997-8#1)(2007-10#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
accuracy is described##2##3##(2007-11#1)(2008-3#1)
accuracy is improved##2##3##(2008-3#2)
accuracy is not##2##3##(2008-10#1)(2008-3#1)
accuracy is##28##2##(2007-11#1)(2008-10#2)(2008-2#6)(2008-3#12)(2008-6#2)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#2)
accuracy may##2##2##(2008-8#1)(2012-2#1)
accuracy of +/-0##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
accuracy of 0##7##3##(2008-2#3)(2008-3#4)
accuracy of 1##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
accuracy of 4%##2##3##(2008-10#1)(2008-3#1)
accuracy of 5##2##3##(2008-3#2)
accuracy of 95%##2##3##(2008-3#1)(2010-8#1)
accuracy of 97##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
accuracy of CRD for##2##4##(2008-2#2)
accuracy of MRI##2##3##(1994-2#1)(2009-11#1)
accuracy of a few##5##4##(2008-3#5)
accuracy of a##12##3##(1992-3#1)(2007-10#1)(2008-3#7)(2008-7#1)(2010-11#1)(2013-1#1)
accuracy of about##2##3##(2008-10#1)(2010-8#1)
accuracy of an##4##3##(2007-12#1)(2008-10#1)(2012-1#1)(2012-2#1)
accuracy of analysis##2##3##(2008-10#2)
accuracy of approximately##5##3##(2008-2#2)(2008-3#3)
accuracy of better than 0##2##5##(1992-7#1)(2008-10#1)
accuracy of better than 1##2##5##(2008-2#2)
accuracy of better than 1%##2##5##(2008-3#2)
accuracy of better than##10##4##(1992-7#1)(2008-10#1)(2008-2#4)(2008-3#4)
accuracy of both##3##3##(2008-10#1)(2008-3#2)
accuracy of diagnosis##2##3##(2008-6#1)(2008-7#1)
accuracy of the FDTD##2##4##(2008-3#2)
accuracy of the analysis##3##4##(2008-10#2)(2012-2#1)
accuracy of the analytical##2##4##(2008-10#2)
accuracy of the determination of##2##5##(2008-10#2)
accuracy of the determinations##2##4##(2008-10#2)
accuracy of the developed method##8##5##(2008-10#8)
accuracy of the developed##16##4##(2008-10#16)
accuracy of the interferometer##3##4##(2008-3#3)
accuracy of the method is##4##5##(2008-10#2)(2008-3#2)
accuracy of the method was##12##5##(2008-10#11)(2008-5#1)
accuracy of the method##23##4##(2008-10#20)(2008-3#2)(2008-5#1)
accuracy of the methods##3##4##(2008-10#3)
accuracy of the order of##3##5##(2008-3#3)
accuracy of the procedure was##2##5##(2008-10#2)
accuracy of the procedure##4##4##(2008-10#2)(2008-3#1)(2010-5#1)
accuracy of the proposed method##10##5##(2008-10#10)
accuracy of the proposed procedure was##2##6##(2008-10#2)
accuracy of the proposed procedure##3##5##(2008-10#3)
accuracy of the proposed##15##4##(2008-10#15)
accuracy of the results##4##4##(2008-10#3)(2008-3#1)
accuracy of the retrieval##2##4##(2008-2#1)(2008-3#1)
accuracy of the retrieved##4##4##(2008-2#1)(2008-3#3)
accuracy of the system##2##4##(2008-6#1)(2008-9#1)
accuracy of the technique by##2##5##(2007-12#1)(2008-3#1)
accuracy of the technique##10##4##(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2010-12#1)
accuracy of the two##2##4##(2008-10#1)(2012-2#1)
accuracy of the##200##3##(1991-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-5#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-2#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-10#87)(2008-11#1)(2008-12#1)(2008-2#17)(2008-3#48)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-8#2)
accuracy of these##3##3##(2008-12#1)(2008-3#2)
accuracy of this method##2##4##(1990-12#1)(2008-2#1)
accuracy of this##11##3##(1990-12#1)(1994-8#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2013-1#2)(2013-8#1)
accuracy of##457##2##(1990-12#1)(1990-9#3)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-2#3)(1994-3#4)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#3)(2007-11#8)(2007-12#8)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#124)(2008-11#5)(2008-12#3)(2008-2#40)(2008-3#113)(2008-4#2)(2008-5#4)(2008-6#9)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#3)(2012-1#5)(2012-12#5)(2012-2#11)(2012-3#1)(2012-7#1)(2013-1#9)(2013-8#12)
accuracy on##2##2##(1993-3#1)(2008-10#1)
accuracy only improved in the moderate category##2##7##(2013-1#2)
accuracy or##4##2##(2008-11#2)(2008-3#1)(2008-8#1)
accuracy over the##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)
accuracy over##6##2##(2008-10#2)(2008-3#2)(2008-6#1)(2010-8#1)
accuracy profiles##2##2##(2008-10#2)
accuracy required##2##2##(2008-2#1)(2008-3#1)
accuracy study##2##2##(2008-12#1)(2013-8#1)
accuracy than conventional##2##3##(2008-10#2)
accuracy than the##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
accuracy than those##2##3##(2008-10#1)(2013-8#1)
accuracy than##9##2##(1992-11#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
accuracy that is##4##3##(2008-2#2)(2008-3#1)(2008-9#1)
accuracy that##7##2##(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)
accuracy the##4##2##(2008-10#1)(2008-7#1)(2010-3#1)(2012-2#1)
accuracy to##9##2##(1990-9#1)(1992-11#2)(1996-1#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-2#1)
accuracy using##2##2##(2008-10#2)
accuracy was accessed by##2##4##(2008-10#1)(2008-7#1)
accuracy was assessed by##2##4##(2008-10#2)
accuracy was assessed through recovery##5##5##(2008-10#5)
accuracy was assessed##8##3##(2008-10#8)
accuracy was evaluated by##2##4##(2008-10#2)
accuracy was evaluated##3##3##(2008-10#3)
accuracy was observed##2##3##(2008-10#1)(2013-8#1)
accuracy was studied##2##3##(2008-10#2)
accuracy was##45##2##(1990-6#1)(1992-11#1)(1997-8#1)(2008-10#29)(2008-2#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-7#1)(2013-8#2)
accuracy were##6##2##(2008-10#4)(2008-3#1)(2012-12#1)
accuracy when##5##2##(1992-3#1)(1994-2#1)(2008-2#1)(2008-3#1)(2013-8#1)
accuracy with which##4##3##(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#1)
accuracy with##10##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2009-11#1)(2011-2#1)
accuracy within##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
accuracy##1150##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-11#13)(1992-2#2)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#5)(1994-3#9)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2007-10#5)(2007-11#18)(2007-12#15)(2007-5#4)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#352)(2008-11#9)(2008-12#9)(2008-2#93)(2008-3#237)(2008-4#5)(2008-5#6)(2008-6#22)(2008-7#23)(2008-8#14)(2008-9#11)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#3)(2009-4#5)(2009-5#4)(2009-8#8)(2009-9#4)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#2)(2010-7#11)(2010-8#17)(2010-9#2)(2011-1#7)(2011-2#25)(2011-3#5)(2011-7#1)(2012-1#7)(2012-12#10)(2012-2#21)(2012-3#13)(2012-7#1)(2013-1#24)(2013-8#27)
accuracy)##2##1##(2008-10#1)(2009-2#1)
accurate alignment##2##2##(2008-3#1)(2013-1#1)
accurate analysis of the##2##4##(2008-10#2)
accurate analysis of##4##3##(2008-10#3)(2008-2#1)
accurate analysis##5##2##(2008-10#3)(2008-2#1)(2010-8#1)
accurate and can be##2##4##(1996-5#1)(2010-3#1)
accurate and is##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-3#1)
accurate and precise analytical##3##4##(2008-10#3)
accurate and precise determination of##3##5##(2008-10#3)
accurate and precise results##3##4##(2008-10#2)(2010-3#1)
accurate and precise##24##3##(2008-10#19)(2008-3#1)(2010-3#1)(2010-7#1)(2012-2#2)
accurate and rapid##3##3##(2008-10#2)(2008-9#1)
accurate and reliable##7##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#2)
accurate and reproducible##5##3##(2008-10#3)(2009-1#1)(2011-1#1)
accurate and sensitive##3##3##(2008-7#1)(2010-1#1)(2011-3#1)
accurate and user-friendly##2##3##(2008-10#1)(2008-7#1)
accurate and##89##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#39)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#3)(2008-9#3)(2009-1#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
accurate approximation##2##2##(2008-2#1)(2008-3#1)
accurate as##4##2##(1997-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
accurate assessment of the##5##4##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
accurate assessment of##8##3##(2008-10#4)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
accurate at naming the##2##4##(2007-12#2)
accurate at##3##2##(2007-12#2)(2008-10#1)
accurate blood##2##2##(2010-8#1)(2013-8#1)
accurate calculations##2##2##(2008-2#1)(2008-3#1)
accurate clinical##3##2##(2008-7#1)(2010-3#1)(2011-2#1)
accurate control of##3##3##(2007-12#1)(2008-10#2)
accurate control##4##2##(2007-12#1)(2008-10#3)
accurate data on##2##3##(1994-3#1)(2010-3#1)
accurate data##6##2##(1991-11#1)(1992-12#1)(1994-3#1)(2008-10#1)(2010-3#1)(2011-1#1)
accurate description of##2##3##(2008-10#1)(2008-5#1)
accurate detection##3##2##(2008-10#3)
accurate determination of the##7##4##(1990-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#3)
accurate determination of##19##3##(1990-12#2)(1990-8#1)(1994-12#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#4)(2008-7#1)(2008-9#1)(2010-9#1)
accurate diagnosis and effective##2##4##(2008-7#1)(2011-1#1)
accurate diagnosis and the##2##4##(2008-6#1)(2008-8#1)
accurate diagnosis and##8##3##(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)
accurate diagnosis is##2##3##(2010-8#1)(2012-3#1)
accurate diagnosis of##7##3##(1994-1#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
accurate diagnosis was##2##3##(2007-8#2)
accurate diagnosis##31##2##(1991-11#1)(1992-3#1)(1994-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
accurate diagnostic##3##2##(1991-6#1)(2008-7#1)(2011-2#1)
accurate enough to##2##3##(2008-2#2)
accurate enough##4##2##(2008-2#3)(2010-8#1)
accurate estimate of the##2##4##(2008-3#2)
accurate estimate of##4##3##(1990-3#1)(2008-11#1)(2008-3#2)
accurate estimate##5##2##(1990-3#1)(2007-12#1)(2008-11#1)(2008-3#2)
accurate estimates of the##3##4##(1997-2#1)(2008-2#1)(2010-4#1)
accurate estimates of##6##3##(1992-6#1)(1997-2#1)(2008-2#1)(2008-4#1)(2010-4#1)(2013-7#1)
accurate estimates##8##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-2#1)(2010-4#1)(2013-7#1)
accurate estimation of##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
accurate evaluation of the##2##4##(2007-12#1)(2008-11#1)
accurate evaluation##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
accurate even##2##2##(2007-8#1)(2008-3#1)
accurate for##6##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-12#1)
accurate genetic##2##2##(1997-4#1)(2007-7#1)
accurate history##4##2##(1991-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
accurate identification of microorganisms##4##4##(2008-5#2)(2012-2#2)
accurate identification of##10##3##(1990-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-2#3)(2013-8#1)
accurate identification##12##2##(1990-11#1)(1994-3#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-2#1)(2012-2#3)(2013-8#1)
accurate image##2##2##(2009-10#1)(2009-2#1)
accurate in predicting##2##3##(2008-1#1)(2008-10#1)
accurate in the##2##3##(2008-3#1)(2008-7#1)
accurate in##12##2##(1993-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-12#1)(2009-7#1)(2013-8#2)
accurate information about##3##3##(1996-3#1)(2008-3#2)
accurate information on the##4##4##(1992-9#1)(1993-12#1)(1994-6#2)
accurate information##10##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-6#2)(1996-3#1)(2007-2#1)(2008-3#2)(2010-6#1)
accurate knowledge##2##2##(2010-3#1)(2012-2#1)
accurate mass measurements##2##3##(2008-10#1)(2011-2#1)
accurate mass##6##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#2)
accurate measurement of the##5##4##(1994-9#1)(2007-12#1)(2008-3#3)
accurate measurement of##17##3##(1991-11#1)(1994-9#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#7)
accurate measurement##19##2##(1991-11#1)(1994-9#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#8)
accurate measurements of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
accurate measurements##6##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)
accurate measures of##2##3##(2008-3#1)(2012-1#1)
accurate method for the determination##3##5##(2008-10#3)
accurate method for the##7##4##(2008-10#6)(2008-3#1)
accurate method for##10##3##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)
accurate method to##2##3##(1993-3#1)(2008-10#1)
accurate method##19##2##(1993-3#1)(1995-12#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-3#2)
accurate methods##3##2##(2008-10#2)(2008-5#1)
accurate model##2##2##(2010-4#1)(2013-8#1)
accurate models##2##2##(2008-3#1)(2010-4#1)
accurate molecular weights##2##3##(1995-3#1)(2008-4#1)
accurate molecular##4##2##(1995-3#1)(1997-2#1)(2008-4#2)
accurate nodal staging##2##3##(2008-10#2)
accurate optical##3##2##(2007-12#1)(2008-3#2)
accurate organism identification and##2##4##(2013-1#2)
accurate phase##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
accurate positioning##2##2##(2007-12#1)(2008-3#1)
accurate prediction of the##2##4##(2007-12#1)(2008-10#1)
accurate prediction of##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
accurate predictions of##3##3##(2008-10#2)(2008-3#1)
accurate predictions##6##2##(1992-6#1)(1994-3#1)(2008-10#3)(2008-3#1)
accurate quantification##3##2##(2008-10#3)
accurate quantitation of##2##3##(1990-8#1)(2008-10#1)
accurate quantitative measurements##2##3##(2008-9#1)(2013-1#1)
accurate quantitative##4##2##(1997-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
accurate reconstruction##2##2##(2008-3#1)(2009-3#1)
accurate representation of##3##3##(1993-11#1)(2006-12#1)(2008-9#1)
accurate response##3##2##(1993-12#1)(2007-11#1)(2008-10#1)
accurate results as##2##3##(1990-3#1)(2008-10#1)
accurate results for##2##3##(2008-10#2)
accurate results in##2##3##(2008-10#1)(2012-3#1)
accurate results were obtained##2##4##(2008-10#2)
accurate results were##3##3##(2008-10#3)
accurate results##26##2##(1990-3#1)(2008-10#20)(2008-2#1)(2008-3#2)(2008-9#1)(2012-3#1)
accurate risk assessments##2##3##(2008-10#1)(2008-5#1)
accurate risk##4##2##(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
accurate simulation##3##2##(2008-3#1)(2008-4#1)(2013-8#1)
accurate solution##2##2##(2008-3#1)(2012-1#1)
accurate strain##2##2##(2007-12#1)(2008-8#1)
accurate surface##2##2##(2008-3#1)(2008-6#1)
accurate targeting##2##2##(2008-7#1)(2011-1#1)
accurate technique for##2##3##(2008-2#1)(2011-2#1)
accurate temperature##2##2##(2008-2#2)
accurate test##2##2##(2008-3#1)(2010-8#1)
accurate than the##3##3##(2008-10#3)
accurate than##11##2##(2008-1#1)(2008-10#6)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
accurate three-dimensional##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
accurate to within##2##3##(2008-2#1)(2008-3#1)
accurate to##9##2##(1993-3#1)(2008-2#1)(2008-3#4)(2008-6#1)(2009-3#1)(2012-1#1)
accurate treatment##2##2##(2009-10#1)(2013-7#1)
accurate understanding of##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
accurate values of##2##3##(2008-2#1)(2008-3#1)
accurate values##4##2##(1990-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
accurate when##2##2##(2008-4#1)(2011-1#1)
accurate with##3##2##(2008-3#1)(2009-2#1)(2011-1#1)
accurate##734##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#6)(1991-11#5)(1991-12#3)(1991-3#2)(1991-5#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#6)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#12)(2007-12#28)(2007-2#3)(2007-5#3)(2007-7#2)(2007-8#6)(2008-1#9)(2008-10#178)(2008-11#14)(2008-12#4)(2008-2#38)(2008-3#93)(2008-4#20)(2008-5#8)(2008-6#7)(2008-7#21)(2008-8#7)(2008-9#19)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#5)(2009-3#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#8)(2010-4#6)(2010-5#9)(2010-6#2)(2010-7#4)(2010-8#11)(2010-9#3)(2011-1#14)(2011-2#15)(2011-3#1)(2012-1#3)(2012-12#10)(2012-2#21)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#12)
accurate)##2##1##(2008-3#1)(2008-9#1)
accurately and reliably##4##3##(2008-4#1)(2008-5#1)(2013-1#2)
accurately and##14##2##(1996-1#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
accurately as possible##2##3##(2008-3#1)(2008-6#1)
accurately assess##6##2##(2006-10#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
accurately at##2##2##(2007-9#1)(2008-7#1)
accurately by##4##2##(2007-5#1)(2008-10#2)(2008-3#1)
accurately capture the##2##3##(2008-3#1)(2013-8#1)
accurately certified##2##2##(2008-10#1)(2012-12#1)
accurately define the##2##3##(1994-6#1)(2010-1#1)
accurately describe##3##2##(2008-6#1)(2009-6#1)(2012-3#1)
accurately described##2##2##(2008-10#1)(2013-1#1)
accurately describes##3##2##(2007-12#1)(2008-8#1)(2009-6#1)
accurately detect##3##2##(2006-10#1)(2009-10#1)(2010-11#1)
accurately determine the##2##3##(2008-4#1)(2012-2#1)
accurately determine##4##2##(1994-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
accurately determined by##2##3##(1990-8#1)(2007-11#1)
accurately determined from##2##3##(2008-10#1)(2008-3#1)
accurately determined##7##2##(1990-8#1)(2007-11#1)(2008-10#3)(2008-3#2)
accurately for##3##2##(1996-2#1)(2008-3#2)
accurately from##2##2##(2008-2#1)(2008-5#1)
accurately identified##2##2##(1997-8#1)(2010-7#1)
accurately identify##6##2##(1997-8#1)(2008-10#1)(2009-7#1)(2010-3#2)(2013-8#1)
accurately in the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
accurately in##5##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-3#1)
accurately is##2##2##(2008-10#1)(2008-11#1)
accurately measure the##3##3##(2008-1#1)(2008-10#2)
accurately measure##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
accurately measured##2##2##(2007-11#1)(2008-4#1)
accurately measuring the##2##3##(2007-12#1)(2008-3#1)
accurately measuring##5##2##(1993-1#1)(2007-12#1)(2008-3#2)(2013-1#1)
accurately modeled as a##2##4##(2008-3#2)
accurately modeled##4##2##(2008-2#1)(2008-3#3)
accurately predict the##4##3##(2008-10#1)(2008-2#2)(2013-1#1)
accurately predict##11##2##(1991-12#1)(1992-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2013-1#1)
accurately predicted##4##2##(2008-5#1)(2008-7#1)(2010-8#1)(2012-7#1)
accurately predicting##3##2##(1997-3#1)(2008-2#1)(2008-4#1)
accurately quantified##2##2##(1992-9#1)(2008-9#1)
accurately reflect the##3##3##(1991-3#1)(2010-8#1)(2013-1#1)
accurately reflect##4##2##(1991-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
accurately reflected##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
accurately represent##2##2##(1991-11#1)(2008-6#1)
accurately than##5##2##(1993-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2012-4#1)
accurately the##7##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2011-3#1)
accurately to##2##2##(2008-2#2)
accurately with##2##2##(2008-10#2)
accurately##228##1##(1990-12#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#3)(2006-10#2)(2007-11#5)(2007-12#8)(2007-5#1)(2007-9#1)(2008-1#4)(2008-10#38)(2008-11#3)(2008-12#2)(2008-2#17)(2008-3#32)(2008-4#6)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#3)(2009-7#2)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#8)(2013-8#4)
accused##4##1##(1996-3#2)(2008-3#1)(2011-1#1)
accustomed to##3##2##(1995-2#1)(1997-6#1)(2008-9#1)
accustomed##5##1##(1993-11#1)(1995-2#1)(1997-6#1)(2008-9#1)(2010-4#1)
acellular dermis##4##2##(2008-9#4)
acellular pertussis vaccines##2##3##(1997-8#2)
acellular pertussis##4##2##(1995-5#1)(1997-8#2)(2013-1#1)
acellular vaccines##2##2##(1997-8#2)
acellular##20##1##(1990-3#1)(1995-5#1)(1997-8#4)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#1)(2010-3#1)(2010-7#1)(2012-2#2)(2013-1#2)
acenaphthene##2##1##(2008-10#2)
acenaphthylene##3##1##(2008-10#3)
acenocoumarol##2##1##(2007-8#2)
acepromazine##2##1##(2012-3#1)(2013-8#1)
acervuli##2##1##(2008-10#2)
acesulfame potassium##10##2##(2008-9#10)
acesulfame##12##1##(2008-9#11)(2011-1#1)
acetabular component##5##2##(2008-11#1)(2008-8#4)
acetabular components##4##2##(2008-11#3)(2008-8#1)
acetabular cup##3##2##(2008-5#1)(2008-8#1)(2009-7#1)
acetabular cups##2##2##(2008-5#2)
acetabular fixation##3##2##(2008-11#2)(2008-8#1)
acetabular fractures##3##2##(2008-8#3)
acetabular positioning device##3##3##(2008-8#3)
acetabular shell##2##2##(2008-11#1)(2008-8#1)
acetabular shells##2##2##(2008-11#1)(2008-8#1)
acetabular##42##1##(2007-11#1)(2007-8#6)(2008-11#8)(2008-5#4)(2008-8#19)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
acetabulum and##2##2##(2008-8#1)(2009-4#1)
acetabulum##11##1##(2007-11#2)(2007-8#1)(2008-5#2)(2008-8#2)(2009-4#3)(2013-1#1)
acetal##7##1##(1996-5#1)(2008-4#2)(2009-10#4)
acetaldehyde and##3##2##(1994-5#1)(2008-2#1)(2009-8#1)
acetaldehyde as a model solute##2##5##(2007-12#2)
acetaldehyde on##2##2##(1994-5#1)(2008-10#1)
acetaldehyde##25##1##(1992-5#1)(1994-5#7)(2006-10#1)(2007-12#4)(2008-10#2)(2008-11#4)(2008-2#3)(2009-8#1)(2010-12#1)(2011-2#1)
acetals##2##1##(1996-5#1)(2009-11#1)
acetamide##8##1##(1994-8#1)(1996-2#1)(2008-10#1)(2008-6#5)
acetaminophen and p-aminophenol##2##3##(2008-10#2)
acetaminophen and##8##2##(2008-10#6)(2008-11#1)(2008-3#1)
acetaminophen in##5##2##(2008-10#5)
acetaminophen##44##1##(1991-9#4)(1992-9#1)(1995-11#1)(2006-10#1)(2007-10#1)(2008-10#25)(2008-11#2)(2008-3#2)(2010-4#1)(2010-9#2)(2013-1#2)(2013-8#2)
acetamipird##2##1##(2011-2#2)
acetamiprid##3##1##(2011-2#3)
acetate (pH##2##2##(1990-9#1)(2011-1#1)
acetate and 10##2##3##(1997-4#1)(2008-10#1)
acetate and formate##3##3##(2008-10#2)(2011-1#1)
acetate and the##3##3##(2008-10#1)(2008-7#1)(2010-10#1)
acetate and##31##2##(1991-5#1)(1994-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#20)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
acetate as the##5##3##(2008-10#4)(2008-5#1)
acetate as##10##2##(1991-5#1)(1997-7#1)(2008-10#6)(2008-5#1)(2011-1#1)
acetate at##2##2##(2008-10#1)(2010-10#1)
acetate buffer (0##4##3##(2008-10#4)
acetate buffer (pH 4##2##4##(2008-10#2)
acetate buffer (pH 5##5##4##(2008-10#5)
acetate buffer (pH##12##3##(2008-10#12)
acetate buffer at pH 4##3##5##(2008-10#3)
acetate buffer at pH 6##2##5##(2008-10#2)
acetate buffer at pH##7##4##(2008-10#7)
acetate buffer at##10##3##(2008-10#10)
acetate buffer concentration##2##3##(2008-10#2)
acetate buffer in##2##3##(1996-5#1)(2009-10#1)
acetate buffer medium##2##3##(2008-10#2)
acetate buffer pH 5##2##4##(2008-10#2)
acetate buffer pH##3##3##(2008-10#3)
acetate buffer solution##3##3##(2008-10#3)
acetate buffer##57##2##(1996-5#1)(1997-2#1)(2008-10#52)(2009-10#3)
acetate concentration##2##2##(2008-7#2)
acetate counter-ion##2##2##(1997-2#2)
acetate electrophoresis##2##2##(2008-10#2)
acetate enrichment##2##2##(2008-7#2)
acetate ester synthesis##2##3##(2011-1#2)
acetate extract##3##2##(2008-12#1)(2010-2#1)(2011-1#1)
acetate followed by##2##3##(1996-5#1)(2008-10#1)
acetate for##7##2##(1990-7#1)(2007-5#1)(2008-10#2)(2008-11#3)
acetate in##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
acetate into##4##2##(2008-5#3)(2013-8#1)
acetate ion##3##2##(1997-2#2)(2008-10#1)
acetate ions##4##2##(2008-10#4)
acetate is used##2##3##(2008-10#1)(2008-6#1)
acetate is##5##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
acetate kinase##2##2##(2008-6#2)
acetate or##3##2##(2008-10#2)(2008-7#1)
acetate showed##2##2##(2008-10#1)(2008-11#1)
acetate solution of##2##3##(2008-10#2)
acetate solution##4##2##(2008-10#4)
acetate to##2##2##(2008-10#1)(2008-11#1)
acetate treatment##2##2##(1997-4#1)(2008-4#1)
acetate utilization##2##2##(2008-7#2)
acetate was##6##2##(1997-4#1)(2008-11#1)(2008-7#3)(2010-10#1)
acetate with##2##2##(1993-1#1)(2008-10#1)
acetate##334##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#7)(1997-4#9)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#162)(2008-11#13)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#11)(2008-6#12)(2008-7#19)(2008-8#1)(2009-10#3)(2009-8#1)(2010-10#4)(2010-12#1)(2010-2#1)(2011-1#9)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#4)
acetate)##8##1##(1994-11#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#3)
acetates##3##1##(2008-10#1)(2008-4#2)
acetic acid (0##2##3##(2008-10#2)
acetic acid (2##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
acetic acid (5-HIAA)##2##3##(1995-12#1)(1995-3#1)
acetic acid and ammonium##2##4##(1992-11#1)(2008-10#1)
acetic acid and##15##3##(1990-6#1)(1992-11#1)(1994-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#2)
acetic acid as the##3##4##(1996-5#1)(2008-10#2)
acetic acid as##4##3##(1996-5#1)(2008-10#3)
acetic acid in acetic anhydride##2##5##(2008-10#2)
acetic acid in##7##3##(2008-10#4)(2008-6#1)(2011-1#2)
acetic acid is##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
acetic acid mixture##2##3##(2008-10#1)(2012-12#1)
acetic acid solution##5##3##(1991-2#1)(2008-10#4)
acetic acid to form##2##4##(2008-10#1)(2008-6#1)
acetic acid to##3##3##(2008-10#2)(2008-6#1)
acetic acid was##5##3##(1991-5#2)(1994-3#1)(2008-6#1)(2013-1#1)
acetic acid with##3##3##(2008-10#2)(2008-5#1)
acetic acid##132##2##(1990-6#1)(1991-2#2)(1991-5#3)(1992-11#4)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-12#3)(1995-3#1)(1996-5#1)(1997-4#3)(2007-12#3)(2008-10#58)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#23)(2008-8#2)(2009-8#1)(2011-1#3)(2012-12#4)(2012-2#4)(2013-1#2)(2013-7#1)
acetic acid)##2##2##(2008-10#2)
acetic acid-induced writhing##4##3##(2011-1#2)(2013-7#2)
acetic acid-induced##5##2##(2008-3#1)(2011-1#2)(2013-7#2)
acetic acid-sodium acetate buffer##5##4##(2008-10#5)
acetic acid/sodium acetate buffer##3##4##(2008-10#3)
acetic acids##2##2##(2008-10#2)
acetic and##2##2##(1991-5#1)(2008-5#1)
acetic anhydride##9##2##(2007-11#3)(2008-10#4)(2008-11#1)(2012-1#1)
acetic##174##1##(1990-6#1)(1991-2#2)(1991-5#4)(1992-11#4)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-3#1)(1996-5#1)(1997-4#3)(2007-11#3)(2007-12#3)(2008-10#82)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#25)(2008-8#2)(2009-8#1)(2011-1#6)(2012-1#1)(2012-12#6)(2012-2#4)(2013-1#2)(2013-7#3)
acetiphilus##3##1##(2011-2#3)
aceto-white##2##1##(1991-2#2)
acetoacetate##5##1##(2008-10#3)(2008-11#1)(2012-3#1)
acetoin and##2##2##(2008-6#1)(2013-1#1)
acetoin production##2##2##(2013-1#2)
acetoin##9##1##(2008-6#2)(2013-1#7)
acetolactate##2##1##(2008-6#2)
acetone and##14##2##(1994-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-9#1)
acetone as##3##2##(1992-8#1)(2008-10#2)
acetone extract of the lichen Ramalina farinacea and its (+)-usnic acid##2##11##(2008-11#2)
acetone extract of the##3##4##(2008-10#1)(2008-11#2)
acetone extract##4##2##(2008-10#1)(2008-11#3)
acetone extracts##2##2##(2010-3#1)(2013-8#1)
acetone in a##2##3##(2008-10#2)
acetone in##4##2##(2008-10#3)(2008-5#1)
acetone or##2##2##(2008-10#1)(2008-7#1)
acetone was##4##2##(2008-10#1)(2008-2#1)(2009-12#1)(2013-8#1)
acetone were##2##2##(2008-9#1)(2013-8#1)
acetone##103##1##(1990-5#1)(1990-8#1)(1992-2#1)(1992-8#2)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(2007-11#3)(2008-10#46)(2008-11#4)(2008-2#10)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#20)(2009-12#2)(2010-3#1)(2013-1#1)(2013-8#3)
acetone)##5##1##(1992-2#2)(2008-10#2)(2013-8#1)
acetone-hexane (1##2##2##(2008-10#2)
acetone-soluble##2##1##(2008-10#2)
acetonide##13##1##(1990-11#3)(1991-9#2)(2007-7#2)(2008-10#1)(2009-9#2)(2010-12#2)(2011-2#1)
acetonitrile (ACN)##3##2##(1994-9#1)(2008-10#2)
acetonitrile (v/v)##2##2##(1996-5#1)(2009-8#1)
acetonitrile and the##2##3##(2008-10#2)
acetonitrile and water##3##3##(2008-10#3)
acetonitrile and##21##2##(1990-8#1)(2008-10#16)(2011-1#3)(2012-12#1)
acetonitrile as##5##2##(2007-11#1)(2008-10#4)
acetonitrile containing##3##2##(2008-10#2)(2008-7#1)
acetonitrile gradient##2##2##(2008-10#2)
acetonitrile in the mobile##2##4##(2008-10#2)
acetonitrile in the##4##3##(2008-10#4)
acetonitrile in##7##2##(2007-12#1)(2008-10#6)
acetonitrile or##2##2##(1994-9#1)(2008-10#1)
acetonitrile to##2##2##(1995-6#1)(2008-10#1)
acetonitrile was##2##2##(2008-10#2)
acetonitrile were##2##2##(2008-10#2)
acetonitrile##128##1##(1990-8#3)(1992-6#1)(1994-9#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#98)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#2)(2011-1#5)(2012-12#1)(2013-1#2)
acetonitrile)##4##1##(1990-8#1)(1997-7#1)(2007-11#1)(2008-10#1)
acetonitrile+water##2##1##(2008-10#2)
acetonitrile-0##3##1##(2008-10#2)(2012-3#1)
acetonitrile-phosphate buffer##5##2##(2008-10#5)
acetonitrile-water (70##2##2##(2008-10#2)
acetonitrile-water mixed solvents##2##3##(2008-10#2)
acetonitrile-water mixtures##6##2##(2008-10#6)
acetonitrile-water##22##1##(2008-10#19)(2010-4#1)(2011-1#1)(2011-2#1)
acetonitrile/water##6##1##(2007-12#1)(2008-10#4)(2011-1#1)
acetoxy##3##1##(1996-5#2)(2008-11#1)
acetyl CoA##7##2##(1993-11#7)
acetyl and##3##2##(1993-11#1)(1995-6#1)(1996-5#1)
acetyl carbonyl of##2##3##(1993-11#2)
acetyl chloride##2##2##(2007-11#1)(2011-1#1)
acetyl cholinesterase##4##2##(2013-1#4)
acetyl transferase (CAT)##3##3##(1992-12#2)(1994-6#1)
acetyl transferase##6##2##(1992-12#2)(1994-11#1)(1994-6#1)(1996-12#1)(1997-7#1)
acetyl xylan esterase##3##3##(2011-1#3)
acetyl##39##1##(1992-12#2)(1993-11#12)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#3)(2011-1#5)(2013-1#4)(2013-8#1)
acetyl-CoA##7##1##(1992-9#2)(1994-5#1)(1995-2#1)(1995-6#1)(2013-1#2)
acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes##2##10##(1990-7#2)
acetyl-L-carnitine on the##3##3##(1990-7#2)(1994-6#1)
acetyl-L-carnitine on##4##2##(1990-7#2)(1994-6#1)(1997-2#1)
acetyl-L-carnitine was##2##2##(1992-7#2)
acetyl-L-carnitine##15##1##(1990-3#1)(1990-7#4)(1992-7#7)(1994-6#1)(1997-2#2)
acetyl-protected thiol##2##2##(2009-9#2)
acetylacetonate##4##1##(2008-10#3)(2008-2#1)
acetylacetone and##2##2##(2008-10#2)
acetylacetone##4##1##(2008-10#3)(2008-11#1)
acetylated forms##3##2##(1992-9#2)(2008-10#1)
acetylated##14##1##(1992-9#2)(1993-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#2)(2011-2#2)
acetylation and methylation##3##3##(2009-4#1)(2010-11#1)(2011-9#1)
acetylation and##4##2##(2009-4#1)(2010-11#1)(2011-9#1)(2013-1#1)
acetylation of##3##2##(2008-10#1)(2008-4#2)
acetylation##21##1##(1995-2#1)(1996-5#1)(2008-10#7)(2008-4#3)(2008-7#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-9#1)(2013-1#1)
acetylcholine (ACh)##11##2##(1990-7#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#1)(2012-3#1)
acetylcholine (Ach)##2##2##(1992-8#1)(2011-2#1)
acetylcholine and##6##2##(1990-5#1)(1991-5#1)(1997-1#1)(2008-8#1)(2013-1#2)
acetylcholine are##2##2##(1994-8#1)(1995-11#1)
acetylcholine esterase in##3##3##(1990-2#2)(2008-10#1)
acetylcholine esterase##8##2##(1990-2#2)(1992-11#1)(2008-10#3)(2008-11#1)(2011-1#1)
acetylcholine in the##2##3##(1996-12#1)(2008-7#1)
acetylcholine in##7##2##(1994-8#4)(1996-12#1)(2008-10#1)(2008-7#1)
acetylcholine levels##4##2##(1992-8#2)(1994-8#2)
acetylcholine or##2##2##(1995-12#1)(2007-8#1)
acetylcholine receptor (AChR)##4##3##(1997-5#1)(2009-8#2)(2012-2#1)
acetylcholine receptor subunit##4##3##(1993-11#2)(1995-11#1)(1996-12#1)
acetylcholine receptor##25##2##(1993-11#3)(1994-5#2)(1995-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-7#1)(2008-8#7)(2009-11#1)(2009-8#2)(2010-8#1)(2012-2#2)(2013-1#1)
acetylcholine receptors (nAChRs)##3##3##(2007-8#1)(2008-8#1)(2011-2#1)
acetylcholine receptors##13##2##(1990-8#1)(1995-11#3)(2007-8#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
acetylcholine regulating stomatal movement##2##4##(2008-8#2)
acetylcholine release##4##2##(1992-3#1)(1993-5#1)(1997-2#1)(2013-8#1)
acetylcholine to##2##2##(2008-8#1)(2011-2#1)
acetylcholine was##2##2##(2008-10#1)(2013-8#1)
acetylcholine##127##1##(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#2)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#3)(1993-11#3)(1993-12#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-8#7)(1995-11#8)(1995-12#3)(1995-3#1)(1995-6#1)(1996-12#7)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#16)(2009-11#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
acetylcholine-induced bronchoconstriction in##2##3##(1994-11#2)
acetylcholine-induced##4##1##(1994-11#2)(1997-1#1)(2011-1#1)
acetylcholinesterase (AChE) in##2##3##(1990-5#1)(1994-5#1)
acetylcholinesterase (AChE) was##2##3##(2008-10#2)
acetylcholinesterase (AChE)##10##2##(1990-5#1)(1992-12#1)(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)
acetylcholinesterase activity of the rat pheochromocytoma cell line PC12##2##9##(2008-11#2)
acetylcholinesterase activity of the rat##3##5##(2008-11#3)
acetylcholinesterase activity##6##2##(1992-8#1)(2008-11#4)(2008-4#1)
acetylcholinesterase and butyrylcholinesterase##3##3##(2008-10#2)(2008-7#1)
acetylcholinesterase and##4##2##(2008-10#3)(2008-7#1)
acetylcholinesterase inhibition##3##2##(1992-8#1)(1997-7#1)(2008-10#1)
acetylcholinesterase inhibitor##3##2##(1993-12#1)(1996-9#1)(2012-2#1)
acetylcholinesterase inhibitors##2##2##(1995-3#1)(2008-10#1)
acetylcholinesterase##49##1##(1990-5#2)(1992-11#1)(1992-12#1)(1992-8#4)(1993-12#1)(1994-5#1)(1994-8#7)(1995-3#2)(1996-9#1)(1997-7#3)(2008-10#12)(2008-11#6)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
acetylene##9##1##(1992-3#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)
acetylene-air flame##2##2##(2008-10#1)(2008-3#1)
acetylenes##2##1##(2008-7#1)(2009-12#1)
acetylenic##3##1##(1996-5#2)(2009-12#1)
acetylhydrolase##5##1##(1997-7#5)
acetylisoniazid##2##1##(2008-10#2)
acetylornithine aminotransferase##2##2##(1990-5#2)
acetylsalicylhydroxamic acid##2##2##(2008-10#2)
acetylsalicylic acid (ASA)##5##3##(2008-10#4)(2008-7#1)
acetylsalicylic acid and##2##3##(2008-10#2)
acetylsalicylic acid by##2##3##(2008-10#2)
acetylsalicylic acid##22##2##(1990-12#2)(1990-9#1)(1991-2#1)(1993-11#1)(2008-10#16)(2008-7#1)
acetylsalicylic##23##1##(1990-12#2)(1990-9#1)(1991-2#1)(1993-11#1)(1994-9#1)(2008-10#16)(2008-7#1)
acetyltransferase (ChAT)##5##2##(1991-9#1)(1992-8#1)(1993-3#1)(2009-11#1)(2009-3#1)
acetyltransferase activity##4##2##(1991-2#1)(1992-8#1)(1993-12#2)
acetyltransferase fusion gene##2##3##(1990-8#1)(1995-6#1)
acetyltransferase reporter##3##2##(1994-11#1)(1995-2#1)(1995-6#1)
acetyltransferase##42##1##(1990-11#2)(1990-12#1)(1990-8#2)(1991-11#1)(1991-2#4)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#4)(1995-6#2)(1996-12#3)(1996-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)
acetyltransferases##3##1##(1992-6#2)(2008-4#1)
achaete-scute##2##1##(2009-5#2)
achalasia in##2##2##(2011-1#1)(2013-1#1)
achalasia is a##3##3##(2011-1#3)
achalasia is##4##2##(1992-9#1)(2011-1#3)
achalasia##13##1##(1990-12#2)(1992-9#3)(2011-1#6)(2013-1#2)
achenes##4##1##(2008-10#4)
achievable and##2##2##(2009-8#1)(2012-3#1)
achievable at the##2##3##(1993-1#1)(2010-6#1)
achievable by##2##2##(2008-10#1)(2008-3#1)
achievable for the##2##3##(2007-12#1)(2008-2#1)
achievable for##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
achievable goal for##2##3##(2008-10#1)(2008-11#1)
achievable goal##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
achievable in##5##2##(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
achievable with##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
achievable##53##1##(1992-2#1)(1993-1#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#2)(2008-7#2)(2009-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)
achieve 100%##2##2##(2008-10#1)(2012-2#1)
achieve a complete response##2##4##(2008-6#2)
achieve a good##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
achieve a maximum##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
achieve a reduction##3##3##(2007-7#1)(2008-1#1)(2008-11#1)
achieve a simple##2##3##(2008-3#1)(2012-3#1)
achieve a sustained##2##3##(2008-8#1)(2009-8#1)
achieve a##74##2##(1991-9#1)(1992-3#4)(1992-9#1)(1993-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
achieve an overall##2##3##(1997-3#1)(2008-3#1)
achieve an##19##2##(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2012-3#1)(2013-1#1)
achieve better##7##2##(1992-9#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
achieve clinical cure##2##3##(1992-6#1)(2010-5#1)
achieve clinical##3##2##(1992-6#1)(2009-4#1)(2010-5#1)
achieve early detection of##3##4##(1990-8#1)(2008-10#1)(2009-4#1)
achieve even##2##2##(2008-3#1)(2008-8#1)
achieve fast##2##2##(1994-9#1)(2013-1#1)
achieve greater##8##2##(1993-1#1)(1994-1#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-3#1)
achieve high sensitivity##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
achieve high##15##2##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
achieve improved##4##2##(1996-2#1)(1997-2#1)(2008-3#1)(2013-1#1)
achieve its##6##2##(1991-12#2)(1994-1#1)(1996-3#1)(2007-4#1)(2011-1#1)
achieve meaningful##2##2##(1993-3#1)(2012-3#1)
achieve more##4##2##(1992-3#1)(2008-3#1)(2008-7#1)(2010-11#1)
achieve optimum##3##2##(2008-10#1)(2009-2#1)(2013-1#1)
achieve quality##3##2##(1991-3#1)(1995-1#1)(1996-2#1)
achieve results##2##2##(2008-9#1)(2010-5#1)
achieve safe##3##2##(2010-12#1)(2010-3#1)(2011-2#1)
achieve significant##2##2##(2008-10#2)
achieve state of the art results##2##6##(1995-5#2)
achieve success in##2##3##(1995-12#1)(2008-1#1)
achieve successful##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
achieve superresolution##2##2##(2008-3#2)
achieve than##2##2##(2008-11#1)(2010-8#1)
achieve the desired##6##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)
achieve the goals##2##3##(1996-2#1)(2008-11#1)
achieve the reconstruction##2##3##(1993-6#1)(2007-11#1)
achieve the required##3##3##(1995-1#1)(2007-12#1)(2008-3#1)
achieve the same goal##2##4##(1993-1#1)(2007-12#1)
achieve the same##6##3##(1993-1#1)(2007-12#2)(2011-2#2)(2013-1#1)
achieve the##70##2##(1990-11#1)(1990-3#1)(1992-12#1)(1993-1#2)(1993-6#1)(1994-12#2)(1995-1#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#6)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2013-1#1)(2013-8#3)
achieve their goals##2##3##(2007-2#1)(2008-12#1)
achieve their##9##2##(1994-12#1)(1995-5#1)(2007-2#1)(2008-12#1)(2008-9#1)(2010-3#2)(2011-2#2)
achieve these##7##2##(1993-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)(2011-2#1)
achieve this aim##3##3##(1991-2#1)(1996-7#1)(2012-3#1)
achieve this goal##6##3##(2006-6#1)(2007-2#1)(2008-12#1)(2009-10#2)(2012-3#1)
achieve this##26##2##(1990-11#1)(1991-2#1)(1991-3#1)(1996-7#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
achieve total##2##2##(1991-5#1)(1995-11#1)
achieve two##2##2##(2009-12#1)(2010-3#1)
achieve very high##2##3##(2008-10#1)(2008-2#1)
achieve very##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
achieve whole-field##2##2##(2007-12#1)(2008-8#1)
achieve##546##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-12#4)(1993-3#1)(1993-6#1)(1994-1#4)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#4)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#7)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#20)(2007-12#27)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#8)(2008-10#51)(2008-11#29)(2008-12#9)(2008-2#25)(2008-3#55)(2008-4#6)(2008-5#6)(2008-6#6)(2008-7#22)(2008-8#9)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#8)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#11)(2011-2#24)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#10)(2013-1#20)(2013-7#2)(2013-8#9)
achieved HIV-RNA##2##2##(2008-5#2)
achieved a complete##3##3##(1990-12#1)(1991-2#1)(1991-6#1)
achieved a detection limit of##2##5##(2007-12#1)(2008-10#1)
achieved a detection limit##3##4##(2007-12#1)(2008-10#2)
achieved a detection##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
achieved a good##2##3##(1992-12#1)(2008-7#1)
achieved a high##2##3##(1997-4#1)(2009-3#1)
achieved a satisfactory response##2##4##(2012-3#2)
achieved a satisfactory##3##3##(2010-2#1)(2012-3#2)
achieved a score of 100% in all areas##2##8##(2011-2#2)
achieved a##43##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
achieved after a##2##3##(2007-7#1)(2008-11#1)
achieved after the##4##3##(1991-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
achieved after##16##2##(1991-12#1)(1991-8#1)(1993-1#1)(1995-8#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
achieved an accuracy of##2##4##(2008-3#1)(2012-2#1)
achieved an average##2##3##(2007-11#1)(2008-3#1)
achieved an overall##2##3##(2007-11#1)(2008-3#1)
achieved an##14##2##(1992-5#1)(1993-2#1)(2007-10#1)(2007-11#2)(2008-2#2)(2008-3#4)(2012-2#1)(2012-3#1)(2013-1#1)
achieved and maintained##2##3##(2008-11#2)
achieved and the##2##3##(2008-10#1)(2009-10#1)
achieved and##13##2##(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)
achieved are##2##2##(2008-10#1)(2008-11#1)
achieved as a##2##3##(2007-11#1)(2008-3#1)
achieved as##8##2##(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)
achieved at 225##2##3##(2008-10#1)(2008-12#1)
achieved at a##9##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
achieved at low##2##3##(2007-12#1)(2010-4#1)
achieved at pH##2##3##(1995-6#1)(2008-10#1)
achieved at the cost of##2##5##(1990-6#1)(2008-7#1)
achieved at the expense of##3##5##(1995-12#1)(2008-2#1)(2011-1#1)
achieved at the##8##3##(1990-6#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
achieved at##43##2##(1990-6#1)(1991-12#1)(1991-8#1)(1992-6#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
achieved between the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
achieved between##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
achieved by a combination of##4##5##(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
achieved by a##15##3##(1991-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2013-8#1)
achieved by an increase in##2##5##(2007-12#1)(2008-2#1)
achieved by an##5##3##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
achieved by applying##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
achieved by both##2##3##(2008-10#1)(2011-2#1)
achieved by changing the##2##4##(2008-10#1)(2010-2#1)
achieved by either##2##3##(2008-10#1)(2008-3#1)
achieved by electron beam irradiation##2##5##(1991-6#1)(1994-11#1)
achieved by first##2##3##(2008-10#2)
achieved by gentle##2##3##(2008-10#2)
achieved by in##2##3##(1996-2#1)(2008-5#1)
achieved by increasing the##2##4##(2008-8#1)(2012-12#1)
achieved by injection of##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
achieved by matching##2##3##(2007-11#1)(2008-1#1)
achieved by means of a##3##5##(1991-12#1)(2008-3#1)(2013-8#1)
achieved by means of##10##4##(1991-12#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#4)(2013-8#1)
achieved by measurement of##2##4##(2008-3#2)
achieved by sampling##2##3##(2008-10#2)
achieved by substituting##3##3##(1990-2#1)(1994-8#1)(2008-5#1)
achieved by the addition of##2##5##(2008-10#2)
achieved by the##38##3##(1991-6#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-3#1)(1995-6#1)(2006-10#1)(2007-11#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2010-11#1)(2013-1#1)
achieved by this method##2##4##(2007-12#1)(2008-2#1)
achieved by this##5##3##(1990-2#1)(2007-12#1)(2008-10#2)(2008-2#1)
achieved by two##5##3##(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#2)
achieved by use of a##9##5##(2007-11#2)(2007-12#6)(2008-2#1)
achieved by use of an##2##5##(2007-11#1)(2007-12#1)
achieved by use of##26##4##(1990-8#1)(2007-11#5)(2007-12#13)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#1)
achieved by using a##5##4##(2008-10#5)
achieved by using the##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
achieved by using##21##3##(1994-12#1)(2007-8#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#2)
achieved by varying##2##3##(2008-2#1)(2008-7#1)
achieved by##310##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-8#3)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#3)(1996-5#4)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#20)(2007-12#27)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#96)(2008-11#6)(2008-12#3)(2008-2#13)(2008-3#24)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#5)
achieved complete remission##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
achieved complete response##2##3##(1990-12#1)(2007-10#1)
achieved complete##8##2##(1990-12#1)(1990-8#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-12#1)(2011-2#1)
achieved despite##2##2##(2007-12#1)(2008-10#1)
achieved during the##4##3##(1991-2#1)(2008-10#2)(2012-12#1)
achieved either by##2##3##(2008-10#1)(2008-7#1)
achieved either##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
achieved enrichment factors (EF)##2##4##(2008-10#2)
achieved experimentally with##2##3##(2007-12#1)(2008-3#1)
achieved experimentally##8##2##(2007-12#1)(2008-3#7)
achieved following##2##2##(2008-10#1)(2009-5#1)
achieved for a##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
achieved for both##4##3##(2008-10#3)(2009-3#1)
achieved for determination of##2##4##(2008-10#2)
achieved for the determination of##2##5##(2008-10#2)
achieved for the##8##3##(2007-12#1)(2007-8#1)(2008-10#6)
achieved for##55##2##(1994-1#2)(1995-6#1)(2007-11#1)(2007-12#8)(2007-8#1)(2007-9#2)(2008-10#28)(2008-3#8)(2008-6#1)(2008-8#1)(2009-3#1)(2013-1#1)
achieved from the##3##3##(2008-11#1)(2010-3#1)(2010-7#1)
achieved from##12##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
achieved full##3##2##(1996-7#1)(2007-11#1)(2008-12#1)
achieved fusion##2##2##(2008-8#2)
achieved greater##3##2##(2008-3#1)(2012-2#2)
achieved higher##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
achieved if the##2##3##(1992-3#1)(1994-11#1)
achieved if##5##2##(1992-3#1)(1994-11#1)(1997-7#1)(2007-12#1)(2010-4#1)
achieved in 2##2##3##(1997-8#1)(2011-2#1)
achieved in 60%##2##3##(1993-1#1)(2007-7#1)
achieved in 91%##2##3##(2008-1#1)(2011-2#1)
achieved in a##8##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#1)
achieved in all cases##3##4##(1995-5#1)(2008-9#1)(2009-3#1)
achieved in all##6##3##(1995-5#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)
achieved in an##2##3##(2007-11#1)(2008-3#1)
achieved in batch##2##3##(2008-11#2)
achieved in less than##4##4##(2008-10#4)
achieved in many##2##3##(1991-12#1)(2008-1#1)
achieved in one##2##3##(2008-3#1)(2010-2#1)
achieved in only##2##3##(2008-10#1)(2008-7#1)
achieved in the presence of##2##5##(2008-10#1)(2008-11#1)
achieved in the treatment of##3##5##(1990-6#1)(2010-3#1)(2011-2#1)
achieved in the##17##3##(1990-6#1)(1992-9#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
achieved in this##3##3##(1994-3#1)(1997-6#1)(2008-3#1)
achieved in two##3##3##(2008-10#1)(2008-3#2)
achieved in##132##2##(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-10#2)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#27)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)
achieved is##6##2##(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2012-1#1)
achieved many##2##2##(1993-3#1)(1994-3#1)
achieved mostly##2##2##(1996-11#1)(2007-8#1)
achieved on a##5##3##(1990-8#1)(1995-6#1)(2008-10#2)(2008-2#1)
achieved on an##3##3##(2008-10#2)(2012-12#1)
achieved on the##5##3##(1993-1#1)(2008-10#3)(2008-11#1)
achieved on##19##2##(1990-8#1)(1993-1#1)(1995-6#1)(2008-10#11)(2008-11#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
achieved only by##2##3##(1992-2#1)(2008-2#1)
achieved only in##2##3##(1994-11#1)(2007-11#1)
achieved only##10##2##(1992-2#1)(1993-11#1)(1994-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
achieved over the whole##2##4##(2007-11#1)(2013-8#1)
achieved over the##3##3##(1990-2#1)(2007-11#1)(2013-8#1)
achieved over##6##2##(1990-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2013-8#1)
achieved partial##2##2##(1990-6#1)(2008-10#1)
achieved remission##2##2##(1991-8#2)
achieved results##3##2##(2008-10#2)(2011-2#1)
achieved simply##2##2##(1995-2#1)(2008-2#1)
achieved simultaneously##4##2##(2008-2#1)(2008-3#3)
achieved superior##2##2##(1992-11#1)(2012-1#1)
achieved the best##2##3##(2008-10#1)(2013-1#1)
achieved the##15##2##(1992-9#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
achieved this##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
achieved through a##5##3##(1994-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-3#1)
achieved through the use of##3##5##(2008-10#1)(2008-3#1)(2010-3#1)
achieved through the##7##3##(1994-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-3#1)
achieved through##37##2##(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-2#1)(2007-11#1)(2007-12#7)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-7#1)
achieved to##4##2##(1991-3#1)(2007-11#1)(2008-10#1)(2012-12#1)
achieved under the optimized conditions##2##5##(2008-10#1)(2013-1#1)
achieved under##10##2##(1991-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-6#1)(2010-1#1)(2013-1#1)
achieved using a##9##3##(1992-9#1)(2008-10#6)(2008-12#1)(2008-5#1)
achieved using the##7##3##(1990-12#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-4#1)
achieved using##48##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1992-9#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-4#1)(2011-3#1)(2013-1#1)
achieved via the##2##3##(2008-5#1)(2010-9#1)
achieved via##5##2##(1996-5#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-9#1)
achieved was##8##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)
achieved were##5##2##(2008-10#5)
achieved when a##2##3##(2008-10#1)(2008-3#1)
achieved when the##11##3##(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2010-2#1)
achieved when##30##2##(1994-2#1)(1995-6#1)(1997-4#1)(2006-6#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-6#2)(2008-7#1)(2010-2#1)
achieved with 0##3##3##(1990-7#1)(2008-10#2)
achieved with a simple##3##4##(2007-11#1)(2007-12#2)
achieved with a##35##3##(2007-11#5)(2007-12#9)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#6)(2011-2#1)(2012-12#1)
achieved with an##7##3##(1994-5#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-5#1)
achieved with conventional##2##3##(2008-10#1)(2008-3#1)
achieved with longer##2##3##(2007-12#1)(2008-3#1)
achieved with low##2##3##(2008-10#1)(2009-7#1)
achieved with minimal##2##3##(2008-10#1)(2009-5#1)
achieved with the proposed method##2##5##(2008-10#1)(2009-5#1)
achieved with the proposed##3##4##(2008-10#2)(2009-5#1)
achieved with the use of the##2##6##(2007-11#1)(2008-3#1)
achieved with the##23##3##(1991-9#1)(1993-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-3#4)(2009-5#1)(2010-3#1)(2011-2#1)
achieved with this##2##3##(1997-8#1)(2010-7#1)
achieved with##151##2##(1990-10#1)(1990-7#1)(1991-3#1)(1991-9#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#11)(2007-12#15)(2007-8#2)(2008-1#3)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#20)(2008-4#1)(2008-5#3)(2008-7#6)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)
achieved within a##2##3##(2007-12#1)(2008-10#1)
achieved within##15##2##(2007-12#1)(2008-10#10)(2008-2#1)(2008-8#1)(2009-11#1)(2009-6#1)
achieved without any##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
achieved without the need##2##4##(2007-12#1)(2008-3#1)
achieved without the##3##3##(2007-12#1)(2008-3#2)
achieved without##20##2##(1993-1#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
achieved##1532##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#5)(1990-5#5)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#6)(1991-5#2)(1991-6#4)(1991-8#7)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#4)(1993-1#6)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#4)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#7)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#9)(1995-3#4)(1995-5#4)(1995-6#6)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#7)(2006-10#1)(2006-6#1)(2007-10#5)(2007-11#78)(2007-12#99)(2007-2#2)(2007-4#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#13)(2008-10#451)(2008-11#50)(2008-12#20)(2008-2#63)(2008-3#141)(2008-4#14)(2008-5#29)(2008-6#26)(2008-7#46)(2008-8#18)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#7)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#10)(2010-4#4)(2010-5#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#35)(2011-3#1)(2011-4#1)(2012-1#6)(2012-12#17)(2012-2#19)(2012-3#12)(2012-7#2)(2013-1#32)(2013-7#1)(2013-8#14)
achievement and##6##2##(1994-1#1)(2007-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)
achievement gap##3##2##(2008-12#3)
achievement in##4##2##(2009-7#2)(2010-10#1)(2010-5#1)
achievement motivation##2##2##(2009-7#2)
achievement of a##4##3##(1994-3#1)(1996-2#1)(2007-5#1)(2012-3#1)
achievement of academic##2##3##(2011-2#2)
achievement of the##2##3##(2008-10#1)(2010-5#1)
achievement of##33##2##(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-3#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
achievement outcomes##3##2##(2008-12#1)(2009-7#1)(2010-7#1)
achievement scores##2##2##(2007-8#1)(2009-12#1)
achievement##86##1##(1990-4#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#4)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#3)(2009-7#10)(2010-1#13)(2010-10#2)(2010-3#2)(2010-5#2)(2010-7#2)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#1)
achievements and challenges##3##3##(1993-8#1)(2010-8#2)
achievements and future##3##3##(1993-12#2)(2008-5#1)
achievements and##8##2##(1993-12#2)(1993-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#2)
achievements in the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
achievements in##8##2##(2007-8#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-3#2)(2013-7#1)
achievements of the##4##3##(2008-12#2)(2012-12#1)(2013-1#1)
achievements of##15##2##(1995-1#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#3)(2013-1#1)
achievements##46##1##(1993-12#2)(1993-8#1)(1994-3#1)(1995-1#2)(1996-1#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#2)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#6)(2013-1#1)(2013-7#1)
achieves a constant##2##3##(2007-7#1)(2008-10#1)
achieves a##4##2##(2007-7#1)(2008-10#2)(2010-12#1)
achieves high##2##2##(1990-9#1)(2008-3#1)
achieves the same##3##3##(2008-7#1)(2009-6#1)(2012-3#1)
achieves the##7##2##(2008-10#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
achieves##34##1##(1990-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-3#3)(2013-8#1)
achieving a common goal##2##4##(1996-3#1)(2008-10#1)
achieving a more##3##3##(1990-6#1)(1991-6#1)(2008-4#1)
achieving a response##2##3##(2008-11#1)(2008-5#1)
achieving a score of##2##4##(2013-1#2)
achieving a sustained##2##3##(2008-5#1)(2012-1#1)
achieving a##36##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-12#1)(1994-2#1)(1994-3#2)(1996-3#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#5)
achieving all of##2##3##(1996-1#1)(1996-3#1)
achieving an##5##2##(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2011-2#1)
achieving and sustaining##2##3##(1996-2#1)(2008-1#1)
achieving and##3##2##(1996-2#1)(2008-1#1)(2012-3#1)
achieving compensation of the circulatory system##2##6##(2008-7#2)
achieving good##3##2##(2011-2#2)(2012-2#1)
achieving high##4##2##(1996-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
achieving higher##2##2##(2007-10#1)(2008-6#1)
achieving its##2##2##(1995-8#1)(1996-2#1)
achieving maximal##2##2##(2008-1#1)(2008-3#1)
achieving one of the##2##4##(1994-9#1)(1996-1#1)
achieving optimal##4##2##(1991-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
achieving such##2##2##(1995-1#1)(2008-7#1)
achieving target##2##2##(2008-1#1)(2013-1#1)
achieving the##16##2##(1990-11#1)(1992-12#1)(1995-2#1)(1996-3#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
achieving these##3##2##(1993-12#1)(1994-12#1)(2008-11#1)
achieving this goal##4##3##(1992-12#1)(1994-11#1)(2008-7#1)(2010-3#1)
achieving this##9##2##(1992-12#1)(1994-11#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)
achieving##189##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-4#2)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#3)(1996-2#2)(1996-3#4)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#12)(2008-3#15)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#3)(2009-5#1)(2009-7#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#4)
achilles tendon##2##2##(2009-10#1)(2012-2#1)
achiral##2##1##(2008-10#2)
achondroplasia##4##1##(2007-8#1)(2009-3#1)(2011-1#1)(2013-1#1)
achondroplastic adolescent##2##2##(2009-3#2)
achondroplastic patients##2##2##(2007-8#1)(2011-1#1)
achondroplastic##6##1##(2007-8#2)(2009-3#2)(2011-1#2)
achromatic and##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
achromatic doublets and##2##3##(2008-3#2)
achromatic doublets with a reduced secondary spectrum##2##7##(2008-3#2)
achromatic doublets with##3##3##(2008-3#3)
achromatic doublets##5##2##(2008-3#5)
achromatic fringe##2##2##(2008-2#2)
achromatic optical##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
achromatic phase##3##2##(2007-11#2)(2008-3#1)
achromatic polarization rotator##2##3##(2008-2#2)
achromatic##40##1##(2007-11#8)(2007-12#3)(2008-2#9)(2008-3#20)
achromatically##2##1##(2007-11#2)
acibenzolar-S-methyl (ASM)##2##2##(2008-10#2)
acibenzolar-S-methyl##4##1##(2008-10#4)
acid (0##7##2##(2008-10#7)
acid (1##4##2##(1990-11#1)(2008-10#3)
acid (1)##3##2##(1990-11#1)(2008-10#2)
acid (10##2##2##(1993-6#1)(2008-10#1)
acid (11##2##2##(2008-12#1)(2013-1#1)
acid (12-HETE)##2##2##(1992-8#1)(1994-8#1)
acid (14##2##2##(1990-2#1)(1995-5#1)
acid (16##2##2##(1991-12#1)(1993-6#1)
acid (18##2##2##(1993-6#1)(1994-12#1)
acid (2##19##2##(1993-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-8#1)
acid (2)##4##2##(1990-11#1)(2008-10#2)(2008-11#1)
acid (20##6##2##(1990-7#1)(1992-3#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-2#1)
acid (22##2##2##(1992-3#1)(2008-2#1)
acid (3##2##2##(2008-10#1)(2008-11#1)
acid (3)##3##2##(2008-10#2)(2008-11#1)
acid (5##2##2##(1995-11#1)(2008-11#1)
acid (5-HIAA)##9##2##(1992-1#1)(1993-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(2008-10#2)(2008-3#1)
acid (50##3##2##(1995-12#2)(1997-4#1)
acid (6##2##2##(1993-8#1)(2008-5#1)
acid (75##2##2##(2008-10#1)(2008-5#1)
acid (AA) was##2##3##(1991-2#1)(2008-10#1)
acid (AA)##28##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#2)(1993-3#1)(1993-8#1)(1995-5#1)(1997-2#1)(2008-10#16)(2008-11#1)(2008-5#1)(2010-9#1)
acid (ABA)##4##2##(2008-10#2)(2009-6#1)(2009-8#1)
acid (ALA)##4##2##(1992-8#1)(2008-6#1)(2012-1#1)(2012-3#1)
acid (AMPA)##4##2##(1995-11#1)(1995-12#1)(1996-5#1)(2011-1#1)
acid (AP-5)##2##2##(1997-2#1)(2008-11#1)
acid (ASA)##6##2##(2008-10#5)(2008-7#1)
acid (ATRA)##4##2##(2007-4#1)(2008-4#1)(2008-9#1)(2011-2#1)
acid (BA)##2##2##(2008-10#2)
acid (BABA)##3##2##(2008-10#2)(2009-6#1)
acid (BCA) assay##2##3##(2008-10#1)(2008-9#1)
acid (BCA)##3##2##(2008-10#2)(2008-9#1)
acid (C16##3##2##(1990-8#1)(2011-1#2)
acid (C18##3##2##(1996-6#2)(2008-11#1)
acid (CA)##5##2##(2008-10#3)(2011-2#1)(2012-12#1)
acid (CAA)##2##2##(2008-10#1)(2008-11#1)
acid (CAS##2##2##(2008-5#1)(2008-9#1)
acid (DCA)##3##2##(1995-3#1)(2008-10#2)
acid (DEHPA)##2##2##(2008-10#2)
acid (DHAA)##2##2##(1993-3#1)(1997-2#1)
acid (DMA)##8##2##(2008-10#8)
acid (DMSA)##3##2##(1992-12#1)(2008-8#1)(2013-1#1)
acid (DOPAC)##6##2##(1992-1#1)(1992-7#1)(1994-2#1)(1995-3#1)(2008-10#2)
acid (DPA)##3##2##(2008-10#2)(2011-2#1)
acid (DTPA)##5##2##(1990-8#1)(2008-10#3)(2008-5#1)
acid (EA)##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
acid (EDTA) and##2##3##(2008-10#1)(2008-5#1)
acid (EDTA)##11##2##(2008-10#7)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
acid (FA) in##3##3##(1992-8#1)(2009-8#1)(2013-1#1)
acid (FA)##8##2##(1992-2#1)(1992-8#1)(2008-10#1)(2008-6#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
acid (GA)##5##2##(2008-10#3)(2008-6#1)(2008-9#1)
acid (GABA) on##3##3##(1992-3#1)(2008-9#1)(2012-2#1)
acid (GABA)##19##2##(1990-5#1)(1992-3#1)(1993-12#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)
acid (GLA)##2##2##(2008-5#1)(2008-7#1)
acid (Glu)##2##2##(1991-5#1)(2008-10#1)
acid (HA)##9##2##(1996-12#1)(2008-10#5)(2010-10#1)(2013-8#2)
acid (HIBA)##3##2##(2008-10#3)
acid (HSA)##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
acid (HVA)##4##2##(1992-7#1)(1993-1#1)(1995-3#1)(2008-3#1)
acid (LA)##4##2##(1992-5#1)(1994-3#1)(2008-5#2)
acid (LTA)##2##2##(1995-6#1)(1996-12#1)
acid (MA)##2##2##(1996-12#1)(2008-10#1)
acid (MAA)##4##2##(1990-12#1)(2008-10#3)
acid (MPA) as##2##3##(2008-10#1)(2013-8#1)
acid (MPA)##4##2##(2008-10#2)(2012-12#1)(2013-8#1)
acid (NA) and##3##3##(2008-10#2)(2011-1#1)
acid (NA)##5##2##(2008-10#4)(2011-1#1)
acid (NAA)##4##2##(1996-5#1)(2008-10#2)(2008-12#1)
acid (OA)##4##2##(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)
acid (P=0##2##2##(2008-10#2)
acid (PA)##6##2##(1991-5#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-8#1)(2009-6#1)
acid (RA) was##2##3##(1993-9#1)(2008-11#1)
acid (RA)##16##2##(1990-11#1)(1990-6#1)(1992-5#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-9#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-5#2)(2012-1#1)
acid (RNA)##3##2##(2008-10#1)(2009-11#1)(2010-9#1)
acid (SA) and##4##3##(2008-10#3)(2009-8#1)
acid (SA) is##3##3##(2008-10#2)(2011-2#1)
acid (SA)##17##2##(2008-10#12)(2008-12#1)(2009-6#1)(2009-8#2)(2011-2#1)
acid (TA)##2##2##(2008-10#2)
acid (TCA) and##3##3##(2008-10#3)
acid (TCA)##7##2##(1993-6#1)(1995-3#1)(2008-10#4)(2012-1#1)
acid (TFA) and##2##3##(2008-10#1)(2008-7#1)
acid (TFA)##4##2##(2008-10#3)(2008-7#1)
acid (VPA)##7##2##(1996-5#2)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
acid (ZA)##2##2##(2008-7#1)(2013-1#1)
acid (aa) polypeptide##2##3##(1990-5#1)(1993-2#1)
acid (aa) protein##3##3##(1993-9#1)(1995-8#1)(1997-7#1)
acid (aa)##30##2##(1990-11#2)(1990-5#1)(1991-6#4)(1991-7#1)(1991-9#1)(1993-12#2)(1993-2#2)(1993-6#5)(1993-9#2)(1994-12#3)(1994-8#1)(1995-8#2)(1997-7#2)(2008-10#1)(2010-5#1)
acid (pH 2##3##3##(1994-8#1)(2008-10#1)(2010-3#1)
acid (pH 3##2##3##(2008-10#1)(2011-1#1)
acid (pH##9##2##(1994-8#1)(1996-5#2)(2008-10#3)(2010-3#2)(2011-1#1)
acid (vitamin C)##4##3##(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
acid (vitamin##5##2##(1992-9#1)(2008-10#2)(2008-5#1)(2008-7#1)
acid 168##2##2##(1993-3#1)(1997-8#1)
acid 244##2##2##(1990-10#2)
acid A##4##2##(1992-8#2)(2011-3#1)(2012-2#1)
acid B##3##2##(1995-3#1)(2008-10#2)
acid N-hydroxysuccinimidyl ester)-4##2##3##(2008-10#2)
acid N-oxide##3##2##(1995-3#1)(2008-10#2)
acid S-methyl ester (BTH)##2##4##(2008-10#2)
acid a##2##2##(1994-5#1)(2008-10#1)
acid accumulation##2##2##(1994-3#1)(2008-10#1)
acid addition##2##2##(2008-10#1)(2008-11#1)
acid affects##2##2##(1996-5#1)(2008-10#1)
acid after##2##2##(1994-12#1)(2008-10#1)
acid agonist##2##2##(1992-12#1)(2012-2#1)
acid alone##5##2##(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#1)
acid also##2##2##(2008-7#1)(2012-3#1)
acid amide##5##2##(1992-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-3#1)
acid amides of phenolic benzylamines##2##5##(2008-5#2)
acid amides of##3##3##(2008-5#3)
acid amides##5##2##(1991-5#1)(1992-11#1)(2008-5#3)
acid analysis in##2##3##(1995-3#1)(2008-10#1)
acid analysis of##2##3##(1990-2#1)(1993-11#1)
acid analysis##35##2##(1990-11#2)(1990-2#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-6#1)(1997-3#1)(2008-10#8)(2008-2#2)(2008-4#3)(2008-9#2)
acid and 0##7##3##(2008-10#5)(2008-6#1)(2011-2#1)
acid and 1##2##3##(2008-10#2)
acid and 2##3##3##(2008-10#3)
acid and a##9##3##(1991-2#1)(1992-6#1)(2008-10#7)
acid and alanine##2##3##(1995-2#1)(2008-5#1)
acid and alkali##3##3##(2008-10#3)
acid and amino acid##2##4##(1993-6#1)(2013-8#1)
acid and amino##3##3##(1993-6#1)(2008-10#1)(2013-8#1)
acid and ammonium##4##3##(1992-11#1)(2008-10#2)(2013-1#1)
acid and at##2##3##(1992-12#1)(1996-2#1)
acid and base##3##3##(1990-11#1)(2010-12#1)(2012-12#1)
acid and caffeine##2##3##(2008-10#2)
acid and calcium##2##3##(2008-10#1)(2009-6#1)
acid and catecholamines##2##3##(2008-10#2)
acid and chlorogenic acid##2##4##(2008-10#2)
acid and cholesterol##2##3##(1992-6#1)(2010-2#1)
acid and coenzyme##2##3##(1993-8#1)(2008-10#1)
acid and dehydroascorbic acid##2##4##(1993-3#1)(2008-10#1)
acid and determined spectrophotometrically as its##2##6##(2008-10#2)
acid and determined spectrophotometrically##3##4##(2008-10#3)
acid and docosahexaenoic##2##3##(1990-5#1)(1996-7#1)
acid and dopamine##2##3##(1993-8#1)(2008-10#1)
acid and ethanol##2##3##(2008-10#1)(2008-6#1)
acid and glucose##2##3##(2008-10#1)(2008-6#1)
acid and hydrogen peroxide##5##4##(2008-10#5)
acid and its application##2##4##(2008-10#2)
acid and its major##2##4##(1996-5#1)(2008-10#1)
acid and its##15##3##(1993-11#3)(1993-8#1)(1994-5#1)(1996-5#1)(2008-10#8)(2008-11#1)
acid and other##2##3##(2008-5#1)(2010-3#1)
acid and p-coumaric acid##2##4##(2008-10#1)(2008-11#1)
acid and paracetamol##3##3##(2008-10#3)
acid and permanganate##3##3##(2008-10#3)
acid and protein##2##3##(1994-3#1)(1996-12#1)
acid and sodium tetrahydroborate##3##4##(2008-10#3)
acid and sodium##6##3##(1994-9#1)(2008-10#5)
acid and sorbic acid##4##4##(2008-10#4)
acid and syringic acid##3##4##(2011-1#3)
acid and the##15##3##(1991-12#1)(1993-8#1)(2008-10#8)(2008-5#1)(2008-9#2)(2010-3#1)(2013-1#1)
acid and their##2##3##(2008-10#2)
acid and to##2##3##(1994-11#1)(1995-8#1)
acid and##362##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#7)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#181)(2008-11#7)(2008-12#1)(2008-4#2)(2008-5#19)(2008-6#7)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#2)
acid and/or##3##2##(2008-10#3)
acid anhydrides##4##2##(1994-3#1)(1995-11#3)
acid anilide##2##2##(2008-10#2)
acid antibodies##3##2##(2007-7#1)(2008-4#2)
acid appears to##2##3##(1991-9#1)(2009-12#1)
acid are described##2##3##(2008-10#2)
acid are##13##2##(1993-11#1)(1994-8#1)(2008-10#9)(2008-11#1)(2009-8#1)
acid as a##12##3##(2008-10#9)(2008-6#2)(2009-10#1)
acid as an##6##3##(1994-9#1)(2008-10#4)(2012-2#1)
acid as the catalyst##2##4##(2008-10#1)(2008-5#1)
acid as the##14##3##(1996-5#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#1)(2012-3#1)
acid as well as##4##4##(1996-7#1)(2008-10#3)
acid as##62##2##(1994-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-7#1)(2007-11#2)(2008-10#41)(2008-11#1)(2008-5#3)(2008-6#4)(2009-10#1)(2010-1#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
acid at 80 degrees C##2##5##(2008-10#2)
acid at a##2##3##(1994-8#1)(2008-10#1)
acid at amino acid##2##4##(1991-8#1)(1993-8#1)
acid at concentration##2##3##(1992-9#1)(2008-10#1)
acid at concentrations##2##3##(2008-10#1)(2008-5#1)
acid at different concentrations##2##4##(2012-2#2)
acid at pH 7##2##4##(2008-5#2)
acid at pH##6##3##(2008-10#3)(2008-5#2)(2008-6#1)
acid at position##7##3##(1991-9#1)(1994-3#1)(1995-5#1)(1997-3#1)(2008-10#3)
acid at the##4##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-5#1)
acid at##45##2##(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-3#1)(2008-10#22)(2008-4#1)(2008-5#4)(2008-6#2)(2010-3#1)(2012-2#2)
acid bacteria##24##2##(1995-8#1)(1997-4#5)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#2)(2012-2#4)(2013-1#2)
acid based on##7##3##(2008-10#7)
acid before##2##2##(1991-12#1)(2008-10#1)
acid binding protein##9##3##(1991-2#1)(1991-9#1)(1994-8#2)(1995-2#2)(2008-8#2)(2009-8#1)
acid binding##12##2##(1991-2#1)(1991-9#1)(1994-8#2)(1995-2#2)(1996-2#1)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#1)
acid biosynthesis in##3##3##(1995-6#1)(1997-2#2)
acid biosynthesis##9##2##(1992-8#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#2)(2008-9#2)(2013-8#1)
acid biosynthetic enzymes##2##3##(1992-4#1)(2008-7#1)
acid biosynthetic##5##2##(1992-4#3)(2008-7#2)
acid bomb and conventional wet digestion methods##3##7##(2008-10#3)
acid bomb##4##2##(2008-10#4)
acid buffer (pH##2##3##(1995-3#1)(2008-10#1)
acid buffer solution##5##3##(1993-8#1)(2008-10#4)
acid buffer##14##2##(1993-8#1)(1995-3#1)(2008-10#12)
acid but not by##2##4##(1994-9#1)(1995-5#1)
acid but not##3##3##(1994-9#1)(1995-5#1)(2008-10#1)
acid but##6##2##(1994-6#1)(1994-9#1)(1995-5#1)(1997-3#1)(2008-10#2)
acid by a##3##3##(1992-8#1)(2008-10#1)(2008-6#1)
acid by hydrogen peroxide##3##4##(1994-5#1)(2008-10#2)
acid by partial##2##3##(2008-10#2)
acid by the##7##3##(1990-12#1)(2008-10#5)(2008-6#1)
acid by using##2##3##(1992-11#1)(2008-6#1)
acid by##49##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-9#1)(1992-11#1)(1992-8#2)(1994-5#1)(2008-10#29)(2008-12#1)(2008-6#7)(2008-7#1)(2011-2#2)(2013-8#1)
acid can be effectively##2##4##(2008-10#1)(2008-6#1)
acid can be##5##3##(1992-3#1)(2008-10#3)(2008-6#1)
acid can##7##2##(1990-8#1)(1992-3#1)(1993-9#1)(2008-10#3)(2008-6#1)
acid catalyst for##2##3##(2008-7#1)(2010-12#1)
acid catalyst##4##2##(1993-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
acid catalysts##3##2##(2010-12#1)(2012-12#1)(2013-1#1)
acid catalyzed##3##2##(1992-12#1)(1996-2#1)(2007-11#1)
acid cation-exchange resin##2##3##(2008-10#2)
acid cause##2##2##(1992-9#1)(2008-10#1)
acid chain##4##2##(1993-8#3)(2011-2#1)
acid chains of##2##3##(1993-8#1)(1994-11#1)
acid chains##4##2##(1993-8#1)(1994-11#1)(1997-2#1)(2008-5#1)
acid chloride##2##2##(2008-10#2)
acid citrate dextrose##2##3##(2011-2#2)
acid column##2##2##(1997-2#1)(2008-10#1)
acid compared to##2##3##(1994-11#1)(1995-11#1)
acid complex##5##2##(2008-10#5)
acid composition and##10##3##(1990-5#1)(1990-7#2)(1990-8#1)(1992-12#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-7#1)(2012-1#1)
acid composition of the##13##4##(1990-5#1)(1990-8#1)(1991-12#2)(1992-10#1)(1992-9#1)(1993-8#1)(2008-7#1)(2008-9#2)(2010-4#2)(2013-1#1)
acid composition of##28##3##(1990-5#2)(1990-8#1)(1991-12#4)(1991-2#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-8#1)(1994-9#1)(1996-7#1)(2008-11#1)(2008-7#3)(2008-9#2)(2010-4#5)(2011-1#1)(2012-1#1)(2013-1#1)
acid composition was##2##3##(1997-8#1)(2010-4#1)
acid composition##64##2##(1990-5#3)(1990-7#2)(1990-8#3)(1991-12#5)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#3)(1996-7#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#6)(2008-9#2)(2009-5#3)(2010-4#7)(2011-1#3)(2012-1#2)(2013-1#2)
acid compositions##6##2##(1997-2#1)(2008-11#1)(2010-2#3)(2012-2#1)
acid compounds##2##2##(2008-10#2)
acid concentration and temperature##2##4##(2008-10#2)
acid concentration and##4##3##(2008-10#4)
acid concentration between##2##3##(2008-10#2)
acid concentration in the##3##4##(2008-10#2)(2008-5#1)
acid concentration in##5##3##(1996-12#1)(2008-10#3)(2008-5#1)
acid concentration is##2##3##(2008-10#2)
acid concentration of##5##3##(2008-10#2)(2008-6#3)
acid concentration##43##2##(1996-12#1)(2008-10#34)(2008-3#1)(2008-5#1)(2008-6#3)(2010-1#1)(2013-1#2)
acid concentrations and##2##3##(2008-10#1)(2008-12#1)
acid concentrations in##2##3##(1990-12#1)(2008-4#1)
acid concentrations##11##2##(1990-12#2)(1992-3#1)(1994-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-4#1)
acid conditions##2##2##(2008-10#1)(2008-11#1)
acid conjugate##2##2##(1990-8#2)
acid constituents##2##2##(2008-11#1)(2008-7#1)
acid consumption##2##2##(1990-8#1)(2008-11#1)
acid containing##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
acid content in##9##3##(2008-10#6)(2008-11#1)(2008-12#1)(2013-1#1)
acid content of##6##3##(1990-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)
acid content##25##2##(1990-5#1)(1994-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-5#6)(2008-9#1)(2010-4#2)(2012-2#1)(2013-1#1)
acid contents of##2##3##(2008-10#2)
acid contents##3##2##(1996-7#1)(2008-10#2)
acid could be##3##3##(2008-10#3)
acid could##5##2##(2008-10#5)
acid cycle##7##2##(2008-1#1)(2008-4#1)(2008-7#4)(2008-8#1)
acid decarboxylase##7##2##(1991-5#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-9#1)(2013-8#1)
acid decreased##2##2##(2008-10#1)(2008-7#1)
acid deprivation##3##2##(1990-12#1)(1993-6#2)
acid derivative##6##2##(1991-6#1)(2007-1#1)(2008-10#1)(2010-12#2)(2011-2#1)
acid derivatives are##3##3##(1994-11#1)(2008-10#1)(2012-3#1)
acid derivatives as##3##3##(1992-12#1)(1997-3#1)(2013-1#1)
acid derivatives of##2##3##(2012-2#2)
acid derivatives##24##2##(1990-3#1)(1991-5#1)(1992-12#2)(1994-11#1)(1994-9#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-10#9)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
acid derived##5##2##(1994-3#1)(2008-10#1)(2008-6#1)(2010-4#2)
acid detection##4##2##(2008-10#2)(2012-3#1)(2013-8#1)
acid determination in##3##3##(2008-10#3)
acid determination##8##2##(2008-10#8)
acid diacylester##2##2##(2008-10#2)
acid did not affect##2##4##(2008-10#1)(2008-6#1)
acid did not##6##3##(1990-5#1)(1995-11#1)(2008-10#2)(2008-6#1)(2013-1#1)
acid did##7##2##(1990-5#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-6#1)(2013-1#1)
acid digested samples##2##3##(2008-10#2)
acid digested##7##2##(2008-10#7)
acid digestion and##3##3##(2008-10#3)
acid digestion for##3##3##(2008-10#3)
acid digestion of##3##3##(2008-10#3)
acid digestion procedure was##2##4##(2008-10#1)(2010-5#1)
acid digestion procedure##3##3##(2008-10#2)(2010-5#1)
acid digestion##20##2##(2008-10#18)(2010-5#1)(2011-2#1)
acid digests of##4##3##(1990-8#2)(2008-10#2)
acid dimethyl ester##2##3##(1996-5#2)
acid directly##2##2##(2008-10#2)
acid disodium salt##2##3##(2008-10#2)
acid dissociation constants##7##3##(2008-10#7)
acid dissociation##8##2##(1990-5#1)(2008-10#7)
acid dissolution of##4##3##(2008-10#4)
acid dissolution##7##2##(2008-10#7)
acid diuretic peptide##2##3##(1991-12#2)
acid due to##3##3##(1993-11#1)(2008-10#2)
acid efficiently##2##2##(2008-6#1)(2013-1#1)
acid elution##2##2##(1990-12#1)(2008-10#1)
acid emerged##2##2##(2008-10#1)(2010-3#1)
acid enantiomers##2##2##(1991-12#1)(2008-10#1)
acid enzyme##2##2##(1993-8#1)(2008-8#1)
acid esters of##2##3##(1995-6#1)(2008-11#1)
acid esters##10##2##(1991-5#1)(1991-9#2)(1994-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
acid etching##3##2##(2008-12#1)(2009-7#2)
acid ethyl ester &gt##2##4##(1997-7#2)
acid ethyl ester##11##3##(1992-6#4)(1995-2#1)(1995-3#1)(1997-7#2)(2008-10#1)(2009-8#1)(2011-1#1)
acid ethyl esters##2##3##(2007-11#1)(2008-11#1)
acid ethyl##13##2##(1992-6#4)(1995-2#1)(1995-3#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)
acid excretion and##2##3##(1993-12#1)(2008-10#1)
acid excretion##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
acid extraction##5##2##(1990-7#1)(2008-10#2)(2008-4#1)(2008-9#1)
acid extracts from##5##3##(1996-12#1)(2008-10#4)
acid extracts##10##2##(1991-7#1)(1996-12#1)(2008-10#8)
acid fast bacilli##2##3##(2007-7#1)(2008-1#1)
acid followed by##2##3##(2008-10#2)
acid for 24##2##3##(1997-4#1)(2013-1#1)
acid for both##2##3##(2008-11#1)(2013-1#1)
acid for the##7##3##(1990-12#1)(1991-12#1)(2008-10#3)(2008-5#1)(2008-8#1)
acid for##30##2##(1990-12#1)(1991-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-6#1)(2013-1#2)
acid form##4##2##(1991-12#1)(1992-12#1)(2008-10#2)
acid formation##2##2##(1994-3#1)(2008-6#1)
acid formed##4##2##(1991-2#1)(1991-5#2)(2008-10#1)
acid from the##5##3##(1990-12#1)(1991-5#1)(1992-8#1)(1994-8#1)(2011-2#1)
acid from##24##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-10#6)(2008-6#6)(2011-2#2)(2012-3#2)(2013-1#2)
acid functional groups)##2##3##(2008-10#2)
acid functional##5##2##(2008-10#3)(2008-5#1)(2010-2#1)
acid gastro-oesophageal reflux##3##3##(1996-3#3)
acid gave##2##2##(1996-5#1)(2008-11#1)
acid gel##3##2##(1990-8#2)(2010-8#1)
acid glycoprotein##2##2##(1990-2#1)(2008-10#1)
acid group##6##2##(1996-7#1)(2008-10#4)(2010-6#1)
acid groups##6##2##(1992-6#1)(2008-10#2)(2010-4#2)(2012-2#1)
acid had a##3##3##(1995-5#1)(2008-5#2)
acid had##5##2##(1990-11#1)(1995-5#1)(2008-10#1)(2008-5#2)
acid has been studied##2##4##(2008-10#2)
acid has been##9##3##(2007-11#1)(2008-10#8)
acid has##14##2##(1993-1#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
acid have##3##2##(1990-12#1)(2008-10#1)(2012-1#1)
acid herbicide##2##2##(2008-10#2)
acid herbicides##2##2##(2008-10#2)
acid hydrazide##2##2##(2007-11#2)
acid hydrolases##2##2##(1992-12#2)
acid hydrolysis and##2##3##(1994-11#1)(2010-2#1)
acid hydrolysis##16##2##(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1994-11#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
acid identity of##3##3##(1995-3#1)(2008-10#2)
acid identity##17##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#5)(2008-4#1)
acid immobilised onto glycidoxypropyl-modified Fractosil 1000)##2##6##(1997-2#2)
acid improves##2##2##(1994-6#1)(2008-11#1)
acid in a##10##3##(2008-10#8)(2008-6#1)(2013-1#1)
acid in acidic medium##3##4##(2008-10#3)
acid in acidic##4##3##(2008-10#4)
acid in an##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
acid in aqueous##5##3##(2008-10#4)(2008-5#1)
acid in fruit juices##3##4##(2008-10#3)
acid in human urine##6##4##(1995-12#1)(1997-2#1)(2008-10#4)
acid in human##8##3##(1995-12#1)(1997-2#1)(2008-10#5)(2008-5#1)
acid in mice##2##3##(1992-9#1)(1995-5#1)
acid in pharmaceutical formulations##5##4##(2008-10#5)
acid in pharmaceutical##7##3##(2008-10#7)
acid in pharmaceuticals##4##3##(2008-10#4)
acid in plasma##2##3##(1992-9#1)(2008-10#1)
acid in platelets##2##3##(1991-12#1)(1992-12#1)
acid in the presence of##5##5##(1995-11#1)(1997-2#1)(2008-10#2)(2012-3#1)
acid in the##41##3##(1990-5#1)(1990-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#2)(1995-11#1)(1995-5#2)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
acid in urine and##2##4##(2008-10#2)
acid in urine##7##3##(1990-8#1)(2008-10#6)
acid in various##2##3##(2008-10#2)
acid in vitro##2##3##(1994-6#1)(2008-10#1)
acid in water##3##3##(1996-5#1)(2008-10#1)(2011-3#1)
acid in##214##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#1)(1996-5#1)(1997-2#3)(1997-4#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#118)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
acid incorporation##5##2##(1990-11#2)(1994-8#2)(1995-11#1)
acid increases##3##2##(1993-3#1)(1993-8#2)
acid induced##5##2##(1992-5#1)(1994-3#1)(2008-10#1)(2008-9#1)(2011-2#1)
acid induces##2##2##(2008-10#1)(2009-6#1)
acid induction##2##2##(1993-9#1)(1994-9#1)
acid inhibited the##2##3##(1994-11#1)(2012-3#1)
acid inhibited##5##2##(1992-8#1)(1994-11#1)(1994-6#1)(2012-3#1)(2013-1#1)
acid inhibitor##2##2##(1993-11#1)(1996-11#1)
acid inhibitory##2##2##(1993-11#1)(1997-1#1)
acid inhibits the##2##3##(1990-12#1)(1994-6#1)
acid inhibits##6##2##(1990-12#2)(1994-6#1)(2008-10#1)(2008-6#1)(2009-8#1)
acid instead of##2##3##(1990-7#1)(1993-8#1)
acid interactions##2##2##(1993-6#1)(2008-8#1)
acid into the##3##3##(1990-7#1)(2008-10#1)(2011-3#1)
acid into##7##2##(1990-11#2)(1990-7#1)(2008-10#1)(2008-5#1)(2011-3#1)(2013-1#1)
acid invertase was##2##3##(2008-9#2)
acid invertase##9##2##(2008-9#9)
acid is a major##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
acid is a potent##4##4##(1992-12#1)(1992-8#1)(1993-8#1)(2010-2#1)
acid is a##7##3##(1992-12#1)(1992-8#1)(1993-8#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
acid is added to the##2##5##(1990-11#1)(2008-10#1)
acid is known##2##3##(2008-5#1)(2012-1#1)
acid is likely##2##3##(1994-8#1)(2011-2#1)
acid is necessary##2##3##(2008-10#1)(2009-8#1)
acid is present##2##3##(1994-5#1)(2008-6#1)
acid is reported##3##3##(2007-11#1)(2008-10#1)(2010-2#1)
acid is the##5##3##(1992-12#1)(2008-10#2)(2008-9#1)(2010-12#1)
acid is used##4##3##(2008-10#2)(2008-11#1)(2008-6#1)
acid is##62##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1992-12#2)(1992-8#2)(1993-3#1)(1993-8#2)(1994-5#2)(1994-8#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#20)(2008-11#4)(2008-3#1)(2008-5#3)(2008-6#4)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
acid itself##2##2##(2008-10#1)(2011-1#1)
acid lactase##2##2##(1991-12#2)
acid leachates from##2##3##(1997-4#2)
acid leachates##3##2##(1997-4#3)
acid leaching with##2##3##(2008-10#2)
acid leaching##4##2##(2008-10#4)
acid lesions##7##2##(1993-12#2)(1993-6#2)(1994-3#1)(1995-12#2)
acid level##7##2##(1990-11#1)(1991-9#1)(1992-12#1)(1994-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
acid levels and##4##3##(2008-10#1)(2011-1#2)(2012-2#1)
acid levels in##5##3##(1990-12#1)(1993-1#1)(1993-3#1)(1995-12#1)(2011-1#1)
acid levels were higher in##3##5##(1995-12#1)(1996-9#1)(2011-1#1)
acid levels were##5##3##(1990-12#1)(1995-12#1)(1996-9#1)(2008-4#1)(2011-1#1)
acid levels##24##2##(1990-12#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-12#2)(1995-8#1)(1996-7#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2010-1#1)(2011-1#5)(2012-2#1)(2013-1#1)
acid liberation induced by##2##4##(1994-3#1)(1995-11#1)
acid liberation##7##2##(1994-3#3)(1995-11#3)(1997-1#1)
acid ligand##2##2##(1993-8#1)(1995-2#1)
acid may be##6##3##(1992-12#1)(1992-8#1)(1992-9#1)(1995-11#1)(1996-5#1)(2008-10#1)
acid may##9##2##(1992-12#1)(1992-8#2)(1992-9#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-11#1)
acid media was##3##3##(2008-10#3)
acid media##18##2##(2008-10#18)
acid medium and##4##3##(2008-10#4)
acid medium to form##2##4##(2008-10#1)(2008-5#1)
acid medium to##3##3##(2008-10#2)(2008-5#1)
acid medium##45##2##(1993-9#1)(2008-10#43)(2008-5#1)
acid metabolism in##5##3##(1990-9#1)(1993-8#1)(1995-2#1)(2008-1#1)(2012-2#1)
acid metabolism##17##2##(1990-9#1)(1993-8#1)(1994-8#3)(1995-2#1)(2008-1#2)(2008-11#3)(2008-3#1)(2012-1#1)(2012-2#4)
acid method##4##2##(1990-8#1)(1992-11#1)(2008-10#2)
acid methyl ester (FAME)##5##4##(2008-10#4)(2009-3#1)
acid methyl ester##16##3##(1991-12#2)(2007-11#4)(2008-10#7)(2008-11#1)(2008-7#1)(2009-3#1)
acid methyl##24##2##(1991-12#2)(1997-2#1)(2007-11#4)(2008-10#11)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)(2013-1#1)
acid mine drainage (AMD)##2##4##(2008-10#2)
acid mine drainage##4##3##(2008-10#3)(2008-6#1)
acid mine##5##2##(2008-10#4)(2008-6#1)
acid mixture and##2##3##(2008-10#2)
acid mixture of##2##3##(2008-10#2)
acid mixture##11##2##(2008-10#10)(2012-12#1)
acid mixtures##5##2##(2008-10#4)(2008-5#1)
acid modified##4##2##(2008-10#4)
acid moieties##2##2##(2006-12#1)(2008-10#1)
acid moiety##3##2##(2008-10#3)
acid molecules##3##2##(1994-12#1)(2008-10#1)(2012-2#1)
acid monolayer##3##2##(2008-10#3)
acid nucleus basalis##2##3##(1991-9#2)
acid nucleus##3##2##(1991-9#2)(1993-6#1)
acid number determination##3##3##(2008-10#3)
acid number##4##2##(2008-10#4)
acid of the##2##3##(1994-2#1)(2008-10#1)
acid of##12##2##(1994-2#1)(1994-5#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
acid on the chemiluminescence##2##4##(2008-10#2)
acid on the viscosity##3##4##(1994-11#2)(2008-5#1)
acid on the##17##3##(1990-5#1)(1994-11#2)(1995-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2013-1#1)
acid on##49##2##(1990-10#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-8#2)(1993-3#1)(1993-8#2)(1994-11#3)(1994-8#1)(1995-5#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#5)(2008-6#2)(2010-12#1)(2010-5#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#3)
acid or protein##2##3##(1997-4#1)(2008-9#1)
acid or##33##2##(1990-11#1)(1990-7#1)(1991-12#3)(1991-2#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#17)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)
acid over the range##2##4##(2008-10#1)(2008-6#1)
acid oxidase##3##2##(2008-10#3)
acid oxidation##17##2##(1993-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-1#6)(2008-10#3)(2008-11#1)(2009-8#1)(2011-2#1)
acid pH##3##2##(1990-2#1)(2008-9#1)(2009-7#1)
acid patterns##2##2##(1990-7#1)(1992-12#1)
acid peels##2##2##(2007-7#2)
acid peptide in##2##3##(1992-6#1)(2008-11#1)
acid peptide##10##2##(1990-7#1)(1992-6#2)(1992-9#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
acid per##4##2##(1990-9#1)(2008-10#3)
acid phosphatase activity in##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
acid phosphatase activity##4##3##(1993-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
acid phosphatase in##2##3##(1995-3#1)(2008-12#1)
acid phosphatase##22##2##(1990-9#1)(1991-8#1)(1992-12#3)(1992-3#3)(1993-11#1)(1993-8#2)(1995-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#3)(2012-1#1)(2013-1#2)
acid photo-oxidation assay##2##3##(2008-5#2)
acid plus##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
acid polymers are##2##3##(2008-5#2)
acid polymers##5##2##(2008-5#5)
acid polypeptide##3##2##(1991-9#1)(1992-8#1)(1995-2#1)
acid pool##4##2##(1990-12#3)(2008-8#1)
acid preparation##4##2##(2008-10#1)(2013-1#3)
acid pretreatment on cadmium toxicity in##2##6##(1993-12#2)
acid pretreatment##9##2##(1993-12#5)(2013-1#4)
acid prevents##2##2##(1990-11#1)(1991-5#1)
acid probes##4##2##(2008-10#2)(2008-9#2)
acid produced by##3##3##(2008-5#1)(2008-6#2)
acid produced##5##2##(1990-2#1)(2008-5#1)(2008-6#3)
acid production and##3##3##(1994-3#1)(2008-10#1)(2012-1#1)
acid production by a##2##4##(2008-7#1)(2012-2#1)
acid production by the##2##4##(2008-10#2)
acid production by##6##3##(2008-10#2)(2008-7#3)(2012-2#1)
acid production in##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
acid production rate##2##3##(2008-6#1)(2008-7#1)
acid production using##2##3##(2008-6#2)
acid production was##2##3##(1993-3#1)(2008-7#1)
acid production##33##2##(1991-5#1)(1993-3#1)(1994-3#1)(2008-10#8)(2008-5#3)(2008-6#5)(2008-7#9)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
acid profile##8##2##(1996-7#1)(2008-5#1)(2010-11#1)(2010-4#2)(2011-2#2)(2013-1#1)
acid profiles##14##2##(1991-12#1)(2008-10#9)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
acid protein##12##2##(1990-12#1)(1991-5#1)(1991-9#2)(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)
acid proteins##2##2##(1995-8#1)(2008-9#1)
acid provided##3##2##(2008-11#2)(2008-7#1)
acid provides##2##2##(1992-8#2)
acid pump inhibitor##2##3##(1996-3#2)
acid rain on##2##3##(2008-10#2)
acid rain##6##2##(2008-10#6)
acid ratio##3##2##(1994-9#1)(2008-12#1)(2012-2#1)
acid reached##2##2##(1992-3#1)(2008-6#1)
acid reaction##3##2##(2008-10#3)
acid reactive substance##4##3##(1994-6#1)(1995-12#1)(2008-10#1)(2012-2#1)
acid reactive substances##12##3##(1992-3#2)(1993-2#1)(1995-3#1)(2008-10#3)(2011-2#4)(2012-2#1)
acid reactive##17##2##(1992-3#2)(1993-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(2008-10#4)(2010-5#1)(2011-2#4)(2012-2#2)
acid reacts with##2##3##(1994-5#2)
acid receptor##7##2##(1991-9#1)(1992-3#1)(1992-8#1)(1995-2#1)(2007-12#1)(2012-1#1)(2012-2#1)
acid reduced##5##2##(1990-7#1)(1992-12#1)(1994-6#1)(2008-10#2)
acid reduces##2##2##(1990-12#1)(2008-10#1)
acid region of##2##3##(1994-5#1)(1995-6#1)
acid region##5##2##(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#2)
acid regurgitation##2##2##(2013-1#2)
acid release and##3##3##(1991-12#1)(1997-1#1)(2009-12#1)
acid release##10##2##(1990-2#1)(1991-12#3)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
acid released from the##2##4##(2008-11#1)(2008-5#1)
acid released##4##2##(2008-11#1)(2008-5#3)
acid remaining in##2##3##(1994-6#1)(2012-2#1)
acid repression##2##2##(1996-3#2)
acid requirements##2##2##(1997-4#1)(2012-2#1)
acid residue in the##2##4##(1991-2#1)(1993-11#1)
acid residue in##3##3##(1991-2#1)(1993-11#1)(2008-8#1)
acid residue##21##2##(1991-2#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-8#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)
acid residues in##12##3##(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#2)(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
acid residues of##8##3##(1992-9#1)(1995-2#2)(1995-3#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
acid residues were##2##3##(1990-7#1)(1994-9#1)
acid residues while##2##3##(1990-5#1)(1994-11#1)
acid residues##111##2##(1990-11#2)(1990-12#3)(1990-5#3)(1990-7#3)(1990-8#1)(1991-12#5)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#6)(1992-9#1)(1993-11#4)(1993-3#3)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#3)(1996-10#3)(1997-2#2)(1997-4#4)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
acid resulted in a##2##4##(1992-8#1)(2013-1#1)
acid resulted in##3##3##(1992-8#1)(2008-5#1)(2013-1#1)
acid results in##2##3##(1994-6#1)(1996-5#1)
acid revealed##2##2##(2008-10#1)(2008-7#1)
acid salt##2##2##(1995-3#1)(2008-10#1)
acid samples##5##2##(1990-8#1)(2008-10#2)(2008-4#2)
acid secretion and##3##3##(1992-6#1)(1997-1#2)
acid secretion in the##2##4##(1993-12#2)
acid secretion in##5##3##(1992-6#1)(1993-12#3)(1995-12#1)
acid secretion is##3##3##(1997-1#3)
acid secretion##26##2##(1990-9#1)(1992-6#3)(1993-11#1)(1993-12#3)(1994-2#1)(1995-12#1)(1997-1#14)(1997-6#1)(2008-10#1)
acid secretory##2##2##(1995-12#1)(1997-1#1)
acid self-assembled##2##2##(2008-10#2)
acid sequence analysis of the##2##5##(1992-3#1)(1994-5#1)
acid sequence analysis of##4##4##(1992-12#1)(1992-3#1)(1994-5#1)(1995-6#1)
acid sequence analysis##11##3##(1990-2#1)(1990-7#1)(1991-12#1)(1992-12#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)
acid sequence data##4##3##(1991-10#1)(1991-9#1)(1992-8#1)(2008-10#1)
acid sequence differences##2##3##(2008-10#1)(2008-9#1)
acid sequence of the##29##4##(1990-12#1)(1990-5#2)(1990-7#3)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1996-12#3)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)
acid sequence of##74##3##(1990-11#1)(1990-12#2)(1990-5#3)(1990-7#5)(1991-12#4)(1991-2#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#4)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#3)(1994-6#2)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#4)(1996-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-2#1)
acid sequence similarity##4##3##(1995-11#1)(2008-10#2)(2011-1#1)
acid sequence##240##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#4)(1990-7#8)(1990-8#2)(1991-10#1)(1991-12#6)(1991-2#5)(1991-5#3)(1991-6#2)(1991-9#4)(1992-10#1)(1992-12#7)(1992-3#9)(1992-6#2)(1992-7#1)(1992-8#9)(1992-9#5)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#5)(1993-9#5)(1994-11#4)(1994-12#5)(1994-5#1)(1994-6#6)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#8)(1995-8#3)(1996-10#4)(1996-12#8)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#5)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#5)(2009-2#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
acid sequences by##2##3##(2008-9#1)(2012-2#1)
acid sequences of the##17##4##(1991-12#1)(1993-12#2)(1993-3#1)(1995-5#1)(1996-8#1)(1997-6#1)(2007-6#1)(2008-10#8)(2008-5#1)
acid sequences of##52##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-9#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)
acid sequences##109##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-5#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#7)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-6#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
acid sequencing##10##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-7#1)
acid show##2##2##(1997-4#1)(2008-10#1)
acid showed##5##2##(2008-10#2)(2008-11#1)(2009-12#1)(2012-2#1)
acid side chains##4##3##(1990-12#1)(1992-3#1)(1995-5#1)(2009-8#1)
acid signal##4##2##(1991-2#1)(1992-3#1)(1994-11#1)(2008-10#1)
acid significantly##4##2##(1994-6#1)(2008-5#1)(2008-7#2)
acid sites##2##2##(2008-10#1)(2013-1#1)
acid skin##2##2##(2008-5#1)(2012-2#1)
acid sodium##2##2##(1993-9#1)(2008-10#1)
acid soil##2##2##(2008-10#2)
acid soils##3##2##(2008-10#2)(2009-8#1)
acid solution (pH 2)##2##4##(2008-10#2)
acid solution and##5##3##(2008-10#4)(2008-5#1)
acid solution as##2##3##(2008-10#2)
acid solution containing##2##3##(2008-10#2)
acid solution to##2##3##(2008-10#2)
acid solution##40##2##(1991-2#1)(1996-2#1)(2008-10#36)(2008-5#1)(2011-1#1)
acid solutions##12##2##(1992-12#1)(2008-10#10)(2008-4#1)
acid stability##3##2##(1997-4#3)
acid stream (flow rate##2##4##(2008-10#2)
acid structure##5##2##(2008-4#4)(2010-11#1)
acid substituent##2##2##(1991-5#1)(1995-2#1)
acid substitution in the##4##4##(1991-1#1)(1995-8#1)(2008-10#2)
acid substitution in##5##3##(1990-11#1)(1991-1#1)(1995-8#1)(2008-10#2)
acid substitution##19##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-8#1)(2006-6#1)(2008-10#4)(2008-8#1)(2011-3#1)(2012-12#1)
acid substitutions at##3##3##(1995-5#1)(1997-8#1)(2008-4#1)
acid substitutions in the##4##4##(1991-2#1)(1991-6#1)(2008-10#1)(2013-8#1)
acid substitutions in##7##3##(1990-11#1)(1991-2#1)(1991-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
acid substitutions##34##2##(1990-11#1)(1990-8#4)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-8#1)(1997-9#2)(2008-10#2)(2008-4#7)(2008-8#1)(2009-8#2)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
acid substrate##3##2##(1992-6#1)(1994-9#1)(2008-7#1)
acid such as##2##3##(1993-8#1)(2008-10#1)
acid supplementation on##2##3##(1993-6#1)(2008-11#1)
acid supplementation##5##2##(1992-9#1)(1993-6#2)(2008-11#1)(2011-1#1)
acid supplements##3##2##(1992-9#2)(2008-5#1)
acid synthase##4##2##(1995-2#2)(2009-8#1)(2012-2#1)
acid synthesis by##2##3##(1992-8#1)(1993-12#1)
acid synthesis##14##2##(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#1)(1995-6#2)(1996-5#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
acid synthesized by##2##3##(2007-10#1)(2013-1#1)
acid system##2##2##(2008-10#1)(2008-5#1)
acid than##2##2##(1994-11#1)(2008-10#1)
acid that##3##2##(2008-10#2)(2008-5#1)
acid there was##2##3##(2008-5#1)(2011-2#1)
acid through##2##2##(1994-3#1)(2008-10#1)
acid to a##2##3##(1993-9#1)(2008-5#1)
acid to be##3##3##(1994-8#1)(2008-11#1)(2008-5#1)
acid to form##4##3##(2008-10#3)(2008-6#1)
acid to the##8##3##(1990-12#1)(1991-8#1)(1996-5#1)(2008-10#3)(2008-5#1)(2009-6#1)
acid to##56##2##(1990-12#1)(1990-7#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#27)(2008-11#1)(2008-5#5)(2008-6#4)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
acid toxicity##2##2##(1995-5#1)(2008-6#1)
acid transfer##2##2##(1992-8#1)(2011-2#1)
acid transport by##2##3##(1994-8#1)(2011-2#1)
acid transport system##2##3##(1990-5#1)(1991-9#1)
acid transport through##2##3##(1990-12#1)(1995-2#1)
acid transport##10##2##(1990-12#3)(1990-5#1)(1991-9#2)(1994-8#1)(1995-2#1)(2011-2#2)
acid transporter##5##2##(1994-12#1)(2008-5#1)(2012-2#3)
acid treated##2##2##(2008-8#1)(2013-1#1)
acid treatment of the##2##4##(1991-9#1)(1992-6#1)
acid treatment##13##2##(1991-9#1)(1992-6#1)(1996-5#1)(2008-10#5)(2008-8#2)(2010-12#1)(2010-3#1)(2010-5#1)
acid under##3##2##(2008-10#2)(2010-7#1)
acid units##2##2##(2008-10#2)
acid uptake##5##2##(1992-3#1)(1995-11#3)(2008-11#1)
acid urease##3##2##(2008-10#3)
acid using a##3##3##(2008-10#3)
acid using an##2##3##(2008-10#2)
acid using##13##2##(2007-12#1)(2008-10#11)(2008-6#1)
acid values in##4##3##(2008-10#4)
acid vapor partial digestion##2##4##(2008-10#2)
acid vapor##5##2##(2008-10#5)
acid variations##2##2##(2008-5#2)
acid volume##3##2##(2008-10#3)
acid was achieved##2##3##(2008-10#2)
acid was added to the##3##5##(2008-10#3)
acid was added to##5##4##(2008-10#5)
acid was also##3##3##(2008-10#2)(2008-9#1)
acid was between##2##3##(2008-10#1)(2011-1#1)
acid was determined by##2##4##(2008-7#1)(2012-3#1)
acid was developed##2##3##(2008-10#2)
acid was found to be the##2##6##(2009-3#1)(2011-2#1)
acid was found to be##5##5##(1991-5#1)(1992-12#1)(2008-11#1)(2009-3#1)(2011-2#1)
acid was found to##7##4##(1991-5#1)(1992-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-2#1)
acid was found##9##3##(1991-5#1)(1992-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
acid was made##2##3##(2008-10#2)
acid was not##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
acid was observed with##2##4##(1994-3#1)(2012-2#1)
acid was performed##2##3##(2008-10#1)(2013-1#1)
acid was produced efficiently from##2##5##(2008-6#1)(2011-2#1)
acid was produced##5##3##(2008-6#3)(2011-2#2)
acid was selected##3##3##(2008-10#2)(2008-5#1)
acid was studied##2##3##(2008-10#2)
acid was the##2##3##(2008-10#2)
acid was used for the##2##5##(2008-10#2)
acid was used for##5##4##(1997-2#2)(2008-10#3)
acid was used to##2##4##(2008-10#1)(2008-2#1)
acid was used##9##3##(1990-8#1)(1997-2#2)(2008-10#5)(2008-2#1)
acid was verified##2##3##(2008-10#2)
acid was##103##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-5#3)(1992-12#1)(1992-3#2)(1994-3#1)(1994-6#2)(1997-2#2)(2008-10#55)(2008-11#4)(2008-2#1)(2008-5#5)(2008-6#5)(2008-7#1)(2008-9#5)(2009-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)
acid were also##2##3##(1990-5#1)(2013-1#1)
acid were determined by##2##4##(2008-10#2)
acid were determined##4##3##(2008-10#4)
acid were found to##2##4##(1990-10#1)(2013-1#1)
acid were found##4##3##(1990-10#1)(2008-11#2)(2013-1#1)
acid were investigated##3##3##(2008-10#2)(2008-6#1)
acid were the##2##3##(2008-11#1)(2010-4#1)
acid were used##2##3##(2008-10#2)
acid were##42##2##(1990-10#1)(1990-5#3)(1991-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1997-7#1)(2007-10#1)(2008-10#21)(2008-11#4)(2008-6#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
acid when##3##2##(2008-10#3)
acid which is##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
acid which##8##2##(1992-6#1)(1993-8#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-2#1)
acid with a##10##3##(1994-2#1)(2008-10#7)(2011-2#1)(2012-2#1)
acid with alkaline##3##3##(2008-10#3)
acid with the##3##3##(2008-10#3)
acid with##45##2##(1990-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-3#1)(2008-10#28)(2008-11#1)(2008-5#5)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
acid without##4##2##(2008-10#3)(2013-1#1)
acid would##3##2##(1991-2#1)(2008-6#1)(2009-5#1)
acid yielded##2##2##(1992-9#1)(2008-10#1)
acid##5601##1##(1990-10#5)(1990-11#31)(1990-12#46)(1990-2#25)(1990-3#5)(1990-5#51)(1990-6#5)(1990-7#36)(1990-8#47)(1990-9#7)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#54)(1991-2#36)(1991-3#3)(1991-5#36)(1991-6#12)(1991-7#4)(1991-8#16)(1991-9#43)(1992-1#2)(1992-10#8)(1992-11#17)(1992-12#49)(1992-2#5)(1992-3#58)(1992-4#7)(1992-5#10)(1992-6#33)(1992-7#4)(1992-8#71)(1992-9#36)(1993-1#7)(1993-10#1)(1993-11#39)(1993-12#38)(1993-2#9)(1993-3#37)(1993-5#1)(1993-6#36)(1993-8#57)(1993-9#18)(1994-10#2)(1994-11#51)(1994-12#27)(1994-2#11)(1994-3#24)(1994-5#35)(1994-6#40)(1994-8#44)(1994-9#27)(1995-10#1)(1995-11#48)(1995-12#42)(1995-2#33)(1995-3#36)(1995-5#39)(1995-6#37)(1995-8#19)(1995-9#2)(1996-10#8)(1996-11#1)(1996-12#25)(1996-2#10)(1996-3#13)(1996-5#45)(1996-6#9)(1996-7#12)(1996-8#2)(1996-9#2)(1997-1#26)(1997-2#42)(1997-3#13)(1997-4#39)(1997-6#8)(1997-7#24)(1997-8#15)(1997-9#7)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#2)(2007-1#6)(2007-10#3)(2007-11#27)(2007-12#9)(2007-3#1)(2007-4#2)(2007-6#5)(2007-7#9)(2007-8#1)(2008-1#17)(2008-10#2119)(2008-11#153)(2008-12#27)(2008-2#14)(2008-3#27)(2008-4#75)(2008-5#219)(2008-6#130)(2008-7#91)(2008-8#61)(2008-9#78)(2009-10#5)(2009-11#3)(2009-12#10)(2009-2#6)(2009-3#4)(2009-4#2)(2009-5#6)(2009-6#20)(2009-7#9)(2009-8#27)(2009-9#9)(2010-1#10)(2010-10#5)(2010-11#7)(2010-12#12)(2010-2#20)(2010-3#20)(2010-4#32)(2010-5#12)(2010-6#7)(2010-7#6)(2010-8#2)(2010-9#2)(2011-1#56)(2011-10#3)(2011-2#86)(2011-3#6)(2012-1#20)(2012-12#18)(2012-2#76)(2012-3#34)(2012-9#3)(2013-1#120)(2013-7#6)(2013-8#27)
acid&gt##4##1##(2008-10#4)
acid) (ABTS)##2##2##(2008-10#2)
acid) (PLGA)##4##2##(2009-11#2)(2009-7#2)
acid) and##25##2##(1990-7#1)(1990-8#2)(1994-8#1)(1995-11#1)(2008-10#15)(2008-3#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-1#1)
acid) are##2##2##(1990-3#1)(2008-10#1)
acid) as a##2##3##(2008-10#2)
acid) as##4##2##(2008-10#3)(2011-1#1)
acid) films##2##2##(2008-10#1)(2010-4#1)
acid) in##6##2##(2008-10#6)
acid) was##2##2##(2008-10#1)(2008-7#1)
acid) were##5##2##(1990-5#1)(2008-10#4)
acid)##137##1##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#2)(1995-11#4)(1995-6#1)(1995-8#2)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#74)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#5)(2009-12#1)(2009-7#3)(2010-3#1)(2010-4#4)(2010-5#1)(2011-1#3)(2012-12#1)(2013-1#4)
acid- and##2##2##(1994-11#1)(1997-1#1)
acid- or##2##2##(2008-10#1)(2008-11#1)
acid-##6##1##(1994-11#1)(1997-1#1)(2008-10#2)(2008-11#2)
acid-(1--&gt##4##1##(1992-12#2)(2010-6#2)
acid-2K##2##1##(2008-10#2)
acid-NaOH (pH##2##2##(2008-10#2)
acid-activated##2##1##(1990-12#1)(1993-12#1)
acid-ammonium##2##1##(1990-10#1)(2008-10#1)
acid-assisted##4##1##(2008-10#2)(2013-1#2)
acid-base balance##4##2##(2007-12#1)(2008-5#1)(2010-7#1)(2012-3#1)
acid-base behavior##4##2##(2008-10#4)
acid-base catalysis##2##2##(1993-8#1)(2008-10#1)
acid-base equilibria in##2##3##(2008-10#2)
acid-base equilibria of##3##3##(2008-10#3)
acid-base equilibria##8##2##(2008-10#8)
acid-base indicator##2##2##(2008-10#2)
acid-base indicators##3##2##(2008-10#3)
acid-base properties of the##3##4##(1995-6#1)(2008-10#2)
acid-base properties of##4##3##(1995-6#1)(2008-10#3)
acid-base properties##8##2##(1995-6#1)(2008-10#7)
acid-base systems##2##2##(2008-10#2)
acid-base titration##4##2##(2008-10#4)
acid-base##53##1##(1993-8#2)(1994-5#1)(1995-6#1)(2007-12#2)(2008-10#42)(2008-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
acid-based##8##1##(2007-12#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-2#2)(2013-1#1)
acid-binding protein##6##2##(1994-8#2)(1997-4#2)(2013-1#2)
acid-binding##12##1##(1991-2#1)(1993-2#1)(1994-8#2)(1997-4#2)(2008-10#1)(2008-8#3)(2013-1#2)
acid-catalyzed##6##1##(1995-3#2)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#1)
acid-coated##3##1##(2008-10#1)(2008-11#2)
acid-containing##6##1##(1991-8#1)(1994-9#2)(2008-6#1)(2011-3#2)
acid-dependent##3##1##(2008-10#2)(2009-6#1)
acid-digested##4##1##(2008-10#4)
acid-digestion##3##1##(2008-10#3)
acid-extractable##3##1##(2008-10#3)
acid-fast bacilli##3##2##(1991-11#1)(2008-11#1)(2013-1#1)
acid-fast organisms##2##2##(1993-2#2)
acid-fast##7##1##(1991-11#1)(1993-2#2)(1996-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
acid-imbedded##3##1##(2008-10#3)
acid-induced##17##1##(1991-8#1)(1992-12#1)(1992-9#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#3)(2013-7#2)
acid-insoluble##2##1##(1992-11#1)(2008-11#1)
acid-labile##2##1##(1997-7#1)(2008-4#1)
acid-matched##2##1##(2008-10#2)
acid-mediated##2##1##(2010-2#1)(2012-2#1)
acid-pretreated##2##1##(2013-1#2)
acid-reactive substances##5##2##(1995-12#4)(2010-4#1)
acid-reactive##6##1##(1995-12#4)(2010-4#1)(2012-5#1)
acid-related symptom##2##2##(2013-1#2)
acid-related symptoms##3##2##(2013-1#3)
acid-related##6##1##(2011-2#1)(2013-1#5)
acid-resistant##3##1##(1995-8#1)(1996-2#1)(2008-10#1)
acid-responsive##2##1##(1997-7#1)(2008-7#1)
acid-rich##7##1##(1992-8#2)(1994-11#1)(1994-6#1)(1995-2#1)(2008-6#1)(2008-8#1)
acid-sensitive##2##1##(1992-9#2)
acid-sodium acetate##6##2##(2008-10#6)
acid-sodium##7##1##(2008-10#7)
acid-soluble##4##1##(1996-8#1)(1997-2#2)(2008-3#1)
acid-stable##4##1##(1990-11#1)(1992-9#1)(1995-3#2)
acid-volatile##2##1##(2008-10#2)
acid-washed PM 1648 instilled mice##2##5##(2008-10#2)
acid-washed PM 1648 instilled##3##4##(2008-10#3)
acid-washed PM 1648##5##3##(2008-10#5)
acid/base##2##1##(2008-10#2)
acid]##7##1##(1990-3#1)(1994-9#1)(1995-12#1)(2008-10#2)(2012-2#1)(2012-3#1)
acidic Fc-fusion##2##2##(2011-2#2)
acidic amino acids##2##3##(1990-7#1)(2008-5#1)
acidic amino##3##2##(1990-7#1)(2008-4#1)(2008-5#1)
acidic and alkaline##2##3##(2008-10#2)
acidic and basic##10##3##(1993-11#1)(1997-4#1)(2008-10#6)(2008-5#1)(2012-3#1)
acidic and calcareous soils##2##4##(2012-6#2)
acidic and neutral##4##3##(1990-8#1)(1994-9#1)(2008-10#2)
acidic and##25##2##(1990-8#1)(1991-6#1)(1993-11#1)(1994-9#1)(1997-4#1)(2008-10#13)(2008-5#2)(2012-12#1)(2012-3#1)(2012-6#2)(2013-1#1)
acidic aqueous##3##2##(2008-10#3)
acidic buffer##3##2##(2008-10#3)
acidic carrier##3##2##(2008-10#3)
acidic cation exchanger##2##3##(2008-10#2)
acidic compounds##2##2##(2008-10#2)
acidic conditions (pH##2##3##(1991-12#1)(2008-10#1)
acidic conditions##21##2##(1990-8#2)(1991-12#1)(1995-8#1)(1996-5#2)(2008-10#11)(2008-4#1)(2010-3#1)(2012-2#2)
acidic domain##2##2##(1993-2#1)(1995-6#1)
acidic exchange##2##2##(2008-10#2)
acidic fibroblast growth factor##4##4##(1990-8#2)(1991-2#1)(1997-7#1)
acidic glycosphingolipids##2##2##(1990-7#1)(1994-3#1)
acidic groups##3##2##(2008-10#3)
acidic hydrolysis of##3##3##(2008-10#3)
acidic hydrolysis##5##2##(1997-2#2)(2008-10#3)
acidic ion##2##2##(1990-8#1)(2008-10#1)
acidic lipid bilayers##2##3##(1990-2#2)
acidic lipids in the##2##4##(1994-5#2)
acidic media has been##2##4##(2008-10#2)
acidic media##22##2##(1995-8#1)(2008-10#17)(2009-11#1)(2010-3#1)(2010-6#1)(2012-2#1)
acidic medium and##3##3##(2008-10#3)
acidic medium is##2##3##(2008-10#2)
acidic medium to form a##4##5##(2008-10#4)
acidic medium to form##7##4##(2008-10#7)
acidic medium##39##2##(2008-10#38)(2008-8#1)
acidic membrane ion exchanger was##2##5##(1994-5#2)
acidic metabolites were##2##3##(2008-10#2)
acidic methanol##2##2##(1990-9#1)(2008-10#1)
acidic oligosaccharides were##2##3##(1993-11#2)
acidic or##3##2##(2008-10#2)(2008-11#1)
acidic pH and##3##3##(1991-12#1)(2008-8#1)(2013-8#1)
acidic pH##17##2##(1991-12#2)(1991-5#1)(1992-11#1)(1994-5#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-8#4)(2013-8#1)
acidic phospholipid bilayers##2##3##(1990-2#2)
acidic phospholipid##3##2##(1990-2#2)(2008-7#1)
acidic potassium permanganate chemiluminescence##2##4##(2008-10#2)
acidic potassium permanganate##8##3##(2008-10#8)
acidic protease##3##2##(1993-12#3)
acidic protein##13##2##(1990-7#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-1#1)
acidic proteins##2##2##(2008-4#1)(2009-8#1)
acidic recognition site##2##3##(1994-5#2)
acidic residues##4##2##(1992-7#1)(1994-5#1)(1994-8#1)(1995-6#1)
acidic resins##4##2##(2008-10#4)
acidic silica column##2##3##(2008-10#2)
acidic soil##6##2##(2008-10#1)(2008-12#1)(2012-6#2)(2012-9#2)
acidic solution (pH##2##3##(2008-10#2)
acidic solution##18##2##(2008-10#16)(2008-11#1)(2008-5#1)
acidic solutions of##2##3##(2008-10#2)
acidic solutions##5##2##(2008-10#5)
acidic streams using##2##3##(2008-10#2)
acidic waste solutions##2##3##(2008-10#2)
acidic waste##4##2##(2008-10#4)
acidic##372##1##(1990-10#1)(1990-2#4)(1990-5#1)(1990-7#5)(1990-8#8)(1990-9#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#3)(1992-11#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#4)(1993-12#3)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#12)(1994-6#3)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#4)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#2)(2006-6#3)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#210)(2008-11#5)(2008-12#2)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#1)(2009-1#1)(2009-11#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#1)(2012-6#4)(2012-9#2)(2013-1#2)(2013-8#1)
acidification and##2##2##(1990-2#1)(2008-10#1)
acidification by##2##2##(1992-6#1)(2008-10#1)
acidification gradient##3##2##(2012-3#3)
acidification in##2##2##(2008-10#1)(2008-7#1)
acidification of the samples##2##4##(2008-10#2)
acidification of the##7##3##(1990-11#1)(2008-10#4)(2008-9#1)(2009-10#1)
acidification of##8##2##(1990-11#1)(1994-8#1)(2008-10#4)(2008-9#1)(2009-10#1)
acidification##37##1##(1990-11#1)(1990-2#3)(1990-7#1)(1992-6#1)(1994-6#2)(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#18)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#2)(2012-3#3)
acidified samples##3##2##(2008-10#3)
acidified seawater##2##2##(2012-12#2)
acidified urine##2##2##(2008-10#2)
acidified water##2##2##(2008-10#2)
acidified with 0##3##3##(2008-10#3)
acidified with##5##2##(2008-10#5)
acidified##37##1##(1990-12#2)(2007-12#1)(2008-10#28)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)
acidify the##4##2##(1992-6#1)(1994-6#1)(2008-10#1)(2011-1#1)
acidify##5##1##(1992-6#1)(1994-6#1)(1997-4#1)(2008-10#1)(2011-1#1)
acidifying##4##1##(1993-8#1)(2008-10#2)(2008-7#1)
acidities##6##1##(2008-10#6)
acidity and##8##2##(2007-12#1)(2008-10#7)
acidity as##2##2##(2008-10#2)
acidity constants of##7##3##(2008-10#7)
acidity constants##9##2##(2008-10#9)
acidity in##3##2##(2008-10#2)(2008-5#1)
acidity of the##8##3##(2008-10#7)(2013-1#1)
acidity of##12##2##(2008-10#11)(2013-1#1)
acidity were##2##2##(2008-10#2)
acidity##79##1##(1995-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#64)(2008-4#1)(2008-5#4)(2011-2#2)(2012-2#2)(2013-1#2)
acidless##2##1##(2008-5#2)
acidobasic##2##1##(2008-10#2)
acidocaldarius##3##1##(1990-2#3)
acidophila can##2##2##(2008-6#2)
acidophila##6##1##(2008-6#6)
acidophilus LA-1##2##2##(2008-5#2)
acidophilus##9##1##(2008-5#6)(2012-2#2)(2013-1#1)
acidosis and##7##2##(1990-12#2)(1990-3#2)(1990-8#1)(1993-6#1)(2008-5#1)
acidosis in##2##2##(1996-11#1)(2007-7#1)
acidosis##35##1##(1990-12#2)(1990-3#2)(1990-5#3)(1990-8#1)(1991-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1996-11#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-1#1)
acidotic crises##2##2##(1994-3#2)
acidotic##4##1##(1990-6#1)(1994-3#2)(2012-12#1)
acids (2##3##2##(1993-6#1)(2008-10#2)
acids (HA)##4##2##(2008-10#4)
acids (HAs)##3##2##(2008-10#3)
acids (pKa &lt##2##3##(1995-5#2)
acids (pKa##3##2##(1995-5#3)
acids 5##2##2##(1996-5#1)(2008-10#1)
acids accounted for##2##3##(1990-5#1)(2010-11#1)
acids acting##2##2##(1992-9#1)(2013-1#1)
acids also##5##2##(2006-12#1)(2008-5#1)(2008-8#2)(2011-1#1)
acids analysis and##2##3##(2008-10#1)(2008-8#1)
acids analyzed##2##2##(2008-10#1)(2008-11#1)
acids and DNA##2##3##(2008-10#1)(2010-5#1)
acids and bases##3##3##(2008-10#3)
acids and cholesterol##3##3##(1992-8#2)(2012-2#1)
acids and for##2##3##(2008-10#2)
acids and glucose##2##3##(1994-5#1)(2010-8#1)
acids and has##4##3##(1990-7#2)(1992-8#1)(2008-9#1)
acids and iron load##2##4##(2012-2#2)
acids and iron##5##3##(2012-2#5)
acids and metal##3##3##(2008-10#2)(2013-1#1)
acids and other##3##3##(2006-12#1)(2008-10#2)
acids and sterols##2##3##(2008-10#2)
acids and the determination of##2##5##(2008-10#2)
acids and the##4##3##(1991-12#1)(1995-5#1)(2008-10#2)
acids and their##6##3##(1997-2#1)(2008-1#1)(2008-10#3)(2008-9#1)
acids and then##2##3##(2008-10#2)
acids and to##2##3##(1990-11#1)(1991-7#1)
acids and##121##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-12#3)(1991-5#2)(1991-7#1)(1991-8#1)(1992-8#4)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#3)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-2#2)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#49)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#6)(2013-1#5)(2013-8#1)
acids are analyzed by##2##4##(2008-4#2)
acids are extracted in##2##4##(2008-10#2)
acids are important##2##3##(2008-5#1)(2011-1#1)
acids are not##2##3##(1993-2#1)(2010-10#1)
acids are prepared##2##3##(1992-11#1)(2008-10#1)
acids are used##3##3##(1994-12#1)(1996-12#1)(2008-8#1)
acids are##35##2##(1992-11#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-7#2)(2006-12#1)(2008-10#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
acids as well as##4##4##(1995-3#1)(2008-10#2)(2008-5#1)
acids as##15##2##(1993-11#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-5#3)(2011-1#1)(2012-2#1)(2013-1#1)
acids at pH##3##3##(1994-12#1)(1995-6#2)
acids at the##7##3##(1992-6#1)(1992-9#1)(2008-10#4)(2008-9#1)
acids at##17##2##(1992-6#1)(1992-9#1)(1994-12#1)(1995-6#2)(1996-5#1)(2008-10#8)(2008-9#2)(2012-2#1)
acids based on##2##3##(2008-10#2)
acids based##3##2##(1991-7#1)(2008-10#2)
acids but not##2##3##(2008-10#1)(2011-2#1)
acids but##3##2##(2008-10#2)(2011-2#1)
acids by a##2##3##(2008-10#1)(2011-1#1)
acids by gas chromatography##2##4##(2008-10#1)(2008-12#1)
acids by gas##3##3##(2008-10#2)(2008-12#1)
acids by##26##2##(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#2)(2008-10#14)(2008-12#1)(2008-5#2)(2010-2#1)(2011-1#1)(2011-2#1)
acids can be##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
acids can##5##2##(1990-8#1)(2007-11#1)(2008-10#3)
acids could be##2##3##(1995-3#1)(2008-10#1)
acids could##3##2##(1995-3#1)(2008-10#1)(2008-4#1)
acids extracted from##2##3##(2008-10#2)
acids for##8##2##(1990-11#1)(1990-12#4)(2008-10#1)(2008-5#1)(2012-1#1)
acids found in##2##3##(2008-10#2)
acids from an##2##3##(2008-10#2)
acids from different##2##3##(2008-10#1)(2009-8#1)
acids from the##9##3##(1991-5#1)(1992-12#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-6#1)
acids from##32##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-8#2)(1995-12#1)(1995-2#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-6#3)(2009-8#1)(2013-1#1)
acids had##2##2##(2008-10#1)(2008-5#1)
acids has been developed##2##4##(1992-11#1)(2008-10#1)
acids has been##5##3##(1990-12#1)(1990-2#1)(1992-11#1)(2008-10#2)
acids has##9##2##(1990-12#1)(1990-2#2)(1992-11#1)(1996-6#1)(2008-10#3)(2008-8#1)
acids have been carried out in##2##6##(2008-10#2)
acids have been##8##3##(1992-11#1)(2008-10#4)(2008-9#1)(2010-1#1)(2012-3#1)
acids have##9##2##(1990-3#1)(1992-11#1)(2008-10#4)(2008-9#1)(2010-1#1)(2012-3#1)
acids having##2##2##(2008-10#1)(2013-1#1)
acids in N##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
acids in a##3##3##(1990-8#1)(2008-10#2)
acids in all##2##3##(1991-12#1)(1992-3#1)
acids in betaine##2##3##(2008-10#2)
acids in cerebrospinal fluid##2##4##(1994-9#2)
acids in dilute aqueous##2##4##(2008-10#2)
acids in plasma##3##3##(1991-12#2)(1992-3#1)
acids in serum##4##3##(1993-2#3)(2008-10#1)
acids in the amino terminal region##3##6##(1994-11#3)
acids in the##34##3##(1990-5#1)(1990-6#1)(1991-12#2)(1991-5#1)(1991-9#1)(1994-11#3)(1995-11#2)(1995-2#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#2)(2012-1#2)(2012-2#2)
acids in this##2##3##(1992-8#1)(2008-6#1)
acids in urine##3##3##(1994-9#2)(2008-10#1)
acids in##142##2##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#7)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#5)(1992-8#1)(1992-9#1)(1993-2#3)(1993-3#2)(1994-11#3)(1994-8#1)(1994-9#5)(1995-11#4)(1995-2#1)(1995-6#2)(1995-9#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#45)(2008-11#5)(2008-4#3)(2008-5#6)(2008-6#4)(2008-8#3)(2008-9#3)(2009-9#1)(2010-12#1)(2010-4#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
acids into##7##2##(1992-10#1)(1992-3#2)(2008-10#1)(2008-5#2)(2008-9#1)
acids is the##2##3##(1991-12#1)(1992-8#1)
acids is##11##2##(1990-12#1)(1991-12#1)(1992-8#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-9#1)(2010-10#1)
acids it##2##2##(1997-6#1)(2008-10#1)
acids like##4##2##(2008-10#2)(2008-7#2)
acids may##5##2##(1990-12#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-5#1)
acids metabolism by VO 208##2##5##(2008-11#2)
acids mixture##2##2##(1994-6#1)(2008-10#1)
acids of the##8##3##(1992-6#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
acids of##33##2##(1990-7#1)(1991-5#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#1)(2011-2#1)(2012-2#1)
acids on the##4##3##(1997-3#1)(2008-10#2)(2008-5#1)
acids on##12##2##(1993-6#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)
acids or their##3##3##(1995-5#1)(1995-6#1)(2008-10#1)
acids or##8##2##(1992-9#1)(1993-8#1)(1995-5#1)(1995-6#1)(2008-10#3)(2012-2#1)
acids play##2##2##(1992-11#1)(2008-11#1)
acids present in##3##3##(1990-12#1)(2008-5#1)(2013-8#1)
acids released by##3##3##(2008-10#3)
acids released##6##2##(1990-8#2)(1991-12#1)(2008-10#3)
acids residues##2##2##(1993-3#1)(1995-12#1)
acids resulted in##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
acids significantly##2##2##(2008-11#2)
acids solutions##3##2##(2008-10#3)
acids studied##2##2##(1994-9#1)(2011-1#1)
acids tested##2##2##(1994-6#1)(2008-10#1)
acids that##11##2##(1992-3#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
acids to the##3##3##(1992-6#2)(2008-10#1)
acids to##21##2##(1990-11#1)(1990-2#1)(1992-11#1)(1992-6#2)(1992-8#1)(1994-3#1)(1995-5#2)(1997-4#1)(2008-10#3)(2008-11#2)(2008-5#3)(2010-10#1)(2012-2#2)
acids together with##2##3##(2008-10#1)(2008-11#1)
acids under##3##2##(2008-10#2)(2010-2#1)
acids using##8##2##(2008-10#7)(2011-1#1)
acids via##4##2##(1992-6#1)(1993-9#1)(2008-5#1)(2010-10#1)
acids was achieved##2##3##(1990-8#1)(2008-10#1)
acids was found##2##3##(2007-12#1)(2008-11#1)
acids was investigated##2##3##(1994-9#1)(2008-5#1)
acids was observed##2##3##(1993-9#1)(2013-1#1)
acids was studied##3##3##(1992-3#1)(1994-9#1)(2008-10#1)
acids was used##3##3##(2008-10#3)
acids was##32##2##(1990-5#1)(1990-8#1)(1992-3#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-5#1)(2008-6#1)(2013-1#1)
acids were determined##3##3##(2008-10#2)(2012-2#1)
acids were extracted##2##3##(1993-2#1)(2012-2#1)
acids were found##3##3##(2008-10#1)(2008-11#2)
acids were identified##2##3##(1992-5#1)(1997-3#1)
acids were incubated with##2##4##(1994-8#2)
acids were purified##2##3##(1996-5#1)(2008-5#1)
acids were separated##3##3##(1994-9#2)(2008-10#1)
acids were studied##2##3##(2008-10#2)
acids were the##2##3##(2008-10#1)(2009-8#1)
acids were##57##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-5#1)(1993-2#4)(1994-8#3)(1994-9#6)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(2007-11#1)(2008-10#16)(2008-11#3)(2008-5#5)(2008-6#1)(2008-7#1)(2009-8#2)(2010-4#1)(2012-2#2)(2013-1#1)
acids when##3##2##(1994-12#1)(1997-6#1)(2011-1#1)
acids which are##2##3##(1995-12#1)(2011-1#1)
acids which##8##2##(1993-6#1)(1993-8#1)(1995-12#2)(1996-12#1)(2011-1#2)(2013-1#1)
acids with a##7##3##(1990-12#2)(1994-11#1)(1996-6#1)(2008-10#2)(2008-8#1)
acids with the##3##3##(2008-10#3)
acids with##33##2##(1990-12#3)(1990-7#1)(1991-7#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#2)(2006-12#1)(2008-10#15)(2008-4#1)(2008-8#1)(2010-5#1)(2012-2#1)
acids within##4##2##(1995-5#2)(2008-11#1)(2008-9#1)
acids##1469##1##(1990-11#9)(1990-12#19)(1990-2#15)(1990-3#3)(1990-5#13)(1990-6#1)(1990-7#9)(1990-8#15)(1991-11#1)(1991-12#20)(1991-2#8)(1991-3#1)(1991-5#13)(1991-6#3)(1991-7#5)(1991-8#3)(1991-9#6)(1992-10#2)(1992-11#10)(1992-12#8)(1992-3#18)(1992-5#1)(1992-6#8)(1992-8#15)(1992-9#10)(1993-11#7)(1993-12#5)(1993-2#14)(1993-3#8)(1993-6#13)(1993-8#10)(1993-9#5)(1994-11#18)(1994-12#15)(1994-2#1)(1994-3#3)(1994-5#7)(1994-6#13)(1994-8#13)(1994-9#18)(1995-11#17)(1995-12#12)(1995-2#13)(1995-3#10)(1995-5#20)(1995-6#19)(1995-8#9)(1995-9#4)(1996-10#2)(1996-12#4)(1996-2#2)(1996-3#8)(1996-5#11)(1996-6#5)(1996-7#3)(1996-9#1)(1997-2#13)(1997-3#9)(1997-4#5)(1997-6#7)(1997-7#6)(1997-8#1)(2006-12#5)(2007-11#6)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#465)(2008-11#50)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#33)(2008-5#76)(2008-6#15)(2008-7#17)(2008-8#22)(2008-9#25)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#17)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#15)(2011-2#23)(2012-1#6)(2012-12#3)(2012-2#26)(2012-3#7)(2013-1#35)(2013-8#8)
acids) and##6##2##(1991-7#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#2)
acids) of##3##2##(1990-8#1)(2008-10#2)
acids)##46##1##(1990-11#1)(1990-8#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-8#1)(1994-6#1)(1995-6#1)(1997-9#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#6)(2008-9#3)(2009-10#1)(2011-2#2)(2011-3#1)(2013-1#2)
aciduria due to##2##3##(1990-8#1)(1993-8#1)
aciduria##7##1##(1990-8#2)(1991-12#1)(1993-8#1)(1994-3#2)(2008-10#1)
acinar cell##3##2##(1992-8#1)(1993-6#1)(2008-7#1)
acinar cells and the##2##4##(1995-11#1)(2008-7#1)
acinar cells and##5##3##(1995-11#3)(2008-7#1)(2013-1#1)
acinar cells##19##2##(1991-5#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-6#3)(1995-11#7)(2008-7#1)(2009-7#2)(2013-1#1)
acinar##26##1##(1991-12#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-8#2)(1993-6#4)(1994-8#1)(1995-11#7)(2007-12#1)(2008-7#2)(2009-7#2)(2012-12#1)(2013-1#1)
acini and chief cells##3##4##(1994-8#3)
acini and##6##2##(1994-8#6)
acini##23##1##(1991-8#2)(1992-12#2)(1993-6#1)(1994-8#7)(1995-11#6)(2007-12#5)
acinus##6##1##(1995-11#1)(2007-12#5)
acitretin##2##1##(2007-11#2)
acitric##9##1##(2008-5#9)
acivicin##3##1##(1990-7#1)(2008-7#2)
acknowledge and##3##2##(1995-11#1)(2008-12#1)(2009-6#1)
acknowledge that##7##2##(1996-11#1)(2008-11#2)(2008-8#1)(2010-11#1)(2013-1#2)
acknowledge the##5##2##(1995-1#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
acknowledge these##2##2##(1993-2#1)(2007-11#1)
acknowledge##21##1##(1993-2#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-11#1)(2007-11#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
acknowledged and##4##2##(1994-12#1)(2008-12#1)(2012-2#1)(2012-3#1)
acknowledged by the##2##3##(1994-1#1)(2012-3#1)
acknowledged by##5##2##(1991-3#1)(1994-1#1)(2008-11#1)(2012-3#2)
acknowledged in the literature##3##4##(2008-11#3)
acknowledged in the##4##3##(2008-11#3)(2012-2#1)
acknowledged that##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
acknowledged the##5##2##(1991-6#1)(1994-1#1)(1995-2#1)(2011-1#1)(2012-12#1)
acknowledged##37##1##(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-12#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)
acknowledgement of the##2##3##(1997-7#1)(2008-11#1)
acknowledgement##3##1##(1997-7#1)(2008-11#1)(2012-12#1)
acknowledges the##3##2##(2008-11#1)(2008-12#1)(2009-12#1)
acknowledges##6##1##(1992-1#1)(2008-11#1)(2008-12#2)(2009-12#1)(2011-2#1)
acknowledging the##4##2##(1991-2#1)(2008-11#1)(2008-12#1)(2010-11#1)
acknowledging##6##1##(1991-2#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-11#1)(2012-3#1)
aclacinomycin##2##1##(1994-5#2)
aclada subgroups##2##2##(2008-10#2)
aclada##5##1##(2008-10#5)
acne and##2##2##(2007-7#1)(2009-2#1)
acne fulminans##2##2##(2006-10#2)
acne in##3##2##(2009-2#1)(2011-1#1)(2011-2#1)
acne management##3##2##(2008-5#3)
acne may##2##2##(2008-5#2)
acne products##2##2##(2010-8#2)
acne treatment##2##2##(2008-5#1)(2010-8#1)
acne vulgaris were##2##3##(2007-7#1)(2010-8#1)
acne vulgaris##18##2##(1997-8#1)(2007-7#6)(2008-5#4)(2010-8#7)
acne##62##1##(1993-2#1)(1997-8#3)(2006-10#3)(2007-7#12)(2008-10#1)(2008-5#22)(2009-2#2)(2010-8#11)(2011-1#1)(2011-2#2)(2012-12#4)
acneiform folliculitis##2##2##(2006-10#2)
acnes than##2##2##(2008-5#2)
acnes##8##1##(2008-5#8)
acorn##9##1##(1990-5#4)(1993-6#1)(2008-10#1)(2008-9#3)
acoustic and##4##2##(2007-5#1)(2008-9#1)(2009-11#1)(2009-9#1)
acoustic emission##2##2##(2008-3#2)
acoustic emissions##2##2##(2008-3#1)(2013-7#1)
acoustic field##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
acoustic fields in##2##3##(2008-2#2)
acoustic fields##3##2##(2008-2#3)
acoustic frequency##4##2##(2008-3#4)
acoustic impedance##2##2##(2009-5#1)(2011-2#1)
acoustic neuroma##10##2##(2008-7#7)(2011-2#3)
acoustic parameters##2##2##(2009-2#1)(2013-8#1)
acoustic seafloor discrimination##2##3##(2007-5#2)
acoustic signal##3##2##(2008-3#2)(2009-5#1)
acoustic startle response##3##3##(1996-2#1)(1996-5#1)(2008-4#1)
acoustic startle##4##2##(1996-2#1)(1996-5#1)(2008-4#2)
acoustic stimuli##3##2##(1996-2#1)(2008-4#2)
acoustic variables##4##2##(2013-7#4)
acoustic wave DNA biosensor##2##4##(2008-10#2)
acoustic wave devices##3##3##(2007-12#1)(2008-10#1)(2009-3#1)
acoustic wave sensor##3##3##(2008-10#3)
acoustic wave sensors##2##3##(2008-10#1)(2009-3#1)
acoustic wave##36##2##(2007-11#1)(2007-12#4)(2008-10#24)(2008-3#2)(2009-3#4)(2009-5#1)
acoustic waves with##2##3##(2007-11#1)(2007-12#1)
acoustic waves##11##2##(2007-11#2)(2007-12#5)(2008-10#1)(2008-3#3)
acoustic##156##1##(1991-3#1)(1993-5#1)(1993-9#1)(1994-7#1)(1996-2#3)(1996-5#1)(1996-6#1)(2006-12#1)(2007-11#7)(2007-12#15)(2007-5#7)(2007-7#1)(2008-10#28)(2008-11#1)(2008-2#7)(2008-3#27)(2008-4#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#2)(2009-3#4)(2009-5#7)(2009-9#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#7)(2013-8#2)
acoustical##3##1##(1991-12#1)(2008-8#1)(2008-9#1)
acoustically induced##2##2##(2007-12#1)(2008-3#1)
acoustically##9##1##(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#3)(2009-2#1)(2009-5#1)(2011-1#1)
acoustics##10##1##(2007-11#1)(2007-12#1)(2008-3#6)(2008-4#1)(2011-1#1)
acousto-optic Bragg cell was##2##4##(2008-3#2)
acousto-optic Bragg cell##7##3##(2008-3#7)
acousto-optic Bragg##8##2##(2008-3#8)
acousto-optic Q##2##2##(2008-3#2)
acousto-optic cell##2##2##(2008-3#2)
acousto-optic cells##4##2##(2008-2#1)(2008-3#3)
acousto-optic devices##3##2##(2007-12#2)(2008-10#1)
acousto-optic imaging##2##2##(2007-11#1)(2008-3#1)
acousto-optic interaction##3##2##(2007-12#1)(2008-2#2)
acousto-optic modulator and##2##3##(2007-12#1)(2008-2#1)
acousto-optic modulator##8##2##(2007-11#1)(2007-12#3)(2008-2#3)(2013-8#1)
acousto-optic modulators##2##2##(2008-3#2)
acousto-optic tunable filter (AOTF)##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
acousto-optic tunable filter##12##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#2)
acousto-optic tunable filters##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
acousto-optic tunable##16##2##(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#4)(2008-3#2)
acousto-optic##65##1##(2007-11#5)(2007-12#14)(2008-10#6)(2008-2#13)(2008-3#26)(2013-8#1)
acousto-optical##2##1##(2008-3#2)
acpP##2##1##(1992-4#2)
acquainted with##2##2##(1994-12#1)(2011-2#1)
acquire a##13##2##(1992-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
acquire an##3##2##(2007-7#1)(2008-11#1)(2009-9#1)
acquire different##2##2##(1990-12#1)(2013-8#1)
acquire fluorescence##2##2##(2008-10#1)(2011-1#1)
acquire genetic information and to disclose##2##6##(2008-7#2)
acquire genetic##3##2##(2008-1#1)(2008-7#2)
acquire ontogenic resistance##2##3##(2008-10#2)
acquire the infection during##2##4##(1990-9#2)
acquire the##11##2##(1990-9#2)(1992-11#1)(1995-2#1)(1996-1#1)(2008-10#4)(2008-4#1)(2012-2#1)
acquire##81##1##(1990-12#1)(1990-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1993-6#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-2#2)(1996-1#2)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
acquired HIV infection##2##3##(1996-11#2)
acquired HIV##3##2##(1996-11#3)
acquired PMWaV##2##2##(2008-10#2)
acquired TSWV##2##2##(2008-10#2)
acquired a##8##2##(1993-12#2)(1993-6#1)(2008-11#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#1)
acquired after##2##2##(1990-9#1)(2012-12#1)
acquired and congenital##2##3##(2008-4#1)(2012-2#1)
acquired and maintained##2##3##(1993-6#1)(1996-3#1)
acquired and transmitted by##3##4##(2008-10#3)
acquired and transmitted##4##3##(2008-10#4)
acquired and##18##2##(1991-6#1)(1993-6#1)(1996-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#1)
acquired at##10##2##(1995-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-1#1)
acquired by a##3##3##(1994-8#1)(2008-3#2)
acquired by accumulating##2##3##(2008-10#2)
acquired by the##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
acquired by using##2##3##(2008-2#1)(2012-7#1)
acquired by##25##2##(1994-8#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
acquired cystic kidney disease##3##4##(2011-2#3)
acquired data##2##2##(2008-1#1)(2008-2#1)
acquired diseases##4##2##(1994-5#1)(1997-3#1)(2008-5#1)(2010-10#1)
acquired disorder##2##2##(1994-5#1)(2008-7#1)
acquired during the##4##3##(1990-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
acquired during##7##2##(1990-9#1)(2007-2#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
acquired for##5##2##(2008-10#2)(2008-2#1)(2009-10#1)(2012-12#1)
acquired form of angioedema##2##4##(2013-1#2)
acquired form##3##2##(2007-8#1)(2013-1#2)
acquired from a##4##3##(2008-2#1)(2008-3#1)(2011-7#1)(2013-8#1)
acquired from the##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
acquired from##19##2##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
acquired genetic##3##2##(1993-12#1)(2008-7#1)(2013-8#1)
acquired heart disease##2##3##(2009-12#1)(2012-2#1)
acquired heart##3##2##(2009-12#1)(2012-2#2)
acquired images of##2##3##(2007-11#1)(2012-1#1)
acquired images##4##2##(2007-11#1)(2008-10#1)(2009-7#1)(2012-1#1)
acquired immune deficiency syndrome##4##4##(1991-9#1)(1992-2#1)(1994-3#1)(2011-2#1)
acquired immune##5##2##(1991-9#1)(1992-2#1)(1994-3#1)(2006-10#1)(2011-2#1)
acquired immunity and##2##3##(2008-8#1)(2011-2#1)
acquired immunity##3##2##(1997-3#1)(2008-8#1)(2011-2#1)
acquired immunodeficiency syndrome (AIDS) or##2##5##(1991-9#1)(1997-3#1)
acquired immunodeficiency syndrome (AIDS) patients##2##5##(1996-2#1)(1997-8#1)
acquired immunodeficiency syndrome (AIDS)##18##4##(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#2)(1993-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#1)(2011-3#1)
acquired immunodeficiency syndrome##33##3##(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-9#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-12#1)(2008-2#2)(2011-3#1)(2013-1#1)
acquired immunodeficiency##34##2##(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-9#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-12#1)(2008-2#2)(2011-2#1)(2011-3#1)(2013-1#1)
acquired in a continuous mode##2##5##(2008-10#2)
acquired in a##3##3##(2008-10#3)
acquired in the##5##3##(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
acquired in this##2##3##(2008-2#1)(2008-5#1)
acquired in##21##2##(1995-3#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2013-1#1)
acquired infections##2##2##(2011-3#1)(2013-8#1)
acquired it##2##2##(2008-1#1)(2008-5#1)
acquired or##2##2##(2007-7#1)(2009-3#1)
acquired over##2##2##(2008-10#1)(2008-3#1)
acquired pneumonia##4##2##(2008-10#1)(2013-1#3)
acquired resistance (SAR)##7##3##(2008-10#6)(2011-10#1)
acquired resistance in##3##3##(2008-10#3)
acquired resistance of##2##3##(2008-11#1)(2012-1#1)
acquired resistance##22##2##(2008-10#15)(2008-11#2)(2010-5#2)(2011-10#1)(2011-2#1)(2012-1#1)
acquired the ability to##2##4##(1995-2#1)(2008-10#1)
acquired the infection##2##3##(1991-12#1)(1996-11#1)
acquired the virus##3##3##(2008-10#3)
acquired the##9##2##(1991-12#1)(1992-2#1)(1995-2#1)(1996-11#1)(2008-10#4)(2010-11#1)
acquired through##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
acquired using##4##2##(2008-10#2)(2008-6#1)(2012-3#1)
acquired with a##4##3##(2007-11#1)(2008-3#2)(2011-1#1)
acquired with an##4##3##(2007-11#1)(2008-3#3)
acquired with##14##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#7)(2011-1#1)
acquired##396##1##(1990-12#1)(1990-5#1)(1990-6#3)(1990-9#4)(1991-12#4)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-2#3)(1992-5#1)(1993-1#3)(1993-12#4)(1993-5#1)(1993-6#3)(1993-9#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#6)(1997-8#2)(2006-10#1)(2007-11#4)(2007-12#15)(2007-2#2)(2007-7#3)(2007-8#7)(2008-1#8)(2008-10#73)(2008-11#9)(2008-12#1)(2008-2#12)(2008-3#31)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#13)(2008-8#2)(2008-9#8)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#8)(2009-6#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#13)(2011-10#1)(2011-2#20)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#3)(2012-2#9)(2012-3#6)(2012-7#1)(2013-1#13)(2013-8#6)
acquires a##2##2##(1995-2#1)(1996-2#1)
acquires##10##1##(1992-11#1)(1993-8#2)(1994-8#1)(1995-2#1)(1996-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
acquiring a##4##2##(1993-2#1)(2008-3#1)(2008-9#1)(2010-6#1)
acquiring an##2##2##(2008-10#1)(2013-1#1)
acquiring the virus##2##3##(2008-10#2)
acquiring the##7##2##(1995-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-12#1)
acquiring##39##1##(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2010-6#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
acquisition access feeding##2##3##(2008-10#2)
acquisition access period##4##3##(2008-10#4)
acquisition access periods (AAPs)##3##4##(2008-10#3)
acquisition access periods##4##3##(2008-10#4)
acquisition access##10##2##(2008-10#10)
acquisition and analysis##3##3##(2008-4#1)(2008-7#1)(2009-12#1)
acquisition and in##2##3##(1992-12#1)(1994-8#1)
acquisition and processing##7##3##(2007-11#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-6#1)
acquisition and retention of spatial##2##5##(1991-2#1)(1994-8#1)
acquisition and retention of##4##4##(1991-2#1)(1993-12#1)(1994-8#1)(2012-2#1)
acquisition and retention##6##3##(1991-2#1)(1993-12#1)(1994-8#1)(2012-2#3)
acquisition and transmission##3##3##(2008-10#3)
acquisition and##44##2##(1991-2#2)(1992-1#1)(1992-12#1)(1993-12#1)(1994-8#2)(1996-1#1)(2006-4#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-1#2)(2012-2#3)
acquisition as##3##2##(1991-6#1)(2008-5#1)(2011-2#1)
acquisition by##6##2##(2008-10#4)(2009-8#1)(2013-8#1)
acquisition decisions##2##2##(1994-12#2)
acquisition for##2##2##(2008-10#1)(2008-9#1)
acquisition in Canadian hospitals##3##4##(1994-12#2)(1996-2#1)
acquisition in##10##2##(1991-1#1)(1994-12#2)(1996-2#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)
acquisition is##2##2##(2008-8#1)(2008-9#1)
acquisition of HCV##2##3##(2007-7#1)(2012-1#1)
acquisition of a new response##2##5##(1993-6#2)
acquisition of a##9##3##(1992-10#1)(1993-5#1)(1993-6#3)(2007-11#2)(2008-10#1)(2008-8#1)
acquisition of an##3##3##(1993-12#1)(2008-7#1)(2009-6#1)
acquisition of data##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
acquisition of food##2##3##(1991-2#1)(2008-9#1)
acquisition of hypovirulence##2##3##(2008-9#2)
acquisition of knowledge##3##3##(2008-12#2)(2011-2#1)
acquisition of new##2##3##(2010-4#1)(2012-3#1)
acquisition of the CPP##2##4##(1993-6#2)
acquisition of the##14##3##(1991-2#1)(1992-9#1)(1993-6#3)(1994-6#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#2)
acquisition of##91##2##(1991-2#3)(1992-10#3)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#6)(1994-6#1)(1994-8#2)(1995-8#2)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#7)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
acquisition or##3##2##(1993-6#1)(1994-8#1)(1996-1#1)
acquisition rate##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2011-1#1)
acquisition rather than##2##3##(2008-11#1)(2008-4#1)
acquisition speed##2##2##(2011-1#1)(2011-7#1)
acquisition time of##3##3##(2007-12#1)(2008-3#2)
acquisition time##5##2##(2007-12#1)(2008-3#2)(2010-6#1)(2012-12#1)
acquisition times##2##2##(1997-8#1)(2008-7#1)
acquisition to##4##2##(2008-2#1)(2008-3#1)(2008-5#2)
acquisition trials##2##2##(1993-3#1)(2008-5#1)
acquisition via##2##2##(2008-10#1)(2011-1#1)
acquisition was##4##2##(2010-6#1)(2011-1#2)(2011-7#1)
acquisition when##2##2##(2008-10#1)(2008-8#1)
acquisition with##2##2##(1992-10#1)(2008-10#1)
acquisition##299##1##(1991-1#1)(1991-2#6)(1991-6#1)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#4)(1993-5#4)(1993-6#8)(1994-12#4)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#7)(1995-11#1)(1995-3#1)(1995-8#2)(1996-1#2)(1996-2#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-11#8)(2007-12#6)(2007-7#2)(2008-1#2)(2008-10#52)(2008-11#18)(2008-12#3)(2008-2#4)(2008-3#19)(2008-4#8)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#15)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#6)(2011-7#2)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#4)
acquisitions on##2##2##(1991-2#1)(2008-1#1)
acquisitions##18##1##(1991-2#2)(1992-1#1)(1994-3#1)(1996-2#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)
acquittal##2##1##(2012-12#1)(2013-1#1)
acral melanoma##3##2##(2010-6#3)
acral##7##1##(1992-2#1)(2008-9#1)(2010-6#4)(2012-3#1)
acridan-based##2##1##(2008-10#2)
acridine orange (AO) and##2##4##(2008-10#1)(2008-9#1)
acridine orange (AO)##5##3##(2008-10#2)(2008-12#2)(2008-9#1)
acridine orange and##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
acridine orange##17##2##(1990-6#3)(1991-11#1)(1992-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#4)
acridine##19##1##(1990-6#3)(1991-11#1)(1992-11#1)(1992-3#1)(1993-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#4)
acridinium##3##1##(1992-9#1)(2008-10#1)(2012-2#1)
acridones##5##1##(1996-4#5)
acrivastine##7##1##(2008-10#7)
acrocentric##3##1##(1993-12#2)(2008-12#1)
acrolein##7##1##(1996-12#2)(2008-5#1)(2013-1#4)
acromegalic patients and controls##2##4##(2013-1#2)
acromegalic patients##9##2##(2009-2#1)(2013-1#8)
acromegaly##6##1##(2008-4#2)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)
acronym for##2##2##(2008-3#2)
acronym##6##1##(1996-12#1)(2008-3#4)(2011-2#1)
acronyms##2##1##(2012-3#2)
acropetal##2##1##(2008-10#2)
acrophase around##2##2##(2008-11#1)(2010-8#1)
acrophase##8##1##(2008-11#3)(2008-6#1)(2010-8#4)
acrosomal complex##6##2##(2007-12#6)
acrosomal##15##1##(1994-8#3)(2007-12#8)(2008-7#3)(2008-8#1)
acrosome and the##2##3##(2008-7#2)
acrosome and##7##2##(2007-12#1)(2008-7#5)(2009-4#1)
acrosome biogenesis##3##2##(2012-2#3)
acrosome of##3##2##(1995-6#1)(2008-7#2)
acrosome reaction and##3##3##(1992-8#1)(2008-8#2)
acrosome reaction in##3##3##(1992-8#1)(2013-1#2)
acrosome reaction##20##2##(1992-8#4)(2008-4#5)(2008-8#9)(2013-1#2)
acrosome##44##1##(1992-8#4)(1995-6#1)(2007-12#2)(2008-4#6)(2008-7#12)(2008-8#11)(2009-4#1)(2012-2#5)(2013-1#2)
across Canada##12##2##(1993-12#1)(1994-2#2)(1995-1#1)(1995-2#1)(2007-12#1)(2008-11#2)(2008-12#1)(2012-12#2)(2013-1#1)
across Europe##2##2##(2012-2#1)(2013-1#1)
across North America##3##3##(1995-1#1)(2008-11#1)(2011-9#1)
across Western##2##2##(2011-1#1)(2012-2#1)
across a PTFE##2##3##(2008-10#2)
across a broad range of##3##5##(2008-2#2)(2008-8#1)
across a broad##5##3##(2008-2#2)(2008-5#1)(2008-8#2)
across a number of##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
across a range of##7##4##(1993-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-12#1)(2013-8#1)
across a set of##2##4##(2008-3#1)(2008-7#1)
across a spectral range##2##4##(2008-2#1)(2008-3#1)
across a wide range of##4##5##(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
across a wide##9##3##(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-1#1)
across a##67##2##(1990-3#1)(1990-8#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-5#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
across age groups##2##3##(2008-10#1)(2008-2#1)
across age##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
across all age groups##2##4##(2008-11#1)(2010-7#1)
across all environments and##2##4##(2008-10#1)(2011-2#1)
across all four##3##3##(2008-11#1)(2008-12#1)(2008-3#1)
across all groups##2##3##(1996-12#1)(2008-9#1)
across all hospitals##2##3##(1996-1#1)(2012-2#1)
across all three##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
across all treatments##2##3##(2013-1#2)
across all##43##2##(1996-1#1)(1996-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#1)
across an entire##3##3##(1996-1#1)(1996-2#1)(2008-2#1)
across an##9##2##(1995-2#1)(1996-1#1)(1996-2#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
across and##3##2##(1992-12#1)(2008-3#1)(2012-1#1)
across areas##2##2##(1991-3#1)(2008-10#1)
across both##3##2##(1994-3#1)(2008-10#1)(2012-2#1)
across cellular membranes##2##3##(1990-5#1)(1997-7#1)
across clinical##2##2##(1997-3#1)(2010-5#1)
across conditions##2##2##(2008-11#1)(2008-5#1)
across countries##7##2##(1993-2#2)(2008-7#2)(2010-3#1)(2012-2#1)(2013-8#1)
across cultures##2##2##(2013-8#2)
across days##6##2##(2008-12#6)
across different organisms##2##3##(2008-8#2)
across different racial##2##3##(2008-5#2)
across different##25##2##(1993-12#1)(1994-12#1)(1995-1#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-7#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
across disciplines##2##2##(2008-11#2)
across diverse HIV-1 subtypes##2##4##(2013-1#2)
across diverse##6##2##(1990-8#1)(1997-1#1)(2008-8#1)(2012-2#1)(2013-1#2)
across each##2##2##(2007-12#1)(2010-4#1)
across environmental gradients##2##3##(2008-8#1)(2010-3#1)
across ethnic groups##2##3##(2008-1#1)(2012-2#1)
across five##2##2##(2008-11#1)(2011-1#1)
across food##2##2##(2007-12#1)(2008-1#1)
across four##6##2##(1994-2#1)(2007-12#1)(2008-2#1)(2009-7#1)(2012-12#1)(2013-8#1)
across gender##5##2##(2008-10#1)(2009-7#2)(2010-1#2)
across geographic areas##2##3##(1992-12#1)(2012-3#1)
across groups##2##2##(2008-9#1)(2011-2#1)
across habitats##2##2##(2008-9#2)
across hospital types##2##3##(1992-12#1)(1994-3#1)
across laboratories##2##2##(2008-10#1)(2008-8#1)
across large##2##2##(1994-12#1)(2008-2#1)
across levels of##2##3##(2007-11#1)(2009-2#1)
across mammalian##2##2##(2008-11#1)(2012-12#1)
across many##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
across multiple studies##2##3##(2012-12#2)
across multiple##12##2##(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
across nine##2##2##(1995-3#1)(2012-3#1)
across other##2##2##(2008-10#1)(2008-5#1)
across ownership types##2##3##(1995-2#2)
across phyla##2##2##(2008-4#2)
across provider types##2##3##(1994-12#1)(1995-3#1)
across provider##4##2##(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)
across racial and ethnic##2##4##(1997-1#1)(2008-5#1)
across regions##2##2##(2008-1#1)(2010-4#1)
across seasons##3##2##(2008-10#1)(2009-12#1)(2009-7#1)
across sectors##2##2##(1991-2#1)(2009-4#1)
across seven##3##2##(2007-12#1)(2008-10#2)
across several##5##2##(1993-2#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-10#1)
across sites##2##2##(1991-3#1)(2008-10#1)
across six##2##2##(2012-2#1)(2013-8#1)
across spatial scales##2##3##(2009-12#1)(2009-2#1)
across spatial##3##2##(2008-3#1)(2009-12#1)(2009-2#1)
across specialties and##2##3##(1994-1#2)
across species and##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
across species##17##2##(1993-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#2)(2012-2#3)(2012-3#2)
across states##3##2##(1994-2#1)(1996-2#1)(2008-10#1)
across strata##2##2##(1993-9#1)(1995-9#1)
across studies##3##2##(1994-3#1)(2008-11#1)(2012-12#1)
across subjects##2##2##(1996-7#1)(2009-6#1)
across tasks##2##2##(2007-8#1)(2009-11#1)
across the 4 localities##2##4##(2011-1#2)
across the 4##3##3##(2008-3#1)(2011-1#2)
across the United States##7##4##(1991-12#1)(1992-12#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-2#1)
across the WAN##2##3##(2010-3#2)
across the beam##4##3##(2007-11#2)(2009-7#1)(2012-1#1)
across the blood-brain barrier##3##4##(1997-2#1)(2012-2#2)
across the cell membrane of##2##5##(1990-5#1)(2008-8#1)
across the cell membrane##7##4##(1990-5#1)(1993-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#2)
across the cellular membrane##2##4##(2009-8#1)(2010-11#1)
across the continuum of care##2##5##(1996-1#1)(1996-12#1)
across the continuum##3##3##(1996-1#1)(1996-12#1)(1997-1#1)
across the country are##2##4##(1991-12#1)(1992-2#1)
across the country is##2##4##(1994-1#1)(1995-3#1)
across the country##13##3##(1991-12#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2011-1#1)(2013-1#1)
across the course of##2##4##(2008-12#1)(2012-2#1)
across the cytoplasmic membrane##4##4##(1991-10#2)(1991-5#1)(2008-9#1)
across the different##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
across the entire lifetime##2##4##(2009-2#2)
across the entire##10##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#2)(2009-7#1)(2009-9#2)(2013-3#1)
across the field##4##3##(2008-9#1)(2012-12#3)
across the five##4##3##(1993-3#1)(2008-9#1)(2011-1#1)(2012-3#1)
across the globe##7##3##(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
across the gradient##2##3##(2008-10#1)(2008-3#1)
across the inner##2##3##(1990-2#1)(2008-11#1)
across the knee joint##2##4##(2009-4#1)(2013-1#1)
across the landscape##2##3##(2008-10#1)(2008-8#1)
across the life##2##3##(2011-1#1)(2012-3#1)
across the lifespan##4##3##(2008-9#2)(2009-5#1)(2010-7#1)
across the membrane##5##3##(1990-2#1)(1991-5#1)(1993-8#1)(2008-7#1)(2009-3#1)
across the mitochondrial membranes##2##4##(1990-2#1)(1994-8#1)
across the mitochondrial##3##3##(1990-2#1)(1994-8#1)(2008-8#1)
across the nation##3##3##(2008-11#1)(2010-8#2)
across the nuclear envelope##3##4##(2011-2#3)
across the nuclear##4##3##(1995-2#1)(2011-2#3)
across the oolemma##2##3##(1990-12#2)
across the phantom##2##3##(2008-3#1)(2008-5#1)
across the plasma membrane##5##4##(1990-5#1)(1992-5#1)(1993-11#1)(1993-3#1)(2008-11#1)
across the polarizing direction##2##4##(2008-2#2)
across the range of##2##4##(1994-8#1)(2008-12#1)
across the region##3##3##(1997-9#1)(2008-10#2)
across the regions##2##3##(2008-10#1)(2008-7#1)
across the skin##3##3##(2008-11#2)(2008-3#1)
across the spectrum of##3##4##(2008-3#1)(2008-8#1)(2012-12#1)
across the surface of the##2##5##(2008-2#1)(2011-2#1)
across the surface of##3##4##(2008-2#1)(2011-2#1)(2013-1#1)
across the three##7##3##(1991-3#1)(1991-9#1)(1996-3#2)(2008-10#1)(2008-12#1)(2012-2#1)
across the two##2##3##(1993-2#1)(2011-2#1)
across the various##2##3##(2009-9#1)(2013-8#1)
across the visible##2##3##(2007-12#1)(2008-2#1)
across the world##3##3##(2008-5#1)(2010-5#1)(2012-6#1)
across the##338##2##(1990-11#2)(1990-12#3)(1990-2#5)(1990-5#2)(1991-10#3)(1991-12#4)(1991-3#1)(1991-5#6)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-12#2)(1996-3#3)(1996-4#1)(1996-7#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#4)(1997-9#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-11#8)(2008-12#4)(2008-2#15)(2008-3#19)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#13)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#6)(2012-6#1)(2013-1#11)(2013-3#1)(2013-7#1)(2013-8#6)
across these##8##2##(1995-2#1)(1995-3#1)(2006-10#1)(2008-2#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
across this##4##2##(2008-3#2)(2012-3#1)(2013-7#1)
across three##6##2##(1995-1#1)(2008-10#4)(2011-2#1)
across thresholds##2##2##(2008-4#2)
across time##8##2##(2008-12#1)(2009-11#1)(2009-2#1)(2009-7#2)(2010-6#1)(2011-2#1)(2013-8#1)
across traits##2##2##(2012-2#1)(2012-3#1)
across trials##6##2##(2008-10#4)(2008-12#1)(2012-12#1)
across two environments##2##3##(2008-10#2)
across two##6##2##(1994-5#1)(2008-10#2)(2008-6#1)(2010-7#1)(2012-5#1)
across various##3##2##(1994-11#1)(2008-7#1)(2008-8#1)
across varying##2##2##(2008-10#1)(2013-1#1)
across vertebrate##2##2##(2012-2#1)(2012-3#1)
across western and central New York##2##6##(2008-10#2)
across which##2##2##(2012-3#1)(2013-1#1)
across wide##2##2##(2008-3#1)(2012-2#1)
across years##3##2##(2008-10#3)
across##937##1##(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#4)(1990-8#2)(1991-10#3)(1991-12#4)(1991-2#1)(1991-3#4)(1991-5#6)(1991-9#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#4)(1994-11#2)(1994-12#6)(1994-2#8)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#6)(1995-11#1)(1995-2#8)(1995-3#7)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#6)(1996-12#4)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#1)(1996-7#3)(1996-9#4)(1997-1#7)(1997-2#4)(1997-3#8)(1997-5#1)(1997-6#1)(1997-7#5)(1997-9#2)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#21)(2007-2#1)(2007-5#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#110)(2008-11#37)(2008-12#19)(2008-2#29)(2008-3#42)(2008-4#11)(2008-5#21)(2008-6#6)(2008-7#25)(2008-8#31)(2008-9#21)(2009-1#1)(2009-10#6)(2009-11#6)(2009-12#5)(2009-2#6)(2009-3#1)(2009-4#4)(2009-5#7)(2009-6#7)(2009-7#18)(2009-8#11)(2009-9#6)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#9)(2010-4#9)(2010-5#7)(2010-6#1)(2010-7#8)(2010-8#10)(2010-9#1)(2011-1#20)(2011-2#24)(2011-9#1)(2012-1#5)(2012-12#19)(2012-2#38)(2012-3#35)(2012-5#1)(2012-6#2)(2013-1#37)(2013-3#1)(2013-7#3)(2013-8#18)
across-row##4##1##(2008-10#4)
across-the-board##2##1##(1995-12#1)(2008-4#1)
acrylamide##10##1##(1990-5#1)(1991-7#1)(2008-10#4)(2008-2#2)(2009-10#2)
acrylate and##3##2##(1996-5#1)(2008-10#1)(2008-12#1)
acrylate##18##1##(1996-5#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#1)
acrylate)##3##1##(1995-3#1)(2008-12#1)(2008-8#1)
acrylates##3##1##(2008-5#1)(2008-8#2)
acrylic acid and##2##3##(2008-6#1)(2009-9#1)
acrylic acid##10##2##(2008-10#1)(2008-5#3)(2008-6#3)(2009-9#1)(2010-4#2)
acrylic and sulphonic polyanions##2##4##(2008-10#2)
acrylic denture##2##2##(2008-12#2)
acrylic glue##5##2##(1997-3#3)(1997-6#2)
acrylic glues##2##2##(2008-9#2)
acrylic microspheres##2##2##(2008-10#2)
acrylic resin##2##2##(2008-12#1)(2013-1#1)
acrylic##38##1##(1997-3#3)(1997-6#2)(2007-11#1)(2008-10#8)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#3)(2008-9#2)(2009-9#1)(2010-4#3)(2011-2#2)(2013-1#4)
acrylics##2##1##(2008-6#1)(2013-1#1)
acrylodan##3##1##(1994-5#2)(2008-8#1)
acrylonitrile##3##1##(2007-7#1)(2008-3#1)(2010-2#1)
acryloyl chloride##2##2##(2008-5#2)
act against##3##2##(1995-6#1)(2008-10#1)(2009-2#1)
act antagonistically to##2##3##(2008-7#1)(2010-1#1)
act antagonistically##3##2##(2008-7#1)(2010-1#1)(2012-3#1)
act as a##53##3##(1990-5#1)(1991-9#1)(1992-2#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-12#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-2#2)(2012-8#1)(2013-1#2)(2013-8#1)
act as agonists##3##3##(1995-3#1)(2008-4#1)(2008-5#1)
act as an effective##2##4##(2008-2#1)(2013-8#1)
act as an##14##3##(1990-12#1)(1990-2#1)(1990-7#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
act as biocontrol agents##2##4##(2008-10#2)
act as both##4##3##(1994-3#1)(2008-10#2)(2012-2#1)
act as ecological generalists##2##4##(2008-9#2)
act as hydroxyl radical scavengers to##2##6##(1995-6#2)
act as key##2##3##(1993-6#1)(2012-3#1)
act as potent##2##3##(2008-10#1)(2008-8#1)
act as primary##2##3##(1993-3#1)(2008-7#1)
act as signaling##2##3##(1990-11#1)(2009-2#1)
act as the##4##3##(1992-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
act as##179##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-2#2)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-12#2)(1996-2#1)(1996-4#2)(1997-4#1)(1997-7#2)(2007-11#5)(2007-12#6)(2007-5#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#5)
act at the##3##3##(1990-11#1)(1990-5#1)(2008-6#1)
act at##8##2##(1990-11#1)(1990-5#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)
act both as##2##3##(2008-11#1)(2008-5#1)
act both##4##2##(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
act by binding to##2##4##(1993-9#1)(2008-4#1)
act by##12##2##(1990-7#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-4#1)(2008-8#1)(2010-7#1)
act differently##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
act directly on##2##3##(1994-3#1)(1994-6#1)
act for##5##2##(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#2)
act in a##7##3##(1990-11#1)(1990-5#1)(1990-7#1)(1996-9#1)(2008-8#1)(2010-5#1)(2010-6#1)
act in concert to##2##4##(1996-12#1)(2011-2#1)
act in concert##3##3##(1996-12#1)(2009-10#1)(2011-2#1)
act in the same##2##4##(2008-8#1)(2009-10#1)
act in the##3##3##(2008-8#1)(2009-10#2)
act in##21##2##(1990-11#1)(1990-5#1)(1990-7#1)(1993-1#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-8#5)(2009-10#3)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
act is##4##2##(1994-1#1)(2011-2#2)(2012-3#1)
act like a##2##3##(2008-10#1)(2008-9#1)
act like##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
act not only as##2##4##(2008-10#1)(2008-4#1)
act of##13##2##(1994-2#1)(1997-3#1)(2007-10#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
act on the##11##3##(1990-5#1)(1992-8#1)(1993-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2013-7#1)
act on##25##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2011-2#1)(2013-7#1)
act synergistically to##2##3##(1991-9#1)(2009-4#1)
act synergistically with##4##3##(2006-6#1)(2008-10#2)(2008-8#1)
act synergistically##7##2##(1991-9#1)(2006-6#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-8#1)
act through a##2##3##(1990-12#1)(2008-3#1)
act through the same##2##4##(1995-12#1)(2010-10#1)
act through##10##2##(1990-12#1)(1991-12#1)(1991-5#1)(1995-11#1)(1995-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)
act to prevent##2##3##(2008-11#1)(2013-7#1)
act to##12##2##(1991-9#1)(1993-12#1)(1994-11#1)(1995-5#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-7#1)
act together to##3##3##(1991-2#1)(1993-11#1)(2009-12#1)
act together##4##2##(1991-2#1)(1993-11#1)(1993-6#1)(2009-12#1)
act##374##1##(1990-11#5)(1990-12#4)(1990-2#2)(1990-5#4)(1990-7#5)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#6)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#4)(1995-5#3)(1995-6#5)(1995-8#4)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#38)(2008-11#15)(2008-12#4)(2008-2#6)(2008-3#8)(2008-4#10)(2008-5#10)(2008-6#5)(2008-7#17)(2008-8#25)(2008-9#9)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#4)(2010-5#2)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#5)(2012-8#1)(2013-1#7)(2013-7#3)(2013-8#7)
acted as a##14##3##(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#6)(2008-5#1)(2010-1#2)(2013-1#2)
acted as an activator for the##3##6##(2008-10#3)
acted as an activator##4##4##(2008-10#3)(2011-2#1)
acted as an##7##3##(1991-5#1)(1994-9#1)(2008-10#4)(2011-2#1)
acted as##33##2##(1991-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#13)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
acted by##2##2##(1990-5#1)(1994-11#1)
acted in##2##2##(1994-3#1)(2008-8#1)
acted on##2##2##(2008-5#2)
acted synergistically to##2##3##(1991-12#1)(1993-6#1)
acted upon##3##2##(2008-8#1)(2009-10#1)(2011-2#1)
acted##56##1##(1990-5#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#2)(2009-10#1)(2009-5#1)(2010-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)
acteoside##2##1##(2008-10#2)
actigraphy##5##1##(2008-6#1)(2012-12#4)
actin and calmodulin##3##3##(1990-12#2)(1990-5#1)
actin and microtubule##2##3##(2009-10#1)(2009-12#1)
actin and spectrin##2##3##(1996-12#2)
actin and##24##2##(1990-12#2)(1990-2#2)(1990-5#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-12#2)(2008-11#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)
actin assembly##3##2##(2008-1#2)(2008-9#1)
actin binding site##2##3##(1994-5#1)(1994-8#1)
actin binding##5##2##(1994-5#1)(1994-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
actin bundles for##2##3##(2008-7#2)
actin bundles##4##2##(1993-8#1)(2008-3#1)(2008-7#2)
actin concentration##3##2##(1992-3#1)(1993-8#2)
actin cytoskeleton is##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
actin cytoskeleton may##2##3##(2008-11#1)(2008-9#1)
actin cytoskeleton##27##2##(1996-12#2)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#2)(2011-1#2)(2011-2#1)(2012-12#2)
actin depolymerization##2##2##(2009-7#1)(2012-12#1)
actin dynamics in##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
actin dynamics##6##2##(2008-1#1)(2008-11#1)(2012-2#3)(2013-8#1)
actin filament bundles at##3##4##(2012-2#3)
actin filament bundles##4##3##(2012-2#4)
actin filament##16##2##(1991-5#1)(1994-6#1)(1996-12#1)(2008-1#2)(2008-11#1)(2009-12#1)(2009-8#1)(2009-9#2)(2011-2#1)(2012-2#5)
actin filaments and##4##3##(1993-8#3)(2007-12#1)
actin filaments containing##2##3##(1997-7#2)
actin filaments with##2##3##(1995-2#2)
actin filaments##34##2##(1993-6#2)(1993-8#3)(1993-9#1)(1994-6#2)(1995-2#3)(1997-7#2)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-6#2)(2008-7#1)(2008-9#4)(2009-9#3)(2012-2#1)
actin gene##4##2##(2008-10#2)(2010-5#2)
actin in the##5##3##(1990-12#1)(1992-4#1)(1996-12#1)(2008-11#1)(2011-2#1)
actin in##12##2##(1990-12#1)(1992-4#1)(1993-3#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-11#1)(2011-2#2)
actin is##4##2##(1993-8#2)(1994-11#1)(2008-9#1)
actin nucleation##2##2##(2012-2#2)
actin patches have also been##2##5##(2008-11#2)
actin polymerization in##2##3##(1997-6#1)(2009-10#1)
actin polymerization##12##2##(1990-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#6)(2009-10#2)
actin promoter##2##2##(2010-5#1)(2012-3#1)
actin regulatory proteins##2##3##(2012-2#2)
actin ring##2##2##(1994-6#1)(2008-11#1)
actin to##2##2##(2008-1#2)
actin was##6##2##(1991-5#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#1)(1997-7#1)
actin were##4##2##(1991-5#1)(1994-8#1)(2008-11#1)(2011-2#1)
actin with##2##2##(1994-5#1)(2011-2#1)
actin##295##1##(1990-12#4)(1990-2#6)(1990-5#11)(1990-7#3)(1991-5#11)(1991-6#3)(1992-2#2)(1992-3#5)(1992-4#4)(1992-9#1)(1993-3#3)(1993-6#2)(1993-8#11)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#6)(1994-6#7)(1994-8#8)(1995-2#8)(1995-3#1)(1996-12#7)(1996-2#2)(1996-5#1)(1997-6#7)(1997-7#9)(2007-12#3)(2008-1#14)(2008-10#5)(2008-11#43)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#14)(2009-10#4)(2009-12#2)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#5)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#21)(2012-3#1)(2013-1#1)(2013-8#2)
actin-based##3##1##(2008-10#2)(2012-2#1)
actin-binding peptide##2##2##(1993-8#2)
actin-binding protein##6##2##(1990-7#1)(1994-8#1)(2008-1#1)(2008-6#1)(2011-1#1)(2012-2#1)
actin-binding proteins##7##2##(1993-8#1)(2008-1#2)(2009-9#1)(2011-2#1)(2012-2#2)
actin-binding site##3##2##(1993-8#2)(2011-2#1)
actin-binding##27##1##(1990-5#1)(1990-7#1)(1993-8#7)(1994-5#1)(1994-8#2)(2008-1#3)(2008-6#1)(2009-7#2)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#3)
actin-myosin##3##1##(1992-9#1)(2010-8#1)(2012-2#1)
actin-related##3##1##(1995-2#2)(2011-1#1)
acting Ap(4)A##2##2##(2009-2#2)
acting across##2##2##(2008-8#1)(2011-1#1)
acting analogs##4##2##(2008-1#4)
acting and##2##2##(1996-11#1)(2008-1#1)
acting as a platform##4##4##(2010-12#3)(2012-2#1)
acting as a##25##3##(1990-5#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-12#3)(2011-1#1)(2012-2#2)(2012-6#1)
acting as an##5##3##(1990-7#1)(1993-9#1)(2007-11#1)(2008-5#1)(2012-2#1)
acting as catalysts##2##3##(1992-8#1)(1996-12#1)
acting as##53##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#1)
acting at the##2##3##(1992-8#1)(2008-5#1)
acting at##5##2##(1992-8#1)(1995-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
acting directly##2##2##(1994-11#1)(2011-2#1)
acting in the##4##3##(1997-8#1)(2008-10#1)(2010-4#1)(2012-3#1)
acting in##10##2##(1992-9#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)(2012-3#2)
acting insulin##2##2##(2008-1#1)(2008-8#1)
acting more##2##2##(1993-12#1)(1995-3#1)
acting mutagens##3##2##(1992-8#1)(1996-2#2)
acting on a##7##3##(1996-12#1)(2008-10#1)(2008-2#3)(2008-7#1)(2013-1#1)
acting on distinct##2##3##(2008-4#2)
acting on the##10##3##(1992-8#1)(1995-12#1)(1997-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)
acting on these##2##3##(2009-12#1)(2012-3#1)
acting on##44##2##(1990-12#1)(1992-8#1)(1994-8#2)(1995-12#2)(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#3)(2009-12#2)(2010-10#1)(2010-9#1)(2012-3#2)(2013-1#2)
acting opioid##2##2##(1993-6#1)(2008-7#1)
acting through a##3##3##(1990-7#1)(1992-1#1)(1995-2#1)
acting through##6##2##(1990-7#1)(1992-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-4#1)
acting upon the##2##3##(2007-12#1)(2008-10#1)
acting upon##4##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
acting via##5##2##(1992-8#1)(1993-12#1)(1995-6#1)(2007-12#1)(2008-5#1)
acting##195##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-3#3)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#2)(1994-8#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#4)(2008-2#6)(2008-3#5)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#2)(2009-2#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#9)(2012-12#2)(2012-2#3)(2012-3#5)(2012-6#1)(2013-1#4)
actinic damage##3##2##(2008-5#2)(2010-8#1)
actinic keratoses##2##2##(2010-8#1)(2011-2#1)
actinic keratosis lesions##3##3##(2010-8#3)
actinic keratosis##7##2##(1990-6#2)(2010-8#5)
actinic##18##1##(1990-6#2)(2008-3#3)(2008-5#4)(2010-8#7)(2011-2#2)
actinides and lanthanides##3##3##(2008-10#3)
actinides and##5##2##(2008-10#5)
actinides##9##1##(2008-10#9)
actinobacterial strains##2##2##(2012-2#2)
actinobacterial##8##1##(2011-2#5)(2012-2#3)
actinomyces##2##1##(2008-1#1)(2013-8#1)
actinomycete##5##1##(2008-10#4)(2009-2#1)
actinomycetemcomitans##3##1##(2007-7#2)(2013-1#1)
actinomycetes and##2##2##(1995-11#1)(2008-10#1)
actinomycetes##15##1##(1995-11#1)(2007-11#1)(2008-10#11)(2009-6#1)(2010-12#1)
actinomycin D and##4##3##(1991-5#1)(1994-9#2)(2008-11#1)
actinomycin D##19##2##(1991-5#1)(1992-1#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-2#1)(2008-11#6)(2008-4#1)(2008-6#1)
actinomycin##20##1##(1991-5#1)(1992-1#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-12#1)(1997-2#1)(2008-11#6)(2008-4#1)(2008-6#1)
actinomycosis is##2##2##(2009-5#1)(2010-12#1)
actinomycosis##16##1##(1992-2#1)(2007-12#1)(2008-1#6)(2009-5#4)(2010-12#2)(2013-8#2)
actinophylla##3##1##(2008-10#3)
actins##7##1##(1990-5#2)(1995-2#3)(2008-11#1)(2008-7#1)
action against##8##2##(1995-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-7#1)(2013-8#1)
action aimed##2##2##(1991-6#1)(2008-11#1)
action and the##5##3##(1991-12#1)(1991-2#1)(1995-8#1)(2008-7#1)(2010-6#1)
action and##40##2##(1991-12#1)(1991-2#2)(1993-12#1)(1993-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#1)
action are discussed##2##3##(1990-12#1)(1993-12#1)
action are##7##2##(1990-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
action as well as##3##4##(2008-4#1)(2011-2#2)
action as##7##2##(1992-12#1)(2008-4#1)(2008-6#1)(2010-8#1)(2011-2#3)
action at the##2##3##(1991-6#1)(1992-3#1)
action at##9##2##(1991-2#1)(1991-6#1)(1992-3#1)(1994-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
action being##2##2##(2008-6#1)(2010-8#1)
action between##2##2##(2008-10#1)(2008-4#1)
action by the##3##3##(1997-2#1)(2009-11#1)(2011-1#1)
action by##10##2##(1991-1#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-10#1)(2011-1#1)(2012-2#1)
action can##2##2##(1994-8#1)(2009-10#1)
action coping##2##2##(2009-7#2)
action could##3##2##(1996-2#1)(2008-10#1)(2012-3#1)
action exerted##2##2##(2007-11#1)(2009-6#1)
action for the##4##3##(1990-7#1)(1993-3#1)(2008-11#1)(2008-7#1)
action for##17##2##(1990-7#1)(1993-3#2)(1994-1#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-7#2)(2010-9#1)
action from##2##2##(1992-11#1)(1997-3#1)
action has been##2##3##(1992-3#1)(2007-12#1)
action has##3##2##(1992-3#1)(2007-11#1)(2007-12#1)
action have##3##2##(1994-3#1)(1997-4#1)(2008-8#1)
action in rodents##2##3##(1990-3#1)(2008-7#1)
action in the central##2##4##(1991-5#1)(2013-8#1)
action in the##8##3##(1990-5#1)(1991-5#1)(1992-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(2008-2#1)(2013-8#1)
action in this##3##3##(1990-11#1)(1996-12#1)(2008-5#1)
action in vitro##3##3##(1997-4#2)(2008-10#1)
action in vivo##2##3##(2008-10#1)(2008-4#1)
action in##42##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#2)(1992-12#1)(1992-2#1)(1993-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-4#2)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
action is mediated##2##3##(2008-7#1)(2012-3#1)
action is not##3##3##(1990-11#1)(1996-5#1)(2008-7#1)
action is still##2##3##(2009-8#1)(2010-10#1)
action is##26##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-6#1)(1994-8#2)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#2)
action mechanism##2##2##(2008-5#1)(2010-11#1)
action mechanisms##2##2##(1994-11#1)(2008-11#1)
action model##2##2##(2008-11#1)(2008-7#1)
action not##2##2##(1997-3#1)(2008-4#1)
action of 1##3##3##(1990-11#1)(1990-2#1)(2008-7#1)
action of 5-HT on the##2##5##(1993-12#1)(2008-7#1)
action of AA##2##3##(1993-8#1)(1995-5#1)
action of CGRP##2##3##(1992-6#2)
action of EA##2##3##(1995-12#2)
action of UDCA##2##3##(2008-8#2)
action of a##13##3##(1991-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-5#1)(2010-3#1)
action of acupuncture was##2##4##(1995-12#2)
action of acupuncture##4##3##(1995-12#3)(2008-10#1)
action of adenosine##3##3##(1996-2#3)
action of an##5##3##(1990-2#1)(1992-3#1)(2007-12#1)(2008-11#1)(2008-6#1)
action of androgens##2##3##(2008-4#1)(2009-4#1)
action of antiestrogens##2##3##(2008-11#2)
action of benziodarone##2##3##(1990-11#2)
action of cannabidiol##2##3##(2010-10#2)
action of central ET-1##2##4##(1994-11#2)
action of drugs##2##3##(1994-11#1)(1997-6#1)
action of forskolin##4##3##(1993-3#1)(1996-5#1)(1997-7#2)
action of glutamate##3##3##(1995-12#1)(2008-7#2)
action of many##2##3##(2008-4#1)(2008-6#1)
action of multiple##3##3##(1994-12#1)(1995-5#1)(2012-3#1)
action of parathyroid hormone##2##4##(1994-6#1)(2013-8#1)
action of phospholipids on the##2##5##(1995-8#2)
action of protonophores##2##3##(1996-4#2)
action of retinoic acid##2##4##(1990-6#2)
action of several##3##3##(1991-5#1)(1992-9#1)(2009-9#1)
action of the Isabella volatiles##2##5##(2008-10#2)
action of the drug##5##4##(1990-11#2)(1991-10#1)(1994-8#1)(2008-10#1)
action of the enzyme##2##4##(1990-11#1)(2008-10#1)
action of the##55##3##(1990-11#3)(1990-5#3)(1991-10#1)(1992-3#2)(1992-9#1)(1993-3#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-2#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
action of these compounds##2##4##(1994-2#1)(1994-8#1)
action of these drugs##2##4##(2008-11#1)(2010-11#1)
action of these##17##3##(1990-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2010-11#1)
action of this##6##3##(1992-3#1)(1994-3#1)(1996-3#1)(1997-2#2)(2008-10#1)
action of two##3##3##(1993-3#1)(2007-11#1)(2007-12#1)
action of##406##2##(1990-11#7)(1990-12#1)(1990-2#7)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-5#3)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#6)(1992-6#8)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#8)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#6)(1994-8#10)(1994-9#1)(1995-11#1)(1995-12#13)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#5)(1995-8#3)(1996-12#1)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#8)(1997-4#2)(1997-6#2)(1997-7#7)(2007-11#3)(2007-12#7)(2008-1#4)(2008-10#52)(2008-11#31)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#9)(2008-5#12)(2008-6#5)(2008-7#17)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#4)
action on the##17##3##(1990-5#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(2007-11#1)(2008-10#2)(2008-7#2)(2012-12#1)
action on tumor##2##3##(2013-7#1)(2013-8#1)
action on##60##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-6#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#2)(1993-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-5#3)(1997-6#1)(1997-7#1)(2007-11#4)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#3)(2010-1#1)(2010-8#2)(2011-2#1)(2011-3#2)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
action plan for##3##3##(2007-4#1)(2011-2#2)
action plan##15##2##(1991-3#1)(1993-2#1)(1995-12#1)(1995-3#2)(1996-3#1)(2007-4#1)(2008-3#1)(2009-6#1)(2011-1#3)(2011-2#3)
action planning##2##2##(1995-3#1)(1996-2#1)
action plans##3##2##(1996-2#1)(2007-6#1)(2013-1#1)
action potential amplitude##2##3##(2008-4#2)
action potential duration##2##3##(1992-3#1)(2013-7#1)
action potential firing##2##3##(1996-2#1)(2013-8#1)
action potential of the##3##4##(2008-11#3)
action potential of##4##3##(2008-11#4)
action potential##34##2##(1990-7#1)(1991-5#2)(1992-3#2)(1993-12#2)(1996-2#2)(1997-7#1)(2008-11#5)(2008-4#4)(2008-5#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#2)(2009-8#1)(2012-3#1)(2013-7#1)(2013-8#2)
action potentials in the##3##4##(1992-12#1)(2008-11#1)(2009-12#1)
action potentials in##7##3##(1992-12#1)(1993-12#1)(1996-5#1)(2008-1#1)(2008-11#1)(2009-12#1)(2013-1#1)
action potentials of the##2##4##(1995-8#1)(2008-8#1)
action potentials that are##2##4##(1990-5#1)(2008-4#1)
action potentials that##4##3##(1990-5#1)(2008-11#1)(2008-4#1)(2009-12#1)
action potentials##28##2##(1990-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-8#2)(1996-5#1)(1997-6#1)(2008-1#1)(2008-11#7)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#1)(2012-2#1)(2013-1#3)
action provides##2##2##(1990-2#1)(2008-7#1)
action research approach##4##3##(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)
action research process##2##3##(2007-10#1)(2008-11#1)
action research##18##2##(1991-2#1)(1995-3#3)(1996-2#1)(2007-10#2)(2008-1#1)(2008-11#6)(2008-12#1)(2009-1#1)(2011-2#2)
action should be taken##2##4##(1996-2#1)(2013-8#1)
action should be##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
action steps##3##2##(1993-1#1)(1994-12#1)(2008-8#1)
action studies##3##2##(2008-5#1)(2011-2#2)
action taken to reduce##2##4##(1992-2#1)(1993-1#1)
action taken##3##2##(1992-2#1)(1993-1#1)(2011-2#1)
action that##6##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)
action therapy##2##2##(2008-6#2)
action threshold##5##2##(2008-10#2)(2008-4#3)
action throughout##2##2##(2008-9#1)(2010-5#1)
action to be taken##2##4##(2008-10#1)(2012-2#1)
action to the##2##3##(1993-5#1)(1996-12#1)
action to##14##2##(1992-3#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
action under##3##2##(1993-6#1)(1994-3#2)
action upon##2##2##(1994-3#1)(2011-1#1)
action via##3##2##(1994-8#1)(1997-4#1)(2008-11#1)
action was more pronounced at 21 degrees C##2##8##(2008-10#2)
action was##16##2##(1990-8#1)(1992-5#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-10#6)(2008-5#1)(2008-9#1)(2011-1#1)(2013-7#1)
action were##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
action with##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
action##1148##1##(1990-11#10)(1990-12#5)(1990-2#12)(1990-3#4)(1990-5#11)(1990-6#2)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#4)(1991-10#1)(1991-12#6)(1991-2#9)(1991-3#3)(1991-5#9)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#13)(1992-5#2)(1992-6#11)(1992-8#8)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#13)(1993-2#2)(1993-3#12)(1993-5#4)(1993-6#2)(1993-8#4)(1993-9#2)(1994-1#3)(1994-11#10)(1994-12#4)(1994-2#12)(1994-3#10)(1994-5#5)(1994-6#11)(1994-8#20)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#26)(1995-2#7)(1995-3#11)(1995-5#9)(1995-6#8)(1995-8#6)(1996-1#2)(1996-12#7)(1996-2#28)(1996-3#8)(1996-4#2)(1996-5#12)(1996-7#1)(1997-1#3)(1997-2#10)(1997-3#3)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#9)(2007-10#2)(2007-11#19)(2007-12#9)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#8)(2008-10#118)(2008-11#82)(2008-12#5)(2008-2#14)(2008-3#15)(2008-4#43)(2008-5#40)(2008-6#14)(2008-7#48)(2008-8#23)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#7)(2009-2#3)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#8)(2010-11#6)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#6)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#17)(2011-2#38)(2011-3#5)(2012-1#1)(2012-12#15)(2012-2#21)(2012-3#9)(2012-7#1)(2013-1#25)(2013-7#8)(2013-8#15)
action&quot##3##1##(1991-3#1)(2008-11#1)(2008-7#1)
action)##3##1##(2008-10#1)(2008-4#2)
action?##3##1##(1994-5#1)(2008-4#1)(2009-8#1)
actionable##4##1##(1996-3#1)(1997-1#1)(2008-8#1)(2010-8#1)
actions against##2##2##(1992-2#1)(1997-3#1)
actions and##10##2##(1990-5#1)(1991-1#1)(1992-6#1)(1996-1#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-6#1)
actions are##11##2##(1991-9#1)(1992-2#1)(1992-3#1)(2008-4#4)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
actions at##2##2##(1992-3#1)(1994-1#1)
actions by##5##2##(1990-7#1)(1992-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
actions designed to##2##3##(2008-12#1)(2008-9#1)
actions for##5##2##(1993-2#1)(1996-11#1)(2008-11#1)(2008-12#1)(2013-7#1)
actions in a##2##3##(1992-8#1)(2009-10#1)
actions in the##5##3##(1996-2#1)(1997-2#1)(2009-7#1)(2011-2#1)(2012-3#1)
actions in##16##2##(1992-8#1)(1993-6#1)(1995-5#1)(1996-2#1)(1997-2#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
actions may##2##2##(2009-8#1)(2012-2#1)
actions needed to##2##3##(2008-1#1)(2010-5#1)
actions of GH##2##3##(1991-12#1)(1993-6#1)
actions of PTPase##2##3##(2008-8#2)
actions of insulin##2##3##(1991-12#1)(2011-2#1)
actions of the LPS-serum complex##2##5##(1992-3#2)
actions of the##14##3##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#2)(1992-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-8#2)(2008-11#1)(2008-8#1)(2010-11#1)
actions of these two drugs##2##5##(1993-8#1)(1995-12#1)
actions of these##4##3##(1992-12#1)(1993-8#1)(1995-12#1)(2009-12#1)
actions of##113##2##(1990-2#1)(1990-5#4)(1990-8#1)(1991-1#4)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#2)(2008-1#1)(2008-10#8)(2008-11#9)(2008-4#8)(2008-5#4)(2008-7#8)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
actions on the##2##3##(1995-11#1)(1997-4#1)
actions on##14##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-11#1)(1997-4#1)(1997-7#1)(2008-4#2)(2009-8#1)(2012-12#1)
actions related to the##2##4##(2008-10#1)(2008-11#1)
actions should##2##2##(2010-10#1)(2011-2#1)
actions taken to##3##3##(1992-1#1)(2008-10#1)(2012-12#1)
actions taken##7##2##(1992-1#2)(1993-2#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
actions that have been taken##2##5##(1996-1#1)(2012-3#1)
actions that##11##2##(1993-12#1)(1993-3#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
actions to be##2##3##(1997-5#1)(2007-8#1)
actions to increase##2##3##(1994-3#1)(1997-4#1)
actions to##13##2##(1993-3#1)(1994-3#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-5#1)(2010-9#1)(2011-1#1)
actions were##2##2##(2008-7#1)(2012-3#1)
actions##318##1##(1990-12#2)(1990-2#2)(1990-5#5)(1990-7#1)(1990-8#1)(1991-1#6)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#4)(1992-3#4)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#4)(1993-5#4)(1993-6#4)(1993-8#2)(1994-1#3)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#3)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#4)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#23)(2008-12#3)(2008-4#30)(2008-5#7)(2008-7#15)(2008-8#8)(2008-9#8)(2009-10#3)(2009-12#2)(2009-3#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#4)(2013-8#5)
actions)##2##1##(2008-4#1)(2013-8#1)
activable##2##1##(1995-6#1)(2008-8#1)
activate BPlg##2##2##(1993-8#2)
activate a##11##2##(1991-5#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)
activate an##2##2##(2009-7#1)(2011-2#1)
activate and##5##2##(1997-3#1)(2008-4#2)(2009-8#1)(2013-1#1)
activate both##2##2##(1995-2#1)(2013-1#1)
activate dSMAD2##2##2##(2008-9#2)
activate endogenous##2##2##(1996-9#1)(2008-10#1)
activate phospholipase##2##2##(1990-2#1)(1997-6#1)
activate protein kinase C##3##4##(1991-9#1)(1992-8#1)(2008-11#1)
activate protein kinase##4##3##(1991-9#1)(1992-8#1)(2008-11#1)(2010-11#1)
activate the ORL-1 receptor##2##4##(2008-11#2)
activate the enzyme##2##3##(1991-9#1)(1992-6#1)
activate the same##2##3##(1991-12#1)(2010-5#1)
activate the transcription factor##2##4##(2008-11#1)(2009-3#1)
activate the transcription##3##3##(1997-7#1)(2008-11#1)(2009-3#1)
activate the##47##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
activate transcription from##2##3##(1991-5#1)(1994-8#1)
activate transcription##5##2##(1991-5#1)(1994-8#1)(1995-2#1)(2010-8#1)(2012-1#1)
activate two##2##2##(2007-12#1)(2008-7#1)
activate##187##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-9#3)(1992-11#1)(1992-4#1)(1992-6#3)(1992-8#3)(1993-12#3)(1993-3#3)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#4)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#4)(2006-12#3)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#9)(2008-2#1)(2008-4#8)(2008-5#1)(2008-7#12)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
activated 1##2##2##(1994-8#1)(2008-4#1)
activated B cells##8##3##(1991-3#2)(1993-11#1)(1995-6#3)(2012-3#1)(2013-1#1)
activated Bax##2##2##(2011-2#1)(2013-1#1)
activated PC##2##2##(1995-2#1)(2008-10#1)
activated PKC##3##2##(1992-9#1)(1993-9#1)(1997-1#1)
activated T cells##7##3##(1990-12#1)(1997-7#1)(1997-8#1)(2008-4#1)(2009-6#1)(2010-5#1)(2012-12#1)
activated T##10##2##(1990-12#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-4#2)(2008-9#1)(2009-6#1)(2010-5#1)(2012-12#1)
activated T-cells##2##2##(1994-5#1)(1997-4#1)
activated after##3##2##(1990-11#1)(1997-7#1)(2010-3#1)
activated alumina in##2##3##(2008-10#2)
activated alumina##4##2##(2008-10#4)
activated and##6##2##(1990-2#1)(1993-9#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#1)
activated anion##2##2##(2008-8#2)
activated at##8##2##(1992-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-8#1)
activated both the##2##3##(1993-11#1)(1995-12#1)
activated both##4##2##(1993-11#1)(1993-12#1)(1993-8#1)(1995-12#1)
activated by 1##2##3##(1993-8#1)(1995-2#1)
activated by Ca(2+)##2##3##(2008-4#1)(2008-8#1)
activated by Ca2+##2##3##(1995-6#2)
activated by a##6##3##(1991-2#1)(1995-6#1)(2008-10#1)(2008-4#2)(2008-9#1)
activated by adenosine##2##3##(2008-4#2)
activated by all##2##3##(1996-12#1)(2008-4#1)
activated by anti##2##3##(1991-12#1)(2008-10#1)
activated by cell##2##3##(1995-11#1)(2008-8#1)
activated by glutaraldehyde##2##3##(2008-10#2)
activated by insulin##3##3##(1997-6#3)
activated by interaction with##2##4##(1993-8#1)(1995-6#1)
activated by phorbol##2##3##(2008-11#2)
activated by replacement of##2##4##(1991-5#1)(1992-3#1)
activated by the##15##3##(1991-2#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2011-1#1)
activated by##144##2##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#8)(1996-12#8)(1996-2#2)(1997-2#3)(1997-6#3)(2008-1#1)(2008-10#9)(2008-11#12)(2008-2#1)(2008-3#1)(2008-4#15)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#5)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
activated carbon (AC) at pH##3##5##(2008-10#3)
activated carbon (AC)##5##3##(2008-10#5)
activated carbon and##6##3##(2008-10#6)
activated carbon column##5##3##(2008-10#5)
activated carbon for##2##3##(2008-10#2)
activated carbon was##2##3##(2008-10#2)
activated carbon##43##2##(1992-5#1)(2008-10#39)(2008-6#3)
activated cells##7##2##(1993-11#1)(1994-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)
activated charcoal as##2##3##(2008-10#2)
activated charcoal##9##2##(1991-9#1)(2008-10#7)(2013-1#1)
activated complement##2##2##(1993-3#1)(2008-9#1)
activated during the##2##3##(1993-12#1)(2008-11#1)
activated during##7##2##(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#2)(2012-12#1)
activated either by##2##3##(1994-8#1)(2008-4#1)
activated enzyme##2##2##(1990-8#1)(1995-2#1)
activated ester##2##2##(2008-10#1)(2008-4#1)
activated factor##2##2##(1991-9#1)(2008-8#1)
activated following##2##2##(1993-11#1)(2008-8#1)
activated for##2##2##(2008-6#1)(2010-7#1)
activated form of the##2##4##(1991-9#1)(1992-9#1)
activated form of##5##3##(1991-9#1)(1992-9#2)(1995-2#1)(2008-9#1)
activated forms of##3##3##(1994-9#1)(1997-7#1)(2008-9#1)
activated growth factor receptors##2##4##(2008-4#1)(2012-12#1)
activated homopolymers##2##2##(2009-10#2)
activated human##7##2##(1992-12#1)(1994-11#1)(1994-5#1)(1995-12#2)(2008-11#1)(2008-7#1)
activated in a cell-free system##2##5##(1991-5#1)(1994-8#1)
activated in a##3##3##(1991-5#1)(1994-8#1)(2008-9#1)
activated in response to##3##4##(1992-8#1)(2008-4#1)(2013-8#1)
activated in the##7##3##(1993-12#1)(1994-5#1)(1996-2#2)(1996-3#1)(2008-10#1)(2008-3#1)
activated in vitro by##2##4##(1991-9#1)(1995-12#1)
activated in vitro##3##3##(1991-9#1)(1993-9#1)(1995-12#1)
activated in##37##2##(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
activated killer##3##2##(1991-8#1)(1992-2#1)(2008-11#1)
activated kinase##3##2##(2009-7#1)(2011-2#1)(2012-12#1)
activated lymphocytes and##2##3##(2008-4#1)(2011-2#1)
activated lymphocytes##5##2##(1997-5#1)(2008-4#2)(2008-7#1)(2011-2#1)
activated macrophages and##2##3##(2008-4#1)(2009-12#1)
activated macrophages may##2##3##(1994-5#1)(2008-11#1)
activated macrophages##8##2##(1992-9#1)(1993-12#1)(1994-5#2)(2008-11#2)(2008-4#1)(2009-12#1)
activated membranes##4##2##(1994-8#4)
activated microglia##3##2##(2008-6#1)(2008-8#1)(2009-12#1)
activated mitomycin C##2##3##(1992-3#1)(1995-2#1)
activated mitomycin##3##2##(1992-3#1)(1995-2#1)(1995-5#1)
activated monocytes##3##2##(1993-9#1)(1994-11#1)(2012-2#1)
activated neutrophils##3##2##(1991-9#2)(2008-4#1)
activated oncogenes##2##2##(1997-7#1)(2008-6#1)
activated partial thromboplastin time##4##4##(1991-2#1)(1994-9#1)(2008-10#1)(2008-7#1)
activated partial thromboplastin##5##3##(1991-2#1)(1994-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
activated partial##6##2##(1991-2#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
activated phosphite##2##2##(2008-4#2)
activated platelets##7##2##(1991-12#1)(1997-7#2)(2006-6#1)(2008-1#1)(2010-3#2)
activated polycarbonate surface##2##3##(2008-10#2)
activated polycarbonate##4##2##(2008-10#4)
activated protein C##5##3##(1993-11#1)(1997-3#1)(2007-12#2)(2011-2#1)
activated protein kinase##4##3##(1993-8#1)(1994-11#1)(2012-2#1)(2013-7#1)
activated protein##11##2##(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-2#1)(1997-3#1)(2007-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
activated receptor##6##2##(1996-12#1)(1996-2#1)(2006-8#1)(2012-2#1)(2013-8#2)
activated sludge##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
activated states##3##2##(1997-7#3)
activated the##15##2##(1993-8#1)(1995-12#2)(1995-2#3)(2008-10#2)(2008-11#3)(2008-4#1)(2009-8#1)(2012-1#1)(2013-1#1)
activated to produce##2##3##(1990-5#1)(2008-9#1)
activated to##3##2##(1990-5#1)(1995-11#1)(2008-9#1)
activated upon##2##2##(2008-12#1)(2008-9#1)
activated when##8##2##(1990-12#1)(1990-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2010-5#1)
activated with a##2##3##(1996-5#1)(2008-8#1)
activated with##8##2##(1992-2#1)(1993-8#1)(1996-5#1)(2008-10#4)(2008-8#1)
activated within##2##2##(1994-9#1)(1995-6#1)
activated##640##1##(1990-11#4)(1990-12#5)(1990-2#4)(1990-5#3)(1990-6#1)(1990-8#6)(1990-9#1)(1991-12#2)(1991-2#8)(1991-3#4)(1991-5#3)(1991-8#1)(1991-9#12)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#5)(1993-11#8)(1993-12#9)(1993-3#7)(1993-6#4)(1993-8#11)(1993-9#5)(1994-10#1)(1994-11#11)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#12)(1994-6#1)(1994-8#9)(1994-9#3)(1995-11#9)(1995-12#11)(1995-2#15)(1995-5#4)(1995-6#15)(1995-8#2)(1996-12#11)(1996-2#12)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#14)(1997-8#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#7)(2008-10#96)(2008-11#37)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#42)(2008-5#6)(2008-6#8)(2008-7#28)(2008-8#17)(2008-9#17)(2009-1#1)(2009-10#5)(2009-12#4)(2009-6#2)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#5)
activates PI 3-kinase##2##3##(1994-11#1)(2008-11#1)
activates PKC##2##2##(1992-12#1)(2010-11#1)
activates a##6##2##(1992-1#1)(1993-3#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-1#1)
activates phospholipase C##2##3##(1993-3#1)(1994-8#1)
activates phospholipase##4##2##(1993-3#1)(1993-8#1)(1994-8#1)(1997-1#1)
activates the same##3##3##(1991-12#1)(1995-12#1)(2013-8#1)
activates the##21##2##(1990-12#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-3#1)(2007-11#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
activates transcription of##3##3##(1992-8#1)(1995-2#1)(2008-9#1)
activates transcription##7##2##(1990-11#1)(1991-10#1)(1991-11#1)(1992-8#1)(1995-2#1)(2008-9#2)
activates##104##1##(1990-11#3)(1990-12#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#4)(1995-11#4)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#3)(2007-11#2)(2008-10#4)(2008-11#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
activating a##2##2##(2008-10#1)(2008-3#1)
activating agent##2##2##(1991-5#1)(2008-6#1)
activating and##7##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-4#1)(2010-6#1)
activating autoantibodies##2##2##(2010-4#2)
activating dipeptide##2##2##(1990-8#2)
activating effect of##3##3##(1990-5#1)(1994-8#2)
activating effect on##3##3##(1990-8#1)(1997-4#1)(2008-10#1)
activating effect was##2##3##(1990-5#2)
activating effect##9##2##(1990-5#3)(1990-8#1)(1994-3#1)(1994-8#2)(1997-4#1)(2008-10#1)
activating factor##7##2##(1991-9#1)(1993-6#2)(1995-2#2)(1995-3#1)(2008-1#1)
activating group##3##2##(1994-11#3)
activating lipids##2##2##(1993-12#2)
activating mutations in the##4##4##(1996-5#1)(2009-4#1)(2012-1#1)(2013-1#1)
activating mutations in##5##3##(1996-5#1)(2009-4#2)(2012-1#1)(2013-1#1)
activating mutations##6##2##(1996-5#1)(2008-8#1)(2009-4#2)(2012-1#1)(2013-1#1)
activating natural##2##2##(2012-2#1)(2013-1#1)
activating protein##10##2##(1990-5#1)(1991-12#1)(1991-5#3)(1992-8#1)(1993-6#1)(1993-8#2)(2013-1#1)
activating signals##2##2##(1994-11#1)(2009-8#1)
activating the transcription of##2##4##(2008-9#1)(2011-1#1)
activating the transcription##3##3##(2008-9#2)(2011-1#1)
activating the##20##2##(1994-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
activating transcription factor##2##3##(2009-3#1)(2011-2#1)
activating transcription factor-2 (ATF-2)##2##4##(1997-2#2)
activating transcription##6##2##(1997-2#3)(2009-3#1)(2009-8#1)(2011-2#1)
activating##156##1##(1990-12#2)(1990-2#2)(1990-5#6)(1990-7#1)(1990-8#3)(1991-12#2)(1991-5#4)(1991-9#4)(1992-10#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#6)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#4)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-8#2)
activation also##2##2##(2008-7#1)(2009-12#1)
activation analysis##6##2##(1991-12#1)(2008-10#4)(2009-6#1)
activation and DNA##3##3##(1997-1#1)(2008-4#1)(2011-2#1)
activation and adhesion##2##3##(1996-2#1)(2008-7#1)
activation and contributes to the##2##5##(1994-3#1)(1995-2#1)
activation and gene##3##3##(2008-11#2)(2008-9#1)
activation and inactivation of##2##4##(1992-11#1)(2008-4#1)
activation and proliferation of##2##4##(1997-3#1)(2008-9#1)
activation and that##3##3##(1992-6#1)(1996-2#1)(2008-10#1)
activation and the##5##3##(1990-2#1)(1993-8#1)(1997-2#1)(2012-2#1)(2013-1#1)
activation and##85##2##(1990-2#2)(1991-10#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#3)(1997-1#2)(1997-2#1)(1997-3#1)(2006-6#2)(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-2#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
activation are##5##2##(1995-12#1)(1995-5#1)(1996-2#1)(2008-4#1)(2011-1#1)
activation as measured by##2##4##(2006-6#1)(2011-2#1)
activation as##5##2##(1991-2#1)(2006-6#1)(2007-8#1)(2008-11#1)(2011-2#1)
activation at##5##2##(1992-12#1)(2008-10#1)(2008-4#1)(2013-1#2)
activation barriers of##4##3##(2008-10#4)
activation by a##4##3##(1995-8#2)(2008-10#1)(2008-4#1)
activation by all three Brn-3 factors##2##6##(1996-12#2)
activation by the##6##3##(1990-5#2)(1993-2#1)(1993-8#1)(1994-6#1)(1995-8#1)
activation by##52##2##(1990-5#6)(1990-7#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#4)(1996-12#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-6#2)(2008-10#3)(2008-11#3)(2008-4#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
activation can be##2##3##(2008-4#2)
activation can##6##2##(1995-2#1)(2008-4#2)(2010-8#1)(2012-12#1)(2012-2#1)
activation causes##2##2##(1997-7#1)(2009-12#1)
activation depends##2##2##(1992-12#1)(2008-9#1)
activation does not##3##3##(1995-8#1)(1997-7#1)(2008-4#1)
activation domain##5##2##(1994-12#1)(1995-6#1)(1997-4#1)(2008-8#2)
activation during experience predicted##2##4##(2008-11#2)
activation during##15##2##(1992-8#1)(1994-3#1)(1994-8#1)(1996-2#2)(1997-4#1)(2008-11#6)(2008-9#1)(2009-6#1)(2012-12#1)
activation energies of##3##3##(1996-7#1)(2008-11#1)(2008-9#1)
activation energies##6##2##(1996-7#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
activation energy (E(a))##2##3##(1996-7#1)(2008-10#1)
activation energy for##7##3##(1992-3#1)(2008-10#5)(2012-2#1)
activation energy of the##3##4##(1991-5#1)(2007-11#1)(2007-12#1)
activation energy of##5##3##(1990-2#1)(1991-5#1)(1996-7#1)(2007-11#1)(2007-12#1)
activation energy was##4##3##(1992-3#1)(2008-10#3)
activation energy##30##2##(1990-2#2)(1991-5#1)(1992-3#2)(1993-8#1)(1996-7#3)(2007-11#1)(2007-12#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)
activation enzymes##3##2##(2008-9#3)
activation events##2##2##(1992-8#1)(2008-9#1)
activation following##2##2##(2007-10#1)(2008-9#1)
activation for##5##2##(1996-2#1)(2008-8#1)(2010-10#1)(2010-11#1)(2013-1#1)
activation from the##2##3##(1994-8#1)(1995-6#1)
activation from##4##2##(1994-8#1)(1995-6#1)(2008-9#1)(2009-6#1)
activation function##4##2##(2008-9#2)(2010-8#2)
activation has##2##2##(2008-11#1)(2008-9#1)
activation in a##4##3##(1991-9#1)(1995-11#1)(1996-6#1)(2008-7#1)
activation in inbred mouse strains##2##5##(1997-7#2)
activation in rat##5##3##(1990-7#1)(1991-2#1)(1993-3#1)(1994-11#1)(2013-7#1)
activation in response to##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
activation in the frigid mutant##2##5##(1991-2#2)
activation in the right##2##4##(1996-2#1)(2012-12#1)
activation in the##22##3##(1991-2#2)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-12#2)(2013-8#1)
activation in visual##2##3##(1995-11#1)(2008-11#1)
activation in##83##2##(1990-11#1)(1990-7#1)(1991-2#3)(1991-9#1)(1992-12#3)(1992-2#1)(1993-3#1)(1994-11#5)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#14)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
activation induced by##7##3##(1990-2#1)(1990-5#1)(1992-12#1)(1995-6#1)(1995-8#1)(2008-4#1)(2008-8#1)
activation induced##8##2##(1990-2#1)(1990-5#1)(1992-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-4#1)(2008-8#1)
activation is a##2##3##(2008-11#1)(2009-6#1)
activation is involved in the##2##5##(1997-2#1)(2010-3#1)
activation is required for##2##4##(1994-11#1)(1997-7#1)
activation is required##3##3##(1994-11#1)(1997-7#1)(2007-12#1)
activation is##25##2##(1991-2#1)(1992-11#1)(1993-8#1)(1994-11#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-4#3)(2008-8#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
activation leading##2##2##(2009-8#1)(2010-3#1)
activation leads to##2##3##(2008-4#1)(2008-7#1)
activation levels##3##2##(2007-12#1)(2010-7#1)(2013-1#1)
activation loci##3##2##(2009-6#3)
activation marker##2##2##(2008-4#1)(2012-2#1)
activation may provide##2##3##(1995-8#1)(2009-6#1)
activation may##8##2##(1991-4#1)(1995-8#2)(2008-7#2)(2009-6#1)(2012-3#1)(2013-7#1)
activation motif##3##2##(1997-3#3)
activation observed with##2##3##(1993-8#1)(2012-12#1)
activation obtained##2##2##(1992-9#1)(2009-6#1)
activation occurred##4##2##(1990-8#1)(1992-12#1)(1997-3#2)
activation occurs##2##2##(1994-2#1)(2008-11#1)
activation of 5-HT1A receptors##2##4##(1990-5#1)(1995-12#1)
activation of Abl##2##3##(2012-12#2)
activation of Akt and ERK1/2##2##5##(2010-1#2)
activation of Akt##3##3##(2009-5#1)(2010-1#2)
activation of Aurora-A##2##3##(2012-12#2)
activation of G-protein##2##3##(1996-2#1)(2012-2#1)
activation of Gs##2##3##(1992-3#1)(1995-6#1)
activation of HIV-1 precursors##2##4##(2011-3#2)
activation of HIV-1##3##3##(2011-3#3)
activation of HSF##3##3##(1995-11#3)
activation of K+##2##3##(1994-3#2)
activation of MAP kinase##4##4##(1992-8#1)(1993-8#2)(1995-8#1)
activation of MAP##5##3##(1992-8#1)(1993-8#2)(1995-8#1)(2013-7#1)
activation of MAPK##2##3##(2010-12#1)(2013-1#1)
activation of MAPKs##3##3##(1995-6#2)(2009-8#1)
activation of NADPH oxidase and##2##5##(1994-6#1)(2008-4#1)
activation of NADPH oxidase in a cell-free system##2##8##(1990-5#1)(1993-8#1)
activation of NADPH oxidase##8##4##(1990-5#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-4#1)(2009-12#2)
activation of NFκB##3##3##(2011-2#3)
activation of PKA##2##3##(1990-12#1)(2012-2#1)
activation of PKC##5##3##(1992-12#1)(1992-9#2)(1997-2#1)(2008-8#1)
activation of PLA2##2##3##(1993-11#1)(1994-6#1)
activation of RII beta-type##2##4##(1994-8#2)
activation of Ras##3##3##(1994-8#3)
activation of STATs 1 and 3 in##2##7##(2012-3#2)
activation of T cells##4##4##(2007-11#1)(2007-12#1)(2008-4#1)(2009-6#1)
activation of T##5##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-6#1)
activation of a specific##2##4##(1995-8#1)(2011-2#1)
activation of a##23##3##(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)
activation of all##2##3##(1993-8#1)(2008-10#1)
activation of both##7##3##(1993-8#1)(1994-11#1)(1996-2#1)(1997-7#1)(2008-4#1)(2010-6#1)(2012-3#1)
activation of brain##2##3##(1994-2#1)(2011-2#1)
activation of c-Myc##2##3##(1994-9#2)
activation of caspase-3##4##3##(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
activation of cell##3##3##(1993-3#1)(2008-11#1)(2012-12#1)
activation of cellular##3##3##(1993-3#1)(2012-3#2)
activation of different##3##3##(1990-5#1)(2012-3#1)(2013-1#1)
activation of either##4##3##(1995-2#1)(1996-2#2)(2012-2#1)
activation of endogenous##2##3##(1991-12#1)(1991-2#1)
activation of endothelial##2##3##(2008-1#1)(2008-5#1)
activation of entanglement##2##3##(2012-2#2)
activation of extracellular##2##3##(1992-9#1)(2010-12#1)
activation of free oxidized##2##4##(2009-10#2)
activation of genes##2##3##(2008-8#1)(2010-6#1)
activation of glucocorticoid##2##3##(1996-12#1)(2009-6#1)
activation of heat shock factor 1##2##6##(1994-8#2)
activation of heat shock factor##4##5##(1994-8#3)(2010-2#1)
activation of heat shock transcription factor##2##6##(1994-11#1)(1995-11#1)
activation of heat shock##6##4##(1994-11#1)(1994-8#3)(1995-11#1)(2010-2#1)
activation of immune##2##3##(2012-12#1)(2012-3#1)
activation of inflammatory##2##3##(2008-12#1)(2010-5#1)
activation of innate immune##2##4##(2012-12#1)(2012-2#1)
activation of many##2##3##(1990-5#1)(2008-8#1)
activation of matrix metalloproteinase-2##2##4##(2013-1#1)(2013-7#1)
activation of matrix##4##3##(2008-5#2)(2013-1#1)(2013-7#1)
activation of microglia in denervated neuropil##2##6##(1997-3#2)
activation of multiple##2##3##(1990-11#1)(1994-8#1)
activation of neutrophil##2##3##(1992-5#1)(1994-8#1)
activation of nuclear##3##3##(1992-9#1)(1995-8#1)(2010-3#1)
activation of one##2##3##(1996-2#1)(2013-8#1)
activation of p72syk was##2##4##(1992-6#1)(1993-11#1)
activation of p72syk##5##3##(1992-6#3)(1993-11#2)
activation of pancreatic##2##3##(2013-1#1)(2013-7#1)
activation of peroxisome##2##3##(2008-7#1)(2010-10#1)
activation of phospholipase A2 and D##2##6##(1996-2#2)
activation of phospholipase A2##3##4##(1991-5#1)(1996-2#2)
activation of phospholipase C and##2##5##(2008-11#2)
activation of phospholipase C##3##4##(1995-2#1)(2008-11#2)
activation of phospholipase D##2##4##(1997-2#1)(2010-9#1)
activation of phospholipase##9##3##(1991-5#1)(1992-9#1)(1995-2#1)(1996-2#2)(1997-2#1)(2008-11#2)(2010-9#1)
activation of platelets by##2##4##(1992-12#1)(2006-6#1)
activation of platelets##4##3##(1992-12#2)(2006-6#2)
activation of protein kinase C (PKC)##2##6##(1995-11#1)(2008-8#1)
activation of protein kinase C in##5##6##(1991-9#1)(1992-12#1)(1992-9#1)(1997-1#1)(2008-11#1)
activation of protein kinase C##23##5##(1990-12#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#4)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)
activation of protein kinase##26##4##(1990-12#3)(1990-7#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#4)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)
activation of protein tyrosine##2##4##(1993-3#1)(1994-6#1)
activation of protein##30##3##(1990-12#3)(1990-7#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#4)(1993-3#2)(1993-6#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
activation of purified##2##3##(1992-9#1)(1997-2#1)
activation of quiescent##3##3##(1993-12#1)(2008-10#2)
activation of rat##2##3##(1990-12#1)(1991-2#1)
activation of several##2##3##(2008-10#1)(2009-10#1)
activation of specific##3##3##(1993-3#1)(2006-6#1)(2010-9#1)
activation of systemic##2##3##(2007-12#1)(2008-10#1)
activation of the MAP kinase##2##5##(1995-8#1)(1997-6#1)
activation of the MAPK cascade##2##5##(1995-2#1)(2009-8#1)
activation of the N-methyl-D-aspartate##2##4##(1994-8#1)(1997-2#1)
activation of the PI3K pathway##2##5##(2010-9#1)(2012-1#1)
activation of the cAMP##2##4##(1996-5#1)(2008-11#1)
activation of the cation##2##4##(2008-8#2)
activation of the enzyme by##2##5##(1993-11#1)(2008-7#1)
activation of the enzyme##7##4##(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(2008-10#1)(2008-7#1)
activation of the hypothalamic-pituitary-adrenal##2##4##(1997-2#1)(2008-4#1)
activation of the innate immune system##2##6##(2010-8#1)(2011-2#1)
activation of the kinase##3##4##(1990-12#1)(1995-2#1)(2013-8#1)
activation of the left##2##4##(2012-12#2)
activation of the mitogen-activated##2##4##(1995-2#1)(2008-7#1)
activation of the receptor##2##4##(1996-5#1)(2008-4#1)
activation of the right hemisphere##2##5##(1996-2#2)
activation of the right##3##4##(1996-2#2)(2008-11#1)
activation of the rostral ventrolateral medulla##2##6##(1997-6#2)
activation of the system##2##4##(1992-5#2)
activation of the##145##3##(1990-12#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#4)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#4)(1996-5#4)(1996-6#1)(1997-2#4)(1997-3#3)(1997-6#3)(1997-7#3)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#6)(2008-2#1)(2008-4#8)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-8#1)(2013-1#2)(2013-7#3)(2013-8#1)
activation of these receptors##2##4##(2008-4#1)(2012-1#1)
activation of these##6##3##(1993-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-2#1)
activation of this##4##3##(1990-12#1)(1994-5#1)(2011-2#1)(2012-12#1)
activation of transcription##4##3##(1990-5#1)(1995-2#1)(2008-4#1)(2008-9#1)
activation of tyrosine##2##3##(1996-2#1)(2011-2#1)
activation of various##5##3##(2008-11#1)(2008-2#1)(2010-12#1)(2010-7#1)(2013-1#1)
activation of voltage-dependent##2##3##(1996-2#1)(1996-5#1)
activation of β-catenin##2##3##(2013-1#2)
activation of##644##2##(1990-11#3)(1990-12#9)(1990-5#11)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#5)(1991-9#5)(1992-11#2)(1992-12#14)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#6)(1992-8#4)(1992-9#12)(1993-11#6)(1993-12#10)(1993-2#2)(1993-3#9)(1993-6#5)(1993-8#9)(1993-9#1)(1994-10#1)(1994-11#12)(1994-12#1)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#18)(1994-9#2)(1995-11#12)(1995-12#6)(1995-2#17)(1995-3#1)(1995-5#1)(1995-6#11)(1995-8#8)(1996-12#7)(1996-2#25)(1996-5#8)(1996-6#1)(1997-1#2)(1997-2#9)(1997-3#5)(1997-4#1)(1997-6#4)(1997-7#8)(1997-8#1)(2006-10#2)(2006-6#4)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#10)(2008-10#18)(2008-11#21)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#38)(2008-5#7)(2008-6#5)(2008-7#16)(2008-8#18)(2008-9#5)(2009-10#9)(2009-11#2)(2009-12#4)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#3)(2009-8#14)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#15)(2011-3#5)(2012-1#2)(2012-12#12)(2012-2#17)(2012-3#12)(2012-8#1)(2013-1#17)(2013-7#8)(2013-8#3)
activation on the##3##3##(2008-1#1)(2008-10#1)(2009-8#1)
activation on##9##2##(1993-3#1)(1994-11#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
activation or##13##2##(1992-3#2)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)
activation parameters for the##3##4##(1992-3#1)(2008-10#2)
activation parameters##8##2##(1992-3#1)(1996-2#2)(1996-7#2)(2008-10#3)
activation pathway##4##2##(1990-8#1)(1996-2#1)(2008-4#2)
activation pattern##4##2##(1995-12#2)(1996-12#1)(2012-2#1)
activation patterns of##2##3##(1996-12#1)(2013-8#1)
activation patterns within##2##3##(2008-11#1)(2009-6#1)
activation patterns##7##2##(1996-12#1)(2008-11#1)(2008-9#1)(2009-6#3)(2013-8#1)
activation process##4##2##(1993-6#2)(2008-4#1)(2008-6#1)
activation products##2##2##(1993-11#1)(2008-10#1)
activation promotes##2##2##(2012-12#1)(2013-8#1)
activation properties##2##2##(1993-11#1)(2008-7#1)
activation protocols##2##2##(2008-11#1)(2013-1#1)
activation response##2##2##(1995-5#1)(1997-6#1)
activation signal##2##2##(2008-4#2)
activation state##4##2##(1995-6#1)(2008-1#1)(2008-9#1)(2010-12#1)
activation status##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
activation studies##2##2##(1995-5#1)(1995-6#1)
activation suggests that##2##3##(1992-8#1)(2008-4#1)
activation system##2##2##(1992-2#1)(1992-8#1)
activation test##3##2##(2008-10#1)(2012-3#2)
activation that##2##2##(2012-2#1)(2013-8#1)
activation theory of stress (CATS)##2##5##(2010-4#2)
activation therapy##3##2##(2009-11#2)(2011-2#1)
activation through the##3##3##(1994-11#2)(2013-1#1)
activation through##6##2##(1991-2#1)(1994-11#2)(2008-1#1)(2013-1#1)(2013-8#1)
activation time##4##2##(2008-7#3)(2013-1#1)
activation to the##2##3##(1992-8#1)(2008-9#1)
activation to##4##2##(1992-12#1)(1992-8#1)(2008-4#1)(2008-9#1)
activation using the##2##3##(1993-3#1)(1994-3#1)
activation using##4##2##(1993-3#1)(1994-3#1)(2008-6#1)(2008-7#1)
activation via##3##2##(2008-4#1)(2011-2#1)(2013-8#1)
activation was determined##2##3##(2008-10#1)(2012-3#1)
activation was found##2##3##(1992-6#1)(1996-12#1)
activation was greater##2##3##(1994-8#1)(2008-10#1)
activation was observed in##2##4##(2008-9#1)(2010-3#1)
activation was observed##4##3##(1990-5#1)(1997-2#1)(2008-9#1)(2010-3#1)
activation was obtained##2##3##(1992-9#1)(2010-11#1)
activation was##35##2##(1990-2#2)(1990-5#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-3#1)(2012-3#2)
activation were##5##2##(1992-9#1)(1995-12#1)(1996-12#1)(2008-3#1)(2008-4#1)
activation which##2##2##(1993-3#1)(2012-2#1)
activation with glutaraldehyde##2##3##(2008-10#2)
activation with##12##2##(1992-8#1)(1993-6#2)(1995-12#2)(2008-10#3)(2008-4#1)(2008-8#1)(2009-11#1)(2009-8#1)
activation##1586##1##(1990-11#5)(1990-12#11)(1990-2#9)(1990-5#25)(1990-6#1)(1990-7#5)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#7)(1991-2#18)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#10)(1992-10#1)(1992-11#6)(1992-12#27)(1992-2#3)(1992-3#10)(1992-4#3)(1992-5#6)(1992-6#17)(1992-8#15)(1992-9#21)(1993-11#10)(1993-12#12)(1993-2#3)(1993-3#18)(1993-6#10)(1993-8#19)(1993-9#3)(1994-10#1)(1994-11#35)(1994-12#6)(1994-2#11)(1994-3#14)(1994-5#6)(1994-6#16)(1994-8#29)(1994-9#4)(1995-11#26)(1995-12#19)(1995-2#27)(1995-3#1)(1995-5#11)(1995-6#31)(1995-8#24)(1996-12#18)(1996-2#46)(1996-5#8)(1996-6#3)(1996-7#7)(1997-1#5)(1997-2#25)(1997-3#13)(1997-4#5)(1997-5#1)(1997-6#7)(1997-7#19)(1997-8#1)(2006-10#3)(2006-6#12)(2007-10#3)(2007-11#2)(2007-12#7)(2007-7#1)(2007-8#9)(2008-1#18)(2008-10#83)(2008-11#78)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#88)(2008-5#28)(2008-6#10)(2008-7#47)(2008-8#40)(2008-9#48)(2009-1#1)(2009-10#12)(2009-11#6)(2009-12#10)(2009-2#1)(2009-4#4)(2009-5#4)(2009-6#27)(2009-7#4)(2009-8#21)(2009-9#1)(2010-1#4)(2010-10#5)(2010-11#9)(2010-12#8)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#7)(2010-8#6)(2010-9#4)(2011-1#7)(2011-2#36)(2011-3#5)(2012-1#6)(2012-12#29)(2012-2#40)(2012-3#29)(2012-8#1)(2012-9#1)(2013-1#40)(2013-7#12)(2013-8#13)
activation&quot##2##1##(1993-8#1)(2013-8#1)
activation) and##2##2##(1995-12#1)(2008-4#1)
activation)##8##1##(1993-8#1)(1995-12#3)(1995-6#1)(1997-7#1)(2008-4#1)(2008-7#1)
activation-induced apoptosis in##2##3##(2008-10#2)
activation-induced apoptosis##5##2##(2008-10#5)
activation-induced##6##1##(2008-10#5)(2013-1#1)
activation-resistant conformation##2##2##(1995-6#2)
activational##2##1##(1994-3#1)(1996-12#1)
activations in the##2##3##(2008-10#1)(2012-12#1)
activations in##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
activations of##5##2##(1994-11#1)(1997-2#1)(2008-10#1)(2010-7#1)(2013-1#1)
activations##15##1##(1994-11#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2010-7#1)(2012-12#5)(2013-1#1)
activator (tPA)##3##2##(2008-11#1)(2008-8#1)(2010-3#1)
activator activity in MCF-7 cells##4##5##(2008-11#4)
activator activity in##5##3##(2008-11#4)(2010-3#1)
activator activity##9##2##(1990-11#1)(2008-11#6)(2008-8#1)(2010-3#1)
activator and##3##2##(1993-12#1)(1995-6#1)(2006-6#1)
activator for the catalysis of##2##5##(2008-10#2)
activator for the##5##3##(1995-2#1)(2008-10#4)
activator for##11##2##(1993-6#1)(1995-2#1)(2007-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
activator function##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
activator in the##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
activator in##5##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
activator inhibitor##4##2##(1992-7#1)(1994-9#1)(2010-6#1)(2011-2#1)
activator inhibitor-1 (PAI-1)##6##3##(1993-12#1)(1994-9#1)(1995-8#1)(2008-3#1)(2008-4#1)(2013-1#1)
activator inhibitor-1##12##2##(1993-12#1)(1994-9#1)(1995-8#2)(1997-1#1)(2008-3#1)(2008-4#2)(2011-2#2)(2013-1#2)
activator is not##2##3##(1993-12#1)(2007-10#1)
activator is##3##2##(1993-12#1)(2006-7#1)(2007-10#1)
activator of NF-kappaB##2##3##(2008-11#1)(2010-6#1)
activator of PKC##2##3##(1992-8#1)(1992-9#1)
activator of protein kinase C (PKC)##2##6##(1992-9#1)(2008-11#1)
activator of protein kinase C##5##5##(1991-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(2008-11#1)
activator of the##2##3##(1990-2#1)(2011-2#1)
activator of##38##2##(1990-11#1)(1990-2#3)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#2)(1992-9#2)(1994-11#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
activator phorbol 12-myristate 13-acetate (PMA)##2##5##(1995-11#1)(1997-1#1)
activator protein##7##2##(1990-11#1)(1993-3#1)(1994-3#1)(1997-4#1)(2008-9#2)(2010-4#1)
activator protein-1 and nuclear factor kappa B activity##2##8##(1994-6#2)
activator protein-1##4##2##(1994-6#4)
activator proteins##3##2##(1993-9#1)(1995-6#1)(1995-8#1)
activator transcription##2##2##(2011-1#1)(2012-3#1)
activator was##3##2##(1990-12#1)(1995-6#1)(2008-7#1)
activator which##3##2##(1991-5#1)(1993-6#1)(1997-7#1)
activator##213##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-9#3)(1992-12#3)(1992-7#1)(1992-8#4)(1992-9#2)(1993-12#5)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#5)(1994-5#2)(1994-6#4)(1994-9#2)(1995-11#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#4)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#2)(2006-6#1)(2006-7#1)(2007-10#7)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#13)(2008-11#20)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#4)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#3)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#6)(2013-1#8)(2013-8#1)
activator)##6##1##(1994-5#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#1)
activators and##4##2##(1992-6#1)(1994-12#1)(2007-10#1)(2008-9#1)
activators in##4##2##(1990-12#1)(1993-12#1)(1994-5#1)(1996-2#1)
activators nor##2##2##(1992-11#1)(1992-12#1)
activators of the##2##3##(1995-5#1)(1996-2#1)
activators of##15##2##(1991-12#1)(1995-5#1)(1996-2#3)(1997-2#1)(2008-1#1)(2008-7#1)(2009-3#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
activators on##2##2##(1993-3#1)(1995-11#1)
activators or##2##2##(1996-2#1)(2008-9#1)
activators##70##1##(1990-11#1)(1990-12#1)(1990-7#3)(1991-12#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-6#2)(1993-12#2)(1993-3#4)(1993-6#1)(1993-9#2)(1994-12#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#2)(1995-11#3)(1995-5#1)(1995-6#2)(1996-2#6)(1996-9#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
active DNA##3##2##(1990-7#2)(2008-7#1)
active ERK##2##2##(2013-1#2)
active Gus##2##2##(1993-8#2)
active HB-EGF##2##2##(1997-1#2)
active IDU##3##2##(2012-1#3)
active Mu##2##2##(2012-3#2)
active Q-switching##2##2##(2008-2#1)(2008-3#1)
active RA##2##2##(2006-10#1)(2008-7#1)
active TB##3##2##(2007-2#1)(2008-8#1)(2010-5#1)
active TE##2##2##(2010-3#2)
active TNF##3##2##(1994-2#3)
active TrPs##4##2##(2010-9#4)
active abduction##3##2##(2013-1#3)
active adolescents##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
active against C##2##3##(1991-8#1)(2008-5#1)
active against HIV##2##3##(1990-8#1)(1991-3#1)
active against##30##2##(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#4)(2008-7#2)(2008-8#2)(2010-12#1)(2010-3#4)(2011-1#1)(2011-2#3)(2012-12#1)
active agent##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)
active agents##4##2##(1993-11#1)(1993-3#1)(2008-11#1)(2008-7#1)
active analogues##2##2##(1991-5#1)(2008-8#1)
active and highly##2##3##(2008-7#1)(2008-9#1)
active and inactive##8##3##(1992-6#1)(1994-12#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
active and passive##8##3##(1995-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)
active and##46##2##(1990-3#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-4#1)(2012-12#1)(2012-2#2)(2013-1#3)
active antibody##3##2##(1994-8#2)(1995-2#1)
active antiretroviral therapy (HAART)##11##4##(2007-7#1)(2008-11#1)(2008-3#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)
active antiretroviral therapy##18##3##(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)
active antiretroviral##19##2##(2007-12#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)
active area of research##3##4##(2008-3#1)(2008-4#1)(2010-2#1)
active area of##4##3##(2008-3#2)(2008-4#1)(2010-2#1)
active area##8##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-2#1)
active as a##2##3##(1990-7#1)(1995-11#1)
active as##9##2##(1990-7#1)(1991-8#1)(1992-10#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-7#2)(2013-7#1)
active assortative mating##2##3##(2008-10#2)
active at levels##2##3##(1995-2#1)(2008-3#1)
active at##13##2##(1990-7#2)(1992-2#1)(1993-11#1)(1993-9#1)(1995-12#1)(1995-2#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
active avoidance##4##2##(1991-2#1)(2008-4#1)(2013-1#2)
active bleeding##3##2##(1991-6#1)(2013-1#2)
active but##2##2##(1990-7#1)(1995-2#1)
active carbon##2##2##(2008-10#1)(2011-2#1)
active caspase-3##2##2##(2012-1#2)
active cell##3##2##(1991-11#1)(1996-12#1)(2009-5#1)
active cells##3##2##(2008-10#2)(2008-11#1)
active cellular##2##2##(2008-10#1)(2013-1#1)
active center##4##2##(1990-7#2)(2008-11#1)(2008-8#1)
active channels##2##2##(1994-12#1)(2008-9#1)
active chronic gastritis and##2##4##(2008-5#2)
active chronic##3##2##(2008-5#3)
active complex##2##2##(1992-12#1)(1993-6#1)
active component of##5##3##(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
active component##6##2##(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
active components and##3##3##(1996-2#1)(2008-10#2)
active components of##3##3##(2008-10#3)
active components##14##2##(1996-2#1)(2008-10#9)(2008-11#1)(2008-5#1)(2011-3#1)(2013-1#1)
active compound##8##2##(1997-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)
active compounds in##2##3##(2008-4#1)(2012-3#1)
active compounds##18##2##(1994-11#1)(1994-6#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#1)
active conformation##4##2##(2008-8#2)(2009-10#1)(2012-2#1)
active constituent of##2##3##(1997-7#1)(2009-12#1)
active constituents##2##2##(2008-10#2)
active contours (snakes)##2##3##(2007-11#1)(2007-12#1)
active contours##3##2##(2007-11#1)(2007-12#1)(2010-8#1)
active control of the##2##4##(2007-11#1)(2008-2#1)
active control##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
active coping##3##2##(2008-4#2)(2011-1#1)
active cosmetic##2##2##(2008-5#2)
active dialysis centers in Saudi Arabia##2##6##(2007-7#1)(2008-1#1)
active disease and in##2##4##(1990-3#1)(2008-1#1)
active disease and##3##3##(1990-3#2)(2008-1#1)
active disease##15##2##(1990-3#2)(1991-5#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#4)(2012-3#1)(2013-1#1)
active dots##2##2##(2009-11#2)
active drug##3##2##(1993-11#1)(1996-1#1)(2012-1#1)
active drugs##4##2##(1991-4#1)(2008-6#1)(2010-3#2)
active during##4##2##(1991-5#1)(2008-10#2)(2012-2#1)
active element in the##2##4##(2008-11#1)(2010-5#1)
active enzyme and##2##3##(1990-5#1)(1993-8#1)
active enzyme##11##2##(1990-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-3#1)(2008-7#1)
active enzymes##4##2##(1992-3#1)(1995-6#1)(1997-7#1)(2008-7#1)
active ester##2##2##(2008-5#2)
active estrogen##3##2##(1994-12#1)(2008-11#2)
active estrogens and##2##3##(1994-8#1)(2012-3#1)
active euthanasia##2##2##(1990-6#1)(1991-2#1)
active exercises##2##2##(2007-8#2)
active feedback##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
active for##5##2##(1995-2#1)(2008-10#2)(2010-7#1)(2012-3#1)
active form of the##2##4##(1990-10#1)(1994-11#1)
active form of##11##3##(1990-10#1)(1991-6#1)(1991-9#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
active form##20##2##(1990-10#1)(1990-12#1)(1990-2#3)(1991-6#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
active forms of##3##3##(1992-2#1)(1994-9#1)(2008-8#1)
active forms##6##2##(1991-12#1)(1991-6#1)(1992-2#1)(1994-9#1)(1995-6#1)(2008-8#1)
active fraction##4##2##(1991-12#1)(1996-5#1)(2008-10#1)(2008-5#1)
active fractions##3##2##(1991-12#1)(1996-5#1)(2008-10#1)
active fragment of##2##3##(1990-12#1)(1991-2#1)
active fragment##3##2##(1990-12#2)(1991-2#1)
active from the##3##3##(2007-12#3)
active gene##3##2##(1994-8#1)(1995-6#1)(2010-10#1)
active genes in##4##3##(1996-10#2)(1996-2#1)(1997-8#1)
active genes##5##2##(1996-10#2)(1996-2#1)(1997-8#1)(2008-12#1)
active group##3##2##(2008-10#2)(2013-1#1)
active groups##2##2##(2008-10#2)
active growth##4##2##(1994-6#1)(2008-7#3)
active haemodialysis##2##2##(1991-6#2)
active histidase##2##2##(1994-5#2)
active human##2##2##(1993-6#1)(1996-2#1)
active in the##21##3##(1991-3#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#2)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-2#1)(2010-2#2)(2010-3#1)(2013-1#1)
active in this field##2##4##(2008-12#2)
active in##69##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#4)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#3)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
active individuals##3##2##(1990-3#1)(2007-8#1)(2008-5#1)
active ingredient in a##2##4##(2008-5#2)
active ingredient in##3##3##(2008-5#2)(2012-3#1)
active ingredient to##2##3##(2008-5#2)
active ingredient##22##2##(2008-10#1)(2008-11#2)(2008-5#15)(2011-2#2)(2012-2#1)(2012-3#1)
active ingredients and excipients##2##4##(2008-10#2)
active ingredients and##3##3##(2008-10#2)(2008-8#1)
active ingredients are##3##3##(2008-5#2)(2012-12#1)
active ingredients in cough-cold##2##4##(2008-10#2)
active ingredients in##7##3##(2008-10#4)(2008-8#1)(2010-9#2)
active ingredients##22##2##(2008-10#6)(2008-11#1)(2008-5#7)(2008-8#2)(2010-9#3)(2011-2#2)(2012-12#1)
active interfacing##2##2##(2008-10#2)
active intermediates##2##2##(1993-8#1)(1996-5#1)
active interventions##2##2##(1991-12#1)(2013-1#1)
active intracellular##2##2##(1991-9#1)(2008-11#1)
active involvement of##2##3##(1990-10#1)(2008-10#1)
active involvement##4##2##(1990-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
active knee extension range of motion##2##6##(2008-12#2)
active learning##7##2##(2009-9#7)
active length##2##2##(2007-12#1)(2009-2#1)
active life##4##2##(1991-11#1)(1993-12#1)(2007-8#1)(2008-6#1)
active lifestyle##3##2##(2009-8#1)(2012-3#2)
active ligands##2##2##(2008-8#2)
active male##2##2##(1995-12#1)(2008-4#1)
active management of##2##3##(2008-10#1)(2011-3#1)
active management##3##2##(2008-10#1)(2009-7#1)(2011-3#1)
active material##5##2##(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
active matter##2##2##(2008-5#2)
active matter'##2##2##(2008-5#2)
active measures##2##2##(2009-10#1)(2011-1#1)
active mechanism##2##2##(2008-6#1)(2012-2#1)
active medical conditions##2##3##(2010-1#2)
active medium##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
active member of the##2##4##(1991-3#1)(1995-2#1)
active men##2##2##(2008-8#1)(2012-3#1)
active metabolite of##6##3##(1991-8#1)(1992-1#1)(1992-3#1)(1995-2#2)(2008-7#1)
active metabolite##13##2##(1991-8#2)(1992-1#1)(1992-3#1)(1995-2#2)(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-3#1)
active metabolites##5##2##(2008-10#2)(2008-7#2)(2013-1#1)
active method##2##2##(2007-5#1)(2008-12#1)
active methylene##2##2##(2007-11#1)(2008-11#1)
active mode locking of a##2##5##(2007-11#1)(2007-12#1)
active mode locking##3##3##(2007-11#2)(2007-12#1)
active molecule##5##2##(2008-10#1)(2008-4#1)(2008-5#2)(2009-6#1)
active muscle power##3##3##(1995-8#3)
active mutants were##2##3##(1992-9#1)(1993-11#1)
active mutants##3##2##(1992-9#2)(1993-11#1)
active nanostructures##5##2##(2010-12#5)
active neurons##2##2##(1993-12#1)(2009-5#1)
active new##2##2##(2010-5#1)(2012-3#1)
active not only##2##3##(1990-7#1)(1992-8#1)
active nurses##2##2##(1992-12#1)(1997-3#1)
active nutritional counseling can improve##2##5##(2007-7#2)
active nutritional counseling##4##3##(2007-7#4)
active on HIV-1 integrase##2##4##(2011-3#2)
active on HIV-1##3##3##(2011-3#3)
active on##11##2##(1990-8#1)(1992-11#1)(1992-8#1)(1993-6#1)(2008-10#2)(2009-6#2)(2011-3#3)
active optical control system##2##4##(2008-3#2)
active optical##4##2##(2007-11#1)(2008-3#3)
active optics##2##2##(2008-3#2)
active or##5##2##(1990-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-3#1)
active organ##2##2##(2008-10#1)(2008-3#1)
active over a##2##3##(1991-5#1)(2012-2#1)
active oxygen species (AOS)##2##4##(2008-10#2)
active oxygen species##6##3##(1994-6#2)(1995-8#1)(2008-10#3)
active oxygen##11##2##(1994-5#1)(1994-6#2)(1995-8#1)(1996-2#3)(2008-10#3)(2008-8#1)
active packaging##4##2##(2010-5#1)(2010-7#3)
active part of##2##3##(2009-12#1)(2011-1#1)
active part##6##2##(2008-10#3)(2008-5#1)(2009-12#1)(2011-1#1)
active participants in##3##3##(1995-2#1)(1997-3#1)(2008-11#1)
active participation in##2##3##(2007-8#1)(2008-10#1)
active participation of the##2##4##(2008-10#1)(2009-9#1)
active participation of##7##3##(1991-3#1)(1993-3#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-1#1)
active participation##13##2##(1991-3#1)(1992-1#1)(1993-3#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-1#1)(2011-1#1)(2013-1#1)
active particles##4##2##(2013-8#4)
active patients##3##2##(1992-5#1)(2007-8#1)(2013-1#1)
active peptide##3##2##(1993-3#1)(1993-6#1)(2008-10#1)
active peptides##10##2##(1993-6#1)(1994-3#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-4#1)(2008-5#2)(2012-1#1)(2013-8#1)
active period##4##2##(2008-10#1)(2008-7#2)(2012-2#1)
active phase##5##2##(2007-12#2)(2007-8#1)(2008-4#1)(2008-5#1)
active pixel##2##2##(2008-10#2)
active pocket##2##2##(2008-8#2)
active polarization##2##2##(2008-2#1)(2008-3#1)
active power##2##2##(2008-3#1)(2013-1#1)
active principle at##2##3##(1992-3#2)
active principle of##3##3##(1991-2#1)(1991-8#1)(1992-3#1)
active principle##12##2##(1990-3#1)(1991-2#1)(1991-8#1)(1992-3#4)(2008-10#4)(2011-1#1)
active principles of##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
active principles##9##2##(2008-10#5)(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
active process##3##2##(1992-7#1)(2010-10#1)(2012-3#1)
active product##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
active production##2##2##(1994-6#1)(2008-11#1)
active products##2##2##(2011-1#1)(2012-2#1)
active protease##2##2##(1993-12#1)(2008-4#1)
active protein##5##2##(1992-3#1)(1993-6#1)(1994-8#1)(2008-8#1)(2012-3#1)
active proteins##4##2##(1996-5#2)(1997-4#1)(2008-7#1)
active pulmonary##2##2##(1990-12#1)(2010-5#1)
active radiation##5##2##(2008-10#3)(2008-3#1)(2013-7#1)
active range of motion##2##4##(2008-12#2)
active range of##3##3##(2008-12#3)
active receptor##2##2##(1990-11#1)(1992-9#1)
active recombinant human##3##3##(1990-8#1)(1995-6#1)(2008-11#1)
active recombinant##7##2##(1990-8#1)(1994-11#1)(1995-6#1)(2008-11#2)(2009-2#1)(2010-5#1)
active regions with##2##3##(2007-12#2)
active regions##3##2##(2007-12#2)(2008-8#1)
active renin##3##2##(1991-9#2)(1996-5#1)
active replication##2##2##(1992-3#1)(2008-11#1)
active role in##11##3##(1992-3#1)(1993-1#1)(1994-1#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-5#1)(2010-11#2)(2013-1#1)
active role##15##2##(1992-3#1)(1993-1#1)(1994-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#2)(2010-12#1)(2013-1#1)
active roles##2##2##(2008-1#1)(2008-10#1)
active sampling##4##2##(2008-10#4)
active scar##2##2##(2009-6#2)
active scars##3##2##(2009-6#3)
active secretion##2##2##(2008-11#1)(2010-11#1)
active segment##2##2##(2008-2#2)
active shape##2##2##(2012-1#2)
active site and##3##3##(1992-6#1)(2007-11#1)(2007-7#1)
active site cysteine##4##3##(1995-2#2)(1995-5#2)
active site glutamic acid##2##4##(1994-5#2)
active site in##3##3##(1990-2#1)(1992-5#1)(1992-6#1)
active site is##4##3##(1990-5#2)(1992-5#2)
active site of GCAP##2##4##(1992-3#2)
active site of the enzyme##9##5##(1990-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1994-5#1)(1994-8#1)(2008-4#1)(2008-5#1)(2009-9#1)
active site of the##12##4##(1990-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-4#1)(2008-5#1)(2009-9#1)
active site of this##2##4##(1990-5#1)(1995-5#1)
active site of##43##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#2)(1992-11#3)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#1)(1993-11#1)(1993-9#1)(1994-5#7)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-10#2)
active site peptide of##2##4##(1992-11#1)(1992-5#1)
active site residue##2##3##(1993-11#1)(1994-6#1)
active site residues##5##3##(1992-11#2)(1995-2#1)(1997-4#1)(2009-9#1)
active site structure##2##3##(1992-6#1)(2008-5#1)
active site to stabilize##2##4##(1992-6#1)(1994-5#1)
active site##164##2##(1990-2#2)(1990-5#7)(1990-7#1)(1990-8#4)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#7)(1992-12#2)(1992-3#9)(1992-4#3)(1992-5#4)(1992-6#16)(1992-7#1)(1992-8#2)(1993-11#7)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#14)(1994-6#2)(1994-8#4)(1995-11#1)(1995-2#8)(1995-3#2)(1995-5#9)(1995-6#7)(1995-8#2)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#4)(1997-7#1)(2007-11#1)(2007-7#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-9#3)(2010-10#3)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#4)
active sites and##2##3##(2008-10#1)(2008-9#1)
active sites in the##2##4##(1997-4#1)(2007-12#1)
active sites in##3##3##(1992-5#1)(1997-4#1)(2007-12#1)
active sites of the##2##4##(1995-5#1)(2008-10#1)
active sites of##7##3##(1992-8#2)(1994-12#1)(1995-5#1)(2008-10#1)(2012-12#2)
active sites##24##2##(1991-11#1)(1992-5#2)(1992-8#3)(1993-11#1)(1994-12#1)(1995-5#2)(1997-4#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)
active solid##2##2##(2008-10#2)
active species##9##2##(1990-5#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-3#1)(2010-12#2)
active stage of the##2##4##(2012-3#1)(2013-1#1)
active state of##2##3##(1990-8#1)(1996-2#1)
active state##5##2##(1990-2#1)(1990-8#1)(1996-2#1)(2008-11#1)(2012-3#1)
active steroids##2##2##(1994-9#1)(2012-3#1)
active students##3##2##(2008-1#1)(2012-12#2)
active substance content##2##3##(2008-10#2)
active substance##8##2##(1990-5#1)(1994-2#1)(2008-10#4)(2008-11#1)(2011-1#1)
active substances in##2##3##(2008-10#2)
active substances##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2011-1#1)
active support##2##2##(1995-3#1)(2007-10#1)
active surface##3##2##(2008-10#2)(2008-3#1)
active surveillance to##2##3##(2010-11#1)(2011-2#1)
active surveillance##10##2##(2008-7#1)(2009-5#1)(2010-10#2)(2010-11#1)(2011-2#2)(2012-12#3)
active tetrameric##2##2##(1995-2#1)(2008-9#1)
active than the##5##3##(1990-11#1)(1991-12#1)(1992-6#1)(2008-5#1)(2010-5#1)
active than##13##2##(1990-11#1)(1991-12#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-8#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)
active throughout##2##2##(1995-5#1)(2008-10#1)
active topological defects##2##3##(2008-7#2)
active topological##3##2##(2008-7#3)
active transcriptional##2##2##(1990-5#1)(2012-2#1)
active transport of##3##3##(1990-5#1)(1990-9#1)(2011-2#1)
active transport##7##2##(1990-5#1)(1990-9#1)(1994-8#1)(1997-7#1)(2010-11#1)(2011-2#1)(2011-3#1)
active treatment##7##2##(1991-1#1)(1995-8#1)(2007-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-3#1)
active tuberculosis##4##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
active under##2##2##(1992-12#1)(2008-7#1)
active vitamin D3##2##3##(1991-5#2)
active was##2##2##(1990-5#1)(1995-5#1)
active when##5##2##(1995-8#1)(2008-1#1)(2008-10#1)(2010-9#1)(2013-8#1)
active zones##2##2##(1997-7#2)
active##1753##1##(1990-10#2)(1990-11#5)(1990-12#13)(1990-2#8)(1990-3#8)(1990-5#16)(1990-6#1)(1990-7#12)(1990-8#8)(1990-9#3)(1991-1#3)(1991-11#3)(1991-12#9)(1991-2#7)(1991-3#6)(1991-4#1)(1991-5#12)(1991-6#14)(1991-7#1)(1991-8#9)(1991-9#12)(1992-1#2)(1992-10#4)(1992-11#10)(1992-12#16)(1992-2#5)(1992-3#22)(1992-4#3)(1992-5#11)(1992-6#25)(1992-7#2)(1992-8#9)(1992-9#8)(1993-1#5)(1993-10#1)(1993-11#16)(1993-12#8)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#16)(1993-8#13)(1993-9#4)(1994-1#1)(1994-11#12)(1994-12#7)(1994-2#9)(1994-3#4)(1994-5#27)(1994-6#15)(1994-8#21)(1994-9#4)(1995-1#1)(1995-11#7)(1995-12#8)(1995-2#21)(1995-3#11)(1995-5#18)(1995-6#21)(1995-8#15)(1996-1#1)(1996-10#2)(1996-12#8)(1996-2#15)(1996-3#4)(1996-5#11)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#11)(1997-6#9)(1997-7#14)(1997-8#7)(1997-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#34)(2007-12#32)(2007-2#2)(2007-5#4)(2007-7#9)(2007-8#12)(2008-1#16)(2008-10#197)(2008-11#60)(2008-12#18)(2008-2#26)(2008-3#41)(2008-4#35)(2008-5#89)(2008-6#13)(2008-7#60)(2008-8#39)(2008-9#35)(2009-1#1)(2009-10#5)(2009-11#8)(2009-12#5)(2009-2#4)(2009-5#6)(2009-6#9)(2009-7#8)(2009-8#8)(2009-9#16)(2010-1#3)(2010-10#8)(2010-11#9)(2010-12#25)(2010-2#4)(2010-3#11)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#8)(2010-8#6)(2010-9#10)(2011-1#18)(2011-10#1)(2011-2#31)(2011-3#10)(2011-4#1)(2012-1#13)(2012-12#15)(2012-2#22)(2012-3#41)(2013-1#49)(2013-7#4)(2013-8#14)
active)##2##1##(2009-9#1)(2011-2#1)
active-core optical fiber##2##3##(2007-11#2)
active-site ligands##2##2##(1990-8#2)
active-site##18##1##(1990-7#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1993-11#2)(1994-5#2)(1995-2#2)(1995-3#1)(1995-6#1)(1997-6#1)(2008-4#1)(2009-9#1)
active-site-modified##2##1##(1994-5#2)
actively Q -switched##2##3##(2007-12#2)
actively Q-switched##2##2##(2007-12#2)
actively absorbed##2##2##(1997-7#1)(2008-6#1)
actively and##2##2##(2008-10#1)(2012-12#1)
actively expressed in##2##3##(1990-5#1)(2008-8#1)
actively expressed##3##2##(1990-5#1)(1997-4#1)(2008-8#1)
actively followed up##2##3##(1993-9#1)(2008-1#1)
actively growing mycelium##2##3##(1997-1#1)(2008-10#1)
actively growing##5##2##(1993-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-9#1)
actively in##3##2##(2008-12#1)(2010-5#1)(2011-2#1)
actively involved in the##3##4##(1994-11#1)(1996-12#1)(2011-2#1)
actively involved in##10##3##(1994-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#2)
actively involved##12##2##(1994-11#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#2)
actively mode-locked Er-doped fiber##2##4##(2007-12#2)
actively mode-locked##7##2##(2007-11#1)(2007-12#5)(2008-2#1)
actively participate in##2##3##(2008-11#1)(2011-2#1)
actively participates in##2##3##(2008-12#1)(2008-7#1)
actively seek information##2##3##(1995-3#1)(2007-12#1)
actively seek##5##2##(1995-12#1)(1995-3#1)(2007-12#1)(2009-5#1)(2012-3#1)
actively studied in##2##3##(1990-5#1)(1991-9#1)
actively synchronized##2##2##(2007-11#2)
actively tilted##3##2##(2008-2#3)
actively transcribed##2##2##(1993-12#1)(1993-2#1)
actively transposing##2##2##(1995-8#2)
actively with##2##2##(1997-8#1)(2008-10#1)
actively##132##1##(1990-2#1)(1990-5#2)(1991-12#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
actives##7##1##(2008-5#7)
activin A in##2##3##(1995-8#1)(2012-12#1)
activin A induced a##2##4##(1995-8#2)
activin A were##2##3##(1992-6#1)(1992-8#1)
activin A##23##2##(1990-12#3)(1992-6#5)(1992-8#1)(1994-9#3)(1995-8#9)(2009-10#1)(2012-12#1)
activin A-##3##2##(1994-9#3)
activin as a##2##3##(1990-11#1)(1992-6#1)
activin levels##2##2##(1992-6#2)
activin##51##1##(1990-11#5)(1990-12#4)(1992-6#14)(1992-8#4)(1993-8#4)(1994-9#9)(1995-8#9)(2009-10#1)(2012-12#1)
activin-A cDNA##2##2##(1994-11#2)
activin-A##6##1##(1994-11#6)
activin-induced##2##1##(1992-8#1)(1994-9#1)
activins##3##1##(1992-8#3)
activism##6##1##(1996-1#1)(2008-1#1)(2008-5#1)(2009-5#2)(2011-2#1)
activists##4##1##(1995-6#3)(2011-2#1)
activities (e##2##2##(2008-11#1)(2010-12#1)
activities (i##2##2##(2009-7#1)(2009-9#1)
activities across##2##2##(2008-7#1)(2010-10#1)
activities against both##2##3##(2008-11#1)(2012-3#1)
activities against human##3##3##(1991-2#1)(2011-2#1)(2013-1#1)
activities against several##2##3##(2008-10#1)(2011-3#1)
activities against the##3##3##(2008-5#1)(2010-6#1)(2013-1#1)
activities against##25##2##(1991-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
activities along##2##2##(2007-5#1)(2008-10#1)
activities and a##3##3##(1990-3#1)(1994-11#1)(2008-5#1)
activities and the##5##3##(1991-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-8#1)
activities and youth##2##3##(2009-7#2)
activities and##72##2##(1990-3#2)(1991-12#2)(1992-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#1)(2009-6#3)(2009-7#4)(2010-12#3)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#2)
activities are##26##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#1)
activities around the##2##3##(2011-2#1)(2013-1#1)
activities as well as the##2##5##(1992-8#1)(2008-11#1)
activities as well as##4##4##(1992-8#1)(2008-11#1)(2008-2#1)(2012-3#1)
activities as##8##2##(1990-4#1)(1992-8#1)(2008-11#1)(2008-2#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
activities associated with the##2##4##(1990-2#1)(1997-2#1)
activities associated with##5##3##(1990-2#1)(1995-3#1)(1997-2#1)(2008-11#1)(2013-1#1)
activities at a##3##3##(1992-6#1)(1993-3#1)(2012-3#1)
activities at##7##2##(1992-6#1)(1993-3#1)(1993-6#1)(1997-4#1)(2012-3#1)(2013-1#2)
activities before##2##2##(2007-10#1)(2008-11#1)
activities being##3##2##(1995-11#1)(2008-7#1)(2013-1#1)
activities between##3##2##(2008-9#1)(2010-12#1)(2011-2#1)
activities but##4##2##(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
activities by##5##2##(1992-8#1)(2008-11#1)(2008-12#1)(2009-1#1)(2011-3#1)
activities can be##6##3##(1994-8#2)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#1)
activities can##9##2##(1992-12#1)(1994-8#2)(2007-12#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#1)
activities compared##2##2##(2008-11#1)(2011-2#1)
activities could be##3##3##(1994-11#1)(1997-4#1)(2008-12#1)
activities decreased##2##2##(2008-9#1)(2011-3#1)
activities did not##3##3##(1991-12#1)(2011-10#1)(2011-2#1)
activities differed##2##2##(1991-12#1)(1995-11#1)
activities during##6##2##(1993-3#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
activities exhibited by##2##3##(2008-7#1)(2011-3#1)
activities exhibited##4##2##(1994-11#1)(2008-7#1)(2011-3#1)(2013-1#1)
activities expressed relative to tissue mass##2##6##(2013-1#2)
activities expressed##4##2##(1992-3#1)(1994-11#1)(2013-1#2)
activities for service delivery##9##4##(2013-8#9)
activities for the##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
activities for their##2##3##(2008-11#1)(2013-1#1)
activities for##23##2##(1991-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#9)
activities from##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
activities has been##2##3##(1991-12#1)(2008-12#1)
activities has##3##2##(1991-12#1)(2008-12#1)(2010-12#1)
activities have been implicated in##2##5##(2008-4#1)(2009-5#1)
activities have been##5##3##(1991-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-5#1)
activities have##10##2##(1990-7#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-3#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)
activities in a##3##3##(1994-12#1)(1995-6#1)(2013-8#1)
activities in all##2##3##(2008-10#1)(2008-5#1)
activities in aqueous##2##3##(2008-10#1)(2013-1#1)
activities in rat##3##3##(1992-8#1)(1994-6#1)(2008-10#1)
activities in the brain##2##4##(1995-12#1)(2008-11#1)
activities in the##19##3##(1992-8#1)(1993-2#1)(1993-9#2)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#3)
activities in their##2##3##(1996-3#1)(2007-10#1)
activities in trypanosomatid parasites of plants##2##6##(2008-10#2)
activities in vitro and##3##4##(1990-12#1)(1991-8#1)(1993-8#1)
activities in vitro##7##3##(1990-12#2)(1991-8#1)(1993-8#1)(2008-10#1)(2011-1#1)(2011-3#1)
activities in##125##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-6#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#1)(1997-4#2)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
activities including##2##2##(2008-7#1)(2010-4#1)
activities involved in##4##3##(2008-10#2)(2009-10#1)(2010-4#1)
activities involving repetitive hand use##2##5##(2008-9#2)
activities is##2##2##(1991-1#1)(1996-5#1)
activities may be##3##3##(1991-2#1)(1993-8#1)(2008-5#1)
activities may##5##2##(1991-2#1)(1993-8#1)(1994-2#1)(2008-5#1)(2012-1#1)
activities must be##2##3##(1994-2#1)(1994-3#1)
activities of a##6##3##(1994-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)
activities of beta-1##2##3##(2008-10#2)
activities of both the##2##4##(2008-10#1)(2008-11#1)
activities of both##6##3##(1992-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
activities of catalase and##2##4##(2008-10#1)(2008-7#1)
activities of cytolytic T##2##4##(1991-9#2)
activities of daily living (ADL)##4##5##(1995-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
activities of daily living and##4##5##(1991-12#1)(1995-3#1)(2011-2#1)(2013-1#1)
activities of daily living##20##4##(1991-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(2007-10#2)(2008-1#1)(2008-7#3)(2009-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
activities of daily##21##3##(1991-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(2007-10#2)(2008-1#1)(2008-7#3)(2009-3#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)
activities of different##2##3##(2008-10#2)
activities of gamma-GT##2##3##(1994-5#2)
activities of glutathione##2##3##(1991-12#1)(2011-2#1)
activities of human##3##3##(1997-2#1)(1997-4#1)(2011-2#1)
activities of key metabolic enzymes##2##5##(1994-8#1)(2008-11#1)
activities of key##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
activities of lactate dehydrogenase##2##4##(1995-11#1)(2013-1#1)
activities of other##2##3##(1992-8#1)(1993-6#1)
activities of protein kinase C##2##5##(1993-8#1)(1997-6#1)
activities of some##4##3##(1990-8#1)(1993-2#1)(2008-10#1)(2013-1#1)
activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions##2##15##(1994-6#2)
activities of superoxide dismutase##5##4##(1990-3#1)(1991-12#1)(1994-6#3)
activities of the DGN##2##4##(2012-2#2)
activities of the crude##2##4##(2008-12#1)(2013-1#1)
activities of the essential##2##4##(2008-12#1)(2013-1#1)
activities of the quality assurance system##2##6##(2012-12#2)
activities of the two##2##4##(1992-9#1)(2010-5#1)
activities of the venom of##2##5##(2008-5#2)
activities of the##48##3##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-12#3)(2008-5#4)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
activities of these enzymes##3##4##(1994-8#1)(1995-11#1)(2008-10#1)
activities of these##13##3##(1990-7#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)
activities of this enzyme##2##4##(1994-5#1)(1997-2#1)
activities of this##3##3##(1994-5#1)(1997-2#1)(2008-11#1)
activities of three##2##3##(1992-8#1)(2008-10#1)
activities of two##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
activities of zeaxanthins##2##3##(2008-11#2)
activities of##282##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#3)(1992-6#4)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#4)(1994-3#4)(1994-5#6)(1994-6#3)(1994-8#4)(1995-1#1)(1995-11#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#2)(1996-2#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#33)(2008-11#20)(2008-12#4)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#8)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-4#1)(2010-5#3)(2010-8#2)(2011-2#16)(2011-3#4)(2012-12#8)(2012-2#8)(2012-3#5)(2012-6#2)(2013-1#18)(2013-7#2)(2013-8#3)
activities on the organization's bottom line##2##6##(2008-9#2)
activities on the##5##3##(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)
activities on##14##2##(1995-3#1)(1995-8#1)(1997-3#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#3)(2011-2#2)(2011-3#3)
activities over the##2##3##(1993-2#1)(2013-1#1)
activities over##3##2##(1993-2#1)(2012-12#1)(2013-1#1)
activities present in##2##3##(1994-8#1)(1997-2#1)
activities related to##3##3##(2008-1#1)(2008-5#1)(2011-10#1)
activities remained##2##2##(1996-5#1)(2008-10#1)
activities reported##2##2##(1992-9#1)(2009-7#1)
activities showed a##2##3##(1991-12#1)(2008-5#1)
activities showed##3##2##(1991-12#1)(1996-9#1)(2008-5#1)
activities such as##9##3##(1992-12#1)(1993-2#1)(1994-12#2)(2007-11#1)(2008-5#1)(2009-5#1)(2011-2#1)(2011-3#1)
activities than##6##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
activities that are##3##3##(1993-3#1)(1994-2#1)(2008-7#1)
activities that can##2##3##(2008-7#1)(2012-2#1)
activities that do not##2##4##(1995-2#1)(2008-4#1)
activities that have##2##3##(1996-1#1)(2008-10#1)
activities that involve##2##3##(1993-1#1)(2010-8#1)
activities that promote##2##3##(1994-1#1)(2010-8#1)
activities that support the##2##4##(1992-1#1)(2008-12#1)
activities that were##2##3##(1991-9#1)(2012-12#1)
activities that would##2##3##(1991-12#1)(2008-7#1)
activities that##34##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-1#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
activities they##2##2##(2008-11#1)(2012-1#1)
activities through##2##2##(2008-1#1)(2009-5#1)
activities to the##2##3##(1996-1#1)(2011-3#1)
activities to##14##2##(1990-8#1)(1992-3#1)(1993-1#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-12#1)(2009-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#2)
activities toward##2##2##(1990-7#1)(1997-3#1)
activities under##2##2##(2009-10#1)(2010-8#1)
activities undertaken by##2##3##(1993-9#1)(2013-1#1)
activities undertaken##3##2##(1993-9#1)(2008-12#1)(2013-1#1)
activities using##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
activities was##6##2##(1991-12#1)(1991-2#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
activities were also##3##3##(1990-5#1)(2011-10#1)(2011-2#1)
activities were detected in##2##4##(1990-11#1)(1992-6#1)
activities were determined##2##3##(1994-11#1)(1994-8#1)
activities were evaluated##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
activities were found in##2##4##(1990-7#1)(2008-10#1)
activities were found##4##3##(1990-7#1)(1996-7#1)(2008-10#2)
activities were induced##2##3##(1994-3#1)(2008-11#1)
activities were inhibited by##3##4##(1990-11#1)(1994-3#1)(2008-11#1)
activities were measured in##3##4##(1992-8#1)(1992-9#1)(1995-3#1)
activities were measured##6##3##(1992-6#1)(1992-8#1)(1992-9#1)(1995-3#1)(2008-5#1)(2008-7#1)
activities were monitored##2##3##(2008-11#1)(2008-6#1)
activities were not##2##3##(1992-2#1)(2008-12#1)
activities were observed in##2##4##(1992-3#1)(2008-8#1)
activities were significantly##3##3##(1995-11#1)(2008-10#2)
activities were##73##2##(1990-11#4)(1990-5#2)(1990-7#2)(1991-9#2)(1992-2#1)(1992-3#2)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#2)(2013-1#3)
activities when##2##2##(2009-9#1)(2010-3#1)
activities which##5##2##(1990-11#1)(1990-12#1)(1990-9#1)(2008-5#1)(2010-10#1)
activities will be##2##3##(1991-5#1)(2008-8#1)
activities will##4##2##(1991-5#2)(1995-1#1)(2008-8#1)
activities with the##3##3##(1992-10#1)(1995-2#1)(1996-3#1)
activities with##11##2##(1991-5#1)(1992-10#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2011-1#1)(2013-1#1)
activities within the##2##3##(2008-11#1)(2010-8#1)
activities without##2##2##(2008-1#1)(2008-9#1)
activities would be##2##3##(2008-12#1)(2010-11#1)
activities##1392##1##(1990-10#2)(1990-11#14)(1990-12#6)(1990-2#6)(1990-3#8)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#8)(1990-8#6)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#30)(1991-2#11)(1991-5#14)(1991-6#1)(1991-8#3)(1991-9#20)(1992-1#9)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#8)(1992-5#2)(1992-6#19)(1992-8#16)(1992-9#4)(1993-1#8)(1993-11#3)(1993-12#12)(1993-2#9)(1993-3#9)(1993-6#7)(1993-8#9)(1993-9#4)(1994-1#6)(1994-11#17)(1994-12#8)(1994-2#14)(1994-3#10)(1994-5#7)(1994-6#8)(1994-8#12)(1994-9#3)(1995-1#2)(1995-11#13)(1995-12#9)(1995-2#17)(1995-3#17)(1995-5#4)(1995-6#4)(1995-8#5)(1996-1#4)(1996-11#2)(1996-12#8)(1996-2#10)(1996-3#10)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#10)(1997-3#15)(1997-4#13)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#1)(1997-9#1)(2006-6#1)(2007-1#2)(2007-10#10)(2007-11#18)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#1)(2008-1#13)(2008-10#112)(2008-11#87)(2008-12#42)(2008-2#3)(2008-3#3)(2008-4#17)(2008-5#37)(2008-6#14)(2008-7#37)(2008-8#14)(2008-9#32)(2009-1#2)(2009-10#10)(2009-11#1)(2009-12#6)(2009-3#4)(2009-4#1)(2009-5#8)(2009-6#5)(2009-7#16)(2009-8#4)(2009-9#5)(2010-10#4)(2010-11#3)(2010-12#8)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#7)(2010-6#1)(2010-8#14)(2010-9#1)(2011-1#11)(2011-10#3)(2011-2#56)(2011-3#23)(2012-1#7)(2012-12#29)(2012-2#32)(2012-3#23)(2012-6#2)(2012-9#1)(2013-1#76)(2013-7#7)(2013-8#21)
activities)##5##1##(1994-2#1)(1995-3#1)(2008-5#1)(2010-2#1)(2010-4#1)
activity (&lt##2##2##(1994-5#1)(1997-7#1)
activity (0##4##2##(1993-11#1)(1993-8#1)(1994-8#1)(1997-2#1)
activity (ALP)##2##2##(2008-11#1)(2013-1#1)
activity (EC(50) =##2##3##(2013-1#2)
activity (IC _ 50##2##4##(2008-5#2)
activity (IC(50)##2##2##(2008-5#1)(2013-1#1)
activity (i##3##2##(1992-3#1)(2008-5#1)(2009-8#1)
activity (p &lt##4##3##(1996-5#1)(2008-11#1)(2009-5#1)(2013-1#1)
activity (p##5##2##(1996-5#1)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
activity A##2##2##(1996-12#2)
activity after 2##2##3##(2008-10#1)(2008-6#1)
activity after##23##2##(1990-11#1)(1991-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-12#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-11#1)(2012-3#1)(2013-8#1)
activity against F##3##3##(2008-10#2)(2011-10#1)
activity against Micrococcus luteus##2##4##(1997-6#1)(2008-12#1)
activity against P##3##3##(2008-5#3)
activity against S##2##3##(2007-11#1)(2008-10#1)
activity against Streptococcus pneumoniae##2##4##(2007-12#1)(2011-2#1)
activity against a broad spectrum of##2##6##(2008-10#1)(2008-5#1)
activity against a##5##3##(2008-10#1)(2008-5#2)(2012-2#1)(2013-8#1)
activity against all of the tested##2##6##(2010-5#1)(2012-3#1)
activity against all##4##3##(2010-3#1)(2010-5#2)(2012-3#1)
activity against bacterial##2##3##(2012-1#1)(2012-3#1)
activity against both##4##3##(2008-10#1)(2009-10#1)(2010-3#1)(2012-3#1)
activity against human##3##3##(1997-7#1)(2008-11#1)(2010-2#1)
activity against solid##2##3##(2008-11#1)(2008-5#1)
activity against the##12##3##(1992-5#1)(1992-6#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
activity against##110##2##(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#3)(1995-3#1)(1996-9#1)(1997-6#2)(1997-7#2)(2007-11#4)(2007-12#1)(2008-10#18)(2008-11#11)(2008-12#1)(2008-5#9)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2010-2#2)(2010-3#7)(2010-5#3)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#7)(2013-1#1)(2013-8#3)
activity allowed##2##2##(1993-2#1)(2008-3#1)
activity along the##2##3##(2008-9#1)(2011-2#1)
activity along##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
activity also##4##2##(1990-11#1)(1990-7#1)(1997-5#1)(2009-9#1)
activity alterations##2##2##(2008-7#1)(2011-3#1)
activity although##2##2##(1990-11#1)(1993-6#1)
activity among the##2##3##(2008-10#2)
activity among##9##2##(1990-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
activity and ADH##3##3##(1997-8#3)
activity and DNA##2##3##(1990-11#1)(2008-7#1)
activity and a##5##3##(1997-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
activity and also##2##3##(1995-5#1)(2008-7#1)
activity and an increase in##3##5##(1991-2#2)(2011-2#1)
activity and an##6##3##(1990-8#1)(1991-2#3)(1991-5#1)(2011-2#1)
activity and are##2##3##(2008-1#1)(2012-3#1)
activity and as##2##3##(1991-5#1)(1994-6#1)
activity and body##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
activity and cell proliferation and increased cellular apoptosis##2##8##(2013-1#2)
activity and cell proliferation##3##4##(2013-1#3)
activity and cell##5##3##(2008-1#1)(2009-9#1)(2013-1#3)
activity and chemical##2##3##(2008-12#1)(2009-10#1)
activity and decrease##2##3##(1992-8#1)(2008-5#1)
activity and decreased##2##3##(1991-9#2)
activity and duration of##2##4##(1992-12#1)(2007-11#1)
activity and enhanced##2##3##(1992-3#1)(2008-1#1)
activity and expression of##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2010-12#1)
activity and expression##5##3##(1996-12#1)(2008-10#1)(2008-11#2)(2010-12#1)
activity and gene expression##2##4##(2010-12#1)(2011-2#1)
activity and growth##2##3##(2008-5#1)(2008-9#1)
activity and health##3##3##(1995-5#1)(2010-1#1)(2013-1#1)
activity and high##3##3##(2008-10#2)(2008-5#1)
activity and higher##2##3##(2008-10#1)(2013-1#1)
activity and in##5##3##(1991-12#1)(1994-9#1)(2008-5#2)(2008-7#1)
activity and inhibition##2##3##(1990-11#1)(1991-8#1)
activity and intracellular##2##3##(1990-2#1)(1994-11#1)
activity and is##4##3##(1993-3#1)(1995-6#1)(2008-5#1)(2008-9#1)
activity and its inhibition by manganese (II) chloride##2##8##(2008-7#2)
activity and its##6##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-7#2)(2008-8#1)
activity and mRNA##3##3##(1994-11#1)(1995-6#2)
activity and no##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
activity and nutrition##3##3##(2008-7#2)(2012-2#1)
activity and osteocalcin##2##3##(2012-4#2)
activity and other##2##3##(1991-9#1)(2009-6#1)
activity and phosphorylation##2##3##(1994-11#1)(1995-6#1)
activity and protein content in VAT##2##6##(2013-1#2)
activity and protein##4##3##(1993-12#1)(2013-1#3)
activity and responses to##2##4##(1995-12#1)(1996-5#1)
activity and serum melatonin levels##2##5##(1995-3#2)
activity and serum##5##3##(1995-3#3)(2008-7#1)(2008-8#1)
activity and stability of##3##4##(1994-11#1)(1997-6#1)(2008-10#1)
activity and stability##7##3##(1994-11#2)(1995-3#1)(1997-6#2)(2008-10#2)
activity and structure##2##3##(2012-1#1)(2013-1#1)
activity and subsequent##2##3##(2008-11#1)(2013-8#1)
activity and that the##2##4##(1992-6#1)(1995-2#1)
activity and that##6##3##(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
activity and the corresponding##2##4##(1991-12#1)(2008-9#1)
activity and the presence of##2##5##(2011-2#1)(2012-12#1)
activity and the##42##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-6#1)(1997-7#1)(2006-6#2)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#2)(2011-2#1)(2012-12#1)(2013-8#1)
activity and their##2##3##(2008-5#1)(2008-8#1)
activity and then##2##3##(1992-1#1)(1994-2#1)
activity and to##4##3##(1990-8#1)(1992-3#1)(2008-10#1)(2008-7#1)
activity and total##2##3##(2008-6#1)(2009-2#1)
activity and was##3##3##(1990-11#1)(1993-9#1)(2009-10#1)
activity and##420##2##(1990-11#6)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#7)(1991-5#6)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#6)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#8)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#1)(1995-12#8)(1995-2#3)(1995-3#8)(1995-5#3)(1995-6#6)(1995-8#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#4)(1997-7#4)(1997-8#6)(2006-10#2)(2006-6#2)(2007-11#3)(2007-12#3)(2007-6#2)(2007-8#3)(2008-1#5)(2008-10#40)(2008-11#22)(2008-12#3)(2008-4#7)(2008-5#15)(2008-6#1)(2008-7#23)(2008-8#10)(2008-9#5)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#7)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#3)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#1)(2012-4#2)(2013-1#26)(2013-7#1)(2013-8#4)
activity appears to##2##3##(1990-11#1)(2008-6#1)
activity appears##4##2##(1990-11#1)(1995-5#1)(2008-11#1)(2008-6#1)
activity are not##2##3##(1994-8#1)(1995-11#1)
activity are##19##2##(1990-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-7#1)(1996-9#1)(1997-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)
activity as a function of##2##5##(1990-10#1)(2012-2#1)
activity as a##9##3##(1990-10#1)(1990-8#1)(1994-11#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
activity as an##3##3##(1992-12#1)(1993-2#1)(1995-12#1)
activity as compared to the##2##5##(2010-5#2)
activity as compared with##2##4##(1997-6#1)(2010-9#1)
activity as compared##4##3##(1997-6#1)(2010-5#2)(2010-9#1)
activity as determined by##2##4##(1990-8#1)(1993-3#1)
activity as determined##3##3##(1990-8#1)(1993-3#1)(2008-11#1)
activity as measured##2##3##(1995-5#1)(1997-2#1)
activity as well as##7##4##(1992-6#1)(1992-8#1)(2007-11#1)(2008-10#2)(2009-3#2)
activity as well##9##3##(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(2007-11#1)(2008-10#2)(2009-3#2)
activity as##44##2##(1990-10#1)(1990-7#1)(1990-8#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-3#2)(2010-5#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
activity assay of##2##3##(2008-10#1)(2009-10#1)
activity assay##8##2##(2008-10#1)(2008-4#5)(2008-9#1)(2009-10#1)
activity assessed by##2##3##(1991-3#1)(1991-9#1)
activity associated with its##2##4##(1990-11#1)(2013-1#1)
activity associated with##6##3##(1990-11#1)(1995-12#1)(1995-5#1)(2008-4#1)(2009-6#1)(2013-1#1)
activity at 110°C##2##3##(2013-1#2)
activity at a##2##3##(2008-7#1)(2011-2#1)
activity at concentrations##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
activity at least##3##3##(1994-9#1)(2008-10#1)(2010-11#1)
activity at low pH##2##4##(1990-5#1)(2008-10#1)
activity at pH##4##3##(1994-5#1)(2008-10#1)(2008-8#2)
activity at rest and##2##4##(2012-12#1)(2013-8#1)
activity at the##9##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-2#1)
activity at##52##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-9#2)(1993-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-4#2)(1997-2#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-4#3)(2008-7#5)(2008-8#2)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
activity based on##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
activity because##2##2##(2008-6#1)(2008-7#1)
activity before##2##2##(1991-6#1)(2013-8#1)
activity being##2##2##(2008-10#1)(2008-7#1)
activity between pH##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
activity between the##2##3##(1993-12#1)(1995-12#1)
activity between##9##2##(1991-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
activity both in##2##3##(2008-5#1)(2012-1#1)
activity both##3##2##(2008-5#1)(2012-1#1)(2013-1#1)
activity but a##2##3##(1993-6#1)(2008-10#1)
activity but also##2##3##(1992-12#1)(1996-2#1)
activity but not##3##3##(1991-2#1)(1991-5#1)(1993-8#1)
activity but the##2##3##(2007-11#1)(2008-8#1)
activity but##18##2##(1991-2#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
activity by a##3##3##(1992-3#2)(1994-8#1)
activity by the##7##3##(1993-12#1)(1995-1#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
activity by using##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
activity by##74##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#5)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
activity can be enhanced##2##4##(2007-11#1)(2008-8#1)
activity can be measured##2##4##(2008-1#1)(2009-8#1)
activity can be##12##3##(1994-8#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)
activity can##22##2##(1990-2#1)(1994-8#3)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#3)(2013-1#1)
activity cannot be##4##3##(1992-2#1)(1993-3#1)(1994-8#1)(2008-11#1)
activity caused by##2##3##(2008-11#1)(2011-1#1)
activity caused##4##2##(1990-2#1)(1995-5#1)(2008-11#1)(2011-1#1)
activity changes##3##2##(1991-6#1)(1997-2#1)(2010-11#1)
activity coefficient##2##2##(2008-10#2)
activity coefficients of##4##3##(1990-8#1)(2008-10#3)
activity coefficients##11##2##(1990-8#2)(2008-10#7)(2008-5#1)(2008-7#1)
activity comparable to##5##3##(1990-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(2011-1#1)
activity compared to##5##3##(1994-11#1)(1995-2#1)(1996-12#1)(2009-8#1)(2013-1#1)
activity compared with the control##2##5##(2008-10#1)(2008-3#1)
activity compared with the##3##4##(1991-11#1)(2008-10#1)(2008-3#1)
activity compared with##5##3##(1991-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
activity compared##10##2##(1991-11#1)(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-8#1)(2013-1#1)
activity concentration##2##2##(1992-3#1)(2008-10#1)
activity confirming that##2##3##(1992-8#1)(2008-10#1)
activity contained##2##2##(1992-3#1)(1993-3#1)
activity correlated with##4##3##(1991-6#1)(1994-11#1)(2006-10#1)(2009-9#1)
activity correlated##6##2##(1991-6#1)(1994-11#1)(2006-10#1)(2006-6#1)(2009-9#1)(2012-1#1)
activity correlates with##2##3##(1995-6#1)(2009-9#1)
activity could be##8##3##(1992-3#1)(1992-6#1)(1992-9#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
activity could##13##2##(1992-3#1)(1992-6#1)(1992-9#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-5#1)
activity counseling##6##2##(2008-4#6)
activity curves##2##2##(1995-5#1)(1996-12#1)
activity declined in##2##3##(1993-3#1)(1996-9#1)
activity decreased and##3##3##(1991-12#1)(1994-11#1)(1995-11#1)
activity decreased in##2##3##(1991-12#1)(1993-12#1)
activity decreased significantly with age##2##5##(1990-3#2)
activity decreased##12##2##(1990-3#2)(1990-7#1)(1991-12#3)(1993-12#1)(1993-3#1)(1994-11#1)(1995-11#1)(2008-5#1)(2008-7#1)
activity decreases##2##2##(2008-10#1)(2008-12#1)
activity depends on##4##3##(1991-2#1)(1995-2#1)(2008-12#1)(2008-4#1)
activity detected in##2##3##(2008-10#2)
activity developed##2##2##(1996-5#1)(2010-7#1)
activity did not differ significantly##2##5##(1994-2#2)
activity did not vary##2##4##(2008-10#2)
activity did not##5##3##(1994-2#2)(1995-6#1)(2008-10#2)
activity displayed##2##2##(1991-5#1)(1995-12#1)
activity does not##2##3##(1990-3#1)(1993-1#1)
activity driven by##2##3##(1996-3#1)(2008-10#1)
activity due to hypopnoea##2##4##(2010-8#2)
activity due to##5##3##(1993-6#1)(1997-4#1)(2010-8#2)(2011-1#1)
activity during a##3##3##(1996-5#1)(2008-4#1)(2012-12#1)
activity during aging##2##3##(2008-7#1)(2011-2#1)
activity during the##8##3##(1994-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-8#1)(2013-8#1)
activity during these##2##3##(1992-6#1)(2011-2#1)
activity during##39##2##(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#3)(1994-6#1)(1996-5#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#6)(2008-9#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
activity elevated##2##2##(2011-2#2)
activity elicited by##2##3##(1991-12#1)(1997-4#1)
activity enhancement##2##2##(1990-11#1)(2008-10#1)
activity equivalent to##3##3##(1991-6#1)(1993-8#1)(1994-9#1)
activity exhibited a##2##3##(1990-5#1)(2008-10#1)
activity exhibited by##4##3##(1994-8#1)(1995-12#1)(1995-3#1)(2008-12#1)
activity exhibited##6##2##(1990-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-12#1)
activity expressed by##5##3##(1992-6#1)(1993-9#1)(2008-10#2)(2011-1#1)
activity expressed##7##2##(1992-6#1)(1993-9#1)(1994-11#1)(2008-10#2)(2008-8#1)(2011-1#1)
activity following##6##2##(1990-11#1)(1991-11#1)(1993-8#1)(2008-11#1)(2008-8#1)(2009-3#1)
activity for at least##2##4##(2008-10#2)
activity for oxidation of##2##4##(2008-10#2)
activity for several##2##3##(2008-10#2)
activity for the same##2##4##(1997-2#1)(2008-6#1)
activity for the##14##3##(1991-5#1)(1991-9#2)(1993-1#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-11#1)
activity for which##2##3##(1995-2#1)(1997-7#1)
activity for##51##2##(1991-5#1)(1991-9#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
activity from the##8##3##(1992-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-5#1)(2008-9#1)(2009-6#1)
activity from##24##2##(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#2)(1994-12#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)
activity greatly##2##2##(1992-12#1)(2008-11#1)
activity had##2##2##(1990-2#1)(2009-8#1)
activity has a##3##3##(1996-5#1)(2008-7#1)(2013-1#1)
activity has also been##2##4##(2008-12#1)(2008-5#1)
activity has become##2##3##(1996-1#1)(2008-7#1)
activity has been detected##2##4##(1991-1#1)(1994-2#1)
activity has been shown to be##3##6##(1992-8#1)(1993-11#1)(1994-8#1)
activity has been shown to##4##5##(1992-8#1)(1993-11#1)(1993-2#1)(1994-8#1)
activity has been##18##3##(1991-1#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-8#1)
activity has##30##2##(1991-1#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#2)
activity have been##8##3##(1996-5#1)(1997-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-5#1)
activity have##12##2##(1996-5#1)(1997-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#2)
activity in 1##2##3##(1996-12#1)(2012-2#1)
activity in HL-60 cells##2##4##(1993-6#1)(1994-11#1)
activity in HeLa##2##3##(2008-9#1)(2010-3#1)
activity in PC12 cells##2##4##(2008-11#2)
activity in a concentration-dependent manner##2##5##(1993-12#1)(1995-5#1)
activity in a large number of##2##6##(1995-12#1)(2008-4#1)
activity in a##30##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#3)(2009-6#1)(2012-2#1)(2013-8#1)
activity in adult##2##3##(2008-7#1)(2012-1#1)
activity in all##2##3##(2008-10#1)(2011-1#1)
activity in an in##2##4##(1991-12#1)(1992-3#1)
activity in an##7##3##(1991-12#1)(1992-3#1)(1995-3#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
activity in basic##2##3##(2007-8#1)(2008-10#1)
activity in biological##2##3##(1991-5#1)(2008-11#1)
activity in both##11##3##(1990-11#1)(1990-12#1)(1991-5#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#1)
activity in bovine##2##3##(1992-10#1)(1994-9#1)
activity in brain##5##3##(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
activity in cells##2##3##(1995-6#1)(2008-11#1)
activity in comparison with##3##4##(1992-8#1)(2008-12#1)(2012-1#1)
activity in comparison##4##3##(1992-8#1)(2008-12#1)(2008-7#1)(2012-1#1)
activity in control and nucleus basalis-lesioned rats##2##7##(1991-12#2)
activity in control##3##3##(1990-8#1)(1991-12#2)
activity in crude##2##3##(1994-11#1)(1995-2#1)
activity in culture##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
activity in cultured##2##3##(1995-11#1)(1995-6#1)
activity in different##2##3##(2008-8#1)(2011-2#1)
activity in erythrocytes is##2##4##(1993-6#1)(2008-7#1)
activity in erythrocytes##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
activity in general##2##3##(1990-6#1)(2008-7#1)
activity in guinea pig neocortical slices##2##6##(1996-5#2)
activity in health##2##3##(1993-12#1)(1997-1#1)
activity in human liver##4##4##(1992-6#2)(1993-9#2)
activity in human serum is due to biotinidase##2##8##(1990-8#2)
activity in human##13##3##(1990-8#2)(1992-6#2)(1993-9#2)(1994-11#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-5#1)
activity in isolated##4##3##(1990-7#1)(1994-6#2)(2008-8#1)
activity in lymphoid cells##2##4##(1994-8#1)(2008-4#1)
activity in lymphoid##3##3##(1994-2#1)(1994-8#1)(2008-4#1)
activity in mammalian cells##3##4##(1993-6#1)(2008-11#2)
activity in mice by##2##4##(2010-2#1)(2012-12#1)
activity in mice##5##3##(2008-4#1)(2008-5#2)(2010-2#1)(2012-12#1)
activity in milk##3##3##(2008-10#2)(2013-1#1)
activity in more##2##3##(2009-2#1)(2010-7#1)
activity in mouse##4##3##(1991-9#1)(1992-5#1)(1992-6#2)
activity in normal and##2##4##(2008-11#1)(2011-1#1)
activity in normal##3##3##(1993-11#1)(2008-11#1)(2011-1#1)
activity in patients with##2##4##(1992-12#1)(2011-1#1)
activity in patients##3##3##(1992-12#1)(2011-1#1)(2013-1#1)
activity in plasma and##2##4##(2008-7#2)
activity in platelets##2##3##(2011-1#2)
activity in preparations treated with##2##5##(1992-5#2)
activity in rat liver microsomes##2##5##(1992-8#1)(1993-8#1)
activity in rat liver##3##4##(1991-12#1)(1992-8#1)(1993-8#1)
activity in rat##10##3##(1990-11#1)(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-11#1)(2008-12#1)(2011-2#1)
activity in rats##5##3##(1994-11#1)(1994-8#1)(2008-12#2)(2013-8#1)
activity in real##2##3##(2008-10#1)(2011-1#1)
activity in red##2##3##(1990-9#1)(2008-8#1)
activity in response to activation of the##2##7##(1997-6#1)(2008-11#1)
activity in response to##6##4##(1991-2#1)(1994-11#2)(1997-6#1)(2008-11#2)
activity in serum##4##3##(1990-8#1)(2008-10#2)(2008-4#1)
activity in several##3##3##(1992-2#1)(1994-11#1)(2012-3#1)
activity in single##2##3##(1994-8#1)(2008-10#1)
activity in solution##2##3##(1996-12#1)(2008-10#1)
activity in some##2##3##(1990-2#1)(2008-9#1)
activity in specific##2##3##(1994-6#1)(2007-8#1)
activity in the culture##2##4##(1992-5#1)(1997-3#1)
activity in the first##2##4##(2008-10#1)(2008-11#1)
activity in the liver##3##4##(1995-2#1)(2008-6#2)
activity in the presence of##9##5##(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(2011-2#1)
activity in the range##2##4##(2008-10#1)(2008-8#1)
activity in the roots##2##4##(2008-10#1)(2008-12#1)
activity in the same##2##4##(2010-3#1)(2011-2#1)
activity in the##133##3##(1990-11#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1992-12#2)(1992-3#2)(1992-5#3)(1992-8#4)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2008-10#11)(2008-11#14)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#4)(2009-11#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
activity in this##6##3##(1991-1#1)(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#1)(2013-1#1)
activity in tissue##3##3##(1996-12#1)(2008-11#1)(2012-2#1)
activity in transgenic##4##3##(1994-8#1)(1995-2#1)(1995-6#1)(2008-9#1)
activity in type##2##3##(1994-2#1)(2012-12#1)
activity in unanesthetized##4##3##(1997-6#3)(2008-4#1)
activity in visual##2##3##(2008-11#1)(2012-2#1)
activity in vitro and in##2##5##(2008-10#1)(2010-11#1)
activity in vitro and##4##4##(1995-3#1)(2008-10#1)(2008-9#1)(2010-11#1)
activity in vitro of##2##4##(1991-12#1)(2008-11#1)
activity in vitro##32##3##(1990-2#1)(1990-5#1)(1991-12#3)(1992-3#1)(1992-8#1)(1994-5#1)(1994-8#2)(1995-3#2)(1996-5#4)(1997-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-9#2)(2009-4#1)(2010-11#1)(2012-2#1)(2012-3#1)
activity in vivo##7##3##(1990-11#1)(1993-8#1)(1995-2#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-9#1)
activity in##637##2##(1990-11#6)(1990-12#7)(1990-2#9)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#12)(1991-2#6)(1991-3#2)(1991-5#13)(1991-6#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#7)(1992-5#6)(1992-6#7)(1992-7#1)(1992-8#9)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#8)(1993-3#10)(1993-5#1)(1993-6#5)(1993-8#9)(1993-9#4)(1994-11#12)(1994-12#1)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#7)(1994-8#9)(1994-9#4)(1995-11#5)(1995-12#8)(1995-2#12)(1995-3#6)(1995-5#3)(1995-6#4)(1995-8#6)(1996-12#9)(1996-2#8)(1996-3#2)(1996-5#9)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#5)(1997-6#8)(1997-7#4)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#52)(2008-11#50)(2008-12#11)(2008-2#1)(2008-3#4)(2008-4#15)(2008-5#11)(2008-6#12)(2008-7#19)(2008-8#13)(2008-9#13)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#3)(2010-10#2)(2010-11#6)(2010-12#2)(2010-2#3)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#11)(2011-10#1)(2011-2#12)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#14)
activity including##2##2##(1994-2#1)(2008-10#1)
activity increase##3##2##(1992-3#1)(2008-4#1)(2012-12#1)
activity increased from##2##3##(1990-5#1)(2010-10#1)
activity increased significantly in##2##4##(1992-3#1)(2008-7#1)
activity increased significantly##4##3##(1992-3#1)(2008-7#2)(2009-6#1)
activity increased##18##2##(1990-5#2)(1991-12#1)(1992-3#2)(1993-12#1)(1995-11#1)(2008-11#1)(2008-7#6)(2008-8#1)(2009-6#1)(2010-10#1)(2010-11#1)
activity increases##2##2##(1990-2#1)(1991-2#1)
activity index##6##2##(2006-10#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-8#2)
activity indicated that##5##3##(1992-8#1)(1994-6#2)(2008-9#1)(2011-3#1)
activity indicated##6##2##(1992-8#1)(1994-12#1)(1994-6#2)(2008-9#1)(2011-3#1)
activity indicates that##2##3##(1993-8#1)(1997-3#1)
activity induced by##4##3##(1994-3#1)(1997-4#1)(2008-4#2)
activity induced##5##2##(1994-3#1)(1997-4#1)(2008-4#2)(2012-12#1)
activity into##3##2##(1993-11#1)(2008-1#1)(2008-11#1)
activity is a##11##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-10#1)(1994-2#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-2#1)(2013-1#1)
activity is altered##2##3##(1994-6#1)(2008-7#1)
activity is an##2##3##(2008-9#1)(2013-8#1)
activity is associated with##3##4##(1994-11#1)(1995-5#1)(1995-6#1)
activity is described##2##3##(1996-5#1)(2012-2#1)
activity is determined by##2##4##(2008-4#1)(2012-3#1)
activity is due to##2##4##(1992-3#1)(2008-1#1)
activity is increased##4##3##(1994-11#1)(2008-4#1)(2008-6#1)(2008-8#1)
activity is less##2##3##(2008-7#1)(2008-8#1)
activity is measured##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
activity is mediated##2##3##(1993-3#1)(2010-8#1)
activity is modulated by##2##4##(2008-5#1)(2011-1#1)
activity is needed##2##3##(2007-10#1)(2012-2#1)
activity is not altered##2##4##(1997-2#1)(2008-11#1)
activity is not##7##3##(1992-11#1)(1992-12#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
activity is present in##3##4##(1990-11#1)(1993-8#1)(1994-9#1)
activity is present##4##3##(1990-11#1)(1993-8#1)(1994-9#1)(2013-8#1)
activity is presented##2##3##(1990-5#1)(2008-10#1)
activity is regulated by##4##4##(1990-8#1)(1997-4#1)(2008-4#1)(2009-8#1)
activity is regulated##5##3##(1990-8#1)(1992-6#1)(1997-4#1)(2008-4#1)(2009-8#1)
activity is required for the##2##5##(1992-10#1)(2013-7#1)
activity is required for##5##4##(1992-10#1)(1997-1#1)(2008-11#1)(2012-12#1)(2013-7#1)
activity is sensitive to##2##4##(1994-2#1)(1994-9#1)
activity is##133##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-3#4)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-6#1)(1994-9#4)(1995-12#2)(1995-5#3)(1995-6#5)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
activity level of##2##3##(2008-10#1)(2012-12#1)
activity level##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-12#2)
activity levels and##2##3##(2008-10#1)(2008-11#1)
activity levels during##2##3##(2008-10#1)(2012-2#1)
activity levels of##3##3##(1990-8#1)(1992-9#1)(2012-3#1)
activity levels were##2##3##(1996-12#1)(2012-12#1)
activity levels##21##2##(1990-8#1)(1991-5#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
activity limitations##4##2##(2009-5#3)(2011-3#1)
activity markedly##2##2##(1994-11#1)(1995-6#1)
activity may be##7##3##(1992-9#1)(1997-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-12#1)
activity may play a role in##2##6##(1995-12#1)(2008-10#1)
activity may reflect the##2##4##(2008-11#1)(2009-10#1)
activity may##24##2##(1992-10#1)(1992-3#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
activity measured in the##2##4##(1993-12#1)(1994-8#1)
activity measured in##3##3##(1993-12#1)(1994-8#1)(2008-10#1)
activity measured##4##2##(1993-12#1)(1994-8#1)(1995-5#1)(2008-10#1)
activity measurement and##2##3##(1997-1#1)(2008-12#1)
activity measurement##4##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
activity measurements##2##2##(1990-8#1)(1995-5#1)
activity mediated by##2##3##(1994-11#1)(2008-10#1)
activity mediated##3##2##(1994-11#1)(2008-10#1)(2009-6#1)
activity might be##3##3##(1990-12#1)(1995-8#1)(2008-8#1)
activity might##6##2##(1990-12#1)(1995-8#1)(2008-4#1)(2008-8#1)(2013-1#2)
activity modulation##2##2##(1991-5#1)(2011-2#1)
activity monitoring##2##2##(2008-8#1)(2010-8#1)
activity more##3##2##(1994-8#1)(2008-11#1)(2013-1#1)
activity needed##2##2##(1997-6#1)(2008-10#1)
activity nor##4##2##(1990-5#1)(1995-3#1)(2008-11#1)(2008-8#1)
activity not##2##2##(1995-12#1)(2012-2#1)
activity observed after##2##3##(2008-4#2)
activity observed in##4##3##(1990-12#1)(1990-2#1)(1993-9#1)(2008-2#1)
activity observed##8##2##(1990-12#1)(1990-2#1)(1991-11#1)(1993-9#1)(1995-12#1)(2008-2#1)(2008-4#2)
activity obtained##3##2##(2008-6#2)(2010-8#1)
activity occurred at##2##3##(1994-9#1)(2008-10#1)
activity occurred##3##2##(1993-3#1)(1994-9#1)(2008-10#1)
activity occurring##2##2##(1991-11#1)(2013-1#1)
activity of 1-4 was##2##4##(2013-1#2)
activity of 2##3##3##(2008-10#1)(2009-9#1)(2013-1#1)
activity of 27##2##3##(1994-5#1)(2013-1#1)
activity of AP-1##2##3##(1996-2#2)
activity of Agouti paca##2##4##(2008-5#2)
activity of C##3##3##(2008-10#2)(2012-6#1)
activity of Crohn's disease##2##4##(2010-12#1)(2013-8#1)
activity of HMG-CoA lyase##2##4##(1990-8#2)
activity of LDH was##2##4##(2008-11#2)
activity of P##2##3##(2008-10#2)
activity of PKC was##2##4##(2008-11#1)(2008-8#1)
activity of PKC##4##3##(1992-6#2)(2008-11#1)(2008-8#1)
activity of PKMζ is##2##4##(2012-3#2)
activity of Pseudomonas fluorescens B5##2##5##(2008-10#2)
activity of Pseudomonas fluorescens##3##4##(2008-10#3)
activity of a single channel##2##5##(2011-3#2)
activity of a##30##3##(1990-5#1)(1991-9#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#1)
activity of about##2##3##(1997-7#1)(2008-9#1)
activity of acid phosphatase##2##4##(1995-3#1)(2008-7#1)
activity of acid##3##3##(1995-3#1)(2008-7#1)(2008-9#1)
activity of adenylate cyclase##2##4##(1990-7#1)(1990-8#1)
activity of alanine##2##3##(2008-10#1)(2008-12#1)
activity of alcohol dehydrogenase##2##4##(1992-11#1)(2008-11#1)
activity of an##8##3##(1991-5#1)(1993-2#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-10#2)(2010-11#1)
activity of antimicrobial agents##3##4##(2008-7#3)
activity of aqueous and##2##4##(2010-3#2)
activity of aqueous##3##3##(2010-3#3)
activity of both##6##3##(1992-11#1)(1994-9#1)(1996-6#1)(2008-10#2)(2008-11#1)
activity of bovine##2##3##(1990-5#1)(1992-9#1)
activity of brain##3##3##(1994-8#1)(2008-7#2)
activity of calcium antagonists##3##4##(1994-9#3)
activity of cathepsin D in serum##2##6##(2008-7#2)
activity of cathepsin D##3##4##(2008-7#3)
activity of cathepsin##5##3##(2008-7#4)(2009-8#1)
activity of cyclic##2##3##(1993-8#1)(1996-12#1)
activity of cytochrome P450SCC##2##4##(1997-2#2)
activity of cytochrome##6##3##(1990-11#1)(1995-2#2)(1997-2#2)(2008-11#1)
activity of cytosolic NADPH-dependent T3 binding##2##6##(1991-5#2)
activity of cytosolic##4##3##(1990-5#1)(1991-5#3)
activity of different##6##3##(1992-5#1)(2008-12#1)(2009-3#2)(2012-2#2)
activity of docetaxel in##2##4##(2008-6#2)
activity of each##2##3##(1994-5#1)(2008-5#1)
activity of ecto-nucleoside triphosphate diphosphohydrolase 3##2##6##(2008-4#2)
activity of electrolyte##2##3##(2008-10#2)
activity of endogenous##2##3##(2008-10#1)(2009-12#1)
activity of enzyme##2##3##(2008-10#1)(2012-2#1)
activity of enzymes##6##3##(1991-5#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
activity of essential oil##2##4##(2010-5#1)(2012-3#1)
activity of essential oils from##2##5##(2010-3#1)(2011-2#1)
activity of essential oils##4##4##(2008-10#2)(2010-3#1)(2011-2#1)
activity of essential##6##3##(2008-10#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
activity of ethanol##2##3##(2008-11#1)(2012-2#1)
activity of exoglycosidases##2##3##(2009-8#2)
activity of flavonoids in the##2##5##(2008-5#2)
activity of four##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
activity of growth##3##3##(1990-12#1)(2008-12#1)(2012-1#1)
activity of hepatic##2##3##(1995-6#1)(1996-12#1)
activity of human Cu##4##4##(1997-2#4)
activity of human##12##3##(1990-12#3)(1990-2#1)(1993-8#1)(1997-2#4)(2008-5#2)(2008-9#1)
activity of individual##2##3##(1993-6#1)(2008-9#1)
activity of influenza A viruses##3##5##(1992-9#2)(1996-6#1)
activity of insulin##2##3##(2008-3#1)(2008-8#1)
activity of its##4##3##(2008-5#1)(2009-3#1)(2010-5#1)(2012-12#1)
activity of lipoamide dehydrogenase##2##4##(1996-12#2)
activity of lysosomal##2##3##(1991-7#1)(2006-6#1)
activity of masseter##2##3##(1993-12#1)(2010-6#1)
activity of multiple##3##3##(1995-3#1)(1996-2#1)(2008-5#1)
activity of novel##3##3##(1992-3#1)(2007-11#1)(2008-8#1)
activity of osteoclasts##3##3##(1997-7#1)(2010-10#1)(2012-2#1)
activity of other##4##3##(2007-8#1)(2008-10#1)(2008-6#1)(2013-7#1)
activity of p53##2##3##(1995-2#1)(2007-8#1)
activity of peritoneal##2##3##(1991-12#2)
activity of phospholipase##5##3##(1993-3#1)(1994-11#1)(1994-5#2)(2011-2#1)
activity of plant##2##3##(2008-12#1)(2012-2#1)
activity of plasma##3##3##(1997-7#1)(2009-7#1)(2013-1#1)
activity of protein kinase##3##4##(1992-6#1)(1997-8#1)(2012-3#1)
activity of protein##5##3##(1992-6#1)(1997-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
activity of proteins##2##3##(2008-10#1)(2008-11#1)
activity of purified##4##3##(1992-9#1)(1995-6#1)(2008-11#1)(2008-8#1)
activity of rat##4##3##(1994-2#1)(2008-10#1)(2008-11#2)
activity of recombinant glycoprotein##2##4##(2008-7#2)
activity of recombinant##6##3##(1991-3#1)(1995-12#1)(2008-10#1)(2008-7#2)(2011-2#1)
activity of recombined single chain insulin##2##6##(2008-9#2)
activity of reconstituted F(0)##2##4##(2008-8#2)
activity of saponins##2##3##(1997-4#1)(2010-2#1)
activity of selected##2##3##(2008-5#2)
activity of seminal##2##3##(1990-5#1)(1994-3#1)
activity of several##2##3##(2008-10#1)(2008-6#1)
activity of sodium##2##3##(1996-2#1)(2008-9#1)
activity of soil##2##3##(2008-11#2)
activity of some##9##3##(1995-6#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)(2013-7#1)
activity of surfactant##2##3##(1994-5#1)(2007-11#1)
activity of the acetone extract##2##5##(2008-11#2)
activity of the antibody##2##4##(1994-8#1)(1995-5#1)
activity of the brain##3##4##(2008-11#1)(2008-7#1)(2010-8#1)
activity of the cells##3##4##(1994-6#1)(2008-10#1)(2008-11#1)
activity of the compost##2##4##(2008-10#2)
activity of the corresponding##3##4##(1991-12#1)(2007-11#1)(2008-10#1)
activity of the culture##2##4##(2008-7#1)(2008-8#1)
activity of the drug##3##4##(1991-3#1)(1996-7#1)(2010-12#1)
activity of the enzyme in##2##5##(1996-2#1)(2008-10#1)
activity of the enzyme##20##4##(1990-2#1)(1990-7#2)(1991-12#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
activity of the essential oils##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
activity of the essential##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
activity of the extracts was##2##5##(2008-10#1)(2013-1#1)
activity of the immobilized enzyme##2##5##(2008-10#2)
activity of the immobilized##4##4##(2008-10#4)
activity of the intact##2##4##(1995-2#1)(2008-10#1)
activity of the most##2##4##(1991-6#1)(1994-8#1)
activity of the muscle##2##4##(1997-2#1)(2008-5#1)
activity of the other##2##4##(1994-8#1)(1997-4#1)
activity of the pathogen##3##4##(2008-10#3)
activity of the protein##2##4##(2007-8#1)(2009-3#1)
activity of the purified##3##4##(1990-12#1)(1997-6#1)(2008-10#1)
activity of the putative##2##4##(1990-7#1)(1992-6#1)
activity of the rat neuronal cell line PC12##3##8##(2008-11#3)
activity of the rat##7##4##(1990-5#2)(2008-11#5)
activity of the recombinant human##2##5##(1990-2#1)(1990-8#1)
activity of the reconstituted##2##4##(1995-2#1)(2008-4#1)
activity of the rectus abdominis##2##5##(2009-6#1)(2012-12#1)
activity of the substrate##2##4##(1990-8#1)(2008-11#1)
activity of the transformants##2##4##(2008-10#1)(2008-8#1)
activity of the##283##3##(1990-11#6)(1990-12#3)(1990-2#4)(1990-5#4)(1990-7#3)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-9#5)(1992-10#1)(1992-11#5)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#5)(1994-6#6)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-5#4)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#4)(1997-8#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#37)(2008-11#21)(2008-12#2)(2008-4#5)(2008-5#14)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#4)(2009-11#1)(2009-3#3)(2009-4#2)(2009-6#4)(2009-8#2)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-2#1)(2012-1#2)(2012-12#5)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#2)
activity of their##2##3##(2008-4#1)(2008-8#1)
activity of these cells##2##4##(1993-5#1)(2008-7#1)
activity of these compounds##4##4##(1992-9#1)(1995-12#1)(2007-11#1)(2009-8#1)
activity of these enzymes##5##4##(1990-7#1)(2008-10#2)(2008-11#2)
activity of these##21##3##(1990-7#1)(1991-1#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-12#1)(2007-11#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
activity of this enzyme##4##4##(1990-12#1)(1991-9#1)(1992-6#1)(1993-8#1)
activity of this oil##2##4##(2008-12#1)(2010-5#1)
activity of this peptide was##2##5##(1997-3#2)
activity of this peptide##3##4##(1992-6#1)(1997-3#2)
activity of this##19##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-3#1)
activity of three##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
activity of two human##2##4##(1994-6#1)(2008-11#1)
activity of two##3##3##(1994-6#1)(2008-10#1)(2008-11#1)
activity of type##2##3##(1994-5#1)(2008-8#1)
activity of various##4##3##(1994-12#1)(1994-8#1)(1996-5#1)(2008-9#1)
activity of wild-type##3##3##(1995-6#1)(1995-8#1)(2008-9#1)
activity of yeast##2##3##(1992-3#1)(2008-10#1)
activity of##1179##2##(1990-10#2)(1990-11#9)(1990-12#16)(1990-2#10)(1990-3#1)(1990-5#13)(1990-6#1)(1990-7#14)(1990-8#9)(1991-1#6)(1991-11#3)(1991-12#14)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#15)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#12)(1992-10#1)(1992-11#10)(1992-12#4)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#6)(1992-6#10)(1992-8#8)(1992-9#10)(1993-1#2)(1993-11#10)(1993-12#7)(1993-2#2)(1993-3#6)(1993-5#3)(1993-6#6)(1993-8#10)(1993-9#2)(1994-10#2)(1994-11#14)(1994-12#7)(1994-2#12)(1994-3#3)(1994-5#9)(1994-6#15)(1994-7#2)(1994-8#16)(1994-9#7)(1995-11#6)(1995-12#14)(1995-2#14)(1995-3#8)(1995-5#9)(1995-6#9)(1995-8#5)(1996-10#1)(1996-12#5)(1996-2#12)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#15)(1997-3#5)(1997-4#7)(1997-6#8)(1997-7#11)(1997-8#6)(2006-10#1)(2006-6#3)(2007-11#17)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#6)(2008-1#5)(2008-10#157)(2008-11#80)(2008-12#21)(2008-2#3)(2008-3#2)(2008-4#18)(2008-5#51)(2008-6#17)(2008-7#32)(2008-8#34)(2008-9#33)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#8)(2009-4#6)(2009-5#2)(2009-6#6)(2009-7#3)(2009-8#10)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#6)(2010-4#3)(2010-5#8)(2010-6#3)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#14)(2011-3#8)(2012-1#8)(2012-12#8)(2012-2#15)(2012-3#17)(2012-6#1)(2013-1#39)(2013-7#8)(2013-8#6)
activity on a##3##3##(1992-3#1)(1994-5#1)(2013-1#1)
activity on organic##2##3##(2008-10#2)
activity on the apical membrane##2##5##(2008-4#2)
activity on the##10##3##(1992-3#1)(1993-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-9#1)
activity on##59##2##(1990-5#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-9#2)(1993-11#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#8)(2013-8#2)
activity only##7##2##(1992-3#1)(1992-8#1)(1995-12#1)(1997-4#1)(2008-11#1)(2009-6#1)(2010-11#1)
activity or by##2##3##(1994-2#2)
activity or##17##2##(1991-8#1)(1993-11#1)(1993-5#1)(1994-2#2)(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#2)(2011-2#1)(2013-1#3)
activity over a##2##3##(1994-5#1)(2010-2#1)
activity over##6##2##(1994-5#1)(1997-7#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-3#1)
activity partially##2##2##(2008-5#1)(2010-11#1)
activity participation and##2##3##(2009-3#1)(2009-6#1)
activity participation##3##2##(2009-3#1)(2009-6#1)(2012-2#1)
activity patterns##3##2##(2009-6#1)(2012-12#1)(2012-2#1)
activity peaked##2##2##(1993-8#1)(2011-1#1)
activity per##2##2##(2010-8#1)(2011-1#1)
activity plays##2##2##(1995-8#1)(2010-10#1)
activity present in the##2##4##(1992-6#1)(2008-10#1)
activity present in##4##3##(1990-12#1)(1992-6#1)(2008-10#1)(2010-2#1)
activity presented##2##2##(2007-8#1)(2011-10#1)
activity produced by##3##3##(1990-2#1)(1994-2#1)(2008-9#1)
activity produced##4##2##(1990-2#1)(1993-12#1)(1994-2#1)(2008-9#1)
activity profile##3##2##(1996-3#1)(2010-10#2)
activity profiles##3##2##(1994-11#1)(2008-10#1)(2012-12#1)
activity ratio##2##2##(1996-12#1)(2008-10#1)
activity ratios##2##2##(1994-8#1)(2008-10#1)
activity recording##2##2##(2008-10#1)(2010-8#1)
activity reflects##3##2##(1992-8#1)(1994-2#1)(2011-2#1)
activity regulate##2##2##(1996-2#1)(2009-8#1)
activity related to##2##3##(2008-11#2)
activity related##3##2##(2008-11#2)(2012-2#1)
activity relationship (QSAR)##2##3##(2007-11#2)
activity relationship##5##2##(2007-11#2)(2008-10#1)(2011-1#1)(2013-1#1)
activity relationships##3##2##(2007-11#1)(2009-12#1)(2012-2#1)
activity remained##6##2##(1990-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
activity remains##2##2##(2008-11#1)(2008-8#1)
activity represent##2##2##(2008-1#1)(2008-8#1)
activity results in##2##3##(2007-6#1)(2013-1#1)
activity returned##2##2##(1990-12#1)(1995-5#1)
activity returns to##2##3##(1990-2#1)(2011-2#1)
activity revealed##2##2##(1995-11#1)(2008-10#1)
activity score##3##2##(2011-2#2)(2013-1#1)
activity seen##2##2##(1994-11#1)(2008-12#1)
activity should##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
activity showed a decrease of##2##5##(1994-8#1)(2008-7#1)
activity showed a##5##3##(1993-12#1)(1994-8#1)(1997-2#1)(2008-7#1)(2008-8#1)
activity showed that##2##3##(2008-10#1)(2012-2#1)
activity showed##9##2##(1993-12#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
activity significantly increased##2##3##(1994-3#1)(2008-6#1)
activity significantly##3##2##(1992-12#1)(1994-3#1)(2008-6#1)
activity similar to that of##2##5##(1993-6#1)(2007-12#1)
activity similar to that##4##4##(1993-6#1)(2007-12#1)(2008-7#2)
activity staining##5##2##(2008-10#5)
activity still##2##2##(1993-9#1)(1994-6#1)
activity stimulated by##3##3##(1994-6#1)(1995-8#1)(1996-9#1)
activity such as##3##3##(1996-4#1)(2010-9#1)(2011-2#1)
activity testing##2##2##(1993-6#1)(2010-6#1)
activity than that of##3##4##(2008-10#2)(2008-5#1)
activity than the##4##3##(2008-11#1)(2008-5#1)(2010-11#1)(2013-8#1)
activity than##33##2##(1990-12#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-8#1)(1995-2#1)(2008-10#6)(2008-11#5)(2008-4#2)(2008-5#3)(2008-6#1)(2010-11#2)(2012-2#1)(2013-1#1)(2013-8#3)
activity that can be used##2##5##(1992-3#1)(2008-4#1)
activity that is##4##3##(1990-11#1)(1994-2#1)(1995-6#1)(2008-4#1)
activity that was##4##3##(1992-8#1)(1994-12#1)(1995-6#1)(2008-10#1)
activity that##33##2##(1990-11#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-6#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
activity the##4##2##(1997-4#1)(2008-8#1)(2012-12#1)(2013-8#1)
activity through the##3##3##(2008-5#1)(2008-7#1)(2009-3#1)
activity through##8##2##(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-2#1)
activity to a##2##3##(1993-8#1)(2008-4#1)
activity to an extent##3##4##(1995-2#1)(1996-5#1)(2008-11#1)
activity to form##2##3##(1992-8#1)(2012-12#1)
activity to the reduction of##2##5##(2008-10#2)
activity to the##8##3##(1992-8#1)(1994-9#1)(1996-2#1)(1996-7#1)(2008-10#2)(2008-5#1)(2010-5#1)
activity to##49##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-8#3)(1992-9#1)(1993-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#10)(2008-11#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
activity together##2##2##(2009-6#1)(2011-2#1)
activity toward methylated DNA##2##4##(1995-5#2)
activity toward the##5##3##(1992-11#1)(1995-6#1)(2008-10#2)(2008-11#1)
activity toward##23##2##(1991-9#1)(1992-11#1)(1993-8#1)(1994-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1997-2#1)(2008-10#9)(2008-11#1)(2008-7#1)
activity towards the oxidation of##4##5##(2008-10#4)
activity towards the oxidation##5##4##(2008-10#5)
activity towards the##9##3##(1990-11#1)(1994-11#1)(2008-10#6)(2012-12#1)
activity towards##23##2##(1990-11#1)(1991-9#1)(1992-8#2)(1992-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1997-7#1)(2008-10#7)(2008-5#1)(2009-12#1)(2011-1#2)(2012-12#1)
activity under the same##2##4##(1991-5#1)(1993-6#1)
activity under##7##2##(1991-1#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1997-3#1)(2008-5#1)
activity until##2##2##(2009-8#1)(2011-2#1)
activity up to##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
activity upon##3##2##(1994-1#1)(1996-12#1)(2008-11#1)
activity using a##4##3##(1990-7#1)(1992-9#1)(1994-12#1)(2008-10#1)
activity using the##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
activity using##19##2##(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(2006-10#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)
activity variations##2##2##(1996-5#1)(2010-12#1)
activity versus##2##2##(1992-2#1)(2010-8#1)
activity via##3##2##(1994-2#1)(1996-12#1)(1997-7#1)
activity vs##2##2##(2008-5#2)
activity was abolished by##2##4##(1994-6#1)(2011-2#1)
activity was also studied##2##4##(1993-2#1)(2013-8#1)
activity was also##10##3##(1990-5#1)(1991-1#1)(1991-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(2008-10#1)(2008-7#1)(2013-8#2)
activity was assayed##2##3##(1990-12#1)(2008-7#1)
activity was assessed in##2##4##(1991-5#1)(2008-10#1)
activity was assessed##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2012-1#1)
activity was associated with##6##4##(1990-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-8#1)(2009-7#1)
activity was associated##7##3##(1990-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-8#1)(2008-10#1)(2009-7#1)
activity was at##3##3##(1992-9#1)(2008-6#1)(2008-7#1)
activity was characterized##2##3##(1992-12#1)(2012-3#1)
activity was clearly##2##3##(2008-11#1)(2008-8#1)
activity was confirmed by##2##4##(1995-12#1)(1995-6#1)
activity was confirmed##3##3##(1995-12#1)(1995-6#1)(2010-3#1)
activity was decreased##2##3##(2008-10#1)(2008-8#1)
activity was demonstrated in##2##4##(2008-7#2)
activity was demonstrated##3##3##(2008-11#1)(2008-7#2)
activity was dependent##2##3##(1992-12#1)(1995-2#1)
activity was detected by##3##4##(1992-9#1)(1997-3#1)(2008-6#1)
activity was detected in##3##4##(1996-5#1)(2008-10#2)
activity was detected##13##3##(1991-12#1)(1992-9#1)(1993-12#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#2)
activity was determined by measuring##2##5##(1993-3#1)(2008-6#1)
activity was determined by##4##4##(1993-2#1)(1993-3#1)(2008-6#1)(2013-1#1)
activity was determined##10##3##(1990-8#1)(1993-2#1)(1993-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#2)(2013-1#1)
activity was developed##2##3##(2008-10#1)(2010-7#1)
activity was due to##3##4##(1993-12#1)(1996-2#1)(2008-10#1)
activity was due##4##3##(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)
activity was eliminated##2##3##(1994-11#1)(2008-10#1)
activity was enhanced##2##3##(2008-8#1)(2010-11#1)
activity was evaluated by a##2##5##(2011-2#1)(2013-1#1)
activity was evaluated by##3##4##(1994-8#1)(2011-2#1)(2013-1#1)
activity was evaluated##5##3##(1994-8#1)(2011-2#2)(2013-1#2)
activity was examined##2##3##(1991-2#1)(2012-3#1)
activity was found in##3##4##(1990-7#1)(1991-5#1)(1994-12#1)
activity was found to be increased##2##6##(1990-2#1)(1997-3#1)
activity was found to be significantly##2##6##(2008-10#1)(2008-7#1)
activity was found to be##8##5##(1990-2#1)(1990-7#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-7#1)
activity was found to##10##4##(1990-2#1)(1990-7#1)(1992-8#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-7#1)
activity was found##17##3##(1990-2#1)(1990-7#2)(1991-5#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)
activity was greater in##2##4##(1992-12#1)(1996-9#1)
activity was higher##4##3##(1994-11#1)(1995-11#1)(1997-8#1)(2011-2#1)
activity was identified in cell-free extracts of##2##7##(1992-9#1)(1994-11#1)
activity was identified##5##3##(1990-8#1)(1992-9#1)(1994-11#1)(1995-5#1)(2012-2#1)
activity was increased by##2##4##(1992-9#1)(1997-7#1)
activity was increased##5##3##(1991-12#1)(1992-9#1)(1993-12#1)(1997-7#1)(2008-4#1)
activity was induced##3##3##(1994-6#1)(2008-10#2)
activity was inhibited by the##2##5##(1992-12#1)(2008-11#1)
activity was inhibited by##10##4##(1990-11#1)(1991-5#1)(1992-12#2)(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2012-2#1)
activity was inhibited##15##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-12#2)(1993-8#1)(1994-11#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
activity was inversely##2##3##(1990-8#1)(1993-8#1)
activity was investigated in##2##4##(1996-2#1)(2008-5#1)
activity was investigated##3##3##(1994-8#1)(1996-2#1)(2008-5#1)
activity was measured in##5##4##(1990-2#1)(1990-3#1)(1991-2#1)(2008-10#1)(2008-6#1)
activity was measured when##2##4##(1990-11#1)(2012-12#1)
activity was measured##11##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(2008-10#2)(2008-6#1)(2010-11#1)(2012-12#1)(2013-1#1)
activity was not affected##3##4##(1997-1#1)(1997-7#2)
activity was not required for##2##5##(1992-10#1)(2007-12#1)
activity was not##11##3##(1992-10#1)(1993-3#1)(1994-11#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
activity was observed at##4##4##(1995-8#1)(2008-11#1)(2008-6#1)(2012-2#1)
activity was observed in##4##4##(1991-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
activity was observed##18##3##(1991-12#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)
activity was obtained##4##3##(1991-6#1)(1997-2#1)(1997-4#1)(2008-6#1)
activity was only##2##3##(1991-8#1)(2008-7#1)
activity was partially##2##3##(1993-2#1)(1994-6#1)
activity was positively correlated with##2##5##(2008-10#1)(2011-2#1)
activity was present##2##3##(1993-3#1)(1993-8#1)
activity was quantified##3##3##(2006-6#1)(2008-10#1)(2011-2#1)
activity was recorded for the##2##5##(2008-10#1)(2013-8#1)
activity was recorded##5##3##(1992-8#1)(1994-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
activity was recovered##3##3##(1991-2#1)(1997-4#1)(2008-11#1)
activity was reduced##4##3##(1993-9#1)(1995-8#1)(2008-10#1)(2008-8#1)
activity was reported##2##3##(1992-6#1)(2012-12#1)
activity was retained##3##3##(1990-5#1)(1996-4#1)(1997-8#1)
activity was seen in##5##4##(1991-12#1)(1992-6#1)(1995-11#1)(1997-3#1)(2008-6#1)
activity was seen##6##3##(1991-12#1)(1992-6#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-6#1)
activity was sensitive to##2##4##(1990-11#1)(1994-8#1)
activity was shown##2##3##(1990-5#1)(2008-7#1)
activity was significantly higher in the##2##6##(2008-11#1)(2008-7#1)
activity was significantly higher in##4##5##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
activity was significantly higher than##2##5##(1990-11#1)(2008-5#1)
activity was significantly higher##6##4##(1990-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
activity was significantly##11##3##(1990-11#1)(1991-2#1)(1992-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)
activity was similar##2##3##(1991-12#1)(1994-11#1)
activity was studied in##4##4##(1991-12#1)(1995-11#1)(2010-11#1)(2012-3#1)
activity was studied##6##3##(1991-12#1)(1994-6#1)(1995-11#1)(2008-5#1)(2010-11#1)(2012-3#1)
activity was suppressed by##2##4##(1992-8#1)(1996-5#1)
activity was suppressed##3##3##(1992-8#1)(1993-12#1)(1996-5#1)
activity was tested by##3##4##(1996-5#1)(2011-1#2)
activity was tested##5##3##(1994-12#1)(1996-5#1)(2008-5#1)(2011-1#2)
activity was the##2##3##(2008-11#1)(2008-6#1)
activity was unaffected by##2##4##(1995-11#1)(1995-12#1)
activity was unaffected##4##3##(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)
activity was##348##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-7#4)(1990-8#3)(1991-1#1)(1991-12#11)(1991-2#5)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#9)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#8)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#12)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#4)(1994-8#5)(1995-11#6)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#4)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#6)(1997-8#3)(2006-6#1)(2007-12#2)(2008-10#43)(2008-11#13)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#12)(2008-6#14)(2008-7#16)(2008-8#7)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#7)(2013-8#4)
activity well##2##2##(1992-2#1)(2008-10#1)
activity were associated with##3##4##(1995-4#1)(2013-1#1)(2013-8#1)
activity were detected##3##3##(2008-10#1)(2010-10#1)(2012-12#1)
activity were found##2##3##(2008-7#1)(2013-1#1)
activity were increased in##2##4##(1991-12#1)(2008-10#1)
activity were investigated and##2##4##(2009-3#1)(2013-1#1)
activity were investigated in##3##4##(1990-5#1)(1994-3#1)(1997-6#1)
activity were investigated##8##3##(1990-5#1)(1994-3#1)(1997-2#1)(1997-6#1)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#1)
activity were measured##2##3##(2008-10#2)
activity were observed##5##3##(1995-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
activity were obtained##2##3##(2008-6#2)
activity were##61##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#2)(1994-8#2)(1995-11#2)(1995-3#1)(1995-4#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#16)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#4)(2013-8#3)
activity when assayed in##2##4##(1990-10#1)(1995-2#1)
activity when##17##2##(1990-10#1)(1992-10#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-2#1)(2012-12#1)(2013-8#2)
activity which is##2##3##(1993-11#1)(2008-5#1)
activity which was##2##3##(1991-5#1)(2012-2#1)
activity which##15##2##(1990-11#4)(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
activity while##5##2##(2008-5#1)(2008-8#1)(2010-1#1)(2012-12#1)(2013-1#1)
activity will##2##2##(2008-7#1)(2009-12#1)
activity with EC50 values of##2##5##(2008-11#2)
activity with IC(50) values##3##4##(2008-10#2)(2011-2#1)
activity with a calculated##2##4##(1991-11#1)(1995-3#1)
activity with a##8##3##(1990-2#1)(1991-11#1)(1992-3#1)(1995-2#1)(1995-3#2)(1995-6#1)(2010-12#1)
activity with an##5##3##(1992-1#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-2#1)
activity with okadaic acid##2##4##(2008-2#1)(2008-4#1)
activity with the##6##3##(1991-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2009-3#1)
activity with##65##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-11#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-5#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-7#1)
activity within the##2##3##(2008-10#1)(2008-5#1)
activity within##7##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)
activity without##8##2##(1991-9#2)(1992-3#2)(2008-1#1)(2008-10#2)(2008-8#1)
activity would##4##2##(1991-2#1)(1994-11#1)(2008-11#1)(2013-1#1)
activity##5989##1##(1990-10#4)(1990-11#66)(1990-12#55)(1990-2#55)(1990-3#11)(1990-4#2)(1990-5#58)(1990-6#7)(1990-7#36)(1990-8#36)(1990-9#9)(1991-1#21)(1991-10#1)(1991-11#15)(1991-12#74)(1991-2#44)(1991-3#9)(1991-4#1)(1991-5#82)(1991-6#18)(1991-7#5)(1991-8#28)(1991-9#41)(1992-1#4)(1992-10#10)(1992-11#29)(1992-12#48)(1992-2#13)(1992-3#79)(1992-4#2)(1992-5#21)(1992-6#66)(1992-7#4)(1992-8#63)(1992-9#44)(1993-1#13)(1993-11#33)(1993-12#55)(1993-2#13)(1993-3#51)(1993-5#6)(1993-6#31)(1993-8#57)(1993-9#19)(1994-1#1)(1994-10#2)(1994-11#87)(1994-12#35)(1994-2#52)(1994-3#24)(1994-5#36)(1994-6#55)(1994-7#2)(1994-8#85)(1994-9#32)(1995-1#2)(1995-11#39)(1995-12#76)(1995-2#79)(1995-3#57)(1995-4#3)(1995-5#56)(1995-6#57)(1995-8#39)(1995-9#2)(1996-1#5)(1996-10#2)(1996-12#43)(1996-2#46)(1996-3#10)(1996-4#7)(1996-5#34)(1996-6#5)(1996-7#4)(1996-9#10)(1997-1#23)(1997-2#56)(1997-3#17)(1997-4#34)(1997-5#1)(1997-6#42)(1997-7#56)(1997-8#24)(1997-9#1)(2006-10#7)(2006-6#12)(2007-10#4)(2007-11#48)(2007-12#20)(2007-2#2)(2007-5#4)(2007-6#5)(2007-7#6)(2007-8#17)(2008-1#34)(2008-10#664)(2008-11#367)(2008-12#70)(2008-2#10)(2008-3#27)(2008-4#136)(2008-5#211)(2008-6#95)(2008-7#201)(2008-8#137)(2008-9#92)(2009-1#1)(2009-10#14)(2009-11#6)(2009-12#12)(2009-2#15)(2009-3#34)(2009-4#8)(2009-5#19)(2009-6#38)(2009-7#10)(2009-8#31)(2009-9#19)(2010-1#7)(2010-10#16)(2010-11#38)(2010-12#30)(2010-2#21)(2010-3#26)(2010-4#9)(2010-5#32)(2010-6#10)(2010-7#9)(2010-8#21)(2010-9#13)(2011-1#58)(2011-10#3)(2011-2#145)(2011-3#22)(2011-7#1)(2012-1#27)(2012-12#72)(2012-2#94)(2012-3#54)(2012-4#2)(2012-6#2)(2012-7#3)(2013-1#202)(2013-7#17)(2013-8#99)
activity) and##6##2##(1990-8#1)(1991-9#1)(1992-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
activity) was##2##2##(1991-2#1)(1992-11#1)
activity)##32##1##(1990-8#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#3)(1993-8#2)(1994-5#1)(1995-11#1)(1996-12#2)(1996-9#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#2)
activity-based##3##1##(2008-6#1)(2011-1#1)(2013-7#1)
activity-dependent regulation##2##2##(2008-8#1)(2009-8#1)
activity-dependent synaptic##3##2##(1994-8#1)(1997-7#1)(2012-2#1)
activity-dependent##13##1##(1994-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-1#2)(2008-8#1)(2009-3#1)(2009-8#3)(2012-2#1)(2013-8#1)
activity-related##2##1##(2009-10#1)(2012-2#1)
activity-response curves##2##2##(2008-5#2)
activity]##4##1##(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
actomyosin ATPase activity##3##3##(1992-9#2)(1995-6#1)
actomyosin##5##1##(1992-9#3)(1995-2#1)(1995-6#1)
actor##9##1##(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#3)
actors have##2##2##(2008-10#1)(2009-5#1)
actors in health##2##3##(1997-1#1)(2011-1#1)
actors in the##2##3##(1995-2#1)(2009-9#1)
actors in##5##2##(1995-2#1)(1997-1#1)(2009-9#1)(2011-1#1)(2013-1#1)
actors##19##1##(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-9#3)(2010-1#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
actors'##2##1##(2009-9#2)
acts as a catalyst##2##4##(1996-5#1)(2008-10#1)
acts as a natural##2##4##(2008-5#1)(2012-12#1)
acts as a potent##5##4##(1990-2#1)(1996-2#1)(1996-5#1)(2008-10#1)(2010-3#1)
acts as a specific##2##4##(2008-10#1)(2008-11#1)
acts as a tumor suppressor gene##2##6##(1995-2#1)(2013-1#1)
acts as a weak ionophore##2##5##(1994-3#2)
acts as a weak##3##4##(1993-6#1)(1994-3#2)
acts as a##77##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#3)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
acts as an agonist at##2##5##(1993-6#2)
acts as an agonist##3##4##(1993-6#2)(2008-6#1)
acts as an inhibitor of##2##5##(1991-8#1)(2008-11#1)
acts as an##19##3##(1991-5#1)(1991-8#1)(1992-1#1)(1993-6#2)(1994-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
acts as one of##2##4##(1990-8#1)(2008-11#1)
acts as the##5##3##(1994-5#1)(2008-10#2)(2008-5#1)(2009-7#1)
acts as##113##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#3)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
acts at a##2##3##(1994-8#1)(2008-5#1)
acts at the##4##3##(1992-8#1)(1994-9#1)(1995-3#1)(1997-6#1)
acts at##9##2##(1991-9#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-6#1)(2006-6#1)(2008-5#1)(2013-1#1)
acts both as##2##3##(2008-10#1)(2008-7#1)
acts both##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
acts by##6##2##(1990-2#1)(1990-7#1)(1993-3#1)(1994-2#1)(2008-10#1)(2009-7#1)
acts directly on##3##3##(1992-8#1)(2007-8#1)(2008-7#1)
acts in an##2##3##(1993-3#1)(2011-2#1)
acts in parallel to##2##4##(2008-9#1)(2009-8#1)
acts in the##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
acts in##10##2##(1993-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)
acts not only as a##2##5##(1992-12#1)(2008-5#1)
acts on the##4##3##(1995-3#1)(2007-12#1)(2008-8#1)(2013-1#1)
acts on##13##2##(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-3#1)(2007-12#1)(2008-8#1)(2009-12#1)(2013-1#1)
acts primarily##2##2##(1995-11#1)(2008-11#1)
acts through##2##2##(1990-5#1)(2007-12#1)
acts to##6##2##(1992-8#1)(1993-12#1)(2008-2#1)(2008-6#2)(2009-8#1)
acts##201##1##(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#5)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#3)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#9)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
actual and potential##4##3##(1990-12#1)(2008-12#1)(2009-4#1)(2009-5#1)
actual and##6##2##(1990-12#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-3#1)
actual cases##2##2##(2008-1#1)(2008-3#1)
actual clinical practice##2##3##(2008-7#2)
actual clinical##4##2##(1992-3#1)(2008-7#2)(2011-1#1)
actual concentration##2##2##(1995-12#1)(2008-10#1)
actual data collection##2##3##(2008-4#1)(2010-3#1)
actual data##4##2##(1992-2#1)(2008-10#1)(2008-4#1)(2010-3#1)
actual exercise##5##2##(1992-12#5)
actual experience of the##2##4##(2008-11#1)(2011-2#1)
actual health##4##2##(1991-12#1)(1992-2#1)(2008-11#1)(2009-9#1)
actual level of##3##3##(1993-2#1)(2008-7#1)(2012-3#1)
actual measurements##2##2##(2008-3#2)
actual mechanism of##2##3##(2008-10#1)(2008-11#1)
actual mechanism##4##2##(1991-1#1)(1993-6#1)(2008-10#1)(2008-11#1)
actual or potential##4##3##(2012-12#1)(2012-2#1)(2013-1#2)
actual or##5##2##(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
actual patient##2##2##(1997-3#1)(2012-1#1)
actual patients##2##2##(2008-11#1)(2012-12#1)
actual physician##2##2##(1994-1#1)(1994-3#1)
actual practice##5##2##(1991-11#1)(1992-1#1)(1993-2#1)(1997-8#1)(2010-7#1)
actual rates of##2##3##(1994-6#1)(2008-2#1)
actual results##2##2##(1992-3#1)(2008-3#1)
actual sample##3##2##(2008-10#3)
actual samples##4##2##(2008-10#4)
actual surface##2##2##(2008-3#2)
actual use of##4##3##(1995-3#2)(2008-11#2)
actual use##11##2##(1992-3#1)(1995-3#2)(1996-9#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)
actual values##4##2##(1990-8#1)(2007-11#1)(2008-3#2)
actual weight##4##2##(1991-2#1)(1996-8#1)(2007-12#1)(2008-12#1)
actual##287##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#4)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#4)(1994-6#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#46)(2008-11#13)(2008-12#7)(2008-2#14)(2008-3#30)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
actuality##5##1##(2008-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
actually a##2##2##(2008-10#1)(2008-5#1)
actually be##2##2##(2008-11#1)(2011-2#1)
actually contribute to##2##3##(1993-2#1)(1994-2#1)
actually decreased the##2##3##(1990-7#1)(2009-8#1)
actually delivered##3##2##(1992-3#1)(2007-4#1)(2008-2#1)
actually increase##2##2##(2008-2#1)(2008-8#1)
actually increased##2##2##(1990-12#1)(2008-10#1)
actually increases##3##2##(1990-5#1)(2008-8#1)(2011-2#1)
actually measured##2##2##(2008-7#1)(2013-8#1)
actually occurred##2##2##(2008-9#1)(2011-1#1)
actually present##2##2##(1992-5#1)(2008-9#1)
actually promote##2##2##(1991-9#1)(1996-1#1)
actually provide##2##2##(1995-2#1)(2013-1#1)
actually reach the##2##3##(1991-12#1)(1991-2#1)
actually reduce##4##2##(2008-7#2)(2010-3#1)(2011-3#1)
actually reduced##2##2##(2008-10#1)(2008-3#1)
actually reported##2##2##(1996-7#1)(2009-7#1)
actually the##3##2##(1995-8#1)(2008-11#1)(2011-1#1)
actually##120##1##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-3#2)(1996-7#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#13)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#5)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-12#1)(2013-1#4)(2013-8#3)
actuarial RFS##2##2##(2011-2#2)
actuarial overall survival was##2##4##(1991-8#2)
actuarial overall survival##3##3##(1991-8#2)(1994-12#1)
actuarial patient survival##2##3##(1992-5#1)(2007-12#1)
actuarial patient##3##2##(1992-5#1)(2007-12#1)(2008-1#1)
actuarial survival rate was##2##4##(1991-6#1)(2007-8#1)
actuarial survival rate##3##3##(1991-6#1)(2007-8#2)
actuarial survival rates##2##3##(2008-3#1)(2012-2#1)
actuarial survival##12##2##(1990-2#1)(1990-9#1)(1991-6#1)(1993-9#1)(1996-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#2)
actuarial##31##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#3)(1992-2#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-11#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#4)(2011-3#1)(2012-2#2)
actuated##5##1##(1992-3#1)(1996-2#1)(2008-10#2)(2009-5#1)
actuation behavior##2##2##(2010-4#2)
actuation of##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
actuation##13##1##(2008-10#2)(2008-3#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-4#5)(2011-1#1)
actuator##7##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
actuators and##2##2##(2007-12#1)(2009-5#1)
actuators##12##1##(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#1)
acuformis has##2##2##(2008-10#2)
acuformis in Washington##2##3##(2008-10#2)
acuformis in##3##2##(2008-10#3)
acuformis##13##1##(2008-10#13)
acuity and colour vision##2##4##(2008-7#2)
acuity and##6##2##(2008-3#1)(2008-7#3)(2012-12#1)(2013-1#1)
acuity improved##2##2##(2010-10#1)(2011-1#1)
acuity of##7##2##(2010-10#1)(2010-8#1)(2011-2#3)(2013-7#1)(2013-8#1)
acuity was##3##2##(1991-2#1)(2009-3#1)(2011-2#1)
acuity##42##1##(1991-2#1)(1993-12#1)(1996-1#2)(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#4)(2009-3#2)(2010-10#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#15)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
aculeate##2##1##(2007-12#1)(2008-9#1)
aculeus##4##1##(2008-6#4)
acuminata##6##1##(1994-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
acuminata)##2##1##(2008-10#1)(2011-1#1)
acuminatum##7##1##(2007-8#2)(2008-10#1)(2011-1#2)(2012-12#1)(2012-3#1)
acupoint##3##1##(2008-9#1)(2012-3#1)(2013-1#1)
acupoints for##2##2##(2008-10#1)(2012-3#1)
acupoints of HM##2##3##(2008-9#2)
acupoints of##6##2##(2008-9#5)(2010-7#1)
acupoints##11##1##(2008-10#1)(2008-9#5)(2010-7#2)(2012-3#1)(2013-1#2)
acupuncture and moxibustion##5##3##(2008-10#5)
acupuncture and##10##2##(2006-10#1)(2008-10#5)(2011-2#1)(2012-3#2)(2013-1#1)
acupuncture as##3##2##(1993-3#1)(2008-10#2)
acupuncture for##3##2##(1993-3#1)(2008-11#1)(2012-3#1)
acupuncture in##4##2##(1995-12#1)(2007-10#1)(2008-10#2)
acupuncture meridians##2##2##(2010-7#2)
acupuncture needle##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
acupuncture on##4##2##(2010-6#1)(2012-3#3)
acupuncture or moxibustion##2##3##(2008-10#2)
acupuncture or##3##2##(2008-10#3)
acupuncture points##2##2##(2008-10#2)
acupuncture skills##8##2##(2012-3#8)
acupuncture therapy##2##2##(2012-3#1)(2013-8#1)
acupuncture to##2##2##(2008-10#2)
acupuncture treatment##4##2##(2006-10#1)(2010-6#1)(2010-7#1)(2013-1#1)
acupuncture was##3##2##(1995-12#2)(2008-10#1)
acupuncture were##2##2##(2006-10#1)(2008-10#1)
acupuncture with##3##2##(2008-10#2)(2008-8#1)
acupuncture##101##1##(1993-3#7)(1993-7#1)(1995-12#4)(1997-6#5)(2006-10#6)(2007-10#1)(2008-10#35)(2008-11#2)(2008-8#2)(2010-6#5)(2010-7#4)(2011-2#1)(2012-3#24)(2013-1#3)(2013-8#1)
acupuncturists##2##1##(2008-10#2)
acus##2##1##(2012-2#2)
acuta##2##1##(2007-7#1)(2008-10#1)
acutatum and C##3##3##(2008-10#3)
acutatum and the##2##3##(2008-10#2)
acutatum and##7##2##(2008-10#7)
acutatum by##2##2##(2008-10#2)
acutatum conidia##2##2##(2008-10#2)
acutatum from strawberry##4##3##(2008-10#4)
acutatum from##8##2##(2008-10#8)
acutatum isolates##5##2##(2008-10#5)
acutatum on##9##2##(2008-10#9)
acutatum populations##2##2##(2008-10#2)
acutatum was##4##2##(2008-10#4)
acutatum were##5##2##(2008-10#5)
acutatum##87##1##(2008-10#87)
acutatum-##2##1##(2008-10#2)
acutatum-M##3##1##(2008-10#3)
acutatum-O##3##1##(2008-10#3)
acutatum-specific##3##1##(2008-10#3)
acute (&lt##2##2##(2008-8#1)(2011-2#1)
acute CHF##3##2##(2008-3#3)
acute EBV infection##2##3##(2008-5#1)(2011-2#1)
acute EBV##3##2##(2008-5#1)(2011-2#2)
acute EtOH treatment##2##3##(2008-10#2)
acute EtOH##6##2##(2008-10#6)
acute PE##6##2##(2011-2#6)
acute Q fever##3##3##(2007-12#3)
acute ST elevation myocardial infarction##2##5##(2008-3#1)(2010-5#1)
acute ST##3##2##(2008-3#2)(2010-5#1)
acute abdomen and##2##3##(1991-6#1)(1993-5#1)
acute abdomen due to##2##4##(2009-9#1)(2012-2#1)
acute abdomen##14##2##(1990-6#1)(1991-6#1)(1993-5#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
acute abdominal pain and##2##4##(2008-12#1)(2008-7#1)
acute abdominal pain##7##3##(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-8#1)(2013-1#1)
acute abdominal##9##2##(2007-2#1)(2007-8#1)(2008-12#2)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
acute administration of##2##3##(2008-10#1)(2013-8#1)
acute admission##2##2##(1996-9#1)(2008-8#1)
acute alcohol withdrawal##2##3##(1991-12#1)(1995-11#1)
acute alcohol##3##2##(1991-12#1)(1995-11#1)(2008-11#1)
acute and chronic administration##2##4##(1990-3#1)(1992-3#1)
acute and chronic effects##2##4##(1994-5#1)(2008-5#1)
acute and chronic health##2##4##(2008-7#1)(2012-12#1)
acute and chronic models of##2##5##(2008-12#2)
acute and chronic pain episodes##2##5##(2008-7#2)
acute and chronic##42##3##(1990-3#1)(1991-9#3)(1992-3#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#4)(2008-8#1)(2009-12#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#4)(2013-8#1)
acute and late##2##3##(2008-6#2)
acute and long-term treatment of##2##5##(2007-8#1)(2012-3#1)
acute and long-term##4##3##(2007-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
acute and persistent##2##3##(2010-1#1)(2010-12#1)
acute and preventive##2##3##(1995-11#1)(2008-9#1)
acute and subacute##3##3##(1994-11#1)(2008-3#2)
acute and##83##2##(1990-3#1)(1991-1#1)(1991-9#3)(1992-3#2)(1992-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-5#1)(1997-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
acute angle##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
acute anterior##3##2##(2007-11#2)(2013-1#1)
acute aortic dissection##8##3##(2007-8#4)(2011-2#1)(2012-1#2)(2013-1#1)
acute aortic##10##2##(2007-8#5)(2010-12#1)(2011-2#1)(2012-1#2)(2013-1#1)
acute appendicitis##10##2##(1991-12#1)(1993-6#2)(1997-8#1)(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#3)
acute arterial##3##2##(2006-6#1)(2008-8#1)(2011-2#1)
acute arthritis##2##2##(1990-6#2)
acute asthma exacerbation##2##3##(2008-10#1)(2013-1#1)
acute asthma##8##2##(1992-3#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#2)(2013-1#1)
acute back pain##3##3##(1993-6#1)(2007-11#1)(2009-3#1)
acute bacterial meningitis##6##3##(1995-11#1)(1996-3#1)(2007-5#1)(2008-9#2)(2010-12#1)
acute bacterial##14##2##(1991-3#2)(1994-2#1)(1995-11#2)(1996-3#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-9#2)(2010-12#1)
acute biliary pancreatitis##2##3##(2007-8#2)
acute biliary##3##2##(1992-9#1)(2007-8#2)
acute bleeding##2##2##(2010-12#1)(2011-2#1)
acute brain injury##2##3##(2008-11#1)(2008-7#1)
acute carbon monoxide poisoning##4##4##(1990-5#2)(1991-9#1)(2009-11#1)
acute cardiac##2##2##(2008-11#1)(2011-2#1)
acute care and##3##3##(1994-12#1)(1994-3#1)(2011-2#1)
acute care hospital##6##3##(1996-1#1)(2010-10#2)(2010-11#1)(2011-2#2)
acute care hospitals in##3##4##(1996-12#1)(2008-11#1)(2011-1#1)
acute care hospitals##13##3##(1992-2#1)(1993-12#1)(1994-3#2)(1996-12#1)(1997-1#1)(1997-3#1)(2008-11#3)(2010-10#1)(2010-8#1)(2011-1#1)
acute care institutions##2##3##(1993-12#1)(1996-1#1)
acute care psychiatric##2##3##(1992-3#2)
acute care setting##7##3##(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-3#1)(2011-1#1)
acute care systems##2##3##(1994-3#2)
acute care##68##2##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#8)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#4)(1997-2#1)(1997-3#3)(2007-10#1)(2007-12#2)(2008-11#4)(2008-3#1)(2008-7#1)(2009-5#3)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-3#1)(2013-1#2)
acute care-based##2##2##(1996-12#1)(1997-3#1)
acute cellular rejection (ACR)##2##4##(2008-10#2)
acute cerebellar ataxia##2##3##(2011-2#2)
acute cerebral infarction##3##3##(2007-10#2)(2008-2#1)
acute cerebral##7##2##(2006-7#1)(2007-10#2)(2008-2#1)(2009-11#1)(2012-3#1)(2013-8#1)
acute challenge##3##2##(1996-2#2)(2008-7#1)
acute chest pain##4##3##(2008-3#2)(2011-2#1)(2012-2#1)
acute chest##5##2##(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
acute child psychiatric##2##3##(1996-9#2)
acute childhood##2##2##(1997-8#1)(2011-2#1)
acute cholangitis and##2##3##(1997-8#1)(2013-1#1)
acute cholangitis due to##2##4##(2013-1#2)
acute cholangitis##5##2##(1997-8#1)(2013-1#4)
acute cholecystitis caused by gallbladder stones##2##6##(2008-5#2)
acute cholecystitis##8##2##(1990-9#1)(1997-8#3)(2008-5#3)(2013-8#1)
acute colonic diverticulitis##5##3##(2009-8#2)(2010-8#3)
acute compartment syndrome##3##3##(2009-1#2)(2009-3#1)
acute complications##4##2##(1992-9#1)(1994-6#2)(2013-7#1)
acute condition##3##2##(1991-1#1)(1992-12#2)
acute conditions##3##2##(1990-12#1)(1991-6#1)(1997-3#1)
acute congestive heart failure##3##4##(2008-3#2)(2011-2#1)
acute coronary events##2##3##(2008-7#1)(2011-2#1)
acute coronary ischemic syndromes without elevation of the ST##2##9##(2008-10#2)
acute coronary ischemic syndromes##4##4##(2008-10#4)
acute coronary ischemic##5##3##(2008-10#5)
acute coronary syndrome and##6##4##(2008-3#4)(2011-2#2)
acute coronary syndrome as##2##4##(2008-3#2)
acute coronary syndrome in the##4##5##(2008-3#3)(2008-7#1)
acute coronary syndrome in##5##4##(2008-3#4)(2008-7#1)
acute coronary syndrome were##2##4##(2008-3#2)
acute coronary syndrome##46##3##(2008-10#2)(2008-11#7)(2008-3#21)(2008-5#1)(2008-7#3)(2009-10#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-2#1)(2013-8#1)
acute coronary syndrome]##2##3##(2013-1#1)(2013-8#1)
acute coronary syndromes (ACS)##4##4##(2008-3#4)
acute coronary syndromes and##4##4##(2008-3#3)(2009-10#1)
acute coronary syndromes##49##3##(2008-10#2)(2008-11#1)(2008-3#34)(2008-4#1)(2008-7#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#4)
acute coronary##111##2##(1990-12#1)(2008-10#11)(2008-11#8)(2008-3#56)(2008-4#1)(2008-5#2)(2008-7#5)(2009-10#5)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#12)(2012-2#1)(2013-1#1)(2013-8#2)
acute decompensated congestive heart failure##2##5##(2008-3#2)
acute decompensated heart failure##4##4##(2008-3#3)(2010-3#1)
acute decompensated##6##2##(2008-3#5)(2010-3#1)
acute diarrhea##2##2##(2008-12#1)(2011-2#1)
acute diarrhoea in##2##3##(2007-7#1)(2009-5#1)
acute diarrhoea##4##2##(2007-7#3)(2009-5#1)
acute disease and##2##3##(1997-8#1)(2012-2#1)
acute disease caused by##2##4##(2008-7#1)(2008-9#1)
acute disease##8##2##(1994-6#1)(1997-8#3)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
acute disseminated encephalomyelitis##2##3##(2012-12#2)
acute disseminated##3##2##(1997-7#1)(2012-12#2)
acute doses of EMR produced by mobile phones##2##8##(2008-12#2)
acute doses##4##2##(1992-3#1)(2008-12#2)(2008-7#1)
acute dystonia in##2##3##(2012-12#2)
acute dystonia##5##2##(2008-7#2)(2012-12#3)
acute effect of##4##3##(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)
acute effect##5##2##(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)
acute effects##5##2##(1992-3#1)(1993-8#1)(1997-2#1)(2008-7#1)(2011-2#1)
acute emesis##2##2##(2010-12#2)
acute encephalitis##2##2##(2008-12#1)(2011-2#1)
acute episode of##3##3##(2010-10#1)(2010-3#1)(2012-12#1)
acute episode##4##2##(1991-8#1)(2010-10#1)(2010-3#1)(2012-12#1)
acute exacerbation of chronic obstructive pulmonary disease##2##7##(2010-2#1)(2011-2#1)
acute exacerbation of chronic##4##4##(1997-4#1)(2008-10#1)(2010-2#1)(2011-2#1)
acute exacerbation##6##2##(1997-4#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
acute exacerbations of asthma##2##4##(2007-11#2)
acute exacerbations of chronic bronchitis##2##5##(1996-11#1)(2008-7#1)
acute exacerbations of chronic##3##4##(1996-11#1)(2007-12#1)(2008-7#1)
acute exacerbations of##7##3##(1996-11#1)(2007-11#2)(2007-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
acute exacerbations##11##2##(1996-11#1)(2007-11#2)(2007-12#1)(2008-7#1)(2010-5#2)(2011-2#3)(2013-8#1)
acute exercise stress##2##3##(2008-10#2)
acute exercise##3##2##(2008-10#2)(2013-1#1)
acute exhaustive exercise##2##3##(2013-1#2)
acute experimental##2##2##(1992-6#1)(2007-8#1)
acute exposure of##2##3##(1993-12#1)(1994-5#1)
acute exposure to##4##3##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
acute exposure##8##2##(1990-6#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
acute exposures to##2##3##(2008-9#1)(2011-1#1)
acute facial palsy##3##3##(2006-12#2)(2012-3#1)
acute flaccid paralysis##4##3##(2010-8#3)(2011-1#1)
acute food deprivation and##2##4##(2011-1#2)
acute food deprivation##3##3##(2011-1#3)
acute food intake on##2##4##(2011-1#2)
acute food intake##4##3##(2011-1#4)
acute food##7##2##(2011-1#7)
acute gastroenteritis##6##2##(1996-6#1)(2009-5#2)(2011-2#2)(2013-8#1)
acute glomerulonephritis (AGN) in##2##4##(2007-7#2)
acute glomerulonephritis##5##2##(1997-5#1)(2007-7#2)(2011-2#2)
acute glucose fluctuations##2##3##(2009-11#2)
acute gonococcal salpingitis##2##3##(1994-2#2)
acute graft-versus-host disease##2##3##(2012-2#2)
acute graft-versus-host##3##2##(1991-5#1)(2012-2#2)
acute hamstring##2##2##(2011-1#2)
acute heart failure##4##3##(2008-3#3)(2011-2#1)
acute hemorrhage##2##2##(1992-6#1)(1993-9#1)
acute hepatic failure##3##3##(1997-2#1)(2008-7#1)(2009-7#1)
acute hepatic##5##2##(1991-11#1)(1997-2#1)(2008-7#1)(2008-9#1)(2009-7#1)
acute hepatitis E##2##3##(2010-8#1)(2012-3#1)
acute hepatitis in##3##3##(1995-2#1)(1995-3#1)(2008-7#1)
acute hepatitis##15##2##(1991-8#1)(1995-2#1)(1995-3#4)(1996-3#3)(2007-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#2)
acute hepatotoxicity##2##2##(2010-4#2)
acute herpes##2##2##(1994-3#1)(1995-5#1)
acute hospital setting##2##3##(2007-10#2)
acute hospital stroke units##3##4##(2011-1#3)
acute hospital##8##2##(1994-12#1)(2007-10#3)(2008-11#1)(2011-1#3)
acute hospitalization##3##2##(2011-2#3)
acute hypoxia##4##2##(1993-12#1)(1995-12#2)(2010-12#1)
acute iatrogenic water intoxication##2##4##(1995-11#2)
acute iliofemoral##2##2##(1997-8#2)
acute illness episodes##2##3##(2010-2#2)
acute illness##10##2##(1992-1#1)(2008-11#1)(2009-10#1)(2010-2#5)(2012-2#1)(2013-1#1)
acute illnesses##2##2##(2007-7#2)
acute in##2##2##(2008-4#1)(2012-2#1)
acute increase in##2##3##(1994-8#1)(1995-2#1)
acute increase##3##2##(1994-8#1)(1995-2#1)(2010-10#1)
acute infection of##2##3##(1990-9#1)(2009-4#1)
acute infection##10##2##(1990-9#1)(2007-8#1)(2008-2#1)(2008-4#2)(2009-3#1)(2009-4#2)(2012-2#1)(2013-1#1)
acute infections##5##2##(1990-12#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
acute infectious disease##2##3##(2008-7#2)
acute infectious##3##2##(1990-2#1)(2008-7#2)
acute infectivity##2##2##(1992-8#2)
acute inflammation##2##2##(2008-7#1)(2010-9#1)
acute inflammatory demyelinating##2##3##(1995-5#1)(2008-7#1)
acute inflammatory##4##2##(1995-5#1)(1996-5#1)(2008-7#1)(2008-8#1)
acute injuries##2##2##(2009-6#1)(2012-2#1)
acute inpatient##3##2##(1992-1#1)(1992-12#1)(2013-8#1)
acute insulin response##2##3##(2008-1#1)(2010-10#1)
acute insulin##3##2##(2008-1#1)(2010-10#1)(2011-2#1)
acute intermittent porphyria##3##3##(1990-2#2)(1991-2#1)
acute interstitial nephritis##4##3##(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#1)
acute interstitial##5##2##(2007-7#1)(2008-1#2)(2008-8#1)(2011-2#1)
acute intestinal ischemia##3##3##(1993-5#3)
acute intestinal##5##2##(1990-3#1)(1993-5#3)(2012-2#1)
acute intra-dialytic symptoms##6##3##(2007-7#3)(2008-1#3)
acute intracranial hypertension##2##3##(2008-7#2)
acute intracranial##3##2##(2008-7#2)(2011-2#1)
acute intraperitoneal##2##2##(1996-2#1)(2011-2#1)
acute ischaemia-reperfusion##2##2##(2012-2#1)(2013-7#1)
acute ischaemic stroke##6##3##(1992-2#2)(1997-5#1)(1997-8#1)(2008-8#1)(2009-11#1)
acute ischaemic##8##2##(1992-2#2)(1997-5#1)(1997-8#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
acute ischemic stroke and##2##4##(2007-10#1)(2008-10#1)
acute ischemic stroke patients##2##4##(2007-10#1)(2012-12#1)
acute ischemic stroke##42##3##(2006-7#3)(2007-10#28)(2008-10#1)(2008-8#3)(2009-11#2)(2009-6#1)(2012-12#4)
acute ischemic##45##2##(2006-7#3)(2007-10#30)(2008-10#1)(2008-8#3)(2009-11#2)(2009-6#1)(2011-2#1)(2012-12#4)
acute kidney injury and##2##4##(2008-8#1)(2013-1#1)
acute kidney injury##5##3##(2008-8#1)(2010-5#1)(2013-1#1)(2013-8#2)
acute kidney##7##2##(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
acute left##2##2##(2007-10#1)(2012-12#1)
acute lethality##3##2##(1997-3#1)(2008-7#2)
acute leukaemia##5##2##(1995-2#1)(2008-5#2)(2009-4#1)(2011-2#1)
acute leukaemias##2##2##(1995-11#1)(2011-2#1)
acute leukemia and##4##3##(1991-9#1)(1997-7#1)(2008-7#1)(2013-8#1)
acute leukemia patients##2##3##(2007-2#1)(2011-2#1)
acute leukemia##22##2##(1991-2#1)(1991-9#1)(1994-8#2)(1997-7#2)(2007-2#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
acute leukemia]##2##2##(2011-2#1)(2012-3#1)
acute liver failure##5##3##(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
acute liver##7##2##(1992-12#1)(1992-6#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
acute locoregional toxicity in patients with breast cancer##2##8##(2013-1#2)
acute low##2##2##(2008-8#1)(2012-2#1)
acute lower##2##2##(2008-7#1)(2013-8#1)
acute lung injury##6##3##(1991-9#1)(1993-10#1)(2008-12#1)(2010-10#1)(2010-8#1)(2012-2#1)
acute lung##7##2##(1991-9#1)(1993-10#1)(2008-12#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
acute lymphoblastic leukaemia (ALL)##3##4##(2008-12#1)(2010-11#1)(2011-2#1)
acute lymphoblastic leukaemia##10##3##(1996-6#1)(2008-12#4)(2008-7#2)(2010-11#2)(2011-2#1)
acute lymphoblastic leukemia (ALL)##5##4##(1991-2#1)(2010-6#1)(2011-1#1)(2011-2#2)
acute lymphoblastic leukemia and##2##4##(2011-2#1)(2012-12#1)
acute lymphoblastic leukemia in##2##4##(2011-1#1)(2011-2#1)
acute lymphoblastic leukemia##21##3##(1991-2#2)(2008-10#2)(2008-11#4)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#3)
acute lymphoblastic leukemia]##2##3##(2011-2#2)
acute lymphoblastic##35##2##(1991-2#2)(1996-6#1)(2008-10#2)(2008-11#4)(2008-12#5)(2008-7#2)(2008-9#1)(2009-4#1)(2010-11#2)(2010-6#1)(2011-1#2)(2011-2#8)(2012-12#3)(2013-7#1)
acute lymphocytic leukemia##2##3##(1991-8#1)(1994-8#1)
acute mania##2##2##(1995-5#1)(2013-8#1)
acute medical admissions##2##3##(2010-12#2)
acute medical##8##2##(1990-5#1)(1991-6#1)(2008-3#1)(2010-12#2)(2010-5#1)(2010-7#2)
acute megakaryoblastic leukaemia##2##3##(2008-12#1)(2009-12#1)
acute mental##2##2##(2009-3#1)(2013-1#1)
acute monoblastic leukemia 5##2##4##(2011-2#2)
acute monoblastic leukemia##3##3##(2011-2#3)
acute monoblastic##4##2##(2011-2#4)
acute monocytic leukemia##3##3##(1991-4#2)(1993-6#1)
acute monocytic##4##2##(1991-4#2)(1993-6#1)(1997-1#1)
acute mountain sickness and high altitude pulmonary edema##3##8##(1992-2#3)
acute myeloblastic leukemia##2##3##(1997-5#1)(2007-10#1)
acute myelocytic leukemia (AML)##2##4##(1992-10#1)(2011-2#1)
acute myelocytic leukemia##8##3##(1991-2#2)(1992-10#1)(2008-7#2)(2011-2#3)
acute myelocytic##9##2##(1991-2#2)(1992-10#1)(2008-7#2)(2011-2#4)
acute myelogenous leukaemia##2##3##(2006-6#2)
acute myelogenous leukemia (AML)##2##4##(2008-4#1)(2010-4#1)
acute myelogenous leukemia and##2##4##(1994-12#1)(2008-7#1)
acute myelogenous leukemia##7##3##(1994-12#2)(1997-4#1)(2008-4#1)(2008-7#1)(2010-4#2)
acute myelogenous##9##2##(1994-12#2)(1997-4#1)(2006-6#2)(2008-4#1)(2008-7#1)(2010-4#2)
acute myeloid leukaemia is##2##4##(2011-3#1)(2013-8#1)
acute myeloid leukaemia##7##3##(2008-5#1)(2009-3#2)(2011-2#1)(2011-3#1)(2013-8#2)
acute myeloid leukemia (AML)##6##4##(2007-10#1)(2010-1#1)(2011-2#2)(2012-12#2)
acute myeloid leukemia in a##2##5##(1990-8#2)
acute myeloid leukemia in##3##4##(1990-8#2)(2011-1#1)
acute myeloid leukemia or##2##4##(2010-11#1)(2011-2#1)
acute myeloid leukemia##26##3##(1990-8#2)(1994-5#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-1#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#1)
acute myeloid##35##2##(1990-8#2)(1994-5#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-3#2)(2010-1#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
acute myocardial infarct##4##3##(1990-12#1)(1990-9#1)(1991-6#1)(1992-5#1)
acute myocardial infarction (AMI) and##2##5##(2008-5#1)(2010-12#1)
acute myocardial infarction (AMI)##13##4##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(2006-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-6#1)(2010-11#1)(2010-12#1)
acute myocardial infarction (MI)##2##4##(2008-3#1)(2010-10#1)
acute myocardial infarction and acute coronary##2##6##(2008-3#1)(2011-2#1)
acute myocardial infarction and##7##4##(1995-12#1)(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
acute myocardial infarction has been##2##5##(1990-12#1)(2008-3#1)
acute myocardial infarction in two##2##5##(2006-8#1)(2008-1#1)
acute myocardial infarction in##12##4##(1991-9#1)(1994-11#1)(1997-8#3)(2006-8#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
acute myocardial infarction is##2##4##(1991-9#1)(2011-1#1)
acute myocardial infarction with##4##4##(1990-9#1)(1997-3#1)(2010-5#1)(2011-2#1)
acute myocardial infarction##100##3##(1990-12#2)(1990-3#1)(1990-9#4)(1991-9#5)(1992-3#2)(1992-6#1)(1992-9#2)(1993-12#4)(1994-11#1)(1994-12#1)(1995-12#4)(1995-2#1)(1995-8#2)(1997-2#2)(1997-3#4)(1997-8#4)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#16)(2008-5#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#8)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)
acute myocardial infarction]##4##3##(1990-12#1)(1994-6#1)(2008-10#1)(2013-1#1)
acute myocardial ischemia##4##3##(1997-2#1)(2009-4#1)(2009-5#1)(2010-8#1)
acute myocardial##120##2##(1990-12#4)(1990-3#1)(1990-9#5)(1991-3#1)(1991-6#1)(1991-9#5)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#4)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-8#2)(1996-9#1)(1997-2#3)(1997-3#5)(1997-8#4)(2006-8#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#17)(2008-5#2)(2009-11#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#8)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#5)
acute necrosis##2##2##(1996-11#1)(2008-5#1)
acute necrotizing##3##2##(2010-2#1)(2012-3#2)
acute non-lymphoid leukemia##2##3##(1991-2#1)(1992-12#1)
acute occlusion of##2##3##(2008-10#1)(2008-12#1)
acute onset of severe##2##4##(2006-10#1)(2012-2#1)
acute onset of##10##3##(1997-3#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
acute onset##16##2##(1997-3#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
acute optic neuritis##2##3##(1992-3#1)(2011-1#1)
acute or chronic##13##3##(1991-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
acute or subacute##2##3##(1990-6#1)(1993-12#1)
acute or##18##2##(1990-6#1)(1991-3#1)(1992-9#1)(1993-12#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
acute otitis media##3##3##(2007-10#1)(2008-11#1)(2013-8#1)
acute pain was diagnosed more often##2##6##(2013-1#2)
acute pain##8##2##(2008-4#1)(2008-7#1)(2013-1#6)
acute pancreatitis and the##2##4##(2008-3#1)(2013-1#1)
acute pancreatitis and##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
acute pancreatitis following##2##3##(1992-4#1)(2013-1#1)
acute pancreatitis##42##2##(1990-3#2)(1992-4#1)(1997-8#1)(2008-3#1)(2008-5#3)(2009-7#1)(2009-8#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#19)(2013-8#5)
acute patellar tendinopathy after##2##4##(2013-1#2)
acute patients##2##2##(2008-10#1)(2008-11#1)
acute pelvic inflammatory disease##2##4##(2007-7#2)
acute phase protein##3##3##(1992-12#1)(1994-6#1)(1997-3#1)
acute phase response##5##3##(1992-12#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-12#1)
acute phase##33##2##(1991-11#2)(1992-12#3)(1992-9#1)(1993-12#3)(1993-3#2)(1994-6#2)(1995-12#1)(1997-3#2)(1997-5#6)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
acute poisoning##2##2##(2012-2#1)(2013-1#1)
acute promyelocytic leukemia (APL)##3##4##(1991-9#1)(2007-4#1)(2008-8#1)
acute promyelocytic leukemia##6##3##(1991-9#2)(2007-12#1)(2007-4#2)(2008-8#1)
acute psychiatric##2##2##(1992-2#1)(2013-1#1)
acute psychosis##3##2##(1995-11#2)(2011-2#1)
acute pulmonary edema##2##3##(2009-1#1)(2011-2#1)
acute pulmonary embolism##6##3##(2007-10#1)(2010-10#1)(2011-2#4)
acute pulmonary thromboembolism##2##3##(2010-6#2)
acute pulmonary##15##2##(1991-11#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#1)(2009-1#1)(2010-10#1)(2010-6#2)(2011-2#5)(2012-2#1)
acute pyelonephritis##5##2##(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
acute radiation-induced##2##2##(1991-3#1)(2008-7#1)
acute reactions##2##2##(1992-10#2)
acute rectal##2##2##(2008-7#2)
acute regulation of##2##3##(1994-12#1)(2008-4#1)
acute rejection and##2##3##(2008-3#1)(2011-3#1)
acute rejection episodes##2##3##(2007-7#2)
acute rejection in##2##3##(2007-7#1)(2008-1#1)
acute rejection##17##2##(1991-11#1)(1993-2#2)(2007-7#4)(2008-1#3)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
acute renal failure (ARF) in##2##5##(2008-4#2)
acute renal failure (ARF)##7##4##(2008-1#2)(2008-4#4)(2012-3#1)
acute renal failure at##2##4##(2007-7#1)(2011-2#1)
acute renal failure in critically ill patients##2##7##(2007-8#1)(2008-3#1)
acute renal failure in the##2##5##(2008-1#1)(2008-4#1)
acute renal failure in##8##4##(2007-8#1)(2008-1#4)(2008-3#1)(2008-4#2)
acute renal failure##38##3##(1990-9#1)(1992-9#1)(2007-7#2)(2007-8#2)(2008-1#11)(2008-11#1)(2008-3#1)(2008-4#11)(2008-8#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
acute renal##42##2##(1990-9#1)(1992-9#1)(1995-12#1)(2007-7#2)(2007-8#2)(2008-1#11)(2008-11#1)(2008-3#1)(2008-4#11)(2008-8#2)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
acute respiratory distress syndrome##4##4##(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
acute respiratory distress##7##3##(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
acute respiratory failure##4##3##(1992-2#1)(1993-10#1)(2007-8#1)(2009-7#1)
acute respiratory illness##2##3##(2008-10#1)(2012-12#1)
acute respiratory infection##2##3##(1993-5#1)(2008-1#1)
acute respiratory infections in##4##4##(2010-4#1)(2013-1#1)(2013-8#2)
acute respiratory infections##6##3##(1990-12#1)(1991-12#1)(2010-4#1)(2013-1#1)(2013-8#2)
acute respiratory syndrome (SARS)##4##4##(2007-7#2)(2008-10#1)(2010-2#1)
acute respiratory syndrome##8##3##(2007-12#2)(2007-7#3)(2008-10#1)(2009-5#1)(2010-2#1)
acute respiratory##34##2##(1990-12#1)(1991-12#1)(1992-2#1)(1993-10#1)(1993-5#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#3)
acute response##3##2##(1995-12#1)(2008-8#1)(2009-5#1)
acute restraint stress##2##3##(1994-2#2)
acute restraint##3##2##(1994-2#2)(1995-12#1)
acute right##2##2##(2007-8#1)(2013-1#1)
acute severe##4##2##(2007-8#1)(2009-3#1)(2009-5#1)(2010-12#1)
acute side effects##2##3##(1996-3#1)(2008-6#1)
acute sinusitis in##2##3##(2011-1#2)
acute sinusitis##6##2##(1991-6#1)(1993-2#1)(2011-1#3)(2011-2#1)
acute soft tissue##2##3##(1994-2#1)(2007-11#1)
acute stage of##7##3##(1990-9#1)(1992-2#1)(1995-5#2)(1997-6#1)(2008-12#1)(2008-7#1)
acute stage##13##2##(1990-12#1)(1990-9#1)(1992-2#1)(1995-5#3)(1997-3#1)(1997-6#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-11#1)
acute stimulation##2##2##(1997-6#1)(2011-2#1)
acute stress##8##2##(1995-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
acute stroke and their##2##4##(2007-10#2)
acute stroke and##4##3##(2007-10#3)(2008-8#1)
acute stroke care##2##3##(2008-8#1)(2013-8#1)
acute stroke in##2##3##(2007-10#2)
acute stroke is##2##3##(2007-10#2)
acute stroke therapy##2##3##(2007-10#1)(2007-9#1)
acute stroke##50##2##(1994-6#1)(1995-5#1)(1996-3#1)(2007-10#25)(2007-9#5)(2008-7#1)(2008-8#10)(2009-11#3)(2011-1#2)(2013-8#1)
acute studies##3##2##(1995-12#3)
acute symptoms##2##2##(1991-6#1)(2008-3#1)
acute systemic##2##2##(2010-3#1)(2011-2#1)
acute thrombosis in##2##3##(2006-6#2)
acute thrombosis##4##2##(2006-6#2)(2011-2#2)
acute tinnitus##2##2##(1995-6#2)
acute tolerance##2##2##(1991-1#1)(1995-5#1)
acute toxicities##2##2##(2008-10#1)(2008-6#1)
acute toxicity of##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
acute toxicity tests##2##3##(2008-10#2)
acute toxicity was##2##3##(2008-12#1)(2008-7#1)
acute toxicity##17##2##(1992-11#1)(1992-6#1)(1994-12#1)(1996-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)(2013-1#1)(2013-7#1)
acute treatment##5##2##(1992-11#1)(1994-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
acute tubular necrosis and interstitial nephritis##2##6##(2012-12#2)
acute tubular necrosis and##3##4##(2012-12#3)
acute tubular necrosis##6##3##(1996-12#1)(2008-1#1)(2008-4#1)(2012-12#3)
acute tubular##7##2##(1996-12#1)(2008-1#2)(2008-4#1)(2012-12#3)
acute uncomplicated##2##2##(2011-2#2)
acute unilateral##2##2##(1994-9#1)(2011-1#1)
acute viral hepatitis##7##3##(2007-12#1)(2007-7#4)(2008-7#1)(2010-4#1)
acute viral##9##2##(1995-2#1)(2007-12#1)(2007-7#4)(2008-7#1)(2010-4#1)(2011-2#1)
acute visual##2##2##(2007-10#1)(2012-3#1)
acute##1849##1##(1990-11#1)(1990-12#9)(1990-2#4)(1990-3#6)(1990-5#7)(1990-6#11)(1990-8#2)(1990-9#14)(1991-1#6)(1991-10#1)(1991-11#8)(1991-12#6)(1991-2#8)(1991-3#6)(1991-4#2)(1991-5#1)(1991-6#8)(1991-8#8)(1991-9#15)(1992-1#3)(1992-10#4)(1992-11#2)(1992-12#9)(1992-2#11)(1992-3#15)(1992-4#1)(1992-5#1)(1992-6#9)(1992-8#3)(1992-9#8)(1993-10#2)(1993-11#1)(1993-12#17)(1993-2#5)(1993-3#4)(1993-5#5)(1993-6#7)(1993-8#4)(1993-9#3)(1994-11#12)(1994-12#9)(1994-2#11)(1994-3#10)(1994-5#4)(1994-6#12)(1994-8#8)(1994-9#5)(1995-11#11)(1995-12#28)(1995-2#6)(1995-3#10)(1995-5#11)(1995-6#3)(1995-8#3)(1996-1#5)(1996-11#3)(1996-12#4)(1996-2#9)(1996-3#10)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#8)(1997-1#7)(1997-2#8)(1997-3#20)(1997-4#2)(1997-5#12)(1997-6#2)(1997-7#3)(1997-8#20)(2006-10#3)(2006-12#4)(2006-6#5)(2006-7#4)(2006-8#2)(2007-10#78)(2007-11#16)(2007-12#18)(2007-2#8)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#33)(2007-8#24)(2007-9#9)(2008-1#34)(2008-10#62)(2008-11#46)(2008-12#26)(2008-2#4)(2008-3#109)(2008-4#30)(2008-5#32)(2008-6#8)(2008-7#81)(2008-8#39)(2008-9#20)(2009-1#5)(2009-10#11)(2009-11#12)(2009-12#5)(2009-2#1)(2009-3#8)(2009-4#6)(2009-5#14)(2009-6#4)(2009-7#6)(2009-8#9)(2009-9#3)(2010-1#6)(2010-10#14)(2010-11#9)(2010-12#20)(2010-2#9)(2010-3#9)(2010-4#13)(2010-5#7)(2010-6#8)(2010-7#2)(2010-8#12)(2010-9#1)(2011-1#38)(2011-2#153)(2011-3#2)(2012-1#8)(2012-12#34)(2012-2#34)(2012-3#28)(2012-5#1)(2013-1#100)(2013-7#7)(2013-8#47)
acute- and##2##2##(1993-12#1)(1996-1#1)
acute-care hospitals##2##2##(1993-12#1)(2008-11#1)
acute-care##4##1##(1993-12#1)(1995-3#1)(2007-8#1)(2008-11#1)
acute-phase reaction##2##2##(1993-8#1)(1995-11#1)
acute-phase response##3##2##(1990-2#2)(1992-12#1)
acute-phase##6##1##(1990-2#2)(1992-12#1)(1993-8#1)(1995-11#1)(2012-3#1)
acute-stroke##2##1##(2008-8#2)
acutely and##3##2##(1990-3#1)(1992-8#1)(2008-7#1)
acutely compensated##4##2##(1991-2#4)
acutely dissociated##2##2##(1995-5#1)(2010-12#1)
acutely ill patients##2##3##(1995-2#1)(2007-10#1)
acutely ill##8##2##(1992-4#1)(1994-12#1)(1995-2#1)(1997-6#1)(2007-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
acutely lethal##4##2##(1995-2#1)(1997-3#3)
acutely or chronically##3##3##(1992-9#1)(1994-12#1)(1996-12#1)
acutely or##4##2##(1992-9#1)(1994-12#1)(1996-12#1)(2008-10#1)
acutely suppressed##2##2##(1995-12#1)(2013-8#1)
acutely toxic##2##2##(1993-3#1)(2008-7#1)
acutely##52##1##(1990-3#1)(1991-2#4)(1991-5#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-3#3)(1997-6#2)(2007-10#2)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#4)(2013-1#1)(2013-8#1)
acyclic and cyclic##2##3##(1995-3#1)(1996-5#1)
acyclic carbonyl##2##2##(1990-9#2)
acyclic polyether##2##2##(2008-10#2)
acyclic polyethers with lipophilic amide##2##5##(2008-10#2)
acyclic##14##1##(1990-9#3)(1994-8#1)(1995-3#1)(1996-5#3)(2008-10#5)(2008-11#1)
acyclovir triphosphate##4##2##(1995-2#4)
acyclovir##17##1##(1991-12#1)(1994-3#1)(1994-8#1)(1995-2#4)(1995-6#5)(1996-6#1)(2007-7#1)(2011-2#1)(2012-2#2)
acyl carrier protein##3##3##(1992-4#2)(1994-12#1)
acyl chain length##6##3##(1990-7#1)(1993-8#2)(1994-5#3)
acyl chain of##2##3##(1993-8#1)(1994-3#1)
acyl chain region##2##3##(1994-3#2)
acyl chain##20##2##(1990-7#4)(1992-6#2)(1993-11#1)(1993-8#4)(1994-3#5)(1994-5#3)(1997-2#1)
acyl chains of##2##3##(2008-10#1)(2008-11#1)
acyl chains##10##2##(1990-7#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#3)(2013-1#1)
acyl chlorides in the presence of pyridine##2##7##(1996-2#1)(2007-11#1)
acyl donor##4##2##(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
acyl groups##2##2##(1995-6#1)(1997-2#1)
acyl transfer from##2##3##(1991-12#1)(1992-8#1)
acyl transfer##3##2##(1991-12#1)(1992-8#1)(2008-10#1)
acyl transferase##2##2##(1993-6#1)(2013-1#1)
acyl##64##1##(1990-12#2)(1990-5#1)(1990-7#5)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#4)(1994-12#1)(1994-3#5)(1994-5#3)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#4)(2007-11#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
acyl-##2##1##(1990-2#1)(2008-3#1)
acyl-ACP##3##1##(1995-6#3)
acyl-CoA dehydrogenase (MCAD)##3##3##(1990-8#1)(1991-8#1)(1995-5#1)
acyl-CoA dehydrogenase##7##2##(1990-8#2)(1991-8#2)(1993-3#1)(1995-5#2)
acyl-CoA esters##4##2##(1994-8#4)
acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate##2##7##(1990-5#2)
acyl-CoA##23##1##(1990-5#3)(1990-8#2)(1991-8#2)(1993-3#2)(1994-8#9)(1995-3#1)(1995-5#3)(1996-5#1)
acyl-CoA-binding protein##2##2##(1994-8#2)
acyl-CoAs##4##1##(1990-5#1)(1992-8#2)(1994-8#1)
acyl-L-carnitine##2##1##(1992-8#2)
acyl-acyl carrier##2##2##(1995-6#2)
acyl-coenzyme A binding protein##3##4##(1995-5#3)
acyl-coenzyme A oxidase##3##3##(1990-5#1)(1994-6#2)
acyl-coenzyme A##6##2##(1990-5#1)(1994-6#2)(1995-5#3)
acyl-enzyme##3##1##(1990-8#2)(2008-7#1)
acyl-homoserine##2##1##(2008-9#2)
acylase##7##1##(1990-11#2)(1992-11#2)(2008-8#2)(2008-9#1)
acylated on nitrogen##4##3##(1995-3#3)(1996-5#1)
acylated sucroses##2##2##(1992-11#1)(1995-3#1)
acylated##13##1##(1992-11#1)(1992-3#1)(1993-6#2)(1994-8#1)(1995-3#4)(1996-5#2)(2008-12#1)(2008-3#1)
acylation and##2##2##(2008-3#1)(2008-4#1)
acylation of the##2##3##(1993-8#1)(2007-11#1)
acylation of##8##2##(1990-5#2)(1993-8#1)(1995-6#1)(2007-11#1)(2008-7#2)(2009-2#1)
acylation with##2##2##(1990-12#1)(2008-3#1)
acylation##28##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#6)(1993-8#1)(1994-8#1)(1995-3#1)(1995-6#3)(1997-4#1)(2007-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2009-2#2)
acylcarnitines##2##1##(1991-12#1)(2012-2#1)
acylcoenzyme A##2##2##(1994-8#2)
acylhydrazones##2##1##(2013-1#2)
acyltransferase##21##1##(1990-5#3)(1991-12#1)(1991-2#4)(1993-6#2)(1993-8#2)(1994-8#3)(1995-3#2)(1995-5#1)(1995-6#1)(1997-2#1)(2012-12#1)
ad hoc##14##2##(1991-12#1)(1992-12#2)(1992-3#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#3)(2009-11#1)(2011-9#1)(2012-12#1)
ad lib##2##2##(1993-8#1)(2008-9#1)
ad libitum##13##2##(1991-12#1)(1992-3#1)(1994-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
ad##37##1##(1990-5#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-3#2)(1993-12#1)(1993-8#1)(1994-7#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#4)(2008-9#1)(2009-11#1)(2010-4#1)(2011-9#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
adFNDI##3##1##(2008-4#3)
ada##4##1##(1991-9#3)(1992-8#1)
adalimumab 160/80mg##2##2##(2012-2#2)
adalimumab 40mg every other week##2##5##(2012-2#2)
adalimumab 80/40mg##2##2##(2012-2#2)
adalimumab and##2##2##(2012-2#2)
adalimumab##16##1##(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#11)
adamantinoma of the calcaneum##2##4##(2010-3#2)
adamantinoma of##3##2##(2010-11#1)(2010-3#2)
adamantinoma##7##1##(2008-6#1)(2010-11#4)(2010-3#2)
adanine dinucleotide##2##2##(2008-10#2)
adapt a##4##2##(2007-11#1)(2008-4#1)(2008-5#2)
adapt the method for##2##4##(1997-3#1)(2008-10#1)
adapt the##13##2##(1993-12#1)(1994-12#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
adapt their##4##2##(2008-11#2)(2011-1#1)(2012-3#1)
adapt them to##2##3##(2008-3#1)(2009-6#1)
adapt themselves to##3##3##(2008-1#1)(2009-7#1)(2013-1#1)
adapt to changing##2##3##(1991-1#1)(2009-6#1)
adapt to new##3##3##(1995-3#1)(2008-10#1)(2010-4#1)
adapt to the local##2##4##(2008-6#1)(2012-12#1)
adapt to the##8##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2012-12#1)(2012-2#1)(2012-6#1)
adapt to##35##2##(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
adapt##80##1##(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#4)
adaptability and##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
adaptability of##3##2##(2007-12#1)(2008-3#2)
adaptability to##2##2##(1994-12#1)(2009-5#1)
adaptability##12##1##(1994-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-7#1)
adaptable algorithm##2##2##(2008-9#1)(2010-4#1)
adaptable to##8##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)(2010-8#1)
adaptable##16##1##(1992-12#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-4#2)(2010-5#1)(2010-8#1)
adaptation and speciation##2##3##(1996-6#1)(2008-8#1)
adaptation and the##2##3##(2008-8#1)(2010-3#1)
adaptation and##18##2##(1994-2#1)(1996-6#1)(2008-10#5)(2008-8#3)(2008-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#3)
adaptation are##4##2##(1991-12#1)(1991-4#1)(1992-3#1)(1996-2#1)
adaptation difficulties##2##2##(2012-2#2)
adaptation for##3##2##(1990-8#1)(1993-9#1)(2008-8#1)
adaptation in response to##2##4##(2009-7#1)(2009-9#1)
adaptation in the##5##3##(1995-5#1)(2007-12#2)(2008-5#1)(2008-9#1)
adaptation in##19##2##(1992-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
adaptation into##2##2##(2013-1#2)
adaptation is##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
adaptation may##2##2##(2008-11#1)(2009-8#1)
adaptation mechanisms##3##2##(2008-5#2)(2012-3#1)
adaptation occurred##3##2##(1997-7#1)(2008-5#1)(2008-8#1)
adaptation of a##4##3##(1990-12#1)(1990-5#1)(2008-4#1)(2008-9#1)
adaptation of existing##2##3##(2008-10#1)(2009-6#1)
adaptation of the method##2##4##(2008-10#1)(2008-2#1)
adaptation of the##25##3##(1991-5#1)(1992-2#1)(1992-5#1)(1993-5#1)(1996-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
adaptation of this##2##3##(2008-4#1)(2008-9#1)
adaptation of##60##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-2#2)(1992-5#1)(1993-5#2)(1994-8#2)(1995-6#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#1)(2009-6#1)(2010-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
adaptation procedure##3##2##(2008-11#3)
adaptation process##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
adaptation programmes##2##2##(2008-11#2)
adaptation rate##3##2##(2007-11#1)(2008-3#2)
adaptation should##2##2##(2008-10#1)(2008-8#1)
adaptation to a##6##3##(1990-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-6#1)
adaptation to climate change and variability##2##6##(2008-8#2)
adaptation to different##5##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-7#1)
adaptation to hypoxia##2##3##(2012-2#1)(2013-1#1)
adaptation to increased##2##3##(1994-8#1)(2009-1#1)
adaptation to ischemia##3##3##(1996-9#2)(2008-10#1)
adaptation to low temperature##2##4##(2011-1#2)
adaptation to stress##3##3##(2008-10#1)(2012-3#2)
adaptation to the##8##3##(1991-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
adaptation to their##2##3##(2009-6#1)(2011-2#1)
adaptation to##64##2##(1990-2#1)(1991-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-9#2)(1997-6#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#3)(2012-6#1)(2012-7#2)(2013-1#2)(2013-7#1)(2013-8#2)
adaptation were##2##2##(1996-2#1)(2010-9#1)
adaptation##288##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#4)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#4)(1996-6#2)(1996-9#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#26)(2008-11#23)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#21)(2008-9#10)(2009-1#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#9)(2012-6#1)(2012-7#4)(2013-1#22)(2013-7#2)(2013-8#6)
adaptationist##2##1##(2008-8#2)
adaptations in muscle##2##3##(2012-3#2)
adaptations in##12##2##(1991-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-8#2)
adaptations may##2##2##(2009-8#2)
adaptations of the##2##3##(2008-4#2)
adaptations of##9##2##(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2013-1#1)
adaptations that occur during##2##4##(2008-4#1)(2013-8#1)
adaptations that##3##2##(2008-4#1)(2010-5#1)(2013-8#1)
adaptations to the##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
adaptations to##15##2##(1992-1#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
adaptations##74##1##(1991-3#1)(1992-1#1)(1993-5#2)(1995-8#1)(1996-9#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-12#2)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#3)(2013-8#4)
adaptative##3##1##(1991-12#1)(2009-4#1)(2012-3#1)
adapted and non-adapted##2##3##(2008-11#2)
adapted and##3##2##(2008-11#3)
adapted by##2##2##(1992-1#1)(2008-6#1)
adapted cells##3##2##(2008-10#1)(2008-11#2)
adapted for the detection of##2##5##(1990-12#1)(2008-10#1)
adapted for the##4##3##(1990-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
adapted for use in a##2##5##(1990-2#1)(2007-8#1)
adapted for use in##5##4##(1990-2#1)(2007-8#1)(2008-2#1)(2010-11#1)(2012-12#1)
adapted for use with##2##4##(2008-1#1)(2008-4#1)
adapted for use##7##3##(1990-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-11#1)(2012-12#1)
adapted for##24##2##(1990-12#1)(1990-2#1)(1994-12#1)(1994-3#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-4#3)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
adapted from the##2##3##(1994-2#1)(2008-3#1)
adapted from##9##2##(1994-2#1)(1996-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
adapted method##2##2##(2008-10#1)(2010-2#1)
adapted protection##2##2##(2008-7#2)
adapted strain was##2##3##(2013-8#2)
adapted strain##4##2##(2013-8#4)
adapted the##3##2##(1994-2#1)(2007-12#1)(2012-1#1)
adapted to a centrifugal##2##4##(1993-8#1)(1995-12#1)
adapted to a##10##3##(1993-8#1)(1995-12#1)(1997-6#1)(2008-10#4)(2008-9#1)(2009-4#1)(2010-12#1)
adapted to any##2##3##(1993-2#1)(2008-10#1)
adapted to bread wheat##2##4##(2008-10#2)
adapted to different##3##3##(1991-5#1)(2007-11#1)(2011-2#1)
adapted to grow##2##3##(2008-11#2)
adapted to high##2##3##(2008-12#2)
adapted to other##2##3##(1996-1#1)(2008-6#1)
adapted to provide##2##3##(2008-2#1)(2012-12#1)
adapted to serum##2##3##(2008-11#1)(2008-4#1)
adapted to study the##2##4##(2008-5#1)(2008-9#1)
adapted to the##28##3##(1995-1#1)(1995-11#1)(1997-6#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#2)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
adapted to various##2##3##(2008-10#1)(2008-3#1)
adapted to##134##2##(1990-5#1)(1991-1#1)(1991-5#2)(1993-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-8#1)(1997-4#1)(1997-6#4)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#15)(2008-12#6)(2008-2#4)(2008-3#11)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#8)(2009-10#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2012-6#1)(2013-1#3)(2013-8#1)
adapted##236##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#2)(1992-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#5)(1997-7#1)(2007-11#2)(2007-12#6)(2007-8#2)(2008-1#4)(2008-10#34)(2008-11#27)(2008-12#9)(2008-2#7)(2008-3#14)(2008-4#11)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#10)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#7)(2012-6#1)(2013-1#7)(2013-8#6)
adapter protein##2##2##(2008-6#1)(2009-7#1)
adapter proteins##2##2##(2011-2#1)(2012-12#1)
adapter##8##1##(1995-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
adapting a##2##2##(2008-10#1)(2008-2#1)
adapting the##4##2##(1995-12#1)(1997-2#1)(2008-11#1)(2008-3#1)
adapting to the##2##3##(1992-2#1)(2007-12#1)
adapting to##5##2##(1992-2#1)(1993-12#1)(2007-12#1)(2009-8#1)(2010-7#1)
adapting##19##1##(1992-1#1)(1992-2#1)(1993-12#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-7#1)(2012-2#2)
adaption##2##1##(1995-11#1)(2013-8#1)
adaptive and##5##2##(1997-2#1)(2008-2#1)(2008-7#1)(2009-4#1)(2013-1#1)
adaptive behavior##4##2##(2008-2#1)(2008-6#1)(2008-8#2)
adaptive cellular##3##2##(2008-7#1)(2012-1#1)(2013-8#1)
adaptive changes in##2##3##(1990-12#1)(2009-7#1)
adaptive changes##7##2##(1990-12#1)(1993-6#1)(1996-2#1)(1996-9#1)(2008-4#1)(2009-7#1)(2013-1#1)
adaptive control##2##2##(2008-3#1)(2008-6#1)
adaptive controller##2##2##(1997-2#2)
adaptive deme formation##4##3##(2008-9#4)
adaptive development##3##2##(2011-1#3)
adaptive diversification##2##2##(2008-8#2)
adaptive evolution##8##2##(2008-8#4)(2011-1#2)(2013-1#2)
adaptive filter##3##2##(2008-3#2)(2010-8#1)
adaptive filtering##3##2##(2008-3#2)(2010-8#1)
adaptive functioning##2##2##(1996-1#1)(2010-7#1)
adaptive functions##2##2##(2009-8#2)
adaptive immune response by##2##4##(2008-4#1)(2013-1#1)
adaptive immune response##4##3##(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)
adaptive immune responses against##2##4##(2009-3#1)(2012-12#1)
adaptive immune responses##10##3##(1995-2#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#2)
adaptive immune##15##2##(1995-2#1)(2008-1#1)(2008-10#2)(2008-4#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
adaptive immunity and##2##3##(1996-12#1)(2010-5#1)
adaptive immunity##5##2##(1995-5#1)(1996-12#1)(2008-5#1)(2008-6#1)(2010-5#1)
adaptive interferometer##3##2##(2007-11#2)(2008-3#1)
adaptive maternal##2##2##(2008-8#2)
adaptive mechanism##3##2##(2009-8#1)(2011-1#1)(2012-12#1)
adaptive mechanisms##4##2##(1992-3#1)(1995-12#1)(2010-4#1)(2012-3#1)
adaptive mesh##2##2##(2008-3#1)(2008-6#1)
adaptive mutations##6##2##(2008-2#1)(2008-9#5)
adaptive optic##2##2##(2008-2#1)(2008-3#1)
adaptive optical##3##2##(2008-3#3)
adaptive optics (AO)##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
adaptive optics are discussed##2##4##(2007-12#1)(2008-2#1)
adaptive optics confocal scanning laser ophthalmoscope##2##6##(2011-1#2)
adaptive optics for##2##3##(2008-3#2)
adaptive optics in##2##3##(2007-11#1)(2007-12#1)
adaptive optics is##2##3##(2007-11#2)
adaptive optics system with##2##4##(2007-11#1)(2008-3#1)
adaptive optics system##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
adaptive optics systems##3##3##(2007-12#1)(2008-3#2)
adaptive optics that##2##3##(2007-12#2)
adaptive optics##38##2##(1990-8#1)(2007-11#6)(2007-12#10)(2008-2#5)(2008-3#13)(2011-1#3)
adaptive or maladaptive##2##3##(2009-11#1)(2012-12#1)
adaptive pattern##2##2##(2008-10#1)(2008-4#1)
adaptive phase##4##2##(2007-11#3)(2007-12#1)
adaptive plasticity##2##2##(2008-8#2)
adaptive potential##2##2##(1992-3#1)(2008-10#1)
adaptive processes##2##2##(2008-7#1)(2008-8#1)
adaptive radiation and##2##3##(1996-6#1)(2008-8#1)
adaptive radiation in##3##3##(2008-8#3)
adaptive radiation##11##2##(1996-4#1)(1996-6#1)(1997-4#2)(2008-8#5)(2008-9#1)(2010-3#1)
adaptive radiations##3##2##(2008-8#2)(2008-9#1)
adaptive response in##2##3##(2008-7#2)
adaptive response may be##2##4##(2008-7#2)
adaptive response of##2##3##(2008-5#1)(2013-1#1)
adaptive response##17##2##(1996-6#1)(2008-5#1)(2008-7#12)(2010-12#1)(2011-1#1)(2013-1#1)
adaptive responses and##2##3##(1996-6#1)(2008-7#1)
adaptive responses of##2##3##(1994-12#1)(1996-12#1)
adaptive responses to##2##3##(1994-2#1)(1996-12#1)
adaptive responses##16##2##(1994-12#1)(1994-2#1)(1996-12#2)(1996-6#1)(2006-10#2)(2008-7#7)(2011-2#1)(2013-8#1)
adaptive sequential sensing##2##3##(2008-6#2)
adaptive significance of##3##3##(1993-12#1)(1997-4#1)(2008-9#1)
adaptive system##2##2##(2007-11#1)(2008-1#1)
adaptive systems##2##2##(2008-1#1)(2008-3#1)
adaptive testing##3##2##(2010-2#3)
adaptive traits##2##2##(2008-8#1)(2008-9#1)
adaptive two-band algorithm##2##3##(2008-3#2)
adaptive value of floral integration##2##5##(2009-8#2)
adaptive value of##3##3##(2008-8#1)(2009-8#2)
adaptive value##4##2##(2008-8#1)(2009-8#3)
adaptive wave-front##3##2##(2007-11#2)(2008-3#1)
adaptive##341##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1992-3#4)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-6#4)(1996-9#3)(1997-2#4)(1997-3#1)(1997-4#3)(2006-10#2)(2007-11#20)(2007-12#19)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#51)(2008-4#4)(2008-5#2)(2008-6#10)(2008-7#27)(2008-8#30)(2008-9#20)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#12)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#7)(2013-1#12)(2013-8#8)
adaptive-optic##2##1##(2007-11#1)(2008-2#1)
adaptive-optics system##3##2##(2007-11#2)(2007-12#1)
adaptive-optics systems##2##2##(2007-12#1)(2008-2#1)
adaptive-optics##10##1##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#1)
adaptively important genes##2##3##(2008-8#2)
adaptively to##2##2##(2008-8#1)(2009-12#1)
adaptively##11##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#4)(2009-12#1)(2010-12#1)(2011-2#1)
adaptogenic##2##1##(1994-6#1)(2010-5#1)
adaptor protein##6##2##(1997-4#1)(1997-7#1)(2008-6#1)(2013-1#3)
adaptor proteins##4##2##(2012-12#4)
adaptor##17##1##(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-12#5)(2013-1#3)
adaptors and##2##2##(1995-11#1)(2013-1#1)
adaptors##5##1##(1995-11#1)(2008-2#1)(2012-12#2)(2013-1#1)
adapts to##2##2##(1994-12#1)(1996-12#1)
adapts##8##1##(1993-12#1)(1994-12#1)(1996-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2011-2#1)
adatoms##2##1##(2009-11#2)
adaxial surface##2##2##(2008-10#2)
adaxial##3##1##(2008-10#2)(2008-5#1)
add a##7##2##(1997-3#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)
add any##2##2##(2008-6#1)(2012-3#1)
add significantly to##2##3##(2008-9#1)(2012-2#1)
add the##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
add to previous##2##3##(2008-3#1)(2008-9#1)
add to the evidence##2##4##(1995-12#1)(2011-2#1)
add to the understanding of the##3##6##(1994-11#1)(2008-12#1)(2009-7#1)
add to the##12##3##(1993-9#1)(1994-11#1)(1995-12#1)(2007-7#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
add to##20##2##(1992-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-7#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-8#1)
add up##2##2##(1990-11#1)(1997-6#1)
add value to##2##3##(1990-4#1)(1997-1#1)
add##64##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
add-drop filter##3##2##(2008-2#3)
add-drop multiplexer based on a selective fused coupler##2##8##(2008-2#2)
add-drop multiplexer##3##2##(2008-2#2)(2008-3#1)
add-drop##14##1##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#7)
add-on devices##4##2##(1996-2#2)(1997-1#2)
add-on##9##1##(1994-12#1)(1996-2#2)(1997-1#2)(2008-10#1)(2008-7#1)(2009-10#1)(2013-8#1)
added 2##2##2##(1993-3#1)(1995-11#1)
added 6 h after LPS + IFN gamma##2##8##(1993-3#2)
added ATP##4##2##(1991-6#1)(2008-4#3)
added Mg2+##2##2##(1992-3#2)
added a##3##2##(2008-10#2)(2008-11#1)
added advantage##2##2##(2008-4#1)(2008-9#1)
added along with##2##3##(1993-3#1)(2008-10#1)
added amount##3##2##(2008-10#3)
added an##2##2##(1997-1#1)(2008-12#1)
added and the amount##2##4##(1990-12#1)(2008-10#1)
added and##11##2##(1990-12#1)(1995-2#2)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)
added as a##2##3##(1990-8#1)(1994-12#1)
added as an##3##3##(2008-10#2)(2010-2#1)
added as##13##2##(1990-5#1)(1990-8#1)(1994-12#2)(2008-10#4)(2008-11#2)(2008-8#1)(2009-6#1)(2010-2#1)
added at 1##2##3##(2008-10#2)
added at the##2##3##(1990-5#1)(2007-11#1)
added at##9##2##(1990-5#1)(1993-6#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)
added back to the##2##4##(1997-4#1)(2008-10#1)
added back##3##2##(1997-4#1)(2008-10#1)(2012-1#1)
added benefit##3##2##(2008-8#2)(2010-4#1)
added by##3##2##(2008-11#1)(2008-3#2)
added chelating agents##2##3##(2008-10#2)
added directly to##2##3##(1993-8#1)(2008-2#1)
added directly##3##2##(1993-8#1)(2008-10#1)(2008-2#1)
added during##2##2##(2008-10#2)
added extracellularly##2##2##(1993-6#1)(2008-6#1)
added flexibility in##2##3##(1995-6#1)(2008-11#1)
added flexibility##3##2##(1995-6#1)(2008-11#1)(2008-3#1)
added for##7##2##(1992-1#1)(1992-12#1)(1994-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
added in a##2##3##(1995-12#1)(2007-11#1)
added in the##9##3##(1997-8#1)(2007-11#2)(2008-10#3)(2008-5#1)(2012-12#1)(2013-1#1)
added in vitro##2##3##(1995-2#1)(2008-11#1)
added in##24##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-8#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-5#2)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)
added into the##6##3##(1993-6#1)(2008-10#4)(2011-1#1)
added into##9##2##(1993-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2011-1#1)
added only##2##2##(1991-12#1)(2008-2#1)
added or##2##2##(1996-3#1)(2008-10#1)
added phospholipid##2##2##(1990-5#2)
added risk##2##2##(1992-2#2)
added surfactant##2##2##(2008-10#2)
added to a##11##3##(1991-5#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-7#1)
added to an##3##3##(1997-2#1)(2008-10#2)
added to cultured##2##3##(1990-2#1)(1993-3#1)
added to each##2##3##(2008-10#2)
added to form##2##3##(2008-10#1)(2008-12#1)
added to plasma##2##3##(1990-12#1)(1994-2#1)
added to samples##3##3##(1990-2#1)(2008-10#2)
added to soil##7##3##(2008-10#7)
added to the culture medium##3##5##(1990-11#1)(2008-1#1)(2008-11#1)
added to the culture##6##4##(1990-11#1)(1990-2#1)(2008-1#1)(2008-11#3)
added to the enzyme##2##4##(1993-11#1)(2008-10#1)
added to the incubation medium##2##5##(1995-11#1)(2008-5#1)
added to the medium##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
added to the sample solution##3##5##(2008-10#3)
added to the sample##7##4##(2008-10#7)
added to the samples##5##4##(2008-10#5)
added to the soil##2##4##(2008-10#2)
added to the solution##7##4##(2007-11#1)(2008-10#6)
added to the upper##2##4##(1992-6#1)(2008-11#1)
added to the water##3##4##(2008-10#2)(2008-2#1)
added to the wine##2##4##(2008-10#2)
added to the##144##3##(1990-11#1)(1990-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#58)(2008-11#16)(2008-12#2)(2008-2#6)(2008-3#4)(2008-5#8)(2008-6#4)(2008-7#3)(2008-9#3)(2009-1#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
added to this##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
added to various##2##3##(1995-11#1)(2013-7#1)
added to##278##2##(1990-11#2)(1990-12#2)(1990-2#4)(1991-3#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#110)(2008-11#24)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#12)(2008-6#8)(2008-7#6)(2008-8#2)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
added together with##2##3##(2008-11#2)
added together##4##2##(2008-11#2)(2008-2#1)(2010-4#1)
added up to##2##3##(1992-10#1)(2008-9#1)
added value of##4##3##(1993-12#1)(1995-2#1)(2007-4#1)(2012-1#1)
added value##6##2##(1993-12#1)(1995-2#1)(1997-2#1)(2007-4#1)(2008-6#1)(2012-1#1)
added was##4##2##(2008-10#2)(2008-11#1)(2010-3#1)
added with##4##2##(1992-3#1)(1994-12#1)(2007-12#1)(2008-11#1)
added zinc##2##2##(1994-5#2)
added##638##1##(1990-10#1)(1990-11#8)(1990-12#6)(1990-2#4)(1990-3#1)(1990-5#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#9)(1992-6#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#7)(1993-6#7)(1993-8#4)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#3)(1995-11#4)(1995-12#2)(1995-2#7)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#3)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#4)(2007-10#2)(2007-11#10)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#200)(2008-11#47)(2008-12#10)(2008-2#17)(2008-3#25)(2008-4#6)(2008-5#16)(2008-6#16)(2008-7#11)(2008-8#10)(2008-9#12)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#5)(2010-3#3)(2010-4#6)(2010-5#1)(2010-8#1)(2011-1#9)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#3)
addendum we discuss##2##3##(2009-8#2)
addendum we##6##2##(2009-8#5)(2013-1#1)
addendum##14##1##(2008-2#1)(2008-8#1)(2009-8#10)(2011-2#1)(2013-1#1)
adders##2##1##(2008-2#1)(2010-8#1)
addict##4##1##(1990-9#1)(1991-12#1)(1994-3#1)(2012-2#1)
addicted to drugs##3##3##(2011-1#3)
addicted to##8##2##(1993-11#1)(2007-7#1)(2009-9#1)(2011-1#3)(2011-2#1)(2013-1#1)
addicted##14##1##(1993-11#1)(1996-5#1)(2007-7#2)(2008-6#1)(2009-9#1)(2011-1#5)(2011-2#2)(2013-1#1)
addiction and smoking##2##3##(2007-7#1)(2008-8#1)
addiction and##9##2##(1991-6#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
addiction are##2##2##(2008-12#1)(2008-6#1)
addiction as##2##2##(2008-6#1)(2011-2#1)
addiction in##5##2##(2008-6#1)(2009-6#1)(2011-1#2)(2012-3#1)
addiction is a##3##3##(2009-7#1)(2012-12#1)(2013-7#1)
addiction is##4##2##(2009-7#2)(2012-12#1)(2013-7#1)
addiction to##2##2##(2008-5#1)(2012-2#1)
addiction treatment##3##2##(2008-12#2)(2008-6#1)
addiction##74##1##(1991-1#3)(1991-6#1)(1993-12#1)(1993-3#1)(1996-11#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#6)(2008-4#4)(2008-5#2)(2008-6#10)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#6)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#5)
addiction)##2##1##(2008-4#1)(2010-11#1)
addiction?##2##1##(2009-7#1)(2011-2#1)
addictions and##2##2##(2008-6#1)(2009-10#1)
addictions##7##1##(1992-12#1)(1994-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2013-8#1)
addictive behaviors##2##2##(1993-6#1)(2013-1#1)
addictive component##2##2##(2008-11#1)(2013-1#1)
addictive##11##1##(1990-11#1)(1993-6#1)(1995-6#1)(2008-11#1)(2008-6#2)(2009-4#1)(2012-3#1)(2013-1#3)
addicts##26##1##(1990-9#1)(1991-1#4)(1991-12#4)(1991-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-11#1)(2007-2#1)(2007-7#4)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
addicts?##2##1##(2007-10#1)(2007-9#1)
adding 0##5##2##(2008-10#2)(2008-11#3)
adding 1##3##2##(1995-11#1)(2008-11#2)
adding 2##3##2##(1990-8#1)(1991-9#1)(1993-9#1)
adding HF##2##2##(2008-10#2)
adding Triton##2##2##(2008-10#2)
adding a trace amount of sodium sulfide##2##7##(2008-5#1)(2013-1#1)
adding a##19##2##(1991-1#1)(1992-3#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#3)(2008-9#1)(2010-12#1)(2013-1#1)
adding additional##2##2##(2008-7#1)(2012-3#1)
adding an##4##2##(2008-10#3)(2010-7#1)
adding any##2##2##(2008-10#2)
adding appropriate##2##2##(2008-10#2)
adding both##2##2##(2008-5#1)(2010-3#1)
adding calcium##2##2##(2008-10#1)(2009-12#1)
adding or##2##2##(2008-11#1)(2008-3#1)
adding oral##2##2##(2009-6#1)(2012-2#1)
adding the##18##2##(1990-12#1)(1994-3#1)(2008-10#8)(2008-11#4)(2008-6#1)(2008-8#2)(2010-4#1)
adding to the##2##3##(2008-10#1)(2008-11#1)
adding up to##3##3##(1990-3#1)(2010-4#1)(2012-2#1)
adding up##4##2##(1990-3#1)(2010-3#1)(2010-4#1)(2012-2#1)
adding water##2##2##(2008-10#1)(2008-2#1)
adding##188##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#4)(1994-12#2)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-3#3)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#66)(2008-11#19)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#3)(2009-6#2)(2010-12#1)(2010-3#2)(2010-4#3)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
addition and removal##2##3##(2008-11#1)(2008-2#1)
addition and##18##2##(1994-11#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)
addition as##3##2##(2008-10#2)(2010-5#1)
addition for##2##2##(2008-11#1)(2009-10#1)
addition in the##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
addition in##6##2##(1992-11#1)(2008-10#4)(2008-6#1)
addition into the##2##3##(2008-10#1)(2008-11#1)
addition is##3##2##(1995-2#1)(2008-10#2)
addition it##2##2##(2008-11#1)(2012-3#1)
addition line##8##2##(2008-10#4)(2008-8#4)
addition lines##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
addition method and##5##3##(2008-10#5)
addition method was##6##3##(2008-10#6)
addition method##60##2##(2008-10#60)
addition model##3##2##(1990-7#3)
addition of 0##6##3##(1997-7#1)(2008-10#4)(2010-3#1)
addition of 1##4##3##(1991-5#1)(1992-8#1)(1996-2#1)(2008-10#1)
addition of 10##2##3##(2008-10#1)(2008-11#1)
addition of 2##3##3##(1994-6#1)(1996-12#1)(2008-10#1)
addition of 20##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
addition of 200 muM SA##2##5##(2008-10#2)
addition of 5##2##3##(1990-7#1)(1991-2#1)
addition of ATP##4##3##(1992-12#1)(1995-2#1)(2008-4#1)(2008-8#1)
addition of BSA##2##3##(1995-12#1)(2008-10#1)
addition of DS salt##2##4##(2008-5#2)
addition of EUL##3##3##(2010-2#3)
addition of FAD##2##3##(2010-2#2)
addition of FeSO(4)##2##3##(2008-11#1)(2008-7#1)
addition of HGF##4##3##(2008-11#4)
addition of Mg(2+)##3##3##(2008-10#2)(2008-8#1)
addition of Mn2+##3##3##(1992-5#3)
addition of NaCl##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
addition of a mixture##2##4##(2008-10#2)
addition of a##43##3##(1990-7#1)(1993-1#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
addition of alkyl- and##2##4##(2009-10#2)
addition of an##11##3##(1992-8#1)(1992-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#2)(2011-2#1)
addition of both##2##3##(1992-3#1)(2009-8#1)
addition of calcium ionophore##2##4##(1993-6#1)(2008-10#1)
addition of calcium##3##3##(1992-3#1)(1993-6#1)(2008-10#1)
addition of chitin to##2##4##(2008-10#2)
addition of climbazole##2##3##(2008-5#2)
addition of cytochrome b(5) to##2##5##(2011-2#2)
addition of cytochrome b(5)##3##4##(2011-2#3)
addition of dexamethasone##2##3##(2008-11#2)
addition of different##4##3##(2008-10#2)(2008-6#1)(2011-2#1)
addition of either##4##3##(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)
addition of enzyme##2##3##(2008-10#2)
addition of excess##5##3##(1992-2#1)(1994-11#1)(1995-11#1)(2008-10#2)
addition of exogenous##4##3##(1995-2#1)(2008-11#1)(2012-3#2)
addition of fresh##3##3##(1992-11#1)(2011-2#2)
addition of glucose##3##3##(2008-10#2)(2008-7#1)
addition of glycerol##2##3##(2008-10#1)(2008-11#1)
addition of human##2##3##(1994-3#1)(1997-7#1)
addition of insulin##2##3##(1993-6#2)
addition of lamellulae between every##2##5##(2010-10#2)
addition of multiple coupled optical resonators##2##6##(2007-11#1)(2008-3#1)
addition of multiple##3##3##(2007-11#1)(2008-3#1)(2010-11#1)
addition of other##3##3##(2008-5#2)(2008-6#1)
addition of potassium##2##3##(2008-10#1)(2008-7#1)
addition of protein kinase C##2##5##(1990-8#1)(1992-8#1)
addition of proteins##3##3##(2008-10#3)
addition of salt##4##3##(2008-10#4)
addition of salts##2##3##(2008-10#1)(2009-8#1)
addition of several##2##3##(2008-10#1)(2008-11#1)
addition of six##2##3##(2008-6#1)(2010-11#1)
addition of small amount of##2##5##(2008-10#2)
addition of small amounts##2##4##(1994-2#1)(2008-10#1)
addition of small##5##3##(1994-2#1)(2008-10#4)
addition of sodium##7##3##(1991-8#1)(1994-9#1)(2008-10#4)(2011-2#1)
addition of sucrose##2##3##(1992-9#1)(2008-5#1)
addition of the enzyme##2##4##(1992-12#1)(2008-10#1)
addition of the##48##3##(1990-7#2)(1990-8#2)(1991-5#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#7)(2008-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#1)
addition of these##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
addition of thymidine to the medium##3##6##(1993-12#3)
addition of triethylamine##2##3##(2008-7#2)
addition of two##2##3##(2008-11#1)(2008-7#1)
addition of water##3##3##(2008-10#2)(2009-8#1)
addition of yeast##2##3##(2008-11#1)(2008-12#1)
addition of##644##2##(1990-11#3)(1990-12#2)(1990-2#5)(1990-5#2)(1990-7#4)(1990-8#7)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#5)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#5)(1992-6#2)(1992-8#10)(1992-9#5)(1993-1#1)(1993-11#6)(1993-12#5)(1993-3#3)(1993-6#8)(1993-8#6)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#8)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#5)(1996-2#6)(1996-5#6)(1996-6#1)(1996-7#2)(1997-1#4)(1997-2#3)(1997-4#1)(1997-7#6)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#174)(2008-11#53)(2008-12#3)(2008-2#6)(2008-3#18)(2008-4#11)(2008-5#22)(2008-6#7)(2008-7#13)(2008-8#14)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#5)(2010-4#11)(2011-1#7)(2011-2#17)(2011-3#1)(2012-2#7)(2012-3#5)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#1)
addition on##3##2##(2008-10#2)(2008-11#1)
addition or##5##2##(2007-11#1)(2008-11#1)(2008-9#1)(2009-8#2)
addition reaction##2##2##(2008-10#1)(2008-5#1)
addition reactions##3##2##(2008-10#2)(2008-8#1)
addition techniques##2##2##(1990-8#1)(2008-3#1)
addition the results##2##3##(1993-6#1)(1997-4#1)
addition the##9##2##(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-6#1)
addition theorems##3##2##(2008-2#3)
addition to a##15##3##(1990-2#1)(1994-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-1#1)
addition to age##2##3##(2010-4#1)(2013-1#1)
addition to being##6##3##(1990-11#1)(1991-11#1)(1992-8#1)(1993-3#1)(2008-10#1)(2012-2#1)
addition to binding##3##3##(1990-11#1)(2008-11#1)(2008-9#1)
addition to clinical##4##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)
addition to data from##2##4##(1997-8#1)(2008-7#1)
addition to direct##2##3##(2008-11#1)(2012-3#1)
addition to discussing the##2##4##(1993-2#1)(2008-4#1)
addition to established##2##3##(2008-11#1)(2008-7#1)
addition to having##2##3##(1997-8#1)(2007-11#1)
addition to identifying##2##3##(2008-5#1)(2009-2#1)
addition to individual##2##3##(2008-7#1)(2011-2#1)
addition to its##15##3##(1990-6#1)(1991-5#1)(1993-12#1)(1993-8#1)(1995-11#1)(1997-3#1)(1997-6#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-12#1)
addition to more##2##3##(1991-12#1)(2008-7#1)
addition to other##7##3##(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
addition to providing##9##3##(1993-3#1)(1995-3#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-11#1)(2009-4#1)
addition to reducing the##2##4##(1995-5#1)(2008-10#1)
addition to reducing##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
addition to standard##3##3##(2008-3#1)(2010-7#1)(2013-1#1)
addition to the basic##2##4##(1992-1#1)(2008-2#1)
addition to the direct##3##4##(2008-2#1)(2008-3#2)
addition to the expected##4##4##(1991-6#1)(2007-12#1)(2008-3#1)(2008-5#1)
addition to the known##2##4##(1996-10#1)(2012-2#1)
addition to the standard##2##4##(2007-8#1)(2009-2#1)
addition to the traditional##2##4##(2007-8#1)(2008-9#1)
addition to the two##2##4##(1994-11#1)(2008-4#1)
addition to the usual##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
addition to the viral##2##4##(1990-8#1)(2008-10#1)
addition to the##170##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#3)(2007-11#1)(2007-12#3)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)
addition to their##16##3##(1992-8#1)(1993-5#1)(1994-8#2)(1995-3#1)(1997-1#1)(2008-10#4)(2008-7#1)(2009-1#1)(2011-1#3)(2012-12#1)
addition to these functions##2##4##(2008-4#1)(2013-8#1)
addition to these##10##3##(1993-11#1)(1994-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
addition to this##10##3##(1990-8#1)(1991-3#1)(1992-2#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
addition to##560##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#3)(1996-8#3)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#5)(1997-6#4)(1997-7#2)(1997-8#4)(2006-10#4)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#8)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#73)(2008-11#23)(2008-12#9)(2008-2#17)(2008-3#26)(2008-4#14)(2008-5#18)(2008-6#5)(2008-7#22)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#4)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#22)(2012-1#4)(2012-12#9)(2012-2#12)(2012-3#8)(2013-1#17)(2013-7#2)(2013-8#5)
addition was##3##2##(1994-6#1)(2008-10#1)(2011-1#1)
addition with##3##2##(2008-10#2)(2008-3#1)
addition##2850##1##(1990-11#11)(1990-12#10)(1990-2#8)(1990-3#3)(1990-5#13)(1990-6#7)(1990-7#11)(1990-8#22)(1990-9#5)(1991-1#3)(1991-11#4)(1991-12#7)(1991-2#9)(1991-3#4)(1991-5#12)(1991-6#5)(1991-7#1)(1991-8#7)(1991-9#13)(1992-1#3)(1992-10#2)(1992-11#10)(1992-12#21)(1992-2#10)(1992-3#11)(1992-4#3)(1992-5#8)(1992-6#8)(1992-8#18)(1992-9#13)(1993-1#1)(1993-11#15)(1993-12#16)(1993-2#5)(1993-3#12)(1993-5#1)(1993-6#14)(1993-8#14)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#13)(1994-12#14)(1994-2#9)(1994-3#9)(1994-5#12)(1994-6#17)(1994-7#2)(1994-8#13)(1994-9#8)(1995-1#2)(1995-11#15)(1995-12#17)(1995-2#31)(1995-3#13)(1995-5#8)(1995-6#18)(1995-8#8)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#18)(1996-2#21)(1996-3#5)(1996-4#1)(1996-5#17)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#15)(1997-2#15)(1997-3#10)(1997-4#10)(1997-5#3)(1997-6#11)(1997-7#15)(1997-8#12)(1997-9#2)(2006-10#5)(2006-12#1)(2007-1#2)(2007-10#9)(2007-11#29)(2007-12#44)(2007-2#5)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#13)(2007-9#1)(2008-1#25)(2008-10#614)(2008-11#150)(2008-12#32)(2008-2#69)(2008-3#114)(2008-4#62)(2008-5#92)(2008-6#24)(2008-7#95)(2008-8#69)(2008-9#66)(2009-1#3)(2009-10#12)(2009-11#5)(2009-12#8)(2009-2#6)(2009-3#6)(2009-4#4)(2009-5#12)(2009-6#9)(2009-7#17)(2009-8#22)(2009-9#12)(2010-1#4)(2010-10#15)(2010-11#7)(2010-12#16)(2010-2#12)(2010-3#11)(2010-4#23)(2010-5#8)(2010-6#6)(2010-7#8)(2010-8#13)(2010-9#3)(2011-1#31)(2011-10#2)(2011-2#95)(2011-3#1)(2012-1#11)(2012-12#31)(2012-2#48)(2012-3#29)(2012-4#2)(2012-7#1)(2013-1#63)(2013-7#5)(2013-8#27)
addition-subtraction algorithm##2##2##(2008-3#2)
addition/recovery##2##1##(2008-10#2)
additional &quot##2##2##(1991-3#1)(2013-8#1)
additional 16##2##2##(2011-2#1)(2012-3#1)
additional QTL##3##2##(2008-10#2)(2012-3#1)
additional UVB filters##2##3##(2008-5#2)
additional advantage of##2##3##(2008-10#1)(2008-3#1)
additional advantage##5##2##(2008-10#4)(2008-3#1)
additional advantages##3##2##(1996-3#1)(2008-10#1)(2012-1#1)
additional analysis of##3##3##(2008-10#1)(2009-1#1)(2012-3#1)
additional analysis##6##2##(1997-5#1)(2008-10#1)(2008-3#2)(2009-1#1)(2012-3#1)
additional antibodies##2##2##(2008-7#1)(2011-2#1)
additional application of##2##3##(1995-12#1)(2007-8#1)
additional applications of##2##3##(2008-10#2)
additional applications##3##2##(2008-10#2)(2008-2#1)
additional benefit in##3##3##(2008-5#1)(2013-1#1)(2013-7#1)
additional benefit of##3##3##(2006-10#1)(2008-3#1)(2012-3#1)
additional benefit##11##2##(1991-12#1)(1991-8#1)(1994-3#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
additional benefits##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
additional biopsy##2##2##(2008-5#1)(2012-2#1)
additional burden##2##2##(2007-11#1)(2008-1#1)
additional case of##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
additional cases of##2##3##(2011-2#1)(2012-3#1)
additional cases##3##2##(1990-6#1)(2011-2#1)(2012-3#1)
additional clinical information##2##3##(1991-3#1)(1997-8#1)
additional clinical##3##2##(1991-3#1)(1997-8#1)(2007-12#1)
additional compensatory##2##2##(2009-2#2)
additional complexities##2##2##(1994-12#1)(2008-11#1)
additional components##2##2##(2007-11#1)(2007-12#1)
additional consideration of##2##3##(2007-12#1)(2011-2#1)
additional consideration##3##2##(1991-12#1)(2007-12#1)(2011-2#1)
additional considerations##2##2##(2008-11#1)(2008-9#1)
additional constraints##2##2##(2008-7#1)(2012-3#1)
additional contribution##2##2##(2008-10#1)(2010-4#1)
additional control##2##2##(2008-10#1)(2010-12#1)
additional data on##2##3##(1991-3#1)(2011-2#1)
additional data##8##2##(1991-3#1)(1993-8#1)(1996-3#1)(1997-4#1)(2008-5#1)(2009-8#2)(2011-2#1)
additional dependent##2##2##(2008-8#1)(2009-6#1)
additional diagnostic##3##2##(1990-3#1)(1990-9#1)(1995-1#1)
additional effect##2##2##(1991-6#1)(2007-8#1)
additional effects##2##2##(1993-3#1)(2007-12#1)
additional evidence for##6##3##(1992-3#2)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
additional evidence of##2##3##(1994-7#1)(2009-5#1)
additional evidence that##3##3##(2006-6#1)(2007-11#1)(2009-8#1)
additional evidence##15##2##(1992-3#2)(1994-7#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
additional experimental##2##2##(2008-10#2)
additional experiments##4##2##(1990-5#1)(1991-12#1)(2007-12#1)(2008-4#1)
additional expression##2##2##(1991-6#1)(2008-11#1)
additional factors of##2##3##(1997-4#1)(2012-12#1)
additional factors such as##2##4##(1995-1#1)(2007-12#1)
additional factors##10##2##(1995-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2012-12#1)
additional families with##2##3##(1990-12#1)(1994-8#1)
additional features##2##2##(2008-10#1)(2008-2#1)
additional findings##2##2##(1997-3#1)(2011-2#1)
additional flexibility##2##2##(1997-8#1)(2007-8#1)
additional four##3##2##(1990-2#1)(1997-3#1)(2010-8#1)
additional funding##2##2##(2008-10#1)(2013-1#1)
additional gain##2##2##(2007-11#1)(2008-6#1)
additional genes##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
additional groups##4##2##(2008-10#1)(2008-9#3)
additional health##2##2##(2008-10#1)(2008-11#1)
additional indication##2##2##(2008-10#1)(2008-5#1)
additional information about##2##3##(1996-5#1)(2010-12#1)
additional information for##2##3##(1996-11#1)(2008-10#1)
additional information on the##4##4##(2008-10#2)(2008-7#1)(2013-1#1)
additional information on##5##3##(2008-10#3)(2008-7#1)(2013-1#1)
additional information to##3##3##(2007-10#1)(2008-4#1)(2011-2#1)
additional information##25##2##(1993-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-10#1)(2008-10#6)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
additional inoculum##2##2##(2008-10#2)
additional inputs##2##2##(1992-2#1)(2009-10#1)
additional insight into##3##3##(1991-10#1)(2009-8#1)(2012-3#1)
additional insights into the##3##4##(1992-11#1)(2009-10#1)(2012-2#1)
additional intraoperative##2##2##(2007-8#1)(2009-4#1)
additional intravenous##2##2##(1991-6#1)(2011-2#1)
additional investigations##2##2##(1992-5#2)
additional items##3##2##(2011-1#2)(2012-2#1)
additional layers##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
additional lesions##2##2##(1993-8#1)(1997-3#1)
additional markers##4##2##(1997-5#2)(2008-10#1)(2008-5#1)
additional measurements of##2##3##(2008-3#2)
additional measurements##4##2##(1991-8#1)(2008-3#3)
additional mechanism##5##2##(1992-12#1)(1994-8#1)(1995-5#1)(2008-10#1)(2013-1#1)
additional modifications##2##2##(1991-12#1)(2011-2#1)
additional month##2##2##(1996-2#1)(2008-10#1)
additional motifs##2##2##(1997-7#1)(2008-5#1)
additional mutant##2##2##(1995-6#1)(2008-10#1)
additional mutation##4##2##(1995-3#1)(1997-3#1)(2008-7#1)(2008-8#1)
additional mutations##2##2##(2008-6#1)(2013-1#1)
additional nucleotides##2##2##(1992-6#1)(1997-3#1)
additional nutritional##2##2##(2010-11#1)(2010-6#1)
additional optical##2##2##(2008-3#2)
additional oxygen##2##2##(1994-3#1)(2013-7#1)
additional palatability information##2##3##(2010-4#2)
additional peak corresponding to##2##4##(2008-10#2)
additional peak##3##2##(2008-10#3)
additional phase##2##2##(2007-12#1)(2008-2#1)
additional preconcentration##2##2##(2008-10#2)
additional procedures##2##2##(2011-2#2)
additional properties##2##2##(2009-3#1)(2013-1#1)
additional psychiatric##2##2##(1994-2#1)(2009-7#1)
additional radiation##2##2##(2008-6#1)(2012-2#1)
additional reagents##2##2##(1990-12#1)(2008-10#1)
additional reduction##2##2##(2008-10#2)
additional reference##2##2##(2008-10#1)(2011-2#1)
additional regions##2##2##(1992-11#1)(1994-6#1)
additional regulatory##3##2##(1994-3#1)(2012-3#2)
additional research##5##2##(1993-12#1)(2006-10#1)(2008-6#1)(2009-8#1)(2010-10#1)
additional resistance##2##2##(2008-10#1)(2012-12#1)
additional resources##2##2##(2008-10#1)(2008-8#1)
additional risk factors such as##2##5##(2008-11#2)
additional risk factors##5##3##(1992-8#1)(2006-10#1)(2008-11#2)(2008-3#1)
additional risk##8##2##(1992-8#1)(2006-10#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
additional role##2##2##(1994-11#2)
additional samples##2##2##(2010-7#1)(2012-3#1)
additional sites##2##2##(1993-12#1)(2008-10#1)
additional slow##2##2##(2009-8#2)
additional sodium##2##2##(1995-12#1)(1996-2#1)
additional sources##2##2##(1991-3#1)(2008-11#1)
additional species##2##2##(2008-5#2)
additional steps##4##2##(2008-10#2)(2008-4#2)
additional strains##3##2##(2008-10#2)(2012-3#1)
additional studies##6##2##(2008-10#2)(2008-5#1)(2010-6#1)(2012-1#1)(2012-12#1)
additional study##3##2##(1993-12#1)(1993-9#1)(2008-10#1)
additional support for the##2##4##(2008-1#1)(2011-1#1)
additional support for##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
additional support to##4##3##(1992-7#1)(2008-11#1)(2008-12#1)(2013-1#1)
additional support##8##2##(1992-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2013-1#3)
additional surgery##2##2##(2008-6#1)(2009-1#1)
additional surgical##2##2##(1992-9#1)(2013-1#1)
additional temperature##2##2##(2008-3#2)
additional therapeutic##3##2##(2008-1#1)(2009-7#1)(2012-2#1)
additional therapy##5##2##(1990-11#1)(1997-8#1)(2008-6#1)(2009-6#1)(2013-1#1)
additional to that##2##3##(1992-5#1)(2008-9#1)
additional to##4##2##(1990-9#1)(1992-5#1)(2008-9#2)
additional tool##4##2##(2007-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
additional tools for demonstrating the efficiency##2##6##(1995-1#1)(1995-3#1)
additional tools for##3##3##(1995-1#1)(1995-3#1)(2008-11#1)
additional tools##5##2##(1995-1#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-11#1)
additional training and##2##3##(1990-2#1)(1992-10#1)
additional training##3##2##(1990-2#1)(1992-10#1)(2008-1#1)
additional treatment##5##2##(1997-2#1)(2007-11#1)(2008-10#1)(2010-8#1)(2013-1#1)
additional use of##2##3##(1997-7#1)(2008-10#1)
additional variance##2##2##(2008-2#1)(2010-8#1)
additional weeks##2##2##(1991-6#1)(2008-7#1)
additional work##2##2##(2008-7#1)(2008-9#1)
additional##938##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#8)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#6)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#5)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#6)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#8)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#5)(1994-3#7)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#6)(1995-2#8)(1995-3#5)(1995-5#4)(1995-6#4)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#8)(1996-3#6)(1996-5#3)(1996-6#2)(1997-1#3)(1997-2#5)(1997-3#7)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#5)(2006-10#4)(2006-12#3)(2006-6#1)(2007-10#3)(2007-11#20)(2007-12#23)(2007-2#3)(2007-7#4)(2007-8#8)(2008-1#7)(2008-10#170)(2008-11#29)(2008-12#9)(2008-2#18)(2008-3#41)(2008-4#23)(2008-5#21)(2008-6#15)(2008-7#28)(2008-8#13)(2008-9#27)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#5)(2009-8#11)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#10)(2011-2#34)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#21)(2012-3#19)(2013-1#30)(2013-7#6)(2013-8#9)
additionally to##3##2##(1997-6#1)(2008-5#1)(2011-2#1)
additionally with##2##2##(1990-10#1)(2008-7#1)
additionally##39##1##(1990-10#1)(1990-2#1)(1992-6#1)(1993-12#2)(1995-5#1)(1996-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
additions of##12##2##(1991-8#1)(1992-6#1)(1993-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)
additions to##3##2##(2008-7#2)(2012-2#1)
additions were##3##2##(2008-10#2)(2008-8#1)
additions##63##1##(1991-8#1)(1992-6#2)(1993-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#41)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#2)
additive EuroSCORE##2##2##(2007-8#2)
additive Gaussian noise##2##3##(2008-2#2)
additive and the##2##3##(2008-10#1)(2008-3#1)
additive and##11##2##(1990-2#1)(1994-9#1)(2007-8#2)(2008-10#6)(2008-3#1)
additive by##2##2##(2008-4#2)
additive effect##9##2##(1992-3#1)(1994-7#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
additive effects on##4##3##(2007-11#1)(2008-10#3)
additive effects##12##2##(1996-12#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-9#1)(2013-7#1)
additive for##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
additive gene##3##2##(2008-10#2)(2009-5#1)
additive genetic variation##2##3##(2008-8#1)(2008-9#1)
additive genetic##7##2##(2008-10#1)(2008-8#4)(2008-9#1)(2013-1#1)
additive in the##3##3##(2008-10#3)
additive in##7##2##(1990-5#1)(2008-10#5)(2011-2#1)
additive interactions##2##2##(2008-11#1)(2012-6#1)
additive is##2##2##(2008-10#1)(2009-8#1)
additive model##4##2##(1997-7#1)(2011-1#3)
additive noise##5##2##(2008-2#3)(2008-3#2)
additive of##3##2##(1994-9#1)(2008-10#2)
additive on##3##2##(2008-10#3)
additive or##4##2##(1991-8#1)(2008-10#2)(2013-8#1)
additive to the##2##3##(1992-11#1)(2008-10#1)
additive to##6##2##(1990-2#1)(1990-3#1)(1992-11#1)(1994-3#1)(1996-5#1)(2008-10#1)
additive was##3##2##(2008-10#1)(2011-1#2)
additive when##2##2##(1991-5#1)(2008-10#1)
additive##173##1##(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#3)(1997-7#1)(2007-11#2)(2007-8#4)(2008-10#68)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#5)(2008-8#7)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#5)(2011-2#5)(2012-6#2)(2013-1#1)(2013-7#1)(2013-8#2)
additively##6##1##(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
additives and##7##2##(1994-9#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#2)(2012-12#1)
additives are##2##2##(2008-10#2)
additives for##3##2##(2008-11#2)(2009-11#1)
additives in##9##2##(2008-10#5)(2008-5#1)(2010-9#2)(2012-3#1)
additives on##3##2##(1992-9#1)(2008-11#1)(2008-5#1)
additives such as##3##3##(1994-9#1)(2008-11#1)(2008-6#1)
additives to##6##2##(1994-3#1)(2008-10#2)(2008-11#2)(2012-2#1)
additives were##4##2##(1994-3#1)(1994-9#1)(2008-11#1)(2009-11#1)
additives with##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
additives##88##1##(1990-3#3)(1992-9#2)(1994-3#3)(1994-9#3)(2007-2#1)(2008-10#30)(2008-11#12)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2009-10#1)(2009-11#6)(2010-4#3)(2010-7#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#1)
additivity of##3##2##(2008-10#2)(2013-8#1)
additivity was##2##2##(1995-11#1)(2008-10#1)
additivity##12##1##(1992-12#2)(1992-3#1)(1995-11#1)(1995-5#1)(2008-10#5)(2008-7#1)(2013-8#1)
address a range of##2##4##(2008-10#1)(2008-12#1)
address a##4##2##(1994-2#1)(1996-1#1)(2008-10#1)(2008-12#1)
address all##2##2##(2008-4#1)(2013-1#1)
address any##2##2##(2008-11#2)
address barriers to##2##3##(2008-4#1)(2012-2#1)
address digital detector system (PADDS)##2##5##(2008-3#2)
address gaps in##4##3##(1995-12#1)(2008-11#1)(2010-3#1)(2012-12#1)
address how##3##2##(1995-5#1)(2010-3#1)(2012-2#1)
address is##3##2##(1996-8#2)(2010-3#1)
address issues of##2##3##(1997-3#1)(2012-3#1)
address issues##7##2##(1997-3#1)(2008-1#1)(2008-12#2)(2010-5#1)(2012-12#1)(2012-3#1)
address of the##2##3##(1990-9#1)(1991-7#1)
address one##3##2##(2007-10#1)(2008-12#1)(2012-12#1)
address questions##5##2##(1991-1#1)(1992-10#1)(2008-7#1)(2009-5#1)(2013-8#1)
address several##3##2##(2008-7#1)(2012-3#2)
address some of the##5##4##(1991-12#1)(1993-11#1)(1995-12#1)(2008-12#1)(2008-7#1)
address some of##6##3##(1991-12#1)(1993-11#1)(1995-12#1)(2007-12#1)(2008-12#1)(2008-7#1)
address specific issues##2##3##(2009-7#1)(2013-1#1)
address specific##6##2##(1992-1#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-1#2)
address the effects of##2##4##(2008-1#1)(2012-3#1)
address the following##2##3##(1997-4#1)(2008-1#1)
address the importance of##2##4##(2008-7#1)(2009-11#1)
address the issue of##4##4##(1991-12#1)(1995-8#1)(1996-12#1)(2010-10#1)
address the issue##8##3##(1991-12#1)(1992-1#1)(1993-2#1)(1995-8#1)(1996-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
address the kinetics of##2##4##(2008-11#1)(2009-5#1)
address the lack of##3##4##(1992-1#1)(2008-7#1)(2011-2#1)
address the limitations of the##2##5##(1994-2#1)(2010-3#1)
address the major##2##3##(1993-1#1)(2013-8#1)
address the multiple##3##3##(2008-1#1)(2010-3#1)(2012-12#1)
address the need for##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
address the needs of##4##4##(1993-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
address the possibility that##2##4##(2008-10#1)(2008-9#1)
address the possible##2##3##(1997-4#1)(2009-8#1)
address the problem of##4##4##(1997-1#1)(2007-12#2)(2008-1#1)
address the problem##6##3##(1997-1#1)(1997-3#1)(2007-12#2)(2008-1#1)(2012-12#1)
address the problems of##3##4##(1993-12#1)(2010-9#1)(2013-8#1)
address the question of how##2##5##(2008-9#1)(2009-3#1)
address the question of whether##2##5##(2008-8#1)(2012-2#1)
address the question of##5##4##(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
address the question##8##3##(1991-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
address the relative##2##3##(1994-9#1)(2011-2#1)
address the role of##2##4##(1995-6#1)(2012-1#1)
address the use of##2##4##(2008-10#1)(2008-8#1)
address the##140##2##(1991-1#2)(1991-12#2)(1991-3#1)(1992-1#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(2007-12#3)(2008-1#7)(2008-10#5)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-10#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#6)
address them##3##2##(1995-2#1)(2008-6#1)(2009-5#1)
address these challenges##3##3##(2010-11#1)(2011-2#1)(2012-12#1)
address these issues##6##3##(2008-1#1)(2008-11#2)(2008-5#1)(2010-8#1)(2013-1#1)
address these problems##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2009-9#1)(2013-8#1)
address these##37##2##(1996-3#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#10)
address this concern##2##3##(2008-8#1)(2011-2#1)
address this deficit##2##3##(2008-9#1)(2013-1#1)
address this issue##17##3##(1992-6#1)(1993-1#1)(1995-8#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#5)(2008-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
address this knowledge gap##2##4##(2012-2#1)(2013-1#1)
address this need##3##3##(1997-2#1)(2008-1#1)(2008-11#1)
address this problem##9##3##(1993-3#1)(1997-8#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#2)
address this question##9##3##(1994-11#1)(2008-11#3)(2008-8#2)(2008-9#1)(2012-1#1)(2013-8#1)
address this##63##2##(1992-6#2)(1993-1#1)(1993-3#1)(1994-11#2)(1995-8#1)(1996-1#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
address what##3##2##(1996-6#1)(2008-11#1)(2008-8#1)
address whether these##2##3##(1993-12#1)(1997-2#1)
address whether##4##2##(1993-12#1)(1997-2#1)(1997-6#1)(2009-12#1)
address##434##1##(1990-11#1)(1990-9#1)(1991-1#3)(1991-12#4)(1991-3#2)(1991-7#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-3#4)(1992-6#2)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#4)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#5)(1996-6#1)(1996-8#2)(1997-1#3)(1997-2#6)(1997-3#7)(1997-4#2)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#14)(2008-10#15)(2008-11#34)(2008-12#16)(2008-2#3)(2008-3#18)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#17)(2008-8#11)(2008-9#4)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#2)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#2)(2010-3#7)(2010-5#2)(2010-6#2)(2010-8#6)(2010-9#4)(2011-1#9)(2011-10#2)(2011-2#15)(2012-1#6)(2012-12#12)(2012-2#10)(2012-3#16)(2013-1#16)(2013-7#1)(2013-8#22)
addressable microelectrodes##2##2##(2010-2#2)
addressable##6##1##(2008-2#1)(2008-3#2)(2010-2#2)(2011-1#1)
addressed a##3##2##(2008-5#1)(2008-8#1)(2010-3#1)
addressed and##6##2##(1991-12#1)(1992-2#1)(1994-1#2)(2008-9#1)(2012-12#1)
addressed are##4##2##(2008-11#2)(2009-3#1)(2011-2#1)
addressed as##5##2##(1991-12#1)(1994-11#1)(1994-7#1)(2007-12#1)(2008-7#1)
addressed at the##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
addressed at##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
addressed before##4##2##(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
addressed by a##4##3##(1996-1#1)(2007-8#1)(2012-3#2)
addressed by these##2##3##(1993-1#1)(1997-2#1)
addressed by this##2##3##(1996-2#1)(2013-1#1)
addressed by##31##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
addressed during##2##2##(1991-1#1)(2012-2#1)
addressed for the##5##3##(2008-3#1)(2013-8#4)
addressed for##7##2##(2007-12#1)(2008-3#1)(2012-2#1)(2013-8#4)
addressed from a##2##3##(1994-2#1)(2009-5#1)
addressed here##2##2##(2008-10#2)
addressed how##2##2##(2008-6#1)(2008-9#1)
addressed in the literature##3##4##(1995-2#1)(2007-11#1)(2008-2#1)
addressed in the##12##3##(1992-9#1)(1994-12#1)(1995-2#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
addressed in this##5##3##(1993-1#1)(1996-1#1)(2008-4#1)(2009-8#1)(2012-2#1)
addressed in##34##2##(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
addressed include the##3##3##(1991-3#1)(1993-11#1)(2008-5#1)
addressed include##4##2##(1991-3#1)(1993-11#1)(1995-2#1)(2008-5#1)
addressed liquid-crystal spatial light##4##4##(2007-12#2)(2008-3#2)
addressed liquid-crystal##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
addressed spatial light modulator##4##4##(2008-2#1)(2008-3#3)
addressed spatial light modulators##2##4##(2007-12#1)(2008-3#1)
addressed spatial light##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
addressed the questions of##2##4##(2008-7#1)(2009-3#1)
addressed the##16##2##(1992-1#1)(1992-12#1)(1992-3#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#2)(2012-3#1)
addressed these##4##2##(1995-12#1)(2008-10#1)(2008-6#1)(2013-1#1)
addressed this issue##2##3##(2007-8#1)(2009-8#1)
addressed this##5##2##(1995-11#1)(2007-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
addressed through##3##2##(1995-3#1)(2008-9#1)(2013-8#1)
addressed to the##5##3##(1996-11#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-7#1)
addressed to##17##2##(1992-3#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
addressed with##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2013-8#1)
addressed##313##1##(1991-1#1)(1991-12#3)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#6)(2007-12#12)(2007-5#1)(2007-7#3)(2007-8#15)(2008-1#4)(2008-10#22)(2008-11#8)(2008-12#4)(2008-2#9)(2008-3#15)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#15)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#19)
addresses a##4##2##(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
addresses all##5##2##(2007-12#1)(2008-1#1)(2008-4#2)(2013-1#1)
addresses an##2##2##(1995-12#1)(2008-10#1)
addresses both##2##2##(2008-12#1)(2008-7#1)
addresses how##2##2##(2008-1#1)(2008-11#1)
addresses many##2##2##(2007-12#1)(2008-11#1)
addresses recent##2##2##(2008-1#1)(2008-3#1)
addresses some of the##3##4##(1991-12#2)(2008-7#1)
addresses some of##4##3##(1991-12#2)(2008-7#1)(2008-9#1)
addresses some##6##2##(1991-12#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
addresses the challenges##3##3##(1992-1#1)(1994-3#1)(2008-12#1)
addresses the issue of##4##4##(1993-1#1)(2008-7#1)(2008-9#1)(2009-6#1)
addresses the issues##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
addresses the question of how##2##5##(2008-10#1)(2008-9#1)
addresses the question of the##2##5##(2009-12#1)(2009-8#1)
addresses the question of##4##4##(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)
addresses the##58##2##(1992-1#2)(1992-2#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
addresses these issues##3##3##(1992-9#1)(2008-6#1)(2009-10#1)
addresses these##5##2##(1992-9#1)(2008-6#1)(2009-10#1)(2010-8#1)(2012-3#1)
addresses this##3##2##(2008-4#1)(2008-9#1)(2009-11#1)
addresses two questions##2##3##(1997-1#1)(2008-7#1)
addresses two##4##2##(1996-3#1)(1997-1#1)(2008-7#1)(2013-8#1)
addresses##135##1##(1991-12#3)(1992-1#2)(1992-2#3)(1992-3#3)(1992-9#1)(1993-1#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#3)(1995-12#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(2006-10#1)(2007-12#3)(2007-2#1)(2008-1#6)(2008-10#8)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#2)
addressing and##2##2##(2013-1#1)(2013-8#1)
addressing cultural##2##2##(1995-1#1)(2008-12#1)
addressing disparities##2##2##(2012-2#1)(2013-1#1)
addressing health##2##2##(1996-12#1)(2012-12#1)
addressing many of##2##3##(1993-2#1)(2008-9#1)
addressing stress##2##2##(1994-2#1)(2008-7#1)
addressing the challenges of the##2##5##(1991-3#1)(1992-12#1)
addressing the needs of##2##4##(2009-5#1)(2011-2#1)
addressing the##44##2##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-11#4)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
addressing these issues##2##3##(1997-2#1)(2008-12#1)
addressing these##8##2##(1994-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-7#1)
addressing this problem##2##3##(2008-10#1)(2011-2#1)
addressing this question##2##3##(2010-10#1)(2010-5#1)
addressing this##6##2##(1993-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
addressing##144##1##(1991-3#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-7#1)(1997-1#2)(1997-2#5)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#8)(2008-12#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#8)(2013-8#2)
adds a##2##2##(2007-11#1)(2008-10#1)
adds three##2##2##(2010-10#1)(2012-2#1)
adds to the growing body of evidence##2##7##(2009-2#1)(2010-5#1)
adds to the##9##3##(2007-12#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
adds to##14##2##(1994-2#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
adds##35##1##(1994-1#2)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
adduct and##2##2##(1992-8#1)(1996-5#1)
adduct by##2##2##(1992-3#1)(2008-8#1)
adduct complexes##2##2##(1993-11#2)
adduct formation in##2##3##(1993-8#1)(1994-5#1)
adduct formation with##2##3##(1995-6#1)(2008-10#1)
adduct formation##13##2##(1993-8#3)(1994-5#1)(1995-6#2)(1995-9#1)(2008-10#4)(2008-11#1)(2011-2#1)
adduct ions##4##2##(2008-10#3)(2008-4#1)
adduct levels were found##2##4##(1994-2#1)(2008-12#1)
adduct levels were##3##3##(1994-2#2)(2008-12#1)
adduct levels##8##2##(1994-2#4)(2008-12#4)
adduct of the##2##3##(1991-5#1)(1995-5#1)
adduct of##9##2##(1990-11#1)(1991-5#1)(1992-3#1)(1993-11#1)(1995-5#3)(1996-2#1)(2008-8#1)
adduct was##9##2##(1990-7#1)(1992-3#2)(1992-8#1)(2008-10#4)(2009-10#1)
adduct##81##1##(1990-11#3)(1990-7#1)(1991-5#4)(1991-9#1)(1992-3#7)(1992-6#2)(1992-8#3)(1993-11#6)(1993-8#4)(1994-2#4)(1994-5#3)(1994-8#1)(1995-5#3)(1995-6#3)(1995-9#1)(1996-2#1)(1996-5#3)(2008-10#21)(2008-11#1)(2008-12#4)(2008-4#1)(2008-8#2)(2009-10#1)(2011-2#1)
adducted##8##1##(1990-7#3)(1993-11#2)(1993-8#3)
adduction##3##1##(2009-3#1)(2009-9#1)(2013-1#1)
adductor tendon##2##2##(2009-10#2)
adductor##5##1##(2008-9#1)(2009-10#4)
adductors##2##1##(2009-3#1)(2012-1#1)
adducts and##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
adducts as##4##2##(1993-11#1)(1994-8#3)
adducts by##3##2##(1992-6#1)(1994-2#1)(2008-10#1)
adducts formed##2##2##(1993-11#1)(2013-1#1)
adducts generated by##2##3##(1994-8#2)
adducts in##10##2##(1993-6#3)(1993-8#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-12#2)(2012-12#1)
adducts of##5##2##(1990-5#1)(1992-12#1)(1994-11#1)(2008-10#2)
adducts to##2##2##(1990-11#1)(1994-8#1)
adducts was##2##2##(1993-11#2)
adducts were##3##2##(1991-2#1)(1994-8#1)(1995-6#1)
adducts with##6##2##(1993-11#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#2)
adducts##81##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#6)(1993-6#5)(1993-8#1)(1994-11#1)(1994-2#2)(1994-5#3)(1994-8#10)(1995-2#3)(1995-6#2)(1996-2#1)(1996-5#4)(1997-7#1)(2006-10#1)(2008-10#8)(2008-11#3)(2008-12#7)(2008-8#1)(2010-7#2)(2010-8#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
adductus##4##1##(2012-2#3)(2012-3#1)
adefovir refractory patients##3##3##(2013-1#3)
adefovir##11##1##(2007-12#1)(2009-8#2)(2013-1#8)
adefovir-resistant HBV mutants##2##3##(2013-1#2)
adefovir-resistant##6##1##(2013-1#6)
adenine N7##2##2##(1992-6#1)(1993-11#1)
adenine analyser##2##2##(1990-8#2)
adenine and##2##2##(1993-1#1)(2008-10#1)
adenine bases##2##2##(1994-12#1)(2008-10#1)
adenine dinucleotide (NADH)##2##3##(2008-10#1)(2013-1#1)
adenine dinucleotide and##2##3##(1993-11#1)(2008-5#1)
adenine dinucleotide phosphate##5##3##(1992-12#2)(2008-5#1)(2011-2#2)
adenine dinucleotide##18##2##(1991-9#1)(1992-12#3)(1993-11#1)(1994-11#1)(1995-3#2)(1997-2#1)(2008-10#3)(2008-5#2)(2011-2#3)(2013-1#1)
adenine in##3##2##(2008-10#3)
adenine methylation##4##2##(1990-5#1)(1994-12#2)(2008-9#1)
adenine nucleotide##6##2##(1992-6#1)(1994-6#1)(1994-8#1)(1995-8#1)(2008-11#1)(2012-2#1)
adenine nucleotides and##2##3##(1995-12#1)(1996-6#1)
adenine nucleotides in##2##3##(1991-8#1)(1994-6#1)
adenine nucleotides##12##2##(1990-8#1)(1991-8#1)(1992-6#3)(1994-6#1)(1995-12#1)(1996-6#1)(2008-4#1)(2008-7#3)
adenine units##2##2##(2008-10#2)
adenine##87##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-8#5)(1991-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#7)(1993-1#2)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#15)(2008-11#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#3)(2012-2#1)(2013-1#2)
adenines and 2##2##3##(1992-4#2)
adenines##7##1##(1992-4#2)(1993-11#3)(1996-3#1)(2008-10#1)
adeno-associated virus (AAV)##2##3##(2008-8#1)(2011-3#1)
adeno-associated virus (rAAV)##4##3##(2008-5#1)(2008-8#2)(2008-9#1)
adeno-associated virus vector##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
adeno-associated virus vectors##2##3##(1992-12#1)(2008-5#1)
adeno-associated virus##16##2##(1992-12#3)(1993-2#2)(2008-11#1)(2008-5#2)(2008-8#4)(2008-9#3)(2011-3#1)
adeno-associated##20##1##(1992-12#3)(1993-2#2)(2008-11#1)(2008-5#2)(2008-8#5)(2008-9#6)(2011-3#1)
adenocarcinoma and##14##2##(1990-2#1)(1991-12#1)(1991-4#1)(1992-2#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-1#3)(2013-1#1)
adenocarcinoma cases was##2##3##(2013-1#2)
adenocarcinoma cases##3##2##(1990-3#1)(2013-1#2)
adenocarcinoma cell line##6##3##(1993-9#2)(1997-1#1)(2008-11#2)(2013-1#1)
adenocarcinoma cells##6##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
adenocarcinoma in a##4##3##(1991-8#1)(2007-2#1)(2008-1#1)(2013-1#1)
adenocarcinoma in##6##2##(1991-8#1)(2007-2#1)(2008-1#1)(2009-5#1)(2010-7#1)(2013-1#1)
adenocarcinoma is##2##2##(2008-12#1)(2008-9#1)
adenocarcinoma of the lung##2##4##(1994-3#1)(2007-6#1)
adenocarcinoma of the ovary##3##4##(1993-2#1)(2013-1#2)
adenocarcinoma of the pancreas##4##4##(1990-9#1)(1994-3#1)(1994-8#1)(2012-3#1)
adenocarcinoma of the sinonasal##2##4##(1990-6#1)(1993-6#1)
adenocarcinoma of the##27##3##(1990-10#1)(1990-6#2)(1990-9#1)(1991-8#1)(1992-2#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1997-3#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-4#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
adenocarcinoma of urachal cyst associated with PMP##2##7##(2009-5#2)
adenocarcinoma of##33##2##(1990-10#1)(1990-6#3)(1990-9#1)(1991-8#1)(1992-2#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1997-3#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-5#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
adenocarcinoma tumor##2##2##(1990-12#1)(2008-11#1)
adenocarcinoma was##2##2##(1993-8#1)(2008-11#1)
adenocarcinoma with extensive pilomatrixoma-like areas##2##5##(2013-7#2)
adenocarcinoma with##6##2##(1992-2#2)(2011-2#1)(2013-7#3)
adenocarcinoma##165##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#3)(1992-2#6)(1992-8#4)(1992-9#3)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-10#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#9)(2008-10#1)(2008-11#9)(2008-12#6)(2008-4#4)(2008-9#7)(2009-1#1)(2009-12#2)(2009-4#2)(2009-5#7)(2010-11#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#10)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#16)(2013-7#5)(2013-8#7)
adenocarcinoma)##4##1##(1994-8#1)(2008-11#3)
adenocarcinoma]##2##1##(1990-9#1)(1992-5#1)
adenocarcinomas and##2##2##(1992-5#1)(1994-9#1)
adenocarcinomas were##2##2##(1990-11#1)(2012-2#1)
adenocarcinomas##19##1##(1990-11#1)(1990-2#1)(1992-5#1)(1992-9#1)(1994-9#4)(1995-2#1)(1995-3#1)(2006-12#1)(2008-11#1)(2008-2#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
adenofibromas##3##1##(1993-5#1)(1994-2#2)
adenoid cystic carcinoma##4##3##(1991-11#1)(1991-6#1)(2013-8#2)
adenoid##5##1##(1991-11#1)(1991-6#1)(2007-10#1)(2013-8#2)
adenoma and CRC tissues##2##4##(2010-12#2)
adenoma and carcinoma##3##3##(1990-11#2)(1993-9#1)
adenoma and##13##2##(1990-11#2)(1993-5#1)(1993-9#1)(1996-9#1)(2008-12#1)(2008-5#1)(2010-12#4)(2012-1#1)(2013-8#1)
adenoma in##7##2##(1990-6#1)(1991-6#1)(1994-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
adenoma is a##2##3##(2008-10#1)(2013-8#1)
adenoma is##5##2##(2008-10#2)(2008-8#1)(2012-1#1)(2013-8#1)
adenoma of the trachea##2##4##(2008-8#2)
adenoma of the##10##3##(1990-10#1)(1992-8#1)(2007-8#1)(2008-10#2)(2008-8#2)(2009-1#1)(2012-1#2)
adenoma of##11##2##(1990-10#1)(1990-11#1)(1992-8#1)(2007-8#1)(2008-10#2)(2008-8#2)(2009-1#1)(2012-1#2)
adenoma or normal##2##3##(1992-8#1)(2008-7#1)
adenoma or##3##2##(1990-11#1)(1992-8#1)(2008-7#1)
adenoma was##2##2##(2008-9#1)(2011-2#1)
adenoma##98##1##(1990-10#2)(1990-11#7)(1990-3#2)(1990-6#1)(1990-9#1)(1991-6#1)(1992-5#2)(1992-8#3)(1993-2#1)(1993-5#2)(1993-9#2)(1994-3#1)(1996-11#1)(1996-9#1)(2006-12#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-1#2)(2009-12#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#9)(2010-8#1)(2011-2#3)(2012-1#11)(2012-12#2)(2013-1#1)(2013-8#8)
adenomas and 7##2##3##(1993-9#1)(2008-5#1)
adenomas and a##2##3##(2008-5#1)(2011-2#1)
adenomas and carcinomas##3##3##(1990-11#2)(1991-6#1)
adenomas and in##2##3##(1990-11#1)(2008-5#1)
adenomas and##19##2##(1990-11#7)(1991-6#1)(1993-9#1)(2008-5#3)(2009-12#4)(2011-2#3)
adenomas in##5##2##(1991-2#1)(2007-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
adenomas is##2##2##(1990-7#1)(2013-1#1)
adenomas of the##3##3##(1990-10#1)(2008-12#1)(2011-2#1)
adenomas or##3##2##(1996-5#1)(2012-3#2)
adenomas was##2##2##(2009-1#1)(2013-1#1)
adenomas were detected##2##3##(1990-11#1)(2013-8#1)
adenomas were##5##2##(1990-11#1)(1990-12#1)(2008-9#1)(2013-8#2)
adenomas##88##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-7#3)(1991-2#2)(1991-6#1)(1992-5#2)(1992-6#3)(1993-12#2)(1993-9#1)(1994-5#1)(1995-9#2)(1996-11#1)(1996-5#1)(2007-5#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#4)(2009-1#2)(2009-12#5)(2009-3#1)(2009-7#1)(2010-8#1)(2011-2#9)(2012-3#3)(2013-1#7)(2013-8#9)
adenomatoid odontogenic tumor##2##3##(2013-1#2)
adenomatoid odontogenic##3##2##(2013-1#3)
adenomatoid##8##1##(2007-10#2)(2008-2#3)(2013-1#3)
adenomatous colon polyps##3##3##(2008-3#2)(2008-4#1)
adenomatous polyposis (FAP)##5##3##(2008-11#1)(2008-4#2)(2009-12#2)
adenomatous polyposis coli##4##3##(1990-3#1)(2007-4#1)(2012-1#2)
adenomatous polyposis##17##2##(1990-3#1)(1991-6#1)(2007-4#1)(2008-11#1)(2008-4#2)(2009-12#7)(2011-2#1)(2012-1#2)(2012-3#1)
adenomatous polyps of the large##2##5##(1993-9#2)
adenomatous polyps##7##2##(1993-9#2)(1997-8#3)(2008-1#1)(2009-12#1)
adenomatous##33##1##(1990-10#1)(1990-3#1)(1991-6#1)(1993-9#2)(1997-8#3)(2006-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#3)(2009-12#8)(2009-5#1)(2011-2#1)(2012-1#2)(2012-3#1)
adenomyoepithelioma##3##1##(1990-12#3)
adenopathies of different##2##3##(2013-7#2)
adenopathies##7##1##(2008-1#1)(2008-7#1)(2013-1#1)(2013-7#4)
adenopathy##3##1##(1991-5#1)(1995-1#2)
adenoregulin##10##1##(1993-3#6)(1994-5#4)
adenosine 3'##7##2##(1990-12#1)(1994-11#1)(1994-2#1)(1994-9#3)(1995-8#1)
adenosine 5'-triphosphate (ATP)##3##3##(1990-5#1)(2008-4#2)
adenosine A(2A)##2##2##(2008-10#2)
adenosine A1 and##2##3##(1993-6#1)(1995-12#1)
adenosine A1 receptor agonist##2##4##(1995-12#1)(1997-1#1)
adenosine A1 receptor antagonism##2##4##(2007-8#2)
adenosine A1 receptor##8##3##(1995-12#1)(1995-5#2)(1997-1#2)(2007-8#3)
adenosine A1 receptors##5##3##(1994-6#1)(1995-12#1)(1997-1#3)
adenosine A1##18##2##(1993-6#2)(1994-6#1)(1995-12#4)(1995-5#2)(1997-1#6)(2007-8#3)
adenosine A2 receptor##4##3##(1990-12#3)(1991-12#1)
adenosine A2 receptors##2##3##(1990-12#1)(1996-5#1)
adenosine A2##6##2##(1990-12#4)(1991-12#1)(1996-5#1)
adenosine A2A receptor##2##3##(1995-12#2)
adenosine A2A##3##2##(1995-11#1)(1995-12#2)
adenosine activity in##2##3##(2008-7#2)
adenosine activity##3##2##(2008-7#3)
adenosine analogue##2##2##(1993-6#1)(1995-5#1)
adenosine analogues##4##2##(1994-8#2)(1995-3#1)(1995-8#1)
adenosine and guanosine##2##3##(2008-4#2)
adenosine and##13##2##(1993-12#3)(1995-8#1)(1997-7#1)(2008-10#1)(2008-4#7)
adenosine antagonists##2##2##(2007-8#1)(2008-4#1)
adenosine by##3##2##(2008-4#2)(2008-5#1)
adenosine concentration##3##2##(1993-12#1)(2008-4#1)(2008-7#1)
adenosine content##2##2##(1993-12#2)
adenosine deaminase complexed with##2##4##(1991-5#2)
adenosine deaminase gene##2##3##(1995-9#2)
adenosine deaminase##15##2##(1990-12#1)(1991-3#1)(1991-5#2)(1992-12#2)(1993-12#1)(1995-3#2)(1995-9#2)(1997-3#1)(1997-7#1)(2008-10#1)(2010-9#1)
adenosine derivatives##3##2##(1991-12#1)(2008-4#2)
adenosine diphosphate (ADP)##2##3##(1997-7#1)(2006-6#1)
adenosine diphosphate and epinephrine##2##4##(1997-6#2)
adenosine diphosphate##7##2##(1993-6#1)(1996-7#1)(1997-6#2)(1997-7#1)(2006-6#1)(2009-5#1)
adenosine from spinal cord synaptosomes##2##5##(1996-2#2)
adenosine from the spinal cord##2##5##(1996-2#2)
adenosine from##4##2##(1996-2#4)
adenosine in the##3##3##(2008-4#3)
adenosine in##9##2##(1991-1#1)(1993-6#1)(1996-2#1)(1997-7#2)(2008-4#3)(2008-7#1)
adenosine is##4##2##(1990-12#1)(1996-2#1)(1996-5#1)(2008-4#1)
adenosine kinase (ADK)##2##3##(2009-8#2)
adenosine kinase activity##3##3##(1997-7#3)
adenosine kinase##7##2##(1997-7#5)(2009-8#2)
adenosine levels##3##2##(1997-7#1)(2008-4#1)(2008-7#1)
adenosine mediated##2##2##(1993-11#2)
adenosine modulation of Fc##2##4##(1994-6#2)
adenosine monophosphate##4##2##(1994-8#1)(1995-8#1)(2008-10#1)(2009-3#1)
adenosine on##4##2##(1994-11#1)(1996-5#1)(2008-4#2)
adenosine or##4##2##(1994-6#2)(1995-8#1)(2008-5#1)
adenosine receptor activation##2##3##(1997-2#1)(2008-4#1)
adenosine receptor agonists##3##3##(1995-12#2)(1995-8#1)
adenosine receptor antagonists##5##3##(1995-8#1)(2008-4#4)
adenosine receptor##24##2##(1990-12#1)(1993-3#2)(1993-6#1)(1994-5#2)(1995-12#3)(1995-8#3)(1997-2#2)(2008-4#10)
adenosine receptors in##2##3##(1992-9#1)(2008-4#1)
adenosine receptors##14##2##(1992-9#1)(1993-6#1)(1995-12#1)(1995-3#2)(1995-8#1)(2007-8#1)(2008-4#5)(2008-5#1)(2008-7#1)
adenosine release##2##2##(1996-2#2)
adenosine to##4##2##(2008-4#1)(2008-5#2)(2010-9#1)
adenosine triphosphatase##2##2##(1994-8#1)(2008-9#1)
adenosine triphosphate (ATP)##5##3##(1991-9#2)(1997-6#1)(2007-10#1)(2009-4#1)
adenosine triphosphate##10##2##(1991-9#2)(1995-12#1)(1997-6#1)(2007-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-12#1)(2013-1#1)
adenosine was##2##2##(1992-9#1)(1995-3#1)
adenosine were##2##2##(1997-7#1)(2008-11#1)
adenosine##286##1##(1990-12#8)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-9#2)(1992-12#2)(1992-3#2)(1992-9#6)(1993-11#5)(1993-12#8)(1993-3#2)(1993-6#10)(1993-8#1)(1994-11#4)(1994-2#1)(1994-5#2)(1994-6#7)(1994-8#7)(1994-9#3)(1995-11#2)(1995-12#12)(1995-3#9)(1995-5#4)(1995-8#12)(1995-9#2)(1996-2#11)(1996-5#6)(1996-7#1)(1997-1#6)(1997-2#6)(1997-3#1)(1997-6#3)(1997-7#14)(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#5)(2008-10#6)(2008-11#1)(2008-4#63)(2008-5#8)(2008-7#10)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-1#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
adenosine)##2##1##(1997-1#1)(2008-11#1)
adenosine-3'##3##1##(1991-10#1)(1993-6#1)(2009-2#1)
adenosine-containing products##3##2##(2008-5#3)
adenosinergic modulation and##2##3##(1997-2#2)
adenosinergic modulation of ethanol-induced motor incoordination##2##6##(1997-2#2)
adenosinergic modulation of##3##3##(1997-2#3)
adenosinergic modulation##5##2##(1997-2#5)
adenosis##4##1##(1994-12#4)
adenosquamous carcinoma##2##2##(1993-8#2)
adenosquamous##5##1##(1993-8#2)(1994-9#1)(1996-9#2)
adenotonsillectomy##2##1##(1995-12#1)(2007-12#1)
adenoviral infection##2##2##(2008-11#2)
adenoviral vector carrying##3##3##(2010-1#3)
adenoviral vector##6##2##(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#3)
adenoviral vectors##9##2##(1995-2#2)(1997-1#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-4#1)
adenoviral##22##1##(1995-2#3)(1997-1#1)(2007-11#1)(2008-11#10)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#3)
adenovirus and##3##2##(1994-8#1)(1997-1#1)(2008-12#1)
adenovirus major late promoter##3##4##(1997-2#1)(1997-3#1)(2008-11#1)
adenovirus on##3##2##(1997-7#1)(2011-3#2)
adenovirus production##4##2##(2008-11#4)
adenovirus recombinants##2##2##(1997-3#1)(2008-11#1)
adenovirus replication##3##2##(2008-11#3)
adenovirus type 5##2##3##(1994-5#1)(1995-2#1)
adenovirus type 9##2##3##(1992-9#2)
adenovirus type##4##2##(1992-9#2)(1994-5#1)(1995-2#1)
adenovirus vaccine##2##2##(2011-2#2)
adenovirus vector was##2##3##(1994-5#1)(2010-1#1)
adenovirus vector##6##2##(1994-5#1)(2008-11#2)(2008-9#1)(2010-1#2)
adenovirus vectors for##2##3##(2008-11#2)
adenovirus vectors##4##2##(1994-5#2)(2008-11#2)
adenovirus were##2##2##(2011-1#2)
adenovirus##91##1##(1992-8#1)(1992-9#7)(1993-2#1)(1994-5#5)(1994-8#1)(1995-2#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#4)(1997-8#1)(2008-11#20)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#4)(2008-9#4)(2010-1#5)(2011-1#2)(2011-2#8)(2011-3#3)(2012-3#3)(2013-8#7)
adenovirus-based vector##3##2##(1997-4#1)(2008-2#1)(2008-4#1)
adenovirus-enhanced transferrinfection (AVET)##2##3##(1997-4#2)
adenovirus-mediated##4##1##(1994-5#1)(2008-8#1)(2010-1#2)
adenoviruses##10##1##(1992-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-11#3)(2008-8#1)(2011-2#1)(2013-8#1)
adenylate cyclase activity in coronary vascular smooth muscle cells##2##9##(1990-8#2)
adenylate cyclase activity##6##3##(1990-8#4)(1992-6#1)(1994-8#1)
adenylate cyclase stimulating activity##2##4##(1990-7#1)(1992-9#1)
adenylate cyclase stimulation##2##3##(1990-7#1)(2008-4#1)
adenylate cyclase##34##2##(1990-12#2)(1990-5#1)(1990-7#4)(1990-8#5)(1991-2#3)(1991-9#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#2)(1994-8#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#4)(2010-1#1)
adenylate cyclase-activating##2##2##(1995-11#2)
adenylate energy charge##2##3##(1996-6#1)(2013-1#1)
adenylate kinase (AK)##2##3##(1994-12#1)(2008-8#1)
adenylate kinase from B##2##4##(1992-3#2)
adenylate kinase##10##2##(1992-3#3)(1994-12#1)(2008-4#3)(2008-8#2)(2009-5#1)
adenylate##56##1##(1990-12#2)(1990-5#1)(1990-7#4)(1990-8#5)(1991-2#3)(1991-9#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#7)(2008-7#1)(2008-8#2)(2009-5#1)(2010-1#1)(2013-1#1)
adenylosuccinate synthetase##3##2##(1995-6#3)
adenylsuccinate##3##1##(1995-12#3)
adenylyl cyclase activity##5##3##(1992-3#1)(1994-3#1)(1995-12#2)(2008-4#1)
adenylyl cyclase in##2##3##(1997-1#2)
adenylyl cyclase signal transduction##2##4##(1995-11#2)
adenylyl cyclase was##2##3##(1992-3#2)
adenylyl cyclase##33##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-3#8)(1993-6#1)(1994-3#1)(1995-11#6)(1995-12#3)(1995-6#1)(1995-8#1)(1997-1#3)(1997-2#1)(2008-4#2)(2008-9#2)(2009-8#1)
adenylyl cyclases##3##2##(1992-3#2)(2008-9#1)
adenylyl##37##1##(1990-12#1)(1991-2#1)(1991-9#1)(1992-3#10)(1993-6#1)(1994-3#1)(1995-11#6)(1995-12#3)(1995-6#1)(1995-8#1)(1997-1#3)(1997-2#2)(2008-4#2)(2008-9#3)(2009-8#1)
adequacy and##4##2##(1991-2#1)(1994-3#1)(2007-12#1)(2011-2#1)
adequacy as##2##2##(1992-9#1)(2011-2#1)
adequacy in##2##2##(2007-12#1)(2011-1#1)
adequacy of antimicrobial therapy##2##4##(2013-8#2)
adequacy of##31##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-5#2)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#3)(2012-2#1)(2012-3#2)(2013-8#2)
adequacy scores##4##2##(1993-1#4)
adequacy##56##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#4)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#3)(2007-12#4)(2007-9#2)(2008-1#3)(2008-11#2)(2008-5#3)(2009-10#2)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#5)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#2)
adequate accuracy and##2##3##(2008-3#1)(2011-2#1)
adequate accuracy##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
adequate amounts##4##2##(1995-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
adequate analgesia##2##2##(2008-7#1)(2011-2#1)
adequate and##5##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#1)
adequate arterial##2##2##(2006-10#1)(2008-7#1)
adequate bone##2##2##(2012-12#1)(2013-1#1)
adequate care##4##2##(1990-2#1)(1994-12#1)(2007-7#1)(2011-1#1)
adequate choice of##2##3##(2008-10#1)(2008-11#1)
adequate collateral##2##2##(2007-8#2)
adequate control##4##2##(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
adequate diagnosis##2##2##(2009-8#1)(2012-12#1)
adequate dialysis##4##2##(1996-2#1)(2007-12#1)(2008-1#2)
adequate doses##2##2##(1991-4#1)(2008-6#1)
adequate evaluation##2##2##(1993-11#1)(1997-4#1)
adequate evidence##3##2##(1993-3#1)(2008-10#1)(2010-8#1)
adequate exercise##3##2##(2010-6#1)(2011-1#1)(2012-2#1)
adequate experimental##2##2##(2008-1#1)(2008-10#1)
adequate explanation##3##2##(2008-10#1)(2009-5#1)(2010-8#1)
adequate exposure##3##2##(1990-5#1)(1992-1#1)(2011-2#1)
adequate financial##2##2##(2011-2#1)(2012-12#1)
adequate for a##2##3##(2007-7#1)(2008-10#1)
adequate for the determination of##3##5##(2008-10#3)
adequate for the##10##3##(1995-6#1)(2007-7#1)(2008-10#6)(2008-6#1)(2013-1#1)
adequate for##37##2##(1991-1#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1994-5#1)(1995-6#1)(1995-9#1)(1997-5#1)(1997-8#2)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
adequate function##2##2##(2012-2#1)(2013-1#1)
adequate funding##2##2##(1995-3#1)(2008-11#1)
adequate in##5##2##(1991-12#1)(1992-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
adequate information about the##3##4##(2011-2#1)(2012-2#2)
adequate information##6##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#2)
adequate knowledge of##2##3##(1990-2#1)(1993-2#1)
adequate knowledge##3##2##(1990-2#1)(1993-2#1)(2011-2#1)
adequate maintenance##2##2##(1990-9#1)(1993-9#1)
adequate management##3##2##(1992-2#1)(2008-8#1)(2013-1#1)
adequate medical##4##2##(1993-12#1)(1997-5#1)(1997-8#1)(2007-8#1)
adequate method of##2##3##(2007-8#1)(2012-3#1)
adequate mineral##2##2##(2008-10#1)(2008-8#1)
adequate multidisciplinary##2##2##(1993-11#1)(2009-1#1)
adequate number of##2##3##(1990-2#1)(2008-5#1)
adequate pain relief##2##3##(2008-7#1)(2010-11#1)
adequate performance##2##2##(1996-1#1)(2010-7#1)
adequate precision##2##2##(1990-9#1)(2008-10#1)
adequate preoperative##2##2##(2011-2#2)
adequate preparation##5##2##(1993-6#1)(2008-12#3)(2012-3#1)
adequate prevention##3##2##(2008-1#1)(2011-2#2)
adequate protection against##2##3##(2008-2#1)(2008-5#1)
adequate protection##4##2##(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
adequate return##2##2##(1992-1#1)(2010-6#1)
adequate safety and##2##3##(1996-1#1)(2013-1#1)
adequate sensitivity##5##2##(1993-6#1)(2008-1#1)(2008-10#2)(2008-6#1)
adequate shelf life##3##3##(2008-10#3)
adequate size##2##2##(1996-2#1)(1996-3#1)
adequate smears##2##2##(1990-6#1)(2013-8#1)
adequate staffing##2##2##(1994-1#1)(2009-6#1)
adequate support##2##2##(1991-2#1)(2008-12#1)
adequate time##2##2##(2006-12#1)(2010-8#1)
adequate tissue##3##2##(1992-12#1)(2008-1#1)(2011-2#1)
adequate to##16##2##(1992-12#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#1)
adequate training##2##2##(2008-11#1)(2013-1#1)
adequate treatment of##5##3##(1994-5#1)(1996-12#1)(2006-12#1)(2008-11#1)(2011-2#1)
adequate treatment##14##2##(1990-9#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-12#1)(2008-11#2)(2009-6#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
adequate tutorial support##2##3##(2008-11#2)
adequate##440##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#2)(1991-4#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#4)(1992-12#5)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#4)(1997-7#1)(1997-8#5)(2006-10#1)(2006-12#2)(2007-11#5)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#13)(2008-10#62)(2008-11#24)(2008-12#7)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#10)(2008-6#6)(2008-7#12)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#32)(2011-3#2)(2012-12#14)(2012-2#14)(2012-3#5)(2012-5#1)(2013-1#17)(2013-8#6)
adequately address the##2##3##(2008-1#1)(2010-5#1)
adequately address##3##2##(1997-3#1)(2008-1#1)(2010-5#1)
adequately addressed##2##2##(2012-12#1)(2013-1#1)
adequately assess the##2##3##(2010-11#1)(2013-7#1)
adequately based on##2##3##(2008-11#1)(2010-12#1)
adequately define##2##2##(2008-11#1)(2008-5#1)
adequately describe the##3##3##(2007-11#1)(2008-9#1)(2013-1#1)
adequately described using##2##3##(1996-2#1)(2008-10#1)
adequately described##6##2##(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
adequately examined##2##2##(2012-2#1)(2012-3#1)
adequately explain##2##2##(2008-1#1)(2008-8#1)
adequately explored##2##2##(2012-5#1)(2013-1#1)
adequately fit##2##2##(1997-7#1)(2010-11#1)
adequately prepare##2##2##(2008-12#1)(2011-1#1)
adequately prepared##2##2##(2007-5#1)(2012-3#1)
adequately protect##2##2##(2009-4#1)(2010-1#1)
adequately to##3##2##(2009-11#1)(2012-12#1)(2013-1#1)
adequately with##2##2##(1992-4#1)(2008-12#1)
adequately##112##1##(1990-11#2)(1990-12#1)(1990-3#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-2#1)(1994-8#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
adhaerens HP15 is##2##3##(2011-2#2)
adhaerens HP15##5##2##(2011-2#5)
adhaerens##6##1##(2011-2#6)
adhere and##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
adhere to a##2##3##(2008-1#1)(2008-12#1)
adhere to the##5##3##(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)
adhere to their##2##3##(2008-11#1)(2008-3#1)
adhere to##31##2##(1990-12#1)(1992-3#1)(1995-9#1)(1996-12#2)(1996-3#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)
adhere##41##1##(1990-12#1)(1990-2#1)(1992-3#1)(1995-9#1)(1996-12#2)(1996-3#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#4)(2009-5#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
adhered to the##5##3##(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
adhered to##9##2##(2008-10#4)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)
adhered##14##1##(1996-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)
adherence and##10##2##(1991-5#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
adherence are##2##2##(2008-7#1)(2009-4#1)
adherence improvement strategies##2##3##(1994-3#2)
adherence in##8##2##(2007-10#1)(2008-7#2)(2010-12#1)(2011-1#3)(2012-3#1)
adherence inhibition##2##2##(1991-12#2)
adherence is##2##2##(2008-3#1)(2010-11#1)
adherence measures##2##2##(2009-9#1)(2010-11#1)
adherence of human##2##3##(1991-7#1)(1993-9#1)
adherence of the##2##3##(2008-10#1)(2008-9#1)
adherence of##18##2##(1991-7#1)(1993-9#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#3)
adherence or##2##2##(2008-4#1)(2008-7#1)
adherence rates##2##2##(2012-3#2)
adherence than##2##2##(2008-3#1)(2008-4#1)
adherence to a##2##3##(1996-11#1)(2011-2#1)
adherence to dietary##2##3##(2008-1#1)(2008-10#1)
adherence to epithelial cells##2##4##(2008-10#1)(2008-5#1)
adherence to epithelial##3##3##(2008-10#1)(2008-5#2)
adherence to hair##2##3##(2008-5#2)
adherence to infection##3##3##(2008-1#1)(2011-2#2)
adherence to the##13##3##(1992-6#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-12#2)
adherence to their##2##3##(1994-3#1)(2008-8#1)
adherence to treatment##3##3##(2010-12#1)(2012-12#1)(2012-3#1)
adherence to##67##2##(1991-3#1)(1992-12#1)(1992-6#1)(1994-3#3)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-6#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
adherence was##4##2##(2008-11#1)(2013-8#3)
adherence were##2##2##(2008-10#1)(2008-4#1)
adherence with antihypertensive therapies##2##4##(2008-3#2)
adherence with antihypertensive##4##3##(2008-3#4)
adherence with##8##2##(1997-7#1)(2008-3#5)(2009-9#1)(2010-9#1)
adherence##200##1##(1991-12#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#8)(1992-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#7)(1994-9#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#20)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-4#5)(2009-7#3)(2009-8#1)(2009-9#3)(2010-11#6)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#13)(2011-2#9)(2012-12#5)(2012-2#4)(2012-3#10)(2013-1#9)(2013-8#8)
adherens junction (AJ)##3##3##(2008-9#1)(2009-10#1)(2012-2#1)
adherens junctions##3##2##(1991-5#1)(2009-10#1)(2009-3#1)
adherens##6##1##(1991-5#1)(2008-9#1)(2009-10#2)(2009-3#1)(2012-2#1)
adherent and nonadherent##2##3##(2008-10#2)
adherent and suspension cells##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
adherent and suspension##5##3##(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)
adherent and##9##2##(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2011-1#1)
adherent cell monolayers##2##3##(2008-4#2)
adherent cell##3##2##(2008-4#2)(2009-7#1)
adherent cells and##2##3##(2008-11#1)(2008-2#1)
adherent cells or##2##3##(2008-2#1)(2010-11#1)
adherent cells was##3##3##(2008-10#1)(2008-11#2)
adherent cells##24##2##(1992-2#1)(1995-5#1)(2008-10#1)(2008-11#8)(2008-2#2)(2008-4#1)(2008-9#1)(2010-10#2)(2010-11#4)(2010-6#1)(2011-2#1)(2012-4#1)
adherent cultures##3##2##(1991-6#1)(2008-11#1)(2008-4#1)
adherent placenta##3##2##(1995-12#2)(2013-1#1)
adherent to the##4##3##(2007-8#1)(2008-7#1)(2010-12#1)(2010-4#1)
adherent to##5##2##(2007-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-4#1)
adherent##72##1##(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-2#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-5#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#14)(2008-12#1)(2008-2#4)(2008-4#6)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
adherente##2##1##(2008-5#2)
adherently##2##1##(2008-11#2)
adheres to the##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2011-1#1)
adheres##6##1##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2011-1#1)(2012-2#1)
adhering and##2##2##(1991-12#1)(2011-2#1)
adhering to the##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
adhering to##8##2##(1990-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
adhering##16##1##(1990-12#1)(1991-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#2)(2011-2#2)
adhesin families##2##2##(2011-1#2)
adhesin##6##1##(1996-12#1)(2008-10#2)(2009-6#1)(2011-1#2)
adhesins and##3##2##(1995-2#1)(2006-6#1)(2013-1#1)
adhesins##9##1##(1995-2#1)(1996-12#1)(2006-6#1)(2008-10#2)(2011-1#2)(2013-1#2)
adhesiolysis during##2##2##(1991-3#1)(2008-5#1)
adhesiolysis for##2##2##(1993-1#1)(1993-3#1)
adhesiolysis##11##1##(1991-3#4)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
adhesion and biofilm formation##3##4##(2007-12#1)(2010-4#1)(2013-1#1)
adhesion and cell##2##3##(2012-2#2)
adhesion and growth##2##3##(2008-11#1)(2013-1#1)
adhesion and metabolism##2##3##(2008-11#2)
adhesion and proliferation##2##3##(2008-5#2)
adhesion and spreading##2##3##(2008-9#2)
adhesion and##41##2##(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-6#1)(2011-1#1)(2012-2#4)(2012-8#1)(2013-1#3)
adhesion are##5##2##(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#2)
adhesion assay##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
adhesion assays##2##2##(2008-1#1)(2008-4#1)
adhesion behavior##2##2##(1990-8#1)(1995-8#1)
adhesion between cells and##2##4##(1994-6#1)(2011-1#1)
adhesion between##3##2##(1994-6#1)(2008-7#1)(2011-1#1)
adhesion complex##3##2##(1993-6#2)(1994-9#1)
adhesion culture##2##2##(2008-11#2)
adhesion deficiency type 1##2##4##(2011-2#1)(2012-12#1)
adhesion deficiency type##3##3##(2011-2#2)(2012-12#1)
adhesion deficiency##5##2##(2011-2#4)(2012-12#1)
adhesion energies##2##2##(2010-4#2)
adhesion factor##2##2##(1993-9#1)(2008-11#1)
adhesion force and##2##3##(2008-11#2)
adhesion force##4##2##(2008-10#1)(2008-11#3)
adhesion formation and reproductive outcome##2##5##(1992-3#2)
adhesion formation and##4##3##(1991-1#1)(1992-1#1)(1992-3#2)
adhesion formation in##2##3##(1992-2#1)(1995-12#1)
adhesion formation##14##2##(1991-1#2)(1992-1#3)(1992-2#1)(1992-3#5)(1995-12#2)(1996-2#1)
adhesion in the##4##3##(1995-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
adhesion in##5##2##(1992-9#1)(1995-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
adhesion is##3##2##(2008-12#1)(2008-9#1)(2010-4#1)
adhesion may be##2##3##(2006-6#1)(2008-8#1)
adhesion molecule##21##2##(1990-11#1)(1991-5#1)(1993-8#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-6#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#4)(2009-9#1)(2013-1#1)
adhesion molecule-1##9##2##(1993-8#1)(1995-12#2)(2006-7#1)(2008-5#1)(2009-10#1)(2010-1#1)(2012-2#1)(2012-3#1)
adhesion molecules and##4##3##(1994-9#1)(1996-2#1)(2008-1#1)(2009-8#1)
adhesion molecules on##2##3##(1994-9#1)(1996-2#1)
adhesion molecules##22##2##(1994-9#3)(1995-5#1)(1996-12#1)(1996-2#3)(1997-7#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#4)(2012-2#1)
adhesion of bacteria to##2##4##(2006-6#1)(2013-8#1)
adhesion of cells##2##3##(2008-11#1)(2011-1#1)
adhesion of human##2##3##(1990-2#1)(1997-7#1)
adhesion of monocytes to the endothelial cells##2##7##(1995-12#2)
adhesion of monocytes##4##3##(1992-12#1)(1995-12#2)(1997-8#1)
adhesion of platelets to a##2##5##(1997-7#2)
adhesion of platelets to##3##4##(1997-7#3)
adhesion of platelets##4##3##(1997-7#4)
adhesion of the##5##3##(2006-6#1)(2008-10#1)(2009-7#1)(2010-4#1)(2012-2#1)
adhesion of##34##2##(1990-2#1)(1990-9#1)(1992-12#1)(1993-8#1)(1995-12#3)(1996-12#1)(1997-7#6)(1997-8#1)(2006-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#1)
adhesion on##4##2##(2008-11#2)(2009-11#1)(2011-2#1)
adhesion onto##2##2##(1996-12#1)(2010-1#1)
adhesion or##3##2##(1993-3#1)(2009-7#1)(2011-2#1)
adhesion promoters##2##2##(2008-5#1)(2010-4#1)
adhesion properties##5##2##(2008-10#4)(2008-5#1)
adhesion rates##4##2##(2008-11#4)
adhesion receptor##2##2##(1994-9#1)(2008-3#1)
adhesion reformation##3##2##(1992-1#3)
adhesion sites##3##2##(2008-7#1)(2012-12#1)(2013-7#1)
adhesion system##2##2##(1991-5#1)(1994-11#1)
adhesion tension##3##2##(1997-1#2)(2008-5#1)
adhesion to and##2##3##(1995-2#1)(2013-1#1)
adhesion to endothelial cells##4##4##(1992-12#1)(1995-12#2)(2009-3#1)
adhesion to mucus##2##3##(2012-1#2)
adhesion to the##8##3##(1992-9#1)(1994-6#1)(1996-2#1)(2008-11#2)(2009-10#1)(2011-1#1)(2012-3#1)
adhesion to vascular endothelium##2##4##(1992-12#1)(1996-2#1)
adhesion to##38##2##(1990-5#1)(1990-8#2)(1992-12#3)(1992-9#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#3)(1997-4#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2009-10#2)(2009-3#2)(2011-1#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)
adhesion under flow##2##3##(2008-1#2)
adhesion under##6##2##(1992-12#1)(2008-1#3)(2008-4#2)
adhesion was##5##2##(2008-11#1)(2010-4#1)(2012-2#1)(2013-1#2)
adhesion##379##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-5#2)(1992-1#6)(1992-12#10)(1992-2#1)(1992-3#6)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#6)(1993-8#3)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-9#8)(1995-12#10)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-12#6)(1996-2#11)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#2)(1997-7#8)(1997-8#1)(2006-6#5)(2006-7#1)(2007-12#2)(2008-1#13)(2008-10#18)(2008-11#36)(2008-12#2)(2008-3#3)(2008-4#10)(2008-5#17)(2008-7#12)(2008-8#5)(2008-9#9)(2009-10#5)(2009-11#4)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#12)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-2#2)(2010-4#12)(2010-6#1)(2011-1#7)(2011-2#7)(2012-1#4)(2012-12#6)(2012-2#24)(2012-3#4)(2012-5#1)(2012-8#2)(2013-1#12)(2013-7#3)(2013-8#2)
adhesionculture##2##1##(2008-11#2)
adhesions can be##2##3##(1991-3#1)(1995-2#1)
adhesions causing##2##2##(1992-2#1)(2011-2#1)
adhesions or##2##2##(1991-2#1)(2007-8#1)
adhesions were##3##2##(1994-9#1)(1995-2#1)(2008-9#1)
adhesions##31##1##(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#4)(1994-12#2)(1994-2#1)(1994-9#2)(1995-12#1)(1995-2#4)(1996-1#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
adhesive AH109A cells##3##3##(2008-11#3)
adhesive and##4##2##(1994-9#1)(2008-12#1)(2008-8#2)
adhesive bond##3##2##(2010-4#3)
adhesive bonding and finishing protocols##2##5##(2008-7#2)
adhesive cells##4##2##(2008-11#2)(2008-9#2)
adhesive failures##2##2##(2013-1#2)
adhesive forces##2##2##(2008-1#1)(2009-6#1)
adhesive is##4##2##(2008-3#2)(2013-1#2)
adhesive joint##3##2##(2010-4#3)
adhesive molecules##2##2##(1993-9#1)(2006-10#1)
adhesive papillae##3##2##(2008-5#3)
adhesive properties of##2##3##(2010-4#1)(2012-2#1)
adhesive properties##4##2##(1990-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
adhesive protein##2##2##(1993-6#1)(1994-6#1)
adhesive rehabilitation##2##2##(2009-8#2)
adhesive system##7##2##(1990-5#1)(2008-12#3)(2009-8#1)(2010-9#1)(2013-1#1)
adhesive systems##3##2##(2008-12#2)(2013-1#1)
adhesive tape##2##2##(2007-11#1)(2008-5#1)
adhesive##100##1##(1990-11#2)(1990-5#1)(1990-8#1)(1991-3#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#2)(1995-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#8)(2008-3#7)(2008-4#1)(2008-5#9)(2008-7#6)(2008-8#7)(2008-9#3)(2009-6#1)(2009-8#7)(2010-4#7)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#8)
adhesiveness of##3##2##(1992-9#2)(1995-12#1)
adhesiveness##8##1##(1990-11#1)(1992-9#2)(1994-11#1)(1995-12#1)(1996-6#1)(1997-1#1)(2011-2#1)
adhesives##12##1##(1990-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-9#1)(2010-10#1)(2010-4#2)(2011-2#1)
adiabatic mode transformation in##2##4##(2007-11#1)(2007-12#1)
adiabatic##13##1##(1992-7#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)
adiabatically transformed into a##2##4##(2007-12#1)(2012-2#1)
adiabatically##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#2)
adipate##2##1##(2008-10#2)
adipic acid##3##2##(2008-10#2)(2008-5#1)
adipic##5##1##(2008-10#3)(2008-5#1)(2009-11#1)
adipocyte differentiation of 3T3-L1##2##4##(2008-3#2)
adipocyte differentiation##11##2##(1990-4#1)(1994-12#2)(2008-11#1)(2008-3#7)
adipocyte precursor cells##4##3##(1992-9#1)(2008-11#1)(2008-5#2)
adipocyte precursor##5##2##(1992-9#2)(2008-11#1)(2008-5#2)
adipocyte specific##2##2##(2011-2#2)
adipocyte##36##1##(1990-4#1)(1992-12#1)(1992-9#5)(1994-11#2)(1994-12#3)(2006-8#1)(2008-11#6)(2008-3#7)(2008-5#5)(2011-2#4)(2012-2#1)
adipocyte-derived##4##1##(1990-4#1)(2009-2#3)
adipocytes after##2##2##(1994-6#1)(2008-11#1)
adipocytes and appears to be##2##5##(2008-1#1)(2008-5#1)
adipocytes and##7##2##(1994-8#1)(1995-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2012-4#1)
adipocytes are##2##2##(1990-4#1)(2010-10#1)
adipocytes from##4##2##(1991-12#1)(1993-6#1)(1994-6#1)(2011-2#1)
adipocytes is##2##2##(1990-4#1)(2008-8#1)
adipocytes to##3##2##(1994-6#2)(2008-3#1)
adipocytes with the##2##3##(1993-8#1)(1994-8#1)
adipocytes with##4##2##(1991-12#1)(1993-8#1)(1994-8#1)(2011-2#1)
adipocytes##75##1##(1990-11#2)(1990-4#3)(1991-12#7)(1992-11#1)(1993-6#3)(1993-8#2)(1994-6#4)(1994-8#2)(1995-8#4)(1997-1#2)(2006-8#1)(2008-1#1)(2008-11#8)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#10)(2012-2#4)(2012-4#2)(2012-5#1)(2013-1#1)
adipocytes)##2##1##(1994-8#2)
adipocytokine##3##1##(2008-3#2)(2013-8#1)
adipocytokines##4##1##(2008-3#1)(2010-10#3)
adipogenesis and osteogenesis##2##3##(2008-11#2)
adipogenesis and##4##2##(2008-11#2)(2008-5#1)(2010-10#1)
adipogenesis in##2##2##(1994-12#1)(2008-11#1)
adipogenesis of##2##2##(2008-11#2)
adipogenesis##19##1##(1994-12#1)(1997-2#1)(2008-11#11)(2008-3#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
adipogenic genes##4##2##(2010-4#3)(2012-2#1)
adipogenic transcriptional factors##2##3##(2008-5#2)
adipogenic transcriptional##3##2##(2008-5#2)(2012-2#1)
adipogenic##17##1##(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2010-4#3)(2012-2#5)(2013-1#1)
adipokine##2##1##(2012-2#1)(2013-1#1)
adipokines##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
adiponectin and##5##2##(2008-3#1)(2011-1#2)(2013-1#2)
adiponectin concentrations##2##2##(2011-1#2)
adiponectin gene and##3##3##(2011-1#3)
adiponectin gene##9##2##(2011-1#8)(2011-2#1)
adiponectin level was associated with##2##5##(2011-1#1)(2013-1#1)
adiponectin level##6##2##(2011-1#5)(2013-1#1)
adiponectin levels in##5##3##(2010-11#1)(2011-1#3)(2012-1#1)
adiponectin levels were##4##3##(2011-1#4)
adiponectin levels##16##2##(2010-11#1)(2011-1#11)(2012-1#1)(2013-1#2)(2013-8#1)
adiponectin##48##1##(2008-3#2)(2010-11#1)(2011-1#35)(2011-2#1)(2012-1#1)(2013-1#7)(2013-8#1)
adipose and##4##2##(1990-11#1)(2007-12#1)(2008-3#1)(2010-6#1)
adipose cells##7##2##(1990-11#3)(1990-12#2)(1992-9#1)(2008-10#1)
adipose eyelid##6##2##(2010-8#6)
adipose precursor cells##4##3##(1990-11#3)(1993-6#1)
adipose tissue and liver##2##4##(1996-2#1)(2008-1#1)
adipose tissue and the##2##4##(1990-9#1)(1995-6#1)
adipose tissue and##7##3##(1990-12#1)(1990-9#1)(1995-6#1)(1996-2#1)(2008-1#2)(2008-11#1)
adipose tissue by cold vapour atomic fluorescence spectrometry##2##8##(2008-10#2)
adipose tissue development##3##3##(1993-6#1)(2008-5#1)(2011-2#1)
adipose tissue hormones##3##3##(2012-3#1)(2013-8#2)
adipose tissue in##5##3##(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)
adipose tissue inflammation and insulin resistance in##2##7##(2012-2#2)
adipose tissue inflammation##3##3##(2012-2#3)
adipose tissue is##4##3##(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
adipose tissue mass##2##3##(2012-2#2)
adipose tissue to the##2##4##(2008-6#1)(2011-2#1)
adipose tissue was##2##3##(2008-3#1)(2010-8#1)
adipose tissue##84##2##(1990-12#1)(1990-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#7)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#9)(2008-6#1)(2009-10#1)(2009-2#2)(2009-5#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-2#4)(2012-2#10)(2012-3#1)(2012-8#3)(2013-1#4)(2013-8#2)
adipose tissue)##2##2##(2013-1#2)
adipose tissues of##2##3##(2010-4#2)
adipose tissues##5##2##(2008-11#1)(2008-9#1)(2010-4#2)(2013-8#1)
adipose##123##1##(1990-11#7)(1990-12#3)(1990-9#1)(1992-9#2)(1993-3#1)(1993-6#2)(1994-12#2)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#8)(2008-2#1)(2008-3#13)(2008-4#2)(2008-5#11)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2010-4#3)(2010-6#4)(2010-7#1)(2010-8#8)(2011-2#4)(2012-2#10)(2012-3#1)(2012-5#1)(2012-8#3)(2013-1#7)(2013-8#3)
adipose-derived stem cells (ADSCs)##2##4##(2012-12#1)(2012-3#1)
adipose-derived stem cells##8##3##(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2012-5#2)(2012-6#1)
adipose-derived##10##1##(2009-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#2)(2012-5#2)(2012-6#1)
adiposity and##5##2##(1996-11#1)(2008-1#1)(2010-3#1)(2012-2#1)(2012-5#1)
adiposity##22##1##(1996-11#1)(2008-1#1)(2008-3#1)(2010-3#1)(2010-6#2)(2012-2#14)(2012-5#1)(2013-1#1)
adjBMI##2##1##(2008-12#2)
adjacency##6##1##(1996-3#1)(2007-11#4)(2008-8#1)
adjacent anatomic##2##2##(2012-3#1)(2013-1#1)
adjacent areas of##2##3##(1995-11#1)(2007-10#1)
adjacent areas##6##2##(1995-11#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
adjacent basic##2##2##(1992-3#1)(1995-8#1)
adjacent cell##2##2##(1990-11#1)(2009-8#1)
adjacent cells##8##2##(1994-6#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)
adjacent genes##2##2##(1990-11#1)(2008-7#1)
adjacent in##2##2##(1992-6#1)(1995-5#1)
adjacent lateral##2##2##(1992-5#1)(1994-3#1)
adjacent longitudinal modes of##2##4##(2007-12#1)(2008-3#1)
adjacent markers##2##2##(1997-5#1)(2012-3#1)
adjacent mesophyll cells##2##3##(2008-10#1)(2012-2#1)
adjacent muscle tissue##2##3##(1992-9#1)(2007-10#1)
adjacent muscle##3##2##(1992-9#1)(2007-10#1)(2008-10#1)
adjacent nonexposed##2##2##(2008-10#2)
adjacent nt##2##2##(1997-4#2)
adjacent peaks##2##2##(2008-10#2)
adjacent pixels##3##2##(2008-3#1)(2013-8#2)
adjacent plants##3##2##(2008-10#3)
adjacent proteins in##2##3##(2010-12#1)(2011-3#1)
adjacent proteins##3##2##(2010-12#1)(2011-3#2)
adjacent segment disease (ASD)##2##4##(2012-12#1)(2012-3#1)
adjacent segment disease##4##3##(2012-12#2)(2012-3#2)
adjacent segment##6##2##(2012-12#3)(2012-3#3)
adjacent skin##3##2##(2008-12#1)(2009-5#2)
adjacent structure##2##2##(2013-1#2)
adjacent structures##4##2##(1992-11#1)(1993-3#1)(2007-5#1)(2009-3#1)
adjacent tissue##2##2##(2012-1#1)(2013-8#1)
adjacent tissues##5##2##(1990-5#1)(1992-8#1)(1992-9#1)(2007-4#1)(2010-12#1)
adjacent to a##4##3##(1996-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
adjacent to leaf##2##3##(2008-10#2)
adjacent to strawberry fields##2##4##(2008-10#2)
adjacent to the 5'##2##4##(2008-10#1)(2012-2#1)
adjacent to the gene##2##4##(1992-3#1)(1995-8#1)
adjacent to the rab GDP dissociation inhibitor##2##7##(1996-10#2)
adjacent to the##41##3##(1992-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#2)(1996-5#1)(1997-3#2)(1997-7#2)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
adjacent to##86##2##(1992-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-10#3)(1996-2#1)(1996-5#2)(1997-3#2)(1997-7#4)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#27)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
adjacent trees##8##2##(2008-10#8)
adjacent##335##1##(1990-11#3)(1990-5#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#7)(1995-8#4)(1996-10#3)(1996-2#3)(1996-5#5)(1996-8#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#6)(2007-10#3)(2007-11#3)(2007-12#16)(2007-4#1)(2007-5#3)(2008-1#4)(2008-10#73)(2008-11#2)(2008-12#5)(2008-2#5)(2008-3#14)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#5)(2009-10#6)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-12#4)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#9)(2013-1#12)(2013-8#4)
adjective##5##1##(1993-2#1)(2008-11#4)
adjoining areas##2##2##(2007-7#1)(2013-1#1)
adjoining##10##1##(1990-3#1)(1990-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-1#1)
adjoint##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
adjudged to be##2##3##(1992-11#1)(2013-8#1)
adjudicated##2##1##(2008-8#1)(2010-10#1)
adjudin##7##1##(2012-2#7)
adjunct for##2##2##(2008-9#1)(2011-2#1)
adjunct in##3##2##(1993-1#1)(1997-8#1)(2007-8#1)
adjunct or##2##2##(2008-10#1)(2008-8#1)
adjunct therapies##2##2##(2008-11#1)(2011-2#1)
adjunct therapy in##2##3##(1992-5#1)(2008-7#1)
adjunct therapy with levodopa##2##4##(2008-7#2)
adjunct therapy with##3##3##(2008-7#3)
adjunct therapy##6##2##(1992-5#1)(2008-7#5)
adjunct to conventional##2##3##(2008-6#1)(2010-3#1)
adjunct to the##4##3##(1994-3#1)(1995-2#1)(2007-8#1)(2013-1#1)
adjunct to##32##2##(1990-10#1)(1991-8#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#3)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
adjunct treatment##2##2##(2008-11#2)
adjunct##57##1##(1990-10#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#3)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#2)
adjunctive therapies##4##2##(2008-4#1)(2011-2#1)(2013-1#2)
adjunctive therapy in##3##3##(1994-12#1)(2011-2#2)
adjunctive therapy##8##2##(1994-12#1)(2008-5#1)(2008-7#1)(2011-10#1)(2011-2#3)(2012-1#1)
adjunctive treatment for##2##3##(2009-9#1)(2013-8#1)
adjunctive treatment in##2##3##(2008-7#1)(2011-2#1)
adjunctive treatment of##4##3##(1992-9#1)(2006-12#1)(2011-1#1)(2011-2#1)
adjunctive treatment with##5##3##(2006-12#1)(2008-6#4)
adjunctive treatment##14##2##(1992-9#1)(1994-11#1)(2006-12#2)(2008-6#4)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
adjunctive use of##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
adjunctive##50##1##(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-5#1)(1996-3#1)(1997-8#1)(2006-12#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
adjuncts to##7##2##(1992-12#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
adjuncts##9##1##(1992-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)
adjust expenditures##2##2##(1992-12#2)
adjust for##12##2##(1990-8#1)(1991-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-3#1)
adjust payments##2##2##(1995-2#1)(1997-1#1)
adjust the##18##2##(1991-12#1)(1994-9#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-8#4)(2008-9#1)(2010-8#1)(2011-3#1)
adjust their intentions##2##3##(2009-12#2)
adjust their##7##2##(2008-2#1)(2008-4#1)(2009-12#2)(2009-6#1)(2012-3#1)(2012-5#1)
adjust to##5##2##(1995-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
adjust##63##1##(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1992-12#2)(1993-12#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-12#3)(2009-4#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-3#2)(2012-5#1)(2013-7#1)
adjustable parameter##2##2##(2008-10#1)(2008-3#1)
adjustable parameters##2##2##(2008-2#1)(2008-7#1)
adjustable##31##1##(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#4)
adjusted according to the##3##4##(1991-6#1)(2008-12#1)(2008-7#1)
adjusted and##2##2##(2008-10#1)(2011-2#1)
adjusted as##2##2##(2008-7#1)(2009-12#1)
adjusted average per capita cost (AAPCC) formula##2##7##(1993-3#2)
adjusted average per capita cost (AAPCC)##3##6##(1991-3#1)(1993-3#2)
adjusted average per capita##4##4##(1991-3#1)(1993-3#2)(1996-3#1)
adjusted by the##3##3##(2008-3#1)(2010-5#1)(2013-8#1)
adjusted by##12##2##(1993-12#1)(2007-12#1)(2008-10#6)(2008-3#2)(2010-5#1)(2013-8#1)
adjusted for age and sex##2##5##(1995-11#1)(1995-5#1)
adjusted for age##8##3##(1995-11#1)(1995-5#1)(2008-11#1)(2009-7#1)(2010-5#1)(2011-2#3)
adjusted for confounders##2##3##(2008-8#1)(2012-2#1)
adjusted for differences in##2##4##(1990-9#1)(1995-3#1)
adjusted for maternal age##2##4##(1995-6#1)(2010-6#1)
adjusted for the##3##3##(1995-2#1)(2010-4#1)(2011-2#1)
adjusted for##33##2##(1990-9#1)(1993-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
adjusted in##2##2##(2008-10#1)(2012-3#1)
adjusted incidence##3##2##(1994-12#1)(1994-2#1)(2008-4#1)
adjusted life years##2##3##(2012-12#2)
adjusted odds ratio (OR)##2##4##(2007-10#1)(2008-6#1)
adjusted odds ratios##3##3##(1993-9#1)(2008-11#1)(2013-1#1)
adjusted odds##5##2##(1993-9#1)(2007-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
adjusted relative risk##3##3##(1993-9#1)(2008-6#2)
adjusted relative##4##2##(1993-9#1)(2008-3#1)(2008-6#2)
adjusted sedentary behavior indicators for physical activity##2##7##(2013-1#2)
adjusted so that##2##3##(1997-2#1)(2007-12#1)
adjusted the##2##2##(1996-2#1)(2011-2#1)
adjusted their##2##2##(1996-5#1)(2008-8#1)
adjusted to 5##2##3##(2008-10#1)(2010-5#1)
adjusted to maintain##2##3##(2007-7#1)(2008-2#1)
adjusted to pH 2##3##4##(1996-5#1)(2008-10#2)
adjusted to pH 3##3##4##(2008-10#3)
adjusted to pH 4##2##4##(2008-10#2)
adjusted to pH 6##2##4##(2008-10#1)(2008-7#1)
adjusted to pH##14##3##(1996-5#1)(2008-10#12)(2008-7#1)
adjusted to the clinical severity level##2##6##(2009-6#2)
adjusted to the##9##3##(1990-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#2)(2011-2#1)
adjusted to##55##2##(1990-6#1)(1990-8#1)(1992-12#1)(1992-2#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-6#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
adjusted with a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
adjusted with##12##2##(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
adjusted##195##1##(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-9#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#55)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#3)(2009-12#1)(2009-6#2)(2009-7#3)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#11)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
adjusters for##3##2##(1993-3#1)(1994-3#2)
adjusters##5##1##(1993-3#2)(1994-3#2)(1997-1#1)
adjusting for age and##2##4##(2007-10#1)(2008-3#1)
adjusting for age##9##3##(2007-10#2)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
adjusting for confounding factors##2##4##(2011-1#1)(2012-12#1)
adjusting for other##5##3##(1992-12#1)(1995-12#1)(2009-6#1)(2012-2#1)(2012-5#1)
adjusting for patient##2##3##(2012-1#1)(2012-3#1)
adjusting for potential confounders##3##4##(2009-3#1)(2013-1#2)
adjusting for potential##4##3##(2009-3#1)(2010-11#1)(2013-1#2)
adjusting for relevant##2##3##(2010-6#1)(2013-1#1)
adjusting for the##2##3##(1995-12#1)(2012-3#1)
adjusting for##45##2##(1992-12#1)(1993-12#2)(1994-2#2)(1995-12#2)(1995-2#1)(1995-9#1)(1997-7#1)(2007-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#3)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#2)(2013-1#5)(2013-8#1)
adjusting services##2##2##(1992-2#2)
adjusting the level of##2##4##(2008-11#1)(2012-2#1)
adjusting the pH##2##3##(2008-10#1)(2013-1#1)
adjusting the##33##2##(1990-2#1)(1992-10#1)(1992-2#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
adjusting to##2##2##(2008-7#1)(2010-5#1)
adjusting##103##1##(1990-2#1)(1991-1#1)(1992-10#1)(1992-12#2)(1992-2#6)(1993-12#3)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#3)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-1#3)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#3)(2012-5#2)(2013-1#7)(2013-8#1)
adjustment and##16##2##(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-11#2)(2009-7#1)(2009-8#2)(2010-2#1)(2012-7#1)(2013-1#3)
adjustment are##3##2##(1994-1#1)(2008-8#1)(2012-7#1)
adjustment as##2##2##(1995-2#1)(2009-11#1)
adjustment by##3##2##(1990-12#1)(1997-1#1)(2007-2#1)
adjustment difficulties##2##2##(2013-8#2)
adjustment disorders##2##2##(2010-5#1)(2013-8#1)
adjustment factor##2##2##(1991-3#1)(2012-7#1)
adjustment factors##2##2##(1996-12#1)(1996-2#1)
adjustment for a##2##3##(1991-8#1)(1994-3#1)
adjustment for age##2##3##(1991-12#1)(2008-3#1)
adjustment for confounders##2##3##(2008-8#1)(2010-6#1)
adjustment for confounding##2##3##(1992-9#1)(2010-1#1)
adjustment for potential confounding##2##4##(2008-4#1)(2010-1#1)
adjustment for potential##3##3##(2008-4#1)(2010-1#1)(2011-1#1)
adjustment for##33##2##(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-9#1)(1994-3#1)(1995-12#1)(1997-1#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
adjustment formula##2##2##(1992-12#2)
adjustment in the##5##3##(1992-12#1)(1995-3#1)(2008-2#1)(2010-7#1)(2011-2#1)
adjustment in##14##2##(1991-1#1)(1992-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-2#1)(2009-7#1)(2010-1#2)(2010-7#2)(2011-2#1)
adjustment is not##2##3##(2008-2#1)(2009-11#1)
adjustment is required##2##3##(1995-2#1)(2008-2#1)
adjustment is##8##2##(1993-11#1)(1995-2#1)(2008-2#3)(2008-7#1)(2009-11#1)(2009-12#1)
adjustment of children##2##3##(1993-1#1)(1996-1#1)
adjustment of the##29##3##(1990-12#1)(1992-2#1)(2007-11#4)(2007-12#7)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#1)
adjustment of##51##2##(1990-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1995-2#1)(1996-1#1)(1997-8#1)(2007-11#6)(2007-12#8)(2007-8#3)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#7)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-3#1)
adjustment or##4##2##(2007-11#1)(2013-1#3)
adjustment problems##6##2##(2009-7#2)(2009-8#3)(2010-7#1)
adjustment than##2##2##(2009-7#2)
adjustment to##5##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
adjustment was##2##2##(2010-8#1)(2011-1#1)
adjustment##244##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#4)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#6)(1992-2#6)(1992-3#3)(1992-5#1)(1992-9#2)(1993-1#7)(1993-11#1)(1993-12#2)(1994-1#1)(1994-3#1)(1995-12#2)(1995-2#8)(1995-3#4)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#5)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#7)(2007-12#15)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#11)(2009-12#1)(2009-6#1)(2009-7#11)(2009-8#10)(2010-1#6)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#2)(2012-7#3)(2013-1#12)(2013-8#5)
adjustments and##5##2##(1991-3#1)(1994-3#1)(1995-12#1)(2007-12#1)(2010-7#1)
adjustments are##3##2##(1991-1#1)(1991-12#1)(2008-1#1)
adjustments can##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
adjustments for##6##2##(1992-12#1)(1995-5#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-6#1)
adjustments have been made##2##4##(1992-12#1)(2008-10#1)
adjustments in the##2##3##(1992-3#1)(2007-11#1)
adjustments in##6##2##(1992-3#1)(1993-1#1)(2007-11#1)(2007-12#1)(2010-7#1)(2013-8#1)
adjustments of the##2##3##(2008-10#1)(2012-3#1)
adjustments of##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2010-6#1)(2012-3#1)
adjustments to the##5##3##(1991-3#1)(1993-3#1)(1996-1#1)(2008-9#2)
adjustments to##8##2##(1991-1#1)(1991-3#1)(1993-3#1)(1996-1#1)(2008-6#1)(2008-9#2)(2010-3#1)
adjustments##59##1##(1990-6#1)(1991-1#3)(1991-12#1)(1991-3#2)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#2)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-4#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#5)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-3#1)(2010-6#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
adjusts the##2##2##(2007-12#1)(2012-2#1)
adjusts##6##1##(1994-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
adjuvant RT##3##2##(2007-10#2)(2008-6#1)
adjuvant activity##4##2##(1997-4#2)(2010-5#2)
adjuvant and##3##2##(1996-9#1)(2008-3#1)(2008-7#1)
adjuvant arthritis##2##2##(2013-1#1)(2013-8#1)
adjuvant chemoendocrine##2##2##(1994-7#1)(1997-7#1)
adjuvant chemotherapy for##3##3##(1995-9#1)(2012-12#1)(2013-1#1)
adjuvant chemotherapy in patients##2##4##(2008-10#1)(2008-6#1)
adjuvant chemotherapy in##4##3##(1991-8#1)(2008-10#1)(2008-6#2)
adjuvant chemotherapy was##2##3##(2010-3#1)(2013-8#1)
adjuvant chemotherapy##29##2##(1991-8#1)(1992-10#1)(1993-11#1)(1993-9#1)(1995-9#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-6#5)(2008-7#1)(2010-3#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
adjuvant containing##2##2##(1991-5#2)
adjuvant external##2##2##(1990-10#1)(2008-6#1)
adjuvant for##4##2##(1991-5#1)(1995-2#1)(2007-11#1)(2011-2#1)
adjuvant in##3##2##(1990-2#1)(2007-7#1)(2009-1#1)
adjuvant or##4##2##(1995-5#1)(2007-10#1)(2008-11#1)(2008-6#1)
adjuvant radiation therapy##5##3##(1992-12#2)(1994-8#1)(2008-6#1)(2012-1#1)
adjuvant radiation##7##2##(1992-12#2)(1994-8#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
adjuvant radiotherapy of##2##3##(1990-10#1)(1992-12#1)
adjuvant radiotherapy##9##2##(1990-10#1)(1992-12#3)(1993-12#1)(1994-3#1)(2007-10#2)(2013-1#1)
adjuvant systemic therapy##6##3##(1995-4#2)(1996-11#1)(2007-5#2)(2008-10#1)
adjuvant systemic treatment##2##3##(1993-1#1)(2007-5#1)
adjuvant systemic##8##2##(1993-1#1)(1995-4#2)(1996-11#1)(2007-5#3)(2008-10#1)
adjuvant tamoxifen##2##2##(1991-4#1)(2008-10#1)
adjuvant therapies##5##2##(1993-11#1)(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)
adjuvant therapy for patients##2##4##(1997-7#1)(2008-7#1)
adjuvant therapy for##6##3##(1992-8#1)(1997-7#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-2#1)
adjuvant therapy in##3##3##(1992-11#1)(1997-7#1)(2008-7#1)
adjuvant therapy of##4##3##(1993-11#2)(1993-2#1)(2010-7#1)
adjuvant therapy##32##2##(1990-10#2)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1997-7#2)(2008-10#2)(2008-6#4)(2008-7#2)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
adjuvant treatment of##4##3##(1992-8#1)(1993-11#1)(2010-7#1)(2013-1#1)
adjuvant treatment with##2##3##(2010-6#1)(2012-3#1)
adjuvant treatment##12##2##(1990-9#1)(1992-8#2)(1993-11#1)(1995-4#1)(2007-10#1)(2008-2#1)(2010-6#1)(2010-7#1)(2012-3#2)(2013-1#1)
adjuvant trials##2##2##(1992-8#2)
adjuvant##197##1##(1990-10#5)(1990-12#2)(1990-2#2)(1990-9#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#3)(1992-10#2)(1992-11#1)(1992-12#5)(1992-8#5)(1993-1#2)(1993-11#6)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#6)(1995-9#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-7#3)(2007-10#6)(2007-11#2)(2007-5#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#15)(2008-7#4)(2009-1#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#10)(2013-8#2)
adjuvant-induced##2##1##(2008-10#1)(2008-5#1)
adjuvants are##2##2##(1995-5#1)(1996-2#1)
adjuvants for##3##2##(1995-5#2)(1996-12#1)
adjuvants##25##1##(1990-11#1)(1990-3#1)(1991-5#1)(1995-2#2)(1995-5#10)(1996-12#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
adlayer##3##1##(2008-3#1)(2009-6#2)
administer a##2##2##(1994-9#1)(1996-3#1)
administer medications##3##2##(1995-3#1)(2007-10#1)(2008-12#1)
administer##28##1##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(2007-10#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
administered 0##24##2##(2008-9#24)
administered 1##3##2##(2008-10#1)(2008-9#2)
administered 12 mg/kg##3##3##(2008-9#3)
administered 15##2##2##(1994-2#1)(2012-1#1)
administered 24##2##2##(1993-5#1)(2008-9#1)
administered 3 mg/kg##2##3##(2008-9#2)
administered 3 or##2##3##(2008-9#2)
administered 3##6##2##(1995-3#2)(2008-9#4)
administered 30 min pre-antigen##2##4##(1992-3#2)
administered 30 min##4##3##(1992-3#3)(1994-5#1)
administered 50 mg/kg or greater##4##5##(2008-9#4)
administered 50 mg/kg##5##3##(2008-9#5)
administered 50##6##2##(2008-9#6)
administered N2O##2##2##(1993-1#2)
administered a##8##2##(1992-12#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-3#1)(2011-2#1)(2013-1#2)
administered alone##3##2##(1993-12#1)(1997-4#1)(2011-2#1)
administered and the##2##3##(1991-2#1)(2008-12#1)
administered antimicrobial##2##2##(2008-10#1)(2012-3#1)
administered as a single##2##4##(1991-11#1)(2011-1#1)
administered as a##5##3##(1991-11#1)(2007-11#1)(2007-9#1)(2010-11#1)(2011-1#1)
administered as##11##2##(1991-11#1)(1992-12#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-8#1)
administered at a dose of##3##5##(1991-2#1)(2008-3#1)(2008-7#1)
administered at a##5##3##(1991-2#1)(1994-2#1)(1996-3#1)(2008-3#1)(2008-7#1)
administered at the dose of##2##5##(1990-9#1)(2011-2#1)
administered at the##6##3##(1990-3#1)(1990-9#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
administered at##17##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
administered before##3##2##(1992-12#1)(2007-11#1)(2011-2#1)
administered by inhalation##2##3##(2008-5#2)
administered by oral##2##3##(2010-5#1)(2012-2#1)
administered by the##2##3##(1993-6#1)(1996-2#1)
administered by##18##2##(1991-8#1)(1993-10#1)(1993-6#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
administered during the##4##3##(1993-12#1)(1996-6#1)(2008-1#1)(2008-10#1)
administered during##6##2##(1993-12#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)
administered every 2##3##3##(2008-7#2)(2011-2#1)
administered every##6##2##(1990-7#1)(1992-2#1)(2008-7#2)(2010-12#1)(2011-2#1)
administered for##10##2##(1990-2#1)(1990-9#1)(1993-2#1)(1995-11#1)(1995-12#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
administered i##3##2##(1990-10#1)(1997-2#1)(2010-8#1)
administered immediately##2##2##(1993-12#1)(1993-5#1)
administered in a##3##3##(1990-5#1)(1996-1#1)(2008-5#1)
administered in an##3##3##(2008-5#1)(2010-3#1)(2013-1#1)
administered in drinking water##2##4##(1997-6#1)(2008-5#1)
administered in the##5##3##(1991-6#1)(1997-4#1)(2009-9#1)(2013-1#1)(2013-7#1)
administered in##35##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#3)(1992-9#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
administered into the##2##3##(1994-8#1)(1995-12#1)
administered into##3##2##(1994-8#1)(1995-12#1)(2008-9#1)
administered intraperitoneally##4##2##(1990-5#1)(1992-12#1)(1997-4#1)(2008-10#1)
administered intravenously at##3##3##(1994-8#1)(2008-11#1)(2013-1#1)
administered intravenously##7##2##(1994-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2013-1#2)
administered melatonin##2##2##(1994-5#1)(2008-3#1)
administered on days##2##3##(1991-2#1)(2007-10#1)
administered on##6##2##(1990-2#1)(1991-2#1)(2007-10#2)(2008-6#1)(2011-2#1)
administered once a day##3##4##(1990-5#1)(2008-7#2)
administered once daily in##2##4##(1992-8#1)(2012-1#1)
administered once daily##5##3##(1991-11#1)(1992-8#2)(2012-1#1)(2013-1#1)
administered once##9##2##(1990-5#1)(1991-11#1)(1992-8#3)(2008-7#2)(2012-1#1)(2013-1#1)
administered orally at##2##3##(2008-5#1)(2013-1#1)
administered orally to##2##3##(1991-5#1)(2008-10#1)
administered orally##12##2##(1991-5#1)(1992-5#1)(1993-8#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-5#3)(2011-1#1)(2013-1#1)
administered over a##2##3##(1994-1#1)(2008-12#1)
administered over##3##2##(1994-1#1)(2008-12#1)(2011-2#1)
administered parenterally##2##2##(2013-7#1)(2013-8#1)
administered perioperatively##2##2##(2011-2#1)(2012-3#1)
administered postoperatively##2##2##(1990-8#1)(2013-8#1)
administered prophylactically to##2##3##(1993-3#1)(2007-10#1)
administered prophylactically##3##2##(1990-3#1)(1993-3#1)(2007-10#1)
administered saline##2##2##(1996-12#1)(2013-1#1)
administered scopolamine##2##2##(1990-7#1)(1993-12#1)
administered simultaneously##2##2##(1990-2#1)(2008-7#1)
administered substance P##2##3##(1994-8#1)(1995-12#1)
administered the same doses for##2##5##(2008-9#2)
administered the same doses##3##4##(2008-9#3)
administered the##10##2##(1994-5#1)(2007-10#1)(2008-11#2)(2008-9#4)(2009-11#1)(2011-1#1)
administered through##2##2##(2011-2#2)
administered to adrenal-intact rats##2##4##(1994-2#2)
administered to all patients##2##4##(2008-3#1)(2008-7#1)
administered to each##3##3##(1991-2#1)(1994-8#1)(2007-8#1)
administered to the patients##2##4##(2007-7#1)(2010-8#1)
administered to the##8##3##(1992-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#2)
administered to##70##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-2#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
administered together##3##2##(1995-3#1)(2008-10#1)(2011-1#1)
administered using##2##2##(2007-8#1)(2009-5#1)
administered with the##2##3##(1991-5#1)(2011-2#1)
administered with##16##2##(1991-5#3)(1995-5#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
administered within##2##2##(1995-5#1)(2007-10#1)
administered##532##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#5)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#3)(1991-11#4)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#5)(1991-6#4)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#8)(1992-5#1)(1992-6#1)(1992-8#6)(1992-9#3)(1993-1#5)(1993-10#1)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#7)(1994-5#5)(1994-6#3)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#10)(1995-2#2)(1995-3#6)(1995-5#6)(1995-8#1)(1996-1#2)(1996-12#5)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#2)(1997-4#7)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-10#8)(2007-11#7)(2007-12#2)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#26)(2008-11#13)(2008-12#8)(2008-3#6)(2008-4#5)(2008-5#19)(2008-6#4)(2008-7#19)(2008-8#4)(2008-9#58)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#7)(2010-8#4)(2011-1#9)(2011-2#30)(2011-3#2)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#26)(2013-7#3)(2013-8#9)
administering an##2##2##(2008-11#1)(2008-7#1)
administering the##4##2##(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)
administering##32##1##(1993-6#1)(1994-9#1)(1995-3#2)(1995-5#2)(1996-12#2)(2007-10#2)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
administers the##2##2##(1993-12#1)(1996-2#1)
administrated##18##1##(1993-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#1)(2011-3#1)(2012-3#6)(2013-1#1)
administrating##3##1##(2008-9#1)(2012-12#1)(2012-3#1)
administration (0##2##2##(1991-10#1)(2006-6#1)
administration (i##2##2##(1991-1#1)(2008-8#1)
administration a##2##2##(1990-11#1)(2008-12#1)
administration also##4##2##(1991-1#1)(1994-5#1)(2008-7#1)(2011-2#1)
administration and after##2##3##(1994-5#2)
administration and health##4##3##(1991-12#1)(1992-1#1)(1993-12#1)(2008-1#1)
administration and##36##2##(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1992-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-12#1)
administration are##9##2##(1992-1#1)(1993-11#1)(1993-2#1)(1995-1#1)(2007-11#1)(2008-8#2)(2010-10#1)(2011-1#1)
administration as##2##2##(1993-3#1)(2008-7#1)
administration at the##2##3##(1995-6#1)(1997-3#1)
administration at##4##2##(1995-6#1)(1997-3#1)(2008-7#1)(2012-2#1)
administration by##2##2##(2008-11#1)(2010-6#1)
administration caused an##2##3##(1994-5#1)(2009-8#1)
administration caused##4##2##(1994-5#1)(2008-10#1)(2009-8#1)(2010-5#1)
administration did not##3##3##(1995-12#2)(2011-1#1)
administration during##4##2##(1993-2#1)(1994-3#1)(1996-12#1)(2007-10#1)
administration education for the##2##4##(1991-1#1)(1992-3#1)
administration education for##4##3##(1991-1#1)(1992-3#1)(1995-1#1)(1996-3#1)
administration education in##3##3##(1991-1#1)(1996-3#1)(1997-3#1)
administration education programs##5##3##(1992-2#1)(1993-2#2)(1995-12#1)(1996-3#1)
administration education##33##2##(1991-1#4)(1991-12#1)(1991-2#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#4)(1994-2#1)(1995-1#2)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#5)(1997-2#1)(1997-3#4)(2009-8#1)
administration for##6##2##(1997-7#1)(2007-12#1)(2008-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
administration has##2##2##(1991-6#1)(1996-3#1)
administration have##2##2##(1993-8#1)(2008-3#1)
administration in rabbits##2##3##(2011-1#2)
administration in rats##2##3##(1994-6#1)(2006-12#1)
administration in the##7##3##(1991-9#1)(1992-3#1)(1994-1#1)(2008-1#2)(2008-11#1)(2010-5#1)
administration in##39##2##(1991-1#2)(1991-9#1)(1992-1#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-10#1)(2008-1#3)(2008-11#1)(2008-12#2)(2009-3#1)(2010-5#2)(2010-7#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
administration increased##2##2##(1990-12#1)(2012-2#1)
administration is##6##2##(1997-1#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
administration led to##2##3##(1992-12#1)(1993-11#1)
administration may##2##2##(2011-1#1)(2011-2#1)
administration of 0##5##3##(1994-3#1)(1994-8#1)(1995-12#1)(1997-8#1)(2008-10#1)
administration of 1##2##3##(1991-5#1)(2008-10#1)
administration of 1-PP##2##3##(1995-12#2)
administration of 1000 mg/kg##4##4##(1995-3#4)
administration of 2##4##3##(1992-3#1)(1993-12#1)(1995-12#1)(2008-10#1)
administration of 500##2##3##(1995-3#1)(2008-10#1)
administration of AMD3100##2##3##(2008-7#2)
administration of DKT##3##3##(2011-2#3)
administration of EtOH##2##3##(2008-10#2)
administration of HET##2##3##(2008-10#2)
administration of HKT##2##3##(2008-10#2)
administration of KF19514 inhibited##2##4##(1997-7#2)
administration of L-arginine##2##3##(1995-12#2)
administration of L-carnitine##2##3##(1991-12#2)
administration of LMWH##2##3##(2008-1#2)
administration of NC-1800##2##3##(1997-7#2)
administration of NGF##2##3##(1991-12#1)(1993-12#1)
administration of RS extract##3##4##(2008-11#3)
administration of a drug##2##4##(1994-9#1)(2008-4#1)
administration of a single dose of##2##6##(1990-6#1)(2012-3#1)
administration of a single##3##4##(1990-6#1)(2008-10#1)(2012-3#1)
administration of a##23##3##(1990-6#1)(1991-12#1)(1993-10#1)(1993-12#1)(1994-3#1)(1994-9#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
administration of alpha-MSH##2##3##(1993-5#1)(2008-6#1)
administration of an##7##3##(1990-6#1)(1992-8#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
administration of angiotensin##2##3##(1994-2#1)(2008-1#1)
administration of antibiotics##3##3##(2009-4#1)(2012-1#1)(2013-1#1)
administration of antimicrobial##2##3##(2011-2#1)(2013-1#1)
administration of appropriate##2##3##(2007-7#1)(2008-4#1)
administration of bacterial##2##3##(1990-12#1)(2012-1#1)
administration of capsaicin##2##3##(1990-7#1)(1997-4#1)
administration of cocaine##2##3##(1991-2#1)(1993-12#1)
administration of contrast##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2012-12#1)
administration of corticosterone##2##3##(1994-6#2)
administration of dicyclohexylcarbodiimide##2##3##(2008-9#2)
administration of dieldrin##2##3##(2008-10#2)
administration of diisopropylcarbodiimide##2##3##(2008-9#2)
administration of drugs##2##3##(2008-6#1)(2012-3#1)
administration of each##2##3##(2007-11#1)(2008-11#1)
administration of either##4##3##(1990-7#1)(1991-9#1)(1995-12#1)(2007-10#1)
administration of estrogen##2##3##(2007-10#1)(2008-6#1)
administration of fluids##2##3##(1992-11#1)(2013-1#1)
administration of high##3##3##(1991-11#1)(1995-2#1)(1996-8#1)
administration of higher doses##2##4##(2008-11#1)(2008-5#1)
administration of intravenous##4##3##(2007-12#1)(2008-12#1)(2012-2#1)(2013-1#1)
administration of medication##2##3##(1996-8#1)(2008-5#1)
administration of morphine##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
administration of nicotine##5##3##(1995-12#1)(2008-3#4)
administration of oral##3##3##(1991-12#1)(2008-5#1)(2013-1#1)
administration of oxygen##3##3##(1991-6#1)(1994-3#1)(2008-10#1)
administration of potassium##2##3##(1992-9#1)(2007-10#1)
administration of proanthocyanidins##2##3##(2011-2#2)
administration of psychotropic##2##3##(1996-9#2)
administration of recombinant human##2##4##(2007-12#2)
administration of the drug##2##4##(1993-11#1)(2008-10#1)
administration of the first##2##4##(2007-11#1)(2013-8#1)
administration of the vitamin##2##4##(1992-9#1)(1997-7#1)
administration of the##43##3##(1991-1#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1995-12#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2011-2#2)(2013-1#1)(2013-8#1)
administration of these agents##2##4##(2008-3#1)(2011-2#1)
administration of this dose of##2##5##(1994-8#1)(1995-3#1)
administration of this##4##3##(1994-8#1)(1995-11#1)(1995-3#1)(2009-8#1)
administration of##452##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#2)(1992-3#5)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#5)(1993-5#5)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#8)(1994-8#9)(1994-9#1)(1995-11#2)(1995-12#26)(1995-2#2)(1995-3#11)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#3)(1996-9#3)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#12)(1997-8#2)(2007-10#6)(2007-11#6)(2007-12#3)(2007-5#2)(2007-7#1)(2007-9#2)(2008-1#8)(2008-10#33)(2008-11#17)(2008-12#8)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#13)(2008-6#5)(2008-7#18)(2008-8#4)(2008-9#7)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#28)(2012-1#5)(2012-12#5)(2012-2#12)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#6)
administration on the##5##3##(1991-4#1)(1994-2#1)(1994-5#1)(1996-3#1)(2011-2#1)
administration on##10##2##(1991-4#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-3#1)(2007-8#1)(2008-8#1)(2009-3#1)(2011-2#1)
administration or##4##2##(1990-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
administration programs must##3##3##(1991-1#1)(1997-2#2)
administration programs##16##2##(1991-1#1)(1992-3#1)(1993-1#2)(1993-2#2)(1995-1#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)
administration regimen##2##2##(2007-11#1)(2013-8#1)
administration resulted in##4##3##(1991-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
administration route##2##2##(1993-11#1)(1995-12#1)
administration students##5##2##(1992-3#1)(1996-1#3)(2009-8#1)
administration techniques##2##2##(2008-7#1)(2010-8#1)
administration than in##2##3##(1993-12#1)(1996-6#1)
administration to mice##2##3##(1996-2#1)(2009-12#1)
administration to##17##2##(1990-3#1)(1991-1#1)(1992-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-3#1)
administration via##2##2##(1994-9#1)(2007-8#1)
administration was##12##2##(1991-1#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
administration were##3##2##(1993-1#1)(2011-2#2)
administration with a##2##3##(1995-3#1)(2008-10#1)
administration with the##2##3##(1993-11#1)(1993-3#1)
administration with##6##2##(1993-11#1)(1993-3#1)(1995-3#1)(2008-10#2)(2012-2#1)
administration##1031##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#4)(1990-7#6)(1990-8#1)(1990-9#2)(1991-1#22)(1991-10#1)(1991-11#2)(1991-12#15)(1991-2#10)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#2)(1991-9#5)(1992-1#7)(1992-10#2)(1992-11#4)(1992-12#8)(1992-2#5)(1992-3#14)(1992-5#6)(1992-6#3)(1992-8#3)(1992-9#6)(1993-1#12)(1993-10#1)(1993-11#11)(1993-12#17)(1993-2#12)(1993-3#5)(1993-5#8)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#15)(1994-3#10)(1994-5#10)(1994-6#16)(1994-8#11)(1994-9#4)(1995-1#11)(1995-11#2)(1995-12#42)(1995-2#7)(1995-3#21)(1995-5#6)(1995-6#2)(1995-8#1)(1996-1#13)(1996-11#3)(1996-12#14)(1996-2#20)(1996-3#16)(1996-5#6)(1996-6#10)(1996-8#3)(1996-9#3)(1997-1#6)(1997-2#11)(1997-3#11)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#13)(1997-8#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#12)(2007-11#16)(2007-12#7)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#17)(2008-10#49)(2008-11#30)(2008-12#14)(2008-2#2)(2008-3#15)(2008-4#11)(2008-5#22)(2008-6#6)(2008-7#38)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#4)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#9)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#15)(2011-2#50)(2011-3#1)(2012-1#6)(2012-12#10)(2012-2#23)(2012-3#12)(2013-1#29)(2013-7#2)(2013-8#10)
administration's##4##1##(1991-1#2)(1995-1#1)(1995-12#1)
administration)##5##1##(1993-8#1)(2012-2#3)(2013-1#1)
administration]##3##1##(1996-9#1)(2008-12#1)(2013-8#1)
administrations of the##2##3##(1990-7#1)(1993-12#1)
administrations of##6##2##(1990-7#2)(1993-12#1)(2008-10#1)(2012-1#1)(2012-2#1)
administrations##15##1##(1990-2#1)(1990-7#2)(1991-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-1#1)(2012-2#1)
administrative and clinical systems##4##4##(2013-8#4)
administrative and clinical##9##3##(1992-1#1)(1996-2#1)(2013-8#7)
administrative and##14##2##(1992-1#1)(1992-4#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#7)
administrative burdens##2##2##(1991-3#1)(2006-10#1)
administrative capacity##2##2##(1997-3#2)
administrative complexity##2##2##(2008-4#2)
administrative costs in##2##3##(1994-2#1)(1994-3#1)
administrative costs##7##2##(1991-3#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-3#1)(2012-2#1)
administrative data for##2##3##(1996-1#1)(1996-12#1)
administrative data from##2##3##(1995-2#1)(2012-1#1)
administrative data##12##2##(1993-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-10#1)(2012-1#1)
administrative databases##6##2##(1996-3#2)(2008-6#2)(2011-1#2)
administrative decision##2##2##(1992-12#1)(2010-8#1)
administrative decision-making##2##2##(1994-3#2)
administrative fellowship##2##2##(1993-2#2)
administrative fellowships##2##2##(1993-2#2)
administrative functions##2##2##(1992-1#1)(1997-3#1)
administrative issues##2##2##(1991-1#1)(1996-3#1)
administrative leaders##2##2##(1996-3#1)(2010-8#1)
administrative procedures##2##2##(2010-5#1)(2012-3#1)
administrative records##2##2##(2010-11#1)(2012-12#1)
administrative structures##2##2##(1992-1#1)(1994-7#1)
administrative support##4##2##(1992-1#1)(1993-2#1)(1995-2#1)(2008-7#1)
administrative work##2##2##(1992-4#1)(2012-2#1)
administrative##162##1##(1991-1#4)(1991-12#5)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#7)(1992-12#3)(1992-2#1)(1992-4#2)(1993-12#2)(1993-2#7)(1993-6#1)(1994-12#3)(1994-2#2)(1994-3#5)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-3#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#8)(1996-5#1)(1997-2#3)(1997-3#6)(2006-10#1)(2007-10#2)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#2)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#3)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#22)
administrator##23##1##(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-1#2)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-12#1)
administrator's role##2##2##(1992-1#1)(1996-2#1)
administrator's##3##1##(1992-1#1)(1992-12#1)(1996-2#1)
administrators and clinicians##2##3##(1992-3#2)
administrators and employees##2##3##(1996-12#1)(2008-12#1)
administrators and physicians##3##3##(1992-2#1)(1995-12#1)(1997-1#1)
administrators and##21##2##(1991-3#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(2008-12#2)(2012-12#1)
administrators are##7##2##(1991-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1997-2#1)
administrators can##3##2##(1994-1#1)(1994-12#1)(1994-3#1)
administrators for##3##2##(1993-1#1)(1994-2#1)(1997-3#1)
administrators have##4##2##(1991-1#1)(1993-12#1)(1996-12#1)(1996-2#1)
administrators in the##2##3##(1992-3#1)(2008-1#1)
administrators in##7##2##(1992-12#1)(1992-3#2)(1993-1#2)(1995-1#1)(2008-1#1)
administrators is##2##2##(1994-2#1)(2009-6#1)
administrators must##2##2##(1991-3#1)(1995-1#1)
administrators of##2##2##(1992-2#1)(2008-1#1)
administrators should##4##2##(1995-1#2)(1995-12#1)(1996-3#1)
administrators to##4##2##(1991-1#1)(1993-1#2)(1995-2#1)
administrators who##6##2##(1993-2#1)(1994-1#1)(1995-12#1)(1996-3#1)(2008-5#1)(2009-6#1)
administrators will##3##2##(1991-9#1)(1995-1#1)(1995-2#1)
administrators##137##1##(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#4)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#8)(1992-3#6)(1993-1#10)(1993-12#3)(1993-2#4)(1993-3#2)(1994-1#5)(1994-12#2)(1994-2#4)(1994-3#4)(1995-1#12)(1995-12#6)(1995-2#5)(1996-1#3)(1996-12#4)(1996-2#6)(1996-3#5)(1997-1#3)(1997-2#3)(1997-3#2)(2007-10#1)(2007-9#1)(2008-1#5)(2008-11#1)(2008-12#4)(2008-5#1)(2009-4#1)(2009-6#2)(2009-8#3)(2012-12#1)(2013-1#1)(2013-8#1)
administrators'##5##1##(1991-2#1)(1991-3#1)(2007-10#1)(2008-1#1)(2009-6#1)
admired##2##1##(1996-3#1)(2008-11#1)
admission and discharge##5##3##(1990-2#1)(1991-2#1)(1992-1#1)(2008-3#1)(2008-6#1)
admission and##19##2##(1990-2#1)(1991-12#1)(1991-2#3)(1992-1#1)(1996-3#1)(2007-10#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#2)(2013-1#1)
admission electrocardiogram##2##2##(2008-3#2)
admission for##6##2##(1992-2#1)(1995-9#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-3#1)
admission in##6##2##(1996-9#1)(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
admission into##2##2##(1994-3#1)(1995-2#1)
admission of nursing home##3##4##(1994-12#3)
admission of##6##2##(1991-2#2)(1994-12#3)(2008-10#1)
admission on##2##2##(2011-2#1)(2013-1#1)
admission or##2##2##(1992-1#1)(1992-6#1)
admission process##3##2##(1997-2#3)
admission rates for##2##3##(1994-12#1)(2008-11#1)
admission rates##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
admission requirements##2##2##(2008-12#2)
admission test##3##2##(1994-3#3)
admission to a##2##3##(1990-3#1)(1994-2#1)
admission to hospital and##2##4##(1991-11#1)(1996-1#1)
admission to hospital##3##3##(1991-11#1)(1995-5#1)(1996-1#1)
admission to the hospital##5##4##(1990-9#1)(1992-3#1)(1997-7#1)(2011-1#1)(2011-2#1)
admission to the##12##3##(1990-9#1)(1992-3#1)(1993-3#1)(1994-1#1)(1997-7#1)(2007-10#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
admission to##24##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
admission was##3##2##(1992-6#1)(2010-12#1)(2013-1#1)
admission were##3##2##(1994-12#1)(2007-8#1)(2012-3#1)
admission##201##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#3)(1991-2#5)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#5)(1992-9#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#6)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#1)(2006-8#4)(2007-10#8)(2007-12#3)(2007-8#8)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#14)(2008-4#1)(2008-6#7)(2008-7#10)(2008-8#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2010-12#3)(2010-6#1)(2011-1#4)(2011-2#16)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#16)(2013-8#4)
admissions and length of stay##2##5##(1992-3#2)
admissions and##9##2##(1991-11#1)(1992-1#1)(1992-3#2)(1996-3#1)(1997-3#1)(2007-1#1)(2008-11#1)(2011-1#1)
admissions in##6##2##(1990-9#1)(1993-1#1)(1996-9#1)(1997-4#1)(2008-1#1)(2011-2#1)
admissions to the##3##3##(1992-12#1)(1996-9#1)(2007-10#1)
admissions to##7##2##(1991-1#1)(1992-12#2)(1996-9#1)(1997-2#1)(2007-10#1)(2010-11#1)
admissions##63##1##(1990-11#2)(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1993-1#1)(1993-12#3)(1994-2#1)(1996-1#2)(1996-3#4)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#4)(2008-4#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
admit##8##1##(1991-12#1)(1992-6#1)(1994-3#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
admits the##2##2##(1991-3#1)(2008-3#1)
admittance##2##1##(2008-3#1)(2012-2#1)
admitted at##2##2##(2007-10#1)(2013-7#1)
admitted because of##5##3##(1993-12#1)(2007-8#1)(2008-7#1)(2009-1#1)(2011-2#1)
admitted children##2##2##(1996-9#1)(2013-1#1)
admitted during##2##2##(1995-12#1)(2007-8#1)
admitted for##25##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1994-9#1)(1996-3#1)(2006-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#2)
admitted in our##4##3##(2011-2#1)(2012-3#1)(2013-1#2)
admitted in the##7##3##(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#3)
admitted in##21##2##(1994-3#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#5)(2012-3#5)(2013-1#5)(2013-8#1)
admitted patients##6##2##(1991-1#2)(1997-3#1)(2008-11#1)(2013-1#2)
admitted that##3##2##(1995-5#1)(1996-3#1)(2013-8#1)
admitted to Brisbane neurosurgical units##2##5##(2008-7#2)
admitted to a general##2##4##(2013-1#2)
admitted to a##11##3##(1991-8#1)(1993-12#1)(2007-10#2)(2007-12#1)(2008-3#2)(2010-11#1)(2011-2#1)(2013-1#2)
admitted to an intensive care unit##2##6##(1991-11#1)(2012-12#1)
admitted to an##4##3##(1991-11#1)(2012-12#2)(2013-1#1)
admitted to having##2##3##(2008-10#1)(2008-7#1)
admitted to hospital for##3##4##(1992-5#1)(1993-9#1)(2007-2#1)
admitted to hospital with acute onset##2##6##(2007-12#1)(2011-2#1)
admitted to hospital with##5##4##(1992-6#1)(1993-3#1)(2007-12#1)(2008-7#1)(2011-2#1)
admitted to hospital##16##3##(1990-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-8#2)
admitted to nursing homes and##2##5##(1994-12#1)(1994-2#1)
admitted to our department##5##4##(1997-8#1)(2008-12#1)(2011-2#2)(2012-3#1)
admitted to our hospital because of##2##6##(2008-7#1)(2012-2#1)
admitted to our hospital because##3##5##(2008-1#1)(2008-7#1)(2012-2#1)
admitted to our hospital##12##4##(1991-12#1)(1993-6#1)(2007-10#1)(2008-1#4)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
admitted to our institution##2##4##(2008-12#1)(2012-2#1)
admitted to our##25##3##(1991-12#1)(1993-6#1)(1994-12#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#4)(2008-12#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
admitted to the Department of##2##5##(1995-11#1)(2012-12#1)
admitted to the coronary##2##4##(2008-3#1)(2012-3#1)
admitted to the emergency department with##2##6##(2008-3#1)(2011-2#1)
admitted to the emergency department##4##5##(2008-3#1)(2011-2#2)(2013-7#1)
admitted to the emergency##6##4##(2007-8#1)(2008-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
admitted to the hospital because of##3##6##(1993-6#1)(2008-1#1)(2008-10#1)
admitted to the hospital because##4##5##(1993-6#1)(2008-1#1)(2008-10#1)(2012-3#1)
admitted to the hospital due to##2##6##(2011-1#1)(2013-8#1)
admitted to the hospital##13##4##(1993-6#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
admitted to the##37##3##(1991-12#1)(1991-2#1)(1991-5#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-4#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-10#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
admitted to two##2##3##(1993-2#1)(2011-1#1)
admitted to##129##2##(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-8#4)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#9)(2008-4#2)(2008-7#7)(2009-10#1)(2010-11#1)(2010-6#1)(2011-1#4)(2011-2#14)(2012-12#5)(2012-2#3)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#6)
admitted with a##4##3##(2007-8#1)(2008-6#1)(2010-12#1)(2013-8#1)
admitted with the diagnosis of##2##5##(2007-10#1)(2011-2#1)
admitted with##29##2##(1990-12#1)(1993-9#1)(1995-9#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-10#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#2)
admitted##246##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-5#1)(1991-8#2)(1992-2#2)(1992-5#2)(1992-6#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#4)(1996-9#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2006-5#1)(2006-8#5)(2007-10#10)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#3)(2007-8#9)(2008-1#7)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#13)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#15)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#7)(2011-2#24)(2012-12#7)(2012-2#3)(2012-3#12)(2013-1#23)(2013-7#2)(2013-8#10)
admitting and registration##2##3##(1992-12#1)(1996-2#1)
admitting##10##1##(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-7#1)(2009-12#1)
admixed##3##1##(2008-11#1)(2010-3#1)(2011-2#1)
admixture of##8##2##(1997-8#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#1)
admixture##12##1##(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#1)
admixtures on the##2##3##(2008-10#2)
admixtures upon the##2##3##(2008-10#2)
admixtures##12##1##(2008-10#12)
adnexa##3##1##(2011-1#2)(2012-3#1)
adnexae##2##1##(1996-2#2)
adnexal cystic masses##2##3##(1991-2#2)
adnexal masses##2##2##(1996-3#1)(2013-1#1)
adnexal surgery##3##2##(1996-3#2)(2010-3#1)
adnexal torsion in##2##3##(2009-5#1)(2012-2#1)
adnexal##11##1##(1991-2#2)(1996-3#3)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
adnexectomy##8##1##(1993-2#1)(1994-7#1)(1996-3#3)(2007-8#1)(2008-10#1)(2011-1#1)
ado##3##1##(1995-2#1)(2008-8#1)(2012-2#1)
adolescence and adulthood##2##3##(1997-7#1)(2009-2#1)
adolescence and##9##2##(1993-9#1)(1997-7#1)(2008-11#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-3#1)(2013-1#1)
adolescence are significantly##2##3##(2008-11#1)(2010-8#1)
adolescence are##4##2##(2008-11#1)(2009-7#2)(2010-8#1)
adolescence for##2##2##(2009-7#2)
adolescence on##2##2##(2009-7#1)(2012-12#1)
adolescence##97##1##(1990-12#1)(1990-6#1)(1993-9#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-11#13)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#6)(2009-12#2)(2009-2#1)(2009-5#3)(2009-7#19)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
adolescence]##4##1##(1990-10#1)(2008-9#2)(2012-3#1)
adolescent AN##2##2##(2013-1#2)
adolescent adjustment##5##2##(2009-7#2)(2009-8#3)
adolescent alcohol##2##2##(2008-6#1)(2010-9#1)
adolescent and young adult##2##4##(2009-5#1)(2011-1#1)
adolescent and##6##2##(2008-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#2)
adolescent anorexia nervosa##2##3##(2013-1#2)
adolescent barriers##2##2##(2010-11#2)
adolescent boys##6##2##(2008-10#1)(2009-5#2)(2010-7#1)(2012-12#1)(2013-1#1)
adolescent boys' body image and body change strategies##2##8##(2007-12#2)
adolescent cannabis use##2##3##(2009-9#1)(2013-8#1)
adolescent cannabis##4##2##(2009-7#1)(2009-9#1)(2013-8#2)
adolescent children##3##2##(1991-1#1)(1993-12#1)(2010-5#1)
adolescent crowds##2##2##(2009-7#2)
adolescent depression##2##2##(2008-11#1)(2010-7#1)
adolescent developmental##2##2##(2007-2#1)(2010-7#1)
adolescent drinking##2##2##(1994-2#1)(2010-7#1)
adolescent engagement##2##2##(2009-7#2)
adolescent females##2##2##(2008-11#1)(2009-10#1)
adolescent girls and##4##3##(1996-12#1)(2010-10#1)(2011-2#2)
adolescent girls had##2##3##(2011-1#2)
adolescent girls in##2##3##(2008-1#1)(2011-2#1)
adolescent girls with eating disorders##2##5##(2008-11#2)
adolescent girls with##4##3##(2008-11#2)(2011-1#1)(2013-1#1)
adolescent girls##29##2##(1991-11#1)(1996-12#1)(2007-12#1)(2008-1#4)(2008-11#2)(2008-4#1)(2009-10#1)(2010-10#1)(2010-7#2)(2011-1#4)(2011-2#3)(2013-1#8)
adolescent girls' body##2##3##(2007-12#1)(2010-10#1)
adolescent girls'##5##2##(2007-12#2)(2010-10#1)(2013-1#2)
adolescent health care##2##3##(2008-8#2)
adolescent health##7##2##(2008-11#1)(2008-7#1)(2008-8#4)(2009-5#1)
adolescent inpatient##4##2##(1992-3#2)(1993-1#2)
adolescent invulnerability##2##2##(2010-7#2)
adolescent males##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
adolescent mental health##4##3##(2008-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
adolescent mothers##6##2##(1993-3#1)(1995-1#1)(2013-1#4)
adolescent patients with##4##3##(1996-6#1)(2010-11#1)(2010-3#1)(2012-12#1)
adolescent patients##7##2##(1991-2#1)(1996-6#1)(2008-8#1)(2010-11#1)(2010-3#2)(2012-12#1)
adolescent popularity##3##2##(2010-1#2)(2013-1#1)
adolescent population##5##2##(2008-4#1)(2009-11#1)(2009-7#1)(2012-12#1)(2013-8#1)
adolescent problem##2##2##(2008-9#1)(2009-9#1)
adolescent psychiatric##5##2##(1991-2#1)(1993-12#1)(1993-2#1)(1996-7#1)(2008-11#1)
adolescent psychosocial##3##2##(2009-8#1)(2013-1#2)
adolescent reproductive##2##2##(2008-1#1)(2012-12#1)
adolescent smoking cessation##3##3##(2009-7#3)
adolescent smoking##5##2##(2009-7#3)(2013-1#2)
adolescent students in##2##3##(2008-9#1)(2013-1#1)
adolescent students##4##2##(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
adolescent substance abuse##3##3##(1991-2#1)(2008-6#1)(2009-9#1)
adolescent substance##5##2##(1991-1#2)(1991-2#1)(2008-6#1)(2009-9#1)
adolescent time use##2##3##(2013-1#2)
adolescent weight##3##2##(2013-1#3)
adolescent with##7##2##(2008-4#2)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
adolescent##278##1##(1990-12#7)(1990-6#1)(1991-1#6)(1991-11#1)(1991-12#1)(1991-2#3)(1992-1#2)(1992-3#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#4)(1995-1#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#2)(2008-11#14)(2008-12#1)(2008-3#2)(2008-4#8)(2008-6#6)(2008-7#2)(2008-8#6)(2008-9#9)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#3)(2009-5#8)(2009-6#1)(2009-7#26)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-7#9)(2010-9#1)(2011-1#9)(2011-2#10)(2012-12#11)(2012-2#4)(2012-3#1)(2013-1#39)(2013-8#7)
adolescent's##4##1##(2007-2#1)(2009-7#1)(2011-1#2)
adolescent-being##2##1##(2012-3#2)
adolescent]##2##1##(1990-10#1)(1990-6#1)
adolescents (51% girls) aged##2##4##(2009-7#1)(2010-7#1)
adolescents (M##3##2##(2009-7#2)(2010-1#1)
adolescents (aged##2##2##(2013-1#2)
adolescents (e##2##2##(2008-11#1)(2009-7#1)
adolescents 14 to##2##3##(2008-1#1)(2008-9#1)
adolescents aged##3##2##(1990-9#1)(1997-6#1)(2009-7#1)
adolescents and adults##10##3##(1993-1#1)(1996-2#1)(1997-8#1)(2007-8#3)(2008-11#1)(2013-1#2)(2013-8#1)
adolescents and to identify##2##4##(1994-2#1)(2013-1#1)
adolescents and to##3##3##(1994-2#1)(2013-1#2)
adolescents and young adults who##2##5##(2009-10#1)(2013-1#1)
adolescents and young adults##9##4##(2008-11#1)(2008-12#1)(2008-6#4)(2009-10#1)(2010-4#1)(2013-1#1)
adolescents and young##10##3##(2008-11#2)(2008-12#1)(2008-6#4)(2009-10#1)(2010-4#1)(2013-1#1)
adolescents and##35##2##(1993-1#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-8#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#4)(2008-8#1)(2009-10#1)(2009-7#3)(2010-1#1)(2010-4#1)(2013-1#9)(2013-8#1)
adolescents are##7##2##(2008-11#2)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2013-1#1)
adolescents as##5##2##(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
adolescents at##2##2##(1993-3#1)(1996-1#1)
adolescents by##2##2##(1990-6#1)(2008-9#1)
adolescents for##2##2##(1992-1#1)(2008-6#1)
adolescents from##5##2##(2009-7#1)(2010-9#2)(2013-1#2)
adolescents has##2##2##(1996-12#1)(2009-7#1)
adolescents have##4##2##(2007-12#1)(2008-2#1)(2010-11#1)(2013-1#1)
adolescents hospitalized for##3##3##(1991-1#1)(2013-1#2)
adolescents in a##2##3##(1993-2#1)(1997-3#1)
adolescents in families##2##3##(2009-8#2)
adolescents in relation##2##3##(2008-9#2)
adolescents in rural Uganda##2##4##(2012-2#1)(2013-1#1)
adolescents in the United States##2##5##(2010-7#1)(2012-12#1)
adolescents in the##9##3##(1993-3#1)(1997-5#1)(2008-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
adolescents in this##2##3##(2007-7#1)(2013-1#1)
adolescents in##43##2##(1993-2#1)(1993-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#8)(2009-10#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
adolescents included##2##2##(1997-5#1)(2008-1#1)
adolescents is##10##2##(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#2)
adolescents living in##2##3##(2010-9#1)(2011-1#1)
adolescents living##3##2##(2010-9#1)(2011-1#1)(2013-1#1)
adolescents of color##3##3##(2009-7#3)
adolescents of##9##2##(2007-12#1)(2008-9#1)(2009-7#3)(2010-2#2)(2012-2#1)(2013-1#1)
adolescents on##2##2##(1996-6#1)(2013-1#1)
adolescents present##2##2##(1992-3#1)(2008-9#1)
adolescents presenting with##2##3##(1990-6#1)(2012-12#1)
adolescents regarding##2##2##(2013-1#2)
adolescents reported##4##2##(1993-3#1)(1994-2#1)(2010-11#1)(2010-9#1)
adolescents should be##2##3##(1996-6#1)(2010-10#1)
adolescents was##4##2##(2008-1#1)(2008-9#1)(2010-2#1)(2013-1#1)
adolescents were##7##2##(1990-2#1)(2008-11#1)(2009-11#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
adolescents who are##2##3##(2009-7#1)(2012-12#1)
adolescents who have##2##3##(2008-11#1)(2008-2#1)
adolescents who##18##2##(1996-1#1)(2008-11#2)(2008-2#1)(2009-7#6)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
adolescents whose parents##2##3##(2008-11#1)(2010-11#1)
adolescents whose##3##2##(2008-11#1)(2009-9#1)(2010-11#1)
adolescents will##2##2##(2009-7#1)(2011-2#1)
adolescents with HIV/AIDS##2##3##(2009-5#1)(2009-7#1)
adolescents with a history of SLI##2##6##(2012-3#2)
adolescents with a##5##3##(2008-4#1)(2009-3#1)(2012-3#2)(2013-1#1)
adolescents with and without##5##4##(2011-1#2)(2012-3#2)(2013-1#1)
adolescents with cancer##3##3##(1993-3#1)(2010-11#2)
adolescents with cochlear implants##2##4##(2012-2#2)
adolescents with early##2##3##(2008-1#2)
adolescents with low##4##3##(2009-7#1)(2010-1#1)(2011-1#2)
adolescents with more than one pregnancy##2##6##(2012-12#2)
adolescents with more than one##3##5##(2012-12#3)
adolescents with no##2##3##(2008-1#1)(2008-4#1)
adolescents with or without##2##4##(2007-11#1)(2011-1#1)
adolescents with paternal##2##3##(2011-1#2)
adolescents with schizophrenia##5##3##(2011-2#5)
adolescents with substance##2##3##(2008-6#1)(2012-12#1)
adolescents with##67##2##(1993-3#3)(1995-12#1)(1996-12#2)(2007-11#1)(2008-1#4)(2008-11#2)(2008-4#3)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#7)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)
adolescents##494##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-2#6)(1992-1#4)(1992-11#3)(1992-3#2)(1992-6#1)(1993-1#2)(1993-2#3)(1993-3#9)(1994-2#5)(1994-8#1)(1995-12#5)(1996-1#3)(1996-12#5)(1996-2#1)(1996-6#3)(1996-7#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#4)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-7#1)(2007-8#4)(2008-1#8)(2008-10#4)(2008-11#33)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#9)(2008-5#3)(2008-6#11)(2008-7#5)(2008-8#6)(2008-9#28)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#51)(2009-8#6)(2009-9#5)(2010-1#12)(2010-10#2)(2010-11#10)(2010-12#2)(2010-2#7)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-9#8)(2011-1#24)(2011-2#19)(2012-1#1)(2012-12#21)(2012-2#16)(2012-3#10)(2013-1#59)(2013-7#3)(2013-8#8)
adolescents' academic##3##2##(2009-7#3)
adolescents' conduct problems##3##3##(2009-7#3)
adolescents' depressive##2##2##(2009-9#1)(2010-4#1)
adolescents' explanations##2##2##(2009-7#2)
adolescents' perceived##2##2##(2009-11#1)(2009-7#1)
adolescents' psychological##4##2##(2009-11#1)(2009-7#1)(2010-7#2)
adolescents' understanding of##2##3##(2009-7#1)(2010-5#1)
adolescents'##45##1##(2008-9#1)(2009-11#4)(2009-7#23)(2009-9#2)(2010-1#3)(2010-4#1)(2010-5#2)(2010-7#3)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
adolescents]##8##1##(1990-9#1)(1996-6#1)(2007-3#1)(2008-11#1)(2008-9#1)(2013-1#2)(2013-8#1)
adopt a type##2##3##(1993-11#1)(1997-7#1)
adopt a##22##2##(1992-11#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-8#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
adopt in##3##2##(1992-9#1)(1994-5#1)(2008-8#1)
adopt the##14##2##(1990-2#2)(1992-4#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#1)(2013-1#1)
adopt this##2##2##(2008-1#1)(2008-12#1)
adopt##85##1##(1990-2#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#9)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-11#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
adopted a##15##2##(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
adopted an##2##2##(2007-12#1)(2013-1#1)
adopted and the##2##3##(1992-1#1)(2008-10#1)
adopted and##7##2##(1992-1#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#2)
adopted as a##7##3##(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
adopted as the##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
adopted as##15##2##(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
adopted by the##8##3##(1991-8#1)(1992-2#1)(1995-12#1)(1997-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
adopted by##25##2##(1991-8#1)(1992-2#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
adopted for the##6##3##(2008-10#4)(2013-1#2)
adopted for##15##2##(1995-5#1)(1996-8#1)(2008-10#6)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
adopted from##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2013-1#1)
adopted in the##4##3##(1992-10#1)(1993-3#1)(2008-10#1)(2008-2#1)
adopted in##24##2##(1992-10#1)(1993-3#1)(1993-8#1)(1996-5#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#7)(2013-8#1)
adopted is##3##2##(1991-2#1)(2008-10#1)(2009-2#1)
adopted the##6##2##(1994-12#1)(1995-6#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-4#1)
adopted to improve##2##3##(2008-6#1)(2012-1#1)
adopted to##17##2##(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#2)
adopted##210##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#30)(2008-11#7)(2008-12#7)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#8)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#17)(2013-8#4)
adopting a##11##2##(1990-2#1)(1991-3#1)(1992-3#1)(1994-1#1)(1997-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)
adopting more##2##2##(2008-8#1)(2011-2#1)
adopting the##6##2##(1994-1#1)(1996-3#1)(2007-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
adopting##38##1##(1990-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1994-1#2)(1994-2#2)(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
adoption agencies##2##2##(1994-2#2)
adoption and##5##2##(1995-3#1)(2009-11#2)(2010-8#1)(2013-1#1)
adoption by##2##2##(1991-12#1)(1994-12#1)
adoption of a##8##3##(1995-1#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)
adoption of evidence-based postoperative pain assessment practices##2##7##(2010-11#2)
adoption of the Medicare fee schedule##2##6##(1993-3#1)(1994-1#1)
adoption of the three##3##4##(2010-11#3)
adoption of the##15##3##(1991-2#1)(1993-3#1)(1994-1#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-3#2)(2008-8#1)(2010-11#3)(2011-2#1)(2012-3#1)
adoption of these##3##3##(2008-10#1)(2010-12#1)(2010-8#1)
adoption of##64##2##(1991-12#2)(1991-2#1)(1993-3#1)(1994-1#2)(1995-1#2)(1995-3#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-11#7)(2010-12#1)(2010-3#2)(2010-8#3)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)
adoption process##3##2##(2013-1#3)
adoption status##2##2##(2009-8#2)
adoption studies##2##2##(1994-2#2)
adoption to##2##2##(2008-5#1)(2008-9#1)
adoption##112##1##(1991-1#1)(1991-12#3)(1991-2#1)(1993-3#3)(1994-1#2)(1994-12#2)(1994-2#4)(1995-1#2)(1995-3#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#6)(2009-11#6)(2009-6#1)(2009-8#2)(2010-11#7)(2010-12#2)(2010-3#2)(2010-8#11)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#8)
adoptions##2##1##(2008-5#2)
adoptive T-cell##2##2##(2010-11#2)
adoptive and##2##2##(2009-2#1)(2009-8#1)
adoptive immunotherapy##3##2##(1990-12#1)(2011-2#1)(2012-2#1)
adoptive transfer of##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
adoptive transfer##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
adoptive##19##1##(1990-12#1)(1990-2#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#3)(2009-2#1)(2009-8#1)(2010-11#2)(2011-2#3)(2012-2#2)(2013-1#1)
adoptively##2##1##(2008-9#1)(2012-2#1)
adopts a##8##2##(1991-5#1)(1992-3#1)(1993-11#1)(1993-8#1)(1996-12#1)(1997-7#1)(2008-5#1)(2012-2#1)
adopts an##2##2##(1992-8#1)(1994-5#1)
adopts the 3(10)-helical conformation##2##4##(1995-2#2)
adopts the##3##2##(1990-12#1)(1995-2#2)
adopts##22##1##(1990-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-5#1)(2012-2#1)
adrenal adenoma##5##2##(2008-8#2)(2011-2#3)
adrenal adenomas and##3##3##(1990-11#3)
adrenal adenomas##5##2##(1990-11#3)(2011-2#1)(2013-1#1)
adrenal and##6##2##(1992-3#1)(1995-12#2)(2008-4#1)(2008-7#1)(2013-1#1)
adrenal androgen production##2##3##(1990-9#1)(2012-3#1)
adrenal cells##3##2##(1990-12#1)(1991-3#2)
adrenal chromaffin cells##6##3##(1992-6#2)(1994-5#2)(1995-11#1)(1996-5#1)
adrenal cortex mitochondria##2##3##(1990-11#2)
adrenal cortex##26##2##(1990-11#3)(1990-5#2)(1990-7#1)(1991-5#1)(1991-8#5)(1993-8#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-5#1)(2007-10#1)(2008-4#3)(2011-1#2)(2011-2#1)
adrenal gland and##6##3##(1991-2#1)(1993-11#1)(1993-12#1)(2008-11#1)(2008-4#1)(2011-2#1)
adrenal gland is##3##3##(1993-3#1)(2008-5#1)(2013-1#1)
adrenal gland##37##2##(1990-3#1)(1990-5#4)(1991-2#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#4)(1994-5#1)(1994-6#1)(1995-3#1)(1996-12#2)(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#1)(2011-2#6)(2012-12#1)(2013-1#1)
adrenal glands was##2##3##(1993-3#1)(2011-2#1)
adrenal glands##10##2##(1990-12#1)(1991-8#1)(1992-8#1)(1993-3#1)(2007-10#1)(2011-2#3)(2013-1#2)
adrenal hyperplasia (CAH)##5##3##(2008-4#3)(2008-8#1)(2010-2#1)
adrenal hyperplasia##18##2##(1990-11#1)(2007-7#1)(2008-1#3)(2008-4#7)(2008-7#1)(2008-8#2)(2010-2#2)(2012-3#1)
adrenal hypoplasia##2##2##(2008-4#1)(2011-1#1)
adrenal insufficiency##4##2##(1990-12#1)(1992-5#1)(2008-4#1)(2012-3#1)
adrenal mass##2##2##(2008-1#1)(2008-4#1)
adrenal medulla##10##2##(1990-5#2)(1991-8#1)(1992-3#2)(1996-12#2)(1996-5#1)(2008-11#2)
adrenal steroidogenesis##2##2##(1991-3#1)(1995-12#1)
adrenal tumor cell line SW-13##2##5##(1990-12#2)
adrenal tumor##5##2##(1990-11#1)(1990-12#2)(1992-2#1)(2008-5#1)
adrenal##200##1##(1990-11#10)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#9)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#5)(1991-6#2)(1991-8#8)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#5)(1993-11#1)(1993-12#1)(1993-3#8)(1993-8#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#8)(1995-3#1)(1996-12#5)(1996-2#3)(1996-5#5)(1997-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#5)(2008-11#5)(2008-12#1)(2008-4#20)(2008-5#5)(2008-7#5)(2008-8#7)(2009-9#1)(2010-2#2)(2011-1#3)(2011-2#14)(2012-12#2)(2012-3#5)(2013-1#10)
adrenalectomied and sham-operated##2##3##(2012-1#2)
adrenalectomied##3##1##(2012-1#3)
adrenalectomized (ADX)##2##2##(1990-12#1)(1994-2#1)
adrenalectomized animals##2##2##(1990-5#2)
adrenalectomized rats##2##2##(1990-12#1)(1994-2#1)
adrenalectomized##7##1##(1990-12#2)(1990-5#3)(1994-2#2)
adrenalectomy and##4##2##(2011-2#1)(2012-12#3)
adrenalectomy##21##1##(1992-2#1)(1993-5#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#10)
adrenalin##2##1##(2013-1#2)
adrenaline and##2##2##(1994-9#1)(1997-3#1)
adrenaline cells##2##2##(1996-5#2)
adrenaline chromaffin cells##2##3##(1996-5#2)
adrenaline in##2##2##(2008-10#1)(2013-1#1)
adrenaline is##2##2##(1997-3#1)(2008-11#1)
adrenaline release##2##2##(1997-6#1)(2008-5#1)
adrenaline##24##1##(1991-2#1)(1991-8#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-5#4)(1997-3#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2013-1#1)
adrenals and gonads##2##3##(2008-4#1)(2009-2#1)
adrenals and##4##2##(1994-2#1)(2008-4#1)(2009-2#1)(2013-1#1)
adrenals##11##1##(1990-11#1)(1990-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(2008-4#1)(2009-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
adrenarche and##2##2##(2008-4#1)(2011-1#1)
adrenarche##7##1##(2008-4#6)(2011-1#1)
adrenergic agonist##2##2##(1992-8#1)(2008-2#1)
adrenergic agonists##2##2##(1992-8#1)(1997-1#1)
adrenergic and##4##2##(1994-9#1)(1996-2#1)(2007-8#1)(2008-11#1)
adrenergic receptor subtypes##3##3##(1993-12#2)(1994-6#1)
adrenergic receptor##8##2##(1993-12#3)(1994-6#1)(1994-9#1)(2008-10#1)(2008-4#1)(2010-6#1)
adrenergic receptors##10##2##(1993-12#5)(1994-6#1)(1994-9#1)(2008-3#1)(2008-4#1)(2010-12#1)
adrenergic stimulation##2##2##(1994-2#1)(2007-10#1)
adrenergic##50##1##(1990-5#1)(1991-12#1)(1992-8#3)(1993-12#9)(1993-3#1)(1993-5#1)(1994-2#1)(1994-6#4)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-6#1)(2013-8#1)
adrenergically induced Na+##2##3##(1995-12#2)
adrenoceptor##4##1##(1995-11#1)(1996-2#1)(2008-3#1)(2008-5#1)
adrenoceptors##3##1##(1993-12#1)(2008-5#1)(2008-7#1)
adrenocortical carcinoma##4##2##(1992-10#2)(1995-12#1)(1997-5#1)
adrenocortical failure##2##2##(1993-6#1)(2012-2#1)
adrenocortical secretion##2##2##(2008-11#2)
adrenocortical##17##1##(1990-9#1)(1992-10#2)(1993-11#3)(1993-3#2)(1993-6#1)(1995-12#2)(1997-5#1)(2008-11#2)(2008-7#2)(2012-2#1)
adrenocorticotropic hormone (ACTH) and corticosterone##2##5##(1996-12#1)(2008-4#1)
adrenocorticotropic hormone (ACTH) and##3##4##(1995-11#1)(1996-12#1)(2008-4#1)
adrenocorticotropic hormone (ACTH)##7##3##(1992-8#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
adrenocorticotropic hormone##15##2##(1990-2#2)(1992-8#1)(1993-5#2)(1994-2#1)(1995-11#1)(1996-12#1)(2008-4#3)(2011-1#1)(2011-2#2)(2013-1#1)
adrenocorticotropic##18##1##(1990-2#4)(1992-8#1)(1993-5#2)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-4#3)(2011-1#1)(2011-2#2)(2013-1#1)
adrenocorticotropin##2##1##(1996-2#1)(2008-4#1)
adrenoleukodystrophy##4##1##(1993-3#2)(1993-8#1)(1995-2#1)
adrenomedullin##5##1##(1994-11#1)(1994-6#2)(1995-12#1)(2010-12#1)
adrenoreceptor antagonist##2##2##(2013-1#2)
adrenoreceptor##5##1##(2013-1#5)
adrenoreceptors##3##1##(1994-5#1)(2008-10#1)(2013-1#1)
adriamycin (ADR) and##2##3##(1995-4#1)(2011-3#1)
adriamycin (ADR)##6##2##(1990-2#1)(1993-12#1)(1994-7#1)(1995-4#1)(2008-10#1)(2011-3#1)
adriamycin and cisplatin##3##3##(1991-8#1)(1992-10#1)(2010-3#1)
adriamycin and##5##2##(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(2010-3#1)
adriamycin plus etoposide##2##3##(1993-8#2)
adriamycin plus##3##2##(1993-8#3)
adriamycin##46##1##(1990-2#5)(1991-4#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#6)(1994-7#1)(1995-4#1)(1997-7#1)(2008-10#6)(2008-6#2)(2008-7#2)(2009-4#1)(2010-3#4)(2011-3#1)
adriamycin-perfused rat heart##2##3##(1990-5#2)
adriamycin-perfused##3##1##(1990-5#3)
adriamycinol##2##1##(2008-10#2)
adriamycinone##2##1##(2008-10#2)
adriblastina and##2##2##(2008-10#2)
adriblastina##10##1##(2008-10#10)
ads##4##1##(1990-11#1)(1997-1#2)(2008-12#1)
adsorb##9##1##(1992-12#1)(1993-12#1)(2007-11#1)(2008-10#6)
adsorbate##9##1##(2007-12#4)(2008-10#3)(2008-2#1)(2010-12#1)
adsorbates##6##1##(1992-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
adsorbed Tween 20##2##3##(2008-7#2)
adsorbed and##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)
adsorbed at the mercury electrode##4##5##(2008-10#4)
adsorbed at the##5##3##(2008-10#4)(2013-1#1)
adsorbed at##6##2##(2008-10#4)(2008-7#1)(2013-1#1)
adsorbed by##4##2##(2008-10#3)(2008-6#1)
adsorbed complex##4##2##(2008-10#4)
adsorbed compounds##2##2##(2008-10#2)
adsorbed electroactive##2##2##(2008-10#2)
adsorbed in the##2##3##(1994-5#1)(2008-3#1)
adsorbed in##4##2##(1994-5#1)(2008-10#2)(2008-3#1)
adsorbed metal##2##2##(2008-10#2)
adsorbed molecule##2##2##(2009-11#2)
adsorbed on Whatman 1PS filter paper##2##6##(2008-10#2)
adsorbed on a small column packed with##3##7##(2008-10#3)
adsorbed on a##6##3##(1990-8#1)(2008-10#5)
adsorbed on silica##2##3##(2008-10#1)(2008-11#1)
adsorbed on the column##3##4##(2008-10#3)
adsorbed on the electrode##2##4##(2008-10#2)
adsorbed on the mercury electrode##2##5##(2008-10#2)
adsorbed on the surface of a##2##6##(2008-10#2)
adsorbed on the surface of the##2##6##(2008-10#2)
adsorbed on the surface of##5##5##(2008-10#5)
adsorbed on the##18##3##(2008-10#15)(2008-11#1)(2008-2#1)(2008-7#1)
adsorbed on##46##2##(1990-8#1)(1991-5#1)(2008-10#39)(2008-11#2)(2008-2#1)(2008-7#1)(2011-1#1)
adsorbed onto a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
adsorbed onto the##3##3##(1990-12#1)(2008-10#2)
adsorbed onto##9##2##(1990-12#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#1)
adsorbed protein##3##2##(1994-6#1)(2008-10#1)(2008-2#1)
adsorbed species##3##2##(2008-10#3)
adsorbed thiocyanate##2##2##(2007-12#2)
adsorbed to the##2##3##(1995-5#1)(2008-10#1)
adsorbed to##4##2##(1990-5#1)(1995-5#1)(1997-2#1)(2008-10#1)
adsorbed was obtained##2##3##(2008-10#2)
adsorbed was##3##2##(2008-10#2)(2010-5#1)
adsorbed##168##1##(1990-12#3)(1990-5#1)(1990-8#2)(1991-5#1)(1992-12#2)(1992-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-2#2)(2007-11#2)(2007-12#5)(2008-10#112)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-11#2)(2010-10#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
adsorbent and##4##2##(2008-10#4)
adsorbent for##4##2##(2008-10#4)
adsorbent packed in a column and determined similarly##4##8##(2008-10#4)
adsorbent packed in a column##6##5##(2008-10#6)
adsorbent surface##3##2##(2008-10#3)
adsorbent was##2##2##(2008-10#1)(2010-5#1)
adsorbent with##2##2##(2008-10#2)
adsorbent##57##1##(1990-7#1)(2008-10#45)(2008-4#2)(2008-7#4)(2010-5#1)(2013-1#2)(2013-8#2)
adsorbents for preconcentration##2##3##(2008-10#2)
adsorbents for##3##2##(2008-10#3)
adsorbents were##2##2##(1997-2#1)(2008-10#1)
adsorbents##24##1##(1997-2#8)(2008-10#15)(2013-1#1)
adsorbing Hb##2##2##(2008-10#2)
adsorbing##14##1##(1990-8#1)(1994-12#1)(2008-10#10)(2008-11#1)(2008-9#1)
adsorbs##2##1##(2008-10#1)(2008-5#1)
adsorption and desorption of##3##4##(2008-10#2)(2008-2#1)
adsorption and desorption##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
adsorption and##20##2##(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
adsorption at##2##2##(2008-10#2)
adsorption behaviour##3##2##(1997-2#3)
adsorption by##5##2##(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#2)
adsorption capacities are##2##3##(2008-10#2)
adsorption capacities of##2##3##(2008-10#2)
adsorption capacities##6##2##(2008-10#5)(2013-1#1)
adsorption capacity for##2##3##(2008-7#1)(2013-8#1)
adsorption capacity of the##4##4##(2008-10#3)(2011-2#1)
adsorption capacity of##7##3##(2008-10#6)(2011-2#1)
adsorption capacity##10##2##(2008-10#7)(2008-7#1)(2011-2#1)(2013-8#1)
adsorption cathodic stripping##3##3##(2008-10#3)
adsorption cathodic##4##2##(2008-10#4)
adsorption characteristics##2##2##(2008-10#2)
adsorption coefficient##2##2##(2008-10#2)
adsorption coefficients##2##2##(2008-10#2)
adsorption collection of##2##3##(2008-10#2)
adsorption collection##3##2##(2008-10#3)
adsorption constant##3##2##(2008-10#3)
adsorption effect##2##2##(2008-10#2)
adsorption equilibrium##3##2##(2008-10#3)
adsorption followed by##2##3##(1990-12#1)(2008-10#1)
adsorption for##3##2##(2008-10#2)(2013-1#1)
adsorption free##2##2##(2008-10#1)(2008-2#1)
adsorption from##10##2##(2008-10#10)
adsorption is##3##2##(1990-2#1)(2008-10#2)
adsorption isotherm models##2##3##(2008-10#2)
adsorption isotherm of##2##3##(1992-5#1)(2013-1#1)
adsorption isotherm##7##2##(1992-5#1)(2008-10#5)(2013-1#1)
adsorption isotherms##4##2##(2008-10#3)(2011-2#1)
adsorption kinetics and##2##3##(2008-10#1)(2013-8#1)
adsorption kinetics##3##2##(2008-10#2)(2013-8#1)
adsorption maximum at##2##3##(2008-10#2)
adsorption method##3##2##(1990-12#2)(2008-10#1)
adsorption model##2##2##(2010-5#1)(2013-8#1)
adsorption occurred##2##2##(2010-5#2)
adsorption of albumin on##2##4##(2008-6#1)(2008-7#1)
adsorption of albumin##3##3##(2008-6#2)(2008-7#1)
adsorption of fluoxetine##2##3##(2008-10#2)
adsorption of heavy metal ions##5##5##(2008-10#5)
adsorption of heavy metal##7##4##(2008-10#6)(2013-1#1)
adsorption of proteins##2##3##(1997-2#1)(2008-10#1)
adsorption of silver##2##3##(2008-10#2)
adsorption of the##9##3##(2007-11#1)(2008-10#8)
adsorption of##95##2##(1990-2#1)(1997-2#1)(2007-11#1)(2008-10#79)(2008-3#2)(2008-6#3)(2008-7#1)(2010-4#2)(2010-5#1)(2013-1#3)(2013-8#1)
adsorption on a##2##3##(2008-10#2)
adsorption on the electrode surface##2##5##(2008-10#2)
adsorption on the surface of the##3##6##(2008-10#3)
adsorption on the##7##3##(2008-10#7)
adsorption on##19##2##(1992-6#1)(1994-2#1)(2008-10#15)(2008-6#1)(2008-7#1)
adsorption onto##5##2##(2008-10#3)(2008-7#1)(2010-11#1)
adsorption potential##2##2##(2008-10#2)
adsorption preconcentration##3##2##(2008-10#3)
adsorption process##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
adsorption properties of the##2##4##(2008-10#2)
adsorption properties of##4##3##(2008-10#4)
adsorption properties##7##2##(2008-10#7)
adsorption sites##4##2##(2007-12#1)(2008-10#3)
adsorption techniques##2##2##(1994-9#1)(2008-10#1)
adsorption time##2##2##(2008-10#2)
adsorption to##3##2##(2008-10#3)
adsorption using##2##2##(1991-8#1)(2008-10#1)
adsorption was found##2##3##(2008-7#2)
adsorption was studied##2##3##(2008-10#1)(2013-1#1)
adsorption was##8##2##(2008-10#3)(2008-7#2)(2010-4#1)(2010-5#1)(2013-1#1)
adsorption were##2##2##(2008-10#1)(2008-6#1)
adsorption##371##1##(1990-12#3)(1990-2#3)(1991-8#1)(1992-5#2)(1992-6#1)(1994-2#1)(1994-9#1)(1997-2#6)(2007-11#3)(2007-12#2)(2008-10#259)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#11)(2008-7#17)(2009-11#3)(2009-2#1)(2010-11#1)(2010-4#6)(2010-5#8)(2010-7#1)(2011-2#4)(2013-1#13)(2013-8#11)
adsorption-desorption##7##1##(2008-10#4)(2008-5#1)(2008-6#1)(2009-11#1)
adsorption/desorption##2##1##(2008-10#2)
adsorption/elution##2##1##(1992-12#2)
adsorptions##3##1##(1994-9#1)(2008-10#2)
adsorptive accumulation of the##3##4##(2008-10#3)
adsorptive accumulation of##6##3##(2008-10#6)
adsorptive accumulation##9##2##(2008-10#9)
adsorptive cathodic stripping voltammetric procedure was developed for the##2##9##(2008-10#2)
adsorptive cathodic stripping voltammetric procedure was##3##6##(2008-10#3)
adsorptive cathodic stripping voltammetry using##2##5##(2008-10#2)
adsorptive cathodic stripping voltammetry##10##4##(2008-10#10)
adsorptive cathodic stripping voltammogram of##2##5##(2008-10#2)
adsorptive cathodic stripping##15##3##(2008-10#15)
adsorptive material##2##2##(2008-10#2)
adsorptive polarographic##4##2##(2008-10#4)
adsorptive preconcentration##3##2##(2008-10#3)
adsorptive stripping voltammetric determination of##3##5##(2008-10#3)
adsorptive stripping voltammetric measurements of##2##5##(2008-10#2)
adsorptive stripping voltammetric##10##3##(2008-10#10)
adsorptive stripping voltammetry (AdSV)##2##4##(2008-10#2)
adsorptive stripping voltammetry on a##2##5##(2008-10#2)
adsorptive stripping voltammetry on##3##4##(2008-10#3)
adsorptive stripping voltammetry with a##2##5##(2008-10#2)
adsorptive stripping voltammetry##38##3##(2008-10#38)
adsorptive stripping##58##2##(2008-10#58)
adsorptive transfer##2##2##(2008-10#2)
adsorptive voltammetric##3##2##(2008-10#3)
adsorptive voltammetry##4##2##(2008-10#4)
adsorptive##116##1##(2008-10#115)(2008-11#1)
adsorptive-catalytic stripping##3##2##(2008-10#3)
adsorptivity##2##1##(2008-10#2)
adult (3-month-old) and aged##2##4##(1991-12#1)(1994-3#1)
adult Anopheles##2##2##(2012-12#2)
adult Chinese##2##2##(2008-7#1)(2013-8#1)
adult DRG##2##2##(1996-12#2)
adult Diploptera punctata males##2##4##(1995-11#2)
adult Drosophila melanogaster##3##3##(1997-7#1)(2008-5#1)(2008-8#1)
adult Drosophila##4##2##(1997-7#1)(2008-5#1)(2008-8#1)(2008-9#1)
adult ICUs##2##2##(2007-11#2)
adult Nucleus##2##2##(2008-9#2)
adult Schwann cells and olfactory ensheathing glia##2##7##(2008-7#2)
adult Sprague-Dawley##2##2##(2008-10#1)(2008-7#1)
adult T cell leukemia##2##4##(2008-11#1)(2008-4#1)
adult T-cell leukemia (ATL)##2##4##(1991-11#1)(2012-12#1)
adult T-cell##4##2##(1991-11#2)(2012-12#2)
adult Wistar rats were##2##4##(1991-2#1)(2008-7#1)
adult Wistar rats##4##3##(1991-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
adult age group##2##3##(2010-12#1)(2013-7#1)
adult age##3##2##(1990-3#1)(2010-12#1)(2013-7#1)
adult alcohol##3##2##(1994-2#1)(2012-12#2)
adult alveolar##2##2##(1994-3#2)
adult and aged rats##2##4##(1994-3#2)
adult and aged##4##3##(1991-12#1)(1994-3#2)(2008-5#1)
adult and child##2##3##(1991-12#1)(2008-11#1)
adult and embryonic##2##3##(2007-12#1)(2008-11#1)
adult and fetal##2##3##(1991-11#1)(1997-5#1)
adult and neonatal##3##3##(1997-2#1)(2008-5#2)
adult and##27##2##(1991-11#1)(1991-12#3)(1994-11#1)(1994-3#2)(1997-2#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-7#2)
adult animals##11##2##(1990-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-6#1)(1997-9#1)(2008-4#3)(2008-7#1)(2012-12#1)
adult asthma##3##2##(1996-1#2)(2012-12#1)
adult behavior##4##2##(1993-12#1)(2007-8#1)(2009-7#2)
adult birds##2##2##(1996-8#1)(2011-2#1)
adult body##5##2##(2008-11#1)(2010-2#2)(2011-1#1)(2011-2#1)
adult bone marrow##2##3##(2008-10#1)(2009-10#1)
adult bone##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
adult brain##8##2##(1993-12#1)(1996-12#1)(2008-1#1)(2008-4#1)(2008-7#3)(2012-3#1)
adult branch##2##2##(2008-11#2)
adult cardiac##4##2##(2007-9#2)(2008-12#1)(2013-1#1)
adult cardiomyocytes##4##2##(1994-6#1)(2008-7#3)
adult care##2##2##(2008-11#1)(2011-2#1)
adult cat##3##2##(1993-12#1)(1994-8#1)(1997-3#1)
adult cats##3##2##(1993-12#2)(1994-8#1)
adult cattle##2##2##(1993-2#1)(2012-3#1)
adult cell##2##2##(2007-12#1)(2008-8#1)
adult child##4##2##(1994-12#1)(1995-2#1)(2010-4#1)(2010-9#1)
adult children##5##2##(1993-3#1)(2013-1#4)
adult cirrhotics##4##2##(2012-3#4)
adult cochlear implant patients##3##4##(2008-9#3)
adult cochlear implant recipients and normal-hearing adults##2##7##(2008-9#2)
adult cochlear implant recipients##3##4##(2008-9#3)
adult cochlear implant users with##2##5##(2008-9#2)
adult cochlear implant users##5##4##(2008-9#5)
adult cochlear implant##12##3##(2008-9#12)
adult cochlear implantation##2##3##(2008-9#2)
adult cochlear implantees##2##3##(2008-9#2)
adult cochlear##16##2##(2008-9#16)
adult cortical##2##2##(1996-12#1)(2007-8#1)
adult day care##8##3##(1992-1#3)(1992-3#1)(1994-3#2)(1996-2#1)(1997-2#1)
adult day centers##2##3##(1994-2#2)
adult day##10##2##(1992-1#3)(1992-3#1)(1994-2#2)(1994-3#2)(1996-2#1)(1997-2#1)
adult dental##3##2##(2008-5#1)(2012-12#2)
adult depression##2##2##(2008-11#1)(2010-7#1)
adult development##3##2##(2007-12#2)(2008-6#1)
adult diseases##2##2##(2012-2#2)
adult education principles##2##3##(1992-2#1)(1995-3#1)
adult education##4##2##(1991-3#1)(1992-2#1)(1995-3#1)(2008-12#1)
adult emergence##4##2##(2007-12#2)(2008-10#1)(2008-6#1)
adult fecundity##3##2##(2008-11#3)
adult female##8##2##(1990-11#1)(1992-8#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
adult females of##2##3##(2008-12#1)(2008-7#1)
adult females##10##2##(1991-12#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
adult fish##6##2##(2008-7#3)(2009-7#2)(2010-8#1)
adult forebrain##2##2##(1995-12#2)
adult group##3##2##(1995-3#1)(2007-8#1)(2008-8#1)
adult groups##2##2##(2008-5#1)(2008-9#1)
adult hamster##2##2##(1996-2#2)
adult hamsters##2##2##(1992-10#1)(1996-2#1)
adult health##4##2##(2011-1#1)(2012-2#2)(2013-1#1)
adult height##2##2##(2007-11#1)(2013-1#1)
adult hepatocytes##3##2##(2008-11#2)(2012-2#1)
adult horses##3##2##(2012-12#1)(2013-8#2)
adult household dogs##2##3##(2012-3#2)
adult human brain##3##3##(1991-7#1)(1996-10#1)(2007-8#1)
adult human##15##2##(1991-7#1)(1992-8#1)(1994-2#3)(1995-6#1)(1996-10#1)(1996-5#3)(1997-8#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-8#1)
adult humans##3##2##(2011-2#2)(2012-2#1)
adult humerii##2##2##(2013-8#2)
adult illiterates##3##2##(2009-9#3)
adult inbreeding depression##2##3##(2008-9#2)
adult influences##2##2##(2009-7#2)
adult insects##3##2##(2007-12#1)(2008-10#2)
adult intensive care units##2##4##(1996-9#2)
adult is##4##2##(2008-10#1)(2008-6#1)(2011-1#1)(2013-7#1)
adult learning##4##2##(1992-1#1)(1995-2#1)(1995-3#1)(2007-5#1)
adult level##2##2##(1997-2#2)
adult levels##3##2##(1990-11#1)(1990-5#1)(1992-6#1)
adult life##18##2##(1993-3#1)(1995-12#4)(2008-10#2)(2008-12#1)(2008-7#3)(2008-8#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
adult liver##4##2##(1990-11#1)(1994-3#1)(2008-7#1)(2013-1#1)
adult livers##2##2##(2013-1#2)
adult lung##4##2##(1994-11#2)(1994-9#1)(2013-1#1)
adult male Wistar##2##3##(2008-11#1)(2008-12#1)
adult male and female##3##4##(1995-3#1)(2008-10#1)(2008-11#1)
adult male rats##3##3##(1992-12#1)(1993-12#1)(1994-8#1)
adult male##26##2##(1992-12#1)(1993-12#2)(1993-5#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#2)(2008-7#1)(2009-5#1)(2009-9#1)(2012-12#1)(2013-8#1)
adult males and females##4##4##(2007-12#1)(2008-10#1)(2008-12#1)(2013-7#1)
adult males##16##2##(1991-12#2)(1994-8#1)(1995-12#1)(1996-12#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-7#1)
adult mammalian##4##2##(1997-6#1)(2008-11#1)(2008-7#1)(2009-10#1)
adult marsh tits##2##3##(1994-3#2)
adult meadow voles##2##3##(1994-8#2)
adult men who had been##2##5##(1996-11#1)(1996-6#1)
adult men who##3##3##(1996-11#1)(1996-6#1)(2008-3#1)
adult men##4##2##(1992-9#1)(1996-11#1)(1996-6#1)(2008-3#1)
adult mice##9##2##(1993-3#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-2#2)(2012-3#1)
adult mites##4##2##(2007-12#4)
adult mosquitoes##2##2##(2007-10#1)(2013-1#1)
adult mouse neocortex##2##3##(2008-11#2)
adult mouse##14##2##(1990-12#2)(1995-2#2)(1997-7#2)(2008-11#4)(2008-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
adult nervous system##2##3##(1994-12#1)(1997-3#1)
adult neural##3##2##(2008-11#1)(2008-9#1)(2013-7#1)
adult neurogenesis in##2##3##(1996-5#1)(2008-11#1)
adult neurogenesis##6##2##(1996-5#2)(2008-11#1)(2008-7#2)(2012-2#1)
adult nursing##2##2##(2008-11#2)
adult offspring with##2##3##(2008-10#1)(2013-1#1)
adult offspring##3##2##(1991-1#1)(2008-10#1)(2013-1#1)
adult oncology##2##2##(2008-11#1)(2012-3#1)
adult onset##8##2##(1992-8#3)(1994-2#1)(2008-1#2)(2008-7#1)(2013-8#1)
adult or##5##2##(1992-10#1)(2008-10#1)(2008-11#2)(2008-5#1)
adult ossifying fibroma&quot##2##3##(2013-7#2)
adult pancreas##3##2##(2008-1#1)(2013-7#2)
adult participants##2##2##(2009-3#1)(2009-4#1)
adult patient##12##2##(1992-3#1)(1993-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
adult patients and##2##3##(1992-12#1)(2008-10#1)
adult patients in##3##3##(2008-1#1)(2009-4#1)(2013-1#1)
adult patients undergoing##3##3##(2007-8#2)(2008-8#1)
adult patients who##3##3##(1991-11#1)(2012-3#2)
adult patients with atopic dermatitis##2##5##(2011-1#1)(2012-1#1)
adult patients with locally advanced##2##5##(2008-6#2)
adult patients with##22##3##(1991-2#2)(1992-12#1)(1997-3#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-6#3)(2008-7#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
adult patients##59##2##(1991-11#1)(1991-2#3)(1991-4#1)(1992-12#2)(1993-12#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-12#2)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#6)(2013-7#1)
adult phases##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
adult pig##2##2##(1990-11#1)(2012-2#1)
adult pigs##2##2##(2007-8#1)(2009-7#1)
adult plant resistance to stripe rust##2##6##(2008-10#2)
adult plant resistance to##3##4##(2008-10#3)
adult plant resistance##5##3##(2008-10#5)
adult plant##14##2##(2008-10#14)
adult plants of##3##3##(2008-10#3)
adult plants##9##2##(2008-10#7)(2008-5#1)(2008-8#1)
adult population a##2##3##(2010-7#1)(2013-1#1)
adult population in##4##3##(1995-9#1)(2008-11#1)(2012-12#1)(2013-8#1)
adult population was##2##3##(1995-9#1)(2013-8#1)
adult population##32##2##(1992-5#1)(1995-9#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-11#2)(2008-8#4)(2009-12#2)(2010-7#1)(2012-12#4)(2013-1#6)(2013-7#1)(2013-8#5)
adult postoperative patients##3##3##(1993-12#2)(2010-11#1)
adult psychiatric##3##2##(1993-2#2)(1996-11#1)
adult rat brain##2##3##(1993-12#1)(2008-1#1)
adult rat cerebral cortex##2##4##(1996-12#1)(2008-11#1)
adult rat hepatocytes##4##3##(1993-8#2)(1995-8#2)
adult rat spinal cord##2##4##(1995-12#1)(1995-5#1)
adult rat##30##2##(1991-12#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-5#2)(1995-8#2)(1996-12#7)(1997-3#2)(2008-1#1)(2008-11#2)(2009-10#1)(2012-2#1)
adult raters##2##2##(2012-3#2)
adult rats was##2##3##(1991-12#1)(1991-5#1)
adult rats##29##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#3)(1993-6#1)(1994-2#3)(1994-6#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(2007-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-7#3)
adult residents##2##2##(2007-10#1)(2013-8#1)
adult respiratory distress syndrome (ARDS)##2##5##(1991-9#1)(1993-2#1)
adult respiratory distress syndrome##6##4##(1991-9#3)(1993-2#1)(1994-11#1)(2006-10#1)
adult respiratory##7##2##(1991-9#3)(1992-2#1)(1993-2#1)(1994-11#1)(2006-10#1)
adult retina##2##2##(1996-5#2)
adult roles##2##2##(2009-7#2)
adult samples##2##2##(2007-12#1)(2010-2#1)
adult skeletal muscle##4##3##(1991-12#1)(2008-11#1)(2009-3#2)
adult smokers##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
adult stage of##2##3##(2008-10#1)(2011-2#1)
adult stage##8##2##(1990-3#2)(2008-10#4)(2011-2#1)(2013-1#1)
adult stages##8##2##(1995-6#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-9#1)(2013-1#2)
adult stem cell##4##3##(2009-3#2)(2012-12#1)(2013-7#1)
adult stem cells##4##3##(2008-11#1)(2008-9#1)(2010-10#1)(2012-2#1)
adult stem##8##2##(2008-11#1)(2008-9#1)(2009-3#2)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
adult striatum##2##2##(1996-2#1)(1996-5#1)
adult students##2##2##(1996-1#1)(1996-2#1)
adult subjects##5##2##(2008-5#1)(2008-6#1)(2008-9#3)
adult survival##3##2##(2008-9#2)(2012-2#1)
adult testes##2##2##(2009-10#1)(2012-2#1)
adult thrips##4##2##(2008-10#4)
adult tissues such as##2##4##(2008-6#1)(2008-9#1)
adult tissues##10##2##(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1997-7#2)(2008-6#1)(2008-9#1)(2009-12#1)
adult traits##2##2##(2008-8#1)(2012-3#1)
adult trees##3##2##(2008-5#2)(2008-8#1)
adult type##4##2##(1991-9#1)(1996-9#1)(2011-1#2)
adult users of the##2##4##(2008-9#2)
adult users##4##2##(2008-9#4)
adult values##2##2##(1992-2#1)(1994-11#1)
adult viability##3##2##(2008-8#2)(2011-2#1)
adult visual##5##2##(1994-8#3)(2007-8#1)(2012-2#1)
adult volunteers##2##2##(2008-5#1)(2012-12#1)
adult with##10##2##(1997-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
adult women in##6##3##(1991-6#2)(2008-4#1)(2012-2#1)(2013-1#2)
adult women##11##2##(1991-6#2)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#2)
adult worms##3##2##(1996-12#2)(2012-3#1)
adult zebrafish testis and ovary##2##5##(2008-7#2)
adult zebrafish##5##2##(1992-9#1)(2008-10#1)(2008-7#2)(2009-5#1)
adult##1150##1##(1990-11#6)(1990-12#3)(1990-3#4)(1990-5#7)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#5)(1991-12#10)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#5)(1992-1#4)(1992-10#6)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#4)(1993-11#1)(1993-12#20)(1993-2#4)(1993-3#7)(1993-5#2)(1993-6#8)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#11)(1994-12#4)(1994-2#21)(1994-3#16)(1994-5#1)(1994-6#5)(1994-8#12)(1994-9#3)(1995-1#1)(1995-11#6)(1995-12#11)(1995-2#6)(1995-3#4)(1995-5#5)(1995-6#6)(1995-8#2)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#21)(1996-2#10)(1996-3#2)(1996-5#16)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#12)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#7)(1997-8#7)(1997-9#2)(2006-10#5)(2007-10#6)(2007-11#5)(2007-12#36)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#17)(2007-9#4)(2008-1#13)(2008-10#78)(2008-11#43)(2008-12#17)(2008-2#1)(2008-3#6)(2008-4#12)(2008-5#27)(2008-6#17)(2008-7#51)(2008-8#29)(2008-9#69)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#5)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#11)(2009-8#5)(2009-9#7)(2010-10#6)(2010-11#9)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#9)(2010-8#9)(2010-9#2)(2011-1#15)(2011-2#27)(2012-1#2)(2012-12#32)(2012-2#27)(2012-3#29)(2013-1#51)(2013-7#20)(2013-8#17)
adult's##2##1##(2007-12#1)(2008-12#1)
adult)##5##1##(1997-2#4)(2008-10#1)
adult-directed##2##1##(1992-3#1)(2013-8#1)
adult-onset##6##1##(2006-10#2)(2008-3#1)(2008-7#2)(2012-3#1)
adult-plant leaf##2##2##(2008-10#2)
adult-plant resistance##2##2##(2008-10#2)
adult-plant##9##1##(2008-10#9)
adulterated soybean##2##2##(2008-10#2)
adulterated##6##1##(1996-12#1)(2008-10#4)(2010-5#1)
adulteration of##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
adulteration##8##1##(2008-10#6)(2008-8#1)(2010-4#1)
adulthood (approximate age##2##3##(2009-7#2)
adulthood in the##2##3##(1996-5#2)
adulthood in##3##2##(1996-5#2)(2011-2#1)
adulthood is##2##2##(2007-8#1)(2009-7#1)
adulthood##107##1##(1992-2#3)(1993-12#1)(1993-3#2)(1993-9#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#9)(1996-6#1)(1996-8#1)(1996-9#2)(1997-7#1)(1997-8#4)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#6)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#11)(2009-8#3)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-7#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-7#1)
adults (0-1 day)##2##3##(1997-8#2)
adults (LADA)##2##2##(2008-3#1)(2009-5#1)
adults (aged##2##2##(2012-2#1)(2013-1#1)
adults (n =##2##3##(2009-7#1)(2010-8#1)
adults aged over##2##3##(2012-12#1)(2012-3#1)
adults aged##9##2##(1990-2#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
adults and 1##2##3##(2008-12#1)(2008-3#1)
adults and a##2##3##(2008-8#1)(2009-11#1)
adults and children with##2##4##(1996-2#1)(1997-2#1)
adults and children##17##3##(1996-2#2)(1996-7#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)
adults and is##2##3##(2006-10#1)(2008-10#1)
adults and larvae##2##3##(2008-10#1)(2008-8#1)
adults and the##3##3##(2011-1#1)(2013-7#1)(2013-8#1)
adults and their##3##3##(2008-12#2)(2008-6#1)
adults and##62##2##(1993-12#1)(1994-3#1)(1994-5#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
adults appears to be##2##4##(1991-12#1)(2009-12#1)
adults are##18##2##(1992-1#1)(1994-6#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-1#3)(2013-8#2)
adults at the##4##3##(2008-2#3)(2008-9#1)
adults at##7##2##(1993-12#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-9#1)
adults can##2##2##(2008-10#1)(2013-7#1)
adults decreased with##2##3##(2008-10#2)
adults differs##2##2##(2008-10#1)(2008-7#1)
adults for##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
adults from##6##2##(2008-1#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
adults had##4##2##(1990-3#1)(1994-3#1)(2008-9#1)(2012-12#1)
adults has##2##2##(1995-1#1)(2007-8#1)
adults have##6##2##(2007-12#1)(2008-9#3)(2010-5#1)(2013-1#1)
adults in Australia##2##3##(2012-12#1)(2013-8#1)
adults in Japan##2##3##(2008-7#1)(2013-1#1)
adults in a##4##3##(1995-9#2)(2008-9#1)(2012-12#1)
adults in the United States##5##5##(1997-1#1)(2008-3#1)(2010-10#1)(2010-8#1)(2013-1#1)
adults in the##12##3##(1995-9#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2010-10#1)(2010-8#1)(2013-1#1)
adults in##50##2##(1991-11#1)(1992-5#1)(1995-5#1)(1995-9#3)(1997-1#1)(1997-6#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#1)
adults is not##2##3##(1997-8#1)(2008-11#1)
adults is##10##2##(1991-11#1)(1991-12#1)(1995-5#1)(1996-11#2)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2013-7#1)
adults living in the##2##4##(2008-5#1)(2011-2#1)
adults living##4##2##(2008-5#2)(2008-7#1)(2011-2#1)
adults may##4##2##(2007-12#1)(2007-7#1)(2008-9#1)(2011-2#1)
adults of the##6##3##(1991-11#1)(1994-3#1)(2007-12#1)(2008-9#1)(2010-8#1)(2013-8#1)
adults of##14##2##(1991-11#1)(1991-5#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-7#2)(2013-8#1)
adults on##5##2##(1997-4#1)(1997-8#1)(2008-10#1)(2010-7#2)
adults or##2##2##(2008-9#2)
adults over##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
adults participated in a##2##4##(2008-7#1)(2013-8#1)
adults per##2##2##(2008-10#1)(2011-2#1)
adults presenting with##2##3##(2013-1#2)
adults ranged from##2##3##(2008-9#1)(2011-2#1)
adults reported##2##2##(2009-7#1)(2012-2#1)
adults residing in##2##3##(2013-1#1)(2013-8#1)
adults showed##2##2##(1992-6#1)(1997-8#1)
adults suffering from##2##3##(2010-11#1)(2010-12#1)
adults that##5##2##(1994-8#1)(1996-11#1)(2008-8#1)(2011-2#2)
adults to##9##2##(2008-1#1)(2008-11#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
adults under##2##2##(1992-2#1)(2013-8#1)
adults using a##3##3##(2013-1#2)(2013-8#1)
adults using cochlear implants##2##4##(2008-9#2)
adults using##8##2##(2008-11#1)(2008-9#3)(2012-1#1)(2013-1#2)(2013-8#1)
adults was##4##2##(1990-12#1)(1996-11#1)(1996-8#1)(2010-8#1)
adults were##15##2##(1990-12#1)(1994-8#1)(2008-12#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
adults who had##2##3##(2008-9#1)(2009-6#1)
adults who stutter##2##3##(2012-12#2)
adults who were##5##3##(1996-11#1)(2007-2#1)(2012-12#2)(2013-8#1)
adults who##14##2##(1996-11#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#4)(2013-1#2)(2013-8#2)
adults with ADHD##2##3##(2008-2#1)(2008-6#1)
adults with RHD##2##3##(2012-3#2)
adults with a##4##3##(1997-4#1)(2008-7#1)(2008-9#1)(2010-7#1)
adults with an##2##3##(1996-2#1)(2008-5#1)
adults with atopic dermatitis##2##4##(2012-1#1)(2013-1#1)
adults with attention-deficit/hyperactivity disorder##3##4##(2008-2#2)(2011-2#1)
adults with cancer##3##3##(2008-11#1)(2010-11#1)(2012-2#1)
adults with chronic nonmalignant pain##2##5##(2010-3#2)
adults with chronic##6##3##(1997-2#1)(2006-10#1)(2008-8#1)(2010-3#2)(2013-1#1)
adults with congenital heart disease##2##5##(2008-12#1)(2010-6#1)
adults with congenital##3##3##(1992-5#1)(2008-12#1)(2010-6#1)
adults with cystic fibrosis##3##4##(1993-2#1)(2007-6#1)(2011-1#1)
adults with developmental dyslexia##2##4##(2012-2#2)
adults with developmental##3##3##(2010-12#1)(2012-2#2)
adults with diabetes##2##3##(2010-4#2)
adults with no##2##3##(2007-11#1)(2012-2#1)
adults with type##2##3##(2008-1#1)(2013-8#1)
adults with##94##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-2#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#4)(2008-2#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#4)(2010-12#3)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#3)
adults##816##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#5)(1991-3#2)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#1)(1995-9#4)(1996-1#2)(1996-11#8)(1996-2#8)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#13)(2006-10#5)(2006-12#1)(2007-10#3)(2007-11#8)(2007-12#19)(2007-2#4)(2007-6#1)(2007-7#6)(2007-8#11)(2008-1#21)(2008-10#29)(2008-11#25)(2008-12#31)(2008-2#10)(2008-3#14)(2008-4#5)(2008-5#13)(2008-6#14)(2008-7#21)(2008-8#17)(2008-9#60)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#4)(2009-2#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#8)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#7)(2010-2#3)(2010-3#12)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#2)(2011-1#14)(2011-2#60)(2012-1#10)(2012-12#24)(2012-2#24)(2012-3#16)(2013-1#65)(2013-7#17)(2013-8#28)
adults' expectations##2##2##(2009-7#2)
adults'##14##1##(2008-12#1)(2009-12#1)(2009-7#7)(2010-10#3)(2012-12#1)(2013-1#1)
adults)##6##1##(1995-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)
adults?##3##1##(2008-8#1)(2008-9#1)(2009-11#1)
adults]##5##1##(1994-12#1)(1996-11#1)(1997-8#1)(2008-10#1)(2013-1#1)
advance as##2##2##(1995-6#1)(2007-2#1)
advance care planning##4##3##(2010-4#1)(2010-8#1)(2012-3#2)
advance care##6##2##(2010-4#1)(2010-8#1)(2012-3#4)
advance directive decision making##2##4##(2008-12#2)
advance directive##4##2##(1993-12#1)(1994-1#1)(2008-12#2)
advance directives##9##2##(1992-12#2)(1993-2#3)(1994-1#2)(1996-3#1)(2010-8#1)
advance for##3##2##(2008-8#1)(2010-12#1)(2012-12#1)
advance in the##8##3##(1993-11#1)(1996-6#1)(1997-7#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
advance in this##2##3##(2009-5#1)(2010-10#1)
advance in##22##2##(1993-11#1)(1996-6#1)(1997-7#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
advance information for##2##3##(2008-7#2)
advance information##3##2##(2008-7#3)
advance into the##2##3##(2008-10#1)(2010-8#1)
advance is##3##2##(1994-5#1)(1997-6#1)(2008-11#1)
advance knowledge of the##2##4##(2008-3#1)(2010-8#1)
advance knowledge of##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
advance of the##4##3##(2008-10#3)(2012-7#1)
advance of##11##2##(1991-12#1)(2008-10#4)(2008-5#2)(2008-7#1)(2012-3#1)(2012-6#1)(2012-7#1)
advance our understanding of##4##4##(2009-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
advance our##5##2##(2009-4#1)(2009-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
advance the##8##2##(1994-12#1)(2008-11#2)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
advance##128##1##(1991-1#1)(1991-12#2)(1992-12#4)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#3)(1994-1#3)(1994-12#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-6#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#9)(2008-8#4)(2008-9#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#6)(2012-6#1)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#2)
advanced CHF##3##2##(2009-10#3)
advanced HIV disease##3##3##(2013-1#3)
advanced NSCLC patients##2##3##(2010-8#1)(2012-1#1)
advanced NSCLC##6##2##(2008-10#1)(2010-8#2)(2012-1#2)(2012-3#1)
advanced Parkinson's disease##3##3##(1996-3#1)(2008-7#1)(2010-12#1)
advanced RCC##2##2##(2013-1#2)
advanced age##14##2##(1990-6#1)(1994-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-2#2)(2011-3#1)
advanced analytical##3##2##(2008-11#1)(2010-7#1)(2013-1#1)
advanced and##8##2##(1991-8#1)(1995-10#1)(1995-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
advanced and/or metastatic##2##3##(1990-2#1)(2008-6#1)
advanced backcross##2##2##(2008-10#1)(2013-8#1)
advanced bladder##2##2##(1990-6#1)(2007-4#1)
advanced breast cancer and##3##4##(1991-6#1)(1991-8#2)
advanced breast cancer patients##3##4##(1994-8#2)(1997-7#1)
advanced breast cancer##30##3##(1990-10#1)(1991-4#2)(1991-6#3)(1991-8#7)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#4)(1997-7#2)(2007-5#2)
advanced breast##34##2##(1990-10#1)(1991-4#2)(1991-6#3)(1991-8#7)(1992-2#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#4)(1997-7#2)(2007-10#1)(2007-5#2)(2011-2#1)(2013-8#1)
advanced by##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
advanced cancer patients##8##3##(1991-12#1)(1992-10#1)(2010-2#3)(2013-8#3)
advanced cancer##19##2##(1991-12#1)(1992-10#1)(1992-5#1)(1992-6#1)(2007-11#1)(2008-2#2)(2008-7#4)(2010-2#3)(2012-3#2)(2013-8#3)
advanced cancers##2##2##(1991-3#1)(2013-1#1)
advanced cases##3##2##(1990-6#1)(2012-3#2)
advanced cervical##2##2##(2009-5#1)(2012-2#1)
advanced chemical##3##2##(2008-10#2)(2010-4#1)
advanced chronic renal failure (CRF)##2##5##(2007-7#1)(2008-1#1)
advanced chronic renal failure##3##4##(2007-7#2)(2008-1#1)
advanced chronic##4##2##(2007-7#2)(2008-1#1)(2009-10#1)
advanced cirrhosis and##2##3##(2008-9#1)(2009-8#1)
advanced clinical##2##2##(1994-9#1)(2011-3#1)
advanced colon carcinoma##2##3##(1990-8#1)(1992-10#1)
advanced colorectal cancer##9##3##(1990-12#2)(1990-8#1)(1991-3#1)(1992-2#2)(1993-12#1)(1994-2#1)(2010-9#1)
advanced colorectal##10##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-2#2)(1993-12#1)(1994-2#1)(2008-5#1)(2010-9#1)
advanced degenerative changes in the##2##5##(2007-8#1)(2012-12#1)
advanced disease##14##2##(1990-8#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-8#3)(1993-12#1)(1997-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-2#2)
advanced fibrosis##2##2##(2011-2#1)(2012-12#1)
advanced gastric cancer##4##3##(1990-2#2)(1991-4#1)(2010-12#1)
advanced gastric carcinoma##2##3##(1991-4#1)(2012-2#1)
advanced gastric##7##2##(1990-2#2)(1991-4#2)(2010-12#1)(2012-2#1)(2012-3#1)
advanced glycation end products (AGEs)##2##5##(1994-6#1)(2008-1#1)
advanced glycation end products##10##4##(1993-6#1)(1994-6#2)(2008-1#2)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#2)
advanced glycation end##11##3##(1993-6#1)(1994-6#2)(2008-1#3)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#2)
advanced glycation##13##2##(1993-6#1)(1994-6#2)(2008-1#3)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)
advanced gonarthrosis##3##2##(2007-8#3)
advanced head and neck cancer##4##5##(1990-12#1)(1990-6#1)(1993-9#1)(1995-8#1)
advanced head and neck##7##4##(1990-12#2)(1990-6#2)(1993-9#1)(1995-8#1)(1995-9#1)
advanced hepatocellular carcinoma##2##3##(2011-2#2)
advanced hilar##2##2##(2013-1#2)
advanced imaging##6##2##(1994-3#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
advanced in the##2##3##(2008-12#1)(2008-9#1)
advanced in##7##2##(1990-12#1)(1992-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
advanced intermediate##2##2##(2007-11#1)(2009-5#1)
advanced into the##2##3##(2008-11#1)(2013-1#1)
advanced into##3##2##(2008-11#1)(2013-1#2)
advanced laser simulator##2##3##(2008-2#2)
advanced lung cancer##3##3##(2010-2#3)
advanced malignancies##3##2##(1994-3#1)(2008-7#1)(2012-3#1)
advanced malignant##5##2##(1991-6#1)(1993-6#1)(2007-8#2)(2012-3#1)
advanced management##4##2##(2008-1#2)(2010-12#2)
advanced materials##2##2##(1996-12#1)(2010-10#1)
advanced maternal age##2##3##(2012-3#2)
advanced medical##2##2##(2008-1#1)(2009-5#1)
advanced modulation##2##2##(2008-3#2)
advanced non small cell lung cancer (NSCLC)##2##7##(2008-10#1)(2010-8#1)
advanced non-small cell lung cancer##7##5##(1990-2#2)(1994-12#1)(2007-4#1)(2008-10#1)(2010-8#2)
advanced non-small cell lung##8##4##(1990-2#2)(1994-12#1)(2007-4#1)(2008-10#1)(2010-8#2)(2012-2#1)
advanced non-small-cell lung cancer##3##4##(1994-6#1)(2012-1#2)
advanced or metastatic soft-tissue sarcoma##3##5##(2008-6#3)
advanced or metastatic##5##3##(2008-6#3)(2009-9#2)
advanced our knowledge##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
advanced our##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)
advanced ovarian cancer##7##3##(1991-8#2)(1992-2#2)(2009-5#2)(2013-8#1)
advanced ovarian carcinoma##2##3##(1993-2#1)(2009-5#1)
advanced ovarian##9##2##(1991-8#2)(1992-2#2)(1993-2#1)(2009-5#3)(2013-8#1)
advanced oxidation process##3##3##(2008-10#3)
advanced practice nurses (APNs)##2##4##(2008-12#1)(2012-2#1)
advanced practice nurses##4##3##(2008-12#2)(2012-2#1)(2012-3#1)
advanced practice nursing students##2##4##(2010-3#2)
advanced practice##8##2##(1996-3#1)(2008-12#2)(2008-8#1)(2010-3#2)(2012-2#1)(2012-3#1)
advanced proliferations##2##2##(2011-2#2)
advanced prostate cancer##4##3##(1990-2#1)(1995-8#1)(1997-7#1)(2008-7#1)
advanced prostate##6##2##(1990-2#1)(1995-8#1)(1997-7#1)(2008-7#1)(2010-10#1)(2011-2#1)
advanced pulmonary fibrosis##3##3##(2006-10#3)
advanced pulmonary##4##2##(2006-10#3)(2010-10#1)
advanced rapidly##2##2##(2008-1#1)(2008-10#1)
advanced rectal cancer##4##3##(1990-10#1)(1994-8#1)(2011-3#1)(2013-1#1)
advanced renal cancer##2##3##(1991-6#1)(2008-5#1)
advanced renal failure##2##3##(1992-5#1)(2008-1#1)
advanced renal##5##2##(1991-6#1)(1992-5#1)(2008-1#1)(2008-5#1)(2013-1#1)
advanced skills##2##2##(2007-8#1)(2009-2#1)
advanced soft tissue sarcoma##2##4##(2008-6#2)
advanced soft tissue##3##3##(2008-6#3)
advanced solid tumors##2##3##(1992-10#1)(1996-10#1)
advanced squamous cell carcinoma of the##2##6##(1992-3#1)(2007-11#1)
advanced stage of##3##3##(1993-11#1)(2008-10#1)(2010-2#1)
advanced stage##18##2##(1991-6#1)(1991-8#1)(1993-11#1)(1995-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
advanced stages of##13##3##(1993-9#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)
advanced stages##18##2##(1993-9#1)(1995-3#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
advanced study courses##2##3##(1994-12#2)
advanced the##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
advanced through the##2##3##(2010-4#1)(2011-1#1)
advanced to##8##2##(1996-1#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
advanced yoga practitioners##2##3##(1991-10#1)(1991-12#1)
advanced##556##1##(1990-10#4)(1990-11#1)(1990-12#8)(1990-2#6)(1990-3#2)(1990-6#7)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#4)(1991-4#5)(1991-6#6)(1991-7#1)(1991-8#11)(1991-9#1)(1992-10#6)(1992-12#1)(1992-2#7)(1992-3#4)(1992-5#5)(1992-6#1)(1992-8#5)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#1)(1994-12#6)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#6)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#5)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#6)(1997-8#1)(2006-10#4)(2006-12#1)(2007-10#2)(2007-11#10)(2007-12#2)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#11)(2008-1#15)(2008-10#25)(2008-11#11)(2008-12#7)(2008-2#8)(2008-3#18)(2008-4#5)(2008-5#9)(2008-6#12)(2008-7#21)(2008-8#6)(2008-9#10)(2009-10#6)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#8)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#5)(2010-4#4)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#6)(2011-2#34)(2011-3#5)(2012-1#6)(2012-12#4)(2012-2#15)(2012-3#18)(2013-1#23)(2013-7#1)(2013-8#13)
advanced-stage##5##1##(2008-7#3)(2011-2#1)(2013-1#1)
advancement and##2##2##(1995-12#1)(2006-12#1)
advancement for##2##2##(1996-1#1)(2008-10#1)
advancement in the##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
advancement in##9##2##(1992-3#1)(1994-3#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)
advancement is##2##2##(2007-12#1)(2011-2#1)
advancement of knowledge##2##3##(2008-10#1)(2010-6#1)
advancement of##23##2##(1993-12#1)(1994-3#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-3#1)
advancement program##3##2##(1993-12#1)(1995-2#2)
advancement will##2##2##(1994-12#1)(2008-1#1)
advancement##58##1##(1992-3#1)(1993-12#2)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#2)(1995-2#3)(1996-1#1)(2006-12#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)
advancements in the understanding##2##4##(2010-6#1)(2013-1#1)
advancements in the##4##3##(2008-10#1)(2009-3#1)(2010-6#1)(2013-1#1)
advancements in##10##2##(1996-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
advancements##16##1##(1996-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
advances and their##2##3##(2008-11#1)(2008-8#1)
advances and##13##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
advances have been achieved in the treatment of##2##8##(2010-3#1)(2011-2#1)
advances have been made in the##6##6##(1990-9#1)(2007-12#1)(2008-3#2)(2008-8#1)(2011-2#1)
advances have been made in##12##5##(1990-9#1)(1992-12#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
advances have been made##14##4##(1990-9#1)(1992-12#1)(1995-8#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
advances have been##17##3##(1990-9#1)(1992-12#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
advances have##23##2##(1990-9#1)(1991-2#1)(1992-12#1)(1995-12#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
advances in biogerontology##2##3##(2008-3#1)(2009-5#1)
advances in biomedical##2##3##(2008-7#1)(2009-5#1)
advances in both##3##3##(2008-10#1)(2009-10#1)(2010-7#1)
advances in cancer##2##3##(1997-1#1)(2009-4#1)
advances in chemical##2##3##(2009-7#2)
advances in computer technology##2##4##(1993-2#1)(2006-12#1)
advances in digital##2##3##(2008-1#1)(2008-12#1)
advances in functional##2##3##(2008-4#1)(2008-9#1)
advances in genetic##4##3##(2008-7#2)(2008-8#1)(2009-10#1)
advances in imaging##7##3##(2008-6#1)(2008-8#3)(2010-5#1)(2011-2#1)(2012-2#1)
advances in instrument##2##3##(2008-10#1)(2009-2#1)
advances in medical##2##3##(1994-12#1)(2007-7#1)
advances in medicine##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
advances in molecular biology have##3##5##(2007-7#1)(2009-1#1)(2012-3#1)
advances in molecular biology##4##4##(2007-7#1)(2008-9#1)(2009-1#1)(2012-3#1)
advances in molecular##7##3##(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-3#1)
advances in optical##2##3##(2008-3#1)(2011-7#1)
advances in our knowledge##2##4##(2010-6#1)(2013-7#1)
advances in our understanding of the##5##6##(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
advances in our understanding of##9##5##(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-5#1)(2012-1#1)
advances in our##12##3##(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-7#1)
advances in pathophysiology##2##3##(2006-10#1)(2013-7#1)
advances in percutaneous coronary##2##4##(2008-11#1)(2011-2#1)
advances in rapid##2##3##(2008-3#1)(2013-1#1)
advances in solid-phase##2##3##(1997-4#1)(2008-10#1)
advances in stroke##2##3##(2007-9#2)
advances in systems##2##3##(2011-2#1)(2013-8#1)
advances in techniques##3##3##(2008-9#1)(2009-12#1)(2010-11#1)
advances in technology##4##3##(2007-12#1)(2008-1#1)(2008-7#1)(2009-12#1)
advances in the basic neurosciences##2##5##(2008-4#2)
advances in the field of##5##5##(2006-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
advances in the field##9##4##(2006-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)
advances in the knowledge##2##4##(2007-12#1)(2013-1#1)
advances in the management of##3##5##(2007-11#1)(2008-4#1)(2008-7#1)
advances in the treatment of##7##5##(1996-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
advances in the understanding##3##4##(2008-9#1)(2009-3#1)(2011-2#1)
advances in the##63##3##(1990-11#1)(1992-2#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
advances in these##3##3##(1993-12#1)(2010-7#1)(2011-2#1)
advances in this field##6##4##(2006-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-8#1)
advances in this##9##3##(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-9#1)(2013-8#2)
advances in understanding of the##2##5##(2008-1#1)(2012-12#1)
advances in understanding the pathophysiology of##3##6##(2008-1#1)(2008-5#1)(2011-1#1)
advances in understanding the##6##4##(2008-1#2)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
advances in understanding##8##3##(2008-1#3)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
advances in##257##2##(1990-11#1)(1990-9#1)(1992-1#1)(1992-2#2)(1993-1#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#3)(2007-9#4)(2008-1#8)(2008-10#14)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#17)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#19)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#14)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#9)
advances into##3##2##(1993-2#1)(2008-11#1)(2012-2#1)
advances made in##6##3##(2006-10#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
advances made##7##2##(2006-10#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
advances of the last##2##4##(2007-12#1)(2008-5#1)
advances of the##4##3##(2007-12#1)(2007-7#1)(2008-5#1)(2010-8#1)
advances of##11##2##(1995-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#2)(2011-1#1)
advances that have##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
advances that##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)
advances the##4##2##(1991-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
advances will##3##2##(2008-11#1)(2011-10#1)(2012-2#1)
advances##391##1##(1990-11#2)(1990-9#4)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-1#3)(1993-12#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#5)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#1)(2007-7#4)(2007-9#4)(2008-1#9)(2008-10#25)(2008-11#20)(2008-12#5)(2008-2#2)(2008-3#13)(2008-4#11)(2008-5#11)(2008-6#7)(2008-7#22)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#5)(2010-3#5)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#27)(2011-3#1)(2011-7#3)(2012-1#1)(2012-12#7)(2012-2#17)(2012-3#7)(2013-1#11)(2013-7#3)(2013-8#10)
advancing our understanding of##2##4##(2008-8#1)(2008-9#1)
advancing the treatment##2##3##(2008-10#1)(2012-12#1)
advancing the##10##2##(1993-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
advancing##34##1##(1993-11#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
advantage and##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
advantage due to an increase in##2##6##(1997-7#2)
advantage during##2##2##(1997-3#1)(2009-5#1)
advantage for the##4##3##(1992-3#1)(1995-11#1)(2008-10#1)(2012-3#1)
advantage for##17##2##(1990-11#1)(1991-4#1)(1992-3#1)(1995-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-3#1)
advantage in a##2##3##(2008-10#1)(2008-2#1)
advantage in that##2##3##(2008-3#2)
advantage in the##5##3##(2007-8#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-9#1)
advantage in using##2##3##(2007-11#1)(2007-8#1)
advantage in##30##2##(1990-12#1)(1994-12#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#4)(2010-9#1)(2012-1#1)
advantage is that the##2##4##(2008-10#1)(2008-9#1)
advantage is that##3##3##(2008-10#2)(2008-9#1)
advantage is##8##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-12#1)(2012-7#1)
advantage of EBUS-GS lies in##2##5##(2010-8#2)
advantage of EBUS-GS##3##3##(2010-8#3)
advantage of a##14##3##(1997-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
advantage of high##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
advantage of its##2##3##(2008-10#1)(2009-10#1)
advantage of recent##2##3##(2008-11#1)(2009-4#1)
advantage of reduced##4##3##(2008-3#1)(2011-2#2)(2012-3#1)
advantage of such##3##3##(2007-7#1)(2008-11#1)(2009-5#1)
advantage of the ability of##2##5##(2008-10#1)(2008-5#1)
advantage of the ability##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
advantage of the fact that##2##5##(2008-4#2)
advantage of the new##2##4##(2008-3#1)(2012-1#1)
advantage of the proposed##3##4##(2008-10#3)
advantage of the slow##2##4##(1993-8#1)(2007-12#1)
advantage of the unique##2##4##(2008-12#1)(2008-2#1)
advantage of the use of##2##5##(2008-10#1)(2008-9#1)
advantage of the##62##3##(1990-8#1)(1993-8#1)(1994-2#1)(1994-3#2)(1995-3#2)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#4)(2008-10#15)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
advantage of these##4##3##(2008-2#2)(2008-4#1)(2010-1#1)
advantage of this approach is that it##2##7##(2008-4#1)(2012-1#1)
advantage of this approach is that the##2##7##(2008-4#1)(2012-1#1)
advantage of this approach is that##4##6##(2008-4#2)(2012-1#2)
advantage of this approach##6##4##(1994-2#1)(2008-10#1)(2008-4#2)(2012-1#2)
advantage of this method is its##2##6##(2007-12#1)(2008-11#1)
advantage of this method is that it##2##7##(2008-2#1)(2008-3#1)
advantage of this method is that##6##6##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
advantage of this method is##8##5##(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
advantage of this new##2##4##(2008-10#2)
advantage of this system is that##2##6##(2008-10#1)(2008-2#1)
advantage of this system##3##4##(1993-12#1)(2008-10#1)(2008-2#1)
advantage of this technique is##2##5##(2007-12#1)(2008-10#1)
advantage of this technique##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
advantage of this##34##3##(1993-12#2)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#5)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#1)(2012-1#2)(2013-8#1)
advantage of using an##2##4##(2008-10#1)(2008-2#1)
advantage of using##9##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)
advantage of##261##2##(1990-11#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#3)(1994-3#4)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-7#2)(2007-11#4)(2007-12#13)(2007-7#2)(2008-1#2)(2008-10#56)(2008-11#9)(2008-12#1)(2008-2#20)(2008-3#25)(2008-4#14)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#2)
advantage on##2##2##(1992-8#1)(2008-7#1)
advantage over conventional##3##3##(1994-12#1)(1996-2#1)(2007-11#1)
advantage over other##4##3##(2008-10#2)(2009-1#1)(2013-1#1)
advantage over the##5##3##(1991-2#1)(2008-10#2)(2008-3#1)(2008-7#1)
advantage over##24##2##(1991-2#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
advantage that the##7##3##(1993-3#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
advantage that##20##2##(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)
advantage to the##2##3##(1994-8#1)(2008-11#1)
advantage to##11##2##(1993-2#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-2#2)(2012-2#1)
advantage was##4##2##(2007-11#1)(2008-10#1)(2008-7#2)
advantage##426##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#6)(1994-3#6)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#5)(1997-4#1)(1997-7#5)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#17)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#81)(2008-11#14)(2008-12#1)(2008-2#28)(2008-3#36)(2008-4#15)(2008-5#10)(2008-6#4)(2008-7#16)(2008-8#13)(2008-9#12)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#6)(2009-5#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#5)(2012-12#4)(2012-2#6)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#5)(2013-8#2)
advantage&quot##2##1##(1996-1#1)(2008-10#1)
advantageous because##5##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
advantageous effects##2##2##(1995-12#1)(2013-1#1)
advantageous for##10##2##(1995-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#1)
advantageous in##9##2##(1997-7#1)(2008-10#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#2)(2013-1#1)
advantageous method##2##2##(2007-11#1)(2008-10#1)
advantageous over##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
advantageous properties##3##2##(2008-3#1)(2008-7#2)
advantageous to use##2##3##(2008-3#1)(2008-4#1)
advantageous to##6##2##(2008-10#3)(2008-3#1)(2008-4#1)(2009-6#1)
advantageous##80##1##(1991-12#1)(1995-12#3)(1995-5#1)(1997-6#1)(1997-7#1)(2007-11#2)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#5)
advantageously used for##2##3##(2008-10#2)
advantageously used##3##2##(2008-10#2)(2008-5#1)
advantageously##6##1##(2008-10#3)(2008-5#2)(2008-6#1)
advantages above##2##2##(2009-7#1)(2010-3#1)
advantages and disadvantages in##2##4##(2008-10#1)(2010-2#1)
advantages and disadvantages of both##2##5##(1991-1#1)(2008-10#1)
advantages and disadvantages of each##5##5##(1992-2#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
advantages and disadvantages of pacifier use##2##6##(2007-10#2)
advantages and disadvantages of the##6##5##(2007-5#1)(2008-10#3)(2008-3#1)(2009-5#1)
advantages and disadvantages of##33##4##(1991-1#1)(1992-2#1)(1993-3#1)(1996-3#1)(1997-2#1)(2007-10#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-4#2)(2008-9#3)(2009-5#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-8#1)
advantages and disadvantages that##2##4##(2008-3#1)(2008-7#1)
advantages and disadvantages to##2##4##(1997-3#1)(2008-4#1)
advantages and disadvantages##54##3##(1991-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#10)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-7#1)(2008-9#3)(2009-5#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
advantages and drawbacks of##5##4##(2008-10#3)(2008-3#1)(2012-12#1)
advantages and drawbacks##8##3##(1996-12#1)(2008-10#4)(2008-3#1)(2009-12#1)(2012-12#1)
advantages and limitations are##3##4##(2008-10#2)(2008-3#1)
advantages and limitations of each##3##5##(2008-4#1)(2008-9#1)(2010-8#1)
advantages and limitations of the##5##5##(2008-10#2)(2008-3#1)(2008-9#1)(2013-7#1)
advantages and limitations of##13##4##(1990-10#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2012-3#1)(2013-7#1)
advantages and limitations##24##3##(1990-10#1)(1992-3#1)(1994-1#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-4#2)(2008-9#3)(2010-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
advantages and the##2##3##(1990-3#1)(2008-10#1)
advantages and##100##2##(1990-10#1)(1990-3#1)(1991-1#1)(1992-2#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#6)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
advantages are its simplicity##2##4##(2008-10#1)(2008-5#1)
advantages are##5##2##(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
advantages as##2##2##(2008-10#1)(2008-11#1)
advantages compared to other##2##4##(2007-8#1)(2012-3#1)
advantages compared to##3##3##(2007-8#1)(2008-5#1)(2012-3#1)
advantages compared with other##2##4##(2008-10#1)(2011-2#1)
advantages compared with##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
advantages compared##7##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
advantages for the##3##3##(1993-2#1)(2008-9#1)(2012-3#1)
advantages for##17##2##(1992-8#1)(1993-1#1)(1993-2#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)
advantages have been##2##3##(2008-10#1)(2011-2#1)
advantages have##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
advantages in the##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
advantages in this##2##3##(2008-10#1)(2008-11#1)
advantages in using##2##3##(2008-4#1)(2008-9#1)
advantages in##21##2##(1993-1#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-8#1)
advantages include##4##2##(1992-8#1)(2008-10#1)(2008-2#1)(2011-7#1)
advantages is##2##2##(2008-10#1)(2008-3#1)
advantages like##2##2##(2008-10#1)(2010-5#1)
advantages of a##5##3##(1994-3#1)(1997-1#1)(2008-3#2)(2008-7#1)
advantages of being highly##2##4##(2008-10#1)(2008-3#1)
advantages of being##6##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)
advantages of both##2##3##(2008-3#1)(2008-8#1)
advantages of complete##2##3##(2008-3#1)(2012-12#1)
advantages of each##4##3##(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
advantages of high##5##3##(1992-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-1#1)
advantages of low resistance##3##4##(2008-10#3)
advantages of microchip##2##3##(2008-10#2)
advantages of rapidity##2##3##(1997-4#1)(2008-10#1)
advantages of simple##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
advantages of such##2##3##(2008-10#1)(2010-11#1)
advantages of the method##3##4##(1990-11#1)(2007-11#1)(2008-10#1)
advantages of the present##3##4##(2008-10#2)(2008-2#1)
advantages of the proposed##4##4##(2008-10#1)(2008-3#2)(2012-12#1)
advantages of the system##2##4##(2007-8#1)(2008-10#1)
advantages of the##45##3##(1990-11#1)(1990-5#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#2)
advantages of these##3##3##(1995-1#1)(2007-12#1)(2009-5#1)
advantages of this approach##2##4##(2008-10#1)(2011-2#1)
advantages of this device##2##4##(2008-3#1)(2011-2#1)
advantages of this method include##2##5##(1994-8#1)(2008-10#1)
advantages of this method##6##4##(1990-7#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
advantages of this technique are##2##5##(2007-12#1)(2008-11#1)
advantages of this##31##3##(1990-7#1)(1991-6#1)(1993-1#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-11#3)(2007-12#3)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
advantages of using##6##3##(2008-10#3)(2008-3#2)(2012-12#1)
advantages of##212##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-11#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#8)(2007-12#9)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#60)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#27)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)
advantages over competing##2##3##(2007-11#2)
advantages over conventional##10##3##(1994-9#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2011-2#1)
advantages over existing##6##3##(1991-9#1)(1996-12#1)(2008-10#1)(2008-2#2)(2009-10#1)
advantages over other techniques##2##4##(2007-11#1)(2008-1#1)
advantages over other##8##3##(1994-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
advantages over the conventional##2##4##(1994-1#1)(2008-6#1)
advantages over the traditional##2##4##(1997-4#1)(2008-10#1)
advantages over the##15##3##(1993-3#1)(1994-1#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#2)(2012-3#1)
advantages over traditional##5##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#2)
advantages over##74##2##(1990-8#1)(1991-9#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-5#1)(1994-9#2)(1996-12#1)(1997-1#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-1#3)(2008-10#17)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
advantages such as##4##3##(2008-10#3)(2011-2#1)
advantages to the##3##3##(1990-5#1)(1992-1#1)(1997-2#1)
advantages to##9##2##(1990-5#1)(1992-1#1)(1992-11#1)(1996-3#1)(1997-2#1)(2008-5#1)(2008-9#1)(2013-1#2)
advantages were##2##2##(1991-5#1)(2006-12#1)
advantages when##2##2##(2008-10#1)(2008-4#1)
advantages which##2##2##(1992-3#1)(2010-5#1)
advantages with regard to##2##4##(2007-8#1)(2008-11#1)
advantages with respect to##2##4##(2009-1#1)(2012-2#1)
advantages with##6##2##(2007-8#1)(2008-11#1)(2008-6#1)(2009-1#1)(2012-12#1)(2012-2#1)
advantages##559##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-8#2)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#5)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#1)(2006-12#2)(2007-10#2)(2007-11#15)(2007-12#13)(2007-2#3)(2007-5#2)(2007-6#1)(2007-8#8)(2008-1#9)(2008-10#138)(2008-11#11)(2008-12#6)(2008-2#23)(2008-3#43)(2008-4#21)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#12)(2008-9#19)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#7)(2011-2#19)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#12)(2012-2#16)(2012-3#11)(2013-1#7)(2013-7#1)(2013-8#2)
advection##5##1##(1992-7#1)(2007-10#1)(2008-3#1)(2008-9#2)
advent of managed care##3##4##(1994-12#1)(1996-12#1)(1997-2#1)
advent of new##4##3##(2008-5#1)(2009-10#1)(2010-7#1)(2013-1#1)
advent of newer##2##3##(2007-2#1)(2011-2#1)
advent of the##7##3##(1993-2#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
advent of##57##2##(1993-2#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
advent##60##1##(1993-2#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
adventitia and##2##2##(1997-8#1)(2008-11#1)
adventitia##9##1##(1991-8#1)(1993-8#1)(1997-3#1)(1997-8#4)(2008-11#1)(2008-7#1)
adventitial and##2##2##(1992-12#1)(2010-4#1)
adventitial##7##1##(1992-12#1)(1997-1#1)(1997-8#3)(2010-4#2)
adventitious agents##2##2##(2008-11#2)
adventitious root##6##2##(2008-10#1)(2008-12#4)(2008-9#1)
adventitious roots##5##2##(2008-10#3)(2008-9#2)
adventitious shoots##2##2##(2008-12#2)
adventitious##20##1##(1993-11#1)(2008-10#4)(2008-11#4)(2008-12#6)(2008-5#1)(2008-9#3)(2013-1#1)
adventure##3##1##(2008-10#2)(2012-2#1)
adversarial##3##1##(1994-1#1)(1995-12#1)(2008-6#1)
adverse cardiac events (MACE)##2##4##(2008-11#1)(2008-3#1)
adverse cardiac events##4##3##(2008-11#2)(2008-3#1)(2010-12#1)
adverse cardiovascular##3##2##(2008-7#1)(2009-1#1)(2013-8#1)
adverse changes##2##2##(1991-1#1)(1992-11#1)
adverse clinical events##2##3##(1997-4#1)(2009-12#1)
adverse clinical outcomes##3##3##(2007-10#1)(2009-5#2)
adverse clinical##6##2##(1992-11#1)(1997-4#1)(2007-10#1)(2009-12#1)(2009-5#2)
adverse conditions is##2##3##(2008-10#1)(2008-11#1)
adverse conditions##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
adverse consequence of##2##3##(2012-12#1)(2013-1#1)
adverse consequences for##2##3##(1992-2#1)(2012-12#1)
adverse consequences of##5##3##(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
adverse consequences##11##2##(1991-2#1)(1992-2#2)(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2012-12#1)
adverse drug events##3##3##(2007-9#1)(2011-2#1)(2011-3#1)
adverse drug reaction##4##3##(2007-7#1)(2008-8#2)(2010-5#1)
adverse drug reactions (ADR)##2##4##(1994-6#1)(2011-2#1)
adverse drug reactions (ADRs)##3##4##(2008-11#1)(2011-2#2)
adverse drug reactions and##6##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)
adverse drug reactions associated with##2##5##(2008-8#1)(2010-5#1)
adverse drug reactions in##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
adverse drug reactions is##2##4##(2013-8#2)
adverse drug reactions were##3##4##(2010-5#1)(2011-2#2)
adverse drug reactions##46##3##(1994-6#2)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-8#5)(2010-5#8)(2010-6#2)(2011-2#11)(2013-8#5)
adverse drug##55##2##(1994-6#3)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-8#7)(2010-5#9)(2010-6#2)(2011-2#12)(2011-3#1)(2013-8#5)
adverse early##2##2##(2011-2#1)(2012-3#1)
adverse ecological effects##2##3##(2007-5#1)(2008-12#1)
adverse effect in##2##3##(1995-3#1)(2008-11#1)
adverse effect level##2##3##(2008-5#1)(2013-1#1)
adverse effect of the##3##4##(1991-1#1)(2008-11#1)(2008-7#1)
adverse effect of##10##3##(1991-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-4#1)(2012-3#1)(2013-1#1)
adverse effect on the##5##4##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
adverse effect on##11##3##(1994-9#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#2)(2013-1#2)
adverse effect profile##3##3##(1996-3#1)(2008-8#1)(2011-2#1)
adverse effect##38##2##(1991-1#1)(1992-4#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)
adverse effects and##4##3##(1991-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
adverse effects are##4##3##(1997-8#1)(2007-11#1)(2007-6#1)(2008-8#1)
adverse effects from HDS##2##4##(2007-12#2)
adverse effects from##6##3##(2007-12#2)(2010-4#1)(2011-2#2)(2013-1#1)
adverse effects have been##2##4##(2008-5#1)(2012-2#1)
adverse effects in patients with##2##5##(2007-7#1)(2013-1#1)
adverse effects in patients##3##4##(2007-7#1)(2008-1#1)(2013-1#1)
adverse effects in##8##3##(1990-5#1)(1991-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
adverse effects of drugs##3##4##(1996-6#2)(2011-2#1)
adverse effects of the##2##4##(2008-6#1)(2011-2#1)
adverse effects of their##2##4##(2008-11#1)(2011-1#1)
adverse effects of##30##3##(1995-3#1)(1996-6#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
adverse effects on growth rate##2##5##(2007-11#2)
adverse effects on the ecological balance of the healthy##2##9##(2012-3#2)
adverse effects on the immune system##2##6##(2008-10#2)
adverse effects on the##9##4##(1996-9#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-2#1)(2012-3#3)
adverse effects on##20##3##(1994-12#1)(1996-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-1#1)(2012-3#3)(2013-1#1)
adverse effects related##2##3##(2008-8#1)(2011-2#1)
adverse effects such as##4##4##(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
adverse effects that##2##3##(2008-9#1)(2013-1#1)
adverse effects to##2##3##(2008-10#1)(2008-4#1)
adverse effects were noted##2##4##(1991-2#1)(2008-7#1)
adverse effects were observed##3##4##(1996-3#1)(2007-11#1)(2011-2#1)
adverse effects were##8##3##(1991-2#1)(1993-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-1#1)
adverse effects with##4##3##(2008-12#1)(2008-7#2)(2013-1#1)
adverse effects##153##2##(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#1)
adverse effects]##2##2##(1993-6#1)(1995-5#1)
adverse event profile##4##3##(1996-8#1)(2007-11#1)(2009-7#1)(2012-3#1)
adverse event reports##2##3##(2012-3#1)(2013-1#1)
adverse event was##2##3##(2008-5#1)(2013-1#1)
adverse event##28##2##(1991-12#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)
adverse events and##7##3##(1992-1#2)(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
adverse events are##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
adverse events associated with##3##4##(1996-8#1)(2008-11#1)(2012-12#1)
adverse events during##2##3##(2008-7#1)(2009-5#1)
adverse events from##3##3##(1994-2#1)(2010-10#1)(2012-3#1)
adverse events in##12##3##(2007-8#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)
adverse events may##2##3##(2008-8#2)
adverse events occurred##2##3##(2008-3#1)(2008-7#1)
adverse events of##2##3##(2008-11#1)(2011-2#1)
adverse events related to##3##4##(2008-11#1)(2008-5#1)(2008-8#1)
adverse events such as##2##4##(2008-10#1)(2011-2#1)
adverse events that are##2##4##(2008-7#1)(2010-12#1)
adverse events was##2##3##(2008-11#1)(2012-12#1)
adverse events were##7##3##(1992-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
adverse events##98##2##(1992-1#2)(1992-8#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-8#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#14)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#6)(2008-8#15)(2009-12#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#6)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#5)
adverse experiences##2##2##(2008-10#1)(2013-1#1)
adverse health effects##6##3##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#1)
adverse health outcomes in##2##4##(2008-1#1)(2008-11#1)
adverse health##9##2##(1994-9#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#2)
adverse immune effects in##2##4##(2008-10#2)
adverse immune effects##3##3##(2008-10#3)
adverse impact on##4##3##(1996-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
adverse impact##5##2##(1996-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
adverse marital##2##2##(2009-7#2)
adverse neighborhoods##3##2##(2008-1#2)(2010-7#1)
adverse obstetric##2##2##(2011-2#1)(2013-1#1)
adverse outcome##6##2##(1990-5#1)(1994-11#2)(2007-7#1)(2007-8#1)(2009-6#1)
adverse outcomes##15##2##(1992-2#1)(1994-1#1)(1994-11#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-9#1)(2012-2#4)(2013-1#1)
adverse pregnancy outcome##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
adverse pregnancy outcomes##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
adverse pregnancy##7##2##(2007-12#1)(2008-11#2)(2011-1#1)(2011-2#2)(2013-1#1)
adverse prognosis##3##2##(1997-7#1)(2008-3#1)(2012-12#1)
adverse reaction to##2##3##(1990-12#1)(2008-1#1)
adverse reaction##6##2##(1990-12#1)(2008-1#1)(2008-11#1)(2010-11#1)(2013-1#1)(2013-8#1)
adverse reactions and##3##3##(1997-1#1)(2007-11#1)(2008-5#1)
adverse reactions such as##2##4##(2007-11#1)(2008-5#1)
adverse reactions to mosquito bites##3##5##(2011-1#3)
adverse reactions to##11##3##(1990-3#1)(1995-11#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-1#3)(2011-2#1)
adverse reactions##36##2##(1990-2#1)(1990-3#1)(1991-9#2)(1992-3#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#3)(2009-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
adverse respiratory outcomes at 15 months##2##6##(2010-6#2)
adverse respiratory outcomes##3##3##(2010-6#3)
adverse respiratory##4##2##(2008-11#1)(2010-6#3)
adverse selection##4##2##(1996-3#1)(1997-1#1)(1997-3#1)(2008-7#1)
adverse##572##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#2)(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-1#2)(1992-11#4)(1992-2#3)(1992-3#3)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#5)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#2)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#12)(2007-12#7)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#34)(2008-11#57)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#26)(2008-8#40)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#2)(2009-7#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#1)(2010-4#4)(2010-5#12)(2010-6#6)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#13)(2011-2#46)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#21)(2012-3#15)(2013-1#36)(2013-7#1)(2013-8#10)
adversely affect the##7##3##(1990-6#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)(2013-1#1)
adversely affect##18##2##(1990-6#1)(1991-1#1)(1993-2#2)(1996-11#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
adversely affected by##7##3##(1992-2#1)(2007-5#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-4#1)(2013-8#1)
adversely affected##11##2##(1992-2#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-4#1)(2013-8#1)
adversely affecting##3##2##(2007-11#1)(2008-7#1)(2009-12#1)
adversely affects the##2##3##(2008-7#1)(2009-11#1)
adversely affects##5##2##(1994-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)
adversely effect##2##2##(1995-2#1)(2010-4#1)
adversely impact##2##2##(1997-2#1)(2008-7#1)
adversely influenced##2##2##(2007-12#1)(2012-2#1)
adversely##45##1##(1990-6#1)(1991-1#1)(1992-2#1)(1993-2#2)(1994-2#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
adversity##5##1##(2009-11#1)(2010-7#4)
advertised##5##1##(1990-6#3)(1996-1#1)(2007-2#1)
advertisement call of C##2##4##(2013-7#2)
advertisement call of##3##3##(2013-7#3)
advertisement call##5##2##(2013-7#5)
advertisement calls with##2##3##(2009-9#1)(2013-7#1)
advertisement##9##1##(2008-12#2)(2009-9#1)(2013-7#6)
advertisements in##2##2##(2008-11#1)(2012-12#1)
advertisements##10##1##(1994-3#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-12#1)
advertising and##2##2##(1991-5#1)(1993-12#1)
advertising campaign##4##2##(1995-1#1)(1995-5#1)(1997-6#1)(2012-2#1)
advertising campaigns##2##2##(2011-1#1)(2012-2#1)
advertising for prescription##2##3##(1996-1#1)(2008-12#1)
advertising of prescription drugs##2##4##(1996-1#1)(2008-12#1)
advertising of prescription##3##3##(1996-1#1)(2008-12#2)
advertising##26##1##(1990-2#1)(1991-5#1)(1993-12#2)(1995-1#1)(1995-5#1)(1996-1#3)(1996-3#1)(1997-1#2)(1997-6#2)(2008-12#6)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#3)
advice about##2##2##(1994-2#1)(2008-3#1)
advice and documentation##2##3##(1992-2#1)(2007-2#1)
advice and##16##2##(1990-3#1)(1992-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-2#5)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#3)
advice as##2##2##(1995-6#1)(2012-3#1)
advice at##2##2##(1990-8#1)(2011-2#1)
advice by##5##2##(1996-8#1)(2007-2#1)(2009-7#1)(2011-2#2)
advice for##4##2##(2007-7#3)(2008-7#1)
advice in##2##2##(1993-1#1)(2008-11#1)
advice is##4##2##(1992-12#1)(2008-1#1)(2008-7#1)(2011-2#1)
advice on##11##2##(1990-10#1)(1991-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-4#2)(2011-1#2)
advice regarding##3##2##(2008-11#2)(2008-7#1)
advice services##2##2##(2007-2#1)(2011-2#1)
advice to the##3##3##(1991-6#1)(2008-12#1)(2013-8#1)
advice to##10##2##(1991-6#1)(1996-1#1)(1996-2#1)(2007-2#2)(2008-1#1)(2008-12#1)(2008-5#1)(2009-9#1)(2013-8#1)
advice##111##1##(1990-10#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#22)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#10)(2013-8#1)
advisable for##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
advisable to##9##2##(1992-12#1)(1996-6#1)(2007-7#1)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
advisable##22##1##(1990-9#1)(1992-12#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)
advise##7##1##(1992-9#1)(1993-12#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-8#1)
advised about the##2##3##(1994-3#1)(2008-10#1)
advised about##3##2##(1994-3#1)(2008-10#1)(2008-3#1)
advised not to##2##3##(1991-6#1)(1992-11#1)
advised that##2##2##(2007-2#1)(2008-8#1)
advised to be##2##3##(1996-11#1)(2012-2#1)
advised to use##2##3##(2008-1#1)(2012-12#1)
advised to##21##2##(1993-1#1)(1996-11#1)(1997-4#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#4)(2012-12#1)(2012-2#4)
advised##47##1##(1991-6#1)(1992-11#1)(1992-5#1)(1993-1#1)(1994-3#1)(1994-7#1)(1996-11#2)(1997-2#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-2#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#2)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#3)
adviser##2##1##(1994-5#1)(1996-8#1)
advisers##5##1##(1991-2#1)(1992-4#1)(1992-5#1)(1996-2#1)(2007-2#1)
advises##3##1##(1993-3#1)(1994-12#1)(2008-8#1)
advising##17##1##(1993-3#1)(2007-2#1)(2008-11#1)(2010-3#10)(2011-1#1)(2011-2#1)(2013-1#2)
advisor##3##1##(1992-11#1)(2008-9#1)(2010-3#1)
advisors to##2##2##(1995-12#1)(2008-11#1)
advisors##12##1##(1995-12#3)(1997-2#2)(2008-11#4)(2010-3#1)(2011-2#1)(2012-2#1)
advisory committee##3##2##(1996-2#1)(1996-3#1)(2008-5#1)
advisory on##2##2##(1991-9#1)(1994-1#1)
advisory##23##1##(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-12#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-5#1)(2013-1#2)
advocacy and##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#2)(2011-1#1)
advocacy campaign##3##2##(1995-1#1)(2012-12#2)
advocacy for##4##2##(1994-3#1)(2011-2#2)(2013-1#1)
advocacy groups##2##2##(1995-6#1)(2012-2#1)
advocacy in##3##2##(2008-2#1)(2009-12#1)(2012-3#1)
advocacy of##3##2##(1995-3#1)(2010-2#1)(2012-2#1)
advocacy on##2##2##(2008-6#1)(2011-2#1)
advocacy training programs##2##3##(1993-1#2)
advocacy training##4##2##(1993-1#3)(2007-5#1)
advocacy##61##1##(1993-1#3)(1994-12#2)(1994-3#1)(1995-1#1)(1995-3#4)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-5#1)(2007-5#7)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#3)(2009-12#8)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)
advocate a more##2##3##(1995-5#1)(1997-8#1)
advocate and##2##2##(2008-11#1)(2010-1#1)
advocate for##8##2##(1993-12#1)(1995-2#1)(2007-2#2)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
advocate the use of the##2##5##(1990-9#1)(2007-8#1)
advocate the##4##2##(1990-9#1)(2007-12#1)(2007-8#1)(2012-3#1)
advocate##45##1##(1990-9#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)
advocated and##2##2##(2008-7#1)(2010-10#1)
advocated as a##4##3##(1991-12#1)(2008-11#1)(2009-6#1)(2010-2#1)
advocated as##8##2##(1991-12#1)(1997-5#1)(2008-11#2)(2008-7#1)(2009-6#1)(2010-2#1)(2012-1#1)
advocated by the##2##3##(2008-7#1)(2009-2#1)
advocated by##6##2##(1990-9#1)(1993-12#1)(2008-11#2)(2008-7#1)(2009-2#1)
advocated for##6##2##(1991-9#1)(1995-12#1)(2007-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
advocated in##2##2##(2007-12#1)(2008-11#1)
advocated that##4##2##(1992-3#1)(1994-3#1)(1997-7#1)(2008-8#1)
advocated the##2##2##(1994-3#1)(2010-1#1)
advocated to improve the##2##4##(2008-8#1)(2012-2#1)
advocated to##4##2##(1991-3#1)(1991-6#1)(2008-8#1)(2012-2#1)
advocated##51##1##(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#1)(1996-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
advocates a##2##2##(1991-1#1)(2008-10#1)
advocates and##2##2##(2007-11#1)(2007-5#1)
advocates in##3##2##(1993-1#1)(2008-8#2)
advocates of##3##2##(1992-1#1)(2008-7#1)(2013-8#1)
advocates the##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
advocates##25##1##(1991-1#1)(1992-1#3)(1992-2#1)(1993-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-11#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-6#1)(2013-8#1)
advocating for##2##2##(2009-8#1)(2012-12#1)
advocating the##2##2##(2008-10#1)(2008-11#1)
advocating##13##1##(1991-1#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
aecial##2##1##(2008-10#2)
aeciospores##4##1##(2008-10#4)
aedeagi##3##1##(2008-8#3)
aegypti##21##1##(2007-10#6)(2008-5#12)(2011-2#2)(2013-8#1)
aeneus##2##1##(2008-5#1)(2008-9#1)
aenigmaticum##2##1##(2008-5#2)
aequorin and##2##2##(1990-8#2)
aequorin##5##1##(1990-8#5)
aerated##10##1##(1994-3#2)(2008-10#5)(2008-12#2)(2010-3#1)
aeration and##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
aeration rate##2##2##(2008-8#1)(2010-11#1)
aeration##14##1##(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-8#1)(2010-11#3)(2012-2#1)
aerial diseases##2##2##(2008-10#2)
aerial dissemination##2##2##(2008-10#2)
aerial drift##2##2##(2007-5#2)
aerial growth##2##2##(2008-10#1)(2012-2#1)
aerial hyphae##2##2##(2008-8#1)(2012-2#1)
aerial image##3##2##(2008-2#1)(2008-3#2)
aerial oxidation##3##2##(1995-3#1)(2008-10#2)
aerial part of##2##3##(2008-11#1)(2010-5#1)
aerial parts of the plant##2##5##(2007-11#1)(2008-10#1)
aerial parts of the##3##4##(2007-11#1)(2008-10#1)(2008-12#1)
aerial parts of##7##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
aerial parts##9##2##(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2012-2#1)(2013-1#1)
aerial##42##1##(1992-3#1)(1995-3#1)(1997-7#1)(2007-11#1)(2007-5#3)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2010-2#1)(2010-5#1)(2012-2#3)(2013-1#1)
aero-optic linking equation to a##2##5##(2008-3#2)
aero-optic linking equation##3##3##(2008-3#3)
aeroallergens in##3##2##(2008-5#1)(2013-1#2)
aeroallergens##7##1##(2008-5#4)(2013-1#2)(2013-8#1)
aerobic and anaerobic##6##3##(1991-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2013-8#2)
aerobic and##11##2##(1991-2#1)(2007-7#1)(2008-5#1)(2008-7#2)(2009-12#1)(2013-1#3)(2013-8#2)
aerobic bacteria from the blood of septicaemic neonatal calves##2##9##(2011-1#2)
aerobic bacteria in##2##3##(2008-5#1)(2011-1#1)
aerobic bacteria isolated from##3##4##(1991-3#1)(2013-8#2)
aerobic bacteria##12##2##(1991-3#1)(2008-1#1)(2008-10#2)(2008-5#2)(2011-1#4)(2013-8#2)
aerobic capacity##2##2##(2012-2#1)(2013-1#1)
aerobic conditions##9##2##(1991-2#2)(1993-8#1)(1997-4#1)(2008-10#3)(2008-7#2)
aerobic coryneform##4##2##(2008-5#4)
aerobic coryneforms##3##2##(2008-5#3)
aerobic dance##5##2##(2007-12#4)(2007-6#1)
aerobic endospore-forming bacteria##4##3##(2008-10#4)
aerobic exercise##5##2##(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
aerobic fitness level##3##3##(2013-8#3)
aerobic fitness##5##2##(2010-8#1)(2012-2#1)(2013-8#3)
aerobic glycolysis##3##2##(2009-4#1)(2010-12#1)(2013-8#1)
aerobic granules##2##2##(2013-1#2)
aerobic metabolism##3##2##(1993-9#1)(2008-11#1)(2008-7#1)
aerobic or anaerobic##2##3##(1995-6#1)(1996-12#1)
aerobic or##3##2##(1995-6#1)(1996-12#1)(2013-1#1)
aerobic organisms##2##2##(2007-7#1)(2008-10#1)
aerobic training group##2##3##(2013-1#2)
aerobic training##9##2##(2008-7#2)(2013-1#7)
aerobic##123##1##(1990-2#1)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-9#3)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#3)(1995-3#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#6)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#11)(2008-6#3)(2008-7#9)(2009-1#2)(2009-12#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#21)(2013-8#10)
aerobic-anaerobic##2##1##(2008-12#1)(2008-2#1)
aerobically##3##1##(1991-11#1)(1994-8#1)(1995-6#1)
aerobiological##2##1##(2008-5#1)(2010-5#1)
aerobiosis##2##1##(1997-4#1)(2008-12#1)
aerodigestive tract##5##2##(1992-9#1)(2008-1#1)(2009-5#1)(2013-1#2)
aerodigestive##6##1##(1992-9#2)(2008-1#1)(2009-5#1)(2013-1#2)
aerodynamic diameter##6##2##(1992-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)
aerodynamic forces##2##2##(2007-12#1)(2008-3#1)
aerodynamic mechanisms##2##2##(2007-12#2)
aerodynamic##20##1##(1992-2#1)(1992-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#4)(2008-11#2)(2008-2#1)(2008-3#4)
aerodynamics##3##1##(2007-12#1)(2009-11#2)
aerogel##5##1##(2008-3#4)(2010-4#1)
aerogels##2##1##(2010-4#2)
aerogenes##3##1##(2010-3#2)(2010-6#1)
aeromedical##3##1##(1991-12#1)(2012-3#2)
aerophytic##2##1##(2013-7#2)
aerosol absorption##2##2##(2008-2#1)(2008-3#1)
aerosol administration##2##2##(1996-3#1)(1997-1#1)
aerosol and Rayleigh##2##3##(2008-2#1)(2008-3#1)
aerosol and gas##2##3##(2008-2#2)
aerosol and##14##2##(1991-1#1)(1992-3#1)(1995-3#1)(2008-10#2)(2008-2#6)(2008-3#3)
aerosol are##2##2##(2008-2#2)
aerosol backscatter measurements##2##3##(2008-2#1)(2008-3#1)
aerosol backscatter##12##2##(2008-2#7)(2008-3#5)
aerosol bolus dispersion##3##3##(1997-2#3)
aerosol bolus##5##2##(1997-1#2)(1997-2#3)
aerosol by##6##2##(1993-2#1)(1995-3#1)(2008-10#3)(2013-8#1)
aerosol concentrations##2##2##(2008-3#2)
aerosol containment##3##2##(2008-9#3)
aerosol content##2##2##(2008-2#2)
aerosol could be##2##3##(1994-12#2)
aerosol could##3##2##(1994-12#2)(2008-3#1)
aerosol defense sprays##2##3##(2008-10#2)
aerosol delivery of##2##3##(1997-1#2)
aerosol delivery system##2##3##(1992-3#2)
aerosol delivery systems##3##3##(1992-3#1)(1995-3#1)(1997-1#1)
aerosol delivery##12##2##(1992-3#5)(1994-12#1)(1995-3#2)(1997-1#3)(2012-1#1)
aerosol deposition##2##2##(2008-10#1)(2008-11#1)
aerosol events##2##2##(2007-11#1)(2008-10#1)
aerosol exposure##2##2##(2008-10#2)
aerosol extinction and##3##3##(2008-3#3)
aerosol extinction coefficient spectra##2##4##(2008-3#2)
aerosol extinction coefficient##5##3##(2008-2#1)(2008-3#4)
aerosol extinction##15##2##(2008-2#2)(2008-3#13)
aerosol generation and##2##3##(1992-3#1)(2008-10#1)
aerosol generation##3##2##(1992-3#1)(1995-3#1)(2008-10#1)
aerosol in the##2##3##(1996-3#1)(2008-2#1)
aerosol in##4##2##(1995-3#1)(1996-3#1)(2008-2#2)
aerosol information##2##2##(2008-3#2)
aerosol inhaled&quot##4##2##(1992-3#4)
aerosol layer##7##2##(2008-2#5)(2008-3#2)
aerosol layers##2##2##(2008-3#2)
aerosol loading##4##2##(2008-2#3)(2008-3#1)
aerosol mass##4##2##(1996-3#1)(2008-10#2)(2008-11#1)
aerosol measurements##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
aerosol microstructure##2##2##(2008-3#2)
aerosol model##2##2##(2008-3#2)
aerosol models##4##2##(2008-2#3)(2008-3#1)
aerosol monitoring##2##2##(2008-3#1)(2008-5#1)
aerosol optical depth##4##3##(2008-2#4)
aerosol optical properties##7##3##(2008-2#5)(2008-3#2)
aerosol optical thickness over##2##4##(2008-3#2)
aerosol optical thickness##9##3##(2008-2#5)(2008-3#4)
aerosol optical##26##2##(2008-2#16)(2008-3#10)
aerosol parameters##3##2##(2008-3#3)
aerosol particles and##3##3##(2008-3#3)
aerosol particles in##2##3##(1994-12#1)(2008-10#1)
aerosol particles is presented##2##4##(2008-11#1)(2008-2#1)
aerosol particles with##2##3##(1996-2#1)(2008-3#1)
aerosol particles##19##2##(1994-12#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)
aerosol pentamidine##3##2##(1996-12#2)(1997-2#1)
aerosol phase##3##2##(2008-2#3)
aerosol properties from##6##3##(2008-2#1)(2008-3#5)
aerosol properties##11##2##(2008-2#2)(2008-3#9)
aerosol reflectance##2##2##(2008-3#2)
aerosol refractive index##5##3##(2008-2#1)(2008-3#4)
aerosol remote sensing over land##2##5##(2008-3#2)
aerosol research##2##2##(1994-1#1)(2008-10#1)
aerosol retrieval##3##2##(2008-2#2)(2008-3#1)
aerosol samples##5##2##(2008-10#4)(2008-3#1)
aerosol scattering##3##2##(2008-2#2)(2008-3#1)
aerosol size distribution##3##3##(2008-2#1)(2008-3#2)
aerosol size distributions##7##3##(2008-2#1)(2008-3#6)
aerosol size##11##2##(2008-2#2)(2008-3#9)
aerosol studies##3##2##(1994-1#2)(2008-3#1)
aerosol systems##2##2##(1992-3#2)
aerosol therapy##4##2##(1992-3#1)(1994-12#1)(1997-1#1)(2010-3#1)
aerosol treatment##2##2##(1997-1#1)(2010-3#1)
aerosol types##3##2##(2008-3#3)
aerosol volume##3##2##(2008-2#1)(2008-3#2)
aerosol was##4##2##(1992-2#1)(1994-12#2)(2008-2#1)
aerosol with##2##2##(1996-3#1)(2008-3#1)
aerosol##384##1##(1990-5#2)(1991-1#4)(1992-2#2)(1992-3#22)(1993-2#2)(1994-1#3)(1994-12#8)(1994-2#1)(1995-2#1)(1995-3#10)(1996-1#2)(1996-12#2)(1996-2#6)(1996-3#10)(1997-1#12)(1997-2#4)(2007-11#1)(2008-10#35)(2008-11#8)(2008-2#91)(2008-3#140)(2008-5#3)(2008-7#1)(2008-9#5)(2010-3#4)(2012-1#1)(2013-1#1)(2013-8#3)
aerosol's##2##1##(2008-3#2)
aerosol-derived airway morphometry##5##3##(1996-2#2)(1997-2#3)
aerosol-soot mixtures##3##2##(2008-3#3)
aerosol-volume##2##1##(2008-3#2)
aerosolization of##3##2##(1993-2#3)
aerosolization##4##1##(1993-2#4)
aerosolized Bacillus##2##2##(2007-12#1)(2008-3#1)
aerosolized ET-1##2##2##(1992-3#2)
aerosolized##18##1##(1990-9#1)(1992-2#1)(1992-3#4)(1993-2#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-3#1)
aerosols and##12##2##(1996-1#1)(1997-1#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-9#1)
aerosols are##2##2##(2007-11#1)(2008-3#1)
aerosols at##4##2##(2008-2#1)(2008-3#3)
aerosols by##6##2##(1992-2#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
aerosols can be##2##3##(2008-10#1)(2008-3#1)
aerosols could be##2##3##(2008-2#1)(2008-3#1)
aerosols derived from##2##3##(2008-2#1)(2008-3#1)
aerosols for##3##2##(1996-1#1)(2008-2#1)(2008-3#1)
aerosols from ground-based##2##3##(2008-3#2)
aerosols from##3##2##(2008-3#3)
aerosols in the atmosphere##2##4##(2008-2#1)(2008-3#1)
aerosols in the##9##3##(1992-3#1)(1995-3#1)(1997-1#1)(2008-2#2)(2008-3#2)(2013-1#1)(2013-8#1)
aerosols in##16##2##(1992-3#3)(1995-3#1)(1997-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2013-1#2)(2013-8#1)
aerosols is##3##2##(2008-11#1)(2008-3#2)
aerosols of##3##2##(1996-1#2)(1997-1#1)
aerosols produced by jet##2##4##(1991-1#1)(1995-3#1)
aerosols that##4##2##(1997-1#1)(2008-2#3)
aerosols to##4##2##(1994-12#2)(1996-1#1)(1997-2#1)
aerosols were##7##2##(1992-2#1)(1994-12#1)(1996-1#1)(2008-2#2)(2008-3#2)
aerosols with the##3##3##(1997-1#1)(2008-3#2)
aerosols with##6##2##(1997-1#1)(2008-2#1)(2008-3#4)
aerosols##151##1##(1991-1#1)(1992-2#4)(1992-3#8)(1994-12#3)(1995-3#2)(1996-1#9)(1996-2#1)(1996-3#1)(1997-1#7)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#34)(2008-3#51)(2008-7#1)(2008-9#3)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
aerospace##4##1##(2008-3#2)(2008-7#1)(2008-9#1)
aeruginosa BLSE##2##2##(2010-4#2)
aeruginosa FR##2##2##(2008-6#2)
aeruginosa KM110##2##2##(2012-2#2)
aeruginosa and A##2##3##(2008-7#2)
aeruginosa and##5##2##(2008-7#2)(2008-8#1)(2010-3#1)(2012-2#1)
aeruginosa exotoxin##5##2##(2008-10#2)(2008-5#3)
aeruginosa isolated##2##2##(2008-12#1)(2008-7#1)
aeruginosa lasR mutant containing a plasmid with lasR under the control of##2##12##(1995-2#2)
aeruginosa strains##2##2##(2007-7#2)
aeruginosa using##2##2##(2008-10#1)(2008-6#1)
aeruginosa was##3##2##(1992-11#1)(2008-10#1)(2012-3#1)
aeruginosa##102##1##(1990-11#1)(1990-6#1)(1991-3#1)(1992-11#1)(1994-2#2)(1995-2#8)(2007-7#4)(2008-10#9)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#2)(2009-11#2)(2009-6#7)(2010-10#2)(2010-3#2)(2010-4#2)(2011-2#4)(2012-12#1)(2012-2#15)(2012-3#6)(2013-1#8)(2013-8#3)
aeruginosa-induced##4##1##(2012-2#4)
aesculetin##3##1##(2008-10#3)
aesculin and##4##2##(2008-10#4)
aesthetascs and##3##2##(2007-12#3)
aesthetascs##4##1##(2007-12#4)
aesthetic and##2##2##(2010-8#1)(2012-3#1)
aesthetic characteristics##2##2##(2008-5#1)(2010-8#1)
aesthetic mate preferences##2##3##(2008-9#2)
aesthetic preferences##2##2##(2008-9#2)
aesthetic replacement of##2##3##(2008-7#2)
aesthetic results##2##2##(2008-9#1)(2012-3#1)
aesthetic##34##1##(1990-9#1)(1992-9#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#6)(2010-6#1)(2010-8#5)(2011-2#1)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#3)
aesthetically acceptable##2##2##(2008-4#1)(2012-2#1)
aesthetically##5##1##(2007-5#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
aesthetics##6##1##(2007-12#1)(2008-7#3)(2010-8#1)(2013-1#1)
aestivum L##11##2##(2008-11#1)(2008-12#5)(2008-5#2)(2008-8#1)(2011-2#2)
aestivum##14##1##(2008-10#1)(2008-11#1)(2008-12#6)(2008-5#2)(2008-8#2)(2011-2#2)
aestivum)##16##1##(2008-10#13)(2008-11#1)(2008-12#1)(2008-9#1)
aestivum-Ag##2##1##(2008-8#2)
aetiologic##2##1##(2008-5#2)
aetiological agent##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
aetiological diagnosis##2##2##(1990-3#1)(1997-3#1)
aetiological factors##2##2##(2008-6#1)(2009-7#1)
aetiological hypothesis##2##2##(2008-4#1)(2010-1#1)
aetiological##13##1##(1990-3#1)(1991-11#2)(1997-3#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
aetiologies and##2##2##(2008-12#1)(2012-2#1)
aetiologies##8##1##(1991-5#1)(1995-10#2)(2008-12#1)(2008-9#1)(2010-10#1)(2012-2#2)
aetiology and##10##2##(1991-6#1)(1997-1#1)(2007-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-12#1)(2012-2#1)
aetiology in##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
aetiology of cardiac##2##3##(2008-10#1)(2011-2#1)
aetiology of this##4##3##(2008-12#1)(2008-9#1)(2009-4#1)(2009-7#1)
aetiology of##33##2##(1990-8#1)(1992-5#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
aetiology##69##1##(1990-8#2)(1991-5#1)(1991-6#1)(1992-5#3)(1993-6#2)(1996-11#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#5)(2012-2#6)(2013-1#4)(2013-8#1)
aetiopathogenesis of##3##2##(1996-5#2)(2007-7#1)
aetiopathogenesis##5##1##(1990-9#1)(1996-5#2)(2007-7#1)(2008-5#1)
af##4##1##(1992-11#1)(2007-11#2)(2013-1#1)
afarensis##3##1##(1994-3#3)
affair##2##1##(1995-12#1)(2008-10#1)
affairs##9##1##(1991-1#1)(1992-1#1)(1997-2#1)(2008-11#2)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
affect 1##2##2##(2011-2#1)(2012-12#1)
affect a large proportion of the##2##6##(2010-10#1)(2013-8#1)
affect a##10##2##(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
affect adolescent##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
affect all##3##2##(1990-11#1)(2008-1#1)(2008-7#1)
affect and##3##2##(2009-11#1)(2010-1#1)(2011-2#1)
affect antibiotic##2##2##(1993-11#1)(2009-4#1)
affect any##4##2##(1996-5#1)(2008-11#1)(2012-2#2)
affect bacterial##3##2##(2008-10#2)(2012-2#1)
affect basal##2##2##(1990-12#1)(1994-2#1)
affect behavior##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
affect bone##2##2##(1991-11#1)(2011-2#1)
affect both##3##2##(1990-11#1)(1994-9#1)(2011-2#1)
affect brain development and##2##4##(1993-12#1)(2012-12#1)
affect brain##3##2##(1993-12#1)(2012-12#1)(2013-1#1)
affect cardiovascular##2##2##(2008-5#1)(2009-11#1)
affect cell growth##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
affect cell##7##2##(1994-11#1)(1995-6#1)(1996-12#1)(2008-11#1)(2009-7#1)(2011-2#1)(2012-12#1)
affect cellular##2##2##(1991-5#1)(2008-10#1)
affect data##2##2##(2009-10#1)(2012-2#1)
affect development of##2##3##(1990-11#1)(2012-12#1)
affect each##2##2##(2008-8#1)(2009-10#1)
affect fitness##2##2##(2008-8#2)
affect gene##2##2##(2008-8#1)(2012-12#1)
affect growth rate##3##3##(1996-3#1)(2007-11#2)
affect growth##5##2##(1996-3#1)(2007-11#2)(2008-10#1)(2011-1#1)
affect health##4##2##(1994-3#1)(2009-3#1)(2011-2#1)(2013-1#1)
affect host##2##2##(2008-10#1)(2012-3#1)
affect in##2##2##(1995-6#1)(2008-7#1)
affect interactions##2##2##(2008-8#1)(2012-2#1)
affect it##2##2##(1995-12#1)(2006-6#1)
affect male##2##2##(2008-4#1)(2011-2#1)
affect many##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
affect maximum##2##2##(2008-10#1)(2008-11#1)
affect medical##2##2##(1993-2#1)(2010-6#1)
affect neuronal##2##2##(2008-10#1)(2008-4#1)
affect nursing##2##2##(1991-1#1)(1995-12#1)
affect of##2##2##(1991-5#1)(1994-2#1)
affect on the##2##3##(2010-4#2)
affect on##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#2)
affect other##3##2##(1992-12#1)(1992-6#1)(1997-2#1)
affect outcome##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
affect overall##3##2##(2008-6#1)(2008-7#1)(2012-2#1)
affect patient##4##2##(1993-2#1)(2008-3#1)(2010-11#1)(2010-3#1)
affect patients##2##2##(1990-6#1)(2011-2#1)
affect quality of life##2##4##(2008-7#1)(2010-12#1)
affect quality##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
affect rates of##2##3##(1991-12#1)(2008-8#1)
affect regulation##5##2##(2008-6#2)(2009-11#1)(2013-1#2)
affect results##2##2##(1992-12#1)(2012-2#1)
affect several##2##2##(2008-5#1)(2012-1#1)
affect sexual trait expression##2##4##(2012-3#2)
affect sexual trait##3##3##(2012-3#3)
affect sexual##5##2##(1993-8#1)(2008-7#1)(2012-3#3)
affect significantly##2##2##(1993-12#1)(1997-6#1)
affect social##2##2##(2008-11#1)(2008-8#1)
affect the ability of##5##4##(1990-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
affect the ability to##2##4##(2008-9#1)(2009-3#1)
affect the ability##7##3##(1990-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)
affect the accuracy of the##2##5##(2008-10#1)(2008-3#1)
affect the accuracy of##3##4##(2008-10#2)(2008-3#1)
affect the accuracy##4##3##(2008-10#3)(2008-3#1)
affect the activity of##5##4##(1990-2#2)(1990-5#1)(1992-3#1)(2011-1#1)
affect the amount of##2##4##(2008-10#1)(2008-6#1)
affect the association##2##3##(2008-12#1)(2009-8#1)
affect the binding##2##3##(1995-8#1)(2008-10#1)
affect the biosynthesis of##2##4##(2008-6#1)(2009-6#1)
affect the care##2##3##(1991-3#1)(1995-2#1)
affect the choice of##2##4##(1993-1#1)(2008-10#1)
affect the course of##2##4##(1997-6#1)(2012-3#1)
affect the development of##2##4##(1991-8#1)(2008-11#1)
affect the effectiveness of##2##4##(2010-6#1)(2013-7#1)
affect the efficiency of##2##4##(1991-9#1)(2008-10#1)
affect the evolution of##2##4##(2008-8#2)
affect the evolutionary##2##3##(2008-8#1)(2012-3#1)
affect the expression of##4##4##(1991-1#1)(1995-2#1)(2008-8#2)
affect the expression##5##3##(1991-1#1)(1995-2#1)(2008-6#1)(2008-8#2)
affect the extraction##2##3##(2008-10#2)
affect the fluorescence##3##3##(1994-5#1)(1997-2#1)(2008-9#1)
affect the growth##2##3##(1995-2#1)(2008-4#1)
affect the health##2##3##(2008-7#1)(2010-9#1)
affect the laser##2##3##(2008-2#2)
affect the level of##4##4##(1996-2#1)(1996-3#1)(2008-10#1)(2008-8#1)
affect the magnitude of##2##4##(1996-3#1)(2008-4#1)
affect the maximum##2##3##(2008-10#1)(2008-11#1)
affect the mean##2##3##(2008-3#1)(2012-2#1)
affect the measurement##2##3##(2008-8#1)(2012-2#1)
affect the natural history of##2##5##(1993-11#1)(2007-7#1)
affect the nervous system##2##4##(1991-12#1)(2008-2#1)
affect the observed##2##3##(1992-3#1)(2008-10#1)
affect the operation of the##2##5##(2008-3#1)(2008-7#1)
affect the outcome of the##2##5##(2008-2#1)(2008-5#1)
affect the outcome of##4##4##(1993-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
affect the outcomes of##2##4##(2008-8#1)(2011-1#1)
affect the overall##3##3##(1991-2#1)(1991-3#1)(2011-2#1)
affect the pathogenicity of##2##4##(2008-10#1)(2008-6#1)
affect the performance of##7##4##(2008-10#4)(2008-2#2)(2010-2#1)
affect the performance##8##3##(2008-10#4)(2008-2#2)(2009-8#1)(2010-2#1)
affect the physical##2##3##(2007-10#1)(2008-8#1)
affect the quality of life##2##5##(2008-12#1)(2008-5#1)
affect the quality of##10##4##(1991-12#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
affect the quality##11##3##(1991-12#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
affect the rate of##2##4##(1991-12#1)(1993-9#1)
affect the rate##3##3##(1991-12#1)(1993-9#1)(2008-11#1)
affect the relative intensity of sexual selection##2##7##(2008-8#2)
affect the response of##2##4##(2008-10#1)(2008-4#1)
affect the response to##2##4##(2007-11#1)(2008-11#1)
affect the response##5##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)
affect the responses##3##3##(1990-11#1)(1990-5#1)(1991-9#1)
affect the results##5##3##(1992-9#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
affect the sensitivity of the##2##5##(1990-12#1)(2008-10#1)
affect the sensitivity##3##3##(1990-12#1)(2008-10#2)
affect the size of##3##4##(1991-2#1)(2008-10#2)
affect the size##4##3##(1991-2#1)(2008-10#2)(2008-9#1)
affect the spatial##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
affect the structure##2##3##(1994-5#1)(2008-7#1)
affect the survival of##3##4##(2008-10#2)(2009-10#1)
affect the virus##2##3##(2008-10#1)(2008-11#1)
affect the##406##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-2#1)(1992-3#4)(1992-9#1)(1993-1#2)(1993-11#6)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#73)(2008-11#20)(2008-12#6)(2008-2#11)(2008-3#11)(2008-4#5)(2008-5#14)(2008-6#9)(2008-7#14)(2008-8#21)(2008-9#6)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#4)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#11)(2013-7#4)(2013-8#1)
affect their ability to##2##4##(1992-12#1)(1997-1#1)
affect their##18##2##(1990-12#1)(1992-12#1)(1993-2#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
affect these##4##2##(1996-12#1)(2008-10#1)(2009-11#1)(2012-3#1)
affect this##6##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
affect to##3##2##(1990-8#1)(2008-6#1)(2013-7#1)
affect young people##2##3##(2008-4#1)(2012-3#1)
affect your##2##2##(1993-2#1)(2008-10#1)
affect##958##1##(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#8)(1990-6#2)(1990-7#2)(1990-8#4)(1991-1#5)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#3)(1991-5#7)(1991-6#2)(1991-8#2)(1991-9#6)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#9)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#10)(1993-12#6)(1993-2#7)(1993-3#6)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#4)(1994-5#6)(1994-8#5)(1994-9#6)(1995-1#2)(1995-11#6)(1995-12#12)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#6)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#10)(1996-3#5)(1996-5#7)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#5)(1997-4#6)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#127)(2008-11#48)(2008-12#13)(2008-2#15)(2008-3#17)(2008-4#21)(2008-5#24)(2008-6#18)(2008-7#22)(2008-8#47)(2008-9#15)(2009-1#1)(2009-10#5)(2009-11#8)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#7)(2009-8#15)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#8)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#3)(2010-8#8)(2010-9#4)(2011-1#10)(2011-2#43)(2012-1#6)(2012-12#12)(2012-2#30)(2012-3#18)(2012-5#2)(2013-1#30)(2013-7#8)(2013-8#13)
affected (P##2##2##(1991-9#1)(2012-2#1)
affected (P&lt##2##2##(2007-2#1)(2008-5#1)
affected a##2##2##(2008-7#1)(2013-1#1)
affected all##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
affected and##9##2##(1994-2#1)(1994-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-7#1)(2011-2#1)
affected areas##6##2##(1993-3#1)(2010-1#1)(2011-2#3)(2013-7#1)
affected at##5##2##(1993-12#1)(1995-3#1)(1997-4#1)(2008-6#1)(2013-1#1)
affected both by##2##3##(2007-11#1)(2008-10#1)
affected both the##3##3##(1996-2#1)(2008-10#2)
affected both##8##2##(1996-2#1)(2007-11#1)(2008-10#5)(2012-12#1)
affected by &quot##2##3##(1993-2#1)(1993-3#1)
affected by LiCl##2##3##(1992-6#2)
affected by a number of##2##5##(2008-11#1)(2013-1#1)
affected by a##11##3##(1990-2#1)(1990-8#1)(1994-11#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
affected by adenosine##2##3##(1993-6#1)(2008-4#1)
affected by aging##2##3##(1994-5#2)
affected by an##7##3##(1990-3#1)(1993-5#1)(1994-7#1)(1995-5#1)(2008-3#1)(2009-6#1)(2012-3#1)
affected by any##2##3##(1994-9#1)(2008-10#1)
affected by autoimmune##2##3##(1991-5#1)(1992-12#1)
affected by both##6##3##(1997-5#1)(2008-10#3)(2008-12#1)(2011-2#1)
affected by certain##2##3##(1990-11#1)(2008-5#1)
affected by changes in##3##4##(2008-10#2)(2011-2#1)
affected by changes##4##3##(2008-10#2)(2009-11#1)(2011-2#1)
affected by chronic##2##3##(1997-2#1)(2008-1#1)
affected by competition##2##3##(2008-8#1)(2009-10#1)
affected by crop##2##3##(2008-12#2)
affected by dietary##4##3##(1997-4#2)(2008-3#1)(2010-2#1)
affected by different##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
affected by either##2##3##(2008-6#1)(2009-10#1)
affected by environmental##3##3##(2008-10#1)(2013-1#2)
affected by familial##3##3##(1990-6#1)(1993-12#1)(2011-2#1)
affected by increased metabolic load##2##5##(2008-11#2)
affected by increased##4##3##(1993-3#1)(2008-10#1)(2008-11#2)
affected by initial##2##3##(2008-10#1)(2013-8#1)
affected by interferences##2##3##(2008-10#2)
affected by irrigation##2##3##(2008-10#1)(2008-12#1)
affected by matrix##2##3##(2008-10#2)
affected by multiple##2##3##(1993-12#1)(2008-3#1)
affected by noise##2##3##(2008-3#1)(2008-9#1)
affected by other##3##3##(1990-2#1)(1992-6#1)(2013-8#1)
affected by peri-implantitis##3##3##(2013-1#3)
affected by plant##2##3##(2008-10#1)(2011-2#1)
affected by severe##3##3##(1990-9#1)(2009-8#1)(2013-1#1)
affected by soil##2##3##(2008-10#1)(2013-8#1)
affected by such experiences##2##4##(1992-2#1)(2008-11#1)
affected by such##4##3##(1991-9#1)(1992-2#1)(2008-10#1)(2008-11#1)
affected by temperature##6##3##(2008-10#5)(2010-8#1)
affected by the AIDS##2##4##(1993-1#1)(2008-4#1)
affected by the C-domain of##2##5##(2008-9#2)
affected by the amount of##2##5##(2008-10#2)
affected by the change##2##4##(1992-1#1)(2008-3#1)
affected by the concentration of##2##5##(1990-6#1)(2008-10#1)
affected by the degree of##2##5##(2008-10#2)
affected by the disease##6##4##(1990-6#1)(2008-10#3)(2008-7#1)(2010-5#1)
affected by the matrix and##2##5##(2008-10#2)
affected by the matrix##4##4##(2008-10#3)(2010-11#1)
affected by the permeant cation species##2##6##(1990-11#2)
affected by the presence of other##3##6##(2008-10#3)
affected by the presence of the##2##6##(1993-3#1)(2008-11#1)
affected by the presence of##14##5##(1990-8#1)(1991-12#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-11#2)(2008-3#1)
affected by the##127##3##(1990-11#4)(1990-6#2)(1990-8#2)(1991-12#5)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#36)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
affected by these changes##2##4##(1995-1#1)(1997-2#1)
affected by these##6##3##(1990-6#1)(1995-1#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)
affected by this##3##3##(1990-9#1)(1994-11#1)(2013-8#1)
affected by two##2##3##(1994-11#1)(2008-2#1)
affected by type##2##3##(1990-5#1)(2010-8#1)
affected by viral##2##3##(1992-12#1)(1997-6#1)
affected by##516##2##(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#6)(1990-7#3)(1990-8#5)(1990-9#4)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#4)(1992-8#3)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#4)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#2)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#108)(2008-11#25)(2008-12#16)(2008-2#8)(2008-3#18)(2008-4#8)(2008-5#13)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#11)(2009-10#5)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#4)(2011-10#1)(2011-2#19)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#25)(2013-8#11)
affected carcass##2##2##(2010-2#1)(2012-2#1)
affected cell type##2##3##(2008-3#1)(2008-8#1)
affected cell##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
affected child##2##2##(2007-12#1)(2009-7#1)
affected children##4##2##(1993-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
affected communities##2##2##(1997-2#1)(2013-1#1)
affected countries##3##2##(1993-6#1)(2011-2#2)
affected differently##2##2##(1994-11#1)(1995-5#1)
affected digit##3##2##(2008-9#3)
affected dogs##2##2##(2008-5#1)(2012-3#1)
affected during##3##2##(2011-2#2)(2012-3#1)
affected families##3##2##(1997-5#1)(2008-8#1)(2009-9#1)
affected functional##2##2##(2008-1#1)(2008-11#1)
affected genes##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
affected group##2##2##(1990-3#1)(2008-3#1)
affected in a##4##3##(1995-12#1)(1996-6#1)(2008-6#1)(2012-2#1)
affected in the##2##3##(1995-6#1)(2012-2#1)
affected in their##2##3##(2008-10#2)
affected in this##2##3##(1992-3#1)(2008-7#1)
affected in##33##2##(1992-3#1)(1995-12#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)
affected individual##2##2##(1997-3#1)(2008-7#1)
affected individuals##18##2##(1990-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
affected limbs##2##2##(1991-8#1)(2007-11#1)
affected mainly##5##2##(2008-10#4)(2013-1#1)
affected members of##3##3##(1995-8#1)(1997-7#1)(1997-8#1)
affected members were##2##3##(2008-7#1)(2010-3#1)
affected members##9##2##(1995-8#1)(1996-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2008-7#2)(2010-3#1)
affected more##9##2##(1996-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)
affected muscle##2##2##(2013-1#2)
affected neither in##2##3##(1992-1#1)(2008-10#1)
affected neither##5##2##(1992-1#1)(2008-10#2)(2008-7#1)(2010-11#1)
affected only by##2##3##(2008-10#1)(2008-2#1)
affected only##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
affected patients##11##2##(1993-3#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2009-8#1)
affected persons##2##2##(2008-1#1)(2009-5#1)
affected physicians##2##2##(1991-3#1)(1993-12#1)
affected pregnancies##3##2##(2008-1#2)(2010-11#1)
affected production##2##2##(1997-3#1)(2008-10#1)
affected relatives##7##2##(1992-9#4)(2008-1#3)
affected sib pair##3##3##(1997-5#3)
affected sib-pair analyses revealed##2##4##(1997-5#2)
affected sib-pair##4##2##(1997-5#4)
affected sibling pairs##2##3##(1997-5#2)
affected sibpair##3##2##(2008-9#3)
affected significantly (P &lt##3##4##(1996-6#1)(2008-10#2)
affected significantly by##6##3##(1997-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
affected significantly##10##2##(1996-6#1)(1997-7#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
affected since##2##2##(2008-10#1)(2013-1#1)
affected status##4##2##(1997-5#3)(2008-4#1)
affected teeth##5##2##(2008-1#2)(2008-12#2)(2013-1#1)
affected than the##2##3##(1996-3#1)(2010-11#1)
affected than##6##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)
affected the expected##2##3##(2008-10#1)(2008-9#1)
affected the expression of##2##4##(1995-6#1)(2008-10#1)
affected the expression##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
affected the fatty acid##2##4##(2010-4#2)
affected the growth of##2##4##(2008-10#1)(2008-7#1)
affected the production of##2##4##(2008-5#1)(2013-1#1)
affected the relationship between##2##4##(2008-10#2)
affected the relative##2##3##(2008-10#2)
affected the##84##2##(1990-2#1)(1991-12#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#27)(2008-11#3)(2008-12#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-10#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-5#1)(2013-1#4)
affected their##3##2##(1993-3#1)(2008-5#1)(2012-12#1)
affected tissues and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
affected tissues##4##2##(2008-10#1)(2011-2#1)(2012-12#2)
affected to##3##2##(1996-6#1)(2008-3#1)(2012-3#1)
affected under##3##2##(1997-2#1)(2008-10#1)(2012-12#1)
affected upper extremity##2##3##(2007-10#2)
affected vertebral body##2##3##(1996-8#1)(2007-11#1)
affected when##4##2##(1990-7#1)(2008-10#2)(2008-7#1)
affected with a##3##3##(1992-2#1)(1993-6#1)(2008-4#1)
affected with##13##2##(1991-3#1)(1992-2#1)(1992-6#1)(1993-6#2)(1994-11#1)(1997-6#1)(2007-7#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-2#1)
affected women##3##2##(1996-12#1)(2008-1#1)(2010-11#1)
affected##1187##1##(1990-11#8)(1990-12#4)(1990-2#5)(1990-3#4)(1990-5#5)(1990-6#8)(1990-7#4)(1990-8#5)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#6)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#5)(1992-5#4)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#1)(1993-12#9)(1993-2#5)(1993-3#15)(1993-5#2)(1993-6#8)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#7)(1994-12#8)(1994-2#3)(1994-3#4)(1994-5#7)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#3)(1995-11#5)(1995-12#8)(1995-2#4)(1995-3#6)(1995-5#4)(1995-6#6)(1995-8#3)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#2)(1996-8#1)(1997-1#6)(1997-2#7)(1997-3#6)(1997-4#7)(1997-5#27)(1997-6#3)(1997-7#7)(1997-8#6)(2006-10#2)(2007-1#1)(2007-10#8)(2007-11#6)(2007-12#7)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#5)(2008-1#26)(2008-10#214)(2008-11#44)(2008-12#33)(2008-2#14)(2008-3#27)(2008-4#17)(2008-5#33)(2008-6#15)(2008-7#32)(2008-8#23)(2008-9#22)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#11)(2010-12#4)(2010-2#9)(2010-3#4)(2010-4#8)(2010-5#5)(2010-7#2)(2010-8#9)(2011-1#11)(2011-10#2)(2011-2#64)(2011-3#1)(2012-1#5)(2012-12#12)(2012-2#20)(2012-3#18)(2012-4#1)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#49)(2013-7#2)(2013-8#17)
affected)##2##1##(1997-5#1)(2007-7#1)
affecting a##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
affecting all##2##2##(1993-12#1)(2008-10#1)
affecting approximately 1##2##3##(2008-7#2)
affecting approximately##3##2##(2008-7#2)(2012-3#1)
affecting both crops##2##3##(2008-10#2)
affecting both its differentiation and the function of specific cell types##2##11##(2008-4#2)
affecting both the##3##3##(2008-10#1)(2010-5#2)
affecting both##11##2##(1993-3#1)(2008-10#3)(2008-4#2)(2008-7#2)(2010-5#2)(2013-7#1)
affecting cell growth##2##3##(2008-11#2)
affecting cell##3##2##(2008-11#3)
affecting children and##2##3##(2013-1#2)
affecting children##3##2##(2008-7#1)(2013-1#2)
affecting coconut##2##2##(2008-10#2)
affecting disease##2##2##(2008-10#1)(2012-2#1)
affecting in particular the##2##4##(1992-6#1)(2008-5#1)
affecting in particular##3##3##(1992-6#1)(1997-8#1)(2008-5#1)
affecting in##4##2##(1992-6#1)(1997-2#1)(1997-8#1)(2008-5#1)
affecting intracellular##2##2##(1995-8#1)(2008-6#1)
affecting its##3##2##(2012-3#2)(2013-1#1)
affecting many##3##2##(1992-5#1)(2008-4#1)(2012-12#1)
affecting men##2##2##(2008-5#2)
affecting more##2##2##(1995-5#1)(2008-7#1)
affecting multiple##2##2##(2011-1#1)(2013-1#1)
affecting nearly 1##2##3##(2008-4#1)(2008-9#1)
affecting only##2##2##(2007-8#1)(2008-11#1)
affecting other##3##2##(1990-12#1)(1997-8#1)(2012-2#1)
affecting performance##2##2##(1992-11#1)(2008-5#1)
affecting peripheral nerves##2##3##(2008-7#1)(2012-3#1)
affecting research##2##2##(2008-11#2)
affecting stomach##2##2##(2008-12#1)(2012-1#1)
affecting survival##3##2##(2007-10#1)(2008-10#1)(2010-11#1)
affecting the activity of the##2##5##(1992-3#1)(2008-10#1)
affecting the binding of##3##4##(1993-3#1)(1994-6#1)(2008-10#1)
affecting the cell##2##3##(2008-11#2)
affecting the chemiluminescence##2##3##(2008-10#2)
affecting the enzymatic hydrolysis##2##4##(2008-10#2)
affecting the extraction efficiency##2##4##(2008-10#2)
affecting the extraction##3##3##(2008-10#3)
affecting the face##2##3##(2011-2#1)(2012-12#1)
affecting the fiber##2##3##(2007-12#1)(2008-10#1)
affecting the mandibular##2##3##(2011-2#1)(2013-1#1)
affecting the outcome##2##3##(2007-7#1)(2008-10#1)
affecting the progression of##2##4##(1994-5#1)(2011-2#1)
affecting the reaction##2##3##(2008-10#2)
affecting the response##4##3##(2008-10#3)(2008-6#1)
affecting the results##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
affecting the sensitivity of the##2##5##(2008-10#2)
affecting the sensitivity of##4##4##(2008-10#3)(2010-5#1)
affecting the separation##2##3##(2008-10#2)
affecting the spleen##2##3##(1992-2#1)(2008-7#1)
affecting the target##2##3##(1993-6#1)(2008-10#1)
affecting the##189##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#2)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-3#2)(1993-6#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-3#2)(1996-8#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#69)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#3)(2009-3#2)(2009-6#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#1)
affecting their##6##2##(1996-12#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-8#1)
affecting these##2##2##(1995-1#1)(2011-2#1)
affecting this##2##2##(2008-10#1)(2011-2#1)
affecting various##2##2##(1990-6#1)(1996-4#1)
affecting virtually all##2##3##(1994-12#1)(1996-6#1)
affecting young##3##2##(2006-10#1)(2008-1#1)(2008-7#1)
affecting##466##1##(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#3)(1991-11#2)(1991-12#2)(1991-5#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#6)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#5)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#10)(2008-10#114)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#22)(2008-6#6)(2008-7#22)(2008-8#19)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#5)(2011-10#1)(2011-2#17)(2012-1#3)(2012-12#8)(2012-2#12)(2012-3#14)(2013-1#18)(2013-7#2)(2013-8#6)
affection in##2##2##(2007-2#1)(2013-1#1)
affection of lung##2##3##(2013-1#2)
affection of the##4##3##(1990-8#1)(1991-11#1)(1991-6#2)
affection of##11##2##(1990-8#3)(1991-11#1)(1991-6#2)(1991-9#1)(1994-11#1)(2013-1#3)
affection##28##1##(1990-3#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-6#1)(1993-5#1)(1994-11#1)(1997-5#4)(2007-11#1)(2007-2#1)(2007-8#2)(2008-12#2)(2010-11#1)(2013-1#5)
affections from##2##2##(2013-1#2)
affections of the##2##3##(1990-8#1)(2008-10#1)
affections##10##1##(1990-3#1)(1990-8#2)(1995-5#1)(1997-7#1)(2008-10#2)(2008-9#1)(2013-1#2)
affective and##5##2##(2008-11#1)(2008-2#1)(2012-2#2)(2013-7#1)
affective disorder##10##2##(1995-11#3)(1996-7#2)(1997-5#3)(1997-6#1)(2008-8#1)
affective disorders##14##2##(1991-11#1)(1992-2#2)(1992-5#1)(1996-12#1)(1996-7#3)(1997-5#1)(1997-6#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
affective fronto-limbic circuitry##2##3##(2013-8#2)
affective modulation##2##2##(2008-4#1)(2012-2#1)
affective processing##2##2##(2013-8#2)
affective profiles are##2##3##(1994-2#2)
affective psychoses##2##2##(1995-11#1)(1997-5#1)
affective recovery##2##2##(2009-8#2)
affective state and##2##3##(2008-4#1)(2013-1#1)
affective symptoms##3##2##(2013-8#3)
affective##89##1##(1991-11#1)(1991-2#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-6#1)(1994-2#3)(1995-11#4)(1996-1#1)(1996-12#1)(1996-7#6)(1997-5#5)(1997-6#2)(2007-12#1)(2007-7#1)(2008-1#6)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#5)(2008-8#1)(2008-9#1)(2009-8#4)(2010-1#1)(2010-4#1)(2010-6#2)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#12)
affectively##2##1##(1994-2#1)(2010-2#1)
affects a##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
affects about##2##2##(1997-8#1)(2013-8#1)
affects access to##2##3##(1995-1#1)(2007-7#1)
affects all##2##2##(2008-10#1)(2008-8#1)
affects approximately##4##2##(2007-10#1)(2009-9#1)(2012-12#1)(2012-3#1)
affects both the##2##3##(2008-3#1)(2009-8#1)
affects both##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
affects brain##2##2##(2009-12#1)(2013-1#1)
affects control##2##2##(2008-10#1)(2008-8#1)
affects how##3##2##(1993-3#1)(2008-11#1)(2012-12#1)
affects its##3##2##(1991-2#1)(2008-10#1)(2008-8#1)
affects mainly##3##2##(1997-8#1)(2007-12#1)(2007-8#1)
affects many##4##2##(2008-10#2)(2010-4#1)(2012-3#1)
affects memory##2##2##(2007-8#1)(2008-6#1)
affects nearly##2##2##(2008-3#1)(2013-8#1)
affects older##2##2##(1991-12#1)(2010-8#1)
affects only##3##2##(1990-8#1)(2012-3#2)
affects particularly##2##2##(2007-10#1)(2008-8#1)
affects patient##2##2##(1991-3#1)(2011-2#1)
affects patients##3##2##(2009-8#1)(2011-2#1)(2012-1#1)
affects people##2##2##(2008-1#1)(2008-6#1)
affects plant##2##2##(2009-8#2)
affects primarily##2##2##(1990-5#1)(2006-10#1)
affects rural##2##2##(1992-12#1)(2013-1#1)
affects several##5##2##(1990-12#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-5#1)
affects sexual##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
affects the activity##2##3##(1992-3#1)(1997-6#1)
affects the development##2##3##(2012-12#1)(2012-3#1)
affects the expression of the##2##5##(1997-8#1)(2008-9#1)
affects the expression of##5##4##(1996-5#1)(1997-8#1)(2008-12#1)(2008-9#2)
affects the expression##6##3##(1996-5#1)(1997-8#1)(2008-12#1)(2008-9#2)(2010-3#1)
affects the orientation of##2##4##(1994-5#1)(2007-11#1)
affects the prognosis of##2##4##(1993-9#1)(2011-2#1)
affects the quality##2##3##(2008-8#1)(2008-9#1)
affects the skin##3##3##(2008-5#2)(2012-3#1)
affects the##122##2##(1990-12#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-5#4)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#10)(2012-12#4)(2012-2#4)(2012-3#3)(2013-7#3)(2013-8#1)
affects their##6##2##(1991-8#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#2)
affects up to##3##3##(2010-5#1)(2011-1#1)(2013-8#1)
affects women##2##2##(2011-2#2)
affects young##3##2##(1991-9#1)(2010-3#1)(2010-4#1)
affects##355##1##(1990-12#6)(1990-5#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#7)(2008-10#32)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#16)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#25)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#22)(2012-1#2)(2012-12#6)(2012-2#17)(2012-3#12)(2012-6#1)(2013-1#11)(2013-7#5)(2013-8#7)
afferent and two efferent vessels##2##5##(2011-2#2)
afferent and##4##2##(1993-5#2)(2011-2#2)
afferent fibers in the##3##4##(1993-12#2)(1997-2#1)
afferent fibers in##4##3##(1993-12#2)(1997-2#2)
afferent fibers##11##2##(1990-7#1)(1993-12#2)(1994-8#1)(1995-12#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
afferent fibres##3##2##(1996-2#1)(1997-3#1)(2008-7#1)
afferent input##3##2##(1990-5#2)(2007-8#1)
afferent neurons##8##2##(1995-12#2)(1996-12#1)(1996-5#1)(1997-3#1)(2008-12#1)(2008-4#2)
afferent pathways##3##2##(1995-3#1)(2008-5#1)(2008-7#1)
afferent signals##2##2##(2008-11#2)
afferent terminal##3##2##(1990-5#1)(1993-12#1)(1994-8#1)
afferent terminals##6##2##(1990-5#3)(1993-12#1)(1997-3#1)(2008-8#1)
afferent##73##1##(1990-5#6)(1990-6#1)(1990-7#1)(1992-6#2)(1993-12#6)(1993-5#4)(1994-8#2)(1995-12#5)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
afferents are##4##2##(1997-3#2)(2008-1#1)(2008-4#1)
afferents in the##2##3##(1993-12#1)(2008-11#1)
afferents is##2##2##(1993-12#1)(1996-5#1)
afferents may##2##2##(1992-6#1)(1993-12#1)
afferents of the##3##3##(1997-2#2)(1997-3#1)
afferents on##3##2##(1993-12#1)(1997-2#2)
afferents to##2##2##(1993-6#1)(1995-12#1)
afferents##38##1##(1991-2#1)(1992-6#2)(1993-12#7)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#3)(1997-2#7)(1997-3#5)(2008-1#1)(2008-11#1)(2008-4#4)(2008-7#1)(2013-8#1)
affiliated hospitals##2##2##(1995-1#1)(2010-12#1)
affiliated service group rules##2##4##(1991-2#2)
affiliated with a##2##3##(1993-12#1)(2007-12#1)
affiliated with##5##2##(1993-12#1)(2007-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
affiliated##15##1##(1991-2#2)(1992-2#1)(1993-12#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
affiliates##3##1##(1993-12#2)(2008-11#1)
affiliation and##2##2##(1990-9#1)(2011-2#1)
affiliation in##2##2##(2008-10#2)
affiliation of the##4##3##(2008-12#2)(2009-6#1)(2009-7#1)
affiliation of##6##2##(1993-12#1)(2008-12#2)(2008-9#1)(2009-6#1)(2009-7#1)
affiliation with##3##2##(1992-2#1)(1995-1#1)(2008-6#1)
affiliation##32##1##(1990-9#1)(1992-2#1)(1993-12#6)(1995-1#2)(1996-1#2)(1996-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#4)(2011-2#1)(2013-7#1)
affiliations and##2##2##(1993-12#1)(2008-12#1)
affiliations##7##1##(1990-11#1)(1991-1#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-12#1)
affiliative##2##1##(1996-3#1)(2008-11#1)
affine##2##1##(2008-2#1)(2011-2#1)
affinities and##4##2##(1995-11#1)(2008-10#1)(2008-4#1)(2010-7#1)
affinities are##4##2##(1995-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
affinities at guinea-pig gallbladder##2##4##(1997-7#2)
affinities at##4##2##(1995-11#1)(1995-3#1)(1997-7#2)
affinities for the##4##3##(1990-11#1)(1990-12#1)(1993-3#1)(1995-3#1)
affinities for these##2##3##(1992-3#1)(2008-11#1)
affinities for##17##2##(1990-11#2)(1990-12#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)
affinities of the##5##3##(1990-7#1)(1990-8#1)(2008-10#1)(2009-12#1)(2011-2#1)
affinities of these compounds for##2##5##(1995-12#2)
affinities of these compounds##3##4##(1990-11#1)(1995-12#2)
affinities of these##4##3##(1990-11#1)(1993-11#1)(1995-12#2)
affinities of##20##2##(1990-11#2)(1990-7#1)(1990-8#2)(1991-8#1)(1991-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1995-12#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#2)
affinities to##5##2##(1990-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
affinities were##2##2##(1993-8#1)(1994-6#1)
affinities##80##1##(1990-11#5)(1990-12#1)(1990-7#3)(1990-8#3)(1991-11#2)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-6#3)(1996-5#2)(1997-7#3)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-7#1)
affinity (IC50 =##3##3##(1993-11#1)(1993-8#1)(2010-12#1)
affinity (Kd = 0##7##4##(1990-8#1)(1993-11#1)(1994-8#4)(1995-12#1)
affinity (Kd =##9##3##(1990-8#1)(1993-11#1)(1994-8#4)(1995-11#1)(1995-12#1)(1996-2#1)
affinity (Kd##11##2##(1990-11#2)(1990-8#1)(1993-11#1)(1994-8#4)(1995-11#1)(1995-12#1)(1996-2#1)
affinity Ca(2+)-binding##2##2##(1995-6#2)
affinity DHP binding##2##3##(1991-2#2)
affinity adsorbent##2##2##(2008-7#2)
affinity adsorbents##2##2##(1997-2#2)
affinity analysis##2##2##(2009-11#2)
affinity and a##2##3##(1990-8#1)(1991-2#1)
affinity and are##2##3##(1993-6#1)(2008-4#1)
affinity and high##2##3##(1993-1#1)(1993-8#1)
affinity and selectivity##5##3##(2008-10#1)(2008-4#2)(2008-9#1)(2012-2#1)
affinity and specificity##3##3##(1995-2#1)(2008-4#1)(2008-9#1)
affinity and the##2##3##(2010-11#1)(2011-2#1)
affinity and total binding##2##4##(1993-6#2)
affinity and##45##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#3)(1992-3#1)(1993-1#4)(1993-3#1)(1993-6#3)(1993-8#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1997-2#2)(2008-10#3)(2008-11#1)(2008-4#5)(2008-9#2)(2010-11#1)(2011-2#3)(2012-2#2)
affinity as a##2##3##(1994-2#1)(2008-3#1)
affinity at human##2##3##(2008-4#1)(2009-12#1)
affinity at##6##2##(1992-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-4#1)(2009-12#1)
affinity between the##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2009-3#1)
affinity between##10##2##(1992-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-8#1)(2009-3#1)(2012-2#1)
affinity binding of##5##3##(1991-2#1)(1994-8#1)(2008-3#3)
affinity binding sites was##2##4##(1990-5#2)
affinity binding sites##9##3##(1990-12#1)(1990-5#6)(1993-1#1)(1993-3#1)
affinity binding##22##2##(1990-12#1)(1990-5#7)(1991-2#2)(1993-1#2)(1993-3#1)(1994-8#1)(1997-4#2)(2008-3#4)(2009-12#2)
affinity by##6##2##(1990-12#1)(1990-8#1)(1993-8#2)(2009-3#1)(2012-2#1)
affinity chromatography also##2##3##(1995-6#1)(2008-10#1)
affinity chromatography and hydrophobic interaction chromatography##2##6##(1991-5#2)
affinity chromatography and##9##3##(1991-5#3)(1991-9#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-8#2)
affinity chromatography of##2##3##(1990-11#1)(1990-8#1)
affinity chromatography on a##4##4##(1990-11#1)(1992-12#1)(1997-2#1)(2008-4#1)
affinity chromatography on##11##3##(1990-11#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-4#1)(2009-9#1)
affinity chromatography was used to##2##5##(1997-7#1)(2008-9#1)
affinity chromatography with##3##3##(2008-10#2)(2008-11#1)
affinity chromatography##71##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-5#8)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#3)(1997-2#3)(1997-7#1)(2008-10#8)(2008-11#3)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#5)(2009-3#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)
affinity column and##3##3##(1991-5#1)(1992-9#1)(2011-1#1)
affinity column##11##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#2)(1992-9#1)(1993-6#1)(1995-2#1)(1997-6#1)(2008-7#1)(2011-1#1)
affinity columns##3##2##(1990-5#1)(1994-11#1)(2008-10#1)
affinity constant of##5##3##(1995-12#1)(2008-10#4)
affinity constant##13##2##(1991-5#1)(1995-12#1)(2008-10#10)(2008-11#1)
affinity constants##5##2##(1997-6#1)(2008-4#1)(2008-8#2)(2010-5#1)
affinity for ATP##2##3##(1993-6#2)
affinity for Blue Sepharose##2##4##(1990-12#1)(1997-1#1)
affinity for DNA##4##3##(1990-11#1)(1992-6#1)(1996-2#1)(2009-5#1)
affinity for S6c (Ki##2##4##(1991-11#2)
affinity for alkali##3##3##(2008-10#3)
affinity for antithrombin III##2##4##(1995-2#2)
affinity for both##2##3##(1996-5#1)(2008-4#1)
affinity for calcium##2##3##(1990-2#1)(1993-6#1)
affinity for gelatin##2##3##(1995-5#2)
affinity for heme##3##3##(1990-8#1)(1994-8#2)
affinity for heparin##2##3##(1995-2#2)
affinity for ss-DNA##2##3##(1997-2#2)
affinity for the protein##2##4##(1995-2#1)(2008-10#1)
affinity for the##36##3##(1990-11#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-8#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#3)(1997-4#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-7#1)(2010-10#1)
affinity for##138##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#2)(1992-11#3)(1992-12#2)(1992-3#2)(1992-6#3)(1992-9#1)(1993-11#1)(1993-6#3)(1993-8#7)(1994-11#4)(1994-5#2)(1994-8#4)(1995-11#6)(1995-12#4)(1995-2#10)(1995-3#4)(1995-5#2)(1995-6#4)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
affinity has##2##2##(1995-2#1)(2008-4#1)
affinity impurities##2##2##(2008-7#2)
affinity in a##2##3##(1992-3#1)(2008-10#1)
affinity in the lung##2##4##(1990-5#2)
affinity in the##5##3##(1990-5#2)(1993-3#1)(1995-12#1)(1995-3#1)
affinity in##10##2##(1990-5#3)(1992-3#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(2008-10#1)(2011-1#1)
affinity is##3##2##(1990-11#1)(1990-8#1)(1997-2#1)
affinity labeled##2##2##(1995-11#2)
affinity labeling of##2##3##(1991-9#1)(1992-8#1)
affinity labeling##5##2##(1991-12#2)(1991-9#1)(1992-8#1)(2008-6#1)
affinity labelled##2##2##(1990-11#2)
affinity ligand for##2##3##(1993-9#1)(2008-7#1)
affinity ligands for the##2##4##(1991-1#2)
affinity matrix##8##2##(1990-12#1)(1990-7#1)(1994-8#2)(2008-4#4)
affinity maturation##3##2##(2008-4#1)(2008-8#2)
affinity neurotensin receptor##3##3##(1997-2#3)
affinity neurotensin##4##2##(1997-2#4)
affinity of 0##3##3##(1991-5#1)(1992-9#1)(2008-11#1)
affinity of a##3##3##(1993-3#1)(1995-12#1)(2008-5#1)
affinity of an##2##3##(1990-8#1)(1993-8#1)
affinity of the enzyme##2##4##(1990-7#1)(1993-6#1)
affinity of the modified##2##4##(1995-2#1)(2008-5#1)
affinity of the##32##3##(1990-5#2)(1990-7#2)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#3)(1993-8#2)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#4)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2010-1#1)
affinity of these##2##3##(2008-10#1)(2008-11#1)
affinity of##89##2##(1990-2#1)(1990-5#6)(1990-7#4)(1990-8#4)(1991-12#1)(1991-2#1)(1991-5#3)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#4)(1993-8#4)(1994-5#3)(1994-6#3)(1995-11#2)(1995-12#2)(1995-2#7)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#1)(2010-1#1)(2011-2#1)
affinity purification of##4##3##(1990-8#1)(2008-4#2)(2008-7#1)
affinity purification##11##2##(1990-8#1)(1991-7#1)(1993-8#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-7#2)
affinity purifications##2##2##(1990-12#1)(2008-7#1)
affinity purified##3##2##(1990-8#1)(1993-3#1)(2010-3#1)
affinity receptors for##2##3##(1993-6#1)(1994-11#1)
affinity receptors##6##2##(1993-6#4)(1994-11#1)(1996-5#1)
affinity relative to##2##3##(1990-7#1)(1994-6#1)
affinity selection##3##2##(2008-1#2)(2008-4#1)
affinity sensing##2##2##(2008-2#2)
affinity sensors for cocaine and cholinesterase inhibitors##2##7##(2008-10#2)
affinity separation of##2##3##(2008-7#2)
affinity site (Kd =##2##4##(1996-2#2)
affinity site##4##2##(1990-5#1)(1995-11#1)(1996-2#2)
affinity sites##3##2##(1995-11#1)(1995-12#1)(1995-6#1)
affinity specific##2##2##(1990-12#1)(1997-8#1)
affinity state##2##2##(1995-6#1)(1997-7#1)
affinity support##4##2##(1993-8#3)(2010-5#1)
affinity tag##3##2##(2008-4#2)(2008-7#1)
affinity tags##2##2##(1997-3#2)
affinity than##5##2##(1992-6#1)(1995-11#1)(1995-6#2)(2008-1#1)
affinity to p75R##3##3##(1994-2#3)
affinity to the##8##3##(1990-2#1)(1990-5#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
affinity to##37##2##(1990-2#1)(1990-5#4)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-2#4)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-3#3)(2007-11#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#1)
affinity towards##3##2##(1992-6#1)(2008-10#2)
affinity values##3##2##(1990-8#2)(1996-5#1)
affinity was##10##2##(1992-10#1)(1993-3#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)
affinity with##5##2##(1992-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2009-6#1)
affinity##787##1##(1990-11#18)(1990-12#12)(1990-2#5)(1990-5#25)(1990-7#9)(1990-8#25)(1991-1#5)(1991-11#4)(1991-12#9)(1991-2#12)(1991-5#18)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#7)(1992-12#4)(1992-3#8)(1992-6#14)(1992-8#4)(1992-9#7)(1993-1#7)(1993-11#4)(1993-12#2)(1993-3#7)(1993-6#24)(1993-8#24)(1993-9#1)(1994-11#8)(1994-12#4)(1994-2#5)(1994-3#1)(1994-5#10)(1994-6#5)(1994-8#17)(1995-11#21)(1995-12#12)(1995-2#31)(1995-3#15)(1995-5#6)(1995-6#17)(1995-8#7)(1996-1#1)(1996-12#7)(1996-2#9)(1996-3#1)(1996-5#7)(1996-7#1)(1997-1#4)(1997-2#20)(1997-3#5)(1997-4#8)(1997-6#4)(1997-7#4)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#6)(2008-10#78)(2008-11#16)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#41)(2008-5#12)(2008-6#6)(2008-7#20)(2008-8#18)(2008-9#9)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#13)(2013-1#2)(2013-7#5)(2013-8#3)
affinity-based##3##1##(1995-2#1)(2008-2#2)
affinity-labeled##2##1##(1990-12#1)(1995-2#1)
affinity-purified##8##1##(1990-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-3#1)
affirm that##2##2##(1991-8#1)(2012-2#1)
affirm##7##1##(1991-12#1)(1991-8#1)(1992-2#1)(1996-3#1)(2007-11#1)(2012-2#2)
affirmation##2##1##(2008-10#2)
affirmed a lower court's##2##4##(1995-6#2)
affirmed a##3##2##(1992-12#1)(1995-6#2)
affirmed the##2##2##(1991-7#1)(1995-12#1)
affirmed##6##1##(1991-7#1)(1992-12#1)(1995-12#1)(1995-6#2)(2008-9#1)
affirms##3##1##(1992-6#1)(1993-12#1)(2007-11#1)
affixed to##4##2##(2007-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
affixed##6##1##(1994-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
afflicted with##3##2##(1994-3#1)(2007-8#1)(2012-3#1)
afflicted##8##1##(1991-6#1)(1994-3#1)(1995-12#1)(1995-3#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
afflicting##2##1##(2008-4#1)(2010-8#1)
afflicts##4##1##(1996-1#1)(2008-1#1)(2008-5#1)(2013-1#1)
affluence##3##1##(2008-1#1)(2011-1#1)(2013-1#1)
affluent##7##1##(1990-8#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-9#1)
afford a##4##2##(1991-2#1)(1995-11#1)(2008-10#1)(2012-12#1)
afford not to##2##3##(1991-2#1)(1994-2#1)
afford protection against##3##3##(1990-11#1)(1993-6#1)(1995-5#1)
afford the##4##2##(1997-6#1)(2007-11#1)(2008-11#2)
afford to##7##2##(1993-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
afford##47##1##(1990-11#2)(1991-2#2)(1992-4#2)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#2)(1995-11#2)(1995-2#2)(1995-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#6)(2007-7#1)(2008-10#2)(2008-11#5)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
affordability##4##1##(1995-1#1)(1995-3#1)(2009-3#1)(2012-2#1)
affordable and##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
affordable health##2##2##(1995-1#1)(1996-8#1)
affordable housing##2##2##(2008-11#2)
affordable to##2##2##(1991-3#1)(1995-6#1)
affordable##25##1##(1991-3#2)(1992-12#1)(1994-2#1)(1995-1#2)(1995-6#1)(1996-8#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-11#5)(2008-7#2)(2008-8#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
afforded a##4##2##(1991-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
afforded an##2##2##(1995-3#1)(1997-4#1)
afforded by the##7##3##(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-3#1)
afforded by##18##2##(1991-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-3#2)(2008-5#3)(2008-7#1)(2010-4#1)(2011-1#1)
afforded protection##2##2##(1992-9#1)(2008-10#1)
afforded the corresponding##2##3##(1996-5#2)
afforded the desired##3##3##(1995-3#1)(1996-5#1)(2009-12#1)
afforded the##11##2##(1995-3#1)(1996-2#1)(1996-5#4)(2007-11#1)(2008-11#1)(2009-10#1)(2009-12#1)(2013-1#1)
afforded##59##1##(1990-11#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#6)(1997-4#1)(1997-7#1)(2007-1#1)(2007-11#3)(2008-10#12)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#2)
affording a##3##2##(1992-8#1)(2007-11#1)(2012-3#1)
affording##13##1##(1992-12#1)(1992-8#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
affords a##2##2##(1990-2#1)(2013-1#1)
affords an##2##2##(1993-11#1)(2010-5#1)
affords the##6##2##(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
affords##27##1##(1990-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
afibrinogenemia##2##1##(1997-7#1)(2007-2#1)
afimbrial mutants##2##2##(2008-10#2)
afimbrial##4##1##(2008-10#4)
aflatoxin B(1)##2##2##(2008-10#1)(2010-5#1)
aflatoxin B1##5##2##(1992-9#1)(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)
aflatoxin M1##8##2##(2008-12#2)(2013-1#6)
aflatoxin accumulation in grain##2##4##(2008-10#2)
aflatoxin accumulation##8##2##(2008-10#8)
aflatoxin biosynthesis##2##2##(2008-10#2)
aflatoxin concentration in grain##2##4##(2008-10#2)
aflatoxin concentration##3##2##(2008-10#3)
aflatoxin contamination in the##2##4##(2008-10#2)
aflatoxin contamination in##3##3##(2008-10#3)
aflatoxin contamination of##2##3##(2008-10#2)
aflatoxin contamination##9##2##(2008-10#9)
aflatoxin content of##2##3##(2008-10#2)
aflatoxin content##6##2##(2008-10#6)
aflatoxin exposure##2##2##(1991-11#2)
aflatoxin in maize##3##3##(2008-10#3)
aflatoxin in##8##2##(1997-6#2)(2008-10#6)
aflatoxin induced liver damage##2##4##(1992-9#2)
aflatoxin production and##4##3##(2008-10#4)
aflatoxin production by##2##3##(1992-9#1)(2008-10#1)
aflatoxin production in corn (Zea##2##5##(2008-10#2)
aflatoxin production in##5##3##(2008-10#5)
aflatoxin production##19##2##(1992-9#3)(2008-10#16)
aflatoxin values##2##2##(2008-10#2)
aflatoxin when##2##2##(2008-10#2)
aflatoxin##99##1##(1991-11#3)(1992-9#6)(1997-6#4)(2008-10#64)(2008-12#12)(2010-4#1)(2010-5#2)(2012-3#1)(2013-1#6)
aflatoxin-resistant maize genotypes##2##3##(2008-10#2)
aflatoxins and##3##2##(1991-11#1)(1992-11#1)(2010-4#1)
aflatoxins##21##1##(1991-11#2)(1992-11#4)(2008-10#5)(2008-12#1)(2010-4#8)(2010-7#1)
aforementioned##26##1##(1991-12#1)(1993-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
afraid of##2##2##(2007-8#1)(2011-2#1)
afraid to##3##2##(1992-9#1)(1995-12#1)(1995-2#1)
afraid##6##1##(1992-9#1)(1995-12#1)(1995-2#1)(2007-8#1)(2011-2#1)(2012-12#1)
african american##5##2##(2009-5#1)(2010-8#3)(2011-1#1)
african americans##2##2##(2009-7#1)(2012-2#1)
african##8##1##(1991-11#1)(2009-5#1)(2009-7#1)(2010-8#3)(2011-1#1)(2012-2#1)
africana##6##1##(2008-10#5)(2012-5#1)
africanum##6##1##(2008-12#6)
after 0##2##2##(1995-3#1)(2008-12#1)
after 1 day##3##3##(2008-10#2)(2008-11#1)
after 1 h of##2##4##(1995-12#1)(1997-2#1)
after 1 h##8##3##(1995-12#1)(1996-2#2)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
after 1 min of##2##4##(2007-12#1)(2008-6#1)
after 1 month##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
after 1 to##2##3##(2008-10#1)(2012-3#1)
after 1 week in##3##4##(1992-9#1)(2008-11#1)(2008-5#1)
after 1 week of##3##4##(1992-9#1)(2008-10#1)(2011-2#1)
after 1 week##8##3##(1992-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
after 1 year of##3##4##(1997-4#1)(2009-7#1)(2013-1#1)
after 1 year##6##3##(1994-2#1)(1997-4#1)(2008-10#1)(2009-7#1)(2010-8#1)(2013-1#1)
after 1##47##2##(1990-12#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#2)(2009-7#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
after 1-2##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
after 1-3##2##2##(1993-6#1)(2008-6#1)
after 10 days##5##3##(1992-12#1)(1995-2#1)(1995-3#1)(2008-10#1)(2010-5#1)
after 10 min of##2##4##(1993-11#1)(1995-5#1)
after 10 min##6##3##(1993-11#1)(1994-11#1)(1995-5#1)(2006-6#1)(2008-10#1)(2008-5#1)
after 10 years of##2##4##(1997-5#1)(2010-3#1)
after 10##19##2##(1990-5#1)(1991-1#1)(1992-12#1)(1993-11#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-5#1)(2006-6#1)(2008-10#4)(2008-12#1)(2008-5#2)(2010-3#1)(2010-5#1)
after 100 generations##2##3##(2008-8#1)(2013-1#1)
after 100##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
after 11 weeks##2##3##(1992-8#1)(2008-10#1)
after 11##4##2##(1992-8#1)(2008-10#2)(2008-9#1)
after 12 days##2##3##(1992-3#1)(2008-11#1)
after 12 h##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
after 12 hrs##2##3##(1991-3#1)(2008-12#1)
after 12 months of##2##4##(2007-8#1)(2008-12#1)
after 12 months##7##3##(1990-9#1)(1993-1#1)(2007-8#1)(2008-1#1)(2008-12#1)(2012-12#1)(2012-2#1)
after 12 weeks of##3##4##(1992-11#1)(2007-10#1)(2008-7#1)
after 12 weeks##4##3##(1992-11#1)(2007-10#1)(2007-12#1)(2008-7#1)
after 12##25##2##(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-1#2)(1995-11#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
after 120 min##2##3##(2008-11#1)(2012-2#1)
after 125 days##2##3##(2008-10#2)
after 13##2##2##(2008-9#1)(2012-3#1)
after 14 days of##4##4##(1995-3#1)(2007-11#1)(2008-11#1)(2008-7#1)
after 14 days##7##3##(1995-3#1)(2007-11#2)(2008-11#2)(2008-7#1)(2009-7#1)
after 14 months##2##3##(1991-8#1)(2008-7#1)
after 14 nmol##2##3##(1991-9#2)
after 14##11##2##(1991-8#1)(1991-9#2)(1995-3#1)(2007-11#2)(2008-11#2)(2008-7#2)(2009-7#1)
after 144 h of##2##4##(2008-6#2)
after 15 and##2##3##(2006-12#1)(2011-2#1)
after 15 days##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
after 15 days' culture##2##4##(2008-11#2)
after 15 min of sitting##2##5##(2010-3#2)
after 15 min of##4##4##(1996-12#1)(2010-3#2)(2011-2#1)
after 15 min##8##3##(1992-8#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-3#2)(2011-2#1)
after 15 months##2##3##(1992-2#1)(2008-10#1)
after 15 years of age##2##5##(2013-1#2)
after 15##21##2##(1990-12#1)(1992-2#1)(1992-8#1)(1994-6#1)(1996-12#1)(2006-12#1)(2008-10#3)(2008-11#4)(2008-5#1)(2010-3#2)(2011-2#2)(2013-1#2)(2013-8#1)
after 15-20##2##2##(2007-8#1)(2008-5#1)
after 16##3##2##(1995-12#1)(2008-11#1)(2011-2#1)
after 168##2##2##(1994-6#1)(2008-11#1)
after 18##2##2##(2007-8#2)
after 1992##2##2##(1990-6#1)(1991-3#1)
after 1 hour of##2##3##(2011-1#2)
after 2 and 3##2##4##(1995-3#1)(2008-5#1)
after 2 and 4##2##4##(1991-6#1)(2008-10#1)
after 2 and##5##3##(1991-6#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
after 2 days##3##3##(1993-9#1)(2008-12#1)(2011-2#1)
after 2 h of##2##4##(1994-8#1)(2008-10#1)
after 2 h##4##3##(1994-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
after 2 hr##3##3##(1993-8#1)(2008-11#1)(2008-6#1)
after 2 min##4##3##(1990-7#2)(1994-11#1)(2008-6#1)
after 2 months of##4##4##(1996-12#1)(2008-12#1)(2008-7#1)(2010-10#1)
after 2 months##7##3##(1996-12#1)(2007-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-10#1)
after 2 to 3 years##2##5##(1991-8#1)(2013-1#1)
after 2 to##4##3##(1991-8#1)(2008-10#2)(2013-1#1)
after 2 weeks and##2##4##(2008-10#1)(2008-11#1)
after 2 weeks##11##3##(1991-12#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-11#2)
after 2 years of##2##4##(2011-1#1)(2013-1#1)
after 2 years##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
after 2##51##2##(1990-7#2)(1991-12#1)(1991-6#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#6)(2008-12#4)(2008-5#3)(2008-6#3)(2008-7#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
after 2-3 years##2##2##(2013-8#2)
after 20 min of##2##4##(2008-10#1)(2008-7#1)
after 20 min##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
after 20 months##2##3##(2011-2#1)(2012-12#1)
after 20 weeks##2##3##(1992-2#2)
after 20##12##2##(1990-8#1)(1992-2#2)(1995-12#1)(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
after 20%##2##2##(1994-7#1)(2008-8#1)
after 200##2##2##(2007-2#1)(2008-8#1)
after 23 days of##2##4##(2008-10#1)(2011-3#1)
after 23##3##2##(1994-7#1)(2008-10#1)(2011-3#1)
after 24 h of exposure##2##5##(2008-10#1)(2008-7#1)
after 24 h of##5##4##(1996-12#1)(2007-8#1)(2008-10#2)(2008-7#1)
after 24 h##16##3##(1990-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-6#1)(2008-7#1)(2013-1#1)
after 24 hours##3##3##(1993-6#1)(2008-5#1)(2011-1#1)
after 24 hrs##2##3##(2008-12#1)(2010-11#1)
after 24 months of##2##4##(1990-3#1)(1991-12#1)
after 24 months##5##3##(1990-3#1)(1991-12#1)(1994-6#1)(2008-4#1)(2012-12#1)
after 24 weeks of##3##4##(2007-8#1)(2008-8#1)(2009-8#1)
after 24 weeks##5##3##(2007-8#1)(2008-10#1)(2008-8#1)(2009-8#2)
after 24##35##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
after 24h##2##2##(2008-10#1)(2012-3#1)
after 25##3##2##(1993-2#1)(2007-12#1)(2008-11#1)
after 26 weeks##2##3##(1992-2#1)(2008-7#1)
after 27##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
after 28##3##2##(1990-6#1)(2008-10#1)(2008-7#1)
after 3 and##3##3##(2008-10#3)
after 3 days of##2##4##(1997-4#1)(2008-10#1)
after 3 days##6##3##(1994-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-3#1)
after 3 h##2##3##(1995-3#1)(2008-10#1)
after 3 months##7##3##(1994-6#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
after 3 to##2##3##(1991-3#1)(2008-10#1)
after 3 weeks of##3##4##(1995-11#1)(1996-5#1)(2008-5#1)
after 3 weeks##4##3##(1995-11#1)(1996-5#1)(2008-10#1)(2008-5#1)
after 3 years of no tillage##2##6##(2008-10#2)
after 3 years of##3##4##(2008-10#2)(2008-9#1)
after 3##34##2##(1991-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-10#12)(2008-12#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
after 30 days##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
after 30 min of##4##4##(2007-8#1)(2008-10#2)(2008-7#1)
after 30 min##11##3##(1990-12#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-7#3)
after 30 minutes##2##3##(1990-12#1)(2007-10#1)
after 30##23##2##(1990-12#2)(1991-5#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2012-3#1)(2013-1#1)
after 30min##3##2##(2007-12#1)(2008-10#2)
after 35##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
after 3h of##2##3##(2008-10#2)
after 3h##3##2##(2008-10#3)
after 3 weeks of storage##2##4##(2013-1#2)
after 4 days##3##3##(1990-2#1)(1995-2#1)(2007-8#1)
after 4 h of##3##4##(1995-12#1)(1997-4#1)(2008-10#1)
after 4 h##6##3##(1992-6#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
after 4 weeks of therapy##2##5##(2007-7#1)(2008-7#1)
after 4 weeks of##5##4##(2007-7#1)(2008-5#1)(2008-7#2)(2013-1#1)
after 4 weeks##9##3##(1992-2#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#2)(2013-1#2)
after 4 years of##4##4##(1993-8#1)(1994-12#1)(2008-10#1)(2012-3#1)
after 4 years##5##3##(1993-8#1)(1994-12#1)(2007-7#1)(2008-10#1)(2012-3#1)
after 4##30##2##(1990-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2012-3#1)(2013-1#2)
after 4-6##2##2##(1995-9#1)(2007-7#1)
after 40 min##3##3##(1993-6#1)(1995-12#1)(2008-10#1)
after 40##5##2##(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#1)
after 43##2##2##(2008-6#1)(2012-12#1)
after 45##2##2##(2007-8#1)(2008-11#1)
after 48 h of##5##4##(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
after 48 h##14##3##(1995-3#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
after 48##19##2##(1991-3#1)(1995-3#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
after 5 days of##4##4##(1995-3#1)(2008-10#1)(2008-12#1)(2011-1#1)
after 5 days##9##3##(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2010-12#1)(2010-5#1)(2011-1#1)
after 5 months of##2##4##(1994-8#1)(2008-10#1)
after 5 years##3##3##(1994-12#1)(2007-7#1)(2009-8#1)
after 5##22##2##(1990-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)
after 50##2##2##(2008-10#1)(2013-8#1)
after 5min##2##2##(2008-10#1)(2012-1#1)
after 6 days##2##3##(1995-8#1)(2012-2#1)
after 6 h of##2##4##(2008-10#1)(2008-5#1)
after 6 h##5##3##(1993-8#1)(2008-10#1)(2008-5#2)(2008-7#1)
after 6 hours##2##3##(1994-11#1)(2011-2#1)
after 6 hr##3##3##(2008-6#3)
after 6 min##2##3##(1994-11#1)(1994-6#1)
after 6 months in##2##4##(1990-6#1)(2011-2#1)
after 6 months of life##2##5##(2008-10#2)
after 6 months of treatment##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
after 6 months of##7##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-8#1)
after 6 months##18##3##(1990-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
after 6 weeks##4##3##(2007-8#1)(2008-3#1)(2013-1#2)
after 6##47##2##(1990-2#1)(1990-6#2)(1991-3#1)(1992-11#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
after 60 min##8##3##(1995-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-7#3)(2010-5#1)
after 60 s##2##3##(2008-10#2)
after 60##10##2##(1995-12#1)(1995-2#1)(1997-8#1)(2008-10#3)(2008-7#3)(2010-5#1)
after 7 and 14 days of administration of 1000 mg/kg per day##2##12##(1995-3#2)
after 7 days of##2##4##(1995-3#1)(2010-11#1)
after 7 days##8##3##(1990-2#1)(1995-3#2)(1995-8#1)(2007-8#1)(2008-11#1)(2009-8#1)(2010-11#1)
after 7##14##2##(1990-2#1)(1995-3#4)(1995-8#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-11#1)
after 70##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
after 72 h and##2##4##(1992-8#1)(2008-10#1)
after 72 h of##4##4##(1995-8#1)(2008-11#2)(2011-2#1)
after 72 h##7##3##(1992-8#1)(1995-8#1)(2008-10#2)(2008-11#2)(2011-2#1)
after 72 hours##3##3##(2008-2#1)(2008-5#1)(2013-1#1)
after 72##11##2##(1992-8#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#2)
after 8 and##2##3##(2007-11#1)(2008-10#1)
after 8 h of##2##4##(2008-10#1)(2008-11#1)
after 8 h##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
after 8 months##3##3##(1990-6#1)(2008-10#1)(2010-3#1)
after 8 weeks of##4##4##(1992-6#1)(2013-1#3)
after 8 weeks##5##3##(1992-6#1)(2012-3#1)(2013-1#3)
after 8##16##2##(1990-6#1)(1992-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)(2012-3#1)(2013-1#3)
after 9 days##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
after 9 months of##2##4##(2007-11#1)(2008-10#1)
after 9 months##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
after 9##9##2##(1991-9#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-2#1)
after 90 days##2##3##(1990-5#1)(1997-4#1)
after 90 min##2##3##(1992-6#1)(2008-10#1)
after 90##6##2##(1990-5#1)(1992-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
after 96 h of##2##4##(1992-8#1)(2008-6#1)
after 96 h##3##3##(1992-8#1)(2008-6#1)(2008-7#1)
after 96##5##2##(1992-8#1)(1994-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
after AAPs of##2##3##(2008-10#2)
after AMI##5##2##(1990-12#2)(1992-3#1)(2006-8#2)
after Alzheimer's##2##2##(1992-2#1)(2008-6#1)
after AuTM injection##5##3##(1994-5#4)(1995-3#1)
after AuTM##7##2##(1994-5#4)(1995-3#3)
after B##3##2##(2008-10#3)
after BMT##4##2##(2008-1#4)
after BRTO##3##2##(2013-1#3)
after CABG##2##2##(2007-8#1)(2008-4#1)
after CPB##4##2##(2007-8#4)
after CSD##2##2##(2007-10#2)
after DEX exposure##3##3##(1995-12#3)
after DEX##4##2##(1995-12#4)
after DNA##3##2##(1995-2#1)(2008-11#1)(2008-12#1)
after FBP##2##2##(1992-3#2)
after GH##2##2##(1995-12#1)(2008-4#1)
after GnRH-a therapy##2##3##(1996-2#2)
after GnRH-a##3##2##(1996-2#3)
after HL##3##2##(1991-2#3)
after HPLC##3##2##(1990-5#1)(1992-12#1)(1993-12#1)
after HT##2##2##(1996-3#1)(2008-8#1)
after Hurricane Katrina##2##3##(2011-2#1)(2012-2#1)
after IA (P = 0##3##5##(2011-2#3)
after IAN block for amalgam restoration##2##6##(2012-12#2)
after IFN-gamma stimulation##2##3##(1992-12#2)
after IL-2 injection##2##3##(1991-6#2)
after IL-2##3##2##(1991-6#3)
after IV##2##2##(1997-8#1)(2011-2#1)
after January 2008##2##3##(2012-12#2)
after July##3##2##(2008-10#1)(2012-2#2)
after KB##4##2##(1991-10#2)(1991-12#2)
after LPS injection##2##3##(1997-2#1)(2008-10#1)
after LPS##6##2##(1993-3#2)(1993-6#1)(1997-2#1)(2008-10#1)(2008-12#1)
after LTP induction##2##3##(1997-2#1)(2008-7#1)
after Li+##2##2##(1996-12#2)
after MCAO##4##2##(1997-2#1)(2007-10#2)(2011-2#1)
after MCT administration##2##3##(1994-5#2)
after NGF administration##2##3##(1993-12#2)
after NGF##4##2##(1993-12#2)(1996-12#1)(1996-2#1)
after OPCAB##2##2##(2007-8#2)
after PCI##3##2##(2011-2#1)(2013-1#2)
after PTA##2##2##(2008-7#2)
after PTCA##4##2##(1992-4#2)(1992-9#2)
after PTCCSL##2##2##(2008-5#2)
after RT##2##2##(2010-3#2)
after SAH##3##2##(2007-10#2)(2012-3#1)
after SDS-PAGE##2##2##(1993-8#1)(1996-2#1)
after STZ induction##2##3##(2012-3#1)(2013-1#1)
after Surgery##2##2##(1994-12#1)(2013-8#1)
after TBI##3##2##(1993-12#1)(2010-4#1)(2012-2#1)
after TCDD##3##2##(1992-12#1)(2008-10#2)
after TKA##3##2##(2008-8#1)(2013-1#2)
after TKR##3##2##(2008-8#2)(2012-2#1)
after TPA##2##2##(1990-2#1)(2008-8#1)
after UV irradiation##2##3##(2008-10#1)(2008-3#1)
after UV##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
after VP/FK treatment##2##3##(2012-12#2)
after World War II##2##4##(1996-1#1)(2013-1#1)
after a 1-h treatment##2##4##(1997-4#2)
after a 2##2##3##(1991-12#1)(1993-9#1)
after a 24-h post-treatment incubation##2##5##(1997-4#2)
after a 24-h##4##3##(1992-5#1)(1997-4#2)(2008-11#1)
after a 3-day##2##3##(2008-10#1)(2011-2#1)
after a brief##2##3##(1992-12#1)(2008-11#1)
after a chronic##2##3##(2008-11#1)(2013-1#1)
after a coronary artery bypass grafting##2##6##(2012-3#2)
after a cycle of##2##4##(2007-12#1)(2008-7#1)
after a failed##2##3##(2010-5#1)(2012-12#1)
after a fall##3##3##(2006-10#1)(2008-7#1)(2008-9#1)
after a few##6##3##(1995-2#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)
after a fixed time##2##4##(2008-10#2)
after a fixed##3##3##(1994-9#1)(2008-10#2)
after a follow-up##2##3##(1990-6#1)(2008-7#1)
after a founder event##4##4##(2008-9#4)
after a free##2##3##(2010-6#1)(2012-12#1)
after a gap##2##3##(2007-9#1)(2013-8#1)
after a healthy subject has taken tablets##2##7##(2008-10#2)
after a knee##2##3##(2013-1#2)
after a local##2##3##(1995-3#1)(1997-7#1)
after a long##6##3##(1991-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(2008-11#1)(2009-4#1)
after a longer##3##3##(1990-9#1)(1994-3#1)(2011-2#1)
after a mean duration of##2##5##(2008-7#2)
after a mean of##2##4##(1990-6#1)(2007-7#1)
after a mean##6##3##(1990-6#1)(2007-7#2)(2007-8#1)(2008-7#2)
after a median##2##3##(1990-6#1)(2010-12#1)
after a negative##2##3##(2010-5#1)(2011-2#1)
after a new chemotherapy combination##2##5##(1992-2#2)
after a partial hepatectomy##2##4##(1990-12#2)
after a period of##5##4##(1991-11#1)(1991-9#1)(1992-9#1)(2008-10#1)(2012-2#1)
after a pre-reduction##2##3##(2008-10#2)
after a previous##3##3##(2008-10#2)(2008-6#1)
after a proper##2##3##(2008-10#2)
after a reaction##2##3##(1995-5#1)(2008-10#1)
after a series of##2##4##(2007-8#1)(2008-6#1)
after a short description of the##2##6##(1990-5#1)(2008-10#1)
after a short period of##3##5##(1997-2#1)(2013-1#2)
after a short##9##3##(1990-5#1)(1991-3#1)(1997-2#1)(1997-5#1)(2008-10#2)(2010-3#1)(2013-1#2)
after a similar##2##3##(1995-5#1)(1996-5#1)
after a simple##4##3##(2008-10#2)(2010-2#1)(2013-1#1)
after a single administration##2##4##(1995-3#2)
after a single##21##3##(1990-11#1)(1994-5#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-1#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
after a specified##2##3##(1994-2#1)(2008-10#1)
after a spinal##3##3##(2009-12#2)(2013-1#1)
after a standard kindling stimulus##2##5##(1992-12#2)
after a standard##3##3##(1990-7#1)(1992-12#2)
after a stroke##4##3##(1995-5#1)(2007-10#1)(2008-7#1)(2009-11#1)
after a subcutaneous##3##3##(1995-12#1)(2008-8#1)(2012-2#1)
after a traffic accident##2##4##(1995-3#1)(2009-3#1)
after a traumatic##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
after a very##2##3##(2007-11#1)(2009-4#1)
after a##314##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#5)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#7)(1997-5#4)(1997-6#1)(1997-7#2)(2006-10#2)(2007-10#4)(2007-11#6)(2007-12#5)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#18)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#12)(2012-12#4)(2012-2#4)(2012-3#8)(2012-8#1)(2013-1#17)(2013-8#1)
after abdominal##3##2##(1990-6#1)(2008-10#1)(2013-1#1)
after ablation##2##2##(1994-8#1)(2008-3#1)
after about 2 min##2##4##(1990-7#2)
after about 2##3##3##(1990-7#2)(2008-11#1)
after about##6##2##(1990-7#2)(1995-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
after abstinence##2##2##(2008-4#1)(2011-2#1)
after abuse##3##2##(2010-3#3)
after accounting for##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
after acetylation##2##2##(2008-10#1)(2008-4#1)
after acid digestion##3##3##(2008-10#3)
after acid##6##2##(2008-10#5)(2008-12#1)
after acquisition##2##2##(1992-8#1)(2008-10#1)
after activation of a##2##4##(1993-12#1)(2008-10#1)
after activation of the##2##4##(1992-5#1)(1994-2#1)
after activation of##5##3##(1992-5#1)(1993-12#1)(1994-2#1)(2006-6#1)(2008-10#1)
after activation##10##2##(1992-5#1)(1993-12#1)(1994-2#1)(2006-6#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-10#1)
after acupuncture##3##2##(2006-10#2)(2008-10#1)
after acute and chronic##2##4##(1992-3#1)(2008-10#1)
after acute coronary syndrome##2##4##(2009-10#1)(2010-4#1)
after acute coronary##3##3##(2009-10#1)(2010-4#1)(2011-2#1)
after acute ischemic stroke##2##4##(2007-10#2)
after acute myocardial infarction in##4##5##(1997-8#3)(2006-8#1)
after acute myocardial infarction##9##4##(1990-9#1)(1995-8#1)(1997-8#3)(2006-8#2)(2008-5#1)(2011-2#1)
after acute##22##2##(1990-9#1)(1992-3#1)(1993-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-8#3)(2006-8#2)(2007-10#3)(2008-10#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-2#3)(2013-8#1)
after adaptation##2##2##(2008-10#1)(2008-5#1)
after adding##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
after addition of the##2##4##(1990-7#1)(1991-5#1)
after addition of##17##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-3#1)(2008-10#3)(2008-5#2)(2011-2#1)(2013-1#1)
after addition##18##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)
after adjusting for age##4##4##(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)
after adjusting for other##3##4##(1992-12#1)(1995-12#1)(2012-5#1)
after adjusting for##19##3##(1992-12#1)(1993-12#2)(1994-2#1)(1995-12#1)(2008-11#1)(2008-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-5#2)(2013-1#2)
after adjustment for##7##3##(1991-12#1)(1991-8#1)(1992-2#1)(2008-11#1)(2010-3#1)(2010-8#1)(2012-2#1)
after adjustment##10##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#1)(2008-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
after administration of DKT##2##4##(2011-2#2)
after administration of a##3##4##(2008-10#1)(2008-5#1)(2010-9#1)
after administration of bronchodilator##2##4##(2011-2#2)
after administration of##23##3##(1990-5#1)(1992-5#1)(1993-12#1)(1995-3#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#4)(2012-3#1)
after administration was##2##3##(2008-10#1)(2012-2#1)
after administration##35##2##(1990-5#1)(1990-7#1)(1992-5#1)(1993-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)
after admission##13##2##(1995-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-6#1)(2009-3#2)(2011-2#2)(2013-1#3)(2013-8#1)
after adsorption of##4##3##(2008-10#3)(2008-6#1)
after adsorption##7##2##(1992-6#1)(2008-10#4)(2008-6#1)(2013-8#1)
after adsorptive preconcentration##2##3##(2008-10#2)
after adult eclosion##2##3##(2007-12#1)(2008-10#1)
after adult emergence##2##3##(2007-12#1)(2008-10#1)
after adult##4##2##(2007-12#2)(2008-10#2)
after aerobic##2##2##(2008-7#2)
after aerosol##2##2##(1997-1#2)
after age##3##2##(1991-6#1)(1996-7#1)(2008-1#1)
after agitation##2##2##(2008-5#2)
after all##7##2##(1991-12#1)(1993-2#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
after allergen challenge##2##3##(1994-11#2)
after allogeneic hematopoietic stem cell##2##5##(2011-2#1)(2012-2#1)
after allogeneic stem cell transplantation##2##5##(2008-7#1)(2011-2#1)
after allogeneic##7##2##(2006-10#1)(2008-1#1)(2008-7#1)(2011-2#3)(2012-2#1)
after amplification##2##2##(2008-10#1)(2008-2#1)
after an AMI##3##3##(2009-6#3)
after an acute myocardial##2##4##(1991-3#1)(2008-10#1)
after an acute##6##3##(1991-3#1)(1995-12#1)(2007-10#1)(2008-10#1)(2010-6#1)(2013-1#1)
after an average of##2##4##(1992-4#1)(1994-3#1)
after an average##3##3##(1992-4#1)(1994-3#1)(2009-3#1)
after an episode of acute##2##5##(2007-8#1)(2013-1#1)
after an episode of##7##4##(2007-8#1)(2008-4#1)(2012-3#1)(2013-1#3)(2013-7#1)
after an initial##8##3##(1992-2#2)(1995-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
after an intense##2##3##(2011-2#1)(2013-1#1)
after an intravenous##2##3##(1992-5#1)(2008-10#1)
after an ischemic stroke##3##4##(2009-11#2)(2013-1#1)
after an ischemic##4##3##(1993-3#1)(2009-11#2)(2013-1#1)
after an operation##3##3##(2007-8#1)(2008-10#1)(2010-8#1)
after an oral##2##3##(2012-3#2)
after an overnight##2##3##(2008-10#2)
after an##80##2##(1990-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-3#1)(2009-6#3)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#1)
after analysing##2##2##(2008-10#2)
after analysis of##2##3##(2006-8#1)(2007-8#1)
after analysis##3##2##(2006-8#1)(2007-8#1)(2008-10#1)
after angioplasty##6##2##(1997-8#2)(2008-1#2)(2008-4#2)
after ankle arthroscopy##2##3##(2010-7#2)
after annealing##4##2##(2007-11#1)(2013-8#3)
after another##2##2##(2008-10#2)
after anoxia##2##2##(1997-2#1)(2008-1#1)
after anterior cruciate ligament reconstruction##2##5##(2008-11#2)
after anthesis##10##2##(2008-10#5)(2008-11#2)(2008-12#2)(2008-9#1)
after antigen encounter##2##3##(2013-1#2)
after antigen##3##2##(2008-11#1)(2013-1#2)
after antitubercular##2##2##(2008-7#1)(2012-12#1)
after any##2##2##(1992-5#1)(2011-1#1)
after aortic##2##2##(1996-9#1)(2008-12#1)
after appendectomy##2##2##(1991-8#1)(2008-10#1)
after application of a##5##4##(2007-11#1)(2008-10#2)(2008-5#2)
after application of the##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
after application of##15##3##(1995-11#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#4)(2013-1#1)
after application##27##2##(1995-11#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-5#7)(2012-12#1)(2013-1#1)
after applying different digestion##2##4##(2008-10#2)
after applying the##3##3##(2008-10#3)
after applying##8##2##(1990-7#1)(2008-10#6)(2008-5#1)
after appropriate##5##2##(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
after approximately 3##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
after approximately##6##2##(1997-5#1)(2007-12#1)(2008-10#3)(2008-7#1)
after around 10##2##3##(2008-10#1)(2010-1#1)
after arthroplasty##2##2##(2007-11#2)
after arthroscopic##3##2##(2007-8#2)(2013-1#1)
after artificial##2##2##(2008-10#2)
after ascospore##2##2##(2008-10#2)
after assisted##2##2##(1991-3#1)(1996-9#1)
after at least 6 months of##2##6##(1991-8#1)(2010-5#1)
after at least##5##3##(1991-8#1)(1993-2#1)(1995-2#1)(2008-5#1)(2010-5#1)
after attachment##2##2##(2008-11#2)
after attaining maturity##2##3##(2009-9#1)(2012-2#1)
after average##2##2##(1994-1#1)(2007-11#1)
after bacterial challenge##2##3##(2010-5#2)
after bacterial##4##2##(2008-10#2)(2010-5#2)
after balloon##4##2##(1992-9#1)(1997-8#1)(2008-12#1)(2011-2#1)
after becoming##2##2##(1992-8#1)(2008-10#1)
after bee sting acupuncture##3##4##(2012-3#3)
after beginning##2##2##(1991-8#1)(2010-11#1)
after behavioral##2##2##(2008-3#1)(2008-7#1)
after being bitten by##2##4##(2010-1#1)(2012-12#1)
after being exposed to##2##4##(2008-10#1)(2008-9#1)
after being treated##3##3##(1996-6#1)(2006-10#1)(2007-5#1)
after being##35##2##(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#2)
after bilateral##7##2##(1990-5#2)(1991-5#1)(1996-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
after binding##2##2##(1991-12#1)(2009-2#1)
after biopsy or##2##3##(1991-3#1)(2011-2#1)
after biopsy##4##2##(1991-3#1)(2007-11#1)(2010-3#1)(2011-2#1)
after birth and##3##3##(1995-8#1)(2008-11#1)(2012-3#1)
after birth the##2##3##(1990-5#1)(1991-11#1)
after birth until##2##3##(1994-7#1)(2011-2#1)
after birth##53##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-7#1)(1995-12#4)(1995-2#1)(1995-8#2)(1996-3#1)(1996-5#3)(1997-2#1)(1997-6#6)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#4)(2012-3#3)
after birth) and##2##3##(1994-8#1)(1995-12#1)
after birth)##6##2##(1992-2#1)(1993-6#1)(1994-8#1)(1995-12#2)(1997-2#1)
after bleaching##2##2##(2008-5#2)
after blocking##3##2##(1995-2#1)(2007-10#1)(2008-5#1)
after bloom##5##2##(2008-10#5)
after blunt abdominal trauma##2##4##(1990-2#1)(2008-10#1)
after blunt##5##2##(1990-2#1)(1990-9#2)(2008-10#1)(2008-7#1)
after bone marrow transplantation##4##4##(1991-2#1)(1993-2#1)(1997-7#2)
after bone marrow##5##3##(1991-2#1)(1993-2#1)(1997-7#2)(2013-8#1)
after both##5##2##(1995-12#1)(2007-8#1)(2008-8#1)(2010-5#1)(2013-1#1)
after brachial plexus injuries##3##4##(2008-9#3)
after breast cancer##4##3##(1996-11#1)(2008-4#2)(2011-1#1)
after breast##7##2##(1994-12#1)(1995-8#1)(1996-11#1)(2008-4#2)(2009-1#1)(2011-1#1)
after brief##4##2##(1993-12#1)(1995-2#1)(2012-3#2)
after budbreak##3##2##(2008-10#3)
after burial##2##2##(2008-10#2)
after burn injury##2##3##(2008-8#1)(2012-3#1)
after calcium##2##2##(1991-11#1)(1996-11#1)
after cancer therapy##2##3##(2008-7#1)(2009-10#1)
after cancer##6##2##(2008-7#3)(2008-8#1)(2009-10#2)
after capsaicin##2##2##(1992-6#1)(2008-11#1)
after cardiac arrest##2##3##(1990-9#2)
after cardiac surgery in##2##4##(2012-2#2)
after cardiac surgery##8##3##(2007-8#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
after cardiac##16##2##(1990-9#2)(1994-3#1)(2006-10#1)(2007-8#2)(2008-5#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
after cardiopulmonary bypass##7##3##(1990-3#1)(2006-10#2)(2007-8#1)(2007-9#2)(2011-2#1)
after cardiopulmonary##8##2##(1990-3#1)(1995-11#1)(2006-10#2)(2007-8#1)(2007-9#2)(2011-2#1)
after careful##5##2##(1990-3#1)(1995-12#1)(1996-5#1)(2013-1#1)(2013-8#1)
after castration##4##2##(1991-5#1)(1993-8#1)(1995-2#1)(1996-5#1)
after catheter##2##2##(1990-11#1)(2012-12#1)
after cation-exchange##2##2##(2008-10#2)
after cauliflower##3##2##(2008-10#3)
after cell division in the nuclei of##2##7##(1990-11#2)
after cell##7##2##(1990-11#2)(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
after cells were##2##3##(1991-12#1)(1991-9#1)
after cellular exposure to##2##4##(1990-11#1)(1994-11#1)
after centrifugation##3##2##(2008-10#2)(2008-5#1)
after cesarean##2##2##(1995-12#1)(2012-12#1)
after cessation of##4##3##(1991-8#1)(1992-4#1)(2007-11#1)(2008-5#1)
after challenge##2##2##(1997-3#1)(2009-6#1)
after changing##3##2##(1990-2#1)(2011-1#1)(2013-1#1)
after chemical##3##2##(1992-3#1)(2008-3#2)
after chemotherapy and##3##3##(1992-7#1)(2008-10#1)(2009-4#1)
after chemotherapy##15##2##(1991-4#1)(1992-7#1)(1993-11#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-7#3)(2009-4#2)
after childbirth##2##2##(2010-6#1)(2011-2#1)
after cholecystectomy##3##2##(1990-9#1)(2013-8#2)
after chronic##8##2##(1991-1#1)(1994-6#1)(1997-2#2)(2008-7#4)
after cleaning##2##2##(1997-2#1)(2013-8#1)
after clinical##4##2##(1990-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
after cloning##4##2##(1994-3#1)(2008-10#2)(2008-9#1)
after clopidogrel treatment is##2##4##(2008-4#2)
after clopidogrel##3##2##(2008-11#1)(2008-4#2)
after closed reduction##2##3##(2011-2#2)
after closed##5##2##(1992-4#1)(2007-8#1)(2011-2#2)(2012-3#1)
after closure of##4##3##(1996-6#1)(2007-8#3)
after cloud point extraction##4##4##(2008-10#4)
after coating##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
after cochlear implantation in##2##4##(2008-9#2)
after cochlear implantation##10##3##(2008-9#8)(2012-2#2)
after cochlear##11##2##(2008-9#9)(2012-2#2)
after cold##2##2##(2013-8#2)
after colectomy##2##2##(2009-5#1)(2012-1#1)
after collection of##2##3##(1990-12#1)(2008-10#1)
after collection##5##2##(1990-12#1)(2008-10#3)(2011-1#1)
after combination##2##2##(1997-5#1)(2008-5#1)
after combined training##2##3##(2013-8#2)
after combined treatment##2##3##(2010-12#1)(2013-1#1)
after combined##6##2##(2007-8#2)(2010-12#1)(2013-1#1)(2013-8#2)
after comparison##2##2##(1991-12#1)(2008-10#1)
after complete##3##2##(1990-8#1)(1992-3#1)(2008-10#1)
after completely##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
after completing the##2##3##(1990-11#1)(2007-11#1)
after completing##4##2##(1990-11#1)(2007-11#1)(2007-8#1)(2010-8#1)
after completion of chemotherapy##2##4##(1991-6#1)(2008-6#1)
after completion of the##2##4##(2007-11#1)(2008-10#1)
after completion of##12##3##(1990-7#1)(1991-6#2)(1992-6#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
after complexation##4##2##(2008-10#4)
after compression of##2##3##(2007-12#1)(2010-4#1)
after compression##3##2##(2007-12#1)(2010-4#2)
after conclusion of the##2##4##(1997-3#1)(2013-1#1)
after conditioning##4##2##(1994-8#1)(2007-4#1)(2008-7#1)(2010-2#1)
after conjugation##2##2##(1995-11#1)(1997-1#1)
after conservative treatment##2##3##(2007-8#2)
after conservative##3##2##(1993-8#1)(2007-8#2)
after considerable##3##2##(1991-2#1)(2007-10#1)(2008-11#1)
after consumption of a##2##4##(1991-8#1)(1996-2#1)
after consumption of the##2##4##(2008-3#1)(2013-1#1)
after consumption of##4##3##(1991-8#1)(1996-2#1)(2008-3#1)(2013-1#1)
after contact with##4##3##(2008-10#2)(2009-6#1)(2012-12#1)
after contact##6##2##(2008-10#4)(2009-6#1)(2012-12#1)
after continuous##2##2##(1990-8#1)(2013-8#1)
after contrast material administration##2##4##(2008-7#1)(2011-2#1)
after contrast##3##2##(1997-8#1)(2008-7#1)(2011-2#1)
after controlled##2##2##(2008-12#1)(2012-3#1)
after controlling for demographic##3##4##(2012-3#1)(2013-1#2)
after controlling for social##2##4##(1992-8#1)(2013-1#1)
after controlling for##19##3##(1992-8#1)(1994-2#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
after controlling##21##2##(1992-8#1)(1994-2#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
after conversion of##3##3##(1997-4#2)(2008-10#1)
after conversion to##2##3##(2008-10#2)
after conversion##7##2##(1997-4#2)(2008-10#4)(2012-12#1)
after corneal##2##2##(2013-1#2)
after coronary angioplasty##3##3##(1992-4#1)(1992-9#1)(1996-8#1)
after coronary artery bypass grafting##3##5##(2007-8#2)(2007-9#1)
after coronary artery bypass##4##4##(2007-8#3)(2007-9#1)
after coronary artery##5##3##(2007-8#3)(2007-9#1)(2012-12#1)
after coronary##14##2##(1992-4#1)(1992-5#1)(1992-9#1)(1996-8#2)(1997-3#1)(2007-8#3)(2007-9#1)(2008-8#1)(2011-2#2)(2012-12#1)
after correction for the##3##4##(1990-8#1)(2007-6#1)(2008-3#1)
after correction for##5##3##(1990-8#1)(2007-6#1)(2008-3#1)(2011-2#2)
after correction##7##2##(1990-8#1)(2007-6#1)(2008-10#2)(2008-3#1)(2011-2#2)
after cortical##2##2##(1991-5#1)(2007-10#1)
after cranial surgery##2##3##(2011-2#1)(2012-3#1)
after creation##2##2##(2007-7#1)(2007-8#1)
after cultivation##3##2##(1990-5#1)(1995-12#1)(2008-12#1)
after culture for##2##3##(2008-10#1)(2008-9#1)
after culture##5##2##(1992-2#1)(2008-10#2)(2008-12#1)(2008-9#1)
after culturing##2##2##(1993-8#1)(2013-1#1)
after curative surgery##2##3##(1991-6#1)(1996-11#1)
after cutting##2##2##(1997-3#1)(2012-1#1)
after damage##2##2##(2007-8#1)(2008-8#1)
after day 18##2##3##(1993-6#1)(2008-9#1)
after day 25)##2##3##(2008-10#2)
after day##6##2##(1993-6#1)(2008-10#3)(2008-7#1)(2008-9#1)
after death##2##2##(2008-12#1)(2012-3#1)
after deep##2##2##(2012-12#1)(2013-1#1)
after delivery to the##2##4##(2008-10#1)(2008-9#1)
after delivery##14##2##(1990-6#1)(1991-6#1)(1992-4#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
after demyelination##2##2##(2008-7#2)
after denaturing##2##2##(2008-3#1)(2010-11#1)
after denervation##2##2##(2008-5#1)(2008-9#1)
after dental##2##2##(2007-12#1)(2012-12#1)
after depletion of protein kinase C##2##6##(1990-12#2)
after depletion of##3##3##(1990-12#2)(2009-11#1)
after deployment##2##2##(1994-11#1)(2008-11#1)
after deposition on##2##3##(2008-10#1)(2012-2#1)
after derivatization with##3##3##(1990-8#1)(1996-5#1)(2008-11#1)
after derivatization##6##2##(1990-8#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)
after desorption with##2##3##(2008-10#2)
after diagnosis and##2##3##(1991-6#1)(1997-3#1)
after diagnosis of##4##3##(1992-10#1)(1995-2#1)(1997-3#1)(2012-3#1)
after diagnosis##18##2##(1991-6#1)(1992-10#1)(1995-2#1)(1997-3#3)(1997-7#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
after diagnostic##3##2##(2008-10#1)(2008-9#2)
after dialysis##2##2##(2007-7#1)(2011-2#1)
after diazepam injection##2##3##(2013-1#2)
after dietary##2##2##(1991-5#1)(2008-1#1)
after different##7##2##(1992-2#1)(1994-5#1)(2008-10#3)(2008-11#1)(2012-3#1)
after differentiation##2##2##(1992-12#1)(2009-10#1)
after digestion with##4##3##(1992-8#1)(2008-10#3)
after digestion##11##2##(1992-8#1)(1993-11#1)(2008-10#8)(2008-11#1)
after dilation##2##2##(1993-6#2)
after dilution of the##2##4##(2008-10#2)
after dilution of##3##3##(2008-10#3)
after direct irradiation with ultraviolet light##2##6##(2008-10#2)
after direct##5##2##(1991-7#1)(2008-10#2)(2008-8#2)
after discectomy##2##2##(2007-11#2)
after discharge from the##2##4##(2010-10#1)(2012-12#1)
after discharge##18##2##(1992-1#1)(1994-3#1)(1995-11#1)(1996-3#1)(2007-1#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
after discontinuation of antiplatelet therapy##2##5##(2011-2#2)
after discontinuation of the drug##2##5##(1992-2#1)(2011-2#1)
after discontinuation of the##4##4##(1992-2#1)(1996-3#1)(2008-7#1)(2011-2#1)
after discontinuation of##8##3##(1992-2#1)(1996-3#1)(2008-7#1)(2008-8#1)(2011-2#4)
after discontinuing levamisole##2##3##(2008-1#2)
after discontinuing the##2##3##(2008-1#2)
after discontinuing##6##2##(2007-12#1)(2008-1#4)(2013-8#1)
after discovery of##2##3##(2012-2#2)
after dissection of##2##3##(2008-12#1)(2008-9#1)
after dissolution##5##2##(2008-10#5)
after donor nephrectomy##2##3##(2007-7#1)(2011-2#1)
after doses of 0##2##4##(2010-11#1)(2013-8#1)
after doses of##3##3##(2008-2#1)(2010-11#1)(2013-8#1)
after doses##4##2##(2008-2#1)(2010-11#1)(2013-8#2)
after dosing##4##2##(1996-1#1)(2008-9#1)(2012-12#2)
after drinking##3##2##(2007-12#1)(2008-12#2)
after drug administration##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
after drug exposure##3##3##(1996-12#1)(1997-4#1)(2013-1#1)
after drug injection##2##3##(1994-2#1)(2013-8#1)
after drug intake##2##3##(2008-7#2)
after drug##14##2##(1994-2#2)(1995-12#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
after dry##3##2##(1990-8#1)(1997-2#1)(2008-5#1)
after drying##2##2##(2008-10#1)(2008-6#1)
after each##25##2##(1992-3#1)(1993-6#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2009-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
after early planned operation##2##4##(1997-8#2)
after early surgical##2##3##(2006-7#1)(2008-7#1)
after early##5##2##(1996-6#1)(1997-8#2)(2006-7#1)(2008-7#1)
after eating##3##2##(1991-8#1)(1993-6#1)(2008-10#1)
after effects##2##2##(2008-8#1)(2010-11#1)
after either##4##2##(1992-9#1)(1995-5#2)(2008-7#1)
after ejaculation##3##2##(1992-12#2)(1997-6#1)
after elective##7##2##(1991-6#1)(1997-8#1)(2007-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
after electron##2##2##(1992-6#1)(2008-8#1)
after electrophoresis##2##2##(1990-2#1)(2008-10#1)
after elimination##2##2##(1991-12#1)(1992-8#1)
after elution##2##2##(1996-12#1)(2008-10#1)
after embolisation was##2##3##(1996-6#1)(1997-3#1)
after embolisation##9##2##(1995-11#2)(1996-3#2)(1996-6#2)(1997-3#2)(1997-6#1)
after embolization##2##2##(2006-12#1)(2008-7#1)
after emergence##5##2##(2008-10#5)
after emergency##3##2##(1992-5#1)(1993-9#1)(1997-8#1)
after endoluminal##2##2##(2011-2#1)(2013-8#1)
after endoscopic sphincterotomy##3##3##(1990-2#1)(2007-8#1)(2008-5#1)
after endoscopic##8##2##(1990-2#1)(2007-8#1)(2008-5#1)(2009-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
after endovascular abdominal aneurysm repair##2##5##(2010-12#1)(2011-3#1)
after endovascular treatment##3##3##(1995-11#1)(1996-3#1)(2013-1#1)
after endovascular##9##2##(1995-11#1)(1996-3#2)(2008-11#1)(2010-12#1)(2011-3#2)(2012-1#1)(2013-1#1)
after enrichment##2##2##(2008-10#1)(2008-5#1)
after entry##2##2##(1993-9#1)(1994-2#1)
after enzymatic hydrolysis##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
after enzymatic##5##2##(2008-10#2)(2008-7#1)(2009-12#1)(2013-1#1)
after equilibrating##2##2##(2008-10#2)
after establishment of##2##3##(1995-6#1)(1996-6#1)
after ethanol##2##2##(1994-6#1)(2009-8#1)
after evaporation##2##2##(2008-10#2)
after every##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
after excision of the##3##4##(2010-5#1)(2011-2#1)(2013-1#1)
after excision of##6##3##(1990-3#1)(2007-8#2)(2010-5#1)(2011-2#1)(2013-1#1)
after excision##7##2##(1990-3#1)(2007-8#2)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
after excitation##2##2##(1993-11#1)(1994-11#1)
after exercise##6##2##(2008-5#1)(2008-7#2)(2012-1#1)(2013-1#1)(2013-8#1)
after exhaustive exercise##2##3##(2013-1#2)
after exogenous##2##2##(2008-10#1)(2008-7#1)
after experiencing##3##2##(2008-6#1)(2012-12#1)(2012-2#1)
after exposing the##2##3##(2010-4#1)(2013-1#1)
after exposure for##2##3##(1992-6#1)(2008-10#1)
after exposure of 1##2##4##(2013-1#2)
after exposure of##6##3##(1994-11#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#2)
after exposure to TPA##2##4##(1993-9#2)
after exposure to a##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
after exposure to an##2##4##(2008-10#1)(2008-4#1)
after exposure to different##2##4##(1996-12#1)(2013-1#1)
after exposure to soil at##2##5##(2008-10#2)
after exposure to the##5##4##(2007-12#1)(2008-10#1)(2008-6#1)(2011-2#2)
after exposure to##43##3##(1990-8#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-6#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#2)
after exposure##61##2##(1990-8#1)(1991-9#2)(1992-12#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-6#1)(1996-12#1)(1996-3#1)(1996-8#2)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#4)
after extensive##3##2##(2010-11#1)(2010-3#1)(2011-2#1)
after external fixation##3##3##(2009-4#3)
after extracorporeal shockwave lithotripsy##2##4##(2013-1#2)
after extracorporeal##3##2##(2007-12#1)(2013-1#2)
after extraction##7##2##(1995-12#1)(2008-10#5)(2012-1#1)
after extrusion##2##2##(2008-9#1)(2012-2#1)
after extubation##4##2##(2007-8#3)(2010-7#1)
after failure of the##2##4##(1991-6#1)(2008-7#1)
after fatigue##3##2##(2008-9#1)(2013-8#2)
after feeding##4##2##(1991-12#1)(2007-5#1)(2008-10#1)(2008-11#1)
after fertilization##2##2##(2008-7#1)(2008-9#1)
after few##3##2##(2009-7#1)(2012-2#1)(2013-8#1)
after filtration##2##2##(2008-10#2)
after final##2##2##(2007-11#1)(2008-9#1)
after first##4##2##(1990-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
after first-line platinum-based chemotherapy##2##4##(2007-10#2)
after first-line##3##2##(1994-8#1)(2007-10#2)
after five days of##3##4##(2007-7#1)(2008-12#2)
after five days##4##3##(2007-7#1)(2008-12#3)
after five months##2##3##(2008-5#1)(2011-1#1)
after five years##3##3##(1992-5#1)(2011-2#2)
after five##13##2##(1992-5#1)(1993-12#1)(1995-11#1)(2007-6#1)(2007-7#1)(2008-12#4)(2008-5#1)(2011-1#1)(2011-2#2)
after fixation##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
after floods##2##2##(2013-8#2)
after focal demyelination##3##3##(2008-7#3)
after focal##4##2##(2007-10#1)(2008-7#3)
after following##2##2##(2011-2#1)(2013-8#1)
after food##2##2##(1995-5#1)(2008-7#1)
after four days##2##3##(1994-2#1)(2008-11#1)
after four weeks of##2##4##(2013-1#2)
after four weeks##5##3##(1992-9#1)(2008-7#1)(2011-2#1)(2013-1#2)
after four##15##2##(1992-9#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-7#2)(2011-2#1)(2013-1#3)
after free##2##2##(2007-12#1)(2012-12#1)
after freeze-drying##4##2##(2008-10#3)(2008-11#1)
after freezing and thawing##3##4##(2008-11#2)(2008-5#1)
after freezing and##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
after freezing##5##2##(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
after fruit set##4##3##(2008-10#4)
after fruit##5##2##(2008-10#5)
after full##2##2##(2008-12#1)(2013-1#1)
after further##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
after garlic oil treatment##2##4##(2008-9#2)
after gastric##3##2##(2007-8#1)(2012-2#1)(2012-5#1)
after gastroenteric surgery or##2##4##(1991-8#2)
after gel electrophoresis##2##3##(1993-11#1)(2010-11#1)
after gel##3##2##(1992-6#1)(1993-11#1)(2010-11#1)
after general anaesthesia for##2##4##(2012-12#2)
after general anaesthesia##3##3##(2009-3#1)(2012-12#2)
after general##5##2##(2008-10#1)(2009-3#1)(2012-12#3)
after germination##2##2##(2008-10#1)(2008-8#1)
after glucose##5##2##(1995-9#1)(2007-11#1)(2008-7#1)(2010-2#1)(2011-1#1)
after gradual##2##2##(2008-10#1)(2008-11#1)
after grafting##2##2##(1991-2#1)(1997-2#1)
after grazing##2##2##(2008-12#1)(2012-2#1)
after growing##2##2##(2008-10#2)
after growth##4##2##(1997-1#1)(2008-10#1)(2009-11#1)(2012-2#1)
after hCG##2##2##(2008-5#1)(2008-9#1)
after hair##2##2##(2008-10#1)(2008-5#1)
after haloperidol##3##2##(1995-12#1)(1996-7#2)
after harvest##9##2##(2008-10#8)(2011-2#1)
after having been##2##3##(2008-11#1)(2013-1#1)
after having##10##2##(1990-3#2)(1990-6#1)(1992-4#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
after he##5##2##(1995-6#1)(1996-5#1)(1997-5#1)(2007-5#1)(2008-12#1)
after head injury##2##3##(1991-12#1)(2008-7#1)
after head##5##2##(1991-12#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#1)
after heading and##3##3##(2008-9#3)
after heading##5##2##(2008-9#5)
after heads emerged##2##3##(2008-10#2)
after headspace##2##2##(2008-10#2)
after heart##3##2##(1997-3#2)(2013-1#1)
after heat shock##6##3##(1990-11#1)(1994-8#1)(1997-7#1)(2008-7#2)(2012-3#1)
after heat treatment##4##3##(1990-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
after heat##11##2##(1990-11#2)(1990-12#1)(1994-8#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-7#2)(2012-2#1)(2012-3#1)
after heating at##5##3##(1994-8#1)(2008-10#1)(2008-2#1)(2011-2#2)
after heating to##3##3##(2007-12#1)(2008-10#2)
after heating##12##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2010-4#1)(2011-2#3)(2012-2#1)
after hematopoietic stem cell transplantation##2##5##(1997-8#1)(2010-11#1)
after her##4##2##(1991-11#1)(1992-4#1)(2011-2#1)(2013-1#1)
after high pressure homogenization##2##4##(2008-7#2)
after high##4##2##(2008-7#3)(2010-9#1)
after high-dose##2##2##(2008-7#1)(2012-12#1)
after hip##4##2##(2008-8#3)(2009-3#1)
after his first##2##3##(1997-6#1)(2012-12#1)
after his##10##2##(1992-3#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
after histamine##4##2##(1996-1#1)(2008-12#3)
after hospital discharge##3##3##(1991-1#1)(2007-12#1)(2013-1#1)
after hospitalization##2##2##(1995-2#1)(1997-3#1)
after hybridization##3##2##(2008-9#3)
after hydrogen outdiffusion##2##3##(2007-12#2)
after hydrolysis of##2##3##(1995-6#1)(2008-12#1)
after i##12##2##(1991-1#1)(1991-8#1)(1992-9#3)(1993-12#2)(1994-2#1)(1995-12#1)(1996-12#1)(2008-11#1)(2013-1#1)
after illness or##2##3##(1997-2#1)(2011-1#1)
after illumination##2##2##(1992-9#1)(2008-7#1)
after imipramine administration in all three strains##2##7##(1994-2#2)
after immobilization##2##2##(1995-12#1)(1995-5#1)
after immunization with##4##3##(1995-12#2)(1995-5#1)(2008-7#1)
after immunization##9##2##(1990-12#1)(1995-12#2)(1995-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-7#1)
after implant placement##4##3##(2007-12#1)(2013-1#3)
after implantation of a##5##4##(2007-8#1)(2008-11#1)(2008-7#2)(2011-2#1)
after implantation of##7##3##(1996-2#1)(2007-8#1)(2008-11#2)(2008-7#2)(2011-2#1)
after implantation##20##2##(1990-8#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#8)(2011-2#1)(2012-2#1)
after implementation of the managed care system##2##7##(2006-10#2)
after implementation of the##4##4##(1995-12#1)(2006-10#2)(2008-3#1)
after implementation of##5##3##(1991-3#1)(1995-12#1)(2006-10#2)(2008-3#1)
after implementation##7##2##(1991-3#1)(1995-12#1)(1997-2#1)(2006-10#2)(2008-10#1)(2008-3#1)
after in situ##3##3##(1990-11#1)(1994-11#1)(2008-10#1)
after in vitro fertilization##5##4##(1995-6#3)(2008-9#1)(2013-1#1)
after in vitro treatment of##2##5##(1990-2#1)(1996-5#1)
after in vitro##9##3##(1990-2#1)(1995-6#3)(1996-2#1)(1996-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
after in vivo initiation with paracetamol##2##6##(1995-11#2)
after in vivo##5##3##(1995-11#2)(2008-5#1)(2012-2#2)
after in##18##2##(1990-11#1)(1990-2#1)(1994-11#1)(1995-11#2)(1995-6#3)(1996-2#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
after incorporation##4##2##(1990-7#1)(1992-3#1)(2008-5#1)(2010-11#1)
after incubation for##4##3##(1996-2#1)(2008-10#1)(2010-6#1)(2012-12#1)
after incubation in the##2##4##(1992-5#1)(2008-10#1)
after incubation in##3##3##(1992-5#1)(2008-10#1)(2008-12#1)
after incubation of##7##3##(1990-12#3)(1990-8#1)(1994-8#2)(2012-1#1)
after incubation with a##2##4##(1990-12#1)(2008-10#1)
after incubation with the##2##4##(1993-8#1)(2008-11#1)
after incubation with##12##3##(1990-12#1)(1991-3#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-8#1)
after incubation##27##2##(1990-12#4)(1990-8#1)(1991-3#1)(1992-5#1)(1993-8#1)(1994-8#3)(1995-3#1)(1995-5#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-8#1)
after induction CCRT##2##3##(2008-10#2)
after induction chemotherapy##2##3##(1990-6#1)(2008-10#1)
after induction of##3##3##(1992-12#1)(2008-7#1)(2008-8#1)
after induction##14##2##(1990-5#1)(1990-6#1)(1992-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2010-11#1)(2013-8#2)
after infection and##2##3##(2008-10#1)(2008-11#1)
after infection by##2##3##(2008-10#1)(2009-10#1)
after infection with##5##3##(1996-12#1)(2008-10#2)(2008-9#1)(2011-10#1)
after infection##15##2##(1991-9#1)(1992-8#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-10#1)
after informed consent##2##3##(2008-5#1)(2012-3#1)
after infusion of##2##3##(1990-12#1)(2008-1#1)
after infusion##5##2##(1990-12#1)(1992-8#1)(2007-8#1)(2008-1#1)(2008-3#1)
after ingesting##3##2##(2008-10#1)(2008-12#1)(2010-6#1)
after ingestion of##6##3##(1990-9#1)(2008-10#1)(2008-7#2)(2010-6#1)(2013-1#1)
after ingestion##7##2##(1990-9#1)(2008-10#2)(2008-7#2)(2010-6#1)(2013-1#1)
after inhibition##3##2##(1992-6#1)(1992-9#1)(2008-7#1)
after initial diagnosis##2##3##(2008-7#1)(2011-2#1)
after initial loading##2##3##(2013-1#2)
after initial##19##2##(1992-1#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#2)(2013-1#3)
after initiating##2##2##(2007-12#1)(2011-2#1)
after initiation of PD+HD therapy##2##5##(2011-2#2)
after initiation of##16##3##(1992-2#1)(1993-3#1)(1996-11#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
after initiation##17##2##(1992-2#1)(1993-3#1)(1996-11#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-7#1)
after injection and##2##3##(1993-11#1)(2012-1#1)
after injection of a##2##4##(1990-6#1)(2008-12#1)
after injection of beta-AP(1-40)##2##4##(2008-8#2)
after injection of the##2##4##(1995-12#1)(2008-11#1)
after injection of##17##3##(1990-5#1)(1990-6#1)(1995-12#2)(1995-3#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2012-12#2)
after injection##38##2##(1990-12#1)(1990-5#2)(1990-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
after injections of##4##3##(1991-12#1)(1992-11#1)(1995-2#1)(1996-5#1)
after injections##6##2##(1991-12#1)(1991-2#1)(1992-11#1)(1995-2#1)(1996-5#1)(2013-8#1)
after injury##24##2##(1993-12#1)(1995-11#1)(1995-12#3)(1997-2#1)(2007-8#1)(2008-7#4)(2008-8#1)(2009-3#2)(2010-11#1)(2012-3#5)(2012-7#1)(2013-1#3)
after inoculation and incubation at 20 degrees C##3##8##(2008-10#3)
after inoculation and##9##3##(2008-10#9)
after inoculation but##2##3##(2008-10#2)
after inoculation in##2##3##(2008-10#2)
after inoculation of##4##3##(2008-10#4)
after inoculation on##4##3##(2008-10#4)
after inoculation time##2##3##(2008-5#2)
after inoculation was##2##3##(2008-10#2)
after inoculation with the pathogen##4##5##(2008-10#4)
after inoculation with the##7##4##(1991-3#1)(2008-10#6)
after inoculation with##17##3##(1991-3#1)(1997-6#2)(2008-10#14)
after inoculation##131##2##(1991-3#1)(1993-8#1)(1995-2#1)(1997-6#2)(2008-10#118)(2008-11#2)(2008-5#4)(2008-8#2)
after insertion##2##2##(2008-5#1)(2013-1#1)
after intake##3##2##(1993-8#1)(2009-11#1)(2009-9#1)
after intercourse##2##2##(2008-12#2)
after interferon##2##2##(2007-8#1)(2013-8#1)
after intermittent##2##2##(1993-2#1)(2008-10#1)
after intervention##6##2##(1994-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
after interventional##2##2##(2012-12#1)(2013-1#1)
after intra-articular##2##2##(2008-9#1)(2013-1#1)
after intracerebroventricular administration##2##3##(1992-3#1)(1995-12#1)
after intracerebroventricular injection of##2##4##(1997-2#1)(2008-8#1)
after intracerebroventricular##4##2##(1992-3#1)(1995-12#1)(1997-2#1)(2008-8#1)
after intracranial surgery##2##3##(2008-7#2)
after intradermal##2##2##(1990-7#1)(1992-6#1)
after intramedullary nailing##2##3##(2007-11#2)
after intramedullary##4##2##(2007-11#4)
after intramuscular##2##2##(1992-5#1)(1995-3#1)
after intraperitoneal (i##2##3##(1994-8#1)(1995-12#1)
after intraperitoneal injection of##3##4##(1990-12#1)(1992-3#1)(2012-1#1)
after intraperitoneal##5##2##(1990-12#1)(1992-3#1)(1994-8#1)(1995-12#1)(2012-1#1)
after intrathecal injection of fluorescein##3##5##(2008-12#3)
after intravenous (i##2##3##(1993-12#1)(2006-12#1)
after intravenous and##2##3##(1992-5#1)(2011-2#1)
after intravenous injection of##4##4##(1992-12#1)(1992-5#1)(1994-5#1)(2013-8#1)
after intravenous injection##7##3##(1992-12#2)(1992-5#1)(1993-11#1)(1994-5#1)(2008-7#1)(2013-8#1)
after intravenous##15##2##(1992-12#2)(1992-5#2)(1993-11#1)(1993-12#1)(1994-5#1)(2006-12#1)(2007-10#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
after intraventricular injection##3##3##(1991-12#3)
after intraventricular##4##2##(1991-12#4)
after introduction of##6##3##(1991-8#1)(1991-9#1)(1994-8#1)(2007-8#1)(2008-11#1)(2011-2#1)
after irradiation and##3##3##(2007-11#2)(2008-10#1)
after irradiation of##2##3##(1993-3#1)(2008-3#1)
after irradiation with##4##3##(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
after irradiation##20##2##(1992-9#1)(1993-3#1)(1995-6#2)(1996-5#1)(1997-4#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#2)
after ischemia##2##2##(1990-5#2)
after ischemic stroke##3##3##(2007-10#3)
after ischemic##4##2##(2007-10#3)(2010-8#1)
after islet##3##2##(2010-11#3)
after isolation from##2##3##(1996-12#1)(2008-2#1)
after isolation of the##3##4##(2007-8#2)(2008-12#1)
after isolation##9##2##(1995-8#1)(1996-12#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-2#1)(2010-11#1)
after it has##2##3##(2007-11#1)(2008-10#1)
after it was first##2##4##(2008-10#2)
after it was##5##3##(1990-3#1)(2008-10#3)(2011-1#1)
after it##10##2##(1990-3#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-1#1)
after its administration##3##3##(2007-8#1)(2008-10#2)
after its conclusion##2##3##(1992-2#2)
after its preconcentration onto##2##4##(2008-10#2)
after its preconcentration##3##3##(2008-10#3)
after its treatment##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
after its##37##2##(1990-5#1)(1991-12#1)(1991-2#2)(1992-2#2)(1996-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#18)(2008-12#1)(2008-8#1)(2009-12#2)(2010-8#1)(2011-2#1)(2012-3#1)
after ketamine injection##3##3##(2013-1#3)
after kidney##4##2##(1995-2#1)(2008-10#1)(2012-12#2)
after knee arthroplasty##4##3##(2011-2#4)
after knee##6##2##(2007-11#1)(2011-2#4)(2013-1#1)
after labor##2##2##(2008-9#1)(2011-2#1)
after laparoscopic cholecistectomy##2##3##(2011-2#2)
after laparoscopic cholecystectomy##8##3##(2008-12#3)(2008-8#1)(2009-3#2)(2011-2#1)(2012-3#1)
after laparoscopic##20##2##(1992-2#1)(2008-12#4)(2008-8#1)(2009-3#2)(2011-1#2)(2011-2#5)(2012-12#4)(2012-3#1)
after laparoscopy##3##2##(1995-3#3)
after laparotomy##3##2##(2008-6#1)(2010-8#1)(2011-1#1)
after laser irradiation##3##3##(2007-12#2)(2012-2#1)
after laser treatment##3##3##(1990-11#1)(1993-6#1)(2007-12#1)
after laser##8##2##(1990-11#1)(1991-2#1)(1993-6#2)(2007-12#3)(2012-2#1)
after last##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
after late##2##2##(2008-10#1)(2008-2#1)
after leaving the##2##3##(1997-6#1)(2009-5#1)
after lesion##2##2##(1992-5#1)(1997-2#1)
after light initiation##5##3##(2008-10#5)
after light##6##2##(2008-10#6)
after limb sparing##2##3##(2011-1#2)
after limb-salvage surgery##2##3##(2008-6#2)
after lithium##2##2##(1992-2#1)(1995-11#1)
after liver resection##2##3##(2012-3#1)(2013-1#1)
after liver transplantation##10##3##(1992-6#1)(1993-2#1)(1994-6#1)(2006-10#5)(2008-5#1)(2011-2#1)
after liver##14##2##(1992-6#1)(1993-2#1)(1994-6#1)(2006-10#5)(2008-11#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
after load##2##2##(2012-2#2)
after loading##2##2##(2008-10#1)(2010-5#1)
after local application##2##3##(1993-11#1)(1995-12#1)
after local##7##2##(1990-12#1)(1993-11#1)(1995-12#1)(2008-7#2)(2010-12#1)(2011-2#1)
after long##3##2##(1991-12#1)(2008-10#2)
after long-term follow-up##2##3##(1991-12#1)(2007-12#1)
after long-term treatment with##2##4##(2008-1#1)(2010-5#1)
after long-term treatment##3##3##(1997-5#1)(2008-1#1)(2010-5#1)
after long-term##15##2##(1991-11#1)(1991-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-6#1)
after loss of##2##3##(2008-9#1)(2011-2#1)
after low dose##2##3##(2008-7#2)
after low##4##2##(1994-12#1)(1997-4#1)(2008-7#2)
after lumbar##4##2##(1995-11#1)(2012-12#2)(2013-8#1)
after lumpectomy##2##2##(1991-11#1)(1994-12#1)
after lung transplantation##4##3##(2012-2#4)
after lung##6##2##(2012-2#4)(2013-1#2)
after major##7##2##(1996-3#1)(2007-8#2)(2009-5#1)(2009-6#2)(2010-8#1)
after many years##2##3##(2012-3#1)(2013-7#1)
after many##3##2##(2008-3#1)(2012-3#1)(2013-7#1)
after mass##2##2##(1990-6#1)(2008-10#1)
after maternal##2##2##(1992-5#1)(1994-3#1)
after maturity##2##2##(2008-9#2)
after measurement##2##2##(2008-10#1)(2010-5#1)
after mechanical##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
after median##3##2##(1991-2#1)(1997-3#1)(2012-2#1)
after membrane##3##2##(2008-10#2)(2011-2#1)
after meningitis##2##2##(2008-8#1)(2008-9#1)
after meniscus repair and anterior cruciate ligament reconstruction##2##8##(2013-1#2)
after menopause##2##2##(2008-7#1)(2010-12#1)
after microinjection of##2##3##(1994-8#1)(1997-2#1)
after microwave##3##2##(2008-10#2)(2011-2#1)
after microwave-assisted digestion##2##3##(2008-10#2)
after microwave-assisted##5##2##(2008-10#5)
after mild##5##2##(1990-5#1)(1994-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
after mitral valve##3##3##(1994-3#1)(2007-8#1)(2011-2#1)
after mixing##6##2##(1990-2#1)(2008-10#5)
after modifying##2##2##(2007-12#1)(2011-2#1)
after more than##5##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
after multi-organ##2##2##(2007-8#2)
after multiple##9##2##(1996-11#2)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
after mutations##2##2##(2008-1#1)(2011-2#1)
after myocardial infarction##2##3##(1993-2#1)(1994-11#1)
after myocardial##7##2##(1990-8#1)(1993-2#1)(1994-11#1)(2008-10#2)(2009-4#1)(2013-1#1)
after myotomy##2##2##(1990-12#1)(1992-9#1)
after nematode##2##2##(2008-10#2)
after neoadjuvant chemotherapy##2##3##(2009-5#1)(2010-3#1)
after neoadjuvant##3##2##(2009-5#1)(2010-3#1)(2010-7#1)
after nephrectomy##7##2##(2008-1#1)(2011-2#4)(2013-1#2)
after nerve##2##2##(1993-12#1)(2011-2#1)
after nickel##2##2##(2008-10#2)
after nine extinction trials##3##4##(2008-5#3)
after nine months of##2##4##(2007-7#1)(2013-1#1)
after nine months##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
after nine##8##2##(1994-2#1)(2007-7#1)(2008-5#3)(2011-2#1)(2012-2#1)(2013-1#1)
after nociceptive stimulation##2##3##(1993-12#2)
after normal delivery##3##3##(1991-3#1)(1992-12#1)(2011-2#1)
after normal##5##2##(1991-3#1)(1992-12#1)(1997-2#1)(2008-10#1)(2011-2#1)
after normalization for##2##3##(1995-12#1)(2008-7#1)
after normalization of##2##3##(2011-1#2)
after normalization##4##2##(1995-12#1)(2008-7#1)(2011-1#2)
after normalizing##2##2##(1995-12#1)(2013-1#1)
after occupational##2##2##(1991-11#1)(2010-12#1)
after on-line hydrolysis##2##3##(2008-10#2)
after on-line##6##2##(2008-10#6)
after one and##2##3##(2008-10#1)(2008-7#1)
after one month of##2##4##(2011-1#1)(2013-1#1)
after one month##4##3##(2007-8#1)(2011-1#1)(2013-1#2)
after one year of treatment##2##5##(1991-11#1)(2013-1#1)
after one year of##3##4##(1991-11#1)(2011-1#1)(2013-1#1)
after one year##10##3##(1990-8#1)(1991-11#1)(1991-6#1)(1995-1#1)(2007-11#1)(2010-8#2)(2011-1#1)(2013-1#2)
after one##29##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-6#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#3)(2011-1#2)(2013-1#6)
after one-step##2##2##(1993-6#1)(2008-10#1)
after only 2 days##2##4##(1993-6#1)(1995-12#1)
after only 2##3##3##(1993-6#1)(1995-12#1)(2008-10#1)
after only three##2##3##(2008-10#1)(2013-1#1)
after only##13##2##(1993-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2013-1#1)
after onset of stroke##3##4##(1995-5#1)(2007-10#1)(2009-11#1)
after onset of symptoms##3##4##(1996-6#1)(2008-10#1)(2009-9#1)
after onset of##9##3##(1992-5#1)(1995-5#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)
after onset##10##2##(1992-5#1)(1995-5#2)(1996-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)
after operation of##2##3##(2008-3#1)(2012-3#1)
after operation##31##2##(1990-2#1)(1993-11#1)(1993-2#1)(1995-11#1)(1996-8#1)(1997-3#1)(2007-11#6)(2007-7#1)(2007-8#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)
after or##2##2##(1990-8#1)(1990-9#1)
after oral administration in##2##4##(2008-11#1)(2008-12#1)
after oral administration of the##2##5##(1996-5#1)(2008-10#1)
after oral administration of##7##4##(1996-5#2)(1996-6#1)(2008-10#3)(2008-11#1)
after oral administration##12##3##(1996-2#1)(1996-5#2)(1996-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2011-1#1)
after oral and intravenous administration##2##5##(2011-1#2)
after oral intubation of##3##4##(2008-11#3)
after oral treatment##2##3##(1992-11#1)(1993-12#1)
after oral##24##2##(1990-2#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-5#1)(2011-1#3)(2012-3#1)
after orthotopic liver transplantation##2##4##(1993-2#1)(2011-2#1)
after osmotic##2##2##(1990-2#1)(2013-7#1)
after osteochondral##2##2##(2011-2#2)
after ovarian surgery##3##3##(1992-3#3)
after oviposition##5##2##(2007-12#4)(2008-12#1)
after oxidation of##3##3##(2008-10#3)
after ozonation##2##2##(2008-10#1)(2013-1#1)
after pacemaker implantation##2##3##(2008-3#1)(2013-8#1)
after packing##3##2##(2008-10#2)(2011-2#1)
after pancreatic##3##2##(2008-6#1)(2012-12#1)(2013-1#1)
after pancreaticoduodenectomy##2##2##(2013-1#2)
after parathyroidectomy##2##2##(2012-12#2)
after partial hepatectomy##3##3##(1990-12#1)(1995-6#1)(1996-2#1)
after partial##10##2##(1990-12#2)(1994-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-7#1)
after participating in##2##3##(2011-2#1)(2013-1#1)
after parturition##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
after passage of a##2##4##(2007-11#1)(2012-2#1)
after passage##4##2##(2007-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
after passing through##2##3##(2008-10#2)
after passive##2##2##(1995-5#2)
after pelvic##3##2##(2009-3#1)(2012-3#2)
after penetrating##2##2##(1991-11#1)(1991-9#1)
after penetration##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
after percutaneous coronary intervention##3##4##(2008-3#1)(2008-7#1)(2009-5#1)
after percutaneous coronary##4##3##(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)
after percutaneous transluminal coronary angioplasty##3##5##(1995-8#1)(2007-10#2)
after percutaneous transluminal##4##3##(1995-8#1)(2007-10#2)(2008-1#1)
after percutaneous##12##2##(1990-2#1)(1995-8#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
after peripheral##3##2##(1994-2#1)(2008-3#1)(2008-4#1)
after permeabilization##2##2##(1997-7#1)(2006-6#1)
after pharmacological##3##2##(1996-5#1)(2011-2#1)(2013-7#1)
after photobleaching##7##2##(2008-1#5)(2008-7#1)(2008-9#1)
after photodynamic##2##2##(1992-6#2)
after physical##2##2##(2007-11#1)(2007-8#1)
after placement of##2##3##(1990-5#1)(2008-10#1)
after placement##4##2##(1990-5#1)(2007-7#1)(2008-10#2)
after planting##14##2##(2008-10#14)
after platelet##2##2##(2006-6#2)
after plating##3##2##(1992-6#1)(1993-6#1)(2008-9#1)
after pneumonectomy##2##2##(1995-11#1)(2007-8#1)
after pollination##9##2##(2008-10#5)(2008-11#3)(2008-9#1)
after polyadenylation##3##2##(1994-11#3)
after polymerase chain reaction##2##4##(2008-10#1)(2013-1#1)
after polymerization##3##2##(1995-2#1)(2008-5#1)(2012-2#1)
after post-column##2##2##(2008-10#2)
after pre-concentration in##2##3##(2008-10#2)
after pre-concentration##5##2##(2008-10#5)
after pre-treatment with##2##3##(2011-2#2)
after pre-treatment##3##2##(1993-9#1)(2011-2#2)
after precolumn##3##2##(1990-12#1)(1990-8#1)(2008-10#1)
after preconcentration of its##3##4##(2008-10#3)
after preconcentration of their##2##4##(2008-10#2)
after preconcentration of##8##3##(2008-10#7)(2013-8#1)
after preconcentration on a##2##4##(2008-10#2)
after preconcentration on##5##3##(2008-10#5)
after preconcentration using##3##3##(2008-10#3)
after preconcentration with the ion pair of##2##7##(2008-10#2)
after preconcentration##26##2##(2008-10#25)(2013-8#1)
after preincubation##2##2##(1991-9#1)(1992-5#1)
after prenatal##4##2##(1991-12#1)(1992-2#1)(1995-12#1)(1996-5#1)
after preoperative##2##2##(1992-6#1)(2010-7#1)
after presentation##2##2##(2008-7#1)(2012-12#1)
after pretreatment of##3##3##(1991-12#1)(1991-2#1)(2013-8#1)
after pretreatment with rimalkalim##2##4##(1997-7#2)
after pretreatment with##9##3##(1995-12#2)(1996-5#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-5#1)
after pretreatment##12##2##(1991-12#1)(1991-2#1)(1995-12#2)(1996-5#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2013-8#1)
after previous##5##2##(1997-8#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
after primary ocular infection##2##4##(2012-3#2)
after primary percutaneous coronary intervention##2##5##(2009-12#1)(2013-1#1)
after primary surgery##4##3##(1990-6#1)(1993-9#1)(2007-11#1)(2008-9#1)
after primary##15##2##(1990-6#1)(1992-5#1)(1993-1#1)(1993-9#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-3#3)(2013-1#2)
after prior##3##2##(1992-9#1)(2008-4#1)(2013-1#1)
after prolonged decubitus position##2##4##(2009-3#2)
after prolonged##12##2##(1990-9#1)(1992-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#2)(2010-12#1)(2011-2#1)
after propagation of##2##3##(2007-12#1)(2008-3#1)
after propagation##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
after prostatic massage##2##3##(1991-2#2)
after protein supplementation##4##3##(2013-1#4)
after protein##7##2##(2008-1#2)(2008-10#1)(2013-1#4)
after puberty##10##2##(1990-5#2)(1991-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
after pulmonary resection##2##3##(2007-8#1)(2010-8#1)
after pulmonary##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
after purification of the##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
after purification##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
after rTMS##2##2##(2011-2#2)
after radiation therapy and##2##4##(1993-8#1)(2013-8#1)
after radiation therapy for##2##4##(1993-8#1)(2013-8#1)
after radiation therapy##9##3##(1993-8#5)(1993-9#1)(2008-7#1)(2013-8#2)
after radical prostatectomy and##2##4##(2009-5#1)(2011-2#1)
after radical prostatectomy##5##3##(2008-4#1)(2009-5#2)(2010-10#1)(2011-2#1)
after radical##10##2##(1990-9#1)(1992-12#1)(1992-8#1)(2008-10#1)(2008-4#1)(2009-5#2)(2010-10#1)(2011-2#1)(2012-2#1)
after radiotherapy for##3##3##(1996-9#1)(2011-2#1)(2013-1#1)
after radiotherapy of##2##3##(2008-7#1)(2012-12#1)
after radiotherapy##10##2##(1990-6#1)(1992-10#1)(1992-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
after rapid##4##2##(1996-4#1)(2008-7#2)(2011-2#1)
after reaction with##3##3##(1990-8#1)(2008-10#2)
after receiving##9##2##(1991-2#1)(2007-7#1)(2008-1#2)(2008-7#2)(2010-12#1)(2010-3#1)(2013-8#1)
after recording the##2##3##(2009-5#1)(2013-7#1)
after recording##4##2##(2008-3#2)(2009-5#1)(2013-7#1)
after recovery from##2##3##(2008-10#1)(2011-1#1)
after recovery##4##2##(1996-5#1)(2008-10#1)(2009-7#1)(2011-1#1)
after reduction of##8##3##(1991-5#1)(1994-12#1)(1996-2#1)(2008-10#5)
after reduction to##2##3##(2008-10#2)
after reduction##11##2##(1991-5#1)(1994-12#1)(1996-2#1)(2008-10#8)
after rehabilitation##3##2##(1993-1#1)(2007-11#1)(2007-8#1)
after release##4##2##(2007-9#1)(2009-11#2)(2010-3#1)
after removal of PKC##2##4##(1995-5#2)
after removal of hemodialysis indwelling catheters##2##6##(2008-1#2)
after removal of the##6##4##(1990-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-2#2)
after removal of##19##3##(1990-10#1)(1990-5#2)(1990-6#1)(1991-2#1)(1992-6#1)(1992-8#1)(1994-3#1)(1995-5#2)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-12#1)(2011-2#2)
after removal##20##2##(1990-10#1)(1990-5#2)(1990-6#1)(1991-2#1)(1992-6#1)(1992-8#1)(1994-3#1)(1995-5#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2011-2#2)
after removing the##5##3##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
after removing##6##2##(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
after renal transplantation in##2##4##(1992-12#1)(2008-4#1)
after renal transplantation##11##3##(1992-12#1)(2007-10#2)(2008-1#3)(2008-4#1)(2008-8#2)(2011-2#1)(2012-12#1)
after renal##13##2##(1992-12#1)(2007-10#2)(2008-1#3)(2008-4#1)(2008-8#3)(2011-2#2)(2012-12#1)
after reoperation##2##2##(2007-8#1)(2008-9#1)
after repair of##3##3##(2007-8#2)(2008-8#1)
after repeated##7##2##(1990-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
after reperfusion in##2##3##(2007-10#2)
after reperfusion##8##2##(1990-7#1)(1992-9#1)(2007-10#3)(2011-2#3)
after resection of the##3##4##(2008-7#1)(2011-2#1)(2011-3#1)
after resection of##9##3##(2007-11#1)(2007-8#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
after resection##15##2##(2007-11#3)(2007-8#3)(2008-6#2)(2008-7#3)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
after residue##2##2##(1994-9#1)(2008-10#1)
after resistance exercise##2##3##(2008-5#2)
after resuscitation##2##2##(1990-12#1)(2012-3#1)
after return##3##2##(1997-6#1)(2007-2#2)
after revascularization##2##2##(2008-1#1)(2008-9#1)
after revision surgery##2##3##(2012-3#2)
after revision##3##2##(2007-11#1)(2012-3#2)
after right##3##2##(1990-3#1)(2007-8#2)
after rising##3##2##(1994-6#1)(2008-7#1)(2011-2#1)
after routine dental implant surgery##2##5##(2013-1#2)
after routine##4##2##(2007-7#1)(2011-2#1)(2013-1#2)
after ruling out##2##3##(2011-2#1)(2012-12#1)
after rupture of##2##3##(2008-7#1)(2011-2#1)
after salvage##2##2##(1990-6#1)(2012-3#1)
after sample collection##3##3##(2008-10#3)
after sample digestion##2##3##(2008-10#2)
after sample injection and##2##4##(1992-11#1)(1995-3#1)
after sample injection##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
after sample##9##2##(1992-11#1)(1995-3#1)(2008-10#7)
after sampling##3##2##(2008-10#3)
after scab inoculation of##2##4##(2008-10#2)
after scab inoculation##3##3##(2008-10#3)
after screening##4##2##(1992-5#1)(1993-12#1)(2008-7#1)(2011-2#1)
after seeding##3##2##(2008-10#2)(2010-5#1)
after selection##2##2##(2008-10#2)
after selective##2##2##(2008-5#1)(2008-7#1)
after separation by##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
after separation from##2##3##(2008-10#2)
after separation of##4##3##(2008-10#3)(2010-2#1)
after separation on##2##3##(2008-10#2)
after separation with##2##3##(2008-10#2)
after separation##14##2##(1990-12#1)(2008-10#11)(2008-11#1)(2010-2#1)
after sequential##3##2##(2008-10#2)(2012-3#1)
after serial##2##2##(2008-10#1)(2008-11#1)
after serum##3##2##(1997-1#2)(2008-7#1)
after settlement##2##2##(2010-8#2)
after seven##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
after several minutes##2##3##(1990-2#1)(1997-7#1)
after several years of##3##4##(1995-11#1)(1995-6#1)(2012-3#1)
after several years##4##3##(1995-11#1)(1995-6#1)(2008-9#1)(2012-3#1)
after several##9##2##(1990-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-3#1)
after severe##4##2##(2008-1#1)(2008-10#1)(2012-1#1)(2012-3#1)
after sexting##2##2##(2013-1#2)
after she##3##2##(1995-11#1)(2008-5#1)(2012-3#1)
after short##3##2##(1995-11#1)(2008-10#2)
after significant##2##2##(2007-12#1)(2012-12#1)
after simple##5##2##(1996-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
after single oral##2##3##(2008-5#1)(2011-1#1)
after single##6##2##(1996-1#1)(2008-5#1)(2008-6#1)(2011-1#2)(2011-3#1)
after six months##6##3##(1993-3#1)(2007-7#2)(2008-11#1)(2008-5#1)(2008-9#1)
after six##9##2##(1990-5#1)(1993-3#1)(1994-5#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-5#1)(2008-9#1)
after skin##2##2##(2008-5#1)(2012-12#1)
after slaughter##2##2##(1990-3#1)(1997-5#1)
after soaking in##2##3##(2006-11#1)(2008-12#1)
after sodium dodecyl##2##3##(2008-10#1)(2008-11#1)
after sodium##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
after soil##3##2##(1993-8#1)(2008-10#2)
after solid phase##2##3##(2008-10#2)
after solid##3##2##(2008-1#1)(2008-10#2)
after solid-phase extraction using##2##4##(2008-10#2)
after solubilization by##2##3##(2008-11#2)
after solubilization##5##2##(1990-11#1)(1994-5#1)(1994-6#1)(2008-11#2)
after some##5##2##(1991-11#1)(1996-11#1)(1997-6#1)(2008-10#2)
after sorption on##2##3##(2008-10#2)
after sorption##3##2##(2008-10#3)
after sowing##6##2##(2008-12#6)
after spaceflight##2##2##(2009-7#2)
after specific in vitro challenge was##2##6##(2013-1#2)
after specific##7##2##(1991-9#1)(1993-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
after spinal cord##3##3##(1995-11#1)(2007-11#1)(2013-8#1)
after spinal##4##2##(1995-11#1)(2007-11#1)(2009-7#1)(2013-8#1)
after spraying##5##2##(2008-10#3)(2011-2#2)
after staining the##2##3##(2008-10#1)(2008-11#1)
after staining with##4##3##(2006-8#1)(2008-10#1)(2008-7#1)(2009-12#1)
after staining##6##2##(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)
after standard##3##2##(2008-10#1)(2010-3#1)(2012-3#1)
after start of##2##3##(1991-6#1)(1992-5#1)
after start-up##2##2##(1991-3#2)
after starting the##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
after starting treatment with##2##4##(2011-2#1)(2012-3#1)
after starting treatment##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
after starting##12##2##(1991-11#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
after stent implantation##3##3##(2008-11#1)(2009-11#1)(2009-5#1)
after stereotactic##3##2##(2008-7#1)(2011-2#2)
after stimulation of the##2##4##(1994-11#1)(1995-8#1)
after stimulation of##4##3##(1991-3#1)(1994-11#1)(1995-6#1)(1995-8#1)
after stimulation with IFNγ##3##4##(2011-2#3)
after stimulation with##12##3##(1991-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#3)
after stimulation##25##2##(1991-12#1)(1991-2#1)(1991-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
after stopping##5##2##(1995-3#1)(2007-7#2)(2009-8#1)(2010-2#1)
after storage##2##2##(1992-2#1)(1995-6#1)
after stratification##2##2##(1992-10#1)(2012-2#1)
after streptokinase##2##2##(1990-3#2)
after stress##2##2##(1992-5#1)(2013-1#1)
after stroke onset##7##3##(2007-10#1)(2007-9#2)(2008-3#1)(2008-7#1)(2013-1#2)
after stroke##28##2##(1991-11#1)(1997-5#1)(2007-10#6)(2007-11#1)(2007-9#3)(2008-11#3)(2008-3#1)(2008-7#5)(2009-10#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#2)
after study##2##2##(2008-10#1)(2008-3#1)
after subarachnoid hemorrhage##2##3##(2007-10#1)(2010-4#1)
after subchronic##2##2##(1995-3#1)(2008-10#1)
after subcutaneous##3##2##(1992-2#2)(2008-10#1)
after subsequent##2##2##(1997-8#1)(2008-10#1)
after substantial##2##2##(1993-2#1)(1994-6#1)
after subtotal##3##2##(1993-3#1)(2009-7#1)(2013-1#1)
after successful antibiotic treatment##2##4##(2010-6#2)
after successful closed reduction##2##4##(2013-7#2)
after successful resuscitation##2##3##(1996-3#1)(2008-3#1)
after successful##16##2##(1990-3#1)(1993-12#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-6#2)(2011-3#1)(2012-3#1)(2013-7#2)
after successive additions of##2##4##(1993-8#1)(2008-10#1)
after such a##2##3##(1994-2#1)(2008-10#1)
after such an##2##3##(2008-7#1)(2012-12#1)
after such##6##2##(1994-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)
after sulfo-SMCC modification##2##3##(2008-10#2)
after sunrise##4##2##(2008-10#4)
after surface##2##2##(2010-2#1)(2012-2#1)
after surgery and##10##3##(1991-6#1)(1993-3#2)(1997-4#1)(1997-5#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
after surgery by##3##3##(1997-2#1)(2012-1#1)(2012-2#1)
after surgery for##4##3##(1993-6#1)(1995-11#1)(2007-8#1)(2008-6#1)
after surgery in##3##3##(2008-7#1)(2011-2#2)
after surgery is##4##3##(2007-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
after surgery or##2##3##(2008-7#1)(2010-6#1)
after surgery showed##2##3##(2008-7#1)(2013-1#1)
after surgery to##2##3##(2010-10#1)(2013-8#1)
after surgery was##6##3##(1990-8#1)(1994-12#1)(1995-4#1)(2007-11#1)(2010-10#1)(2011-2#1)
after surgery were##2##3##(2007-11#1)(2012-12#1)
after surgery with##2##3##(2008-12#1)(2008-7#1)
after surgery##157##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-3#3)(1993-6#1)(1994-12#5)(1994-8#1)(1995-11#1)(1995-3#2)(1995-4#3)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#12)(2007-7#1)(2007-8#25)(2008-1#2)(2008-10#3)(2008-12#1)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#3)(2009-1#2)(2009-4#2)(2009-5#1)(2010-10#3)(2010-12#1)(2010-4#3)(2010-6#2)(2011-1#1)(2011-2#15)(2012-1#4)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#11)(2013-8#2)
after surgical intervention##3##3##(1990-2#1)(2008-7#1)(2008-8#1)
after surgical procedures##2##3##(1992-1#1)(1993-5#1)
after surgical removal of the##2##5##(1995-12#1)(2009-3#1)
after surgical resection and##3##4##(2010-3#1)(2011-2#1)(2013-8#1)
after surgical resection of the giant-cell tumour##2##7##(2007-11#2)
after surgical resection of##3##4##(2007-11#2)(2011-2#1)
after surgical resection##8##3##(1991-12#1)(2007-11#2)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
after surgical therapy##2##3##(1990-9#1)(2008-7#1)
after surgical treatment of bone metastases##4##6##(2007-11#4)
after surgical treatment of##10##4##(1991-6#1)(2007-11#6)(2007-8#1)(2008-6#1)(2013-1#1)
after surgical treatment##20##3##(1991-2#1)(1991-6#1)(1995-2#1)(2007-11#6)(2007-8#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
after surgical##46##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(2007-11#8)(2007-8#5)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#2)
after switching##2##2##(2008-7#1)(2009-11#1)
after taking##5##2##(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#1)
after temporary##2##2##(1993-3#1)(2008-12#1)
after ten years of##2##4##(2008-9#2)
after ten##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)
after termination of##4##3##(1992-6#1)(1993-12#1)(1996-12#1)(2008-1#1)
after tertiary##2##2##(1993-11#1)(2013-1#1)
after than before##2##3##(1991-6#1)(2012-2#1)
after that the##2##3##(2008-10#1)(2010-8#1)
after that##9##2##(1990-2#1)(1992-3#1)(2008-10#3)(2008-12#1)(2009-7#1)(2010-8#1)(2011-1#1)
after the 'stop' cue##2##4##(2008-11#2)
after the 1991 Gulf War##2##5##(2011-2#2)
after the 1st##5##3##(1995-8#2)(2008-5#1)(2009-12#1)(2010-8#1)
after the 20 and 50##2##5##(2008-10#2)
after the 9th day##2##4##(1994-7#1)(2008-10#1)
after the A6-cut##2##3##(2008-6#2)
after the DB exercise##2##4##(2012-2#2)
after the Fontan operation##2##4##(2007-8#2)
after the NaP application##2##4##(2011-2#2)
after the accident##5##3##(1990-9#2)(1992-4#1)(1995-3#1)(2013-1#1)
after the acute##4##3##(1991-11#1)(1991-8#1)(1996-9#1)(2010-10#1)
after the addition of the##2##5##(1990-7#1)(1992-12#1)
after the addition of##12##4##(1990-7#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-8#1)(2007-12#1)(2008-10#5)(2008-4#1)
after the administration of the##3##5##(1995-12#1)(1996-6#1)(2013-1#1)
after the administration of##13##4##(1990-12#1)(1992-11#1)(1994-8#2)(1995-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-2#1)(2013-1#1)
after the admission##3##3##(1990-9#1)(2007-8#1)(2008-7#1)
after the age of##4##4##(1994-5#1)(1994-6#1)(2008-9#1)(2011-2#1)
after the appearance of##2##4##(2008-10#2)
after the application of the##2##5##(2012-1#1)(2013-1#1)
after the application of##8##4##(1992-12#1)(1996-12#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#3)
after the beginning of the##2##5##(1991-7#1)(2008-10#1)
after the beginning of##4##4##(1990-9#1)(1991-7#1)(2008-10#2)
after the care##2##3##(1997-8#2)
after the competition##3##3##(2008-5#3)
after the completion of the##2##5##(2008-8#1)(2013-8#1)
after the completion of##6##4##(1991-8#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-8#1)
after the complication##2##3##(1997-3#1)(2012-12#1)
after the consumption##2##3##(2010-4#2)
after the course##2##3##(1996-2#1)(2007-11#1)
after the crisis##2##3##(2008-2#2)
after the death of a##4##5##(2008-11#1)(2009-5#2)(2010-9#1)
after the death of##6##4##(1994-11#1)(1995-11#1)(2008-11#1)(2009-5#2)(2010-9#1)
after the deep##2##3##(2008-6#1)(2012-2#1)
after the delivery##2##3##(2008-7#1)(2012-3#1)
after the development of##2##4##(2008-10#1)(2008-7#1)
after the diagnosis of##4##4##(2007-10#1)(2007-5#1)(2009-8#1)(2010-6#1)
after the diagnosis##7##3##(2007-10#1)(2007-5#1)(2007-8#1)(2008-6#1)(2009-8#1)(2010-6#1)(2012-12#1)
after the discontinuation of##2##4##(2007-8#1)(2008-11#1)
after the discovery of##4##4##(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)
after the discovery##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-5#1)
after the dose##3##3##(2006-10#1)(2008-6#2)
after the earthquake##2##3##(1996-4#1)(2013-8#1)
after the embolization##2##3##(2008-7#1)(2012-12#1)
after the end of the##3##5##(1995-6#1)(2013-8#2)
after the end of therapy##2##5##(2007-11#1)(2008-1#1)
after the end of treatment##2##5##(2008-10#1)(2013-1#1)
after the end of##16##4##(1995-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#5)
after the eruption of##2##4##(2008-2#1)(2008-3#1)
after the event##7##3##(1991-3#1)(1992-5#1)(2007-10#1)(2007-12#1)(2013-8#3)
after the exposure to##2##4##(1996-2#1)(2008-10#1)
after the exposure##3##3##(1996-2#1)(2008-10#2)
after the first 3##2##4##(1993-2#1)(2011-2#1)
after the first dose##2##4##(2006-10#1)(2008-7#1)
after the first examination##2##4##(2008-5#1)(2008-7#1)
after the first harvest##2##4##(2008-10#2)
after the first operation##2##4##(1991-3#1)(2010-12#1)
after the first passage##2##4##(2008-10#2)
after the first phase##2##4##(1994-6#1)(2011-3#1)
after the first stage##2##4##(2011-2#1)(2012-2#1)
after the first year of##3##5##(1990-11#1)(2008-1#1)(2013-1#1)
after the first year##4##4##(1990-11#1)(1994-3#1)(2008-1#1)(2013-1#1)
after the first##45##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-6#2)(1992-4#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1996-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#5)(2013-8#2)
after the head##3##3##(1995-3#1)(2007-11#1)(2013-8#1)
after the imaginal molt##2##4##(2008-6#2)
after the imaginal##3##3##(1995-11#1)(2008-6#2)
after the immunization##2##3##(1990-12#1)(1993-2#1)
after the impact##2##3##(1995-6#1)(2008-3#1)
after the implementation of a##3##5##(2008-3#1)(2013-1#2)
after the implementation of##6##4##(1997-8#1)(2007-12#1)(2008-3#1)(2010-8#1)(2013-1#2)
after the impoundment##2##3##(2010-8#2)
after the incubation of cells with##2##6##(2008-11#2)
after the incubation with##2##4##(1993-8#1)(2008-11#1)
after the incubation##4##3##(1993-8#1)(2008-11#3)
after the induction of##5##4##(1991-5#1)(2008-11#2)(2012-2#1)(2013-1#1)
after the initial assessment##2##4##(1993-2#1)(2007-1#1)
after the initial operation##5##4##(2008-7#1)(2011-2#3)(2012-3#1)
after the initial##31##3##(1990-9#1)(1993-2#1)(1994-5#1)(1995-1#1)(2007-1#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-2#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
after the initiation of the##2##5##(2008-10#1)(2012-3#1)
after the initiation of##7##4##(1992-1#1)(2008-10#1)(2009-7#1)(2010-5#1)(2011-1#2)(2012-3#1)
after the injection of##6##4##(1991-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-7#1)
after the injection##13##3##(1990-12#1)(1990-5#1)(1991-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
after the injury##3##3##(2007-11#1)(2007-8#2)
after the insertion of##2##4##(2007-8#1)(2008-10#1)
after the insult##3##3##(1996-5#1)(2008-7#2)
after the intervention were##2##4##(2008-12#2)
after the intervention##8##3##(2008-12#6)(2012-12#1)(2013-1#1)
after the introduction of the##4##5##(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
after the introduction of##9##4##(1994-12#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
after the laser##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
after the last chronic stress##2##5##(1995-12#2)
after the last dose of##2##5##(1995-3#1)(2008-7#1)
after the last dose##3##4##(1995-3#1)(1997-7#1)(2008-7#1)
after the last##22##3##(1990-7#1)(1991-9#1)(1993-12#1)(1994-5#1)(1995-12#3)(1995-3#2)(1996-1#1)(1996-12#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-7#1)(2010-12#2)(2012-7#1)
after the loss##2##3##(2008-3#1)(2013-1#1)
after the meal##3##3##(1996-12#1)(2008-7#1)(2010-2#1)
after the medication##3##3##(2008-9#3)
after the mortality##2##3##(2008-5#2)
after the on-line wavelet transform##2##5##(2008-10#2)
after the onset of symptoms##4##5##(2008-5#2)(2008-7#1)(2010-10#1)
after the onset of the##2##5##(2012-12#1)(2013-1#1)
after the onset of##22##4##(1994-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#3)(2010-10#1)(2012-12#1)(2012-5#1)(2013-1#3)(2013-8#1)
after the onset##23##3##(1994-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#3)(2010-10#1)(2010-4#1)(2012-12#1)(2012-5#1)(2013-1#3)(2013-8#1)
after the operation##34##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1994-11#2)(1994-3#2)(1994-9#1)(2006-6#2)(2007-10#3)(2007-11#1)(2007-8#4)(2008-10#3)(2008-6#1)(2008-7#3)(2010-10#1)(2011-2#4)(2012-3#1)(2013-1#2)
after the oral administration of##2##5##(2008-11#1)(2010-10#1)
after the oral##3##3##(2008-11#1)(2008-6#1)(2010-10#1)
after the original##2##3##(1992-8#1)(2008-6#1)
after the patient##4##3##(1991-2#1)(1997-5#1)(2007-9#1)(2008-11#1)
after the period##2##3##(1991-2#1)(1993-1#1)
after the pretreatment##2##3##(2013-1#1)(2013-8#1)
after the primary##2##3##(1990-5#1)(2008-6#1)
after the procedure and##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
after the procedure##16##3##(1994-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#1)
after the process of##2##4##(2008-12#1)(2013-8#1)
after the reaction##2##3##(2007-11#1)(2008-10#1)
after the removal of the##2##5##(1990-6#1)(2008-3#1)
after the removal of##3##4##(1990-6#1)(2008-3#1)(2011-2#1)
after the return##2##3##(1990-9#1)(2010-12#1)
after the same period of##2##5##(1992-6#1)(2008-5#1)
after the same##5##3##(1992-6#1)(2007-11#1)(2008-5#2)(2009-10#1)
after the samples##2##3##(2008-10#1)(2008-3#1)
after the second injection and##2##5##(1990-12#1)(2008-12#1)
after the second injection##4##4##(1990-12#1)(1996-12#2)(2008-12#1)
after the second surgery##2##4##(2007-5#1)(2010-3#1)
after the second##16##3##(1990-12#1)(1992-3#1)(1994-7#1)(1996-12#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-6#2)(2009-5#1)(2010-3#1)(2013-1#1)
after the separation##2##3##(1991-6#1)(2008-10#1)
after the start of insulin therapy##3##6##(1993-12#3)
after the start of treatment##2##5##(1990-2#1)(2011-1#1)
after the start of##12##4##(1990-2#1)(1993-12#3)(1994-6#1)(1995-12#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
after the storm##2##3##(2011-2#2)
after the surgery##10##3##(2007-11#3)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
after the surgical procedure##3##4##(2011-2#2)(2012-12#1)
after the surgical treatment##2##4##(2011-2#1)(2013-8#1)
after the surgical##6##3##(2008-3#1)(2011-2#3)(2012-12#1)(2013-8#1)
after the tenth##2##3##(1996-2#1)(2012-12#1)
after the third##3##3##(1991-5#1)(1995-3#1)(2008-6#1)
after the transfer##2##3##(2008-10#1)(2008-12#1)
after the trauma##2##3##(2008-10#1)(2010-1#1)
after the treatment of##2##4##(2008-8#2)
after the treatment##11##3##(1995-11#1)(1997-8#1)(2007-11#4)(2008-5#1)(2008-8#2)(2010-12#1)(2013-1#1)
after the two-week##2##3##(2009-6#2)
after the use of a hair dye##2##7##(2012-3#2)
after the use of##6##4##(1992-6#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-3#2)
after the withdrawal of serum##2##5##(1996-2#2)
after the withdrawal of##3##4##(1996-2#2)(2008-5#1)
after the year##2##3##(1994-7#1)(2012-12#1)
after the##872##2##(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#8)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#4)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#4)(1993-1#1)(1993-12#5)(1993-2#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#7)(1994-3#6)(1994-5#5)(1994-6#6)(1994-7#3)(1994-8#3)(1994-9#5)(1995-1#1)(1995-11#5)(1995-12#10)(1995-2#5)(1995-3#7)(1995-4#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#6)(2006-10#2)(2006-6#2)(2007-1#1)(2007-10#9)(2007-11#21)(2007-12#9)(2007-2#1)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#19)(2007-9#1)(2008-1#5)(2008-10#105)(2008-11#30)(2008-12#15)(2008-2#13)(2008-3#17)(2008-4#4)(2008-5#27)(2008-6#26)(2008-7#34)(2008-8#10)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#5)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#10)(2011-2#41)(2011-3#1)(2012-1#5)(2012-12#12)(2012-2#16)(2012-3#13)(2012-5#1)(2012-7#1)(2013-1#55)(2013-7#3)(2013-8#30)
after their arrival##2##3##(2011-2#1)(2012-2#1)
after their first##2##3##(2010-8#2)
after their##31##2##(1990-12#1)(1992-5#1)(1993-3#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
after therapy in##2##3##(1990-3#1)(1996-2#1)
after therapy##12##2##(1990-3#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
after these##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
after they had been##3##4##(1995-9#1)(1996-12#1)(1997-7#1)
after they had received mandibular##2##5##(2013-1#2)
after they had##9##3##(1995-9#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-8#1)(2009-6#1)(2013-1#2)
after they have become##2##4##(1997-6#1)(2008-1#1)
after they have been##2##4##(1990-11#1)(2009-7#1)
after they have##5##3##(1990-11#1)(1993-2#1)(1997-6#1)(2008-1#1)(2009-7#1)
after they were##2##3##(2008-1#1)(2008-10#1)
after they##25##2##(1990-11#1)(1992-2#1)(1993-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2013-1#2)
after this treatment##2##3##(1993-9#1)(2009-12#1)
after this##9##2##(1992-5#1)(1993-9#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-12#1)(2010-3#1)(2012-2#1)
after thoracic surgery##2##3##(1991-2#1)(2007-8#1)
after thoracic surgical procedures##2##4##(2007-8#2)
after thoracic##4##2##(1991-2#1)(2007-8#3)
after thorough##4##2##(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
after three days of##2##4##(2008-5#1)(2012-2#1)
after three days##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
after three months of##2##4##(2010-8#1)(2012-2#1)
after three months##4##3##(1993-3#1)(2008-5#1)(2010-8#1)(2012-2#1)
after three weeks of##2##4##(2008-5#2)
after three weeks##3##3##(2008-5#3)
after three years of##2##4##(1995-1#2)
after three##19##2##(1990-7#1)(1992-6#1)(1993-3#1)(1995-1#2)(1997-7#1)(2008-10#1)(2008-5#7)(2009-8#1)(2010-12#1)(2010-8#1)(2012-2#2)
after thrombin stimulation##2##3##(1992-12#1)(1993-8#1)
after thrombolysis##3##2##(1990-3#1)(1996-6#1)(2007-9#1)
after tobacco##2##2##(1991-12#1)(2007-12#1)
after tooth separation##3##3##(2008-12#3)
after topical application of##2##4##(1992-9#1)(2008-5#1)
after topical application##3##3##(1992-9#1)(2008-5#2)
after topical##5##2##(1992-2#1)(1992-9#1)(2008-12#1)(2008-5#2)
after total hip arthroplasty and##3##5##(2007-8#1)(2008-6#1)(2011-2#1)
after total hip arthroplasty##4##4##(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
after total hip replacement##6##4##(2007-8#1)(2010-10#4)(2013-1#1)
after total hip##11##3##(2007-8#2)(2008-6#1)(2010-10#4)(2011-2#1)(2013-1#3)
after total joint##2##3##(2008-10#1)(2011-2#1)
after total knee arthroplasty##7##4##(2007-11#2)(2007-8#1)(2008-8#3)(2012-2#1)
after total knee##8##3##(2007-11#2)(2007-8#2)(2008-8#3)(2012-2#1)
after total##26##2##(1990-9#1)(2007-11#2)(2007-8#5)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2010-10#4)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
after toxin##2##2##(1996-11#1)(2008-5#1)
after tracheal##3##2##(2012-12#1)(2013-1#2)
after training##5##2##(1994-8#1)(2008-4#1)(2009-8#1)(2013-1#2)
after transcervical resection of##2##4##(2011-2#1)(2013-1#1)
after transcervical##3##2##(1991-8#1)(2011-2#1)(2013-1#1)
after transcranial##2##2##(2010-5#1)(2010-7#1)
after transection##3##2##(1996-12#2)(2012-3#1)
after transfection of##2##3##(1995-6#1)(2012-2#1)
after transfection with a##2##4##(2008-11#1)(2008-8#1)
after transfection with##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
after transfection##10##2##(1990-12#1)(1992-12#1)(1995-2#1)(1995-6#1)(2008-11#3)(2008-2#1)(2008-8#1)(2012-2#1)
after transfer to##2##3##(1997-3#1)(2012-4#1)
after transfer##6##2##(1994-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-4#1)
after transient##6##2##(1990-7#1)(1991-11#1)(1996-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
after transplantation of mononuclear##2##4##(2012-1#2)
after transplantation##26##2##(1994-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#3)(2013-1#1)
after transplantation&quot##2##2##(2009-10#2)
after trauma to##2##3##(2013-1#2)
after trauma##16##2##(1995-12#2)(2007-11#2)(2007-8#1)(2008-2#1)(2008-8#2)(2012-3#1)(2012-7#2)(2013-1#3)(2013-8#2)
after traumatic brain injury##3##4##(2007-11#1)(2008-7#1)(2013-8#1)
after traumatic##7##2##(2007-11#1)(2008-11#1)(2008-7#2)(2008-9#1)(2013-1#1)(2013-8#1)
after travel##2##2##(2007-2#1)(2011-2#1)
after treatment (18##2##3##(2011-1#2)
after treatment and##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
after treatment began##2##3##(1990-10#1)(2008-5#1)
after treatment for##5##3##(1991-6#1)(1992-6#1)(2007-10#1)(2010-11#1)(2013-1#1)
after treatment had##2##3##(1997-4#1)(2008-7#1)
after treatment in##4##3##(1990-2#1)(1995-11#1)(1997-3#1)(2008-6#1)
after treatment of the##3##4##(1991-11#1)(1995-12#1)(2008-11#1)
after treatment of##16##3##(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1994-11#1)(1995-12#2)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-6#1)(2011-1#1)
after treatment or##3##3##(1992-1#1)(1997-4#1)(2011-1#1)
after treatment was##3##3##(1990-12#1)(1991-9#1)(1993-8#1)
after treatment were##3##3##(1991-2#1)(2013-1#2)
after treatment with 3##2##4##(1992-12#1)(1993-8#1)
after treatment with an##2##4##(1991-12#1)(2008-4#1)
after treatment with the##6##4##(1993-11#1)(1996-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
after treatment with##48##3##(1990-12#2)(1990-2#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
after treatment withdrawal##2##3##(2007-11#2)
after treatment##168##2##(1990-10#3)(1990-12#3)(1990-2#5)(1990-3#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#7)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-5#3)(1996-6#3)(1996-9#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#9)(2011-10#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#13)(2013-8#1)
after treatment)##3##2##(1991-2#1)(1994-8#1)(2008-10#1)
after tumour resection##2##3##(2007-11#1)(2012-8#1)
after two broccoli##2##3##(2008-10#2)
after two hours of##2##4##(1994-3#1)(2010-7#1)
after two months of##3##4##(2008-5#1)(2013-1#2)
after two months##5##3##(1997-6#1)(2007-8#1)(2008-5#1)(2013-1#2)
after two years of treatment##2##5##(2007-8#1)(2012-3#1)
after two years of##4##4##(1994-2#1)(2007-8#1)(2012-3#1)(2013-7#1)
after two years##10##3##(1990-11#1)(1992-5#2)(1994-2#1)(1995-5#1)(1996-3#1)(2007-8#1)(2012-3#1)(2013-7#2)
after two##36##2##(1990-11#2)(1992-5#2)(1993-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#2)(1996-3#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#2)(2009-5#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#2)
after undergoing an##2##3##(2008-6#1)(2011-2#1)
after undergoing##5##2##(1996-9#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
after unilateral fusion##2##3##(2008-8#2)
after unilateral##6##2##(1994-3#1)(1994-8#1)(1997-3#1)(2008-5#1)(2008-8#2)
after use of##3##3##(1992-11#1)(2008-2#1)(2008-5#1)
after use##5##2##(1992-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-6#1)
after using##5##2##(1992-3#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
after vaccination##9##2##(1991-8#1)(1994-8#1)(1995-5#1)(1996-11#1)(2007-2#2)(2008-9#1)(2011-2#1)(2012-2#1)
after valve##2##2##(1997-5#1)(2008-10#1)
after various##2##2##(2008-10#1)(2013-1#1)
after vascular##2##2##(1992-9#1)(2006-10#1)
after very##2##2##(2008-5#1)(2008-7#1)
after viewing##3##2##(1993-2#1)(2007-12#1)(2009-8#1)
after washing##2##2##(2008-5#2)
after water##3##2##(2008-10#2)(2008-5#1)
after weaning is##3##3##(2013-1#3)
after weaning or litter removal##2##5##(1994-6#2)
after weaning##9##2##(1992-3#1)(1994-6#2)(1996-12#1)(2007-8#1)(2011-1#1)(2013-1#3)
after weeks##4##2##(2008-8#1)(2008-9#3)
after wet##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
after which the##8##3##(1991-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-9#1)
after which they were##2##4##(1993-6#1)(1996-9#1)
after which they##3##3##(1993-6#1)(1996-9#1)(2007-12#1)
after which##29##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-6#1)(1994-9#1)(1995-2#1)(1996-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
after wide##4##2##(1992-2#1)(1994-12#1)(2008-6#1)(2013-1#1)
after withdrawal of##2##3##(1991-3#1)(2008-11#1)
after withdrawal##6##2##(1991-3#1)(1992-11#1)(1995-12#1)(2007-8#1)(2008-11#1)(2013-1#1)
after wounding##8##2##(1997-2#2)(2008-10#3)(2008-7#2)(2012-12#1)
after xylose administration##2##3##(1996-6#2)
after##7323##1##(1990-10#7)(1990-11#20)(1990-12#51)(1990-2#39)(1990-3#21)(1990-5#43)(1990-6#31)(1990-7#21)(1990-8#27)(1990-9#31)(1991-1#8)(1991-10#2)(1991-11#26)(1991-12#43)(1991-2#48)(1991-3#31)(1991-4#2)(1991-5#19)(1991-6#26)(1991-7#2)(1991-8#24)(1991-9#21)(1992-1#7)(1992-10#11)(1992-11#12)(1992-12#37)(1992-2#34)(1992-3#33)(1992-4#15)(1992-5#32)(1992-6#39)(1992-7#2)(1992-8#25)(1992-9#34)(1993-1#15)(1993-10#1)(1993-11#22)(1993-12#42)(1993-2#23)(1993-3#22)(1993-5#2)(1993-6#24)(1993-8#30)(1993-9#17)(1994-1#6)(1994-10#1)(1994-11#32)(1994-12#33)(1994-2#27)(1994-3#35)(1994-5#26)(1994-6#32)(1994-7#8)(1994-8#36)(1994-9#12)(1995-1#5)(1995-10#1)(1995-11#43)(1995-12#82)(1995-2#36)(1995-3#60)(1995-4#6)(1995-5#37)(1995-6#28)(1995-8#20)(1995-9#7)(1996-1#13)(1996-11#16)(1996-12#46)(1996-2#37)(1996-3#19)(1996-4#2)(1996-5#43)(1996-6#24)(1996-7#6)(1996-8#12)(1996-9#17)(1997-1#9)(1997-2#41)(1997-3#32)(1997-4#34)(1997-5#20)(1997-6#26)(1997-7#22)(1997-8#36)(2006-10#22)(2006-11#1)(2006-12#5)(2006-4#1)(2006-6#9)(2006-7#2)(2006-8#7)(2007-1#3)(2007-10#70)(2007-11#138)(2007-12#72)(2007-2#16)(2007-4#3)(2007-5#12)(2007-6#6)(2007-7#48)(2007-8#215)(2007-9#11)(2008-1#71)(2008-10#1212)(2008-11#224)(2008-12#137)(2008-2#44)(2008-3#83)(2008-4#46)(2008-5#204)(2008-6#98)(2008-7#292)(2008-8#122)(2008-9#154)(2009-1#9)(2009-10#22)(2009-11#17)(2009-12#30)(2009-2#4)(2009-3#31)(2009-4#20)(2009-5#25)(2009-6#20)(2009-7#30)(2009-8#15)(2009-9#9)(2010-1#11)(2010-10#19)(2010-11#34)(2010-12#32)(2010-2#12)(2010-3#31)(2010-4#22)(2010-5#26)(2010-6#29)(2010-7#17)(2010-8#49)(2010-9#6)(2011-1#78)(2011-10#2)(2011-2#330)(2011-3#13)(2011-5#1)(2012-1#48)(2012-12#116)(2012-2#133)(2012-3#151)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#10)(2012-8#2)(2013-1#373)(2013-7#20)(2013-8#140)
after&quot##2##1##(1993-12#1)(1996-1#1)
after-effects of##4##2##(1991-12#1)(1991-6#1)(1995-11#1)(1997-5#1)
after-effects##5##1##(1991-12#1)(1991-6#2)(1995-11#1)(1997-5#1)
after-hours##2##1##(1995-12#1)(1995-2#1)
after-school program##3##2##(2012-12#2)(2013-1#1)
after-school##4##1##(2012-12#3)(2013-1#1)
afterdischarge##2##1##(1992-3#1)(1994-2#1)
afterdischarges##2##1##(1991-12#1)(1994-2#1)
afterglow atmospheric pressure glow discharge mass spectrometry##2##7##(2010-5#2)
afterglow##4##1##(2008-3#2)(2010-5#2)
afterhyperpolarization##2##1##(1992-3#1)(1996-2#1)
afterload of##2##2##(2008-8#1)(2012-3#1)
afterload##5##1##(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-3#1)
aftermath of the##4##3##(1993-12#1)(2008-4#1)(2012-1#1)(2013-1#1)
aftermath of##7##2##(1993-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
aftermath##11##1##(1993-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
afternoon and##3##2##(1993-12#1)(2007-12#1)(2012-6#1)
afternoon##13##1##(1993-12#2)(1994-3#1)(2007-12#1)(2008-3#1)(2008-5#4)(2010-5#1)(2011-2#1)(2012-6#1)(2013-8#1)
afternystagmus##9##1##(2008-4#9)
afterpulses##3##1##(2008-3#3)
aftershock##2##1##(1996-4#2)
afterward##4##1##(1995-6#1)(2008-3#1)(2008-8#1)(2011-2#1)
afterwards##20##1##(1990-6#1)(1992-6#1)(1994-12#1)(1995-12#1)(2007-11#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
afterxenotransplantation##2##1##(2008-11#2)
again 4##3##2##(1990-2#1)(1993-12#1)(2013-1#1)
again after##5##2##(1993-6#1)(1995-11#1)(1996-3#1)(2008-2#1)(2013-1#1)
again and##3##2##(2008-7#1)(2009-11#1)(2013-8#1)
again at the end of the##2##6##(2008-10#1)(2008-12#1)
again at##8##2##(1991-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
again become##2##2##(1993-5#1)(2007-2#1)
again by##3##2##(1994-3#1)(2008-10#2)
again following##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
again for##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
again in order##2##3##(1993-9#1)(2008-10#1)
again in the##4##3##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
again in this##2##3##(1997-2#1)(2008-10#1)
again in##16##2##(1990-2#1)(1992-3#1)(1993-9#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
again occurred##2##2##(1991-8#1)(2008-10#1)
again on the##2##3##(2011-2#1)(2013-1#1)
again suggested##3##2##(1992-6#1)(2008-10#1)(2008-6#1)
again the##4##2##(1992-6#1)(1995-11#1)(2008-10#1)(2008-8#1)
again to##6##2##(1991-11#1)(1997-3#1)(2007-12#1)(2008-10#2)(2010-8#1)
again using##2##2##(2007-8#1)(2010-8#1)
again with##5##2##(1994-12#1)(2007-10#1)(2008-10#3)
again##175##1##(1990-2#3)(1990-3#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#4)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#4)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#2)(2009-11#3)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-12#3)(2012-3#2)(2013-1#10)(2013-8#4)
against 10 serotypes of S##2##5##(2012-12#2)
against 10 serotypes of##3##4##(2012-12#3)
against 10##5##2##(1997-4#1)(2008-12#1)(2012-12#3)
against 16##2##2##(2008-10#1)(2012-2#1)
against 2##4##2##(1995-6#2)(2008-11#1)(2013-7#1)
against A##4##2##(2008-10#3)(2008-5#1)
against AIDS##2##2##(1990-11#1)(1995-1#1)
against Alzheimer's disease##2##3##(2008-7#1)(2011-3#1)
against Aspergillus##2##2##(2008-10#1)(2008-5#1)
against B##6##2##(2007-11#1)(2008-10#4)(2010-6#1)
against Botrytis##2##2##(2008-10#2)
against C##12##2##(1991-8#2)(1995-12#1)(2007-11#1)(2008-10#3)(2008-5#4)(2009-9#1)
against CA1 traumatic neuronal injury##2##5##(1995-12#2)
against Calif/09##2##2##(2011-2#2)
against Candida albicans##3##3##(2008-11#1)(2010-5#2)
against Candida##5##2##(2008-11#1)(2008-5#1)(2010-5#2)(2013-1#1)
against DNA##2##2##(1997-2#1)(1997-4#1)
against E##4##2##(2008-12#2)(2008-8#1)(2010-3#1)
against EDTA as well as##2##5##(2008-10#2)
against EDTA##5##2##(2008-10#5)
against EMC-D##3##2##(1997-4#3)
against Escherichia coli##3##3##(2007-11#1)(2010-3#1)(2012-3#1)
against F##6##2##(2008-10#3)(2009-5#2)(2011-10#1)
against FMDV##3##2##(2013-1#3)
against GAP##2##2##(1991-5#1)(1992-12#1)
against Gram-negative##2##2##(2008-10#1)(2008-7#1)
against H##2##2##(2008-10#2)
against HGF was##2##3##(2008-9#2)
against HIV and##3##3##(1991-3#1)(1995-5#1)(2012-3#1)
against HIV##7##2##(1990-6#3)(1990-8#1)(1991-3#1)(1995-5#1)(2012-3#1)
against HIV-1 replicative enzymes##2##4##(2011-3#2)
against HIV-1##7##2##(1992-8#1)(1992-9#1)(2011-3#5)
against HLA##2##2##(2008-9#1)(2011-2#1)
against Haemophilus influenzae type b##2##5##(1995-5#2)
against Haemophilus influenzae type##4##4##(1992-9#1)(1995-5#2)(2008-11#1)
against Helicobacter pylori##2##3##(2008-10#2)
against Helicobacter##3##2##(1991-2#1)(2008-10#2)
against Heterodera schachtii##2##3##(2008-10#1)(2008-12#1)
against Hib disease##2##3##(1995-5#2)
against K##2##2##(2012-3#2)
against Klebsiella pneumoniae##2##3##(2010-3#1)(2012-3#1)
against M##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
against Meloidogyne incognita##2##3##(2008-10#1)(2011-2#1)
against Micrococcus luteus##3##3##(1997-6#1)(2008-12#1)(2012-3#1)
against Mycobacterium tuberculosis##2##3##(2011-2#1)(2012-3#1)
against P##13##2##(1992-6#1)(2008-10#6)(2008-5#4)(2008-8#1)(2012-3#1)
against PVX##2##2##(2008-10#2)
against Phytophthora infestans##2##3##(2008-10#2)
against Phytophthora##3##2##(2008-10#3)
against Plasmodium falciparum in vitro##2##5##(1992-6#1)(1997-4#1)
against Plasmodium falciparum##3##3##(1992-6#1)(1997-4#1)(2008-10#1)
against Plasmopara viticola##2##3##(2008-10#2)
against Propionibacterium acnes##2##3##(2008-5#2)
against Pseudomonas aeruginosa##2##3##(2010-3#1)(2012-2#1)
against Pseudomonas##4##2##(2008-10#1)(2008-12#1)(2010-3#1)(2012-2#1)
against Puumala virus##2##3##(1991-11#2)
against Pythium ultimum##2##3##(2008-10#2)
against R##3##2##(1997-6#1)(2008-10#1)(2009-2#1)
against Rhizoctonia##2##2##(2008-10#2)
against S##6##2##(2007-11#1)(2008-10#1)(2008-8#2)(2010-5#1)(2013-8#1)
against Salmonella##2##2##(1995-9#1)(2012-3#1)
against Staphylococcus aureus##4##3##(1993-2#1)(2008-12#2)(2012-3#1)
against Streptococcus pneumoniae##4##3##(1995-5#1)(2007-12#1)(2011-2#2)
against Streptococcus##5##2##(1995-5#1)(2007-12#1)(2009-6#1)(2011-2#2)
against TB##2##2##(2010-5#1)(2013-1#1)
against W-CI##3##2##(2008-10#3)
against a CoCrMo alloy##2##4##(2008-5#2)
against a background of##2##4##(2008-8#1)(2011-1#1)
against a blank##3##3##(2008-10#3)
against a broad range of##2##5##(2008-10#1)(2009-6#1)
against a broad spectrum of##3##5##(1994-5#1)(2008-10#1)(2008-5#1)
against a broad##5##3##(1994-5#1)(2008-10#2)(2008-5#1)(2009-6#1)
against a database##2##3##(2008-4#1)(2008-9#1)
against a human##2##3##(1995-6#1)(2008-11#1)
against a lethal##2##3##(1994-8#1)(2012-2#1)
against a major##2##3##(2008-11#1)(2008-7#1)
against a number of##2##4##(1994-11#1)(2008-5#1)
against a panel of##4##4##(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
against a peptide corresponding to##2##5##(1991-5#1)(1992-3#1)
against a range of##5##4##(1994-6#1)(2008-10#2)(2008-7#1)(2012-2#1)
against a reagent blank##2##4##(2008-10#2)
against a reference##3##3##(2008-10#2)(2012-12#1)
against a second##2##3##(1997-5#1)(2008-10#1)
against a single##2##3##(1992-2#1)(2010-10#1)
against a synthetic peptide##3##4##(1991-12#1)(1995-6#1)(2008-10#1)
against a synthetic##4##3##(1991-12#1)(1991-8#1)(1995-6#1)(2008-10#1)
against a wide##3##3##(1994-2#1)(2008-6#1)(2013-8#1)
against a##95##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-5#2)(1995-6#2)(1996-12#2)(1997-5#2)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#25)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-6#2)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
against addition of an##2##4##(2008-8#2)
against agricultural##2##2##(2008-9#1)(2010-1#1)
against alcohol##2##2##(1994-5#1)(2009-8#1)
against all the Candida##2##4##(2010-5#2)
against all the##5##3##(2008-10#1)(2010-3#1)(2010-5#2)(2012-12#1)
against all three##2##3##(2008-10#1)(2008-8#1)
against all##17##2##(1994-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
against an##24##2##(1990-5#1)(1990-8#1)(1992-12#1)(1993-2#1)(1994-8#1)(1995-12#2)(1995-6#2)(1996-12#2)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)
against another##2##2##(2008-10#1)(2012-3#1)
against anthracnose##2##2##(2008-10#2)
against any##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
against apoptosis by##3##3##(2008-11#1)(2010-11#2)
against apoptosis##5##2##(2008-11#1)(2010-11#3)(2012-3#1)
against aqueous standards##3##3##(2008-10#3)
against aqueous##4##2##(2008-10#4)
against autologous##2##2##(1993-9#1)(2008-11#1)
against avian##2##2##(1997-6#1)(2008-9#1)
against bacteria and fungi##2##4##(2008-5#1)(2011-1#1)
against bacteria and##3##3##(2008-5#2)(2011-1#1)
against bacteria##4##2##(2008-5#3)(2011-1#1)
against bacterial speck##3##3##(2008-10#3)
against bacterial##10##2##(1992-5#1)(2008-10#5)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
against benzo[a]pyrene##2##2##(2008-10#2)
against beta##2##2##(1993-12#1)(1997-4#1)
against blood##2##2##(1993-1#1)(1995-6#1)
against blue mold##2##3##(2008-10#2)
against both Gram##2##3##(2012-3#2)
against both UVB and UVA##2##5##(2008-5#2)
against both gram positive and gram negative bacteria##2##8##(2008-11#1)(2010-3#1)
against both viruses##3##3##(2008-10#3)
against both##26##2##(1990-12#1)(1992-2#1)(1992-6#2)(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#4)(2009-10#1)(2010-1#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#2)
against bovine##4##2##(1994-5#1)(1995-5#1)(1995-9#1)(1997-2#1)
against brain##3##2##(1994-6#1)(2011-2#1)(2013-1#1)
against breast cancer##3##3##(1994-8#1)(1996-6#1)(1997-7#1)
against burnout##3##2##(2010-2#3)
against cancer cells##2##3##(2008-11#1)(2009-2#1)
against cancer##11##2##(1994-2#1)(2008-11#3)(2008-5#1)(2009-2#2)(2009-5#1)(2011-2#1)(2013-1#2)
against canine##3##2##(1991-6#1)(2008-12#1)(2012-1#1)
against cardiovascular##2##2##(1993-6#1)(1994-11#1)
against cell death##2##3##(1997-9#1)(2011-9#1)
against cell##6##2##(1997-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-9#1)(2013-7#1)
against challenge with##2##3##(1997-6#1)(2009-6#1)
against challenge##3##2##(1997-6#2)(2009-6#1)
against chemical##2##2##(2010-7#2)
against chemically##4##2##(1993-9#1)(1995-2#1)(2008-10#2)
against children and adolescents##3##4##(2008-9#1)(2012-3#2)
against children##7##2##(1993-2#1)(1994-3#1)(2008-9#1)(2011-1#1)(2012-3#3)
against chloroquine-resistant malaria##3##3##(1992-6#3)
against cisplatin##3##2##(1990-12#1)(1993-2#1)(2008-2#1)
against clinical isolates##2##3##(2008-5#1)(2009-7#1)
against clinical##3##2##(1995-5#1)(2008-5#1)(2009-7#1)
against cognitive##2##2##(2008-7#1)(2009-6#1)
against colon cancer##2##3##(1993-11#1)(1993-9#1)
against colon##3##2##(1993-11#1)(1993-9#1)(2008-11#1)
against colorectal cancer##2##3##(2008-8#1)(2009-12#1)
against common##3##2##(2008-10#1)(2009-2#1)(2011-2#1)
against complete proteins (MbSA and ex MbSA)##2##7##(2011-2#2)
against complete##3##2##(2008-7#1)(2011-2#2)
against coptisine##2##2##(2008-11#2)
against crocin##2##2##(2008-11#2)
against damping-off##2##2##(2008-10#2)
against degradation##3##2##(1994-12#1)(2008-11#1)(2008-5#1)
against dermatophytes##2##2##(2008-3#2)
against diet-induced hypercholesterolemia in##2##4##(1990-11#1)(1995-2#1)
against different##6##2##(2008-10#2)(2008-12#1)(2008-3#1)(2010-5#1)(2012-2#1)
against diphtheria##2##2##(1992-2#2)
against disease##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
against diseases##4##2##(2009-10#1)(2009-8#1)(2012-2#2)
against dopaminergic and nondopaminergic neurons##2##5##(2008-7#2)
against dopaminergic neurons##4##3##(2008-7#4)
against dopaminergic##6##2##(2008-7#6)
against drugs##2##2##(2008-8#1)(2013-8#1)
against each##2##2##(2008-8#1)(2011-2#1)
against ear##2##2##(2010-5#2)
against either##6##2##(1993-9#1)(1994-5#1)(2008-10#2)(2008-7#1)(2011-2#1)
against endometrial##2##2##(1994-9#2)
against environmental stress##2##3##(2008-10#2)
against estrogen-induced endometrial##2##3##(1994-9#2)
against ethanol##2##2##(1997-7#1)(2013-8#1)
against ethanol-induced##3##2##(1992-6#1)(2009-8#1)(2012-3#1)
against experimental##7##2##(1993-5#1)(1995-2#1)(1995-5#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
against exploitation##2##2##(2012-3#2)
against external##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
against five##3##2##(1990-12#1)(2007-11#1)(2008-6#1)
against foot-and-mouth disease##2##3##(2013-1#2)
against foreign##7##2##(1992-12#1)(2008-8#4)(2009-9#1)(2012-2#1)
against free radicals##2##3##(1994-6#1)(2010-8#1)
against free##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
against fresh##3##2##(1993-9#2)(2008-10#1)
against fungal pathogens##3##3##(2008-10#2)(2011-2#1)
against fungal##6##2##(2008-10#5)(2011-2#1)
against further##3##2##(1994-3#1)(2007-8#1)(2008-7#1)
against future##2##2##(2008-7#2)
against glutamate neurotoxicity##2##3##(2008-7#2)
against glutamate##5##2##(1993-8#1)(2008-7#3)(2009-12#1)
against gram##3##2##(1997-8#1)(2007-7#1)(2008-8#1)
against gram-positive##2##2##(2007-12#1)(2010-3#1)
against gray leaf spot##2##4##(2008-10#2)
against health##2##2##(1995-2#1)(2011-2#1)
against heart##3##2##(2008-3#2)(2008-7#1)
against heartwater##3##2##(1996-12#1)(2010-1#2)
against hematotoxicity##2##2##(2008-10#2)
against hepatitis A##2##3##(2007-12#1)(2007-2#1)
against hepatitis B virus (HBV)##2##5##(2013-1#2)
against hepatitis B##6##3##(1993-6#1)(1994-5#1)(1997-8#1)(2013-1#3)
against hepatitis##9##2##(1993-6#1)(1994-5#1)(1997-8#1)(2007-12#1)(2007-2#2)(2013-1#3)
against her##2##2##(1992-12#1)(1995-12#1)
against high##4##2##(1997-7#1)(2008-4#1)(2010-4#1)(2012-4#1)
against hospital##2##2##(1993-12#1)(1997-2#1)
against human tumor cells##2##4##(1990-12#2)
against human##22##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
against inactivation by##2##3##(1991-5#1)(1995-11#1)
against inactivation##4##2##(1991-12#1)(1991-5#1)(1992-5#1)(1995-11#1)
against individual##2##2##(1990-5#1)(2008-2#1)
against infection by##4##3##(2008-10#3)(2008-9#1)
against infection with##4##3##(1991-6#1)(2007-11#1)(2009-6#1)(2011-2#1)
against infection##12##2##(1991-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-9#2)(2009-6#2)(2011-2#1)
against infections##2##2##(1993-6#1)(2008-7#1)
against infectious##4##2##(1995-12#1)(1997-6#1)(2008-4#1)(2011-2#1)
against inflammatory##3##2##(2008-7#1)(2009-12#1)(2010-5#1)
against influenza##2##2##(2007-12#1)(2009-12#1)
against insect##2##2##(2007-2#1)(2009-8#1)
against insects##2##2##(2008-7#1)(2012-2#1)
against intestinal##2##2##(2008-10#1)(2013-1#1)
against ischemia##3##2##(1991-9#1)(2008-11#1)(2009-12#1)
against ischemia/reperfusion injury in##2##4##(1996-9#1)(2010-12#1)
against ischemic##2##2##(1995-12#1)(2011-2#1)
against isolates##2##2##(2008-10#2)
against it##2##2##(2008-9#1)(2013-8#1)
against its##4##2##(1990-2#1)(1991-7#1)(1994-3#1)(2008-10#1)
against known resistors##2##3##(2008-10#2)
against known##4##2##(2008-10#2)(2008-2#1)(2008-9#1)
against larvae of##2##3##(2008-11#1)(2008-12#1)
against late blight##5##3##(2008-10#4)(2009-6#1)
against late##7##2##(2007-12#1)(2008-10#4)(2009-6#1)(2010-11#1)
against less##2##2##(2008-10#1)(2013-8#1)
against lethal##5##2##(1992-8#1)(1995-12#1)(1995-2#1)(2009-6#1)(2013-7#1)
against liability##2##2##(1993-12#1)(1994-1#1)
against liver##2##2##(1990-9#1)(2010-12#1)
against malaria##4##2##(1995-5#1)(2011-1#1)(2011-2#2)
against many##6##2##(2007-7#1)(2008-10#2)(2010-8#1)(2012-12#1)(2013-8#1)
against measurements##2##2##(2008-3#2)
against medical advice##2##3##(1993-12#1)(1996-3#1)
against medical##3##2##(1993-12#1)(1996-3#1)(2011-2#1)
against microbial##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)
against more##2##2##(2008-10#1)(2011-2#1)
against mortality##2##2##(2008-8#1)(2011-2#1)
against most of the##2##4##(1990-8#1)(1991-11#1)
against most##4##2##(1990-8#1)(1991-11#1)(2010-12#1)(2011-2#1)
against mouse##3##2##(1993-8#1)(2008-11#1)(2008-9#1)
against multiple cucumber pathogens##2##4##(2008-10#2)
against multiple##5##2##(1992-1#1)(2008-10#4)
against myocardial##2##2##(1996-9#1)(2010-12#1)
against naturally##2##2##(1997-3#1)(2008-11#1)
against neuronal##3##2##(1991-5#1)(1991-6#1)(1995-12#1)
against noise##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
against normal##2##2##(2008-11#1)(2012-12#1)
against one or##3##3##(1993-2#2)(2008-10#1)
against one##6##2##(1990-5#1)(1990-8#1)(1993-2#2)(1995-1#1)(2008-10#1)
against organisms causing serious infections in##2##6##(2008-7#2)
against oropharyngeal and##2##3##(2008-5#2)
against oropharyngeal##3##2##(2008-5#3)
against other##11##2##(1992-12#1)(1993-1#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#1)(2011-2#1)
against oxidative damage##4##3##(1992-9#1)(2008-1#1)(2008-2#1)(2012-2#1)
against oxidative stress##2##3##(2008-10#1)(2008-5#1)
against oxidative##10##2##(1992-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-7#1)
against oxygen##3##2##(1991-9#1)(1992-11#1)(2008-7#1)
against pH##2##2##(2008-10#2)
against partially##2##2##(1990-11#1)(2008-3#1)
against pathogen invasion##2##3##(2008-10#1)(2008-9#1)
against pathogen##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2013-8#1)
against pathogenic##5##2##(1997-6#1)(2008-10#2)(2008-8#1)(2009-6#1)
against pathogens and##3##3##(2007-12#1)(2008-10#1)(2009-6#1)
against pathogens##8##2##(1992-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-6#1)(2011-10#1)(2012-2#1)
against plant pathogens##2##3##(2008-10#2)
against plant##4##2##(2008-10#4)
against polysaccharide##2##2##(2012-12#2)
against postharvest##4##2##(2008-10#4)
against potential##4##2##(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
against powdery mildew##5##3##(2008-10#5)
against pre- and post-emergence##2##4##(2008-10#1)(2013-8#1)
against progressive##2##2##(1993-2#1)(2008-7#1)
against protein##2##2##(1990-12#1)(2008-10#1)
against pulmonary##3##2##(1993-10#1)(2013-1#2)
against purified rat##2##3##(1991-12#1)(1996-2#1)
against purified##5##2##(1991-12#1)(1992-8#1)(1993-9#1)(1996-2#2)
against radiation-induced##3##2##(2008-5#1)(2008-7#2)
against rat liver##2##3##(1990-11#1)(1994-6#1)
against rat##5##2##(1990-11#1)(1993-11#1)(1994-6#1)(1995-12#1)(2008-11#1)
against recombinant##2##2##(2008-4#1)(2009-5#1)
against red##2##2##(1994-12#1)(1995-12#1)
against reference##2##2##(1997-6#1)(2008-10#1)
against rust##2##2##(2008-10#2)
against seedling##2##2##(2008-10#2)
against serogroup B##2##3##(2011-1#1)(2013-8#1)
against serogroup##3##2##(1991-8#1)(2011-1#1)(2013-8#1)
against several human cancer cell lines##2##6##(2010-6#1)(2011-3#1)
against several human##3##3##(2008-10#1)(2010-6#1)(2011-3#1)
against several##14##2##(1990-9#1)(2008-10#3)(2008-11#1)(2010-6#1)(2010-8#1)(2011-3#3)(2013-1#3)(2013-8#1)
against sexually transmitted diseases##2##4##(1990-6#1)(1993-2#1)
against simple##2##2##(2007-11#1)(2008-9#1)
against singlet oxygen##2##3##(2007-11#1)(2008-5#1)
against six##2##2##(1990-12#1)(2008-11#1)
against smoking in##2##3##(2008-1#1)(2010-2#1)
against smoking##5##2##(1993-2#1)(1995-6#1)(2008-1#1)(2010-2#2)
against sodium##2##2##(2010-11#1)(2013-1#1)
against solid##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
against soluble antigens##2##3##(1997-9#1)(2008-11#1)
against some##5##2##(2007-11#1)(2008-8#1)(2012-2#1)(2013-1#2)
against specific##2##2##(2008-11#1)(2008-3#1)
against stresses##2##2##(1991-5#1)(2008-10#1)
against subsequent##3##2##(1990-11#1)(1992-6#1)(2008-8#1)
against such##5##2##(1992-2#1)(1996-12#1)(2008-6#1)(2008-8#1)(2008-9#1)
against superoxide radicals##2##3##(1995-12#1)(1996-5#1)
against superoxide##3##2##(1992-11#1)(1995-12#1)(1996-5#1)
against surface antigens from##2##4##(2008-10#2)
against susceptible##2##2##(2011-2#1)(2013-1#1)
against synthetic##5##2##(1991-9#1)(1994-11#1)(1994-6#1)(1996-12#1)(2008-5#1)
against target##3##2##(1997-5#1)(2008-11#1)(2008-7#1)
against tetanus and##3##3##(1992-2#2)(2009-5#1)
against tetanus##5##2##(1992-2#3)(1995-8#1)(2009-5#1)
against the C-terminal##2##3##(1993-8#1)(1996-12#1)
against the action of##2##4##(2008-4#1)(2008-7#1)
against the adverse##2##3##(2008-5#1)(2013-1#1)
against the background of##4##4##(2008-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
against the background##5##3##(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
against the bacteria##2##3##(2008-5#1)(2010-6#1)
against the benefit of##2##4##(1997-8#1)(2008-8#1)
against the challenges##2##3##(2008-9#1)(2013-8#1)
against the coat proteins##2##4##(2008-10#2)
against the cytotoxic##3##3##(1991-9#1)(1992-7#1)(2008-11#1)
against the decrease in##2##4##(1991-5#1)(2011-1#1)
against the deleterious effects of##2##5##(1991-6#1)(2008-3#1)
against the deleterious effects##3##4##(1991-6#1)(2008-3#1)(2010-4#1)
against the development of##7##4##(1991-2#1)(1991-6#1)(1991-8#1)(1993-11#1)(1995-12#1)(2008-8#1)(2009-6#1)
against the disease##7##3##(2007-8#1)(2008-10#5)(2011-2#1)
against the enzymes##2##3##(1997-3#1)(2008-11#1)
against the extracellular##4##3##(1991-12#1)(1992-12#1)(1996-5#1)(2012-12#1)
against the fungal pathogen Magnaporthe grisea##2##6##(2008-10#2)
against the homologous##2##3##(1990-5#1)(1997-3#1)
against the human##3##3##(1992-6#1)(2008-11#1)(2011-1#1)
against the major##2##3##(2008-10#1)(2008-11#1)
against the most##2##3##(2009-2#1)(2012-3#1)
against the new##2##3##(1990-8#1)(1993-3#1)
against the original##2##3##(1991-9#1)(1992-12#1)
against the other##3##3##(2008-10#3)
against the pathogen##5##3##(2008-10#4)(2011-2#1)
against the public##2##3##(1996-10#1)(2010-4#1)
against the purified##6##3##(1990-11#1)(1990-7#1)(1990-8#1)(1992-8#1)(1993-12#1)(2007-12#1)
against the radiation induced haematological##2##5##(2013-8#2)
against the renal toxicity##2##4##(1994-5#2)
against the renal##3##3##(1994-5#2)(1995-3#1)
against the role of##2##4##(2008-7#2)
against the same##2##3##(2007-11#1)(2008-10#1)
against the tested##2##3##(2008-11#1)(2012-3#1)
against the tumor spheroid##2##4##(2008-11#2)
against the union##2##3##(1995-12#2)
against the virus##4##3##(1997-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
against the##343##2##(1990-11#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#4)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#53)(2008-11#20)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#14)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#9)(2013-8#6)
against their##8##2##(1994-1#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
against them##3##2##(2008-10#1)(2008-3#1)(2009-3#1)
against thermal denaturation##2##3##(1991-5#1)(1993-11#1)
against these##17##2##(1990-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2009-10#1)(2009-12#1)(2012-12#1)(2013-1#1)
against this##18##2##(1990-2#1)(1992-3#1)(1993-2#1)(1995-12#2)(1995-2#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-1#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
against three##4##2##(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
against topoisomerase I##2##3##(1993-8#1)(1995-3#1)
against topoisomerase##3##2##(1993-8#2)(1995-3#1)
against toxic##3##2##(1994-5#1)(2008-5#1)(2008-8#1)
against tuberculosis and##2##3##(1995-2#1)(2009-5#1)
against tuberculosis##7##2##(1995-2#2)(1996-8#1)(2008-7#1)(2009-5#1)(2011-2#2)
against tumor cells##3##3##(1994-6#1)(2008-11#1)(2010-12#1)
against tumor necrosis##2##3##(2010-12#1)(2012-2#1)
against tumor##6##2##(1994-6#1)(2008-11#2)(2010-12#2)(2012-2#1)
against tumors##2##2##(1992-5#1)(2008-5#1)
against two##6##2##(1991-9#1)(1992-2#1)(1992-9#1)(2008-10#2)(2011-2#1)
against type 2 diabetes##3##4##(2012-2#2)(2012-3#1)
against type##4##2##(2008-8#1)(2012-2#2)(2012-3#1)
against typical##3##2##(1995-5#2)(2008-10#1)
against using the##2##3##(2011-2#2)
against using##3##2##(2011-2#2)(2012-2#1)
against various pathogenic##2##3##(1993-3#1)(2012-2#1)
against various##17##2##(1991-2#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-12#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
against violence##3##2##(1992-12#1)(2013-1#2)
against viral##2##2##(1994-12#1)(2007-2#1)
against vitellin cleavage products##2##4##(2007-12#2)
against which##6##2##(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
against women in##2##3##(1995-12#1)(2011-2#1)
against women##4##2##(1990-2#1)(1995-12#1)(2011-2#1)(2012-12#1)
against##2263##1##(1990-11#18)(1990-12#9)(1990-2#7)(1990-3#2)(1990-5#11)(1990-6#8)(1990-7#4)(1990-8#12)(1990-9#4)(1991-11#3)(1991-12#9)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#13)(1991-6#11)(1991-7#2)(1991-8#8)(1991-9#10)(1992-1#1)(1992-11#7)(1992-12#14)(1992-2#15)(1992-3#16)(1992-4#2)(1992-5#12)(1992-6#14)(1992-7#2)(1992-8#15)(1992-9#9)(1993-1#3)(1993-10#1)(1993-11#9)(1993-12#12)(1993-2#12)(1993-3#11)(1993-5#4)(1993-6#7)(1993-8#11)(1993-9#12)(1994-1#3)(1994-11#14)(1994-12#6)(1994-2#8)(1994-3#11)(1994-5#14)(1994-6#16)(1994-7#1)(1994-8#10)(1994-9#14)(1995-1#2)(1995-11#5)(1995-12#43)(1995-2#16)(1995-3#12)(1995-5#31)(1995-6#17)(1995-8#4)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#23)(1996-2#8)(1996-3#5)(1996-5#10)(1996-6#4)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#5)(1997-3#13)(1997-4#15)(1997-5#15)(1997-6#19)(1997-7#12)(1997-8#5)(1997-9#2)(2006-12#1)(2007-1#1)(2007-10#4)(2007-11#23)(2007-12#20)(2007-2#13)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#385)(2008-11#117)(2008-12#34)(2008-2#12)(2008-3#30)(2008-4#26)(2008-5#107)(2008-6#18)(2008-7#83)(2008-8#69)(2008-9#45)(2009-1#2)(2009-10#7)(2009-11#4)(2009-12#11)(2009-2#8)(2009-3#2)(2009-4#1)(2009-5#10)(2009-6#15)(2009-7#4)(2009-8#11)(2009-9#3)(2010-1#8)(2010-10#2)(2010-11#10)(2010-12#9)(2010-2#8)(2010-3#17)(2010-4#6)(2010-5#15)(2010-6#5)(2010-7#2)(2010-8#7)(2010-9#5)(2011-1#23)(2011-10#2)(2011-2#81)(2011-3#12)(2011-9#1)(2012-1#4)(2012-12#27)(2012-2#44)(2012-3#41)(2012-4#1)(2012-7#1)(2013-1#82)(2013-7#12)(2013-8#31)
aganglionic megacolon##2##2##(1994-12#2)
aganglionic##3##1##(1994-12#2)(1995-12#1)
agar amended with##2##3##(2008-10#2)
agar and##10##2##(1991-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
agar at##3##2##(2008-10#1)(2008-5#2)
agar concentration##2##2##(2012-2#2)
agar culture##2##2##(2008-10#1)(2008-9#1)
agar diffusion method against##2##4##(2008-8#1)(2011-1#1)
agar diffusion method##3##3##(2008-5#1)(2008-8#1)(2011-1#1)
agar diffusion test##3##3##(2008-10#1)(2008-5#2)
agar diffusion##7##2##(2008-10#1)(2008-5#3)(2008-8#1)(2011-1#1)(2011-2#1)
agar dilution method##6##3##(1991-8#1)(2008-10#2)(2008-12#1)(2012-12#1)(2012-3#1)
agar dilution##10##2##(1991-8#1)(1994-11#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2012-12#1)(2012-3#1)
agar disc diffusion method##2##4##(2008-12#1)(2008-5#1)
agar had##2##2##(2008-10#1)(2008-7#1)
agar in##2##2##(2008-7#1)(2010-6#1)
agar medium##14##2##(1993-12#2)(1993-8#1)(1994-6#1)(2008-10#8)(2008-8#1)(2011-2#1)
agar or##4##2##(2008-10#3)(2011-1#1)
agar plate##3##2##(2008-10#3)
agar plates and##2##3##(2008-10#1)(2013-7#1)
agar plates##15##2##(1996-11#2)(1997-6#1)(2008-10#5)(2008-7#2)(2010-4#1)(2010-6#3)(2013-7#1)
agar plating##2##2##(2008-10#2)
agar was##4##2##(2008-10#3)(2008-12#1)
agar were##4##2##(2008-10#3)(2008-12#1)
agar##195##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-8#2)(1993-12#4)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-11#2)(1997-3#1)(1997-6#2)(2007-7#5)(2008-10#87)(2008-11#4)(2008-12#7)(2008-2#3)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#16)(2008-9#4)(2009-11#1)(2010-2#2)(2010-4#1)(2010-6#5)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#8)(2012-3#1)(2013-7#1)
agar)##2##1##(1991-8#1)(2009-6#1)
agarobiose oligomers##3##2##(2008-10#3)
agarobiose##4##1##(2008-10#4)
agarose beads##2##2##(2008-10#1)(2008-7#1)
agarose gel electrophoresis showed that##2##5##(2008-10#1)(2008-12#1)
agarose gel electrophoresis##24##3##(1990-11#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-12#1)(2009-11#1)(2012-2#2)(2013-1#2)
agarose gel was##5##3##(2008-10#5)
agarose gel##38##2##(1990-11#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2012-2#2)(2013-1#2)
agarose gels and##2##3##(2008-10#1)(2008-2#1)
agarose gels##7##2##(1992-3#1)(2008-10#2)(2008-2#4)
agarose immobilised insulin receptors##2##4##(1993-8#2)
agarose##73##1##(1990-11#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#2)(1992-9#1)(1993-8#8)(1994-11#3)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#2)(2006-8#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2012-2#2)(2013-1#2)
agarose-based anion exchanger (Q-Sepharose)##2##4##(2008-10#2)
agarose-based##4##1##(2008-10#4)
agate-grinding##2##1##(2009-12#2)
agave species##2##2##(2009-8#2)
agave##5##1##(2008-10#1)(2009-8#4)
age &gt##8##2##(2007-10#1)(2008-1#1)(2008-3#2)(2008-6#1)(2010-3#1)(2010-8#1)(2013-1#1)
age &lt##4##2##(2006-10#1)(2007-10#1)(2008-10#1)(2011-2#1)
age (&gt##2##2##(2011-1#1)(2013-8#1)
age (&lt##2##2##(1994-9#1)(2013-8#1)
age (OR =##2##3##(1994-12#1)(2010-11#1)
age (P &lt##4##3##(1993-2#1)(2007-8#1)(2011-2#1)(2012-3#1)
age (P less than##2##4##(1990-3#1)(1991-9#1)
age (P##9##2##(1990-3#1)(1991-9#1)(1993-2#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
age (mean##5##2##(2007-11#3)(2007-7#1)(2009-7#1)
age (p = 0##4##4##(2008-7#1)(2010-8#2)(2013-7#1)
age (p&lt##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
age (r = -0##2##4##(1995-8#2)
age (r = 0##3##4##(2010-4#1)(2013-1#2)
age (r =##5##3##(1995-8#2)(2010-4#1)(2013-1#2)
age 11##3##2##(2010-1#1)(2011-2#1)(2012-3#1)
age 16##2##2##(2011-1#2)
age 17##2##2##(2008-6#1)(2011-1#1)
age 18 to##2##3##(1996-2#1)(2013-1#1)
age 18##5##2##(1996-2#1)(1997-3#1)(2007-9#1)(2010-6#1)(2013-1#1)
age 19##2##2##(2007-8#1)(2012-12#1)
age 2##3##2##(1995-12#1)(2009-4#1)(2013-1#1)
age 20##6##2##(1995-4#1)(1997-3#1)(2009-9#3)(2011-1#1)
age 22##2##2##(2007-8#1)(2012-12#1)
age 24##2##2##(1993-2#1)(2007-8#1)
age 29##2##2##(1997-3#1)(2008-11#1)
age 3##3##2##(1997-2#1)(2008-10#1)(2011-1#1)
age 30 years##2##3##(1991-6#1)(1992-2#1)
age 30##3##2##(1991-6#1)(1992-2#1)(2008-12#1)
age 33##2##2##(2008-5#1)(2008-6#1)
age 34##7##2##(1990-3#1)(1993-11#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-8#1)
age 35 and##2##3##(1990-6#1)(2011-1#1)
age 35##5##2##(1990-6#1)(1991-3#1)(1997-4#2)(2011-1#1)
age 38##4##2##(1997-3#2)(2007-10#1)(2008-2#1)
age 39##3##2##(1993-11#1)(2008-1#2)
age 4##4##2##(1997-2#1)(2008-9#1)(2011-1#1)(2013-1#1)
age 45##5##2##(1994-3#1)(1994-6#1)(1996-7#1)(2007-11#1)(2008-1#1)
age 46##5##2##(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
age 47##2##2##(2008-4#1)(2011-2#1)
age 49##2##2##(1991-8#1)(2008-1#1)
age 5 and##2##3##(2007-12#1)(2011-2#1)
age 5##4##2##(2007-12#1)(2008-11#1)(2011-2#2)
age 5-7##2##2##(2007-8#2)
age 50##6##2##(1990-6#1)(1990-9#1)(1994-3#2)(1995-2#2)
age 52##2##2##(1995-8#1)(2013-1#1)
age 53##2##2##(2007-12#1)(2007-7#1)
age 57##6##2##(2006-10#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-8#1)
age 58##2##2##(1990-2#1)(2008-7#1)
age 6##2##2##(1994-9#1)(2008-10#1)
age 60##5##2##(2007-12#1)(2008-1#1)(2008-9#1)(2009-9#1)(2012-3#1)
age 61##2##2##(1992-5#1)(2007-8#1)
age 62##5##2##(1990-11#1)(1990-5#1)(1994-3#1)(2008-4#1)(2011-2#1)
age 63##2##2##(2007-8#1)(2011-2#1)
age 65##4##2##(1993-1#1)(1994-6#1)(1995-2#1)(2008-11#1)
age 67##2##2##(1990-8#1)(2007-10#1)
age 68 days##3##3##(1997-4#3)
age 68##5##2##(1997-4#3)(2011-1#1)(2012-12#1)
age 7##3##2##(2007-8#1)(2009-8#1)(2011-1#1)
age 70##6##2##(1990-4#1)(1997-4#3)(2008-5#1)(2008-7#1)
age 80##2##2##(2008-7#1)(2012-12#1)
age 85 years or older##2##5##(2007-10#2)
age = 13##2##3##(2009-7#1)(2010-1#1)
age = 15##2##3##(2009-7#1)(2009-8#1)
age =##19##2##(1995-11#4)(1996-7#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-8#1)(2011-2#1)(2013-1#1)
age after##2##2##(2008-6#1)(2013-1#1)
age amphorae##2##2##(2008-10#2)
age and ICH volume##2##4##(2012-3#2)
age and ICH##3##3##(2012-3#3)
age and clinical##2##3##(1994-12#1)(1997-3#1)
age and development##2##3##(1996-5#2)
age and disease##2##3##(1994-11#1)(2008-7#1)
age and education##3##3##(1990-2#1)(2009-8#1)(2010-1#1)
age and gender##12##3##(1993-8#1)(1994-3#1)(1996-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
age and gender-matched##2##3##(2007-10#2)
age and leaf age##2##4##(2008-10#2)
age and maintenance of##2##4##(2008-6#2)
age and older##4##3##(2011-2#3)(2013-8#1)
age and quantified smoking##2##4##(2008-10#2)
age and sex in##2##4##(2008-3#1)(2011-2#1)
age and sex matched healthy##2##5##(2007-7#1)(2009-8#1)
age and sex matched##4##4##(2007-7#2)(2009-8#1)(2012-2#1)
age and sex of##2##4##(1991-8#2)
age and sex##31##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-8#2)(1994-6#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-6#2)(2007-10#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#5)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
age and sex-matched##2##3##(1997-7#1)(2008-7#1)
age and size##4##3##(2008-8#4)
age and socioeconomic status##2##4##(2012-12#1)(2013-1#1)
age and socioeconomic##4##3##(2012-12#1)(2013-1#3)
age and stroke subtype##2##4##(2007-10#2)
age and the##14##3##(1992-2#2)(1992-5#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-7#1)(2008-9#1)(2013-1#1)
age and underlying##2##3##(1997-3#1)(2008-5#1)
age and were##2##3##(2009-10#1)(2012-2#1)
age and with##2##3##(2007-8#1)(2009-9#1)
age and##211##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-6#2)(1991-8#2)(1992-11#1)(1992-2#2)(1992-5#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-7#1)(1996-9#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#1)(2007-10#6)(2007-11#2)(2007-12#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#8)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#15)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#4)
age are##9##2##(1992-2#1)(1996-3#1)(1996-6#1)(2006-5#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
age as a##3##3##(2008-11#1)(2008-12#1)(2008-4#1)
age as##10##2##(1990-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
age at a##3##3##(2008-8#1)(2010-8#1)(2013-1#1)
age at bilateral implantation##2##4##(2012-2#2)
age at birth##2##3##(1992-6#1)(2012-12#1)
age at diagnosis was##6##4##(1992-2#1)(1992-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
age at diagnosis##12##3##(1990-12#1)(1990-8#1)(1992-2#1)(1992-5#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
age at disease onset##2##4##(2012-12#1)(2013-8#1)
age at first birth##3##4##(1993-9#1)(2009-5#2)
age at first egg##2##4##(2008-12#2)
age at first intercourse was##2##5##(1990-9#2)
age at first intercourse##5##4##(1990-9#5)
age at first sexual##2##4##(1991-6#1)(2010-8#1)
age at first##16##3##(1990-9#5)(1991-6#1)(1993-9#1)(1995-12#1)(2008-12#3)(2008-8#1)(2009-5#2)(2010-8#1)(2012-2#1)
age at implant##2##3##(2008-9#2)
age at implantation and##2##4##(2010-10#2)
age at implantation was##2##4##(2008-9#2)
age at implantation##5##3##(2008-9#3)(2010-10#2)
age at inoculation##5##3##(2008-10#5)
age at maturity and fertility##2##5##(2008-8#2)
age at maturity##3##3##(2008-8#3)
age at menarche##3##3##(1993-9#1)(2013-1#2)
age at onset and##2##4##(2007-7#1)(2011-2#1)
age at onset of##6##4##(1994-11#1)(2007-7#1)(2008-7#3)(2011-2#1)
age at onset##13##3##(1994-11#1)(2007-7#2)(2008-1#1)(2008-7#5)(2011-2#2)(2013-1#2)
age at operation was##2##4##(2007-11#1)(2008-10#1)
age at peak BMD##3##4##(2010-3#3)
age at settlement##3##3##(2007-5#3)
age at sexual maturity##2##4##(2008-8#2)
age at sexual##3##3##(2008-8#2)(2011-1#1)
age at surgery was##3##4##(2009-10#1)(2009-3#2)
age at surgery##4##3##(2007-8#1)(2009-10#1)(2009-3#2)
age at the onset of##2##5##(2007-8#2)
age at the time of##7##5##(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#2)(2011-2#1)(2012-2#1)
age at the##12##3##(2007-11#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#1)
age at time of##2##4##(2008-10#1)(2008-9#1)
age at which the##2##4##(1993-3#1)(2008-10#1)
age at which##8##3##(1991-8#2)(1993-3#1)(2008-10#2)(2008-8#1)(2009-5#1)(2012-12#1)
age at##117##2##(1990-12#1)(1990-8#1)(1990-9#5)(1991-6#1)(1991-8#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-6#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-5#4)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#8)(2009-10#2)(2009-3#2)(2009-5#3)(2010-10#3)(2010-3#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#4)(2013-1#8)(2013-8#1)
age average##3##2##(2008-5#1)(2011-2#2)
age being##2##2##(2008-11#1)(2012-12#1)
age but##2##2##(2008-7#1)(2008-8#1)
age can be##2##3##(2008-8#1)(2010-12#1)
age can##4##2##(1990-3#1)(2008-3#1)(2008-8#1)(2010-12#1)
age categories##2##2##(2011-1#1)(2011-2#1)
age changes##3##2##(1991-12#2)(1994-5#1)
age children##5##2##(1995-12#1)(2007-12#1)(2008-3#1)(2012-2#2)
age dependence of##2##3##(1991-12#1)(2008-7#1)
age dependence##3##2##(1991-12#1)(1996-5#1)(2008-7#1)
age dependent##5##2##(1994-3#1)(1996-5#1)(2007-6#1)(2011-2#1)(2012-12#1)
age did not##2##3##(2011-2#1)(2013-1#1)
age did##3##2##(1996-6#1)(2011-2#1)(2013-1#1)
age differences##4##2##(1993-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
age distribution of the##2##4##(1990-6#1)(1997-8#1)
age distribution of##5##3##(1990-6#1)(1996-1#1)(1997-8#1)(2009-7#1)(2010-8#1)
age distribution##9##2##(1990-6#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#1)(2009-7#1)(2010-3#1)(2010-8#1)(2013-7#1)
age effect##3##2##(1997-3#2)(2010-3#1)
age equal##2##2##(2011-2#1)(2013-1#1)
age estimation##2##2##(1995-6#2)
age for girls##2##3##(2013-1#2)
age for the##5##3##(1990-8#1)(2007-12#1)(2008-11#1)(2011-2#2)
age for##22##2##(1990-8#1)(1993-12#1)(1993-2#1)(1994-6#1)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#4)
age from 18 to##2##4##(2007-11#1)(2008-11#1)
age from##25##2##(1990-2#1)(1990-8#1)(1991-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-11#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
age greater than##3##3##(1991-5#1)(2007-10#1)(2013-8#1)
age group 16-19##2##3##(1990-2#1)(2012-2#1)
age group and##7##3##(1990-2#1)(1991-2#1)(1994-12#1)(2008-7#1)(2009-12#1)(2012-12#1)(2013-1#1)
age group in##2##3##(1994-12#1)(2013-7#1)
age group is##4##3##(1997-1#1)(2007-10#1)(2012-12#1)(2013-8#1)
age group of##10##3##(1991-2#1)(2007-7#1)(2008-11#2)(2008-7#1)(2010-5#2)(2013-8#3)
age group remains##2##3##(1997-1#1)(2012-3#1)
age group to##2##3##(1994-12#1)(1997-4#1)
age group was##3##3##(1994-12#1)(2007-10#1)(2010-2#1)
age group were##5##3##(1991-8#1)(1995-12#1)(2007-8#1)(2008-7#1)(2011-1#1)
age group which##2##3##(2007-7#1)(2013-8#1)
age group##116##2##(1990-12#1)(1990-2#2)(1990-6#2)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-12#4)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-9#2)(1997-1#4)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2011-1#9)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#2)(2013-7#2)(2013-8#12)
age groups and##4##3##(1994-5#1)(1996-9#1)(2007-7#1)(2010-7#1)
age groups are##2##3##(1996-5#1)(2008-5#1)
age groups for##3##3##(1996-6#1)(2008-2#1)(2011-1#1)
age groups in##2##3##(2007-10#1)(2008-7#1)
age groups of##7##3##(1991-12#1)(1993-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
age groups show##2##3##(2010-7#1)(2013-8#1)
age groups##88##2##(1990-11#1)(1990-6#4)(1991-12#4)(1991-6#1)(1992-9#3)(1993-12#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-9#2)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#10)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
age had a significant##2##4##(2008-10#2)
age had the##2##3##(2011-2#2)
age had##6##2##(2008-10#3)(2011-2#3)
age has##3##2##(1991-9#1)(1994-9#1)(2013-7#1)
age in a##3##3##(1994-11#1)(2007-4#1)(2010-6#1)
age in both##4##3##(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)
age in the##11##3##(1990-11#1)(1990-8#1)(1991-11#1)(1996-11#1)(1996-2#1)(2008-7#3)(2011-1#3)
age in##58##2##(1990-11#2)(1990-3#6)(1990-8#1)(1991-1#1)(1991-11#1)(1992-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-4#1)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#6)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
age increased from##2##3##(1997-4#1)(2007-8#1)
age increased##3##2##(1997-4#1)(2007-8#1)(2008-10#1)
age intervals##2##2##(1990-6#1)(1997-7#1)
age is a##2##3##(2009-12#1)(2013-7#1)
age is associated with an increased##2##6##(2008-1#1)(2013-7#1)
age is associated with##6##4##(2008-1#2)(2009-12#1)(2010-3#2)(2013-7#1)
age is not##4##3##(1991-6#1)(1996-5#2)(2008-7#1)
age is##24##2##(1990-11#2)(1990-6#1)(1991-12#1)(1991-6#1)(1992-5#1)(1995-8#2)(1996-5#2)(2008-1#3)(2008-10#1)(2008-7#2)(2009-12#2)(2010-3#2)(2012-1#1)(2012-12#1)(2013-7#2)
age less than##2##3##(1991-2#1)(1997-8#1)
age matched##4##2##(1993-12#1)(1996-5#1)(1997-5#1)(2008-7#1)
age may be##3##3##(2006-5#1)(2008-7#1)(2010-2#1)
age may##5##2##(1997-3#1)(2006-5#1)(2008-3#1)(2008-7#1)(2010-2#1)
age more##2##2##(2007-8#1)(2008-3#1)
age nor##2##2##(2009-3#1)(2013-1#1)
age of 10##5##3##(2008-5#1)(2008-9#2)(2010-3#1)(2011-1#1)
age of 11##3##3##(2010-1#1)(2011-1#1)(2013-8#1)
age of 12##3##3##(2007-8#1)(2008-9#1)(2013-8#1)
age of 15##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
age of 16##4##3##(1991-8#1)(1995-6#1)(2008-10#1)(2008-7#1)
age of 2##2##3##(1997-3#2)
age of 23##2##3##(1997-3#1)(2010-4#1)
age of 24##3##3##(2010-9#1)(2012-12#2)
age of 3##5##3##(1994-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
age of 30 years##4##4##(1997-3#1)(2008-6#1)(2012-2#1)(2013-7#1)
age of 30##7##3##(1991-8#1)(1997-3#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-2#1)(2013-7#1)
age of 32##4##3##(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)
age of 34 years##2##4##(2008-7#1)(2008-9#1)
age of 34##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
age of 35##2##3##(1993-1#1)(2008-7#1)
age of 37##2##3##(2008-1#1)(2008-6#1)
age of 39##3##3##(1995-8#1)(2008-4#1)(2009-8#1)
age of 4##4##3##(1995-12#1)(1996-11#1)(1996-8#1)(2007-11#1)
age of 40 years##3##4##(2008-5#2)(2008-9#1)
age of 40##9##3##(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2012-3#3)
age of 41##3##3##(1994-12#1)(2008-1#1)(2012-3#1)
age of 42 years##2##4##(1992-5#1)(2007-8#1)
age of 42##5##3##(1992-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)
age of 43##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
age of 45##3##3##(1991-12#1)(2007-7#1)(2007-8#1)
age of 50##10##3##(1994-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)
age of 51##2##3##(1993-5#1)(2007-12#1)
age of 52##2##3##(1990-12#1)(2007-7#1)
age of 55##2##3##(1991-11#1)(2012-2#1)
age of 6##5##3##(1994-6#1)(1997-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
age of 62##3##3##(1992-9#1)(2008-7#1)(2013-1#1)
age of 65##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
age of 7##2##3##(1995-12#1)(2013-1#1)
age of 8##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
age of a##6##3##(1996-3#1)(2008-10#3)(2008-8#1)(2008-9#1)
age of chicks from##2##4##(2008-5#1)(2008-8#1)
age of children##2##3##(2011-1#1)(2013-8#1)
age of first##3##3##(1994-2#2)(2009-7#1)
age of infection##2##3##(2008-10#1)(2012-12#1)
age of initial##2##3##(1994-8#1)(1996-12#1)
age of internationalism##2##3##(1992-5#2)
age of menarche##2##3##(2013-1#2)
age of onset and##4##4##(1996-7#2)(2008-2#1)(2008-7#1)
age of onset is##2##4##(2008-7#1)(2009-7#1)
age of onset of##3##4##(1994-2#1)(2008-1#1)(2011-2#1)
age of onset was##3##4##(1996-7#1)(2007-8#1)(2008-8#1)
age of onset##23##3##(1994-2#1)(1995-8#1)(1996-2#1)(1996-7#3)(1997-5#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#2)(2011-2#2)(2013-7#3)
age of over##2##3##(2011-2#2)
age of patients was##5##4##(2007-11#2)(2007-2#1)(2007-8#1)(2011-2#1)
age of patients with##2##4##(2008-9#1)(2012-12#1)
age of patients##12##3##(2007-11#2)(2007-2#1)(2007-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)
age of sexual##2##3##(1990-9#1)(2012-1#1)
age of surgery##2##3##(2009-5#1)(2013-1#1)
age of the patient##8##4##(1990-10#1)(1990-11#1)(1990-9#1)(2007-8#1)(2008-7#2)(2010-3#1)(2012-3#1)
age of the patients was##16##5##(1991-8#1)(1992-8#1)(1993-2#1)(1995-4#1)(1997-8#1)(2007-7#1)(2008-1#4)(2008-11#1)(2010-6#1)(2011-1#2)(2011-3#1)(2012-3#1)
age of the patients##23##4##(1991-8#1)(1992-8#1)(1993-2#1)(1995-4#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#1)(2008-7#1)(2010-6#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
age of the population##3##4##(2008-7#1)(2011-2#2)
age of the##65##3##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#3)(1997-6#3)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#4)(2008-11#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
age of these patients##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
age of two weeks##2##4##(1990-9#1)(1995-8#1)
age of two##3##3##(1990-9#1)(1993-11#1)(1995-8#1)
age of##365##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#2)(1990-9#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-3#1)(1995-4#1)(1995-6#4)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-7#3)(1996-8#1)(1997-3#10)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#5)(2007-7#7)(2007-8#10)(2008-1#16)(2008-10#16)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#7)(2008-7#22)(2008-8#6)(2008-9#14)(2009-10#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#2)(2010-10#2)(2010-3#5)(2010-4#2)(2010-6#2)(2010-8#6)(2010-9#2)(2011-1#7)(2011-2#22)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#9)(2013-1#22)(2013-7#6)(2013-8#6)
age old##2##2##(1990-3#1)(2008-11#1)
age on infection##3##3##(2008-10#3)
age on susceptibility to##2##4##(1996-5#1)(2008-10#1)
age on the##6##3##(1990-3#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
age on##29##2##(1990-3#3)(1991-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(2007-10#1)(2008-1#2)(2008-10#6)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#2)(2011-2#3)(2013-1#1)
age or by##2##3##(1996-7#1)(2008-5#1)
age or sex##2##3##(1991-6#1)(1997-4#1)
age or##20##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1996-7#1)(1997-4#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#2)(2010-11#1)(2011-2#1)
age over##2##2##(2008-12#1)(2013-1#1)
age patterns of##2##3##(2008-3#1)(2009-9#1)
age patterns##3##2##(2008-3#1)(2009-12#1)(2009-9#1)
age range 18-84 years##2##4##(2013-1#2)
age range of##3##3##(1997-6#1)(2008-7#1)(2013-8#1)
age range##21##2##(1990-6#1)(1994-1#1)(1994-12#2)(1994-9#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-7#5)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#2)
age ranged between##3##3##(2007-7#2)(2008-4#1)
age ranged from 20 to##2##5##(2008-1#1)(2012-12#1)
age ranged from##6##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-7#1)(2012-12#1)
age ranged##9##2##(2007-7#3)(2007-8#1)(2008-1#1)(2008-4#2)(2010-7#1)(2012-12#1)
age ranges##3##2##(1994-12#1)(2012-12#1)(2013-1#1)
age ranging from##2##3##(2007-11#1)(2008-1#1)
age received##2##2##(1994-6#1)(1996-5#1)
age related changes in##3##4##(1990-11#2)(2011-2#1)
age related changes##5##3##(1990-11#2)(2008-12#1)(2011-2#2)
age related##15##2##(1990-11#3)(2007-7#1)(2008-12#1)(2008-8#1)(2009-12#2)(2011-1#1)(2011-2#6)
age specific##3##2##(1992-2#1)(1996-3#1)(2010-10#1)
age spots##3##2##(2008-5#2)(2011-2#1)
age structure of##2##3##(2013-1#2)
age structure##4##2##(2013-1#2)(2013-8#2)
age than##5##2##(1993-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
age that##3##2##(2007-10#1)(2009-8#1)(2013-8#1)
age the##6##2##(1991-6#1)(1991-8#1)(1994-11#1)(1994-2#1)(1995-9#1)(1997-5#1)
age they were##2##3##(1994-6#1)(1997-3#1)
age three##2##2##(1991-6#1)(1994-6#1)
age to##8##2##(1991-7#1)(2007-12#1)(2007-5#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
age was 17##3##3##(2007-8#1)(2011-2#2)
age was 29##3##3##(1990-9#1)(2007-10#1)(2008-1#1)
age was 33##4##3##(1990-8#1)(2008-4#1)(2010-1#1)(2012-3#1)
age was 4##2##3##(2007-8#1)(2008-9#1)
age was 48##2##3##(2008-9#1)(2011-2#1)
age was 49##2##3##(2007-11#1)(2008-6#1)
age was 51##2##3##(2008-3#1)(2008-5#1)
age was 52##2##3##(1991-6#1)(2007-10#1)
age was 53 years##2##4##(2011-7#1)(2013-1#1)
age was 57##2##3##(2007-8#1)(2011-2#1)
age was 66##2##3##(2008-3#1)(2008-7#1)
age was 67##2##3##(2008-3#1)(2013-8#1)
age was 68##2##3##(2008-9#1)(2012-3#1)
age was associated with##3##4##(2008-7#1)(2010-3#1)(2011-2#1)
age was between##2##3##(1990-5#1)(2011-2#1)
age was correlated with##2##4##(2009-7#1)(2012-12#1)
age was correlated##3##3##(1991-12#1)(2009-7#1)(2012-12#1)
age was##89##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-10#3)(2007-11#2)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#3)(2009-12#1)(2009-7#1)(2010-1#1)(2010-3#4)(2010-4#1)(2011-1#2)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#1)
age were##16##2##(1993-1#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
age when##5##2##(1995-3#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-1#1)
age while##3##2##(1997-7#1)(2010-11#1)(2012-3#1)
age who##7##2##(1993-1#1)(2006-5#1)(2008-3#1)(2009-7#1)(2011-1#1)(2011-2#2)
age with a##2##3##(2008-4#1)(2013-1#1)
age with##13##2##(1994-6#1)(1994-9#1)(1997-3#1)(2007-11#2)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#2)(2013-1#3)
age##2671##1##(1990-10#1)(1990-11#19)(1990-12#9)(1990-2#11)(1990-3#29)(1990-4#1)(1990-5#5)(1990-6#21)(1990-8#11)(1990-9#13)(1991-1#2)(1991-11#11)(1991-12#34)(1991-2#10)(1991-3#7)(1991-4#3)(1991-5#5)(1991-6#26)(1991-7#2)(1991-8#14)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#6)(1992-12#4)(1992-2#14)(1992-3#5)(1992-4#2)(1992-5#11)(1992-6#7)(1992-8#4)(1992-9#7)(1993-1#8)(1993-10#2)(1993-11#9)(1993-12#19)(1993-2#10)(1993-3#6)(1993-5#2)(1993-6#5)(1993-8#3)(1993-9#8)(1994-1#3)(1994-10#1)(1994-11#12)(1994-12#16)(1994-2#10)(1994-3#10)(1994-5#12)(1994-6#25)(1994-7#1)(1994-8#7)(1994-9#14)(1995-1#3)(1995-10#1)(1995-11#6)(1995-12#11)(1995-2#11)(1995-3#7)(1995-4#4)(1995-5#3)(1995-6#13)(1995-8#21)(1995-9#4)(1996-1#3)(1996-11#5)(1996-12#9)(1996-2#8)(1996-3#18)(1996-5#25)(1996-6#6)(1996-7#8)(1996-8#2)(1996-9#12)(1997-1#6)(1997-2#4)(1997-3#37)(1997-4#22)(1997-5#7)(1997-6#13)(1997-7#7)(1997-8#11)(2006-10#4)(2006-5#4)(2006-8#1)(2007-1#2)(2007-10#31)(2007-11#37)(2007-12#26)(2007-2#8)(2007-4#1)(2007-5#7)(2007-6#4)(2007-7#40)(2007-8#60)(2007-9#2)(2008-1#64)(2008-10#116)(2008-11#53)(2008-12#50)(2008-2#10)(2008-3#44)(2008-4#23)(2008-5#51)(2008-6#32)(2008-7#167)(2008-8#51)(2008-9#65)(2009-1#1)(2009-10#10)(2009-11#1)(2009-12#14)(2009-3#7)(2009-4#4)(2009-5#17)(2009-6#4)(2009-7#24)(2009-8#15)(2009-9#15)(2010-1#14)(2010-10#14)(2010-11#10)(2010-12#7)(2010-2#6)(2010-3#30)(2010-4#14)(2010-5#8)(2010-6#8)(2010-7#3)(2010-8#29)(2010-9#6)(2011-1#76)(2011-2#202)(2011-3#5)(2011-7#2)(2012-1#10)(2012-12#51)(2012-2#45)(2012-3#71)(2012-5#1)(2013-1#134)(2013-3#3)(2013-7#19)(2013-8#66)
age)##20##1##(1990-11#1)(1992-2#1)(1992-6#1)(1996-5#3)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2010-10#1)(2010-2#2)(2012-12#1)
age- and IQ-matched##2##3##(2007-8#1)(2008-11#1)
age- and gender-matched healthy##2##4##(2008-12#1)(2009-8#1)
age- and sex-matched healthy##2##4##(1993-9#1)(2008-7#1)
age- and sex-matched patients##2##4##(1992-8#1)(2008-3#1)
age- and sex-matched##12##3##(1992-8#1)(1993-9#1)(2006-10#1)(2007-10#2)(2008-3#2)(2008-6#1)(2008-7#3)(2011-2#1)
age- and##22##2##(1991-1#1)(1991-12#1)(1992-8#1)(1993-9#1)(1994-9#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
age-##23##1##(1991-1#1)(1991-12#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
age-1 mutant##2##2##(2008-3#2)
age-1##4##1##(2008-3#4)
age-adjusted mortality##2##2##(2012-3#2)
age-adjusted##11##1##(1990-9#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-8#1)(2012-12#1)(2012-3#3)(2013-1#1)
age-appropriate##7##1##(1992-1#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
age-associated diseases##2##2##(2008-7#2)
age-associated##8##1##(1996-12#1)(2008-7#5)(2010-2#1)(2013-7#1)
age-based##2##1##(2008-10#1)(2008-11#1)
age-dependent changes##3##2##(1990-3#1)(1991-12#1)(1995-8#1)
age-dependent decrease##2##2##(1993-12#1)(2008-7#1)
age-dependent##18##1##(1990-3#2)(1991-12#1)(1993-12#1)(1994-8#1)(1995-8#2)(1996-5#2)(2008-3#2)(2008-5#1)(2008-7#3)(2010-8#1)(2011-2#1)(2012-2#1)
age-eligible women##2##2##(2013-1#2)
age-eligible##3##1##(2008-3#1)(2013-1#2)
age-group##3##1##(2007-7#1)(2011-9#1)(2012-3#1)
age-groups##4##1##(1992-2#1)(1993-12#1)(2009-5#1)(2012-12#1)
age-matched control subjects##2##3##(1995-5#1)(2008-7#1)
age-matched control##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
age-matched controls were##2##3##(2008-7#1)(2011-1#1)
age-matched controls with neuromuscular##2##4##(2007-10#2)
age-matched controls##24##2##(1990-3#2)(1991-12#1)(1991-8#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-5#2)(2006-10#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-7#6)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
age-matched healthy controls##2##3##(1996-11#1)(2008-7#1)
age-matched healthy subjects##2##3##(2010-12#1)(2012-3#1)
age-matched healthy##5##2##(1996-11#1)(1996-7#1)(2008-7#1)(2010-12#1)(2012-3#1)
age-matched normal subjects##3##3##(1996-5#1)(2008-7#2)
age-matched normal##5##2##(1993-1#1)(1996-5#1)(2007-10#1)(2008-7#2)
age-matched normotensive##2##2##(1997-6#1)(2011-1#1)
age-matched##56##1##(1990-11#1)(1990-3#2)(1991-12#1)(1991-8#1)(1993-1#1)(1994-5#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-7#1)(1997-6#2)(2006-10#1)(2007-10#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#12)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
age-related changes in the##5##4##(1990-3#1)(2008-11#1)(2008-5#1)(2008-7#2)
age-related changes in##16##3##(1990-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#4)(2013-8#1)
age-related changes##21##2##(1990-3#1)(1991-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#6)(2013-1#1)(2013-8#1)
age-related cognitive decline##2##3##(2008-6#1)(2009-8#1)
age-related cognitive##3##2##(2008-6#1)(2009-8#1)(2012-3#1)
age-related decline in##2##3##(1992-8#1)(2008-7#1)
age-related decline##5##2##(1992-8#1)(2008-11#1)(2008-7#3)
age-related decrease in##5##3##(1990-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(2012-1#1)
age-related decrease##6##2##(1990-3#1)(1994-5#2)(1994-6#1)(1995-8#1)(2012-1#1)
age-related decreases in##2##3##(1996-5#1)(2008-5#1)
age-related differences in##3##3##(2008-11#2)(2009-9#1)
age-related differences##4##2##(2008-11#2)(2008-7#1)(2009-9#1)
age-related diseases in mammals##2##4##(2012-2#2)
age-related diseases in##3##3##(2008-7#1)(2012-2#2)
age-related diseases##8##2##(1994-5#1)(2008-10#1)(2008-7#3)(2012-12#1)(2012-2#2)
age-related disorders##2##2##(1991-12#1)(2008-7#1)
age-related impairment##2##2##(1996-11#1)(2008-3#1)
age-related increase##3##2##(1996-2#1)(2008-5#1)(2009-12#1)
age-related loss of##2##3##(1995-6#1)(2012-2#1)
age-related macular degeneration (AMD)##5##4##(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)
age-related macular degeneration (ARMD)##3##4##(2011-1#2)(2011-2#1)
age-related macular degeneration##17##3##(2007-11#2)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-7#2)(2013-1#1)
age-related macular##18##2##(2007-11#2)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-7#2)(2013-1#1)
age-related memory impairment##2##3##(1994-6#2)
age-related memory##3##2##(1993-12#1)(1994-6#2)
age-related morphological changes##2##3##(1995-8#1)(2008-5#1)
age-related##123##1##(1990-11#1)(1990-3#2)(1991-12#2)(1992-8#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-5#4)(1994-6#5)(1995-6#3)(1995-8#3)(1996-11#1)(1996-2#2)(1996-5#4)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-11#6)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#19)(2008-8#3)(2009-12#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-7#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
age-specific death rates##2##3##(1997-2#1)(1997-7#1)
age-specific incidence rates##2##3##(1991-2#1)(2008-7#1)
age-specific incidence##5##2##(1991-2#1)(1994-11#2)(1994-12#1)(2008-7#1)
age-specific mortality##2##2##(1995-8#1)(2008-8#1)
age-specific rates##3##2##(1991-6#1)(1992-2#1)(2008-7#1)
age-specific##28##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-11#2)(1994-12#2)(1995-8#1)(1997-2#1)(1997-5#2)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
age-standardised incidence##2##2##(1990-2#1)(1995-5#1)
age-standardised##4##1##(1990-2#1)(1995-5#1)(2008-8#2)
age-standardized##5##1##(1990-2#1)(1991-6#2)(1992-2#1)(2011-2#1)
age-structured##2##1##(1995-5#1)(2011-3#1)
age/sex matched##2##2##(1995-12#1)(2011-2#1)
age=21##2##1##(2007-12#1)(2012-1#1)
age?##4##1##(1992-11#1)(1994-3#1)(2010-10#1)(2012-2#1)
age]##6##1##(1996-3#1)(1996-6#1)(2008-10#1)(2008-4#1)(2012-3#2)
aged &gt##6##2##(2008-7#3)(2010-3#1)(2011-2#1)(2012-2#1)
aged &lt##3##2##(2012-12#1)(2013-1#2)
aged 1##4##2##(1991-8#1)(1993-12#1)(1997-3#1)(2011-2#1)
aged 10 days##2##3##(1990-7#1)(2011-2#1)
aged 10##6##2##(1990-7#1)(1997-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
aged 12 months##2##3##(1990-12#1)(2009-5#1)
aged 12 to##2##3##(2009-7#1)(2011-2#1)
aged 12##5##2##(1990-12#1)(1994-6#1)(2009-5#1)(2009-7#1)(2011-2#1)
aged 12-17##2##2##(2008-9#1)(2010-11#1)
aged 12-18 years##2##3##(1997-6#1)(2012-2#1)
aged 14##4##2##(2008-7#1)(2010-8#1)(2013-8#2)
aged 15 years or over##3##5##(1994-6#2)(2011-1#1)
aged 15##5##2##(1994-6#2)(2011-1#3)
aged 15-19##2##2##(1994-2#1)(2013-1#1)
aged 16 to##3##3##(1990-6#1)(2013-1#1)(2013-8#1)
aged 16##4##2##(1990-6#1)(1995-5#1)(2013-1#1)(2013-8#1)
aged 17##2##2##(2008-7#1)(2010-8#1)
aged 18 to##6##3##(1992-1#2)(2008-1#1)(2008-5#1)(2013-1#2)
aged 18 years##3##3##(2010-1#1)(2011-1#1)(2013-1#1)
aged 18##10##2##(1992-1#2)(1997-8#1)(2008-1#1)(2008-5#1)(2010-1#1)(2011-1#1)(2013-1#3)
aged 18+)##2##2##(2009-9#1)(2013-8#1)
aged 20 to##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
aged 20##5##2##(1990-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
aged 21-40 years##2##3##(2009-10#1)(2011-2#1)
aged 22##3##2##(1990-10#1)(2008-10#1)(2011-2#1)
aged 24 to##2##3##(1991-4#1)(2013-1#1)
aged 25##5##2##(2011-1#4)(2013-1#1)
aged 3##4##2##(1991-6#1)(1995-8#1)(1997-3#1)(2013-1#1)
aged 30##2##2##(2008-12#1)(2012-2#1)
aged 33 years##2##3##(1992-11#1)(2010-3#1)
aged 35##2##2##(1994-6#1)(2013-1#1)
aged 35-64 years##2##3##(2008-7#1)(2009-10#1)
aged 35-74##2##2##(2008-10#1)(2011-2#1)
aged 36 to##2##3##(2007-11#1)(2008-7#1)
aged 4 to##2##3##(2008-12#1)(2008-9#1)
aged 40##2##2##(1995-12#1)(2009-5#1)
aged 40-42 in##4##3##(1991-6#2)(1994-11#2)
aged 40-42##8##2##(1991-6#6)(1994-11#2)
aged 44 years##2##3##(1990-12#1)(1991-9#1)
aged 44##3##2##(1990-12#1)(1991-9#1)(1996-11#1)
aged 45 ± 11 years##2##5##(2013-1#1)(2013-8#1)
aged 45##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
aged 48##2##2##(1990-6#1)(1993-8#1)
aged 50##6##2##(1990-9#1)(1995-12#1)(2011-1#2)(2012-12#2)
aged 6 to##4##3##(2009-10#1)(2012-12#1)(2013-1#2)
aged 6##6##2##(1996-3#1)(2009-10#1)(2010-5#1)(2012-12#1)(2013-1#2)
aged 6-12##2##2##(1996-2#1)(2012-1#1)
aged 6-8##2##2##(2007-7#1)(2010-6#1)
aged 60 years or##2##4##(1992-5#1)(1996-6#1)
aged 60 years##4##3##(1992-5#1)(1996-6#1)(2011-1#2)
aged 60##8##2##(1992-5#1)(1996-6#1)(1996-7#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
aged 65 years##3##3##(1994-2#1)(2008-11#1)(2011-1#1)
aged 65##6##2##(1990-12#1)(1994-2#1)(1994-6#1)(2008-11#1)(2010-10#1)(2011-1#1)
aged 70 years and over##2##5##(2008-7#2)
aged 70 years and##3##4##(1996-9#1)(2008-7#2)
aged 70 years##4##3##(1996-9#1)(2008-7#3)
aged 70##5##2##(1996-9#1)(2008-7#3)(2013-1#1)
aged 85 and over##2##4##(1994-5#2)
aged 85 years and over##2##5##(1994-5#1)(2008-7#1)
aged 85 years##4##3##(1994-5#1)(2007-10#1)(2008-7#1)(2012-12#1)
aged 85##6##2##(1994-5#3)(2007-10#1)(2008-7#1)(2012-12#1)
aged Medicare beneficiaries##4##3##(1993-12#2)(1997-1#1)(1997-2#1)
aged Medicare##7##2##(1991-1#1)(1993-12#3)(1997-1#2)(1997-2#1)
aged and disabled Medicare beneficiaries##2##5##(1991-2#1)(1991-3#1)
aged and disabled Medicare##3##4##(1991-2#1)(1991-3#1)(1997-1#1)
aged and palliative care policies##2##5##(2010-10#2)
aged and##9##2##(1990-6#1)(1991-2#1)(1991-3#1)(1994-5#1)(1997-1#1)(2008-10#1)(2010-10#2)(2010-5#1)
aged animals##3##2##(2008-3#1)(2009-12#1)(2013-7#1)
aged as##2##2##(1990-5#1)(1995-12#1)
aged between 1 and 11##2##5##(1997-2#1)(1997-4#1)
aged between 1 and##3##4##(1990-9#1)(1997-2#1)(1997-4#1)
aged between 16##2##3##(2008-1#1)(2012-3#1)
aged between 20##2##3##(2010-7#1)(2011-2#1)
aged between 25 and##2##4##(1992-10#1)(2012-3#1)
aged between 4 and##2##4##(2008-9#1)(2013-1#1)
aged between 5##2##3##(2011-1#1)(2011-2#1)
aged between 6 and##2##4##(1992-9#1)(2013-1#1)
aged between 6##4##3##(1992-9#1)(2008-5#1)(2011-1#1)(2013-1#1)
aged between 65 and 84##2##5##(2008-7#1)(2011-2#1)
aged between 8 and##2##4##(1993-12#1)(2011-2#1)
aged between##43##2##(1990-5#1)(1990-9#2)(1992-10#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#2)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-3#3)(2013-1#5)
aged care in##2##3##(2010-10#2)
aged care##17##2##(2008-11#1)(2010-10#11)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
aged cells##2##2##(2013-1#1)(2013-7#1)
aged from 2##3##3##(1996-12#1)(2008-12#2)
aged from 6 to##2##4##(2007-8#2)
aged from##11##2##(1991-9#1)(1995-3#1)(1996-12#1)(2007-8#2)(2008-12#3)(2010-11#1)(2011-2#1)(2012-2#1)
aged in##3##2##(1991-1#1)(1994-1#1)(2008-10#1)
aged individuals##3##2##(1994-5#1)(2009-1#1)(2013-1#1)
aged less than##4##3##(1990-3#1)(1994-12#1)(2012-12#1)(2013-1#1)
aged less##5##2##(1990-3#1)(1994-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
aged male##2##2##(1997-6#1)(2008-7#1)
aged mice was##2##3##(2008-3#2)
aged mice were##2##3##(2008-3#1)(2009-12#1)
aged mice##8##2##(1994-6#1)(2008-3#4)(2008-5#1)(2009-12#1)(2012-2#1)
aged neurones##2##2##(1996-5#2)
aged over 60##2##3##(1990-6#1)(2012-3#1)
aged over 65##2##3##(1992-9#1)(2012-12#1)
aged over##10##2##(1990-6#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-4#1)(2008-10#1)(2012-12#1)(2012-3#3)
aged patients with##2##3##(2008-7#2)
aged patients##3##2##(2008-7#3)
aged people with##2##3##(2007-11#2)
aged people##6##2##(1990-3#1)(2007-11#3)(2012-3#1)(2013-1#1)
aged persons##3##2##(1991-12#1)(1991-3#1)(1994-12#1)
aged population##4##2##(1992-1#1)(1996-3#1)(2008-7#2)
aged rat##8##2##(1990-5#1)(1991-12#1)(1992-12#1)(1994-2#1)(2009-12#2)(2009-5#1)(2012-1#1)
aged rats following##2##3##(1994-3#1)(2009-5#1)
aged rats in##2##3##(1995-8#1)(1997-2#1)
aged rats were##4##3##(1990-5#1)(1990-7#1)(1994-5#1)(1997-6#1)
aged rats##26##2##(1990-5#1)(1990-7#2)(1992-12#2)(1993-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-2#4)(1997-6#1)(2008-7#2)(2009-5#1)(2012-1#4)
aged skin##3##2##(2008-5#3)
aged subjects##2##2##(1990-6#1)(2008-5#1)
aged two##3##2##(1990-3#1)(1992-4#1)(2010-10#1)
aged under##4##2##(1990-12#1)(1992-8#1)(2008-9#1)(2013-8#1)
aged woman##2##2##(2007-8#2)
aged##584##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#8)(1990-5#6)(1990-6#7)(1990-7#3)(1990-8#1)(1990-9#5)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#9)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#7)(1994-6#7)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#4)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#4)(1997-8#3)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#4)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#20)(2008-11#5)(2008-12#9)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#16)(2008-7#41)(2008-8#1)(2008-9#8)(2009-1#1)(2009-10#6)(2009-12#7)(2009-5#9)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#16)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#3)(2011-1#26)(2011-2#32)(2012-1#7)(2012-12#16)(2012-2#15)(2012-3#13)(2013-1#42)(2013-3#1)(2013-7#4)(2013-8#9)
aged-care##8##1##(2010-10#8)
aged-related##2##1##(1992-8#1)(2008-5#1)
ageing and the##2##3##(2008-10#2)
ageing and##12##2##(1992-11#1)(1995-3#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2012-2#1)
ageing in##5##2##(1990-5#1)(1991-6#1)(2008-5#1)(2008-7#1)(2009-12#1)
ageing is##6##2##(2008-10#1)(2008-5#4)(2009-12#1)
ageing of the##3##3##(1991-11#1)(2008-10#2)
ageing of##7##2##(1990-3#1)(1990-5#1)(1991-11#1)(2007-8#1)(2008-10#3)
ageing or##2##2##(2008-11#1)(2008-7#1)
ageing period##2##2##(2008-10#2)
ageing process##8##2##(1992-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#3)
ageing processes##3##2##(2008-10#2)(2008-7#1)
ageing rats##2##2##(1991-12#2)
ageing##113##1##(1990-3#2)(1990-5#2)(1991-11#1)(1991-12#3)(1991-6#1)(1992-11#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#3)(2007-8#1)(2008-10#19)(2008-11#4)(2008-5#33)(2008-7#10)(2008-8#1)(2009-10#4)(2009-12#7)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)
ageist attitudes##2##2##(2008-11#1)(2012-3#1)
agencies and their patients##2##4##(1995-3#2)
agencies and##13##2##(1991-3#1)(1992-1#1)(1994-3#1)(1995-3#3)(1996-1#1)(1997-2#1)(1997-3#2)(2009-5#1)(2012-12#1)(2013-1#1)
agencies are in##2##3##(1994-1#1)(1996-3#1)
agencies are##4##2##(1994-1#1)(1996-12#1)(1996-3#1)(2011-2#1)
agencies at##2##2##(1996-3#1)(2010-12#1)
agencies for##2##2##(1997-1#1)(2012-2#1)
agencies have##7##2##(1991-3#1)(1994-2#1)(1996-2#2)(1997-1#2)(2008-6#1)
agencies in Metro##2##3##(1997-3#1)(2011-2#1)
agencies in the##3##3##(1994-2#2)(2008-1#1)
agencies in##15##2##(1990-3#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-12#2)(1995-3#3)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2011-2#1)
agencies must##2##2##(1997-3#1)(2008-9#1)
agencies of##2##2##(1995-3#1)(1996-12#1)
agencies or##2##2##(2012-12#1)(2012-2#1)
agencies such as the##3##4##(2008-1#1)(2008-8#1)(2012-2#1)
agencies to##11##2##(1995-12#2)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#1)(2007-2#1)(2009-3#2)
agencies with##2##2##(1995-3#2)
agencies##157##1##(1990-3#1)(1991-12#2)(1991-2#2)(1991-3#3)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#4)(1993-1#1)(1993-2#3)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#8)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#13)(1996-1#9)(1996-12#9)(1996-2#7)(1996-3#4)(1996-4#1)(1997-1#7)(1997-2#7)(1997-3#9)(1997-4#1)(2007-2#4)(2008-1#2)(2008-10#6)(2008-11#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#3)
agency administrators##2##2##(1991-12#2)
agency and##3##2##(2008-11#1)(2009-5#1)(2013-1#1)
agency charged with##2##3##(1992-1#1)(1994-3#1)
agency for the##2##3##(1994-12#1)(1995-5#1)
agency for##4##2##(1994-12#1)(1995-5#1)(1996-3#1)(2006-5#1)
agency in##4##2##(1995-3#1)(1996-3#1)(2012-2#2)
agency relationship##2##2##(1993-12#1)(1997-1#1)
agency setting##4##2##(1996-2#4)
agency staff and##2##3##(1997-3#1)(2006-5#1)
agency was##2##2##(2008-11#1)(2012-12#1)
agency##82##1##(1991-12#3)(1991-3#3)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#3)(1996-2#5)(1996-3#5)(1996-5#1)(1997-1#2)(1997-2#4)(1997-3#6)(2006-5#3)(2007-12#1)(2007-5#1)(2008-11#5)(2008-2#1)(2009-3#1)(2009-5#1)(2010-8#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)
agency's##3##1##(1992-8#1)(1995-6#1)(2006-5#1)
agenda and##4##2##(2008-12#1)(2009-11#1)(2012-12#2)
agenda for the##2##3##(2008-3#1)(2011-1#1)
agenda for##13##2##(1991-12#1)(1992-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
agenda of##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
agenda that##2##2##(2009-8#1)(2011-1#1)
agenda to##2##2##(1991-1#1)(2008-11#1)
agenda##49##1##(1991-1#1)(1991-12#1)(1992-12#2)(1993-2#1)(1994-12#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-12#3)(2013-1#2)(2013-8#1)
agendas of##3##2##(1995-3#1)(1997-2#1)(2009-3#1)
agendas##9##1##(1991-12#1)(1995-3#1)(1997-2#2)(2008-12#2)(2008-6#2)(2009-3#1)
agenesia or##2##2##(2011-2#1)(2012-3#1)
agenesia##4##1##(2007-8#2)(2011-2#1)(2012-3#1)
agenesis and##2##2##(1992-6#1)(2012-3#1)
agenesis of the corpus callosum##4##5##(2008-7#1)(2011-1#2)(2011-2#1)
agenesis of the##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2011-2#1)
agenesis of##9##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-7#3)(2011-1#2)(2011-2#1)
agenesis##24##1##(1992-6#2)(1993-1#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#3)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
agent (sodium##2##2##(2008-10#1)(2008-11#1)
agent N-acetylcysteine##2##2##(1991-11#1)(2012-12#1)
agent Pseudomonas fluorescens##2##3##(2008-10#2)
agent against##6##2##(1990-7#1)(1993-2#1)(1997-5#1)(2008-10#1)(2008-12#1)(2013-8#1)
agent alone##3##2##(1990-8#1)(1997-1#1)(2008-4#1)
agent and its##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
agent and the##4##3##(1995-5#1)(2008-10#2)(2012-3#1)
agent and##30##2##(1990-9#1)(1991-2#1)(1992-11#1)(1995-5#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
agent can be##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
agent can##4##2##(2008-10#1)(2010-12#2)(2012-3#1)
agent capable of##2##3##(2008-5#2)
agent chosen##2##2##(2008-10#1)(2009-8#1)
agent cyclosporin##2##2##(1990-12#1)(2007-11#1)
agent database##2##2##(2010-5#2)
agent dithiothreitol##2##2##(1992-12#1)(1995-11#1)
agent during##2##2##(2008-10#1)(2009-12#1)
agent effective against##2##3##(2008-11#1)(2010-8#1)
agent effective##3##2##(2008-11#1)(2008-3#1)(2010-8#1)
agent for further##2##3##(1994-9#1)(2008-10#1)
agent for the treatment of##2##5##(2008-5#1)(2012-2#1)
agent for the##14##3##(1996-5#1)(2008-10#9)(2008-12#1)(2008-5#1)(2012-2#2)
agent for##57##2##(1990-7#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-12#1)(2008-5#5)(2008-7#5)(2008-8#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
agent from##4##2##(1994-11#1)(1994-6#1)(2008-10#2)
agent has been##4##3##(2008-10#2)(2008-5#1)(2009-5#1)
agent has##12##2##(2007-10#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-10#1)(2013-8#1)
agent in a##2##3##(1991-9#1)(2008-10#1)
agent in human##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
agent in the treatment of##3##5##(1991-6#1)(2008-3#1)(2008-8#1)
agent in the##12##3##(1991-6#1)(1991-9#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)
agent in this##2##3##(1996-12#1)(2008-5#1)
agent in##52##2##(1991-5#1)(1991-6#2)(1991-9#2)(1992-3#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-7#3)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2009-7#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-3#2)
agent inhibits##2##2##(1992-11#1)(1997-2#1)
agent into the##2##3##(1997-8#1)(2010-4#1)
agent into##4##2##(1997-8#1)(2007-11#1)(2008-5#1)(2010-4#1)
agent is a potent##2##4##(1993-3#1)(1995-8#1)
agent is a##3##3##(1993-3#1)(1995-8#1)(2012-3#1)
agent is##15##2##(1993-3#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
agent may be##2##3##(2008-9#1)(2012-2#1)
agent may##4##2##(2008-5#1)(2008-9#2)(2012-2#1)
agent of Fusarium##5##3##(2008-10#5)
agent of Lyme##2##3##(1992-3#1)(2011-2#1)
agent of a##5##3##(1992-8#1)(1997-4#1)(2008-10#2)(2009-2#1)
agent of bacterial##6##3##(2008-10#5)(2009-6#1)
agent of citrus##2##3##(2008-10#2)
agent of grape##2##3##(2008-10#2)
agent of infectious##2##3##(2007-2#1)(2013-8#1)
agent of the##5##3##(2008-10#4)(2008-8#1)
agent of wheat##2##3##(2008-10#2)
agent of white##3##3##(2008-10#3)
agent of##166##2##(1990-3#1)(1990-5#1)(1992-3#1)(1992-8#3)(1997-4#2)(1997-5#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#113)(2008-12#2)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
agent on the##2##3##(1996-3#1)(2008-10#1)
agent on##6##2##(1995-2#1)(1996-3#1)(2008-10#4)
agent or combination##2##3##(2010-4#1)(2011-2#1)
agent or##6##2##(2007-11#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
agent should##3##2##(1991-12#1)(2007-12#1)(2008-10#1)
agent sodium##3##2##(2008-10#2)(2011-1#1)
agent that targets##2##3##(1993-11#1)(2010-5#1)
agent that##20##2##(1992-5#1)(1992-9#1)(1993-11#1)(1993-6#2)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-5#1)
agent to treat##2##3##(2009-12#1)(2013-8#1)
agent to##18##2##(1991-12#1)(1997-4#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
agent under development by##2##4##(2008-5#2)
agent under##5##2##(1996-5#1)(2008-10#2)(2008-5#2)
agent used##4##2##(1992-9#1)(1996-3#1)(1997-4#1)(2008-8#1)
agent was isolated##2##3##(1990-9#1)(2008-5#1)
agent was##17##2##(1990-10#1)(1990-9#1)(1991-3#1)(1992-11#1)(1994-11#1)(2008-10#8)(2008-5#1)(2009-2#1)(2010-8#1)(2012-3#1)
agent were##2##2##(1991-3#1)(2008-10#1)
agent which##4##2##(1991-8#1)(1992-12#1)(1995-3#1)(2008-11#1)
agent with a##4##3##(1991-9#1)(2008-5#1)(2010-7#1)(2013-7#1)
agent with the##2##3##(2008-10#1)(2008-5#1)
agent with##12##2##(1991-9#1)(1993-1#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-7#1)
agent##876##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#8)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#4)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#1)(1992-8#5)(1992-9#7)(1993-1#2)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#4)(1996-12#3)(1996-3#4)(1996-5#4)(1996-9#2)(1997-1#4)(1997-2#2)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#3)(2006-10#2)(2006-6#1)(2007-10#3)(2007-11#9)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#6)(2008-1#8)(2008-10#331)(2008-11#28)(2008-12#11)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#51)(2008-6#5)(2008-7#29)(2008-8#18)(2008-9#10)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#8)(2010-7#3)(2010-8#2)(2011-1#6)(2011-10#1)(2011-2#30)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#17)(2013-1#10)(2013-7#2)(2013-8#11)
agent) and##2##2##(2008-10#2)
agent)##11##1##(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#7)(2011-2#1)
agent-based modeling##3##2##(2008-5#1)(2010-9#2)
agent-based models##3##2##(2010-5#2)(2013-8#1)
agent-based##10##1##(2008-5#1)(2008-8#1)(2010-5#4)(2010-9#2)(2013-8#2)
agents (BCAs)##3##2##(2008-10#3)
agents (e##2##2##(2008-7#1)(2008-8#1)
agents -##2##2##(2007-11#1)(2013-1#1)
agents active##3##2##(1996-2#2)(2011-2#1)
agents against the##2##3##(2008-10#1)(2011-2#1)
agents against##15##2##(1991-8#1)(1992-6#1)(1994-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
agents alone##2##2##(1994-6#1)(1995-2#1)
agents and a##2##3##(1995-8#1)(2009-5#1)
agents and combination##2##3##(2010-9#1)(2012-2#1)
agents and discusses##2##3##(2008-11#1)(2012-1#1)
agents and is##2##3##(2008-3#1)(2008-9#1)
agents and the##7##3##(1992-11#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)
agents and their##2##3##(1992-8#1)(2008-7#1)
agents and##59##2##(1990-3#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-10#1)(1994-5#1)(1995-8#2)(1996-11#1)(1997-4#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-5#1)(2010-11#2)(2010-3#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
agents applied##2##2##(2008-10#1)(2011-2#1)
agents are also##2##3##(1990-2#1)(2013-1#1)
agents are being##2##3##(2008-5#1)(2012-3#1)
agents are currently being##2##4##(2008-7#1)(2011-3#1)
agents are currently##3##3##(2008-7#1)(2010-3#1)(2011-3#1)
agents are listed##2##3##(1996-1#1)(2011-1#1)
agents are often##2##3##(1993-11#1)(2011-1#1)
agents are still lacking##2##4##(1992-6#1)(2007-12#1)
agents are still##3##3##(1992-6#1)(2007-12#1)(2013-1#1)
agents are the most##2##4##(1991-3#1)(2008-11#1)
agents are the##4##3##(1991-3#1)(1993-9#1)(2008-11#1)(2012-12#1)
agents are used##2##3##(2007-8#1)(2008-5#1)
agents are##50##2##(1990-10#1)(1990-2#1)(1991-3#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#2)(1996-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)
agents as##6##2##(1995-3#2)(2008-10#1)(2008-7#1)(2010-5#1)(2013-7#1)
agents associated with##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
agents at##5##2##(1992-12#1)(1992-3#1)(1992-9#1)(2007-12#1)(2008-10#1)
agents available##2##2##(2009-8#1)(2010-5#1)
agents based on the##2##4##(2008-5#1)(2010-2#1)
agents based on##3##3##(2008-5#1)(2010-2#1)(2013-1#1)
agents but##2##2##(2009-6#1)(2010-5#1)
agents by##5##2##(1992-12#1)(2008-11#2)(2008-7#1)(2010-9#1)
agents can##5##2##(1992-12#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)
agents compared##2##2##(2008-11#1)(2012-3#1)
agents containing##2##2##(1992-3#1)(1995-2#1)
agents could be##4##3##(1990-12#1)(1990-2#1)(1997-3#1)(2008-10#1)
agents currently##2##2##(2008-5#1)(2009-6#1)
agents demonstrated##2##2##(2007-11#1)(2008-5#1)
agents did##2##2##(2008-10#2)
agents due to##2##3##(2008-7#1)(2012-3#1)
agents during##3##2##(1990-6#1)(1997-3#1)(2008-2#1)
agents elicit##2##2##(1991-5#1)(1994-11#1)
agents fail to##2##3##(1991-12#1)(2010-4#1)
agents for sedation##2##3##(2008-8#2)
agents for the management of##3##5##(2009-12#1)(2011-2#1)(2013-1#1)
agents for the treatment of##4##5##(2008-5#1)(2009-12#1)(2009-6#1)(2011-2#1)
agents for the treatment##5##4##(2008-5#1)(2009-12#1)(2009-6#1)(2010-1#1)(2011-2#1)
agents for the##13##3##(1990-2#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-12#2)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#2)
agents for treating##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
agents for treatment of##2##4##(2010-6#1)(2011-2#1)
agents for##60##2##(1990-2#1)(1991-1#1)(1992-12#2)(1994-11#1)(1994-3#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#13)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
agents has been##6##3##(1990-2#1)(2008-10#3)(2012-12#1)(2012-2#1)
agents has##11##2##(1990-2#1)(2007-12#1)(2008-10#5)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
agents have been published##2##4##(2006-10#1)(2008-7#1)
agents have been tested##2##4##(2007-10#1)(2008-7#1)
agents have been used for##2##5##(2008-5#1)(2009-1#1)
agents have been used in##2##5##(2008-7#1)(2013-1#1)
agents have been used##5##4##(2008-5#1)(2008-7#1)(2009-1#1)(2009-6#1)(2013-1#1)
agents have been##17##3##(2006-10#2)(2007-10#1)(2007-9#1)(2008-2#1)(2008-5#2)(2008-7#3)(2009-1#1)(2009-6#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-1#2)
agents have demonstrated##2##3##(2007-7#1)(2013-1#1)
agents have emerged##2##3##(2008-7#1)(2012-1#1)
agents have##37##2##(1992-8#1)(2006-10#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#3)
agents in a##3##3##(1990-6#1)(1997-3#1)(2012-12#1)
agents in patients with##3##4##(2006-10#1)(2008-7#1)(2012-2#1)
agents in reducing##2##3##(2008-8#1)(2013-1#1)
agents in the treatment of acute##2##6##(1990-5#1)(2007-10#1)
agents in the treatment of##7##5##(1990-5#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-9#1)
agents in the##17##3##(1990-5#1)(1991-1#1)(1991-9#2)(1995-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#2)
agents in treating##2##3##(2008-2#1)(2008-4#1)
agents in##88##2##(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#2)(1991-9#2)(1992-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-3#3)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#13)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)
agents include##6##2##(2007-7#1)(2008-1#1)(2008-7#1)(2010-3#1)(2012-3#2)
agents including##8##2##(1997-8#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2013-1#1)
agents increases the##2##3##(1996-12#1)(2010-12#1)
agents induce##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
agents inhibit##2##2##(1990-2#1)(1995-5#1)
agents into the##2##3##(1997-1#1)(2008-11#1)
agents into##3##2##(1997-1#1)(2008-11#1)(2008-5#1)
agents involved##2##2##(2008-10#1)(2012-3#1)
agents is an##2##3##(2010-3#1)(2013-1#1)
agents is##17##2##(1992-12#2)(1995-5#1)(1997-1#1)(2007-4#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-3#1)(2013-1#2)
agents known to modulate##2##4##(2008-4#1)(2008-5#1)
agents known to##4##3##(1994-10#1)(2008-4#1)(2008-5#1)(2010-3#1)
agents like##3##2##(1997-6#1)(2008-11#1)(2008-7#1)
agents may also cause##2##4##(2011-2#2)
agents may also##3##3##(2010-3#1)(2011-2#2)
agents may induce##2##3##(2007-7#1)(2008-7#1)
agents may##14##2##(1992-12#1)(1992-8#1)(1996-9#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)
agents must be##2##3##(2008-7#1)(2012-12#1)
agents nacrants##2##2##(2008-5#2)
agents now##2##2##(2008-7#1)(2010-4#1)
agents of the##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
agents of##31##2##(1990-6#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#6)
agents on the##2##3##(2009-7#1)(2013-1#1)
agents on##12##2##(1991-2#1)(1994-5#1)(1994-8#2)(1996-8#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#3)
agents or combinations##2##3##(2009-3#1)(2010-4#1)
agents or##18##2##(1991-9#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)
agents play##2##2##(1993-1#1)(2012-1#1)
agents responsible for##2##3##(1997-2#1)(2008-10#1)
agents should be##2##3##(2011-2#1)(2012-3#1)
agents should##5##2##(1991-6#1)(1996-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
agents showed##2##2##(1996-2#1)(2011-2#1)
agents studied##2##2##(1997-1#1)(2008-10#1)
agents such as sodium##2##4##(2008-10#1)(2008-11#1)
agents such as the##2##4##(2008-7#1)(2010-5#1)
agents such as##21##3##(1990-11#1)(1992-9#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#6)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
agents targeted##2##2##(2009-9#1)(2010-3#1)
agents targeting the##2##3##(2012-1#1)(2013-1#1)
agents targeting##4##2##(2011-2#1)(2012-1#1)(2013-1#2)
agents that are##3##3##(1994-5#1)(2008-5#1)(2013-1#1)
agents that can##2##3##(2007-11#1)(2008-7#1)
agents that cause##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
agents that do not##3##4##(1995-5#1)(1996-2#1)(1997-4#1)
agents that have##2##3##(1995-3#1)(2008-7#1)
agents that induce the##2##4##(1990-2#1)(1995-5#1)
agents that inhibit##2##3##(2006-10#1)(2008-4#1)
agents that target##2##3##(2009-12#1)(2012-2#1)
agents that were##2##3##(2010-3#1)(2011-1#1)
agents that##46##2##(1990-2#2)(1992-5#1)(1992-8#2)(1993-11#3)(1994-11#1)(1994-5#2)(1995-3#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-4#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2009-12#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
agents through##2##2##(1992-2#1)(1995-2#1)
agents to be##3##3##(1995-2#1)(1996-9#1)(2008-10#1)
agents to effectively##2##3##(2008-4#1)(2012-12#1)
agents to the##2##3##(2008-4#1)(2008-5#1)
agents to treat##6##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)
agents to##28##2##(1992-3#1)(1995-2#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2009-11#1)(2009-12#1)(2010-11#1)(2010-3#2)(2010-5#2)(2012-12#1)
agents together##3##2##(2008-10#2)(2011-1#1)
agents used##6##2##(1991-12#1)(1991-8#1)(2006-10#1)(2008-12#1)(2008-7#1)(2010-6#1)
agents was studied##2##3##(1991-3#1)(2008-10#1)
agents was##5##2##(1991-3#1)(1995-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
agents were found to##2##4##(2008-11#1)(2013-1#1)
agents were given##2##3##(1997-7#1)(2008-2#1)
agents were lower##2##3##(2008-10#1)(2008-12#1)
agents were tested##3##3##(1990-5#1)(1993-8#1)(2008-7#1)
agents were used##2##3##(1993-12#1)(2008-5#1)
agents were##28##2##(1990-5#2)(1993-12#1)(1993-8#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#3)(2010-3#1)(2011-2#2)(2013-1#1)
agents when##2##2##(2008-10#1)(2008-5#1)
agents which have##3##3##(1997-7#1)(2009-1#1)(2011-1#1)
agents which##14##2##(1992-12#2)(1994-2#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-1#1)(2009-12#1)(2011-1#1)(2012-1#1)
agents who##3##2##(1992-3#1)(2006-10#1)(2010-5#1)
agents whose##2##2##(1995-11#1)(2008-11#1)
agents will##4##2##(1994-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
agents with a##2##3##(1995-5#1)(2013-8#1)
agents with an##2##3##(2008-1#1)(2009-2#1)
agents with enhanced##2##3##(2007-12#1)(2008-10#1)
agents with high##2##3##(2008-5#1)(2012-12#1)
agents with neurotrophic##3##3##(2008-11#1)(2009-8#2)
agents with##26##2##(1990-2#1)(1991-8#1)(1995-2#1)(1995-5#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#3)(2012-12#1)(2013-8#1)
agents within##2##2##(1991-12#1)(2011-1#1)
agents##1293##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#11)(1990-3#2)(1990-5#3)(1990-6#7)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#5)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#8)(1992-11#3)(1992-12#18)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#8)(1992-9#2)(1993-1#4)(1993-11#6)(1993-12#5)(1993-3#3)(1993-8#4)(1993-9#1)(1994-10#3)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#9)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#7)(1995-3#11)(1995-5#13)(1995-6#5)(1995-8#8)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#2)(1996-8#1)(1996-9#5)(1997-1#10)(1997-2#3)(1997-3#7)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2006-10#10)(2006-12#2)(2006-7#1)(2007-1#15)(2007-10#3)(2007-11#14)(2007-12#14)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#11)(2007-8#3)(2007-9#3)(2008-1#18)(2008-10#176)(2008-11#54)(2008-12#14)(2008-2#10)(2008-3#21)(2008-4#22)(2008-5#78)(2008-6#8)(2008-7#106)(2008-8#41)(2008-9#20)(2009-1#6)(2009-10#1)(2009-11#3)(2009-12#12)(2009-2#1)(2009-3#3)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#8)(2010-12#5)(2010-2#3)(2010-3#19)(2010-4#8)(2010-5#17)(2010-6#6)(2010-7#11)(2010-8#2)(2010-9#10)(2011-1#18)(2011-2#51)(2011-3#2)(2012-1#9)(2012-12#15)(2012-2#21)(2012-3#29)(2012-6#1)(2013-1#54)(2013-7#3)(2013-8#11)
agents)##8##1##(1994-8#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
agents?##2##1##(1995-9#1)(1996-8#1)
agents]##6##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1995-5#1)(1995-6#1)
ages 19##2##2##(1991-1#1)(1992-1#1)
ages 3 to##2##3##(2007-8#1)(2010-2#1)
ages 3##3##2##(1995-1#1)(2007-8#1)(2010-2#1)
ages 6##2##2##(1991-8#1)(2009-7#1)
ages 8 to##2##3##(2012-2#2)
ages 8##3##2##(1994-12#1)(2012-2#2)
ages and##7##2##(1990-8#1)(1995-5#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-2#1)
ages are##3##2##(1992-6#2)(2008-1#1)
ages at##3##2##(1993-2#1)(1994-7#1)(2008-9#1)
ages between##2##2##(2011-1#1)(2011-2#1)
ages by##2##2##(2008-10#1)(2008-3#1)
ages for##2##2##(2008-10#1)(2008-2#1)
ages in##4##2##(1994-11#1)(2008-1#1)(2008-7#1)(2008-8#1)
ages of 45##2##3##(1991-5#1)(2009-11#1)
ages of the##3##3##(2008-12#1)(2008-7#1)(2009-2#1)
ages of##27##2##(1990-2#1)(1991-5#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
ages ranged from##2##3##(1992-9#1)(2009-7#1)
ages ranged##4##2##(1992-9#1)(2008-1#1)(2008-4#1)(2009-7#1)
ages ranging from##2##3##(2008-10#1)(2013-1#1)
ages ranging##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
ages studied##4##2##(1995-12#2)(1996-12#2)
ages to##4##2##(2008-7#3)(2012-3#1)
ages was##2##2##(1991-9#1)(2008-3#1)
ages were##3##2##(2008-12#1)(2008-2#1)(2008-9#1)
ages##187##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#3)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-8#2)(2008-1#7)(2008-10#9)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#6)(2008-7#10)(2008-8#1)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#8)(2009-9#1)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
agglomerans strain##6##2##(2008-10#6)
agglomerans was##2##2##(2008-10#2)
agglomerans##31##1##(2008-10#30)(2010-4#1)
agglomerate##2##1##(2008-3#1)(2008-5#1)
agglomerated##3##1##(2008-10#1)(2008-3#2)
agglomerates##10##1##(2008-2#2)(2008-3#6)(2008-5#2)
agglomeration##3##1##(1992-9#1)(2008-10#1)(2008-5#1)
agglutinated##3##1##(1992-12#1)(1994-3#1)(2008-5#1)
agglutination kinetics of##2##3##(1990-12#2)
agglutination method##2##2##(2007-10#2)
agglutination test (MAT)##2##3##(1991-8#1)(2007-7#1)
agglutination test (≤1 ##2##3##(2012-2#2)
agglutination test##12##2##(1990-12#1)(1991-8#1)(1992-6#1)(1996-12#2)(2007-7#1)(2011-2#2)(2012-2#3)(2012-3#1)
agglutination##29##1##(1990-12#9)(1991-8#1)(1992-6#1)(1992-9#2)(1996-12#2)(2007-10#2)(2007-7#2)(2008-10#1)(2008-5#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)
agglutinin or##3##2##(1994-8#1)(1995-11#1)(2008-11#1)
agglutinin were##2##2##(1995-11#1)(2008-7#1)
agglutinin##37##1##(1990-7#7)(1991-12#2)(1992-6#3)(1993-6#1)(1994-11#3)(1994-8#3)(1995-11#8)(2008-10#2)(2008-11#3)(2008-7#3)(2011-2#2)
aggravate the##2##2##(1992-8#1)(2008-1#1)
aggravate##7##1##(1992-8#1)(1992-9#1)(1994-5#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-1#1)
aggravated by##8##2##(1990-3#1)(1994-12#1)(1995-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)
aggravated##14##1##(1990-3#1)(1991-12#1)(1994-12#1)(1995-10#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
aggravates##3##1##(2011-1#1)(2011-2#1)(2013-1#1)
aggravating factor##3##2##(2008-9#1)(2009-2#1)(2012-12#1)
aggravating##6##1##(2008-12#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-12#1)(2012-2#1)
aggravation of##6##2##(2008-10#2)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
aggravation##11##1##(1993-8#1)(1996-7#1)(2008-10#5)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
aggrecan core protein##2##3##(1992-1#2)
aggrecan mRNA##5##2##(1992-1#1)(2008-11#4)
aggrecan proteoglycan##2##2##(1992-1#2)
aggrecan##16##1##(1992-1#9)(2008-11#5)(2012-12#2)
aggrecan-degrading##2##1##(2012-12#2)
aggregability in##3##2##(1991-12#2)(2008-7#1)
aggregability##7##1##(1990-5#1)(1991-12#4)(2008-7#1)(2011-1#1)
aggregans type strain##2##3##(2011-2#2)
aggregans##4##1##(2011-2#4)
aggregata##5##1##(2008-8#3)(2008-9#2)
aggregate analysis##2##2##(2008-12#1)(2012-12#1)
aggregate and##6##2##(1995-8#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)
aggregate effects##2##2##(2009-11#1)(2012-3#1)
aggregate formation during##2##3##(2008-10#1)(2011-2#1)
aggregate formation##5##2##(1990-12#1)(2008-10#2)(2011-2#2)
aggregate in the##2##3##(2008-10#1)(2008-7#1)
aggregate in##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
aggregate into##3##2##(1994-2#1)(2008-3#1)(2009-10#1)
aggregate is##2##2##(2008-10#1)(2008-3#1)
aggregate level##2##2##(1996-3#1)(2011-9#1)
aggregate of spheres##5##3##(2008-2#3)(2008-3#2)
aggregate of##9##2##(1995-3#2)(2008-2#5)(2008-3#2)
aggregate particles##2##2##(2008-2#2)
aggregate size##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
aggregate structures##2##2##(2012-2#2)
aggregate was##2##2##(2008-11#2)
aggregate##99##1##(1990-12#2)(1991-1#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1994-2#1)(1994-5#3)(1995-3#2)(1995-8#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-1#3)(2008-10#15)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#4)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)
aggregated aerosols by##2##3##(2008-3#2)
aggregated aerosols##4##2##(2008-3#4)
aggregated and##2##2##(2007-5#1)(2013-1#1)
aggregated as##2##2##(2008-10#2)
aggregated at##2##2##(1991-12#1)(2010-8#1)
aggregated in##3##2##(1996-12#1)(2008-10#2)
aggregated into##2##2##(2008-10#1)(2008-3#1)
aggregated or##2##2##(1993-6#1)(2008-10#1)
aggregated pattern of distribution##3##4##(2008-10#3)
aggregated patterns of disease##3##4##(2008-10#3)
aggregated patterns##4##2##(2008-10#4)
aggregated protein##3##2##(1996-5#2)(2008-4#1)
aggregated spatial pattern##2##3##(2008-10#2)
aggregated to form##2##3##(1997-6#1)(2010-8#1)
aggregated##75##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#2)(1997-6#1)(2007-5#1)(2008-10#29)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#3)(2010-8#2)(2011-1#1)(2011-2#4)(2011-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
aggregates and the##2##3##(2008-2#2)
aggregates and##6##2##(2008-10#3)(2008-11#1)(2008-2#2)
aggregates are##2##2##(1994-2#1)(2008-10#1)
aggregates as##2##2##(2008-10#1)(2008-11#1)
aggregates at##2##2##(2008-10#2)
aggregates containing##2##2##(2007-12#1)(2008-11#1)
aggregates from##2##2##(1992-12#1)(2008-10#1)
aggregates in a##2##3##(1991-2#1)(2008-11#1)
aggregates in the##5##3##(1994-5#1)(2008-10#2)(2008-11#2)
aggregates in##12##2##(1991-2#1)(1991-8#1)(1994-5#1)(2008-10#3)(2008-11#5)(2012-12#1)
aggregates is##3##2##(2008-2#1)(2008-9#1)(2010-4#1)
aggregates of bacteria##2##3##(2008-10#1)(2008-3#1)
aggregates of spheres##3##3##(2008-2#2)(2008-3#1)
aggregates of##22##2##(1996-1#1)(1997-5#1)(2007-12#1)(2008-10#9)(2008-2#5)(2008-3#3)(2011-2#1)(2012-2#1)
aggregates on##2##2##(2008-10#2)
aggregates or##2##2##(1994-2#1)(2008-11#1)
aggregates to##2##2##(2008-2#1)(2008-3#1)
aggregates was##2##2##(1990-12#2)
aggregates were not##2##3##(1991-8#1)(2008-10#1)
aggregates were##4##2##(1991-8#1)(2008-10#3)
aggregates with##6##2##(1994-9#1)(2008-1#2)(2008-10#1)(2010-4#2)
aggregates##132##1##(1990-11#1)(1990-12#4)(1991-2#1)(1991-6#1)(1991-8#3)(1992-12#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-5#1)(1997-6#1)(2007-12#5)(2008-1#2)(2008-10#42)(2008-11#19)(2008-2#10)(2008-3#11)(2008-5#2)(2008-9#3)(2010-12#1)(2010-4#5)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
aggregating the##2##2##(1993-8#1)(2010-3#1)
aggregating##5##1##(1990-12#1)(1992-3#1)(1993-8#1)(2008-11#1)(2010-3#1)
aggregation and the##3##3##(1997-7#1)(2008-5#1)(2008-8#1)
aggregation and##29##2##(1990-12#4)(1990-8#1)(1991-12#2)(1991-9#3)(1992-4#1)(1992-8#1)(1994-12#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2010-12#1)(2011-1#1)
aggregation as##2##2##(1990-5#1)(2008-3#1)
aggregation at##3##2##(2008-10#1)(2008-8#2)
aggregation by##6##2##(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
aggregation can##2##2##(2008-10#1)(2013-8#1)
aggregation for##2##2##(2008-7#2)
aggregation in response to##3##4##(1992-4#1)(2008-5#1)(2009-5#1)
aggregation in the##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
aggregation in##25##2##(1990-5#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-4#1)(1994-5#1)(1995-5#1)(1997-2#1)(2006-6#4)(2008-10#5)(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
aggregation induced by arachidonic acid and##2##6##(1990-12#1)(1997-7#1)
aggregation induced by##4##3##(1990-12#1)(1990-5#1)(1997-6#1)(1997-7#1)
aggregation induced##6##2##(1990-12#1)(1990-5#1)(1992-8#1)(1997-6#1)(1997-7#2)
aggregation inhibitors##2##2##(2008-5#1)(2010-11#1)
aggregation is##4##2##(1992-8#2)(2008-9#1)(2010-3#1)
aggregation of CSD-symptomatic trees for##2##5##(2008-10#2)
aggregation of infected##3##3##(2008-10#3)
aggregation of normal##2##3##(1990-5#1)(1991-12#1)
aggregation of teicoplanin##2##3##(2008-10#2)
aggregation of the liposomes##2##4##(1994-11#1)(1994-3#1)
aggregation of the##5##3##(1994-11#1)(1994-3#1)(2008-10#2)(2010-4#1)
aggregation of##51##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#2)(1994-3#1)(1994-5#2)(1996-2#1)(1997-3#2)(2008-1#1)(2008-10#22)(2008-11#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)
aggregation or##2##2##(2007-12#1)(2008-10#1)
aggregation over##2##2##(2008-10#2)
aggregation process##2##2##(1997-3#1)(2010-11#1)
aggregation state of##2##3##(1994-12#1)(1997-2#1)
aggregation techniques##2##2##(2008-8#1)(2010-3#1)
aggregation territories and##2##3##(2009-8#2)
aggregation to##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
aggregation was##13##2##(1990-5#1)(1991-11#1)(1991-12#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-1#3)
aggregation with##2##2##(1990-4#1)(1991-9#1)
aggregation within##3##2##(1990-5#1)(2008-8#2)
aggregation##273##1##(1990-11#1)(1990-12#6)(1990-4#1)(1990-5#13)(1990-8#2)(1991-11#4)(1991-12#6)(1991-2#1)(1991-8#1)(1991-9#6)(1992-12#2)(1992-3#3)(1992-4#2)(1992-8#5)(1992-9#2)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#4)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-2#4)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#4)(2006-6#12)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#57)(2008-11#12)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#10)(2008-8#15)(2008-9#5)(2009-11#4)(2009-5#1)(2009-8#4)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#4)
aggregations are##2##2##(2008-10#1)(2008-8#1)
aggregations of rare variants##2##4##(2012-3#2)
aggregations of##4##2##(2008-10#1)(2008-7#1)(2012-3#2)
aggregations##10##1##(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2012-3#2)
aggression and##13##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2011-2#1)(2012-2#1)
aggression during##2##2##(2008-11#1)(2009-4#1)
aggression in Drosophila##2##3##(2008-10#2)
aggression in children##3##3##(2008-2#2)(2008-4#1)
aggression in##11##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)
aggression of##2##2##(1990-3#1)(2008-10#1)
aggression ratings##2##2##(2008-2#2)
aggression was##2##2##(2008-2#1)(2010-11#1)
aggression##72##1##(1990-3#1)(1995-5#1)(1997-7#1)(2008-10#7)(2008-11#9)(2008-12#4)(2008-2#12)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#5)(2009-4#9)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)
aggressions##2##1##(2007-8#1)(2013-1#1)
aggressive and malignant##2##3##(2007-12#1)(2012-12#1)
aggressive and##14##2##(1990-2#1)(1991-12#1)(1995-2#2)(2006-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-3#2)(2012-12#1)(2013-8#1)
aggressive antibiotic##2##2##(2006-10#1)(2012-2#1)
aggressive approach to##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
aggressive approach##4##2##(2008-11#1)(2008-6#1)(2010-3#1)(2012-3#1)
aggressive bark beetle##2##3##(2008-10#2)
aggressive behavior and##3##3##(1994-9#1)(1996-2#1)(2013-1#1)
aggressive behavior in##2##3##(2008-11#2)
aggressive behavior of##2##3##(1991-4#1)(1997-8#1)
aggressive behavior##18##2##(1991-4#2)(1994-9#1)(1995-2#3)(1996-2#1)(1997-8#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
aggressive behaviour##8##2##(1993-2#2)(1994-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
aggressive behaviours##4##2##(2008-7#1)(2011-2#3)
aggressive biologic##2##2##(1993-3#1)(2008-11#1)
aggressive biological behavior##3##3##(1990-8#1)(2010-3#1)(2012-3#1)
aggressive cases##2##2##(2008-6#2)
aggressive chemotherapy##4##2##(1997-3#2)(2008-6#1)(2012-3#1)
aggressive clinical course and##2##4##(1991-6#1)(2008-9#1)
aggressive clinical management##2##3##(2008-8#1)(2012-3#1)
aggressive clinical##4##2##(1991-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
aggressive course##5##2##(1991-4#1)(1993-6#1)(1993-8#1)(2008-7#1)(2013-7#1)
aggressive disease##2##2##(2008-8#1)(2013-1#1)
aggressive fibromatosis##3##2##(2007-12#1)(2008-6#2)
aggressive forms of##5##3##(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
aggressive in##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
aggressive individuals##2##2##(2008-8#2)
aggressive infection##2##2##(1993-3#2)
aggressive interactions##10##2##(2008-8#8)(2008-9#1)(2009-9#1)
aggressive isolates##3##2##(2008-10#3)
aggressive malignancies##2##2##(2008-1#2)
aggressive malignancy of##2##3##(2008-3#1)(2012-12#1)
aggressive malignancy##3##2##(2008-12#1)(2008-3#1)(2012-12#1)
aggressive management of##4##3##(2008-1#1)(2008-8#1)(2011-2#2)
aggressive management##7##2##(2008-1#1)(2008-8#1)(2010-9#1)(2011-2#2)(2013-1#2)
aggressive melanoma cells##3##3##(2009-3#3)
aggressive melanoma##4##2##(2009-3#4)
aggressive neoplasm##4##2##(2008-11#1)(2010-12#1)(2010-3#1)(2012-1#1)
aggressive on both##2##3##(2008-10#2)
aggressive on##6##2##(2008-10#6)
aggressive or##2##2##(2008-10#1)(2009-6#1)
aggressive osteosarcoma##2##2##(2010-3#2)
aggressive phenotype and poor##2##4##(2008-12#1)(2011-1#1)
aggressive phenotype##4##2##(2008-12#1)(2009-9#1)(2011-1#1)(2012-2#1)
aggressive strain##3##2##(2008-10#3)
aggressive strains showed##2##3##(2008-10#2)
aggressive surgical approach##4##3##(1990-12#1)(1990-9#1)(2012-1#1)(2012-3#1)
aggressive surgical management##2##3##(1997-5#1)(2008-12#1)
aggressive surgical resection##2##3##(2008-7#2)
aggressive surgical##10##2##(1990-12#1)(1990-9#1)(1997-5#1)(2008-12#1)(2008-2#1)(2008-7#3)(2012-1#1)(2012-3#1)
aggressive than the##2##3##(2008-10#2)
aggressive than those##2##3##(2008-10#2)
aggressive than##5##2##(2008-10#5)
aggressive therapeutic##2##2##(1990-3#1)(2008-11#1)
aggressive therapy##5##2##(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-3#1)
aggressive to##4##2##(2008-10#4)
aggressive treatment of##2##3##(2008-7#1)(2010-7#1)
aggressive treatment##8##2##(2007-6#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-3#2)(2013-1#1)
aggressive tumor##5##2##(2009-3#2)(2010-3#1)(2010-6#1)(2010-8#1)
aggressive tumors##2##2##(2008-6#1)(2012-2#1)
aggressive tumour of##2##3##(2008-10#2)
aggressive tumours##2##2##(2008-6#1)(2008-7#1)
aggressive variants##2##2##(2008-10#2)
aggressive##303##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#1)(1991-4#3)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#5)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#47)(2008-11#13)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#10)(2008-7#11)(2008-8#18)(2008-9#6)(2009-10#1)(2009-3#7)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#10)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#17)(2013-1#17)(2013-7#1)(2013-8#4)
aggressively pursuing##2##2##(1996-12#1)(2008-7#1)
aggressively##10##1##(1991-12#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
aggressiveness and##5##2##(2008-10#5)
aggressiveness of isolates of##2##4##(2008-10#2)
aggressiveness of the US-8##2##4##(2008-10#2)
aggressiveness of the lesion##2##4##(1994-6#1)(2008-2#1)
aggressiveness of the##5##3##(1991-2#1)(1994-6#1)(2008-10#2)(2008-2#1)
aggressiveness of##17##2##(1991-2#1)(1993-8#1)(1994-6#1)(2007-11#1)(2008-10#11)(2008-2#1)(2012-3#1)
aggressiveness on potato##2##3##(2008-10#2)
aggressiveness on the##2##3##(1995-5#1)(2008-10#1)
aggressiveness on##9##2##(1995-5#1)(2008-10#8)
aggressiveness to##5##2##(1991-6#1)(2008-10#4)
aggressiveness was##5##2##(2008-10#5)
aggressiveness were##3##2##(2008-10#3)
aggressiveness##73##1##(1991-2#1)(1991-6#1)(1993-8#1)(1994-6#1)(1995-5#1)(2006-12#1)(2007-11#1)(2008-10#59)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#2)
aggressivum f##3##2##(2008-10#3)
aggressivum##4##1##(2008-10#4)
aggressors##2##1##(2008-5#1)(2008-9#1)
agile##4##1##(2007-12#2)(2008-10#1)(2008-2#1)
agility##8##1##(2007-12#3)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
aging and in Alzheimer's disease##2##5##(1993-12#1)(1994-6#1)
aging and in Alzheimer's##3##4##(1993-12#2)(1994-6#1)
aging and in##4##3##(1993-12#2)(1994-6#1)(1995-6#1)
aging and longevity##2##3##(2008-7#1)(2012-3#1)
aging and mortality##2##3##(1993-12#1)(2008-6#1)
aging and the##3##3##(1996-1#1)(2009-12#1)(2010-8#1)
aging and##39##2##(1990-7#2)(1992-12#1)(1992-8#1)(1993-12#4)(1994-12#1)(1994-2#1)(1994-5#5)(1994-6#3)(1995-6#1)(1996-1#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#5)(2009-12#1)(2010-12#1)(2010-8#1)(2012-2#2)(2012-3#2)(2013-1#1)
aging are##3##2##(2008-8#1)(2011-2#1)(2013-7#1)
aging as##2##2##(2008-5#1)(2013-8#1)
aging brain##6##2##(1994-5#1)(1994-6#1)(1994-8#1)(1996-11#1)(2008-7#2)
aging by##2##2##(1994-5#2)
aging can##3##2##(1991-12#1)(1994-8#1)(2008-7#1)
aging changes##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
aging clock&quot##2##2##(1994-5#2)
aging facial skin##2##3##(2008-5#2)
aging has##4##2##(1993-1#1)(1994-5#1)(2008-5#1)(2011-2#1)
aging in mice##2##3##(2012-2#2)
aging in the rat##2##4##(1994-6#2)
aging in the##6##3##(1994-6#2)(2008-2#1)(2008-7#2)(2009-7#1)
aging in vitro##2##3##(2008-7#1)(2011-2#1)
aging in##26##2##(1994-6#2)(1995-3#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-9#2)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
aging interventions##2##2##(2009-5#2)
aging is##14##2##(1994-5#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-12#2)(2012-3#1)(2013-8#1)
aging lung##2##2##(1991-12#2)
aging males##2##2##(2008-12#1)(2009-5#1)
aging may be##2##3##(1994-5#1)(2008-7#1)
aging mice##5##2##(1993-12#2)(1994-5#1)(2013-7#2)
aging of the population##5##4##(1992-1#1)(1996-3#1)(2008-2#1)(2013-1#1)(2013-8#1)
aging of the##10##3##(1992-1#1)(1994-5#2)(1995-12#1)(1996-3#1)(2008-12#1)(2008-2#1)(2009-5#1)(2013-1#1)(2013-8#1)
aging of##22##2##(1990-3#2)(1992-1#2)(1994-5#3)(1995-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#2)(2009-5#2)(2013-1#1)(2013-8#1)
aging on the##4##3##(2008-7#2)(2010-12#1)(2013-7#1)
aging on##9##2##(1994-6#1)(2008-5#1)(2008-7#4)(2010-12#1)(2012-3#1)(2013-7#1)
aging or##5##2##(1993-12#1)(1994-5#3)(2011-2#1)
aging population and##6##3##(1990-3#1)(2007-12#1)(2009-3#1)(2011-2#2)(2012-12#1)
aging population##11##2##(1990-3#1)(1991-12#1)(1995-1#1)(1996-8#1)(2007-12#2)(2008-12#1)(2009-3#1)(2011-2#2)(2012-12#1)
aging process and##3##3##(1997-6#1)(2009-12#1)(2009-5#1)
aging process is##3##3##(1995-6#1)(2008-9#1)(2009-12#1)
aging process of##2##3##(1990-3#1)(1994-6#1)
aging process##25##2##(1990-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-6#1)(1997-2#4)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-5#1)(2012-2#2)(2013-8#1)
aging processes in##2##3##(1994-5#1)(2013-7#1)
aging processes is##2##3##(1990-3#1)(2008-7#1)
aging processes##9##2##(1990-3#1)(1994-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-7#2)
aging rat##5##2##(1994-6#2)(1994-8#1)(1997-2#1)(2008-7#1)
aging rate##2##2##(1994-5#1)(1994-6#1)
aging rats##3##2##(1990-3#1)(1991-12#1)(2008-3#1)
aging research##5##2##(2008-7#1)(2009-5#3)(2012-3#1)
aging society##4##2##(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#1)
aging suggests##2##2##(2008-7#1)(2009-12#1)
aging than the##2##3##(1997-2#1)(2008-9#1)
aging than##3##2##(1997-2#1)(2008-3#1)(2008-9#1)
aging were##4##2##(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
aging##448##1##(1990-3#12)(1990-6#1)(1990-7#3)(1991-1#1)(1991-12#14)(1991-3#2)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#9)(1993-5#1)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#38)(1994-6#20)(1994-8#4)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#7)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#18)(2008-4#4)(2008-5#23)(2008-6#1)(2008-7#55)(2008-8#3)(2008-9#12)(2009-12#13)(2009-2#1)(2009-3#1)(2009-5#18)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#6)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#21)(2012-1#2)(2012-12#1)(2012-2#16)(2012-3#5)(2012-5#1)(2013-1#12)(2013-7#11)(2013-8#8)
aging)##3##1##(1997-4#1)(2010-1#1)(2010-3#1)
aging-related##6##1##(2008-7#1)(2008-9#2)(2013-1#1)(2013-7#2)
aging?##4##1##(1992-11#1)(2008-7#1)(2010-2#1)(2011-2#1)
agitated##9##1##(1990-10#1)(1994-3#2)(2008-11#4)(2009-6#1)(2012-3#1)
agitation and##8##2##(1990-3#1)(1992-5#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-2#1)
agitation in##2##2##(1997-6#1)(2011-2#1)
agitation intensities##2##2##(2008-11#1)(2008-7#1)
agitation rates##2##2##(2008-11#1)(2010-11#1)
agitation speed##6##2##(2008-6#3)(2011-2#1)(2013-1#2)
agitation speeds favored##2##3##(2013-1#2)
agitation system##2##2##(2008-11#2)
agitation##48##1##(1990-3#1)(1992-5#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#13)(2008-5#2)(2008-6#3)(2008-7#2)(2009-6#1)(2010-11#2)(2011-2#7)(2012-2#2)(2013-1#5)
agitation)##2##1##(2007-7#1)(2008-5#1)
aglycon transfer##3##2##(2008-12#3)
aglycon##5##1##(1994-5#2)(2008-12#3)
aglycone##8##1##(1991-5#1)(1991-8#1)(2008-10#1)(2008-11#4)(2012-2#1)
aglycones were##2##2##(2008-10#1)(2008-11#1)
aglycones##6##1##(2008-10#3)(2008-11#3)
agnosic##3##1##(1997-8#3)
ago and##7##2##(1995-1#1)(1997-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
ago but##2##2##(2008-10#2)
ago for##3##2##(2008-9#1)(2009-12#1)(2010-12#1)
ago he##2##2##(1997-5#1)(2007-8#1)
ago that##3##2##(2009-3#1)(2009-8#1)(2013-8#1)
ago was##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
ago##152##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#19)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#5)(2013-8#1)
agonism at##3##2##(1991-1#1)(1995-6#1)(2008-11#1)
agonism##7##1##(1991-1#1)(1994-6#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-5#2)
agonist acting##2##2##(1992-8#1)(2008-7#1)
agonist activity of##2##3##(1997-7#1)(2008-11#1)
agonist activity##6##2##(1992-2#1)(1992-3#1)(1995-12#1)(1997-7#1)(2008-11#1)(2011-3#1)
agonist and antagonist##2##3##(1993-3#1)(2013-8#1)
agonist and##9##2##(1993-3#1)(1995-8#1)(1997-2#1)(2008-2#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-8#1)
agonist at##6##2##(1993-6#2)(1995-11#2)(1995-3#1)(1995-6#1)
agonist binding##5##2##(1994-6#1)(2008-3#2)(2008-4#1)(2008-8#1)
agonist for##3##2##(1992-12#1)(1993-12#1)(2006-10#1)
agonist in the##2##3##(1995-3#1)(2008-9#1)
agonist in##5##2##(1995-3#1)(2008-3#1)(2008-5#2)(2008-9#1)
agonist is##4##2##(1996-2#1)(2008-2#1)(2009-8#1)(2010-7#1)
agonist norepinephrine##2##2##(2008-2#1)(2008-3#1)
agonist of##7##2##(1992-11#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-4#1)(2008-9#1)
agonist on##4##2##(1992-5#1)(1995-11#1)(2008-5#1)(2008-7#1)
agonist or antagonist activity##2##4##(1992-3#1)(1997-4#1)
agonist or antagonist##3##3##(1991-6#1)(1992-3#1)(1997-4#1)
agonist or##4##2##(1991-6#1)(1992-3#1)(1992-8#1)(1997-4#1)
agonist potencies##2##2##(1997-7#2)
agonist potency##2##2##(1994-6#1)(2008-3#1)
agonist to RAR##2##3##(2008-4#2)
agonist to##5##2##(2008-4#3)(2008-6#2)
agonist treatment##2##2##(1993-2#1)(2008-7#1)
agonist##233##1##(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-12#3)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#7)(1994-8#2)(1994-9#2)(1995-11#13)(1995-12#26)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#10)(1996-5#1)(1997-1#1)(1997-2#7)(1997-4#4)(1997-7#3)(2006-10#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#11)(2008-5#9)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#5)(2009-12#2)(2009-7#1)(2009-8#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#10)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
agonist)##6##1##(1992-3#2)(1994-11#2)(1995-12#1)(1997-1#1)
agonist-activated##2##1##(2008-4#1)(2009-7#1)
agonist-dependent##4##1##(1994-8#1)(1997-7#2)(2008-4#1)
agonist-induced##6##1##(1990-12#2)(1995-11#1)(1996-2#1)(2008-5#1)(2008-8#1)
agonist-like activity##2##2##(1991-1#1)(1997-2#1)
agonist-specific##5##1##(1997-7#5)
agonist-stimulated##2##1##(1996-2#1)(1996-5#1)
agonistic and##3##2##(2008-10#2)(2008-8#1)
agonistic interactions##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
agonistic##12##1##(1990-11#1)(1991-12#1)(1992-9#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)
agonists and antagonists on##2##4##(1991-1#1)(2008-5#1)
agonists and antagonists##12##3##(1991-1#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)
agonists and##24##2##(1991-1#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-5#1)(1997-7#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)
agonists are of##2##3##(2009-8#2)
agonists are##5##2##(1993-9#1)(2008-7#2)(2009-8#2)
agonists at##3##2##(1995-3#1)(2008-4#2)
agonists can be##2##3##(1995-11#1)(2011-1#1)
agonists can##3##2##(1995-11#1)(2008-4#1)(2011-1#1)
agonists for the##2##3##(1995-12#1)(1996-2#1)
agonists for##7##2##(1990-5#2)(1993-12#1)(1995-12#2)(1996-2#2)
agonists have##2##2##(1990-11#1)(2008-7#1)
agonists in the##2##3##(1991-1#1)(1995-3#1)
agonists in##11##2##(1990-7#1)(1991-1#1)(1991-8#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-4#1)(2008-7#1)
agonists increase##3##2##(1995-11#1)(1997-7#1)(2008-1#1)
agonists may##3##2##(2009-12#3)
agonists morphine##2##2##(1991-1#1)(1996-2#1)
agonists of##3##2##(1995-12#1)(2006-12#1)(2008-4#1)
agonists on the##3##3##(1995-12#1)(1996-2#1)(2008-12#1)
agonists on##7##2##(1995-12#3)(1996-2#1)(2008-12#1)(2008-4#1)(2013-1#1)
agonists such as##4##3##(1990-2#1)(1990-8#1)(1991-12#1)(2012-2#1)
agonists that##2##2##(2008-1#1)(2009-12#1)
agonists to##7##2##(1992-5#1)(1993-3#1)(1994-5#2)(2006-6#1)(2008-7#1)(2012-12#1)
agonists was##2##2##(1991-1#1)(2010-12#1)
agonists were##3##2##(1994-6#1)(1995-11#1)(2009-12#1)
agonists with##2##2##(1995-12#1)(1997-1#1)
agonists##194##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#8)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1995-11#13)(1995-12#17)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#6)(1996-3#1)(1996-5#5)(1996-9#2)(1997-1#1)(1997-4#1)(1997-7#5)(2006-12#1)(2006-6#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#14)(2008-5#3)(2008-7#13)(2008-8#2)(2008-9#3)(2009-12#8)(2009-3#2)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-12#3)(2011-1#4)(2012-12#1)(2012-2#2)(2013-1#2)
agoraphobia##3##1##(1990-11#1)(2012-2#2)
agr locus##2##2##(1995-8#2)
agr##7##1##(1995-8#7)
agrA##2##1##(1995-8#2)
agranular##7##1##(1992-9#1)(1994-2#1)(1994-3#2)(2008-5#2)(2008-7#1)
agranulocytosis##3##1##(1991-8#1)(1994-3#2)
agree fairly well with data obtained##2##6##(2008-10#2)
agree in##2##2##(1992-2#1)(2008-10#1)
agree on##5##2##(1991-12#1)(1996-9#1)(2008-8#1)(2011-10#1)(2012-12#1)
agree satisfactorily with##2##3##(2008-10#1)(2008-3#1)
agree that##7##2##(1990-6#1)(1992-12#1)(2007-12#1)(2008-3#2)(2009-5#1)(2010-11#1)
agree to within##3##3##(2008-3#3)
agree to##9##2##(1993-12#1)(1997-1#1)(2008-1#1)(2008-3#3)(2009-6#2)(2013-1#1)
agree well with a##2##4##(2007-11#1)(2008-3#1)
agree well with the experimental results##2##6##(2007-11#1)(2008-3#1)
agree well with the##7##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
agree well with those obtained by##2##6##(2008-10#2)
agree well with those##5##4##(1993-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
agree well with##26##3##(1993-11#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#12)(2008-7#2)
agree well##27##2##(1993-11#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#12)(2008-7#3)
agree with a##2##3##(1996-2#1)(2008-10#1)
agree with experimental measurements##2##4##(2007-12#1)(2008-3#1)
agree with experimental##4##3##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
agree with measurements##2##3##(2008-3#2)
agree with that##3##3##(1992-12#1)(2008-10#1)(2008-3#1)
agree with the certified##2##4##(2008-10#2)
agree with the##13##3##(1990-2#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2013-8#1)
agree with their##2##3##(1995-5#1)(2011-2#1)
agree with those obtained by means of a##3##8##(2008-10#3)
agree with those obtained by##7##5##(2008-10#6)(2008-11#1)
agree with those obtained##8##4##(2008-10#7)(2008-11#1)
agree with those of##2##4##(2008-10#2)
agree with those##11##3##(2007-12#1)(2008-10#9)(2008-11#1)
agree with##55##2##(1990-2#1)(1991-6#1)(1992-12#1)(1993-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-12#5)(2007-7#2)(2008-10#19)(2008-11#2)(2008-2#6)(2008-3#8)(2008-8#2)(2010-3#1)(2011-2#1)(2013-8#1)
agree within##2##2##(2007-12#1)(2008-2#1)
agree##127##1##(1990-2#1)(1990-6#1)(1991-12#2)(1991-6#1)(1992-12#2)(1992-2#1)(1993-11#2)(1993-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-12#9)(2007-7#2)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#27)(2008-7#4)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
agreeable##2##1##(2008-10#1)(2009-7#1)
agreeableness##5##1##(2008-5#2)(2009-7#1)(2009-8#2)
agreed on##3##2##(1994-12#1)(2010-3#1)(2010-4#1)
agreed that the##5##3##(2008-10#1)(2008-8#2)(2008-9#1)(2009-8#1)
agreed that##17##2##(1992-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#2)(2012-12#1)(2013-1#1)
agreed to participate in the##2##5##(2008-3#1)(2010-6#1)
agreed to participate in##3##4##(1995-6#1)(2008-3#1)(2010-6#1)
agreed to participate##6##3##(1990-2#1)(1993-12#1)(1995-6#1)(2008-1#1)(2008-3#1)(2010-6#1)
agreed to pay##2##3##(1995-12#2)
agreed to the##3##3##(1990-2#1)(1996-3#1)(2007-11#1)
agreed to##20##2##(1990-2#2)(1991-9#1)(1992-12#1)(1992-4#1)(1993-12#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-6#2)(2010-6#1)(2011-1#1)
agreed upon by##2##3##(2009-9#1)(2011-2#1)
agreed upon##4##2##(1992-3#1)(1996-12#1)(2009-9#1)(2011-2#1)
agreed very well with##2##4##(2008-10#2)
agreed well with the certified##2##5##(2008-10#2)
agreed well with the##5##4##(2008-10#5)
agreed well with those obtained by the##2##7##(2008-10#2)
agreed well with those obtained##3##5##(2008-10#2)(2008-3#1)
agreed well with those##4##4##(2008-10#3)(2008-3#1)
agreed well with##18##3##(2008-10#13)(2008-3#3)(2009-7#1)(2010-10#1)
agreed well##22##2##(2008-10#15)(2008-3#5)(2009-7#1)(2010-10#1)
agreed with that##2##3##(2008-2#1)(2008-3#1)
agreed with the reference##2##4##(2008-10#2)
agreed with the##12##3##(1995-6#1)(2008-10#8)(2008-3#1)(2011-1#1)(2012-12#1)
agreed with those obtained by##3##5##(2008-10#3)
agreed with those##6##3##(2008-10#6)
agreed with##27##2##(1994-9#1)(1995-6#1)(1996-5#1)(2008-10#17)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#1)
agreed##104##1##(1990-2#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#41)(2008-11#1)(2008-2#1)(2008-3#12)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#2)
agreed-upon##2##1##(2011-2#1)(2012-2#1)
agreeing that##2##2##(1995-12#1)(2011-2#1)
agreeing with##5##2##(1993-9#1)(2008-10#2)(2008-7#1)(2010-6#1)
agreeing##11##1##(1993-9#1)(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#2)
agreement about##2##2##(2008-12#1)(2011-2#1)
agreement among##2##2##(2007-8#1)(2008-10#1)
agreement and##9##2##(1994-3#1)(2008-10#3)(2008-3#4)(2008-8#1)
agreement at the##5##3##(2008-10#4)(2008-2#1)
agreement at##7##2##(2008-10#6)(2008-2#1)
agreement between calculated and##2##4##(2008-3#2)
agreement between experimental results and##2##5##(2007-12#1)(2008-3#1)
agreement between experimental##3##3##(2007-12#1)(2008-3#2)
agreement between measured and calculated values of##2##7##(2008-3#2)
agreement between measured and##4##4##(2008-10#1)(2008-3#2)(2009-5#1)
agreement between observed and##3##4##(2008-10#3)
agreement between results##2##3##(2008-10#2)
agreement between the experimental and##2##5##(2008-2#1)(2008-3#1)
agreement between the measured##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
agreement between the model##2##4##(2008-7#1)(2011-2#1)
agreement between the predicted and##2##5##(2008-10#1)(2013-1#1)
agreement between the predicted##3##4##(2008-10#2)(2013-1#1)
agreement between the proposed##3##4##(2008-10#3)
agreement between the results obtained by the proposed##2##8##(2008-10#2)
agreement between the results##4##4##(2008-10#3)(2008-4#1)
agreement between the two##4##4##(1994-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
agreement between the##44##3##(1994-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#16)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#2)(2011-2#3)(2012-7#1)(2013-1#3)
agreement between theoretical and experimental results was obtained##2##8##(2008-2#2)
agreement between theoretical and experimental results##3##6##(2007-12#1)(2008-2#2)
agreement between theory and experiment is##2##6##(1992-5#1)(2008-2#1)
agreement between theory and experiment##4##5##(1992-5#1)(2008-2#1)(2008-3#1)(2008-5#1)
agreement between theory and##5##4##(1992-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
agreement between these##2##3##(2007-11#1)(2008-3#1)
agreement between##99##2##(1992-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#5)(2007-12#7)(2007-7#1)(2008-10#29)(2008-2#8)(2008-3#14)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-7#1)(2013-1#3)
agreement exists between the##2##4##(2008-10#1)(2008-2#1)
agreement for the##2##3##(2008-2#1)(2009-1#1)
agreement for##14##2##(1992-8#1)(1994-3#1)(1995-1#2)(1995-9#1)(2007-12#1)(2008-2#4)(2008-7#1)(2008-9#1)(2009-1#1)(2012-2#1)
agreement in the##3##3##(1993-3#1)(2008-3#2)
agreement in##8##2##(1993-3#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-8#1)(2009-9#1)
agreement is found between##2##4##(2007-12#1)(2008-2#1)
agreement is found##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
agreement is obtained between the##2##5##(2008-2#1)(2008-3#1)
agreement is obtained##6##3##(2008-10#2)(2008-2#1)(2008-3#3)
agreement is##17##2##(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#7)
agreement morphology##3##2##(2012-1#3)
agreement of the##3##3##(1994-1#1)(2007-12#1)(2008-10#1)
agreement of##10##2##(1992-10#1)(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-1#1)(2010-12#1)
agreement on diagnosis and recommendations##2##5##(1995-1#2)
agreement on the##8##3##(1993-12#1)(1997-5#1)(2008-12#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
agreement on##17##2##(1993-12#2)(1995-1#2)(1995-11#1)(1997-5#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
agreement that a##2##3##(2007-8#1)(2012-12#1)
agreement that##8##2##(1994-8#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#1)
agreement to##3##2##(2008-10#1)(2008-2#1)(2009-5#1)
agreement was achieved##2##3##(2007-11#1)(2008-10#1)
agreement was found between the##4##5##(2008-10#2)(2008-3#2)
agreement was found between##10##4##(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)
agreement was found with##3##4##(2007-11#1)(2008-2#2)
agreement was found##15##3##(2007-11#2)(2008-10#5)(2008-2#4)(2008-3#3)(2008-7#1)
agreement was observed between##3##4##(2008-10#3)
agreement was obtained between##3##4##(2008-10#2)(2008-2#1)
agreement was obtained##7##3##(2008-10#5)(2008-2#2)
agreement was##38##2##(2007-11#4)(2008-10#17)(2008-2#7)(2008-3#5)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)
agreement when##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
agreement with a model##2##4##(1995-3#1)(2008-3#1)
agreement with a##14##3##(1990-12#1)(1990-7#1)(1991-9#1)(1992-12#1)(1995-3#1)(1995-5#1)(2007-12#2)(2008-10#3)(2008-3#3)
agreement with an##2##3##(1992-3#1)(2008-3#1)
agreement with certified values##11##4##(2008-10#11)
agreement with certified##14##3##(2008-10#14)
agreement with data##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)
agreement with each other##2##4##(2008-10#1)(2013-8#1)
agreement with expected##2##3##(2008-10#1)(2008-3#1)
agreement with experiment##2##3##(2007-11#1)(2008-10#1)
agreement with experimental data##3##4##(2007-12#1)(2008-2#2)
agreement with experimental##11##3##(1993-11#1)(2007-12#2)(2008-2#3)(2008-3#4)(2010-2#1)
agreement with literature##2##3##(2007-11#1)(2008-10#1)
agreement with numerical simulations##2##4##(2007-12#1)(2008-2#1)
agreement with numerical##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
agreement with other##4##3##(1990-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
agreement with our previous##2##4##(1990-5#1)(1995-12#1)
agreement with our##7##3##(1990-5#1)(1995-12#1)(1995-6#1)(2007-11#2)(2008-2#1)(2008-3#1)
agreement with predictions##3##3##(2007-12#1)(2008-2#2)
agreement with previous studies##3##4##(1995-11#1)(2008-10#1)(2009-8#1)
agreement with previous##13##3##(1992-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)(2010-11#1)
agreement with recent##6##3##(1996-2#1)(2006-6#1)(2008-10#1)(2008-3#2)(2012-2#1)
agreement with results obtained by##2##5##(2008-10#2)
agreement with results##3##3##(2008-10#3)
agreement with simulations##2##3##(2007-11#1)(2007-12#1)
agreement with that##7##3##(1997-7#1)(2008-10#5)(2008-3#1)
agreement with the certified ones##3##5##(2008-10#3)
agreement with the certified value was obtained for##2##8##(2008-10#2)
agreement with the certified value##10##5##(2008-10#10)
agreement with the certified values##14##5##(2008-10#14)
agreement with the certified##28##4##(2008-10#28)
agreement with the data##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
agreement with the expected ones##2##5##(2008-10#1)(2008-2#1)
agreement with the experiment##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
agreement with the experimental results##8##5##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2011-2#1)(2013-8#1)
agreement with the experimental##13##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2009-6#1)(2011-2#1)(2013-8#1)
agreement with the literature##4##4##(1990-3#1)(1993-3#1)(2008-10#2)
agreement with the measurements##4##4##(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
agreement with the observed##2##4##(1992-11#1)(2007-1#1)
agreement with the off-line##2##4##(2007-12#1)(2008-10#1)
agreement with the predicted##3##4##(2008-3#2)(2008-7#1)
agreement with the predictions of##2##5##(1990-8#1)(2008-2#1)
agreement with the previous##2##4##(1997-2#1)(2008-2#1)
agreement with the reference##3##4##(2008-10#3)
agreement with the results of##2##5##(2007-12#1)(2013-1#1)
agreement with the results##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2013-1#1)(2013-8#1)
agreement with the theoretical predictions##2##5##(2008-3#1)(2008-5#1)
agreement with the theoretical##10##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#1)
agreement with the theoretically calculated##2##5##(1995-2#1)(2008-3#1)
agreement with the underlying##2##4##(2007-11#1)(2010-11#1)
agreement with the value##3##4##(2007-11#1)(2008-10#1)(2009-12#1)
agreement with the values obtained by a##2##7##(2008-10#2)
agreement with the values##3##4##(2007-11#1)(2008-10#2)
agreement with the##174##3##(1990-3#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-1#1)(2007-11#9)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#69)(2008-11#1)(2008-2#17)(2008-3#22)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#6)(2013-8#2)
agreement with theoretical expectations##2##4##(2007-11#1)(2008-2#1)
agreement with theoretical predictions##7##4##(2007-11#3)(2007-12#3)(2008-3#1)
agreement with theoretical values##2##4##(2007-11#1)(2007-12#1)
agreement with theoretical##13##3##(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#2)(2011-1#1)
agreement with theory##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
agreement with these##2##3##(1990-5#1)(2007-11#1)
agreement with those given by##2##5##(2008-10#2)
agreement with those obtained by ICP-AES##2##6##(2008-10#2)
agreement with those obtained by a##4##6##(2008-10#4)
agreement with those obtained by the##7##6##(2008-10#7)
agreement with those obtained by using the##2##7##(2008-10#2)
agreement with those obtained by using##3##6##(2008-10#3)
agreement with those obtained by##27##5##(2008-10#27)
agreement with those obtained from##2##5##(2008-10#1)(2008-5#1)
agreement with those obtained using##5##5##(2008-10#5)
agreement with those obtained with##3##5##(2008-10#2)(2008-3#1)
agreement with those obtained##38##4##(2008-10#36)(2008-3#1)(2008-5#1)
agreement with those of the##6##5##(1992-1#1)(2008-10#2)(2008-2#1)(2008-3#2)
agreement with those of##9##4##(1992-1#1)(2008-10#4)(2008-2#1)(2008-3#3)
agreement with those##62##3##(1992-1#1)(2008-10#52)(2008-2#2)(2008-3#5)(2008-5#1)(2012-8#1)
agreement with##433##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#4)(1996-5#1)(1997-2#2)(1997-7#3)(2006-6#1)(2007-1#1)(2007-11#23)(2007-12#24)(2007-8#2)(2008-1#1)(2008-10#174)(2008-11#1)(2008-12#2)(2008-2#38)(2008-3#61)(2008-4#2)(2008-5#8)(2008-7#5)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-8#1)(2013-1#9)(2013-8#4)
agreement within##2##2##(1993-1#1)(2008-10#1)
agreement##779##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#3)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#4)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#3)(1996-2#8)(1996-5#1)(1997-2#3)(1997-5#4)(1997-7#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#34)(2007-12#35)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#263)(2008-11#8)(2008-12#9)(2008-2#74)(2008-3#120)(2008-4#4)(2008-5#19)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#5)(2009-1#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#5)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#9)(2012-1#8)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#12)(2013-8#5)
agreement'##2##1##(1993-12#1)(1997-3#1)
agreement)##4##1##(2012-2#1)(2013-1#3)
agreements were##2##2##(2008-10#2)
agreements with the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
agreements with##5##2##(1991-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
agreements##28##1##(1991-1#2)(1991-2#2)(1992-5#1)(1993-3#2)(1994-1#1)(1996-12#1)(1996-2#2)(1997-3#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#2)
agrees well with previously##2##4##(2007-11#2)
agrees well with that##2##4##(1996-5#1)(2008-3#1)
agrees well with the calculated##2##5##(2008-10#1)(2008-3#1)
agrees well with the##7##4##(2007-12#1)(2008-10#2)(2008-3#4)
agrees well with##17##3##(1996-5#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#7)
agrees with the##8##3##(1992-8#1)(1997-2#1)(2007-11#1)(2008-2#4)(2008-8#1)
agrees with##13##2##(1992-8#1)(1993-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)(2008-8#1)
agrees##32##1##(1992-8#1)(1993-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-11#5)(2007-12#4)(2008-10#2)(2008-2#5)(2008-3#10)(2008-8#1)
agricultural and food##2##3##(1992-11#1)(2008-10#1)
agricultural and nonagricultural environments##2##4##(2008-10#2)
agricultural and##9##2##(1992-11#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-2#1)
agricultural areas##2##2##(2008-10#1)(2013-1#1)
agricultural chemicals##3##2##(2008-10#2)(2008-12#1)
agricultural crops##2##2##(2008-10#1)(2008-5#1)
agricultural environments with##2##3##(2008-10#2)
agricultural environments##3##2##(2008-10#2)(2012-2#1)
agricultural fields##5##2##(2008-10#3)(2008-8#1)(2012-2#1)
agricultural groups##3##2##(2008-12#3)
agricultural landscape##2##2##(2013-1#2)
agricultural pathogens##2##2##(2008-10#1)(2008-9#1)
agricultural practice is replaced##2##4##(2008-11#2)
agricultural practice##6##2##(2008-10#2)(2008-11#2)(2013-1#2)
agricultural practices and##2##3##(2008-11#1)(2008-7#1)
agricultural practices##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
agricultural residues##3##2##(2008-6#3)
agricultural sector##2##2##(2008-12#1)(2011-2#1)
agricultural soils##4##2##(1995-3#1)(2008-10#3)
agricultural systems##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2010-7#1)
agricultural workers##7##2##(2008-11#2)(2008-12#5)
agricultural yield##2##2##(2009-11#1)(2010-7#1)
agricultural##130##1##(1991-6#2)(1992-11#1)(1995-3#1)(1996-3#1)(2007-7#2)(2008-10#55)(2008-11#9)(2008-12#16)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2010-1#3)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#7)(2013-8#1)
agriculturally##2##1##(2008-10#1)(2009-10#1)
agriculture and##3##2##(1990-2#1)(2010-10#1)(2012-12#1)
agriculture can be##2##3##(2008-11#1)(2013-8#1)
agriculture have##2##2##(2008-10#1)(2013-7#1)
agriculture in the##2##3##(2008-11#1)(2010-7#1)
agriculture in##3##2##(2008-11#1)(2010-7#2)
agriculture is##5##2##(2008-11#1)(2008-12#2)(2010-7#2)
agriculture##57##1##(1990-2#1)(1990-6#1)(1991-6#1)(1994-6#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-4#2)(2007-7#1)(2008-10#11)(2008-11#10)(2008-12#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#6)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
agrochemical pest control##2##3##(2008-11#2)
agrochemical##6##1##(1997-7#1)(2008-10#2)(2008-11#2)(2010-12#1)
agrochemicals##4##1##(2008-10#2)(2008-12#1)(2010-7#1)
agrocin 84##5##2##(2008-10#5)
agrocin##8##1##(2008-10#8)
agroecological zones##2##2##(2008-10#2)
agroecological##4##1##(2008-10#3)(2013-8#1)
agroecosystem##3##1##(2008-10#3)
agroecosystems##4##1##(2008-10#1)(2008-5#1)(2008-6#2)
agroindustrial##3##1##(2008-10#2)(2008-6#1)
agroinoculated##2##1##(2008-10#2)
agroinoculation##6##1##(2008-10#6)
agronomic crops##3##2##(2008-10#3)
agronomic performance##2##2##(2008-10#1)(2009-10#1)
agronomic practices##3##2##(1990-9#1)(2008-10#2)
agronomic traits##4##2##(2008-9#3)(2013-8#1)
agronomic##18##1##(1990-9#1)(2008-10#11)(2008-9#3)(2009-10#1)(2012-3#1)(2013-8#1)
agronomically important pathogen##2##3##(1992-8#1)(2008-10#1)
agronomically##5##1##(1992-8#1)(1996-12#1)(2008-10#3)
agrostis##6##1##(2008-10#6)
ahODN-Cu(I)##3##1##(2008-10#3)
ahead and##2##2##(1991-1#1)(2009-5#1)
ahead of the##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
ahead of##7##2##(1990-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
ahead on##2##2##(1993-5#1)(2011-2#1)
ahead##32##1##(1990-6#1)(1991-1#1)(1992-2#1)(1993-5#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-8#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
ahigh##2##1##(2008-11#2)
aicardi syndrome##2##2##(2011-1#2)
aid and##4##2##(1995-3#1)(1996-3#2)(2007-2#1)
aid can be##2##3##(2010-8#1)(2013-1#1)
aid fitting##2##2##(2008-9#1)(2013-1#1)
aid for##11##2##(1992-12#1)(1992-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2013-1#1)
aid in diagnosis##4##3##(1991-11#1)(1997-5#1)(2010-8#1)(2012-2#1)
aid in identification of##2##4##(1991-12#1)(1993-11#1)
aid in the development of##9##5##(2007-12#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
aid in the identification of##2##5##(1995-2#1)(1997-1#1)
aid in the study of the##2##6##(1991-9#1)(2008-10#1)
aid in the study of##3##5##(1991-9#1)(2008-10#1)(2012-2#1)
aid in the understanding##2##4##(1995-5#1)(2008-11#1)
aid in the##30##3##(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
aid in understanding##3##3##(1997-8#1)(2007-7#1)(2008-3#1)
aid in##66##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#2)(1994-6#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#1)
aid is##2##2##(2008-4#1)(2010-8#1)
aid of##57##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-9#1)(1994-11#1)(1996-6#1)(1997-6#1)(2007-11#3)(2007-12#3)(2008-10#23)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
aid organisations##2##2##(1997-7#1)(2007-2#1)
aid the development of more##2##5##(2008-5#1)(2009-12#1)
aid the development of##5##4##(1992-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-12#1)
aid the##15##2##(1992-12#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-6#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-7#1)(2013-1#1)
aid to the##3##3##(1994-7#1)(2009-12#1)(2012-3#1)
aid to##13##2##(1993-3#2)(1994-7#1)(1996-1#1)(1996-12#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#1)
aid with##2##2##(2008-9#1)(2013-7#1)
aid##240##1##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#38)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#8)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#5)(2009-8#1)(2009-9#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#7)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#3)
aid]##2##1##(1991-11#1)(1995-8#1)
aide in##3##2##(1991-12#1)(1991-3#1)(1993-11#1)
aide##8##1##(1991-12#1)(1991-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-2#3)
aided by a##2##3##(2008-12#1)(2008-7#1)
aided by the##3##3##(1992-9#1)(1997-2#1)(2009-6#1)
aided by##10##2##(1992-9#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)(2013-1#1)
aided condition????##2##2##(2012-2#2)
aided in##3##2##(2010-12#1)(2011-2#2)
aided pre-reduction of##2##3##(2008-10#2)
aided the##2##2##(2010-10#1)(2011-2#1)
aided##31##1##(1992-9#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#1)
aides##2##1##(1991-1#1)(1995-2#1)
aiding in the##3##3##(2008-11#1)(2010-5#1)(2013-8#1)
aiding in##4##2##(2008-11#1)(2010-5#2)(2013-8#1)
aiding the##3##2##(2008-9#2)(2011-2#1)
aiding##12##1##(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-12#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-8#1)
aids and##3##2##(1991-11#1)(2009-7#1)(2011-2#1)
aids are##2##2##(2006-10#1)(2008-10#1)
aids for##3##2##(1991-2#1)(2008-2#1)(2009-7#1)
aids in##8##2##(1990-2#1)(1991-2#1)(1993-12#1)(2008-1#1)(2011-2#3)(2013-8#1)
aids the##3##2##(1993-2#1)(2008-11#1)(2008-9#1)
aids##43##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#4)(1993-11#2)(1993-12#1)(1993-2#1)(1995-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-4#1)(2009-7#2)(2010-11#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
ailing##5##1##(1995-2#1)(1996-2#3)(2009-1#1)
ailments including##2##2##(2008-10#1)(2011-1#1)
ailments##12##1##(2007-11#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
aim at##9##2##(1992-9#1)(1994-1#1)(1996-3#1)(2008-2#1)(2008-7#2)(2011-2#2)(2013-8#1)
aim for##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
aim in##2##2##(2008-11#1)(2008-4#1)
aim is to improve##2##4##(1991-12#1)(2008-11#1)
aim is to provide a##2##5##(2008-11#1)(2008-3#1)
aim is to provide##4##4##(1997-7#1)(2008-11#2)(2008-3#1)
aim is to##29##3##(1991-12#1)(1994-9#1)(1996-9#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)
aim is##31##2##(1991-12#1)(1994-9#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)
aim of determining##2##3##(1995-2#1)(1996-11#1)
aim of improving the##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
aim of improving##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)
aim of our investigation was to##4##6##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
aim of our study was to determine the##2##8##(2011-2#1)(2012-6#1)
aim of our study was to determine##3##7##(2007-8#1)(2011-2#1)(2012-6#1)
aim of our study was to##24##6##(1997-8#1)(2007-8#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
aim of our study was##25##5##(1990-5#1)(1997-8#1)(2007-8#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
aim of our study##30##4##(1990-5#1)(1997-8#1)(2007-11#1)(2007-8#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
aim of our##37##3##(1990-5#1)(1997-8#1)(2007-11#1)(2007-8#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
aim of reducing##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
aim of surgery##2##3##(2008-7#2)
aim of the present study was to analyze##4##8##(1995-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
aim of the present study was to determine##3##8##(2008-10#1)(2008-12#1)(2011-1#1)
aim of the present study was to investigate the##11##9##(1990-9#1)(1995-12#1)(1997-2#1)(2008-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
aim of the present study was to investigate##15##8##(1990-9#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
aim of the present study was to##57##7##(1990-9#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-5#5)(2008-7#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
aim of the present study was##59##6##(1990-9#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-5#5)(2008-7#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
aim of the present study##68##5##(1990-9#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-5#7)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#4)
aim of the present work was to develop##2##8##(2008-10#1)(2011-1#1)
aim of the present work was to##7##7##(1990-12#1)(1993-11#1)(1994-9#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
aim of the present work##12##5##(1990-12#1)(1993-11#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
aim of the present##84##4##(1990-12#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#8)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#4)
aim of the study was to compare##7##7##(1990-2#1)(1997-8#1)(2008-11#1)(2012-12#1)(2013-1#3)
aim of the study was to investigate the##3##8##(1994-6#1)(2009-6#1)(2010-3#1)
aim of the study was to investigate##5##7##(1994-6#1)(2007-12#1)(2008-9#1)(2009-6#1)(2010-3#1)
aim of the study was to##56##6##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#3)(2008-11#4)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
aim of the study was##66##5##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#8)(2007-12#1)(2007-7#1)(2007-8#4)(2008-11#4)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
aim of the study##81##4##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#9)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#1)(2008-11#4)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
aim of the##194##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#14)(2008-11#9)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#19)(2013-7#2)(2013-8#7)
aim of this article is to##17##6##(1994-11#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
aim of this article##18##4##(1994-11#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
aim of this paper##31##4##(1993-5#1)(1994-5#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-5#2)(2009-10#2)(2009-2#1)(2009-8#2)(2010-3#3)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#4)
aim of this review article was to##2##7##(2012-2#1)(2013-1#1)
aim of this review article##4##5##(2007-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
aim of this review was to##2##6##(2009-11#1)(2013-1#1)
aim of this review was##3##5##(2009-11#1)(2012-3#1)(2013-1#1)
aim of this review##19##4##(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
aim of this study is to develop##2##7##(2010-8#1)(2011-1#1)
aim of this study is to##37##6##(1992-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
aim of this study is##41##5##(1992-12#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
aim of this study was to compare the##5##8##(1992-10#1)(2008-12#2)(2008-5#1)(2008-7#1)
aim of this study was to compare##11##7##(1992-10#1)(2007-8#2)(2008-12#3)(2008-5#2)(2008-7#1)(2011-2#1)(2013-7#1)
aim of this study was to determine the##17##8##(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-3#1)(2013-8#2)
aim of this study was to determine##26##7##(2007-10#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-3#1)(2013-8#2)
aim of this study was to examine the##7##8##(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
aim of this study was to examine##9##7##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
aim of this study was to explore the##5##8##(2007-7#1)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
aim of this study was to explore##9##7##(2007-7#1)(2008-11#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
aim of this study was to identify the##3##8##(2008-1#1)(2008-5#1)(2010-10#1)
aim of this study was to identify##6##7##(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)
aim of this study was to study the##2##8##(2007-10#1)(2012-2#1)
aim of this study was to##217##6##(1990-6#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#5)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#11)(2008-3#2)(2008-4#3)(2008-5#22)(2008-6#3)(2008-7#14)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#23)(2013-3#1)(2013-7#4)(2013-8#5)
aim of this study was##221##5##(1990-6#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#6)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#11)(2008-3#2)(2008-4#3)(2008-5#22)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#23)(2013-3#1)(2013-7#4)(2013-8#5)
aim of this study##266##4##(1990-11#1)(1990-6#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#6)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#12)(2008-1#3)(2008-10#15)(2008-11#14)(2008-12#12)(2008-3#3)(2008-4#4)(2008-5#24)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#7)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#23)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#9)(2013-1#24)(2013-3#1)(2013-7#4)(2013-8#8)
aim of this work is to##13##6##(2007-11#3)(2008-10#5)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
aim of this work is##15##5##(2007-11#3)(2008-10#7)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
aim of this work was the##2##6##(2007-11#1)(2008-1#1)
aim of this work was##25##5##(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#10)(2008-7#1)(2009-8#1)(2010-5#1)(2013-7#2)
aim of this work##41##4##(1997-2#1)(2007-11#4)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-5#12)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#3)
aim of this##432##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#2)(1994-1#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#5)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#14)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#14)(2008-1#5)(2008-10#35)(2008-11#19)(2008-12#16)(2008-3#3)(2008-4#5)(2008-5#41)(2008-6#3)(2008-7#21)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#39)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#8)(2012-2#13)(2012-3#12)(2013-1#39)(2013-3#1)(2013-7#7)(2013-8#9)
aim of using##2##3##(2008-10#1)(2008-11#1)
aim of##758##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#3)(1997-7#2)(1997-8#7)(2006-6#1)(2006-8#1)(2007-10#6)(2007-11#27)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#28)(2008-1#6)(2008-10#63)(2008-11#35)(2008-12#31)(2008-2#1)(2008-3#8)(2008-4#7)(2008-5#58)(2008-6#4)(2008-7#34)(2008-8#14)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#9)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#11)(2010-4#3)(2010-5#8)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#15)(2011-2#61)(2011-3#3)(2011-7#2)(2012-1#9)(2012-12#13)(2012-2#22)(2012-3#22)(2012-5#1)(2012-6#1)(2013-1#65)(2013-3#1)(2013-7#10)(2013-8#20)
aim to affect##2##3##(2011-2#2)
aim to compare##2##3##(1990-9#1)(2013-8#1)
aim to contribute to the##2##5##(2008-10#1)(2013-7#1)
aim to describe the##2##4##(2010-11#1)(2011-2#1)
aim to determine the##2##4##(2011-2#1)(2013-7#1)
aim to evaluate the##2##4##(2012-3#1)(2013-1#1)
aim to improve##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
aim to provide##2##3##(2008-3#1)(2008-5#1)
aim to reduce##2##3##(1996-1#1)(2008-1#1)
aim to shed light on the##2##6##(2008-8#1)(2009-5#1)
aim to##59##2##(1990-9#1)(1992-6#1)(1996-1#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#4)(2013-8#2)
aim was the##2##3##(2008-10#1)(2012-3#1)
aim was to assess the##4##5##(2008-9#2)(2012-8#1)(2013-1#1)
aim was to compare##3##4##(1996-2#1)(2008-9#1)(2013-1#1)
aim was to determine the##4##5##(1990-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
aim was to evaluate the##3##5##(2007-10#1)(2012-12#1)(2013-8#1)
aim was to evaluate##5##4##(2007-10#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
aim was to examine##3##4##(1997-2#1)(2008-11#1)(2012-1#1)
aim was to formulate##2##4##(2008-3#1)(2008-5#1)
aim was to identify##2##4##(2007-10#1)(2008-6#1)
aim was to investigate##4##4##(2008-7#1)(2010-6#1)(2011-2#2)
aim was to see if##2##5##(2007-10#1)(2010-12#1)
aim was to study##2##4##(1991-11#1)(2009-2#1)
aim was to validate##2##4##(2009-12#1)(2013-1#1)
aim was to##50##3##(1990-11#1)(1990-5#1)(1991-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#3)
aim was##53##2##(1990-11#1)(1990-5#1)(1991-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#3)
aim##927##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#3)(1997-7#3)(1997-8#7)(2006-6#1)(2006-8#1)(2007-10#11)(2007-11#27)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#31)(2008-1#8)(2008-10#78)(2008-11#46)(2008-12#31)(2008-2#3)(2008-3#15)(2008-4#8)(2008-5#62)(2008-6#7)(2008-7#44)(2008-8#17)(2008-9#15)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#9)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#11)(2010-4#3)(2010-5#8)(2010-6#6)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#17)(2011-2#77)(2011-3#4)(2011-7#2)(2012-1#11)(2012-12#20)(2012-2#26)(2012-3#28)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#72)(2013-3#1)(2013-7#15)(2013-8#26)
aimed at achieving a##2##4##(1991-6#1)(2008-4#1)
aimed at achieving##4##3##(1991-6#1)(2007-5#1)(2008-1#1)(2008-4#1)
aimed at analyzing the##2##4##(2012-3#1)(2013-8#1)
aimed at assessing the##2##4##(2008-7#1)(2012-12#1)
aimed at assessing##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
aimed at characterizing the##2##4##(1995-2#1)(2008-10#1)
aimed at characterizing##3##3##(1994-2#1)(1995-2#1)(2008-10#1)
aimed at confirming the##2##4##(2007-11#1)(2011-1#1)
aimed at controlling##4##3##(2008-7#1)(2009-12#1)(2010-11#1)(2013-1#1)
aimed at defining##2##3##(1991-5#1)(2008-11#1)
aimed at determining##2##3##(1994-8#1)(2008-5#1)
aimed at developing##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
aimed at elucidating##2##3##(1992-9#1)(2008-7#1)
aimed at estimating##2##3##(2012-12#1)(2013-8#1)
aimed at evaluating the##6##4##(2007-10#1)(2008-1#1)(2008-10#1)(2012-3#1)(2012-4#1)(2013-1#1)
aimed at evaluating##8##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
aimed at finding##3##3##(1992-5#1)(2008-2#1)(2008-6#1)
aimed at identifying##5##3##(1991-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
aimed at improving the##2##4##(2008-3#1)(2012-3#1)
aimed at improving##8##3##(2008-1#1)(2008-11#1)(2008-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
aimed at increasing##3##3##(2008-4#1)(2013-8#2)
aimed at investigating the prevalence##2##5##(2008-7#1)(2013-8#1)
aimed at investigating the##6##4##(2008-7#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
aimed at investigating##8##3##(1990-6#1)(2008-7#1)(2009-1#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
aimed at maintaining##2##3##(1997-5#1)(2006-10#1)
aimed at obtaining##2##3##(2007-10#1)(2009-10#1)
aimed at optimizing##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
aimed at preventing##4##3##(1996-1#1)(1996-8#1)(2012-2#1)(2013-1#1)
aimed at producing##2##3##(2009-2#1)(2013-1#1)
aimed at promoting##2##3##(1991-8#1)(1993-11#1)
aimed at providing##3##3##(2008-1#1)(2008-4#1)(2012-12#1)
aimed at reducing the thermal loading##2##6##(2008-2#2)
aimed at reducing##7##3##(1996-8#1)(1997-3#1)(2008-2#2)(2008-8#1)(2011-2#1)(2012-12#1)
aimed at the##20##3##(1990-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-8#1)
aimed at understanding##7##3##(1995-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-3#1)(2012-3#1)
aimed at##196##2##(1990-6#2)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-8#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#3)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#9)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#8)(2012-2#5)(2012-3#7)(2012-4#1)(2013-1#11)(2013-8#9)
aimed directly at##2##3##(2007-8#1)(2011-3#1)
aimed to analyze the##2##4##(2012-3#1)(2013-1#1)
aimed to assess the##7##4##(1991-5#1)(1993-6#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
aimed to assess##10##3##(1991-5#1)(1991-6#1)(1993-6#1)(1997-4#1)(2007-8#1)(2008-3#1)(2011-2#1)(2011-8#1)(2012-3#1)(2013-1#1)
aimed to compare the##2##4##(2010-1#1)(2012-3#1)
aimed to describe and##2##4##(2008-11#1)(2013-7#1)
aimed to describe the##4##4##(2010-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
aimed to describe##8##3##(2008-11#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
aimed to determine the##5##4##(2007-10#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
aimed to determine whether##2##4##(2007-11#1)(2009-12#1)
aimed to determine##9##3##(2007-10#1)(2007-11#1)(2009-12#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
aimed to develop a##3##4##(2008-10#1)(2010-1#1)(2012-12#1)
aimed to develop##4##3##(2008-10#1)(2010-1#1)(2010-5#1)(2012-12#1)
aimed to evaluate the##9##4##(2008-11#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
aimed to evaluate##11##3##(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-8#1)
aimed to examine the##4##4##(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
aimed to explore##5##3##(2007-10#1)(2009-10#1)(2011-1#1)(2013-1#2)
aimed to find out##2##4##(2007-7#1)(2012-2#1)
aimed to find##3##3##(2007-7#1)(2008-12#1)(2012-2#1)
aimed to identify the##5##4##(2009-12#1)(2009-8#1)(2012-3#3)
aimed to identify##12##3##(1990-2#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#4)(2012-8#1)
aimed to improve the##2##4##(2008-3#1)(2012-12#1)
aimed to improve##3##3##(1991-6#1)(2008-3#1)(2012-12#1)
aimed to investigate the impact of##2##6##(2013-7#1)(2013-8#1)
aimed to investigate the##12##4##(2008-10#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#4)(2013-7#2)(2013-8#1)
aimed to investigate##14##3##(2008-10#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#2)
aimed to modify the##2##4##(2008-11#1)(2012-2#1)
aimed to provide##2##3##(2011-3#1)(2012-2#1)
aimed to study##2##3##(2008-1#1)(2013-1#1)
aimed to the##2##3##(2008-10#1)(2009-10#1)
aimed to##136##2##(1990-2#1)(1991-5#1)(1991-6#2)(1992-2#1)(1993-6#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#7)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#6)(2011-3#1)(2011-8#1)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#20)(2012-6#1)(2012-8#1)(2013-1#15)(2013-7#5)(2013-8#5)
aimed##339##1##(1990-2#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-8#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#8)(2008-10#18)(2008-11#16)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#6)(2008-5#6)(2008-6#5)(2008-7#11)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#3)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#13)(2011-3#2)(2011-8#1)(2012-1#1)(2012-12#15)(2012-2#11)(2012-3#27)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#27)(2013-7#5)(2013-8#14)
aiming at a##2##3##(2008-10#1)(2012-12#1)
aiming at an##2##3##(1992-3#1)(2008-7#1)
aiming at evaluating the##2##4##(2008-5#2)
aiming at the##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
aiming at##28##2##(1991-9#1)(1992-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
aiming to achieve##2##3##(2009-4#1)(2010-11#1)
aiming to decrease##2##3##(2008-3#1)(2013-1#1)
aiming to improve the##2##4##(2008-6#1)(2012-2#1)
aiming to improve##3##3##(2008-6#1)(2010-5#1)(2012-2#1)
aiming to provide##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
aiming to##33##2##(1991-9#1)(1995-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
aiming##66##1##(1991-9#2)(1992-3#1)(1994-3#1)(1995-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#2)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
aims and##4##2##(1993-11#1)(2007-2#1)(2008-12#1)(2010-1#1)
aims at investigating the##2##4##(2011-2#1)(2012-12#1)
aims at providing a##2##4##(2008-4#1)(2013-1#1)
aims at providing##3##3##(2008-4#1)(2012-12#1)(2013-1#1)
aims at the##3##3##(1997-7#1)(2012-3#1)(2013-8#1)
aims at##26##2##(1991-2#1)(1991-6#2)(1994-6#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
aims for##3##2##(1993-8#1)(2007-8#1)(2010-12#1)
aims is##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
aims of development##2##3##(2012-1#2)
aims of the present study were##4##6##(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
aims of the##12##3##(1992-12#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
aims of this review are##3##5##(1990-11#1)(2008-8#1)(2009-5#1)
aims of this review##5##4##(1990-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-1#1)
aims of this study were to investigate the##2##8##(2010-2#1)(2011-2#1)
aims of this study were to##13##6##(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#3)
aims of this study were##17##5##(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#3)
aims of this study##18##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#3)
aims of this##28##3##(1990-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#4)
aims of##54##2##(1990-11#1)(1992-12#1)(1996-3#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
aims to assess##4##3##(2008-10#1)(2010-6#1)(2012-3#1)(2013-8#1)
aims to clarify##2##3##(1990-12#1)(2008-10#1)
aims to demonstrate the##2##4##(2011-1#1)(2012-2#1)
aims to demonstrate##3##3##(2010-3#1)(2011-1#1)(2012-2#1)
aims to describe##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
aims to determine the##4##4##(2008-11#1)(2011-1#2)(2011-2#1)
aims to evaluate the##3##4##(2008-10#1)(2012-3#1)(2013-8#1)
aims to evaluate##5##3##(2008-10#2)(2012-3#2)(2013-8#1)
aims to examine##2##3##(2007-6#1)(2008-11#1)
aims to further##2##3##(2008-11#1)(2008-7#1)
aims to help##3##3##(1997-7#1)(2008-9#1)(2011-2#1)
aims to highlight the##2##4##(2011-1#1)(2011-2#1)
aims to identify##4##3##(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
aims to improve##2##3##(1993-9#1)(2011-3#1)
aims to investigate the##2##4##(2011-2#1)(2012-2#1)
aims to present##2##3##(2008-12#1)(2013-8#1)
aims to provide a##2##4##(2008-7#1)(2012-2#1)
aims to provide an##2##4##(2008-10#2)
aims to provide##8##3##(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2012-2#1)
aims to reduce##2##3##(2008-7#1)(2010-4#1)
aims to review the##2##4##(1993-3#1)(2008-8#1)
aims to study the##2##4##(2009-5#1)(2012-2#1)
aims to study##3##3##(2007-7#1)(2009-5#1)(2012-2#1)
aims to test##2##3##(2012-6#1)(2013-8#1)
aims to##104##2##(1990-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-11#10)(2008-12#4)(2008-2#1)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#4)(2012-6#1)(2012-8#1)(2013-1#7)(2013-8#4)
aims were##3##2##(1991-6#1)(2008-5#1)(2008-9#1)
aims##214##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#3)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-3#2)(1997-4#1)(1997-7#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#16)(2008-12#10)(2008-2#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#14)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#13)(2011-3#2)(2012-1#3)(2012-12#5)(2012-2#11)(2012-3#7)(2012-6#1)(2012-8#1)(2013-1#13)(2013-8#7)
ainsi que##3##2##(2008-5#1)(2009-4#1)(2013-1#1)
ainsi##4##1##(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
air and its##2##3##(2008-10#2)
air and surface##2##3##(1996-12#1)(2008-10#1)
air and the##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
air and water sensitive##2##4##(2008-10#2)
air and water##4##3##(2008-10#2)(2013-7#2)
air and##33##2##(1990-8#2)(1991-12#1)(1996-12#1)(1996-2#1)(2007-12#4)(2008-1#1)(2008-10#13)(2008-2#2)(2008-3#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-7#2)
air are##3##2##(2008-3#3)
air as a##2##3##(2008-10#1)(2008-2#1)
air as the carrier##2##4##(2008-10#1)(2008-6#1)
air as the##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
air as##7##2##(1995-3#1)(2008-10#3)(2008-2#2)(2008-6#1)
air at##13##2##(1991-4#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2012-2#2)
air atmosphere##2##2##(2008-10#2)
air bags##3##2##(1993-3#1)(1995-5#1)(1997-6#1)
air bubbles##4##2##(2008-10#3)(2013-1#1)
air by use of##2##4##(2007-12#1)(2008-3#1)
air by##14##2##(1991-12#1)(2007-12#2)(2008-10#9)(2008-3#1)(2013-8#1)
air can##2##2##(1991-12#1)(1994-9#1)
air cell##2##2##(2008-12#1)(2008-7#1)
air containing##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
air currents##2##2##(2008-10#2)
air drying##7##2##(2008-10#5)(2008-5#2)
air embolism##7##2##(1991-3#1)(2007-8#1)(2008-7#4)(2011-2#1)
air flow rate##6##3##(1995-3#2)(2008-10#1)(2008-6#3)
air flow##12##2##(1993-2#1)(1995-3#3)(2008-10#3)(2008-3#1)(2008-6#4)
air flowrate##2##2##(2008-6#2)
air for##2##2##(2008-10#2)
air from##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
air gap##3##2##(2008-10#1)(2008-3#2)
air gaps##2##2##(2007-12#2)
air has been##2##3##(2007-11#1)(2008-10#1)
air has##3##2##(2007-11#1)(2008-10#1)(2012-7#1)
air holes in##3##3##(2007-11#2)(2007-12#1)
air holes##9##2##(2007-11#8)(2007-12#1)
air in a##2##3##(2007-12#1)(2008-3#1)
air in the##5##3##(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#1)(2011-2#1)
air in##10##2##(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#1)
air into##2##2##(2008-10#2)
air is##12##2##(1993-1#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#4)(2013-8#1)
air jet##4##2##(1993-2#1)(1994-12#1)(2007-12#1)(2008-3#1)
air layer##2##2##(2007-12#2)
air leak##2##2##(2007-8#2)
air leakage##2##2##(1991-3#1)(2013-1#1)
air leaks##3##2##(1994-6#2)(2010-8#1)
air mass##2##2##(2008-2#2)
air masses##2##2##(2007-12#1)(2012-2#1)
air of##10##2##(2007-2#1)(2008-10#4)(2008-11#2)(2010-4#2)(2012-2#1)
air on the##2##3##(2007-12#1)(2008-10#1)
air on##3##2##(2007-12#1)(2008-10#2)
air optical breakdown##3##3##(2008-2#3)
air or water##2##3##(2008-7#1)(2008-8#1)
air or##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#2)
air over a##2##3##(2007-12#1)(2008-2#1)
air particulate matter##3##3##(2008-10#2)(2008-11#1)
air particulate matters##4##3##(2008-10#4)
air particulate##7##2##(2008-10#6)(2008-11#1)
air passage##3##2##(1991-11#2)(2010-4#1)
air pollutant (NO(2))##2##3##(2008-10#2)
air pollutant##6##2##(1990-8#2)(2008-10#2)(2008-11#2)
air pollutants in##2##3##(1996-3#1)(2008-11#1)
air pollutants##16##2##(1992-9#1)(1996-3#2)(2008-10#2)(2008-11#9)(2008-2#2)
air pollution and##10##3##(1992-9#1)(1995-6#1)(1997-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
air pollution in the##2##4##(1992-9#1)(2008-11#1)
air pollution in##4##3##(1992-9#2)(2008-11#2)
air pollution##34##2##(1991-3#1)(1992-9#7)(1994-9#1)(1995-6#1)(1997-1#4)(1997-5#1)(2008-11#10)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#2)
air pressure cell##2##3##(2008-10#2)
air pressure cells##2##3##(2008-10#2)
air pressure##5##2##(2008-10#4)(2009-10#1)
air purification##2##2##(2008-9#2)
air quality in##3##3##(2008-11#1)(2011-2#1)(2012-1#1)
air quality management##4##3##(2008-11#4)
air quality##20##2##(1993-2#1)(1995-6#1)(1996-8#1)(2008-11#13)(2008-6#1)(2010-5#1)(2011-2#1)(2012-1#1)
air sample matrix##3##3##(2008-10#3)
air sample necessary for the measurement was##2##7##(2008-10#2)
air sample##11##2##(2008-10#11)
air samples and##3##3##(1992-3#1)(2008-10#1)(2010-4#1)
air samples was preconcentrated in##2##5##(2008-10#2)
air samples was##3##3##(2008-10#3)
air samples were higher than the national criteria##2##8##(2010-5#2)
air samples were##5##3##(2008-10#3)(2010-5#2)
air samples##26##2##(1992-3#2)(2008-10#19)(2010-4#2)(2010-5#3)
air sampling##6##2##(2008-10#4)(2008-12#1)(2013-1#1)
air segments##2##2##(2008-10#2)
air temperature and sunlight intensity##2##5##(2008-6#2)
air temperature and##5##3##(2008-10#2)(2008-6#2)(2013-7#1)
air temperature condition and##2##4##(2008-12#2)
air temperature during the##2##4##(2008-12#1)(2011-1#1)
air temperature was##4##3##(2008-10#1)(2008-6#3)
air temperature##20##2##(2008-10#6)(2008-12#4)(2008-6#5)(2008-7#1)(2011-1#1)(2012-6#1)(2013-1#1)(2013-7#1)
air temperatures##5##2##(2008-10#2)(2008-12#2)(2008-3#1)
air than##2##2##(2008-3#1)(2010-5#1)
air to##6##2##(1993-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)
air traffic##4##2##(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#1)
air transport##2##2##(2012-2#2)
air travel and children##2##4##(2008-11#2)
air travel##12##2##(2007-2#4)(2008-11#3)(2010-3#1)(2010-5#4)
air travellers##2##2##(2010-5#2)
air turbulence##2##2##(2007-11#1)(2008-3#1)
air velocity (vg)##2##3##(1995-3#2)
air velocity##3##2##(1995-3#3)
air volumetric flow rate##2##4##(1995-3#2)
air warming (+1##2##3##(2012-5#1)(2012-6#1)
air warming##16##2##(2012-5#4)(2012-6#8)(2012-9#4)
air was found to be##2##5##(2007-12#1)(2008-10#1)
air was preconcentrated in a##2##5##(2008-10#2)
air was##18##2##(1991-3#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
air were##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
air with variable humidity content##2##5##(2008-10#2)
air with##11##2##(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)
air##693##1##(1990-3#1)(1990-6#1)(1990-8#4)(1991-11#2)(1991-12#6)(1991-3#6)(1991-4#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-9#8)(1993-1#2)(1993-2#4)(1993-3#4)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#4)(1994-6#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#12)(1995-5#1)(1995-6#4)(1996-12#7)(1996-2#2)(1996-3#7)(1996-6#2)(1996-8#1)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-11#20)(2007-12#35)(2007-2#6)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#204)(2008-11#57)(2008-12#15)(2008-2#35)(2008-3#44)(2008-4#2)(2008-5#5)(2008-6#21)(2008-7#14)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#9)(2010-5#16)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#11)(2012-3#3)(2012-5#4)(2012-6#9)(2012-7#1)(2012-9#5)(2013-1#10)(2013-7#5)(2013-8#5)
air) and##2##2##(2008-5#1)(2013-8#1)
air)##6##1##(1996-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-8#1)
air-##2##1##(2008-10#1)(2008-3#1)
air-acetylene flame##3##2##(2008-10#3)
air-acetylene##4##1##(2008-10#4)
air-dried##4##1##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
air-dust samples##2##2##(2008-10#2)
air-dust##5##1##(2008-10#5)
air-leaks and intercostal drains##2##4##(2007-8#2)
air-leaks and##3##2##(2007-8#3)
air-liquid##9##1##(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#4)
air-quality##2##1##(1993-2#1)(2008-3#1)
air-sea temperature##3##2##(2008-3#3)
air-silica microstructure fiber that##2##4##(2007-11#2)
air-silica microstructure fiber##6##3##(2007-11#6)
air-silica microstructure##7##2##(2007-11#7)
air-space consolidation##2##2##(2008-1#2)
air-space##3##1##(1992-12#1)(2008-1#2)
air-spaced##2##1##(2007-11#1)(2008-2#1)
air-temperature##2##1##(2008-3#2)
air-tight##2##1##(1990-10#1)(2007-12#1)
air-water interface##4##2##(1994-5#1)(2008-10#2)(2008-2#1)
air/liquid##2##1##(2008-10#2)
air/water interface##3##2##(2008-10#3)
air/water##4##1##(2008-10#4)
airag##2##1##(2013-1#2)
airborne and##3##2##(2008-2#1)(2008-3#2)
airborne ascospore##2##2##(2008-10#2)
airborne ascospores##4##2##(2008-10#4)
airborne carbamates in##3##3##(2008-10#3)
airborne conidia##3##2##(2008-10#3)
airborne dust##3##2##(2008-10#2)(2008-11#1)
airborne inoculum##2##2##(2008-10#2)
airborne laser-induced fluorescence##2##3##(2008-2#2)
airborne laser-induced##3##2##(2008-2#2)(2008-3#1)
airborne lidar##8##2##(2008-2#5)(2008-3#3)
airborne microbial##2##2##(2010-4#2)
airborne multispectral scanners##2##3##(2008-10#2)
airborne nickel##2##2##(1994-9#2)
airborne or##5##2##(2008-2#1)(2008-3#4)
airborne particles##4##2##(1997-2#1)(2008-10#1)(2008-3#2)
airborne particulate matter (PM)##2##4##(2008-10#1)(2009-7#1)
airborne particulate matter collected on filters##2##6##(2008-10#2)
airborne particulate matter##13##3##(2008-10#12)(2009-7#1)
airborne particulate##16##2##(2008-10#13)(2008-11#1)(2008-3#1)(2009-7#1)
airborne particulates##2##2##(2008-10#2)
airborne pollen##2##2##(2012-7#2)
airborne propagules##2##2##(2008-10#2)
airborne spores##4##2##(2008-10#4)
airborne turbulence##2##2##(2008-2#2)
airborne##119##1##(1991-12#1)(1994-3#1)(1994-9#2)(1997-2#1)(2008-10#50)(2008-11#3)(2008-2#18)(2008-3#32)(2009-7#1)(2009-8#1)(2010-4#3)(2010-5#1)(2011-2#2)(2012-7#2)(2013-8#1)
aircraft and##3##2##(1996-12#1)(2008-11#1)(2008-3#1)
aircraft cabin##7##2##(1996-12#7)
aircraft fire##2##2##(1996-12#2)
aircraft##52##1##(1996-12#18)(2007-11#1)(2007-2#7)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#16)(2009-7#1)(2009-9#5)
aircraft-target##3##1##(2008-3#3)
airflow limitation##2##2##(2008-1#1)(2013-8#1)
airflow obstruction##4##2##(1992-3#1)(2008-3#1)(2008-7#1)(2011-2#1)
airflow rate##2##2##(1996-2#1)(1996-3#1)
airflow##15##1##(1991-9#1)(1992-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
airglow##3##1##(2008-2#1)(2008-3#2)
airholes##2##1##(2007-12#2)
airlift reactors##4##2##(2008-7#4)
airline passenger##2##2##(2007-2#1)(2008-10#1)
airline passengers##2##2##(2007-2#2)
airline##9##1##(1997-5#2)(2007-2#3)(2008-10#1)(2010-3#2)(2010-5#1)
airlines##2##1##(2007-2#1)(2009-10#1)
airplane##2##1##(1996-12#1)(2008-2#1)
airport##5##1##(2007-2#3)(2008-10#1)(2008-12#1)
airsacculitis##3##1##(2010-4#3)
airspace##3##1##(1996-2#3)
airspaces##6##1##(1991-9#1)(1996-2#3)(1997-2#1)(2008-10#1)
airtight##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
airway and##5##2##(1992-2#1)(1992-3#1)(1997-1#1)(1997-2#1)(2008-8#1)
airway blood flow##2##3##(1997-1#2)
airway compromise##2##2##(2012-1#2)
airway constriction##2##2##(2007-2#2)
airway deposition##2##2##(1996-12#2)
airway dimension##2##2##(2008-11#2)
airway dimensions for##2##3##(2008-11#2)
airway dimensions##3##2##(2008-11#3)
airway disease##5##2##(1993-2#1)(1993-8#1)(1997-1#1)(2010-5#2)
airway diseases##4##2##(2006-10#1)(2008-3#2)(2009-1#1)
airway epithelial cells##7##3##(1991-5#1)(1994-11#3)(1994-5#2)(2010-5#1)
airway epithelial##10##2##(1991-5#3)(1994-11#3)(1994-5#2)(1995-11#1)(2010-5#1)
airway epithelium##6##2##(1994-6#2)(1995-11#1)(1997-2#2)(2008-4#1)
airway gas exchange##2##3##(1997-1#2)
airway geometry##2##2##(1992-3#1)(2008-11#1)
airway have been##2##3##(2008-10#1)(2013-1#1)
airway hyper-reactivity##3##2##(2010-5#3)
airway hyperresponsiveness and##2##3##(1997-1#1)(2008-3#1)
airway hyperresponsiveness##7##2##(1993-9#1)(1997-1#1)(2008-10#1)(2008-3#4)
airway in##2##2##(2008-8#1)(2012-12#1)
airway infections##2##2##(1994-11#1)(1997-4#1)
airway inflammation##12##2##(1992-2#1)(1992-5#1)(2008-3#1)(2009-1#1)(2010-1#1)(2010-5#3)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
airway inflammatory##2##2##(2008-10#1)(2012-3#1)
airway management##5##2##(2008-2#2)(2010-7#1)(2011-2#2)
airway mucin##2##2##(1993-8#2)
airway obstruction and##3##3##(1995-8#1)(2010-7#1)(2012-12#1)
airway obstruction as##2##3##(1992-3#1)(2012-3#1)
airway obstruction##17##2##(1991-4#1)(1992-3#1)(1995-8#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-11#2)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
airway pressure##13##2##(2007-12#1)(2007-8#6)(2010-5#2)(2010-7#1)(2011-1#1)(2013-7#2)
airway resistance##3##2##(1994-6#1)(2011-2#1)(2012-3#1)
airway retention of##2##3##(1995-12#2)
airway retention##6##2##(1995-12#6)
airway sealing pressure##4##3##(2010-7#4)
airway secretions##2##2##(1991-11#1)(1997-1#1)
airway sensitivity to methacholine##2##4##(2008-1#2)
airway sensitization potential##3##3##(2008-10#3)
airway smooth muscle##4##3##(1996-1#1)(1996-7#1)(1997-1#1)(2010-1#1)
airway trauma##2##2##(2007-11#1)(2010-7#1)
airway##245##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#2)(1991-5#3)(1992-2#8)(1992-3#13)(1992-5#2)(1993-10#1)(1993-2#1)(1993-8#5)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#5)(1995-11#2)(1995-12#6)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#2)(1996-7#2)(1997-1#17)(1997-2#7)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#10)(2007-2#2)(2007-4#1)(2007-8#7)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#2)(2008-8#3)(2009-1#2)(2009-9#1)(2010-1#4)(2010-12#1)(2010-5#13)(2010-7#11)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#4)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#6)
airways (diameter##2##2##(1991-4#2)
airways and##8##2##(1993-3#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-6#1)(2007-12#1)(2009-1#1)(2013-1#1)
airways as a##2##3##(1995-2#1)(2008-4#1)
airways as##3##2##(1995-2#1)(1997-1#1)(2008-4#1)
airways disease##3##2##(1992-11#1)(2008-1#1)(2008-7#1)
airways is##2##2##(2007-6#1)(2008-11#1)
airways obstruction##7##2##(1995-12#1)(2008-12#2)(2008-7#4)
airways of the lung##3##4##(1991-12#1)(1997-1#1)(2008-10#1)
airways of the##5##3##(1991-12#1)(1997-1#2)(2008-10#1)(2008-3#1)
airways of##9##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#2)(2008-10#1)(2008-3#1)
airways via##2##2##(1994-2#1)(1995-12#1)
airways##85##1##(1990-6#1)(1991-12#3)(1991-4#2)(1991-6#2)(1992-11#3)(1992-3#4)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#3)(1995-12#2)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-7#2)(1997-1#13)(1997-2#2)(1997-4#1)(2007-11#1)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-4#1)(2010-1#1)(2010-7#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
airy##2##1##(2008-2#2)
ajoene##3##1##(2008-5#3)
akajimensis is##2##2##(2011-2#2)
akajimensis##4##1##(2011-2#4)
akathisia##5##1##(2008-6#2)(2008-7#3)
akin to##2##2##(1995-3#1)(2008-2#1)
akinesia and##2##2##(2008-7#1)(2012-2#1)
akinesia in##2##2##(2008-7#2)
akinesia##7##1##(1991-3#1)(2008-7#5)(2012-2#1)
akinesis##3##1##(1997-3#2)(2011-2#1)
akinetic mutism##3##2##(2007-8#3)
akinetic##5##1##(2007-8#3)(2008-7#1)(2013-1#1)
akratic##2##1##(2008-10#2)
al##476##1##(1990-11#9)(1990-12#3)(1990-2#2)(1990-5#13)(1990-7#2)(1990-8#11)(1990-9#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-5#3)(1991-6#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#9)(1993-3#6)(1993-6#2)(1993-8#6)(1993-9#3)(1994-11#3)(1994-12#8)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#15)(1997-3#9)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-4#2)(2007-11#5)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#35)(2008-12#7)(2008-2#9)(2008-3#17)(2008-4#9)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#13)(2009-10#2)(2009-2#2)(2009-3#13)(2009-4#1)(2009-5#6)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#5)(2011-2#41)(2012-12#8)(2012-3#9)(2013-1#10)(2013-8#6)
al-3##2##1##(1992-8#2)
ala##4##1##(2008-10#1)(2008-12#1)(2012-12#2)
alachlor##7##1##(1993-12#2)(2008-10#5)
alamethicin##3##1##(1990-2#1)(1992-3#2)
alane decomposition##3##2##(2010-4#3)
alane was##2##2##(2010-4#2)
alane##10##1##(1996-2#1)(2008-3#1)(2008-8#1)(2010-4#7)
alanine amino transferase (ALT)##2##4##(2008-10#2)
alanine aminotransferase (ALT) and##2##4##(2009-8#1)(2013-1#1)
alanine aminotransferase (ALT)##10##3##(1995-3#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
alanine aminotransferase level##2##3##(2007-12#1)(2013-8#1)
alanine aminotransferase levels##2##3##(2013-1#2)
alanine aminotransferase##21##2##(1991-12#2)(1993-2#1)(1994-5#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
alanine and aspartate##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
alanine and##5##2##(1992-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
alanine at##5##2##(1992-8#1)(1993-8#1)(2007-6#1)(2008-10#2)
alanine is##2##2##(1997-1#1)(2008-10#1)
alanine or##3##2##(1994-11#1)(1994-3#1)(2008-4#1)
alanine production##3##2##(2008-11#1)(2008-7#2)
alanine substitutions##3##2##(1994-9#1)(2007-11#1)(2010-5#1)
alanine transaminase##3##2##(2008-11#2)(2011-2#1)
alanine was##2##2##(1992-6#1)(2008-10#1)
alanine were##2##2##(2008-11#1)(2008-5#1)
alanine##102##1##(1990-2#1)(1991-12#2)(1992-3#1)(1992-6#6)(1992-8#3)(1993-11#1)(1993-2#1)(1993-8#3)(1994-11#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#6)(1995-6#2)(1996-12#1)(1996-5#2)(1997-1#2)(1997-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#17)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
alanine-rich##2##1##(1993-9#1)(1995-2#1)
alanines##5##1##(1992-6#1)(1995-2#3)(1995-6#1)
alantolactone##2##1##(2008-10#2)
alanyl aminopeptidase##2##2##(1990-2#2)
alanyl##3##1##(1990-2#2)(1995-6#1)
alanyl- and threonyl-tRNA synthetases##2##4##(2012-2#2)
alaptide##2##1##(1991-12#2)
alarm cues##2##2##(2010-8#2)
alarm sensor##2##2##(2008-10#2)
alarm##20##1##(1990-7#1)(1995-2#1)(1996-4#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
alarmed##3##1##(1994-12#1)(2007-12#1)(2008-6#1)
alarming rate##4##2##(2008-1#1)(2008-4#1)(2008-7#1)(2012-3#1)
alarming rise in##2##3##(2008-8#1)(2013-1#1)
alarming##12##1##(1995-6#1)(1996-1#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
alarmingly##2##1##(2008-10#1)(2013-8#1)
alarms##6##1##(1994-8#1)(1996-4#2)(2008-3#1)(2011-2#2)
alata##2##1##(2008-10#1)(2008-5#1)
alate##3##1##(2008-10#2)(2009-5#1)
alba##14##1##(2008-10#2)(2008-5#4)(2008-8#3)(2011-3#4)(2013-1#1)
albedo and phase function##2##4##(2008-2#2)
albedo and##7##2##(2008-2#7)
albedo from##3##2##(2008-2#2)(2008-3#1)
albedo is##2##2##(2008-2#1)(2008-3#1)
albedo of a##2##3##(2008-2#1)(2008-3#1)
albedo of the##3##3##(2008-3#3)
albedo of##7##2##(2008-2#1)(2008-3#6)
albedo on##3##2##(2008-2#3)
albedo values in the##2##4##(2008-3#2)
albedo values##4##2##(2008-3#4)
albedo was##4##2##(2008-3#4)
albedo##59##1##(2008-2#27)(2008-3#32)
albedos##2##1##(2008-2#1)(2008-3#1)
albeit at different##2##3##(1991-9#1)(1996-2#1)
albeit at##4##2##(1991-9#1)(1992-11#1)(1994-11#1)(1996-2#1)
albeit in##3##2##(2007-12#1)(2008-5#1)(2009-12#1)
albeit less##3##2##(1992-6#1)(2008-11#1)(2011-1#1)
albeit limited##2##2##(1993-1#1)(2008-6#1)
albeit not##2##2##(2008-10#2)
albeit the##3##2##(1992-9#1)(1993-11#1)(2011-1#1)
albeit with a##2##3##(2008-4#1)(2008-8#1)
albeit with##4##2##(1997-7#1)(2008-3#1)(2008-4#1)(2008-8#1)
albeit##44##1##(1991-3#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
albendazole treatment##2##2##(1995-12#1)(2007-12#1)
albendazole was##3##2##(2008-10#2)(2010-11#1)
albendazole##12##1##(1995-12#1)(1996-12#2)(2007-12#2)(2007-8#1)(2008-10#3)(2009-10#1)(2010-11#1)(2011-2#1)
albicans PKC1 gene##2##3##(1996-6#2)
albicans TUB2 gene##2##3##(1990-5#2)
albicans and##9##2##(2008-11#1)(2008-4#1)(2008-5#5)(2010-5#1)(2013-1#1)
albicans biofilm##3##2##(2013-1#3)
albicans cell wall components##2##4##(2008-5#2)
albicans cell wall##3##3##(2008-5#3)
albicans cells##6##2##(1996-6#1)(2008-5#5)
albicans hyphal growth##2##3##(2009-8#2)
albicans in the alimentary##2##4##(2008-5#2)
albicans in the##3##3##(2008-11#1)(2008-5#2)
albicans in##8##2##(2008-11#2)(2008-5#5)(2012-3#1)
albicans infection##2##2##(2008-5#2)
albicans is##5##2##(1991-9#1)(1996-12#1)(2008-4#1)(2008-5#2)
albicans isolates##3##2##(2008-5#2)(2012-3#1)
albicans serotype##2##2##(2008-5#2)
albicans strains isolated from##2##4##(2008-5#2)
albicans strains##4##2##(2008-5#3)(2013-8#1)
albicans to##3##2##(1990-5#1)(2008-5#1)(2013-1#1)
albicans##130##1##(1990-5#6)(1991-12#3)(1991-9#4)(1992-6#1)(1992-8#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#5)(1997-4#3)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#5)(2008-4#2)(2008-5#62)(2009-8#3)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#9)(2013-1#9)(2013-8#1)
albicidin biosynthesis genes##3##3##(2008-10#3)
albicidin biosynthesis##4##2##(2008-10#4)
albicidin##9##1##(2008-10#9)
albicinctus and##2##2##(2008-10#2)
albilineans could be##2##3##(2008-10#2)
albilineans##14##1##(2008-10#14)
albinism##7##1##(1997-4#2)(2008-6#5)
albino and pigmented medaka##3##4##(2008-11#3)
albino medaka were##2##3##(2008-11#2)
albino mice##8##2##(1992-2#2)(1992-5#1)(1997-7#1)(2010-1#2)(2010-11#1)(2013-1#1)
albino rat##3##2##(1994-8#2)(2008-10#1)
albino rats were##5##3##(1994-8#1)(2008-10#2)(2011-2#1)(2012-2#1)
albino rats##12##2##(1993-5#1)(1994-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)
albino strain##2##2##(2008-10#2)
albino wistar rats##2##3##(2008-12#2)
albino##39##1##(1992-2#2)(1992-5#1)(1992-8#1)(1993-5#1)(1994-6#1)(1994-8#3)(1997-7#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-5#1)(2008-7#1)(2010-1#2)(2010-11#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
albino-3##2##1##(1992-8#2)
albitarsis##5##1##(2007-12#3)(2012-12#2)
albite##2##1##(2013-8#2)
albo-atrum from##2##2##(2008-10#2)
albo-atrum##8##1##(2008-10#8)
albolabrin##2##1##(1990-5#2)
albolabris##2##1##(1990-5#1)(1993-3#1)
albopictus in Florida##2##3##(1992-8#2)
albopictus in##3##2##(1992-8#3)
albopictus##7##1##(1992-8#4)(2007-7#3)
alborufus castaneus##3##2##(2008-5#3)
alborufus lena##3##2##(2008-5#3)
alborufus##7##1##(2008-5#7)
album##5##1##(1992-9#1)(2007-2#2)(2008-10#1)(2008-12#1)
album&quot##5##1##(1993-2#5)
albumin adsorption##2##2##(2008-7#2)
albumin and globulins##2##3##(2008-10#1)(2010-4#1)
albumin and hemoglobin##2##3##(2008-1#1)(2008-7#1)
albumin and the##3##3##(1992-12#1)(1993-12#1)(2008-10#1)
albumin and##33##2##(1991-2#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-2#1)
albumin are##3##2##(1993-6#1)(2008-1#1)(2008-10#1)
albumin as an##2##3##(2008-11#1)(2009-11#1)
albumin as the##3##3##(1991-12#2)(2008-10#1)
albumin as##9##2##(1990-12#1)(1991-12#2)(2008-10#2)(2008-11#1)(2009-11#1)(2009-9#1)(2012-2#1)
albumin by##4##2##(1991-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
albumin concentration and##3##3##(1992-9#2)(1997-8#1)
albumin concentration correlated##2##3##(1992-9#1)(2008-1#1)
albumin concentration##11##2##(1992-9#5)(1993-8#1)(1993-9#1)(1997-8#1)(2008-1#2)(2008-10#1)
albumin excretion in##7##3##(1997-8#4)(2008-7#1)(2013-1#2)
albumin excretion rate##2##3##(2012-1#1)(2012-3#1)
albumin excretion##13##2##(1997-8#5)(2008-1#2)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#3)
albumin for##3##2##(2008-7#2)(2013-1#1)
albumin globule##2##2##(2008-10#2)
albumin in##11##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2009-6#1)
albumin is##3##2##(1995-2#2)(2008-7#1)
albumin level##3##2##(2007-12#1)(2008-1#1)(2011-2#1)
albumin levels##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2009-6#1)
albumin molecule##3##2##(1994-6#1)(2008-10#2)
albumin molecules##2##2##(2008-5#2)
albumin on##4##2##(1993-8#1)(1995-12#1)(2008-6#1)(2008-7#1)
albumin production ability##2##3##(2008-11#2)
albumin production##3##2##(2008-11#3)
albumin protein solders##2##3##(2008-3#2)
albumin protein##3##2##(1992-11#1)(2008-3#2)
albumin secretion##9##2##(2008-11#7)(2013-1#2)
albumin should be reserved for##2##5##(1997-3#1)(2011-2#1)
albumin solutions##2##2##(1997-3#1)(2008-6#1)
albumin to creatinine ratio##3##4##(2012-2#1)(2013-1#2)
albumin to##4##2##(2008-2#1)(2012-2#1)(2013-1#2)
albumin transfusion##6##2##(2013-1#6)
albumin using##2##2##(2008-10#2)
albumin variants##2##2##(1991-12#2)
albumin with##2##2##(2008-10#1)(2008-7#1)
albumin##335##1##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#2)(1990-5#1)(1990-8#3)(1991-11#1)(1991-12#8)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#9)(1993-8#6)(1993-9#2)(1994-6#1)(1994-8#6)(1994-9#1)(1995-11#1)(1995-12#9)(1995-2#6)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-8#7)(2007-11#1)(2007-12#3)(2008-1#10)(2008-10#95)(2008-11#28)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#23)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#2)(2009-9#2)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#19)(2013-8#1)
albumin)##5##1##(2008-10#2)(2008-3#2)(2008-9#1)
albumin-bound##3##1##(2008-3#1)(2008-5#1)(2010-7#1)
albumin-fixed membrane##5##2##(2008-5#5)
albumin-fixed##6##1##(2008-5#6)
albumin/creatinine ratio##2##2##(1992-9#2)
albuminemia##3##1##(1991-12#1)(1991-8#1)(1997-3#1)
albumins were detected##2##3##(1991-12#1)(2008-5#1)
albumins were##3##2##(1991-12#1)(2008-5#2)
albumins##10##1##(1991-12#2)(1995-2#1)(2008-12#3)(2008-5#4)
albuminuria and##4##2##(1993-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
albuminuria has##2##2##(1992-9#1)(2012-2#1)
albuminuria in##2##2##(2012-1#1)(2012-6#1)
albuminuria##19##1##(1992-9#3)(1993-12#1)(1994-8#1)(2008-1#3)(2008-10#1)(2008-7#1)(2010-8#1)(2012-1#2)(2012-2#2)(2012-6#4)
albus and M##3##3##(2008-6#3)
albus##11##1##(1994-12#1)(2008-10#1)(2008-12#1)(2008-6#6)(2011-2#2)
albuterol##2##1##(1997-2#1)(2008-8#1)
alcian blue concentration##2##3##(2008-10#2)
alcian blue##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
alcohol (PVA)##5##2##(2008-10#2)(2008-5#1)(2009-11#1)(2012-3#1)
alcohol abuse and##3##3##(2008-11#1)(2009-2#1)(2012-2#1)
alcohol abuse##19##2##(1990-2#3)(1992-12#1)(1993-8#1)(1994-2#1)(1996-6#1)(1997-2#2)(2008-11#2)(2008-2#1)(2008-9#1)(2009-2#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
alcohol addiction##3##2##(1993-12#1)(2008-4#1)(2012-3#1)
alcohol and breast cancer##2##4##(1994-2#2)
alcohol and drug dependent patients##2##5##(1992-12#2)
alcohol and drug use##2##4##(2010-9#1)(2011-1#1)
alcohol and drug##9##3##(1990-2#1)(1992-12#3)(2008-6#2)(2010-9#1)(2011-1#1)(2013-1#1)
alcohol and marijuana use##3##4##(2009-5#1)(2009-7#2)
alcohol and marijuana##5##3##(2009-5#2)(2009-7#3)
alcohol and nicotine##4##3##(2008-1#1)(2009-6#3)
alcohol and other##3##3##(1995-8#1)(2009-9#1)(2012-12#1)
alcohol and the##4##3##(1991-1#2)(2008-10#1)(2008-5#1)
alcohol and tobacco in##2##4##(2008-1#2)
alcohol and tobacco##4##3##(1994-12#1)(2008-1#3)
alcohol and##46##2##(1990-2#1)(1991-1#2)(1992-12#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-9#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#1)
alcohol and/or##2##2##(1990-9#1)(1994-2#1)
alcohol are##2##2##(1994-2#1)(1996-1#1)
alcohol as an##2##3##(2008-10#2)
alcohol as##4##2##(1997-8#1)(2008-1#1)(2008-10#2)
alcohol at##2##2##(1994-2#1)(2012-12#1)
alcohol by##3##2##(1994-5#1)(2008-10#2)
alcohol concentration##7##2##(1994-11#1)(2008-10#3)(2011-2#2)(2013-1#1)
alcohol concentrations##2##2##(1992-6#1)(2008-10#1)
alcohol consumers##2##2##(2012-12#1)(2013-1#1)
alcohol consumption and##4##3##(1992-6#1)(2008-11#1)(2009-7#1)(2013-1#1)
alcohol consumption in##3##3##(1993-12#1)(1995-11#1)(2008-7#1)
alcohol consumption may##2##3##(1990-8#1)(2011-2#1)
alcohol consumption##35##2##(1990-8#2)(1990-9#1)(1992-6#3)(1992-9#1)(1993-12#2)(1993-9#1)(1994-2#3)(1994-7#1)(1995-11#2)(1996-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#2)(2009-6#1)(2009-7#3)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
alcohol consumption]##4##2##(1990-9#1)(1996-3#1)(1997-2#2)
alcohol dehydrogenase (ADH)##4##3##(1993-3#1)(1994-9#1)(1997-8#1)(2008-11#1)
alcohol dehydrogenase in##2##3##(1990-5#1)(1994-8#1)
alcohol dehydrogenase inactivated hepatocytes##2##4##(1994-8#2)
alcohol dehydrogenase##33##2##(1990-5#2)(1991-10#2)(1992-11#1)(1993-11#1)(1993-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-3#1)(1995-5#3)(1997-8#2)(2008-10#3)(2008-11#2)(2008-5#3)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
alcohol dependence and##4##3##(1995-11#1)(2009-10#1)(2009-2#1)(2012-2#1)
alcohol dependence in##5##3##(2008-10#1)(2008-8#1)(2012-1#1)(2012-2#2)
alcohol dependence##29##2##(1991-12#3)(1994-2#2)(1995-11#1)(2008-10#1)(2008-2#8)(2008-8#1)(2009-10#4)(2009-2#1)(2010-1#1)(2012-1#2)(2012-2#5)
alcohol dependent##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
alcohol drinking behaviour##2##3##(2009-7#2)
alcohol drinking##8##2##(1990-2#1)(1997-6#1)(2007-9#1)(2009-7#2)(2010-5#1)(2011-2#1)(2013-8#1)
alcohol during##2##2##(2012-12#2)
alcohol eluates##2##2##(2008-10#2)
alcohol exposure##4##2##(2008-11#2)(2011-2#2)
alcohol in the##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
alcohol in##8##2##(1991-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)
alcohol injection##2##2##(1990-8#2)
alcohol intake in##3##3##(1993-12#1)(2008-2#2)
alcohol intake##11##2##(1993-12#3)(1993-9#1)(1994-6#1)(2008-11#1)(2008-2#4)(2011-2#1)
alcohol into##2##2##(1997-8#1)(2012-12#1)
alcohol intoxication##2##2##(1995-11#1)(2012-2#1)
alcohol is##6##2##(1992-12#1)(1993-7#1)(1995-11#1)(2007-12#1)(2008-10#2)
alcohol may##2##2##(1994-2#1)(2008-7#1)
alcohol metabolism##2##2##(1994-12#1)(2009-10#1)
alcohol misusers in relapse##2##4##(1993-12#2)
alcohol mixture##2##2##(2008-5#1)(2011-1#1)
alcohol on##4##2##(1991-11#1)(1994-11#2)(2008-10#1)
alcohol or aldehyde##3##3##(1994-8#1)(2010-7#2)
alcohol or drug##2##3##(1992-12#1)(1994-2#1)
alcohol or##15##2##(1992-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-7#3)(2012-2#1)(2013-1#1)(2013-8#1)
alcohol oxidase##10##2##(1991-5#2)(1994-11#1)(1995-9#1)(1997-7#1)(2008-10#4)(2008-7#1)
alcohol policies##2##2##(2008-1#1)(2008-11#1)
alcohol problems##5##2##(1993-12#1)(2008-11#4)
alcohol related##2##2##(2008-1#1)(2012-3#1)
alcohol sample##3##2##(2008-10#3)
alcohol samples##3##2##(2008-10#3)
alcohol screening##2##2##(2008-11#2)
alcohol through##2##2##(2008-7#1)(2009-12#1)
alcohol to##3##2##(1990-2#1)(2008-7#1)(2009-8#1)
alcohol use and delinquent behavior##2##5##(2009-8#2)
alcohol use and##9##3##(2007-2#1)(2008-11#3)(2008-12#2)(2009-8#2)(2010-7#1)
alcohol use disorder##3##3##(2013-8#3)
alcohol use disorders##6##3##(2011-2#1)(2012-3#3)(2013-8#2)
alcohol use in##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
alcohol use##53##2##(1992-12#1)(2007-2#1)(2008-1#1)(2008-11#12)(2008-12#4)(2008-6#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#5)(2010-7#3)(2010-9#3)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#1)(2013-8#10)
alcohol users##2##2##(2012-12#2)
alcohol was##4##2##(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)
alcohol withdrawal state complicated##2##4##(2012-2#2)
alcohol withdrawal state##3##3##(1991-12#1)(2012-2#2)
alcohol withdrawal##7##2##(1991-12#1)(1995-11#2)(2008-2#2)(2012-2#2)
alcohol##569##1##(1990-11#2)(1990-2#8)(1990-5#3)(1990-8#5)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#5)(1991-5#2)(1991-9#5)(1992-11#1)(1992-12#7)(1992-3#3)(1992-6#5)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#11)(1993-3#6)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#6)(1994-12#3)(1994-2#22)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#7)(1995-3#2)(1995-5#4)(1995-8#3)(1995-9#2)(1996-1#3)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#2)(1997-1#1)(1997-2#5)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#7)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-9#1)(2008-1#11)(2008-10#76)(2008-11#40)(2008-12#8)(2008-2#20)(2008-3#4)(2008-4#4)(2008-5#20)(2008-6#9)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#7)(2009-11#4)(2009-12#2)(2009-2#2)(2009-5#4)(2009-6#6)(2009-7#14)(2009-8#9)(2009-9#4)(2010-1#2)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#7)(2010-9#4)(2011-1#5)(2011-2#16)(2012-1#3)(2012-12#16)(2012-2#16)(2012-3#8)(2013-1#17)(2013-7#2)(2013-8#18)
alcohol)##19##1##(1990-8#1)(1997-8#2)(2007-12#2)(2008-10#6)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)
alcohol-dependence##2##1##(2009-10#2)
alcohol-dependent patients##2##2##(1995-11#1)(2008-2#1)
alcohol-dependent##7##1##(1990-2#1)(1991-1#1)(1995-11#1)(2008-2#4)
alcohol-glycine composite##2##2##(2008-5#2)
alcohol-induced liver##3##2##(2006-10#1)(2012-2#2)
alcohol-induced oxidative stress in##2##4##(2012-2#2)
alcohol-induced##7##1##(1992-6#1)(2006-10#1)(2009-12#1)(2012-2#4)
alcohol-related problems##5##2##(1995-11#1)(2008-11#1)(2008-12#3)
alcohol-related##10##1##(1992-12#1)(1994-2#2)(1995-11#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)
alcohol/hydroxysteroid##2##1##(1992-8#2)
alcoholic beverage##3##2##(1995-2#1)(2008-10#2)
alcoholic beverages and##2##3##(2008-9#1)(2013-1#1)
alcoholic beverages##15##2##(1991-9#1)(2008-10#8)(2008-8#1)(2008-9#2)(2011-1#2)(2013-1#1)
alcoholic chronic pancreatitis##5##3##(2009-7#5)
alcoholic cirrhosis##3##2##(1990-8#1)(1993-12#1)(2013-1#1)
alcoholic drinks per##2##3##(1993-9#1)(2013-1#1)
alcoholic drinks##3##2##(1993-9#1)(2008-10#1)(2013-1#1)
alcoholic extract##2##2##(2008-10#1)(2010-5#1)
alcoholic group##2##2##(2008-10#2)
alcoholic hepatitis##2##2##(2009-7#2)
alcoholic liver disease##7##3##(1993-12#2)(1994-7#2)(2006-10#1)(2008-8#1)(2010-12#1)
alcoholic liver injury##3##3##(1994-7#1)(2009-7#1)(2012-3#1)
alcoholic liver##13##2##(1991-5#1)(1993-12#2)(1994-7#5)(2006-10#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-3#1)
alcoholic men##2##2##(1991-12#2)
alcoholic patients##8##2##(1991-12#3)(1994-7#2)(1996-11#1)(2009-10#1)(2009-7#1)
alcoholic patients]##2##2##(1995-11#1)(2008-10#1)
alcoholic##93##1##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-5#1)(1991-9#2)(1993-12#3)(1993-9#2)(1994-11#1)(1994-2#5)(1994-7#8)(1995-11#2)(1995-2#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#10)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#5)
alcoholics and##3##2##(1993-2#1)(1997-5#2)
alcoholics is##2##2##(1994-2#1)(1995-11#1)
alcoholics to##2##2##(1994-2#2)
alcoholics with##2##2##(1995-11#1)(1997-5#1)
alcoholics##34##1##(1991-11#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#14)(1994-7#1)(1995-11#2)(1996-7#3)(1997-5#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#3)
alcoholics' decision making##2##3##(2013-7#2)
alcoholism and tuberculosis##3##3##(2011-2#3)
alcoholism and##10##2##(1994-2#2)(1995-12#1)(1996-1#1)(2006-10#1)(2008-4#1)(2011-2#3)(2012-12#1)
alcoholism has##2##2##(2008-2#2)
alcoholism is##2##2##(1994-2#1)(2009-7#1)
alcoholism treatment##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
alcoholism##81##1##(1991-1#4)(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#2)(1993-2#4)(1994-2#23)(1994-5#1)(1994-6#1)(1995-11#3)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-5#7)(2006-10#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#2)
alcoholism-related brain damage##2##3##(2008-6#2)
alcoholism]##3##1##(1991-11#1)(1992-9#1)(1994-3#1)
alcohols and##11##2##(1990-7#1)(1992-6#1)(2007-11#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)
alcohols are##2##2##(2007-11#1)(2008-10#1)
alcohols in##3##2##(1990-5#1)(1995-3#1)(2007-12#1)
alcohols is##6##2##(1990-7#1)(1996-5#1)(2008-10#2)(2008-6#1)(2009-6#1)
alcohols on the##2##3##(1992-6#1)(2009-8#1)
alcohols on##4##2##(1990-12#2)(1992-6#1)(2009-8#1)
alcohols using##2##2##(2007-11#1)(2008-5#1)
alcohols was##2##2##(1994-6#1)(2007-11#1)
alcohols were prepared##2##3##(2007-11#1)(2008-5#1)
alcohols were##7##2##(1990-8#1)(1996-5#1)(2007-11#3)(2008-5#1)(2009-8#1)
alcohols with##3##2##(1996-5#1)(2008-10#2)
alcohols##95##1##(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#4)(1990-8#1)(1991-5#1)(1992-6#5)(1992-7#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#3)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#12)(2007-12#3)(2008-10#20)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#2)(2009-6#2)(2009-8#4)(2010-12#1)(2010-7#2)(2013-1#1)(2013-7#1)
alcuronium##3##1##(1995-11#3)
aldehyde dehydrogenase (ALDH)##2##3##(1994-5#1)(2008-11#1)
aldehyde dehydrogenase##13##2##(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#5)(2008-10#2)(2008-11#1)(2010-12#1)
aldehyde dehydrogenase-3##2##2##(1992-8#2)
aldehyde##46##1##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#4)(1995-2#5)(1995-3#1)(1996-5#4)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-10#2)(2009-12#1)(2010-12#1)(2010-7#3)(2011-1#1)
aldehydes and##6##2##(1996-5#2)(2007-11#1)(2008-10#2)(2010-12#1)
aldehydes condense##2##2##(1996-5#2)
aldehydes in##2##2##(2008-10#1)(2008-8#1)
aldehydes using##2##2##(2008-10#2)
aldehydes with##6##2##(1991-5#1)(1996-5#1)(2007-11#3)(2010-12#1)
aldehydes##41##1##(1991-5#1)(1993-3#1)(1994-12#1)(1996-5#8)(2007-11#4)(2008-10#12)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#4)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)
alder##3##1##(2008-10#1)(2008-12#1)(2012-3#1)
aldicarb sulfoxide##2##2##(2008-10#2)
aldicarb##6##1##(2008-10#6)
aldimine##3##1##(1992-6#3)
aldo-1 was##2##2##(1990-5#2)
aldo-keto##2##1##(1992-3#1)(1994-6#1)
aldol reaction##3##2##(2007-11#2)(2010-7#1)
aldol##4##1##(1990-7#1)(2007-11#2)(2010-7#1)
aldolase gene##4##2##(1995-8#4)
aldolase##13##1##(1990-12#1)(1990-5#1)(1992-8#1)(1993-8#2)(1995-8#6)(2008-10#1)(2012-2#1)
aldose reductase activity##2##3##(1992-8#2)
aldose reductase and sorbitol dehydrogenase##2##5##(1996-2#2)
aldose reductase and##3##3##(1996-2#2)(2008-1#1)
aldose reductase gene expression##3##4##(1992-8#3)
aldose reductase##12##2##(1992-8#5)(1994-8#1)(1995-5#1)(1996-2#3)(2008-1#1)(2009-11#1)
aldose##13##1##(1992-8#5)(1994-8#1)(1995-5#1)(1996-2#3)(2008-1#1)(2008-10#1)(2009-11#1)
aldosterone synthase##5##2##(1990-11#1)(1990-5#3)(2008-4#1)
aldosterone##24##1##(1990-11#4)(1990-5#4)(1991-12#1)(1992-12#6)(1994-7#1)(1995-12#1)(2008-1#2)(2008-4#4)(2008-8#1)
aldosterone-producing adrenal adenomas and##2##4##(1990-11#2)
aldosterone-producing##3##1##(1990-11#3)
aldosteronism##4##1##(1990-11#3)(2008-4#1)
aldotetrofuranoses##2##1##(1990-9#2)
alemtuzumab for##2##2##(2008-7#1)(2009-12#1)
alemtuzumab##8##1##(2008-12#3)(2008-7#1)(2009-12#4)
alendronate and##3##2##(2008-11#3)
alendronate in##2##2##(2008-10#2)
alendronate use##2##2##(2008-11#2)
alendronate users##4##2##(2008-11#4)
alendronate##32##1##(1995-11#1)(2008-10#9)(2008-11#15)(2008-4#1)(2008-7#1)(2008-8#4)(2010-3#1)
aleophilum##3##1##(2008-10#3)
alert medical##2##2##(1991-8#1)(1996-2#1)
alert the##7##2##(1992-2#1)(2006-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
alert to##4##2##(1997-4#1)(2008-8#1)(2008-9#1)(2010-12#1)
alert##35##1##(1991-12#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-12#1)(1995-12#3)(1996-2#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
alerted to the##3##3##(2008-12#1)(2008-7#1)(2010-8#1)
alerted##4##1##(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
alerting structures##3##2##(1995-6#3)
alerting the doctor##2##3##(1994-3#2)
alerting the##4##2##(1994-3#2)(2008-4#1)(2011-2#1)
alerting##10##1##(1994-3#2)(1995-6#3)(2007-12#1)(2008-4#1)(2011-2#2)(2012-2#1)
alertness related training##2##3##(2013-8#2)
alertness related##3##2##(2013-8#3)
alertness##6##1##(1990-12#1)(2013-8#5)
alerts and##3##2##(1994-2#1)(2007-2#1)(2012-12#1)
alerts##7##1##(1993-12#1)(1994-2#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
aleurone##6##1##(2008-10#3)(2008-8#3)
alexandrite laser##3##2##(2008-3#3)
alexandrite##8##1##(2007-11#2)(2008-2#1)(2008-3#5)
alexia##3##1##(2010-7#3)
alexithymia in##2##2##(2008-11#1)(2008-9#1)
alexithymia##8##1##(2008-11#5)(2008-9#2)(2011-2#1)
alfa administered every 2 weeks##2##5##(2008-7#2)
alfa administered##3##2##(2008-7#3)
alfa and##2##2##(1990-3#1)(2008-7#1)
alfa at a starting dose of 80##2##7##(2008-7#2)
alfa on##2##2##(1991-2#1)(2008-7#1)
alfa was##3##2##(2008-7#3)
alfa##34##1##(1990-3#1)(1991-2#1)(2008-7#30)(2009-5#1)(2009-9#1)
alfalfa (Medicago sativa L##4##4##(2008-11#2)(2011-2#1)(2012-3#1)
alfalfa (Medicago sativa##5##3##(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#1)
alfalfa (Medicago sativa)##4##3##(2008-10#2)(2008-12#2)
alfalfa (Medicago##9##2##(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2011-2#1)(2012-3#1)
alfalfa and##7##2##(2008-10#3)(2008-5#1)(2011-2#3)
alfalfa biomass##4##2##(2008-10#4)
alfalfa leaves##3##2##(2008-10#3)
alfalfa plants##2##2##(2008-10#2)
alfalfa populations##4##2##(2008-10#3)(2012-3#1)
alfalfa rust##2##2##(2008-10#2)
alfalfa stem##2##2##(2008-11#2)
alfalfa witches'-broom##3##2##(2008-10#3)
alfalfa##74##1##(2008-10#47)(2008-11#5)(2008-12#3)(2008-5#6)(2008-6#1)(2008-8#3)(2010-4#1)(2011-2#6)(2012-3#2)
alfalfae##4##1##(2008-10#4)
alfentanil##2##1##(1991-1#1)(2013-7#1)
algC##3##1##(2008-7#3)
algD##4##1##(2008-7#4)
algG##2##1##(2008-7#2)
algR##2##1##(2008-7#2)
alga was##2##2##(2008-10#1)(2008-6#1)
alga##38##1##(1991-12#1)(1992-8#1)(1994-11#3)(2007-7#5)(2008-10#12)(2008-11#6)(2008-12#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-3#1)
algae and the##2##3##(2009-6#1)(2012-2#1)
algae and##7##2##(2007-5#1)(2008-8#2)(2009-6#1)(2012-1#1)(2012-2#2)
algae collected##3##2##(2008-10#3)
algae communities##2##2##(2007-5#2)
algae cover has##2##3##(2008-5#2)
algae extracts##2##2##(2008-11#1)(2010-7#1)
algae from##4##2##(2007-12#1)(2008-11#2)(2008-5#1)
algae in##4##2##(1994-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
algae of##2##2##(2008-10#1)(2009-10#1)
algae samples##6##2##(2008-10#5)(2008-11#1)
algae was##2##2##(2007-5#1)(2008-10#1)
algae were##2##2##(2007-5#1)(2008-10#1)
algae with##2##2##(2008-10#1)(2012-2#1)
algae##82##1##(1990-7#1)(1994-8#1)(2007-12#1)(2007-5#10)(2008-10#23)(2008-11#7)(2008-3#1)(2008-5#8)(2008-7#3)(2008-8#7)(2009-10#1)(2009-4#1)(2009-6#1)(2010-7#2)(2011-10#1)(2011-2#1)(2012-1#2)(2012-2#9)(2013-1#2)
algal biomass##2##2##(2008-10#1)(2008-6#1)
algal production system##3##3##(2012-1#3)
algal##29##1##(1990-12#1)(1990-7#1)(1992-8#2)(1994-11#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#2)(2009-6#1)(2009-8#4)(2010-6#1)(2011-2#2)(2012-1#4)(2012-2#1)
algebra##3##1##(2007-11#1)(2008-3#1)(2008-9#1)
algebraic##13##1##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#5)(2008-7#1)(2009-12#1)
algebraically##2##1##(1992-6#1)(2008-2#1)
alginate complex coacervation system##2##4##(2010-5#2)
alginate genes##3##2##(2008-7#3)
alginate microspheres##3##2##(2008-7#3)
alginate pellet##2##2##(2008-10#2)
alginate pellets##6##2##(2008-10#6)
alginate with snail##2##3##(2008-11#2)
alginate with##3##2##(2008-11#3)
alginate##50##1##(1992-8#1)(2008-10#10)(2008-11#8)(2008-5#1)(2008-6#1)(2008-7#9)(2009-7#1)(2010-5#5)(2011-1#1)(2011-2#8)(2012-1#3)(2012-2#1)(2013-1#1)
alginate/poly-L##4##1##(2008-11#4)
alginates##3##1##(2008-10#3)
alginic acid##3##2##(2008-10#2)(2010-5#1)
alginolyticus is##2##2##(1997-8#2)
alginolyticus##6##1##(1997-8#6)
algodystrophy stage II##2##3##(2006-10#2)
algodystrophy##3##1##(2006-10#2)(2007-8#1)
algorithm (GA)##3##2##(2008-10#1)(2008-3#2)
algorithm allows##2##2##(2007-11#1)(2008-6#1)
algorithm also##2##2##(2008-7#1)(2009-4#1)
algorithm and a##3##3##(2008-3#1)(2008-4#1)(2009-9#1)
algorithm and show##2##3##(2008-3#2)
algorithm and the##4##3##(1992-12#1)(2008-3#3)
algorithm and##33##2##(1992-12#1)(1993-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#15)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
algorithm applied to##2##3##(2008-2#1)(2008-3#1)
algorithm are##11##2##(2008-10#1)(2008-2#5)(2008-3#4)(2008-4#1)
algorithm based on a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
algorithm based on the##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
algorithm based on##16##3##(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#1)
algorithm based##17##2##(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#1)
algorithm by use of##2##4##(2008-2#1)(2008-3#1)
algorithm by using##3##3##(2011-3#2)(2013-8#1)
algorithm by##9##2##(1997-3#1)(2008-2#3)(2008-3#1)(2011-3#2)(2012-3#1)(2013-8#1)
algorithm can be used with##2##5##(2008-2#1)(2008-3#1)
algorithm can be used##3##4##(2008-2#2)(2008-3#1)
algorithm can be##7##3##(1997-2#1)(2007-11#1)(2008-2#3)(2008-3#1)(2012-2#1)
algorithm can##10##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
algorithm does not##3##3##(2007-12#1)(2008-2#1)(2009-12#1)
algorithm for designing the##2##4##(2008-2#1)(2008-3#1)
algorithm for designing##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
algorithm for estimating the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
algorithm for extraction of##2##4##(2008-2#2)
algorithm for hyperspectral##3##3##(2008-3#3)
algorithm for integrating##2##3##(2008-2#1)(2010-7#1)
algorithm for management of##2##4##(2008-4#1)(2013-1#1)
algorithm for management##3##3##(2008-4#1)(2013-1#2)
algorithm for multiple##2##3##(2012-2#2)
algorithm for phase retrieval##2##4##(2008-2#1)(2008-8#1)
algorithm for reconstructing the##2##4##(2008-3#2)
algorithm for reconstructing##3##3##(2007-11#1)(2008-3#2)
algorithm for retrieving the##2##4##(2008-2#1)(2008-3#1)
algorithm for retrieving##3##3##(2008-2#2)(2008-3#1)
algorithm for solving##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
algorithm for the design of diffractive##2##6##(2007-11#1)(2008-2#1)
algorithm for the simultaneous##2##4##(2008-2#1)(2008-4#1)
algorithm for the##22##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#3)(2008-4#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-3#1)(2013-1#2)
algorithm for training##2##3##(2008-2#1)(2010-8#1)
algorithm for##119##2##(1993-8#1)(1997-7#1)(2007-11#6)(2007-12#4)(2008-10#6)(2008-12#1)(2008-2#29)(2008-3#36)(2008-4#2)(2008-6#1)(2008-8#3)(2009-12#2)(2009-4#1)(2009-9#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#3)(2011-3#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
algorithm has been applied##2##4##(2007-12#1)(2008-10#1)
algorithm has been developed for the##3##6##(2008-10#1)(2008-3#2)
algorithm has been developed to##2##5##(2008-2#1)(2008-3#1)
algorithm has been developed##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
algorithm has been##12##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2010-8#2)
algorithm has##16##2##(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#6)(2010-4#1)(2010-8#2)
algorithm in conjunction with the first##2##6##(2008-2#2)
algorithm in order##2##3##(2008-3#1)(2010-8#1)
algorithm in the##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
algorithm in which the##2##4##(2007-11#1)(2008-3#1)
algorithm in##18##2##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2009-12#1)(2010-8#2)(2012-12#1)(2012-2#3)(2013-1#1)
algorithm include##2##2##(2008-2#2)
algorithm includes##3##2##(2008-3#1)(2008-9#1)(2011-1#1)
algorithm including##2##2##(2011-2#1)(2013-8#1)
algorithm is able to##2##4##(2008-3#1)(2009-12#1)
algorithm is adopted##2##3##(2008-2#2)
algorithm is also##2##3##(2008-2#1)(2008-3#1)
algorithm is applied to a##3##5##(1995-2#1)(2008-2#1)(2012-1#1)
algorithm is applied to##9##4##(1995-2#1)(2008-2#3)(2008-3#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-1#1)
algorithm is applied##12##3##(1995-2#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-1#1)
algorithm is based on a##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
algorithm is based on the##6##5##(2008-10#1)(2008-2#1)(2008-3#3)(2011-3#1)
algorithm is based on##13##4##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#6)(2011-3#1)
algorithm is compared to##2##4##(2008-6#1)(2012-1#1)
algorithm is compared with##3##4##(2008-3#1)(2009-9#1)(2010-8#1)
algorithm is compared##5##3##(2008-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2012-1#1)
algorithm is demonstrated by##2##4##(2008-3#2)
algorithm is demonstrated on##2##4##(2007-7#1)(2008-3#1)
algorithm is demonstrated##6##3##(2007-12#1)(2007-7#1)(2008-3#4)
algorithm is described##4##3##(2008-2#1)(2008-3#3)
algorithm is developed to##3##4##(2008-3#3)
algorithm is developed##6##3##(2008-2#1)(2008-3#3)(2009-4#1)(2013-1#1)
algorithm is evaluated through##2##4##(2008-2#1)(2008-3#1)
algorithm is evaluated##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
algorithm is extended##2##3##(2008-3#2)
algorithm is found to##2##4##(2008-2#1)(2008-3#1)
algorithm is implemented##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
algorithm is introduced that##2##4##(2007-11#1)(2008-3#1)
algorithm is investigated by##3##4##(2008-2#1)(2008-3#2)
algorithm is more##2##3##(2009-9#1)(2012-3#1)
algorithm is presented for##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
algorithm is presented##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
algorithm is proposed for##2##4##(2008-10#1)(2008-3#1)
algorithm is proposed to##2##4##(2008-10#1)(2008-8#1)
algorithm is proposed##6##3##(2008-10#2)(2008-3#3)(2008-8#1)
algorithm is tested on##2##4##(2008-3#1)(2013-8#1)
algorithm is tested##3##3##(2008-3#1)(2009-12#1)(2013-8#1)
algorithm is that##2##3##(2008-3#2)
algorithm is then##2##3##(2008-3#1)(2009-10#1)
algorithm is used for##2##4##(2008-3#2)
algorithm is used to determine##2##5##(2007-11#1)(2008-3#1)
algorithm is used to##5##4##(2007-11#1)(2008-3#4)
algorithm is used##8##3##(2007-11#1)(2008-3#6)(2008-6#1)
algorithm is##124##2##(1995-2#1)(2007-11#7)(2007-12#1)(2007-7#2)(2008-10#10)(2008-2#22)(2008-3#53)(2008-6#6)(2008-8#1)(2009-10#2)(2009-12#3)(2009-4#1)(2009-9#2)(2010-8#3)(2011-1#2)(2011-3#1)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#2)
algorithm itself##2##2##(2008-3#2)
algorithm may##2##2##(2011-1#1)(2012-1#1)
algorithm of##8##2##(2008-10#2)(2008-3#2)(2009-4#1)(2013-1#2)(2013-8#1)
algorithm on the##2##3##(2008-2#1)(2013-1#1)
algorithm on##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
algorithm places rectangles##2##3##(2008-6#2)
algorithm requires##4##2##(2008-3#3)(2013-8#1)
algorithm series##2##2##(2008-3#2)
algorithm successfully##2##2##(2008-2#2)
algorithm that combines##2##3##(2011-1#1)(2013-8#1)
algorithm that compensates##2##3##(2008-2#2)
algorithm that incorporates##2##3##(2009-4#1)(2012-2#1)
algorithm that is##3##3##(2008-3#3)
algorithm that permits##2##3##(2008-2#1)(2008-3#1)
algorithm that uses##3##3##(2008-2#1)(2008-3#2)
algorithm that##33##2##(1997-3#1)(2007-11#1)(2008-2#6)(2008-3#16)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
algorithm then##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
algorithm to analyze##2##3##(2008-2#1)(2010-8#1)
algorithm to be##3##3##(2008-2#1)(2008-6#1)(2010-9#1)
algorithm to compute##2##3##(2008-2#1)(2009-12#1)
algorithm to detect##2##3##(2008-10#1)(2008-3#1)
algorithm to determine the##2##4##(1997-3#1)(2007-12#1)
algorithm to determine##3##3##(1997-3#1)(2007-12#1)(2008-2#1)
algorithm to estimate the##2##4##(2008-2#1)(2012-3#1)
algorithm to estimate##3##3##(2008-2#2)(2012-3#1)
algorithm to make##2##3##(2011-3#1)(2013-1#1)
algorithm to reconstruct##2##3##(2007-11#1)(2008-3#1)
algorithm to##47##2##(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#12)(2008-3#12)(2008-6#2)(2008-7#1)(2009-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
algorithm used in##2##3##(2008-2#1)(2008-3#1)
algorithm used to##3##3##(2008-2#2)(2008-3#1)
algorithm used##8##2##(2008-10#1)(2008-2#3)(2008-3#3)(2010-4#1)
algorithm uses##6##2##(2008-2#3)(2008-3#3)
algorithm was applied to##5##4##(2008-3#3)(2008-7#1)(2009-6#1)
algorithm was applied##6##3##(2008-10#1)(2008-3#3)(2008-7#1)(2009-6#1)
algorithm was developed##3##3##(1994-2#1)(2008-12#1)(2008-3#1)
algorithm was employed to##2##4##(2008-10#2)
algorithm was tested##2##3##(2008-3#2)
algorithm was used for##2##4##(2008-10#1)(2010-4#1)
algorithm was used to##4##4##(2008-10#3)(2008-3#1)
algorithm was used##8##3##(2008-10#4)(2008-3#3)(2010-4#1)
algorithm was##26##2##(1994-2#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#9)(2008-7#1)(2009-6#1)(2010-4#1)(2010-8#1)(2013-8#1)
algorithm were used##2##3##(2008-10#1)(2008-2#1)
algorithm were##4##2##(2008-10#3)(2008-2#1)
algorithm which##4##2##(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)
algorithm with the ability to##2##5##(2008-3#1)(2011-1#1)
algorithm with the##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
algorithm with##13##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2010-12#1)(2011-1#1)(2013-8#1)
algorithm yields##3##2##(2008-2#2)(2011-2#1)
algorithm##815##1##(1992-12#2)(1993-11#1)(1993-8#1)(1994-2#1)(1995-2#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#1)(2007-11#29)(2007-12#28)(2007-7#2)(2007-9#3)(2008-10#70)(2008-11#3)(2008-12#3)(2008-2#149)(2008-3#288)(2008-4#5)(2008-6#30)(2008-7#15)(2008-8#7)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#15)(2009-2#1)(2009-4#5)(2009-6#3)(2009-8#1)(2009-9#8)(2010-12#1)(2010-2#2)(2010-4#6)(2010-7#3)(2010-8#20)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#8)(2011-3#6)(2012-1#7)(2012-12#1)(2012-2#17)(2012-3#11)(2013-1#13)(2013-8#13)
algorithm's##5##1##(2008-2#3)(2008-3#1)(2008-8#1)
algorithm-based##2##1##(2007-12#1)(2008-2#1)
algorithmic##5##1##(1991-12#2)(2008-10#1)(2008-6#1)(2009-10#1)
algorithms and provides##2##3##(2008-3#1)(2008-9#1)
algorithms and##15##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#7)(2008-7#2)(2008-9#1)(2013-1#1)
algorithms are applied to##2##4##(2008-3#2)
algorithms are derived##2##3##(2008-2#1)(2012-1#1)
algorithms are presented##3##3##(2008-2#1)(2010-9#1)(2011-1#1)
algorithms are##19##2##(2007-11#1)(2008-2#5)(2008-3#7)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
algorithms based on##2##3##(1996-4#1)(2008-2#1)
algorithms based##3##2##(1996-4#1)(2008-2#1)(2008-7#1)
algorithms can be##4##3##(2008-3#3)(2010-2#1)
algorithms can##8##2##(2008-2#1)(2008-3#4)(2008-7#1)(2010-2#1)(2013-8#1)
algorithms described##2##2##(2008-3#1)(2008-9#1)
algorithms for data reduction##2##4##(2007-12#1)(2008-3#1)
algorithms for data##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
algorithms for different##2##3##(2008-3#2)
algorithms for estimating##2##3##(2008-3#2)
algorithms for##42##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#17)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
algorithms from##2##2##(2008-2#1)(2008-6#1)
algorithms have been##3##3##(2009-9#1)(2010-2#1)(2010-8#1)
algorithms have##5##2##(2008-3#1)(2009-9#1)(2010-2#2)(2010-8#1)
algorithms is##5##2##(2008-3#3)(2008-7#1)(2010-5#1)
algorithms may##2##2##(2008-9#1)(2012-2#1)
algorithms of the##2##3##(1994-3#1)(2008-3#1)
algorithms of##5##2##(1994-3#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
algorithms should##2##2##(2007-12#1)(2008-11#1)
algorithms show##3##2##(1996-1#1)(2008-3#2)
algorithms that have##2##3##(2008-3#1)(2008-6#1)
algorithms that use##3##3##(2008-3#2)(2010-9#1)
algorithms that##9##2##(2007-12#1)(2008-3#5)(2008-6#1)(2010-9#1)(2012-2#1)
algorithms to##11##2##(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#5)(2009-2#1)(2010-2#1)
algorithms used to##2##3##(2008-3#2)
algorithms used##4##2##(2008-3#2)(2008-4#1)(2008-9#1)
algorithms using##2##2##(1994-2#1)(2007-11#1)
algorithms utilize##2##2##(2008-3#2)
algorithms were used##2##3##(2008-2#1)(2009-11#1)
algorithms were##3##2##(2008-2#1)(2008-7#1)(2009-11#1)
algorithms with##2##2##(2008-3#2)
algorithms##236##1##(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#25)(2008-3#81)(2008-4#2)(2008-6#13)(2008-7#12)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-9#4)(2010-10#1)(2010-12#1)(2010-2#9)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
algorithms)##2##1##(2008-10#1)(2010-12#1)
alia##3##1##(1990-12#1)(2008-11#1)(2008-3#1)
aliased##2##1##(2008-2#2)
aliasing##4##1##(2007-11#1)(2008-3#3)
alien Thinopyrum##2##2##(2008-5#2)
alien addition line##2##3##(2008-8#2)
alien additional line##2##3##(2008-9#2)
alien chromosome##5##2##(2008-10#1)(2008-5#4)
alien##20##1##(2008-10#4)(2008-5#9)(2008-8#4)(2008-9#2)(2013-1#1)
alienated##3##1##(1991-1#1)(2008-4#1)(2009-10#1)
alienation##2##1##(2008-9#1)(2012-1#1)
align the##4##2##(1992-1#1)(1994-3#1)(2008-3#1)(2013-1#1)
align their##2##2##(2008-3#2)
align to##2##2##(2008-11#1)(2012-3#1)
align with##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
align##29##1##(1992-1#1)(1992-3#1)(1993-1#1)(1994-3#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
aligned and##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
aligned by##2##2##(2008-3#1)(2009-10#1)
aligned in the##2##3##(2008-2#1)(2008-9#1)
aligned in##4##2##(1991-5#1)(2008-2#2)(2008-9#1)
aligned on##3##2##(1995-6#1)(2008-2#1)(2008-6#1)
aligned parallel##2##2##(2007-12#1)(2008-3#1)
aligned to##3##2##(1997-2#1)(2008-3#1)(2011-2#1)
aligned with the##7##3##(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)
aligned with##14##2##(1993-6#1)(1994-8#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)
aligned##90##1##(1991-5#1)(1992-11#1)(1993-6#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-1#1)(1997-2#1)(2007-11#2)(2007-12#6)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#11)(2008-4#3)(2008-6#3)(2008-7#13)(2008-9#4)(2009-10#1)(2009-12#1)(2009-9#4)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#6)(2013-1#7)
aligners##3##1##(2008-3#1)(2013-1#2)
aligning forces for quality initiative##4##5##(2013-1#4)
aligning forces##5##2##(2013-1#5)
aligning##15##1##(1995-1#1)(2008-3#2)(2008-4#4)(2010-10#1)(2011-2#2)(2013-1#5)
alignment and adjustment##6##3##(2008-4#4)(2008-9#2)
alignment and##19##2##(1993-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-9#2)(2009-3#1)(2013-1#3)
alignment at##2##2##(2008-4#1)(2011-2#1)
alignment between##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
alignment errors and##2##3##(2008-2#1)(2008-3#1)
alignment errors##4##2##(2008-2#1)(2008-3#3)
alignment for##6##2##(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
alignment in##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
alignment is##7##2##(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
alignment layer##4##2##(2008-10#4)
alignment method##2##2##(2008-3#1)(2012-2#1)
alignment of nucleotide##2##3##(2008-10#1)(2008-9#1)
alignment of polyaniline nanofibres##2##4##(2008-7#2)
alignment of the##24##3##(1992-9#1)(1993-12#1)(1994-2#1)(1994-8#1)(1997-4#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#2)(2011-1#1)(2013-8#1)
alignment of##55##2##(1991-3#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#6)(2007-12#3)(2008-10#6)(2008-2#3)(2008-3#5)(2008-4#3)(2008-7#6)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
alignment on##2##2##(2008-3#1)(2013-1#1)
alignment or##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
alignment parameters##2##2##(2007-11#1)(2013-1#1)
alignment perturbations##2##2##(2013-1#2)
alignment procedure is##3##3##(2008-2#2)(2008-3#1)
alignment procedure##5##2##(2008-2#3)(2008-3#2)
alignment revealed##3##2##(1993-8#1)(2008-10#1)(2011-1#1)
alignment technique##4##2##(2007-11#1)(2008-3#2)(2009-8#1)
alignment techniques##2##2##(2008-4#1)(2008-7#1)
alignment tolerance##4##2##(2008-2#3)(2008-3#1)
alignment tolerances##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
alignment tools##2##2##(2010-9#1)(2012-2#1)
alignment was##2##2##(2009-3#1)(2013-1#1)
alignment with a##2##3##(1995-12#1)(2013-1#1)
alignment with##4##2##(1995-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
alignment##232##1##(1991-3#2)(1991-6#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#2)(2007-11#13)(2007-12#12)(2008-10#19)(2008-12#2)(2008-2#22)(2008-3#38)(2008-4#22)(2008-7#8)(2008-8#1)(2008-9#12)(2009-12#1)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#30)(2013-8#4)
alignment-sensing scheme for##2##3##(2008-2#2)
alignments and##4##2##(2008-4#3)(2008-9#1)
alignments of##5##2##(1994-6#1)(1995-3#1)(2008-4#1)(2008-9#1)(2009-9#1)
alignments that##2##2##(2008-9#1)(2011-3#1)
alignments with##2##2##(2008-4#2)
alignments##27##1##(1994-6#1)(1995-3#1)(2008-10#1)(2008-4#8)(2008-7#2)(2008-9#5)(2009-4#1)(2009-9#1)(2010-4#1)(2011-3#4)(2013-1#1)(2013-8#1)
aligns##4##1##(1994-3#1)(1995-2#1)(1997-1#1)(1997-3#1)
alike are##2##2##(1994-6#1)(2010-12#1)
alike to##2##2##(2008-10#1)(2008-11#1)
alike##24##1##(1991-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
alimentary canal##3##2##(2008-10#1)(2008-7#2)
alimentary tract##4##2##(2008-5#2)(2009-9#1)(2011-2#1)
alimentary##14##1##(2008-10#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-9#1)(2011-2#1)(2013-7#1)
alimentation##2##1##(2008-12#2)
aliphatic alcohols is##2##3##(2008-10#2)
aliphatic alcohols##8##2##(1990-5#1)(1996-5#1)(2007-11#1)(2008-10#5)
aliphatic amine##2##2##(2007-12#1)(2008-4#1)
aliphatic amines at##2##3##(2008-10#2)
aliphatic amines in##7##3##(2008-10#7)
aliphatic amines##18##2##(2007-12#1)(2008-10#17)
aliphatic amino##2##2##(1994-8#1)(2008-5#1)
aliphatic and aromatic##3##3##(1996-5#1)(2008-10#2)
aliphatic and##4##2##(1996-5#1)(2008-10#3)
aliphatic hydrocarbons##4##2##(2008-11#4)
aliphatic nitriles##2##2##(2012-3#2)
aliphatic##66##1##(1990-5#1)(1992-3#2)(1994-2#1)(1994-8#3)(1995-3#1)(1995-9#1)(1996-5#8)(2007-11#1)(2007-12#2)(2008-10#31)(2008-11#5)(2008-4#2)(2008-5#1)(2009-10#1)(2009-5#1)(2010-4#1)(2012-3#4)
aliquot and##2##2##(2008-10#2)
aliquot mixed with##2##3##(2008-10#2)
aliquot of a##2##3##(2008-10#1)(2008-11#1)
aliquot of the##6##3##(2008-10#6)
aliquot of##14##2##(2008-10#13)(2008-11#1)
aliquot##24##1##(2008-10#21)(2008-11#1)(2008-12#1)(2008-8#1)
aliquot)##2##1##(2008-10#1)(2009-6#1)
aliquoted##2##1##(1990-12#1)(2008-8#1)
aliquots of this##2##3##(2008-10#2)
aliquots of##8##2##(1995-2#1)(1996-2#1)(2008-10#5)(2008-11#1)
aliquots were##2##2##(1992-1#1)(1994-3#1)
aliquots##20##1##(1992-1#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-9#1)
alive 8##2##2##(1990-8#1)(2007-5#1)
alive after##2##2##(2008-7#1)(2011-2#1)
alive and disease free at##2##5##(1991-8#1)(1992-5#1)
alive and well##5##3##(1994-12#1)(1995-1#1)(2007-8#1)(2008-6#1)(2013-1#1)
alive and##14##2##(1991-6#1)(1991-8#2)(1992-5#1)(1994-12#1)(1995-1#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
alive at the end of the study##2##7##(2008-6#1)(2011-2#1)
alive at the##3##3##(2008-6#1)(2010-3#1)(2011-2#1)
alive at##9##2##(1991-8#1)(1992-9#1)(1994-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
alive but##2##2##(1992-6#1)(1994-5#1)
alive for##3##2##(1991-2#1)(2008-10#1)(2013-8#1)
alive in##3##2##(1992-9#1)(1997-2#1)(2009-4#1)
alive today##2##2##(1990-9#1)(2013-8#1)
alive with no evidence of disease##4##6##(2007-5#1)(2008-10#1)(2008-6#2)
alive with##7##2##(2007-5#1)(2008-10#1)(2008-6#3)(2011-2#1)(2012-12#1)
alive without evidence of disease##2##5##(1990-2#2)
alive without##4##2##(1990-2#2)(2010-1#1)(2012-12#1)
alive##76##1##(1990-2#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-2#1)(1991-6#1)(1991-8#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-4#1)(2008-6#6)(2008-7#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#10)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#2)
alizarin red S##4##3##(2008-10#2)(2013-7#2)
alizarin##7##1##(2008-10#5)(2013-7#2)
alk1##3##1##(1991-9#3)
alk2##3##1##(1991-9#3)
alkali aluminosilicate glasses##2##3##(2008-3#2)
alkali and alkali-earth metal salts##2##5##(2008-10#2)
alkali and alkaline earth metal cations is##2##7##(2008-10#2)
alkali and alkaline earth metal cations##4##6##(2008-10#4)
alkali and alkaline earth metal ions##3##6##(2008-10#3)
alkali and alkaline earth metal##9##5##(2008-10#9)
alkali and alkaline earth metals and##2##6##(2008-10#2)
alkali and alkaline earth##13##4##(2008-10#13)
alkali and alkaline earths##3##4##(2008-10#3)
alkali and alkaline##17##3##(2008-10#17)
alkali and##20##2##(1992-6#1)(2008-10#19)
alkali earth##2##2##(2008-10#2)
alkali light chain##2##3##(1993-9#2)
alkali metal cations##4##3##(2008-10#4)
alkali metal ion##2##3##(2008-10#2)
alkali metal ions##7##3##(2008-10#6)(2012-2#1)
alkali metal picrates##6##3##(2008-10#6)
alkali metal##27##2##(2008-10#23)(2008-2#2)(2012-2#2)
alkali metals and##3##3##(2008-10#3)
alkali metals##5##2##(1997-7#1)(2008-10#4)
alkali or alkaline earth##3##4##(2007-11#1)(2008-10#2)
alkali or##4##2##(2007-11#1)(2008-10#3)
alkali solution##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
alkali treatment##3##2##(1992-6#2)(2008-2#1)
alkali##106##1##(1992-6#3)(1992-8#1)(1993-9#2)(1994-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#83)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2012-2#2)(2013-8#2)
alkali-labile##5##1##(1991-3#2)(1993-11#1)(1996-2#1)(2008-4#1)
alkali-metal##2##1##(1997-7#2)
alkaline and acid##2##3##(1993-11#1)(2009-7#1)
alkaline and alkaline-earth metals##2##4##(2008-10#2)
alkaline and alkaline-earth##3##3##(2008-10#3)
alkaline and transition metal ions##2##5##(2008-10#2)
alkaline and transition##3##3##(2008-10#3)
alkaline and##10##2##(1990-11#1)(1993-11#1)(2008-10#7)(2009-7#1)
alkaline aqueous solution##2##3##(1992-3#1)(2008-10#1)
alkaline buffer solution##2##3##(2008-10#2)
alkaline buffer##3##2##(2008-10#2)(2008-7#1)
alkaline cations##2##2##(2008-10#2)
alkaline comet assay##4##3##(1997-4#4)
alkaline conditions (pH##2##3##(1991-7#1)(2008-10#1)
alkaline conditions##13##2##(1991-7#1)(1993-11#1)(1995-3#1)(1995-8#1)(1996-5#2)(2008-10#5)(2008-11#1)(2008-6#1)
alkaline earth and other transition metal cations##2##7##(2008-10#2)
alkaline earth and##8##3##(2008-10#6)(2009-7#1)(2010-11#1)
alkaline earth ions##2##3##(2007-11#1)(2008-10#1)
alkaline earth metal cations##6##4##(2008-10#6)
alkaline earth metal ions##5##4##(2008-10#5)
alkaline earth metal##15##3##(2008-10#15)
alkaline earth metals##8##3##(2008-10#8)
alkaline earth##52##2##(2007-11#1)(2008-10#49)(2009-7#1)(2010-11#1)
alkaline elution##4##2##(1992-3#1)(1993-12#2)(1994-8#1)
alkaline extraction##3##2##(1991-9#1)(1992-8#1)(2008-6#1)
alkaline fusion and##2##3##(2008-10#2)
alkaline hydrolysis and##2##3##(1991-12#1)(2008-11#1)
alkaline hydrolysis of##3##3##(2008-10#3)
alkaline hydrolysis##10##2##(1991-12#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-4#1)
alkaline hydrothermal conversion of the##2##5##(2008-10#2)
alkaline hydrothermal conversion of##3##4##(2008-10#3)
alkaline media##9##2##(1995-8#1)(2008-10#8)
alkaline medium was##2##3##(2008-10#2)
alkaline medium##31##2##(2008-10#31)
alkaline metal##2##2##(2008-10#2)
alkaline metals##3##2##(2008-10#3)
alkaline pH and##2##3##(1990-7#2)
alkaline pH##15##2##(1990-7#2)(1992-6#1)(1993-6#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
alkaline phosphatase (ALP##2##3##(1991-5#1)(2008-10#1)
alkaline phosphatase (ALP) activity##2##4##(2008-10#1)(2008-11#1)
alkaline phosphatase (ALP)##14##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#3)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#2)
alkaline phosphatase (AP) was##2##4##(1995-12#1)(2008-11#1)
alkaline phosphatase (AP)##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
alkaline phosphatase (SEAP)##4##3##(2008-11#2)(2008-7#1)(2011-2#1)
alkaline phosphatase activity and##2##4##(2008-10#1)(2012-4#1)
alkaline phosphatase activity##12##3##(1994-12#1)(2008-10#3)(2008-11#4)(2008-5#2)(2012-4#1)(2013-1#1)
alkaline phosphatase and##6##3##(1991-4#1)(1993-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
alkaline phosphatase as##4##3##(1992-11#1)(1995-11#1)(1995-2#1)(2008-11#1)
alkaline phosphatase in##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2009-5#1)
alkaline phosphatase isoenzymes##2##3##(1991-5#1)(1992-6#1)
alkaline phosphatase levels##2##3##(1991-8#1)(1992-3#1)
alkaline phosphatase was##2##3##(1993-6#1)(2008-10#1)
alkaline phosphatase were##2##3##(1991-10#1)(1994-11#1)
alkaline phosphatase##124##2##(1990-12#2)(1990-5#1)(1990-6#2)(1991-10#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-5#4)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#5)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#8)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(2007-12#1)(2008-10#20)(2008-11#14)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#6)(2013-8#1)
alkaline protease##5##2##(2008-11#1)(2008-5#1)(2008-6#3)
alkaline proteinase##2##2##(1992-9#2)
alkaline salts##2##2##(1997-2#1)(2008-10#1)
alkaline side##2##2##(1994-3#1)(2008-9#1)
alkaline single-cell gel electrophoresis##2##4##(1997-4#2)
alkaline solution##18##2##(1995-11#1)(1995-3#1)(1995-6#1)(2008-10#14)(2008-8#1)
alkaline solutions##6##2##(1995-2#1)(2008-10#5)
alkaline treatment of the##2##4##(1991-10#1)(2008-10#1)
alkaline treatment##3##2##(1991-10#1)(2008-10#1)(2013-1#1)
alkaline##406##1##(1990-11#3)(1990-12#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#3)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-3#7)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#10)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#2)(1996-5#2)(1997-2#1)(1997-4#9)(2007-11#1)(2007-12#1)(2008-10#196)(2008-11#22)(2008-4#9)(2008-5#8)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#9)(2009-5#1)(2009-7#3)(2009-9#1)(2010-11#1)(2010-4#2)(2011-1#4)(2011-2#3)(2012-1#3)(2012-2#3)(2012-3#1)(2012-4#2)(2013-1#11)(2013-8#4)
alkaline-earth metals##5##2##(2008-10#5)
alkaline-earth##6##1##(2008-10#6)
alkaline-labile##2##1##(1990-11#1)(2008-10#1)
alkalinisation##3##1##(1991-12#1)(2013-1#2)
alkalinity and##3##2##(2012-2#2)(2013-1#1)
alkalinity##7##1##(2008-10#1)(2012-2#2)(2013-1#1)(2013-8#3)
alkalinization of##3##2##(1990-11#1)(1992-12#1)(1994-6#1)
alkalinization with##2##2##(2007-7#1)(2008-10#1)
alkalinization##12##1##(1990-11#1)(1990-12#2)(1990-2#2)(1992-12#1)(1994-6#1)(2007-7#1)(2008-10#1)(2013-1#1)(2013-8#2)
alkalinized##2##1##(2008-10#1)(2011-3#1)
alkaloid concentration##2##2##(2007-1#2)
alkaloid salts##3##2##(2008-10#3)
alkaloid which##2##2##(1994-8#1)(2008-7#1)
alkaloid##34##1##(1993-8#2)(1994-12#1)(1994-8#3)(1995-11#2)(1996-12#1)(1997-2#1)(1997-4#1)(2007-1#3)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#1)
alkaloids and##6##2##(2007-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-3#1)(2013-8#1)
alkaloids from##3##2##(1994-12#1)(2007-11#1)(2008-10#1)
alkaloids in##3##2##(2008-10#2)(2008-11#1)
alkaloids were separated##2##3##(2008-10#2)
alkaloids were##8##2##(2007-11#1)(2008-10#7)
alkaloids with the lycoctonine skeleton##2##5##(2007-11#2)
alkaloids with##3##2##(2007-11#2)(2013-8#1)
alkaloids##54##1##(1994-12#3)(1995-12#1)(1995-5#2)(2007-1#1)(2007-11#7)(2008-10#21)(2008-11#1)(2008-12#2)(2008-7#2)(2009-11#2)(2010-7#1)(2011-3#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
alkalosis##3##1##(1996-6#1)(1997-8#1)(2007-7#1)
alkane monooxygenase##2##2##(1994-12#2)
alkane##9##1##(1991-9#2)(1993-11#1)(1994-12#3)(1996-3#1)(2010-12#1)(2011-1#1)
alkane-inducible##3##1##(1991-9#2)(1993-12#1)
alkanes##2##1##(2007-11#1)(2008-10#1)
alkavinone is##2##2##(1994-5#2)
alkavinone##4##1##(1994-5#4)
alkene 4##3##2##(1996-5#3)
alkene group##3##2##(1996-5#1)(2009-10#2)
alkene##11##1##(1996-5#6)(2007-11#2)(2008-7#1)(2009-10#2)
alkenes##4##1##(2007-11#2)(2009-8#1)(2012-3#1)
alkenyl halides##2##2##(2009-5#1)(2010-5#1)
alkenyl triflates##2##2##(2010-5#2)
alkenyl##4##1##(2009-5#1)(2010-5#3)
alkoxide complexes##2##2##(1997-7#2)
alkoxide##5##1##(1997-7#4)(2012-12#1)
alkoxyl##2##1##(1996-5#1)(2008-10#1)
alkoxyresorufin O-dealkylation##2##2##(1994-8#2)
alkoxyresorufin##3##1##(1994-8#2)(2008-11#1)
alkoxyresorufins##2##1##(1994-8#2)
alkoxysilanes##2##1##(2008-5#1)(2010-12#1)
alkyl alcohols##3##2##(2009-8#3)
alkyl chain of##2##3##(1995-11#1)(2008-10#1)
alkyl chain##9##2##(1990-11#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-5#2)
alkyl chains of##2##3##(2008-5#2)
alkyl chains##5##2##(2008-10#1)(2008-5#3)(2011-2#1)
alkyl esters##2##2##(1995-2#1)(2008-7#1)
alkyl ether##2##2##(2008-10#1)(2008-5#1)
alkyl groups at the##2##4##(1994-12#1)(2008-11#1)
alkyl groups##5##2##(1994-12#1)(2008-10#1)(2008-11#2)(2008-4#1)
alkyl halides##3##2##(2007-11#1)(2011-1#2)
alkyl lactate##2##2##(2008-5#2)
alkyl radical##2##2##(1996-5#1)(2009-5#1)
alkyl side chains##2##3##(1995-3#1)(2008-10#1)
alkyl tails##2##2##(2008-10#1)(2011-2#1)
alkyl##70##1##(1990-11#2)(1994-12#1)(1995-11#3)(1995-2#1)(1995-3#5)(1996-5#1)(2007-11#4)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#13)(2008-7#1)(2009-5#2)(2009-8#4)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-2#4)(2013-8#1)
alkyl-diol silica (ADS) precolumn##2##4##(2008-10#2)
alkyl-diol##3##1##(2008-10#3)
alkylacylglycerol##3##1##(1992-8#3)
alkylamine)##2##1##(1995-6#1)(2008-7#1)
alkylamino derivatives##2##2##(2007-11#2)
alkylammonium cations over##2##3##(2008-10#2)
alkylammonium cations##4##2##(2008-10#4)
alkylammonium##5##1##(2008-10#5)
alkylate##2##1##(1992-11#1)(2008-11#1)
alkylated##2##1##(1994-8#1)(2007-11#1)
alkylating activity##2##2##(2008-4#2)
alkylating agent##4##2##(1995-12#1)(1995-8#1)(2010-12#1)(2011-2#1)
alkylating agents and##2##3##(1992-11#1)(2008-11#1)
alkylating agents##13##2##(1992-11#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-5#2)(2010-3#1)
alkylating##25##1##(1992-11#1)(1995-12#1)(1995-8#2)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-4#2)(2008-5#2)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#1)
alkylation of beta-dicarbonyl compounds##2##4##(2007-11#2)
alkylation of##7##2##(1994-8#1)(2007-11#3)(2008-10#1)(2009-9#2)
alkylation##20##1##(1992-11#3)(1993-11#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#2)(2010-7#1)
alkylations##2##1##(1996-3#1)(1997-3#1)
alkylator##2##1##(2010-11#1)(2010-4#1)
alkylators##3##1##(1996-3#1)(2010-4#1)(2013-1#1)
alkyldibenzylamines as neutral carriers##2##4##(2008-10#2)
alkylic##2##1##(2008-10#2)
alkylphenols and pesticides were##2##4##(2008-10#2)
alkylphenols and pesticides##3##3##(2008-10#3)
alkylphenols for##2##2##(2008-11#2)
alkylphenols in##6##2##(2008-10#5)(2008-11#1)
alkylphenols##14##1##(2008-10#10)(2008-11#4)
alkylresorcinol##2##1##(2008-11#2)
alkylresorcinols##6##1##(2008-11#6)
alkyltransferase (AGT)##2##2##(1995-5#1)(2008-5#1)
alkyltransferase##7##1##(1992-8#3)(1993-11#1)(1995-5#2)(2008-5#1)
alkyltrimethylammonium cations##2##2##(2008-10#2)
alkyltrimethylammonium surfactants##2##2##(2008-10#2)
alkyltrimethylammonium##4##1##(2008-10#4)
alkyne and diyne co-reactants led to 1##2##7##(2012-3#2)
alkyne##9##1##(1995-3#1)(1997-7#1)(2009-12#1)(2010-2#2)(2010-7#2)(2012-3#2)
alkynes##2##1##(2010-7#1)(2012-2#1)
alkynyl##4##1##(2008-4#2)(2009-11#2)
all &quot##5##2##(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2011-2#1)
all 10##9##2##(1991-1#1)(1991-5#2)(1991-9#1)(2008-10#3)(2008-9#1)(2011-2#1)
all 11 isolates that were##2##5##(2008-10#2)
all 11##4##2##(2008-10#3)(2013-1#1)
all 12##5##2##(1990-5#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
all 13##4##2##(2008-10#2)(2009-2#1)(2009-7#1)
all 14##4##2##(1992-4#1)(1996-12#1)(2007-11#1)(2008-10#1)
all 15##6##2##(1990-5#1)(2008-10#2)(2008-12#2)(2010-12#1)
all 16 elements of the##2##5##(2007-12#1)(2008-3#1)
all 16 elements of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
all 16##5##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
all 18##2##2##(2006-10#1)(2009-10#1)
all 19##2##2##(2008-10#1)(2010-3#1)
all 20##2##2##(1993-8#1)(2008-6#1)
all 23##2##2##(2009-2#1)(2012-3#1)
all 24##5##2##(2008-1#1)(2008-10#1)(2008-7#2)(2010-1#1)
all 25##2##2##(2011-2#1)(2012-3#1)
all 3 years##2##3##(2008-10#2)
all 3##14##2##(1991-5#1)(1992-8#1)(1996-11#1)(1996-6#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
all 4##6##2##(2008-1#1)(2008-11#1)(2012-3#3)(2013-8#1)
all 40##2##2##(2008-10#1)(2008-12#1)
all 45##2##2##(1996-3#1)(2008-10#1)
all 5 patients##2##3##(2007-10#1)(2008-1#1)
all 5##10##2##(1990-6#1)(1991-8#1)(1994-11#1)(2007-10#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-6#1)
all 6 patients with##2##4##(1991-5#1)(2010-8#1)
all 6##7##2##(1991-5#1)(1994-9#1)(1995-6#1)(2008-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
all 7##3##2##(1991-2#1)(1995-8#1)(2008-6#1)
all 8##2##2##(2008-11#1)(2008-8#1)
all 9##4##2##(1990-2#1)(1992-10#1)(2008-7#1)(2011-2#1)
all AhR ligands##2##3##(2008-10#2)
all As##2##2##(2008-10#1)(2009-6#1)
all Avr loci##2##3##(2008-10#2)
all BCC##2##2##(2013-1#2)
all C##4##2##(2008-10#2)(2008-5#2)
all CMV##2##2##(2008-10#2)
all Canadian##2##2##(2007-12#1)(2007-4#1)
all ED##2##2##(2008-11#1)(2011-9#1)
all European##2##2##(2008-10#2)
all F##2##2##(2008-10#2)
all HIV-infected##2##2##(2009-12#1)(2011-2#1)
all Medicaid##4##2##(1991-1#1)(1991-9#1)(1992-1#1)(1995-2#1)
all NT##2##2##(2008-4#1)(2008-5#1)
all T##2##2##(2008-10#1)(2008-4#1)
all TB##2##2##(2011-2#2)
all Trichoderma##2##2##(2008-10#2)
all U##2##2##(1992-2#1)(1997-2#1)
all VA##2##2##(1991-12#1)(1993-12#1)
all X##2##2##(1997-2#1)(2008-10#1)
all abilities are intentional##2##4##(2010-2#2)
all about##2##2##(2008-7#1)(2010-6#1)
all active##3##2##(1993-11#1)(1994-2#1)(2008-4#1)
all acute##2##2##(1996-1#1)(2011-2#1)
all adult patients##3##3##(1991-2#1)(2008-5#2)
all adult##6##2##(1991-2#1)(1993-6#1)(2007-12#1)(2008-5#3)
all age groups and##2##4##(1996-9#1)(2007-7#1)
all age groups##14##3##(1990-6#1)(1991-12#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
all age##16##2##(1990-6#1)(1991-12#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
all ages##23##2##(1991-3#1)(1992-3#1)(1993-1#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-5#2)(2006-10#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
all amino acids##2##3##(1990-12#2)
all amino##3##2##(1990-12#2)(2008-7#1)
all analyses##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
all analysis##2##2##(2008-10#1)(2008-2#1)
all analytes##7##2##(1996-5#1)(2008-10#6)
all analyzed##4##2##(2008-12#1)(2011-2#2)(2013-1#1)
all anatomic##2##2##(2012-2#1)(2012-3#1)
all angles##4##2##(2007-11#1)(2008-3#2)(2013-1#1)
all animals in the##2##4##(1992-3#1)(2007-10#1)
all animals were killed##2##4##(2007-10#1)(2009-12#1)
all animals were##4##3##(1992-3#1)(1995-12#1)(2007-10#1)(2009-12#1)
all animals##17##2##(1991-12#2)(1992-3#2)(1993-11#1)(1994-3#1)(1995-11#2)(1995-12#1)(1996-5#1)(2007-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2011-1#1)(2013-1#1)
all antibiotics##3##2##(1996-8#1)(2007-7#1)(2011-2#1)
all appear to##2##3##(2008-10#1)(2008-8#1)
all appear##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
all applications##3##2##(2008-10#1)(2008-7#2)
all are##5##2##(1995-2#1)(2008-10#2)(2008-4#1)(2008-9#1)
all areas of the##4##4##(1996-1#1)(2007-8#1)(2008-12#1)(2012-1#1)
all areas of##9##3##(1993-12#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-1#1)
all areas##11##2##(1993-12#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#2)(2012-1#1)
all articles that##2##3##(2012-12#2)
all aspects of the##3##4##(1996-1#1)(2008-10#2)
all aspects of##19##3##(1993-1#1)(1994-9#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2013-1#1)
all aspects##21##2##(1993-1#1)(1994-9#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-1#1)(2013-1#1)
all associated##3##2##(2008-9#1)(2009-10#1)(2012-3#1)
all at once##3##3##(1995-2#1)(2011-1#1)(2011-2#1)
all at##9##2##(1992-6#1)(1993-9#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
all attempts to##2##3##(2008-10#1)(2008-4#1)
all available data##4##3##(2008-5#1)(2010-11#1)(2011-2#2)
all available evidence##2##3##(1992-3#1)(2010-8#1)
all available reference##2##3##(2008-10#1)(2012-3#1)
all available##21##2##(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1996-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
all based on##2##3##(2007-11#1)(2008-4#1)
all basic##2##2##(2008-4#1)(2008-8#1)
all be considered##2##3##(1994-12#1)(2012-12#1)
all be##9##2##(1992-3#1)(1994-12#1)(2008-2#1)(2008-8#2)(2011-2#2)(2012-12#1)(2013-8#1)
all been##11##2##(1990-11#1)(1990-8#1)(1994-11#1)(1994-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)
all below##5##2##(2008-10#5)
all beta##2##2##(1991-10#1)(1993-6#1)
all biological##3##2##(1990-5#1)(2010-11#1)(2013-1#1)
all biomedical##2##2##(2009-5#1)(2012-2#1)
all bone graft substitutes##2##4##(2008-8#2)
all brain regions##3##3##(1993-8#1)(2008-11#1)(2012-3#1)
all brain##5##2##(1993-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
all brains##2##2##(1994-8#1)(1997-2#1)
all but one case##3##4##(2008-10#1)(2008-6#1)(2009-10#1)
all but one of the##2##5##(2008-10#2)
all but one##15##3##(1990-12#2)(1991-8#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-6#1)(2009-10#1)(2011-2#2)(2013-1#1)
all but the##6##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
all but two##7##3##(1993-2#2)(1994-3#1)(2008-10#2)(2008-7#1)(2012-3#1)
all but##38##2##(1990-12#2)(1990-2#1)(1991-8#1)(1992-3#1)(1993-2#2)(1994-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#1)
all by the##2##3##(1990-2#1)(1990-9#1)
all by##3##2##(1990-2#1)(1990-9#2)
all calibration curves##2##3##(2008-10#1)(2012-3#1)
all calibration##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
all cancers##5##2##(1990-2#2)(1993-9#1)(1994-2#1)(1997-3#1)
all cardiac##3##2##(1990-2#1)(2007-8#2)
all cases and##8##3##(1990-12#1)(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
all cases except##3##3##(1991-8#1)(2007-7#1)(2008-12#1)
all cases in##4##3##(2008-2#1)(2008-4#1)(2009-8#1)(2013-1#1)
all cases of##15##3##(1990-12#1)(1990-9#1)(1992-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
all cases the##13##3##(1992-3#1)(1993-8#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
all cases was##3##3##(2007-10#1)(2008-6#1)(2012-12#1)
all cases were##4##3##(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
all cases where##4##3##(1990-11#1)(1992-11#1)(1997-6#1)(2008-9#1)
all cases##187##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-7#1)(2007-8#7)(2008-1#3)(2008-10#38)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#8)(2013-7#1)
all categories of##4##3##(1992-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
all categories##5##2##(1992-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
all cause##2##2##(1994-10#1)(2011-2#1)
all caused##2##2##(1992-11#1)(2012-3#1)
all causes##2##2##(1997-3#1)(2007-8#1)
all cell lines examined##3##4##(1995-12#1)(1997-7#1)(2008-11#1)
all cell lines##7##3##(1991-4#1)(1992-4#1)(1992-9#2)(1995-12#1)(1997-7#1)(2008-11#1)
all cell types of##2##4##(2008-11#1)(2008-8#1)
all cell types##6##3##(1995-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-12#1)
all cell##15##2##(1991-4#1)(1992-4#1)(1992-9#2)(1995-12#2)(1997-7#1)(2008-11#4)(2008-4#2)(2008-8#1)(2009-12#1)
all cells and##2##3##(2008-5#1)(2008-8#1)
all cells of the##2##4##(1994-5#1)(2008-10#1)
all cells of##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
all cells were##2##3##(1994-11#1)(1995-5#1)
all cells##15##2##(1991-9#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-5#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
all cellular##3##2##(1994-5#1)(2008-10#1)(2008-7#1)
all characterized##2##2##(2012-2#1)(2013-1#1)
all chickens##2##2##(2008-5#1)(2012-1#1)
all children in the##2##4##(1994-9#1)(1995-3#1)
all children in##3##3##(1991-8#1)(1994-9#1)(1995-3#1)
all children with##5##3##(1994-3#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
all children##16##2##(1991-8#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
all chromosomes##2##2##(1994-12#1)(2008-11#1)
all claims##2##2##(1995-1#1)(1996-12#1)
all classes of##2##3##(2008-4#1)(2010-4#1)
all classes##3##2##(1992-12#1)(2008-4#1)(2010-4#1)
all clinic##2##2##(2011-2#1)(2011-3#1)
all clinical areas##2##3##(2007-10#1)(2008-11#1)
all clinical studies##2##3##(2009-11#1)(2011-2#1)
all clinical##5##2##(2007-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#1)
all clones##4##2##(1992-9#2)(2008-9#1)(2012-2#1)
all coexisting##2##2##(2008-10#2)
all colonic##2##2##(1991-6#1)(2013-8#1)
all combinations of##2##3##(2007-8#1)(2008-9#1)
all combinations##7##2##(2007-8#2)(2008-10#3)(2008-7#1)(2008-9#1)
all common##6##2##(1992-8#1)(1994-12#1)(2008-10#2)(2008-4#1)(2012-3#1)
all commonly##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
all complex##2##2##(2008-7#1)(2010-2#1)
all components of the##3##4##(1996-3#1)(2009-5#1)(2011-2#1)
all components of##5##3##(1996-3#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
all components##9##2##(1996-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-5#1)(2011-2#1)
all compounds with##2##3##(2008-10#2)
all compounds##13##2##(1996-5#1)(2008-10#10)(2010-6#1)(2012-2#1)
all concentration levels##2##3##(2008-10#2)
all concentration##3##2##(2008-10#3)
all concentrations studied##3##3##(1994-8#1)(2008-10#2)
all concentrations##7##2##(1994-8#1)(2008-10#4)(2008-11#1)(2013-7#1)
all conditions of##2##3##(2008-3#1)(2008-9#1)
all conditions##16##2##(1990-8#1)(1994-5#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-1#2)(2012-2#1)
all consistent with##2##3##(2008-10#1)(2008-11#1)
all constituents##2##2##(2008-10#2)
all continents##2##2##(2008-12#1)(2008-5#1)
all contribute to##4##3##(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
all contribute##5##2##(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
all control##2##2##(1997-8#1)(2009-8#1)
all costs##2##2##(1991-12#1)(1997-3#1)
all could##2##2##(2008-8#1)(2008-9#1)
all countries##5##2##(1994-12#1)(1997-1#1)(1997-8#1)(2009-6#1)(2010-2#1)
all crosses##3##2##(2008-10#2)(2008-5#1)
all cultivars tested##2##3##(2008-10#2)
all cultivars##12##2##(2008-10#10)(2009-8#1)(2011-2#1)
all cultures##5##2##(1990-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
all current##4##2##(1994-12#1)(2008-5#1)(2010-5#1)(2012-1#1)
all data sets##5##3##(2008-10#4)(2008-9#1)
all data##11##2##(1990-3#1)(1991-9#1)(1993-8#1)(1995-12#1)(2008-10#5)(2008-7#1)(2008-9#1)
all degrees of##3##3##(1994-7#1)(2008-2#1)(2008-3#1)
all dendritic##3##2##(2008-9#1)(2012-2#2)
all derivatives##2##2##(1995-2#1)(1997-7#1)
all described##2##2##(2008-10#2)
all developmental stages##4##3##(2008-10#1)(2008-8#2)(2011-2#1)
all developmental##7##2##(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#1)
all diagnosed##3##2##(1997-3#1)(2009-9#1)(2012-12#1)
all different##4##2##(1991-12#1)(1995-6#1)(2007-11#1)(2008-12#1)
all digits##3##2##(2008-3#2)(2008-9#1)
all dimensions##3##2##(2008-3#1)(2010-3#1)(2013-8#1)
all disciplines and##2##3##(1995-2#1)(1995-5#1)
all disciplines##3##2##(1993-3#1)(1995-2#1)(1995-5#1)
all disorders##2##2##(2008-11#1)(2010-5#1)
all displayed##2##2##(1995-2#1)(2008-9#1)
all dosed groups of females##2##5##(2008-9#2)
all dosed groups of males and females##2##7##(2008-9#2)
all dosed groups of males##3##5##(2008-9#3)
all dosed groups of##6##4##(2008-9#6)
all dosed groups##9##3##(2008-9#9)
all dosed##10##2##(2008-9#10)
all doses studied##2##3##(2008-11#2)
all doses##7##2##(1993-6#1)(2008-11#3)(2008-12#2)(2008-7#1)
all due to##2##3##(2012-2#1)(2013-1#1)
all dyslipidemic drugs##2##3##(2010-2#2)
all efforts##2##2##(2008-11#1)(2009-10#1)
all eight strains##2##3##(2008-10#2)
all eight##10##2##(1992-8#1)(1994-8#1)(1996-12#1)(2008-10#4)(2008-3#1)(2010-10#1)(2012-3#1)
all elective##2##2##(1991-11#1)(2007-10#1)
all electrodes##2##2##(2008-10#1)(2008-9#1)
all elements of the##2##4##(2007-12#1)(2008-2#1)
all elements##15##2##(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)
all eligible patients were##2##4##(1997-7#1)(2010-12#1)
all eligible##4##2##(1993-1#1)(1993-2#1)(1997-7#1)(2010-12#1)
all employees##5##2##(1993-2#2)(1994-1#1)(1995-2#1)(1995-6#1)
all enrollees##2##2##(1995-3#1)(1996-2#1)
all environments##3##2##(2008-10#2)(2011-2#1)
all enzymatic##2##2##(1993-2#1)(1994-6#1)
all enzymes##4##2##(1995-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
all essential##5##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
all ethical##2##2##(1991-3#1)(2012-2#1)
all evaluation##2##2##(2008-3#2)
all events##2##2##(2008-10#2)
all examined tissues##2##3##(2009-8#2)
all examined##6##2##(2007-11#2)(2008-7#1)(2009-8#2)(2011-1#1)
all exhibit##2##2##(1992-6#1)(1992-8#1)
all exhibited a##2##3##(2008-10#1)(2011-2#1)
all exhibited##5##2##(1990-5#1)(1994-5#1)(1997-6#1)(2008-10#1)(2011-2#1)
all existing##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
all experimental groups##2##3##(1991-2#1)(2008-12#1)
all experimental##9##2##(1991-2#1)(1991-5#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#2)
all experiments##8##2##(1990-8#1)(2008-10#4)(2008-5#1)(2008-7#2)
all exposed groups##7##3##(2008-8#1)(2008-9#6)
all exposed##9##2##(2008-7#2)(2008-8#1)(2008-9#6)
all expression##2##2##(2008-11#1)(2009-4#1)
all extant##2##2##(1994-11#1)(2010-3#1)
all extracts##3##2##(2008-12#1)(2008-5#2)
all factors##2##2##(1992-8#1)(2008-3#1)
all faculty members##2##3##(1992-1#1)(2008-12#1)
all families##4##2##(1991-12#1)(2008-10#2)(2008-11#1)
all family members##2##3##(1990-12#1)(1993-12#1)
all family##3##2##(1990-12#2)(1993-12#1)
all fatty acids##2##3##(2008-11#1)(2009-8#1)
all female##2##2##(2009-11#1)(2011-2#1)
all females were maintained to age 714 days (mid-R-16)##3##9##(1997-4#3)
all females were##4##3##(1997-4#3)(2008-10#1)
all females##6##2##(1997-4#3)(2008-10#1)(2008-9#2)
all field##5##2##(1993-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
all fields##4##2##(1992-3#1)(2007-8#1)(2008-10#2)
all findings##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
all five differentials##2##3##(2008-10#2)
all five patients##3##3##(2008-5#1)(2009-12#1)(2013-1#1)
all five##35##2##(1990-12#1)(1990-3#1)(1992-6#1)(1993-12#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
all floral##2##2##(2008-10#1)(2008-8#1)
all food items##2##3##(1993-9#1)(2009-5#1)
all food##3##2##(1993-9#1)(2008-11#1)(2009-5#1)
all for##3##2##(1996-1#1)(2008-10#2)
all foreign ions studied do not interfere with determination##2##9##(2008-10#2)
all foreign ions studied do not interfere with##3##8##(2008-10#3)
all forms of##10##3##(1991-12#1)(1995-6#1)(2007-12#1)(2008-1#2)(2008-10#2)(2011-2#2)(2013-1#1)
all forms##11##2##(1991-12#1)(1995-6#1)(2007-12#1)(2008-1#2)(2008-10#2)(2009-5#1)(2011-2#2)(2013-1#1)
all formulations##2##2##(1997-7#1)(2008-10#1)
all four branches of nursing##2##5##(2008-11#2)
all four cases##4##3##(1990-5#1)(1996-12#1)(2007-11#1)(2008-10#1)
all four limbs##4##3##(2008-7#1)(2010-8#1)(2011-2#2)
all four of##2##3##(1995-8#1)(2008-10#1)
all four##64##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#1)
all from##4##2##(1993-3#1)(2008-6#1)(2009-10#1)(2012-12#1)
all fungal##3##2##(1997-3#1)(2008-10#2)
all future##3##2##(1996-6#1)(2008-11#1)(2008-12#1)
all gene##2##2##(1994-12#1)(2007-11#1)
all genes##5##2##(1996-12#1)(2008-7#3)(2012-3#1)
all genotypes##5##2##(2008-10#5)
all geographic regions##2##3##(2008-10#1)(2011-10#1)
all geographic##3##2##(2008-10#2)(2011-10#1)
all germ##3##2##(2008-8#2)(2012-2#1)
all group members##2##3##(2008-8#1)(2008-9#1)
all groups of##6##3##(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
all groups##36##2##(1990-9#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
all growth indices##2##3##(2008-12#2)
all growth##6##2##(1992-8#1)(2008-10#3)(2008-12#2)
all had##8##2##(1990-2#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)
all have been##2##3##(2008-10#1)(2012-12#1)
all have limitations and##2##4##(2008-12#1)(2012-8#1)
all have##11##2##(1993-3#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-12#1)(2010-6#1)(2012-12#1)(2012-8#1)
all health and social care##2##5##(2008-11#2)
all health care professionals##2##4##(2008-1#1)(2013-1#1)
all health care##5##3##(1994-3#1)(1996-3#1)(2007-2#1)(2008-1#1)(2013-1#1)
all health##10##2##(1994-3#2)(1996-3#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2013-1#1)
all higher##3##2##(1995-2#1)(2007-12#1)(2010-11#1)
all highly##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
all histological##2##2##(1997-3#1)(2012-3#1)
all hospital employees##3##3##(1993-3#1)(1994-12#2)
all hospital##6##2##(1992-12#1)(1993-3#1)(1994-12#2)(2011-2#1)(2012-2#1)
all hospitals in the##2##4##(1996-12#1)(2007-10#1)
all hospitals in##3##3##(1996-12#1)(1997-2#1)(2007-10#1)
all hospitals with##2##3##(2008-3#1)(2013-1#1)
all hospitals##12##2##(1990-6#1)(1991-9#1)(1992-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
all host plants##2##3##(2008-10#2)
all host##5##2##(2007-12#1)(2008-10#3)(2008-9#1)
all hosts of##2##3##(2008-10#2)
all hosts##4##2##(2008-10#4)
all human##10##2##(1992-6#1)(1993-8#2)(1995-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-3#1)(2013-1#2)
all identified##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
all important##5##2##(1996-1#1)(1996-3#1)(2007-12#1)(2010-11#1)(2012-2#1)
all in the##5##3##(1990-11#1)(1995-2#1)(1997-8#1)(2008-5#1)(2012-2#1)
all in##19##2##(1990-11#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
all including##2##2##(1990-12#1)(1994-8#1)
all increased##4##2##(1991-12#1)(1995-11#1)(2011-3#1)(2013-8#1)
all independent##2##2##(1990-12#1)(2008-8#1)
all indices##2##2##(2008-10#1)(2011-2#1)
all individuals and##2##3##(2008-11#1)(2012-2#1)
all individuals are##2##3##(2008-10#1)(2008-8#1)
all individuals##13##2##(1996-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#2)(2009-10#1)(2012-2#2)
all induced##3##2##(1991-6#1)(2008-10#1)(2011-10#1)
all infants##2##2##(1994-9#1)(2010-11#1)
all infection##2##2##(2008-10#2)
all inhibited##2##2##(1995-11#1)(1997-4#1)
all injection analysis (AIA)##2##4##(2008-10#2)
all injection analysis##3##3##(2008-10#3)
all instances##10##2##(1990-11#1)(1991-12#1)(1995-5#1)(1996-2#1)(2008-10#6)
all interaction##2##2##(2007-11#1)(2010-10#1)
all interventions##3##2##(2012-2#2)(2013-1#1)
all investigated compounds##2##3##(2008-10#2)
all investigated##5##2##(2008-10#4)(2008-7#1)
all involved##4##2##(1990-6#1)(1992-3#1)(1995-6#1)(2007-12#1)
all is##2##2##(2007-8#1)(2008-12#1)
all isolated##4##2##(2007-10#1)(2008-10#1)(2008-12#1)(2009-11#1)
all isolates in##2##3##(2008-10#2)
all isolates of the##3##4##(2008-10#3)
all isolates of##7##3##(1996-12#1)(2008-10#6)
all isolates tested##4##3##(2008-10#4)
all isolates were##3##3##(2008-10#3)
all isolates##31##2##(1996-12#1)(2008-10#30)
all issues##2##2##(2008-2#1)(2011-2#1)
all its##9##2##(1994-3#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)
all key##2##2##(1993-3#1)(2009-11#1)
all kinds of##15##3##(1990-2#2)(1991-5#1)(1994-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
all kinds##17##2##(1990-2#2)(1991-5#1)(1992-2#1)(1993-12#1)(1994-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
all known##20##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-11#3)(1994-11#1)(1994-5#1)(1996-12#1)(1997-4#1)(1997-9#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2011-2#1)(2011-3#1)
all labeled##2##2##(1995-6#1)(2008-10#1)
all laboratories##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
all layers of the##2##4##(2008-10#1)(2011-2#1)
all layers##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
all leaf##4##2##(2008-10#4)
all leaves##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
all lesions##3##2##(1994-1#1)(1997-3#1)(2008-10#1)
all letters##3##2##(1997-2#1)(2012-2#1)(2013-8#1)
all levels of the organization##3##5##(1992-9#1)(1993-12#1)(1996-3#1)
all levels of the##8##4##(1992-12#1)(1992-9#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)
all levels of##17##3##(1992-12#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)
all levels##25##2##(1992-12#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-5#1)(2010-9#1)(2012-3#1)
all life##2##2##(2008-11#1)(2012-12#1)
all lineages##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
all lipid classes##2##3##(1992-9#1)(2008-11#1)
all lipid##4##2##(1992-9#1)(1994-11#1)(1994-12#1)(2008-11#1)
all living organisms##2##3##(1994-11#1)(2008-10#1)
all living##4##2##(1994-11#1)(1995-6#1)(2008-10#1)(2013-8#1)
all located at the##2##4##(1993-11#1)(1997-4#1)
all located##4##2##(1993-11#1)(1997-4#1)(2010-4#1)(2011-1#1)
all locations##6##2##(2008-10#4)(2008-3#1)(2013-8#1)
all loci except##2##3##(2008-10#1)(2008-11#1)
all loci##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
all lower##4##2##(2008-1#1)(2008-10#3)
all lung##3##2##(1993-8#1)(2009-1#1)(2011-3#1)
all major species##2##3##(2008-1#1)(2008-2#1)
all major##23##2##(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-11#1)(1997-5#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-7#1)
all mammalian cells##2##3##(1992-12#1)(2013-7#1)
all mammalian##5##2##(1992-12#1)(1993-12#1)(2008-11#1)(2013-1#1)(2013-7#1)
all mammals##2##2##(1992-11#1)(1993-6#1)
all manifested##2##2##(2007-7#1)(2011-2#1)
all markers##2##2##(1997-8#1)(2008-12#1)
all materials##8##2##(2008-3#1)(2010-3#1)(2013-1#6)
all matrix elements##2##3##(2008-10#2)
all measured##3##2##(2008-3#1)(2008-5#1)(2009-8#1)
all measurements##2##2##(2008-10#1)(2008-9#1)
all measures of##4##3##(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
all measures##6##2##(1991-1#1)(2007-9#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
all mechanisms of dispersal were##2##5##(2008-10#2)
all medical specialties##2##3##(1992-11#1)(2011-2#1)
all medical##10##2##(1992-11#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-6#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
all member##2##2##(1992-2#1)(2008-11#1)
all members of the##10##4##(1994-2#1)(1995-2#2)(1996-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2013-8#1)
all members of##12##3##(1994-2#1)(1995-2#2)(1995-3#1)(1996-4#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2013-8#1)
all members##13##2##(1994-2#1)(1995-2#2)(1995-3#1)(1996-4#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-4#1)(2013-8#1)
all metal ions##2##3##(2008-10#2)
all metal##3##2##(2008-10#3)
all metals##2##2##(2008-10#1)(2012-3#1)
all methods##6##2##(1995-6#1)(2008-10#2)(2008-6#1)(2010-3#1)(2011-1#1)
all mice in the##2##4##(2008-10#1)(2008-9#1)
all mice##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
all minor##2##2##(1992-6#1)(2008-10#1)
all model##2##2##(2009-12#1)(2012-3#1)
all models##9##2##(1996-4#1)(2007-10#3)(2008-10#2)(2008-12#1)(2011-1#1)(2012-12#1)
all more##3##2##(2012-2#1)(2013-8#2)
all mothers##3##2##(1995-6#1)(2008-1#1)(2012-12#1)
all mouse genotypes##2##3##(2013-8#2)
all mouse##3##2##(1995-6#1)(2013-8#2)
all mutants##4##2##(1991-8#1)(1995-2#1)(2008-10#1)(2008-4#1)
all natural##2##2##(1997-6#1)(2013-8#1)
all necessary##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
all negative##2##2##(1994-7#1)(2008-1#1)
all neurons##3##2##(1993-12#1)(1994-2#1)(1996-6#1)
all new compounds##2##3##(1995-3#1)(2007-11#1)
all new##6##2##(1995-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2010-6#1)
all newborns##3##2##(1992-4#1)(2007-11#1)(2011-1#1)
all newly##3##2##(2008-10#2)(2012-2#1)
all nine##3##2##(1996-5#1)(2008-10#2)
all normal##2##2##(1992-11#1)(2008-4#1)
all nurses##4##2##(1990-2#1)(2008-12#1)(2012-3#1)(2013-8#1)
all observed in##2##3##(2008-3#1)(2010-5#1)
all observed##4##2##(1997-4#1)(2008-3#1)(2010-5#1)(2013-1#1)
all of its##6##3##(1992-11#1)(1992-2#1)(1994-9#1)(1997-3#1)(2009-11#1)(2010-9#1)
all of our##5##3##(1990-9#1)(1997-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
all of the above parameters##3##5##(1994-5#1)(2008-8#1)(2013-1#1)
all of the above##6##4##(1994-5#1)(1996-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
all of the elements##2##4##(2008-10#2)
all of the essential##2##4##(1994-8#1)(2011-1#1)
all of the functional centers of the ribosome##2##8##(2007-12#2)
all of the functional##3##4##(2007-12#3)
all of the isolates##2##4##(2008-10#2)
all of the major##3##4##(1994-8#1)(2008-12#1)(2008-4#1)
all of the other##2##4##(1992-2#1)(2008-10#1)
all of the patients were##2##5##(2008-1#1)(2008-9#1)
all of the patients##3##4##(2008-1#1)(2008-9#1)(2010-8#1)
all of the tested##3##4##(2008-5#1)(2010-5#1)(2012-3#1)
all of the##136##3##(1990-5#2)(1990-7#1)(1990-8#3)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#30)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#6)(2008-9#3)(2009-2#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
all of them are##3##4##(1996-9#1)(2008-9#1)(2012-2#1)
all of them had##2##4##(2007-8#1)(2012-12#1)
all of them##27##3##(1991-11#1)(1993-8#1)(1993-9#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-8#2)(2008-9#3)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
all of these areas##2##4##(1994-8#1)(1997-2#1)
all of these factors##3##4##(1992-8#1)(1993-12#1)(2008-12#1)
all of these functions##2##4##(1995-6#1)(2013-1#1)
all of these##39##3##(1991-2#2)(1991-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
all of us##3##3##(1996-2#1)(1996-8#1)(2012-8#1)
all of which are##8##4##(1991-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)
all of which can##2##4##(2008-10#1)(2008-7#1)
all of which have been##2##5##(1992-9#1)(2008-8#1)
all of which have##6##4##(1992-9#1)(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
all of which produce a##2##5##(2008-11#1)(2008-7#1)
all of which were##6##4##(1994-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
all of which##38##3##(1991-1#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-9#2)(1995-9#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
all of whom had##3##4##(2007-1#1)(2008-9#1)(2009-5#1)
all of whom##7##3##(1991-11#1)(1992-9#1)(2007-1#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#1)
all of##278##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-8#3)(2008-1#3)(2008-10#47)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#6)(2008-7#11)(2008-8#12)(2008-9#11)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#2)
all on a##2##3##(1995-5#1)(2008-8#1)
all optical##3##2##(2007-11#2)(2008-2#1)
all or most of##2##4##(1996-3#1)(2008-10#1)
all or##9##2##(1991-12#1)(1994-1#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-6#1)
all orders##2##2##(2007-11#1)(2013-8#1)
all organic##2##2##(2008-10#2)
all organisms##3##2##(2008-4#2)(2008-8#1)
all organizations##2##2##(2008-12#1)(2008-7#1)
all organs##3##2##(1990-8#1)(1997-5#1)(2009-4#1)
all other cases##3##3##(1996-9#1)(2007-8#1)(2008-11#1)
all other elements##3##3##(2008-10#2)(2008-3#1)
all other factors##2##3##(1995-12#1)(2012-3#1)
all other populations##2##3##(2008-10#1)(2008-9#1)
all other species##4##3##(2009-4#3)(2010-8#1)
all other treatments##2##3##(2008-10#1)(2008-12#1)
all other##94##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#6)(2012-2#1)(2012-3#2)(2013-8#1)
all others##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)
all outcome measures##3##3##(2008-6#1)(2010-4#1)(2012-2#1)
all outcomes##2##2##(2008-8#1)(2010-12#1)
all ovarian##3##2##(1990-2#1)(1997-3#1)(2007-8#1)
all over Egypt##2##3##(2008-10#2)
all over the world##14##4##(1992-5#1)(1994-9#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
all over the##22##3##(1992-5#1)(1994-9#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
all over##26##2##(1992-5#1)(1994-9#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
all overseas##2##2##(1991-5#2)
all p &lt##2##3##(2009-11#1)(2013-1#1)
all pH values##4##3##(1993-8#1)(2008-10#2)(2008-3#1)
all pH##5##2##(1993-8#1)(2008-10#3)(2008-3#1)
all pairs of##3##3##(2008-10#2)(2012-12#1)
all pairs##4##2##(2008-10#2)(2009-11#1)(2012-12#1)
all parameters except##3##3##(2008-3#1)(2009-8#1)(2012-3#1)
all parameters##9##2##(1997-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-8#1)
all parasites##2##2##(1997-7#1)(2010-3#1)
all participants completed##2##3##(2008-1#1)(2009-9#1)
all participants##14##2##(1996-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
all parties involved##2##3##(1994-12#1)(2009-11#1)
all parties##6##2##(1994-12#1)(1994-3#1)(1996-12#2)(1997-7#1)(2009-11#1)
all parts of the##5##4##(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#2)
all parts of##7##3##(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#2)
all pathogenic strains##2##3##(2008-10#2)
all pathogenic##4##2##(2008-10#4)
all patient##4##2##(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
all patients admitted##2##3##(2006-8#1)(2008-3#1)
all patients and##7##3##(1993-3#1)(2007-7#2)(2007-8#2)(2012-12#1)(2012-2#1)
all patients are##2##3##(1997-6#1)(2010-4#1)
all patients diagnosed with##3##4##(2006-8#1)(2008-8#1)(2012-1#1)
all patients except##2##3##(1997-8#1)(2008-3#1)
all patients had##3##3##(1992-11#2)(1996-6#1)
all patients in##4##3##(1990-3#1)(1990-8#1)(2007-7#1)(2010-7#1)
all patients received##2##3##(1990-6#1)(1997-7#1)
all patients to##2##3##(2008-5#1)(2010-4#1)
all patients treated##3##3##(1996-3#1)(2007-8#1)(2008-6#1)
all patients was##4##3##(1997-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
all patients were in##2##4##(1992-9#1)(2007-8#1)
all patients were##4##3##(1992-9#1)(2007-8#1)(2008-9#1)(2010-3#1)
all patients who##4##3##(1996-2#1)(1997-4#1)(2008-5#1)(2011-2#1)
all patients with a##2##4##(2012-2#1)(2013-8#1)
all patients with an##2##4##(1992-12#1)(2007-8#1)
all patients with##28##3##(1990-9#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-2#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
all patients within two##2##4##(1996-3#1)(2007-7#1)
all patients yawned##2##3##(2008-7#2)
all patients##185##2##(1990-3#3)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-2#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#6)(2006-10#1)(2006-8#2)(2007-10#3)(2007-11#6)(2007-2#1)(2007-7#7)(2007-8#11)(2008-1#6)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#18)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#2)
all pediatric##2##2##(2008-11#1)(2013-1#1)
all people##6##2##(1995-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2010-4#1)(2013-7#1)
all peptides##2##2##(1991-2#1)(1995-11#1)
all periods##2##2##(2008-2#1)(2013-1#1)
all persons##2##2##(1991-5#1)(2012-3#1)
all pertinent##2##2##(1993-12#1)(2012-2#1)
all pesticides##2##2##(2008-10#2)
all phases of the##6##4##(1995-6#1)(2007-12#1)(2008-11#2)(2008-8#1)(2012-3#1)
all phases of##13##3##(1992-1#1)(1992-2#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
all phases##17##2##(1992-1#1)(1992-2#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
all photosynthetic##2##2##(2008-11#1)(2011-2#1)
all physical##2##2##(1995-3#1)(2008-10#1)
all physicians##3##2##(1992-3#1)(1996-6#1)(2007-11#1)
all plant species##3##3##(2008-10#3)
all plant##8##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2013-7#1)
all plants##5##2##(2008-10#5)
all players in the##2##4##(1996-12#1)(2009-10#1)
all plots within the quadrat sizes tested##2##7##(2008-10#2)
all plots##5##2##(2008-10#5)
all points##2##2##(2007-12#1)(2008-3#1)
all populations to##2##3##(2008-10#1)(2008-9#1)
all populations##17##2##(2008-1#1)(2008-10#9)(2008-5#2)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#2)
all positions##2##2##(2011-2#1)(2012-1#1)
all positive##3##2##(1990-11#1)(2009-12#1)(2009-3#1)
all possible combinations of##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
all possible combinations##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
all possible##30##2##(1990-12#1)(1991-6#1)(1994-12#2)(1995-5#1)(1995-6#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2012-12#1)
all potential##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
all predicted##2##2##(2008-10#1)(2008-3#1)
all pregnant women in##2##4##(1990-6#1)(1994-6#1)
all pregnant women##6##3##(1990-6#1)(1991-11#1)(1994-6#1)(1995-6#1)(2007-2#1)(2010-8#1)
all premature infants##2##3##(1996-11#1)(2008-9#1)
all presented##3##2##(2007-10#1)(2008-7#1)(2010-5#1)
all previous##5##2##(1994-11#1)(2008-11#1)(2011-2#2)(2011-3#1)
all previously##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)
all primary##5##2##(1992-11#1)(1996-12#1)(2007-10#1)(2008-10#1)(2010-3#1)
all procedures##3##2##(2008-10#1)(2009-3#1)(2009-9#1)
all products tested##2##3##(2007-6#2)
all products##6##2##(2007-6#3)(2008-12#1)(2008-6#1)(2008-7#1)
all profiles##2##2##(2008-10#2)
all protocols##2##2##(2008-10#1)(2008-9#1)
all providers##2##2##(1997-2#2)
all public##3##2##(1996-1#1)(1997-3#1)(2012-2#1)
all published##5##2##(1994-2#1)(1996-9#1)(2011-7#1)(2012-1#1)(2012-12#1)
all quadrat sizes##2##3##(2008-10#2)
all questions##2##2##(1996-7#1)(2009-12#1)
all races and##2##3##(1992-2#1)(2010-3#1)
all races of##3##3##(2008-10#3)
all races##9##2##(1992-2#1)(1995-12#1)(2008-10#6)(2010-3#1)
all radiation##5##2##(1994-12#1)(1995-1#1)(1996-6#1)(2008-7#2)
all randomized controlled trials##2##4##(2010-2#1)(2012-3#1)
all randomized##3##2##(2010-2#2)(2012-3#1)
all rats were##2##3##(1992-11#1)(2008-10#1)
all rats##5##2##(1991-6#1)(1992-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
all recommended##2##2##(1993-3#1)(2011-2#1)
all red##3##2##(1992-11#1)(1995-6#1)(1997-6#1)
all regions of the##3##4##(1990-7#1)(2008-10#1)(2012-1#1)
all regions##11##2##(1990-7#1)(1991-12#1)(1994-3#1)(1994-5#1)(2008-10#4)(2008-12#2)(2012-1#1)
all relevant articles##2##3##(2008-11#1)(2013-1#1)
all relevant data##2##3##(2007-7#1)(2008-7#1)
all relevant factors##2##3##(1996-1#1)(2008-11#1)
all relevant parameters##3##3##(2007-4#1)(2008-3#2)
all relevant studies##2##3##(2008-12#1)(2013-1#1)
all relevant##17##2##(1993-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
all renal##2##2##(2008-1#1)(2010-9#1)
all reported##2##2##(1992-6#1)(2008-10#1)
all reproductive##2##2##(1997-4#1)(2008-9#1)
all required##3##2##(1990-5#1)(1995-12#1)(2008-5#1)
all requirements##2##2##(2008-7#1)(2013-1#1)
all resistant isolates##2##3##(2008-10#2)
all resistant##4##2##(2008-10#3)(2008-4#1)
all respects##2##2##(2009-8#1)(2009-9#1)
all respondents##4##2##(1990-6#1)(1993-3#1)(1997-3#1)(2009-5#1)
all results##2##2##(2008-10#1)(2011-2#1)
all root##2##2##(2008-10#2)
all samples at##2##3##(2008-12#1)(2011-2#1)
all samples##26##2##(1991-11#1)(1994-12#1)(2007-5#1)(2008-10#16)(2008-12#2)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#2)
all sampling dates##3##3##(2008-10#2)(2013-8#1)
all sampling##6##2##(2008-10#3)(2013-7#1)(2013-8#2)
all samplings##2##2##(2008-12#1)(2008-6#1)
all scales##2##2##(2008-6#1)(2012-3#1)
all secondary##2##2##(2008-5#1)(2012-12#1)
all sections##2##2##(2011-2#1)(2012-1#1)
all seeds##4##2##(2008-12#3)(2012-3#1)
all segments##3##2##(1995-5#1)(1997-1#1)(2008-10#1)
all sensory##2##2##(2008-12#1)(2010-4#1)
all sequenced##2##2##(2008-10#1)(2013-8#1)
all sequences##3##2##(1997-8#1)(2008-10#2)
all services##3##2##(1994-1#1)(1996-1#1)(1997-3#1)
all seven##7##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)
all sexually active##2##3##(2008-8#1)(2013-1#1)
all show##3##2##(1995-5#1)(2008-6#1)(2010-4#1)
all showed##7##2##(1990-11#1)(1992-5#1)(1995-8#1)(2008-10#2)(2008-7#1)(2009-4#1)
all significant##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
all significantly##7##2##(1993-8#1)(1996-5#1)(2008-10#4)(2011-1#1)
all sites and##3##3##(2007-5#1)(2008-10#2)
all sites of disease##2##4##(2008-6#1)(2012-2#1)
all sites of##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
all sites##16##2##(1990-2#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-6#1)(2012-2#1)
all situations##4##2##(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)
all six##17##2##(1992-6#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
all sizes##3##2##(1996-4#1)(2008-2#1)(2011-2#1)
all soils##2##2##(2008-10#2)
all solid-state##2##2##(2008-10#1)(2008-2#1)
all sources of##2##3##(2008-10#1)(2010-1#1)
all spatial##2##2##(2008-10#1)(2008-7#1)
all species and##3##3##(1993-12#1)(2008-2#1)(2012-6#1)
all species##23##2##(1991-2#1)(1993-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#1)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#1)
all specimens##6##2##(2007-12#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
all stages of##12##3##(1990-7#1)(1994-2#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#3)
all stages##15##2##(1990-7#1)(1994-2#1)(1996-6#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#3)
all stakeholders##5##2##(2007-4#1)(2008-12#1)(2008-8#1)(2010-3#1)(2013-8#1)
all standards##2##2##(2007-8#1)(2008-10#1)
all states##4##2##(1991-1#1)(2008-10#3)
all steps of the analytical procedure##2##6##(2008-10#2)
all steps of the##4##4##(2008-10#3)(2010-7#1)
all steps##8##2##(2008-10#4)(2008-2#1)(2008-4#2)(2010-7#1)
all stimuli##2##2##(2008-5#1)(2008-9#1)
all strains of##2##3##(2008-10#1)(2008-9#1)
all strains tested##2##3##(2008-10#1)(2008-5#1)
all strains were##3##3##(2008-10#3)
all strains##18##2##(1997-7#1)(2008-10#12)(2008-5#3)(2008-7#1)(2008-9#1)
all strata##2##2##(2008-1#1)(2008-5#1)
all structures of##2##3##(2007-11#1)(2011-2#1)
all structures##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
all studied##5##2##(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
all studies reporting##2##3##(2011-2#2)
all studies##10##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-3#2)
all subjects in the##2##4##(2011-2#2)
all subjects received##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
all subjects##25##2##(1990-9#1)(1991-11#1)(1992-6#1)(1993-12#1)(1996-5#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#7)(2011-2#3)(2012-2#2)(2013-1#3)
all subpopulations##2##2##(2008-10#1)(2008-8#1)
all substances##2##2##(2008-10#2)
all successful##2##2##(1992-12#1)(1997-1#1)
all such cases##2##3##(1991-11#1)(2009-9#1)
all such##4##2##(1991-11#1)(1991-3#1)(2009-10#1)(2009-9#1)
all surgical##4##2##(1995-3#1)(2007-12#1)(2007-7#1)(2011-2#1)
all surgically treated##2##3##(2008-6#1)(2008-7#1)
all suspected##2##2##(2008-9#1)(2010-10#1)
all symptomatic##2##2##(2008-10#2)
all symptoms of##2##3##(2008-10#1)(2011-2#1)
all symptoms##5##2##(1990-12#1)(1994-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
all system##2##2##(1992-3#1)(1997-3#1)
all systems##2##2##(2008-10#1)(2013-1#1)
all targets##2##2##(1997-1#1)(2013-1#1)
all tasks##2##2##(1994-8#1)(2009-11#1)
all taxa##3##2##(2008-10#2)(2009-4#1)
all team members##2##3##(1993-12#1)(2008-3#1)
all temperature regimes##2##3##(2008-10#2)
all temperatures##12##2##(1990-9#1)(2008-10#10)(2011-2#1)
all test##8##2##(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
all tested isolates##3##3##(2008-10#3)
all tested species##2##3##(2008-10#2)
all tested##25##2##(1990-12#1)(1991-6#1)(1996-8#1)(2007-11#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-4#1)(2013-1#2)
all tests##9##2##(1991-6#1)(1992-6#1)(1994-1#1)(1994-8#1)(2008-10#4)(2013-8#1)
all the above##5##3##(1990-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
all the advantages##3##3##(2008-10#1)(2009-5#1)(2013-8#1)
all the aforementioned##2##3##(1993-12#1)(2011-1#1)
all the agonists##2##3##(1995-12#1)(1997-7#1)
all the analytes were##2##4##(2008-10#1)(2012-1#1)
all the analytes##6##3##(2008-10#4)(2011-1#1)(2012-1#1)
all the animals were##2##4##(2008-7#1)(2011-2#1)
all the animals##4##3##(1990-3#1)(2008-7#2)(2011-2#1)
all the arsenic##2##3##(2008-10#2)
all the available##5##3##(1995-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
all the beta-blockers tested##3##4##(1995-6#3)
all the binding sites in the##2##6##(2011-3#2)
all the biological##2##3##(2008-4#1)(2008-5#1)
all the cases studied##2##4##(2007-11#1)(2008-3#1)
all the cases##14##3##(1990-6#1)(1990-7#1)(1994-9#1)(2007-11#1)(2007-7#2)(2008-10#4)(2008-3#1)(2010-7#1)(2012-12#1)(2012-2#1)
all the channels of##2##4##(2008-3#2)
all the clinical##2##3##(1991-11#1)(2007-7#1)
all the components of##2##4##(2008-10#1)(2010-1#1)
all the components##3##3##(2008-10#2)(2010-1#1)
all the compounds investigated##2##4##(2008-10#1)(2008-11#1)
all the compounds##10##3##(1992-11#1)(1994-11#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
all the considered##3##3##(1992-2#1)(2008-10#2)
all the data##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
all the dialysis##2##3##(2008-1#2)
all the different types of##2##5##(2008-7#2)
all the different##5##3##(1995-3#1)(1996-5#1)(2008-10#1)(2008-7#2)
all the elements##11##3##(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2013-1#1)(2013-8#2)
all the examined##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
all the experimental##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
all the factors##2##3##(1993-12#1)(2011-2#1)
all the five##2##3##(2008-10#1)(2008-5#1)
all the four##5##3##(1990-11#1)(2008-10#4)
all the fractional##2##3##(2008-2#1)(2008-3#1)
all the groups##5##3##(1994-8#1)(2008-5#2)(2008-8#1)(2010-1#1)
all the important##2##3##(2008-3#2)
all the infected##2##3##(2008-5#1)(2011-2#1)
all the information##4##3##(1990-11#1)(2008-11#1)(2008-4#1)(2009-10#1)
all the investigated##2##3##(2007-12#1)(2008-10#1)
all the isolates##6##3##(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-2#1)
all the known##2##3##(1996-5#1)(2008-9#1)
all the main features of##2##5##(1992-5#1)(2007-12#1)
all the major##3##3##(1997-7#1)(2008-9#1)(2009-2#1)
all the metal##3##3##(2008-10#3)
all the methods##5##3##(1995-5#1)(2008-10#2)(2008-2#1)(2008-9#1)
all the models##2##3##(2008-10#1)(2009-7#1)
all the more difficult##2##4##(2008-1#1)(2008-3#1)
all the more##6##3##(1991-3#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)
all the necessary##3##3##(2008-10#2)(2008-7#1)
all the neurons##2##3##(1992-8#1)(2008-11#1)
all the nine##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
all the observed##3##3##(1995-6#1)(2008-2#1)(2012-2#1)
all the other##10##3##(1991-6#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
all the parameters that##2##4##(2007-12#1)(2008-10#1)
all the parameters##12##3##(1992-2#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-12#5)(2008-3#1)(2008-7#1)(2009-8#1)
all the participants##2##3##(2008-1#1)(2008-7#1)
all the patients with##2##4##(2007-11#1)(2008-7#1)
all the patients##15##3##(1990-6#1)(1990-9#1)(1993-12#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2010-7#4)(2011-2#1)
all the polysaccharides##2##3##(2012-12#2)
all the possible##3##3##(2007-10#1)(2011-2#1)(2012-3#1)
all the procedures##2##3##(2008-5#1)(2011-3#1)
all the relevant##2##3##(1996-12#1)(2008-8#1)
all the samples##14##3##(1990-7#2)(2008-10#5)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
all the selected##2##3##(2008-10#1)(2012-1#1)
all the sites##3##3##(1994-7#1)(2008-10#2)
all the six metal ions##2##5##(2008-10#2)
all the species examined##2##4##(1993-2#1)(2008-7#1)
all the species##5##3##(1993-2#1)(2007-12#2)(2008-7#1)(2013-8#1)
all the stages##3##3##(2008-9#1)(2010-2#1)(2013-1#1)
all the states of##2##4##(1994-3#1)(2008-3#1)
all the strains sensitive to##2##5##(2008-10#2)
all the strains##5##3##(1993-12#1)(2008-10#3)(2008-5#1)
all the students##2##3##(2013-1#1)(2013-8#1)
all the studied compounds##2##4##(2008-10#2)
all the studied##6##3##(2008-10#4)(2011-2#1)(2012-1#1)
all the studies##2##3##(2008-3#1)(2011-1#1)
all the study##2##3##(2008-1#1)(2013-8#1)
all the subjects##2##3##(2008-5#1)(2013-1#1)
all the subregions##2##3##(2008-3#2)
all the symptoms##2##3##(2013-1#1)(2013-7#1)
all the test##2##3##(1996-5#1)(2008-10#1)
all the tested##4##3##(2008-10#1)(2008-3#1)(2010-3#1)(2012-3#1)
all the three##13##3##(1992-12#1)(1992-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#1)
all the time##3##3##(1994-6#1)(2009-4#1)(2011-3#1)
all the tissues##3##3##(1995-8#1)(2008-5#1)(2009-7#1)
all the tumors##3##3##(2013-1#3)
all the types of##2##4##(2008-10#1)(2008-7#1)
all the variables##2##3##(1993-8#1)(2012-12#1)
all the various##2##3##(1993-1#1)(2013-8#1)
all the way to##2##4##(2008-10#1)(2011-1#1)
all the way##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
all the##620##2##(1990-11#6)(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#1)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#1)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#9)(2007-12#13)(2007-2#1)(2007-7#9)(2007-8#3)(2008-1#10)(2008-10#144)(2008-11#10)(2008-12#14)(2008-2#10)(2008-3#36)(2008-4#9)(2008-5#20)(2008-6#3)(2008-7#21)(2008-8#15)(2008-9#13)(2009-10#3)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-5#4)(2010-7#5)(2010-9#1)(2011-1#11)(2011-10#2)(2011-2#19)(2011-3#6)(2012-1#3)(2012-12#7)(2012-2#9)(2012-3#5)(2013-1#19)(2013-7#3)(2013-8#14)
all their##6##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
all these areas##2##3##(2010-10#1)(2010-7#1)
all these cases##3##3##(2008-1#1)(2008-10#2)
all these factors##4##3##(2008-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
all these metal ions##3##4##(2008-10#3)
all these results##2##3##(1996-5#1)(2008-10#1)
all these species##2##3##(2008-9#1)(2010-3#1)
all these systems##2##3##(1990-12#1)(2008-11#1)
all these##63##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2010-10#2)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
all this##3##2##(2008-7#1)(2009-10#1)(2011-2#1)
all those##9##2##(1992-6#1)(1993-11#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)
all three agents together##2##4##(2008-10#2)
all three agents##4##3##(2008-10#4)
all three cases##5##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
all three cell##3##3##(1990-12#1)(1995-6#1)(2008-11#1)
all three components of the##2##5##(2007-11#1)(2008-8#1)
all three components of##3##4##(1990-7#1)(2007-11#1)(2008-8#1)
all three domains##2##3##(2008-7#1)(2010-11#1)
all three elements##2##3##(2008-10#1)(2008-3#1)
all three factors in##2##4##(2008-10#1)(2008-8#1)
all three fibre types##2##4##(2011-2#2)
all three genes##2##3##(1995-12#1)(2011-2#1)
all three groups##5##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
all three isolates##3##3##(2007-12#1)(2008-10#2)
all three measures##2##3##(2008-4#1)(2010-11#1)
all three media##2##3##(2008-10#2)
all three methods##3##3##(1991-3#1)(2008-10#1)(2008-12#1)
all three of the##2##4##(1997-3#1)(2007-12#1)
all three of these##5##4##(2008-10#1)(2008-4#2)(2010-5#1)(2012-1#1)
all three of##9##3##(1991-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-4#2)(2010-5#1)(2012-1#1)
all three operationalizations##2##3##(1997-1#2)
all three populations##2##3##(2008-10#2)
all three regions of##2##4##(1990-5#1)(2012-2#1)
all three regions##3##3##(1990-5#1)(2008-10#1)(2012-2#1)
all three sites##2##3##(1992-3#1)(2010-5#1)
all three soils##3##3##(2008-10#3)
all three species##6##3##(1990-5#1)(1993-2#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-8#1)
all three strains of##2##4##(2008-10#2)
all three strains##7##3##(1994-2#2)(2008-10#4)(2008-11#1)
all three studies##4##3##(2007-12#1)(2008-9#1)(2011-2#2)
all three sugars##2##3##(2008-6#1)(2011-2#1)
all three tested##2##3##(2008-10#1)(2013-1#1)
all three types of##4##4##(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
all three wavelengths##2##3##(2008-2#1)(2008-3#1)
all three##225##2##(1990-12#1)(1990-2#2)(1990-5#5)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-2#3)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#6)(2008-1#2)(2008-10#68)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#5)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-5#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#1)
all through##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
all time periods##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
all time points##2##3##(2012-1#1)(2013-1#1)
all time##8##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
all times##7##2##(1990-12#1)(1993-6#1)(1997-2#1)(2007-6#1)(2009-11#1)(2010-10#1)(2010-8#1)
all tissues examined##2##3##(1993-3#1)(2008-12#1)
all tissues##9##2##(1990-11#1)(1993-11#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
all to##2##2##(1990-5#1)(1992-10#1)
all together##4##2##(1991-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
all too often##2##3##(1993-12#1)(1996-12#1)
all too##4##2##(1993-12#1)(1996-12#1)(2008-10#1)(2011-2#1)
all traffic##2##2##(1990-6#1)(2011-2#1)
all traits##2##2##(2008-10#1)(2008-9#1)
all transformed##2##2##(1990-11#1)(1993-6#1)
all treated groups##2##3##(2012-12#1)(2012-2#1)
all treated##3##2##(2008-4#1)(2012-12#1)(2012-2#1)
all treatment groups##2##3##(2008-11#1)(2011-1#1)
all treatment##7##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-1#2)
all treatments##13##2##(1995-3#1)(2008-10#6)(2008-12#1)(2010-4#1)(2011-2#2)(2013-1#2)
all trials##3##2##(2008-10#2)(2010-3#1)
all tropical##2##2##(2008-10#1)(2008-8#1)
all tumors##4##2##(1990-12#1)(1990-2#1)(1990-9#1)(2008-4#1)
all tumours##3##2##(1991-11#1)(1995-2#1)(2011-2#1)
all type##2##2##(2008-10#2)
all types of##34##3##(1990-12#1)(1990-5#1)(1992-3#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
all types##39##2##(1990-12#1)(1990-5#1)(1992-3#1)(1994-12#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
all under##2##2##(1992-3#1)(1994-9#1)
all undergo##2##2##(1993-8#1)(2008-10#1)
all units##5##2##(1992-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
all university##2##2##(1992-9#1)(1997-8#1)
all values of##2##3##(2008-2#1)(2012-3#1)
all values##3##2##(2008-2#1)(2012-3#2)
all variables were##2##3##(1992-3#1)(2008-10#1)
all variables##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
all vertebrates##3##2##(1994-5#1)(1995-11#1)(2008-4#1)
all viral##2##2##(2008-10#1)(2008-9#1)
all virulences were significantly associated##2##5##(2008-10#2)
all water##2##2##(2008-10#2)
all wavelengths##6##2##(1995-6#1)(2007-12#1)(2008-3#4)
all were##24##2##(1991-12#1)(1992-10#1)(1993-12#1)(2007-6#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)(2011-7#1)(2013-1#2)
all who##2##2##(1996-12#1)(2007-2#1)
all with a##4##3##(2008-11#1)(2008-7#2)(2009-8#1)
all with##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#1)
all within##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
all women##10##2##(1990-6#1)(1991-2#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
all work hours##2##3##(1993-1#2)
all year round##2##3##(2008-5#1)(2013-7#1)
all year##3##2##(2008-11#1)(2008-5#1)(2013-7#1)
all years##6##2##(2008-10#4)(2008-5#1)(2010-2#1)
all yeast##2##2##(1990-7#1)(1995-2#1)
all zones##2##2##(2008-10#1)(2008-9#1)
all##5695##1##(1990-11#21)(1990-12#22)(1990-2#20)(1990-3#14)(1990-5#21)(1990-6#17)(1990-7#11)(1990-8#19)(1990-9#20)(1991-1#8)(1991-10#4)(1991-11#13)(1991-12#28)(1991-2#22)(1991-3#17)(1991-4#3)(1991-5#17)(1991-6#15)(1991-7#1)(1991-8#13)(1991-9#16)(1992-1#6)(1992-10#7)(1992-11#15)(1992-12#16)(1992-2#24)(1992-3#39)(1992-4#4)(1992-5#7)(1992-6#33)(1992-7#1)(1992-8#18)(1992-9#19)(1993-1#8)(1993-11#21)(1993-12#47)(1993-2#21)(1993-3#15)(1993-5#2)(1993-6#14)(1993-8#28)(1993-9#15)(1994-1#9)(1994-10#1)(1994-11#18)(1994-12#29)(1994-2#23)(1994-3#25)(1994-5#23)(1994-6#8)(1994-7#8)(1994-8#22)(1994-9#20)(1995-1#16)(1995-11#18)(1995-12#33)(1995-2#42)(1995-3#28)(1995-4#2)(1995-5#29)(1995-6#43)(1995-8#15)(1995-9#4)(1996-1#21)(1996-10#2)(1996-11#10)(1996-12#47)(1996-2#22)(1996-3#25)(1996-4#4)(1996-5#28)(1996-6#17)(1996-7#9)(1996-8#7)(1996-9#9)(1997-1#15)(1997-2#31)(1997-3#43)(1997-4#24)(1997-5#5)(1997-6#22)(1997-7#22)(1997-8#20)(1997-9#5)(2006-10#8)(2006-12#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-10#24)(2007-11#79)(2007-12#92)(2007-2#10)(2007-3#1)(2007-4#8)(2007-5#5)(2007-6#8)(2007-7#40)(2007-8#47)(2007-9#5)(2008-1#78)(2008-10#1218)(2008-11#162)(2008-12#110)(2008-2#61)(2008-3#165)(2008-4#97)(2008-5#143)(2008-6#53)(2008-7#183)(2008-8#132)(2008-9#142)(2009-1#3)(2009-10#21)(2009-11#16)(2009-12#19)(2009-2#12)(2009-3#12)(2009-4#15)(2009-5#24)(2009-6#11)(2009-7#10)(2009-8#34)(2009-9#8)(2010-1#14)(2010-10#14)(2010-11#16)(2010-12#22)(2010-2#18)(2010-3#38)(2010-4#28)(2010-5#25)(2010-6#18)(2010-7#16)(2010-8#33)(2010-9#11)(2011-1#58)(2011-10#4)(2011-2#255)(2011-3#16)(2011-7#3)(2011-9#1)(2012-1#26)(2012-12#64)(2012-2#119)(2012-3#79)(2012-4#1)(2012-5#1)(2012-6#3)(2012-8#4)(2013-1#160)(2013-7#22)(2013-8#77)
all)##2##1##(2008-11#1)(2008-12#1)
all-atom##2##1##(1993-11#1)(2008-4#1)
all-cause mortality during##2##3##(2007-10#1)(2008-7#1)
all-cause mortality in patients with##2##5##(2009-2#1)(2010-1#1)
all-cause mortality in##6##3##(2008-7#1)(2009-2#1)(2010-1#1)(2011-2#2)(2012-2#1)
all-cause mortality risk and##2##4##(2013-8#2)
all-cause mortality##21##2##(1991-8#1)(1993-12#2)(2007-10#2)(2008-3#1)(2008-7#4)(2009-2#1)(2010-1#1)(2010-2#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
all-cause##24##1##(1991-8#1)(1993-12#2)(1997-4#1)(2007-10#2)(2008-3#1)(2008-7#4)(2009-10#1)(2009-2#1)(2010-1#1)(2010-2#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
all-ceramic restorations##2##2##(2009-8#2)
all-ceramic##4##1##(2008-7#1)(2009-7#1)(2009-8#2)
all-dielectric nonpolarizing beam splitters##2##4##(2008-2#2)
all-dielectric##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
all-digital##3##1##(2008-3#3)
all-diploid##2##1##(2010-3#2)
all-fiber modulators based on##2##4##(2008-3#2)
all-fiber##14##1##(2007-11#4)(2007-12#4)(2008-2#1)(2008-3#5)
all-light atom guide##2##3##(2007-12#2)
all-optical code-division multiplexing##2##3##(2008-3#2)
all-optical code-division##3##2##(2008-2#1)(2008-3#2)
all-optical communication##2##2##(2007-12#1)(2008-2#1)
all-optical logic##2##2##(2008-3#2)
all-optical packet##2##2##(2008-3#2)
all-optical poling##4##2##(2007-11#3)(2007-12#1)
all-optical processing##2##2##(2007-11#1)(2007-12#1)
all-optical quartz-enhanced photoacoustic spectroscopy system is##2##6##(2013-8#2)
all-optical quartz-enhanced photoacoustic spectroscopy system##3##5##(2013-8#3)
all-optical realization of##2##3##(2008-3#2)
all-optical switch##6##2##(2007-11#4)(2007-12#1)(2008-2#1)
all-optical switching##8##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
all-optical##68##1##(2007-11#15)(2007-12#12)(2008-2#11)(2008-3#25)(2012-2#2)(2013-8#3)
all-pass filter##2##2##(2007-11#2)
all-pass##3##1##(2007-11#3)
all-payer reimbursement##2##2##(1993-3#1)(1996-12#1)
all-payer##7##1##(1992-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1996-12#1)
all-round##3##1##(2008-9#2)(2010-12#1)
all-serial##2##1##(2008-2#1)(2008-3#1)
all-site##2##1##(2010-1#2)
all-sky##2##1##(2008-2#1)(2008-3#1)
all-solid-state Cr##2##2##(2007-11#2)
all-solid-state electrodes##3##2##(2008-10#3)
all-solid-state laser##4##2##(2008-2#1)(2008-3#3)
all-solid-state potassium-selective electrode##2##3##(2008-10#2)
all-solid-state tunable##3##2##(2007-11#2)(2008-2#1)
all-solid-state##29##1##(2007-11#6)(2007-12#1)(2008-10#13)(2008-2#5)(2008-3#4)
all-stage resistance##2##2##(2008-10#2)
all-trans and##2##2##(1992-8#1)(1992-9#1)
all-trans isomers##3##2##(1991-5#3)
all-trans retinoic acid (RA)##3##4##(1996-5#1)(2008-5#1)(2012-1#1)
all-trans retinoic acid##9##3##(1996-5#1)(2007-4#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
all-trans##20##1##(1991-5#3)(1992-8#1)(1992-9#1)(1993-9#1)(1996-5#1)(2007-12#1)(2007-4#1)(2008-5#2)(2008-8#1)(2010-2#4)(2011-2#2)(2012-1#1)(2013-1#1)
all-trans-retinoic acid (ATRA)##2##3##(2008-4#1)(2008-9#1)
all-trans-retinoic acid##6##2##(1994-6#2)(1996-5#2)(2008-4#1)(2008-9#1)
all-triploid##2##1##(2010-3#2)
all-weather##2##1##(2008-2#1)(2008-3#1)
all?##3##1##(1991-3#1)(1996-6#1)(2007-12#1)
allantoic fluid samples from##2##4##(2008-5#2)
allantoic##3##1##(2008-10#1)(2008-5#2)
allantoin and betaine##2##3##(2008-10#2)
allantoin##3##1##(1997-3#1)(2008-10#2)
allata##5##1##(1991-12#1)(1995-11#2)(2008-7#2)
allay##5##1##(1995-2#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-7#1)
allegations of sexual##2##3##(1992-2#2)
allegations of##5##2##(1991-12#1)(1992-2#2)(2007-2#1)(2007-9#1)
allegations##14##1##(1991-12#2)(1992-12#1)(1992-2#2)(1995-12#1)(2007-2#1)(2007-9#1)(2008-10#6)
alleged sexual##2##2##(1995-6#1)(2011-2#1)
alleged that##3##2##(1995-12#1)(1995-6#1)(1997-5#1)
alleged##13##1##(1995-12#1)(1995-6#2)(1996-5#1)(1997-5#2)(2008-10#4)(2008-12#1)(2010-6#1)(2011-2#1)
allegedly##4##1##(1994-1#2)(1995-12#1)(2009-6#1)
alleging##6##1##(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1997-5#2)
allele 1##2##2##(1993-3#2)
allele 4##4##2##(1993-3#3)(2008-12#1)
allele and##8##2##(1993-6#1)(1994-8#1)(1997-5#1)(2008-1#1)(2008-10#1)(2009-3#1)(2012-2#1)(2013-1#1)
allele at##6##2##(2008-10#3)(2008-8#1)(2008-9#2)
allele conferring##2##2##(2008-10#2)
allele distribution in##2##3##(1996-3#1)(1996-5#1)
allele distribution##3##2##(1996-3#1)(1996-5#1)(1997-5#1)
allele dropout##2##2##(2008-4#1)(2012-3#1)
allele frequencies and##3##3##(2008-10#2)(2008-4#1)
allele frequencies in##3##3##(1995-12#1)(2008-10#2)
allele frequencies were##8##3##(2011-1#8)
allele frequencies##32##2##(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#9)(2008-12#4)(2008-4#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#11)(2013-1#1)
allele frequency differences##2##3##(2008-12#1)(2009-5#1)
allele frequency##8##2##(1995-12#3)(2008-12#2)(2008-9#1)(2009-5#1)(2013-1#1)
allele from the high##2##4##(2008-10#1)(2008-2#1)
allele from the##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
allele from##4##2##(1997-2#1)(2008-10#2)(2008-2#1)
allele had##5##2##(1995-2#1)(2008-10#1)(2008-12#2)(2008-5#1)
allele has been##2##3##(1995-12#1)(2012-2#1)
allele in the##2##3##(1996-5#1)(1997-3#1)
allele in##9##2##(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#3)
allele is##7##2##(2008-1#1)(2008-12#3)(2009-8#1)(2010-12#1)(2012-12#1)
allele of the##6##3##(1993-6#1)(1995-9#1)(1997-4#1)(2008-4#1)(2009-5#1)(2012-3#1)
allele of##12##2##(1993-3#1)(1993-6#1)(1995-9#1)(1997-4#3)(2008-12#1)(2008-4#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-3#1)
allele on##4##2##(1993-2#3)(2008-10#1)
allele revealed##2##2##(1990-8#1)(1991-8#1)
allele richness##2##2##(2008-10#1)(2013-8#1)
allele sharing (P = 0##2##5##(1997-5#2)
allele sharing among##2##3##(1997-5#1)(2012-3#1)
allele sharing##11##2##(1997-5#9)(2008-1#1)(2012-3#1)
allele specific##2##2##(2008-8#1)(2012-3#1)
allele that is##2##3##(1993-6#1)(2008-5#1)
allele that##5##2##(1993-6#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
allele was found##3##3##(1993-11#1)(2010-12#1)(2011-2#1)
allele was##12##2##(1993-11#1)(2008-10#4)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#3)
allele were detected##2##3##(1994-11#1)(2009-2#1)
allele were##5##2##(1992-6#1)(1994-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
allele##258##1##(1990-11#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-5#1)(1991-8#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#3)(1993-3#8)(1993-6#4)(1993-9#2)(1994-11#3)(1994-12#3)(1994-3#2)(1994-8#2)(1995-12#8)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#11)(1997-7#2)(1997-8#5)(1997-9#2)(2007-6#2)(2008-1#3)(2008-10#53)(2008-12#16)(2008-2#1)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#14)(2009-2#4)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#3)(2010-12#4)(2010-2#4)(2010-4#2)(2010-6#1)(2011-1#14)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#13)(2013-1#5)(2013-8#1)
allele)##7##1##(2008-10#6)(2008-12#1)
allele-specific PCR##3##2##(1995-12#1)(2008-4#1)(2013-1#1)
allele-specific expression##2##2##(1993-2#1)(1997-7#1)
allele-specific odds ratio = 0##2##5##(2010-2#2)
allele-specific##17##1##(1990-5#1)(1993-2#2)(1993-3#2)(1995-12#1)(1996-6#1)(1997-7#2)(2008-4#3)(2008-9#1)(2010-2#2)(2011-2#1)(2013-1#1)
alleles and the##2##3##(2008-12#1)(2008-9#1)
alleles and##11##2##(1993-2#1)(2008-10#2)(2008-12#3)(2008-8#1)(2008-9#1)(2012-3#3)
alleles are##6##2##(1995-12#1)(1997-3#2)(2008-7#1)(2008-9#1)(2011-2#1)
alleles at each##2##3##(2008-10#1)(2008-5#1)
alleles at##9##2##(1990-8#1)(1997-8#1)(2008-10#4)(2008-5#1)(2011-2#2)
alleles between##2##2##(1993-3#1)(2011-1#1)
alleles can##2##2##(1995-2#1)(2008-10#1)
alleles during##2##2##(2008-7#1)(2011-1#1)
alleles for##4##2##(2008-10#3)(2009-10#1)
alleles from##4##2##(1994-12#1)(2008-10#3)
alleles in the##9##3##(1993-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
alleles in##22##2##(1993-3#2)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)
alleles of##14##2##(1997-3#1)(1997-5#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#4)(2011-1#1)(2012-3#1)(2013-1#1)
alleles on##2##2##(1994-12#1)(2008-10#1)
alleles per##8##2##(2008-10#4)(2008-5#1)(2012-3#1)(2013-8#2)
alleles revealed##2##2##(1997-3#1)(2012-5#1)
alleles that were##2##3##(2007-12#1)(2008-5#1)
alleles that##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
alleles to##2##2##(2008-12#1)(2012-3#1)
alleles was##3##2##(1993-3#1)(1997-3#1)(2012-1#1)
alleles were detected in##3##4##(1993-3#1)(2008-10#1)(2008-7#1)
alleles were detected##4##3##(1993-3#1)(2008-10#2)(2008-7#1)
alleles were found##3##3##(2008-5#3)
alleles were identified##2##3##(2009-8#1)(2012-12#1)
alleles were observed in##2##4##(2008-10#1)(2008-5#1)
alleles were observed##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
alleles were shared by AI##2##5##(2008-10#2)
alleles were unique to only##2##5##(2008-10#2)
alleles were##27##2##(1993-3#1)(1997-2#1)(2008-10#7)(2008-12#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
alleles with PIC and HET values of 0##2##8##(2008-12#2)
alleles with##8##2##(1992-3#1)(1997-5#2)(1997-8#1)(2008-12#3)(2012-12#1)
alleles within##2##2##(2008-10#1)(2012-3#1)
alleles##258##1##(1990-5#1)(1990-8#2)(1991-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#5)(1993-6#3)(1994-12#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#13)(1997-5#6)(1997-8#8)(1997-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#68)(2008-11#2)(2008-12#22)(2008-4#2)(2008-5#10)(2008-7#4)(2008-8#7)(2008-9#17)(2009-10#1)(2009-5#5)(2009-8#2)(2010-2#1)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#10)(2012-2#1)(2012-3#24)(2012-5#1)(2013-1#5)(2013-8#3)
alleles) and##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
alleles)##6##1##(1997-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
allelic differences in##2##3##(1993-6#1)(2008-2#1)
allelic discrimination##3##2##(2008-10#3)
allelic distribution##2##2##(1997-3#1)(2008-3#1)
allelic diversity for##2##3##(2008-10#1)(2008-5#1)
allelic diversity of##2##3##(2008-12#1)(2008-5#1)
allelic diversity##6##2##(2008-10#2)(2008-12#1)(2008-5#3)
allelic effects##3##2##(2008-8#2)(2012-3#1)
allelic forms##2##2##(1990-5#1)(1995-5#1)
allelic frequencies of##2##3##(2008-12#1)(2009-8#1)
allelic frequencies##4##2##(2008-12#2)(2008-9#1)(2009-8#1)
allelic frequency##2##2##(1990-3#1)(2009-5#1)
allelic imbalance##3##2##(1994-12#1)(2012-3#2)
allelic or##2##2##(1992-8#1)(2008-10#1)
allelic relationship of##2##3##(2008-10#2)
allelic relationships of##2##3##(2008-10#2)
allelic to##3##2##(1995-6#1)(2008-10#2)
allelic variants##5##2##(1991-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
allelic variation at##2##3##(2008-10#1)(2012-3#1)
allelic variation##3##2##(2008-10#1)(2012-3#2)
allelic##70##1##(1990-3#1)(1990-5#1)(1991-8#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#3)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#20)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#8)(2013-1#1)(2013-8#1)
allelism tests##2##2##(2008-10#2)
allelism##4##1##(2007-7#1)(2008-10#3)
allelopathy##2##1##(2008-10#1)(2008-7#1)
allene##5##1##(1996-5#1)(2009-10#3)(2010-3#1)
allergen Phl p 1##2##4##(2012-2#2)
allergen as a##2##3##(2008-10#2)
allergen binding##2##2##(2008-10#2)
allergen concentrations##2##2##(2008-10#1)(2012-12#1)
allergen in##3##2##(2007-7#1)(2008-10#2)
allergen##42##1##(1991-2#2)(1994-11#2)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#13)(2008-11#6)(2008-5#1)(2008-8#2)(2010-1#1)(2010-5#3)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)
allergen-induced##2##1##(2008-10#1)(2008-3#1)
allergen-specific IgE in##2##3##(2008-10#1)(2008-11#1)
allergen-specific IgE##7##2##(1990-12#1)(2008-10#4)(2008-11#2)
allergen-specific##10##1##(1990-12#1)(2008-10#5)(2008-11#2)(2009-5#1)(2010-5#1)
allergenic extract##2##2##(2007-2#2)
allergenic extracts##2##2##(2007-2#2)
allergenic##16##1##(1996-5#1)(2007-2#4)(2008-11#7)(2008-4#1)(2009-10#1)(2013-1#1)(2013-8#1)
allergenicity##3##1##(2010-5#2)(2013-1#1)
allergens and##8##2##(1993-3#1)(1997-2#1)(2010-5#2)(2011-2#3)(2013-8#1)
allergens are the##2##3##(1991-3#1)(2010-5#1)
allergens are##6##2##(1991-3#1)(2007-7#1)(2008-5#1)(2009-10#1)(2010-5#2)
allergens for the##2##3##(1990-8#1)(2013-1#1)
allergens in##6##2##(1990-3#2)(2007-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
allergens that##2##2##(2008-10#1)(2010-5#1)
allergens were##2##2##(2009-10#1)(2013-1#1)
allergens##60##1##(1990-3#3)(1990-8#1)(1991-3#1)(1992-3#1)(1993-3#1)(1996-5#3)(1997-2#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#3)(2009-10#4)(2009-5#1)(2009-6#1)(2010-5#6)(2010-6#1)(2011-2#16)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
allergic and##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
allergic bronchopulmonary aspergillosis##2##3##(1994-3#1)(2010-5#1)
allergic conditions##2##2##(2009-6#1)(2010-4#1)
allergic conjunctivitis##2##2##(1991-2#1)(2012-3#1)
allergic contact dermatitis##6##3##(2007-11#1)(2007-7#1)(2008-5#3)(2012-3#1)
allergic disease##4##2##(2008-11#2)(2010-6#1)(2011-1#1)
allergic diseases in##2##3##(2010-5#2)
allergic diseases such as##2##4##(2008-10#1)(2012-12#1)
allergic diseases##16##2##(1991-2#1)(1992-3#1)(1994-6#3)(1994-8#1)(2008-10#1)(2008-3#3)(2009-6#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
allergic disorders##2##2##(2008-10#1)(2010-6#1)
allergic fungal rhinosinusitis##2##3##(2009-2#1)(2012-1#1)
allergic history of patients##2##4##(2011-2#2)
allergic history of##3##3##(2011-2#3)
allergic history##4##2##(2011-2#4)
allergic inflammation##2##2##(1997-7#1)(2010-6#1)
allergic inflammatory##2##2##(1992-3#1)(2013-1#1)
allergic or##2##2##(1990-3#1)(2007-11#1)
allergic patients##3##2##(2011-1#1)(2013-1#2)
allergic reaction##7##2##(1990-3#1)(1991-1#1)(1993-6#1)(2007-5#1)(2008-11#1)(2010-6#1)(2013-1#1)
allergic reactions in##2##3##(2008-11#1)(2008-12#1)
allergic reactions to##3##3##(1990-12#1)(2007-5#1)(2010-4#1)
allergic reactions##13##2##(1990-12#1)(1990-8#2)(1994-11#1)(1995-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
allergic response##4##2##(2010-1#1)(2010-5#1)(2012-12#2)
allergic rhinitis (AR) and asthma##2##5##(2008-7#1)(2012-12#1)
allergic rhinitis (AR)##4##3##(2008-7#1)(2012-12#2)(2013-8#1)
allergic rhinitis and##4##3##(2008-7#1)(2010-6#2)(2013-1#1)
allergic rhinitis in##4##3##(2012-2#2)(2013-1#1)(2013-8#1)
allergic rhinitis##43##2##(2007-11#8)(2008-10#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#2)(2010-5#1)(2010-6#3)(2011-2#2)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
allergic sensitization##3##2##(1992-3#1)(2010-5#2)
allergic subjects##3##2##(2008-11#1)(2010-5#1)(2013-8#1)
allergic symptoms##2##2##(2008-10#1)(2013-8#1)
allergic to all##3##3##(2011-2#3)
allergic to##5##2##(1996-11#1)(2011-2#3)(2013-8#1)
allergic##165##1##(1990-12#1)(1990-3#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1992-3#3)(1992-5#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#5)(1994-8#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-7#1)(2007-11#11)(2007-5#2)(2007-7#3)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#11)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#4)(2009-2#1)(2009-5#1)(2009-6#3)(2010-1#1)(2010-4#2)(2010-5#10)(2010-6#9)(2011-1#3)(2011-2#15)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#6)
allergies and##4##2##(1990-8#1)(1996-3#1)(2008-10#1)(2010-5#1)
allergies in##2##2##(2008-7#1)(2012-3#1)
allergies may##2##2##(1990-8#1)(1995-11#1)
allergies##18##1##(1990-8#3)(1994-2#2)(1995-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
allergy and clinical immunology##3##4##(2012-12#3)
allergy and##8##2##(1991-11#1)(1993-2#1)(2007-12#1)(2011-2#1)(2012-12#3)(2013-1#1)
allergy in##3##2##(1996-8#1)(2009-2#1)(2013-1#1)
allergy is##4##2##(1995-3#1)(2007-5#1)(2008-11#1)(2013-1#1)
allergy or##4##2##(1996-3#1)(2008-10#1)(2008-7#2)
allergy reaction evaluation system##4##4##(2008-11#4)
allergy sufferers##3##2##(1994-2#3)
allergy to##2##2##(1991-11#1)(2012-1#1)
allergy##67##1##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-8#1)(1993-2#1)(1994-11#1)(1994-2#3)(1995-3#1)(1996-3#3)(1996-8#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#10)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-5#6)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#6)(2013-8#4)
alleviate pain in##2##3##(1995-12#1)(2008-11#1)
alleviate pain##3##2##(1995-12#1)(2008-11#1)(2010-12#1)
alleviate the current##2##3##(1994-1#1)(2008-3#1)
alleviate the symptoms of##2##4##(2011-3#1)(2012-2#1)
alleviate the symptoms##3##3##(2011-3#2)(2012-2#1)
alleviate the##13##2##(1992-8#1)(1994-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
alleviate this##2##2##(1992-12#1)(2008-6#1)
alleviate##36##1##(1990-5#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
alleviated by##6##2##(1991-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-5#1)
alleviated the##2##2##(1997-2#1)(2008-7#1)
alleviated with spectral filters and precision tinted ophthalmic lenses##2##9##(2013-1#2)
alleviated with##3##2##(2008-10#1)(2013-1#2)
alleviated##20##1##(1991-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-7#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#2)
alleviates##7##1##(1991-12#1)(1996-5#1)(2007-11#2)(2008-12#1)(2012-9#1)(2013-8#1)
alleviating pain and##2##3##(2007-8#1)(2008-7#1)
alleviating pain##3##2##(1994-2#1)(2007-8#1)(2008-7#1)
alleviating the##6##2##(1994-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-6#1)
alleviating##20##1##(1993-9#1)(1994-1#1)(1994-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-8#2)
alleviation of symptoms##3##3##(1993-11#1)(2008-7#1)(2009-7#1)
alleviation of##9##2##(1993-11#1)(1993-2#1)(1994-2#1)(2008-7#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
alleviation##10##1##(1993-11#1)(1993-2#1)(1994-2#1)(2008-7#2)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
alley##4##1##(1993-12#1)(1993-5#2)(2010-7#1)
alliance between##2##2##(1996-2#1)(2008-6#1)
alliance of academic health##2##4##(1997-2#2)
alliance stakeholders##2##2##(2013-1#2)
alliance with##2##2##(2008-4#1)(2008-6#1)
alliance##27##1##(1992-1#2)(1993-1#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#2)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#9)
alliances are##5##2##(1992-1#1)(1997-2#1)(2008-10#1)(2013-1#2)
alliances had##2##2##(2013-1#2)
alliances have##3##2##(2013-1#3)
alliances in health care##2##4##(1992-1#2)
alliances in##4##2##(1992-1#2)(2009-11#1)(2013-1#1)
alliances of##2##2##(1992-12#1)(1997-2#1)
alliances##57##1##(1991-1#1)(1992-1#10)(1992-12#1)(1993-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#3)(1997-3#3)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2013-1#28)
alliances'##4##1##(2013-1#4)
allied health education##2##3##(1996-2#2)
allied health professionals##2##3##(2008-8#1)(2011-1#1)
allied health##9##2##(1995-2#1)(1996-1#1)(1996-2#5)(2008-8#1)(2011-1#1)
allied with##2##2##(2008-10#1)(2008-6#1)
allied##14##1##(1995-2#1)(1996-1#1)(1996-2#5)(1997-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
alligator gar##4##2##(2008-7#4)
alligator##7##1##(2008-7#4)(2008-8#1)(2010-3#2)
allii urediniospores and##2##3##(2008-10#2)
allii##19##1##(2008-10#19)
allis shad##3##2##(2008-12#3)
allo-##2##1##(2008-8#1)(2012-12#1)
allo-HSCT##2##1##(2011-2#1)(2013-1#1)
allo-deposition##2##1##(2008-10#2)
alloanti-D##2##1##(1994-12#2)
alloantibodies in##2##2##(1994-3#2)
alloantibodies##10##1##(1994-12#1)(1994-3#2)(1994-9#1)(2008-9#1)(2010-11#1)(2011-2#4)
alloantibody##3##1##(1992-12#1)(1992-6#1)(1994-12#1)
allocate more resources to##2##4##(1992-1#1)(2008-8#1)
allocate more##3##2##(1992-1#1)(2008-5#1)(2008-8#1)
allocate resources##4##2##(1993-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
allocate##13##1##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#2)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#2)(2013-1#2)
allocated for##2##2##(1990-2#1)(2008-10#1)
allocated in##2##2##(2008-6#1)(2011-2#1)
allocated into##8##2##(2007-8#1)(2008-10#3)(2010-12#1)(2012-2#2)(2012-3#1)
allocated on the##2##3##(1991-9#1)(1992-2#1)
allocated to the##6##3##(1994-2#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)
allocated to three groups##2##4##(2008-12#1)(2008-5#1)
allocated to two##2##3##(2008-10#1)(2009-8#1)
allocated to##30##2##(1991-8#2)(1994-2#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#5)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
allocated##53##1##(1990-2#1)(1991-8#2)(1991-9#1)(1992-2#1)(1993-12#1)(1994-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#6)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
allocates##2##1##(2006-10#1)(2011-2#1)
allocating##11##1##(1991-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-11#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
allocation and the##2##3##(1992-3#1)(2008-9#1)
allocation and##8##2##(1992-3#1)(1995-1#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)
allocation are##2##2##(2008-12#1)(2008-8#1)
allocation concealment##2##2##(2008-10#2)
allocation decisions##4##2##(1992-3#1)(1994-12#1)(1995-1#1)(1997-1#1)
allocation in the##2##3##(2010-6#1)(2012-12#1)
allocation in##6##2##(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#1)(2012-12#1)
allocation of resources to##2##4##(2008-9#2)
allocation of resources##5##3##(2007-4#1)(2008-8#1)(2008-9#2)(2012-12#1)
allocation of scarce##2##3##(2008-7#1)(2012-12#1)
allocation of##26##2##(1991-6#1)(1995-12#1)(2007-11#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2010-4#1)(2012-12#2)(2012-2#2)
allocation theory##3##2##(2008-8#1)(2008-9#2)
allocation to the##3##3##(1995-6#1)(2008-5#1)(2008-9#1)
allocation to##9##2##(1995-6#1)(2008-5#1)(2008-8#5)(2008-9#2)
allocation with##2##2##(2012-12#2)
allocation##113##1##(1991-6#1)(1992-1#1)(1992-3#3)(1994-12#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-6#2)(1997-1#1)(2007-11#1)(2007-12#2)(2007-4#4)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#32)(2008-9#16)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-1#2)(2012-12#6)(2012-2#2)(2013-1#4)(2013-8#3)
allocentric spatial processing##2##3##(1994-3#2)
allocentric##5##1##(1994-3#4)(1994-8#1)
allochthonous inputs##6##2##(2008-9#6)
allochthonous##7##1##(1992-5#1)(2008-9#6)
allodynia and##5##2##(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#1)
allodynia in##2##2##(2009-12#1)(2012-12#1)
allodynia##25##1##(1996-12#1)(1996-6#3)(1997-2#2)(2008-4#1)(2008-9#9)(2009-12#3)(2011-2#4)(2012-12#1)(2013-1#1)
allodynic##2##1##(1996-12#1)(1996-6#1)
allogeneic HSCT##3##2##(2010-5#2)(2011-2#1)
allogeneic and autologous##3##3##(1993-9#1)(2008-11#1)(2008-4#1)
allogeneic and##4##2##(1993-9#1)(2008-11#1)(2008-4#1)(2013-1#1)
allogeneic bone marrow transplantation##2##4##(1997-3#1)(2008-1#1)
allogeneic bone marrow transplantation]##2##4##(1991-5#1)(2008-1#1)
allogeneic bone marrow##4##3##(1991-5#1)(1997-3#1)(2008-1#2)
allogeneic hematopoietic stem cell transplantation (HSCT) in##2##7##(2010-5#1)(2011-2#1)
allogeneic hematopoietic stem cell transplantation##4##5##(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
allogeneic hematopoietic stem cell##5##4##(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#2)
allogeneic hematopoietic##6##2##(2008-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#2)
allogeneic mixed lymphocyte##2##3##(1991-9#1)(2008-10#1)
allogeneic peripheral##2##2##(2006-10#2)
allogeneic stem cell transplantation##5##4##(2008-7#1)(2011-2#3)(2012-12#1)
allogeneic##50##1##(1991-5#2)(1991-9#1)(1992-9#1)(1993-9#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-3#1)(2006-10#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-5#3)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
allogenic##6##1##(2007-8#1)(2009-3#2)(2010-6#1)(2012-1#1)(2012-3#1)
allograft and autograft PCL reconstruction##2##5##(2013-1#2)
allograft and autograft##4##3##(2010-3#1)(2012-3#1)(2013-1#2)
allograft and##6##2##(2008-3#1)(2008-6#1)(2010-3#1)(2012-3#1)(2013-1#2)
allograft bone in##2##3##(1996-3#1)(2008-3#1)
allograft dysfunction##5##2##(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-3#1)
allograft fixation##4##2##(2009-3#4)
allograft for##2##2##(2011-2#1)(2012-2#1)
allograft in##3##2##(2012-12#1)(2012-3#2)
allograft is##2##2##(1992-12#1)(2012-3#1)
allograft recipients##10##2##(1991-11#1)(1992-12#1)(2008-1#4)(2008-10#2)(2008-4#1)(2008-5#1)
allograft reconstruction##4##2##(2008-6#4)
allograft rejection##2##2##(2008-10#1)(2008-5#1)
allograft survival##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
allograft tricortical iliac crest##2##4##(2009-10#2)
allograft##82##1##(1991-11#1)(1992-12#2)(1996-3#1)(1997-8#1)(2007-7#2)(2008-1#8)(2008-10#8)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#1)(2008-8#2)(2009-10#4)(2009-3#6)(2010-10#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#10)(2013-1#3)
allografts and##2##2##(1996-3#1)(2009-3#1)
allografts have a##2##3##(2008-7#1)(2012-3#1)
allografts have##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
allografts in patients##3##3##(2008-8#1)(2012-2#2)
allografts in##4##2##(1996-3#1)(2008-8#1)(2012-2#2)
allografts##36##1##(1992-12#4)(1995-11#1)(1996-3#4)(2007-7#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#8)(2009-3#3)(2010-11#1)(2010-3#1)(2011-3#1)(2012-2#3)(2012-3#3)
alloherpesvirus##3##1##(2012-3#3)
alloimmune##2##1##(2008-10#1)(2012-3#1)
alloimmunization##6##1##(1991-11#2)(1991-3#1)(1994-6#2)(2011-2#1)
allometric growth in##2##3##(2013-7#2)
allometric relationships##3##2##(2008-8#2)(2010-8#1)
allometric##14##1##(2008-5#1)(2008-8#5)(2009-5#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
allometry coefficients##2##2##(2011-2#2)
allometry##16##1##(1993-12#2)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#9)
allopatric and##2##2##(2008-8#2)
allopatric populations##2##2##(2008-10#1)(2013-7#1)
allopatric##7##1##(2008-10#2)(2008-8#3)(2013-7#2)
allopatry were##2##2##(2008-10#2)
allopatry##6##1##(2008-10#6)
alloplasm##2##1##(2008-8#2)
alloplasmic wheat##3##2##(2008-8#3)
alloplasmic##4##1##(2008-5#1)(2008-8#3)
alloplastic##7##1##(2007-12#1)(2010-6#1)(2012-2#1)(2012-3#4)
alloplasty##3##1##(2007-11#2)(2007-8#1)
allopolyploid##4##1##(2008-9#2)(2013-1#2)
allopurinol##10##1##(1995-12#1)(1996-9#1)(2008-10#6)(2008-7#1)(2008-9#1)
allopurinol-treated DMD patients##2##3##(1995-12#2)
allopurinol-treated##3##1##(1995-12#3)
allorecognition##3##1##(2012-3#3)
allostatic load##3##2##(2010-12#3)
allosteric effect##2##2##(1992-8#1)(1995-11#1)
allosteric effectors such as##2##4##(1990-8#2)
allosteric effectors##3##2##(1990-8#2)(1997-2#1)
allosteric effects##3##2##(1991-10#1)(1997-2#1)(2012-2#1)
allosteric enzyme##2##2##(1990-8#1)(1994-11#1)
allosteric inhibitor##3##2##(1995-2#1)(1997-2#1)(2008-4#1)
allosteric interaction##7##2##(1995-11#7)
allosteric interactions##2##2##(1995-11#1)(2012-1#1)
allosteric mechanism##2##2##(1995-2#1)(1995-5#1)
allosteric model##4##2##(1990-8#2)(1997-2#2)
allosteric properties of the##2##4##(1990-8#2)
allosteric properties of##3##3##(1990-8#3)
allosteric regulation##2##2##(1991-5#1)(1995-5#1)
allosteric theory##2##2##(1990-8#2)
allosteric##61##1##(1990-8#19)(1991-1#1)(1991-10#1)(1991-5#1)(1992-8#3)(1993-8#1)(1994-11#1)(1995-11#10)(1995-2#4)(1995-5#4)(1997-2#5)(2008-3#2)(2008-4#2)(2008-8#1)(2009-5#1)(2012-1#2)(2012-12#1)(2012-2#2)
allosterically##4##1##(1991-1#1)(1995-11#2)(2012-2#1)
allostery in##2##2##(1990-8#1)(1997-2#1)
allostery##4##1##(1990-8#1)(1997-2#3)
allotetraploid unisexual clone##2##3##(2008-9#2)
allotetraploid unisexual##3##2##(2008-9#3)
allotetraploid##9##1##(2008-9#6)(2009-9#2)(2011-2#1)
allotment gardens##2##2##(2008-10#2)
allotment##3##1##(1992-12#1)(2008-10#2)
allotransplant##2##1##(2008-10#2)
allotransplantation##4##1##(2008-9#1)(2011-2#2)(2013-1#1)
allotriploid##7##1##(2008-9#7)
allotype##2##1##(1992-6#1)(1997-8#1)
allotypes##3##1##(1993-2#1)(1997-8#2)
allow a higher##2##3##(1991-6#1)(2008-7#1)
allow a more##2##3##(1993-5#1)(2008-4#1)
allow a##27##2##(1990-7#1)(1991-6#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#2)(2011-7#1)(2013-1#2)
allow accurate##2##2##(2008-10#1)(2012-2#1)
allow an##4##2##(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)
allow analysis of##5##3##(1992-3#1)(1995-6#1)(2008-4#2)(2008-9#1)
allow better##4##2##(1995-3#1)(2007-8#1)(2008-4#1)(2009-1#1)
allow comparison##2##2##(2008-10#2)
allow determination of the##2##4##(1992-6#1)(2008-4#1)
allow determination of##3##3##(1992-6#1)(1995-3#1)(2008-4#1)
allow differentiation of##2##3##(2008-12#1)(2010-11#1)
allow direct##3##2##(1990-8#1)(1996-7#1)(2008-2#1)
allow early##2##2##(1993-2#1)(2007-11#1)
allow effective##2##2##(2008-10#1)(2008-7#1)
allow efficient##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
allow exploration of##2##3##(2008-12#1)(2009-12#1)
allow for a##4##3##(2007-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
allow for appropriate##2##3##(1997-3#1)(2008-10#1)
allow for efficient##2##3##(2009-5#1)(2011-2#1)
allow for more##4##3##(1992-3#1)(2008-10#2)(2011-2#1)
allow for precise##2##3##(2008-2#1)(2011-2#1)
allow for the identification of##2##5##(2009-5#1)(2013-1#1)
allow for the##30##3##(1991-8#1)(1992-11#1)(1992-12#2)(1995-3#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
allow for their##2##3##(2007-11#1)(2008-10#1)
allow for##104##2##(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#6)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#5)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
allow future##2##2##(1991-11#1)(2008-7#1)
allow greater##4##2##(1994-2#1)(2008-11#1)(2011-2#2)
allow identification of##2##3##(2008-5#1)(2012-2#1)
allow improved##3##2##(1997-8#1)(2008-1#1)(2008-3#1)
allow individuals to##2##3##(1996-5#1)(2010-4#1)
allow investigators to##3##3##(2008-4#1)(2008-9#1)(2010-6#1)
allow it to##3##3##(1995-3#1)(2008-1#1)(2008-5#1)
allow its##4##2##(2008-10#3)(2008-5#1)
allow less##3##2##(2010-11#1)(2012-3#1)(2013-8#1)
allow more##6##2##(2007-10#1)(2008-10#1)(2008-2#1)(2010-12#1)(2013-8#2)
allow one to estimate the##2##5##(2008-3#1)(2009-8#1)
allow one to predict##2##4##(1996-4#1)(2008-3#1)
allow one to##19##3##(1996-4#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#4)(2008-9#1)(2009-8#1)(2012-3#1)
allow only determination of##2##4##(2008-10#2)
allow patients to##2##3##(2008-8#1)(2010-6#1)
allow patients##5##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
allow physicians to##2##3##(2007-3#1)(2008-7#1)
allow quantification of##2##3##(2007-10#1)(2008-3#1)
allow rapid##4##2##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
allow researchers to##3##3##(2008-7#1)(2009-8#1)(2010-4#1)
allow some##3##2##(1991-1#1)(1995-6#1)(2008-9#1)
allow successful##2##2##(2008-7#1)(2010-8#1)
allow the conclusion that##2##4##(2008-2#1)(2009-4#1)
allow the determination of the##2##5##(2008-2#1)(2008-3#1)
allow the determination of##8##4##(2008-10#6)(2008-2#1)(2008-3#1)
allow the development of##4##4##(1997-6#1)(2008-10#1)(2008-5#1)(2010-5#1)
allow the direct##2##3##(2008-10#1)(2012-3#1)
allow the formation of##2##4##(1992-9#1)(1993-12#1)
allow the generation of##2##4##(2008-11#1)(2008-5#1)
allow the identification##2##3##(1996-5#1)(2008-2#1)
allow the measurement of##3##4##(1994-3#1)(2008-3#1)(2008-7#1)
allow the simultaneous##3##3##(2008-10#2)(2008-9#1)
allow the use of##5##4##(1996-2#1)(2008-10#3)(2008-3#1)
allow the##120##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
allow their##5##2##(1996-5#1)(2008-10#3)(2008-11#1)
allow them to become##2##4##(1997-3#1)(2010-9#1)
allow them to##8##3##(1995-2#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-4#1)(2010-9#1)(2012-12#1)
allow this##2##2##(1992-9#1)(2009-8#1)
allow to##15##2##(1990-5#1)(1996-12#1)(2007-10#1)(2007-11#3)(2008-10#5)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
allow two##2##2##(2008-9#1)(2009-6#1)
allow us to differentiate##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
allow us to estimate##2##4##(1992-6#1)(2013-8#1)
allow us to##41##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-6#2)(1993-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-7#5)(2008-8#4)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
allow us##42##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-6#2)(1993-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-7#5)(2008-8#4)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
allow users to search##2##4##(2008-4#1)(2008-7#1)
allow users to##4##3##(2008-11#1)(2008-4#2)(2008-7#1)
allow visualization of##4##3##(1995-12#1)(2008-1#1)(2008-3#1)(2008-4#1)
allow##649##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#5)(1992-3#4)(1992-6#7)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#6)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#5)(1995-5#4)(1995-6#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#6)(2007-11#16)(2007-12#7)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#14)(2008-10#105)(2008-11#22)(2008-12#8)(2008-2#25)(2008-3#43)(2008-4#26)(2008-5#13)(2008-6#6)(2008-7#32)(2008-8#22)(2008-9#25)(2009-1#1)(2009-10#6)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#7)(2010-10#1)(2010-11#5)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#23)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#10)(2012-5#1)(2013-1#12)(2013-7#2)(2013-8#10)
allowable concentration of##2##3##(1997-4#1)(2008-11#1)
allowable##10##1##(1995-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)
allowance for##3##2##(1993-9#1)(2008-3#1)(2008-8#1)
allowance##9##1##(1992-9#2)(1993-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-4#1)
allowances##6##1##(1992-9#1)(1994-12#1)(1997-4#2)(2010-6#1)(2013-8#1)
allowed a comparison##2##3##(2008-5#2)
allowed a sampling frequency of##2##5##(2008-10#2)
allowed a##37##2##(1991-2#1)(1994-12#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-5#2)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
allowed accurate##2##2##(1994-12#1)(2008-10#1)
allowed all##2##2##(2007-11#1)(2008-8#1)
allowed an##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
allowed at least##2##3##(2008-10#1)(2008-3#1)
allowed at##4##2##(1997-8#1)(2008-10#2)(2008-3#1)
allowed both##2##2##(2008-10#2)
allowed by##3##2##(2007-12#1)(2010-11#1)(2011-1#1)
allowed calculation of##2##3##(1997-1#1)(2008-4#1)
allowed calculations of##3##3##(2008-10#2)(2013-1#1)
allowed charges##3##2##(1992-1#1)(1994-2#2)
allowed complete##3##2##(2008-10#2)(2013-1#1)
allowed detection of the##2##4##(2008-10#1)(2008-5#1)
allowed detection of##3##3##(2008-10#2)(2008-5#1)
allowed determination of##4##3##(1996-5#1)(2008-10#2)(2008-11#1)
allowed determination##5##2##(1996-5#1)(2008-10#3)(2008-11#1)
allowed differentiation of##3##3##(2008-10#2)(2010-5#1)
allowed discrimination between##3##3##(1996-12#1)(2008-10#2)
allowed discrimination##5##2##(1996-12#1)(2008-10#4)
allowed during##2##2##(1996-4#1)(2012-2#1)
allowed easy##2##2##(2008-10#1)(2008-5#1)
allowed effective##2##2##(1991-5#1)(1995-1#1)
allowed efficient##2##2##(2008-11#2)
allowed for a quantitative##2##4##(2008-7#1)(2010-7#1)
allowed for a##3##3##(2008-7#1)(2010-7#1)(2011-2#1)
allowed for an##2##3##(2008-10#1)(2008-8#1)
allowed for the##14##3##(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2009-7#1)(2010-2#1)(2013-1#2)
allowed for##35##2##(1994-12#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#2)(2010-2#2)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#2)
allowed full##2##2##(2008-10#1)(2012-2#1)
allowed her to##2##3##(2007-2#1)(2013-1#1)
allowed identification of the##3##4##(1995-6#1)(2010-5#1)(2011-2#1)
allowed identification of##6##3##(1995-6#1)(1997-2#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
allowed its##2##2##(2008-10#1)(2008-7#1)
allowed more##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
allowed patients to##2##3##(1994-6#1)(2012-3#1)
allowed quantitative##2##2##(2007-12#1)(2008-10#1)
allowed safe##2##2##(2007-8#1)(2013-1#1)
allowed temperature-dependent##2##2##(1995-8#1)(2008-10#1)
allowed that##3##2##(2008-10#3)
allowed the assessment of the##2##5##(2008-10#2)
allowed the design of##3##4##(1995-2#1)(2008-10#2)
allowed the detection of##10##4##(1990-5#1)(1992-6#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#3)(2010-4#1)
allowed the determination of##16##4##(2008-10#15)(2008-11#1)
allowed the determination##17##3##(2008-10#16)(2008-11#1)
allowed the development of a##2##5##(2008-10#1)(2008-6#1)
allowed the discrimination between##2##4##(2008-10#2)
allowed the estimation of the##2##5##(2008-8#1)(2009-10#1)
allowed the estimation of##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
allowed the formation of##3##4##(1996-5#1)(2008-10#2)
allowed the generation of##3##4##(1995-12#1)(1996-6#1)(2008-11#1)
allowed the identification of the three genotypic classes##2##8##(2008-10#2)
allowed the identification of##8##4##(1990-5#1)(2008-10#6)(2008-7#1)
allowed the identification##9##3##(1990-5#1)(2008-10#6)(2008-7#1)(2009-8#1)
allowed the preparation of##2##4##(1996-5#1)(2008-4#1)
allowed the purification of##2##4##(1997-2#1)(2010-10#1)
allowed the rapid##2##3##(1993-2#1)(2009-7#1)
allowed the sample##2##3##(2008-10#2)
allowed the selective##2##3##(2008-10#2)
allowed the separation of##2##4##(2008-10#2)
allowed the separation##3##3##(2008-10#3)
allowed the use of##5##4##(2008-10#3)(2008-11#2)
allowed the##133##2##(1990-12#1)(1990-5#2)(1991-5#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#2)(2007-8#1)(2008-10#67)(2008-11#7)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
allowed to be##4##3##(1992-6#1)(1995-1#1)(2008-10#1)(2008-9#1)
allowed to demonstrate##2##3##(2007-12#1)(2012-3#1)
allowed to dry##3##3##(2008-10#3)
allowed to interact with DMSO solutions of##2##7##(2008-10#2)
allowed to interact##3##3##(1993-6#1)(2008-10#2)
allowed to obtain a##2##4##(2008-10#2)
allowed to obtain##4##3##(2007-11#1)(2008-10#3)
allowed to react with the##2##5##(2008-10#1)(2009-9#1)
allowed to react with##3##4##(2008-10#2)(2009-9#1)
allowed to react##4##3##(2008-10#3)(2009-9#1)
allowed to reduce##2##3##(2008-10#1)(2012-12#1)
allowed to##82##2##(1990-11#1)(1990-12#3)(1991-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#26)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#2)(2013-7#2)
allowed us to achieve##2##4##(2008-2#1)(2008-3#1)
allowed us to better understand the##2##6##(2008-10#1)(2009-5#1)
allowed us to conclude that##3##5##(1993-8#1)(2007-11#1)(2011-2#1)
allowed us to determine the##3##5##(2008-10#3)
allowed us to determine##7##4##(1996-12#1)(2008-10#4)(2008-3#1)(2009-8#1)
allowed us to distinguish##2##4##(2008-10#1)(2011-10#1)
allowed us to identify##4##4##(1991-9#1)(1995-6#1)(2007-12#1)(2008-10#1)
allowed us to investigate##2##4##(2008-4#1)(2011-2#1)
allowed us to isolate##2##4##(1993-8#1)(1997-4#1)
allowed us to measure the##3##5##(1993-8#1)(2008-3#1)(2010-7#1)
allowed us to obtain a##2##5##(2008-10#1)(2008-3#1)
allowed us to propose a##2##5##(1993-11#1)(2008-10#1)
allowed us to retrieve##2##4##(2008-2#2)
allowed us to study the##2##5##(1993-2#1)(2008-10#1)
allowed us to test the##2##5##(2008-8#2)
allowed us to test##3##4##(2008-8#3)
allowed us to trace the##2##5##(2008-10#1)(2008-3#1)
allowed us to##78##3##(1990-2#2)(1991-9#1)(1993-11#1)(1993-2#1)(1993-8#4)(1995-6#2)(1996-12#2)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#3)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-12#1)
allowed##585##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#2)(1990-6#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#9)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#2)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#202)(2008-11#28)(2008-12#7)(2008-2#16)(2008-3#23)(2008-4#9)(2008-5#16)(2008-6#4)(2008-7#11)(2008-8#14)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#3)(2010-8#2)(2011-1#4)(2011-10#1)(2011-2#21)(2012-12#6)(2012-2#3)(2012-3#7)(2013-1#12)(2013-7#3)(2013-8#4)
allowing a more##2##3##(1994-12#1)(2008-10#1)
allowing a##24##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#3)(2013-1#1)
allowing accurate##2##2##(1990-12#1)(2008-11#1)
allowing an##6##2##(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)
allowing analysis of##2##3##(2008-1#1)(2008-4#1)
allowing analytical##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
allowing animals to##2##3##(2008-11#1)(2008-8#1)
allowing both the##2##3##(2007-11#1)(2008-5#1)
allowing determination of the##2##4##(1996-5#1)(2008-4#1)
allowing determination of##4##3##(1992-5#1)(1995-2#1)(1996-5#1)(2008-4#1)
allowing direct##2##2##(1993-12#1)(2007-4#1)
allowing easy##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
allowing for a##2##3##(2008-10#1)(2008-11#1)
allowing for an##2##3##(2008-10#1)(2008-3#1)
allowing for arbitrary##2##3##(2008-10#1)(2008-2#1)
allowing for reliable##2##3##(2011-2#1)(2012-12#1)
allowing for the determination of##2##5##(2008-10#1)(2008-2#1)
allowing for the##7##3##(1990-5#1)(2008-10#3)(2008-2#1)(2009-8#1)(2010-8#1)
allowing for##47##2##(1990-5#1)(1993-11#2)(1994-12#1)(1996-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#9)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
allowing full##2##2##(1990-9#1)(2008-3#1)
allowing good##2##2##(2008-10#1)(2008-7#1)
allowing high throughput##2##3##(2008-4#1)(2010-12#1)
allowing high##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
allowing it to##6##3##(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)
allowing its##2##2##(2008-6#1)(2011-1#1)
allowing long-term##2##2##(2008-5#1)(2008-7#1)
allowing more##2##2##(1991-3#1)(2012-2#1)
allowing one to##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
allowing one##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
allowing patients to##2##3##(2011-1#1)(2012-2#1)
allowing prediction of##2##3##(1995-11#1)(1996-6#1)
allowing quantitative##2##2##(2008-2#1)(2012-2#1)
allowing substituted consent##2##3##(1995-2#2)
allowing the detection of##2##4##(2008-10#2)
allowing the determination of the##3##5##(2008-10#3)
allowing the determination of##6##4##(2008-10#6)
allowing the direct##3##3##(2008-10#2)(2008-3#1)
allowing the evaluation of##2##4##(1995-5#1)(2008-5#1)
allowing the identification of the##2##5##(2007-10#1)(2013-8#1)
allowing the simultaneous##2##3##(2008-10#2)
allowing the surgeon##2##3##(1992-12#1)(2008-7#1)
allowing the user to##2##4##(2008-6#1)(2008-9#1)
allowing the##66##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#20)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
allowing their##3##2##(2008-10#2)(2011-2#1)
allowing them to##5##3##(2007-5#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
allowing time for the##2##4##(2008-10#1)(2008-7#1)
allowing to##8##2##(1996-11#1)(2007-11#1)(2008-10#4)(2011-2#2)
allowing us to##10##3##(2007-12#3)(2008-10#1)(2008-3#2)(2008-7#1)(2009-3#1)(2011-2#1)(2013-8#1)
allowing##331##1##(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-5#2)(1993-11#2)(1993-12#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#80)(2008-11#13)(2008-12#2)(2008-2#13)(2008-3#27)(2008-4#9)(2008-5#11)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#9)(2009-10#2)(2009-11#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#4)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#15)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#6)
allows a direct##2##3##(1992-3#1)(2008-3#1)
allows a fast##2##3##(2008-2#1)(2008-3#1)
allows a good##2##3##(2008-10#2)
allows a more##5##3##(1993-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
allows a quantitative##2##3##(1992-5#1)(2012-2#1)
allows a##57##2##(1990-12#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-2#1)(1993-9#2)(1995-11#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
allows all##2##2##(1991-5#1)(1992-6#1)
allows an easy##2##3##(2008-10#1)(2011-1#1)
allows an##10##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2011-1#1)(2011-2#1)
allows application of the##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
allows application##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
allows assessment of##2##3##(1990-11#1)(1995-2#1)
allows better##5##2##(1990-9#1)(2007-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
allows both##3##2##(2008-10#1)(2008-5#1)(2009-6#1)
allows cells to##2##3##(2007-10#1)(2009-5#1)
allows complete##2##2##(2008-10#1)(2008-11#1)
allows controlled##2##2##(1997-8#1)(2008-4#1)
allows detecting##4##2##(2007-11#1)(2008-10#1)(2010-12#1)(2012-2#1)
allows determination of the##4##4##(1996-4#1)(2008-10#2)(2008-3#1)
allows determination of##9##3##(1996-4#1)(2007-7#1)(2008-10#5)(2008-3#1)(2010-8#1)
allows determining##2##2##(2008-10#2)
allows discrimination between##2##3##(1995-11#1)(2009-9#1)
allows early##3##2##(1992-5#1)(2007-10#1)(2011-2#1)
allows easy##3##2##(1993-9#1)(1997-3#1)(2013-8#1)
allows estimation of the##2##4##(1992-12#2)
allows estimation of##3##3##(1992-12#2)(1992-6#1)
allows fast##2##2##(2007-12#1)(2008-3#1)
allows flexibility##2##2##(2008-11#1)(2010-10#1)
allows for a##20##3##(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-3#1)
allows for an##4##3##(1994-12#1)(2008-3#3)
allows for continuous##2##3##(2007-11#1)(2008-3#1)
allows for early##3##3##(2007-11#1)(2007-8#2)
allows for efficient##2##3##(2008-11#1)(2008-3#1)
allows for higher##2##3##(2007-12#1)(2011-2#1)
allows for more##2##3##(2008-4#2)
allows for proper##2##3##(2008-3#1)(2013-1#1)
allows for rapid##3##3##(2008-11#2)(2011-2#1)
allows for the direct##3##4##(2008-10#3)
allows for the identification##2##4##(2007-10#1)(2013-8#1)
allows for the possibility of##2##5##(1991-5#1)(2012-2#1)
allows for the possibility##3##4##(1991-5#1)(2008-8#1)(2012-2#1)
allows for the use of##2##5##(2008-2#1)(2010-6#1)
allows for the##44##3##(1990-5#1)(1991-5#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
allows for##153##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-12#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-8#6)(2008-10#18)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#29)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
allows formation of a##2##4##(1995-2#2)
allows gas replacement in##2##4##(2008-10#2)
allows higher##2##2##(1995-2#1)(2008-4#1)
allows highly##2##2##(2008-10#1)(2008-11#1)
allows identification of##3##3##(2008-10#1)(2009-11#1)(2010-2#1)
allows improved##2##2##(2008-3#1)(2010-12#1)
allows individual##2##2##(1994-2#1)(2008-10#1)
allows information##2##2##(2008-10#2)
allows it to##2##3##(2008-5#1)(2012-2#1)
allows it##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
allows its determination##2##3##(2008-10#2)
allows its##4##2##(2007-7#1)(2008-10#3)
allows manipulation of##2##3##(1994-9#1)(2008-11#1)
allows measurement of##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
allows measurements##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
allows more precise##3##3##(2008-9#1)(2011-2#1)(2011-7#1)
allows more##6##2##(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2011-7#1)
allows not only##2##3##(2008-2#1)(2010-2#1)
allows one to measure the##2##5##(2007-11#1)(2010-7#1)
allows one to obtain##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
allows one to##34##3##(1990-12#1)(1996-12#1)(2007-11#6)(2007-12#5)(2008-10#7)(2008-2#2)(2008-3#5)(2008-7#2)(2008-9#3)(2010-7#1)(2011-2#1)
allows one##36##2##(1990-12#1)(1996-12#1)(2007-11#6)(2007-12#5)(2008-10#8)(2008-2#2)(2008-3#5)(2008-7#2)(2008-9#4)(2010-7#1)(2011-2#1)
allows only##2##2##(1997-8#1)(2008-10#1)
allows patients to##3##3##(1991-12#1)(2007-12#1)(2008-8#1)
allows precise##4##2##(1995-1#1)(2006-12#1)(2008-10#2)
allows quantitation of##2##3##(2008-10#2)
allows quantitation##3##2##(2008-10#3)
allows quantitative##5##2##(1991-5#1)(2007-7#1)(2008-10#2)(2010-12#1)
allows rapid##5##2##(2008-10#1)(2008-11#2)(2008-9#2)
allows real-time##3##2##(2007-12#1)(2009-5#1)(2013-1#1)
allows reconstruction of##2##3##(2008-3#1)(2008-4#1)
allows scientists to##3##3##(2008-2#1)(2009-11#2)
allows selective##3##2##(2008-2#2)(2010-8#1)
allows sensitive detection of##2##4##(2008-10#1)(2008-4#1)
allows sensitive##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
allows simultaneous##12##2##(1996-1#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#3)(2008-9#1)
allows small##2##2##(2007-11#1)(2008-10#1)
allows stable##2##2##(2007-12#1)(2013-8#1)
allows the accurate##2##3##(2008-10#1)(2008-3#1)
allows the analysis of##5##4##(1991-11#1)(2008-10#4)
allows the application of##3##4##(2008-10#1)(2008-6#1)(2011-1#1)
allows the assessment of##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
allows the bioorganic chemist to##3##5##(2009-9#3)
allows the calculation of##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
allows the detection of##7##4##(1996-12#1)(2008-1#1)(2008-10#2)(2010-11#1)(2010-4#1)(2012-2#1)
allows the determination of 0##4##5##(2008-10#4)
allows the determination of the##4##5##(2008-10#1)(2008-3#1)(2010-10#1)(2010-5#1)
allows the determination of##26##4##(2008-10#23)(2008-3#1)(2010-10#1)(2010-5#1)
allows the determination##27##3##(2008-10#24)(2008-3#1)(2010-10#1)(2010-5#1)
allows the direct determination of##3##5##(1991-12#1)(2008-10#2)
allows the direct##6##3##(1991-12#1)(2008-10#5)
allows the evaluation of##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
allows the generation of##3##4##(2008-10#1)(2008-2#2)
allows the health##2##3##(1992-2#1)(2008-3#1)
allows the identification of##5##4##(1992-10#1)(1992-9#1)(1997-4#1)(2008-7#1)(2009-5#1)
allows the isolation of##3##4##(2008-10#2)(2008-7#1)
allows the isolation##4##3##(2008-10#2)(2008-7#1)(2010-6#1)
allows the measurement of##4##4##(2008-10#2)(2008-3#2)
allows the patient to##4##4##(1993-12#1)(2007-8#1)(2013-1#1)(2013-8#1)
allows the phase##3##3##(2007-11#1)(2008-3#2)
allows the possibility##2##3##(2008-10#1)(2009-12#1)
allows the production of##2##4##(1997-3#1)(2010-7#1)
allows the quantitative##2##3##(2008-1#1)(2008-10#1)
allows the researcher to##2##4##(2008-9#1)(2009-5#1)
allows the separation of##3##4##(2008-10#3)
allows the separation##4##3##(2008-10#4)
allows the simultaneous determination of##5##5##(2008-10#5)
allows the simultaneous##9##3##(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)
allows the study of##4##4##(1996-6#1)(2008-2#2)(2008-4#1)
allows the use of##6##4##(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
allows the user to##5##4##(2008-2#1)(2008-3#2)(2008-6#1)(2009-12#1)
allows the##232##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-8#1)(2008-1#7)(2008-10#73)(2008-11#7)(2008-2#15)(2008-3#23)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#6)(2008-9#2)(2009-12#4)(2009-5#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#4)
allows their determination##2##3##(2008-10#1)(2009-8#1)
allows them to be##2##4##(2008-11#1)(2011-1#1)
allows them to##8##3##(1990-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#1)
allows this##4##2##(1996-2#1)(2007-11#1)(2008-2#1)(2009-12#1)
allows to detect##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
allows to determine##3##3##(2008-10#3)
allows to differentiate##2##3##(2007-11#1)(2008-10#1)
allows to obtain##2##3##(2008-7#1)(2011-2#1)
allows to predict the##2##4##(2007-8#1)(2008-10#1)
allows to predict##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
allows to the##2##3##(2008-10#2)
allows to##44##2##(1991-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#5)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
allows two##2##2##(2008-2#1)(2008-3#1)
allows us to calculate the##2##5##(2008-7#1)(2008-8#1)
allows us to describe##2##4##(1995-5#1)(2008-3#1)
allows us to determine##5##4##(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#1)
allows us to develop##2##4##(2008-3#1)(2012-3#1)
allows us to establish##2##4##(2008-3#2)
allows us to examine##2##4##(2010-7#1)(2013-1#1)
allows us to make##2##4##(2008-10#1)(2008-7#1)
allows us to obtain##2##4##(2008-2#1)(2012-12#1)
allows us to perform##2##4##(2007-12#1)(2008-2#1)
allows us to postulate##2##4##(1992-6#1)(2013-1#1)
allows us to reduce##2##4##(1994-12#1)(2008-10#1)
allows us to##63##3##(1990-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-5#1)(2007-11#3)(2007-12#4)(2008-10#7)(2008-2#6)(2008-3#16)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#3)(2010-5#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
allows us##66##2##(1990-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-5#1)(1995-6#1)(2007-11#3)(2007-12#4)(2008-10#7)(2008-2#6)(2008-3#16)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#3)(2010-5#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
allows users to##5##3##(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-3#1)
allows very##2##2##(2008-10#1)(2008-3#1)
allows visualization of##2##3##(1997-4#1)(2011-7#1)
allows##994##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#5)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#5)(1994-1#1)(1994-12#4)(1994-2#2)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#7)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#3)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#2)(1997-2#3)(1997-3#5)(1997-4#7)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#7)(2007-11#42)(2007-12#42)(2007-6#1)(2007-7#3)(2007-8#13)(2008-1#13)(2008-10#204)(2008-11#32)(2008-12#10)(2008-2#54)(2008-3#115)(2008-4#33)(2008-5#15)(2008-6#6)(2008-7#31)(2008-8#13)(2008-9#26)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#7)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#10)(2011-2#25)(2011-3#3)(2011-7#3)(2012-12#11)(2012-2#18)(2012-3#9)(2013-1#17)(2013-7#1)(2013-8#12)
alloxan##2##1##(2011-2#1)(2012-2#1)
alloxan-induced diabetic rats##6##3##(2011-1#1)(2012-12#1)(2012-2#4)
alloxan-induced##11##1##(2008-11#5)(2011-1#1)(2012-12#1)(2012-2#4)
alloy and pharmaceutical##2##3##(2008-10#2)
alloy and##8##2##(2008-10#7)(2012-2#1)
alloy electrode##3##2##(2008-10#3)
alloy electrodes##2##2##(2008-10#2)
alloy foams##3##2##(2009-7#3)
alloy for##2##2##(2009-7#1)(2012-2#1)
alloy is##3##2##(2009-7#3)
alloy nanoporous nanoparticles##4##3##(2012-2#4)
alloy samples with satisfactory results##3##5##(2008-10#3)
alloy samples##13##2##(2008-10#13)
alloy were##3##2##(2008-5#1)(2009-7#1)(2012-2#1)
alloy with##3##2##(2008-10#2)(2009-7#1)
alloy##102##1##(1990-10#1)(1991-9#1)(1993-9#1)(2007-12#1)(2008-10#51)(2008-3#4)(2008-5#2)(2008-7#2)(2009-11#1)(2009-7#17)(2009-9#1)(2012-2#14)(2013-1#4)(2013-8#2)
alloy)##3##1##(2008-10#3)
alloying at the nanoscale##2##4##(2009-11#2)
alloying at the##3##3##(2009-11#3)
alloying on##3##2##(2008-10#2)(2009-11#1)
alloying##11##1##(1993-5#1)(2008-10#2)(2008-7#2)(2009-11#5)(2009-7#1)
alloys and biological samples##3##4##(2008-10#3)
alloys and biological##4##3##(2008-10#4)
alloys and environmental samples after preconcentration##2##6##(2008-10#2)
alloys and environmental samples after##3##5##(2008-10#3)
alloys and environmental samples##7##4##(2008-10#7)
alloys and##19##2##(2008-10#18)(2012-2#1)
alloys by hydride generation atomic absorption spectrometry##2##7##(2008-10#2)
alloys by##6##2##(2008-10#6)
alloys for##3##2##(2008-10#2)(2012-2#1)
alloys is##2##2##(2008-10#2)
alloys using##4##2##(2008-10#3)(2012-2#1)
alloys was##2##2##(2008-10#1)(2009-7#1)
alloys with##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
alloys##84##1##(1995-3#1)(2007-11#1)(2008-10#60)(2008-2#2)(2008-7#2)(2009-7#6)(2012-2#7)(2013-1#5)
allozyme analysis##3##2##(2008-10#3)
allozyme and##2##2##(2008-10#1)(2010-3#1)
allozyme genotype##6##2##(2008-10#6)
allozyme##16##1##(2008-10#13)(2008-5#1)(2008-9#1)(2010-3#1)
allozymes##5##1##(2008-10#5)
allura red in##2##3##(2008-10#2)
allura red##3##2##(2008-10#3)
allyl glycosides of the outer##2##5##(1992-12#2)
allyl glycosides##3##2##(1992-12#3)
allyl##9##1##(1992-11#1)(1992-12#4)(1996-5#1)(2007-7#1)(2008-10#1)(2012-12#1)
allylamine antimycotics##2##2##(2008-8#2)
allylamine##4##1##(1996-5#1)(2008-3#1)(2008-8#2)
allylamines##2##1##(1996-5#2)
allylic alcohols##5##2##(1996-5#1)(2007-11#2)(2008-8#1)(2010-7#1)
allylic esters##3##2##(1996-5#3)
allylic##14##1##(1992-12#1)(1994-11#1)(1995-2#1)(1996-5#5)(2007-11#4)(2008-8#1)(2010-7#1)
allylsilanes 7 and 8 were##2##5##(2008-6#2)
allylsilanes 7##3##2##(2008-6#3)
allysine##2##1##(1990-7#2)
alm1##3##1##(2008-10#3)
almond (Prunus dulcis)##2##3##(2008-10#2)
almond and peach isolates##2##4##(2008-10#2)
almond and peach##3##3##(2008-10#3)
almond and##7##2##(2008-10#7)
almond anthracnose##2##2##(2008-10#2)
almond isolates from##2##3##(2008-10#2)
almond isolates##4##2##(2008-10#4)
almond leaves##2##2##(2008-10#2)
almond were##2##2##(2008-10#1)(2013-8#1)
almond##46##1##(1991-5#1)(1992-12#1)(2008-10#36)(2008-11#2)(2008-5#2)(2013-8#4)
almost 10##2##2##(2007-12#1)(2007-7#1)
almost 10% of##2##3##(1995-5#1)(2009-3#1)
almost 100%##5##2##(1992-8#1)(2008-10#2)(2008-2#2)
almost 2##2##2##(2007-8#1)(2011-1#1)
almost 2-fold##2##2##(1993-11#1)(2008-10#1)
almost 20 years##2##3##(2008-10#1)(2008-12#1)
almost 40%##2##2##(2007-11#1)(2008-10#1)
almost 400##2##2##(1997-6#1)(2010-3#1)
almost 50##2##2##(1997-5#1)(2009-4#1)
almost 50% of##2##3##(2008-10#1)(2013-1#1)
almost 50%##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
almost 80%##2##2##(1993-6#1)(2008-9#1)
almost 800##2##2##(1997-6#1)(2008-5#1)
almost a factor of##2##4##(1992-3#1)(2008-10#1)
almost a straight line##2##4##(2008-10#1)(2008-3#1)
almost a##10##2##(1992-3#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2012-2#1)
almost absent##2##2##(2008-10#1)(2011-2#1)
almost all of the##4##4##(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)
almost all of them are##2##5##(1996-9#1)(2012-2#1)
almost all of them##4##4##(1996-9#1)(2008-8#1)(2008-9#1)(2012-2#1)
almost all of##13##3##(1996-9#1)(1997-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#2)(2012-2#1)(2012-3#1)
almost all the##4##3##(1990-6#1)(2008-12#1)(2008-6#1)(2010-2#1)
almost all##72##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#1)(1996-9#1)(1997-3#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
almost always##18##2##(1991-11#1)(1992-1#1)(1992-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-8#1)(2010-6#1)(2011-2#2)
almost an##2##2##(2008-4#1)(2011-2#1)
almost any##5##2##(2007-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#1)
almost anywhere##2##2##(1993-11#1)(2008-9#1)
almost as##4##2##(1991-8#1)(1994-2#1)(1997-3#1)(2008-2#1)
almost at the##2##3##(1993-3#1)(2008-10#1)
almost certainly##8##2##(1992-12#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
almost complete inhibition of##2##4##(1994-8#1)(2008-4#1)
almost complete inhibition##3##3##(1994-11#1)(1994-8#1)(2008-4#1)
almost complete##22##2##(1990-2#1)(1994-11#1)(1994-8#1)(1995-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-7#2)
almost completed##2##2##(1993-3#1)(2008-8#1)
almost completely inhibited the##2##4##(1994-11#1)(2011-2#1)
almost completely inhibited##6##3##(1992-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(2008-4#1)(2011-2#1)
almost completely suppressed the##2##4##(1996-5#1)(2008-10#1)
almost completely##34##2##(1990-12#1)(1991-5#1)(1992-12#2)(1992-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-6#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)
almost constant##12##2##(1996-8#1)(1997-6#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)
almost disappeared##2##2##(2008-10#1)(2008-5#1)
almost entirely of##2##3##(2008-10#1)(2008-5#1)
almost entirely##8##2##(1993-9#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
almost equal##8##2##(1991-5#1)(1992-5#1)(1995-11#1)(1997-3#2)(2008-10#1)(2011-1#1)(2012-3#1)
almost equally in##2##3##(2008-10#2)
almost equally##9##2##(1992-12#1)(1992-4#1)(1994-2#1)(1994-5#1)(1997-6#1)(2008-10#3)(2011-1#1)
almost equivalent##2##2##(1994-3#1)(2008-11#1)
almost every##11##2##(1993-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)
almost exclusively in##3##3##(2007-12#1)(2008-10#2)
almost exclusively on##5##3##(1993-3#1)(1997-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
almost exclusively to##2##3##(1992-2#1)(2012-2#1)
almost exclusively##19##2##(1992-11#1)(1992-2#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#2)
almost fully##2##2##(1995-8#1)(2008-7#1)
almost half of the##4##4##(1993-6#1)(2008-5#1)(2011-2#2)
almost half of##5##3##(1993-6#1)(1997-8#1)(2008-5#1)(2011-2#2)
almost half the##2##3##(1992-11#1)(2008-2#1)
almost half##12##2##(1992-11#1)(1993-6#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2011-2#2)
almost identical to that of##2##5##(1995-2#1)(2007-12#1)
almost identical to that##3##4##(1995-11#1)(1995-2#1)(2007-12#1)
almost identical to the##3##4##(1991-2#1)(1995-9#1)(2009-8#1)
almost identical to##7##3##(1991-2#1)(1995-11#1)(1995-2#1)(1995-9#1)(2007-12#1)(2009-8#1)(2010-7#1)
almost identical##18##2##(1991-2#1)(1991-8#1)(1992-3#1)(1994-11#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#1)
almost identically##2##2##(1990-2#1)(1993-8#1)
almost immediate##2##2##(1990-5#1)(1992-12#1)
almost in##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
almost independent of the##2##4##(2008-11#1)(2008-2#1)
almost independent of##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
almost inevitable##3##2##(2009-3#1)(2012-12#1)(2013-1#1)
almost insignificant##2##2##(1992-6#1)(2008-10#1)
almost invariably##6##2##(1997-7#1)(2007-10#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-3#1)
almost linear##3##2##(2008-3#1)(2012-2#2)
almost linearly with##2##3##(2007-9#1)(2008-3#1)
almost lost##2##2##(1994-2#1)(2008-9#1)
almost no interference##3##3##(2008-10#3)
almost no studies##2##3##(2008-10#1)(2012-12#1)
almost no##14##2##(1990-11#1)(1991-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
almost none##2##2##(1994-9#1)(2008-11#1)
almost normal##5##2##(1992-11#1)(1994-3#1)(1995-8#1)(2008-5#1)(2012-3#1)
almost normally##2##2##(1992-11#1)(2008-7#1)
almost not##2##2##(2008-10#2)
almost one##8##2##(1992-5#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-12#1)(2012-3#1)
almost parallel##2##2##(1995-5#1)(2008-8#1)
almost perfect##2##2##(2007-11#1)(2008-12#1)
almost quantitative##2##2##(1992-12#1)(2008-10#1)
almost quantitatively##2##2##(2008-10#1)(2008-6#1)
almost reached##2##2##(2008-11#1)(2013-1#1)
almost similar to##2##3##(2008-10#1)(2008-12#1)
almost similar##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)
almost simultaneously##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
almost the same as that of the##2##7##(2008-2#1)(2008-5#1)
almost the same as the##2##5##(1995-12#1)(2008-10#1)
almost the same as##7##4##(1993-6#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
almost the same##15##3##(1993-6#1)(1995-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)
almost the whole##2##3##(2008-5#1)(2012-3#1)
almost the##19##2##(1993-6#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2012-3#1)
almost three##2##2##(1995-2#1)(2008-10#1)
almost to##3##2##(1991-2#1)(1992-6#1)(2008-9#1)
almost totally##8##2##(1990-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-6#1)(2012-2#1)
almost transform limited##2##3##(2007-12#1)(2008-2#1)
almost twice as##2##3##(2011-2#1)(2012-2#1)
almost twice the##2##3##(1997-6#1)(2008-10#1)
almost twice##6##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
almost two##2##2##(2007-12#1)(2011-2#1)
almost unchanged##2##2##(2008-11#1)(2008-7#1)
almost uniformly##2##2##(1991-2#1)(2008-11#1)
almost universal##3##2##(2009-3#1)(2009-4#1)(2012-2#1)
almost##552##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#4)(1992-1#2)(1992-11#7)(1992-12#6)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#5)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#8)(1997-7#3)(1997-8#5)(2006-10#1)(2007-10#4)(2007-11#14)(2007-12#11)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#96)(2008-11#20)(2008-12#14)(2008-2#13)(2008-3#16)(2008-4#12)(2008-5#19)(2008-6#7)(2008-7#13)(2008-8#9)(2008-9#11)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#7)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#8)(2011-2#20)(2012-1#1)(2012-12#3)(2012-2#18)(2012-3#9)(2013-1#9)(2013-8#3)
alone (p =##3##3##(1996-9#2)(2008-3#1)
alone (p##5##2##(1994-1#1)(1996-9#2)(2008-10#1)(2008-3#1)
alone after##2##2##(1994-11#1)(2008-10#1)
alone also##2##2##(2008-10#1)(2008-12#1)
alone and in combination to##2##5##(2008-10#2)
alone and in combination with##5##5##(1990-2#1)(1991-1#1)(1993-12#1)(2007-7#1)(2009-8#1)
alone and in combination##9##4##(1990-2#1)(1991-1#1)(1993-12#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-8#1)
alone and in##12##3##(1990-2#1)(1991-1#1)(1993-12#1)(1994-12#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-8#1)
alone and increased##2##3##(2009-7#1)(2012-4#1)
alone and the##2##3##(2008-12#1)(2009-7#1)
alone and##45##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-12#2)(1997-7#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#2)(2011-2#4)(2012-1#2)(2012-3#1)(2012-4#1)(2013-8#1)
alone are not##2##3##(1992-6#1)(2009-10#1)
alone are##6##2##(1990-7#1)(1992-6#1)(1995-5#2)(2009-10#1)(2012-2#1)
alone as##5##2##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
alone at##4##2##(1993-8#1)(1994-7#1)(1995-12#1)(2008-11#1)
alone by the##2##3##(1994-9#1)(1996-2#1)
alone can##4##2##(1991-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
alone cannot be##2##3##(2009-2#1)(2013-8#1)
alone cannot##6##2##(2007-12#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2013-8#1)
alone caused##4##2##(1993-8#1)(1994-5#1)(2008-10#1)(2008-4#1)
alone consistently##2##2##(2008-10#2)
alone could##3##2##(1990-8#1)(1994-8#1)(2008-10#1)
alone decreased##2##2##(1993-12#1)(1994-5#1)
alone did not have##2##4##(2008-11#1)(2008-9#1)
alone did not induce##2##4##(1996-12#1)(2008-10#1)
alone did not##10##3##(1993-8#1)(1994-3#1)(1996-12#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2013-1#1)
alone do not##2##3##(2008-10#1)(2008-5#1)
alone does not##5##3##(1990-6#1)(1997-7#1)(2008-7#1)(2008-9#1)(2009-8#1)
alone exhibited##3##2##(1994-11#1)(2008-10#1)(2010-4#1)
alone for the##2##3##(2008-1#1)(2012-3#1)
alone for##10##2##(1994-6#1)(1995-9#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
alone had no effect on##4##5##(1990-2#1)(1993-6#1)(1994-12#1)(1994-9#1)
alone had no##5##3##(1990-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)
alone had##6##2##(1990-2#1)(1990-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)
alone has##4##2##(1994-12#1)(1994-6#1)(2008-10#1)(2008-7#1)
alone have##2##2##(1993-12#1)(2013-8#1)
alone in the##6##3##(1990-7#1)(1991-1#1)(2008-10#1)(2008-8#1)(2013-1#2)
alone in##27##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-2#1)(1994-11#1)(1995-2#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
alone induced##2##2##(2009-4#1)(2012-12#1)
alone is essential##2##3##(1992-6#1)(2008-10#1)
alone is not a##2##4##(1993-9#1)(1994-2#1)
alone is not sufficient to##4##5##(1996-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
alone is not sufficient##5##4##(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
alone is not##10##3##(1990-12#1)(1991-3#1)(1993-9#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
alone is sufficient##2##3##(1994-8#1)(2007-12#1)
alone is##22##2##(1990-12#1)(1991-3#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#2)(2012-12#1)
alone may be sufficient##3##4##(1991-2#1)(1995-4#1)(2006-12#1)
alone may be##5##3##(1991-2#1)(1995-4#1)(2006-12#1)(2008-9#1)(2012-3#1)
alone may not##3##3##(2008-5#1)(2009-5#1)(2010-11#1)
alone may##12##2##(1991-2#1)(1994-3#2)(1995-12#1)(1995-4#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2012-3#1)
alone nor##2##2##(1995-5#1)(2013-8#1)
alone or as##3##3##(2008-4#2)(2008-6#1)
alone or by##2##3##(1995-2#1)(2010-3#1)
alone or combined with##6##4##(2007-11#3)(2007-5#1)(2011-2#1)(2013-8#1)
alone or combined##8##3##(2007-11#3)(2007-5#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
alone or in association##2##4##(1997-4#1)(2008-7#1)
alone or in combination with NaCl##2##6##(2007-3#2)
alone or in combination with a##2##6##(2008-10#1)(2012-12#1)
alone or in combination with other##5##6##(1992-3#1)(1995-2#1)(2008-11#1)(2008-3#1)(2013-1#1)
alone or in combination with##30##5##(1992-3#1)(1993-12#2)(1994-8#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-3#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2009-5#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
alone or in combination##38##4##(1992-3#1)(1993-12#2)(1993-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-3#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
alone or in the presence of##2##6##(1993-8#1)(1995-8#1)
alone or in the##3##4##(1993-8#1)(1995-8#1)(2011-2#1)
alone or in##48##3##(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-3#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
alone or the##4##3##(2008-10#3)(2009-6#1)
alone or with##5##3##(1991-6#1)(1994-11#1)(2009-2#1)(2009-9#1)(2012-3#1)
alone or##88##2##(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
alone produced a##2##3##(1994-11#1)(2010-6#1)
alone produced##3##2##(1994-11#1)(2008-7#1)(2010-6#1)
alone provided##2##2##(1995-6#1)(2008-10#1)
alone resulted in##2##3##(1995-12#1)(2008-11#1)
alone showed no significant##3##4##(1993-8#1)(2008-12#1)(2009-9#1)
alone showed##5##2##(1993-8#1)(1994-5#1)(2008-11#1)(2008-12#1)(2009-9#1)
alone significantly##2##2##(1995-3#1)(2010-4#1)
alone the##2##2##(2008-10#1)(2008-8#1)
alone to##5##2##(1991-6#1)(2006-10#1)(2008-1#1)(2008-6#1)(2009-7#1)
alone under the##2##3##(2008-10#1)(2011-2#1)
alone versus##2##2##(2011-2#1)(2012-3#1)
alone was found##2##3##(1994-1#1)(2008-4#1)
alone was ineffective##2##3##(1994-9#1)(1997-1#1)
alone was not##2##3##(1992-12#1)(2008-10#1)
alone was performed##2##3##(2007-11#1)(2009-9#1)
alone was used##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
alone was##26##2##(1991-8#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-1#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#2)(2009-9#1)(2012-2#2)(2013-1#1)
alone were##4##2##(1990-12#2)(1997-1#1)(2013-8#1)
alone when##2##2##(2008-11#1)(2012-3#1)
alone will not##2##3##(1991-12#1)(2008-12#1)
alone will##3##2##(1991-12#1)(1996-2#1)(2008-12#1)
alone with##3##2##(2008-7#2)(2009-12#1)
alone without##2##2##(2011-2#1)(2012-12#1)
alone##705##1##(1990-10#1)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#4)(1990-7#5)(1990-8#7)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#4)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#9)(1993-3#2)(1993-6#5)(1993-8#7)(1993-9#4)(1994-1#2)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#6)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#10)(1995-2#10)(1995-3#5)(1995-4#3)(1995-5#10)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#1)(1996-12#14)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#2)(2006-10#4)(2006-12#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#114)(2008-11#26)(2008-12#9)(2008-2#2)(2008-3#18)(2008-4#10)(2008-5#18)(2008-6#13)(2008-7#26)(2008-8#14)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#5)(2009-8#7)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#8)(2010-3#10)(2010-4#4)(2010-5#3)(2010-6#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#29)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#12)(2012-3#14)(2012-4#1)(2012-6#1)(2013-1#22)(2013-7#3)(2013-8#11)
alone) or##2##2##(2009-9#1)(2012-12#1)
alone)##9##1##(1994-5#1)(1995-5#1)(1996-5#1)(2008-9#1)(2009-9#2)(2011-2#2)(2012-12#1)
along a certain##2##3##(2008-10#1)(2008-11#1)
along a common##2##3##(2008-10#1)(2009-8#1)
along a depth gradient##2##4##(2011-2#2)
along a fiber##2##3##(2007-12#1)(2008-3#1)
along a given##2##3##(2008-10#2)
along a gradient of socio-economic development##2##6##(2007-12#2)
along a horizontal path##2##4##(2008-2#1)(2008-3#1)
along a line##2##3##(2007-11#1)(2008-2#1)
along a productivity gradient##3##4##(2008-8#1)(2008-9#2)
along a single##2##3##(2008-3#1)(2010-4#1)
along a transect##2##3##(2008-10#2)
along a##58##2##(1993-5#1)(1996-10#1)(1996-4#1)(2007-11#7)(2007-12#8)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
along an acidification gradient##2##4##(2012-3#2)
along an optical fiber##2##4##(2007-11#1)(2008-3#1)
along an optical##3##3##(2007-11#2)(2008-3#1)
along an##11##2##(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)(2012-2#1)(2012-3#2)(2012-6#1)
along certain##2##2##(2008-2#1)(2008-3#1)
along it##2##2##(1990-8#1)(2008-7#1)
along its length##3##3##(1996-5#1)(2008-7#1)(2011-1#1)
along its##10##2##(1996-5#1)(2007-8#1)(2008-11#1)(2008-3#4)(2008-7#1)(2009-7#1)(2011-1#1)
along lines##3##2##(1997-4#1)(2008-11#1)(2010-10#1)
along longitudinal##2##2##(1993-5#1)(2008-9#1)
along microtubules##2##2##(2010-11#1)(2010-7#1)
along one##2##2##(2008-3#1)(2009-11#1)
along other##2##2##(2008-11#1)(2008-9#1)
along several##2##2##(2007-5#1)(2013-8#1)
along similar lines##2##3##(1992-1#1)(1995-3#1)
along the Pacific##2##3##(2008-10#1)(2009-2#1)
along the anterior##5##3##(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-2#1)
along the axis of##2##4##(2008-3#1)(2009-8#1)
along the axis##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
along the beam##2##3##(2008-2#2)
along the cavity##2##3##(2007-11#1)(2008-3#1)
along the central axis##2##4##(2007-10#1)(2009-2#1)
along the coast and##2##4##(1990-6#1)(2010-8#1)
along the coast##3##3##(1990-6#1)(2008-5#1)(2010-8#1)
along the continuum of##2##4##(1992-12#1)(1997-3#1)
along the course of##2##4##(2011-2#2)
along the crypt-villus axis of rat small intestine##2##8##(1990-12#2)
along the crypt-villus axis of##4##5##(1990-12#2)(1991-12#2)
along the crystal##2##3##(2008-2#1)(2008-3#1)
along the curvature##2##3##(2009-2#2)
along the direction of propagation of##2##6##(2007-12#1)(2008-2#1)
along the direction of propagation##3##5##(2007-12#1)(2008-2#2)
along the direction of the##2##5##(2008-3#2)
along the direction of##7##4##(1993-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
along the entire length of the##2##6##(1997-4#1)(2009-7#1)
along the entire##4##3##(1997-4#1)(2007-5#1)(2009-7#1)(2009-8#1)
along the fiber##4##3##(2007-11#4)
along the inner surface of the##2##6##(2008-11#1)(2011-2#1)
along the inner##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
along the length of the##4##5##(1997-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
along the length of##7##4##(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
along the line##3##3##(2007-11#1)(2008-3#2)
along the lines of##2##4##(2008-2#1)(2012-3#1)
along the longitudinal axis of##2##5##(2008-7#1)(2008-9#1)
along the longitudinal##6##3##(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)
along the meridian##3##3##(2008-9#3)
along the molecule##2##3##(1992-9#2)
along the optical axis##3##4##(2008-2#2)(2008-3#1)
along the optical##4##3##(2008-2#3)(2008-3#1)
along the path##2##3##(2008-3#2)
along the plane of the##2##5##(1994-3#1)(2006-12#1)
along the reaction##2##3##(2008-10#2)
along the right##2##3##(2010-2#1)(2013-7#1)
along the road##2##3##(1995-3#1)(2008-7#1)
along the routes##2##3##(2011-2#2)
along the siloxy bilayers##2##4##(2008-10#2)
along the study##2##3##(2008-12#1)(2013-8#1)
along the surface##2##3##(1996-12#1)(2008-10#1)
along the symbiotic##2##3##(2008-11#2)
along the two##2##3##(2008-3#2)
along the waveguide##2##3##(2007-11#1)(2007-12#1)
along the way##5##3##(1996-3#1)(2008-12#1)(2008-4#1)(2010-10#1)(2012-1#1)
along the whole##2##3##(1990-5#1)(2008-3#1)
along the year##2##3##(2008-5#2)
along the z##2##3##(2007-12#1)(2008-3#1)
along the##281##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1991-12#2)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#1)(2006-10#2)(2006-12#2)(2007-10#2)(2007-11#13)(2007-12#13)(2007-5#3)(2007-7#1)(2008-10#35)(2008-11#7)(2008-12#3)(2008-2#17)(2008-3#32)(2008-4#3)(2008-5#11)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#3)(2013-2#1)(2013-7#7)(2013-8#5)
along their apicobasal axes##2##4##(2007-12#2)
along their##8##2##(1992-12#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)
along these lines##2##3##(1992-12#1)(2009-9#1)
along these##3##2##(1992-12#1)(2009-9#1)(2011-2#1)
along this##4##2##(1991-3#1)(1992-12#1)(2007-12#1)(2008-10#1)
along three##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
along transects##2##2##(2008-10#1)(2013-7#1)
along two##5##2##(1996-2#1)(2008-2#2)(2009-10#1)(2013-7#1)
along which##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)
along with 1##2##3##(2009-8#1)(2012-12#1)
along with T9##2##3##(2012-12#2)
along with a description of##3##5##(1991-2#1)(1992-1#1)(2008-4#1)
along with a detection limit of 0##2##7##(2008-10#2)
along with a discussion of##2##5##(2007-12#1)(2008-4#1)
along with a list of##2##5##(2008-10#1)(2008-2#1)
along with a new##2##4##(2008-5#1)(2008-8#1)
along with a reference##2##4##(2008-2#1)(2008-3#1)
along with a review of the relevant literature##3##8##(2008-7#1)(2011-2#1)(2013-1#1)
along with a review of the##5##6##(2008-7#2)(2011-2#2)(2013-1#1)
along with a##47##3##(1990-8#1)(1991-2#1)(1992-1#1)(1992-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#2)
along with all##2##3##(2008-7#1)(2013-1#1)
along with an##10##3##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)
along with appropriate##2##3##(2008-4#1)(2012-2#1)
along with considerations##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
along with data##2##3##(1992-1#1)(2009-7#1)
along with growth##2##3##(2010-10#1)(2012-3#1)
along with increased##4##3##(1995-5#1)(1996-2#1)(2008-7#1)(2009-12#1)
along with increasing##2##3##(2007-8#1)(2008-10#1)
along with its##8##3##(2008-10#2)(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
along with low##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
along with one##4##3##(2008-10#3)(2008-3#1)
along with optical##2##3##(2008-2#1)(2008-3#1)
along with other##18##3##(1996-12#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
along with patient##2##3##(1996-3#1)(2010-7#1)
along with possible##2##3##(2008-2#1)(2008-3#1)
along with recently##2##3##(2007-11#1)(2008-6#1)
along with recommendations for##2##4##(2008-2#1)(2011-2#1)
along with representative##2##3##(2007-11#1)(2008-10#1)
along with several##2##3##(2008-10#1)(2012-12#1)
along with simulations##2##3##(1995-2#1)(2007-11#1)
along with sodium##2##3##(2008-10#1)(2010-3#1)
along with some##3##3##(2008-10#1)(2008-6#1)(2013-7#1)
along with specific##2##3##(1996-1#1)(2008-2#1)
along with that of##2##4##(2012-12#1)(2013-1#1)
along with that##3##3##(1995-1#1)(2012-12#1)(2013-1#1)
along with the experimental##2##4##(2007-11#1)(2008-10#1)
along with the known##2##4##(1994-8#1)(2009-10#1)
along with the results of##2##5##(2008-10#1)(2013-8#1)
along with the##93##3##(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-3#1)(1994-8#2)(1995-1#1)(1996-12#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
along with their##11##3##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)
along with those##4##3##(1993-8#1)(1996-12#1)(2008-2#1)(2012-2#1)
along with three other##2##4##(2008-10#1)(2011-2#1)
along with tillage information##2##4##(2008-10#2)
along with##461##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#3)(1995-1#3)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#2)(2007-10#1)(2007-11#12)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#76)(2008-11#13)(2008-12#9)(2008-2#18)(2008-3#24)(2008-4#20)(2008-5#8)(2008-6#6)(2008-7#21)(2008-8#13)(2008-9#7)(2009-10#4)(2009-12#3)(2009-5#3)(2009-7#5)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#6)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#7)(2011-2#24)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#14)(2012-2#11)(2012-3#7)(2012-7#1)(2013-1#19)(2013-7#3)(2013-8#5)
along##941##1##(1990-11#2)(1990-12#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#5)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#5)(1993-5#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-8#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#9)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#5)(1997-6#3)(1997-7#2)(2006-10#2)(2006-12#4)(2007-10#3)(2007-11#34)(2007-12#32)(2007-2#1)(2007-5#7)(2007-7#6)(2007-8#4)(2008-1#3)(2008-10#131)(2008-11#31)(2008-12#18)(2008-2#48)(2008-3#77)(2008-4#26)(2008-5#25)(2008-6#12)(2008-7#35)(2008-8#27)(2008-9#24)(2009-10#7)(2009-11#3)(2009-12#4)(2009-2#5)(2009-5#5)(2009-6#2)(2009-7#9)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#7)(2010-7#5)(2010-8#11)(2010-9#1)(2011-1#9)(2011-2#42)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#17)(2012-2#22)(2012-3#12)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#25)(2013-2#1)(2013-7#14)(2013-8#11)
alongside the##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
alongside##16##1##(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
alongwith a##2##2##(2010-8#1)(2013-8#1)
alopecia and##5##2##(1990-2#1)(1992-2#1)(2008-5#2)(2009-12#1)
alopecia areata in##2##3##(2007-7#2)
alopecia areata##10##2##(2007-7#7)(2010-6#2)(2011-2#1)
alopecia at##2##2##(2008-10#1)(2012-3#1)
alopecia##42##1##(1990-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1996-10#1)(1997-7#1)(2007-7#9)(2007-8#1)(2008-10#3)(2008-5#7)(2008-8#1)(2009-12#1)(2010-6#7)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
aloud and##2##2##(2008-9#1)(2009-2#1)
aloud##5##1##(1995-2#1)(2008-9#2)(2009-2#2)
alpestris##3##1##(2008-11#2)(2008-7#1)
alpha 1 (I) and alpha 2 (I) collagen##2##8##(1991-5#2)
alpha 1 (I)##5##3##(1991-5#4)(1994-12#1)
alpha 1 and##2##3##(1995-11#1)(1995-2#1)
alpha 1 beta 2 gamma##2##5##(1995-11#2)
alpha 1 beta##5##3##(1993-8#3)(1995-11#2)
alpha 1 subunit with##2##4##(1994-6#2)
alpha 1 subunit##5##3##(1994-6#4)(1996-2#1)
alpha 1##34##2##(1990-12#2)(1991-5#4)(1992-12#1)(1992-4#1)(1993-8#3)(1993-9#2)(1994-12#5)(1994-6#6)(1994-9#1)(1995-11#4)(1995-2#1)(1995-6#2)(1996-2#1)(2008-12#1)
alpha 1- and alpha##2##4##(1991-6#1)(1994-9#1)
alpha 1-PI cDNA##3##3##(1990-8#3)
alpha 1-PI##4##2##(1990-8#4)
alpha 1-acid glycoprotein##3##3##(1991-12#2)(1992-12#1)
alpha 1-adrenoceptor##3##2##(1995-11#3)
alpha 1-adrenoceptors##3##2##(1991-6#2)(1995-11#1)
alpha 1-antitrypsin Pittsburgh##2##3##(1992-12#1)(1993-2#1)
alpha 1-antitrypsin##6##2##(1990-12#1)(1992-12#1)(1992-3#2)(1993-2#1)(1994-3#1)
alpha 1-microglobulin##2##2##(1992-3#1)(1993-3#1)
alpha 1Deltag(nu =0) +##2##4##(2008-3#2)
alpha 1Deltag(nu##3##2##(2008-3#3)
alpha 1a##2##2##(1994-6#2)
alpha 1b##4##2##(1993-12#1)(1994-6#2)(1995-11#1)
alpha 2 (I) collagen##3##4##(1991-5#2)(1992-8#1)
alpha 2 interferon##4##3##(1990-12#4)
alpha 2##20##2##(1990-12#4)(1991-2#6)(1991-5#2)(1992-12#1)(1992-8#1)(1993-8#2)(1994-8#1)(1995-11#2)(1995-2#1)
alpha 2(I)##4##2##(1990-5#1)(1991-5#3)
alpha 2--&gt##12##2##(1992-12#1)(1994-11#10)(1994-5#1)
alpha 2-adrenoceptor##3##2##(1992-6#1)(1994-6#2)
alpha 2-adrenoceptors##4##2##(1990-5#1)(1991-6#1)(1994-6#2)
alpha 2-macroglobulin##2##2##(1992-9#1)(1993-3#1)
alpha 2M##4##2##(1993-3#4)
alpha 3 beta 2##4##4##(1995-11#4)
alpha 3 beta 4 and alpha 4 beta 2##2##9##(1995-11#2)
alpha 3 beta 4##5##4##(1992-4#1)(1995-11#4)
alpha 3 beta##10##3##(1992-4#1)(1995-11#8)(1995-6#1)
alpha 4 beta 2 gamma 2L##3##6##(1995-11#3)
alpha 4 beta 2 nicotinic receptor-mediated inward##2##7##(1995-11#2)
alpha 4 beta 2##6##4##(1995-11#6)
alpha 4 beta 4 octamer##2##5##(1991-10#2)
alpha 4 beta##8##3##(1991-10#2)(1995-11#6)
alpha 4 subunit##2##3##(1995-11#2)
alpha 4##12##2##(1991-10#2)(1995-11#10)
alpha 5 beta 3 gamma 2##2##6##(1995-11#2)
alpha 5 beta 3 gamma 3##3##6##(1995-11#3)
alpha 5 beta 3 gamma##7##5##(1995-11#7)
alpha 5 beta##8##3##(1992-2#1)(1995-11#7)
alpha 5##10##2##(1992-2#2)(1993-9#1)(1995-11#7)
alpha 5/beta 1##5##3##(1993-9#5)
alpha 5/beta##6##2##(1993-9#6)
alpha 7 cDNA##3##3##(1996-12#3)
alpha 7 genotype##2##3##(1996-12#2)
alpha 7 homopolymer##2##3##(2010-8#2)
alpha 7 subunit##2##3##(1996-12#2)
alpha 7##13##2##(1996-12#10)(2010-8#3)
alpha = 0##5##3##(2008-10#3)(2013-1#2)
alpha = 78##2##3##(1996-2#1)(2007-11#1)
alpha = 91##2##3##(1996-2#1)(1997-7#1)
alpha = beta = gamma = 90 degrees##3##8##(1992-11#1)(1997-7#2)
alpha =##17##2##(1992-11#1)(1996-2#3)(1997-7#4)(2007-11#2)(2008-10#3)(2008-2#1)(2009-11#1)(2013-1#2)
alpha A &gt##2##3##(1995-5#2)
alpha A- and beta-interferons##3##4##(1990-2#3)
alpha A-interferon##2##2##(1990-2#2)
alpha AGA##3##2##(1993-12#3)
alpha Amy3 expression##2##3##(1994-11#2)
alpha Amy3 mRNA##3##3##(1994-11#3)
alpha Amy3##9##2##(1994-11#9)
alpha B##2##2##(1995-2#2)
alpha B-Crystallin##2##2##(1991-12#2)
alpha B-crystallin mRNA in slow muscle##2##6##(1991-12#2)
alpha B-crystallin mRNA in##4##4##(1991-12#4)
alpha B-crystallin##6##2##(1991-12#6)
alpha BFV-4 and alpha BFV-5 inhibited the##2##7##(1994-5#2)
alpha BFV-4##3##2##(1994-5#3)
alpha BFV-5##3##2##(1994-5#3)
alpha C##4##2##(1995-2#2)(1995-5#2)
alpha Coh##2##2##(1994-3#2)
alpha G##3##2##(1995-2#1)(1995-5#2)
alpha GalNAc##2##2##(1990-7#2)
alpha GalNAc-specific##2##2##(1990-7#2)
alpha H coupling constants##2##4##(1992-3#1)(1994-5#1)
alpha H##3##2##(1992-3#2)(1994-5#1)
alpha N##2##2##(1995-5#2)
alpha S##2##2##(1995-11#2)
alpha T##3##2##(1995-5#3)
alpha T3 cells##2##3##(1992-12#2)
alpha activity##4##2##(1993-3#1)(1995-4#1)(1996-7#1)(2008-10#1)
alpha and IL-1##2##3##(1993-6#1)(1995-2#1)
alpha and a##2##3##(1994-8#1)(1995-6#1)
alpha and beta chains of##2##5##(1994-8#1)(1997-4#1)
alpha and beta chains##3##4##(1994-6#1)(1994-8#1)(1997-4#1)
alpha and beta estimates##2##4##(2008-10#2)
alpha and beta forms of##2##5##(1992-9#1)(1994-6#1)
alpha and beta subunit genes were##2##6##(1991-2#2)
alpha and beta subunit genes##3##5##(1991-2#3)
alpha and beta subunits##13##4##(1990-7#1)(1990-8#1)(1991-10#2)(1991-7#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#1)
alpha and beta##42##3##(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#3)(1991-2#3)(1991-7#2)(1992-11#1)(1992-6#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#5)(1994-6#3)(1994-8#2)(1995-11#1)(1995-6#2)(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)
alpha and epsilon##3##3##(1995-2#1)(1995-6#1)(2008-8#1)
alpha and gamma are##2##4##(2008-6#2)
alpha and gamma##6##3##(2008-6#5)(2008-8#1)
alpha and n##2##3##(2008-3#2)
alpha and rho##2##3##(2008-2#1)(2010-5#1)
alpha and the##4##3##(1994-12#1)(1995-6#2)(1997-4#1)
alpha and##100##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-10#3)(1991-12#1)(1991-2#3)(1991-7#2)(1992-11#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#5)(1995-11#1)(1995-2#3)(1995-4#2)(1995-6#7)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#7)(2008-8#5)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
alpha anomer##2##2##(1990-11#1)(1995-5#1)
alpha are##2##2##(1993-8#1)(2009-12#1)
alpha as a##3##3##(1995-4#2)(2009-12#1)
alpha as##4##2##(1995-11#1)(1995-4#2)(2009-12#1)
alpha at##5##2##(1995-11#2)(1995-2#1)(1995-6#2)
alpha beta dimers##3##3##(1990-8#1)(1992-3#1)(1994-8#1)
alpha beta##8##2##(1990-8#1)(1992-3#1)(1993-8#1)(1994-8#4)(1995-5#1)
alpha but not##4##3##(1994-8#1)(1994-9#1)(1995-11#1)(2008-11#1)
alpha by##5##2##(1990-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#1)
alpha cell##2##2##(1990-11#1)(2013-7#1)
alpha cells##3##2##(1990-11#2)(1995-2#1)
alpha chain##13##2##(1990-12#1)(1991-2#1)(1992-12#4)(1994-6#3)(1997-5#1)(1997-8#1)(1997-9#2)
alpha coefficient##5##2##(2008-10#1)(2013-1#3)(2013-8#1)
alpha counter##2##2##(2008-10#2)
alpha fetoprotein##2##2##(2008-10#1)(2013-7#1)
alpha gene encodes##2##3##(1993-3#1)(1993-6#1)
alpha gene##12##2##(1990-7#1)(1993-12#2)(1993-3#4)(1993-6#1)(1994-2#1)(1994-9#2)(2013-1#1)
alpha has been##2##3##(1995-6#1)(1997-5#1)
alpha has##3##2##(1990-7#1)(1995-6#1)(1997-5#1)
alpha helices##2##2##(1991-12#1)(2008-10#1)
alpha in##8##2##(1991-7#1)(1992-2#1)(1992-8#1)(1994-7#1)(1995-2#1)(1996-12#1)(1997-5#1)(2007-12#1)
alpha increased##2##2##(1994-9#1)(1995-8#1)
alpha is a##2##3##(1995-2#1)(2009-7#1)
alpha is##12##2##(1990-11#1)(1993-6#1)(1994-8#1)(1995-2#2)(1997-3#2)(2008-10#1)(2008-7#1)(2009-12#2)(2009-7#1)
alpha isoform of##2##3##(1994-8#1)(2012-12#1)
alpha isoform##3##2##(1994-8#1)(1995-2#1)(2012-12#1)
alpha mRNA in##2##3##(1993-3#1)(2008-12#1)
alpha mRNA##8##2##(1991-2#3)(1993-3#2)(1995-2#2)(2008-12#1)
alpha monomer##2##2##(2008-7#2)
alpha of##2##2##(1995-6#1)(2013-1#1)
alpha on the##2##3##(1990-2#1)(1995-6#1)
alpha on##6##2##(1990-11#1)(1990-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-5#1)
alpha or beta##4##3##(1990-7#1)(1993-8#1)(2008-6#1)(2008-8#1)
alpha or##9##2##(1990-7#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-5#1)(1997-1#1)(2008-6#1)(2008-8#1)
alpha phase##5##2##(1993-11#1)(2009-7#4)
alpha polypeptides##2##2##(1994-5#1)(1995-6#1)
alpha production##2##2##(1994-12#1)(1994-9#1)
alpha protein##3##2##(1995-2#1)(2009-7#2)
alpha radiation##2##2##(2008-7#2)
alpha s2-CasA##2##2##(1993-6#2)
alpha s2-CasD##2##2##(1993-6#2)
alpha satellite DNA##2##3##(1997-6#2)
alpha satellite##4##2##(1997-6#3)(2008-7#1)
alpha subunit and##3##3##(1990-7#1)(1992-9#1)(1995-8#1)
alpha subunit in transcriptional##2##4##(1995-6#2)
alpha subunit in##4##3##(1995-6#2)(1995-8#1)(1997-7#1)
alpha subunit of the##5##4##(1991-5#1)(1992-11#1)(1994-2#1)(1994-8#1)(2008-8#1)
alpha subunit of##15##3##(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#2)(1995-8#1)(1996-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
alpha subunit to##2##3##(1995-2#1)(1995-6#1)
alpha subunit##47##2##(1990-12#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-8#5)(1995-2#4)(1995-6#4)(1995-8#9)(1996-12#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-2#1)
alpha subunits and##3##3##(1990-7#1)(1995-11#1)(1995-6#1)
alpha subunits##10##2##(1990-7#1)(1992-2#1)(1994-8#3)(1995-11#1)(1995-6#4)
alpha to##2##2##(1996-5#1)(2010-10#1)
alpha was found to##2##4##(1995-2#1)(1995-4#1)
alpha was##14##2##(1990-2#1)(1990-8#3)(1992-11#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(2010-1#1)
alpha were##2##2##(1992-11#1)(1996-12#1)
alpha with##4##2##(1991-9#1)(1992-9#1)(2009-7#1)(2012-12#1)
alpha##996##1##(1990-11#20)(1990-12#15)(1990-2#13)(1990-4#1)(1990-5#6)(1990-7#16)(1990-8#21)(1991-10#5)(1991-12#18)(1991-2#16)(1991-5#25)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#6)(1992-10#3)(1992-11#9)(1992-12#22)(1992-2#5)(1992-3#13)(1992-4#4)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#9)(1993-11#5)(1993-12#21)(1993-2#4)(1993-3#28)(1993-5#2)(1993-6#19)(1993-8#21)(1993-9#11)(1994-11#27)(1994-12#11)(1994-2#12)(1994-3#9)(1994-5#19)(1994-6#38)(1994-7#1)(1994-8#37)(1994-9#18)(1995-11#69)(1995-12#3)(1995-2#37)(1995-3#2)(1995-4#6)(1995-5#19)(1995-6#43)(1995-8#14)(1995-9#2)(1996-12#19)(1996-2#6)(1996-5#6)(1996-7#1)(1996-8#1)(1997-1#8)(1997-2#1)(1997-3#3)(1997-4#11)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#1)(1997-9#2)(2007-11#4)(2007-12#3)(2007-2#1)(2008-1#3)(2008-10#30)(2008-11#13)(2008-12#3)(2008-2#10)(2008-3#16)(2008-4#2)(2008-5#4)(2008-6#8)(2008-7#13)(2008-8#15)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#8)(2009-2#1)(2009-7#9)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#4)
alpha(1)##2##1##(2008-10#2)
alpha(1)-adrenoceptor antagonist##3##2##(2008-10#1)(2008-6#2)
alpha(1--&gt##3##1##(2009-12#3)
alpha(1B)##2##1##(2008-11#1)(2008-4#1)
alpha(1B)-AR mRNA##4##2##(2008-4#4)
alpha(1B)-AR##9##1##(2008-4#9)
alpha(1B)-adrenergic receptor##2##2##(2008-4#2)
alpha(2-6)##2##1##(1991-9#2)
alpha(E)-catenin##2##1##(1994-9#2)
alpha) and##4##2##(1991-9#1)(1993-6#1)(1994-5#1)(1995-6#1)
alpha) by##2##2##(1992-9#1)(1993-8#1)
alpha) has##2##2##(1992-9#1)(1997-5#1)
alpha) in##2##2##(1992-8#1)(1994-2#1)
alpha) is##2##2##(1995-2#2)
alpha) or##2##2##(1994-8#1)(1997-1#1)
alpha)##33##1##(1990-12#1)(1990-8#1)(1991-9#2)(1992-3#1)(1992-8#1)(1992-9#6)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-6#2)(1996-12#1)(1997-1#2)(1997-5#1)(2008-1#1)(2008-10#1)(2009-7#1)(2012-3#1)
alpha- and LH beta-subunit##2##4##(1996-2#2)
alpha- and beta- myosin heavy chain gene expression##3##8##(1992-3#3)
alpha- and beta- myosin heavy chain gene##4##7##(1992-3#4)
alpha- and beta- myosin heavy chain##6##6##(1992-3#6)
alpha- and beta-CGRP##5##3##(1992-6#5)
alpha- and beta-adrenergic##2##3##(1991-12#2)
alpha- and beta-chains##4##3##(1991-6#1)(1992-8#1)(1997-4#2)
alpha- and beta-relaxation##2##3##(1995-3#2)
alpha- and beta-subunits of##3##4##(1990-2#2)(1991-3#1)
alpha- and beta-subunits##4##3##(1990-2#2)(1991-3#2)
alpha- and beta-zearalenol##2##3##(1997-6#2)
alpha- and lutropin##2##3##(1996-2#2)
alpha- and##53##2##(1990-11#1)(1990-2#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-3#6)(1992-6#6)(1992-8#2)(1993-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-2#4)(1997-4#3)(1997-6#2)(2008-10#9)(2008-12#1)(2008-5#2)
alpha- or##3##2##(1990-8#1)(1994-2#1)(1996-2#1)
alpha-##76##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#6)(1992-6#6)(1992-8#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-3#2)(1996-12#1)(1996-2#9)(1997-4#3)(1997-6#2)(2007-11#1)(2008-10#18)(2008-12#1)(2008-5#2)
alpha-1##13##1##(1990-2#1)(1992-8#2)(1995-2#2)(1995-5#2)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
alpha-1-antitrypsin##4##1##(1993-8#4)
alpha-2##8##1##(1990-2#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-6#1)(2008-10#1)(2008-7#1)(2010-7#1)
alpha-2b interferon##3##2##(1990-6#2)(1992-2#1)
alpha-2b plus##2##2##(2010-11#1)(2013-1#1)
alpha-2b##6##1##(1990-6#2)(1992-2#2)(2010-11#1)(2013-1#1)
alpha-3 acetylcholine receptor subunit##2##4##(1993-11#2)
alpha-3##3##1##(1993-11#3)
alpha-308##4##1##(1995-12#4)
alpha-AT in##2##2##(1992-3#2)
alpha-AT level##2##2##(1992-3#2)
alpha-AT##5##1##(1992-3#5)
alpha-Amylase##2##1##(2008-10#2)
alpha-Btx##4##1##(2008-8#4)
alpha-CD did not##2##3##(2008-10#2)
alpha-CD##9##1##(2008-10#8)(2008-6#1)
alpha-CGRP##5##1##(1992-6#5)
alpha-D-galactosidase##2##1##(1995-11#1)(2008-11#1)
alpha-D-glucosidase##2##1##(1995-11#2)
alpha-D-mannopyranoside##3##1##(1992-12#2)(2008-4#1)
alpha-FP##5##1##(1992-3#5)
alpha-GP##4##1##(2008-10#4)
alpha-GPC##2##1##(1994-6#2)
alpha-Gi##3##1##(1994-6#2)(1997-1#1)
alpha-Gs##4##1##(1994-6#3)(1997-1#1)
alpha-H-amino acids##2##2##(1991-5#1)(1992-11#1)
alpha-IFN##2##1##(2008-7#2)
alpha-KGDH##5##1##(1995-5#5)
alpha-L-Rhap-(1--&gt##2##1##(1993-11#2)
alpha-LA##6##1##(2008-7#6)
alpha-MHC promoter##2##2##(1991-9#2)
alpha-MHC##3##1##(1991-9#3)
alpha-MSH and##6##2##(1993-5#5)(1995-2#1)
alpha-MSH for##3##2##(1993-5#1)(1995-2#2)
alpha-MSH release##2##2##(1993-5#2)
alpha-MSH##27##1##(1993-5#20)(1995-2#5)(2008-1#1)(2008-6#1)
alpha-Si##3##1##(2008-10#3)
alpha-Tocopherol##3##1##(1991-2#1)(2008-10#1)(2008-11#1)
alpha-Tomatine##2##1##(2008-10#2)
alpha-[PMo(12)O(40)](3-) complex was##2##3##(2008-10#2)
alpha-[PMo(12)O(40)](3-) complex##3##2##(2008-10#3)
alpha-[PMo(12)O(40)](3-)##5##1##(2008-10#5)
alpha-acetolactic acid##2##2##(2008-6#2)
alpha-actin labelled##2##2##(2008-11#2)
alpha-actin##4##1##(1993-8#1)(2007-8#1)(2008-11#2)
alpha-actinin from chicken gizzard##2##4##(1993-8#2)
alpha-actinin##10##1##(1993-8#6)(1993-9#3)(2010-6#1)
alpha-adrenergic##6##1##(1991-12#2)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#1)
alpha-adrenoceptor##2##1##(1991-6#1)(1997-7#1)
alpha-amidating enzyme##2##2##(2008-11#2)
alpha-amidating monooxygenase##3##2##(1993-5#1)(1994-11#2)
alpha-amidating##5##1##(1993-5#1)(1994-11#2)(2008-11#2)
alpha-amino group##2##2##(1992-6#2)
alpha-amino##7##1##(1992-6#2)(1992-8#2)(1996-5#1)(2007-11#1)(2009-8#1)
alpha-amino-3-hydroxy-5-methyl-4-isoxasole-propionic acid (AMPA##2##3##(1995-12#2)
alpha-amino-3-hydroxy-5-methyl-4-isoxazole##2##1##(1995-11#1)(1995-2#1)
alpha-amino-n-butyric acid##3##2##(1992-3#2)(1997-2#1)
alpha-aminoadipic##2##1##(2008-7#1)(2010-4#1)
alpha-aminoisobutyric acid uptake##2##3##(1995-11#2)
alpha-aminoisobutyric##3##1##(1995-11#2)(1995-2#1)
alpha-amylase (EC 3##2##3##(1990-7#1)(1991-5#1)
alpha-amylase activity in##2##3##(1991-5#1)(1997-3#1)
alpha-amylase activity##5##2##(1991-5#2)(1997-3#1)(2008-8#1)(2013-1#1)
alpha-amylase and##5##2##(1990-3#2)(2008-10#2)(2008-8#1)
alpha-amylase by##2##2##(1992-12#1)(2008-10#1)
alpha-amylase from Bacillus licheniformis##4##4##(1997-4#4)
alpha-amylase from##6##2##(1992-8#1)(1997-4#4)(2008-10#1)
alpha-amylase gene##8##2##(1994-11#1)(2008-10#1)(2008-8#6)
alpha-amylase using##2##2##(1990-9#1)(1991-5#1)
alpha-amylase was##3##2##(1990-3#1)(1997-3#1)(2008-10#1)
alpha-amylase##60##1##(1990-11#1)(1990-12#3)(1990-3#7)(1990-7#1)(1990-9#2)(1991-5#5)(1992-12#2)(1992-8#1)(1994-11#2)(1997-3#3)(1997-4#4)(2008-10#10)(2008-6#2)(2008-7#1)(2008-8#13)(2009-8#1)(2013-1#2)
alpha-amylase-deficient mutant##2##2##(2008-10#2)
alpha-amylases##3##1##(1997-4#3)
alpha-and beta-subunits of##2##3##(1994-5#1)(2008-8#1)
alpha-blocker##2##1##(2007-9#1)(2008-10#1)
alpha-blockers##2##1##(1993-2#1)(2011-1#1)
alpha-bungarotoxin binding and sensitivity to nicotine-induced##2##6##(1996-12#2)
alpha-bungarotoxin binding##5##2##(1996-12#5)
alpha-bungarotoxin receptor levels##2##3##(1996-12#2)
alpha-bungarotoxin##11##1##(1992-8#1)(1996-12#8)(2008-8#2)
alpha-carbon hydroxylation##3##2##(1990-6#2)(1993-11#1)
alpha-carbon##6##1##(1990-6#2)(1992-8#1)(1993-11#1)(2007-11#2)
alpha-carbonyl##2##1##(1993-6#1)(2007-11#1)
alpha-catenin##9##1##(1993-6#5)(1994-9#4)
alpha-chain##11##1##(1990-5#1)(1991-6#1)(1995-6#8)(1997-7#1)
alpha-chains##3##1##(1990-8#2)(1994-6#1)
alpha-cholest-8(14)-en-15-one##3##1##(1992-3#2)(1993-6#1)
alpha-chymotrypsin##9##1##(1990-8#1)(1993-11#1)(1996-12#2)(1996-5#1)(1997-2#1)(2008-10#1)(2008-7#2)
alpha-cristobalite##2##1##(1992-7#2)
alpha-crystallin##4##1##(1992-12#3)(2010-9#1)
alpha-cyano-4-hydroxycinnamic acid (CHCA)##2##3##(2008-10#2)
alpha-cyclodextrin (CD) and##2##3##(2008-10#2)
alpha-cyclodextrin##7##1##(1995-5#1)(1997-2#1)(2008-10#5)
alpha-diazo-beta-ketoesters##2##1##(2009-5#2)
alpha-difluoromethylornithine##2##1##(1992-8#1)(1992-9#1)
alpha-diimine ligands##2##2##(2008-10#2)
alpha-dimer##2##1##(1995-6#2)
alpha-diol##2##1##(1990-11#1)(1990-8#1)
alpha-dipeptides##2##1##(1995-6#2)
alpha-emitter)##2##1##(2008-7#2)
alpha-endosulfan##2##1##(2008-10#2)
alpha-erythro-2-pentulofuranose (0##2##2##(1990-9#2)
alpha-fetoprotein (AFP)##4##2##(1990-9#1)(2008-10#1)(2008-8#1)(2011-1#1)
alpha-fetoprotein##11##1##(1990-2#1)(1990-9#2)(1992-3#1)(1995-5#1)(2008-10#2)(2008-8#2)(2011-1#1)(2011-2#1)
alpha-galactosidase from coffee bean##2##4##(1995-11#2)
alpha-galactosidase##4##1##(1995-11#2)(2007-7#1)(2008-5#1)
alpha-globin mRNA##3##2##(2008-6#1)(2008-8#1)(2008-9#1)
alpha-globin##7##1##(1990-8#4)(2008-6#1)(2008-8#1)(2008-9#1)
alpha-glucosidase gene from Aspergillus niger##2##5##(1997-2#2)
alpha-glucosidase##11##1##(1991-5#2)(1995-3#1)(1997-2#3)(2007-12#3)(2008-6#1)(2011-3#1)
alpha-glucosyl fluoride##2##2##(1995-5#2)
alpha-glycerophosphate##3##1##(2008-10#3)
alpha-granules are##2##2##(1997-7#2)
alpha-granules##7##1##(1990-5#1)(1997-7#5)(2010-3#1)
alpha-helical character##2##2##(1995-2#2)
alpha-helical coiled-coil##3##2##(1992-6#2)(1995-3#1)
alpha-helical conformation##4##2##(1994-5#2)(1995-2#2)
alpha-helical content in a hydrophobic medium##2##6##(1995-3#2)
alpha-helical content##3##2##(1993-11#1)(1995-3#2)
alpha-helical domain##2##2##(1997-2#1)(1997-4#1)
alpha-helical peptide##2##2##(1993-11#1)(1995-3#1)
alpha-helical protein##2##2##(1993-8#1)(1994-5#1)
alpha-helical region##2##2##(1991-12#1)(1991-2#1)
alpha-helical secondary structure##2##3##(1994-2#1)(1994-3#1)
alpha-helical structure##6##2##(1990-5#2)(1992-5#1)(1993-11#1)(1995-2#1)(2012-2#1)
alpha-helical##48##1##(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#2)(1993-11#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1995-11#1)(1995-2#6)(1995-3#7)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-2#1)
alpha-helices C and D##2##4##(1993-11#2)
alpha-helices and connecting peptides can be##2##6##(2008-10#2)
alpha-helices and connecting peptides##3##4##(2008-10#3)
alpha-helices and##6##2##(1991-6#1)(2008-10#5)
alpha-helices of the##2##3##(1992-9#1)(1994-6#1)
alpha-helices of##3##2##(1992-9#1)(1994-6#2)
alpha-helices##15##1##(1991-6#1)(1992-9#1)(1993-11#2)(1994-6#3)(1995-12#1)(1995-2#1)(2008-10#5)(2008-7#1)
alpha-helicity##2##1##(1990-5#1)(1995-11#1)
alpha-helix and beta-sheet##3##3##(1992-6#1)(2008-7#1)(2008-9#1)
alpha-helix and##5##2##(1992-6#1)(2008-7#1)(2008-8#1)(2008-9#2)
alpha-helix at##3##2##(1992-6#1)(1992-8#1)(1993-11#1)
alpha-helix content##2##2##(1995-11#1)(1995-12#1)
alpha-helix formation##2##2##(1994-8#1)(1995-12#1)
alpha-helix inducing##2##2##(1990-5#2)
alpha-helix poly(L-lysine)##2##2##(1992-6#2)
alpha-helix structure##2##2##(1992-6#1)(1995-12#1)
alpha-helix##39##1##(1990-12#1)(1990-5#2)(1992-6#7)(1992-8#2)(1993-11#2)(1993-8#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#3)(1995-6#1)(1997-4#2)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#3)
alpha-hydrogen##2##1##(1995-2#2)
alpha-hydroxy acid##3##2##(2008-5#3)
alpha-hydroxy acids##3##2##(2008-5#3)
alpha-hydroxy##8##1##(1992-12#1)(2008-10#1)(2008-5#6)
alpha-hydroxyacids##3##1##(2007-11#2)(2008-5#1)
alpha-hydroxyisobutyric acid (HIBA)##2##3##(2008-10#2)
alpha-hydroxylase##2##1##(1994-6#1)(1997-7#1)
alpha-hydroxylation in##2##2##(1995-9#2)
alpha-hydroxylation##8##1##(1993-11#1)(1994-6#2)(1995-12#1)(1995-9#4)
alpha-hydroxysteroid dehydrogenase##3##2##(1990-11#2)(1994-6#1)
alpha-hydroxysteroid##6##1##(1990-11#4)(1990-12#1)(1994-6#1)
alpha-induced##5##1##(1997-1#4)(2008-7#1)
alpha-interferon##9##1##(1991-3#1)(1992-2#1)(1996-6#4)(2008-7#1)(2011-1#2)
alpha-kainic acid##2##2##(1992-8#2)
alpha-ketoglutarate (AKG)##2##2##(2007-8#2)
alpha-ketoglutarate dehydrogenase##2##2##(1995-5#2)
alpha-ketoglutarate##17##1##(1993-6#1)(1995-5#2)(2007-8#4)(2008-11#1)(2008-4#6)(2008-7#1)(2008-8#2)
alpha-ketoisocaproic acid (KIC)##2##3##(2008-11#2)
alpha-ketoisocaproic acid##3##2##(2008-11#3)
alpha-lactalbumin##7##1##(1994-11#1)(2008-10#3)(2008-7#3)
alpha-linolenic acid##3##2##(2008-10#1)(2010-4#1)(2012-1#1)
alpha-linolenic##5##1##(1990-3#1)(1994-11#1)(2008-10#1)(2010-4#1)(2012-1#1)
alpha-lipoic acid##8##2##(1992-12#3)(1994-11#1)(1994-6#1)(2008-1#1)(2008-5#1)(2013-8#1)
alpha-lytic protease##5##2##(1993-11#4)(1995-3#1)
alpha-mannosidase##5##1##(2008-5#1)(2008-8#4)
alpha-melanocyte-stimulating hormone release from##2##4##(1993-5#2)
alpha-melanocyte-stimulating hormone##10##2##(1993-5#6)(1996-2#1)(2008-8#2)(2009-8#1)
alpha-meso##3##1##(1994-5#3)
alpha-methyl##3##1##(1991-12#1)(1991-5#2)
alpha-myosin heavy chain gene##3##4##(1991-9#3)
alpha-myosin heavy chain promoter##2##4##(1991-9#2)
alpha-myosin heavy chain##6##3##(1991-9#6)
alpha-naphtholphthalein in poly(isobutyl methacrylate)##2##4##(2008-10#2)
alpha-naphtholphthalein in##4##2##(2008-10#4)
alpha-one antitrypsin##2##2##(1993-6#2)
alpha-peptide##3##1##(1991-3#2)(2006-12#1)
alpha-peptides##2##1##(1991-3#1)(2006-12#1)
alpha-phosphate##3##1##(1992-6#1)(1993-8#2)
alpha-pinene##8##1##(2008-10#2)(2008-12#2)(2008-3#2)(2010-5#2)
alpha-proton##2##1##(1992-6#1)(1992-8#1)
alpha-receptor blockers##2##2##(1993-2#2)
alpha-sarcin##4##1##(1993-2#2)(1997-4#2)
alpha-subunit isoforms##2##2##(1994-8#2)
alpha-subunit promoter##2##2##(1996-5#2)
alpha-subunit##36##1##(1990-11#3)(1990-4#1)(1990-5#2)(1991-12#1)(1991-3#4)(1991-9#1)(1993-11#3)(1994-5#7)(1994-8#3)(1995-2#1)(1995-6#1)(1996-12#2)(1996-5#3)(2008-5#1)(2008-8#2)(2012-2#1)
alpha-subunits of##2##2##(1990-4#1)(1995-6#1)
alpha-subunits##10##1##(1990-4#2)(1990-8#1)(1991-9#4)(1994-6#1)(1995-6#2)
alpha-synuclein##3##1##(2008-7#3)
alpha-tocopherol and##6##2##(1990-2#1)(1992-5#1)(1994-9#1)(2008-10#2)(2008-5#1)
alpha-tocopherol content in oxidized LDL##2##5##(2009-8#2)
alpha-tocopherol content in##3##3##(1991-12#1)(2009-8#2)
alpha-tocopherol in##3##2##(1991-12#1)(1994-12#1)(2008-10#1)
alpha-tocopherol##47##1##(1990-2#3)(1990-8#3)(1991-12#10)(1992-5#1)(1992-9#2)(1994-12#1)(1994-9#5)(1995-2#1)(1996-2#5)(2008-10#4)(2008-12#1)(2008-5#4)(2009-8#6)(2011-1#1)
alpha-tocopheryl acetate##2##2##(1990-2#2)
alpha-tocopheryl##3##1##(1990-2#2)(2009-8#1)
alpha-tomatine##5##1##(2008-10#5)
alpha-toxin protein##2##2##(2010-6#2)
alpha-toxin##13##1##(2008-9#1)(2010-6#12)
alpha-trifluoromethyl-beta-alanyl##2##1##(1994-8#2)
alpha-trinositol##5##1##(1995-12#5)
alpha-tropomyosin##3##1##(1997-7#3)
alpha-tubulin##5##1##(1992-6#2)(1992-9#1)(1994-5#1)(2008-7#1)
alpha-type##2##1##(1994-8#1)(1997-1#1)
alpha/alpha' subunits##2##2##(1992-6#2)
alpha/alpha'##5##1##(1992-6#5)
alpha/beta##7##1##(1991-5#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-5#1)
alpha1 and##2##2##(2008-7#1)(2011-2#1)
alpha1##11##1##(1997-7#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#3)(2011-2#1)
alpha1-adrenoceptor antagonists##2##2##(1995-12#2)
alpha1-adrenoceptor subtype##2##2##(1995-12#2)
alpha1-adrenoceptor subtypes##2##2##(1995-12#2)
alpha1-adrenoceptor##8##1##(1995-12#8)
alpha1-adrenoceptor-G protein coupling##2##3##(2008-3#2)
alpha1-adrenoceptors##2##1##(1995-12#2)
alpha1A- and alpha1B-adrenoceptors##2##3##(1995-12#2)
alpha1D-adrenoceptor##2##1##(1995-12#2)
alpha1c/86D##2##1##(2008-8#2)
alpha2##16##1##(1997-7#2)(2008-11#12)(2008-3#1)(2008-7#1)
alpha2(I) collagen##2##2##(1997-7#2)
alpha2(I)##3##1##(1997-7#3)
alpha2-adrenergic##2##1##(1997-4#2)
alpha2-adrenoceptors in the##2##3##(1995-12#1)(1997-7#1)
alpha2-adrenoceptors that regulate##2##3##(1995-12#2)
alpha2-adrenoceptors##7##1##(1995-12#4)(1997-4#1)(1997-7#2)
alpha2-macroglobulin##2##1##(2008-11#1)(2011-2#1)
alpha2M##5##1##(2008-11#5)
alpha2M/K692##2##1##(2008-11#2)
alpha2M/K696##2##1##(2008-11#2)
alpha3##2##1##(2008-11#2)
alpha5##2##1##(2008-11#2)
alphabet##4##1##(2008-3#1)(2008-4#1)(2009-12#1)(2013-8#1)
alphabeta T cell##2##3##(2008-4#1)(2009-8#1)
alphabeta##6##1##(2008-4#1)(2008-8#1)(2009-8#4)
alphabetamADP##2##1##(2008-4#2)
alphabetical##2##1##(1997-3#1)(2008-2#1)
alphacalcidol##3##1##(2008-1#3)
alphanumeric pagers##2##2##(2010-8#2)
alphanumeric paging system##2##3##(2010-8#2)
alphanumeric paging##4##2##(2010-8#4)
alphanumeric##8##1##(2010-8#8)
alphavirus##5##1##(1997-4#1)(2008-4#1)(2008-5#3)
alpine##4##1##(2008-3#1)(2009-5#2)(2010-6#1)
alpinus##9##1##(2010-8#9)
alprazolam##2##1##(1991-12#2)
already a##4##2##(1991-11#1)(2008-10#1)(2009-5#1)(2010-7#1)
already applied##3##2##(2008-1#1)(2008-10#2)
already at the##2##3##(1991-12#1)(2008-5#1)
already at##9##2##(1990-9#1)(1991-12#1)(1992-3#1)(1994-3#1)(1994-6#1)(2008-5#2)(2013-1#1)(2013-8#1)
already available##5##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2013-1#1)
already be found##2##3##(1996-1#1)(2008-7#1)
already be##7##2##(1992-6#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
already been established##2##3##(1997-4#1)(2006-12#1)
already been reported##4##3##(1991-12#1)(1993-8#1)(1994-11#1)(2013-8#1)
already been##48##2##(1990-12#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-8#2)(1996-2#2)(1996-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
already being##3##2##(1994-2#1)(2008-1#1)(2010-8#1)
already covered by##2##3##(1990-2#1)(1993-1#1)
already demonstrated##3##2##(1993-3#1)(2007-7#1)(2008-9#1)
already described##2##2##(2008-1#1)(2008-11#1)
already during##2##2##(1994-3#1)(2007-12#1)
already established##8##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
already evident##3##2##(1994-8#1)(1996-5#1)(2008-1#1)
already exist##2##2##(1996-2#1)(2009-6#1)
already existing##4##2##(2008-11#1)(2008-2#1)(2009-11#1)(2013-7#1)
already exists##3##2##(1996-11#1)(1996-2#1)(2008-3#1)
already formed##2##2##(2013-1#2)
already found##2##2##(1990-6#1)(2008-10#1)
already had##5##2##(1990-11#1)(1991-9#1)(1996-6#1)(2010-12#1)(2012-12#1)
already have##7##2##(1993-3#2)(1995-12#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-4#1)
already in clinical use##2##4##(2009-7#1)(2012-12#1)
already in clinical##3##3##(2009-7#1)(2012-12#1)(2012-2#1)
already in place##3##3##(1995-12#1)(2008-10#2)
already in the##2##3##(1992-3#1)(2012-1#1)
already in##16##2##(1990-6#1)(1992-10#1)(1992-3#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-7#1)(2010-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
already indicated##2##2##(1997-4#1)(2008-8#1)
already infected##2##2##(2008-10#1)(2008-6#1)
already influenced##2##2##(1993-11#1)(2011-2#1)
already known##6##2##(1990-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
already observed##2##2##(1992-5#1)(1995-3#1)
already on the##3##3##(1990-12#1)(1994-3#1)(2008-7#1)
already on##8##2##(1990-12#1)(1993-1#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
already present in##3##3##(1991-12#1)(2007-12#1)(2011-2#1)
already present##10##2##(1991-12#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)
already proven##3##2##(2008-4#1)(2009-10#1)(2012-12#1)
already reported##4##2##(1997-4#1)(2008-11#1)(2008-3#1)(2008-5#1)
already shown##2##2##(1994-11#1)(1997-4#1)
already the##3##2##(2007-2#1)(2010-3#1)(2011-2#1)
already used##5##2##(1993-12#1)(2008-10#1)(2012-1#1)(2012-2#1)(2012-3#1)
already using##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
already vulnerable##2##2##(2008-7#1)(2012-2#1)
already was##2##2##(1993-3#1)(2008-10#1)
already within##2##2##(1994-3#1)(2013-8#1)
already##336##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#4)(1994-6#2)(1994-8#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#2)(1997-7#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#27)(2008-11#25)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#7)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#4)(2008-9#5)(2009-10#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#15)(2012-1#4)(2012-12#6)(2012-2#9)(2012-3#2)(2012-6#1)(2013-1#11)(2013-7#2)(2013-8#8)
als##6##1##(2008-6#2)(2008-9#2)(2012-12#2)
also &quot##2##2##(1991-8#1)(1997-6#1)
also P##3##2##(1995-5#1)(2008-10#1)(2008-12#1)
also a particular##2##3##(2008-5#1)(2009-6#1)
also a series of##2##4##(2008-3#1)(2011-4#1)
also a source of##2##4##(2008-11#1)(2009-5#1)
also a trend##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
also a##90##2##(1990-11#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-4#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
also able to##12##3##(1992-9#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)
also able##13##2##(1992-9#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)
also about##3##2##(1993-9#1)(1995-5#1)(2008-8#1)
also accelerated##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
also acceptable##2##2##(1992-8#1)(2010-10#1)
also accompanied by##2##3##(2008-10#1)(2008-8#1)
also account for##2##3##(1990-2#1)(2012-12#1)
also accounts for##2##3##(1997-2#1)(2008-2#1)
also accumulated##3##2##(1993-6#1)(1993-8#1)(1995-2#1)
also achieved an##2##3##(2007-11#1)(2008-2#1)
also achieved##18##2##(1991-8#1)(1994-5#1)(1995-6#1)(2007-11#2)(2008-10#8)(2008-2#2)(2008-7#1)(2010-3#1)(2011-1#1)
also acquired##2##2##(1993-6#1)(2008-11#1)
also act as##2##3##(2010-10#1)(2013-1#1)
also act##4##2##(1993-12#1)(2008-4#1)(2010-10#1)(2013-1#1)
also activated##2##2##(2010-5#1)(2012-2#1)
also active in##2##3##(2007-8#1)(2008-9#1)
also active##5##2##(1993-6#1)(1994-5#1)(2007-8#1)(2008-5#1)(2008-9#1)
also acts as a##2##4##(2008-3#1)(2013-1#1)
also acts as##3##3##(1993-6#1)(2008-3#1)(2013-1#1)
also acts##5##2##(1991-6#1)(1993-6#1)(2007-12#1)(2008-3#1)(2013-1#1)
also add##2##2##(2008-3#1)(2012-2#1)
also added to##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
also added##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
also address##5##2##(1995-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2013-1#1)
also addressed##15##2##(1994-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
also addresses the##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
also adjusted##2##2##(2007-8#1)(2009-7#1)
also admitted##2##2##(1991-2#1)(2010-6#1)
also affect the##11##3##(1990-5#1)(1991-3#1)(1996-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
also affect##17##2##(1990-5#1)(1991-3#1)(1994-5#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
also affected by the##3##4##(1990-6#1)(2008-10#2)
also affected by##8##3##(1990-6#1)(1994-11#1)(1995-6#1)(2008-10#3)(2011-2#1)(2013-1#1)
also affected the##4##3##(1993-8#1)(2008-10#2)(2008-8#1)
also affected##28##2##(1990-6#1)(1991-11#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
also affects the##3##3##(1997-2#1)(1997-5#1)(2011-1#1)
also affects##11##2##(1995-12#1)(1995-5#1)(1997-2#1)(1997-5#1)(2008-10#2)(2009-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
also after##4##2##(2006-6#1)(2007-8#1)(2008-1#1)(2013-8#1)
also agreed##2##2##(2008-10#1)(2008-11#1)
also agrees##2##2##(2007-11#1)(2008-2#1)
also aid in##3##3##(1993-11#1)(2008-11#1)(2012-2#1)
also aid##4##2##(1993-11#1)(2008-11#2)(2012-2#1)
also aids##2##2##(1993-2#1)(2013-8#1)
also allow us to##2##4##(2008-11#1)(2010-4#1)
also allow##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
also allowed for##2##3##(2008-10#1)(2008-8#1)
also allowed the##2##3##(1993-12#1)(1996-5#1)
also allowed us to determine##2##5##(2008-10#1)(2008-3#1)
also allowed us to##4##4##(2008-10#2)(2008-3#2)
also allowed##14##2##(1993-12#1)(1996-5#1)(1996-6#1)(2008-10#6)(2008-3#2)(2008-8#1)(2008-9#1)(2012-3#1)
also allows a##4##3##(1990-12#1)(1996-6#1)(2008-12#1)(2008-2#1)
also allows for the##2##4##(2008-10#1)(2008-3#1)
also allows for##7##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-4#1)(2012-12#1)
also allows##22##2##(1990-12#1)(1991-12#1)(1994-2#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#3)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
also alter the##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2012-1#1)
also altered##3##2##(1992-7#1)(1994-3#1)(1995-5#1)
also among the##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
also amplified##2##2##(1997-7#1)(2008-10#1)
also an important##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)
also an increase in the##4##5##(1990-7#1)(2007-12#1)(2008-12#1)(2011-2#1)
also an##29##2##(1990-7#1)(1993-9#1)(1995-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
also analysed##7##2##(1991-6#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-12#1)
also analyzed in##3##3##(1997-6#1)(2008-11#1)(2011-2#1)
also analyzed the##4##3##(1992-6#1)(2008-5#1)(2008-8#1)(2009-5#1)
also analyzed using##2##3##(2008-10#2)
also analyzed##29##2##(1990-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-6#1)(1994-12#1)(1995-6#1)(1997-6#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
also analyzes##2##2##(1997-3#1)(2010-1#1)
also antagonized the##2##3##(1990-5#1)(1994-11#1)
also antagonized##3##2##(1990-5#1)(1994-11#1)(1995-12#1)
also apparent that##3##3##(1995-3#1)(2008-12#1)(2011-1#1)
also apparent##5##2##(1995-3#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)
also appear to be##2##4##(1995-12#1)(2009-9#1)
also appear to##5##3##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
also appeared in##2##3##(1994-3#1)(1997-6#1)
also appeared to be a##2##5##(1995-11#1)(1995-12#1)
also appeared to be##4##4##(1995-11#1)(1995-12#1)(2008-11#1)(2012-2#1)
also appeared to##6##3##(1995-11#1)(1995-12#1)(2008-11#2)(2010-2#1)(2012-2#1)
also appeared##11##2##(1993-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-6#1)(2008-11#3)(2010-2#1)(2010-3#1)(2012-2#1)
also appears to be##5##4##(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-3#1)
also appears to##10##3##(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-3#1)
also appears##12##2##(1990-11#1)(1992-11#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-3#1)
also applicable for##2##3##(1993-9#1)(2008-10#1)
also applicable to##9##3##(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)
also applicable##11##2##(1993-9#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)
also applied for the##2##4##(2008-10#2)
also applied for##3##3##(2008-10#2)(2009-6#1)
also applied to the analysis of##2##6##(1996-5#1)(2008-10#1)
also applied to the##4##4##(1993-12#1)(1996-5#1)(2008-10#2)
also applied to##12##3##(1993-12#1)(1996-5#1)(2008-10#8)(2008-3#1)(2013-8#1)
also applied##21##2##(1993-12#1)(1996-5#1)(2007-11#1)(2008-10#15)(2008-3#1)(2009-6#1)(2013-8#1)
also applies to##8##3##(1992-5#1)(1995-2#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-3#1)
also applies##9##2##(1992-5#1)(1995-2#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-4#1)(2008-8#2)(2010-3#1)
also apply to##4##3##(2008-10#1)(2008-4#2)(2010-10#1)
also apply##9##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-10#1)(2012-3#1)(2013-8#1)
also are##10##2##(1990-12#1)(1992-12#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#2)
also argues##2##2##(1995-6#1)(2011-2#1)
also arisen##2##2##(2008-10#1)(2009-11#1)
also arises from##2##3##(1997-7#1)(2008-3#1)
also as a##6##3##(1992-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
also as an##3##3##(2007-7#1)(2008-10#1)(2009-10#1)
also as##20##2##(1990-3#1)(1992-12#1)(1993-2#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-8#1)
also asked##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-8#1)
also assayed##5##2##(1991-2#1)(2008-10#1)(2009-10#1)(2013-1#2)
also assessed after##2##3##(1996-12#1)(2008-5#1)
also assessed##24##2##(1991-5#1)(1991-8#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
also assist in##6##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#2)
also assist##7##2##(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#2)
also associated with an##6##4##(1993-11#1)(1996-5#1)(2008-6#1)(2011-2#1)(2013-1#2)
also associated with elevated##2##4##(1996-12#1)(2008-3#1)
also associated with increased##5##4##(1996-12#1)(2010-8#1)(2012-2#1)(2012-6#1)(2013-1#1)
also associated with##47##3##(1990-9#1)(1991-11#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-12#2)(1996-5#1)(1997-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)(2013-7#1)
also associated##49##2##(1990-9#1)(1991-11#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-12#2)(1996-5#1)(1997-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)(2013-7#1)
also at the##3##3##(2008-10#2)(2008-3#1)
also at##15##2##(1990-5#1)(1994-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-8#1)(2012-12#1)(2012-3#1)
also attempted to##2##3##(1992-3#1)(2008-3#1)
also attenuated##4##2##(1990-12#1)(1994-9#1)(2008-11#1)(2008-4#1)
also augmented##2##2##(1991-12#1)(2013-1#1)
also available##6##2##(1991-12#1)(1991-3#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-7#1)
also based on the##2##4##(1991-5#1)(2008-10#1)
also based on##3##3##(1991-5#1)(1993-11#1)(2008-10#1)
also be a##9##3##(1991-8#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-6#1)(2013-7#1)
also be addressed##5##3##(1994-7#1)(1995-12#1)(2008-7#1)(2008-8#1)(2010-3#1)
also be applicable to##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)
also be applicable##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)
also be applied to monitor##2##5##(1992-3#1)(2010-5#1)
also be applied to other types of##2##7##(2008-2#1)(2008-9#1)
also be applied to other##3##5##(1991-5#1)(2008-2#1)(2008-9#1)
also be applied to##15##4##(1990-5#1)(1991-5#2)(1992-3#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-5#1)(2011-2#1)
also be applied##18##3##(1990-5#1)(1991-5#2)(1992-3#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#1)(2010-5#1)(2011-2#1)
also be assessed##3##3##(2008-11#1)(2008-5#1)(2011-1#1)
also be at##2##3##(1991-5#1)(1992-2#1)
also be beneficial##2##3##(2010-5#1)(2011-2#1)
also be calculated##2##3##(2008-5#1)(2008-7#1)
also be compensated by##2##4##(1995-6#1)(2008-3#1)
also be considered as a##2##5##(2008-10#1)(2011-1#1)
also be considered as##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
also be considered for##3##4##(2008-6#1)(2010-10#1)(2011-2#1)
also be considered##14##3##(1992-6#1)(1995-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
also be derived##2##3##(2008-10#2)
also be detected in##4##4##(1990-11#1)(1996-12#1)(2008-11#1)(2008-9#1)
also be detected##9##3##(1990-11#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
also be explained by##2##4##(1994-2#1)(2012-3#1)
also be found in##4##4##(1996-3#1)(1997-6#1)(2009-2#1)(2009-9#1)
also be found##7##3##(1996-3#1)(1997-6#1)(2007-12#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-3#1)
also be generated##3##3##(1994-12#1)(2008-8#1)(2009-11#1)
also be influenced by the##2##5##(1996-12#1)(2008-8#1)
also be influenced by##3##4##(1996-12#1)(2008-8#1)(2011-2#1)
also be influenced##4##3##(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
also be inhibited by##2##4##(1995-2#1)(2008-8#1)
also be investigated##3##3##(1991-11#1)(2008-3#2)
also be involved in##3##4##(1997-3#1)(2008-8#1)(2009-7#1)
also be involved##7##3##(1995-5#1)(1997-3#1)(2008-10#1)(2008-8#2)(2009-7#1)(2012-3#1)
also be made##2##3##(2008-2#1)(2008-7#1)
also be measured##6##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)
also be more##3##3##(2007-7#1)(2008-7#1)(2009-5#1)
also be observed in the##2##5##(1996-12#1)(2013-7#1)
also be observed in##3##4##(1996-12#1)(2012-12#1)(2013-7#1)
also be observed##4##3##(1996-12#1)(2008-12#1)(2012-12#1)(2013-7#1)
also be of use##2##4##(2008-2#1)(2008-3#1)
also be of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
also be prepared##2##3##(1996-2#1)(2010-12#1)
also be presented##2##3##(2008-5#1)(2011-2#1)
also be related to##2##4##(2006-10#1)(2013-8#1)
also be related##3##3##(2006-10#1)(2008-1#1)(2013-8#1)
also be seen##3##3##(1992-9#1)(2008-10#1)(2008-12#1)
also be sufficient##2##3##(1993-11#1)(2008-10#1)
also be supplemented##2##3##(2008-10#1)(2010-12#1)
also be taken into account##3##5##(1992-6#1)(2008-9#1)(2013-7#1)
also be taken into##5##4##(1992-4#1)(1992-6#1)(2008-10#1)(2008-9#1)(2013-7#1)
also be the cause of a##2##6##(2008-4#1)(2011-2#1)
also be used as a##3##5##(2008-4#1)(2008-7#1)(2013-8#1)
also be used as an##3##5##(2008-10#2)(2009-5#1)
also be used as the##2##5##(1994-12#1)(2011-2#1)
also be used as##11##4##(1994-12#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
also be used for the##2##5##(2008-11#1)(2008-3#1)
also be used for##10##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
also be used in##4##4##(1992-2#1)(2008-3#1)(2008-6#1)(2012-6#1)
also be used to detect##2##5##(2008-10#1)(2008-4#1)
also be used to determine the##3##6##(1990-12#1)(2008-4#1)(2008-9#1)
also be used to determine##6##5##(1990-12#1)(1994-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
also be used to##35##4##(1990-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(2006-4#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#4)(2008-7#4)(2008-8#2)(2008-9#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
also be used##67##3##(1990-12#1)(1991-8#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#7)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-8#2)
also be useful for the##2##5##(2008-2#1)(2012-12#1)
also be useful for##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
also be useful in the##2##5##(1995-2#1)(2012-8#1)
also be useful in##4##4##(1995-2#1)(2008-5#1)(2012-8#1)(2013-8#1)
also be useful##13##3##(1992-12#1)(1994-1#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-8#1)(2013-8#1)
also be utilized##3##3##(1990-12#1)(1994-5#1)(2009-10#1)
also be well##2##3##(2008-10#1)(2008-6#1)
also be##403##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#3)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#3)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-6#3)(1997-7#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#52)(2008-11#10)(2008-12#4)(2008-2#19)(2008-3#25)(2008-4#26)(2008-5#12)(2008-6#5)(2008-7#18)(2008-8#15)(2008-9#11)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#4)(2010-4#4)(2010-5#5)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#12)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#5)(2012-6#1)(2012-8#1)(2013-1#2)(2013-7#3)(2013-8#6)
also bears##2##2##(2008-9#1)(2012-2#1)
also became##2##2##(2008-10#1)(2011-1#1)
also because of##3##3##(1993-5#1)(2011-2#1)(2012-2#1)
also because##7##2##(1993-1#1)(1993-5#1)(1997-1#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
also become##10##2##(1991-3#1)(1995-3#1)(1995-6#1)(1997-4#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-4#1)(2011-1#1)
also becomes a##2##3##(2008-11#1)(2013-7#1)
also becomes##3##2##(2008-11#1)(2010-3#1)(2013-7#1)
also becoming##3##2##(2008-11#2)(2008-12#1)
also been a##2##3##(2007-12#1)(2013-1#1)
also been achieved##2##3##(1995-5#1)(2007-11#1)
also been analyzed##2##3##(1995-6#1)(2012-3#1)
also been applied to##2##4##(2008-10#2)
also been applied##3##3##(2008-10#3)
also been carried##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
also been compared with##2##4##(2008-10#2)
also been compared##3##3##(2008-10#3)
also been considered##2##3##(2008-2#1)(2011-2#1)
also been demonstrated##8##3##(1994-5#1)(2007-11#2)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#2)
also been determined by##2##4##(2008-10#2)
also been determined##5##3##(1992-6#1)(2008-10#3)(2009-8#1)
also been developed##6##3##(1993-3#1)(1994-7#1)(2008-10#3)(2010-8#1)
also been discussed##6##3##(2008-10#5)(2008-7#1)
also been estimated##2##3##(2008-10#1)(2011-2#1)
also been found##9##3##(1996-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)
also been identified##9##3##(1991-1#1)(1992-8#1)(1993-8#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-2#1)
also been implicated in the##2##5##(2010-11#1)(2011-2#1)
also been implicated in##6##4##(1992-9#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
also been implicated##7##3##(1992-9#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
also been introduced##2##3##(2010-12#1)(2012-2#1)
also been investigated in##2##4##(2008-3#1)(2011-2#1)
also been investigated##11##3##(1990-7#1)(2007-5#1)(2008-10#5)(2008-3#2)(2010-1#1)(2011-2#1)
also been linked##2##3##(2013-1#2)
also been noted##2##3##(1992-9#1)(2008-10#1)
also been observed in human##2##5##(1994-3#1)(2009-12#1)
also been observed in##4##4##(1994-3#1)(2008-10#1)(2008-11#1)(2009-12#1)
also been observed##13##3##(1992-3#1)(1994-3#1)(1996-2#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)
also been obtained##5##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-2#2)
also been performed##3##3##(2008-10#3)
also been proposed##6##3##(1995-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-8#1)
also been reported in##4##4##(1994-11#1)(2007-8#1)(2010-6#1)(2011-1#1)
also been reported to be##3##5##(1991-1#1)(2007-10#1)(2012-12#1)
also been reported to##5##4##(1991-1#1)(2007-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
also been reported##17##3##(1991-1#1)(1994-11#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#2)(2011-1#1)(2012-12#1)(2013-8#1)
also been shown to be##4##5##(2008-10#1)(2008-3#1)(2010-11#1)(2012-12#1)
also been shown to contribute to##2##6##(2008-9#1)(2012-12#1)
also been shown to##21##4##(1990-8#1)(1993-8#1)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-12#2)
also been shown##27##3##(1990-8#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-12#2)
also been studied##14##3##(1990-8#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-6#1)(2010-5#1)(2012-2#1)
also been tested##3##3##(2007-12#1)(2008-10#2)
also been used as##5##4##(2008-10#3)(2008-3#1)(2009-8#1)
also been used for##3##4##(2008-3#1)(2008-4#1)(2008-6#1)
also been used successfully in##2##5##(2008-10#2)
also been used to##4##4##(2008-2#1)(2008-6#1)(2009-10#1)(2013-1#1)
also been used##17##3##(1994-6#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-10#1)(2009-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
also been utilized##2##3##(1991-9#1)(2008-3#1)
also been##286##2##(1990-7#1)(1990-8#2)(1991-1#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-2#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#63)(2008-11#18)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#12)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#3)
also being##8##2##(1992-10#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#3)
also believed that##3##3##(1995-1#1)(2007-7#1)(2008-3#1)
also beneficial changes in##2##4##(2013-1#2)
also beneficial##3##2##(2008-12#1)(2013-1#2)
also benefit##2##2##(1994-11#1)(1997-6#1)
also best##2##2##(1995-3#1)(1997-7#1)
also better##3##2##(2008-7#1)(2009-8#1)(2011-1#1)
also between##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
also binds a##2##3##(1995-8#2)
also binds to##6##3##(1994-11#1)(1994-8#2)(1997-7#1)(2008-7#1)(2013-1#1)
also binds##12##2##(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#2)(1997-7#1)(2008-6#1)(2008-7#1)(2013-1#1)
also blocked##4##2##(1991-9#1)(1992-8#1)(1995-12#1)(2008-11#1)
also blocks##2##2##(2008-6#1)(2012-3#1)
also bound to##4##3##(1990-11#1)(1991-12#1)(1993-3#1)(2008-11#1)
also bound##6##2##(1990-11#1)(1991-12#1)(1993-3#1)(1997-2#1)(2008-11#1)(2010-10#1)
also briefly##7##2##(1994-9#1)(2008-11#2)(2008-3#3)(2010-9#1)
also brings##2##2##(1994-6#1)(1995-3#1)
also built a##2##3##(2007-12#1)(2008-5#1)
also built##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
also by a##2##3##(1990-11#1)(2008-10#1)
also by an##2##3##(1994-5#1)(2007-12#1)
also by other##2##3##(1992-8#1)(1992-9#1)
also by the##7##3##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
also by##41##2##(1990-11#1)(1990-8#2)(1991-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#5)(2012-2#1)(2012-3#1)
also calculated and##5##3##(1994-8#1)(2008-10#2)(2008-3#1)(2010-9#1)
also calculated for different##2##4##(2008-3#2)
also calculated for##4##3##(1996-3#1)(2008-3#2)(2013-1#1)
also calculated from##2##3##(2008-3#1)(2010-6#1)
also calculated##19##2##(1994-8#1)(1996-12#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-3#4)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
also called##22##2##(1990-12#1)(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2010-11#1)(2013-1#2)
also can be used to##2##5##(2008-2#1)(2008-4#1)
also can be##8##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-8#1)
also can##20##2##(1991-12#1)(1994-3#1)(1995-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
also capable of##10##3##(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)
also capable##11##2##(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
also carried out by##2##4##(2008-10#2)
also carried out for##2##4##(2008-10#1)(2008-11#1)
also carried out to##2##4##(2007-12#1)(2013-1#1)
also carried out with a##2##5##(2008-5#1)(2013-1#1)
also carried out with##3##4##(2008-5#1)(2011-1#1)(2013-1#1)
also carried out##24##3##(1993-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2013-1#2)
also carried##27##2##(1993-6#1)(1995-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-5#2)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2013-1#2)
also cause##14##2##(1995-5#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#4)
also caused a significant##2##4##(1993-1#1)(2009-8#1)
also caused a##4##3##(1993-1#1)(1993-11#1)(1994-8#1)(2009-8#1)
also caused by##2##3##(2008-9#1)(2011-2#1)
also caused significant##3##3##(1992-6#1)(1995-12#1)(1995-3#1)
also caused##19##2##(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
also causes an##2##3##(2008-10#2)
also causes##13##2##(1993-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)
also changed##4##2##(1993-11#1)(2008-11#1)(2008-5#1)(2012-2#1)
also changes in##2##3##(1993-1#1)(2013-1#1)
also changes##3##2##(1993-1#1)(2013-1#2)
also characterised##2##2##(1991-5#1)(2009-5#1)
also characterized by a##2##4##(2008-5#1)(2013-8#1)
also characterized by##8##3##(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-8#1)(2013-8#1)
also characterized##15##2##(1991-8#2)(1993-11#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#2)
also checked##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
also clarify##3##2##(1997-1#1)(1997-9#1)(2008-2#1)
also clearly##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
also collected##7##2##(1994-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-12#1)
also colonized##2##2##(2008-10#2)
also comments##2##2##(1994-6#1)(2008-10#1)
also common in##2##3##(1995-9#1)(2008-1#1)
also common##9##2##(1991-12#1)(1995-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-5#1)(2010-10#1)
also commonly used##2##3##(1996-8#1)(2008-11#1)
also commonly##4##2##(1996-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
also comparable##3##2##(2010-8#1)(2011-1#1)(2011-2#1)
also compare##7##2##(1995-2#1)(2007-11#2)(2008-2#2)(2008-3#2)
also compared the##3##3##(1996-3#1)(2008-11#1)(2008-7#1)
also compared with a##2##4##(2008-2#1)(2010-5#1)
also compared with the##4##4##(2008-2#3)(2008-5#1)
also compared with##13##3##(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#1)(2010-5#1)(2011-10#1)
also compared##25##2##(1994-8#1)(1995-4#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2010-5#1)(2011-10#1)(2012-12#1)
also completed a##2##3##(2008-7#1)(2013-8#1)
also completed measures of##2##4##(2008-11#1)(2010-11#1)
also completed measures##3##3##(2008-11#1)(2008-9#1)(2010-11#1)
also completed the##4##3##(1994-12#1)(2007-12#1)(2008-5#1)(2008-7#1)
also completed##10##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2013-8#1)
also completely##3##2##(1992-12#1)(1994-6#1)(2013-8#1)
also computed##2##2##(2008-10#1)(2008-3#1)
also conclude that##2##3##(2008-8#1)(2008-9#1)
also concluded that##4##3##(1991-6#1)(1992-3#1)(1993-12#1)(2013-1#1)
also concurrently##2##2##(1993-12#1)(2012-1#1)
also conducted##11##2##(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-1#3)(2013-8#2)
also confer##2##2##(2009-9#1)(2013-1#1)
also confers##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
also confirm##2##2##(2008-3#1)(2009-4#1)
also confirmed by the results of##2##6##(1997-4#1)(2008-10#1)
also confirmed by the##3##4##(1995-6#1)(1997-4#1)(2008-10#1)
also confirmed by##10##3##(1994-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-6#1)
also confirmed that the##2##4##(2008-11#1)(2008-8#1)
also confirmed that##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
also confirmed the##2##3##(2009-11#1)(2009-5#1)
also confirmed##22##2##(1990-7#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
also conserved##2##2##(1992-3#1)(2010-4#1)
also consider the##2##3##(2008-2#1)(2008-6#1)
also consider##8##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-2#2)
also considered in##2##3##(2008-10#1)(2008-8#1)
also considered##20##2##(1991-6#1)(1994-11#1)(1995-12#1)(2007-4#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)
also considering##2##2##(1990-3#1)(2008-10#1)
also considers##7##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#1)(2012-2#1)
also consistent with##10##3##(1990-5#1)(1991-8#1)(1993-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
also constructed##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
also contain##8##2##(1990-11#1)(1991-12#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
also contained a##3##3##(2007-12#1)(2008-10#2)
also contained an##3##3##(1993-12#1)(2008-10#2)
also contained##21##2##(1990-2#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-6#1)(1997-3#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
also containing##5##2##(1990-5#1)(1992-12#1)(1994-6#1)(2008-10#1)(2011-1#1)
also contains a##6##3##(1991-12#1)(1993-3#1)(1995-9#1)(2007-11#1)(2007-12#2)
also contains an##2##3##(1993-12#1)(2008-9#1)
also contains the##3##3##(1991-3#1)(2008-3#1)(2008-9#1)
also contains##23##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#4)(2010-9#1)(2012-2#1)
also contribute to the development of##2##6##(2012-2#1)(2013-8#1)
also contribute to the##10##4##(1993-11#1)(1993-2#1)(1994-11#1)(2008-1#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-8#1)
also contribute to these##2##4##(1990-11#1)(1991-3#1)
also contribute to##27##3##(1990-11#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
also contributed to##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
also contributes to##7##3##(1992-3#1)(2007-11#2)(2008-10#2)(2008-8#1)(2012-2#1)
also controlled##5##2##(1991-3#1)(1997-3#1)(2008-10#3)
also corrected##2##2##(1994-8#1)(2008-1#1)
also correctly##2##2##(1995-12#1)(2008-7#1)
also correlated well with the##2##5##(1991-9#1)(2008-10#1)
also correlated with##4##3##(1991-8#1)(2007-12#1)(2008-10#1)(2009-4#1)
also correlated##7##2##(1991-8#1)(1991-9#1)(2007-12#1)(2008-10#3)(2009-4#1)
also could##3##2##(2008-10#2)(2008-8#1)
also counsel##2##2##(2008-7#1)(2009-9#1)
also cover the##2##3##(2008-7#1)(2010-4#1)
also cover##3##2##(2008-7#1)(2010-4#1)(2012-2#1)
also covered##3##2##(1991-1#1)(2011-2#1)(2012-2#1)
also critical for##3##3##(2008-4#1)(2012-12#2)
also critical##7##2##(1997-4#1)(2008-4#2)(2011-2#1)(2012-12#2)(2013-7#1)
also critically##3##2##(2008-10#2)(2008-12#1)
also cultured##2##2##(1995-3#1)(2007-10#1)
also deal with##2##3##(1994-7#1)(2008-3#1)
also deals with##2##3##(1991-6#1)(1995-11#1)
also dealt with##2##3##(2008-10#1)(2008-5#1)
also decided##2##2##(2008-8#1)(2009-6#1)
also declined##2##2##(1990-6#1)(2008-7#1)
also decrease##2##2##(1997-1#1)(2011-2#1)
also decreased by##4##3##(1994-11#1)(1995-2#1)(1996-11#1)(2008-10#1)
also decreased the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
also decreased with##2##3##(2008-12#1)(2008-7#1)
also decreased##17##2##(1990-5#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
also decreases##3##2##(1990-7#1)(2008-9#1)(2013-8#1)
also defined##4##2##(1990-11#1)(1993-11#1)(2009-10#1)(2009-8#1)
also defines##2##2##(1993-2#1)(1994-3#1)
also delayed in##2##3##(1997-3#1)(2012-12#1)
also demonstrate a##7##3##(1991-8#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
also demonstrate that the##5##4##(1995-3#1)(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
also demonstrate that##13##3##(1991-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-3#1)(2012-2#1)(2013-1#1)
also demonstrate the effects of##2##5##(2008-3#1)(2011-2#1)
also demonstrate the utility of##2##5##(2008-5#1)(2012-2#1)
also demonstrate the##12##3##(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
also demonstrate##43##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#3)(2008-2#7)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
also demonstrated a##4##3##(1992-3#1)(2008-2#1)(2008-4#1)(2012-12#1)
also demonstrated in the##4##4##(1991-10#1)(1991-5#1)(2007-12#1)(2008-10#1)
also demonstrated in##8##3##(1990-7#1)(1991-10#1)(1991-5#1)(2007-12#1)(2008-10#3)(2008-5#1)
also demonstrated similarity to##2##4##(1993-9#1)(1995-6#1)
also demonstrated that the##7##4##(1990-7#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-3#1)
also demonstrated that##23##3##(1990-7#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
also demonstrated the##6##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
also demonstrated to be##2##4##(1994-12#1)(1995-2#1)
also demonstrated to##3##3##(1994-12#1)(1995-2#1)(2008-3#1)
also demonstrated##82##2##(1990-5#1)(1990-7#2)(1991-10#1)(1991-5#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-11#4)(2007-12#6)(2008-10#16)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
also demonstrates that the##2##4##(2008-10#1)(2010-2#1)
also demonstrates that##10##3##(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#2)(2010-2#1)(2013-1#1)
also demonstrates##13##2##(1995-12#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-4#2)(2010-2#1)(2012-2#1)(2013-1#1)
also depend on##3##3##(1992-3#1)(1992-6#1)(2008-8#1)
also depend##4##2##(1992-3#1)(1992-6#1)(2008-8#1)(2012-2#1)
also depended on the##2##4##(1997-1#1)(2008-9#1)
also depended on##3##3##(1997-1#1)(2008-3#1)(2008-9#1)
also depended##4##2##(1992-3#1)(1997-1#1)(2008-3#1)(2008-9#1)
also dependent on the##4##4##(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
also dependent on##7##3##(1994-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
also dependent upon##2##3##(1992-9#1)(1994-8#1)
also dependent##9##2##(1992-9#1)(1994-2#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
also depends on the##2##4##(1994-2#1)(1997-4#1)
also depends on##3##3##(1994-2#1)(1997-4#1)(2007-11#1)
also depends##5##2##(1994-2#1)(1997-4#1)(2007-11#1)(2008-10#2)
also derive##5##2##(1990-2#1)(2008-2#1)(2008-3#2)(2009-9#1)
also derived##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
also describe a##6##3##(1994-10#1)(1994-3#1)(2008-1#1)(2008-3#1)(2012-1#1)(2012-2#1)
also describe how##4##3##(2007-12#1)(2008-2#1)(2008-4#1)(2010-11#1)
also describe the##6##3##(1995-1#1)(1997-3#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-6#1)
also describe##24##2##(1994-10#1)(1994-3#1)(1995-1#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
also described that##3##3##(1996-2#1)(2008-4#2)
also described the##2##3##(2008-10#1)(2012-3#1)
also described##66##2##(1992-1#1)(1993-12#1)(1994-2#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#12)(2008-11#2)(2008-2#7)(2008-3#2)(2008-4#14)(2008-9#3)(2009-9#2)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#3)
also describes some##2##3##(1993-2#1)(2008-6#1)
also describes the##10##3##(1990-6#1)(1992-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)
also describes##20##2##(1990-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
also detect##2##2##(1992-9#1)(2011-2#1)
also detectable in##2##3##(1995-11#1)(2008-4#1)
also detected by##5##3##(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
also detected in the##9##4##(1993-3#1)(1994-11#1)(1996-12#2)(2008-10#2)(2008-8#1)(2009-12#1)(2010-5#1)
also detected in##24##3##(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#5)(2008-1#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-12#1)(2010-5#1)(2012-2#1)
also detected when##2##3##(1995-12#1)(2006-6#1)
also detected##59##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-12#2)(1996-12#5)(1996-2#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-2#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
also determine the##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
also determine##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
also determined and##2##3##(1990-2#1)(2008-10#1)
also determined by##8##3##(1990-12#1)(1992-9#1)(1993-12#1)(2008-10#3)(2008-3#1)(2008-8#1)
also determined in##5##3##(1991-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-5#1)
also determined using##3##3##(2007-10#1)(2008-10#2)
also determined##58##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-11#1)(2008-10#26)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2009-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
also determines##3##2##(1991-12#1)(1991-5#1)(2011-2#1)
also develop in##2##3##(2008-10#1)(2012-1#1)
also develop##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
also developed a##6##3##(1992-12#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-12#1)
also developed for##4##3##(2008-10#4)
also developed to##5##3##(1992-3#1)(2008-10#3)(2008-3#1)
also developed##31##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-12#1)(1997-3#1)(2006-4#1)(2007-10#1)(2008-10#12)(2008-3#3)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
also diagnosed##3##2##(1992-8#1)(2011-2#2)
also did not induce##2##4##(2008-10#1)(2008-11#1)
also did not##7##3##(1990-7#1)(1993-6#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#2)
also differ in##2##3##(1995-12#1)(2008-8#1)
also differ significantly##2##3##(2008-8#1)(2012-12#1)
also differ##7##2##(1995-12#1)(1996-12#1)(2008-11#1)(2008-8#3)(2012-12#1)
also differed significantly##2##3##(2008-10#1)(2013-1#1)
also differed##7##2##(1992-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
also different##6##2##(2007-7#1)(2008-10#1)(2008-7#2)(2010-3#1)(2011-2#1)
also diminished##3##2##(1991-9#1)(1997-4#1)(2008-7#1)
also directly##2##2##(2011-2#2)
also discriminated##2##2##(1995-5#1)(2008-10#1)
also discuss a##2##3##(2008-3#1)(2013-8#1)
also discuss the##33##3##(1990-11#1)(1992-5#1)(1993-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#2)
also discuss##58##2##(1990-11#1)(1992-4#1)(1992-5#1)(1993-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
also discussed here##2##3##(2008-1#1)(2008-10#1)
also discussed in terms of##2##5##(2008-10#1)(2008-6#1)
also discussed in the##4##4##(1993-11#1)(1997-6#1)(2008-10#1)(2008-6#1)
also discussed in this paper##2##5##(2008-10#1)(2008-11#1)
also discussed in this##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
also discussed in##11##3##(1993-11#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-6#2)(2010-7#1)
also discussed the##3##3##(2008-1#1)(2009-8#1)(2012-3#1)
also discussed##173##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#5)(2007-8#5)(2008-1#3)(2008-10#45)(2008-11#4)(2008-2#9)(2008-3#17)(2008-4#14)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#2)(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#5)
also discusses how to##2##4##(2008-4#2)
also discusses the##6##3##(1990-6#1)(2007-12#1)(2008-1#1)(2009-10#2)(2013-1#1)
also discusses##18##2##(1990-6#1)(1991-12#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-1#2)(2008-4#4)(2009-10#2)(2009-5#1)(2010-10#1)(2013-1#1)(2013-8#2)
also display##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
also displayed##3##2##(1990-6#1)(1993-12#1)(2009-10#1)
also displays##6##2##(1990-5#1)(1995-2#1)(1997-2#2)(1997-4#1)(2008-3#1)
also dissected##2##2##(2008-12#1)(2009-10#1)
also distinctly##2##2##(2008-4#1)(2008-6#1)
also distinguishable by##2##3##(1990-11#1)(2008-10#1)
also distinguished##2##2##(1997-8#1)(2008-5#1)
also divided##2##2##(2007-8#1)(2012-3#1)
also do not##2##3##(2008-10#2)
also do##3##2##(1992-11#1)(2008-10#2)
also documented##4##2##(1996-1#1)(1996-2#1)(2008-7#1)(2011-2#1)
also does not##2##3##(1995-6#1)(1996-5#1)
also done##8##2##(1992-6#1)(1994-12#1)(2007-7#1)(2008-5#3)(2013-8#2)
also dramatically##2##2##(1996-7#1)(2008-10#1)
also due to##3##3##(1995-2#1)(2007-2#1)(2011-2#1)
also due##4##2##(1990-8#1)(1995-2#1)(2007-2#1)(2011-2#1)
also effective against##3##3##(1997-4#1)(2008-10#2)
also effective for##2##3##(1990-2#1)(1997-2#1)
also effective in reducing##2##4##(1990-5#1)(2008-3#1)
also effective in the##2##4##(2007-11#1)(2008-3#1)
also effective in##8##3##(1990-5#1)(1994-8#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)
also effective##15##2##(1990-10#1)(1990-2#1)(1990-5#1)(1992-5#1)(1994-8#2)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
also effectively##4##2##(1994-1#1)(2008-10#2)(2009-7#1)
also elevated##4##2##(1990-5#1)(2006-10#1)(2008-10#1)(2013-1#1)
also elicit##2##2##(2008-10#2)
also elicited a##2##3##(2008-10#2)
also eliminated##2##2##(2008-10#1)(2008-11#1)
also eliminates##2##2##(1994-6#1)(2008-3#1)
also elucidated##2##2##(2008-10#2)
also emerged as##2##3##(2009-11#1)(2010-6#1)
also emerged##3##2##(2009-11#1)(2010-6#1)(2011-1#1)
also emphasized the##2##3##(1990-3#1)(1991-6#1)
also emphasizes##5##2##(2006-10#1)(2007-8#1)(2009-8#1)(2013-1#2)
also employed to##4##3##(1993-8#1)(2008-10#2)(2008-3#1)
also employed##7##2##(1993-8#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)
also enables##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
also encompasses##3##2##(1996-12#1)(1996-3#1)(2008-9#1)
also encouraged##2##2##(2011-2#1)(2012-12#1)
also endogenous##2##2##(1994-2#1)(1994-5#1)
also enhance##4##2##(1995-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
also enhanced the##6##3##(1993-8#1)(1994-11#2)(1995-6#1)(2008-11#1)(2008-5#1)
also enhanced##18##2##(1993-12#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-5#3)
also enhances the##2##3##(1995-12#1)(2008-10#1)
also enhances##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
also essential for##4##3##(1995-6#1)(2008-11#1)(2008-7#1)(2012-1#1)
also essential##8##2##(1995-6#1)(1997-1#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-7#1)(2012-1#1)
also establishes##2##2##(2008-3#1)(2013-1#1)
also estimated##3##2##(2007-7#1)(2008-3#1)(2008-8#1)
also evaluate the##4##3##(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
also evaluate##5##2##(1993-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
also evaluated and##3##3##(2007-12#1)(2008-10#2)
also evaluated in##5##3##(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)
also evaluated the##3##3##(2008-11#1)(2013-7#2)
also evaluated##55##2##(1990-5#1)(1990-9#1)(1993-12#1)(1995-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-7#2)
also evidence that##5##3##(1991-8#1)(1992-4#1)(1995-5#1)(2008-11#1)(2013-1#1)
also evidence##10##2##(1991-8#1)(1992-4#1)(1995-5#1)(2008-1#1)(2008-11#2)(2008-9#1)(2010-5#1)(2010-8#1)(2013-1#1)
also evidenced##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
also evident at##2##3##(2008-5#1)(2013-1#1)
also evident##10##2##(1990-11#1)(1990-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2013-1#1)
also evolve##2##2##(2008-10#1)(2008-6#1)
also evolved##3##2##(1997-3#1)(2008-8#1)(2010-6#1)
also examine##4##2##(1992-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
also examined and##2##3##(1994-11#1)(2008-10#1)
also examined for the##2##4##(2008-10#1)(2009-12#1)
also examined for##3##3##(2008-10#2)(2009-12#1)
also examined in the##3##4##(1993-1#1)(1997-8#1)(2008-10#1)
also examined in##5##3##(1993-1#1)(1997-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
also examined protein kinase C (PKC)##2##6##(1992-8#1)(2008-11#1)
also examined the##12##3##(1992-5#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2009-5#1)(2011-2#1)
also examined using##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
also examined whether##2##3##(2008-12#1)(2009-8#1)
also examined##75##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-6#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-12#3)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-6#1)(2011-1#1)(2011-2#3)
also examines##3##2##(2008-11#1)(2008-9#1)(2009-4#1)
also excellent##2##2##(2008-11#1)(2012-3#1)
also exert##2##2##(1994-11#1)(2008-3#1)
also exerted##2##2##(1992-2#1)(2011-2#1)
also exhibit##9##2##(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
also exhibited a##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
also exhibited by the##2##4##(1990-2#1)(1996-8#1)
also exhibited high##2##3##(1997-4#1)(2013-1#1)
also exhibited##23##2##(1990-2#1)(1990-5#2)(1991-8#1)(1992-3#1)(1992-9#1)(1994-5#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#2)
also exhibits a##3##3##(1993-2#1)(1996-8#1)(2007-11#1)
also exhibits##5##2##(1993-2#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
also exist in the##2##4##(2008-2#1)(2008-8#1)
also exist in##3##3##(1994-8#1)(2008-2#1)(2008-8#1)
also exist##5##2##(1993-11#1)(1994-8#1)(2008-2#1)(2008-8#1)(2013-8#1)
also exists in##2##3##(1991-3#1)(1997-2#1)
also exists##11##2##(1991-3#1)(1994-12#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
also expected to##2##3##(1995-1#1)(2010-8#1)
also expected##3##2##(1995-1#1)(2008-10#1)(2010-8#1)
also experience##2##2##(2008-7#1)(2011-1#1)
also experienced##2##2##(1990-10#1)(2006-12#1)
also explain the##3##3##(1994-9#1)(2007-11#1)(2008-10#1)
also explain##5##2##(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
also explained##3##2##(2008-4#1)(2008-7#1)(2010-6#1)
also explains the##3##3##(1994-3#1)(2007-11#1)(2008-4#1)
also explains##4##2##(1994-3#1)(2007-11#1)(2008-4#1)(2012-1#1)
also explore##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
also explored##13##2##(1992-1#1)(1992-12#1)(1995-2#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-9#1)(2013-1#1)
also explores##3##2##(1996-3#1)(2008-10#1)(2008-7#1)
also exposed to##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
also exposed##6##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
also express##4##2##(2007-12#1)(2008-4#1)(2008-7#1)(2011-1#1)
also expressed in##8##3##(1994-10#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
also expressed##15##2##(1992-12#1)(1992-9#1)(1994-10#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
also extended to##2##3##(1992-9#1)(2008-10#1)
also extracted with##2##3##(2008-10#2)
also extracted##3##2##(2008-10#3)
also facilitate the production##2##4##(2007-11#1)(2010-10#1)
also facilitate the##4##3##(2007-11#1)(2008-9#1)(2010-10#1)(2012-3#1)
also facilitate##7##2##(1994-11#1)(2007-11#1)(2008-9#1)(2009-11#1)(2010-10#1)(2012-3#2)
also fail##2##2##(1995-11#1)(1996-6#1)
also failed to##6##3##(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(2008-5#1)(2009-9#1)
also fairly##2##2##(1992-6#1)(1997-6#1)
also favored##2##2##(1990-8#1)(2008-8#1)
also favourable for##2##3##(1997-7#1)(2010-8#1)
also features a##2##3##(2008-10#1)(2008-9#1)
also felt##2##2##(1997-3#1)(2013-8#1)
also find that##7##3##(1992-2#1)(1995-11#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
also find##10##2##(1992-2#1)(1995-11#1)(2008-10#2)(2008-3#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
also focus on##2##3##(2008-10#1)(2008-2#1)
also followed during the##2##4##(2008-10#2)
also followed##3##2##(1994-5#1)(2008-10#2)
also for a##4##3##(1991-6#1)(1992-3#1)(1996-5#1)(2013-8#1)
also for future##2##3##(1991-6#1)(2008-4#1)
also for other##4##3##(2008-7#2)(2011-1#1)(2011-2#1)
also for the##9##3##(1990-5#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-3#2)(2009-5#1)(2013-1#1)(2013-8#1)
also for##57##2##(1990-5#1)(1991-2#1)(1991-6#2)(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
also formed##7##2##(1990-7#1)(1990-8#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-12#1)
also forms a very##2##4##(1992-3#1)(2008-10#1)
also forms a##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
also forms##4##2##(1991-9#1)(1992-3#1)(2008-10#1)(2008-3#1)
also found evidence##3##3##(2008-10#1)(2008-8#2)
also found for the##5##4##(1995-6#1)(1996-7#1)(2008-10#2)(2008-3#1)
also found for##8##3##(1995-6#1)(1996-7#1)(2007-6#1)(2008-10#3)(2008-3#2)
also found in other##2##4##(1992-9#1)(1997-7#1)
also found in the##5##4##(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-6#1)
also found in##28##3##(1990-2#1)(1992-11#1)(1992-5#1)(1992-9#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-3#1)
also found no##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
also found that the addition of##2##6##(2008-10#1)(2008-5#1)
also found that the##19##4##(1990-2#1)(1994-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
also found that##60##3##(1990-2#1)(1991-2#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
also found the##2##3##(1990-12#1)(2010-7#1)
also found to be##19##4##(1992-12#1)(1992-6#1)(1993-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#3)(2013-1#1)
also found to have##2##4##(2008-1#1)(2008-12#1)
also found to##37##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-2#1)(1995-3#1)(1995-6#1)(1996-3#2)(1996-5#1)(1997-1#2)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-2#3)(2013-1#1)
also found with##2##3##(2008-10#1)(2008-3#1)
also found within the##2##4##(1994-3#1)(2008-5#1)
also found##185##2##(1990-12#3)(1990-2#2)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#34)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-3#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
also from the##5##3##(1991-5#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-5#1)
also from##18##2##(1991-5#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)
also fulfilled##2##2##(1994-5#1)(2008-5#1)
also fully##2##2##(2008-10#1)(2008-11#1)
also functions as a##2##4##(2007-12#1)(2008-11#1)
also functions##3##2##(2007-12#1)(2008-11#1)(2009-7#1)
also further##4##2##(1992-11#1)(1992-12#2)(2008-2#1)
also gained##2##2##(2008-12#1)(2008-3#1)
also gave rise to##2##4##(2008-5#1)(2008-7#1)
also gave##11##2##(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
also generally##2##2##(1997-5#1)(2012-3#1)
also generated##3##2##(1995-5#1)(2008-5#1)(2008-7#1)
also generates##4##2##(1993-2#1)(1995-2#1)(2008-10#1)(2008-4#1)
also give some##2##3##(1996-4#1)(1997-4#1)
also give##9##2##(1996-4#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
also given##16##2##(1992-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#1)(2011-2#1)(2013-1#1)
also gives##4##2##(1990-2#1)(1994-3#1)(1995-6#1)(2008-10#1)
also greater in##2##3##(2008-10#1)(2008-5#1)
also greater##5##2##(1993-8#1)(1995-1#1)(2008-10#2)(2008-5#1)
also greatly##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
also grow##2##2##(2008-10#1)(2008-8#1)
also had a higher##2##4##(1995-2#1)(2006-10#1)
also had a significant##2##4##(2008-10#1)(2011-10#1)
also had a##11##3##(1991-5#1)(1995-12#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-5#1)(2008-10#3)(2009-4#1)(2011-10#1)
also had an impact on##2##5##(2008-10#2)
also had an##3##3##(2008-10#2)(2009-1#1)
also had higher##3##3##(1995-2#1)(2008-3#1)(2010-4#1)
also had lower##2##3##(2010-4#1)(2011-2#1)
also had no##2##3##(1990-7#1)(1993-3#1)
also had reduced##2##3##(2008-7#1)(2008-9#1)
also had the##5##3##(1997-3#1)(2008-10#2)(2012-12#1)(2013-1#1)
also had##62##2##(1990-7#1)(1991-5#1)(1992-8#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-2#2)(1996-8#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#2)(2009-2#2)(2009-4#1)(2009-7#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#1)
also has a##12##3##(1990-5#1)(1992-3#2)(1992-9#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-11#1)
also has an##5##3##(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
also has been reported to##2##5##(2008-10#1)(2009-3#1)
also has been##7##3##(2008-10#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-6#1)(2011-3#1)
also has higher##2##3##(1997-4#1)(2008-10#1)
also has the ability to##2##5##(1996-2#1)(2008-10#1)
also has the##6##3##(1990-7#1)(1991-9#1)(1996-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
also has to##2##3##(2008-2#1)(2012-12#1)
also has##58##2##(1990-5#1)(1990-7#1)(1991-9#1)(1992-3#2)(1992-8#2)(1992-9#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#2)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
also have a role in treating##2##6##(2008-4#1)(2011-2#1)
also have a role in##3##5##(1991-9#1)(2008-4#1)(2011-2#1)
also have a role##4##4##(1991-9#1)(2008-4#1)(2008-5#1)(2011-2#1)
also have a##14##3##(1991-9#2)(1993-3#1)(1996-3#1)(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#1)
also have an important role in##2##6##(2008-7#1)(2010-11#1)
also have an important role##3##5##(2008-7#1)(2010-11#1)(2012-3#1)
also have an important##4##4##(1995-6#1)(2008-7#1)(2010-11#1)(2012-3#1)
also have an##7##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)
also have been##2##3##(2008-4#1)(2008-9#1)
also have demonstrated that##2##4##(2008-10#1)(2013-1#1)
also have implications for##2##4##(2011-2#1)(2013-8#1)
also have potential##2##3##(1994-6#1)(2010-5#1)
also have significant##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
also have the##4##3##(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#1)
also have##78##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#2)(1993-1#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
also having##2##2##(2007-12#1)(2007-7#1)
also help improve##2##3##(1992-12#1)(2007-9#1)
also help in##2##3##(1994-12#1)(2008-7#1)
also help to##7##3##(2008-10#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#1)
also help us##2##3##(2008-2#1)(2009-10#1)
also help##16##2##(1992-12#1)(1994-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-3#1)(2011-2#2)(2012-2#1)
also helped##2##2##(2007-7#1)(2008-12#1)
also helpful for##2##3##(1990-6#1)(1994-12#1)
also helpful##3##2##(1990-6#1)(1994-12#1)(2011-1#1)
also helps to##2##3##(2008-3#1)(2008-9#1)
also high at##2##3##(1990-10#1)(1995-3#1)
also high##6##2##(1990-10#1)(1995-3#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
also higher in##7##3##(1991-12#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
also higher when##2##3##(2008-9#1)(2009-9#1)
also higher##13##2##(1991-12#1)(1994-2#1)(1994-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2013-1#1)
also highest##2##2##(2008-11#1)(2009-7#1)
also highlight the##5##3##(2008-1#1)(2008-3#1)(2009-9#1)(2010-5#1)(2012-2#1)
also highlight##7##2##(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#1)
also highlighted the##2##3##(2008-11#2)
also highlighted##7##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-1#1)(2011-1#1)(2013-1#1)
also highlights some of the##2##5##(1997-2#1)(2008-5#1)
also highlights the importance of##2##5##(2007-12#1)(2009-3#1)
also highlights the need##2##4##(2011-2#2)
also highlights the##4##3##(2007-12#1)(2009-3#1)(2011-2#2)
also highlights##11##2##(1997-2#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#3)(2013-1#1)(2013-7#1)
also highly##11##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-11#1)(1995-2#1)(2008-1#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#2)
also identified a##2##3##(2009-2#1)(2010-3#1)
also identified as##4##3##(1995-9#1)(2008-1#1)(2008-12#1)(2008-3#1)
also identified from##2##3##(1994-12#1)(2008-11#1)
also identified in the##2##4##(2008-10#1)(2009-6#1)
also identified in##3##3##(2008-10#2)(2009-6#1)
also identified the##3##3##(2008-10#3)
also identified##41##2##(1992-6#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-8#1)
also identifies some##2##3##(2011-2#2)
also identifies##6##2##(1993-2#1)(1997-1#1)(2008-9#1)(2010-10#1)(2011-2#2)
also identify##4##2##(1996-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
also illustrate that##2##3##(2008-2#1)(2012-2#1)
also illustrate##5##2##(1994-3#1)(2007-12#1)(2008-2#2)(2012-2#1)
also illustrated the##2##3##(2008-12#1)(2009-5#1)
also illustrated##6##2##(1994-2#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)
also impaired##3##2##(1991-7#1)(1993-5#1)(2008-1#1)
also implemented##3##2##(2008-3#1)(2010-8#1)(2012-3#1)
also implicate##2##2##(1997-2#1)(2008-10#1)
also implicated in the##3##4##(1991-4#1)(1994-9#1)(2008-4#1)
also implicated in##4##3##(1991-4#1)(1994-9#1)(2008-10#1)(2008-4#1)
also implicated##7##2##(1991-4#1)(1994-9#1)(1996-11#1)(2008-10#2)(2008-4#1)(2010-10#1)
also implies that##2##3##(1990-11#1)(1992-8#1)
also imply that##2##3##(2008-8#1)(2013-1#1)
also important for the##2##4##(2008-7#1)(2010-8#1)
also important for##7##3##(1994-5#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
also important in##4##3##(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)
also important##23##2##(1992-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-8#2)
also improve##3##2##(2008-7#2)(2013-1#1)
also improved the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
also improved to##2##3##(2008-3#1)(2013-1#1)
also improved##13##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
also improves the selectivities##2##4##(2008-10#2)
also improves the##5##3##(2007-11#1)(2008-10#3)(2008-12#1)
also improves##7##2##(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)
also in a##5##3##(1994-5#1)(2008-10#4)
also in agreement with##2##4##(2008-10#2)
also in children##2##3##(2008-8#1)(2012-1#1)
also in other##5##3##(1991-12#1)(1991-2#1)(1997-6#1)(2008-11#1)(2012-2#1)
also in our##2##3##(1995-5#1)(2008-5#1)
also in patients with##2##4##(1993-8#1)(2012-2#1)
also in patients##4##3##(1993-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
also in preventing##2##3##(1992-12#1)(2008-11#1)
also in terms of##5##4##(1992-11#1)(1997-1#1)(2007-9#1)(2008-10#1)(2013-7#1)
also in the absence of##2##5##(1996-5#1)(2008-10#1)
also in the presence of##5##5##(2008-10#4)(2008-4#1)
also in the##38##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-5#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#6)(2009-3#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)
also in this##2##3##(1991-4#1)(2010-2#1)
also in those##2##3##(1996-6#1)(1997-8#1)
also in##158##2##(1990-5#3)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#9)(2008-3#4)(2008-4#8)(2008-5#3)(2008-7#12)(2008-8#5)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#2)
also include##8##2##(1995-8#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
also included in the study##2##5##(2008-10#1)(2008-5#1)
also included in the##7##4##(1994-2#1)(1996-3#1)(2008-10#3)(2008-5#2)
also included##43##2##(1991-1#1)(1992-8#1)(1993-1#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-3#1)(2009-8#2)(2010-8#1)(2012-3#1)
also includes a##4##3##(1994-12#1)(1996-3#1)(2007-11#1)(2008-2#1)
also includes an##2##3##(1993-9#1)(2008-4#1)
also includes the##4##3##(1993-9#1)(1996-12#1)(2008-2#1)(2008-9#1)
also includes##21##2##(1992-12#1)(1993-9#2)(1994-12#2)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-7#1)(2008-9#3)
also including##2##2##(2012-1#1)(2012-2#1)
also incorporated##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
also increase the##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
also increase##10##2##(1991-8#1)(1994-5#1)(1995-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)(2013-1#1)
also increased in the##3##4##(1996-11#1)(1996-12#1)(2008-3#1)
also increased in##5##3##(1996-11#1)(1996-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
also increased linearly##2##3##(2008-10#1)(2008-11#1)
also increased significantly##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
also increased the number of##2##5##(1991-5#1)(1993-6#1)
also increased the##15##3##(1991-12#1)(1991-5#1)(1993-6#2)(1995-8#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)
also increased with increasing##2##4##(1995-6#1)(2008-12#1)
also increased with##4##3##(1995-6#1)(2008-12#1)(2008-5#1)(2009-7#1)
also increased##73##2##(1991-12#2)(1991-5#1)(1992-12#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-6#1)(1995-12#2)(1995-3#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#1)
also increases the##5##3##(1994-5#1)(1995-11#1)(2008-3#1)(2011-2#2)
also increases with##2##3##(1995-3#1)(2008-10#1)
also increases##12##2##(1991-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-3#1)(2009-11#1)(2011-2#2)(2013-1#1)
also increasing the##2##3##(2008-10#1)(2008-7#1)
also increasing##7##2##(1995-11#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
also increasingly##4##2##(2006-12#1)(2008-4#2)(2008-7#1)
also independent of##3##3##(1993-3#1)(2008-4#1)(2013-1#1)
also indicate a##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
also indicate that a##2##4##(2008-8#1)(2012-2#1)
also indicate that the##8##4##(1990-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-3#1)
also indicate that##27##3##(1990-8#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#2)
also indicate the##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
also indicate##35##2##(1990-8#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-3#1)(2012-2#1)(2013-1#4)
also indicated a##2##3##(2008-10#1)(2011-1#1)
also indicated by##2##3##(1996-5#1)(2013-1#1)
also indicated that the##7##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#2)
also indicated that##15##3##(1991-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-8#1)
also indicated the presence of##2##5##(1992-8#1)(2013-1#1)
also indicated the##5##3##(1992-8#1)(1995-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
also indicated##28##2##(1990-11#1)(1991-6#1)(1992-8#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
also indicates that the##2##4##(1992-9#1)(2008-10#1)
also indicates that##3##3##(1992-9#1)(2008-10#1)(2008-2#1)
also indicates the##2##3##(2008-9#1)(2013-1#1)
also indicates##7##2##(1992-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
also indicating##2##2##(2008-10#2)
also indirectly##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
also induce the##2##3##(2008-4#1)(2008-7#1)
also induce##5##2##(1995-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-10#1)
also induced a##3##3##(1992-11#1)(2008-10#1)(2008-7#1)
also induced an##3##3##(1991-12#1)(1993-6#1)(2008-12#1)
also induced by the##3##4##(1990-12#1)(1993-8#1)(2008-5#1)
also induced by##10##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)
also induced during##2##3##(1991-11#1)(2008-7#1)
also induced the##3##3##(1990-12#1)(2008-4#1)(2008-5#1)
also induced##31##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-5#1)
also induces a##2##3##(1997-4#1)(2012-2#1)
also induces cell##2##3##(2008-11#1)(2011-1#1)
also induces##10##2##(1994-6#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
also infected by##2##3##(2008-10#1)(2008-12#1)
also infected##3##2##(2008-10#2)(2008-12#1)
also influence the##8##3##(1994-9#1)(1997-1#1)(2006-6#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-6#1)
also influence##16##2##(1993-12#1)(1994-9#1)(1995-5#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-6#1)(2012-2#1)
also influenced by the##2##4##(1994-5#1)(2009-6#1)
also influenced by##4##3##(1994-5#1)(2008-6#1)(2009-6#1)(2012-12#1)
also influences the##2##3##(1993-9#1)(2008-4#1)
also influences##4##2##(1990-8#1)(1993-9#1)(2008-4#1)(2008-7#1)
also inhibit the##3##3##(1991-1#1)(1993-8#1)(1996-4#1)
also inhibit##5##2##(1990-12#1)(1991-1#1)(1993-8#1)(1996-4#1)(2008-8#1)
also inhibited by##16##3##(1990-2#1)(1990-5#1)(1992-11#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
also inhibited purified##2##3##(1991-8#1)(1997-3#1)
also inhibited the##8##3##(1995-11#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#2)
also inhibited##47##2##(1990-2#2)(1990-5#1)(1991-8#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-6#2)(2008-10#5)(2008-11#4)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
also inhibits the##2##3##(1991-6#1)(2008-8#1)
also inhibits##10##2##(1991-6#2)(1994-2#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-8#4)
also installed##2##2##(2008-2#2)
also integrate##2##2##(2011-2#1)(2012-2#1)
also introduce##5##2##(1995-9#1)(2008-3#2)(2008-4#1)(2008-7#1)
also introduced##3##2##(2008-5#1)(2010-1#1)(2012-3#1)
also introduces##3##2##(1994-12#1)(2008-9#1)(2010-8#1)
also investigate how##2##3##(2008-8#1)(2013-7#1)
also investigate the##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-2#1)
also investigate##12##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#3)(2010-2#1)(2012-2#1)(2013-7#1)
also investigated and##5##3##(2008-10#3)(2008-12#1)(2008-3#1)
also investigated as##2##3##(2008-10#1)(2008-3#1)
also investigated by##4##3##(2008-10#4)
also investigated for##5##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
also investigated in order to##3##5##(1994-6#1)(2008-7#1)(2010-4#1)
also investigated in##7##3##(1992-6#1)(1992-8#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
also investigated the effects of##2##5##(1994-6#1)(2008-7#1)
also investigated the##11##3##(1994-6#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
also investigated##113##2##(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-9#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#51)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#1)(2009-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
also involve##6##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)
also involved in the##8##4##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
also involved in##16##3##(1996-2#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
also involved##20##2##(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
also involves##3##2##(1993-6#1)(2007-12#1)(2008-5#1)
also is discussed##2##3##(1992-3#1)(2008-10#1)
also is##11##2##(1992-3#1)(1993-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)
also isolated from##4##3##(1992-9#1)(1997-4#1)(2008-10#1)(2008-8#1)
also isolated##12##2##(1992-9#1)(1993-2#1)(1993-6#2)(1995-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
also it is the##2##4##(1995-1#1)(2007-11#1)
also it##4##2##(1995-1#1)(2007-11#1)(2008-10#1)(2008-12#1)
also its##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
also itself##2##2##(1991-6#1)(2012-3#1)
also known as &quot##2##4##(2009-5#1)(2010-4#1)
also known as vascular permeability factor##2##6##(1992-9#1)(2008-9#1)
also known as vascular##3##4##(1991-2#1)(1992-9#1)(2008-9#1)
also known as##40##3##(1991-2#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
also known to##8##3##(1990-5#1)(1993-8#1)(1994-6#1)(2008-11#1)(2010-3#1)(2012-12#2)(2012-2#1)
also known##51##2##(1990-5#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-6#2)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#1)
also laid##2##2##(1997-5#1)(2008-10#1)
also largely##3##2##(2008-1#1)(2010-12#1)(2013-1#1)
also lead to##9##3##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2013-7#1)(2013-8#2)
also leads to the##2##4##(1995-6#1)(2009-7#1)
also leads to##9##3##(1992-9#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2009-7#1)(2011-1#1)(2012-2#1)
also led to a significant##2##5##(1994-6#1)(2011-10#1)
also led to a##5##4##(1992-8#1)(1993-12#1)(1994-6#1)(2008-3#1)(2011-10#1)
also led to the##2##4##(1991-9#1)(2008-10#1)
also led to##11##3##(1991-10#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-3#1)(2011-10#1)
also lend##2##2##(2008-2#1)(2008-7#1)
also less##4##2##(2008-10#2)(2009-9#1)(2011-2#1)
also likely to be##4##4##(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
also likely to have##2##4##(1994-2#1)(2008-5#1)
also likely to##8##3##(1994-2#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-2#1)(2013-8#1)
also likely##10##2##(1994-2#1)(1997-7#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-2#1)(2012-2#1)(2013-8#1)
also limited##2##2##(2008-9#1)(2012-2#1)
also linked##2##2##(2008-2#1)(2010-3#1)
also lists##2##2##(1997-2#1)(2008-4#1)
also localized##2##2##(2008-8#1)(2008-9#1)
also looked##2##2##(1996-12#1)(2008-12#1)
also looks at##2##3##(1991-1#1)(2008-1#1)
also lower in##2##3##(2009-7#1)(2013-1#1)
also lower##6##2##(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
also lowered##2##2##(2008-10#1)(2013-1#1)
also made significant##2##3##(2008-12#1)(2008-8#1)
also made to##3##3##(2008-5#1)(2009-5#1)(2011-2#1)
also made##14##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-1#1)
also maintained##4##2##(2007-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
also make an##2##3##(1992-5#1)(2012-1#1)
also make it possible to##2##5##(1992-3#1)(2008-10#1)
also make##9##2##(1992-3#1)(1992-5#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-3#1)
also makes it##4##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#1)
also makes the##2##3##(2008-10#1)(2008-8#1)
also makes##9##2##(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-1#2)
also manifests##2##2##(1990-8#1)(1997-2#1)
also mapped##2##2##(1995-6#1)(1997-8#1)
also marked##2##2##(1994-5#1)(2012-3#1)
also markedly##2##2##(1997-1#1)(2008-11#1)
also may be##11##3##(1991-5#1)(1992-8#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#1)(2013-1#1)
also may cause##2##3##(1997-4#1)(2008-12#1)
also may have##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
also may play a role in##2##6##(1995-3#1)(2009-5#1)
also may play a role##3##5##(1995-3#1)(2008-10#1)(2009-5#1)
also may##28##2##(1991-5#1)(1992-8#1)(1995-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#3)
also measure##2##2##(2008-2#1)(2008-3#1)
also measured and##2##3##(2008-10#1)(2011-2#1)
also measured by a##2##4##(2008-10#1)(2008-2#1)
also measured for##2##3##(2008-10#2)
also measured the##2##3##(1992-2#1)(2007-12#1)
also measured using##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
also measured##39##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-3#1)(1997-4#1)(2006-6#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)
also mediate##3##2##(1993-12#1)(1995-8#1)(2008-1#1)
also mentioned##4##2##(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
also might##2##2##(2007-8#1)(2008-10#1)
also minimizes the number of##2##5##(2008-2#1)(2010-9#1)
also minimizes the##3##3##(2008-1#1)(2008-2#1)(2010-9#1)
also modeled##2##2##(2008-3#1)(2008-8#1)
also modified##5##2##(1992-7#1)(2008-10#1)(2008-5#2)(2008-9#1)
also monitored##3##2##(1990-12#1)(1997-4#1)(2008-10#1)
also more likely to##2##4##(2008-8#1)(2011-2#1)
also more likely##3##3##(2007-10#1)(2008-8#1)(2011-2#1)
also more##17##2##(1991-6#1)(1992-2#1)(1995-5#1)(1997-4#2)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
also must be##2##3##(2008-7#1)(2011-2#1)
also must##3##2##(2008-7#1)(2009-10#1)(2011-2#1)
also named##3##2##(1997-6#1)(2008-1#1)(2008-7#1)
also nearly##2##2##(2008-2#1)(2012-3#1)
also necessary to##6##3##(2007-12#1)(2008-5#1)(2009-2#1)(2009-6#1)(2011-2#2)
also necessary##9##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-2#2)
also need to be##5##4##(2007-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
also need to##8##3##(1997-1#1)(2007-4#1)(2008-12#1)(2012-12#2)(2012-2#1)(2013-1#2)
also need##9##2##(1997-1#1)(2006-10#1)(2007-4#1)(2008-12#1)(2012-12#2)(2012-2#1)(2013-1#2)
also needed##8##2##(1992-12#1)(1994-2#1)(1994-5#1)(1997-7#1)(2011-1#1)(2012-2#1)(2013-8#2)
also negative##2##2##(1992-6#1)(2011-2#1)
also new##3##2##(1992-3#1)(1997-7#1)(2008-10#1)
also no##9##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
also normalized##2##2##(2011-2#2)
also not consistent##2##3##(2007-10#1)(2011-2#1)
also not##15##2##(1993-5#1)(1993-6#1)(1995-12#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
also note##2##2##(2008-10#1)(2010-6#1)
also noted that##2##3##(2008-6#1)(2010-7#1)
also noted##14##2##(1990-3#1)(1992-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-6#2)(2008-8#1)(2010-7#2)(2013-1#1)
also noticed that##2##3##(2008-5#1)(2011-2#1)
also noticed##7##2##(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
also observed a##3##3##(1993-3#1)(2007-10#1)(2008-3#1)
also observed at the##2##4##(1996-5#1)(2008-7#1)
also observed at##3##3##(1996-5#1)(2008-6#1)(2008-7#1)
also observed for##6##3##(1991-1#1)(1992-10#1)(1992-6#1)(1997-3#1)(2008-9#1)(2012-2#1)
also observed in the##23##4##(1991-12#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
also observed in##48##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-6#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
also observed on##4##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
also observed that the##3##4##(1995-11#1)(2008-3#1)(2012-3#1)
also observed that##16##3##(1992-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-8#1)
also observed to##2##3##(1993-6#1)(2008-11#1)
also observed when##6##3##(1991-2#1)(1991-5#1)(1993-12#1)(1994-5#1)(1997-6#1)(2008-10#1)
also observed with##2##3##(1992-3#1)(2010-8#1)
also observed within##4##3##(1991-12#1)(1992-8#1)(2008-10#2)
also observed##141##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#28)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
also obtained by##3##3##(1992-10#1)(2008-5#1)(2008-8#1)
also obtained from the##2##4##(2008-7#1)(2010-5#1)
also obtained from##7##3##(1992-12#1)(1994-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-5#1)
also obtained in the##3##4##(1990-8#1)(2008-2#1)(2008-5#1)
also obtained in##4##3##(1990-8#1)(2007-11#1)(2008-2#1)(2008-5#1)
also obtained with##3##3##(1994-11#1)(2008-3#1)(2008-8#1)
also obtained##44##2##(1990-8#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-1#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
also occur in the##2##4##(1995-12#1)(2008-10#1)
also occur in##9##3##(1991-12#1)(1995-12#2)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-12#1)
also occur through##3##3##(1995-6#1)(2008-10#2)
also occur under##2##3##(1997-8#1)(2008-10#1)
also occur within the##2##4##(2009-12#1)(2012-12#1)
also occur##24##2##(1991-12#1)(1991-9#1)(1995-12#2)(1995-6#1)(1997-4#1)(1997-8#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2012-12#2)(2013-7#1)
also occurred in##4##3##(1995-11#1)(2008-9#3)
also occurred##9##2##(1995-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#4)
also occurs in the##2##4##(1992-8#1)(2008-5#1)
also occurs in##7##3##(1992-12#1)(1992-8#1)(1994-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
also occurs##11##2##(1992-12#1)(1992-8#1)(1994-8#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-1#1)
also of interest to##2##4##(1993-11#1)(2008-10#1)
also of interest##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
also of the##10##3##(1993-2#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)
also of##30##2##(1990-2#1)(1991-11#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)
also offer##3##2##(1996-1#1)(2008-7#2)
also offered##3##2##(1997-4#1)(2008-12#1)(2009-9#1)
also offers a##2##3##(2008-11#1)(2008-9#1)
also offers an##2##3##(2008-9#1)(2010-3#1)
also offers the##2##3##(2007-12#1)(2008-5#1)
also offers##10##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2010-3#1)
also often##3##2##(2007-11#1)(2008-8#1)(2012-2#1)
also on its##4##3##(1991-2#2)(2008-10#1)(2008-5#1)
also on the##10##3##(1990-11#2)(1991-12#1)(1995-11#1)(2008-10#1)(2008-2#2)(2010-12#1)(2012-12#1)(2012-3#1)
also on##29##2##(1990-11#2)(1991-12#1)(1991-2#2)(1995-11#1)(1995-2#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
also one of the most##2##5##(2008-10#1)(2013-7#1)
also one of the##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2013-7#1)
also operate##2##2##(2008-12#1)(2009-5#1)
also optimized for##2##3##(2008-10#2)
also optimized##4##2##(2008-10#4)
also other##7##2##(1991-2#1)(1992-9#1)(1994-8#1)(1995-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
also outline##2##2##(1991-3#1)(2010-12#1)
also outlined##3##2##(2008-4#2)(2011-1#1)
also outlines the##2##3##(2008-11#1)(2008-4#1)
also part of##2##3##(2008-5#1)(2012-12#1)
also partially##3##2##(1996-5#1)(2008-11#1)(2008-2#1)
also participate in the##5##4##(2007-5#2)(2008-7#1)(2009-10#1)(2011-2#1)
also participate in##6##3##(2007-5#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
also participated in##3##3##(2008-11#2)(2010-4#1)
also participated##5##2##(2006-8#1)(2008-11#2)(2009-11#1)(2010-4#1)
also participates in##2##3##(2007-12#1)(2009-10#1)
also particularly##3##2##(2008-12#1)(2008-2#1)(2010-3#1)
also pay##2##2##(1990-4#1)(2008-9#1)
also penetrated##2##2##(2008-10#2)
also perceived##2##2##(2009-7#1)(2012-3#1)
also performed an##2##3##(1991-6#1)(2008-2#1)
also performed in##4##3##(1991-5#1)(1992-10#1)(2008-10#1)(2008-5#1)
also performed on the##2##4##(2008-10#1)(2008-2#1)
also performed on##4##3##(1994-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
also performed with##4##3##(1992-8#1)(1994-5#1)(1996-1#1)(2013-1#1)
also performed##36##2##(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-5#2)(1994-8#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-2#2)(2013-1#2)
also permits the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
also permits to##2##3##(2007-11#1)(2008-10#1)
also permits##6##2##(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)
also phosphorylated##4##2##(1991-2#1)(1992-3#1)(1992-6#1)(2008-11#1)
also placed##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2010-3#1)
also play a role in the##5##6##(1995-8#1)(1997-3#1)(2009-1#1)(2009-9#1)(2010-3#1)
also play a role in##7##5##(1992-8#1)(1994-6#1)(1995-8#1)(1997-3#1)(2009-1#1)(2009-9#1)(2010-3#1)
also play a role##10##4##(1992-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-3#1)
also play a##15##3##(1992-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-3#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
also play an important role in the##4##7##(1996-3#1)(2008-10#2)(2008-3#1)
also play an important role in##6##6##(1994-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
also play an important##7##4##(1994-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
also play an##8##3##(1994-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
also play important roles in##2##5##(2008-8#1)(2009-11#1)
also play##26##2##(1992-8#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
also played##6##2##(1990-9#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)
also plays a major role in##2##6##(2008-3#1)(2012-12#1)
also plays a major##3##4##(1993-9#1)(2008-3#1)(2012-12#1)
also plays a role in##2##5##(2009-5#1)(2011-1#1)
also plays a##6##3##(1993-9#1)(1997-8#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-12#1)
also point to##2##3##(1994-12#1)(2007-12#1)
also point##3##2##(1994-12#1)(2007-12#1)(2012-2#1)
also pointed out##2##3##(2008-10#1)(2010-12#1)
also points to##2##3##(2010-11#1)(2011-2#1)
also points##4##2##(1993-6#1)(2010-11#1)(2011-2#2)
also positive##4##2##(1991-12#1)(1992-6#1)(1996-5#1)(2008-10#1)
also possess a##2##3##(2008-10#1)(2010-5#1)
also possess the##3##3##(2007-5#1)(2008-9#2)
also possess##11##2##(1993-12#1)(1993-9#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-7#1)(2008-9#2)(2010-5#1)(2013-1#1)
also possesses some##2##3##(1995-5#1)(2013-1#1)
also possesses##4##2##(1992-3#1)(1995-5#1)(2008-10#1)(2013-1#1)
also possible in##2##3##(2008-11#1)(2008-9#1)
also possible to##7##3##(1997-4#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)
also possible##18##2##(1994-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-9#2)(2009-2#1)(2013-1#1)
also potent inhibitors of##2##4##(1990-5#1)(1991-9#1)
also potent##3##2##(1990-5#1)(1991-9#1)(2013-8#1)
also potentially##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
also potentiated##5##2##(1990-5#1)(1990-7#2)(1997-4#1)(2008-4#1)
also practical##2##2##(2007-11#1)(2008-9#1)
also predict##4##2##(1997-6#1)(2007-12#1)(2008-8#1)(2012-3#1)
also predicted by##3##3##(1997-7#1)(1997-8#1)(2011-1#1)
also predicted##6##2##(1997-6#1)(1997-7#1)(1997-8#1)(2008-8#1)(2011-1#1)(2012-3#1)
also predicts that##4##3##(1993-12#1)(2007-11#1)(2008-7#1)(2008-8#1)
also predicts##6##2##(1993-12#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
also prepared by##2##3##(2008-10#1)(2008-2#1)
also prepared##9##2##(1992-12#1)(1992-9#1)(1993-8#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-2#1)(2009-11#1)
also present an##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)
also present and##2##3##(2008-3#1)(2012-3#1)
also present as##2##3##(2008-10#1)(2013-1#1)
also present experimental results##2##4##(2008-3#2)
also present in other##3##4##(1992-8#1)(2008-10#1)(2008-7#1)
also present in the##5##4##(1990-5#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-8#1)
also present in##24##3##(1990-5#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)
also present new##2##3##(2008-7#1)(2009-8#1)
also present some##3##3##(2008-8#1)(2009-12#1)(2013-1#1)
also present##77##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#2)(2007-12#6)(2008-10#10)(2008-2#6)(2008-3#8)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
also presented and##4##3##(1995-5#1)(2008-10#1)(2008-3#2)
also presented as an application##2##5##(2008-2#1)(2008-3#1)
also presented for the##2##4##(1993-8#1)(2008-10#1)
also presented for##5##3##(1991-2#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-5#1)
also presented in##4##3##(2008-10#3)(2011-1#1)
also presented that##4##3##(1993-6#1)(1995-6#1)(2007-12#1)(2008-4#1)
also presented##106##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#4)(2007-12#6)(2007-8#2)(2008-10#20)(2008-12#1)(2008-2#13)(2008-3#21)(2008-4#9)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#5)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
also presents an##2##3##(1995-9#1)(2008-12#1)
also presents the##2##3##(1991-3#1)(2013-8#1)
also presents##12##2##(1991-3#1)(1995-9#1)(1996-1#1)(1997-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
also prevent the##2##3##(2008-10#1)(2008-8#1)
also prevent##8##2##(1993-2#1)(1994-1#1)(2008-10#1)(2008-8#2)(2009-8#1)(2010-5#1)(2013-1#1)
also prevented the##2##3##(1991-7#1)(2008-11#1)
also prevented##6##2##(1991-12#1)(1991-7#1)(1994-2#1)(1994-8#1)(1997-1#1)(2008-11#1)
also primes##2##2##(1992-3#1)(1992-8#1)
also probably##2##2##(1993-11#1)(2008-8#1)
also produce##6##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
also produced a significant##3##4##(1992-8#1)(1997-7#1)(2008-10#1)
also produced a##4##3##(1992-8#1)(1997-7#1)(2008-10#2)
also produced by##3##3##(1992-6#1)(1995-12#1)(2008-11#1)
also produced##16##2##(1990-10#1)(1992-6#1)(1992-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
also produces an##3##3##(1994-6#1)(1995-3#1)(2008-10#1)
also produces##7##2##(1994-6#1)(1995-3#1)(2008-10#3)(2008-7#1)(2008-9#1)
also promote##5##2##(1995-5#1)(2008-11#2)(2009-11#1)(2010-12#1)
also promoted##2##2##(1994-9#1)(2008-9#1)
also promotes##3##2##(1990-5#1)(2008-7#1)(2009-10#1)
also propose##4##2##(2008-3#1)(2008-4#1)(2008-8#1)(2012-1#1)
also proposed to##2##3##(2008-2#2)
also proposed##20##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
also proposes##3##2##(1991-12#1)(2008-10#1)(2012-12#1)
also protect against the development of##2##6##(1991-6#1)(1993-11#1)
also protect against##3##3##(1991-6#1)(1993-11#1)(1994-3#1)
also protect##4##2##(1991-6#1)(1993-11#1)(1994-3#1)(2011-2#1)
also protects##2##2##(1995-5#1)(1997-7#1)
also proved to be##4##4##(1993-3#1)(2008-10#2)(2012-6#1)
also proved to##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2012-6#1)
also proved useful in##2##4##(1992-9#1)(2008-10#1)
also proved useful##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
also proved##12##2##(1992-7#1)(1992-9#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2012-3#1)(2012-6#1)
also proven##2##2##(2008-1#1)(2008-5#1)
also provide a basis for##2##5##(1992-3#1)(2008-4#1)
also provide a##10##3##(1992-3#1)(1993-3#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)
also provide an##6##3##(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
also provide insight into##2##4##(2009-8#2)
also provide the##5##3##(2008-3#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
also provide##44##2##(1992-12#1)(1992-3#2)(1993-3#2)(2007-2#1)(2008-10#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
also provided by##2##3##(1994-3#1)(2007-12#1)
also provided for##8##3##(2007-9#1)(2008-1#1)(2008-4#5)(2010-10#1)
also provided good##2##3##(2008-10#1)(2009-11#1)
also provided support##2##3##(2008-12#1)(2010-4#1)
also provided##53##2##(1991-12#1)(1994-3#1)(1995-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#15)(2008-5#1)(2008-7#3)(2008-9#4)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2012-2#1)(2012-3#1)
also provides a conceptual##2##4##(2008-8#1)(2013-8#1)
also provides a means##2##4##(2008-10#1)(2008-12#1)
also provides a##23##3##(1991-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-2#1)(1997-1#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
also provides an overview of##2##5##(2008-4#1)(2013-1#1)
also provides an##5##3##(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
also provides higher##2##3##(2008-3#1)(2008-4#1)
also provides##53##2##(1991-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-12#2)(1996-2#2)(1997-1#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
also purified##3##2##(1990-12#1)(2008-8#1)(2009-8#1)
also put##2##2##(2010-8#1)(2011-2#1)
also quantify the##4##3##(2008-3#2)(2008-7#1)(2009-2#1)
also quantify##6##2##(1996-3#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)
also quantitatively##2##2##(1995-2#1)(2008-11#1)
also raised##2##2##(2009-4#1)(2013-1#1)
also rapidly##3##2##(1994-3#1)(1994-9#1)(2008-11#1)
also rated as##2##3##(2010-10#1)(2012-2#1)
also rated##5##2##(1996-1#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-2#1)
also reacted##3##2##(1991-9#1)(1994-3#1)(2008-10#1)
also reacts with##2##3##(1996-2#1)(2008-10#1)
also realized##2##2##(2007-11#2)
also receive##3##2##(1996-2#1)(2008-5#1)(2008-7#1)
also received the##2##3##(2009-6#1)(2010-11#1)
also received##5##2##(1992-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-11#1)
also recently been##3##3##(2006-10#1)(2009-11#1)(2010-11#1)
also recently##5##2##(1994-11#1)(2006-10#1)(2009-11#1)(2010-11#1)(2010-3#1)
also recognised##2##2##(1993-8#2)
also recognize##2##2##(1993-1#1)(2010-12#1)
also recognizes##2##2##(1990-12#1)(1990-7#1)
also recommended##2##2##(2008-12#1)(2013-1#1)
also recommends##2##2##(1995-12#1)(2009-5#1)
also recorded##12##2##(1993-2#1)(1995-12#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-12#1)(2010-4#1)(2013-1#1)
also reduce the##2##3##(1994-9#1)(1996-11#1)
also reduce##11##2##(1994-9#1)(1996-11#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
also reduced by##6##3##(1994-8#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-2#1)
also reduced in##5##3##(1990-12#1)(1993-12#2)(2008-10#1)(2012-12#1)
also reduced the##10##3##(1991-5#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
also reduced##32##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#2)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-10#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
also reduces##5##2##(2008-3#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)
also referred to as##2##4##(2008-3#1)(2011-2#1)
also referred to##3##3##(2008-3#1)(2009-4#1)(2011-2#1)
also reflect##3##2##(1992-9#1)(2008-11#1)(2008-8#1)
also reflected the##2##3##(2008-10#1)(2008-5#1)
also reflected##5##2##(1990-5#1)(1991-12#1)(2008-10#2)(2008-5#1)
also registered##3##2##(1993-2#1)(1996-12#1)(2008-5#1)
also regulate##2##2##(1994-8#1)(2008-9#1)
also regulated by##2##3##(1993-11#1)(1996-2#1)
also regulated##3##2##(1993-11#1)(1996-2#1)(2008-9#1)
also regulates##3##2##(2008-4#1)(2008-7#1)(2012-3#1)
also related to##3##3##(1994-3#1)(2008-10#1)(2008-7#1)
also relatively high##2##3##(1991-6#1)(2010-6#1)
also relatively##7##2##(1991-6#1)(1995-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2013-7#1)
also release##2##2##(2008-10#1)(2008-8#1)
also released into##2##3##(1994-9#1)(1997-4#1)
also released##6##2##(1994-8#1)(1994-9#1)(1997-1#1)(1997-4#1)(2008-10#2)
also remained##3##2##(1994-11#1)(2007-12#1)(2008-3#1)
also remains##3##2##(1996-2#1)(1997-3#1)(2012-12#1)
also remarkably##2##2##(2008-10#2)
also removed##2##2##(2008-6#1)(2013-1#1)
also removes##4##2##(2007-11#2)(2008-10#1)(2011-2#1)
also repeated##2##2##(1991-11#1)(2013-1#1)
also report##16##2##(1990-11#1)(1992-11#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2010-9#1)(2011-2#1)
also reported by others##2##4##(1993-8#1)(2011-2#1)
also reported for##3##3##(1993-1#1)(1994-2#1)(2011-2#1)
also reported that##2##3##(2007-8#1)(2008-2#1)
also reported##38##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-9#1)(1993-1#2)(1993-8#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)
also reports##3##2##(1992-3#1)(1996-1#1)(2008-7#1)
also represent##5##2##(1993-8#1)(1996-4#1)(1996-9#1)(2006-12#1)(2008-10#1)
also require further##2##3##(2010-3#2)
also require##7##2##(2008-11#1)(2009-8#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-8#1)
also required for the##3##4##(1990-11#1)(2010-11#1)(2013-7#1)
also required for##6##3##(1990-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2010-11#1)(2013-7#1)
also required to##2##3##(2008-7#1)(2011-1#1)
also required##16##2##(1990-11#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
also requires a##2##3##(1991-5#1)(1996-12#1)
also requires##4##2##(1991-5#1)(1996-12#1)(2007-11#1)(2008-11#1)
also resistant to##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
also resistant##6##2##(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)
also respond##2##2##(1993-11#1)(2008-4#1)
also responded to##5##3##(1991-2#1)(1992-12#1)(1992-6#1)(1994-9#1)(2008-8#1)
also responsible for##5##3##(1990-8#1)(1996-1#1)(2008-10#2)(2010-5#1)
also restored##2##2##(1995-12#1)(2008-7#1)
also result from##3##3##(1994-9#1)(2007-12#1)(2008-7#1)
also result in a##4##4##(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
also result in##8##3##(1990-8#1)(1997-7#1)(2008-11#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
also result##12##2##(1990-8#1)(1994-9#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
also resulted in a##2##4##(2008-10#1)(2008-7#1)
also resulted in##15##3##(1990-8#1)(1991-9#1)(1992-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)
also results in the##2##4##(1991-2#1)(2008-6#1)
also results in##5##3##(1991-2#1)(1993-9#1)(2008-6#1)(2008-9#1)(2011-2#1)
also results##6##2##(1991-2#1)(1993-9#1)(2006-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
also reveal that##2##3##(2008-10#1)(2008-3#1)
also reveal the##2##3##(2008-2#1)(2008-7#1)
also reveal##8##2##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
also revealed a##3##3##(1997-7#1)(2008-12#1)(2009-7#1)
also revealed an##2##3##(2008-8#1)(2012-2#1)
also revealed that##7##3##(1993-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
also revealed the presence of a##2##6##(2008-10#1)(2013-1#1)
also revealed the presence of##3##5##(2008-10#1)(2008-4#1)(2013-1#1)
also revealed the##6##3##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
also revealed##28##2##(1990-7#1)(1991-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
also reveals that##2##3##(2008-2#1)(2012-3#1)
also reveals##5##2##(1993-2#1)(2007-12#1)(2008-2#1)(2009-12#1)(2012-3#1)
also reversed##3##2##(1992-3#1)(2007-11#1)(2008-10#1)
also review the literature on##2##5##(1990-2#1)(2007-8#1)
also review the##5##3##(1990-2#1)(1994-12#1)(2007-8#1)(2009-11#1)(2010-12#1)
also review##12##2##(1990-2#1)(1994-12#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)
also reviewed the##3##3##(2008-10#1)(2009-5#1)(2010-8#1)
also reviewed##22##2##(1993-12#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
also reviews the##3##3##(1991-2#1)(1995-2#1)(2008-2#1)
also reviews various##2##3##(1991-12#1)(2013-1#1)
also reviews##5##2##(1991-12#1)(1991-2#1)(1995-2#1)(2008-2#1)(2013-1#1)
also scored##3##2##(1991-2#1)(2008-5#1)(2009-5#1)
also screened##3##2##(2011-2#1)(2012-3#2)
also secreted##2##2##(1991-9#1)(2008-10#1)
also seems to be##2##4##(1990-2#1)(1993-9#1)
also seems##3##2##(1990-2#1)(1993-9#1)(2011-2#1)
also seen in the##4##4##(1991-10#1)(1996-12#1)(2008-7#2)
also seen in##12##3##(1991-10#1)(1991-11#1)(1995-11#1)(1996-12#1)(2008-1#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-9#1)
also seen##21##2##(1990-5#1)(1991-10#1)(1991-11#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-11#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)
also sensitive to##2##3##(1990-5#1)(2007-12#1)
also separated##4##2##(1997-2#1)(2008-10#2)(2008-9#1)
also sequenced##4##2##(1993-6#1)(1995-12#1)(2008-10#1)(2008-12#1)
also serve as a##7##4##(2008-7#2)(2010-8#4)(2011-2#1)
also serve as##11##3##(1995-3#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-8#4)(2011-2#1)
also serve##14##2##(1990-11#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#2)(2010-8#4)(2011-2#1)
also served as a##2##4##(2008-10#1)(2013-1#1)
also served as##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
also served to##2##3##(2008-1#1)(2008-10#1)
also served##7##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
also serves as a##4##4##(2008-10#1)(2008-3#1)(2010-8#1)(2012-12#1)
also serves as##5##3##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
also serves to##5##3##(1994-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#1)
also serves##10##2##(1994-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
also share##6##2##(1992-3#1)(1992-8#1)(1994-12#1)(2008-7#1)(2009-10#1)(2010-3#1)
also shared##2##2##(1993-2#1)(2008-10#1)
also shed##2##2##(2008-8#1)(2012-2#1)
also shortened##2##2##(1990-7#1)(2008-10#1)
also should##2##2##(1992-3#1)(2012-2#1)
also show a##4##3##(1991-3#1)(1992-5#1)(1996-5#1)(2011-2#1)
also show how the##3##4##(1991-1#1)(2008-2#1)(2008-7#1)
also show how##8##3##(1991-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#1)
also show major##2##3##(1991-3#1)(1997-2#1)
also show some##2##3##(1994-5#1)(2008-8#1)
also show that in##2##4##(1994-9#1)(2009-3#1)
also show that the##20##4##(1990-12#1)(1992-6#1)(1992-9#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2012-2#3)(2012-3#1)(2013-1#2)
also show that##58##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-2#1)(1994-8#1)(1994-9#2)(1997-7#1)(1997-9#1)(2007-11#4)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-3#1)(2010-10#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)
also show the##5##3##(1995-3#1)(2007-12#2)(2008-10#1)(2008-3#1)
also show##93##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-9#1)(2007-11#4)(2007-12#4)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
also showed a high##3##4##(1992-8#1)(1994-6#1)(2008-10#1)
also showed a significant##2##4##(2008-7#1)(2012-2#1)
also showed a##15##3##(1991-5#1)(1992-8#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
also showed greater##2##3##(2008-10#1)(2009-11#1)
also showed increased##2##3##(1997-5#1)(2008-11#1)
also showed positive##2##3##(2008-5#1)(2010-8#1)
also showed significant##2##3##(2008-11#1)(2008-8#1)
also showed significantly##2##3##(2008-10#1)(2013-1#1)
also showed that the##10##4##(1990-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
also showed that this##2##4##(2008-5#2)
also showed that##29##3##(1990-12#2)(1992-9#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-8#2)
also showed the##2##3##(2008-10#1)(2009-8#1)
also showed##98##2##(1990-12#2)(1991-5#1)(1991-8#2)(1992-8#3)(1992-9#1)(1993-12#2)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
also showing##4##2##(1991-10#1)(1995-3#1)(2008-1#1)(2012-2#1)
also shown that the method##2##5##(2008-10#1)(2008-2#1)
also shown that the##12##4##(1990-8#1)(1992-5#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-11#1)
also shown that##27##3##(1990-2#1)(1990-8#1)(1992-5#1)(1993-12#1)(1994-11#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-7#1)
also shown to be##8##4##(1991-5#1)(1992-3#1)(2008-10#1)(2008-3#1)(2010-5#2)(2010-7#1)(2012-3#1)
also shown to##20##3##(1991-10#1)(1991-5#2)(1992-3#1)(1992-6#1)(1995-2#1)(1996-6#1)(1997-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#2)(2010-7#1)(2012-2#1)(2012-3#1)
also shown##59##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-2#2)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2012-2#1)(2012-3#2)
also shows a strong##2##4##(2008-3#1)(2008-8#1)
also shows a##5##3##(1997-4#1)(2008-10#1)(2008-3#2)(2008-8#1)
also shows how##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
also shows that the##2##4##(2008-10#1)(2010-7#1)
also shows that##8##3##(1992-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)
also shows the##2##3##(2008-5#1)(2009-7#1)
also shows##30##2##(1991-10#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-6#1)(1996-1#1)(1997-4#1)(2008-10#3)(2008-11#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
also significant in##2##3##(2008-10#1)(2011-1#1)
also significant##9##2##(1995-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
also significantly associated with##3##4##(2011-1#2)(2011-2#1)
also significantly changed##2##3##(2008-10#1)(2009-8#1)
also significantly decreased in##2##4##(1990-7#1)(1993-3#1)
also significantly decreased##5##3##(1990-7#1)(1991-9#1)(1993-3#1)(1994-8#1)(2008-4#1)
also significantly higher in##2##4##(2009-6#1)(2011-2#1)
also significantly higher##8##3##(1991-4#1)(1995-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)
also significantly improved##2##3##(2008-5#1)(2008-7#1)
also significantly increased the##2##4##(1995-9#1)(2007-11#1)
also significantly increased##4##3##(1991-5#1)(1995-9#1)(2007-11#1)(2012-1#1)
also significantly reduced##5##3##(1990-7#1)(1994-6#1)(2008-10#2)(2013-1#1)
also significantly##49##2##(1990-7#2)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2013-1#1)
also similar to##3##3##(1994-6#1)(2008-10#1)(2008-8#1)
also similar##8##2##(1994-6#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)
also social##2##2##(2007-11#1)(2012-12#1)
also some characteristic##2##3##(2008-10#1)(2008-7#1)
also some##11##2##(1990-2#1)(1990-5#1)(1991-6#1)(1995-3#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)
also sometimes##4##2##(1994-12#1)(2008-1#1)(2008-9#1)(2013-1#1)
also sought to##2##3##(1996-12#1)(2008-10#1)
also specific##2##2##(1990-12#1)(1993-9#1)
also specifically##3##2##(1992-3#1)(1993-6#1)(1996-5#1)
also specified##2##2##(2007-8#1)(2013-1#1)
also stated that##3##3##(1995-6#1)(2008-1#1)(2009-4#1)
also stated##4##2##(1992-6#1)(1995-6#1)(2008-1#1)(2009-4#1)
also stimulate##5##2##(1991-5#1)(1992-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
also stimulated##13##2##(1990-4#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(2008-10#2)(2008-11#2)(2012-2#1)
also stimulates the##3##3##(1992-11#1)(1995-2#1)(2008-8#1)
also stimulates##6##2##(1992-11#1)(1993-6#1)(1995-2#1)(2008-8#1)(2009-10#1)(2012-3#1)
also strengthen the##2##3##(2008-12#1)(2012-3#1)
also stressed##3##2##(2008-10#1)(2008-4#1)(2009-4#1)
also strong##2##2##(1995-3#1)(2009-2#1)
also strongly inhibited##2##3##(1992-3#1)(1995-6#1)
also strongly##10##2##(1991-9#1)(1992-3#1)(1995-5#1)(1995-6#1)(2008-11#3)(2008-5#1)(2008-8#1)(2013-8#1)
also studied by##3##3##(1996-2#1)(2008-10#2)
also studied for their##2##4##(1995-3#1)(2008-10#1)
also studied for##6##3##(1993-12#1)(1995-3#1)(2008-10#3)(2013-8#1)
also studied the##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2009-12#1)(2012-3#1)
also studied using##3##3##(2008-10#2)(2009-3#1)
also studied##89##2##(1990-2#1)(1990-3#1)(1991-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#43)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
also study##3##2##(2008-2#1)(2008-6#1)(2009-11#1)
also subject to##2##3##(2008-11#1)(2010-6#1)
also subject##3##2##(2008-11#1)(2010-6#1)(2012-2#1)
also subjected to##2##3##(2008-10#1)(2013-7#1)
also substantially##4##2##(1992-8#1)(1995-2#1)(2008-2#1)(2010-8#1)
also successfully detected##2##3##(2008-10#2)
also successfully##7##2##(2008-10#6)(2008-7#1)
also suffered from septic##2##4##(2007-5#1)(2010-5#1)
also suffered from##5##3##(1990-3#1)(1997-7#1)(2007-5#1)(2010-3#1)(2010-5#1)
also suggest that a##3##4##(2008-10#1)(2009-10#1)(2012-3#1)
also suggest that the relative##2##5##(1996-5#1)(2011-2#1)
also suggest that the##13##4##(1991-12#1)(1991-5#1)(1992-6#1)(1992-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
also suggest that##41##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-3#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-5#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
also suggest the existence of##2##5##(2008-10#1)(2008-7#1)
also suggest the##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
also suggest##50##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-3#2)(1994-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-5#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
also suggested a##2##3##(1996-5#1)(2012-2#1)
also suggested for##2##3##(1992-8#1)(2010-5#1)
also suggested that there##2##4##(2007-6#1)(2008-12#1)
also suggested that##13##3##(1990-12#1)(1990-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-9#1)
also suggested##26##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-12#2)(1994-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
also suggestive of##4##3##(2007-11#1)(2009-8#1)(2010-8#1)(2012-2#1)
also suggests that the##3##4##(1990-8#1)(2008-10#1)(2009-11#1)
also suggests that##14##3##(1990-8#1)(1992-11#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-3#1)
also suggests##19##2##(1990-8#1)(1991-1#1)(1992-11#1)(1996-2#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)
also suitable for##7##3##(1992-6#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-6#1)
also suitable##8##2##(1992-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)
also summarized##8##2##(1991-12#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2012-3#1)
also support the##4##3##(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
also support##10##2##(1992-3#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
also supported by the##2##4##(2008-10#1)(2008-7#1)
also supported by##8##3##(1990-5#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-7#2)
also supported the##6##3##(1997-5#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
also supported##20##2##(1990-5#1)(1992-1#1)(1994-12#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2011-1#1)(2013-1#1)
also supports the##3##3##(1995-12#1)(2011-2#1)(2012-3#1)
also supports##4##2##(1995-12#1)(2009-3#1)(2011-2#1)(2012-3#1)
also suppressed the##7##3##(1993-9#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-5#1)(2012-2#1)
also suppressed##19##2##(1991-3#1)(1991-9#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
also surveyed##3##2##(1996-12#1)(2009-8#1)(2012-3#1)
also suspected##3##2##(2008-10#2)(2013-1#1)
also take into##2##3##(2008-3#1)(2013-8#1)
also take##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
also taken into account##6##4##(1991-5#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)
also takes##3##2##(1995-5#1)(2008-2#1)(2008-4#1)
also taking##2##2##(2008-10#1)(2008-5#1)
also targeted##2##2##(2009-8#1)(2013-1#1)
also tended to improve##2##4##(2013-1#2)
also tended to##5##3##(1994-12#1)(1995-1#1)(2007-8#1)(2013-1#2)
also termed##3##2##(2008-1#1)(2008-4#1)(2011-2#1)
also tested as##2##3##(1995-2#1)(2008-10#1)
also tested for##5##3##(1995-2#1)(2008-10#2)(2008-9#2)
also tested in a##2##4##(2008-11#2)
also tested in##7##3##(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-3#1)
also tested##34##2##(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#3)(1997-7#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#4)(2009-12#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
also that the##3##3##(1992-12#1)(2007-12#1)(2008-10#1)
also that##15##2##(1992-12#1)(1994-6#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-4#1)(2011-10#1)(2012-1#1)
also the combination##2##3##(1997-8#1)(2007-7#1)
also the effect of the##2##5##(2008-10#1)(2008-7#1)
also the first##8##3##(2008-10#2)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#3)
also the formation##2##3##(1990-12#1)(2008-10#1)
also the most##5##3##(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)
also the number##2##3##(2008-10#1)(2008-11#1)
also the timing of the##2##5##(2009-10#1)(2009-12#1)
also the##129##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-3#3)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#4)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#2)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#3)
also their limitations##2##3##(2008-10#1)(2008-11#1)
also their##12##2##(1991-12#1)(1993-11#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
also this##2##2##(1990-11#1)(2008-10#1)
also those##2##2##(2006-6#1)(2009-3#1)
also three##2##2##(2011-2#2)
also through##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
also to a##3##3##(1997-6#1)(2008-7#1)(2011-2#1)
also to be an##2##4##(1993-11#1)(2009-7#1)
also to be##5##3##(1991-12#1)(1993-11#1)(2008-7#1)(2009-7#1)(2011-3#1)
also to introduce##2##3##(2008-4#1)(2010-3#1)
also to other##2##3##(2007-2#1)(2008-2#1)
also to the##17##3##(1990-11#1)(1991-6#1)(1992-9#2)(1995-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2013-1#1)
also to##104##2##(1990-11#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-7#3)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#5)(2013-1#2)(2013-7#1)
also took##2##2##(2008-5#1)(2013-1#1)
also treated##4##2##(1990-2#1)(2008-10#2)(2008-5#1)
also true for##2##3##(1994-3#1)(2008-5#1)
also true##3##2##(1992-10#1)(1994-3#1)(2008-5#1)
also try to##2##3##(1992-3#1)(2009-11#1)
also two##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
also unable to##2##3##(1995-6#1)(2008-12#1)
also under development##2##3##(1991-12#1)(2008-10#1)
also under##4##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-11#1)
also undergo##3##2##(1995-6#1)(2008-7#1)(2009-10#1)
also undergone##2##2##(1992-8#1)(2010-6#1)
also underline##2##2##(2008-10#1)(2011-2#1)
also underscores the importance of##2##5##(1990-8#1)(2012-2#1)
also underscores the##3##3##(1990-8#1)(2008-7#1)(2012-2#1)
also undertaken to determine##2##4##(1994-10#1)(2012-3#1)
also undertaken##5##2##(1994-10#2)(2008-10#2)(2012-3#1)
also underwent##2##2##(1990-11#1)(2011-2#1)
also use##7##2##(1992-12#1)(1997-4#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-3#1)
also used as a##4##4##(1996-8#1)(2008-10#1)(2008-12#1)(2010-8#1)
also used as an##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
also used as##11##3##(1996-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
also used for comparison##2##4##(2008-10#1)(2010-8#1)
also used for other##2##4##(1996-3#1)(2009-8#1)
also used for the determination of##4##6##(2008-10#4)
also used for the##6##4##(2008-10#6)
also used for##16##3##(1991-12#1)(1994-3#1)(1996-3#1)(2008-10#11)(2009-8#1)(2010-8#1)
also used in the##3##4##(1995-6#1)(2008-10#1)(2009-6#1)
also used in##10##3##(1994-9#1)(1995-6#1)(2008-10#5)(2008-9#2)(2009-6#1)
also used to calculate##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
also used to directly##2##4##(2008-10#1)(2008-7#1)
also used to follow##2##4##(2008-10#2)
also used to##42##3##(1994-2#1)(1995-5#1)(2007-11#2)(2008-10#17)(2008-2#2)(2008-3#7)(2008-5#2)(2008-7#4)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
also used##101##2##(1990-9#1)(1991-12#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#43)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#7)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
also useful for##5##3##(1993-2#1)(1994-11#1)(2008-1#2)(2008-2#1)
also useful in##11##3##(1992-3#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-8#1)(2012-2#1)
also useful to##3##3##(1997-1#1)(2007-2#1)(2012-3#1)
also useful##20##2##(1992-3#1)(1993-2#1)(1994-11#1)(1994-9#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
also utilized##3##2##(1995-8#1)(2008-2#1)(2012-2#1)
also validated the##2##3##(2008-5#2)
also validated##6##2##(2008-1#1)(2008-10#1)(2008-5#2)(2010-5#1)(2011-1#1)
also varied with##2##3##(1991-6#1)(2008-10#1)
also varied##5##2##(1991-6#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-3#1)
also varies##4##2##(1990-6#1)(1995-2#1)(2008-10#1)(2008-8#1)
also vary##2##2##(1995-5#1)(2008-2#1)
also verified##6##2##(2008-10#3)(2008-9#2)(2011-1#1)
also very good##2##3##(2008-10#2)
also very similar##2##3##(1992-8#1)(2008-10#1)
also very##20##2##(1990-5#1)(1990-8#1)(1992-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)
also was an##2##3##(2008-10#1)(2010-3#1)
also was assessed##3##3##(2008-10#3)
also was associated with##4##4##(2008-10#3)(2012-2#1)
also was correlated with##2##4##(2008-10#2)
also was detected##2##3##(2008-10#2)
also was determined##2##3##(2008-10#2)
also was examined##2##3##(2008-10#2)
also was found##5##3##(2008-10#4)(2013-1#1)
also was not##3##3##(1993-8#1)(1994-5#1)(2009-9#1)
also was observed##3##3##(2008-10#1)(2012-1#1)(2013-1#1)
also was present in##3##4##(2008-10#3)
also was reduced##2##3##(2008-10#2)
also was the most##2##4##(2008-10#2)
also was the##3##3##(2008-10#2)(2013-1#1)
also was used to##2##4##(2008-10#2)
also was used##3##3##(1995-1#1)(2008-10#2)
also was##70##2##(1990-11#1)(1990-6#1)(1992-11#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-1#1)(1997-7#1)(2008-10#51)(2008-12#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
also weakly##4##2##(1995-12#1)(1997-8#1)(2008-4#1)(2008-9#1)
also well##10##2##(1990-3#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#2)
also were assessed##2##3##(2008-10#2)
also were compared##3##3##(2008-10#2)(2012-3#1)
also were conducted##2##3##(2008-10#2)
also were consistent with##2##4##(2008-10#2)
also were detected##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
also were evaluated##3##3##(2008-10#3)
also were examined##2##3##(2008-10#1)(2008-12#1)
also were found##5##3##(2008-10#5)
also were observed in##2##4##(1993-11#1)(2008-10#1)
also were observed##5##3##(1993-11#1)(2007-12#1)(2008-10#3)
also were tested##6##3##(2008-10#5)(2011-2#1)
also were used to##2##4##(2008-10#2)
also were##81##2##(1993-11#1)(1993-2#1)(1994-11#2)(1994-9#1)(1995-2#1)(1995-3#1)(1997-5#1)(2007-12#1)(2008-10#65)(2008-12#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#2)(2012-3#1)
also when the##2##3##(1990-9#1)(2008-10#1)
also when##4##2##(1990-9#1)(2008-10#3)
also widely##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
also will be##2##3##(2008-10#1)(2010-3#1)
also will reduce the##2##4##(1994-11#1)(2008-9#1)
also will##13##2##(1994-11#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-3#1)
also with the##7##3##(1990-11#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)
also with##26##2##(1990-11#1)(1990-7#1)(1993-12#1)(1995-1#1)(1995-3#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#3)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
also within##3##2##(2006-6#1)(2008-10#1)(2008-3#1)
also worked##3##2##(2009-6#1)(2010-1#1)(2013-1#1)
also yield##2##2##(2007-11#1)(2008-10#1)
also yielded##4##2##(1992-11#1)(1993-8#1)(2008-10#2)
also yields##2##2##(2008-11#1)(2008-3#1)
also##9008##1##(1990-10#4)(1990-11#33)(1990-12#35)(1990-2#25)(1990-3#13)(1990-4#2)(1990-5#41)(1990-6#9)(1990-7#26)(1990-8#29)(1990-9#10)(1991-1#12)(1991-10#6)(1991-11#15)(1991-12#59)(1991-2#28)(1991-3#25)(1991-4#3)(1991-5#38)(1991-6#27)(1991-7#3)(1991-8#23)(1991-9#29)(1992-1#8)(1992-10#7)(1992-11#23)(1992-12#42)(1992-2#15)(1992-3#50)(1992-4#3)(1992-5#14)(1992-6#35)(1992-7#3)(1992-8#45)(1992-9#42)(1993-1#12)(1993-11#37)(1993-12#48)(1993-2#29)(1993-3#34)(1993-5#5)(1993-6#36)(1993-8#39)(1993-9#18)(1994-1#7)(1994-10#5)(1994-11#45)(1994-12#46)(1994-2#42)(1994-3#45)(1994-5#35)(1994-6#45)(1994-7#4)(1994-8#46)(1994-9#30)(1995-1#12)(1995-11#33)(1995-12#68)(1995-2#67)(1995-3#45)(1995-4#1)(1995-5#46)(1995-6#57)(1995-8#22)(1995-9#10)(1996-1#18)(1996-10#1)(1996-11#7)(1996-12#48)(1996-2#48)(1996-3#22)(1996-4#4)(1996-5#40)(1996-6#10)(1996-7#6)(1996-8#9)(1996-9#10)(1997-1#34)(1997-2#37)(1997-3#58)(1997-4#50)(1997-5#14)(1997-6#29)(1997-7#40)(1997-8#26)(1997-9#3)(2006-10#18)(2006-12#8)(2006-4#2)(2006-5#1)(2006-6#13)(2006-8#1)(2007-1#1)(2007-10#20)(2007-11#131)(2007-12#165)(2007-2#20)(2007-4#3)(2007-5#10)(2007-6#5)(2007-7#35)(2007-8#52)(2007-9#6)(2008-1#101)(2008-10#1591)(2008-11#335)(2008-12#124)(2008-2#267)(2008-3#421)(2008-4#254)(2008-5#256)(2008-6#100)(2008-7#341)(2008-8#254)(2008-9#231)(2009-1#9)(2009-10#56)(2009-11#29)(2009-12#41)(2009-2#16)(2009-3#21)(2009-4#19)(2009-5#50)(2009-6#33)(2009-7#32)(2009-8#67)(2009-9#26)(2010-1#17)(2010-10#27)(2010-11#31)(2010-12#40)(2010-2#16)(2010-3#59)(2010-4#38)(2010-5#40)(2010-6#24)(2010-7#31)(2010-8#65)(2010-9#13)(2011-1#101)(2011-10#5)(2011-2#287)(2011-3#13)(2011-4#1)(2011-7#3)(2012-1#31)(2012-12#86)(2012-2#170)(2012-3#113)(2012-5#1)(2012-6#5)(2012-7#2)(2012-8#2)(2013-1#235)(2013-7#28)(2013-8#94)
alteplase and##2##2##(2007-11#1)(2008-7#1)
alteplase##6##1##(1991-6#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-7#1)
alter a##2##2##(1995-3#1)(2008-9#1)
alter either the##2##3##(1992-3#1)(1993-12#1)
alter either##5##2##(1992-3#2)(1993-12#1)(1993-6#1)(1997-4#1)
alter gene##2##2##(2008-10#1)(2010-5#1)
alter hippocampal##2##2##(1992-11#1)(1993-12#1)
alter immune function##3##3##(2008-10#2)(2008-11#1)
alter its##3##2##(1990-6#1)(1990-7#1)(1995-11#1)
alter management##2##2##(2008-12#1)(2012-12#1)
alter some##2##2##(1991-12#1)(2008-10#1)
alter the activity of##2##4##(1991-9#1)(2012-3#1)
alter the behavior##2##3##(2007-12#1)(2013-1#1)
alter the evolutionary##2##3##(2008-8#1)(2012-3#1)
alter the expression of##5##4##(1992-3#1)(1994-8#1)(2008-5#1)(2009-12#1)(2010-9#1)
alter the expression##6##3##(1992-3#1)(1994-8#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-9#1)
alter the hepatic##2##3##(1991-12#1)(1994-6#1)
alter the intracellular##2##3##(1994-6#1)(2010-4#1)
alter the mechanics of the##2##5##(2010-1#1)(2011-2#1)
alter the natural##3##3##(2008-7#1)(2008-9#1)(2010-12#1)
alter the normal##3##3##(1994-6#1)(2013-1#2)
alter the physiology of##2##4##(2008-11#1)(2011-2#1)
alter the response##2##3##(1992-3#1)(2008-10#1)
alter the##132##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-7#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)
alter this##2##2##(1991-3#1)(2008-8#1)
alter##246##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#5)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#11)(2008-9#6)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#1)
alteration and##2##2##(2008-11#1)(2011-2#1)
alteration in gene##2##3##(2008-11#1)(2008-2#1)
alteration in the##14##3##(1990-12#1)(1990-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-2#1)
alteration in##51##2##(1990-12#2)(1990-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#5)(2008-10#2)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#4)
alteration may##3##2##(1995-9#1)(2007-8#1)(2013-1#1)
alteration of cellular##2##3##(1991-4#1)(2008-11#1)
alteration of consciousness##4##3##(2010-6#1)(2013-8#3)
alteration of host##2##3##(2008-10#1)(2009-8#1)
alteration of its##2##3##(1992-6#1)(1992-9#1)
alteration of the gut commensal##2##5##(2011-2#2)
alteration of the##25##3##(1990-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-6#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#2)(2013-1#1)
alteration of##78##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-12#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-3#1)(2013-1#2)(2013-8#3)
alteration on##2##2##(2008-5#1)(2008-6#1)
alteration that##2##2##(1992-12#1)(1997-8#1)
alteration with##2##2##(2008-10#1)(2013-1#1)
alteration##176##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#4)(2009-10#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#4)
alterations and##14##2##(1992-12#1)(1994-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
alterations are the##2##3##(2009-4#1)(2012-3#1)
alterations are##13##2##(1990-2#1)(1992-8#1)(1993-9#1)(1995-6#1)(1996-5#2)(2008-11#1)(2008-2#1)(2009-4#2)(2011-3#1)(2012-2#1)(2012-3#1)
alterations caused by##2##3##(2008-5#2)
alterations caused##3##2##(2008-5#2)(2008-8#1)
alterations during##2##2##(2010-12#1)(2013-1#1)
alterations found in##5##3##(1991-12#1)(1995-6#1)(2008-1#1)(2008-11#1)(2013-7#1)
alterations found##6##2##(1991-12#1)(1995-6#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
alterations from##2##2##(2008-11#1)(2008-7#1)
alterations has##2##2##(2008-1#1)(2008-12#1)
alterations have been##3##3##(1997-5#1)(2008-7#1)(2013-1#1)
alterations have##5##2##(1997-5#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-1#1)
alterations in culture condition##2##4##(2008-11#2)
alterations in expression of##3##4##(1996-12#1)(1996-5#1)(2013-1#1)
alterations in human cancers##2##4##(2009-5#2)
alterations in human##5##3##(1995-6#1)(2008-10#1)(2008-5#1)(2009-5#2)
alterations in myocardial##2##3##(2010-8#2)
alterations in patients##2##3##(2013-1#1)(2013-8#1)
alterations in peripheral##2##3##(2008-7#1)(2013-1#1)
alterations in specific##2##3##(2009-12#1)(2012-2#1)
alterations in the expression of##4##5##(1992-8#1)(1996-12#1)(2013-8#2)
alterations in the expression##6##4##(1992-8#1)(1996-12#1)(1996-5#1)(2008-3#1)(2013-8#2)
alterations in the##44##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
alterations in their##2##3##(1993-12#1)(2008-8#1)
alterations in##149##2##(1990-2#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-3#4)(1992-8#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#4)(1996-5#3)(1996-6#2)(1996-7#1)(1997-2#3)(1997-7#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#5)
alterations include##2##2##(2007-7#1)(2008-7#1)
alterations induced by##3##3##(1995-2#1)(1996-5#1)(2008-5#1)
alterations induced##4##2##(1995-2#1)(1996-5#1)(2008-5#1)(2013-8#1)
alterations is##3##2##(1996-6#1)(2008-3#1)(2013-1#1)
alterations leading to##2##3##(1995-12#1)(2009-12#1)
alterations may be##2##3##(2008-7#1)(2010-12#1)
alterations may##4##2##(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
alterations observed##3##2##(2008-1#3)
alterations of DNA##2##3##(1995-12#1)(2008-7#1)
alterations of synaptic##2##3##(1994-6#1)(1996-5#1)
alterations of the gonadal steroid##2##5##(2008-11#2)
alterations of the##17##3##(1992-6#1)(1993-3#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#2)(2011-3#1)(2012-1#1)
alterations of these parameters##2##4##(2007-10#1)(2008-7#1)
alterations of these##3##3##(2007-10#1)(2008-7#1)(2012-2#1)
alterations of##60##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-3#1)(1992-5#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-6#2)(1995-12#2)(1996-2#1)(1996-5#1)(1997-6#2)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
alterations on##3##2##(1990-2#1)(1996-2#1)(2007-10#1)
alterations that##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)
alterations to SC##2##3##(2008-5#2)
alterations to the##2##3##(1995-6#1)(2008-5#1)
alterations to##9##2##(1992-3#1)(1995-6#1)(1995-8#1)(2008-5#3)(2008-7#1)(2009-12#1)(2012-3#1)
alterations using##2##2##(1994-6#1)(2009-7#1)
alterations were##9##2##(1990-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
alterations which##5##2##(1996-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-2#1)
alterations##387##1##(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#2)(1992-8#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-12#5)(1996-2#2)(1996-5#7)(1996-6#4)(1996-7#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-12#2)(2007-7#4)(2008-1#10)(2008-10#24)(2008-11#12)(2008-12#9)(2008-2#7)(2008-3#7)(2008-4#5)(2008-5#20)(2008-6#6)(2008-7#25)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#4)(2013-1#12)(2013-7#4)(2013-8#13)
alterations?##2##1##(1994-8#2)
altered DNA##2##2##(1991-9#1)(2008-11#1)
altered after##5##2##(1993-6#1)(1996-12#1)(1996-5#1)(2009-11#1)(2012-12#1)
altered and can##2##3##(2007-11#1)(2008-8#1)
altered and##5##2##(1994-9#1)(1995-2#1)(2007-11#1)(2008-8#1)(2013-8#1)
altered at##3##2##(1995-3#1)(2008-10#1)(2008-8#1)
altered barrier##2##2##(2008-7#1)(2012-1#1)
altered behavioral##3##2##(2008-8#1)(2009-6#1)(2013-8#1)
altered body composition##2##3##(1996-11#1)(1997-8#1)
altered bone##2##2##(2010-10#1)(2013-1#1)
altered by a##3##3##(2008-6#1)(2008-8#1)(2009-9#1)
altered by site-directed mutagenesis to##2##5##(1992-1#1)(1993-11#1)
altered by site-directed mutagenesis##4##4##(1991-2#1)(1992-1#2)(1993-11#1)
altered by the##9##3##(1990-2#1)(1992-5#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
altered by##55##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#2)(1991-4#2)(1992-1#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-5#1)(1996-12#2)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-4#1)(2011-2#3)(2012-2#1)
altered cell line##2##3##(2008-11#2)
altered cell##4##2##(2008-11#3)(2009-9#1)
altered during##3##2##(1995-11#1)(2008-3#1)(2013-1#1)
altered energy##2##2##(2008-2#1)(2008-4#1)
altered expression levels##3##3##(2008-7#2)(2008-9#1)
altered expression of##5##3##(1993-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
altered expression##9##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
altered formation of##2##3##(2008-10#1)(2008-7#1)
altered fractionation##2##2##(1992-10#2)
altered from##2##2##(1991-9#1)(1993-3#1)
altered genes##2##2##(2008-10#1)(2008-8#1)
altered in a##3##3##(1996-12#1)(2008-11#1)(2012-2#1)
altered in either##2##3##(1996-12#1)(2008-10#1)
altered in expression##2##3##(1990-2#1)(2008-8#1)
altered in the##7##3##(1991-9#1)(1995-6#1)(1997-2#1)(2008-12#1)(2008-8#1)(2009-6#1)(2012-2#1)
altered in##38##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#3)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
altered interaction##2##2##(1997-7#1)(2010-10#1)
altered intracellular##2##2##(1990-8#1)(2008-7#1)
altered levels of##3##3##(1993-3#1)(1997-3#1)(2012-2#1)
altered mRNA##2##2##(1995-2#1)(2011-2#1)
altered mental status##2##3##(2012-12#1)(2013-1#1)
altered metabolism##2##2##(1992-9#1)(2009-8#1)
altered pain##2##2##(2008-5#1)(2011-2#1)
altered patterns of##2##3##(1995-2#1)(2008-10#1)
altered phenotype##2##2##(2008-10#1)(2008-11#1)
altered phenotypes##2##2##(2008-10#1)(2012-2#1)
altered processing of APP##2##4##(1992-6#2)
altered properties##2##2##(1993-8#1)(1995-2#1)
altered protein##3##2##(1991-10#1)(2009-5#1)(2010-12#1)
altered proteins##2##2##(1991-2#1)(2010-12#1)
altered regulation of##2##3##(2008-8#1)(2009-12#1)
altered secondary structure##2##3##(1990-12#1)(1992-6#1)
altered secretion##2##2##(1994-8#1)(2008-4#1)
altered sensitivity##2##2##(2008-10#1)(2008-7#1)
altered sensorium##4##2##(2008-1#1)(2009-11#3)
altered significantly##3##2##(1997-2#1)(2008-11#1)(2008-3#1)
altered target##2##2##(2008-4#1)(2008-5#1)
altered the expression of##3##4##(2008-10#1)(2008-11#2)
altered the pattern of protein##2##5##(1993-9#1)(1995-6#1)
altered the pattern of##3##4##(1993-9#1)(1995-12#1)(1995-6#1)
altered the##26##2##(1991-2#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-9#1)(2010-3#1)(2012-1#1)
altered to##2##2##(2008-10#2)
altered upon##2##2##(2008-1#1)(2012-3#1)
altered when##2##2##(1994-8#1)(2008-10#1)
altered with##2##2##(1993-1#1)(2013-8#1)
altered##430##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-9#5)(1992-1#5)(1992-10#4)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#9)(1995-3#4)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-5#4)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-6#2)(1997-7#4)(1997-8#2)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#1)(2008-1#7)(2008-10#43)(2008-11#22)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#11)(2009-1#5)(2009-10#1)(2009-11#5)(2009-12#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#7)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#12)(2012-1#5)(2012-12#5)(2012-2#10)(2012-3#3)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#8)
altering the##43##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-5#2)(1996-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
altering##69##1##(1990-12#2)(1990-5#1)(1991-1#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
alternant PAHs studied##2##3##(2008-10#2)
alternant PAHs##5##2##(2008-10#5)
alternant and##2##2##(2008-10#2)
alternant##11##1##(2008-10#11)
alternaria##3##1##(2008-10#3)
alternata and##2##2##(2008-10#2)
alternata apple pathotype##3##3##(2008-10#3)
alternata in##3##2##(2008-10#3)
alternata pathotypes##2##2##(2008-10#2)
alternata##52##1##(2008-10#52)
alternate 5'##2##2##(1993-12#2)
alternate approach##2##2##(1994-3#1)(2008-3#1)
alternate day##2##2##(2007-7#2)
alternate frames##2##2##(2008-3#2)
alternate methods##2##2##(1990-11#1)(2008-4#1)
alternate pathway##2##2##(2009-2#1)(2013-7#1)
alternate protocol describes the##2##4##(2008-4#2)
alternate protocol describes##6##3##(2008-4#6)
alternate protocol details##3##3##(2008-2#1)(2008-4#2)
alternate protocol is##3##3##(2008-4#3)
alternate protocol##19##2##(2008-1#1)(2008-2#3)(2008-4#14)(2008-9#1)
alternate protocol)##2##2##(2008-2#2)
alternate protocols describe##2##3##(2008-4#1)(2008-9#1)
alternate protocols##14##2##(2008-2#2)(2008-4#9)(2008-9#3)
alternate site##2##2##(1994-3#1)(2011-2#1)
alternate splicing of##2##3##(1990-7#1)(1994-11#1)
alternate splicing##4##2##(1990-7#2)(1994-11#1)(1994-2#1)
alternate##110##1##(1990-11#1)(1990-5#1)(1990-7#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#4)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#26)(2008-8#1)(2008-9#5)(2009-2#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)
alternated between##2##2##(2008-11#1)(2008-3#1)
alternated dual task##3##3##(2012-2#3)
alternated with segments of the##2##5##(2008-10#2)
alternated with##5##2##(2008-10#3)(2009-8#1)(2012-3#1)
alternated##12##1##(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)(2012-2#3)(2012-3#1)
alternately spliced##2##2##(1994-12#2)
alternately with##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
alternately##10##1##(1994-12#2)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#2)
alternating current##4##2##(2006-12#1)(2008-10#3)
alternating d(TA)n sequence##3##3##(1997-3#3)
alternating high and low temperatures##2##5##(2008-10#2)
alternating hydrophobic##2##2##(1990-2#1)(1994-5#1)
alternating layers of##4##3##(2008-10#3)(2008-2#1)
alternating least squares##3##3##(2007-12#1)(2008-10#2)
alternating magnetic fields##2##3##(2008-3#1)(2012-2#1)
alternating magnetic##3##2##(2008-3#1)(2012-2#2)
alternating rows of##2##3##(2008-10#2)
alternating trilinear decomposition##3##3##(2008-10#3)
alternating##62##1##(1990-2#1)(1991-5#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-3#3)(1997-7#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#9)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#2)(2012-3#1)
alternation and##3##2##(1991-2#1)(1993-5#1)(1994-8#1)
alternation in##3##2##(1994-8#2)(2007-11#1)
alternation task and##2##3##(1991-2#1)(2012-2#1)
alternation task##3##2##(1991-2#1)(2008-8#1)(2012-2#1)
alternation##16##1##(1990-7#1)(1991-2#3)(1993-5#1)(1994-8#6)(2007-11#2)(2007-12#1)(2008-8#1)(2012-2#1)
alternations of##4##2##(2008-10#1)(2011-2#1)(2011-3#2)
alternations##7##1##(1996-6#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#2)
alternative RNA processing##2##3##(1992-6#2)
alternative RNA splicing##2##3##(1990-12#1)(1992-6#1)
alternative RNA##4##2##(1990-12#1)(1992-6#3)
alternative and##13##2##(1990-6#1)(1995-2#1)(2008-10#4)(2008-6#2)(2008-8#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-8#1)
alternative approach for##2##3##(2008-11#1)(2008-9#1)
alternative approach is##2##3##(2011-2#1)(2012-2#1)
alternative approach to##7##3##(1994-1#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
alternative approach##22##2##(1990-12#1)(1994-1#1)(1995-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
alternative approaches for##2##3##(1997-1#1)(2010-3#1)
alternative approaches to##3##3##(1994-2#2)(2010-11#1)
alternative approaches##7##2##(1994-2#2)(1997-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-3#1)
alternative assays##2##2##(2008-5#1)(2012-2#1)
alternative calibration##3##2##(2008-10#2)(2008-2#1)
alternative configurations and##2##3##(1991-1#2)
alternative conservative##2##2##(1991-3#1)(2010-5#1)
alternative control measures##2##3##(2008-10#2)
alternative control##4##2##(2008-10#3)(2008-11#1)
alternative derivation for##2##3##(2008-2#1)(2008-3#1)
alternative derivation##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
alternative designs##2##2##(2008-2#1)(2009-12#1)
alternative devices##2##2##(2008-12#2)
alternative drug##4##2##(1997-2#1)(2010-6#1)(2012-12#1)(2013-1#1)
alternative energy##2##2##(2011-2#1)(2012-12#1)
alternative experimental##2##2##(2008-5#1)(2008-9#1)
alternative explanation##5##2##(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)
alternative explanations##2##2##(2008-9#1)(2010-6#1)
alternative fixation##2##2##(2008-11#1)(2009-8#1)
alternative food##8##2##(2008-8#8)
alternative for a##3##3##(1991-1#1)(2008-10#1)(2009-5#1)
alternative for the##16##3##(1991-12#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
alternative for treatment of##2##4##(2008-8#1)(2010-8#1)
alternative for treatment##3##3##(1991-2#1)(2008-8#1)(2010-8#1)
alternative for##49##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
alternative forms of##4##3##(1992-3#1)(1997-5#1)(2007-4#1)(2008-10#1)
alternative fumigants through drip irrigation systems##2##6##(2008-10#2)
alternative fumigants##4##2##(2008-10#4)
alternative health care##4##3##(1997-6#1)(2008-12#1)(2008-7#2)
alternative health##6##2##(1996-12#1)(1997-6#1)(2008-12#1)(2008-7#2)(2008-8#1)
alternative hypotheses##3##2##(1995-2#1)(2008-8#2)
alternative hypothesis##3##2##(1992-6#1)(2008-11#1)(2008-8#1)
alternative in order to##2##4##(1992-6#1)(2010-4#1)
alternative in the treatment of##2##5##(2008-7#1)(2011-2#1)
alternative in the##4##3##(1995-11#1)(2008-7#1)(2011-2#2)
alternative in##15##2##(1992-4#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-2#1)
alternative is to##2##3##(1991-1#1)(2008-10#1)
alternative is##6##2##(1991-1#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)
alternative magnetic field is##2##4##(2008-8#2)
alternative mechanism##3##2##(1990-8#1)(2008-7#1)(2009-5#1)
alternative mechanisms##4##2##(1993-11#1)(2008-12#1)(2008-6#1)(2008-9#1)
alternative media##2##2##(2008-12#1)(2008-6#1)
alternative medicine##22##2##(1994-9#1)(1997-5#2)(1997-6#7)(2008-1#1)(2008-10#8)(2009-5#1)(2009-6#2)
alternative method for the determination of##2##6##(2008-10#2)
alternative method for the##3##4##(2008-10#3)
alternative method for##7##3##(2007-11#1)(2008-10#4)(2008-3#2)
alternative method in##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
alternative method of##8##3##(2007-11#1)(2007-5#1)(2008-10#3)(2008-4#1)(2010-12#1)(2012-2#1)
alternative method that##3##3##(2007-11#1)(2008-2#1)(2008-6#1)
alternative method to##7##3##(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)
alternative method##33##2##(1994-9#1)(1997-4#1)(2007-11#3)(2007-5#1)(2008-10#13)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
alternative methods are##2##3##(1990-9#1)(1997-6#1)
alternative methods for##5##3##(1992-12#1)(1994-2#1)(2008-1#1)(2008-4#1)(2010-3#1)
alternative methods that##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
alternative methods##20##2##(1990-9#1)(1992-12#3)(1993-3#1)(1994-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2010-3#1)(2010-5#1)
alternative model##7##2##(1993-12#2)(1997-4#1)(1997-7#1)(2008-6#1)(2008-7#2)
alternative models##7##2##(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)
alternative or supplement to##2##4##(1996-3#1)(2008-10#1)
alternative or##5##2##(1996-3#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)
alternative outcomes##4##2##(2008-8#3)(2012-3#1)
alternative oxidase##4##2##(1991-5#1)(2008-9#2)(2009-8#1)
alternative pathway of##2##3##(2009-6#1)(2009-8#1)
alternative pathway##9##2##(1994-11#4)(1994-8#1)(1995-2#1)(2008-9#1)(2009-6#1)(2009-8#1)
alternative pathways##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
alternative payment##2##2##(1993-1#1)(1993-12#1)
alternative phenotypes##3##2##(2008-8#2)(2010-1#1)
alternative policy##2##2##(2008-7#1)(2012-12#1)
alternative procedure for##5##3##(2008-10#2)(2008-11#1)(2011-2#2)
alternative procedure is##2##3##(2008-2#1)(2008-3#1)
alternative procedure was##2##3##(2008-10#2)
alternative procedure##14##2##(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#2)(2012-12#1)
alternative procedures are##2##3##(2008-4#1)(2008-9#1)
alternative procedures for##2##3##(1994-2#1)(2012-2#1)
alternative procedures##5##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
alternative public policies##2##3##(2013-1#2)
alternative reproductive##2##2##(2010-8#2)
alternative route##2##2##(1992-12#1)(1997-1#1)
alternative routes##3##2##(1992-12#1)(1995-5#1)(2008-10#1)
alternative sample introduction##2##3##(2008-10#2)
alternative sample##4##2##(1992-6#1)(2007-12#1)(2008-10#2)
alternative site##2##2##(1992-2#1)(2011-2#1)
alternative source##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
alternative splicing and##2##3##(1993-2#1)(2008-11#1)
alternative splicing events##2##3##(1993-8#1)(2008-4#1)
alternative splicing of a##3##4##(1993-11#1)(1994-6#1)(1994-9#1)
alternative splicing of the gene##2##5##(1993-8#1)(2008-7#1)
alternative splicing of##8##3##(1990-12#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-9#1)(2008-7#1)
alternative splicing##31##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-10#1)(2010-12#2)
alternative stable equilibria##2##3##(2008-8#2)
alternative strategies for##3##3##(1992-2#1)(2007-11#1)(2008-11#1)
alternative strategies##5##2##(1992-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-3#1)
alternative strategy for##2##3##(2008-10#1)(2008-9#1)
alternative strategy##8##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)
alternative structures##2##2##(1991-1#1)(1997-3#1)
alternative surgical technique for##2##4##(2008-7#1)(2008-9#1)
alternative surgical##5##2##(2007-8#1)(2008-7#3)(2008-9#1)
alternative system for##2##3##(2008-10#1)(2010-7#1)
alternative system##5##2##(2008-10#1)(2008-2#1)(2010-7#1)(2010-8#1)(2013-1#1)
alternative technique for##5##3##(2007-8#1)(2008-10#2)(2011-1#1)(2013-8#1)
alternative technique##13##2##(1991-12#1)(2007-8#2)(2008-10#7)(2008-3#1)(2011-1#1)(2013-8#1)
alternative techniques##4##2##(1991-11#1)(1997-7#1)(2009-3#1)(2013-7#1)
alternative test##2##2##(2008-5#1)(2012-3#1)
alternative tests##2##2##(1994-2#1)(2008-10#1)
alternative that##2##2##(2008-6#1)(2008-9#1)
alternative therapeutic approach##3##3##(2008-1#1)(2008-5#1)(2013-7#1)
alternative therapeutic##4##2##(2007-7#1)(2008-1#1)(2008-5#1)(2013-7#1)
alternative therapies##7##2##(1996-1#1)(1997-5#1)(1997-6#3)(2008-6#1)(2010-8#1)
alternative therapy for##2##3##(2012-12#1)(2013-1#1)
alternative therapy##5##2##(1997-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
alternative to a##2##3##(2008-10#1)(2008-2#1)
alternative to an##4##3##(1996-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
alternative to both##2##3##(1991-5#1)(1994-2#1)
alternative to conventional##14##3##(1990-5#1)(1996-9#1)(2006-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-2#1)(2009-4#1)(2012-2#2)(2013-1#1)(2013-7#1)
alternative to existing##3##3##(2008-10#3)
alternative to femoral##2##3##(2007-7#1)(2011-2#1)
alternative to in vivo testing##2##5##(2008-5#2)
alternative to interventional##2##3##(2008-4#1)(2013-1#1)
alternative to open##2##3##(1997-8#1)(2008-10#1)
alternative to other##4##3##(1990-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
alternative to pulpotomy##2##3##(2011-2#2)
alternative to standard##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
alternative to surgery for##2##4##(1994-9#1)(2008-11#1)
alternative to surgery##4##3##(1991-8#1)(1994-9#1)(2008-10#1)(2008-11#1)
alternative to surgical##3##3##(1996-6#1)(1997-8#1)(2009-4#1)
alternative to the classical##2##4##(2008-10#1)(2008-11#1)
alternative to the conventional##2##4##(2008-10#1)(2009-2#1)
alternative to the more commonly used##2##6##(1997-4#1)(2008-1#1)
alternative to the surgical treatment##2##5##(2008-10#1)(2008-7#1)
alternative to the use of##3##5##(2007-12#1)(2008-10#1)(2012-2#1)
alternative to the##42##3##(1990-2#1)(1990-8#2)(1992-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1997-4#1)(2007-12#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
alternative to time-consuming##2##3##(2007-12#1)(2008-10#1)
alternative to traditional##11##3##(1990-5#1)(1992-1#1)(1992-5#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
alternative to##216##2##(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-5#4)(1993-1#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#5)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-1#4)(2008-10#49)(2008-11#5)(2008-12#3)(2008-2#14)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#7)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#5)(2013-7#1)
alternative treatment for##2##3##(1997-6#1)(2010-11#1)
alternative treatment##8##2##(1997-6#1)(2007-10#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-11#1)(2011-2#1)
alternative treatments##4##2##(1993-2#1)(1996-6#1)(2008-11#1)(2008-8#1)
alternative way to##2##3##(2008-12#1)(2008-6#1)
alternative way##3##2##(2008-11#1)(2008-12#1)(2008-6#1)
alternative ways of##3##3##(2010-11#2)(2011-2#1)
alternative ways to##4##3##(1994-2#1)(2008-4#1)(2010-11#1)(2011-1#1)
alternative ways##7##2##(1994-2#1)(2008-4#1)(2010-11#3)(2011-1#1)(2011-2#1)
alternative when##2##2##(2008-10#1)(2009-7#1)
alternative with##2##2##(2008-10#1)(2011-2#1)
alternative##973##1##(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#5)(1990-9#3)(1991-1#6)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#4)(1991-8#1)(1992-1#3)(1992-12#11)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#9)(1992-9#2)(1993-1#4)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#6)(1993-5#2)(1993-6#5)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#7)(1994-12#7)(1994-2#8)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#10)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#10)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#7)(1997-4#6)(1997-5#4)(1997-6#15)(1997-7#6)(1997-8#7)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#9)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#8)(2008-1#8)(2008-10#176)(2008-11#28)(2008-12#15)(2008-2#24)(2008-3#28)(2008-4#26)(2008-5#23)(2008-6#20)(2008-7#36)(2008-8#40)(2008-9#37)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#7)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#1)(2010-11#9)(2010-12#7)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#6)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#5)(2011-2#32)(2012-1#1)(2012-12#13)(2012-2#24)(2012-3#14)(2012-8#1)(2013-1#31)(2013-7#5)(2013-8#6)
alternative&quot##2##1##(1994-1#1)(2008-7#1)
alternative?##2##1##(2010-9#1)(2011-2#1)
alternatively by##4##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
alternatively spliced exons##3##3##(2008-7#2)(2008-8#1)
alternatively spliced transcripts##2##3##(1991-9#1)(1994-11#1)
alternatively spliced##19##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)
alternatively used##2##2##(2008-10#2)
alternatively##50##1##(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-4#1)(1997-7#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)
alternatives and##4##2##(1992-3#1)(1994-12#1)(2008-11#1)(2012-1#1)
alternatives are##3##2##(1991-1#1)(1993-3#1)(2008-10#1)
alternatives currently##2##2##(2008-10#2)
alternatives for##10##2##(1992-3#1)(1994-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2011-2#2)
alternatives in the##2##3##(1993-6#1)(2013-1#1)
alternatives in##4##2##(1992-1#1)(1993-6#1)(1996-1#1)(2013-1#1)
alternatives such as##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
alternatives that##4##2##(1992-1#1)(1997-7#1)(2008-11#1)(2010-7#1)
alternatives to antibodies##2##3##(2009-5#1)(2010-7#1)
alternatives to hospitalization##2##3##(1992-1#1)(1995-1#1)
alternatives to methyl bromide will##2##5##(2008-10#2)
alternatives to methyl bromide##4##4##(2008-10#4)
alternatives to the use of##2##5##(1996-12#1)(1997-1#1)
alternatives to the##4##3##(1991-1#1)(1996-12#1)(1997-1#1)(2012-3#1)
alternatives to##45##2##(1991-1#2)(1991-2#1)(1992-1#1)(1993-1#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#2)(2007-11#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
alternatives were##3##2##(1996-1#1)(2009-9#1)(2011-2#1)
alternatives with##2##2##(1992-3#1)(1993-11#1)
alternatives##115##1##(1990-11#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#3)(1992-3#4)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-3#2)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#3)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
alternatives]##2##1##(1997-4#1)(1997-6#1)
alters a conserved##2##3##(1995-6#1)(2008-8#1)
alters a##3##2##(1995-6#1)(2008-8#1)(2010-12#1)
alters expression##2##2##(1993-6#1)(2008-7#1)
alters memory##2##2##(1993-12#1)(2009-8#1)
alters the interaction##2##3##(2011-2#2)
alters the##28##2##(1991-12#2)(1991-9#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#2)
alters##64##1##(1990-7#1)(1991-10#1)(1991-12#2)(1991-9#2)(1992-2#1)(1992-3#2)(1993-12#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
although I##2##2##(1992-3#1)(1994-2#1)
although a decrease##2##3##(2008-10#1)(2008-11#1)
although a few##2##3##(2008-10#1)(2011-2#1)
although a large number of##2##5##(1994-2#1)(2008-1#1)
although a low level of##2##5##(2008-10#1)(2011-10#1)
although a significant reduction in##2##5##(2012-2#2)
although a significant##3##3##(2012-12#1)(2012-2#2)
although a##41##2##(1990-7#1)(1991-1#1)(1991-10#1)(1993-12#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
although about##2##2##(1990-11#1)(1991-8#1)
although additional##2##2##(1996-12#1)(2008-10#1)
although all##3##2##(1993-2#1)(2008-10#1)(2008-4#1)
although almost##2##2##(1995-11#1)(1997-8#1)
although an##4##2##(1991-7#1)(1996-7#1)(2008-3#1)(2008-5#1)
although apoptosis##2##2##(2008-11#1)(2012-12#1)
although at a slightly##2##4##(2008-10#1)(2008-2#1)
although at a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
although at lower levels##2##4##(1990-12#1)(2012-2#1)
although at lower##3##3##(1990-12#1)(2008-6#1)(2012-2#1)
although at##8##2##(1990-12#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-2#1)
although both##6##2##(1991-4#1)(1995-2#1)(1995-5#1)(2008-3#1)(2008-6#1)(2008-7#1)
although cell##2##2##(2008-11#1)(2012-5#1)
although certain##2##2##(1992-3#1)(1996-6#1)
although clinical##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
although consistent##2##2##(2008-10#1)(2008-5#1)
although data##2##2##(2008-10#1)(2009-6#1)
although differences##2##2##(1997-4#1)(2012-3#1)
although different##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
although disease##2##2##(2008-10#2)
although efficiency##2##2##(2008-10#1)(2008-11#1)
although further##5##2##(2007-12#1)(2008-11#2)(2008-5#1)(2009-6#1)
although he##5##2##(1991-7#1)(1993-3#1)(2006-10#1)(2007-2#1)(2008-7#1)
although high##4##2##(1995-6#1)(2008-10#3)
although in all##2##3##(1996-7#1)(2008-10#1)
although in the##6##3##(1992-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-1#1)
although in##21##2##(1990-3#1)(1992-11#1)(1992-6#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
although indicative of##2##3##(2007-6#1)(2010-8#1)
although individual##2##2##(2008-10#1)(2012-12#1)
although it can be##2##4##(1992-8#1)(2011-1#1)
although it can##3##3##(1992-8#1)(2007-12#1)(2011-1#1)
although it does##2##3##(1995-6#1)(2008-7#1)
although it has been shown to be##2##7##(2007-10#1)(2007-2#1)
although it has been##3##4##(2007-10#1)(2007-2#1)(2008-9#1)
although it has##4##3##(2007-10#1)(2007-2#1)(2008-5#1)(2008-9#1)
although it is not##2##4##(1997-3#1)(2007-7#1)
although it is##12##3##(1990-12#1)(1994-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-6#1)(2012-2#1)
although it may also##2##4##(2008-9#1)(2013-8#1)
although it may##4##3##(1997-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
although it was##8##3##(1994-6#1)(2007-8#1)(2008-10#4)(2010-4#1)(2011-2#1)
although it##46##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1994-6#2)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
although its##12##2##(1990-5#1)(1992-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
although largely##2##2##(1991-8#1)(1996-2#1)
although less##4##2##(1990-12#1)(2006-6#1)(2007-12#1)(2012-2#1)
although limited##4##2##(1991-4#1)(2008-2#1)(2008-7#2)
although long-term##2##2##(1992-1#1)(2009-2#1)
although many##8##2##(1990-9#1)(1994-6#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-1#1)
although maybe##2##2##(2008-11#1)(2012-3#1)
although mild##2##2##(1993-12#1)(1994-12#1)
although more##5##2##(1990-5#1)(1993-12#1)(2007-7#1)(2008-11#1)(2010-5#1)
although most##5##2##(1992-8#1)(1995-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
although multiple##2##2##(2008-10#1)(2010-8#1)
although neither##2##2##(2008-5#1)(2011-2#1)
although no##5##2##(1990-5#1)(2008-10#2)(2008-11#1)(2008-7#1)
although none of##2##3##(1997-8#1)(2011-2#1)
although none##3##2##(1997-8#1)(2011-2#1)(2012-3#1)
although not always##2##3##(1997-7#1)(2006-5#1)
although not significantly##2##3##(1993-9#1)(2011-2#1)
although not statistically significant##2##4##(1995-5#1)(2007-8#1)
although not##18##2##(1990-7#1)(1990-8#1)(1991-4#1)(1993-9#2)(1995-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)
although numerous##2##2##(2007-12#1)(2011-2#1)
although one##4##2##(1991-12#1)(2008-11#1)(2008-5#2)
although only##4##2##(1995-1#1)(2008-5#1)(2008-9#1)(2012-3#1)
although other bacteria##2##3##(2008-5#2)
although other##16##2##(1993-6#1)(1995-9#1)(1997-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#1)
although patients##3##2##(1991-11#1)(2010-12#1)(2013-1#1)
although previous studies##2##3##(1995-8#1)(1996-5#1)
although rare##5##2##(1991-2#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-7#1)
although reduced##2##2##(1992-3#1)(2007-6#1)
although reduction of##2##3##(1995-3#1)(2008-10#1)
although reduction##3##2##(1995-3#1)(2008-10#2)
although significant##4##2##(1990-3#1)(1996-1#1)(2008-10#1)(2008-7#1)
although smaller##2##2##(1991-6#1)(2008-5#1)
although some berries##2##3##(2008-10#2)
although some of these##2##4##(1997-6#1)(2007-12#1)
although some of##4##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)
although some##24##2##(1992-11#1)(1992-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
although still##3##2##(1994-6#1)(2012-2#1)(2013-7#1)
although strain##2##2##(1996-12#1)(2008-10#1)
although such##3##2##(2008-3#1)(2008-9#1)(2009-6#1)
although that##3##2##(1997-6#1)(2011-2#1)(2012-1#1)
although the difference##2##3##(2008-1#1)(2008-10#1)
although the effect##3##3##(1993-6#1)(2007-12#1)(2009-12#1)
although the effects##2##3##(2008-3#1)(2010-2#1)
although the extent of##3##4##(1992-3#1)(1994-3#1)(2008-7#1)
although the incidence of##2##4##(1992-3#1)(2013-1#1)
although the inhibitory##2##3##(1995-6#1)(1996-5#1)
although the latter is##2##4##(1990-11#1)(2008-10#1)
although the latter##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
although the level of expression##2##5##(1996-12#1)(2012-2#1)
although the level of##3##4##(1996-12#1)(2008-10#1)(2012-2#1)
although the level was##2##4##(1992-9#1)(2008-11#1)
although the level##5##3##(1992-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
although the levels##3##3##(1995-6#1)(1997-6#1)(2008-10#1)
although the magnitude of the##3##5##(1990-12#1)(2008-8#1)(2008-9#1)
although the majority of##2##4##(2008-10#1)(2008-5#1)
although the majority##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
although the mechanisms##3##3##(1990-8#1)(2008-4#1)(2012-1#1)
although the molecular weight of##2##5##(1991-12#1)(2008-7#1)
although the molecular##3##3##(1991-12#1)(2008-7#2)
although the patients##3##3##(1996-5#1)(2008-10#1)(2009-10#1)
although the peak##3##3##(1996-2#1)(2008-3#1)(2010-3#1)
although the possibility that##2##4##(2008-10#1)(2008-5#1)
although the possibility##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
although the predominant##2##3##(2008-3#1)(2011-1#1)
although the presence of##2##4##(1991-2#1)(1991-8#1)
although the prevalence of##2##4##(2008-10#1)(2009-5#1)
although the results##2##3##(2008-10#1)(2012-2#1)
although the risk##2##3##(1995-6#1)(2013-1#1)
although the specific##2##3##(2010-3#1)(2013-1#1)
although the total##4##3##(1997-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
although the two##3##3##(1993-12#1)(1995-6#1)(2011-1#1)
although the##210##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#3)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#5)(2009-10#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#2)
although their##9##2##(1990-6#1)(1990-8#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
although there are a number of##2##6##(2006-10#1)(2007-8#1)
although there are##11##3##(1996-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)(2013-1#1)
although there is evidence that##2##5##(1996-5#1)(2010-1#1)
although there is evidence##3##4##(1996-5#1)(2010-1#1)(2012-3#1)
although there is no##2##4##(1990-6#1)(1994-5#1)
although there is some evidence##2##5##(2007-2#1)(2008-3#1)
although there is some##4##4##(2007-2#1)(2008-11#1)(2008-3#1)(2008-9#1)
although there is##11##3##(1990-6#1)(1994-5#1)(1996-5#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)
although there was a##5##4##(1994-8#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-1#1)
although there was no##2##4##(1995-11#1)(2011-1#1)
although there was some evidence##2##5##(1994-3#1)(2010-8#1)
although there was some##3##4##(1994-3#1)(1995-12#1)(2010-8#1)
although there was##12##3##(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)
although there were no##2##4##(2007-12#1)(2011-2#1)
although there were##7##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
although there##44##2##(1990-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
although these were##2##3##(1995-1#1)(2010-3#1)
although these##11##2##(1995-1#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2010-3#1)(2012-2#2)
although they are not##2##4##(1996-7#1)(2011-2#1)
although they are##9##3##(1994-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(2008-9#1)(2010-4#1)(2011-2#2)(2013-8#1)
although they can be##2##4##(2008-10#1)(2008-2#1)
although they did##2##3##(1993-3#1)(2008-7#1)
although they have been##2##4##(2010-12#1)(2013-7#1)
although they may##2##3##(1995-5#1)(2008-4#1)
although they were##3##3##(1996-5#1)(2007-7#1)(2013-1#1)
although they##26##2##(1993-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
although this did not##2##4##(2008-6#1)(2012-2#1)
although this effect was not##2##5##(2009-2#1)(2010-10#1)
although this effect##5##3##(1992-11#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-10#1)
although this has##2##3##(2006-5#1)(2013-8#1)
although this is##2##3##(1996-12#1)(2013-1#1)
although this last##2##3##(2008-10#2)
although this was not##2##4##(1990-6#1)(2008-11#1)
although this was##4##3##(1990-6#1)(2006-12#1)(2008-11#1)(2013-1#1)
although this##26##2##(1990-6#1)(1992-10#1)(1992-11#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
although trends were##2##3##(2008-10#2)
although two##2##2##(2008-10#2)
although use of##2##3##(1994-9#1)(2008-12#1)
although we##5##2##(2008-10#3)(2008-8#1)(2009-9#1)
although with variable##2##3##(1995-3#1)(2011-2#1)
although with##8##2##(1991-12#1)(1995-3#1)(1995-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)
although##976##1##(1990-11#5)(1990-12#9)(1990-3#4)(1990-5#7)(1990-6#5)(1990-7#3)(1990-8#7)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#10)(1991-2#6)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#8)(1993-8#1)(1993-9#3)(1994-12#4)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#6)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#6)(1995-12#5)(1995-2#8)(1995-3#8)(1995-5#7)(1995-6#8)(1995-8#3)(1995-9#2)(1996-1#4)(1996-12#12)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#9)(1996-6#3)(1996-7#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#12)(1997-4#6)(1997-5#3)(1997-6#7)(1997-7#4)(1997-8#3)(1997-9#1)(2006-10#9)(2006-12#2)(2006-5#2)(2006-6#1)(2007-10#6)(2007-11#5)(2007-12#18)(2007-2#5)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#9)(2008-1#12)(2008-10#132)(2008-11#44)(2008-12#8)(2008-2#17)(2008-3#30)(2008-4#22)(2008-5#41)(2008-6#14)(2008-7#34)(2008-8#22)(2008-9#28)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#4)(2009-6#6)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#5)(2010-2#1)(2010-3#8)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#11)(2011-1#10)(2011-10#1)(2011-2#37)(2012-1#6)(2012-12#14)(2012-2#19)(2012-3#13)(2012-5#1)(2013-1#26)(2013-7#6)(2013-8#10)
altitude above the sea surface##2##5##(2008-3#2)
altitude in the##2##3##(2008-8#1)(2013-7#1)
altitude in##4##2##(2008-8#1)(2009-5#1)(2012-2#1)(2013-7#1)
altitude of##5##2##(2007-11#1)(2008-3#4)
altitude range of##4##3##(2008-3#4)
altitude range resolutions##2##3##(2008-2#2)
altitude range##10##2##(2008-2#4)(2008-3#6)
altitude resolution of##2##3##(2008-3#2)
altitude resolution##3##2##(2008-2#1)(2008-3#2)
altitude##70##1##(1990-8#1)(1992-2#7)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#8)(2008-3#31)(2008-5#1)(2008-8#5)(2009-5#4)(2012-2#5)(2012-6#2)(2013-1#1)(2013-7#2)
altitudes above##2##2##(2008-3#1)(2008-8#1)
altitudes of the##2##3##(2008-3#1)(2008-5#1)
altitudes of##5##2##(2008-2#1)(2008-3#3)(2008-5#1)
altitudes##28##1##(1990-8#1)(1991-5#1)(2008-2#8)(2008-3#12)(2008-5#1)(2008-8#2)(2009-5#1)(2013-7#2)
altitudinal gradient##3##2##(2008-8#2)(2012-6#1)
altitudinal##8##1##(2008-8#4)(2012-6#3)(2013-7#1)
altogether in##2##2##(2008-10#2)
altogether the##2##2##(2008-7#1)(2010-2#1)
altogether##19##1##(1990-2#1)(1990-8#1)(1992-4#1)(1994-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#2)
altruism in##2##2##(2008-8#1)(2012-3#1)
altruism##24##1##(1992-3#1)(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-8#10)(2008-9#4)(2010-4#2)(2012-3#2)
altruistic behavior##2##2##(2008-12#1)(2013-1#1)
altruistic##11##1##(1992-3#1)(1993-5#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
altruists##2##1##(2008-8#1)(2012-3#1)
alum crystals##2##2##(2008-3#2)
alum##4##1##(1991-8#1)(2008-3#2)(2011-2#1)
alumina microcolumns##2##2##(2008-10#2)
alumina paper##6##2##(2008-10#6)
alumina##32##1##(1990-2#1)(1992-2#1)(2007-11#2)(2008-10#23)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)
aluminate##6##1##(2008-10#6)
aluminium alloys##4##2##(2008-10#4)
aluminium and manganese##5##3##(2008-10#5)
aluminium and##12##2##(2008-10#11)(2008-3#1)
aluminium chloride with##4##3##(2008-10#4)
aluminium chloride##7##2##(2008-10#7)
aluminium in the##3##3##(1995-6#1)(2008-10#2)
aluminium in##12##2##(1990-3#1)(1992-3#2)(1995-6#2)(2008-10#7)
aluminium ion##4##2##(2008-10#4)
aluminium of##2##2##(1992-3#1)(2008-10#1)
aluminium salts##2##2##(2008-10#2)
aluminium was##2##2##(2008-10#2)
aluminium were##2##2##(2008-10#2)
aluminium##109##1##(1990-3#2)(1992-3#6)(1995-6#2)(1996-12#1)(1996-2#2)(2008-10#84)(2008-3#2)(2008-5#3)(2008-7#5)(2010-11#1)(2013-8#1)
aluminium-base##2##1##(2008-10#2)
aluminon##4##1##(2008-10#4)
aluminosilicate##3##1##(2007-11#1)(2008-3#2)
aluminum (Al)##5##2##(1996-2#1)(2008-10#2)(2009-6#1)(2009-8#1)
aluminum alloy##4##2##(2008-10#2)(2013-8#2)
aluminum alloy)##2##2##(2008-10#2)
aluminum alloys##4##2##(2008-10#4)
aluminum and indium##2##3##(2008-10#2)
aluminum and##8##2##(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#3)(2012-2#1)
aluminum chloride##2##2##(1992-12#1)(2008-10#1)
aluminum coating##2##2##(2007-12#2)
aluminum concentrations##5##2##(1992-11#5)
aluminum exposure##3##2##(1992-11#3)
aluminum film##2##2##(2008-3#2)
aluminum garnet##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)
aluminum hydride sources##3##3##(1996-2#3)
aluminum hydride##6##2##(1996-2#3)(1996-5#1)(2008-10#1)(2009-11#1)
aluminum hydroxide##3##2##(1991-5#3)
aluminum in new and used lubricating oils##2##7##(2008-10#2)
aluminum in##10##2##(2008-10#10)
aluminum ions##3##2##(1994-11#2)(2008-10#1)
aluminum is##2##2##(2008-10#1)(2008-3#1)
aluminum nanoparticles##5##2##(2010-4#5)
aluminum oxide and##2##3##(2008-10#2)
aluminum oxide##3##2##(2008-10#2)(2008-2#1)
aluminum phthalocyanine##8##2##(1992-6#1)(2008-10#7)
aluminum plate##2##2##(2007-12#1)(2008-2#1)
aluminum tetrasulfophthalocyanines at a##2##4##(2012-3#2)
aluminum tetrasulfophthalocyanines at##3##3##(2012-3#3)
aluminum tetrasulfophthalocyanines##8##2##(2012-3#8)
aluminum was##6##2##(1992-11#1)(2007-8#1)(2008-10#4)
aluminum were detected from soils in which the major clay mineralogy was##2##12##(2008-10#2)
aluminum were##4##2##(2008-10#4)
aluminum with##2##2##(1992-11#1)(2008-10#1)
aluminum##188##1##(1991-12#1)(1991-2#1)(1991-5#3)(1992-11#20)(1992-12#5)(1992-6#1)(1994-11#4)(1995-5#1)(1996-2#4)(1996-3#1)(1996-5#1)(2007-11#4)(2007-12#4)(2007-5#2)(2007-8#6)(2008-1#1)(2008-10#76)(2008-2#8)(2008-3#13)(2008-4#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-4#6)(2010-8#1)(2012-2#1)(2012-3#8)(2013-1#2)(2013-8#2)
aluminum(III)##4##1##(2008-10#4)
aluminum-coated##3##1##(2008-2#1)(2008-3#2)
alumni association##2##2##(1996-1#2)
alumni##4##1##(1993-12#1)(1996-1#2)(2012-2#1)
alveolar and##3##2##(2008-1#1)(2009-12#1)(2011-2#1)
alveolar bone is more compliant than##2##6##(2011-2#2)
alveolar bone is##3##3##(2011-2#3)
alveolar bone##9##2##(2007-12#2)(2011-2#5)(2012-12#1)(2013-1#1)
alveolar damage##2##2##(1994-5#1)(2011-2#1)
alveolar epithelial cells##4##3##(1991-9#1)(1994-3#3)
alveolar epithelial##6##2##(1991-9#1)(1993-2#1)(1994-3#4)
alveolar epithelium##4##2##(1995-8#3)(2008-10#1)
alveolar haemorrhage##2##2##(2011-2#2)
alveolar hemorrhage##3##2##(2006-10#1)(2008-1#2)
alveolar injury##2##2##(1995-3#2)
alveolar macrophages to##2##3##(1990-5#2)
alveolar macrophages were##2##3##(1992-8#1)(1993-3#1)
alveolar macrophages##26##2##(1990-5#3)(1990-6#2)(1992-12#1)(1992-8#9)(1993-3#5)(1993-8#2)(1994-12#1)(1995-12#1)(1996-3#1)(2012-3#1)
alveolar microlithiasis##2##2##(2012-12#2)
alveolar nerve##2##2##(2011-7#1)(2012-12#1)
alveolar process and palate##2##4##(2012-12#2)
alveolar process and##3##3##(2011-2#1)(2012-12#2)
alveolar proteinosis##4##2##(2007-2#1)(2007-8#1)(2010-7#2)
alveolar ridge##6##2##(2007-12#6)
alveolar soft-part sarcoma##3##3##(2006-12#3)
alveolar surface##2##2##(1992-5#1)(2010-7#1)
alveolar type II##6##3##(1990-7#1)(1992-3#1)(1993-3#2)(1995-8#2)
alveolar type of##3##3##(2010-11#3)
alveolar type##9##2##(1990-7#1)(1992-3#1)(1993-3#2)(1995-8#2)(2010-11#3)
alveolar type-II cells##3##3##(1994-3#3)
alveolar type-II##4##2##(1994-11#1)(1994-3#3)
alveolar##131##1##(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#3)(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#9)(1993-2#2)(1993-3#7)(1993-8#2)(1994-11#1)(1994-12#4)(1994-3#7)(1994-5#1)(1995-12#3)(1995-3#2)(1995-8#5)(1996-2#2)(1996-3#1)(1997-1#2)(1997-3#1)(2006-10#2)(2006-12#3)(2007-12#10)(2007-2#1)(2007-8#2)(2008-1#5)(2008-10#2)(2008-12#1)(2008-6#1)(2009-12#2)(2009-4#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-7#5)(2011-2#11)(2011-7#1)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#2)
alveolarization##3##1##(2009-9#3)
alveoli and##2##2##(2008-8#1)(2012-12#1)
alveoli##10##1##(1991-12#1)(1997-6#2)(2007-12#1)(2007-8#2)(2008-7#1)(2008-8#2)(2012-12#1)
alveolitis##4##1##(1991-12#1)(1997-8#1)(2006-10#2)
alveomucin##3##1##(2013-1#3)
always a challenge##2##3##(1991-3#1)(2008-11#1)
always a difference##2##3##(2008-10#1)(2008-3#1)
always a##9##2##(1991-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
always accompanied by a##2##4##(1994-11#1)(2008-2#1)
always affected##2##2##(2008-3#1)(2011-2#1)
always appeared##2##2##(1993-12#1)(2008-10#1)
always associated with the##2##4##(2008-10#2)
always associated with##8##3##(1990-6#1)(1997-1#1)(2008-10#4)(2008-12#1)(2013-1#1)
always be kept in mind##2##5##(2011-2#1)(2012-2#1)
always be the##2##3##(1997-3#1)(2010-6#1)
always be##29##2##(1990-2#1)(1991-2#1)(1992-11#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)
always been an##3##3##(2007-5#2)(2008-4#1)
always been difficult##2##3##(2008-10#1)(2011-1#1)
always been##26##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(2007-10#1)(2007-5#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-3#1)(2012-7#1)
always below 2%##2##3##(2008-10#2)
always better##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
always close to##2##3##(1993-12#1)(2008-10#1)
always consider##2##2##(2008-2#1)(2008-7#1)
always differed##2##2##(2008-10#1)(2008-8#1)
always equal to the##2##4##(2007-12#1)(2008-10#1)
always found##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
always had a##2##3##(2008-5#1)(2008-8#1)
always had##3##2##(2008-5#1)(2008-8#2)
always have##3##2##(1994-3#1)(1997-1#1)(2008-4#1)
always higher in##2##3##(2010-8#1)(2013-8#1)
always higher##5##2##(1995-3#1)(2008-10#2)(2010-8#1)(2013-8#1)
always in the##2##3##(2007-8#1)(2008-10#1)
always in##5##2##(1994-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
always included##2##2##(1997-8#1)(2008-5#1)
always increase with##2##3##(2008-8#2)
always induced##2##2##(2008-10#2)
always larger than##3##3##(1995-9#1)(2007-11#1)(2007-12#1)
always lower than 0##2##4##(2008-10#1)(2008-3#1)
always lower than##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
always more##2##2##(2008-9#1)(2012-12#1)
always necessary##4##2##(2007-11#1)(2007-2#1)(2008-6#1)(2008-7#1)
always observed##4##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-11#1)
always performed##2##2##(1996-3#1)(2011-2#1)
always possible##4##2##(2008-1#1)(2009-3#1)(2011-2#2)
always present in##6##3##(1992-3#1)(1997-3#1)(2007-11#1)(2008-10#3)
always present##10##2##(1992-3#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-1#1)
always provide##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
always shows##2##2##(2008-10#2)
always statistically significant##2##3##(2008-10#1)(2012-1#1)
always the##9##2##(1994-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-9#2)(2011-2#1)
always to be##2##3##(1997-5#1)(2011-2#1)
always to##3##2##(1991-1#1)(1997-5#1)(2011-2#1)
always well##2##2##(1997-3#1)(2008-10#1)
always were associated with##2##4##(2008-10#2)
always were##4##2##(2008-10#4)
always with##3##2##(1991-3#1)(1995-1#1)(2006-6#1)
always##397##1##(1990-11#2)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#4)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#1)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#11)(2007-12#10)(2007-2#3)(2007-5#2)(2007-8#4)(2008-1#5)(2008-10#75)(2008-11#16)(2008-12#11)(2008-2#8)(2008-3#12)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#19)(2008-9#14)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#5)
am##16##1##(1990-3#1)(1992-3#1)(1996-4#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-7#1)
amacrine cells##5##2##(2008-8#1)(2008-9#4)
amalgam and##2##2##(2008-10#2)
amalgam electrodes##4##2##(2008-10#4)
amalgam fillings##8##2##(1993-8#4)(1995-6#4)
amalgam system##2##2##(2008-10#2)
amalgam##35##1##(1990-10#3)(1990-9#3)(1992-11#1)(1993-8#4)(1995-3#3)(1995-6#4)(2008-10#14)(2010-1#1)(2012-12#2)
amalgam-alloy electrode##2##2##(2008-10#2)
amalgam-alloy##6##1##(2008-10#6)
amalgamation of##4##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)
amalgamation##10##1##(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-9#3)
amalgams##3##1##(2008-10#3)
amantadine inhibits##2##2##(1992-3#2)
amantadine##15##1##(1992-3#4)(1996-2#1)(1997-2#3)(2007-12#1)(2008-7#1)(2011-10#2)(2011-2#3)
amara##2##1##(2008-10#2)
amarali and G##3##3##(2010-3#3)
amarali##4##1##(2010-3#4)
amaranth grain##7##2##(2008-11#7)
amaranth##13##1##(2008-10#3)(2008-11#10)
amaranthi as a##2##3##(2008-10#2)
amaranthi##6##1##(2008-10#6)
amaranthin biosynthesis##3##2##(2008-4#3)
amaranthin synthesis##3##2##(2008-4#3)
amaranthin##6##1##(2008-4#6)
amaranticolor##3##1##(2008-10#3)
amarus##3##1##(2013-1#3)
amassed##4##1##(2008-1#1)(2008-4#1)(2008-9#1)(2011-10#1)
amastatin##2##1##(1994-8#1)(1995-6#1)
amastigote##4##1##(1990-7#1)(1991-11#1)(2012-2#2)
amastigotes##2##1##(2007-11#1)(2012-2#1)
amateur##4##1##(1992-6#1)(2007-11#1)(2008-7#1)(2010-1#1)
amateurs##2##1##(2010-1#1)(2011-2#1)
amaurosis##2##1##(2010-10#1)(2011-2#1)
amazilia##4##1##(2008-5#4)
amazing##2##1##(1996-3#1)(2008-9#1)
amazonicum##5##1##(2013-7#5)
amber##7##1##(1990-7#1)(2008-10#4)(2008-8#1)(2011-2#1)
amberlite XAD-2 resin##3##3##(2008-10#3)
amberlite XAD-2##4##2##(2008-10#4)
amberlite##6##1##(2008-10#6)
ambidextrous##2##1##(1997-2#2)
ambient CO(2)##4##2##(2008-10#4)
ambient aerosol##2##2##(2008-3#1)(2008-5#1)
ambient air and##3##3##(2007-12#1)(2008-10#2)
ambient air as##2##3##(1995-3#1)(2008-10#1)
ambient air by##2##3##(2007-12#1)(2008-10#1)
ambient air of Madrid (Spain)##2##5##(2008-10#1)(2008-11#1)
ambient air pollution##3##3##(1992-9#1)(2008-11#2)
ambient air##27##2##(1991-12#1)(1992-9#1)(1995-3#1)(2007-12#4)(2008-10#13)(2008-11#4)(2008-3#3)
ambient and elevated##2##3##(2008-10#1)(2012-12#1)
ambient and##7##2##(1995-3#1)(1996-6#1)(2008-10#2)(2008-2#1)(2012-12#1)(2012-9#1)
ambient background##3##2##(2008-11#3)
ambient condition##2##2##(2008-8#1)(2013-1#1)
ambient conditions##15##2##(1992-3#1)(1993-12#1)(1995-3#2)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-8#1)
ambient laboratory conditions##2##3##(2007-11#1)(2008-10#1)
ambient levels of##2##3##(1992-9#1)(2008-11#1)
ambient light##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-8#1)
ambient pH##3##2##(2008-10#3)
ambient pressure##8##2##(1996-5#1)(2008-10#4)(2008-3#1)(2012-2#2)
ambient temperature and##5##3##(2008-10#3)(2010-12#1)(2011-2#1)
ambient temperature is##2##3##(1996-12#1)(2007-11#1)
ambient temperature##38##2##(1992-6#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-7#1)(2013-7#1)
ambient temperatures##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
ambient##166##1##(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-2#1)(1994-5#1)(1995-3#6)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#56)(2008-11#11)(2008-2#4)(2008-3#17)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-7#1)(2012-9#2)(2013-1#1)(2013-7#1)(2013-8#2)
ambigua##2##1##(2010-8#2)
ambiguities and##2##2##(2008-11#1)(2008-7#1)
ambiguities##8##1##(1990-9#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
ambiguity by##2##2##(2007-12#1)(2008-2#1)
ambiguity function of##2##3##(2008-3#2)
ambiguity function##4##2##(2007-11#2)(2008-3#2)
ambiguity in the determination of optical constants of thin absorbing films from spectroscopic reflectance and transmittance measurements##2##17##(2008-2#2)
ambiguity in the##3##3##(2008-2#2)(2008-3#1)
ambiguity in##6##2##(1992-4#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
ambiguity of the##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
ambiguity of##5##2##(2007-11#1)(2008-1#1)(2008-12#2)(2011-2#1)
ambiguity problem##2##2##(2007-11#1)(2008-3#1)
ambiguity##33##1##(1990-5#1)(1992-4#1)(1993-2#1)(2007-11#5)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#4)(2008-2#4)(2008-3#6)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#2)
ambiguous genitalia##7##2##(2007-7#1)(2008-10#6)
ambiguous nature of the##2##4##(2008-11#2)
ambiguous##34##1##(1993-6#1)(1996-2#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#7)(2011-3#1)(2012-2#1)
ambisense##5##1##(2008-10#5)
ambition##3##1##(1990-4#1)(2008-7#1)(2012-2#1)
ambitions##2##1##(1994-11#1)(2008-12#1)
ambitious##5##1##(1992-2#1)(2007-2#1)(2008-12#1)(2008-9#1)(2013-1#1)
ambivalence##3##1##(2010-12#1)(2010-2#1)(2012-12#1)
ambivalent##2##1##(1992-8#1)(2008-5#1)
amblyopia in##3##2##(2008-7#1)(2012-12#1)(2013-7#1)
amblyopia##10##1##(2008-7#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-7#4)
amboinicus##9##1##(2012-2#9)
ambrosia beetle##2##2##(2011-2#2)
ambroxol hydrochloride and doxycycline in##3##5##(2008-10#3)
ambroxol hydrochloride##5##2##(2008-10#3)(2010-5#2)
ambroxol##8##1##(2008-10#6)(2010-5#2)
ambulance services##3##2##(1996-6#2)(2012-12#1)
ambulance workers##3##2##(2012-1#3)
ambulance##14##1##(1996-6#2)(2007-9#2)(2008-1#1)(2008-4#1)(2010-3#2)(2012-1#3)(2012-12#1)(2013-1#2)
ambulances to##4##2##(2010-3#3)(2010-8#1)
ambulances##7##1##(2008-6#1)(2008-7#1)(2010-3#4)(2010-8#1)
ambulation and##2##2##(2008-7#1)(2009-3#1)
ambulation##6##1##(1991-9#1)(1994-3#1)(2008-7#2)(2009-3#2)
ambulatorial##2##1##(1990-3#1)(2008-5#1)
ambulatory and inpatient##2##3##(1991-11#1)(1997-1#1)
ambulatory and##3##2##(1991-11#1)(1992-3#1)(1997-1#1)
ambulatory blood pressure monitoring (ABPM)##2##5##(1992-8#1)(2009-11#1)
ambulatory blood pressure monitoring in##3##5##(2009-11#1)(2010-1#2)
ambulatory blood pressure monitoring##6##4##(1992-8#1)(2009-11#2)(2010-1#3)
ambulatory blood pressure values##2##4##(2008-7#1)(2013-8#1)
ambulatory blood pressure##10##3##(1992-5#1)(1992-8#1)(2008-7#1)(2009-11#2)(2010-1#3)(2012-1#1)(2013-8#1)
ambulatory blood##11##2##(1992-5#1)(1992-8#1)(2008-7#1)(2009-11#2)(2010-1#3)(2010-12#1)(2012-1#1)(2013-8#1)
ambulatory care clinics##2##3##(1991-12#1)(2011-1#1)
ambulatory care for the##2##4##(1991-3#1)(1995-2#1)
ambulatory care for##3##3##(1991-3#1)(1991-6#1)(1995-2#1)
ambulatory care services##2##3##(1991-3#1)(1995-12#1)
ambulatory care##25##2##(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#2)(1993-12#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#2)
ambulatory monitoring##2##2##(2008-3#1)(2008-7#1)
ambulatory patients with##2##3##(1996-7#1)(1997-6#1)
ambulatory patients##4##2##(1996-7#1)(1997-6#1)(2011-2#1)(2013-1#1)
ambulatory peritoneal dialysis (CAPD) for##2##5##(2007-12#1)(2007-7#1)
ambulatory peritoneal dialysis (CAPD)##14##4##(1995-12#1)(2007-12#5)(2007-7#3)(2008-1#3)(2008-10#1)(2011-2#1)
ambulatory peritoneal dialysis##31##3##(1992-5#1)(1995-12#1)(2007-12#19)(2007-7#3)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
ambulatory peritoneal##33##2##(1992-5#1)(1995-12#1)(2007-12#21)(2007-7#3)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
ambulatory services##2##2##(1995-2#1)(1996-2#1)
ambulatory setting##4##2##(1996-3#1)(2008-11#1)(2008-9#1)(2013-1#1)
ambulatory settings##2##2##(2008-3#1)(2013-7#1)
ambulatory surgery##7##2##(1991-1#5)(1995-2#1)(1997-2#1)
ambulatory surgical##2##2##(1997-1#1)(2008-8#1)
ambulatory visit##2##2##(1991-1#1)(2013-1#1)
ambulatory##150##1##(1990-11#2)(1990-2#1)(1990-9#1)(1991-1#9)(1991-11#1)(1991-12#1)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#1)(1995-12#2)(1995-2#4)(1996-1#1)(1996-2#3)(1996-3#4)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#7)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#21)(2007-7#3)(2008-1#3)(2008-10#3)(2008-11#4)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#2)(2010-1#3)(2010-11#1)(2010-12#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
amebic liver abscess##2##3##(2006-10#2)
amebic##5##1##(1993-3#1)(2006-10#2)(2011-2#2)
amelanotic##2##1##(1991-5#1)(2008-2#1)
ameliorate the##8##2##(1993-12#1)(1994-5#1)(1996-2#1)(2008-5#3)(2010-7#1)(2011-2#1)
ameliorate##22##1##(1993-12#2)(1994-5#1)(1996-2#1)(1996-7#1)(1997-6#1)(2008-1#2)(2008-11#2)(2008-5#3)(2008-7#3)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
ameliorated by##10##2##(1993-12#2)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
ameliorated the##3##2##(1994-5#1)(1997-2#1)(2008-10#1)
ameliorated with##2##2##(1996-3#1)(2013-1#1)
ameliorated##23##1##(1993-11#1)(1993-12#2)(1994-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-6#2)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
ameliorates disease##2##2##(2008-5#1)(2012-2#1)
ameliorates the##2##2##(1995-6#1)(2007-12#1)
ameliorates##13##1##(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-2#3)(2013-1#1)
ameliorating the##2##2##(2008-7#1)(2011-1#1)
ameliorating##3##1##(2008-7#1)(2009-6#1)(2011-1#1)
amelioration of pain##2##3##(1991-2#1)(2007-11#1)
amelioration of the##2##3##(1990-3#1)(2010-4#1)
amelioration of##11##2##(1990-3#1)(1991-2#2)(1992-9#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
amelioration was##2##2##(2008-10#2)
amelioration##18##1##(1990-3#1)(1991-2#2)(1992-9#1)(2007-11#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
ameloblastic fibro-odontoma##2##2##(2007-12#1)(2013-1#1)
ameloblastoma##2##1##(2007-12#1)(2013-1#1)
amelogenin##3##1##(1993-11#3)
amenability to##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
amenability##5##1##(2008-10#2)(2008-4#1)(2011-2#2)
amenable and##2##2##(2007-12#1)(2013-8#1)
amenable for##3##2##(1992-9#1)(2010-2#1)(2010-8#1)
amenable to experimental##2##3##(2008-8#1)(2012-2#1)
amenable to structural##2##3##(1997-7#1)(2008-4#1)
amenable to treatment##2##3##(2008-4#1)(2010-12#1)
amenable to##40##2##(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-7#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#2)(2011-2#4)(2012-2#3)(2013-1#2)
amenable##47##1##(1992-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#1)
amendable to##2##2##(2008-8#2)
amended soil##5##2##(2008-10#5)
amended with Al(2)(SO(4))(3)##2##3##(2008-10#2)
amended with compost##3##3##(2008-10#3)
amended with either##2##3##(2008-10#2)
amended with silicon##2##3##(2008-10#2)
amended with the##2##3##(2008-10#2)
amended with##40##2##(1994-3#1)(2008-10#39)
amended##56##1##(1994-3#1)(1997-5#1)(2008-10#50)(2008-12#1)(2010-3#2)(2013-8#1)
amending the soil##2##3##(2008-10#2)
amending##4##1##(2008-10#4)
amendment did not##2##3##(2008-10#2)
amendment of##6##2##(2008-10#6)
amendment solutions at##2##3##(2008-10#2)
amendment solutions##3##2##(2008-10#3)
amendment to##3##2##(1995-6#1)(1996-5#1)(2008-10#1)
amendment with##3##2##(2008-10#3)
amendment##35##1##(1995-6#2)(1996-5#1)(2008-10#29)(2009-11#2)(2011-1#1)
amendments can be##2##3##(2008-10#2)
amendments did not##2##3##(2008-10#2)
amendments on##3##2##(2008-10#3)
amendments to the##4##3##(1992-12#1)(1992-2#1)(1996-3#1)(1997-6#1)
amendments to##6##2##(1992-12#1)(1992-2#1)(1996-3#1)(1997-6#1)(2008-10#2)
amendments##33##1##(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1996-3#1)(1997-6#1)(2008-10#27)
amends##2##1##(1992-11#1)(1992-3#1)
amenorrhea##8##1##(1991-11#1)(1992-12#1)(2007-7#2)(2008-7#1)(2010-1#2)(2012-3#1)
america##11##1##(2008-10#7)(2009-6#1)(2009-9#1)(2011-2#2)
american phytopathological society##18##3##(2008-10#18)
american##42##1##(2006-10#2)(2007-8#1)(2008-10#19)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-8#5)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
americana##13##1##(1990-11#2)(1990-5#2)(1992-12#1)(2008-8#2)(2011-1#4)(2011-2#2)
americana)##6##1##(2008-10#4)(2013-1#2)
americans##3##1##(2008-8#1)(2009-7#1)(2012-2#1)
americanum##12##1##(2008-10#11)(2008-5#1)
americium##4##1##(1990-11#1)(2008-10#3)
amidase##6##1##(1990-2#1)(1991-7#1)(1996-5#1)(2009-6#3)
amidating activity##2##2##(1994-11#2)
amidation of the##2##3##(2008-10#1)(2011-2#1)
amidation##8##1##(1990-12#1)(1992-8#1)(2008-10#1)(2008-12#2)(2009-9#1)(2011-2#2)
amide I and##2##3##(2008-5#2)
amide I band##2##3##(1997-7#1)(2007-12#1)
amide I##5##2##(1997-7#1)(2007-12#1)(2008-5#3)
amide and##4##2##(1991-5#1)(1994-3#2)(1995-11#1)
amide bond##4##2##(1991-11#1)(1994-11#1)(2007-7#1)(2008-12#1)
amide derivative##2##2##(2008-10#2)
amide linkage##3##2##(1992-3#1)(1995-2#1)(2008-4#1)
amide linkages##4##2##(2008-10#3)(2008-4#1)
amide moiety##2##2##(2008-10#1)(2008-8#1)
amide nitrogen##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
amide of##2##2##(1994-11#1)(2008-5#1)
amide or##2##2##(1991-12#1)(2008-10#1)
amide proton chemical##2##3##(1994-5#1)(1995-2#1)
amide proton exchange##2##3##(2008-4#2)
amide proton shifts##2##3##(1995-2#2)
amide proton##9##2##(1992-4#1)(1994-5#1)(1995-2#3)(2008-4#2)(2012-12#2)
amide to##4##2##(1994-3#3)(1996-5#1)
amide##83##1##(1990-4#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-3#8)(1994-5#2)(1995-11#1)(1995-2#5)(1995-6#1)(1996-5#2)(1997-7#3)(2007-12#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#7)(2008-8#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
amides and##3##2##(2008-5#1)(2010-8#2)
amides##20##1##(1990-8#4)(1991-5#1)(1992-11#1)(1992-5#2)(1996-5#2)(1997-2#1)(2008-10#2)(2008-5#4)(2010-8#2)(2013-8#1)
amidines##4##1##(1995-11#4)
amidinium-carboxylate##2##1##(2008-10#2)
amido black diazoaminoazobenzene##2##3##(2008-10#2)
amido##3##1##(1997-7#1)(2008-10#2)
amidolytic activity##4##2##(1993-11#2)(1995-5#1)(1995-6#1)
amidolytic##5##1##(1993-11#2)(1995-5#2)(1995-6#1)
amidoximated orlon##2##2##(2008-10#2)
amidoximated##3##1##(2008-10#3)
amidoxime##3##1##(2008-10#3)
amidst the##2##2##(2007-10#1)(2012-3#1)
amidst##3##1##(2007-10#1)(2012-3#1)(2013-8#1)
amifostine##6##1##(2008-7#5)(2011-2#1)
amikacin and ceftazidime##2##3##(2007-7#1)(2008-7#1)
amikacin and##3##2##(2007-7#2)(2008-7#1)
amikacin##17##1##(1990-6#2)(1991-3#2)(2007-7#5)(2008-10#3)(2008-7#2)(2012-3#1)(2013-1#1)(2013-8#1)
amiloride at##3##2##(2008-4#3)
amiloride in##3##2##(1991-5#1)(2008-10#2)
amiloride##26##1##(1990-2#2)(1991-5#5)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-9#1)(2008-10#3)(2008-4#7)(2008-8#1)
amiloride-sensitive##2##1##(1990-2#1)(1992-11#1)
aminated polystyrene membrane##2##3##(2008-10#2)
amine accumulation in##3##3##(2010-11#3)
amine and##4##2##(2008-10#4)
amine carcinogens by##2##3##(1992-6#1)(1997-2#1)
amine carcinogens##3##2##(1992-6#2)(1997-2#1)
amine complexes##3##2##(1997-7#1)(2008-10#2)
amine compounds##2##2##(1992-3#1)(2008-10#1)
amine containing dye)##2##3##(1990-6#2)
amine containing##5##2##(1990-6#3)(2008-6#1)(2010-4#1)
amine coupling method##2##3##(2008-10#2)
amine coupling##4##2##(2008-10#3)(2013-8#1)
amine derivatives##3##2##(2008-10#3)
amine followed by##2##3##(2008-10#2)
amine group of##2##3##(1992-6#1)(2008-10#1)
amine group to##2##3##(2008-10#2)
amine group##10##2##(1992-6#1)(2008-10#9)
amine groups##5##2##(2008-10#5)
amine ligands##3##2##(1997-7#1)(2008-7#2)
amine oxidase from Escherichia coli##2##5##(1995-5#2)
amine oxidase##4##2##(1991-9#2)(1995-5#2)
amine was##2##2##(1993-12#1)(2008-10#1)
amine##119##1##(1990-5#1)(1990-6#3)(1991-5#1)(1991-9#4)(1992-3#1)(1992-6#4)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#4)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#61)(2008-4#1)(2008-6#1)(2008-7#6)(2009-8#1)(2010-11#4)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
amine)##4##1##(2008-10#4)
amine-reactive##2##1##(1995-5#1)(2008-9#1)
amine-type neutral##2##2##(2008-10#2)
amines and amino acids##5##4##(1995-3#1)(2008-10#4)
amines and their##2##3##(1992-6#1)(2008-7#1)
amines and##16##2##(1992-6#1)(1995-3#3)(1996-2#1)(2008-10#8)(2008-7#1)(2010-8#1)(2013-7#1)
amines are##3##2##(2008-10#2)(2008-7#1)
amines as##2##2##(1997-3#1)(2008-10#1)
amines by##3##2##(2008-10#2)(2011-1#1)
amines can##2##2##(1990-8#1)(2008-10#1)
amines for##3##2##(1997-2#1)(2008-10#2)
amines have been##2##3##(2008-10#2)
amines have##3##2##(2008-10#2)(2010-11#1)
amines in food##2##3##(2008-10#2)
amines in tap##2##3##(2008-10#2)
amines in the##2##3##(1993-3#1)(2008-10#1)
amines in wastewater##2##3##(2008-10#2)
amines in water##3##3##(2008-10#3)
amines in##20##2##(1993-3#1)(1996-5#1)(2007-11#1)(2008-10#16)(2008-7#1)
amines is##3##2##(1992-3#1)(2008-10#2)
amines such as##2##3##(1991-9#1)(2012-12#1)
amines to##6##2##(1996-5#1)(2008-10#2)(2009-10#2)(2010-8#1)
amines using##4##2##(1994-9#1)(1995-6#1)(2008-10#2)
amines was##2##2##(1995-3#1)(1995-6#1)
amines were##5##2##(1994-11#1)(2008-10#4)
amines with##5##2##(1991-5#1)(1996-5#1)(2008-10#3)
amines##159##1##(1990-8#4)(1991-5#3)(1991-9#3)(1992-2#1)(1992-3#1)(1992-6#4)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-3#5)(1995-6#3)(1996-2#2)(1996-5#8)(1997-2#5)(1997-3#1)(1997-7#1)(2007-11#5)(2007-12#1)(2008-10#83)(2008-4#3)(2008-7#5)(2008-8#1)(2009-10#2)(2009-8#1)(2010-11#1)(2010-8#5)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
amino Acid change in##2##4##(2008-10#2)
amino Acid##5##2##(2008-10#2)(2010-1#1)(2010-7#1)(2012-2#1)
amino N in##2##3##(2012-8#2)
amino N##3##2##(2012-8#3)
amino acid (aa) protein##2##4##(1995-8#1)(1997-7#1)
amino acid (aa) sequence of##3##5##(1990-11#1)(1991-6#1)(1993-12#1)
amino acid (aa) sequence##11##4##(1990-11#2)(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#3)(1995-8#1)
amino acid (aa) sequences of##3##5##(1991-6#1)(1991-9#1)(1993-6#1)
amino acid (aa) sequences##6##4##(1991-6#2)(1991-9#1)(1993-6#2)(1993-9#1)
amino acid (aa)##27##3##(1990-11#2)(1991-6#3)(1991-7#1)(1991-9#1)(1993-12#2)(1993-2#2)(1993-6#5)(1993-9#1)(1994-12#3)(1994-8#1)(1995-8#2)(1997-7#2)(2008-10#1)(2010-5#1)
amino acid 11##2##3##(1990-12#2)
amino acid N##3##3##(2012-9#3)
amino acid amides##2##3##(1991-5#1)(1992-11#1)
amino acid analysis and plasma desorption mass spectrometry (PDMS)##2##9##(1990-8#1)(1992-3#1)
amino acid analysis and##4##4##(1990-8#1)(1992-3#1)(1995-3#1)(1995-6#1)
amino acid analysis##15##3##(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#3)
amino acid and a##2##4##(1992-6#1)(2008-10#1)
amino acid and##11##3##(1992-6#1)(1992-8#1)(1995-12#1)(2008-10#7)(2011-2#1)
amino acid at position##4##4##(1991-9#1)(1995-5#1)(2008-10#2)
amino acid at##6##3##(1991-9#1)(1995-5#1)(2008-10#3)(2008-4#1)
amino acid biosynthetic##2##3##(2008-7#2)
amino acid change##8##3##(1991-2#1)(1992-2#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-5#1)(2012-3#1)
amino acid changes in the##3##5##(1993-8#1)(1994-11#1)(2013-1#1)
amino acid changes##13##3##(1990-7#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-12#1)(2008-10#3)(2008-5#2)(2008-8#1)(2013-1#1)
amino acid composition and sequence##2##5##(1990-7#1)(2012-1#1)
amino acid composition and##8##4##(1990-5#1)(1990-7#2)(1990-8#1)(1992-12#1)(1994-9#1)(2008-7#1)(2012-1#1)
amino acid composition of the connecting peptide and##2##8##(2008-9#2)
amino acid composition of the##6##5##(1990-5#1)(1990-8#1)(1992-9#1)(1993-8#1)(2008-9#2)
amino acid composition of##9##4##(1990-5#2)(1990-8#1)(1992-9#1)(1993-8#1)(1994-9#1)(2008-9#2)(2012-1#1)
amino acid composition##29##3##(1990-5#3)(1990-7#2)(1990-8#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-8#1)(1994-12#1)(1994-9#3)(2008-10#1)(2008-7#3)(2008-9#2)(2012-1#2)
amino acid content in##2##4##(2008-11#1)(2008-12#1)
amino acid content##6##3##(1994-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)
amino acid deprivation##2##3##(1993-6#2)
amino acid derivative##2##3##(2010-12#2)
amino acid derivatives##8##3##(1994-9#1)(1997-3#1)(2008-10#5)(2008-7#1)
amino acid difference between##2##4##(1997-4#1)(1997-8#1)
amino acid difference##3##3##(1994-12#1)(1997-4#1)(1997-8#1)
amino acid differences##6##3##(1990-8#1)(1997-8#2)(2008-10#1)(2011-1#2)
amino acid exchanges##2##3##(1997-6#1)(2013-8#1)
amino acid for the##2##4##(1991-12#1)(2008-8#1)
amino acid for##3##3##(1991-12#1)(2008-11#1)(2008-8#1)
amino acid form##2##3##(1992-12#1)(2008-10#1)
amino acid homology##4##3##(1991-12#1)(1993-11#1)(2008-10#1)(2008-9#1)
amino acid identities of##3##4##(2008-10#3)
amino acid identities##11##3##(2008-10#9)(2008-8#2)
amino acid identity and##2##4##(1990-12#1)(1992-3#1)
amino acid identity of##2##4##(1995-3#1)(2008-10#1)
amino acid identity to the##2##5##(1993-3#1)(2008-10#1)
amino acid identity to##3##4##(1993-3#1)(1996-6#1)(2008-10#1)
amino acid identity with the##2##5##(1995-6#1)(2008-4#1)
amino acid identity with##5##4##(1991-5#1)(1995-6#2)(1995-8#1)(2008-4#1)
amino acid identity##16##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#4)(2008-4#1)
amino acid in eukaryotes whose biosynthesis##2##6##(2012-2#2)
amino acid in the##6##4##(1993-11#1)(1993-6#2)(1995-5#1)(2008-7#1)(2012-2#1)
amino acid in##11##3##(1993-11#2)(1993-6#2)(1995-5#1)(2008-10#2)(2008-7#1)(2012-2#3)
amino acid incorporation##2##3##(1994-8#2)
amino acid infusion##2##3##(2010-7#2)
amino acid insertion##2##3##(1994-9#2)
amino acid is##3##3##(1990-12#1)(1992-8#1)(1994-5#1)
amino acid levels##7##3##(1990-12#2)(1993-6#1)(1995-8#1)(2008-10#2)(2010-1#1)
amino acid long##2##3##(1995-3#1)(1997-7#1)
amino acid mature##2##3##(1990-12#1)(1994-11#1)
amino acid methionine##2##3##(2008-10#1)(2008-3#1)
amino acid of##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
amino acid or DNA##3##4##(2008-10#3)
amino acid or##4##3##(1997-4#1)(2008-10#3)
amino acid pairs##3##3##(1995-2#2)(2008-1#1)
amino acid peptide##4##3##(1992-9#1)(1996-5#1)(2008-10#1)(2008-11#1)
amino acid permeases##2##3##(1990-5#2)
amino acid polypeptide##2##3##(1991-9#1)(1992-8#1)
amino acid pool##3##3##(1990-12#3)
amino acid position##3##3##(1991-11#1)(2007-6#1)(2013-8#1)
amino acid positions##5##3##(1993-8#1)(1994-11#1)(1997-9#1)(2008-10#1)(2008-9#1)
amino acid preferring##2##3##(1994-5#2)
amino acid profile##2##3##(2011-2#2)
amino acid protein with a##3##5##(1991-5#1)(1997-7#1)(2008-6#1)
amino acid protein with##5##4##(1991-5#1)(1997-7#1)(2008-11#2)(2008-6#1)
amino acid protein##10##3##(1990-12#1)(1991-5#1)(1991-9#2)(1994-9#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-6#1)
amino acid region##3##3##(1994-5#1)(1995-2#1)(2008-10#1)
amino acid repeat region##2##4##(2008-10#2)
amino acid repeats##2##3##(2008-10#1)(2008-6#1)
amino acid replacement##2##3##(1991-8#1)(1992-12#1)
amino acid replacements in##2##4##(1995-5#1)(1997-9#1)
amino acid replacements##6##3##(1991-8#1)(1991-9#1)(1995-5#2)(1997-9#2)
amino acid residue in##2##4##(1993-11#1)(2008-8#1)
amino acid residue##13##3##(1991-9#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-8#1)(1995-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
amino acid residues and has a##2##6##(1991-5#1)(2008-10#1)
amino acid residues and##12##4##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-10#1)(1997-4#2)(1997-8#1)(2008-10#1)
amino acid residues from the##3##5##(1991-12#1)(1991-9#1)(1992-5#1)
amino acid residues in the##7##5##(1993-11#1)(1994-5#1)(1995-5#1)(1995-6#2)(2008-9#2)
amino acid residues in##11##4##(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#2)(1995-8#1)(2008-10#1)(2008-9#2)(2012-3#1)
amino acid residues of the##4##5##(1995-2#1)(1995-3#1)(1997-8#1)(2008-11#1)
amino acid residues of##7##4##(1992-9#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
amino acid residues that are##2##5##(2008-10#2)
amino acid residues that contribute to##2##6##(1995-5#1)(2008-4#1)
amino acid residues that were##2##5##(1997-4#1)(2010-2#1)
amino acid residues that##6##4##(1995-5#1)(1997-4#1)(2008-10#2)(2008-4#1)(2010-2#1)
amino acid residues which##3##4##(1995-2#1)(1996-10#1)(1997-2#1)
amino acid residues with a##5##5##(1990-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#1)
amino acid residues with##6##4##(1990-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#1)(2008-8#1)
amino acid residues##91##3##(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#3)(1996-10#3)(1997-2#1)(1997-4#4)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
amino acid residues)##5##3##(1991-2#1)(1992-3#1)(1997-2#1)(1997-4#1)(2011-2#1)
amino acid sequence analysis of##2##5##(1992-12#1)(1992-3#1)
amino acid sequence analysis##8##4##(1990-2#1)(1990-7#1)(1991-12#1)(1992-12#2)(1992-3#1)(1993-6#1)(1994-12#1)
amino acid sequence and the##3##5##(1993-8#1)(1997-2#1)(2008-10#1)
amino acid sequence and##6##4##(1991-6#1)(1992-8#1)(1993-8#1)(1997-2#1)(2008-10#2)
amino acid sequence data##2##4##(1991-9#1)(2008-10#1)
amino acid sequence deduced##3##4##(1991-9#1)(1993-9#1)(1995-6#1)
amino acid sequence determined##2##4##(1990-7#1)(1991-2#1)
amino acid sequence for##2##4##(1992-8#1)(2008-6#1)
amino acid sequence from##3##4##(1991-2#1)(1993-11#1)(1993-9#1)
amino acid sequence homology to##3##5##(1991-5#1)(1995-12#1)(1997-4#1)
amino acid sequence homology with##3##5##(1992-6#1)(1996-10#1)(2008-9#1)
amino acid sequence homology##7##4##(1990-12#1)(1991-5#1)(1992-6#1)(1995-12#1)(1996-10#1)(1997-4#1)(2008-9#1)
amino acid sequence identities##3##4##(1990-7#1)(1997-3#1)(2008-10#1)
amino acid sequence identity between##2##5##(1991-5#1)(2008-10#1)
amino acid sequence identity with##2##5##(1992-3#1)(2010-5#1)
amino acid sequence identity##6##4##(1991-5#1)(1992-3#1)(1993-8#1)(2008-10#2)(2010-5#1)
amino acid sequence in##3##4##(1997-7#1)(2008-9#1)(2013-8#1)
amino acid sequence includes##2##4##(1994-8#1)(2008-10#1)
amino acid sequence is##5##4##(1993-3#1)(1995-12#1)(1995-6#1)(1996-6#1)(2008-10#1)
amino acid sequence level##2##4##(1997-2#1)(1997-4#1)
amino acid sequence of a##5##5##(1992-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-5#1)
amino acid sequence of human##6##5##(1993-11#1)(1993-3#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-8#1)
amino acid sequence of the protein##4##6##(1991-2#1)(1993-8#1)(1994-6#1)(2009-2#1)
amino acid sequence of the rat##3##6##(1990-12#1)(1992-8#1)(1996-12#1)
amino acid sequence of the##28##5##(1990-12#1)(1990-5#2)(1990-7#3)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1996-12#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)
amino acid sequence of##73##4##(1990-11#1)(1990-12#2)(1990-5#3)(1990-7#5)(1991-12#4)(1991-2#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#4)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#3)(1994-6#2)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-2#1)
amino acid sequence revealed##4##4##(1992-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
amino acid sequence showed a high##2##6##(1990-2#1)(1996-3#1)
amino acid sequence showed##4##4##(1990-2#1)(1995-6#1)(1996-10#1)(1996-3#1)
amino acid sequence shows##6##4##(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-11#1)
amino acid sequence similarities with##2##5##(1996-10#1)(2008-10#1)
amino acid sequence similarities##3##4##(1992-7#1)(1996-10#1)(2008-10#1)
amino acid sequence similarity##3##4##(1995-11#1)(2008-10#1)(2011-1#1)
amino acid sequence was determined##3##5##(1992-9#1)(1993-12#1)(1995-6#1)
amino acid sequence was found to be##2##7##(1993-9#1)(1994-9#1)
amino acid sequence was##12##4##(1990-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
amino acid sequence with those of##2##6##(2008-10#2)
amino acid sequence with##4##4##(1990-12#1)(2008-10#2)(2009-2#1)
amino acid sequence##228##3##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#4)(1990-7#8)(1990-8#2)(1991-12#6)(1991-2#5)(1991-5#3)(1991-6#2)(1991-9#4)(1992-10#1)(1992-12#7)(1992-3#9)(1992-6#2)(1992-7#1)(1992-8#8)(1992-9#5)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#5)(1993-9#5)(1994-11#3)(1994-12#5)(1994-6#6)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#7)(1995-8#3)(1996-10#4)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#5)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#5)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
amino acid sequences and##2##4##(1992-8#1)(2008-10#1)
amino acid sequences are##3##4##(1992-10#1)(1997-7#1)(2008-8#1)
amino acid sequences between##2##4##(1994-11#1)(2008-10#1)
amino acid sequences for##2##4##(1991-5#1)(1997-8#1)
amino acid sequences in the##3##5##(1994-11#1)(2008-10#1)(2008-5#1)
amino acid sequences of all##2##5##(1990-11#1)(1993-6#1)
amino acid sequences of both##3##5##(1991-2#1)(1992-8#1)(2008-7#1)
amino acid sequences of mouse##2##5##(1991-9#1)(1993-2#1)
amino acid sequences of the##15##5##(1991-12#1)(1993-12#2)(1993-3#1)(1996-8#1)(1997-6#1)(2007-6#1)(2008-10#7)(2008-5#1)
amino acid sequences of these##4##5##(1991-12#1)(1991-9#1)(1993-8#1)(1997-8#1)
amino acid sequences of##48##4##(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-9#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1996-10#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)
amino acid sequences were compared##2##5##(2008-10#1)(2013-8#1)
amino acid sequences were determined by automated Edman degradation##2##9##(1992-3#1)(1994-11#1)
amino acid sequences were determined##3##5##(1992-3#1)(1994-11#1)(2008-8#1)
amino acid sequences were##9##4##(1992-11#1)(1992-3#1)(1994-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
amino acid sequences##99##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#7)(1994-12#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-8#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2007-6#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-8#1)
amino acid sequencing and##3##4##(1990-12#1)(1994-8#1)(1997-7#1)
amino acid sequencing of##3##4##(1990-2#1)(1991-12#1)(1993-11#1)
amino acid sequencing##9##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-8#1)(1997-1#1)(1997-7#1)
amino acid side chains##3##4##(1990-12#1)(1992-3#1)(1995-5#1)
amino acid signal peptide##2##4##(1991-2#1)(1994-11#1)
amino acid similarities##2##3##(2008-10#1)(2008-8#1)
amino acid starvation##3##3##(1993-6#2)(2008-12#1)
amino acid substitution at##2##4##(1993-12#1)(2006-6#1)
amino acid substitution in the##3##5##(1995-8#1)(2008-10#2)
amino acid substitution in##4##4##(1990-11#1)(1995-8#1)(2008-10#2)
amino acid substitution of##3##4##(1993-3#1)(1994-11#1)(2012-12#1)
amino acid substitution##17##3##(1990-11#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-8#1)(2006-6#1)(2008-10#4)(2008-8#1)(2011-3#1)(2012-12#1)
amino acid substitutions at##2##4##(1995-5#1)(1997-8#1)
amino acid substitutions in the##3##5##(1991-6#1)(2008-10#1)(2013-8#1)
amino acid substitutions in##6##4##(1990-11#1)(1991-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
amino acid substitutions##31##3##(1990-11#1)(1990-8#3)(1991-6#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-8#1)(1997-9#2)(2008-10#2)(2008-4#6)(2008-8#1)(2009-8#2)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
amino acid supplementation##2##3##(1993-6#1)(2008-11#1)
amino acid transport##5##3##(1990-12#3)(1990-5#1)(1994-8#1)
amino acid transporters##4##3##(2008-7#4)
amino acid uptake##2##3##(1995-11#1)(2008-11#1)
amino acid was##2##3##(2008-11#1)(2011-1#1)
amino acid which##2##3##(1992-6#1)(2008-10#1)
amino acid with##3##3##(1992-6#1)(2008-10#1)(2010-7#1)
amino acid##952##2##(1990-11#9)(1990-12#25)(1990-2#5)(1990-5#16)(1990-7#20)(1990-8#15)(1991-10#1)(1991-11#1)(1991-12#20)(1991-2#12)(1991-5#9)(1991-6#8)(1991-7#1)(1991-8#5)(1991-9#19)(1992-10#2)(1992-11#3)(1992-12#14)(1992-2#1)(1992-3#21)(1992-4#2)(1992-5#1)(1992-6#13)(1992-7#2)(1992-8#21)(1992-9#11)(1993-1#1)(1993-11#16)(1993-12#8)(1993-2#6)(1993-3#16)(1993-5#1)(1993-6#19)(1993-8#15)(1993-9#7)(1994-11#18)(1994-12#13)(1994-2#2)(1994-5#9)(1994-6#7)(1994-8#14)(1994-9#11)(1995-11#9)(1995-12#5)(1995-2#11)(1995-3#8)(1995-5#14)(1995-6#19)(1995-8#13)(1995-9#1)(1996-10#8)(1996-12#7)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#14)(1997-3#6)(1997-4#19)(1997-6#4)(1997-7#10)(1997-8#9)(1997-9#7)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#4)(2007-7#1)(2008-1#2)(2008-10#123)(2008-11#20)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#17)(2008-5#17)(2008-6#6)(2008-7#17)(2008-8#29)(2008-9#19)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#3)(2010-11#4)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#3)(2010-7#4)(2011-1#7)(2011-2#10)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#12)(2012-3#3)(2012-9#3)(2013-1#5)(2013-8#8)
amino acid)##3##2##(1994-8#1)(1995-8#2)
amino acid-based##3##2##(2007-12#1)(2008-12#1)(2012-2#1)
amino acid-rich##3##2##(1992-8#2)(2008-8#1)
amino acids (aa) and##5##4##(1990-11#1)(1991-11#1)(1991-9#1)(1993-12#1)(1997-7#1)
amino acids (aa) with a##2##5##(1993-12#1)(1994-12#1)
amino acids (aa)##24##3##(1990-11#3)(1991-11#1)(1991-9#1)(1993-12#3)(1993-2#3)(1993-6#2)(1993-9#1)(1994-12#4)(1995-12#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(2013-1#1)
amino acids 201-319##2##3##(1995-11#2)
amino acids also##4##3##(2006-12#1)(2008-8#2)(2011-1#1)
amino acids and has a calculated molecular weight of##2##9##(1990-7#2)
amino acids and has a##3##5##(1990-7#2)(1992-8#1)
amino acids and nucleic acids##3##5##(2008-2#2)(2013-1#1)
amino acids and organic##2##4##(2008-10#1)(2008-4#1)
amino acids and other##2##4##(2006-12#1)(2008-10#1)
amino acids and##50##3##(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-8#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
amino acids are##7##3##(1993-2#1)(1994-6#1)(2006-12#1)(2008-10#1)(2008-6#1)(2011-2#2)
amino acids as##5##3##(1993-11#1)(1995-3#1)(2008-10#2)(2011-1#1)
amino acids associated with##2##4##(1990-11#1)(2008-10#1)
amino acids at pH##2##4##(1995-6#2)
amino acids at the##6##4##(1992-9#1)(2008-10#4)(2008-9#1)
amino acids at##11##3##(1992-9#1)(1995-6#2)(2008-10#6)(2008-9#2)
amino acids between residues##2##4##(1991-5#1)(2008-11#1)
amino acids by##6##3##(1994-5#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#1)
amino acids compared with##3##4##(1995-9#1)(2008-10#1)(2010-4#1)
amino acids containing##2##3##(1993-2#1)(1994-3#1)
amino acids did not##3##4##(1992-8#2)(2008-10#1)
amino acids for protein synthesis##2##5##(1990-12#1)(2012-1#1)
amino acids for##5##3##(1990-12#4)(2012-1#1)
amino acids from the##3##4##(1992-9#1)(1995-12#1)(1995-2#1)
amino acids from##5##3##(1992-9#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-6#1)
amino acids has been##2##4##(1990-12#1)(1992-11#1)
amino acids has##3##3##(1990-12#1)(1992-11#1)(1996-6#1)
amino acids have been##2##4##(2008-10#1)(2010-1#1)
amino acids highly homologous##2##4##(1993-12#1)(2008-9#1)
amino acids in N terminal##2##5##(2008-8#1)(2008-9#1)
amino acids in Sargassum fusiforme##2##5##(2008-10#2)
amino acids in flow systems##2##5##(2008-10#2)
amino acids in the amino terminal region##2##7##(1994-11#2)
amino acids in the##12##4##(1991-12#1)(1991-5#1)(1991-9#1)(1994-11#2)(1995-2#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
amino acids in##40##3##(1990-12#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-3#2)(1994-11#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#2)
amino acids including cysteine##2##4##(1994-6#1)(2008-10#1)
amino acids long##4##3##(1990-2#1)(1993-3#1)(1995-2#1)(1996-12#1)
amino acids longer##2##3##(1992-3#1)(1993-8#1)
amino acids may##2##3##(1990-12#1)(1995-5#1)
amino acids of the##5##4##(1992-6#1)(1993-6#1)(2008-10#2)(2008-11#1)
amino acids of##21##3##(1990-7#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
amino acids on the##3##4##(1997-3#1)(2008-10#2)
amino acids on##6##3##(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
amino acids or##3##3##(1992-9#1)(1993-8#1)(2008-10#1)
amino acids plus##2##3##(1990-2#1)(1992-6#1)
amino acids possessing##2##3##(1994-6#1)(2008-10#1)
amino acids produced##2##3##(2008-10#2)
amino acids responsible for the##2##5##(1995-5#1)(2013-8#1)
amino acids resulted in##2##4##(1995-12#1)(2008-11#1)
amino acids such as##2##4##(2010-6#1)(2012-1#1)
amino acids that are##2##4##(1994-6#1)(2008-10#1)
amino acids that is##2##4##(1997-7#1)(2008-6#1)
amino acids that##9##3##(1992-3#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
amino acids to##8##3##(1990-11#1)(1992-11#1)(1992-6#2)(1995-5#1)(1997-4#1)(2008-10#1)(2012-2#1)
amino acids using##4##3##(2008-10#4)
amino acids was##6##3##(1993-9#1)(1997-3#1)(2008-10#3)(2008-5#1)
amino acids were obtained##2##4##(1994-9#1)(2008-6#1)
amino acids were separated##2##4##(1994-9#1)(2008-10#1)
amino acids were##16##3##(1990-12#1)(1990-7#1)(1991-12#1)(1994-9#2)(1995-6#1)(1997-3#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-4#1)
amino acids which##5##3##(1993-6#1)(1993-8#1)(1995-12#2)(1996-12#1)
amino acids while##2##3##(2008-10#1)(2008-5#1)
amino acids with a calculated molecular##2##6##(1990-12#1)(1996-6#1)
amino acids with a predicted molecular##2##6##(2008-10#2)
amino acids with a##6##4##(1990-12#1)(1994-11#1)(1996-6#1)(2008-10#2)(2008-8#1)
amino acids with the##2##4##(2008-10#2)
amino acids with##21##3##(1990-12#2)(1990-7#1)(1991-7#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#2)(2006-12#1)(2008-10#8)(2008-8#1)(2010-5#1)
amino acids within the##2##4##(1995-5#1)(2008-11#1)
amino acids within##3##3##(1995-5#2)(2008-11#1)
amino acids##594##2##(1990-11#7)(1990-12#14)(1990-2#5)(1990-5#6)(1990-7#7)(1990-8#2)(1991-11#1)(1991-12#8)(1991-2#8)(1991-5#6)(1991-7#1)(1991-8#1)(1991-9#6)(1992-11#4)(1992-12#7)(1992-3#4)(1992-6#6)(1992-8#8)(1992-9#5)(1993-11#4)(1993-12#4)(1993-2#7)(1993-3#6)(1993-6#8)(1993-8#10)(1993-9#2)(1994-11#8)(1994-12#9)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#11)(1994-8#3)(1994-9#6)(1995-11#6)(1995-12#11)(1995-2#8)(1995-3#3)(1995-5#9)(1995-6#13)(1995-8#8)(1995-9#2)(1996-10#2)(1996-12#3)(1996-3#3)(1996-5#4)(1996-6#4)(1997-2#8)(1997-3#9)(1997-4#4)(1997-6#3)(1997-7#6)(1997-8#1)(2006-12#4)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#132)(2008-11#25)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#26)(2008-6#4)(2008-7#7)(2008-8#17)(2008-9#9)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#6)(2010-5#4)(2010-6#1)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#2)
amino acids) and##3##3##(1995-6#1)(2008-8#2)
amino acids) is##2##3##(1991-5#1)(1992-3#1)
amino acids) with##2##3##(1992-3#1)(1992-8#1)
amino acids)##28##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-3#3)(1992-8#1)(1994-6#1)(1995-6#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#6)(2008-9#2)(2011-3#1)(2013-1#2)
amino aluminum phthalocyanine (TAAlPc)##2##4##(2008-10#2)
amino aluminum phthalocyanine##3##3##(2008-10#3)
amino and carboxyl##2##3##(1990-7#1)(1996-12#1)
amino and##7##2##(1990-7#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-4#2)
amino compounds in##4##3##(2008-10#1)(2012-8#3)
amino compounds##5##2##(2008-10#2)(2012-8#3)
amino group in##3##3##(2007-11#1)(2008-10#2)
amino group of the##3##4##(1992-3#1)(2008-10#2)
amino group of##9##3##(1990-12#1)(1990-5#1)(1992-3#2)(1995-6#1)(2008-10#3)(2009-9#1)
amino group##19##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-3#3)(1995-6#1)(2007-11#1)(2008-10#10)(2009-9#1)
amino groups and##4##3##(1995-12#1)(1997-2#1)(2008-10#2)
amino groups at##2##3##(1992-6#1)(2013-1#1)
amino groups in##3##3##(1990-12#1)(1993-11#1)(2008-10#1)
amino groups of##3##3##(2008-10#2)(2008-7#1)
amino groups on the##2##4##(1994-5#1)(2008-10#1)
amino groups##22##2##(1990-12#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
amino nitrogen##2##2##(1996-5#1)(2012-8#1)
amino terminal segment##2##3##(1994-12#2)
amino terminal##8##2##(1990-5#1)(1992-6#1)(1994-11#3)(1994-12#2)(1997-2#1)
amino terminus (residue 1 to##2##5##(1997-6#1)(1997-8#1)
amino terminus or##2##3##(1992-3#1)(1996-12#1)
amino terminus##20##2##(1991-10#1)(1991-8#3)(1992-3#1)(1992-5#1)(1992-8#3)(1995-2#1)(1996-12#2)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#4)
amino transferase##5##2##(1994-8#1)(2008-10#4)
amino##1712##1##(1990-11#17)(1990-12#41)(1990-2#10)(1990-5#24)(1990-7#28)(1990-8#18)(1991-10#3)(1991-11#2)(1991-12#28)(1991-2#20)(1991-3#1)(1991-5#16)(1991-6#8)(1991-7#2)(1991-8#10)(1991-9#25)(1992-10#2)(1992-11#7)(1992-12#21)(1992-2#1)(1992-3#33)(1992-4#2)(1992-5#2)(1992-6#23)(1992-7#2)(1992-8#35)(1992-9#16)(1993-1#1)(1993-11#21)(1993-12#12)(1993-2#13)(1993-3#22)(1993-5#1)(1993-6#28)(1993-8#25)(1993-9#9)(1994-11#30)(1994-12#24)(1994-2#3)(1994-3#1)(1994-5#16)(1994-6#19)(1994-8#20)(1994-9#17)(1995-11#15)(1995-12#17)(1995-2#21)(1995-3#12)(1995-5#23)(1995-6#34)(1995-8#24)(1995-9#3)(1996-10#10)(1996-12#13)(1996-2#1)(1996-3#5)(1996-5#8)(1996-6#6)(1996-8#2)(1997-1#2)(1997-2#24)(1997-3#15)(1997-4#23)(1997-6#8)(1997-7#17)(1997-8#11)(1997-9#8)(2006-12#5)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-6#4)(2007-7#2)(2008-1#3)(2008-10#297)(2008-11#55)(2008-12#5)(2008-2#7)(2008-3#4)(2008-4#30)(2008-5#47)(2008-6#10)(2008-7#25)(2008-8#53)(2008-9#30)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#7)(2009-9#7)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-4#10)(2010-5#7)(2010-6#1)(2010-7#5)(2011-1#10)(2011-2#23)(2011-3#2)(2012-1#6)(2012-12#2)(2012-2#19)(2012-3#4)(2012-8#7)(2012-9#3)(2013-1#17)(2013-8#10)
amino- and##2##2##(1991-5#1)(2008-10#1)
amino-acid residues##4##2##(1994-3#2)(1995-8#1)(1996-12#1)
amino-acid sequence of multiple lectins##2##5##(1990-5#2)
amino-acid sequence of##6##3##(1990-5#4)(1996-12#1)(1997-3#1)
amino-acid sequence was##3##3##(1990-5#1)(1995-6#1)(1997-3#1)
amino-acid sequence##18##2##(1990-5#6)(1991-2#1)(1993-6#1)(1994-12#3)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#2)(2008-8#1)
amino-acid sequences##4##2##(1990-5#1)(1994-11#2)(1994-12#1)
amino-acid sequencing##2##2##(1990-5#1)(1994-12#1)
amino-acid##39##1##(1990-5#8)(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-11#2)(1994-12#8)(1994-3#3)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#2)(2008-8#1)(2008-9#1)(2010-10#2)
amino-acids##3##1##(1995-6#1)(2008-12#1)(2013-1#1)
amino-alcohols##3##1##(2008-10#3)
amino-modified silica-coated magnetic nanoparticles##3##4##(2008-10#3)
amino-modified##4##1##(2008-10#4)
amino-terminal and##2##2##(1991-12#1)(1995-6#1)
amino-terminal domain##4##2##(1990-11#1)(1990-5#1)(1991-9#1)(1995-6#1)
amino-terminal regions##2##2##(1991-12#1)(1995-11#1)
amino-terminal sequence of the##2##4##(1992-9#1)(1995-6#1)
amino-terminal sequence of##4##3##(1990-2#2)(1992-9#1)(1995-6#1)
amino-terminal sequence##9##2##(1990-2#2)(1990-5#1)(1991-9#1)(1992-9#1)(1995-11#1)(1995-6#2)(2008-10#1)
amino-terminal sequences##5##2##(1990-12#1)(1992-8#1)(1995-11#1)(1996-8#2)
amino-terminal sequencing##2##2##(1992-3#2)
amino-terminal##45##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#2)(1990-7#1)(1991-12#3)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-8#2)(1995-11#3)(1995-6#7)(1996-8#3)(1997-4#1)(1997-6#3)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
amino-terminated##3##1##(2008-10#3)
amino-terminus##3##1##(1990-12#1)(1993-11#1)(1994-8#1)
aminoacid##6##1##(1992-9#5)(2008-10#1)
aminoacids##4##1##(1990-7#1)(2008-1#1)(2008-11#1)(2012-3#1)
aminoacyl-tRNA synthetase##4##2##(1994-6#2)(2012-2#2)
aminoacyl-tRNA##5##1##(1994-6#2)(1994-8#1)(2012-2#2)
aminoacylase##2##1##(2008-5#2)
aminoacylated##3##1##(1993-11#1)(1997-3#1)(2012-2#1)
aminoacylation of##4##2##(1994-8#2)(1997-3#1)(2008-4#1)
aminoacylation##11##1##(1993-8#1)(1994-8#2)(1997-3#4)(2008-4#1)(2008-8#1)(2012-2#2)
aminoacylproline hydrolase##4##2##(1992-3#4)
aminoalkylindoles##2##1##(1991-1#2)
aminobenzyl alcohols##2##2##(1990-7#2)
aminocaproic acid##4##2##(2008-10#3)(2008-7#1)
aminocaproic##5##1##(2008-10#4)(2008-7#1)
aminoglutethimide in##2##2##(1990-10#1)(1993-1#1)
aminoglutethimide##4##1##(1990-10#3)(1993-1#1)
aminoglycoside antibiotics##2##2##(2008-9#1)(2009-8#1)
aminoglycoside##10##1##(1995-2#2)(1995-8#1)(2006-10#1)(2008-9#1)(2009-8#2)(2011-2#1)(2013-8#2)
aminoglycosides and##2##2##(1995-2#1)(2008-7#1)
aminoglycosides are trafficked##2##3##(2012-2#2)
aminoglycosides##16##1##(1995-2#5)(2007-7#1)(2008-12#1)(2008-7#1)(2009-8#5)(2012-2#3)
aminoguanidine##3##1##(1995-12#2)(2010-12#1)
aminomethylbenzoic acid and##4##3##(2008-10#4)
aminomethylbenzoic acid##7##2##(2008-10#7)
aminomutase##2##1##(2008-9#2)
aminooxy##3##1##(1995-12#1)(2008-4#2)
aminooxyacetic acid##2##2##(1992-3#2)
aminopeptidase (EC 3##4##3##(1990-2#4)
aminopeptidase N##5##2##(1990-11#2)(1995-8#2)(2008-11#1)
aminopeptidase activity##2##2##(1990-2#1)(2012-6#1)
aminopeptidase has##2##2##(1990-2#1)(1994-8#1)
aminopeptidase##36##1##(1990-11#4)(1990-2#9)(1991-3#1)(1991-5#3)(1992-3#3)(1992-5#3)(1992-8#1)(1993-6#1)(1994-2#1)(1994-8#3)(1995-6#1)(1995-8#2)(2008-11#1)(2012-2#2)(2012-6#1)
aminopeptidase-M##2##1##(1991-5#2)
aminopeptidases##6##1##(1990-2#3)(1992-5#2)(2010-3#1)
aminophenols##3##1##(1994-5#1)(2008-10#2)
aminophospholipid exposure##3##2##(2006-6#3)
aminophylline##12##1##(2007-8#5)(2008-10#7)
aminopropyl##10##1##(2008-10#6)(2008-5#1)(2009-8#1)(2013-8#2)
aminopropyl-glass bead##3##2##(2008-10#3)
aminopropyl-glass##4##1##(2008-10#4)
aminopropyltransferase##2##1##(2009-8#2)
aminopyridine##2##1##(1995-3#1)(1996-2#1)
aminosaccharides and##3##2##(1991-7#3)
aminosaccharides##4##1##(1991-7#4)
aminoterminal procollagen type-III peptide in##2##5##(1992-5#2)
aminoterminal##4##1##(1992-5#2)(1993-6#1)(1996-5#1)
aminotransferase (ALT)##11##2##(1995-3#1)(2008-10#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
aminotransferase and##2##2##(1995-12#1)(1997-5#1)
aminotransferase in##2##2##(1991-12#1)(1996-10#1)
aminotransferase##70##1##(1990-5#4)(1990-7#4)(1991-12#2)(1992-3#2)(1992-6#4)(1993-2#3)(1993-9#2)(1994-5#2)(1994-6#4)(1995-12#3)(1995-3#2)(1996-10#2)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-5#1)(2009-8#3)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#3)
aminotransferase)##2##1##(2008-10#2)
aminotransferases##5##1##(1992-6#1)(1994-8#1)(1996-11#1)(2008-10#1)(2011-2#1)
aminotriazole##2##1##(2008-10#2)
amiodarone and desethylamiodarone##2##3##(1990-5#2)
amiodarone and##3##2##(1990-5#3)
amiodarone for##2##2##(2006-10#1)(2007-8#1)
amiodarone##16##1##(1990-5#7)(1993-6#3)(1994-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-3#1)
amipurimycin##2##1##(1996-5#2)
amitriptyline intoxication##2##2##(2013-1#2)
amitriptyline##12##1##(1990-11#1)(1992-9#1)(1995-2#5)(2008-10#2)(2013-1#3)
amitrole and atrazin-2-hydroxy##2##3##(2008-10#2)
amitrole with##3##2##(2008-10#3)
amitrole##12##1##(1996-2#1)(2008-10#11)
amlodipine 5mg##2##2##(2008-3#2)
amlodipine besylate in##2##3##(2008-10#2)
amlodipine besylate##5##2##(2008-10#5)
amlodipine##20##1##(1994-9#2)(2007-10#3)(2008-10#6)(2008-3#6)(2012-12#2)(2012-3#1)
ammine-complexes of copper(II)##2##3##(2008-10#2)
ammine-complexes##4##1##(2008-10#4)
ammonia (NH(3))##2##2##(2008-10#2)
ammonia absorption##2##2##(2008-3#2)
ammonia accumulation##2##2##(2008-11#1)(2008-7#1)
ammonia and##18##2##(1991-9#1)(1994-2#1)(2007-12#1)(2008-10#13)(2008-11#1)(2009-8#1)
ammonia at##2##2##(2007-12#2)
ammonia buffer##3##2##(2008-10#3)
ammonia by##4##2##(2008-10#1)(2008-3#2)(2008-6#1)
ammonia concentration##4##2##(2008-11#1)(2008-3#1)(2010-5#2)
ammonia concentrations##4##2##(2008-11#1)(2008-3#2)(2009-4#1)
ammonia detection##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
ammonia detoxification##3##2##(2008-11#2)(2008-7#1)
ammonia gas##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
ammonia in a##2##3##(2010-5#1)(2011-2#1)
ammonia in##11##2##(2007-12#1)(2008-10#8)(2010-5#1)(2011-2#1)
ammonia is##3##2##(2008-10#3)
ammonia molecules##2##2##(2008-10#1)(2008-2#1)
ammonia on##2##2##(1995-3#1)(2008-11#1)
ammonia produced##2##2##(1992-11#1)(2008-10#1)
ammonia solution##2##2##(2008-10#1)(2008-2#1)
ammonia was##9##2##(1990-8#1)(1992-11#1)(1994-5#1)(2008-10#2)(2008-11#4)
ammonia with hypobromite##2##3##(2008-10#2)
ammonia with##3##2##(2008-10#3)
ammonia##185##1##(1990-8#1)(1991-9#1)(1992-11#5)(1993-8#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-3#5)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#84)(2008-11#26)(2008-2#11)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-9#2)(2009-4#2)(2009-8#1)(2010-5#3)(2011-2#2)(2013-1#1)
ammonia-ammonium chloride buffer##3##3##(2008-10#3)
ammonia-lyase##4##1##(1994-5#2)(1994-6#2)
ammonia/ammonium chloride buffer##2##3##(2008-10#2)
ammonium acetate and 1##2##4##(2008-10#2)
ammonium acetate and##5##3##(1996-5#1)(2008-10#4)
ammonium acetate as##2##3##(2008-10#1)(2011-1#1)
ammonium acetate buffer##2##3##(2008-10#2)
ammonium acetate##25##2##(1996-5#1)(2008-10#20)(2011-1#3)(2012-3#1)
ammonium aluminium##2##2##(2008-10#2)
ammonium and nitrate##6##3##(2008-10#6)
ammonium and nitrite##2##3##(2008-10#2)
ammonium and phosphate##2##3##(2008-10#2)
ammonium and##16##2##(2008-10#15)(2008-9#1)
ammonium assimilation##3##2##(1997-1#3)
ammonium at##2##2##(2008-10#2)
ammonium bromide##9##2##(2008-10#9)
ammonium cations##3##2##(2008-10#3)
ammonium chloride##12##2##(1992-11#2)(1995-11#1)(1997-3#1)(2008-10#6)(2008-6#2)
ammonium concentration##3##2##(2008-10#3)
ammonium determination##2##2##(2008-10#2)
ammonium diethyl dithiophosphate##3##3##(2008-10#3)
ammonium diethyldithiophosphate##2##2##(2008-10#2)
ammonium dihydrogenphosphate and##2##3##(2008-10#2)
ammonium dihydrogenphosphate##6##2##(2008-10#6)
ammonium hydroxide##4##2##(2008-10#1)(2008-4#1)(2008-7#2)
ammonium in the##2##3##(2008-10#2)
ammonium in##6##2##(2008-10#6)
ammonium ion and##2##3##(2008-10#2)
ammonium ion concentration in the##2##5##(1995-8#1)(2008-10#1)
ammonium ion selective##2##3##(2008-10#2)
ammonium ion##16##2##(1995-8#1)(2008-10#13)(2008-11#1)(2013-1#1)
ammonium ion-selective##2##2##(2008-10#2)
ammonium ions##9##2##(2008-10#7)(2008-11#2)
ammonium molybdate in##2##3##(2008-10#2)
ammonium molybdate to##2##3##(2008-10#2)
ammonium molybdate##12##2##(2008-10#12)
ammonium nitrate and##2##3##(2008-10#1)(2009-3#1)
ammonium nitrate##7##2##(1991-12#2)(2008-10#4)(2009-3#1)
ammonium oxalate solution##2##3##(2008-10#2)
ammonium pyrolidine##2##2##(2008-10#2)
ammonium pyrrolidine dithiocarbamate (APDC)##7##4##(2008-10#7)
ammonium pyrrolidine dithiocarbamate##8##3##(2008-10#8)
ammonium salt of##3##3##(2008-10#3)
ammonium salt##6##2##(2008-10#5)(2010-4#1)
ammonium salts##7##2##(2007-11#3)(2008-10#4)
ammonium selective##2##2##(2008-10#2)
ammonium sulfate and##2##3##(1992-12#1)(2008-10#1)
ammonium sulfate fractionation##6##3##(1991-12#2)(1994-6#1)(1994-8#1)(1997-4#1)(2010-11#1)
ammonium sulfate fractions##2##3##(2008-10#2)
ammonium sulfate in##2##3##(1995-6#1)(2008-10#1)
ammonium sulfate precipitation and##6##4##(1991-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-4#1)
ammonium sulfate precipitation##10##3##(1991-9#1)(1992-8#1)(1994-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)
ammonium sulfate##32##2##(1990-11#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-6#2)(1994-8#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2013-1#2)
ammonium sulphate##5##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-8#1)(1995-9#1)
ammonium thiocyanate##7##2##(1990-12#1)(2008-10#3)(2008-12#2)(2009-11#1)
ammonium with##3##2##(2008-10#3)
ammonium##295##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-12#4)(1991-5#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-8#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#3)(1997-3#1)(1997-4#2)(2007-11#3)(2008-10#213)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#2)(2011-1#5)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
ammonium-sensitive##2##1##(2008-10#2)
ammunition##6##1##(1995-11#1)(2008-10#1)(2008-11#4)
amnesia and##4##2##(1996-9#1)(2008-7#1)(2008-8#1)(2012-2#1)
amnesia in##2##2##(1994-8#1)(2008-10#1)
amnesia##17##1##(1991-2#1)(1992-11#1)(1993-12#1)(1993-5#1)(1994-8#2)(1995-11#1)(1996-9#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-2#1)(2012-3#1)
amnesic##2##1##(1990-11#1)(1993-12#1)
amnestic effect of##2##3##(1993-12#1)(1994-8#1)
amnestic syndrome with##2##3##(2008-7#1)(2012-2#1)
amnestic##7##1##(1993-12#1)(1994-8#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
amniocenteses##4##1##(1996-3#1)(2012-3#3)
amniocentesis and##2##2##(1990-9#1)(2012-3#1)
amniocentesis in##2##2##(1990-2#1)(1990-9#1)
amniocentesis##17##1##(1990-2#1)(1990-5#1)(1990-9#3)(1992-10#1)(1992-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2012-3#4)(2013-1#3)
amniocytes##2##1##(1990-5#1)(1992-6#1)
amnion tissue##3##2##(1993-3#3)
amnion##6##1##(1990-11#1)(1993-1#1)(1993-3#3)(1994-12#1)
amnion-derived WISH cells##2##3##(1997-1#2)
amniote##4##1##(2010-3#4)
amniotes##6##1##(1996-5#1)(1997-3#2)(2008-8#1)(2010-3#1)(2012-3#1)
amniotic fluid and##4##3##(1995-8#1)(2008-9#2)(2012-2#1)
amniotic fluid cells##2##3##(1992-6#2)
amniotic fluid samples##2##3##(1990-9#1)(2012-2#1)
amniotic fluid was##2##3##(1990-12#1)(2012-2#1)
amniotic fluid##27##2##(1990-12#5)(1990-9#3)(1992-10#1)(1992-12#1)(1992-6#2)(1995-8#3)(2008-1#1)(2008-5#1)(2008-9#2)(2012-12#3)(2012-2#5)
amniotic membrane transplantation##2##3##(2011-1#1)(2011-2#1)
amniotic membrane##7##2##(1993-3#1)(2008-10#1)(2011-1#3)(2011-2#2)
amniotic##39##1##(1990-12#5)(1990-9#3)(1992-10#1)(1992-12#1)(1992-6#2)(1993-1#2)(1993-3#1)(1995-8#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#1)
amoebae to##2##2##(1997-3#1)(2009-8#1)
amoebae##5##1##(1997-3#1)(2008-8#1)(2009-8#2)(2012-2#1)
amoebic liver abscess##3##3##(1995-10#1)(2012-2#2)
amoebic##4##1##(1995-10#1)(2012-12#1)(2012-2#2)
amoeboid##3##1##(2008-6#1)(2008-7#1)(2012-2#1)
among 1##4##2##(1993-12#1)(2008-10#2)(2009-7#1)
among 10##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
among 17##2##2##(2007-10#1)(2009-5#1)
among 2##5##2##(2008-10#4)(2011-1#1)
among 21##2##2##(2008-10#1)(2008-5#1)
among 29##2##2##(1993-2#1)(2008-11#1)
among 30##2##2##(2008-10#1)(2013-1#1)
among 33##3##2##(1992-6#1)(1995-6#1)(2008-5#1)
among 36##2##2##(1994-11#1)(2008-5#1)
among 39##2##2##(2008-10#1)(2009-5#1)
among 41##2##2##(2008-10#1)(2008-5#1)
among 46##2##2##(1990-2#1)(2013-7#1)
among 6##3##2##(2007-8#1)(2008-12#1)(2008-8#1)
among 72##2##2##(2008-10#2)
among 9##2##2##(2008-12#1)(2010-2#1)
among Adults in##2##3##(2008-10#1)(2013-1#1)
among Adults##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
among African American men##4##4##(2009-5#3)(2012-3#1)
among African American##6##3##(2009-5#3)(2009-7#1)(2010-4#1)(2012-3#1)
among African Americans##6##3##(2008-4#1)(2008-5#1)(2009-11#1)(2010-10#1)(2010-4#2)
among African##12##2##(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-4#3)(2012-3#1)
among African-Americans in the##2##4##(2010-6#1)(2013-8#1)
among American Indians##3##3##(2011-2#3)
among American##5##2##(1992-8#1)(2008-8#1)(2011-2#3)
among Asian##3##2##(2008-5#1)(2010-5#1)(2012-2#1)
among B##3##2##(2008-10#2)(2012-2#1)
among Brazilian##3##2##(2012-1#2)(2013-8#1)
among C##3##2##(1993-9#2)(2008-10#1)
among COPD patients##2##3##(2013-8#2)
among California##2##2##(2008-10#1)(2009-2#1)
among Canadian##4##2##(2007-12#1)(2008-10#1)(2010-4#1)(2012-2#1)
among Children##2##2##(2008-11#1)(2012-2#1)
among Chilean adolescents]##2##3##(2013-1#1)(2013-8#1)
among Chilean##4##2##(2013-1#3)(2013-8#1)
among Chinese children and adolescents##2##5##(2007-12#2)
among Chinese children##3##3##(2007-12#2)(2011-1#1)
among Chinese women##2##3##(2013-1#2)
among Chinese##8##2##(2007-12#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
among Dutch##2##2##(1991-6#1)(2011-2#1)
among European##2##2##(2008-10#2)
among HG 3##2##3##(2008-10#2)
among HIV infected patients##2##4##(2007-8#2)
among HIV-infected individuals##2##3##(2010-5#1)(2012-12#1)
among HIV-infected persons##2##3##(2010-5#2)
among HIV-infected##7##2##(2010-5#4)(2011-2#1)(2012-12#2)
among HIV-positive women##2##3##(2011-1#2)
among HIV-positive##4##2##(1996-3#1)(2011-1#2)(2011-2#1)
among Hispanic##3##2##(1991-1#1)(2008-3#1)(2012-12#1)
among Hispanics##2##2##(1995-12#1)(2012-12#1)
among IVDUs##4##2##(1991-1#1)(1992-9#3)
among Iranian patients with##2##4##(2009-10#1)(2012-2#1)
among Iranian patients##3##3##(2008-12#1)(2009-10#1)(2012-2#1)
among Iranian##4##2##(2008-12#1)(2009-10#1)(2012-2#1)(2012-3#1)
among Japanese##4##2##(2008-10#1)(2009-7#1)(2010-4#1)(2012-12#1)
among Jews##2##2##(2007-7#1)(2009-11#1)
among Latino##3##2##(2008-12#1)(2009-9#1)(2013-1#1)
among M##2##2##(2007-7#1)(2008-10#1)
among Nepalese##2##2##(2012-3#2)
among Nigerian##2##2##(2011-1#1)(2013-1#1)
among North American##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
among North##4##2##(1993-12#1)(1995-1#1)(2008-10#1)(2012-3#1)
among Norwegian##10##2##(1990-9#2)(1991-9#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-6#1)(1996-9#1)(1997-6#2)
among Old Order Anabaptist children##2##5##(2008-12#2)
among Old##3##2##(2007-12#1)(2008-12#2)
among Pacific##3##2##(2008-1#2)(2012-2#1)
among Pacificans##4##2##(2008-1#4)
among Pennsylvania##2##2##(1992-1#1)(2008-10#1)
among Prunus species##2##3##(2011-2#2)
among S##2##2##(2010-8#1)(2013-8#1)
among SIVs##2##2##(2013-1#2)
among South African youth##2##4##(2011-1#2)
among Spanish##2##2##(2008-10#1)(2011-2#1)
among States##3##2##(1994-3#1)(1996-1#1)(1996-2#1)
among T##3##2##(2008-10#1)(2012-3#2)
among Turkish##4##2##(1992-5#2)(2009-12#1)(2012-12#1)
among UC##2##2##(2013-8#2)
among V##3##2##(2008-10#3)
among X##5##2##(2008-10#5)
among a group of##4##4##(2008-11#2)(2008-12#1)(2012-1#1)
among a large##2##3##(2009-2#1)(2012-3#1)
among a sample of##3##4##(1996-1#1)(2009-7#1)(2010-9#1)
among a##28##2##(1990-7#1)(1991-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
among accessions##3##2##(2008-10#1)(2008-5#2)
among adolescent girls##2##3##(1991-11#1)(2013-1#1)
among adolescent##9##2##(1991-1#1)(1991-11#1)(2008-11#1)(2009-10#1)(2009-5#3)(2013-1#2)
among adolescents in##6##3##(1996-1#1)(2008-9#2)(2009-10#1)(2012-12#2)
among adolescents is##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
among adolescents who##2##3##(2009-7#2)
among adolescents with##3##3##(2010-11#1)(2012-12#1)(2013-1#1)
among adolescents##36##2##(1994-2#2)(1996-1#1)(1996-12#1)(1996-6#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-9#6)(2009-10#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2012-12#4)(2012-2#1)(2013-1#7)
among adult women##3##3##(1991-6#1)(2008-9#1)(2012-2#1)
among adult##8##2##(1991-6#1)(2008-10#1)(2008-9#2)(2009-12#1)(2009-4#1)(2012-2#1)(2013-8#1)
among adults in the##2##4##(1995-9#1)(2010-10#1)
among adults##10##2##(1991-12#1)(1995-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
among affected##3##2##(1997-5#1)(2010-8#1)(2012-3#1)
among african##2##2##(2009-7#1)(2011-1#1)
among all participants##2##3##(1996-3#1)(2010-7#1)
among all patients##2##3##(2007-8#1)(2011-2#1)
among all strains##3##3##(2008-10#3)
among all the##11##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#3)
among all##43##2##(1990-5#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-3#1)
among amino##2##2##(1997-2#1)(2008-10#1)
among amniotes##2##2##(2008-8#1)(2010-3#1)
among an at random sample of family doctors in North Holland (n = 521)##2##14##(1991-8#2)
among an##6##2##(1991-8#2)(1992-12#1)(2008-10#1)(2009-7#1)(2010-1#1)
among and between##2##3##(2010-10#1)(2012-3#1)
among and##3##2##(2008-10#1)(2010-10#1)(2012-3#1)
among anurans##2##2##(2008-5#2)
among athletes##2##2##(1996-6#1)(2010-7#1)
among bacteria##2##2##(1994-8#1)(2008-10#1)
among bacterial##2##2##(1993-12#1)(2008-10#1)
among blacks##2##2##(1995-12#1)(2007-10#1)
among blood donors in##2##4##(2009-4#1)(2013-1#1)
among both the##5##3##(1995-11#1)(2008-1#1)(2008-10#1)(2010-7#1)(2013-8#1)
among both##12##2##(1994-1#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-8#2)
among cancer survivors##3##3##(2008-7#3)
among cancer##4##2##(1991-3#1)(2008-7#3)
among caregivers of##4##3##(1995-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
among caregivers##5##2##(1995-2#1)(2008-3#1)(2008-7#2)(2013-8#1)
among carriers##2##2##(2010-6#1)(2012-3#1)
among cases##4##2##(1991-6#1)(2008-6#1)(2011-1#2)
among cell##2##2##(2008-1#1)(2010-12#1)
among cells##2##2##(2008-11#1)(2012-12#1)
among certain##3##2##(1990-12#1)(2010-1#1)(2013-1#1)
among chemical##2##2##(2007-11#1)(2010-7#1)
among children and adolescents##6##4##(2007-12#1)(2008-11#1)(2010-11#2)(2010-7#1)(2012-12#1)
among children and young##2##4##(1991-6#1)(2013-8#1)
among children and##10##3##(1991-6#1)(2007-12#1)(2008-11#1)(2010-11#2)(2010-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
among children in Brazil and##2##5##(2008-9#2)
among children in##5##3##(1997-4#1)(2007-7#1)(2008-9#2)(2011-2#1)
among children under##2##3##(2008-1#1)(2013-1#1)
among children who##5##3##(1994-6#2)(2009-7#1)(2012-1#2)
among children with##7##3##(1992-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-2#2)(2013-1#1)
among children##45##2##(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#1)(1994-6#3)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
among chronic##3##2##(2007-7#1)(2012-12#2)
among circumpolar indigenous individuals##2##4##(2013-1#2)
among clinical##3##2##(1997-8#1)(2010-7#1)(2012-2#1)
among clinicians and##2##3##(1990-6#1)(2013-1#1)
among clinicians##6##2##(1990-6#1)(1997-2#1)(2008-1#1)(2011-2#2)(2013-1#1)
among closely related##2##3##(2008-8#1)(2008-9#1)
among closely##3##2##(1991-10#1)(2008-8#1)(2008-9#1)
among collections##2##2##(2008-10#2)
among college students##3##3##(2007-12#1)(2009-4#1)(2013-8#1)
among common##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
among communities##2##2##(1996-12#1)(2011-2#1)
among community##3##2##(2007-10#1)(2009-10#1)(2012-12#1)
among competitors##2##2##(2008-1#1)(2008-8#1)
among continents##2##2##(2008-10#2)
among controls compared to##2##4##(2011-1#2)
among cortical##2##2##(1995-2#1)(2009-8#1)
among countries##5##2##(1996-3#1)(1997-8#1)(2008-10#2)(2009-7#1)
among cropping systems##3##3##(2008-10#3)
among cultivars##3##2##(2008-10#3)
among current##3##2##(1992-3#1)(1994-1#1)(2007-12#1)
among dental##2##2##(1996-9#1)(2009-5#1)
among depressed adolescents##2##3##(2010-2#2)
among depressed##4##2##(2009-11#1)(2010-2#3)
among diabetes patients##2##3##(2008-8#1)(2011-1#1)
among diabetes##3##2##(2008-1#1)(2008-8#1)(2011-1#1)
among diabetic patients##2##3##(2007-2#1)(2008-8#1)
among diabetics##3##2##(1992-11#1)(2011-2#2)
among different populations##4##3##(1997-8#1)(2011-2#1)(2013-1#2)
among different species##5##3##(1997-3#1)(2008-10#1)(2010-3#1)(2012-3#1)(2013-8#1)
among different##55##2##(1990-3#1)(1994-11#1)(1994-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#2)
among disciplines##2##2##(1991-12#1)(2008-1#1)
among distinct##2##2##(2008-10#1)(2008-8#1)
among diverse##3##2##(1995-2#1)(2009-10#2)
among doctors##3##2##(1990-6#1)(1991-4#2)
among drug users in Norway##2##5##(1996-11#2)
among drug users in##3##4##(1991-12#1)(1996-11#2)
among drug users##5##3##(1991-12#3)(1996-11#2)
among drug##6##2##(1991-12#3)(1996-11#3)
among each population of##2##4##(1994-9#2)
among each##4##2##(1994-9#2)(2008-10#1)(2008-8#1)
among early adolescents##2##3##(2009-7#2)
among early##3##2##(2008-12#1)(2009-7#2)
among eastern##2##2##(2008-10#1)(2008-8#1)
among education workers##4##3##(2007-12#4)
among eight##4##2##(1993-12#1)(2008-10#3)
among elderly Brazilians assisted at healthcare facilities##2##7##(2013-8#2)
among elderly individuals##2##3##(2013-8#2)
among elderly##9##2##(2007-10#1)(2008-3#2)(2010-1#1)(2011-1#1)(2013-8#4)
among employees##2##2##(1990-2#1)(1991-12#1)
among environments##2##2##(2008-10#1)(2008-8#1)
among ethnic groups##3##3##(2008-1#1)(2010-8#1)(2012-12#1)
among ethnic##4##2##(2008-1#2)(2010-8#1)(2012-12#1)
among evaluators##2##2##(2013-1#2)
among experiments##3##2##(2008-10#3)
among experts##3##2##(2011-10#1)(2011-2#1)(2013-1#1)
among factory##2##2##(2008-11#1)(2010-8#1)
among families##3##2##(2009-11#1)(2010-3#1)(2012-12#1)
among family members##4##3##(1990-12#1)(2009-11#1)(2011-2#1)(2012-2#1)
among family##5##2##(1990-12#1)(1991-12#1)(2009-11#1)(2011-2#1)(2012-2#1)
among female victims of child abuse##2##6##(2009-9#2)
among female##6##2##(2008-1#1)(2008-8#1)(2009-9#2)(2010-8#1)(2011-1#1)
among females in##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
among females##7##2##(1991-1#1)(1994-6#1)(1995-9#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
among females)##2##2##(1993-9#1)(1994-12#1)
among fields within##3##3##(2008-10#3)
among fields##6##2##(2008-10#6)
among fish##3##2##(2008-12#1)(2008-6#1)(2008-8#1)
among fishermen##3##2##(1993-11#2)(1995-6#1)
among five isolates##2##3##(2008-10#2)
among five##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
among four species##2##3##(2008-5#1)(2009-8#1)
among four##6##2##(1992-2#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-8#1)
among free-living animals##3##3##(2008-9#3)
among gay##2##2##(2008-12#1)(2009-5#1)
among gender and digit##2##4##(2008-9#2)
among gender##4##2##(1994-2#1)(2008-12#1)(2008-9#2)
among genes##3##2##(2008-10#1)(2008-7#2)
among genetic##3##2##(1993-12#1)(2008-10#1)(2009-3#1)
among genotypes##2##2##(2008-10#1)(2012-5#1)
among girls##2##2##(2008-9#1)(2013-1#1)
among group members##2##3##(1996-2#1)(2008-8#1)
among group##3##2##(1996-2#1)(2008-8#2)
among groups in##2##3##(2008-5#2)
among groups of##2##3##(2008-10#1)(2011-2#1)
among groups##10##2##(2008-10#2)(2008-5#2)(2009-1#1)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#1)
among health care professionals##3##4##(1992-12#1)(1992-3#1)(1997-3#1)
among health care providers in##2##5##(1992-2#1)(2010-11#1)
among health care providers##4##4##(1992-12#1)(1992-2#1)(1996-3#1)(2010-11#1)
among health care##10##3##(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1996-3#1)(1997-3#1)(2008-11#1)(2010-11#1)
among health professionals and##3##4##(1993-2#1)(2010-9#1)(2012-3#1)
among health professionals##5##3##(1993-12#1)(1993-2#1)(2008-11#1)(2010-9#1)(2012-3#1)
among health##20##2##(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-11#2)(2010-11#1)(2010-9#1)(2012-3#1)
among healthcare professionals##3##3##(2008-12#1)(2013-1#2)
among healthcare workers in Jamaica##2##5##(2011-2#2)
among healthcare workers in##3##4##(2011-2#2)(2012-12#1)
among healthcare workers##4##3##(2011-2#2)(2012-12#2)
among healthcare##7##2##(2008-12#1)(2011-2#2)(2012-12#2)(2013-1#2)
among healthy children##3##3##(2011-1#2)(2012-2#1)
among healthy subjects##3##3##(1990-2#1)(2008-5#1)(2012-2#1)
among healthy##10##2##(1990-2#1)(1991-11#1)(2008-10#3)(2008-5#1)(2011-1#2)(2012-2#2)
among heart##2##2##(2008-9#1)(2012-3#1)
among hemodialysis patients##3##3##(2008-1#1)(2010-5#2)
among hemodialysis##4##2##(2008-1#2)(2010-5#2)
among high school students in the Tiko health district##2##9##(2013-1#2)
among high school students##3##4##(2008-7#1)(2013-1#2)
among high##7##2##(1995-1#1)(2007-12#1)(2007-4#1)(2008-7#1)(2012-12#1)(2013-1#2)
among homosexual and bisexual men##2##5##(1991-11#1)(2013-7#1)
among homosexual men in##2##4##(1996-11#2)
among homosexual men##3##3##(1996-11#3)
among homosexual##5##2##(1991-11#1)(1996-11#3)(2013-7#1)
among homosexuals in##2##3##(1993-6#1)(1996-11#1)
among hospitalized patients##2##3##(2007-12#1)(2013-1#1)
among hospitalized##4##2##(2007-12#1)(2008-11#1)(2009-4#1)(2013-1#1)
among hospitals##5##2##(1992-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(2010-8#1)
among host##2##2##(2008-10#2)
among human##6##2##(1990-8#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-11#1)
among humans##2##2##(2007-12#1)(2013-1#1)
among hybrids##2##2##(2008-10#1)(2012-3#1)
among hypertensive##2##2##(2012-2#1)(2013-8#1)
among independent community dwelling older adults##2##6##(2008-12#2)
among individual##7##2##(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
among individuals and##3##3##(2008-11#1)(2008-12#1)(2010-9#1)
among individuals are##2##3##(2008-1#1)(2008-8#1)
among individuals with##5##3##(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
among individuals within##4##3##(2008-10#2)(2008-5#1)(2012-7#1)
among individuals##25##2##(1992-10#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
among infants and##3##3##(1992-12#1)(2008-8#1)(2011-2#1)
among infants in##2##3##(1992-11#2)
among infants##8##2##(1992-11#2)(1992-12#2)(1997-4#1)(2008-8#1)(2009-6#1)(2011-2#1)
among infected plants##2##3##(2008-10#2)
among insects##4##2##(2007-12#3)(2010-4#1)
among intravenous drug users (IVDUs)##2##5##(1991-1#1)(1992-9#1)
among intravenous drug users##4##4##(1991-1#1)(1991-12#1)(1992-9#1)(2013-8#1)
among intravenous drug##6##3##(1990-3#1)(1991-1#1)(1991-12#1)(1992-9#1)(2013-8#2)
among isolates and##2##3##(2008-10#2)
among isolates for##2##3##(2008-10#2)
among isolates from different##2##4##(2008-10#2)
among isolates from the##3##4##(2008-10#3)
among isolates from##6##3##(2008-10#6)
among isolates in the##3##4##(2008-10#3)
among isolates in##4##3##(2008-10#4)
among isolates of either##2##4##(2008-10#2)
among isolates of##10##3##(1996-12#1)(2008-10#8)(2012-2#1)
among isolates sampled from##2##4##(2008-10#2)
among isolates within##6##3##(2008-10#6)
among isolates##50##2##(1996-12#1)(2008-10#48)(2012-2#1)
among its##4##2##(1995-2#1)(2007-11#1)(2010-12#1)(2012-12#1)
among juveniles##2##2##(2008-11#1)(2008-9#1)
among key##2##2##(2007-5#1)(2008-10#1)
among laboratories and##2##3##(2008-9#1)(2012-3#1)
among laboratories##4##2##(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
among large##2##2##(2008-11#1)(2011-2#1)
among lesions##2##2##(2008-10#2)
among lineages##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)
among local##2##2##(1996-1#1)(2009-5#1)
among locations in##2##3##(2008-10#1)(2011-2#1)
among locations were##2##3##(2008-10#2)
among locations##8##2##(1993-6#1)(2008-10#6)(2011-2#1)
among loci##2##2##(2008-10#1)(2010-5#1)
among long-term##4##2##(2007-2#1)(2008-1#1)(2008-7#1)(2010-10#1)
among low income##3##3##(1991-6#2)(2008-9#1)
among low##5##2##(1991-6#2)(1995-1#1)(2008-10#1)(2008-9#1)
among low-income##3##2##(1997-2#1)(2008-9#1)(2013-1#1)
among lung##2##2##(1992-11#1)(2008-1#1)
among machinists##2##2##(1991-12#2)
among maize genotypes##2##3##(2011-2#2)
among male Filipino seafarers##2##4##(2011-2#2)
among male physicians who##2##4##(2011-2#2)
among male##8##2##(2007-2#1)(2008-7#1)(2008-8#1)(2011-2#4)(2012-2#1)
among males and females##2##4##(2008-5#1)(2009-5#1)
among males and##6##3##(1990-6#1)(1993-9#1)(1994-12#1)(2008-5#1)(2008-8#1)(2009-5#1)
among males##12##2##(1990-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-9#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-5#1)(2013-1#1)(2013-8#1)
among managed care##2##3##(1994-1#1)(1994-3#1)
among mangrove##2##2##(2007-5#1)(2008-5#1)
among many##10##2##(1991-3#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#2)(2011-1#1)
among markers##2##2##(2008-8#2)
among medical patients##2##3##(2010-12#2)
among medical specialties and systems of care##2##7##(1992-4#2)
among medical students in##4##4##(1993-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
among medical##12##2##(1992-4#2)(1993-3#1)(1995-2#1)(2008-7#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
among members of##3##3##(1996-6#1)(2008-10#1)(2009-5#1)
among men in##2##3##(1991-3#1)(1995-2#1)
among men##15##2##(1991-3#1)(1991-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-5#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
among middle##2##2##(1990-9#1)(2012-12#1)
among migrant##2##2##(2009-10#1)(2011-2#1)
among military personnel of Ukrainian Armed##2##6##(2011-1#2)
among military personnel##3##3##(2011-1#2)(2011-2#1)
among minority##2##2##(2012-3#2)
among modes##2##2##(2007-11#1)(2008-2#1)
among most##2##2##(1991-1#1)(2010-3#1)
among mothers##5##2##(2008-9#2)(2009-5#1)(2010-10#1)(2011-1#1)
among multiple sclerosis patients##2##4##(2010-2#1)(2012-12#1)
among multiple##5##2##(1995-12#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-12#1)
among muscles monitored with##2##4##(2012-2#2)
among neighboring##2##2##(1991-1#1)(2008-9#1)
among new users of meloxicam##2##5##(2008-11#2)
among newborns##2##2##(1991-3#2)
among newly##3##2##(1994-3#1)(2012-12#1)(2013-1#1)
among nine##2##2##(2008-10#1)(2008-5#1)
among nonrelatives##2##2##(2008-8#2)
among nonresponders##2##2##(2008-9#2)
among normal##2##2##(1995-5#1)(2013-1#1)
among northern Native##2##3##(2012-3#2)
among northern##3##2##(2012-3#3)
among nurses in##2##3##(2008-7#1)(2012-3#1)
among nurses##5##2##(1990-2#1)(2008-11#1)(2008-7#1)(2012-3#2)
among nursing home residents##2##4##(1995-2#2)
among nursing home##3##3##(1995-2#2)(1997-2#1)
among nursing##7##2##(1995-2#2)(1996-3#2)(1997-2#1)(2008-11#1)(2008-12#1)
among obese children##2##3##(2009-9#1)(2011-1#1)
among obese##4##2##(2008-10#1)(2009-9#1)(2011-1#1)(2013-1#1)
among occupied patches##2##3##(2008-8#2)
among older adults##7##3##(1997-3#1)(2008-4#1)(2009-11#1)(2010-11#1)(2010-8#1)(2013-1#2)
among older people##2##3##(2012-12#1)(2013-1#1)
among older##20##2##(1992-6#1)(1994-1#1)(1994-3#2)(1997-3#1)(2007-12#1)(2008-4#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#3)
among one##3##2##(1992-6#1)(2012-12#1)(2013-7#1)
among oral##2##2##(2007-11#1)(2008-1#1)
among organ transplant recipients##2##4##(2007-12#2)
among other causes##2##3##(2007-10#1)(2008-10#1)
among other factors##2##3##(1994-9#1)(2012-2#1)
among other things##10##3##(1990-2#1)(1994-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
among other##30##2##(1990-2#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-3#2)(1996-6#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
among others##29##2##(1990-6#1)(1990-8#1)(1991-8#1)(1992-6#2)(1993-11#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
among our##2##2##(2007-8#1)(2013-1#1)
among pairs of##3##3##(2008-10#3)
among parental##2##2##(2008-9#1)(2009-2#1)
among parents of##2##3##(1993-3#1)(2011-1#1)
among parents##5##2##(1993-3#1)(1994-6#1)(2008-9#1)(2011-1#1)(2013-8#1)
among participants##4##2##(2008-11#1)(2011-2#2)(2013-8#1)
among participating##2##2##(1997-3#1)(2008-3#1)
among patches##4##2##(2008-8#1)(2008-9#3)
among pathovars of##2##3##(2008-10#2)
among pathovars##3##2##(2008-10#3)
among pathways##2##2##(1994-2#1)(2012-2#1)
among patient populations##2##3##(1995-2#1)(2011-2#1)
among patient##4##2##(1995-2#1)(2007-11#1)(2008-4#1)(2011-2#1)
among patients admitted to##2##4##(2006-8#2)
among patients and##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
among patients of##2##3##(2012-3#1)(2013-1#1)
among patients on##3##3##(2007-7#2)(2011-3#1)
among patients presenting##2##3##(2008-3#1)(2008-8#1)
among patients receiving##2##3##(2009-8#1)(2010-3#1)
among patients treated##3##3##(1992-9#1)(2007-8#1)(2008-3#1)
among patients who##4##3##(2008-11#1)(2008-6#1)(2011-2#2)
among patients with systemic lupus erythematosus##2##6##(2006-10#2)
among patients with the##2##4##(2008-1#1)(2012-3#1)
among patients with type##2##4##(2008-7#1)(2011-2#1)
among patients with##38##3##(1991-3#1)(2006-10#4)(2007-10#3)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
among patients without##2##3##(1992-5#1)(2007-8#1)
among patients##84##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-2#2)(1994-12#1)(2006-10#5)(2006-8#3)(2007-10#3)(2007-11#2)(2007-7#5)(2007-8#4)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#1)(2009-12#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
among pea cultivars##2##3##(2008-10#2)
among pediatric patients##2##3##(2008-12#1)(2013-1#1)
among people living with HIV/AIDS##6##5##(2011-1#6)
among people of##2##3##(2007-12#1)(2013-8#1)
among people with##5##3##(1997-1#2)(2008-3#1)(2010-4#2)
among people##18##2##(1990-11#1)(1991-9#1)(1997-1#2)(2007-12#1)(2008-3#2)(2010-4#2)(2011-1#7)(2012-3#1)(2013-8#1)
among persons aged 40-42##2##4##(1991-6#2)
among persons at##2##3##(1997-3#2)
among persons of##2##3##(1994-12#1)(2010-8#1)
among persons with##3##3##(2007-10#1)(2008-2#1)(2012-1#1)
among persons##15##2##(1991-6#2)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#2)(1997-3#2)(2007-10#1)(2008-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
among phenotypes##4##2##(2008-10#1)(2011-1#3)
among phenotypic##2##2##(2008-10#1)(2008-8#1)
among physicians in##2##3##(1992-5#1)(2008-7#1)
among physicians##11##2##(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-1#1)(1995-5#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
among plant##4##2##(2008-10#2)(2008-5#2)
among plant-associated##2##2##(2008-10#2)
among plants##4##2##(1997-4#1)(2008-8#1)(2008-9#2)
among polygynous than monogamous##2##4##(2008-9#2)
among polygynous##3##2##(2008-9#3)
among poplar clones##2##3##(2011-2#2)
among population##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
among populations adapted to##2##4##(2012-3#2)
among populations from##2##3##(2008-10#1)(2008-8#1)
among populations in##2##3##(2008-10#2)
among populations of##4##3##(2008-10#3)(2010-3#1)
among populations that##2##3##(2008-10#1)(2008-8#1)
among populations was found##2##4##(2008-10#2)
among populations was##3##3##(2008-10#3)
among populations within regions##2##4##(2008-10#2)
among populations within##3##3##(2008-10#2)(2013-1#1)
among populations##33##2##(2008-1#1)(2008-10#17)(2008-8#4)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
among potential##2##2##(1990-11#1)(2010-12#1)
among pregnant women in##3##4##(1990-6#1)(2013-1#1)(2013-8#1)
among pregnant women##10##3##(1990-6#1)(1994-6#1)(2007-12#1)(2008-4#1)(2010-8#2)(2012-3#1)(2013-1#2)(2013-8#1)
among pregnant##11##2##(1990-6#1)(1994-6#1)(1995-6#1)(2007-12#1)(2008-4#1)(2010-8#2)(2012-3#1)(2013-1#2)(2013-8#1)
among primary school children in##3##5##(2008-10#2)(2010-8#1)
among primary##5##2##(1995-6#1)(2008-1#1)(2008-10#2)(2010-8#1)
among prisoners##2##2##(2008-12#2)
among professionals##2##2##(2012-3#1)(2013-1#1)
among providers##7##2##(1994-1#2)(1994-12#1)(1996-12#1)(1996-2#1)(2013-8#2)
among provinces##3##2##(2008-10#3)
among public health##3##3##(1995-12#1)(1997-1#1)(2007-12#1)
among public##5##2##(1992-1#1)(1995-12#1)(1997-1#1)(2007-12#1)(2012-12#1)
among quality##2##2##(1995-12#1)(1995-3#1)
among raters##2##2##(2008-10#2)
among referring##2##2##(2008-12#1)(2012-2#1)
among regions and##2##3##(2008-10#2)
among regions##9##2##(2008-10#9)
among relatively healthy older##2##4##(2011-1#2)
among relatively##3##2##(2007-12#1)(2011-1#2)
among researchers and##3##3##(1996-4#1)(2008-1#1)(2011-1#1)
among researchers##4##2##(1992-2#1)(1996-4#1)(2008-1#1)(2011-1#1)
among residents of a##2##4##(2011-2#1)(2013-1#1)
among residents of##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
among residents##5##2##(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
among respondents##2##2##(1993-6#1)(1995-6#1)
among risk factors##2##3##(1992-10#1)(2012-12#1)
among rural##6##2##(2009-5#1)(2010-10#1)(2010-6#1)(2012-1#1)(2013-1#2)
among sampling##5##2##(2008-10#5)
among school children in##3##4##(2007-7#1)(2008-10#1)(2011-2#1)
among school children##4##3##(1991-9#1)(2007-7#1)(2008-10#1)(2011-2#1)
among school##6##2##(1991-12#1)(1991-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
among schoolchildren##6##2##(1992-6#1)(1996-11#2)(2010-8#3)
among seafarers##4##2##(2011-2#4)
among secondary school##2##3##(2011-2#1)(2013-1#1)
among selected##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
among senior##2##2##(1996-1#1)(2007-3#1)
among seven##5##2##(1994-11#1)(1997-5#1)(2008-10#3)
among several other materials##2##4##(2013-1#2)
among several##10##2##(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-1#2)
among sexual##2##2##(2008-12#1)(2011-2#1)
among single##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
among sites##3##2##(1992-6#1)(2008-10#1)(2008-8#1)
among six##5##2##(2008-10#3)(2008-9#2)
among social##3##2##(2008-8#1)(2010-1#1)(2012-3#1)
among soil##2##2##(2008-10#2)
among some##4##2##(1993-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
among species in##2##3##(2008-8#1)(2010-8#1)
among species that##2##3##(2008-10#1)(2010-6#1)
among species##18##2##(1991-6#1)(1992-10#1)(1993-3#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-2#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
among spotted fever group##2##4##(1991-8#1)(1995-12#1)
among staff##3##2##(1994-2#1)(1996-2#1)(2011-1#1)
among stakeholders##2##2##(2011-1#1)(2013-1#1)
among strain##2##2##(1994-8#1)(2008-10#1)
among strains from##3##3##(2008-10#3)
among strains of X##2##4##(2008-10#2)
among strains of##5##3##(2008-10#5)
among strains##27##2##(2008-10#24)(2008-2#1)(2008-5#1)(2009-5#1)
among students and##3##3##(2008-11#1)(2008-12#1)(2010-4#1)
among students is##2##3##(2007-12#1)(2013-1#1)
among students##8##2##(1993-6#1)(2007-12#1)(2008-11#2)(2008-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
among studies of##2##3##(2009-6#1)(2011-1#1)
among studies##6##2##(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#1)
among study##2##2##(1995-2#1)(2012-2#1)
among subjects with##2##3##(1995-9#1)(2012-3#1)
among subjects##8##2##(1993-12#1)(1995-9#1)(2008-4#1)(2012-3#1)(2013-1#3)(2013-8#1)
among subpopulations##5##2##(2008-10#4)(2008-4#1)
among successive##2##2##(2007-11#1)(2008-7#1)
among surgeons##2##2##(2010-12#1)(2013-1#1)
among survivors##3##2##(2008-6#1)(2008-7#1)(2008-8#1)
among symptomatic and asymptomatic pregnant women##2##6##(2010-8#2)
among target##2##2##(2008-3#1)(2012-12#1)
among taxa in##2##3##(2008-8#1)(2008-9#1)
among taxa##3##2##(2008-8#1)(2008-9#2)
among teenagers##2##2##(2008-9#1)(2009-7#1)
among the 17##2##3##(2008-10#1)(2008-11#1)
among the 9##3##3##(1991-5#1)(2008-12#2)
among the Japanese##2##3##(2008-7#2)
among the New##2##3##(2008-5#1)(2011-1#1)
among the Xavánte##2##3##(1991-12#2)
among the affected##2##3##(2007-7#1)(2011-1#1)
among the aging##2##3##(2008-12#1)(2009-12#1)
among the arsenic exposed population##2##5##(2011-2#2)
among the best##2##3##(1995-11#1)(2008-5#1)
among the biocontrol isolates##2##4##(2008-10#2)
among the cells##2##3##(2008-11#1)(2008-6#1)
among the children##2##3##(2012-3#1)(2013-1#1)
among the common##2##3##(2008-10#1)(2008-8#1)
among the different groups##2##4##(1996-12#1)(2012-3#1)
among the different##12##3##(1990-9#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#2)(2013-8#1)
among the drug addicts##3##4##(2007-7#3)
among the elderly in##3##4##(2008-8#1)(2011-2#1)(2012-1#1)
among the elderly##12##3##(1990-2#1)(1994-12#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#2)
among the experimental groups##2##4##(2008-5#2)
among the female##2##3##(2009-7#1)(2011-2#1)
among the first 25##2##4##(2008-9#2)
among the first##5##3##(1993-3#1)(2008-8#1)(2008-9#2)(2012-2#1)
among the five##3##3##(2008-10#2)(2011-2#1)
among the four##10##3##(1990-8#1)(1994-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)
among the fungi##2##3##(2008-9#1)(2009-6#1)
among the general##3##3##(2008-11#1)(2012-12#1)(2012-3#1)
among the groups##4##3##(1990-3#1)(2012-2#1)(2013-1#2)
among the highest in the world##3##6##(2008-12#1)(2008-7#1)(2010-12#1)
among the highest##8##3##(2006-10#1)(2008-12#1)(2008-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2012-1#1)
among the index##2##3##(1993-1#1)(2008-9#1)
among the instruments##2##3##(1995-3#1)(2011-1#1)
among the isolates that##2##4##(2008-10#2)
among the isolates##8##3##(2008-10#7)(2008-12#1)
among the key##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
among the largest##3##3##(1996-3#1)(1997-7#1)(2007-12#1)
among the last##2##3##(1997-8#1)(2010-4#1)
among the latter##2##3##(2008-10#1)(2011-2#1)
among the lowest##2##3##(1996-1#1)(2009-10#1)
among the major##3##3##(1996-2#1)(2010-5#1)(2012-2#1)
among the male##2##3##(1993-11#1)(2013-8#1)
among the migrants##2##3##(1992-8#2)
among the most common##9##4##(1993-1#1)(2008-10#1)(2008-12#2)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)
among the most important##3##4##(1994-9#1)(2008-12#1)(2013-7#1)
among the most prevalent of##2##5##(2008-5#1)(2013-8#1)
among the most##36##3##(1992-6#1)(1993-1#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
among the newly##2##3##(2011-2#1)(2013-1#1)
among the nine##6##3##(1992-2#1)(2008-10#3)(2008-5#1)(2011-1#1)
among the number of##2##4##(2006-6#1)(2008-5#1)
among the other##3##3##(2008-10#2)(2011-2#1)
among the patients with##2##4##(2008-10#1)(2008-12#1)
among the patients##6##3##(1990-5#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
among the people##2##3##(2010-8#1)(2013-8#1)
among the poor##2##3##(2008-11#1)(2008-7#1)
among the population of##4##4##(2007-10#1)(2011-2#1)(2013-8#2)
among the population##5##3##(1997-6#1)(2007-10#1)(2011-2#1)(2013-8#2)
among the populations##4##3##(1990-8#1)(2008-10#2)(2009-9#1)
among the potential##4##3##(2008-10#1)(2010-12#1)(2010-8#1)(2010-9#1)
among the primary##2##3##(1997-3#1)(2008-3#1)
among the provinces##2##3##(2008-7#1)(2008-8#1)
among the range##2##3##(2008-8#2)
among the residents##2##3##(2008-1#1)(2013-8#1)
among the respondents##3##3##(2008-4#1)(2010-8#2)
among the risk##2##3##(1990-9#1)(2012-2#1)
among the same##3##3##(1997-4#1)(2008-11#1)(2008-9#1)
among the sampled isolates##2##4##(2008-10#2)
among the seven##2##3##(2008-4#1)(2009-8#1)
among the sites##2##3##(2008-10#1)(2008-6#1)
among the species##4##3##(1997-4#1)(2008-8#1)(2009-8#1)(2010-4#1)
among the strains##2##3##(2008-5#2)
among the subjects##2##3##(1995-12#1)(2009-6#1)
among the ten##2##3##(2008-11#1)(2013-8#1)
among the tested##6##3##(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#1)
among the three groups##8##4##(1991-9#1)(1993-1#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-5#1)(2013-8#1)
among the three##30##3##(1991-9#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-5#1)(2013-8#2)
among the treated##2##3##(2008-12#1)(2009-6#1)
among the two groups##2##4##(2007-11#1)(2010-8#1)
among the two##5##3##(2007-11#1)(2008-10#2)(2008-7#1)(2010-8#1)
among the various##12##3##(1990-7#1)(1990-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#1)(2007-11#1)(2008-10#3)(2008-6#1)(2011-2#1)
among the workers##2##3##(1996-3#1)(2009-12#1)
among the younger##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
among the##586##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#5)(1992-8#2)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#4)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-7#9)(2007-8#3)(2008-1#7)(2008-10#107)(2008-11#14)(2008-12#19)(2008-2#2)(2008-3#14)(2008-4#5)(2008-5#26)(2008-6#5)(2008-7#22)(2008-8#13)(2008-9#15)(2009-10#4)(2009-12#5)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#11)(2010-9#2)(2011-1#12)(2011-2#22)(2011-3#1)(2012-1#6)(2012-12#3)(2012-2#11)(2012-3#13)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#25)
among their##9##2##(1992-3#1)(1994-9#1)(1995-1#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
among them a##2##3##(1995-6#1)(2008-7#1)
among them and##2##3##(2008-8#1)(2011-2#1)
among them is##4##3##(2008-12#1)(2008-3#1)(2011-2#2)
among them were##3##3##(1991-12#1)(2008-10#1)(2013-8#1)
among them##38##2##(1990-3#1)(1990-6#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-7#1)(1995-6#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
among themselves##4##2##(1992-1#1)(2006-6#1)(2008-10#2)
among these data##2##3##(2011-2#1)(2013-1#1)
among these genes##4##3##(1997-7#1)(1997-8#1)(2008-8#1)(2009-6#1)
among these organs##2##3##(2008-11#1)(2011-2#1)
among these patients##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
among these populations was low##2##5##(2008-10#1)(2013-1#1)
among these populations##7##3##(1994-9#1)(2008-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
among these species##4##3##(1993-12#1)(2008-10#2)(2008-5#1)
among these the##2##3##(1995-5#1)(1995-8#1)
among these three groups##2##4##(2008-10#2)
among these three##5##3##(1994-12#1)(1997-2#1)(2008-10#3)
among these##68##2##(1990-3#1)(1992-3#1)(1993-12#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#4)
among this group##2##3##(1990-3#1)(2007-2#1)
among this population##5##3##(2008-11#1)(2008-12#2)(2009-5#1)(2010-8#1)
among this##9##2##(1990-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-8#1)(2013-1#1)
among those aged##3##3##(2008-4#1)(2010-3#1)(2011-2#1)
among those diagnosed within##2##4##(2011-2#2)
among those diagnosed##3##3##(2011-2#3)
among those having##2##3##(1997-3#1)(2008-8#1)
among those not##3##3##(2008-6#2)(2012-2#1)
among those who##5##3##(1993-3#2)(2008-1#1)(2008-3#1)(2008-8#1)
among those with##5##3##(1991-12#2)(2008-2#1)(2011-2#1)(2012-2#1)
among those##38##2##(1991-12#2)(1993-3#2)(1995-12#1)(1995-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#5)(2012-2#2)(2013-8#1)
among three##5##2##(1997-3#1)(2008-10#2)(2008-8#1)(2010-7#1)
among time##2##2##(1992-2#1)(2013-1#1)
among tissues##4##2##(1992-11#1)(2008-11#2)(2010-3#1)
among tomato##2##2##(2008-10#2)
among total##2##2##(2008-11#1)(2008-9#1)
among traits##3##2##(2008-8#1)(2009-8#1)(2012-3#1)
among transfer##2##2##(1990-11#1)(2008-8#1)
among transplant##2##2##(2006-10#1)(2008-8#1)
among travellers##2##2##(1997-4#1)(2007-2#1)
among treatments##3##2##(2008-10#2)(2010-4#1)
among two groups of##2##4##(1996-1#1)(2009-10#1)
among two##8##2##(1996-1#1)(1997-2#1)(2008-10#3)(2008-8#1)(2009-10#1)(2009-9#1)
among type 2##2##3##(2011-1#1)(2013-8#1)
among university students##2##3##(2012-12#2)
among urban##3##2##(2007-12#1)(2009-7#1)(2012-1#1)
among users of##3##3##(1995-5#1)(2008-11#1)(2008-5#1)
among users##4##2##(1995-3#1)(1995-5#1)(2008-11#1)(2008-5#1)
among variables in##2##3##(2008-10#1)(2008-7#1)
among variables##5##2##(1993-2#1)(2008-10#2)(2008-7#1)(2010-2#1)
among various##9##2##(1990-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
among veterans##2##2##(2012-1#1)(2012-3#1)
among which 1##2##3##(2011-3#1)(2013-8#1)
among which the most##2##4##(1996-12#1)(2008-10#1)
among which the##6##3##(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2010-12#1)(2011-1#1)
among which##24##2##(1991-12#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#2)
among white students##2##3##(2012-12#2)
among white##5##2##(2011-2#1)(2012-12#3)(2012-2#1)
among whom##2##2##(2008-3#1)(2010-4#1)
among wild-type##2##2##(1990-12#1)(2008-10#1)
among women and##3##3##(2009-10#1)(2013-1#1)(2013-8#1)
among women in##10##3##(1991-6#2)(1997-4#1)(2007-4#2)(2009-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
among women living with##2##4##(1996-3#1)(2011-1#1)
among women with##7##3##(1997-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
among women##45##2##(1990-6#1)(1991-11#3)(1991-6#3)(1991-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-4#3)(2007-4#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#4)
among workers exposed to##3##4##(1992-3#1)(1994-2#1)(2012-2#1)
among workers##7##2##(1991-9#1)(1992-3#1)(1994-2#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
among working-age adults in##2##4##(2012-2#1)(2013-1#1)
among years##5##2##(2008-10#5)
among young adults##6##3##(1995-9#1)(2008-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
among young and##2##3##(2007-12#1)(2008-3#1)
among young people in##2##4##(2008-5#1)(2013-8#1)
among young people##7##3##(1990-3#1)(1997-6#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
among young##27##2##(1990-3#1)(1990-6#1)(1991-3#1)(1995-9#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#4)
among younger women##2##3##(1990-6#1)(1993-6#1)
among younger##4##2##(1990-6#1)(1993-6#1)(1996-6#1)(2011-1#1)
among youth with disabilities or special health care needs##2##9##(2010-11#2)
among youth##9##2##(1997-6#1)(2007-12#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-11#2)(2012-2#1)(2013-8#1)
among youths##2##2##(1992-5#1)(2008-7#1)
among##3427##1##(1990-11#5)(1990-12#4)(1990-2#10)(1990-3#11)(1990-5#2)(1990-6#11)(1990-7#4)(1990-8#7)(1990-9#7)(1991-1#12)(1991-10#2)(1991-11#8)(1991-12#32)(1991-2#8)(1991-3#11)(1991-4#3)(1991-5#6)(1991-6#16)(1991-8#16)(1991-9#11)(1992-1#5)(1992-10#5)(1992-11#10)(1992-12#9)(1992-2#10)(1992-3#12)(1992-4#4)(1992-5#6)(1992-6#18)(1992-8#4)(1992-9#5)(1993-1#6)(1993-11#7)(1993-12#14)(1993-2#15)(1993-3#8)(1993-5#1)(1993-6#11)(1993-8#1)(1993-9#7)(1994-1#9)(1994-11#8)(1994-12#15)(1994-2#12)(1994-3#16)(1994-5#4)(1994-6#13)(1994-7#2)(1994-8#6)(1994-9#10)(1995-1#14)(1995-11#4)(1995-12#20)(1995-2#14)(1995-3#7)(1995-4#1)(1995-5#13)(1995-6#13)(1995-8#8)(1995-9#5)(1996-1#11)(1996-11#9)(1996-12#12)(1996-2#9)(1996-3#21)(1996-4#2)(1996-5#5)(1996-6#10)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#6)(1997-2#12)(1997-3#20)(1997-4#16)(1997-5#5)(1997-6#7)(1997-7#6)(1997-8#10)(1997-9#2)(2006-10#10)(2006-6#2)(2006-8#4)(2006-9#1)(2007-10#14)(2007-11#18)(2007-12#49)(2007-2#15)(2007-3#1)(2007-4#6)(2007-5#3)(2007-7#25)(2007-8#13)(2007-9#2)(2008-1#54)(2008-10#615)(2008-11#95)(2008-12#79)(2008-2#20)(2008-3#54)(2008-4#33)(2008-5#75)(2008-6#18)(2008-7#75)(2008-8#117)(2008-9#115)(2009-1#2)(2009-10#21)(2009-11#13)(2009-12#12)(2009-2#10)(2009-3#3)(2009-4#12)(2009-5#41)(2009-6#11)(2009-7#24)(2009-8#17)(2009-9#13)(2010-1#12)(2010-10#12)(2010-11#14)(2010-12#28)(2010-2#13)(2010-3#21)(2010-4#22)(2010-5#23)(2010-6#13)(2010-7#13)(2010-8#41)(2010-9#6)(2011-1#85)(2011-10#1)(2011-2#165)(2011-3#5)(2012-1#24)(2012-12#64)(2012-2#85)(2012-3#97)(2012-5#2)(2012-6#2)(2012-7#2)(2013-1#157)(2013-7#15)(2013-8#104)
among-group##3##1##(2008-10#1)(2008-8#2)
amongst a cohort of##2##4##(2007-7#2)
amongst a##4##2##(2007-6#1)(2007-7#2)(2011-1#1)
amongst children##2##2##(2012-12#1)(2013-1#1)
amongst many other##2##3##(2008-11#1)(2011-1#1)
amongst older##2##2##(1995-12#1)(2013-1#1)
amongst others##2##2##(2008-10#2)
amongst patients##2##2##(1995-10#1)(2008-7#1)
amongst staff in##2##3##(2008-11#2)
amongst staff##3##2##(2008-11#2)(2010-10#1)
amongst the children##2##3##(2009-11#1)(2012-12#1)
amongst the different##2##3##(2008-10#1)(2009-8#1)
amongst the elderly##2##3##(2006-10#1)(2008-7#1)
amongst the five areas (P2##2##5##(1993-1#2)
amongst the genes##2##3##(1995-6#1)(2008-7#1)
amongst the highest reported##2##4##(2008-11#1)(2008-5#1)
amongst the highest##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
amongst the most##2##3##(2007-8#1)(2011-2#1)
amongst the##31##2##(1992-6#1)(1993-1#2)(1995-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#4)(2009-11#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2013-1#1)
amongst them##2##2##(2013-1#2)
amongst these##2##2##(2007-12#1)(2008-4#1)
amongst various##3##2##(2008-12#1)(2008-3#1)(2012-2#1)
amongst##107##1##(1992-6#1)(1993-1#2)(1995-10#1)(1995-12#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#7)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#9)(2013-7#1)(2013-8#1)
amorphous aggregates##2##2##(2008-10#1)(2008-11#1)
amorphous and##3##2##(2008-3#2)(2008-5#1)
amorphous content of the samples##2##5##(2008-10#2)
amorphous content of##5##3##(2008-10#5)
amorphous content##7##2##(2008-10#7)
amorphous fluoropolymer##3##2##(2008-10#2)(2012-2#1)
amorphous iron oxide##2##3##(2008-10#2)
amorphous iron##3##2##(2008-10#3)
amorphous material##4##2##(2008-10#3)(2008-3#1)
amorphous materials##2##2##(1995-3#1)(2008-7#1)
amorphous silica##3##2##(2008-10#3)
amorphous silicon##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
amorphous##70##1##(1990-4#1)(1990-7#1)(1991-12#1)(1994-8#1)(1995-11#1)(1995-3#2)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#32)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)
amosite fibers##4##2##(1991-12#4)
amosite##7##1##(1991-12#7)
amount and quality of##2##4##(1991-11#1)(2007-12#1)
amount and##18##2##(1990-5#1)(1991-11#1)(1995-11#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
amount as##2##2##(2008-10#1)(2008-3#1)
amount at##3##2##(1990-12#1)(1996-12#1)(2008-7#1)
amount by##2##2##(2008-10#2)
amount for##5##2##(1990-12#1)(1992-12#2)(2008-10#1)(2008-5#1)
amount in##3##2##(2008-10#1)(2009-7#1)(2013-8#1)
amount is##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
amount of 1 mg##2##4##(2008-5#1)(2011-2#1)
amount of 1##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
amount of DNA##6##3##(1996-12#2)(1996-5#1)(2008-10#1)(2010-2#1)(2011-1#1)
amount of F-actin##2##3##(1991-5#1)(2008-7#1)
amount of HEG##2##3##(2008-10#2)
amount of HRP-SjAb bound##2##4##(2008-10#2)
amount of Hsp70##2##3##(1991-9#2)
amount of a##2##3##(1994-2#1)(2008-3#1)
amount of acid##3##3##(2008-10#2)(2008-9#1)
amount of adsorbent##5##3##(2008-10#4)(2010-5#1)
amount of alpha phase##2##4##(2009-7#2)
amount of ammonia##2##3##(2008-10#2)
amount of antibody##6##3##(1994-5#1)(1996-5#1)(2008-10#3)(2008-9#1)
amount of apoptosis##2##3##(2008-6#2)
amount of aromatase mRNA in##2##5##(1993-8#2)
amount of aromatase##3##3##(1993-8#3)
amount of arsenic##3##3##(2008-10#3)
amount of available##3##3##(2008-12#1)(2008-9#1)(2010-12#1)
amount of biological##2##3##(2008-10#1)(2009-12#1)
amount of biomass##2##3##(2008-6#1)(2008-7#1)
amount of biotinylated##2##3##(2008-10#1)(2008-11#1)
amount of bisphenol##2##3##(2008-10#1)(2013-1#1)
amount of blood##4##3##(1994-3#2)(1996-9#2)
amount of bone##2##3##(2008-11#1)(2013-1#1)
amount of bound##3##3##(1990-12#1)(1996-5#1)(2008-7#1)
amount of chromium##2##3##(2008-10#2)
amount of collagen##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
amount of community benefit##2##4##(1997-1#2)
amount of community##3##3##(1997-1#2)(2008-11#1)
amount of copper##2##3##(2008-10#2)
amount of data available##2##4##(2008-1#1)(2008-10#1)
amount of data in##2##4##(2008-10#2)
amount of data##17##3##(1991-1#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)
amount of disease##8##3##(2008-10#8)
amount of drug##4##3##(1997-2#1)(2008-10#1)(2008-8#1)(2010-4#1)
amount of dsDNA##3##3##(2008-10#3)
amount of eluent##6##3##(2008-10#6)
amount of energy available for##2##5##(2008-8#2)
amount of energy##13##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#3)(2010-3#1)(2013-1#2)
amount of enzyme##4##3##(1992-3#1)(1996-12#1)(2008-10#2)
amount of evidence demonstrates##2##4##(2008-1#1)(2008-11#1)
amount of evidence##3##3##(2008-1#1)(2008-11#1)(2011-1#1)
amount of fat##2##3##(2008-4#1)(2012-3#1)
amount of food##9##3##(1991-12#1)(2008-5#1)(2008-9#2)(2009-5#5)
amount of formaldehyde in##3##4##(2008-10#3)
amount of genomic##2##3##(2008-7#1)(2008-9#1)
amount of human##2##3##(1990-11#1)(2013-1#1)
amount of hydrogen peroxide##2##4##(2008-10#2)
amount of immune##2##3##(1996-5#1)(2008-10#1)
amount of information is##2##4##(2008-10#1)(2008-7#1)
amount of information##13##3##(1993-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#5)(2009-5#1)
amount of initial##2##3##(2008-10#1)(2008-5#1)
amount of intracellular##3##3##(2008-10#1)(2008-11#2)
amount of iron##4##3##(2008-10#3)(2013-8#1)
amount of knowledge##2##3##(1994-5#1)(2012-2#1)
amount of labeled##2##3##(2008-10#1)(2008-4#1)
amount of lead##4##3##(1995-11#1)(2007-12#1)(2008-10#2)
amount of ligand##6##3##(2008-10#4)(2008-4#2)
amount of lipid##2##3##(2008-6#1)(2009-2#1)
amount of lipids##2##3##(1996-8#1)(2009-2#1)
amount of lipofuscin in##2##4##(1995-3#2)
amount of mRNA##2##3##(1996-2#1)(1996-6#1)
amount of manganese##2##3##(2008-10#2)
amount of material removed##2##4##(2008-10#2)
amount of material##7##3##(1995-2#1)(2007-11#1)(2008-10#4)(2012-12#1)
amount of methanol##2##3##(2008-10#2)
amount of neurofilament protein##2##4##(1996-12#2)
amount of nitrite##3##3##(2008-10#3)
amount of noise##2##3##(2007-12#2)
amount of normal##2##3##(2008-10#1)(2008-2#1)
amount of one##2##3##(2008-10#2)
amount of organic##3##3##(1997-4#1)(2008-10#2)
amount of pathogen DNA quantified##2##5##(2008-10#2)
amount of pathogen DNA##5##4##(2008-10#5)
amount of pathogen##6##3##(2008-10#6)
amount of phospholipids##3##3##(1993-6#1)(1994-12#1)(2008-11#1)
amount of radiation##2##3##(2008-7#1)(2013-1#1)
amount of radioactivity##2##3##(1993-6#1)(1994-6#1)
amount of reagent##3##3##(2008-10#2)(2013-8#1)
amount of reagents and##2##4##(2008-10#2)
amount of reagents##3##3##(2008-10#3)
amount of recombinant##2##3##(2008-10#1)(2008-11#1)
amount of research##2##3##(2009-1#1)(2011-2#1)
amount of reserpine##2##3##(2008-12#2)
amount of sample matrix##2##4##(2008-10#2)
amount of sample to be##2##5##(2008-10#2)
amount of sample##12##3##(2007-12#1)(2008-10#10)(2010-4#1)
amount of sequence##2##3##(2008-10#1)(2008-7#1)
amount of sodium##4##3##(2008-1#1)(2008-5#2)(2013-1#1)
amount of soil##2##3##(2008-10#1)(2008-12#1)
amount of t-PA##2##3##(2008-11#2)
amount of tartaric acid##3##4##(2008-5#3)
amount of the modifier##2##4##(2008-10#2)
amount of the variance in the##2##6##(1995-3#1)(2008-9#1)
amount of the##41##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-2#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#1)
amount of these##3##3##(1990-6#1)(2008-11#1)(2008-8#1)
amount of time spent##2##4##(2008-2#1)(2008-5#1)
amount of time##13##3##(1996-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2011-2#1)
amount of tissue##5##3##(2007-8#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)
amount of total soluble##2##4##(2008-12#2)
amount of total##6##3##(1990-2#1)(1996-12#1)(2008-12#2)(2008-5#1)(2010-2#1)
amount of toxin##2##3##(2007-12#1)(2008-10#1)
amount of type I collagen##3##5##(2008-5#1)(2008-9#2)
amount of virus##2##3##(2008-10#2)
amount of water##5##3##(1995-3#1)(2008-10#2)(2008-3#1)(2008-8#1)
amount of weight##2##3##(1991-2#1)(2013-1#1)
amount of work##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
amount of yeast biomass##2##4##(2008-10#2)
amount of##893##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#6)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-6#9)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-6#5)(1993-8#5)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#3)(1996-12#10)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#12)(2007-12#15)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#312)(2008-11#44)(2008-12#20)(2008-2#13)(2008-3#16)(2008-4#11)(2008-5#29)(2008-6#18)(2008-7#24)(2008-8#17)(2008-9#23)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#5)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#7)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#4)(2010-7#1)(2010-8#8)(2011-1#4)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#15)(2013-8#11)
amount on the##2##3##(2008-10#2)
amount or##3##2##(1991-12#1)(1992-3#1)(1993-12#1)
amount that is##2##3##(1993-3#1)(2009-5#1)
amount to##6##2##(1990-2#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-3#1)(2011-2#1)
amount was##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
amount were investigated##2##3##(2008-10#1)(2012-1#1)
amount were##3##2##(1993-8#1)(2008-10#1)(2012-1#1)
amount##1046##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#7)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#2)(1991-11#4)(1991-12#9)(1991-2#3)(1991-3#1)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#6)(1992-6#9)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#8)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#7)(1995-2#5)(1995-3#7)(1995-5#4)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#12)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#8)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#5)(1997-6#1)(1997-7#3)(1997-8#2)(2007-10#3)(2007-11#13)(2007-12#16)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#354)(2008-11#49)(2008-12#27)(2008-2#14)(2008-3#23)(2008-4#11)(2008-5#35)(2008-6#19)(2008-7#28)(2008-8#24)(2008-9#24)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#5)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#4)(2010-7#1)(2010-8#9)(2011-1#5)(2011-10#1)(2011-2#20)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#7)(2013-1#18)(2013-8#15)
amount)##5##1##(1992-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
amounted to##15##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-9#1)(1996-1#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)
amounted##19##1##(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
amounting to##7##2##(1992-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
amounts (&lt##3##2##(1995-11#1)(1997-5#1)(2008-10#1)
amounts and##7##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)
amounts as##2##2##(1993-9#1)(1994-5#1)
amounts at##2##2##(1995-11#1)(2008-3#1)
amounts by##6##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#2)
amounts for##2##2##(1995-6#1)(1995-8#1)
amounts found in##2##3##(2008-10#1)(2012-2#1)
amounts from##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
amounts in the##4##3##(1993-12#1)(1993-6#1)(1995-2#1)(2008-6#1)
amounts in##14##2##(1990-11#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#2)
amounts of 2##2##3##(1990-8#1)(2008-10#1)
amounts of Cr(VI)##3##3##(2008-10#3)
amounts of DNA##5##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-12#2)
amounts of IAA##3##3##(2008-10#3)
amounts of NADH##3##3##(2008-10#3)
amounts of PCV-2 DNA##2##4##(2012-3#2)
amounts of Pd##2##3##(2008-10#2)
amounts of Zn and##2##4##(1993-12#1)(2010-2#1)
amounts of Zn##3##3##(1993-12#1)(2008-10#1)(2010-2#1)
amounts of a##7##3##(1994-9#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-4#2)
amounts of actin##2##3##(1991-5#2)
amounts of active##2##3##(1992-3#1)(2008-11#1)
amounts of alcohol##2##3##(1997-8#1)(2008-7#1)
amounts of aluminium##2##3##(2008-10#2)
amounts of aluminum##3##3##(1992-11#1)(2008-10#2)
amounts of an##2##3##(1990-5#1)(2008-11#1)
amounts of analytes##3##3##(1996-5#1)(2008-10#2)
amounts of antimony##2##3##(2008-10#2)
amounts of both##4##3##(2008-10#2)(2008-11#1)(2010-5#1)
amounts of cadmium in##3##4##(2008-10#3)
amounts of cadmium is##2##4##(2008-10#2)
amounts of cadmium##8##3##(2008-10#8)
amounts of chloride##2##3##(2008-10#2)
amounts of copper##9##3##(2008-10#9)
amounts of data##10##3##(1995-12#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
amounts of dietary##2##3##(1991-12#1)(2012-2#1)
amounts of different##3##3##(2008-10#2)(2008-2#1)
amounts of dimers and monomers##2##5##(1997-2#2)
amounts of drug##2##3##(2008-5#1)(2008-8#1)
amounts of each##3##3##(2008-10#3)
amounts of ethanol##4##3##(1990-12#1)(2008-6#1)(2013-1#2)
amounts of food##2##3##(1993-6#1)(2013-1#1)
amounts of glutamic acid##2##4##(2008-10#1)(2011-2#1)
amounts of heavy metals in##2##5##(2008-10#2)
amounts of hydrogen peroxide##2##4##(1991-5#1)(2008-10#1)
amounts of hydrogen##4##3##(1991-5#1)(2008-10#3)
amounts of iron in##2##4##(2008-10#2)
amounts of iron##6##3##(2008-10#6)
amounts of irrigation##2##3##(2008-10#1)(2008-12#1)
amounts of label##2##3##(1992-12#1)(1992-9#1)
amounts of lead from##2##4##(1992-3#1)(2008-10#1)
amounts of lead##6##3##(1992-3#1)(2008-10#5)
amounts of manganese##2##3##(2008-10#2)
amounts of metal##3##3##(2008-10#2)(2010-11#1)
amounts of methyl##2##3##(2008-3#1)(2008-5#1)
amounts of monoclonal antibody##2##4##(1994-2#1)(2008-10#1)
amounts of monoclonal##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
amounts of negatively charged##2##4##(1996-8#1)(2008-10#1)
amounts of nickel##2##3##(2008-10#2)
amounts of nitrate##3##3##(2008-10#3)
amounts of nucleic##4##3##(2008-10#4)
amounts of products##2##3##(1993-8#1)(2008-5#1)
amounts of protein##3##3##(1990-12#1)(2008-10#1)(2008-2#1)
amounts of radioactivity##3##3##(1990-12#1)(1991-12#1)(2008-9#1)
amounts of recombinant protein##2##4##(1994-11#1)(2008-11#1)
amounts of recombinant##3##3##(1994-11#1)(2008-11#2)
amounts of salbutamol##2##3##(2008-10#2)
amounts of sample##4##3##(2008-10#2)(2008-7#1)(2010-7#1)
amounts of selenium##3##3##(2008-10#3)
amounts of sodium##3##3##(2008-1#1)(2008-10#2)
amounts of soil##2##3##(2008-10#1)(2008-12#1)
amounts of sulfur##3##3##(2008-10#3)
amounts of synthetic##2##3##(1993-6#1)(2008-4#1)
amounts of target##2##3##(2008-10#2)
amounts of the##38##3##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#3)(1992-9#1)(1994-5#2)(1995-11#2)(1995-6#1)(1996-9#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#2)(2010-5#1)(2011-3#2)(2012-2#1)(2013-1#1)
amounts of their##2##3##(1994-2#1)(2008-5#1)
amounts of these two##2##4##(2007-2#1)(2010-2#1)
amounts of these##10##3##(1990-11#1)(1995-6#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-12#1)(2010-2#1)
amounts of this protein##2##4##(1992-11#1)(1992-12#1)
amounts of this##6##3##(1992-11#1)(1992-12#1)(2008-10#2)(2008-11#2)
amounts of total##2##3##(1994-11#1)(2009-12#1)
amounts of uranium(VI)##2##3##(2008-10#2)
amounts of volatile##2##3##(2008-10#1)(2009-8#1)
amounts of water##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
amounts of zinc##5##3##(1990-11#1)(2008-10#4)
amounts of##619##2##(1990-11#5)(1990-12#6)(1990-2#3)(1990-5#4)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#3)(1991-5#10)(1992-10#1)(1992-11#2)(1992-12#9)(1992-3#7)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1996-12#2)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#5)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#283)(2008-11#31)(2008-12#11)(2008-2#7)(2008-3#7)(2008-4#10)(2008-5#20)(2008-6#6)(2008-7#15)(2008-8#8)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-1#3)(2012-12#1)(2012-2#11)(2012-3#4)(2012-8#1)(2013-1#8)(2013-8#4)
amounts on the##2##3##(2008-7#1)(2008-9#1)
amounts or##3##2##(1993-9#1)(2008-10#1)(2008-11#1)
amounts to##13##2##(1993-6#1)(1994-5#1)(1996-2#1)(1996-6#1)(2008-10#3)(2008-11#3)(2008-6#1)(2010-4#1)(2012-2#1)
amounts up to##2##3##(2008-10#1)(2008-9#1)
amounts were##5##2##(1990-11#1)(1994-11#1)(2008-10#2)(2008-7#1)
amounts##753##1##(1990-11#9)(1990-12#6)(1990-2#3)(1990-5#5)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#11)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#9)(1992-3#7)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#2)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#10)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#315)(2008-11#41)(2008-12#15)(2008-2#12)(2008-3#9)(2008-4#11)(2008-5#26)(2008-6#9)(2008-7#19)(2008-8#10)(2008-9#10)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#11)(2011-3#2)(2012-1#3)(2012-12#1)(2012-2#13)(2012-3#4)(2012-8#1)(2013-1#8)(2013-8#5)
amounts)##3##1##(2011-2#3)
amoxicillin and##5##2##(1994-11#1)(2008-12#1)(2011-1#2)(2012-12#1)
amoxicillin##12##1##(1994-11#2)(1995-3#1)(1996-11#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-1#2)(2012-12#3)
amoxicillin-clavulanate##2##1##(2007-7#1)(2011-2#1)
amoxycillin and##3##2##(2008-10#3)
amoxycillin##9##1##(1990-3#1)(1991-3#3)(1997-3#1)(2008-10#4)
amperometric ammonia sensor##2##3##(2008-10#2)
amperometric assay of##2##3##(1992-11#1)(2008-10#1)
amperometric biosensor based on##9##4##(2008-10#9)
amperometric biosensor for hydrogen peroxide##3##5##(2008-10#3)
amperometric biosensor for screening##2##4##(2008-10#2)
amperometric biosensor for##8##3##(2008-10#8)
amperometric biosensor##26##2##(2008-10#26)
amperometric biosensors##6##2##(2008-10#6)
amperometric current-time##2##2##(2008-10#1)(2013-1#1)
amperometric detection (AD)##2##3##(2008-10#2)
amperometric detection at a##4##4##(2008-10#4)
amperometric detection at##9##3##(2008-10#9)
amperometric detection for##3##3##(2008-10#3)
amperometric detection of NADH##3##4##(2008-10#3)
amperometric detection of underivatized amino acids in anion-exchange chromatography##2##9##(2008-10#2)
amperometric detection of underivatized amino acids##4##6##(2008-10#4)
amperometric detection of##23##3##(2008-10#23)
amperometric detection on##2##3##(2008-10#2)
amperometric detection was##4##3##(2008-10#4)
amperometric detection with##3##3##(2008-10#3)
amperometric detection##80##2##(1991-7#2)(1992-1#1)(1995-2#1)(2008-10#75)(2008-6#1)
amperometric detector for microchip##2##4##(2008-10#2)
amperometric detector for the##4##4##(2008-10#4)
amperometric detector for##12##3##(2008-10#12)
amperometric detector with a##2##4##(1991-5#1)(2008-10#1)
amperometric detector##26##2##(1991-5#1)(2008-10#25)
amperometric detectors for##2##3##(2008-10#2)
amperometric determination of##8##3##(2008-10#7)(2010-5#1)
amperometric determination##9##2##(2008-10#8)(2010-5#1)
amperometric enzyme electrode for the##2##5##(2008-10#2)
amperometric enzyme##3##2##(2008-10#3)
amperometric glucose biosensors##2##3##(2008-10#2)
amperometric glucose sensor##3##3##(2008-10#3)
amperometric glucose##8##2##(2008-10#8)
amperometric immunosensor based on##2##4##(2008-10#2)
amperometric immunosensor for the##2##4##(2008-10#2)
amperometric immunosensor for##3##3##(2008-10#3)
amperometric immunosensor##6##2##(2008-10#6)
amperometric immunosensors##3##2##(2008-10#3)
amperometric measurements at##2##3##(2008-10#2)
amperometric measurements##5##2##(2008-10#3)(2009-10#1)(2010-5#1)
amperometric method##4##2##(2008-10#4)
amperometric monitoring of flowing streams##2##5##(2008-10#2)
amperometric pH-sensing##2##2##(2008-10#2)
amperometric response of the biosensor##2##5##(2008-10#2)
amperometric response of the##3##4##(2008-10#3)
amperometric response of##5##3##(2008-10#5)
amperometric response##15##2##(2008-10#14)(2013-1#1)
amperometric screen-printed##2##2##(2008-10#2)
amperometric selectivity##2##2##(2008-10#2)
amperometric sensor for the##2##4##(2008-10#2)
amperometric sensor for##6##3##(2008-10#6)
amperometric sensor##8##2##(2008-10#8)
amperometric sensors##3##2##(2008-10#3)
amperometric working##2##2##(2008-10#2)
amperometric##255##1##(1991-5#1)(1991-7#2)(1992-1#1)(1992-11#1)(1995-2#1)(2008-10#241)(2008-6#1)(2009-10#1)(2010-5#3)(2013-1#3)
amperometric-rotating biosensor##2##2##(2008-10#2)
amperometrically##7##1##(1995-3#1)(2008-10#6)
amperometry at a##2##3##(2008-10#2)
amperometry at the interface between two immiscible electrolyte solutions##2##9##(2008-10#2)
amperometry at##7##2##(2008-10#7)
amperometry with##2##2##(2008-10#2)
amperometry##25##1##(1991-7#1)(2008-10#24)
amphetamine (1##3##2##(1993-6#1)(1994-2#2)
amphetamine and piperidine in human urine##2##6##(1990-8#2)
amphetamine and##8##2##(1990-8#2)(1993-3#1)(1993-6#1)(1994-2#1)(2008-10#2)(2013-1#1)
amphetamine in rat's blood and brain##3##6##(2008-10#3)
amphetamine in##6##2##(1994-2#2)(2008-10#3)(2013-1#1)
amphetamine intravenous self-administration##2##3##(1993-6#2)
amphetamine##45##1##(1990-12#1)(1990-8#2)(1991-1#1)(1992-2#1)(1992-7#2)(1993-3#2)(1993-6#8)(1994-2#6)(1994-8#1)(1995-12#1)(1996-6#1)(2008-10#11)(2008-11#1)(2008-4#2)(2013-1#5)
amphetamine-induced inhibition of gastric emptying and intestinal transit##2##8##(2013-1#2)
amphetamine-induced inhibition of gastric emptying##3##5##(2013-1#3)
amphetamine-induced##6##1##(1993-6#1)(1994-2#2)(2013-1#3)
amphetamines according to##2##3##(2008-10#2)
amphetamines and##2##2##(2007-1#1)(2008-10#1)
amphetamines from##2##2##(2008-10#2)
amphetamines##19##1##(1991-1#1)(1991-2#1)(2007-1#1)(2008-10#13)(2008-5#1)(2010-4#2)
amphibamids and branchiosaurids##2##3##(2010-6#2)
amphibamids and##3##2##(2010-6#3)
amphibamids##7##1##(2010-6#7)
amphibian##14##1##(1990-12#1)(1994-11#3)(1996-2#1)(1997-1#1)(1997-3#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-6#2)(2013-1#1)
amphibians##21##1##(1990-5#1)(1995-12#1)(1996-5#4)(1997-3#4)(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#3)(2013-1#3)(2013-7#1)
amphiboles##2##1##(1991-12#2)
amphid##2##1##(1995-3#2)
amphidinolide E##2##2##(2008-6#2)
amphihaploids##2##1##(2008-10#2)
amphipathic alpha-helical series##2##3##(1995-3#2)
amphipathic alpha-helical##5##2##(1990-2#1)(1994-5#1)(1995-3#2)(1997-2#1)
amphipathic beta-structural peptides##2##3##(1990-2#2)
amphipathic beta-structure##3##2##(1990-2#3)
amphipathic compounds##2##2##(1990-5#2)
amphipathic helix##3##2##(1991-5#1)(1995-5#1)(2008-10#1)
amphipathic helixes##2##2##(1994-2#1)(1994-5#1)
amphipathic##25##1##(1990-2#7)(1990-5#2)(1991-5#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-11#1)(1995-3#2)(1995-5#1)(1997-2#2)(2006-12#1)(2008-10#2)
amphipatic##2##1##(2011-2#2)
amphiphile##7##1##(1992-5#3)(2008-10#2)(2008-12#1)(2009-5#1)
amphiphiles##6##1##(1992-11#1)(2008-11#3)(2008-5#1)(2012-2#1)
amphiphilic G2##2##2##(1994-6#1)(1995-12#1)
amphiphilic block copolymers##2##3##(2009-9#1)(2010-2#1)
amphiphilic character##3##2##(1994-5#2)(1994-8#1)
amphiphilic forms##4##2##(1990-5#3)(1994-6#1)
amphiphilic leader sequence##3##3##(1991-10#3)
amphiphilic leader##4##2##(1991-10#4)
amphiphilic molecules##2##2##(2008-10#1)(2008-5#1)
amphiphilic peptides##2##2##(1994-11#2)
amphiphilic##36##1##(1990-5#3)(1990-8#1)(1991-10#7)(1994-11#2)(1994-2#1)(1994-5#3)(1994-6#4)(1994-8#1)(1995-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2009-9#2)(2010-2#1)(2012-2#2)
amphipod##3##1##(2008-10#1)(2008-6#1)(2012-1#1)
amphipods in##2##2##(2008-6#1)(2012-3#1)
amphipods##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
ampho-acetates##2##1##(2008-5#2)
ampholytic##4##1##(2010-8#2)(2013-1#2)
amphoteric and##3##2##(2008-10#1)(2008-5#2)
amphoteric##9##1##(1994-3#1)(2008-10#6)(2008-5#2)
amphotericin B and##4##3##(1990-11#1)(2008-5#3)
amphotericin B followed by##2##4##(2007-12#1)(2010-10#1)
amphotericin B in##4##3##(2008-5#3)(2008-7#1)
amphotericin B plus flucytosine##2##4##(2011-2#2)
amphotericin B##40##2##(1990-11#2)(1992-6#8)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#17)(2008-7#3)(2010-10#1)(2011-2#3)(2012-1#1)
amphotericin##45##1##(1990-11#2)(1992-6#11)(1996-11#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#17)(2008-7#3)(2010-10#1)(2011-2#4)(2012-1#1)
amphoterics##3##1##(2008-5#3)
amphotropic retroviruses##2##2##(1990-5#2)
amphotropic##5##1##(1990-5#4)(2008-11#1)
ampicillin and##5##2##(2008-10#4)(2012-3#1)
ampicillin resistance##3##2##(1990-11#1)(1990-6#2)
ampicillin##36##1##(1990-11#1)(1990-6#4)(1993-8#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#11)(2008-11#1)(2008-12#1)(2009-12#4)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#1)
ampicillin-sulbactam##3##1##(2013-8#3)
ample evidence that##2##3##(1991-5#1)(2011-1#1)
ample evidence##4##2##(1991-5#1)(2008-3#1)(2008-7#1)(2011-1#1)
ample opportunity##2##2##(2008-12#1)(2011-2#1)
ample##9##1##(1991-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
amplicon and##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
amplicon size##2##2##(2008-10#1)(2008-12#1)
amplicon vectors##3##2##(2008-4#3)
amplicon##27##1##(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#6)(2008-8#4)(2010-10#1)(2011-2#2)
amplicons are##3##2##(2008-2#2)(2008-9#1)
amplicons were##2##2##(2008-10#2)
amplicons with##2##2##(2008-10#2)
amplicons##19##1##(1995-12#1)(2007-6#1)(2008-10#10)(2008-2#4)(2008-4#1)(2008-9#1)(2011-2#1)
amplif ier##2##2##(2007-12#2)
amplif##3##1##(2007-12#3)
amplifiable DNA##2##2##(2008-10#1)(2009-8#1)
amplifiable##3##1##(2008-10#2)(2009-8#1)
amplification activity##2##2##(1991-6#2)
amplification and expression##3##3##(1992-9#1)(2008-2#2)
amplification and sequencing of the##2##5##(2010-10#1)(2012-2#1)
amplification and sequencing of##4##4##(1993-12#1)(2008-10#1)(2010-10#1)(2012-2#1)
amplification and sequencing##6##3##(1993-12#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#2)
amplification and the##6##3##(2008-10#3)(2008-3#2)(2011-2#1)
amplification and##33##2##(1990-6#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-8#1)(2007-11#6)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-8#2)
amplification as##2##2##(1990-6#1)(2008-1#1)
amplification at a##2##3##(2007-11#1)(2008-3#1)
amplification at##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplification by the##3##3##(1990-11#1)(2008-10#1)(2008-3#1)
amplification by##11##2##(1990-11#1)(1991-6#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
amplification effect##2##2##(2008-10#1)(2008-3#1)
amplification for##3##2##(1993-3#1)(2007-12#1)(2008-11#1)
amplification have been##2##3##(2008-3#1)(2008-4#1)
amplification in Cr##2##3##(2007-12#1)(2008-3#1)
amplification in a##6##3##(2007-11#2)(2007-12#3)(2008-3#1)
amplification in medulloblastomas##2##3##(1991-4#2)
amplification in the##5##3##(1994-12#1)(2007-11#2)(2007-12#1)(2011-3#1)
amplification in##25##2##(1991-4#2)(1994-12#1)(1997-6#1)(2007-11#6)(2007-12#7)(2008-10#1)(2008-3#3)(2008-9#1)(2011-3#1)(2013-8#2)
amplification is used##2##3##(2008-2#1)(2008-8#1)
amplification is##8##2##(1993-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)
amplification kit##2##2##(2008-12#2)
amplification laser##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
amplification methods##4##2##(2008-10#1)(2008-9#1)(2010-6#1)(2010-7#1)
amplification might##2##2##(1994-12#1)(2012-1#1)
amplification of DNA##3##3##(1990-3#1)(2008-2#1)(2008-9#1)
amplification of RNA by##2##4##(2008-2#2)
amplification of a specific##2##4##(1991-2#1)(2008-10#1)
amplification of a##13##3##(1991-2#1)(1993-9#1)(1995-12#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2011-2#1)
amplification of broadband##2##3##(2007-11#2)
amplification of cDNA ends (RACE)##5##5##(1992-12#1)(1997-6#1)(2008-9#1)(2010-5#2)
amplification of cDNA ends##6##4##(1992-12#1)(1997-6#1)(2008-5#1)(2008-9#1)(2010-5#2)
amplification of cDNA##10##3##(1990-11#1)(1992-12#1)(1993-2#1)(1994-12#1)(1997-6#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-5#2)
amplification of genomic##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
amplification of pre-parietal cells##2##4##(1995-6#2)
amplification of such##2##3##(2008-11#1)(2008-4#1)
amplification of the MDR1##2##4##(2007-10#2)
amplification of the viral##3##4##(2008-10#2)(2008-9#1)
amplification of the##36##3##(1992-9#1)(1993-8#2)(1994-12#2)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#13)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
amplification of##126##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(2007-10#2)(2007-11#4)(2007-12#12)(2008-1#1)(2008-10#32)(2008-11#6)(2008-2#11)(2008-3#3)(2008-4#4)(2008-5#3)(2008-8#1)(2008-9#7)(2010-4#1)(2010-5#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
amplification on##2##2##(2011-2#1)(2013-1#1)
amplification or##6##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
amplification process##4##2##(2007-12#3)(2008-2#1)
amplification product##2##2##(2008-10#2)
amplification products were##3##3##(2008-10#2)(2008-12#1)
amplification products##7##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)
amplification protocol##2##2##(2008-1#1)(2009-12#1)
amplification reactions##3##2##(1996-12#1)(1997-6#2)
amplification scheme##4##2##(2007-11#2)(2007-12#2)
amplification step##4##2##(2008-1#3)(2008-10#1)
amplification system##7##2##(2007-11#1)(2007-12#2)(2008-11#3)(2008-9#1)
amplification systems##6##2##(1997-6#1)(2007-11#2)(2007-12#2)(2008-2#1)
amplification technique for##2##3##(2008-3#2)
amplification technique##3##2##(2007-12#1)(2008-3#2)
amplification techniques##3##2##(1995-8#1)(2008-4#1)(2009-12#1)
amplification that##2##2##(2007-11#1)(2007-12#1)
amplification to achieve##2##3##(2007-11#1)(2008-2#1)
amplification to##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
amplification using primers##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
amplification using##4##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
amplification was carried out##2##4##(1994-10#1)(2008-10#1)
amplification was##11##2##(1991-4#1)(1994-10#1)(1996-7#2)(2008-10#4)(2008-5#1)(2010-4#1)(2010-5#1)
amplification with a##2##3##(2008-10#1)(2008-3#1)
amplification with##9##2##(1996-12#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-6#1)
amplification##463##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1991-2#1)(1991-4#8)(1991-6#6)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#2)(1993-9#2)(1994-10#2)(1994-12#11)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#4)(1997-6#7)(1997-7#3)(2007-10#2)(2007-11#45)(2007-12#50)(2007-7#1)(2008-1#8)(2008-10#86)(2008-11#16)(2008-12#7)(2008-2#29)(2008-3#27)(2008-4#15)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#15)(2009-10#2)(2009-12#2)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#7)
amplification)##4##1##(2008-11#2)(2008-2#1)(2012-12#1)
amplifications and##2##2##(2008-9#1)(2011-3#1)
amplifications in##3##2##(2007-11#1)(2008-11#1)(2013-8#1)
amplifications of##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
amplifications##20##1##(1990-7#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2011-3#1)(2013-8#1)
amplified CHO##2##2##(2008-11#2)
amplified DNA fragments##3##3##(1990-12#1)(1997-2#1)(2008-4#1)
amplified DNA from##3##3##(2008-10#3)
amplified DNA##16##2##(1990-12#2)(1993-12#1)(1994-12#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)
amplified PCR products##2##3##(2008-10#2)
amplified PCR##3##2##(2008-10#3)
amplified Ti##2##2##(2007-12#1)(2008-2#1)
amplified a fragment##2##3##(2008-10#2)
amplified a product of##2##4##(2008-10#2)
amplified a single 1##2##4##(2008-10#2)
amplified a##15##2##(1994-12#1)(2008-10#14)
amplified and cloned##4##3##(2008-10#2)(2008-11#1)(2009-5#1)
amplified and labeled##2##3##(2008-10#1)(2008-4#1)
amplified and sequenced##8##3##(1995-11#1)(2007-6#1)(2008-10#4)(2008-12#1)(2013-8#1)
amplified and##21##2##(1992-6#1)(1992-9#1)(1995-11#1)(2007-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2013-8#1)
amplified by PCR and##6##4##(1995-8#1)(1997-8#1)(2008-10#2)(2008-8#2)
amplified by PCR with##2##4##(1992-3#1)(2008-10#1)
amplified by PCR##18##3##(1992-3#1)(1992-9#1)(1995-11#1)(1995-8#2)(1997-8#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-8#4)(2011-1#1)
amplified by a##4##3##(2007-12#1)(2008-2#3)
amplified by polymerase chain reaction (PCR)##3##6##(2008-10#2)(2010-6#1)
amplified by polymerase chain reaction from##3##6##(2008-10#3)
amplified by polymerase chain reaction##11##5##(1990-5#1)(2008-10#9)(2010-6#1)
amplified by reverse##3##3##(1996-12#1)(1997-6#1)(2008-10#1)
amplified by the##9##3##(1995-12#1)(1995-6#1)(1997-7#2)(2008-10#3)(2008-11#1)(2008-5#1)
amplified by##62##2##(1990-5#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#2)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#6)(2010-5#1)(2010-6#1)(2011-1#2)
amplified cDNA##3##2##(1992-8#1)(1993-11#1)(1993-9#1)
amplified detection of##2##3##(2008-10#2)
amplified enzyme-linked immunosorbent assay##2##4##(2008-10#2)
amplified fragment length polymorphism (AFLP) analysis##6##6##(2008-10#6)
amplified fragment length polymorphism (AFLP) and microsatellite markers##2##8##(2008-10#2)
amplified fragment length polymorphism (AFLP) and##8##6##(2008-10#8)
amplified fragment length polymorphism (AFLP) loci##2##6##(2008-10#2)
amplified fragment length polymorphism (AFLP) markers##9##6##(2008-10#8)(2008-7#1)
amplified fragment length polymorphism (AFLP)##38##5##(2008-10#37)(2008-7#1)
amplified fragment length polymorphism among##2##5##(1996-8#1)(2008-10#1)
amplified fragment length polymorphism analysis##4##5##(2008-10#4)
amplified fragment length polymorphism marker##4##5##(2008-10#4)
amplified fragment length polymorphism markers##5##5##(2008-10#5)
amplified fragment length polymorphism##66##4##(1996-8#1)(2008-10#63)(2008-7#1)(2011-2#1)
amplified fragment length polymorphisms (AFLP)##2##5##(2008-10#2)
amplified fragment length polymorphisms (AFLPs)##3##5##(2008-10#2)(2008-9#1)
amplified fragment length polymorphisms##10##4##(2008-10#9)(2008-9#1)
amplified fragment length##76##3##(1996-8#1)(2008-10#72)(2008-7#1)(2008-9#1)(2011-2#1)
amplified fragment##78##2##(1996-8#2)(2008-10#72)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
amplified fragments##7##2##(1992-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2012-2#1)
amplified from the##7##3##(1996-6#1)(1997-7#1)(2008-10#3)(2008-8#1)(2010-4#1)
amplified from total##2##3##(2008-10#1)(2008-4#1)
amplified from##34##2##(1993-12#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-8#3)(2010-4#1)(2013-8#1)
amplified genes##4##2##(1995-12#1)(2008-11#3)
amplified in a##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
amplified in##13##2##(1990-6#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-7#1)(2010-1#1)
amplified microsatellite polymorphic##2##3##(2008-5#2)
amplified microsatellite##4##2##(2008-10#1)(2008-5#3)
amplified microsatellites##3##2##(2008-10#3)
amplified only from##2##3##(2008-10#2)
amplified polymorphic DNA (RAPD) analyses##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) analysis##7##5##(2008-10#7)
amplified polymorphic DNA (RAPD) and microsatellite-primed##2##6##(2008-10#1)(2008-5#1)
amplified polymorphic DNA (RAPD) and##3##5##(2008-10#2)(2008-5#1)
amplified polymorphic DNA (RAPD) marker##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) markers and##2##6##(2008-10#2)
amplified polymorphic DNA (RAPD) markers were used##2##7##(2008-10#2)
amplified polymorphic DNA (RAPD) markers were##3##6##(2008-10#3)
amplified polymorphic DNA (RAPD) markers##15##5##(1995-6#1)(1996-10#1)(2008-10#12)(2013-7#1)
amplified polymorphic DNA (RAPD)##47##4##(1995-6#1)(1996-10#1)(2008-10#42)(2008-5#2)(2013-7#1)
amplified polymorphic DNA and amplified fragment length polymorphism##2##8##(2008-10#2)
amplified polymorphic DNA and##4##4##(2008-10#4)
amplified polymorphic DNA markers and##2##5##(2008-10#2)
amplified polymorphic DNA markers##10##4##(2008-10#9)(2008-5#1)
amplified polymorphic DNA##82##3##(1995-6#1)(1996-10#1)(1997-8#1)(2007-10#1)(2008-10#71)(2008-5#4)(2011-2#1)(2012-3#1)(2013-7#1)
amplified polymorphic##85##2##(1995-6#1)(1996-10#1)(1997-8#1)(2007-10#1)(2008-10#72)(2008-5#6)(2011-2#1)(2012-3#1)(2013-7#1)
amplified polymorphism##4##2##(2008-10#4)
amplified porA##2##2##(1993-12#2)
amplified product was##3##3##(1996-8#1)(2006-8#1)(2008-10#1)
amplified products##7##2##(1990-3#1)(1993-6#1)(2008-10#3)(2011-2#1)(2012-2#1)
amplified pulse##2##2##(2007-12#1)(2008-3#1)
amplified pulses##2##2##(2007-11#1)(2007-12#1)
amplified ras oncogene##3##3##(2008-11#3)
amplified real samples##3##3##(2008-10#3)
amplified region (SCAR) marker##4##4##(2008-10#3)(2008-5#1)
amplified region (SCAR)##7##3##(2008-10#5)(2008-5#2)
amplified region##10##2##(1990-7#3)(2008-10#5)(2008-5#2)
amplified regions##2##2##(2008-10#1)(2012-3#1)
amplified sample##2##2##(2008-10#2)
amplified signal##4##2##(2007-11#3)(2008-3#1)
amplified spontaneous emission (ASE)##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
amplified spontaneous emission and##2##4##(2007-12#2)
amplified spontaneous emission from a##2##5##(2007-12#1)(2008-2#1)
amplified spontaneous emission from##3##4##(2007-12#2)(2008-2#1)
amplified spontaneous emission is##2##4##(2007-12#1)(2008-2#1)
amplified spontaneous emission##22##3##(2007-11#3)(2007-12#11)(2008-2#5)(2008-3#3)
amplified systems##2##2##(2007-12#2)
amplified target DNA##2##3##(1993-12#1)(2008-10#1)
amplified the##6##2##(1990-12#1)(1992-8#1)(1993-6#1)(2008-10#2)(2008-11#1)
amplified three##2##2##(2008-10#1)(2008-11#1)
amplified using polymerase chain reaction##2##5##(2006-8#1)(2008-10#1)
amplified using the polymerase chain reaction##2##6##(1991-11#1)(2008-11#1)
amplified using the##4##3##(1991-11#1)(1997-6#1)(2008-11#1)(2008-12#1)
amplified using##11##2##(1991-11#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
amplified was##2##2##(2008-10#1)(2013-1#1)
amplified with the##2##3##(1996-8#1)(2008-10#1)
amplified with##8##2##(1996-8#1)(1997-8#1)(2008-10#4)(2008-2#2)
amplified##545##1##(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#3)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#3)(1995-11#2)(1995-12#2)(1995-3#2)(1995-6#2)(1995-8#4)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#3)(1997-9#1)(2006-8#2)(2007-10#1)(2007-11#18)(2007-12#28)(2007-6#1)(2008-1#1)(2008-10#282)(2008-11#25)(2008-12#6)(2008-2#20)(2008-3#10)(2008-4#5)(2008-5#18)(2008-7#5)(2008-8#11)(2008-9#3)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#13)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
amplifier and ADC##2##3##(2011-1#2)
amplifier and an##3##3##(2007-11#2)(2008-2#1)
amplifier and##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#2)
amplifier as a##2##3##(2008-2#1)(2008-3#1)
amplifier as##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplifier at##3##2##(2007-12#2)(2008-3#1)
amplifier based on periodically poled##2##5##(2007-11#1)(2008-3#1)
amplifier based on##6##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplifier by##2##2##(2007-11#1)(2007-12#1)
amplifier chain##4##2##(2008-2#4)
amplifier circuit##3##2##(2011-1#3)
amplifier employing##3##2##(2007-11#2)(2007-12#1)
amplifier for the##2##3##(2008-3#1)(2009-7#1)
amplifier for##3##2##(2008-3#1)(2009-7#1)(2010-8#1)
amplifier gain##3##2##(2007-11#2)(2008-3#1)
amplifier has##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
amplifier in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
amplifier in##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
amplifier is##9##2##(2007-12#6)(2008-2#2)(2008-3#1)
amplifier of##2##2##(2007-11#1)(2007-12#1)
amplifier performance##2##2##(2008-2#1)(2008-3#1)
amplifier pumped by a##3##4##(2007-11#1)(2007-12#2)
amplifier pumped by##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
amplifier stage##2##2##(2007-11#1)(2007-12#1)
amplifier system##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
amplifier that produces##2##3##(2007-11#2)
amplifier that##6##2##(2007-11#4)(2008-2#2)
amplifier to generate##2##3##(2007-11#1)(2009-10#1)
amplifier to##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-8#1)
amplifier was##3##2##(2007-12#2)(2011-1#1)
amplifier with a##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
amplifier with##11##2##(2007-11#5)(2007-12#3)(2008-3#3)
amplifier##198##1##(2007-11#53)(2007-12#64)(2008-10#9)(2008-2#37)(2008-3#25)(2009-10#1)(2009-7#1)(2010-8#2)(2011-1#6)
amplifier)##2##1##(2008-2#2)
amplifiers and##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
amplifiers are##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
amplifiers in##3##2##(2007-12#3)
amplifiers with a##2##3##(2007-11#1)(2008-5#1)
amplifiers##51##1##(1990-12#1)(2007-11#19)(2007-12#12)(2008-2#9)(2008-3#6)(2008-5#1)(2008-8#2)(2008-9#1)
amplifies the##4##2##(1996-7#1)(2008-10#2)(2013-8#1)
amplifies##8##1##(1990-12#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
amplify DNA from##3##3##(2008-10#3)
amplify DNA##7##2##(1990-7#1)(2008-10#5)(2009-6#1)
amplify a##10##2##(1992-8#1)(1993-8#1)(2008-10#5)(2008-2#1)(2008-9#1)(2009-8#1)
amplify sequences from##2##3##(2008-10#2)
amplify sequences##3##2##(1992-6#1)(2008-10#2)
amplify the##19##2##(1991-7#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
amplify##75##1##(1990-7#1)(1991-7#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#31)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
amplifying DNA##5##2##(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
amplifying and##2##2##(1995-6#1)(2008-4#1)
amplifying medium##2##2##(2007-12#1)(2008-2#1)
amplifying the##3##2##(1994-11#1)(2008-11#1)(2008-4#1)
amplifying##30##1##(1993-8#1)(1994-11#1)(1995-5#2)(1995-6#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-9#3)(2011-2#1)(2012-2#1)
amplimers##3##1##(2008-10#2)(2008-12#1)
amplitude and a##3##3##(1990-9#1)(2007-11#1)(2008-2#1)
amplitude and binary##2##3##(2008-2#1)(2008-3#1)
amplitude and frequency##4##3##(2007-12#1)(2009-12#1)(2010-3#1)(2012-7#1)
amplitude and phase modulation##2##4##(2007-11#2)
amplitude and phase of the##2##5##(2007-11#1)(2008-3#1)
amplitude and phase of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
amplitude and phase##24##3##(2007-11#7)(2007-12#5)(2007-9#1)(2008-2#2)(2008-3#8)(2012-2#1)
amplitude and the phase of the##2##6##(2007-11#1)(2008-2#1)
amplitude and the phase of##5##5##(2007-11#2)(2007-12#1)(2008-2#2)
amplitude and the phase##9##4##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#1)
amplitude and the##17##3##(1996-2#2)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#1)(2008-7#1)
amplitude and##73##2##(1990-12#1)(1990-9#1)(1992-3#1)(1993-3#1)(1994-8#1)(1996-2#2)(1997-2#1)(1997-6#1)(2007-11#12)(2007-12#9)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#12)(2008-4#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-7#2)
amplitude at a##2##3##(1990-8#1)(1993-12#1)
amplitude at##4##2##(1990-8#1)(1993-12#1)(2007-11#1)(2008-7#1)
amplitude but##3##2##(1992-3#1)(1997-4#1)(2008-2#1)
amplitude control modules##2##3##(2008-3#2)
amplitude control##3##2##(2008-3#3)
amplitude decreased##3##2##(1993-9#2)(2008-6#1)
amplitude distribution##2##2##(2007-12#1)(2008-2#1)
amplitude distributions##2##2##(2007-12#1)(2008-2#1)
amplitude during ocular fixation##2##4##(2008-7#2)
amplitude during##3##2##(2008-10#1)(2008-7#2)
amplitude fluctuation##2##2##(2007-11#1)(2008-3#1)
amplitude fluctuations##2##2##(2007-11#1)(2007-12#1)
amplitude from##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
amplitude in a##2##3##(1995-12#1)(2008-3#1)
amplitude in the##2##3##(1996-6#1)(2008-11#1)
amplitude in##10##2##(1995-12#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)
amplitude increased##3##2##(2008-10#1)(2009-3#2)
amplitude information onto##3##3##(2008-3#3)
amplitude information##5##2##(2008-3#5)
amplitude is##4##2##(2008-11#1)(2008-3#2)(2008-8#1)
amplitude jitter##4##2##(2007-11#1)(2007-12#3)
amplitude mask##2##2##(2008-3#2)
amplitude modulation and##4##3##(2007-12#2)(2008-3#2)
amplitude modulation##18##2##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#10)
amplitude modulations##2##2##(2007-11#1)(2008-2#1)
amplitude modulator##3##2##(2007-12#1)(2008-3#2)
amplitude motor units##2##3##(1993-12#2)
amplitude noise suppression##2##3##(2007-12#2)
amplitude noise##6##2##(2007-11#3)(2007-12#3)
amplitude of 1##2##3##(2008-2#1)(2008-7#1)
amplitude of 25##2##3##(2008-10#1)(2008-11#1)
amplitude of the##41##3##(1990-7#1)(1990-9#1)(1991-10#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-3#1)(1996-6#1)(1997-4#2)(2007-11#3)(2007-12#3)(2008-10#5)(2008-2#3)(2008-3#8)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)
amplitude of##74##2##(1990-5#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-12#3)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-4#3)(2007-11#3)(2007-12#5)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#2)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#1)
amplitude on##2##2##(2008-10#1)(2008-3#1)
amplitude or the##2##3##(1992-3#1)(2008-2#1)
amplitude or##4##2##(1992-3#1)(2007-11#1)(2008-2#1)(2011-2#1)
amplitude oscillations##3##2##(1994-11#1)(2008-10#2)
amplitude rather than##2##3##(1990-11#1)(2008-3#1)
amplitude scatterers##2##2##(2008-2#2)
amplitude that is due to the##2##6##(2008-3#2)
amplitude to##2##2##(1997-4#1)(2008-2#1)
amplitude transmission##2##2##(2008-3#2)
amplitude was##4##2##(2008-6#1)(2008-7#2)(2013-8#1)
amplitude were##3##2##(2008-10#1)(2008-7#1)(2010-3#1)
amplitude which##2##2##(1990-5#1)(1995-12#1)
amplitude with##2##2##(2008-2#1)(2013-8#1)
amplitude##390##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#4)(1993-12#8)(1993-3#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-5#3)(1996-6#2)(1997-2#2)(1997-3#1)(1997-4#6)(1997-6#1)(1997-7#1)(2007-11#33)(2007-12#42)(2007-9#1)(2008-10#35)(2008-11#6)(2008-2#42)(2008-3#90)(2008-4#3)(2008-5#4)(2008-6#9)(2008-7#14)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#4)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-5#1)(2012-7#2)(2013-8#4)
amplitude)##3##1##(1990-7#1)(2008-3#1)(2009-8#1)
amplitude-based encryption##5##2##(2008-3#5)
amplitude-division##4##1##(2007-12#3)(2008-3#1)
amplitude-modulated laser##2##2##(2008-3#2)
amplitude-modulated##4##1##(2007-12#1)(2008-3#3)
amplitude-modulation##3##1##(2007-11#1)(2007-12#2)
amplitude-phase##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
amplitude-squeezed light##2##2##(2007-12#1)(2008-3#1)
amplitude-squeezed##3##1##(2007-12#2)(2008-3#1)
amplitude-to-phase conversion in##2##3##(2007-11#2)
amplitudes are##7##2##(2008-11#1)(2008-2#4)(2008-3#2)
amplitudes at##2##2##(1993-12#1)(2008-10#1)
amplitudes in the##3##3##(1990-11#1)(2007-12#1)(2008-10#1)
amplitudes of the##13##3##(1992-8#1)(1997-2#1)(2008-10#2)(2008-2#3)(2008-3#4)(2010-6#1)(2011-2#1)
amplitudes of##30##2##(1990-7#1)(1991-1#1)(1992-8#1)(1995-2#1)(1997-2#4)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#9)(2008-8#3)(2010-6#1)(2010-9#1)(2011-2#1)
amplitudes that are##2##3##(2007-12#1)(2008-3#1)
amplitudes were##3##2##(1991-9#1)(1993-12#1)(2008-7#1)
amplitudes##72##1##(1990-11#2)(1990-7#1)(1991-1#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-12#3)(1995-2#2)(1996-6#1)(1997-2#4)(2007-11#4)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#10)(2008-3#20)(2008-7#1)(2008-8#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-7#1)
amply##4##1##(1994-11#1)(1997-2#1)(2007-8#1)(2008-11#1)
ampulla##3##1##(1990-6#1)(1990-9#1)(2008-11#1)
ampullary adenocarcinoma##2##2##(2013-1#2)
ampullary##5##1##(1990-6#1)(1990-9#1)(2013-1#3)
amputated##6##1##(1990-12#1)(1991-3#1)(2008-9#2)(2009-1#1)(2010-6#1)
amputation and##4##2##(2008-6#2)(2011-3#1)(2013-8#1)
amputation at any time##2##4##(2008-6#2)
amputation at##3##2##(2008-6#2)(2008-9#1)
amputation in##3##2##(2008-9#1)(2010-3#1)(2011-2#1)
amputation of the##3##3##(2007-7#1)(2008-8#1)(2009-3#1)
amputation of##4##2##(1995-2#1)(2007-7#1)(2008-8#1)(2009-3#1)
amputation##51##1##(1990-3#1)(1995-2#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-6#13)(2008-8#2)(2008-9#5)(2009-1#1)(2009-3#5)(2010-3#7)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#2)(2013-1#2)(2013-8#1)
amputations in##2##2##(2008-1#2)
amputations##14##1##(1992-6#5)(2007-11#1)(2008-1#2)(2008-7#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-8#2)
amputee##7##1##(2007-7#3)(2010-3#3)(2013-1#1)
amputees and##3##2##(2008-6#2)(2010-3#1)
amputees##9##1##(2008-6#3)(2010-3#2)(2012-12#2)(2013-1#2)
amu##2##1##(2008-10#2)
amurensis##4##1##(1994-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
amygdala activity than light-skinned##2##4##(2008-11#2)
amygdala activity was observed##2##4##(2008-11#2)
amygdala activity##6##2##(2008-11#6)
amygdala and putamen##2##3##(1993-12#2)
amygdala and the##3##3##(1993-6#1)(1994-2#1)(2008-7#1)
amygdala and##13##2##(1993-12#2)(1993-6#4)(1994-2#1)(1997-2#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#1)
amygdala is##5##2##(1991-1#1)(1992-6#1)(1994-8#1)(2008-11#2)
amygdala lesions##4##2##(1993-6#4)
amygdala neurons##3##2##(1993-6#1)(1997-7#2)
amygdala or##4##2##(1990-5#1)(1993-6#1)(1996-12#1)(2007-10#1)
amygdala##129##1##(1990-5#2)(1991-1#3)(1991-10#3)(1992-1#1)(1992-12#1)(1992-6#3)(1992-8#4)(1993-12#16)(1993-6#25)(1994-2#5)(1994-8#4)(1995-12#3)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-7#4)(2007-10#2)(2007-8#1)(2008-11#22)(2008-6#3)(2008-7#10)(2009-10#3)(2011-1#1)(2013-8#2)
amygdala-kindled rats##5##2##(1992-3#2)(1994-2#2)(1996-12#1)
amygdala-kindled##6##1##(1992-3#2)(1994-2#2)(1996-12#2)
amygdali##3##1##(2008-10#3)
amygdaloid neurons##3##2##(2008-10#3)
amygdaloid nucleus##2##2##(1991-5#1)(1995-12#1)
amygdaloid##8##1##(1991-5#1)(1994-2#2)(1995-12#1)(2008-10#3)(2012-1#1)
amylase activity##4##2##(2008-10#4)
amylase and##3##2##(2008-12#2)(2012-2#1)
amylase from##3##2##(1991-8#1)(2008-10#2)
amylase level##2##2##(2011-2#1)(2013-1#1)
amylase levels##2##2##(1993-12#1)(2010-1#1)
amylase release from##2##3##(1991-8#1)(1992-12#1)
amylase release in##2##3##(1992-12#2)
amylase release##8##2##(1991-8#1)(1992-12#7)
amylase was##2##2##(1990-12#1)(2013-8#1)
amylase##40##1##(1990-12#7)(1991-8#2)(1992-12#7)(1993-12#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#3)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
amylin action##2##2##(2008-9#2)
amylin and##2##2##(1991-12#1)(1993-11#1)
amylin responsive protein##2##3##(2008-9#2)
amylin was##2##2##(1991-12#2)
amylin##18##1##(1991-12#6)(1992-6#1)(1993-11#3)(2008-9#8)
amylo-1##2##1##(1995-5#2)
amyloderamosa##3##1##(1990-11#3)
amyloglucosidase##3##1##(2008-10#1)(2008-6#2)
amyloid A##4##2##(1991-12#1)(2009-10#2)(2009-8#1)
amyloid and hyalin##2##3##(2013-7#2)
amyloid beta protein (A beta)##2##5##(1994-8#1)(1995-12#1)
amyloid beta protein precursor##2##4##(1992-12#1)(1992-6#1)
amyloid beta protein##8##3##(1992-12#2)(1992-6#1)(1994-11#1)(1994-8#2)(1995-12#2)
amyloid beta##14##2##(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-8#2)(1995-12#2)(1996-5#3)
amyloid beta-protein precursor (APP)##3##4##(1991-2#1)(1992-12#1)(1994-9#1)
amyloid beta-protein precursor##4##3##(1991-2#1)(1992-12#1)(1994-9#2)
amyloid beta-protein##7##2##(1991-11#1)(1991-2#1)(1992-12#2)(1994-9#3)
amyloid beta/A4 protein##2##3##(1992-12#1)(1992-9#1)
amyloid deposition and##2##3##(2010-8#1)(2013-8#1)
amyloid deposition in##4##3##(1991-1#1)(1991-11#1)(1994-5#2)
amyloid deposition##9##2##(1991-1#1)(1991-11#1)(1992-9#1)(1994-5#2)(2008-5#1)(2010-4#1)(2010-8#1)(2013-8#1)
amyloid deposits in##2##3##(1994-11#1)(1994-6#1)
amyloid deposits##9##2##(1991-11#1)(1992-6#2)(1994-11#2)(1994-6#1)(1994-8#1)(2007-7#1)(2008-5#1)
amyloid fibril formation##2##3##(1992-8#1)(1994-8#1)
amyloid fibril protein##2##3##(1992-3#2)
amyloid fibril##5##2##(1992-3#3)(1992-8#1)(1994-8#1)
amyloid fibrillogenesis##2##2##(2012-1#2)
amyloid fibrils are##2##3##(1994-8#2)
amyloid fibrils##3##2##(1994-8#3)
amyloid formation##7##2##(1991-11#2)(1994-8#3)(1996-2#1)(2010-11#1)
amyloid in##2##2##(1992-9#1)(1994-5#1)
amyloid inhibitors##2##2##(2010-11#2)
amyloid is##2##2##(1991-11#1)(1994-8#1)
amyloid peptide##3##2##(1991-1#1)(1994-8#2)
amyloid plaques##4##2##(2008-5#3)(2010-8#1)
amyloid polypeptide##4##2##(1992-6#2)(1994-8#2)
amyloid precursor protein (APP)##3##4##(1993-11#1)(1993-8#1)(1995-12#1)
amyloid precursor protein gene in##2##5##(1993-3#1)(1993-8#1)
amyloid precursor protein gene##3##4##(1993-3#1)(1993-8#1)(1994-8#1)
amyloid precursor protein##17##3##(1991-9#1)(1992-12#3)(1992-3#1)(1993-11#2)(1993-3#1)(1993-8#2)(1994-8#1)(1995-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2012-3#1)
amyloid precursor##18##2##(1991-9#1)(1992-12#4)(1992-3#1)(1993-11#2)(1993-3#1)(1993-8#2)(1994-8#1)(1995-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2012-3#1)
amyloid precursor-like protein 2 (APLP2)##2##5##(1996-12#2)
amyloid protein precursor (APP)##5##4##(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)
amyloid protein precursor##8##3##(1991-9#2)(1992-8#1)(1992-9#2)(1993-3#1)(1994-11#2)
amyloid protein##11##2##(1991-9#2)(1992-8#1)(1992-9#2)(1993-3#1)(1994-11#2)(2008-7#1)(2010-12#1)(2011-2#1)
amyloid was##3##2##(1994-8#2)(2008-11#1)
amyloid##148##1##(1990-7#2)(1991-1#2)(1991-11#8)(1991-12#1)(1991-2#1)(1991-9#4)(1992-12#9)(1992-3#5)(1992-6#6)(1992-8#3)(1992-9#7)(1993-11#2)(1993-2#1)(1993-3#2)(1993-8#3)(1994-11#7)(1994-5#4)(1994-6#1)(1994-8#20)(1994-9#3)(1995-12#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#4)(1997-2#2)(2007-10#1)(2007-7#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#4)(2010-12#2)(2010-4#1)(2010-8#3)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
amyloid-β##3##1##(2010-8#1)(2011-1#1)(2013-1#1)
amyloidogenic conformer (A beta##2##4##(1996-2#2)
amyloidogenic conformer##3##2##(1996-2#3)
amyloidogenic##7##1##(1992-12#3)(1996-2#3)(2011-2#1)
amyloidosis and##4##2##(1993-2#1)(2006-10#1)(2008-1#1)(2011-2#1)
amyloidosis associated with multiple myeloma in a##2##7##(2011-2#2)
amyloidosis associated with##3##3##(2008-7#1)(2011-2#2)
amyloidosis has##2##2##(2010-8#1)(2012-3#1)
amyloidosis in a##2##3##(2008-11#1)(2013-1#1)
amyloidosis in##4##2##(1996-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
amyloidosis is##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
amyloidosis of the##4##3##(2007-7#1)(2008-10#2)(2009-5#1)
amyloidosis was found##2##3##(2007-7#1)(2008-1#1)
amyloidosis was##3##2##(2007-7#2)(2008-1#1)
amyloidosis were##2##2##(2007-7#1)(2008-1#1)
amyloidosis##74##1##(1991-11#1)(1991-12#1)(1992-8#2)(1993-2#2)(1994-6#2)(1994-8#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-7#11)(2007-8#5)(2008-1#4)(2008-10#2)(2008-11#2)(2008-7#4)(2009-5#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#5)(2011-2#13)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
amyloidosis)##3##1##(2010-4#1)(2011-2#1)(2012-2#1)
amyloliquefaciens##10##1##(1990-11#2)(1991-6#2)(2008-10#3)(2013-1#3)
amylolytic##3##1##(2008-10#1)(2008-8#2)
amylose and##2##2##(1995-11#1)(2008-10#1)
amylose content##2##2##(2008-10#1)(2008-9#1)
amylose tris-(3##3##2##(2008-10#3)
amylose were##2##2##(1995-11#1)(2013-8#1)
amylose##20##1##(1990-7#1)(1990-9#3)(1994-8#1)(1995-11#4)(1995-12#1)(1997-6#1)(2008-10#6)(2008-9#1)(2013-8#2)
amylovora and##7##2##(2008-10#6)(2008-8#1)
amylovora cells were##2##3##(2008-10#2)
amylovora could##2##2##(2008-10#2)
amylovora in##4##2##(2008-10#4)
amylovora on##4##2##(2008-10#4)
amylovora or##2##2##(2008-10#2)
amylovora strain##3##2##(2008-10#3)
amylovora was##5##2##(2008-10#5)
amylovora##67##1##(2008-10#66)(2008-8#1)
amyopathic dermatomyositis##5##2##(2006-10#5)
amyotrophic lateral sclerosis and##3##4##(2008-7#1)(2012-3#2)
amyotrophic lateral sclerosis##13##3##(1993-9#1)(1996-5#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-7#1)(2012-3#2)(2013-1#2)
amyotrophic##14##1##(1993-9#1)(1996-5#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-7#1)(2012-3#2)(2013-1#3)
amyotrophy##3##1##(2008-7#3)
an &quot##39##2##(1990-3#1)(1990-9#2)(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(2006-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
an 'orphan##2##2##(2010-10#2)
an 11 year##3##3##(1996-6#1)(2008-1#1)(2012-3#1)
an 11##7##2##(1995-9#2)(1996-5#1)(1996-6#1)(2008-1#1)(2012-3#1)(2013-8#1)
an 11-bp##2##2##(1996-10#1)(2010-4#1)
an 11-year-old boy who presented with##2##6##(2011-2#1)(2013-1#1)
an 11-year-old boy##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
an 11-year-old##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
an 18##6##2##(1992-12#1)(1997-4#1)(2008-11#2)(2008-4#1)(2009-5#1)
an 18-kDa##2##2##(1991-8#1)(2008-10#1)
an 18-month period##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
an 18-month##7##2##(1993-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)
an 18-year-old##2##2##(1991-2#1)(1996-7#1)
an 8 x 8##4##4##(2008-10#1)(2008-2#3)
an 8##16##2##(1994-12#1)(1995-11#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#5)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)
an 8%##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
an 8-day treatment for PDA##2##5##(2012-2#2)
an 8-day##4##2##(2009-8#1)(2012-2#3)
an 8-h day##2##3##(2008-10#1)(2010-10#1)
an 8-h##3##2##(2008-10#2)(2010-10#1)
an 8-nt##2##2##(1994-12#1)(1995-8#1)
an 8-week##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
an 8-year history of##2##4##(2011-1#1)(2012-3#1)
an 8-year period##4##3##(1990-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
an 8-year##8##2##(1990-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
an 8-year-old boy##2##3##(1996-5#1)(2007-5#1)
an 8-year-old##6##2##(1996-5#1)(1997-3#1)(2007-5#1)(2010-5#1)(2012-12#1)(2012-3#1)
an 80 kDa##2##3##(1992-6#1)(2011-2#1)
an A##10##2##(1990-11#1)(1993-3#2)(1994-12#1)(2008-10#4)(2008-3#1)(2009-5#1)
an ABCD matrix##2##3##(2007-12#1)(2008-2#1)
an ABCD##3##2##(2007-12#1)(2008-2#2)
an ABI Prism 7700##2##4##(2008-10#1)(2008-4#1)
an ABI##4##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)
an ACS##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
an ADR##3##2##(1993-1#2)(2008-11#1)
an AFM##2##2##(2008-7#2)
an AIDS clinical trial##2##4##(1997-4#2)
an AIDS patient##2##3##(1996-2#1)(2009-2#1)
an AIDS vaccine##2##3##(1993-3#1)(1994-2#1)
an AIDS##16##2##(1990-6#1)(1992-9#2)(1993-3#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-4#2)(1997-5#1)(1997-6#1)(2008-5#1)(2009-12#1)(2009-2#1)
an AMI##4##2##(1995-2#1)(2009-6#3)
an AMP receptor##2##3##(2008-4#2)
an ANN##3##2##(2008-10#3)
an AO##7##2##(2008-2#1)(2008-3#6)
an AOS##2##2##(2007-11#1)(2008-2#1)
an AP##2##2##(2008-10#1)(2008-5#1)
an APD and##2##3##(2011-10#2)
an APD##3##2##(2011-10#3)
an ARF##3##2##(1993-6#3)
an ASP intervention##2##3##(2013-1#2)
an ASP##4##2##(2013-1#4)
an AT##3##2##(1993-11#1)(1995-5#1)(2008-4#1)
an AT-rich##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
an ATP##5##2##(1990-7#1)(1991-9#1)(1994-5#1)(1997-4#1)(2008-11#1)
an ATP-binding##2##2##(1995-2#1)(2008-4#1)
an ATP-dependent##3##2##(1991-6#1)(1994-12#2)
an ATPase##2##2##(1991-2#1)(1995-3#1)
an AVM in the##2##4##(2008-7#2)
an AVM##4##2##(2008-7#3)(2012-3#1)
an Abbott-adjusted##2##2##(2009-5#2)
an Abel##2##2##(2008-2#1)(2008-3#1)
an Achilles##2##2##(2008-1#1)(2012-2#1)
an Active##4##2##(1996-12#1)(2008-10#2)(2009-10#1)
an Ad##2##2##(1990-3#1)(1997-3#1)
an African##6##2##(1991-5#1)(1993-6#2)(1994-3#1)(2009-11#1)(2010-8#1)
an Ag/AgCl reference electrode##3##4##(1991-5#1)(2008-10#2)
an Agilent##2##2##(2008-7#1)(2011-1#1)
an Agrobacterium-mediated##3##2##(2008-10#2)(2008-8#1)
an Ah##2##2##(1992-8#1)(1993-12#1)
an AlGaAs##3##2##(2007-12#2)(2008-2#1)
an Ala mutation at position##2##5##(1992-6#2)
an Ala##5##2##(1992-3#2)(1992-6#2)(2011-2#1)
an Allee effect##3##3##(2008-10#2)(2008-8#1)
an Alu##2##2##(1993-11#1)(1993-12#1)
an Amberlite##2##2##(2008-10#2)
an American##2##2##(1991-2#1)(2008-3#1)
an Amplatzer##2##2##(2010-5#1)(2012-12#1)
an ArF excimer laser##2##4##(2007-12#2)
an Arab population##2##3##(2007-12#1)(2008-6#1)
an Arab##3##2##(2007-12#1)(2008-6#1)(2011-2#1)
an Arabidopsis##7##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)
an Asian country##3##3##(2007-7#1)(2008-10#2)
an Asian sample##2##3##(2008-12#1)(2013-3#1)
an Asian##9##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-6#1)(2013-3#1)
an Australia-wide##2##2##(2007-11#1)(2008-10#1)
an Australian perspective##2##3##(2008-10#1)(2008-11#1)
an Australian##13##2##(1996-1#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2013-1#1)
an E##11##2##(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1996-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-9#1)
an E-box##2##2##(1995-6#1)(1997-7#1)
an EC(50)##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
an EC50 of##3##3##(1993-11#1)(1994-9#1)(1997-2#1)
an EC50##5##2##(1993-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-2#1)
an EDTA##2##2##(2008-10#2)
an EEG##3##2##(1990-9#1)(1994-3#1)(2008-7#1)
an ELISA format##2##3##(1995-2#1)(2008-9#1)
an ELISA technique##2##3##(1993-12#1)(2008-4#1)
an ELISA##15##2##(1991-3#1)(1992-12#1)(1993-12#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-12#2)(2008-4#2)(2008-9#1)
an EM algorithm##2##3##(1997-3#1)(2008-2#1)
an EM##3##2##(1997-3#1)(2008-2#1)(2010-2#1)
an EMG##2##2##(1993-12#1)(1993-9#1)
an ENaC inhibitor combined with##2##5##(2009-9#2)
an ENaC inhibitor/ HCTZ combination##2##5##(2009-9#2)
an ENaC##4##2##(2009-9#4)
an EPA##2##2##(2008-10#1)(2008-2#1)
an ER##2##2##(1990-5#1)(1996-9#1)
an ERK-dependent##2##2##(2008-4#1)(2013-1#1)
an ESR##3##2##(2007-7#1)(2008-10#2)
an Effective##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
an Emergency##2##2##(2012-3#1)(2013-1#1)
an English University##2##3##(2008-11#1)(2008-12#1)
an English##3##2##(2008-11#1)(2008-12#1)(2008-4#1)
an Er##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
an Er(3+)/Yb(3+)##2##2##(2007-12#1)(2008-3#1)
an Er-Yb##2##2##(2007-11#2)
an Escherichia coli expression system##2##5##(1994-12#1)(1994-5#1)
an Escherichia coli mutant##2##4##(1997-7#1)(2008-6#1)
an Escherichia coli##8##3##(1990-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1997-7#1)(2008-6#1)(2008-7#1)
an Experimental##2##2##(2009-1#1)(2012-12#1)
an F(1)##2##2##(2008-10#1)(2013-1#1)
an F(2) population of##3##4##(2008-10#3)
an F(2) population##7##3##(2008-10#5)(2008-8#1)(2008-9#1)
an F(2)##8##2##(2008-10#5)(2008-8#2)(2008-9#1)
an F2##3##2##(2008-5#1)(2008-8#2)
an FIA system##2##3##(2008-10#2)
an Fc##2##2##(1991-2#1)(2008-10#1)
an H##2##2##(2008-10#1)(2008-3#1)
an HIV prevention##2##3##(2008-4#1)(2008-7#1)
an HIV##11##2##(1993-12#1)(1996-5#1)(1997-5#1)(2007-7#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2013-8#1)
an HIV-antibody test##2##3##(1996-5#2)
an HIV-infected patient##2##3##(1996-9#1)(2007-12#1)
an HIV-infected##4##2##(1996-9#1)(2006-10#1)(2007-12#2)
an HIV-positive##4##2##(1992-12#1)(1993-6#1)(1996-5#1)(1997-5#1)
an HMO and##2##3##(1994-12#1)(1996-2#1)
an HMO##8##2##(1992-1#1)(1993-12#4)(1994-12#1)(1996-2#1)(1997-1#1)
an HPLC method##4##3##(2008-10#4)
an HPLC##13##2##(1994-8#1)(1997-4#1)(2008-10#10)(2008-4#1)
an HPV##2##2##(2008-11#2)
an HPV-negative##2##2##(2013-1#2)
an HR##2##2##(2008-10#1)(2008-3#1)
an HSP##2##2##(1994-11#2)
an I##3##2##(1990-5#1)(1991-7#1)(1995-8#1)
an IC(50) of##2##3##(2008-10#1)(2008-9#1)
an IC(50) value of##2##4##(2010-5#1)(2013-1#1)
an IC(50)##4##2##(2008-10#1)(2008-9#1)(2010-5#1)(2013-1#1)
an IC50 of##13##3##(1991-8#2)(1991-9#1)(1993-12#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-2#2)(1997-4#1)(2010-11#1)
an IC50##18##2##(1991-8#2)(1991-9#3)(1993-12#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-8#1)(1996-2#2)(1997-4#1)(2008-12#1)(2008-5#1)(2010-11#1)
an ICP-MS##4##2##(2008-10#4)
an ICP-OES##2##2##(2008-10#2)
an ICU##3##2##(1997-1#1)(2008-4#1)(2012-12#1)
an IP3##2##2##(1991-6#1)(2008-8#1)
an IR##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
an Ideal##2##2##(1996-12#1)(2009-9#1)
an IgE-mediated##2##2##(1991-11#1)(1996-3#1)
an IgG##5##2##(1990-12#2)(1994-2#2)(1994-5#1)
an IgM monoclonal##2##3##(2008-11#2)
an InGaAs##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
an Indian context##2##3##(2013-1#2)
an Indian perspective##2##3##(2009-11#2)
an Indian##7##2##(1997-4#1)(2008-5#1)(2009-11#2)(2011-2#1)(2013-1#2)
an Integrated##2##2##(2010-4#1)(2012-1#1)
an Intensive Care Unit##2##4##(2010-9#1)(2012-3#1)
an Interprofessional##3##2##(2008-11#2)(2008-12#1)
an Intracavity##2##2##(2008-2#1)(2008-3#1)
an Iranian##6##2##(2008-12#1)(2008-8#1)(2010-8#2)(2012-2#1)(2013-1#1)
an Irish##4##2##(1991-12#1)(2008-11#2)(2008-12#1)
an Italian##8##2##(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)
an LC##2##2##(2008-10#2)
an LDL##3##2##(1991-6#1)(1996-8#1)(2008-5#1)
an LED##3##2##(2008-10#2)(2008-3#1)
an M##2##2##(1992-1#1)(2008-10#1)
an M(2)##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
an M(r) of##3##3##(1992-12#1)(1995-5#1)(2008-10#1)
an M-profile fiber##2##3##(2007-12#1)(2008-2#1)
an MDI with a spacer device##2##6##(1996-1#1)(2008-3#1)
an MDI with a spacer##3##5##(1996-1#2)(2008-3#1)
an MDI##8##2##(1996-1#5)(1997-1#2)(2008-3#1)
an MRI##4##2##(1992-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
an Mr of##2##3##(1990-11#1)(1996-2#1)
an Mr##3##2##(1990-11#2)(1996-2#1)
an N##3##2##(2008-10#3)
an N-acyltransferase##2##2##(1994-8#2)
an N-linked glycosylation##2##3##(1994-11#1)(2008-11#1)
an N-linked##3##2##(1991-9#1)(1994-11#1)(2008-11#1)
an N-terminal domain##2##3##(2008-8#1)(2012-2#1)
an N-terminal extension##2##3##(1991-6#2)
an N-terminal propeptide##3##3##(1994-5#1)(1995-3#1)(2009-10#1)
an N-terminal##21##2##(1991-10#1)(1991-6#2)(1992-6#1)(1993-12#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-2#1)
an NDA##2##2##(2008-5#2)
an NH2-terminal fragment of##2##4##(1990-12#1)(1997-1#1)
an NHS##3##2##(1997-7#1)(2008-11#1)(2013-8#1)
an NMDA##4##2##(1994-8#1)(1995-12#1)(2008-5#1)(2009-12#1)
an NMR##3##2##(1991-5#1)(2008-10#1)(2012-2#1)
an O-Mo-O-P dihedral angle of##2##5##(1996-2#2)
an O/W emulsion and##2##4##(2008-5#2)
an O/W##3##2##(2008-5#3)
an O2##3##2##(1992-8#1)(2008-7#1)(2011-1#1)
an OAH##9##2##(2008-7#9)
an OCT##3##2##(2008-3#2)(2011-2#1)
an ODS##3##2##(2008-10#3)
an OF##2##2##(2008-10#2)
an OFSTED for the NHS##2##5##(2008-7#2)
an OH##3##2##(2007-12#2)(2008-10#1)
an OPD##2##2##(2008-3#2)
an OR##4##2##(2008-11#1)(2008-2#1)(2013-1#2)
an ORF of##2##3##(1997-4#1)(2008-7#1)
an ORF##7##2##(1993-2#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-4#1)(2008-7#1)
an OSCE##2##2##(1994-2#1)(2008-11#1)
an Objective Structured Clinical Examination (OSCE)##2##6##(2008-11#2)
an Objective Structured Clinical##3##4##(2008-11#2)(2012-3#1)
an Ohio##2##2##(1995-12#2)
an Ontario##2##2##(1995-12#1)(1997-1#1)
an Optical##2##2##(2008-2#1)(2008-3#1)
an Oryza##2##2##(2008-10#2)
an R##5##2##(1992-8#1)(2008-10#4)
an R-factor of##2##3##(1997-6#1)(2008-8#1)
an RGD-containing##2##2##(1994-11#1)(2009-7#1)
an RIP##2##2##(2008-10#2)
an RIS can##2##3##(1991-1#1)(1994-2#1)
an RIS##3##2##(1991-1#1)(1994-2#2)
an RNA polymerase##2##3##(1994-3#1)(2008-7#1)
an RNA structure##2##3##(1991-5#1)(1994-8#1)
an RNA##17##2##(1991-5#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-6#2)(2008-4#6)(2008-7#1)(2010-4#1)
an RNase protection assay##2##4##(1993-6#1)(1997-7#1)
an RNase##3##2##(1993-6#1)(1995-8#1)(1997-7#1)
an RPE that corresponded to 70% of oxygen uptake reserve##2##10##(2013-8#2)
an RPE that corresponded to##3##5##(2013-8#3)
an RR of##2##3##(1992-11#2)
an RS##2##2##(1995-6#1)(2008-8#1)
an RSD##2##2##(2008-10#2)
an S =##2##3##(2007-11#1)(2012-12#1)
an S##5##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-12#1)
an SIA system##2##3##(2008-10#2)
an SIA##4##2##(2008-10#4)
an SKM##2##2##(2011-2#2)
an SPE##2##2##(2008-10#2)
an SV40##2##2##(1993-12#1)(1995-6#1)
an UV-Vis##2##2##(2008-10#2)
an X chromosome-linked##2##3##(1994-8#2)
an X##5##2##(1994-8#2)(2008-10#2)(2008-12#1)
an X-linked##8##2##(2007-7#3)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
an X-ray diffraction##2##3##(2008-9#1)(2010-5#1)
an X-ray lens##2##3##(2008-10#2)
an X-ray##6##2##(1992-11#1)(2008-10#3)(2008-9#1)(2010-5#1)
an a priori##4##3##(2008-2#4)
an abandoned##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
an abasic site##2##3##(1995-5#2)
an abdominal aortic aneurysm##5##4##(1992-5#1)(2008-11#1)(2010-7#1)(2011-2#2)
an abdominal operation##2##3##(1994-2#1)(2011-2#1)
an abdominal##15##2##(1992-5#1)(1994-2#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#4)(2013-1#2)
an aberrant##5##2##(1991-9#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
an aberrated##2##2##(2007-12#1)(2008-3#1)
an aberration##2##2##(2008-3#2)
an aberration-corrected##3##2##(2008-3#2)(2010-12#1)
an ability of##2##3##(1992-5#1)(2009-6#1)
an ability to interact with##2##5##(1992-11#1)(2012-3#1)
an ability to##10##3##(1992-11#1)(1994-2#1)(1995-5#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-2#1)(2012-3#1)
an ability##14##2##(1990-11#1)(1992-11#1)(1992-5#1)(1994-2#1)(1995-5#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-6#2)(2010-2#1)(2012-3#1)
an abnormal ECG##2##3##(2008-3#1)(2010-8#1)
an abnormal morphology##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
an abnormal thermogram##3##3##(1993-11#3)
an abnormal##43##2##(1990-5#1)(1991-3#1)(1993-11#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
an abnormality##4##2##(1996-2#1)(2007-10#1)(2008-2#1)(2008-6#1)
an abnormally high##2##3##(1995-5#1)(1997-1#1)
an abnormally##9##2##(1995-5#1)(1997-1#1)(2008-2#1)(2008-6#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
an abortion##6##2##(1990-6#1)(1990-9#1)(1995-8#1)(1997-6#2)(2011-1#1)
an about##5##2##(1992-11#1)(1997-2#1)(2008-8#2)(2011-2#1)
an abridged##3##2##(1994-1#1)(2008-11#1)(2010-11#1)
an abrupt##5##2##(1991-5#1)(1992-6#1)(1996-4#1)(2008-11#1)(2008-8#1)
an abscess in the##2##4##(2011-2#1)(2012-3#1)
an abscess##6##2##(1991-6#1)(2007-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
an absence of##10##3##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-7#1)
an absence##11##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-7#1)(2013-8#1)
an absent##2##2##(2008-12#1)(2008-9#1)
an absolute contraindication to the##2##5##(1994-8#1)(2011-2#1)
an absolute contraindication##4##3##(1991-6#1)(1994-8#1)(2011-2#2)
an absolute requirement for##3##4##(1990-11#1)(1994-11#1)(2007-12#1)
an absolute requirement##7##3##(1990-11#1)(1992-1#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)
an absolute##33##2##(1990-11#1)(1991-6#1)(1992-1#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#8)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)
an absorbable##3##2##(1996-6#1)(2008-9#1)(2010-3#1)
an absorbance maxima at##2##4##(2008-10#2)
an absorbance maximum at##2##4##(1992-8#1)(2008-10#1)
an absorbance##10##2##(1992-8#1)(1996-4#1)(2008-10#6)(2008-2#1)(2008-3#1)
an absorbed pump power of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
an absorbed pump##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
an absorbed##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
an absorbing medium##5##3##(2007-12#1)(2008-3#4)
an absorbing solution##4##3##(2008-10#4)
an absorbing##19##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#9)(2013-1#1)
an absorption band##2##3##(2007-12#1)(2008-2#1)
an absorption length of##2##4##(2007-12#1)(2008-3#1)
an absorption maximum at##7##4##(2008-10#7)
an absorption spectrum##2##3##(1994-6#1)(2008-2#1)
an absorption##28##2##(1994-6#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-2#6)(2008-3#6)(2012-2#1)
an abstract for##2##3##(2008-12#2)
an abstract##10##2##(1990-5#1)(2008-12#4)(2008-5#1)(2010-4#3)(2011-2#1)
an abundance of##7##3##(1992-3#1)(1992-7#1)(1995-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
an abundance##8##2##(1992-3#1)(1992-7#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
an abundant and##2##3##(2010-4#1)(2013-1#1)
an abundant protein in##2##4##(1994-12#1)(1994-2#1)
an abundant protein##3##3##(1991-5#1)(1994-12#1)(1994-2#1)
an abundant##12##2##(1991-2#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-1#1)
an ac##3##2##(2008-11#1)(2008-3#2)
an academic health sciences##2##4##(1995-1#1)(1995-2#1)
an academic health##7##3##(1994-3#5)(1995-1#1)(1995-2#1)
an academic medical center##3##4##(1995-3#1)(2008-3#1)(2011-1#1)
an academic medical library##2##4##(1991-1#2)
an academic medical##5##3##(1991-1#2)(1995-3#1)(2008-3#1)(2011-1#1)
an academic role##2##3##(2008-11#1)(2012-3#1)
an academic urban hospital##2##4##(2008-3#2)
an academic year##3##3##(2008-12#1)(2011-1#2)
an academic##30##2##(1991-1#2)(1992-1#2)(1994-3#5)(1995-1#1)(1995-2#2)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2010-8#1)(2011-1#3)(2011-2#1)(2012-3#2)
an accelerated schedule##2##3##(1992-2#1)(2007-2#1)
an accelerated state##2##3##(2007-11#1)(2013-8#1)
an accelerated##19##2##(1990-9#1)(1992-2#2)(1993-1#1)(1995-12#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-12#2)(2008-6#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
an accelerating##2##2##(1995-6#1)(2008-1#1)
an acceleration in##2##3##(2008-10#1)(2013-8#1)
an acceleration of##2##3##(2008-8#1)(2012-2#1)
an acceleration##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
an acceptable accuracy##2##3##(2008-10#1)(2008-3#1)
an acceptable airway##2##3##(2010-7#1)(2013-8#1)
an acceptable alternative to##2##4##(2011-2#1)(2012-3#1)
an acceptable alternative##3##3##(1994-12#1)(2011-2#1)(2012-3#1)
an acceptable level of##4##4##(2008-10#3)(2009-11#1)
an acceptable level##6##3##(1991-2#1)(2008-10#3)(2009-11#1)(2009-8#1)
an acceptable range##3##3##(2008-10#3)
an acceptable##33##2##(1991-2#1)(1991-3#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
an accepted part of##2##4##(1994-3#1)(1997-4#1)
an accepted##11##2##(1994-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-8#1)
an acceptor stream containing##3##4##(2008-10#3)
an acceptor stream##5##3##(2008-10#5)
an acceptor##10##2##(1993-11#1)(1995-11#1)(1996-5#1)(2008-10#6)(2008-11#1)
an access##3##2##(2007-11#1)(2007-8#2)
an accessible##2##2##(2008-10#1)(2012-12#1)
an accessory plantaris muscle in##2##5##(2012-2#2)
an accessory##5##2##(1995-2#1)(2008-10#1)(2012-2#2)(2013-1#1)
an accident##2##2##(1995-11#1)(2010-8#1)
an accidental duplication of an article that has already been published in##7##12##(2008-11#6)(2008-7#1)
an accidental duplication of an article that has already been published##8##11##(2008-11#6)(2008-7#1)(2012-3#1)
an accidental##9##2##(2008-11#6)(2008-7#1)(2012-3#1)(2013-1#1)
an accompanying paper##2##3##(1995-2#1)(2008-3#1)
an accompanying##6##2##(1991-12#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
an account of a##2##4##(2008-10#1)(2008-11#1)
an account of the##7##4##(1995-2#1)(2008-10#2)(2008-12#2)(2008-7#1)(2013-1#1)
an account of##9##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
an account##10##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
an accumulation mode##2##3##(2008-2#1)(2008-3#1)
an accumulation of##19##3##(1992-11#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-11#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#3)
an accumulation potential of -0##5##5##(2008-10#5)
an accumulation potential of##6##4##(2008-10#6)
an accumulation time of##3##4##(2008-10#3)
an accumulation time##4##3##(2008-10#4)
an accumulation##34##2##(1992-11#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-11#1)(1997-7#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#3)
an accumulative##2##2##(2010-1#1)(2013-1#1)
an accuracy better than 0##2##5##(2008-3#2)
an accuracy better than##3##4##(2008-2#1)(2008-3#2)
an accuracy of 1##2##4##(2007-12#1)(2008-1#1)
an accuracy of 89%##3##4##(1990-9#1)(1993-8#1)(2008-11#1)
an accuracy of a few##2##5##(2008-3#2)
an accuracy of better than##6##5##(2008-2#3)(2008-3#3)
an accuracy of the order of##2##6##(2008-3#2)
an accuracy of##48##3##(1990-9#1)(1993-8#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#23)(2008-5#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
an accuracy that is##2##4##(2008-2#1)(2008-9#1)
an accuracy##57##2##(1990-9#1)(1993-8#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#9)(2008-3#25)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
an accurate and reliable##2##4##(2008-11#1)(2008-3#1)
an accurate and##8##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
an accurate depiction of##2##4##(2008-9#1)(2012-2#1)
an accurate determination of the##2##5##(2008-10#1)(2008-12#1)
an accurate determination of##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
an accurate diagnosis##7##3##(1991-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-6#1)(2010-6#1)
an accurate history##2##3##(1991-11#1)(2013-8#1)
an accurate map##2##3##(2008-4#1)(2012-12#1)
an accurate measurement of##2##4##(2007-11#1)(2008-3#1)
an accurate method##3##3##(1993-3#1)(2008-10#1)(2008-2#1)
an accurate representation of##2##4##(2006-12#1)(2008-9#1)
an accurate understanding of##2##4##(2008-1#1)(2008-11#1)
an accurate##77##2##(1990-6#1)(1990-8#1)(1991-11#3)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#3)
an acetabular##2##2##(2008-8#2)
an acetate buffer##4##3##(2008-10#4)
an acetate##6##2##(2008-10#4)(2008-7#1)(2010-10#1)
an acetic acid##3##3##(1991-5#1)(2008-10#2)
an acetic##4##2##(1991-5#1)(2008-10#3)
an acetone##2##2##(2008-10#2)
an acetonitrile-phosphate buffer##2##3##(2008-10#2)
an acetylcholinesterase##2##2##(1992-11#1)(1993-12#1)
an achievable goal##2##3##(2008-11#1)(2008-4#1)
an achromatic##10##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#3)
an achromatizing##2##2##(2008-3#2)
an acid mixture##2##3##(2008-10#2)
an acid solution##3##3##(2008-10#3)
an acid##17##2##(1990-2#1)(2007-7#1)(2008-10#10)(2008-5#2)(2008-6#1)(2009-7#1)(2011-2#1)
an acidic solution and##2##4##(2008-10#2)
an acidic solution##3##3##(2008-10#3)
an acidic##38##2##(1990-8#1)(1992-8#1)(1994-11#1)(1994-5#3)(1994-6#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-6#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#2)
an acidification##3##2##(2009-10#1)(2012-3#2)
an acidified##4##2##(2007-12#1)(2008-10#2)(2012-1#1)
an acoustic##5##2##(1994-7#1)(2008-10#2)(2008-3#1)(2008-7#1)
an acousto-optic modulator##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
an acousto-optic tunable filter for##2##5##(2007-11#1)(2008-3#1)
an acousto-optic tunable filter##5##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
an acousto-optic##13##2##(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#2)
an acquired##5##2##(1996-11#1)(2006-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
an acquisition access period##2##4##(2008-10#2)
an acquisition##4##2##(1993-6#1)(2008-10#2)(2008-3#1)
an acrosomal complex##2##3##(2007-12#2)
an acrosome##2##2##(2008-7#2)
an act of##2##3##(1997-3#1)(2009-10#1)
an actin##3##2##(2008-11#2)(2012-2#1)
an actin-binding protein##2##3##(1990-7#1)(2012-2#1)
an actin-binding##4##2##(1990-5#1)(1990-7#1)(1993-8#1)(2012-2#1)
an action is##2##3##(2008-11#1)(2008-7#1)
an action of the##2##4##(1994-8#1)(2013-1#1)
an action of these##2##4##(1992-12#1)(1994-2#1)
an action of##4##3##(1992-12#1)(1994-2#1)(1994-8#1)(2013-1#1)
an action on##5##3##(1993-12#1)(1994-9#1)(2008-4#1)(2010-8#1)(2013-1#1)
an action research approach##2##4##(2007-10#1)(2008-11#1)
an action research##3##3##(2007-10#2)(2008-11#1)
an action##25##2##(1992-12#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(2007-10#2)(2007-4#1)(2008-11#2)(2008-4#2)(2008-7#1)(2010-8#2)(2011-2#2)(2013-1#3)
an activated carbon column##3##4##(2008-10#3)
an activated carbon##4##3##(2008-10#4)
an activated form of##2##4##(1991-9#1)(2008-9#1)
an activated phenotype##3##3##(1993-9#1)(1997-3#1)(2008-7#1)
an activated##13##2##(1991-2#1)(1991-9#1)(1993-9#1)(1995-8#1)(1997-3#2)(2008-10#4)(2008-7#1)(2008-9#1)(2009-8#1)
an activating##2##2##(1990-8#1)(2010-6#1)
an activation of the##2##4##(2008-10#1)(2010-1#1)
an activation of##6##3##(1992-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-1#1)
an activation##15##2##(1992-6#1)(1994-12#1)(1994-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-1#1)
an activator for##4##3##(2008-10#3)(2009-12#1)
an activator of protein kinase C##3##6##(1991-12#1)(1992-8#1)(2008-11#1)
an activator of##7##3##(1991-12#1)(1992-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
an activator##23##2##(1991-12#1)(1992-8#3)(1993-12#2)(1994-5#1)(1995-2#1)(1995-5#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)
an active CDC28 gene##2##4##(1991-5#2)
an active and##6##3##(1992-10#1)(1992-12#1)(1994-11#1)(1995-6#1)(2008-9#1)(2010-3#1)
an active catheter##2##3##(2009-9#2)
an active enzyme##2##3##(1991-7#1)(1994-5#1)
an active life##2##3##(2007-8#1)(2008-6#1)
an active medium##2##3##(2007-12#1)(2008-3#1)
an active metabolite of##2##4##(1992-3#1)(2008-7#1)
an active molecule##2##3##(2008-10#1)(2008-5#1)
an active optical##3##3##(2007-11#1)(2008-3#2)
an active or##2##3##(2008-2#1)(2008-4#1)
an active participation##2##3##(2008-10#1)(2009-9#1)
an active principle##2##3##(1992-3#1)(2011-1#1)
an active role in the##4##5##(1992-3#1)(2008-10#2)(2008-5#1)
an active role in triggering##2##5##(2010-11#2)
an active role in##10##4##(1992-3#1)(1994-1#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-5#1)(2010-11#2)(2013-1#1)
an active role##12##3##(1992-3#1)(1994-1#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#2)(2010-12#1)(2013-1#1)
an active site##4##3##(1992-11#1)(1992-3#1)(1993-11#1)(1994-12#1)
an active##127##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-3#1)(1997-4#2)(1997-7#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#3)(2009-6#1)(2009-9#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#1)(2013-7#1)
an active-site##2##2##(1990-7#1)(2008-4#1)
an actively mode-locked##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
an actively##7##2##(2007-11#1)(2007-12#3)(2008-2#3)
an activin-binding protein##2##3##(1992-8#1)(1994-11#1)
an activity that##2##3##(1995-2#1)(1995-6#1)
an activity which mimics##2##4##(1990-11#2)
an activity##15##2##(1990-11#2)(1990-12#2)(1991-6#2)(1993-9#1)(1994-12#1)(1995-2#1)(1995-6#1)(2007-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
an actual beam in the laboratory##2##6##(2008-2#1)(2008-3#1)
an actual##15##2##(1991-12#1)(1993-3#1)(1996-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2012-1#1)(2012-2#2)(2013-7#1)
an actuator##2##2##(2007-11#1)(2008-3#1)
an acute abdomen##6##3##(1991-6#1)(1995-3#1)(1997-3#1)(2009-9#1)(2010-12#1)(2012-12#1)
an acute and##4##3##(1992-3#1)(1995-12#1)(2007-10#1)(2007-11#1)
an acute care setting##5##4##(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#1)
an acute care##12##3##(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#1)
an acute coronary##2##3##(2008-3#1)(2008-5#1)
an acute disease##2##3##(1994-6#1)(2008-7#1)
an acute hospital##3##3##(2007-10#2)(2008-11#1)
an acute ischemic stroke##2##4##(2007-10#2)
an acute ischemic##3##3##(2007-10#2)(2011-2#1)
an acute myocardial infarction (AMI)##2##5##(2008-3#1)(2010-11#1)
an acute myocardial infarction##5##4##(1990-9#1)(2008-11#2)(2008-3#1)(2010-11#1)
an acute myocardial##7##3##(1990-9#1)(1991-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-11#1)
an acute onset of##4##4##(2008-11#1)(2009-3#1)(2012-12#1)(2013-8#1)
an acute phase##2##3##(1992-12#1)(1997-3#1)
an acute pulmonary##2##3##(1994-11#1)(2010-6#1)
an acute surgical##3##3##(1991-6#1)(2010-10#2)
an acute##109##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-3#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#4)(2007-10#8)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#3)(2009-5#1)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-3#2)(2010-6#2)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
an acutely ill##2##3##(2009-8#1)(2011-2#1)
an acyl donor##2##3##(1997-2#1)(2008-4#1)
an acyl##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
an ad hoc##2##3##(1992-12#1)(1997-3#1)
an ad libitum##2##3##(2008-10#1)(2013-8#1)
an ad##4##2##(1992-12#1)(1997-3#1)(2008-10#1)(2013-8#1)
an adaptation of##6##3##(1992-2#1)(2008-11#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
an adaptation to##4##3##(2008-10#1)(2009-1#1)(2011-2#1)(2013-1#1)
an adaptation##13##2##(1990-8#1)(1992-2#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
an adapted##5##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
an adaptive mechanism##2##3##(2009-8#1)(2012-12#1)
an adaptive optics system##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
an adaptive optics##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2011-1#1)
an adaptive phase controller##3##4##(2007-11#3)
an adaptive radiation##3##3##(1997-4#2)(2008-8#1)
an adaptive response to##2##4##(2008-7#2)
an adaptive response##3##3##(2008-7#3)
an adaptive##45##2##(1990-11#1)(1996-9#1)(1997-4#2)(2007-11#5)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#11)(2008-6#3)(2008-7#4)(2008-8#2)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
an adaptive-optics loop##2##3##(2007-11#1)(2007-12#1)
an adaptively##2##2##(2007-11#1)(2011-2#1)
an add-on##3##2##(1994-12#1)(2008-7#1)(2013-8#1)
an added##9##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)
an addition of##3##3##(1997-8#1)(2008-5#1)(2010-3#1)
an addition to the##2##4##(1991-2#1)(2008-12#1)
an addition##7##2##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)
an additional 2##3##3##(1994-11#1)(1996-2#1)(2008-10#1)
an additional case of##2##4##(2009-3#1)(2013-1#1)
an additional channel##2##3##(2008-10#1)(2008-2#1)
an additional criterion to##2##4##(2008-10#2)
an additional factor##3##3##(1992-6#1)(2008-10#1)(2012-3#1)
an additional marker of##2##4##(1995-3#1)(2008-3#1)
an additional mechanism##4##3##(1992-12#1)(1994-8#1)(1995-5#1)(2013-1#1)
an additional mutation##2##3##(1995-3#1)(1997-3#1)
an additional negative##2##3##(2008-4#1)(2011-2#1)
an additional signal##2##3##(2007-12#1)(2008-4#1)
an additional source of##5##4##(2008-10#2)(2009-9#1)(2010-6#1)(2013-1#1)
an additional source##6##3##(2008-10#2)(2008-5#1)(2009-9#1)(2010-6#1)(2013-1#1)
an additional tool for##2##4##(2008-11#1)(2011-2#1)
an additional tool##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
an additional treatment##2##3##(2008-10#1)(2013-1#1)
an additional unknown##2##3##(2008-3#1)(2009-10#1)
an additional##175##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#3)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#34)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#3)
an additive effect##5##3##(1992-3#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-12#1)
an additive##22##2##(1990-2#1)(1991-8#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-8#1)
an adduct##2##2##(1993-11#1)(1995-6#1)
an adducted##2##2##(1990-7#1)(1993-8#1)
an adenine##3##2##(1991-12#1)(1991-8#1)(1993-1#1)
an adenine-repressible gene##2##3##(1995-8#2)
an adenocarcinoma##3##2##(1992-2#1)(1997-3#1)(2007-8#1)
an adenosine A2 receptor##2##4##(1990-12#2)
an adenosine##6##2##(1990-12#2)(1993-6#1)(1995-8#1)(1995-9#1)(2008-9#1)
an adenovirus vector##2##3##(2008-11#1)(2010-1#1)
an adenovirus##5##2##(1992-9#3)(2008-11#1)(2010-1#1)
an adenovirus-mediated siRNA system##2##4##(2010-1#2)
an adenylate cyclase##2##3##(2008-4#1)(2010-1#1)
an adenylyl cyclase##2##3##(1992-3#2)
an adequate explanation##2##3##(2008-10#1)(2009-5#1)
an adequate##56##2##(1990-6#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-9#2)(1996-2#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
an adhesion##4##2##(1993-9#1)(2008-10#1)(2008-7#1)(2009-6#1)
an adhesive##4##2##(2008-12#1)(2010-4#1)(2012-2#2)
an adjacent##12##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-3#1)(2010-4#1)
an adjunct to the##3##4##(1995-2#1)(2007-8#1)(2013-1#1)
an adjunct to##20##3##(1991-8#1)(1992-1#1)(1995-2#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
an adjunct##25##2##(1991-8#1)(1992-1#1)(1995-2#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
an adjunctive treatment##3##3##(1992-9#1)(1994-11#1)(2008-7#1)
an adjunctive##4##2##(1992-9#1)(1994-11#1)(2008-5#1)(2008-7#1)
an adjustable##5##2##(2007-8#1)(2008-2#2)(2008-3#2)
an adjustment##5##2##(1992-2#2)(2008-10#1)(2011-2#1)(2012-7#1)
an adjuvant therapy##3##3##(1990-10#2)(2012-2#1)
an adjuvant##18##2##(1990-10#2)(1990-2#2)(1991-5#3)(1991-8#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
an administrative role##3##3##(1992-1#1)(2008-1#2)
an administrative##7##2##(1991-1#1)(1992-1#1)(1995-6#1)(1997-2#1)(2008-1#2)(2012-3#1)
an admixture of malignant##2##4##(2011-2#1)(2012-1#1)
an admixture of##5##3##(1997-8#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-1#1)
an adolescent girl##2##3##(2008-11#1)(2009-3#1)
an adolescent with##4##3##(2008-4#2)(2012-12#1)(2012-2#1)
an adolescent##13##2##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2009-3#1)(2010-12#1)(2012-12#1)(2012-2#1)
an adrenal##4##2##(1990-5#1)(1992-12#1)(2008-4#1)(2008-5#1)
an adsorbed##5##2##(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)
an adsorption##2##2##(2008-10#2)
an adsorptive##2##2##(2008-10#2)
an adult child##2##3##(1994-12#1)(2010-4#1)
an adult female##2##3##(2007-10#1)(2008-9#1)
an adult human##2##3##(1992-8#1)(1997-8#1)
an adult individual##2##3##(2008-11#1)(2008-9#1)
an adult male with##2##4##(2007-7#1)(2007-8#1)
an adult male##3##3##(2007-2#1)(2007-7#1)(2007-8#1)
an adult man##2##3##(2007-7#1)(2012-3#1)
an adult of##2##3##(2008-11#1)(2008-7#1)
an adult patient with##2##4##(2006-10#1)(2013-1#1)
an adult patient##8##3##(1992-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
an adult population##3##3##(1995-9#1)(1997-4#1)(2012-12#1)
an adult with##8##3##(1997-3#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
an adult##68##2##(1990-3#1)(1992-3#2)(1992-8#1)(1994-12#1)(1994-6#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#2)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#1)(2009-5#1)(2010-11#3)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
an advance of##2##3##(2012-6#1)(2012-7#1)
an advanced ovarian##2##3##(2009-5#2)
an advanced stage##8##3##(1991-6#1)(1991-8#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2010-2#1)(2013-1#1)
an advanced##32##2##(1991-6#1)(1991-8#1)(1993-1#1)(1994-12#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-5#2)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
an advantage for##3##3##(1995-11#1)(2008-10#1)(2008-2#1)
an advantage in terms of##2##5##(2008-1#1)(2008-11#1)
an advantage in##8##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
an advantage over##3##3##(1994-6#1)(2008-11#1)(2008-7#1)
an advantage that the##2##4##(1993-3#1)(2008-10#1)
an advantage##21##2##(1993-3#1)(1994-6#1)(1995-11#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#2)
an advantageous##6##2##(1995-12#1)(2008-10#4)(2008-7#1)
an advection-diffusion equation##2##3##(2008-7#1)(2008-8#1)
an adverse effect of##2##4##(2008-10#1)(2008-7#1)
an adverse effect on the##3##5##(1994-9#1)(2008-10#1)(2012-2#1)
an adverse effect on##5##4##(1994-9#1)(1997-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
an adverse effect##8##3##(1994-9#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
an adverse event##3##3##(2008-11#2)(2013-1#1)
an adverse outcome##2##3##(1990-5#1)(2009-6#1)
an adverse##16##2##(1990-12#1)(1990-5#1)(1994-9#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-4#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
an advertising campaign##2##3##(1995-1#1)(1997-6#1)
an advisory##3##2##(1996-2#1)(1996-8#1)(2013-1#1)
an aerobic##3##2##(2011-2#2)(2013-1#1)
an aerodynamic##2##2##(1997-1#1)(2008-3#1)
an aerosol##9##2##(1992-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-2#3)(2008-3#2)
an aesthetically##2##2##(2008-5#1)(2012-2#1)
an aetiological##2##2##(1997-3#1)(2008-4#1)
an affected digit##2##3##(2008-9#2)
an affected##4##2##(2008-7#1)(2008-9#2)(2010-3#1)
an affective##2##2##(1996-1#1)(2013-8#1)
an affinity column of##2##4##(1993-6#1)(2008-7#1)
an affinity column##3##3##(1991-5#1)(1993-6#1)(2008-7#1)
an affinity for##3##3##(1993-8#1)(2009-7#1)(2010-10#1)
an affinity of 0##2##4##(1992-9#1)(2008-11#1)
an affinity##16##2##(1991-5#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-5#1)(2012-2#2)
an agar diffusion test##2##4##(2008-10#1)(2008-5#1)
an agar dilution method##2##4##(1991-8#1)(2008-12#1)
an agar dilution##3##3##(1991-8#1)(2008-12#1)(2008-5#1)
an agar medium##2##3##(2008-10#2)
an agar##10##2##(1991-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2010-2#1)
an agarose##3##2##(1990-11#1)(2008-4#2)
an age dependent##2##3##(1994-3#1)(2011-2#1)
an age of##3##3##(1993-12#1)(2008-7#1)(2010-8#1)
an age##9##2##(1990-3#1)(1993-12#1)(1994-3#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)
an age- and##2##3##(2007-10#1)(2009-5#1)
an age-adjusted##2##2##(2012-12#1)(2013-1#1)
an age-appropriate##2##2##(2008-7#1)(2011-2#1)
an age-correlated##2##2##(1990-3#2)
an age-dependent##5##2##(1996-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
an age-related decrease in##3##4##(1994-6#1)(1995-8#1)(2012-1#1)
an age-related##9##2##(1994-6#1)(1995-8#1)(1996-5#1)(2008-3#1)(2008-7#3)(2009-12#1)(2012-1#1)
an aged care##3##3##(2008-11#1)(2010-10#1)(2012-3#1)
an aged##4##2##(1992-3#1)(2008-11#1)(2010-10#1)(2012-3#1)
an agency setting##3##3##(1996-2#3)
an agency##5##2##(1993-12#1)(1996-2#3)(2006-5#1)
an agenda##3##2##(2011-2#1)(2013-1#2)
an agent of##3##3##(2007-10#1)(2009-2#1)(2009-5#1)
an agent that##4##3##(1993-6#1)(1995-2#1)(2008-10#1)(2010-5#1)
an agent##15##2##(1991-8#1)(1993-6#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-5#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-2#2)(2013-8#1)
an agent-based##2##2##(2008-8#1)(2013-8#1)
an agglutination##2##2##(2007-10#1)(2008-10#1)
an aggravating factor##2##3##(2008-9#1)(2012-12#1)
an aggregate processing speed of##2##5##(2007-12#1)(2008-3#1)
an aggregate##9##2##(1992-3#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#3)
an aggregated pattern of distribution##2##5##(2008-10#2)
an aggregated##5##2##(1996-5#1)(2008-10#3)(2008-2#1)
an aggressive and##2##3##(1995-2#1)(2013-8#1)
an aggressive behavior##2##3##(1994-9#1)(1995-2#1)
an aggressive phenotype##2##3##(2008-12#1)(2009-9#1)
an aggressive surgical approach##3##4##(1990-12#1)(1990-9#1)(2012-3#1)
an aggressive##37##2##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1993-3#1)(1994-9#1)(1995-2#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
an aging population and##3##4##(2007-12#1)(2009-3#1)(2012-12#1)
an aging population##5##3##(1995-1#1)(2007-12#2)(2009-3#1)(2012-12#1)
an aging society##3##3##(1993-1#1)(1993-12#1)(1994-2#1)
an aging##14##2##(1990-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(2007-12#2)(2008-1#1)(2008-12#1)(2009-3#1)(2009-5#1)(2012-12#1)
an agonist at##3##3##(1993-6#2)(1995-3#1)
an agonist of##2##3##(1994-2#1)(2008-9#1)
an agonist to 5HT1A##2##4##(2008-6#2)
an agonist to##4##3##(2008-4#2)(2008-6#2)
an agonist##13##2##(1992-12#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)
an agreement with##3##3##(2008-5#3)
an agreement##4##2##(2007-6#1)(2008-5#3)
an agricultural area##2##3##(2008-10#2)
an agricultural##7##2##(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#1)
an agrocin 84-sensitive##2##3##(2008-10#2)
an agrocin##3##2##(2008-10#3)
an agronomically##2##2##(2008-10#2)
an aid for##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
an aid in the##3##4##(1991-9#1)(1994-6#1)(2008-4#1)
an aid in##7##3##(1991-11#1)(1991-12#1)(1991-9#1)(1994-6#1)(1997-8#1)(2008-4#1)(2012-12#1)
an aid to##7##3##(1993-3#1)(1994-7#1)(1996-1#1)(1996-12#1)(2008-12#1)(2010-4#2)
an aid##17##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#2)(2012-12#1)
an ailing##2##2##(1995-2#1)(2009-1#1)
an aim to##2##3##(2007-10#1)(2012-3#1)
an air gap##2##3##(2008-3#2)
an air stream##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
an air##16##2##(1994-12#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)
an air-agitated##2##2##(2008-7#2)
an airborne##5##2##(2008-2#1)(2008-3#3)(2011-2#1)
an aircraft cabin##3##3##(1996-12#3)
an aircraft##10##2##(1996-12#4)(2007-11#1)(2008-2#1)(2008-3#3)(2009-9#1)
an airline##2##2##(1997-5#1)(2008-10#1)
an airtight##2##2##(2008-10#1)(2008-8#1)
an alanine##8##2##(1992-6#3)(1994-5#1)(1995-5#2)(2007-6#1)(2008-10#1)
an alarming##6##2##(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
an albumin##2##2##(2008-10#1)(2008-4#1)
an alcohol##5##2##(1990-11#1)(1991-5#1)(1995-3#1)(2007-12#1)(2008-5#1)
an alcoholic##3##2##(2008-10#1)(2013-1#2)
an aldehyde##4##2##(1993-11#1)(1994-5#1)(1994-8#1)(2009-12#1)
an aldose reductase inhibitor##2##4##(1994-8#1)(2009-11#1)
an algorithm for management##2##4##(2013-1#2)
an algorithm for the##5##4##(2007-12#1)(2008-2#1)(2009-4#1)(2011-10#1)(2013-1#1)
an algorithm for##14##3##(1993-8#1)(2007-12#1)(2008-2#3)(2008-3#4)(2009-4#1)(2011-10#1)(2013-1#3)
an algorithm is##3##3##(2008-3#3)
an algorithm that##5##3##(2008-2#2)(2008-3#3)
an algorithm to##3##3##(2008-2#2)(2008-3#1)
an algorithm##39##2##(1993-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#8)(2008-3#17)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-10#1)(2013-1#3)
an alien##2##2##(2008-5#1)(2008-9#1)
an aligned##2##2##(2011-2#1)(2013-1#1)
an alignment##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
an aliphatic##3##2##(1994-8#1)(1996-5#1)(2008-4#1)
an aliquot of##2##3##(2008-10#2)
an aliquot##3##2##(2008-10#3)
an alkali##2##2##(1993-9#1)(2008-10#1)
an alkaline enzyme##3##3##(2008-9#3)
an alkaline medium is##2##4##(2008-10#2)
an alkaline medium##10##3##(2008-10#10)
an alkaline pH##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
an alkaline phosphatase##2##3##(2008-10#1)(2008-4#1)
an alkaline solution##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
an alkaline##42##2##(1990-11#1)(1990-8#1)(1992-8#1)(1993-6#1)(1995-3#1)(1997-4#1)(2008-10#24)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)
an alkaloid##2##2##(1996-12#1)(2008-7#1)
an alkanethiol##2##2##(2008-10#1)(2008-3#1)
an alkene##2##2##(1996-5#1)(2008-7#1)
an alkyl group##3##3##(1995-3#2)(2008-10#1)
an alkyl##4##2##(1995-3#2)(2008-10#2)
an alkylating agent##2##3##(2010-12#1)(2011-2#1)
an alkylating##4##2##(1997-2#1)(2010-11#1)(2010-12#1)(2011-2#1)
an all##2##2##(1995-3#1)(2008-11#1)
an all-dielectric##3##2##(2007-11#1)(2008-3#2)
an all-digital##2##2##(2008-3#2)
an all-fiber##3##2##(2007-12#1)(2008-3#2)
an all-optical triode##2##3##(2008-2#2)
an all-optical##14##2##(2007-12#4)(2008-2#5)(2008-3#5)
an all-payer##2##2##(1994-12#1)(1996-12#1)
an all-solid-state laser##2##3##(2008-3#2)
an all-solid-state tunable##2##3##(2007-11#2)
an all-solid-state##8##2##(2007-11#3)(2008-10#2)(2008-3#3)
an allele of the##3##4##(1995-9#1)(1997-4#1)(2012-3#1)
an allele of##4##3##(1995-9#1)(1997-4#2)(2012-3#1)
an allele##7##2##(1995-9#1)(1997-4#2)(2008-10#3)(2012-3#1)
an allele-specific##4##2##(1995-12#1)(1997-7#1)(2008-4#2)
an allene##3##2##(1996-5#1)(2009-10#2)
an allergic reaction to the##2##5##(1991-1#1)(1993-6#1)
an allergic reaction##3##3##(1990-3#1)(1991-1#1)(1993-6#1)
an allergic##4##2##(1990-3#1)(1991-1#1)(1993-6#1)(2013-1#1)
an alliance##3##2##(1997-2#1)(2008-4#1)(2013-1#1)
an allogeneic##2##2##(1991-5#1)(1994-5#1)
an allosteric site##2##3##(1990-8#2)
an allosteric##5##2##(1990-8#3)(1992-8#1)(1997-2#1)
an allotetraploid##2##2##(2008-9#1)(2009-9#1)
an alloy##2##2##(2008-10#2)
an almost complete##3##3##(2007-10#1)(2007-11#1)(2009-6#1)
an almost equal##3##3##(1997-3#2)(2008-10#1)
an almost##25##2##(1992-11#2)(1992-5#1)(1992-6#1)(1993-8#1)(1995-2#1)(1997-3#2)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
an alpha##7##2##(1991-10#1)(1992-4#1)(1994-8#1)(1995-5#3)(2008-10#1)
an alpha-helical structure##2##3##(1990-5#1)(2012-2#1)
an alpha-helical##7##2##(1990-5#1)(1991-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(2012-2#1)
an alpha-helix at##2##3##(1992-6#1)(1992-8#1)
an alpha-helix##5##2##(1992-6#2)(1992-8#1)(1995-12#1)(2008-9#1)
an alpha2-adrenoceptor##2##2##(1995-12#2)
an alpine##2##2##(2008-3#1)(2009-5#1)
an already##5##2##(1990-8#1)(1995-2#1)(2007-12#1)(2013-1#2)
an alteration in the##4##4##(1993-12#1)(1993-9#1)(2010-12#1)(2012-2#1)
an alteration in##11##3##(1990-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(2010-12#1)(2012-2#2)
an alteration of the##3##4##(1997-6#1)(2008-2#1)(2008-5#1)
an alteration of##6##3##(1993-6#1)(1995-12#1)(1997-6#1)(2008-2#1)(2008-5#1)(2011-2#1)
an alteration##17##2##(1990-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#2)
an altered##23##2##(1990-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-1#2)(2013-7#1)(2013-8#1)
an alternate procedure##2##3##(2008-4#2)
an alternate protocol describes##2##4##(2008-4#2)
an alternate protocol##5##3##(2008-1#1)(2008-2#1)(2008-4#3)
an alternate splicing##2##3##(1990-7#2)
an alternate##20##2##(1990-7#2)(1993-12#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#5)(2009-2#1)(2010-2#1)(2013-1#3)
an alternating##4##2##(1994-5#1)(2008-11#1)(2009-11#2)
an alternative and effective##2##4##(2008-10#2)
an alternative and##7##3##(2008-10#4)(2008-6#1)(2010-11#1)(2013-8#1)
an alternative approach to the##2##5##(2008-2#1)(2008-9#1)
an alternative approach to##5##4##(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
an alternative approach##11##3##(1995-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
an alternative calibration##2##3##(2008-10#2)
an alternative design##2##3##(1997-8#1)(2011-2#1)
an alternative explanation##3##3##(2007-11#1)(2008-7#1)(2008-9#1)
an alternative for patients##2##4##(2008-1#1)(2010-6#1)
an alternative for the##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
an alternative for##11##3##(1991-1#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#3)(2010-6#1)(2010-8#1)(2013-1#2)
an alternative host for##2##4##(2008-10#2)
an alternative in##3##3##(1994-11#1)(2007-8#1)(2012-2#1)
an alternative means##2##3##(2008-8#1)(2009-12#1)
an alternative mechanism##2##3##(1990-8#1)(2008-7#1)
an alternative method for##3##4##(2008-10#2)(2008-3#1)
an alternative method in which##2##5##(2008-10#2)
an alternative method of##4##4##(2007-11#1)(2007-5#1)(2008-10#1)(2010-12#1)
an alternative method that##2##4##(2007-11#1)(2008-2#1)
an alternative method to##5##4##(2008-10#3)(2008-5#1)(2008-8#1)
an alternative method##19##3##(1994-9#1)(1997-4#1)(2007-11#2)(2007-5#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
an alternative model of##2##4##(1997-4#1)(2008-7#1)
an alternative model##5##3##(1997-4#1)(1997-7#1)(2008-6#1)(2008-7#2)
an alternative or##2##3##(2008-10#1)(2010-6#1)
an alternative paradigm##2##3##(1995-4#1)(2010-12#1)
an alternative pathway##2##3##(1994-11#1)(1995-2#1)
an alternative procedure##5##3##(2008-10#3)(2008-2#1)(2012-12#1)
an alternative source of##2##4##(2008-10#1)(2008-11#1)
an alternative splicing##2##3##(1993-6#1)(1995-8#1)
an alternative strategy##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
an alternative surgical approach##2##4##(2008-7#2)
an alternative surgical##4##3##(2007-8#1)(2008-7#2)(2008-9#1)
an alternative technique for##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
an alternative technique##9##3##(1991-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2013-8#1)
an alternative therapeutic approach##2##4##(2008-5#1)(2013-7#1)
an alternative to conventional##8##4##(1996-9#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2013-7#1)
an alternative to standard##2##4##(2008-10#1)(2008-6#1)
an alternative to surgical##2##4##(1996-6#1)(1997-8#1)
an alternative to the traditional##2##5##(2008-10#1)(2012-3#1)
an alternative to the use of##2##6##(2007-12#1)(2008-10#1)
an alternative to the##22##4##(1990-8#1)(1995-1#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
an alternative to traditional##6##4##(1990-5#1)(1992-1#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
an alternative to##104##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-5#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)
an alternative treatment to##2##4##(2008-12#1)(2008-9#1)
an alternative treatment##5##3##(1997-6#1)(2008-12#1)(2008-6#1)(2008-9#2)
an alternative way##2##3##(2008-11#1)(2008-6#1)
an alternative##287##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-9#3)(1995-1#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#3)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#64)(2008-11#8)(2008-12#4)(2008-2#12)(2008-3#10)(2008-4#4)(2008-5#9)(2008-6#6)(2008-7#14)(2008-8#7)(2008-9#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#1)(2011-2#10)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#3)
an alternatively spliced##3##3##(1993-8#1)(1994-8#1)(2008-6#1)
an altitude of##2##3##(2008-3#2)
an altitude range of##2##4##(2008-3#2)
an altitude##5##2##(2008-3#5)
an altruistic act##2##3##(2008-10#1)(2012-3#1)
an aluminium##3##2##(2008-5#1)(2008-7#2)
an aluminum##11##2##(1991-12#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-8#2)
an alumni##2##2##(1996-1#1)(2012-2#1)
an ambient##2##2##(2008-3#2)
an ambitious##3##2##(1992-2#1)(2008-12#1)(2013-1#1)
an ambulatory##3##2##(1997-1#1)(2008-11#2)
an amendment to##2##3##(1995-6#1)(2008-10#1)
an amendment##3##2##(1995-6#1)(2008-10#2)
an amide##2##2##(1991-12#1)(2010-6#1)
an amine##5##2##(2008-10#3)(2008-6#1)(2010-2#1)
an amino acid change##3##4##(1991-2#1)(1992-2#1)(2008-10#1)
an amino acid composition##2##4##(1992-7#1)(1992-8#1)
an amino acid residue##3##4##(1991-9#1)(1992-8#1)(1993-11#1)
an amino acid sequence##2##4##(1994-12#1)(2007-12#1)
an amino acid substitution##6##4##(1990-8#1)(1993-3#1)(1994-11#1)(2008-10#3)
an amino acid##27##3##(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-5#1)(2010-12#1)
an amino group in##2##4##(2007-11#1)(2008-10#1)
an amino group##4##3##(1992-3#1)(2007-11#1)(2008-10#2)
an amino##36##2##(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-12#1)
an amino-terminal##2##2##(1990-5#1)(1995-6#1)
an aminoglycoside##2##2##(1995-2#1)(2006-10#1)
an aminopeptidase##2##2##(1991-5#1)(1994-2#1)
an aminopropyl##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
an ammonia##4##2##(2008-10#2)(2008-2#2)
an ammonium sulfate##2##3##(1994-6#1)(1996-12#1)
an ammonium##8##2##(1994-6#1)(1996-12#1)(2008-10#5)(2008-7#1)
an amorphous material##2##3##(2008-10#2)
an amorphous metal hydroxide##2##4##(2008-5#2)
an amorphous##9##2##(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#3)
an amount equal to##3##4##(1992-3#1)(1993-3#1)(1995-3#1)
an amount of##6##3##(1993-11#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
an amount##11##2##(1992-3#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#1)
an amperometric biosensor based on##2##5##(2008-10#2)
an amperometric biosensor for the##2##5##(2008-10#2)
an amperometric biosensor##5##3##(2008-10#5)
an amperometric detector for flow injection analysis of##2##8##(2008-10#2)
an amperometric detector for flow injection analysis##3##7##(2008-10#3)
an amperometric detector for##7##4##(2008-10#7)
an amperometric detector##9##3##(1991-5#1)(2008-10#8)
an amperometric##25##2##(1991-5#1)(2008-10#23)(2010-5#1)
an amphipathic alpha-helical##2##3##(1994-5#1)(1997-2#1)
an amphipathic##4##2##(1990-2#1)(1994-5#1)(1997-2#1)(2008-10#1)
an ampicillin##2##2##(1993-8#1)(2011-2#1)
an amplification##6##2##(1996-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)
an amplified fragment length polymorphism##2##5##(2008-10#2)
an amplified##10##2##(1990-7#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)
an amplifier##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
an amplitude comparable with##2##4##(2008-3#2)
an amplitude##8##2##(1991-8#1)(1994-6#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-6#1)
an amplitude-division soft-x-ray##2##3##(2007-12#2)
an amplitude-division##3##2##(2007-12#3)
an amylose column##2##3##(1994-8#1)(1995-12#1)
an amylose##3##2##(1990-9#1)(1994-8#1)(1995-12#1)
an anaerobic##5##2##(2008-1#1)(2008-6#2)(2008-7#1)(2013-1#1)
an analgesic##2##2##(2008-11#1)(2011-2#1)
an analog of the##2##4##(1993-6#1)(1993-8#1)
an analog of##8##3##(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-9#1)(2009-8#1)
an analog spatial light modulator##2##5##(2007-11#1)(2008-3#1)
an analog##13##2##(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)
an analogous##12##2##(1991-7#1)(1995-3#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-9#1)(2012-12#1)
an analogue of##5##3##(1990-3#1)(1990-5#1)(1990-7#1)(2010-3#1)(2013-1#1)
an analogue##9##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-9#1)(2009-11#3)(2010-3#1)(2013-1#1)
an analogy with##2##3##(1992-9#1)(2008-11#1)
an analogy##6##2##(1992-9#1)(1996-3#1)(2008-11#2)(2008-2#1)(2008-3#1)
an analysis based on##2##4##(2008-10#1)(2008-3#1)
an analysis of a##3##4##(2008-11#1)(2008-2#1)(2009-12#1)
an analysis of data##2##4##(2010-11#1)(2011-1#1)
an analysis of its##2##4##(2012-3#1)(2013-7#1)
an analysis of molecular variance##3##5##(2008-10#3)
an analysis of the cost##2##5##(2012-12#2)
an analysis of the##35##4##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-11#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#2)
an analysis of variance##3##4##(2008-10#2)(2008-7#1)
an analysis of##94##3##(1990-10#1)(1990-11#2)(1990-6#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-2#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
an analysis taking##2##3##(1992-9#1)(2008-10#1)
an analysis that##2##3##(2009-10#1)(2010-3#1)
an analysis time of##2##4##(2008-10#2)
an analysis##116##2##(1990-10#1)(1990-11#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-2#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)
an analyst##2##2##(2008-10#2)
an analyte is##2##3##(2008-10#2)
an analyte##10##2##(1996-5#1)(2008-10#7)(2008-7#2)
an analytic##7##2##(2008-12#1)(2008-2#1)(2008-3#3)(2010-5#1)(2012-2#1)
an analytical approach##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
an analytical curve##2##3##(2008-10#2)
an analytical expression for the##5##5##(2007-11#1)(2008-2#3)(2008-3#1)
an analytical expression for##7##4##(2007-11#2)(2008-2#3)(2008-3#2)
an analytical expression##8##3##(2007-11#2)(2008-2#3)(2008-3#3)
an analytical frequency of 90##2##5##(2008-10#2)
an analytical frequency of##4##4##(2008-10#4)
an analytical method for##4##4##(2008-10#3)(2008-2#1)
an analytical method to##4##4##(1996-12#1)(2008-10#2)(2009-9#1)
an analytical method was##2##4##(2008-10#2)
an analytical method##13##3##(1996-12#1)(2008-10#10)(2008-2#1)(2009-9#1)
an analytical model for the##2##5##(2008-3#2)
an analytical procedure was developed##2##5##(2008-10#1)(2012-1#1)
an analytical procedure##8##3##(1997-2#1)(2008-10#6)(2012-1#1)
an analytical protocol##2##3##(2008-10#2)
an analytical sequence##2##3##(2008-10#2)
an analytical solution of the##2##5##(2007-11#1)(2008-3#1)
an analytical solution##6##3##(2007-11#2)(2008-10#1)(2008-3#3)
an analytical strategy##2##3##(2007-7#1)(2008-10#1)
an analytical study##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
an analytical system##2##3##(2008-10#1)(2008-9#1)
an analytical technique##2##3##(2009-12#1)(2012-2#1)
an analytical throughput of##6##4##(2008-10#6)
an analytical throughput##7##3##(2008-10#7)
an analytical tool for##3##4##(1991-5#1)(1992-11#1)(2012-1#1)
an analytical tool##6##3##(1991-5#1)(1992-11#1)(2008-10#2)(2008-7#1)(2012-1#1)
an analytical##99##2##(1991-12#1)(1991-5#1)(1992-11#1)(1996-12#1)(1997-2#1)(2007-11#5)(2007-7#1)(2008-10#54)(2008-12#1)(2008-2#8)(2008-3#13)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
an analyzer##2##2##(2007-11#1)(2008-3#1)
an anamorphic external cavity##2##4##(2008-3#2)
an anamorphic##3##2##(2007-12#1)(2008-3#2)
an anatomic##3##2##(2011-2#2)(2012-2#1)
an anatomical##5##2##(1991-6#1)(1996-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
an anatomically normal##2##3##(2010-10#1)(2013-1#1)
an anatomically##5##2##(2010-10#1)(2010-3#1)(2012-1#1)(2013-1#2)
an ancestral condition##3##3##(2008-8#1)(2009-8#1)(2012-2#1)
an ancestral##11##2##(1990-7#1)(1992-3#1)(1994-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
an anchored##2##2##(1997-7#1)(2008-10#1)
an ancient##12##2##(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#2)(2011-2#1)(2013-8#1)
an androgen##5##2##(1990-11#2)(1991-5#1)(2008-4#1)(2012-12#1)
an anemic##2##2##(1990-10#1)(2011-2#1)
an anesthetic##6##2##(1990-5#3)(1993-1#1)(2010-1#1)(2011-1#1)
an aneurysm of the##2##4##(1991-6#1)(1997-8#1)
an aneurysm##10##2##(1991-6#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
an aneurysmal##3##2##(1997-3#1)(2008-12#1)(2008-7#1)
an angiogenesis##2##2##(1991-12#1)(2008-11#1)
an angiogenic##3##2##(1990-4#1)(1994-6#1)(2008-9#1)
an angiographic##2##2##(1990-6#1)(2008-7#1)
an angiotensin AT1##3##3##(1995-12#3)
an angiotensin converting enzyme##2##4##(1995-12#1)(2008-1#1)
an angiotensin##6##2##(1995-12#4)(2008-1#1)(2013-1#1)
an angle of incidence of##4##5##(2008-2#3)(2008-3#1)
an angle of incidence##5##4##(2008-2#4)(2008-3#1)
an angle of##10##3##(1997-7#1)(2008-2#6)(2008-3#3)
an angle##19##2##(1992-9#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-2#8)(2008-3#5)(2013-1#1)
an angled##2##2##(2007-11#2)
an angular range of##2##4##(2008-3#2)
an angular##8##2##(2007-11#2)(2008-2#2)(2008-3#3)(2009-6#1)
an animal model for##6##4##(1992-11#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-11#1)(2013-1#1)
an animal model of human##2##5##(1992-11#1)(1995-2#1)
an animal model of##17##4##(1990-11#1)(1992-11#1)(1992-9#1)(1993-12#2)(1995-2#1)(1996-7#1)(1996-8#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-9#1)(2010-1#1)(2012-12#1)(2012-2#1)
an animal model##36##3##(1990-11#1)(1992-11#2)(1992-9#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#3)(2008-9#2)(2009-11#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
an animal shelter in##2##4##(2013-8#2)
an animal that##2##3##(1994-8#1)(2008-9#1)
an animal tissue##2##3##(2008-10#1)(2008-7#1)
an animal##50##2##(1990-11#1)(1992-11#2)(1992-9#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2010-1#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
an animal's##2##2##(1996-12#1)(2009-4#1)
an anion exchange column##3##4##(2008-10#3)
an anion exchange##5##3##(2008-10#5)
an anion exchanger##3##3##(2008-10#3)
an anion excluder##3##3##(2008-10#3)
an anion##13##2##(1996-12#1)(2008-10#11)(2011-2#1)
an anion-exchange column##8##3##(1990-8#1)(2008-10#7)
an anion-exchange resin##8##3##(2008-10#8)
an anion-exchange##19##2##(1990-8#1)(1991-2#1)(2008-10#17)
an anionic resin##2##3##(2008-10#2)
an anionic##10##2##(1994-5#1)(2008-10#9)
an anisotropic medium##3##3##(2007-11#2)(2008-3#1)
an anisotropic##8##2##(2007-11#4)(2008-3#2)(2008-6#1)(2009-11#1)
an ankle##4##2##(2008-12#1)(2008-8#1)(2010-3#1)(2012-3#1)
an ankylosed##2##2##(2007-12#1)(2011-2#1)
an annotated bibliography##2##3##(1992-1#1)(1993-2#1)
an annotated##3##2##(1992-1#1)(1993-2#1)(2008-7#1)
an annual plant##2##3##(2008-9#2)
an annual savings of##2##4##(1992-2#1)(2008-1#1)
an annual##24##2##(1992-2#1)(1992-9#1)(1994-12#2)(1996-1#1)(1996-11#1)(1996-3#3)(1997-8#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2012-12#1)(2012-3#1)
an annular pupil filter##2##4##(2007-12#2)
an annular pupil##3##3##(2007-11#1)(2007-12#2)
an annular##10##2##(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)
an anodic peak was observed at##2##6##(2008-10#2)
an anodic##7##2##(2008-10#7)
an anomalous##7##2##(2007-11#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-9#1)(2012-12#1)(2012-3#1)
an anomaly##3##2##(2007-11#1)(2007-5#1)(2013-1#1)
an anonymous##5##2##(1990-11#1)(1991-8#1)(1991-9#1)(2008-11#1)(2012-3#1)
an answer to the##2##4##(2008-10#1)(2011-2#1)
an answer##3##2##(2008-10#1)(2009-12#1)(2011-2#1)
an antagonist of the##4##4##(1996-2#1)(2008-4#1)(2008-8#2)
an antagonist of##8##3##(1992-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-4#2)(2008-8#2)
an antagonist##15##2##(1992-12#1)(1994-5#1)(1995-3#2)(1996-2#1)(1997-2#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#2)
an antagonistic effect##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
an antagonistic sterile fungus StFCh1-1 in the rhizosphere condition##2##9##(2008-12#2)
an antagonistic##9##2##(2008-10#2)(2008-12#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-3#1)(2012-12#1)
an antennal##2##2##(1994-8#1)(2008-10#1)
an anterior communicating artery aneurysm##3##5##(1996-3#2)(2008-7#1)
an anterior dislocation##2##3##(2008-8#1)(2009-3#1)
an anterior##21##2##(1991-3#1)(1992-9#2)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
an anteriorly##2##2##(1992-9#1)(2008-7#1)
an anterograde factor##2##3##(1995-2#2)
an anterograde##3##2##(1995-12#1)(1995-2#2)
an anterolateral approach##2##3##(2009-3#2)
an anterolateral##3##2##(2008-5#1)(2009-3#2)
an anthropological##3##2##(1991-12#1)(2012-12#2)
an anthropomorphic phantom##2##3##(1997-8#1)(2012-1#1)
an anti conformation##2##3##(1992-3#1)(1993-11#1)
an anti##4##2##(1992-3#1)(1993-11#1)(2010-2#1)(2012-2#1)
an anti-E##2##2##(1993-9#2)
an anti-HIV##2##2##(1994-11#1)(2011-3#1)
an anti-Hofmeister selectivity pattern with high##2##6##(2008-10#2)
an anti-IL-6 monoclonal antibody##2##4##(1994-2#1)(2009-4#1)
an anti-LAS monoclonal antibody##2##4##(2008-10#2)
an anti-aging##4##2##(1990-3#1)(2008-4#1)(2011-2#1)(2013-7#1)
an anti-apoptotic##2##2##(2008-1#1)(2011-2#1)
an anti-inflammatory action##2##3##(2009-6#2)
an anti-inflammatory drug##3##3##(1995-12#2)(2008-10#1)
an anti-inflammatory##11##2##(1990-6#1)(1995-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-6#2)
an anti-neoplastic##2##2##(2008-2#1)(2011-2#1)
an anti-oxidant##3##2##(2008-1#2)(2008-5#1)
an anti-sense##2##2##(1993-11#1)(2008-10#1)
an antibacterial and antifungal material##2##5##(2008-10#2)
an antibacterial and antifungal##3##4##(2008-10#3)
an antibacterial##8##2##(1997-8#1)(2008-10#4)(2008-5#1)(2012-3#2)
an antibiotic treatment##2##3##(1997-4#1)(2008-11#1)
an antibiotic##11##2##(1996-6#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2011-2#1)
an antibody against the##3##4##(1991-9#1)(1992-9#1)(2007-10#1)
an antibody against##8##3##(1990-5#1)(1991-9#1)(1992-9#1)(1993-11#1)(1995-5#1)(2007-10#1)(2010-6#1)(2012-2#1)
an antibody directed against##2##4##(1994-8#1)(2009-8#1)
an antibody raised against##4##4##(1992-11#1)(1993-12#1)(2008-10#1)(2008-11#1)
an antibody response##2##3##(1991-1#1)(2008-4#1)
an antibody to the##2##4##(2008-10#1)(2008-11#1)
an antibody to##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
an antibody##45##2##(1990-5#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-10#8)(2008-11#3)(2008-4#6)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-2#1)(2012-2#1)
an anticancer agent##3##3##(2008-3#1)(2010-11#1)(2012-3#1)
an anticancer##4##2##(1997-4#1)(2008-3#1)(2010-11#1)(2012-3#1)
an anticipated##2##2##(2009-8#1)(2013-1#1)
an anticoagulant##6##2##(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2010-10#1)
an antidepressant##4##2##(1996-7#1)(2008-2#1)(2008-6#1)(2012-3#1)
an antiepileptic##3##2##(2008-11#2)(2008-7#1)
an antifungal##7##2##(1992-11#2)(1997-4#1)(2008-10#3)(2011-2#1)
an antigen of##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
an antigen##20##2##(1990-12#1)(1992-9#1)(1993-3#1)(1994-11#2)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-4#2)(2008-8#1)(2010-6#1)
an antigenic##3##2##(1996-12#1)(2007-12#1)(2008-5#1)
an antigenically##2##2##(1996-1#1)(2008-10#1)
an antihyperlipidemic agent##2##3##(1990-2#1)(1991-4#1)
an antihypertensive agent##2##3##(1990-7#1)(2008-8#1)
an antihypertensive##3##2##(1990-7#1)(2008-10#1)(2008-8#1)
an antimicrobial peptide##2##3##(2011-2#2)
an antimicrobial##6##2##(1994-3#1)(2007-7#1)(2008-8#1)(2010-4#1)(2011-2#2)
an antineoplastic##3##2##(1990-10#1)(2007-11#1)(2008-7#1)
an antinociceptive##2##2##(1993-5#1)(2011-2#1)
an antioxidant effect##4##3##(1996-9#2)(2011-2#2)
an antioxidant##12##2##(1991-5#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#2)
an antiproliferative##2##2##(2008-3#1)(2011-3#1)
an antipsychotic##4##2##(2008-11#1)(2011-10#1)(2012-3#2)
an antiretroviral##2##2##(2008-5#1)(2011-1#1)
an antisense RNA transcript##3##4##(1992-8#1)(1994-11#1)(1995-2#1)
an antisense RNA##5##3##(1992-12#1)(1992-8#1)(1994-11#1)(1995-2#1)(2011-1#1)
an antisense##10##2##(1992-12#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
an antiseptic##2##2##(2008-10#2)
an antiserum raised against the##2##5##(1996-2#1)(2008-10#1)
an antiserum that##2##3##(1994-12#1)(2008-10#1)
an antiserum##7##2##(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#3)
an antithrombotic agent##2##3##(1994-6#2)
an antitumoral##2##2##(1995-12#1)(2008-11#1)
an antiulcer##3##2##(1993-3#2)(1997-7#1)
an antiviral activity of##2##4##(2007-8#2)
an antiviral##3##2##(2007-8#2)(2012-3#1)
an anucleate##2##2##(2008-6#2)
an anxiety disorder##4##3##(2008-4#1)(2010-5#1)(2013-8#2)
an anxiety##6##2##(1996-2#1)(2008-1#1)(2008-4#1)(2010-5#1)(2013-8#2)
an anxiolytic##2##2##(1992-7#1)(1993-12#1)
an anxious attachment style##3##4##(2012-2#3)
an anxious##4##2##(2010-5#1)(2012-2#3)
an aortic dissection##2##3##(2007-7#1)(2013-1#1)
an aortic##7##2##(1994-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2011-2#2)(2013-1#1)
an aperiodic optical superlattice##2##4##(2007-11#2)
an aperiodic##3##2##(2007-11#2)(2008-3#1)
an aperture##6##2##(2007-12#2)(2008-3#4)
an apical##2##2##(2007-12#1)(2011-2#1)
an apodized##2##2##(2007-12#1)(2008-3#1)
an apolar##2##2##(2008-10#2)
an apoptotic##2##2##(1995-11#1)(1995-12#1)
an apparatus##4##2##(1990-7#1)(1991-5#1)(1991-9#1)(2008-10#1)
an apparent Kd of##3##4##(1990-5#3)
an apparent Kd##4##3##(1990-5#3)(1994-5#1)
an apparent Km of##3##4##(1992-3#2)(2008-11#1)
an apparent MW of##2##4##(1991-2#1)(2008-10#1)
an apparent dissociation constant of##2##5##(1993-9#1)(2008-9#1)
an apparent dissociation constant##3##4##(1990-12#1)(1993-9#1)(2008-9#1)
an apparent increase in the##2##5##(1991-12#1)(1994-12#1)
an apparent inhibition##2##3##(2008-10#1)(2008-8#1)
an apparent molecular mass of##5##5##(1992-6#1)(1993-6#1)(1993-8#1)(1997-2#1)(1997-4#1)
an apparent molecular mass##7##4##(1992-6#1)(1993-6#1)(1993-8#1)(1994-3#1)(1997-2#1)(1997-4#1)(2008-10#1)
an apparent molecular weight of##5##5##(1990-11#1)(1992-7#1)(1994-11#1)(1994-9#1)(1997-2#1)
an apparent molecular weight##6##4##(1990-11#1)(1992-7#1)(1994-11#2)(1994-9#1)(1997-2#1)
an apparent molecular##14##3##(1990-11#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1997-2#2)(1997-4#1)(2008-10#2)
an apparent##77##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-2#2)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-11#1)(2011-1#1)(2013-1#1)
an apparently healthy##5##3##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
an apparently homogeneous##3##3##(1990-11#1)(1991-12#1)(1994-11#1)
an apparently##19##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(2008-10#2)(2008-7#2)(2009-7#1)(2011-2#1)(2013-1#2)
an appeal##2##2##(1991-1#1)(1996-5#1)
an appealing alternative##2##3##(2007-12#1)(2012-12#1)
an appealing##6##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-12#1)
an appendectomy##2##2##(1997-5#1)(2011-2#1)
an appendix##2##2##(2012-12#1)(2012-3#1)
an applicant for##2##3##(1991-11#1)(1993-1#1)
an application for##2##3##(2009-3#1)(2013-1#1)
an application in##4##3##(1992-9#1)(2008-10#2)(2008-12#1)
an application of the##8##4##(1994-2#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
an application of this##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
an application of##14##3##(1992-2#1)(1994-2#1)(1995-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2011-2#1)(2013-8#1)
an application to##7##3##(1992-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-7#1)(2013-7#1)
an application##42##2##(1992-2#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
an applied dc##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
an applied field##2##3##(2007-12#1)(2008-3#1)
an applied magnetic field##2##4##(2008-10#1)(2008-7#1)
an applied potential of##6##4##(2008-10#6)
an applied potential##7##3##(2008-10#7)
an applied voltage##2##3##(2007-12#1)(2008-2#1)
an applied##24##2##(1992-2#1)(1993-1#1)(2007-11#1)(2007-12#4)(2008-10#10)(2008-2#2)(2008-3#1)(2008-7#3)(2009-9#1)
an appointment##2##2##(1996-3#1)(2008-7#1)
an appraisal of##2##3##(2007-8#1)(2011-2#1)
an appreciable##11##2##(1992-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-7#1)(2012-3#1)
an appreciation of the##5##4##(2008-4#2)(2011-2#1)(2013-8#2)
an appreciation of##9##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#3)(2011-2#1)(2013-8#2)
an appreciation##10##2##(1991-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#3)(2011-2#1)(2013-8#2)
an appressorium##5##2##(2008-10#5)
an approach are##2##3##(1996-11#1)(2008-4#1)
an approach based on the##2##5##(2008-1#1)(2011-1#1)
an approach based on##4##4##(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)
an approach for the##2##4##(1991-3#1)(2008-2#1)
an approach for##16##3##(1991-3#1)(1995-1#2)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2010-10#1)
an approach is##3##3##(1992-8#1)(1997-4#1)(2013-1#1)
an approach that combines##2##4##(1994-6#1)(2010-5#1)
an approach that##6##3##(1994-6#1)(1996-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-5#1)
an approach to analyzing##2##4##(2008-4#1)(2008-9#1)
an approach to the##4##4##(1994-8#1)(2008-2#1)(2008-8#1)(2008-9#1)
an approach to##27##3##(1991-2#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2013-1#1)
an approach which##2##3##(1992-6#1)(1994-9#1)
an approach with##2##3##(2008-7#1)(2012-12#1)
an approach##84##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#3)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
an appropriate and##2##3##(2007-11#1)(2008-10#1)
an appropriate balance between##2##4##(1992-3#1)(2010-4#1)
an appropriate choice of##3##4##(1990-8#1)(2007-11#1)(2008-2#1)
an appropriate combination##2##3##(1991-9#1)(2008-4#1)
an appropriate diet##2##3##(1992-10#1)(2011-2#1)
an appropriate filter##2##3##(2007-12#1)(2008-3#1)
an appropriate incubation##2##3##(1992-9#1)(2008-11#1)
an appropriate method##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
an appropriate model##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
an appropriate outcome measure##2##4##(1995-5#1)(2013-1#1)
an appropriate response##2##3##(1997-3#1)(2008-1#1)
an appropriate tool##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
an appropriate treatment##3##3##(1997-8#1)(2007-12#1)(2011-2#1)
an appropriate##126##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#2)(2007-10#1)(2007-11#8)(2007-12#4)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#4)(2008-6#3)(2008-7#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
an appropriately##8##2##(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-3#1)
an approved##2##2##(2008-10#1)(2008-8#1)
an approx##4##2##(1990-8#1)(1993-12#1)(1994-12#1)(1997-4#1)
an approximate formula for the##2##5##(1992-9#1)(1995-9#1)
an approximate molecular weight of##4##5##(1990-12#1)(1990-2#1)(1994-6#1)(2008-8#1)
an approximate##24##2##(1990-12#2)(1990-2#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-9#2)(1997-2#1)(1997-7#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#2)
an approximately 1##3##3##(2007-11#1)(2008-10#2)
an approximately##26##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-2#4)(1995-6#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-6#1)
an approximation technique##2##3##(2008-10#1)(2008-3#1)
an approximation##6##2##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
an aprotic##2##2##(2008-10#2)
an aquarium air pump##2##4##(2008-10#2)
an aquatic##4##2##(2008-10#3)(2008-6#1)
an aqueous buffer##2##3##(1992-12#1)(1994-3#1)
an aqueous phase##4##3##(2008-10#3)(2008-5#1)
an aqueous sample##3##3##(2008-10#2)(2008-3#1)
an aqueous solution containing##3##4##(2008-10#2)(2011-2#1)
an aqueous solution of pH 2##2##6##(2008-10#2)
an aqueous solution of the##2##5##(2008-10#1)(2008-5#1)
an aqueous solution of##9##4##(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-5#1)
an aqueous solution##31##3##(1995-2#1)(1996-2#1)(2007-11#3)(2008-10#19)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-2#1)
an aqueous suspension of##2##4##(2008-2#1)(2008-7#1)
an aqueous##74##2##(1992-12#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-11#4)(2007-12#1)(2008-10#45)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#2)(2009-12#2)(2009-4#1)(2009-6#1)(2011-2#2)
an arbitrarily shaped##2##3##(2008-2#2)
an arbitrarily##7##2##(2007-11#2)(2008-2#2)(2008-3#3)
an arbitrary angle##4##3##(2008-2#1)(2008-3#3)
an arbitrary complex##3##3##(2007-11#1)(2008-3#2)
an arbitrary input##3##3##(2007-12#1)(2008-3#2)
an arbitrary number##2##3##(1997-2#1)(2008-2#1)
an arbitrary time##2##3##(2007-11#1)(2010-5#1)
an arbitrary##41##2##(1997-2#1)(2007-11#2)(2007-12#6)(2008-2#7)(2008-3#22)(2008-6#1)(2009-11#1)(2010-5#1)
an arc plasma##2##3##(2008-2#2)
an arc##5##2##(2008-2#4)(2008-3#1)
an architectural##2##2##(1995-8#1)(2008-3#1)
an architecture##2##2##(2010-8#1)(2011-2#1)
an area in which the##2##5##(2008-10#2)
an area in which##4##4##(2008-10#4)
an area in##5##3##(1991-12#1)(2008-10#4)
an area is##2##3##(1991-12#1)(2008-3#1)
an area of intense##3##4##(2008-11#1)(2008-7#1)(2008-8#1)
an area of intensive##2##4##(2007-5#1)(2013-8#1)
an area of##33##3##(1990-7#1)(1991-11#2)(1994-8#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-6#3)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-6#1)(2011-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
an area that has##3##4##(1995-1#1)(2008-11#1)(2009-8#1)
an area that##6##3##(1995-1#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
an area where##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
an area which##3##3##(1991-12#1)(2009-12#1)(2013-7#1)
an area with a##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
an area with##5##3##(1992-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
an area##79##2##(1990-7#1)(1991-11#2)(1991-12#4)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#2)(1997-6#3)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-8#2)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-7#3)(2013-8#2)
an arginine residue##2##3##(2008-12#1)(2009-7#1)
an arginine##4##2##(1993-3#1)(1995-5#1)(2008-12#1)(2009-7#1)
an argon laser##2##3##(2008-3#1)(2008-9#1)
an argon##6##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)
an argument##4##2##(1991-6#1)(1995-12#1)(2008-1#1)(2008-9#1)
an arm##3##2##(2007-10#1)(2007-7#1)(2009-10#1)
an aromatic##3##2##(1991-12#1)(1996-5#1)(2008-10#1)
an arrangement##4##2##(1993-1#1)(1995-6#1)(2008-2#1)(2009-8#1)
an array of detectors##2##4##(2008-2#1)(2008-3#1)
an array of micromechanical##2##4##(2008-3#2)
an array of non-specific##2##4##(2008-10#2)
an array of off-axis##3##4##(2008-2#1)(2008-3#2)
an array of##69##3##(1992-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#6)(2007-12#4)(2008-10#11)(2008-11#1)(2008-2#8)(2008-3#17)(2008-4#3)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
an array##77##2##(1992-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#6)(2007-12#4)(2008-10#13)(2008-11#1)(2008-2#9)(2008-3#20)(2008-4#4)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
an array-based immunosorbent assay##2##4##(2008-10#2)
an arsenic##2##2##(2008-10#2)
an art of##2##3##(1993-11#1)(2008-7#1)
an art##3##2##(1991-2#1)(1993-11#1)(2008-7#1)
an arterial autograft##2##3##(2006-6#2)
an arterial##8##2##(1990-11#1)(1991-3#1)(1993-9#1)(2006-10#1)(2006-6#2)(2008-10#1)(2012-12#1)
an arteriovenous fistula##4##3##(1994-9#1)(1996-9#1)(2007-7#1)(2008-1#1)
an artery##4##2##(2008-7#1)(2008-9#2)(2009-1#1)
an arthrodesis##5##2##(2008-6#1)(2010-3#1)(2010-5#3)
an arthroscopic##2##2##(2007-11#1)(2013-1#1)
an article##12##2##(1991-1#1)(2007-2#1)(2008-11#6)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
an artifact of##2##3##(2008-7#1)(2009-8#1)
an artifact##3##2##(1990-5#1)(2008-7#1)(2009-8#1)
an artificial eye##2##3##(2007-12#2)
an artificial intelligence##2##3##(2007-11#2)
an artificial mouth system##2##4##(2008-10#2)
an artificial neural network (ANN)##4##5##(2008-10#3)(2010-8#1)
an artificial neural network consisting of three layers of nodes was trained by applying a back-propagation learning rule##3##18##(2008-10#3)
an artificial neural network##12##4##(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#1)(2010-8#2)
an artificial##45##2##(1992-12#1)(1993-8#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#4)
an artificially##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
an artist##2##2##(2008-10#2)
an as yet unknown##3##4##(2008-11#1)(2008-7#1)(2010-10#1)
an as yet##5##3##(1994-6#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)
an aspartic acid##3##3##(1993-3#1)(1993-8#1)(1994-5#1)
an aspartic##4##2##(1991-9#1)(1993-3#1)(1993-8#1)(1994-5#1)
an aspartyl##3##2##(1994-5#1)(1995-6#1)(2008-5#1)
an aspect of##5##3##(2007-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)
an aspect##8##2##(2007-12#2)(2007-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)
an aspheric##2##2##(2008-3#2)
an aspherical lens##3##3##(2008-2#2)(2008-3#1)
an assay for##6##3##(1992-6#1)(2008-10#2)(2008-4#2)(2010-4#1)
an assay of##4##3##(1990-7#1)(2008-10#1)(2008-4#1)(2008-6#1)
an assay system##2##3##(1992-12#1)(2008-4#1)
an assay##21##2##(1990-12#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(2008-10#5)(2008-4#5)(2008-6#1)(2010-12#1)(2010-4#1)
an assertive##2##2##(2008-11#2)
an assessment of its##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
an assessment of the##15##4##(1991-12#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1997-3#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)
an assessment of##33##3##(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-5#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
an assessment tool##4##3##(2008-11#2)(2008-3#1)(2011-2#1)
an assessment##52##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-3#1)(1997-6#1)(2006-5#1)(2008-1#1)(2008-11#11)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
an asset##2##2##(1994-9#1)(2008-10#1)
an assistant##3##2##(1996-8#1)(2008-2#1)(2009-11#1)
an associate##3##2##(2008-10#1)(2009-7#1)(2010-5#1)
an associated##23##2##(1992-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-10#1)(2013-1#1)
an association between a##2##4##(1997-4#1)(2010-11#1)
an association between the##7##4##(1990-2#1)(1990-8#1)(1997-5#1)(2008-8#2)(2010-3#1)(2013-8#1)
an association between these##2##4##(2009-10#1)(2012-3#1)
an association between this##2##4##(2008-6#1)(2013-1#1)
an association between##42##3##(1990-2#1)(1990-8#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
an association constant for tetrol I-1##2##6##(2008-10#2)
an association constant##3##3##(1996-5#1)(2008-10#2)
an association of##12##3##(1990-3#1)(1990-8#1)(1993-12#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-7#1)(2009-2#2)(2011-2#1)(2012-12#1)
an association study##2##3##(1997-5#1)(2012-3#1)
an association with the##2##4##(1991-12#1)(2010-12#1)
an association with##8##3##(1991-12#1)(1993-9#1)(1997-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
an association##81##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-12#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-5#2)(1997-8#2)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#6)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
an associative learning##2##3##(2008-1#1)(2012-2#1)
an associative##9##2##(1990-11#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#2)
an assumed##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
an assumption that##2##3##(1992-6#1)(2008-8#1)
an assumption##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
an aster yellows##3##3##(2008-10#3)
an aster-like structure##2##3##(2008-6#2)
an asthma##4##2##(1997-1#1)(2008-3#1)(2010-8#1)(2013-1#1)
an astigmatic##2##2##(2007-11#1)(2008-2#1)
an astrocytic cell line##2##4##(1994-11#2)
an asylum##2##2##(2009-10#2)
an asymmetric distribution##2##3##(1994-2#1)(2012-2#1)
an asymmetric##24##2##(1991-2#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2009-10#1)(2009-9#1)(2010-7#1)(2012-2#1)
an asymptomatic patient##2##3##(1991-11#1)(2012-12#1)
an asymptomatic##15##2##(1991-11#1)(1991-2#1)(1992-12#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-6#1)(2010-6#1)(2012-12#2)(2012-3#1)
an asymptote##2##2##(2008-10#2)
an asymptotic analysis##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
an asymptotic##9##2##(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
an asymptotically stable##2##3##(2013-8#2)
an asymptotically##3##2##(2012-1#1)(2013-8#2)
an at##3##2##(1991-8#2)(2013-7#1)
an at-risk group##2##3##(2007-6#1)(2013-1#1)
an atherogenic##3##2##(1992-9#1)(2007-8#1)(2008-3#1)
an athlete##5##2##(2008-8#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-3#1)
an atmosphere containing##2##3##(2008-3#1)(2008-5#1)
an atmosphere of##4##3##(1997-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
an atmosphere##8##2##(1991-12#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2013-1#1)
an atmospheric pressure##2##3##(2008-3#2)
an atmospheric##4##2##(2008-3#4)
an atmospheric-pressure##3##2##(2008-2#2)(2008-3#1)
an atomic absorption spectrometer##2##4##(2008-10#2)
an atomic absorption spectrometric##2##4##(2008-10#2)
an atomic absorption spectrophotometric method##2##5##(2008-10#2)
an atomic absorption##7##3##(2008-10#7)
an atomic force microscope##7##4##(2007-11#1)(2008-3#4)(2010-4#2)
an atomic force##8##3##(2007-11#1)(2008-10#1)(2008-3#4)(2010-4#2)
an atomic##28##2##(1993-11#1)(1994-5#1)(2007-11#3)(2007-12#3)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2010-4#2)(2012-2#1)
an atomic-force microscope##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
an atrial septal defect##3##4##(2007-8#3)
an atrial septal##4##3##(1994-11#1)(2007-8#3)
an atrial##5##2##(1994-11#1)(2007-8#4)
an attack##4##2##(1991-9#1)(2007-12#3)
an attempt at##4##3##(2008-12#1)(2009-9#1)(2010-4#1)(2013-8#1)
an attempt has been made to enhance##2##7##(2010-8#1)(2013-1#1)
an attempt has been made to##3##6##(2007-2#1)(2010-8#1)(2013-1#1)
an attempt to better##3##4##(1996-12#1)(2008-10#2)
an attempt to clarify##2##4##(1993-11#1)(2008-9#1)
an attempt to determine##2##4##(1993-1#1)(2010-4#1)
an attempt to develop a##2##5##(2008-10#1)(2011-2#1)
an attempt to develop##6##4##(1992-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
an attempt to elucidate the##2##5##(1996-2#1)(1997-7#1)
an attempt to elucidate##3##4##(1996-2#1)(1997-7#1)(2008-9#1)
an attempt to enhance##2##4##(2008-10#1)(2011-1#1)
an attempt to establish##2##4##(2010-4#1)(2013-8#1)
an attempt to identify##6##4##(1992-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-8#1)
an attempt to minimize the##2##5##(2008-3#1)(2008-5#1)
an attempt to overcome##3##4##(1996-12#1)(1996-3#1)(2008-10#1)
an attempt to understand##6##4##(1990-5#1)(2008-3#1)(2008-9#2)(2010-6#1)(2013-8#1)
an attempt to##99##3##(1990-12#2)(1990-5#1)(1991-2#1)(1991-9#2)(1992-11#2)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-7#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
an attempt was made to##4##5##(1990-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
an attempt##114##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-2#1)(1991-9#2)(1992-11#2)(1992-3#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
an attempted##2##2##(1993-12#1)(1994-2#1)
an attenuated##6##2##(1992-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
an attenuation of##2##3##(2007-12#1)(2008-2#1)
an attenuation##5##2##(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
an attitude##3##2##(2007-11#1)(2008-5#1)(2011-3#1)
an attractive alternative to conventional##2##5##(2008-10#1)(2012-2#1)
an attractive alternative to##4##4##(2008-1#1)(2008-10#2)(2012-2#1)
an attractive alternative##11##3##(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2012-2#1)
an attractive application##2##3##(2008-10#1)(2008-3#1)
an attractive approach to##3##4##(2008-7#1)(2009-9#1)(2013-1#1)
an attractive approach##4##3##(1997-3#1)(2008-7#1)(2009-9#1)(2013-1#1)
an attractive candidate##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
an attractive model for##2##4##(1996-12#1)(1997-4#1)
an attractive model##3##3##(1996-12#1)(1997-4#1)(2012-3#1)
an attractive option for##2##4##(2012-3#1)(2012-8#1)
an attractive option##4##3##(2010-8#1)(2011-2#1)(2012-3#1)(2012-8#1)
an attractive sink##2##3##(2008-8#2)
an attractive solution##2##3##(1995-2#1)(2008-11#1)
an attractive system for##2##4##(2007-12#1)(2008-11#1)
an attractive target for cancer##2##5##(1995-2#1)(2008-11#1)
an attractive target for##6##4##(1995-2#1)(2008-11#2)(2009-4#1)(2011-2#1)(2013-1#1)
an attractive technique for the##2##5##(2008-10#1)(2010-9#1)
an attractive technique##4##3##(2008-10#3)(2010-9#1)
an attractive way##2##3##(2008-2#1)(2012-2#1)
an attractive##65##2##(1995-2#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#2)
an attribute##3##2##(1991-9#1)(1997-3#2)
an atypical antipsychotic##3##3##(2008-6#2)(2010-2#1)
an atypical carcinoid##2##3##(2008-4#1)(2008-8#1)
an atypical case of##3##4##(2008-6#1)(2012-1#1)(2012-3#1)
an atypical##19##2##(1993-10#1)(1993-2#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
an audience##5##2##(2008-5#1)(2009-6#3)(2013-1#1)
an audio speaker##2##3##(2008-2#1)(2008-3#1)
an audio##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
an audit of##3##3##(1992-5#1)(1993-1#1)(2007-11#1)
an audit##8##2##(1992-5#1)(1993-1#4)(1994-12#1)(2007-11#1)(2007-9#1)
an auditing##2##2##(1991-3#1)(2013-1#1)
an auditory##5##2##(2008-1#2)(2008-11#1)(2008-9#1)(2010-5#1)
an augmented##2##2##(2008-10#1)(2013-1#1)
an authentic##2##2##(1990-7#1)(2011-2#1)
an author##2##2##(1992-3#1)(2008-9#1)
an autistic##2##2##(2008-11#1)(2011-2#1)
an autoantibody##2##2##(1994-12#1)(2013-1#1)
an autocatalytic process##2##3##(1994-3#1)(1995-3#1)
an autocatalytic##3##2##(1994-3#1)(1995-3#1)(1995-8#1)
an autocorrelation##2##2##(2008-2#2)
an autocorrelator##2##2##(2007-11#2)
an autocrine##8##2##(1990-2#1)(1990-7#1)(1992-9#1)(1993-9#1)(2008-11#1)(2008-4#1)(2009-8#1)(2012-2#1)
an autocrine/paracrine fashion##2##3##(1993-3#2)
an autocrine/paracrine##3##2##(1993-3#2)(2010-11#1)
an autoimmune disease and##2##4##(2008-1#1)(2008-11#1)
an autoimmune disease##9##3##(1990-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
an autoimmune disorder##3##3##(1991-4#1)(2012-2#2)
an autoimmune##17##2##(1990-12#1)(1990-5#1)(1991-4#1)(1996-11#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
an autologous##4##2##(1994-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
an automated cell##2##3##(2008-11#2)
an automated flow injection##3##4##(2008-10#3)
an automated method##2##3##(2010-8#1)(2012-1#1)
an automated procedure to##2##4##(2008-10#1)(2010-2#1)
an automated procedure##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
an automated process##2##3##(2008-10#1)(2010-1#1)
an automated sample handling##2##4##(1997-6#1)(2008-10#1)
an automated sample##3##3##(1997-6#1)(2008-10#2)
an automated system##4##3##(1991-12#1)(2008-10#2)(2008-4#1)
an automated##57##2##(1990-2#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-8#2)(1995-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#26)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2009-10#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#4)(2012-1#1)(2012-2#1)(2013-1#1)
an automatic and##2##3##(2008-10#1)(2008-3#1)
an automatic injector##2##3##(2008-10#2)
an automatic##28##2##(1990-8#1)(1991-12#1)(1991-5#2)(2007-12#1)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#2)(2009-12#1)(2010-8#3)(2012-12#1)(2012-3#1)
an automation##3##2##(2008-10#3)
an autonomous##4##2##(1990-3#1)(2008-12#1)(2012-12#1)(2013-1#1)
an autonomously replicating##2##3##(1995-2#1)(2008-8#1)
an autopsy##2##2##(1997-8#1)(2008-7#1)
an autoradiographic##3##2##(1995-12#1)(2008-3#1)(2008-7#1)
an autoregulatory##3##2##(1997-7#1)(2008-2#1)(2008-6#1)
an autosomal dominant condition##2##4##(1997-3#1)(2008-4#1)
an autosomal dominant disorder##9##4##(1997-3#1)(2007-10#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#2)
an autosomal dominant trait##2##4##(2007-7#1)(2010-6#1)
an autosomal dominant##28##3##(1992-6#1)(1993-12#1)(1997-3#3)(1997-6#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#2)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
an autosomal recessive disorder with##2##5##(2010-3#1)(2012-12#1)
an autosomal recessive disorder##6##4##(1991-8#1)(1991-9#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
an autosomal recessive mode of inheritance##2##6##(2008-1#2)
an autosomal recessive syndrome##3##4##(2007-10#1)(2008-4#2)
an autosomal recessive##21##3##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1994-9#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-4#3)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
an autosomal##51##2##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-6#1)(1997-3#3)(1997-6#1)(2007-10#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-12#3)(2008-2#1)(2008-4#5)(2008-7#5)(2008-8#2)(2010-3#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
an auxiliary##9##2##(1991-3#1)(1991-8#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-7#1)
an available##3##2##(2007-12#1)(2009-11#1)(2012-12#1)
an avalanche photodiode##2##3##(2008-3#2)
an average 15##2##3##(1992-12#1)(2007-7#1)
an average accuracy of##2##4##(2008-3#1)(2010-8#1)
an average age of##11##4##(1990-12#1)(1994-12#1)(2007-8#1)(2008-9#3)(2009-10#1)(2010-8#1)(2013-1#3)
an average age##13##3##(1990-12#1)(1994-12#1)(1997-3#1)(2007-8#1)(2008-9#3)(2009-10#1)(2010-8#1)(2013-1#4)
an average annual##5##3##(1993-1#1)(1993-3#1)(1994-9#1)(2011-2#2)
an average doubling time of##2##5##(2008-11#2)
an average follow-up of##8##4##(1990-12#1)(1992-6#1)(2006-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
an average follow-up##9##3##(1990-12#1)(1992-6#1)(2006-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
an average genetic##2##3##(2008-10#2)
an average grain diameter##2##4##(2009-7#2)
an average life##2##3##(1993-9#1)(1995-6#1)
an average of 0##5##4##(1990-12#1)(2008-10#2)(2008-8#1)(2013-7#1)
an average of 1##3##4##(1991-5#1)(2008-10#1)(2012-2#1)
an average of 10##4##4##(2007-8#1)(2007-9#1)(2008-7#1)(2012-2#1)
an average of 16##2##4##(2008-10#1)(2009-6#1)
an average of 2##3##4##(1995-11#1)(2008-3#1)(2012-2#1)
an average of 3##2##4##(1990-7#1)(2007-2#1)
an average of 4##6##4##(1990-7#1)(2008-10#1)(2008-9#1)(2013-1#2)(2013-7#1)
an average of 5##7##4##(1990-7#1)(1992-8#1)(2008-10#3)(2008-3#1)(2012-1#1)
an average of 6##4##4##(1994-12#1)(1997-7#1)(2008-10#1)(2008-9#1)
an average of 7##3##4##(1993-3#1)(2009-3#1)(2012-12#1)
an average of 8 months##2##5##(1994-3#1)(2008-7#1)
an average of 8##4##4##(1990-7#1)(1994-3#1)(2008-7#1)(2009-3#1)
an average of a##2##4##(2011-2#2)
an average of##90##3##(1990-12#2)(1990-2#1)(1990-7#4)(1991-3#1)(1991-5#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#9)(2009-10#1)(2009-3#2)(2009-6#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#2)
an average output power of 1##2##6##(2007-11#1)(2008-3#1)
an average output power of##4##5##(2007-11#2)(2008-3#2)
an average pore##2##3##(1990-8#1)(2008-10#1)
an average power as high as##2##6##(2007-11#1)(2008-3#1)
an average power of 0##4##5##(2007-11#1)(2007-12#3)
an average power of 1##2##5##(2007-12#1)(2008-3#1)
an average power of##13##4##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#2)
an average power##15##3##(2007-11#5)(2007-12#6)(2008-2#1)(2008-3#3)
an average rate of##2##4##(2008-10#1)(2010-8#1)
an average rate##3##3##(1995-2#1)(2008-10#1)(2010-8#1)
an average ratio of##2##4##(2008-1#2)
an average recovery of 97##2##5##(2008-10#2)
an average recovery of 99##2##5##(2008-10#2)
an average recovery of##7##4##(2008-10#7)
an average recovery##8##3##(2008-10#8)
an average relative##6##3##(2008-10#4)(2008-7#1)(2013-8#1)
an average roughness##2##3##(2012-2#2)
an average slope of##2##4##(2008-10#1)(2011-2#1)
an average specific productivity of 1##2##6##(2008-6#2)
an average specific##4##3##(2008-11#2)(2008-6#2)
an average survival##2##3##(1994-6#1)(2007-10#1)
an average##277##2##(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#5)(1991-3#1)(1991-5#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-12#4)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#8)(2007-12#11)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#44)(2008-11#8)(2008-12#4)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#9)(2008-9#15)(2009-10#2)(2009-11#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-4#2)(2010-6#2)(2010-8#5)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#10)(2013-7#2)(2013-8#4)
an averaging time of##3##4##(2008-3#3)
an aversive event##2##3##(2008-11#2)
an aversive##4##2##(2008-11#2)(2008-4#1)(2010-10#1)
an avian##4##2##(1997-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
an avidin##2##2##(2008-10#1)(2011-2#1)
an avidin-biotin##2##2##(1996-5#1)(2008-4#1)
an avirulence locus##2##3##(2008-10#2)
an avirulence##3##2##(2008-10#3)
an avulsion##2##2##(2008-9#2)
an awareness of the##3##4##(2008-12#1)(2008-4#1)(2008-7#1)
an awareness of##4##3##(1996-1#1)(2008-12#1)(2008-4#1)(2008-7#1)
an awareness##5##2##(1996-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
an axial##7##2##(1991-12#1)(1994-8#1)(1996-2#1)(2008-3#2)(2009-2#1)(2012-3#1)
an axicon lens##3##3##(2007-11#3)
an axicon##4##2##(2007-11#3)(2008-2#1)
an axis##3##2##(2008-3#2)(2008-6#1)
an axisymmetric##2##2##(2008-3#1)(2008-7#1)
an azimuthal##2##2##(2008-2#1)(2008-3#1)
an azo dye##2##3##(2007-12#1)(2008-10#1)
an azo##4##2##(2007-12#1)(2008-10#3)
an azobenzene##2##2##(2008-10#1)(2008-3#1)
an azobenzene-doped polymer##2##3##(2007-12#2)
an ear##2##2##(2008-10#1)(2012-3#1)
an earlier age of onset##2##5##(1996-7#1)(2011-2#1)
an earlier age##4##3##(1993-12#1)(1996-7#1)(2008-3#1)(2011-2#1)
an earlier article##2##3##(1994-3#1)(2008-12#1)
an earlier onset##2##3##(2008-11#1)(2008-5#1)
an earlier paper##6##3##(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
an earlier report##3##3##(2008-1#1)(2008-10#2)
an earlier stage of##3##4##(1997-7#1)(2008-10#1)(2010-1#1)
an earlier stage##7##3##(1992-3#1)(1994-11#1)(1994-7#1)(1997-7#1)(2008-1#1)(2008-10#1)(2010-1#1)
an earlier study which##2##4##(1993-12#2)
an earlier study##10##3##(1991-3#1)(1993-12#2)(1995-8#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-3#1)
an earlier work##2##3##(2008-10#2)
an earlier##65##2##(1991-3#1)(1991-5#1)(1992-3#2)(1993-12#3)(1993-3#1)(1994-11#1)(1994-3#2)(1994-7#1)(1995-3#2)(1995-8#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
an early age##6##3##(1992-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2012-12#1)
an early and##5##3##(1991-5#1)(1992-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
an early biomarker##2##3##(2009-12#1)(2010-5#1)
an early detection##3##3##(2010-8#1)(2011-1#1)(2013-8#1)
an early diagnosis##5##3##(1990-6#1)(1991-5#1)(1995-8#1)(2007-2#1)(2011-2#1)
an early event in##2##4##(1990-7#1)(2010-3#1)
an early event##4##3##(1990-7#1)(1991-1#1)(2007-4#1)(2010-3#1)
an early intervention##2##3##(2011-3#1)(2013-1#1)
an early marker##2##3##(2007-8#1)(2008-1#1)
an early phase##3##3##(2007-7#1)(2011-1#1)(2012-2#1)
an early stage of##11##4##(1992-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#2)(2010-3#1)(2013-8#1)
an early stage to##2##4##(1992-6#1)(2008-10#1)
an early stage##38##3##(1990-9#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
an early step##2##3##(1992-3#1)(2008-10#1)
an early transient##2##3##(1996-5#1)(2008-8#1)
an early warning system##2##4##(2008-10#1)(2008-8#1)
an early warning##4##3##(2008-10#1)(2008-7#1)(2008-8#2)
an early##144##2##(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#8)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#6)
an easier##4##2##(1990-12#1)(2007-12#1)(2011-2#1)(2013-8#1)
an easily##9##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)
an easy and reliable means##2##5##(1995-2#1)(1997-7#1)
an easy and##10##3##(1990-8#1)(1994-12#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-3#1)
an easy task##2##3##(2008-9#1)(2010-2#1)
an easy way to##3##4##(1997-2#1)(2007-12#1)(2008-10#1)
an easy way##4##3##(1997-2#1)(2007-12#1)(2008-10#2)
an easy##29##2##(1990-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2013-8#1)
an easy-to-implement##2##2##(2007-11#1)(2008-12#1)
an easy-to-use##2##2##(2008-9#1)(2013-1#1)
an eating disorder##4##3##(2007-7#1)(2011-2#3)
an eating##5##2##(2007-7#1)(2011-2#3)(2012-1#1)
an eccentric##2##2##(2008-3#1)(2013-1#1)
an eccrine##2##2##(2007-7#1)(2008-5#1)
an echinocandin##2##2##(2008-10#1)(2011-2#1)
an echocardiogram##2##2##(2007-10#1)(2013-1#1)
an ecological perspective##4##3##(2008-1#1)(2008-11#1)(2009-7#2)
an ecological##12##2##(1992-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#2)(2010-11#1)(2011-2#1)
an ecologically important##2##3##(1996-2#1)(2008-10#1)
an economic analysis##3##3##(1997-2#1)(2008-7#2)
an economic##11##2##(1991-3#1)(1994-12#1)(1997-2#1)(2008-10#4)(2008-7#2)(2012-2#1)(2013-1#1)
an economical and##5##3##(1994-2#1)(2008-1#1)(2008-10#2)(2008-4#1)
an economical way##2##3##(2008-8#1)(2008-9#1)
an economical##9##2##(1994-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
an economically feasible##2##3##(2008-10#1)(2011-2#1)
an economically important##7##3##(2007-2#1)(2008-10#5)(2010-10#1)
an economically##11##2##(2007-2#1)(2008-10#7)(2010-10#1)(2011-2#2)
an ecosystem##3##2##(1997-7#2)(2009-4#1)
an ectopic##5##2##(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
an edge##6##2##(2008-3#2)(2008-6#1)(2008-9#1)(2013-1#1)(2013-7#1)
an education program##2##3##(2008-9#1)(2013-1#1)
an education##6##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#2)
an educational and support##2##4##(2011-2#2)
an educational and##3##3##(1993-12#1)(2011-2#2)
an educational intervention##4##3##(2008-8#2)(2008-9#1)(2012-1#1)
an educational program to##2##4##(1997-7#1)(2012-2#1)
an educational program##3##3##(1990-6#1)(1997-7#1)(2012-2#1)
an educational strategy##2##3##(2008-11#1)(2008-12#1)
an educational##26##2##(1990-12#1)(1990-6#1)(1993-12#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
an effect in##5##3##(1996-12#1)(2006-10#1)(2007-12#1)(2008-9#1)(2010-6#1)
an effect of the##5##4##(1995-6#1)(1996-5#1)(2008-12#1)(2008-3#1)(2010-10#1)
an effect of##19##3##(1993-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2009-2#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
an effect on the##14##4##(1990-2#1)(1992-9#1)(1994-11#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-2#1)
an effect on##34##3##(1990-2#1)(1991-11#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-8#2)(1995-12#1)(1996-11#1)(1996-2#1)(1997-4#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
an effect that is##2##4##(1993-3#1)(1994-6#1)
an effect that was##5##4##(1990-5#2)(1993-5#2)(1995-2#1)
an effect that##10##3##(1990-5#2)(1993-3#1)(1993-5#2)(1994-6#1)(1995-2#1)(2008-11#1)(2010-2#1)(2013-1#1)
an effect##82##2##(1990-2#1)(1990-5#3)(1991-11#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-3#2)(1993-5#2)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-4#4)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
an effective adjunct##3##3##(2008-11#1)(2009-5#2)
an effective alternative to##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
an effective alternative##9##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
an effective and economical##2##4##(1991-12#1)(2008-5#1)
an effective and reliable##3##4##(2008-10#2)(2013-1#1)
an effective and reproducible##2##4##(2008-10#1)(2009-5#1)
an effective and safe##3##4##(1992-5#1)(2008-11#1)(2008-4#1)
an effective and##19##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-5#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-8#1)(2013-1#1)
an effective antioxidant##2##3##(2008-10#1)(2011-1#1)
an effective approach##7##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
an effective area of##3##4##(2007-11#2)(2008-3#1)
an effective clinical##2##3##(2008-12#1)(2013-1#1)
an effective compliance program##2##4##(1996-12#2)
an effective diagnostic##2##3##(1993-3#1)(2008-9#1)
an effective inhibitor of##3##4##(1990-5#1)(1992-9#1)(2008-11#1)
an effective intervention for##3##4##(1997-4#1)(2008-10#1)(2008-12#1)
an effective intervention##5##3##(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
an effective learning##2##3##(2008-12#1)(2013-8#1)
an effective manual process##2##4##(1996-3#2)
an effective means for##2##4##(2008-10#2)
an effective means of classifying##2##5##(2008-3#2)
an effective means of##10##4##(1993-11#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
an effective means to##3##4##(1995-1#1)(2008-6#1)(2008-8#1)
an effective means##16##3##(1993-11#1)(1994-11#1)(1995-1#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
an effective method for##5##4##(1991-2#1)(2008-4#3)(2011-2#1)
an effective method of##9##4##(1991-7#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)
an effective method to##5##4##(2008-10#2)(2011-3#1)(2012-12#1)(2013-1#1)
an effective method##22##3##(1991-2#1)(1991-7#1)(1993-12#1)(1997-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
an effective microsymbiont of##2##4##(2011-2#2)
an effective modality##2##3##(1991-4#1)(2013-1#1)
an effective on-line##2##3##(2008-10#1)(2008-7#1)
an effective probe##2##3##(1990-2#1)(2008-2#1)
an effective response to##2##4##(1994-11#1)(2013-8#1)
an effective safety program##2##4##(1991-12#1)(1995-2#1)
an effective sample size##3##4##(2008-10#3)
an effective screening##2##3##(1997-4#1)(2008-2#1)
an effective strategy for improving##2##5##(2010-7#1)(2013-1#1)
an effective strategy for the##2##5##(2008-10#1)(2013-1#1)
an effective strategy for##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#2)
an effective strategy##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
an effective technique for##2##4##(2008-10#2)
an effective technique##4##3##(2008-10#4)
an effective therapeutic##4##3##(1993-2#1)(2008-6#1)(2011-2#2)
an effective therapy for##2##4##(1991-4#1)(2007-10#1)
an effective therapy##4##3##(1991-4#1)(2006-10#1)(2007-10#1)(2007-8#1)
an effective tool for the##2##5##(2008-10#1)(2008-11#1)
an effective tool for##5##4##(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)
an effective tool in##3##4##(1996-3#1)(2007-11#1)(2008-10#1)
an effective tool to##7##4##(1992-2#1)(1994-3#1)(2008-10#1)(2010-10#1)(2012-7#1)(2013-7#1)(2013-8#1)
an effective tool##15##3##(1992-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-10#1)(2012-7#1)(2013-7#1)(2013-8#1)
an effective treatment for##8##4##(2007-11#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-7#2)(2012-3#2)
an effective treatment of##3##4##(2008-5#1)(2012-2#1)(2013-8#1)
an effective treatment##17##3##(1992-8#1)(1997-6#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
an effective vaccine##2##3##(1995-5#1)(2011-2#1)
an effective way to##5##4##(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
an effective##309##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#4)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#8)(2007-12#6)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#49)(2008-11#16)(2008-12#5)(2008-2#10)(2008-3#13)(2008-4#8)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#5)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#3)(2010-8#4)(2011-1#4)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#6)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#8)
an effector##4##2##(1990-7#1)(1997-4#1)(2011-1#1)(2012-2#1)
an effervescent##2##2##(2008-10#1)(2012-2#1)
an efficacious##4##2##(1990-6#1)(1991-5#1)(2007-11#1)(2009-12#1)
an efficacy##3##2##(1994-9#1)(2007-11#1)(2009-6#1)
an efficiency of##7##3##(2007-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-6#1)
an efficiency##13##2##(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)
an efficient algorithm##2##3##(2012-2#1)(2013-8#1)
an efficient alternative##3##3##(1993-11#1)(2007-12#1)(2011-2#1)
an efficient and cost-effective way##3##5##(1994-3#2)(2010-8#1)
an efficient and effective##2##4##(1994-2#1)(1994-8#1)
an efficient and fast##2##4##(2008-10#1)(2008-3#1)
an efficient and##11##3##(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-8#1)(2012-3#1)
an efficient detection scheme##2##4##(2012-2#2)
an efficient inhibitor of##2##4##(1994-8#1)(2013-1#1)
an efficient means of##2##4##(2008-10#1)(2008-3#1)
an efficient means to##3##4##(1997-2#1)(2008-10#2)
an efficient means##7##3##(1995-2#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
an efficient method for##4##4##(1991-9#1)(2007-11#1)(2008-4#1)(2008-9#1)
an efficient method of##5##4##(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#1)
an efficient method##11##3##(1991-9#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2011-2#1)
an efficient procedure for##2##4##(2008-10#1)(2008-11#1)
an efficient system for##2##4##(1993-8#1)(2008-11#1)
an efficient technique for the##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
an efficient tool for##3##4##(2007-12#1)(2008-10#2)
an efficient use of##2##4##(2008-10#1)(2008-3#1)
an efficient vector##2##3##(2008-10#1)(2008-3#1)
an efficient way to##2##4##(2008-10#1)(2008-3#1)
an efficient way##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2010-11#1)
an efficient##130##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-9#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#7)(2007-12#6)(2008-10#20)(2008-11#8)(2008-2#7)(2008-3#17)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
an effort to better##5##4##(1993-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-9#1)
an effort to determine the##2##5##(2008-11#1)(2012-3#1)
an effort to develop a##2##5##(1997-7#1)(2008-10#1)
an effort to develop##5##4##(1995-2#1)(1997-7#1)(2008-10#2)(2009-9#1)
an effort to identify##4##4##(1993-2#1)(1997-1#1)(2008-11#1)(2013-1#1)
an effort to increase##3##4##(1997-3#1)(2008-8#1)(2010-8#1)
an effort to understand##2##4##(2008-5#1)(2009-9#1)
an effort to##59##3##(1990-11#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#4)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#2)(2012-3#5)(2013-1#2)(2013-8#1)
an effort##60##2##(1990-11#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#4)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#2)(2012-3#5)(2013-1#2)(2013-8#1)
an egg##3##2##(2008-12#1)(2008-9#2)
an eight##6##2##(1994-2#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
an eight-level phase##2##3##(2008-2#1)(2008-3#1)
an eight-level##3##2##(2008-2#2)(2008-3#1)
an eight-stranded##2##2##(1991-5#1)(1997-4#1)
an eight-week##4##2##(1990-2#1)(2009-11#1)(2011-1#2)
an elastase-specific inhibitor##2##3##(1992-6#2)
an elastic modulus##2##3##(2010-4#1)(2012-2#1)
an elastic stable intramedullary nail##2##5##(2011-2#2)
an elastic##7##2##(2007-12#1)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#2)(2012-2#1)
an elderly female patient##2##4##(1993-6#1)(2012-2#1)
an elderly patient##5##3##(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
an elderly person from a##2##5##(2008-6#2)
an elderly population##8##3##(1992-12#1)(1994-6#1)(2008-3#1)(2008-7#3)(2012-12#2)
an elderly woman##4##3##(1991-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
an elderly##28##2##(1991-2#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(2008-3#1)(2008-6#4)(2008-7#6)(2008-8#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
an elective##9##2##(1992-6#1)(1995-1#1)(1996-12#2)(2007-10#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
an electric field##12##3##(1990-7#1)(1990-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-12#1)
an electric##18##2##(1990-7#1)(1990-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-7#1)(2009-12#1)(2013-1#1)
an electric-field##2##2##(2007-12#1)(2008-2#1)
an electrical discharge between two##2##5##(2008-2#1)(2008-3#1)
an electrical discharge##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
an electrical field##2##3##(2007-12#1)(2008-2#1)
an electrical potential##3##3##(2008-10#1)(2008-9#1)(2012-1#1)
an electrical signal##2##3##(2008-9#1)(2009-8#1)
an electrical##24##2##(1994-5#1)(2007-12#4)(2008-10#5)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#1)(2012-1#1)
an electrically##8##2##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)
an electro-absorbing semiconductor modulator##2##4##(2007-12#2)
an electro-optic modulator##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
an electro-optic##13##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#5)
an electro-optical##2##2##(2008-2#1)(2008-3#1)
an electro-optically Q-switched##3##3##(2008-3#3)
an electroactive##11##2##(2008-10#10)(2008-5#1)
an electroanalytical##3##2##(2008-10#3)
an electrocardiogram in##2##3##(1994-6#1)(2008-12#1)
an electrocardiogram##5##2##(1991-8#1)(1994-6#2)(2008-12#2)
an electrocatalytic##2##2##(2008-10#2)
an electrochemical active##2##3##(2008-10#2)
an electrochemical cell##2##3##(2008-10#2)
an electrochemical detector for##2##4##(2008-10#2)
an electrochemical detector##6##3##(2008-10#4)(2008-6#1)(2012-1#1)
an electrochemical##32##2##(2008-10#27)(2008-6#1)(2008-7#1)(2010-2#1)(2012-1#1)(2013-1#1)
an electrochemically##4##2##(2008-10#4)
an electrode composition##2##3##(2008-10#2)
an electrode surface##2##3##(2008-10#2)
an electrode##21##2##(1993-8#1)(1995-3#1)(2007-11#1)(2008-10#16)(2012-2#1)(2012-3#1)
an electrode/electrolyte interface##3##3##(2008-10#3)
an electrolyte##5##2##(1994-9#1)(2008-10#4)
an electromagnetic field##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2013-7#1)
an electromagnetic##10##2##(2007-10#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2011-2#1)(2013-7#1)
an electromechanical##2##2##(2008-10#1)(2008-7#1)
an electromyographic study##2##3##(1990-11#1)(1996-5#1)
an electron beam##4##3##(2007-12#3)(2008-7#1)
an electron capture detector##6##4##(2008-10#6)
an electron capture##7##3##(2008-10#7)
an electron microscope##2##3##(1997-2#1)(2008-7#1)
an electron spin resonance (ESR)##2##5##(2008-10#2)
an electron spin##3##3##(1996-2#1)(2008-10#2)
an electron transfer##3##3##(1996-3#1)(2008-10#2)
an electron##31##2##(1991-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#5)(2008-10#16)(2008-7#2)
an electron-trapping device##2##3##(2008-3#2)
an electron-withdrawing##2##2##(1995-3#1)(1995-6#1)
an electronic health record##6##4##(2007-12#1)(2013-1#5)
an electronic health##7##3##(1996-12#1)(2007-12#1)(2013-1#5)
an electronic medical record##3##4##(1996-3#1)(2007-9#1)(2009-10#1)
an electronic medical##4##3##(1996-3#1)(2007-9#1)(2009-10#1)(2010-8#1)
an electronic microcosm##2##3##(2008-8#2)
an electronic nose##3##3##(2008-10#2)(2008-11#1)
an electronic structure##2##3##(2008-11#2)
an electronic##51##2##(1990-8#1)(1991-8#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#4)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-2#2)(2010-8#1)(2012-3#1)(2013-1#5)
an electronically controlled##2##3##(1995-12#1)(2007-12#1)
an electronically tuned Ti##3##4##(2007-12#3)
an electronically##7##2##(1995-12#1)(2007-12#5)(2010-7#1)
an electroosmotic flow##2##3##(1996-5#1)(2008-10#1)
an electroosmotic pump##2##3##(2008-10#2)
an electroosmotic##4##2##(1996-5#1)(2008-10#3)
an electrophoretic##6##2##(1992-8#1)(2008-10#3)(2008-4#2)
an electrophysiological##4##2##(1995-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
an electrospray ionization##2##3##(2008-10#1)(2011-2#1)
an electrostatic force##3##3##(2008-10#2)(2008-2#1)
an electrostatic interaction##4##3##(1996-5#1)(2008-10#3)
an electrostatic potential##3##3##(2008-2#1)(2008-4#1)(2009-5#1)
an electrostatic##12##2##(1996-5#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-4#1)(2009-5#1)
an electrothermal##2##2##(2008-10#2)
an element in##2##3##(1992-6#1)(2012-2#1)
an element of##4##3##(1991-3#1)(1992-12#1)(2007-11#1)(2013-1#1)
an element##12##2##(1991-3#1)(1992-12#1)(1992-6#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-6#1)(2012-2#1)(2013-1#1)
an elemental##2##2##(2007-12#1)(2008-10#1)
an elementary##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
an elevated level of##3##4##(1990-5#1)(1992-9#1)(1993-9#1)
an elevated level##5##3##(1990-5#1)(1991-7#1)(1992-9#1)(1993-9#1)(1996-12#1)
an elevated risk for##2##4##(2011-1#1)(2013-1#1)
an elevated risk##4##3##(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
an elevated##28##2##(1990-5#2)(1991-7#1)(1992-9#2)(1993-9#1)(1994-5#1)(1996-12#1)(1997-5#2)(2008-10#2)(2008-3#2)(2008-6#1)(2009-10#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
an elevation in##4##3##(1990-6#1)(2008-10#1)(2009-5#1)(2013-1#1)
an elevation of##6##3##(1990-11#1)(1990-2#1)(1993-11#1)(1995-8#1)(2007-11#1)(2011-2#1)
an elevation##10##2##(1990-11#1)(1990-2#1)(1990-6#1)(1993-11#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
an elicitor of systemic resistance##2##5##(2008-10#2)
an elicitor of##3##3##(2008-10#3)
an elicitor##5##2##(1994-11#1)(2008-10#4)
an eligible##2##2##(1993-12#1)(2013-1#1)
an elite##3##2##(2008-10#3)
an ellipsoid##2##2##(1990-2#1)(2008-3#1)
an elliptic disk##2##3##(2008-2#2)
an elliptic##5##2##(2008-2#2)(2008-3#3)
an elliptical##7##2##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
an elliptical-cross-section cylinder##2##3##(2008-3#2)
an elliptically polarized##2##3##(2007-11#1)(2007-12#1)
an elongated##7##2##(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-1#1)
an eluent##3##2##(1990-8#1)(2008-10#2)
an elusive##2##2##(1995-12#1)(2010-5#1)
an embryo##4##2##(1993-2#1)(1995-2#1)(2008-11#1)(2012-3#1)
an embryonic##3##2##(2008-7#1)(2009-1#1)(2010-7#1)
an emergency department observation unit##3##5##(2008-3#3)
an emergency department##7##3##(1994-2#1)(1994-8#1)(2007-5#1)(2008-3#3)(2010-11#1)
an emergency##33##2##(1991-3#1)(1992-1#2)(1992-11#1)(1992-8#1)(1993-9#2)(1994-2#1)(1994-3#2)(1994-8#1)(1996-1#2)(1996-6#1)(1997-2#1)(2007-5#1)(2008-1#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
an emergent##5##2##(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
an emerging and##3##3##(2008-9#1)(2010-10#1)(2013-1#1)
an emerging area##2##3##(1996-12#1)(2008-12#1)
an emerging cause of##2##4##(2011-1#1)(2012-3#1)
an emerging disease in##2##4##(2009-8#1)(2012-12#1)
an emerging new##2##3##(2008-3#1)(2009-3#1)
an emerging technique##3##3##(2010-11#2)(2012-2#1)
an emerging##47##2##(1993-3#1)(1996-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
an emission wavelength of##6##4##(2008-10#5)(2008-3#1)
an emission wavelength##8##3##(2008-10#7)(2008-3#1)
an emission##13##2##(2008-10#10)(2008-3#3)
an emollient##2##2##(2008-5#1)(2010-8#1)
an emotion##2##2##(2008-11#1)(2012-1#1)
an emotional##3##2##(2008-11#2)(2008-7#1)
an emotionally##2##2##(1995-1#1)(1996-1#1)
an emphasis on the##6##4##(1991-6#1)(2007-12#1)(2008-10#1)(2010-9#1)(2012-2#2)
an emphasis on##30##3##(1991-6#1)(1992-12#2)(2007-12#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
an emphasis placed on##3##4##(1997-3#1)(2006-10#1)(2008-11#1)
an emphasis##36##2##(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
an empirical Bayes##2##3##(2008-7#1)(2012-3#1)
an empirical approach##2##3##(2008-4#1)(2010-5#1)
an empirical example of##2##4##(2008-9#1)(2012-3#1)
an empirical example##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
an empirical likelihood based##2##4##(2009-12#1)(2010-2#1)
an empirical model that##2##4##(2008-3#2)
an empirical study##6##3##(1992-2#1)(1992-3#1)(2008-11#1)(2008-12#2)(2009-8#1)
an empirical##31##2##(1992-2#2)(1992-3#1)(1994-1#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-2#2)(2012-3#2)
an empirically based##2##3##(2008-12#1)(2010-7#1)
an empirically##3##2##(2008-12#1)(2010-7#1)(2011-2#1)
an employee##10##2##(1991-3#2)(1992-1#1)(1993-1#1)(1994-2#5)(2012-3#1)
an employer##4##2##(1994-12#1)(1994-2#1)(1996-1#1)(1997-5#1)
an empty##4##2##(1992-8#1)(2008-8#1)(2010-11#1)(2011-2#1)
an emulator with##2##3##(2007-11#2)
an emulsion##6##2##(2008-10#2)(2008-5#2)(2009-11#2)
an enabling environment##2##3##(1994-7#1)(2010-12#1)
an enabling##5##2##(1994-11#1)(1994-7#1)(1997-3#1)(2009-12#1)(2010-12#1)
an encapsulated##2##2##(2008-11#2)
an enchondroma##2##2##(2008-9#1)(2010-3#1)
an enclosed##2##2##(2008-10#1)(2013-1#1)
an enclosure##3##2##(1996-12#1)(2008-2#1)(2012-2#1)
an encoder##2##2##(2008-2#1)(2013-8#1)
an encouraging##7##2##(1991-9#1)(1992-2#1)(2008-10#1)(2008-3#1)(2010-12#2)(2012-3#1)
an encrypted##3##2##(2008-3#3)
an end user##2##3##(1991-12#1)(2008-9#1)
an end##12##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(2008-10#3)(2008-6#2)(2008-9#1)(2013-8#1)
an end-column##2##2##(2008-10#2)
an end-stage renal##3##3##(2007-7#1)(2013-1#2)
an end-to-end##3##2##(1991-9#1)(2007-7#1)(2008-3#1)
an endangered species##4##3##(1991-5#2)(2008-5#2)
an endangered##6##2##(1991-5#2)(2008-11#1)(2008-5#2)(2008-8#1)
an endemic area for##3##4##(2008-5#2)(2012-2#1)
an endemic area##5##3##(2007-2#1)(2008-5#2)(2008-7#1)(2012-2#1)
an endemic region##2##3##(2008-10#1)(2012-3#1)
an endemic##17##2##(1991-11#2)(2007-2#1)(2008-10#2)(2008-5#3)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
an endochitinase##2##2##(2008-10#2)
an endodontic##2##2##(2013-1#1)(2013-8#1)
an endogenous TSH receptor##2##4##(1993-3#2)
an endogenous gene##2##3##(1990-5#1)(2008-2#1)
an endogenous ligand for##2##4##(1996-12#2)
an endogenous ligand##3##3##(1990-5#1)(1996-12#2)
an endogenous reference##2##3##(2008-10#2)
an endogenous##38##2##(1990-2#1)(1990-5#3)(1991-10#1)(1991-2#1)(1991-5#1)(1992-8#4)(1993-3#2)(1994-11#2)(1994-2#1)(1994-5#2)(1995-8#1)(1996-12#2)(1996-2#2)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#1)
an endometrial suction curette##2##4##(1992-12#2)
an endometrial##3##2##(1992-12#2)(2011-2#1)
an endopolygalacturonase##2##2##(2008-10#2)
an endoprotease##3##2##(1991-9#1)(1995-8#1)(2008-7#1)
an endorectal silicone catheter with a balloon in the extremity##2##10##(2013-1#2)
an endoscope##2##2##(2008-3#2)
an endoscopic transsphenoidal approach##4##4##(2011-2#4)
an endoscopic##12##2##(1990-6#1)(2007-7#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#5)(2013-8#1)
an endothelial cell##2##3##(1992-9#1)(2010-11#1)
an endothelial##6##2##(1990-5#1)(1992-9#1)(1995-2#1)(2008-11#2)(2010-11#1)
an endothelin##2##2##(1990-2#2)
an endothelium-dependent relaxation##2##3##(1995-12#1)(1996-2#1)
an endovascular procedure##2##3##(2008-7#1)(2011-2#1)
an endovascular##7##2##(1991-3#1)(2007-10#2)(2008-11#1)(2008-7#1)(2011-2#2)
an endpoint##4##2##(1992-9#1)(2006-10#1)(2008-10#1)(2008-9#1)
an enduring##2##2##(1995-5#1)(2008-9#1)
an energy density of##2##4##(2008-3#1)(2008-5#1)
an energy dispersive X-ray##2##4##(2008-9#1)(2012-2#1)
an energy function##2##3##(2008-3#2)
an energy of##5##3##(2007-11#1)(2007-12#2)(2008-8#1)(2012-2#1)
an energy##20##2##(1996-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
an energy-##2##2##(1990-2#1)(2007-2#1)
an energy-dispersive X-ray spectrometer for a scanning electron microscope##2##9##(2008-10#2)
an engineered##3##2##(2009-7#2)(2012-2#1)
an engineering##4##2##(2008-11#2)(2008-2#1)(2009-12#1)
an enhanced expression of##2##4##(1990-2#1)(2008-11#1)
an enhanced level of##2##4##(1995-3#1)(2008-11#1)
an enhanced##39##2##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(2007-11#3)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
an enhancement factor of##3##4##(2008-10#2)(2008-2#1)
an enhancement in##5##3##(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
an enhancement of the##8##4##(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#4)(2008-11#1)
an enhancement of##12##3##(1992-12#1)(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)
an enhancement##21##2##(1992-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)
an enhancer##5##2##(1994-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
an enhancing##4##2##(2006-12#1)(2008-6#1)(2008-7#2)
an enigma##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
an enlarged##8##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
an enlargement of the##3##4##(2008-3#1)(2009-7#1)(2012-2#1)
an enormous impact on##2##4##(2008-1#1)(2008-10#1)
an enormous##15##2##(1997-5#1)(2006-4#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
an enquiry##2##2##(1991-9#1)(2008-12#1)
an enriched environment##5##3##(1992-11#5)
an enriched##8##2##(1991-12#1)(1992-11#5)(1992-8#1)(2013-8#1)
an enriching##2##2##(2008-10#1)(2009-4#1)
an enrichment factor of##8##4##(2008-10#8)
an enrichment factor##9##3##(2008-10#9)
an enrichment of##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
an enrichment##16##2##(2008-10#13)(2008-11#1)(2008-7#1)(2009-4#1)
an ensemble of##6##3##(1994-5#1)(2008-3#3)(2008-4#1)(2010-3#1)
an ensemble##7##2##(1994-5#1)(2007-11#1)(2008-3#3)(2008-4#1)(2010-3#1)
an enterocyte##2##2##(1991-12#2)
an enterprise##2##2##(1995-3#1)(1996-1#1)
an enthalpy##2##2##(1994-3#1)(2008-11#1)
an entire epidemic##2##3##(2008-10#2)
an entire##19##2##(1993-1#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
an entirely##7##2##(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)
an entity##6##2##(1991-12#1)(1991-3#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
an entrance##3##2##(2008-2#1)(2008-3#2)
an enumeration##2##2##(1996-3#1)(2013-8#1)
an envelope of##2##3##(2007-11#1)(2008-10#1)
an envelope##4##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
an environment in which##3##4##(1995-6#1)(2008-9#1)(2010-8#1)
an environment of##5##3##(1996-12#1)(2008-1#1)(2008-12#1)(2013-1#1)(2013-8#1)
an environment that##2##3##(2010-11#1)(2013-8#1)
an environment where##6##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
an environment##32##2##(1991-12#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#3)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
an environmental sample##2##3##(2007-6#1)(2008-10#1)
an environmental##15##2##(1991-12#3)(1992-12#1)(1997-7#1)(2007-6#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
an environmentally##5##2##(2008-10#2)(2008-3#1)(2008-8#2)
an enzymatic reaction##2##3##(2008-10#1)(2009-5#1)
an enzymatic##18##2##(1992-11#1)(1992-6#1)(1994-9#1)(2008-10#12)(2009-5#1)(2012-2#2)
an enzymatically active##3##3##(1991-5#1)(1994-11#1)(1995-6#1)
an enzyme electrode##2##3##(2008-10#2)
an enzyme immunoassay##5##3##(1990-5#1)(1991-5#2)(2008-10#1)(2008-5#1)
an enzyme in a##2##4##(1991-5#1)(2008-10#1)
an enzyme in the##2##4##(2008-10#1)(2008-7#1)
an enzyme in##4##3##(1991-5#1)(2008-10#2)(2008-7#1)
an enzyme involved in##3##4##(1991-9#1)(1992-8#1)(2012-2#1)
an enzyme of the##2##4##(1994-8#1)(2010-12#1)
an enzyme of##5##3##(1992-1#1)(1994-11#1)(1994-8#1)(1997-2#1)(2010-12#1)
an enzyme that is##3##4##(1994-12#1)(2008-4#1)(2009-8#1)
an enzyme that##9##3##(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2009-8#1)
an enzyme which##3##3##(1990-2#1)(1990-5#1)(1997-3#1)
an enzyme with a##2##4##(1997-2#1)(2009-11#1)
an enzyme with##3##3##(1994-8#1)(1997-2#1)(2009-11#1)
an enzyme##69##2##(1990-2#1)(1990-5#3)(1990-8#1)(1991-5#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-4#4)(2008-5#2)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
an enzyme-linked immunosorbent assay (ELISA) for##4##6##(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
an enzyme-linked immunosorbent assay (ELISA)##11##5##(1993-9#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-4#2)(2010-4#1)(2011-2#1)(2013-7#1)
an enzyme-linked immunosorbent assay##17##4##(1991-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-4#2)(2010-4#1)(2011-2#2)(2013-7#1)
an enzyme-linked##19##2##(1991-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(2008-10#7)(2008-11#2)(2008-4#2)(2010-4#1)(2011-2#2)(2013-7#1)
an eosinophil##2##2##(1992-12#1)(1994-11#1)
an eosinophilic##2##2##(1990-3#1)(1991-12#1)
an ephedra##2##2##(2008-10#2)
an epidemic of##6##3##(1990-6#2)(1993-12#1)(1996-11#1)(2007-7#1)(2008-3#1)
an epidemic that##2##3##(2008-10#1)(2010-12#1)
an epidemic##18##2##(1990-6#2)(1991-12#1)(1992-2#2)(1993-12#1)(1996-11#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-3#1)(2010-12#1)(2013-8#1)
an epidemiologic study##2##3##(1994-2#1)(2008-3#1)
an epidemiologic##3##2##(1990-6#1)(1994-2#1)(2008-3#1)
an epidemiological model##2##3##(1994-3#1)(2008-8#1)
an epidemiological study on##2##4##(2008-5#1)(2008-7#1)
an epidemiological##10##2##(1992-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
an epidemiologically##2##2##(1994-3#1)(2008-10#1)
an epidural abscess##2##3##(2008-5#1)(2012-3#1)
an epidural catheter##3##3##(1993-10#2)(2011-2#1)
an epidural##8##2##(1993-10#3)(2007-2#2)(2008-5#1)(2011-2#1)(2012-3#1)
an episode of##16##3##(1992-9#1)(1994-3#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
an episode##17##2##(1992-9#1)(1994-3#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
an episomal##3##2##(1995-2#2)(2010-2#1)
an epistatic##2##2##(2008-10#1)(2010-5#1)
an epistemological##3##2##(2009-5#1)(2010-1#1)(2012-2#1)
an epithelial##4##2##(1993-12#1)(2007-12#1)(2008-10#1)(2009-9#1)
an epitope in##2##3##(1995-3#1)(1997-1#1)
an epitope##7##2##(1992-3#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2012-12#1)
an epoxy resin##2##3##(2008-10#1)(2008-5#1)
an epoxy##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
an equal amount of##3##4##(1996-2#1)(2007-11#1)(2008-2#1)
an equal number of##5##4##(1991-7#1)(1993-11#1)(2010-1#1)(2012-2#1)(2013-1#1)
an equal volume of saline##2##5##(1991-12#1)(2011-2#1)
an equal volume of##5##4##(1991-12#1)(1992-6#1)(1997-2#1)(2008-12#1)(2011-2#1)
an equal##20##2##(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-11#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
an equally##2##2##(2008-11#1)(2008-7#1)
an equation for##2##3##(2008-7#1)(2013-8#1)
an equation that##4##3##(2008-3#3)(2011-2#1)
an equation##7##2##(2008-10#1)(2008-3#3)(2008-7#1)(2011-2#1)(2013-8#1)
an equatorial##2##2##(1995-11#1)(2009-8#1)
an equilibrium between the##4##4##(1992-11#1)(2008-10#2)(2013-8#1)
an equilibrium between##6##3##(1992-11#1)(1992-3#1)(2008-10#3)(2013-8#1)
an equilibrium dialysis##2##3##(1993-12#1)(2008-11#1)
an equilibrium dissociation constant##2##4##(1994-5#1)(1997-2#1)
an equilibrium model for##2##4##(2008-12#1)(2008-4#1)
an equilibrium##22##2##(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2009-5#1)(2013-8#1)
an equimolar ratio of##2##4##(1990-8#1)(1994-5#1)
an equimolar##5##2##(1990-8#1)(1994-2#1)(1994-5#1)(1996-12#1)(2008-10#1)
an equitable##2##2##(2008-1#1)(2008-8#1)
an equivalence##2##2##(2008-10#1)(2008-3#1)
an equivalent amount of##3##4##(1991-2#1)(1992-6#1)(2008-10#1)
an equivalent increase##2##3##(1992-6#1)(2009-8#1)
an equivalent of##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
an equivalent##29##2##(1991-2#1)(1992-6#2)(1995-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#2)(2012-2#1)(2013-8#1)
an equivocal##2##2##(1997-8#1)(2008-7#1)
an era##13##2##(1993-12#1)(1995-2#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
an erbium fiber laser##2##4##(2007-12#2)
an erbium##4##2##(2007-12#2)(2008-3#2)
an erbium-doped fiber amplifier (EDFA)##2##5##(2008-2#2)
an erbium-doped fiber amplifier with##2##5##(2007-12#1)(2008-3#1)
an erbium-doped fiber amplifier##11##4##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#4)
an erbium-doped fiber laser##3##4##(2007-12#2)(2008-3#1)
an erbium-doped fiber##15##3##(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#5)
an erbium-doped##16##2##(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#6)
an ergometer##2##2##(2008-9#2)
an erratic##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
an error analysis##2##3##(2008-10#1)(2008-2#1)
an error in the##3##4##(2008-10#1)(2008-3#2)
an error of##6##3##(1993-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
an error signal##3##3##(2007-11#3)
an error##29##2##(1993-6#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#6)(2011-2#1)
an erythropoietin##2##2##(2008-4#1)(2008-8#1)
an escalating##3##2##(1990-11#1)(1992-8#1)(2008-5#1)
an esophageal##2##2##(2007-8#1)(2009-4#1)
an especially##2##2##(1992-6#1)(2008-11#1)
an essential component in the##4##5##(2008-5#1)(2010-1#1)(2012-1#1)(2013-8#1)
an essential component in##5##4##(1990-5#1)(2008-5#1)(2010-1#1)(2012-1#1)(2013-8#1)
an essential component of the##5##5##(1991-6#1)(1994-11#1)(1995-2#1)(1997-3#1)(2012-2#1)
an essential component of##21##4##(1991-6#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
an essential component##28##3##(1990-5#1)(1991-6#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
an essential element##5##3##(2008-10#3)(2012-12#1)(2012-2#1)
an essential gene in the##2##5##(2008-10#2)
an essential gene##4##3##(1993-12#1)(1996-6#1)(2008-10#2)
an essential nutrient for##2##4##(2008-10#1)(2008-5#1)
an essential nutrient##3##3##(2008-10#1)(2008-5#2)
an essential part of all radiation safety programs##2##8##(1994-12#1)(1995-1#1)
an essential part of the treatment of##2##7##(1992-1#1)(2008-1#1)
an essential part of the treatment##3##6##(1992-1#1)(2008-1#1)(2011-2#1)
an essential part of##12##4##(1992-1#1)(1994-12#1)(1995-1#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
an essential prerequisite for##2##4##(1994-6#1)(2011-1#1)
an essential prerequisite##5##3##(1994-6#1)(1995-12#1)(2007-8#1)(2011-1#1)(2013-7#1)
an essential requirement for##2##4##(1991-2#1)(2008-10#1)
an essential requirement##3##3##(1991-11#1)(1991-2#1)(2008-10#1)
an essential resource for##3##4##(1996-2#1)(2008-8#1)(2008-9#1)
an essential role for##2##4##(1994-12#1)(1996-2#1)
an essential role in the##8##5##(1990-5#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#2)
an essential role in##20##4##(1990-5#1)(1992-11#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
an essential role##27##3##(1990-5#1)(1992-11#1)(1992-3#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
an essential step##7##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
an essential tool for##3##4##(1996-1#1)(2008-4#1)(2008-9#1)
an essential tool##5##3##(1996-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)
an essential##165##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#3)(1993-6#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#4)(1995-5#1)(1995-6#4)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-3#3)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#6)
an essentially##3##2##(1992-9#1)(2008-10#1)(2009-7#1)
an established role##2##3##(2007-4#1)(2008-5#1)
an established treatment for end-stage##2##5##(2011-2#1)(2011-3#1)
an established treatment for##3##4##(1992-9#1)(2011-2#1)(2011-3#1)
an established treatment##4##3##(1992-9#1)(2011-2#2)(2011-3#1)
an established##46##2##(1991-1#1)(1992-9#3)(1994-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2010-6#1)(2011-2#8)(2011-3#2)(2013-1#1)(2013-8#1)
an ester##2##2##(1992-3#1)(1997-7#1)
an estimate of 1##2##4##(1991-5#1)(2013-1#1)
an estimate of developmental##2##4##(2008-8#2)
an estimate of the##15##4##(1992-1#1)(1996-3#1)(1997-3#3)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)
an estimate of##29##3##(1991-5#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-3#3)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
an estimate##32##2##(1990-5#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-12#1)(1996-3#2)(1997-3#3)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
an estimated 130##2##3##(1994-9#1)(2009-5#1)
an estimated 6##2##3##(1994-6#1)(2008-8#1)
an estimated##52##2##(1990-6#1)(1991-11#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#3)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-12#2)(2007-5#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#2)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
an estimation of the##2##4##(2008-10#1)(2008-3#1)
an estimation of##5##3##(2008-10#1)(2008-3#3)(2008-7#1)
an estimation##8##2##(2007-12#1)(2008-10#1)(2008-3#4)(2008-7#1)(2013-8#1)
an estimator designed##2##3##(2008-3#2)
an estimator of##2##3##(2008-10#1)(2010-3#1)
an estimator##4##2##(2008-10#1)(2008-3#2)(2010-3#1)
an estrogen receptor##4##3##(1991-2#1)(1993-3#1)(2008-6#1)(2013-1#1)
an estrogen##7##2##(1991-2#1)(1993-3#1)(1997-7#1)(2008-10#1)(2008-6#1)(2013-1#2)
an estrogenic##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
an etalon##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
an ethanolic##2##2##(2008-10#1)(2011-2#1)
an ether##2##2##(1994-8#1)(2008-10#1)
an ethical challenge##2##3##(2012-2#1)(2013-1#1)
an ethical problem##2##3##(1990-12#1)(2008-7#1)
an ethical##15##2##(1990-12#1)(1992-3#2)(1994-11#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
an ethnically diverse sample of##2##5##(2009-7#2)
an ethnically diverse sample##3##4##(2008-5#1)(2009-7#2)
an ethnically##4##2##(2008-1#1)(2008-5#1)(2009-7#2)
an ethnographic study of##2##4##(2008-9#1)(2009-5#1)
an ethnographic study##4##3##(1993-1#1)(2008-9#1)(2009-5#1)(2010-9#1)
an ethnographic##6##2##(1993-1#1)(2008-1#1)(2008-9#2)(2009-5#1)(2010-9#1)
an ethyl##2##2##(1995-3#1)(2008-10#1)
an ethylene##5##2##(2008-10#3)(2008-2#2)
an etiologic##3##2##(2007-5#1)(2011-2#1)(2012-1#1)
an etiological##4##2##(1992-5#1)(2007-11#1)(2008-3#1)(2012-12#1)
an etiology##4##2##(2007-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
an evacuee's##2##2##(2011-2#2)
an evaluation and##2##3##(2008-10#1)(2011-2#1)
an evaluation for##2##3##(2008-10#1)(2011-1#1)
an evaluation of a##3##4##(1992-2#1)(1993-2#1)(2008-9#1)
an evaluation of an##2##4##(2008-12#1)(2011-1#1)
an evaluation of the impact##2##5##(2008-11#1)(2008-3#1)
an evaluation of the##15##4##(1994-1#1)(1996-7#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-3#2)(2010-5#1)(2010-6#1)(2012-3#2)
an evaluation of##40##3##(1990-6#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-11#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#2)(2008-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-8#1)
an evaluation study##2##3##(1994-1#1)(2008-11#1)
an evaluation##60##2##(1990-6#2)(1990-9#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#1)(2008-9#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-8#1)
an evaluative##2##2##(1992-3#1)(1993-1#1)
an evanescent field##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
an evanescent##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
an evaporation##2##2##(2008-10#1)(2008-11#1)
an even better##3##3##(1995-6#1)(2008-1#1)(2008-2#1)
an even distribution of##3##4##(1990-11#1)(2008-10#1)(2008-5#1)
an even greater##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
an even higher##7##3##(1991-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
an even more##3##3##(2008-5#1)(2010-5#1)(2013-1#1)
an even##28##2##(1990-11#1)(1991-6#1)(1992-6#1)(1993-12#1)(1995-6#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
an event occurring##2##3##(2008-1#1)(2008-11#1)
an event##11##2##(1991-2#1)(1996-2#1)(1997-3#1)(1997-5#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)
an event-related##3##2##(1995-12#1)(2008-11#1)(2012-1#1)
an eventual##2##2##(2008-10#1)(2012-12#1)
an ever more##2##3##(1994-1#1)(2011-1#1)
an ever##5##2##(1993-5#1)(1994-1#1)(2008-5#1)(2011-1#1)(2011-2#1)
an ever-expanding##3##2##(1994-2#1)(1996-1#1)(2011-2#1)
an ever-increasing##2##2##(1997-2#1)(2008-12#1)
an everyday##2##2##(2007-10#1)(2008-7#1)
an evidence##4##2##(2008-10#3)(2011-10#1)
an evidence-based review##2##3##(2011-2#2)
an evidence-based##14##2##(1993-12#1)(2008-12#1)(2008-6#2)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-7#1)(2013-1#3)
an evident improvement in##2##4##(1990-2#1)(2008-2#1)
an evident##8##2##(1990-2#1)(1992-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
an evolution##2##2##(1994-3#1)(1997-6#1)
an evolutionarily conserved##4##3##(1995-6#1)(1997-1#1)(1997-7#1)(2008-7#1)
an evolutionarily##8##2##(1995-6#1)(1997-1#1)(1997-7#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)
an evolutionary dead end##2##4##(2008-9#1)(2010-5#1)
an evolutionary framework##3##3##(2008-8#1)(2009-6#1)(2010-3#1)
an evolutionary model##2##3##(1997-4#1)(2008-8#1)
an evolutionary perspective##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
an evolutionary##23##2##(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#3)
an evolving##5##2##(1991-12#1)(1996-6#1)(2008-8#1)(2010-5#1)(2011-7#1)
an ex vivo##3##3##(2008-5#2)(2012-2#1)
an exact diagnosis of##2##4##(1995-5#1)(2011-2#1)
an exact ray trace##3##4##(2008-2#1)(2008-3#2)
an exact replica of the##2##5##(2008-3#2)
an exact solution##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
an exact##31##2##(1990-11#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#12)(2008-5#1)(2011-2#1)(2012-3#1)
an exaggerated##6##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
an exaggeration##2##2##(1990-11#1)(2012-2#1)
an examination of the##5##4##(1991-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
an examination of their##2##4##(1996-12#1)(1996-3#1)
an examination of##15##3##(1991-12#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
an examination##18##2##(1991-12#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#3)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
an example from the##2##4##(1992-12#1)(1995-9#1)
an example from##4##3##(1992-12#1)(1995-9#1)(2008-7#1)(2008-8#1)
an example in##2##3##(2008-2#1)(2009-8#1)
an example of a##8##4##(1990-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)
an example of an##2##4##(2007-9#1)(2008-11#1)
an example of application##2##4##(2008-2#1)(2008-7#1)
an example of how a##3##5##(1993-3#1)(1995-6#1)(2008-7#1)
an example of how##6##4##(1993-3#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
an example of its use##2##5##(1993-3#1)(2008-11#1)
an example of the general##2##5##(1993-9#1)(1994-2#1)
an example of the##15##4##(1992-11#1)(1993-9#1)(1994-2#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2009-8#1)(2010-12#1)
an example of this##2##4##(1995-1#1)(1996-12#1)
an example of##56##3##(1990-8#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-1#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)
an example that##2##3##(2008-3#1)(2010-11#1)
an example to##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#2)
an example using##3##3##(1996-3#1)(2008-11#1)(2013-7#1)
an example##142##2##(1990-8#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-6#2)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-11#4)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#4)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#2)
an exceedingly##2##2##(2008-11#1)(2011-2#1)
an excellent Nernstian##2##3##(2008-10#2)
an excellent alternative to the##2##5##(2008-10#1)(2012-2#1)
an excellent alternative##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
an excellent catalytic activity##2##4##(2008-10#2)
an excellent correlation between##4##4##(1992-2#1)(1995-2#1)(2008-10#1)(2008-5#1)
an excellent correlation##9##3##(1990-12#1)(1992-2#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-5#1)
an excellent discrimination##2##3##(2007-11#1)(2008-10#1)
an excellent electrocatalytic activity##2##4##(2008-10#2)
an excellent example of how##2##5##(1993-12#1)(2013-1#1)
an excellent example of##3##4##(1993-12#1)(2008-9#1)(2013-1#1)
an excellent example##4##3##(1993-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
an excellent fit##2##3##(2008-11#1)(2008-2#1)
an excellent linear##3##3##(1996-2#1)(2008-10#2)
an excellent method for##2##4##(2008-10#1)(2008-4#1)
an excellent method##5##3##(2008-1#2)(2008-10#2)(2008-4#1)
an excellent model system##2##4##(1995-3#1)(1997-3#1)
an excellent model##3##3##(1995-3#1)(1997-3#1)(2008-7#1)
an excellent opportunity##2##3##(1996-3#1)(2009-9#1)
an excellent outcome##2##3##(2012-12#1)(2013-1#1)
an excellent prognosis##2##3##(1997-1#1)(2006-10#1)
an excellent response##2##3##(2007-7#2)
an excellent safety profile##2##4##(2008-10#1)(2008-2#1)
an excellent sorbent##2##3##(2008-10#2)
an excellent starting##2##3##(2008-7#1)(2008-9#1)
an excellent target for##2##4##(2008-5#1)(2009-4#1)
an excellent tool for##5##4##(1997-6#1)(2008-1#1)(2008-10#2)(2008-2#1)
an excellent way to##2##4##(1991-2#1)(2008-12#1)
an excellent way##4##3##(1991-2#1)(1992-3#1)(2008-12#1)(2013-1#1)
an excellent##147##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#40)(2008-11#1)(2008-12#4)(2008-2#8)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#11)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)
an exception to the##2##4##(1995-12#1)(1997-8#1)
an exception to this##2##4##(2010-8#1)(2012-3#1)
an exception to##4##3##(1995-12#1)(1997-8#1)(2010-8#1)(2012-3#1)
an exception##7##2##(1995-12#1)(1997-8#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-3#1)
an exceptional case of##3##4##(1997-8#1)(2008-9#1)(2013-1#1)
an exceptional##11##2##(1991-12#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#3)
an exceptionally##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)
an excess of the##4##4##(1992-8#1)(2008-10#2)(2012-2#1)
an excess of unlabeled##2##4##(1991-12#1)(1993-9#1)
an excess of##28##3##(1990-12#1)(1991-12#2)(1992-8#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-11#1)(2012-2#1)
an excess##31##2##(1990-12#1)(1991-12#2)(1992-8#1)(1993-8#1)(1993-9#2)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2012-2#1)
an excessive##5##2##(1991-12#1)(1997-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
an exchange of##2##3##(1996-5#1)(2007-6#1)
an exchange##6##2##(1991-6#1)(1995-11#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-6#1)
an excimer laser##2##3##(2008-2#1)(2008-3#1)
an excised##4##2##(2007-8#1)(2008-10#3)
an excision##2##2##(2009-3#1)(2013-1#1)
an excisional##3##2##(1991-1#1)(1994-12#1)(2012-12#1)
an excitation wavelength at##2##4##(2008-10#1)(2008-2#1)
an excitation wavelength of##7##4##(1997-2#1)(2008-10#6)
an excitation wavelength##9##3##(1997-2#1)(2008-10#7)(2008-2#1)
an excitation##14##2##(1997-2#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)
an exciting new##2##3##(2008-4#1)(2008-9#1)
an exciting##12##2##(1992-9#1)(1995-12#1)(1996-2#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
an exclusive##5##2##(1990-2#1)(1995-3#1)(2008-10#1)(2008-7#1)(2011-3#1)
an exclusively##4##2##(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
an execution##2##2##(2008-12#1)(2008-3#1)
an executive##4##2##(1996-5#1)(2008-1#1)(2008-4#1)(2010-3#1)
an exemplary##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
an exemption##2##2##(1995-2#1)(1996-1#1)
an exercise program##2##3##(2007-6#1)(2008-11#1)
an exercise##5##2##(1995-11#1)(2007-6#2)(2008-11#1)(2010-4#1)
an exhaustive##5##2##(1994-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-10#1)
an existing method##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
an existing##18##2##(1994-12#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
an exo-beta-1##6##2##(1992-11#2)(2008-10#4)
an exogenous substrate##2##3##(1991-2#1)(2008-5#1)
an exogenous##11##2##(1991-2#1)(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
an exotic nuisance##2##3##(2007-2#2)
an exotic##5##2##(2007-2#3)(2008-10#1)(2011-2#1)
an expanded latissimus dorsi musculocutaneus##2##5##(2011-2#2)
an expanded##18##2##(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-12#1)(2011-2#4)(2013-1#2)
an expanding##8##2##(2007-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
an expansion of the##2##4##(1997-4#1)(2013-1#1)
an expansion of##3##3##(1997-4#1)(2010-5#1)(2013-1#1)
an expansion##5##2##(1997-4#1)(2007-12#1)(2009-1#1)(2010-5#1)(2013-1#1)
an expansive##3##2##(2008-7#1)(2013-1#2)
an expectation##2##2##(2008-11#1)(2008-12#1)
an expected##9##2##(1994-2#1)(1995-6#1)(1995-9#1)(2008-1#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-12#2)
an experience of##2##3##(2008-12#1)(2013-1#1)
an experience##6##2##(2008-12#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
an experienced##13##2##(1991-12#1)(1991-3#1)(1996-3#1)(1997-6#1)(2008-11#3)(2008-7#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
an experiential##3##2##(2008-11#1)(2008-4#1)(2012-1#1)
an experiment in which##3##4##(2007-11#2)(2008-2#1)
an experiment in##6##3##(1994-6#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
an experiment that##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2012-2#1)
an experiment to##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
an experiment using##2##3##(2008-3#2)
an experiment with##3##3##(1994-8#1)(2008-11#1)(2008-3#1)
an experiment##33##2##(1994-11#1)(1994-6#1)(1994-8#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#9)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-7#1)(2013-7#1)
an experimental Parkinsonian animal model##3##5##(2008-10#3)
an experimental analysis of##2##4##(2008-7#1)(2012-2#1)
an experimental analysis##3##3##(2008-2#1)(2008-7#1)(2012-2#1)
an experimental and a control group##2##6##(2008-12#1)(2010-12#1)
an experimental animal##3##3##(1996-3#1)(2008-1#1)(2012-2#1)
an experimental approach to##2##4##(1991-6#1)(2008-10#1)
an experimental approach##3##3##(1991-6#1)(2008-10#1)(2009-7#1)
an experimental demonstration of##3##4##(2007-11#1)(2007-12#2)
an experimental demonstration##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
an experimental design##8##3##(1996-2#1)(2008-10#5)(2008-11#1)(2008-5#1)
an experimental group##5##3##(1993-12#1)(1994-3#1)(2007-11#1)(2008-12#1)(2010-6#1)
an experimental investigation of the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
an experimental investigation of##5##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
an experimental method##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
an experimental model##8##3##(1992-8#1)(1992-9#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
an experimental observation of##2##4##(2007-11#1)(2007-12#1)
an experimental research]##3##3##(2013-8#3)
an experimental setup##3##3##(2008-3#3)
an experimental study in##2##4##(2008-9#1)(2012-3#1)
an experimental study of the##6##5##(2007-12#3)(2008-2#2)(2008-3#1)
an experimental study of##8##4##(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#2)(2008-3#1)
an experimental study##15##3##(1992-9#1)(1993-3#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-3#1)
an experimental system for##2##4##(1993-2#1)(1996-2#1)
an experimental system##7##3##(1993-2#1)(1994-2#1)(1996-2#1)(2008-3#3)(2008-8#1)
an experimental test of##2##4##(2007-10#1)(2008-9#1)
an experimental test##3##3##(2007-10#1)(2008-11#1)(2008-9#1)
an experimental trial##2##3##(1997-8#1)(2008-3#1)
an experimental validation##2##3##(2008-3#1)(2009-11#1)
an experimental verification of##2##4##(2007-11#1)(2008-3#1)
an experimental verification##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
an experimental##128##2##(1991-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#11)(2007-12#8)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#3)(2008-2#9)(2008-3#17)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
an experimentally determined##2##3##(1994-12#1)(2008-4#1)
an experimentally induced##2##3##(1993-3#1)(2010-8#1)
an experimentally##8##2##(1993-3#1)(1994-12#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-8#1)(2012-2#1)
an experimenter##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
an expert in##4##3##(1994-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
an expert meeting##2##3##(1990-2#1)(1992-3#1)
an expert system##2##3##(1990-7#1)(2008-10#1)
an expert##19##2##(1990-2#1)(1990-7#1)(1991-9#1)(1992-3#1)(1994-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-10#2)(2010-8#2)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
an explanation for the##8##4##(1992-8#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
an explanation for##14##3##(1992-8#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
an explanation of the##3##4##(2008-3#1)(2008-4#1)(2009-12#1)
an explanation of##6##3##(1995-11#1)(1996-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-2#1)
an explanation##24##2##(1992-8#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
an explanatory##4##2##(1997-7#1)(2008-2#1)(2008-8#1)(2009-12#1)
an explicit##7##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)(2013-1#1)
an exploration of the##2##4##(1993-1#1)(2008-12#1)
an exploration of##6##3##(1993-1#1)(2008-11#2)(2008-12#2)(2011-1#1)
an exploration##7##2##(1993-1#1)(1996-2#1)(2008-11#2)(2008-12#2)(2011-1#1)
an explorative study##2##3##(2011-2#1)(2013-1#1)
an exploratory framework for##2##4##(2012-3#2)
an exploratory study of##2##4##(1995-3#1)(2009-5#1)
an exploratory study##8##3##(1995-3#1)(2008-6#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#2)
an exploratory survey##2##3##(1993-2#1)(1993-3#1)
an exploratory##26##2##(1991-8#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#2)(2010-10#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
an explosion of##3##3##(2006-10#1)(2008-11#1)(2008-5#1)
an explosive##4##2##(2008-1#1)(2008-10#3)
an exponent of -0##2##4##(2008-7#2)
an exponential decrease##3##3##(1995-2#1)(2008-11#1)(2008-3#1)
an exponential function##2##3##(2008-10#1)(2008-2#1)
an exponential increase in the##2##5##(2009-6#1)(2012-2#1)
an exponential increase##4##3##(1995-9#1)(2009-6#1)(2012-2#2)
an exponential model##2##3##(2008-10#1)(2013-8#1)
an exponential##19##2##(1994-2#1)(1995-2#2)(1995-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2009-6#1)(2012-2#3)(2013-8#1)
an exponentially##2##2##(2008-1#1)(2008-3#1)
an exposed##4##2##(1990-11#1)(1994-11#1)(1995-6#1)(2008-9#1)
an exposure time of##2##4##(2008-3#2)
an exposure to##3##3##(2009-12#1)(2013-1#1)(2013-8#1)
an exposure##9##2##(1995-2#1)(2007-12#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
an expressed gene##2##3##(1995-9#1)(1997-8#1)
an expressed##8##2##(1990-12#2)(1992-2#1)(1995-9#1)(1997-8#1)(2007-7#1)(2008-7#1)(2012-3#1)
an expression for the##3##4##(2008-10#1)(2008-3#2)
an expression for##4##3##(2008-10#1)(2008-3#3)
an expression of the##3##4##(2008-10#2)(2008-4#1)
an expression of##5##3##(2007-7#1)(2008-10#3)(2008-4#1)
an expression plasmid containing##2##4##(1992-12#1)(1994-11#1)
an expression vector##7##3##(1991-2#1)(1991-9#1)(1993-8#1)(1997-2#1)(1997-8#1)(2008-8#1)(2010-5#1)
an expression##24##2##(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-11#2)(1997-2#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#2)(2008-8#1)(2010-12#1)(2010-5#1)
an extended experimental##2##3##(2008-2#1)(2008-3#1)
an extended period of time##3##5##(1997-2#1)(2008-10#1)(2009-11#1)
an extended period of##5##4##(1997-2#1)(2007-12#1)(2008-10#1)(2009-11#1)(2011-2#1)
an extended period##8##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#2)
an extended spectrum##2##3##(2008-11#1)(2008-3#1)
an extended version of##2##4##(2008-2#1)(2008-9#1)
an extended##52##2##(1991-2#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-2#4)(2012-2#1)
an extended-cavity diode laser##2##4##(2007-12#2)
an extension of a##4##4##(2007-11#1)(2008-10#2)(2009-5#1)
an extension of our previous work##2##6##(1997-2#1)(2008-10#1)
an extension of our previous##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
an extension of the##20##4##(1992-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#2)(2010-5#1)
an extension of##39##3##(1991-11#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#2)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
an extension##47##2##(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#2)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#2)(2008-6#2)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#2)
an extensive collection of##2##4##(2008-10#2)
an extensive literature review##2##4##(2007-4#1)(2008-12#1)
an extensive literature##3##3##(2007-4#1)(2008-12#1)(2010-9#1)
an extensive range of##2##4##(1990-8#1)(2012-2#1)
an extensive review of the literature##2##6##(1995-1#1)(1996-12#1)
an extensive survey##2##3##(2008-10#2)
an extensive##43##2##(1990-2#1)(1990-8#1)(1992-4#1)(1992-6#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#6)(2009-3#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
an extent that##4##3##(1990-11#2)(1994-6#1)(2008-10#1)
an extent##10##2##(1990-11#2)(1990-9#1)(1992-2#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)
an exterior##2##2##(1995-2#1)(2007-12#1)
an external cavity to##2##4##(2007-11#1)(2007-12#1)
an external cavity##8##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
an external magnetic field##4##4##(2008-3#3)(2008-7#1)
an external medium##2##3##(2008-3#1)(2008-7#1)
an external resonant cavity##3##4##(2007-11#1)(2007-12#2)
an external stimulus##2##3##(2007-12#1)(2008-10#1)
an external##60##2##(1990-9#1)(1991-11#1)(1992-1#2)(1993-12#1)(1994-12#1)(1996-3#1)(1997-2#1)(2007-11#6)(2007-12#10)(2008-10#6)(2008-2#6)(2008-3#12)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
an external-cavity configuration##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
an external-cavity diode laser##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
an external-cavity laser diode##2##4##(2008-3#2)
an external-cavity laser##3##3##(2007-11#1)(2008-3#2)
an external-cavity semiconductor laser##2##4##(2007-12#1)(2008-3#1)
an external-cavity semiconductor##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
an external-cavity##17##2##(2007-11#4)(2007-12#5)(2008-2#2)(2008-3#6)
an externally##6##2##(2007-11#2)(2007-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
an extinction ratio of##2##4##(2008-2#1)(2008-3#1)
an extinction##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
an extinguished delay CS##2##4##(2008-5#2)
an extinguished trace CS##2##4##(2008-5#2)
an extinguished##4##2##(2008-5#4)
an extra##18##2##(1990-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)(2013-1#1)(2013-8#1)
an extracellular##14##2##(1991-5#1)(1993-12#1)(1994-2#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)
an extrachromosomal##2##2##(1995-2#2)
an extracorporeal##2##2##(1990-8#1)(2008-11#1)
an extract from the##2##4##(1990-2#1)(2008-10#1)
an extract from##6##3##(1990-2#2)(1993-2#1)(2008-10#2)(2008-5#1)
an extract of the##2##4##(1997-4#1)(2008-10#1)
an extract of##8##3##(1990-6#1)(1992-5#1)(1992-8#1)(1993-6#1)(1997-4#1)(2008-10#3)
an extract##17##2##(1990-2#2)(1990-6#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-5#1)
an extracted##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
an extraction chromatographic##2##3##(2008-10#2)
an extraction medium##2##3##(2008-10#2)
an extraction##18##2##(1990-5#2)(1991-8#1)(2008-10#15)
an extraordinarily##4##2##(1990-8#1)(1992-3#1)(2008-10#1)(2010-5#1)
an extraordinary challenge##2##3##(1997-3#1)(2008-4#1)
an extraordinary##4##2##(1990-10#1)(1993-6#1)(1997-3#1)(2008-4#1)
an extreme of##2##3##(2008-2#1)(2012-3#1)
an extreme##16##2##(1992-11#1)(1992-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-1#1)(2010-3#2)(2011-2#2)(2012-3#2)(2013-1#1)
an extreme-ultraviolet (EUV)##2##3##(2007-11#1)(2008-3#1)
an extreme-ultraviolet##8##2##(2007-11#2)(2008-2#2)(2008-3#4)
an extremely high##5##3##(1990-6#1)(1994-8#1)(2008-10#2)(2008-3#1)
an extremely important##3##3##(1992-2#1)(2008-9#1)(2011-1#1)
an extremely large number of##2##5##(1994-2#1)(2008-3#1)
an extremely large##6##3##(1992-8#1)(1994-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
an extremely low##2##3##(1994-8#1)(2008-11#1)
an extremely potent##2##3##(1995-2#1)(2008-8#1)
an extremely rapid##2##3##(1995-2#1)(2011-1#1)
an extremely rare case of a##2##6##(2008-10#1)(2013-1#1)
an extremely rare case of##3##5##(2008-10#1)(2013-1#2)
an extremely rare##23##3##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#3)(2008-7#1)(2010-11#1)(2011-1#1)(2012-12#2)(2013-1#5)
an extremely short##3##3##(2008-2#1)(2011-2#2)
an extremely valuable resource##2##4##(2008-11#1)(2012-2#1)
an extremely variable##2##3##(2008-9#1)(2011-2#1)
an extremely weak##2##3##(1995-5#1)(2007-11#1)
an extremely##79##2##(1990-6#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-2#3)(1995-5#1)(1996-6#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#5)
an extrinsic##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
an eye on##3##3##(1994-2#1)(2008-11#1)(2008-12#1)
an eye##11##2##(1993-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
an eye-safe##2##2##(2008-3#2)
an eye-tracker##2##2##(2009-2#2)
an eye-tracking##2##2##(2013-1#2)
an eyelid##2##2##(1992-12#1)(2010-8#1)
an f/5##2##2##(2007-12#2)
an fMRI##3##2##(2008-11#2)(2009-2#1)
an herbal##4##2##(1994-6#1)(2008-10#2)(2011-2#1)
an heterologous##2##2##(1994-11#1)(2008-5#1)
an historical overview of##3##4##(2008-4#1)(2009-10#1)(2010-1#1)
an historical##7##2##(1994-5#1)(1995-3#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-1#2)
an homogeneous##4##2##(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
an hospital##2##2##(2008-10#1)(2008-11#1)
an hour after##2##3##(1997-3#1)(2008-7#1)
an hour##8##2##(1992-12#1)(1997-3#1)(2008-10#3)(2008-7#1)(2010-12#1)(2012-12#1)
an hybrid##2##2##(2007-8#1)(2008-6#1)
an i##10##2##(1991-12#2)(1994-2#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(2008-12#1)
an iatrogenic complication##3##3##(1993-1#1)(1996-3#1)(2008-9#1)
an iatrogenic##8##2##(1991-6#1)(1993-1#1)(1996-3#2)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#1)
an ice storm##2##3##(2008-2#1)(2008-9#1)
an ice##6##2##(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)
an idea about##2##3##(2008-10#1)(2008-5#1)
an idea of##2##3##(2008-4#1)(2013-1#1)
an idea##9##2##(1991-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
an ideal Gaussian##2##3##(2007-12#1)(2008-3#1)
an ideal candidate##3##3##(1991-9#1)(2009-2#1)(2012-2#1)
an ideal carrier##2##3##(1995-5#1)(2011-2#1)
an ideal framework##2##3##(1996-1#1)(2008-7#1)
an ideal model##2##3##(1996-3#1)(2008-8#1)
an ideal setting##2##3##(1994-12#1)(2008-12#1)
an ideal system##2##3##(2009-2#1)(2013-1#1)
an ideal tool##2##3##(2008-10#1)(2012-2#1)
an ideal##59##2##(1991-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
an idealized##3##2##(2008-3#2)(2008-9#1)
an ideally##2##2##(2008-8#1)(2009-4#1)
an identical##31##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-3#1)(1993-8#2)(1994-9#2)(1995-6#2)(1995-8#1)(1996-5#2)(1997-2#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#1)
an identifiable##2##2##(2008-4#1)(2008-6#1)
an identification##3##2##(1995-6#1)(1997-4#1)(2008-11#1)
an identified##3##2##(1990-7#1)(2008-6#1)(2008-8#1)
an identity##5##2##(1991-6#1)(2007-11#2)(2008-10#1)(2012-12#1)
an idiopathic##4##2##(2008-10#1)(2008-7#1)(2010-6#1)(2011-1#1)
an idiosyncratic reaction##2##3##(2008-10#1)(2013-8#1)
an idler output##2##3##(2007-11#2)
an idler##4##2##(2007-11#2)(2008-3#2)
an ileostomy##2##2##(2009-5#2)
an iliac##3##2##(1990-3#1)(2008-11#1)(2012-3#1)
an ill##3##2##(1991-11#1)(2008-11#1)(2009-7#1)
an ill-posed problem##2##3##(2008-11#1)(2008-3#1)
an ill-posed##3##2##(1997-2#1)(2008-11#1)(2008-3#1)
an illness that##2##3##(2007-10#1)(2009-10#1)
an illness##5##2##(1994-9#1)(2007-10#1)(2009-10#1)(2010-10#1)(2011-2#1)
an illuminated##5##2##(2008-2#3)(2008-3#2)
an illustration of the##5##4##(1990-5#1)(2008-11#1)(2008-3#2)(2012-2#1)
an illustration of##6##3##(1990-5#1)(2008-11#1)(2008-3#3)(2012-2#1)
an illustration##9##2##(1990-5#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2012-2#1)(2012-3#1)
an illustrative case##2##3##(2006-10#1)(2009-3#1)
an illustrative example of##2##4##(2008-10#1)(2011-2#1)
an illustrative example##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
an illustrative##6##2##(2006-10#1)(2008-10#2)(2009-3#1)(2011-2#1)(2013-1#1)
an image and##2##3##(2007-12#1)(2008-9#1)
an image intensifier##2##3##(2008-3#1)(2008-9#1)
an image matrix of##2##4##(2011-1#2)
an image of a##2##4##(2007-12#1)(2008-3#1)
an image of an##2##4##(2008-2#1)(2009-6#1)
an image of the##4##4##(2008-2#3)(2008-4#1)
an image of##10##3##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)
an image sensor##3##3##(2008-3#2)(2011-1#1)
an image sequence##2##3##(2008-11#1)(2012-2#1)
an image that##2##3##(2008-2#1)(2008-3#1)
an image with##2##3##(2008-3#1)(2011-1#1)
an image##57##2##(1991-1#1)(1991-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#15)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#4)(2009-6#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
an image-plane hologram##2##3##(2008-3#2)
an image-processing##2##2##(2008-10#1)(2008-3#1)
an imaginary##3##2##(1995-1#1)(2008-7#1)(2009-10#1)
an imaging detector##2##3##(2008-2#1)(2008-3#1)
an imaging spectrograph##2##3##(2007-12#1)(2008-10#1)
an imaging spectrometer##2##3##(2007-12#1)(2013-8#1)
an imaging system that##2##4##(2007-11#1)(2008-3#1)
an imaging system##4##3##(2007-11#2)(2008-3#2)
an imaging technique that##2##4##(2007-12#1)(2010-9#1)
an imaging technique##4##3##(2007-12#1)(2008-3#1)(2010-12#1)(2010-9#1)
an imaging##31##2##(1992-12#1)(1993-2#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#8)(2008-7#2)(2009-9#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-8#1)
an imbalance between##10##3##(1993-2#1)(1995-2#2)(2008-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
an imbalance in the##2##4##(1991-2#1)(1997-7#1)
an imbalance##13##2##(1991-2#1)(1993-2#1)(1995-2#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
an imidazole##2##2##(1994-5#1)(2011-2#1)
an iminodiacetate##2##2##(2008-10#2)
an immature##2##2##(2008-11#1)(2008-5#1)
an immediate increase##2##3##(1991-12#1)(1992-6#1)
an immediate##23##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#2)(2013-8#1)
an immense##3##2##(2007-12#1)(2008-1#1)(2012-2#1)
an immobilized cell##2##3##(1995-3#1)(2008-10#1)
an immobilized##14##2##(1990-12#2)(1990-5#1)(1995-3#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-7#1)
an immune response to the##3##5##(1994-11#2)(2008-11#1)
an immune response to##4##4##(1994-11#2)(2007-5#1)(2008-11#1)
an immune response##8##3##(1994-11#2)(2007-5#1)(2008-10#3)(2008-11#1)(2009-5#1)
an immune##19##2##(1994-11#2)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2009-5#1)(2012-12#3)(2012-2#1)(2013-1#2)
an immunization##2##2##(1992-5#1)(1993-2#1)
an immunoRNase##2##2##(2009-2#2)
an immunoaffinity column##5##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-4#1)
an immunoaffinity##6##2##(1992-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
an immunoassay##6##2##(1991-12#1)(1992-11#1)(2008-10#3)(2008-7#1)
an immunocapture##2##2##(2008-10#2)
an immunocompetent adult##2##3##(2010-8#2)
an immunocompetent patient who##2##4##(2009-4#1)(2011-2#1)
an immunocompetent patient##6##3##(1996-6#1)(2008-10#1)(2009-4#2)(2011-2#1)(2013-1#1)
an immunocompetent##11##2##(1996-3#1)(1996-6#1)(2008-10#1)(2008-8#1)(2009-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
an immunogenic##2##2##(1996-12#1)(2008-10#1)
an immunoglobulin##4##2##(1990-12#1)(2008-10#1)(2008-4#2)
an immunogold##2##2##(1997-3#1)(2008-10#1)
an immunohistochemical study##6##3##(1992-2#1)(1993-9#1)(1994-6#1)(1995-12#1)(2008-12#1)(2012-3#1)
an immunohistochemical##10##2##(1992-2#1)(1992-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-7#2)(2008-12#1)(2012-3#1)
an immunoinhibitory##2##2##(2008-4#1)(2012-3#1)
an immunologic##4##2##(1990-10#1)(1991-12#1)(1991-2#1)(2008-4#1)
an immunological basis##2##3##(1991-2#1)(1995-3#1)
an immunological response##2##3##(1994-3#1)(2008-10#1)
an immunological##8##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1994-3#1)(1995-3#1)(2008-10#1)
an immunologically privileged##2##3##(2009-10#2)
an immunologically##4##2##(2008-5#1)(2009-10#3)
an immunomagnetic##3##2##(2008-10#1)(2010-3#2)
an immunophilin##2##2##(1992-11#1)(1993-8#1)
an immunoreaction##2##2##(2008-10#2)
an immunoreactor##2##2##(2008-10#2)
an immunosensor##2##2##(2008-10#2)
an immunosuppressive effect##2##3##(1994-2#1)(2008-10#1)
an immunosuppressive##5##2##(1990-5#1)(1990-9#1)(1994-2#1)(1994-3#1)(2008-10#1)
an impact on the patient's##2##5##(2007-8#1)(2008-10#1)
an impact on the##15##4##(1991-3#1)(1992-3#1)(1995-2#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-7#1)(2012-2#2)(2013-1#1)
an impact on##32##3##(1991-3#1)(1991-7#1)(1992-3#1)(1992-8#1)(1994-2#1)(1995-2#1)(1996-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-2#4)(2013-1#2)
an impact##36##2##(1990-11#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-8#1)(1994-2#1)(1995-2#1)(1996-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#2)
an impaired ability to##2##4##(2008-4#1)(2009-12#1)
an impaired##7##2##(1996-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)
an impairment in the##4##4##(2008-3#2)(2009-10#1)(2012-2#1)
an impairment in##8##3##(1992-11#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-10#1)(2012-2#1)
an impairment of##5##3##(1996-5#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-11#1)
an impairment##13##2##(1992-11#1)(1994-3#1)(1996-5#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2009-10#1)(2012-2#1)
an impending##3##2##(2007-11#1)(2008-1#1)(2008-4#1)
an imperative##2##2##(1993-3#1)(2012-3#1)
an imperfect##6##2##(1993-12#1)(1995-8#1)(1996-8#1)(2007-12#1)(2008-3#1)(2012-3#1)
an impermeable##4##2##(1992-11#1)(1993-11#1)(1997-1#1)(2009-8#1)
an implant##6##2##(2008-11#1)(2008-9#3)(2013-1#2)
an implantable##3##2##(2007-7#1)(2008-12#1)(2011-1#1)
an implanted##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
an implementation of the##2##4##(2007-12#1)(2008-10#1)
an implementation of##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
an implementation##5##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)
an implicit##2##2##(2009-5#1)(2012-3#1)
an important addition to the##3##5##(2008-11#1)(2008-9#1)(2010-9#1)
an important advance in##2##4##(2008-9#2)
an important analytical##3##3##(2008-10#2)(2008-9#1)
an important and##11##3##(1993-1#1)(1997-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-8#2)
an important aspect in##2##4##(2008-5#1)(2010-11#1)
an important aspect of the##2##5##(1991-11#1)(1997-4#1)
an important aspect of##11##4##(1991-11#1)(1992-11#1)(1994-11#1)(1997-4#1)(2007-9#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#1)
an important aspect##15##3##(1991-11#1)(1992-11#1)(1994-11#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
an important biological##3##3##(1995-12#1)(2008-7#1)(2010-10#1)
an important but##4##3##(1995-3#1)(2008-9#1)(2009-6#1)(2011-1#1)
an important candidate##2##3##(1997-5#1)(2008-6#1)
an important cause of morbidity and mortality##5##7##(2007-2#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
an important cause of##27##4##(1992-4#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
an important challenge in##3##4##(1994-12#1)(1997-2#1)(2012-12#1)
an important challenge##5##3##(1994-12#1)(1997-2#1)(2008-5#1)(2010-6#1)(2012-12#1)
an important character##2##3##(2007-12#1)(2013-7#1)
an important class of##3##4##(2008-1#1)(2008-10#1)(2012-12#1)
an important clinical##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
an important component in the##3##5##(2008-4#2)(2008-5#1)
an important component in##4##4##(2008-4#2)(2008-5#1)(2009-9#1)
an important component of a##2##5##(2008-7#1)(2008-8#1)
an important component of the##7##5##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
an important component of##15##4##(1993-3#1)(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
an important component##21##3##(1992-5#1)(1993-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)
an important concern##4##3##(1992-8#1)(1994-3#1)(1995-3#1)(2013-8#1)
an important consideration in##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
an important consideration##6##3##(1993-1#1)(1994-11#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
an important contribution##3##3##(1995-2#1)(2008-9#1)(2010-7#1)
an important control##2##3##(2008-10#1)(2013-8#1)
an important coping##2##3##(2008-12#1)(2012-12#1)
an important cytokine##2##3##(1994-6#1)(2008-9#1)
an important degree of##2##4##(1991-9#1)(2008-10#1)
an important determinant of the##6##5##(1990-2#1)(1992-2#1)(1993-3#1)(1996-3#1)(1997-8#1)(2008-10#1)
an important determinant of##18##4##(1990-12#1)(1990-2#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
an important determinant##19##3##(1990-12#1)(1990-2#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
an important diagnostic role##2##4##(2007-12#1)(2011-2#1)
an important differential diagnosis##2##4##(1992-5#1)(2012-12#1)
an important disease of##7##4##(2008-10#7)
an important disease##10##3##(2008-10#9)(2008-11#1)
an important effect on##2##4##(1996-3#1)(2008-12#1)
an important element for the##2##5##(1990-5#1)(2008-10#1)
an important element in the##3##5##(1996-12#1)(2012-3#1)(2013-1#1)
an important element in##5##4##(1992-2#1)(1996-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
an important element of the##2##5##(2008-5#1)(2012-2#1)
an important element of##3##4##(2008-4#1)(2008-5#1)(2012-2#1)
an important element##10##3##(1990-5#1)(1992-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
an important factor for##5##4##(1992-10#1)(2008-5#1)(2008-6#1)(2011-3#1)(2013-7#1)
an important factor in determining the##3##6##(2008-2#1)(2008-3#1)(2008-5#1)
an important factor in determining##4##5##(2007-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
an important factor in explaining##2##5##(2008-8#1)(2012-12#1)
an important factor in the##7##5##(1993-9#1)(1996-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-2#1)
an important factor in##22##4##(1993-9#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
an important factor to##2##4##(2008-10#1)(2008-11#1)
an important factor##41##3##(1991-12#1)(1992-10#1)(1993-9#1)(1994-7#1)(1995-2#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
an important feature of the##4##5##(1992-4#1)(2008-9#1)(2009-4#1)(2013-1#1)
an important feature of##7##4##(1992-4#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
an important feature##9##3##(1992-4#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
an important first step##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
an important focus in##2##4##(1992-2#1)(1996-1#1)
an important focus##3##3##(1992-2#1)(1996-1#1)(2009-12#1)
an important food##2##3##(2008-5#1)(2010-10#1)
an important function in##2##4##(2008-12#1)(2012-2#1)
an important function##4##3##(1995-6#1)(2008-12#1)(2012-2#2)
an important goal##2##3##(2007-12#1)(2012-2#1)
an important human##3##3##(1992-2#1)(2008-7#1)(2008-9#1)
an important impact##5##3##(2008-1#1)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
an important indicator of##2##4##(1990-9#1)(2009-5#1)
an important influence on the##3##5##(1996-4#1)(2008-10#1)(2008-5#1)
an important influence on##4##4##(1990-12#1)(1996-4#1)(2008-10#1)(2008-5#1)
an important issue in##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
an important issue##10##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#2)
an important link between##2##4##(2008-1#1)(2013-8#1)
an important link##4##3##(1990-7#1)(2008-1#1)(2008-5#1)(2013-8#1)
an important means of##5##4##(1992-2#1)(1993-1#1)(2008-10#2)(2011-1#1)
an important means##6##3##(1992-2#1)(1993-1#1)(2008-10#2)(2010-11#1)(2011-1#1)
an important mechanism for##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
an important mechanism of resistance##2##5##(2008-10#2)
an important mechanism of##8##4##(2008-10#4)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
an important mechanism##14##3##(1993-2#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
an important mediator of##3##4##(1994-11#2)(2008-6#1)
an important mediator##5##3##(1994-11#2)(2008-10#1)(2008-6#1)(2010-9#1)
an important model##3##3##(2008-4#1)(2008-6#1)(2008-7#1)
an important modulator of##2##4##(2009-8#1)(2010-11#1)
an important new##2##3##(1994-11#1)(2011-1#1)
an important outcome##3##3##(1991-11#1)(2010-5#1)(2011-2#1)
an important parameter for##2##4##(2008-10#1)(2008-9#1)
an important parameter##5##3##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)
an important part in##6##4##(1991-9#1)(1993-9#1)(1995-5#2)(1996-3#1)(2012-12#1)
an important part of the care##2##6##(1993-12#1)(2008-7#1)
an important part of the##10##5##(1990-6#1)(1993-12#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
an important part of##23##4##(1990-6#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#1)
an important part##30##3##(1990-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-5#2)(1996-3#2)(1996-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)
an important pathogen##3##3##(2006-10#1)(2008-10#2)
an important pathological##2##3##(2008-5#1)(2010-10#1)
an important percentage##2##3##(2008-1#1)(2012-12#1)
an important pest##2##3##(2008-6#1)(2011-2#1)
an important physiological##2##3##(2008-6#1)(2008-7#1)
an important place in##2##4##(1992-5#1)(2008-11#1)
an important post-translational##2##3##(1993-3#1)(2009-7#1)
an important prerequisite##2##3##(2008-10#1)(2008-8#1)
an important problem in##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
an important process##4##3##(1995-3#1)(2008-10#1)(2010-4#1)(2012-1#1)
an important prognostic##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
an important proportion of the##2##5##(2008-5#1)(2011-2#1)
an important proportion of##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
an important public health problem in##2##6##(2007-12#1)(2012-2#1)
an important public health problem##4##5##(2007-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
an important public health##6##4##(1991-6#1)(2007-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
an important question in##2##4##(2008-11#1)(2008-8#1)
an important question##3##3##(2008-11#2)(2008-8#1)
an important reason for##2##4##(2008-5#1)(2012-2#1)
an important recent##2##3##(1992-2#1)(2008-5#1)
an important reduction in##2##4##(1993-8#1)(2012-2#1)
an important reduction##3##3##(1990-3#1)(1993-8#1)(2012-2#1)
an important regulator of##4##4##(1995-2#1)(1997-4#1)(2008-4#1)(2008-8#1)
an important regulatory mechanism##2##4##(1992-8#1)(1996-12#1)
an important regulatory##4##3##(1990-8#1)(1991-5#1)(1992-8#1)(1996-12#1)
an important resource for##3##4##(2007-5#2)(2008-7#1)
an important risk factor for##3##5##(2012-1#1)(2012-12#1)(2012-3#1)
an important risk factor##6##4##(2006-10#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
an important role and##2##4##(1994-12#1)(2008-8#1)
an important role as##3##4##(1991-9#1)(2008-3#1)(2008-4#1)
an important role during##4##4##(1991-9#1)(2008-5#1)(2008-8#1)(2008-9#1)
an important role for the##4##5##(1991-8#1)(1995-2#1)(1997-6#1)(2012-2#1)
an important role for these##2##5##(1996-5#1)(2012-3#1)
an important role for##17##4##(1990-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-2#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)(2012-3#1)
an important role in both##2##5##(2011-2#2)
an important role in cell growth##2##6##(2011-2#2)
an important role in cell##3##5##(2008-9#1)(2011-2#2)
an important role in controlling##4##5##(1997-1#1)(2008-10#1)(2008-9#1)(2009-11#1)
an important role in its##4##5##(2007-5#1)(2008-10#1)(2008-8#2)
an important role in mediating##4##5##(1990-12#1)(1995-12#1)(2008-4#1)(2008-9#1)
an important role in pain##3##5##(1996-12#1)(2008-4#1)(2008-8#1)
an important role in protection against##2##6##(2009-6#1)(2013-7#1)
an important role in regulating##6##5##(1991-12#1)(1991-3#1)(1994-11#1)(2008-11#1)(2008-4#1)(2008-8#1)
an important role in regulation of##2##6##(2008-1#1)(2010-11#1)
an important role in structuring##2##5##(2008-8#1)(2010-8#1)
an important role in the development and##2##7##(2008-11#1)(2009-5#1)
an important role in the development of the##2##8##(1993-3#1)(2008-3#1)
an important role in the development of##9##7##(1993-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
an important role in the development##11##6##(1993-3#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
an important role in the etiology of##2##7##(1990-8#1)(2009-11#1)
an important role in the extraction process##2##7##(2008-10#2)
an important role in the function of##2##7##(1991-12#1)(1997-2#1)
an important role in the maintenance##2##6##(2008-5#1)(2008-7#1)
an important role in the occurrence of##2##7##(1990-8#1)(2012-2#1)
an important role in the overall##2##6##(2012-3#1)(2013-1#1)
an important role in the pathogenesis of##4##7##(2008-2#1)(2011-2#1)(2012-12#1)(2013-3#1)
an important role in the pathogenesis##5##6##(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-3#1)
an important role in the pathophysiology of##4##7##(2008-7#1)(2009-8#1)(2013-1#2)
an important role in the recovery of##2##7##(2008-11#1)(2008-6#1)
an important role in the regulation of##9##7##(1991-5#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-2#1)(2008-8#2)(2012-2#1)(2012-3#1)
an important role in the##124##5##(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#5)(2013-3#1)(2013-7#2)(2013-8#1)
an important role in this##6##5##(1992-3#1)(1993-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)
an important role in tumor##4##5##(1994-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
an important role in tumorigenesis##2##5##(2008-7#1)(2008-9#1)
an important role in##292##4##(1990-12#2)(1990-2#1)(1990-8#2)(1990-9#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#23)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#9)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#18)(2008-9#11)(2009-10#2)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#7)(2011-2#20)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#10)(2013-3#1)(2013-7#4)(2013-8#2)
an important role of##2##4##(1995-12#1)(2009-11#1)
an important role to play##4##5##(1992-3#1)(1993-12#1)(2008-11#1)(2012-12#1)
an important role to##5##4##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
an important role##343##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-8#2)(1990-9#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#3)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#3)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#28)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#11)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#20)(2008-9#12)(2009-10#2)(2009-11#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#6)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#7)(2011-2#21)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#8)(2012-7#1)(2013-1#11)(2013-3#1)(2013-7#4)(2013-8#3)
an important secondary##2##3##(1991-8#1)(2008-7#1)
an important selective force##2##4##(2008-8#1)(2012-12#1)
an important selective##3##3##(2008-8#1)(2009-8#1)(2012-12#1)
an important signaling event in the##2##6##(1992-8#1)(2011-1#1)
an important site##2##3##(2012-2#1)(2013-8#1)
an important source of##3##4##(2008-10#2)(2008-3#1)
an important source##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
an important step in the##4##5##(1997-2#1)(2008-5#1)(2009-7#1)(2009-8#1)
an important step in##8##4##(1994-9#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-11#1)
an important step toward##2##4##(2008-11#1)(2012-2#1)
an important step towards##2##4##(2008-10#1)(2011-1#1)
an important step##16##3##(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
an important structural role in##2##5##(1995-6#1)(2008-10#1)
an important structural role##3##4##(1995-6#1)(2008-10#1)(2009-8#1)
an important structural##6##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-8#1)
an important subject##2##3##(2008-11#1)(2008-9#1)
an important target for##5##4##(1995-2#1)(1997-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
an important target##6##3##(1995-2#1)(1997-4#1)(2008-5#1)(2012-2#2)(2013-8#1)
an important task in##3##4##(2008-2#1)(2008-4#1)(2010-2#1)
an important task##6##3##(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-2#1)
an important technique##3##3##(2008-5#1)(2009-11#1)(2009-5#1)
an important technology for##2##4##(1995-2#1)(2008-7#1)
an important therapeutic##4##3##(2007-11#1)(2009-3#1)(2011-2#1)(2013-8#1)
an important tool for the##4##5##(1997-4#1)(2008-2#1)(2008-9#1)(2009-4#1)
an important tool for##16##4##(1996-3#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
an important tool in the##7##5##(1992-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-3#1)(2013-8#1)
an important tool in##10##4##(1992-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-8#1)
an important tool to##2##4##(2008-11#1)(2010-4#1)
an important tool##31##3##(1992-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
an important topic##3##3##(2008-10#1)(2008-12#1)(2009-9#1)
an important variable to##2##4##(2008-10#2)
an important way##3##3##(1993-1#1)(2007-12#1)(2008-10#1)
an important##1068##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-11#2)(1991-12#7)(1991-3#1)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#7)(1992-3#5)(1992-4#2)(1992-5#4)(1992-8#6)(1992-9#2)(1993-1#5)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#8)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#10)(1994-12#6)(1994-2#7)(1994-3#2)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#10)(1995-2#11)(1995-3#4)(1995-5#3)(1995-6#7)(1995-8#4)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#9)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#4)(1997-9#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#14)(2007-2#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#16)(2008-10#115)(2008-11#39)(2008-12#10)(2008-2#9)(2008-3#31)(2008-4#25)(2008-5#38)(2008-6#14)(2008-7#36)(2008-8#52)(2008-9#44)(2009-10#5)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#5)(2009-6#5)(2009-7#8)(2009-8#9)(2009-9#4)(2010-1#4)(2010-10#7)(2010-11#16)(2010-12#11)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#7)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#15)(2011-2#55)(2011-3#6)(2011-7#3)(2012-1#4)(2012-12#20)(2012-2#29)(2012-3#22)(2012-7#1)(2013-1#29)(2013-3#2)(2013-7#10)(2013-8#21)
an imposed##3##2##(1996-2#2)(2008-8#1)
an impoverished##5##2##(1992-8#1)(2007-2#2)(2011-2#2)
an imprecision##2##2##(2008-10#2)
an impression of##2##3##(2008-11#1)(2013-1#1)
an impression##3##2##(2008-11#2)(2013-1#1)
an impressive##3##2##(1992-1#1)(2008-5#1)(2010-11#1)
an imprint##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
an improved design of##2##4##(2008-3#1)(2013-8#1)
an improved detection limit of##2##5##(2008-10#2)
an improved method to##2##4##(1990-12#1)(2008-5#1)
an improved method##3##3##(1990-12#1)(2008-5#1)(2012-3#1)
an improved methodology##2##3##(1992-8#1)(2008-10#1)
an improved precision##2##3##(1994-9#1)(2008-10#1)
an improved procedure to##2##4##(1990-12#1)(2008-11#1)
an improved procedure##4##3##(1990-12#1)(1991-8#1)(1992-6#1)(2008-11#1)
an improved surface##2##3##(2008-2#1)(2008-3#1)
an improved therapeutic##3##3##(1996-9#1)(2008-5#1)(2008-7#1)
an improved understanding##2##3##(1992-8#1)(2013-1#1)
an improved##83##2##(1990-12#2)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#17)(2008-11#3)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
an improvement in overall##2##4##(1991-2#1)(2008-6#1)
an improvement in quality of life##2##6##(2008-4#1)(2008-7#1)
an improvement in the##15##4##(1992-9#1)(1994-2#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
an improvement in##43##3##(1991-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#3)
an improvement of the##7##4##(2007-10#1)(2008-10#5)(2012-12#1)
an improvement of##18##3##(1990-3#1)(1995-5#1)(1997-6#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
an improvement over the##2##4##(1994-9#1)(2008-3#1)
an improvement over##3##3##(1994-9#1)(2008-2#1)(2008-3#1)
an improvement##72##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-6#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2010-4#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#3)
an impurity##5##2##(2007-11#2)(2008-10#2)(2008-11#1)
an in depth##2##3##(2008-11#1)(2008-5#1)
an in silico##2##3##(2009-8#1)(2012-2#1)
an in situ##16##3##(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#6)(2013-1#1)
an in vitro assay for##2##5##(1992-9#1)(1994-12#1)
an in vitro assay##4##4##(1992-9#1)(1993-11#1)(1994-12#1)(2013-1#1)
an in vitro efficacy##2##4##(2008-5#2)
an in vitro experiment##2##4##(1994-11#1)(1994-6#1)
an in vitro fertilization##2##4##(2012-3#1)(2013-1#1)
an in vitro immunization##3##4##(2008-11#3)
an in vitro model of vitamin D synthesis##2##8##(2008-10#2)
an in vitro model of##3##5##(2008-10#2)(2008-5#1)
an in vitro model system##2##5##(2008-11#2)
an in vitro model##9##4##(1992-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#3)
an in vitro skin equivalent model##2##6##(2008-5#2)
an in vitro study##5##4##(1992-8#1)(1993-12#1)(2011-2#1)(2013-1#2)
an in vitro system to##4##5##(1994-6#1)(1996-2#1)(2008-11#1)(2013-8#1)
an in vitro system using##2##5##(1993-3#1)(1996-12#1)
an in vitro system##14##4##(1990-2#1)(1990-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#2)(1996-2#1)(2008-11#2)(2013-8#1)
an in vitro##79##3##(1990-12#2)(1990-2#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#12)(2008-12#3)(2008-4#1)(2008-5#10)(2008-7#1)(2009-11#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
an in vivo assay##5##4##(1990-5#1)(1991-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
an in vivo method##2##4##(1991-12#1)(2008-5#1)
an in vivo system##2##4##(1995-2#1)(1996-12#1)
an in vivo##32##3##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-9#1)(1992-7#1)(1994-11#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#6)(2008-7#2)(2009-12#3)(2009-6#1)(2011-1#1)(2013-1#2)
an in##133##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-8#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#14)(2008-12#4)(2008-3#6)(2008-4#1)(2008-5#17)(2008-7#3)(2009-11#1)(2009-12#3)(2009-6#1)(2009-7#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#1)
an in-depth analysis of##2##4##(2007-11#1)(2008-1#1)
an in-depth interview##2##3##(1995-6#1)(2009-4#1)
an in-depth##11##2##(1991-1#1)(1991-3#1)(1994-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-4#1)(2010-5#1)(2012-2#1)
an in-frame stop codon##3##4##(1990-11#1)(1992-11#1)(1993-11#1)
an in-frame##7##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-11#1)(1997-4#1)
an in-hospital support group for employee victims of violence##2##9##(1991-12#2)
an in-hospital##3##2##(1991-12#2)(2008-3#1)
an in-house##3##2##(1993-12#1)(1997-2#1)(2012-12#1)
an in-line##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
an in-process##2##2##(2008-10#1)(2008-2#1)
an in-vitro##2##2##(2009-11#1)(2011-3#1)
an in-vivo##2##2##(2008-9#1)(2010-6#1)
an inability to##4##3##(1994-12#2)(1994-3#1)(2009-3#1)
an inactivated vaccine##2##3##(2008-5#2)
an inactivated##3##2##(2008-5#3)
an inactive form##2##3##(1997-2#1)(2008-5#1)
an inactive odor##2##3##(2008-10#2)
an inactive##20##2##(1990-2#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-12#4)(1993-8#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
an inadequate resection##2##3##(2008-9#1)(2009-12#1)
an inadequate##10##2##(1992-12#1)(1994-9#1)(2008-4#2)(2008-9#1)(2009-12#1)(2012-12#2)(2013-1#2)
an inappropriate##6##2##(1990-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#1)
an inborn error##2##3##(1992-9#1)(2013-8#1)
an inbred##2##2##(2008-10#1)(2012-3#1)
an incentive for##2##3##(1992-1#1)(2012-12#1)
an incentive to##3##3##(1992-12#1)(1993-3#1)(1994-3#1)
an incentive##5##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-3#1)(2012-12#1)
an incidence angle##4##3##(2008-2#1)(2008-3#3)
an incidence of 1##2##4##(1990-6#1)(1995-12#1)
an incidence of##18##3##(1990-6#1)(1991-11#1)(1993-9#2)(1995-12#1)(1997-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#2)
an incidence##28##2##(1990-6#1)(1991-11#1)(1992-8#1)(1993-9#2)(1995-12#1)(1997-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
an incident pump power of##3##5##(2007-12#1)(2008-2#2)
an incident wavelength of##2##4##(2008-2#1)(2008-3#1)
an incident##15##2##(1993-12#1)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#6)(2013-1#1)
an incidental finding during##3##4##(1992-9#1)(1993-5#1)(2008-12#1)
an incidental finding in##2##4##(1995-11#1)(2007-8#1)
an incidental finding##9##3##(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
an incidental renocolic fistula was##2##5##(2013-1#2)
an incidental##16##2##(1991-3#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
an incised disc and##2##4##(2009-4#2)
an incision##3##2##(2011-2#1)(2012-12#2)
an inclined##3##2##(1993-12#1)(2008-3#2)
an inclusion complex##2##3##(2008-10#2)
an inclusion##6##2##(2008-10#2)(2008-3#4)
an inclusive##2##2##(2008-6#1)(2010-8#1)
an incoherent##9##2##(2007-11#3)(2008-2#1)(2008-3#5)
an incoherently##3##2##(2007-11#1)(2008-3#2)
an incoming##3##2##(2007-11#2)(2008-3#1)
an incompatible##2##2##(1997-6#1)(2008-10#1)
an incomplete palmar arch##2##4##(2008-9#2)
an incomplete##13##2##(1991-5#1)(1992-12#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2012-12#1)(2012-3#1)
an incompletely##3##2##(1993-11#1)(2008-10#1)(2008-7#1)
an inconsistency##2##2##(1996-9#1)(2008-11#1)
an inconsistent##2##2##(2008-2#1)(2013-1#1)
an incorrect##4##2##(2008-11#1)(2008-2#1)(2010-10#1)(2011-2#1)
an increase and##3##3##(1994-6#1)(1996-9#1)(2012-2#1)
an increase at##2##3##(2010-2#1)(2010-5#1)
an increase from##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
an increase in FN##2##4##(2012-2#2)
an increase in [Ca2+]i##2##4##(1992-6#1)(1994-9#1)
an increase in [Mg2+]i##2##4##(1993-11#1)(1994-6#1)
an increase in blood flow##2##5##(1990-7#1)(1996-3#1)
an increase in blood##5##4##(1990-7#1)(1991-5#1)(1996-3#1)(2008-10#1)(2011-2#1)
an increase in bone##2##4##(1993-11#1)(2008-8#1)
an increase in both##4##4##(1990-7#2)(1993-8#1)(2009-11#1)
an increase in cAMP##2##4##(1993-3#1)(1995-12#1)
an increase in cell##5##4##(1995-11#1)(1996-12#1)(2008-11#1)(2009-7#1)(2013-8#1)
an increase in child##2##4##(2008-10#1)(2008-11#1)
an increase in cortical##2##4##(1995-12#1)(1996-5#1)
an increase in cytosolic Ca2+##2##5##(1992-4#1)(1994-6#1)
an increase in cytosolic##3##4##(1992-4#1)(1994-6#1)(2008-7#1)
an increase in hemoglobin was##2##5##(1994-9#1)(2008-7#1)
an increase in intracellular##4##4##(1991-5#1)(1993-12#1)(1995-11#1)(2008-11#1)
an increase in its##4##4##(1990-10#1)(1990-11#1)(1997-1#1)(2008-11#1)
an increase in locomotor activity##2##5##(1996-12#1)(2008-10#1)
an increase in mRNA##2##4##(1993-5#1)(2008-11#1)
an increase in mean##2##4##(1993-12#1)(2007-8#1)
an increase in mucosal##2##4##(1993-11#2)
an increase in patient##2##4##(1992-1#1)(2011-1#1)
an increase in plasma##3##4##(1994-11#1)(2008-6#1)(2010-8#1)
an increase in power##2##4##(2007-11#1)(2008-3#1)
an increase in sensitivity of##2##5##(1990-5#1)(2008-2#1)
an increase in sensitivity##4##4##(1990-5#1)(1991-6#1)(2008-10#1)(2008-2#1)
an increase in serum##5##4##(1996-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-6#1)
an increase in spontaneous##2##4##(1990-5#1)(1995-12#1)
an increase in stability##2##4##(1995-2#1)(2008-5#1)
an increase in temperature##3##4##(1997-2#2)(2008-3#1)
an increase in the Vmax##2##5##(1990-2#1)(1990-5#1)
an increase in the activity of##3##6##(1994-5#1)(2008-11#2)
an increase in the activity##4##5##(1994-5#1)(2008-11#2)(2008-7#1)
an increase in the amount of the##2##7##(1992-3#1)(1992-6#1)
an increase in the amount of##8##6##(1992-3#1)(1992-6#2)(1994-6#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)
an increase in the average##2##5##(2008-2#1)(2013-8#1)
an increase in the fluorescence##2##5##(2008-10#2)
an increase in the incidence of##2##6##(2008-9#1)(2013-7#1)
an increase in the levels of##3##6##(1992-12#1)(2008-10#1)(2008-5#1)
an increase in the maximum##3##5##(2007-8#1)(2008-8#2)
an increase in the number and##3##6##(1991-6#1)(1997-2#1)(2010-12#1)
an increase in the number of##11##6##(1995-6#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
an increase in the number##15##5##(1991-6#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-6#1)(2008-10#3)(2008-2#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
an increase in the percentage of##4##6##(1992-8#1)(2011-2#3)
an increase in the probability##3##5##(2008-9#1)(2011-2#2)
an increase in the range of##2##6##(2007-12#1)(2008-8#1)
an increase in the ratio of##3##6##(2008-6#1)(2011-1#1)(2012-1#1)
an increase in the ratio##4##5##(1993-2#1)(2008-6#1)(2011-1#1)(2012-1#1)
an increase in the risk##2##5##(2006-10#1)(2011-2#1)
an increase in the sensitivity of the##2##7##(2008-10#1)(2008-3#1)
an increase in the total##3##5##(1994-9#1)(2008-1#2)
an increase in the##148##4##(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#3)(2010-12#1)(2010-4#2)(2010-6#2)(2010-8#3)(2011-1#6)(2011-2#12)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
an increase in their##3##4##(1990-7#1)(2008-3#1)(2013-8#1)
an increase in total##3##4##(1992-11#1)(2008-5#1)(2008-9#1)
an increase in##430##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#4)(1990-5#6)(1990-6#1)(1990-7#5)(1991-12#3)(1991-2#3)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#2)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#4)(1994-5#4)(1994-6#7)(1994-8#1)(1994-9#4)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#4)(1995-6#3)(1995-8#1)(1996-12#7)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-6#1)(1997-7#5)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-8#5)(2008-1#4)(2008-10#48)(2008-11#23)(2008-12#7)(2008-2#5)(2008-3#17)(2008-4#4)(2008-5#15)(2008-6#6)(2008-7#11)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#10)(2011-2#19)(2011-3#1)(2012-1#1)(2012-2#11)(2012-3#4)(2012-9#2)(2013-1#7)(2013-7#1)(2013-8#8)
an increase of a factor of##2##6##(2008-2#1)(2008-3#1)
an increase of the order in the##2##7##(2008-10#2)
an increase of the##25##4##(1991-12#1)(1991-4#1)(1993-8#1)(1994-3#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-10#1)(2009-11#1)
an increase of##91##3##(1990-2#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#5)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
an increase to##3##3##(1994-2#1)(2008-11#1)(2008-5#1)
an increase##550##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#5)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#5)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#2)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#4)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#9)(1994-5#4)(1994-6#8)(1994-8#2)(1994-9#5)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#5)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#7)(1997-6#1)(1997-7#5)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-8#7)(2008-1#6)(2008-10#57)(2008-11#34)(2008-12#11)(2008-2#7)(2008-3#24)(2008-4#4)(2008-5#24)(2008-6#7)(2008-7#14)(2008-8#16)(2008-9#11)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#5)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#10)(2011-10#1)(2011-2#20)(2011-3#1)(2012-1#1)(2012-2#15)(2012-3#4)(2012-5#1)(2012-9#2)(2013-1#11)(2013-7#2)(2013-8#10)
an increased activity of##2##4##(1996-4#1)(2008-7#1)
an increased affinity for##2##4##(1991-12#1)(1995-6#1)
an increased amount of##4##4##(2008-10#3)(2008-7#1)
an increased appreciation of##2##4##(2012-12#1)(2013-1#1)
an increased awareness of the##3##5##(1991-3#1)(2007-12#1)(2008-7#1)
an increased capacity of##2##4##(1996-5#1)(2008-9#1)
an increased capacity##3##3##(1996-5#1)(2008-7#1)(2008-9#1)
an increased contribution##2##3##(2008-10#1)(2011-2#1)
an increased emphasis on the use of##2##7##(2008-7#1)(2010-8#1)
an increased expression of##2##4##(1997-2#1)(2008-11#1)
an increased frequency of##3##4##(1991-3#1)(1997-3#1)(2008-4#1)
an increased half-life##2##3##(2009-2#1)(2011-1#1)
an increased incidence of##9##4##(1994-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
an increased level of##3##4##(1992-1#1)(2008-7#1)(2013-1#1)
an increased likelihood of##7##4##(1995-2#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
an increased metabolic rate##2##4##(2008-7#2)
an increased molecular weight##2##4##(1992-9#1)(2008-11#1)
an increased need to##3##4##(1996-9#1)(2008-7#2)
an increased need##4##3##(1996-9#1)(2008-7#2)(2010-8#1)
an increased number of##6##4##(1990-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
an increased number##7##3##(1990-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-8#1)
an increased prevalence of##4##4##(2008-1#1)(2008-2#1)(2008-7#1)(2012-5#1)
an increased production of##3##4##(2008-7#1)(2008-9#1)(2009-5#1)
an increased proportion of##3##4##(1994-3#1)(2008-11#1)(2008-9#1)
an increased rate of##8##4##(1990-2#1)(1990-5#1)(1990-8#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#1)(2012-12#1)
an increased rate##9##3##(1990-2#1)(1990-5#1)(1990-8#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#2)(2012-12#1)
an increased risk for cardiovascular##2##5##(2008-3#1)(2012-2#1)
an increased risk for development of##2##6##(2008-3#1)(2008-7#1)
an increased risk for##18##4##(1996-11#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
an increased risk of breast cancer##2##6##(1990-8#1)(1993-11#1)
an increased risk of developing##3##5##(1990-12#1)(2007-5#1)(2012-2#1)
an increased risk of stroke##2##5##(2007-10#1)(2011-2#1)
an increased risk of##44##4##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
an increased risk to##3##4##(2008-4#1)(2009-7#1)(2013-1#1)
an increased risk##67##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1996-11#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#2)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)
an increased sensitivity of##3##4##(1992-11#1)(1992-8#1)(1997-7#1)
an increased sensitivity##4##3##(1992-11#1)(1992-8#1)(1997-7#1)(2008-2#1)
an increased specific##2##3##(1995-5#1)(2008-11#1)
an increased susceptibility##2##3##(2007-2#1)(2008-5#1)
an increased understanding and##2##4##(1994-5#1)(1996-1#1)
an increased understanding##3##3##(1994-5#1)(1996-1#1)(2009-11#1)
an increased##269##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#2)(1991-12#4)(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#3)(2008-1#6)(2008-10#15)(2008-11#17)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#24)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#15)(2011-3#1)(2012-12#7)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#1)
an increasing cause##2##3##(1997-5#1)(2011-2#1)
an increasing demand##2##3##(2008-5#1)(2008-8#1)
an increasing interest in the##2##5##(2008-10#1)(2013-8#1)
an increasing interest in##4##4##(2008-10#2)(2012-12#1)(2013-8#1)
an increasing interest##5##3##(2008-10#3)(2012-12#1)(2013-8#1)
an increasing need for##3##4##(2008-10#1)(2010-12#1)(2011-1#1)
an increasing number of patients##3##5##(1992-3#1)(1994-5#1)(2011-2#1)
an increasing number of##17##4##(1991-6#1)(1992-3#1)(1993-3#2)(1994-5#1)(1995-3#1)(1997-4#1)(2006-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)
an increasing population##2##3##(1991-3#1)(2008-11#1)
an increasing problem in##2##4##(2008-10#1)(2008-5#1)
an increasing problem##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
an increasing proportion of the##3##5##(1997-1#1)(2008-10#1)(2008-9#1)
an increasing proportion of##4##4##(1990-3#1)(1997-1#1)(2008-10#1)(2008-9#1)
an increasing role in the##2##5##(2008-8#1)(2012-3#1)
an increasing role of##3##4##(2006-5#1)(2009-5#1)(2011-2#1)
an increasing role##7##3##(2006-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#2)
an increasing share of##5##4##(1991-2#1)(1992-3#1)(1993-11#1)(1996-2#1)(1997-1#1)
an increasing trend##6##3##(1993-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-6#1)
an increasing##96##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-3#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-4#2)(1997-5#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#3)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
an increasingly common##3##3##(2012-2#1)(2013-1#2)
an increasingly competitive environment##2##4##(1994-12#1)(1996-1#1)
an increasingly competitive##5##3##(1994-12#2)(1994-2#1)(1996-1#1)(2008-10#1)
an increasingly important role in##3##5##(2010-12#1)(2011-2#1)(2011-7#1)
an increasingly important##12##3##(1991-1#1)(1992-2#1)(1994-2#1)(2006-6#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
an increasingly popular##6##3##(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
an increasingly recognized cause of##2##5##(2008-7#1)(2011-1#1)
an increasingly##46##2##(1991-1#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#2)(1994-2#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#2)(2013-1#4)
an increment of##6##3##(1990-8#1)(1993-9#2)(2008-10#1)(2008-5#2)
an incremental cycling test to exhaustion##2##6##(2011-2#2)
an incremental increase in##2##4##(1992-3#1)(2008-8#1)
an incremental##8##2##(1992-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
an incubation temperature##3##3##(2008-10#2)(2013-1#1)
an incubation##5##2##(1994-12#1)(2008-10#3)(2013-1#1)
an incubator##8##2##(2008-10#1)(2008-11#4)(2008-5#2)(2010-6#1)
an indefinite##2##2##(2008-12#1)(2008-4#1)
an independent and##2##3##(1994-7#1)(1995-4#1)
an independent cohort##2##3##(2007-10#1)(2011-2#1)
an independent contractor##2##3##(1993-1#1)(2013-7#1)
an independent factor##2##3##(2012-2#1)(2012-3#1)
an independent method##2##3##(1995-5#1)(2008-10#1)
an independent prognostic##2##3##(1993-11#1)(2011-2#1)
an independent risk factor for developing##2##6##(1992-9#1)(2008-6#1)
an independent risk factor for##11##5##(1992-9#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
an independent risk factor##14##4##(1992-9#1)(1994-12#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#2)
an independent risk##16##3##(1992-9#1)(1994-12#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#2)
an independent scientific field##2##4##(1994-12#2)
an independent scientific##3##3##(1994-12#2)(2013-1#1)
an independent set of##3##4##(2008-10#2)(2012-3#1)
an independent variable##2##3##(2008-11#1)(2008-7#1)
an independent##90##2##(1990-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1994-12#6)(1994-3#2)(1994-5#1)(1994-7#2)(1994-8#1)(1995-4#2)(1995-5#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)
an index for##6##3##(1990-2#1)(1990-6#1)(1993-12#1)(2008-11#2)(2012-7#1)
an index of refraction##3##4##(2008-2#1)(2008-3#2)
an index of##32##3##(1990-6#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#3)(1995-12#3)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)
an index##53##2##(1990-2#1)(1990-6#2)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#3)(1994-5#1)(1995-12#3)(1995-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#2)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)
an indication for resection##2##4##(2013-1#2)
an indication for##6##3##(1990-2#1)(1995-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
an indication of the##7##4##(1990-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2013-1#1)
an indication of##22##3##(1990-5#1)(1994-7#1)(1995-2#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-5#1)(2009-8#1)(2010-9#2)(2013-1#1)(2013-8#1)
an indication that##4##3##(2008-10#2)(2008-11#1)(2010-3#1)
an indication##33##2##(1990-2#1)(1990-5#1)(1994-7#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-9#2)(2011-2#1)(2013-1#3)(2013-8#2)
an indicator electrode for potentiometric##2##5##(2008-10#2)
an indicator electrode for##3##4##(2008-10#3)
an indicator electrode##21##3##(2008-10#21)
an indicator for the##3##4##(2008-11#2)(2008-7#1)
an indicator for##10##3##(1994-5#1)(1995-2#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)
an indicator of a##2##4##(2008-10#2)
an indicator of both##2##4##(1991-11#1)(2008-10#1)
an indicator of the##7##4##(2008-10#4)(2008-5#1)(2012-12#1)(2013-7#1)
an indicator of##38##3##(1990-3#1)(1991-11#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#13)(2008-3#3)(2008-5#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-7#1)
an indicator##82##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1992-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-11#1)(1996-12#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#41)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
an indigenous##3##2##(2007-7#1)(2008-10#2)
an indirect ELISA##2##3##(1994-8#1)(2008-11#1)
an indirect competitive immunoassay##2##4##(2008-10#2)
an indirect competitive##4##3##(2008-10#4)
an indirect consequence of##3##4##(1997-3#1)(2008-8#2)
an indirect effect##2##3##(1994-8#1)(2011-2#1)
an indirect method of##2##4##(1993-11#1)(1993-3#1)
an indirect test##2##3##(1997-1#1)(2008-2#1)
an indirect##40##2##(1991-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-5#1)(2011-2#1)(2012-1#1)
an indispensable element in##2##4##(1994-2#1)(2006-10#1)
an indispensable##10##2##(1991-5#2)(1994-2#1)(2006-10#1)(2008-10#2)(2009-11#1)(2010-1#1)(2011-2#1)(2012-3#1)
an individual cell##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
an individual has##2##3##(1996-3#1)(2008-11#1)
an individual host##2##3##(2008-10#1)(2010-2#1)
an individual patient##6##3##(1992-8#1)(2008-2#1)(2008-4#1)(2009-9#1)(2012-1#1)(2013-8#1)
an individual plant##2##3##(2008-10#1)(2009-8#1)
an individual to the##2##4##(2008-7#1)(2013-8#1)
an individual to##5##3##(1995-6#1)(2007-2#1)(2008-12#1)(2008-7#1)(2013-8#1)
an individual tree##2##3##(2008-10#2)
an individual with the##2##4##(2007-12#1)(2011-1#1)
an individual with##11##3##(1994-12#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-4#1)(2009-10#1)(2009-2#1)(2011-1#3)(2013-1#1)
an individual##95##2##(1990-9#2)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#4)(1996-3#1)(1997-2#1)(2007-12#3)(2007-2#3)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#3)
an individual's genetic##3##3##(2008-3#1)(2008-4#1)(2012-3#1)
an individual's response to##3##4##(1996-12#1)(1997-1#1)(2008-5#1)
an individual's##28##2##(1990-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
an individual-based model##2##3##(2008-8#1)(2008-9#1)
an individual-based##7##2##(2008-8#3)(2008-9#2)(2011-1#1)(2011-2#1)
an individualised##2##2##(2011-3#2)
an individualized##4##2##(2007-7#1)(2008-11#1)(2010-12#1)(2010-3#1)
an individually##2##2##(1990-3#1)(1990-8#1)
an indolent##5##2##(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
an indoor##2##2##(2008-10#1)(2008-3#1)
an induced##4##2##(2008-10#2)(2008-9#1)(2009-12#1)
an inducer of##2##3##(1990-11#1)(2008-10#1)
an inducible##9##2##(1990-11#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)
an induction of##5##3##(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
an induction##7##2##(1995-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
an inductive##3##2##(2007-8#1)(2008-11#1)(2010-10#1)
an inductively coupled plasma##7##4##(2007-12#1)(2008-10#5)(2008-3#1)
an inductively coupled##9##3##(2007-12#1)(2008-10#7)(2008-3#1)
an industrial furnace##2##3##(2008-2#2)
an industrial scale##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
an industrial##18##2##(1995-3#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2013-1#1)
an industry##2##2##(1994-12#1)(1995-2#1)
an indwelling catheter##3##3##(1990-3#2)(1993-2#1)
an indwelling##5##2##(1990-3#2)(1993-2#1)(1997-2#1)(2008-11#1)
an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma##2##11##(1992-12#2)
an ineffective##3##2##(1992-12#2)(2008-10#1)
an inefficient##2##2##(2008-5#1)(2011-2#1)
an inert##10##2##(1990-7#1)(2007-12#1)(2008-10#5)(2008-4#1)(2009-10#1)(2012-2#1)
an inevitable##2##2##(1992-3#1)(2012-2#1)
an inexorable decline in##2##4##(2007-7#1)(2010-10#1)
an inexpensive and##6##3##(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
an inexpensive method##2##3##(2008-10#1)(2010-5#1)
an inexpensive##19##2##(1991-5#1)(2007-11#2)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
an infant in##2##3##(2008-11#1)(2009-12#1)
an infant oral##2##3##(2011-2#2)
an infant who##2##3##(1991-2#1)(2008-5#1)
an infant with##5##3##(1997-3#1)(2007-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
an infant##26##2##(1991-2#1)(1993-12#1)(1995-6#1)(1995-8#1)(1997-3#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)
an infarct##2##2##(2008-11#1)(2013-8#1)
an infarction##4##2##(1994-11#1)(2007-10#1)(2008-12#1)(2012-1#1)
an infected##12##2##(1990-6#1)(2007-8#1)(2008-10#5)(2008-9#1)(2011-3#3)(2013-1#1)
an infection control link nurse programme##2##6##(2008-11#2)
an infection of a##2##4##(2008-11#1)(2011-2#1)
an infection of the central nervous system##2##7##(2008-7#1)(2010-12#1)
an infection of##4##3##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
an infection with##2##3##(2010-5#1)(2010-6#1)
an infection##21##2##(1992-9#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#4)
an infectious agent##2##3##(1992-2#1)(2012-2#1)
an infectious cDNA clone##2##4##(2008-10#2)
an infectious disease##5##3##(1990-12#1)(1991-8#1)(1997-3#1)(2007-7#1)(2013-8#1)
an infectious etiology##2##3##(2009-5#1)(2011-2#1)
an infectious##22##2##(1990-11#1)(1990-12#1)(1991-8#1)(1991-9#2)(1992-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-8#1)(2009-1#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#2)
an inferior##3##2##(2008-8#1)(2011-2#2)
an inferred##2##2##(2007-11#1)(2008-10#1)
an infinite homogeneous##2##3##(2007-11#1)(2008-3#1)
an infinite number of##2##4##(2008-3#1)(2008-8#1)
an infinite number##3##3##(1992-6#1)(2008-3#1)(2008-8#1)
an infinite##22##2##(1992-6#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#5)(2008-8#1)(2009-10#1)(2009-12#1)(2012-3#1)
an infinitely##2##2##(2008-2#1)(2008-3#1)
an inflammatory disease##2##3##(1996-7#1)(2012-12#1)
an inflammatory process##3##3##(1995-5#1)(2008-12#1)(2008-4#1)
an inflammatory reaction##2##3##(2008-12#1)(2010-3#1)
an inflammatory response##5##3##(2008-9#4)(2012-3#1)
an inflammatory##31##2##(1990-12#1)(1990-6#2)(1991-8#2)(1994-11#1)(1995-5#1)(1996-3#2)(1996-7#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-3#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)
an influence in##2##3##(2007-11#1)(2008-5#1)
an influence of the##2##4##(1990-7#1)(2008-5#1)
an influence of##3##3##(1990-7#1)(2008-5#2)
an influence on health##2##4##(1993-12#1)(2008-4#1)
an influence on the##6##4##(1991-1#1)(1991-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)
an influence on##16##3##(1991-1#1)(1991-5#1)(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#2)
an influence##21##2##(1990-7#1)(1991-1#1)(1991-5#1)(1993-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#2)
an influential role in##2##4##(2008-5#1)(2009-4#1)
an influential##6##2##(1992-3#1)(1993-12#1)(2008-11#1)(2008-5#2)(2009-4#1)
an influenza A##2##3##(1991-8#1)(1992-9#1)
an influenza pandemic##3##3##(2008-11#2)(2009-5#1)
an influenza##8##2##(1991-8#1)(1992-9#1)(1996-6#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-6#1)
an influx of Ca2+##3##4##(1991-12#1)(1994-2#1)(1995-11#1)
an influx of##6##3##(1991-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-4#1)(2008-5#1)
an informal##4##2##(1996-3#1)(1997-4#1)(2009-9#1)(2011-2#1)
an information##8##2##(1992-2#1)(1997-1#1)(2007-5#1)(2008-2#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#1)
an information-theoretic##3##2##(2008-3#1)(2010-10#1)(2012-2#1)
an informed consent##2##3##(2008-12#1)(2008-5#1)
an informed##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)
an infrared reflectometry technique (Ober2)##2##5##(2008-7#2)
an infrared##11##2##(2007-12#2)(2008-2#3)(2008-3#3)(2008-7#2)(2011-1#1)
an infrastructure##3##2##(1992-12#1)(1997-1#1)(2008-1#1)
an infrequent##4##2##(2008-9#1)(2010-3#1)(2011-2#2)
an infusion of##2##3##(2007-9#1)(2010-7#1)
an infusion##4##2##(2007-9#1)(2008-4#1)(2010-7#1)(2011-2#1)
an ingredient of##2##3##(1994-8#1)(2008-9#1)
an ingredient##4##2##(1994-8#1)(2008-9#2)(2010-4#1)
an inhalation##2##2##(1994-2#1)(2008-10#1)
an inhaled corticosteroid##2##3##(2008-11#1)(2012-1#1)
an inhaled##3##2##(2008-11#1)(2012-1#2)
an inherent##12##2##(1990-2#1)(1995-8#1)(2008-11#3)(2008-3#3)(2008-7#1)(2009-10#2)(2011-2#1)
an inherently higher##2##3##(1994-11#1)(1995-5#1)
an inherently##3##2##(1994-11#1)(1995-11#1)(1995-5#1)
an inherited##7##2##(1990-5#1)(1992-11#1)(1994-11#1)(1996-8#1)(1997-3#1)(2009-12#1)(2010-6#1)
an inhibiting effect##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
an inhibition of the enzyme##2##5##(1990-8#1)(1992-11#1)
an inhibition of the##6##4##(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(2008-4#1)(2008-5#1)
an inhibition of##13##3##(1990-11#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
an inhibition##17##2##(1990-11#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
an inhibitor of NO##2##4##(1997-2#1)(2011-2#1)
an inhibitor of both##4##4##(1991-8#1)(2008-11#2)(2008-4#1)
an inhibitor of cyclooxygenase##2##4##(2008-11#2)
an inhibitor of lipoxygenase##3##4##(1992-3#1)(2008-11#2)
an inhibitor of protein kinase C##3##6##(1993-8#1)(1994-6#1)(2008-11#1)
an inhibitor of protein##5##4##(1992-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(2008-11#1)
an inhibitor of the##8##4##(1990-12#1)(1992-3#1)(1995-3#1)(2008-4#2)(2008-7#1)(2009-8#1)(2009-9#1)
an inhibitor of##85##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#5)(1996-2#1)(1997-1#2)(1997-2#2)(1997-7#1)(2008-10#3)(2008-11#12)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#1)(2009-9#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
an inhibitor##92##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#3)(1992-12#2)(1992-3#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#5)(1996-2#1)(1997-1#2)(1997-2#2)(1997-7#1)(2008-10#3)(2008-11#14)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#2)(2009-8#1)(2009-9#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
an inhibitory compound##2##3##(2008-10#1)(2008-6#1)
an inhibitory effect of##3##4##(2008-5#1)(2011-2#2)
an inhibitory effect on the##4##5##(1992-2#1)(1992-5#1)(1995-12#1)(2008-10#1)
an inhibitory effect on##9##4##(1992-2#1)(1992-5#1)(1994-10#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-9#1)
an inhibitory effect##14##3##(1992-2#1)(1992-5#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
an inhibitory role##3##3##(1991-2#1)(1995-12#1)(2013-1#1)
an inhibitory##31##2##(1991-2#2)(1991-5#2)(1992-2#1)(1992-5#1)(1993-12#3)(1993-5#1)(1994-10#1)(1994-8#1)(1995-12#3)(1997-4#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
an inhomogeneous##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
an initial and##2##3##(1995-12#1)(2008-10#1)
an initial concentration of##2##4##(2008-10#1)(2011-2#1)
an initial condition##2##3##(2008-8#1)(2013-8#1)
an initial course##2##3##(2008-11#1)(2013-1#1)
an initial decrease in##2##4##(2008-11#1)(2008-5#1)
an initial decrease##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
an initial guess##2##3##(2008-3#2)
an initial increase##3##3##(1990-7#1)(1995-5#1)(2009-8#1)
an initial linear##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
an initial period of##3##4##(2007-8#1)(2008-7#1)(2008-8#1)
an initial phase##2##3##(2008-10#1)(2008-2#1)
an initial screening##4##3##(1991-1#1)(2008-10#2)(2011-2#1)
an initial step in##2##4##(2008-1#1)(2010-4#1)
an initial step toward##2##4##(2008-10#1)(2008-5#1)
an initial step##5##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-4#1)
an initial##127##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-6#1)(1992-1#2)(1992-2#2)(1993-6#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#3)(1997-5#3)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#5)
an initially##10##2##(1993-6#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
an initiative##8##2##(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
an initiator of##2##3##(1994-11#1)(2009-8#1)
an initiator##7##2##(1994-11#1)(1995-9#1)(1997-6#1)(2008-10#2)(2008-12#1)(2009-8#1)
an injectable##6##2##(2007-5#1)(2008-5#2)(2008-9#1)(2009-7#1)(2013-1#1)
an injected volume of##3##4##(2008-10#3)
an injected##6##2##(2008-10#5)(2008-3#1)
an injection of##4##3##(1993-1#1)(1993-6#1)(1997-2#1)(2011-2#1)
an injection valve##2##3##(2008-10#2)
an injection volume of 100##2##5##(2008-10#2)
an injection volume of##4##4##(2008-10#3)(2008-5#1)
an injection##14##2##(1993-1#1)(1993-6#1)(1994-9#1)(1997-2#1)(2008-10#5)(2008-5#2)(2009-6#1)(2011-2#1)(2012-3#1)
an injection-locked##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
an injection-seeded##2##2##(2007-12#1)(2008-3#1)
an injury to##2##3##(2008-12#1)(2013-1#1)
an injury##6##2##(1995-12#1)(2008-12#1)(2008-7#1)(2009-3#2)(2013-1#1)
an innate immune system##2##4##(2006-10#1)(2009-3#1)
an innate##4##2##(2006-10#1)(2008-10#1)(2009-3#1)(2009-9#1)
an inner core##2##3##(2008-10#1)(2008-4#1)
an inner diameter of 20##2##5##(2007-12#1)(2008-2#1)
an inner diameter of##3##4##(2007-12#2)(2008-2#1)
an inner membrane##2##3##(1992-7#1)(2010-2#1)
an inner##16##2##(1991-1#1)(1992-7#1)(1994-9#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)
an innocuous##2##2##(1991-12#1)(2011-2#1)
an innovative and##4##3##(1992-12#1)(1997-2#1)(2008-10#1)(2010-3#1)
an innovative approach for##2##4##(1992-1#1)(1992-12#1)
an innovative approach##5##3##(1992-1#1)(1992-12#1)(1994-3#1)(2008-10#1)(2008-12#1)
an innovative method##2##3##(1991-2#1)(2007-11#1)
an innovative model##2##3##(1996-1#1)(2008-12#1)
an innovative way##2##3##(1992-5#1)(2010-3#1)
an innovative##50##2##(1991-2#2)(1992-1#2)(1992-12#2)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-1#1)(1997-1#1)(1997-2#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#6)(2008-4#1)(2008-5#2)(2008-6#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-3#3)(2010-6#1)(2010-7#1)(2012-12#3)(2012-3#1)(2013-1#2)
an inoculum##5##2##(2008-10#5)
an inorganic##7##2##(2008-10#3)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)
an inotropic##2##2##(2008-5#2)
an inpatient##9##2##(1991-2#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-12#1)
an input price index##3##4##(1992-2#1)(1993-1#2)
an input##17##2##(1992-2#1)(1993-1#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#4)
an inquiry##2##2##(1990-6#1)(1995-8#1)
an insect vector##2##3##(2008-10#1)(2008-9#1)
an insect##12##2##(1993-12#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#3)(2008-9#1)(2012-2#1)
an insecticide##2##2##(1993-8#1)(2011-2#1)
an insert##4##2##(1991-7#2)(1994-12#1)(2008-10#1)
an insertion of##2##3##(1990-8#1)(1993-6#1)
an insertion##6##2##(1990-8#1)(1993-12#1)(1993-6#1)(1997-8#1)(2008-2#1)(2013-1#1)
an insertional mutation in the##2##5##(1996-2#1)(2008-11#1)
an insertional mutation##3##3##(1993-9#1)(1996-2#1)(2008-11#1)
an insertional##5##2##(1993-9#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-9#1)
an inside##3##2##(1994-12#1)(1995-2#1)(2008-11#1)
an insight into the##7##4##(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)(2010-6#1)(2012-3#1)
an insight into##15##3##(1995-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-3#1)
an insight##18##2##(1995-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-3#1)
an insignificant##3##2##(1990-2#1)(2008-2#1)(2008-7#1)
an insoluble##8##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
an inspiration to##2##3##(2007-2#1)(2008-5#1)
an instability##2##2##(2007-12#2)
an instance of##2##3##(1993-6#2)
an instantaneous##2##2##(2007-12#1)(2008-2#1)
an institution##4##2##(1991-6#1)(1992-12#1)(1996-1#1)(2011-2#1)
an institutional##8##2##(1993-1#1)(1993-2#1)(1993-6#1)(1996-12#1)(2008-12#1)(2008-7#1)(2009-2#1)(2013-1#1)
an instructional##4##2##(1990-3#1)(1996-1#1)(2012-3#1)(2013-1#1)
an instructive##3##2##(1996-4#1)(2010-10#1)(2010-11#1)
an instrument for measuring##2##4##(2012-2#1)(2013-1#1)
an instrument for##7##3##(1994-3#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)
an instrument has##2##3##(2008-3#1)(2012-12#1)
an instrument that is##2##4##(2008-10#1)(2008-3#1)
an instrument that##4##3##(2007-7#1)(2008-10#1)(2008-3#2)
an instrument to##4##3##(1993-3#1)(1997-1#1)(2008-10#1)(2013-1#1)
an instrument with##3##3##(1993-2#1)(2008-3#2)
an instrument##36##2##(1990-3#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-1#2)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#7)(2008-7#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
an instrumental##5##2##(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#1)
an instrumented##2##2##(2013-1#2)
an insufficient amount of##2##4##(2008-10#1)(2012-2#1)
an insufficient understanding of##2##4##(2010-9#1)(2013-1#1)
an insufficient##10##2##(1990-3#1)(1991-5#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#1)
an insulating##2##2##(2008-7#1)(2010-2#1)
an insulin receptor##2##3##(1993-8#1)(2008-12#1)
an insulin##13##2##(1990-12#1)(1990-8#1)(1992-10#1)(1992-6#1)(1993-8#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-3#1)
an insurance perspective##3##3##(1993-12#2)(1994-2#1)
an insurance##5##2##(1991-12#1)(1993-1#1)(1993-12#2)(1994-2#1)
an insurer##3##2##(1993-1#1)(1997-5#2)
an intact##18##2##(1991-7#1)(1991-9#1)(1993-11#1)(1993-9#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
an integer multiple of##2##4##(2007-12#2)
an integer##3##2##(2007-12#2)(2008-3#1)
an integral and##2##3##(1996-12#1)(2013-1#1)
an integral component of the##2##5##(2008-10#1)(2008-4#1)
an integral component of##8##4##(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#2)(2012-3#2)
an integral component##9##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#2)(2012-3#2)
an integral equation of the first kind##2##7##(2008-10#1)(2008-2#1)
an integral equation##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
an integral membrane protein from Mycobacterium tuberculosis##2##7##(2009-7#2)
an integral membrane protein##7##4##(1990-11#1)(1990-12#1)(1993-11#1)(2008-10#1)(2009-7#2)(2011-2#1)
an integral membrane##9##3##(1990-11#1)(1990-12#1)(1991-10#1)(1993-11#1)(2008-10#1)(2008-4#1)(2009-7#2)(2011-2#1)
an integral part of the##12##5##(1991-2#1)(1992-6#1)(1993-12#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#2)
an integral part of##35##4##(1991-2#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#3)
an integral part##37##3##(1991-2#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
an integral role in the##4##5##(1992-2#1)(1993-3#1)(2007-4#1)(2008-11#1)
an integral role in##5##4##(1992-2#1)(1993-3#1)(2007-4#1)(2008-11#1)(2010-10#1)
an integral##75##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#1)
an integrated approach to health system reform##2##7##(1993-12#2)
an integrated approach to teaching clinical##2##6##(2008-11#2)
an integrated approach to the##2##5##(2009-4#1)(2012-1#1)
an integrated approach to##10##4##(1993-12#2)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2012-1#1)
an integrated approach##15##3##(1993-12#2)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-4#1)(2012-1#1)(2012-3#1)
an integrated component of##2##4##(2012-2#1)(2012-3#1)
an integrated component##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
an integrated delivery system##6##4##(1996-1#2)(1996-3#2)(1997-3#1)(2008-1#1)
an integrated delivery##8##3##(1996-1#2)(1996-3#3)(1997-1#1)(1997-3#1)(2008-1#1)
an integrated health care system##6##5##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)
an integrated health care##8##4##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-3#1)
an integrated health system##2##4##(1997-3#2)
an integrated health##11##3##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-3#3)(2008-1#1)
an integrated medical care organization##2##5##(1995-3#2)
an integrated model##2##3##(1994-12#1)(2008-3#1)
an integrated optical microcavity##2##4##(2007-11#1)(2008-10#1)
an integrated optical##6##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
an integrated part of the##2##5##(1992-11#1)(1994-2#1)
an integrated part of##3##4##(1992-11#1)(1994-2#1)(2008-10#1)
an integrated part##4##3##(1992-11#1)(1994-2#1)(2008-10#1)(2008-7#1)
an integrated pest management program##2##5##(2008-10#1)(2013-8#1)
an integrated pest management##3##4##(2008-10#2)(2013-8#1)
an integrated public##2##3##(1995-12#1)(2008-6#1)
an integrated system of##4##4##(1995-2#1)(1997-1#2)(2008-2#1)
an integrated system##7##3##(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-3#1)(2008-2#1)
an integrated view of##2##4##(2008-7#2)
an integrated##138##2##(1990-5#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-12#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#4)(1996-1#3)(1996-12#4)(1996-2#1)(1996-3#3)(1997-1#3)(1997-2#1)(1997-3#7)(1997-7#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#5)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#3)
an integrating##3##2##(2008-2#2)(2008-3#1)
an integration of##2##3##(1994-11#1)(1996-2#1)
an integration##7##2##(1994-11#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
an integrative approach to##2##4##(2008-8#2)
an integrative medicine##2##3##(2008-1#1)(2008-12#1)
an integrative research review##2##4##(1992-2#1)(2009-6#1)
an integrative review of##2##4##(2008-4#1)(2013-1#1)
an integrative review##4##3##(1992-2#1)(2008-4#1)(2012-3#1)(2013-1#1)
an integrative##15##2##(1992-2#2)(1994-2#1)(1994-5#1)(1995-5#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
an intellectual##2##2##(1993-12#1)(2011-2#1)
an intelligent##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
an intended##2##2##(2008-5#1)(2012-3#1)
an intense burst of##2##4##(2008-10#1)(2008-5#1)
an intense glycogen##2##3##(2008-5#2)
an intense##32##2##(1992-8#1)(1994-2#1)(1995-5#1)(1997-1#2)(2007-11#4)(2007-12#3)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2009-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
an intensification of##2##3##(1996-4#1)(2008-10#1)
an intensified CCD camera##3##4##(2007-12#1)(2008-3#2)
an intensified CCD##4##3##(2007-12#2)(2008-3#2)
an intensified##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
an intensity contrast of##2##4##(2007-12#2)
an intensity of 1##3##4##(2007-12#1)(2008-3#2)
an intensity of##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-8#1)
an intensity that##2##3##(1990-7#1)(2007-11#1)
an intensity##22##2##(1990-7#2)(1994-6#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
an intensity-modulated##3##2##(2007-12#1)(2008-2#2)
an intensive care unit (ICU)##2##5##(1992-2#1)(1995-12#1)
an intensive care unit##8##4##(1991-11#1)(1992-2#1)(1995-12#1)(2008-3#1)(2008-8#1)(2009-5#2)(2012-12#1)
an intensive care##12##3##(1991-11#1)(1991-3#1)(1992-2#1)(1995-12#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#3)(2011-2#1)(2012-12#1)
an intensive fluorescence in ultraviolet region##2##6##(2008-10#2)
an intensive treatment##2##3##(2008-3#1)(2012-2#1)
an intensive##23##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-2#1)(1995-12#1)(2008-10#5)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
an intensively##3##2##(2007-12#1)(2008-10#2)
an intentional##2##2##(2007-11#1)(2012-3#1)
an inter-laboratory study##3##3##(2008-10#3)
an interacting regulatory network##2##4##(2011-2#2)
an interacting##6##2##(2008-2#2)(2009-11#1)(2010-1#1)(2011-2#2)
an interaction between muscarinic##2##4##(1995-12#2)
an interaction between the##3##4##(1991-2#1)(2008-10#2)
an interaction between##12##3##(1991-2#1)(1995-12#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)
an interaction effect##4##3##(2008-4#1)(2013-1#1)(2013-8#2)
an interaction of##4##3##(1990-6#1)(1994-5#1)(1997-7#1)(2008-10#1)
an interaction with the##2##4##(1996-2#1)(2012-12#1)
an interaction with##6##3##(1992-5#1)(1992-6#1)(1996-2#1)(1996-5#1)(2008-8#1)(2012-12#1)
an interaction##36##2##(1990-6#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-7#2)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
an interactive information##2##3##(1995-2#2)
an interactive##16##2##(1991-1#1)(1994-1#1)(1995-2#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2012-2#1)
an intercalation binding mode for##2##5##(1992-3#2)
an intercalation binding mode##3##4##(1992-3#3)
an intercalation##4##2##(1992-3#4)
an interconnect##2##2##(2008-2#1)(2008-3#1)
an interconnection##3##2##(2008-2#2)(2010-8#1)
an interdigitated##3##2##(2008-10#2)(2008-8#1)
an interdisciplinary approach##5##3##(1994-3#1)(1997-8#1)(2007-12#1)(2008-4#1)(2013-1#1)
an interdisciplinary assessment##3##3##(1995-1#1)(2013-1#2)
an interdisciplinary team##2##3##(1994-12#1)(2011-2#1)
an interdisciplinary##26##2##(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-1#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
an interest in##4##3##(1995-1#1)(1995-2#1)(2008-11#1)(2012-2#1)
an interest##6##2##(1991-6#1)(1991-9#1)(1995-1#1)(1995-2#1)(2008-11#1)(2012-2#1)
an interesting alternative##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
an interesting and##2##3##(1992-5#1)(1994-6#1)
an interesting case of##4##4##(2007-2#1)(2008-10#1)(2010-6#1)(2012-12#1)
an interesting case##6##3##(2007-2#1)(2008-10#1)(2010-11#1)(2010-6#1)(2012-12#1)(2013-1#1)
an interesting example of##2##4##(2008-10#1)(2010-11#1)
an interesting example##3##3##(1991-4#1)(2008-10#1)(2010-11#1)
an interesting possibility##2##3##(2008-8#1)(2011-2#1)
an interesting tool to##2##4##(2008-10#1)(2012-12#1)
an interesting tool##4##3##(2008-10#1)(2008-11#1)(2010-10#1)(2012-12#1)
an interesting##55##2##(1991-4#1)(1992-1#1)(1992-5#2)(1994-6#1)(1996-1#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
an interface between##3##3##(1996-2#1)(2007-11#1)(2008-4#1)
an interface##12##2##(1993-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2010-10#1)
an interfacial##2##2##(2009-11#1)(2012-2#1)
an interference microscope##3##3##(2008-3#3)
an interference pattern##2##3##(2008-2#1)(2008-3#1)
an interference signal##2##3##(2008-3#2)
an interference study##2##3##(2008-10#2)
an interference##16##2##(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#9)(2009-10#1)
an interfering##3##2##(2008-10#3)
an interferogram##6##2##(2008-2#3)(2008-3#3)
an interferometer with a##2##4##(2008-3#2)
an interferometer##11##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
an interferometric array illuminator##2##4##(2008-2#2)
an interferometric technique##2##3##(2007-11#1)(2008-3#1)
an interferometric##15##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#4)(2012-2#1)
an intergenic region##2##3##(2008-10#1)(2008-8#1)
an interim analysis##3##3##(2008-5#1)(2012-2#2)
an interim report##2##3##(1991-1#1)(1995-3#1)
an interim##10##2##(1991-1#1)(1992-12#1)(1992-8#1)(1995-3#1)(1997-3#2)(2008-5#1)(2008-8#1)(2012-2#2)
an interlaced##2##2##(2008-3#1)(2011-1#1)
an intermediary##2##2##(1995-12#1)(2008-10#1)
an intermediate form##2##3##(1992-2#1)(1992-3#1)
an intermediate in class II##2##5##(1995-11#2)
an intermediate in the##2##4##(1992-4#1)(2008-5#1)
an intermediate in##4##3##(1992-4#1)(1995-11#2)(2008-5#1)
an intermediate layer##3##3##(2008-10#1)(2008-12#2)
an intermediate level of##3##4##(2008-7#1)(2008-8#1)(2009-2#1)
an intermediate step##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2012-1#1)
an intermediate that##2##3##(1995-3#1)(2007-11#1)
an intermediate##57##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#2)(1995-11#3)(1995-3#1)(1995-5#2)(1996-2#2)(1996-5#1)(2007-11#3)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
an intermingled##2##2##(2007-8#1)(2008-8#1)
an intermittent##2##2##(1990-6#1)(2007-12#1)
an internal audit##3##3##(1996-12#1)(2007-9#2)
an internal coating of##2##4##(2008-10#2)
an internal medicine service]##2##4##(1992-5#1)(1996-3#1)
an internal medicine##4##3##(1992-5#2)(1996-3#1)(2009-9#1)
an internal positive control##3##4##(2008-10#3)
an internal quality##2##3##(2008-9#1)(2011-2#1)
an internal standard##27##3##(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-8#1)(2010-4#1)
an internal##82##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
an international comparison##2##3##(1993-2#1)(2012-12#1)
an international perspective##4##3##(2008-11#1)(2008-12#1)(2009-12#1)(2012-3#1)
an international standard##2##3##(1993-2#1)(2008-7#1)
an international##52##2##(1991-9#1)(1993-1#2)(1993-2#3)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-4#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-7#3)(2009-10#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-10#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
an internship##3##2##(1992-2#1)(1993-3#1)(2011-2#1)
an interphase on##3##3##(2008-3#1)(2009-6#2)
an interplay between##2##3##(2008-1#1)(2010-3#1)
an interplay##3##2##(1990-11#1)(2008-1#1)(2010-3#1)
an interposed##2##2##(1990-3#1)(2008-7#1)
an interpretation##6##2##(1992-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2013-1#2)
an interpretive##2##2##(2010-10#1)(2010-9#1)
an interruption of the##2##4##(1990-5#1)(2008-7#1)
an interspecific hybrid##2##3##(2008-10#1)(2011-2#1)
an interspecific##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
an interstitial impurity in a crystal##2##6##(2007-11#2)
an interstitial##6##2##(1991-12#1)(2007-11#2)(2007-8#1)(2012-12#2)
an interval of five##2##4##(1993-11#1)(2010-8#1)
an interval of one##2##4##(1991-6#1)(1996-8#1)
an interval of##13##3##(1991-6#2)(1992-10#1)(1993-11#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-8#1)(2012-12#1)
an interval##17##2##(1991-6#2)(1992-10#1)(1993-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
an intervening##2##2##(1991-5#1)(2008-8#1)
an intervention program##2##3##(1991-2#1)(2007-12#1)
an intervention to improve##2##4##(2008-6#1)(2010-4#1)
an intervention to##4##3##(2008-6#1)(2010-4#1)(2012-3#1)(2013-8#1)
an intervention##19##2##(1991-2#1)(1993-11#1)(1993-2#1)(1994-3#1)(2007-12#1)(2008-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
an interview with##8##3##(1996-8#1)(2008-4#2)(2009-12#1)(2010-5#1)(2012-2#1)(2012-3#2)
an interview##13##2##(1991-6#1)(1992-11#1)(1996-8#1)(2008-11#1)(2008-4#2)(2009-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
an interviewer-administered##2##2##(2008-11#1)(2010-11#1)
an intestinal bacterial##2##3##(2008-11#1)(2012-2#1)
an intestinal##9##2##(1995-3#1)(2008-11#3)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#2)
an intimal##2##2##(1997-6#1)(2011-2#1)
an intimate other##2##3##(2008-11#2)
an intimate##8##2##(1992-2#1)(2008-11#3)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
an intra-aortic balloon pump##2##4##(2013-1#2)
an intra-atrial conduit##2##3##(2007-8#2)
an intra-operative##3##2##(2008-6#2)(2012-12#1)
an intracaval##2##2##(1991-6#1)(2008-1#1)
an intracavity acousto-optic tunable filter##2##5##(2007-12#2)
an intracavity frequency-doubled Nd##2##4##(2007-12#1)(2008-2#1)
an intracavity##32##2##(2007-11#9)(2007-12#11)(2008-2#4)(2008-3#8)
an intracellular Ca(2+)##2##3##(2008-8#1)(2009-10#1)
an intracellular Ca2+##2##3##(1996-2#1)(1997-4#1)
an intracellular pathogen##2##3##(2009-8#1)(2011-2#1)
an intracellular protein##5##3##(1990-7#1)(1992-8#1)(1993-3#1)(2008-11#2)
an intracellular reporter##2##3##(2008-11#1)(2008-9#1)
an intracellular##38##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-2#2)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#1)(2013-1#4)
an intracerebral haemorrhage##2##3##(2008-7#2)
an intracerebral##4##2##(1992-12#1)(2008-12#1)(2008-7#2)
an intracranial##6##2##(1992-6#1)(1995-5#1)(2006-12#1)(2008-7#3)
an intradural##2##2##(2011-2#1)(2012-2#1)
an intramolecular chaperone##2##3##(1995-3#2)
an intramolecular##16##2##(1991-5#1)(1992-12#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-5#1)(2009-7#1)(2009-9#1)
an intramuscular##5##2##(1990-12#1)(1992-5#1)(1995-8#1)(2007-7#1)(2012-12#1)
an intraocular##3##2##(1990-11#1)(2009-12#1)(2011-1#1)
an intraoperative##7##2##(1990-10#1)(1994-11#1)(2008-10#2)(2008-6#1)(2010-7#1)(2012-3#1)
an intraoral approach##2##3##(2012-12#1)(2013-1#1)
an intraperitoneal injection of lipopolysaccharide (LPS) or##2##7##(1997-2#1)(2009-12#1)
an intraperitoneal##4##2##(1994-8#1)(1997-2#1)(2009-12#1)(2013-1#1)
an intrastrand cross-link##2##3##(1992-3#2)
an intrastriatal injection of##2##4##(1995-5#2)
an intrathoracic##2##2##(1991-3#1)(2008-11#1)
an intrauterine##4##2##(1992-2#1)(1993-2#1)(2010-11#1)(2013-1#1)
an intravascular##4##2##(1990-3#1)(2008-11#1)(2008-4#1)(2010-8#1)
an intravenous bolus##3##3##(1992-12#1)(2007-10#1)(2008-6#1)
an intravenous infusion##2##3##(2007-10#1)(2008-1#1)
an intravenous pyelogram##2##3##(2008-7#1)(2009-1#1)
an intravenous##14##2##(1992-12#1)(1992-5#1)(1993-6#1)(1995-12#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#1)(2012-2#1)
an intricate##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
an intriguing##8##2##(1990-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
an intrinsic defect in##2##4##(1990-5#1)(2008-7#1)
an intrinsic motivation##2##3##(2008-11#2)
an intrinsic##28##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2010-11#1)(2011-2#1)
an intrinsically##3##2##(2008-2#1)(2008-8#1)(2009-7#1)
an introduced isolate of Rhizoctonia solani##2##6##(2008-10#2)
an introduced##7##2##(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#1)
an introduction to a##2##4##(1993-3#1)(2008-7#1)
an introduction to the##6##4##(1992-3#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-7#1)
an introduction to##18##3##(1992-3#1)(1993-3#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#6)(2008-7#2)(2012-12#1)
an introduction##27##2##(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#7)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
an introductory##6##2##(1997-1#1)(2008-11#2)(2008-3#1)(2012-12#1)(2012-3#1)
an intron##11##2##(1991-2#1)(1991-9#4)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#1)
an intron-containing##2##2##(1991-9#1)(2008-10#1)
an intronic##2##2##(1993-12#1)(2011-1#1)
an intronless##2##2##(1997-7#1)(2008-10#1)
an intuitive##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
an intussuseptum##2##2##(1993-9#2)
an invagination##2##2##(2008-6#1)(2011-2#1)
an invaluable tool for##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
an invaluable tool##6##3##(1996-1#1)(2008-10#1)(2008-9#3)(2012-3#1)
an invaluable##9##2##(1996-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#4)(2012-3#1)
an invariant##6##2##(1992-6#1)(1992-9#1)(1995-2#1)(2007-11#1)(2008-4#1)(2010-4#1)
an invasion##2##2##(2008-10#1)(2008-8#1)
an invasive procedure##3##3##(2007-7#1)(2012-2#2)
an invasive##19##2##(1993-12#1)(1993-9#1)(1994-12#2)(1997-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
an inventory of the##2##4##(2008-5#1)(2013-1#1)
an inventory of##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
an inventory##5##2##(1993-2#1)(2008-5#1)(2008-7#2)(2013-1#1)
an inverse Monte Carlo##2##4##(2008-3#2)
an inverse correlation between##4##4##(1993-9#1)(2008-7#1)(2011-2#1)(2012-12#1)
an inverse correlation was found##2##5##(1992-2#1)(2008-7#1)
an inverse correlation##6##3##(1992-2#1)(1993-9#1)(2008-7#2)(2011-2#1)(2012-12#1)
an inverse linear##3##3##(1991-12#1)(2008-10#2)
an inverse relationship between##15##4##(1991-5#1)(1994-6#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#3)
an inverse relationship with##2##4##(2008-7#1)(2011-2#1)
an inverse relationship##18##3##(1991-5#1)(1993-12#1)(1994-6#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#3)
an inverse##47##2##(1991-12#1)(1991-5#2)(1992-2#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#3)(2013-8#3)
an inversion algorithm that##2##4##(2008-3#2)
an inversion algorithm##3##3##(2008-3#3)
an inversion procedure##2##3##(2008-3#1)(2009-5#1)
an inversion scheme##3##3##(2008-3#3)
an inversion##12##2##(2008-11#1)(2008-2#3)(2008-3#7)(2009-5#1)
an inverted##11##2##(1994-12#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2009-11#1)(2012-3#1)(2013-1#1)
an investigation in a##2##4##(1991-3#1)(2007-12#1)
an investigation in##3##3##(1991-3#1)(2007-12#1)(2008-12#1)
an investigation into the effect of##2##6##(2008-2#1)(2008-6#1)
an investigation into the##6##4##(1990-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
an investigation of the##10##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2011-1#1)
an investigation of##15##3##(1994-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#1)(2012-8#1)
an investigation on the##2##4##(1993-5#1)(2008-7#1)
an investigation on##6##3##(1993-5#1)(2008-10#3)(2008-5#1)(2008-7#1)
an investigation was##2##3##(2008-10#2)
an investigation##38##2##(1990-11#1)(1991-3#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)
an investigational##2##2##(2009-9#1)(2011-2#1)
an investigator to##2##3##(2008-1#1)(2010-7#1)
an investment in##2##3##(2007-12#1)(2008-10#1)
an investment##4##2##(1992-2#1)(1996-3#1)(2007-12#1)(2008-10#1)
an invisible##2##2##(1991-6#1)(2008-11#1)
an involvement of##13##3##(1990-5#1)(1991-2#1)(1992-12#2)(1992-5#1)(1992-9#1)(2008-11#4)(2008-7#1)(2010-8#1)(2012-3#1)
an inward current##2##3##(1997-2#1)(2008-8#1)
an inward##4##2##(1993-3#1)(1997-2#1)(2008-8#1)(2011-2#1)
an inward-rectifying##2##2##(1994-12#2)
an iodine-stabilized##3##2##(2007-12#2)(2008-2#1)
an ion associate##4##3##(2008-10#4)
an ion channel##2##3##(1994-8#1)(2008-11#1)
an ion exchange membrane##2##4##(2008-10#2)
an ion exchange resin##2##4##(2008-10#2)
an ion exchange##7##3##(1997-4#1)(2008-10#6)
an ion mobility spectrometer##3##4##(2008-10#3)
an ion mobility##4##3##(2008-10#4)
an ion pair##4##3##(2008-10#4)
an ion selective##2##3##(2008-10#2)
an ion trap mass spectrometer##2##5##(2008-10#2)
an ion trap##4##3##(2008-10#4)
an ion##39##2##(1994-8#1)(1997-4#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-8#1)
an ion-exchange##4##2##(1991-8#1)(1997-2#1)(2008-10#1)(2009-11#1)
an ion-pair##4##2##(2008-10#4)
an ion-pairing##3##2##(1994-9#1)(2008-10#1)(2010-3#1)
an ion-selective electrode##5##3##(2008-10#5)
an ion-selective##6##2##(2008-10#6)
an ionic strength of 0##3##5##(1997-7#1)(2008-10#2)
an ionic strength of##4##4##(1990-12#1)(1997-7#1)(2008-10#2)
an ionic strength##5##3##(1990-12#1)(1997-7#1)(2008-10#3)
an ionic##13##2##(1990-11#1)(1990-12#1)(1997-7#1)(2007-12#1)(2008-10#7)(2009-12#1)(2010-7#1)
an ionizable mobile carrier##2##4##(1992-6#2)
an ionizable##3##2##(1992-6#2)(1997-2#1)
an ionization buffer##2##3##(2008-10#2)
an ionization##3##2##(2008-10#3)
an ionophore##12##2##(2008-10#11)(2009-12#1)
an iron chelator##3##3##(1991-9#1)(2008-10#1)(2008-11#1)
an iron uptake system##2##4##(1996-8#1)(1997-7#1)
an iron##15##2##(1990-12#1)(1991-12#1)(1991-9#1)(1993-11#1)(1996-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-11#1)(2012-12#1)(2013-8#1)
an iron-regulated promoter##2##3##(2008-10#2)
an iron-sulfur##2##2##(1991-5#1)(1993-11#1)
an irradiance of##2##3##(2007-12#1)(2008-12#1)
an irradiance##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
an irradiated##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
an irrational##2##2##(1991-11#1)(2008-9#1)
an irregular##7##2##(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#1)
an irreplaceable role##2##3##(2009-10#1)(2013-8#1)
an irreversible and##2##3##(1991-4#1)(1991-5#1)
an irreversible effect##2##3##(1990-5#1)(2008-8#1)
an irreversible##22##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-8#2)(1993-6#1)(1994-11#2)(1996-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
an irritant##3##2##(1995-6#1)(1996-12#1)(2008-5#1)
an ischaemic##6##2##(1991-11#1)(1992-2#1)(1993-9#1)(1996-8#1)(2008-10#1)(2008-8#1)
an ischemic insult##2##3##(1993-3#1)(2008-3#1)
an ischemic stroke##5##3##(2007-10#1)(2009-11#2)(2013-1#1)(2013-8#1)
an ischemic##13##2##(1990-3#1)(1993-3#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#2)(2010-5#1)(2013-1#1)(2013-8#1)
an island##3##2##(1992-1#1)(2008-1#2)
an isoamylase-hyperproducing mutant##2##3##(1990-11#2)
an isocratic elution with##2##4##(2008-10#2)
an isocratic##9##2##(2008-10#8)(2008-5#1)
an isoelectric point (pI)##2##4##(1995-12#1)(1996-5#1)
an isoelectric point of 3##2##5##(2008-10#2)
an isoelectric point##7##3##(1990-11#1)(1995-12#1)(1996-5#1)(2008-10#4)
an isoelectric##8##2##(1990-11#1)(1991-12#1)(1995-12#1)(1996-5#1)(2008-10#4)
an isoflavone##2##2##(2012-2#2)
an isoform of##2##3##(1993-9#1)(2012-12#1)
an isoform##3##2##(1993-9#1)(1996-6#1)(2012-12#1)
an isolate from##2##3##(2008-10#2)
an isolate of the##2##4##(2008-10#2)
an isolate of##9##3##(2008-10#8)(2008-5#1)
an isolate##17##2##(2008-10#15)(2008-5#1)(2008-6#1)
an isolated case##2##3##(2007-7#1)(2008-9#1)
an isolated perfused##2##3##(1991-9#1)(1996-5#1)
an isolated##38##2##(1991-12#2)(1991-9#1)(1992-3#1)(1994-5#2)(1995-5#1)(1996-5#1)(1997-7#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#6)
an isolation##3##2##(2008-12#1)(2008-3#2)
an isoleucine##7##2##(1995-11#2)(2008-10#5)
an isometric##2##2##(2008-10#1)(2013-8#1)
an isoschizomer of##3##3##(1993-12#1)(1993-9#2)
an isothermal##3##2##(2008-3#1)(2008-7#2)
an isotope effect on##2##4##(1995-2#2)
an isotope effect##3##3##(1993-11#1)(1995-2#2)
an isotropic medium and##3##4##(2007-11#2)(2008-2#1)
an isotropic medium##4##3##(2007-11#3)(2008-2#1)
an isotropic##15##2##(2007-11#4)(2008-2#3)(2008-3#7)(2008-6#1)
an issue for##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)
an issue in##2##3##(1996-9#1)(2011-2#1)
an issue of##4##3##(2008-5#1)(2011-2#2)(2012-3#1)
an issue that##2##3##(2008-11#1)(2011-2#1)
an issue##19##2##(1992-3#1)(1994-5#1)(1996-3#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#4)(2012-3#1)
an italian cross-sectional study##2##4##(2013-1#2)
an item response##2##3##(2009-11#1)(2012-2#1)
an item##4##2##(2009-11#1)(2012-2#3)
an iterative algorithm for##2##4##(2008-2#1)(2008-3#1)
an iterative algorithm to##2##4##(2007-11#1)(2008-3#1)
an iterative algorithm##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
an iterative method for##2##4##(2008-3#1)(2010-3#1)
an iterative method##3##3##(2008-3#2)(2010-3#1)
an iterative procedure##2##3##(2008-3#2)
an iterative process##3##3##(2008-4#1)(2011-8#1)(2012-2#1)
an iterative reconstruction##2##3##(2008-3#1)(2011-1#1)
an iterative scheme##2##3##(2008-2#2)
an iterative technique##2##3##(2008-10#1)(2008-3#1)
an iterative##41##2##(1992-9#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#8)(2008-3#15)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
an mRNA of##2##3##(1993-2#1)(1993-3#1)
an mRNA species of##2##4##(1991-6#1)(1994-6#1)
an mRNA##9##2##(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#1)(1994-6#1)(2008-11#1)(2011-2#2)(2012-3#1)
an methods##2##2##(2007-11#1)(2007-8#1)
an n = 2##2##4##(2008-2#2)
an n =##3##3##(2008-2#2)(2010-2#1)
an o/w##2##2##(2008-5#2)
an oat##2##2##(2008-10#1)(2008-9#1)
an object and##5##3##(2008-11#1)(2008-3#3)(2013-8#1)
an object from its##2##4##(2008-3#2)
an object from##3##3##(2008-3#3)
an object into##2##3##(2008-3#1)(2009-2#1)
an object is##3##3##(2008-3#2)(2012-2#1)
an object of investigation##2##4##(2008-3#1)(2013-1#1)
an object of##4##3##(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
an object that has##2##4##(2008-2#1)(2008-3#1)
an object that##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
an object with##2##3##(2008-3#1)(2012-12#1)
an object without##2##3##(2008-3#1)(2011-1#1)
an object##51##2##(1996-2#2)(2007-11#1)(2007-12#5)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#22)(2008-6#2)(2009-2#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
an object's surface##2##3##(2008-3#2)
an objective and##2##3##(2007-8#1)(2008-5#1)
an objective in##2##3##(2008-2#1)(2008-7#1)
an objective lens##2##3##(2008-2#1)(2008-3#1)
an objective measure of##2##4##(1994-7#1)(2010-7#1)
an objective method for evaluating the##2##6##(2007-10#1)(2011-2#1)
an objective method for##3##4##(2007-10#1)(2011-2#1)(2012-12#1)
an objective method##4##3##(2007-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
an objective test##2##3##(2008-10#1)(2010-12#1)
an objective##36##2##(1990-12#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-7#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
an oblate##2##2##(2008-2#1)(2008-3#1)
an obligate biotrophic##2##3##(2010-3#2)
an obligate parasite##2##3##(2008-10#1)(2011-2#1)
an obligate##9##2##(2008-10#3)(2008-11#1)(2008-9#1)(2010-3#2)(2010-8#1)(2011-2#1)
an obligation in the##2##4##(1994-12#1)(2008-11#1)
an obligation##5##2##(1992-3#1)(1994-12#2)(2008-11#2)
an obligatory##6##2##(1991-11#1)(1993-11#1)(1996-5#1)(2008-1#1)(2011-1#1)(2013-1#1)
an oblique##5##2##(1990-11#1)(1994-12#1)(2007-8#1)(2008-5#1)(2008-7#1)
an observation period of##3##4##(1992-11#1)(1997-4#1)(2008-5#1)
an observation##13##2##(1990-3#1)(1990-8#1)(1992-11#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2012-12#1)(2012-3#2)
an observational study##7##3##(1990-9#1)(1991-3#1)(1995-3#1)(1996-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
an observational##13##2##(1990-9#1)(1991-3#1)(1995-3#1)(1996-3#1)(1996-8#1)(2008-2#1)(2010-4#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
an observed##6##2##(1995-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
an observer##5##2##(2007-4#1)(2008-2#4)
an obsession##2##2##(2008-10#1)(2012-12#1)
an obstacle to##5##3##(1995-2#1)(1996-3#1)(2008-12#1)(2008-3#1)(2009-10#1)
an obstacle##6##2##(1995-2#1)(1996-3#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-11#1)
an obstructive##5##2##(2008-10#1)(2008-11#3)(2013-1#1)
an obvious##6##2##(1993-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
an occasion##2##2##(1993-2#1)(2008-5#1)
an occipital##2##2##(2008-7#1)(2011-2#1)
an occluded##3##2##(1997-2#1)(2008-12#1)(2008-5#1)
an occult##3##2##(1991-6#1)(1992-2#1)(2008-12#1)
an occupational therapist##3##3##(2011-2#1)(2012-2#1)(2013-7#1)
an occupational##6##2##(1992-5#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
an ocean sediment reference material##2##5##(2008-10#2)
an ocean##3##2##(2008-10#2)(2008-3#1)
an oceanographically based##2##3##(2008-9#2)
an octadecyl##2##2##(2008-10#2)
an octadecyl-bonded silica##2##3##(2008-10#2)
an ocular##4##2##(1994-8#1)(2008-6#1)(2009-3#1)(2013-8#1)
an odds ratio of##2##4##(2008-2#1)(2011-1#1)
an odds ratio##3##3##(2008-2#1)(2011-1#1)(2011-2#1)
an odds##5##2##(1994-7#1)(2008-2#1)(2010-11#1)(2011-1#1)(2011-2#1)
an odorant##2##2##(2008-10#1)(2008-12#1)
an odyssey##2##2##(1992-12#1)(2010-3#1)
an off-axis design for a##2##5##(2008-2#1)(2008-3#1)
an off-axis reference beam##2##4##(2008-3#2)
an off-axis##13##2##(2007-11#1)(2008-2#2)(2008-3#10)
an offensive##5##2##(1992-12#4)(1997-4#1)
an offer of##2##3##(1992-5#1)(1994-6#1)
an office##8##2##(1991-1#3)(1993-1#1)(1997-3#1)(1997-5#1)(2008-10#1)(2011-1#1)
an office-based##3##2##(2013-1#3)
an official method##4##3##(2008-10#4)
an official of##2##3##(1992-5#1)(1997-5#1)
an official##8##2##(1992-5#1)(1997-5#1)(2008-10#5)(2008-5#1)
an offline##2##2##(2010-8#1)(2013-8#1)
an offset of##2##3##(2008-2#1)(2008-3#1)
an offset point beacon##2##4##(2008-3#2)
an offset##7##2##(2008-2#2)(2008-3#3)(2008-6#1)(2013-1#1)
an often##7##2##(1990-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-8#1)
an oil##9##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-6#1)(2012-2#1)
an oil-in-water emulsion##2##3##(2008-10#1)(2008-5#1)
an oil-in-water##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#2)
an oily##2##2##(2008-5#2)
an old problem##2##3##(1993-8#1)(2010-8#1)
an old##20##2##(1991-2#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#1)(2013-1#1)
an older##10##2##(1994-8#2)(2008-3#2)(2008-9#1)(2010-10#3)(2012-12#1)(2012-2#1)
an olfactory##3##2##(1994-3#1)(2008-5#1)(2008-8#1)
an oligoclonal##2##2##(2008-11#1)(2011-2#1)
an oligodeoxyribonucleotide##3##2##(1990-5#1)(1993-12#1)(2008-4#1)
an oligomer##2##2##(1990-7#1)(1994-8#1)
an oligomeric##3##2##(2010-9#2)(2012-1#1)
an oligonucleotide##10##2##(1993-11#1)(1993-3#1)(1995-2#1)(2008-4#5)(2008-9#1)(2011-2#1)
an oligosaccharide##6##2##(1994-8#1)(2008-12#1)(2008-4#4)
an olive##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
an omnidirectional reflector##2##3##(2007-12#1)(2008-3#1)
an omnidirectional##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
an on-axis uniform circular beacon##2##5##(2008-3#2)
an on-axis##4##2##(2008-2#1)(2008-3#3)
an on-chip##2##2##(2008-10#1)(2009-12#1)
an on-line metal##2##3##(2008-10#1)(2010-5#1)
an on-line microwave##2##3##(2008-10#2)
an on-line preconcentration system for copper##2##6##(2008-10#2)
an on-line preconcentration system for##5##5##(2008-10#5)
an on-line preconcentration system##6##4##(2008-10#6)
an on-line preconcentration##7##3##(2008-10#7)
an on-line solid-phase extraction##2##4##(1997-2#1)(2008-10#1)
an on-line system##4##3##(2008-10#4)
an on-line##45##2##(1992-11#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#37)(2008-11#1)(2008-7#1)(2010-5#1)
an on/off##2##2##(2008-7#1)(2012-1#1)
an onboard diffuser##2##3##(2008-3#2)
an onboard##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
an oncogene##2##2##(1994-12#1)(2010-3#1)
an oncolytic##2##2##(1995-2#1)(2013-1#1)
an ongoing challenge##3##3##(1996-3#1)(2008-7#1)(2011-2#1)
an ongoing process##2##3##(1997-2#1)(2008-7#1)
an ongoing##35##2##(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
an online questionnaire##3##3##(2008-4#1)(2011-2#1)(2013-7#1)
an online randomized controlled trial##3##5##(2010-10#3)
an online survey##4##3##(2010-8#1)(2010-9#1)(2013-1#2)
an online##18##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
an only##2##2##(1995-3#1)(2008-10#1)
an onset of##2##3##(1993-1#1)(2008-5#1)
an onset##3##2##(1993-1#1)(1994-9#1)(2008-5#1)
an ontology##2##2##(2008-7#2)
an oocyte##2##2##(2012-2#2)
an opaque##8##2##(1993-6#1)(2007-12#2)(2008-2#1)(2008-3#4)
an open and##2##3##(1995-6#1)(1996-11#1)
an open circuit##2##3##(2008-10#1)(2010-12#1)
an open mind##2##3##(2007-8#1)(2009-7#1)
an open procedure##3##3##(2010-3#1)(2011-2#1)(2013-8#1)
an open pyelolithotomy was performed and##2##6##(2008-10#2)
an open question##2##3##(1996-11#1)(1996-4#1)
an open reading frame (ORF) encoding a##2##7##(1993-12#1)(1994-11#1)
an open reading frame (ORF) of##4##6##(1991-9#1)(1995-8#1)(2008-10#1)(2008-7#1)
an open reading frame (ORF) previously##2##6##(1996-8#1)(1997-3#1)
an open reading frame (ORF)##16##5##(1991-9#1)(1993-12#2)(1994-11#1)(1994-12#4)(1995-8#2)(1996-8#1)(1997-3#1)(2008-10#3)(2008-7#1)
an open reading frame encoding a protein##3##7##(1990-11#1)(2008-10#1)(2008-8#1)
an open reading frame encoding a##7##6##(1990-11#1)(1990-5#1)(1992-9#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-8#1)
an open reading frame encoding##13##5##(1990-11#1)(1990-5#1)(1991-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-6#2)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
an open reading frame of 1##3##6##(1992-3#1)(1997-9#1)(2008-9#1)
an open reading frame of##25##5##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#2)(1992-3#1)(1992-8#1)(1993-2#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-3#1)(1997-2#2)(1997-6#1)(1997-9#1)(2008-4#1)(2008-8#1)(2008-9#1)
an open reading frame that##3##5##(1992-10#1)(1997-2#1)(2008-9#1)
an open reading frame##64##4##(1990-11#2)(1990-12#1)(1990-5#2)(1991-12#3)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1994-11#2)(1994-12#5)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2012-3#1)
an open source##2##3##(2009-12#2)
an open study##3##3##(1990-12#1)(1991-2#1)(1991-3#1)
an open surgical##2##3##(1994-7#1)(2008-7#1)
an open tube##2##3##(2008-10#2)
an open urban area##2##4##(2008-10#1)(2008-11#1)
an open vessel##3##3##(2008-10#3)
an open##138##2##(1990-11#2)(1990-12#2)(1990-5#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-6#1)(1994-11#2)(1994-12#5)(1994-6#1)(1994-7#1)(1994-8#2)(1995-2#1)(1995-6#6)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-9#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-12#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
an open-angle mechanism##2##3##(2011-2#2)
an open-ended questionnaire##2##3##(1993-3#1)(2007-11#1)
an open-ended##4##2##(1993-3#1)(1995-12#1)(2007-11#1)(2010-9#1)
an open-label##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2009-11#1)
an opening##3##2##(1994-12#1)(2008-3#1)(2008-9#1)
an operant paradigm##2##3##(2008-10#2)
an operant##6##2##(1993-6#1)(2008-10#2)(2008-4#2)(2009-11#1)
an operating temperature##2##3##(2008-10#1)(2008-3#1)
an operating##11##2##(1991-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#1)(2011-2#1)
an operation for##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
an operation##16##2##(1992-6#1)(1993-2#1)(1993-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
an operational definition##3##3##(2008-10#1)(2013-1#2)
an operational##13##2##(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2013-1#2)
an operations##2##2##(1991-1#1)(1993-2#1)
an operative##3##2##(1990-3#1)(2007-8#1)(2012-3#1)
an operator##5##2##(2008-10#2)(2008-5#2)(2008-9#1)
an operon##3##2##(1990-11#1)(1991-9#1)(2008-10#1)
an opinion##2##2##(1990-12#1)(2010-12#1)
an opioid##4##2##(1991-5#1)(1996-12#1)(2008-11#1)(2008-7#1)
an opponent's##2##2##(2008-11#2)
an opportunist##2##2##(2007-7#1)(2008-8#1)
an opportunistic pathogen##3##3##(2010-10#1)(2011-2#1)(2012-3#1)
an opportunistic##7##2##(2007-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
an opportunity for health##2##4##(1996-12#1)(2008-7#1)
an opportunity for more##2##4##(2008-10#1)(2008-11#1)
an opportunity for##18##3##(1993-2#1)(1995-3#1)(1996-12#3)(1997-2#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-1#1)
an opportunity to improve##2##4##(2009-11#1)(2013-1#1)
an opportunity to reduce##2##4##(2009-4#1)(2013-1#1)
an opportunity to##42##3##(1991-3#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-3#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#5)
an opportunity##65##2##(1991-3#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#2)(2007-2#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#5)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#5)
an opposite effect##3##3##(1990-12#1)(1996-2#1)(2008-10#1)
an opposite##6##2##(1990-12#1)(1996-2#2)(2008-10#1)(2008-5#1)(2008-6#1)
an optical Fourier##2##3##(2008-3#1)(2011-1#1)
an optical arrangement##2##3##(2008-2#1)(2008-3#1)
an optical axis##2##3##(2007-11#1)(2008-3#1)
an optical beam##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
an optical biosensor##5##3##(1995-12#1)(1997-2#1)(2008-10#3)
an optical cavity##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
an optical coherence tomography##2##4##(2008-3#1)(2009-9#1)
an optical coherent transient##2##4##(2007-12#2)
an optical correlator##2##3##(2008-2#1)(2008-3#1)
an optical coupling##2##3##(2008-2#2)
an optical density##2##3##(2008-3#1)(2010-3#1)
an optical device##2##3##(2007-11#1)(2008-10#1)
an optical diode##3##3##(2007-11#2)(2008-3#1)
an optical disk drive##3##4##(2008-2#2)(2008-3#1)
an optical disk##13##3##(2008-2#7)(2008-3#6)
an optical double-random phase-encoding encryption system##2##6##(2008-3#2)
an optical efficiency of##2##4##(2007-11#1)(2008-2#1)
an optical element##2##3##(2007-11#1)(2008-3#1)
an optical fiber by##2##4##(2007-12#1)(2008-3#1)
an optical fiber from##2##4##(2007-11#2)
an optical fiber has been##2##5##(2007-11#2)
an optical fiber is##4##4##(2007-11#2)(2007-12#2)
an optical fiber##35##3##(2007-11#13)(2007-12#6)(2008-10#3)(2008-2#1)(2008-3#11)(2013-8#1)
an optical frequency##4##3##(2007-12#2)(2008-2#2)
an optical head for##2##4##(2008-3#2)
an optical head##3##3##(2008-3#3)
an optical heterodyne##2##3##(2008-2#2)
an optical implementation of##2##4##(2007-12#1)(2008-3#1)
an optical implementation##4##3##(2007-12#2)(2008-3#2)
an optical interconnect system##2##4##(2008-2#1)(2008-3#1)
an optical interconnect##3##3##(2008-2#2)(2008-3#1)
an optical interconnection##2##3##(2008-2#1)(2008-3#1)
an optical interferometer composed of tapered couplers##2##7##(2008-3#2)
an optical interferometer##3##3##(2008-3#2)(2011-1#1)
an optical microscope##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-10#1)
an optical octave##2##3##(2007-11#1)(2007-12#1)
an optical parametric oscillator (OPO)##5##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)
an optical parametric oscillator##9##4##(2007-11#4)(2007-12#3)(2008-10#1)(2008-5#1)
an optical parametric##11##3##(2007-11#6)(2007-12#3)(2008-10#1)(2008-5#1)
an optical path##2##3##(2008-3#2)
an optical pickup##3##3##(2007-12#1)(2008-3#2)
an optical power##2##3##(2008-2#2)
an optical pulse##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
an optical pumping##2##3##(2008-3#2)
an optical resolution##2##3##(2007-12#1)(2008-3#1)
an optical ring##4##3##(2007-11#1)(2008-3#3)
an optical sensor for##2##4##(1996-5#1)(2008-10#1)
an optical sensor##5##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#2)
an optical shutter##3##3##(2008-2#1)(2008-3#2)
an optical signal##2##3##(2008-10#1)(2008-3#1)
an optical source##2##3##(2007-11#1)(2008-3#1)
an optical spatial##2##3##(2007-11#1)(2008-3#1)
an optical spectrometer##2##3##(2008-3#2)
an optical system can be##2##5##(2008-2#1)(2008-3#1)
an optical system can##3##4##(2008-2#2)(2008-3#1)
an optical system that is##2##5##(2007-12#1)(2008-3#1)
an optical system that##3##4##(2007-12#1)(2008-3#2)
an optical system with##2##4##(2008-3#2)
an optical system##17##3##(2007-12#3)(2008-2#2)(2008-3#11)(2008-4#1)
an optical technique for##3##4##(2008-2#1)(2008-3#2)
an optical test##2##3##(2008-3#2)
an optical thickness##2##3##(2008-2#2)
an optical trap##6##3##(2008-2#2)(2008-3#3)(2012-2#1)
an optical vortex trap##2##4##(2009-5#2)
an optical vortex##3##3##(2007-11#1)(2009-5#2)
an optical waveguide##3##3##(2007-11#1)(2008-3#2)
an optical##313##2##(1992-11#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(2007-11#42)(2007-12#44)(2008-10#21)(2008-2#54)(2008-3#127)(2008-4#1)(2008-5#4)(2009-10#1)(2009-5#3)(2009-9#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
an optical-fiber##2##2##(2008-2#1)(2008-3#1)
an optical-to-optical conversion efficiency of##2##5##(2007-11#2)
an optical-to-optical##4##2##(2007-11#2)(2008-2#2)
an optically active##5##3##(2008-10#1)(2008-2#4)
an optically addressable##2##3##(2008-3#2)
an optically addressed spatial light modulator##2##6##(2008-2#1)(2008-3#1)
an optically addressed##7##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
an optically injected semiconductor laser##2##5##(2007-11#2)
an optically interconnected##2##3##(2008-2#1)(2008-3#1)
an optically pumped##2##3##(2007-12#2)
an optically thick scattering##2##4##(2008-3#2)
an optically thick##5##3##(2007-12#1)(2008-10#1)(2008-3#3)
an optically thin##2##3##(2008-2#1)(2008-3#1)
an optically trapped##2##3##(2007-11#1)(2012-2#1)
an optically##51##2##(2007-11#7)(2007-12#9)(2008-10#2)(2008-2#13)(2008-3#18)(2012-2#2)
an optimal growth rate at##2##5##(2008-10#2)
an optimal pH##3##3##(1990-2#1)(1995-2#1)(2008-10#1)
an optimal treatment##2##3##(2011-2#1)(2013-1#1)
an optimal value for##2##4##(2008-3#2)
an optimal##57##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-4#1)(2013-1#2)(2013-8#1)
an optimally##2##2##(2012-2#1)(2013-1#1)
an optimised##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
an optimization algorithm##3##3##(2007-11#1)(2008-3#2)
an optimization of##2##3##(2008-3#1)(2008-6#1)
an optimization study##2##3##(2008-2#1)(2011-2#1)
an optimization##12##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
an optimized version of##2##4##(2011-1#1)(2012-2#1)
an optimized version##3##3##(2011-1#2)(2012-2#1)
an optimized##21##2##(1992-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
an optimum beam##2##3##(2008-3#2)
an optimum calibration##2##3##(2008-10#2)
an optimum dose of##2##4##(1993-6#1)(2013-1#1)
an optimum near##2##3##(2008-10#2)
an optimum response at pH##2##5##(2008-10#2)
an optimum temperature##5##3##(2007-11#1)(2008-10#3)(2012-2#1)
an optimum##49##2##(1991-3#1)(1993-6#1)(1994-8#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#8)(2008-3#5)(2008-5#1)(2008-6#1)(2009-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
an option for the##3##4##(2007-6#2)(2008-5#1)
an option for##5##3##(1994-12#1)(2007-6#2)(2007-7#1)(2008-5#1)
an option in##3##3##(1997-6#1)(2011-2#1)(2012-1#1)
an optional##5##2##(2008-10#1)(2008-2#1)(2008-4#2)(2011-2#1)
an optoelectronic device##2##3##(2008-3#2)
an optoelectronic##12##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#8)
an optofluidic##2##2##(2010-8#1)(2011-1#1)
an optomechanical##2##2##(2008-3#1)(2012-2#1)
an oral daily dose of##2##5##(1994-6#2)
an oral dose##2##3##(1996-5#1)(2009-11#1)
an oral formulation##2##3##(2008-5#2)
an oral glucose tolerance test (OGTT)##2##6##(1994-12#1)(2012-3#1)
an oral glucose tolerance test##3##5##(1994-12#1)(2008-3#1)(2012-3#1)
an oral sustained release##2##4##(2008-11#1)(2012-2#1)
an oral##34##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1994-12#1)(1994-6#2)(1995-3#2)(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#5)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
an orange##2##2##(1995-4#1)(2007-12#1)
an orange-red##3##2##(2008-10#2)(2008-5#1)
an orbiting##4##2##(2008-3#2)(2011-2#2)
an orbitozygomatic##2##2##(2006-12#2)
an orchard##3##2##(2008-10#3)
an orchestrated##2##2##(2008-7#1)(2012-3#1)
an orchidectomy##3##2##(2007-8#1)(2008-6#2)
an order of magnitude and##2##5##(2008-2#1)(2012-2#1)
an order of magnitude greater than that##2##7##(2007-12#1)(2008-3#1)
an order of magnitude greater##4##5##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
an order of magnitude higher than that##2##7##(2008-10#1)(2008-7#1)
an order of magnitude higher than##3##6##(1991-5#1)(2008-10#1)(2008-7#1)
an order of magnitude higher##4##5##(1991-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
an order of magnitude larger than##3##6##(2007-11#1)(2009-9#1)(2010-8#1)
an order of magnitude less##2##5##(1997-2#1)(2008-2#1)
an order of magnitude lower than the##2##7##(1995-8#1)(2008-10#1)
an order of magnitude lower than##3##6##(1995-8#1)(2007-11#1)(2008-10#1)
an order of magnitude lower##4##5##(1990-8#1)(1995-8#1)(2007-11#1)(2008-10#1)
an order of magnitude##37##4##(1990-8#1)(1991-5#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
an order of##40##3##(1990-8#1)(1991-5#1)(1993-8#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
an order##43##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
an order-of-magnitude improvement##2##3##(2007-12#2)
an order-of-magnitude##4##2##(2007-11#1)(2007-12#2)(2008-8#1)
an ordered array##2##3##(1996-6#1)(2008-3#1)
an ordered##12##2##(1991-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
an ordinal scale##2##3##(2008-10#1)(2012-1#1)
an ordinal##6##2##(2008-10#2)(2008-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
an ordinary least squares##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
an ordinary##11##2##(1992-5#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-9#1)(2012-1#1)
an organ##13##2##(1990-3#1)(1993-12#2)(1993-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)
an organic modifier##7##3##(1990-8#1)(2008-10#6)
an organic nanowire spin valve##2##5##(2008-7#2)
an organic phase##2##3##(2008-10#2)
an organic solvent##8##3##(1992-3#1)(2008-10#6)(2008-7#1)
an organic##48##2##(1990-8#1)(1992-3#1)(1994-9#1)(1995-12#1)(2007-12#3)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2010-2#1)(2010-4#1)(2012-8#1)
an organisation##2##2##(2008-12#1)(2008-6#1)
an organism and##2##3##(1990-8#2)
an organism##10##2##(1990-7#1)(1990-8#2)(1995-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)
an organism's##5##2##(1995-12#1)(2008-4#1)(2008-7#1)(2008-8#2)
an organization are##2##3##(1995-3#1)(2012-3#1)
an organization is##2##3##(1991-12#1)(1994-2#1)
an organization##19##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1997-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-3#2)
an organization's##7##2##(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-1#1)(2009-10#1)(2010-8#1)
an organization-wide##2##2##(1996-2#2)
an organizational##8##2##(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(2008-11#1)
an organized##8##2##(1990-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
an organophosphate insecticide##2##3##(2009-3#1)(2013-1#1)
an organophosphate##3##2##(1997-5#1)(2009-3#1)(2013-1#1)
an organophosphorous##2##2##(1995-3#1)(2008-10#1)
an organophosphorus##2##2##(2008-10#2)
an orientation##7##2##(1991-11#1)(1994-5#1)(1996-1#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-8#1)
an oriented##5##2##(2008-10#1)(2008-2#3)(2009-11#1)
an origin##3##2##(1992-2#1)(2007-11#1)(2008-10#1)
an original method##2##3##(1995-6#1)(2008-2#1)
an original procedure##2##3##(1990-12#1)(2008-5#1)
an original##27##2##(1990-10#1)(1990-12#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-6#2)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-2#1)
an ornamental plant##2##3##(2008-12#1)(2011-2#1)
an orthodontic##3##2##(1990-10#1)(2008-12#1)(2012-12#1)
an orthogonal##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
an orthopaedic##3##2##(2008-5#1)(2012-12#2)
an orthophosphate calibration graph##2##4##(2008-10#2)
an orthophosphate##3##2##(2008-10#3)
an oscillating##8##2##(2006-12#1)(2007-11#1)(2008-10#3)(2008-2#3)
an oscillation##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
an oscillator-amplifier##2##2##(2008-3#2)
an oscillatory##4##2##(2008-11#2)(2008-2#1)(2009-9#1)
an osmiophilic##2##2##(1997-2#1)(2008-10#1)
an osmotic##4##2##(1996-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
an osseous##3##2##(1994-7#1)(2010-5#1)(2010-6#1)
an ossifying##2##2##(1992-2#2)
an osteoblastic##4##2##(2008-11#2)(2008-6#1)(2010-3#1)
an osteochondral##2##2##(2011-2#1)(2013-1#1)
an osteogenic##3##2##(2008-11#2)(2012-6#1)
an osteolytic lesion##3##3##(2007-11#1)(2008-12#2)
an osteoporotic##3##2##(1991-11#2)(2008-8#1)
an otherwise healthy##2##3##(1994-9#1)(2008-10#1)
an otherwise##12##2##(1994-9#1)(1995-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
an out-of-phase##2##2##(2007-12#1)(2008-3#1)
an out-of-plane##2##2##(2008-10#1)(2008-2#1)
an out-patient##4##2##(1993-12#1)(1994-11#1)(2008-5#1)(2008-9#1)
an outbreak in the##2##4##(1995-6#1)(2008-10#1)
an outbreak in##5##3##(1995-6#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
an outbreak of##13##3##(1991-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
an outbreak##20##2##(1991-11#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-12#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
an outcome of##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
an outcome##7##2##(1995-12#1)(1996-3#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-12#1)
an outcomes##2##2##(1997-1#1)(1997-2#1)
an outer membrane protein##2##4##(1990-11#1)(2008-5#1)
an outer##15##2##(1990-11#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
an outgroup##4##2##(2007-12#1)(2008-10#2)(2009-11#1)
an outlier##3##2##(1993-12#1)(1993-3#1)(2008-10#1)
an outline of the##7##4##(1992-12#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)
an outline of##10##3##(1992-12#1)(1993-2#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
an outline##11##2##(1992-12#1)(1992-3#1)(1993-2#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
an outlook into##2##3##(2008-5#1)(2010-12#1)
an outlook on the##2##4##(2008-5#1)(2008-8#1)
an outlook on##3##3##(2008-5#1)(2008-8#1)(2010-10#1)
an outlook##5##2##(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#1)
an outpatient basis##7##3##(1993-6#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-11#1)(2013-1#1)
an outpatient study##2##3##(1993-2#2)
an outpatient##22##2##(1991-1#2)(1991-2#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-3#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-12#2)(2013-1#1)
an output image##2##3##(2007-11#1)(2008-2#1)
an output power of 1##3##5##(2007-12#1)(2008-3#2)
an output power of##9##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
an output##23##2##(2007-11#4)(2007-12#4)(2008-2#6)(2008-3#9)
an outside##3##2##(1994-1#1)(2008-8#1)(2013-8#1)
an outstanding##6##2##(1991-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)
an outward##3##2##(1990-2#1)(1991-5#1)(2009-1#1)
an oval##2##2##(2008-3#1)(2010-10#1)
an ovarian##6##2##(1990-10#1)(1992-9#1)(1996-3#1)(2007-4#1)(2008-9#1)(2011-2#1)
an ovariole##2##2##(2008-7#2)
an ovary##2##2##(1993-9#1)(2008-10#1)
an oven##2##2##(2008-10#1)(2008-2#1)
an over##4##2##(2008-12#1)(2008-8#1)(2011-3#1)(2013-1#1)
an over-reliance on##2##3##(1996-11#1)(2011-1#1)
an overactive##2##2##(2008-4#1)(2009-2#1)
an overall accuracy of##2##4##(1990-9#1)(2007-5#1)
an overall agreement of##2##4##(1992-10#1)(2010-12#1)
an overall assessment##2##3##(2010-9#1)(2011-2#1)
an overall decrease in##3##4##(1997-8#1)(2007-12#1)(2008-6#1)
an overall efficiency of##2##4##(2008-3#2)
an overall improvement of##3##4##(1994-5#1)(2008-12#1)(2010-2#1)
an overall improvement##4##3##(1994-5#1)(1997-3#1)(2008-12#1)(2010-2#1)
an overall incidence of##5##4##(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
an overall large##2##3##(1997-3#1)(2009-9#1)
an overall picture of the##2##5##(1995-6#1)(2012-5#1)
an overall picture of##3##4##(1995-6#1)(2008-11#1)(2012-5#1)
an overall prevalence of##2##4##(2008-8#1)(2011-1#1)
an overall prevalence##3##3##(1994-6#1)(2008-8#1)(2011-1#1)
an overall reduction in the##2##5##(2007-7#1)(2008-10#1)
an overall reduction in##3##4##(2007-10#1)(2007-7#1)(2008-10#1)
an overall reduction##4##3##(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)
an overall##105##2##(1990-9#1)(1991-3#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)
an overall-sign##2##2##(2008-2#2)
an overarching##2##2##(2008-4#1)(2008-7#1)
an overdetermined set of##2##4##(2008-3#2)
an overdose of vitamin pills##2##5##(2008-10#2)
an overdose of##4##3##(1991-6#1)(2008-10#2)(2011-1#1)
an overestimation of the##2##4##(2008-2#2)
an overestimation of##6##3##(2008-10#1)(2008-11#1)(2008-2#2)(2011-1#1)(2011-2#1)
an overestimation##7##2##(2008-10#1)(2008-11#1)(2008-2#3)(2011-1#1)(2011-2#1)
an overexpression of##2##3##(1992-8#1)(2007-8#1)
an overhead##2##2##(2008-10#1)(2008-8#1)
an overlapping##2##2##(1993-6#1)(2010-5#1)
an overlay##3##2##(2008-3#2)(2008-5#1)
an overlooked##3##2##(1994-12#1)(1996-6#1)(2008-3#1)
an overnight##3##2##(2008-10#2)(2010-7#1)
an overproduction of##2##3##(2008-10#1)(2008-7#1)
an overriding second toe##2##4##(2010-11#2)
an overview about##2##3##(2010-10#1)(2013-1#1)
an overview and##5##3##(1991-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
an overview for##2##3##(1996-2#1)(2008-4#1)
an overview of a##2##4##(1991-12#1)(1995-3#1)
an overview of computer simulation##2##5##(2008-4#2)
an overview of current##4##4##(1994-1#1)(2008-4#1)(2011-2#1)(2012-2#1)
an overview of different##2##4##(2008-3#1)(2012-2#1)
an overview of how##4##4##(2007-4#1)(2008-11#2)(2008-9#1)
an overview of issues##2##4##(2008-4#2)
an overview of our recent##2##5##(2007-5#1)(2011-2#1)
an overview of our##4##4##(2007-12#1)(2007-5#1)(2008-10#1)(2011-2#1)
an overview of published##2##4##(1992-1#1)(2010-11#1)
an overview of recent##3##4##(2008-4#1)(2008-5#1)(2009-5#1)
an overview of some of the##3##6##(2007-5#1)(2008-12#1)(2008-7#1)
an overview of some##4##4##(1995-1#1)(2007-5#1)(2008-12#1)(2008-7#1)
an overview of the current##6##5##(2009-2#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
an overview of the field##4##5##(2007-12#1)(2008-4#2)(2009-9#1)
an overview of the literature##2##5##(2009-1#1)(2012-2#1)
an overview of the most important##2##6##(2010-9#1)(2011-2#1)
an overview of the most##5##5##(1991-6#1)(2008-4#1)(2010-11#1)(2010-9#1)(2011-2#1)
an overview of the problems##2##5##(2009-6#1)(2010-12#1)
an overview of the six##2##5##(1997-2#1)(2008-6#1)
an overview of the##93##4##(1991-1#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-2#3)(1997-4#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#3)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
an overview of their##3##4##(2008-5#1)(2011-1#1)(2013-1#1)
an overview of these##2##4##(1992-1#1)(1992-12#1)
an overview of this##3##4##(1994-2#1)(1996-1#1)(2011-2#1)
an overview of##187##3##(1990-6#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(2007-12#3)(2007-4#1)(2007-5#3)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#21)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#8)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#3)
an overview on the##4##4##(2008-10#1)(2008-4#1)(2009-7#1)(2010-11#1)
an overview on##5##3##(2008-10#2)(2008-4#1)(2009-7#1)(2010-11#1)
an overview##225##2##(1990-6#1)(1990-8#1)(1991-1#4)(1991-12#2)(1991-2#2)(1991-6#1)(1992-1#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#3)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#3)(2007-4#1)(2007-5#3)(2007-7#2)(2008-1#3)(2008-10#17)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#23)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#4)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#16)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#6)(2013-8#3)
an overweight##2##2##(2012-2#1)(2013-1#1)
an overwhelming##2##2##(1991-1#1)(2011-2#1)
an ovine##3##2##(1993-2#1)(2008-7#1)(2010-6#1)
an oxidant##5##2##(2008-10#5)
an oxidase##2##2##(2008-10#1)(2008-5#1)
an oxidation##2##2##(2008-10#1)(2008-5#1)
an oxidative burst##2##3##(1991-2#2)
an oxidative stress##5##3##(1993-6#1)(1994-9#1)(2008-10#1)(2010-12#1)(2013-1#1)
an oxidative##13##2##(1991-2#2)(1993-11#1)(1993-6#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#2)
an oxidized##4##2##(1995-2#1)(1995-6#1)(2008-10#2)
an oxidizing agent##3##3##(1996-5#1)(2008-10#2)
an oxidizing##5##2##(1991-9#1)(1996-5#1)(2008-10#3)
an oxygen electrode##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
an oxygen##9##2##(1992-11#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
an oxygen-permeable film##2##3##(2008-11#2)
an oxygen-rich##2##2##(2008-11#1)(2011-2#1)
an oxygen-sensitive##2##2##(1997-1#1)(2008-10#1)
an ozone hole##2##3##(1991-5#2)
an ozone##3##2##(1991-5#2)(2008-10#1)
an pI of##2##3##(2008-10#2)
an rDNA analysis##2##3##(2008-10#2)
an ubiquitin##3##2##(1997-2#1)(1997-3#1)(2012-2#1)
an ubiquitous##5##2##(1990-12#1)(1994-12#1)(2008-5#1)(2008-8#1)(2010-10#1)
an ultra##2##2##(2008-10#1)(2010-1#1)
an ultrabroadband##2##2##(2007-11#1)(2008-3#1)
an ultrafast optical##4##3##(2007-12#4)
an ultrafast##12##2##(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#2)
an ultrafiltration membrane with a##2##5##(2008-10#2)
an ultrafiltration##5##2##(1995-2#1)(1995-3#1)(2008-10#2)(2011-2#1)
an ultrashort optical pulse##3##4##(2007-11#2)(2008-3#1)
an ultrashort optical##4##3##(2007-11#2)(2008-3#2)
an ultrashort pulse##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
an ultrashort##14##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#3)
an ultrashort-pulsed##2##2##(2007-11#1)(2007-12#1)
an ultrasonic##16##2##(1990-9#1)(1992-11#1)(1993-2#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-3#1)(2010-8#1)
an ultrasound wave##2##3##(2007-12#1)(2008-3#1)
an ultrasound##9##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
an ultrasound-assisted##2##2##(2008-10#2)
an ultrastructural##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
an ultraviolet##3##2##(2008-10#1)(2008-2#2)
an umbrella##2##2##(1992-6#1)(2012-2#1)
an unaffected##2##2##(1992-6#1)(2008-3#1)
an unambiguous##6##2##(1995-9#2)(2008-10#1)(2008-3#1)(2011-2#2)
an unapodized##2##2##(2008-2#1)(2008-3#1)
an unbalanced##3##2##(2008-10#2)(2008-2#1)
an unbiased estimate of##2##4##(2008-3#1)(2008-8#1)
an unbiased estimate##3##3##(2008-3#2)(2008-8#1)
an unbiased##5##2##(1990-11#1)(2008-3#2)(2008-8#1)(2012-2#1)
an uncemented##3##2##(2008-8#1)(2009-4#1)(2012-12#1)
an uncertain##3##2##(1990-9#1)(1996-3#1)(2007-2#1)
an uncertainty of 0##2##4##(2006-4#1)(2008-2#1)
an uncertainty of less than##2##5##(2008-10#1)(2008-3#1)
an uncertainty of##10##3##(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#3)
an uncertainty##14##2##(1992-6#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-2#4)(2008-3#3)
an unchanged##3##2##(1990-6#1)(2008-3#1)(2012-2#1)
an uncharacterized##3##2##(1996-6#1)(2008-11#1)(2008-8#1)
an unclear##2##2##(2010-10#1)(2013-1#1)
an uncoated##8##2##(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)
an uncommon case of##4##4##(1993-6#1)(2007-10#1)(2011-2#2)
an uncommon cause of lower##2##5##(2008-8#1)(2013-1#1)
an uncommon cause of##9##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
an uncommon cause##10##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
an uncommon circumstance##2##3##(2011-2#2)
an uncommon clinical entity##4##4##(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)
an uncommon clinical##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
an uncommon condition##5##3##(2006-10#1)(2007-7#1)(2008-7#1)(2010-4#1)(2011-2#1)
an uncommon disease##3##3##(2008-1#2)(2009-5#1)
an uncommon manifestation of##2##4##(2007-10#1)(2007-7#1)
an uncommon tumor##2##3##(2011-2#1)(2012-12#1)
an uncommon##78##2##(1990-5#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-6#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#3)(2008-12#4)(2008-6#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
an uncompetitive##3##2##(1991-12#1)(1994-5#1)(1996-8#1)
an uncomplicated postoperative recovery##2##4##(2008-7#1)(2008-8#1)
an uncomplicated##5##2##(1996-9#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)
an unconditioned##2##2##(1996-2#1)(1997-7#1)
an unconjugated primary##2##3##(2008-9#2)
an unconjugated##3##2##(2008-9#2)(2013-1#1)
an uncontrolled##3##2##(2007-10#1)(2008-3#1)(2013-8#1)
an undamaged##3##2##(1995-2#1)(2008-8#1)(2009-4#1)
an under-recognised##2##2##(2010-10#1)(2010-12#1)
an under-recognized##2##2##(2008-10#1)(2008-7#1)
an underestimated##5##2##(1992-9#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
an underestimation of the##3##4##(2008-2#1)(2008-3#1)(2012-3#1)
an underestimation of##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
an underestimation##6##2##(2008-2#3)(2008-3#1)(2011-2#1)(2012-3#1)
an undergraduate nursing##2##3##(2008-11#2)
an undergraduate programme##2##3##(2008-11#2)
an undergraduate##10##2##(1992-12#1)(2008-11#7)(2012-1#2)
an underlying cause##2##3##(2009-3#1)(2013-8#1)
an underlying condition##2##3##(2008-4#1)(2011-2#1)
an underlying neurological##2##3##(2011-1#1)(2013-1#1)
an underlying##25##2##(1994-2#1)(1995-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
an understanding of how the##2##5##(1993-1#1)(2009-12#1)
an understanding of how##6##4##(1993-1#1)(1994-1#1)(2008-9#2)(2009-12#1)(2009-6#1)
an understanding of the mechanisms##2##5##(2008-7#1)(2013-1#1)
an understanding of the##32##4##(1990-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-10#1)(2011-2#2)(2013-1#1)
an understanding of##58##3##(1990-12#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
an understanding##60##2##(1990-12#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-12#1)(2013-1#2)
an underutilized##2##2##(1992-1#1)(2011-1#1)
an undesirable##2##2##(2008-3#1)(2013-1#1)
an undetermined##2##2##(1992-2#1)(2007-12#1)
an undiagnosed##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
an undoped##2##2##(2008-10#1)(2008-2#1)
an undue##2##2##(1996-5#1)(1997-7#1)
an unequivocal##4##2##(1997-3#1)(2008-10#1)(2008-2#1)(2009-8#1)
an uneventful recovery##11##3##(1993-9#1)(1994-2#1)(1997-3#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
an uneventful##15##2##(1993-9#1)(1994-2#1)(1997-3#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
an unexpected and##2##3##(2008-6#1)(2011-1#1)
an unexpected##25##2##(1990-12#1)(1992-6#1)(1992-9#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#2)
an unexpectedly large##2##3##(2012-12#1)(2013-1#1)
an unexpectedly##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
an unfamiliar##7##2##(1994-8#1)(2008-4#1)(2010-2#3)(2012-12#1)(2013-7#1)
an unfavorable outcome##5##3##(2009-8#1)(2012-3#4)
an unfavorable##12##2##(1993-11#1)(1997-1#1)(2008-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#4)(2013-1#2)
an unfavourable clinical##2##3##(2008-7#1)(2013-1#1)
an unfavourable##7##2##(1991-12#1)(1992-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
an unfolding##2##2##(1997-2#1)(2007-12#1)
an unhealthy##3##2##(2010-6#2)(2013-1#1)
an unidentified##12##2##(1990-12#1)(1992-2#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-5#1)
an uninterrupted##3##2##(1994-12#1)(2008-8#1)(2011-1#1)
an unique##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
an unknown compound##2##3##(1990-8#1)(2008-10#1)
an unknown input scene##2##4##(2008-2#2)
an unknown number of##2##4##(1994-12#1)(2008-9#1)
an unknown##37##2##(1990-8#1)(1994-12#1)(1994-9#1)(1996-9#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
an unlikely explanation##2##3##(2008-10#1)(2010-6#1)
an unlikely##4##2##(1996-2#1)(2008-10#1)(2010-6#1)(2013-1#1)
an unlimited##2##2##(2008-2#2)
an unmanaged##2##2##(1995-2#1)(2008-10#1)
an unmodified carbon paste electrode##2##5##(2008-10#2)
an unmodified##5##2##(1990-7#1)(1993-11#1)(2007-12#1)(2008-10#2)
an unnamed##2##2##(2008-10#1)(2008-2#1)
an unnecessary##2##2##(1991-6#1)(1992-5#1)
an unobserved##2##2##(1992-6#1)(2011-2#1)
an unperturbed##2##2##(2007-11#1)(2008-10#1)
an unprecedented resolution##2##3##(2008-5#1)(2009-6#1)
an unprecedented##9##2##(1996-2#1)(1997-7#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)
an unpredictable##2##2##(2008-8#1)(2009-5#1)
an unrecognized##5##2##(1993-2#1)(1996-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
an unrelated##6##2##(1997-3#1)(2008-10#1)(2008-8#2)(2009-6#1)(2013-1#1)
an unreliable##2##2##(2008-10#2)
an unrestricted covariate##2##3##(1994-2#2)
an unrestricted##3##2##(1994-2#2)(2009-4#1)
an unselected##2##2##(2008-3#1)(2012-3#1)
an unstable resonator##5##3##(2008-2#1)(2008-3#4)
an unstable tautomer##2##3##(2007-12#2)
an unstable##20##2##(1996-3#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-4#1)(2009-5#1)(2011-2#2)(2013-1#1)
an unstratified##2##2##(1995-9#1)(2008-3#1)
an unstructured##4##2##(2010-11#1)(2013-1#3)
an untapped source of##2##4##(2008-7#1)(2010-2#1)
an untreatable##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
an untreated control##3##3##(1993-9#1)(2008-5#2)
an untreated##7##2##(1992-2#1)(1993-9#1)(2008-10#2)(2008-5#3)
an ununited ossicle##2##3##(2008-9#2)
an ununited##3##2##(1991-3#1)(2008-9#2)
an unusual and##2##3##(2008-6#1)(2008-9#1)
an unusual arrangement##2##3##(1990-11#1)(2009-8#1)
an unusual bacterium##3##3##(2007-7#2)(2009-8#1)
an unusual case of a##4##5##(2006-10#1)(2008-10#1)(2008-9#1)(2011-2#1)
an unusual case of##20##4##(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
an unusual case##25##3##(1997-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)
an unusual cause of##6##4##(2008-1#1)(2008-10#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
an unusual cause##8##3##(2008-1#1)(2008-10#1)(2009-3#1)(2009-8#2)(2010-12#1)(2013-1#1)(2013-8#1)
an unusual clinical presentation##2##4##(2007-8#1)(2008-11#1)
an unusual complication of##3##4##(2006-10#1)(2009-9#1)(2011-2#1)
an unusual complication##5##3##(2006-10#1)(2008-7#2)(2009-9#1)(2011-2#1)
an unusual form of##4##4##(2006-10#1)(2007-10#1)(2009-6#1)(2012-2#1)
an unusual location for##2##4##(2008-10#1)(2011-2#1)
an unusual location##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
an unusual mode of##2##4##(2009-10#2)
an unusual presentation##8##3##(1997-8#1)(2007-7#1)(2008-7#4)(2011-2#1)(2012-3#1)
an unusual type##2##3##(1993-8#1)(2008-12#1)
an unusual##127##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#5)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#5)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
an unusually large##2##3##(2007-11#1)(2013-7#1)
an unusually##10##2##(1990-12#1)(1990-8#1)(1993-12#1)(1993-2#2)(1994-8#1)(1997-7#1)(2007-11#1)(2012-12#1)(2013-7#1)
an unwanted##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
an unweighted##2##2##(1991-12#1)(2008-10#1)
an up to##2##3##(2007-12#1)(2011-2#1)
an up##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
an up-regulation of##4##3##(1991-5#1)(1994-6#1)(2010-11#1)(2010-4#1)
an up-to-date##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
an upcoming##3##2##(2008-7#1)(2009-8#1)(2010-12#1)
an update of the##2##4##(2008-9#1)(2012-1#1)
an update of##6##3##(1994-3#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-2#2)
an update on the current##2##5##(2011-1#1)(2013-1#1)
an update on the##5##4##(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
an update on##12##3##(1991-3#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
an update##30##2##(1991-1#1)(1991-3#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#2)
an updated overview##2##3##(2008-9#1)(2011-1#1)
an updated##7##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-8#1)
an upper eyelid crease##2##4##(2010-8#2)
an upper limit of##2##4##(1991-5#1)(2008-10#1)
an upper limit##6##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#3)
an upper##18##2##(1991-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-8#1)
an upside-down##3##2##(2008-2#1)(2008-3#2)
an upstream##3##2##(1994-12#1)(1995-8#1)(2008-4#1)
an upward##2##2##(2008-7#1)(2010-1#1)
an urban and rural##2##4##(2012-12#2)
an urban area of##2##4##(2008-7#1)(2009-10#1)
an urban area with##2##4##(2008-5#1)(2011-1#1)
an urban area##8##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-12#1)
an urban health##2##3##(1997-4#1)(2009-10#1)
an urban population##5##3##(1990-2#1)(1991-1#1)(2008-11#1)(2008-3#1)(2011-2#1)
an urban sample of##2##4##(2009-7#1)(2013-1#1)
an urban setting##2##3##(2009-6#1)(2012-12#1)
an urban##40##2##(1990-2#1)(1991-1#1)(1993-10#1)(1994-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-10#3)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#1)
an urgent need for##5##4##(2007-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)
an urgent need to develop##2##5##(2009-5#1)(2010-5#1)
an urgent need to##7##4##(1996-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#1)
an urgent need##14##3##(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
an urgent##22##2##(1996-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-9#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
an useful tool in##2##4##(1992-3#1)(2006-10#1)
an useful##5##2##(1992-3#1)(2006-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
an x-ray##4##2##(2008-2#1)(2008-3#1)(2009-11#1)(2012-12#1)
an##23328##1##(1990-10#16)(1990-11#80)(1990-12#103)(1990-2#64)(1990-3#44)(1990-4#3)(1990-5#88)(1990-6#52)(1990-7#59)(1990-8#83)(1990-9#34)(1991-1#42)(1991-10#6)(1991-11#45)(1991-12#126)(1991-2#82)(1991-3#54)(1991-4#13)(1991-5#96)(1991-6#65)(1991-7#13)(1991-8#41)(1991-9#85)(1992-1#47)(1992-10#13)(1992-11#74)(1992-12#113)(1992-2#90)(1992-3#135)(1992-4#8)(1992-5#40)(1992-6#93)(1992-7#9)(1992-8#94)(1992-9#80)(1993-1#60)(1993-10#7)(1993-11#81)(1993-12#151)(1993-2#67)(1993-3#110)(1993-5#12)(1993-6#69)(1993-8#69)(1993-9#64)(1994-1#23)(1994-10#1)(1994-11#107)(1994-12#144)(1994-2#129)(1994-3#117)(1994-5#86)(1994-6#76)(1994-7#14)(1994-8#104)(1994-9#65)(1995-1#36)(1995-11#52)(1995-12#131)(1995-2#178)(1995-3#111)(1995-4#4)(1995-5#81)(1995-6#123)(1995-8#70)(1995-9#26)(1996-1#56)(1996-10#6)(1996-11#27)(1996-12#139)(1996-2#136)(1996-3#107)(1996-4#15)(1996-5#100)(1996-6#33)(1996-7#16)(1996-8#22)(1996-9#27)(1997-1#76)(1997-2#141)(1997-3#123)(1997-4#92)(1997-5#43)(1997-6#66)(1997-7#93)(1997-8#72)(1997-9#3)(2006-10#33)(2006-12#13)(2006-4#6)(2006-5#4)(2006-6#7)(2006-7#3)(2006-9#1)(2007-1#2)(2007-10#96)(2007-11#547)(2007-12#639)(2007-2#43)(2007-3#1)(2007-4#12)(2007-5#35)(2007-6#17)(2007-7#122)(2007-8#162)(2007-9#20)(2008-1#233)(2008-10#3564)(2008-11#908)(2008-12#334)(2008-2#877)(2008-3#1623)(2008-4#413)(2008-5#588)(2008-6#271)(2008-7#714)(2008-8#474)(2008-9#445)(2009-1#21)(2009-10#108)(2009-11#92)(2009-12#84)(2009-2#39)(2009-3#71)(2009-4#58)(2009-5#110)(2009-6#78)(2009-7#77)(2009-8#114)(2009-9#88)(2010-1#54)(2010-10#97)(2010-11#97)(2010-12#102)(2010-2#52)(2010-3#103)(2010-4#79)(2010-5#105)(2010-6#76)(2010-7#51)(2010-8#136)(2010-9#30)(2011-1#244)(2011-10#10)(2011-2#787)(2011-3#40)(2011-7#7)(2011-8#2)(2012-1#82)(2012-12#287)(2012-2#472)(2012-3#357)(2012-4#1)(2012-5#4)(2012-6#3)(2012-7#7)(2012-8#3)(2012-9#3)(2013-1#672)(2013-3#3)(2013-7#73)(2013-8#291)
ana##3##1##(2013-8#3)
anabolic agents##2##2##(2010-7#2)
anabolic compounds##2##2##(2008-10#2)
anabolic effect##3##2##(1997-7#1)(2007-8#1)(2013-1#1)
anabolic effects on##3##3##(1993-11#1)(2008-8#1)(2013-1#1)
anabolic hormones##2##2##(2011-2#1)(2012-2#1)
anabolic steroids and##2##3##(1991-3#1)(2008-5#1)
anabolic steroids in##3##3##(2008-10#2)(2010-11#1)
anabolic steroids##7##2##(1991-3#2)(2008-10#2)(2008-5#1)(2010-11#1)(2010-4#1)
anabolic##33##1##(1991-3#3)(1992-6#1)(1993-11#1)(1997-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#3)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
anabolic/catabolic##2##1##(2008-5#2)
anabolites##5##1##(2008-7#5)
anaemia and##6##2##(1994-6#1)(1995-5#1)(2007-8#1)(2008-5#1)(2009-4#2)
anaemia could##2##2##(1990-3#1)(2008-5#1)
anaemia in children aged##2##4##(2009-10#2)
anaemia in diabetes##3##3##(2008-1#3)
anaemia in##7##2##(2008-1#3)(2009-10#4)
anaemia virus##8##2##(2007-6#2)(2008-5#4)(2009-6#2)
anaemia was##2##2##(2009-10#1)(2011-1#1)
anaemia with##2##2##(1995-3#1)(2012-2#1)
anaemia##65##1##(1990-11#2)(1990-3#1)(1990-9#1)(1991-3#3)(1993-8#1)(1994-6#2)(1995-3#2)(1995-5#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#7)(2008-11#1)(2008-5#7)(2008-7#2)(2009-10#9)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-2#4)(2013-8#4)
anaemic##4##1##(1990-3#3)(2010-8#1)
anaerobes were##2##2##(2007-7#2)
anaerobes##12##1##(1996-6#1)(2007-12#1)(2007-7#5)(2008-12#4)(2011-2#1)
anaerobic and##6##2##(1990-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#2)
anaerobic bacteria##9##2##(1990-8#1)(1991-2#1)(2008-5#1)(2008-6#1)(2011-1#5)
anaerobic bacterium##4##2##(1990-11#2)(1990-12#1)(2008-9#1)
anaerobic capacity##2##2##(2008-5#2)
anaerobic co-digestion##2##2##(2013-1#2)
anaerobic condition##2##2##(1994-6#1)(2013-1#1)
anaerobic conditions##15##2##(1991-2#2)(1993-8#1)(1995-5#1)(1995-6#2)(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
anaerobic digester##2##2##(2008-6#1)(2008-7#1)
anaerobic digesters##4##2##(2008-6#1)(2008-7#3)
anaerobic digestion process##2##3##(2008-6#2)
anaerobic digestion##3##2##(2008-6#3)
anaerobic environment of##2##3##(2008-6#2)
anaerobic granular sludges##3##3##(2008-10#3)
anaerobic metabolism##3##2##(2010-11#1)(2012-12#1)(2013-1#1)
anaerobic systems##2##2##(2008-6#1)(2008-7#1)
anaerobic##113##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1991-2#3)(1993-8#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-3#1)(1997-4#2)(2007-7#4)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-5#5)(2008-6#12)(2008-7#11)(2008-8#1)(2008-9#6)(2010-11#1)(2010-12#1)(2011-1#6)(2011-2#13)(2012-12#1)(2012-3#1)(2013-1#12)(2013-8#2)
anaerobically##2##1##(1992-6#1)(2011-1#1)
anaerobiosis##6##1##(1996-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-6#2)
anaesthesia and##6##2##(1992-11#2)(2008-5#1)(2008-7#1)(2010-7#2)
anaesthesia for caesarean section##4##4##(2006-10#1)(2009-7#1)(2010-11#1)(2012-12#1)
anaesthesia for##9##2##(1990-6#1)(1996-6#1)(2006-10#1)(2007-8#2)(2009-7#1)(2010-11#1)(2012-12#2)
anaesthesia in patients at##2##4##(2006-10#2)
anaesthesia in patients##3##3##(1990-6#1)(2006-10#2)
anaesthesia in##7##2##(1990-6#1)(1991-9#1)(2006-10#2)(2008-2#1)(2011-1#1)(2012-2#1)
anaesthesia is##3##2##(1992-11#2)(2007-8#1)
anaesthesia management##3##2##(2010-7#3)
anaesthesia or##2##2##(2011-2#1)(2013-1#1)
anaesthesia to##3##2##(1995-5#1)(1996-9#1)(2008-12#1)
anaesthesia using##2##2##(2010-7#1)(2011-2#1)
anaesthesia was induced##2##3##(1996-6#1)(2010-7#1)
anaesthesia was##4##2##(1996-6#1)(2010-7#2)(2011-1#1)
anaesthesia were##3##2##(1996-6#1)(2008-8#1)(2010-7#1)
anaesthesia with propofol##2##3##(2011-2#2)
anaesthesia with##4##2##(2006-10#1)(2011-2#3)
anaesthesia##100##1##(1990-6#2)(1991-9#1)(1992-11#7)(1993-10#2)(1994-2#1)(1994-3#1)(1995-5#1)(1996-6#4)(1996-9#1)(1997-6#1)(2006-10#10)(2007-11#1)(2007-8#4)(2007-9#4)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-3#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#15)(2010-8#2)(2011-1#6)(2011-2#11)(2012-12#2)(2012-2#2)(2013-1#3)
anaesthesiological course##2##2##(2009-3#2)
anaesthesiologist##2##1##(2010-7#2)
anaesthesiologists##4##1##(2007-9#1)(2008-8#1)(2010-7#1)(2011-2#1)
anaesthesiology##5##1##(1993-5#1)(2008-1#1)(2009-5#2)(2010-7#1)
anaesthetic and##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
anaesthetic drugs##2##2##(2007-9#1)(2008-8#1)
anaesthetic implications##2##2##(2010-7#1)(2011-1#1)
anaesthetic management##4##2##(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
anaesthetic technique##2##2##(2008-7#1)(2008-8#1)
anaesthetic techniques##4##2##(1991-6#1)(1994-3#2)(2011-2#1)
anaesthetic vapours##3##2##(1991-6#2)(1997-3#1)
anaesthetic##37##1##(1991-6#4)(1992-11#1)(1993-10#1)(1994-3#4)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#2)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#3)(2010-7#7)(2011-1#3)(2011-2#3)(2013-1#1)
anaesthetics##4##1##(1991-6#1)(1994-3#1)(1995-11#1)(2010-7#1)
anaesthetised rat##3##2##(1991-2#2)(1997-2#1)
anaesthetised rats##2##2##(1991-2#1)(1995-12#1)
anaesthetised##9##1##(1991-2#3)(1995-12#2)(1995-9#1)(1996-6#1)(1997-2#1)(2008-7#1)
anaesthetist##4##1##(2007-9#1)(2009-3#1)(2012-12#2)
anaesthetized##8##1##(1995-12#3)(1996-5#1)(2007-10#1)(2008-7#1)(2011-2#2)
anagen I##2##2##(2008-5#2)
anagen##8##1##(2008-5#6)(2008-8#2)
anakinra##4##1##(2012-2#4)
anal anatomy and##2##3##(1997-8#2)
anal anatomy##3##2##(1997-8#3)
anal atresia##2##2##(2008-7#1)(2008-8#1)
anal canal##4##2##(2013-1#4)
anal cancer##6##2##(1991-6#3)(2010-12#3)
anal incontinence##3##2##(2011-2#3)
anal intercourse (median =##2##4##(2011-1#2)
anal intercourse with##2##3##(2008-12#2)
anal intercourse##5##2##(2008-12#2)(2010-7#1)(2011-1#2)
anal intraepithelial##2##2##(2011-1#1)(2013-8#1)
anal sphincter##4##2##(2011-2#4)
anal##58##1##(1990-3#1)(1991-6#3)(1992-5#3)(1996-11#1)(1996-8#2)(1997-8#3)(2007-10#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#3)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#10)(2012-2#1)(2013-1#6)(2013-7#3)(2013-8#3)
analgesia (p=0##2##2##(2008-10#2)
analgesia and antiemetic##3##3##(2012-2#3)
analgesia and the##2##3##(1991-1#1)(2008-7#1)
analgesia and##17##2##(1990-7#2)(1991-1#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
analgesia at##2##2##(1990-7#1)(2008-7#1)
analgesia during##5##2##(1990-8#1)(1991-6#1)(1993-10#1)(1995-3#1)(2012-3#1)
analgesia for##4##2##(2007-12#1)(2007-9#1)(2008-10#1)(2012-3#1)
analgesia in##9##2##(1990-7#1)(1993-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#2)
analgesia scores##2##2##(2008-10#2)
analgesia was##5##2##(1993-12#1)(1996-2#1)(2007-11#2)(2007-8#1)
analgesia with##3##2##(1993-1#1)(2009-5#1)(2012-3#1)
analgesia##89##1##(1990-7#5)(1990-8#1)(1991-1#1)(1991-6#1)(1992-2#1)(1993-1#2)(1993-10#3)(1993-12#3)(1993-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#7)(2008-11#1)(2008-3#3)(2008-7#5)(2008-8#5)(2009-12#2)(2009-5#4)(2010-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#2)(2013-8#3)
analgesia]##2##1##(2009-5#1)(2012-3#1)
analgesic action##2##2##(1997-2#1)(2011-1#1)
analgesic activity and##2##3##(1992-3#1)(2008-12#1)
analgesic activity of##2##3##(2013-1#2)
analgesic activity##8##2##(1992-3#1)(2008-11#1)(2008-12#2)(2011-1#2)(2013-1#2)
analgesic agents##2##2##(2008-8#1)(2009-5#1)
analgesic and##6##2##(1993-12#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)
analgesic consumption##3##2##(2009-3#3)
analgesic effect of##4##3##(1996-2#2)(2008-11#1)(2011-2#1)
analgesic effect##15##2##(1990-10#1)(1990-6#1)(1991-2#1)(1993-11#1)(1996-2#3)(2008-10#1)(2008-11#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-7#3)
analgesic effectiveness of##3##3##(2007-8#1)(2010-4#2)
analgesic effects of##4##3##(1990-5#1)(2008-10#1)(2012-1#1)(2013-1#1)
analgesic effects##8##2##(1990-5#1)(1991-1#1)(2008-10#2)(2009-12#1)(2010-7#1)(2012-1#1)(2013-1#1)
analgesic efficacy##3##2##(1990-6#1)(1993-1#1)(2010-12#1)
analgesic medications##3##2##(1993-11#1)(2010-6#1)(2011-2#1)
analgesic properties of##2##3##(1995-12#1)(2011-2#1)
analgesic requirements##3##2##(2007-11#2)(2009-5#1)
analgesic use##3##2##(1993-12#1)(2010-11#1)(2012-3#1)
analgesic##99##1##(1990-10#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-2#1)(1992-3#1)(1993-1#3)(1993-11#2)(1993-12#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-2#1)(2006-10#2)(2007-11#6)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#3)(2009-3#3)(2009-5#4)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#5)(2011-1#4)(2011-2#9)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#4)
analgesics and##7##2##(1992-5#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
analgesics for medically compromised patients undergoing oral surgery##2##8##(1993-1#2)
analgesics in the##3##3##(1991-8#1)(1995-5#1)(2011-2#1)
analgesics##36##1##(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-1#2)(1993-9#2)(1994-3#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#2)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#4)
analgesics)##3##1##(2008-10#1)(2010-11#2)
analgetic drugs and##2##3##(2007-11#2)
analgetic##5##1##(1991-5#1)(1994-3#1)(2007-11#3)
analgetics intake##2##2##(2007-11#2)
analgetics##6##1##(1995-11#2)(1997-5#1)(2007-11#3)
analise the##2##2##(2013-8#2)
analog K##2##2##(1994-8#2)
analog and##3##2##(1993-12#1)(2008-2#1)(2011-3#1)
analog binding##2##2##(1991-9#1)(1993-12#1)
analog does##2##2##(1991-2#1)(1992-6#1)
analog in##4##2##(1990-2#1)(1992-12#1)(1992-6#1)(1994-8#1)
analog is##4##2##(1991-5#1)(1994-12#1)(1997-6#1)(2008-4#1)
analog of ATP##2##3##(1995-8#1)(2008-4#1)
analog of the##4##3##(1992-12#1)(1993-6#1)(1993-8#1)(2008-2#1)
analog of##27##2##(1990-5#1)(1992-12#1)(1993-11#2)(1993-6#1)(1993-8#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#2)(1996-4#1)(1997-6#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-8#1)
analog to the##2##3##(1993-8#1)(1994-12#1)
analog to##6##2##(1993-8#1)(1994-12#1)(1997-4#1)(2008-11#2)(2012-12#1)
analog was##3##2##(1991-2#1)(1991-9#1)(1992-11#1)
analog##166##1##(1990-12#1)(1990-2#4)(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#6)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#4)(1993-1#2)(1993-11#2)(1993-12#2)(1993-6#4)(1993-8#5)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#7)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#3)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#6)(2008-3#5)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
analog-to-digital conversion##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
analog-to-digital##9##1##(2007-12#1)(2008-2#2)(2008-3#5)(2011-1#1)
analogical##3##1##(2008-3#2)(2010-6#1)
analogies##5##1##(2007-12#2)(2008-10#1)(2012-3#2)
analogous systems##2##2##(1994-5#1)(2008-10#1)
analogous to a##4##3##(2008-3#2)(2009-11#1)(2011-2#1)
analogous to that##5##3##(1991-5#2)(1994-11#1)(2007-11#1)(2010-10#1)
analogous to the##22##3##(1990-11#1)(1990-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
analogous to those##4##3##(1992-6#1)(1993-11#1)(1994-11#1)(2012-3#1)
analogous to##52##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-9#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1997-2#2)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
analogous with##2##2##(2007-12#1)(2008-2#1)
analogous##113##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-5#3)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#11)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-5#2)(2010-7#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
analogs 2a and 2b##2##4##(2013-1#2)
analogs J and K##2##4##(1994-8#2)
analogs and##6##2##(1997-4#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
analogs are##4##2##(1992-6#1)(1994-5#1)(2008-1#1)(2008-8#1)
analogs as##3##2##(1992-11#1)(1993-8#1)(2007-5#1)
analogs by##2##2##(2008-10#2)
analogs have been##2##3##(2008-10#1)(2008-5#1)
analogs have##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
analogs in the##2##3##(1995-6#1)(2008-10#1)
analogs in##6##2##(1991-12#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-4#1)
analogs is##4##2##(1992-9#1)(1995-3#1)(2008-4#2)
analogs of GTP and##2##4##(1991-5#2)
analogs of GTP##3##3##(1991-5#2)(1993-6#1)
analogs of cocaine##2##3##(1991-12#2)
analogs of emergent iono-neuronal dynamics##2##5##(2009-5#2)
analogs of the pseudosubstrate domain of smooth muscle##2##8##(1992-9#2)
analogs of the##7##3##(1990-5#1)(1992-8#1)(1992-9#2)(1995-3#1)(2008-10#1)(2008-4#1)
analogs of vitamin D##2##4##(1992-1#2)
analogs of##39##2##(1990-11#2)(1990-2#3)(1990-5#1)(1991-12#2)(1991-5#2)(1992-1#2)(1992-11#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-3#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2009-5#2)(2012-2#1)
analogs on##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
analogs that##2##2##(2008-4#1)(2008-6#1)
analogs were synthesized##3##3##(1995-3#1)(2008-6#1)(2011-2#1)
analogs were##9##2##(1992-8#1)(1992-9#1)(1994-11#1)(1995-3#1)(2008-6#1)(2009-2#3)(2011-2#1)
analogs with##5##2##(1994-8#1)(1995-12#2)(2009-2#1)(2013-8#1)
analogs##178##1##(1990-11#2)(1990-2#3)(1990-5#2)(1991-1#2)(1991-12#4)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#1)(1993-6#2)(1993-8#4)(1994-11#3)(1994-12#2)(1994-5#6)(1994-6#3)(1994-8#11)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#12)(1995-5#1)(1995-6#4)(1996-2#2)(1997-4#1)(2007-11#5)(2007-12#1)(2007-5#1)(2008-1#5)(2008-10#17)(2008-11#6)(2008-4#15)(2008-5#2)(2008-6#2)(2008-8#3)(2009-2#6)(2009-5#2)(2009-7#1)(2010-12#2)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
analogs]##2##1##(1997-4#1)(2008-4#1)
analogue and##2##2##(1994-8#2)
analogue for##2##2##(1993-11#1)(2011-3#1)
analogue inhibited cholesterol esterification in##2##5##(1994-8#2)
analogue inhibited##3##2##(1994-8#2)(1995-2#1)
analogue inhibitor##3##2##(1992-11#1)(2010-2#2)
analogue inhibitors##2##2##(1991-9#1)(1992-8#1)
analogue is##2##2##(1990-12#1)(1995-2#1)
analogue of a##2##3##(1992-5#1)(2013-7#1)
analogue of genistein##2##3##(1992-12#1)(2010-3#1)
analogue of the##3##3##(1990-7#1)(1996-2#1)(2010-5#1)
analogue of##23##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#2)(2010-3#1)(2010-5#1)(2013-1#1)(2013-7#1)
analogue to##2##2##(2008-5#1)(2011-1#1)
analogue was incorporated into##2##4##(1992-10#1)(2008-10#1)
analogue which##2##2##(1990-12#1)(1991-9#1)
analogue with##3##2##(2008-8#2)(2013-1#1)
analogue##141##1##(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#3)(1990-7#3)(1991-1#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#2)(1993-11#4)(1993-5#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#7)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#3)(1996-3#1)(1996-5#3)(1997-1#1)(1997-6#1)(1997-7#3)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#6)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2009-11#5)(2010-2#2)(2010-3#3)(2010-5#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
analogue)##3##1##(1994-11#1)(1997-7#1)(2008-1#1)
analogues (0-11 ns)##2##3##(1991-5#2)
analogues and their##2##3##(1995-3#1)(2013-1#1)
analogues and##11##2##(1990-5#1)(1991-2#1)(1993-1#2)(1994-11#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2013-1#1)
analogues are##4##2##(1996-7#1)(2007-11#1)(2008-6#1)(2010-6#1)
analogues as##4##2##(1992-12#1)(1995-3#1)(1996-2#1)(2007-11#1)
analogues could be##2##3##(1994-9#1)(2008-7#1)
analogues could##4##2##(1994-9#1)(2008-7#1)(2008-8#2)
analogues have##2##2##(1990-2#1)(1994-8#1)
analogues in the##2##3##(1991-5#1)(2008-6#1)
analogues in##7##2##(1991-5#2)(1996-11#1)(2006-10#1)(2008-4#2)(2008-6#1)
analogues is##2##2##(1992-6#1)(2010-1#1)
analogues may##2##2##(1995-3#1)(2011-2#1)
analogues might##2##2##(1994-6#1)(2008-4#1)
analogues of alpha-MSH##2##3##(1993-5#2)
analogues of the anticonvulsant##2##4##(1994-8#2)
analogues of the##6##3##(1992-6#1)(1994-8#2)(1995-2#1)(2008-7#1)(2011-2#1)
analogues of thiazole-4-carboxamide adenine dinucleotide##2##5##(1995-3#2)
analogues of##29##2##(1991-9#3)(1992-6#1)(1993-5#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-3#3)(1997-7#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#3)(2013-1#2)
analogues on the##2##3##(1994-8#1)(1995-5#1)
analogues on##3##2##(1994-8#1)(1995-5#1)(2008-10#1)
analogues tested##2##2##(1990-2#1)(2007-11#1)
analogues that##2##2##(1990-2#1)(2007-11#1)
analogues was achieved##2##3##(1996-5#2)
analogues was##5##2##(1994-11#1)(1996-5#2)(2011-2#2)
analogues were##6##2##(1991-5#1)(1992-3#1)(1995-11#1)(2007-11#1)(2008-8#1)(2010-5#1)
analogues which##2##2##(1990-12#1)(2007-11#1)
analogues with##4##2##(1990-2#1)(1992-11#1)(1995-11#2)
analogues##171##1##(1990-12#1)(1990-2#4)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#7)(1991-8#2)(1991-9#3)(1992-11#3)(1992-12#2)(1992-3#4)(1992-6#5)(1992-8#2)(1993-1#2)(1993-5#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#11)(1994-9#1)(1995-11#7)(1995-2#2)(1995-3#12)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-7#3)(1997-7#3)(2006-10#1)(2007-11#10)(2008-10#8)(2008-11#3)(2008-4#8)(2008-6#4)(2008-7#3)(2008-8#5)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-6#2)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
analogy between##5##2##(1992-3#1)(2007-12#2)(2008-3#2)
analogy is##2##2##(1996-3#1)(1997-3#1)
analogy of##2##2##(2008-2#2)
analogy to previous##2##3##(1996-5#1)(2009-6#1)
analogy to the##3##3##(1997-6#2)(2008-2#1)
analogy to##12##2##(1995-6#1)(1996-2#1)(1996-5#1)(1997-6#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)
analogy with the##4##3##(1991-11#1)(1992-9#1)(1993-11#1)(2008-10#1)
analogy with##10##2##(1990-9#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)
analogy##47##1##(1990-9#1)(1991-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1994-2#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-6#2)(2007-12#4)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#6)(2008-8#1)(2009-11#1)(2009-6#1)(2013-8#1)
analyse and interpret##2##3##(2012-12#2)
analyse and model##2##3##(2008-7#1)(2011-2#1)
analyse and##7##2##(1990-12#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-12#2)
analyse the data##2##3##(2008-10#1)(2008-12#1)
analyse the etiopathogenesis##2##3##(1993-5#1)(2009-5#1)
analyse the##50##2##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#9)(2009-5#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#3)(2012-5#2)(2013-8#1)
analyse their##3##2##(1993-9#1)(2008-5#1)(2009-5#1)
analyse them##2##2##(2008-10#1)(2012-12#1)
analyse##110##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-12#2)(1992-5#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1995-11#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#14)(2008-8#1)(2009-5#4)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#2)(2013-1#5)(2013-8#1)
analysed a##4##2##(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)
analysed after##5##2##(2008-10#2)(2012-2#1)(2012-7#1)(2013-1#1)
analysed and compared##2##3##(2007-12#1)(2008-9#1)
analysed and discussed##2##3##(2008-10#1)(2010-11#1)
analysed and the##2##3##(2008-10#2)
analysed and##19##2##(1990-2#1)(1996-12#1)(2007-12#1)(2008-10#10)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-12#1)
analysed as a function of##2##5##(2008-10#2)
analysed as a##3##3##(2008-10#2)(2012-8#1)
analysed as##7##2##(1992-9#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-8#1)
analysed before##2##2##(1996-5#1)(2007-11#1)
analysed both##2##2##(1993-9#1)(2008-11#1)
analysed by a##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
analysed by gas##6##3##(1990-5#1)(2008-10#5)
analysed by inductively coupled plasma##2##5##(2008-10#2)
analysed by inductively coupled##3##4##(2008-10#3)
analysed by qualitative content analysis##2##5##(2011-2#1)(2012-3#1)
analysed by the proposed##2##4##(2008-10#2)
analysed by the##8##3##(1990-5#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-3#1)
analysed by##81##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#2)(1992-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#31)(2008-11#7)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
analysed data##3##2##(2010-3#2)(2011-2#1)
analysed elements##2##2##(2008-10#2)
analysed for the presence of##2##5##(1994-2#1)(2008-11#1)
analysed for the##5##3##(1994-2#1)(2008-10#1)(2008-11#2)(2012-2#1)
analysed for their##4##3##(2008-10#1)(2008-12#2)(2013-1#1)
analysed for##38##2##(1991-12#1)(1993-8#1)(1994-2#1)(1995-8#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-12#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2012-6#1)(2012-9#1)(2013-1#1)
analysed from##2##2##(2007-6#1)(2013-1#1)
analysed in a##2##3##(1991-5#1)(2012-1#1)
analysed in both##2##3##(2008-10#2)
analysed in detail##2##3##(1995-3#1)(2007-11#1)
analysed in order to##4##4##(1990-6#1)(2008-10#2)(2008-11#1)
analysed in terms of##4##4##(1990-8#1)(2006-4#1)(2008-10#2)
analysed in the##7##3##(1996-2#1)(1997-4#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-11#1)
analysed in this paper##2##4##(2008-9#2)
analysed in##40##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-6#1)(1992-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-7#3)(2008-9#2)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#2)
analysed retrospectively##5##2##(1990-11#1)(1990-8#1)(1992-11#1)(1997-2#1)(2011-2#1)
analysed samples##5##2##(2008-10#4)(2010-4#1)
analysed several##2##2##(1991-5#1)(2008-7#1)
analysed the clinical##2##3##(1991-3#1)(2007-8#1)
analysed the entire##2##3##(2008-12#1)(2008-7#1)
analysed the##32##2##(1990-12#1)(1990-3#2)(1990-8#1)(1991-3#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-10#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
analysed to determine##2##3##(2007-11#2)
analysed to provide##2##3##(2008-11#2)
analysed to##12##2##(1991-6#1)(1996-8#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)
analysed using a##7##3##(2008-10#1)(2008-11#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
analysed using both##2##3##(1997-7#1)(2008-10#1)
analysed using the##6##3##(1994-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
analysed using##42##2##(1992-8#1)(1994-3#1)(1994-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-7#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
analysed were##2##2##(2008-10#1)(2008-7#1)
analysed with the##5##3##(2008-10#4)(2013-1#1)
analysed with##16##2##(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
analysed without prior##2##3##(2008-10#2)
analysed without##3##2##(2008-10#2)(2008-11#1)
analysed##482##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#2)(1990-6#2)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#5)(1991-6#3)(1991-8#5)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#2)(2006-4#1)(2007-10#2)(2007-11#9)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#123)(2008-11#28)(2008-12#14)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#17)(2008-6#4)(2008-7#16)(2008-8#6)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#6)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#1)(2010-8#3)(2011-1#4)(2011-10#1)(2011-2#19)(2011-3#2)(2012-1#7)(2012-12#7)(2012-2#11)(2012-3#5)(2012-6#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#19)(2013-8#9)
analyser and##4##2##(1990-2#1)(2007-10#1)(2008-10#1)(2011-1#1)
analyser can##2##2##(2008-10#2)
analyser for##6##2##(2008-10#6)
analyser was##2##2##(2008-10#2)
analyser which##2##2##(1991-6#1)(2008-10#1)
analyser with##2##2##(1990-8#1)(2008-10#1)
analyser##54##1##(1990-2#1)(1990-8#3)(1991-6#1)(1993-12#1)(1994-9#1)(1995-12#2)(2007-10#4)(2008-10#36)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
analysers was##2##2##(2008-10#2)
analysers##16##1##(1990-2#1)(1993-12#1)(1994-9#1)(2008-10#13)
analyses across##2##2##(2012-12#1)(2013-1#1)
analyses after##4##2##(1990-2#1)(1995-2#1)(2008-10#1)(2013-1#1)
analyses allow the##2##3##(1996-5#1)(2008-10#1)
analyses and the##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
analyses and##35##2##(1990-5#1)(1991-2#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
analyses are given for##2##4##(1994-11#1)(2008-3#1)
analyses are needed##2##3##(1993-12#1)(1997-3#1)
analyses are performed using##2##4##(2007-12#1)(2009-12#1)
analyses are performed##5##3##(1993-3#1)(1995-3#1)(2007-12#1)(2009-12#1)(2010-11#1)
analyses are presented##3##3##(1994-1#1)(2008-3#2)
analyses are required to##3##4##(2008-12#1)(2008-4#1)(2010-7#1)
analyses are##34##2##(1992-12#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-11#1)(1995-12#1)(1995-3#2)(1997-3#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#2)
analyses at##2##2##(1990-8#1)(2009-11#1)
analyses based on##6##3##(1996-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)
analyses be##2##2##(1996-12#1)(2008-10#1)
analyses before##2##2##(2008-10#1)(2008-5#1)
analyses between the##2##3##(2008-10#1)(2010-3#1)
analyses between##5##2##(1991-12#1)(2008-10#2)(2008-12#1)(2010-3#1)
analyses by the##2##3##(2007-12#1)(2008-10#1)
analyses by##8##2##(1993-11#1)(1996-10#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
analyses can be##3##3##(2008-10#2)(2008-4#1)
analyses can##5##2##(1995-5#1)(2008-10#2)(2008-4#1)(2009-8#1)
analyses carried out##2##3##(2008-10#1)(2008-5#1)
analyses confirmed that##2##3##(2008-10#2)
analyses confirmed the##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
analyses confirmed##6##2##(2006-12#1)(2008-10#4)(2011-2#1)
analyses consisted of##2##3##(2008-10#1)(2008-5#1)
analyses demonstrate that##2##3##(1992-3#1)(1997-7#1)
analyses demonstrated that the##2##4##(2008-10#1)(2009-7#1)
analyses demonstrated that##9##3##(1995-1#1)(2008-10#4)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
analyses demonstrated##11##2##(1993-3#1)(1995-1#1)(2008-10#4)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
analyses detected##2##2##(1996-12#1)(2008-10#1)
analyses determined that##2##3##(2008-10#1)(2010-11#1)
analyses determined##3##2##(2007-12#1)(2008-10#1)(2010-11#1)
analyses did not support##2##4##(1994-6#1)(1997-5#1)
analyses did##4##2##(1994-6#1)(1997-5#1)(2008-4#1)(2012-2#1)
analyses do not change##2##4##(1995-2#2)
analyses exhibited an##2##3##(2008-10#2)
analyses exhibited##3##2##(2008-10#3)
analyses for the##2##3##(2008-10#1)(2009-11#1)
analyses for##8##2##(1995-2#1)(2008-10#4)(2008-8#1)(2009-11#1)(2010-3#1)
analyses gave##2##2##(2008-1#1)(2008-10#1)
analyses have been##2##3##(2007-12#1)(2008-10#1)
analyses have revealed##4##3##(2008-10#2)(2008-8#1)(2011-1#1)
analyses have shown that##4##4##(1992-12#1)(1994-11#1)(1995-8#1)(2012-2#1)
analyses have##14##2##(1990-3#1)(1992-12#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
analyses identified four##3##3##(2008-10#2)(2013-7#1)
analyses identified##8##2##(2008-10#3)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
analyses in a##2##3##(1990-6#1)(2010-3#1)
analyses in the##4##3##(1991-12#1)(2008-8#1)(2009-5#2)
analyses in which the##2##4##(2008-10#1)(2008-7#1)
analyses in##19##2##(1990-11#1)(1990-6#1)(1991-12#2)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#2)(2010-3#1)(2011-2#1)(2013-1#1)
analyses include##2##2##(2008-10#1)(2011-2#1)
analyses included##5##2##(1997-5#1)(1997-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
analyses indicate that the##5##4##(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-7#1)
analyses indicate that##7##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-7#1)
analyses indicate##9##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-3#1)(2013-7#1)
analyses indicated that the##11##4##(1992-3#1)(1993-6#1)(1997-8#1)(2008-10#5)(2008-9#1)(2011-1#1)(2013-1#1)
analyses indicated that##31##3##(1990-5#1)(1992-3#1)(1993-12#5)(1993-6#1)(1995-9#1)(1997-8#1)(2007-7#1)(2008-10#11)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
analyses indicated##40##2##(1990-11#1)(1990-5#1)(1992-3#1)(1993-12#5)(1993-6#1)(1995-9#1)(1997-8#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
analyses involving##2##2##(2008-10#1)(2011-2#1)
analyses is limited##2##3##(2008-10#1)(2008-4#1)
analyses is##6##2##(2008-10#2)(2008-3#1)(2008-4#2)(2009-8#1)
analyses made##2##2##(2007-10#1)(2008-6#1)
analyses of DNA sequences##2##4##(2008-10#2)
analyses of a##4##3##(1997-3#1)(2008-10#2)(2008-3#1)
analyses of both##2##3##(2008-10#2)
analyses of different##2##3##(2008-10#1)(2009-8#1)
analyses of four##2##3##(2008-10#2)
analyses of gene##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
analyses of promoter##3##3##(1994-6#1)(2008-1#1)(2008-10#1)
analyses of sequences##2##3##(2008-10#2)
analyses of several##3##3##(1993-9#1)(2008-10#2)
analyses of the beta-tubulin##2##4##(2008-10#2)
analyses of the internal transcribed spacer##2##6##(2008-10#2)
analyses of the mutant##2##4##(1992-12#1)(2008-8#1)
analyses of the##86##3##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#4)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#4)(2010-3#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
analyses of their##4##3##(1993-12#1)(1996-7#1)(2008-7#1)(2010-3#1)
analyses of these data##3##4##(1992-12#1)(2008-4#1)(2008-6#1)
analyses of these##11##3##(1990-12#1)(1992-12#1)(1994-5#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2012-2#1)
analyses of this##3##3##(1993-8#1)(2008-10#2)
analyses of three##2##3##(2008-10#2)
analyses of variance##6##3##(1993-2#1)(1993-5#1)(2008-12#1)(2008-4#2)(2009-11#1)
analyses of##297##2##(1990-12#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-12#2)(1995-2#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#122)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#4)(2009-8#2)(2010-3#7)(2010-4#4)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
analyses on the##4##3##(1993-5#1)(2008-10#1)(2009-5#1)(2012-12#1)
analyses on##17##2##(1993-5#1)(1997-5#1)(2007-12#1)(2007-6#2)(2008-10#5)(2008-11#2)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
analyses only##2##2##(1990-5#1)(2008-10#1)
analyses per h##2##3##(2008-10#2)
analyses per hour##2##3##(2008-10#2)
analyses per##4##2##(2008-10#4)
analyses performed with##2##3##(2008-10#2)
analyses performed##7##2##(2008-10#6)(2010-3#1)
analyses provide##2##2##(1992-6#1)(2011-1#1)
analyses provided a##2##3##(2012-2#2)
analyses provided##4##2##(2008-11#1)(2008-2#1)(2012-2#2)
analyses reveal##3##2##(1993-3#1)(2009-5#1)(2012-3#1)
analyses revealed a##4##3##(1990-11#1)(1992-10#1)(1997-5#1)(2013-8#1)
analyses revealed no##2##3##(1992-9#1)(2009-9#1)
analyses revealed that most##2##4##(2008-11#1)(2010-8#1)
analyses revealed that the##7##4##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2010-3#1)
analyses revealed that##27##3##(1996-8#1)(1997-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-7#1)
analyses revealed the##4##3##(1994-12#1)(1995-12#1)(2006-12#1)(2008-10#1)
analyses revealed##53##2##(1990-11#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-5#2)(2006-12#1)(2007-11#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#1)
analyses several##2##2##(2011-2#1)(2012-3#1)
analyses show a significant##2##4##(1993-1#1)(2011-2#1)
analyses show that the##5##4##(1990-7#1)(1995-5#1)(2007-12#1)(2008-3#1)(2010-11#1)
analyses show that##11##3##(1990-7#1)(1992-3#1)(1994-11#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2010-11#1)
analyses show##13##2##(1990-7#1)(1992-3#1)(1993-1#1)(1994-11#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-2#1)
analyses showed no##2##3##(2008-10#1)(2013-1#1)
analyses showed significant##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
analyses showed that the expression##2##5##(2008-10#1)(2008-6#1)
analyses showed that the##6##4##(1990-11#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)
analyses showed that##22##3##(1990-11#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
analyses showed the##2##3##(1994-12#1)(2008-10#1)
analyses showed##33##2##(1990-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#9)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
analyses strongly##2##2##(2008-10#2)
analyses suggest that the##2##4##(1991-9#1)(2008-11#1)
analyses suggest that##6##3##(1991-9#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
analyses suggest##9##2##(1991-12#1)(1991-9#1)(1992-2#1)(2008-10#3)(2008-11#1)(2008-9#2)
analyses suggested that the##2##4##(2008-10#1)(2009-2#1)
analyses suggested that##6##3##(1995-5#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-2#1)
analyses that incorporate##3##3##(2010-3#1)(2010-6#1)(2013-7#1)
analyses that##8##2##(1993-12#1)(1993-2#1)(1994-1#1)(2008-4#1)(2010-3#2)(2010-6#1)(2013-7#1)
analyses the##14##2##(1991-6#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-4#2)(2013-1#2)(2013-8#1)
analyses to determine the##2##4##(2008-3#1)(2008-8#1)
analyses to determine##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
analyses to examine##4##3##(2007-6#1)(2008-6#1)(2008-7#1)(2008-8#1)
analyses to##17##2##(1993-12#1)(1996-1#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2012-3#2)
analyses uncovered##2##2##(2008-5#1)(2012-2#1)
analyses using a##3##3##(1993-8#1)(1997-3#1)(1997-7#1)
analyses using##19##2##(1990-7#1)(1992-11#1)(1992-8#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-1#1)
analyses utilizing##2##2##(1997-6#1)(2008-10#1)
analyses was##4##2##(2008-10#3)(2011-2#1)
analyses were carried out by##3##5##(2008-10#2)(2008-5#1)
analyses were carried out in##2##5##(2008-5#1)(2008-6#1)
analyses were carried out##8##4##(1997-7#1)(2008-10#4)(2008-5#2)(2008-6#1)
analyses were conducted to examine##2##5##(1996-1#1)(2013-1#1)
analyses were conducted to##7##4##(1996-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
analyses were conducted using##2##4##(1994-8#1)(2009-7#1)
analyses were conducted##13##3##(1994-8#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
analyses were consistent##2##3##(2008-4#1)(2009-7#1)
analyses were not##2##3##(1992-9#1)(2008-8#1)
analyses were performed on##5##4##(2008-10#3)(2010-3#1)(2013-1#1)
analyses were performed to determine##2##5##(2008-7#1)(2012-12#1)
analyses were performed to##7##4##(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)
analyses were performed using##3##4##(2010-11#1)(2011-2#1)(2012-2#1)
analyses were performed with##2##4##(2008-10#1)(2012-2#1)
analyses were performed##26##3##(1990-8#1)(1994-12#1)(1997-8#1)(2007-10#2)(2008-10#7)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#1)
analyses were used to identify##2##5##(2007-10#1)(2013-8#1)
analyses were used to##7##4##(2007-10#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
analyses were used##9##3##(2007-10#1)(2008-10#2)(2008-12#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
analyses were##73##2##(1990-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-6#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#2)(2013-8#1)
analyses when##2##2##(2008-9#1)(2009-12#1)
analyses which##2##2##(1995-12#1)(2008-10#1)
analyses with##15##2##(1992-6#1)(1994-9#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
analyses##1236##1##(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#7)(1992-6#4)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#16)(1993-2#2)(1993-3#6)(1993-5#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#7)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#8)(1995-3#5)(1995-5#10)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#6)(1996-2#3)(1996-3#4)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-2#8)(1997-3#6)(1997-4#7)(1997-5#9)(1997-6#1)(1997-7#8)(1997-8#9)(2006-12#2)(2007-10#6)(2007-11#4)(2007-12#15)(2007-4#1)(2007-5#1)(2007-6#6)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#386)(2008-11#26)(2008-12#18)(2008-2#10)(2008-3#25)(2008-4#25)(2008-5#30)(2008-6#19)(2008-7#44)(2008-8#28)(2008-9#29)(2009-10#6)(2009-11#6)(2009-12#9)(2009-2#2)(2009-4#5)(2009-5#9)(2009-6#1)(2009-7#17)(2009-8#15)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#4)(2010-2#3)(2010-3#20)(2010-4#11)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#14)(2011-2#32)(2011-3#1)(2012-1#5)(2012-12#17)(2012-2#27)(2012-3#11)(2012-7#1)(2013-1#37)(2013-7#8)(2013-8#12)
analyses)##4##1##(2008-10#2)(2008-11#1)(2008-2#1)
analysing a##7##2##(1992-12#1)(1997-4#1)(2008-10#4)(2008-7#1)
analysing and##3##2##(2008-8#1)(2010-10#1)(2012-12#1)
analysing complex##2##2##(2008-10#2)
analysing different##2##2##(1997-4#1)(2008-10#1)
analysing several##4##2##(2008-10#4)
analysing the data##2##3##(1994-9#1)(2008-11#1)
analysing the effect##2##3##(1994-2#1)(2013-1#1)
analysing the##21##2##(1990-6#1)(1991-9#1)(1994-2#1)(1994-9#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#3)(2011-3#1)(2013-1#1)
analysing##88##1##(1990-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-9#2)(1994-2#2)(1994-3#1)(1994-9#3)(1995-12#1)(1996-9#1)(1997-4#3)(1997-7#1)(2008-10#36)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
analysis (BIA)##7##2##(2008-10#6)(2011-2#1)
analysis (BIS-FIA) system with spectrofluorimetric detection##2##6##(2008-10#2)
analysis (BSA)##3##2##(2008-10#2)(2008-9#1)
analysis (CFA)##3##2##(2008-10#3)
analysis (FIA) for the determination of##2##6##(2008-10#2)
analysis (FIA) for the##4##4##(2008-10#4)
analysis (FIA) method##2##3##(2008-10#2)
analysis (FIA) system##14##3##(2008-10#13)(2008-11#1)
analysis (FIA) technique##3##3##(2008-10#3)
analysis (FIA) was##2##3##(2008-10#2)
analysis (FIA)##53##2##(2008-10#52)(2008-11#1)
analysis (MRA)##2##2##(2008-10#2)
analysis (MSFIA)##3##2##(2008-10#3)
analysis (P less than##2##4##(1992-2#1)(1996-2#1)
analysis (PCA) for the##2##4##(2008-10#2)
analysis (PCA) for##3##3##(2008-10#2)(2010-5#1)
analysis (PCA) is a##2##4##(2008-10#1)(2010-7#1)
analysis (PCA) is##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
analysis (PCA) was##6##3##(1996-5#1)(2008-10#5)
analysis (PCA)##49##2##(1996-5#2)(2008-1#1)(2008-10#37)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
analysis (PLS-DA)##2##2##(2008-10#2)
analysis (QDA)##4##2##(2008-10#3)(2011-2#1)
analysis (SFA)##5##2##(2008-10#5)
analysis (SIA) method##2##3##(2008-10#2)
analysis (SIA)##31##2##(2008-10#31)
analysis (TGA)##7##2##(2008-10#6)(2009-3#1)
analysis - a##2##3##(2008-10#1)(2010-10#1)
analysis -##5##2##(2008-10#4)(2010-10#1)
analysis Part##4##2##(2008-10#4)
analysis a##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
analysis according to##4##3##(2007-8#1)(2008-11#1)(2010-11#2)
analysis accuracy of the##3##4##(2008-3#3)
analysis accuracy##5##2##(2008-3#4)(2013-8#1)
analysis adjusted for##2##3##(2008-8#1)(2011-2#1)
analysis after##5##2##(1991-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
analysis allowed us to##4##4##(1997-9#1)(2007-11#1)(2008-10#1)(2008-5#1)
analysis allowed##6##2##(1997-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
analysis allows##3##2##(1990-11#1)(2008-5#1)(2013-1#1)
analysis along with##3##3##(2007-11#1)(2008-8#1)(2010-10#1)
analysis also revealed that##2##4##(1993-2#1)(2008-4#1)
analysis also revealed##3##3##(1993-2#1)(2008-4#2)
analysis also shows##2##3##(1992-9#1)(2008-7#1)
analysis also##17##2##(1992-9#1)(1993-2#1)(1996-1#1)(1997-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
analysis and PCR##2##3##(1997-4#1)(2008-12#1)
analysis and Southern##2##3##(1992-3#1)(2008-9#1)
analysis and a##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
analysis and also##3##3##(2008-10#2)(2008-3#1)
analysis and an##3##3##(2008-2#1)(2008-3#2)
analysis and artificial neural networks##5##5##(2008-10#5)
analysis and assessment##2##3##(2008-11#1)(2011-2#1)
analysis and by##6##3##(1992-3#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#1)
analysis and can##2##3##(2008-10#1)(2008-3#1)
analysis and canonical##2##3##(2008-10#2)
analysis and classification##2##3##(2008-10#1)(2012-12#1)
analysis and clustering analysis##2##4##(2008-5#2)
analysis and clustering##3##3##(2008-5#2)(2009-11#1)
analysis and compared##2##3##(2008-10#1)(2013-1#1)
analysis and comparison##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
analysis and confirmed##2##3##(1993-3#1)(2008-11#1)
analysis and current situation##2##4##(2013-1#2)
analysis and design##2##3##(2007-12#1)(2008-3#1)
analysis and discriminant analysis##2##4##(1992-2#1)(2008-3#1)
analysis and environmental##3##3##(2008-10#3)
analysis and experimental##3##3##(2008-11#1)(2008-3#2)
analysis and expression##3##3##(1993-2#1)(2008-8#1)(2008-9#1)
analysis and for the##2##4##(1997-3#1)(2008-10#1)
analysis and for##6##3##(1997-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
analysis and gene##2##3##(2008-7#1)(2008-9#1)
analysis and identification of##2##4##(1993-12#1)(2008-10#1)
analysis and immunoblotting##2##3##(1996-5#1)(2008-8#1)
analysis and in situ hybridization##2##5##(1995-11#1)(2008-6#1)
analysis and in##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
analysis and interpretation of##3##4##(1994-2#1)(2008-12#1)(2008-7#1)
analysis and interpretation##9##3##(1994-2#1)(1995-6#1)(1996-6#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-2#1)
analysis and its##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
analysis and ligand##2##3##(1994-11#1)(1995-2#1)
analysis and linkage##2##3##(2008-10#1)(2008-4#1)
analysis and logistic regression##3##4##(2008-8#2)(2013-8#1)
analysis and multivariate##2##3##(2008-10#1)(2012-12#1)
analysis and offers##3##3##(2008-10#1)(2008-4#2)
analysis and optical##2##3##(2008-3#1)(2010-4#1)
analysis and partial least##3##4##(2008-10#1)(2013-8#2)
analysis and preliminary##2##3##(1993-9#1)(2008-3#1)
analysis and principal component##2##4##(1996-5#1)(2008-10#1)
analysis and provide##2##3##(2008-10#1)(2008-9#1)
analysis and purification##2##3##(2010-7#1)(2013-1#1)
analysis and reporting##2##3##(1994-2#1)(2010-11#1)
analysis and reverse##2##3##(1992-8#1)(2008-4#1)
analysis and review##5##3##(1991-12#1)(1992-3#1)(1993-12#2)(1995-2#1)
analysis and sequence analysis of##2##5##(1992-8#1)(2008-10#1)
analysis and sequence##3##3##(1992-8#1)(2008-10#1)(2011-1#1)
analysis and sorting of##2##4##(2008-9#2)
analysis and sorting##3##3##(2008-5#1)(2008-9#2)
analysis and stepwise##2##3##(2008-10#2)
analysis and the results##2##4##(2008-3#1)(2010-8#1)
analysis and the##22##3##(1990-7#1)(1992-6#1)(1993-12#1)(1996-2#1)(2008-10#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
analysis and their##2##3##(2008-10#1)(2013-1#1)
analysis and therefore##2##3##(2008-3#1)(2012-2#1)
analysis and to##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
analysis and visualization##5##3##(2008-4#3)(2008-9#1)(2011-7#1)
analysis and##422##2##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#3)(1991-12#4)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-2#1)(2007-4#1)(2008-1#4)(2008-10#122)(2008-11#13)(2008-12#5)(2008-2#3)(2008-3#25)(2008-4#12)(2008-5#12)(2008-6#2)(2008-7#13)(2008-8#14)(2008-9#24)(2009-10#3)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#7)(2011-3#2)(2011-7#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#11)(2013-8#11)
analysis applied to##2##3##(2008-10#1)(2008-3#1)
analysis applied##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
analysis approach##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
analysis are also##3##3##(2008-4#3)
analysis are consistent with##2##4##(1995-6#1)(2010-12#1)
analysis are described##2##3##(2008-10#1)(2008-11#1)
analysis are discussed##5##3##(1995-1#1)(1996-6#1)(2008-10#2)(2011-2#1)
analysis are presented##2##3##(2007-11#1)(2008-2#1)
analysis are##37##2##(1994-9#1)(1995-1#1)(1995-6#1)(1996-6#1)(1996-8#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
analysis as a##5##3##(1990-5#1)(1992-9#1)(2008-11#1)(2008-8#1)(2009-10#1)
analysis as it##2##3##(2008-10#1)(2011-2#1)
analysis as the##2##3##(1990-7#1)(2008-10#1)
analysis as well as##5##4##(1990-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
analysis as##28##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-9#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-5#1)(2007-10#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)
analysis assessed##2##2##(2008-5#1)(2008-7#1)
analysis at a##4##3##(2008-10#2)(2008-9#1)(2012-5#1)
analysis at the##2##3##(2008-10#2)
analysis at##15##2##(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-5#1)
analysis based on a##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
analysis based on the##9##4##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-7#1)
analysis based on##33##3##(1992-11#1)(1994-5#1)(1997-4#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-3#3)(2008-5#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
analysis based##34##2##(1992-11#1)(1994-5#1)(1997-4#1)(2007-11#2)(2008-10#13)(2008-11#1)(2008-3#3)(2008-5#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
analysis because it##2##3##(2008-10#1)(2008-6#1)
analysis because##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
analysis before##2##2##(1994-11#1)(2011-2#1)
analysis between the##3##3##(2008-1#1)(2011-1#1)(2012-12#1)
analysis between##10##2##(1996-5#1)(2008-1#1)(2008-10#2)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
analysis both##2##2##(2008-10#1)(2009-10#1)
analysis by ICP-OES##2##3##(2008-10#2)
analysis by a##3##3##(2008-10#2)(2008-3#1)
analysis by capillary electrophoresis##2##4##(2008-10#1)(2008-4#1)
analysis by capillary##3##3##(2008-10#2)(2008-4#1)
analysis by distance indices (SADIE)##4##5##(2008-10#4)
analysis by distance indices##5##4##(2008-10#5)
analysis by distance##6##3##(2008-10#6)
analysis by flow cytometry##2##4##(2008-11#1)(2008-9#1)
analysis by gas chromatography (GC)##2##5##(2008-10#2)
analysis by gas chromatography##3##4##(2008-10#3)
analysis by gas##4##3##(2008-10#3)(2011-2#1)
analysis by graphite furnace atomic absorption spectrometry##2##7##(2008-10#2)
analysis by high-performance liquid chromatography##2##5##(1990-8#1)(2008-10#1)
analysis by laser##2##3##(2008-10#1)(2008-3#1)
analysis by liquid chromatography##2##4##(2008-10#2)
analysis by means of##2##4##(2008-9#2)
analysis by near-infrared##2##3##(2008-10#1)(2008-3#1)
analysis by the proposed##2##4##(2008-10#2)
analysis by the##7##3##(1990-8#1)(1995-8#1)(1996-6#1)(2008-10#3)(2008-3#1)
analysis by use of##3##4##(2008-3#3)
analysis by##103##2##(1990-8#2)(1992-3#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-6#1)(1997-1#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#51)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#7)(2009-11#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
analysis can be applied to##2##5##(2008-3#2)
analysis can be used for##2##5##(2007-11#1)(2007-12#1)
analysis can be used to##5##5##(1994-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-6#1)
analysis can be used##7##4##(1994-3#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-6#1)
analysis can be##20##3##(1994-3#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2009-8#1)(2013-1#1)
analysis can##30##2##(1991-9#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2009-8#1)(2010-12#1)(2013-1#1)
analysis carried out on##2##4##(2008-3#1)(2008-9#1)
analysis carried##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
analysis combined with##2##3##(2008-10#1)(2008-6#1)
analysis combined##3##2##(2008-10#2)(2008-6#1)
analysis concept##2##2##(2009-10#1)(2013-1#1)
analysis confirmed that the##2##4##(1997-7#1)(2008-10#1)
analysis confirmed that##9##3##(1992-9#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2011-1#1)
analysis confirmed the##7##3##(2008-10#3)(2009-12#1)(2009-9#1)(2010-7#1)(2012-12#1)
analysis confirmed##24##2##(1992-6#1)(1992-9#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#6)(2008-11#2)(2009-1#1)(2009-12#2)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
analysis confirms the##2##3##(2010-8#1)(2011-1#1)
analysis confirms##4##2##(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
analysis consisted of##4##3##(1996-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
analysis consists##2##2##(1997-3#1)(2012-2#1)
analysis could be##4##3##(2008-10#4)
analysis could##7##2##(2008-10#6)(2011-2#1)
analysis data for##2##3##(1990-8#1)(2008-10#1)
analysis data##4##2##(1990-8#1)(1992-12#1)(2008-10#1)(2013-8#1)
analysis demonstrate##2##2##(2008-3#1)(2009-5#1)
analysis demonstrated a##5##3##(1991-5#1)(1994-9#1)(2008-9#2)(2013-1#1)
analysis demonstrated that the##11##4##(1992-3#1)(1992-9#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)
analysis demonstrated that##24##3##(1990-12#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2011-1#1)
analysis demonstrated the##4##3##(1991-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
analysis demonstrated##38##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
analysis demonstrates that##2##3##(1994-6#1)(2008-9#1)
analysis demonstrates##3##2##(1991-2#1)(1994-6#1)(2008-9#1)
analysis described in##2##3##(1997-2#1)(2008-10#1)
analysis described##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
analysis detected a##2##3##(1994-12#1)(1997-7#1)
analysis detected##4##2##(1993-2#1)(1994-12#1)(1997-7#1)(1997-9#1)
analysis detects##2##2##(2008-4#1)(2011-2#1)
analysis did not##3##3##(2008-10#2)(2012-2#1)
analysis divided##3##2##(2008-10#2)(2011-2#1)
analysis does not##2##3##(1994-2#1)(1997-8#1)
analysis does##3##2##(1994-2#1)(1997-8#1)(2008-10#1)
analysis due to##2##3##(2008-10#1)(2013-8#1)
analysis during##2##2##(1997-3#1)(2012-2#1)
analysis either##3##2##(2008-4#2)(2011-2#1)
analysis employing##2##2##(2008-10#2)
analysis employs##2##2##(2007-11#1)(2008-3#1)
analysis especially##2##2##(2008-2#1)(2011-2#1)
analysis evidenced##2##2##(1990-6#1)(2013-7#1)
analysis examines the##2##3##(1994-12#1)(1996-1#1)
analysis finds##2##2##(1994-2#1)(2009-10#1)
analysis focused on##2##3##(2007-12#1)(2011-2#1)
analysis focuses on##4##3##(1991-1#1)(2009-10#1)(2011-2#2)
analysis followed by##3##3##(2008-10#2)(2012-12#1)
analysis followed##4##2##(2008-10#2)(2008-12#1)(2012-12#1)
analysis following##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
analysis for a##4##3##(1997-3#1)(2007-12#1)(2008-11#1)(2009-11#1)
analysis for both##2##3##(2008-1#1)(2008-10#1)
analysis for each##2##3##(2008-10#1)(2012-5#1)
analysis for human##2##3##(1993-2#1)(2010-12#1)
analysis for retrieval of##2##4##(2008-3#2)
analysis for the determination of##9##5##(2008-10#8)(2008-11#1)
analysis for the selection of##2##5##(2008-10#1)(2010-1#1)
analysis for the##25##3##(1991-12#1)(1997-4#1)(2008-10#15)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)
analysis for which##2##3##(2008-10#1)(2008-3#1)
analysis for##109##2##(1991-12#1)(1993-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#44)(2008-11#5)(2008-2#2)(2008-3#13)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#7)(2009-10#2)(2009-11#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#2)
analysis found that##4##3##(2008-9#2)(2010-8#1)(2011-2#1)
analysis found##7##2##(1992-2#1)(2008-9#3)(2010-8#1)(2011-2#1)(2013-1#1)
analysis from##8##2##(1993-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)
analysis further##4##2##(1992-8#1)(2008-10#2)(2013-8#1)
analysis gave##2##2##(2008-10#2)
analysis grouped the##2##3##(2008-10#2)
analysis grouped##3##2##(2008-10#3)
analysis had##2##2##(2007-10#1)(2008-11#1)
analysis has become##2##3##(2008-10#1)(2009-5#1)
analysis has been carried out##2##5##(2007-11#1)(2008-3#1)
analysis has been developed##3##4##(2008-10#2)(2008-4#1)
analysis has been made of##2##5##(1992-6#1)(2008-3#1)
analysis has been made##3##4##(1992-6#1)(2008-10#1)(2008-3#1)
analysis has been performed##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
analysis has been used in##2##5##(1991-1#1)(2008-3#1)
analysis has been##20##3##(1991-1#1)(1992-6#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)
analysis has demonstrated##2##3##(1996-12#1)(2008-7#1)
analysis has identified##2##3##(1992-6#1)(2008-10#1)
analysis has revealed that##3##4##(1994-11#1)(1996-3#1)(2009-3#1)
analysis has revealed##4##3##(1991-1#1)(1994-11#1)(1996-3#1)(2009-3#1)
analysis has shown that the##2##5##(1992-2#1)(1995-8#1)
analysis has shown that this##2##5##(1991-9#1)(1994-11#1)
analysis has shown that##7##4##(1991-9#1)(1992-2#1)(1992-8#1)(1994-11#1)(1995-8#2)(2008-11#1)
analysis has##46##2##(1991-1#2)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1994-11#2)(1995-8#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2009-3#1)(2009-5#1)(2012-2#2)
analysis have been used##2##4##(2007-11#1)(2010-4#1)
analysis have been##7##3##(1996-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-4#1)(2010-5#1)
analysis have##13##2##(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-4#1)(2010-5#1)
analysis identified a##3##3##(1993-12#1)(1996-7#1)(2008-10#1)
analysis identified the##2##3##(2008-10#1)(2012-3#1)
analysis identified##19##2##(1990-4#1)(1991-12#2)(1993-12#1)(1996-7#1)(1997-3#1)(2008-10#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
analysis identifies##3##2##(1994-9#1)(2008-8#1)(2011-2#1)
analysis in a##6##3##(1990-7#1)(1997-7#1)(2008-10#1)(2010-10#1)(2012-12#1)(2012-3#1)
analysis in addition to##2##4##(1991-12#1)(2008-10#1)
analysis in addition##3##3##(1991-12#1)(2008-10#2)
analysis in all##2##3##(2008-10#1)(2008-5#1)
analysis in an##2##3##(1990-11#1)(2008-10#1)
analysis in aqueous##2##3##(2008-10#2)
analysis in human blood##2##4##(1997-2#1)(2008-10#1)
analysis in human skin##2##4##(2008-10#2)
analysis in human##5##3##(1997-2#1)(2008-10#3)(2008-12#1)
analysis in order to##6##4##(2008-10#6)
analysis in patients with##2##4##(2007-11#1)(2008-6#1)
analysis in plant##2##3##(2008-10#2)
analysis in terms of##2##4##(1995-5#1)(2008-2#1)
analysis in the presence of##2##5##(1990-11#1)(2008-4#1)
analysis in the##20##3##(1990-11#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#1)
analysis in three##2##3##(2008-10#1)(2011-2#1)
analysis in various##2##3##(1993-3#1)(2008-11#1)
analysis in water##2##3##(2008-10#2)
analysis in which##4##3##(1993-8#1)(2008-3#1)(2009-11#1)(2009-12#1)
analysis in##160##2##(1990-11#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-7#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#71)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
analysis included##4##2##(2007-4#1)(2008-10#1)(2010-2#1)(2013-7#1)
analysis includes##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
analysis including##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
analysis increased##3##2##(2008-10#2)(2010-10#1)
analysis indicate that##4##3##(1991-9#1)(1993-12#1)(1994-3#1)(1997-5#1)
analysis indicated a##4##3##(1990-6#1)(1990-7#1)(1993-3#1)(1995-3#1)
analysis indicated an##2##3##(1993-12#1)(2008-2#1)
analysis indicated that BCMoV##2##4##(2008-10#2)
analysis indicated that a single##2##5##(2008-10#2)
analysis indicated that a##5##4##(1991-6#1)(2008-10#3)(2008-9#1)
analysis indicated that disease##2##4##(2008-10#2)
analysis indicated that each##2##4##(2008-10#1)(2008-9#1)
analysis indicated that the##24##4##(1990-11#1)(1990-2#3)(1991-9#1)(1992-5#1)(1993-3#2)(1993-8#1)(1996-3#1)(2008-10#9)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)
analysis indicated that there##2##4##(2008-5#1)(2008-9#1)
analysis indicated that these##2##4##(2008-10#1)(2010-12#1)
analysis indicated that##58##3##(1990-11#1)(1990-2#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-8#1)(1996-3#1)(1997-3#1)(2008-10#25)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)
analysis indicated the presence of a single##2##7##(1990-2#1)(1997-2#1)
analysis indicated the##6##3##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#3)
analysis indicated##78##2##(1990-11#1)(1990-2#4)(1990-6#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#5)(1993-8#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#30)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
analysis indicates that the##6##4##(1991-2#1)(1994-12#1)(1996-2#1)(1997-7#1)(2010-7#1)(2011-1#1)
analysis indicates that##27##3##(1990-5#1)(1990-8#1)(1991-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1996-2#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)
analysis indicates the##3##3##(1992-10#1)(2008-10#1)(2010-8#1)
analysis indicates##31##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1996-2#2)(1997-7#1)(2007-12#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#1)
analysis instrument##2##2##(2008-10#2)
analysis into a##2##3##(2012-1#1)(2013-1#1)
analysis into##3##2##(2008-1#1)(2012-1#1)(2013-1#1)
analysis involving##2##2##(2007-11#1)(2008-10#1)
analysis is a##13##3##(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
analysis is able to##2##4##(2008-10#1)(2009-5#1)
analysis is an important##2##4##(2008-4#1)(2009-8#1)
analysis is an##3##3##(2008-4#1)(2009-8#1)(2010-5#1)
analysis is applied to##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
analysis is based on a##4##5##(1996-2#1)(2008-11#1)(2008-3#1)(2008-9#1)
analysis is based on##8##4##(1996-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2013-1#1)
analysis is based upon##2##4##(1991-3#1)(1991-5#1)
analysis is based##11##3##(1991-3#1)(1991-5#1)(1996-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-11#1)(2013-1#1)
analysis is compared##2##3##(2008-10#2)
analysis is conducted##2##3##(2010-2#1)(2012-2#1)
analysis is demonstrated##3##3##(2007-5#1)(2008-2#1)(2008-9#1)
analysis is described##3##3##(2008-10#2)(2009-12#1)
analysis is discussed##2##3##(2008-10#1)(2008-3#1)
analysis is essential for the##2##5##(2008-2#1)(2009-2#1)
analysis is essential##3##3##(2008-2#1)(2008-9#1)(2009-2#1)
analysis is given of##2##4##(2008-2#1)(2008-3#1)
analysis is given##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
analysis is illustrated by the##2##5##(2008-10#2)
analysis is illustrated by##5##4##(2008-10#3)(2008-3#2)
analysis is less than##2##4##(2008-10#1)(2008-3#1)
analysis is less##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
analysis is made of the##3##5##(2008-10#1)(2008-3#2)
analysis is made##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
analysis is not possible##2##4##(1997-3#1)(2008-4#1)
analysis is not##7##3##(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)
analysis is now##2##3##(2008-10#1)(2008-4#1)
analysis is performed by##2##4##(2008-10#1)(2009-5#1)
analysis is performed on##2##4##(2008-2#1)(2008-4#1)
analysis is performed with##3##4##(2008-2#1)(2008-3#2)
analysis is performed##12##3##(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-5#1)
analysis is possible##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
analysis is presented that##2##4##(2008-3#2)
analysis is presented##9##3##(2007-12#1)(2008-10#2)(2008-3#5)(2013-8#1)
analysis is proposed##2##3##(2008-10#2)
analysis is provided##2##3##(2008-4#1)(2008-7#1)
analysis is required##2##3##(2008-10#1)(2010-4#1)
analysis is shown##2##3##(2007-12#1)(2009-4#1)
analysis is still##3##3##(2007-6#1)(2008-10#1)(2011-2#1)
analysis is that the##3##4##(2008-7#1)(2010-12#1)(2011-2#1)
analysis is the##7##3##(1994-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
analysis is to##2##3##(1993-3#1)(2008-12#1)
analysis is used for##3##4##(2008-4#1)(2013-1#2)
analysis is used to##7##4##(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-6#1)
analysis is used##11##3##(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2010-6#1)(2013-1#2)
analysis is very##2##3##(2008-10#2)
analysis is##177##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#25)(2008-4#12)(2008-5#4)(2008-7#8)(2008-9#9)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
analysis it is##2##3##(1995-6#1)(2008-5#1)
analysis made evident the correlation between the##2##7##(2008-2#2)
analysis made##3##2##(2008-2#2)(2012-3#1)
analysis manifold##3##2##(2008-10#3)
analysis may be##4##3##(1991-1#1)(2008-10#2)(2008-4#1)
analysis may##10##2##(1991-1#1)(1992-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-11#1)
analysis method for the determination of##3##6##(2008-10#3)
analysis method for the##4##4##(2008-10#3)(2008-3#1)
analysis method for##6##3##(2008-10#5)(2008-3#1)
analysis method is##5##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)
analysis method##27##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
analysis methodology##5##2##(2008-10#3)(2008-6#1)(2008-7#1)
analysis methods are##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
analysis methods for##3##3##(2008-10#2)(2010-4#1)
analysis methods were used##2##4##(1995-6#1)(2008-10#1)
analysis methods##21##2##(1990-8#1)(1995-6#1)(1997-5#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
analysis mode##3##2##(2008-10#3)
analysis model##5##2##(2008-3#3)(2012-3#2)
analysis must be##2##3##(1990-7#1)(2008-3#1)
analysis must##3##2##(1990-7#1)(2008-11#1)(2008-3#1)
analysis not##2##2##(2007-11#1)(2009-12#1)
analysis obtained##2##2##(2008-10#1)(2010-5#1)
analysis of 1##3##3##(2008-10#3)
analysis of 100##2##3##(2007-5#1)(2008-10#1)
analysis of 11##2##3##(2008-5#1)(2010-3#1)
analysis of 150##2##3##(2009-12#1)(2012-2#1)
analysis of 16##2##3##(1992-8#1)(2012-2#1)
analysis of 165##2##3##(2008-10#2)
analysis of 16S##3##3##(2008-10#3)
analysis of 2##2##3##(2008-10#2)
analysis of 20##2##3##(1997-8#1)(2008-10#1)
analysis of 24##2##3##(2008-10#1)(2008-9#1)
analysis of 30##2##3##(2008-10#2)
analysis of 41##2##3##(1990-8#1)(2008-10#1)
analysis of 52##2##3##(1993-9#1)(2008-10#1)
analysis of AFLP##2##3##(2008-10#2)
analysis of Allium##2##3##(2008-10#2)
analysis of As##2##3##(2008-10#2)
analysis of BTEX##3##3##(2008-10#3)
analysis of Cr##2##3##(2008-10#2)
analysis of Cu##2##3##(2008-10#2)
analysis of DNA content and##4##5##(1992-9#1)(2008-9#3)
analysis of DNA content##5##4##(1992-9#1)(1997-7#1)(2008-9#3)
analysis of DNA##14##3##(1992-9#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-9#4)(2011-1#2)
analysis of Drosophila##2##3##(1993-6#1)(2012-12#1)
analysis of EEG##2##3##(1994-3#1)(2008-7#1)
analysis of HLA genes##2##4##(1997-8#2)
analysis of ITS2##2##3##(2008-10#2)
analysis of PCR##3##3##(1992-8#1)(2008-10#2)
analysis of PCR-amplified##2##3##(2008-10#2)
analysis of RAPD##3##3##(2008-10#3)
analysis of RDX##2##3##(2008-10#2)
analysis of RNA##5##3##(2008-5#1)(2008-9#3)(2011-3#1)
analysis of SRM##2##3##(2008-10#2)
analysis of a 10##2##4##(1997-3#2)
analysis of a certified##2##4##(2008-10#2)
analysis of a complex##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
analysis of a diffractive optical##2##5##(2008-3#2)
analysis of a human##4##4##(1991-6#1)(1993-12#1)(1993-3#1)(2012-2#1)
analysis of a large number of##3##6##(1994-3#1)(2008-10#2)
analysis of a large##4##4##(1994-3#1)(2008-10#2)(2008-2#1)
analysis of a new##4##4##(1990-12#1)(1996-6#1)(2008-10#1)(2008-8#1)
analysis of a novel##2##4##(1996-10#1)(2008-8#1)
analysis of a polymerase chain reaction-amplified region of##2##8##(2008-10#2)
analysis of a putative##2##4##(1995-12#1)(1997-4#1)
analysis of a sample##2##4##(2008-10#1)(2011-1#1)
analysis of a selected##2##4##(1991-9#1)(2007-8#1)
analysis of a series of##2##5##(2008-10#1)(2008-3#1)
analysis of a set of##3##5##(2008-10#2)(2009-10#1)
analysis of a single##3##4##(2008-2#1)(2008-4#2)
analysis of a small##2##4##(1991-12#1)(2008-4#1)
analysis of a three-dimensional##2##4##(2007-12#1)(2009-4#1)
analysis of a wide##2##4##(1997-2#1)(2008-10#1)
analysis of a##119##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#6)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
analysis of activities##2##3##(1990-11#2)
analysis of additional##2##3##(2008-10#1)(2009-6#1)
analysis of adolescent##2##3##(2009-7#1)(2013-1#1)
analysis of adult mouse##2##4##(1995-2#1)(1997-7#1)
analysis of adult##4##3##(1995-2#1)(1997-7#1)(2007-8#1)(2008-7#1)
analysis of alcohol##2##3##(2008-10#2)
analysis of all the##5##4##(1996-5#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
analysis of all##14##3##(1993-11#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
analysis of alpha-tocopherol##2##3##(1990-8#1)(2008-10#1)
analysis of aluminium##2##3##(2008-10#2)
analysis of amino acid##2##4##(1993-3#1)(2008-10#1)
analysis of amino acids##2##4##(2008-10#1)(2008-11#1)
analysis of amino##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-4#1)
analysis of ammonium and nitrate##2##5##(2008-10#2)
analysis of an##14##3##(1990-12#1)(1992-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
analysis of ancient ceramics##2##4##(2008-10#2)
analysis of ancient##3##3##(2008-10#3)
analysis of antifouling agent Irgarol 1051 and its decyclopropylated degradation product in seawater##2##13##(2008-10#2)
analysis of antifouling##3##3##(2008-10#2)(2008-11#1)
analysis of archaeological##2##3##(2008-10#1)(2012-9#1)
analysis of aroma compounds##2##4##(2008-10#2)
analysis of aroma##4##3##(2008-10#3)(2012-2#1)
analysis of aromatic##3##3##(2008-10#3)
analysis of arsenic##4##3##(2008-10#4)
analysis of atrazine##2##3##(2008-10#2)
analysis of average##2##3##(2007-11#1)(2008-7#1)
analysis of bacterial gene expression##2##5##(2008-7#1)(2008-9#1)
analysis of bacterial##5##3##(2008-10#2)(2008-7#1)(2008-9#2)
analysis of benzene##2##3##(2008-10#2)
analysis of binary and ternary mixtures##2##6##(2008-10#2)
analysis of binary mixtures of##2##5##(2008-10#2)
analysis of binary mixtures##3##4##(2008-10#3)
analysis of binary##6##3##(2008-10#6)
analysis of binding##4##3##(1990-12#1)(1990-2#1)(1993-5#1)(1993-8#1)
analysis of biological##4##3##(2008-10#2)(2008-7#1)(2009-12#1)
analysis of blood and##2##4##(2008-3#1)(2012-12#1)
analysis of blood##7##3##(1994-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
analysis of bone marrow aspirates##2##5##(2008-10#2)
analysis of bone marrow##3##4##(2008-10#2)(2008-7#1)
analysis of bone##4##3##(2008-10#2)(2008-7#1)(2009-7#1)
analysis of both##12##3##(1993-12#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#2)(2011-2#1)(2013-8#1)
analysis of brain##2##3##(2008-7#1)(2010-12#1)
analysis of cDNA clones##7##4##(1995-8#2)(1996-10#1)(1996-2#2)(1997-2#2)
analysis of cDNA##8##3##(1995-8#2)(1996-10#1)(1996-2#2)(1997-2#2)(2008-8#1)
analysis of calcium##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
analysis of cancer##3##3##(1994-2#1)(2009-12#1)(2009-6#1)
analysis of carbamazepine##3##3##(2008-10#2)(2011-2#1)
analysis of cases##2##3##(1990-9#1)(2007-2#1)
analysis of cell adhesion##2##4##(2008-4#2)
analysis of cell##8##3##(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)
analysis of cells##4##3##(2008-9#1)(2009-11#1)(2012-1#1)(2012-3#1)
analysis of cellular DNA content##2##5##(2008-9#2)
analysis of cellular##7##3##(2008-10#1)(2008-11#1)(2008-9#3)(2010-12#1)(2012-3#1)
analysis of certified reference material##5##5##(2008-10#5)
analysis of certified reference materials and by##2##7##(2008-10#2)
analysis of certified reference materials and##5##6##(2008-10#5)
analysis of certified reference materials##12##5##(2008-10#12)
analysis of certified reference##18##4##(2008-10#18)
analysis of certified##19##3##(2008-10#19)
analysis of changes in the##3##5##(2008-9#1)(2010-8#1)(2011-2#1)
analysis of changes in##4##4##(2007-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
analysis of chloride##2##3##(2008-10#1)(2013-1#1)
analysis of chloroplast##2##3##(2008-1#1)(2008-5#1)
analysis of chromium##3##3##(2008-10#3)
analysis of clinical and##2##4##(2008-3#1)(2009-3#1)
analysis of clinical##8##3##(1997-7#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#2)(2013-8#1)
analysis of clopidogrel bisulphate##2##4##(2008-10#2)
analysis of commercial##2##3##(2008-10#2)
analysis of complex##10##3##(1993-9#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-5#1)(2012-3#1)
analysis of contemporary##2##3##(2008-5#1)(2012-12#1)
analysis of covariance showed##2##4##(2008-10#1)(2012-12#1)
analysis of covariance##8##3##(1996-7#1)(2008-10#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
analysis of crosses between##2##4##(2008-10#2)
analysis of cystic fibrosis##2##4##(1990-3#1)(1990-4#1)
analysis of cystic##3##3##(1990-3#2)(1990-4#1)
analysis of data collected##2##4##(2008-10#1)(2012-12#1)
analysis of data from two##2##5##(2007-4#1)(2012-3#1)
analysis of data from##6##4##(1994-11#1)(1997-8#1)(2007-4#1)(2010-11#1)(2011-8#1)(2012-3#1)
analysis of data obtained##2##4##(2011-1#1)(2011-2#1)
analysis of data on the##2##5##(1993-9#1)(1995-12#1)
analysis of data on##5##4##(1993-9#1)(1994-7#1)(1995-12#1)(1997-7#1)(2008-12#1)
analysis of data was##2##4##(2011-1#1)(2013-1#1)
analysis of data##28##3##(1992-3#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-12#2)(1997-2#1)(1997-7#1)(1997-8#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-12#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
analysis of death##2##3##(1997-3#1)(2013-1#1)
analysis of depth##2##3##(2008-2#1)(2010-11#1)
analysis of diagnostic##2##3##(1991-6#1)(2012-12#1)
analysis of diazinon##2##3##(2008-10#2)
analysis of different##14##3##(2007-8#1)(2008-10#11)(2008-7#1)(2012-2#1)
analysis of digitized##2##3##(2008-3#1)(2008-5#1)
analysis of dioxins in##2##4##(2008-10#2)
analysis of disease##4##3##(1997-5#1)(2008-10#2)(2008-4#1)
analysis of diversity##3##3##(2008-10#2)(2011-1#1)
analysis of double-stranded##2##3##(2008-2#2)
analysis of drug##6##3##(1990-2#1)(1992-3#1)(1993-12#1)(2008-11#2)(2008-4#1)
analysis of drug-treated cells##2##4##(1992-12#2)
analysis of dynamic##4##3##(2008-1#1)(2008-10#1)(2008-3#2)
analysis of each of the##2##5##(1992-3#1)(1995-5#1)
analysis of each of##3##4##(1992-3#1)(1995-5#1)(2007-8#1)
analysis of each sample##3##4##(2008-10#3)
analysis of each##6##3##(1992-3#1)(1995-5#1)(2007-8#1)(2008-10#3)
analysis of early##2##3##(2010-12#1)(2011-2#1)
analysis of effects##2##3##(2008-10#1)(2012-2#1)
analysis of eight##3##3##(2008-10#3)
analysis of embryonic##2##3##(1993-2#1)(2008-9#1)
analysis of energy##2##3##(2008-10#1)(2008-3#1)
analysis of environmental samples##2##4##(2008-10#1)(2012-12#1)
analysis of environmental##4##3##(2008-10#3)(2012-12#1)
analysis of events##2##3##(2008-12#1)(2008-2#1)
analysis of experimental data##2##4##(2007-11#1)(2008-2#1)
analysis of experimental##4##3##(1994-9#1)(2007-11#1)(2008-2#1)(2012-3#1)
analysis of explosives##5##3##(2008-10#5)
analysis of expression##3##3##(2008-4#2)(2008-7#1)
analysis of extracts##3##3##(2008-10#3)
analysis of factors##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
analysis of fatty acid methyl esters##2##6##(2008-10#2)
analysis of female##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
analysis of fetal##2##3##(1996-12#1)(2013-1#1)
analysis of field##2##3##(1993-12#1)(2008-10#1)
analysis of fluorescence##3##3##(1994-5#1)(2008-10#1)(2008-2#1)
analysis of focus group##2##4##(2009-5#1)(2013-1#1)
analysis of food##2##3##(2008-10#1)(2009-5#1)
analysis of four##8##3##(1995-2#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-3#1)
analysis of fringe##3##3##(2008-3#3)
analysis of full-length cDNA##2##4##(2008-10#1)(2008-8#1)
analysis of functional##2##3##(1996-7#1)(1997-3#1)
analysis of gait##2##3##(2010-3#1)(2013-1#1)
analysis of gamma##2##3##(2008-8#1)(2012-3#1)
analysis of gene expression in##2##5##(2008-11#1)(2008-7#1)
analysis of gene expression##7##4##(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)
analysis of gene##9##3##(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-1#1)(2013-8#1)
analysis of genes##3##3##(1994-12#1)(1997-4#1)(1997-6#1)
analysis of genetic##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
analysis of genomic DNA suggests##2##5##(1991-2#1)(1991-9#1)
analysis of genomic DNA##5##4##(1991-2#1)(1991-9#1)(1992-3#1)(1997-6#1)(2008-10#1)
analysis of genomic clones##2##4##(1990-8#1)(1991-6#1)
analysis of genomic##8##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1997-6#1)(2008-10#1)
analysis of glass##8##3##(2008-10#8)
analysis of glucose##3##3##(1994-6#1)(2008-10#2)
analysis of healthcare##4##3##(2009-8#1)(2010-1#1)(2010-4#1)(2012-12#1)
analysis of hepatitis##2##3##(2008-10#1)(2012-2#1)
analysis of high purity##2##4##(2008-10#2)
analysis of how##2##3##(1997-1#1)(2008-11#1)
analysis of human disease##4##4##(2008-4#3)(2008-7#1)
analysis of human genomic DNA##3##5##(1991-6#1)(1993-6#1)(2008-9#1)
analysis of human##22##3##(1990-2#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#4)
analysis of hundreds of##2##4##(2008-10#1)(2010-5#1)
analysis of in situ hybridization##2##5##(1995-2#1)(2010-1#1)
analysis of in situ##3##4##(1995-2#1)(2008-10#1)(2010-1#1)
analysis of in##4##3##(1995-2#1)(2008-10#1)(2008-4#1)(2010-1#1)
analysis of individual##5##3##(1991-5#1)(2008-10#2)(2008-9#1)(2009-9#1)
analysis of inorganic arsenic##2##4##(2008-10#2)
analysis of inorganic##3##3##(2008-10#2)(2009-6#1)
analysis of installing dust control devices##2##6##(2009-12#2)
analysis of internal transcribed##2##4##(2008-10#2)
analysis of intracellular##2##3##(2008-4#1)(2008-9#1)
analysis of iron in##3##4##(2008-10#3)
analysis of iron##4##3##(2008-10#4)
analysis of isolates##4##3##(2008-10#3)(2008-7#1)
analysis of its##12##3##(1991-5#1)(1993-8#1)(1994-8#1)(1995-6#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-7#1)
analysis of key##3##3##(1994-2#1)(2008-8#1)(2013-1#1)
analysis of large##7##3##(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
analysis of lead##2##3##(2008-10#2)
analysis of ligand##2##3##(1990-5#1)(2008-1#1)
analysis of light##3##3##(2008-10#2)(2008-3#1)
analysis of literature##2##3##(2009-5#1)(2012-12#1)
analysis of liver tissue##2##4##(1992-6#1)(2008-10#1)
analysis of long##2##3##(1996-6#1)(2008-10#1)
analysis of longitudinal data##2##4##(1997-8#1)(2011-1#1)
analysis of longitudinal##4##3##(1992-3#1)(1997-8#1)(2011-1#2)
analysis of low##2##3##(2008-10#1)(2008-8#1)
analysis of lungs##2##3##(2007-12#1)(2012-3#1)
analysis of lymphoid##2##3##(2008-10#1)(2008-5#1)
analysis of mRNA##2##3##(1990-7#1)(1993-6#1)
analysis of major components##2##4##(2012-2#1)(2013-8#1)
analysis of major##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
analysis of malignant hematological##2##4##(2008-4#2)
analysis of many##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
analysis of medical##3##3##(1993-3#1)(1994-6#1)(2009-6#1)
analysis of meiotic##2##3##(2008-2#1)(2008-5#1)
analysis of membrane##2##3##(1993-8#1)(2008-9#1)
analysis of mercury in Traditional Chinese Medicines##2##7##(2008-10#2)
analysis of metabolic##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
analysis of metabolites##3##3##(2008-10#1)(2010-5#2)
analysis of microarray data##2##4##(2008-7#1)(2010-3#1)
analysis of microcystins##2##3##(2008-10#2)
analysis of mitochondrial DNA sequence##2##5##(2008-4#1)(2010-8#1)
analysis of mitochondrial DNA##3##4##(2008-4#1)(2010-8#1)(2013-8#1)
analysis of mitochondrial membrane potential using JC-1##2##7##(2008-9#2)
analysis of mitochondrial membrane potential using##3##6##(1993-11#1)(2008-9#2)
analysis of mitochondrial membrane potential##4##5##(1993-11#2)(2008-9#2)
analysis of mitochondrial##7##3##(1993-11#2)(2008-4#1)(2008-9#2)(2010-8#1)(2013-8#1)
analysis of mitotic chromosomes##2##4##(2008-5#1)(2008-9#1)
analysis of mitotic##3##3##(1995-9#1)(2008-5#1)(2008-9#1)
analysis of molecular variance indicated that##2##6##(2008-10#2)
analysis of molecular variance revealed that##2##6##(2008-10#2)
analysis of molecular variance##11##4##(2008-10#9)(2011-2#2)
analysis of molecular##16##3##(2008-10#11)(2008-3#1)(2008-4#1)(2009-3#1)(2011-2#2)
analysis of morphine##2##3##(2008-10#2)
analysis of morphological##2##3##(2007-12#1)(2008-8#1)
analysis of mortality##2##3##(1991-6#1)(2009-7#1)
analysis of most##2##3##(2008-10#1)(2008-3#1)
analysis of multicomponent polycyclic aromatic##2##5##(2008-10#2)
analysis of multicomponent##4##3##(2008-10#3)(2013-8#1)
analysis of multiple##5##3##(1997-4#2)(2008-11#1)(2008-3#1)(2008-4#1)
analysis of neuronal##2##3##(1994-12#1)(2008-4#1)
analysis of nevirapine##2##3##(2008-10#2)
analysis of nitrite and nitrate##2##5##(2008-10#2)
analysis of nitrite##5##3##(2008-10#5)
analysis of normal and##2##4##(2007-7#1)(2012-2#1)
analysis of nuclear DNA content##2##5##(1994-3#1)(2008-11#1)
analysis of nuclear##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
analysis of nucleic acid##2##4##(2008-10#1)(2008-4#1)
analysis of nucleic acids##2##4##(2008-2#1)(2008-9#1)
analysis of nucleic##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
analysis of nucleotide sequences##2##4##(1994-8#1)(2008-10#1)
analysis of null##2##3##(1996-3#1)(2008-3#1)
analysis of nursing##2##3##(1997-2#1)(2008-12#1)
analysis of one of the##2##5##(1995-3#1)(2008-8#1)
analysis of one of##3##4##(1992-8#1)(1995-3#1)(2008-8#1)
analysis of one##7##3##(1992-8#1)(1995-3#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
analysis of open##2##3##(1996-6#1)(2008-7#1)
analysis of optical##6##3##(2008-2#2)(2008-3#4)
analysis of ordinal data##3##4##(2008-10#3)
analysis of organic vapours in air##2##6##(2008-10#2)
analysis of organic##6##3##(1990-8#1)(2008-10#4)(2008-11#1)
analysis of organophosphorus pesticide residues##3##5##(2008-10#3)
analysis of organophosphorus##6##3##(2008-10#6)
analysis of original##2##3##(1991-2#1)(2012-2#1)
analysis of other##4##3##(2008-10#3)(2008-2#1)
analysis of our case##3##4##(1991-12#1)(2007-10#1)(2009-3#1)
analysis of our experience##2##4##(2008-1#1)(2011-2#1)
analysis of our##6##3##(1991-12#1)(2007-10#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-12#1)
analysis of patient##2##3##(2008-10#1)(2013-1#1)
analysis of patients in##2##4##(1994-12#1)(2007-8#1)
analysis of patients with##4##4##(2008-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
analysis of patients##10##3##(1994-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
analysis of peptides##3##3##(1995-6#1)(2008-10#1)(2008-4#1)
analysis of peripheral blood##4##4##(2008-9#3)(2013-1#1)
analysis of pesticides##5##3##(2008-10#5)
analysis of pharmaceutical preparations##2##4##(2008-10#2)
analysis of pharmaceutical##5##3##(2008-10#5)
analysis of phase II##2##4##(1997-8#1)(2008-5#1)
analysis of phenolic compounds in##2##5##(2008-10#2)
analysis of phenolic compounds##3##4##(2008-10#3)
analysis of phosphate in##2##4##(2008-10#2)
analysis of phosphate##3##3##(2008-10#3)
analysis of phosphorus##3##3##(2008-10#2)(2008-12#1)
analysis of physiological##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
analysis of plant##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
analysis of plants##2##3##(2008-10#2)
analysis of plasma##2##3##(1991-5#1)(2008-10#1)
analysis of polybrominated diphenyl ethers##2##5##(2008-10#2)
analysis of polycyclic aromatic hydrocarbons (PAHs)##5##6##(2008-10#5)
analysis of polycyclic aromatic hydrocarbons by##2##6##(2008-10#2)
analysis of polycyclic aromatic hydrocarbons in##5##6##(2008-10#5)
analysis of polycyclic aromatic hydrocarbons##13##5##(2008-10#13)
analysis of polymerase chain reaction##2##5##(1992-8#1)(1995-12#1)
analysis of population##2##3##(2008-10#1)(2008-12#1)
analysis of potassium##2##3##(2008-10#2)
analysis of practice patterns##2##4##(1990-6#1)(2007-12#1)
analysis of protein##5##3##(1997-2#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-4#1)
analysis of proteins##8##3##(1993-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)
analysis of protoberberine##2##3##(2008-10#2)
analysis of pure##2##3##(2008-10#2)
analysis of questionnaire##2##3##(1996-1#1)(2012-12#1)
analysis of radiograms obtained from##2##5##(2007-8#2)
analysis of rat##8##3##(1990-12#2)(1994-12#1)(1994-6#1)(1996-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
analysis of raw##2##3##(2008-10#1)(2010-4#1)
analysis of reactive##3##3##(2007-12#2)(2008-10#1)
analysis of real samples##4##4##(2008-10#4)
analysis of real##8##3##(2008-10#7)(2008-2#1)
analysis of recombinant cDNA expression##2##5##(2008-4#2)
analysis of recombinant##3##3##(2008-4#2)(2010-6#1)
analysis of reference##2##3##(2008-10#2)
analysis of regulatory##2##3##(1991-9#1)(2008-11#1)
analysis of residual##2##3##(2007-11#1)(2011-1#1)
analysis of results##4##3##(1991-12#1)(1991-8#1)(2008-5#1)(2011-1#1)
analysis of risk factors##2##4##(2007-8#1)(2009-4#1)
analysis of root##2##3##(2008-10#1)(2009-6#1)
analysis of samples##4##3##(2008-10#2)(2008-4#1)(2009-2#1)
analysis of saturation##2##3##(1990-8#1)(1995-3#1)
analysis of secondary data##2##4##(2012-12#1)(2013-1#1)
analysis of secondary##3##3##(1990-5#1)(2012-12#1)(2013-1#1)
analysis of serum##5##3##(1996-3#1)(2008-10#3)(2010-12#1)
analysis of several##9##3##(1995-6#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)
analysis of sex##3##3##(1990-3#1)(1995-6#1)(2011-1#1)
analysis of sibutramine and citalopram##2##5##(2012-3#2)
analysis of single##5##3##(1992-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-12#1)
analysis of single-copy##2##3##(1994-12#1)(2008-10#1)
analysis of small##5##3##(2008-10#3)(2008-4#1)(2010-6#1)
analysis of sodium in##2##4##(2008-10#2)
analysis of sodium##3##3##(2008-10#3)
analysis of soil and sediment samples##2##6##(2008-10#2)
analysis of soils##2##3##(2008-10#2)
analysis of solid##4##3##(2008-10#4)
analysis of soluble##3##3##(2008-10#3)
analysis of some##20##3##(1994-11#1)(2008-10#15)(2008-2#1)(2008-7#2)(2012-12#1)
analysis of specific##3##3##(2008-10#2)(2008-4#1)
analysis of spiked samples##3##4##(2008-10#3)
analysis of spiked##6##3##(2008-10#6)
analysis of spontaneous##2##3##(1990-3#1)(1995-8#1)
analysis of standard reference materials##3##5##(2008-10#3)
analysis of standard##4##3##(2008-10#3)(2012-2#1)
analysis of sterile##2##3##(2012-2#2)
analysis of subwavelength diffractive optical elements##2##6##(2008-3#2)
analysis of such data##2##4##(2008-3#1)(2012-2#1)
analysis of such##11##3##(1996-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-12#1)(2012-2#1)
analysis of surgical##2##3##(2007-11#1)(2010-12#1)
analysis of synthetic##10##3##(2008-10#7)(2008-2#2)(2008-4#1)
analysis of system##2##3##(2008-11#1)(2008-2#1)
analysis of technical##3##3##(2008-10#1)(2008-3#2)
analysis of temporal and spatial##2##5##(2007-11#1)(2008-8#1)
analysis of temporal##5##3##(2007-11#1)(2008-3#1)(2008-4#2)(2008-8#1)
analysis of terpenes##2##3##(2008-10#2)
analysis of the CP##4##4##(1997-6#1)(2008-10#3)
analysis of the DNA##3##4##(1993-6#1)(1996-3#1)(1997-4#1)
analysis of the DPH2##3##4##(1993-9#3)
analysis of the ITS regions##2##5##(2008-10#2)
analysis of the ITS##4##4##(2008-10#3)(2010-3#1)
analysis of the PCR products##2##5##(2008-10#2)
analysis of the PCR##3##4##(2008-10#3)
analysis of the active##2##4##(2008-10#2)
analysis of the autumnal cooling rate##2##6##(2008-8#2)
analysis of the available##3##4##(2008-1#1)(2010-8#1)(2012-12#1)
analysis of the binding##2##4##(1996-12#1)(2008-10#1)
analysis of the cell cycle##2##5##(2008-11#1)(2008-9#1)
analysis of the clinical##4##4##(1993-11#1)(1993-12#1)(1993-5#1)(2007-8#1)
analysis of the cloned##2##4##(1993-3#1)(2008-10#1)
analysis of the clones##2##4##(1993-6#1)(1997-8#1)
analysis of the coat protein##2##5##(2008-10#2)
analysis of the combined##2##4##(1992-9#1)(2008-10#1)
analysis of the complete##3##4##(2008-10#3)
analysis of the contribution of##3##5##(1992-5#1)(2008-11#1)(2008-12#1)
analysis of the current##2##4##(1993-2#1)(2010-4#1)
analysis of the cytochrome##2##4##(1995-6#1)(2008-10#1)
analysis of the data collected##2##5##(1990-8#1)(1991-12#1)
analysis of the data was##2##5##(1995-8#1)(2007-10#1)
analysis of the data##16##4##(1990-8#1)(1991-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)(2012-12#1)
analysis of the deduced amino acid##2##6##(1993-9#1)(2008-10#1)
analysis of the demographic##2##4##(2008-5#1)(2008-9#1)
analysis of the device##2##4##(2008-11#1)(2008-9#1)
analysis of the different##2##4##(2011-2#2)
analysis of the diffraction##2##4##(2008-2#1)(2008-3#1)
analysis of the distribution of##2##5##(2008-10#2)
analysis of the effect of##7##5##(1991-6#1)(2008-10#1)(2008-3#2)(2009-6#2)(2013-1#1)
analysis of the effects of##5##5##(1992-6#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
analysis of the efficiency##2##4##(2008-3#1)(2013-1#1)
analysis of the entire##3##4##(1997-6#1)(2008-10#2)
analysis of the enzyme##2##4##(1992-8#1)(1997-2#1)
analysis of the experimental##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
analysis of the expression of##3##5##(1994-11#1)(2008-10#1)(2012-1#1)
analysis of the expression##4##4##(1994-11#1)(1996-8#1)(2008-10#1)(2012-1#1)
analysis of the fluorescence##2##4##(2008-10#2)
analysis of the focus groups##2##5##(2012-3#2)
analysis of the following##2##4##(2008-10#1)(2008-12#1)
analysis of the gel##2##4##(2008-11#1)(2008-6#1)
analysis of the genetic structure of##2##6##(2008-10#2)
analysis of the genetic structure##3##5##(2008-10#3)
analysis of the genetic##4##4##(2008-10#3)(2011-2#1)
analysis of the genome of the##4##6##(1995-8#1)(1996-6#2)(1997-3#1)
analysis of the genome of##5##5##(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)
analysis of the genome##6##4##(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)(2008-7#1)
analysis of the grating##2##4##(2008-3#2)
analysis of the growth##2##4##(2007-11#1)(2008-1#1)
analysis of the herbicide##2##4##(2008-10#2)
analysis of the historical##2##4##(2008-6#1)(2011-2#1)
analysis of the human##4##4##(1990-7#1)(1992-11#1)(2009-5#1)(2011-2#1)
analysis of the image##2##4##(2008-1#1)(2008-2#1)
analysis of the implementation##2##4##(2007-12#2)
analysis of the incubation##2##4##(1991-2#1)(1995-2#1)
analysis of the individual##2##4##(1990-6#1)(2008-12#1)
analysis of the interaction between##2##5##(2008-10#1)(2009-11#1)
analysis of the interaction of##2##5##(2008-10#2)
analysis of the interaction##4##4##(2008-10#3)(2009-11#1)
analysis of the internal transcribed spacer (ITS) region of##2##9##(2008-10#2)
analysis of the internal transcribed spacer (ITS)##3##7##(2008-10#3)
analysis of the internal transcribed spacer region##3##7##(2008-10#3)
analysis of the internal transcribed spacer##8##6##(2008-10#8)
analysis of the internal##9##4##(1992-3#1)(2008-10#8)
analysis of the interview transcripts##2##5##(1993-3#1)(2009-5#1)
analysis of the interviews##3##4##(2007-2#1)(2013-1#2)
analysis of the isolated##2##4##(1990-2#1)(2009-10#1)
analysis of the key##2##4##(2008-5#1)(2009-10#1)
analysis of the kinetic##2##4##(1995-12#1)(1995-5#1)
analysis of the literature##2##4##(1992-9#1)(2008-7#1)
analysis of the magnetic##2##4##(1997-7#1)(2009-11#1)
analysis of the major##3##4##(1992-3#1)(2008-7#1)(2009-5#1)
analysis of the model##2##4##(1992-9#1)(2011-1#1)
analysis of the mouse##2##4##(1992-12#1)(1993-3#1)
analysis of the mutants##2##4##(2008-7#1)(2008-9#1)
analysis of the noise properties of##2##6##(2008-3#2)
analysis of the noise##3##4##(2008-3#3)
analysis of the non-surgical treatment of##2##6##(2007-8#2)
analysis of the novel##2##4##(1993-11#1)(2011-2#1)
analysis of the performance of##2##5##(2008-2#1)(2013-8#1)
analysis of the performance##4##4##(2007-11#1)(2008-2#2)(2013-8#1)
analysis of the population##4##4##(1997-5#1)(1997-7#1)(2008-10#2)
analysis of the presence of the##2##6##(2008-11#1)(2010-3#1)
analysis of the promoter##3##4##(1990-11#1)(1997-6#1)(2012-3#1)
analysis of the proposed##2##4##(2008-3#2)
analysis of the protein##5##4##(1990-7#1)(1992-3#1)(1994-11#1)(1997-4#1)(2010-11#1)
analysis of the proteome##2##4##(2008-4#1)(2009-6#1)
analysis of the purified##2##4##(1991-8#1)(1992-8#1)
analysis of the quenching##2##4##(2008-10#2)
analysis of the recombinant##3##4##(1990-11#1)(1997-4#1)(1997-6#1)
analysis of the relationship between##2##5##(1992-6#1)(1992-9#1)
analysis of the relationships between##2##5##(1996-2#1)(2008-7#1)
analysis of the rep-PCR##2##4##(2008-10#2)
analysis of the response##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
analysis of the responses##2##4##(2008-11#1)(2011-2#1)
analysis of the results##5##4##(1991-12#1)(1995-5#1)(2008-10#3)
analysis of the role of##2##5##(1997-5#1)(2013-8#1)
analysis of the samples##3##4##(2008-10#2)(2011-1#1)
analysis of the scattering##2##4##(2008-2#2)
analysis of the secondary##2##4##(2012-12#1)(2012-2#1)
analysis of the selected##2##4##(2008-10#1)(2012-2#1)
analysis of the sensitivity of##2##5##(2008-11#1)(2008-3#1)
analysis of the spatial##4##4##(2008-10#2)(2008-9#2)
analysis of the spectra of##2##5##(1992-8#1)(2008-8#1)
analysis of the spectral##2##4##(2008-10#1)(2008-3#1)
analysis of the structure of##4##5##(1992-12#2)(1994-6#1)(2013-1#1)
analysis of the structure##6##4##(1992-12#2)(1994-6#1)(2008-2#1)(2008-9#1)(2013-1#1)
analysis of the surface##3##4##(2008-10#2)(2008-5#1)
analysis of the system is##2##5##(2008-2#2)
analysis of the system##4##4##(2008-10#1)(2008-2#2)(2008-9#1)
analysis of the target##2##4##(2008-10#1)(2013-1#1)
analysis of the three##3##4##(1993-12#1)(1997-6#1)(2008-10#1)
analysis of the total##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
analysis of the transcription##2##4##(1994-6#1)(2008-1#1)
analysis of the transmission##3##4##(2008-3#2)(2009-11#1)
analysis of the two##3##4##(1994-6#2)(2008-10#1)
analysis of the upstream##2##4##(1991-9#1)(2008-9#1)
analysis of the various##2##4##(1990-3#1)(2008-9#1)
analysis of the visual##2##4##(1995-5#1)(1995-8#1)
analysis of the##795##3##(1990-11#7)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#7)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#5)(1993-11#5)(1993-12#4)(1993-2#5)(1993-3#5)(1993-5#2)(1993-6#6)(1993-9#6)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#7)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#7)(1996-12#4)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#3)(1997-6#9)(1997-7#6)(1997-8#2)(1997-9#1)(2006-8#1)(2007-10#1)(2007-11#19)(2007-12#10)(2007-2#1)(2007-8#4)(2008-1#8)(2008-10#185)(2008-11#26)(2008-12#12)(2008-2#29)(2008-3#53)(2008-4#6)(2008-5#14)(2008-6#7)(2008-7#34)(2008-8#12)(2008-9#23)(2009-10#8)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#7)(2009-6#4)(2009-7#5)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#18)(2012-1#2)(2012-12#11)(2012-2#10)(2012-3#10)(2013-1#18)(2013-8#12)
analysis of their##16##3##(1993-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#4)(2009-11#1)(2012-2#1)
analysis of these cells##4##4##(1995-6#1)(1997-3#1)(2008-4#1)(2012-1#1)
analysis of these compounds##5##4##(1993-12#1)(2008-10#3)(2008-4#1)
analysis of these data##3##4##(1995-9#1)(1996-6#1)(2008-3#1)
analysis of these genes##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
analysis of these sequences##2##4##(1993-6#1)(2008-10#1)
analysis of these##49##3##(1990-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#2)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)
analysis of this kind##2##4##(1991-2#1)(2008-10#1)
analysis of this region##3##4##(1993-8#1)(1997-3#1)(2011-3#1)
analysis of this resistance##2##4##(2008-10#2)
analysis of this sequence##2##4##(1997-3#1)(1997-9#1)
analysis of this##29##3##(1991-2#1)(1991-9#2)(1993-2#1)(1993-8#1)(1994-2#1)(1997-3#2)(1997-4#1)(1997-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-3#2)(2012-3#1)
analysis of three##11##3##(1995-12#1)(2008-10#7)(2008-8#1)(2012-3#1)(2013-8#1)
analysis of total##12##3##(1994-12#1)(2008-10#7)(2012-2#3)(2013-1#1)
analysis of trace amounts of##2##5##(2008-10#2)
analysis of trace elements in##2##5##(2008-10#2)
analysis of trace elements##3##4##(2008-10#2)(2010-11#1)
analysis of trace heavy metals##2##5##(2008-10#2)
analysis of trace metals in estuarine waters##3##7##(2008-10#3)
analysis of trace metals in##5##5##(2008-10#5)
analysis of trace##20##3##(2008-10#19)(2010-11#1)
analysis of transcript##2##3##(2008-7#2)
analysis of transcriptional##2##3##(1994-2#1)(2010-11#1)
analysis of two standard reference materials##2##6##(2008-10#2)
analysis of two##24##3##(1990-12#1)(1993-2#1)(1994-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
analysis of two-dimensional##2##3##(1994-5#1)(2007-12#1)
analysis of ultra-trace##2##3##(2008-10#2)
analysis of uranium##2##3##(2008-10#2)
analysis of urea##2##3##(2008-10#2)
analysis of urine##4##3##(2008-1#1)(2008-10#3)
analysis of variance (ANOVA) and paired##2##6##(2009-2#1)(2012-2#1)
analysis of variance (ANOVA) and##4##5##(1995-2#1)(2008-10#1)(2009-2#1)(2012-2#1)
analysis of variance (ANOVA)##9##4##(1995-2#1)(2008-10#5)(2009-2#1)(2012-2#1)(2013-1#1)
analysis of variance and##2##4##(1990-3#1)(2013-1#1)
analysis of variance showed that##2##5##(1993-2#1)(2013-1#1)
analysis of variance##32##3##(1990-3#2)(1990-8#1)(1991-2#1)(1992-2#1)(1993-2#1)(1995-2#1)(2008-10#13)(2008-7#2)(2009-2#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
analysis of various##7##3##(2008-10#4)(2008-3#1)(2008-7#2)
analysis of very##2##3##(2008-10#2)
analysis of viral##3##3##(2008-10#1)(2008-9#2)
analysis of volatile##3##3##(2008-10#3)
analysis of water and##2##4##(2008-10#2)
analysis of water samples##3##4##(2008-10#3)
analysis of water##5##3##(2008-10#5)
analysis of whole##2##3##(1994-8#1)(2008-5#1)
analysis of zinc##3##3##(2008-10#3)
analysis of##3354##2##(1990-10#2)(1990-11#10)(1990-12#10)(1990-2#8)(1990-3#11)(1990-4#1)(1990-5#11)(1990-6#6)(1990-7#6)(1990-8#17)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#16)(1991-2#8)(1991-3#4)(1991-5#9)(1991-6#9)(1991-8#3)(1991-9#11)(1992-1#2)(1992-10#1)(1992-11#6)(1992-12#10)(1992-2#7)(1992-3#16)(1992-5#1)(1992-6#10)(1992-7#1)(1992-8#13)(1992-9#8)(1993-1#2)(1993-11#11)(1993-12#17)(1993-2#14)(1993-3#10)(1993-5#4)(1993-6#14)(1993-8#10)(1993-9#15)(1994-1#3)(1994-11#12)(1994-12#22)(1994-2#8)(1994-3#6)(1994-5#4)(1994-6#16)(1994-7#3)(1994-8#7)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#14)(1995-2#14)(1995-3#6)(1995-5#9)(1995-6#12)(1995-8#14)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#9)(1996-2#14)(1996-3#9)(1996-4#1)(1996-5#8)(1996-6#10)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#24)(1997-3#20)(1997-4#17)(1997-5#8)(1997-6#13)(1997-7#16)(1997-8#14)(1997-9#2)(2006-8#1)(2007-10#5)(2007-11#40)(2007-12#45)(2007-2#3)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#17)(2008-1#40)(2008-10#1160)(2008-11#84)(2008-12#27)(2008-2#95)(2008-3#160)(2008-4#84)(2008-5#51)(2008-6#16)(2008-7#93)(2008-8#56)(2008-9#122)(2009-1#1)(2009-10#19)(2009-11#11)(2009-12#7)(2009-2#4)(2009-3#6)(2009-4#4)(2009-5#15)(2009-6#14)(2009-7#13)(2009-8#8)(2009-9#6)(2010-1#9)(2010-10#4)(2010-11#14)(2010-12#16)(2010-2#6)(2010-3#14)(2010-4#12)(2010-5#14)(2010-6#7)(2010-7#5)(2010-8#11)(2010-9#4)(2011-1#38)(2011-2#62)(2011-3#4)(2011-5#1)(2011-8#1)(2012-1#8)(2012-12#42)(2012-2#54)(2012-3#46)(2012-9#1)(2013-1#63)(2013-7#4)(2013-8#30)
analysis offers##3##2##(2008-10#2)(2010-9#1)
analysis often##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
analysis on BDV p24##2##4##(2011-1#2)
analysis on a##3##3##(1995-6#1)(2008-4#1)(2011-2#1)
analysis on five##2##3##(2008-10#1)(2010-12#1)
analysis on the##9##3##(1997-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#1)
analysis on##48##2##(1995-6#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
analysis only##3##2##(1990-9#1)(1993-11#1)(2011-1#1)
analysis or##10##2##(1991-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-10#1)(2013-8#1)
analysis performed for the##2##4##(2008-10#2)
analysis performed##6##2##(2008-10#5)(2008-8#1)
analysis pipeline##2##2##(2008-7#1)(2011-2#1)
analysis placed##4##2##(1995-9#1)(2008-10#3)
analysis points to##2##3##(2008-4#1)(2008-9#1)
analysis predicts that the##2##4##(1997-8#1)(2010-10#1)
analysis predicts that##4##3##(1993-6#2)(1997-8#1)(2010-10#1)
analysis predicts##5##2##(1993-6#2)(1997-8#1)(2007-11#1)(2010-10#1)
analysis presented in this##4##4##(1993-3#1)(2008-4#1)(2013-1#2)
analysis presented##6##2##(1993-3#1)(2008-3#1)(2008-4#2)(2013-1#2)
analysis procedure##8##2##(2008-10#6)(2008-9#2)
analysis procedures##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
analysis process##2##2##(2008-10#2)
analysis produced##3##2##(2008-10#3)
analysis program##2##2##(2007-7#1)(2008-2#1)
analysis programs##2##2##(2008-4#1)(2009-5#1)
analysis proved that##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
analysis proved##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
analysis proves that##2##3##(2008-10#1)(2008-9#1)
analysis provided##3##2##(2010-5#1)(2012-12#1)(2012-3#1)
analysis provides##10##2##(1992-1#1)(1992-3#1)(2007-12#1)(2008-10#3)(2008-4#1)(2011-1#2)(2012-2#1)
analysis ranged from 0##2##4##(2008-10#2)
analysis rather than##2##3##(2008-10#1)(2010-9#1)
analysis rather##3##2##(2008-10#2)(2010-9#1)
analysis relies on the##2##4##(2007-12#1)(2008-3#1)
analysis required##2##2##(2008-10#2)
analysis requires##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)
analysis resulted in##4##3##(2008-10#3)(2008-5#1)
analysis results of##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
analysis results##9##2##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)(2010-8#1)(2013-8#1)
analysis revealed a single##2##4##(1995-2#1)(2009-9#1)
analysis revealed a##18##3##(1992-8#2)(1993-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-9#1)(2010-10#3)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
analysis revealed an##9##3##(1993-3#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-1#1)
analysis revealed four factors##2##4##(2008-10#1)(2010-10#1)
analysis revealed no significant differences##4##5##(1993-11#1)(2007-2#1)(2008-5#2)
analysis revealed no##6##3##(1992-2#1)(1993-11#1)(2007-2#1)(2008-10#1)(2008-5#2)
analysis revealed that all##2##4##(1992-4#1)(2008-10#1)
analysis revealed that both##3##4##(1991-2#1)(1996-2#1)(2009-3#1)
analysis revealed that in##2##4##(1994-8#1)(2007-12#1)
analysis revealed that one##2##4##(1990-2#1)(2008-8#1)
analysis revealed that the gene##4##5##(1995-6#1)(1997-6#1)(2008-10#1)(2013-1#1)
analysis revealed that the##32##4##(1990-11#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-11#3)(1994-12#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-1#1)(2013-1#1)
analysis revealed that these##3##4##(1992-12#1)(1997-4#1)(1997-8#1)
analysis revealed that##100##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
analysis revealed the presence of a##2##6##(2008-8#1)(2011-2#1)
analysis revealed the presence of##6##5##(1994-6#1)(2008-10#3)(2008-8#1)(2011-2#1)
analysis revealed the##9##3##(1994-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
analysis revealed##178##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#6)(1993-3#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#36)(2008-11#6)(2008-12#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
analysis reveals a##5##3##(1990-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)
analysis reveals that the##3##4##(2008-10#1)(2008-2#1)(2010-10#1)
analysis reveals that##13##3##(1990-8#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
analysis reveals the presence of##2##5##(1995-12#1)(2008-11#1)
analysis reveals the##3##3##(1995-12#2)(2008-11#1)
analysis reveals##31##2##(1990-8#2)(1993-3#1)(1995-12#2)(1995-2#1)(1996-1#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
analysis run##2##2##(2008-10#1)(2008-7#1)
analysis scheme##3##2##(2008-3#2)(2009-10#1)
analysis separated##3##2##(2008-10#3)
analysis should be##3##3##(2007-7#1)(2008-10#1)(2010-11#1)
analysis should##5##2##(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-11#1)
analysis show that##5##3##(1992-9#1)(1994-11#1)(1997-1#1)(2008-12#1)(2008-3#1)
analysis show##7##2##(1992-9#1)(1994-11#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-3#1)
analysis showed a significant##4##4##(2008-10#2)(2010-1#1)(2010-4#1)
analysis showed a##20##3##(1990-5#1)(1992-12#1)(1993-6#1)(1995-5#2)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-8#1)(2013-1#1)(2013-8#1)
analysis showed an##4##3##(1990-12#1)(2008-8#1)(2009-8#1)(2012-2#1)
analysis showed low##2##3##(2011-1#1)(2013-8#1)
analysis showed no##5##3##(1990-11#1)(1991-5#1)(1993-2#1)(2008-11#1)(2012-3#1)
analysis showed significant##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
analysis showed that a##3##4##(1991-2#1)(1995-6#1)(2008-8#1)
analysis showed that after##2##4##(2008-9#1)(2009-3#1)
analysis showed that both##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
analysis showed that only the##2##5##(2008-10#1)(2010-2#1)
analysis showed that only##3##4##(2008-10#1)(2010-2#1)(2011-2#1)
analysis showed that the##51##4##(1990-11#1)(1990-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
analysis showed that there##2##4##(2008-12#1)(2011-2#1)
analysis showed that these##2##4##(2008-11#1)(2009-6#1)
analysis showed that this increase##2##5##(1995-5#1)(2008-11#1)
analysis showed that this##4##4##(1995-5#1)(2008-11#1)(2008-6#1)(2008-8#1)
analysis showed that##134##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#10)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#13)(2008-9#8)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-10#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#2)
analysis showed the presence of##4##5##(1990-9#1)(2008-10#2)(2008-5#1)
analysis showed the##10##3##(1990-11#1)(1990-9#1)(1992-3#1)(1995-8#1)(2008-10#3)(2008-5#2)(2008-8#1)
analysis showed##212##2##(1990-11#3)(1990-12#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#2)(1996-12#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#36)(2008-11#14)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#15)(2008-9#10)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#6)(2011-10#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#5)
analysis shows a##3##3##(1995-3#1)(2011-2#2)
analysis shows four##2##3##(1991-6#1)(2008-10#1)
analysis shows that the##10##4##(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
analysis shows that##29##3##(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#2)(1997-9#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#5)(2008-8#3)(2008-9#1)(2011-2#1)(2013-8#2)
analysis shows the##2##3##(1992-11#1)(1992-3#1)
analysis shows##44##2##(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-9#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#6)(2008-3#5)(2008-5#1)(2008-8#4)(2008-9#2)(2009-7#1)(2011-2#3)(2013-8#2)
analysis software##9##2##(1995-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2013-1#1)
analysis study##2##2##(2008-10#1)(2008-7#1)
analysis such as##6##3##(1993-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-3#1)
analysis suggest that##2##3##(1993-2#1)(2008-9#1)
analysis suggest##3##2##(1993-2#1)(2008-10#1)(2008-9#1)
analysis suggested that the##3##4##(1993-8#1)(2008-10#1)(2008-11#1)
analysis suggested that this##2##4##(1993-6#1)(1997-2#1)
analysis suggested that##16##3##(1991-3#1)(1993-6#1)(1993-8#1)(1997-2#3)(2008-10#6)(2008-11#2)(2008-9#2)
analysis suggested the existence of##3##5##(1995-2#1)(1997-6#1)(2008-11#1)
analysis suggested the##7##3##(1993-2#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
analysis suggested##26##2##(1991-3#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-2#3)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-9#2)(2011-2#1)
analysis suggests a##2##3##(2011-1#1)(2012-12#1)
analysis suggests that the##6##4##(1992-3#1)(1996-12#1)(2008-8#3)(2011-2#1)
analysis suggests that##17##3##(1991-6#1)(1991-8#1)(1992-3#2)(1993-12#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-1#1)
analysis suggests the##2##3##(1993-8#1)(2010-5#1)
analysis suggests##22##2##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
analysis supports the##2##3##(1990-6#1)(2008-9#1)
analysis supports##3##2##(1990-6#1)(2008-10#1)(2008-9#1)
analysis system (ByT-FAS)##4##3##(2008-10#4)
analysis system and##2##3##(2008-10#1)(2013-8#1)
analysis system employing##2##3##(2008-10#2)
analysis system for the##2##4##(2008-10#2)
analysis system for##10##3##(1994-6#1)(2008-10#8)(2012-3#1)
analysis system was##2##3##(2008-10#2)
analysis system with##5##3##(2008-10#5)
analysis system##54##2##(1994-6#1)(2008-10#41)(2008-11#1)(2008-2#1)(2008-7#4)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
analysis systems that##2##3##(2008-10#2)
analysis systems##13##2##(2008-10#12)(2010-11#1)
analysis takes about##2##3##(2008-10#2)
analysis takes##3##2##(2008-10#2)(2008-2#1)
analysis taking into account##2##4##(2008-10#1)(2008-7#1)
analysis taking##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
analysis technique that##2##3##(2008-10#1)(2008-5#1)
analysis technique was##2##3##(1996-1#1)(2008-10#1)
analysis technique##14##2##(1996-1#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)
analysis techniques are##3##3##(2008-10#2)(2008-3#1)
analysis techniques for##3##3##(2008-10#3)
analysis techniques such##2##3##(2008-10#1)(2008-5#1)
analysis techniques##20##2##(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)
analysis that is##5##3##(1992-8#1)(1995-5#1)(2008-3#1)(2008-4#1)(2008-6#1)
analysis that##23##2##(1992-8#1)(1994-11#1)(1995-5#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
analysis the##11##2##(1991-12#1)(1995-4#1)(1995-5#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-9#1)
analysis through##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
analysis time and the##2##4##(2008-10#2)
analysis time and##6##3##(2008-10#6)
analysis time for##4##3##(2008-10#4)
analysis time is##3##3##(2008-10#3)
analysis time of##5##3##(1991-5#1)(2008-10#4)
analysis time than##3##3##(2008-10#3)
analysis time was less than##2##5##(2008-10#2)
analysis time was##9##3##(2008-10#8)(2011-1#1)
analysis time##47##2##(1991-5#1)(1993-9#1)(2008-10#41)(2008-11#1)(2011-1#1)(2012-1#1)(2013-8#1)
analysis times##7##2##(1991-5#1)(2008-10#6)
analysis to analyze##2##3##(1994-3#1)(2008-9#1)
analysis to be##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
analysis to describe the##2##4##(2008-3#1)(2008-9#1)
analysis to describe##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)
analysis to determine the##5##4##(1990-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
analysis to determine whether##2##4##(2008-10#1)(2008-5#1)
analysis to determine##11##3##(1990-11#1)(1994-10#1)(1994-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2013-1#1)
analysis to evaluate##2##3##(2008-10#1)(2008-6#1)
analysis to examine the##2##4##(1994-9#1)(2007-10#1)
analysis to facilitate##2##3##(2007-12#1)(2008-9#1)
analysis to identify##5##3##(1993-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-3#1)
analysis to measure##2##3##(2008-3#1)(2013-1#1)
analysis to predict##2##3##(2008-2#1)(2008-3#1)
analysis to study the##2##4##(1997-4#1)(2013-8#1)
analysis to study##3##3##(1997-4#1)(2009-12#1)(2013-8#1)
analysis to the##6##3##(1992-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
analysis to##99##2##(1990-11#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#3)(2009-12#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
analysis tool##4##2##(2008-2#1)(2008-7#2)(2010-12#1)
analysis tools that are##2##4##(2009-10#1)(2011-3#1)
analysis tools that##3##3##(2009-10#1)(2011-3#1)(2013-1#1)
analysis tools##16##2##(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)
analysis used##4##2##(1996-5#1)(1997-3#1)(2008-10#1)(2009-5#1)
analysis useful##2##2##(1991-12#1)(2008-4#1)
analysis uses##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
analysis using RNA from##2##4##(1994-11#1)(1994-12#1)
analysis using a probe##2##4##(1990-8#1)(1993-8#1)
analysis using a##19##3##(1990-12#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-4#1)(2013-1#2)
analysis using an antibody##2##4##(2008-10#1)(2009-8#1)
analysis using an##7##3##(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2013-1#2)
analysis using specific##2##3##(1995-11#1)(1995-12#1)
analysis using the##22##3##(1990-7#1)(1993-12#1)(1994-11#1)(1996-5#1)(1997-3#1)(2008-10#10)(2008-4#3)(2008-9#1)(2010-8#1)(2012-1#1)(2013-7#1)
analysis using##131##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#45)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#14)(2008-5#2)(2008-7#1)(2008-9#8)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
analysis varied##2##2##(2008-10#2)
analysis via##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
analysis was achieved by##2##4##(2008-10#2)
analysis was achieved##3##3##(2008-10#3)
analysis was also performed##2##4##(1995-2#1)(2008-10#1)
analysis was also used to##3##5##(2007-11#2)(2008-7#1)
analysis was also##6##3##(1995-2#1)(2007-11#2)(2008-10#1)(2008-7#1)(2013-1#1)
analysis was applied to both##2##5##(2008-10#1)(2008-2#1)
analysis was applied to the data##2##6##(2008-10#1)(2011-2#1)
analysis was applied to the##3##5##(2008-10#2)(2011-2#1)
analysis was applied to##9##4##(2008-10#5)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
analysis was applied##10##3##(2008-10#6)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
analysis was based on##4##4##(2007-11#1)(2008-10#1)(2013-8#2)
analysis was carried out for##3##5##(2008-1#1)(2008-10#1)(2011-1#1)
analysis was carried out in##2##5##(1993-11#1)(2012-3#1)
analysis was carried out on the##2##6##(2009-2#1)(2011-2#1)
analysis was carried out on##4##5##(1990-3#1)(2008-6#1)(2009-2#1)(2011-2#1)
analysis was carried out##16##4##(1990-3#1)(1993-11#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#2)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
analysis was carried##17##3##(1990-3#1)(1993-11#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#2)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
analysis was compared##2##3##(1991-12#1)(2011-2#1)
analysis was completed within##2##4##(2008-10#2)
analysis was completed##5##3##(1992-12#1)(2008-10#4)
analysis was conducted in##2##4##(1997-8#1)(2013-8#1)
analysis was conducted on##3##4##(1994-8#1)(2008-10#1)(2012-3#1)
analysis was conducted to determine##2##5##(2008-10#1)(2012-1#1)
analysis was conducted to##3##4##(2008-10#1)(2008-6#1)(2012-1#1)
analysis was conducted using##6##4##(1993-8#1)(1996-2#1)(2008-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
analysis was conducted##19##3##(1991-1#1)(1993-8#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
analysis was consistent with##2##4##(1994-5#1)(2008-8#1)
analysis was demonstrated##2##3##(2008-10#1)(2011-1#1)
analysis was developed##2##3##(2008-10#1)(2008-2#1)
analysis was done by using the##2##6##(2008-10#1)(2013-8#1)
analysis was done by using##3##5##(2008-10#1)(2013-8#2)
analysis was done by##5##4##(2008-10#2)(2013-8#3)
analysis was done to##2##4##(2011-2#1)(2013-8#1)
analysis was done##12##3##(1997-8#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#4)
analysis was employed to##3##4##(2008-10#2)(2010-5#1)
analysis was employed##5##3##(1997-2#1)(2008-10#2)(2009-7#1)(2010-5#1)
analysis was extended to##2##4##(2008-10#1)(2010-12#1)
analysis was found to be##2##5##(2008-10#1)(2008-8#1)
analysis was made for##2##4##(2008-10#1)(2011-2#1)
analysis was made of the##4##5##(1991-1#1)(1994-1#1)(2012-12#1)(2013-1#1)
analysis was made##8##3##(1991-1#1)(1994-1#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
analysis was performed after 15##2##5##(2008-11#1)(2011-2#1)
analysis was performed after##3##4##(1990-8#1)(2008-11#1)(2011-2#1)
analysis was performed and the##2##5##(2008-11#1)(2013-1#1)
analysis was performed and##4##4##(2008-11#2)(2008-6#1)(2013-1#1)
analysis was performed by##6##4##(2008-10#3)(2008-3#1)(2010-12#1)(2011-2#1)
analysis was performed in##7##4##(1996-12#1)(1996-9#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
analysis was performed on##4##4##(1991-12#1)(2008-10#1)(2009-4#1)(2011-1#1)
analysis was performed to determine the##4##6##(2008-10#2)(2008-7#1)(2011-2#1)
analysis was performed to##9##4##(2008-10#5)(2008-7#1)(2011-2#2)(2013-1#1)
analysis was performed using the##3##5##(2008-10#1)(2008-7#1)(2012-12#1)
analysis was performed using##11##4##(1995-6#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
analysis was performed##57##3##(1990-8#1)(1991-12#1)(1995-6#1)(1996-12#1)(1996-9#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
analysis was restricted to##2##4##(1993-12#1)(2008-11#1)
analysis was tested##2##3##(2008-10#2)
analysis was the##2##3##(2010-12#1)(2011-1#1)
analysis was then##2##3##(2008-10#1)(2011-2#1)
analysis was to##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
analysis was undertaken to##3##4##(1995-11#1)(1995-5#1)(2008-10#1)
analysis was undertaken##6##3##(1995-11#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
analysis was used for data analysis##2##6##(2010-11#1)(2011-1#1)
analysis was used for##3##4##(2010-11#1)(2011-1#1)(2012-12#1)
analysis was used to calculate##2##5##(2008-2#1)(2013-8#1)
analysis was used to determine##7##5##(1993-8#1)(1995-6#1)(1996-7#1)(2007-7#1)(2008-10#3)
analysis was used to evaluate the##3##6##(2011-1#1)(2012-3#1)(2013-1#1)
analysis was used to examine##2##5##(1996-7#1)(2011-2#1)
analysis was used to identify the##3##6##(1996-5#1)(2010-6#1)(2013-7#1)
analysis was used to identify##9##5##(1996-5#1)(2008-10#4)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#1)
analysis was used to measure##2##5##(2008-10#1)(2008-11#1)
analysis was used to quantify##2##5##(2010-1#1)(2010-12#1)
analysis was used to##40##4##(1993-12#1)(1993-8#1)(1995-6#1)(1996-5#1)(1996-7#2)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
analysis was used##48##3##(1993-12#1)(1993-8#1)(1995-6#1)(1996-5#2)(1996-7#2)(2007-7#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
analysis was##257##2##(1990-3#1)(1990-8#1)(1991-1#2)(1991-12#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-8#2)(1994-1#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#3)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#86)(2008-11#9)(2008-12#6)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#8)(2011-2#22)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#8)
analysis we have##2##3##(1995-9#1)(2008-3#1)
analysis we##9##2##(1991-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
analysis were applied to##2##4##(2008-10#2)
analysis were applied##3##3##(2008-10#3)
analysis were consistent with##2##4##(2008-10#1)(2008-8#1)
analysis were done##2##3##(2008-12#1)(2008-8#1)
analysis were employed##2##3##(1997-5#1)(2008-10#1)
analysis were performed##4##3##(2008-11#1)(2012-2#2)(2013-1#1)
analysis were used for##2##4##(1997-3#1)(2008-9#1)
analysis were used to determine the##2##6##(1995-11#1)(2008-12#1)
analysis were used to identify##3##5##(1992-8#1)(2010-2#1)(2011-2#1)
analysis were used to##8##4##(1992-8#1)(1995-11#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-2#1)(2011-2#1)
analysis were used##11##3##(1992-8#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#1)
analysis were validated statistically and by recovery studies##2##8##(2010-5#2)
analysis were validated##3##3##(2008-10#1)(2010-5#2)
analysis were##54##2##(1991-8#1)(1992-8#1)(1995-11#1)(1997-3#1)(1997-5#1)(2007-10#2)(2007-8#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
analysis when compared##2##3##(1997-7#1)(2008-10#1)
analysis when##3##2##(1997-7#1)(2008-10#1)(2010-4#1)
analysis which##4##2##(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)
analysis while##2##2##(2008-10#1)(2008-5#1)
analysis will##6##2##(1991-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-10#1)
analysis with DNA##2##3##(2008-10#2)
analysis with a##13##3##(1990-5#1)(1990-8#1)(1993-8#1)(1994-9#1)(1995-6#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#1)
analysis with data##2##3##(1990-12#1)(2008-10#1)
analysis with in situ##2##4##(2008-10#1)(2011-1#1)
analysis with partial##2##3##(2008-10#1)(2008-7#1)
analysis with simultaneous live/dead discrimination using##2##6##(2008-4#2)
analysis with the##12##3##(1991-9#1)(1993-3#1)(1995-6#1)(2008-10#6)(2008-2#1)(2008-4#1)(2009-10#1)
analysis with##102##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-10#45)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
analysis without any##2##3##(2008-10#2)
analysis without##4##2##(2008-10#4)
analysis would##2##2##(2008-11#1)(2011-1#1)
analysis yielded the##2##3##(1997-2#1)(2008-12#1)
analysis yielded##4##2##(1997-2#1)(2008-12#1)(2008-5#1)(2010-9#1)
analysis yields##4##2##(2008-11#1)(2008-3#2)(2008-7#1)
analysis##8933##1##(1990-10#2)(1990-11#24)(1990-12#24)(1990-2#17)(1990-3#14)(1990-4#2)(1990-5#23)(1990-6#11)(1990-7#22)(1990-8#40)(1990-9#7)(1991-1#9)(1991-10#1)(1991-11#4)(1991-12#43)(1991-2#20)(1991-3#9)(1991-5#18)(1991-6#16)(1991-8#15)(1991-9#25)(1992-1#7)(1992-10#3)(1992-11#16)(1992-12#28)(1992-2#20)(1992-3#38)(1992-4#1)(1992-5#2)(1992-6#27)(1992-7#1)(1992-8#36)(1992-9#23)(1993-1#5)(1993-11#25)(1993-12#44)(1993-2#31)(1993-3#30)(1993-5#4)(1993-6#30)(1993-8#21)(1993-9#22)(1994-1#7)(1994-10#1)(1994-11#30)(1994-12#50)(1994-2#28)(1994-3#21)(1994-5#12)(1994-6#26)(1994-7#5)(1994-8#17)(1994-9#15)(1995-1#11)(1995-11#11)(1995-12#38)(1995-2#30)(1995-3#22)(1995-4#3)(1995-5#22)(1995-6#41)(1995-8#27)(1995-9#6)(1996-1#12)(1996-10#4)(1996-11#4)(1996-12#28)(1996-2#33)(1996-3#18)(1996-4#1)(1996-5#30)(1996-6#19)(1996-7#9)(1996-8#5)(1996-9#7)(1997-1#12)(1997-2#57)(1997-3#46)(1997-4#35)(1997-5#21)(1997-6#27)(1997-7#35)(1997-8#38)(1997-9#9)(2006-10#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#19)(2007-11#97)(2007-12#104)(2007-2#6)(2007-4#5)(2007-5#7)(2007-6#5)(2007-7#17)(2007-8#35)(2008-1#71)(2008-10#3075)(2008-11#257)(2008-12#91)(2008-2#211)(2008-3#391)(2008-4#255)(2008-5#167)(2008-6#54)(2008-7#236)(2008-8#170)(2008-9#325)(2009-1#3)(2009-10#60)(2009-11#24)(2009-12#29)(2009-2#12)(2009-3#20)(2009-4#16)(2009-5#31)(2009-6#29)(2009-7#23)(2009-8#33)(2009-9#17)(2010-1#19)(2010-10#31)(2010-11#32)(2010-12#49)(2010-2#15)(2010-3#25)(2010-4#30)(2010-5#50)(2010-6#21)(2010-7#21)(2010-8#43)(2010-9#14)(2011-1#130)(2011-10#1)(2011-2#207)(2011-3#9)(2011-5#1)(2011-7#3)(2011-8#1)(2012-1#25)(2012-12#91)(2012-2#133)(2012-3#119)(2012-5#3)(2012-6#2)(2012-7#2)(2012-9#1)(2013-1#176)(2013-7#24)(2013-8#120)
analysis&quot##2##1##(1995-2#1)(2007-11#1)
analysis) and##2##2##(2008-10#1)(2008-7#1)
analysis) are##2##2##(2008-4#1)(2011-2#1)
analysis) for##2##2##(2008-10#2)
analysis) have been##2##3##(2008-10#1)(2009-8#1)
analysis) of##2##2##(2008-10#1)(2012-12#1)
analysis) or##2##2##(1992-2#1)(1996-2#1)
analysis)##32##1##(1992-2#4)(1993-11#1)(1996-2#2)(2007-7#1)(2008-10#12)(2008-4#3)(2008-7#2)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
analysis-based##2##1##(2008-3#1)(2008-5#1)
analysis-hydride generation-gas phase derivative molecular##2##5##(2008-10#2)
analysis-hydride##3##1##(2008-10#3)
analysis-mass spectrometry##3##2##(2008-10#3)
analysis?##2##1##(2008-10#1)(2012-12#1)
analysis]##13##1##(1990-8#1)(1993-11#1)(1994-9#1)(1996-2#1)(1996-6#1)(1996-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#4)
analyst##8##1##(1993-2#1)(2008-10#4)(2008-11#2)(2012-12#1)
analysts##11##1##(1991-2#1)(1992-11#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)
analyte absorbance##2##2##(2008-10#2)
analyte adsorption##2##2##(2007-11#1)(2008-10#1)
analyte and the##5##3##(2008-10#4)(2010-7#1)
analyte and##16##2##(1996-5#1)(2008-10#14)(2010-7#1)
analyte at##5##2##(2008-10#5)
analyte cations##2##2##(2008-10#2)
analyte concentration and##2##3##(2008-10#2)
analyte concentration in the##3##4##(2008-10#3)
analyte concentration was##2##3##(2008-10#2)
analyte concentration##19##2##(2008-10#16)(2008-3#1)(2008-7#1)(2010-2#1)
analyte concentrations##10##2##(1997-2#1)(2008-10#6)(2008-3#1)(2008-7#1)(2013-1#1)
analyte determination##2##2##(2008-10#2)
analyte elements in##2##3##(2008-10#2)
analyte elements##8##2##(2008-10#8)
analyte extraction##4##2##(2008-10#4)
analyte from##9##2##(1996-5#1)(2008-10#6)(2008-7#1)(2009-11#1)
analyte in a##3##3##(2008-10#3)
analyte in the presence##2##4##(2008-10#2)
analyte in the##12##3##(2008-10#10)(2009-8#1)(2010-5#1)
analyte in##18##2##(2008-10#16)(2009-8#1)(2010-5#1)
analyte ions in##3##3##(2008-10#3)
analyte ions##7##2##(2008-10#7)
analyte is determined##2##3##(2008-10#2)
analyte is##13##2##(2008-10#12)(2008-4#1)
analyte loss##2##2##(2008-10#2)
analyte mass##3##2##(2008-10#3)
analyte on the##3##3##(2008-10#3)
analyte preconcentration##3##2##(2008-10#3)
analyte pulse width##3##3##(2008-10#3)
analyte pulse##6##2##(2008-10#6)
analyte quantification##2##2##(2008-10#1)(2008-7#1)
analyte recoveries##2##2##(2008-10#2)
analyte sample##2##2##(2008-10#2)
analyte signal (NAS)-based##2##3##(2008-10#2)
analyte signal##10##2##(2008-10#10)
analyte signal-based##2##2##(2008-10#2)
analyte solution was##2##3##(2008-10#2)
analyte solution##10##2##(2008-10#10)
analyte solutions##2##2##(2008-10#1)(2008-7#1)
analyte species##2##2##(2008-10#1)(2010-7#1)
analyte to be##2##3##(2008-10#2)
analyte to##6##2##(2008-10#6)
analyte transfer##2##2##(2008-10#2)
analyte was##14##2##(2008-10#13)(2011-1#1)
analyte were##2##2##(2008-10#2)
analyte with a##2##3##(2008-10#1)(2008-3#1)
analyte with##7##2##(2008-10#5)(2008-3#1)(2009-7#1)
analyte##325##1##(1996-5#2)(1997-2#3)(2007-11#2)(2007-12#1)(2008-10#282)(2008-3#3)(2008-4#3)(2008-7#10)(2009-11#3)(2009-3#1)(2009-7#1)(2009-8#2)(2010-2#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
analytes and the##4##3##(2008-10#4)
analytes and##15##2##(1996-5#1)(2008-10#13)(2008-3#1)
analytes are in the range of 0##2##7##(2008-10#2)
analytes are in the range of##3##6##(2008-10#3)
analytes are quantitatively##2##3##(2008-10#2)
analytes are##21##2##(1992-11#1)(2008-10#18)(2008-3#1)(2013-1#1)
analytes as##4##2##(2008-10#4)
analytes by##3##2##(2008-10#3)
analytes can be##4##3##(1996-5#1)(2008-10#3)
analytes concentration in##2##3##(2008-10#2)
analytes could be well separated within 12 min in a 40 cm length capillary at the separation voltage of 12 kV in a 100 mmol l(-1) borate buffer (pH##2##29##(2008-10#2)
analytes could be##5##3##(2008-10#4)(2013-1#1)
analytes during##2##2##(1993-2#1)(2008-10#1)
analytes from the##3##3##(2008-10#3)
analytes from##8##2##(1997-2#1)(2008-10#7)
analytes has##2##2##(1994-9#1)(2008-10#1)
analytes have been investigated##2##4##(2008-10#2)
analytes have been##5##3##(2008-10#5)
analytes in a##4##3##(2008-10#3)(2008-9#1)
analytes in both##2##3##(2008-10#2)
analytes in complex##2##3##(2008-10#2)
analytes in real##2##3##(2008-10#2)
analytes in serum##2##3##(2008-10#1)(2008-3#1)
analytes in the##9##3##(2008-10#8)(2011-1#1)
analytes in water##2##3##(2008-10#2)
analytes in##41##2##(1997-2#1)(2008-10#33)(2008-3#3)(2008-4#2)(2008-9#1)(2011-1#1)
analytes investigated##2##2##(2008-10#2)
analytes is##4##2##(2008-10#4)
analytes of interest##6##3##(1994-9#1)(2008-10#5)
analytes of##7##2##(1994-9#1)(2008-10#6)
analytes on the##4##3##(2008-10#3)(2008-3#1)
analytes on##8##2##(2008-10#7)(2008-3#1)
analytes over##2##2##(2008-10#2)
analytes retained on the##2##4##(2008-10#2)
analytes retained on##3##3##(2008-10#3)
analytes retained##4##2##(2008-10#4)
analytes spiked##2##2##(2008-1#1)(2008-10#1)
analytes that##2##2##(2008-10#2)
analytes to##2##2##(2008-10#1)(2008-9#1)
analytes using##3##2##(2008-10#3)
analytes was##8##2##(2008-10#8)
analytes were also##2##3##(2008-10#2)
analytes were detected##5##3##(2008-10#3)(2011-1#1)(2013-1#1)
analytes were determined##4##3##(2008-10#4)
analytes were evaluated##3##3##(1996-5#1)(2008-10#2)
analytes were extracted##3##3##(2008-10#3)
analytes were obtained##2##3##(2008-10#2)
analytes were separated##2##3##(2008-10#2)
analytes were simultaneously##3##3##(2007-11#1)(2008-10#2)
analytes were then##4##3##(2008-10#4)
analytes were vaporized##2##3##(2008-10#2)
analytes were##53##2##(1996-5#1)(2007-11#1)(2008-10#47)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
analytes which##2##2##(1994-9#1)(2008-10#1)
analytes with the##3##3##(2008-10#3)
analytes with##7##2##(2008-10#7)
analytes##365##1##(1990-8#1)(1992-11#1)(1993-2#1)(1994-9#4)(1996-5#6)(1997-2#4)(2007-11#1)(2008-1#1)(2008-10#312)(2008-12#1)(2008-3#7)(2008-4#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-5#3)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#6)
analytic approaches##2##2##(2009-8#1)(2012-2#1)
analytic expression for##2##3##(2008-3#1)(2009-5#1)
analytic expression##5##2##(2007-10#1)(2008-2#2)(2008-3#1)(2009-5#1)
analytic expressions for##2##3##(2007-11#1)(2008-2#1)
analytic expressions##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
analytic framework##4##2##(1992-3#1)(1994-3#1)(2007-12#1)(2008-12#1)
analytic hierarchy process (AHP)##2##4##(2008-10#1)(2013-1#1)
analytic hierarchy process##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
analytic method for##2##3##(2008-10#1)(2008-3#1)
analytic method##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
analytic methods are##2##3##(2008-5#1)(2009-7#1)
analytic methods##4##2##(1996-2#2)(2008-5#1)(2009-7#1)
analytic model##3##2##(1990-8#1)(2008-2#1)(2011-1#1)
analytic results##2##2##(2008-3#1)(2008-9#1)
analytic solution for##2##3##(2007-11#1)(2008-2#1)
analytic solution##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-2#1)
analytic solutions##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
analytic strategies##2##2##(2007-10#1)(2011-1#1)
analytic techniques##2##2##(1996-7#1)(2008-11#1)
analytic##80##1##(1990-8#1)(1992-3#2)(1994-3#1)(1995-2#2)(1996-2#3)(1996-7#1)(2007-10#2)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#20)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#1)
analytical and background##2##3##(2008-3#2)
analytical and bioanalytical##3##3##(2008-10#2)(2008-4#1)
analytical and diagnostic potential of##2##5##(1997-6#2)
analytical and experimental##2##3##(2007-12#1)(2008-11#1)
analytical and numerical techniques##2##4##(2007-12#1)(2008-8#1)
analytical and preparative##2##3##(1991-5#1)(2008-10#1)
analytical and##40##2##(1991-5#1)(1994-8#1)(1996-3#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-2#2)
analytical application for##2##3##(2008-10#2)
analytical application of##4##3##(2008-10#4)
analytical application##13##2##(2008-10#13)
analytical applications of the##4##4##(2008-10#3)(2008-2#1)
analytical applications of##8##3##(2008-10#7)(2008-2#1)
analytical applications##21##2##(2007-12#1)(2008-10#17)(2008-2#2)(2010-7#1)
analytical approach for the##2##4##(2008-10#1)(2008-2#1)
analytical approach is used to##2##5##(2007-12#1)(2008-10#1)
analytical approach to##2##3##(2008-10#2)
analytical approach##15##2##(1995-11#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2010-11#1)
analytical approaches##2##2##(2008-10#2)
analytical approximation for##2##3##(2007-11#1)(2008-8#1)
analytical approximation##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
analytical as well as##2##4##(2008-10#1)(2008-3#1)
analytical assay##2##2##(2008-10#2)
analytical assays##5##2##(2008-10#4)(2010-7#1)
analytical calculation of the##2##4##(2008-2#1)(2008-3#1)
analytical characteristic##2##2##(2008-10#2)
analytical characteristics have been##2##4##(2008-10#2)
analytical characteristics of each##2##4##(2008-10#2)
analytical characteristics of the##7##4##(2008-10#7)
analytical characteristics of##14##3##(2008-10#14)
analytical characteristics such as##2##4##(2008-10#2)
analytical characteristics were obtained##2##4##(2008-10#2)
analytical characteristics were studied##3##4##(2008-10#3)
analytical characteristics were##5##3##(2008-10#5)
analytical characteristics##30##2##(2008-10#30)
analytical chemical##3##2##(2008-10#3)
analytical chemist##2##2##(2008-10#2)
analytical chemistry and##3##3##(2008-10#2)(2008-5#1)
analytical chemistry of##2##3##(2008-10#1)(2010-7#1)
analytical chemistry##35##2##(2008-10#24)(2008-11#1)(2008-5#1)(2010-7#9)
analytical chemists##3##2##(2008-10#2)(2010-11#1)
analytical column with##2##3##(2008-10#2)
analytical column##17##2##(1990-8#3)(2008-10#14)
analytical columns##3##2##(2008-10#3)
analytical concentration##2##2##(2008-10#2)
analytical conditions for the determination of##3##6##(2008-10#3)
analytical conditions for##5##3##(2008-10#4)(2010-4#1)
analytical conditions of##2##3##(2008-10#1)(2011-1#1)
analytical conditions were##2##3##(2008-10#2)
analytical conditions##18##2##(2008-10#15)(2010-10#1)(2010-4#1)(2011-1#1)
analytical curve for##2##3##(2008-10#2)
analytical curve is##3##3##(2008-10#3)
analytical curve was linear##3##4##(2008-10#3)
analytical curve was##7##3##(2008-10#7)
analytical curve##17##2##(2008-10#17)
analytical curves##9##2##(2008-10#9)
analytical data for##2##3##(2008-10#2)
analytical data were##2##3##(2008-10#2)
analytical data##13##2##(1995-5#1)(2008-10#12)
analytical description of the##2##4##(2007-11#2)
analytical detection##2##2##(1997-4#1)(2008-10#1)
analytical determination of##5##3##(2008-10#5)
analytical determination##8##2##(2008-10#8)
analytical determinations##4##2##(2008-10#4)
analytical development##5##2##(2008-10#1)(2010-12#1)(2010-7#1)(2012-2#2)
analytical errors##3##2##(2008-10#2)(2008-6#1)
analytical evaluation of##2##3##(2008-10#1)(2008-9#1)
analytical expression for the apparent infection rate##2##7##(2008-10#2)
analytical expression for the##15##4##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#3)
analytical expression for##17##3##(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#4)
analytical expression is given for the##2##6##(2008-3#2)
analytical expression of the##2##4##(2007-12#1)(2008-3#1)
analytical expression##23##2##(2007-11#4)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#9)
analytical expressions for the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
analytical expressions for##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)
analytical features##5##2##(2008-10#5)
analytical figures of merit are##2##5##(2008-10#2)
analytical figures of merit were##2##5##(2008-10#2)
analytical figures of merit##11##4##(2008-10#11)
analytical figures of merits##2##4##(2008-10#2)
analytical figures of##13##3##(2008-10#13)
analytical formula is##2##3##(2007-12#1)(2008-2#1)
analytical formula##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
analytical formulas##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
analytical frequency of##5##3##(2008-10#5)
analytical frequency was##3##3##(2008-10#3)
analytical frequency##10##2##(2008-10#10)
analytical grade##3##2##(2008-10#3)
analytical information##6##2##(1992-2#4)(2008-10#2)
analytical instrumentation##3##2##(2008-10#3)
analytical instruments##3##2##(2008-10#3)
analytical inversion of reflectometric and ellipsometric data of absorbing media##2##10##(2008-3#2)
analytical inversion of##3##3##(2008-3#3)
analytical investigation##2##2##(2008-11#1)(2008-2#1)
analytical issues##2##2##(2008-6#1)(2008-9#1)
analytical laboratories##4##2##(2008-10#3)(2009-11#1)
analytical laboratory##2##2##(2008-10#2)
analytical lines##2##2##(2008-10#2)
analytical measurements##7##2##(2008-10#6)(2008-3#1)
analytical method based on##4##4##(2008-10#3)(2013-1#1)
analytical method for the determination of##15##6##(2008-10#15)
analytical method for the##20##4##(2008-10#20)
analytical method for##29##3##(1993-3#1)(2008-10#26)(2008-2#1)(2008-5#1)
analytical method is presented##2##4##(2008-10#1)(2008-3#1)
analytical method is##9##3##(2008-10#6)(2008-3#2)(2012-3#1)
analytical method to##6##3##(1996-12#1)(2008-10#2)(2009-9#2)(2012-2#1)
analytical method using##3##3##(2008-10#2)(2008-3#1)
analytical method was##5##3##(2008-10#5)
analytical method will##2##3##(2008-10#2)
analytical method##79##2##(1993-3#1)(1996-12#1)(2008-10#63)(2008-2#1)(2008-3#3)(2008-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#2)
analytical methodology##15##2##(1995-11#1)(2008-10#13)(2010-11#1)
analytical methods and##4##3##(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
analytical methods are##3##3##(2008-3#1)(2008-5#1)(2010-5#1)
analytical methods can be used##2##5##(1993-3#1)(2008-10#1)
analytical methods for the##3##4##(2008-10#3)
analytical methods for##12##3##(1994-3#1)(1994-9#1)(2008-10#10)
analytical methods have##2##3##(2008-10#2)
analytical methods in##2##3##(2008-9#1)(2010-9#1)
analytical methods to measure##2##4##(2008-9#1)(2010-5#1)
analytical methods to##4##3##(1997-4#1)(2008-11#1)(2008-9#1)(2010-5#1)
analytical methods used##2##3##(1996-12#1)(2008-10#1)
analytical methods were##2##3##(2008-10#1)(2008-7#1)
analytical methods which##2##3##(1990-2#1)(2008-10#1)
analytical methods##61##2##(1990-2#1)(1993-3#2)(1994-3#1)(1994-9#1)(1996-12#1)(1997-4#1)(2008-10#37)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-3#1)(2013-1#1)
analytical minimalism##3##2##(2008-10#3)
analytical model for the##3##4##(2008-3#3)
analytical model for##4##3##(2008-3#4)
analytical model##14##2##(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#5)(2008-8#2)
analytical modeling##4##2##(2008-11#1)(2008-3#2)(2009-6#1)
analytical models of##2##3##(2008-3#1)(2008-7#1)
analytical models##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
analytical parameter##3##2##(2008-10#3)
analytical parameters and##2##3##(2008-10#2)
analytical parameters have been##4##4##(2008-10#4)
analytical parameters of##3##3##(2008-10#3)
analytical parameters were##5##3##(2008-10#5)
analytical parameters##26##2##(2008-10#25)(2013-8#1)
analytical pathways##2##2##(2008-10#2)
analytical performance characteristics for##2##4##(2008-10#2)
analytical performance characteristics##4##3##(2008-10#4)
analytical performance for##4##3##(2008-10#3)(2008-6#1)
analytical performance of the method##3##5##(2008-10#3)
analytical performance of the proposed##3##5##(2008-10#3)
analytical performance of the##9##4##(2008-10#9)
analytical performance of##14##3##(2008-10#14)
analytical performance was evaluated with##2##5##(2008-10#2)
analytical performance was##4##3##(2008-10#3)(2008-2#1)
analytical performance##33##2##(2008-10#31)(2008-2#1)(2008-6#1)
analytical performances of a##2##4##(2008-10#2)
analytical performances of##5##3##(2008-10#5)
analytical performances##10##2##(2008-10#10)
analytical pervaporation##2##2##(2008-10#2)
analytical potential of##2##3##(2008-10#2)
analytical potential##3##2##(2008-10#3)
analytical precision##9##2##(2008-10#8)(2009-8#1)
analytical predictions##2##2##(2008-3#2)
analytical problems##7##2##(2007-9#1)(2008-10#2)(2010-11#2)(2010-7#2)
analytical procedure for the determination of##2##6##(2008-10#2)
analytical procedure for the simultaneous determination of##2##7##(2008-10#2)
analytical procedure for the##7##4##(2008-10#7)
analytical procedure for##10##3##(2008-10#10)
analytical procedure has been developed for##2##6##(2008-10#2)
analytical procedure is based on the##2##6##(2008-10#2)
analytical procedure to##2##3##(1997-2#1)(2008-10#1)
analytical procedure was applied to##2##5##(2008-10#2)
analytical procedure was developed for the determination of##2##8##(2008-10#1)(2012-1#1)
analytical procedure was developed for##3##5##(2008-10#2)(2012-1#1)
analytical procedure was developed##4##4##(2008-10#3)(2012-1#1)
analytical procedure was##11##3##(2008-10#10)(2012-1#1)
analytical procedure##50##2##(1996-5#1)(1997-2#1)(2008-10#46)(2008-5#1)(2012-1#1)
analytical procedures and##2##3##(2008-10#1)(2010-11#1)
analytical procedures for##2##3##(2008-10#2)
analytical procedures##15##2##(1992-3#1)(2008-10#11)(2008-11#1)(2008-9#1)(2010-11#1)
analytical process##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
analytical properties of the##2##4##(2008-10#2)
analytical properties of##4##3##(2008-10#4)
analytical properties were##2##3##(2008-10#2)
analytical properties##7##2##(2008-10#7)
analytical protocol##4##2##(2008-10#3)(2010-11#1)
analytical purposes##9##2##(2008-10#6)(2008-3#1)(2010-7#1)(2011-2#1)
analytical range##4##2##(2008-10#4)
analytical reactions##2##2##(2008-10#1)(2010-7#1)
analytical reagent##3##2##(2008-10#2)(2008-9#1)
analytical reagents##5##2##(2008-10#5)
analytical recoveries were between##2##4##(2008-10#2)
analytical recoveries were##3##3##(2008-10#3)
analytical recoveries##6##2##(2008-10#6)
analytical recovery were##2##3##(2008-10#2)
analytical recovery##4##2##(1993-12#1)(2008-10#3)
analytical research and development##3##4##(2008-10#3)
analytical response##7##2##(2008-10#7)
analytical result##2##2##(2008-10#2)
analytical results and##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
analytical results are##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
analytical results demonstrate that##2##4##(2008-10#1)(2008-3#1)
analytical results for##5##3##(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#1)
analytical results obtained##6##3##(2008-10#6)
analytical results of##2##3##(2008-10#2)
analytical results were found to be##2##6##(2008-10#2)
analytical results were##6##3##(2008-10#6)
analytical results##44##2##(1995-2#1)(1997-2#1)(2007-11#3)(2007-12#2)(2008-10#24)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
analytical samples##2##2##(2008-10#2)
analytical scale##2##2##(2008-10#1)(2011-1#1)
analytical scheme was##2##3##(2008-10#2)
analytical self-focus##2##2##(2010-10#2)
analytical sensitivity and##4##3##(2008-10#3)(2011-1#1)
analytical sensitivity of the##2##4##(2008-10#1)(2011-2#1)
analytical sensitivity##14##2##(2008-10#11)(2008-4#1)(2011-1#1)(2011-2#1)
analytical separation##6##2##(2008-10#6)
analytical sequence##3##2##(2008-10#3)
analytical signal in##2##3##(2008-10#2)
analytical signal is##3##3##(2008-10#3)
analytical signal of##4##3##(2008-10#4)
analytical signal to##3##3##(2008-10#3)
analytical signal##43##2##(2008-10#43)
analytical signals for##2##3##(2008-10#2)
analytical signals were##3##3##(2008-10#3)
analytical signals##18##2##(2007-11#2)(2008-10#15)(2008-3#1)
analytical solution for##3##3##(2008-3#2)(2011-2#1)
analytical solution of the##3##4##(2007-11#2)(2008-3#1)
analytical solution##14##2##(2007-11#4)(2008-10#2)(2008-3#6)(2011-2#2)
analytical solutions##4##2##(2008-2#1)(2008-3#3)
analytical standards of##2##3##(1995-3#1)(2008-10#1)
analytical strategy##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
analytical studies of the##2##4##(2008-10#1)(2010-3#1)
analytical studies##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2010-3#1)
analytical study was conducted##2##4##(2011-2#1)(2013-1#1)
analytical study was##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
analytical study##8##2##(2008-10#2)(2008-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
analytical support##2##2##(2008-10#2)
analytical system is##4##3##(2008-10#3)(2008-9#1)
analytical system was##3##3##(2008-10#3)
analytical system##17##2##(2008-10#13)(2008-9#1)(2010-7#2)(2013-8#1)
analytical systems to##2##3##(2008-10#2)
analytical systems##8##2##(2008-10#8)
analytical technique for##3##3##(2008-10#2)(2009-12#1)
analytical technique##14##2##(2008-10#11)(2008-3#1)(2009-12#1)(2012-2#1)
analytical techniques and the##2##4##(2008-10#1)(2010-11#1)
analytical techniques and##8##3##(2008-10#5)(2008-11#1)(2010-11#2)
analytical techniques are##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
analytical techniques for the##3##4##(2008-10#3)
analytical techniques for##5##3##(2008-10#5)
analytical techniques such as##2##4##(2008-10#2)
analytical techniques##41##2##(2007-12#1)(2008-10#29)(2008-11#2)(2008-4#1)(2008-9#2)(2010-11#3)(2010-5#1)(2010-6#1)(2010-7#1)
analytical test problems##2##3##(2007-9#2)
analytical test##4##2##(2007-9#2)(2008-10#2)
analytical throughput of 20##2##4##(2008-10#2)
analytical throughput of##8##3##(2008-10#8)
analytical throughput##12##2##(2008-10#12)
analytical time##3##2##(2008-10#3)
analytical tool for studying##2##4##(1991-5#1)(2008-2#1)
analytical tool for the investigation of##2##6##(2008-10#1)(2008-7#1)
analytical tool for the##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
analytical tool for##8##3##(1991-5#1)(1992-11#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-1#1)
analytical tool in##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
analytical tool##17##2##(1991-5#1)(1992-11#1)(1996-12#1)(2008-10#8)(2008-2#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#1)
analytical tools for##6##3##(2008-10#6)
analytical tools in environmental##2##4##(2008-10#2)
analytical tools in##3##3##(2008-10#2)(2008-4#1)
analytical tools##20##2##(2008-10#12)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)
analytical treatment of the##2##4##(1997-2#1)(2007-11#1)
analytical treatment of##3##3##(1997-2#1)(2007-11#1)(2008-2#1)
analytical ultracentrifugation##4##2##(1994-5#1)(1995-2#2)(2011-2#1)
analytical usefulness##3##2##(2008-10#3)
analytical utility of##4##3##(2008-10#4)
analytical utility##5##2##(2008-10#5)
analytical wavelengths##3##2##(2008-10#3)
analytical##1300##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#3)(1991-12#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#5)(1992-3#1)(1993-12#1)(1993-3#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#5)(1996-3#2)(1996-5#1)(1997-2#6)(1997-3#2)(1997-4#2)(1997-6#2)(2007-10#2)(2007-11#28)(2007-12#12)(2007-7#2)(2007-9#3)(2008-1#2)(2008-10#904)(2008-11#14)(2008-12#2)(2008-2#36)(2008-3#74)(2008-4#9)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#12)(2008-9#13)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#13)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#27)(2010-9#2)(2011-1#4)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#12)(2013-8#4)
analytically and numerically that##2##4##(2007-11#1)(2007-12#1)
analytically and numerically##7##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2011-2#1)
analytically and##12##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#1)(2008-8#2)(2011-2#1)
analytically calculated##2##2##(2007-11#1)(2008-3#1)
analytically derived##2##2##(2008-2#1)(2008-3#1)
analytically for##3##2##(2008-10#1)(2008-3#2)
analytically the##5##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#2)
analytically##60##1##(1990-8#1)(1996-2#1)(2007-11#7)(2007-12#6)(2008-10#9)(2008-11#1)(2008-2#9)(2008-3#15)(2008-6#1)(2008-8#2)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
analytics##5##1##(1992-2#1)(1994-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
analyze a##18##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#4)(2008-9#2)(2011-2#2)(2012-2#1)
analyze an##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
analyze and predict the##2##4##(2008-10#1)(2010-5#1)
analyze and##12##2##(1991-2#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2010-5#1)(2010-6#1)
analyze cell##2##2##(2008-4#1)(2008-9#1)
analyze data##3##2##(1993-3#1)(1997-3#1)(2008-1#1)
analyze different##2##2##(2008-10#1)(2011-2#1)
analyze how##3##2##(2008-3#1)(2009-4#1)(2011-1#1)
analyze in detail the##5##4##(1991-6#1)(2008-3#2)(2012-3#1)(2013-1#1)
analyze in##7##2##(1991-6#1)(1995-5#1)(1997-3#1)(2008-3#2)(2012-3#1)(2013-1#1)
analyze molecular##2##2##(2008-10#1)(2008-4#1)
analyze performance##2##2##(1996-3#1)(2008-2#1)
analyze some##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
analyze such##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
analyze the behavior of##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
analyze the clinical##2##3##(2012-12#1)(2013-7#1)
analyze the data##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
analyze the differences in##2##4##(1996-3#1)(2010-9#1)
analyze the effect of##7##4##(1995-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2011-2#1)
analyze the effects of##2##4##(2008-3#2)
analyze the evolution of the##2##5##(2007-11#1)(2013-1#1)
analyze the evolution of##4##4##(1993-3#1)(2007-11#1)(2008-9#1)(2013-1#1)
analyze the evolutionary##3##3##(1993-2#1)(2008-8#2)
analyze the factors##2##3##(2008-8#1)(2013-1#1)
analyze the genetic##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
analyze the impact of##2##4##(2008-2#1)(2011-1#1)
analyze the influence of##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
analyze the influence##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
analyze the literature on##2##4##(1994-1#1)(2011-2#1)
analyze the performance of the##2##5##(2008-2#1)(2008-3#1)
analyze the possible##3##3##(1992-5#1)(2008-9#1)(2013-7#1)
analyze the radiation##2##3##(2007-12#1)(2008-10#1)
analyze the relation between##2##4##(2008-1#1)(2008-3#1)
analyze the relationship between##3##4##(2007-8#1)(2008-3#1)(2010-2#1)
analyze the relationship##4##3##(2007-8#1)(2008-3#1)(2010-2#1)(2011-1#1)
analyze the results of##3##4##(1990-6#1)(2012-3#1)(2013-1#1)
analyze the results##6##3##(1990-6#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
analyze the usefulness of##2##4##(2009-3#1)(2013-1#1)
analyze the##203##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#8)(2008-12#2)(2008-2#13)(2008-3#22)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#12)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#10)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#3)(2013-8#2)
analyze these##4##2##(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)
analyze this##4##2##(1994-12#1)(2007-11#1)(2007-12#1)(2009-10#1)
analyze trends in##2##3##(1994-12#1)(2009-10#1)
analyze whether##2##2##(2008-10#1)(2012-3#1)
analyze##457##1##(1990-11#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-2#1)(1993-3#7)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#10)(2007-12#14)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#63)(2008-11#18)(2008-12#7)(2008-2#28)(2008-3#43)(2008-4#15)(2008-5#6)(2008-6#7)(2008-7#5)(2008-8#24)(2008-9#21)(2009-1#1)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#4)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#21)(2011-7#1)(2012-12#1)(2012-2#12)(2012-3#11)(2013-1#15)(2013-7#4)(2013-8#3)
analyzed 115##2##2##(2008-10#1)(2011-2#1)
analyzed DNA##2##2##(2008-10#2)
analyzed Xist expression##2##3##(1997-2#2)
analyzed a##9##2##(1991-3#1)(1992-9#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
analyzed according to##7##3##(1993-11#1)(1995-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
analyzed after##5##2##(1994-12#1)(2008-10#3)(2010-6#1)
analyzed all##2##2##(2008-3#1)(2009-4#1)
analyzed and compared with##5##4##(1996-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
analyzed and compared##10##3##(1994-12#1)(1996-11#1)(2008-10#1)(2008-3#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
analyzed and discussed in terms of##2##6##(2007-11#1)(2008-10#1)
analyzed and discussed##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
analyzed and experimentally##2##3##(2007-12#1)(2008-2#1)
analyzed and found to##2##4##(1993-12#1)(2007-12#1)
analyzed and the##9##3##(1997-8#1)(2008-10#6)(2008-4#1)(2013-7#1)
analyzed and their##2##3##(1993-3#1)(1996-2#1)
analyzed and##62##2##(1991-12#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
analyzed as a##5##3##(1992-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
analyzed as##13##2##(1990-8#1)(1992-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
analyzed at the##5##3##(1994-3#1)(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
analyzed at##13##2##(1994-3#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
analyzed based on##5##3##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
analyzed by DNA fingerprinting##2##4##(2008-10#2)
analyzed by GC-MS##2##3##(2008-10#1)(2012-3#1)
analyzed by HPLC##5##3##(1993-11#1)(1995-11#1)(2008-10#1)(2009-8#1)(2011-1#1)
analyzed by PCR##3##3##(2008-12#1)(2009-8#1)(2012-12#1)
analyzed by SDS-PAGE and##4##4##(1991-2#1)(2008-4#1)(2008-8#1)(2011-1#1)
analyzed by SDS-PAGE##7##3##(1991-12#1)(1991-2#1)(1992-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
analyzed by Southern##2##3##(2008-10#1)(2008-8#1)
analyzed by a##15##3##(1990-8#2)(1994-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-9#1)(2013-1#2)
analyzed by applying##2##3##(2008-11#1)(2008-5#1)
analyzed by both##4##3##(1990-8#1)(2008-10#2)(2012-2#1)
analyzed by capillary electrophoresis##2##4##(2008-10#1)(2008-12#1)
analyzed by electrophoretic##2##3##(2008-4#1)(2008-9#1)
analyzed by fitting##2##3##(2008-10#1)(2008-8#1)
analyzed by gas chromatography##3##4##(2008-10#2)(2008-9#1)
analyzed by gas##6##3##(2008-10#4)(2008-9#1)(2013-8#1)
analyzed by high-performance liquid chromatography##4##5##(1992-2#1)(2008-10#2)(2008-5#1)
analyzed by high-performance##6##3##(1992-2#1)(1993-11#1)(2008-10#2)(2008-5#2)
analyzed by immunohistochemistry and##2##4##(2011-2#1)(2013-8#1)
analyzed by means of the##2##5##(2008-3#1)(2008-7#1)
analyzed by means of##9##4##(1992-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
analyzed by real-time##3##3##(2008-10#1)(2010-4#1)(2012-3#1)
analyzed by restriction##2##3##(2008-10#2)
analyzed by reverse phase##2##4##(1990-12#1)(2008-10#1)
analyzed by reverse##5##3##(1990-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
analyzed by scanning electron microscopy (SEM)##2##6##(2008-10#1)(2012-2#1)
analyzed by scanning electron microscopy##4##5##(2008-10#1)(2009-7#1)(2010-5#1)(2012-2#1)
analyzed by scanning##5##3##(2007-12#1)(2008-10#1)(2009-7#1)(2010-5#1)(2012-2#1)
analyzed by selected ion monitoring##2##5##(2008-10#2)
analyzed by the##26##3##(1990-2#1)(1990-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#12)(2008-12#1)(2008-2#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
analyzed by this method##3##4##(2008-10#2)(2008-4#1)
analyzed by this##6##3##(1993-12#1)(2008-10#4)(2008-4#1)
analyzed by use of a##3##5##(1997-7#1)(2007-11#1)(2008-3#1)
analyzed by use of the##8##5##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
analyzed by use of##13##4##(1997-7#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#6)
analyzed by using the##5##4##(2008-10#4)(2010-7#1)
analyzed by using##10##3##(1997-7#1)(2008-10#6)(2008-6#1)(2010-7#1)(2013-8#1)
analyzed by##297##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#3)(1990-8#4)(1991-12#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#3)(2007-12#4)(2008-10#82)(2008-11#13)(2008-12#6)(2008-2#12)(2008-3#20)(2008-4#7)(2008-5#16)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-7#3)(2009-8#4)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#10)
analyzed clinical##2##2##(2007-11#1)(2011-2#1)
analyzed contained##2##2##(1994-12#1)(1997-2#1)
analyzed data from a##2##4##(2013-1#2)
analyzed data from the##2##4##(2010-12#1)(2010-6#1)
analyzed data from##6##3##(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
analyzed data##8##2##(1993-12#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
analyzed differences##2##2##(1992-12#1)(2010-6#1)
analyzed directly by##4##3##(2008-10#3)(2012-1#1)
analyzed directly##5##2##(2007-11#1)(2008-10#3)(2012-1#1)
analyzed during 1994##2##3##(2008-10#2)
analyzed during##8##2##(1993-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
analyzed factors##3##2##(2008-12#1)(2008-6#1)(2008-7#1)
analyzed for a##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2009-8#1)
analyzed for genetic##2##3##(2008-10#2)
analyzed for statistical significance##2##4##(2009-2#2)
analyzed for the expression of##2##5##(1996-12#1)(2008-10#1)
analyzed for the first time##2##5##(2008-11#1)(2008-2#1)
analyzed for the presence of##2##5##(2008-10#2)
analyzed for the##17##3##(1992-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#2)(2013-8#1)
analyzed for their##8##3##(1992-2#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-7#1)(2012-3#1)
analyzed for##108##2##(1990-5#1)(1990-6#1)(1991-3#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#37)(2008-11#4)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2012-5#1)(2013-7#1)(2013-8#2)
analyzed from the##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
analyzed from##10##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#2)
analyzed group##4##2##(2007-8#1)(2011-2#3)
analyzed here##4##2##(2008-2#2)(2008-3#2)
analyzed in a single##2##4##(2008-9#1)(2012-2#1)
analyzed in a##15##3##(1991-5#1)(1992-11#1)(1994-1#1)(1994-8#1)(1997-2#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#2)(2009-2#1)(2009-5#1)(2012-2#1)
analyzed in detail##6##3##(1995-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
analyzed in eight##2##3##(2008-7#2)
analyzed in five##3##3##(2008-7#2)(2011-2#1)
analyzed in human##2##3##(1992-8#1)(1994-3#1)
analyzed in more detail##3##4##(1995-6#1)(1997-5#1)(2008-5#1)
analyzed in order to##4##4##(1990-2#1)(1991-3#1)(2008-10#2)
analyzed in parallel with##2##4##(1993-6#1)(1995-3#1)
analyzed in relation to##4##4##(1991-3#1)(1991-6#1)(2007-10#1)(2012-1#1)
analyzed in several##2##3##(2008-10#1)(2011-3#1)
analyzed in terms of the##5##5##(1994-12#1)(1995-6#1)(2007-11#2)(2008-3#1)
analyzed in terms of##13##4##(1991-5#1)(1994-12#1)(1995-6#1)(1997-6#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-3#2)
analyzed in the presence of##2##5##(1992-2#1)(1995-2#1)
analyzed in the##18##3##(1992-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-6#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
analyzed in this study##2##4##(2008-7#1)(2011-2#1)
analyzed in this##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
analyzed in two##2##3##(2008-10#1)(2008-7#1)
analyzed in##118##2##(1990-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1997-2#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#9)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
analyzed included##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
analyzed ions##3##2##(2008-10#3)
analyzed its##2##2##(2008-9#2)
analyzed on the basis of the##4##6##(1994-12#1)(2007-11#1)(2008-3#1)(2009-4#1)
analyzed on the basis of##9##5##(1994-12#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)
analyzed on the##10##3##(1994-12#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
analyzed on##16##2##(1994-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-7#1)
analyzed or##2##2##(1993-5#1)(2008-10#1)
analyzed over##2##2##(2008-10#1)(2012-2#1)
analyzed patients##3##2##(2011-2#2)(2013-1#1)
analyzed periods##2##2##(2008-1#1)(2011-1#1)
analyzed quantitatively##4##2##(1991-8#1)(1997-8#1)(2008-3#2)
analyzed retrospectively##5##2##(1990-6#1)(1997-8#1)(2011-2#1)(2013-1#2)
analyzed separately##3##2##(1993-2#1)(2008-2#1)(2012-3#1)
analyzed so##3##2##(1992-6#1)(2008-2#2)
analyzed spatially##2##2##(2008-10#1)(2008-2#1)
analyzed statistically by##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
analyzed statistically##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#2)
analyzed that##2##2##(2007-12#1)(2008-12#1)
analyzed the correlation between##2##4##(1992-9#1)(2010-5#1)
analyzed the data##3##3##(2007-8#1)(2008-3#1)(2012-3#1)
analyzed the effect of##3##4##(2010-5#1)(2013-1#2)
analyzed the effects of these##2##5##(2008-11#1)(2008-8#1)
analyzed the effects of##5##4##(1990-5#1)(2008-11#1)(2008-3#1)(2008-8#2)
analyzed the expression pattern of##2##5##(1992-3#1)(1995-2#1)
analyzed the expression##3##3##(1992-12#1)(1992-3#1)(1995-2#1)
analyzed the prevalence of##2##4##(1993-2#1)(2009-5#1)
analyzed the results of##2##4##(2008-2#1)(2011-2#1)
analyzed the results##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
analyzed the role of##2##4##(1992-3#1)(2013-1#1)
analyzed the##95##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-5#2)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#2)
analyzed theoretically by##4##3##(1990-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
analyzed three##3##2##(1991-2#1)(2007-7#1)(2012-3#1)
analyzed through##3##2##(1990-3#1)(1994-11#1)(2008-9#1)
analyzed to assess##2##3##(2010-5#1)(2013-1#1)
analyzed to demonstrate##2##3##(1997-1#1)(2008-10#1)
analyzed to determine the##8##4##(1995-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
analyzed to determine their##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
analyzed to determine##15##3##(1994-2#1)(1995-1#1)(1995-12#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#2)
analyzed to elucidate##2##3##(2008-10#1)(2013-1#1)
analyzed to identify##3##3##(1995-1#1)(2008-12#1)(2013-1#1)
analyzed to investigate##2##3##(2008-2#1)(2008-8#1)
analyzed to study the##2##4##(2008-10#1)(2008-8#1)
analyzed to yield##2##3##(1997-7#1)(2011-1#1)
analyzed to##48##2##(1992-5#1)(1994-2#2)(1995-1#2)(1995-12#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-5#2)(2011-1#1)(2013-1#6)(2013-8#2)
analyzed two##3##2##(2008-10#1)(2009-8#1)(2010-7#1)
analyzed under##5##2##(2008-10#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
analyzed using a##16##3##(1992-11#1)(1993-11#1)(2007-10#1)(2008-10#5)(2008-3#1)(2009-5#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-1#2)
analyzed using an##3##3##(2007-10#1)(2008-10#2)
analyzed using both##2##3##(2008-10#1)(2009-8#1)
analyzed using modified##2##3##(2008-10#1)(2013-1#1)
analyzed using polymerase chain reaction##2##5##(2008-10#2)
analyzed using the proposed##3##4##(2008-10#2)(2008-8#1)
analyzed using the sequence of the##2##6##(2008-10#2)
analyzed using the##23##3##(1991-2#1)(1992-8#1)(2007-8#1)(2008-10#10)(2008-12#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
analyzed using##109##2##(1991-11#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-5#1)(1996-5#1)(1997-5#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-10#39)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
analyzed via##2##2##(2008-10#1)(2013-8#1)
analyzed were##6##2##(1992-11#1)(1994-7#1)(2008-10#3)(2008-3#1)
analyzed whether##4##2##(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
analyzed with a##7##3##(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
analyzed with both##2##3##(2008-10#2)
analyzed with respect to##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
analyzed with the##9##3##(2008-10#6)(2008-3#1)(2008-5#1)(2011-1#1)
analyzed with##57##2##(1990-11#1)(1991-3#1)(1993-11#1)(1994-11#1)(1995-11#1)(1996-11#1)(1997-2#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#6)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
analyzed within the framework of##2##5##(1990-8#1)(2007-11#1)
analyzed within##3##2##(1990-8#1)(2007-11#1)(2013-1#1)
analyzed##1610##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#7)(1990-6#3)(1990-7#6)(1990-8#6)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#6)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#3)(1992-11#5)(1992-12#7)(1992-2#10)(1992-3#9)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#6)(1993-12#10)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#7)(1993-9#6)(1994-1#1)(1994-11#9)(1994-12#9)(1994-2#3)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#10)(1995-2#10)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#5)(1996-1#3)(1996-11#3)(1996-12#8)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-8#2)(1997-1#3)(1997-2#11)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#4)(1997-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#8)(2007-11#28)(2007-12#33)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#14)(2008-1#7)(2008-10#369)(2008-11#48)(2008-12#33)(2008-2#74)(2008-3#126)(2008-4#23)(2008-5#47)(2008-6#10)(2008-7#25)(2008-8#29)(2008-9#28)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#7)(2009-8#11)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#6)(2010-4#5)(2010-5#11)(2010-6#5)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#30)(2011-2#54)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#6)(2012-12#12)(2012-2#20)(2012-3#42)(2012-5#1)(2013-1#70)(2013-7#19)(2013-8#39)
analyzer and##7##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
analyzer azimuth##2##2##(2008-3#2)
analyzer based on##2##3##(2008-10#1)(2008-2#1)
analyzer based##3##2##(2008-10#2)(2008-2#1)
analyzer for##3##2##(2008-10#3)
analyzer is##2##2##(2007-11#1)(2008-2#1)
analyzer multilayers for##2##3##(2008-3#2)
analyzer was##3##2##(2008-10#1)(2008-2#2)
analyzer with a##2##3##(2007-11#1)(2008-3#1)
analyzer with the##2##3##(2007-11#1)(2008-10#1)
analyzer with##7##2##(1993-8#1)(2007-11#2)(2008-10#3)(2008-3#1)
analyzer##67##1##(1992-3#1)(1993-8#1)(1995-8#1)(2007-11#4)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#17)(2008-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#3)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
analyzers that##2##2##(2008-10#2)
analyzers##11##1##(2008-10#6)(2008-2#1)(2008-3#3)(2013-1#1)
analyzes a##3##2##(1991-3#1)(1992-12#1)(2008-8#1)
analyzes changes in##2##3##(1996-3#1)(2007-12#1)
analyzes current##2##2##(2007-8#1)(2010-5#1)
analyzes of##2##2##(2008-7#1)(2013-1#1)
analyzes the data##2##3##(2009-7#1)(2012-3#1)
analyzes the##34##2##(1990-11#1)(1991-1#1)(1991-12#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
analyzes were##2##2##(2008-10#1)(2013-7#1)
analyzes##64##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#2)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
analyzing DNA##2##2##(1992-5#1)(2008-4#1)
analyzing a series of seven replicates##4##6##(2008-10#4)
analyzing a single##2##3##(2008-10#1)(2008-4#1)
analyzing a##19##2##(1993-2#1)(2008-10#14)(2008-3#1)(2008-4#1)(2012-3#1)(2013-7#1)
analyzing all##2##2##(1996-1#1)(2008-10#1)
analyzing and##5##2##(2007-11#1)(2008-4#1)(2008-8#2)(2009-7#1)
analyzing cells##2##2##(2008-4#1)(2010-12#1)
analyzing data from##3##3##(1997-2#1)(2008-3#2)
analyzing data##6##2##(1997-2#1)(2008-10#1)(2008-3#3)(2012-3#1)
analyzing experimental##2##2##(2008-7#1)(2010-12#1)
analyzing fringe patterns##2##3##(2008-2#1)(2008-3#1)
analyzing gene expression##2##3##(2008-4#2)
analyzing its##2##2##(2009-7#1)(2012-2#1)
analyzing large##2##2##(2008-3#1)(2013-1#1)
analyzing longitudinal data##2##3##(2009-8#2)
analyzing medical##2##2##(1995-2#1)(2009-10#1)
analyzing microarray##2##2##(2008-10#1)(2008-4#1)
analyzing molecular##2##2##(2008-4#1)(2012-2#1)
analyzing of##3##2##(1990-12#1)(2008-10#1)(2012-3#1)
analyzing real##3##2##(2008-10#3)
analyzing such##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
analyzing system##4##2##(1996-5#1)(2008-10#3)
analyzing the association##2##3##(2008-8#1)(2012-3#1)
analyzing the data##2##3##(2008-2#2)
analyzing the##70##2##(1990-6#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#2)(1995-12#1)(1996-10#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-2#10)(2008-3#4)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
analyzing their##4##2##(1993-8#1)(1995-1#1)(1997-3#1)(2008-10#1)
analyzing them##2##2##(1992-1#1)(2010-1#1)
analyzing these##2##2##(2008-10#2)
analyzing variation##2##2##(2008-7#1)(2013-1#1)
analyzing various##3##2##(1995-2#1)(2008-10#2)
analyzing##260##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#3)(2007-6#1)(2008-1#2)(2008-10#76)(2008-11#2)(2008-2#13)(2008-3#16)(2008-4#23)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#10)(2009-10#3)(2009-11#1)(2009-4#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#5)
anamnesis and##2##2##(1992-9#1)(1997-3#1)
anamnesis can##2##2##(1992-9#1)(2007-11#1)
anamnesis##10##1##(1990-9#1)(1991-3#1)(1992-5#1)(1992-9#2)(1997-3#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
anamnestic##3##1##(1990-12#1)(1993-2#2)
anamorph and teleomorph##2##3##(2008-10#2)
anamorph genera##4##2##(2008-10#4)
anamorph##9##1##(2008-10#9)
anamorphic concentration##3##2##(2007-12#1)(2008-3#2)
anamorphic external cavity##3##3##(2008-3#3)
anamorphic##11##1##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#6)
anamorphism and aberrations##2##3##(2007-11#2)
anamorphism##3##1##(2007-11#3)
anamorphs##3##1##(2008-10#2)(2010-3#1)
ananassae##3##1##(2008-5#3)
ananatis##4##1##(2008-10#4)
anaphase I##2##2##(2008-5#1)(2009-12#1)
anaphase##7##1##(2008-11#2)(2008-5#3)(2009-12#1)(2011-2#1)
anaphases##2##1##(2008-11#2)
anaphor comprehension##3##2##(2007-12#3)
anaphor##4##1##(2007-12#4)
anaphylactic or anaphylactoid reactions##2##4##(1991-11#1)(2011-1#1)
anaphylactic reaction##2##2##(2007-5#1)(2008-10#1)
anaphylactic reactions##3##2##(2007-12#1)(2009-6#1)(2013-1#1)
anaphylactic shock##7##2##(1991-8#1)(2008-10#2)(2011-2#3)(2012-3#1)
anaphylactic##17##1##(1991-11#1)(1991-8#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#3)(2009-6#1)(2010-1#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
anaphylactoid reaction##2##2##(1991-11#1)(1994-6#1)
anaphylactoid reactions are##2##3##(1991-11#1)(2008-8#1)
anaphylactoid reactions##4##2##(1991-11#1)(2008-8#2)(2011-1#1)
anaphylactoid##7##1##(1990-8#1)(1991-11#2)(1994-6#1)(2008-8#2)(2011-1#1)
anaphylaxis in##4##2##(1991-11#1)(2010-5#1)(2013-1#2)
anaphylaxis##40##1##(1991-11#3)(1991-8#1)(1992-3#1)(1992-6#1)(1995-11#1)(1996-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-1#6)(2010-5#1)(2010-6#4)(2011-2#1)(2012-3#6)(2013-1#7)(2013-8#1)
anaplasia##2##1##(1990-2#1)(2011-2#1)
anaplastic ependymoma##3##2##(2012-12#3)
anaplastic large cell lymphoma (ALCL)##3##5##(1997-3#1)(2011-2#2)
anaplastic thyroid cancer##3##3##(2008-12#2)(2013-1#1)
anaplastic thyroid carcinoma##2##3##(2008-10#1)(2008-12#1)
anaplastic thyroid##5##2##(2008-10#1)(2008-12#3)(2013-1#1)
anaplastic##18##1##(1995-12#1)(1997-3#1)(2008-10#1)(2008-12#6)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)
anastamosis##2##1##(2007-10#1)(2011-1#1)
anastigmatic##3##1##(2008-2#1)(2008-3#2)
anastomose with tester##2##3##(2008-10#2)
anastomose with##3##2##(2008-10#2)(2008-12#1)
anastomosed to the##2##3##(2007-8#1)(2013-1#1)
anastomosed with tester##2##3##(2008-10#2)
anastomosed with##3##2##(2008-10#3)
anastomosed##6##1##(1991-3#1)(2007-8#1)(2008-10#3)(2013-1#1)
anastomoses and##2##2##(1996-9#1)(2008-7#1)
anastomoses are performed##2##3##(2008-9#1)(2011-3#1)
anastomoses are##4##2##(2007-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
anastomoses was##2##2##(2007-8#2)
anastomoses##35##1##(1990-3#1)(1991-6#1)(1996-9#1)(1997-1#1)(2007-7#3)(2007-8#13)(2008-7#1)(2008-9#3)(2011-3#2)(2012-2#1)(2013-1#7)(2013-7#1)
anastomosis and##2##2##(2007-8#1)(2008-10#1)
anastomosis between##2##2##(1990-9#1)(2007-8#1)
anastomosis for##3##2##(1996-3#1)(2007-8#1)(2008-1#1)
anastomosis group (AG)##2##3##(2008-10#2)
anastomosis group 1 (AG-1)##2##4##(2008-10#2)
anastomosis group##14##2##(2008-10#14)
anastomosis grouping##2##2##(2008-10#1)(2008-12#1)
anastomosis groups##2##2##(2008-10#1)(2008-12#1)
anastomosis in##6##2##(1992-9#2)(1993-3#2)(2008-1#1)(2009-5#1)
anastomosis is##5##2##(1991-9#1)(2009-12#1)(2013-1#3)
anastomosis of the##3##3##(2007-8#1)(2008-7#1)(2010-12#1)
anastomosis of##4##2##(2007-8#2)(2008-7#1)(2010-12#1)
anastomosis or##3##2##(1993-6#1)(2008-10#1)(2013-1#1)
anastomosis reaction##2##2##(2008-10#2)
anastomosis reactions##4##2##(2008-10#4)
anastomosis site##2##2##(2008-7#1)(2012-2#1)
anastomosis was performed in##2##4##(1991-6#1)(2008-10#1)
anastomosis was performed##3##3##(1991-11#1)(1991-6#1)(2008-10#1)
anastomosis was##5##2##(1991-11#1)(1991-6#1)(2007-8#2)(2008-10#1)
anastomosis with##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)
anastomosis##105##1##(1990-3#3)(1990-6#1)(1990-9#3)(1991-11#1)(1991-3#4)(1991-6#2)(1991-9#2)(1992-9#3)(1993-3#6)(1993-6#1)(1993-9#1)(1994-3#1)(1996-3#1)(2007-7#2)(2007-8#17)(2008-1#2)(2008-10#32)(2008-12#4)(2008-7#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#5)
anastomosis)##2##1##(1990-3#1)(2013-1#1)
anastomosis]##2##1##(1991-6#1)(1991-9#1)
anastomotic stricture##6##2##(2010-12#1)(2013-7#5)
anastomotic techniques##2##2##(2013-1#2)
anastomotic##21##1##(2006-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#4)(2011-2#1)(2013-1#3)(2013-7#5)
anatipestifer septicaemia##2##2##(2008-5#2)
anatipestifer##3##1##(2008-5#3)
anatomic and##5##2##(1992-4#1)(1994-12#1)(2010-8#1)(2011-7#1)(2012-3#1)
anatomic basis for##2##3##(2012-3#2)
anatomic basis##3##2##(2012-2#1)(2012-3#2)
anatomic characteristics of##2##3##(2008-10#1)(2012-3#1)
anatomic characteristics##3##2##(2008-10#2)(2012-3#1)
anatomic correlation of the##2##4##(1994-3#1)(2007-10#1)
anatomic correlation of##3##3##(1994-3#1)(2007-10#2)
anatomic features##3##2##(2010-8#1)(2011-2#1)(2012-3#1)
anatomic landmarks##2##2##(2006-12#1)(2008-1#1)
anatomic limitations##2##2##(2011-7#1)(2013-1#1)
anatomic location##5##2##(1994-6#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)
anatomic position##3##2##(2007-12#1)(2008-9#1)(2009-4#1)
anatomic relationships of the##2##4##(2012-3#2)
anatomic relationships##3##2##(2008-1#1)(2012-3#2)
anatomic sites##6##2##(1994-1#1)(1997-7#1)(2007-5#1)(2008-5#1)(2012-3#1)(2013-8#1)
anatomic structures##6##2##(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
anatomic study##2##2##(2008-9#1)(2011-2#1)
anatomic variations of##2##3##(2008-9#1)(2011-2#1)
anatomic variations##4##2##(1996-6#1)(2008-9#1)(2011-2#2)
anatomic##92##1##(1990-9#1)(1991-10#2)(1992-4#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-6#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-7#1)(2006-12#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#13)(2011-7#3)(2012-2#4)(2012-3#11)(2013-1#5)(2013-8#2)
anatomical and biomechanical##2##3##(2007-8#1)(2009-7#1)
anatomical and clinical##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
anatomical and functional information##2##4##(2008-1#1)(2012-12#1)
anatomical and functional##5##3##(2007-11#1)(2008-1#1)(2012-12#1)(2013-1#2)
anatomical and morphological##2##3##(2010-3#1)(2010-5#1)
anatomical and physiological properties##2##4##(1997-6#1)(2009-5#1)
anatomical and physiological##11##3##(1990-6#1)(1991-6#1)(1997-6#2)(2008-11#1)(2008-5#1)(2009-5#1)(2012-3#1)(2013-1#3)
anatomical and##32##2##(1990-6#1)(1991-6#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)
anatomical barriers##2##2##(2008-10#1)(2011-2#1)
anatomical basis of##2##3##(1991-3#1)(2008-7#1)
anatomical changes##2##2##(2008-6#1)(2013-8#1)
anatomical circumstances##2##2##(2011-2#2)
anatomical considerations##2##2##(2011-2#2)
anatomical consistency##2##2##(1995-6#2)
anatomical defect##2##2##(1990-6#1)(2011-1#1)
anatomical details##2##2##(1991-6#1)(2012-3#1)
anatomical distribution of##2##3##(1996-2#1)(2008-4#1)
anatomical factors##2##2##(2008-10#2)
anatomical features of##2##3##(2012-2#1)(2013-1#1)
anatomical features##5##2##(1991-11#1)(1996-9#1)(2008-5#1)(2012-2#1)(2013-1#1)
anatomical information and##2##3##(2011-1#1)(2012-12#1)
anatomical information##5##2##(2008-1#1)(2011-1#2)(2011-2#1)(2012-12#1)
anatomical knowledge of##2##3##(1990-8#1)(2008-10#1)
anatomical knowledge##3##2##(1990-8#1)(2008-10#1)(2008-6#1)
anatomical landmarks and##2##3##(2010-6#1)(2012-12#1)
anatomical landmarks##3##2##(2008-9#1)(2010-6#1)(2012-12#1)
anatomical left##2##2##(2008-10#2)
anatomical location and##3##3##(1994-5#1)(2008-12#1)(2011-2#1)
anatomical location##7##2##(1994-5#1)(1996-12#1)(2008-12#1)(2011-2#3)(2013-8#1)
anatomical models##3##2##(1991-12#3)
anatomical overlap##2##2##(1993-12#1)(1997-3#1)
anatomical properties##2##2##(2009-12#1)(2009-4#1)
anatomical region##2##2##(2008-11#1)(2011-2#1)
anatomical regions of the##2##4##(1992-3#1)(2012-2#1)
anatomical relation##2##2##(1995-6#1)(2011-2#1)
anatomical remodeling##2##2##(2008-7#2)
anatomical remodelling##2##2##(1993-3#1)(1995-12#1)
anatomical site##2##2##(2008-3#1)(2013-1#1)
anatomical sites##3##2##(2008-5#1)(2008-6#1)(2009-11#1)
anatomical structure##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
anatomical structures##4##2##(2010-8#2)(2011-2#1)(2012-12#1)
anatomical studies##3##2##(1994-3#1)(2008-11#1)(2009-11#1)
anatomical variables of the##2##4##(2008-7#2)
anatomical variants##5##2##(1996-3#1)(2008-10#1)(2012-2#3)
anatomical variations##5##2##(1991-2#1)(2007-8#2)(2008-11#1)(2010-8#1)
anatomical##207##1##(1990-6#4)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#3)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-6#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#4)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-8#7)(2008-1#2)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#7)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#22)(2012-1#1)(2012-12#4)(2012-2#12)(2012-3#3)(2012-5#3)(2013-1#11)(2013-8#3)
anatomically correct##2##2##(2010-3#1)(2010-8#1)
anatomically modern humans##2##3##(2010-5#2)
anatomically modern##4##2##(1994-3#2)(2010-5#2)
anatomically normal##3##2##(2010-10#1)(2013-1#2)
anatomically realistic##2##2##(2013-1#1)(2013-8#1)
anatomically reduced fracture##2##3##(2013-1#2)
anatomically reduced##4##2##(2008-8#1)(2013-1#3)
anatomically##26##1##(1992-10#1)(1994-3#2)(1994-5#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#1)(2012-1#1)(2013-1#7)(2013-8#1)
anatomies##2##1##(2008-6#1)(2013-7#1)
anatomists##2##1##(2008-7#1)(2009-3#1)
anatomo-pathologic##2##1##(1990-2#1)(1993-8#1)
anatomo-pathological##4##1##(1990-9#1)(1991-6#1)(1993-3#1)(1996-6#1)
anatomopathological##5##1##(1990-5#1)(1993-9#1)(2008-5#2)(2011-2#1)
anatomy and development##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
anatomy and function##4##3##(1993-6#1)(2007-11#1)(2007-7#1)(2013-1#1)
anatomy and physiology of the##4##5##(1997-1#1)(2007-8#1)(2010-9#1)(2012-2#1)
anatomy and physiology##6##3##(1997-1#1)(2007-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
anatomy and the##3##3##(1992-6#1)(2007-12#1)(2010-6#1)
anatomy and##45##2##(1990-9#1)(1992-6#1)(1993-6#1)(1994-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#1)(2010-6#2)(2010-9#1)(2011-2#5)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
anatomy in the##2##3##(2007-11#1)(2010-3#1)
anatomy in these##2##3##(2006-12#1)(2009-8#1)
anatomy in##9##2##(1990-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2009-4#1)(2009-8#1)(2010-3#1)(2012-2#2)
anatomy is##2##2##(2012-2#1)(2013-1#1)
anatomy of the flap##2##4##(1991-5#1)(2008-9#1)
anatomy of the proximal##2##4##(2007-11#2)
anatomy of the##22##3##(1990-11#1)(1991-5#1)(1994-9#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-7#3)(2008-9#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#2)
anatomy of this##3##3##(1994-3#1)(1996-9#1)(2010-11#1)
anatomy of##30##2##(1990-11#1)(1991-5#1)(1994-3#1)(1994-9#1)(1996-9#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#3)(2008-7#3)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)
anatomy was##2##2##(1994-3#1)(2012-2#1)
anatomy##155##1##(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-6#2)(1994-3#2)(1994-6#1)(1994-9#1)(1996-5#2)(1996-9#3)(1997-1#1)(1997-8#3)(2006-12#2)(2007-11#9)(2007-12#11)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#7)(2008-12#2)(2008-7#13)(2008-8#2)(2008-9#8)(2009-4#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#15)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
ancestor of the##2##3##(1997-6#1)(2008-10#1)
ancestor of##11##2##(1997-6#1)(2008-1#1)(2008-10#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)
ancestor with the##3##3##(2008-10#2)(2012-2#1)
ancestor with##5##2##(2008-10#4)(2012-2#1)
ancestor##34##1##(1993-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
ancestors of##6##2##(2008-10#1)(2009-2#1)(2009-6#3)(2009-8#1)
ancestors##12##1##(1994-9#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-6#3)(2009-8#1)(2011-2#1)
ancestral clone##2##2##(2008-8#2)
ancestral condition##5##2##(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
ancestral gene##5##2##(1991-6#1)(1992-12#1)(1995-6#1)(2007-11#1)(2008-7#1)
ancestral genes##3##2##(1994-8#1)(1995-6#1)(2008-7#1)
ancestral node values##2##3##(2008-8#2)
ancestral node##3##2##(2008-8#3)
ancestral origin of##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
ancestral origin##6##2##(2008-10#1)(2008-12#4)(2011-2#1)
ancestral population##2##2##(2009-5#1)(2010-5#1)
ancestral state##2##2##(2010-3#1)(2010-6#1)
ancestral##61##1##(1990-7#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-8#2)(1995-6#2)(1995-8#1)(1996-6#1)(1997-6#1)(1997-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-7#4)(2008-8#8)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
ancestry and##3##2##(2009-5#1)(2011-2#1)(2012-3#1)
ancestry##10##1##(1990-2#1)(2008-12#1)(2008-5#2)(2009-5#3)(2011-2#1)(2012-3#1)(2013-1#1)
ancestry-informative##2##1##(2008-12#2)
anchor cell##6##2##(1994-12#1)(2007-12#5)
anchor for##2##2##(1992-9#1)(2011-2#1)
anchor points##2##2##(2008-10#1)(2010-10#1)
anchor sequence##2##2##(1994-8#1)(1997-7#1)
anchor the##2##2##(2008-10#1)(2008-7#1)
anchor##37##1##(1990-7#1)(1991-2#1)(1992-3#3)(1992-9#1)(1994-12#2)(1994-8#3)(1995-2#1)(1995-6#1)(1997-6#1)(1997-7#4)(2007-12#5)(2008-10#5)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#2)
anchorage##9##1##(2007-12#1)(2007-7#1)(2008-11#3)(2008-5#2)(2008-7#2)
anchorage-dependent and##4##2##(1994-3#1)(1997-1#2)(2012-3#1)
anchorage-dependent cells##7##2##(2008-11#7)
anchorage-dependent##16##1##(1994-3#1)(1997-1#2)(2008-1#1)(2008-11#11)(2012-3#1)
anchorage-independent growth in soft-agar culture##2##5##(1992-9#2)
anchorage-independent growth of##2##3##(1991-12#1)(1991-2#1)
anchorage-independent growth##4##2##(1991-12#1)(1991-2#1)(1992-9#2)
anchorage-independent##9##1##(1991-12#1)(1991-2#1)(1992-9#2)(1994-3#1)(1995-9#1)(1997-1#2)(2008-6#1)
anchored B-Lynch##2##2##(2011-2#2)
anchored by##2##2##(1997-2#1)(2013-8#1)
anchored chloromethylated polymeric##2##3##(2008-10#2)
anchored chloromethylated##3##2##(2008-10#3)
anchored in the##2##3##(2008-4#1)(2008-7#1)
anchored on the##2##3##(1996-5#1)(2008-10#1)
anchored on##6##2##(1990-2#1)(1996-5#1)(2008-10#2)(2010-3#1)(2011-1#1)
anchored to the plasma membrane by##2##6##(1992-3#1)(1995-6#1)
anchored to the plasma membrane##3##5##(1992-3#1)(1995-6#1)(1996-3#1)
anchored to the##10##3##(1991-10#1)(1992-3#1)(1995-6#1)(1996-3#2)(1997-3#1)(1997-4#1)(2008-12#1)(2008-7#1)(2010-4#1)
anchored to##12##2##(1991-10#1)(1992-3#1)(1995-6#1)(1996-3#2)(1997-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2012-2#1)
anchored##48##1##(1990-2#1)(1991-10#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#2)(1995-6#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
anchoring junction##3##2##(2009-10#3)
anchoring junctions##3##2##(2009-10#3)
anchoring of the##4##3##(1997-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
anchoring of##6##2##(1995-2#1)(1997-6#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
anchoring##27##1##(1993-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-10#7)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
anchors##9##1##(1992-3#1)(1994-12#3)(2008-7#2)(2008-8#2)(2008-9#1)
ancient DNA##5##2##(2008-12#2)(2010-6#1)(2012-2#2)
ancient and##4##2##(1991-2#1)(2008-10#3)
ancient duplication of##2##3##(1996-3#1)(2009-10#1)
ancient glass##3##2##(2008-10#3)
ancient physicians such as Avicenna had described this topic several hundred years ago##2##13##(2013-1#2)
ancient principles of medicine are too different in comparison with modern medicine and description of diseases which Avicenna has talked about them and their managements are too much different##2##29##(2013-1#2)
ancient##80##1##(1991-2#2)(1991-5#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#2)(1996-3#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#21)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#5)
ancillary care##2##2##(2009-6#2)
ancillary data##3##2##(2008-3#3)
ancillary##29##1##(1992-1#1)(1994-6#2)(1995-1#1)(1996-1#2)(1997-2#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#2)(2009-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
ancrod##4##1##(1994-6#2)(1994-9#1)(1997-2#1)
ancrod-formed fibrin##2##2##(1994-9#2)
and % tail DNA##2##4##(2010-5#2)
and %##6##2##(1992-8#1)(2008-10#1)(2010-5#2)(2011-1#1)(2012-12#1)
and %K##2##2##(2008-10#2)
and &gt##30##2##(1993-2#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#8)(2008-4#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
and &lt##32##2##(1992-8#1)(1992-9#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#14)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#5)
and &quot##131##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#4)(1997-6#2)(1997-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#3)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#10)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
and 'Erysimum' isolates##2##3##(2008-10#2)
and 'Orlando'##2##2##(2008-10#2)
and 'social'##3##2##(2008-11#3)
and (-)##2##2##(1997-4#1)(2008-10#1)
and (-)-epicatechin##2##2##(1993-8#1)(2012-1#1)
and (-)-epigallocatechin##2##2##(2008-11#2)
and (0##6##2##(2008-10#1)(2008-8#2)(2010-12#2)(2011-3#1)
and (1##8##2##(1991-8#1)(1992-11#4)(2008-10#1)(2008-2#1)(2008-3#1)
and (1)##2##2##(2008-11#1)(2008-2#1)
and (1)A(1g) --&gt##2##3##(1997-7#2)
and (1)H NMR##2##3##(2008-10#1)(2010-2#1)
and (1)H##6##2##(1996-2#1)(1997-7#2)(2008-10#1)(2010-2#1)(2012-2#1)
and (1)H-NMR##2##2##(2007-11#1)(2008-10#1)
and (1)HNMR##2##2##(2008-10#2)
and (13)C NMR spectroscopic data##2##5##(2008-10#1)(2013-1#1)
and (13)C NMR spectroscopy##2##4##(2008-10#2)
and (13)C NMR##14##3##(1996-2#2)(2008-10#8)(2009-7#1)(2011-2#1)(2013-1#2)
and (13)C##18##2##(1996-2#2)(2008-10#8)(2008-4#1)(2009-7#3)(2011-2#1)(2013-1#3)
and (13)C-NMR##2##2##(2007-11#2)
and (15)N##3##2##(1996-5#1)(2009-7#2)
and (2##2##2##(2008-6#1)(2009-11#1)
and (2) a##10##3##(1994-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2013-8#1)
and (2) by the##2##4##(2008-1#1)(2012-12#1)
and (2) by##5##3##(1992-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
and (2) continuous##2##3##(2008-10#2)
and (2) identifying##2##3##(2008-10#1)(2012-12#1)
and (2) in##3##3##(1992-1#1)(1995-11#1)(2008-3#1)
and (2) it##2##3##(2008-10#1)(2009-9#1)
and (2) that the##2##4##(1991-2#2)
and (2) that##4##3##(1991-2#2)(1996-2#1)(2009-7#1)
and (2) the absence of##2##5##(1994-12#1)(2007-5#1)
and (2) the magnitude of##2##5##(1994-2#1)(1997-1#1)
and (2) the ratio of##3##5##(1991-1#1)(2008-3#1)(2012-2#1)
and (2) the##26##3##(1991-1#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
and (2) to compare##2##4##(1993-12#1)(2010-8#1)
and (2) to##6##3##(1993-12#1)(1994-1#1)(2010-8#2)(2013-1#2)
and (2) whether##2##3##(2007-8#1)(2012-6#1)
and (2)##116##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#2)(2009-11#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#1)
and (2)D at##2##3##(2008-10#2)
and (3##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)
and (3) a##5##3##(1993-5#1)(1996-11#1)(2009-5#1)(2013-1#2)
and (3) an##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
and (3) determine##2##3##(1994-12#1)(2013-1#1)
and (3) higher##2##3##(1993-12#1)(2008-12#1)
and (3) the##11##3##(1991-12#1)(1991-5#1)(1992-1#1)(1992-3#1)(1994-3#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
and (3) to##5##3##(1992-12#1)(1995-12#1)(2008-4#1)(2009-1#1)(2009-5#1)
and (3) when the##2##4##(1993-3#1)(2010-5#1)
and (3)##95##2##(1990-7#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1994-12#3)(1994-3#2)(1995-12#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)
and (3S##2##2##(2007-12#2)
and (4##2##2##(2008-10#2)
and (4) development of##2##4##(2008-11#1)(2012-12#1)
and (4) how##3##3##(2007-12#1)(2008-4#2)
and (4) the##8##3##(1991-2#1)(1991-7#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-6#1)
and (4)##47##2##(1991-11#1)(1991-2#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and (5##4##2##(2008-10#3)(2008-3#1)
and (5) the##5##3##(1991-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)
and (5)##25##2##(1991-3#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1997-2#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-9#1)(2013-1#3)(2013-7#1)
and (6) obtaining the antiserum and/or isolating the antibody##2##9##(2008-4#2)
and (6)##12##2##(1993-12#1)(1993-3#1)(1994-8#1)(1997-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#2)
and (68)Ga##2##2##(2010-6#2)
and (7##2##2##(2008-10#1)(2011-1#1)
and (7)##3##2##(1997-3#1)(2009-6#1)(2013-1#1)
and (9##2##2##(2008-10#1)(2008-3#1)
and (B)##2##2##(2007-8#1)(2008-10#1)
and (D)##2##2##(2008-10#2)
and (NH(4))(2)SO(4) mixture##2##3##(2008-10#2)
and (R##7##2##(1996-2#7)
and (V)##4##2##(2008-10#3)(2010-5#1)
and (VI)##5##2##(2008-10#4)(2013-7#1)
and (b) a##2##3##(1994-1#2)
and (b) determination##2##3##(2008-10#2)
and (b) in##2##3##(2008-10#1)(2008-11#1)
and (b) the##13##3##(1990-11#1)(1990-5#1)(1993-12#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-1#1)(2013-8#1)
and (b)##50##2##(1990-11#1)(1990-5#1)(1991-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#9)(2008-8#1)(2009-11#1)(2009-2#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
and (c) a##2##3##(1991-1#1)(1994-1#1)
and (c) the##7##3##(1990-7#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#2)
and (c)##37##2##(1990-7#1)(1991-1#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
and (d)##19##2##(1990-5#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#3)(2009-9#1)(2010-10#1)(2010-7#1)
and (e) an##2##3##(1997-8#1)(2008-1#1)
and (e)##13##2##(1991-9#1)(1992-1#1)(1992-2#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-5#1)(2012-2#1)(2012-3#1)
and (f) the##2##3##(1996-12#1)(2012-2#1)
and (f)##6##2##(1996-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
and (for##3##2##(2007-11#1)(2010-3#1)(2013-8#1)
and (ii) a##5##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-5#1)
and (ii) that##3##3##(1993-5#1)(1994-8#1)(2008-5#1)
and (ii) the##20##3##(1990-3#1)(1991-2#1)(1993-8#1)(1994-8#1)(1996-4#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2013-1#1)
and (ii) to##5##3##(2008-10#2)(2008-8#1)(2010-10#1)(2011-2#1)
and (ii)##86##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-8#3)(1995-12#1)(1995-2#2)(1996-4#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#28)(2008-11#4)(2008-2#2)(2008-3#6)(2008-5#4)(2008-7#2)(2008-8#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-5#1)(2013-1#5)(2013-8#1)
and (iii) a reduction##2##4##(2008-10#2)
and (iii) a##8##3##(2008-10#4)(2008-3#1)(2008-8#2)(2010-5#1)
and (iii) an##2##3##(1990-7#1)(1994-3#1)
and (iii) the##8##3##(1994-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2010-10#1)(2013-1#1)
and (iii) to##2##3##(2008-10#1)(2008-5#1)
and (iii) with##2##3##(1994-3#1)(2007-12#1)
and (iii)##67##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-6#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
and (in##3##2##(1994-2#1)(2008-5#1)(2012-12#1)
and (iv) the##6##3##(1990-9#1)(1991-9#1)(1993-8#1)(2008-11#1)(2008-9#1)(2009-7#1)
and (iv)##28##2##(1990-9#1)(1991-9#1)(1993-8#1)(1995-5#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#5)(2008-9#2)(2009-7#1)(2011-1#1)
and (or) the##2##3##(2007-11#1)(2007-12#1)
and (or)##8##2##(1991-6#1)(2007-11#4)(2007-12#3)
and (v)##9##2##(1996-12#1)(1996-5#1)(2008-10#5)(2008-5#1)(2013-7#1)
and *OH##2##2##(2009-12#1)(2010-7#1)
and +/-##4##2##(1992-11#1)(2008-10#3)
and +/-0##7##2##(2008-10#3)(2008-3#4)
and +/-1##2##2##(2008-10#2)
and +/-3##2##2##(2008-3#2)
and +/-3%##2##2##(2008-3#2)
and +10##2##2##(1996-4#1)(2008-9#1)
and +13##3##2##(1990-5#1)(2009-9#1)(2012-2#1)
and +3##2##2##(1994-11#1)(1997-4#1)
and - if##2##3##(2009-11#1)(2012-9#1)
and -##3##2##(1997-8#1)(2009-11#1)(2012-9#1)
and -0##16##2##(2008-10#14)(2008-7#1)(2012-12#1)
and -1 for##2##3##(2008-10#2)
and -1##15##2##(1995-3#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
and -10##5##2##(2008-10#3)(2008-3#1)(2008-4#1)
and -112##2##2##(1997-2#2)
and -2##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2012-7#1)(2013-1#1)
and -2-4)##2##2##(2008-10#2)
and -20##2##2##(1997-7#1)(2008-11#1)
and -25##4##2##(2008-2#1)(2008-3#1)(2010-12#2)
and -3##11##2##(1991-12#2)(1997-4#2)(2008-10#4)(2008-4#1)(2008-9#1)(2009-4#1)
and -4##2##2##(1993-6#1)(1995-2#1)
and -40##4##2##(1994-9#2)(2008-10#1)(2011-2#1)
and -46##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
and -5##2##2##(1995-2#1)(2008-10#1)
and -59##2##2##(2008-12#1)(2008-6#1)
and -6##3##2##(1990-11#1)(1994-11#1)(1995-5#1)
and -7 MPa##2##3##(2008-10#2)
and -7##6##2##(2008-10#3)(2011-2#3)
and -8##3##2##(2008-10#3)
and -9##2##2##(2008-4#1)(2013-7#1)
and -B##5##2##(1992-12#1)(1997-4#1)(2008-10#3)
and -E were##2##3##(1992-12#1)(1994-12#1)
and -II##5##2##(1993-9#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
and -III from M##2##4##(1993-11#2)
and -L genes was##2##4##(1990-12#2)
and -L genes##3##3##(1990-12#3)
and -L##5##2##(1990-12#3)(2008-10#2)
and -challenged##2##2##(2008-10#1)(2008-9#1)
and -dependent##2##2##(2008-6#2)
and -galactosaminide substrates##2##3##(1990-5#2)
and -gamma##3##2##(1994-12#1)(2007-11#2)
and -independent##8##2##(1991-12#1)(1993-3#1)(1994-6#2)(1995-11#1)(2008-8#1)(2009-4#1)(2012-3#1)
and -negative##3##2##(2008-5#1)(2009-6#1)(2010-3#1)
and -phthalocyanines##2##2##(2008-10#2)
and -positive##2##2##(1993-9#1)(2008-10#1)
and -resistant##2##2##(1992-6#1)(2009-10#1)
and -selectivity of##3##3##(2008-10#3)
and -selectivity##5##2##(2008-10#5)
and -susceptible##2##2##(2008-10#2)
and / or##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
and /etanaeee/##2##2##(2010-2#2)
and 0 degrees C (experiment##2##5##(2008-10#2)
and 0 to##3##3##(2008-10#2)(2008-5#1)
and 0##975##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-3#5)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#7)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#6)(1996-3#1)(1996-5#4)(1996-7#1)(1997-2#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#4)(2007-12#9)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#540)(2008-11#21)(2008-12#27)(2008-2#15)(2008-3#31)(2008-5#17)(2008-6#13)(2008-7#11)(2008-8#6)(2008-9#16)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#5)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#18)(2011-2#23)(2011-3#3)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#7)(2012-7#1)(2013-1#19)(2013-7#5)(2013-8#6)
and 0% respectively##2##3##(2010-3#2)
and 0%##10##2##(1990-8#1)(1991-4#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-3#2)(2010-8#1)(2012-12#1)
and 0-0##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
and 1 (0##2##3##(2007-8#1)(2011-2#1)
and 1 638 cm(-1)##3##4##(2013-8#3)
and 1 S##2##3##(1990-6#1)(2010-6#1)
and 1 case of##4##4##(1994-12#1)(2007-10#1)(2007-8#1)(2012-3#1)
and 1 case##6##3##(1994-12#1)(2007-10#1)(2007-8#2)(2012-3#1)(2013-1#1)
and 1 cm##2##3##(2008-10#1)(2008-2#1)
and 1 for##2##3##(2008-10#2)
and 1 from##2##3##(2008-10#2)
and 1 h##2##3##(1992-8#1)(2013-1#1)
and 1 in the##3##4##(1996-1#1)(2012-12#1)(2013-1#1)
and 1 mM##3##3##(1990-7#1)(1995-2#1)(1997-1#1)
and 1 microg##2##3##(2008-10#2)
and 1 ml of##2##4##(2008-10#2)
and 1 month after##2##4##(2008-10#1)(2013-8#1)
and 1 month##4##3##(1995-2#1)(2008-10#1)(2010-4#1)(2013-8#1)
and 1 muM##2##3##(2008-10#1)(2008-11#1)
and 1 mug##2##3##(2008-10#2)
and 1 nM##2##3##(1991-2#1)(2008-11#1)
and 1 nmol##3##3##(1997-2#3)
and 1 of##2##3##(1991-11#1)(2007-11#1)
and 1 out of##2##4##(2008-5#1)(2009-5#1)
and 1 patient underwent##2##4##(2008-1#2)
and 1 patient##3##3##(1992-6#1)(2008-1#2)
and 1 patients##2##3##(1991-5#1)(2008-7#1)
and 1 to##2##3##(1997-3#1)(2008-10#1)
and 1 with##5##3##(1990-3#1)(1994-3#1)(2007-8#1)(2008-7#1)(2010-3#1)
and 1 x 10(-4)moll(-1) triiodide##2##5##(2008-10#2)
and 1 x##6##3##(1994-6#1)(2008-10#5)
and 1 year##6##3##(1994-3#1)(1995-3#1)(2007-8#3)(2008-10#1)
and 1##711##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#3)(1992-11#2)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#4)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#6)(1994-8#2)(1995-11#6)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-6#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2006-10#1)(2007-10#2)(2007-11#11)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#315)(2008-11#13)(2008-12#18)(2008-2#11)(2008-3#26)(2008-4#2)(2008-5#15)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#13)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#7)(2013-1#15)(2013-8#10)
and 1% for##2##3##(2008-10#1)(2008-2#1)
and 1% sodium##2##3##(1992-3#1)(2008-10#1)
and 1%##21##2##(1992-1#1)(1992-2#1)(1992-3#1)(1995-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)
and 1-3##2##2##(2008-5#1)(2008-8#1)
and 1-5%##2##2##(2008-10#2)
and 1-IC##3##2##(2008-10#3)
and 1-naphthalenacetamide##2##2##(2008-10#2)
and 1-naphthol##2##2##(2008-10#1)(2008-5#1)
and 1/2 years##3##3##(1990-6#3)
and 1/2##4##2##(1990-6#3)(2008-10#1)
and 10 as##2##3##(2007-11#1)(2008-10#1)
and 10 at##2##3##(1995-11#1)(2008-12#1)
and 10 days postinoculation##2##4##(2008-10#2)
and 10 days##5##3##(2008-10#3)(2011-2#1)(2013-8#1)
and 10 days)##2##3##(2008-1#1)(2008-12#1)
and 10 degrees##4##3##(2007-11#1)(2009-10#1)(2010-3#1)(2011-2#1)
and 10 for##3##3##(2008-10#3)
and 10 healthy##3##3##(2006-10#1)(2007-10#1)(2008-7#1)
and 10 in##2##3##(2008-10#1)(2013-1#1)
and 10 m##2##3##(2008-10#2)
and 10 mM##5##3##(1997-4#1)(2008-10#3)(2008-11#1)
and 10 mg##3##3##(2008-10#1)(2011-1#1)(2011-3#1)
and 10 mg/kg##4##3##(1995-12#1)(1996-2#2)(2008-7#1)
and 10 microM##2##3##(1992-3#1)(1992-8#1)
and 10 micrograms/ml##3##3##(1990-2#1)(1994-11#2)
and 10 microm##5##3##(2007-12#2)(2008-3#2)(2009-7#1)
and 10 min##4##3##(1997-2#1)(2008-10#2)(2013-1#1)
and 10 mm beyond the##2##5##(1995-2#2)
and 10 mm##7##3##(1990-3#1)(1995-2#2)(2007-10#2)(2008-10#1)(2008-3#1)
and 10 months##4##3##(1991-6#1)(2008-7#1)(2010-1#1)(2011-2#1)
and 10 mug##4##3##(2008-10#4)
and 10 ng##5##3##(2008-10#5)
and 10 patients with##2##4##(2007-10#1)(2010-12#1)
and 10 patients##5##3##(1993-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2010-12#1)
and 10 pg##2##3##(2008-10#1)(2011-3#1)
and 10 samples##2##3##(1992-3#1)(2013-1#1)
and 10 to##2##3##(1993-3#1)(2008-10#1)
and 10 weeks##2##3##(1997-6#1)(2007-11#1)
and 10 were##3##3##(1993-1#1)(1996-5#1)(2008-10#1)
and 10 years##8##3##(1990-9#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#2)
and 10##297##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-6#3)(1991-8#3)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-5#2)(1996-2#2)(1996-5#3)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#2)(2007-10#7)(2007-11#7)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#83)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#21)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#4)
and 10% of the##2##4##(1990-2#1)(2008-5#1)
and 10% of##3##3##(1990-2#1)(2008-10#1)(2008-5#1)
and 10% were##2##3##(2008-10#1)(2010-11#1)
and 10%##33##2##(1990-2#1)(1991-11#1)(1996-12#2)(1996-5#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
and 10(-3)-6x10(-2) M##2##3##(2008-10#2)
and 10(-4)##3##2##(1992-12#1)(2008-10#2)
and 10(-5) M)##2##3##(1995-12#1)(1997-4#1)
and 10(-5)##4##2##(1995-12#1)(1997-4#1)(2008-10#2)
and 10(-6) M##2##3##(1993-9#2)
and 10(-6)##4##2##(1993-9#2)(1997-4#1)(2008-10#1)
and 10(-7) M##4##3##(1990-11#1)(1993-9#3)
and 10(-7)##6##2##(1990-11#1)(1993-9#3)(1996-2#1)(2008-10#1)
and 10(4)##2##2##(2008-10#2)
and 10(5)##4##2##(1995-2#1)(1996-7#1)(2008-10#1)(2008-11#1)
and 10(6)##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and 10(8)##2##2##(2008-10#1)(2008-9#1)
and 10)##6##2##(1993-12#2)(1995-8#1)(1996-4#1)(2013-1#1)(2013-8#1)
and 10-##2##2##(1995-12#1)(1995-8#1)
and 10-15%##2##2##(2008-10#1)(2008-3#1)
and 10-fold##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
and 10-month follow-up##2##3##(2011-2#1)(2013-1#1)
and 10-year actuarial##2##3##(1991-8#1)(2008-3#1)
and 10-year survival##2##3##(2010-3#1)(2011-2#1)
and 10-year##10##2##(1991-8#1)(1993-11#1)(2008-3#1)(2010-3#5)(2011-2#1)(2012-2#1)
and 100 and##2##3##(1997-2#1)(2008-10#1)
and 100 days##3##3##(1992-12#1)(1996-5#1)(2013-8#1)
and 100 degrees C for##2##5##(1992-9#1)(2008-12#1)
and 100 degrees C##6##4##(1992-9#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-5#2)
and 100 degrees##7##3##(1992-9#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)
and 100 mg##4##3##(2008-10#2)(2008-5#2)
and 100 mg/kg females were##2##5##(2008-9#2)
and 100 mg/kg females##3##4##(2008-9#3)
and 100 mg/kg##5##3##(2008-9#4)(2013-1#1)
and 100 microM##3##3##(1990-12#1)(1992-8#1)(1997-4#1)
and 100 mug##2##3##(2008-10#2)
and 100 mul##2##3##(2008-10#2)
and 100 mum PDMS##2##4##(2008-10#2)
and 100 ng ml(-1)##2##4##(2008-10#2)
and 100 ng##3##3##(2008-10#3)
and 100 nm)##2##3##(2010-4#1)(2011-1#1)
and 100##88##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#3)(1996-5#1)(1997-2#2)(1997-4#1)(2007-11#2)(2008-10#30)(2008-11#2)(2008-12#5)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#5)(2009-3#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and 100% and##2##3##(2008-10#1)(2008-5#1)
and 100% for##4##3##(2008-10#1)(2008-5#2)(2013-1#1)
and 100% in the##2##4##(1990-2#1)(2012-12#1)
and 100% in##3##3##(1990-2#1)(2011-2#1)(2012-12#1)
and 100% of patients##2##4##(1996-1#1)(2008-5#1)
and 100% of##6##3##(1996-1#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
and 100% on##2##3##(2008-10#1)(2008-6#1)
and 100% oxygen##2##3##(2008-10#2)
and 100% were##2##3##(1990-8#1)(2008-10#1)
and 100%##46##2##(1990-2#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-6#1)(1993-2#1)(1996-1#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and 100%)##2##2##(2008-10#2)
and 1000 mg/kg##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
and 1000##14##2##(1995-12#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2012-2#2)(2013-1#1)
and 100mM##2##2##(2008-10#1)(2011-2#1)
and 100mugL(-1)##2##2##(2008-10#2)
and 100ng##2##2##(2008-10#1)(2010-4#1)
and 101##6##2##(1990-9#1)(1995-5#1)(1997-4#1)(2008-10#2)(2012-2#1)
and 101%##2##2##(2008-10#2)
and 102##11##2##(1993-12#1)(1997-8#1)(2008-10#7)(2008-3#1)(2010-3#1)
and 103##8##2##(1990-2#1)(1996-12#1)(2008-10#4)(2012-12#1)(2012-2#1)
and 103% for##2##3##(2008-10#2)
and 103%##5##2##(2008-10#5)
and 104##5##2##(2008-10#4)(2012-3#1)
and 104%##2##2##(2008-10#2)
and 105##5##2##(1991-8#1)(1995-12#1)(2008-10#1)(2011-1#1)(2013-8#1)
and 105%##8##2##(2008-10#8)
and 106##6##2##(1990-2#1)(1994-11#1)(1995-5#1)(2008-10#2)(2012-2#1)
and 106%##5##2##(2008-10#5)
and 1064 nm for##2##4##(2008-3#2)
and 1064 nm##5##3##(2008-2#2)(2008-3#3)
and 107##7##2##(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#1)
and 108%##2##2##(2008-10#2)
and 109##2##2##(2012-2#1)(2013-1#1)
and 109%##2##2##(2008-10#2)
and 10mugl(-1)##2##2##(2008-10#2)
and 10th##7##2##(1992-3#1)(2007-12#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#2)
and 11 and##2##3##(1994-12#1)(2008-10#1)
and 11 control patients##2##4##(1996-9#1)(2008-7#1)
and 11 days##3##3##(2008-3#1)(2008-7#2)
and 11 months##3##3##(1997-4#1)(2007-7#1)(2013-8#1)
and 11 of##3##3##(1996-12#2)(2008-2#1)
and 11 patients##2##3##(1991-3#1)(2007-11#1)
and 11 weeks##2##3##(1991-2#1)(1995-8#1)
and 11 were##3##3##(1993-9#1)(1994-12#1)(2008-10#1)
and 11 with##3##3##(1991-8#1)(1994-3#1)(2010-3#1)
and 11 years##2##3##(1997-2#1)(2008-4#1)
and 11##109##2##(1990-11#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#7)
and 11% of##2##3##(1990-6#1)(2008-10#1)
and 11%##15##2##(1990-11#1)(1990-6#1)(1992-6#1)(1997-4#1)(2008-10#5)(2008-2#1)(2008-7#2)(2010-12#1)(2012-1#1)(2013-8#1)
and 110 days##2##3##(2008-10#1)(2013-8#1)
and 110##8##2##(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
and 1100 degrees C##2##4##(2008-10#2)
and 1100##3##2##(1995-2#1)(2008-10#2)
and 111##2##2##(2008-10#1)(2012-3#1)
and 112##4##2##(2007-8#1)(2008-10#2)(2009-11#1)
and 114##4##2##(1990-7#1)(1995-6#1)(2011-2#1)(2012-2#1)
and 115##5##2##(1993-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)
and 115-kDa##2##2##(1993-11#2)
and 118##3##2##(1994-2#1)(2008-2#1)(2010-8#1)
and 12 as##2##3##(1996-12#1)(2008-10#1)
and 12 females##3##3##(1991-2#1)(2008-5#1)(2008-7#1)
and 12 from##2##3##(1996-10#1)(2007-7#1)
and 12 h after##2##4##(2010-2#1)(2012-3#1)
and 12 h##5##3##(1992-3#1)(1995-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
and 12 healthy##3##3##(1996-7#1)(2008-11#2)
and 12 hr##3##3##(2008-5#1)(2008-6#2)
and 12 mg/kg females##3##4##(2008-9#3)
and 12 mg/kg groups##2##4##(2008-9#2)
and 12 mg/kg##15##3##(2008-9#15)
and 12 mm##2##3##(2008-12#2)
and 12 months after the##2##5##(2007-8#1)(2013-1#1)
and 12 months after##5##4##(1997-1#1)(1997-6#1)(2007-8#1)(2008-3#1)(2013-1#1)
and 12 months of##2##4##(1990-8#1)(2008-8#1)
and 12 months post##2##4##(2007-11#1)(2008-6#1)
and 12 months##25##3##(1990-8#1)(1991-2#1)(1993-12#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#5)
and 12 of##2##3##(2008-10#1)(2013-1#1)
and 12 to##2##3##(2008-10#1)(2008-4#1)
and 12 weeks after##2##4##(2007-11#1)(2008-7#1)
and 12 weeks##13##3##(2006-10#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#2)(2013-1#3)
and 12 were##2##3##(2008-9#1)(2012-3#1)
and 12 years##4##3##(1991-2#1)(2008-6#1)(2008-9#1)(2009-10#1)
and 12##189##2##(1990-12#2)(1990-8#2)(1991-2#3)(1991-6#2)(1992-11#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-7#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#6)(1996-5#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-5#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#28)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#18)(2009-10#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#14)(2013-8#2)
and 12% for##2##3##(2008-10#1)(2012-12#1)
and 12% proteins##2##3##(1990-2#2)
and 12%##10##2##(1990-2#2)(1993-12#1)(1993-2#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
and 12-O-tetradecanoylphorbol-13-acetate##2##2##(1995-12#1)(2013-1#1)
and 12-month##3##2##(2007-10#2)(2008-12#1)
and 120 degrees##5##3##(1995-2#1)(2008-2#2)(2013-1#2)
and 120 min##2##3##(2010-2#1)(2013-1#1)
and 120 s##2##3##(2008-10#2)
and 120##24##2##(1990-2#1)(1995-12#1)(1995-2#3)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#3)
and 121##2##2##(1996-2#1)(2008-10#1)
and 122##3##2##(2008-10#1)(2008-6#1)(2010-10#1)
and 123##5##2##(1991-11#1)(1996-9#1)(2007-8#1)(2008-1#1)(2013-1#1)
and 124##4##2##(1993-12#1)(2011-2#1)(2013-1#2)
and 125##2##2##(2008-10#1)(2011-2#1)
and 1250##3##2##(2007-12#1)(2008-10#2)
and 126##3##2##(1991-6#1)(1993-11#1)(2008-10#1)
and 128##3##2##(2008-10#1)(2009-4#1)(2013-1#1)
and 129##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
and 13 QTL##2##3##(2008-10#1)(2008-8#1)
and 13 months##2##3##(2008-11#1)(2008-4#1)
and 13 patients##3##3##(1992-1#1)(1997-8#1)(2011-1#1)
and 13 to##2##3##(1994-5#1)(2008-10#1)
and 13 were##2##3##(1993-12#1)(2012-2#1)
and 13 years##3##3##(1990-8#1)(1993-12#1)(1996-12#1)
and 13##81##2##(1990-5#2)(1990-8#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
and 13%##12##2##(1990-12#1)(1990-6#1)(1996-12#1)(1996-9#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
and 13-24##2##2##(1995-4#2)
and 13-cis-retinoic acid##2##3##(1994-6#2)
and 130##7##2##(1990-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2010-1#1)(2011-2#1)
and 1300 degrees C##5##4##(2008-10#5)
and 131##3##2##(1991-12#1)(2008-9#1)(2010-6#1)
and 132##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
and 133##2##2##(2008-10#1)(2010-1#1)
and 1333##2##2##(2007-10#2)
and 135##9##2##(1991-8#1)(1995-5#1)(1997-8#1)(2008-12#1)(2008-3#1)(2008-6#2)(2012-1#1)(2013-8#1)
and 136##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and 138##3##2##(1994-11#1)(2008-10#1)(2012-3#1)
and 139##2##2##(1997-2#1)(2008-6#1)
and 13C NMR spectra##2##4##(1992-12#1)(1995-11#1)
and 13C NMR spectroscopy##3##4##(1991-5#1)(1995-11#2)
and 13C NMR##12##3##(1991-5#1)(1992-12#2)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#3)(2008-11#1)(2008-12#1)(2009-7#1)
and 13C##17##2##(1991-5#1)(1992-12#2)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-11#3)(1995-5#1)(2008-11#1)(2008-12#1)(2009-7#4)
and 13C(beta)##2##2##(2009-7#2)
and 13C-NMR##3##2##(1990-5#1)(1994-3#2)
and 14 days##10##3##(1995-3#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
and 14 in##2##3##(2008-10#1)(2009-4#1)
and 14 isolates of C##2##5##(2008-10#2)
and 14 new open reading frames##2##6##(1995-6#1)(1995-9#1)
and 14 new##3##3##(1995-6#1)(1995-9#1)(2008-10#1)
and 14 of##4##3##(2008-10#3)(2013-1#1)
and 14 years##5##3##(2013-1#4)(2013-7#1)
and 14##92##2##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-1#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#5)(2009-2#1)(2009-4#2)(2010-4#1)(2010-7#3)(2011-2#5)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#1)
and 14% of##3##3##(1990-12#1)(1991-5#1)(1994-12#1)
and 14%##14##2##(1990-12#1)(1991-5#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-1#1)
and 14)##2##2##(2008-10#2)
and 14-3-3##2##2##(2012-12#2)
and 140##9##2##(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#3)
and 1400##3##2##(2008-10#2)(2008-3#1)
and 141##2##2##(1997-4#1)(2010-11#1)
and 143##4##2##(1992-9#1)(2008-10#1)(2012-3#1)(2013-7#1)
and 144##2##2##(2008-1#1)(2011-2#1)
and 145##2##2##(1992-3#1)(2008-9#1)
and 1450 ppm fluoride##4##4##(2011-2#4)
and 1450##5##2##(2008-10#1)(2011-2#4)
and 148##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
and 149##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
and 14th##3##2##(1990-9#2)(2007-2#1)
and 15 MV##3##3##(2008-3#1)(2013-1#2)
and 15 cases##2##3##(2007-11#1)(2007-8#1)
and 15 cm##2##3##(2008-10#1)(2008-12#1)
and 15 controls##2##3##(2008-7#1)(2013-8#1)
and 15 days##4##3##(1995-2#1)(2007-8#1)(2008-10#1)(2013-8#1)
and 15 degrees C##4##4##(1997-4#1)(2008-10#2)(2011-2#1)
and 15 female##21##3##(2008-8#3)(2008-9#17)(2011-2#1)
and 15 females##3##3##(1991-12#2)(2008-7#1)
and 15 mg##2##3##(2008-11#1)(2008-9#1)
and 15 microM##2##3##(1993-9#1)(1995-5#1)
and 15 microm##2##3##(2007-12#1)(2008-2#1)
and 15 min of##2##4##(2008-10#2)
and 15 min on the##2##5##(1993-1#2)
and 15 min##6##3##(1993-1#2)(1993-12#1)(2008-10#2)(2008-12#1)
and 15 months##2##3##(2007-8#1)(2013-1#1)
and 15 pairs of##2##4##(2010-3#2)
and 15 patients##2##3##(1991-12#1)(1994-3#1)
and 15 weeks after##2##4##(2008-9#1)(2012-3#1)
and 15 weeks post-capture##2##4##(2008-5#2)
and 15 weeks##4##3##(2008-5#2)(2008-9#1)(2012-3#1)
and 15 with##2##3##(2008-11#1)(2008-6#1)
and 15 years of age##2##5##(2006-10#1)(2008-6#1)
and 15 years##7##3##(1993-9#1)(2006-10#1)(2007-7#1)(2008-6#1)(2013-1#3)
and 15##166##2##(1990-2#1)(1990-6#2)(1991-12#3)(1991-6#2)(1991-8#1)(1991-9#2)(1992-2#1)(1993-1#3)(1993-12#2)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#3)(1997-4#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#4)(2008-10#34)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#22)(2009-10#1)(2009-2#1)(2010-3#2)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#3)
and 15% of those##2##4##(2008-1#1)(2008-11#1)
and 15% of##9##3##(1991-11#1)(1997-2#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)
and 15%##23##2##(1991-11#1)(1992-5#1)(1994-11#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)
and 15%)##2##2##(2011-3#1)(2013-1#1)
and 15-acetyldeoxynivalenol##3##2##(1997-6#1)(2008-10#2)
and 15-fold##2##2##(1990-10#1)(2008-10#1)
and 150 mM##2##3##(1997-2#1)(2008-12#1)
and 150 mg/kg##2##3##(2008-10#2)
and 150##25##2##(1991-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-2#1)(1997-2#2)(2007-7#1)(2008-10#10)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)
and 150%##3##2##(1993-3#1)(1995-12#1)(2007-12#1)
and 150-fs##2##2##(2007-11#1)(2008-3#1)
and 151##3##2##(2011-2#1)(2012-1#1)(2013-1#1)
and 152##2##2##(1997-4#1)(2008-9#1)
and 153##4##2##(1994-8#1)(2008-10#2)(2011-3#1)
and 1550 nm##2##3##(2008-2#2)
and 157##5##2##(1992-10#1)(1994-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
and 15N NMR assignments of##5##5##(2009-7#5)
and 15N NMR assignments##6##4##(2009-7#6)
and 15N NMR##9##3##(1992-3#1)(1993-11#1)(1995-5#1)(2009-7#6)
and 15N assignment of the oxidized and reduced##2##8##(2009-7#2)
and 15N chemical shift assignments##2##5##(1993-11#1)(2009-7#1)
and 15N resonance assignment of the##4##6##(2009-7#4)
and 15N resonance assignment of##5##5##(2009-7#5)
and 15N resonance assignments of a##2##6##(2009-7#2)
and 15N resonance assignments of the##3##6##(2009-7#3)
and 15N resonance assignments of##9##5##(2009-7#9)
and 15N resonance assignments##10##4##(2009-7#10)
and 15N resonance##15##3##(2009-7#15)
and 15N resonances of the##2##5##(2009-7#2)
and 15N resonances##3##3##(1995-2#1)(2009-7#2)
and 15N##33##2##(1992-3#1)(1993-11#2)(1995-2#1)(1995-5#1)(2009-7#28)
and 15min of##2##3##(2008-10#2)
and 15th##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
and 16 cases##2##3##(1995-11#1)(2008-11#1)
and 16 h##3##3##(2008-10#2)(2008-11#1)
and 16 isolates##2##3##(2008-10#2)
and 16 patients##2##3##(1992-2#1)(2012-4#1)
and 16 to##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
and 16 with##4##3##(2007-11#1)(2008-5#2)(2012-3#1)
and 16##93##2##(1990-2#3)(1990-8#1)(1991-5#2)(1991-8#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#3)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#21)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#2)
and 16% in##2##3##(2008-10#1)(2008-4#1)
and 16%##16##2##(1990-3#1)(1993-8#1)(1993-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and 16)##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
and 160##8##2##(1991-12#1)(1991-5#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2011-1#1)
and 160%##2##2##(2008-11#1)(2008-3#1)
and 1600##2##2##(1995-8#1)(2008-10#1)
and 163##3##2##(1993-2#1)(2008-1#1)(2008-10#1)
and 165##2##2##(1991-12#1)(2013-1#1)
and 166##2##2##(1996-5#1)(2008-10#1)
and 168##4##2##(1993-3#1)(1997-4#1)(1997-6#1)(2013-1#1)
and 169##2##2##(1993-1#1)(2010-8#1)
and 17 normal##2##3##(2008-4#1)(2013-1#1)
and 17 patients##2##3##(1990-2#1)(2008-6#1)
and 17 were##2##3##(2008-3#1)(2013-8#1)
and 17##68##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-11#1)(1995-3#3)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#4)(2009-4#1)(2010-11#1)(2011-2#2)(2013-1#2)(2013-8#2)
and 17% of##2##3##(2008-5#1)(2012-2#1)
and 17%##10##2##(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#1)
and 170##4##2##(1990-7#1)(2008-3#1)(2010-9#2)
and 1700##2##2##(1994-12#1)(1995-5#1)
and 172##2##2##(2008-10#1)(2008-7#1)
and 176##3##2##(2008-10#1)(2010-1#1)(2010-6#1)
and 179##3##2##(1992-4#1)(1997-4#1)(2010-11#1)
and 18 and##2##3##(1996-5#1)(2008-10#1)
and 18 degrees C##2##4##(2008-12#1)(2008-7#1)
and 18 degrees##3##3##(2008-12#1)(2008-7#2)
and 18 in##4##3##(1990-5#1)(2008-11#2)(2012-12#1)
and 18 months of age##4##5##(1993-12#2)(2008-10#1)(2008-7#1)
and 18 months of##5##4##(1990-2#1)(1993-12#2)(2008-10#1)(2008-7#1)
and 18 months were##2##4##(2008-3#2)
and 18 months##14##3##(1990-2#1)(1993-1#1)(1993-12#2)(1994-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#1)
and 18 of##9##3##(1990-5#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-8#3)(2013-1#2)
and 18 patients##2##3##(2008-10#1)(2011-2#1)
and 18 weeks after##2##4##(2010-12#1)(2012-3#1)
and 18 weeks##4##3##(1993-3#1)(2010-12#2)(2012-3#1)
and 18 were##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
and 18 years##2##3##(2011-1#1)(2013-1#1)
and 18##92##2##(1990-11#2)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#2)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-5#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)
and 18% of the##2##4##(1993-11#2)
and 18% of##3##3##(1991-8#1)(1993-11#2)
and 18%##10##2##(1990-10#1)(1990-12#1)(1991-8#1)(1993-11#2)(2008-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
and 18-week-old##2##2##(2013-7#2)
and 180 degrees##2##3##(2008-2#1)(2011-2#1)
and 180##8##2##(1996-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
and 182##2##2##(2010-2#1)(2013-1#1)
and 184##2##2##(1997-8#1)(2008-10#1)
and 186##2##2##(2008-4#1)(2013-1#1)
and 187##2##2##(2009-10#1)(2011-2#1)
and 19 months after##2##4##(1990-5#1)(1994-12#1)
and 19 months##4##3##(1990-5#2)(1994-1#1)(1994-12#1)
and 19 of##2##3##(1995-12#1)(2008-10#1)
and 19 were##3##3##(1990-2#1)(2013-1#2)
and 19 years##2##3##(1995-6#1)(2009-5#1)
and 19##65##2##(1990-11#1)(1990-2#2)(1990-5#2)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-5#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#7)
and 19% of##2##3##(1997-2#1)(2008-10#1)
and 19%##8##2##(1993-6#1)(1997-2#1)(2008-10#3)(2009-5#1)(2011-2#1)(2013-1#1)
and 190##2##2##(1992-10#1)(1996-12#1)
and 1900##2##2##(2008-3#1)(2011-2#1)
and 191##4##2##(1991-2#1)(1993-8#1)(1997-8#2)
and 1927##2##2##(2009-9#1)(2011-1#1)
and 194##3##2##(1995-1#1)(2008-10#1)(2012-2#1)
and 1940##2##2##(2009-10#1)(2009-7#1)
and 196 K##2##3##(2008-3#2)
and 196##4##2##(2008-10#1)(2008-3#2)(2008-8#1)
and 198##2##2##(1994-12#1)(1995-3#1)
and 1983##2##2##(2008-7#1)(2011-2#1)
and 1984##3##2##(1990-3#1)(1990-6#1)(1991-1#1)
and 1985##6##2##(1990-8#2)(1991-6#1)(1993-3#1)(1996-11#1)(1997-5#1)
and 1986##3##2##(1990-2#1)(1991-2#1)(1993-9#1)
and 1987##8##2##(1990-11#1)(1990-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(2008-11#1)(2008-8#1)
and 1988##14##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-12#2)(1992-2#2)(1993-1#3)(1995-3#1)(1995-6#1)(1997-7#1)
and 1989##14##2##(1990-11#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1993-2#1)(1995-3#1)(2008-10#1)
and 1990##10##2##(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-9#1)(1997-5#1)(1997-6#1)(2008-10#1)
and 1991 are##2##3##(1994-2#1)(1996-1#1)
and 1991 at the##2##4##(1992-6#1)(1994-7#1)
and 1991##12##2##(1992-4#2)(1992-6#1)(1992-9#1)(1993-9#2)(1994-2#1)(1994-7#1)(1995-1#1)(1996-1#1)(2007-5#1)(2008-10#1)
and 1992##7##2##(1993-6#1)(1995-2#1)(1995-5#1)(1997-6#2)(2008-10#2)
and 1993##10##2##(1994-11#1)(1995-12#1)(2008-10#5)(2008-5#2)(2008-6#1)
and 1994##13##2##(1995-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-5#2)(2008-10#4)(2008-5#3)
and 1995 and##2##3##(1995-6#1)(2009-7#1)
and 1995 we##2##3##(1996-11#1)(2008-7#1)
and 1995 with##2##3##(1996-11#1)(2008-6#1)
and 1995##22##2##(1995-12#1)(1995-6#1)(1996-11#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#5)(2008-6#1)(2008-7#2)(2009-7#1)(2010-7#1)
and 1996 and##2##3##(2008-10#1)(2008-4#1)
and 1996 for##2##3##(2008-10#1)(2008-7#1)
and 1996 to 1997##2##4##(2008-10#2)
and 1996 to evaluate the##2##5##(2008-10#2)
and 1996 to##4##3##(2008-10#4)
and 1996 were##2##3##(1997-6#1)(2008-4#1)
and 1996##22##2##(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#15)(2008-4#2)(2008-6#1)(2008-7#1)
and 1997##20##2##(1996-1#1)(2008-10#15)(2008-11#2)(2008-7#1)(2008-8#1)
and 1998##19##2##(2006-12#1)(2008-10#14)(2008-5#3)(2008-9#1)
and 1999##26##2##(2007-11#6)(2007-6#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-8#1)(2013-8#1)
and 1H##4##2##(1992-3#1)(1993-11#1)(1994-2#1)(2009-7#1)
and 1H-NMR##5##2##(1990-11#2)(1990-7#1)(1994-3#1)(1995-3#1)
and 1a-3##2##2##(1993-11#2)
and 1x10(-6)##2##2##(2008-10#2)
and 2 PR in grade##2##5##(1990-12#2)
and 2 are##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
and 2 cases of##3##4##(1991-6#1)(2009-10#1)(2013-8#1)
and 2 days after##3##4##(2008-10#2)(2008-5#1)
and 2 from##2##3##(2008-10#1)(2011-2#1)
and 2 h after##2##4##(2008-10#2)
and 2 h##3##3##(1990-3#1)(2008-10#2)
and 2 had asymptomatic##2##4##(1990-9#1)(1991-2#1)
and 2 had##6##3##(1990-9#2)(1991-12#1)(1991-2#1)(1993-12#1)(2012-2#1)
and 2 hours##2##3##(1991-9#1)(2011-2#1)
and 2 in##3##3##(1997-6#2)(2013-1#1)
and 2 mM##4##3##(1992-6#1)(1993-8#1)(1994-9#1)(2008-10#1)
and 2 mg##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
and 2 million##2##3##(1992-6#1)(1993-6#1)
and 2 ml of##2##4##(2008-10#2)
and 2 ml##4##3##(2008-10#4)
and 2 mm##2##3##(2008-12#1)(2008-2#1)
and 2 months##7##3##(2007-10#1)(2008-10#2)(2008-6#1)(2009-3#2)(2013-1#1)
and 2 ng ml(-1) for##3##5##(2008-10#3)
and 2 of 3##2##4##(2007-10#1)(2007-11#1)
and 2 of the##3##4##(1991-5#1)(1994-7#1)(2008-10#1)
and 2 of##14##3##(1991-12#1)(1991-5#1)(1992-4#1)(1994-12#1)(1994-7#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#5)
and 2 patients were##3##4##(1990-12#1)(1997-3#1)(2008-10#1)
and 2 patients##9##3##(1990-12#1)(1991-8#2)(1996-3#1)(1997-3#1)(2008-10#1)(2008-7#2)(2013-1#1)
and 2 species##2##3##(2008-10#1)(2011-2#1)
and 2 to##4##3##(1994-12#1)(2008-10#2)(2010-5#1)
and 2 weeks##4##3##(1990-11#1)(1992-10#1)(2007-10#1)(2009-8#1)
and 2 were##12##3##(1990-2#1)(1994-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2013-1#1)
and 2 with##2##3##(1991-5#1)(1992-6#1)
and 2 x##2##3##(1994-5#1)(2008-10#1)
and 2 years in##2##4##(1994-7#1)(2007-10#1)
and 2 years##7##3##(1994-7#1)(2007-10#5)(2007-8#1)
and 2##633##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#2)(1991-12#7)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#2)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#6)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#4)(1994-11#2)(1994-12#2)(1994-2#3)(1994-5#2)(1994-7#2)(1994-8#5)(1994-9#2)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#9)(2007-11#9)(2007-12#11)(2007-4#1)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#217)(2008-11#23)(2008-12#15)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#15)(2008-6#3)(2008-7#9)(2008-8#12)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#21)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#7)(2012-7#1)(2013-1#21)(2013-7#1)(2013-8#6)
and 2% at##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
and 2% of the##2##4##(1997-4#2)
and 2% of##3##3##(1997-4#2)(1997-6#1)
and 2%##20##2##(1990-3#1)(1992-2#2)(1997-4#2)(1997-6#1)(2008-10#8)(2008-11#1)(2008-3#2)(2009-5#1)(2013-1#2)
and 2) a##2##3##(2012-1#1)(2012-2#1)
and 2) the##4##3##(1994-11#1)(1994-3#1)(1996-9#1)(2007-5#1)
and 2) to##3##3##(1995-2#1)(1995-3#1)(2008-10#1)
and 2)##35##2##(1990-11#2)(1990-2#1)(1991-8#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##3##2##(2008-10#3)
and 2-4##2##2##(2008-11#1)(2012-12#1)
and 2-8##2##2##(2008-10#2)
and 2-D gel electrophoresis##2##4##(2008-4#1)(2008-7#1)
and 2-D##6##2##(1992-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
and 2-HPbetaCD##2##2##(2008-11#2)
and 2-ethoxyethanol##3##2##(2007-12#3)
and 2-ethylhexyl##2##2##(2008-10#1)(2008-5#1)
and 2-fold##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
and 2-h##2##2##(1994-12#1)(2012-7#1)
and 2-hydroxypropyl-beta-cyclodextrin##3##2##(2008-10#1)(2008-11#2)
and 2-mercaptoethanol##3##2##(1990-8#1)(1991-12#1)(1992-12#1)
and 2-mercaptosuccinic acid were##2##4##(1990-5#2)
and 2-mercaptosuccinic acid##3##3##(1990-5#3)
and 2-methoxy##2##2##(1993-8#1)(2008-10#1)
and 2-methyl-5-butyloxymethyl-8-quinolinol##2##2##(2008-10#2)
and 2-nitrophenyl octyl ether##2##4##(2008-10#2)
and 2-propanol##2##2##(1994-9#1)(2008-10#1)
and 2-week-old##2##2##(1991-9#1)(2008-10#1)
and 2-year post-implementation to obtain feedback from the acute care registered nurses (RNs)##2##13##(2013-1#2)
and 2-year survival##3##3##(2007-12#1)(2012-1#1)(2012-2#1)
and 2-year##8##2##(2007-12#1)(2008-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and 2/3##3##2##(1990-6#1)(1993-9#1)(2007-8#1)
and 20 age-matched healthy##2##4##(1996-11#1)(1996-7#1)
and 20 cm from the##2##5##(2013-8#2)
and 20 cm##3##3##(2008-6#1)(2013-8#2)
and 20 control subjects##2##4##(1997-8#2)
and 20 controls##2##3##(2009-6#1)(2013-1#1)
and 20 days after##3##4##(1995-12#1)(2008-10#1)(2008-12#1)
and 20 days##4##3##(1995-12#1)(1997-3#1)(2008-10#1)(2008-12#1)
and 20 degrees C##8##4##(1990-8#1)(2008-10#6)(2011-2#1)
and 20 h##2##3##(2008-10#1)(2010-5#1)
and 20 healthy##6##3##(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
and 20 in##2##3##(2011-2#1)(2012-3#1)
and 20 mM##2##3##(1994-9#1)(2008-10#1)
and 20 minutes of tourniquet ischemia##2##6##(2006-12#2)
and 20 minutes##3##3##(2006-12#2)(2012-2#1)
and 20 ml of##2##4##(2008-10#2)
and 20 mug##2##3##(2008-11#2)
and 20 mul of##2##4##(2008-10#2)
and 20 mul##3##3##(2008-10#3)
and 20 ng ml(-1) for##2##5##(2008-10#2)
and 20 ng ml(-1)##3##4##(2008-10#3)
and 20 ng##6##3##(1990-8#1)(2008-10#5)
and 20 nm##2##3##(2008-2#1)(2009-9#1)
and 20 of##2##3##(1995-12#1)(2008-6#1)
and 20 patients##2##3##(1992-2#1)(2011-2#1)
and 20 to##2##3##(2008-10#1)(2010-11#1)
and 20 weeks##2##3##(1993-6#1)(2007-11#1)
and 20 were##3##3##(2008-7#1)(2011-2#2)
and 20##141##2##(1990-12#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-7#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#2)(1996-11#1)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#4)(2008-1#2)(2008-10#37)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
and 20% for##2##3##(2008-10#1)(2009-3#1)
and 20%##21##2##(1990-5#1)(1990-8#1)(1993-3#2)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-6#1)(2013-1#2)
and 200 mg/body of 5-FU and 20 mg/body of##2##9##(1994-7#2)
and 200 mg/kg body##2##4##(1992-5#1)(2008-10#1)
and 200 mg/kg females##4##4##(2008-9#4)
and 200 mg/kg##10##3##(1992-5#1)(2008-10#2)(2008-9#5)(2012-2#2)
and 200 micros##2##3##(2008-2#2)
and 200 ms##2##3##(1994-11#1)(2008-3#1)
and 200 nM##2##3##(1994-12#1)(1994-9#1)
and 200##44##2##(1990-3#1)(1990-5#1)(1991-12#1)(1992-3#2)(1992-5#1)(1994-11#1)(1994-12#1)(1994-7#2)(1994-9#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#3)(2008-9#5)(2011-2#1)(2012-2#2)(2013-8#1)
and 2000 to##2##3##(2008-10#2)
and 2000##28##2##(1991-1#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-2#1)(2012-9#1)
and 2001##24##2##(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-8#3)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)
and 2002 and##2##3##(2008-10#1)(2008-9#1)
and 2002##25##2##(2007-11#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-12#2)(2008-9#1)(2011-2#1)
and 2003 in##2##3##(2011-2#1)(2013-1#1)
and 2003 with##2##3##(2008-5#1)(2010-3#1)
and 2003##21##2##(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and 2004##19##2##(2008-10#7)(2008-11#4)(2008-5#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#3)(2012-12#1)
and 2005##24##2##(2008-1#1)(2008-10#6)(2008-12#6)(2008-8#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
and 2005)##2##2##(2008-10#1)(2008-5#1)
and 2006 to##2##3##(2010-4#1)(2011-2#1)
and 2006 was conducted##2##4##(2008-9#1)(2010-9#1)
and 2006##21##2##(2008-12#4)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#3)
and 2007##16##2##(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#1)
and 2007)##3##2##(2010-6#1)(2012-3#1)(2013-1#1)
and 2008 and##2##3##(2011-3#1)(2013-8#1)
and 2008 were##2##3##(2011-2#1)(2013-1#1)
and 2008##34##2##(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#1)(2013-8#3)
and 2009##15##2##(2011-2#4)(2012-1#1)(2012-3#4)(2013-1#4)(2013-8#2)
and 201##3##2##(1990-3#1)(1993-3#1)(1996-2#1)
and 2010##24##2##(1996-1#1)(2012-12#3)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#8)
and 2011##11##2##(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#2)
and 2012##2##2##(2013-1#1)(2013-8#1)
and 202##2##2##(2007-10#1)(2011-2#1)
and 207##4##2##(1997-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
and 208##3##2##(2008-10#1)(2009-8#1)(2010-5#1)
and 20th##4##2##(1993-12#1)(2007-8#1)(2008-6#1)(2012-3#1)
and 21 days after##2##4##(2008-10#2)
and 21 days##3##3##(1995-11#1)(2008-10#2)
and 21 degrees C##3##4##(2008-10#3)
and 21 in##3##3##(1992-12#1)(2010-1#1)(2010-5#1)
and 21 men##2##3##(2007-11#2)
and 21##56##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#2)(2007-11#2)(2007-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#10)(2008-6#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
and 21% of the##2##4##(2007-2#1)(2007-7#1)
and 21% with##2##3##(2008-3#1)(2011-3#1)
and 21%##8##2##(1993-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#1)(2011-3#1)
and 210 kDa)##2##3##(2008-11#2)
and 210 nm##2##3##(2008-3#2)
and 210##7##2##(2008-11#2)(2008-3#3)(2009-2#1)(2009-7#1)
and 215##2##2##(2008-10#1)(2011-2#1)
and 219##2##2##(2008-10#1)(2010-4#1)
and 21q##3##2##(1997-5#3)
and 21st##3##2##(2009-4#1)(2011-1#1)(2013-1#1)
and 22 days after##2##4##(2008-10#1)(2013-1#1)
and 22 degrees C##3##4##(1996-5#1)(2008-10#2)
and 22 h##2##3##(1992-8#1)(2008-6#1)
and 22 patients##3##3##(1992-3#1)(2008-6#1)(2008-8#1)
and 22##66##2##(1990-8#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-3#4)(1992-8#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#3)(1997-8#2)(2006-8#1)(2007-11#3)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
and 22% of##4##3##(1994-8#1)(1997-2#1)(1997-8#1)(2010-12#1)
and 22%##9##2##(1994-8#1)(1995-4#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-8#1)
and 220##4##2##(1993-11#1)(2008-10#2)(2008-9#1)
and 222##3##2##(1990-5#1)(1991-2#1)(2013-1#1)
and 223##2##2##(2008-10#2)
and 225##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
and 23 +/-##2##3##(2008-4#1)(2013-1#1)
and 23 isolates of##2##4##(2008-10#2)
and 23 patients##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
and 23 were##2##3##(1992-5#1)(2011-2#1)
and 23##54##2##(1990-2#1)(1990-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-11#1)(1995-9#1)(1996-5#3)(1997-2#1)(1997-5#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and 23%##6##2##(1990-8#1)(1991-11#1)(1996-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
and 230 mum##2##3##(2007-12#1)(2008-11#1)
and 230##3##2##(2007-12#1)(2008-11#1)(2010-12#1)
and 2300 degrees C##3##4##(2008-10#3)
and 2300##4##2##(2008-10#4)
and 235##2##2##(1992-9#1)(2008-9#1)
and 239##2##2##(1997-2#1)(2008-10#1)
and 23S##3##2##(1992-3#1)(1992-6#1)(2008-10#1)
and 24 degrees C##4##4##(2008-10#2)(2008-3#2)
and 24 h after##3##4##(1995-12#1)(2008-10#1)(2012-3#1)
and 24 h##15##3##(1990-12#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
and 24 hours##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
and 24 hr##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
and 24 months after##2##4##(1992-9#1)(2010-8#1)
and 24 months##8##3##(1990-6#1)(1992-9#1)(1997-9#1)(2007-7#2)(2007-8#1)(2008-4#1)(2010-8#1)
and 24 with##2##3##(1990-11#1)(2008-7#1)
and 24##75##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-6#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)
and 24% of##2##3##(2008-10#1)(2012-1#1)
and 24%##7##2##(1990-6#1)(2008-10#2)(2011-2#1)(2012-1#2)(2013-1#1)
and 24-hour##5##2##(1992-4#1)(1995-9#3)(1996-7#1)
and 24-month-old##2##2##(1997-9#1)(2008-3#1)
and 240##7##2##(1990-7#1)(1995-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-4#2)
and 2400##2##2##(1992-11#1)(2008-10#1)
and 242##3##2##(1993-6#1)(1996-11#1)(2010-5#1)
and 243##4##2##(2008-10#1)(2008-2#2)(2011-2#1)
and 245##2##2##(1995-6#1)(2008-10#1)
and 24h urinary##2##3##(2011-2#2)
and 24h##4##2##(2008-10#1)(2010-4#1)(2011-2#2)
and 25 degrees C##18##4##(1990-7#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)
and 25 degrees##19##3##(1990-7#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)
and 25 men##2##3##(2008-7#2)
and 25##79##2##(1990-2#1)(1990-7#2)(1990-8#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#2)(1994-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-7#2)(2010-2#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
and 25% in the##2##4##(1990-12#1)(1997-4#1)
and 25% in##3##3##(1990-12#1)(1997-4#1)(2008-10#1)
and 25% of the##2##4##(1995-8#1)(2008-4#1)
and 25% of##4##3##(1995-8#1)(2008-4#1)(2008-5#1)(2013-8#1)
and 25%##19##2##(1990-12#2)(1990-2#1)(1991-8#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
and 25-fold##2##2##(2006-6#1)(2008-10#1)
and 250 for##2##3##(2008-10#2)
and 250##14##2##(1996-12#1)(2006-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
and 2500 degrees C##2##4##(2008-10#2)
and 250mugl(-1)##2##2##(2008-10#2)
and 256 mg/kg##5##3##(2008-9#5)
and 256##8##2##(1993-11#1)(2008-3#1)(2008-9#5)(2013-1#1)
and 257##2##2##(2011-2#1)(2012-3#1)
and 25mugl(-1)##2##2##(2008-10#2)
and 26 were##2##3##(1995-2#1)(2008-10#1)
and 26##32##2##(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1993-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(2007-10#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
and 26% of the##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
and 26% of##5##3##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
and 26%##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#2)
and 266 nm##3##3##(2008-3#2)(2012-2#1)
and 266##4##2##(2008-11#1)(2008-3#2)(2012-2#1)
and 27 degrees C##2##4##(1994-3#1)(1994-5#1)
and 27##34##2##(1990-6#1)(1992-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1996-5#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and 27% of the##2##4##(1991-9#1)(1996-12#1)
and 27% of##3##3##(1991-9#1)(1996-12#1)(2008-6#1)
and 27%##11##2##(1990-6#1)(1991-6#1)(1991-9#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-2#1)(2012-3#1)
and 270##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
and 2700##2##2##(2008-10#2)
and 275##2##2##(2008-2#1)(2008-9#1)
and 277##2##2##(2008-1#1)(2011-3#1)
and 28 and##2##3##(2010-6#1)(2011-2#1)
and 28 days##3##3##(2008-10#2)(2008-7#1)
and 28 degrees C##4##4##(2008-10#2)(2008-11#1)(2010-1#1)
and 28 years##2##3##(2008-10#1)(2008-12#1)
and 28##55##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-1#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)
and 28%##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
and 280 mg/kg##2##3##(2013-1#2)
and 280##4##2##(1994-5#1)(2010-6#1)(2013-1#2)
and 285##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
and 288##2##2##(1991-12#1)(2012-12#1)
and 29 years##2##3##(2007-12#1)(2010-3#1)
and 29##34##2##(1990-2#2)(1990-9#1)(1991-1#1)(1991-4#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
and 29% at##2##3##(1991-9#1)(2011-3#1)
and 29% of##2##3##(1995-8#1)(2008-10#1)
and 29%##8##2##(1991-9#1)(1995-8#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-3#1)
and 293 cells##2##3##(2008-11#2)
and 293##4##2##(2008-11#2)(2008-8#1)(2013-8#1)
and 294##4##2##(1997-4#1)(2008-3#2)(2011-2#1)
and 296##2##2##(1997-6#1)(2008-10#1)
and 2971 cm(-1)##2##3##(2008-10#2)
and 2B##2##2##(1995-8#1)(1997-2#1)
and 2C##2##2##(1995-8#1)(2008-10#1)
and 2D NMR##7##3##(1994-5#1)(1995-2#1)(2008-9#1)(2010-2#1)(2010-6#1)(2013-1#2)
and 2D##12##2##(1992-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
and 2nd generation youth##2##4##(2009-7#2)
and 2nd##5##2##(1990-10#1)(1992-12#1)(2009-7#2)(2010-5#1)
and 2ngml(-1)##2##2##(2008-10#2)
and 3 M##2##3##(1991-7#1)(2008-10#1)
and 3 alpha##3##3##(1990-11#2)(1996-2#1)
and 3 and##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2009-11#1)
and 3 are##3##3##(1992-6#1)(1996-2#1)(2008-6#1)
and 3 at##2##3##(1990-5#1)(2008-10#1)
and 3 beta-hydroxy-5##2##3##(1992-3#1)(1993-6#1)
and 3 beta-hydroxy-5-cholestenoic acid##3##4##(1994-8#3)
and 3 days##8##3##(1992-3#1)(1993-2#1)(1997-6#1)(2007-10#2)(2008-10#1)(2008-5#1)(2010-12#1)
and 3 degrees C##2##4##(1991-8#1)(2008-3#1)
and 3 degrees##3##3##(1991-8#1)(2008-2#1)(2008-3#1)
and 3 h##3##3##(1992-3#1)(1995-3#1)(2008-12#1)
and 3 had##4##3##(1994-3#1)(2008-10#1)(2011-2#2)
and 3 in the##2##4##(2008-10#1)(2011-2#1)
and 3 in##7##3##(1992-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#3)
and 3 month##2##3##(2008-12#1)(2011-2#1)
and 3 months after##4##4##(1991-6#1)(2008-10#2)(2008-5#1)
and 3 months##12##3##(1991-6#1)(1993-12#3)(1996-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#2)(2013-1#1)
and 3 mug l(-1) for##2##5##(2008-10#2)
and 3 of##6##3##(1991-2#1)(1992-3#1)(1995-5#1)(1995-6#1)(2011-2#1)(2013-1#1)
and 3 or##2##3##(1992-2#1)(2009-4#1)
and 3 other##2##3##(2008-5#1)(2011-2#1)
and 3 patients##4##3##(1990-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
and 3 show##2##3##(1995-8#1)(1997-7#1)
and 3 times##2##3##(1994-11#1)(2009-4#1)
and 3 was##2##3##(2008-1#1)(2012-3#1)
and 3 weeks##5##3##(1994-5#1)(2008-3#1)(2008-5#2)(2011-2#1)
and 3 were##8##3##(1992-6#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#2)(2012-3#1)(2013-8#1)
and 3 with##4##3##(2008-11#1)(2008-7#2)(2011-2#1)
and 3 x##2##3##(1991-5#1)(2008-10#1)
and 3##418##2##(1990-11#6)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#2)(1994-11#1)(1994-3#4)(1994-5#2)(1994-8#6)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#4)(1997-8#3)(2007-10#4)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#135)(2008-11#12)(2008-12#10)(2008-2#3)(2008-3#15)(2008-4#6)(2008-5#13)(2008-6#5)(2008-7#10)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#3)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#27)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#10)(2013-3#1)(2013-8#5)
and 3% of##2##3##(2008-12#1)(2008-7#1)
and 3%##13##2##(1993-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-1#1)(2013-8#1)
and 3' UTR##2##3##(2008-10#1)(2008-8#1)
and 3' untranslated regions of##2##5##(1993-2#1)(2010-9#1)
and 3' untranslated##3##3##(1993-2#1)(2008-10#1)(2010-9#1)
and 3'##28##2##(1990-7#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-8#2)(1995-8#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#4)(2010-5#2)(2010-9#1)
and 3'-NTR##2##2##(2008-10#2)
and 3'-end##2##2##(2008-10#2)
and 3'-terminal sequences of##2##4##(2008-10#1)(2008-9#1)
and 3'-terminal##3##2##(2008-10#2)(2008-9#1)
and 3) a##2##3##(1993-1#1)(2011-2#1)
and 3) the##2##3##(1997-5#1)(2008-7#1)
and 3)##29##2##(1990-2#1)(1990-8#1)(1991-2#1)(1993-1#1)(1993-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
and 3-D vision##2##3##(2007-8#2)
and 3-D##4##2##(2007-8#2)(2008-3#1)(2008-4#1)
and 3-dimensional##2##2##(2012-12#1)(2013-1#1)
and 3-month##2##2##(2008-3#2)
and 30 June##2##3##(1990-2#1)(1992-9#1)
and 30 days after##2##4##(1991-5#1)(2008-10#1)
and 30 days##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
and 30 days)##2##3##(1991-2#1)(1996-5#1)
and 30 degrees C##12##4##(2008-10#9)(2008-12#1)(2008-8#1)(2010-4#1)
and 30 degrees C) and##2##5##(2008-10#2)
and 30 degrees C)##3##4##(2008-10#3)
and 30 degrees##19##3##(2007-8#2)(2008-10#12)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-4#1)
and 30 females##2##3##(2008-1#1)(2008-5#1)
and 30 min after the##2##5##(2008-7#1)(2011-2#1)
and 30 min after##3##4##(1994-2#1)(2008-7#1)(2011-2#1)
and 30 min for##2##4##(2008-10#1)(2008-12#1)
and 30 min of##2##4##(2011-2#1)(2012-3#1)
and 30 min##10##3##(1993-1#2)(1994-2#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
and 30 ng##2##3##(2008-10#2)
and 30 nucleotides##2##3##(2008-10#1)(2008-2#1)
and 30 ppm##2##3##(2008-3#1)(2013-8#1)
and 30 years##2##3##(2010-3#1)(2011-2#1)
and 30##131##2##(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-9#2)(1993-1#2)(1993-12#6)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-6#1)(1995-8#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
and 30% for##2##3##(1995-3#1)(2008-3#1)
and 30% had history of constitutional symptoms##2##7##(2013-1#2)
and 30% in the##2##4##(1990-12#1)(2013-1#1)
and 30% in##5##3##(1990-12#1)(1996-9#1)(2008-10#1)(2009-4#1)(2013-1#1)
and 30% of the##2##4##(2008-3#1)(2010-4#1)
and 30% of##3##3##(2008-3#1)(2010-4#1)(2012-2#1)
and 30%##31##2##(1990-12#2)(1991-5#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#3)(2013-8#1)
and 30%)##2##2##(1997-2#1)(2010-4#1)
and 30-40##2##2##(2008-12#1)(2008-3#1)
and 300 mg##3##3##(1991-3#1)(1996-12#1)(2011-2#1)
and 300##17##2##(1991-3#1)(1992-5#1)(1993-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#2)
and 3000##2##2##(1990-5#1)(1992-12#1)
and 300ngml(-1)##2##2##(2008-10#2)
and 301##2##2##(2008-10#2)
and 305##2##2##(2008-10#1)(2008-5#1)
and 30min##2##2##(2008-10#1)(2008-7#1)
and 31 kDa##2##3##(1993-8#1)(2007-10#1)
and 31 patients##2##3##(1991-8#1)(2007-8#1)
and 31##30##2##(1991-3#1)(1991-8#3)(1993-12#1)(1993-8#1)(1994-1#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
and 31% of cationic arsenic##2##5##(2008-10#2)
and 31% of##3##3##(1992-9#1)(2008-10#2)
and 31%##14##2##(1990-9#1)(1992-9#1)(1994-8#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2012-2#1)(2013-8#1)
and 315##2##2##(2008-11#1)(2008-2#1)
and 316##2##2##(2008-3#1)(2009-4#1)
and 318##2##2##(2010-5#2)
and 31P##3##2##(1994-2#2)(1995-3#1)
and 32 +/-##2##3##(1996-2#1)(2008-10#1)
and 32 degrees C##2##4##(2008-5#2)
and 32 degrees C) and##2##5##(2008-10#1)(2008-5#1)
and 32 degrees C)##3##4##(2008-10#1)(2008-5#1)(2010-4#1)
and 32 degrees##5##3##(2008-10#1)(2008-5#3)(2010-4#1)
and 32 microM phosphate ion##2##5##(2008-10#2)
and 32##42##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 32% of the##2##4##(2008-10#2)
and 32% of##3##3##(2008-10#2)(2008-5#1)
and 32%##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
and 32%)##2##2##(2008-10#1)(2008-7#1)
and 320##4##2##(1992-6#1)(1994-6#1)(2007-12#1)(2011-2#1)
and 33 degrees##4##3##(1995-11#3)(2011-2#1)
and 33##42##2##(1990-2#1)(1990-7#1)(1991-4#2)(1993-12#1)(1993-5#1)(1993-9#1)(1995-11#3)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)
and 33%##10##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1994-8#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)
and 332##2##2##(2008-10#1)(2008-3#1)
and 336##3##2##(1990-11#1)(2008-10#1)(2013-1#1)
and 337##2##2##(1991-9#1)(2008-10#1)
and 34##17##2##(1990-11#2)(1990-2#1)(1990-5#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)
and 34%##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
and 340##2##2##(1994-5#1)(1996-6#1)
and 343##2##2##(1994-9#1)(2007-10#1)
and 344##2##2##(1990-8#1)(2008-10#1)
and 345##2##2##(2008-10#1)(2012-12#1)
and 347##2##2##(1996-2#1)(2010-7#1)
and 35 %##2##3##(2008-5#2)
and 35 degrees C were established as providing the optimum##2##10##(2008-10#2)
and 35 degrees C were##4##5##(2008-10#4)
and 35 degrees C##14##4##(1997-6#1)(2008-10#8)(2008-2#1)(2008-6#1)(2009-8#1)(2011-2#2)
and 35 degrees##15##3##(1995-5#1)(1997-6#1)(2008-10#8)(2008-2#1)(2008-6#1)(2009-8#1)(2011-2#2)
and 35 healthy##2##3##(1996-7#1)(2008-1#1)
and 35 in##2##3##(2008-8#1)(2010-2#1)
and 35 years##2##3##(2008-10#1)(2010-3#1)
and 35##50##2##(1990-3#1)(1990-6#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
and 35% of the##5##4##(1990-12#1)(1997-2#1)(2008-10#2)(2013-8#1)
and 35% of##7##3##(1990-12#1)(1997-2#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
and 35%##15##2##(1990-12#1)(1991-6#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
and 350 nm##3##3##(1995-5#1)(2008-10#1)(2008-2#1)
and 350##7##2##(1995-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
and 355 nm##2##3##(2008-2#1)(2008-3#1)
and 355##3##2##(2008-2#1)(2008-3#2)
and 357##2##2##(2008-10#1)(2011-2#1)
and 36 h##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
and 36 isolates##2##3##(2008-10#2)
and 36 months##2##3##(2007-11#1)(2010-1#1)
and 36##37##2##(1990-2#1)(1990-5#1)(1991-11#1)(1993-2#1)(1995-6#1)(1996-12#1)(1996-3#2)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
and 36% for##2##3##(2008-10#1)(2011-2#1)
and 36% of the##2##4##(2008-10#1)(2011-2#1)
and 36% of##6##3##(1991-8#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
and 36%##14##2##(1990-2#1)(1991-8#1)(1993-12#1)(1993-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#2)
and 360##2##2##(2008-10#1)(2008-5#1)
and 365##3##2##(2008-10#2)(2011-1#1)
and 37 degrees C were##3##5##(1992-3#1)(1992-6#1)(2008-10#1)
and 37 degrees C##17##4##(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#2)(1996-12#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-8#1)
and 37 degrees##19##3##(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#2)(1996-12#1)(1996-2#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-8#1)
and 37 of##2##3##(1994-1#1)(2008-10#1)
and 37##46##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and 37% of##2##3##(1997-6#1)(2009-5#1)
and 37%##8##2##(1990-3#1)(1994-8#1)(1997-6#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-2#1)
and 371##2##2##(1995-1#1)(1997-4#1)
and 38 ku##2##3##(2008-9#2)
and 38##31##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-8#1)(2008-9#2)(2009-4#1)(2013-1#1)(2013-8#1)
and 38% in##2##3##(2008-10#1)(2008-7#1)
and 38% of the##2##4##(1992-12#1)(2008-7#1)
and 38% of##4##3##(1992-12#1)(2007-12#1)(2008-7#1)(2008-9#1)
and 38%##14##2##(1991-12#1)(1992-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)
and 384##4##2##(1990-11#1)(1993-8#1)(2011-2#1)(2012-12#1)
and 39 weeks##2##3##(1996-11#1)(2008-9#1)
and 39##16##2##(1991-8#2)(1991-9#2)(1995-2#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-3#1)
and 39%##2##2##(2011-1#1)(2011-2#1)
and 390##2##2##(2007-11#1)(2009-7#1)
and 394##3##2##(1992-12#1)(2008-10#1)(2012-3#1)
and 3D CT scan##2##4##(2010-3#2)
and 3D##14##2##(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-12#2)(2010-3#2)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#1)
and 3b)##3##2##(1992-12#2)(2011-1#1)
and 3h##2##2##(2008-10#2)
and 3rd##11##2##(2007-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-2#1)(2013-1#1)
and 4 M##2##3##(1992-3#1)(2008-10#1)
and 4 days##2##3##(2007-8#1)(2008-10#1)
and 4 degrees C##2##4##(2008-10#1)(2008-7#1)
and 4 h##6##3##(1994-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2013-1#1)
and 4 in the##2##4##(2008-10#1)(2008-3#1)
and 4 in##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
and 4 min##3##3##(2008-10#2)(2008-7#1)
and 4 months of##2##4##(1991-6#1)(1992-2#1)
and 4 months##8##3##(1991-4#1)(1991-6#1)(1992-2#2)(1992-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
and 4 of##4##3##(1994-9#1)(2008-10#2)(2011-2#1)
and 4 patients##3##3##(2008-7#2)(2012-3#1)
and 4 times##3##3##(1997-3#1)(2008-3#1)(2008-8#1)
and 4 to##3##3##(2008-10#3)
and 4 weeks (n =##2##5##(2007-10#2)
and 4 weeks later##2##4##(2007-7#1)(2008-10#1)
and 4 weeks of##4##4##(2008-10#1)(2008-7#1)(2009-3#1)(2009-7#1)
and 4 weeks##13##3##(1997-3#1)(2007-10#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-3#2)(2009-7#1)
and 4 were##8##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#2)(2012-2#1)
and 4 with##4##3##(1996-12#1)(1996-3#1)(2007-11#1)(2007-2#1)
and 4 years##3##3##(1993-9#1)(2007-7#1)(2008-10#1)
and 4##300##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#5)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-5#1)(1993-6#2)(1993-9#3)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#103)(2008-11#9)(2008-12#9)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#1)
and 4% for##4##3##(2007-12#1)(2008-10#3)
and 4% in##2##3##(1995-3#1)(2008-10#1)
and 4% of##4##3##(1992-9#1)(1996-1#1)(2008-10#1)(2013-1#1)
and 4%##20##2##(1990-2#1)(1992-9#1)(1995-3#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-10#8)(2009-7#1)(2010-7#1)(2010-8#2)(2013-1#2)
and 4'##2##2##(1993-11#1)(2008-9#1)
and 4) in##2##3##(1997-5#1)(2011-1#1)
and 4) the##4##3##(1991-3#1)(1995-11#1)(1997-6#1)(2008-8#1)
and 4)##15##2##(1991-3#1)(1992-3#1)(1994-12#1)(1995-11#1)(1997-5#1)(1997-6#1)(2008-11#3)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-9#1)
and 4-5##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
and 4-amino-5-(imidazol-2-yl)imidazole##2##2##(1993-11#2)
and 4-aminoantipyrine##2##2##(2008-10#2)
and 4-en-VPA##3##2##(1996-5#3)
and 4-ethyl##2##2##(2008-10#2)
and 4-fold increase##2##3##(1993-6#1)(1996-12#1)
and 4-hydroxynonenal##2##2##(2009-8#2)
and 4-hydroxyproline##2##2##(1994-8#1)(2009-12#1)
and 4-mm-long##2##2##(2007-12#1)(2008-3#1)
and 40 degrees C##5##4##(1991-12#1)(2008-10#3)(2010-4#1)
and 40 healthy controls##4##4##(2007-7#1)(2008-12#2)(2012-3#1)
and 40 healthy##5##3##(1991-8#1)(2007-7#1)(2008-12#2)(2012-3#1)
and 40 min##2##3##(2008-10#1)(2008-7#1)
and 40 minutes##2##3##(1996-1#1)(2007-10#1)
and 40 per##2##3##(2008-5#2)
and 40 ppm##2##3##(2008-3#1)(2013-8#1)
and 40 samples##2##3##(2008-10#2)
and 40 times the##2##4##(1991-5#1)(1997-5#1)
and 40 years##3##3##(2008-4#1)(2012-3#2)
and 40##65##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-5#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#13)(2008-12#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#5)
and 40% of the##2##4##(1991-9#1)(2008-7#1)
and 40%##16##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-6#1)(1996-2#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-2#1)
and 40-kDa##3##2##(1993-1#1)(1995-5#2)
and 400 mOsm##2##3##(2008-11#2)
and 400##17##2##(1990-9#1)(1991-11#1)(1991-2#1)(1993-2#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2010-3#2)(2012-2#1)
and 41##10##2##(1990-11#1)(1991-6#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-10#2)(2011-2#1)
and 41%##4##2##(1991-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
and 410##2##2##(1993-2#1)(1996-11#1)
and 414##3##2##(1992-10#1)(1996-6#1)(2012-2#1)
and 42 days##2##3##(2008-10#1)(2013-1#1)
and 42 patients##3##3##(1994-7#1)(2007-10#1)(2013-8#1)
and 42##24##2##(1990-2#1)(1991-4#1)(1992-8#1)(1994-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#5)(2013-7#1)(2013-8#1)
and 42% identity with the##2##5##(1992-3#1)(1993-2#1)
and 42% in##2##3##(1993-5#1)(1995-3#1)
and 42% of##2##3##(2013-1#1)(2013-8#1)
and 42%##12##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-1#2)(2013-8#2)
and 43 degrees C##6##4##(2008-11#1)(2008-12#5)
and 43##23##2##(1991-8#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#5)(2009-7#1)(2012-12#1)(2013-1#1)
and 43% of the##2##4##(1994-3#1)(2007-12#1)
and 43% of##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
and 43%##6##2##(1994-3#1)(1994-7#1)(1996-12#2)(2007-12#1)(2008-10#1)
and 430 nm##2##3##(2007-11#1)(2008-10#1)
and 430##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
and 436##2##2##(1997-6#1)(2008-10#1)
and 44##13##2##(1994-8#1)(1995-6#1)(1995-8#2)(2006-10#1)(2007-7#1)(2008-2#2)(2011-2#3)(2013-8#2)
and 44%##5##2##(1994-2#1)(2008-10#2)(2008-2#1)(2012-1#1)
and 441##2##2##(2008-3#1)(2013-1#1)
and 448##2##2##(2008-10#1)(2008-9#1)
and 45 degrees C##7##4##(2008-10#2)(2008-12#1)(2008-7#2)(2010-4#2)
and 45 degrees##11##3##(2007-11#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#2)(2010-4#2)
and 45 kDa##2##3##(1993-1#1)(2008-4#1)
and 45##39##2##(1992-2#1)(1992-5#1)(1993-1#1)(1994-12#1)(1995-8#1)(2007-11#2)(2007-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#4)(2009-3#1)(2010-4#2)(2013-1#4)(2013-7#1)(2013-8#2)
and 45% for##2##3##(2008-10#1)(2008-8#1)
and 45% in##2##3##(1992-12#1)(1997-4#1)
and 45%##8##2##(1990-8#1)(1992-12#1)(1994-2#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
and 450 nm##2##3##(2008-10#1)(2008-11#1)
and 450##12##2##(1993-8#2)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#3)(2008-3#2)(2010-2#1)
and 45Ca uptake##2##3##(1993-3#2)
and 45Ca##3##2##(1993-3#3)
and 46##22##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1992-4#1)(1996-5#1)(2007-10#2)(2008-10#6)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
and 46% of the##2##4##(2008-10#1)(2013-8#1)
and 46% of##3##3##(2008-10#2)(2013-8#1)
and 46%##7##2##(1992-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
and 460 nm for##2##4##(2008-10#2)
and 469##2##2##(2008-11#2)
and 47##18##2##(1994-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#1)
and 47% of the##3##4##(1994-9#1)(2008-10#1)(2013-8#1)
and 47%##7##2##(1994-9#1)(2007-10#1)(2008-10#2)(2008-3#1)(2013-8#2)
and 48 h after##3##4##(2008-10#1)(2008-12#1)(2010-5#1)
and 48 h following##2##4##(1996-12#1)(2008-7#1)
and 48 h##11##3##(1995-12#2)(1996-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2010-5#1)
and 48 hours##3##3##(2007-10#1)(2013-1#2)
and 48 hrs##2##3##(2008-12#1)(2008-8#1)
and 48##43##2##(1991-8#1)(1992-12#1)(1992-2#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#2)(2013-1#3)
and 48%##5##2##(1991-12#1)(1991-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
and 480 nm##2##3##(1996-2#1)(2008-10#1)
and 480##4##2##(1996-2#2)(2008-10#1)(2010-4#1)
and 49 years##3##3##(1990-10#1)(2007-2#1)(2011-2#1)
and 49##18##2##(1990-10#1)(1990-3#1)(1991-4#1)(1995-10#1)(1996-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
and 49% had##2##3##(1992-5#1)(2012-3#1)
and 49%##6##2##(1991-4#1)(1992-5#1)(1994-2#1)(1994-8#1)(2008-10#1)(2012-3#1)
and 490##2##2##(2008-10#1)(2008-12#1)
and 490nm##2##2##(2008-10#2)
and 499##2##2##(2008-10#1)(2012-12#1)
and 4A##2##2##(1995-6#1)(1996-12#1)
and 4D##3##2##(2007-11#2)(2008-11#1)
and 4th##6##2##(1992-9#1)(1994-11#1)(2008-12#2)(2008-5#1)(2008-7#1)
and 5 Hz##2##3##(2006-12#1)(2008-5#1)
and 5 alpha-dihydrotestosterone (DHT)##2##4##(1990-11#1)(1991-5#1)
and 5 and##5##3##(2008-10#4)(2009-12#1)
and 5 are##2##3##(1993-3#1)(2012-2#1)
and 5 cm##2##3##(2008-12#1)(2013-1#1)
and 5 days per week##2##5##(2013-1#2)
and 5 days##9##3##(1992-5#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#3)
and 5 in the##3##4##(1992-2#1)(1997-6#1)(2008-5#1)
and 5 in##4##3##(1992-2#1)(1996-5#1)(1997-6#1)(2008-5#1)
and 5 kb)##2##3##(1995-6#1)(2008-10#1)
and 5 mM##4##3##(1995-6#1)(2008-10#3)
and 5 mg##2##3##(2008-10#2)
and 5 mg/kg##2##3##(1996-2#1)(2008-7#1)
and 5 microM##3##3##(1994-9#1)(1995-12#1)(2008-10#1)
and 5 min after##2##4##(2008-12#1)(2012-3#1)
and 5 min of##2##4##(2008-10#2)
and 5 min##7##3##(1992-9#1)(2008-10#3)(2008-12#2)(2012-3#1)
and 5 ml##2##3##(2008-10#2)
and 5 of##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
and 5 on##2##3##(2008-10#2)
and 5 patients##2##3##(1994-12#1)(2008-7#1)
and 5 positions##2##3##(1994-9#1)(2008-8#1)
and 5 to##2##3##(2008-10#2)
and 5 weeks after##2##4##(2008-10#1)(2013-8#1)
and 5 weeks of age##2##5##(1997-3#1)(1997-6#1)
and 5 weeks##5##3##(1990-5#1)(1997-3#1)(1997-6#1)(2008-10#1)(2013-8#1)
and 5 were##7##3##(1990-5#1)(1993-9#1)(1994-5#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#1)
and 5 with##3##3##(1991-11#1)(1995-4#1)(2008-7#1)
and 5 wt##2##3##(2008-10#1)(2008-5#1)
and 5 x 10(-6)##2##4##(2008-10#1)(2008-3#1)
and 5 x##8##3##(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
and 5 years after##2##4##(2007-8#1)(2011-2#1)
and 5 years##9##3##(1990-9#1)(2007-7#1)(2007-8#1)(2008-9#2)(2009-8#1)(2011-2#2)(2013-1#1)
and 5##330##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-5#4)(1991-6#2)(1991-8#3)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#5)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#5)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#113)(2008-11#12)(2008-12#12)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#9)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#11)(2013-8#3)
and 5% for##3##3##(2008-10#2)(2008-3#1)
and 5% of##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
and 5%##41##2##(1990-11#1)(1991-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2010-2#1)(2013-1#2)
and 5' flanking##3##3##(1991-5#1)(1993-12#1)(1994-11#1)
and 5'##8##2##(1991-5#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-8#1)(1997-7#1)(2008-2#1)
and 5'-fluorouracil##2##2##(1990-2#2)
and 5'-nucleotidase##2##2##(1994-2#1)(1997-7#1)
and 5'-triphosphate##2##2##(1990-7#2)
and 5)##6##2##(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
and 5-##2##2##(2007-5#1)(2008-3#1)
and 5-10##2##2##(1990-12#1)(2008-10#1)
and 5-6##2##2##(2008-12#1)(2008-9#1)
and 5-ASA##3##2##(2011-3#3)
and 5-Fluorouracil##2##2##(1997-7#1)(2008-6#1)
and 5-HT in##2##3##(1992-11#1)(1994-2#1)
and 5-HT transporter##2##3##(1994-2#2)
and 5-HT##7##2##(1990-5#1)(1992-11#1)(1994-2#4)(2008-7#1)
and 5-HT1 and##2##3##(1994-6#2)
and 5-HT1E sites##3##3##(1994-2#3)
and 5-HT1E##6##2##(1994-2#6)
and 5-HT2 receptor##2##3##(1994-2#1)(1994-6#1)
and 5-HT2 receptors##4##3##(1993-9#1)(1994-2#2)(1994-6#1)
and 5-HT2##7##2##(1993-9#1)(1994-2#3)(1994-6#3)
and 5-HTT315##3##2##(1996-12#3)
and 5-MTO##2##2##(1995-12#2)
and 5-fluorouracil (5FU)##2##3##(1992-2#1)(1995-4#1)
and 5-fluorouracil in##2##3##(1990-8#1)(1991-4#1)
and 5-fluorouracil##9##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-2#1)(1995-4#1)(1997-7#1)(2008-4#1)(2009-4#1)
and 5-hydroxyindoleacetic acid##2##3##(1992-1#1)(1997-7#1)
and 5-hydroxytryptamine##2##2##(1990-5#1)(2008-4#1)
and 5-min##2##2##(2008-2#1)(2008-9#1)
and 5-year survival##3##3##(1990-10#1)(2010-12#1)(2011-3#1)
and 5-year##7##2##(1990-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-3#1)
and 50 and##2##3##(1995-12#1)(2010-8#1)
and 50 degrees C##4##4##(1991-5#1)(1994-11#1)(2008-10#1)(2008-8#1)
and 50 degrees##5##3##(1991-5#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
and 50 mg##3##3##(2008-10#2)(2008-12#1)
and 50 mg/kg##6##3##(1996-2#1)(2008-10#3)(2008-9#1)(2010-1#1)
and 50 microM##6##3##(1990-12#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#1)(2010-6#1)
and 50 min##2##3##(2008-10#1)(2013-8#1)
and 50 ml L(-1))##2##4##(2008-12#2)
and 50 patients##2##3##(2011-2#2)
and 50 to##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
and 50 years##2##3##(2007-7#1)(2008-7#1)
and 50##73##2##(1990-12#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
and 50% of the##2##4##(1990-7#1)(2008-4#1)
and 50% of##6##3##(1990-7#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
and 50% were##2##3##(2008-11#1)(2013-1#1)
and 50%##32##2##(1990-12#1)(1990-7#1)(1992-3#1)(1992-5#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#5)
and 500 mg/kg##2##3##(2008-9#1)(2013-1#1)
and 500 mug l(-1)##2##4##(2008-10#2)
and 500 mug##3##3##(2008-10#3)
and 500 nm##3##3##(1997-7#1)(2008-10#2)
and 500##26##2##(1994-7#1)(1997-2#1)(1997-7#2)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#2)
and 5000##2##2##(2008-11#1)(2008-9#1)
and 50mugl(-1)##2##2##(2008-10#2)
and 51 years##2##3##(2008-12#1)(2013-1#1)
and 51##21##2##(1995-3#2)(1995-5#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-9#1)(2010-4#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
and 51% in##2##3##(2012-2#1)(2012-3#1)
and 51%##8##2##(1994-12#1)(2006-8#1)(2008-10#3)(2008-3#1)(2012-2#1)(2012-3#1)
and 512##2##2##(1996-2#1)(2008-10#1)
and 52 weeks##2##3##(1995-8#1)(2013-7#1)
and 52##29##2##(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
and 52% were##2##3##(2008-10#1)(2010-1#1)
and 52%##9##2##(1990-12#1)(1991-2#1)(1996-10#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
and 520 nm##4##3##(2008-10#4)
and 520##6##2##(2008-10#4)(2008-8#1)(2008-9#1)
and 53##19##2##(1990-12#1)(1992-11#1)(1993-2#1)(1995-10#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#4)(2013-1#1)(2013-8#1)
and 53% at##2##3##(2008-7#1)(2011-2#1)
and 53%##9##2##(1992-9#1)(1994-8#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#2)
and 535 nm##2##3##(2008-10#1)(2008-2#1)
and 54 years##3##3##(1992-10#1)(2008-11#1)(2012-12#1)
and 54##25##2##(1990-11#1)(1990-7#1)(1992-10#1)(1993-11#1)(1994-8#1)(1995-5#2)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
and 54%##2##2##(2008-1#1)(2012-12#1)
and 540##3##2##(1992-8#1)(2008-3#1)(2008-8#1)
and 55 degrees C##3##4##(1990-5#1)(2008-10#2)
and 55 degrees##4##3##(1990-5#1)(1993-3#1)(2008-10#2)
and 55##33##2##(1990-2#1)(1990-5#1)(1990-9#1)(1993-3#1)(1994-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-8#2)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#1)
and 55%##8##2##(1990-11#1)(1992-5#1)(1996-8#1)(1997-2#1)(2007-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
and 550 nm##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
and 550##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
and 555 nm##2##3##(2008-3#2)
and 56##21##2##(1990-12#2)(1991-8#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
and 56%##9##2##(1990-12#1)(1990-3#1)(1995-3#1)(2008-10#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#2)
and 560##2##2##(2008-2#1)(2008-4#1)
and 57##19##2##(1990-3#1)(1991-6#1)(1995-8#1)(1996-9#1)(1997-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#3)
and 57% of##2##3##(2006-8#1)(2010-3#1)
and 57%##9##2##(1992-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(2006-8#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
and 570##2##2##(2008-10#1)(2008-9#1)
and 575##2##2##(1997-4#1)(2011-1#1)
and 58 kDa##3##3##(1995-12#1)(1996-12#2)
and 58##16##2##(1992-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#2)(1997-6#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)
and 58% for##2##3##(2008-10#1)(2013-1#1)
and 58% of the##3##4##(1991-9#1)(1993-8#1)(2013-1#1)
and 58%##9##2##(1990-12#1)(1991-9#1)(1993-1#1)(1993-8#1)(2008-10#2)(2012-3#1)(2013-1#2)
and 59 years##2##3##(2008-12#1)(2008-5#1)
and 59##15##2##(1994-12#1)(1996-11#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#2)
and 59%##6##2##(1990-7#1)(1995-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)
and 59-61##2##2##(1994-5#1)(1995-6#1)
and 590##3##2##(1993-11#1)(2007-12#1)(2008-10#1)
and 5FU##2##2##(1992-2#1)(1995-4#1)
and 5HT2C##2##2##(2008-6#2)
and 5S##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
and 5th##4##2##(2007-7#1)(2008-12#2)(2008-7#1)
and 6 +/-##2##3##(2008-4#1)(2010-1#1)
and 6 and 12##2##4##(2008-8#1)(2008-9#1)
and 6 caused##2##3##(2008-10#2)
and 6 days##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
and 6 from##2##3##(2008-10#1)(2008-7#1)
and 6 h##3##3##(1995-5#1)(2008-10#2)
and 6 have##2##3##(2008-4#1)(2008-7#1)
and 6 hours##4##3##(2007-10#2)(2012-2#2)
and 6 in##2##3##(1995-6#1)(2008-10#1)
and 6 months after the##2##5##(2008-7#1)(2011-2#1)
and 6 months after##5##4##(2007-8#1)(2008-7#1)(2009-11#1)(2011-2#2)
and 6 months of age##2##5##(1995-5#1)(2008-3#1)
and 6 months##19##3##(1993-12#1)(1995-5#1)(1996-5#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#2)(2011-2#3)(2013-1#1)
and 6 ng##2##3##(2008-10#2)
and 6 of##3##3##(1993-11#1)(1993-6#1)(2008-10#1)
and 6 patients##3##3##(2007-10#1)(2008-7#1)(2010-2#1)
and 6 to 8##2##4##(2008-10#2)
and 6 weeks after##2##4##(2008-10#1)(2012-1#1)
and 6 weeks##9##3##(1994-3#1)(2007-11#2)(2008-10#2)(2011-2#2)(2012-1#1)(2012-2#1)
and 6 were##7##3##(2008-10#5)(2010-3#1)(2011-2#1)
and 6 with##3##3##(1991-3#1)(1994-12#1)(2011-2#1)
and 6 years##2##3##(2011-2#1)(2013-1#1)
and 6##254##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-5#3)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#3)(2007-11#7)(2007-3#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#81)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#4)(2009-11#2)(2009-4#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
and 6%##15##2##(1995-10#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2010-2#1)(2013-8#1)
and 6)##8##2##(1990-2#1)(1992-4#1)(2008-10#2)(2008-4#2)(2010-5#1)(2011-1#1)
and 6-12 months after##2##4##(2013-8#2)
and 6-12##3##2##(2008-10#1)(2013-8#2)
and 6-9 months following##2##4##(1995-2#2)
and 6-9##3##2##(1995-2#2)(2008-1#1)
and 6-ethoxy analogues##2##3##(1995-3#2)
and 6-methyl coumarin##2##3##(2008-11#2)
and 6-positions of the##2##4##(1991-5#1)(1994-12#1)
and 60 +/-##2##3##(2008-10#1)(2008-3#1)
and 60 days##4##3##(2007-10#2)(2008-5#1)(2013-8#1)
and 60 degrees C##2##4##(2008-10#1)(2008-5#1)
and 60 mg/kg##2##3##(1991-5#1)(1991-8#1)
and 60 min##9##3##(1990-12#1)(1991-3#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-7#1)(2008-9#2)
and 60 minutes##3##3##(1994-11#1)(1996-9#1)(2010-3#1)
and 60 months##2##3##(2012-12#1)(2013-1#1)
and 60##64##2##(1990-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-9#2)(1997-1#1)(1997-2#1)(2007-10#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
and 60% of the##2##4##(1990-12#1)(2013-8#1)
and 60% of them##2##4##(2011-2#2)
and 60% of##10##3##(1990-12#1)(1994-2#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#2)
and 60%##23##2##(1990-12#1)(1990-6#1)(1991-6#1)(1994-1#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#3)(2013-1#1)(2013-8#2)
and 60%fatigue##3##2##(2013-8#3)
and 600##9##2##(1991-6#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#1)(2012-2#1)
and 603##2##2##(2008-10#1)(2011-2#1)
and 61##15##2##(1991-12#1)(1991-9#1)(1992-5#1)(1993-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
and 61% of##3##3##(1990-8#1)(1992-9#1)(2011-2#1)
and 61%##5##2##(1990-8#1)(1992-9#1)(1997-4#1)(2008-10#1)(2011-2#1)
and 610##2##2##(2007-12#1)(2008-8#1)
and 62##10##2##(1990-5#1)(1990-9#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)
and 62% in##2##3##(2008-1#1)(2008-10#1)
and 62%##7##2##(1992-3#1)(1992-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2012-12#1)
and 625##2##2##(2008-10#1)(2013-1#1)
and 63##12##2##(1993-1#1)(1995-3#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#3)
and 63%##7##2##(1990-12#1)(1991-6#1)(1994-11#1)(2008-10#2)(2012-2#2)
and 633##2##2##(2006-8#1)(2008-3#1)
and 64 years##2##3##(1991-1#1)(2011-2#1)
and 64##19##2##(1990-10#1)(1990-2#1)(1991-1#2)(1993-2#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
and 64%##7##2##(1992-3#1)(1993-2#1)(1997-7#1)(2008-10#2)(2008-9#1)(2012-3#1)
and 65 years##6##3##(1993-9#1)(1997-4#1)(2008-5#1)(2009-11#1)(2010-3#2)
and 65##24##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1993-9#1)(1995-11#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-3#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 65%##11##2##(1990-7#1)(1993-11#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-11#1)(2013-8#2)
and 653##2##2##(1992-8#1)(2008-10#1)
and 66 kDa##2##3##(2008-11#1)(2008-5#1)
and 66##19##2##(1990-12#1)(1990-7#1)(1991-8#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-8#1)
and 66%##5##2##(1997-7#1)(2008-10#2)(2013-1#1)(2013-7#1)
and 67 were##2##3##(2008-12#2)
and 67##15##2##(1990-3#1)(1992-5#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
and 67% of##4##3##(1990-2#1)(2008-12#1)(2008-6#1)(2012-2#1)
and 67%##7##2##(1990-2#1)(1990-3#1)(1992-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-2#1)
and 675##2##2##(2008-10#1)(2008-2#1)
and 68##12##2##(1991-8#1)(1995-3#1)(1996-3#1)(1996-5#2)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#2)(2013-8#1)
and 68% had##2##3##(2008-6#1)(2013-1#1)
and 68%##10##2##(1990-10#1)(1993-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
and 680 nm##2##3##(1996-2#1)(2008-10#1)
and 680##3##2##(1996-2#1)(2008-10#2)
and 69##8##2##(1991-3#1)(1992-4#1)(1997-5#1)(2008-12#2)(2008-6#1)(2010-8#1)(2011-3#1)
and 69%##2##2##(1993-3#1)(2012-3#1)
and 6p##2##2##(2012-3#2)
and 6th##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2012-2#2)
and 7 d after##2##4##(2008-8#1)(2011-2#1)
and 7 days of##2##4##(1995-3#1)(2010-11#1)
and 7 days##12##3##(1990-2#1)(1990-5#1)(1995-3#1)(2007-10#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)
and 7 degrees C##2##4##(2008-5#1)(2012-2#1)
and 7 had##2##3##(1994-12#1)(2013-1#1)
and 7 in##2##3##(2008-10#2)
and 7 months##5##3##(1990-6#1)(1994-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
and 7 of the##3##4##(1994-5#1)(2008-10#1)(2009-11#1)
and 7 of##5##3##(1992-10#1)(1994-5#1)(2008-10#1)(2009-11#1)(2010-3#1)
and 7 were##5##3##(1991-6#1)(1997-2#2)(2008-10#1)(2013-8#1)
and 7 with chronic##2##4##(1994-12#1)(2011-2#1)
and 7 with##3##3##(1994-12#1)(2008-7#1)(2011-2#1)
and 7##198##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#2)(1992-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-3#2)(1997-7#4)(2006-10#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#68)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-2#3)(2013-1#10)(2013-8#3)
and 7% in the##2##4##(2007-8#2)
and 7% in##3##3##(2007-8#3)
and 7% of##3##3##(1991-8#1)(2008-10#1)(2009-5#1)
and 7%##14##2##(1990-2#1)(1991-8#1)(1992-1#1)(2007-8#3)(2008-10#5)(2008-12#1)(2009-5#1)(2013-1#1)
and 7)##5##2##(1995-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
and 7-hydroxymethylnalidixic acid##2##3##(2008-10#2)
and 70 days##2##3##(2008-5#1)(2010-8#1)
and 70 kDa##2##3##(1994-6#2)
and 70 years##2##3##(2007-10#1)(2008-1#1)
and 70##35##2##(1993-8#2)(1994-6#2)(1994-8#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-5#2)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)
and 70% identical##2##3##(1991-9#1)(1995-6#1)
and 70% of##3##3##(1994-5#1)(2012-2#1)(2013-8#1)
and 70%##19##2##(1991-9#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)(2009-5#1)(2012-2#3)(2013-8#1)
and 700 mg/L females were##2##5##(2008-9#2)
and 700 mg/L females##3##4##(2008-9#3)
and 700 mg/L##11##3##(2008-9#11)
and 700##17##2##(1994-8#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#11)
and 7000 infectious units/cell##2##4##(2008-11#2)
and 71##13##2##(1990-11#1)(1990-2#1)(1997-6#1)(2007-10#1)(2008-10#6)(2008-7#1)(2010-8#1)(2011-1#1)
and 71% of the##3##4##(2008-10#3)
and 71% of##4##3##(2008-10#3)(2008-9#1)
and 71%##8##2##(2008-10#3)(2008-12#2)(2008-9#2)(2013-1#1)
and 718##2##2##(2008-10#1)(2011-2#1)
and 72 h##5##3##(1995-11#1)(1996-12#1)(2008-10#2)(2008-12#1)
and 72##22##2##(1990-5#1)(1991-8#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
and 72% of##2##3##(2008-10#1)(2013-1#1)
and 72%##7##2##(1996-6#1)(1997-2#1)(2008-10#2)(2009-4#1)(2012-12#1)(2013-1#1)
and 723##3##2##(2008-3#2)(2013-8#1)
and 73##15##2##(1991-11#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#3)
and 73% of##2##3##(1991-4#1)(2008-10#1)
and 73%##11##2##(1991-4#1)(1993-8#1)(1994-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#1)
and 74 markers##3##3##(1996-12#3)
and 74##16##2##(1991-12#1)(1991-2#1)(1994-3#1)(1996-12#3)(1997-7#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)
and 74% of##2##3##(2008-6#1)(2010-3#1)
and 74%##9##2##(1992-9#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-6#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#1)
and 740 nm##2##3##(2008-10#2)
and 75 %##2##3##(2008-8#1)(2012-12#1)
and 75 degrees C##2##4##(2008-10#1)(2008-6#1)
and 75 kDa##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
and 75 ng##2##3##(2008-10#2)
and 75 patients##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
and 75 years##3##3##(1990-9#2)(1993-9#1)
and 75##34##2##(1990-8#1)(1990-9#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)
and 75% with##2##3##(2008-10#2)
and 75%##13##2##(1994-9#1)(2007-7#1)(2008-10#4)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
and 75-kDa##2##2##(1994-2#1)(2008-10#1)
and 750 ppm##3##3##(1996-12#2)(2008-10#1)
and 750##7##2##(1996-12#2)(2008-10#3)(2008-12#1)(2008-5#1)
and 76##7##2##(1992-5#1)(1992-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
and 76% for##2##3##(2008-10#1)(2011-2#1)
and 76%##8##2##(1995-3#1)(1996-9#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-6#1)(2011-2#1)
and 77##18##2##(1990-12#1)(1991-12#1)(1993-8#1)(1993-9#1)(1994-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-11#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)
and 77% of##3##3##(1992-1#1)(1992-9#1)(2008-10#1)
and 77%##9##2##(1991-6#1)(1992-1#1)(1992-10#1)(1992-9#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
and 770##4##2##(1990-11#1)(1992-12#1)(1992-9#1)(1997-6#1)
and 78##25##2##(1990-2#1)(1991-12#1)(1992-8#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(2007-7#2)(2008-10#2)(2008-6#1)(2009-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
and 78% with##3##3##(1990-9#1)(1992-6#1)(2010-7#1)
and 78%##8##2##(1990-12#1)(1990-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(2008-2#1)(2010-7#1)
and 79##17##2##(1991-12#1)(1991-4#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-9#1)(2009-4#1)(2009-9#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and 79%##3##2##(1995-11#1)(2008-1#1)(2013-8#1)
and 7D##3##2##(2008-5#3)
and 7DS##2##2##(2008-10#2)
and 7NSK2 induced##2##3##(2008-10#2)
and 7NSK2##3##2##(2008-10#3)
and 7th##3##2##(1992-5#1)(1992-6#1)(2009-7#1)
and 8 are##2##3##(1997-8#1)(2008-4#1)
and 8 days##3##3##(1997-3#1)(2008-7#1)(2008-9#1)
and 8 degrees C##2##4##(2008-10#2)
and 8 female)##2##3##(2008-12#1)(2011-2#1)
and 8 genes##2##3##(1997-8#1)(2007-12#1)
and 8 h##3##3##(1996-12#1)(1996-2#1)(2011-1#1)
and 8 had##2##3##(2008-7#1)(2012-2#1)
and 8 isolates##2##3##(2008-10#1)(2011-1#1)
and 8 mg l(-1)##2##4##(2008-10#2)
and 8 mg##4##3##(2008-10#2)(2008-12#2)
and 8 months##2##3##(1991-3#1)(2013-8#1)
and 8 mug ml(-1) of##2##5##(2008-10#2)
and 8 mug##3##3##(2008-10#3)
and 8 of the##2##4##(1993-8#1)(1995-3#1)
and 8 of##4##3##(1991-2#1)(1993-8#1)(1995-3#1)(2012-2#1)
and 8 patients##4##3##(1990-12#1)(1991-11#1)(1991-6#1)(2010-3#1)
and 8 pg##2##3##(2008-10#1)(2011-3#1)
and 8 week##2##3##(1994-8#1)(1997-6#1)
and 8 weeks##7##3##(1996-11#1)(2008-10#1)(2008-5#3)(2009-12#1)(2009-3#1)
and 8 were##5##3##(1992-8#1)(1995-11#1)(2008-6#2)(2010-1#1)
and 8 with##3##3##(1992-2#1)(1993-8#1)(2008-10#1)
and 8 x##2##3##(1992-5#1)(2008-11#1)
and 8 years##2##3##(1996-3#1)(2013-1#1)
and 8 × 10(-4) g/ml##2##5##(2013-1#2)
and 8##222##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#4)(2007-10#5)(2007-11#2)(2007-12#4)(2007-7#2)(2008-10#60)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#3)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#15)(2013-8#5)
and 8% in##2##3##(2008-8#1)(2011-2#1)
and 8% of all##2##4##(1994-5#1)(2008-10#1)
and 8% of the##2##4##(1990-5#1)(1993-12#1)
and 8% of##5##3##(1990-5#1)(1993-12#1)(1994-5#1)(1995-8#1)(2008-10#1)
and 8%##14##2##(1990-5#1)(1993-12#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)
and 8)##7##2##(1991-10#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-4#3)
and 8-hydroxyquinoline##2##2##(2008-10#2)
and 8-oxo-7##2##2##(2008-10#2)
and 8-positions##2##2##(1995-3#2)
and 80 g##2##3##(1993-3#1)(2008-7#1)
and 80 to##2##3##(2008-10#2)
and 80 years##4##3##(1990-5#1)(1991-1#1)(2008-4#1)(2008-7#1)
and 80##40##2##(1990-5#1)(1991-1#1)(1991-5#1)(1992-5#1)(1993-3#1)(1995-12#2)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#4)(2013-1#1)
and 80% of##6##3##(1990-5#1)(1991-9#1)(2008-10#1)(2008-11#1)(2011-2#2)
and 80% similarity##2##3##(1993-2#1)(1997-7#1)
and 80%##19##2##(1990-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1995-3#1)(1995-6#1)(1995-9#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#1)(2010-8#1)(2011-2#2)(2013-8#1)
and 80%)##2##2##(2008-10#1)(2013-8#1)
and 800 mg/L males and females at##2##7##(2008-9#2)
and 800 mg/L males and females##3##6##(2008-9#3)
and 800 mg/L males##4##4##(2008-9#4)
and 800 mg/L##8##3##(2008-9#8)
and 800 mg/kg##2##3##(2008-9#2)
and 800 nm##4##3##(2007-12#1)(2008-10#3)
and 800##18##2##(2007-12#1)(2008-10#5)(2008-11#1)(2008-9#10)(2012-2#1)
and 803##2##2##(1993-3#1)(2008-10#1)
and 81##18##2##(1990-12#2)(1997-4#1)(1997-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#2)(2011-2#1)(2012-2#2)(2013-1#2)
and 81%##8##2##(1991-9#1)(1995-3#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-3#1)
and 818##3##2##(1993-3#1)(1997-6#1)(2008-3#1)
and 82##13##2##(1991-6#1)(1993-3#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
and 82% of##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
and 82%##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
and 83##10##2##(1990-11#1)(1991-11#1)(1994-2#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
and 83%##8##2##(1991-6#1)(1992-6#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
and 830 nm)##2##3##(2008-3#1)(2011-1#1)
and 84##10##2##(1991-5#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-10#1)(2011-2#1)(2012-12#1)
and 84% of##4##3##(1991-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
and 84%##8##2##(1990-12#1)(1991-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and 85 mum##2##3##(2008-10#2)
and 85 years##3##3##(1990-5#1)(2008-7#2)
and 85##20##2##(1990-2#1)(1990-5#2)(1991-2#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#1)
and 85% of##4##3##(1990-7#1)(2008-10#3)
and 85%##16##2##(1990-7#1)(1991-8#1)(1992-6#1)(2007-11#1)(2008-10#8)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
and 850 nm##2##3##(2007-11#1)(2007-12#1)
and 850##4##2##(1996-6#1)(2007-11#1)(2007-12#1)(2008-12#1)
and 854##2##2##(1990-12#1)(2013-1#1)
and 859##3##2##(2008-2#2)(2008-3#1)
and 86##10##2##(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-7#1)(2010-8#1)(2013-1#1)
and 86%##6##2##(1994-9#1)(1997-4#1)(2008-3#2)(2008-6#1)(2013-1#1)
and 865##4##2##(2008-2#2)(2008-3#1)(2012-12#1)
and 87 were##2##3##(1994-3#1)(2008-1#1)
and 87##11##2##(1990-12#1)(1994-3#1)(1996-1#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)
and 87% in##2##3##(2007-8#1)(2011-2#1)
and 87% of##3##3##(1994-2#1)(1997-3#1)(2013-8#1)
and 87%##9##2##(1994-11#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
and 88##9##2##(1990-7#1)(1996-12#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#1)
and 88% of the##2##4##(1997-3#1)(2007-8#1)
and 88% of##5##3##(1993-11#1)(1997-3#1)(2007-8#1)(2009-11#1)(2010-7#1)
and 88% respectively##2##3##(1994-2#1)(2008-7#1)
and 88%##10##2##(1993-11#1)(1993-2#1)(1994-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#1)
and 89##14##2##(1990-9#1)(1991-8#1)(1991-9#1)(1992-11#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
and 89% of##2##3##(2008-10#1)(2008-8#1)
and 89%##7##2##(1991-4#1)(1995-12#1)(2008-10#3)(2008-7#1)(2008-8#1)
and 8b in CH(2)Cl(2) at -78 degrees C followed by##2##10##(1996-5#2)
and 8b in##3##3##(1996-5#3)
and 9 kDa##2##3##(1992-12#1)(2008-10#1)
and 9 months of age##3##5##(1990-3#2)(1992-2#1)
and 9 months of##4##4##(1990-3#2)(1992-2#1)(2012-3#1)
and 9 months##6##3##(1990-3#2)(1992-2#2)(1997-7#1)(2012-3#1)
and 9 of##2##3##(2007-7#1)(2011-1#1)
and 9 patients had##2##4##(1995-12#1)(2010-3#1)
and 9 patients##3##3##(1992-8#1)(1995-12#1)(2010-3#1)
and 9 weeks##3##3##(1996-5#1)(2008-11#1)(2008-9#1)
and 9 x##2##3##(2008-3#2)
and 9##126##2##(1990-3#4)(1990-6#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-9#1)(1996-12#4)(1996-5#3)(1996-7#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#27)(2008-11#3)(2008-12#4)(2008-3#5)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
and 9%##5##2##(1995-12#1)(2007-7#1)(2008-10#2)(2008-12#1)
and 9)##3##2##(2008-10#2)(2008-11#1)
and 90 degrees C##2##4##(2008-10#1)(2008-12#1)
and 90 degrees##4##3##(2008-10#1)(2008-12#1)(2008-2#2)
and 90 to##2##3##(2008-10#2)
and 90 years##2##3##(2008-5#1)(2011-1#1)
and 90##29##2##(1991-12#1)(1992-3#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and 90% of##2##3##(2008-10#1)(2012-2#1)
and 90% relative humidity##2##4##(2008-10#1)(2008-3#1)
and 90%##15##2##(1991-12#2)(1991-6#1)(1992-11#1)(1994-2#1)(2008-10#4)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
and 900##3##2##(1994-6#1)(2008-10#2)
and 91##6##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
and 91%##3##2##(1994-8#1)(1994-9#1)(2010-8#1)
and 92##14##2##(1990-7#1)(1992-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
and 92%##6##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)
and 93 +/-##2##3##(1995-12#1)(1997-1#1)
and 93 K##2##3##(1996-2#2)
and 93##14##2##(1991-4#1)(1994-12#1)(1995-12#1)(1996-2#2)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-3#2)
and 93% in##2##3##(1996-9#1)(2008-10#1)
and 93% of##2##3##(1993-11#1)(2008-10#1)
and 93%##10##2##(1993-11#1)(1995-2#1)(1996-9#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
and 94##9##2##(1995-12#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#1)(2013-8#1)
and 94% of##3##3##(2008-1#1)(2008-6#1)(2013-1#1)
and 94%##8##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
and 945##4##2##(1995-6#1)(2008-11#3)
and 95 kDa##2##3##(1993-6#1)(1996-12#1)
and 95##22##2##(1990-2#1)(1990-8#1)(1992-3#1)(1993-6#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2011-2#4)(2013-1#2)(2013-8#2)
and 95% and##2##3##(2008-10#1)(2013-8#1)
and 95% confidence interval##2##4##(1993-9#1)(2013-8#1)
and 95% confidence intervals##3##4##(2010-3#1)(2011-2#2)
and 95% confidence##6##3##(1993-9#1)(2008-10#1)(2010-3#1)(2011-2#2)(2013-8#1)
and 95% of the##2##4##(2008-10#1)(2011-1#1)
and 95% of##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
and 95%##24##2##(1990-3#1)(1993-9#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-8#3)
and 96 h of exposure##2##5##(2008-12#1)(2008-7#1)
and 96 h of##3##4##(1992-8#1)(2008-12#1)(2008-7#1)
and 96 h##6##3##(1992-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)
and 96##24##2##(1991-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1996-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
and 96% for##2##3##(2008-3#1)(2008-7#1)
and 96% of the patients##2##5##(1992-11#1)(2011-2#1)
and 96% of the##4##4##(1992-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
and 96% of##6##3##(1992-11#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
and 96%##14##2##(1992-11#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#2)(2013-1#1)
and 97##16##2##(1992-2#1)(1992-3#1)(1996-10#1)(1996-11#1)(2008-10#7)(2008-7#1)(2008-9#1)(2011-1#2)(2013-1#1)
and 97%##7##2##(1990-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2012-2#1)
and 974##2##2##(1994-11#1)(2008-3#1)
and 98##33##2##(1992-5#1)(1993-8#1)(2008-10#12)(2008-11#1)(2008-5#5)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#2)
and 98%##7##2##(1993-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)
and 980 nm##2##3##(2007-12#1)(2008-2#1)
and 99##32##2##(1993-3#1)(1993-6#1)(2008-10#15)(2008-12#3)(2008-5#6)(2010-3#1)(2010-8#1)(2011-1#3)(2013-1#1)
and 99% of##3##3##(1995-3#1)(1997-7#1)(2008-10#1)
and 99%##10##2##(1995-3#1)(1997-7#1)(2008-10#6)(2011-1#1)(2013-1#1)
and A and##2##3##(1995-6#1)(2008-6#1)
and A beta##6##3##(1994-11#1)(1995-12#3)(1996-5#2)
and A##73##2##(1992-3#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-6#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-10#24)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#1)(2009-8#3)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-8#7)
and A(2B)##2##2##(2008-4#2)
and A+T-rich DNA analyses##3##4##(2008-10#3)
and A/J mice##4##3##(1991-8#2)(2012-1#2)
and A/J##5##2##(1991-8#2)(2012-1#3)
and A1##2##2##(1991-6#1)(2008-9#1)
and A2 mating##2##3##(2008-10#2)
and A2##14##2##(1992-9#2)(1993-6#1)(1996-5#1)(2008-10#8)(2008-9#1)(2009-3#1)
and A3##6##2##(1992-3#2)(1995-3#1)(2008-10#1)(2008-12#2)
and AA##4##2##(1991-8#1)(1997-2#2)(2010-9#1)
and AA560##4##2##(1990-11#4)
and AAC were##2##3##(2008-10#2)
and AAC##3##2##(2008-10#3)
and AAL-TB##2##2##(2008-10#2)
and AAS##3##2##(2008-10#3)
and AB##3##2##(1992-8#1)(2008-10#2)
and AC##6##2##(2008-10#3)(2008-5#1)(2009-7#1)(2011-1#1)
and ACBP##4##2##(1994-8#4)
and ACC##5##2##(2008-10#2)(2010-7#1)(2011-10#1)(2011-2#1)
and ACD blood##6##3##(2011-2#6)
and ACE##2##2##(2008-4#1)(2008-9#1)
and ACN##4##2##(1994-9#3)(2008-10#1)
and ACT-toxin##2##2##(2008-10#2)
and ACTH##2##2##(1993-5#1)(1995-2#1)
and ACTH-(4-10)##2##2##(1993-5#2)
and AD##8##2##(1995-12#1)(2008-10#1)(2008-7#2)(2011-1#2)(2011-2#2)
and ADH##4##2##(1997-8#4)
and ADH1C##2##2##(2012-2#2)
and ADHD##4##2##(2008-2#1)(2009-8#1)(2013-8#2)
and ADP##14##2##(1991-9#6)(1993-12#1)(1994-6#1)(1995-11#1)(2006-6#1)(2007-10#1)(2008-4#2)(2008-7#1)
and ADP/O ratios##2##3##(1994-8#2)
and ADP/O##3##2##(1994-8#3)
and AF-toxins##2##2##(2008-10#2)
and AFLP Analyses##2##3##(2008-10#2)
and AFLP analyses##3##3##(2008-10#3)
and AFLP##12##2##(2008-10#11)(2008-5#1)
and AFS detection##3##3##(2008-10#3)
and AFS##5##2##(2008-10#5)
and AG-6 GV##2##3##(2008-10#2)
and AG-6##3##2##(2008-10#3)
and AG-8##3##2##(2008-10#2)(2008-12#1)
and AG-MIN##3##2##(2008-10#3)
and AH##2##2##(1995-1#1)(2009-7#1)
and AIDS awareness##2##3##(1994-3#1)(2009-7#1)
and AIDS##19##2##(1990-6#1)(1992-12#1)(1994-3#2)(1995-1#1)(1995-12#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-3#1)
and AII##6##2##(1994-9#1)(2008-10#5)
and ALP##8##2##(1994-5#1)(2007-12#1)(2008-11#3)(2011-1#1)(2012-3#1)(2013-1#1)
and ALT##3##2##(1996-12#1)(2008-10#1)(2013-8#1)
and AM1##2##2##(2008-10#1)(2008-11#1)
and AMBER##2##2##(1996-5#2)
and AML##4##2##(2006-6#1)(2007-2#1)(2010-1#1)(2011-2#1)
and AMP##11##2##(1990-8#1)(1997-7#2)(2008-10#2)(2008-4#2)(2008-8#3)(2013-1#1)
and AMPA receptor##2##3##(2008-7#1)(2009-8#1)
and AMPA##10##2##(1995-5#1)(2008-7#2)(2009-8#1)(2011-1#6)
and ANF##2##2##(1990-12#2)
and ANGII##2##2##(1992-8#2)
and ANN##5##2##(2008-10#5)
and ANOVA##4##2##(1991-2#1)(1992-6#1)(2012-12#1)(2012-2#1)
and ANS##2##2##(1993-11#1)(2013-8#1)
and ANTA##4##2##(2008-11#4)
and AO##2##2##(2008-10#2)
and AP##3##2##(1995-2#2)(1997-3#1)
and AP-PPG##2##2##(2008-4#2)
and APACHE##2##2##(2009-5#1)(2010-10#1)
and API##3##2##(2008-10#2)(2008-6#1)
and APLP2 mRNA in##4##4##(1996-12#4)
and APLP2 mRNA##8##3##(1996-12#8)
and APLP2##9##2##(1996-12#9)
and AR##3##2##(1991-9#1)(2012-12#2)
and ARF##2##2##(2008-1#1)(2009-8#1)
and ARG2(-/-) mice##2##3##(2013-8#2)
and ARMD##2##2##(2011-1#2)
and AS##2##2##(1994-6#1)(2007-11#1)
and ASL##2##2##(2011-1#1)(2011-2#1)
and AT-rich##2##2##(2008-12#1)(2008-8#1)
and ATCC##2##2##(2008-12#1)(2008-6#1)
and ATP release##3##3##(1991-12#1)(1994-5#1)(2007-10#1)
and ATP##26##2##(1990-7#1)(1990-8#2)(1991-12#2)(1991-5#2)(1992-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#2)
and ATP-binding##2##2##(1990-8#1)(1993-11#1)
and ATP7B##3##2##(2012-2#3)
and AUC##2##2##(1994-12#1)(2008-11#1)
and AUDPC(S)##2##2##(2008-10#2)
and AVP##2##2##(1993-12#1)(2008-8#1)
and AVT-R##3##2##(2008-7#3)
and Abl##4##2##(2011-2#3)(2012-12#1)
and Achilles##2##2##(1995-8#1)(2008-9#1)
and Acinetobacter##4##2##(2010-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
and Ackers##3##2##(1990-8#1)(1997-2#2)
and Activation of##2##3##(2012-3#1)(2013-8#1)
and Activation##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
and Active##3##2##(2008-10#1)(2009-10#1)(2012-1#1)
and Activity of##2##3##(2008-10#1)(2013-1#1)
and Activity##5##2##(2008-10#1)(2012-2#1)(2013-1#3)
and Acute##5##2##(2007-2#1)(2008-8#4)
and Administration##2##2##(1991-12#1)(1992-1#1)
and Ado##2##2##(1990-8#2)
and Adolescent##9##2##(2006-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-1#2)(2010-3#1)
and Advance##2##2##(2008-8#2)
and Adverse##3##2##(2010-8#1)(2011-2#1)(2013-7#1)
and Aelia##2##2##(2013-8#2)
and Afghanistan##3##2##(2012-2#1)(2013-1#2)
and Aflatoxin Production##2##3##(2008-10#1)(2013-1#1)
and Aflatoxin##3##2##(2008-10#2)(2013-1#1)
and Africa##5##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
and African American men in##2##5##(2009-5#2)
and African American##6##3##(2008-12#1)(2008-5#1)(2009-5#2)(2012-2#1)(2012-3#1)
and African Americans##4##3##(2008-1#1)(2008-12#1)(2010-4#1)(2012-2#1)
and African##13##2##(2008-1#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#2)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#1)
and Ag##2##2##(2008-10#1)(2010-11#1)
and Ag(+)##3##2##(2008-10#2)(2010-11#1)
and Ag(2)S##2##2##(2008-10#1)(2008-3#1)
and Ag(I)##4##2##(2008-10#4)
and Aggregation##2##2##(2008-10#2)
and Aggressiveness of##2##3##(2008-10#2)
and Agricultural##2##2##(2008-10#1)(2010-4#1)
and Airborne##4##2##(2008-2#1)(2008-3#3)
and Akt##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
and Al in##2##3##(2008-10#2)
and Al were##2##3##(2008-10#2)
and Al##18##2##(2007-12#1)(2008-10#14)(2008-2#1)(2008-3#2)
and Al(3+)##4##2##(2008-10#4)
and Al(III)##6##2##(2008-10#6)
and Alcohol##2##2##(2008-6#1)(2013-8#1)
and Alizarin Red S##2##4##(2008-10#2)
and Allied Health##3##3##(2011-1#1)(2013-1#2)
and Allied Sciences##2##3##(1996-4#2)
and Allied##6##2##(1996-4#2)(2008-7#1)(2011-1#1)(2013-1#2)
and Alternaria alternata##2##3##(2008-10#2)
and Alternaria spp##2##3##(2013-1#2)
and Alternaria##7##2##(2008-10#5)(2013-1#2)
and Alumina##2##2##(2009-8#2)
and Alzheimer##2##2##(1997-2#1)(2008-7#1)
and Alzheimer's disease (AD)##6##4##(2008-7#3)(2009-10#1)(2009-12#1)(2011-1#1)
and Alzheimer's disease##14##3##(1992-12#1)(1995-6#1)(1996-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)
and Alzheimer's disease]##2##3##(1997-5#1)(2013-8#1)
and Alzheimer's##17##2##(1992-12#1)(1995-6#1)(1996-12#1)(1997-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#2)(2013-8#1)
and Amberlite XAD-7##2##3##(2008-10#2)
and Amberlite##4##2##(1992-12#1)(2008-10#3)
and American##18##2##(1991-1#1)(1991-2#1)(1992-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and Amerindians##2##2##(2008-12#1)(2012-3#1)
and Ammonium##2##2##(2008-10#1)(2008-11#1)
and Among##3##2##(2008-10#3)
and An##7##2##(2007-12#1)(2008-11#1)(2008-8#3)(2012-12#2)
and Analysis of##2##3##(2007-12#1)(2008-10#1)
and Analysis##4##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-4#1)
and Analytical##2##2##(2009-9#1)(2010-11#1)
and Andean isolates from##3##4##(2008-10#3)
and Anderson##2##2##(1993-6#1)(2013-8#1)
and Ang II##2##3##(2008-1#2)
and Angiogenesis##2##2##(2008-11#1)(2010-1#1)
and Anglo##4##2##(2008-9#2)(2011-2#1)(2012-2#1)
and Animal##2##2##(2008-7#1)(2013-1#1)
and Anxiety##3##2##(1994-6#1)(2010-8#1)(2013-8#1)
and Aph3##3##2##(2008-10#3)
and Apoptotic##2##2##(2008-11#1)(2011-2#1)
and Apple##4##2##(2008-10#4)
and Application of##2##3##(2008-10#1)(2008-11#1)
and Application to##2##3##(2008-5#1)(2009-5#1)
and Application##7##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2012-2#1)
and Appropriateness Criteria##2##3##(2007-4#2)
and April 2006##2##3##(2008-10#1)(2013-8#1)
and April##15##2##(1992-1#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
and Ar##4##2##(2007-12#2)(2008-3#2)
and Arab##2##2##(2012-12#2)
and Arabidopsis thaliana##4##3##(1991-6#2)(2008-1#1)(2009-8#1)
and Arabidopsis##12##2##(1991-6#2)(2008-1#1)(2008-10#4)(2009-10#4)(2009-8#1)
and Arctic##2##2##(1990-12#1)(2013-1#1)
and Arg##9##2##(1992-4#2)(1995-5#1)(2008-11#1)(2008-8#1)(2012-12#4)
and Arizona##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
and Arp3##3##2##(2012-2#3)
and Arthus and delayed##2##4##(2008-7#2)
and Artificial Neural Networks##2##4##(2008-10#2)
and Aryl##2##2##(1996-5#1)(2010-8#1)
and As##4##2##(2008-10#4)
and As(III)##2##2##(2008-10#2)
and As(III+V)##2##2##(2008-10#2)
and As(V) in##10##3##(2008-10#10)
and As(V) were##4##3##(2008-10#4)
and As(V)##29##2##(2008-10#28)(2010-5#1)
and Asia##6##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
and Asian##4##2##(1993-2#1)(1996-3#1)(2008-12#1)(2008-5#1)
and Asians##2##2##(2008-1#1)(2008-12#1)
and Asn##2##2##(1992-4#1)(1992-6#1)
and Asp##3##2##(1991-5#1)(1994-12#1)(2008-11#1)
and Asperger's disorder##2##3##(2007-8#2)
and Aspergillus ear rots and##2##5##(2008-10#2)
and Aspergillus ear rots##3##4##(2008-10#3)
and Aspergillus ear##6##3##(2008-10#6)
and Aspergillus flavus##2##3##(2008-10#1)(2008-12#1)
and Aspergillus##19##2##(1990-12#1)(1992-11#1)(1994-3#1)(2008-10#7)(2008-12#1)(2008-5#4)(2008-6#1)(2009-6#1)(2012-3#2)
and Assessment##5##2##(1997-2#1)(2008-11#1)(2009-9#1)(2010-7#1)(2013-1#1)
and Association##2##2##(1991-1#1)(2008-10#1)
and Atlantic##4##2##(1993-1#1)(2007-5#1)(2010-3#1)(2010-8#1)
and Attention##2##2##(2008-9#1)(2010-8#1)
and Au##3##2##(2008-10#1)(2008-3#2)
and Auditory Brainstem Responses##2##4##(2008-2#2)
and Auger electron##2##3##(2008-2#1)(2009-11#1)
and August##14##2##(1991-12#1)(1994-12#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#2)
and August)##4##2##(2008-10#2)(2011-2#2)
and Australia have##2##3##(1992-5#1)(2008-9#1)
and Australia##21##2##(1992-1#1)(1992-5#1)(1993-2#1)(1995-6#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-9#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#1)
and Australia)##2##2##(2008-10#1)(2010-2#1)
and Australian##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
and AvrPiz-t##3##2##(2008-10#3)
and AvrTU##2##2##(2008-10#2)
and B =##2##3##(1997-7#1)(2008-10#1)
and B cell##3##3##(1995-5#1)(2007-10#1)(2008-4#1)
and B cells##5##3##(1993-6#1)(1997-8#1)(2007-5#1)(2008-4#1)(2013-1#1)
and B from##2##3##(1994-12#1)(2008-10#1)
and B in##4##3##(1994-9#1)(2008-10#3)
and B lymphocytes##2##3##(1990-9#1)(2013-8#1)
and B viruses##2##3##(1996-6#1)(2011-2#1)
and B were##12##3##(1994-9#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
and B##190##2##(1990-11#1)(1990-12#3)(1990-5#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#2)(1994-12#2)(1994-5#2)(1994-9#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-2#9)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#4)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#61)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#10)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#3)(2010-3#1)(2010-6#2)(2011-2#9)(2012-12#1)(2012-8#1)(2013-1#5)(2013-7#3)(2013-8#4)
and B(12)##5##2##(2008-10#5)
and B(2)##2##2##(2008-10#2)
and B)##7##2##(1994-12#1)(1994-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(2012-12#1)(2013-7#1)
and B-cell##5##2##(1991-4#1)(1992-12#1)(1995-6#1)(2008-8#1)(2010-5#1)
and B-cells##3##2##(2007-10#1)(2008-10#2)
and B-responding cells were##2##4##(1994-9#2)
and B-responding cells##3##3##(1994-9#3)
and B10##2##2##(1991-1#1)(2008-12#1)
and B104##2##2##(1993-8#1)(2008-10#1)
and B2##8##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#5)
and B3)##2##2##(2008-11#1)(2008-5#1)
and B4##3##2##(1991-5#1)(1995-3#2)
and B4)##2##2##(2008-12#2)
and B6##3##2##(1992-9#1)(2008-8#1)(2011-2#1)
and B6C3F 1##2##3##(2008-9#2)
and B7##2##2##(1997-9#1)(2007-5#1)
and B73##2##2##(2008-10#2)
and BAL##2##2##(1996-9#1)(2008-10#1)
and BALB/c mice##4##3##(1993-5#3)(1996-12#1)
and BALB/c##5##2##(1993-2#1)(1993-5#3)(1996-12#1)
and BALB/cByJ (mean##3##3##(2008-5#3)
and BAP##2##2##(2008-12#1)(2013-1#1)
and BAPP##2##2##(2008-2#2)
and BBB##2##2##(2007-11#1)(2012-2#1)
and BC##3##2##(2008-10#2)(2013-1#1)
and BC(1)F(1) populations derived from##2##5##(2008-10#2)
and BC(1)F(1) populations##3##3##(2008-10#3)
and BCP(1)-selfed generations were##2##4##(2008-10#2)
and BCP(2)##3##2##(2008-10#3)
and BDNF##5##2##(1994-8#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-5#1)
and BER##3##2##(2008-10#3)
and BHK cells##3##3##(1992-5#1)(2008-11#2)
and BHK##4##2##(1992-5#1)(2008-11#3)
and BHK21##2##2##(2008-11#2)
and BHT##7##2##(1996-2#1)(2008-10#2)(2008-5#4)
and BI##2##2##(2008-10#1)(2012-3#1)
and BMC measurements##2##3##(2011-2#2)
and BMI##10##2##(2008-11#1)(2008-7#1)(2009-9#2)(2011-1#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
and BMP##2##2##(2011-2#1)(2012-12#1)
and BOX-PCR##2##2##(2008-10#2)
and BP##4##2##(1997-5#1)(2008-10#2)(2008-5#1)
and BRL 24924##4##3##(1990-5#4)
and BS##2##2##(2008-10#2)
and BSA##8##2##(2008-10#6)(2008-7#1)(2011-2#1)
and BT##3##2##(2007-7#1)(2008-10#2)
and BUN##2##2##(1990-12#1)(1994-5#1)
and BV1##2##2##(2008-10#2)
and BXSB-Yaa##3##2##(1994-8#1)(1996-5#2)
and BYMV-CFP##2##2##(2008-10#2)
and Ba(2+)##2##2##(2008-10#2)
and Ba)##2##2##(2008-10#2)
and Bacillus licheniformis##2##3##(2008-10#1)(2011-2#1)
and Bacillus subtilis##5##3##(1997-2#1)(2008-10#3)(2011-1#1)
and Bacillus##14##2##(1997-2#1)(2007-11#1)(2008-10#8)(2011-1#2)(2011-2#2)
and Bacteroides forsythus##3##3##(2008-12#3)
and Bacteroides##4##2##(2007-7#1)(2008-12#3)
and Bactrocera carambolae##2##3##(2011-2#2)
and Bactrocera##4##2##(2011-2#4)
and BamHI##2##2##(2008-5#1)(2009-3#1)
and Basic##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)
and Bax##7##2##(2008-5#2)(2008-9#2)(2010-8#1)(2013-1#1)(2013-7#1)
and Bayer##2##2##(1996-5#1)(2008-3#1)
and Bayesian approaches##2##3##(1994-9#1)(2010-6#1)
and Bayesian methods##4##3##(2007-12#1)(2008-10#2)(2010-4#1)
and Bayesian statistics##2##3##(1993-12#1)(2008-10#1)
and Bayesian##14##2##(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#6)(2008-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)
and Bean##4##2##(2008-10#4)
and Beauregard##2##2##(1992-3#2)
and Beauveria bassiana (Bals##2##4##(2008-6#2)
and Beer's law is obeyed in the range##2##8##(2008-10#2)
and Beer's law is obeyed##3##5##(2008-10#3)
and Beer's law##4##3##(2008-10#4)
and Behavior##2##2##(1990-11#1)(2012-12#1)
and Behavioral##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
and Bi in##5##3##(2008-10#5)
and Bi##11##2##(2008-10#11)
and Bifidobacterium##3##2##(2008-5#1)(2013-1#2)
and Bim##3##2##(2013-1#3)
and Biocontrol Efficacy of##2##4##(2008-10#2)
and Biocontrol##4##2##(2008-10#4)
and Biological Characterization of##5##4##(2008-10#5)
and Biological Significance##2##3##(2010-8#1)(2012-12#1)
and Biological##13##2##(1994-12#1)(2008-10#8)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)
and Biostatistics##2##2##(2010-5#1)(2013-8#1)
and Birth##2##2##(2009-11#1)(2013-1#1)
and BisEMA##2##2##(2013-1#2)
and BisGMA##4##2##(2013-1#4)
and Blk##2##2##(1995-6#2)
and Blood Institute##6##3##(1992-12#1)(2008-3#2)(2009-12#1)(2011-2#1)(2013-1#1)
and Blood##8##2##(1992-12#1)(1997-5#1)(2008-3#2)(2009-12#2)(2011-2#1)(2013-1#1)
and BmNPV##3##2##(1997-3#1)(1997-4#1)(2008-11#1)
and Body Composition in##2##4##(2012-2#1)(2012-3#1)
and Body##5##2##(2007-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
and Bone##3##2##(2007-8#1)(2008-6#1)(2011-2#1)
and Botrytis cinerea##7##3##(2008-10#6)(2009-6#1)
and Botrytis##8##2##(2008-10#7)(2009-6#1)
and Bovine Parainfluenza type 3 virus##2##6##(2008-11#2)
and Bovine##3##2##(1992-2#1)(2008-11#2)
and Bowel##2##2##(1995-11#1)(2008-9#1)
and Box-Behnken##2##2##(2008-10#2)
and Bragg diffraction##2##3##(2007-12#1)(2008-3#1)
and Bragg grating##2##3##(2007-11#1)(2008-2#1)
and Bragg##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
and Brassica##4##2##(2008-10#2)(2011-1#1)(2011-10#1)
and Brazil##10##2##(1993-3#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-3#1)(2013-8#1)
and BrdU##2##2##(2007-12#1)(2008-9#1)
and Britain##3##2##(1990-6#1)(2008-10#1)(2008-8#1)
and British Columbia##3##3##(2008-10#2)(2010-8#1)
and British##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
and Brome mosaic virus##2##4##(2008-10#2)
and Brown##2##2##(1991-3#1)(2013-1#1)
and Brugada syndrome##2##3##(2011-2#2)
and Buffalo##3##2##(1993-12#2)(2008-10#1)
and Burkholderia##3##2##(2008-10#2)(2008-7#1)
and Burkitt lymphomas##2##3##(2009-8#2)
and C =##2##3##(1990-2#1)(1992-6#1)
and C and##2##3##(1997-7#1)(2008-7#1)
and C are##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
and C in##3##3##(1992-12#1)(2007-12#1)(2010-4#1)
and C were administered##2##4##(1997-6#1)(2013-1#1)
and C were##3##3##(1997-6#1)(2008-1#1)(2013-1#1)
and C##161##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#8)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#2)(2006-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#45)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#3)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#4)(2012-6#1)(2013-1#7)(2013-7#3)(2013-8#2)
and C(18)##5##2##(2008-10#5)
and C)##5##2##(1995-6#1)(2008-10#2)(2008-4#2)
and C-banding##7##2##(2008-12#3)(2008-4#1)(2008-5#3)
and C-peptide levels##2##3##(2007-12#1)(2010-4#1)
and C-peptide##3##2##(1994-12#1)(2007-12#1)(2010-4#1)
and C-reactive protein (CRP)##3##4##(1994-12#1)(2012-2#1)(2013-8#1)
and C-reactive protein##7##3##(1994-12#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and C-terminal domains##3##3##(1992-9#1)(1995-2#1)(1997-2#1)
and C-terminal fragments##2##3##(1990-12#1)(1992-12#1)
and C-terminal regions##2##3##(1991-10#1)(2013-1#1)
and C-terminal segments##2##3##(1992-6#1)(2008-6#1)
and C-terminal##19##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-2#1)(1997-8#1)(2008-4#1)(2008-6#1)(2009-7#1)(2013-1#1)
and C-type lectin##2##3##(2010-4#2)
and C-type##3##2##(2010-4#3)
and C/EBPbeta mRNA abundance##2##4##(2010-4#2)
and C/EBPbeta##3##2##(2010-4#3)
and C1##4##2##(2008-10#2)(2013-1#2)
and C11##2##2##(1990-7#1)(1994-5#1)
and C18##4##2##(1990-8#1)(1992-8#1)(2008-10#2)
and C2##6##2##(2008-10#2)(2008-12#1)(2008-4#1)(2012-3#1)(2013-1#1)
and C3 and C4 averaged##2##5##(2008-10#2)
and C3 was##2##3##(1993-6#1)(2013-1#1)
and C3##7##2##(1993-6#1)(2008-10#2)(2008-7#1)(2013-1#3)
and C4##5##2##(2007-2#1)(2008-10#3)(2008-9#1)
and C57##2##2##(1995-12#1)(2013-8#1)
and C57BL/6 mice##4##3##(1997-8#1)(2008-12#1)(2013-1#2)
and C57BL/6J##2##2##(1991-12#1)(2011-2#1)
and C6##4##2##(1992-6#2)(1993-6#1)(2013-1#1)
and C6-ceramide##2##2##(1995-12#1)(2011-2#1)
and C7##4##2##(2008-7#1)(2008-9#1)(2010-9#2)
and C77##4##2##(2008-10#4)
and C9##2##2##(1993-11#1)(1994-2#1)
and CA##7##2##(1994-12#2)(1995-3#3)(2008-10#2)
and CA1##4##2##(1994-8#1)(1995-12#1)(1996-12#2)
and CA125 levels##2##3##(1992-9#2)
and CA3 pyramidal##2##3##(1990-5#1)(2008-11#1)
and CA3##6##2##(1990-5#1)(1996-12#2)(2008-11#1)(2008-12#2)
and CAD##2##2##(2009-10#1)(2011-2#1)
and CAF##2##2##(1994-7#1)(1995-4#1)
and CAT activities##2##3##(1994-6#1)(2013-1#1)
and CAT##10##2##(1992-12#1)(1992-3#3)(1994-6#2)(1995-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
and CBF##2##2##(2008-7#2)
and CBG##2##2##(1990-2#2)
and CBS##2##2##(2008-10#1)(2013-8#1)
and CCD##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
and CCK##2##2##(1991-5#1)(1993-12#1)
and CCK-8##3##2##(1994-2#1)(1995-12#1)(2008-7#1)
and CD##8##2##(1992-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-8#1)
and CD11b##3##2##(1991-2#1)(2006-6#2)
and CD11c##3##2##(1994-6#2)(2006-6#1)
and CD133##2##2##(2008-9#1)(2009-11#1)
and CD14##2##2##(2008-10#1)(2012-2#1)
and CD15 antigens##2##3##(1991-2#1)(2008-11#1)
and CD19(+)##3##2##(2008-10#3)
and CD28##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
and CD34(+) cells##2##3##(2008-8#2)
and CD34+##2##2##(2011-2#1)(2012-2#1)
and CD4 cell##2##3##(2008-5#2)
and CD4##5##2##(1990-12#1)(2008-5#2)(2008-8#1)(2012-12#1)
and CD4(+)##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
and CD49f##2##2##(2009-12#1)(2013-1#1)
and CD63##4##2##(1997-3#1)(2006-6#2)(2012-3#1)
and CD68##2##2##(2012-3#1)(2013-8#1)
and CD71+##2##2##(2007-8#2)
and CD8##4##2##(1991-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
and CD8+##10##2##(1995-12#3)(1995-2#1)(1997-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
and CD86##4##2##(2008-10#2)(2008-11#2)
and CDEA##2##2##(2008-10#2)
and CDK2##4##2##(1993-11#3)(1997-1#1)
and CDS NIS##2##3##(2008-3#2)
and CDS##4##2##(2008-3#4)
and CE##3##2##(1996-5#2)(2008-10#1)
and CEOs##3##2##(1994-2#1)(1995-3#2)
and CF##4##2##(2008-10#3)(2008-5#1)
and CFA##3##2##(2012-3#3)
and CG##2##2##(2008-1#1)(2008-5#1)
and CGF-1##2##2##(1995-2#2)
and CGRP##6##2##(1992-6#2)(1997-3#2)(2007-2#1)(2013-8#1)
and CGRP-LI##2##2##(1994-8#2)
and CH _ 2##3##4##(2008-5#3)
and CH(3)COOH…OH(2)##2##2##(2012-12#2)
and CH(4) in combustion##2##4##(2008-2#2)
and CH(4) in##3##3##(2007-12#1)(2008-2#2)
and CH(4)##8##2##(2007-12#1)(2008-2#3)(2008-3#4)
and CHA0r##2##2##(2008-10#2)
and CHO cells##2##3##(2008-11#2)
and CHO##5##2##(2008-11#5)
and CHO-K1##3##2##(2008-11#3)
and CHS17##2##2##(2008-10#2)
and CI##6##2##(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
and CIN##4##2##(2011-1#4)
and CINC-3##2##2##(2013-1#2)
and CIho 10644##3##3##(2008-10#3)
and CK##2##2##(1994-12#1)(2008-11#1)
and CL##5##2##(2008-10#5)
and CLN10##2##2##(2009-5#2)
and CLP##4##2##(2012-3#4)
and CML##2##2##(1991-4#1)(1994-10#1)
and CMV##2##2##(2008-10#1)(2011-2#1)
and CN##4##2##(2007-11#1)(2008-9#2)(2011-2#1)
and CNS##4##2##(1993-6#1)(2008-5#1)(2010-12#1)(2011-1#1)
and CO##10##2##(1991-8#2)(1992-12#1)(1994-6#3)(2008-10#1)(2010-12#1)(2013-8#2)
and CO(2) were used to##2##5##(2008-3#2)
and CO(2) were##4##3##(2007-12#1)(2008-3#3)
and CO(2)##19##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)
and CO2##7##2##(1996-1#1)(1996-12#1)(1997-1#2)(2008-2#1)(2008-6#1)(2013-8#1)
and COMB##3##2##(1993-3#3)
and COMFORT-B##3##2##(2012-2#3)
and COONa groups##2##3##(1997-2#2)
and COPD##4##2##(1995-12#1)(2008-6#1)(2011-2#1)(2012-12#1)
and COS-1 cells##5##3##(2008-8#5)
and COX-2##2##2##(2006-10#1)(2011-2#1)
and CP##7##2##(2008-10#6)(2011-2#1)
and CPB##2##2##(2008-11#1)(2012-3#1)
and CPT##3##2##(1994-8#2)(2007-12#1)
and CPU##2##2##(2008-3#1)(2012-2#1)
and CQI/TQM##2##2##(1993-12#1)(1993-2#1)
and CR usage##2##3##(2010-3#2)
and CR##3##2##(2008-6#1)(2010-3#2)
and CRC tissues##3##3##(2010-12#3)
and CRF##2##2##(1994-9#1)(2009-3#1)
and CRH##2##2##(1990-12#1)(1993-5#1)
and CRM##2##2##(2008-10#1)(2008-12#1)
and CRMs of##2##3##(1997-8#1)(2008-10#1)
and CRP##6##2##(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
and CRS##2##2##(2008-10#2)
and CS##4##2##(2008-10#2)(2013-1#2)
and CS-1##2##2##(2008-10#2)
and CSF was##2##3##(1995-8#1)(2007-8#1)
and CSF##11##2##(1991-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(2007-8#1)(2008-12#1)(2012-3#2)(2013-7#1)
and CT appearances##2##3##(2008-7#1)(2012-2#1)
and CT features##2##3##(2008-10#1)(2008-7#1)
and CT findings##2##3##(1997-3#1)(2012-2#1)
and CT imaging##2##3##(2007-12#1)(2012-2#1)
and CT scan of##2##4##(2007-8#1)(2008-7#1)
and CT scan showed##2##4##(2013-1#2)
and CT scan##8##3##(2007-8#2)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#2)
and CT scans showed##2##4##(2008-1#1)(2011-2#1)
and CT scans##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
and CT##37##2##(1992-5#1)(1993-9#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#6)(2011-2#2)(2012-12#4)(2012-2#7)(2013-1#3)
and CTEPH##2##2##(2010-6#2)
and CTP##2##2##(1997-7#1)(2008-11#1)
and CTscans##2##2##(2007-11#1)(2011-2#1)
and CV##2##2##(2008-10#2)
and CVA4##3##2##(2013-8#3)
and CVD##3##2##(2008-3#1)(2011-1#1)(2013-7#1)
and CVd-III##2##2##(2008-10#2)
and CVd-IV##4##2##(2008-10#4)
and CXB H mice##2##4##(1994-5#2)
and CYP##3##2##(2007-11#2)(2011-1#1)
and CYP1A1##2##2##(1995-11#1)(2008-11#1)
and CYP2B1##3##2##(1994-8#3)
and Ca##6##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#2)(2009-8#1)
and Ca(2+) signaling##3##3##(2008-11#2)(2009-8#1)
and Ca(2+)##15##2##(1997-7#1)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)
and Ca(2+)-dependent##4##2##(1991-12#1)(1992-7#1)(1994-6#1)(2009-2#1)
and Ca2+ are##2##3##(1992-11#1)(2009-10#1)
and Ca2+ in##2##3##(1994-5#1)(1997-1#1)
and Ca2+ influx##2##3##(1994-11#1)(1995-5#1)
and Ca2+##19##2##(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#2)(1995-6#4)(1996-2#2)(1996-5#1)(1997-1#1)(2009-10#1)
and CaCO(3)##2##2##(2013-1#2)
and CaCl(2)##3##2##(2008-10#3)
and CaLCV##2##2##(2008-10#2)
and CaM kinase##2##3##(1994-6#2)
and CaM##4##2##(1994-6#2)(2008-8#2)
and CaMV##2##2##(2008-10#2)
and Calcium##2##2##(2008-10#1)(2008-8#1)
and Caldicellulosiruptor bescii##2##3##(2013-1#2)
and Cameroon##2##2##(2008-10#1)(2012-12#1)
and Campylobacter##2##2##(2007-12#1)(2008-10#1)
and Canada from##2##3##(2008-10#1)(2009-11#1)
and Canada were##4##3##(2007-12#1)(2008-10#2)(2008-12#1)
and Canada##30##2##(1991-12#2)(1992-2#1)(1992-3#1)(1994-1#1)(1994-2#1)(2007-12#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#2)
and Canadian##8##2##(1991-6#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2013-8#1)
and Cancer##5##2##(2008-7#2)(2009-5#1)(2012-2#2)
and Candida albicans##6##3##(2006-6#1)(2007-7#1)(2008-5#2)(2011-2#1)(2012-2#1)
and Candida glabrata##3##3##(2008-11#2)(2008-5#1)
and Candida spp##2##3##(2010-6#1)(2011-2#1)
and Candida##19##2##(1997-1#1)(2006-6#1)(2007-7#1)(2008-11#3)(2008-5#7)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
and Carbon##2##2##(2008-10#2)
and Care##4##2##(1994-3#2)(1996-12#1)(2011-2#1)
and Caribbean##6##2##(2008-11#1)(2008-4#3)(2010-10#1)(2011-2#1)
and Carnation Italian ringspot virus##2##5##(2008-10#2)
and Carotid##2##2##(2006-7#1)(2011-1#1)
and Caspase-3 in##2##3##(2008-9#1)(2013-8#1)
and Caspase-3##7##2##(2008-9#1)(2013-1#1)(2013-8#5)
and Castleman disease##2##3##(2011-2#2)
and Caucasian populations##2##3##(2008-12#1)(2010-3#1)
and Caucasian##5##2##(2008-10#1)(2008-12#1)(2010-3#2)(2012-3#1)
and Caucasians with##2##3##(2011-2#1)(2012-2#1)
and Caucasians##4##2##(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
and Cd in##3##3##(1990-5#1)(2008-10#2)
and Cd##26##2##(1990-5#1)(1993-12#1)(1997-4#1)(2008-10#18)(2008-11#1)(2008-5#1)(2013-1#3)
and Cd(2+)##17##2##(2008-10#15)(2008-11#1)(2013-1#1)
and Cd(II) were##2##3##(2008-10#2)
and Cd(II)##10##2##(2008-10#8)(2008-5#2)
and Cd)##3##2##(2008-10#3)
and CdL(2)##2##2##(2008-10#2)
and CdS##2##2##(2008-2#1)(2008-8#1)
and Cdkn2a deficient mice##3##4##(2008-8#3)
and Ce##3##2##(2008-10#3)
and Ce(3+)##3##2##(2008-10#3)
and Ce(IV) in##2##3##(2008-10#2)
and Cell Wall##2##3##(2008-10#1)(2012-1#1)
and Cell##5##2##(2008-10#2)(2008-11#1)(2008-6#1)(2012-1#1)
and Cellular##2##2##(2008-10#1)(2008-5#1)
and Central##6##2##(1995-3#1)(2007-5#1)(2008-10#3)(2008-7#1)
and Cereal yellow dwarf virus-RPV##3##5##(2008-10#3)
and Cereal yellow dwarf##4##4##(2008-10#4)
and Cerro##2##2##(2008-3#2)
and Cervical##4##2##(1997-1#3)(2008-12#1)
and Change##2##2##(2008-12#1)(2008-6#1)
and Characterization of a##6##4##(1996-2#1)(2008-10#4)(2008-5#1)
and Characterization of##23##3##(1996-2#2)(1997-7#2)(2008-10#14)(2008-11#1)(2008-5#1)(2009-11#1)(2010-2#1)(2013-8#1)
and Charles##2##2##(2008-9#1)(2010-1#1)
and Chemical Properties of##2##4##(1997-7#1)(2013-8#1)
and Chemical##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2013-8#1)
and Chemotherapy##3##2##(2007-1#1)(2008-5#1)(2010-8#1)
and Cherry##3##2##(2008-10#2)(2008-9#1)
and Chest##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
and Chiba##4##2##(2008-10#4)
and Child Health##2##3##(1995-1#1)(2012-12#1)
and Child Oncology##2##3##(2008-9#2)
and Child##9##2##(1995-1#1)(2008-9#3)(2010-6#2)(2012-12#2)(2012-2#1)
and Children##8##2##(1996-12#3)(2007-12#1)(2008-12#1)(2008-9#1)(2010-1#1)(2013-1#1)
and Children's##2##2##(2007-10#1)(2011-2#1)
and Chile##3##2##(2010-12#1)(2013-1#2)
and Chili veinal mottle virus##2##5##(2008-10#2)
and China##7##2##(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
and Chinese cabbage##3##3##(2008-10#2)(2011-3#1)
and Chinese herbal##2##3##(2008-10#2)
and Chinese##16##2##(1993-9#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-8#1)
and Chlamydia trachomatis##2##3##(1997-3#1)(2013-8#1)
and Chlamydia##5##2##(1997-3#2)(2010-12#1)(2013-1#1)(2013-8#1)
and Chronic##4##2##(2008-8#1)(2010-10#1)(2011-1#2)
and Cisplatin Followed by##2##4##(2008-10#2)
and Cisplatin in##2##3##(2008-10#1)(2008-6#1)
and Cisplatin##5##2##(2008-10#4)(2008-6#1)
and Cistanche##2##2##(2011-2#2)
and Citrus viroid##2##3##(2008-10#2)
and Citrus##5##2##(2008-10#5)
and Cl##4##2##(2008-9#3)(2012-12#1)
and Cladosporium##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
and Clare Vaughan##2##3##(1996-8#2)
and Class##3##2##(2008-11#2)(2011-2#1)
and Clinic of##2##3##(2008-9#1)(2011-2#1)
and Clinical Outcomes##2##3##(2008-2#1)(2012-1#1)
and Clinical Significance##3##3##(2010-8#3)
and Clinical##16##2##(1991-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and Clostridium##3##2##(1990-9#1)(2007-12#1)(2010-12#1)
and ClustalX##2##2##(2008-9#2)
and Co concentrations were##2##4##(2008-10#1)(2013-8#1)
and Co concentrations##3##3##(2008-10#1)(2013-8#2)
and Co in##2##3##(2008-10#1)(2013-8#1)
and Co##15##2##(2008-10#7)(2008-5#2)(2010-6#1)(2010-7#1)(2013-8#4)
and Co(II) were##3##3##(2008-10#3)
and Co(II)##21##2##(2008-10#21)
and Coast##6##2##(2008-10#1)(2011-1#2)(2011-2#2)(2012-3#1)
and Cochliobolus##2##2##(2008-10#2)
and Cochrane Database of Systematic Reviews##2##6##(2013-1#2)
and Cochrane databases##2##3##(2013-1#2)
and Cochrane##4##2##(2013-1#4)
and Cognitive##3##2##(2008-11#1)(2009-10#1)(2012-3#1)
and Cohen's kappa##3##3##(1997-8#1)(2010-1#1)(2011-2#1)
and Col##2##2##(2012-12#1)(2012-3#1)
and Collaborating Centres##3##3##(2011-2#3)
and Colletotrichum##3##2##(1997-4#1)(2008-10#2)
and Colocasia##2##2##(2008-10#2)
and Colombia##7##2##(2008-10#3)(2008-5#2)(2012-12#2)
and Colonization of##4##3##(2008-10#4)
and Color##2##2##(2008-5#1)(2010-6#1)
and Common##3##2##(2008-10#3)
and Community Medicine##3##3##(1994-2#1)(1996-1#1)(1997-3#1)
and Community##8##2##(1991-1#1)(1993-5#1)(1994-2#1)(1996-1#2)(1997-2#1)(1997-3#1)(2010-10#1)
and Concanavalin A-Sepharose##2##3##(1991-5#1)(1992-12#1)
and Concanavalin##3##2##(1991-12#1)(1991-5#1)(1992-12#1)
and Conclusion##3##2##(2013-1#1)(2013-8#2)
and Conformational##2##2##(2008-9#1)(2009-9#1)
and Conformations of##2##3##(1996-5#1)(2008-10#1)
and Congress##2##2##(2008-11#1)(2008-6#1)
and Conscientiousness and with##2##4##(2010-12#2)
and Control of##4##3##(1996-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
and Control##12##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
and Costa Rica##4##3##(1990-6#1)(2008-10#1)(2008-5#2)
and Cougarblight##4##2##(2008-10#4)
and Cox##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
and CpG##3##2##(1991-6#1)(1995-2#1)(1995-8#1)
and Cr (III)##2##3##(2008-10#2)
and Cr and##2##3##(2008-10#1)(2008-11#1)
and Cr##26##2##(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)
and Cr(2+)##4##2##(2007-11#4)
and Cr(4+)##2##2##(2008-2#1)(2008-3#1)
and Cr(III) in the##2##4##(2008-10#2)
and Cr(III) in##4##3##(2008-10#4)
and Cr(III)##20##2##(2008-10#20)
and Cr(VI) species in##2##4##(2008-10#2)
and Cr(VI) species##3##3##(2008-10#3)
and Cr(VI)##26##2##(2008-10#26)
and CrF(6)##3##2##(1996-2#3)
and Croatian##2##2##(2008-10#1)(2013-1#1)
and Crohn's disease##3##3##(1995-8#1)(2010-12#1)(2011-2#1)
and Crop##5##2##(2008-10#4)(2008-12#1)
and Crossroads##2##2##(1995-12#1)(1996-11#1)
and Crown##2##2##(2008-10#2)
and Cryptosporidium spp##3##3##(2012-12#3)
and Cryptosporidium##5##2##(2007-12#1)(2012-12#4)
and Csp I)##2##3##(1992-6#2)
and Cu and##2##3##(2008-10#2)
and Cu for##2##3##(2008-10#2)
and Cu in##4##3##(2008-10#4)
and Cu were##6##3##(1997-4#2)(2008-10#3)(2008-11#1)
and Cu##35##2##(1997-4#5)(2008-10#28)(2008-11#1)(2008-3#1)
and Cu(2)##4##2##(1997-7#4)
and Cu(2+)##12##2##(2008-10#11)(2013-1#1)
and Cu(II) in##4##3##(1995-2#1)(2008-10#3)
and Cu(II) ions##2##3##(2008-10#2)
and Cu(II) were 0##2##4##(2008-10#2)
and Cu(II) were##3##3##(2008-10#3)
and Cu(II)##21##2##(1995-2#1)(2008-10#20)
and Cu) and##2##3##(2008-10#2)
and Cu)##5##2##(2008-10#4)(2009-10#1)
and CuNb(py)(4)OF(5)##2##2##(1996-2#2)
and Cuba##2##2##(2008-10#1)(2013-1#1)
and Current##3##2##(2011-2#2)(2013-1#1)
and Cx##3##2##(2013-1#2)(2013-7#1)
and Cy3##2##2##(2008-10#1)(2010-12#1)
and Cyclospora cayetanensis##3##3##(2007-7#3)
and Cypress##2##2##(2008-10#2)
and Cys##6##2##(1993-12#1)(1995-8#1)(2008-10#3)(2011-2#1)
and Cytochemical##4##2##(2008-10#4)
and D are##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
and D were##2##3##(2013-1#2)
and D##74##2##(1991-5#2)(1992-12#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-9#2)(1994-6#3)(1995-5#1)(1995-6#6)(1996-2#2)(1997-1#4)(2007-10#2)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)
and D(2)##4##2##(2007-11#1)(2008-2#2)(2010-12#1)
and D)##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
and D-amino acid##2##3##(1995-11#1)(2008-10#1)
and D-amphetamine##4##2##(1993-12#1)(1993-3#3)
and D-proline##2##2##(2008-10#1)(2008-5#1)
and D-serine##4##2##(1995-11#1)(1996-5#2)(2012-2#1)
and D2 receptors##3##3##(1993-9#1)(2008-5#1)(2008-7#1)
and D2##10##2##(1990-5#1)(1993-9#1)(1994-3#1)(1996-5#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
and D3##5##2##(1993-3#1)(1993-9#1)(1997-6#2)(2008-5#1)
and DA in the##3##4##(2008-10#1)(2008-7#2)
and DA in##5##3##(2008-10#2)(2008-7#3)
and DA output in the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAC)##2##14##(2008-6#2)
and DA##23##2##(1993-12#1)(1994-2#1)(1996-12#4)(1997-7#4)(2008-10#6)(2008-6#2)(2008-7#5)
and DAD##2##2##(2011-2#2)
and DAI (Pearson r =##2##5##(2011-3#2)
and DAPI##3##2##(1992-3#1)(2008-12#2)
and DBA/2 mice##2##3##(1993-12#1)(1996-12#1)
and DBA/2##3##2##(1993-12#1)(1996-12#2)
and DBH##3##2##(1995-11#1)(2008-5#1)(2013-1#1)
and DBP (p&lt##2##3##(2008-10#2)
and DBP##6##2##(1991-10#2)(2008-10#3)(2013-8#1)
and DCS##2##2##(2011-1#1)(2012-2#1)
and DDC##2##2##(1990-12#1)(1997-2#1)
and DEAE groups were##2##4##(2013-1#2)
and DEAE groups##3##3##(2013-1#3)
and DEAE sorbing solids##2##4##(2008-10#2)
and DEAE##8##2##(1992-12#1)(2008-10#2)(2010-11#1)(2013-1#4)
and DFS##2##2##(2008-10#1)(2011-2#1)
and DHA##7##2##(1994-8#1)(2008-11#1)(2010-1#1)(2012-1#2)(2013-1#2)
and DHAA##2##2##(1993-3#2)
and DHEA-S##2##2##(1990-11#1)(2012-3#1)
and DM##2##2##(2010-2#1)(2011-2#1)
and DMDS##2##2##(2008-10#2)
and DMSO##4##2##(2008-10#2)(2008-8#1)(2011-1#1)
and DNA and##3##3##(1992-3#2)(2008-9#1)
and DNA binding proteins##3##4##(2008-2#1)(2008-8#1)(2010-5#1)
and DNA binding##5##3##(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
and DNA content##6##3##(1996-5#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-9#2)
and DNA damage##9##3##(1994-11#2)(1994-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-1#1)
and DNA end-joining##2##3##(2013-1#2)
and DNA fingerprint##3##3##(2008-10#3)
and DNA fingerprints were used to##2##6##(2008-10#2)
and DNA fingerprints##4##3##(2008-10#4)
and DNA fragmentation##4##3##(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#1)
and DNA in##2##3##(2008-4#1)(2010-2#1)
and DNA methylation##2##3##(2008-7#1)(2009-12#1)
and DNA polymerase##2##3##(2011-2#1)(2012-3#1)
and DNA polymorphism##2##3##(2008-10#2)
and DNA repair##6##3##(1993-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
and DNA replication##2##3##(1990-5#1)(2010-10#1)
and DNA sequence analyses##2##4##(1994-12#1)(2008-10#1)
and DNA sequence analysis of##2##5##(2008-10#2)
and DNA sequence analysis##5##4##(1993-12#1)(1997-4#2)(2008-10#2)
and DNA sequence##7##3##(1993-12#1)(1994-12#1)(1997-4#2)(2008-10#3)
and DNA sequences##6##3##(2008-2#1)(2008-4#5)
and DNA sequencing of the##2##5##(2008-10#1)(2009-2#1)
and DNA sequencing of##4##4##(2008-10#2)(2008-8#1)(2009-2#1)
and DNA sequencing##11##3##(1991-2#1)(1997-7#1)(2008-10#5)(2008-7#1)(2008-8#2)(2009-2#1)
and DNA synthesis in##5##4##(1990-2#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-2#1)
and DNA synthesis##14##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-8#1)(1997-1#1)
and DNA##148##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#8)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-8#2)(1994-11#5)(1994-12#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-7#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#11)(2008-5#4)(2008-7#7)(2008-8#5)(2008-9#11)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-3#1)(2012-4#1)(2013-1#5)
and DNA-B##13##2##(2008-10#13)
and DNA-DNA##2##2##(2008-10#2)
and DNA-binding activity##2##3##(1992-3#1)(2012-2#1)
and DNA-binding##3##2##(1992-3#1)(1997-7#1)(2012-2#1)
and DNA-nicking domains##2##3##(2008-10#2)
and DNA-protein##2##2##(1993-9#1)(2008-4#1)
and DNAase##2##2##(1994-12#1)(1994-6#1)
and DNC diets##2##3##(2010-2#2)
and DON in##2##3##(2008-10#2)
and DON##12##2##(2008-10#12)
and DP##3##2##(2008-10#2)(2013-1#1)
and DR##2##2##(1997-8#1)(2011-2#1)
and DRD4##3##2##(1997-5#2)(2012-1#1)
and DS##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
and DSB##2##2##(1995-8#1)(2008-11#1)
and DSC##3##2##(2008-5#1)(2009-7#1)(2011-3#1)
and DSM-IV##2##2##(1997-8#2)
and DT##5##2##(1995-11#4)(2013-1#1)
and DV##2##2##(1991-9#2)
and DVB/CAR/PDMS##2##2##(2008-10#2)
and DVT##2##2##(2011-2#1)(2012-2#1)
and DZ##4##2##(1997-4#4)
and Dai population##2##3##(2011-1#2)
and Datura stramonium##2##3##(2008-10#2)
and Datura##3##2##(2008-10#3)
and David##2##2##(1990-8#1)(2008-11#1)
and De##3##2##(2010-4#1)(2012-2#1)(2013-1#1)
and Death##2##2##(2012-12#1)(2013-1#1)
and December 1988##3##3##(1990-12#2)(1992-10#1)
and December 1994##4##3##(1994-9#1)(1995-3#1)(1996-2#1)(2008-11#1)
and December 2000 in##2##4##(2007-7#1)(2008-10#1)
and December 2001 were reviewed##2##5##(2007-10#1)(2007-12#1)
and December 2005##2##3##(2008-8#1)(2011-1#1)
and December 2006##3##3##(2010-3#1)(2012-2#1)(2013-1#1)
and December 2010##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
and December 31##5##3##(2009-6#1)(2011-2#4)
and December##40##2##(1990-12#2)(1991-8#2)(1992-10#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
and Delta##3##2##(1993-3#1)(2008-3#1)(2008-5#1)
and Democrats##2##2##(1997-5#1)(2008-7#1)
and Denmark##2##2##(1992-9#1)(1993-2#1)
and Dennis##2##2##(1991-8#2)
and Department of##4##3##(1992-12#1)(2007-11#1)(2013-8#2)
and Depression##6##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
and Depressive Symptoms##2##3##(2010-10#1)(2013-1#1)
and Design##4##2##(2008-7#1)(2013-8#3)
and Detection of##4##3##(2008-10#4)
and Development of##5##3##(2008-10#5)
and Development##21##2##(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-3#1)(1994-9#2)(1995-2#1)(2008-10#5)(2008-11#3)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
and Diabetes##2##2##(1996-8#1)(2008-3#1)
and Diabrotica##2##2##(2008-5#2)
and Diagnostic##3##2##(1995-3#1)(2008-10#1)(2013-7#1)
and Dioscorea##3##2##(2008-5#3)
and Discussion##10##2##(2007-11#2)(2007-8#1)(2008-6#6)(2010-12#1)
and Disease##9##2##(1994-3#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#4)
and Dispersal of Ascospores##2##4##(2008-10#2)
and Distribution of##3##3##(2008-10#3)
and Distribution##4##2##(2008-10#3)(2012-12#1)
and Dithizone##2##2##(2008-10#2)
and Diversity of##4##3##(2008-10#4)
and Doehlert##3##2##(2008-10#3)
and Doppler##5##2##(1995-6#1)(1996-6#1)(2008-1#1)(2008-2#1)(2009-4#1)
and Dor##2##2##(2011-1#1)(2011-2#1)
and Down syndrome groups##3##4##(1990-3#3)
and Down syndrome##5##3##(1990-3#5)
and Down's syndrome##2##3##(1996-5#1)(2008-7#1)
and Down's##4##2##(1990-2#1)(1996-5#1)(2008-10#1)(2008-7#1)
and Dr##5##2##(1997-5#1)(2008-5#3)(2012-12#1)
and Droplets##2##2##(2008-3#1)(2012-1#1)
and Drosophila melanogaster##4##3##(1991-12#2)(1993-12#1)(1995-6#1)
and Drosophila##9##2##(1991-12#2)(1993-12#1)(1995-6#1)(2007-8#1)(2008-2#1)(2008-9#2)(2009-3#1)
and Drug##61##2##(1994-1#3)(1995-8#1)(1996-5#3)(1997-4#1)(1997-5#2)(2006-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-7#2)(2009-9#2)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#4)
and Dutch##3##2##(1992-5#2)(2008-10#1)
and Dynamic##2##2##(2007-8#1)(2008-5#1)
and Dynastab##2##2##(2007-8#2)
and E and##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2012-3#1)
and E are##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
and E of the##2##4##(1993-11#1)(2009-7#1)
and E were##5##3##(1993-11#1)(1997-6#1)(2008-10#2)(2011-2#1)
and E##76##2##(1990-5#1)(1991-5#1)(1992-9#2)(1993-11#3)(1993-12#2)(1994-3#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#4)(2006-11#4)(2007-7#4)(2008-10#25)(2008-11#1)(2008-12#2)(2008-5#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-4#3)(2011-2#3)(2012-3#1)(2013-1#1)
and E(f) =##3##3##(2008-6#3)
and E2 proteins##2##3##(2008-8#1)(2008-9#1)
and E2##14##2##(1990-11#1)(1991-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)
and E3##9##2##(1991-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-10#1)
and E4##2##2##(1996-6#1)(2008-8#1)
and E7##5##2##(1995-2#4)(2008-9#1)
and E83/K84##2##2##(1995-2#2)
and EA##3##2##(2008-10#1)(2008-11#2)
and EAST##2##2##(2010-9#2)
and EC were##2##3##(2008-10#1)(2008-12#1)
and EC##7##2##(2008-10#2)(2008-12#2)(2012-4#2)(2013-8#1)
and ECF bleaching sequences##2##4##(2008-6#2)
and ECS##2##2##(1996-12#2)
and ED##3##2##(2009-5#1)(2010-10#1)(2013-8#1)
and EDTA as##3##3##(1995-2#1)(2008-10#2)
and EDTA##13##2##(1992-3#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#7)(2008-8#1)
and EEG##3##2##(1991-11#1)(2011-1#1)(2013-8#1)
and EGF receptor##2##3##(2008-6#1)(2013-7#1)
and EGF##15##2##(1991-12#8)(1993-6#1)(1994-3#1)(2008-4#1)(2008-6#3)(2013-7#1)
and EGFR##4##2##(1993-9#1)(2008-11#1)(2008-7#1)(2012-3#1)
and EGVGE##3##2##(2012-12#3)
and EHR##2##2##(2008-4#1)(2013-7#1)
and EIA##2##2##(1990-9#1)(2008-10#1)
and ELISA are##2##3##(1997-3#1)(2008-10#1)
and ELISA##17##2##(1990-12#1)(1992-12#1)(1993-9#1)(1995-5#1)(1997-3#2)(1997-4#1)(2008-10#6)(2008-6#1)(2008-9#2)(2013-1#1)
and EMBASE##5##2##(1994-3#2)(2012-1#1)(2013-1#2)
and EMG##4##2##(1993-12#1)(1997-7#1)(2009-6#1)(2010-8#1)
and EMV##2##2##(2008-10#2)
and ENETS grading systems were not##2##6##(2011-2#2)
and ENRO##3##2##(2008-10#3)
and EPA##4##2##(1991-12#1)(1994-11#2)(2008-10#1)
and EPO##3##2##(2008-11#1)(2008-8#2)
and EPR spectra##2##3##(1990-12#1)(1997-7#1)
and EPR##6##2##(1990-12#1)(1993-11#1)(1996-2#1)(1997-7#3)
and EPS I##3##3##(2008-10#3)
and ER##10##2##(1991-11#2)(1993-1#2)(1995-4#1)(1997-7#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
and ERCP##2##2##(1991-5#1)(2013-1#1)
and ERK##2##2##(2008-4#2)
and ES##2##2##(1994-9#1)(2008-10#1)
and ESI-MS##3##2##(2007-11#1)(2008-10#2)
and EST##3##2##(1997-6#1)(1997-8#1)(2008-7#1)
and ET-3##3##2##(1990-2#2)(1994-11#1)
and ET1##2##2##(1990-2#1)(2013-1#1)
and ETT##3##2##(2008-8#1)(2010-7#2)
and East Chapman##3##3##(2008-10#3)
and East##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
and Eastern##6##2##(1995-3#5)(2008-7#1)
and EcoRI##3##2##(1991-9#1)(1992-3#1)(1993-12#1)
and Economic##4##2##(1994-3#1)(2008-10#1)(2010-5#1)(2011-2#1)
and Ecuador##2##2##(2008-6#1)(2008-8#1)
and Edman degradation##2##3##(1990-5#1)(2010-4#1)
and Education##5##2##(1995-6#2)(1997-2#1)(2008-2#1)(2013-8#1)
and Effect of##2##3##(2008-10#1)(2010-11#1)
and Effect##3##2##(2008-10#1)(2010-11#1)(2011-2#1)
and Effects of##3##3##(2008-10#2)(2012-2#1)
and Effects##4##2##(2008-10#3)(2012-2#1)
and Efficacy of##2##3##(2008-10#1)(2008-8#1)
and Electrochemical##2##2##(1996-2#1)(2009-9#1)
and Electrochemistry of##2##3##(1996-2#2)
and Electron##2##2##(1996-9#1)(2008-10#1)
and Electronic##3##2##(1996-2#1)(2008-10#1)(2010-8#1)
and Elevated##2##2##(2013-1#1)(2013-7#1)
and Emax##3##2##(1995-12#1)(2010-3#2)
and Emergency##4##2##(1992-12#2)(2008-11#1)(2013-1#1)
and Emotional State##2##3##(2013-1#2)
and End Results (SEER)##2##4##(1997-3#1)(2012-3#1)
and End Results##3##3##(1997-3#1)(2012-3#2)
and Endothelial##2##2##(2009-11#1)(2010-5#1)
and Engineering##3##2##(2008-2#1)(2008-8#1)(2013-8#1)
and England##2##2##(1990-9#1)(1992-1#1)
and English##15##2##(2007-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-7#3)(2011-2#5)(2012-12#1)(2013-8#1)
and Enhanced##2##2##(2013-1#1)(2013-7#1)
and Enterobacter cloacae##3##3##(2008-11#1)(2008-9#1)(2010-6#1)
and Enterobacter##4##2##(2008-11#1)(2008-9#1)(2010-3#1)(2010-6#1)
and Enterobacteriaceae count##2##3##(2007-3#2)
and Enterococcus faecalis)##2##3##(2008-5#1)(2010-3#1)
and Enterococcus##4##2##(2008-5#1)(2009-8#1)(2010-3#1)(2010-8#1)
and Environment##2##2##(1995-3#1)(2007-6#1)
and Environmental Factors##2##3##(2008-10#1)(2008-11#1)
and Environmental Sciences##2##3##(2008-10#2)
and Environmental##8##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
and Epomophorus##2##2##(2007-5#2)
and Epstein-Barr virus##2##3##(2007-12#1)(2013-8#1)
and Er##2##2##(2008-2#2)
and Erwinia##2##2##(2008-10#2)
and Escape##2##2##(2008-10#2)
and Escherichia coli genes##2##4##(1997-6#2)
and Escherichia coli##9##3##(1990-11#1)(1994-11#1)(1996-3#1)(1997-2#1)(1997-6#2)(2007-5#1)(2008-10#1)(2010-3#1)
and Escherichia##12##2##(1990-11#1)(1994-11#1)(1996-3#1)(1997-2#2)(1997-6#2)(2007-5#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-2#1)
and Ethibond suture as##2##4##(2012-3#2)
and Ethibond suture##3##3##(2012-3#3)
and Ethnic##2##2##(2008-5#1)(2010-10#1)
and Eu(3+)##3##2##(2008-10#3)
and Europe##23##2##(1991-9#1)(1994-3#1)(1995-3#1)(2006-10#1)(2008-10#8)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#2)(2009-4#2)(2012-1#1)(2012-12#1)(2013-1#1)
and European countries##2##3##(2011-2#1)(2012-3#1)
and European##12##2##(2008-1#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-1#2)
and Euscelis incisus##2##3##(2008-10#2)
and Evaluation of##3##3##(2008-10#3)
and Evaluation##9##2##(1995-2#1)(1996-3#1)(2007-6#1)(2008-10#3)(2008-11#1)(2011-9#1)(2012-12#1)
and Evans##3##2##(1995-2#1)(1997-2#1)(2008-5#1)
and Evolution##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
and Exercise##3##2##(2007-12#1)(2008-12#1)(2010-6#1)
and Experiment##2##2##(2008-11#1)(2008-6#1)
and Experimental Group##2##3##(2007-6#2)
and Experimental##7##2##(1996-5#1)(2007-6#2)(2008-10#2)(2008-3#1)(2012-12#1)
and Express Five SFM##2##4##(2008-7#2)
and Expression of##7##3##(2008-10#5)(2008-6#1)(2010-8#1)
and Expression##8##2##(2008-10#5)(2008-6#1)(2008-7#1)(2010-8#1)
and Exserohilum##2##2##(2008-10#2)
and Extension##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
and F =##2##3##(2007-11#2)
and F and##2##3##(2008-6#2)
and F##65##2##(1990-8#2)(2007-11#2)(2007-6#1)(2008-10#45)(2008-11#1)(2008-12#2)(2008-6#6)(2008-9#3)(2010-3#1)(2011-2#1)(2013-1#1)
and F(1)##9##2##(2008-10#7)(2008-8#1)(2013-1#1)
and F(2##4##2##(2008-10#4)
and F(2) generations##3##3##(2008-10#3)
and F(2)##8##2##(2008-10#6)(2008-8#2)
and F(3) progeny from##2##4##(2008-10#2)
and F(3) progeny##3##3##(2008-10#3)
and F(3)##8##2##(2008-10#8)
and F1##3##2##(1994-8#1)(2008-12#1)(2010-2#1)
and F2##10##2##(1992-8#1)(1996-12#1)(2008-10#4)(2008-12#2)(2013-8#2)
and F3##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
and FA##8##2##(2008-10#5)(2008-11#2)(2012-1#1)
and FAD##3##2##(1990-8#1)(1994-8#1)(2009-10#1)
and FAME##2##2##(2008-10#2)
and FBS##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
and FCFP##2##2##(2011-2#2)
and FDA##4##2##(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)
and FGA##3##2##(2008-12#3)
and FGA)##2##2##(2008-12#2)
and FGD type##2##3##(2011-1#2)
and FGF##2##2##(1997-1#2)
and FHB resistance##2##3##(2008-10#2)
and FHB##3##2##(2008-10#3)
and FI##6##2##(2008-10#6)
and FIA variables##2##3##(2008-10#2)
and FIA##4##2##(2008-10#4)
and FIR##2##2##(2010-8#2)
and FIS1B##4##2##(2009-10#4)
and FISH analysis##2##3##(1997-3#1)(2008-4#1)
and FISH##8##2##(1997-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-3#1)
and FK506##2##2##(1991-9#2)
and FKBP-FK506##2##2##(1991-9#2)
and FL were##3##3##(1992-2#1)(2008-10#1)(2011-1#1)
and FL##5##2##(1992-2#3)(2008-10#1)(2011-1#1)
and FMLP##2##2##(1993-6#2)
and FN of##2##3##(2008-12#2)
and FOXO##2##2##(2008-7#1)(2012-2#1)
and FP##2##2##(1996-1#1)(1996-2#1)
and FT-IR##5##2##(2008-10#3)(2012-2#1)(2013-8#1)
and FT-Raman##4##2##(2008-10#2)(2013-1#2)
and FT3##2##2##(2012-3#2)
and FTIR spectra##2##3##(2008-10#1)(2013-8#1)
and FTIR##7##2##(1994-11#1)(1997-7#1)(2008-10#3)(2013-1#1)(2013-8#1)
and FVC##3##2##(2008-7#1)(2011-2#2)
and FWHM##2##2##(2008-2#1)(2013-8#1)
and FYY140-142GSA TCS##2##3##(2008-10#2)
and Factor##2##2##(1994-11#1)(2008-5#1)
and Faculty of Medicine##2##4##(2008-10#2)
and Families##2##2##(2009-11#1)(2010-10#1)
and Family##5##2##(1990-6#1)(1996-3#1)(1996-4#1)(2009-9#1)(2012-12#1)
and Fatigue subscales##2##3##(2008-7#2)
and Fatigue##3##2##(2008-7#2)(2010-7#1)
and FcgammaR/CR co-operation##2##3##(2008-10#2)
and Fe concentrations##2##3##(2008-10#2)
and Fe in##6##3##(2008-10#6)
and Fe were##3##3##(2008-10#3)
and Fe##27##2##(1996-2#1)(2007-12#1)(2008-10#22)(2008-12#1)(2008-2#1)(2013-1#1)
and Fe(2+)##2##2##(2008-10#2)
and Fe(3+) and##2##3##(2008-8#1)(2010-11#1)
and Fe(3+)##10##2##(2008-10#6)(2008-8#1)(2008-9#2)(2010-11#1)
and Fe(II)##14##2##(2008-10#14)
and Fe(III) can be determined in the##2##7##(2008-10#2)
and Fe(III) can be determined##3##5##(2008-10#3)
and Fe(III) can be##4##4##(2008-10#4)
and Fe(III) can##5##3##(2008-10#5)
and Fe(III) in##6##3##(2008-10#6)
and Fe(III) is##2##3##(2008-10#2)
and Fe(III) were##3##3##(2008-10#3)
and Fe(III)##36##2##(2008-10#35)(2010-4#1)
and Fe)##2##2##(2008-10#2)
and FeSO(4)##2##2##(2008-10#1)(2008-11#1)
and February##5##2##(2007-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
and Fever##2##2##(2008-4#1)(2009-6#1)
and Field Conditions##2##3##(2008-10#2)
and Field##3##2##(2008-10#3)
and Fischer##2##2##(1995-6#1)(2008-6#1)
and Fisher's##5##2##(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and Fisoneb##2##2##(1996-12#2)
and Florida##8##2##(1994-3#1)(1996-5#2)(2008-10#2)(2008-5#1)(2010-3#1)(2011-1#1)
and Fo47##3##2##(2008-10#3)
and Forgac##3##2##(1995-6#3)
and Fos##2##2##(1994-8#1)(1996-2#1)
and Fourier transform infrared (FTIR) spectrometric detection has been developed for the determination of##2##14##(2008-10#2)
and Fourier transform infrared (FTIR)##3##5##(2008-10#3)
and Fourier transform infrared spectrometry (FTIR)##2##6##(2008-10#2)
and Fourier transform infrared spectrometry##3##5##(1997-2#1)(2008-10#2)
and Fourier transform infrared spectroscopy (FT-IR)##2##6##(2012-2#1)(2013-1#1)
and Fourier transform infrared spectroscopy##4##5##(2008-10#2)(2012-2#1)(2013-1#1)
and Fourier transform infrared##12##4##(1997-2#1)(2008-10#8)(2008-5#1)(2012-2#1)(2013-1#1)
and Fourier transform mid infrared spectroscopy##2##6##(2008-10#2)
and Fourier transform##15##3##(1997-2#1)(2008-10#10)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
and Fourier##17##2##(1997-2#1)(2008-10#10)(2008-2#2)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
and France##6##2##(2008-1#1)(2008-10#4)(2011-2#1)
and French##3##2##(1992-5#1)(2007-2#1)(2010-3#1)
and Fresnel##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
and Freundlich##5##2##(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
and Fruit##2##2##(2008-10#1)(2012-3#1)
and Fry##4##2##(1994-11#1)(2008-3#2)(2011-1#1)
and Function of##3##3##(2008-6#1)(2010-1#1)(2013-1#1)
and Function##6##2##(2007-12#1)(2008-6#1)(2009-4#1)(2010-1#1)(2013-1#2)
and Functional##5##2##(2008-4#1)(2008-7#1)(2011-8#1)(2012-12#1)(2012-2#1)
and Fusarium head blight##2##4##(2008-10#2)
and Fusarium oxysporum f##3##4##(2008-10#3)
and Fusarium oxysporum##6##3##(2008-10#6)
and Fusarium spp##2##3##(2011-2#1)(2013-1#1)
and Fusarium wilt##2##3##(2008-10#2)
and Fusarium##22##2##(2008-10#19)(2010-7#1)(2011-2#1)(2013-1#1)
and Future##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
and Fuzzy##2##2##(2008-10#1)(2010-8#1)
and G allele##2##3##(2011-1#2)
and G protein##3##3##(1995-8#1)(2008-3#2)
and G proteins##2##3##(1993-9#1)(1995-11#1)
and G##33##2##(1990-7#1)(1993-9#1)(1995-11#1)(1995-8#2)(1996-4#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2010-3#3)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#1)
and G(2)/M phases##2##3##(2008-11#1)(2010-2#1)
and G/G##3##2##(2011-1#3)
and G1##2##2##(1994-11#1)(2013-8#1)
and G2 phases of##2##4##(1994-3#1)(2008-9#1)
and G2##7##2##(1994-3#1)(1994-5#1)(1994-6#1)(1997-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
and G3##2##2##(1995-6#1)(2013-1#1)
and G4##2##2##(2013-1#2)
and G7##2##2##(2008-10#1)(2008-12#1)
and GABA##9##2##(1992-11#1)(1992-12#1)(1992-3#1)(1995-2#1)(1996-12#1)(1997-2#3)(2008-7#1)
and GABA(A) receptors##2##3##(2008-8#2)
and GABA(A)##3##2##(2008-8#3)
and GABAB##4##2##(1995-11#1)(1995-5#1)(2008-7#1)(2013-8#1)
and GABAergic interneurons##2##3##(2009-8#1)(2013-8#1)
and GABAergic##4##2##(1995-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
and GAP-43##2##2##(1995-5#2)
and GART)##2##2##(1997-8#2)
and GATA##2##2##(2012-2#1)(2012-3#1)
and GBC mutants##2##3##(2008-10#2)
and GBMT##2##2##(1994-8#2)
and GBW##2##2##(2008-10#2)
and GC##4##2##(2008-10#1)(2008-5#1)(2013-1#2)
and GC-MS##9##2##(1997-1#1)(2008-10#6)(2008-11#1)(2012-2#1)
and GC/MS##8##2##(2008-10#4)(2008-11#2)(2008-12#2)
and GC/MS/MS##2##2##(2008-10#2)
and GD3##2##2##(1990-8#1)(1996-5#1)
and GDP##4##2##(1991-2#1)(1991-5#1)(1995-5#1)(2008-6#1)
and GE##2##2##(2013-1#2)
and GEP##2##2##(2008-10#1)(2011-2#1)
and GEPR-9##6##2##(1996-12#6)
and GFAAS determination##2##3##(2008-10#2)
and GFAAS##6##2##(2008-10#6)
and GFP##4##2##(2008-1#1)(2008-7#2)(2008-9#1)
and GGT##2##2##(2009-6#1)(2010-11#1)
and GH secretion##2##3##(1991-12#1)(1991-9#1)
and GH##16##2##(1991-12#1)(1991-9#1)(1994-8#5)(1995-8#1)(1996-2#2)(1997-2#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-7#2)
and GHPSAM##3##2##(2008-10#3)
and GI##5##2##(1991-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
and GIP(7-30)##2##2##(1997-4#2)
and GLP##3##2##(1995-8#3)
and GLP-1##3##2##(2010-11#1)(2011-2#1)(2012-3#1)
and GM-CSF##5##2##(1991-12#1)(1992-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
and GM-CSF)##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
and GM4##4##2##(1996-5#2)(2008-10#2)
and GMP##3##2##(1992-8#1)(2008-11#1)(2012-2#1)
and GP##3##2##(1990-9#1)(2008-3#1)(2011-1#1)
and GPDH##2##2##(2008-11#2)
and GR##4##2##(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)
and GRPR##3##2##(2010-6#3)
and GS##2##2##(2008-11#2)
and GSH levels##2##3##(2012-3#1)(2013-1#1)
and GSH##10##2##(1993-8#1)(1994-2#1)(2008-10#2)(2010-11#1)(2011-3#1)(2012-3#1)(2013-1#3)
and GSK-3β##2##2##(2013-7#2)
and GST pi##2##3##(1990-2#1)(1994-2#1)
and GST##4##2##(1990-2#1)(1994-2#1)(2011-10#1)(2011-2#1)
and GTN##2##2##(1995-11#2)
and GTP gamma##4##3##(1991-6#1)(1993-6#1)(1993-8#1)(1994-3#1)
and GTP##18##2##(1990-7#3)(1991-6#1)(1992-8#4)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-6#1)(2008-4#4)
and GaAs##2##2##(2008-2#1)(2008-3#1)
and Gadd45##3##2##(2008-9#3)
and Ganga##2##2##(2008-7#2)
and Gas##7##2##(2008-2#5)(2008-3#2)
and Gaussian##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
and Gd(III)##2##2##(2008-10#2)
and Ge##3##2##(2007-11#2)(2008-3#1)
and Gemcitabine##2##2##(2010-3#2)
and Gen11 were##2##3##(2011-10#2)
and Gene##3##2##(2008-10#1)(2012-12#1)(2013-8#1)
and General##4##2##(1990-6#1)(1994-1#1)(2008-1#1)(2008-10#1)
and Genetic Analysis of##2##4##(2008-10#2)
and Genetic##12##2##(2008-10#10)(2008-5#1)(2013-1#1)
and Gengoroubuna##4##2##(2008-5#4)
and Genome##4##2##(2008-10#1)(2008-4#2)(2012-3#1)
and Genomic##2##2##(2008-10#2)
and Genotype##2##2##(2008-10#2)
and Georgia##3##2##(1991-1#1)(2008-10#2)
and German measles##5##3##(2012-12#5)
and German##9##2##(1995-1#1)(2008-10#2)(2008-11#1)(2012-12#5)
and Ghana##4##2##(2008-12#1)(2010-10#1)(2011-1#2)
and Giardia intestinalis##2##3##(2009-10#1)(2011-1#1)
and Giardia spp##2##3##(2012-12#2)
and Giardia##4##2##(2009-10#1)(2011-1#1)(2012-12#2)
and Giemsa stains##2##3##(2008-5#1)(2008-9#1)
and Glenn counties##2##3##(2008-10#2)
and Gliocladium roseum##3##3##(2008-10#3)
and Global##4##2##(2007-2#1)(2008-3#2)(2013-1#1)
and Gly##4##2##(2008-10#1)(2008-5#2)(2012-2#1)
and Glycine##2##2##(1991-5#1)(2008-10#1)
and GnRH##3##2##(1994-9#2)(2009-6#1)
and Golgi##3##2##(1994-11#1)(2008-5#1)(2009-8#1)
and Good##2##2##(2012-12#1)(2013-1#1)
and Graev##2##2##(2012-1#2)
and Gram negative bacteria##2##4##(1994-11#1)(2010-5#1)
and Gram negative##4##3##(1994-11#1)(2010-10#1)(2010-5#1)(2012-3#1)
and Gram positive bacteria##2##4##(2010-5#1)(2012-3#1)
and Gram##6##2##(1994-11#1)(2010-10#1)(2010-5#2)(2012-3#2)
and Graves' disease##2##3##(1990-6#1)(2012-3#1)
and Graves'##4##2##(1990-6#1)(1995-12#2)(2012-3#1)
and Great##2##2##(2008-10#1)(2013-8#1)
and Grip##2##2##(2007-12#1)(2013-8#1)
and Group 2##5##3##(1995-12#1)(2008-3#2)(2010-3#1)(2011-1#1)
and Group C##2##3##(2007-7#1)(2010-4#1)
and Group II##4##3##(1995-12#1)(2007-8#1)(2008-10#2)
and Group II's##2##3##(1993-2#2)
and Group##18##2##(1993-2#2)(1995-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#2)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-2#1)
and Growth of##3##3##(2008-10#3)
and Growth##5##2##(2008-10#4)(2012-2#1)
and H##28##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-9#1)(2012-12#2)
and H'##2##2##(2008-8#2)
and H(+) in##2##3##(2008-10#2)
and H(+)##3##2##(2008-10#3)
and H(2)##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-4#2)(2011-2#1)
and H(2)O##12##2##(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-8#1)
and H(2)O(2) in##2##3##(2008-10#2)
and H(2)O(2) production##2##3##(2008-10#1)(2008-11#1)
and H(2)O(2) was##2##3##(2008-10#2)
and H(2)O(2)##20##2##(2008-10#17)(2008-11#1)(2009-8#1)(2010-7#1)
and H)##2##2##(2008-10#1)(2008-12#1)
and H+##3##2##(1991-12#1)(1994-11#1)(1994-3#1)
and H-7##3##2##(1990-2#1)(1991-2#1)(1995-8#1)
and H-point##2##2##(2008-10#2)
and H1##2##2##(1992-8#1)(1994-8#1)
and H10##2##2##(1990-12#2)
and H1N1##2##2##(2012-12#1)(2013-8#1)
and H2##4##2##(1995-5#1)(2008-12#1)(2008-9#1)(2009-2#1)
and H240##2##2##(2010-4#2)
and H26##2##2##(2011-2#2)
and H2O##5##2##(2008-11#1)(2008-2#2)(2008-3#2)
and H2O2##10##2##(1990-5#2)(1992-11#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#2)(2013-8#1)
and H3 subtypes##3##3##(1992-9#3)
and H8##2##2##(1994-11#1)(1994-9#1)
and HA in##2##3##(2008-10#2)
and HA##5##2##(2007-8#1)(2008-10#2)(2010-10#1)(2013-8#1)
and HAART##2##2##(2010-4#1)(2010-5#1)
and HB##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
and HBV DNA##2##3##(2008-4#2)
and HBV##10##2##(1995-2#1)(2007-7#1)(2008-4#2)(2008-8#1)(2009-4#2)(2009-5#1)(2011-1#1)(2012-12#1)
and HBV-DNA##3##2##(2011-1#2)(2013-8#1)
and HBsAg##3##2##(1997-6#1)(2011-1#1)(2013-1#1)
and HC##3##2##(2008-10#1)(2013-8#2)
and HC-toxin##2##2##(2008-10#2)
and HCB##3##2##(1993-5#1)(2008-10#1)(2008-11#1)
and HCC##3##2##(1993-2#1)(2006-10#1)(2013-8#1)
and HCV##10##2##(1991-8#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-3#1)
and HCl##10##2##(2008-10#8)(2009-10#1)(2009-9#1)
and HD was##2##3##(2007-12#1)(2008-1#1)
and HD##5##2##(1992-8#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#1)
and HDL##7##2##(1991-12#1)(1991-2#1)(1991-6#1)(2008-3#2)(2008-6#1)(2012-3#1)
and HDL-C##3##2##(2008-3#2)(2011-1#1)
and HDL3##2##2##(1990-12#1)(1990-8#1)
and HEC gel##2##3##(2008-5#2)
and HEK293 cells##2##3##(2008-4#2)
and HELLP##2##2##(2008-4#2)
and HF with##2##3##(2008-10#2)
and HF##7##2##(2008-10#4)(2011-2#3)
and HFA227##2##2##(1996-1#2)
and HG##2##2##(1992-8#1)(2008-1#1)
and HGC (Pearson r =##2##5##(2011-3#2)
and HGC##3##2##(2011-3#3)
and HI##2##2##(1997-6#2)
and HIIE##2##2##(2013-8#2)
and HIV epidemics##2##3##(2010-4#1)(2010-5#1)
and HIV in##3##3##(2008-10#1)(2011-2#2)
and HIV infection in##2##4##(1991-5#1)(1993-11#1)
and HIV infection##11##3##(1990-2#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#1)(1995-3#1)(2006-10#1)(2011-1#1)(2012-12#1)
and HIV prevention##3##3##(2009-5#3)
and HIV sexual risk behavior##2##5##(2008-12#2)
and HIV status##2##3##(2009-7#2)
and HIV##51##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#2)(1993-8#2)(1994-11#2)(1995-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#2)(2008-10#3)(2008-12#2)(2008-5#1)(2008-8#1)(2009-5#4)(2009-7#2)(2009-8#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#1)
and HIV-1 infection##3##3##(1997-2#1)(2008-11#1)(2008-2#1)
and HIV-1##10##2##(1991-8#1)(1991-9#2)(1997-2#1)(1997-3#1)(2008-11#1)(2008-2#2)(2009-4#1)(2010-5#1)
and HIV-1/AIDS##5##2##(2009-4#5)
and HIV-2##7##2##(1990-5#1)(1990-8#3)(1992-6#1)(1994-11#1)(2011-2#1)
and HIV-infected patients##2##3##(2007-12#1)(2011-2#1)
and HIV-infected##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
and HIV-positive##2##2##(1993-6#1)(1996-5#1)
and HIV/AIDS##4##2##(2007-7#2)(2009-10#1)(2010-10#1)
and HL-60##3##2##(1990-2#1)(2008-4#1)(2011-2#1)
and HLA class II##2##4##(1995-12#1)(1997-8#1)
and HLA##8##2##(1991-11#1)(1993-3#1)(1995-12#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#1)(2011-2#1)
and HLA-B51##2##2##(2008-8#2)
and HLA-DQB1*0501##2##2##(2012-12#2)
and HLA-DR##2##2##(1990-6#1)(2008-10#1)
and HLA-Dr##2##2##(1990-12#2)
and HMBC##2##2##(2007-11#1)(2008-11#1)
and HMO##3##2##(1993-12#1)(1996-12#1)(1996-2#1)
and HNO(3) in##2##3##(2008-10#1)(2008-3#1)
and HNO(3)##8##2##(2008-10#6)(2008-3#2)
and HNPP##2##2##(1997-3#2)
and HNS##4##2##(2013-8#4)
and HOMA-IR##4##2##(2008-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
and HP##2##2##(2008-10#1)(2012-3#1)
and HPLC determination of##3##4##(2008-10#2)(2008-5#1)
and HPLC methods for the##2##5##(2008-10#2)
and HPLC methods##4##3##(2008-10#3)(2011-2#1)
and HPLC procedures##2##3##(1990-8#1)(2008-10#1)
and HPLC separation##2##3##(1992-3#1)(2008-10#1)
and HPLC##28##2##(1990-8#1)(1992-2#1)(1992-3#1)(1995-3#1)(1997-4#1)(2008-10#14)(2008-11#4)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
and HPLC)##2##2##(1994-12#1)(2008-10#1)
and HPLC-UV##2##2##(2008-10#2)
and HPLC/diode-array UV##2##3##(2008-10#2)
and HPV##2##2##(2008-10#1)(2011-2#1)
and HR##7##2##(1990-5#2)(1991-2#1)(2008-10#1)(2008-11#2)(2008-5#1)
and HRP##7##2##(2008-10#3)(2012-4#4)
and HRT##2##2##(2013-1#2)
and HRV##2##2##(2008-6#1)(2011-1#1)
and HS##4##2##(1991-9#2)(2008-5#2)
and HSA##4##2##(2008-10#4)
and HSP70 expression##2##3##(2008-10#2)
and HSP70 synthesis occurred successively##2##5##(1995-11#2)
and HSP70##9##2##(1994-8#1)(1995-11#3)(2008-10#3)(2009-4#1)(2009-6#1)
and HUVEC##2##2##(2008-11#1)(2008-8#1)
and HVA##3##2##(1992-7#1)(1995-3#1)(2008-3#1)
and HYPD haplotype##2##3##(2013-1#2)
and Haemophilus b conjugate##2##4##(1995-5#2)
and Haemophilus influenzae type b##2##5##(1995-3#1)(1995-5#1)
and Haemophilus influenzae##3##3##(1994-11#1)(1995-3#1)(1995-5#1)
and Haemophilus##7##2##(1994-11#1)(1995-3#1)(1995-5#3)(2008-5#1)(2010-10#1)
and Hand##3##2##(2008-9#3)
and Hansenula polymorpha##2##3##(2008-11#1)(2013-1#1)
and Hap4/Hap2 dihaplotype##2##3##(2011-1#2)
and Hargal##3##2##(2008-12#3)
and Hartman##2##2##(1991-5#1)(2010-12#1)
and Harvard Medical School##2##4##(2008-4#1)(2010-5#1)
and Harvard##3##2##(2008-12#1)(2008-4#1)(2010-5#1)
and Harvest Index (HI)##2##4##(2008-12#2)
and Hawaii##2##2##(2007-5#1)(2008-10#1)
and Hb &gt##2##3##(1996-12#2)
and Hb##7##2##(1990-7#1)(1996-12#2)(2008-10#1)(2008-12#2)(2011-2#1)
and HbA1c##2##2##(2011-2#1)(2012-3#1)
and He##2##2##(2008-8#1)(2010-7#1)
and HeLa cells##3##3##(1996-5#2)(2008-8#1)
and HeLa##4##2##(1996-5#2)(2008-8#2)
and Health Care##3##3##(1994-12#1)(2008-11#2)
and Health##48##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#16)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)
and Healthy##2##2##(2013-1#1)(2013-8#1)
and Helicobacter pylori##3##3##(1991-8#1)(1997-1#1)(2008-7#1)
and Helicobacter##4##2##(1991-8#1)(1997-1#1)(2008-7#1)(2012-12#1)
and Heliospheric##3##2##(2008-2#1)(2008-3#2)
and Henry##2##2##(1990-11#1)(2008-6#1)
and HepG2##3##2##(2007-10#1)(2012-12#1)(2013-1#1)
and Hepatic##2##2##(2008-10#1)(2013-1#1)
and Hepatitis B##2##3##(2008-10#1)(2012-3#1)
and Hepatitis##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
and Heterodera glycines##4##3##(2008-10#4)
and Hf##2##2##(1997-7#1)(2008-10#1)
and Hf(IV)##7##2##(2008-10#7)
and Hg##9##2##(1990-5#4)(2006-6#1)(2008-10#4)
and Hg(2+)##10##2##(2008-10#10)
and Hg(II)##3##2##(2008-10#3)
and HiPco##2##2##(2008-10#2)
and High##3##2##(1995-6#1)(2008-3#1)(2012-2#1)
and His-241##6##2##(1992-3#6)
and Hispanic##11##2##(1994-9#1)(2008-1#1)(2008-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)
and Hispanics##5##2##(1995-12#1)(2010-3#1)(2010-4#1)(2011-2#2)
and Histological##2##2##(1995-4#1)(2007-10#1)
and Hoechst 33342##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
and Hoechst##4##2##(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
and Hoehn &amp##2##3##(2008-7#2)
and Holstein##4##2##(2013-1#4)
and Holter##3##2##(1996-3#3)
and Honduras##2##2##(1992-5#1)(2008-10#1)
and Hong Kong##4##3##(2008-2#1)(2008-5#2)(2011-1#1)
and Hospital##9##2##(1991-12#1)(1992-1#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
and Hospitals##2##2##(1991-2#1)(1997-1#1)
and Host Specificity##3##3##(2008-10#3)
and Host##6##2##(2008-10#6)
and Hsp90##3##2##(1997-4#1)(2010-4#1)(2012-12#1)
and Human##19##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)
and Hx##4##2##(2008-10#4)
and HxfB##2##2##(2008-10#2)
and Hydraenidae##2##2##(2007-12#2)
and Hydrocote##2##2##(1995-3#2)
and Hymenolepis##2##2##(2008-12#1)(2011-2#1)
and I have##2##3##(2007-11#1)(2009-10#1)
and I##35##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-6#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#3)
and I've been##2##3##(2008-2#1)(2010-9#1)
and I(-)##5##2##(2008-10#5)
and I02##2##2##(2011-2#2)
and I720K##2##2##(2013-1#2)
and I=0##3##2##(2008-10#3)
and IAPP##2##2##(1992-6#1)(2010-11#1)
and IBA##2##2##(2008-10#1)(2008-12#1)
and IBD were##2##3##(2008-12#2)
and IBD##4##2##(2008-12#2)(2010-12#2)
and IC-PCR##2##2##(2008-10#2)
and ICA##2##2##(2008-7#1)(2013-1#1)
and ICCG##3##2##(2008-7#3)
and ICD-10##6##2##(1991-1#1)(1994-6#2)(2008-11#1)(2012-12#1)(2013-7#1)
and ICH volume##3##3##(2007-10#1)(2012-3#2)
and ICH##4##2##(2007-10#1)(2012-3#3)
and ICP##3##2##(2008-10#2)(2008-7#1)
and ICP-AES determination of##3##4##(2008-10#3)
and ICP-AES determination##4##3##(2008-10#4)
and ICP-AES##9##2##(2008-10#9)
and ICP-MS##4##2##(2008-10#4)
and ICP-OES##6##2##(2008-10#6)
and ICU##2##2##(1996-3#1)(2007-8#1)
and IF2##3##2##(1991-12#2)(1991-5#1)
and IFN gamma##2##3##(1994-12#1)(1996-2#1)
and IFN##3##2##(1994-12#1)(1996-2#2)
and IFN-gamma##10##2##(1993-12#3)(1994-8#1)(2008-10#2)(2008-11#3)(2009-12#1)
and IFN-γ##5##2##(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)
and IGF##4##2##(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
and IGF-1##9##2##(1994-11#5)(1996-2#1)(2008-3#1)(2008-9#2)
and IGF-I mRNA##4##3##(2008-9#2)(2010-5#2)
and IGF-I signaling##2##3##(1997-1#1)(2008-6#1)
and IGF-I##22##2##(1991-5#1)(1992-4#1)(1992-9#1)(1996-2#2)(1997-1#1)(2008-6#1)(2008-8#2)(2008-9#4)(2010-5#5)(2010-8#1)(2011-1#1)(2012-3#2)
and IGF-binding##2##2##(2011-1#1)(2013-1#1)
and IGFBP-3##7##2##(2008-4#1)(2008-5#1)(2011-1#3)(2013-1#2)
and II are##2##3##(1991-12#1)(2008-10#1)
and II genes##2##3##(2008-10#2)
and II##90##2##(1991-12#3)(1991-2#2)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-12#6)(1995-5#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-5#1)(2006-6#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#32)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)
and II)##11##2##(1991-11#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#1)
and III in##4##3##(2008-1#1)(2008-6#1)(2008-7#2)
and III were##2##3##(2007-8#1)(2008-11#1)
and III##41##2##(1990-8#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#2)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#1)(2013-8#3)
and III)##7##2##(1995-5#1)(2008-10#3)(2008-5#1)(2011-2#2)
and IIIa##2##2##(1994-7#1)(2011-3#1)
and IKDC scores##2##3##(2013-1#2)
and IKDC##5##2##(2013-1#5)
and IL-1 alpha##2##3##(1993-8#1)(1996-12#1)
and IL-1 beta##3##3##(1995-2#1)(1996-12#1)(2008-4#1)
and IL-1##9##2##(1990-5#2)(1993-6#1)(1993-8#1)(1995-2#1)(1996-12#3)(2008-4#1)
and IL-10 production##2##3##(2008-11#2)
and IL-10##13##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-12#4)(2011-3#2)(2012-12#1)(2013-1#1)
and IL-12##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
and IL-1Ra##4##2##(1996-12#4)
and IL-1alpha##2##2##(2008-10#1)(2008-5#1)
and IL-1beta levels##3##3##(1997-7#3)
and IL-1beta##6##2##(1997-7#3)(2007-8#1)(2008-11#1)(2008-5#1)
and IL-2##10##2##(1991-12#2)(1991-6#1)(1992-8#1)(1994-5#1)(1995-5#1)(2008-11#1)(2008-7#2)(2008-8#1)
and IL-4##8##2##(1992-5#1)(2008-11#7)
and IL-5##4##2##(1994-11#1)(2007-2#1)(2010-12#1)(2012-3#1)
and IL-6 in##3##3##(1994-6#1)(2008-10#1)(2008-6#1)
and IL-6 levels##2##3##(2008-6#1)(2013-1#1)
and IL-6 might be##2##4##(2008-3#1)(2013-1#1)
and IL-6##21##2##(1994-6#2)(1995-12#2)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)
and IL-7 gene##3##3##(1995-2#3)
and IL-8##3##2##(1996-12#2)(2008-10#1)
and IL5##3##2##(2008-7#3)
and IMT##4##2##(2008-3#2)(2008-8#1)(2011-2#1)
and IN##2##2##(2008-10#1)(2013-1#1)
and IP##2##2##(2008-7#1)(2008-9#1)
and IP-10/CXCL10##2##2##(2012-1#2)
and IPC##2##2##(2010-1#1)(2013-8#1)
and IPV##2##2##(1995-5#1)(2011-2#1)
and IR spectra##4##3##(1996-2#1)(2008-10#2)(2013-8#1)
and IR spectroscopy##3##3##(1996-2#2)(2008-10#1)
and IR##17##2##(1996-2#4)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#3)(2013-8#1)
and IRS-2##3##2##(2008-6#3)
and IRSs##2##2##(2008-12#2)
and ISF-induced microsomes##2##3##(1994-8#2)
and ITO##2##2##(2009-11#2)
and ITS##6##2##(2008-10#5)(2010-3#1)
and ITS-2 regions##2##3##(2008-10#2)
and ITS1##2##2##(2008-10#2)
and ITS2 regions##2##3##(2008-10#1)(2010-10#1)
and ITS2##4##2##(2008-10#3)(2010-10#1)
and ITS2)##5##2##(2008-10#4)(2008-12#1)
and ITS4##2##2##(2008-10#2)
and IV of the##4##4##(1990-8#1)(1997-3#1)(2011-2#2)
and IV of##5##3##(1990-8#1)(1996-6#1)(1997-3#1)(2011-2#2)
and IV were##3##3##(1996-6#1)(2008-12#1)(2013-1#1)
and IV##39##2##(1990-12#1)(1990-8#1)(1991-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-6#2)(1997-3#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#9)(2012-3#1)(2013-1#2)(2013-8#2)
and IV)##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and IVD101 medium##3##3##(2008-11#3)
and IX##6##2##(1990-8#1)(1995-8#1)(2008-10#1)(2011-2#3)
and Identification of##6##3##(2008-10#6)
and Identification##8##2##(1995-2#1)(2008-10#6)(2008-5#1)
and IgA antibodies##4##3##(1990-2#1)(1994-2#1)(2008-4#1)(2008-7#1)
and IgA in##3##3##(1996-12#1)(2008-11#1)(2008-7#1)
and IgA production##2##3##(2008-11#2)
and IgA##18##2##(1990-2#1)(1991-2#1)(1994-2#1)(1996-12#3)(2007-10#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2010-4#1)(2013-1#1)
and IgE production##2##3##(2008-11#2)
and IgE##4##2##(1991-9#1)(2008-11#2)(2013-1#1)
and IgG##19##2##(1990-3#1)(1991-12#1)(1992-8#1)(1994-9#2)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2012-2#1)
and IgG1##3##2##(2008-10#3)
and IgG2##2##2##(1995-11#2)
and IgG3##5##2##(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)
and IgM##12##2##(1990-12#1)(1992-9#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-7#4)(2011-2#1)
and Il-5##3##2##(2009-5#3)
and Illinois##3##2##(1997-2#1)(2008-10#2)
and Image Analysis##2##3##(2008-10#2)
and Image Display System (CAPIDS)##2##5##(2011-1#2)
and Image##4##2##(2008-10#2)(2011-1#2)
and Imaging##2##2##(2009-8#1)(2013-8#1)
and Impatiens##2##2##(2008-10#1)(2008-5#1)
and Implications for##3##3##(2008-10#2)(2008-2#1)
and Improvement##2##2##(1996-6#1)(1997-2#1)
and Improving##2##2##(2010-8#1)(2013-1#1)
and In Planta##3##3##(2008-10#3)
and In##13##2##(1997-7#1)(2008-1#1)(2008-10#9)(2011-1#1)(2012-2#1)
and In(3+)##2##2##(2008-10#2)
and In(III)##4##2##(2008-10#4)
and InP##2##2##(2008-3#2)
and InSb and of evaporated Cr##2##6##(2008-3#2)
and Increases##2##2##(2008-10#1)(2008-6#1)
and India##12##2##(2008-10#4)(2008-7#1)(2010-12#4)(2011-1#1)(2012-12#1)(2012-3#1)
and Indian##5##2##(2008-10#2)(2010-3#2)(2012-12#1)
and Induced##3##2##(2008-10#3)
and Induces##2##2##(2008-10#1)(2010-6#1)
and Industrial##3##2##(2008-3#2)(2009-12#1)
and Industriousness##3##2##(2012-1#3)
and Infant##4##2##(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)
and Infection of##3##3##(2008-10#3)
and Infection##4##2##(2008-10#4)
and Infectious Disease##3##3##(1995-12#1)(2007-12#1)(2007-2#1)
and Infectious##7##2##(1995-12#1)(2007-12#1)(2007-2#1)(2008-5#3)(2011-2#1)
and Inflammation##2##2##(2008-3#1)(2013-1#1)
and Information##9##2##(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-2#1)(2011-2#2)(2013-1#1)
and Ingie##2##2##(2012-1#2)
and Inhibition##2##2##(2011-2#1)(2013-1#1)
and Insulin##3##2##(2008-8#1)(2010-8#1)(2012-2#1)
and Intended Adopters##2##3##(2010-8#2)
and Intended##3##2##(2010-8#3)
and Interaction##2##2##(2008-10#1)(2012-3#1)
and Intermediate##2##2##(2009-5#1)(2009-8#1)
and Internal Transcribed Spacer##2##4##(2008-10#2)
and Internal##4##2##(1997-7#1)(2008-10#2)(2008-3#1)
and International##2##2##(1995-1#1)(2008-10#1)
and Internet##4##2##(2008-11#1)(2008-12#1)(2013-8#2)
and Intralipid##3##2##(2008-3#3)
and Inula##2##2##(2008-10#1)(2008-5#1)
and Invasion of##2##3##(2010-8#1)(2012-3#1)
and Iowa##2##2##(2008-10#2)
and Ireland##7##2##(2008-10#2)(2008-12#1)(2008-9#2)(2009-5#1)(2012-2#1)
and Is##3##2##(2008-10#3)
and Islands (p = 0##2##5##(2011-2#2)
and Islands##6##2##(2011-2#6)
and Israel##7##2##(1996-2#1)(2008-10#5)(2008-11#1)
and Israeli##3##2##(2008-1#1)(2008-10#2)
and Italian##2##2##(2008-10#1)(2008-11#1)
and Italy##6##2##(1992-8#1)(2008-10#2)(2011-2#3)
and Its Clinical##2##3##(2012-12#2)
and Its Effect on##3##4##(2008-10#2)(2012-3#1)
and Its Effects on##2##4##(2008-10#1)(2008-2#1)
and Its Impact on##2##4##(2008-10#1)(2012-12#1)
and Its Relationship##2##3##(2008-10#2)
and Its Use##2##3##(2008-10#2)
and Its##31##2##(1990-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#18)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
and Ixodes##2##2##(2008-5#1)(2011-1#1)
and J##9##2##(1991-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-5#3)(2010-2#1)(2011-2#1)
and JNK activation##2##3##(2008-4#1)(2012-12#1)
and JNK##7##2##(2008-4#2)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#2)
and Jamaica##2##2##(2011-2#2)
and January 31##2##3##(1993-2#1)(2011-2#1)
and January##12##2##(1993-2#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)(2012-1#1)
and Japan was##2##3##(2008-10#2)
and Japan##19##2##(1991-11#1)(2007-5#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-8#2)(2010-12#1)
and Japanese##4##2##(2008-10#3)(2012-1#1)
and Jeddah##2##2##(2008-1#1)(2013-1#1)
and Jkb##3##2##(1994-12#1)(1994-3#2)
and John##8##2##(1990-8#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#4)
and Johnson##3##2##(1992-6#1)(2008-3#1)(2010-8#1)
and Jordan##3##2##(1992-3#2)(2009-2#1)
and Joystick##2##2##(2012-2#2)
and Jsa##3##2##(1994-12#3)
and July 2002##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
and July 2008##2##3##(2011-2#2)
and July##14##2##(1994-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
and June 2009##3##3##(2010-4#1)(2011-2#2)
and June##17##2##(1991-1#1)(1993-5#1)(1994-9#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#4)(2013-8#1)
and June-July##2##2##(2008-5#1)(2013-7#1)
and Jurkat##2##2##(1991-9#1)(2008-8#1)
and K =##2##3##(2008-2#1)(2008-9#1)
and K in##3##3##(1996-4#1)(2008-10#1)(2013-7#1)
and K##22##2##(1990-8#1)(1991-5#1)(1994-8#2)(1996-4#2)(1997-2#1)(2007-7#1)(2008-10#6)(2008-12#3)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
and K(+) and##3##3##(2008-10#3)
and K(+) are##2##3##(2008-10#2)
and K(+)##16##2##(2008-10#11)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
and K)##2##2##(2008-10#2)
and K+ currents##2##3##(1994-11#1)(1996-2#1)
and K+##10##2##(1990-7#2)(1992-6#2)(1994-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
and K-ras##3##2##(1993-11#1)(2009-12#1)(2009-8#1)
and KBr##2##2##(2007-12#1)(2008-10#1)
and KC chemokine##2##3##(2008-10#2)
and KD##2##2##(1990-7#1)(2012-2#1)
and KDR##2##2##(2008-9#2)
and KI##3##2##(2008-10#3)
and KMnO(4) in##2##3##(2008-10#2)
and KMnO(4)##3##2##(2008-10#3)
and KOH##2##2##(2007-7#2)
and Kaposi's sarcoma##2##3##(1990-8#1)(1996-8#1)
and Karnofsky##3##2##(2007-11#3)
and Kashmir##3##2##(2011-2#2)(2013-8#1)
and Kd2##2##2##(1991-8#1)(1995-11#1)
and Kelly##2##2##(1993-12#1)(2008-10#1)
and Key##3##2##(1993-2#1)(2008-4#1)(2008-9#1)
and Ki = 0##2##4##(1991-5#1)(1993-8#1)
and Ki values for##2##4##(1990-12#1)(1991-12#1)
and Ki values##4##3##(1990-12#1)(1991-12#2)(1994-6#1)
and Ki##6##2##(1990-12#1)(1991-12#2)(1991-5#1)(1993-8#1)(1994-6#1)
and Ki-67##5##2##(2008-6#1)(2010-8#1)(2013-8#3)
and Kim##3##2##(1991-12#2)(1997-8#1)
and Kirchhoff's##2##2##(2008-2#2)
and Klebsiella pneumoniae##3##3##(2007-7#2)(2011-2#1)
and Klebsiella##4##2##(2007-7#2)(2011-2#2)
and Klotz plot##2##3##(2008-10#2)
and Km parameters##2##3##(1991-9#1)(1995-2#1)
and Km values for##2##4##(1991-12#1)(1995-2#1)
and Km values##3##3##(1990-2#1)(1991-12#1)(1995-2#1)
and Km##9##2##(1990-2#1)(1991-12#1)(1991-9#2)(1992-6#1)(1994-8#1)(1995-2#3)
and Knowledge##2##2##(2007-2#1)(2008-7#1)
and Kruskal-Wallis##3##2##(1994-2#1)(2008-9#1)(2013-1#1)
and Kupffer##2##2##(1997-6#1)(2008-4#1)
and Kv7##2##2##(2008-8#2)
and Kviteseid##2##2##(1994-11#2)
and Kyrgyzstan were##2##3##(2008-10#2)
and Kyrgyzstan##3##2##(2008-10#3)
and L##31##2##(1990-12#2)(1990-2#1)(1992-12#1)(1993-6#4)(1993-8#1)(2006-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-8#1)(2011-10#1)(2011-2#4)(2012-2#1)(2012-3#1)
and L(S)##2##2##(2010-8#2)
and L)##2##2##(1995-12#1)(2008-10#1)
and L-683##2##2##(1993-8#2)
and L-FABP##3##2##(1994-8#1)(2013-1#2)
and L-arginine##4##2##(1993-8#1)(1997-7#2)(2010-12#1)
and L-citrulline levels##2##3##(1990-12#1)(2007-10#1)
and L-citrulline##4##2##(1990-12#1)(2007-10#3)
and L-methionine##2##2##(1996-2#1)(2008-10#1)
and L-type##3##2##(1990-8#1)(2008-8#1)(2009-8#1)
and L2##2##2##(2011-2#1)(2013-1#1)
and L3##2##2##(1993-12#1)(2008-3#1)
and L4##5##2##(1991-2#2)(2008-10#1)(2008-8#1)(2011-2#1)
and LA##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
and LA4+##2##2##(2008-10#2)
and LAK cells##3##3##(1990-12#1)(1993-6#1)(1994-6#1)
and LAK##6##2##(1990-12#1)(1991-8#1)(1992-2#2)(1993-6#1)(1994-6#1)
and LB##3##2##(2008-11#2)(2012-2#1)
and LC##2##2##(2008-10#1)(2008-3#1)
and LD##2##2##(2008-7#2)
and LDH##5##2##(1994-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
and LDL cholesterol as##3##4##(1992-11#1)(1993-12#1)(2012-2#1)
and LDL cholesterol##7##3##(1991-6#1)(1992-11#1)(1993-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
and LDL##18##2##(1990-3#1)(1991-6#1)(1992-11#1)(1993-12#1)(1994-11#1)(1995-5#1)(1995-6#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
and LDL-C levels##2##3##(2008-12#2)
and LDL-C##4##2##(2008-12#2)(2011-1#1)(2011-2#1)
and LDL-C &lt##2##2##(2012-6#2)
and LDL-cholesterol##5##2##(1991-6#1)(1993-12#1)(1993-2#1)(2008-10#2)
and LGA##2##2##(2011-1#2)
and LH receptor in the##2##5##(2008-8#2)
and LH receptor in##3##4##(2008-8#3)
and LH receptor##4##3##(2008-8#4)
and LH##13##2##(1990-6#1)(1995-11#1)(1996-2#3)(1996-7#1)(2008-7#1)(2008-8#4)(2011-2#1)(2013-8#1)
and LIF##4##2##(1996-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
and LIN-12##3##2##(2007-12#3)
and LL patients##2##3##(2007-7#2)
and LL##4##2##(2007-7#4)
and LM##2##2##(2008-6#1)(2008-9#1)
and LMH##2##2##(1993-12#2)
and LMWH##2##2##(2008-8#1)(2013-1#1)
and LN##2##2##(1993-9#1)(1995-1#1)
and LOD##3##2##(2008-10#3)
and LOQ##3##2##(2008-10#3)
and LP##3##2##(2008-10#1)(2012-2#2)
and LPS##8##2##(1993-11#1)(1995-12#3)(1997-8#1)(2008-11#1)(2012-1#2)
and LS##2##2##(2008-7#1)(2012-3#1)
and LTB4##2##2##(1991-8#1)(1994-8#1)
and LV##3##2##(2011-2#1)(2012-2#1)(2013-7#1)
and LY294002##2##2##(1995-8#2)
and La##6##2##(2007-5#1)(2008-10#3)(2008-5#1)(2013-7#1)
and Laboratory##4##2##(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
and Lachin##2##2##(1992-6#1)(1997-3#1)
and Lactobacillus##4##2##(1993-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
and Lactococcus lactis##3##3##(1991-9#2)(1995-8#1)
and Laminaria##2##2##(2008-10#1)(2013-1#1)
and Langmuir##5##2##(2008-10#4)(2008-6#1)
and Lanzarote##2##2##(2008-10#2)
and Large##2##2##(1996-9#1)(2008-3#1)
and Late##2##2##(2008-10#2)
and Latin America##4##3##(1993-1#1)(1993-3#1)(2009-4#1)(2011-2#1)
and Latin##6##2##(1993-1#1)(1993-3#1)(2008-10#1)(2008-2#1)(2009-4#1)(2011-2#1)
and Lauridromia intermedia##2##3##(2007-12#2)
and Learning##4##2##(2008-11#3)(2010-8#1)
and Leishmania##2##2##(1991-6#1)(2013-1#1)
and Leporinus##2##2##(2008-7#1)(2013-7#1)
and Ler##2##2##(2012-3#2)
and Lettuce##2##2##(2008-10#2)
and Lewisite##2##2##(2008-11#2)
and Leydig cell##2##3##(1992-12#1)(2008-4#1)
and Leydig##3##2##(1992-12#1)(2008-4#1)(2009-10#1)
and Lifestyle##2##2##(2008-12#1)(2011-2#1)
and Light##2##2##(2008-10#1)(2008-3#1)
and Lincoln Stein##2##3##(2008-7#2)
and Lincoln##3##2##(2008-7#2)(2011-2#1)
and Linear Discriminant Analysis##2##4##(2008-10#2)
and Linked##2##2##(1997-7#1)(2009-5#1)
and Listeria monocytogenes##2##3##(2008-10#2)
and Listeria##3##2##(1997-4#1)(2008-10#2)
and Literacy##2##2##(1996-1#1)(2011-2#1)
and Literature Review##5##3##(2006-10#1)(2011-2#3)(2012-3#1)
and Local##3##2##(1991-1#1)(2008-10#2)
and London##2##2##(1995-12#1)(2008-7#1)
and Longitudinal##2##2##(2008-3#1)(2008-8#1)
and Louisiana##3##2##(2008-10#2)(2013-8#1)
and Lowry##3##2##(2008-10#3)
and Lp(a)##2##2##(2013-7#2)
and Lr23 and adult plant genes Lr13 and Lr34##2##9##(2008-10#2)
and Lr23##5##2##(2008-10#5)
and Lr26##2##2##(2008-10#2)
and Ltnβ##2##2##(2011-1#2)
and Lu(III)##2##2##(2008-10#2)
and Lu)##2##2##(2008-10#2)
and Lung##4##2##(2008-5#1)(2010-8#1)(2011-2#2)
and Lymphocytes##2##2##(2008-8#2)
and Lys##3##2##(1992-3#2)(1995-2#1)
and Lys)##2##2##(1990-2#1)(2006-12#1)
and M proteins##2##3##(1997-4#1)(2008-5#1)
and M##87##2##(1992-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#47)(2008-12#1)(2008-5#7)(2008-6#3)(2008-7#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)
and M(1)##2##2##(2008-11#1)(2011-2#1)
and M(2)##2##2##(2007-11#1)(2008-11#1)
and M(sum)##2##2##(2013-1#2)
and M+TTH##2##2##(2012-3#2)
and M19 were##2##3##(2008-10#2)
and M19##3##2##(2008-10#3)
and M2##10##2##(1990-2#3)(1992-10#2)(1992-8#1)(1996-5#1)(1997-7#1)(2007-12#1)(2010-4#1)
and M2)##2##2##(1997-3#1)(2008-10#1)
and M5##5##2##(1991-2#1)(1997-3#3)(2008-11#1)
and M6##3##2##(1991-2#1)(1997-7#1)(2008-5#1)
and MA##2##2##(2013-1#1)(2013-8#1)
and MALDI-TOF##2##2##(2008-8#1)(2009-2#1)
and MALDI-TOF-MS##2##2##(2009-9#1)(2010-12#1)
and MAO##3##2##(2009-12#2)(2009-8#1)
and MAO-B##2##2##(1994-6#1)(1994-8#1)
and MAP kinase##3##3##(1995-2#1)(1995-8#1)(1997-6#1)
and MAP##5##2##(1995-2#1)(1995-8#1)(1997-6#1)(2013-8#2)
and MAPK##2##2##(2008-8#1)(2011-2#1)
and MBP##2##2##(1992-11#1)(1995-12#1)
and MC##3##2##(1990-7#1)(2008-10#2)
and MCAO+EA##2##2##(2008-10#2)
and MCS##2##2##(2013-1#2)
and MDA##4##2##(1996-2#1)(2008-5#1)(2009-5#2)
and MDA-MB-231##2##2##(1992-9#1)(2008-11#1)
and MDD##4##2##(2008-10#1)(2009-9#3)
and MDM2##2##2##(2011-2#2)
and MEDLINE databases for##2##4##(1994-3#1)(2013-1#1)
and MEDLINE databases##3##3##(1994-3#1)(2009-7#1)(2013-1#1)
and MEDLINE##6##2##(1991-1#1)(1994-3#2)(2009-7#1)(2012-3#1)(2013-1#1)
and MEP##2##2##(2011-2#1)(2012-2#1)
and MESS-2##4##2##(2008-10#4)
and MF##2##2##(1992-5#1)(2010-9#1)
and MFS##2##2##(1994-12#1)(2008-6#1)
and MG##3##2##(2008-10#3)
and MHC class I##2##4##(2008-1#1)(2008-7#1)
and MHC class II##2##4##(1995-12#1)(1997-8#1)
and MHC class##6##3##(1995-12#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-8#1)
and MHC##9##2##(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-8#1)
and ML##2##2##(2008-5#1)(2008-9#1)
and MM##4##2##(1991-8#1)(2008-10#2)(2011-2#1)
and MMA##2##2##(1995-11#1)(2008-10#1)
and MMP-2 activity##3##3##(2011-2#3)
and MMP-2##6##2##(2008-11#1)(2011-2#4)(2013-1#1)
and MMP-9##12##2##(1993-3#1)(1997-3#3)(2012-3#8)
and MMRPE##2##2##(2013-1#2)
and MO##2##2##(1994-3#1)(2013-8#1)
and MP##6##2##(2008-10#2)(2010-2#1)(2011-1#1)(2013-1#2)
and MPP+##2##2##(1995-5#2)
and MPhi##5##2##(2010-1#5)
and MR angiography##2##3##(1997-8#1)(2007-10#1)
and MR findings in##2##4##(1996-6#1)(2011-2#1)
and MR findings##3##3##(1996-6#1)(1997-8#1)(2011-2#1)
and MR for##2##3##(2012-2#2)
and MR imaging##6##3##(1997-8#2)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
and MR##18##2##(1996-6#1)(1997-8#6)(2007-10#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#3)
and MR-1##2##2##(1990-7#2)
and MRA##3##2##(2007-10#1)(2008-10#1)(2012-2#1)
and MRI findings##4##3##(2007-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
and MRI scan##2##3##(2007-8#1)(2008-9#1)
and MRI##38##2##(1992-6#1)(2007-10#2)(2007-11#4)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#5)(2013-1#3)
and MRV findings##2##3##(2012-3#2)
and MRV##3##2##(2012-3#3)
and MS in##3##3##(2008-3#2)(2011-1#1)
and MS##18##2##(1994-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-10#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
and MS/MS##2##2##(2008-10#1)(2008-8#1)
and MSA##3##2##(2008-10#1)(2008-7#2)
and MSA-P##4##2##(2008-7#4)
and MT##3##2##(2008-5#2)(2013-1#1)
and MTT##5##2##(2007-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
and MVK##2##2##(1995-11#1)(1996-5#1)
and MaYMFV##2##2##(2008-10#2)
and Mages are##2##3##(2008-9#2)
and Magnaporthe grisea##3##3##(1997-6#1)(2008-10#2)
and Magnetic##3##2##(1997-7#3)
and Maintenance##2##2##(2008-1#1)(2010-8#1)
and Maize mosaic virus##2##4##(2008-10#2)
and Maize##3##2##(2008-10#3)
and Making a Difference##2##4##(2008-11#2)
and Malassezia furfur##2##3##(2008-5#2)
and Malus##2##2##(2008-10#2)
and Man-76##3##2##(2008-10#3)
and Management of Acute##2##4##(2008-12#1)(2008-4#1)
and Management of##5##3##(2008-12#1)(2008-4#1)(2010-8#1)(2010-9#1)(2011-2#1)
and Management##11##2##(1997-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Mandarin##3##2##(2008-9#2)(2013-8#1)
and Manitoba##3##2##(1994-2#1)(2010-8#2)
and Mantoux test##2##3##(2008-1#1)(2012-3#1)
and Map##2##2##(2010-5#1)(2011-2#1)
and Mapping of##4##3##(2008-10#4)
and March 2000##2##3##(2007-7#2)
and March 2001##2##3##(2007-8#1)(2008-5#1)
and March 2005##2##3##(2008-9#1)(2010-3#1)
and March 2006##2##3##(2009-3#1)(2012-3#1)
and March 2010##2##3##(2012-2#1)(2013-1#1)
and March 31##2##3##(2008-11#1)(2013-1#1)
and March##21##2##(1995-5#1)(1996-6#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and Marital Quality##2##3##(2007-10#1)(2011-2#1)
and Markers##2##2##(2008-10#1)(2008-5#1)
and Maryland##3##2##(1997-2#1)(2008-10#2)
and Materials##2##2##(2011-1#1)(2013-8#1)
and Maternal##2##2##(2012-12#2)
and Matric##2##2##(2008-10#2)
and May##16##2##(1996-9#1)(2007-7#1)(2008-10#10)(2008-5#1)(2010-2#1)(2012-2#1)(2012-3#1)
and Mayo##3##2##(1997-2#1)(2008-9#2)
and MeHg(+)##4##2##(2008-10#4)
and Meckel's cave##2##3##(2011-2#2)
and Meckel's##3##2##(2011-2#3)
and Medicaid recipients##3##3##(1992-2#1)(1995-12#1)(1995-3#1)
and Medicaid##39##2##(1991-12#2)(1991-2#2)(1991-3#3)(1992-12#4)(1992-2#2)(1992-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#6)(1996-3#4)(1997-2#4)(1997-3#4)(2008-11#1)(2008-12#1)
and Medical##12##2##(1991-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)
and Medicare Part##3##3##(1996-2#2)(2010-5#1)
and Medicare##14##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(2010-5#1)
and Medicine##4##2##(2008-7#1)(2009-7#1)(2010-2#1)(2013-1#1)
and Mediterranean##2##2##(2008-10#2)
and Medley PC##2##3##(2011-2#2)
and Medline##3##2##(2009-2#1)(2011-2#2)
and Meloidogyne##2##2##(2008-10#2)
and Memory##3##2##(2008-12#2)(2010-6#1)
and Meniere's disease##2##3##(2012-3#2)
and Mental Health##4##3##(2009-6#1)(2012-12#2)(2013-1#1)
and Mental##5##2##(2009-6#1)(2010-12#1)(2012-12#2)(2013-1#1)
and Mesoamerican groups##2##3##(2008-10#2)
and Metabolic Syndrome in##2##4##(2008-3#2)
and Metabolic Syndrome##4##3##(2008-3#2)(2008-8#1)(2013-1#1)
and Metabolic##7##2##(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Method##4##2##(2007-12#1)(2008-6#1)(2010-8#1)(2013-1#1)
and Methods##100##2##(2007-11#2)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#6)(2008-7#10)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#49)(2013-8#15)
and Mexican##3##2##(2008-10#2)(2009-4#1)
and Mexico##11##2##(2008-10#6)(2008-12#1)(2008-5#2)(2013-8#2)
and Mg x 624 A##4##5##(2008-3#4)
and Mg##14##2##(1991-5#2)(1997-6#1)(2008-10#6)(2008-3#4)(2008-8#1)
and Mg(2+) were##2##3##(2008-10#1)(2010-4#1)
and Mg(2+)##13##2##(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)(2010-4#1)
and Mg(II) in##3##3##(2008-10#3)
and Mg(II)##4##2##(2008-10#4)
and Mg)##2##2##(2008-10#2)
and Mg2+##13##2##(1990-5#1)(1990-7#1)(1991-9#1)(1993-11#3)(1994-6#1)(1995-11#2)(1995-6#3)(2008-5#1)
and MgCl2##3##2##(1993-6#1)(1993-9#1)(2008-1#1)
and MgF(2)##2##2##(2008-10#1)(2008-3#1)
and MgO##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
and MiLV##3##2##(2008-10#3)
and Michael##2##2##(1994-2#1)(2013-1#1)
and Michigan##6##2##(1992-2#2)(1992-3#1)(1995-12#2)(2008-10#1)
and Microdochium nivale##2##3##(2008-10#2)
and Microsporum canis##2##3##(2008-5#2)
and Middle##2##2##(2008-10#2)
and Mie theory##2##3##(2008-2#1)(2008-3#1)
and Mie##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
and Migration of##2##3##(2010-8#1)(2012-1#1)
and Migration##3##2##(2008-10#1)(2010-8#1)(2012-1#1)
and Miller##2##2##(2008-10#1)(2008-7#1)
and Minnesota##4##2##(2008-10#4)
and Mirafiori lettuce virus##2##4##(2008-10#2)
and Missouri##3##2##(2008-10#3)
and Mn in##5##3##(2008-10#4)(2010-8#1)
and Mn prior to their determination by##2##7##(2008-10#2)
and Mn##27##2##(2008-10#24)(2008-7#1)(2010-8#2)
and Mn(2+)##4##2##(2008-10#3)(2012-12#1)
and Mn(II)##7##2##(2008-10#7)
and Mo##6##2##(2008-10#6)
and Mo(VI)##4##2##(2008-10#3)(2010-11#1)
and Molecular Characterization of##5##4##(2008-10#4)(2012-2#1)
and Molecular Characterization##6##3##(2008-10#5)(2012-2#1)
and Molecular Mapping of a##3##5##(2008-10#3)
and Molecular Markers##2##3##(2008-10#2)
and Molecular##27##2##(1994-12#1)(1996-10#1)(1996-2#1)(1997-7#2)(2008-10#19)(2009-5#1)(2012-2#1)(2013-1#1)
and Molt-4 cells##2##3##(1997-4#2)
and Monitoring##2##2##(1997-8#1)(2013-1#1)
and Mono##2##2##(1991-12#1)(1992-9#1)
and Monte Carlo simulation##2##4##(2008-3#2)
and Monte Carlo simulations##3##4##(2008-2#1)(2008-3#1)(2012-3#1)
and Monte Carlo##6##3##(2008-12#1)(2008-2#1)(2008-3#3)(2012-3#1)
and Morocco##3##2##(2008-10#2)(2008-12#1)
and Mossbauer##2##2##(1997-7#1)(2012-12#1)
and Mp705##2##2##(2008-10#2)
and Mr##3##2##(1991-12#1)(1997-7#2)
and Ms##2##2##(1992-12#1)(1994-3#1)
and Mucor##2##2##(2008-5#1)(2008-6#1)
and Multi##2##2##(2010-8#1)(2011-2#1)
and Munk##2##2##(2008-2#1)(2008-3#1)
and Mycobacterium bovis BCG##2##4##(1996-11#1)(1997-4#1)
and Mycobacterium bovis##4##3##(1996-11#1)(1997-4#1)(2012-3#2)
and Mycobacterium tuberculosis##3##3##(1993-3#1)(2011-2#1)(2012-2#1)
and Mycobacterium##11##2##(1993-3#1)(1996-11#1)(1997-4#1)(2007-12#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
and Mycosphaerella##3##2##(2008-10#3)
and Mycotoxin##2##2##(2008-10#2)
and MyoD##4##2##(1993-12#1)(2009-3#3)
and Müller##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
and N is##2##3##(2008-8#1)(2009-12#1)
and N##41##2##(1990-2#1)(1991-8#1)(1992-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1997-3#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2012-1#2)(2013-1#1)
and N(2) adsorption-desorption##3##3##(2008-10#3)
and N(2)##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
and N(2)O##2##2##(2008-3#1)(2012-2#1)
and N(8)##2##2##(2008-4#1)(2011-1#1)
and N-acetyl##2##2##(1991-12#1)(1994-11#1)
and N-acetyl-cysteine##3##2##(1993-12#1)(2008-5#2)
and N-acetylcysteine##2##2##(2008-10#2)
and N-chlorosuccinimide##2##2##(2008-10#2)
and N-methyl protoporphyrin IX##3##4##(1995-12#3)
and N-terminal##9##2##(1990-8#2)(1991-2#1)(1994-11#1)(1995-2#2)(2008-2#1)(2008-7#2)
and N-terminal-formylated##2##2##(1990-8#2)
and N2##2##2##(2008-10#2)
and N3##3##2##(1990-6#1)(1993-11#1)(2008-11#1)
and NA are##3##3##(1994-8#1)(2008-11#2)
and NA metabolism in hypothalamus##2##5##(2008-8#2)
and NA##12##2##(1994-8#2)(1997-7#4)(2008-11#3)(2008-7#1)(2008-8#2)
and NABP##2##2##(2008-9#2)
and NAD##4##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
and NAD+##2##2##(1992-11#1)(1995-5#1)
and NADH in normal and cancer##3##6##(2008-10#3)
and NADH in##4##3##(2008-10#4)
and NADH were##2##3##(2008-10#1)(2008-8#1)
and NADH##16##2##(1990-11#1)(1990-7#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-9#2)(2013-1#3)
and NADP##3##2##(1990-7#3)
and NADPH##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
and NADPH-d##3##2##(1995-12#1)(1997-2#2)
and NC##6##2##(2008-10#3)(2008-11#2)(2008-5#1)
and ND##5##2##(2008-10#4)(2013-8#1)
and ND4 position##2##3##(2007-12#2)
and ND4##3##2##(2007-12#2)(2008-8#1)
and NEDD9##6##2##(2012-12#6)
and NF kappa B##2##4##(1994-6#1)(1994-8#1)
and NF-kappaB##6##2##(2008-11#2)(2008-9#4)
and NF-κB##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
and NGF##2##2##(2008-11#1)(2008-5#1)
and NH(4)(+)##2##2##(2008-10#2)
and NH3##2##2##(2008-10#2)
and NIES##2##2##(2008-10#2)
and NIH 3T3##2##3##(1993-11#2)
and NIH/3T3 cells##2##3##(1991-5#2)
and NIST SRM##2##3##(2008-10#2)
and NIST##4##2##(2008-10#4)
and NK cell##7##3##(1991-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
and NK cells##4##3##(1991-8#1)(1992-2#1)(2008-4#1)(2012-3#1)
and NK##12##2##(1991-8#2)(1992-2#1)(2008-10#1)(2008-4#2)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
and NKA##3##2##(2008-4#1)(2008-8#2)
and NMDA receptors##5##3##(1994-8#1)(1995-11#2)(1997-2#2)
and NMDA##9##2##(1994-8#1)(1995-11#2)(1997-2#5)(2008-7#1)
and NMR spectral##3##3##(2008-10#1)(2010-5#1)(2011-1#1)
and NMR spectroscopy##4##3##(1990-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
and NMR##19##2##(1990-7#1)(1991-8#1)(1992-12#2)(1994-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
and NMR)##2##2##(1991-6#1)(2008-11#1)
and NN##3##2##(1996-2#3)
and NO##19##2##(1991-12#2)(1992-3#2)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2011-3#3)(2013-8#1)
and NO(2)##6##2##(2008-10#2)(2008-3#3)(2012-2#1)
and NO2##2##2##(2008-3#2)
and NOK##2##2##(1995-2#1)(1997-4#1)
and NP##6##2##(1997-4#3)(2008-8#1)(2010-6#1)(2013-8#1)
and NPM-ALK##2##2##(2011-2#2)
and NPR1##2##2##(2008-10#1)(2011-2#1)
and NRT##4##2##(2008-6#1)(2008-9#3)
and NS##3##2##(1996-5#1)(2009-1#1)(2011-1#1)
and NT##3##2##(2008-10#2)(2008-4#1)
and NT-proBNP##4##2##(2008-7#3)(2011-2#1)
and Na##10##2##(1997-6#1)(2008-10#4)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
and Na(+)##7##2##(2008-10#4)(2008-5#1)(2008-6#1)(2012-7#1)
and Na(+)-K(+)-2Cl-##2##2##(2008-8#2)
and Na+##7##2##(1992-7#1)(1992-8#1)(1994-6#1)(1995-5#2)(2008-12#1)(2008-5#1)
and NaBH(4)##3##2##(2008-10#3)
and NaCl at##2##3##(1993-3#1)(2008-10#1)
and NaCl##15##2##(1990-7#1)(1992-3#1)(1992-6#1)(1993-3#1)(1997-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2009-8#1)(2011-1#1)
and NaOH##3##2##(2008-10#2)(2008-5#1)
and NaSA##2##2##(2008-10#2)
and Nafion sensitized##2##3##(2008-10#2)
and Nafion##5##2##(2008-10#5)
and Nagasaki##2##2##(1996-8#1)(2008-5#1)
and Naples##2##2##(1993-5#1)(2008-10#1)
and National##6##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
and Natural##2##2##(2008-10#2)
and Nb(2)O(5) as##2##3##(1996-2#1)(2008-10#1)
and Nbs1##2##2##(2011-2#2)
and Nd##6##2##(2007-11#2)(2008-10#1)(2008-3#2)(2012-2#1)
and Nd(III)##5##2##(2008-10#5)
and Nei's##3##2##(2008-10#3)
and Neisseria spp##2##3##(2011-2#2)
and Neisseria##3##2##(2010-12#1)(2011-2#2)
and Neonatal##3##2##(2008-11#1)(2010-3#2)
and Nernstian##2##2##(2008-10#2)
and Neuro-2a cells##2##3##(2008-11#2)
and Neutral##2##2##(2008-10#1)(2008-11#1)
and New Mexico##2##3##(1990-8#1)(2008-10#1)
and New World X##2##4##(2008-10#2)
and New World##5##3##(2007-12#1)(2008-10#3)(2008-8#1)
and New York##7##3##(1994-9#1)(1996-1#1)(2011-1#3)(2011-2#1)(2013-8#1)
and New Zealand##15##3##(1992-11#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#2)
and New##37##2##(1990-8#1)(1991-2#1)(1992-11#2)(1992-6#1)(1994-9#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
and Newfoundland##3##2##(2008-10#3)
and Ni in the##2##4##(2007-11#1)(2008-10#1)
and Ni in##6##3##(2007-11#1)(2008-10#5)
and Ni were##7##3##(2008-10#7)
and Ni##31##2##(2007-11#1)(2008-10#28)(2008-11#1)(2011-2#1)
and Ni(2+)##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
and Ni(II)##14##2##(2008-10#14)
and Nicaragua##4##2##(2007-12#1)(2008-5#1)(2011-2#2)
and Nicotiana benthamiana plants##2##4##(2008-10#2)
and Nicotiana benthamiana##4##3##(2008-10#4)
and Nicotiana##6##2##(2008-10#6)
and NifA##2##2##(1993-12#1)(2008-9#1)
and Nigeria##3##2##(2008-10#2)(2008-9#1)
and Nile##2##2##(2008-10#1)(2008-5#1)
and Non-Hispanic##3##2##(2010-10#1)(2010-7#1)(2012-12#1)
and North America##17##3##(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and North American##3##3##(2007-2#1)(2008-9#1)(2010-8#1)
and North Dakota##2##3##(2008-10#2)
and North##28##2##(1997-8#3)(2007-2#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
and Northern blot analysis##4##4##(1995-6#1)(1996-12#1)(1997-8#1)(2008-9#1)
and Northern blot##7##3##(1992-3#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-8#1)(2008-9#1)
and Northern##12##2##(1990-11#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)
and Northern-blot##2##2##(1990-11#1)(1991-9#1)
and Norway##7##2##(1990-11#2)(2008-10#2)(2008-7#3)
and Notch signaling##3##3##(2007-12#1)(2009-5#1)(2010-3#1)
and Notch##4##2##(2007-12#1)(2009-5#1)(2010-3#2)
and Nottinghamshire##2##2##(2008-10#1)(2008-11#1)
and November 2011##2##3##(2013-1#2)
and November##8##2##(1991-2#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#2)
and Nuclear##2##2##(1994-1#1)(2008-10#1)
and Number##2##2##(1995-5#1)(2013-1#1)
and Nurr1##2##2##(1995-12#2)
and Nursing##4##2##(1990-12#1)(1992-12#1)(2008-12#1)(2012-3#1)
and O##8##2##(1996-12#1)(1996-2#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-8#1)
and O(2)##7##2##(2007-12#3)(2008-10#1)(2008-2#1)(2010-4#1)(2012-2#1)
and O(3)##5##2##(2008-11#1)(2008-2#1)(2008-3#3)
and O(rd)##4##2##(2008-12#4)
and O-linked##3##2##(1990-5#1)(1992-6#1)(2008-1#1)
and O157##2##2##(2012-2#2)
and O2##5##2##(1991-5#1)(2008-10#1)(2008-5#2)(2013-8#1)
and OA##3##2##(2008-7#1)(2010-8#2)
and OCT##3##2##(2011-1#2)(2013-1#1)
and ODS##2##2##(2008-10#2)
and OECD##2##2##(1996-3#1)(2011-1#1)
and OH##5##2##(2008-2#1)(2008-3#4)
and OH-radical generation##2##3##(1993-8#2)
and OM##4##2##(2009-11#1)(2010-2#2)(2012-4#1)
and OP##6##2##(1996-2#1)(2008-10#3)(2011-2#2)
and OPCs##2##2##(2008-7#1)(2012-4#1)
and OPZ19(1800)##2##2##(2008-10#2)
and OR##6##2##(2008-10#4)(2012-2#2)
and ORF186##2##2##(1991-7#2)
and ORF4##2##2##(2008-10#2)
and OSCC##2##2##(2012-3#1)(2013-1#1)
and OT2##2##2##(2008-10#2)
and OY-NIM##3##2##(2008-10#3)
and Obesity##5##2##(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#2)
and Objective##3##2##(2008-5#1)(2010-6#1)(2013-1#1)
and Objectives##8##2##(1996-9#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
and Obstetrics (FIGO)##2##3##(1995-3#1)(2007-4#1)
and Obstetrics##7##2##(1994-5#1)(1995-3#1)(2007-4#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
and Occupational##2##2##(1991-12#1)(2008-11#1)
and Ocimum sanctum exhibited antibacterial activity against##2##7##(2010-3#2)
and Ocimum sanctum##3##3##(2010-3#2)(2012-2#1)
and Ocimum##4##2##(2008-5#1)(2010-3#2)(2012-2#1)
and October 2009##2##3##(2012-3#1)(2013-7#1)
and October##13##2##(1995-12#1)(1996-11#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#3)(2011-2#3)(2012-3#1)(2013-7#1)
and Octopus##2##2##(2008-5#1)(2008-7#1)
and Ohio in##2##3##(2008-10#2)
and Ohio##7##2##(1997-1#1)(2008-10#6)
and Okrun##2##2##(2008-10#2)
and Oncidium orchid##2##3##(2008-10#2)
and Oncology of##2##3##(1992-5#1)(2008-9#1)
and Oncology##8##2##(1992-5#1)(2008-9#7)
and One##2##2##(2008-12#1)(2010-5#1)
and Ongoing Weight Loss diets##3##5##(2008-3#3)
and Ontario##5##2##(1995-2#1)(2007-12#1)(2008-10#3)
and Oregon##9##2##(2008-10#8)(2012-3#1)
and Orientation##2##2##(2008-2#1)(2010-2#1)
and Origin of Xanthomonas##2##4##(2008-10#2)
and Origin of##3##3##(2008-10#3)
and Oshar##2##2##(2008-12#2)
and Osteoarthritis##2##2##(2008-10#1)(2010-12#1)
and Other Plants##2##3##(2008-10#2)
and Other##21##2##(2008-10#8)(2008-6#1)(2011-2#11)(2013-1#1)
and Outcomes##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
and Ox##2##2##(1993-6#1)(2008-10#1)
and Oxidative##2##2##(2008-10#1)(2008-7#1)
and P &lt##6##3##(1992-9#1)(1994-12#2)(1994-3#1)(2012-2#1)(2012-3#1)
and P = 0##6##4##(1991-12#1)(1995-6#1)(2008-10#3)(2013-1#1)
and P =##7##3##(1991-12#1)(1995-6#1)(2007-10#1)(2008-10#3)(2013-1#1)
and P concentrations##2##3##(1995-8#1)(2008-12#1)
and P is##2##3##(2008-10#1)(2013-1#1)
and P##137##2##(1991-12#2)(1992-12#1)(1992-9#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(2007-10#1)(2007-7#2)(2008-10#87)(2008-12#5)(2008-4#1)(2008-5#7)(2009-6#1)(2010-12#1)(2010-3#4)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#4)
and P(N)##2##2##(2012-7#2)
and P(crit)##2##2##(2013-1#2)
and P-glycoprotein##3##2##(2011-3#2)(2012-3#1)
and P2##7##2##(1992-9#1)(1994-6#4)(2008-4#1)(2008-9#1)
and P22##2##2##(2008-3#2)
and P2X receptors##2##3##(2008-4#2)
and P2X(4)##2##2##(2008-4#2)
and P2X(7) receptors##5##3##(2008-4#5)
and P2X(7)##6##2##(2008-4#6)
and P2Y##3##2##(2008-4#3)
and P2Y(1) receptors##2##3##(2008-4#2)
and P2Y(12)##6##2##(2008-4#6)
and P3##6##2##(1995-8#2)(2008-8#2)(2011-2#1)(2013-8#1)
and P4##3##2##(1990-11#2)(2008-6#1)
and P450 reductase##5##3##(1994-8#5)
and P=0##4##2##(2008-12#1)(2009-4#2)(2011-1#1)
and PA##5##2##(1992-12#1)(1995-8#2)(2008-10#1)(2013-1#1)
and PAF##2##2##(1994-9#2)
and PAGE##2##2##(2008-4#1)(2008-8#1)
and PAH##2##2##(1995-11#1)(2008-10#1)
and PAI-1##9##2##(1993-12#1)(1994-9#8)
and PAL activities in UV-C-treated fruit##2##6##(2008-10#2)
and PAR2##5##2##(2008-7#1)(2009-8#4)
and PAS##2##2##(1992-11#1)(2012-3#1)
and PAUP*##2##2##(2008-4#1)(2008-9#1)
and PBB 77##2##3##(2008-10#2)
and PBB##3##2##(2008-10#3)
and PBDEs##3##2##(2008-10#3)
and PBS##2##2##(2007-2#1)(2008-11#1)
and PC##2##2##(2007-7#1)(2008-10#1)
and PC12##2##2##(1997-2#1)(2008-11#1)
and PCA##4##2##(1997-3#1)(2008-10#2)(2008-7#1)
and PCB##4##2##(2008-10#1)(2008-11#1)(2008-7#2)
and PCBs##4##2##(2008-10#3)(2008-8#1)
and PCNA##2##2##(1995-6#1)(2011-2#1)
and PCP##2##2##(2008-10#1)(2009-3#1)
and PCR was##2##3##(1995-12#1)(2008-4#1)
and PCR##26##2##(1990-12#1)(1990-7#1)(1992-6#1)(1993-12#1)(1994-1#3)(1995-12#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2012-2#2)(2013-8#1)
and PCR-based##3##2##(1997-2#2)(1997-8#1)
and PD##21##2##(1990-2#1)(1991-4#1)(1995-12#1)(2008-10#1)(2008-12#7)(2008-7#2)(2011-2#6)(2012-12#2)
and PDT in##2##3##(2007-8#1)(2012-3#1)
and PDT##7##2##(2007-8#1)(2009-4#5)(2012-3#1)
and PDV##2##2##(2008-10#2)
and PE##3##2##(1992-10#1)(2008-12#2)
and PEF##2##2##(1996-3#1)(2007-2#1)
and PEG##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
and PET##3##2##(1995-12#1)(2008-1#1)(2012-12#1)
and PF##2##2##(1990-12#1)(2011-2#1)
and PFF##3##2##(1990-12#3)
and PFS##2##2##(2008-10#1)(2010-2#1)
and PFT##2##2##(2007-2#2)
and PG##3##2##(2008-10#2)(2008-11#1)
and PGA-alginate methods##3##3##(2011-2#3)
and PGA-alginate##4##2##(2011-2#4)
and PGE(2)##2##2##(2008-7#1)(2009-12#1)
and PGE2##3##2##(1993-12#1)(1995-3#1)(2008-5#1)
and PH##3##2##(2008-9#1)(2011-1#2)
and PHB##4##2##(2008-10#4)
and PI##12##2##(1996-1#1)(1996-6#1)(1997-3#1)(2008-10#6)(2008-8#1)(2009-3#2)
and PIC##2##2##(2010-3#1)(2011-2#1)
and PIL##2##2##(2008-3#2)
and PIP2##3##2##(1992-12#1)(1993-8#1)(2008-8#1)
and PKA##5##2##(1995-6#1)(1996-2#1)(1997-2#1)(2009-12#2)
and PKC##10##2##(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-8#1)(2013-8#1)
and PKC-epsilon##3##2##(1995-11#2)(2008-8#1)
and PKC-α##2##2##(2012-3#2)
and PLC-gamma 2 by##2##4##(1993-3#2)
and PLC-gamma 2##4##3##(1993-3#4)
and PLD##2##2##(1995-8#1)(2011-2#1)
and PLL1 are##3##3##(2009-8#3)
and PLOV females##2##3##(1997-4#2)
and PLS methods##3##3##(2008-10#3)
and PLS##5##2##(2008-10#5)
and PLSR##4##2##(2013-8#4)
and PM3##4##2##(1996-5#1)(2008-10#2)(2008-11#1)
and PMA##5##2##(1993-6#1)(1995-6#1)(2008-11#1)(2008-8#2)
and PMA-induced##3##2##(1993-6#1)(1994-8#1)(1995-6#1)
and PMMA##4##2##(1991-1#1)(2010-4#3)
and PMNL##4##2##(2006-6#2)(2010-1#2)
and PNS##5##2##(1995-12#1)(2008-7#3)(2011-2#1)
and PP##2##2##(2008-11#1)(2010-4#1)
and PP2B/calcineurin and a widely utilized strategy for inhibiting protein tyrosine phosphatases##2##12##(2008-2#1)(2008-4#1)
and PPARdelta##5##2##(2008-1#3)(2008-3#1)(2008-5#1)
and PPI##3##2##(1997-4#1)(2008-11#1)(2008-7#1)
and PPO##4##2##(1996-2#1)(1997-3#1)(2008-10#2)
and PPY##2##2##(1997-6#2)
and PR##7##2##(1997-7#2)(2008-10#3)(2013-8#2)
and PR-1b##2##2##(2008-10#2)
and PRK##2##2##(2009-10#2)
and PRL##3##2##(1990-7#1)(1994-3#1)(2013-1#1)
and PS##8##2##(1992-10#1)(1993-11#3)(1995-12#1)(2008-10#2)(2008-8#1)
and PS-264##2##2##(2008-10#2)
and PSA##2##2##(2010-1#1)(2012-12#1)
and PST##5##2##(1990-12#4)(1994-11#1)
and PT##2##2##(2012-12#1)(2013-8#1)
and PT/RTS = 0##2##4##(2008-7#2)
and PTDM##2##2##(2008-1#2)
and PTFE##5##2##(1990-9#1)(2007-7#4)
and PTH##10##2##(1991-5#1)(1991-6#1)(1993-3#1)(2008-8#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
and PV 61) and##2##4##(2008-10#2)
and PV##4##2##(1996-5#1)(2008-10#2)(2010-5#1)
and PVA##3##2##(2008-10#2)(2008-5#1)
and PVA-derived##2##2##(2008-5#2)
and PVC##3##2##(2008-10#3)
and Pacific##8##2##(1997-2#2)(2008-10#1)(2008-5#1)(2008-8#3)(2010-4#1)
and PainSmart infusion pumps##2##4##(2010-9#2)
and Palm##2##2##(2008-10#1)(2013-8#1)
and Pan##2##2##(2008-11#1)(2008-2#1)
and Pantoea##4##2##(2008-10#4)
and Pap##2##2##(1997-2#1)(2011-2#1)
and Paramecium##2##2##(2008-12#1)(2008-4#1)
and Paramphistomum eggs##2##3##(1996-12#2)
and Parental##2##2##(2009-11#1)(2010-9#1)
and Parkinson's disease##5##3##(1994-2#1)(2008-7#2)(2009-5#1)(2012-12#1)
and Parkinson's##8##2##(1994-2#1)(1996-2#1)(2008-7#4)(2009-5#1)(2012-12#1)
and Partial##5##2##(2007-11#1)(2008-10#4)
and Pathfinder##2##2##(1996-7#1)(2008-3#1)
and Pathogenic Characterization of##2##4##(2008-10#2)
and Pathogenic##8##2##(2008-10#8)
and Pathogenicity of##4##3##(2008-10#4)
and Pathogenicity##5##2##(2008-10#5)
and Pathological##2##2##(1991-5#1)(2008-3#1)
and Patterns of##2##3##(2008-10#2)
and Pb and##2##3##(2008-10#2)
and Pb by##4##3##(2008-10#4)
and Pb determination##2##3##(2008-10#2)
and Pb in sample solutions were determined by inductively coupled plasma mass spectrometry (ICP-MS)##2##14##(2013-8#2)
and Pb in##17##3##(2008-10#14)(2011-2#1)(2013-8#2)
and Pb was##2##3##(2008-10#2)
and Pb were found to be 0##2##7##(2008-10#2)
and Pb were##4##3##(2008-10#4)
and Pb##56##2##(2008-10#51)(2008-5#1)(2011-2#2)(2013-8#2)
and Pb(2+)##10##2##(2008-10#10)
and Pb(II) as##2##3##(2008-10#2)
and Pb(II) by##3##3##(2008-10#3)
and Pb(II) from##2##3##(2008-10#2)
and Pb(II) in##2##3##(2008-10#2)
and Pb(II) ions by##2##4##(2008-10#1)(2013-1#1)
and Pb(II) ions##3##3##(2008-10#2)(2013-1#1)
and Pb(II) were##4##3##(2008-10#4)
and Pb(II)##33##2##(2008-10#31)(2013-1#2)
and Pd as##2##3##(2008-10#2)
and Pd from##2##3##(2008-10#2)
and Pd was##2##3##(2008-10#2)
and Pd##11##2##(2008-10#10)(2008-11#1)
and Pd(II)##4##2##(2008-10#4)
and Pd(IV)##2##2##(2008-10#2)
and Peach##2##2##(1992-12#1)(2008-10#1)
and Pearson correlation##2##3##(2011-2#1)(2012-2#1)
and Pediococcus##2##2##(1997-4#1)(2012-2#1)
and Pedon 5##3##3##(2008-12#3)
and Peer##2##2##(2010-9#1)(2013-1#1)
and Pej-SGP-IV##2##2##(2008-5#2)
and Penicillium expansum##2##3##(2008-10#2)
and Penicillium##5##2##(1993-12#1)(2008-10#3)(2008-5#1)
and Pennisetum##2##2##(1990-5#1)(2008-10#1)
and Pennsylvania##2##2##(1995-2#1)(2008-10#1)
and Pepper golden mosaic virus##2##5##(2008-10#2)
and Pepper mottle virus##2##4##(2008-10#2)
and Pepper##4##2##(2008-10#4)
and Peptostreptococcus spp##2##3##(2007-7#2)
and Persistence##2##2##(2008-10#1)(2013-1#1)
and Peyer's##2##2##(2008-11#1)(2009-9#1)
and PgR##3##2##(1991-12#3)
and PhIP##2##2##(1992-6#1)(1997-2#1)
and Pharmaceutical##2##2##(2010-5#1)(2012-2#1)
and Phase##3##2##(1994-1#1)(2008-8#1)(2009-11#1)
and Phe psi Phe##2##4##(1992-8#2)
and Phe3##2##2##(1991-9#1)(1993-3#1)
and Phenotypic##3##2##(2008-10#3)
and Phomopsis##9##2##(2008-10#9)
and Phylogeny of##2##3##(2008-10#1)(2008-8#1)
and Physical##7##2##(1991-9#1)(1995-4#1)(2007-12#1)(2008-10#2)(2013-1#2)
and Physiological##2##2##(2008-10#1)(2013-1#1)
and Phytophthora sojae##2##3##(2008-10#2)
and Phytophthora##8##2##(2008-10#8)
and Pi##2##2##(1990-8#1)(1995-6#1)
and Picea##3##2##(2008-10#1)(2008-7#2)
and Pichia##2##2##(1997-4#1)(2008-10#1)
and Pimelodus sp##2##3##(2008-12#2)
and Pioneer##2##2##(2008-10#2)
and Pitfalls##2##2##(2009-6#1)(2011-1#1)
and Plasmodium##3##2##(1992-6#1)(2008-7#1)(2010-12#1)
and Pleurotus##2##2##(2008-10#2)
and Poisson##2##2##(1994-2#1)(2007-11#1)
and Poland##3##2##(1997-3#1)(2013-1#2)
and Polymerase Chain Reaction##2##4##(2007-10#1)(2008-10#1)
and Polymerase Chain##4##3##(2007-10#1)(2008-10#3)
and Polymorphisms##2##2##(1997-7#1)(2009-5#1)
and Polyscias spp##2##3##(2008-10#2)
and Polyscias##3##2##(2008-10#3)
and Ponceau 4R by##3##4##(2008-10#3)
and Ponceau 4R##6##3##(2008-10#6)
and Population##4##2##(2008-10#2)(2010-4#1)(2013-8#1)
and Porcine##2##2##(2012-3#2)
and Potato##5##2##(2008-10#5)
and Potential##2##2##(2008-10#2)
and Practice##10##2##(2008-10#1)(2008-11#6)(2008-4#1)(2008-7#2)
and Pratylenchus penetrans##2##3##(2008-10#2)
and Pratylenchus##3##2##(2008-10#3)
and Pregnancy##2##2##(2007-2#1)(2010-12#1)
and President of the##2##4##(1994-1#1)(2009-7#1)
and Prevention##25##2##(1991-1#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-6#2)(2012-12#1)
and Preventive Dentistry##2##3##(2013-1#2)
and Preventive##3##2##(1995-9#1)(2013-1#2)
and Primary##2##2##(2008-1#1)(2012-2#1)
and Private##3##2##(1992-2#1)(1993-12#1)(2008-9#1)
and Pro##3##2##(1990-7#1)(1992-11#1)(1992-6#1)
and Processing##2##2##(2008-6#1)(2012-12#1)
and Production of##2##3##(2008-10#2)
and Prognostic##2##2##(2008-10#2)
and Program##2##2##(1991-12#1)(1992-2#1)
and Progression##2##2##(2011-1#1)(2013-1#1)
and Properties of##2##3##(1996-2#1)(2010-2#1)
and Properties##3##2##(1996-2#1)(2010-1#1)(2010-2#1)
and Protein##2##2##(2008-11#1)(2009-11#1)
and Proventil##2##2##(1992-2#2)
and Prussian blue##2##3##(2008-10#1)(2010-5#1)
and Pseudomonas aeruginosa##3##3##(1990-6#1)(2009-6#1)(2012-2#1)
and Pseudomonas fluorescens##3##3##(2008-10#3)
and Pseudomonas putida##5##3##(2008-10#4)(2011-1#1)
and Pseudomonas syringae pv##2##4##(2008-10#2)
and Pseudomonas syringae##3##3##(2008-10#3)
and Pseudomonas##23##2##(1990-5#1)(1990-6#1)(1997-6#1)(2008-10#13)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-7#1)
and PstI##2##2##(1997-2#1)(2008-10#1)
and PsychInfo##2##2##(2008-11#1)(2009-11#1)
and Psychological##3##2##(2008-10#1)(2009-10#1)(2010-8#1)
and Pt##9##2##(2008-10#7)(2008-11#1)(2012-3#1)
and Pt(IV)##5##2##(2008-10#5)
and Pt) as##2##3##(2008-10#2)
and Pt)##4##2##(2008-10#4)
and PtMo##2##2##(2008-10#2)
and Ptr ToxC##2##3##(2008-10#2)
and Ptr##5##2##(2008-10#5)
and PubMed##3##2##(2008-6#1)(2009-9#1)(2011-2#1)
and Public Health##6##3##(1995-12#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
and Public##9##2##(1995-12#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
and Pulmonary##2##2##(2009-5#1)(2011-1#1)
and Purpose##2##2##(2008-3#1)(2013-8#1)
and Pv##2##2##(2013-8#2)
and Pyracantha spp##2##3##(2008-10#2)
and Pyracantha##4##2##(2008-10#4)
and Pyrenophora tritici-repentis##2##3##(2008-10#2)
and Pythium spp##3##3##(2008-10#3)
and Pythium##12##2##(2008-10#12)
and Q Sepharose ion exchange##2##5##(1991-5#1)(1997-1#1)
and Q##20##2##(1991-5#1)(1992-2#1)(1997-1#1)(2008-10#4)(2008-3#1)(2011-10#1)(2012-5#5)(2012-6#2)(2012-7#1)(2012-9#2)(2013-8#1)
and Q-switched##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
and Q8r2-96)##2##2##(2008-10#2)
and QOL##2##2##(2008-7#1)(2010-5#1)
and QRS duration##2##3##(1992-6#1)(2008-10#1)
and QRS##3##2##(1992-6#1)(2008-10#1)(2012-12#1)
and QT##2##2##(2010-5#1)(2010-6#1)
and QTL analyses##2##3##(2008-8#2)
and QTL##3##2##(2008-10#1)(2008-8#2)
and QTc##2##2##(2008-8#1)(2010-1#1)
and QUADAS##3##2##(2008-12#3)
and Qigong##2##2##(2013-1#2)
and Qingdao##2##2##(1995-6#1)(2010-8#1)
and QoL in##2##3##(2012-1#1)(2012-12#1)
and QoL##3##2##(2012-1#2)(2012-12#1)
and Quality of Life##3##4##(2008-10#1)(2012-2#1)(2012-3#1)
and Quality of##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
and Quality##7##2##(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and Quantification of##2##3##(2008-10#2)
and Quantification##3##2##(2008-10#3)
and Quantitative##3##2##(2008-10#2)(2008-7#1)
and Quebec's##2##2##(2008-11#1)(2011-2#1)
and Quercus##2##2##(2008-8#1)(2011-10#1)
and R = 0##2##4##(1996-2#2)
and R wave##4##3##(1996-6#4)
and R##55##2##(1990-11#1)(1990-8#2)(1994-12#1)(1995-8#2)(1996-2#2)(1996-5#1)(1996-6#4)(1996-8#1)(2008-10#33)(2008-12#1)(2008-2#3)(2008-5#1)(2008-9#2)(2012-2#1)
and R(w) = 0##2##4##(1997-7#2)
and R-R##2##2##(1991-10#1)(1994-3#1)
and R2##8##2##(1993-11#3)(2008-10#1)(2008-7#1)(2010-3#3)
and R259##2##2##(1995-5#2)
and RA##4##2##(1994-11#2)(2007-8#1)(2008-5#1)
and RACE-PCR##2##2##(2008-7#1)(2008-8#1)
and RAPD analyses##3##3##(2008-10#2)(2008-5#1)
and RAPD grouping##2##3##(2008-10#2)
and RAPD markers##3##3##(2008-10#1)(2008-5#2)
and RAPD##15##2##(2008-10#10)(2008-5#5)
and RAPD-based matrices##2##3##(2013-7#2)
and RB##2##2##(1993-8#1)(1997-7#1)
and RD##2##2##(1991-4#1)(1997-6#1)
and RDX##3##2##(2008-10#1)(2008-3#2)
and REE from##2##3##(2008-10#2)
and REE##4##2##(2008-10#4)
and REEs##2##2##(2008-10#1)(2008-9#1)
and RF##2##2##(2008-2#1)(2011-2#1)
and RFLP analysis##2##3##(2008-5#1)(2008-8#1)
and RFLP##10##2##(2008-10#3)(2008-5#3)(2008-8#4)
and RG IV##2##3##(2008-10#2)
and RG##6##2##(2008-10#6)
and RH##4##2##(1992-8#1)(2008-10#3)
and RI##5##2##(1996-6#1)(1997-3#2)(2008-10#1)(2013-8#1)
and RILs##2##2##(2008-10#2)
and RLS##2##2##(2012-12#2)
and RM##2##2##(1991-7#1)(2013-1#1)
and RMS of##2##3##(2008-10#2)
and RNA analysis##2##3##(1990-5#1)(2008-4#1)
and RNA blot##2##3##(1990-7#1)(2008-10#1)
and RNA interference##2##3##(2008-7#1)(2011-1#1)
and RNA polymerase II##2##4##(1997-2#1)(2011-2#1)
and RNA polymerase##4##3##(1995-6#1)(1997-2#1)(2011-2#1)(2012-12#1)
and RNA probes##3##3##(1994-2#1)(2008-4#1)(2008-9#1)
and RNA replication##2##3##(2013-1#2)
and RNA##54##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-12#1)(1997-2#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-4#4)(2008-7#3)(2008-9#9)(2009-10#2)(2009-5#2)(2010-12#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#3)
and RNA2##3##2##(2008-10#2)(2008-8#1)
and RNase##6##2##(1991-9#1)(2008-4#2)(2009-2#1)(2011-2#1)(2012-3#1)
and ROS##3##2##(2008-5#3)
and RP##2##2##(2008-10#1)(2013-1#1)
and RP-HPLC##2##2##(1996-5#1)(2008-5#1)
and RS##3##2##(2008-12#1)(2008-8#2)
and RSD##3##2##(2008-10#2)(2012-3#1)
and RSV##2##2##(2011-2#2)
and RT plus surgery vs##2##5##(2010-3#2)
and RT##13##2##(1990-11#3)(1997-6#1)(2008-3#1)(2010-3#3)(2013-1#5)
and RT-PCR##8##2##(2007-4#2)(2008-10#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-3#1)
and RTI-COC-32##2##2##(1991-12#2)
and RTS##2##2##(2011-2#2)
and Rab##2##2##(1994-9#1)(2008-8#1)
and Rac1##2##2##(2008-10#1)(2011-2#1)
and Rac2##2##2##(1997-7#2)
and Radiation##4##2##(1994-12#1)(2008-2#2)(2008-6#1)
and Ralstonia solanacearum##2##3##(2008-10#2)
and Ralstonia##3##2##(2008-10#3)
and Raman spectra of##3##4##(2007-12#1)(2008-10#2)
and Raman spectra##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2010-12#1)
and Raman spectroscopy##6##3##(2008-10#5)(2013-8#1)
and Raman spectrum##2##3##(2008-10#1)(2013-8#1)
and Raman##25##2##(2007-11#2)(2007-12#1)(2008-10#11)(2008-3#2)(2009-12#1)(2010-10#3)(2010-12#1)(2013-1#1)(2013-8#3)
and Random Amplified Polymorphic DNA##2##5##(2008-10#2)
and Ras##4##2##(1994-8#1)(1996-2#1)(2013-8#2)
and Rasch##2##2##(2011-2#1)(2012-2#1)
and Rayleigh extinction##2##3##(2008-2#1)(2008-3#1)
and Rayleigh##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
and Rcm 5##2##3##(2008-10#2)
and Re(2)O(7)##3##2##(1996-2#3)
and Reactive##2##2##(1995-11#1)(2008-10#1)
and Real##2##2##(1991-2#1)(2013-1#1)
and Reasons for##2##3##(2010-11#1)(2013-1#1)
and Recommendations##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
and Reduced##3##2##(2008-10#2)(2008-8#1)
and Reduces##3##2##(2008-10#2)(2010-7#1)
and Refractive##2##2##(2008-2#2)
and Rehabilitation##3##2##(1992-3#1)(2011-2#1)(2013-1#1)
and Related##15##2##(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2007-1#1)(2008-10#4)(2008-7#2)(2008-9#1)(2013-1#3)
and Relationship with##2##3##(2008-10#2)
and Relationship##5##2##(2008-10#3)(2008-9#1)(2010-8#1)
and Renal##2##2##(2008-10#1)(2011-2#1)
and Reproductive##4##2##(2008-10#1)(2008-4#1)(2010-1#1)(2011-2#1)
and Research##9##2##(1992-8#1)(1993-12#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
and Resistance in##2##3##(2008-10#2)
and Resistance##3##2##(2008-10#2)(2013-1#1)
and Resistant##3##2##(2008-10#3)
and Respirgard II##3##3##(1993-2#2)(1996-12#1)
and Responsibility##3##2##(2008-12#2)(2012-1#1)
and Resulting##2##2##(2008-10#1)(2011-1#1)
and Retention of##2##3##(1995-2#1)(2008-10#1)
and Rev##4##2##(1993-2#2)(1993-8#1)(1994-8#1)
and Review of the Literature##6##5##(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Review of##7##3##(2008-1#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Review##9##2##(1995-12#2)(2008-1#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Rg1##2##2##(1995-8#1)(2010-12#1)
and Rh##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
and Rh(III)##4##2##(2008-10#4)
and Rhizoctonia solani##3##3##(2008-10#3)
and Rhizoctonia##5##2##(2008-10#5)
and Rhodamine B##2##3##(2008-10#1)(2009-11#1)
and Rhodamine##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
and Rhode Island##4##3##(1994-2#1)(1996-1#2)(2012-1#1)
and Rhopalosiphum padi##2##3##(2008-10#2)
and Rhy##2##2##(2011-3#2)
and Riberao Pretto##2##3##(2007-10#2)
and Rice##2##2##(2008-10#1)(2008-3#1)
and Rich##2##2##(1997-8#1)(2008-10#1)
and Richard##2##2##(1995-12#1)(2008-7#1)
and Ridomil Gold EC##2##4##(2008-10#2)
and Ringer's##2##2##(1990-7#1)(1995-12#1)
and Rio de Janeiro##3##4##(1991-6#2)(2013-8#1)
and Ripley's##2##2##(2008-10#1)(2008-9#1)
and Risk Factors for##2##4##(2009-9#1)(2011-2#1)
and Risk Reduction##2##3##(2011-2#1)(2013-1#1)
and Risk of##2##3##(2008-10#1)(2013-8#1)
and Risk##7##2##(2008-10#1)(2009-4#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
and Rodel appliqués were obtained at incidence angles of 8 degrees##2##11##(2008-3#2)
and Rodel##3##2##(2008-3#3)
and Role in##2##3##(2008-10#1)(2013-1#1)
and Roman low-avoidance##2##3##(1994-2#2)
and Romania##2##2##(2008-10#1)(2013-8#1)
and Root##3##2##(2008-10#3)
and Rough Lemon##2##3##(2008-10#2)
and Rowe##2##2##(1994-12#1)(2007-8#1)
and Rph9##2##2##(2008-10#2)
and RsaI##2##2##(1995-12#1)(2008-10#1)
and Rsp3##4##2##(2008-10#4)
and Ru##4##2##(2008-10#4)
and Russell##2##2##(1995-6#1)(2008-10#1)
and Rx3##2##2##(2008-10#2)
and Rz##2##2##(2008-11#1)(2008-5#1)
and S =##2##3##(1997-2#1)(2008-5#1)
and S were##2##3##(2008-1#1)(2013-1#1)
and S##84##2##(1992-6#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-7#3)(2008-1#1)(2008-10#36)(2008-11#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#2)(2010-11#1)(2010-2#1)(2011-1#6)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#4)
and S)##3##2##(1990-5#1)(2008-10#2)
and S-100 protein##2##3##(1991-6#1)(2008-4#1)
and S-100##4##2##(1991-6#1)(2008-4#1)(2011-1#1)(2012-2#1)
and S1 nuclease##2##3##(1991-11#1)(1993-12#1)
and S1##5##2##(1991-11#1)(1992-12#1)(1993-12#1)(1995-3#1)(2012-12#1)
and S2##2##2##(1997-2#1)(2008-9#1)
and S6##2##2##(2008-10#1)(2013-1#1)
and SA##8##2##(1995-11#1)(2008-10#3)(2009-6#1)(2011-1#2)(2011-2#1)
and SAM##3##2##(1994-5#2)(1995-11#1)
and SAR##2##2##(2011-10#1)(2013-1#1)
and SAT##2##2##(2013-1#2)
and SB202190##2##2##(2011-2#2)
and SC##3##2##(2008-5#2)(2008-7#1)
and SC-791##4##2##(2008-10#4)
and SCLP##4##2##(2012-3#4)
and SCs##2##2##(2008-7#2)
and SD =##2##3##(1993-1#2)
and SD rats##2##3##(1996-12#1)(1997-6#1)
and SD##6##2##(1993-1#2)(1996-12#1)(1997-6#3)
and SDF1-3'##2##2##(2008-9#2)
and SDS##2##2##(1997-2#1)(2008-10#1)
and SDS-PAGE##3##2##(1990-8#1)(1992-8#1)(2008-4#1)
and SE##2##2##(2008-10#1)(2012-1#1)
and SECV##2##2##(2008-10#2)
and SEM were##2##3##(2008-10#2)
and SEM##8##2##(1991-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-2#1)
and SES##2##2##(2010-3#1)(2011-1#1)
and SF##3##2##(1994-8#2)(2012-1#1)
and SF-36##2##2##(2012-12#2)
and SFA##2##2##(2008-3#1)(2010-2#1)
and SH##2##2##(1993-2#1)(1995-3#1)
and SH3 domains##2##3##(2008-6#1)(2012-12#1)
and SH3##3##2##(1991-12#1)(2008-6#1)(2012-12#1)
and SHBG##2##2##(1990-11#1)(2008-3#1)
and SHG##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
and SHR##2##2##(1994-2#1)(2006-8#1)
and SIDS##2##2##(1992-11#1)(2013-1#1)
and SIV##4##2##(1997-3#4)
and SL##2##2##(2008-11#1)(2013-1#1)
and SLCV-E##3##2##(2008-10#3)
and SLE##3##2##(2008-10#2)(2010-5#1)
and SLS##2##2##(2008-10#2)
and SM##4##2##(2008-5#1)(2012-2#1)(2013-1#2)
and SN-38##2##2##(1995-5#1)(2008-8#1)
and SNAP-25##2##2##(1995-6#2)
and SNP treated KU812 cells##3##5##(2008-11#3)
and SNP##5##2##(2008-11#3)(2008-4#1)(2012-2#1)
and SNU##2##2##(2008-12#2)
and SO(2)##3##2##(2008-10#2)(2008-3#1)
and SO(4)(2-)##5##2##(2008-10#5)
and SOWG##2##2##(2008-10#2)
and SP##9##2##(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)
and SP-C##4##2##(2007-11#3)(2008-9#1)
and SPE##3##2##(2008-10#3)
and SPFMV##2##2##(2008-10#2)
and SPME##5##2##(2008-10#5)
and SPSS##2##2##(2007-7#1)(2009-8#1)
and SR##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
and SRM##6##2##(2008-10#6)
and SS##4##2##(2011-2#2)(2013-8#2)
and SSA##4##2##(1990-7#3)(2013-1#1)
and SSCP##2##2##(2008-10#2)
and SSE##3##2##(2013-1#2)(2013-8#1)
and SSEA-1##2##2##(2008-11#2)
and SSR##2##2##(2008-10#2)
and SST##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
and SSTR5##4##2##(1995-2#3)(1997-2#1)
and ST-R##2##2##(2010-12#2)
and ST-segment##2##2##(2008-12#1)(2012-12#1)
and STDs##2##2##(1996-9#1)(2011-1#1)
and STI##5##2##(2008-10#1)(2008-12#2)(2011-2#2)
and SUMER##2##2##(2008-3#2)
and SV40 transformation##2##3##(1995-12#1)(2008-11#1)
and SV40##4##2##(1990-12#1)(1993-8#1)(1995-12#1)(2008-11#1)
and SW##4##2##(1991-8#2)(2008-11#1)(2011-2#1)
and SWV##4##2##(2008-10#4)
and SYBR Green##2##3##(2008-10#1)(2012-2#1)
and Saccharomyces cerevisiae##9##3##(1990-5#2)(1994-12#1)(1996-6#3)(2008-6#2)(2012-2#1)
and Safety in##2##3##(2007-2#1)(2012-12#1)
and Safety of##2##3##(2011-2#2)
and Safety##6##2##(1992-3#1)(1995-12#1)(2007-2#1)(2011-2#2)(2012-12#1)
and Safranine##4##2##(2008-10#4)
and Salmonella minnesota##2##3##(1990-5#1)(1993-11#1)
and Salmonella##9##2##(1990-5#1)(1993-11#1)(1994-8#2)(1997-3#1)(2007-12#1)(2010-4#2)(2011-1#1)
and Salter##5##2##(2007-8#4)(2012-3#1)
and San Diego##3##3##(2012-2#2)(2013-8#1)
and San##6##2##(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#2)(2013-8#1)
and Sandell's sensitivity were found to be##4##7##(2008-10#4)
and Sandell's sensitivity##13##3##(2008-10#13)
and Sarcoma-180 (S-180)##2##3##(1992-3#1)(2008-5#1)
and Sarcoma-180##3##2##(1992-3#2)(2008-5#1)
and Sargassum##2##2##(2008-10#1)(2011-2#1)
and Satisfaction##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
and Saudi##2##2##(2007-7#1)(2009-7#1)
and Saururus chinensis (Lour##2##4##(2008-10#2)
and Savannah##3##2##(2008-10#3)
and Savitzky-Golay##2##2##(2013-8#2)
and Sb were##3##3##(2008-10#3)
and Sb##18##2##(2008-10#18)
and Sb(III)##2##2##(2008-10#2)
and Sc##2##2##(2008-10#2)
and Scandinavian##2##2##(2007-2#1)(2010-3#1)
and Schefflera##2##2##(2008-10#2)
and Schmitt##3##2##(2008-3#3)
and Schwann cells##4##3##(2008-7#4)
and Science##3##2##(2011-1#3)
and Sclerotium rolfsii##4##3##(2008-10#4)
and ScrFI##2##2##(2008-10#2)
and Se in##5##3##(2008-10#5)
and Se speciation##3##3##(2008-10#3)
and Se were##3##3##(2008-10#3)
and Se##28##2##(2008-10#28)
and Se(IV)##5##2##(2008-10#5)
and Second##2##2##(1995-9#1)(2009-10#1)
and Section##2##2##(1995-2#2)
and Seeds##2##2##(2008-10#2)
and Selective##2##2##(2008-10#2)
and Sephadex##2##2##(1990-11#1)(2008-8#1)
and September 1993##2##3##(1995-1#1)(1997-3#1)
and September 2000##2##3##(2007-7#1)(2008-5#1)
and September##18##2##(1990-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#2)(2013-7#1)
and Septoria tritici##2##3##(2008-10#2)
and Septoria##4##2##(2008-10#4)
and Sequence##2##2##(2008-10#2)
and Ser L244--&gt##2##3##(1993-11#2)
and Ser##7##2##(1990-7#1)(1991-3#1)(1993-11#2)(1997-7#1)(1997-8#1)(2008-10#1)
and Ser23##2##2##(1995-5#1)(2010-12#1)
and Serological##2##2##(2008-1#1)(2008-4#1)
and Serratia marcescens##2##3##(2008-10#1)(2011-2#1)
and Sertoli cells##2##3##(1995-6#1)(2009-10#1)
and Sex##2##2##(2008-5#2)
and Sexual Health##2##3##(2009-9#1)(2013-1#1)
and Sexual Risk Behavior##2##4##(2012-1#1)(2013-1#1)
and Sexual##5##2##(2008-10#1)(2009-9#1)(2012-1#1)(2013-1#2)
and SgCV##2##2##(2008-10#2)
and Shigella##2##2##(2008-10#1)(2013-8#1)
and Si in##2##3##(2008-10#1)(2008-7#1)
and Si were##2##3##(2008-10#2)
and Si##8##2##(1993-1#1)(2008-10#5)(2008-3#1)(2008-7#1)
and SiO(2)##3##2##(2008-3#3)
and Sida##2##2##(2008-10#2)
and Sider honeys##2##3##(2008-10#2)
and Sigma Theta Tau##3##4##(1997-3#1)(2013-1#2)
and Signaling##2##2##(2008-4#1)(2008-9#1)
and Simon##2##2##(1990-3#1)(2008-4#1)
and Simple##2##2##(1996-5#1)(2008-11#1)
and Simulated##2##2##(2008-10#2)
and Simultaneous##2##2##(1995-5#1)(2008-10#1)
and Simvastatin##2##2##(1991-6#1)(2012-2#1)
and Sindbis virus##2##3##(2008-4#2)
and Sm##3##2##(2008-10#3)
and SmaI##2##2##(1993-8#1)(2008-10#1)
and Smac/DIABLO##2##2##(2008-11#2)
and Smokers##2##2##(2010-4#2)
and Sn in##2##3##(2008-10#2)
and Sn##7##2##(2008-10#7)
and Sn)##2##2##(2008-10#1)(2009-9#1)
and Social Policy##2##3##(2013-1#2)
and Social Services##2##3##(1994-1#1)(1995-3#1)
and Social##10##2##(1993-6#2)(1994-1#1)(1994-2#1)(1995-3#1)(1996-4#1)(2009-4#1)(2013-1#3)
and Sohag Cancer Center between##2##5##(2008-10#2)
and Soil##2##2##(2008-10#2)
and Soil-borne rye mosaic virus##2##5##(2008-8#2)
and Solanaceae##5##2##(2008-10#3)(2008-5#1)(2013-7#1)
and Solanum tuberosum##2##3##(1993-12#1)(2008-7#1)
and Solar Ultraviolet##4##3##(2008-2#2)(2008-3#2)
and Somatization##2##2##(2012-5#2)
and South Africa##8##3##(2008-10#7)(2011-2#1)
and South America##10##3##(2008-10#6)(2008-5#3)(2011-2#1)
and South Carolina##4##3##(1993-3#1)(1996-1#1)(2008-10#2)
and South Korea##2##3##(2008-8#1)(2010-12#1)
and South##35##2##(1992-2#2)(1993-3#1)(1995-3#1)(1996-1#1)(2008-10#18)(2008-5#3)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#2)
and Southeast Asia is##2##4##(2009-5#1)(2013-8#1)
and Southeast Asia##5##3##(2008-10#1)(2009-5#3)(2013-8#1)
and Southeast##6##2##(2008-10#1)(2008-11#1)(2009-5#3)(2013-8#1)
and Southern analysis##5##3##(1994-8#1)(1995-6#1)(2008-8#3)
and Southern blot analyses##3##4##(2006-12#1)(2008-10#1)(2008-6#1)
and Southern blot analysis##4##4##(1990-2#1)(1993-12#1)(2008-10#1)(2008-9#1)
and Southern blot hybridization##2##4##(2008-10#1)(2008-9#1)
and Southern blot##10##3##(1990-2#1)(1993-12#1)(2006-12#1)(2008-10#4)(2008-6#1)(2008-9#2)
and Southern hybridization using##2##4##(1996-12#2)
and Southern hybridization##4##3##(1992-3#1)(1996-10#1)(1996-12#2)
and Southern##25##2##(1990-2#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-12#2)(2006-12#1)(2008-10#4)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2013-7#2)(2013-8#1)
and Soxhlet##3##2##(2008-10#3)
and Sp1##4##2##(1993-12#1)(1993-6#2)(1997-8#1)
and Spain##2##2##(1991-4#1)(2013-1#1)
and Spanish##7##2##(2008-12#3)(2008-2#2)(2008-7#1)(2012-12#1)
and Spatial Patterns of##2##4##(2008-10#2)
and Spatial##6##2##(2008-10#6)
and Specific##2##2##(2008-10#2)
and Spectroscopy##2##2##(1992-3#1)(2012-1#1)
and Spirodela polyrhiza##2##3##(2011-1#2)
and Spiroplasma##2##2##(2008-10#2)
and Spontaneous##2##2##(1994-12#1)(2010-3#1)
and Sports##2##2##(1996-8#1)(2010-1#1)
and Sporulation of##2##3##(2008-10#2)
and Sporulation##3##2##(2008-10#3)
and Spread of##3##3##(2008-10#3)
and Sr##2##2##(2008-10#2)
and Sr12##2##2##(2008-10#2)
and St##5##2##(1991-3#1)(2008-10#4)
and Stability##2##2##(1996-2#1)(2010-8#1)
and Stage II##2##3##(2013-8#2)
and Stagonospora##3##2##(2008-10#3)
and Staphylococcus aureus were##2##4##(1997-3#1)(2011-2#1)
and Staphylococcus aureus##11##3##(1990-2#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and Staphylococcus##13##2##(1990-2#1)(1995-5#1)(1997-3#1)(1997-4#2)(2008-12#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and State##10##2##(1994-1#1)(1996-1#4)(1996-12#1)(1996-3#1)(1997-2#1)(2008-6#1)(2013-1#1)
and States##2##2##(1994-12#1)(1995-12#1)
and Statistical##14##2##(2008-3#1)(2008-7#2)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#7)(2013-1#1)
and Statistics)##2##2##(1991-9#1)(2008-3#1)
and Stauffers Obersulzer##2##3##(2008-10#2)
and Stellaria media##2##3##(2008-10#1)(2008-7#1)
and Stem##3##2##(2008-10#2)(2008-8#1)
and Stenotrophomonas##2##2##(2008-10#1)(2013-8#1)
and Stigonema##2##2##(2013-7#2)
and Stokes vectors##2##3##(2007-11#2)
and Stokes##3##2##(2007-11#3)
and Strategies##2##2##(2011-2#2)
and Streptococcus mutans##2##3##(1997-8#1)(2012-2#1)
and Streptococcus pneumoniae##3##3##(1997-4#1)(2008-8#1)(2011-1#1)
and Streptococcus##10##2##(1990-6#1)(1993-2#1)(1996-8#1)(1997-4#2)(1997-8#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
and Streptomyces##3##2##(1990-5#1)(1994-5#1)(2008-10#1)
and Stroke##2##2##(2007-10#1)(2010-2#1)
and Structural Characterization of##3##4##(1996-2#2)(1997-7#1)
and Structural##4##2##(1996-2#2)(1997-7#1)(2008-2#1)
and Structure of the##2##4##(1997-7#1)(2008-10#1)
and Structure of##5##3##(1996-5#1)(1997-7#2)(2008-10#2)
and Structure##7##2##(1996-5#1)(1997-7#2)(2008-10#3)(2011-2#1)
and Student's t-test##2##3##(2013-1#1)(2013-8#1)
and Student's##4##2##(1990-9#1)(2008-7#1)(2013-1#1)(2013-8#1)
and Study##2##2##(2008-10#1)(2008-12#1)
and Sucre##2##2##(2008-12#1)(2008-5#1)
and Sudan##4##2##(2008-4#1)(2009-7#1)(2013-1#2)
and Sun##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
and Suppression of##2##3##(2008-10#2)
and Surgery##3##2##(1997-6#1)(2008-1#1)(2009-8#1)
and Survival of##5##3##(2008-10#3)(2009-10#1)(2013-8#1)
and Susceptible##5##2##(2008-10#5)
and Suzuki##2##2##(2009-12#2)
and Sweden##7##2##(1990-11#2)(1991-2#1)(1992-3#1)(2008-7#1)(2010-4#1)(2011-4#1)
and Switzerland##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
and Symptom##2##2##(2008-10#1)(2008-4#1)
and Syria##2##2##(2008-1#1)(2008-10#1)
and Syrian##2##2##(2008-11#1)(2009-2#1)
and T = -100 degrees C##2##6##(1996-2#2)
and T antigen##3##3##(1993-8#3)
and T cell proliferation##3##4##(2008-11#1)(2012-3#2)
and T cell responses to##2##5##(2008-4#1)(2011-1#1)
and T cell##12##3##(1991-9#1)(1992-2#1)(2008-11#1)(2008-4#4)(2011-1#1)(2012-3#2)(2013-1#2)
and T cells##11##3##(1994-11#1)(1995-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#2)(2011-2#1)
and T is##2##3##(1995-3#1)(2008-2#1)
and T lymphocyte##5##3##(1990-2#1)(1991-12#1)(2008-4#1)(2008-7#2)
and T lymphocytes##8##3##(1994-3#1)(1994-8#1)(1997-8#1)(2007-10#1)(2008-4#2)(2011-2#1)(2012-2#1)
and T wave##2##3##(2010-8#1)(2013-8#1)
and T##115##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-8#3)(1994-11#1)(1994-12#6)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2009-12#1)(2010-3#4)(2010-8#1)(2011-1#4)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
and T(2)##7##2##(2007-8#1)(2008-10#2)(2010-8#3)(2012-2#1)
and T(4)##2##2##(2007-8#1)(2010-4#1)
and T(8)##2##2##(2008-10#1)(2011-2#1)
and T)##2##2##(1990-8#1)(1997-4#1)
and T-2 toxin##3##3##(1997-6#1)(2011-2#2)
and T-cell receptor##4##3##(1994-3#1)(1997-7#1)(1997-9#1)(2008-10#1)
and T-cell##16##2##(1991-9#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#3)(1995-5#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2008-10#2)(2012-1#1)
and T-cells in##2##3##(1996-12#1)(2008-10#1)
and T-cells##3##2##(1996-12#1)(2008-10#2)
and T-lymphocytes##2##2##(2008-10#1)(2013-8#1)
and T-matrix calculations##2##3##(2008-2#1)(2008-3#1)
and T1##4##2##(2008-10#2)(2010-2#1)(2011-2#1)
and T2##22##2##(1991-12#3)(1991-8#2)(1992-12#1)(1996-2#2)(2006-12#2)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-2#6)(2011-2#1)
and T2-weighted images##3##3##(1991-11#1)(1997-8#1)(2012-12#1)
and T2-weighted##5##2##(1991-11#1)(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
and T24##2##2##(1992-6#1)(1997-7#1)
and T2DM##5##2##(2008-3#2)(2009-11#1)(2010-10#1)(2011-1#1)
and T3 were##2##3##(1991-12#1)(2008-10#1)
and T3##12##2##(1990-3#2)(1990-6#1)(1991-12#2)(1991-8#1)(2008-10#2)(2008-7#1)(2010-2#1)(2011-1#2)
and T30##4##2##(2008-10#3)(2013-7#1)
and T36##2##2##(2008-10#2)
and T4 in##2##3##(2007-8#1)(2013-1#1)
and T4##9##2##(1990-2#1)(1991-12#1)(1991-8#1)(1993-3#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
and TA##4##2##(1997-8#1)(2008-10#3)
and TA1535##2##2##(2008-9#2)
and TAL1##3##2##(1994-8#3)
and TAMRA##3##2##(2009-8#3)
and TAT##2##2##(2008-11#1)(2009-6#1)
and TATA box were##2##4##(1997-2#1)(2010-5#1)
and TATA##3##2##(1997-2#1)(1997-7#1)(2010-5#1)
and TB are##2##3##(2008-10#1)(2009-4#1)
and TB##13##2##(1993-5#1)(1997-2#1)(2008-10#1)(2009-12#1)(2009-4#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
and TBARS##3##2##(2008-10#1)(2010-4#2)
and TBHQ##2##2##(2008-10#2)
and TBP##3##2##(2008-10#3)
and TBZ##4##2##(2008-10#1)(2011-10#3)
and TC##2##2##(1990-2#1)(2008-7#1)
and TCA##2##2##(2008-11#1)(2008-9#1)
and TCDD##2##2##(1995-11#1)(2008-7#1)
and TCE##2##2##(2008-10#1)(2010-4#1)
and TCF##2##2##(1994-11#2)
and TDeltaS(0)##4##2##(2008-10#4)
and TE##2##2##(2008-3#1)(2008-7#1)
and TEA##2##2##(2008-10#1)(2008-3#1)
and TEE##2##2##(2008-10#1)(2011-2#1)
and TEGDMA##2##2##(2013-1#2)
and TETRASPORE##2##2##(2009-10#2)
and TGA##3##2##(2008-10#2)(2013-1#1)
and TGF alpha in##2##4##(1991-7#1)(1994-7#1)
and TGF##4##2##(1991-12#2)(1991-7#1)(1994-7#1)
and TGF-alpha##4##2##(1992-9#3)(2012-3#1)
and TGF-beta are##2##3##(2008-11#1)(2008-9#1)
and TGF-beta##11##2##(1990-12#1)(1992-2#2)(1992-3#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-3#1)
and TIMP##2##2##(1992-6#2)
and TIMP-1 secretions##2##3##(1992-9#1)(2008-5#1)
and TIMP-1##6##2##(1992-9#1)(2008-1#1)(2008-5#3)(2008-9#1)
and TL2##3##2##(2008-10#3)
and TLI##2##2##(2013-1#2)
and TLR4##2##2##(2008-10#2)
and TM##8##2##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#2)
and TMV##2##2##(2008-10#2)
and TNF##6##2##(1992-12#1)(1994-11#1)(1994-3#1)(1995-5#1)(2008-11#1)(2011-2#1)
and TNF-alpha##8##2##(1993-6#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
and TNFalpha##3##2##(2006-6#1)(2008-11#1)(2008-6#1)
and TNT was##2##3##(2008-10#2)
and TNT##4##2##(2008-10#4)
and TNX##2##2##(2008-10#2)
and TPA##4##2##(1992-5#1)(1995-12#1)(1996-12#1)(2013-1#1)
and TPC-1##2##2##(1993-8#2)
and TPO##2##2##(2008-8#2)
and TPP##3##2##(2008-10#1)(2013-1#2)
and TRH##2##2##(1992-6#1)(1994-6#1)
and TSH C##3##3##(1993-8#3)
and TSH levels##3##3##(2008-4#2)(2012-3#1)
and TSH##10##2##(1991-12#1)(1991-6#1)(1993-8#3)(1994-11#1)(2008-4#2)(2011-1#1)(2012-3#1)
and TSH-binding inhibitor immunoglobulin (TBII) activities##2##6##(1991-12#1)(1991-5#1)
and TSP##3##2##(2009-10#2)(2013-8#1)
and TSWV##2##2##(2008-10#2)
and TT##2##2##(2006-10#1)(2008-10#1)
and TUNEL##5##2##(2007-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
and Taiwan##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
and Tanzania##3##2##(1997-6#1)(2008-10#2)
and TaqMan##6##2##(2008-10#4)(2010-4#1)(2012-2#1)
and Task##2##2##(2009-10#2)
and Taylor's##2##2##(1994-2#1)(2008-10#1)
and Tb(III)##2##2##(1991-5#1)(2008-10#1)
and Tc##2##2##(1995-12#1)(2008-8#1)
and Te by##2##3##(2008-10#2)
and Te##4##2##(2008-10#4)
and Teacher##2##2##(2007-5#1)(2011-2#1)
and Technical##3##2##(1997-5#1)(2007-4#1)(2010-8#1)
and Technology##16##2##(1990-11#1)(1996-12#1)(2008-10#2)(2008-2#2)(2008-3#6)(2008-7#2)(2009-5#1)(2011-2#1)
and Temperature on##2##3##(2008-10#2)
and Temperature##3##2##(2008-10#3)
and Temporal##2##2##(2008-10#2)
and Tennessee##2##2##(2008-10#2)
and Territorial##3##2##(1994-2#1)(1995-12#1)(2013-1#1)
and Testing Programme##3##3##(2008-10#3)
and Testing##6##2##(2008-10#6)
and Texas##8##2##(1993-3#1)(2008-10#6)(2013-8#1)
and Tf##2##2##(1990-8#2)
and Th##2##2##(1995-12#1)(2008-10#1)
and Th(IV)##17##2##(2008-10#17)
and Th1##2##2##(2008-7#1)(2012-2#1)
and Th17##4##2##(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
and Th2##5##2##(2008-11#2)(2008-4#1)(2010-5#1)(2012-12#1)
and Thailand##6##2##(1996-9#3)(1997-6#1)(2008-10#2)
and Thatcher##3##2##(2008-10#1)(2008-5#2)
and The##12##2##(1991-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-3#1)
and Their##18##2##(1995-3#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
and Theoretical##2##2##(1996-2#1)(2012-12#1)
and Theory##2##2##(1996-12#1)(2013-1#1)
and Thermoanaerobacter tengcongensis##2##3##(2011-1#2)
and Thielaviopsis basicola on##2##4##(2008-10#2)
and Thielaviopsis basicola##3##3##(2008-10#3)
and Thr##2##2##(1991-9#1)(2008-2#1)
and Thymus##3##2##(2008-10#1)(2008-12#2)
and Thyroid##2##2##(2008-4#1)(2008-8#1)
and Ti##6##2##(2008-10#3)(2008-3#1)(2013-8#2)
and Ti(IV) ions from solution samples##2##6##(2008-10#2)
and Ti(IV) ions##3##3##(2008-10#3)
and Ti(IV)##6##2##(2008-10#6)
and Ti)##4##2##(2008-10#4)
and TiO(2)##2##2##(2008-10#1)(2013-1#1)
and TiO2##5##2##(2007-12#1)(2008-10#4)
and Tillage##2##2##(2008-10#2)
and Time##5##2##(2007-12#2)(2008-10#1)(2008-5#2)
and Tiotriazoline##2##2##(2011-1#2)
and Tissue##4##2##(1995-8#1)(2008-10#1)(2010-1#1)(2013-1#1)
and Title X##2##3##(1991-1#1)(1991-3#1)
and Tl##7##2##(2008-10#6)(2013-8#1)
and Tm##2##2##(2008-2#1)(2008-3#1)
and Tobacco mosaic virus##3##4##(2008-10#3)
and Tomato in##2##3##(2008-10#2)
and Tomato leaf curl##2##4##(2008-10#2)
and Tomato yellow leaf curl##3##5##(2008-10#3)
and Tomato##9##2##(2008-10#8)(2011-2#1)
and Total Problems##2##3##(2010-8#2)
and Total##4##2##(2008-2#1)(2010-8#2)(2011-2#1)
and Training##2##2##(2012-2#1)(2013-1#1)
and Transfusion##3##2##(2008-11#1)(2013-1#2)
and Transmission##4##2##(2008-10#2)(2008-2#1)(2009-9#1)
and Trauma##2##2##(2008-12#1)(2010-9#1)
and Traumatology of the Locomotor##3##5##(2007-11#2)(2007-8#1)
and Traumatology of the##4##4##(2007-11#3)(2007-8#1)
and Traumatology of##5##3##(2007-11#3)(2007-8#2)
and Traumatology##14##2##(2007-11#6)(2007-8#5)(2009-4#1)(2013-1#2)
and Treatment of High Blood Cholesterol in Adults##2##8##(2008-3#2)
and Treatment of##10##3##(1994-3#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#3)(2010-11#1)(2011-2#1)
and Treatment##20##2##(1994-3#1)(2008-1#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#4)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
and Treponema##3##2##(2010-11#1)(2013-8#2)
and Trichoderma##5##2##(2008-10#4)(2008-5#1)
and Trichophyton mentagrophytes##2##3##(2008-5#2)
and Trichophyton##3##2##(2008-5#3)
and Trichoplusia ni BTI-TN-5B1-4##2##4##(2008-11#2)
and Trichoplusia ni##5##3##(2008-11#3)(2008-7#2)
and Trichoplusia##6##2##(2008-11#3)(2008-7#3)
and Trinidad##3##2##(2008-4#2)(2009-7#1)
and Triton X-100##9##3##(1990-2#1)(2008-10#7)(2008-12#1)
and Triturus##2##2##(2008-7#2)
and Tropical Medicine##2##3##(2009-2#1)(2010-1#1)
and Tropical##4##2##(2008-10#1)(2008-5#1)(2009-2#1)(2010-1#1)
and Trp##3##2##(1995-3#1)(1997-3#1)(2008-11#1)
and Tukey's test##4##3##(2008-12#2)(2013-1#2)
and Tukey's##6##2##(2008-11#1)(2008-12#3)(2013-1#2)
and Turkey##6##2##(2008-10#5)(2008-12#1)
and Two##2##2##(1997-7#1)(2008-10#1)
and Two-Phase##2##2##(2007-5#1)(2010-4#1)
and Type 2##2##3##(2008-9#1)(2013-1#1)
and Type II##3##3##(1994-2#1)(2008-8#1)(2008-9#1)
and Type##8##2##(1994-2#1)(1997-8#1)(2008-8#2)(2008-9#3)(2013-1#1)
and Tyr 60##2##3##(1995-5#2)
and Tyr##4##2##(1995-5#2)(2008-10#2)
and U##27##2##(1991-8#2)(1994-1#1)(2008-10#18)(2008-11#1)(2009-7#1)(2010-8#2)(2012-12#1)(2012-2#1)
and U937##3##2##(1992-3#1)(1995-3#1)(2012-12#1)
and UDP##3##2##(1992-8#1)(2008-4#2)
and UDPGTh2 were##2##3##(2008-11#2)
and UDPGTh2##3##2##(2008-11#3)
and UHMWPE cable##3##3##(2009-3#3)
and UI##2##2##(2008-10#1)(2010-10#1)
and UK##2##2##(2008-10#1)(2008-11#1)
and UNICEF##2##2##(2010-5#2)
and UO(2)(2+)##2##2##(2008-10#2)
and UO(2)(PBI)(2)##3##2##(2008-10#3)
and US##3##2##(2008-8#1)(2009-12#1)(2013-1#1)
and US-04##2##2##(2008-10#2)
and US-1##2##2##(2008-10#2)
and US-8 clonal lineages for##2##5##(2008-10#2)
and US-8 clonal lineages##3##4##(2008-10#3)
and US-8 isolates##4##3##(2008-10#4)
and US-8##12##2##(2008-10#12)
and US-8)##2##2##(2008-10#2)
and US14##2##2##(2008-10#2)
and USA##2##2##(2010-8#1)(2012-12#1)
and USEPA##2##2##(2008-10#2)
and UTP##9##2##(1993-8#2)(1995-11#1)(2008-4#6)
and UV detection at##4##4##(2008-10#2)(2008-5#2)
and UV detection##11##3##(1997-2#1)(2008-10#6)(2008-5#3)(2011-1#1)
and UV irradiation##2##3##(2008-10#2)
and UV pulses##2##3##(2007-12#1)(2008-2#1)
and UV radiation##2##3##(2008-2#1)(2011-2#1)
and UV##38##2##(1994-8#1)(1997-2#2)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-2#3)(2008-5#5)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#1)
and UV-A##2##2##(1991-6#1)(2008-11#1)
and UV-VIS##3##2##(1990-12#1)(2008-10#2)
and UV-Vis spectroscopy##2##3##(2008-10#1)(2009-8#1)
and UV-Vis##5##2##(2008-10#3)(2009-8#1)(2013-8#1)
and UV-vis spectroscopy##2##3##(2007-11#1)(2008-10#1)
and UV-vis##5##2##(2007-11#1)(2008-10#4)
and UV-visible spectrophotometry##2##3##(2008-10#2)
and UV-visible##5##2##(2008-10#5)
and UVA protection##2##3##(2008-5#2)
and UVA##8##2##(2008-10#1)(2008-5#7)
and UVB-tolerant##2##2##(2008-11#2)
and Ultrastructural##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
and Uncertainty##2##2##(1990-8#1)(2008-2#1)
and United States##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
and United##4##2##(1990-3#1)(2008-10#1)(2010-12#1)(2012-3#1)
and University##2##2##(1993-2#1)(2008-11#1)
and Upper##2##2##(2008-10#1)(2009-2#1)
and Urban##2##2##(1996-5#1)(2012-1#1)
and Ustilago maydis##2##3##(1996-6#1)(2010-7#1)
and Ustilago##4##2##(1996-6#1)(2008-5#2)(2010-7#1)
and Utility##2##2##(2008-10#1)(2010-8#1)
and Utilization##3##2##(2008-10#2)(2008-11#1)
and V in##3##3##(2008-10#3)
and V loss##4##3##(2011-2#4)
and V##40##2##(1990-2#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-6#1)(1996-5#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#6)(2011-3#1)
and V(IV)##4##2##(2008-10#4)
and V(L)-gp130##2##2##(2008-11#2)
and V(max)##3##2##(2008-10#2)(2008-11#1)
and V3##2##2##(1996-2#1)(2008-12#1)
and V6 regions##2##3##(2011-2#2)
and V767 of 4##2##4##(2010-5#2)
and VB##2##2##(2008-10#1)(2008-12#1)
and VCG4B##5##2##(2008-10#5)
and VEGF##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
and VI and a##2##4##(1994-2#1)(1997-2#1)
and VI##11##2##(1990-5#1)(1991-6#1)(1993-12#2)(1994-2#2)(1997-2#1)(2007-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
and VII##4##2##(2008-10#1)(2008-5#3)
and VIII##3##2##(1995-6#1)(2009-10#1)(2012-2#1)
and VIP##3##2##(1994-3#1)(1995-11#1)(2012-3#1)
and VKORC1##3##2##(2011-1#3)
and VKORC1-1639A/G in the Chinese##2##5##(2011-1#2)
and VKORC1-1639A/G##3##2##(2011-1#3)
and VL##2##2##(1996-5#1)(2008-8#1)
and VLDL##6##2##(1993-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-7#1)(2013-1#1)
and VP-16##4##2##(1992-12#2)(1992-6#1)(1993-9#1)
and VP1##3##2##(1994-8#1)(2013-8#2)
and VP3##4##2##(1995-5#1)(1997-4#3)
and VPA##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
and VTA##2##2##(1996-12#1)(1996-5#1)
and Val##3##2##(1992-3#2)(1992-9#1)
and Validation##2##2##(2008-10#1)(2012-3#1)
and Valsartan##4##2##(2008-10#3)(2010-3#1)
and Van##2##2##(2007-11#1)(2008-5#1)
and Varroa##2##2##(2013-1#2)
and Vascular##3##2##(2008-3#2)(2011-1#1)
and Vegetative Compatibility##2##3##(2008-10#2)
and Venezuela##2##2##(2008-10#1)(2008-8#1)
and Venturia inaequalis##3##3##(2008-10#3)
and Vero##3##2##(2007-10#2)(2008-11#1)
and Verticillium dahliae##4##3##(2008-10#4)
and Verticillium wilt##2##3##(2008-10#2)
and Verticillium##7##2##(2008-10#7)
and Vibrational##2##2##(1996-2#1)(2009-6#1)
and Vibrio##2##2##(1990-7#1)(1994-11#1)
and Victoria##3##2##(1996-6#1)(2008-11#2)
and Virulence of##2##3##(2008-10#2)
and Virulence##8##2##(2008-10#8)
and Visceral##2##2##(2008-3#1)(2013-1#1)
and Vitamin##2##2##(2011-1#1)(2013-7#1)
and Vmax of##2##3##(1993-8#1)(1994-6#1)
and Vmax values of##3##4##(1994-5#1)(1995-8#2)
and Vmax##10##2##(1991-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-8#2)(1997-6#2)
and W##9##2##(1990-8#1)(1991-5#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-5#1)
and W(VI) with##2##3##(2008-10#2)
and W(VI)##4##2##(2008-10#4)
and W-7)##2##2##(1990-8#1)(2008-10#1)
and WBC count##3##3##(2008-10#1)(2013-1#2)
and WBC##4##2##(2008-10#1)(2008-4#1)(2013-1#2)
and WBI##4##2##(2011-2#4)
and WHC##2##2##(2010-2#1)(2012-2#1)
and WHR##5##2##(2007-12#5)
and WIPK##2##2##(2009-8#2)
and WNA are##2##3##(2008-8#2)
and WNA##9##2##(2008-8#9)
and WT##2##2##(2008-9#1)(2012-3#1)
and Walking##2##2##(2013-1#1)(2013-8#1)
and Warren##2##2##(1992-7#1)(2008-3#1)
and Water##3##2##(1996-9#1)(2008-10#1)(2008-5#1)
and Web##3##2##(2008-9#2)(2013-8#1)
and Web-based##2##2##(2010-3#2)
and Wechsler Adult Intelligence##2##4##(1994-6#2)
and Welfare##8##2##(1991-1#1)(1991-3#2)(1996-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
and Welsh##2##2##(2008-10#2)
and Werner##2##2##(2009-12#1)(2010-1#1)
and West##8##2##(1990-3#1)(2007-10#3)(2007-2#1)(2008-12#1)(2008-6#1)(2011-2#1)
and Western Europe##4##3##(1997-1#1)(2008-1#1)(2009-4#1)(2011-2#1)
and Western blot analyses##2##4##(1994-12#1)(2006-12#1)
and Western blot analysis##4##4##(1996-12#1)(1996-2#1)(2008-8#1)(2011-2#1)
and Western blot##16##3##(1994-12#1)(1996-12#1)(1996-2#1)(2006-12#1)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#2)(2011-1#1)(2011-2#3)
and Western blots##3##3##(1994-9#1)(1995-8#1)(2008-10#1)
and Western blotting analysis##2##4##(2008-11#1)(2008-8#1)
and Western blotting with a##2##5##(1994-11#1)(2010-12#1)
and Western blotting##8##3##(1993-8#1)(1994-11#1)(1994-8#1)(1995-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-3#1)
and Western##42##2##(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-12#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#4)(2011-3#1)
and Wheat##6##2##(2008-10#5)(2008-5#1)
and White participants##2##3##(2008-11#1)(2012-2#1)
and White##11##2##(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#3)(2012-2#2)
and Whites##3##2##(1993-3#1)(2010-2#1)(2012-2#1)
and Wiesel##2##2##(2009-5#2)
and Wild##3##2##(2008-10#3)
and Willet##3##2##(2013-7#3)
and Wilson disease##2##3##(2006-10#1)(2012-2#1)
and Wilson##3##2##(2006-10#1)(2012-2#2)
and Wilt##2##2##(2008-10#2)
and Wind##2##2##(2008-10#1)(2008-3#1)
and Winter##2##2##(2008-10#2)
and Wisconsin##4##2##(2008-10#2)(2008-12#2)
and Within Populations of##2##4##(2008-10#2)
and Within##3##2##(2008-10#3)
and Wnt signaling##2##3##(2008-7#1)(2012-12#1)
and Wnt##4##2##(2007-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
and Women's##7##2##(1993-3#1)(1994-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#2)
and Worland##4##2##(2008-10#4)
and World##4##2##(1993-3#1)(1996-3#1)(2008-2#1)(2008-7#1)
and X##26##2##(1993-11#2)(1993-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-5#2)(2008-10#12)(2008-3#1)(2008-7#4)(2008-8#1)
and X-ray crystallography##4##3##(1991-11#1)(1996-2#1)(1996-5#1)(2007-11#1)
and X-ray diffraction (XRD)##3##4##(2008-10#2)(2009-7#1)
and X-ray diffraction analysis##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
and X-ray diffraction studies##2##4##(2008-5#1)(2010-5#1)
and X-ray diffraction##15##3##(1993-11#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
and X-ray photoelectron spectroscopy (XPS)##2##5##(2008-10#2)
and X-ray photoelectron spectroscopy##8##4##(1996-12#1)(2008-10#7)
and X-ray photoelectron##10##3##(1996-12#1)(2008-10#8)(2010-4#1)
and X-ray##49##2##(1991-11#1)(1992-3#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2006-4#1)(2007-11#4)(2007-12#2)(2008-10#18)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and XN4##4##2##(2008-10#4)
and XO##2##2##(2008-10#1)(2008-11#1)
and XPD##2##2##(2010-6#1)(2010-8#1)
and XPS spectra##2##3##(2008-10#2)
and XPS##4##2##(2008-10#4)
and XRD##3##2##(2008-10#1)(2008-5#2)
and Xa21##5##2##(2008-10#4)(2008-8#1)
and Xanthomonas campestris##2##3##(2008-10#2)
and Xanthomonas##4##2##(2008-10#4)
and XbaI##3##2##(1992-3#2)(2008-10#1)
and Xenopus laevis##2##3##(1991-6#1)(1997-3#1)
and Xenopus##4##2##(1991-6#1)(1994-8#1)(1995-11#1)(1997-3#1)
and Y = 0##2##4##(2008-10#1)(2011-1#1)
and Y chromosomes##4##3##(1990-3#2)(2008-7#1)(2010-5#1)
and Y point##2##3##(2008-7#2)
and Y##29##2##(1990-11#1)(1990-3#4)(1993-9#1)(1994-1#2)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-7#6)(2008-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
and Y300##3##2##(1995-2#3)
and YAC 876D4##2##3##(1997-8#2)
and YAC##4##2##(1996-8#1)(1997-8#3)
and YAG##2##2##(2008-3#1)(2013-8#1)
and YAG-OPO##2##2##(2008-5#2)
and Yb##6##2##(1997-8#2)(2008-10#1)(2008-3#2)(2010-4#1)
and Yb(3+)##2##2##(2008-10#1)(2010-4#1)
and Yersinia##3##2##(2007-7#1)(2010-4#1)(2012-2#1)
and York##2##2##(1992-1#1)(2008-10#1)
and Young Child Nutrition##3##4##(2010-5#3)
and Young Child##4##3##(2010-5#4)
and Young##7##2##(2008-6#1)(2009-12#1)(2010-5#4)(2012-12#1)
and Young's modulus of##2##4##(2008-3#2)
and Youth##3##2##(2007-12#1)(2008-9#1)(2012-12#1)
and Z = 2##6##4##(1996-2#3)(1997-7#2)(2007-11#1)
and Z = 4 for compound##2##6##(1997-7#2)
and Z = 4##16##4##(1992-12#1)(1996-2#8)(1997-7#6)(2007-11#1)
and Z = 8##2##4##(1996-2#1)(1997-7#1)
and Z =##26##3##(1992-12#1)(1996-2#13)(1997-7#10)(2007-11#2)
and Z##29##2##(1992-12#1)(1996-2#13)(1997-7#10)(2007-11#2)(2008-10#1)(2009-12#1)(2010-5#1)
and ZAPM##3##2##(2008-7#3)
and Zn as##2##3##(2008-10#2)
and Zn by##2##3##(2008-10#2)
and Zn concentrations in##2##4##(1997-4#1)(2008-10#1)
and Zn content##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
and Zn determination##2##3##(2008-10#2)
and Zn from##2##3##(2008-10#2)
and Zn in##18##3##(2008-10#18)
and Zn levels##2##3##(2008-10#1)(2011-2#1)
and Zn were##7##3##(2008-10#6)(2013-8#1)
and Zn##85##2##(1995-3#2)(1997-4#3)(2008-10#70)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and Zn(2+) can be##2##4##(2008-10#2)
and Zn(2+) from aqueous environments##2##5##(2008-10#2)
and Zn(2+) in##2##3##(2008-10#2)
and Zn(2+)##23##2##(2008-10#20)(2008-5#2)(2010-11#1)
and Zn(II) from##2##3##(2008-10#2)
and Zn(II) in##2##3##(2008-10#2)
and Zn(II) using##2##3##(2008-10#2)
and Zn(II) were##2##3##(2008-10#2)
and Zn(II)##24##2##(2008-10#23)(2009-12#1)
and Zn) by##3##3##(2008-10#3)
and Zn) in##2##3##(2008-10#2)
and Zn)##11##2##(2008-10#11)
and Zn2+##5##2##(1991-5#1)(1992-11#3)(2013-8#1)
and ZnO##2##2##(2008-10#1)(2008-7#1)
and Zr##4##2##(2008-10#4)
and ZrO(2)##2##2##(2007-11#1)(2008-2#1)
and [125I]thyroxine##2##2##(1991-5#1)(1993-12#1)
and [2##2##2##(1992-10#1)(1997-1#1)
and [3H]T##2##2##(1990-11#2)
and [Ca2+]i##3##2##(1990-12#1)(1990-7#1)(1997-1#1)
and [D-Ala2##3##2##(1995-6#1)(1996-2#2)
and [Leu11]gastrin-(5-17)##2##2##(1995-12#2)
and [Mn##2##2##(2010-8#2)
and a &quot##8##3##(1991-12#1)(1991-8#1)(1994-3#1)(1995-9#1)(1997-2#1)(2008-4#1)(2008-7#1)(2009-4#1)
and a 0##5##3##(1994-12#1)(2008-10#2)(2009-11#1)(2011-2#1)
and a 1##5##3##(1993-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
and a 2##4##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
and a 2'-hydroxyl in##2##4##(1993-1#2)
and a 20##2##3##(2007-12#1)(2008-10#1)
and a 3-fold increase in##2##5##(1995-2#1)(2008-3#1)
and a 3-fold##3##3##(1995-2#1)(1997-7#1)(2008-3#1)
and a 30%##3##3##(1994-8#1)(2008-8#1)(2013-1#1)
and a 31##2##3##(1990-2#1)(2009-1#1)
and a 4##3##3##(1992-3#1)(2008-10#2)
and a 40%##2##3##(2008-3#1)(2008-4#1)
and a 45 degrees##2##4##(2008-3#2)
and a 50##2##3##(2008-10#1)(2008-12#1)
and a 70%##2##3##(2008-9#1)(2011-2#1)
and a 77 bp##2##4##(1990-7#1)(2008-12#1)
and a Bmax of##2##4##(1990-2#1)(1991-5#1)
and a C-terminal##7##3##(1993-12#1)(1993-6#1)(1995-5#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-2#1)
and a CAAT##2##3##(1993-6#1)(1997-7#1)
and a CCD camera##3##4##(2008-2#1)(2008-3#2)
and a CCD##5##3##(2008-2#2)(2008-3#3)
and a CT##3##3##(1990-6#1)(1992-5#1)(1997-2#1)
and a DNA##2##3##(1996-12#1)(2008-10#1)
and a FWHM of##2##4##(2008-2#1)(2008-3#1)
and a GUS##2##3##(2008-10#2)
and a Gaussian##2##3##(2008-2#1)(2008-3#1)
and a Hill coefficient of 1##2##6##(1993-12#1)(1994-6#1)
and a Km##3##3##(1994-6#1)(1995-5#2)
and a Mann-Whitney test were used to determine##2##8##(2008-10#2)
and a Nd##2##3##(2007-11#1)(2007-12#1)
and a New##2##3##(1996-5#1)(2011-1#1)
and a Q-switched Nd##2##4##(2007-12#1)(2008-3#1)
and a Q-switched##4##3##(2007-12#2)(2008-3#2)
and a R##5##3##(2008-10#5)
and a SYBR Green-based real-time PCR##2##6##(2012-3#2)
and a VLSI##2##3##(2008-3#2)
and a Vmax of 0##2##5##(1992-3#1)(1995-2#1)
and a Vmax of##5##4##(1992-3#2)(1994-6#1)(1995-2#2)
and a Vmax##6##3##(1992-3#3)(1994-6#1)(1995-2#2)
and a approximately##2##3##(2007-5#1)(2008-11#1)
and a bacterium##3##3##(2008-10#3)
and a battery of##2##4##(1990-3#1)(2008-11#1)
and a beam##2##3##(2008-3#2)
and a bending##4##3##(2007-12#1)(2008-3#3)
and a better##9##3##(1995-5#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)
and a bilateral##2##3##(1990-9#1)(1996-2#1)
and a binary##2##3##(2008-10#1)(2008-3#1)
and a binding capacity of##3##5##(1990-5#3)
and a binding##4##3##(1990-5#4)
and a biological##2##3##(2008-5#1)(2013-8#1)
and a brief##2##3##(1992-3#1)(2007-12#1)
and a broader##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
and a buffer##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
and a calibration##3##3##(2008-10#2)(2008-2#1)
and a call##2##3##(1991-3#1)(2012-12#1)
and a candidate##2##3##(2009-9#1)(2012-2#1)
and a case##2##3##(1992-12#1)(2010-5#1)
and a cation##2##3##(2008-10#2)
and a cationic##3##3##(2008-10#3)
and a cell culture##2##4##(1994-9#1)(2008-11#1)
and a cell##4##3##(1994-9#1)(2007-12#1)(2008-11#1)(2011-2#1)
and a central##3##3##(1997-7#1)(2008-10#2)
and a chance##2##3##(2008-12#1)(2011-2#1)
and a change##2##3##(2008-3#2)
and a chest##2##3##(1990-6#1)(2010-12#1)
and a chronic##2##3##(2007-11#1)(2012-12#1)
and a clear##2##3##(2007-10#1)(2010-8#1)
and a clearer##2##3##(2008-10#1)(2008-9#1)
and a clinical evaluation##2##4##(1997-2#1)(2008-1#1)
and a clinical##8##3##(1996-7#1)(1997-2#1)(2008-1#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
and a closer##2##3##(2008-8#1)(2012-3#1)
and a column temperature of##3##5##(2008-10#3)
and a combination of the##2##5##(1994-3#1)(2011-2#1)
and a combination of##8##4##(1991-8#1)(1991-9#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
and a combined##2##3##(2008-10#1)(2010-3#1)
and a commercial##3##3##(2008-2#1)(2010-11#1)(2012-2#1)
and a commercially available enzyme-linked immunosorbent assay (ELISA)##2##8##(1997-4#1)(2010-5#1)
and a commercially available##7##4##(1997-4#1)(2008-10#3)(2008-3#2)(2010-5#1)
and a common##5##3##(1997-4#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-9#1)
and a community##2##3##(2008-7#1)(2008-8#1)
and a comparison is##2##4##(2008-10#1)(2008-5#1)
and a comparison of##3##4##(1990-7#1)(2008-10#1)(2008-2#1)
and a comparison with##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
and a comparison##11##3##(1990-7#1)(1991-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)
and a complementary##2##3##(2008-2#1)(2008-3#1)
and a complete##6##3##(1990-2#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-3#1)
and a complex##3##3##(1995-5#1)(2007-12#1)(2008-10#1)
and a composite##3##3##(1991-5#1)(2008-11#1)(2008-2#1)
and a computer##3##3##(2008-10#2)(2009-10#1)
and a concentration of##2##4##(2008-10#1)(2008-12#1)
and a concentration##3##3##(2008-10#2)(2008-12#1)
and a concomitant##6##3##(1992-1#1)(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
and a confocal##2##3##(2008-3#2)
and a consequent##2##3##(1995-5#1)(2008-2#1)
and a conserved##2##3##(1994-12#1)(1997-7#1)
and a considerable reduction in##2##5##(2008-2#1)(2008-3#1)
and a considerable##5##3##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
and a consistent##4##3##(1997-3#1)(2008-10#1)(2012-2#2)
and a constant amount of##2##5##(2008-10#1)(2008-5#1)
and a constant ionic strength of 0##2##7##(2008-10#1)(2008-5#1)
and a constant##8##3##(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)
and a continuous##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)
and a control group of##4##5##(2007-10#1)(2007-11#1)(2007-8#1)(2011-2#1)
and a control group with##3##5##(1992-2#1)(1995-2#1)(2008-5#1)
and a control group##17##4##(1991-12#1)(1992-2#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-7#1)
and a control##27##3##(1991-12#1)(1992-2#1)(1994-3#1)(1995-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
and a conventional##5##3##(2008-10#1)(2008-3#2)(2009-6#1)(2013-1#1)
and a cooled##3##3##(2008-10#2)(2008-2#1)
and a core##2##3##(2011-2#1)(2012-2#1)
and a correct##2##3##(2007-8#1)(2013-1#1)
and a correlation coefficient of 0##3##6##(2008-10#2)(2010-2#1)
and a correlation coefficient##4##4##(2008-10#3)(2010-2#1)
and a correlation##8##3##(2008-10#6)(2008-7#1)(2010-2#1)
and a corresponding reduction##2##4##(1996-4#1)(2008-10#1)
and a corresponding##12##3##(1995-12#1)(1996-4#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-11#1)(2013-1#1)
and a critical##5##3##(1990-2#1)(1991-3#1)(2008-11#1)(2009-10#1)(2013-1#1)
and a cw##2##3##(2007-12#1)(2008-2#1)
and a cytoplasmic##4##3##(1991-5#1)(2008-6#1)(2010-10#1)(2011-2#1)
and a dark##2##3##(1991-5#1)(2008-10#1)
and a decline in##3##4##(1993-12#1)(1996-12#1)(2010-11#1)
and a decoy receptor##2##4##(2008-11#1)(2008-7#1)
and a decrease in the##8##5##(1994-6#2)(2008-10#3)(2008-3#1)(2008-5#1)(2011-1#1)
and a decrease in##26##4##(1990-2#1)(1990-8#1)(1993-8#1)(1993-9#1)(1994-6#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
and a decrease of finger pressure in##2##7##(2008-1#2)
and a decrease of##6##4##(2008-1#2)(2008-10#3)(2013-8#1)
and a decrease##34##3##(1990-2#1)(1990-8#1)(1993-8#1)(1993-9#1)(1994-6#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and a decreased##8##3##(1990-11#1)(1991-12#1)(1996-2#1)(1997-3#1)(2008-1#2)(2008-10#1)(2013-1#1)
and a delay##2##3##(1994-6#1)(2008-10#1)
and a delayed##4##3##(1994-9#1)(1995-12#1)(1996-5#1)(2008-3#1)
and a deletion of##3##4##(2008-10#2)(2011-1#1)
and a description of the##2##5##(1990-12#1)(1994-2#1)
and a description of##4##4##(1990-12#1)(1994-2#1)(2007-5#1)(2010-12#1)
and a description##5##3##(1990-12#1)(1992-1#1)(1994-2#1)(2007-5#1)(2010-12#1)
and a detailed##3##3##(2008-3#1)(2009-12#1)(2011-2#1)
and a detection limit (3sigma) of##2##6##(2008-10#2)
and a detection limit of 0##11##6##(2008-10#11)
and a detection limit of 1##9##6##(1991-5#1)(2008-10#8)
and a detection limit of 2##4##6##(2008-10#4)
and a detection limit of 20##2##6##(2008-10#2)
and a detection limit of 3##3##6##(2008-10#3)
and a detection limit of 4##2##6##(2008-10#2)
and a detection limit of 6##2##6##(2008-10#2)
and a detection limit of##42##5##(1991-5#1)(2008-10#41)
and a detection limit##47##4##(1991-5#1)(2008-10#45)(2008-3#1)
and a detection##48##3##(1991-5#1)(2008-10#45)(2008-3#1)(2009-5#1)
and a detector##2##3##(2007-11#1)(2008-10#1)
and a diagnostic##2##3##(2008-1#1)(2008-6#1)
and a difference##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
and a different behaviour##2##4##(1992-2#1)(2008-10#1)
and a different##8##3##(1992-2#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)
and a diffraction##2##3##(2007-11#1)(2008-3#1)
and a diffusible##2##3##(1992-8#1)(1994-12#1)
and a digital##4##3##(1992-6#1)(2008-3#2)(2013-1#1)
and a diode array##2##4##(2008-10#2)
and a direct##2##3##(1995-2#1)(2008-11#1)
and a discussion of the##2##5##(2008-4#1)(2008-9#1)
and a discussion of##7##4##(1991-2#1)(1992-1#1)(1994-5#1)(2008-10#1)(2008-4#2)(2008-9#1)
and a discussion##8##3##(1991-2#1)(1992-1#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
and a dissociation constant##2##4##(1990-8#1)(2008-10#1)
and a distal##3##3##(2008-9#2)(2012-2#1)
and a distinct##2##3##(1997-3#1)(2010-10#1)
and a domain at##2##4##(1997-6#1)(1997-8#1)
and a domain##3##3##(1994-2#1)(1997-6#1)(1997-8#1)
and a double##4##3##(1995-6#1)(1997-6#1)(2008-10#2)
and a drug##2##3##(2008-1#1)(2013-8#1)
and a duplex with##2##4##(1993-8#2)
and a dynamic##4##3##(2008-10#3)(2008-3#1)
and a factor of##3##4##(1993-11#1)(2007-12#1)(2008-3#1)
and a family of##2##4##(1996-6#1)(2011-2#1)
and a family##3##3##(1996-6#1)(2008-7#1)(2011-2#1)
and a fast response##2##4##(2008-10#2)
and a fast##5##3##(1996-5#1)(2007-12#1)(2008-10#3)
and a faster##2##3##(2008-10#1)(2008-3#1)
and a few##14##3##(1990-6#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)
and a fiber Bragg grating##2##5##(2007-11#1)(2007-12#1)
and a fiber##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
and a field##2##3##(2008-10#2)
and a final test##2##4##(2010-3#1)(2013-1#1)
and a final##12##3##(1993-3#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-9#1)(2013-1#1)
and a fixed##3##3##(1997-2#1)(2008-3#2)
and a flow rate of 1##2##6##(2008-10#2)
and a flow rate of##4##5##(2008-10#4)
and a flow rate##6##4##(2008-10#6)
and a flow##7##3##(2008-10#7)
and a fluorescent##3##3##(1993-11#1)(2008-10#2)
and a focused##2##3##(2008-3#2)
and a focusing##2##3##(2008-3#2)
and a follow-up##2##3##(2007-11#1)(2008-7#1)
and a formal##4##3##(1996-2#1)(2007-10#1)(2008-10#1)(2011-1#1)
and a fragment of##2##4##(1995-11#2)
and a fragment##3##3##(1995-11#2)(2008-5#1)
and a framework for##4##4##(1991-12#1)(1992-2#1)(1996-2#1)(2010-4#1)
and a free##3##3##(2008-10#1)(2011-2#2)
and a frequency##2##3##(2007-12#1)(2008-2#1)
and a full##2##3##(2007-12#1)(2007-8#1)
and a fully##2##3##(2008-3#1)(2008-4#1)
and a functional##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
and a further##8##3##(1991-6#1)(1993-11#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-7#1)(2011-2#2)
and a gel##2##3##(1997-4#1)(2008-7#1)
and a gene##4##3##(1992-3#1)(1995-2#1)(2008-10#2)
and a general##4##3##(1996-11#1)(1997-7#1)(2008-2#1)(2011-1#1)
and a generalized##4##3##(2008-10#1)(2008-2#1)(2009-10#2)
and a genetic##3##3##(1994-12#1)(2010-8#1)(2011-2#1)
and a genetically engineered##2##4##(1995-2#1)(2008-11#1)
and a girl##2##3##(1997-3#1)(2007-7#1)
and a glass##4##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-5#1)
and a global##2##3##(1997-7#1)(2011-2#1)
and a good correlation was##2##5##(2008-10#1)(2008-3#1)
and a good selectivity##2##4##(2008-10#2)
and a good##14##3##(1992-6#2)(1995-2#1)(1995-4#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-3#2)
and a graphite##2##3##(2008-10#1)(2008-2#1)
and a great##4##3##(2008-11#1)(2008-3#2)(2008-9#1)
and a greater number of##4##5##(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)
and a greater##11##3##(1992-3#1)(1992-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#1)
and a group of##10##4##(1992-2#1)(1994-11#1)(1997-5#2)(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
and a growing##2##3##(2008-4#1)(2013-8#1)
and a half months##3##4##(1990-6#1)(2007-7#1)(2008-9#1)
and a half year##3##4##(1990-9#1)(1992-5#1)(2007-7#1)
and a half years##4##4##(1992-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
and a half##20##3##(1990-5#1)(1990-6#1)(1990-9#1)(1992-4#1)(1992-5#1)(1993-2#1)(1996-6#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-3#1)
and a health##2##3##(2008-11#1)(2008-7#1)
and a height of##2##4##(2011-2#1)(2012-2#1)
and a high degree of##6##5##(1992-3#1)(1995-10#1)(2008-10#3)(2011-2#1)
and a high index of suspicion##2##6##(2010-1#1)(2011-2#1)
and a high level of##4##5##(2008-11#2)(2010-3#1)(2011-2#1)
and a high mortality rate##3##5##(2008-12#1)(2008-3#1)(2012-12#1)
and a high proportion of##3##5##(1995-3#1)(1995-9#1)(2009-2#1)
and a high risk##3##4##(1991-6#1)(2008-4#2)
and a high##54##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-9#1)(2007-11#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#3)
and a higher concentration##2##4##(1996-9#1)(2008-10#1)
and a higher##23##3##(1991-5#1)(1994-2#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
and a highly selective##2##4##(2008-10#2)
and a highly susceptible##2##4##(2008-10#2)
and a highly##11##3##(1990-8#1)(1995-6#1)(1997-5#1)(2008-10#7)(2008-12#1)
and a history of##13##4##(1991-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
and a hologram##2##3##(2007-12#1)(2008-3#1)
and a home##2##3##(1994-12#1)(1997-2#1)
and a homologous##2##3##(1991-12#1)(1995-8#1)
and a hospital##2##3##(1991-3#1)(1996-3#1)
and a host of bacterial pathogens##2##6##(2008-4#1)(2008-9#1)
and a host of##4##4##(1995-1#1)(2008-4#1)(2008-9#1)(2011-1#1)
and a host##5##3##(1995-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)
and a human##8##3##(1994-11#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-11#2)(2008-6#1)(2009-2#1)
and a hybrid##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
and a key for##2##4##(2008-5#1)(2013-7#1)
and a key##4##3##(2008-5#1)(2008-6#1)(2009-12#1)(2013-7#1)
and a laboratory strain##2##4##(2011-2#1)(2012-3#1)
and a laboratory##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
and a lack of adequate testing of the chemical##2##9##(2008-9#2)
and a lack of##7##4##(2007-2#1)(2008-10#1)(2008-12#2)(2008-9#2)(2009-6#1)
and a large number of##4##5##(1993-12#1)(2008-9#1)(2011-2#2)
and a large##31##3##(1993-12#1)(1995-5#1)(1995-8#1)(1996-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
and a larger##10##3##(1990-6#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)
and a laser##2##3##(2008-2#2)
and a late##2##3##(1991-5#1)(2008-11#1)
and a lateral##3##3##(2008-2#1)(2008-3#2)
and a leading cause of##2##5##(2011-1#1)(2012-2#1)
and a least-squares##2##3##(2008-2#1)(2008-3#1)
and a left##4##3##(1991-12#1)(2008-7#1)(2009-3#1)(2011-2#1)
and a less##10##3##(1991-6#1)(2008-10#5)(2008-3#1)(2011-2#1)(2013-1#2)
and a life##2##3##(2006-10#1)(2011-1#1)
and a limit of detection between##2##6##(2008-10#2)
and a limit of detection of##2##6##(2008-10#2)
and a limit of detection##6##5##(2008-10#6)
and a limit of##7##4##(2008-10#7)
and a limited##5##3##(1993-6#1)(1995-11#1)(2007-2#1)(2008-10#1)(2008-5#1)
and a line##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
and a lineage##2##3##(2008-10#2)
and a linear dynamic range of##2##6##(2008-10#2)
and a linear dynamic range##3##5##(2008-10#3)
and a linear range of##3##5##(2008-10#3)
and a linear range##4##4##(2008-10#4)
and a linear relationship was##2##5##(2008-2#1)(2009-7#1)
and a linear##17##3##(2007-12#1)(2008-10#10)(2008-2#2)(2009-7#1)(2011-2#3)
and a link##2##3##(2008-10#1)(2008-2#1)
and a linkage##2##3##(1997-5#1)(2008-4#1)
and a lipophilic##2##3##(2008-10#2)
and a liquid##5##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-9#1)
and a literature review##2##4##(2009-4#1)(2011-2#1)
and a literature##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
and a live##2##3##(2008-10#1)(2008-3#1)
and a local##5##3##(1993-3#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
and a logarithmic##2##3##(2008-8#1)(2009-7#1)
and a long##13##3##(1991-6#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-12#1)
and a long-term##2##3##(2008-10#1)(2008-6#1)
and a longer##2##3##(2008-3#1)(2008-5#1)
and a look##2##3##(2008-1#1)(2009-10#1)
and a loss##4##3##(1995-2#1)(2008-3#2)(2011-1#1)
and a low detection limit of 0##2##7##(2008-10#2)
and a low detection limit##4##5##(2008-10#4)
and a low##28##3##(1990-8#1)(1994-9#1)(1995-12#1)(2006-12#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-3#1)(2012-3#1)
and a low-resolution##2##3##(2008-10#1)(2008-3#1)
and a lower detection limit##2##5##(2008-10#2)
and a lower incidence of##2##5##(1990-8#1)(2011-2#1)
and a lower number of##3##5##(2011-1#1)(2012-3#1)(2013-1#1)
and a lower##18##3##(1990-8#1)(1993-12#2)(1994-2#1)(1996-7#1)(2008-10#5)(2008-11#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and a lump##2##3##(2012-12#1)(2012-3#1)
and a lung##2##3##(1994-5#1)(2008-11#1)
and a magnetic##3##3##(1990-12#1)(2008-3#1)(2008-7#1)
and a major##10##3##(1992-2#1)(1992-6#1)(1993-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#3)(2012-3#1)
and a majority of them##2##5##(1995-2#1)(2008-10#1)
and a majority of##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
and a male##2##3##(1994-12#1)(2011-1#1)
and a marked increase in##2##5##(1992-8#1)(2007-7#1)
and a marked##6##3##(1992-5#1)(1992-8#1)(1994-11#1)(2007-7#1)(2008-10#1)(2012-2#1)
and a mass##3##3##(1996-3#1)(2008-1#1)(2008-10#1)
and a master##2##3##(2008-5#1)(2012-2#1)
and a matched##4##3##(1992-5#1)(1993-8#1)(2008-12#1)(2013-8#1)
and a mathematical model##2##4##(1997-1#1)(2008-10#1)
and a mature##2##3##(1991-12#1)(1992-3#1)
and a maximum of 10##2##5##(1990-6#1)(1992-9#1)
and a maximum of##3##4##(1990-6#1)(1992-9#1)(2008-10#1)
and a maximum##11##3##(1990-6#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
and a mean##10##3##(1990-3#1)(1994-12#1)(2008-10#5)(2008-3#1)(2010-4#1)(2013-1#1)
and a measure of the##2##5##(2007-12#1)(2012-3#1)
and a measure of##4##4##(2007-12#1)(2012-3#2)(2013-1#1)
and a measurement##2##3##(2008-3#2)
and a mechanical##2##3##(2009-4#1)(2013-1#1)
and a mechanism##2##3##(2008-10#1)(2008-3#1)
and a medical##2##3##(1993-9#1)(2013-1#1)
and a member of the##3##5##(1992-12#1)(2008-10#1)(2013-7#1)
and a member of##4##4##(1992-12#1)(2008-10#1)(2013-1#1)(2013-7#1)
and a membrane##2##3##(1995-3#1)(2008-6#1)
and a meta-analysis##2##3##(2007-12#1)(2012-12#1)
and a metal##3##3##(2008-10#1)(2008-3#2)
and a method for##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
and a method that attempts to find that##2##8##(2008-3#2)
and a method that##3##4##(2008-3#2)(2008-8#1)
and a method to##3##4##(2008-3#2)(2008-9#1)
and a method##10##3##(2008-10#1)(2008-11#1)(2008-3#5)(2008-8#1)(2008-9#2)
and a microlens array##2##4##(2007-11#1)(2008-3#1)
and a mild##4##3##(2008-7#2)(2011-1#1)(2011-2#1)
and a mini-column##2##3##(2008-10#2)
and a minimal##2##3##(1992-6#1)(2008-5#1)
and a minimum##9##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
and a minor##4##3##(1990-11#1)(1993-11#2)(2011-2#1)
and a minority of##2##4##(2007-5#1)(2008-8#1)
and a mirror##2##3##(2007-12#1)(2008-3#1)
and a mitochondrial##2##3##(2008-10#1)(2009-10#1)
and a mixture of##5##4##(1995-6#1)(2008-10#4)
and a mobile phase consisting of##2##6##(1991-5#1)(2008-10#1)
and a mobile phase of##5##5##(1990-8#1)(1996-5#1)(2008-10#3)
and a mobile phase##8##4##(1990-8#1)(1991-5#1)(1996-5#1)(2008-10#5)
and a model for the##2##5##(2008-10#1)(2008-3#1)
and a model for##3##4##(1992-12#1)(2008-10#1)(2008-3#1)
and a model system##2##4##(2008-10#2)
and a model##10##3##(1992-12#1)(1992-6#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)
and a moderate##3##3##(1992-12#1)(1997-4#1)(2008-3#1)
and a modified##2##3##(2007-8#1)(2008-10#1)
and a molecular##2##3##(1995-12#1)(2007-7#1)
and a monoclonal antibody to##2##5##(1995-12#1)(1997-1#1)
and a monoclonal antibody##4##4##(1995-12#1)(1997-1#1)(2008-10#1)(2011-2#1)
and a more complete##3##4##(1996-8#1)(2008-3#1)(2008-4#1)
and a more##16##3##(1990-3#1)(1993-6#1)(1995-8#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-8#1)
and a mouse##4##3##(1992-4#1)(1993-3#1)(1996-12#1)(2008-8#1)
and a much##4##3##(1991-2#1)(1992-10#1)(1992-8#1)(2011-2#1)
and a multidisciplinary approach##2##4##(2008-6#1)(2012-3#1)
and a multidisciplinary##3##3##(2008-6#1)(2011-3#1)(2012-3#1)
and a multiple cloning site##2##5##(1991-6#1)(1994-12#1)
and a multiple##3##3##(1991-6#1)(1994-12#1)(2008-10#1)
and a mutant##3##3##(1995-12#1)(2008-7#1)(2010-10#1)
and a national##3##3##(1993-12#2)(2008-9#1)
and a nationwide##2##3##(1991-11#1)(2008-6#1)
and a natural##2##3##(2008-10#1)(2008-5#1)
and a need for##2##4##(2010-3#1)(2013-8#1)
and a need##3##3##(2010-3#1)(2012-3#1)(2013-8#1)
and a negative##8##3##(1990-3#1)(1992-4#1)(1993-2#1)(1994-5#1)(1995-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
and a neighbouring##2##3##(1993-9#1)(1995-8#1)
and a net##2##3##(2007-11#1)(2008-2#1)
and a new drug##2##4##(1991-2#1)(2008-10#1)
and a new method for##2##5##(2008-10#1)(2008-7#1)
and a new method##3##4##(2008-10#1)(2008-7#1)(2010-5#1)
and a new##49##3##(1991-2#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
and a newly##4##3##(1992-9#1)(2008-10#3)
and a noise##2##3##(2007-11#1)(2008-10#1)
and a non-hydrolysable##2##3##(1994-8#1)(1995-3#1)
and a nonlinear##2##3##(2007-12#1)(2008-3#1)
and a normal##6##3##(1990-3#1)(1991-11#1)(1992-12#1)(2008-10#1)(2013-1#2)
and a normalized##2##3##(2007-12#1)(2008-3#1)
and a novel##12##3##(1995-6#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-2#1)
and a number of approaches have been##2##7##(2008-11#1)(2012-3#1)
and a number of other##9##5##(1991-3#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
and a number of##26##4##(1991-12#1)(1991-3#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and a numerical aperture of 0##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
and a numerical##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
and a p101##2##3##(1996-2#2)
and a pH##4##3##(1990-11#1)(2008-10#2)(2009-12#1)
and a pI of##3##4##(1992-8#1)(1995-6#1)(2008-10#1)
and a pair of##2##4##(2008-2#1)(2008-5#1)
and a parallel##3##3##(1995-2#1)(2009-8#1)(2009-9#1)
and a part of the##2##5##(1991-6#1)(2008-10#1)
and a part##3##3##(1990-3#1)(1991-6#1)(2008-10#1)
and a partial##8##3##(1990-5#1)(1993-5#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-3#1)(2013-8#1)
and a partially##2##3##(2008-10#2)
and a patient##6##3##(1991-12#1)(1996-12#1)(2007-11#1)(2008-1#1)(2011-2#2)
and a peak##6##3##(2007-11#2)(2007-12#2)(2008-7#1)(2012-12#1)
and a performance##2##3##(2008-3#2)
and a periodically##2##3##(2007-11#1)(2007-12#1)
and a peripheral##3##3##(1990-8#1)(1996-12#1)(2008-7#1)
and a phase##5##3##(1990-12#1)(2007-11#2)(2007-12#1)(2008-2#1)
and a phase-shifting technique##2##4##(2008-3#2)
and a phase-shifting##4##3##(2008-3#4)
and a phosphate buffer##3##4##(2008-10#3)
and a photometric##2##3##(2008-10#2)
and a photoperiod of##3##4##(2011-2#3)
and a phylogenetic##2##3##(2008-10#1)(2008-4#1)
and a placebo##2##3##(2008-10#1)(2008-5#1)
and a polar##2##3##(2008-10#1)(2008-5#1)
and a polymer##2##3##(2008-10#1)(2008-3#1)
and a polyurethane##2##3##(2008-10#2)
and a poor response##2##4##(1990-10#1)(2008-10#1)
and a poor##8##3##(1990-10#1)(1995-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)
and a poorer##2##3##(1993-11#1)(2010-4#1)
and a population##2##3##(1991-6#1)(2008-10#1)
and a portion of the##2##5##(1991-9#1)(2008-10#1)
and a portion of##3##4##(1991-9#1)(1997-2#1)(2008-10#1)
and a position##2##3##(2008-10#1)(2008-3#1)
and a positive correlation##2##4##(1991-11#1)(2013-8#1)
and a positive##10##3##(1990-8#1)(1991-11#1)(1993-2#1)(2006-10#1)(2008-10#1)(2009-1#1)(2010-2#1)(2010-8#1)(2013-7#1)(2013-8#1)
and a possible##12##3##(1994-12#1)(1994-8#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
and a posterior##2##3##(2007-12#1)(2012-3#1)
and a potential of##2##4##(2008-10#2)
and a potential role for##2##5##(2008-10#1)(2008-8#1)
and a potential##10##3##(1991-7#1)(1992-3#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#1)
and a potentially##2##3##(1993-2#1)(2012-12#1)
and a powerful##2##3##(1991-3#1)(2013-1#1)
and a pre-reducing##2##3##(2008-10#2)
and a precision expressed as relative standard deviation##2##8##(2008-10#2)
and a precision##6##3##(2008-10#5)(2012-1#1)
and a predictive##2##3##(1993-2#1)(2009-3#1)
and a predictor of##2##4##(2008-8#1)(2010-10#1)
and a preference for##2##4##(1994-12#1)(2009-5#1)
and a preliminary##3##3##(1992-2#1)(1993-11#1)(2008-8#1)
and a previously##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
and a primary##7##3##(1990-5#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
and a primer##2##3##(2008-10#2)
and a private##3##3##(1991-9#1)(1997-2#1)(2011-2#1)
and a probable##2##3##(1990-3#1)(2008-10#1)
and a probe##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
and a procedure for##2##4##(2008-10#1)(2008-2#1)
and a procedure##3##3##(2008-10#2)(2008-2#1)
and a profound##2##3##(1997-7#1)(2007-10#1)
and a prognostic indicator##2##4##(1993-11#1)(2013-1#1)
and a programmable pulse shaper##2##5##(2007-12#2)
and a prolonged##3##3##(2006-10#1)(2007-10#1)(2011-2#1)
and a properly##2##3##(2008-3#1)(2008-6#1)
and a proposed##2##3##(2007-2#1)(2008-3#1)
and a protein##2##3##(2008-10#1)(2011-2#1)
and a proton pump inhibitor##2##5##(2012-2#2)
and a pseudorandom##2##3##(2007-12#1)(2008-3#1)
and a pulmonary##2##3##(1990-6#1)(1996-3#1)
and a pulse width##2##4##(2008-3#2)
and a pulse##5##3##(2007-12#1)(2008-3#3)(2008-7#1)
and a pulsed##4##3##(2007-11#2)(2008-3#2)
and a putative##7##3##(1991-9#1)(1993-6#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-4#1)
and a qualitative##3##3##(1995-3#1)(2008-10#1)(2010-7#1)
and a quantitative##3##3##(2008-10#2)(2011-2#1)
and a quarter##2##3##(1992-6#1)(1997-2#1)
and a questionnaire##2##3##(2008-11#1)(2008-12#1)
and a quick##2##3##(1990-9#1)(2013-8#1)
and a radiolabeled##2##3##(1996-3#1)(2008-4#1)
and a random sample of##2##5##(1995-5#1)(2007-10#1)
and a random##3##3##(1990-7#1)(1995-5#1)(2007-10#1)
and a range of##11##4##(1995-5#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)
and a rapid##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
and a rapidly##2##3##(1996-3#1)(2010-12#1)
and a rat##2##3##(2007-12#1)(2008-11#1)
and a rate of##4##4##(1994-6#1)(2007-11#1)(2008-8#1)(2011-1#1)
and a rather##2##3##(1993-6#1)(2011-2#1)
and a ratio of##3##4##(1991-12#1)(1995-5#1)(2007-11#1)
and a reactor##2##3##(2008-10#2)
and a real example##2##4##(2011-1#1)(2012-12#1)
and a real##3##3##(2008-3#1)(2011-1#1)(2012-12#1)
and a recent##3##3##(2008-4#1)(2013-1#1)(2013-7#1)
and a recently##4##3##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and a reciprocal phase shifter##2##5##(2008-3#2)
and a recombinant##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
and a reconstruction##2##3##(2007-11#1)(2008-3#1)
and a recording##2##3##(2007-12#1)(2008-3#1)
and a recovery##2##3##(2008-10#1)(2008-5#1)
and a red##6##3##(2007-12#2)(2008-10#3)(2008-8#1)
and a reduced##10##3##(1990-6#1)(1991-3#1)(1991-7#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-7#1)(2011-2#1)
and a reduction in the##2##5##(2008-9#1)(2013-1#1)
and a reduction in##9##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-3#1)(2013-1#1)(2013-8#2)
and a reduction of the##4##5##(2006-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
and a reduction of##5##4##(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
and a reduction##14##3##(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-3#1)(2013-1#1)(2013-8#2)
and a reference##9##3##(1990-2#1)(2008-10#3)(2008-3#4)(2012-1#1)
and a region##3##3##(1990-5#1)(2008-10#1)(2010-3#1)
and a related##2##3##(1993-12#1)(2008-6#1)
and a relationship between##3##4##(2008-10#2)(2008-3#1)
and a relative accuracy error of##2##6##(2008-10#2)
and a relative risk of##2##5##(1994-9#1)(2008-2#1)
and a relative standard deviation (R##2##6##(2008-10#2)
and a relative standard deviation lower than##2##7##(2008-10#2)
and a relative standard deviation of 1##2##7##(2008-10#2)
and a relative standard deviation of 2##2##7##(2008-10#2)
and a relative standard deviation of##12##6##(2008-10#12)
and a relative standard deviation##19##5##(2008-10#19)
and a relative##30##3##(1994-9#1)(2008-10#23)(2008-2#3)(2008-3#2)(2008-9#1)
and a relatively##5##3##(1994-3#1)(1994-8#1)(1996-12#1)(1997-4#1)(2008-10#1)
and a relevant##3##3##(1993-3#1)(2007-10#1)(2012-2#1)
and a remarkable##2##3##(1992-6#1)(2009-10#1)
and a remote##2##3##(2008-10#1)(2008-3#1)
and a repeat##3##3##(1996-5#1)(2007-2#1)(2010-12#1)
and a repetition rate of##2##5##(2007-12#1)(2008-3#1)
and a representative##2##3##(2008-10#1)(2008-3#1)
and a requirement for##2##4##(2008-10#1)(2008-8#1)
and a requirement##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
and a resin-modified glass ionomer cement##2##6##(2008-12#2)
and a resin-modified glass ionomer##3##5##(2008-12#2)(2009-8#1)
and a resolution##2##3##(2008-3#2)
and a response time of##2##5##(2007-12#1)(2008-10#1)
and a response##3##3##(2007-12#1)(2008-10#2)
and a retrospective##3##3##(1994-2#1)(2008-7#1)(2013-1#1)
and a review of literature##3##5##(2007-7#1)(2008-1#1)(2013-1#1)
and a review of the literature is##3##7##(1991-3#1)(2008-10#1)(2010-12#1)
and a review of the literature on##2##7##(2009-3#1)(2009-6#1)
and a review of the literature##10##6##(1991-3#1)(2007-2#1)(2008-10#2)(2009-3#2)(2009-6#1)(2010-12#1)(2013-1#2)
and a review of the##11##5##(1991-3#1)(2007-2#1)(2008-10#2)(2009-3#2)(2009-6#1)(2010-12#1)(2010-3#1)(2013-1#2)
and a review of##16##4##(1991-3#1)(1993-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2013-1#3)
and a rich##2##3##(2007-12#1)(2013-8#1)
and a right##3##3##(2007-8#1)(2008-1#1)(2013-8#1)
and a ring##2##3##(1997-3#1)(1997-5#1)
and a rising##3##3##(2011-1#1)(2013-8#2)
and a role for##2##4##(1993-12#1)(1997-8#1)
and a rotating##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
and a sample frequency of##4##5##(2008-10#4)
and a sample measurement frequency of##3##6##(2008-10#3)
and a sample throughput of##4##5##(2008-10#4)
and a sample volume of##2##5##(2008-10#2)
and a sample##17##3##(2008-10#16)(2008-5#1)
and a sampling frequency of##6##5##(2008-10#6)
and a sampling frequency##7##4##(2008-10#7)
and a sampling rate of##2##5##(2008-10#2)
and a sampling##10##3##(2008-10#9)(2008-3#1)
and a scheme for##2##4##(1990-5#1)(2008-10#1)
and a search for##3##4##(1997-8#1)(2010-3#1)(2011-2#1)
and a search##4##3##(1997-8#1)(2008-10#1)(2010-3#1)(2011-2#1)
and a second cluster##2##4##(2008-10#2)
and a second group##2##4##(1990-5#1)(2008-9#1)
and a second##33##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#1)(1992-11#1)(1992-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
and a secondary##3##3##(1990-6#1)(1995-12#1)(2008-10#1)
and a segmented##2##3##(2007-11#1)(2008-3#1)
and a selection##2##3##(2008-11#1)(2008-2#1)
and a selectivity##2##3##(2008-10#1)(2008-4#1)
and a semiconductor##3##3##(2007-11#2)(2008-10#1)
and a sense of##3##4##(2008-1#1)(2010-3#1)(2010-4#1)
and a sensitive##2##3##(2008-10#2)
and a sensitivity analysis##3##4##(2008-3#2)(2011-2#1)
and a sensitivity of##3##4##(1997-3#1)(1997-8#1)(2008-10#1)
and a sensitivity##7##3##(1997-3#1)(1997-8#1)(2008-10#2)(2008-3#2)(2011-2#1)
and a separate##3##3##(1991-2#1)(2008-10#1)(2008-3#1)
and a sequence##2##3##(2008-5#1)(2008-6#1)
and a sequential##3##3##(2008-10#3)
and a series of##11##4##(1991-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2011-2#1)
and a set of aerosol models##2##6##(2008-2#2)
and a set of##19##4##(1992-3#1)(1995-12#1)(1996-6#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#2)(2012-3#1)(2013-8#1)
and a severe##4##3##(1997-7#1)(2007-10#1)(2007-8#1)(2012-2#1)
and a short##14##3##(1990-9#1)(1991-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-5#1)(2012-12#1)
and a short-term##2##3##(1997-3#1)(2007-12#1)
and a shorter##5##3##(1992-3#2)(1995-2#1)(1996-6#1)(2009-4#1)
and a significant decrease in##5##5##(1994-3#1)(1997-1#1)(2007-9#1)(2008-10#1)(2013-7#1)
and a significant difference in##2##5##(1994-6#1)(2013-1#1)
and a significant increase in##3##5##(2008-10#2)(2010-1#1)
and a significant increase##4##4##(2008-10#2)(2009-8#1)(2010-1#1)
and a significant inverse correlation##2##5##(2008-7#2)
and a significant reduction of##4##5##(1993-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
and a significant##28##3##(1990-2#1)(1993-3#1)(1994-3#1)(1994-6#2)(1995-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#2)
and a significantly higher##2##4##(2007-12#1)(2008-11#1)
and a significantly lower##2##4##(2007-10#2)
and a significantly reduced##2##4##(1994-8#1)(2008-7#1)
and a significantly##8##3##(1994-8#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-7#2)(2013-1#1)
and a silica##2##3##(2007-12#1)(2008-3#1)
and a silver/silver chloride electrode##2##5##(2008-10#2)
and a similar##4##3##(1990-3#1)(2007-12#2)(2008-5#1)
and a simple method##3##4##(2007-12#1)(2008-4#1)(2008-8#1)
and a simple model##3##4##(1996-2#1)(2008-10#1)(2008-2#1)
and a simple##21##3##(1996-2#1)(2007-12#2)(2008-10#7)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2012-3#1)
and a simplified##2##3##(2008-10#1)(2011-1#1)
and a simulated##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
and a simultaneous##2##3##(2008-3#1)(2008-7#1)
and a single buccal canal##2##5##(2013-1#2)
and a single fiber##3##4##(2008-10#1)(2008-2#2)
and a single##28##3##(1990-12#1)(1991-10#1)(1993-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#5)(2011-1#1)(2012-2#1)(2013-1#2)
and a slight##7##3##(1991-12#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-6#1)(2009-8#1)
and a slope of 56##2##5##(2008-10#2)
and a slope of##6##4##(1996-2#2)(2008-10#4)
and a slope##11##3##(1996-2#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
and a slow##2##3##(1991-12#1)(1994-5#1)
and a slower##2##3##(2008-2#1)(2012-2#1)
and a slowly##2##3##(1996-2#1)(2012-3#1)
and a small amount of##3##5##(1994-8#1)(2008-11#1)(2008-6#1)
and a small##15##3##(1991-12#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
and a smaller##4##3##(1992-12#1)(1995-11#1)(1997-2#1)(2008-3#1)
and a smooth##3##3##(2007-12#2)(2008-10#1)
and a software##3##3##(1996-2#1)(2008-5#1)(2012-3#1)
and a solid##2##3##(2008-10#1)(2013-1#1)
and a solid-state##2##3##(2007-12#1)(2008-10#1)
and a solution##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
and a solvent##2##3##(2008-10#2)
and a spatial filter##2##4##(2007-12#1)(2008-3#1)
and a spatial resolution of##2##5##(2007-12#1)(2008-3#1)
and a spatial##6##3##(2007-12#2)(2008-3#3)(2008-8#1)
and a special##2##3##(1997-2#1)(2007-11#1)
and a specialist center##2##4##(2008-3#2)
and a specially designed furnace##2##5##(2008-10#2)
and a specially##3##3##(2007-11#1)(2008-10#2)
and a specific##6##3##(1992-11#1)(1992-3#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-6#1)
and a specificity of##9##4##(1990-6#1)(1990-9#1)(1994-2#1)(1995-4#1)(2012-3#1)(2013-1#3)(2013-8#1)
and a spectral##3##3##(2008-3#2)(2013-8#1)
and a spectrograph##2##3##(2008-3#2)
and a spinal##2##3##(2007-11#1)(2012-12#1)
and a spot##2##3##(2008-2#1)(2008-3#1)
and a spurious free dynamic range of##2##7##(2008-3#2)
and a standard error of cross validation of 0##2##9##(2008-10#2)
and a standard##9##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2012-2#1)
and a standardized##4##3##(1997-5#1)(2008-10#3)
and a state##4##3##(1995-6#1)(1996-3#1)(2008-11#1)(2008-9#1)
and a statistical analysis of##2##5##(2008-10#1)(2012-12#1)
and a statistical##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
and a statistically significant increase##2##5##(1994-3#1)(2008-7#1)
and a statistically##3##3##(1994-3#1)(2008-7#1)(2013-1#1)
and a steady##2##3##(2008-10#1)(2010-8#1)
and a storage##2##3##(2007-12#1)(2008-10#1)
and a straight##2##3##(2007-11#1)(2008-3#1)
and a strain##2##3##(2007-12#1)(2008-10#1)
and a strategy for##2##4##(2008-11#1)(2008-7#1)
and a strategy to##2##4##(2008-2#1)(2009-4#1)
and a strategy##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)
and a streak camera##2##4##(2007-12#1)(2008-3#1)
and a strong##10##3##(1993-6#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#1)
and a strongly##2##3##(2008-10#1)(2008-11#1)
and a study of##3##4##(2007-6#1)(2008-10#2)
and a sub-sample was##2##4##(2008-10#2)
and a subsequent##8##3##(1990-12#1)(1992-11#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
and a subset of##6##4##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
and a substantial##2##3##(1997-3#1)(2012-12#1)
and a suggestion of##2##4##(1995-11#1)(1995-9#1)
and a suitable##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)
and a summary of the##3##5##(2008-10#1)(2008-4#1)(2011-7#1)
and a summary of##4##4##(1996-1#1)(2008-10#1)(2008-4#1)(2011-7#1)
and a support protocol##3##4##(2008-2#1)(2008-4#2)
and a surface##3##3##(2007-11#1)(2008-4#1)(2008-8#1)
and a surgical##2##3##(2008-11#1)(2008-7#1)
and a survey of the##2##5##(1994-6#1)(2008-11#1)
and a survey of##4##4##(1992-5#1)(1994-6#1)(2008-11#1)(2008-9#1)
and a survey##5##3##(1992-5#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-9#1)
and a susceptible cultivar##3##4##(2008-10#3)
and a susceptible##5##3##(2008-10#5)
and a suspected##2##3##(1991-3#1)(1992-12#1)
and a switching voltage of##2##5##(2007-11#1)(2007-12#1)
and a switching##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and a synopsis of the##2##5##(1992-1#1)(2008-10#1)
and a synthesized polymer##2##4##(2008-10#2)
and a synthetic##5##3##(1990-5#1)(1990-7#1)(1997-3#1)(1997-8#1)(2008-10#1)
and a system##3##3##(2008-9#1)(2012-2#1)(2013-8#1)
and a systematic approach to##2##5##(2006-5#1)(2009-10#1)
and a systematic##4##3##(2006-5#1)(2008-3#1)(2009-10#1)(2011-1#1)
and a team##2##3##(1996-1#1)(2007-12#1)
and a technique for##2##4##(2008-2#1)(2008-3#1)
and a technique##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
and a temperature of##5##4##(1995-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
and a temperature range of##2##5##(1993-8#1)(2008-3#1)
and a temperature##8##3##(1993-8#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
and a temporal##2##3##(2007-12#1)(2013-7#1)
and a terminating event##2##4##(1997-4#2)
and a terminating##3##3##(1997-4#3)
and a test set##3##4##(2008-10#3)
and a test##9##3##(1994-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
and a thick##2##3##(2007-11#1)(2007-12#1)
and a thickness of##2##4##(2007-12#2)
and a thickness##4##3##(2007-12#2)(2008-3#2)
and a third##9##3##(1990-5#1)(1990-8#1)(1992-8#1)(1993-12#1)(1994-5#1)(1996-1#1)(2008-10#2)(2008-11#1)
and a thorough##4##3##(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)
and a time response##2##4##(2007-12#1)(2008-3#1)
and a time##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)
and a total of##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
and a total time##2##4##(2008-10#2)
and a total##13##3##(1990-5#1)(1993-8#1)(2008-10#8)(2008-5#1)(2013-8#2)
and a trade-off##2##3##(2008-10#1)(2008-8#1)
and a tradition of##2##4##(1991-2#1)(1994-3#1)
and a transmission##2##3##(2008-2#1)(2008-5#1)
and a treatment##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
and a trend towards##2##4##(2007-8#2)
and a trend##3##3##(1992-9#1)(2007-8#2)
and a truncated##2##3##(1993-8#1)(2008-3#1)
and a tumor##2##3##(1992-12#1)(2008-10#1)
and a tunable##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
and a two-dimensional##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
and a typical##2##3##(1995-8#1)(2008-10#1)
and a uniform##5##3##(2008-3#3)(2008-7#1)(2010-9#1)
and a unique##4##3##(1994-5#1)(2008-3#1)(2010-3#1)(2012-3#1)
and a used##2##3##(2008-10#2)
and a useful##2##3##(1991-3#1)(2008-10#1)
and a vaccine##2##3##(1995-12#1)(2007-2#1)
and a validation##3##3##(1995-9#1)(2008-10#1)(2008-3#1)
and a value##2##3##(2008-10#1)(2011-1#1)
and a variable##5##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
and a variant##2##3##(1994-11#1)(2008-10#1)
and a variation##2##3##(2008-10#1)(2008-3#1)
and a variety of other##3##5##(1990-5#1)(2007-4#1)(2011-1#1)
and a variety of##22##4##(1990-5#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-1#1)
and a vegetal##2##3##(1997-6#1)(2008-10#1)
and a very high##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
and a very low##3##4##(1991-11#1)(2007-8#1)(2013-1#1)
and a very##14##3##(1990-2#1)(1991-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#1)
and a virus##2##3##(2008-10#1)(2011-2#1)
and a visual##2##3##(1991-2#1)(2012-2#1)
and a volume##2##3##(2008-2#1)(2013-1#1)
and a waste##2##3##(2008-10#1)(2010-8#1)
and a water-soluble##2##3##(1990-11#1)(1991-3#1)
and a wavelength-selective##3##3##(2008-2#2)(2008-3#1)
and a weak##6##3##(1991-5#1)(1992-11#1)(2007-11#1)(2007-12#2)(2008-8#1)
and a well-defined##6##3##(2007-12#1)(2008-10#3)(2008-3#1)(2013-8#1)
and a wide variety of##2##5##(2008-6#1)(2009-8#1)
and a wide##7##3##(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-8#1)
and a wider##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
and a work##2##3##(1996-1#1)(2009-7#1)
and a yeast##2##3##(2008-5#1)(2010-10#1)
and a##3957##2##(1990-10#2)(1990-11#9)(1990-12#13)(1990-2#13)(1990-3#13)(1990-5#23)(1990-6#12)(1990-7#6)(1990-8#13)(1990-9#9)(1991-1#2)(1991-10#2)(1991-11#10)(1991-12#22)(1991-2#11)(1991-3#11)(1991-5#15)(1991-6#11)(1991-7#3)(1991-8#12)(1991-9#9)(1992-1#5)(1992-10#6)(1992-11#7)(1992-12#11)(1992-2#11)(1992-3#21)(1992-4#5)(1992-5#9)(1992-6#18)(1992-8#12)(1992-9#12)(1993-1#5)(1993-11#15)(1993-12#21)(1993-2#12)(1993-3#11)(1993-5#1)(1993-6#13)(1993-8#15)(1993-9#5)(1994-1#3)(1994-11#12)(1994-12#24)(1994-2#15)(1994-3#14)(1994-5#11)(1994-6#13)(1994-8#15)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#23)(1995-2#27)(1995-3#14)(1995-4#2)(1995-5#16)(1995-6#14)(1995-8#13)(1995-9#8)(1996-1#9)(1996-10#4)(1996-11#2)(1996-12#13)(1996-2#21)(1996-3#11)(1996-4#3)(1996-5#10)(1996-6#9)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#9)(1997-2#25)(1997-3#23)(1997-4#17)(1997-5#12)(1997-6#12)(1997-7#20)(1997-8#7)(2006-10#10)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#13)(2007-11#109)(2007-12#166)(2007-2#13)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#14)(2007-8#30)(2007-9#3)(2008-1#33)(2008-10#892)(2008-11#112)(2008-12#45)(2008-2#161)(2008-3#347)(2008-4#53)(2008-5#84)(2008-6#33)(2008-7#101)(2008-8#74)(2008-9#67)(2009-1#4)(2009-10#17)(2009-11#13)(2009-12#9)(2009-2#6)(2009-3#6)(2009-4#7)(2009-5#13)(2009-6#12)(2009-7#14)(2009-8#15)(2009-9#12)(2010-1#3)(2010-10#8)(2010-11#9)(2010-12#16)(2010-2#6)(2010-3#17)(2010-4#13)(2010-5#15)(2010-6#5)(2010-7#2)(2010-8#19)(2010-9#3)(2011-1#47)(2011-10#2)(2011-2#105)(2011-3#4)(2011-7#1)(2012-1#11)(2012-12#31)(2012-2#48)(2012-3#40)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#89)(2013-7#12)(2013-8#52)
and aa##3##2##(1993-12#1)(2011-1#1)(2013-1#1)
and abandoned##2##2##(2008-9#1)(2011-2#1)
and abdomen##5##2##(1991-4#1)(2007-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
and abdominal aorta##2##3##(1994-7#1)(2013-3#1)
and abdominal fat##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
and abdominal hysterectomy##4##3##(1991-11#1)(1994-2#1)(2010-11#1)(2010-3#1)
and abdominal pain##7##3##(1991-9#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#3)
and abdominal##42##2##(1991-11#1)(1991-9#1)(1994-2#1)(1994-7#1)(1996-12#1)(1996-8#2)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#7)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-3#1)(2013-8#1)
and aberrant##8##2##(1995-6#1)(1995-9#1)(1997-4#1)(2008-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
and aberration correction##2##3##(2007-12#1)(2008-3#1)
and aberration##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
and aberrations##5##2##(2007-11#3)(2008-2#1)(2008-3#1)
and abietic##2##2##(1997-2#2)
and abilities##4##2##(1991-2#1)(1993-1#1)(2008-12#1)(2013-1#1)
and ability of##2##3##(2010-8#1)(2013-7#1)
and ability to##18##3##(1991-2#1)(1994-12#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-4#1)(2012-8#1)(2013-1#3)
and ability##23##2##(1991-2#1)(1994-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-4#1)(2012-8#1)(2013-1#3)(2013-7#1)
and abiotic stresses##4##3##(2008-10#1)(2008-8#1)(2010-10#2)
and abiotic suppression##2##3##(2008-10#2)
and abiotic##10##2##(2008-10#5)(2008-6#1)(2008-8#2)(2010-10#2)
and ablation of##3##3##(2007-8#1)(2008-1#1)(2009-10#1)
and ablative neurosurgical procedures##2##4##(2011-1#2)
and ablative##4##2##(2007-12#1)(2010-12#1)(2011-1#2)
and able to understand##2##4##(2013-1#2)
and able to##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#2)
and abnormal expression of##2##4##(2011-2#1)(2013-1#1)
and abnormal##33##2##(1990-10#1)(1991-1#1)(1994-9#1)(1995-3#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#5)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
and abnormalities##3##2##(2008-9#1)(2009-10#1)(2011-7#1)
and abnormally##3##2##(1995-12#1)(2008-10#1)(2009-2#1)
and abolished the##2##3##(1990-5#1)(1997-2#1)
and abolished##4##2##(1990-5#1)(1997-2#1)(1997-3#1)(2008-10#1)
and abolishes the##2##3##(1995-11#1)(1995-6#1)
and abolishes##4##2##(1993-12#1)(1995-11#1)(1995-6#1)(2008-8#1)
and abortion##7##2##(1991-1#1)(1991-6#1)(1994-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2011-2#1)
and about 1##4##3##(1997-4#2)(2012-12#1)(2012-3#1)
and about 2% of##2##4##(1990-2#1)(1994-3#1)
and about 7##2##3##(2008-10#1)(2011-2#1)
and about 70%##2##3##(1996-12#1)(2008-8#1)
and about what##2##3##(2008-7#1)(2009-9#1)
and about##48##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#3)(1997-4#2)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)
and above (p &lt##3##4##(2011-2#3)
and above all##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
and above stimulated##2##3##(1993-11#1)(1995-3#1)
and above the##12##3##(1994-2#1)(1994-3#1)(1995-3#1)(1996-7#1)(2008-10#4)(2008-3#1)(2008-7#2)(2012-2#1)
and above what##2##3##(2008-8#1)(2009-8#1)
and above##51##2##(1990-9#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-3#2)(1996-3#1)(1996-7#1)(1996-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#1)
and above)##3##2##(1990-6#1)(1992-12#1)(1992-6#1)
and aboveground##2##2##(2008-10#2)
and abrasion##2##2##(2008-7#1)(2008-9#1)
and abroad##8##2##(1992-9#1)(1994-1#1)(1994-2#1)(1996-4#1)(1997-8#1)(2008-3#1)(2008-7#1)(2012-12#1)
and abscess##2##2##(2007-8#1)(2011-2#1)
and absence of##62##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#13)(2008-11#4)(2008-7#2)(2008-8#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
and absence##63##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#14)(2008-11#4)(2008-7#2)(2008-8#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
and absent from##3##3##(1990-11#1)(1996-12#1)(2009-6#1)
and absent##10##2##(1990-11#1)(1992-11#1)(1994-12#1)(1996-12#1)(2007-11#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and absolute configuration of##2##4##(1991-12#1)(2009-10#1)
and absolute detection limit##2##4##(2008-10#2)
and absolute detection##3##3##(2008-10#3)
and absolute numbers of##2##4##(1995-12#2)
and absolute##23##2##(1991-12#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-12#2)(2008-10#4)(2008-12#1)(2008-3#3)(2008-8#2)(2008-9#2)(2009-10#1)(2011-1#2)(2012-2#1)(2013-1#1)
and absolutely##2##2##(1990-7#1)(2007-8#1)
and absorbance was measured at##3##5##(1990-2#1)(2008-10#2)
and absorbance##13##2##(1990-2#1)(1994-8#1)(2008-10#9)(2008-7#1)(2010-5#1)
and absorbing##7##2##(2007-11#1)(2008-3#6)
and absorption are##2##3##(2008-2#1)(2008-3#1)
and absorption coefficient##3##3##(2007-11#1)(2008-3#2)
and absorption coefficients are obtained##2##5##(2008-2#1)(2011-1#1)
and absorption coefficients##11##3##(2008-2#5)(2008-3#5)(2011-1#1)
and absorption cross sections of##2##5##(2008-2#1)(2008-3#1)
and absorption cross sections##3##4##(2008-2#1)(2008-3#2)
and absorption from##2##3##(2008-3#1)(2008-5#1)
and absorption images##2##3##(2007-11#1)(2008-3#1)
and absorption in##2##3##(2007-12#1)(2008-2#1)
and absorption of##7##3##(1996-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-2#2)(2013-1#1)
and absorption spectra of##3##4##(2008-10#1)(2008-3#1)(2009-8#1)
and absorption spectra##7##3##(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-8#1)
and absorption spectroscopy of##2##4##(1992-3#1)(2007-11#1)
and absorption##75##2##(1992-3#1)(1996-12#2)(2007-11#6)(2007-12#1)(2008-10#2)(2008-2#19)(2008-3#32)(2008-5#2)(2008-7#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#2)(2013-1#1)
and abstracts of##4##3##(2008-9#1)(2009-9#1)(2013-1#2)
and abstracts##8##2##(1996-3#1)(2008-12#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#2)
and abundance of##11##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#1)(2012-2#2)(2013-7#1)
and abundance##22##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#5)(2008-6#4)(2008-8#4)(2012-2#2)(2013-7#4)
and abundant##10##2##(2008-10#3)(2008-5#1)(2010-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
and abuse in perinatal care##2##5##(2013-1#2)
and abuse in##4##3##(1991-12#1)(2008-11#1)(2013-1#2)
and abuse of##3##3##(1991-1#1)(1995-5#1)(2009-12#1)
and abuse##28##2##(1991-1#8)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-2#1)(1995-3#1)(1995-5#1)(2007-9#1)(2008-11#2)(2009-12#1)(2010-7#1)(2013-1#3)
and ac impedance##2##3##(2008-10#2)
and ac##3##2##(1990-12#1)(2008-10#2)
and academia##4##2##(1993-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
and academic achievement##5##3##(2009-7#1)(2010-1#3)(2012-2#1)
and academic adjustment##3##3##(2010-1#3)
and academic institutions##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
and academic##35##2##(1993-1#2)(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#4)(2008-12#6)(2008-7#2)(2008-9#1)(2009-7#1)(2010-1#6)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#3)
and academics##5##2##(1994-12#1)(2008-11#3)(2008-7#1)
and accelerate the##5##3##(1992-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
and accelerate##7##2##(1992-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
and accelerated atherosclerosis##2##3##(2008-1#1)(2008-3#1)
and accelerated the##3##3##(2008-7#1)(2008-8#2)
and accelerated##16##2##(1990-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#3)(2010-5#1)
and accelerates##5##2##(1990-11#1)(1992-6#1)(2008-10#1)(2008-11#1)(2009-3#1)
and accelerating##2##2##(2007-12#1)(2010-8#1)
and acceleration of##2##3##(2008-10#1)(2008-5#1)
and acceleration##6##2##(2008-10#2)(2008-5#1)(2013-1#3)
and accept##2##2##(1991-3#1)(1997-3#1)
and acceptability in##2##3##(2009-4#1)(2012-3#1)
and acceptability of##4##3##(1995-1#1)(1995-3#1)(2008-12#1)(2013-1#1)
and acceptability##9##2##(1992-1#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
and acceptable results##2##3##(2008-10#1)(2010-5#1)
and acceptable to##3##3##(2008-7#1)(2009-11#1)(2009-2#1)
and acceptable##16##2##(2007-12#3)(2008-10#4)(2008-4#1)(2008-7#2)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#2)(2012-12#1)
and acceptance of##5##3##(1990-10#1)(1993-12#1)(1996-12#1)(2007-2#1)(2008-12#1)
and acceptance##12##2##(1990-10#1)(1993-12#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2012-2#1)
and accepted by##4##3##(1997-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
and accepted##6##2##(1997-2#1)(2008-10#2)(2010-4#1)(2012-12#1)(2012-2#1)
and acceptor##11##2##(1996-12#1)(2007-12#2)(2008-10#4)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)
and access to and##2##4##(1997-3#1)(2007-10#1)
and access to care##2##4##(2010-3#1)(2011-1#1)
and access to health care##2##5##(2008-11#1)(2008-6#1)
and access to health services##2##5##(1992-2#1)(2008-11#1)
and access to health##4##4##(1992-2#1)(2008-11#2)(2008-6#1)
and access to the##3##4##(1991-1#1)(1993-6#1)(2012-2#1)
and access to##23##3##(1991-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-1#2)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#5)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and access##33##2##(1991-1#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-11#5)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
and accessibility of health care##2##5##(2008-11#1)(2012-3#1)
and accessibility of the##2##4##(2007-12#1)(2008-8#1)
and accessibility of##6##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
and accessibility to##2##3##(1997-1#1)(2013-1#1)
and accessibility##14##2##(1992-1#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#2)
and accessible##8##2##(1990-11#1)(1995-1#1)(1995-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-8#1)
and accident##4##2##(1991-12#1)(2008-11#1)(2009-10#1)(2010-7#1)
and accidental##4##2##(1993-10#1)(1995-2#1)(2008-12#1)(2008-5#1)
and accidents##4##2##(1995-3#1)(2012-1#2)(2013-1#1)
and accommodate##2##2##(2008-7#1)(2009-8#1)
and accommodation of##2##3##(2008-10#1)(2011-2#1)
and accommodation##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
and accompanied by a##2##4##(1995-2#1)(2008-10#1)
and accompanied by##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
and accompanying##4##2##(1993-1#1)(2008-1#1)(2008-5#1)(2010-12#1)
and according to the##2##4##(2008-12#1)(2013-1#1)
and according to##4##3##(1992-3#1)(2008-12#1)(2011-2#1)(2013-1#1)
and accordingly##3##2##(1996-4#1)(2008-12#1)(2009-8#1)
and account for the##2##4##(2008-3#2)
and account for##6##3##(1990-6#1)(1996-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
and account##7##2##(1990-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
and accountability##11##2##(1994-11#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-3#1)(2007-10#1)(2008-9#1)(2010-9#1)(2013-8#1)
and accounted for##4##3##(1992-3#1)(1996-5#1)(2008-10#1)(2010-3#1)
and accounting for##3##3##(1995-6#1)(2008-2#1)(2012-12#1)
and accounts for about##2##4##(2011-2#1)(2012-1#1)
and accounts for##9##3##(1991-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
and accounts##13##2##(1991-11#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
and accreditation##4##2##(1996-2#1)(1997-3#1)(2008-11#1)(2012-1#1)
and accrual##2##2##(2010-10#1)(2010-3#1)
and acculturation level##2##3##(2007-12#2)
and acculturation##4##2##(2007-12#2)(2008-4#1)(2009-5#1)
and accumbens##2##2##(1991-5#1)(1997-7#1)
and accumulate##4##2##(1992-12#1)(1993-11#1)(2011-2#2)
and accumulated##10##2##(1991-9#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)
and accumulates in##2##3##(1994-9#1)(2008-4#1)
and accumulates##5##2##(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(2008-4#1)
and accumulating in the##2##4##(2008-10#1)(2008-11#1)
and accumulating##4##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
and accumulation at##2##3##(2008-10#1)(2008-9#1)
and accumulation in##3##3##(2008-10#2)(2008-12#1)
and accumulation of##22##3##(1991-12#1)(1994-6#1)(1995-11#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
and accumulation potential##2##3##(2008-10#2)
and accumulation time##3##3##(2008-10#3)
and accumulation##37##2##(1991-12#1)(1994-6#1)(1995-11#1)(1996-4#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and accuracy and##3##3##(2008-10#3)
and accuracy are##2##3##(2008-10#2)
and accuracy of the developed##2##5##(2008-10#2)
and accuracy of the##20##4##(1991-5#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-9#1)(2010-8#1)
and accuracy of these##2##4##(2008-3#2)
and accuracy of##45##3##(1991-3#1)(1991-5#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#4)
and accuracy than##2##3##(2008-10#1)(2011-2#1)
and accuracy were##5##3##(2008-10#4)(2008-3#1)
and accuracy with##2##3##(2007-11#1)(2008-10#1)
and accuracy##102##2##(1991-3#1)(1991-5#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#53)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#4)
and accurate and is##2##4##(1995-6#1)(2008-3#1)
and accurate and##3##3##(1991-12#1)(1995-6#1)(2008-3#1)
and accurate assessment of the##2##5##(2008-4#1)(2008-9#1)
and accurate detection of##2##4##(2008-10#2)
and accurate diagnosis##4##3##(2007-8#1)(2008-11#1)(2009-10#1)(2010-8#1)
and accurate for the##2##4##(2007-11#1)(2008-10#1)
and accurate high performance##2##4##(2012-2#2)
and accurate identification of microorganisms##2##5##(2008-5#2)
and accurate identification of##3##4##(2008-10#1)(2008-5#2)
and accurate information##2##3##(1991-12#1)(2008-3#1)
and accurate method for the determination of##2##7##(2008-10#2)
and accurate method for the separation##2##6##(2008-10#2)
and accurate method for the##5##5##(2008-10#5)
and accurate method for##8##4##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
and accurate method##11##3##(1995-12#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
and accurate quantification of##2##4##(2008-10#2)
and accurate response##2##3##(2007-11#1)(2008-10#1)
and accurate results##5##3##(2008-10#3)(2008-3#1)(2008-9#1)
and accurate##99##2##(1991-12#2)(1992-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#41)(2008-11#1)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#4)(2009-10#2)(2009-8#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
and accurately##13##2##(1992-9#1)(1996-2#1)(1996-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-3#1)(2012-2#1)
and acemethacin##3##2##(2008-10#3)
and acetaminophen##4##2##(2008-10#4)
and acetate buffer##3##3##(2008-10#1)(2009-10#2)
and acetate ions##2##3##(2008-10#2)
and acetate##8##2##(2008-10#4)(2008-7#1)(2009-10#2)(2013-8#1)
and acetic acid##10##3##(1992-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2012-12#1)
and acetic anhydride were##2##4##(2007-11#2)
and acetic##14##2##(1992-11#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2012-12#1)
and acetone and##3##3##(2008-10#3)
and acetone as##2##3##(2008-10#2)
and acetone##12##2##(1996-5#1)(2008-10#8)(2010-3#1)(2013-8#2)
and acetone)##2##2##(2008-10#1)(2013-8#1)
and acetonitrile##12##2##(1990-8#1)(1995-3#1)(2008-10#8)(2010-5#1)(2011-1#1)
and acetylcholine esterase in##2##4##(1990-2#1)(2008-10#1)
and acetylcholine esterase##3##3##(1990-2#1)(2008-10#1)(2011-1#1)
and acetylcholine##10##2##(1990-2#1)(1990-7#1)(1991-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#2)(2011-1#1)
and acetylcholinesterase activity of the rat##2##6##(2008-11#2)
and acetylcholinesterase##4##2##(2008-11#2)(2008-7#1)(2009-8#1)
and acetylsalicylic acid##3##3##(2008-10#3)
and achievable##4##2##(1992-2#1)(2008-3#3)
and achieve##7##2##(1991-2#1)(1995-1#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
and achieved a##2##3##(2008-5#1)(2009-3#1)
and achieved##7##2##(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#1)
and achievement of##2##3##(1997-2#1)(2012-3#1)
and achievement##4##2##(1993-12#1)(1997-2#1)(2008-12#1)(2012-3#1)
and achievements of the##2##4##(2012-12#1)(2013-1#1)
and achievements of##4##3##(1995-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
and achieves##4##2##(2007-12#1)(2010-12#1)(2010-5#1)(2013-8#1)
and achieving##8##2##(1993-2#1)(1994-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#2)
and achromatic##2##2##(2007-11#1)(2008-3#1)
and acid phosphatase activity##2##4##(1993-11#1)(2013-1#1)
and acid phosphatase##3##3##(1993-11#1)(2013-1#2)
and acid##27##2##(1990-12#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#2)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#10)(2008-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#3)
and acid-base balance##2##3##(2008-5#1)(2012-3#1)
and acid-base##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
and acidic##13##2##(1990-2#1)(1993-11#1)(2008-10#7)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
and acidification##3##2##(2008-10#3)
and acidity##3##2##(1995-5#1)(2008-10#2)
and acne##4##2##(2007-7#1)(2008-5#1)(2010-8#1)(2011-2#1)
and acoustic##3##2##(2008-4#1)(2008-8#1)(2009-5#1)
and acquired disorders of blood coagulation##2##6##(2008-7#2)
and acquired immunity##2##3##(1997-3#1)(2011-2#1)
and acquired resistance##2##3##(2008-11#1)(2012-1#1)
and acquired##20##2##(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#2)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
and acquisition of##6##3##(2007-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-3#2)
and acquisition##10##2##(1992-12#1)(1993-3#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-7#1)(2012-3#3)
and acquisitions##3##2##(1996-2#1)(2008-1#1)(2008-12#1)
and acridine orange##4##3##(1990-6#3)(2008-10#1)
and acrosome reaction##3##3##(1992-8#1)(2008-4#2)
and across species##2##3##(1993-12#1)(2012-3#1)
and across the entire##3##4##(2008-10#1)(2009-7#1)(2013-3#1)
and across the##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#2)(2013-3#1)
and across##21##2##(1993-12#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#2)(2010-4#1)(2012-2#1)(2012-3#3)(2013-3#1)
and across-row##2##2##(2008-10#2)
and acrylamide##2##2##(1990-5#1)(2009-10#1)
and act as##6##3##(1992-9#1)(1993-3#1)(1995-3#1)(2008-3#1)(2009-8#1)(2012-2#1)
and act on##2##3##(1994-2#1)(2008-7#1)
and act##12##2##(1992-9#1)(1993-3#1)(1994-2#1)(1995-3#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
and acted as##5##3##(1995-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
and acted##6##2##(1995-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
and actin filaments##5##3##(1993-6#2)(2008-6#2)(2008-9#1)
and actin in##2##3##(1990-12#1)(2008-1#1)
and actin polymerization##2##3##(1996-12#1)(1997-6#1)
and actin##18##2##(1990-12#1)(1990-5#1)(1993-6#2)(1994-8#1)(1995-3#1)(1996-12#1)(1997-6#1)(2008-1#2)(2008-4#1)(2008-6#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
and acting as##2##3##(1996-12#1)(2011-1#1)
and acting on##2##3##(1995-3#1)(2008-7#1)
and acting##6##2##(1993-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-7#1)(2011-1#1)
and actinic##2##2##(1990-6#1)(2008-5#1)
and actinomycin D##4##3##(1994-3#1)(1995-12#1)(2008-11#1)(2008-6#1)
and actinomycin##5##2##(1994-3#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-6#1)
and action of##3##3##(1992-9#1)(2008-11#1)(2008-7#1)
and action potentials##2##3##(1993-12#1)(2008-11#1)
and action##22##2##(1992-2#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-2#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
and action)##2##2##(2008-4#2)
and actions of the##2##4##(1994-1#1)(1994-12#1)
and actions of##3##3##(1994-1#1)(1994-12#1)(2008-7#1)
and actions that##3##3##(2009-12#1)(2010-12#1)(2012-3#1)
and actions##11##2##(1991-2#1)(1991-3#1)(1994-1#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-1#1)(2012-3#1)
and activate the##2##3##(1991-5#1)(2008-7#1)
and activate##7##2##(1991-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)
and activated T##2##3##(1997-7#1)(2008-4#1)
and activated charcoal##2##3##(2008-10#2)
and activated##26##2##(1990-2#1)(1990-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-10#4)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#2)(2010-1#1)(2013-1#1)
and activates the##5##3##(1995-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
and activates##12##2##(1990-11#1)(1994-11#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
and activating##5##2##(2006-10#1)(2009-3#1)(2012-2#2)(2013-8#1)
and activation are##2##3##(1995-5#1)(1996-2#1)
and activation energy was##2##4##(2008-10#2)
and activation energy##3##3##(2008-10#2)(2008-3#1)
and activation in##2##3##(1994-11#1)(2008-5#1)
and activation of P2Y(2) receptors in rabbit arteries mediates intimal hyperplasia##2##11##(2008-4#2)
and activation of both##2##4##(2010-6#1)(2012-3#1)
and activation of caspase-3##2##4##(2008-6#1)(2011-2#1)
and activation of matrix metalloproteases##2##5##(2008-5#2)
and activation of protein kinase C##3##6##(1990-8#1)(2008-11#2)
and activation of the##9##4##(1990-6#1)(1991-12#1)(1995-2#1)(1995-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
and activation of##48##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#3)(1997-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)
and activation##73##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#4)(1997-1#2)(1997-3#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-2#6)(2012-3#2)(2013-1#1)
and activator##7##2##(1993-6#1)(2008-8#1)(2009-3#1)(2012-3#3)(2013-1#1)
and active disease##2##3##(1990-3#1)(2008-7#1)
and active forms of##2##4##(1992-2#1)(2008-8#1)
and active sites##2##3##(1997-4#1)(2012-12#1)
and active##54##2##(1990-3#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-3#3)(2013-1#4)
and actively##4##2##(1993-11#1)(1997-4#1)(2007-12#1)(2012-12#1)
and activin A##3##3##(1990-12#2)(1992-8#1)
and activin##5##2##(1990-12#2)(1992-8#2)(1994-9#1)
and activities are##2##3##(1995-3#1)(1997-1#1)
and activities in##2##3##(1993-2#1)(2013-1#1)
and activities of antioxidant enzymes##2##5##(2010-5#1)(2012-2#1)
and activities of##8##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#2)(2012-2#1)
and activities were##2##3##(1995-3#1)(2012-2#1)
and activities##25##2##(1992-1#1)(1992-11#1)(1993-2#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
and activity as##2##3##(1991-9#1)(1995-5#1)
and activity in the##2##4##(2008-8#1)(2010-3#1)
and activity in##9##3##(1990-6#1)(1997-1#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-7#1)
and activity of SOD was##2##5##(2011-3#2)
and activity of a##2##4##(1995-3#1)(2011-3#1)
and activity of the##5##4##(1991-11#1)(1995-5#1)(2008-1#1)(2008-5#1)(2008-7#1)
and activity of##22##3##(1991-11#1)(1994-5#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-10#1)(2011-1#1)(2011-3#3)
and activity##57##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-11#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-3#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
and activity-based##2##2##(2011-1#1)(2013-7#1)
and acts as a##4##4##(1995-11#1)(1996-5#1)(2009-8#1)(2012-12#1)
and acts as##5##3##(1995-11#1)(1996-5#1)(2008-10#1)(2009-8#1)(2012-12#1)
and acts by##2##3##(1990-2#1)(1993-3#1)
and acts##12##2##(1990-2#1)(1993-3#1)(1994-9#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-12#1)
and actual practice##2##3##(1991-11#1)(1992-1#1)
and actual severity##4##3##(2008-10#4)
and actual##21##2##(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-7#1)(2012-2#1)
and actually##4##2##(1995-6#1)(1996-3#1)(2008-10#1)(2008-5#1)
and actuators##2##2##(2008-10#1)(2008-8#1)
and acute conditions##2##3##(1991-6#1)(1997-3#1)
and acute coronary syndromes##2##4##(2008-11#1)(2011-2#1)
and acute coronary##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
and acute exacerbations of##2##4##(2008-7#1)(2010-5#1)
and acute glomerulonephritis##2##3##(2011-2#2)
and acute kidney##2##3##(2012-3#1)(2013-8#1)
and acute liver failure##2##4##(2013-1#1)(2013-8#1)
and acute lung injury##2##4##(1993-10#1)(2010-8#1)
and acute lymphoblastic leukemia (ALL)##2##5##(2011-2#2)
and acute myeloid leukaemia##3##4##(2011-2#1)(2013-8#2)
and acute myeloid leukemia##3##4##(2010-1#2)(2011-1#1)
and acute myeloid##6##3##(2010-1#2)(2011-1#1)(2011-2#1)(2013-8#2)
and acute myocardial infarction death##2##5##(2011-1#2)
and acute myocardial infarction in##2##5##(1994-11#1)(2013-1#1)
and acute myocardial infarction were 2##2##6##(2011-1#2)
and acute myocardial infarction were##3##5##(2011-1#3)
and acute myocardial infarction##13##4##(1991-9#3)(1994-11#1)(2008-12#1)(2011-1#6)(2011-2#1)(2013-1#1)
and acute or chronic##2##4##(2008-7#1)(2008-9#1)
and acute or##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
and acute renal failure##3##4##(1992-9#1)(2008-1#1)(2013-8#1)
and acute renal##4##3##(1992-9#1)(2008-1#1)(2011-2#1)(2013-8#1)
and acute toxicity##2##3##(1994-12#1)(2013-7#1)
and acute##85##2##(1991-11#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-3#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2010-1#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#8)(2011-2#9)(2012-12#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
and acyclovir##2##2##(1994-8#1)(1995-2#1)
and ad##2##2##(1993-8#1)(2011-9#1)
and adages##2##2##(2013-1#2)
and adapt to##3##3##(1990-5#1)(1994-2#1)(2013-1#1)
and adapt##11##2##(1990-5#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
and adaptability##3##2##(1996-1#1)(2008-2#1)(2009-5#1)
and adaptation of the##2##4##(2008-3#1)(2012-12#1)
and adaptation of##3##3##(2008-3#1)(2008-7#1)(2012-12#1)
and adaptation to different##2##4##(2010-10#1)(2013-7#1)
and adaptation to##5##3##(1993-12#1)(2008-8#1)(2010-10#1)(2013-7#1)(2013-8#1)
and adaptation##16##2##(1990-10#1)(1991-6#1)(1993-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
and adapted for##2##3##(1990-2#1)(2009-7#1)
and adapted to a##2##4##(2008-10#1)(2009-4#1)
and adapted to##4##3##(2008-10#2)(2009-4#1)(2010-8#1)
and adapted##11##2##(1990-2#1)(1992-1#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-4#1)(2009-7#1)(2010-8#1)
and adaptive immunity##2##3##(2008-5#1)(2008-6#1)
and adaptive responses##6##3##(2006-10#2)(2008-7#4)
and adaptive##22##2##(1994-12#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2013-8#1)
and add##4##2##(1990-5#1)(1992-12#1)(2008-2#1)(2008-9#1)
and added to the##2##4##(2008-11#1)(2008-6#1)
and added to##4##3##(1990-2#1)(2008-11#1)(2008-6#1)(2008-7#1)
and added##14##2##(1990-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#1)(2011-2#1)(2013-7#1)
and addiction##4##2##(2008-12#1)(2008-6#1)(2008-9#1)(2012-12#1)
and addictive##4##2##(1995-6#1)(2008-6#1)(2009-4#1)(2013-1#1)
and adding a##2##3##(1992-3#1)(2008-10#1)
and adding##11##2##(1992-3#1)(1995-11#1)(1996-1#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)
and addition lines##2##3##(2008-10#1)(2008-5#1)
and addition of##7##3##(2008-10#4)(2008-11#1)(2008-4#1)(2009-8#1)
and addition##11##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)
and additional##31##2##(1991-3#1)(1991-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-12#1)
and additionally##3##2##(1992-6#1)(1996-5#1)(2008-3#1)
and additive noise##2##3##(2008-2#1)(2008-3#1)
and additive##10##2##(1992-3#1)(1994-7#1)(2008-10#3)(2008-2#3)(2008-3#1)(2009-9#1)
and additives##2##2##(2008-10#2)
and address the##4##3##(1996-12#1)(2008-3#1)(2009-6#1)(2010-3#1)
and address##15##2##(1990-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
and addressed##3##2##(1997-1#1)(2008-12#1)(2008-7#1)
and addresses##7##2##(1992-1#1)(1992-2#1)(1993-2#1)(1995-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
and addressing the##2##3##(2010-5#1)(2012-3#1)
and addressing##5##2##(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
and adds##3##2##(1997-2#1)(2010-11#1)(2012-2#1)
and adenine##2##2##(1990-10#1)(2008-10#1)
and adenocarcinoma##4##2##(1991-8#1)(2009-5#1)(2012-1#1)(2013-8#1)
and adenocarcinomas##2##2##(2008-2#1)(2012-2#1)
and adenoma##2##2##(1990-11#1)(2013-8#1)
and adenomas##2##2##(1990-11#1)(2013-1#1)
and adenosine receptor##5##3##(1995-12#3)(2008-4#2)
and adenosine##21##2##(1990-12#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-8#2)(2008-11#1)(2008-4#7)(2008-5#1)
and adenovirus##2##2##(2011-1#1)(2011-2#1)
and adequacy of##3##3##(1994-12#1)(2010-11#1)(2012-3#1)
and adequacy##5##2##(1993-1#1)(1994-12#1)(2009-10#1)(2010-11#1)(2012-3#1)
and adequate treatment##5##3##(1990-9#1)(1996-12#1)(1997-3#1)(2010-11#1)(2011-2#1)
and adequate##32##2##(1990-9#2)(1994-12#1)(1995-12#1)(1996-12#2)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
and adequately##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
and adhere to##2##3##(2008-12#1)(2008-7#1)
and adherence to##6##3##(1996-11#1)(1996-3#1)(2008-3#1)(2008-8#2)(2012-3#1)
and adherence##14##2##(1992-9#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-4#1)(2012-3#2)(2013-1#1)
and adherent##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
and adhesiolysis##2##2##(1993-1#1)(1993-12#1)
and adhesion of##3##3##(1995-12#1)(2011-1#1)(2012-8#1)
and adhesion properties of##2##4##(2008-10#2)
and adhesion to##3##3##(1994-9#1)(1996-2#1)(1997-4#1)
and adhesion##21##2##(1992-1#1)(1994-9#2)(1995-12#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-8#1)
and adhesive##6##2##(2008-12#2)(2008-7#2)(2008-9#1)(2013-1#1)
and adipocytes##7##2##(1993-6#2)(2008-3#1)(2010-10#1)(2010-12#1)(2012-2#2)
and adiponectin level in women##2##5##(2011-1#2)
and adiponectin level##3##3##(2011-1#3)
and adiponectin levels were##3##4##(2011-1#3)
and adiponectin levels##4##3##(2011-1#4)
and adiponectin##9##2##(2011-1#9)
and adipose tissue##4##3##(1995-6#1)(2009-5#1)(2010-6#1)(2012-3#1)
and adipose##6##2##(1990-11#1)(1995-6#1)(2009-5#1)(2010-4#1)(2010-6#1)(2012-3#1)
and adipose-derived stem cells##2##4##(2012-12#1)(2012-5#1)
and adiposity##2##2##(2012-2#2)
and adjacent to the##2##4##(2008-7#1)(2008-9#1)
and adjacent to##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
and adjacent##25##2##(1990-11#1)(1991-3#1)(1995-12#1)(1995-8#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and adjunctive##4##2##(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and adjust##2##2##(1991-12#1)(2010-8#1)
and adjustable##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
and adjusted for##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
and adjusted to##2##3##(1992-2#1)(2007-7#1)
and adjusted##8##2##(1992-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#2)(2013-1#1)
and adjusting for age##2##4##(2007-10#1)(2013-1#1)
and adjusting for##4##3##(1995-12#1)(2007-10#1)(2011-1#1)(2013-1#1)
and adjusting the##2##3##(2008-10#1)(2013-1#1)
and adjusting##6##2##(1995-12#1)(2007-10#1)(2008-10#1)(2011-1#1)(2013-1#2)
and adjustment and##2##3##(2009-7#1)(2013-1#1)
and adjustment for##4##3##(2007-12#1)(2008-8#1)(2010-1#2)
and adjustment in##3##3##(1991-1#1)(2009-7#1)(2010-7#1)
and adjustment of##4##3##(1992-3#1)(2008-4#2)(2008-9#1)
and adjustment##24##2##(1991-1#1)(1992-3#1)(1993-1#1)(1996-2#2)(2007-12#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-7#2)(2013-1#2)
and adjustments##3##2##(2008-1#1)(2008-3#1)(2008-4#1)
and adjuvant chemotherapy for##2##4##(1995-9#1)(2013-1#1)
and adjuvant chemotherapy##4##3##(1995-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and adjuvant radiation therapy##2##4##(1992-12#2)
and adjuvant radiation##3##3##(1992-12#2)(2012-2#1)
and adjuvant therapies##2##3##(1993-11#1)(2008-11#1)
and adjuvant##18##2##(1990-12#1)(1990-9#1)(1992-10#1)(1992-12#2)(1993-11#1)(1995-9#1)(1996-11#1)(2008-11#2)(2008-6#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
and administer##2##2##(1994-9#1)(2010-6#1)
and administered by##2##3##(2008-5#1)(2012-3#1)
and administered##11##2##(1992-12#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-5#2)(2009-6#1)(2010-3#1)(2012-3#3)
and administration of cellular##2##4##(2013-1#2)
and administration of##12##3##(1991-12#1)(1991-9#1)(2007-10#2)(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and administration##19##2##(1991-12#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-5#1)(2007-10#2)(2007-12#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and administrative support##2##3##(1992-1#1)(1993-2#1)
and administrative##26##2##(1991-1#2)(1991-3#1)(1992-1#3)(1992-2#1)(1993-2#2)(1993-6#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-12#2)(1996-3#2)(2006-10#1)(2008-12#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)
and administrators##8##2##(1991-1#1)(1996-1#1)(1996-12#1)(1997-2#2)(2007-10#1)(2008-5#1)(2013-1#1)
and admission##3##2##(2008-3#2)(2012-3#1)
and admissions##2##2##(1991-11#1)(2011-2#1)
and admitted##2##2##(1997-2#1)(2011-2#1)
and adolescence##15##2##(1995-2#1)(1995-9#1)(1996-11#1)(2007-7#1)(2008-11#1)(2008-9#3)(2009-12#2)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
and adolescent cancer##2##3##(2010-3#2)
and adolescent inpatient units##2##4##(1993-1#2)
and adolescent obesity##2##3##(2012-2#1)(2012-3#1)
and adolescent psychiatry##3##3##(1995-6#1)(2008-11#1)(2008-4#1)
and adolescent weight##2##3##(2013-1#2)
and adolescent##39##2##(1991-2#1)(1992-1#2)(1993-1#2)(1993-12#2)(1993-2#1)(1995-6#1)(1996-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#3)(2008-4#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-3#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
and adolescents of##2##3##(2007-12#1)(2008-9#1)
and adolescents with##19##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#3)(2013-1#3)(2013-7#1)
and adolescents##109##2##(1990-6#1)(1991-2#5)(1992-1#1)(1992-3#1)(1993-1#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-7#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#5)(2010-3#2)(2010-5#4)(2010-7#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#1)
and adolescents'##2##2##(2009-7#1)(2012-3#1)
and adolescents]##2##2##(2007-3#1)(2008-11#1)
and adopt##2##2##(1995-3#1)(2012-3#1)
and adopted##3##2##(1996-12#1)(2008-11#1)(2008-8#1)
and adopting##4##2##(1996-1#1)(1996-3#1)(2008-7#1)(2011-2#1)
and adoption of the##2##4##(1991-2#1)(2008-3#1)
and adoption of##6##3##(1991-2#1)(1997-6#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)
and adrenal##6##2##(1990-9#1)(1992-2#1)(1995-11#1)(1995-3#1)(2008-8#1)(2013-1#1)
and adrenaline##7##2##(1994-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#3)
and adrenals##2##2##(1994-8#1)(2010-7#1)
and adrenergic##6##2##(1992-8#2)(1995-12#1)(2008-3#1)(2009-9#1)(2013-8#1)
and adrenoreceptor##3##2##(2013-1#3)
and adriamycin##7##2##(1991-4#1)(1991-5#1)(1993-1#1)(1993-8#3)(2010-3#1)
and adsorbed on##2##3##(2008-10#2)
and adsorbed##4##2##(2008-10#4)
and adsorption isotherms##2##3##(2008-10#2)
and adsorption##15##2##(1992-5#1)(1994-9#1)(2008-10#10)(2008-2#1)(2008-5#1)(2013-1#1)
and adsorptive stripping voltammetry##2##4##(2008-10#2)
and adsorptive stripping##4##3##(2008-10#4)
and adsorptive##8##2##(2008-10#8)
and adult animals##3##3##(1990-11#1)(2008-7#1)(2012-12#1)
and adult body size##2##4##(2010-2#1)(2011-1#1)
and adult human retina##2##4##(1996-5#2)
and adult human##3##3##(1994-2#1)(1996-5#2)
and adult life##4##3##(1993-3#1)(2008-10#1)(2009-8#1)(2010-5#1)
and adult mouse##2##3##(2008-7#1)(2012-2#1)
and adult patients##5##3##(1993-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
and adult phases##2##3##(2007-12#1)(2008-6#1)
and adult plant##3##3##(2008-10#3)
and adult population##2##3##(1996-7#1)(2013-1#1)
and adult rat##2##3##(1993-6#1)(1996-12#1)
and adult rats##4##3##(1992-10#1)(1993-6#1)(2013-7#2)
and adult stages of##2##4##(2008-9#1)(2013-1#1)
and adult stages##5##3##(1997-6#1)(2008-10#2)(2008-9#1)(2013-1#1)
and adult##96##2##(1990-11#3)(1990-12#1)(1991-11#1)(1991-12#1)(1992-10#3)(1992-2#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-9#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#6)(2009-8#2)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)
and adulthood##6##2##(1996-8#1)(1996-9#1)(1997-7#1)(2008-11#1)(2008-2#1)(2009-2#1)
and adults (5-7 days)##2##4##(1997-8#2)
and adults during##2##3##(2013-7#1)(2013-8#1)
and adults of##4##3##(1994-3#1)(2008-6#1)(2013-7#2)
and adults were##2##3##(2008-12#1)(2011-2#1)
and adults with congenital##2##4##(1992-5#1)(2010-6#1)
and adults with##9##3##(1992-5#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
and adults##69##2##(1991-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1993-1#1)(1994-3#1)(1995-5#1)(1996-2#2)(1997-1#1)(1997-7#1)(1997-8#4)(2007-11#3)(2007-12#1)(2007-8#4)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#6)(2013-8#3)
and advance##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
and advanced life support##3##4##(2008-11#1)(2013-1#2)
and advanced##20##2##(1990-6#1)(1991-3#2)(1993-9#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-5#1)(2011-2#2)(2013-1#4)
and advances in the##2##4##(1997-7#1)(2007-12#1)
and advances in##4##3##(1996-2#1)(1997-7#1)(2007-12#1)(2011-2#1)
and advances##8##2##(1996-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-2#1)
and advancing##3##2##(2008-11#1)(2008-8#1)(2011-1#1)
and advantageous##2##2##(2008-2#1)(2008-3#1)
and advantages of the##4##4##(1996-1#1)(1997-2#1)(2008-3#1)(2012-12#1)
and advantages of##10##3##(1996-1#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)(2012-12#2)
and advantages##12##2##(1996-1#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
and adventitious roots##2##3##(2008-10#1)(2008-9#1)
and adventitious##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
and adverse drug reactions##4##4##(2008-10#1)(2010-6#1)(2011-2#2)
and adverse effects of##4##4##(2008-11#1)(2008-8#1)(2010-1#1)(2010-11#1)
and adverse effects##7##3##(2008-1#1)(2008-11#1)(2008-8#2)(2010-1#1)(2010-11#1)(2012-2#1)
and adverse events##5##3##(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#1)
and adverse pregnancy##2##3##(2008-11#2)
and adverse##27##2##(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
and advice by##2##3##(1996-8#1)(2011-2#1)
and advice##6##2##(1992-12#1)(1996-8#1)(2008-2#1)(2008-4#1)(2011-2#2)
and advocacy##4##2##(1994-12#1)(1997-1#1)(2011-1#1)(2011-2#1)
and advocate##3##2##(2007-2#1)(2008-1#1)(2010-1#1)
and advocated##2##2##(1994-12#1)(2010-1#1)
and aeration##3##2##(2008-11#2)(2012-2#1)
and aerobic##6##2##(2007-12#1)(2007-7#1)(2008-5#1)(2009-1#1)(2012-3#1)(2013-1#1)
and aerodynamic##3##2##(1992-3#1)(2007-12#2)
and aerosol backscatter##2##3##(2008-2#1)(2008-3#1)
and aerosol mass spectrometer measurement of diesel exhaust particles composition##2##10##(2008-10#2)
and aerosol optical thickness from##2##5##(2008-2#2)
and aerosol optical##3##3##(2008-2#3)
and aerosol profiles##2##3##(2008-3#2)
and aerosol scattering##2##3##(2008-2#1)(2008-3#1)
and aerosol##29##2##(2008-10#4)(2008-2#14)(2008-3#10)(2010-3#1)
and aerosols##11##2##(1997-1#1)(2008-10#1)(2008-2#2)(2008-3#7)
and aesculetin in##2##3##(2008-10#2)
and aesthetic##5##2##(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and affect the##3##3##(1994-8#1)(1995-3#1)(1997-2#1)
and affect##17##2##(1991-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-2#3)(2012-3#1)
and affected##10##2##(1992-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and affecting the##2##3##(2008-10#1)(2008-8#1)
and affecting##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
and affective components##2##3##(2008-2#1)(2010-4#1)
and affective##12##2##(1991-2#1)(1994-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#3)(2010-1#1)(2010-4#1)(2012-3#1)(2013-8#1)
and affects the##2##3##(1990-12#1)(2008-9#1)
and affects##14##2##(1990-12#1)(1990-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#2)(2012-12#1)(2012-3#1)(2013-8#2)
and affinities##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
and affinity chromatography##2##3##(1997-2#1)(2009-9#1)
and affinity for##2##3##(2008-12#1)(2009-2#1)
and affinity of##2##3##(1995-12#1)(1996-7#1)
and affinity purification of##2##4##(2008-4#2)
and affinity##16##2##(1990-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-8#1)(2009-2#1)(2009-9#1)
and affordable##3##2##(2008-11#1)(2010-5#1)(2010-8#1)
and afimbrial##2##2##(2008-10#2)
and aflatoxin accumulation##4##3##(2008-10#4)
and aflatoxin in maize##2##4##(2008-10#2)
and aflatoxin production##8##3##(2008-10#8)
and aflatoxin##18##2##(2008-10#18)
and after 1 year##2##4##(1994-2#1)(2013-1#1)
and after 1##6##3##(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#1)
and after 14##2##3##(1991-9#1)(1995-3#1)
and after 15##2##3##(2008-10#1)(2011-2#1)
and after 2##5##3##(1991-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
and after 3 months of##2##5##(1994-6#1)(2011-2#1)
and after 3##4##3##(1994-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
and after 5##2##3##(2006-12#1)(2008-3#1)
and after 6##3##3##(1994-5#1)(2011-2#1)(2013-7#1)
and after GnRH-a##2##3##(1996-2#2)
and after HA##2##3##(2013-8#2)
and after a##22##3##(1990-2#1)(1990-9#1)(1992-12#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#3)(2009-12#1)(2009-9#1)(2010-8#2)(2011-2#1)(2013-1#2)
and after acclimatization in September##3##5##(2009-12#3)
and after acclimatization in##5##4##(2009-12#5)
and after achieving##2##3##(2008-7#1)(2013-8#1)
and after all##2##3##(1994-12#1)(1997-4#1)
and after axon##2##3##(2008-7#1)(2012-2#1)
and after birth##2##3##(1990-5#1)(2012-2#1)
and after cancer##2##3##(2008-7#2)
and after cardiopulmonary bypass##2##4##(2007-8#1)(2011-2#1)
and after delivery##2##3##(1991-6#1)(2010-6#1)
and after each##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
and after exposure to##2##4##(2008-5#1)(2013-1#1)
and after exposure##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
and after implementation##4##3##(1995-12#1)(1997-2#1)(2006-10#1)(2008-10#1)
and after introduction of##2##4##(2007-8#1)(2011-2#1)
and after maintenance##2##3##(2013-8#2)
and after reversible##2##3##(1991-5#1)(1993-6#1)
and after stimulation##3##3##(1994-11#1)(1997-2#1)(2013-1#1)
and after surgery##5##3##(1990-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-2#1)
and after the application of##4##5##(2008-5#1)(2013-1#3)
and after the end of maintenance##2##6##(2013-8#2)
and after the end of##3##5##(1995-6#1)(2013-8#2)
and after the##62##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1995-12#1)(1995-6#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#6)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#5)
and after treatment##13##3##(1990-12#1)(1991-2#1)(1993-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-5#2)(2008-7#1)(2011-1#2)(2013-1#1)
and after two months##2##4##(2007-8#1)(2008-5#1)
and after two##3##3##(2007-8#1)(2008-5#2)
and after##368##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-5#4)(1996-6#2)(1996-7#4)(1996-8#2)(1997-2#6)(1997-3#2)(1997-4#4)(1997-6#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#14)(2007-9#1)(2008-1#4)(2008-10#41)(2008-11#4)(2008-12#12)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#20)(2008-6#3)(2008-7#20)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#6)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#19)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#11)(2012-3#9)(2012-4#1)(2012-5#1)(2013-1#19)(2013-7#1)(2013-8#15)
and afternoon sessions##2##3##(2008-5#2)
and afterwards##3##2##(1990-6#1)(2008-10#1)(2013-8#1)
and again 4 months later##2##5##(1993-12#1)(2013-1#1)
and again after##2##3##(1995-11#1)(2013-1#1)
and again at##3##3##(1991-2#1)(2007-11#1)(2007-8#1)
and again during##2##3##(1995-11#1)(2008-7#1)
and again in##2##3##(1996-2#1)(2009-8#1)
and again##17##2##(1990-3#1)(1991-2#1)(1993-12#1)(1995-11#2)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2013-1#2)
and against the##3##3##(1991-2#1)(1993-3#1)(2008-4#1)
and against##20##2##(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)
and agar##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
and agarose##2##2##(2008-10#1)(2008-5#1)
and age (P##2##3##(2011-2#1)(2012-3#1)
and age (p&lt##4##3##(2008-10#3)(2011-2#1)
and age 0 year##2##4##(2010-8#2)
and age are##2##3##(2008-8#1)(2011-1#1)
and age at onset of##2##5##(2007-7#1)(2008-7#1)
and age at##11##3##(2007-5#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#2)(2012-2#1)(2013-1#1)
and age for##2##3##(1994-6#1)(2011-2#1)
and age greater than##2##4##(2007-10#1)(2013-8#1)
and age groups##3##3##(1990-6#1)(2007-2#1)(2008-11#1)
and age in##4##3##(1995-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
and age of patients##2##4##(2010-8#1)(2013-1#1)
and age of##8##3##(1994-6#1)(2008-6#1)(2010-8#2)(2011-1#2)(2012-3#1)(2013-1#1)
and age on##3##3##(2007-10#1)(2011-2#2)
and age were##4##3##(1993-1#1)(2007-12#1)(2008-10#1)(2010-8#1)
and age##87##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-1#3)(1993-12#1)(1993-9#1)(1994-6#2)(1995-12#1)(1996-5#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#3)(2010-3#2)(2010-8#5)(2011-1#4)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
and age- and##2##3##(1993-9#1)(2009-8#1)
and age-dependent##2##2##(1994-8#1)(2008-5#1)
and age-matched##2##2##(2006-10#1)(2010-7#1)
and age-related##7##2##(1994-5#1)(1995-8#1)(1997-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
and aged mice##3##3##(1994-6#1)(2008-5#1)(2009-12#1)
and aged rats##5##3##(1990-5#1)(1990-7#1)(1994-3#2)(1997-2#1)
and aged##20##2##(1990-5#1)(1990-7#1)(1991-12#3)(1994-3#3)(1994-6#1)(1995-5#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-5#3)(2009-12#2)(2010-10#1)
and ageing##7##2##(1990-3#2)(1995-5#1)(1996-5#1)(2008-5#2)(2013-7#1)
and agencies##3##2##(1994-8#1)(2012-2#1)(2012-3#1)
and agency##3##2##(1997-3#1)(2007-12#1)(2012-2#1)
and agents##6##2##(1995-5#1)(1997-1#1)(1997-3#1)(2008-10#1)(2011-1#1)(2012-3#1)
and aggregate##5##2##(1991-1#1)(1994-5#1)(2008-2#1)(2011-2#2)
and aggregation##8##2##(1991-9#1)(1996-12#1)(2006-6#2)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
and aggression##2##2##(2008-11#1)(2009-6#1)
and aggressive behavior##3##3##(2008-11#1)(2008-12#1)(2010-8#1)
and aggressive chemotherapy##2##3##(1997-3#1)(2008-6#1)
and aggressive periodontitis##2##3##(2012-3#2)
and aggressive treatment##3##3##(2010-7#1)(2012-3#2)
and aggressive##34##2##(1992-11#1)(1997-3#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)
and aggressively##2##2##(2011-2#1)(2013-8#1)
and aggressiveness on##3##3##(1995-5#1)(2008-10#2)
and aggressiveness to tomato and potato##3##6##(2008-10#3)
and aggressiveness##9##2##(1995-5#1)(2008-10#7)(2010-11#1)
and agility in##2##3##(2011-2#1)(2012-1#1)
and agility##3##2##(2011-2#1)(2012-1#1)(2013-7#1)
and aging in##4##3##(1994-6#1)(2008-3#1)(2008-4#1)(2009-5#1)
and aging##37##2##(1991-12#1)(1994-11#1)(1994-5#3)(1994-6#1)(1994-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
and agitation intensity##2##3##(2008-7#1)(2011-2#1)
and agitation##6##2##(1997-6#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#2)
and agonist##4##2##(1992-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
and agonists##3##2##(1993-12#1)(2006-6#1)(2009-8#1)
and agranular##2##2##(1992-9#1)(2008-7#1)
and agree well with##2##4##(2008-3#2)
and agree##3##2##(2008-3#2)(2008-9#1)
and agreed to##4##3##(1992-4#1)(1995-1#1)(2008-1#1)(2010-6#1)
and agreed##5##2##(1992-3#1)(1992-4#1)(1995-1#1)(2008-1#1)(2010-6#1)
and agreement between##2##3##(1995-12#1)(2010-5#1)
and agreement##6##2##(1995-12#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-1#2)
and agrees well with##2##4##(2007-11#1)(2008-3#1)
and agrees##3##2##(1993-8#1)(2007-11#1)(2008-3#1)
and agricultural entomology##2##3##(2010-1#2)
and agricultural products##2##3##(2008-10#2)
and agricultural residues##2##3##(2008-6#2)
and agricultural samples##2##3##(2008-10#2)
and agricultural##15##2##(1991-6#1)(2008-10#6)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-1#2)
and agriculture##8##2##(1991-6#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2010-7#1)(2013-7#1)(2013-8#1)
and agroinoculation##2##2##(2008-10#2)
and aid in the development of##3##6##(2007-12#1)(2011-1#1)(2011-2#1)
and aid in##6##3##(1996-2#1)(1997-2#1)(2007-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
and aid##9##2##(1993-1#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
and aids in##2##3##(1991-2#1)(2011-2#1)
and aids##3##2##(1991-2#1)(2008-7#1)(2011-2#1)
and aimed##2##2##(1990-2#1)(1996-3#1)
and aiming##2##2##(2008-5#1)(2008-9#1)
and aims at##2##3##(2008-2#1)(2012-3#1)
and aims of##2##3##(2008-4#1)(2011-2#1)
and aims##7##2##(2008-2#1)(2008-4#1)(2009-8#2)(2011-2#1)(2012-3#2)
and air and##3##3##(2008-10#1)(2013-7#2)
and air flow rate on##2##5##(2008-6#2)
and air flow rate##3##4##(2008-6#3)
and air pollution##2##3##(2008-11#1)(2008-2#1)
and air travel##2##3##(2010-5#2)
and air warming##6##3##(2012-6#6)
and air##40##2##(1990-8#2)(1993-2#1)(1995-3#1)(1996-12#1)(1996-6#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#1)(2010-5#2)(2012-3#1)(2012-6#6)(2012-9#1)(2013-7#3)
and air)##2##2##(2008-10#1)(2013-8#1)
and airborne##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
and aircraft##3##2##(2008-2#1)(2008-3#2)
and airway##12##2##(1992-3#3)(1997-1#1)(2008-3#3)(2010-5#2)(2012-12#1)(2013-1#2)
and airways disease##2##3##(1992-11#1)(2008-1#1)
and alachlor##2##2##(2008-10#2)
and alanine aminotransferase##4##3##(1991-12#2)(1996-12#1)(2012-2#1)
and alanine##13##2##(1991-12#2)(1993-8#2)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
and albendazole was 0##2##4##(2008-10#2)
and albumin excretion##5##3##(1997-8#5)
and albumin in urine##2##4##(2008-10#2)
and albumin in##3##3##(2008-10#2)(2009-6#1)
and albumin##20##2##(1991-12#1)(1993-8#1)(1994-8#1)(1997-8#5)(2008-10#3)(2008-11#2)(2009-6#2)(2011-2#4)(2013-1#1)
and albuminuria##4##2##(1994-8#1)(2012-2#1)(2012-6#2)
and alcian blue##2##3##(2008-11#1)(2008-5#1)
and alcohol abuse##3##3##(1994-2#1)(1996-6#1)(2013-1#1)
and alcohol and##2##3##(1991-1#1)(2013-1#1)
and alcohol consumption##3##3##(1990-8#1)(2008-10#1)(2010-4#1)
and alcohol content##2##3##(2008-10#2)
and alcohol dependence##3##3##(2008-8#1)(2012-1#1)(2012-2#1)
and alcohol use are##2##4##(2008-1#1)(2012-12#1)
and alcohol use##7##3##(2008-1#1)(2008-6#1)(2009-8#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
and alcohol##45##2##(1990-8#1)(1991-1#2)(1991-9#2)(1992-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
and alcoholic##3##2##(1991-5#1)(1994-2#2)
and alcoholism##10##2##(1991-3#1)(1993-2#1)(1994-2#2)(1997-5#4)(2008-2#1)(2008-5#1)
and aldehyde dehydrogenase##3##3##(2008-10#2)(2008-11#1)
and aldosterone##3##2##(1990-5#1)(1991-12#1)(2008-8#1)
and alert##2##2##(1996-2#1)(2007-12#1)
and alertness related##2##3##(2013-8#2)
and alfalfa cv##2##3##(2008-10#2)
and alfalfa##8##2##(2008-10#7)(2011-2#1)
and algD##2##2##(2008-7#2)
and algae##9##2##(2007-5#2)(2008-10#1)(2008-7#1)(2010-7#2)(2012-2#3)
and algal##4##2##(1990-12#1)(2009-8#2)(2011-2#1)
and alginate##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
and alginic acid##2##3##(2008-10#2)
and algorithms##2##2##(2010-7#1)(2011-2#1)
and align##3##2##(2008-5#1)(2009-11#1)(2013-1#1)
and aligned##2##2##(1995-3#1)(2011-2#1)
and alignment of##5##3##(2008-10#1)(2008-7#2)(2013-8#2)
and alignment procedure##2##3##(2008-3#2)
and alignment##11##2##(1997-6#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#2)(2013-1#1)(2013-8#2)
and aliphatic##4##2##(2008-10#3)(2012-3#1)
and alkali and alkaline earth cations##2##6##(2008-10#2)
and alkali##9##2##(1996-2#1)(2008-10#6)(2013-8#2)
and alkali-earth##3##2##(2008-10#3)
and alkaline conditions##2##3##(2008-11#1)(2008-6#1)
and alkaline earth metal##10##4##(2008-10#10)
and alkaline earth##16##3##(2008-10#16)
and alkaline medium##2##3##(2008-10#2)
and alkaline pH##3##3##(1990-7#1)(2008-10#1)(2013-8#1)
and alkaline phosphatase (ALP)##4##4##(2007-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
and alkaline phosphatase##14##3##(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)(2013-1#2)
and alkaline##50##2##(1990-7#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(2007-12#1)(2008-10#30)(2008-11#4)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#3)(2013-8#1)
and alkaline-earth metals##3##3##(2008-10#3)
and alkaline-earth##4##2##(2008-10#4)
and alkaloids##3##2##(2008-10#1)(2008-12#2)
and alkylphenols in the##2##4##(2008-10#2)
and alkylphenols in##4##3##(2008-10#4)
and alkylthiols##2##2##(2008-10#2)
and all 5##2##3##(1990-6#1)(2008-9#1)
and all cases were##2##4##(2008-5#1)(2013-1#1)
and all five##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
and all had##3##3##(1990-2#1)(2007-7#1)(2008-6#1)
and all health##2##3##(2008-1#1)(2008-12#1)
and all isolates##3##3##(2008-10#3)
and all its##2##3##(2008-10#1)(2008-4#1)
and all lambs##2##3##(1996-12#2)
and all of the##4##4##(1994-5#1)(1995-2#1)(1995-3#1)(2013-7#1)
and all of##6##3##(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-9#1)(2013-7#1)
and all other##3##3##(1994-8#1)(2008-10#1)(2012-3#1)
and all patients##3##3##(2007-7#1)(2008-11#1)(2010-7#1)
and all tested##2##3##(2008-10#2)
and all the##10##3##(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-2#1)(2011-3#2)(2013-1#1)
and all these##2##3##(2008-10#1)(2013-8#1)
and all were##9##3##(1991-12#1)(1992-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
and all##147##2##(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#37)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#5)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
and all-cause mortality##6##3##(1991-8#1)(2007-10#1)(2010-2#2)(2011-1#1)(2012-2#1)
and all-cause##7##2##(1991-8#1)(1997-4#1)(2007-10#1)(2010-2#2)(2011-1#1)(2012-2#1)
and all-optical##2##2##(2007-11#1)(2007-12#1)
and all-trans retinoic acid (ATRA)##2##5##(2007-4#1)(2011-2#1)
and all-trans retinoic acid##3##4##(2007-4#1)(2011-2#2)
and allele frequencies were##2##4##(2011-1#2)
and allele frequencies##5##3##(2011-1#5)
and allele##7##2##(1993-3#1)(2008-10#1)(2011-1#5)
and allelic frequencies##2##3##(2008-12#2)
and allelic##7##2##(2008-10#3)(2008-12#2)(2008-5#1)(2012-3#1)
and allergens##4##2##(1991-3#1)(2008-10#1)(2011-2#2)
and allergic rhinitis##5##3##(2008-10#2)(2010-6#1)(2011-2#1)(2012-2#1)
and allergic##16##2##(1991-2#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
and allergies##2##2##(1995-11#1)(2008-10#1)
and allergy##5##2##(1997-2#1)(2008-8#1)(2009-5#1)(2013-1#2)
and alleviating##2##2##(1994-2#1)(2012-2#1)
and allied##2##2##(2008-11#1)(2011-1#1)
and allocated##2##2##(1993-12#1)(2012-2#1)
and allocation##5##2##(1995-12#1)(2008-10#1)(2011-3#1)(2012-12#1)(2013-8#1)
and allocentric##2##2##(1994-3#2)
and allodynia##3##2##(1996-6#1)(2008-9#1)(2012-12#1)
and allogeneic##5##2##(1992-9#1)(1994-6#1)(2010-5#2)(2011-2#1)
and allograft fixation##3##3##(2009-3#3)
and allograft##7##2##(2009-3#3)(2010-10#3)(2012-3#1)
and allopurinol##2##2##(2008-10#1)(2008-7#1)
and allotetraploid unisexual##2##3##(2008-9#2)
and allow a##2##3##(2008-7#1)(2011-7#1)
and allow for##4##3##(2008-10#2)(2011-1#1)(2012-12#1)
and allow the##4##3##(1992-9#1)(2008-2#1)(2008-8#1)(2008-9#1)
and allow##23##2##(1992-6#1)(1992-9#1)(1995-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)
and allowed charges##2##3##(1992-1#1)(1994-2#1)
and allowed for the##3##4##(2008-10#2)(2008-12#1)
and allowed for##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2010-5#1)
and allowed the determination of##2##5##(2008-10#2)
and allowed the##7##3##(2007-8#1)(2008-10#5)(2012-3#1)
and allowed to circulate##2##4##(1997-2#1)(2008-1#1)
and allowed to##9##3##(1994-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
and allowed##34##2##(1991-5#1)(1992-1#1)(1994-11#1)(1994-2#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
and allowing for##3##3##(2007-8#1)(2008-10#1)(2009-11#1)
and allowing##9##2##(1995-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
and allows a##3##3##(1993-9#1)(2008-3#2)
and allows for the##4##4##(1997-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
and allows for##11##3##(1993-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2010-4#1)
and allows measurements##2##3##(2007-11#1)(2008-2#1)
and allows one to##2##4##(2007-11#1)(2007-12#1)
and allows simultaneous##2##3##(2008-10#1)(2008-9#1)
and allows the determination of 0##2##6##(2008-10#2)
and allows the determination of##3##5##(2008-10#2)(2010-5#1)
and allows the##18##3##(1992-3#1)(1993-12#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-8#1)
and allows us##2##3##(1995-6#1)(2009-8#1)
and allows##77##2##(1991-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#1)
and alloy samples##3##3##(2008-10#3)
and alloy##5##2##(2008-10#5)
and alloys##4##2##(2008-10#4)
and almond##3##2##(2008-10#3)
and almost all of them##2##5##(1996-9#1)(2008-9#1)
and almost all of##3##4##(1996-9#1)(2008-9#1)(2009-11#1)
and almost all##5##3##(1996-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-11#1)
and almost completely##2##3##(1992-12#1)(1992-3#1)
and almost constant##2##3##(1996-8#1)(2008-10#1)
and almost half##2##3##(1997-8#1)(2008-12#1)
and almost no interference##2##4##(2008-10#2)
and almost no##4##3##(2008-10#2)(2009-11#1)(2012-12#1)
and almost##34##2##(1991-8#1)(1992-12#2)(1992-3#1)(1993-6#1)(1996-8#1)(1996-9#1)(1997-8#2)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
and along the##2##3##(2008-10#1)(2009-2#1)
and along##6##2##(1992-12#1)(2007-11#1)(2008-10#2)(2009-12#1)(2009-2#1)
and alopecia areata##2##3##(2007-7#2)
and alopecia##6##2##(1991-4#1)(1997-7#1)(2007-7#2)(2008-10#1)(2008-5#1)
and alpha 1##3##3##(1992-12#1)(1994-9#1)(1995-11#1)
and alpha 1c##2##3##(1994-6#2)
and alpha 2##3##3##(1991-5#2)(1995-2#1)
and alpha##32##2##(1990-11#1)(1991-5#3)(1991-6#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#8)(1995-2#2)(1995-9#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)
and alpha-##2##2##(2007-11#1)(2008-10#1)
and alpha-1##2##2##(2008-10#1)(2008-7#1)
and alpha-2##2##2##(1990-8#1)(2008-7#1)
and alpha-Gi##2##2##(1994-6#2)
and alpha-MSH##2##2##(1993-5#2)
and alpha-fetoprotein##2##2##(1992-3#1)(1995-5#1)
and alpha-linolenic##2##2##(1990-3#1)(1994-11#1)
and alpha-melanocyte-stimulating hormone##2##3##(2008-8#1)(2009-8#1)
and alpha-tocopherol in##2##3##(1994-12#1)(2008-10#1)
and alpha-tocopherol##6##2##(1994-12#1)(1994-9#2)(2008-10#2)(2011-1#1)
and alpha2##2##2##(2008-11#1)(2008-7#1)
and also a##5##3##(1996-11#1)(1997-5#1)(2008-10#1)(2008-7#2)
and also affect##2##3##(2008-5#1)(2010-12#1)
and also after##2##3##(2006-6#1)(2013-8#1)
and also allowed us to##2##5##(2008-10#2)
and also allows##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
and also an##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
and also are##2##3##(1992-12#1)(2008-3#1)
and also as##2##3##(1993-2#1)(2008-10#1)
and also at##2##3##(2008-10#1)(2008-7#1)
and also be##2##3##(1990-12#1)(1994-1#1)
and also because##4##3##(1993-1#1)(2008-2#1)(2008-4#1)(2011-2#1)
and also between##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
and also by##16##3##(1990-8#2)(1993-3#1)(1995-12#1)(1995-3#1)(2007-2#1)(2008-10#7)(2008-11#1)(2011-2#2)
and also carried##2##3##(1995-6#1)(2010-1#1)
and also demonstrate the##2##4##(2008-3#1)(2012-12#1)
and also demonstrate##4##3##(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
and also for the##2##4##(2008-3#1)(2013-8#1)
and also for##5##3##(2008-10#2)(2008-3#1)(2010-8#1)(2013-8#1)
and also found##2##3##(1990-12#1)(2008-11#1)
and also from##3##3##(2008-10#3)
and also had##2##3##(2010-4#2)
and also has an##2##4##(2008-7#1)(2008-9#1)
and also has##5##3##(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
and also have a##2##4##(1991-9#1)(2008-10#1)
and also highlights##3##3##(2008-5#1)(2011-2#1)(2013-7#1)
and also in a##3##4##(2008-10#3)
and also in patients##2##4##(2008-7#1)(2012-2#1)
and also in the presence of##2##6##(2008-10#1)(2008-4#1)
and also in the##7##4##(1997-2#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)
and also in##34##3##(1991-12#2)(1992-11#1)(1993-12#1)(1994-2#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-4#4)(2008-7#3)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
and also includes##2##3##(2008-2#1)(2008-9#1)
and also increased the##2##4##(1991-12#1)(2008-10#1)
and also indicated that##2##4##(2008-10#1)(2008-8#1)
and also investigate##2##3##(2008-3#1)(2012-2#1)
and also its##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and also may##2##3##(2008-7#1)(2010-10#1)
and also new##2##3##(1992-3#1)(1997-7#1)
and also of##4##3##(1994-9#1)(1995-2#1)(2008-10#1)(2012-3#1)
and also on##4##3##(2008-10#2)(2011-1#1)(2012-12#1)
and also prevention of##3##4##(1991-11#1)(1995-5#1)(2008-7#1)
and also promote##2##3##(2008-11#1)(2010-12#1)
and also provide a##2##4##(1992-3#1)(2008-10#1)
and also provide##7##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#1)(2013-8#1)
and also provides##3##3##(2007-12#1)(2008-11#1)(2013-1#1)
and also reduced##3##3##(2007-10#1)(2008-10#2)
and also show that##2##4##(1994-9#1)(2013-1#1)
and also show##3##3##(1994-9#1)(1995-3#1)(2013-1#1)
and also shows##4##3##(1992-1#1)(2008-9#2)(2009-7#1)
and also significantly##2##3##(1995-9#1)(2011-1#1)
and also suggest that the##2##5##(1991-5#1)(1996-5#1)
and also suggest##3##3##(1990-8#1)(1991-5#1)(1996-5#1)
and also supported##2##3##(2008-10#2)
and also that##2##3##(1994-6#1)(2007-12#1)
and also the first sequence from##2##6##(2011-2#2)
and also the first##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
and also the increased##2##4##(1996-12#1)(2008-1#1)
and also the##33##3##(1991-9#1)(1995-12#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#5)(2008-8#1)(2009-10#3)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)
and also their##3##3##(1997-2#1)(2007-11#1)(2013-1#1)
and also through##2##3##(2008-10#1)(2008-11#1)
and also to estimate##2##4##(2008-10#1)(2008-5#1)
and also to evaluate##2##4##(2007-8#1)(2013-7#1)
and also to some##2##4##(2008-10#2)
and also to study the##2##5##(2006-6#1)(2012-2#1)
and also to the selective determination of##2##7##(2008-10#2)
and also to the##4##4##(1990-11#1)(1992-9#1)(2008-10#2)
and also to##31##3##(1990-11#1)(1992-9#1)(1993-3#1)(1994-2#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#3)(2013-7#1)
and also used##2##3##(2008-10#1)(2008-12#1)
and also was##2##3##(2008-10#2)
and also when##2##3##(1990-9#1)(2008-10#1)
and also will##3##3##(2008-1#1)(2008-10#2)
and also with the##3##4##(1995-3#1)(2008-10#1)(2008-8#1)
and also with##9##3##(1993-12#1)(1995-3#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-3#1)(2012-2#1)
and also within##2##3##(2006-6#1)(2008-10#1)
and also##425##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-6#4)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#4)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#80)(2008-11#11)(2008-12#10)(2008-2#7)(2008-3#18)(2008-4#8)(2008-5#11)(2008-6#3)(2008-7#25)(2008-8#9)(2008-9#9)(2009-10#5)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#7)
and alter the##2##3##(2008-12#1)(2008-7#1)
and alter##7##2##(1990-11#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
and alteration of##7##3##(1994-12#1)(1994-6#1)(2008-10#2)(2010-6#1)(2011-1#1)(2011-2#1)
and alteration##9##2##(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
and alterations in##2##3##(2010-8#2)
and altered cell##2##3##(2008-11#1)(2009-9#1)
and altered sensorium##3##3##(2008-1#1)(2009-11#2)
and altered the##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
and altered##27##2##(1990-9#1)(1993-6#1)(1993-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#2)(2008-8#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
and alternate##9##2##(1990-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)
and alternative medicine (CAM) is##2##5##(2008-10#2)
and alternative medicine (CAM)##5##4##(2008-10#5)
and alternative medicine##11##3##(1997-6#1)(2008-10#7)(2009-5#1)(2009-6#2)
and alternative##30##2##(1990-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#2)(2011-1#1)(2012-2#1)(2013-1#1)
and alters the##2##3##(1991-12#1)(2011-2#1)
and although##12##2##(1991-2#1)(1992-3#1)(1993-3#1)(1995-11#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-3#2)
and altitude##4##2##(2008-8#2)(2009-5#1)(2012-6#1)
and altruism##5##2##(2008-8#3)(2010-4#2)
and alumina##2##2##(1992-2#1)(2008-10#1)
and aluminium in##4##3##(1992-3#2)(2008-10#2)
and aluminium##10##2##(1992-3#3)(1996-2#1)(2008-10#5)(2008-7#1)
and aluminum##15##2##(1994-11#2)(1996-2#1)(2008-10#9)(2008-4#2)(2012-2#1)
and alveolar##6##2##(1994-12#1)(1994-5#1)(1997-1#1)(1997-3#1)(2010-7#1)(2012-3#1)
and always##8##2##(1997-1#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
and ambient temperature (r = 0##2##6##(1997-6#2)
and ambient temperature##4##3##(1997-6#2)(2008-10#1)(2011-2#1)
and ambient##6##2##(1997-6#2)(2007-12#1)(2008-10#2)(2011-2#1)
and ambiguous##2##2##(2008-2#1)(2011-2#1)
and ambulatory blood pressure##2##4##(2008-7#1)(2012-1#1)
and ambulatory care##2##3##(1997-2#1)(2011-1#1)
and ambulatory##8##2##(1997-1#1)(1997-2#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-1#1)
and ameliorates##2##2##(2007-11#1)(2008-1#1)
and amenability to##2##3##(2008-10#1)(2011-2#1)
and amended##3##2##(2008-10#2)(2010-3#1)
and americium##2##2##(2008-10#2)
and amidation##2##2##(2008-12#1)(2009-9#1)
and amide##3##2##(1992-5#1)(2008-5#2)
and amifostine##2##2##(2008-7#2)
and amiloride at##2##3##(2008-4#2)
and amine end groups##2##4##(2008-10#2)
and amine##5##2##(1991-9#1)(2008-10#4)
and amines##2##2##(1996-5#1)(2008-10#1)
and amino acid analysis##2##4##(1993-8#1)(1997-3#1)
and amino acid composition of the##3##6##(1990-5#1)(1992-9#1)(2008-9#1)
and amino acid composition of##4##5##(1990-5#2)(1992-9#1)(2008-9#1)
and amino acid composition##5##4##(1990-5#2)(1992-9#1)(2008-7#1)(2008-9#1)
and amino acid levels##3##4##(1993-6#1)(1995-8#1)(2008-10#1)
and amino acid or DNA##2##5##(2008-10#2)
and amino acid sequence analysis##3##5##(1990-2#1)(1992-12#2)
and amino acid sequence of##4##5##(1990-12#1)(1994-11#2)(1995-5#1)
and amino acid sequence##13##4##(1990-12#1)(1990-2#1)(1990-7#1)(1992-12#2)(1992-8#1)(1992-9#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-5#1)(2008-10#1)
and amino acid sequences##6##4##(1991-12#1)(1991-5#1)(1994-11#1)(2011-1#2)(2013-8#1)
and amino acid sequencing##2##4##(1991-12#1)(1993-8#1)
and amino acid##46##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-6#1)(1995-11#2)(1995-5#1)(1995-8#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#2)(2011-1#3)(2012-1#1)(2013-8#3)
and amino acids were##2##4##(2008-10#1)(2008-7#1)
and amino acids##22##3##(1991-5#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#12)(2008-11#3)(2008-7#1)(2011-2#1)(2012-2#1)
and amino groups##3##3##(2008-7#1)(2009-8#1)(2013-1#1)
and amino positions##2##3##(2008-4#2)
and amino##77##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1997-3#2)(2008-10#17)(2008-11#6)(2008-4#2)(2008-7#3)(2008-9#2)(2009-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
and amino-acid##3##2##(1990-5#1)(1994-12#1)(1995-8#1)
and amino-terminal##2##2##(1990-12#1)(1992-3#1)
and aminomethylphosphonic acid##2##3##(2011-1#2)
and aminophenols##2##2##(1994-5#1)(2008-10#1)
and aminophospholipid exposure##2##3##(2006-6#2)
and aminopropyl sol-gel was##2##4##(2008-10#2)
and aminopropyl sol-gel##3##3##(2008-10#3)
and aminosaccharides and##2##3##(1991-7#2)
and amitriptyline##2##2##(1990-11#1)(1992-9#1)
and ammonia##16##2##(2007-11#1)(2008-10#2)(2008-11#7)(2008-3#3)(2008-6#1)(2008-7#1)(2011-2#1)
and ammonia-N##2##2##(2012-2#2)
and ammonium acetate##4##3##(2008-10#2)(2011-1#1)(2012-3#1)
and ammonium ions##4##3##(2008-10#3)(2008-11#1)
and ammonium molybdate##2##3##(2008-10#2)
and ammonium sulfate##2##3##(2008-10#1)(2008-8#1)
and ammonium tetraphenylborate##3##3##(2008-10#3)
and ammonium##29##2##(1992-11#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
and amniotic##2##2##(2011-1#1)(2012-3#1)
and among fields##2##3##(2008-10#2)
and among isolates##2##3##(2008-10#2)
and among populations##3##3##(2008-10#3)
and among the##8##3##(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
and among these##2##3##(2008-11#1)(2011-2#1)
and among##51##2##(1992-5#1)(1993-6#1)(1994-6#1)(1995-1#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-1#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
and amorphous##6##2##(1995-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
and amount of##11##3##(1994-8#1)(2008-10#4)(2008-12#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
and amounts of##6##3##(1992-3#2)(1992-6#1)(2008-10#2)(2008-5#1)
and amounts##8##2##(1992-3#2)(1992-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
and amoxicillin##2##2##(1994-11#1)(2012-12#1)
and amperometric##6##2##(2008-10#4)(2013-1#2)
and amphetamine##6##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(2008-10#1)
and amphetamines##3##2##(1991-1#1)(1991-2#1)(2008-5#1)
and amphibians##2##2##(1990-5#1)(2008-9#1)
and amphotericin B##4##3##(2008-5#4)
and amphotericin##5##2##(1996-11#1)(2008-5#4)
and ampicillin##2##2##(2008-10#1)(2013-8#1)
and amplification of the##2##4##(2008-9#1)(2012-1#1)
and amplification of ultrashort shaped pulses in the visible by a two-stage noncollinear optical parametric##2##15##(2007-12#2)
and amplification of##9##3##(1992-10#1)(1995-12#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-9#1)(2012-1#1)
and amplification##17##2##(1992-10#1)(1995-12#1)(2007-12#4)(2008-11#1)(2008-3#1)(2008-4#4)(2008-9#2)(2009-12#1)(2012-1#1)(2012-12#1)
and amplified by PCR using##3##5##(1992-9#1)(1995-11#1)(1995-8#1)
and amplified by##5##3##(1992-9#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-12#1)
and amplified fragment length polymorphism (AFLP) analyses##2##7##(2008-10#2)
and amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#1)(2008-7#1)
and amplified fragment length polymorphism (AFLP)##8##6##(2008-10#7)(2008-7#1)
and amplified fragment length polymorphism##15##5##(2008-10#14)(2008-7#1)
and amplified fragment length polymorphisms##2##5##(2008-10#2)
and amplified fragment length##17##4##(2008-10#16)(2008-7#1)
and amplified in##2##3##(2007-12#1)(2010-1#1)
and amplified spontaneous emission##2##4##(2007-12#1)(2008-2#1)
and amplified with##2##3##(2008-10#2)
and amplified##34##2##(1992-9#1)(1995-11#1)(1995-8#1)(2007-12#2)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-1#1)
and amplifier##3##2##(2007-11#2)(2008-3#1)
and amplitude noise##2##3##(2007-11#1)(2007-12#1)
and amplitude of the##2##4##(2008-3#1)(2009-12#1)
and amplitude of##6##3##(1993-12#1)(1995-12#1)(2008-2#1)(2008-3#2)(2009-12#1)
and amplitude##31##2##(1993-12#1)(1995-12#1)(2007-11#5)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#9)(2009-12#1)(2010-3#1)(2012-2#2)
and amplitudes of##3##3##(1995-2#1)(2008-8#2)
and amputation##2##2##(2008-6#1)(2008-8#1)
and amputations##2##2##(2008-1#1)(2013-8#1)
and amygdala##8##2##(1992-12#1)(1993-6#1)(1994-2#1)(1996-7#1)(1997-2#1)(2009-10#2)(2011-1#1)
and amygdaloid##2##2##(2008-10#1)(2012-1#1)
and amylase##3##2##(2008-10#2)(2008-11#1)
and amyloidosis##6##2##(1997-5#1)(1997-8#1)(2008-1#3)(2012-2#1)
and amylose##3##2##(1990-7#1)(1995-11#2)
and an 8 x 8##2##5##(2008-2#2)
and an 8##4##3##(2008-2#3)(2009-9#1)
and an Alternate Protocol##2##4##(2008-4#1)(2008-9#1)
and an N-terminal##2##3##(1991-6#1)(2012-12#1)
and an abdominal##2##3##(2010-10#1)(2013-1#1)
and an abnormal##3##3##(1994-12#1)(1997-3#1)(1997-8#1)
and an about##2##3##(1992-11#1)(2008-8#1)
and an absorption##2##3##(2008-3#2)
and an accumulation##2##3##(1995-2#1)(2008-10#1)
and an accuracy of##3##4##(2008-10#1)(2008-3#1)(2010-8#1)
and an accurate##6##3##(1992-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
and an acidic pH##2##4##(2008-10#1)(2008-11#1)
and an acidic##5##3##(1990-8#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
and an acousto-optic tunable filter##2##5##(2008-2#1)(2008-3#1)
and an acousto-optic##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and an activated##2##3##(1991-2#1)(2008-10#1)
and an active##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
and an acute##3##3##(1992-12#1)(1993-12#1)(2008-11#1)
and an adaptive##5##3##(2007-11#2)(2008-10#1)(2008-3#2)
and an additional##14##3##(1990-10#1)(1990-11#1)(1993-11#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
and an adjacent##2##3##(1992-3#1)(2007-12#1)
and an adult##2##3##(2008-9#1)(2009-5#1)
and an aging##2##3##(1993-12#1)(2007-12#1)
and an alanine##2##3##(1995-5#2)
and an algorithm##3##3##(2008-2#1)(2008-3#2)
and an alkaline##2##3##(1990-11#1)(2008-4#1)
and an alteration##2##3##(1993-9#1)(2008-5#1)
and an altered##2##3##(2008-11#1)(2008-5#1)
and an alternate protocol details variations in the procedure for proteins in nondenaturing gels##2##14##(2008-2#1)(2008-4#1)
and an alternate protocol##4##4##(2008-1#1)(2008-2#1)(2008-4#2)
and an alternative procedure##2##4##(2008-10#1)(2008-2#1)
and an alternative to##2##4##(2008-10#1)(2010-8#1)
and an alternative##6##3##(2007-12#1)(2008-10#3)(2008-2#1)(2010-8#1)
and an ammonium##2##3##(1994-6#1)(2008-7#1)
and an amperometric biosensor##2##4##(2008-10#2)
and an amperometric##3##3##(2008-10#3)
and an analysis of health care##2##6##(1994-1#1)(1995-12#1)
and an analysis of the##3##5##(1992-11#1)(2008-7#1)(2012-12#1)
and an analysis of##11##4##(1990-11#1)(1992-11#1)(1993-2#1)(1994-1#1)(1995-12#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
and an analysis##13##3##(1990-11#1)(1992-11#1)(1993-2#1)(1994-1#1)(1995-12#1)(2008-10#4)(2008-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
and an analytical throughput of##4##5##(2008-10#4)
and an analytical throughput##5##4##(2008-10#5)
and an analytical##8##3##(2008-10#6)(2008-3#1)(2013-1#1)
and an animal model##2##4##(2008-11#1)(2009-11#1)
and an animal##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
and an annual##4##3##(1992-9#1)(1994-12#1)(1996-1#1)(2008-6#1)
and an annular##2##3##(2007-12#2)
and an anodic##3##3##(2008-10#3)
and an antibody##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
and an antifungal##2##3##(2008-10#2)
and an apparent##2##3##(1992-11#1)(2008-9#1)
and an application##2##3##(1996-8#1)(2009-4#1)
and an appreciation of the##2##5##(2008-4#1)(2013-8#1)
and an appreciation of##3##4##(2007-12#1)(2008-4#1)(2013-8#1)
and an appropriate atmospheric stochastic model##2##6##(2008-2#1)(2008-3#1)
and an appropriate method##2##4##(2008-10#1)(2009-12#1)
and an appropriate##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
and an approximately##2##3##(1995-2#2)
and an aqueous##2##3##(2008-10#2)
and an arbitrarily##2##3##(2007-11#1)(2008-2#1)
and an artificial##2##3##(2008-10#1)(2008-5#1)
and an assessment of the##3##5##(1991-12#1)(1992-3#1)(2008-5#1)
and an assessment of##5##4##(1991-12#1)(1992-3#1)(2008-3#1)(2008-5#1)(2010-12#1)
and an assessment##6##3##(1991-12#1)(1992-3#1)(2008-3#2)(2008-5#1)(2010-12#1)
and an associated##5##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-5#1)
and an asymptotic##2##3##(2008-3#1)(2008-7#1)
and an aureolemeter##3##3##(2008-2#3)
and an automated##2##3##(1991-12#1)(1997-6#1)
and an average of##2##4##(2007-2#1)(2008-11#1)
and an average power of##3##5##(2007-12#2)(2008-2#1)
and an average recovery of##2##5##(2008-10#2)
and an average resolution of##2##5##(2013-8#2)
and an average##16##3##(1990-8#1)(1994-6#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-7#1)(2013-1#1)(2013-8#2)
and an effect of##2##4##(2008-3#1)(2010-5#1)
and an effective##4##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
and an efficient##5##3##(2008-10#3)(2008-2#1)(2008-5#1)
and an electrocardiogram##2##3##(1994-6#1)(2008-12#1)
and an electrode##2##3##(1993-8#1)(2012-2#1)
and an electrolyte##2##3##(1994-9#1)(2008-10#1)
and an elite##2##3##(2008-10#2)
and an emission wavelength of##3##5##(2008-10#3)
and an emission wavelength##4##4##(2008-10#4)
and an empirical##2##3##(2008-10#1)(2008-6#1)
and an enhanced##4##3##(1990-6#1)(2007-11#2)(2008-7#1)
and an enhancement##2##3##(2008-10#2)
and an enlarged##2##3##(2007-12#1)(2011-2#1)
and an environmental##2##3##(1991-12#1)(2007-6#1)
and an erbium-doped fiber amplifier##2##5##(2007-11#1)(2008-3#1)
and an erbium-doped##3##3##(2007-11#1)(2008-3#2)
and an error##2##3##(2008-2#1)(2008-3#1)
and an essential##3##3##(2008-5#2)(2008-9#1)
and an estimate of##2##4##(2008-3#1)(2008-6#1)
and an estimated##2##3##(2008-10#1)(2010-3#1)
and an evaluation of##4##4##(1990-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
and an evaluation##6##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
and an even##5##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
and an example is##3##4##(1995-9#1)(2008-3#1)(2008-8#1)
and an example of##3##4##(1992-1#1)(2008-10#1)(2008-2#1)
and an example##6##3##(1992-1#1)(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
and an excellent##4##3##(2008-10#1)(2008-2#2)(2009-7#1)
and an excess of##2##4##(2008-2#1)(2008-9#1)
and an experimental demonstration##2##4##(2007-11#1)(2008-2#1)
and an experimental verification##2##4##(2008-2#1)(2008-3#1)
and an experimental##8##3##(2007-11#1)(2008-2#2)(2008-3#4)(2011-2#1)
and an expert##2##3##(1990-2#1)(2012-3#1)
and an explanation of##2##4##(1996-12#1)(2012-2#1)
and an exponential##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
and an extended##2##3##(2008-10#1)(2009-5#1)
and an extensive##2##3##(1994-2#1)(2008-10#1)
and an external##4##3##(1992-1#1)(2007-12#2)(2008-3#1)
and an extreme##2##3##(2008-3#1)(2011-2#1)
and an extremely##2##3##(1993-6#1)(2007-11#1)
and an idler##2##3##(2008-3#2)
and an image##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
and an immobilized##2##3##(2008-10#2)
and an important cause of##3##5##(2007-8#1)(2008-5#1)(2013-1#1)
and an important##5##3##(1990-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
and an improved##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2012-12#1)
and an improvement in##2##4##(2008-10#1)(2008-11#1)
and an improvement##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
and an in##2##3##(1995-2#1)(2013-1#1)
and an in-depth##2##3##(1991-1#1)(2007-12#1)
and an incidence##2##3##(2008-2#1)(2013-8#1)
and an increase in blood##2##5##(1991-5#1)(2011-2#1)
and an increase in serum##2##5##(1997-8#1)(2009-6#1)
and an increase in the frequency of##2##7##(1992-12#1)(2010-6#1)
and an increase in the percentage of##2##7##(1992-8#1)(2011-2#1)
and an increase in the ratio##2##6##(1993-2#1)(2012-1#1)
and an increase in the##18##5##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)
and an increase in##48##4##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#2)(1996-6#1)(1997-2#2)(1997-8#3)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
and an increase of##4##4##(1994-12#1)(1994-3#1)(2008-5#1)(2012-2#1)
and an increase##52##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#2)(1996-6#1)(1997-2#2)(1997-8#3)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)
and an increased amount of##2##5##(2008-10#1)(2008-7#1)
and an increased level of##2##5##(2008-7#1)(2013-1#1)
and an increased risk of##2##5##(2008-10#1)(2013-1#1)
and an increased##23##3##(1991-2#1)(1994-5#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#2)
and an increasing number of##2##5##(1991-6#1)(2011-1#1)
and an increasing##5##3##(1991-6#2)(2011-1#1)(2011-2#2)
and an index mismatch##2##4##(2008-2#1)(2008-3#1)
and an index of##2##4##(2008-2#1)(2008-5#1)
and an index##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
and an indirect##2##3##(1992-5#1)(1994-8#1)
and an inflammatory##2##3##(1995-5#1)(2008-7#1)
and an inhibitor of##4##4##(1995-3#1)(1995-8#1)(2012-12#1)(2013-8#1)
and an inhibitor##5##3##(1992-9#1)(1995-3#1)(1995-8#1)(2012-12#1)(2013-8#1)
and an initial##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and an inner##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
and an instrumental##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
and an intact##2##3##(1991-7#1)(2011-3#1)
and an integrated##2##3##(1997-7#1)(2008-10#1)
and an integrative##2##3##(1992-2#1)(2008-1#1)
and an intensity##2##3##(2008-3#1)(2011-2#1)
and an interference microscope##2##4##(2008-3#2)
and an intermediate##2##3##(1993-8#1)(2008-3#1)
and an internal##2##3##(1992-8#1)(2008-11#1)
and an intervention##2##3##(1993-2#1)(2013-8#1)
and an intracavity##2##3##(2008-3#2)
and an intracellular##3##3##(1993-3#1)(2009-8#1)(2013-1#1)
and an introduction to##2##4##(2008-2#1)(2008-4#1)
and an ionic strength of 0##2##6##(2008-10#2)
and an ionic##3##3##(2008-10#3)
and an isolate##2##3##(2008-10#2)
and an iterative method##2##4##(2008-3#2)
and an iterative##6##3##(2008-3#5)(2013-1#1)
and an objective##2##3##(1992-8#1)(2008-3#1)
and an opportunity##2##3##(1991-3#1)(2008-12#1)
and an optical implementation##2##4##(2007-12#1)(2008-3#1)
and an optical##13##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)
and an optimization##2##3##(2007-11#1)(2008-3#1)
and an optimum##2##3##(2008-10#1)(2008-6#1)
and an oral##3##3##(2008-5#2)(2013-8#1)
and an organic solvent##2##4##(2008-10#1)(2008-7#1)
and an organic##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
and an original##3##3##(2008-3#2)(2010-10#1)
and an otherwise##2##3##(2007-12#1)(2013-1#1)
and an output##4##3##(2007-11#2)(2008-3#2)
and an overall##5##3##(1991-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)
and an understanding of the##2##5##(2008-8#1)(2010-10#1)
and an unidentified##6##3##(1992-2#1)(2008-10#4)(2008-5#1)
and an unknown##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
and an unmodified control were##2##5##(1990-7#1)(1993-11#1)
and an unpaired##2##3##(1993-6#1)(2007-12#1)
and an unusual##2##3##(1992-12#1)(1995-5#1)
and an update on##2##4##(1991-3#1)(2008-10#1)
and an##915##2##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#4)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#5)(1991-7#1)(1991-9#3)(1992-1#3)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#3)(1993-8#5)(1993-9#2)(1994-1#1)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#7)(1994-8#3)(1994-9#5)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#8)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#8)(2006-10#1)(2007-10#4)(2007-11#27)(2007-12#29)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#5)(2008-10#165)(2008-11#21)(2008-12#11)(2008-2#54)(2008-3#99)(2008-4#12)(2008-5#31)(2008-6#12)(2008-7#22)(2008-8#16)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#31)(2011-3#3)(2012-1#4)(2012-12#9)(2012-2#19)(2012-3#5)(2012-7#1)(2013-1#25)(2013-7#2)(2013-8#15)
and anaemia##4##2##(1990-11#1)(2008-5#1)(2009-7#1)(2011-1#1)
and anaerobic sealants##2##3##(2008-9#2)
and anaerobic##10##2##(1991-2#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)(2013-8#2)
and anaesthesia##3##2##(2006-10#1)(2008-6#1)(2009-5#1)
and anaesthetic##2##2##(1996-6#1)(2008-8#1)
and anal##9##2##(1996-11#1)(1996-8#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and analgesia##10##2##(1993-12#2)(2008-10#1)(2008-8#5)(2011-2#2)
and analgesic effects of##2##4##(1990-5#1)(2013-1#1)
and analgesic effects##3##3##(1990-5#1)(2010-7#1)(2013-1#1)
and analgesic##8##2##(1990-5#1)(2007-11#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
and analgesics##2##2##(2008-10#1)(2008-7#1)
and analgetics##3##2##(1995-11#2)(2007-11#1)
and analog##2##2##(2008-2#1)(2011-1#1)
and analogs##2##2##(1993-11#1)(2008-8#1)
and analogues##5##2##(1992-12#1)(1997-7#2)(2007-11#1)(2008-10#1)
and analyse the##4##3##(1992-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
and analyse##9##2##(1992-5#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
and analysed by##7##3##(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-3#1)(2012-3#1)
and analysed for##6##3##(1994-2#1)(1995-8#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
and analysed the##4##3##(1990-3#1)(1996-12#1)(2008-12#1)(2011-10#1)
and analysed using the##2##4##(1994-5#1)(2008-11#1)
and analysed using##6##3##(1994-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-4#1)
and analysed with content##2##4##(2008-11#1)(2013-1#1)
and analysed##48##2##(1990-3#1)(1991-5#1)(1991-6#1)(1994-2#1)(1994-5#1)(1995-8#2)(1996-12#1)(1996-3#2)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-10#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and analyses of the##2##4##(1996-5#1)(2008-10#1)
and analyses of##10##3##(1991-2#1)(1993-1#1)(1996-5#1)(2008-10#4)(2010-4#1)(2011-1#1)(2012-12#1)
and analyses##12##2##(1991-2#1)(1993-1#1)(1994-3#1)(1996-5#1)(2008-10#4)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
and analysing##7##2##(1994-9#2)(2008-10#1)(2008-11#1)(2011-3#1)(2013-1#2)
and analysis are##2##3##(2008-10#2)
and analysis at##2##3##(2010-5#1)(2012-5#1)
and analysis based on##2##4##(2008-11#1)(2009-5#1)
and analysis by##2##3##(2008-10#1)(2008-11#1)
and analysis for##3##3##(1996-1#1)(2007-11#1)(2008-2#1)
and analysis in the##2##4##(2008-3#1)(2008-5#1)
and analysis in##4##3##(1994-3#1)(1995-5#1)(2008-3#1)(2008-5#1)
and analysis methods##2##3##(2008-12#1)(2009-12#1)
and analysis of a##10##4##(1991-6#1)(1993-12#1)(1994-12#1)(1996-10#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#2)
and analysis of certified reference material##2##6##(2008-10#2)
and analysis of its##3##4##(2008-11#1)(2008-8#2)
and analysis of large-scale##2##4##(2008-4#1)(2013-1#1)
and analysis of molecular##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
and analysis of proteins modified by##3##6##(2008-2#2)(2008-4#1)
and analysis of proteins##4##4##(2008-2#2)(2008-4#1)(2008-9#1)
and analysis of the DNA##2##5##(1993-6#1)(1997-4#1)
and analysis of the clinical##2##5##(1993-12#1)(2007-8#1)
and analysis of the##18##4##(1990-7#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)
and analysis of##117##3##(1990-7#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1995-12#1)(1995-2#4)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#8)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#8)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
and analysis procedure##2##3##(2008-10#1)(2008-9#1)
and analysis techniques##2##3##(2008-10#2)
and analysis time##4##3##(2008-10#4)
and analysis tools##3##3##(2009-10#1)(2011-3#1)(2012-3#1)
and analysis with##5##3##(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
and analysis##204##2##(1990-7#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#32)(2008-11#10)(2008-12#6)(2008-2#11)(2008-3#9)(2008-4#15)(2008-5#2)(2008-7#7)(2008-8#7)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#6)
and analyte concentration##3##3##(2008-10#3)
and analyte##9##2##(2008-10#9)
and analytic##9##2##(1996-2#3)(2007-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-5#1)(2013-1#1)
and analytical application of##3##4##(2008-10#3)
and analytical application##4##3##(2008-10#4)
and analytical applications of##4##4##(2008-10#4)
and analytical applications##6##3##(2008-10#6)
and analytical development##3##3##(2010-12#1)(2012-2#2)
and analytical figures of merit##2##5##(2008-10#2)
and analytical methods##3##3##(2008-10#1)(2008-5#1)(2011-3#1)
and analytical parameters of##2##4##(2008-10#2)
and analytical parameters were##3##4##(2008-10#3)
and analytical parameters##8##3##(2008-10#8)
and analytical performances##2##3##(2008-10#2)
and analytical results##2##3##(1995-2#1)(2008-10#1)
and analytical sensitivity##3##3##(2008-10#3)
and analytical studies##2##3##(2008-7#1)(2010-3#1)
and analytical tools##2##3##(2008-10#1)(2008-8#1)
and analytical##66##2##(1990-11#1)(1990-12#1)(1995-11#1)(1995-2#2)(1997-3#1)(2008-10#42)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
and analytically##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2013-1#2)
and analyze a##7##3##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
and analyze data##2##3##(1997-3#1)(2008-1#1)
and analyze the##11##3##(1991-5#1)(1992-5#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
and analyze##45##2##(1991-5#1)(1992-5#1)(1995-12#1)(1995-3#1)(1996-3#3)(1997-1#2)(1997-3#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)(2013-1#1)
and analyzed as##2##3##(1992-1#1)(2008-3#1)
and analyzed by HPLC##2##4##(1993-11#1)(2009-8#1)
and analyzed by a##3##4##(1990-8#2)(2013-1#1)
and analyzed by means of##2##5##(2009-10#1)(2011-1#1)
and analyzed by the##4##4##(2008-10#2)(2012-3#1)(2013-8#1)
and analyzed by use of a##2##6##(2007-11#1)(2008-3#1)
and analyzed by use of##3##5##(2007-11#1)(2008-3#2)
and analyzed by##36##3##(1990-8#2)(1993-11#1)(1993-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
and analyzed for the##3##4##(1992-3#1)(2008-2#1)(2012-3#1)
and analyzed for their ability to##2##6##(1997-3#1)(2007-11#1)
and analyzed for their##4##4##(1996-12#1)(1997-3#1)(2007-11#1)(2012-3#1)
and analyzed for##11##3##(1992-3#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-3#2)
and analyzed in a##3##4##(2008-12#2)(2009-2#1)
and analyzed in##6##3##(1993-6#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-2#1)
and analyzed on##2##3##(2006-6#1)(2011-7#1)
and analyzed statistically##2##3##(2008-10#1)(2008-11#1)
and analyzed the##6##3##(1990-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
and analyzed their##2##3##(2008-11#2)
and analyzed to identify##2##4##(1995-1#1)(2008-12#1)
and analyzed to##9##3##(1995-1#1)(2007-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2013-1#2)
and analyzed using a##3##4##(2008-3#1)(2009-5#1)(2012-3#1)
and analyzed using##14##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
and analyzed with##5##3##(1990-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
and analyzed##151##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#7)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-7#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
and analyzes the##5##3##(2008-1#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-8#1)
and analyzes##8##2##(2007-8#1)(2008-1#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
and analyzing data##2##3##(1997-2#1)(2012-3#1)
and analyzing the##6##3##(1994-8#2)(2008-10#2)(2008-4#1)(2008-9#1)
and analyzing##25##2##(1993-8#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#2)(2008-10#3)(2008-4#5)(2008-9#3)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)
and anastomosed##2##2##(2008-10#1)(2013-1#1)
and anastomosis##3##2##(1991-6#1)(2010-12#1)(2010-8#1)
and anastomotic##3##2##(2011-2#1)(2013-7#2)
and anatomic characteristics##2##3##(2008-10#2)
and anatomic##5##2##(2007-10#1)(2008-10#2)(2010-6#1)(2011-2#1)
and anatomical##12##2##(1995-11#2)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
and anatomo-pathological##2##2##(1993-3#1)(1996-6#1)
and anatomopathological##2##2##(1990-5#1)(2008-5#1)
and anatomy##4##2##(2007-8#1)(2008-7#2)(2012-12#1)
and ancestral##2##2##(2008-10#1)(2010-6#1)
and anchor##2##2##(1995-6#1)(2008-7#1)
and anchoring##4##2##(2009-10#4)
and ancient##4##2##(1995-3#1)(1995-6#1)(2008-10#1)(2008-12#1)
and ancillary##2##2##(1992-1#1)(2006-10#1)
and and##4##2##(1995-12#1)(2012-12#1)(2013-1#2)
and androgen##10##2##(1993-8#1)(2008-4#4)(2008-6#2)(2011-1#2)(2012-12#1)
and androgens##4##2##(1996-5#1)(2008-11#1)(2009-4#1)(2012-3#1)
and anecdotal##2##2##(2011-2#1)(2013-1#1)
and anemia##6##2##(2007-12#1)(2008-1#1)(2008-10#2)(2010-6#1)(2012-2#1)
and anemic##2##2##(1991-4#1)(2012-2#1)
and anesthesia##6##2##(1990-7#1)(1993-1#1)(1993-12#1)(2010-8#1)(2012-3#2)
and anesthesia-related##2##2##(2010-8#2)
and anesthetic##3##2##(2011-2#2)(2012-2#1)
and aneuploidy##4##2##(2008-7#1)(2012-3#2)(2013-1#1)
and aneurysm formation##2##3##(1997-8#1)(2007-8#1)
and aneurysms##2##2##(2008-7#1)(2011-2#1)
and angelicin##2##2##(2008-11#2)
and anger##4##2##(1995-12#1)(2008-12#2)(2008-4#1)
and angiogenesis in##2##3##(2009-1#1)(2010-1#1)
and angiogenesis of##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
and angiogenesis##11##2##(2008-11#3)(2009-1#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)
and angiogenic##2##2##(2008-1#1)(2008-7#1)
and angiographic##6##2##(1994-9#1)(1996-9#1)(1997-8#1)(2008-11#1)(2008-7#1)(2009-7#1)
and angioplasties##2##2##(1991-8#1)(2011-2#1)
and angioplasty##5##2##(1991-5#1)(1997-8#1)(2011-2#3)
and angiotensin II##4##3##(1996-2#3)(1996-6#1)
and angiotensin converting enzyme##3##4##(1991-3#1)(2007-8#1)(2008-1#1)
and angiotensin##11##2##(1991-3#1)(1994-3#3)(1996-2#3)(1996-6#1)(1997-7#1)(2007-8#1)(2008-1#1)
and angiotensin-converting enzyme##2##3##(1993-8#1)(2008-3#1)
and angiotensinogen##3##2##(1995-6#1)(2008-10#1)(2008-3#1)
and angle of##2##3##(2008-2#1)(2008-3#1)
and angle##5##2##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
and angles##2##2##(1992-4#1)(2008-3#1)
and angular distribution of##3##4##(2008-10#2)(2008-3#1)
and angular distribution##5##3##(2008-10#4)(2008-3#1)
and angular tilt##2##3##(2008-3#2)
and angular##22##2##(2007-11#4)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#8)(2011-2#1)(2013-1#1)
and aniline##3##2##(1991-5#1)(2008-10#2)
and animal cells##4##3##(1994-12#1)(1994-6#1)(2008-2#1)(2008-4#1)
and animal health##4##3##(2007-2#1)(2008-10#1)(2012-1#1)(2013-1#1)
and animal models of##2##4##(2008-7#1)(2010-5#1)
and animal models##9##3##(1996-12#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-12#1)(2010-5#1)(2012-2#1)
and animal studies##5##3##(1995-9#1)(2007-4#1)(2008-11#1)(2008-6#1)(2012-12#1)
and animal##67##2##(1990-8#1)(1991-2#1)(1994-12#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
and animals##33##2##(1990-5#2)(1991-8#1)(1993-11#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#3)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#3)
and anion exchange##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
and anion##8##2##(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)
and anion-exchange##2##2##(2008-10#2)
and anionic species##3##3##(2008-10#3)
and anionic surfactants##2##3##(2008-10#2)
and anionic##14##2##(1990-5#1)(1991-7#1)(1994-12#1)(2008-10#10)(2008-4#1)
and anions in##4##3##(2008-10#4)
and anions on the determination of##2##6##(2008-10#2)
and anions on the##3##4##(2008-10#3)
and anions on##5##3##(2008-10#5)
and anions were##3##3##(2008-10#3)
and anions##34##2##(2008-10#34)
and anisotropic scattering##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
and anisotropic##10##2##(2008-10#2)(2008-2#2)(2008-3#5)(2009-7#1)
and anisotropy##6##2##(2008-10#4)(2008-3#1)(2008-4#1)
and ankle##24##2##(2008-12#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#7)(2012-3#1)(2013-1#1)
and ankles##3##2##(1996-9#1)(2006-10#1)(2009-4#1)
and ankylosing spondylitis##4##3##(2010-12#3)(2012-3#1)
and ankylosis in##2##3##(2011-2#2)
and ankylosis##3##2##(2011-2#3)
and annotation##30##2##(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-2#25)
and annual seroconversion##2##3##(2007-7#2)
and annual##11##2##(1996-2#1)(1997-2#1)(2007-7#2)(2008-10#1)(2008-5#4)(2009-11#1)(2009-4#1)
and anodic stripping voltammetry##4##4##(2008-10#4)
and anodic stripping##5##3##(2008-10#5)
and anodic##7##2##(2008-10#6)(2013-1#1)
and anomalous##5##2##(1995-3#1)(2007-11#2)(2008-12#1)(2012-2#1)
and anorexia##6##2##(1991-1#1)(1993-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2012-3#1)
and anorthite##2##2##(2013-8#2)
and another at the##2##4##(2007-12#1)(2008-3#1)
and another for##4##3##(1997-7#1)(2008-11#1)(2008-3#2)
and another group##2##3##(1990-2#1)(2008-5#1)
and another had##2##3##(1990-3#1)(1991-12#1)
and another method##2##3##(2008-4#1)(2008-9#1)
and another of##4##3##(1993-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
and another one for##2##4##(2008-11#1)(2011-2#1)
and another one##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and another that is##2##4##(2008-2#1)(2008-3#1)
and another that##3##3##(1992-8#1)(2008-2#1)(2008-3#1)
and another two##3##3##(1996-12#1)(2007-7#1)(2007-8#1)
and another using##2##3##(1993-9#1)(2008-10#1)
and another with##3##3##(1995-5#1)(2010-8#1)(2011-1#1)
and another##72##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
and anoxic##2##2##(1992-3#1)(1992-9#1)
and answered##3##2##(2007-12#1)(2007-5#1)(2013-1#1)
and answers##5##2##(1993-3#1)(1996-2#1)(2008-11#2)(2011-2#1)
and antagonist##3##2##(1993-3#1)(1997-7#1)(2013-8#1)
and antagonistic activity##2##3##(2008-10#2)
and antagonistic interactions##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
and antagonistic##11##2##(1995-5#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and antagonists of the androgen receptor##2##6##(1995-3#2)
and antagonists of##3##3##(1993-1#1)(1995-3#2)
and antagonists##14##2##(1991-1#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)
and antegrade##2##2##(2007-9#2)
and anterior cingulate cortex##2##4##(2008-10#1)(2008-11#1)
and anterior cingulate##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
and anterior to##2##3##(2008-7#1)(2011-2#1)
and anterior##25##2##(1992-8#1)(1993-12#1)(1993-5#1)(1994-8#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#4)
and anterolateral##4##2##(2010-5#1)(2010-7#1)(2011-2#2)
and anteromedial##2##2##(2008-9#1)(2011-2#1)
and anthracnose##4##2##(2008-10#4)
and anthropogenic##3##2##(2007-5#1)(2008-11#1)(2008-12#1)
and anthropometric data##2##3##(1993-12#1)(2013-1#1)
and anthropometric measurements##2##3##(2008-7#1)(2013-8#1)
and anthropometric##7##2##(1993-12#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and anthropometry##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
and anti##6##2##(1990-6#1)(1993-12#1)(1996-5#1)(2008-5#1)(2010-1#1)(2012-2#1)
and anti-CD28##2##2##(2008-4#2)
and anti-HCV##4##2##(2007-7#1)(2008-1#2)(2013-8#1)
and anti-HIV##2##2##(2008-10#1)(2009-8#1)
and anti-IgE##2##2##(2008-11#1)(2012-12#1)
and anti-Stokes fluorescence##2##3##(2008-3#2)
and anti-Stokes##6##2##(2007-1#1)(2007-11#2)(2008-3#3)
and anti-TNF-alpha##2##2##(1996-12#1)(2008-10#1)
and anti-TNP antibody##2##3##(2008-10#2)
and anti-angiogenic##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
and anti-apoptotic##6##2##(2009-12#2)(2010-10#1)(2012-12#1)(2012-2#2)
and anti-cancer##2##2##(2008-11#1)(2010-7#1)
and anti-dsDNA##2##2##(2011-2#2)
and anti-hyaluronidase##2##2##(2008-5#2)
and anti-inflammatory activities##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
and anti-inflammatory effect##2##3##(1990-6#1)(2009-12#1)
and anti-inflammatory effects##3##3##(2008-1#1)(2008-3#1)(2013-1#1)
and anti-inflammatory properties##3##3##(1995-11#1)(2008-10#1)(2009-6#1)
and anti-inflammatory##18##2##(1990-5#1)(1990-6#1)(1995-11#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-12#1)(2009-6#1)(2011-1#3)(2012-2#1)(2013-1#2)(2013-7#1)
and anti-microsomal antibodies##2##3##(1991-8#1)(2008-7#1)
and anti-oxidation##2##2##(2010-12#1)(2011-3#1)
and anti-thrombotic##2##2##(2008-10#1)(2010-12#1)
and antibacterial activity of##4##4##(2007-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
and antibacterial##6##2##(1992-11#1)(2007-11#1)(2008-12#1)(2008-5#2)(2012-3#1)
and antibiotic production##2##3##(2008-10#1)(2008-8#1)
and antibiotic resistance##3##3##(1991-3#1)(2008-3#1)(2012-3#1)
and antibiotic susceptibility##5##3##(2007-12#1)(2008-12#1)(2012-12#2)(2012-3#1)
and antibiotic treatment##2##3##(2008-12#1)(2008-9#1)
and antibiotic##23##2##(1991-3#1)(1995-3#1)(1996-6#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
and antibiotic-resistant bacteria##2##3##(2012-2#2)
and antibiotics have been##2##4##(2008-8#1)(2012-3#1)
and antibiotics##10##2##(1991-3#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)
and antibodies to##2##3##(1996-2#1)(2013-7#1)
and antibodies##9##2##(1990-12#1)(1992-12#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-7#1)
and antibody assays##2##3##(2013-1#1)(2013-8#1)
and antibody production in##4##4##(2008-11#4)
and antibody production##10##3##(1994-2#1)(2008-11#8)(2012-12#1)
and antibody##24##2##(1992-6#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-6#1)(2008-10#2)(2008-11#10)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and anticancer##2##2##(2011-2#1)(2013-1#1)
and anticheater adaptations##2##3##(2008-8#2)
and anticipate##4##2##(1995-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
and anticipated##5##2##(1992-1#1)(1992-2#2)(2007-12#1)(2008-4#1)
and anticipatory##3##2##(1992-1#1)(2008-11#1)(2010-8#1)
and anticoagulant##5##2##(1996-6#1)(1996-8#1)(2008-3#1)(2008-8#1)(2013-1#1)
and anticonvulsant effects of NBQX##2##5##(1994-2#2)
and anticonvulsant effects of##3##4##(1994-2#2)(1995-12#1)
and anticonvulsant##5##2##(1991-1#1)(1994-2#3)(1995-12#1)
and antidepressants##3##2##(1996-7#1)(2010-7#1)(2013-1#1)
and antiemetic##4##2##(2012-2#4)
and antifouling##2##2##(2008-10#2)
and antifungal activities in##2##4##(2008-10#1)(2011-1#1)
and antifungal activities##6##3##(2008-10#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
and antifungal activity of a##2##5##(1997-6#1)(2009-2#1)
and antifungal activity##4##3##(1997-6#1)(2008-10#1)(2009-2#1)(2012-2#1)
and antifungal agents##2##3##(2007-8#1)(2010-3#1)
and antifungal##18##2##(1997-6#1)(2007-8#1)(2008-10#7)(2008-5#1)(2009-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
and antigen##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-5#1)
and antigen-coated##2##2##(1995-12#1)(2008-9#1)
and antigen-presenting##3##2##(1995-5#1)(2008-8#1)(2012-2#1)
and antigen-specific##2##2##(2006-10#1)(2008-4#1)
and antigenic##9##2##(1995-11#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-12#1)
and antigenicity##3##2##(1991-8#1)(1997-6#1)(2008-10#1)
and antigens##2##2##(2008-10#1)(2008-4#1)
and antihistamines##2##2##(1990-3#1)(2008-7#1)
and antihyperlipidemic effects##2##3##(2012-2#2)
and antihyperlipidemic##5##2##(2011-1#1)(2012-2#3)(2013-1#1)
and antihypertensive##2##2##(1992-8#1)(2011-2#1)
and antimicrobial activity of##2##4##(2007-11#1)(2013-1#1)
and antimicrobial evaluation of new##2##5##(2012-3#2)
and antimicrobial evaluation of##3##4##(2012-3#3)
and antimicrobial evaluation##4##3##(2007-11#1)(2012-3#3)
and antimicrobial properties##2##3##(2013-1#2)
and antimicrobial resistance##2##3##(2012-3#1)(2013-8#1)
and antimicrobial susceptibility##4##3##(2008-9#1)(2009-5#1)(2013-1#2)
and antimicrobial##23##2##(1990-6#1)(1991-2#1)(1994-2#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-7#1)(2012-3#4)(2013-1#5)(2013-8#1)
and antimony##5##2##(2008-10#4)(2010-5#1)
and antimycotic activity##3##3##(2008-5#3)
and antimycotic##4##2##(2008-5#3)(2011-2#1)
and antineoplastic drugs##2##3##(2007-11#2)
and antineoplastic##3##2##(2007-11#2)(2012-12#1)
and antinutrient##2##2##(2010-2#2)
and antioxidant activities##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
and antioxidant activity##2##3##(2012-2#1)(2013-1#1)
and antioxidant capacity##2##3##(2008-10#2)
and antioxidant defense##3##3##(1996-9#1)(2008-1#1)(2013-1#1)
and antioxidant enzymes##2##3##(2008-5#1)(2011-1#1)
and antioxidant potential##2##3##(2008-10#2)
and antioxidant status in##2##4##(2008-12#1)(2008-7#1)
and antioxidant status##4##3##(2008-12#2)(2008-7#1)(2009-9#1)
and antioxidant##30##2##(1992-9#1)(1996-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#5)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
and antioxidants##13##2##(1991-9#1)(1992-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#4)(2013-8#1)
and antioxidation##2##2##(2008-5#1)(2013-1#1)
and antiphospholipid antibodies##4##3##(2006-10#2)(2008-7#1)(2010-6#1)
and antiphospholipid##7##2##(2006-10#2)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
and antiplatelet agents##2##3##(1993-9#1)(2011-1#1)
and antiproliferative activity##2##3##(1997-1#1)(2008-8#1)
and antiproliferative##3##2##(1997-1#1)(2008-8#1)(2012-3#1)
and antipsychotic medication##2##3##(2008-6#1)(2009-7#1)
and antipsychotic##3##2##(2008-6#1)(2009-7#1)(2010-1#1)
and antireflection coating##2##3##(2008-2#1)(2008-3#1)
and antireflection-coated##2##2##(2008-2#1)(2008-3#1)
and antisense oligodeoxynucleotides##2##3##(1992-6#1)(2008-11#1)
and antisense##12##2##(1992-6#1)(1993-3#1)(1994-11#2)(1996-9#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
and antiserum##2##2##(1991-8#1)(2012-3#1)
and antisocial behavior##3##3##(1994-2#1)(2008-11#1)(2009-5#1)
and antithrombin##3##2##(2008-3#1)(2010-3#2)
and antithrombotic##2##2##(2008-5#1)(2013-8#1)
and antitumor efficacy##2##3##(1995-3#1)(2012-12#1)
and antitumor##4##2##(1995-3#1)(2007-11#1)(2008-8#1)(2012-12#1)
and antiviral##3##2##(1994-8#1)(2008-5#1)(2010-2#1)
and antral##3##2##(1995-11#1)(2008-8#2)
and ants##2##2##(2008-5#2)
and anuria##2##2##(1993-9#1)(2008-12#1)
and anus##2##2##(2010-4#1)(2011-2#1)
and anxieties of##3##3##(1991-3#1)(1995-12#1)(2011-2#1)
and anxieties##6##2##(1991-3#1)(1995-12#1)(2011-2#4)
and anxiety and##2##3##(2010-8#1)(2012-1#1)
and anxiety disorders##4##3##(1993-2#1)(2008-7#1)(2009-10#1)(2010-2#1)
and anxiety to##2##3##(2008-11#1)(2010-12#1)
and anxiety were##3##3##(2007-6#1)(2010-8#1)(2013-1#1)
and anxiety##29##2##(1990-12#1)(1992-12#1)(1992-5#1)(1993-2#1)(1995-1#3)(2007-6#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2012-1#2)(2013-1#1)(2013-7#3)(2013-8#1)
and anxious##6##2##(1992-2#1)(2007-6#3)(2008-5#1)(2009-12#1)
and any number of##2##4##(2008-3#1)(2008-7#1)
and any of the sleep##2##5##(1996-7#1)(2011-2#1)
and any of##5##3##(1996-7#1)(2008-10#1)(2008-7#1)(2011-2#2)
and any##33##2##(1990-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
and aorta##3##2##(1994-11#1)(2008-10#1)(2009-12#1)
and aortic arch##5##3##(2007-8#2)(2009-7#1)(2011-2#1)(2013-8#1)
and aortic##10##2##(1993-3#1)(2007-8#4)(2008-10#1)(2009-7#1)(2011-2#2)(2013-8#1)
and apatite##3##2##(2008-10#1)(2009-7#2)
and aperture##2##2##(2008-2#1)(2008-3#1)
and apex##3##2##(2008-6#1)(2009-2#2)
and aphid##2##2##(2008-10#2)
and apical meristem explants##2##4##(2008-12#2)
and apical meristem##3##3##(2008-12#3)
and apical##11##2##(2008-10#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
and apixaban were##2##3##(2012-12#2)
and apixaban##3##2##(2012-12#3)
and apo##6##2##(1990-8#2)(1992-6#2)(1993-12#1)(1993-6#1)
and apo(a)##2##2##(1992-3#1)(1993-2#1)
and apoA-IV-3 are##2##3##(1990-8#1)(1991-8#1)
and apoB##3##2##(1992-3#3)
and apoE##2##2##(2009-8#2)
and apolipoprotein B##2##3##(1990-12#1)(1995-12#1)
and apolipoprotein##5##2##(1990-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(2008-6#1)
and apolipoproteins##5##2##(1990-12#1)(1993-12#2)(1993-6#2)
and apomorphine-induced##2##2##(1992-12#1)(1995-12#1)
and apoprotein(a)##2##2##(1994-11#2)
and apoptosis after##2##3##(2008-10#1)(2011-2#1)
and apoptosis in##6##3##(2008-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
and apoptosis of the##2##4##(2008-8#1)(2011-2#1)
and apoptosis of##7##3##(1993-3#2)(2008-8#1)(2011-2#3)(2013-1#1)
and apoptosis was##5##3##(1994-6#1)(1995-2#2)(2011-2#1)(2011-3#1)
and apoptosis##77##2##(1993-2#1)(1993-3#3)(1994-10#1)(1994-6#1)(1995-2#5)(1995-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#9)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#5)
and apoptotic cell death##2##4##(1996-2#1)(2012-12#1)
and apoptotic cells##4##3##(1995-2#3)(2008-9#1)
and apoptotic effects##2##3##(2011-2#1)(2013-1#1)
and apoptotic##17##2##(1995-2#4)(1995-6#1)(1996-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
and apothecia##5##2##(2008-10#5)
and apparatus##2##2##(2008-10#1)(2010-5#1)
and apparent competition##2##3##(2008-8#1)(2008-9#1)
and apparent##12##2##(1990-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
and apparently##11##2##(1990-3#1)(1991-2#1)(1992-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(2008-10#2)(2008-7#2)(2013-7#1)
and appear in##2##3##(2008-7#1)(2009-9#1)
and appear to be##4##4##(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
and appear to##6##3##(1995-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#2)
and appear##13##2##(1991-1#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)
and appearance of##7##3##(2007-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
and appearance##13##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and appeared as##2##3##(1990-5#1)(2008-10#1)
and appeared in##2##3##(1995-3#1)(2010-10#1)
and appeared to be##5##4##(1990-5#1)(1995-3#1)(1997-2#1)(2009-12#1)(2013-1#1)
and appeared to##9##3##(1990-5#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#1)
and appeared##17##2##(1990-5#2)(1995-3#2)(1996-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-6#2)(2008-8#1)(2009-12#1)(2010-10#1)(2011-1#1)(2013-1#1)
and appears as a##2##4##(1991-12#1)(2012-2#1)
and appears to be a##2##5##(1997-3#1)(2008-5#1)
and appears to be##10##4##(1991-12#1)(1992-10#1)(1994-1#1)(1994-10#1)(1994-11#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
and appears to##21##3##(1991-12#1)(1992-10#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#2)
and appears##26##2##(1991-12#2)(1992-10#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#2)
and appetite##6##2##(1997-8#1)(2008-3#1)(2009-5#1)(2012-1#1)(2013-8#2)
and apple##20##2##(2008-10#20)
and apples##2##2##(2008-10#2)
and applicability of the##5##4##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
and applicability of##8##3##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#2)(2013-1#1)
and applicability to##4##3##(2008-10#3)(2008-3#1)
and applicability##14##2##(1991-12#1)(1996-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-3#1)(2011-2#3)(2013-1#1)
and applicable to a##2##4##(2008-11#1)(2008-3#1)
and applicable##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
and application for##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
and application in##3##3##(2008-10#2)(2008-7#1)
and application of a##14##4##(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2011-3#2)(2012-2#1)
and application of adhesive##2##4##(2008-12#2)
and application of an electrode##2##5##(2008-10#2)
and application of an##4##4##(1997-1#1)(2008-10#3)
and application of the##4##4##(2008-10#1)(2008-3#2)(2012-3#1)
and application of these##2##4##(1992-3#1)(2007-12#1)
and application of##74##3##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#2)(2008-10#27)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-7#1)
and application to the##2##4##(2008-3#1)(2008-7#1)
and application to##10##3##(2007-12#1)(2008-10#2)(2008-3#4)(2008-7#1)(2012-3#1)(2012-8#1)
and application##106##2##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#3)(2008-10#37)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2010-11#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#7)(2012-8#1)(2013-7#1)
and application-oriented factors##2##3##(2008-10#2)
and applications for##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
and applications in##5##3##(1994-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
and applications of a##2##4##(2008-10#1)(2008-2#1)
and applications of the##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
and applications of##20##3##(1993-3#1)(1996-3#2)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-3#1)(2012-3#2)(2013-1#1)
and applications to##6##3##(1994-9#1)(2008-12#1)(2008-3#2)(2013-1#2)
and applications##66##2##(1992-12#1)(1993-12#1)(1993-3#2)(1994-2#2)(1994-9#1)(1996-2#1)(1996-3#2)(1997-1#1)(2007-11#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
and applied a##2##3##(2009-3#1)(2012-3#1)
and applied as a##2##4##(2008-10#2)
and applied as##3##3##(2008-10#2)(2012-5#1)
and applied aspects of##2##4##(1997-6#1)(2008-5#1)
and applied for the determination of##5##6##(2008-10#5)
and applied for the##7##4##(2008-10#7)
and applied for##9##3##(2008-10#9)
and applied in the##2##4##(2008-10#1)(2011-1#1)
and applied in##6##3##(2007-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-1#1)
and applied it to##2##4##(2007-11#1)(2008-3#1)
and applied potential##3##3##(2008-10#3)
and applied the##2##3##(2008-10#2)
and applied them to##2##4##(1992-3#1)(2011-1#1)
and applied to an##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
and applied to the analysis of##2##6##(1995-3#1)(2008-10#1)
and applied to the determination of the##2##7##(2008-10#1)(2009-8#1)
and applied to the determination of##7##6##(2008-10#5)(2008-3#1)(2009-8#1)
and applied to the##22##4##(1994-12#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-5#1)(2009-8#1)
and applied to##45##3##(1994-12#2)(1995-3#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#1)(2009-8#1)(2011-1#1)(2012-1#1)
and applied voltage on##2##4##(2008-10#2)
and applied voltage were##2##4##(2008-10#2)
and applied voltage##5##3##(2008-10#4)(2010-4#1)
and applied##98##2##(1992-3#1)(1994-12#2)(1995-3#2)(1996-2#1)(1996-5#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#49)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#9)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)
and applies##2##2##(1992-12#1)(2010-8#1)
and apply a##3##3##(2008-10#3)
and apply it to##3##4##(2007-11#1)(2008-2#1)(2008-9#1)
and apply the##4##3##(1992-3#1)(1997-2#1)(2008-5#1)(2013-1#1)
and apply them##2##3##(1991-1#1)(1993-12#1)
and apply##20##2##(1991-1#1)(1992-3#1)(1993-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and applying the##5##3##(1992-2#1)(1993-12#1)(1996-2#1)(2008-5#1)(2009-3#1)
and applying##17##2##(1992-2#1)(1993-12#2)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
and appraisal of the##2##4##(1991-1#1)(2013-8#1)
and appraisal of##4##3##(1991-1#1)(1994-12#1)(2007-8#1)(2013-8#1)
and appraisal##5##2##(1991-1#1)(1994-12#1)(2007-7#1)(2007-8#1)(2013-8#1)
and appraise their##2##3##(1992-3#1)(2008-1#1)
and appraised##3##2##(1994-2#1)(2008-10#2)
and appreciation for##2##3##(2008-8#1)(2009-8#1)
and appreciation of the##2##4##(2008-6#1)(2009-8#1)
and appreciation of##6##3##(2008-1#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-8#1)(2013-1#1)
and appreciation##8##2##(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-8#1)(2013-1#1)
and appressoria##5##2##(2008-10#5)
and appressorial##2##2##(2008-10#2)
and appressorium formation were##2##4##(2008-10#2)
and appressorium formation##6##3##(2008-10#6)
and appressorium##7##2##(2008-10#6)(2009-8#1)
and approach##4##2##(1994-12#1)(2011-1#2)(2011-3#1)
and approached##3##2##(1993-1#1)(2008-10#2)
and approaches for##3##3##(1992-1#1)(1997-2#1)(1997-3#1)
and approaches that##2##3##(2010-12#1)(2010-8#1)
and approaches to##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
and approaches##21##2##(1992-1#1)(1994-6#1)(1995-3#2)(1997-2#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
and appropriate therapy##2##3##(2008-8#1)(2010-1#1)
and appropriate treatment##4##3##(2008-12#1)(2008-9#1)(2010-8#1)(2013-1#1)
and appropriate##51##2##(1990-8#1)(1991-12#1)(1991-8#1)(1993-3#1)(1993-8#1)(1995-2#1)(1997-2#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
and appropriately treat##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
and appropriately##5##2##(2008-3#2)(2011-10#1)(2013-1#1)(2013-8#1)
and appropriateness of##4##3##(2009-6#1)(2013-1#3)
and appropriateness##7##2##(1993-1#1)(2009-4#2)(2009-6#1)(2013-1#3)
and approval of##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
and approval##5##2##(2008-7#1)(2009-5#1)(2012-12#3)
and approved by the##2##4##(2010-12#1)(2012-3#1)
and approved by##3##3##(1994-12#1)(2010-12#1)(2012-3#1)
and approved##6##2##(1992-3#1)(1993-3#1)(1994-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
and approximate##4##2##(2008-10#1)(2008-2#2)(2008-4#1)
and approximately 100##2##3##(1992-11#1)(2008-9#1)
and approximately 2##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
and approximately 5##3##3##(2008-10#1)(2008-3#2)
and approximately half##2##3##(1993-1#1)(2012-3#1)
and approximately##44##2##(1991-9#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-3#1)
and approximation##2##2##(2008-3#1)(2008-6#1)
and aquatic##3##2##(1995-12#1)(2008-10#1)(2009-4#1)
and aqueous extract of##2##4##(2012-2#2)
and aqueous extracts##2##3##(2008-10#1)(2012-2#1)
and aqueous phases##2##3##(2008-10#2)
and aqueous solutions##2##3##(1992-8#1)(2008-10#1)
and aqueous##26##2##(1992-8#2)(2008-10#13)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#3)(2013-1#1)
and arabinose##4##2##(2008-6#3)(2011-1#1)
and arachidonate##2##2##(1991-5#1)(2008-10#1)
and arachidonic acid##8##3##(1990-2#2)(1990-7#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-3#1)(2008-11#1)
and arachidonic acids##4##3##(1990-2#2)(2008-5#1)(2008-7#1)
and arachidonic##13##2##(1990-2#4)(1990-7#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)
and arbitrary orientation##2##3##(2008-2#1)(2008-3#1)
and arbitrary##5##2##(2008-2#3)(2008-3#2)
and arborescens species-groups##2##3##(2008-10#2)
and arbuscular mycorrhizal colonization##2##4##(2008-10#2)
and arbuscular##3##2##(2008-10#3)
and arch##2##2##(2007-11#1)(2012-2#1)
and archaeological##2##2##(2006-4#1)(2012-9#1)
and architectural##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
and architecture##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2009-12#1)
and archived##2##2##(2008-9#1)(2011-2#1)
and arcus senilis were##2##4##(2008-7#2)
and are a##6##3##(1991-12#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
and are able to##4##4##(1993-8#1)(2009-5#1)(2009-7#1)(2010-5#1)
and are almost##2##3##(2009-8#1)(2010-7#1)
and are also##9##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-8#1)(2012-3#3)
and are amenable to##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
and are amenable##4##3##(1992-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
and are associated with##17##4##(1991-12#1)(1992-5#1)(1993-6#1)(1995-5#1)(2007-10#2)(2007-12#1)(2008-7#3)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and are based on the##2##5##(1992-2#1)(2008-4#1)
and are based on##3##4##(1992-2#1)(1994-12#1)(2008-4#1)
and are believed to##2##4##(1993-8#1)(2008-3#1)
and are both##2##3##(1994-8#1)(1996-9#1)
and are capable of##2##4##(2008-1#1)(2008-2#1)
and are characterized by##3##4##(1997-1#1)(2008-7#1)(2011-2#1)
and are characterized##4##3##(1997-1#1)(2007-8#1)(2008-7#1)(2011-2#1)
and are clearly##2##3##(2007-10#1)(2008-10#1)
and are compared with the##2##5##(1991-2#1)(2008-3#1)
and are compared with##6##4##(1991-2#1)(2008-3#5)
and are compared##8##3##(1991-2#1)(1993-8#1)(2008-10#1)(2008-3#5)
and are connected##2##3##(2007-11#1)(2008-2#1)
and are consequently##2##3##(2008-10#1)(2009-2#1)
and are considered##2##3##(2011-2#1)(2013-1#1)
and are consistent with the##4##5##(1990-10#1)(1992-3#1)(1993-6#1)(1995-2#1)
and are consistent with##6##4##(1990-10#1)(1992-3#1)(1993-6#1)(1995-2#1)(1996-12#1)(2008-4#1)
and are critical in the##2##5##(1995-8#1)(2010-5#1)
and are critical##3##3##(1995-8#1)(2008-11#1)(2010-5#1)
and are currently used in##2##5##(2010-11#1)(2011-2#1)
and are currently used##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
and are currently##7##3##(2008-10#2)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#2)
and are dependent##2##3##(1991-5#1)(2012-12#1)
and are derived##2##3##(2013-1#2)
and are described##2##3##(2008-3#1)(2010-3#1)
and are designated as##2##4##(2007-5#1)(2008-10#1)
and are difficult to detect##2##5##(2008-10#1)(2008-9#1)
and are discussed in this##2##5##(2008-4#1)(2010-5#1)
and are discussed in##3##4##(1995-5#1)(2008-4#1)(2010-5#1)
and are discussed##7##3##(1995-11#1)(1995-5#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-5#1)
and are easily##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
and are essential for the##2##5##(2008-4#1)(2013-8#1)
and are essential for##5##4##(1992-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
and are essential##6##3##(1992-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
and are expressed##2##3##(2011-2#2)
and are filled with a##2##5##(2008-3#2)
and are followed##2##3##(2008-1#1)(2008-3#1)
and are found to be in##3##6##(2008-2#2)(2009-9#1)
and are found to be##4##5##(1991-9#1)(2008-2#2)(2009-9#1)
and are found##5##3##(1991-9#1)(2008-2#2)(2009-9#1)(2010-3#1)
and are further##2##3##(2008-10#1)(2009-2#1)
and are generally##4##3##(1992-11#1)(1996-8#1)(2010-11#1)(2010-12#1)
and are higher##2##3##(2009-5#1)(2012-3#1)
and are highly##3##3##(1990-8#1)(2008-11#1)(2008-3#1)
and are important for##2##4##(2008-11#1)(2008-9#1)
and are important##4##3##(2006-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
and are in accord with##2##5##(1994-8#1)(1997-2#1)
and are in##6##3##(1990-8#1)(1992-3#1)(1994-3#2)(1994-8#1)(1997-2#1)
and are increasingly##2##3##(2008-12#1)(2011-2#1)
and are influenced by##3##4##(1992-8#1)(2008-1#1)(2010-9#1)
and are insensitive to##2##4##(1994-5#1)(2008-5#1)
and are involved in a##3##5##(2010-11#1)(2011-2#1)(2012-12#1)
and are involved in the##2##5##(1991-4#1)(2008-7#1)
and are involved in##10##4##(1990-8#1)(1991-4#1)(1997-8#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and are involved##11##3##(1990-8#1)(1991-4#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and are key##2##3##(1995-12#1)(2008-10#1)
and are known as##2##4##(2008-10#1)(2012-2#1)
and are known to be##2##5##(1992-6#1)(2008-11#1)
and are known##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
and are likely to##5##4##(1994-3#1)(1994-8#1)(2008-10#1)(2008-8#1)(2010-11#1)
and are likely##6##3##(1994-3#1)(1994-8#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-2#1)
and are made##2##3##(1994-5#1)(2011-3#1)
and are modulated by##2##4##(2008-8#1)(2013-8#1)
and are more##7##3##(1995-11#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-5#1)(2010-4#1)
and are morphologically##2##3##(1995-2#1)(2007-12#1)
and are not##18##3##(1991-12#1)(1992-1#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-1#1)(2013-1#1)
and are now##3##3##(1991-12#1)(2008-12#1)(2010-8#1)
and are observed in##2##4##(1993-8#1)(2009-5#1)
and are observed##3##3##(1993-8#1)(2008-8#1)(2009-5#1)
and are of##5##3##(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
and are often used##2##4##(2008-4#1)(2013-1#1)
and are often##11##3##(1994-3#1)(1997-8#2)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-2#1)(2012-5#1)(2013-1#1)
and are part of##2##4##(2008-6#1)(2013-1#1)
and are particularly useful##2##4##(1996-12#1)(2008-3#1)
and are particularly##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
and are potentially useful for##2##5##(1993-9#2)
and are potentially##3##3##(1993-9#2)(2012-8#1)
and are presented as##2##4##(1995-5#1)(2008-5#1)
and are presented##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
and are prevalent in##2##4##(2008-11#1)(2012-3#1)
and are produced by##3##4##(1995-11#1)(2008-10#1)(2010-11#1)
and are recognized##2##3##(2008-1#1)(2011-1#1)
and are referred to as &quot##2##6##(2010-3#2)
and are referred to as##5##5##(2008-10#3)(2010-3#2)
and are regarded as##2##4##(2009-6#1)(2010-5#1)
and are regarded##3##3##(1991-3#1)(2009-6#1)(2010-5#1)
and are regulated by##2##4##(1993-11#1)(2008-8#1)
and are relatively##2##3##(2008-9#1)(2011-2#1)
and are relevant to##3##4##(1993-12#1)(2007-11#1)(2008-11#1)
and are reported##2##3##(2008-10#1)(2010-9#1)
and are required##2##3##(2009-10#2)
and are resistant to##2##4##(1995-5#1)(2008-11#1)
and are responsible for##4##4##(1990-6#1)(1992-10#1)(2009-5#1)(2009-8#1)
and are retained##2##3##(1992-3#1)(2007-12#1)
and are robust##2##3##(2011-1#1)(2012-3#1)
and are sensitive to##2##4##(2008-7#1)(2010-9#1)
and are significantly##2##3##(2007-7#1)(2010-12#1)
and are the two procedures comparable in terms of##2##9##(2012-12#2)
and are the##11##3##(1994-2#2)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#2)(2012-12#2)
and are then##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
and are there##2##3##(1994-3#1)(2010-12#1)
and are therefore likely to##2##5##(1991-6#1)(2011-2#1)
and are therefore##5##3##(1990-5#1)(1991-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
and are thus##8##3##(1992-3#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)
and are used to##4##4##(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)
and are used##6##3##(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)
and are useful as##2##4##(1990-8#1)(2008-7#1)
and are useful for##2##4##(1993-12#1)(2008-4#1)
and are useful##5##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
and are usually##4##3##(1990-11#1)(1993-6#1)(2009-3#1)(2013-1#1)
and are very##4##3##(2007-11#1)(2008-11#1)(2010-10#1)(2010-8#1)
and are widely##2##3##(2008-9#2)
and are##548##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#5)(1990-9#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#9)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#7)(1994-5#3)(1994-8#4)(1995-11#5)(1995-12#2)(1995-2#4)(1995-5#9)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#5)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#7)(2007-12#16)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#9)(2008-10#49)(2008-11#22)(2008-12#5)(2008-2#13)(2008-3#33)(2008-4#18)(2008-5#15)(2008-6#6)(2008-7#27)(2008-8#9)(2008-9#12)(2009-10#4)(2009-12#7)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#8)(2010-12#5)(2010-3#6)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#7)(2011-2#26)(2011-3#1)(2012-12#7)(2012-2#11)(2012-3#8)(2012-5#2)(2012-8#1)(2013-1#14)(2013-7#2)(2013-8#6)
and area and##2##3##(2008-10#1)(2011-2#1)
and area effects##2##3##(2008-8#1)(2008-9#1)
and area of##6##3##(1991-6#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2011-1#1)
and area under the curve##2##5##(2007-10#1)(2013-8#1)
and area under the##6##4##(1996-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
and area under##7##3##(1996-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
and area##24##2##(1991-6#1)(1995-8#2)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-9#1)(2013-8#1)
and areas of##5##3##(1993-2#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-8#1)
and areas##9##2##(1993-2#1)(1995-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)
and arginine vasotocin receptor##2##4##(2008-7#2)
and arginine##14##2##(1990-5#2)(1991-12#1)(1992-8#1)(1995-2#2)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#2)(2012-3#1)
and argon as##2##3##(2007-12#1)(2008-10#1)
and argon gas##2##3##(2008-10#1)(2008-3#1)
and argon##12##2##(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#2)(2013-8#1)
and argue that##2##3##(1997-2#1)(2013-8#1)
and argue##4##2##(1997-1#1)(1997-2#1)(2008-4#1)(2013-8#1)
and argues that it##2##4##(1997-3#1)(2013-8#1)
and argues##4##2##(1997-3#1)(2009-6#1)(2010-3#1)(2013-8#1)
and arguments##2##2##(1994-1#1)(2009-6#1)
and arising time##2##3##(2012-12#2)
and arising##3##2##(2008-10#1)(2012-12#2)
and arithmetic##2##2##(2008-11#1)(2008-8#1)
and arm##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
and arms##2##2##(1996-3#1)(2011-2#1)
and aromatic compounds##2##3##(2008-10#1)(2013-1#1)
and aromatic##9##2##(1990-12#1)(1992-8#1)(1996-5#1)(2008-10#5)(2013-1#1)
and around the central canal##2##5##(1995-5#1)(1996-12#1)
and around the##8##3##(1995-5#1)(1996-12#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-10#1)(2013-1#2)
and around##20##2##(1990-6#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-5#1)(2013-1#2)
and arousal##2##2##(1994-3#1)(2008-5#1)
and arranged in a##2##4##(2011-2#1)(2013-8#1)
and arranged##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
and arrangement of##3##3##(1997-7#1)(2008-5#1)(2008-7#1)
and arrangement##5##2##(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#2)
and arrangements##2##2##(1991-3#1)(2008-8#1)
and array##2##2##(2008-3#1)(2012-3#1)
and arrays with##2##3##(2007-11#1)(2008-3#1)
and arrays##5##2##(2007-11#2)(2008-3#1)(2008-4#1)(2008-7#1)
and arrest##6##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
and arrhythmias##3##2##(1992-5#1)(1994-6#1)(2007-8#1)
and arsenate##8##2##(1991-8#2)(2008-10#6)
and arsenazo(III)##2##2##(2008-10#2)
and arsenic species were##3##4##(2008-10#3)
and arsenic##8##2##(2008-10#6)(2008-11#1)(2013-1#1)
and arsenobetaine##2##2##(2008-10#2)
and art##3##2##(2008-4#1)(2009-10#1)(2011-2#1)
and arterial hypertension)##2##3##(2008-1#1)(2011-2#1)
and arterial hypertension]##3##3##(1992-6#1)(1994-2#1)(1996-3#1)
and arterial pressure##4##3##(1990-6#1)(1991-11#1)(1993-12#1)(1995-12#1)
and arterial smooth##2##3##(1997-4#2)
and arterial##25##2##(1990-6#1)(1991-11#2)(1992-6#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-4#2)(2007-12#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
and arteries##2##2##(1991-9#1)(2012-2#1)
and arterioles##2##2##(1997-1#1)(2007-10#1)
and arthralgias##2##2##(1993-8#1)(2012-3#1)
and arthritis##2##2##(1994-5#1)(2012-12#1)
and arthritis]##2##2##(1990-6#2)
and arthropod##2##2##(2008-10#1)(2008-9#1)
and arthroscopic##3##2##(2007-11#2)(2008-8#1)
and articles##4##2##(1991-3#1)(1997-1#1)(2008-7#1)(2013-1#1)
and articular##4##2##(1991-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
and articulate the##3##3##(2008-11#1)(2010-9#1)(2011-2#1)
and articulate##5##2##(1994-12#1)(2008-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
and artificial neural network (ANN)##3##5##(2008-10#3)
and artificial neural network##5##4##(2008-10#5)
and artificial neural networks (ANN)##2##5##(2008-10#2)
and artificial neural networks (ANNs)##2##5##(2008-10#2)
and artificial neural networks##13##4##(1996-2#1)(2008-10#12)
and artificial neural##18##3##(1996-2#1)(2008-10#17)
and artificial surfaces##2##3##(2008-10#2)
and artificial##41##2##(1992-12#1)(1992-5#1)(1996-2#1)(2007-12#1)(2008-10#26)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
and artificially infected##3##3##(2008-10#2)(2008-8#1)
and artificially inoculated##2##3##(2008-10#2)
and artificially##7##2##(1993-12#1)(2008-10#5)(2008-8#1)
and arts##2##2##(2011-2#2)
and aryl##4##2##(2009-10#1)(2010-8#2)(2013-8#1)
and arylsulphatase A##2##3##(1994-3#2)
and arylsulphatase##3##2##(1994-3#2)(2008-7#1)
and as a consequence##7##4##(1992-2#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
and as a detector##2##4##(2008-10#2)
and as a function of the##4##6##(2008-10#2)(2008-2#1)(2008-3#1)
and as a function of##7##5##(2008-10#3)(2008-2#1)(2008-3#2)(2012-2#1)
and as a model##2##4##(1994-5#1)(2008-11#1)
and as a result it##2##5##(1990-8#1)(2013-8#1)
and as a result##10##4##(1990-12#1)(1990-8#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#2)
and as a##78##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#2)
and as an early##2##4##(2008-10#1)(2008-4#1)
and as an indicator electrode in potentiometric titration of##2##9##(2008-10#2)
and as an indicator electrode in##3##6##(2008-10#3)
and as an##16##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2012-3#1)
and as it##3##3##(1996-2#1)(2011-1#1)(2011-2#1)
and as low as##2##4##(2008-10#2)
and as much as##4##4##(2007-11#2)(2007-12#2)
and as new##2##3##(2008-10#1)(2010-11#1)
and as of##2##3##(2008-10#1)(2010-3#1)
and as such it is##2##5##(2010-10#1)(2012-12#1)
and as such##9##3##(1990-9#1)(1991-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-10#1)(2012-1#1)(2012-12#1)
and as the##7##3##(1992-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
and as yet##3##3##(1990-7#1)(1994-2#1)(2009-2#1)
and as##194##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#6)(2008-12#7)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
and asbestos exposure##2##3##(1991-12#1)(2008-12#1)
and ascending##3##2##(2007-12#1)(2007-8#1)(2008-12#1)
and ascites##7##2##(1997-6#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)
and ascitic fluid##3##3##(2007-12#2)(2010-12#1)
and ascorbate##8##2##(1994-12#1)(1995-2#1)(1995-6#2)(1996-9#1)(2008-10#2)(2013-8#1)
and ascorbic acid (AA)##2##4##(2008-10#2)
and ascorbic acid (vitamin C)##2##5##(1992-9#1)(2008-7#1)
and ascorbic acid as##2##4##(2008-10#2)
and ascorbic acid in##3##4##(2008-10#3)
and ascorbic acid##29##3##(1992-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)
and ascorbic##31##2##(1992-9#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)
and ascospore production##2##3##(2008-10#2)
and ascospore##3##2##(2008-10#3)
and ascospores were##2##3##(2008-10#2)
and ascospores##10##2##(2008-10#9)(2010-3#1)
and aseptic##4##2##(1994-7#1)(2007-11#1)(2008-11#1)(2009-5#1)
and asexual##7##2##(2008-10#6)(2010-2#1)
and ash##2##2##(2010-2#1)(2010-4#1)
and ashes##2##2##(2008-10#1)(2012-2#1)
and asialotransferrin)##3##2##(1993-8#3)
and ask##3##2##(1996-1#1)(1997-1#1)(2008-7#1)
and asked for##2##3##(1995-12#1)(2011-2#1)
and asked to##5##3##(1990-11#1)(1996-2#1)(2008-10#1)(2009-11#1)(2010-11#1)
and asked##12##2##(1990-11#1)(1993-12#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
and asking##2##2##(2008-8#1)(2010-8#1)
and asks##2##2##(1992-3#1)(2008-11#1)
and asp##2##2##(1997-3#1)(2010-8#1)
and asparagine##2##2##(1994-6#1)(1997-6#1)
and aspartate aminotransferase##3##3##(2008-12#1)(2009-8#1)(2012-3#1)
and aspartate##10##2##(1991-12#1)(1995-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-3#1)
and aspartic acid##5##3##(1991-5#1)(1994-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
and aspect##2##2##(2007-11#1)(2011-1#1)
and aspects of##3##3##(1993-9#1)(2006-12#1)(2008-5#1)
and aspects##5##2##(1993-9#1)(2006-12#1)(2007-10#1)(2008-5#1)(2011-2#1)
and asphaltenes##3##2##(2008-6#3)
and aspirations##3##2##(1995-2#1)(2008-6#2)
and aspirin##3##2##(1993-3#2)(2007-8#1)
and assay of##2##3##(2008-10#2)
and assay##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-2#1)(2010-5#1)
and assayed for##8##3##(1990-11#1)(1990-2#1)(1990-5#1)(2008-10#3)(2008-4#1)(2008-8#1)
and assayed##14##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1996-5#1)(2007-2#1)(2008-10#5)(2008-4#1)(2008-8#1)
and assays for##2##3##(2006-10#1)(2008-10#1)
and assays##4##2##(2006-10#1)(2008-10#2)(2012-12#1)
and assembled##5##2##(1996-12#1)(1996-2#1)(2008-8#1)(2010-4#1)(2012-3#1)
and assembly is##2##3##(2008-10#1)(2008-4#1)
and assembly of##4##3##(1990-2#1)(1993-9#1)(1994-12#1)(2012-3#1)
and assembly##16##2##(1990-2#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2012-3#1)
and assess its##2##3##(1992-12#1)(2008-3#1)
and assess the##14##3##(1990-11#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and assess##30##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
and assessed by##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
and assessed changes in##2##4##(2012-12#1)(2013-1#1)
and assessed for their##2##4##(2008-10#2)
and assessed for##7##3##(1995-12#1)(2008-10#6)
and assessed its##2##3##(2008-10#1)(2010-12#1)
and assessed the##5##3##(1994-1#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
and assessed##36##2##(1993-6#1)(1994-1#1)(1994-7#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
and assesses the system of service capacity and current activities for service delivery##8##13##(2013-8#8)
and assesses the system of service capacity and##9##8##(2013-8#9)
and assesses the##12##3##(1993-3#1)(1997-3#2)(2013-8#9)
and assesses##14##2##(1993-3#1)(1997-3#2)(2008-12#1)(2009-3#1)(2013-8#9)
and assessing genetic##2##3##(2008-10#1)(2008-12#1)
and assessing of##2##3##(2008-11#1)(2010-5#1)
and assessing the##3##3##(2008-4#1)(2009-8#1)(2012-2#1)
and assessing##22##2##(1990-11#1)(1992-12#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#2)(2009-1#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
and assessment of a##2##4##(2008-9#1)(2011-2#1)
and assessment of the##7##4##(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#1)
and assessment of tumor##2##4##(2007-4#1)(2010-3#1)
and assessment of##31##3##(1991-3#1)(1993-11#1)(1993-12#1)(1995-5#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-3#1)(2010-3#1)(2011-2#4)(2011-8#1)(2012-2#1)(2013-1#2)
and assessment strategies##2##3##(2008-11#1)(2009-9#1)
and assessment##53##2##(1990-6#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1995-5#1)(1997-3#3)(1997-5#2)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-8#1)(2012-2#1)(2013-1#4)
and assessments of##2##3##(1997-5#1)(2006-10#1)
and assets##2##2##(1995-1#1)(1995-2#1)
and assign##4##2##(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)
and assigned##3##2##(1995-6#1)(1996-1#1)(2008-10#1)
and assignment of##3##3##(1993-11#1)(1996-6#2)
and assignment##5##2##(1990-8#1)(1993-11#1)(1995-12#1)(1996-6#2)
and assigns##2##2##(1996-4#1)(2010-10#1)
and assimilate##2##2##(2008-10#1)(2013-8#1)
and assist the##2##3##(2009-8#1)(2009-9#1)
and assist##7##2##(1992-1#1)(2008-10#2)(2008-12#1)(2009-8#1)(2009-9#1)(2011-1#1)
and assistance##2##2##(1995-12#1)(2008-1#1)
and assisted living##2##3##(2008-12#2)
and assisted suicide##3##3##(1991-8#2)(1996-2#1)
and assisted##8##2##(1991-8#2)(1996-2#1)(2007-11#1)(2007-8#1)(2008-12#2)(2012-2#1)
and assisting##2##2##(2008-10#2)
and associate##4##2##(2008-4#1)(2008-6#1)(2009-2#1)(2012-3#1)
and associated behaviors##2##3##(2008-9#1)(2009-10#1)
and associated cell##2##3##(1990-7#1)(2013-1#1)
and associated costs##2##3##(1994-2#1)(2010-12#1)
and associated diagnoses##2##3##(2008-11#2)
and associated disorders##4##3##(1990-7#1)(2008-11#1)(2008-5#1)(2009-6#1)
and associated factors in##2##4##(2009-10#1)(2013-1#1)
and associated factors##7##3##(1996-2#1)(2008-10#1)(2009-10#1)(2012-12#1)(2013-1#3)
and associated lymph##2##3##(1993-2#1)(2011-2#1)
and associated metabolic##2##3##(2007-7#1)(2012-2#1)
and associated morbidity##2##3##(2008-5#1)(2011-2#1)
and associated risk factors in##2##5##(2012-2#1)(2013-8#1)
and associated risk factors##4##4##(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and associated to##3##3##(1992-6#1)(1994-5#1)(2008-5#1)
and associated with poor##2##4##(2011-2#1)(2011-3#1)
and associated with##15##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
and associated##106##2##(1990-11#1)(1990-7#2)(1991-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-11#8)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#3)
and associates for##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
and associates##4##2##(1994-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
and association constant of##2##4##(2008-10#2)
and association constant##3##3##(2008-10#3)
and association mapping##2##3##(2012-3#2)
and association of##3##3##(1993-8#1)(2008-10#1)(2009-5#1)
and association studies##4##3##(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
and association with the##2##4##(2007-12#1)(2008-10#1)
and association with##8##3##(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
and association##28##2##(1992-6#1)(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-8#1)
and associations of##2##3##(2008-1#1)(2013-8#1)
and associations with##4##3##(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and associations##8##2##(2008-1#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and assume##2##2##(1992-4#1)(2008-8#1)
and assumed to##2##3##(2008-10#1)(2008-11#1)
and assumed##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
and assuming a##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
and assuming##5##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
and assumptions##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
and assurance##5##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#1)
and assure##2##2##(1992-11#1)(2010-4#1)
and assured##2##2##(1996-2#1)(2007-11#1)
and assuring the##2##3##(1995-3#1)(2008-10#1)
and assuring##4##2##(1995-3#1)(2008-10#2)(2008-11#1)
and aster##2##2##(2008-10#2)
and asthenia##2##2##(2008-7#1)(2012-3#1)
and asthma (2##2##3##(2011-2#1)(2013-1#1)
and asthma are##2##3##(2011-2#1)(2012-12#1)
and asthma##21##2##(1990-2#1)(1991-9#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-12#1)(2010-5#3)(2011-2#3)(2012-12#2)(2013-1#4)
and asthma]##2##2##(2011-2#1)(2013-1#1)
and asthmatic##3##2##(2010-1#2)(2013-1#1)
and astigmatism were corrected with##2##5##(2007-11#1)(2008-2#1)
and astigmatism##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
and astrocyte##3##2##(1992-12#1)(1996-12#1)(2008-7#1)
and astrocytes##18##2##(1992-12#1)(1994-2#1)(1996-5#3)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#9)(2009-3#1)
and astrocytic##2##2##(1995-12#1)(2008-8#1)
and astroglial##2##2##(2008-7#1)(2008-8#1)
and asymmetric##13##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#6)
and asymmetry##2##2##(2008-2#1)(2008-8#1)
and asymptomatic plants##2##3##(2008-10#2)
and asymptomatic##16##2##(1992-10#1)(1992-9#1)(1996-9#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#2)(2013-1#1)(2013-8#1)
and asymptotic##6##2##(2008-3#1)(2008-9#4)(2009-5#1)
and at 0##2##3##(2008-10#1)(2012-3#1)
and at 1##6##3##(1997-6#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-4#1)
and at 2##2##3##(2008-3#1)(2010-4#1)
and at 20##2##3##(1997-2#1)(2007-10#1)
and at 25 degrees C##2##5##(2008-10#2)
and at 3##5##3##(2007-10#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
and at 37 degrees C##2##5##(1994-3#1)(2008-10#1)
and at 4##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
and at 40 degrees C##2##5##(2008-5#2)
and at 40 degrees##3##4##(2008-5#3)
and at 6##2##3##(2008-12#2)
and at 60 degrees C##2##5##(1996-2#1)(2008-6#1)
and at 60##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
and at a##15##3##(1990-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
and at all##4##3##(2007-6#1)(2008-10#3)
and at an##7##3##(1990-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
and at day##2##3##(1993-12#1)(2008-10#1)
and at different h/d(s) values##2##5##(2008-3#2)
and at different##9##3##(1990-5#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-3#1)
and at each##2##3##(2008-10#1)(2011-10#1)
and at follow-up##2##3##(2008-5#1)(2013-8#1)
and at high concentrations##2##4##(1992-12#1)(2011-2#1)
and at high##6##3##(1992-12#1)(1992-4#1)(1993-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
and at higher##5##3##(1992-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
and at home##3##3##(1992-2#1)(2009-10#1)(2009-8#1)
and at intervals##3##3##(1990-5#1)(2008-3#1)(2008-9#1)
and at least one##9##4##(1991-5#1)(1993-6#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-12#1)
and at least two##3##4##(1995-8#1)(1997-8#1)(2009-9#1)
and at least##27##3##(1990-3#1)(1991-5#1)(1993-3#1)(1993-6#2)(1995-8#2)(1996-3#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-12#2)
and at low##3##3##(1994-8#1)(2008-3#1)(2008-6#1)
and at lower##5##3##(1992-10#1)(1994-12#1)(1996-12#1)(2008-10#2)
and at one##2##3##(1996-3#1)(2008-10#1)
and at pH##2##3##(2008-10#1)(2013-1#1)
and at relapse##3##3##(2008-6#1)(2011-2#2)
and at temperatures##3##3##(1992-6#1)(2008-10#1)(2008-2#1)
and at the 1-year follow-up##2##5##(2008-10#1)(2012-2#1)
and at the end of each##2##6##(2008-10#1)(2008-6#1)
and at the end of the##6##6##(1990-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-8#1)
and at the end of##8##5##(1990-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-8#1)
and at the level of##2##5##(1996-2#1)(2008-7#1)
and at the molecular##2##4##(1997-6#1)(2008-10#1)
and at the protein##2##4##(2008-10#1)(2008-7#1)
and at the same time##19##5##(1990-11#1)(1990-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#2)(2012-2#1)(2013-1#1)
and at the same##21##4##(1990-11#1)(1990-6#1)(1994-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#2)(2012-2#1)(2013-1#1)
and at the##78##3##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#2)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#2)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
and at this##2##3##(2008-6#1)(2008-9#1)
and at three##2##3##(2011-2#1)(2013-8#1)
and at various##4##3##(1996-1#1)(2008-2#2)(2008-3#1)
and at what stage##2##4##(2006-6#1)(2008-10#1)
and at what##4##3##(2006-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
and at##345##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#73)(2008-11#13)(2008-12#3)(2008-2#8)(2008-3#20)(2008-4#4)(2008-5#15)(2008-6#9)(2008-7#11)(2008-8#4)(2008-9#11)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#13)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#7)
and atherosclerosis score##2##3##(2008-3#2)
and atherosclerosis##18##2##(1997-8#1)(2008-11#4)(2008-3#5)(2008-7#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
and atherosclerotic##6##2##(1991-9#1)(1993-3#2)(2008-1#1)(2008-4#1)(2012-2#1)
and atmosphere##3##2##(2008-2#2)(2008-3#1)
and atmospheric parameters##2##3##(2008-2#1)(2008-3#1)
and atmospheric pressure##2##3##(1996-1#1)(2008-2#1)
and atmospheric products##2##3##(2008-3#2)
and atmospheric turbulence##2##3##(2008-3#2)
and atmospheric##18##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#10)(2008-8#1)(2011-2#1)
and atom##3##2##(1996-2#1)(2007-11#1)(2008-9#1)
and atomic absorption spectrometry##4##4##(2008-10#3)(2011-2#1)
and atomic absorption##6##3##(2008-10#5)(2011-2#1)
and atomic emission##2##3##(2008-10#2)
and atomic fluorescence spectrometry (AFS)##2##5##(2008-10#2)
and atomic fluorescence spectrometry##5##4##(2008-10#5)
and atomic fluorescence##7##3##(2008-10#7)
and atomic force microscopy (AFM)##3##5##(2007-12#1)(2008-6#1)(2009-7#1)
and atomic force microscopy##12##4##(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)
and atomic force##13##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)
and atomic##33##2##(2007-12#2)(2008-10#18)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)
and atomic-force##2##2##(2008-3#2)
and atomisation##6##2##(2008-10#6)
and atomization curves##2##3##(2008-10#2)
and atomization temperatures of 1500 and##2##6##(2008-10#2)
and atomization temperatures of##4##4##(2008-10#4)
and atomization temperatures##14##3##(2008-10#14)
and atomization##26##2##(2007-12#1)(2008-10#25)
and atopic dermatitis##2##3##(2008-5#1)(2013-1#1)
and atopic##6##2##(2008-10#1)(2008-11#2)(2008-5#1)(2012-12#1)(2013-1#1)
and atopy (p=0##2##3##(2008-10#2)
and atopy in##3##3##(1996-6#1)(2008-10#2)
and atopy##12##2##(1996-6#1)(2007-6#2)(2008-10#7)(2010-6#2)
and atrazine were##2##3##(2008-10#2)
and atrazine##7##2##(2008-10#7)
and atrial fibrillation in##2##4##(2007-10#1)(2011-2#1)
and atrial fibrillation##5##3##(1996-3#1)(2007-10#1)(2008-10#1)(2011-2#2)
and atrial##10##2##(1994-11#1)(1994-8#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-4#1)(2011-2#2)(2013-1#1)
and atrogin-1 mRNA##2##3##(2013-1#2)
and atrophy of##2##3##(2008-6#1)(2008-7#1)
and atrophy##6##2##(1992-2#1)(1997-2#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
and atropine##3##2##(1994-9#1)(2008-10#1)(2010-4#1)
and attached##6##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
and attachment##5##2##(2008-12#1)(2008-7#2)(2011-2#1)(2013-8#1)
and attain##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
and attained##3##2##(2008-10#1)(2012-1#1)(2012-12#1)
and attempt to##5##3##(1992-3#1)(2008-2#1)(2008-7#2)(2012-2#1)
and attempt##8##2##(1992-3#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-7#1)(2012-2#2)
and attempts to##5##3##(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)
and attempts##8##2##(1992-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
and attend##2##2##(2008-7#1)(2009-8#1)
and attendance benefits##2##3##(1994-6#2)
and attendance##5##2##(1991-12#1)(1994-6#3)(2012-3#1)
and attendant##3##2##(1996-2#1)(2008-8#1)(2012-3#1)
and attention deficit##2##3##(1996-6#1)(2008-11#1)
and attention to##4##3##(1993-2#1)(1996-3#1)(2008-1#1)(2008-9#1)
and attention##18##2##(1991-5#1)(1991-6#2)(1993-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-8#2)
and attentional##2##2##(2007-8#1)(2008-10#1)
and attenuate the##2##3##(1995-1#1)(2013-8#1)
and attenuated##3##2##(1995-12#1)(2008-3#1)(2013-8#1)
and attenuates##3##2##(1996-2#1)(2010-10#1)(2011-3#1)
and attenuation of##3##3##(1992-2#1)(2008-9#1)(2009-8#1)
and attenuation##8##2##(1992-2#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#1)
and attitude of##5##3##(2008-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
and attitude towards the##3##4##(1997-3#1)(2008-5#1)(2013-1#1)
and attitude##15##2##(1990-6#1)(1991-6#1)(1997-3#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
and attitudes of psychiatric healthcare##2##5##(1991-2#2)
and attitudes of##13##3##(1991-2#2)(1996-6#1)(1996-9#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#1)
and attitudes regarding##2##3##(2010-6#1)(2011-2#1)
and attitudes that##2##3##(1996-2#1)(2008-9#1)
and attitudes toward a##2##4##(1991-5#1)(2008-12#1)
and attitudes toward##12##3##(1991-5#1)(1992-1#1)(1993-1#1)(1994-3#1)(2007-10#1)(2008-12#1)(2009-5#2)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
and attitudes towards##6##3##(2008-11#1)(2010-12#1)(2010-3#1)(2012-1#1)(2013-1#2)
and attitudes##57##2##(1991-2#3)(1991-5#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-6#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
and attitudes]##2##2##(1996-3#1)(2008-1#1)
and attitudinal##2##2##(1993-1#1)(2010-11#1)
and attorneys##2##2##(1991-3#1)(1995-12#1)
and attractive##3##2##(2008-6#1)(2008-8#1)(2010-2#1)
and attribute##2##2##(2007-5#1)(2012-7#1)
and attributed to##2##3##(1992-6#1)(2008-10#1)
and atypical##14##2##(1990-12#1)(1994-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-2#1)(2013-1#1)
and audiological##3##2##(1995-6#1)(2008-9#2)
and audit##3##2##(1991-8#1)(1996-8#1)(2013-1#1)
and auditing##2##2##(1994-2#1)(2010-5#1)
and auditory##8##2##(2008-8#2)(2008-9#3)(2012-12#1)(2013-1#2)
and audits##3##2##(1992-3#1)(2008-11#2)
and augmentation index##2##3##(2007-10#2)
and augmentation of##2##3##(1991-9#1)(2008-10#1)
and augmentation##6##2##(1991-9#1)(2007-10#2)(2008-10#1)(2010-8#2)
and augmented##2##2##(2008-11#1)(2008-7#1)
and augments##2##2##(2008-11#1)(2011-1#1)
and authoritative##2##2##(1991-6#1)(2008-12#1)
and authority##3##2##(1991-1#1)(1993-1#1)(2013-7#1)
and autism spectrum##2##3##(2010-7#1)(2012-12#1)
and autism##8##2##(1991-2#1)(1997-8#1)(2007-12#1)(2008-9#1)(2010-7#1)(2012-12#2)(2013-1#1)
and autistic##2##2##(2008-3#1)(2013-1#1)
and autoclaved mulberry leaves##2##4##(2008-10#2)
and autoclaved##3##2##(2008-10#3)
and autocorrelation of##2##3##(2007-11#1)(2008-3#1)
and autocorrelation##3##2##(2007-11#1)(2008-3#2)
and autocrine##4##2##(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
and autogeneic##2##2##(2013-1#2)
and autograft##6##2##(2007-8#1)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
and autohydrolysis##2##2##(1994-11#2)
and autoimmune diabetes##2##3##(2007-5#1)(2008-10#1)
and autoimmune disease##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
and autoimmune diseases##4##3##(2012-1#2)(2013-1#1)(2013-8#1)
and autoimmune##16##2##(1990-11#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
and autoimmunity in##2##3##(2008-10#1)(2008-7#1)
and autoimmunity##5##2##(1993-3#1)(2008-10#2)(2008-4#1)(2008-7#1)
and autologous CTLs##2##3##(2008-11#2)
and autologous bone marrow transplantation for##2##6##(1994-8#1)(1995-8#1)
and autologous bone marrow transplantation##4##5##(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)
and autologous##10##2##(1993-9#1)(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)(2007-9#1)(2008-11#2)(2008-4#1)(2012-2#1)
and automated method##2##3##(2008-10#2)
and automated screening##2##3##(1997-4#1)(2008-10#1)
and automated##21##2##(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-1#1)
and automatic##11##2##(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-10#2)(2010-4#1)(2010-8#1)
and automatically##4##2##(1996-2#1)(2008-3#1)(2009-5#1)(2010-7#1)
and automation of the##2##4##(1991-1#1)(2008-10#1)
and automation##6##2##(1991-1#1)(1992-11#1)(2008-10#4)
and automobile##2##2##(1997-6#1)(2008-10#1)
and autonomic##13##2##(1991-1#1)(1996-12#1)(2007-12#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
and autonomous##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
and autonomy##2##2##(1990-6#1)(1991-2#1)
and autophosphorylation##3##2##(1993-8#2)(1995-2#1)
and autopsy##4##2##(1990-6#1)(1994-7#1)(2006-8#1)(2012-12#1)
and autoradiography##8##2##(1991-2#1)(1993-11#1)(1993-12#1)(1995-11#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-7#1)
and autosomal##5##2##(1992-8#1)(1997-5#1)(1997-8#1)(2008-11#1)(2012-3#1)
and autotransfusion##3##2##(1990-2#1)(1992-3#2)
and autumn##8##2##(2008-10#3)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
and auxiliary##2##2##(1991-3#1)(1997-8#1)
and auxin##3##2##(2008-10#2)(2009-8#1)
and availability of##14##3##(1992-2#1)(1994-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and availability##18##2##(1992-2#1)(1994-1#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
and available data##2##3##(2008-8#1)(2011-2#1)
and available for##2##3##(1991-7#1)(2009-9#1)
and available##18##2##(1991-7#1)(1994-3#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#2)(2011-2#2)
and avenues##2##2##(1990-12#1)(2008-10#1)
and average humidity as##2##4##(2011-1#2)
and average humidity of##2##4##(2011-1#2)
and average humidity##4##3##(2011-1#4)
and average number##2##3##(1992-9#1)(2012-12#1)
and average power##2##3##(1992-12#1)(2008-2#1)
and average premiums paid by##2##5##(1996-3#2)
and average premiums##3##3##(1996-3#3)
and average salary for##2##4##(1995-3#2)
and average##51##2##(1992-12#1)(1992-2#1)(1992-9#1)(1994-1#2)(1994-2#1)(1995-3#2)(1996-2#1)(1996-3#3)(1996-7#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-3#1)(2013-8#1)
and aversion##2##2##(1994-8#1)(2009-5#1)
and avian influenza##3##3##(2007-6#1)(2008-9#1)(2013-8#1)
and avian##11##2##(1990-5#1)(1991-6#1)(1993-2#1)(1997-1#1)(1997-6#1)(2007-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
and avidity##2##2##(1991-5#1)(2008-10#1)
and avirulence in##2##3##(2008-10#2)
and avirulent populations##2##3##(2008-10#2)
and avirulent##5##2##(2008-10#5)
and avoid the##2##3##(2008-3#1)(2008-4#1)
and avoid##15##2##(1993-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and avoidance of high-risk partners##2##5##(2011-2#2)
and avoidance of##11##3##(1992-9#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#4)(2013-1#1)
and avoidant##2##2##(2008-11#1)(2009-5#1)
and avoided the##2##3##(2008-10#2)
and avoiding##8##2##(1991-1#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#2)
and avoids the##5##3##(1990-3#1)(1991-3#1)(2008-10#2)(2008-8#1)
and avoids##10##2##(1990-3#1)(1991-3#1)(1994-11#1)(2008-10#5)(2008-8#1)(2008-9#1)
and awareness and##2##3##(1994-3#1)(2007-7#1)
and awareness of##5##3##(1991-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)
and awareness##11##2##(1991-8#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-2#1)
and away from##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
and away##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
and axes##2##2##(2008-2#1)(2008-7#1)
and axial eye##3##3##(2008-2#1)(2010-1#2)
and axial involvement##2##3##(2010-12#1)(2013-8#1)
and axial resolution##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and axial resolutions##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and axial##17##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#4)(2008-9#1)(2010-1#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
and axillary lymph node metastasis##2##5##(1994-7#1)(2010-6#1)
and axillary lymph##3##3##(1994-7#1)(2010-6#1)(2013-1#1)
and axillary nerve##2##3##(2008-9#1)(2013-1#1)
and axillary temperatures##2##3##(2010-5#2)
and axillary##9##2##(1994-7#2)(2008-9#1)(2010-5#2)(2010-6#1)(2012-1#1)(2013-1#2)
and axis##3##2##(2007-11#2)(2013-1#1)
and axon##3##2##(2007-12#1)(2008-5#1)(2009-12#1)
and axonal loss##2##3##(2007-10#1)(2010-12#1)
and axonal regeneration##2##3##(1996-12#1)(2008-7#1)
and axonal##7##2##(1993-12#1)(1996-12#1)(2007-10#1)(2008-7#2)(2010-12#1)(2013-1#1)
and axons##5##2##(1997-3#2)(2008-11#1)(2008-7#2)
and azathioprine##2##2##(1996-8#1)(2012-3#1)
and azimuthal##2##2##(2007-11#1)(2008-3#1)
and azimuthally polarized beams##2##4##(2007-11#2)
and azithromycin##2##2##(2007-12#2)
and azomethene##2##2##(2008-10#2)
and azygos##2##2##(2012-3#2)
and b##13##2##(1991-3#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-12#2)(2008-3#2)(2010-5#1)(2011-2#1)
and b(2)##2##2##(2012-12#2)
and b(b)##6##2##(2008-2#1)(2008-3#5)
and b) the##3##3##(1991-2#1)(1993-1#1)(2012-2#1)
and b)##11##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#2)(1993-3#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
and bFGF in##2##3##(1997-6#1)(2010-8#1)
and bFGF##7##2##(1992-9#1)(1995-12#1)(1997-6#2)(2008-11#1)(2010-8#1)(2012-1#1)
and bZIP##3##2##(2008-10#3)
and babies##2##2##(1994-6#1)(2009-11#1)
and baby##2##2##(1995-12#1)(2009-9#1)
and bacitracin##2##2##(1991-8#1)(1994-6#1)
and back pain##8##3##(2007-11#1)(2008-12#3)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and back to the##2##4##(2008-3#1)(2008-9#1)
and back to##4##3##(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)
and back##30##2##(1991-5#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#4)(2008-3#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
and backcross populations##4##3##(2008-10#4)
and backcross to##2##3##(2008-10#2)
and backcross##8##2##(1996-12#2)(2008-10#6)
and backcrosses were##2##3##(2008-10#2)
and backcrosses##3##2##(2008-10#2)(2008-8#1)
and background absorption##3##3##(2008-10#3)
and background is##2##3##(2008-2#1)(2008-3#1)
and background signals##3##3##(2008-10#2)(2008-3#1)
and background variables##2##3##(2010-2#1)(2013-1#1)
and background##23##2##(1996-5#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2013-1#1)
and backgrounds##2##2##(2007-11#1)(2008-3#1)
and backscatter##9##2##(2008-2#1)(2008-3#8)
and backscattered##2##2##(2008-10#1)(2008-2#1)
and backscattering##12##2##(2008-2#7)(2008-3#5)
and backward##12##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
and bacoside##2##2##(2012-2#2)
and bacteremia##2##2##(2008-7#1)(2012-3#1)
and bacteria in##2##3##(2008-10#1)(2011-1#1)
and bacteria to##2##3##(2008-5#1)(2008-7#1)
and bacteria were not##2##4##(2008-10#2)
and bacteria##19##2##(1990-2#1)(1992-11#1)(1993-12#1)(1994-5#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-7#4)(2008-8#1)(2011-1#2)(2012-3#1)
and bacterial infection##2##3##(2007-8#1)(2008-7#1)
and bacterial infections##2##3##(1992-8#1)(2009-9#1)
and bacterial multiplication##2##3##(2008-10#2)
and bacterial##28##2##(1990-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-8#1)(1994-9#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and bacteriological##7##2##(1993-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
and bacteriophage##3##2##(1990-11#1)(1994-8#2)
and baculovirus##2##2##(2008-11#1)(2008-4#1)
and bad in 6 patients##3##5##(2007-11#3)
and bad in##4##3##(2007-11#4)
and bad##9##2##(1997-5#1)(2007-11#5)(2010-10#2)(2010-3#1)
and baffle##2##2##(1995-3#1)(2010-5#1)
and balance disorders in cancer patients##2##6##(2013-1#2)
and balance disorders in##3##4##(2013-1#3)
and balance disorders##5##3##(2007-10#1)(2008-7#1)(2013-1#3)
and balance in##3##3##(2008-4#2)(2009-3#1)
and balance##12##2##(1994-12#1)(2007-10#1)(2008-4#3)(2008-7#1)(2009-3#1)(2010-10#1)(2013-1#4)
and balanced##9##2##(1991-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-3#1)
and ball##4##2##(1996-1#1)(2011-2#3)
and balloon##3##2##(2008-3#1)(2010-12#1)(2010-5#1)
and band 3##3##3##(2013-8#3)
and band##11##2##(1995-2#1)(2008-10#5)(2008-3#1)(2013-8#4)
and bandwidth##9##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-3#5)(2012-3#1)
and bandwidths##2##2##(2007-11#1)(2008-10#1)
and bank##2##2##(2008-11#1)(2012-3#1)
and bar##2##2##(2006-12#1)(2009-1#1)
and bare##3##2##(2008-10#1)(2009-11#1)(2009-12#1)
and barely##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
and barium##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
and bark##3##2##(2008-10#2)(2008-5#1)
and barley and##4##3##(1991-12#1)(2008-10#2)(2008-9#1)
and barley genotypes##2##3##(2008-10#2)
and barley##25##2##(1991-12#2)(1992-8#1)(2008-10#15)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#3)(2010-2#1)
and barriers for##2##3##(1992-8#1)(1996-3#1)
and barriers to integration##2##4##(1997-3#1)(2008-11#1)
and barriers to##8##3##(1996-2#1)(1997-3#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
and barriers##15##2##(1991-12#1)(1992-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-11#2)(2008-4#1)(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
and basal ES##2##3##(2012-2#2)
and basal compartments##2##3##(2007-8#1)(2012-2#1)
and basal ganglia##7##3##(1991-12#1)(1996-12#1)(1996-5#2)(2008-7#1)(2009-6#1)(2013-8#1)
and basal##30##2##(1990-7#1)(1991-10#2)(1991-12#1)(1993-9#1)(1994-6#1)(1996-12#1)(1996-5#2)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
and base composition##2##3##(1994-9#1)(2008-5#1)
and base##16##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-7#3)(1994-9#1)(2007-2#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-12#1)(2012-12#1)
and based on a##3##4##(1994-6#1)(2009-10#1)(2013-1#1)
and based on the##2##4##(2011-2#1)(2013-8#1)
and based on##13##3##(1994-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
and based##15##2##(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
and baseline drift##2##3##(2008-10#2)
and baseline##10##2##(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
and basement##2##2##(1992-11#1)(2008-4#1)
and bases##7##2##(1990-5#1)(2008-10#5)(2008-9#1)
and basic fibroblast growth factor##6##5##(1995-11#2)(1997-6#1)(2008-11#3)
and basic media##2##3##(2008-10#2)
and basic research##5##3##(2008-10#1)(2008-11#1)(2008-8#2)(2009-12#1)
and basic scientists##2##3##(1992-1#1)(2007-12#1)
and basic##44##2##(1991-9#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-11#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-3#1)
and basically##2##2##(1994-12#1)(2013-8#1)
and basis##2##2##(2008-5#1)(2013-8#1)
and basophil counts##4##3##(2008-12#1)(2011-1#3)
and basophil##6##2##(2008-12#1)(2011-1#4)(2012-3#1)
and batch composition##2##3##(2011-2#2)
and batch##4##2##(2008-10#1)(2011-2#3)
and battering##2##2##(2009-5#2)
and bcl-2##7##2##(1993-3#2)(2007-12#1)(2008-10#1)(2008-11#3)
and bcl-2/CD95L##2##2##(2012-1#2)
and be a part of##2##5##(2013-1#2)
and be a##3##3##(1993-12#1)(2013-1#2)
and be aware of##2##4##(1997-4#1)(2011-1#1)
and be capable of##2##4##(2008-10#1)(2008-11#1)
and be##35##2##(1990-2#1)(1991-3#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-6#2)(1997-4#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#3)(2010-10#2)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
and beach##2##2##(2007-5#2)
and bead injection##2##3##(2008-10#2)
and beam quality##3##3##(2008-2#3)
and beam shaping##2##3##(2007-11#1)(2008-2#1)
and beam##15##2##(2007-11#1)(2008-2#6)(2008-3#8)
and bean##4##2##(1994-11#1)(2008-10#3)
and bear##2##2##(2008-10#1)(2010-11#1)
and bears##2##2##(2008-10#1)(2010-11#1)
and became##13##2##(1991-10#1)(1991-12#1)(1991-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
and because it##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
and because of the##4##4##(1992-3#1)(2008-5#1)(2009-10#1)(2010-5#1)
and because of their##3##4##(1996-5#1)(2006-5#1)(2008-7#1)
and because of##11##3##(1990-2#1)(1992-3#1)(1996-5#1)(2006-5#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#1)
and because the##4##3##(2008-10#2)(2008-4#1)(2009-10#1)
and because##33##2##(1990-2#1)(1991-1#1)(1992-3#1)(1992-4#1)(1996-5#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
and become##10##2##(1994-11#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
and becomes##8##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
and becoming##4##2##(1994-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
and bed##4##2##(1993-12#2)(2008-1#1)(2011-2#1)
and beds##2##2##(1996-3#1)(2008-10#1)
and bee##2##2##(2008-10#1)(2008-6#1)
and beef##7##2##(1990-5#1)(2008-10#2)(2010-4#1)(2012-3#3)
and been##3##2##(1991-12#1)(1996-2#1)(2008-8#1)
and beet pseudo-yellows virus##2##4##(2008-10#2)
and beetles##2##2##(2007-12#1)(2008-10#1)
and before##8##2##(1992-6#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)
and began to##2##3##(1995-3#1)(2010-11#1)
and began##5##2##(1995-3#1)(1996-3#1)(2008-10#1)(2010-11#1)(2010-8#1)
and begin to##2##3##(2008-1#1)(2008-2#1)
and begin##6##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-4#1)
and beginning of##2##3##(2007-11#1)(2009-7#1)
and beginning##4##2##(1994-2#1)(1996-4#1)(2007-11#1)(2009-7#1)
and begins##2##2##(1993-3#1)(2009-5#1)
and behaves##2##2##(1995-12#1)(2008-7#1)
and behavior and##3##3##(2010-7#1)(2011-2#1)(2013-8#1)
and behavior are##2##3##(1994-6#1)(2008-11#1)
and behavior in##3##3##(2009-8#1)(2009-9#1)(2013-1#1)
and behavior of these##2##4##(1991-6#1)(2008-10#1)
and behavior of##9##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
and behavior problems##3##3##(2009-9#1)(2010-11#2)
and behavior##49##2##(1990-5#1)(1991-6#1)(1993-3#1)(1994-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
and behavioral changes##2##3##(2008-6#1)(2013-1#1)
and behavioral data##2##3##(2008-9#1)(2013-1#1)
and behavioral disorders##2##3##(1991-6#1)(2012-2#1)
and behavioral enrichment##3##3##(2009-4#1)(2009-8#2)
and behavioral problems##2##3##(2007-12#1)(2009-7#1)
and behavioral resistance##2##3##(2010-1#1)(2010-10#1)
and behavioral sciences##3##3##(1996-2#1)(2010-7#2)
and behavioral variables##2##3##(1993-12#1)(2008-7#1)
and behavioral##60##2##(1991-12#1)(1991-6#2)(1992-11#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
and behaviors of practicing community pharmacists towards patient counselling##2##9##(2010-5#2)
and behaviors of##4##3##(2009-8#1)(2010-5#2)(2011-1#1)
and behaviors that##2##3##(2008-2#1)(2009-9#1)
and behaviors##25##2##(1993-3#1)(1995-2#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#3)(2010-5#3)(2011-1#4)
and behaviour of the##2##4##(1990-11#1)(2008-5#1)
and behaviour of##3##3##(1990-11#1)(1996-12#1)(2008-5#1)
and behaviour##21##2##(1990-11#1)(1991-2#1)(1992-3#1)(1994-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
and behavioural factors##5##3##(2010-6#4)(2012-2#1)
and behavioural problems##2##3##(1992-2#1)(2012-1#1)
and behavioural##21##2##(1991-6#1)(1992-2#1)(1993-2#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-9#1)(2010-6#4)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
and behaviourally##2##2##(2008-1#1)(2008-9#1)
and behaviours of##3##3##(2007-12#1)(2007-8#1)(2008-1#1)
and behaviours##8##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-6#3)(2012-12#1)
and behind the##2##3##(2008-3#1)(2008-5#1)
and being in##2##3##(2009-8#1)(2010-11#1)
and being single##2##3##(2011-2#2)
and being##17##2##(1993-1#1)(1996-12#1)(1996-6#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
and beliefs about##4##3##(2007-12#1)(2008-12#1)(2009-11#1)(2009-5#1)
and beliefs of##4##3##(1995-1#1)(1996-1#1)(2011-1#2)
and beliefs regarding their##2##4##(1992-12#1)(1995-1#1)
and beliefs regarding##4##3##(1992-12#1)(1995-1#1)(2013-7#1)(2013-8#1)
and beliefs##21##2##(1992-12#1)(1994-12#1)(1995-1#3)(1996-1#1)(2007-12#2)(2008-12#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#2)(2013-7#1)(2013-8#1)
and believed to##2##3##(1997-2#1)(2008-10#1)
and belong to##2##3##(2008-4#1)(2011-1#1)
and belongs to the##4##4##(1993-6#1)(1994-11#1)(2008-5#1)(2013-1#1)
and belongs to##7##3##(1993-6#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
and belongs##8##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-8#1)
and below the##9##3##(1991-11#1)(1992-7#1)(1996-7#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#2)
and below##13##2##(1991-11#1)(1992-7#1)(1996-7#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)
and bending losses##2##3##(2007-12#1)(2008-3#1)
and bending stiffness##2##3##(2008-5#2)
and bending##5##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#2)
and beneficial to##2##3##(2008-11#1)(2008-12#1)
and beneficial##9##2##(1991-3#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-8#1)
and benefit##10##2##(1991-3#1)(1993-1#1)(1994-1#1)(1996-1#1)(1997-1#1)(2008-3#1)(2008-7#1)(2008-9#3)
and benefiting##2##2##(2007-8#1)(2012-2#1)
and benefits in##2##3##(1995-8#1)(2009-8#1)
and benefits of the##3##4##(1994-2#1)(2008-6#1)(2013-1#1)
and benefits of this procedure##2##5##(2011-2#2)
and benefits of this##4##4##(2007-9#1)(2008-12#1)(2011-2#2)
and benefits of##25##3##(1991-2#1)(1994-2#2)(1996-12#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#3)(2013-1#2)
and benefits##39##2##(1991-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#3)(2013-1#3)
and benfotiamine##4##2##(2012-4#4)
and benign and malignant##2##4##(2007-12#1)(2008-1#1)
and benign##13##2##(1992-5#1)(1992-8#1)(1993-9#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and benomyl##5##2##(2008-10#5)
and benserazide##2##2##(2008-10#2)
and bent##2##2##(1995-2#1)(1995-8#1)
and benthic##3##2##(2012-1#3)
and benzene##3##2##(1994-3#1)(2008-10#2)
and benzo(a)pyrene##2##2##(2008-10#2)
and benzo[a]pyrene (B[a]P)##2##3##(1997-4#1)(2008-10#1)
and benzo[a]pyrene 7##2##3##(1992-2#2)
and benzo[a]pyrene##6##2##(1992-2#2)(1994-5#1)(1997-4#1)(2008-10#2)
and benzoate anion##2##3##(2011-1#2)
and benzoate##3##2##(2010-4#1)(2011-1#2)
and benzoic acid##3##3##(2008-10#3)
and benzothiadiazole##2##2##(2008-10#2)
and benzyl##3##2##(2008-10#2)(2013-1#1)
and benzyloxyresorufin##2##2##(1994-8#2)
and bereavement##4##2##(1991-2#1)(2008-12#2)(2012-3#1)
and berries##4##2##(2008-10#4)
and berry##3##2##(2008-10#3)
and beryllium##2##2##(2008-10#2)
and best friends##3##3##(2009-7#3)
and best practice##2##3##(1995-12#1)(2010-4#1)
and best##14##2##(1993-12#1)(1995-12#1)(1996-3#1)(2008-10#4)(2009-7#3)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
and bestatin##3##2##(1992-5#1)(1996-2#2)
and beta 1##3##3##(1990-3#1)(1991-12#1)(1993-11#1)
and beta 2##4##3##(1992-9#1)(1993-12#2)(1995-11#1)
and beta 2-microglobulin (beta##3##4##(1994-5#1)(1996-12#1)(1997-3#1)
and beta 2-microglobulin##7##3##(1994-5#1)(1995-12#4)(1996-12#1)(1997-3#1)
and beta = 97##2##4##(1992-9#1)(1997-7#1)
and beta =##4##3##(1992-9#1)(1997-7#3)
and beta A4##3##3##(1991-6#3)
and beta adrenergic##2##3##(1994-9#2)
and beta and##3##3##(1994-11#1)(2008-8#2)
and beta blockers##2##3##(1990-2#1)(2008-11#1)
and beta cells##2##3##(1991-7#1)(2008-1#1)
and beta##101##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#4)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#5)(1991-7#2)(1992-11#1)(1992-6#1)(1992-9#4)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1994-11#6)(1994-12#1)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#4)(1995-6#2)(1996-12#3)(1997-3#3)(1997-4#2)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2010-8#1)(2012-3#1)
and beta(2)##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
and beta)##3##2##(1994-5#1)(1996-7#1)(2008-2#1)
and beta-1##15##2##(1991-5#1)(1992-11#2)(1992-7#2)(2008-10#10)
and beta-CGRP##8##2##(1992-6#8)
and beta-actin mRNA##2##3##(1996-12#1)(1996-2#1)
and beta-actin##5##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
and beta-adrenoceptors##6##2##(1994-5#1)(1995-12#5)
and beta-alanine##2##2##(1995-5#2)
and beta-amyloid##2##2##(1991-10#1)(1992-8#1)
and beta-blockers are##2##3##(2008-3#1)(2008-4#1)
and beta-blockers in##2##3##(1993-2#1)(2011-2#1)
and beta-blockers##10##2##(1992-6#1)(1993-2#1)(1994-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#2)
and beta-carotene##3##2##(1992-9#1)(2009-6#2)
and beta-cell function##2##3##(1991-7#1)(2008-1#1)
and beta-cyclodextrin (beta-CD)##2##3##(2008-10#2)
and beta-cyclodextrin##6##2##(2007-11#1)(2008-10#5)
and beta-endorphin given##2##3##(1992-3#2)
and beta-endorphin##10##2##(1991-6#1)(1992-3#5)(1993-5#2)(2008-6#1)(2009-7#1)
and beta-galactosidase##7##2##(1990-2#1)(1990-5#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
and beta-globin##3##2##(1990-8#1)(1994-8#1)(1996-2#1)
and beta-glucosidase##2##2##(2008-10#1)(2008-6#1)
and beta-glucuronidase##2##2##(1991-12#1)(2008-9#1)
and beta-interferons##4##2##(1990-2#4)
and beta-lactam##6##2##(1990-11#5)(1996-3#1)
and beta-lactams##2##2##(2007-2#1)(2008-12#1)
and beta-lactoglobulin##2##2##(2008-10#1)(2008-7#1)
and beta-naphthoflavone-induced##2##2##(1993-11#2)
and beta-naphthol##3##2##(2008-10#3)
and beta-sheet conformations##2##3##(1992-6#1)(2008-5#1)
and beta-sheet##5##2##(1991-6#1)(1992-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
and beta-strand##2##2##(1995-2#1)(1995-5#1)
and beta-subunit##2##2##(1990-2#1)(1994-9#1)
and beta-tubulin##4##2##(2008-10#4)
and better outcomes##2##3##(2008-11#1)(2008-7#1)
and better peak##2##3##(2008-10#1)(2011-1#1)
and better prognosis##2##3##(2008-8#1)(2013-1#1)
and better self-reported physical and mental health than the control group##2##11##(2013-1#2)
and better than##2##3##(1996-5#1)(2008-3#1)
and better understand##2##3##(2012-12#1)(2012-2#1)
and better##67##2##(1990-2#1)(1991-1#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-3#2)(1996-5#2)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
and between 0##5##3##(2008-10#4)(2008-3#1)
and between 2 and##2##4##(2008-10#1)(2011-10#1)
and between 3##2##3##(2008-10#2)
and between 30##2##3##(2007-2#1)(2008-10#1)
and between assay##2##3##(1990-2#1)(2008-10#1)
and between days##4##3##(2008-10#2)(2010-12#2)
and between laboratories##2##3##(1990-12#1)(2008-5#1)
and between pH##2##3##(2008-6#1)(2013-1#1)
and between patients##2##3##(1997-2#1)(2008-7#1)
and between regions##2##3##(2008-10#1)(2013-8#1)
and between species##4##3##(2008-10#1)(2009-6#1)(2012-3#2)
and between the##20##3##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2010-7#1)(2012-12#1)
and between##153##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2008-10#46)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#3)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-12#6)(2012-3#6)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#2)
and between-assay##3##2##(1992-3#1)(1995-12#1)(2008-10#1)
and between-batch##2##2##(1993-9#1)(2008-10#1)
and between-day##3##2##(1991-2#1)(2008-10#2)
and beverages##13##2##(2008-10#4)(2008-8#1)(2008-9#1)(2010-9#2)(2012-12#2)(2012-2#3)
and beyond the##3##3##(2008-1#1)(2008-8#1)(2013-1#1)
and beyond##33##2##(1991-3#1)(1993-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and bias##8##2##(1990-6#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-12#1)(2010-9#1)
and biaxial##2##2##(2006-4#1)(2008-3#1)
and bibliographies of key articles##4##5##(2012-12#4)
and bicyclo [5##2##3##(2009-8#2)
and bidirectional##3##2##(2008-10#1)(2008-3#2)
and bifidobacteria##3##2##(2009-5#3)
and bigger##2##2##(2008-10#1)(2011-2#1)
and bilateral fusion##2##3##(2008-8#2)
and bilateral lesions of##2##4##(2008-7#2)
and bilateral##38##2##(1991-3#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-11#2)(2008-5#2)(2008-7#5)(2008-8#3)(2009-3#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#3)
and bilaterally in##2##3##(1990-6#1)(1993-12#1)
and bilaterally##5##2##(1990-6#1)(1993-12#1)(1997-8#1)(2008-7#1)(2008-9#1)
and bile acid##3##3##(2008-10#2)(2008-2#1)
and bile acids##2##3##(1990-11#1)(1992-3#1)
and bile##8##2##(1990-11#1)(1992-3#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#1)
and biliary##11##2##(1992-6#1)(1992-9#2)(1993-5#1)(2008-7#1)(2010-12#1)(2011-2#3)(2013-1#2)
and bilirubin##6##2##(1990-6#1)(1992-8#1)(1993-1#1)(2008-10#1)(2008-5#1)(2012-12#1)
and binary fluids##3##3##(2008-3#2)(2008-7#1)
and binary mixtures##2##3##(2008-10#1)(2008-7#1)
and binary##11##2##(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#2)(2013-1#1)
and bind to the##3##4##(1992-8#1)(1997-2#1)(2008-9#1)
and bind to##4##3##(1992-8#1)(1997-2#1)(2008-9#1)(2009-7#1)
and bind##6##2##(1992-8#1)(1996-2#1)(1997-2#1)(2008-9#1)(2009-7#1)(2011-1#1)
and binder##2##2##(2008-10#2)
and binding affinity of##2##4##(1997-6#1)(2008-8#1)
and binding affinity##4##3##(1991-8#1)(1993-6#1)(1997-6#1)(2008-8#1)
and binding constant##2##3##(2008-10#2)
and binding of##4##3##(1994-11#1)(1997-2#1)(2008-10#1)(2011-1#1)
and binding pattern of##2##4##(2008-10#2)
and binding site##2##3##(2008-4#1)(2012-2#1)
and binding sites##4##3##(1993-6#1)(2008-10#1)(2008-7#2)
and binding studies##3##3##(1992-12#1)(1995-12#1)(2013-1#1)
and binding to##3##3##(1993-12#1)(1995-2#1)(2008-11#1)
and binding##34##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
and binds to##5##3##(1990-5#2)(1991-2#1)(2009-8#1)(2012-2#1)
and binds##6##2##(1990-5#2)(1991-2#1)(2009-8#1)(2012-2#2)
and binge drinking##2##3##(2009-5#2)
and binomial##2##2##(2008-10#1)(2010-5#1)
and binucleate##2##2##(2008-10#1)(2008-12#1)
and bioaccumulation of##2##3##(2008-10#1)(2008-5#1)
and bioactivity of new##2##4##(2007-11#1)(2012-2#1)
and bioactivity##4##2##(2007-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
and bioadhesion##3##2##(2008-5#1)(2010-5#2)
and bioanalytical##5##2##(2008-10#2)(2008-4#1)(2010-11#1)(2011-2#1)
and bioassay##2##2##(2009-12#1)(2011-3#1)
and bioassays##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
and biochemical analysis##2##3##(2008-10#1)(2009-12#1)
and biochemical approaches have##2##4##(2008-11#1)(2011-1#1)
and biochemical assays##2##3##(2008-10#2)
and biochemical changes##7##3##(1991-2#1)(1996-5#1)(2008-12#1)(2008-7#2)(2012-2#2)
and biochemical characterization of##3##4##(1991-2#1)(1991-9#1)(1993-8#1)
and biochemical characterization##4##3##(1991-2#1)(1991-9#1)(1993-8#1)(2008-10#1)
and biochemical data##4##3##(1993-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
and biochemical effects of##2##4##(1992-3#1)(2010-1#1)
and biochemical effects##3##3##(1992-3#1)(2008-7#1)(2010-1#1)
and biochemical features##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
and biochemical findings##3##3##(1997-3#1)(2007-7#1)(2008-12#1)
and biochemical mechanisms##2##3##(2008-11#1)(2011-2#1)
and biochemical parameters in##2##4##(2008-5#1)(2012-2#1)
and biochemical parameters##8##3##(2008-11#1)(2008-5#3)(2008-7#1)(2011-10#2)(2012-2#1)
and biochemical processes##4##3##(2009-8#2)(2013-8#2)
and biochemical properties##2##3##(2008-10#1)(2012-2#1)
and biochemical responses of##3##4##(2007-12#1)(2008-12#1)(2012-6#1)
and biochemical responses##5##3##(2007-12#1)(2008-12#1)(2008-7#1)(2011-10#1)(2012-6#1)
and biochemical studies##5##3##(1991-8#1)(1992-11#1)(1996-2#1)(1997-4#1)(2009-6#1)
and biochemical study##2##3##(1991-12#1)(2008-10#1)
and biochemical techniques##2##3##(1996-2#1)(2008-9#1)
and biochemical tests##2##3##(1992-5#1)(2012-2#1)
and biochemical##107##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-5#2)(1995-12#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#15)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#10)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-10#4)(2011-2#4)(2012-1#2)(2012-2#5)(2012-3#1)(2012-6#2)(2013-1#1)(2013-8#2)
and biochemically##6##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
and biochemistry of##4##3##(1996-5#1)(2008-11#1)(2008-2#1)(2008-7#1)
and biochemistry##7##2##(1996-5#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-4#1)
and biocompatibility##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
and biocompatible##2##2##(2008-5#1)(2010-10#1)
and biocontrol activity##2##3##(2008-10#2)
and biocontrol##8##2##(2008-10#8)
and biocorrosion behaviors##2##3##(2012-2#2)
and biodegradation of##2##3##(2008-7#2)
and biodegradation##3##2##(2008-11#1)(2008-7#2)
and biodiversity##3##2##(2010-6#1)(2011-2#1)(2012-2#1)
and biodurability)##2##2##(2008-11#2)
and bioengineering applications##2##3##(2008-3#1)(2009-12#1)
and bioengineering##3##2##(2008-3#1)(2009-12#2)
and bioethical##2##2##(2008-7#1)(2013-8#1)
and biofilm formation##6##3##(2007-12#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-1#1)
and biofilm##8##2##(2007-12#1)(2008-7#4)(2008-8#1)(2010-4#1)(2013-1#1)
and biogenesis##2##2##(2012-3#1)(2013-8#1)
and biogenic##2##2##(2008-3#1)(2010-11#1)
and biogeography##2##2##(2008-6#1)(2008-8#1)
and bioinformatic##2##2##(2008-9#1)(2013-8#1)
and bioinformatics##4##2##(1997-4#1)(2008-7#2)(2009-8#1)
and biologic meshes##2##3##(2011-2#2)
and biologic therapies##2##3##(2010-5#1)(2011-2#1)
and biologic##13##2##(1990-8#1)(1991-3#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#6)(2012-12#1)
and biological activities of##2##4##(2007-11#1)(2011-2#1)
and biological activity of##5##4##(1990-2#1)(1993-5#1)(1994-3#1)(2007-11#1)(2008-10#1)
and biological activity##13##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-5#1)(1993-8#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)
and biological and##2##3##(2008-11#1)(2013-1#1)
and biological assays##2##3##(2008-10#2)
and biological behavior##2##3##(2008-10#1)(2011-2#1)
and biological characteristics of##2##4##(2007-8#1)(2008-6#1)
and biological characteristics##6##3##(1990-9#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-6#1)
and biological characterization of##2##4##(1992-12#1)(2008-10#1)
and biological characterization##3##3##(1992-12#1)(2008-10#2)
and biological control##4##3##(1997-7#1)(2008-10#3)
and biological data##2##3##(1992-5#1)(1994-5#1)
and biological defense research##2##4##(1992-12#2)
and biological diversity of##4##4##(2008-10#2)(2008-8#2)
and biological diversity##5##3##(2008-10#3)(2008-8#2)
and biological evaluation of##5##4##(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#2)
and biological evaluation##6##3##(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#3)
and biological fluids using##3##4##(2008-10#3)
and biological fluids with##2##4##(2008-10#1)(2010-4#1)
and biological fluids##20##3##(2008-10#18)(2010-4#2)
and biological function of##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
and biological function##7##3##(1994-11#1)(2008-10#1)(2008-11#1)(2010-2#2)(2011-1#1)(2012-2#1)
and biological functions##3##3##(1990-11#1)(2008-5#1)(2012-1#1)
and biological molecules##3##3##(2008-10#2)(2009-6#1)
and biological parameters##3##3##(1993-6#1)(2008-7#2)
and biological processes##5##3##(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)
and biological profile##3##3##(1997-8#1)(2008-10#1)(2011-3#1)
and biological properties##3##3##(2008-10#2)(2008-9#1)
and biological samples by##3##4##(2008-10#3)
and biological samples is##2##4##(2008-10#2)
and biological samples##32##3##(2008-10#30)(2008-3#1)(2010-6#1)
and biological sciences##2##3##(1994-12#1)(2008-2#1)
and biological significance of##2##4##(2008-10#1)(2012-12#1)
and biological systems##2##3##(1992-3#1)(2008-10#1)
and biological tests##3##3##(2006-12#1)(2008-10#1)(2008-8#1)
and biological variables##2##3##(1996-6#1)(2008-8#1)
and biological##217##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-9#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-12#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#85)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#5)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#1)
and biologically active##2##3##(1996-3#1)(2008-8#1)
and biologically##13##2##(1990-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-1#1)
and biologics##2##2##(2008-10#1)(2011-2#1)
and biologists##3##2##(2008-4#1)(2008-7#1)(2013-8#1)
and biology of##7##3##(1995-3#1)(2007-5#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-7#1)
and biology##13##2##(1990-2#1)(1995-3#1)(2007-5#1)(2008-10#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
and biomarker##4##2##(2008-4#1)(2009-10#1)(2010-10#1)(2010-7#1)
and biomarkers##7##2##(2010-11#2)(2012-2#1)(2012-3#1)(2013-1#3)
and biomass of the##2##4##(2008-5#1)(2013-1#1)
and biomass of##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
and biomass##14##2##(1997-5#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#1)(2013-1#1)
and biomaterials##4##2##(2008-10#1)(2008-12#1)(2012-5#1)(2013-8#1)
and biomechanical properties of##2##4##(2007-11#1)(2008-9#1)
and biomechanical properties##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
and biomechanical##12##2##(1990-6#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-5#2)(2008-9#2)(2009-4#1)(2009-7#1)(2011-7#1)(2012-12#1)
and biomedical research##3##3##(1993-3#1)(2008-11#1)(2008-7#1)
and biomedical##6##2##(1993-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)
and biomedicine##2##2##(1995-11#1)(2008-7#1)
and biometric##2##2##(2008-10#1)(2008-8#1)
and biomimetic##2##2##(2008-5#1)(2009-11#1)
and biomolecules##5##2##(1996-12#1)(2008-5#2)(2010-11#1)(2011-1#1)
and biophysical properties##2##3##(1997-2#1)(2009-12#1)
and biophysical##8##2##(1992-6#1)(1994-5#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-5#2)(2009-12#1)
and biopsies were##3##3##(1996-12#1)(2007-7#1)(2008-5#1)
and biopsy findings##3##3##(2008-11#1)(2008-5#1)(2012-1#1)
and biopsy is##2##3##(2008-10#1)(2012-2#1)
and biopsy was##2##3##(2009-1#1)(2012-2#1)
and biopsy##14##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
and bioreactor##2##2##(2008-6#1)(2012-2#1)
and bioreactors##3##2##(2008-11#2)(2011-2#1)
and biorheological##2##2##(2008-9#2)
and biosensor##2##2##(2008-10#2)
and biosensors##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2010-7#1)
and biotech##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
and biotechnological applications##3##3##(2008-11#1)(2009-10#1)(2010-4#1)
and biotechnological##6##2##(1994-11#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-4#1)
and biotechnology##7##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)
and biotic##6##2##(2008-10#3)(2009-10#1)(2009-6#1)(2009-8#1)
and biotin-labeled##2##2##(2008-10#2)
and biotinylated##6##2##(2008-10#3)(2008-4#1)(2008-9#2)
and biotransformation##2##2##(1996-12#1)(2008-11#1)
and bipolar disorder##7##3##(2008-3#1)(2008-4#2)(2008-7#2)(2009-6#2)
and bipolar##21##2##(1995-3#1)(1996-7#1)(1997-5#3)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2009-6#2)(2010-6#1)(2012-3#1)
and bird##8##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-12#1)
and bird-like##2##2##(2007-8#1)(2009-10#1)
and birds##5##2##(2008-8#1)(2009-5#2)(2009-8#1)(2010-3#1)
and birefringence##2##2##(2008-2#1)(2008-3#1)
and birefringent##3##2##(2007-12#1)(2008-3#2)
and birth defects##2##3##(2008-11#1)(2008-8#1)
and birth order##2##3##(1995-1#1)(1995-6#1)
and birth outcome##3##3##(1991-12#1)(1995-2#2)
and birth outcomes##4##3##(1993-3#2)(1997-7#1)(2013-1#1)
and birth weight##3##3##(1992-2#1)(2008-11#1)(2012-12#1)
and birth##22##2##(1990-9#1)(1991-12#1)(1992-2#1)(1993-3#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-6#1)(1997-7#1)(2007-2#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2012-12#1)(2013-1#1)
and births##2##2##(2008-1#1)(2010-12#1)
and bisexual men##8##3##(1991-11#1)(2008-12#2)(2013-7#5)
and bisexual##18##2##(1991-11#1)(2008-12#10)(2010-3#1)(2010-8#1)(2013-7#5)
and bismuth from cobalt##2##4##(2008-10#2)
and bismuth from##3##3##(2008-10#3)
and bismuth were##3##3##(2008-10#3)
and bismuth##12##2##(2008-10#10)(2010-11#2)
and bisphenol##2##2##(2008-10#2)
and bisphosphonate##3##2##(2007-11#2)(2009-12#1)
and bisphosphonates##3##2##(2007-11#3)
and bit-error##2##2##(2008-2#1)(2008-3#1)
and bitter gourd##2##3##(2013-8#2)
and bitter rot##3##3##(2008-10#3)
and bitter##5##2##(2008-10#3)(2013-8#2)
and bivariate analysis##4##3##(2008-5#1)(2011-2#1)(2013-1#2)
and bivariate##5##2##(1995-1#1)(2008-5#1)(2011-2#1)(2013-1#2)
and bla-1##3##2##(1991-5#3)
and black carbon##2##3##(2008-3#2)
and black tea##3##3##(2008-11#1)(2009-8#2)
and black teas##4##3##(2008-10#2)(2008-11#2)
and black##13##2##(2008-10#4)(2008-11#3)(2008-3#2)(2009-8#2)(2011-2#1)(2012-2#1)
and bladder agenesis##2##3##(2008-10#2)
and bladder cancer##3##3##(1997-4#1)(2008-11#1)(2013-8#1)
and bladder##17##2##(1990-8#1)(1993-8#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-11#3)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
and blade##3##2##(2008-12#2)(2009-12#1)
and blank##5##2##(1990-5#1)(2007-12#1)(2008-10#3)
and blastocyst##4##2##(2008-5#1)(2008-9#2)(2012-3#1)
and blastospores##2##2##(2008-10#2)
and bleaching##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
and bleeding are##2##3##(2010-12#1)(2010-8#1)
and bleeding from##2##3##(2007-7#1)(2008-1#1)
and bleeding##17##2##(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
and blight##2##2##(2008-10#2)
and blindness##3##2##(1996-11#1)(2011-2#2)
and blister##2##2##(1990-2#1)(2011-2#1)
and block polypropylene##2##3##(2007-12#2)
and block the##5##3##(1991-12#1)(1992-3#1)(2008-11#1)(2008-6#1)(2009-4#1)
and block##10##2##(1991-12#1)(1992-3#1)(1994-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
and blocked by##2##3##(1990-12#1)(1994-5#1)
and blocked##4##2##(1990-12#1)(1994-5#1)(2008-7#1)(2008-8#1)
and blocking##5##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
and blocks the##2##3##(2008-7#1)(2008-8#1)
and blocks##5##2##(1995-11#1)(1995-2#1)(2008-7#2)(2008-8#1)
and blood and##2##3##(2008-10#1)(2008-4#1)
and blood cells##3##3##(1993-9#1)(2008-4#2)
and blood chemistry##2##3##(2008-5#1)(2013-1#1)
and blood flow##7##3##(2007-11#2)(2008-12#1)(2008-8#1)(2013-1#2)(2013-8#1)
and blood gas##3##3##(1997-3#1)(1997-7#1)(2010-10#1)
and blood glucose concentrations##2##4##(1993-1#1)(2013-8#1)
and blood glucose##7##3##(1993-1#2)(2008-1#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
and blood lactate##3##3##(2009-1#1)(2013-1#1)(2013-8#1)
and blood loss##3##3##(1992-2#1)(1996-2#1)(2012-3#1)
and blood plasma##3##3##(1995-12#1)(2008-10#2)
and blood pressure (BP)##3##4##(2008-5#1)(2010-5#1)(2011-1#1)
and blood pressure control##2##4##(1996-2#1)(2007-7#1)
and blood pressure in##3##4##(2008-3#1)(2008-7#1)(2013-8#1)
and blood pressure measurement##2##4##(1994-3#1)(2008-8#1)
and blood pressure##27##3##(1991-6#1)(1992-12#1)(1992-9#2)(1994-3#1)(1996-2#1)(1996-5#1)(1997-7#3)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
and blood products##5##3##(2007-9#3)(2008-12#1)(2008-7#1)
and blood sample##2##3##(2008-10#1)(2011-1#1)
and blood samples from##2##4##(1990-7#1)(1996-12#1)
and blood samples were collected##2##5##(1990-12#1)(1997-2#1)
and blood samples were##6##4##(1990-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
and blood samples##14##3##(1990-12#1)(1990-7#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
and blood serum##2##3##(2008-10#1)(2013-1#1)
and blood supply##2##3##(2011-1#1)(2012-2#1)
and blood transfusion##4##3##(1991-8#1)(2007-7#1)(2007-8#1)(2013-1#1)
and blood transfusions##2##3##(1990-5#1)(2008-4#1)
and blood vessel##2##3##(1991-12#1)(2013-1#1)
and blood vessels##6##3##(1992-12#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
and blood##139##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-9#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#4)(2007-10#3)(2007-11#3)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#6)
and blue and##2##3##(2008-10#1)(2008-3#1)
and blue light##4##3##(2007-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
and blue lines##2##3##(2007-11#1)(2008-8#1)
and blue##20##2##(1990-11#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-8#1)(2011-2#1)(2013-1#1)
and blurred vision##2##3##(2008-7#1)(2011-1#1)
and board##2##2##(1992-3#1)(1994-12#1)
and boards##2##2##(1991-1#1)(1996-1#1)
and bobcats##2##2##(2009-4#2)
and body balance##2##3##(2008-12#2)
and body composition analysis##2##4##(2008-11#1)(2008-5#1)
and body composition in##2##4##(2012-12#1)(2012-2#1)
and body composition##8##3##(2008-11#1)(2008-5#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
and body dissatisfaction##2##3##(2007-12#1)(2013-8#1)
and body fat##5##3##(2008-1#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-8#1)
and body flexibility##3##3##(2010-12#3)
and body image##4##3##(2007-12#3)(2010-11#1)
and body mass index (BMI)##7##5##(1994-12#1)(2008-10#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
and body mass index##14##4##(1991-12#1)(1994-12#1)(2008-10#2)(2008-7#2)(2009-9#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
and body mass##19##3##(1991-12#1)(1994-12#1)(2008-10#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
and body of##3##3##(2008-9#1)(2010-6#1)(2013-1#1)
and body satisfaction##7##3##(2007-12#3)(2010-10#3)(2013-8#1)
and body shape##3##3##(2007-12#1)(2007-7#2)
and body size##4##3##(1991-12#1)(2008-9#1)(2013-1#2)
and body weight gain##3##4##(2008-5#1)(2008-9#2)
and body weight##13##3##(1992-2#1)(1997-3#1)(1997-7#1)(2008-5#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
and body##107##2##(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-12#13)(2007-7#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#7)(2013-8#7)
and bogies##2##2##(1995-1#1)(1995-12#1)
and boiling##2##2##(1996-12#1)(2008-10#1)
and bombesin##2##2##(1994-3#1)(2010-6#1)
and bond##5##2##(1990-8#1)(2008-8#2)(2011-2#2)
and bonded to##2##3##(2007-11#1)(2010-4#1)
and bonding strategies on the microshear bond strength of##2##9##(2013-1#2)
and bonding##3##2##(2013-1#3)
and bone and joint infections##2##5##(2013-8#2)
and bone cement##3##3##(2007-11#3)
and bone density##2##3##(1993-7#1)(2008-1#1)
and bone formation##2##3##(1994-12#1)(2007-11#1)
and bone graft##3##3##(2008-11#1)(2010-6#1)(2013-1#1)
and bone grafting##2##3##(2011-2#1)(2012-12#1)
and bone in##2##3##(2008-1#1)(2012-1#1)
and bone loss##2##3##(1994-9#1)(2010-6#1)
and bone marrow transplantation##3##4##(2008-11#2)(2013-8#1)
and bone marrow##16##3##(1990-3#1)(1991-9#1)(1993-11#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2012-12#1)(2013-8#1)
and bone metastases##5##3##(1993-11#1)(2007-10#1)(2007-11#2)(2007-7#1)
and bone metastasis##2##3##(2010-10#1)(2010-3#1)
and bone mineral density in##2##5##(2011-2#1)(2012-2#1)
and bone mineral density##4##4##(1995-9#1)(2011-2#2)(2012-2#1)
and bone mineral##7##3##(1995-9#1)(2008-7#1)(2011-2#4)(2012-2#1)
and bone regeneration##2##3##(2008-5#1)(2010-6#1)
and bone scintigraphy##2##3##(2007-11#1)(2009-4#1)
and bone##105##2##(1990-3#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-9#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#13)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-3#2)(2010-6#4)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#1)(2013-1#2)(2013-8#4)
and bony##3##2##(2010-10#1)(2012-2#1)(2013-8#1)
and books##3##2##(1990-4#1)(2008-10#1)(2013-8#1)
and borate buffer##2##3##(2008-10#2)
and borderline personality disorder##3##4##(2008-4#1)(2009-10#1)(2013-1#1)
and borderline##4##2##(2008-11#1)(2008-4#1)(2009-10#1)(2013-1#1)
and boric acid##3##3##(2008-10#3)
and boron##4##2##(2008-10#2)(2008-3#2)
and boronic acid##3##3##(2008-10#3)
and bortezomib##2##2##(2011-2#2)
and botanical origin##2##3##(2008-10#2)
and both are##3##3##(1995-2#1)(1996-10#1)(2013-1#1)
and both factors##2##3##(2008-8#1)(2008-9#1)
and both have##2##3##(2008-1#1)(2012-2#1)
and both of##2##3##(2008-11#1)(2008-9#1)
and both species##3##3##(2008-10#2)(2008-8#1)
and both the##16##3##(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-1#1)
and both were##4##3##(1995-8#1)(2008-10#2)(2012-2#1)
and both##104##2##(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-3#2)(1997-3#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#3)
and bottled##3##2##(2008-10#3)
and bottom components##2##3##(1992-8#2)
and bottom depths##2##3##(2008-3#2)
and bottom##10##2##(1992-8#2)(2008-10#2)(2008-12#1)(2008-3#3)(2013-1#2)
and botulinum##2##2##(2007-12#1)(2011-2#1)
and bound to the##2##4##(1993-11#1)(2008-11#1)
and bound to##4##3##(1991-5#1)(1993-11#1)(2008-10#1)(2008-11#1)
and bound##13##2##(1991-5#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#1)
and boundary##2##2##(2008-2#1)(2008-3#1)
and bovine liver##2##3##(1992-12#1)(2008-10#1)
and bovine serum albumin (BSA)##6##5##(2008-10#5)(2008-11#1)
and bovine serum albumin##12##4##(1993-11#1)(2008-10#8)(2008-11#3)
and bovine spongiform encephalopathy##2##4##(1996-3#1)(1997-3#1)
and bovine##41##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#5)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#13)(2008-11#3)
and bowel resection##3##3##(2010-12#3)
and bowel##6##2##(2009-5#2)(2010-12#4)
and boys##8##2##(2007-12#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-8#2)
and brachial artery flow-mediated vasodilatation##3##5##(2008-11#3)
and brachial##4##2##(2008-11#3)(2008-9#1)
and bradycardia##3##2##(2008-12#1)(2008-7#2)
and bradykinesia##2##2##(2008-7#2)
and bradykinin##3##2##(1992-6#1)(1997-2#2)
and brain MAO inhibitory activity##2##5##(1994-3#2)
and brain are##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
and brain areas##2##3##(2008-11#1)(2013-8#1)
and brain function##2##3##(2008-7#1)(2009-7#1)
and brain of##4##3##(1993-2#1)(1997-7#1)(2013-1#2)
and brain stem##2##3##(1991-8#1)(1996-2#1)
and brain tissue##2##3##(1990-2#1)(2008-10#1)
and brain were##2##3##(1994-5#1)(1997-7#1)
and brain##77##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#5)(1995-12#1)(1996-10#1)(1996-2#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
and brain-derived neurotrophic factor##2##4##(1997-2#2)
and brains##2##2##(1992-12#1)(2008-7#1)
and brainstem##5##2##(1991-10#1)(1996-12#1)(1996-5#1)(2007-10#1)(2012-3#1)
and branch##3##2##(2008-7#1)(2008-9#1)(2011-1#1)
and branched##4##2##(1996-2#1)(2008-10#2)(2010-10#1)
and branches##2##2##(2008-11#1)(2008-5#1)
and branching of##2##3##(1995-3#1)(2012-2#1)
and branching##7##2##(1993-11#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-7#2)(2012-2#1)
and bread wheat##2##3##(2008-10#2)
and bread##5##2##(2008-10#4)(2011-2#1)
and breadth of##2##3##(1993-12#1)(2009-10#1)
and breakage##2##2##(2008-5#1)(2008-7#1)
and breakdown of##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
and breakdown##6##2##(1993-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
and breaking##2##2##(1995-2#1)(2008-12#1)
and breakpoint##2##2##(2008-4#1)(2008-7#1)
and breast cancer death rates##2##5##(1991-12#2)
and breast cancer risk##3##4##(1990-6#1)(1994-2#1)(2012-2#1)
and breast cancer##20##3##(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-2#2)(1996-3#2)(1997-8#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and breast cancers##4##3##(1991-12#1)(2008-4#1)(2010-10#1)(2012-2#1)
and breast in##2##3##(1991-2#1)(1995-9#1)
and breast##44##2##(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-2#2)(1994-5#3)(1994-6#2)(1995-9#3)(1996-3#2)(1997-8#2)(2007-10#2)(2007-5#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and breastfeeding in##2##3##(2010-12#1)(2012-2#1)
and breath##2##2##(2010-6#1)(2013-8#1)
and breathing##2##2##(1994-12#1)(2012-2#1)
and bred##2##2##(2008-10#1)(2008-9#1)
and breeders##2##2##(2008-9#1)(2012-2#1)
and breeding of##2##3##(2008-8#1)(2013-7#1)
and breeding##8##2##(2008-5#1)(2008-8#5)(2010-10#1)(2013-7#1)
and brefeldin##2##2##(2008-11#1)(2010-3#1)
and brief intervention##7##3##(2008-11#7)
and brief review of the literature##3##6##(2010-9#1)(2012-3#1)(2013-1#1)
and brief##13##2##(1992-1#1)(1992-12#1)(2008-11#8)(2010-9#1)(2012-3#1)(2013-1#1)
and briefly##6##2##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-1#1)
and brightness##2##2##(2013-8#2)
and bring the##2##3##(1990-8#1)(1994-6#1)
and bring##3##2##(1990-8#1)(1994-6#1)(2008-12#1)
and broad spectrum##2##3##(2008-3#1)(2010-12#1)
and broad##12##2##(1991-12#1)(1992-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2010-12#1)(2013-1#1)
and broad-sense##2##2##(2008-10#2)
and broadband ultraviolet-visible light source##2##5##(2008-2#2)
and broadband##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
and broaden the##2##3##(2007-12#1)(2007-4#1)
and broadened the##2##3##(2008-11#1)(2008-3#1)
and broadening##2##2##(1992-8#1)(2008-3#1)
and broader##6##2##(2007-12#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
and broadly##2##2##(2010-4#1)(2013-1#1)
and broccoli##2##2##(2008-10#1)(2008-12#1)
and broken##2##2##(1990-9#1)(2008-2#1)
and bromate##2##2##(2008-10#2)
and bromegrass species##2##3##(2008-10#2)
and bromide##4##2##(2008-10#4)
and bromine##4##2##(2008-10#3)(2008-2#1)
and bromodeoxyuridine incorporation##2##3##(1996-12#1)(2007-12#1)
and bromodeoxyuridine##4##2##(1995-9#1)(1996-12#1)(1996-5#1)(2007-12#1)
and bronchi##3##2##(2007-8#1)(2010-8#1)(2013-1#1)
and bronchial##4##2##(1990-9#1)(1996-7#1)(2010-6#1)(2010-8#1)
and bronchiectasis##2##2##(1997-3#1)(2008-1#1)
and bronchoalveolar lavage fluid##2##4##(1992-3#1)(2008-7#1)
and bronchoalveolar lavage##5##3##(1991-9#1)(1992-3#2)(2008-1#1)(2008-7#1)
and bronchoalveolar##6##2##(1991-9#1)(1992-3#2)(2008-1#1)(2008-10#1)(2008-7#1)
and bronchodilator##2##2##(1997-7#1)(2010-1#1)
and bronchopneumonia##2##2##(2011-2#1)(2012-3#1)
and brought into##2##3##(2008-4#1)(2009-5#1)
and brought to##2##3##(1991-3#1)(2013-8#1)
and brought##7##2##(1991-3#1)(1992-4#1)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
and brown##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
and bruises##2##2##(2008-11#1)(2013-7#1)
and bubble##2##2##(2008-11#1)(2008-6#1)
and budget##4##2##(1993-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
and budgetary##2##2##(1995-1#1)(2012-12#1)
and buffer composition##2##3##(1994-9#1)(2008-10#1)
and buffer##7##2##(1994-9#1)(2008-10#5)(2009-7#1)
and buffering##2##2##(2008-10#1)(2012-3#1)
and buffers##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
and build##7##2##(1997-1#2)(2008-12#1)(2008-2#2)(2008-7#1)(2010-5#1)
and building##7##2##(1991-12#1)(1991-3#1)(1996-1#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
and builds##2##2##(1997-3#1)(2011-2#1)
and built##11##2##(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#6)(2009-6#1)(2009-8#1)
and bulbar##2##2##(2008-10#1)(2008-7#1)
and bulimia nervosa##2##3##(2007-7#2)
and bulimia##4##2##(2007-7#4)
and bulk##13##2##(1994-9#1)(2007-11#1)(2008-10#3)(2008-3#5)(2008-6#1)(2008-7#2)
and bulked##2##2##(2008-10#1)(2008-9#1)
and bulky##2##2##(2008-3#1)(2008-6#1)
and bupropion##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
and burdens##2##2##(1991-3#1)(2012-2#1)
and bureaucratic##2##2##(1993-2#1)(1995-2#1)
and burnout levels##2##3##(2009-5#2)
and burnout##7##2##(1992-1#1)(1996-2#1)(2008-11#1)(2009-5#2)(2010-7#1)(2012-1#1)
and burns##2##2##(1991-6#1)(2008-10#1)
and burst forming units-erythroid##2##4##(2008-10#1)(2008-7#1)
and burst##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
and business##10##2##(1991-12#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-11#2)(2012-3#2)
and butane##2##2##(2008-11#1)(2008-3#1)
and butanol##4##2##(1990-11#1)(2008-10#2)(2013-1#1)
and buttocks##3##2##(1990-3#1)(2008-5#2)
and butyl##2##2##(2008-10#1)(2008-5#1)
and butyrate##2##2##(2008-11#2)
and by 21##2##3##(1997-7#1)(2008-10#1)
and by 4##2##3##(2008-10#1)(2008-3#1)
and by HPLC##2##3##(2008-10#2)
and by Western blot analysis##2##5##(1992-8#1)(1993-6#1)
and by Western blotting##3##4##(1994-11#1)(1994-12#1)(1995-6#1)
and by Western##5##3##(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)
and by a C##2##4##(2008-10#2)
and by a factor of##2##5##(1995-8#1)(2008-10#1)
and by a method##2##4##(2008-10#1)(2008-11#1)
and by a more##2##4##(2008-1#1)(2008-10#1)
and by a##29##3##(1990-5#1)(1991-8#1)(1992-3#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-5#2)(2010-7#1)(2013-1#2)
and by an##4##3##(1992-11#1)(1996-4#1)(2008-10#1)(2008-5#1)
and by analysis of##2##4##(2008-10#2)
and by comparing##3##3##(2008-10#2)(2008-9#1)
and by comparison of##2##4##(2008-10#1)(2008-12#1)
and by comparison with##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
and by comparison##6##3##(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#2)
and by determining the##3##4##(1990-12#1)(2008-10#1)(2008-11#1)
and by direct##3##3##(2007-7#1)(2008-6#1)(2012-3#1)
and by doing##2##3##(2008-7#1)(2012-2#1)
and by fitting##2##3##(2008-10#1)(2008-3#1)
and by identifying##2##3##(1994-1#1)(1994-3#1)
and by including##2##3##(1993-8#1)(2008-10#1)
and by increase##2##3##(1994-6#1)(2008-10#1)
and by increasing the##2##4##(2007-10#1)(2008-9#1)
and by increasing##6##3##(1994-6#1)(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#1)
and by inhibition of##3##4##(1994-2#1)(1996-5#1)(2008-10#1)
and by its##5##3##(1996-7#1)(1997-3#1)(2008-10#1)(2009-1#1)(2011-2#1)
and by manual##2##3##(1992-8#1)(1994-6#1)
and by means of##3##4##(2007-12#1)(2008-10#1)(2009-11#1)
and by measurement of##3##4##(1995-3#1)(2007-12#1)(2008-10#1)
and by measuring##4##3##(1990-12#1)(2008-10#2)(2008-3#1)
and by other##3##3##(1994-8#1)(1997-1#1)(2008-5#1)
and by others##3##3##(1994-3#1)(1997-3#1)(2008-5#1)
and by our##2##3##(1997-3#1)(2010-8#1)
and by polymerase chain reaction (PCR) screening##2##7##(1996-10#1)(1996-12#1)
and by polymerase chain reaction (PCR)##4##6##(1996-10#1)(1996-12#1)(2008-10#2)
and by polymerase chain reaction##5##5##(1996-10#1)(1996-12#1)(2008-10#3)
and by providing##3##3##(1995-3#1)(2008-8#1)(2011-2#1)
and by quantitative##2##3##(1995-2#1)(1996-5#1)
and by recovery measurements on spiked samples##2##7##(2008-10#2)
and by recovery##6##3##(2008-10#3)(2010-5#3)
and by the end of the##2##6##(2010-3#1)(2013-7#1)
and by the nature of##2##5##(1996-12#1)(2008-11#1)
and by the presence of##3##5##(2007-12#1)(2008-10#2)
and by the presence##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
and by the##78##3##(1990-12#2)(1990-5#1)(1991-1#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
and by their##3##3##(1993-3#1)(1997-3#1)(2008-5#1)
and by two##4##3##(2007-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
and by use of##3##4##(1996-3#1)(2007-11#1)(2008-3#1)
and by using a##3##4##(1990-5#1)(2008-10#1)(2010-7#1)
and by using the##4##4##(1995-3#1)(2007-10#1)(2008-10#1)(2008-3#1)
and by using##10##3##(1990-5#1)(1992-12#1)(1994-2#1)(1995-3#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-7#1)
and by way of##2##4##(1993-3#1)(2008-10#1)
and by##533##2##(1990-11#2)(1990-12#8)(1990-2#3)(1990-3#3)(1990-5#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#8)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#5)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#3)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#4)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1997-1#5)(1997-2#3)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#9)(2007-11#6)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#111)(2008-11#23)(2008-12#3)(2008-2#11)(2008-3#27)(2008-4#1)(2008-5#24)(2008-6#5)(2008-7#14)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#13)(2012-1#3)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#6)(2013-8#3)
and bypass##2##2##(2007-12#1)(2008-12#1)
and bystander##3##2##(2008-7#2)(2013-8#1)
and c = 12##2##4##(1996-2#2)
and c =##4##3##(1996-2#3)(2013-8#1)
and c##7##2##(1996-2#3)(2007-11#1)(2008-11#1)(2010-8#1)(2013-8#1)
and c) the##2##3##(1991-6#1)(1992-10#1)
and c)##6##2##(1991-6#2)(1992-10#1)(2007-5#1)(2008-1#1)(2012-2#1)
and c-Fos##3##2##(1992-12#2)(1994-8#1)
and c-Ha-ras##2##2##(1990-12#1)(1992-8#1)
and c-Jun N-terminal##2##3##(2008-4#1)(2012-12#1)
and c-Jun##3##2##(1995-2#1)(2008-4#1)(2012-12#1)
and c-erbB-2 expression##5##3##(1994-7#5)
and c-erbB-2##6##2##(1994-7#6)
and c-fos##7##2##(1992-12#1)(1994-11#1)(1994-8#1)(1997-3#2)(2007-5#1)(2008-9#1)
and c-jun##10##2##(1991-12#3)(1991-2#1)(1991-5#1)(1995-8#2)(1996-12#2)(2008-7#1)
and c-myc expression##2##3##(1990-12#1)(1993-11#1)
and c-myc gene##2##3##(1991-4#1)(2008-8#1)
and c-myc##13##2##(1990-12#3)(1991-4#3)(1992-9#1)(1993-11#1)(1993-6#1)(2008-5#3)(2008-8#1)
and cADPR##2##2##(2010-11#2)
and cAMP##4##2##(1991-2#1)(1991-3#1)(1994-8#1)(1995-8#1)
and cAMP-dependent protein kinase##2##4##(1993-3#1)(1994-6#1)
and cAMP-regulated##2##2##(1991-10#1)(1994-8#1)
and cDNA##14##2##(1992-3#2)(1993-2#1)(1994-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#2)
and cGMP##8##2##(1990-12#1)(1991-12#1)(1991-9#1)(1993-8#1)(2008-4#3)(2009-10#1)
and ca##2##2##(2008-10#1)(2010-10#1)
and cadaver donors##3##3##(2007-7#1)(2008-1#1)(2008-5#1)
and cadaveric##4##2##(2008-1#1)(2010-10#1)(2010-7#1)(2011-2#1)
and cadmium amalgam##2##3##(2008-10#2)
and cadmium in##5##3##(2008-10#4)(2008-12#1)
and cadmium ions were##2##4##(2008-10#2)
and cadmium ions##3##3##(2008-10#3)
and cadmium##27##2##(1994-6#1)(1997-4#2)(2007-11#1)(2008-10#22)(2008-12#1)
and cadmium(II) ions##2##3##(2008-10#2)
and cadmium(II) was##4##3##(2008-10#4)
and cadmium(II)##13##2##(2008-10#13)
and caffeine in##4##3##(1996-5#1)(2008-10#3)
and caffeine##11##2##(1995-8#1)(1996-5#1)(2008-10#5)(2009-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
and calcareous##3##2##(2012-6#3)
and calcification of##2##3##(1997-3#1)(2012-12#1)
and calcification##5##2##(1991-9#1)(1997-3#1)(2009-11#1)(2012-12#1)(2012-2#1)
and calcified tissues##2##3##(1991-2#1)(2008-3#1)
and calcitonin gene-related peptide##4##4##(1997-1#1)(1997-3#2)(2007-2#1)
and calcitonin gene-related##5##3##(1997-1#1)(1997-3#3)(2007-2#1)
and calcitonin##9##2##(1990-12#1)(1992-6#1)(1997-1#1)(1997-3#3)(2007-2#1)(2008-4#2)
and calcium carbonate##5##3##(2008-10#2)(2008-7#1)(2011-2#2)
and calcium ions##2##3##(2008-10#2)
and calcium signals##2##3##(1996-12#1)(2010-11#1)
and calcium supplements##2##3##(1993-11#1)(2011-1#1)
and calcium##52##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-9#2)(1992-6#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-7#3)(2007-12#1)(2008-1#2)(2008-10#13)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#1)
and calcium)##2##2##(2008-10#1)(2010-9#1)
and calcium-dependent##2##2##(1990-5#1)(1994-5#1)
and calcium/calmodulin-dependent##2##2##(1990-8#1)(2008-10#1)
and calculate the##4##3##(1992-12#1)(1997-7#1)(2008-11#1)(2010-8#1)
and calculate##5##2##(1992-12#1)(1997-7#1)(1997-8#1)(2008-11#1)(2010-8#1)
and calculated as##2##3##(2008-10#1)(2008-5#1)
and calculated for##2##3##(2008-3#2)
and calculated values##4##3##(2008-10#1)(2008-3#3)
and calculated##21##2##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#7)(2008-5#1)(2009-3#1)(2012-2#1)
and calculating##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
and calculation of the##2##4##(2008-10#1)(2008-3#1)
and calculation of##4##3##(1996-3#1)(2008-10#2)(2008-3#1)
and calculation##8##2##(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
and calculations of##2##3##(2008-2#1)(2008-3#1)
and calculations##4##2##(1991-6#1)(2008-2#2)(2008-3#1)
and caldesmon##2##2##(1993-8#1)(1994-5#1)
and calf##4##2##(1992-3#1)(1992-6#1)(2008-12#1)(2012-2#1)
and calibrated##2##2##(2008-2#1)(2008-3#1)
and calibration against aqueous##2##4##(2008-10#2)
and calibration against##3##3##(2008-10#3)
and calibration of the##2##4##(2008-10#1)(2008-3#1)
and calibration of##4##3##(2008-10#1)(2008-3#2)(2008-4#1)
and calibration solutions##2##3##(2008-10#2)
and calibration##19##2##(2008-10#10)(2008-2#2)(2008-3#6)(2008-4#1)
and callose##2##2##(2008-10#1)(2011-2#1)
and calls for##2##3##(2008-10#1)(2012-2#1)
and calls##4##2##(1997-3#1)(2008-10#1)(2010-11#1)(2012-2#1)
and calmodulin antagonists##2##3##(2008-10#2)
and calmodulin have been##2##4##(1990-12#1)(1991-9#1)
and calmodulin##10##2##(1990-12#2)(1990-5#1)(1991-9#1)(1992-12#1)(1995-3#1)(2008-10#2)(2008-8#1)(2010-3#1)
and calmodulin-dependent##2##2##(1991-9#1)(1993-6#1)
and caloric intake##2##3##(1991-1#1)(1991-12#1)
and calorimetric##4##2##(1997-2#3)(2008-10#1)
and calpain II##4##3##(1994-5#1)(1995-3#3)
and calpain##5##2##(1994-5#2)(1995-3#3)
and calphostin C##2##3##(1997-1#1)(2008-4#1)
and calphostin##3##2##(1993-11#1)(1997-1#1)(2008-4#1)
and calvaria##4##2##(1990-11#1)(2008-11#3)
and cambium##2##2##(2008-10#1)(2010-3#1)
and camera##2##2##(2008-3#2)
and cameras##2##2##(2008-3#1)(2008-9#1)
and can affect##3##3##(2007-12#1)(2008-7#1)(2012-1#1)
and can also be adapted for##2##6##(1990-12#1)(2008-4#1)
and can also be desorbed with##2##6##(2008-10#2)
and can also be used as##2##6##(2008-10#1)(2008-7#1)
and can also be used to determine##2##7##(2008-10#1)(2008-8#1)
and can also be used to##4##6##(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
and can also be used##7##5##(1995-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
and can also be##14##4##(1990-12#1)(1992-3#1)(1995-6#1)(2008-10#5)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)
and can also##19##3##(1990-12#1)(1991-6#1)(1992-3#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#1)
and can be a##4##4##(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
and can be accessed##4##4##(2008-10#1)(2008-4#2)(2009-2#1)
and can be adapted to##2##5##(1994-12#1)(2008-3#1)
and can be an##3##4##(1993-3#1)(2008-8#1)(2013-1#1)
and can be applied satisfactorily for##2##6##(2008-10#2)
and can be applied to##4##5##(2007-11#1)(2009-11#1)(2010-2#1)(2012-3#1)
and can be applied##8##4##(1990-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-11#1)(2010-2#1)(2012-3#1)
and can be associated with##3##5##(2009-8#1)(2010-5#1)(2012-3#1)
and can be combined with##2##5##(2008-11#1)(2008-5#1)
and can be considered##5##4##(1992-11#1)(2008-10#1)(2008-11#1)(2011-2#2)
and can be controlled##4##4##(2008-11#1)(2008-7#2)(2010-4#1)
and can be correlated with##2##5##(2007-12#1)(2008-9#1)
and can be described by##2##5##(1995-5#1)(2007-12#1)
and can be detected by##2##5##(2008-10#1)(2009-6#1)
and can be detected##3##4##(1991-3#1)(2008-10#1)(2009-6#1)
and can be determined##2##4##(2008-10#1)(2008-11#1)
and can be directly##2##4##(2008-1#1)(2008-10#1)
and can be distinguished##2##4##(2008-10#1)(2010-12#1)
and can be divided into##2##5##(1992-11#1)(2007-12#1)
and can be easily adapted to##2##6##(2008-10#1)(2012-3#1)
and can be easily applied##2##5##(2010-11#1)(2010-4#1)
and can be easily##8##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-3#1)
and can be eluted##2##4##(1990-12#1)(1991-12#1)
and can be explained##2##4##(1990-5#1)(2007-11#1)
and can be extended to other##2##6##(2008-2#1)(2008-3#1)
and can be extended to##3##5##(1994-11#1)(2008-2#1)(2008-3#1)
and can be identified##3##4##(1993-6#1)(2007-11#1)(2007-12#1)
and can be incorporated##2##4##(2008-10#1)(2012-1#1)
and can be made##2##4##(2008-2#2)
and can be measured##2##4##(2008-3#1)(2012-3#1)
and can be performed in##2##5##(2008-3#1)(2012-3#1)
and can be performed##7##4##(1991-3#1)(1992-3#1)(1996-12#1)(2008-1#1)(2008-3#1)(2010-5#1)(2012-3#1)
and can be readily applied to##2##6##(1996-5#1)(2008-10#1)
and can be readily##6##4##(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-7#1)
and can be regenerated##2##4##(2008-10#2)
and can be seen##2##4##(2008-1#1)(2008-7#1)
and can be treated##2##4##(2008-7#2)
and can be used as a new##2##7##(2008-2#1)(2008-5#1)
and can be used as a##5##6##(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2011-1#1)
and can be used as##8##5##(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2011-1#1)(2013-8#1)
and can be used at##2##5##(2008-10#1)(2008-7#1)
and can be used for a period of##2##8##(2008-10#2)
and can be used for at least 2 months without##2##10##(2008-10#2)
and can be used for at least 3 months without any considerable divergence in potential##2##15##(2008-10#2)
and can be used for at least 3 months without any##4##11##(2008-10#4)
and can be used for at least##11##7##(2008-10#11)
and can be used for more than##2##7##(2008-10#2)
and can be used for the determination of##4##8##(2008-10#4)
and can be used for the##6##6##(2008-10#5)(2010-4#1)
and can be used for##30##5##(2007-11#1)(2007-12#1)(2008-10#23)(2008-2#1)(2008-3#2)(2010-4#1)(2013-1#1)
and can be used in a wide range of##2##9##(2008-10#1)(2008-3#1)
and can be used in a wide##3##7##(2008-10#2)(2008-3#1)
and can be used in the##2##6##(2008-10#2)
and can be used in##11##5##(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)
and can be used over a period of##2##8##(2008-10#2)
and can be used over a##3##6##(2008-10#3)
and can be used to determine the##2##7##(1996-2#1)(2006-10#1)
and can be used to study the##2##7##(2008-4#1)(2008-7#1)
and can be used to##22##5##(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-3#1)
and can be used##77##4##(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
and can be useful##2##4##(2008-10#1)(2010-10#1)
and can be utilized##2##4##(2009-12#1)(2010-5#1)
and can be##260##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1991-12#2)(1991-3#3)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-10#2)(2007-11#7)(2007-12#9)(2007-7#3)(2008-1#5)(2008-10#72)(2008-11#10)(2008-12#2)(2008-2#10)(2008-3#19)(2008-4#10)(2008-5#4)(2008-7#15)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#3)
and can cause##2##3##(2006-12#1)(2011-2#1)
and can degrade##2##3##(2008-3#1)(2012-2#1)
and can easily be##3##4##(1990-2#1)(1994-3#1)(2008-2#1)
and can effectively##2##3##(2007-11#1)(2008-9#1)
and can eliminate##2##3##(2008-10#1)(2008-2#1)
and can evaluate##2##3##(2008-9#1)(2013-1#1)
and can even##3##3##(2008-5#1)(2008-8#1)(2010-9#1)
and can facilitate##2##3##(2008-11#1)(2012-12#1)
and can handle##2##3##(2008-2#1)(2008-3#1)
and can have##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
and can help to##2##4##(2008-10#1)(2013-1#1)
and can help##3##3##(2008-10#2)(2013-1#1)
and can in##2##3##(2007-12#1)(2011-2#1)
and can lead to##12##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and can measure##2##3##(1995-5#1)(2008-2#1)
and can mediate the##2##4##(2008-7#1)(2012-2#1)
and can occur##2##3##(1992-4#1)(2013-1#1)
and can often be##2##4##(1997-3#1)(2013-8#1)
and can only be##4##4##(1994-12#1)(2008-1#1)(2008-12#1)(2008-2#1)
and can only##5##3##(1994-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-2#1)
and can prevent##2##3##(2008-10#1)(2011-2#1)
and can produce##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
and can provide a##4##4##(1994-8#1)(2008-11#1)(2009-9#1)(2013-1#1)
and can provide##12##3##(1993-2#1)(1994-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
and can reduce##2##3##(1992-9#1)(2008-3#1)
and can result in##6##4##(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#2)
and can result##7##3##(2008-4#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-2#2)
and can serve as a##3##5##(2007-11#1)(2008-10#1)(2008-6#1)
and can serve as an##3##5##(2008-2#1)(2008-6#1)(2010-12#1)
and can serve as##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#2)(2010-12#1)
and can stimulate##4##3##(1991-5#1)(2008-11#2)(2008-4#1)
and can suppress##2##3##(1994-6#1)(2007-11#1)
and can therefore be used to##2##6##(1995-11#1)(2008-2#1)
and can therefore be##3##4##(1995-11#1)(2008-2#1)(2008-9#1)
and can therefore##6##3##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
and can thus##4##3##(1995-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
and can##465##2##(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-8#1)(1992-9#3)(1993-2#3)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-11#13)(2007-12#16)(2007-7#4)(2008-1#7)(2008-10#95)(2008-11#22)(2008-12#3)(2008-2#20)(2008-3#33)(2008-4#17)(2008-5#7)(2008-6#5)(2008-7#22)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#13)(2012-1#4)(2012-12#5)(2012-2#12)(2012-3#6)(2013-1#13)(2013-8#9)
and canalicular##2##2##(2008-11#2)
and cancellous bone##3##3##(2009-7#1)(2011-2#1)(2013-1#1)
and cancer cell##2##3##(2008-11#1)(2012-12#1)
and cancer control##2##3##(1997-1#1)(2009-4#1)
and cancer development##2##3##(1994-5#1)(2008-11#1)
and cancer diseases##2##3##(2008-10#1)(2013-8#1)
and cancer groups were##2##4##(2008-10#1)(2008-4#1)
and cancer groups##3##3##(2008-10#2)(2008-4#1)
and cancer have##3##3##(2010-6#1)(2012-2#2)
and cancer in##3##3##(1994-2#1)(1996-11#1)(2012-12#1)
and cancer mortality##5##3##(1990-8#1)(2008-7#1)(2010-1#2)(2010-11#1)
and cancer of the cervix##2##5##(2008-11#1)(2008-7#1)
and cancer of the##4##4##(1991-11#1)(2008-11#2)(2008-7#1)
and cancer patients##2##3##(1994-3#1)(1994-6#1)
and cancer risk##3##3##(1990-8#2)(2008-11#1)
and cancer treatments##3##3##(2008-1#1)(2013-1#2)
and cancer##88##2##(1990-8#3)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#2)(2008-1#3)(2008-10#8)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-4#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
and cancer-related##3##2##(2008-4#1)(2010-11#1)(2013-1#1)
and cancerous##5##2##(1990-6#1)(1993-3#1)(2008-11#1)(2008-5#1)(2012-2#1)
and cancers##2##2##(2009-12#1)(2009-5#1)
and candida##2##2##(1991-3#1)(2007-2#1)
and candidate gene##2##3##(2007-10#1)(2008-7#1)
and candidate##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
and candidiasis##2##2##(2008-5#2)
and canine adenovirus type-1##2##4##(2012-3#2)
and canine##5##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#2)
and canker##3##2##(2008-10#3)
and cannabina##3##2##(2008-10#3)
and cannabinoid receptor##2##3##(2008-7#1)(2009-8#1)
and cannabinoid receptors##4##3##(2008-7#4)
and cannabinoid##6##2##(2008-7#5)(2009-8#1)
and cannot be used##2##4##(2008-4#1)(2010-8#1)
and cannot be##14##3##(1996-6#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#2)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
and cannot##19##2##(1991-2#1)(1996-6#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
and canonical correlation analysis##2##4##(2008-10#2)
and canonical##3##2##(2008-10#3)
and canopy##5##2##(2008-10#3)(2008-9#1)(2013-7#1)
and canthaxanthin##2##2##(2013-8#2)
and capabilities of##2##3##(1995-2#1)(2008-9#1)
and capabilities##3##2##(1995-2#1)(1997-2#1)(2008-9#1)
and capable of detecting##3##4##(1990-12#1)(2008-10#2)
and capable of##13##3##(1990-12#1)(1994-9#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-3#3)(2008-8#1)(2009-8#1)(2012-3#2)
and capable##14##2##(1990-12#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-3#3)(2008-8#1)(2009-8#1)(2012-3#2)
and capacitance##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
and capacitive##2##2##(2008-10#2)
and capacitors##2##2##(2008-10#2)
and capacity building##2##3##(2007-12#1)(2010-5#1)
and capacity##13##2##(1995-1#4)(1995-2#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-3#1)(2010-4#1)(2010-5#1)
and capillaries##3##2##(2008-7#3)
and capillary electrophoresis##8##3##(1996-5#2)(2008-10#5)(2008-4#1)
and capillary zone electrophoresis##3##4##(1996-5#2)(2008-10#1)
and capillary##21##2##(1996-5#6)(2008-10#12)(2008-4#1)(2009-4#1)(2010-12#1)
and capitation##4##2##(1994-12#1)(1995-12#1)(1995-2#1)(1997-2#1)
and capped##3##2##(1994-3#1)(2007-11#1)(2008-7#1)
and capping agent##2##3##(2010-12#1)(2011-2#1)
and capsaicin##5##2##(1995-12#1)(2008-4#2)(2008-8#1)(2011-2#1)
and capsular##3##2##(2008-8#3)
and capsule##4##2##(2007-11#1)(2008-10#2)(2010-12#1)
and captive##4##2##(1997-6#1)(2008-8#2)(2008-9#1)
and captopril##4##2##(1994-5#3)(1996-2#1)
and capture of##2##3##(1997-2#1)(2010-2#1)
and capture##4##2##(1997-2#1)(1997-3#1)(2008-2#1)(2010-2#1)
and captured##2##2##(1995-2#1)(2008-7#1)
and carbachol##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
and carbamate##5##2##(2008-10#5)
and carbamazepine##2##2##(2008-8#1)(2008-9#1)
and carboCys##2##2##(2008-10#2)
and carbofuran##2##2##(2008-10#2)
and carbohydrate metabolism##3##3##(1995-8#1)(2008-1#1)(2010-1#1)
and carbohydrate##10##2##(1992-11#1)(1995-8#1)(2008-1#1)(2008-4#3)(2008-5#2)(2008-7#1)(2010-1#1)
and carbohydrates in##2##3##(2008-7#1)(2009-2#1)
and carbohydrates##8##2##(1990-8#1)(1994-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-2#1)(2013-1#1)
and carbon black##2##3##(2008-3#2)
and carbon dioxide production##5##4##(2008-11#4)(2008-4#1)
and carbon dioxide##14##3##(1997-7#1)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-7#2)
and carbon electrodes##2##3##(2008-10#2)
and carbon monoxide (CO)##2##4##(1990-5#1)(2010-12#1)
and carbon monoxide##6##3##(1990-3#1)(1990-5#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
and carbon nanotubes##4##3##(2008-7#2)(2010-7#1)(2012-2#1)
and carbon paste electrodes##2##4##(2008-10#2)
and carbon paste##3##3##(2008-10#3)
and carbon source##2##3##(2008-7#2)
and carbon tetrachloride##3##3##(1995-3#1)(2008-10#1)(2009-8#1)
and carbon##52##2##(1990-3#1)(1990-5#1)(1994-12#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-10#13)(2008-11#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#5)(2009-8#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#2)
and carbonate##8##2##(2008-10#8)
and carbonyl group##2##3##(2008-10#1)(2011-3#1)
and carbonyl##6##2##(1992-6#1)(2008-10#2)(2009-7#1)(2011-3#1)(2012-2#1)
and carboplatin in##3##3##(2007-4#1)(2008-10#1)(2013-1#1)
and carboplatin##9##2##(2007-4#1)(2008-10#5)(2008-7#1)(2010-11#1)(2013-1#1)
and carboxyl terminal##2##3##(1996-12#1)(2008-10#1)
and carboxyl##5##2##(1990-7#1)(1993-8#1)(1996-12#1)(2008-10#1)(2013-8#1)
and carboxyl-terminal##2##2##(1991-12#1)(1995-6#1)
and carboxylate##2##2##(1991-5#1)(2008-10#1)
and carboxylic##2##2##(1992-5#1)(2008-10#1)
and carboxypeptidase##5##2##(1993-8#5)
and carcass characteristics##2##3##(2008-12#2)
and carcass##6##2##(2008-12#2)(2010-4#1)(2013-1#3)
and carcinogenesis in##2##3##(1994-5#1)(2013-8#1)
and carcinogenesis##14##2##(1993-11#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-6#2)(2013-8#1)
and carcinogenic##6##2##(1996-6#1)(2008-10#4)(2008-7#1)
and carcinogenicity studies of##5##4##(2008-8#1)(2008-9#4)
and carcinogenicity studies##7##3##(2008-8#1)(2008-9#6)
and carcinogenicity##11##2##(2008-8#2)(2008-9#9)
and carcinoid tumors##2##3##(2010-9#1)(2012-3#1)
and carcinoid##3##2##(1992-11#1)(2010-9#1)(2012-3#1)
and carcinoma cells##2##3##(1993-9#1)(2008-11#1)
and carcinoma in situ##2##4##(1997-3#1)(2008-1#1)
and carcinoma in##3##3##(1994-7#1)(1997-3#1)(2008-1#1)
and carcinoma of the##4##4##(1991-3#1)(1993-8#1)(2008-1#2)
and carcinoma##13##2##(1990-11#2)(1991-3#1)(1993-8#2)(1993-9#1)(1994-7#1)(1997-3#1)(2008-1#3)(2008-11#1)(2008-8#1)
and carcinomas##4##2##(1990-11#2)(1991-6#1)(1993-8#1)
and cardiac arrhythmias##2##3##(1992-5#1)(2008-8#1)
and cardiac complications##2##3##(1995-5#1)(2008-4#1)
and cardiac disease##2##3##(2007-8#1)(2009-9#1)
and cardiac dysfunction##3##3##(2008-12#1)(2010-3#1)(2011-2#1)
and cardiac events##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
and cardiac function##3##3##(1991-2#1)(2007-11#1)(2008-7#1)
and cardiac hemodynamics##3##3##(1991-5#1)(2007-10#1)(2007-8#1)
and cardiac output##2##3##(2010-8#1)(2013-7#1)
and cardiac surgery##2##3##(1991-11#1)(2006-10#1)
and cardiac toxicity##2##3##(1991-1#1)(2008-10#1)
and cardiac troponin I##2##4##(2008-10#2)
and cardiac##64##2##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#2)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-7#1)
and cardio-vascular##2##2##(2008-3#1)(2013-7#1)
and cardiogenic shock##2##3##(2008-3#1)(2008-4#1)
and cardiometabolic##2##2##(2011-1#1)(2012-12#1)
and cardiopulmonary bypass]##2##3##(2008-10#1)(2010-8#1)
and cardiopulmonary##5##2##(1996-9#1)(2008-10#1)(2009-2#1)(2010-8#2)
and cardiovascular disease (CVD)##4##4##(2008-1#1)(2008-6#1)(2011-1#1)(2013-1#1)
and cardiovascular disease are##2##4##(2008-7#1)(2010-4#1)
and cardiovascular disease is##2##4##(2008-6#1)(2010-6#1)
and cardiovascular disease##28##3##(1992-9#1)(1993-11#2)(2008-1#3)(2008-11#1)(2008-3#4)(2008-6#5)(2008-7#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-6#2)(2011-1#1)(2013-1#2)(2013-8#1)
and cardiovascular diseases in##3##4##(2010-10#1)(2010-6#1)(2013-8#1)
and cardiovascular diseases##12##3##(1991-6#1)(1993-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
and cardiovascular effects of##3##4##(1990-5#1)(1991-1#1)(2008-7#1)
and cardiovascular effects##4##3##(1990-5#1)(1991-1#1)(2008-7#1)(2009-7#1)
and cardiovascular events##5##3##(2012-2#3)(2012-3#2)
and cardiovascular morbidity and mortality##2##5##(2007-12#1)(2008-1#1)
and cardiovascular parameters##2##3##(2008-7#1)(2013-8#1)
and cardiovascular responses to##2##4##(2012-1#2)
and cardiovascular risk factors##8##4##(1993-9#4)(2008-3#1)(2008-7#2)(2012-2#1)
and cardiovascular risk##18##3##(1993-9#4)(2008-1#2)(2008-3#2)(2008-7#2)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#1)
and cardiovascular##94##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-9#4)(1994-2#1)(1994-5#1)(2007-12#1)(2007-8#3)(2008-1#7)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#8)(2012-3#3)(2013-1#2)(2013-8#4)
and care coordination##2##3##(1993-3#1)(1996-1#1)
and care delivery##3##3##(2008-1#2)(2013-1#1)
and care for##3##3##(2008-10#1)(2010-5#1)(2012-1#1)
and care of##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
and care partners##2##3##(2010-5#2)
and care providers##2##3##(1991-12#1)(2013-8#1)
and care recipients##2##3##(2008-6#1)(2009-5#1)
and care##45##2##(1991-12#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-8#1)(1997-3#2)(2007-12#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2010-12#2)(2010-5#4)(2010-6#1)(2011-1#4)(2012-1#1)(2013-1#6)(2013-8#1)
and career##4##2##(2009-12#1)(2010-10#1)(2010-9#1)(2011-1#1)
and careful follow-up##3##3##(1993-3#1)(2008-11#1)(2008-9#1)
and careful planning##2##3##(2007-7#1)(2011-2#1)
and careful##16##2##(1990-6#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#4)
and caregiver burden##3##3##(2007-12#1)(2009-5#1)(2012-2#1)
and caregiver##7##2##(2007-12#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-5#1)(2012-2#1)
and caregivers##5##2##(1996-12#1)(2007-10#1)(2010-8#2)(2012-3#1)
and caregiving##5##2##(1994-3#1)(1995-1#1)(1997-3#1)(2010-6#2)
and carer##3##2##(2008-11#1)(2008-12#1)(2009-6#1)
and carers##6##2##(1997-8#1)(2008-12#1)(2009-6#4)
and caries-related##2##2##(2012-2#2)
and caring##11##2##(2008-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and carnitine##4##2##(1995-12#2)(1995-6#2)
and carotenoid levels##2##3##(2008-10#2)
and carotenoid##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)
and carotenoids##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
and carotid##7##2##(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)
and carp##3##2##(2008-10#1)(2008-7#2)
and carpal tunnel syndrome##2##4##(2008-9#1)(2013-1#1)
and carpal##3##2##(1997-3#1)(2008-9#1)(2013-1#1)
and carpel##2##2##(2008-8#2)
and carrageenan##2##2##(2008-7#1)(2011-10#1)
and carried out##5##3##(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
and carried to the##2##4##(2008-10#2)
and carried##9##2##(1997-6#1)(2008-10#5)(2008-11#1)(2011-2#1)(2013-1#1)
and carrier##6##2##(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
and carriers##3##2##(1990-11#1)(2008-10#1)(2010-7#1)
and carries out##2##3##(1993-3#1)(2008-3#1)
and carries##6##2##(1993-11#1)(1993-3#1)(2007-8#2)(2008-3#1)(2009-10#1)
and carrot##2##2##(1997-4#1)(2008-10#1)
and carry a##3##3##(1991-11#1)(2008-8#1)(2013-1#1)
and carry out##2##3##(2009-9#1)(2013-1#1)
and carry##9##2##(1991-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-1#2)
and carrying##3##2##(2008-10#2)(2008-11#1)
and cartilage##8##2##(1990-11#2)(1991-5#2)(2008-9#1)(2010-10#1)(2011-2#1)(2013-7#1)
and carvacrol##4##2##(2008-10#3)(2008-12#1)
and caryopsis##3##2##(2008-10#2)(2008-5#1)
and cascaded##4##2##(2007-12#2)(2008-2#2)
and case fatality##2##3##(2007-10#1)(2011-2#1)
and case law##2##3##(1992-12#1)(2007-4#1)
and case management##8##3##(1991-12#1)(1992-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#2)(2010-6#1)
and case mix##5##3##(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-3#1)
and case reports have##2##4##(2008-11#1)(2011-2#1)
and case reports##4##3##(1990-6#1)(2008-11#1)(2011-2#1)(2012-12#1)
and case series##2##3##(2012-12#1)(2012-3#1)
and case studies##5##3##(1990-5#1)(1994-12#1)(1996-1#1)(2008-8#1)(2009-10#1)
and case##37##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-12#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#2)(1996-1#2)(1996-3#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-4#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#1)
and case-mix##2##2##(1993-2#2)
and casein##2##2##(2008-10#1)(2008-4#1)
and cases##7##2##(1990-2#1)(1993-12#1)(1994-2#1)(2007-2#1)(2008-1#1)(2008-7#1)(2011-1#1)
and cash flow##2##3##(1994-1#1)(1996-2#1)
and caspase##2##2##(2008-1#1)(2011-2#1)
and caspase-3##6##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#2)(2013-1#1)
and cast iron samples##2##4##(2008-10#2)
and cast##7##2##(2008-10#3)(2008-11#2)(2009-7#1)(2013-1#1)
and casting methods##2##3##(2008-11#2)
and casting##3##2##(2008-11#2)(2008-7#1)
and cat##5##2##(1990-5#1)(1990-6#1)(1993-6#1)(2007-12#1)(2013-1#1)
and catabolic##4##2##(1994-3#1)(2007-7#1)(2008-5#1)(2011-2#1)
and catalase (CAT) activity##2##4##(2009-5#1)(2011-2#1)
and catalase (CAT)##4##3##(1994-6#1)(2009-5#1)(2011-2#1)(2013-1#1)
and catalase activity##2##3##(1994-2#1)(1996-9#1)
and catalase on##2##3##(1992-11#1)(1997-4#1)
and catalase were##2##3##(1994-11#1)(2013-1#1)
and catalase##27##2##(1990-3#1)(1991-12#2)(1992-11#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#3)(1995-6#5)(1995-8#2)(1996-9#1)(1997-4#1)(2008-10#2)(2009-5#1)(2011-2#1)(2013-1#2)
and catalase)##2##2##(1991-12#1)(1995-9#1)
and catalysis##6##2##(1991-5#1)(1993-11#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-8#1)
and catalysts##2##2##(2008-10#2)
and catalytic activity of the##2##5##(2008-10#1)(2009-3#1)
and catalytic activity of##4##4##(2008-10#2)(2009-3#2)
and catalytic activity##5##3##(2008-10#3)(2009-3#2)
and catalytic properties of##4##4##(1991-11#1)(1992-6#1)(2008-10#1)(2009-10#1)
and catalytic properties##5##3##(1991-11#1)(1992-6#1)(2008-10#1)(2009-10#1)(2010-7#1)
and catalytic##27##2##(1991-11#1)(1992-4#2)(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-3#2)(2010-7#1)
and catalyzes the##2##3##(1993-11#1)(1994-8#1)
and cataract##2##2##(1992-9#1)(2007-4#1)
and catechin##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
and catechol was##2##3##(2008-10#2)
and catechol##10##2##(2008-10#8)(2011-1#2)
and catecholamine##5##2##(1995-11#1)(1995-3#2)(2008-1#1)(2008-7#1)
and catecholamines##4##2##(2008-10#3)(2008-7#1)
and categorical variables##2##3##(2008-10#1)(2013-1#1)
and categorize##2##2##(2009-6#1)(2013-1#1)
and categorized as##3##3##(2008-10#2)(2009-3#1)
and categorized##6##2##(2007-7#1)(2008-10#2)(2009-3#1)(2012-3#1)(2013-1#1)
and category##2##2##(2011-2#1)(2012-2#1)
and cathepsin G##7##3##(1991-9#1)(1992-5#2)(1994-5#1)(2008-6#1)(2008-7#2)
and cathepsin##9##2##(1991-2#1)(1991-9#1)(1992-5#2)(1994-5#1)(1995-2#1)(2008-6#1)(2008-7#2)
and cathodic stripping##2##3##(2008-10#2)
and cathodic##8##2##(1992-3#1)(2008-10#7)
and cation exchange##5##3##(2008-10#5)
and cation##17##2##(1991-9#1)(1996-5#1)(2007-12#1)(2008-10#12)(2012-1#1)(2012-2#1)
and cation-exchange chromatography##2##3##(1990-5#1)(2008-4#1)
and cation-exchange##3##2##(1990-5#1)(1991-8#1)(2008-4#1)
and cation-selective##3##2##(2008-10#3)
and cationic compounds##2##3##(1990-8#2)
and cationic surfactants##2##3##(2008-10#1)(2008-5#1)
and cationic##15##2##(1990-8#2)(1997-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
and cations on the##2##4##(2008-10#2)
and cations##13##2##(2008-10#13)
and cats##8##2##(1995-11#2)(2008-3#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
and cattle##6##2##(1991-8#1)(2010-1#1)(2010-4#2)(2011-2#2)
and cauda region##2##3##(1992-3#2)
and cauda##5##2##(1992-3#3)(2008-12#2)
and caudal##8##2##(1991-5#1)(1995-12#2)(1996-12#1)(1996-5#1)(2008-7#1)(2013-7#2)
and caudate nucleus##2##3##(1991-12#1)(1994-8#1)
and caudate##6##2##(1991-12#1)(1993-12#1)(1993-5#1)(1994-8#2)(2008-7#1)
and caudatoputamen##2##2##(1997-2#2)
and cauliflower isolates##2##3##(2008-10#2)
and cauliflower##4##2##(2008-10#4)
and causal##2##2##(2008-11#1)(2012-12#1)
and cause infections##2##3##(1992-9#1)(2008-10#1)
and cause of death##3##4##(1995-3#1)(2012-12#1)(2013-7#1)
and cause the##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
and cause##33##2##(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
and cause-specific survival##2##3##(2012-3#2)
and cause-specific##3##2##(1991-6#1)(2012-3#2)
and caused a##6##3##(1990-12#1)(1994-8#1)(1995-12#1)(2008-5#1)(2010-3#1)(2012-7#1)
and caused an##2##3##(1997-7#1)(2011-1#1)
and caused by##2##3##(1992-5#1)(1997-3#1)
and caused the##2##3##(1995-3#1)(2008-12#1)
and caused##26##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-7#1)
and causes of death##3##4##(2008-7#1)(2011-2#1)(2012-12#1)
and causes of low vision among##2##6##(2010-8#2)
and causes of##10##3##(2008-1#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#2)
and causes the##6##3##(1991-9#1)(1993-6#1)(2008-12#1)(2008-7#1)(2009-6#2)
and causes##39##2##(1990-5#1)(1991-9#2)(1993-6#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-3#1)(2009-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)
and causing##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
and caution##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
and cautions##2##2##(2008-10#1)(2008-9#1)
and caveats##2##2##(2012-3#1)(2013-1#1)
and cavitated caries##2##3##(2012-2#2)
and cavity dumping##2##3##(2007-12#1)(2008-3#1)
and cavity##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
and cefazolin sodium##2##3##(2008-10#2)
and cefazolin##3##2##(2008-10#2)(2008-12#1)
and ceftazidime##3##2##(2007-7#1)(2008-10#1)(2008-7#1)
and ceftriaxone##8##2##(1991-3#1)(2007-12#2)(2008-7#4)(2010-8#1)
and celecoxib##3##2##(2008-12#2)(2011-2#1)
and cell adhesion molecules##2##4##(2009-8#2)
and cell adhesion##5##3##(2007-12#1)(2008-11#1)(2008-8#1)(2009-8#2)
and cell and##2##3##(2008-11#1)(2011-3#1)
and cell apoptosis##4##3##(2008-9#2)(2011-2#1)(2013-1#1)
and cell biological studies##2##4##(1995-3#1)(2008-4#1)
and cell biological##4##3##(1995-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
and cell biology##3##3##(1995-5#1)(2008-10#1)(2008-9#1)
and cell bodies##2##3##(1992-12#1)(1997-3#1)
and cell concentration##2##3##(2008-11#1)(2008-9#1)
and cell culture studies##2##4##(2008-11#1)(2012-2#1)
and cell culture##7##3##(1991-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#2)(2013-1#1)
and cell cultures##2##3##(2007-12#1)(2008-4#1)
and cell cycle analysis##4##4##(2008-11#2)(2008-9#2)
and cell cycle arrest##2##4##(1995-2#1)(2009-8#1)
and cell cycle progression##2##4##(1993-11#1)(1993-8#1)
and cell cycle##17##3##(1993-11#1)(1993-8#1)(1994-9#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-9#6)(2009-8#3)(2012-2#1)
and cell death in##3##4##(1995-5#1)(2008-9#1)(2012-12#1)
and cell death##22##3##(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and cell debris##3##3##(2008-4#1)(2008-8#2)
and cell density##2##3##(1997-3#1)(2012-1#1)
and cell differentiation##4##3##(1992-9#1)(1995-8#1)(2007-12#1)(2011-2#1)
and cell division##8##3##(1991-2#1)(1994-5#1)(2008-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2012-3#1)
and cell extracts##2##3##(1990-5#1)(2008-1#1)
and cell fate##3##3##(2008-10#1)(2008-4#1)(2009-5#1)
and cell fusion##2##3##(1992-5#1)(2008-9#1)
and cell growth in##2##4##(1996-2#1)(2008-11#1)
and cell growth##7##3##(1991-5#1)(1993-9#1)(1994-2#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-9#1)
and cell killing##2##3##(1995-8#2)
and cell line##2##3##(2008-11#1)(2011-2#1)
and cell lines and##2##4##(1994-6#1)(2011-2#1)
and cell lines derived from##2##5##(1993-8#1)(2008-11#1)
and cell lines##12##3##(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#2)(2008-11#2)(2008-4#2)(2008-9#1)(2011-2#1)(2012-2#1)
and cell membrane##2##3##(2008-10#1)(2008-2#1)
and cell membranes##2##3##(1991-3#1)(2008-4#1)
and cell migration##2##3##(1992-6#1)(2011-2#1)
and cell morphology##3##3##(1994-8#1)(2011-1#1)(2012-2#1)
and cell number##3##3##(1992-8#1)(2008-11#1)(2008-4#1)
and cell polarity##2##3##(2012-2#2)
and cell population##2##3##(1993-6#1)(2012-2#1)
and cell proliferation activities##2##4##(1994-11#1)(2008-11#1)
and cell proliferation in human##2##5##(2012-1#1)(2012-2#1)
and cell proliferation in##6##4##(1995-11#2)(2008-4#2)(2012-1#1)(2012-2#1)
and cell proliferation##18##3##(1990-12#1)(1990-2#1)(1993-9#1)(1994-11#1)(1995-11#2)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#3)
and cell specific##2##3##(2008-11#2)
and cell surface expression##3##4##(1995-2#2)(2008-4#1)
and cell surface##6##3##(1994-11#1)(1995-2#3)(2008-4#1)(2010-12#1)
and cell surfaces##2##3##(2009-2#1)(2013-8#1)
and cell survival##5##3##(1997-4#1)(2008-10#2)(2008-7#1)(2008-9#1)
and cell therapy##3##3##(1994-6#1)(2008-11#1)(2008-4#1)
and cell type##2##3##(2008-8#1)(2013-1#1)
and cell types##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
and cell viability of##3##4##(2008-11#2)(2010-10#1)
and cell viability was##2##4##(2008-11#1)(2009-9#1)
and cell viability##8##3##(2008-11#5)(2008-7#1)(2009-9#1)(2010-10#1)
and cell wall##9##3##(1997-6#2)(2008-10#4)(2008-8#1)(2009-10#1)(2013-1#1)
and cell##244##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-8#4)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2007-12#4)(2008-1#5)(2008-10#17)(2008-11#35)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#16)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#17)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#10)(2011-3#3)(2012-1#2)(2012-12#1)(2012-2#15)(2012-3#2)(2013-1#8)(2013-8#2)
and cell-based##5##2##(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-2#1)
and cell-cell##2##2##(1994-5#1)(2008-11#1)
and cell-free##2##2##(2008-11#1)(2008-5#1)
and cell-kill##2##2##(2012-2#2)
and cell-mediated immune##2##3##(2008-10#1)(2008-5#1)
and cell-mediated immunity##2##3##(2008-10#1)(2008-8#1)
and cell-mediated##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
and cell-specific##3##2##(1992-9#2)(1994-5#1)
and cell-to-cell movement##2##3##(2008-10#1)(2008-9#1)
and cell-to-cell##3##2##(1996-10#1)(2008-10#1)(2008-9#1)
and cells of##2##3##(1994-3#1)(2008-5#1)
and cells that##3##3##(1992-3#1)(2007-12#1)(2008-4#1)
and cells##22##2##(1992-3#1)(1992-9#1)(1994-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
and cellular DNA##3##3##(1994-8#1)(2008-11#1)(2008-9#1)
and cellular events##3##3##(2007-12#1)(2008-7#2)
and cellular function##2##3##(2006-6#1)(2008-7#1)
and cellular functions##2##3##(2008-5#1)(2010-12#1)
and cellular level##3##3##(1997-7#1)(2009-6#1)(2011-1#1)
and cellular levels##4##3##(1997-6#1)(2008-2#1)(2008-4#2)
and cellular mechanisms##2##3##(2008-2#1)(2009-8#1)
and cellular processes##4##3##(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)
and cellular protein##2##3##(1995-5#1)(2008-9#1)
and cellular responses##3##3##(1992-3#1)(2008-5#1)(2008-8#1)
and cellular##98##2##(1991-12#2)(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#9)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#8)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and cellulase##2##2##(2008-10#1)(2008-6#1)
and cellulolytic bacterial concentrations##2##4##(2009-4#2)
and cellulolytic##3##2##(2009-4#2)(2013-7#1)
and cellulose were##2##3##(2008-10#2)
and cellulose##7##2##(2008-10#6)(2010-5#1)
and cement##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
and cemented##2##2##(2008-3#1)(2009-3#1)
and censored data##2##3##(1997-3#1)(2008-10#1)
and center##5##2##(2007-12#1)(2008-6#1)(2013-8#3)
and centractin##2##2##(1995-2#2)
and central composite designs##2##4##(2008-10#2)
and central composite##3##3##(2008-10#3)
and central disorders##2##3##(2013-1#2)
and central nervous system (CNS)##2##5##(2008-11#1)(2012-12#1)
and central nervous system##9##4##(1991-12#1)(1992-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#1)
and central nervous##10##3##(1991-12#1)(1992-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)(2011-1#1)(2012-12#1)
and central parts of the##2##5##(1994-3#1)(2009-4#1)
and central##52##2##(1990-6#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
and centrifugation##4##2##(1994-8#1)(2008-10#2)(2008-4#1)
and centrifuged##2##2##(2008-10#1)(2008-9#1)
and centrin-3##2##2##(2008-9#2)
and cephalosporins##3##2##(1996-3#1)(2011-1#2)
and ceramide##5##2##(1992-8#1)(1994-10#2)(2008-5#2)
and cereal##4##2##(2008-10#1)(2008-9#1)(2009-8#1)(2010-1#1)
and cerebellar ataxia##2##3##(2008-7#1)(2013-1#1)
and cerebellar cortex##3##3##(1997-2#2)(2008-7#1)
and cerebellar##16##2##(1991-11#1)(1991-2#1)(1993-12#1)(1995-11#1)(1996-12#2)(1996-5#1)(1997-2#2)(2008-7#3)(2009-8#1)(2011-2#2)(2013-1#1)
and cerebellum in##2##3##(1990-7#1)(2008-7#1)
and cerebellum##15##2##(1990-5#1)(1990-7#2)(1991-4#1)(1993-9#2)(1996-12#3)(1996-5#2)(1997-4#1)(2008-10#1)(2008-6#1)(2008-7#1)
and cerebral amyloid angiopathy##2##4##(1996-11#1)(1996-5#1)
and cerebral blood flow##6##4##(1995-11#1)(1996-5#1)(2007-10#2)(2008-7#1)(2012-3#1)
and cerebral cortex##5##3##(1993-6#1)(1994-6#1)(1995-5#1)(1997-2#1)(2009-5#1)
and cerebral##28##2##(1990-3#2)(1990-9#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-8#2)(2007-10#4)(2008-4#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)
and cerebrospinal fluid (CSF)##2##4##(2008-5#1)(2012-2#1)
and cerebrospinal fluid##6##3##(1991-7#1)(1997-8#1)(2008-5#1)(2009-6#1)(2010-11#1)(2012-2#1)
and cerebrovascular accidents##2##3##(1992-2#1)(2013-8#1)
and cerebrovascular complications##2##3##(2008-11#1)(2008-7#1)
and cerebrovascular deposits##2##3##(1992-12#1)(1996-5#1)
and cerebrovascular disease##9##3##(1990-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#5)
and cerebrovascular diseases##2##3##(2011-1#2)
and cerebrovascular##22##2##(1990-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-11#1)(1996-11#1)(1996-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#7)(2013-8#1)
and certain other##4##3##(1993-11#1)(1994-8#1)(2008-4#1)(2013-8#1)
and certain##36##2##(1990-5#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-7#1)(2013-8#2)
and certainly##3##2##(1991-11#1)(1994-12#1)(2008-4#1)
and certification of##3##3##(2008-10#2)(2009-10#1)
and certification##5##2##(1991-1#1)(1994-12#1)(2008-10#2)(2009-10#1)
and certified samples##2##3##(2008-10#2)
and certified values in##3##4##(2008-10#3)
and certified values##5##3##(2008-10#5)
and certified##13##2##(2008-10#12)(2012-3#1)
and cervical cancer screening##4##4##(1990-8#1)(1997-1#1)(1997-2#1)(2008-12#1)
and cervical cancer##9##3##(1990-8#2)(1994-10#1)(1997-1#1)(1997-2#1)(2008-12#1)(2011-3#1)(2012-12#2)
and cervical intraepithelial neoplasia##3##4##(1992-8#1)(2011-1#2)
and cervical pain##2##3##(2007-11#2)
and cervical##32##2##(1990-8#2)(1991-1#1)(1992-8#1)(1994-10#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-10#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-3#1)(2012-12#2)
and cervix##4##2##(2008-11#1)(2013-1#3)
and cesarean##2##2##(1997-1#1)(2011-2#1)
and cesium##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
and cessation of##2##3##(1993-2#1)(2008-7#1)
and cessation##5##2##(1993-2#1)(1997-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
and cetirizine##2##2##(2007-11#1)(2010-5#1)
and cetyl rhamnoside##2##3##(2008-5#2)
and cetyl##5##2##(2008-10#3)(2008-5#2)
and cetylpyridinium chloride##2##3##(2008-10#2)
and cetylpyridinium##4##2##(2008-10#4)
and cetyltrimethylammonium##3##2##(2008-10#3)
and chain##7##2##(1994-11#2)(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#1)
and challenge##6##2##(1991-8#1)(1993-3#1)(1995-12#1)(1996-2#1)(2008-12#1)(2009-2#1)
and challenged##3##2##(1997-3#1)(2008-10#1)(2010-8#1)
and challenges are##2##3##(2008-10#1)(2010-10#1)
and challenges faced##2##3##(2008-12#1)(2013-1#1)
and challenges facing##3##3##(1992-12#1)(1996-3#1)(2009-6#1)
and challenges for a##2##4##(1995-5#1)(2008-1#1)
and challenges for health information systems##2##6##(2012-12#2)
and challenges for##11##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#4)(2013-1#1)
and challenges in the##3##4##(2008-1#1)(2012-3#2)
and challenges in##7##3##(2008-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#2)
and challenges of the##2##4##(2010-8#1)(2011-2#1)
and challenges of##8##3##(1997-2#1)(2008-12#2)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
and challenges that##4##3##(2007-10#2)(2008-12#1)(2011-2#1)
and challenges to##2##3##(1996-1#1)(2008-9#1)
and challenges##61##2##(1991-11#1)(1991-3#1)(1992-12#1)(1993-8#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-2#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#5)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#4)
and challenging##10##2##(1994-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
and chamigrenal##2##2##(2008-11#2)
and chances of##2##3##(2007-1#1)(2008-7#1)
and change in##16##3##(1994-2#1)(1994-9#1)(1995-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#1)
and change##38##2##(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-3#2)(1996-1#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
and changed##3##2##(1990-11#1)(1993-12#1)(2008-10#1)
and changes in adolescents' psychological well-being over##2##7##(2010-7#2)
and changes in cell##2##4##(2008-10#1)(2008-7#1)
and changes in the surveillance definition of AIDS##2##8##(1992-9#2)
and changes in the##11##4##(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-9#2)(2008-10#2)(2012-3#1)
and changes in these##2##4##(2006-8#1)(2013-8#1)
and changes in##56##3##(1991-2#3)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#2)(1994-2#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-8#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and changes its##2##3##(2007-8#1)(2008-12#1)
and changes of##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
and changes to##2##3##(2008-8#1)(2009-7#1)
and changes##73##2##(1991-2#3)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#2)(1994-1#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-3#1)(1997-1#1)(1997-8#1)(2006-8#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and changing the##7##3##(2007-12#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)
and changing##17##2##(1991-3#1)(1992-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
and channel##5##2##(2007-12#1)(2008-2#2)(2008-6#1)(2008-8#1)
and channels##2##2##(2008-7#1)(2011-1#1)
and chaotic dynamics##2##3##(2008-11#1)(2008-8#1)
and chaotic##5##2##(1996-4#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
and chaotropic##2##2##(1990-2#1)(2009-2#1)
and chapters##2##2##(2008-11#1)(2008-4#1)
and character of the##2##4##(2007-11#1)(2008-9#1)
and character of##7##3##(1992-12#1)(2007-11#1)(2007-9#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)
and character##10##2##(1992-12#1)(2007-11#1)(2007-9#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
and characterisation of the##2##4##(1993-12#1)(1993-2#1)
and characterisation of##10##3##(1990-11#1)(1993-12#1)(1993-2#1)(2007-7#1)(2008-10#4)(2008-5#1)(2012-2#1)
and characterisation##11##2##(1990-11#1)(1993-12#1)(1993-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2012-2#1)
and characterised by##2##3##(1997-1#1)(2008-10#1)
and characterised##14##2##(1990-11#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1997-1#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-7#1)
and characteristic##14##2##(1992-8#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-8#2)(2007-7#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
and characteristics of a##5##4##(1993-3#1)(2007-12#1)(2008-10#2)(2009-11#1)
and characteristics of the##4##4##(1993-6#1)(2008-10#1)(2008-7#1)(2010-6#1)
and characteristics of##19##3##(1991-11#1)(1993-3#1)(1993-6#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-6#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
and characteristics##26##2##(1991-11#1)(1993-3#1)(1993-6#1)(1996-2#2)(1996-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
and characterization are##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
and characterization of a cDNA##4##5##(1993-12#1)(1994-11#1)(1994-12#1)(2008-8#1)
and characterization of a human liver##2##6##(1991-5#1)(1993-11#1)
and characterization of a human##7##5##(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(2008-8#2)
and characterization of a mammalian##2##5##(1994-12#1)(1997-7#1)
and characterization of a new##6##5##(1992-9#1)(2008-10#3)(2008-8#1)(2011-2#1)
and characterization of a novel human##2##6##(1993-11#1)(1997-8#1)
and characterization of a novel##11##5##(1990-12#1)(1990-7#1)(1993-11#1)(1993-2#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-8#1)(2008-9#1)
and characterization of a rat##2##5##(1994-6#1)(1995-6#1)
and characterization of a##70##4##(1990-12#2)(1990-2#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
and characterization of an##7##4##(1991-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-3#1)
and characterization of cDNAs encoding the##2##6##(1992-12#1)(1994-12#1)
and characterization of cDNAs encoding##3##5##(1991-6#1)(1992-12#1)(1994-12#1)
and characterization of cDNAs##4##4##(1991-6#1)(1992-12#1)(1993-6#1)(1994-12#1)
and characterization of gene##2##4##(2008-4#1)(2008-9#1)
and characterization of human##6##4##(1991-6#1)(1994-6#1)(1997-2#1)(2008-9#1)(2009-9#1)(2012-2#1)
and characterization of new##3##4##(1990-7#1)(1993-12#1)(2010-4#1)
and characterization of nonhuman primate##2##5##(2008-9#2)
and characterization of novel##3##4##(1995-11#1)(2008-10#1)(2008-9#1)
and characterization of polyclonal##2##4##(2008-10#1)(2008-4#1)
and characterization of protein##2##4##(1994-8#1)(2008-4#1)
and characterization of recombinant##4##4##(1990-8#2)(1995-11#1)(2012-3#1)
and characterization of the Saccharomyces cerevisiae##2##6##(1995-8#1)(1997-8#1)
and characterization of the gene encoding##3##6##(1993-2#1)(1994-12#1)(1995-8#1)
and characterization of the major##2##5##(1993-5#1)(2008-10#1)
and characterization of the promoter region##2##6##(1993-3#1)(1994-12#1)
and characterization of the##36##4##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#3)(1994-5#1)(1995-11#1)(1995-8#3)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2010-12#1)(2013-8#1)
and characterization of their##2##4##(2008-10#1)(2008-8#1)
and characterization of these##3##4##(2008-4#1)(2011-2#1)(2013-8#1)
and characterization of this##2##4##(2008-10#2)
and characterization of two##6##4##(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(2008-4#1)
and characterization of##267##3##(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#4)(1990-7#5)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#4)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#5)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#7)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1995-11#4)(1995-2#1)(1995-6#2)(1995-8#5)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#5)(1997-4#7)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#37)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#22)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#11)(2008-9#6)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
and characterization##289##2##(1990-11#5)(1990-12#3)(1990-2#2)(1990-5#5)(1990-7#5)(1990-8#4)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#4)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#5)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#8)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1995-11#4)(1995-2#1)(1995-6#2)(1995-8#5)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#7)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#3)(2007-12#7)(2008-1#3)(2008-10#41)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#23)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#6)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
and characterize a##2##3##(2008-2#1)(2008-3#1)
and characterize the##13##3##(1992-1#1)(1995-2#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)
and characterize##30##2##(1990-2#1)(1992-1#1)(1993-11#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#2)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
and characterized a##14##3##(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#2)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
and characterized as the##2##4##(1991-5#1)(1995-2#1)
and characterized as##7##3##(1991-5#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#2)
and characterized by X-ray##2##4##(2008-10#1)(2012-2#1)
and characterized by elemental analysis##4##5##(1996-2#1)(2008-10#3)
and characterized by the##2##4##(1994-8#1)(2008-12#1)
and characterized by##32##3##(1993-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and characterized for##5##3##(2008-10#4)(2013-8#1)
and characterized from##6##3##(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#2)
and characterized in order to study##2##6##(1992-3#1)(1993-11#1)
and characterized in##8##3##(1992-3#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2013-1#1)
and characterized the##2##3##(1991-6#1)(2010-1#1)
and characterized two##2##3##(1993-8#1)(1993-9#1)
and characterized using##5##3##(1991-9#1)(2008-10#4)
and characterized with##4##3##(1995-3#1)(2007-12#1)(2008-10#2)
and characterized##165##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#2)(1991-5#2)(1991-6#3)(1991-9#5)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#5)(1996-12#2)(1996-2#3)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(2007-11#4)(2007-12#5)(2008-10#40)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#5)(2008-7#4)(2008-8#6)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and characterizing##5##2##(1992-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2009-7#1)
and charge distribution##3##3##(1997-2#1)(2007-12#1)(2008-10#1)
and charge##12##2##(1992-8#1)(1993-6#1)(1993-9#1)(1994-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-12#1)(2012-2#1)
and charged##3##2##(2010-12#1)(2010-7#1)(2010-9#1)
and charges##3##2##(1992-12#1)(1993-12#1)(2009-5#1)
and charity##4##2##(1992-2#1)(1993-12#1)(2008-11#2)
and cheap to##2##3##(2008-10#1)(2011-2#1)
and cheap##8##2##(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
and cheaper than##3##3##(2008-10#3)
and cheaper##7##2##(1995-11#1)(2008-10#4)(2008-12#1)(2011-2#1)
and checks##2##2##(2008-10#1)(2008-11#1)
and cheeks##2##2##(2008-5#1)(2008-8#1)
and cheese##3##2##(1990-8#1)(2008-10#1)(2009-8#1)
and chelicerates##2##2##(2007-12#2)
and chemical analysis of##2##4##(2008-10#1)(2013-7#1)
and chemical analysis##5##3##(2008-10#2)(2013-7#1)(2013-8#2)
and chemical and##4##3##(1992-3#1)(2008-10#1)(2008-7#2)
and chemical characteristics of##3##4##(2008-10#1)(2010-4#2)
and chemical characteristics##6##3##(2008-10#2)(2008-5#1)(2009-8#1)(2010-4#2)
and chemical composition of##2##4##(2008-3#2)
and chemical composition##4##3##(2008-10#1)(2008-3#2)(2009-7#1)
and chemical conditions##2##3##(2008-10#2)
and chemical environment##4##3##(2008-10#2)(2008-8#1)(2011-1#1)
and chemical industries##2##3##(1991-3#1)(2012-3#1)
and chemical modifications of##2##4##(1992-9#1)(1995-5#1)
and chemical orthogonality##2##3##(2009-3#2)
and chemical parameters##2##3##(2008-10#2)
and chemical properties of the##2##5##(2008-6#1)(2011-2#1)
and chemical properties of##6##4##(1992-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
and chemical properties that##2##4##(1997-6#1)(2012-1#1)
and chemical properties##20##3##(1990-9#1)(1991-2#1)(1992-8#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#2)(2013-8#1)
and chemical seed##2##3##(2008-10#2)
and chemical shifts##2##3##(1995-5#1)(2008-10#1)
and chemical stability of the##2##5##(2008-2#1)(2011-1#1)
and chemical stability##6##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
and chemical variables affecting the##2##5##(2008-10#2)
and chemical variables##6##3##(2008-10#6)
and chemical##153##2##(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-12#2)(1997-6#2)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#52)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#4)(2010-8#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#7)
and chemically active##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
and chemically inert##2##3##(2008-3#1)(2008-7#1)
and chemically modified beta-cyclodextrins##2##4##(2008-10#2)
and chemically##16##2##(1991-3#1)(1993-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-7#1)(2012-12#1)(2012-2#1)
and chemicals in##2##3##(1991-12#1)(2008-7#1)
and chemicals##11##2##(1991-12#1)(2008-10#2)(2008-6#1)(2008-7#4)(2010-12#1)(2011-2#1)(2013-1#1)
and chemiluminescence detection##5##3##(2008-10#5)
and chemiluminescence##12##2##(2008-1#1)(2008-10#11)
and chemiluminescent nitrogen detection##2##4##(1997-2#2)
and chemiluminescent##4##2##(1991-12#1)(1997-2#2)(2008-10#1)
and chemistry##9##2##(1992-11#1)(2007-11#1)(2008-10#3)(2008-7#1)(2010-11#1)(2012-2#2)
and chemokine##4##2##(2008-10#1)(2009-3#1)(2010-5#1)(2011-2#1)
and chemokines##3##2##(2008-1#1)(2008-4#1)(2010-11#1)
and chemometric data analysis##2##4##(2008-1#1)(2008-10#1)
and chemometric##8##2##(2008-1#1)(2008-10#7)
and chemometrics##5##2##(2007-12#2)(2008-1#1)(2008-10#2)
and chemoresistance and##2##3##(2009-4#1)(2013-1#1)
and chemotactic##3##2##(2008-10#2)(2008-6#1)
and chemotaxis##2##2##(1995-6#1)(2008-9#1)
and chemotherapeutic##3##2##(2008-5#1)(2009-3#1)(2012-12#1)
and chemotherapy for##3##3##(1990-10#1)(2012-12#1)(2013-1#1)
and chemotherapy in the treatment of##3##6##(1993-9#1)(2007-11#1)(2013-1#1)
and chemotherapy in##4##3##(1993-9#1)(2007-11#1)(2013-1#2)
and chemotherapy was##2##3##(1993-9#1)(2012-3#1)
and chemotherapy##44##2##(1990-10#1)(1990-8#3)(1992-2#1)(1993-2#1)(1993-9#2)(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#7)(2013-8#3)
and chemotherapy-induced##5##2##(2008-7#5)
and cherry##2##2##(2008-10#2)
and chest X-ray##3##3##(1997-3#1)(2008-1#1)(2010-11#1)
and chest pain##3##3##(1996-6#1)(2008-1#1)(2013-1#1)
and chest radiography##2##3##(2006-10#1)(2008-3#1)
and chest##18##2##(1991-2#1)(1992-9#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and chewing##3##2##(2013-1#2)(2013-7#1)
and chi##2##2##(1991-3#2)
and chiasma##4##2##(2008-5#4)
and chick brain were##2##4##(1996-12#2)
and chick brain##3##3##(1990-7#1)(1996-12#2)
and chick##10##2##(1990-7#1)(1996-12#5)(1996-2#1)(1997-1#3)
and chicken##16##2##(1991-3#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-5#1)(2007-12#1)(2007-6#2)(2008-10#3)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)
and chief##9##2##(1992-4#1)(1994-8#3)(2011-2#3)(2013-1#2)
and child care##4##3##(1990-2#1)(2008-11#1)(2008-12#1)(2013-1#1)
and child development after##2##4##(1996-9#2)
and child health##9##3##(1990-6#1)(1991-3#1)(1994-3#1)(1995-12#2)(1996-12#2)(1997-2#1)(2009-7#1)
and child##41##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1993-1#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#2)(1996-9#2)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
and child)##2##2##(2008-10#1)(2012-12#1)
and childbearing##3##2##(1995-1#1)(2010-12#1)(2012-12#1)
and childbirth##4##2##(1993-3#1)(1995-1#1)(1995-6#1)(2010-3#1)
and childhood##8##2##(1992-6#1)(1994-2#1)(2008-11#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and children in##5##3##(1990-2#1)(1995-1#1)(2007-11#1)(2008-6#1)(2009-9#1)
and children than##2##3##(2011-2#1)(2013-8#1)
and children who##5##3##(1992-1#1)(1992-2#1)(2008-11#2)(2008-2#1)
and children with AIDS##2##4##(1995-6#2)
and children with##12##3##(1991-12#1)(1994-2#1)(1995-6#2)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2011-1#1)
and children##72##2##(1990-2#3)(1991-12#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#2)(1994-2#1)(1995-1#2)(1995-12#2)(1995-6#2)(1996-2#2)(1996-7#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#10)(2008-12#1)(2008-2#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
and children's academic##2##3##(2008-12#1)(2009-7#1)
and children's health##3##3##(2008-11#2)(2012-12#1)
and children's social competence and behavior problems##2##7##(2010-11#2)
and children's##25##2##(1990-6#2)(1991-12#1)(1993-12#1)(1994-6#5)(2008-11#2)(2008-12#2)(2008-6#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#2)(2011-2#2)(2012-12#1)(2012-2#1)
and chimeras##4##2##(1997-8#1)(2008-8#3)
and chimeric##6##2##(1990-8#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
and chin##6##2##(2008-5#5)(2012-3#1)
and chiral##3##2##(2008-10#2)(2010-4#1)
and chirp##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
and chirped##2##2##(2008-3#2)
and chitin##5##2##(2008-1#1)(2008-10#4)
and chitinase##3##2##(1993-9#1)(2008-10#2)
and chitinolytic##3##2##(2008-10#2)(2008-5#1)
and chitosan##7##2##(2008-10#4)(2008-5#3)
and chives##3##2##(2008-10#3)
and chlamydospore production##3##3##(2008-10#3)
and chlamydospores##5##2##(2008-10#5)
and chloramphenicol##2##2##(1995-6#1)(1997-7#1)
and chlorate in##4##3##(2008-10#4)
and chlorate##11##2##(2008-10#11)
and chlorfenvinphos##4##2##(2008-10#3)(2011-2#1)
and chlorhexidine##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
and chloride ions##2##3##(2008-10#2)
and chloride##11##2##(1992-12#1)(2008-10#6)(2008-8#1)(2010-12#1)(2010-7#1)(2012-2#1)
and chlorides##2##2##(2008-10#1)(2009-11#1)
and chlorinated hydrocarbons##3##3##(2008-10#3)
and chlorinated##4##2##(2008-10#4)
and chlorine##2##2##(2008-10#1)(2008-2#1)
and chloroform##5##2##(2007-12#1)(2008-10#3)(2013-8#1)
and chlorogenic acid##3##3##(2008-10#3)
and chlorogenic##5##2##(2008-10#5)
and chlorophenols##4##2##(1991-11#1)(1996-12#1)(2012-1#2)
and chlorophyll concentration##2##3##(2008-3#1)(2008-9#1)
and chlorophyll content##2##3##(2008-12#1)(2008-3#1)
and chlorophyll contents##2##3##(2008-12#2)
and chlorophyll##7##2##(2008-12#3)(2008-3#3)(2008-9#1)
and chloropicrin##2##2##(2008-10#2)
and chloroplast##7##2##(1991-6#1)(1992-8#1)(1994-11#1)(2008-12#1)(2008-5#1)(2009-8#2)
and chloroquine##2##2##(1992-12#1)(1994-6#1)
and chlorosis in##3##3##(2008-10#3)
and chlorosis##5##2##(2008-10#5)
and chlorothalonil##2##2##(2008-10#2)
and chlorpyrifos##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
and chlortetracycline##4##2##(2008-10#4)
and chocolate##3##2##(2008-10#3)
and choice of##5##3##(1994-5#1)(2008-10#2)(2008-6#1)(2008-7#1)
and choice##12##2##(1990-9#1)(1992-1#1)(1993-12#1)(1994-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-3#1)
and choice-offering were##2##3##(2008-4#2)
and cholecystectomy##3##2##(1990-9#2)(1992-9#1)
and cholecystokinin##2##2##(1992-8#1)(1996-2#1)
and cholera toxin##2##3##(1996-5#1)(2008-4#1)
and cholera##4##2##(1993-3#1)(1996-5#1)(2007-2#1)(2008-4#1)
and cholesterol in##3##3##(1990-2#1)(2009-7#2)
and cholesterol levels##5##3##(1993-3#1)(1994-11#1)(2010-2#1)(2010-5#1)(2013-1#1)
and cholesterol metabolism##2##3##(2008-1#1)(2008-10#1)
and cholesterol##35##2##(1990-2#1)(1990-5#1)(1990-8#2)(1992-6#2)(1992-8#2)(1993-3#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-7#4)(2010-2#1)(2010-5#1)(2012-2#6)(2013-1#1)
and choline on-line##2##3##(2008-10#2)
and choline oxidase##2##3##(1992-11#1)(2008-10#1)
and choline##10##2##(1991-5#1)(1992-11#1)(1992-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)
and cholinergic##10##2##(1991-11#1)(1992-11#1)(1992-8#1)(1996-2#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#1)
and chondrogenesis##2##2##(1991-5#1)(2008-5#1)
and chondrogenic##6##2##(2008-11#5)(2008-5#1)
and chondroitin##4##2##(1992-9#1)(2008-10#2)(2012-6#1)
and choose##2##2##(1992-2#1)(1995-2#1)
and choosing friends##2##3##(2009-7#2)
and choosing the##2##3##(2008-2#1)(2008-4#1)
and choosing##5##2##(2008-2#1)(2008-4#1)(2009-7#2)(2011-2#1)
and chopped chicken breast tissue##2##5##(2007-11#2)
and chordal##2##2##(2007-8#1)(2013-1#1)
and choroidal##3##2##(2010-1#1)(2011-7#1)(2013-1#1)
and chose a##2##3##(2007-12#2)
and chose the##2##3##(1992-11#1)(2009-5#1)
and chose##5##2##(1992-11#1)(1994-3#1)(2007-12#2)(2009-5#1)
and chromatic##3##2##(2008-3#3)
and chromatin condensation##2##3##(2008-1#1)(2008-8#1)
and chromatin structure##3##3##(1994-5#1)(2007-12#1)(2011-2#1)
and chromatin##9##2##(1992-12#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#3)
and chromatographed##2##2##(1997-2#1)(2008-10#1)
and chromatographic conditions were optimized##2##5##(2008-10#2)
and chromatographic conditions##3##3##(2008-10#3)
and chromatographic data##2##3##(2008-10#1)(2011-1#1)
and chromatographic##14##2##(1990-8#1)(1992-3#1)(2008-10#9)(2008-4#1)(2008-5#1)(2011-1#1)
and chromatography on##3##3##(1990-5#1)(1990-7#1)(1991-12#1)
and chromatography##10##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-8#1)(1993-9#1)(1994-6#1)(2008-10#3)(2008-11#1)
and chromium in##8##3##(2008-10#8)
and chromium was##2##3##(2008-10#2)
and chromium##16##2##(2008-10#16)
and chromium(III)##3##2##(2008-10#3)
and chromium(VI) using##2##3##(2008-10#2)
and chromium(VI)##7##2##(2008-10#7)
and chromophore##2##2##(2008-10#1)(2008-3#1)
and chromosomal localization of a##2##5##(1990-12#1)(1997-4#1)
and chromosomal localization of the##2##5##(2008-9#2)
and chromosomal localization of##5##4##(1990-12#1)(1994-8#1)(1997-4#1)(2008-9#2)
and chromosomal mapping of##3##4##(1994-12#1)(1997-8#1)(2008-8#1)
and chromosomal##19##2##(1990-12#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#2)
and chromosome 16##2##3##(1997-5#2)
and chromosome##22##2##(1991-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-5#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-8#1)
and chromosomes##2##2##(2008-10#1)(2008-5#1)
and chronic active inflammation##4##4##(2008-9#4)
and chronic airways obstruction##2##4##(1995-12#1)(2008-12#1)
and chronic conditions##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
and chronic disease##3##3##(1997-3#1)(2008-10#1)(2011-1#1)
and chronic diseases in##2##4##(1997-8#1)(2008-7#1)
and chronic effects of##2##4##(2008-5#1)(2011-2#1)
and chronic effects##4##3##(1994-5#1)(2008-5#1)(2008-6#1)(2011-2#1)
and chronic gastritis##2##3##(2007-2#1)(2008-5#1)
and chronic heart failure##2##4##(2008-7#1)(2010-8#1)
and chronic hepatitis B##2##4##(2009-12#1)(2013-8#1)
and chronic hepatitis C##2##4##(2011-2#1)(2013-8#1)
and chronic hepatitis##4##3##(2009-12#1)(2011-2#1)(2013-8#2)
and chronic illness##3##3##(1997-1#1)(2008-2#1)(2010-10#1)
and chronic inflammation##4##3##(2010-5#1)(2012-12#1)(2012-5#2)
and chronic inflammatory demyelinating polyneuropathy##2##5##(1995-5#1)(2012-3#1)
and chronic inflammatory##5##3##(1995-5#1)(2008-10#1)(2009-3#1)(2010-6#1)(2012-3#1)
and chronic kidney disease##2##4##(2008-8#1)(2010-10#1)
and chronic kidney##3##3##(2008-8#1)(2010-10#1)(2013-8#1)
and chronic low back pain##2##5##(2008-10#1)(2010-1#1)
and chronic lung disease##3##4##(1992-2#1)(2009-3#1)(2012-2#1)
and chronic myelogenous leukemia##2##4##(2008-5#1)(2010-4#1)
and chronic myelomonocytic leukemia##2##4##(1992-10#2)
and chronic obstructive pulmonary disease (COPD)##3##6##(1992-3#1)(1995-12#1)(1996-1#1)
and chronic obstructive pulmonary disease##7##5##(1992-3#1)(1995-12#2)(1996-1#1)(2007-8#1)(2012-2#1)(2012-3#1)
and chronic osteomyelitis##2##3##(2008-11#1)(2010-6#1)
and chronic pain##6##3##(2008-12#1)(2008-7#4)(2008-8#1)
and chronic pancreatitis##2##3##(2008-10#1)(2013-8#1)
and chronic periodontitis##3##3##(2012-3#1)(2013-1#2)
and chronic quis and ibo NB##2##6##(1991-9#2)
and chronic renal failure##3##4##(2008-1#2)(2011-2#1)
and chronic renal##6##3##(1997-2#1)(2008-1#3)(2008-3#1)(2011-2#1)
and chronic##149##2##(1990-3#1)(1991-12#1)(1991-4#1)(1991-9#5)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#3)(1995-5#3)(1996-1#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#3)(2012-5#4)(2013-1#8)(2013-8#8)
and chronoamperometry##4##2##(2008-10#4)
and chrysoeriol##2##2##(2010-6#2)
and chymotrypsin##8##2##(1990-2#1)(1990-5#2)(1991-9#2)(1992-9#1)(1993-11#1)(2008-10#1)
and chymotryptic##2##2##(1992-4#1)(2008-5#1)
and cigarette smoking##4##3##(1991-12#1)(1991-9#1)(1992-4#1)(2013-1#1)
and cigarette##5##2##(1991-12#1)(1991-9#1)(1992-4#1)(2008-10#1)(2013-1#1)
and ciliary body##2##3##(1997-2#1)(1997-3#1)
and ciliary##3##2##(1997-2#1)(1997-3#1)(2008-2#1)
and cimetidine##2##2##(1991-5#1)(2008-11#1)
and cingulate cortex##2##3##(1995-12#2)
and cingulate##4##2##(1991-5#1)(1994-3#1)(1995-12#2)
and cinnamoyl##2##2##(2008-10#1)(2013-1#1)
and cionin##2##2##(1995-12#2)
and ciprofloxacin in##3##3##(2008-10#1)(2011-2#2)
and ciprofloxacin##9##2##(2008-10#4)(2008-7#2)(2011-2#2)(2013-1#1)
and circadian##5##2##(1995-2#1)(2008-11#1)(2008-5#1)(2009-7#2)
and circuit##5##2##(1995-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
and circular dichroism (CD)##2##4##(2008-10#1)(2008-7#1)
and circular dichroism spectroscopy##2##4##(1990-7#1)(1992-3#1)
and circular dichroism##12##3##(1990-7#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-7#2)
and circular##22##2##(1990-7#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#2)
and circularization of##2##3##(2008-3#2)
and circularization##3##2##(2008-3#2)(2008-4#1)
and circulating##5##2##(1990-2#1)(1995-11#1)(2009-7#1)(2010-6#1)(2011-2#1)
and circulatory arrest##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
and circulatory##8##2##(1995-9#1)(1996-6#1)(2007-8#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and circumference##2##2##(1991-11#1)(1995-6#1)
and circumferential spinal fusion with instrumentation##2##6##(2008-8#2)
and circumferential##6##2##(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)
and circumnutation rate##2##3##(2009-6#2)
and circumnutation##4##2##(2009-6#4)
and circumstances##4##2##(2007-8#1)(2008-9#1)(2010-3#1)(2012-12#1)
and circumstantial##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
and cis##2##2##(1990-9#1)(1996-2#1)
and cis-resveratrol##3##2##(2008-10#3)
and cisplatin as induction##2##4##(2008-10#1)(2010-3#1)
and cisplatin as##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
and cisplatin for##2##3##(1995-10#1)(2008-6#1)
and cisplatin in##4##3##(1991-6#1)(1993-8#1)(2007-4#1)(2008-7#1)
and cisplatin##29##2##(1990-10#1)(1990-12#1)(1991-6#2)(1991-8#1)(1992-10#1)(1993-8#2)(1995-10#2)(1995-12#1)(2007-10#2)(2007-4#1)(2008-10#6)(2008-2#1)(2008-6#3)(2008-7#1)(2010-3#2)(2013-1#2)
and cisplatinum##3##2##(1991-2#1)(2009-8#1)(2010-3#1)
and citalopram##4##2##(2012-2#1)(2012-3#3)
and citizens' participation##2##3##(1993-6#2)
and citizens'##3##2##(1993-6#3)
and citrate##5##2##(2008-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
and citric acid##8##3##(2008-10#4)(2013-1#4)
and citric acids##3##3##(2008-10#2)(2008-5#1)
and citric##12##2##(2008-10#7)(2008-5#1)(2013-1#4)
and citrulline##12##2##(1996-2#1)(2006-10#5)(2008-7#5)(2009-4#1)
and citrumelo##3##2##(2008-10#3)
and citrus##6##2##(2008-10#6)
and city##5##2##(1997-4#1)(1997-6#1)(2008-1#1)(2008-11#1)(2011-2#1)
and civil##5##2##(1991-12#1)(1991-6#1)(1996-1#1)(2012-2#1)(2013-1#1)
and civilian##2##2##(2007-8#1)(2010-1#1)
and cladding modes in##3##4##(2008-3#3)
and cladding modes##4##3##(2007-12#1)(2008-3#3)
and clarified##4##2##(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
and clarify##3##2##(2008-8#1)(2010-2#1)(2010-8#1)
and clarity of##2##3##(1997-3#1)(2008-3#1)
and clarity##4##2##(1995-1#1)(1997-3#1)(2008-3#1)(2010-5#1)
and class 3 secretory##2##4##(2007-12#2)
and class 3##4##3##(2007-12#3)(2008-10#1)
and class 4##2##3##(2008-10#2)
and class II##6##3##(1995-5#1)(1997-8#2)(2008-4#2)(2008-9#1)
and class##19##2##(1992-3#1)(1992-7#1)(1995-5#1)(1997-8#2)(2007-12#3)(2008-10#5)(2008-12#1)(2008-4#2)(2008-9#1)(2009-1#1)(2009-5#1)
and classes##2##2##(2008-10#1)(2008-2#1)
and classical dynamics##4##3##(2013-1#4)
and classical##10##2##(1991-12#1)(1993-8#1)(2008-10#3)(2012-2#1)(2013-1#4)
and classification and##2##3##(2008-10#1)(2008-9#1)
and classification of leprosy##2##4##(2009-5#2)
and classification of these##2##4##(2008-10#1)(2010-12#1)
and classification of wines##2##4##(2008-10#2)
and classification of##31##3##(1990-10#1)(1990-3#1)(1992-1#1)(1993-2#2)(1997-8#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
and classification systems##6##3##(1994-2#4)(2007-11#1)(2007-12#1)
and classification##53##2##(1990-10#1)(1990-3#1)(1992-1#1)(1993-2#2)(1994-2#5)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#3)(2009-10#3)(2009-12#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
and classifications##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
and classified as##5##3##(1992-6#1)(2007-8#1)(2008-10#2)(2010-4#1)
and classified into two groups##2##5##(1996-6#1)(2013-1#1)
and classified into##6##3##(1996-10#1)(1996-6#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
and classified##18##2##(1992-6#1)(1995-11#1)(1996-10#1)(1996-6#1)(1997-3#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-4#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
and classify the##2##3##(2009-5#1)(2010-8#1)
and classify##6##2##(2008-10#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
and classifying##4##2##(1997-3#1)(2008-10#2)(2009-7#1)
and classroom##2##2##(2008-12#2)
and clavulanic acid##3##3##(1994-11#1)(2008-10#2)
and clay##3##2##(2008-10#3)
and clean up##2##3##(2008-10#2)
and clean##9##2##(2007-12#1)(2008-10#5)(2011-2#1)(2012-12#1)(2012-3#1)
and clean-up##7##2##(1996-6#1)(2008-10#6)
and cleaned##2##2##(2008-7#1)(2011-1#1)
and cleaning##9##2##(2008-10#5)(2008-4#1)(2009-10#1)(2010-9#1)(2013-1#1)
and cleanliness##2##2##(2008-11#1)(2011-2#1)
and cleanroom##2##2##(2012-2#2)
and cleansing##2##2##(2008-5#1)(2013-1#1)
and cleanup##2##2##(2007-12#1)(2008-10#1)
and clear##10##2##(1991-3#1)(1991-8#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#2)
and clear-cell renal##2##3##(1995-10#1)(2008-10#1)
and clearance in##2##3##(2008-8#1)(2011-2#1)
and clearance rates##3##3##(2008-5#3)
and clearance##9##2##(1994-8#1)(1997-1#2)(2008-5#3)(2008-8#1)(2011-2#2)
and clearly demonstrates the##2##4##(2008-10#1)(2009-6#1)
and clearly##8##2##(1993-3#1)(2008-10#4)(2008-3#1)(2009-6#1)(2010-12#1)
and cleavage##3##2##(1991-12#1)(1996-5#1)(2010-8#1)
and cleft palate##3##3##(1995-3#1)(2009-6#1)(2012-12#1)
and cleft##7##2##(1993-12#1)(1995-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#2)
and client satisfaction##2##3##(1995-12#1)(1996-2#1)
and client##5##2##(1995-12#1)(1996-2#1)(2009-5#1)(2009-9#1)(2012-2#1)
and clients##6##2##(1992-12#1)(1996-2#2)(2008-11#1)(2010-3#1)(2013-8#1)
and climate conditions##2##3##(2008-6#1)(2008-8#1)
and climate data##2##3##(2008-10#1)(2008-8#1)
and climate##13##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-5#1)
and climatic variables##2##3##(2008-8#2)
and climatic##5##2##(2007-7#1)(2008-8#2)(2010-3#1)(2012-2#1)
and clindamycin##2##2##(2010-8#1)(2011-2#1)
and clinic##3##2##(1995-12#1)(1996-1#1)(1997-3#1)
and clinical applicability##2##3##(2010-6#1)(2011-1#1)
and clinical application of##3##4##(2011-2#1)(2013-8#2)
and clinical application##7##3##(1990-2#1)(2007-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-8#2)
and clinical applications of##2##4##(2007-12#1)(2012-2#1)
and clinical applications##14##3##(1991-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-8#1)
and clinical aspects are discussed##2##5##(1990-6#1)(1993-5#1)
and clinical aspects are##3##4##(1990-6#1)(1991-3#1)(1993-5#1)
and clinical aspects of the##2##5##(1990-9#1)(1995-6#1)
and clinical aspects of##3##4##(1990-9#1)(1995-6#1)(2009-8#1)
and clinical aspects##10##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1993-5#1)(1995-6#1)(1997-1#1)(2007-2#1)(2009-8#1)(2013-1#1)
and clinical assessment of##2##4##(1995-5#1)(2011-2#1)
and clinical benefit##2##3##(2008-10#1)(2008-6#1)
and clinical biochemistry##4##3##(1994-12#2)(2008-5#2)
and clinical case##2##3##(2008-7#1)(2012-3#1)
and clinical characteristics of##5##4##(1997-5#1)(2006-12#1)(2008-7#2)(2013-1#1)
and clinical characteristics##9##3##(1990-6#1)(1997-5#1)(2006-12#1)(2008-7#3)(2011-2#2)(2013-1#1)
and clinical condition##2##3##(2007-8#1)(2011-2#1)
and clinical consequences of##3##4##(1995-8#1)(2008-5#1)(2011-1#1)
and clinical consequences##4##3##(1995-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
and clinical considerations##2##3##(2007-8#1)(2013-1#1)
and clinical correlates of##2##4##(2013-8#2)
and clinical course##3##3##(1994-6#1)(2007-12#1)(2013-8#1)
and clinical criteria##2##3##(1990-8#1)(2007-10#1)
and clinical data are##2##4##(1996-3#1)(2012-2#1)
and clinical data that##2##4##(1997-3#1)(2009-9#1)
and clinical data##14##3##(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and clinical decision-making##2##3##(2007-10#1)(2012-2#1)
and clinical diagnosis##2##3##(2007-12#1)(2011-7#1)
and clinical efficacy##2##3##(2008-7#1)(2010-3#1)
and clinical evaluation of##3##4##(2007-11#1)(2007-7#1)(2008-7#1)
and clinical evidence##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
and clinical examination##3##3##(1991-6#1)(2008-12#1)(2009-12#1)
and clinical experience##6##3##(2006-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
and clinical expression of##3##4##(1990-2#1)(2008-4#1)(2010-1#1)
and clinical factors including##2##4##(2008-7#1)(2011-2#1)
and clinical factors##3##3##(2008-7#1)(2010-6#1)(2011-2#1)
and clinical features and##2##4##(1992-12#1)(2013-8#1)
and clinical features are##2##4##(1993-6#1)(2012-12#1)
and clinical features of##7##4##(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-9#1)(2012-3#2)
and clinical features##16##3##(1992-12#1)(1993-6#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-3#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
and clinical findings##3##3##(1993-2#1)(2012-12#1)(2012-2#1)
and clinical guidelines##2##3##(1991-12#1)(1996-1#1)
and clinical implications for##2##4##(2009-11#1)(2012-12#1)
and clinical implications##17##3##(1993-12#1)(1996-2#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#2)
and clinical importance of##2##4##(2008-5#1)(2008-6#1)
and clinical importance##3##3##(2008-5#1)(2008-6#2)
and clinical indications##2##3##(2008-9#1)(2013-8#1)
and clinical information##5##3##(1993-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2012-2#1)
and clinical intervention strategies##2##4##(1993-3#1)(2007-12#1)
and clinical investigations##3##3##(1994-7#1)(2008-2#1)(2013-8#1)
and clinical isolates##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
and clinical laboratories##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
and clinical literature##2##3##(2008-10#1)(2008-12#1)
and clinical management of##4##4##(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)
and clinical management##6##3##(2008-4#2)(2008-6#1)(2011-2#2)(2012-12#1)
and clinical manifestations of##3##4##(2008-7#1)(2013-1#2)
and clinical manifestations##5##3##(1991-11#1)(2007-10#1)(2008-7#1)(2013-1#2)
and clinical medicine##2##3##(1992-2#1)(2009-9#1)
and clinical models##2##3##(2008-10#1)(2008-8#1)
and clinical outcome in##2##4##(1995-12#1)(2011-2#1)
and clinical outcome##7##3##(1995-12#1)(2006-6#1)(2007-12#1)(2008-12#1)(2011-2#2)(2012-12#1)
and clinical outcomes of##2##4##(2008-7#1)(2009-7#1)
and clinical outcomes##13##3##(1997-1#1)(1997-3#1)(2007-12#2)(2007-3#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
and clinical parameters in##2##4##(2008-6#1)(2011-2#1)
and clinical parameters##8##3##(1990-5#1)(1996-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#2)
and clinical perspectives##2##3##(1993-3#1)(2008-4#1)
and clinical picture##2##3##(1990-9#1)(1996-6#1)
and clinical placement##2##3##(2008-11#1)(2013-8#1)
and clinical practice##11##3##(1994-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-7#1)(2010-9#1)(2012-3#1)
and clinical problem##2##3##(2007-11#1)(2008-6#1)
and clinical profile of##2##4##(2009-1#1)(2011-1#1)
and clinical profile##3##3##(2009-1#1)(2010-5#1)(2011-1#1)
and clinical psychology##2##3##(1990-8#1)(2008-2#1)
and clinical recommendations##2##3##(2010-12#1)(2012-12#1)
and clinical reports##5##3##(2008-7#1)(2011-2#2)(2011-7#1)(2013-7#1)
and clinical research as##2##4##(2008-8#1)(2013-1#1)
and clinical research##13##3##(1995-5#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2013-1#1)
and clinical response to##2##4##(1996-8#1)(2008-10#1)
and clinical response##3##3##(1996-8#1)(2008-10#1)(2008-4#1)
and clinical results##8##3##(1990-2#1)(1991-3#1)(1993-11#1)(1997-1#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
and clinical review##2##3##(2011-1#1)(2012-12#1)
and clinical sciences##2##3##(1994-12#2)
and clinical services##2##3##(1994-3#1)(2010-8#1)
and clinical settings##2##3##(2008-12#1)(2012-2#1)
and clinical significance of##6##4##(1997-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
and clinical significance##9##3##(1997-7#1)(2007-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
and clinical signs of##2##4##(1996-12#1)(2009-1#1)
and clinical signs##4##3##(1991-8#1)(1996-12#1)(2009-1#1)(2011-1#1)
and clinical skills##2##3##(1992-3#1)(2008-11#1)
and clinical spectrum##2##3##(2008-4#1)(2008-7#1)
and clinical stage##2##3##(1990-8#1)(1996-9#1)
and clinical status##2##3##(1994-12#1)(2010-9#1)
and clinical studies have revealed##2##5##(1996-9#1)(2010-10#1)
and clinical studies have shown that##3##6##(2008-7#1)(2012-1#1)(2013-7#1)
and clinical studies have suggested that##2##6##(1992-2#1)(2008-7#1)
and clinical studies have##8##4##(1992-2#1)(1996-9#1)(2008-7#2)(2010-10#1)(2012-1#1)(2012-3#1)(2013-7#1)
and clinical studies on##2##4##(1994-2#1)(2009-7#1)
and clinical studies to##4##4##(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
and clinical studies##25##3##(1992-2#1)(1993-6#1)(1994-2#1)(1996-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2009-11#1)(2009-7#3)(2010-10#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-7#1)
and clinical study##2##3##(2007-12#1)(2013-1#1)
and clinical success##2##3##(2006-5#1)(2008-11#1)
and clinical support##2##3##(2008-11#1)(2008-12#1)
and clinical symptoms##3##3##(1991-6#1)(2007-11#1)(2008-12#1)
and clinical system##2##3##(2013-8#2)
and clinical trial##3##3##(2008-6#1)(2009-2#1)(2010-7#1)
and clinical trials of##2##4##(2008-7#1)(2012-3#1)
and clinical trials##12##3##(1992-6#1)(1993-11#1)(1994-12#1)(2007-7#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
and clinical use of##2##4##(2007-12#1)(2008-12#1)
and clinical use##3##3##(1993-11#1)(2007-12#1)(2008-12#1)
and clinical validation##2##3##(2010-5#1)(2012-2#1)
and clinical##478##2##(1990-12#1)(1990-2#4)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#10)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#5)(2007-11#9)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#4)(2008-1#4)(2008-10#17)(2008-11#21)(2008-12#16)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#10)(2008-6#8)(2008-7#28)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#9)(2011-2#26)(2011-7#2)(2012-1#1)(2012-12#20)(2012-2#16)(2012-3#12)(2012-5#1)(2013-1#25)(2013-7#3)(2013-8#23)
and clinically evaluated##2##3##(2008-11#1)(2011-3#1)
and clinically relevant##2##3##(2009-12#1)(2011-2#1)
and clinically significant##4##3##(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
and clinically useful##2##3##(1994-11#1)(2012-2#1)
and clinically##27##2##(1990-5#1)(1992-12#1)(1994-11#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
and clinician##3##2##(2010-6#1)(2010-8#2)
and clinicians to##2##3##(2008-3#1)(2010-5#1)
and clinicians with##2##3##(2008-11#1)(2008-8#1)
and clinicians##29##2##(1992-2#1)(1992-3#2)(1993-3#1)(1997-2#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#4)
and clinicopathologic variables in##2##4##(1994-7#1)(1995-4#1)
and cloacal##4##2##(1996-12#3)(2008-10#1)
and clofibrate##2##2##(1992-8#1)(2008-11#1)
and clonal##6##2##(1993-12#1)(1993-9#1)(2008-10#2)(2008-9#1)(2009-2#1)
and clone the##2##3##(1991-9#1)(1993-8#1)
and cloned in##2##3##(1994-12#1)(2008-11#1)
and cloned into the plasmid vector##2##6##(1992-3#1)(2008-10#1)
and cloned into the##3##4##(1992-3#1)(1993-12#1)(2008-10#1)
and cloned into##9##3##(1992-3#1)(1993-12#1)(1997-4#2)(1997-8#1)(2008-10#2)(2008-8#1)(2009-5#1)
and cloned##28##2##(1990-11#1)(1990-12#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1997-4#2)(1997-8#1)(2008-10#7)(2008-11#3)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#2)
and clonidine##2##2##(1997-4#1)(2009-4#1)
and cloning and##2##3##(1994-8#1)(1995-8#1)
and cloning of a##2##4##(1993-8#1)(1994-12#1)
and cloning of##8##3##(1992-12#1)(1993-8#1)(1994-12#1)(1996-10#1)(2008-11#2)(2008-8#2)
and cloning##12##2##(1992-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#2)
and clopidogrel##3##2##(2008-3#2)(2008-4#1)
and close friend##2##3##(2007-12#2)
and close friends##2##3##(2009-7#2)
and close to##4##3##(1996-6#1)(2008-11#1)(2008-2#1)(2013-8#1)
and close##13##2##(1995-5#1)(1996-4#1)(1996-6#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#2)(2011-1#1)(2013-8#1)
and closed eyes##2##3##(2010-9#2)
and closed##13##2##(1994-12#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#3)(2010-9#2)(2012-12#2)(2012-2#1)
and closed-loop##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
and closed-mouth /etaetaetaeta/ of##2##4##(2010-2#2)
and closely linked##2##3##(2008-10#1)(2008-12#1)
and closely related##3##3##(2008-10#1)(2008-9#1)(2010-10#1)
and closely##12##2##(1991-2#1)(1992-3#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-10#1)(2013-8#1)
and closer##4##2##(1991-6#1)(1993-12#1)(1995-2#1)(2008-10#1)
and closing##4##2##(1993-11#1)(1997-2#1)(2007-8#1)(2008-4#1)
and clostridia##2##2##(2011-2#2)
and closure of##4##3##(1994-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
and closure##5##2##(1994-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
and clot##3##2##(1997-4#1)(2008-1#1)(2013-1#1)
and clothing##2##2##(1990-3#1)(2011-1#1)
and cloud##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
and clouds##2##2##(2008-2#1)(2008-3#1)
and cluster analyses##2##3##(2008-10#1)(2008-12#1)
and cluster analysis were applied##2##5##(2008-10#2)
and cluster analysis##11##3##(1996-5#1)(2008-10#8)(2008-9#1)(2010-5#1)
and cluster in##2##3##(1993-8#1)(2008-6#1)
and cluster##20##2##(1991-8#1)(1993-8#1)(1996-5#1)(2008-10#10)(2008-12#1)(2008-6#2)(2008-9#1)(2010-5#1)(2013-1#2)
and cluster-specific##2##2##(1995-2#2)
and clustered##3##2##(2008-10#2)(2010-12#1)
and clustering of##2##3##(2008-10#1)(2009-8#1)
and clustering##12##2##(1996-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-8#1)(2012-1#1)(2012-2#1)
and clusters of##2##3##(1997-5#1)(2008-3#1)
and clusters##5##2##(1997-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
and co-expression of##2##3##(2008-1#1)(2008-11#1)
and co-factor##2##2##(2008-10#2)
and co-morbid##2##2##(2007-7#1)(2011-2#1)
and co-morbidity##2##2##(1991-1#1)(1995-6#1)
and co-occurring##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
and co-suppression##2##2##(2008-9#2)
and co-workers##3##2##(1994-5#2)(1997-6#1)
and coagulase-negative##2##2##(1990-6#1)(2008-10#1)
and coagulation##5##2##(1991-3#1)(1994-12#1)(2007-12#1)(2008-3#1)(2011-2#1)
and coal fly ash samples##2##5##(2008-10#2)
and coal fly##3##3##(2008-10#3)
and coal samples##2##3##(2008-1#1)(2008-10#1)
and coal##9##2##(2008-1#1)(2008-10#7)(2008-9#1)
and coastal##8##2##(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#1)
and coat protein genes##3##4##(2008-10#3)
and coat protein##7##3##(2008-10#7)
and coat##9##2##(1994-12#1)(2008-10#8)
and coated with##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
and coated##12##2##(1997-1#1)(2008-10#6)(2008-2#2)(2008-5#1)(2013-1#2)
and coating##5##2##(2008-3#2)(2008-4#1)(2010-7#1)(2013-8#1)
and coatings##6##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#2)
and cobalt in##3##3##(2008-10#3)
and cobalt##11##2##(1993-12#1)(2008-10#9)(2013-8#1)
and cobalt(II) ions##2##3##(1992-11#1)(2008-10#1)
and cobalt(II) tetrasulfonated phthalocyanine##2##4##(2008-10#2)
and cobalt(II)##9##2##(1992-11#1)(2008-10#8)
and cobalt(III)##2##2##(2007-11#1)(2008-10#1)
and cocaine##8##2##(1991-1#3)(1993-3#1)(1994-3#1)(1997-5#1)(2009-7#1)(2013-8#1)
and cochlear implant##2##3##(2008-9#2)
and cochlear implantation##2##3##(2008-9#2)
and cochlear##8##2##(2008-1#1)(2008-9#5)(2011-2#2)
and cocoamidopropyl betaine (CAPB)##2##4##(2008-10#1)(2008-5#1)
and coded for a##2##4##(1994-6#1)(2008-10#1)
and codeine##2##2##(2008-10#1)(2008-3#1)
and codes for##2##3##(2008-8#1)(2011-2#1)
and coding##6##2##(1990-11#1)(1992-12#1)(1993-6#1)(1997-3#1)(1997-7#1)(2013-1#1)
and codominant##2##2##(2008-5#2)
and codon##2##2##(1991-12#1)(2012-2#1)
and coefficient##2##2##(2008-5#1)(2013-8#1)
and coefficients of variation##2##4##(2008-10#2)
and coefficients of##6##3##(2007-12#1)(2008-10#4)(2011-2#1)
and coefficients##8##2##(1996-5#1)(2007-12#1)(2008-10#4)(2008-3#1)(2011-2#1)
and coeliac disease##2##3##(1990-9#1)(2008-8#1)
and coelomic##2##2##(1995-8#1)(2007-6#1)
and coenzyme Q(10)##2##3##(2008-10#2)
and coenzyme##5##2##(1990-5#1)(1993-8#1)(2008-10#3)
and coercion##2##2##(2007-7#1)(2009-4#1)
and coexistence in ephemeral-patch##2##4##(2008-9#2)
and coexistence in##3##3##(2008-8#1)(2008-9#2)
and coexistence##7##2##(2008-8#4)(2008-9#2)(2011-2#1)
and coexisting##3##2##(2007-5#1)(2008-10#1)(2013-8#1)
and cofactors##3##2##(2008-10#2)(2013-8#1)
and coffee seedlings##2##3##(2008-5#2)
and coffee##6##2##(1990-6#1)(2008-10#3)(2008-5#2)
and cognition##12##2##(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and cognitive and##2##3##(2010-9#1)(2013-1#1)
and cognitive decline##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
and cognitive deficits in##2##4##(2008-7#1)(2013-7#1)
and cognitive deficits##4##3##(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
and cognitive function##6##3##(1994-6#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
and cognitive functioning##4##3##(1995-5#1)(2008-1#1)(2008-11#1)(2009-10#1)
and cognitive functions##2##3##(2007-8#1)(2008-7#1)
and cognitive impairment##7##3##(1995-2#2)(2008-7#1)(2009-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
and cognitive problems##2##3##(1995-3#1)(2008-8#1)
and cognitive processing##2##3##(2009-11#1)(2012-3#1)
and cognitive status##3##3##(2008-7#2)(2012-3#1)
and cognitive##73##2##(1990-12#2)(1993-12#1)(1994-12#1)(1994-6#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#2)(2007-8#4)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
and cognitive-behavioral therapy##2##3##(2008-1#1)(2008-3#1)
and cognitive-behavioral##3##2##(1994-12#1)(2008-1#1)(2008-3#1)
and cognitive-emotional##2##2##(2008-11#1)(2012-12#1)
and coherence##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
and coherent##8##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
and cohesion##2##2##(2011-1#1)(2013-7#1)
and cohort##3##2##(1994-2#1)(1996-3#2)
and coil##3##2##(2008-2#1)(2010-7#1)(2013-1#1)
and coincided with##2##3##(2008-8#1)(2011-2#1)
and coincident##2##2##(1990-7#1)(2008-3#1)
and cold allodynia##3##3##(2009-12#1)(2011-2#2)
and cold storage##2##3##(2008-10#1)(2008-5#1)
and cold tremor##4##3##(1997-6#4)
and cold vapor atomic absorption##2##5##(2008-10#2)
and cold vapour##2##3##(2008-10#2)
and cold##22##2##(1991-8#2)(1997-6#5)(2008-10#5)(2008-5#2)(2008-7#1)(2009-12#1)(2010-3#1)(2011-2#4)(2013-8#1)
and colitis##2##2##(1996-3#1)(2008-10#1)
and coll##3##2##(2008-10#3)
and collaboration are##2##3##(2008-11#1)(2011-2#1)
and collaboration between the##3##4##(1996-1#1)(2008-11#2)
and collaboration between##5##3##(1996-1#1)(1996-2#1)(2008-11#2)(2008-6#1)
and collaboration of##2##3##(2008-11#1)(2013-1#1)
and collaboration with##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
and collaboration##17##2##(1996-1#2)(1996-2#1)(2008-10#1)(2008-11#5)(2008-6#2)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
and collaborative##12##2##(1994-1#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2010-3#1)(2010-9#1)(2011-3#1)(2011-9#1)(2012-2#2)
and collagen deposition##3##3##(2008-10#1)(2008-7#2)
and collagen type I##2##4##(2008-5#2)
and collagen type##3##3##(2008-5#2)(2009-11#1)
and collagen##31##2##(1990-5#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#11)(2008-7#3)(2008-9#1)(2009-11#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
and collapse##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
and collateral##2##2##(2007-12#1)(2013-1#1)
and collaterals##2##2##(1997-3#1)(2008-12#1)
and colleagues##19##2##(1994-2#2)(1995-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-3#1)
and collect##3##2##(2008-11#2)(2008-7#1)
and collected on the walls of a knotted coil##2##9##(2008-10#2)
and collected##7##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
and collecting##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)
and collection of the##4##4##(2008-10#4)
and collection of##8##3##(2007-11#1)(2008-10#6)(2008-8#1)
and collection practices##2##3##(2008-11#2)
and collection##23##2##(1996-3#1)(2007-11#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2011-2#3)
and collective mechanisms for##2##4##(2008-9#2)
and collective##9##2##(2008-9#5)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
and college##6##2##(2008-11#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
and collision##4##2##(2007-12#1)(2008-3#1)(2012-12#2)
and colloid##2##2##(2008-7#1)(2010-5#1)
and colloidal##3##2##(2008-10#2)(2010-6#1)
and colon cancer##3##3##(1997-7#1)(2009-11#1)(2009-9#1)
and colon carcinoma##2##3##(2008-10#2)
and colon##13##2##(1991-12#1)(1992-9#1)(1994-11#1)(1994-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-5#1)(2009-9#1)(2012-2#1)
and colonic carcinoma##2##3##(1990-7#1)(2009-1#1)
and colonic##4##2##(1990-7#1)(1991-11#1)(1992-9#1)(2009-1#1)
and colonies##4##2##(1995-11#1)(2008-10#1)(2008-8#2)
and colonization by##4##3##(2008-10#4)
and colonization of the##3##4##(2008-10#3)
and colonization of##9##3##(2008-10#8)(2013-1#1)
and colonization##20##2##(1996-6#1)(2008-10#14)(2008-8#4)(2013-1#1)
and colonize##2##2##(2008-10#1)(2011-2#1)
and colonized##6##2##(2008-10#6)
and colonizing##2##2##(2008-8#1)(2011-2#1)
and colony##8##2##(2008-10#5)(2008-8#1)(2011-2#1)(2013-8#1)
and colony-forming##2##2##(1992-9#1)(2008-10#1)
and color in the open air##2##6##(2008-2#2)
and color in##3##3##(2008-2#3)
and color of##2##3##(2008-5#1)(2012-3#1)
and color##11##2##(2007-5#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2012-3#1)(2012-7#1)
and colorectal cancer##10##3##(1993-9#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#3)
and colorectal cancers##2##3##(2010-6#2)
and colorectal##19##2##(1992-5#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#3)(2011-2#2)(2012-12#1)(2013-1#4)
and colorimetric##7##2##(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-5#1)
and colour##8##2##(2008-10#3)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)
and colposcopic##2##2##(1992-3#1)(1992-8#1)
and column temperature##4##3##(2008-10#4)
and column##16##2##(2008-10#14)(2008-2#1)(2008-8#1)
and columns##2##2##(1994-11#1)(2008-3#1)
and coma##5##2##(2007-12#1)(2008-3#2)(2009-8#1)(2012-12#1)
and combination of these##2##4##(2008-6#1)(2010-4#1)
and combination of##6##3##(1996-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#1)(2013-8#1)
and combination regimens##2##3##(2009-9#1)(2011-2#1)
and combination##14##2##(1992-3#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and combinations of##8##3##(1993-1#1)(2008-10#2)(2008-3#1)(2010-6#1)(2013-1#2)(2013-8#1)
and combinations thereof##2##3##(1996-5#1)(2011-1#1)
and combinations##15##2##(1993-1#1)(1995-5#1)(1996-5#1)(2008-10#3)(2008-3#3)(2008-8#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
and combinatorial chemistry##2##3##(1997-3#1)(2008-10#1)
and combinatorial##4##2##(1995-12#1)(1997-3#1)(2008-10#1)(2011-2#1)
and combine##2##2##(2008-4#1)(2012-3#1)
and combined filter/XAD-2##2##3##(2008-10#2)
and combined with the##3##4##(2008-3#1)(2009-7#1)(2010-4#1)
and combined with##7##3##(1996-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-4#1)(2013-8#1)
and combined##36##2##(1993-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-4#3)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#4)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
and combines##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
and combining##5##2##(1996-12#1)(2008-10#4)
and combustion gases##2##3##(2008-2#2)
and combustion##7##2##(2008-10#2)(2008-2#2)(2008-3#3)
and comet##7##2##(1997-4#1)(2010-8#6)
and comfort level##2##3##(2007-12#1)(2008-9#1)
and comfort##6##2##(1992-3#1)(2007-12#1)(2008-9#2)(2013-1#2)
and comfortable##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
and coming##2##2##(2008-11#1)(2013-1#1)
and comment on the##2##4##(1993-12#1)(2009-8#1)
and comment on##4##3##(1993-12#1)(1996-12#1)(2008-1#1)(2009-8#1)
and comment##6##2##(1993-12#1)(1996-12#3)(2008-1#1)(2009-8#1)
and commentary##4##2##(1994-12#1)(1994-3#1)(2008-4#1)(2011-1#1)
and comments on##3##3##(1996-1#1)(1997-2#1)(2007-12#1)
and comments were##2##3##(2007-12#1)(2013-7#1)
and comments##9##2##(1991-3#1)(1992-9#1)(1996-1#2)(1997-2#1)(2007-12#2)(2008-7#1)(2013-7#1)
and commercial drinking water##2##4##(2008-10#2)
and commercial drinking##3##3##(2008-10#3)
and commercial formulations##3##3##(2008-10#3)
and commercial##25##2##(2007-11#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-7#1)(2010-3#1)(2010-9#1)(2012-1#1)(2013-1#1)
and commercially available##2##3##(2008-10#1)(2008-9#1)
and commitment to##3##3##(2007-5#1)(2008-1#1)(2008-4#1)
and commitment##5##2##(2007-5#1)(2008-1#2)(2008-4#1)(2009-7#1)
and committees for##8##3##(2008-10#8)
and commodity##3##2##(2008-10#3)
and common bean##2##3##(2008-10#2)
and common conversion factors##2##4##(2008-2#2)
and common people's##2##3##(2013-8#2)
and common rust##2##3##(2008-10#2)
and common wheat##2##3##(2008-10#1)(2008-8#1)
and common##51##2##(1992-2#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-8#4)
and commonly##4##2##(2007-2#1)(2008-4#1)(2008-9#1)(2009-6#1)
and communicate##4##2##(1995-12#1)(2008-10#1)(2008-5#1)(2009-9#1)
and communicated to##2##3##(1995-1#1)(1996-11#1)
and communicating the##3##3##(1994-3#1)(1997-1#1)(2010-5#1)
and communicating with##2##3##(2007-11#1)(2012-2#1)
and communicating##6##2##(1994-3#1)(1997-1#1)(2007-11#1)(2010-5#2)(2012-2#1)
and communication among##2##3##(1996-4#1)(2013-8#1)
and communication between##2##3##(1995-5#1)(2013-1#1)
and communication in##2##3##(2008-11#1)(2008-4#1)
and communication of##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
and communication skills##4##3##(1993-2#1)(2008-11#1)(2010-10#1)(2012-2#1)
and communication systems##3##3##(1997-8#1)(2008-2#1)(2008-7#1)
and communication##44##2##(1992-3#1)(1993-2#1)(1994-7#1)(1995-5#1)(1996-3#2)(1996-4#2)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
and communications##6##2##(1992-12#1)(1995-12#1)(1996-2#2)(2008-10#1)(2012-12#1)
and communicative##2##2##(2008-2#1)(2013-1#1)
and communities in##2##3##(2008-11#2)
and communities##11##2##(1991-2#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#1)(2012-2#2)
and community building##2##3##(1991-2#1)(2008-4#1)
and community health##5##3##(1990-9#1)(1992-2#1)(1996-1#1)(1996-11#1)(1997-3#1)
and community leaders##2##3##(1996-1#1)(2010-9#1)
and community levels##2##3##(1997-1#1)(2008-9#1)
and community medicine in##2##4##(1997-6#2)
and community medicine##3##3##(1993-5#1)(1997-6#2)
and community members##2##3##(2009-5#1)(2009-9#1)
and community pharmacists##2##3##(2011-1#2)
and community resources##2##3##(2007-2#1)(2009-5#1)
and community violence##2##3##(2008-11#1)(2009-2#1)
and community##62##2##(1990-9#1)(1991-1#2)(1991-2#1)(1992-12#1)(1992-2#2)(1993-12#2)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#2)(2009-9#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and community-based##11##2##(1992-3#1)(1993-1#1)(1994-2#2)(1994-3#1)(1996-2#1)(1996-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
and community-level##3##2##(2008-9#1)(2009-6#2)
and commuting##2##2##(2008-10#1)(2012-12#1)
and comorbid##4##2##(2008-1#2)(2008-6#1)(2009-5#1)
and comorbidities##3##2##(2008-7#1)(2011-2#2)
and comorbidity##3##2##(1991-6#1)(2011-2#1)(2013-1#1)
and compact optical##2##3##(2008-3#2)
and compact##11##2##(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2009-2#1)
and company##3##2##(1993-12#2)(2011-2#1)
and comparable to those obtained##2##5##(2008-10#2)
and comparable with##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
and comparable##15##2##(1993-1#1)(1994-6#1)(1995-3#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
and comparative analysis##4##3##(1991-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
and comparative data##2##3##(2007-12#1)(2008-8#1)
and comparative##21##2##(1991-6#1)(1995-11#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)
and comparatively##3##2##(2008-4#1)(2010-12#1)(2011-1#1)
and compare it to##2##4##(1997-3#1)(2013-1#1)
and compare it with the##3##5##(2008-11#1)(2008-2#1)(2011-2#1)
and compare it with##8##4##(1994-5#1)(1996-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2011-2#1)
and compare it##10##3##(1994-5#1)(1996-11#1)(1997-3#1)(2007-12#2)(2008-11#1)(2008-2#2)(2011-2#1)(2013-1#1)
and compare its##3##3##(1995-3#1)(1997-7#1)(2008-7#1)
and compare the results with##3##5##(2008-3#1)(2008-8#1)(2012-3#1)
and compare the results##4##4##(1991-3#1)(2008-3#1)(2008-8#1)(2012-3#1)
and compare the##22##3##(1991-3#1)(1993-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#5)
and compare their##2##3##(2008-2#1)(2012-12#1)
and compare them to##3##4##(2008-11#1)(2010-2#1)(2012-3#1)
and compare them with theoretical predictions##2##6##(2008-2#1)(2008-3#1)
and compare them##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)
and compare these with##3##4##(2008-3#2)(2011-1#1)
and compare these##6##3##(1992-3#1)(2008-11#1)(2008-3#2)(2011-1#1)(2012-3#1)
and compare this##2##3##(2008-3#1)(2012-1#1)
and compare two##3##3##(2008-3#3)
and compare##79##2##(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#5)(2013-1#9)(2013-7#1)
and compared between##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
and compared by##3##3##(1992-11#1)(2008-2#1)(2008-6#1)
and compared for the##3##4##(2008-10#2)(2008-3#1)
and compared for##6##3##(2008-10#2)(2008-3#2)(2008-6#1)(2013-1#1)
and compared in terms of##4##5##(2008-10#2)(2008-2#2)
and compared in##10##3##(1994-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2009-8#1)
and compared it to##2##4##(1992-12#1)(2011-2#1)
and compared it with other##2##5##(2008-5#1)(2012-1#1)
and compared it with##6##4##(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
and compared it##8##3##(1992-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#1)
and compared its##2##3##(1991-2#1)(2008-3#1)
and compared the data##3##4##(1990-8#1)(1994-7#1)(2008-5#1)
and compared the expression##2##4##(1990-12#1)(2008-7#1)
and compared the results to##2##5##(1995-3#1)(2008-11#1)
and compared the results##4##4##(1995-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
and compared the##20##3##(1990-12#1)(1990-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-7#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-1#1)
and compared their##3##3##(1990-5#1)(1995-12#1)(2008-3#1)
and compared them to##5##4##(1991-1#1)(2007-12#1)(2007-5#1)(2009-8#1)(2013-1#1)
and compared them with##3##4##(1993-12#1)(1994-11#1)(2012-3#1)
and compared them##8##3##(1991-1#1)(1993-12#1)(1994-11#1)(2007-12#1)(2007-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
and compared these##4##3##(2007-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
and compared to a##2##4##(2008-6#1)(2009-11#1)
and compared to conventional##2##4##(2008-5#1)(2013-1#1)
and compared to results##2##4##(2008-10#1)(2012-1#1)
and compared to the##21##4##(1990-11#1)(1990-5#1)(1993-2#2)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)
and compared to those of##2##5##(1996-12#1)(2011-2#1)
and compared to##40##3##(1990-11#1)(1990-5#1)(1991-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and compared using##3##3##(2007-5#1)(2008-12#2)
and compared with a control group##2##6##(2008-3#1)(2013-1#1)
and compared with a control##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
and compared with a##9##4##(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2013-1#1)
and compared with calculated spectra##2##5##(2008-2#2)
and compared with conventional##2##4##(2008-10#1)(2011-1#1)
and compared with data from##2##5##(1993-6#1)(2008-10#1)
and compared with data##3##4##(1993-6#1)(2008-10#1)(2008-2#1)
and compared with each other##2##5##(2008-10#1)(2008-12#1)
and compared with experimental##2##4##(2008-2#1)(2008-3#1)
and compared with other methods##2##5##(2008-3#1)(2008-6#1)
and compared with other##3##4##(1994-1#1)(2008-3#1)(2008-6#1)
and compared with that of##6##5##(1992-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)
and compared with that##8##4##(1992-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)
and compared with the predictions of##2##6##(2007-11#1)(2008-2#1)
and compared with the results of##5##6##(1996-11#1)(2008-10#1)(2008-3#2)(2011-2#1)
and compared with the results##7##5##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
and compared with the##38##4##(1991-2#1)(1993-12#1)(1993-8#1)(1994-11#1)(1996-11#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-2#3)(2008-3#8)(2008-5#2)(2008-6#1)(2011-2#2)(2013-1#2)(2013-8#2)
and compared with theoretical predictions##3##5##(2008-2#2)(2008-3#1)
and compared with theoretical##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
and compared with theory##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
and compared with those in##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
and compared with those of a##2##6##(2008-10#2)
and compared with those of other##4##6##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
and compared with those of the##2##6##(2008-10#1)(2008-3#1)
and compared with those of##15##5##(1993-11#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-8#1)(2010-8#1)(2011-2#1)
and compared with those##24##4##(1990-9#1)(1993-11#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and compared with##149##3##(1990-9#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#23)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
and compared##308##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-7#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#74)(2008-11#9)(2008-12#5)(2008-2#24)(2008-3#33)(2008-5#10)(2008-6#8)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#4)
and compares it to##2##4##(1991-5#1)(2008-9#1)
and compares it with the##2##5##(2007-10#1)(2012-1#1)
and compares it with##3##4##(1996-5#1)(2007-10#1)(2012-1#1)
and compares it##5##3##(1991-5#1)(1996-5#1)(2007-10#1)(2008-9#1)(2012-1#1)
and compares the##3##3##(2008-10#1)(2010-2#1)(2010-3#1)
and compares them##2##3##(2008-1#1)(2008-12#1)
and compares these##2##3##(2008-10#1)(2008-11#1)
and compares##14##2##(1991-5#1)(1992-2#1)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2012-1#1)
and comparing the results with##2##5##(2008-10#1)(2010-11#1)
and comparing the##11##3##(1996-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)
and comparing their##2##3##(1994-1#1)(2008-7#1)
and comparing them with##2##4##(2008-10#1)(2011-2#1)
and comparing these##2##3##(2008-10#1)(2010-1#1)
and comparing##22##2##(1994-1#1)(1995-3#1)(1996-3#1)(2007-6#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#2)
and comparison of the##4##4##(1990-12#1)(1996-8#1)(2008-10#2)
and comparison of##17##3##(1990-12#1)(1992-8#2)(1996-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-9#1)(2012-2#1)
and comparison with a##2##4##(2008-3#2)
and comparison with that of##2##5##(1995-6#1)(2008-10#1)
and comparison with the##4##4##(1993-8#1)(1995-2#1)(2008-10#1)(2008-11#1)
and comparison with##21##3##(1991-6#1)(1993-8#1)(1995-2#2)(1995-6#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#3)(2009-5#1)
and comparison##47##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-8#2)(1993-8#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-8#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#4)(2008-7#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and comparisons between##2##3##(1991-11#1)(2011-2#1)
and comparisons of the##2##4##(2008-10#1)(2008-8#1)
and comparisons of##5##3##(1995-2#1)(2008-10#1)(2008-8#2)(2010-6#1)
and comparisons with##4##3##(1992-4#1)(1994-3#1)(1996-1#1)(2008-7#1)
and comparisons##14##2##(1991-11#1)(1991-3#1)(1992-4#1)(1994-3#1)(1995-2#2)(1996-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-6#1)(2011-2#1)
and compartmentalization of##5##3##(1994-8#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
and compatibility with##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
and compatibility##5##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
and compatible##3##2##(1992-3#1)(2008-10#1)(2008-2#1)
and compelling##3##2##(2007-2#1)(2008-10#1)(2008-6#1)
and compensated for##2##3##(2007-11#1)(2008-3#1)
and compensated##4##2##(2007-11#1)(2008-3#3)
and compensation of##3##3##(1991-12#1)(2008-2#1)(2008-3#1)
and compensation##9##2##(1990-3#1)(1991-12#1)(1993-12#1)(1994-1#2)(1996-2#1)(2008-2#1)(2008-3#1)(2011-1#1)
and compensatory homeostasis##2##3##(2012-2#2)
and compensatory##6##2##(1991-5#1)(2009-7#1)(2012-2#3)(2013-1#1)
and compete for binding##2##4##(1991-3#1)(2008-7#1)
and compete##4##2##(1991-3#1)(1997-1#1)(2006-6#1)(2008-7#1)
and competence of##2##3##(2008-11#1)(2009-11#1)
and competence##11##2##(2008-11#7)(2009-11#2)(2013-1#2)
and competencies##3##2##(1994-2#1)(1997-3#1)(2011-1#1)
and competency##2##2##(1995-3#1)(2007-12#1)
and competent##4##2##(1994-8#1)(1996-12#1)(2008-12#2)
and competing##3##2##(2008-1#1)(2008-9#1)(2011-2#1)
and competition by##2##3##(1996-12#1)(2008-10#1)
and competition for##2##3##(2008-10#1)(2008-5#1)
and competition over##2##3##(2009-10#1)(2010-1#1)
and competition##23##2##(1991-3#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)
and competitive enzyme-linked immunosorbent##2##4##(2011-2#2)
and competitive exclusion##2##3##(1997-3#2)
and competitive inhibition##2##3##(1995-6#1)(2008-7#1)
and competitive##22##2##(1991-3#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#2)(2008-10#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)
and competitors##2##2##(1993-2#1)(1993-3#1)
and complement fixation##3##3##(1992-6#1)(2008-1#1)(2008-5#1)
and complement##15##2##(1990-12#1)(1992-12#1)(1992-6#1)(1995-12#1)(1996-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
and complementary method to##2##4##(2008-10#2)
and complementary##12##2##(1990-6#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-6#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)
and complementation of##2##3##(1995-8#1)(1996-2#1)
and complementation##4##2##(1995-8#1)(1996-2#1)(2008-8#1)(2008-9#1)
and complements##2##2##(2008-4#1)(2012-3#1)
and complete absence of##2##4##(1992-5#1)(2007-12#1)
and complete absence##3##3##(1992-5#1)(2007-12#1)(2008-11#1)
and complete extraction of##2##4##(2008-10#2)
and complete information##2##3##(1994-2#1)(2011-3#1)
and complete occlusion of the fistula was##2##7##(1996-9#1)(1997-3#1)
and complete occlusion of the##3##5##(1996-9#1)(1997-3#1)(2008-12#1)
and complete resolution of##2##4##(2010-9#1)(2012-3#1)
and complete##47##2##(1990-5#1)(1992-5#1)(1994-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-9#3)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#3)
and completed a##2##3##(2012-12#1)(2012-3#1)
and completed suicide##2##3##(2008-11#1)(2009-7#1)
and completed##14##2##(1991-11#1)(1992-12#1)(1995-1#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-5#2)(2009-5#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
and completely##25##2##(1991-5#1)(1991-8#1)(1993-11#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
and completeness of##2##3##(2006-10#1)(2008-7#1)
and completion of##2##3##(1994-12#1)(2010-3#1)
and completion##3##2##(1994-12#1)(1996-3#1)(2010-3#1)
and complex formation##3##3##(2008-10#3)
and complex stability##2##3##(2008-10#1)(2011-2#1)
and complex synthetic mixtures##2##4##(2008-10#2)
and complex##57##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-9#1)(1996-1#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
and complex-valued##2##2##(2007-12#1)(2008-3#1)
and complexation properties of humic acids##2##6##(2008-10#2)
and complexation##7##2##(2008-10#7)
and complexes containing##2##3##(2008-11#2)
and complexes##7##2##(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-7#2)
and complexing agents##4##3##(2008-10#4)
and complexing##5##2##(2008-10#5)
and complexity of##7##3##(1991-3#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2011-2#1)
and complexity##18##2##(1991-3#1)(1992-2#1)(1994-3#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#2)(2011-2#2)
and complexometric##3##2##(2008-10#3)
and compliance with##2##3##(2009-10#1)(2013-1#1)
and compliance##12##2##(1990-6#1)(1994-9#1)(1995-9#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
and compliant##2##2##(2008-10#1)(2010-4#1)
and complicate the##2##3##(2011-2#1)(2012-2#1)
and complicated##12##2##(1991-3#1)(1992-3#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
and complication rates##5##3##(1994-8#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
and complication##6##2##(1994-8#1)(1995-1#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
and complications associated with##3##4##(1990-11#1)(2007-12#1)(2008-11#1)
and complications in##2##3##(2008-7#1)(2013-1#1)
and complications of this##2##4##(1990-9#1)(2011-1#1)
and complications of##16##3##(1990-9#1)(1991-6#1)(1993-2#1)(2007-5#1)(2007-7#2)(2008-11#1)(2008-7#2)(2009-8#1)(2010-3#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and complications related to##2##4##(1990-5#1)(1997-3#1)
and complications were##5##3##(1991-1#1)(1995-12#1)(2012-2#2)(2013-1#1)
and complications##56##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#4)(2008-9#1)(2009-8#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-2#2)(2013-1#7)(2013-8#1)
and complications]##2##2##(1994-3#1)(1997-2#1)
and complimentary##2##2##(2009-11#1)(2010-12#1)
and components of##2##3##(2008-6#1)(2011-2#1)
and components##6##2##(2008-11#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)
and composed of a##2##4##(2008-5#2)
and composite resin##2##3##(2008-12#1)(2009-8#1)
and composite##12##2##(1990-3#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#2)(2009-8#1)(2012-2#1)
and composites##2##2##(1990-2#1)(2009-7#1)
and composition at##2##3##(2009-10#1)(2013-7#1)
and composition in##4##3##(2008-3#1)(2012-1#1)(2012-2#1)(2013-7#1)
and composition of the##12##4##(1994-8#1)(1995-5#1)(1996-7#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
and composition of these##2##4##(2008-11#1)(2010-7#1)
and composition of##22##3##(1990-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-7#1)(2007-5#1)(2008-10#6)(2008-11#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2013-1#2)(2013-7#1)
and composition##45##2##(1990-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-7#1)(1997-2#1)(2007-5#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#3)
and compositional##4##2##(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#1)
and compositions##2##2##(2008-10#1)(2011-10#1)
and compost##3##2##(2008-10#2)(2008-6#1)
and composted##2##2##(2008-10#2)
and compound##7##2##(1992-6#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
and compounds with##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
and compounds##13##2##(1993-3#1)(1994-9#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#2)
and comprehension##4##2##(2008-12#1)(2010-7#1)(2011-2#2)
and comprehensive approach to##2##4##(1993-1#1)(1994-2#1)
and comprehensive##17##2##(1992-3#1)(1993-1#1)(1994-2#3)(1995-3#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
and comprehensively##2##2##(2008-10#1)(2008-6#1)
and compress##2##2##(2007-11#1)(2011-2#1)
and compression of##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
and compression##12##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2013-1#1)
and compressive##3##2##(2008-3#1)(2009-7#1)(2012-2#1)
and comprise##4##2##(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#1)
and comprised of##2##3##(1997-4#1)(2007-10#1)
and comprised##8##2##(1997-4#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-11#1)(2010-8#1)
and comprises##4##2##(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)
and compromised##2##2##(2008-11#1)(2013-1#1)
and compulsive##2##2##(2008-3#1)(2009-7#1)
and computation##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-12#1)
and computational analysis##2##3##(2012-2#2)
and computational efficiency##2##3##(2008-3#2)
and computational methods##2##3##(2008-4#1)(2009-8#1)
and computational neuroscience models##2##4##(2008-9#2)
and computational tools##2##3##(2008-7#1)(2008-8#1)
and computational##24##2##(1990-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#4)
and computed tomographic (CT)##2##4##(2008-1#1)(2008-7#1)
and computed tomographic##8##3##(1993-6#1)(2008-1#2)(2008-7#1)(2009-10#1)(2010-9#1)(2012-12#1)(2013-1#1)
and computed tomography (CT) of the##2##6##(1991-3#1)(2011-1#1)
and computed tomography (CT)##4##4##(1991-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
and computed tomography demonstrated##3##4##(1995-3#1)(2009-3#1)(2013-8#1)
and computed tomography showed##2##4##(1993-3#1)(2013-1#1)
and computed tomography##16##3##(1991-3#1)(1993-3#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and computed##29##2##(1991-3#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
and computer analysis##2##3##(1997-4#1)(2008-10#1)
and computer reconstruction##2##3##(2008-8#2)
and computer simulation results##2##4##(2007-11#1)(2008-3#1)
and computer simulation##8##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-9#1)
and computer simulations##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
and computer technologies##3##3##(1996-12#1)(2008-11#1)(2008-3#1)
and computer tomography##3##3##(2007-11#3)
and computer##33##2##(1993-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#5)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#2)(2009-9#1)(2012-3#1)
and computerized##3##2##(1991-2#1)(1992-9#1)(2013-1#1)
and computing##3##2##(2007-11#1)(2007-12#2)
and concanavalin A##3##3##(1993-6#1)(1993-8#1)(1995-11#1)
and concave##2##2##(2008-3#1)(2012-3#1)
and concentrate##4##2##(2008-10#2)(2008-9#1)(2010-4#1)
and concentrated by##3##3##(1992-11#1)(2011-1#1)(2012-2#1)
and concentrated##13##2##(1992-11#1)(1995-6#1)(2008-10#5)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
and concentrating##2##2##(1995-3#1)(2008-10#1)
and concentration camps##2##3##(2008-7#2)
and concentration dependence of##2##4##(2008-10#1)(2008-2#1)
and concentration in suspension measurements of spherical droplets and cylindrical jets##2##11##(2008-3#2)
and concentration in##6##3##(1991-2#1)(2007-11#1)(2008-3#3)(2008-5#1)
and concentration of the##7##4##(1991-9#1)(1994-9#1)(2008-10#4)(2008-2#1)
and concentration of##35##3##(1991-9#1)(1994-9#1)(1995-3#1)(2008-10#25)(2008-2#3)(2011-2#2)(2011-3#1)(2013-1#1)
and concentration was##2##3##(2008-10#2)
and concentration with##3##3##(2008-10#3)
and concentration##82##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-9#2)(1994-9#1)(1995-3#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#42)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#1)
and concentration-dependent increase in##2##4##(1991-5#1)(1996-12#1)
and concentration-dependent##11##2##(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-8#1)(1996-12#1)(1997-1#2)(2008-3#1)(2008-9#1)(2010-5#1)
and concentrations and##2##3##(2008-10#1)(2008-3#1)
and concentrations of serum##2##4##(1991-12#1)(1992-6#1)
and concentrations of##16##3##(1991-12#1)(1992-6#1)(1993-12#1)(1995-5#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
and concentrations were##2##3##(1991-12#1)(2008-10#1)
and concentrations##29##2##(1991-12#2)(1992-6#1)(1993-12#1)(1995-5#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
and concepts of##4##3##(1995-3#1)(2008-9#1)(2011-2#2)
and concepts##6##2##(1992-1#1)(1995-3#1)(1997-3#1)(2008-9#1)(2011-2#2)
and conceptual##8##2##(1990-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-3#1)
and concern about##4##3##(1990-6#1)(1991-3#1)(1993-12#1)(2011-2#1)
and concern##9##2##(1990-6#1)(1991-3#1)(1992-1#1)(1993-12#1)(1994-2#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-1#1)
and concerns about##4##3##(1994-2#1)(1996-9#1)(2010-8#1)(2012-3#1)
and concerns of##3##3##(1992-2#1)(2008-7#1)(2011-2#1)
and concerns over##2##3##(2008-10#1)(2008-7#1)
and concerns regarding##2##3##(2008-11#1)(2013-1#1)
and concerns##15##2##(1992-2#1)(1994-2#1)(1995-2#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and concise##3##2##(2007-11#1)(2008-4#1)(2012-2#1)
and conclude by##2##3##(1996-2#1)(2011-2#1)
and conclude that the##5##4##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
and conclude that there is a need for professional nursing consensus to define the term##2##15##(2013-1#2)
and conclude that##11##3##(1990-9#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
and conclude with a discussion of##2##6##(1994-3#1)(2009-6#1)
and conclude##15##2##(1990-9#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
and concluded that##2##3##(1990-12#1)(1990-5#1)
and concluded##3##2##(1990-12#1)(1990-5#1)(2008-10#1)
and concludes that##2##3##(1995-1#1)(2011-2#1)
and concludes##4##2##(1995-1#1)(1996-12#1)(2008-9#1)(2011-2#1)
and conclusion##2##2##(2008-6#1)(2009-8#1)
and conclusions of##2##3##(1993-3#1)(1994-2#1)
and conclusions##12##2##(1991-12#1)(1993-3#1)(1994-2#1)(1996-1#1)(2007-11#3)(2007-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
and concomitant##17##2##(1991-3#1)(1995-10#1)(1996-2#1)(1997-4#2)(2007-8#1)(2008-10#2)(2008-4#3)(2008-6#2)(2008-8#1)(2012-12#1)(2013-8#2)
and concomitantly##5##2##(1990-8#1)(1997-4#1)(2008-12#1)(2008-5#1)(2010-9#1)
and concrete##3##2##(1992-1#1)(2008-6#2)
and concurrent##18##2##(1991-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
and concurrently##2##2##(1995-8#1)(2008-7#1)
and condensation of##2##3##(1993-8#1)(2008-10#1)
and condensation##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
and condensed##6##2##(1990-2#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
and condition of##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
and condition##8##2##(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and conditional##4##2##(1995-2#1)(1995-9#1)(2012-2#2)
and conditioned##4##2##(1995-12#1)(2008-10#2)(2009-8#1)
and conditioning of the##2##4##(2008-10#2)
and conditioning##5##2##(1995-5#1)(2008-10#3)(2012-2#1)
and conditions for##4##3##(2008-10#3)(2008-9#1)
and conditions of the##2##4##(1997-8#1)(2008-10#1)
and conditions of##6##3##(1990-2#1)(1992-12#1)(1994-11#1)(1995-12#1)(1997-8#1)(2008-10#1)
and conditions##20##2##(1990-2#1)(1992-12#1)(1994-11#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
and condom use##6##3##(1990-3#1)(1993-2#1)(2011-1#3)(2012-12#1)
and condoms##2##2##(1994-3#1)(2013-1#1)
and conduct##7##2##(1994-2#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
and conductance##2##2##(1993-12#1)(2008-8#1)
and conducted a##2##3##(2011-2#1)(2011-3#1)
and conducted by##4##3##(1993-2#1)(1993-3#2)(2013-1#1)
and conducted##9##2##(1993-2#1)(1993-3#2)(2009-10#1)(2010-10#1)(2011-2#1)(2011-3#1)(2013-1#2)
and conductimetric##2##2##(2008-10#2)
and conducting##4##2##(1991-6#1)(2007-7#1)(2008-11#1)(2010-4#1)
and conduction##4##2##(2007-8#1)(2009-5#1)(2010-7#1)(2013-1#1)
and conductive##2##2##(2008-10#2)
and conductivity##2##2##(1996-4#1)(2008-10#1)
and cone biopsy##2##3##(1994-2#2)
and cone##7##2##(1990-7#1)(1993-11#1)(1994-2#2)(2008-10#1)(2008-3#1)(2013-1#1)
and confabulation##2##2##(2008-4#1)(2008-7#1)
and confers##3##2##(1997-3#1)(2008-10#1)(2009-5#1)
and confidence in##6##3##(1996-1#1)(2008-11#2)(2010-8#2)(2012-1#1)
and confidence interval##3##3##(1996-3#1)(1997-3#1)(2012-1#1)
and confidence intervals##4##3##(1994-11#2)(2008-10#2)
and confidence of##2##3##(2008-11#1)(2009-10#1)
and confidence##23##2##(1994-11#2)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#5)(2008-12#3)(2009-10#1)(2010-5#1)(2010-8#2)(2012-1#2)
and confident##2##2##(1997-3#1)(2008-11#1)
and confidentiality##3##2##(1991-3#1)(2008-9#1)(2010-8#1)
and configuration##3##2##(2008-10#1)(2013-1#2)
and configurations##2##2##(2007-11#1)(2010-10#1)
and confined to##2##3##(1992-10#1)(2007-7#1)
and confined##5##2##(1992-10#1)(2007-11#1)(2007-7#1)(2010-2#1)(2010-4#1)
and confirm that##4##3##(1995-2#1)(2008-2#1)(2009-10#1)(2010-3#1)
and confirm the##8##3##(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#1)
and confirm##18##2##(1995-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-2#1)
and confirmation of##2##3##(2008-5#1)(2013-1#1)
and confirmation##6##2##(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#1)
and confirmed by Western blot##2##5##(1997-4#1)(2011-2#1)
and confirmed by a##2##4##(1992-1#1)(2008-7#1)
and confirmed by the##3##4##(1990-3#1)(1991-5#1)(2010-8#1)
and confirmed by##21##3##(1990-3#1)(1991-5#1)(1992-1#1)(1993-3#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
and confirmed that##5##3##(2006-6#1)(2008-10#2)(2008-7#1)(2009-4#1)
and confirmed the presence##2##4##(2008-7#1)(2012-12#1)
and confirmed the##8##3##(1990-5#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
and confirmed to##2##3##(2007-12#1)(2008-10#1)
and confirmed with##2##3##(2008-11#1)(2010-12#1)
and confirmed##46##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-3#1)(1997-4#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-7#3)(2009-4#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and confirming##2##2##(1991-12#1)(2008-7#1)
and confirms the##5##3##(1991-3#1)(1991-6#1)(2008-3#2)(2009-8#1)
and confirms##6##2##(1991-3#1)(1991-6#1)(2008-3#3)(2009-8#1)
and conflict##3##2##(2008-1#1)(2008-12#1)(2008-7#1)
and conflicting##2##2##(1994-2#1)(2008-4#1)
and conflicts##6##2##(1992-12#1)(2008-1#1)(2008-8#2)(2009-10#1)(2012-2#1)
and confocal image##2##3##(2008-3#2)
and confocal laser scanning microscopy##4##5##(1992-9#1)(2008-10#1)(2008-8#2)
and confocal laser scanning##5##4##(1992-9#1)(1993-11#1)(2008-10#1)(2008-8#2)
and confocal microscopy##4##3##(2007-12#1)(2008-4#2)(2008-7#1)
and confocal scanning##2##3##(2008-7#1)(2008-9#1)
and confocal##16##2##(1992-9#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
and conformation of##3##3##(1993-5#1)(1997-2#1)(2008-10#1)
and conformation##5##2##(1993-5#1)(1995-5#1)(1997-2#1)(2008-10#1)(2009-2#1)
and conformational change of##2##4##(1990-5#1)(2008-9#1)
and conformational##12##2##(1990-5#1)(1993-3#1)(1994-5#1)(2007-11#2)(2008-10#1)(2008-4#2)(2008-8#2)(2008-9#1)(2013-1#1)
and confusing##3##2##(1992-3#1)(2011-2#1)(2012-2#1)
and confusion##4##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-1#1)
and congenic##2##2##(2012-3#1)(2013-1#1)
and congenital abnormalities##2##3##(2012-2#1)(2013-1#1)
and congenital heart disease##3##4##(2009-10#3)
and congenital heart##4##3##(1992-5#1)(2009-10#3)
and congenital malformations##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
and congenital##19##2##(1992-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2009-10#3)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
and congestive cardiac failure##2##4##(2007-7#1)(2011-2#1)
and congestive heart failure##4##4##(1990-2#1)(2007-8#1)(2008-3#1)(2008-7#1)
and congestive##6##2##(1990-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
and congregational support##3##3##(2008-1#1)(2010-2#2)
and conidia of##2##3##(2008-10#2)
and conidia production##3##3##(2008-10#3)
and conidia were##2##3##(2008-10#2)
and conidia##13##2##(2008-10#12)(2010-10#1)
and conidial##2##2##(2008-10#2)
and conifer##2##2##(2008-8#2)
and conjugate##3##2##(1996-5#1)(2007-10#1)(2008-10#1)
and conjugated bile acids##3##4##(1993-2#3)
and conjugated to##2##3##(1994-8#1)(2008-4#1)
and conjugated with##2##3##(2008-10#1)(2008-11#1)
and conjugated##14##2##(1992-3#1)(1993-2#3)(1994-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2009-5#1)
and conjugates##2##2##(1993-11#1)(1996-5#1)
and conjunctiva##3##2##(1997-7#1)(2008-11#1)(2010-10#1)
and connected to a##2##4##(2008-10#1)(2008-2#1)
and connected to##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
and connected##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
and connective tissue##4##3##(1993-2#1)(1994-9#1)(1996-2#1)(2012-3#1)
and connective##5##2##(1993-2#1)(1994-9#1)(1996-2#1)(2012-1#1)(2012-3#1)
and connectivity##5##2##(1994-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-8#1)
and connexin43##2##2##(2008-8#1)(2013-8#1)
and cons of##16##3##(1992-1#1)(1996-6#1)(2008-11#2)(2008-3#1)(2008-4#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and cons##21##2##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and conscious##2##2##(2010-3#1)(2012-2#1)
and consecutive##3##2##(1996-5#1)(2012-2#2)
and consensus##5##2##(1996-1#1)(1997-2#1)(2008-7#1)(2009-5#1)(2009-6#1)
and consent to##2##3##(1992-3#1)(2010-5#1)
and consent##6##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)
and consequences are##2##3##(2008-2#1)(2012-2#1)
and consequences of the##3##4##(2008-11#2)(2008-7#1)
and consequences of their##2##4##(2010-3#1)(2010-9#1)
and consequences of##17##3##(1996-3#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2008-11#3)(2008-7#1)(2008-8#3)(2010-3#1)(2010-9#1)(2012-12#1)
and consequences##30##2##(1991-1#1)(1994-2#1)(1994-5#1)(1996-3#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#3)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
and consequent##12##2##(1990-5#1)(1991-3#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and consequently a##2##3##(2008-5#1)(2013-7#1)
and consequently it##2##3##(1995-5#1)(2008-10#1)
and consequently reduced##2##3##(2007-8#1)(2008-7#1)
and consequently the##8##3##(1997-7#1)(2008-10#4)(2008-3#1)(2009-7#1)(2010-9#1)
and consequently their##2##3##(1992-3#1)(2008-10#1)
and consequently to a##2##4##(1995-12#1)(2008-5#1)
and consequently to##4##3##(1990-3#1)(1995-12#1)(2008-10#1)(2008-5#1)
and consequently##62##2##(1990-3#1)(1992-3#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
and conservation of the##3##4##(1997-6#1)(2007-5#1)(2008-4#1)
and conservation of##4##3##(1991-7#1)(1997-6#1)(2007-5#1)(2008-4#1)
and conservation##9##2##(1991-7#1)(1997-6#1)(2007-5#2)(2008-4#1)(2008-9#2)(2010-8#1)(2013-7#1)
and conservative management##3##3##(2007-11#1)(2013-1#2)
and conservative surgery are the mainstay of therapy for##2##9##(2010-12#2)
and conservative surgery are##3##4##(1990-2#1)(2010-12#2)
and conservative##12##2##(1990-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
and conserved motifs##2##3##(1994-12#1)(2007-12#1)
and conserved region of##2##4##(2008-12#1)(2013-1#1)
and conserved##6##2##(1994-12#1)(1995-5#1)(2007-12#1)(2008-12#1)(2008-8#1)(2013-1#1)
and conserving the##2##3##(2008-10#1)(2008-11#1)
and consider the##6##3##(1996-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-4#1)(2010-5#1)
and consider##13##2##(1991-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and considerable##2##2##(2008-3#1)(2012-2#1)
and considerably##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
and consideration of##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
and consideration##4##2##(1992-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
and considerations for##2##3##(1992-3#1)(2011-2#1)
and considerations of##2##3##(2008-10#1)(2008-11#1)
and considerations##8##2##(1991-5#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2011-2#1)
and considered for##3##3##(2006-5#1)(2012-12#1)(2012-2#1)
and considered##11##2##(1990-9#1)(1992-2#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
and considering a##2##3##(2008-10#1)(2012-2#1)
and considering the##3##3##(2008-7#1)(2009-11#1)(2013-7#1)
and considering##11##2##(1994-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
and considers the##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
and considers##8##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-3#1)(2011-2#1)
and consisted of an##2##4##(1990-2#1)(1992-3#1)
and consisted of the##2##4##(1991-3#1)(1993-8#1)
and consisted of two##2##4##(2008-10#2)
and consisted of##20##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-8#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#4)(2012-12#1)
and consisted##25##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-8#2)(1997-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#4)(2012-12#1)(2012-2#1)
and consistency of the##3##4##(1995-5#1)(2008-10#1)(2008-11#1)
and consistency of##4##3##(1995-5#1)(2008-10#2)(2008-11#1)
and consistency##6##2##(1995-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
and consistent with the##3##4##(2008-10#2)(2012-2#1)
and consistent with##8##3##(1990-3#1)(1990-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#2)
and consistent##21##2##(1990-3#1)(1990-5#1)(1994-2#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)
and consistently##7##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
and consisting of##2##3##(1991-5#1)(1995-2#1)
and consisting##3##2##(1991-5#1)(1995-2#1)(2012-1#1)
and consists of a##5##4##(1995-3#1)(2007-11#2)(2008-10#1)(2011-1#1)
and consists of five##2##4##(1991-6#1)(2008-6#1)
and consists of four##2##4##(1994-12#1)(2009-2#1)
and consists of two##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
and consists of##22##3##(1991-5#1)(1991-6#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#3)(2011-1#1)
and consists##23##2##(1991-5#1)(1991-6#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#3)(2011-1#1)
and consolidation of##3##3##(1994-12#1)(2009-10#1)(2009-6#1)
and consolidation##5##2##(1994-12#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-6#1)
and consonants##3##2##(2013-8#3)
and conspecific##3##2##(2008-10#1)(2008-8#2)
and constant current##2##3##(2008-10#1)(2010-1#1)
and constant##16##2##(1990-11#1)(1997-6#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-1#1)(2012-12#1)
and constipation##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
and constituent##3##2##(1991-12#1)(2008-10#1)(2008-2#1)
and constitute a##2##3##(1994-9#1)(2011-2#1)
and constitute##5##2##(1990-6#1)(1994-3#1)(1994-9#1)(2008-10#1)(2011-2#1)
and constituted##2##2##(1995-12#1)(2007-7#1)
and constitutes the##2##3##(2008-10#1)(2008-8#1)
and constitutes##4##2##(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)
and constitutional##2##2##(2008-10#1)(2011-2#1)
and constitutive##10##2##(1992-12#4)(2006-6#2)(2008-7#1)(2008-8#3)
and constitutively##2##2##(1995-6#1)(2008-7#1)
and constraint##2##2##(2008-8#1)(2012-12#1)
and constraints on the##2##4##(2008-10#1)(2008-2#1)
and constraints to##2##3##(2011-1#1)(2013-8#1)
and constraints##12##2##(1994-2#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
and constricted##2##2##(1993-1#1)(2013-1#1)
and construct a##2##3##(1995-3#1)(2010-10#1)
and construct validity##7##3##(1995-2#1)(2007-12#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
and construct##11##2##(1995-2#1)(1995-3#1)(2007-12#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
and constructed##11##2##(1994-8#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
and construction of a##2##4##(2008-10#1)(2008-3#1)
and construction of the##2##4##(2008-3#1)(2013-1#1)
and construction of##8##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2013-1#1)
and construction##11##2##(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
and constructional##2##2##(1990-3#1)(2008-7#1)
and consult##2##2##(2007-10#1)(2009-4#1)
and consultant##2##2##(1991-12#1)(1992-12#1)
and consultants##2##2##(1993-1#1)(1995-12#1)
and consultations##2##2##(1992-4#1)(1992-9#1)
and consume##3##2##(1996-5#1)(2009-8#1)(2012-2#1)
and consumer##11##2##(1993-12#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
and consumers##13##2##(1993-1#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-12#3)(2008-5#1)(2010-9#1)(2012-2#1)
and consumes##3##2##(2007-7#1)(2008-5#1)(2013-8#1)
and consumption of##8##3##(1993-9#1)(2008-10#1)(2008-3#2)(2011-2#3)(2012-1#1)
and consumption##19##2##(1991-3#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)
and consumptive##2##2##(2008-10#1)(2008-7#1)
and contact time of##2##4##(2008-10#2)
and contact time##5##3##(2008-10#3)(2011-1#1)(2013-8#1)
and contact##16##2##(1994-6#1)(2007-12#1)(2008-10#6)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
and contain a##4##3##(1992-8#1)(1993-12#1)(2009-10#1)(2009-7#1)
and contain many##2##3##(1992-8#1)(2008-7#1)
and contain##16##2##(1992-12#1)(1992-8#2)(1993-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-9#1)(2011-2#1)
and contained a##8##3##(1994-11#1)(1995-3#2)(1997-8#1)(2008-10#2)(2013-8#2)
and contained##27##2##(1994-11#1)(1995-3#2)(1996-12#2)(1997-7#1)(1997-8#2)(2007-12#1)(2007-6#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-8#2)
and containing a##2##3##(1992-3#1)(1994-12#1)
and containing the##3##3##(1992-8#1)(1995-2#1)(2010-2#1)
and containing##13##2##(1992-3#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-2#1)(2011-1#1)
and containment of##2##3##(2008-12#1)(2010-12#1)
and contains a##7##3##(1990-11#1)(1992-8#1)(1993-3#1)(1994-12#1)(1996-2#1)(2008-7#1)(2008-8#1)
and contains an open reading frame of##3##7##(1993-2#2)(1997-2#1)
and contains an open reading frame##4##6##(1993-2#2)(1994-12#1)(1997-2#1)
and contains an##6##3##(1992-8#1)(1993-2#2)(1994-12#1)(1997-2#1)(2008-8#1)
and contains four open reading frames##2##6##(2008-10#2)
and contains four##3##3##(1993-3#1)(2008-10#2)
and contains several##2##3##(1991-5#1)(1993-2#1)
and contains the##8##3##(1992-11#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-7#1)(2008-10#1)(2009-10#1)
and contains##43##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#3)(1993-12#1)(1993-2#3)(1993-3#2)(1994-11#1)(1994-12#3)(1994-5#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#1)(2012-12#1)
and contaminants##4##2##(1994-3#1)(2008-11#2)(2008-4#1)
and contaminated##4##2##(1990-10#1)(2008-10#1)(2008-11#2)
and contamination##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
and contemporary##12##2##(1995-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2012-2#1)(2013-1#1)
and content of physician performance##3##5##(2013-1#3)
and content of the##6##4##(1991-2#1)(1992-12#1)(1994-1#1)(1996-7#1)(2008-10#1)(2008-9#1)
and content of##18##3##(1991-2#1)(1992-12#1)(1994-1#1)(1996-5#1)(1996-7#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-8#2)(2013-1#3)
and content words##2##3##(2008-2#2)
and content##29##2##(1991-2#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-8#1)(1996-5#1)(1996-7#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#2)(2013-1#4)
and contents of the##2##4##(1992-12#1)(2008-9#1)
and contents##5##2##(1992-12#1)(1995-9#1)(2008-10#1)(2008-9#1)(2010-3#1)
and context of these##2##4##(2010-10#1)(2012-2#1)
and context of##3##3##(2008-11#1)(2010-10#1)(2012-2#1)
and context##6##2##(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
and contexts##3##2##(2008-11#1)(2008-12#1)(2010-9#1)
and contextual factors##2##3##(1995-1#1)(2008-11#1)
and contextual##10##2##(1993-12#2)(1995-1#1)(2008-11#3)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
and continents##2##2##(2008-10#1)(2008-8#1)
and contingency##2##2##(1997-2#1)(2009-11#1)
and continually##2##2##(1995-2#1)(2009-10#1)
and continue to##8##3##(1997-1#1)(2008-11#4)(2010-8#1)(2012-12#1)(2012-2#1)
and continue##10##2##(1997-1#1)(2007-12#1)(2007-5#1)(2008-11#4)(2010-8#1)(2012-12#1)(2012-2#1)
and continued by##2##3##(2007-8#1)(2012-12#1)
and continued for##4##3##(1991-9#1)(1997-6#1)(2008-10#1)(2011-3#1)
and continued to##6##3##(1992-2#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-8#1)
and continued until##2##3##(2007-10#1)(2008-10#1)
and continued with##2##3##(2013-1#1)(2013-8#1)
and continued##27##2##(1991-9#1)(1992-2#1)(1995-6#2)(1996-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
and continues to##4##3##(1992-2#1)(1997-3#1)(2007-2#1)(2013-1#1)
and continues##7##2##(1992-2#1)(1997-3#1)(2007-2#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
and continuing education##6##3##(1993-3#1)(1994-3#1)(1995-12#1)(2008-12#2)(2010-8#1)
and continuing##21##2##(1992-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
and continuity of care##4##4##(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)
and continuity of##5##3##(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-11#1)
and continuity##14##2##(1990-5#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-8#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)
and continuous ambulatory##3##3##(1995-2#1)(1997-8#1)(2011-1#1)
and continuous education##2##3##(1994-12#1)(2010-10#1)
and continuous flow/stopped-flow/continuous-flow processing##3##4##(2008-10#3)
and continuous monitoring of##2##4##(2007-11#1)(2008-10#1)
and continuous potato##2##3##(2008-10#2)
and continuous quality improvement##4##4##(1993-12#3)(1995-1#1)
and continuous##64##2##(1990-12#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-5#2)(1995-1#1)(1995-2#2)(1996-12#2)(1997-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#1)(2009-12#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
and continuous-flow##2##2##(2008-10#1)(2008-7#1)
and continuous-wave##2##2##(2008-3#2)
and continuously tunable##2##3##(2008-2#1)(2008-3#1)
and continuously##9##2##(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)
and contour##2##2##(2007-12#1)(2008-9#1)
and contraceptive use##2##3##(1991-3#1)(2012-12#1)
and contraceptive##3##2##(1991-3#1)(1996-11#1)(2012-12#1)
and contract##2##2##(1995-1#1)(2008-5#1)
and contractile##2##2##(1991-9#1)(2008-7#1)
and contractility##4##2##(2006-10#1)(2008-10#1)(2008-7#2)
and contraction of##3##3##(1995-2#1)(2008-7#1)(2010-1#1)
and contraction##7##2##(1992-9#1)(1993-8#1)(1995-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-1#1)
and contractions##3##2##(1995-12#2)(2008-7#1)
and contractual##3##2##(1991-12#1)(1991-2#1)(2008-11#1)
and contraindications of##2##3##(2011-2#1)(2013-8#1)
and contraindications##7##2##(2007-11#1)(2007-8#1)(2011-2#3)(2011-3#1)(2013-8#1)
and contralateral##13##2##(1992-8#2)(1993-12#3)(1993-3#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)
and contrast administration##2##3##(2008-7#2)
and contrast enhanced helical##2##4##(2007-5#2)
and contrast enhanced##3##3##(2007-5#2)(2008-7#1)
and contrast ratios##2##3##(2007-12#1)(2008-3#1)
and contrast the##2##3##(1994-1#1)(2008-9#1)
and contrast##29##2##(1994-1#1)(1995-2#1)(1997-1#1)(2007-12#2)(2007-5#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-6#1)(2008-7#6)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)
and contrasts##4##2##(1994-2#1)(1996-6#1)(2008-8#1)(2010-3#1)
and contribute to the##6##4##(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
and contribute to tissue##2##4##(2008-11#1)(2012-12#1)
and contribute to##17##3##(1994-9#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
and contribute##19##2##(1994-9#1)(1995-6#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
and contributed to the##2##4##(2008-12#1)(2011-2#1)
and contributed to##5##3##(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
and contributed##8##2##(1991-8#1)(1993-2#1)(2008-12#1)(2008-3#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
and contributes to the##8##4##(1993-12#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-12#1)(2008-4#1)(2009-5#1)(2013-8#1)
and contributes to##15##3##(1993-12#2)(1994-3#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2013-8#2)
and contribution of the##2##4##(2008-3#1)(2008-7#1)
and contribution of##5##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
and contribution##6##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
and contributions to##2##3##(2012-12#1)(2013-1#1)
and contributions##3##2##(1995-3#1)(2012-12#1)(2013-1#1)
and control and##2##3##(2008-9#1)(2009-8#1)
and control animals##2##3##(1994-2#1)(2008-10#1)
and control group was##3##4##(2008-10#1)(2008-9#1)(2011-1#1)
and control group##11##3##(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#2)(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
and control groups was##3##4##(2007-10#1)(2011-1#1)(2013-1#1)
and control groups were##4##4##(1991-12#1)(2008-12#1)(2013-1#1)(2013-8#1)
and control groups##25##3##(1991-12#1)(1993-12#1)(1995-11#1)(1997-5#1)(2007-10#1)(2007-2#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and control in the##2##4##(2008-9#1)(2011-1#1)
and control in##6##3##(2008-9#2)(2010-5#1)(2011-1#2)(2012-3#1)
and control is##2##3##(1992-11#1)(1997-1#1)
and control issues##2##3##(2008-11#1)(2011-2#1)
and control its##2##3##(1997-1#1)(2007-12#1)
and control males##2##3##(2008-8#2)
and control measures##5##3##(1996-1#1)(2008-10#1)(2011-2#2)(2012-12#1)
and control mice##3##3##(1990-6#1)(1994-11#1)(1994-8#1)
and control of cellular immune responses##2##6##(2008-4#2)
and control of human##2##4##(1991-9#1)(1994-8#1)
and control of hypertension in##2##5##(2008-11#1)(2011-1#1)
and control of hypertension##4##4##(2008-1#1)(2008-11#2)(2011-1#1)
and control of the##8##4##(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
and control of this##2##4##(2008-6#1)(2008-9#1)
and control of ventricular##2##4##(1991-2#1)(2008-7#1)
and control of##62##3##(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-8#1)(1996-11#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
and control over their##2##4##(1992-1#1)(1996-1#1)
and control plants##2##3##(2008-10#1)(2011-10#1)
and control rates##3##3##(2008-11#3)
and control rats##6##3##(1992-11#1)(1993-12#2)(1994-5#1)(2009-6#1)(2011-2#1)
and control samples##2##3##(2008-8#1)(2012-2#1)
and control strategies##2##3##(2008-10#1)(2008-12#1)
and control subjects##13##3##(1991-11#1)(1991-12#1)(1992-12#1)(1995-5#2)(1996-7#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
and control system##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
and control systems##2##3##(2011-1#1)(2012-2#1)
and control the##6##3##(1994-5#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-6#1)
and control their##2##3##(2008-9#1)(2012-12#1)
and control##268##2##(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#5)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#4)(1997-1#5)(1997-5#1)(1997-6#1)(2007-10#5)(2007-11#5)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#20)(2008-11#21)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#12)(2009-10#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#17)(2011-9#1)(2012-1#1)(2012-12#10)(2012-2#8)(2012-3#6)(2012-6#1)(2013-1#8)(2013-8#6)
and controllable space-variant optical correlation##2##5##(2008-2#2)
and controllable##6##2##(2007-11#1)(2008-2#2)(2009-11#2)(2010-10#1)
and controlled by the##2##4##(2008-5#1)(2008-7#1)
and controlled by##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
and controlled manner##2##3##(2009-9#1)(2010-5#1)
and controlled release##2##3##(2010-4#2)
and controlled##42##2##(1991-9#1)(1994-9#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#3)(2013-8#1)
and controlled-release##2##2##(2013-1#1)(2013-8#1)
and controlling the##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and controlling##20##2##(1992-1#2)(1992-3#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
and controls (p##3##3##(1991-9#1)(2008-12#1)(2008-7#1)
and controls in##2##3##(1990-8#1)(1997-5#1)
and controls on##4##3##(2010-8#1)(2013-1#3)
and controls were##4##3##(1991-7#1)(1997-5#1)(2008-1#1)(2011-2#1)
and controls with##2##3##(1996-11#1)(2013-1#1)
and controls##59##2##(1990-8#2)(1991-12#1)(1991-7#2)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#2)(1997-5#5)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#9)(2013-8#3)
and controversial##7##2##(1993-11#1)(1994-9#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
and controversies in the treatment of##2##6##(1991-8#1)(2010-11#1)
and controversies##6##2##(1991-8#1)(1994-12#1)(2007-9#1)(2008-1#1)(2009-10#1)(2010-11#1)
and controversy##2##2##(2009-10#1)(2010-7#1)
and convenience##6##2##(1991-3#1)(1992-8#1)(2008-3#1)(2011-2#1)(2012-12#2)
and convenient analysis##2##3##(2008-10#2)
and convenient and##2##3##(2008-10#1)(2008-3#1)
and convenient assay for##2##4##(1994-11#1)(2008-4#1)
and convenient assay##3##3##(1994-11#1)(2008-4#1)(2008-5#1)
and convenient method for the##2##5##(1990-12#1)(2008-10#1)
and convenient method for##4##4##(1990-12#1)(2008-10#3)
and convenient method##6##3##(1990-12#1)(2008-10#4)(2008-11#1)
and convenient##28##2##(1990-12#1)(1994-11#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
and conventional tillage treatments##2##4##(2008-10#2)
and conventional tillage##3##3##(2008-10#3)
and conventional wet digestion methods showed a good agreement##2##9##(2008-10#2)
and conventional wet digestion methods##4##5##(2008-10#4)
and conventional##47##2##(1990-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-12#3)(2008-10#16)(2008-3#9)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#3)
and converge##2##2##(2010-3#1)(2010-6#1)
and convergence of##2##3##(1996-3#1)(2008-8#1)
and convergence##4##2##(1996-3#1)(2008-3#1)(2008-8#1)(2010-3#1)
and convergent##3##2##(2007-10#1)(2009-11#1)(2009-12#1)
and conversely##2##2##(1990-11#1)(2010-10#1)
and conversion of##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
and conversion to##2##3##(1992-10#1)(1995-12#1)
and conversion##11##2##(1992-10#1)(1993-8#1)(1995-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#3)(2010-8#1)
and converted##3##2##(2008-10#1)(2008-6#2)
and converting##2##2##(2008-4#1)(2012-12#1)
and convex##5##2##(2007-8#2)(2008-2#1)(2008-3#2)
and convey a##2##3##(2008-10#1)(2012-3#1)
and convey##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
and convincing##3##2##(1990-11#1)(1992-12#1)(2008-10#1)
and convulsions##2##2##(2007-7#1)(2011-1#1)
and cooked beef patties##3##4##(2010-4#3)
and cooked##8##2##(1997-4#1)(2010-4#6)(2012-12#1)
and cool##4##2##(2008-11#1)(2008-12#1)(2008-9#2)
and cooler##3##2##(2008-10#1)(2011-2#1)(2012-4#1)
and cooling devices##2##3##(2008-10#1)(2010-8#1)
and cooling##10##2##(1990-7#1)(2007-11#1)(2008-10#4)(2008-3#2)(2009-1#1)(2010-8#1)
and cooperate##2##2##(1996-3#1)(2011-2#1)
and cooperation between##2##3##(2008-8#1)(2011-2#1)
and cooperation in##2##3##(1992-2#1)(1993-12#1)
and cooperation##8##2##(1992-2#1)(1993-12#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-8#2)(2011-2#1)
and cooperative breeding##3##3##(2008-8#3)
and cooperative##9##2##(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-8#3)(2012-1#1)
and cooperativity##5##2##(1992-3#1)(1994-12#1)(1995-2#1)(2008-10#2)
and coordinate##2##2##(2007-12#1)(2008-10#1)
and coordinated by the##2##4##(1990-3#1)(2008-10#1)
and coordinated##8##2##(1990-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-8#1)(2010-9#1)
and coordinating##4##2##(1993-2#1)(2007-12#1)(2010-4#1)(2010-5#1)
and coordination of care##2##4##(1995-12#1)(2008-11#1)
and coordination of##9##3##(1992-1#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2013-1#1)
and coordination##20##2##(1992-1#1)(1994-3#1)(1995-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
and cope with##3##3##(1993-1#1)(1995-12#1)(2008-7#1)
and coping strategies##6##3##(2007-6#1)(2008-11#1)(2010-10#2)(2011-1#1)(2012-1#1)
and coping##28##2##(1990-10#2)(1991-12#1)(1992-1#1)(1995-1#2)(1996-1#2)(1996-7#1)(2007-10#1)(2007-6#1)(2008-11#3)(2008-12#1)(2010-10#2)(2010-11#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)
and coplanar##2##2##(2008-10#1)(2008-7#1)
and copolymers of##2##3##(2008-3#1)(2009-10#1)
and copper and##2##3##(2008-10#2)
and copper based on the formation of their complexes with##2##10##(2008-10#2)
and copper by##3##3##(2008-10#3)
and copper in##8##3##(1997-4#1)(2008-10#7)
and copper solid amalgam electrodes##2##5##(2008-10#2)
and copper were##4##3##(2008-10#3)(2010-2#1)
and copper with##2##3##(2008-10#2)
and copper##54##2##(1990-8#2)(1992-11#1)(1992-3#1)(1995-3#1)(1997-4#1)(2008-10#46)(2010-2#1)(2013-7#1)
and copper(II) and##4##3##(2008-10#4)
and copper(II) ions##2##3##(2008-10#2)
and copper(II)##11##2##(2008-10#11)
and copper)##2##2##(2008-3#1)(2010-4#1)
and copy number##2##3##(2008-9#1)(2012-3#1)
and copy##3##2##(1990-2#1)(2008-9#1)(2012-3#1)
and cord blood##3##3##(2007-2#1)(2008-4#1)(2010-7#1)
and cord##4##2##(2007-2#1)(2008-4#1)(2010-7#1)(2013-1#1)
and core biopsy##2##3##(2011-2#2)
and core##10##2##(1994-9#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-1#1)(2011-2#2)
and corn steep liquor##2##4##(2008-6#1)(2008-7#1)
and corn##12##2##(2007-11#1)(2008-10#7)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
and cornea##2##2##(2008-3#1)(2011-3#1)
and corneal##2##2##(2008-11#1)(2008-4#1)
and corona radiata##2##3##(2008-12#1)(2008-7#1)
and coronal##5##2##(1995-5#1)(1997-8#1)(2008-10#1)(2013-1#2)
and coronary arteries##4##3##(1994-11#1)(1997-8#1)(2008-7#1)(2010-10#1)
and coronary artery bypass grafting##3##5##(2006-8#1)(2008-8#2)
and coronary artery bypass##4##4##(2006-8#1)(2008-11#1)(2008-8#2)
and coronary artery disease##5##4##(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#2)
and coronary artery##11##3##(1997-8#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)(2013-1#2)
and coronary disease##2##3##(1991-11#1)(2013-1#1)
and coronary events##2##3##(1990-5#1)(2010-9#1)
and coronary heart disease##11##4##(1990-3#1)(1993-2#2)(2008-11#3)(2008-12#1)(2008-3#1)(2009-12#1)(2012-2#1)(2012-3#1)
and coronary##48##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-9#2)(1992-4#1)(1993-2#2)(1994-11#2)(1995-2#1)(1996-8#1)(1997-8#3)(2006-8#1)(2007-7#1)(2007-8#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#2)(2009-12#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
and corporate##4##2##(1993-1#2)(2008-10#1)(2008-11#1)
and corpulence##2##2##(2012-2#2)
and corpus luteum##3##3##(1992-11#1)(2008-9#1)(2010-3#1)
and corpus##5##2##(1992-11#1)(1997-1#1)(1997-2#1)(2008-9#1)(2010-3#1)
and correct##9##2##(1993-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
and corrected for##2##3##(1992-10#1)(2008-10#1)
and corrected##8##2##(1992-10#1)(1994-6#1)(2008-10#4)(2008-2#1)(2008-3#1)
and correcting##2##2##(1997-2#1)(2008-5#1)
and correction for##2##3##(2008-3#1)(2008-5#1)
and correction of the##2##4##(1994-11#1)(2007-8#1)
and correction of##7##3##(1994-11#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-7#1)
and correction##13##2##(1994-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
and correctly##5##2##(1992-2#1)(1995-6#1)(2008-10#2)(2008-11#1)
and corrects##2##2##(2007-12#1)(2008-6#1)
and correlate##4##2##(1993-8#1)(2008-9#1)(2011-2#2)
and correlated the##2##3##(2006-12#1)(2008-3#1)
and correlated these##2##3##(1993-2#1)(2013-1#1)
and correlated to##3##3##(1990-9#1)(2008-10#2)
and correlated with the##4##4##(1995-11#1)(2007-10#1)(2007-11#2)
and correlated with##15##3##(1990-12#1)(1994-3#1)(1995-11#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2008-10#3)(2010-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
and correlated##32##2##(1990-12#1)(1990-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
and correlates of leprosy stigma##2##5##(2009-5#2)
and correlates of##10##3##(1995-11#1)(2009-5#2)(2010-4#1)(2011-2#1)(2013-1#4)(2013-8#1)
and correlates with##4##3##(1996-5#1)(2008-11#1)(2012-2#1)(2013-1#1)
and correlates##19##2##(1992-9#1)(1993-3#1)(1995-11#1)(1996-5#1)(2008-11#1)(2008-7#1)(2009-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
and correlating##2##2##(2008-12#1)(2008-2#1)
and correlation coefficient of##2##4##(2008-10#1)(2010-8#1)
and correlation coefficient##3##3##(2008-10#1)(2010-8#2)
and correlation of##2##3##(1995-3#1)(2007-12#1)
and correlation with##7##3##(1992-8#1)(1993-9#1)(1994-11#1)(1996-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
and correlation##19##2##(1992-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
and correlations with##2##3##(1993-2#1)(2009-4#1)
and correlations##7##2##(1993-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
and correlative##3##2##(1993-5#1)(2011-2#2)
and correspond to##3##3##(1990-5#1)(1994-9#1)(2008-5#1)
and corresponded to a##2##4##(2008-10#2)
and corresponded to##3##3##(2008-10#2)(2012-3#1)
and corresponded##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
and corresponding##21##2##(1990-5#1)(1992-10#1)(1992-3#1)(1992-8#1)(1995-9#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-3#2)(2008-8#1)(2009-10#2)(2011-1#1)(2011-2#1)
and correspondingly##2##2##(1993-3#1)(2008-10#1)
and corresponds to a##2##4##(1995-8#1)(2009-12#1)
and corresponds to the##2##4##(1996-2#1)(2009-7#1)
and corresponds to##5##3##(1991-11#1)(1995-8#1)(1996-2#1)(2009-12#1)(2009-7#1)
and cortex##8##2##(1991-5#1)(1994-2#2)(1995-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
and cortical bone##2##3##(2007-11#1)(2008-8#1)
and cortical cells##5##3##(1996-12#1)(2008-10#3)(2008-9#1)
and cortical slices##2##3##(1990-7#1)(1995-12#1)
and cortical##32##2##(1990-5#1)(1990-7#1)(1991-10#3)(1991-12#1)(1991-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-5#3)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and corticosteroids are##2##3##(2008-7#1)(2010-1#1)
and corticosteroids##8##2##(1997-1#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-3#1)(2012-3#1)
and corticosterone##8##2##(1990-11#1)(1995-12#1)(1996-12#5)(2008-4#1)
and cortisol levels##3##3##(2008-3#1)(2008-6#2)
and cortisol were##3##3##(1995-11#1)(2008-6#1)(2011-2#1)
and cortisol##19##2##(1995-11#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#3)(2010-2#1)(2011-2#2)(2013-1#2)(2013-8#1)
and cosine##3##2##(2007-12#3)
and cosmesis##3##2##(1994-6#1)(2007-12#1)(2012-2#1)
and cosmetic outcomes##2##3##(2009-5#1)(2012-12#1)
and cosmetic product##2##3##(2008-5#2)
and cosmetic##15##2##(1993-5#1)(2007-11#1)(2008-11#1)(2008-5#8)(2009-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
and cosmetically active##2##3##(2008-11#1)(2008-5#1)
and cosmetics##4##2##(2008-10#1)(2008-5#2)(2010-4#1)
and cosmid##3##2##(1993-3#1)(1994-11#1)(2008-4#1)
and cost containment##7##3##(1991-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-9#1)
and cost control##3##3##(1994-1#1)(1994-12#1)(2008-11#1)
and cost data##2##3##(2007-10#1)(2008-1#1)
and cost effective in##2##4##(2008-11#1)(2011-2#1)
and cost effective##13##3##(1992-3#1)(1996-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-9#1)(2011-2#1)(2012-2#1)
and cost effectiveness of##3##4##(1993-12#1)(2007-12#1)(2010-2#1)
and cost effectiveness##10##3##(1993-12#1)(1995-1#2)(2007-12#1)(2008-1#2)(2008-11#1)(2010-2#1)(2010-7#1)(2013-1#1)
and cost efficient##2##3##(1991-12#1)(2008-5#1)
and cost factors##2##3##(1992-2#1)(1994-1#1)
and cost in##3##3##(2008-10#1)(2008-7#2)
and cost of care##5##4##(1992-3#1)(1996-1#1)(2008-11#1)(2012-2#1)(2012-3#1)
and cost of##14##3##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-3#2)(1996-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
and cost per HCC prevented##2##5##(2009-8#2)
and cost per##3##3##(1995-12#1)(2009-8#2)
and cost reduction##2##3##(1996-2#1)(1997-2#1)
and cost saving##2##3##(2007-8#1)(2008-10#1)
and cost savings##5##3##(1994-3#1)(1997-2#2)(2008-10#1)(2013-1#1)
and cost to##2##3##(2008-7#1)(2008-8#1)
and cost##118##2##(1991-12#4)(1991-2#1)(1991-3#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#3)(1994-3#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#2)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#1)(1997-2#6)(1997-3#2)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#13)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-8#3)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
and cost-benefit analysis##2##3##(1992-3#1)(2008-4#1)
and cost-benefit ratios##2##3##(2009-4#2)
and cost-benefit##5##2##(1992-3#1)(2008-4#1)(2008-7#1)(2009-4#2)
and cost-effective means of##2##4##(2008-6#1)(2008-9#1)
and cost-effective use of##2##4##(1994-3#1)(1997-3#1)
and cost-effective##31##2##(1992-2#1)(1994-11#1)(1994-3#3)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
and cost-effectiveness is##2##3##(1995-2#1)(2009-5#1)
and cost-effectiveness of##4##3##(1993-11#1)(1994-9#1)(1997-1#1)(2011-2#1)
and cost-effectiveness##12##2##(1992-12#1)(1993-11#1)(1994-9#1)(1995-2#2)(1997-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-6#1)(2011-2#2)
and cost-efficient##3##2##(1991-2#1)(1997-1#1)(2008-11#1)
and costimulatory molecules##2##3##(2007-12#1)(2008-4#1)
and costly##12##2##(1990-11#1)(1991-12#1)(1994-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-5#1)(2010-8#1)(2012-12#2)
and costs associated with##2##4##(1997-2#2)
and costs in##3##3##(1994-6#1)(1995-2#1)(2009-11#1)
and costs of##13##3##(1990-12#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-9#1)(2011-2#2)
and costs vary##2##3##(1996-3#1)(2008-8#1)
and costs##44##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
and cotransfection of##2##3##(1995-2#1)(2008-2#1)
and cotton root##2##3##(2008-10#2)
and cotton square##2##3##(2011-2#2)
and cotton##15##2##(2007-6#1)(2008-10#9)(2011-2#5)
and cotyledonary##3##2##(2008-12#2)(2013-8#1)
and cotyledons##2##2##(2008-10#2)
and cough with##2##3##(1995-8#1)(2008-1#1)
and cough##7##2##(1995-8#1)(1997-1#2)(2007-8#1)(2008-1#1)(2010-4#1)(2013-1#1)
and coughing##4##2##(1990-3#1)(1992-6#1)(1993-1#1)(2008-5#1)
and could account for the##3##5##(2008-5#2)(2009-11#1)
and could also be##2##4##(1995-12#1)(2008-11#1)
and could also##4##3##(1991-2#1)(1995-11#1)(1995-12#1)(2008-11#1)
and could be easily reused over##2##6##(2008-10#2)
and could be easily##3##4##(2008-10#2)(2008-12#1)
and could be explained by##3##5##(1993-1#1)(1995-12#1)(2008-11#1)
and could be induced##2##4##(1994-2#1)(2009-12#1)
and could be interpreted##2##4##(1993-9#1)(1994-5#1)
and could be observed##2##4##(2008-1#1)(2008-9#1)
and could be used as a##4##6##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
and could be used as##6##5##(1995-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
and could be used for##3##5##(2008-10#2)(2008-11#1)
and could be used in a pH range of 2##4##10##(2008-10#4)
and could be used in a pH range of##5##9##(2008-10#5)
and could be used in the##2##6##(2008-10#2)
and could be used in##8##5##(2008-10#8)
and could be used to##5##5##(1997-4#1)(2008-10#3)(2008-11#1)
and could be used##24##4##(1995-11#1)(1997-4#1)(2008-10#14)(2008-11#2)(2008-12#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and could be useful##2##4##(2008-4#1)(2008-5#1)
and could be##78##3##(1990-11#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
and could bind##3##3##(1990-8#1)(1994-5#1)(2010-12#1)
and could contribute to the##3##5##(1994-2#1)(2008-5#1)(2010-2#1)
and could contribute to##4##4##(1994-2#1)(2008-10#1)(2008-5#1)(2010-2#1)
and could detect##4##3##(1997-5#1)(2008-10#2)(2013-1#1)
and could further be##2##4##(1997-6#1)(2011-1#1)
and could have##3##3##(2007-10#1)(2008-1#1)(2008-7#1)
and could inhibit##2##3##(2008-11#1)(2012-3#1)
and could lead to the##2##5##(2010-12#1)(2011-2#1)
and could lead to##4##4##(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#1)
and could not be##4##4##(1994-8#1)(1997-3#1)(2008-10#2)
and could not produce##2##4##(2008-8#1)(2012-12#1)
and could not##12##3##(1990-10#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-3#1)(2012-12#1)
and could provide##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
and could serve as a##2##5##(2008-10#1)(2008-11#1)
and could serve as##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and could serve##4##3##(2008-10#1)(2008-11#1)(2011-2#2)
and could therefore be##4##4##(1990-8#1)(1992-11#1)(2008-10#1)(2010-12#1)
and could therefore##7##3##(1990-11#1)(1990-8#1)(1992-11#1)(2008-10#2)(2008-8#1)(2010-12#1)
and could thus##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
and could##174##2##(1990-10#1)(1990-11#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-11#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#46)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#3)
and counsel##3##2##(1993-2#1)(1997-6#1)(2008-10#1)
and counseling employees##3##3##(1993-1#1)(1993-2#2)
and counseling##11##2##(1991-6#1)(1993-1#1)(1993-2#2)(1994-2#1)(1997-4#1)(1997-5#2)(2008-7#1)(2010-12#1)(2012-12#1)
and counselling##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
and count##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
and counted the##2##3##(2008-5#1)(2008-7#1)
and counted##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
and counter##3##2##(2008-1#1)(2008-10#1)(2010-6#1)
and counteracted by##2##3##(1990-5#1)(1992-9#1)
and counteracted##4##2##(1990-5#1)(1992-9#1)(2008-10#1)(2013-1#1)
and countercurrent##4##2##(2008-10#2)(2013-1#2)
and counterpropagating##4##2##(2007-11#3)(2007-12#1)
and counting##6##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#1)
and countries##5##2##(1990-11#1)(1991-8#1)(1994-3#1)(2010-10#1)(2012-2#1)
and country##16##2##(1992-3#1)(1993-1#2)(2007-8#12)(2012-12#1)
and counts##3##2##(1997-6#1)(2008-10#1)(2011-1#1)
and county population##2##3##(2009-7#1)(2010-9#1)
and county##5##2##(1997-5#1)(2008-11#1)(2009-7#1)(2010-10#1)(2010-9#1)
and couple##4##2##(2007-12#1)(2008-10#1)(2012-2#2)
and coupled gas chromatography-electroantennographic detection##2##5##(2008-10#2)
and coupled with##4##3##(1992-6#1)(2008-10#2)(2008-3#1)
and coupled##8##2##(1992-6#1)(2008-10#5)(2008-3#1)(2008-4#1)
and couples##4##2##(1994-7#1)(2008-11#1)(2008-8#1)(2009-7#1)
and coupling constants##2##3##(1992-3#1)(2008-3#1)
and coupling of##4##3##(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#1)
and coupling to##2##3##(2007-11#1)(2008-3#1)
and coupling with##3##3##(2008-10#2)(2010-5#1)
and coupling##19##2##(1992-3#1)(1994-3#1)(1995-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2010-5#1)
and course of the disease##2##5##(1994-11#1)(2008-7#1)
and course of the##5##4##(1994-11#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
and course of##8##3##(1994-11#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)
and course##11##2##(1994-11#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#2)
and courses##2##2##(1991-2#1)(2013-1#1)
and covalent binding##3##3##(1995-6#3)
and covalent##4##2##(1992-9#1)(1995-6#3)
and covalently##3##2##(2008-10#1)(2008-5#2)
and covariance##2##2##(1995-2#1)(2008-4#1)
and cover the##3##3##(1992-6#1)(2012-12#1)(2012-3#1)
and cover##5##2##(1992-6#1)(1996-5#1)(1996-6#1)(2012-12#1)(2012-3#1)
and coverage of##2##3##(1991-1#1)(2011-2#1)
and coverage probability##2##3##(1995-2#1)(2012-1#1)
and coverage##10##2##(1991-1#1)(1992-1#1)(1995-2#1)(2008-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#1)
and covered the##2##3##(2008-10#1)(2008-6#1)
and covered with##4##3##(2008-10#3)(2012-2#1)
and covered##12##2##(1996-10#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-6#1)(2012-2#1)
and covering the##2##3##(1992-3#1)(2007-12#1)
and covering##9##2##(1992-3#1)(1997-3#1)(2007-12#1)(2008-10#4)(2012-2#1)(2012-3#1)
and covers the##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
and covers##5##2##(1995-2#1)(2007-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
and covert##3##2##(1995-12#1)(2010-5#1)(2012-1#1)
and cow##3##2##(1991-6#1)(1994-12#1)(1994-5#1)
and coworkers##4##2##(1990-11#1)(1995-6#1)(1997-8#1)(2010-8#1)
and cowpea##3##2##(2008-10#3)
and cows##4##2##(1997-4#1)(2007-11#1)(2013-1#2)
and coxII##3##2##(2008-10#3)
and crack##3##2##(2008-10#1)(2009-6#1)(2012-1#1)
and cranial and nasal bones##2##5##(1997-3#2)
and cranial base##2##3##(2007-12#1)(2011-2#1)
and cranial##5##2##(1997-3#2)(2007-12#1)(2010-12#1)(2011-2#1)
and craniofacial##3##2##(2007-12#1)(2009-2#1)(2013-1#1)
and cream gel##2##3##(2008-5#2)
and cream##3##2##(2008-5#2)(2008-6#1)
and create a##6##3##(1996-1#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-1#1)
and create an##2##3##(2008-9#1)(2012-12#1)
and create new##2##3##(2008-1#1)(2008-10#1)
and create##14##2##(1996-1#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
and created a##4##3##(1992-2#1)(1994-12#1)(2008-5#1)(2008-7#1)
and created##7##2##(1992-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
and creates a##2##3##(1992-12#1)(2009-5#1)
and creates##4##2##(1992-12#2)(1997-6#1)(2009-5#1)
and creatine##4##2##(1990-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
and creating the##2##3##(1996-12#1)(2008-4#1)
and creating##9##2##(1994-3#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-3#1)(2010-4#1)(2010-8#1)
and creatinine in urine##3##4##(1990-8#1)(2008-10#2)
and creatinine##19##2##(1990-8#1)(1995-11#2)(1997-2#1)(2008-1#2)(2008-10#7)(2008-4#2)(2008-7#2)(2010-4#1)(2011-2#1)
and creation of##4##3##(1995-2#1)(2008-10#1)(2010-9#1)(2013-1#1)
and creative financing##2##3##(1993-2#1)(1996-1#1)
and creative##6##2##(1993-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-11#1)(2013-1#1)
and creativity##2##2##(1994-2#1)(2008-11#1)
and credentialing##2##2##(1994-2#1)(1995-3#1)
and credibility##2##2##(2008-11#1)(2009-11#1)
and creep##4##2##(2009-4#1)(2009-9#3)
and crib death in##2##4##(1990-11#1)(1992-4#1)
and criminal justice##3##3##(1996-1#1)(2008-6#1)(2009-9#1)
and criminal##5##2##(1996-1#1)(2008-6#2)(2009-9#1)(2013-8#1)
and criminality##2##2##(1996-6#1)(2008-2#1)
and crises##4##2##(1993-3#1)(1996-3#1)(2008-12#1)(2008-7#1)
and crisis##4##2##(1992-1#1)(1993-3#1)(2008-12#1)(2013-1#1)
and cristae abundance##2##3##(2012-3#2)
and cristae##3##2##(2012-3#3)
and criteria for##5##3##(1992-12#1)(2008-10#2)(2008-12#1)(2008-9#1)
and criteria of##3##3##(1990-6#1)(1991-2#1)(1997-3#1)
and criteria##12##2##(1990-6#1)(1991-2#1)(1992-12#1)(1993-12#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)
and criterion##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
and critical evaluation of##2##4##(2008-12#1)(2013-1#1)
and critical flicker frequency threshold##2##5##(2012-1#2)
and critical flicker frequency##3##4##(2012-1#3)
and critical review of##2##4##(2008-3#1)(2011-2#1)
and critical thinking##2##3##(2008-11#1)(2008-12#1)
and critical##29##2##(1995-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
and critically##8##2##(1996-3#1)(1996-9#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-6#1)
and critique##3##2##(1993-6#1)(1995-1#1)(2008-4#1)
and critiques of##2##3##(2008-11#1)(2012-3#1)
and critiquing##2##2##(2008-11#1)(2008-12#1)
and crop yields##3##3##(2008-12#3)
and crop##12##2##(2008-10#6)(2008-12#3)(2008-2#1)(2012-1#1)(2012-3#1)
and cropping##4##2##(2008-10#4)
and cross section##2##3##(2008-3#1)(2008-5#1)
and cross##10##2##(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-5#1)
and cross-clamping##2##2##(2012-3#2)
and cross-correlation##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and cross-cultural##2##2##(2008-12#1)(2013-1#1)
and cross-link##2##2##(1993-11#1)(2010-4#1)
and cross-linked##5##2##(1995-3#1)(1997-2#1)(2008-10#2)(2008-2#1)
and cross-linking##9##2##(1992-3#1)(1993-11#1)(2008-10#4)(2008-5#2)(2009-7#1)
and cross-phase modulation##2##3##(2007-11#1)(2007-12#1)
and cross-polarization##2##2##(2008-10#1)(2008-3#1)
and cross-reactivity##2##2##(2008-10#1)(2009-12#1)
and cross-sectional##5##2##(1994-3#1)(2008-10#2)(2009-3#1)(2011-2#1)
and cross-validated##2##2##(2007-12#1)(2009-3#1)
and cross-validation##2##2##(2008-12#1)(2012-2#1)
and crosslinkable##2##2##(2008-10#1)(2009-7#1)
and crosslinking##2##2##(2008-10#1)(2008-9#1)
and crown rot##3##3##(2008-10#3)
and crown##6##2##(2008-10#6)
and crucial##2##2##(2009-8#1)(2012-12#1)
and crucian carp##3##3##(2008-9#3)
and crude protein##2##3##(2008-12#1)(2010-2#1)
and crude##3##2##(2008-12#1)(2009-6#1)(2010-2#1)
and crusting##2##2##(2007-7#1)(2008-2#1)
and crystal violet##3##3##(1991-8#1)(2008-12#1)(2008-8#1)
and crystal##13##2##(1991-8#1)(1992-8#2)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-8#1)(2009-7#1)
and crystalline##7##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)
and crystallization##2##2##(2008-10#1)(2013-8#1)
and crystallographic##2##2##(1992-8#1)(1995-5#1)
and ctr-EGR-Xa##2##2##(1994-5#2)
and cubic##8##2##(1995-3#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)
and cucumber##2##2##(2008-10#2)
and cue##2##2##(1993-12#1)(2011-2#1)
and cuffed hemodialysis catheters##3##4##(2007-7#3)
and cultivar of##2##3##(2008-10#2)
and cultivar##7##2##(2008-10#7)
and cultivars of##3##3##(2008-10#2)(2008-12#1)
and cultivars with##2##3##(2008-10#2)
and cultivars##10##2##(2008-10#8)(2008-12#1)(2008-8#1)
and cultivated##10##2##(2008-10#7)(2008-11#1)(2008-6#1)(2013-8#1)
and cultivation of##2##3##(1997-7#1)(2008-5#1)
and cultivation##5##2##(1994-3#1)(1997-7#1)(2008-11#2)(2008-5#1)
and cultural factors were identified##2##5##(2010-3#1)(2012-12#1)
and cultural factors##3##3##(1995-12#1)(2010-3#1)(2012-12#1)
and cultural origin##3##3##(1991-11#1)(2011-2#1)(2012-2#1)
and cultural practices##3##3##(2008-1#1)(2008-10#1)(2009-7#1)
and cultural##47##2##(1990-3#1)(1991-11#1)(1993-11#1)(1995-12#2)(1995-5#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-7#2)(2009-9#1)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and culturally sensitive##2##3##(2010-9#1)(2011-1#1)
and culturally##6##2##(2008-1#1)(2009-5#1)(2010-9#1)(2011-1#3)
and culture in##2##3##(2008-9#1)(2013-8#1)
and culture of human##2##4##(2008-2#1)(2008-9#1)
and culture of##8##3##(2007-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#2)
and culture supernatant##2##3##(1992-12#1)(1993-9#1)
and culture##35##2##(1991-12#1)(1992-12#1)(1993-9#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-10#2)(2008-11#8)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2013-8#2)
and culture-independent##2##2##(2008-10#1)(2012-2#1)
and cultured cells##3##3##(1993-12#1)(2010-2#1)(2013-1#1)
and cultured for##3##3##(1993-3#1)(1995-8#1)(2008-5#1)
and cultured human##2##3##(1991-12#1)(1996-5#1)
and cultured in the presence of##2##6##(2008-4#1)(2011-3#1)
and cultured in vitro##2##4##(2008-5#1)(2008-7#1)
and cultured in##9##3##(1994-9#1)(1995-8#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-11#1)(2011-3#1)
and cultured neuronal##2##3##(1997-2#2)
and cultured on##2##3##(1993-3#1)(2008-10#1)
and cultured with##2##3##(2007-2#1)(2008-6#1)
and cultured##28##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#2)(1994-9#1)(1995-8#3)(1996-5#1)(1997-2#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-4#1)(2012-5#1)(2013-1#2)
and cultures of##2##3##(1991-5#1)(2008-5#1)
and cultures were##2##3##(2008-5#2)
and cultures##13##2##(1991-5#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#4)(2010-10#1)(2013-8#1)
and culturing##3##2##(1992-5#1)(2008-4#1)(2008-8#1)
and cumbersome##4##2##(1990-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
and cumulative##15##2##(2008-10#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
and cuneate fasciculus##2##3##(1996-5#2)
and curation##2##2##(2008-7#1)(2012-1#1)
and curative##3##2##(1993-3#1)(2008-2#1)(2008-7#1)
and curcumin##4##2##(1992-9#2)(1994-8#2)
and cure##8##2##(1996-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-5#1)(2013-1#1)(2013-8#1)
and cured##2##2##(2010-3#1)(2012-12#1)
and cures##2##2##(1990-4#1)(1995-10#1)
and curettage (D&amp##2##3##(1995-3#1)(2012-2#1)
and curettage in##2##3##(1992-12#1)(2008-6#1)
and curettage##9##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1995-3#1)(2008-6#1)(2009-4#1)(2011-1#1)(2012-2#1)
and curing##3##2##(2008-12#1)(2008-3#1)(2013-1#1)
and current perspectives##2##3##(1996-12#1)(2008-11#1)
and current recommendations##2##3##(2008-1#1)(2009-4#1)
and current research##3##3##(1990-11#1)(1995-8#1)(2012-2#1)
and current status of##3##4##(1991-1#1)(1997-3#1)(2009-12#1)
and current status##4##3##(1991-1#1)(1991-12#1)(1997-3#1)(2009-12#1)
and current trends##2##3##(2007-11#1)(2013-1#1)
and current use of##3##4##(2008-11#1)(2008-4#1)(2013-8#1)
and current views on##2##4##(2007-11#1)(2010-3#1)
and current##73##2##(1990-11#2)(1991-1#1)(1991-12#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#10)
and currently available##2##3##(2008-5#1)(2010-11#1)
and currently##8##2##(2008-10#2)(2008-5#2)(2008-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
and curriculum##5##2##(1993-2#2)(1997-2#1)(2008-12#1)(2009-8#1)
and curvature of##2##3##(2008-9#1)(2009-11#1)
and curvature##4##2##(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#1)
and curve##2##2##(2008-10#2)
and custom##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
and customary##2##2##(1991-2#1)(1991-3#1)
and customer##5##2##(1992-1#1)(1993-1#1)(1993-12#1)(1995-3#1)(2013-8#1)
and customizing##2##2##(2008-10#1)(2010-8#1)
and cut##6##2##(1994-3#1)(2008-1#1)(2008-4#1)(2010-4#1)(2010-8#1)(2013-8#1)
and cutaneous lesions##2##3##(2008-5#2)
and cutaneous##14##2##(1997-3#1)(2006-10#1)(2007-8#1)(2008-5#6)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and cuticle##3##2##(2007-12#1)(2008-10#1)(2009-8#1)
and cuts in##2##3##(1997-2#1)(2007-11#1)
and cutting##2##2##(2008-1#1)(2008-11#1)
and cv##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
and cw##2##2##(2008-2#2)
and cyan fluorescent proteins##2##4##(2008-10#1)(2008-9#1)
and cyanobacteria##2##2##(2009-4#1)(2011-2#1)
and cyanobacterial##2##2##(2008-10#2)
and cycle##4##2##(2008-10#1)(2008-7#1)(2009-10#1)(2010-4#1)
and cyclic AMP##3##3##(1992-9#2)(1997-1#1)
and cyclic AMP-dependent protein kinase##2##5##(1993-8#1)(1995-11#1)
and cyclic voltammetric##2##3##(2008-10#1)(2009-9#1)
and cyclic voltammetry (CV)##2##4##(2008-10#2)
and cyclic voltammetry##11##3##(2008-10#9)(2008-4#2)
and cyclic##33##2##(1990-5#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-3#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#11)(2008-4#3)(2009-10#1)(2009-7#2)(2009-9#1)(2010-4#2)
and cyclin##5##2##(1994-11#1)(1997-1#1)(1997-6#1)(2010-6#1)(2013-1#1)
and cyclin-dependent kinase 2##2##4##(2012-3#2)
and cyclin-dependent kinase##4##3##(1994-11#1)(2011-2#1)(2012-3#2)
and cyclization##3##2##(1992-6#1)(2008-6#2)
and cyclo-1##3##2##(2008-10#3)
and cyclohexane##4##2##(2008-10#4)
and cyclohexanone##5##2##(2008-10#5)
and cycloheximide##7##2##(1991-5#1)(1993-12#1)(1994-12#1)(1994-9#3)(2008-10#1)
and cyclooxygenase##5##2##(1994-9#1)(2008-11#3)(2008-7#1)
and cyclophosphamide in##3##3##(1993-2#1)(1997-8#1)(2008-1#1)
and cyclophosphamide plus##2##3##(1991-8#1)(1993-2#1)
and cyclophosphamide treatment##2##3##(1993-2#1)(2008-7#1)
and cyclophosphamide##13##2##(1990-10#1)(1991-8#2)(1993-2#3)(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-3#1)
and cyclosporin##4##2##(1991-5#1)(2008-11#1)(2012-3#2)
and cyclosporine##6##2##(2006-10#1)(2007-7#1)(2008-1#3)(2013-1#1)
and cyclotetrasiloxane##6##2##(2008-5#6)
and cylinders##2##2##(2008-3#2)
and cylindrical##5##2##(1995-5#1)(2008-10#1)(2008-3#2)(2008-7#1)
and cypermethrin##2##2##(2007-10#2)
and cyst##8##2##(1996-3#1)(2008-10#4)(2008-5#1)(2012-2#2)
and cysteamine##2##2##(1995-8#2)
and cysteine in##2##3##(2008-10#1)(2011-2#1)
and cysteine rich##2##3##(1997-7#2)
and cysteine##13##2##(1991-9#2)(1992-12#1)(1997-7#2)(2008-10#5)(2008-5#1)(2011-2#2)
and cystic fibrosis##2##3##(2008-5#1)(2009-1#1)
and cystic##6##2##(1994-9#2)(1997-3#1)(2008-5#1)(2009-1#1)(2013-1#1)
and cystine##10##2##(1991-5#3)(1997-4#1)(2008-10#4)(2008-11#2)
and cysts##2##2##(2008-10#1)(2008-12#1)
and cytochalasin B##2##3##(2008-8#1)(2008-9#1)
and cytochalasin##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
and cytochemical##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
and cytochrome c##2##3##(2008-10#2)
and cytochrome##12##2##(1990-11#1)(1994-5#1)(1994-6#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-7#1)
and cytocompatibility of##2##3##(2009-7#1)(2013-8#1)
and cytocompatibility##3##2##(2008-5#1)(2009-7#1)(2013-8#1)
and cytogenetic##9##2##(1993-8#2)(1994-12#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-3#1)
and cytokeratin 8##2##3##(2008-11#2)
and cytokine production in##4##4##(2008-10#2)(2008-4#1)(2010-12#1)
and cytokine production##11##3##(2008-10#3)(2008-11#2)(2008-4#1)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#1)
and cytokine secretion##2##3##(2008-10#1)(2008-4#1)
and cytokine##19##2##(1993-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2009-6#1)(2010-12#2)(2010-6#1)(2012-2#1)(2013-8#1)
and cytokines were##2##3##(1992-2#1)(2012-2#1)
and cytokines##20##2##(1991-3#1)(1992-2#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#2)(2006-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
and cytokinesis##4##2##(2008-7#1)(2009-9#1)(2011-1#1)(2013-1#1)
and cytologic##2##2##(1990-10#1)(1990-5#1)
and cytological##14##2##(1994-5#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
and cytologically##2##2##(1994-7#1)(2011-2#1)
and cytology##3##2##(1990-12#1)(1994-1#1)(2011-2#1)
and cytoplasm##9##2##(1990-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-7#1)(2012-12#1)
and cytoplasmic antigens##2##3##(2008-9#1)(2011-2#1)
and cytoplasmic domain##2##3##(1993-12#1)(1997-4#1)
and cytoplasmic domains##2##3##(1992-12#1)(2008-11#1)
and cytoplasmic vacuolization##2##3##(2008-10#1)(2008-9#1)
and cytoplasmic##34##2##(1990-8#1)(1991-11#2)(1991-5#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-2#1)(1997-4#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2011-2#3)(2013-8#1)
and cytosine##5##2##(1992-8#3)(2008-10#2)
and cytoskeleton##2##2##(2008-11#1)(2009-9#1)
and cytosol##5##2##(1991-2#1)(1993-8#1)(2008-7#1)(2008-9#2)
and cytosolic fractions##2##3##(1996-2#1)(1996-5#1)
and cytosolic free Ca2+##2##4##(1990-12#1)(1997-1#1)
and cytosolic free##3##3##(1990-12#1)(1997-1#2)
and cytosolic##10##2##(1990-12#2)(1991-8#1)(1992-8#2)(1995-11#1)(1996-2#1)(1996-5#1)(1997-1#2)
and cytostatics##2##2##(2008-11#1)(2011-1#1)
and cytotoxic T cells##2##4##(2008-10#2)
and cytotoxic T##3##3##(1992-2#1)(2008-10#2)
and cytotoxic agent##2##3##(2008-7#2)
and cytotoxic effects##2##3##(1997-4#1)(2009-12#1)
and cytotoxic##20##2##(1992-2#2)(1994-2#1)(1997-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
and cytotoxicity studies##2##3##(1993-5#1)(2008-11#1)
and cytotoxicity##9##2##(1993-5#1)(1994-8#2)(1997-2#1)(2008-11#2)(2008-9#1)(2013-1#2)
and d##10##2##(1992-6#3)(1993-11#1)(2007-11#1)(2008-11#1)(2008-3#4)
and d(s) is the##2##4##(2008-3#2)
and d)##5##2##(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
and daidzin are##2##3##(2008-11#2)
and daidzin##6##2##(2008-11#5)(2010-12#1)
and daily intake of pulses##2##5##(2008-10#2)
and daily##23##2##(1992-12#1)(1992-9#1)(1993-1#1)(1997-1#1)(2008-10#5)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
and dairy products##2##3##(2008-10#1)(2011-2#1)
and dairy##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
and damage to##2##3##(2009-10#1)(2013-1#1)
and damage##16##2##(1995-12#1)(1996-4#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and damaged##3##2##(1992-6#1)(2008-5#1)(2010-2#1)
and damages##2##2##(1995-12#1)(2013-7#1)
and damping-off##3##2##(2008-10#3)
and dams##2##2##(2010-4#2)
and dangerous##4##2##(2008-11#1)(2008-9#1)(2009-9#1)(2013-1#1)
and darbepoetin##2##2##(2008-7#2)
and dark decay##2##3##(2007-11#1)(2008-2#1)
and dark##14##2##(1991-5#2)(1992-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
and data acquisition##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)
and data analysis##5##3##(1997-3#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
and data capture##2##3##(2008-11#1)(2010-8#1)
and data collection##5##3##(1991-2#1)(1995-12#1)(1995-2#1)(2008-8#1)(2010-3#1)
and data from##9##3##(1995-5#1)(1996-3#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)
and data handling##2##3##(2008-2#1)(2008-4#1)
and data interpretation##5##3##(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#1)
and data on the##2##4##(1991-3#1)(2011-2#1)
and data on##6##3##(1991-3#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2011-2#1)
and data processing##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
and data systems were identified##2##5##(2013-8#2)
and data systems##4##3##(2013-8#4)
and data were analysed##2##4##(2012-3#2)
and data were##7##3##(1990-8#1)(2008-1#1)(2008-3#1)(2012-3#2)(2013-1#1)(2013-7#1)
and data##92##2##(1990-8#2)(1991-2#2)(1991-3#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-4#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#5)
and data-dependent system profilometry##2##4##(2008-3#2)
and data-dependent##3##2##(2008-3#3)
and data-driven##2##2##(1995-3#1)(2012-2#1)
and database##6##2##(1996-3#1)(1997-1#1)(2008-4#2)(2008-7#1)(2011-2#1)
and databases##9##2##(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
and date of##4##3##(1996-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
and date##6##2##(1996-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
and dating##2##2##(1994-9#1)(2010-1#1)
and daunomycin in##2##3##(2008-10#1)(2008-11#1)
and daunomycin##4##2##(1994-12#1)(2008-10#2)(2008-11#1)
and daunorubicin##5##2##(1991-2#1)(1993-11#1)(1993-6#1)(2007-4#2)
and day 10##3##3##(1994-2#2)(2007-8#1)
and day care##2##3##(1991-1#1)(2007-3#1)
and day##15##2##(1991-1#1)(1992-3#1)(1994-2#2)(1995-12#1)(1996-3#1)(1996-5#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-10#1)
and day-to-day##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
and days to anthesis##3##4##(2008-10#3)
and days to##4##3##(2008-10#4)
and days##6##2##(1994-3#1)(2008-10#4)(2008-3#1)
and daytime functioning in##2##4##(2010-7#2)
and daytime##8##2##(2008-10#2)(2008-3#1)(2008-8#1)(2010-7#4)
and db/db##2##2##(2008-3#1)(2012-3#1)
and ddCTP##2##2##(1994-11#2)
and de novo##9##3##(1993-11#1)(1994-12#1)(1995-12#1)(1997-1#1)(1997-5#1)(2008-4#1)(2009-12#1)(2009-9#1)(2013-1#1)
and de##12##2##(1990-4#1)(1993-11#1)(1994-12#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-4#1)(2009-12#1)(2009-9#1)(2013-1#2)
and deactivate##2##2##(1995-6#1)(2009-8#1)
and dead cells##2##3##(2008-11#1)(2008-8#1)
and dead##11##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-6#2)(2012-12#1)
and deaf##2##2##(2011-2#1)(2012-3#1)
and deafness##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
and dealing with the##3##4##(2008-10#2)(2011-2#1)
and dealing with##7##3##(1992-2#1)(1995-12#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)
and death and##2##3##(1993-12#1)(2008-12#1)
and death during##2##3##(1991-8#1)(1995-6#1)
and death in the##4##4##(1994-8#1)(2008-11#1)(2010-12#1)(2013-1#1)
and death in##12##3##(1994-8#1)(1997-4#1)(2007-8#1)(2008-11#3)(2010-12#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#1)
and death is##2##3##(2008-3#1)(2012-12#1)
and death of microsclerotia##2##4##(2008-10#2)
and death of plants##2##4##(2008-10#2)
and death of##10##3##(1993-3#1)(1997-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-3#1)
and death rates##2##3##(2008-8#1)(2009-12#1)
and death##83##2##(1991-11#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-5#1)(1992-6#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#4)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#3)(2009-4#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
and death)##2##2##(1995-12#1)(2008-10#1)
and deaths and##2##3##(2011-2#1)(2012-12#1)
and deaths##13##2##(1992-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-12#3)
and debate##8##2##(2007-12#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and debated##4##2##(1993-5#1)(2008-5#1)(2009-8#1)(2010-1#1)
and debilitating condition##3##3##(2008-1#1)(2008-5#1)(2008-6#1)
and debriefing##2##2##(2008-11#1)(2008-8#1)
and decay kinetics##2##3##(2008-10#1)(2011-2#1)
and decay##10##2##(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#1)
and decide##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
and deciphering##2##2##(1997-6#1)(2009-5#1)
and decision making in##2##4##(1997-3#1)(2013-7#1)
and decision making##6##3##(1990-3#1)(1997-3#1)(2007-10#1)(2007-8#1)(2013-1#1)(2013-7#1)
and decision processes##2##3##(2009-7#1)(2012-3#1)
and decision support##3##3##(1994-2#1)(2010-8#1)(2012-12#1)
and decision##19##2##(1990-3#1)(1991-12#1)(1994-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#2)(2009-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#2)
and decision-making##7##2##(1997-1#2)(2008-11#1)(2008-12#1)(2011-2#3)
and decisional##2##2##(2008-11#1)(2009-4#1)
and decisions about##2##3##(2008-1#1)(2010-12#1)
and decisions##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-3#1)
and decline in##2##3##(2010-12#1)(2013-8#1)
and decline over time##3##4##(2008-10#1)(2008-7#2)
and decline with##2##3##(2008-11#1)(2013-8#1)
and decline##8##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#2)
and declined rapidly##2##3##(1992-6#1)(2008-10#1)
and declined thereafter to##2##4##(1993-9#1)(2011-2#1)
and declined thereafter##4##3##(1993-9#2)(1994-11#1)(2011-2#1)
and declined##15##2##(1990-5#1)(1990-6#1)(1992-3#1)(1992-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
and declines##2##2##(1994-3#1)(2008-8#1)
and declining##5##2##(1991-3#1)(1992-3#1)(1995-6#1)(1995-9#1)(2009-10#1)
and decoders##2##2##(2008-2#1)(2008-3#1)
and decoding##6##2##(2008-2#3)(2008-3#3)
and decomposed##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
and decomposition rates##2##3##(2007-5#2)
and decomposition##3##2##(2007-5#2)(2008-10#1)
and decompression of##2##3##(2008-7#1)(2009-3#1)
and decompression##6##2##(1996-11#2)(2008-7#2)(2009-3#1)(2012-12#1)
and decontamination##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
and decortication##2##2##(2007-8#1)(2012-3#1)
and decrease at##2##3##(1992-7#2)
and decrease in##13##3##(1990-6#1)(1992-8#1)(1993-3#1)(2008-10#1)(2008-12#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
and decrease of pain##2##4##(2007-11#2)
and decrease of##11##3##(1993-1#1)(1993-12#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
and decrease the risk of##2##5##(2007-8#1)(2011-2#1)
and decrease the##6##3##(2007-8#1)(2008-10#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
and decrease their##2##3##(1993-2#1)(2008-11#1)
and decrease to##2##3##(1993-11#1)(2008-10#1)
and decrease##56##2##(1990-6#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(2007-11#3)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and decreased after##2##3##(2008-2#1)(2012-3#1)
and decreased expression of##2##4##(2011-2#2)
and decreased in##2##3##(1997-2#1)(2008-10#1)
and decreased leaf growth##2##4##(2013-1#2)
and decreased risk of##2##4##(2007-8#1)(2009-11#1)
and decreased significantly##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
and decreased the##9##3##(1992-2#1)(1993-6#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
and decreased to the##2##4##(1993-8#1)(2008-10#1)
and decreased to##4##3##(1993-11#1)(1993-8#1)(2007-12#1)(2008-10#1)
and decreased ventilatory capacity##2##4##(2013-7#2)
and decreased with increasing age##2##5##(1992-6#2)
and decreased with increasing##6##4##(1990-12#1)(1992-3#1)(1992-6#2)(1996-12#1)(2008-10#1)
and decreased with##7##3##(1990-12#1)(1992-3#1)(1992-6#2)(1996-12#1)(2008-10#1)(2013-3#1)
and decreased##116##2##(1990-12#1)(1990-7#2)(1991-1#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#8)(2013-3#1)(2013-7#3)
and decreases in##9##3##(1994-12#2)(1996-7#1)(1997-2#1)(2008-11#2)(2011-2#1)(2012-3#2)
and decreases the##6##3##(1993-11#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
and decreases##25##2##(1993-11#1)(1993-2#1)(1994-12#2)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#2)
and decreasing of the##2##4##(2008-10#1)(2008-7#1)
and decreasing reimbursements##2##3##(2010-9#1)(2011-7#1)
and decreasing the##5##3##(1994-12#1)(1995-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
and decreasing##25##2##(1992-3#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-8#3)(2010-9#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#1)
and dedicated##4##2##(1992-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
and dedifferentiated##2##2##(2010-3#1)(2011-2#1)
and deduced amino acid sequences of##3##6##(1993-12#1)(1993-2#1)(1996-10#1)
and deduced amino acid sequences##5##5##(1992-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1996-10#1)
and deduced amino acid##6##4##(1992-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1996-10#1)(2008-11#1)
and deduced##11##2##(1992-10#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#3)(1996-10#1)(2008-10#1)(2008-11#1)
and deep venous thrombosis##2##4##(1996-6#1)(2008-3#1)
and deep##34##2##(1993-12#3)(1995-12#1)(1995-3#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)
and deeper##3##2##(1995-3#1)(2008-9#1)(2011-7#1)
and default##3##2##(2009-5#1)(2013-8#2)
and defective##3##2##(1991-7#1)(1991-8#1)(2011-2#1)
and defects in##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
and defects##4##2##(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
and defense##8##2##(1991-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#3)(2010-10#1)
and defensive##2##2##(2008-4#1)(2008-9#1)
and defibrillators##3##2##(2009-10#2)(2010-6#1)
and deficiency##5##2##(1997-7#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-7#1)
and deficient##4##2##(1992-3#1)(1994-5#1)(2008-6#1)(2012-3#1)
and deficits in##4##3##(1995-3#1)(2008-11#1)(2012-12#1)(2013-1#1)
and deficits##5##2##(1995-3#1)(1997-6#1)(2008-11#1)(2012-12#1)(2013-1#1)
and define the##4##3##(1991-2#1)(2008-7#3)
and define##8##2##(1991-2#1)(1994-8#1)(1996-3#1)(2008-7#3)(2008-9#1)(2011-2#1)
and defined as the##2##4##(2007-9#1)(2008-10#1)
and defined by##2##3##(2008-3#1)(2008-7#1)
and defined in##2##3##(2008-7#1)(2008-8#1)
and defined##12##2##(1991-1#1)(1991-2#1)(1995-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
and defines a##3##3##(1991-5#1)(2008-3#1)(2013-1#1)
and defines the##3##3##(1995-12#1)(1996-3#1)(2008-5#1)
and defines##7##2##(1991-5#1)(1995-12#1)(1996-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
and defining##6##2##(1993-12#1)(1993-2#1)(1995-9#1)(2008-2#1)(2008-4#1)(2008-7#1)
and definitely##2##2##(2008-10#1)(2012-3#1)
and definition##5##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
and definitions of##2##3##(1994-12#1)(2007-10#1)
and definitions##6##2##(1994-12#1)(1995-1#1)(1997-3#1)(2007-10#2)(2012-12#1)
and definitive treatment##3##3##(2008-9#1)(2010-12#1)(2011-2#1)
and definitive##9##2##(1991-2#1)(1994-8#1)(1995-8#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
and deflations##2##2##(1992-9#2)
and defocus##2##2##(2008-2#2)
and deformation of##2##3##(2007-12#1)(2008-8#1)
and deformation##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
and deformations##2##2##(1996-4#1)(2009-7#1)
and deformed##2##2##(2008-10#1)(2008-2#1)
and degenerate##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
and degeneration##3##2##(1997-5#1)(2011-2#1)(2012-1#1)
and degenerative and regenerative##2##4##(1994-5#2)
and degenerative changes in##2##4##(2013-1#2)
and degenerative changes##5##3##(1992-9#1)(2007-11#2)(2013-1#2)
and degenerative diseases##3##3##(1992-9#1)(2010-3#1)(2012-2#1)
and degenerative joint##2##3##(2011-2#2)
and degenerative##16##2##(1992-9#2)(1994-5#2)(2007-11#2)(2008-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)
and degradation by##2##3##(2008-9#1)(2013-8#1)
and degradation of the##3##4##(1993-3#1)(2008-7#1)(2011-2#1)
and degradation of##15##3##(1990-11#1)(1991-11#1)(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
and degradation processes##2##3##(2008-7#1)(2012-1#1)
and degradation products##4##3##(2008-10#3)(2012-2#1)
and degradation##36##2##(1990-11#1)(1991-11#1)(1993-3#2)(1994-11#2)(1995-6#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#5)(2013-1#1)(2013-8#4)
and degrade##2##2##(1995-8#1)(2008-1#1)
and degraded##5##2##(1995-2#1)(1995-6#2)(2008-8#1)(2012-2#1)
and degree of##25##3##(1993-11#1)(1996-11#1)(1997-3#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and degrees of##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and dehydration of##2##3##(1994-2#1)(2008-10#1)
and dehydration##4##2##(1990-11#1)(1994-2#1)(2007-2#1)(2008-10#1)
and dehydroascorbic acid##3##3##(1993-3#2)(2008-10#1)
and dehydroepiandrosterone##2##2##(1990-11#1)(2008-1#1)
and deionized water##2##3##(2007-12#1)(2008-10#1)
and delay in##2##3##(1994-3#1)(2013-1#1)
and delay##11##2##(1994-3#1)(1994-8#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-1#1)
and delayed gastric emptying##2##4##(1994-2#1)(2008-3#1)
and delayed neuronal death##2##4##(1990-7#2)
and delayed the##3##3##(1996-3#1)(2008-7#2)
and delayed transplantation##2##3##(2012-7#2)
and delayed##45##2##(1990-12#1)(1990-2#1)(1990-7#2)(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#6)(2009-10#1)(2009-2#1)(2010-4#1)(2012-7#3)(2013-1#1)(2013-8#1)
and delays in##2##3##(1997-2#1)(2007-11#1)
and delays the##7##3##(1993-11#1)(1994-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
and delays##11##2##(1993-11#1)(1994-8#2)(1995-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
and deleterious##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
and deletion analysis##2##3##(1995-8#1)(1997-6#1)
and deletion##7##2##(1995-6#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-7#1)
and deletions of##4##3##(1991-5#1)(1992-3#1)(2008-10#1)(2008-9#1)
and deletions##11##2##(1991-5#1)(1992-3#1)(1993-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
and deliberate##3##2##(1992-5#1)(2008-10#1)(2009-7#1)
and delineates##2##2##(1994-2#1)(2011-1#1)
and delineation##2##2##(2008-7#1)(2012-2#1)
and delinquency##3##2##(1994-2#1)(2012-12#2)
and delinquent behavior##5##3##(2008-11#1)(2009-7#2)(2009-8#2)
and delinquent##6##2##(2008-11#1)(2009-7#2)(2009-8#3)
and deliver##10##2##(1990-3#1)(1993-12#1)(2008-10#2)(2008-11#3)(2008-7#1)(2011-2#1)(2013-8#1)
and delivered##4##2##(1993-12#1)(1997-2#1)(2008-10#2)
and deliveries##2##2##(1991-3#1)(2011-1#1)
and delivering a##2##3##(1992-3#1)(2008-5#1)
and delivering##7##2##(1992-3#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)
and delivers##4##2##(2007-11#1)(2008-3#1)(2012-2#2)
and delivery and##3##3##(2008-10#1)(2010-4#1)(2012-12#1)
and delivery efficiency##3##3##(2008-10#2)(2013-1#1)
and delivery of health services##2##5##(1996-1#1)(2011-1#1)
and delivery of health##3##4##(1996-1#1)(1996-2#1)(2011-1#1)
and delivery of our nation's health services##2##7##(1996-12#1)(1997-2#1)
and delivery of##20##3##(1992-11#1)(1992-3#1)(1993-6#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-4#1)(2008-11#2)(2008-12#3)(2008-3#1)(2009-11#1)(2009-7#1)(2011-1#1)(2013-8#1)
and delivery system##2##3##(1992-3#1)(2008-8#1)
and delivery systems##5##3##(1993-12#1)(1993-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
and delivery##48##2##(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
and delta G degrees 37##2##5##(1991-8#2)
and delta H##2##3##(1994-5#1)(1995-5#1)
and delta Hion =##2##4##(1990-8#2)
and delta S)##3##3##(1990-7#2)(1993-8#1)
and delta subunit##2##3##(1996-12#2)
and delta##35##2##(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-8#2)(1992-5#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-5#2)(1996-12#2)(1996-2#1)(1997-2#1)(2008-2#1)(2008-8#4)(2009-7#4)(2011-1#1)
and delta-opioid receptors##2##3##(1993-3#1)(1996-2#1)
and delta-opioid##3##2##(1992-3#1)(1993-3#1)(1996-2#1)
and deltamethrin##5##2##(2008-10#3)(2011-2#1)(2012-12#1)
and delusions##4##2##(2009-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
and demand##6##2##(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(2008-7#1)(2011-2#1)
and demanding##2##2##(2011-2#1)(2012-2#1)
and demands##3##2##(2008-10#1)(2009-12#1)(2009-5#1)
and dementia in##2##3##(2008-7#1)(2013-1#1)
and dementia##12##2##(1990-3#1)(1991-12#1)(1991-3#1)(2008-6#2)(2008-7#3)(2009-8#1)(2012-12#1)(2013-1#2)
and demethylation##2##2##(1994-9#1)(2011-2#1)
and demographic characteristics of##2##4##(1992-12#1)(2010-3#1)
and demographic characteristics##4##3##(1992-12#1)(2007-12#1)(2008-7#1)(2010-3#1)
and demographic factors##7##3##(1992-6#1)(1993-2#1)(2008-7#1)(2012-12#1)(2013-1#3)
and demographic variables##2##3##(2012-12#1)(2013-1#1)
and demographic##29##2##(1990-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-3#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#4)
and demography of##2##3##(1991-12#1)(2008-5#1)
and demonstrate a method##2##4##(2007-11#1)(2011-2#1)
and demonstrate a novel##4##4##(2007-12#3)(2008-3#1)
and demonstrate a##13##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#5)(2011-2#1)
and demonstrate for the first time the##2##7##(1992-3#1)(2012-2#1)
and demonstrate how##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and demonstrate its application##2##4##(2008-2#1)(2012-2#1)
and demonstrate its##7##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and demonstrate our technique with polarization measurements of##2##8##(2007-11#1)(2007-12#1)
and demonstrate that the##4##4##(1994-8#1)(2008-10#1)(2008-2#1)(2010-5#1)
and demonstrate that these##2##4##(1995-3#1)(2007-11#1)
and demonstrate that##19##3##(1991-9#1)(1992-11#1)(1993-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2010-5#1)(2012-12#2)(2013-1#1)
and demonstrate the association##2##4##(2013-1#2)
and demonstrate the possibility of##2##5##(2007-12#1)(2008-6#1)
and demonstrate the possibility##3##4##(2007-12#1)(2008-2#1)(2008-6#1)
and demonstrate the##17##3##(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#2)
and demonstrate##71##2##(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(2007-11#6)(2007-12#10)(2008-10#4)(2008-2#8)(2008-3#11)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)
and demonstrated a##6##3##(2007-12#1)(2008-11#1)(2008-3#2)(2010-5#1)(2013-1#1)
and demonstrated as##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
and demonstrated by##2##3##(2008-3#2)
and demonstrated experimentally##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
and demonstrated for measuring the##3##5##(2007-12#3)
and demonstrated for##6##3##(2007-12#3)(2008-10#1)(2008-3#2)
and demonstrated that it is##2##5##(2008-10#1)(2008-11#1)
and demonstrated that the##3##4##(1994-8#1)(2008-10#1)(2009-4#1)
and demonstrated that##10##3##(1990-5#1)(1994-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-4#1)(2012-2#1)
and demonstrated the##2##3##(1993-11#1)(2013-7#1)
and demonstrated to##2##3##(1993-6#1)(1997-7#1)
and demonstrated##69##2##(1990-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1997-7#1)(2007-11#4)(2007-12#8)(2007-8#2)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#20)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
and demonstrates a##2##3##(2012-2#1)(2013-1#1)
and demonstrates how##4##3##(1995-1#1)(2007-12#1)(2008-4#1)(2010-5#1)
and demonstrates that the##3##4##(1993-9#1)(1995-3#1)(2008-11#1)
and demonstrates that##8##3##(1992-10#1)(1993-9#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
and demonstrates the importance of##2##5##(2008-6#1)(2008-7#1)
and demonstrates the importance##3##4##(1995-1#1)(2008-6#1)(2008-7#1)
and demonstrates the##9##3##(1995-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)
and demonstrates##27##2##(1991-2#1)(1992-10#1)(1993-9#1)(1995-1#2)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
and demonstrating the##2##3##(2008-3#1)(2008-5#1)
and demonstrating##4##2##(1995-6#1)(2008-3#1)(2008-5#1)(2009-1#1)
and demonstration of##5##3##(1990-6#1)(2007-11#1)(2007-7#2)(2008-1#1)
and demonstration##8##2##(1990-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-6#2)
and denaturation##4##2##(1992-8#1)(1993-11#1)(2008-10#2)
and denatured##9##2##(1990-5#1)(1994-6#1)(1995-3#1)(2008-10#4)(2008-8#1)(2011-2#1)
and denaturing##2##2##(2008-1#1)(2010-11#1)
and dendrites##2##2##(1997-3#1)(2007-12#1)
and dendritic branching points##2##4##(2008-10#2)
and dendritic cell##2##3##(2012-1#1)(2013-1#1)
and dendritic cells##5##3##(2008-4#2)(2008-6#1)(2009-12#1)(2012-1#1)
and dendritic##14##2##(1995-8#2)(1996-2#2)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2012-1#2)(2013-1#1)
and denervation##3##2##(1991-12#1)(2007-8#2)
and dengue##3##2##(2008-5#1)(2011-2#2)
and denial of the problem##2##5##(2011-2#2)
and denial of##3##3##(1990-6#1)(2011-2#2)
and denial##5##2##(1990-6#1)(2008-4#1)(2008-5#1)(2011-2#2)
and dense##9##2##(1991-2#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-7#2)(2012-2#1)
and densities##3##2##(2008-2#1)(2008-9#1)(2010-6#1)
and density in##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
and density measurements##2##3##(2008-10#2)
and density of the##3##4##(2008-1#2)(2008-10#1)
and density of##5##3##(2008-1#2)(2008-10#2)(2008-2#1)
and density##34##2##(1993-9#1)(1995-8#1)(2006-4#1)(2007-5#1)(2008-1#3)(2008-10#10)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#3)(2012-12#2)
and density-dependent##2##2##(2008-8#1)(2008-9#1)
and dental caries in preschool children##2##6##(2011-1#2)
and dental caries##4##3##(2008-9#1)(2011-1#2)(2012-2#1)
and dental state##2##3##(2008-7#2)
and dental treatment##2##3##(2008-5#1)(2008-7#1)
and dental##25##2##(1993-12#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-7#2)(2011-1#3)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#3)
and dentate granule cells##2##4##(1990-5#2)
and dentate gyrus##6##3##(1991-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-11#1)
and dentate##10##2##(1990-5#2)(1991-10#1)(1991-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-7#1)
and dentatorubral-pallidoluysian atrophy##2##3##(1997-5#1)(2008-7#1)
and dentin##8##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(2008-7#1)(2009-8#1)(2012-12#2)
and dentistry##2##2##(2012-1#1)(2012-2#1)
and dentofacial##2##2##(2012-12#1)(2013-1#1)
and deoxycholic acid##2##3##(1990-8#1)(2008-10#1)
and deoxynivalenol (DON) accumulation in##2##5##(2008-10#2)
and deoxynivalenol (DON)##3##3##(2008-10#3)
and deoxynivalenol accumulation##2##3##(2008-10#2)
and deoxynivalenol##8##2##(2008-10#8)
and depend on the##2##4##(2008-5#1)(2011-3#1)
and depend on##6##3##(2008-10#1)(2008-5#2)(2011-3#1)(2012-2#1)(2013-8#1)
and dependence in##4##3##(1992-1#1)(2008-4#1)(2008-7#1)(2009-2#1)
and dependence on##2##3##(2008-1#1)(2013-1#1)
and dependence##10##2##(1991-1#1)(1992-1#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2013-1#1)
and dependency##2##2##(2008-7#1)(2008-8#1)
and dependent on the##3##4##(1991-8#1)(2010-12#1)(2012-2#1)
and dependent on##5##3##(1991-8#1)(1992-9#1)(1993-1#1)(2010-12#1)(2012-2#1)
and dependent##7##2##(1991-8#1)(1992-9#1)(1993-1#1)(2007-2#1)(2008-10#1)(2010-12#1)(2012-2#1)
and depending on##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
and depends on the##10##4##(1995-5#1)(1997-7#1)(2007-12#2)(2008-12#1)(2008-2#1)(2011-2#4)
and depends on##14##3##(1995-5#1)(1997-7#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#5)
and dephosphorylated##5##2##(1993-6#1)(1996-5#2)(1997-2#2)
and dephosphorylation##2##2##(1994-11#1)(1994-9#1)
and depleted##2##2##(2008-10#1)(2013-1#1)
and depletion of##7##3##(1991-2#1)(1995-9#1)(2007-12#1)(2008-8#1)(2009-6#1)(2013-1#2)
and depletion##10##2##(1991-2#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2013-1#2)
and deploy##2##2##(2008-10#1)(2012-1#1)
and deploying##2##2##(2008-10#1)(2010-11#1)
and deployment##3##2##(2008-3#1)(2008-7#1)(2013-8#1)
and depolarization##4##2##(2008-2#2)(2008-3#2)
and depolarized##2##2##(2008-2#2)
and deposited on the##2##4##(2008-10#2)
and deposited on##3##3##(2008-10#3)
and deposited##4##2##(2008-10#4)
and deposition of##6##3##(1992-12#1)(1995-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
and deposition##15##2##(1992-12#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
and depressed##5##2##(1993-3#1)(1995-5#1)(2008-10#1)(2008-7#1)(2009-11#1)
and depression among##2##3##(2012-1#1)(2013-1#1)
and depression and the##2##4##(2008-11#1)(2008-4#1)
and depression and##6##3##(2008-11#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#1)
and depression are##3##3##(1992-8#1)(2013-1#1)(2013-8#1)
and depression following##2##3##(2008-2#1)(2008-8#1)
and depression in##6##3##(2008-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
and depression were##3##3##(2007-7#1)(2012-1#2)
and depression##65##2##(1990-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-2#2)(2010-7#2)(2010-8#2)(2011-2#2)(2012-1#5)(2012-12#3)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#2)
and depression]##3##2##(1992-11#1)(1997-3#2)
and depressive symptoms among##2##4##(2008-7#1)(2009-7#1)
and depressive symptoms in##2##4##(2010-8#1)(2013-8#1)
and depressive symptoms were##2##4##(2009-10#1)(2009-9#1)
and depressive symptoms##16##3##(2008-7#2)(2009-10#2)(2009-7#2)(2009-9#5)(2010-8#4)(2013-8#1)
and depressive##23##2##(1991-6#1)(1996-5#1)(2008-7#2)(2009-10#5)(2009-7#3)(2009-9#5)(2010-5#1)(2010-8#4)(2013-8#1)
and depressive-like##2##2##(2013-1#1)(2013-8#1)
and deprotection##2##2##(2008-4#1)(2008-8#1)
and depth of##3##3##(1995-2#1)(1996-2#1)(2008-3#1)
and depth##14##2##(1992-3#1)(1993-12#1)(1995-2#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2013-8#1)
and deranged##2##2##(1994-11#1)(2010-11#1)
and deregulation of##2##3##(2009-4#1)(2012-12#1)
and derivative spectrophotometric methods##2##4##(2008-10#2)
and derivative spectrophotometry##2##3##(2008-10#2)
and derivative##8##2##(2008-10#6)(2008-11#1)(2010-7#1)
and derivatives##5##2##(1993-1#2)(1994-5#1)(2007-11#1)(2008-11#1)
and derivatization with##2##3##(2008-10#1)(2008-11#1)
and derivatization##7##2##(2008-10#6)(2008-11#1)
and derivatized##4##2##(1990-8#1)(2008-10#2)(2011-3#1)
and derive a##2##3##(2008-8#1)(2008-9#1)
and derive the##2##3##(2008-3#1)(2008-8#1)
and derive##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#2)(2008-9#1)(2013-8#1)
and derived from##3##3##(1995-12#1)(2008-10#1)(2010-4#1)
and derived##6##2##(1995-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-4#1)
and dermal##11##2##(2008-12#1)(2008-5#8)(2008-9#2)
and dermatitis##5##2##(1990-3#1)(1994-11#1)(2008-5#2)(2011-2#1)
and dermatological##2##2##(2008-5#2)
and dermatologists##2##2##(2006-10#1)(2013-1#1)
and dermis##10##2##(1994-12#1)(1996-12#1)(2008-11#1)(2008-5#6)(2008-9#1)
and descending##3##2##(1997-8#1)(2012-2#1)(2013-1#1)
and describe a##5##3##(1991-12#1)(1994-3#1)(2008-3#1)(2008-9#1)(2012-2#1)
and describe an##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
and describe how##6##3##(1993-2#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-12#1)
and describe the anatomy##2##4##(1990-8#1)(1996-9#1)
and describe the##21##3##(1990-8#1)(1993-2#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and describe their##2##3##(2007-12#1)(2007-4#1)
and describe##45##2##(1990-8#1)(1991-12#1)(1993-2#2)(1994-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#1)
and described by the##2##4##(2007-10#1)(2011-2#1)
and described by##7##3##(1993-11#1)(1993-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2011-2#1)(2013-1#1)
and described in##2##3##(2008-2#1)(2008-4#1)
and described using##2##3##(2007-11#1)(2012-12#1)
and described##22##2##(1993-11#1)(1993-6#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and describes how##6##3##(1994-12#1)(1997-2#1)(2008-11#1)(2008-4#2)(2009-12#1)
and describes its##2##3##(1992-1#1)(2009-10#1)
and describes some of the##3##5##(1992-1#1)(1993-2#1)(1994-1#1)
and describes some##4##3##(1992-1#1)(1993-2#1)(1994-1#1)(2011-2#1)
and describes the burden due to selected NCD (diabetes##2##9##(2013-8#2)
and describes the burden##3##4##(2013-8#3)
and describes the burdens due to NCDs##2##7##(2013-8#2)
and describes the burdens due to selected##2##7##(2013-8#2)
and describes the burdens due to##6##6##(2013-8#6)
and describes the##30##3##(1991-11#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-12#1)(1997-2#2)(2008-10#1)(2008-12#2)(2008-6#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#10)
and describes##55##2##(1991-11#1)(1991-12#1)(1992-1#3)(1992-12#1)(1992-4#1)(1993-2#2)(1994-1#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#3)(2008-6#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#10)
and describing##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)
and description of the##3##4##(2008-10#2)(2009-5#1)
and description of##10##3##(1990-6#1)(2008-10#3)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and descriptions##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2013-7#1)
and descriptive study was##2##4##(2007-11#1)(2012-3#1)
and descriptive study##3##3##(2007-11#1)(2012-3#2)
and descriptive##10##2##(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#3)
and desensitization##4##2##(1993-9#2)(2008-3#1)(2008-4#1)
and deserve##2##2##(1993-12#1)(2008-12#1)
and deserves further study##2##4##(1991-6#1)(2008-7#1)
and deserves##3##2##(1991-6#1)(2008-7#1)(2010-12#1)
and design inputs##2##3##(2012-2#2)
and design of a##3##4##(2008-3#2)(2008-8#1)
and design of the##5##4##(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)
and design of##22##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-8#3)(2008-9#2)(2012-12#2)(2012-2#1)(2012-3#1)
and design##40##2##(1997-3#2)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)
and designated as##3##3##(1994-12#1)(2008-10#2)
and designated##10##2##(1990-11#1)(1991-7#1)(1994-12#1)(1995-11#1)(1996-3#1)(2008-10#4)(2008-9#1)
and designed for##2##3##(2008-3#1)(2008-4#1)
and designed##7##2##(1996-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
and designer##3##2##(1991-1#1)(1997-5#1)(2010-11#1)
and designing##6##2##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
and desipramine in##2##3##(1990-5#1)(1991-1#1)
and desipramine##7##2##(1990-5#2)(1991-1#3)(2008-10#2)
and desirability of such##2##4##(1992-2#1)(1994-1#1)
and desirability of##3##3##(1992-2#2)(1994-1#1)
and desirable##2##2##(2010-10#1)(2010-4#1)
and desired##4##2##(1992-4#1)(1995-2#1)(2007-12#1)(2008-10#1)
and desires of older##2##4##(1997-3#1)(2010-10#1)
and desires##3##2##(1997-3#1)(2010-10#1)(2013-1#1)
and desorbed##4##2##(2008-10#3)(2010-5#1)
and desorption can be achieved by using 5##2##8##(2008-10#2)
and desorption of##4##3##(2008-10#3)(2008-2#1)
and desorption##14##2##(1994-2#1)(2007-12#1)(2008-10#10)(2008-2#1)(2010-5#1)
and destabilization##3##2##(1990-8#2)(2011-2#1)
and destination##2##2##(2008-7#1)(2010-6#1)
and destruction of##8##3##(1990-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
and destructive testing##2##3##(2008-11#2)
and destructive##9##2##(2008-10#4)(2008-11#2)(2008-3#2)(2013-1#1)
and detach at the end of a capillary tip##2##9##(2008-10#2)
and detached##5##2##(1994-2#1)(2008-10#4)
and detachment##7##2##(1990-8#1)(2008-11#1)(2008-7#1)(2011-2#3)(2012-1#1)
and detailed protocols for##2##4##(2008-9#2)
and detailed unit presents##2##4##(2008-9#2)
and detailed##26##2##(1990-9#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#5)(2012-12#1)(2013-1#1)
and details a##2##3##(2008-4#1)(2012-12#1)
and details of##2##3##(2008-9#1)(2013-8#1)
and details##7##2##(1994-12#1)(2008-11#1)(2008-4#1)(2008-9#2)(2012-12#1)(2013-8#1)
and detect##9##2##(1993-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-2#1)(2012-3#1)
and detectable##4##2##(1995-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
and detected at the##2##4##(1990-8#1)(2008-10#1)
and detected at##8##3##(1990-8#1)(2008-10#7)
and detected by a##2##4##(2008-10#1)(2008-3#1)
and detected by the##2##4##(2008-10#1)(2008-3#1)
and detected by##14##3##(1990-8#2)(1995-2#1)(2007-11#1)(2008-10#8)(2008-3#2)
and detected in##2##3##(1990-8#1)(2008-10#1)
and detected the##4##3##(2008-10#2)(2008-9#1)(2013-8#1)
and detected using##4##3##(2008-10#3)(2008-4#1)
and detected##41##2##(1990-8#4)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#26)(2008-3#3)(2008-4#1)(2008-9#2)(2013-8#1)
and detecting##5##2##(1996-4#1)(2007-5#1)(2008-10#2)(2010-12#1)
and detection and##3##3##(2008-10#2)(2008-4#1)
and detection by##4##3##(2008-10#3)(2012-2#1)
and detection for##2##3##(2008-10#1)(2012-2#1)
and detection limit 0##4##4##(2008-10#4)
and detection limit of 0##2##5##(2008-10#2)
and detection limit of##9##4##(2008-10#8)(2008-2#1)
and detection limit was##3##4##(2008-10#3)
and detection limit were##3##4##(2008-10#3)
and detection limit##28##3##(2008-10#27)(2008-2#1)
and detection limits are##3##4##(1995-9#2)(2008-10#1)
and detection limits for linear homoscedastic assays##2##7##(1995-9#2)
and detection limits of 0##3##5##(2008-10#3)
and detection limits of##5##4##(2008-10#5)
and detection limits were##2##4##(2008-10#2)
and detection limits##20##3##(1995-9#4)(2008-10#14)(2008-2#1)(2013-1#1)
and detection methods##3##3##(2008-10#3)
and detection of DNA##2##4##(2008-1#1)(2008-10#1)
and detection of a benzo[a]pyrene##2##5##(2008-10#2)
and detection of a##3##4##(2008-10#3)
and detection of the##4##4##(2008-10#2)(2008-4#1)(2008-8#1)
and detection of##52##3##(1992-11#1)(1994-6#1)(1995-2#1)(1997-2#1)(2007-11#2)(2008-1#3)(2008-10#28)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#1)(2013-1#1)
and detection systems##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
and detection was carried out at##2##6##(2008-10#1)(2008-5#1)
and detection was##5##3##(2008-10#4)(2008-5#1)
and detection were##3##3##(2008-10#3)
and detection##162##2##(1992-11#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-9#4)(1996-8#1)(1997-2#1)(2007-11#2)(2008-1#3)(2008-10#111)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-2#3)(2013-1#4)
and detector were##2##3##(2008-10#2)
and detector##27##2##(1990-12#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#12)(2009-5#1)(2011-1#1)
and detectors##6##2##(2008-10#1)(2008-2#2)(2008-3#3)
and detects the##2##3##(2008-10#1)(2010-8#1)
and detects##4##2##(2008-10#2)(2009-5#1)(2010-8#1)
and deteriorated##2##2##(1995-11#1)(2012-12#1)
and deterioration of##3##3##(2008-10#1)(2010-1#1)(2010-3#1)
and deterioration##5##2##(2007-10#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-3#1)
and determinants of##7##3##(1991-8#2)(2008-7#1)(2011-1#2)(2011-2#2)
and determination by FAAS##2##4##(2008-10#2)
and determination by flame atomic absorption spectrometry (FAAS)##2##8##(2008-10#2)
and determination by flame atomic absorption spectrometry##8##7##(2008-10#8)
and determination by flow##2##4##(2008-10#2)
and determination by inductively coupled plasma optical emission spectrometry##2##9##(2008-10#2)
and determination by inductively coupled plasma##3##6##(2008-10#3)
and determination by inductively coupled##4##5##(2008-10#4)
and determination by##28##3##(2008-10#28)
and determination in aqueous medium##2##5##(2008-10#2)
and determination in##7##3##(2008-10#6)(2013-1#1)
and determination limits of the##2##5##(2008-10#2)
and determination limits of##5##4##(2008-10#5)
and determination of Cr(III) and Cr(VI) in##2##7##(2008-10#2)
and determination of Cr(III)##3##4##(2008-10#3)
and determination of aloperine##2##4##(2008-10#2)
and determination of aspoxicillin in human plasma by micellar electrokinetic chromatography##2##11##(1990-8#2)
and determination of copper in##3##5##(2008-10#3)
and determination of copper##9##4##(2008-10#9)
and determination of inorganic##3##4##(2008-10#3)
and determination of l-tyrosine##2##4##(2008-10#2)
and determination of lead in##4##5##(2008-10#4)
and determination of lead##7##4##(2008-10#7)
and determination of metal ions##2##5##(2008-10#2)
and determination of metal##3##4##(2008-10#3)
and determination of nitroaniline##2##4##(2008-10#2)
and determination of terbinafine##2##4##(2008-10#2)
and determination of the pesticide##2##5##(2008-10#2)
and determination of the##9##4##(1995-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-5#1)(2013-1#1)
and determination of these##2##4##(1990-8#1)(2008-10#1)
and determination of this##2##4##(2008-10#1)(2011-2#1)
and determination of trace amounts of##4##6##(2008-10#4)
and determination of trace##8##4##(2008-10#8)
and determination of two##3##4##(2008-10#3)
and determination of ultra trace amounts of##3##7##(2008-10#3)
and determination of##159##3##(1990-8#3)(1992-11#1)(1993-2#1)(1994-5#1)(1995-2#2)(2007-11#1)(2008-10#131)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
and determination using##2##3##(2008-10#2)
and determination##217##2##(1990-8#3)(1992-11#1)(1992-5#1)(1993-2#1)(1994-5#1)(1995-2#2)(2007-11#1)(2008-10#187)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
and determinations of##2##3##(2008-10#1)(2008-4#1)
and determinations##3##2##(2008-10#2)(2008-4#1)
and determine how##3##3##(1991-12#1)(2007-10#1)(2008-10#1)
and determine if##2##3##(2007-11#1)(2011-1#1)
and determine the thermal##2##4##(2008-3#1)(2008-6#1)
and determine the##15##3##(1994-3#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
and determine whether the##2##4##(1994-1#1)(2011-2#1)
and determine whether##6##3##(1994-1#1)(2007-10#1)(2007-12#1)(2008-5#1)(2009-10#1)(2011-2#1)
and determine##35##2##(1991-12#1)(1994-1#1)(1994-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and determined by FAAS##2##4##(2008-10#2)
and determined by HPLC##2##4##(2008-10#1)(2009-8#1)
and determined by flame atomic absorption spectrometry (FAAS)##3##8##(2008-10#3)
and determined by flame atomic absorption spectrometry##4##7##(2008-10#4)
and determined by flame atomic absorption##6##6##(2008-10#6)
and determined by reversed-phase HPLC##2##5##(2008-10#2)
and determined by##26##3##(2008-10#22)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)
and determined in standard and##2##5##(2008-10#2)
and determined in##3##3##(2008-10#3)
and determined its##2##3##(1993-3#1)(1996-7#1)
and determined similarly##6##3##(2008-10#6)
and determined spectrophotometrically using##2##4##(2008-10#2)
and determined spectrophotometrically##7##3##(2008-10#7)
and determined the##11##3##(1993-2#1)(1993-8#1)(1994-5#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-1#1)
and determined their##3##3##(1991-12#1)(1991-9#1)(2008-10#1)
and determined to be##2##4##(2008-10#1)(2008-11#1)
and determined using##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
and determined whether##3##3##(1993-3#1)(2011-2#1)(2012-1#1)
and determined with an##2##4##(2008-10#2)
and determined with##5##3##(2008-10#5)
and determined##88##2##(1991-12#1)(1991-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#59)(2008-11#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)
and determines##3##2##(2008-8#2)(2013-8#1)
and determining the##5##3##(2007-11#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-7#1)
and determining their##2##3##(1995-2#1)(2008-10#1)
and determining##18##2##(1995-2#1)(1996-1#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-9#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-7#1)
and deterministic##4##2##(2008-10#2)(2008-9#1)(2012-12#1)
and detoxification of##2##3##(2008-10#1)(2011-1#1)
and detoxification##5##2##(2008-10#1)(2008-7#2)(2009-8#1)(2011-1#1)
and detuning##2##2##(2008-3#2)
and develop a##7##3##(1991-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
and develop an##3##3##(1992-1#1)(2007-9#1)(2013-1#1)
and develop new##2##3##(2008-11#1)(2008-3#1)
and develop techniques##2##3##(2008-3#1)(2011-2#1)
and develop treatment strategies##2##4##(2012-3#1)(2013-1#1)
and develop##44##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-2#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#4)
and developed a##8##3##(1994-12#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
and developed as##2##3##(2008-10#1)(2009-4#1)
and developed by the##2##4##(1994-2#1)(2008-10#1)
and developed by##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
and developed for the determination of##2##6##(2008-10#2)
and developed for##3##3##(2008-10#3)
and developed in order to##2##5##(2008-1#1)(2008-10#1)
and developed in##5##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
and developed##57##2##(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1994-12#1)(1994-2#1)(1995-2#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
and developing a##3##3##(1995-12#1)(1996-3#1)(2008-7#1)
and developing countries##9##3##(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
and developing germ##2##3##(2008-10#1)(2012-2#1)
and developing improved##2##3##(1995-2#1)(1996-12#1)
and developing##29##2##(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
and development and##6##3##(1994-3#1)(1995-1#1)(2008-10#1)(2009-6#1)(2010-8#1)(2011-1#1)
and development at##4##3##(1990-6#1)(2008-10#1)(2011-1#2)
and development by##2##3##(1992-3#1)(2009-8#1)
and development for##2##3##(2008-11#1)(2013-7#1)
and development in the##2##4##(1996-12#1)(2008-9#1)
and development in##6##3##(1992-12#1)(1996-12#1)(2008-9#1)(2009-2#1)(2009-8#1)(2013-1#1)
and development issues##3##3##(1996-2#1)(2008-11#1)(2011-1#1)
and development of a##5##4##(2008-10#2)(2008-4#1)(2008-5#1)(2010-5#1)
and development of diabetes##2##4##(2010-11#1)(2013-7#1)
and development of new##5##4##(2007-2#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
and development of newer##2##4##(1991-1#1)(2011-1#1)
and development of novel##2##4##(2010-8#1)(2011-3#1)
and development of specific##2##4##(1991-12#1)(2011-2#1)
and development of the nervous system in the brine shrimp Artemia salina Linnaeus##2##13##(2007-12#2)
and development of the nervous system##3##6##(2007-12#2)(2009-3#1)
and development of the##10##4##(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2013-8#1)
and development of##114##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-12#4)(2007-2#3)(2007-5#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2011-3#5)(2012-12#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
and development on##2##3##(1996-5#1)(2009-5#1)
and development process##2##3##(1997-3#1)(2008-11#1)
and development were##3##3##(2008-10#2)(2008-11#1)
and development##239##2##(1990-3#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-2#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#7)(2007-2#4)(2007-5#1)(2008-1#3)(2008-10#32)(2008-11#16)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#6)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-8#8)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#6)(2011-1#14)(2011-2#7)(2011-3#5)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#7)(2013-1#6)(2013-7#4)(2013-8#3)
and developmental biology##2##3##(2007-7#1)(2008-5#1)
and developmental delay##3##3##(1997-3#2)(2013-1#1)
and developmental disabilities##2##3##(1993-3#1)(2010-10#1)
and developmental disorders##3##3##(2013-8#3)
and developmental stage of the##2##5##(2008-10#2)
and developmental##46##2##(1992-3#1)(1993-3#1)(1993-6#2)(1995-3#1)(1997-3#2)(1997-8#2)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
and developmentally##5##2##(1993-3#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
and developments in##3##3##(1991-6#1)(2008-11#1)(2010-7#1)
and developments##5##2##(1991-6#1)(1996-2#1)(2008-11#1)(2008-9#1)(2010-7#1)
and develops##5##2##(1994-12#1)(1994-9#1)(1996-2#1)(2009-10#1)(2010-5#1)
and deviance##2##2##(2009-12#1)(2011-1#1)
and deviant##3##2##(1995-5#1)(2008-12#1)(2013-8#1)
and deviation from##2##3##(2008-2#1)(2008-3#1)
and deviation##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
and deviations##2##2##(1993-8#1)(1994-6#1)
and device##4##2##(2008-3#1)(2009-10#2)(2011-1#1)
and devices##11##2##(1995-1#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#2)
and dew##4##2##(2008-10#4)
and dexamethasone##9##2##(1990-11#1)(1990-3#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-5#2)
and dextransulphate##2##2##(2008-11#2)
and di-(2-ethylhexyl)##2##2##(2008-10#1)(2012-1#1)
and di-ortho methoxybenzoyl thiourea##2##4##(2008-10#2)
and diabetes education##2##3##(2010-4#2)
and diabetes have##2##3##(2008-3#1)(2009-4#1)
and diabetes mellitus (DM)##3##4##(2008-3#1)(2011-2#1)(2012-5#1)
and diabetes mellitus##22##3##(1996-11#1)(2007-10#1)(2008-1#4)(2008-11#1)(2008-3#4)(2008-4#3)(2008-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#2)
and diabetes##65##2##(1990-2#1)(1996-11#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-11#2)(2008-12#2)(2008-3#9)(2008-4#5)(2008-5#2)(2008-7#4)(2008-9#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#4)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#3)(2013-8#3)
and diabetes-extract group##2##3##(2008-12#2)
and diabetic nephropathy##2##3##(1991-11#1)(2008-1#1)
and diabetic retinopathy##4##3##(1991-12#1)(1995-9#1)(2008-5#1)(2011-2#1)
and diabetic subjects##2##3##(2007-11#1)(2012-12#1)
and diabetic##24##2##(1991-11#1)(1991-12#1)(1993-8#1)(1994-8#2)(1995-9#1)(2007-11#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#1)
and diacylglycerol##6##2##(1991-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-10#1)
and diafiltration##2##2##(2008-6#1)(2011-2#1)
and diagnose##3##2##(1997-2#1)(2008-10#1)(2009-10#1)
and diagnosed as##2##3##(2007-8#1)(2011-1#1)
and diagnosed##4##2##(2007-8#1)(2008-3#1)(2011-1#1)(2013-7#1)
and diagnoses##3##2##(1990-12#1)(1993-1#1)(1993-8#1)
and diagnosis are##2##3##(2008-9#1)(2011-2#1)
and diagnosis at##2##3##(1997-6#1)(2012-12#1)
and diagnosis for##2##3##(1992-5#1)(2012-3#1)
and diagnosis in##2##3##(1995-6#1)(2008-6#1)
and diagnosis of pancreatic cancer]##2##5##(1990-11#1)(1990-9#1)
and diagnosis of the##3##4##(2007-12#1)(2010-10#1)(2012-3#1)
and diagnosis of##21##3##(1990-11#1)(1990-9#1)(1992-5#1)(1992-8#1)(1992-9#2)(1994-9#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-11#1)(2009-10#1)(2010-10#1)(2010-12#3)(2010-6#1)(2012-3#1)(2013-1#2)
and diagnosis##41##2##(1990-11#1)(1990-9#1)(1992-5#2)(1992-8#1)(1992-9#2)(1994-9#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#3)(2013-8#1)
and diagnostic accuracy of##2##4##(1995-11#1)(2008-12#1)
and diagnostic accuracy##3##3##(1995-11#1)(2008-12#1)(2012-3#1)
and diagnostic applications##2##3##(2008-11#1)(2010-12#1)
and diagnostic aspects##2##3##(2008-5#1)(2013-8#1)
and diagnostic criteria##2##3##(2011-2#1)(2013-8#1)
and diagnostic method##3##3##(2012-12#3)
and diagnostic potential of##4##4##(1997-6#2)(2008-2#1)(2013-8#1)
and diagnostic problems##2##3##(2007-8#1)(2008-7#1)
and diagnostic##54##2##(1990-9#2)(1991-11#2)(1991-12#1)(1991-8#1)(1992-8#1)(1993-11#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
and diagnostics of##2##3##(2007-8#2)
and diagnostics##5##2##(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)
and diagonal##2##2##(2008-9#1)(2013-8#1)
and dialysate##2##2##(2008-1#1)(2013-1#1)
and dialysis treatment##2##3##(2008-1#1)(2011-2#1)
and dialysis##7##2##(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
and dialyzed##2##2##(1990-5#1)(2008-10#1)
and diameter and##2##3##(2008-10#1)(2008-12#1)
and diameter of the##2##4##(2008-10#1)(2008-6#1)
and diameter of##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
and diameter##6##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2012-2#1)
and diameters##2##2##(2008-7#2)
and diamond##2##2##(1991-5#1)(2007-12#1)
and diaphragm##4##2##(1995-8#2)(2007-8#1)(2008-6#1)
and diarrhea##7##2##(1990-12#1)(1991-9#1)(1992-12#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-2#1)
and diarrhea)##2##2##(1992-2#1)(2008-8#1)
and diarrhoea in##2##3##(1997-8#1)(2009-2#1)
and diarrhoea##6##2##(1990-9#3)(1997-8#1)(2009-2#1)(2011-2#1)
and diarrhoeal##2##2##(2011-2#1)(2012-3#1)
and diastolic arterial blood pressure##2##5##(2011-2#1)(2012-3#1)
and diastolic blood pressure (DBP)##3##5##(1991-10#1)(1992-12#1)(2008-10#1)
and diastolic blood pressure##22##4##(1991-10#1)(1992-12#1)(1992-8#4)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
and diastolic blood##24##3##(1991-10#1)(1992-12#1)(1992-8#4)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#3)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
and diastolic flow##2##3##(2007-8#2)
and diastolic function of the left##2##6##(1991-2#1)(2013-8#1)
and diastolic function##3##3##(1991-2#1)(2006-10#1)(2013-8#1)
and diastolic##47##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-8#4)(1992-9#1)(1994-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#3)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
and diazepam##4##2##(1990-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
and diazinon##3##2##(2008-10#3)
and dibenzofurans##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
and dibutyl phthalate (DBP)##3##4##(2008-10#2)(2010-5#1)
and dibutyl phthalate##4##3##(2008-10#3)(2010-5#1)
and dibutyl##5##2##(2007-11#1)(2008-10#3)(2010-5#1)
and dibutyryl##2##2##(1991-12#1)(1997-7#1)
and dichloroacetic##2##2##(2008-10#2)
and dichloromethane were##2##3##(2008-10#1)(2008-11#1)
and dichloromethane##10##2##(2008-10#7)(2008-11#2)(2013-1#1)
and dichloromethane-methanol##2##2##(2008-10#2)
and dichlorovos##3##2##(2008-10#3)
and dichromate##2##2##(2008-10#1)(2008-3#1)
and diclofenac sodium##2##3##(2008-10#2)
and diclofenac##6##2##(1990-9#2)(2008-10#3)(2008-7#1)
and did not affect the##2##5##(1991-9#1)(2008-10#1)
and did not affect##5##4##(1991-9#1)(1995-11#1)(2008-10#2)(2008-11#1)
and did not amplify DNA##2##5##(2008-10#1)(2009-6#1)
and did not change in##2##5##(1991-12#1)(2011-10#1)
and did not change##3##4##(1991-12#1)(2011-1#1)(2011-10#1)
and did not contain##2##4##(2008-10#1)(2011-2#1)
and did not correlate with##2##5##(2008-10#1)(2008-11#1)
and did not correlate##3##4##(1993-3#1)(2008-10#1)(2008-11#1)
and did not differ##3##4##(1993-6#1)(2008-10#1)(2013-8#1)
and did not exceed##4##4##(2008-10#3)(2008-2#1)
and did not inhibit##2##4##(1995-12#1)(1997-3#1)
and did not interfere with the##2##6##(1997-2#1)(2008-10#1)
and did not interfere with##4##5##(1991-5#1)(1997-2#1)(2008-10#2)
and did not produce##4##4##(1991-3#1)(2008-10#2)(2009-8#1)
and did not react with##2##5##(2008-10#2)
and did not receive##2##4##(2008-6#1)(2012-1#1)
and did not require##4##4##(1992-9#1)(2007-7#1)(2008-10#2)
and did not reveal##2##4##(2008-11#1)(2008-12#1)
and did not seem to##3##5##(1991-6#1)(2008-3#1)(2013-1#1)
and did not##74##3##(1990-2#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-9#2)(1993-3#2)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
and did##76##2##(1990-2#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-9#2)(1993-3#2)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
and die##2##2##(1996-5#1)(2008-10#1)
and died 6##2##3##(1994-9#1)(2011-2#1)
and died##15##2##(1991-4#1)(1993-12#1)(1994-9#1)(1997-3#1)(1997-5#1)(2007-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)
and dielectric##8##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#1)
and dielectrics##2##2##(2008-2#1)(2008-3#1)
and diesel fuel-like##2##3##(2008-10#2)
and diesel##3##2##(2008-10#2)(2011-1#1)
and diet breadth on##2##4##(2008-9#2)
and diet##14##2##(1990-9#1)(1992-11#1)(1993-9#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-12#2)(2013-1#2)
and dietary factors##2##3##(1993-9#1)(2009-8#1)
and dietary fat##2##3##(2008-12#1)(2010-3#1)
and dietary history##2##3##(1997-3#1)(2008-2#1)
and dietary intake##3##3##(2008-1#1)(2010-9#1)(2011-2#1)
and dietary supplements##4##3##(2007-12#1)(2008-10#1)(2010-5#1)(2011-1#1)
and dietary##26##2##(1992-2#1)(1993-9#1)(1997-3#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
and dietary-related factors##2##3##(2011-2#2)
and dietary-related##3##2##(2011-2#3)
and differ from##3##3##(1990-5#1)(2009-9#1)(2011-2#1)
and differ in##2##3##(2008-5#1)(2012-2#1)
and differ##7##2##(1990-5#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
and differed##2##2##(1994-2#1)(1996-7#1)
and difference##5##2##(1992-8#1)(2007-11#1)(2008-3#2)(2008-9#1)
and differences between the##8##4##(1994-6#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
and differences between##18##3##(1993-1#1)(1993-6#1)(1994-6#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-1#2)
and differences in the##5##4##(1994-12#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-7#1)
and differences in##17##3##(1992-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and differences observed##2##3##(2008-10#1)(2008-7#1)
and differences were##3##3##(1991-8#2)(2012-2#1)
and differences##55##2##(1991-3#1)(1991-6#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1997-3#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#4)
and different anions##2##3##(2008-10#2)
and different clinical##2##3##(1997-8#1)(2012-3#1)
and different from the##2##4##(1996-9#1)(2013-8#1)
and different from##4##3##(1996-9#1)(2008-10#1)(2011-3#1)(2013-8#1)
and different in##2##3##(2008-3#1)(2008-5#1)
and different levels of##2##4##(2008-10#1)(2011-2#1)
and different treatment modalities of##3##5##(1992-9#1)(1993-8#1)(2008-7#1)
and different treatment modalities##4##4##(1992-9#1)(1993-8#1)(2007-8#1)(2008-7#1)
and different treatment##5##3##(1990-2#1)(1992-9#1)(1993-8#1)(2007-8#1)(2008-7#1)
and different types of##2##4##(2009-7#1)(2012-3#1)
and different types##3##3##(2008-10#1)(2009-7#1)(2012-3#1)
and different##128##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#4)
and different-ethnic##2##2##(2009-7#2)
and differential access to##2##4##(1992-2#1)(1993-12#1)
and differential diagnoses##3##3##(2007-11#1)(2009-3#1)(2011-2#1)
and differential diagnosis of##2##4##(1996-11#1)(2013-1#1)
and differential diagnosis##6##3##(1992-9#1)(1996-11#1)(2007-5#2)(2008-4#1)(2013-1#1)
and differential effects##2##3##(2007-12#1)(2013-1#1)
and differential expression##2##3##(1992-6#1)(2008-7#1)
and differential pulse cathodic stripping voltammetry##2##6##(2008-10#2)
and differential pulse polarography##3##4##(2008-10#3)
and differential pulse voltammetric##2##4##(2008-10#2)
and differential pulse voltammetry (DPV)##3##5##(2008-10#3)
and differential pulse voltammetry##6##4##(2008-10#6)
and differential pulse##18##3##(2008-10#18)
and differential regulation##2##3##(1996-12#1)(2008-11#1)
and differential scanning calorimetry (DSC)##3##5##(1992-10#1)(2008-5#1)(2009-3#1)
and differential scanning calorimetry##5##4##(1992-10#1)(1995-5#1)(2008-5#2)(2009-3#1)
and differential scanning##6##3##(1992-10#1)(1995-5#1)(2008-10#1)(2008-5#2)(2009-3#1)
and differential##69##2##(1990-12#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-11#5)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-12#1)(2013-1#2)
and differentiate between##2##3##(2008-10#1)(2011-2#1)
and differentiate into##3##3##(2008-11#1)(2008-4#1)(2009-10#1)
and differentiate these##2##3##(2008-10#1)(2008-11#1)
and differentiate##14##2##(1993-12#1)(1995-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
and differentiated into##2##3##(2008-8#1)(2009-10#1)
and differentiated##10##2##(1992-9#1)(1994-11#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#1)(2011-2#1)
and differentiating factors##2##3##(1995-11#1)(2010-10#1)
and differentiating##5##2##(1995-11#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)
and differentiation between##2##3##(2008-11#1)(2008-9#1)
and differentiation factors##3##3##(1994-12#1)(1996-5#1)(2008-4#1)
and differentiation from##2##3##(1991-6#1)(2007-7#1)
and differentiation in the##2##4##(1997-6#1)(2008-5#1)
and differentiation in##9##3##(1993-11#2)(1994-10#1)(1995-12#1)(1997-6#2)(2008-10#1)(2008-5#1)(2009-3#1)
and differentiation of human##3##4##(1993-9#1)(1994-6#1)(2008-11#1)
and differentiation of murine##3##4##(2008-11#1)(2008-4#1)(2008-8#1)
and differentiation of the##9##4##(1991-7#1)(1995-11#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-11#1)(2011-2#1)
and differentiation of##54##3##(1990-12#1)(1991-6#1)(1991-7#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#2)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#6)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#5)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)
and differentiation were##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
and differentiation##128##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#3)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#3)(1997-7#3)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#11)(2008-11#19)(2008-4#5)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#2)(2009-8#2)(2010-11#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#3)
and differently##2##2##(1997-2#1)(2013-1#1)
and differing##4##2##(1993-11#1)(2008-12#2)(2010-5#1)
and differs##2##2##(1994-12#1)(2013-1#1)
and difficult to##11##3##(1991-2#1)(1994-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
and difficult##22##2##(1991-2#1)(1994-11#1)(1995-2#1)(1996-1#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and difficulties in##4##3##(1992-5#1)(2008-7#1)(2010-11#1)(2010-4#1)
and difficulties##14##2##(1992-5#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
and difficulty in interpreting the##2##5##(2011-2#1)(2012-3#1)
and difficulty in##7##3##(1990-6#1)(1992-9#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and difficulty of##2##3##(2008-11#1)(2013-1#1)
and difficulty##12##2##(1990-6#1)(1992-9#1)(1996-1#2)(2007-9#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and diffraction effects##2##3##(2008-3#2)
and diffraction##14##2##(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#6)
and diffractive optical elements##2##4##(2008-3#2)
and diffractive optical##3##3##(2008-3#3)
and diffuse##19##2##(1991-12#2)(1994-9#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-8#1)
and diffuse-reflectance##2##2##(2008-2#2)
and diffusion is##2##3##(2008-1#1)(2013-8#1)
and diffusion of##3##3##(2007-3#1)(2008-10#1)(2008-11#1)
and diffusion##28##2##(1993-6#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
and diffusion-weighted##6##2##(1996-5#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
and digested with##4##3##(1990-7#1)(2008-10#3)
and digested##8##2##(1990-7#1)(1995-5#1)(2008-10#5)(2008-9#1)
and digestible##3##2##(2008-10#1)(2008-12#1)(2009-4#1)
and digestion##3##2##(2008-10#2)(2008-4#1)
and digestive##10##2##(1992-9#1)(1995-2#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
and digit##3##2##(2007-10#1)(2008-9#2)
and digital holography##2##3##(2008-2#1)(2008-3#1)
and digital signal processing##2##4##(2008-2#1)(2008-3#1)
and digital##15##2##(1992-3#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)(2011-1#1)
and dihydrotestosterone##2##2##(1990-11#1)(1994-9#1)
and dihydroxyphenylacetic acid##2##3##(1992-1#1)(1996-7#1)
and diiron##2##2##(1992-8#2)
and dilatation of##4##3##(1994-9#1)(2008-7#2)(2012-2#1)
and dilatation##7##2##(1994-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)
and dilated##3##2##(1995-12#1)(1997-6#1)(2013-1#1)
and dilemmas in##3##3##(1993-3#1)(2009-5#1)(2012-3#1)
and dill##4##2##(2008-10#4)
and diltiazem##4##2##(1990-12#1)(1992-8#1)(1993-3#1)(2012-2#1)
and diluted##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
and dilution of the##2##4##(2008-10#2)
and dilution of##4##3##(1997-5#1)(2008-10#3)
and dilution plating##2##3##(2008-10#2)
and dilution##7##2##(1997-5#1)(2008-10#6)
and dimension of the##2##4##(2008-7#2)
and dimensional##2##2##(2008-3#1)(2008-5#1)
and dimensions of the##3##4##(2007-12#1)(2008-10#1)(2009-11#1)
and dimensions of##5##3##(2007-12#1)(2008-10#2)(2009-11#1)(2009-5#1)
and dimensions##6##2##(2007-12#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-5#1)
and dimer##5##2##(1994-6#1)(1995-8#1)(2008-10#3)
and dimercaprol##2##2##(1992-12#1)(1995-3#1)
and dimeric interleukin-5##2##3##(1994-6#2)
and dimeric##4##2##(1994-6#2)(2008-10#1)(2013-1#1)
and dimers##2##2##(1990-8#1)(2008-5#1)
and dimethyl sulfoxide##2##3##(1995-5#1)(2008-10#1)
and dimethyl##9##2##(1991-7#1)(1995-2#1)(1995-5#1)(1996-5#1)(2008-10#3)(2011-2#1)(2013-8#1)
and dimethylarsinic acid (DMAA)##2##4##(2008-10#2)
and dimethylarsinic acid##5##3##(2008-10#5)
and dimethylarsinic##8##2##(2008-10#8)
and dimethylglyoxime##2##2##(2008-10#2)
and dimetridazole##2##2##(1997-4#2)
and diminished##13##2##(1990-7#1)(1997-5#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#5)(2010-6#1)(2011-2#1)(2013-1#1)
and diminution of##2##3##(2011-2#1)(2012-2#1)
and dioctyl##2##2##(2008-10#2)
and diode##3##2##(2008-10#1)(2008-2#2)
and diodes##3##2##(1993-9#1)(2008-3#1)(2008-7#1)
and dioxin##2##2##(2008-10#2)
and dioxin-like PCBs in food##3##5##(2008-10#3)
and dioxin-like PCBs##5##3##(2008-10#5)
and dioxin-like compounds##2##3##(2008-10#2)
and dioxin-like##10##2##(2008-10#10)
and dioxins##2##2##(1994-3#1)(2008-11#1)
and dip##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
and dipeptide##3##2##(1990-8#1)(1996-3#1)(2008-10#1)
and dipeptides##3##2##(1990-11#2)(1994-8#1)
and diphenyl-mercury##3##2##(2008-10#3)
and diploid##6##2##(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#2)
and diploma##2##2##(2008-12#2)
and diplopia##2##2##(2008-7#1)(2011-2#1)
and dipyridamole##4##2##(1994-5#2)(1995-8#2)
and direct detection of##4##4##(2008-10#3)(2012-3#1)
and direct detection##5##3##(2008-10#3)(2008-3#1)(2012-3#1)
and direct immersion solid-phase microextraction##2##5##(2008-10#2)
and direct injection electrospray mass##2##5##(2008-7#2)
and direct measurement of the##3##5##(2008-10#3)
and direct measures of##2##4##(2011-2#1)(2013-8#1)
and direct method for##2##4##(1995-12#1)(2008-10#1)
and direct method##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
and direct numerical##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
and direct sequencing##2##3##(1992-2#1)(2008-2#1)
and direct the##2##3##(2011-2#1)(2012-12#1)
and direct##79##2##(1990-12#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-8#1)(1995-12#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#27)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-6#2)(2010-3#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and directed to##2##3##(2006-6#1)(2012-12#1)
and directed##10##2##(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)
and directing##2##2##(1994-3#1)(2008-1#1)
and direction of the##3##4##(2007-11#1)(2008-3#1)(2010-8#1)
and direction of##15##3##(1992-3#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#2)(2013-1#1)
and direction##23##2##(1990-8#1)(1992-3#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-5#1)(2010-8#2)(2013-1#2)(2013-8#1)
and directional##2##2##(2008-8#1)(2013-1#1)
and directionality##2##2##(2008-3#1)(2009-12#1)
and directions for future research are##3##6##(1995-2#1)(1996-2#1)(2007-12#1)
and directions for future research##5##5##(1995-2#1)(1996-2#1)(2007-12#1)(2012-12#1)(2012-3#1)
and directions for future##6##4##(1995-2#1)(1996-2#1)(2007-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
and directions for##8##3##(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
and directions##14##2##(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and directly applicable to##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
and directly from##2##3##(2008-10#1)(2012-2#1)
and directly introduced into the graphite furnace##2##7##(2008-10#2)
and directly introduced##3##3##(2008-10#3)
and directly observed##2##3##(1996-3#1)(2007-10#1)
and directly##29##2##(1992-11#1)(1992-8#1)(1994-5#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-1#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#1)
and disabilities##4##2##(2007-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
and disability at##3##3##(2007-10#1)(2008-9#2)
and disability in##5##3##(1993-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
and disability##39##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-10#2)(2007-11#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and disabled##7##2##(1991-2#1)(1991-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(2008-11#1)(2011-2#1)
and disabling##8##2##(1992-5#1)(1994-3#1)(1995-11#1)(2007-11#1)(2008-8#1)(2009-2#1)(2009-5#1)(2013-1#1)
and disadvantages are discussed##2##4##(2008-3#1)(2010-12#1)
and disadvantages of each##8##4##(1992-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2011-2#1)(2013-8#1)
and disadvantages of the##8##4##(1992-3#1)(2007-5#1)(2008-10#4)(2008-3#1)(2009-5#1)
and disadvantages of using##4##4##(1991-3#1)(1996-1#1)(2007-5#1)(2007-6#1)
and disadvantages of##43##3##(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#2)(1993-3#1)(1996-1#1)(1996-3#2)(1997-2#1)(2007-10#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#9)(2008-3#2)(2008-4#3)(2008-9#3)(2009-5#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-8#1)
and disadvantages were##2##3##(2011-7#1)(2012-2#1)
and disadvantages##68##2##(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#3)(1993-3#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-5#2)(2007-6#1)(2007-8#3)(2008-10#12)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-7#1)(2008-9#3)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and disappearance of##5##3##(1995-2#1)(2007-8#1)(2008-4#1)(2011-2#1)(2013-8#1)
and disappeared after##2##3##(1991-2#1)(2008-5#1)
and disappeared##6##2##(1991-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-5#1)(2013-8#1)
and disassembly of##2##3##(1994-12#1)(2011-2#1)
and disaster##2##2##(2009-12#1)(2012-2#1)
and disasters##2##2##(2008-1#1)(2012-2#1)
and disc diffusion##2##3##(2008-12#1)(2008-7#1)
and disc##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
and discharge##15##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-1#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-3#1)(2011-2#1)
and discharged##3##2##(2008-10#2)(2012-12#1)
and discharges##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
and discharging the##2##3##(2008-10#1)(2009-3#1)
and discharging##4##2##(2008-10#3)(2009-3#1)
and discipline##2##2##(2008-7#1)(2012-2#1)
and disclosure of##2##3##(2008-10#1)(2008-7#1)
and disclosure##5##2##(1995-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
and discoloration##3##2##(2007-7#1)(2008-10#2)
and discomfort##8##2##(1992-3#1)(2008-12#3)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
and discontinuous##5##2##(1995-2#1)(2008-10#2)(2008-3#1)(2008-7#1)
and discourse##2##2##(2008-9#1)(2011-1#1)
and discovery of##2##3##(2008-7#1)(2011-2#1)
and discovery##5##2##(1992-3#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
and discrete##5##2##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
and discriminant analysis##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
and discriminant validity##3##3##(2007-12#1)(2008-10#1)(2009-11#1)
and discriminant##9##2##(1992-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)(2009-9#1)
and discriminate##2##2##(2008-11#1)(2008-4#1)
and discriminated##2##2##(2008-10#1)(2008-7#1)
and discriminating##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
and discrimination against##2##3##(1995-12#1)(2010-10#1)
and discrimination are##2##3##(1996-3#1)(2010-4#1)
and discrimination of##3##3##(2008-10#3)
and discrimination power##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
and discrimination##23##2##(1995-12#1)(1996-3#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-1#1)(2013-1#2)
and discriminatory##2##2##(2008-11#2)
and discs##2##2##(2009-4#1)(2009-7#1)
and discuss a##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
and discuss common##2##3##(2008-11#1)(2011-2#1)
and discuss current##4##3##(2010-3#1)(2010-7#1)(2010-9#1)(2012-2#1)
and discuss future##2##3##(2009-3#1)(2011-2#1)
and discuss how to##3##4##(2007-11#1)(2008-4#1)(2008-7#1)
and discuss how##6##3##(1997-1#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#1)
and discuss implications##2##3##(2008-9#1)(2009-7#1)
and discuss integration##2##3##(2007-12#1)(2008-7#1)
and discuss its application##2##4##(2008-11#1)(2008-3#1)
and discuss its##6##3##(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-7#1)
and discuss possible##2##3##(2008-9#1)(2012-1#1)
and discuss potential mechanisms by which##2##6##(2008-7#1)(2012-2#1)
and discuss potential##5##3##(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
and discuss several##2##3##(1994-2#1)(2008-7#1)
and discuss some of the##2##5##(2007-11#1)(2011-2#1)
and discuss the diagnosis and##2##5##(1995-8#1)(2008-10#1)
and discuss the diagnostic##2##4##(2008-6#1)(2013-1#1)
and discuss the implications##2##4##(1995-2#1)(2010-5#1)
and discuss the most##2##4##(2009-10#1)(2010-7#1)
and discuss the possibility##2##4##(1991-5#1)(2009-5#1)
and discuss the possible##2##4##(2008-7#1)(2012-3#1)
and discuss the potential##4##4##(2008-7#1)(2011-1#2)(2013-8#1)
and discuss the role of##2##5##(2008-7#1)(2011-2#1)
and discuss the##53##3##(1991-5#1)(1994-12#1)(1994-2#2)(1995-2#2)(1995-5#2)(1995-8#1)(1997-2#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and discuss their implications for##3##5##(2008-8#1)(2009-5#1)(2011-2#1)
and discuss their implications##4##4##(2007-11#1)(2008-8#1)(2009-5#1)(2011-2#1)
and discuss their relationships##2##4##(2013-1#2)
and discuss their##15##3##(1991-6#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
and discuss two##2##3##(1996-3#1)(2008-11#1)
and discuss various##3##3##(2007-5#1)(2007-7#1)(2010-11#1)
and discuss##142##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-12#2)(1994-2#3)(1995-1#1)(1995-2#2)(1995-5#3)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#4)
and discussed and the##2##4##(2008-10#1)(2008-7#1)
and discussed for##2##3##(2008-10#1)(2008-3#1)
and discussed from##2##3##(2008-10#1)(2010-11#1)
and discussed in detail##2##4##(2008-10#1)(2008-9#1)
and discussed in reference to each##2##6##(2008-7#1)(2012-2#1)
and discussed in relation to##2##5##(1995-3#1)(2008-11#1)
and discussed in the light of##2##6##(2008-10#1)(2012-3#1)
and discussed in##14##3##(1994-11#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)
and discussed the##2##3##(2008-10#1)(2009-5#1)
and discussed to##2##3##(1995-1#1)(2008-10#1)
and discussed##91##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(2007-11#2)(2007-12#1)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#13)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and discusses how they##2##4##(1991-3#1)(2008-7#1)
and discusses how##5##3##(1991-3#1)(1992-3#1)(1994-3#1)(2008-4#1)(2008-7#1)
and discusses possible##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
and discusses some of the##2##5##(1992-1#1)(2008-9#1)
and discusses some of##3##4##(1992-1#1)(2008-4#1)(2008-9#1)
and discusses some##4##3##(1992-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
and discusses the importance of##3##5##(2008-11#2)(2011-2#1)
and discusses the possibilities##2##4##(1994-9#1)(2012-12#1)
and discusses the role of##2##5##(1991-9#1)(2012-12#1)
and discusses the usefulness##2##4##(2008-10#1)(2012-3#1)
and discusses the##35##3##(1990-6#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#2)(2008-9#2)(2009-12#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-3#1)
and discusses their##4##3##(1996-3#1)(2008-11#1)(2008-4#1)(2013-1#1)
and discusses##70##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#6)(2009-12#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
and discussing##4##2##(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
and discussion of the##2##4##(2008-11#1)(2008-8#1)
and discussion of##8##3##(1997-3#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
and discussion##19##2##(1991-6#1)(1994-12#1)(1997-3#1)(2007-5#1)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and discussions that##2##3##(2008-11#1)(2011-2#1)
and disease activity##2##3##(2011-2#1)(2012-1#1)
and disease and##5##3##(1993-9#1)(2008-10#2)(2012-1#1)(2012-2#1)
and disease control##8##3##(2007-2#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-3#3)
and disease development##3##3##(2008-10#3)
and disease for##2##3##(1992-5#1)(2008-1#1)
and disease free##3##3##(1991-8#1)(1992-5#1)(2011-2#1)
and disease in##5##3##(1993-11#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
and disease incidence at midstem elongation##2##6##(2008-10#2)
and disease incidence was##2##4##(2008-10#2)
and disease incidence##6##3##(2008-10#6)
and disease prevention##9##3##(1994-12#2)(1995-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
and disease progression##4##3##(2009-7#1)(2010-1#1)(2010-11#1)(2010-6#1)
and disease resistance in##2##4##(1992-9#1)(2008-8#1)
and disease resistance##4##3##(1992-9#1)(2008-10#2)(2008-8#1)
and disease severity were##2##4##(2008-10#2)
and disease severity##12##3##(1994-9#1)(1996-1#1)(2008-10#7)(2008-7#1)(2010-12#1)(2011-1#1)
and disease states##3##3##(2008-10#1)(2010-10#1)(2010-12#1)
and disease status##3##3##(1994-11#1)(2008-10#1)(2012-12#1)
and disease suppression##2##3##(2008-10#2)
and disease surveillance##2##3##(1997-3#2)
and disease susceptibility##2##3##(2008-10#1)(2008-3#1)
and disease##166##2##(1990-8#1)(1991-5#1)(1991-8#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-12#3)(2007-2#2)(2008-1#2)(2008-10#46)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#3)(2008-9#3)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#2)
and disease-free survival of##2##4##(1993-9#1)(2011-2#1)
and disease-free survival##5##3##(1992-8#1)(1993-9#1)(2008-10#1)(2011-2#2)
and disease-free##6##2##(1992-8#1)(1993-9#1)(1994-2#1)(2008-10#1)(2011-2#2)
and disease-induced##2##2##(2008-10#2)
and disease-related##2##2##(2008-5#1)(2012-2#1)
and diseased leaf area##2##4##(2008-10#2)
and diseased##13##2##(2007-7#1)(2008-10#9)(2008-2#1)(2008-4#1)(2013-1#1)
and diseases are##2##3##(1997-7#1)(2008-1#1)
and diseases in##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
and diseases such as##2##4##(2009-12#1)(2013-7#1)
and diseases##15##2##(1995-9#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#3)(2013-7#2)
and disinfection##4##2##(1997-3#2)(2007-12#1)(2007-7#1)
and disintegration##2##2##(1997-3#2)
and disk##3##2##(2008-2#1)(2008-3#1)(2009-3#1)
and dislocated##2##2##(2007-11#1)(2008-8#1)
and disodium##2##2##(1997-6#1)(2008-10#1)
and disomic##2##2##(2008-10#1)(2008-8#1)
and disorder##3##2##(2009-10#1)(2011-2#1)(2013-8#1)
and disordered eating##5##3##(2007-12#1)(2011-2#1)(2012-2#3)
and disordered##6##2##(2007-11#1)(2007-12#1)(2011-2#1)(2012-2#3)
and disorders of##3##3##(1990-2#1)(1993-11#1)(2008-5#1)
and disorders##7##2##(1990-2#1)(1993-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2012-3#2)
and disorganization##2##2##(2008-10#1)(2008-2#1)
and dispel##2##2##(2008-7#1)(2010-4#1)
and dispensed##2##2##(2008-11#1)(2010-3#1)
and dispensing##3##2##(1995-1#1)(2008-7#1)(2010-5#1)
and dispersal##9##2##(2008-10#2)(2008-8#6)(2008-9#1)
and dispersed by##2##3##(2008-10#1)(2008-8#1)
and dispersed##7##2##(1991-3#2)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)
and dispersion calculations##2##3##(2008-11#2)
and dispersion of the##2##4##(2008-1#1)(2008-10#1)
and dispersion of##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
and dispersion patterns##2##3##(2007-5#1)(2008-10#1)
and dispersion##18##2##(2007-11#5)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2012-12#1)(2013-1#1)
and dispersions##2##2##(2008-2#1)(2008-3#1)
and dispersive##2##2##(2007-12#1)(2008-3#1)
and displaced##2##2##(2009-6#1)(2013-1#1)
and displacement of the##2##4##(2007-8#1)(2009-8#1)
and displacement of##3##3##(2007-8#1)(2009-3#1)(2009-8#1)
and displacement##9##2##(1996-4#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)
and displacements##2##2##(2008-2#1)(2009-4#1)
and display a##2##3##(2008-6#1)(2010-11#1)
and display in##3##3##(2007-11#1)(2012-3#2)
and display of##2##3##(2007-11#1)(2008-3#1)
and display the##3##3##(2008-3#2)(2009-2#1)
and display##22##2##(1990-5#1)(1994-5#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
and displayed in the##2##4##(2008-3#1)(2008-8#1)
and displayed##11##2##(1994-12#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2012-7#1)(2013-1#1)
and displaying##2##2##(2008-10#2)
and displays a##4##3##(1991-5#1)(1995-6#1)(2008-10#1)(2008-4#1)
and displays##8##2##(1991-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-6#2)(2010-8#1)
and disposal of##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2010-9#1)
and disposal##6##2##(1997-4#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-9#1)
and disposition##4##2##(1996-1#1)(2008-1#1)(2008-8#1)(2011-1#1)
and disproportionately##3##2##(2008-9#2)(2010-3#1)
and disrupt##2##2##(1993-3#1)(2010-11#1)
and disruption of##3##3##(2008-8#2)(2012-2#1)
and disruption##4##2##(2008-10#1)(2008-8#2)(2012-2#1)
and disruptive##4##2##(1994-1#1)(2008-12#1)(2010-7#1)(2013-1#1)
and dissatisfaction##2##2##(2007-7#1)(2013-1#1)
and dissection are the##2##4##(2008-11#1)(2012-12#1)
and dissection of##2##3##(2008-7#1)(2008-9#1)
and dissection##7##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
and disseminated intravascular coagulation##2##4##(2006-10#1)(2011-2#1)
and disseminated intravascular##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
and disseminated##5##2##(2006-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
and disseminating##6##2##(1993-12#1)(1996-3#1)(1997-3#2)(2007-7#1)(2010-8#1)
and dissemination is##2##3##(2008-7#2)
and dissemination of##4##3##(2008-10#3)(2008-11#1)
and dissemination##13##2##(1991-4#1)(1992-12#1)(1994-3#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-8#1)(2013-1#1)
and dissociated##3##2##(1997-6#2)(2008-10#1)
and dissociation of the##2##4##(2009-10#1)(2012-12#1)
and dissociation of##3##3##(1993-3#1)(2009-10#1)(2012-12#1)
and dissociation##13##2##(1991-5#1)(1993-1#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#1)
and dissolution of the precipitate with##2##6##(2008-10#2)
and dissolution of the##3##4##(2008-10#2)(2008-11#1)
and dissolution studies##2##3##(2008-10#2)
and dissolution##11##2##(2008-10#5)(2008-11#1)(2009-9#1)(2012-2#4)
and dissolved in ammonium##2##4##(2008-10#2)
and dissolved in##4##3##(2008-10#4)
and dissolved organic matter##2##4##(2008-10#1)(2008-2#1)
and dissolved organic##3##3##(2008-10#2)(2008-2#1)
and dissolved oxygen##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
and dissolved##23##2##(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#2)(2011-2#2)(2013-7#1)
and dissolving##2##2##(2008-10#1)(2008-12#1)
and distal tubal##2##3##(1993-1#2)
and distal tubular##2##3##(1995-11#2)
and distal##19##2##(1993-1#4)(1995-11#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
and distally##2##2##(2010-10#1)(2013-1#1)
and distance of##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
and distance to the nearest##2##5##(2008-10#1)(2012-1#1)
and distance##16##2##(1995-3#1)(1995-6#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#2)(2010-8#1)(2012-1#1)(2013-1#1)
and distances##2##2##(2008-10#2)
and distant metastases##3##3##(1994-8#1)(1996-10#1)(2012-3#1)
and distant metastasis##2##3##(2008-10#1)(2010-3#1)
and distant##12##2##(1990-12#1)(1991-6#1)(1994-8#1)(1995-4#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
and distensibility##4##2##(2013-3#4)
and distension##2##2##(2008-1#1)(2010-12#1)
and distilled water##3##3##(1996-5#1)(2008-2#1)(2009-11#1)
and distilled##5##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)
and distinct from that##2##4##(1992-6#1)(2006-10#1)
and distinct from##4##3##(1992-6#1)(2006-10#1)(2008-10#2)
and distinct##14##2##(1992-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#7)(2008-11#1)(2011-1#1)(2013-1#1)
and distinctive##3##2##(1997-3#1)(2008-4#1)(2013-1#1)
and distinguish between##2##3##(1997-6#1)(2006-4#1)
and distinguish them from##2##4##(2008-10#1)(2008-9#1)
and distinguish them##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
and distinguish##11##2##(1993-12#1)(1996-2#1)(1997-6#1)(2006-4#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and distinguishable##2##2##(2008-10#1)(2008-11#1)
and distinguished##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
and distinguishing##4##2##(2008-1#1)(2008-9#1)(2010-3#1)(2011-2#1)
and distorted##2##2##(2008-10#1)(2012-2#1)
and distortion of the##2##4##(2007-12#1)(2008-5#1)
and distortion of##3##3##(2007-12#1)(2008-5#1)(2011-1#1)
and distortion##4##2##(1995-6#1)(2007-12#1)(2008-5#1)(2011-1#1)
and distortions##3##2##(1997-3#1)(2008-3#1)(2013-1#1)
and distraction##4##2##(2007-12#1)(2010-10#2)(2013-8#1)
and distress##7##2##(1995-12#1)(1996-2#1)(2008-11#3)(2012-3#2)
and distributed by state##2##4##(1995-2#2)
and distributed by##3##3##(1995-2#3)
and distributed in##2##3##(1992-9#1)(2011-2#1)
and distributed##14##2##(1992-9#1)(1994-12#1)(1994-3#1)(1995-2#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-4#1)(2010-8#1)(2011-2#1)
and distribution analysis of##2##4##(2008-10#2)
and distribution analysis##3##3##(2008-10#3)
and distribution in##3##3##(1993-12#1)(2008-5#1)(2013-7#1)
and distribution of species##2##4##(2008-8#2)
and distribution of the##10##4##(1991-3#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
and distribution of wheat bugs##2##5##(2013-8#2)
and distribution of##58##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-12#2)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#2)
and distribution on the##2##4##(1991-2#1)(2008-8#1)
and distribution pattern of##3##4##(2007-12#2)(2009-6#1)
and distribution throughout the##2##4##(2008-10#1)(2009-8#1)
and distribution##92##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-12#3)(2008-10#19)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#6)(2013-8#2)
and distributional impacts of##2##4##(1994-2#2)
and distributional##4##2##(1994-2#2)(2008-9#1)(2010-8#1)
and distributions of##2##3##(1990-8#1)(2008-10#1)
and distributions##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
and district hospitals##2##3##(2011-2#1)(2013-1#1)
and district##6##2##(1990-3#1)(2007-2#1)(2010-8#2)(2011-2#1)(2013-1#1)
and disturbance in##2##3##(2008-9#1)(2013-1#1)
and disturbance of##2##3##(2009-10#1)(2009-6#1)
and disturbance##4##2##(2008-9#1)(2009-10#1)(2009-6#1)(2013-1#1)
and disturbances in##4##3##(2007-11#1)(2008-1#1)(2009-11#1)(2012-3#1)
and disturbances##6##2##(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2009-11#1)(2012-3#1)
and disturbed##2##2##(2011-10#1)(2013-7#1)
and disubstituted##3##2##(1996-2#1)(2009-9#2)
and dithiothreitol##2##2##(1992-12#1)(1993-6#1)
and dityrosine##2##2##(2009-8#2)
and diuretics##5##2##(1994-7#1)(2008-1#2)(2008-5#1)(2013-1#1)
and diuron##3##2##(2008-10#3)
and divalent ions##2##3##(2008-10#1)(2011-2#1)
and divalent##6##2##(2008-10#4)(2011-2#2)
and divergence##8##2##(2008-2#2)(2008-3#1)(2010-3#1)(2012-3#3)(2013-7#1)
and divergent##5##2##(1992-12#1)(1994-6#1)(2007-10#1)(2008-10#1)(2008-8#1)
and diverging##2##2##(2008-2#1)(2010-4#1)
and diverse##21##2##(1990-6#1)(1991-5#1)(1994-11#1)(1994-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
and diversification##2##2##(1991-3#1)(2010-3#1)
and diversion##4##2##(1992-5#1)(2008-3#1)(2009-5#1)(2010-8#1)
and diversity in##3##3##(1990-8#1)(2008-5#1)(2009-2#1)
and diversity of the##4##4##(1997-9#1)(2012-2#3)
and diversity of##20##3##(1994-9#1)(1997-9#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-5#3)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#4)(2013-7#1)
and diversity##41##2##(1990-8#1)(1993-11#1)(1994-9#2)(1997-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#6)(2008-7#2)(2008-8#3)(2009-2#1)(2010-3#1)(2011-2#1)(2012-2#4)(2013-7#6)(2013-8#1)
and divided attention##2##3##(1991-1#1)(2008-4#1)
and divided into##7##3##(1993-5#1)(1995-12#1)(1996-9#1)(2008-12#2)(2011-3#1)(2013-7#1)
and divided##15##2##(1991-1#1)(1993-5#1)(1994-6#1)(1995-12#1)(1996-9#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-3#1)(2013-7#1)
and division of##2##3##(2008-7#1)(2013-8#1)
and division##10##2##(2007-8#1)(2008-3#1)(2008-7#3)(2009-8#1)(2011-2#3)(2013-8#1)
and divorce##3##2##(2008-12#1)(2009-11#1)(2011-2#1)
and dizziness##2##2##(2008-5#1)(2012-12#1)
and dn/dT##2##2##(2008-3#2)
and do not allow##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
and do not require##4##4##(2008-10#2)(2010-1#1)(2013-1#1)
and do not show##2##4##(1997-4#1)(2008-7#1)
and do not##33##3##(1991-1#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
and do show##2##3##(2008-11#1)(2009-11#1)
and do##38##2##(1991-1#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
and docking##4##2##(1995-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
and docosahexaenoic acid##5##3##(1996-7#1)(2008-2#1)(2009-5#1)(2010-1#1)(2013-1#1)
and docosahexaenoic acids##2##3##(1996-7#1)(2011-2#1)
and docosahexaenoic##8##2##(1990-5#1)(1996-7#2)(2008-2#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#1)
and doctors##9##2##(1990-12#1)(1990-3#1)(2007-10#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
and doctors' perceptions##2##3##(1997-5#1)(1997-8#1)
and doctors'##3##2##(1990-9#1)(1997-5#1)(1997-8#1)
and document##7##2##(1992-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-4#1)(2010-3#1)
and documentation are##2##3##(1992-2#1)(1996-3#1)
and documentation of a##3##4##(1995-12#1)(2010-12#1)(2013-1#1)
and documentation of##4##3##(1994-12#1)(1995-12#1)(2010-12#1)(2013-1#1)
and documentation##7##2##(1992-2#1)(1994-12#1)(1995-12#1)(1996-3#1)(2007-2#1)(2010-12#1)(2013-1#1)
and documented##4##2##(1992-1#1)(2008-11#1)(2008-7#1)(2010-3#1)
and documenting##4##2##(1991-8#1)(1996-12#1)(2008-2#1)(2010-10#1)
and documents##5##2##(1994-3#2)(2010-8#1)(2011-2#1)(2013-8#1)
and does not appear to##2##5##(1996-2#1)(1997-1#1)
and does not bind mAbs M1 and##2##7##(1997-3#2)
and does not cause##3##4##(2008-10#2)(2008-12#1)
and does not have a##2##5##(1992-2#1)(2008-10#1)
and does not involve##2##4##(2008-3#1)(2008-9#1)
and does not need any##2##5##(2008-3#2)
and does not need##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
and does not occur in##2##5##(1995-6#1)(2008-11#1)
and does not produce##3##4##(2008-10#2)(2008-3#1)
and does not rely on##2##5##(2008-2#1)(2008-3#1)
and does not require a##2##5##(2008-3#1)(2008-6#1)
and does not require the##2##5##(2008-4#1)(2011-2#1)
and does not require##13##4##(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#3)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)
and does not show##2##4##(1996-2#1)(2008-5#1)
and does not stop##2##4##(2008-3#1)(2008-5#1)
and does not##66##3##(1990-12#1)(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-2#2)(1997-1#1)(1997-3#2)(1997-4#1)(2007-12#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#2)(2008-9#2)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
and does##71##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-2#2)(1997-1#1)(1997-3#2)(1997-4#1)(2007-12#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-6#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
and dog##6##2##(1990-5#2)(1992-10#1)(1994-6#1)(2008-10#1)(2010-3#1)
and dogs were##2##3##(1995-12#1)(2008-12#1)
and dogs##9##2##(1992-6#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
and doing##2##2##(1994-1#1)(2008-10#1)
and domain##7##2##(1991-6#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-8#1)(2009-5#1)(2012-2#1)
and dome formation in##2##4##(1995-10#2)
and dome##3##2##(1995-10#2)(2009-2#1)
and domestic animals in##2##4##(1990-3#1)(2008-12#1)
and domestic animals##5##3##(1990-3#1)(2008-12#2)(2012-2#1)(2013-7#1)
and domestic consumption##2##3##(2011-1#1)(2013-1#1)
and domestic##14##2##(1990-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
and domesticated animals##2##3##(2008-10#1)(2010-1#1)
and dominance##4##2##(1992-11#1)(2008-4#1)(2009-7#1)(2013-7#1)
and dominant##10##2##(1995-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2012-2#2)(2012-3#1)
and dominants##2##2##(2008-8#1)(2010-8#1)
and donor##8##2##(1992-6#1)(1994-11#1)(2008-10#1)(2008-4#1)(2009-12#1)(2011-2#2)(2012-2#1)
and donors##5##2##(1992-12#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
and dopa##2##2##(1990-12#2)
and dopamine (DA)##4##3##(1997-7#1)(2008-10#2)(2013-1#1)
and dopamine in pharmaceutical##3##4##(2008-10#3)
and dopamine in##4##3##(1993-6#1)(2008-10#3)
and dopamine receptors##2##3##(2011-2#1)(2012-2#1)
and dopamine##34##2##(1990-8#2)(1992-11#1)(1993-12#2)(1993-5#1)(1993-6#3)(1993-8#1)(1995-12#2)(1996-5#1)(1997-7#1)(2008-10#10)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
and dopamine-beta-hydroxylase (DBH)##2##3##(1995-11#1)(2013-1#1)
and dopaminergic##6##2##(1993-5#1)(1994-2#2)(2009-11#1)(2010-12#1)(2012-2#1)
and doped samples##2##3##(2008-10#2)
and doped##8##2##(2008-10#6)(2008-2#1)(2008-3#1)
and doping##4##2##(1990-8#1)(1993-3#1)(2007-11#1)(2009-11#1)
and dorsal paragigantocellularis##2##3##(1990-9#2)
and dorsal radioulnar ligaments##2##4##(2008-9#2)
and dorsal raphe##2##3##(1993-3#1)(1994-2#1)
and dorsal##17##2##(1990-9#2)(1993-3#2)(1994-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#5)(2010-8#1)(2012-2#1)(2012-3#1)
and dosage forms##3##3##(2008-10#3)
and dosage of##5##3##(2006-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
and dosage##14##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#1)
and dose dependent##3##3##(1991-5#1)(1993-8#1)(1994-9#1)
and dose dependently##2##3##(1994-2#1)(2012-3#1)
and dose intensity##2##3##(2008-5#1)(2010-4#1)
and dose of##3##3##(1993-11#1)(2008-7#1)(2012-3#1)
and dose rate##2##3##(2008-7#1)(2011-2#1)
and dose rates##3##3##(2007-5#1)(2008-7#2)
and dose##30##2##(1991-5#1)(1991-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-9#1)(1997-1#1)(2007-5#1)(2008-5#2)(2008-6#1)(2008-7#8)(2009-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#4)(2012-3#3)
and dose-dependent increase##2##3##(1994-11#1)(1994-9#1)
and dose-dependent manner##2##3##(1994-11#1)(1995-8#1)
and dose-dependent##15##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2010-1#1)(2013-7#1)
and dose-dependently##2##2##(2008-5#2)
and dose-response##2##2##(1994-11#1)(1996-2#1)
and doses##2##2##(2008-10#1)(2013-1#1)
and dosimetric##2##2##(2007-4#1)(2012-1#1)
and dosing##2##2##(2008-11#1)(2008-5#1)
and dot blot##2##3##(2008-10#1)(2008-9#1)
and dot##5##2##(1990-12#1)(2008-10#1)(2008-9#1)(2009-11#2)
and double stranded##2##3##(1990-5#1)(2008-10#1)
and double##22##2##(1990-5#1)(1990-7#1)(1991-9#2)(1992-3#1)(1992-9#1)(1996-9#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
and double-stranded RNA##2##3##(2008-10#1)(2008-9#1)
and double-stranded##6##2##(2008-10#3)(2008-9#3)
and doubling time##2##3##(2008-11#1)(2011-2#1)
and down##11##2##(1992-9#1)(2006-10#1)(2008-11#3)(2010-12#1)(2010-8#1)(2011-2#3)(2013-8#1)
and down-regulated##2##2##(1993-9#1)(2008-8#1)
and down-regulates##2##2##(2008-8#1)(2011-1#1)
and down-regulation of##4##3##(1997-1#1)(2008-3#1)(2009-9#1)(2010-4#1)
and downregulation of##2##3##(2008-11#1)(2010-12#1)
and downsampling##2##2##(2008-2#1)(2008-3#1)
and downstream##14##2##(1990-11#1)(1991-9#1)(1992-11#2)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
and downward irradiance##2##3##(2008-3#2)
and downward##9##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-11#2)
and downy mildew##5##3##(2008-10#5)
and doxorubicin##6##2##(2008-6#5)(2010-2#1)
and doxycycline##8##2##(2008-10#8)
and doxycycline)##2##2##(2008-10#1)(2012-3#1)
and dozens of##2##3##(2008-10#1)(2009-8#1)
and drainage of the##2##4##(2008-12#1)(2011-2#1)
and drainage of##4##3##(2008-12#1)(2009-7#2)(2011-2#1)
and drainage##10##2##(1993-9#1)(2008-10#1)(2008-12#1)(2009-6#2)(2009-7#2)(2010-1#1)(2011-2#2)
and drained##2##2##(1996-9#1)(1997-8#1)
and draining##3##2##(2007-8#1)(2008-1#1)(2008-7#1)
and drains##2##2##(2007-5#1)(2012-2#1)
and dramatic##6##2##(1993-12#1)(1995-3#1)(2007-12#1)(2007-5#1)(2008-8#1)(2011-2#1)
and dramatically increase##2##3##(1994-12#1)(2012-2#1)
and dramatically##8##2##(1994-12#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-2#1)
and draw##7##2##(1990-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2010-12#1)
and drawbacks of the##2##4##(2007-12#1)(2013-1#1)
and drawbacks of##8##3##(2007-12#1)(2008-10#3)(2008-3#1)(2012-12#1)(2013-1#2)
and drawbacks##12##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#2)
and drawing##6##2##(1995-6#1)(2007-11#1)(2008-1#2)(2008-2#1)(2009-2#1)
and drawn##2##2##(1994-3#1)(1996-6#1)
and draws##4##2##(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)
and dread##3##2##(2008-11#2)(2010-8#1)
and dreaming##2##2##(2013-8#2)
and dreams##2##2##(2008-12#1)(2013-1#1)
and drew##3##2##(1996-5#1)(2008-12#1)(2008-5#1)
and dried##4##2##(1991-5#1)(2008-10#2)(2010-4#1)
and drift in##2##3##(2008-10#2)
and drift##6##2##(2007-5#2)(2008-10#3)(2012-2#1)
and drinking water samples##2##4##(2008-10#2)
and drinking water##8##3##(1990-3#1)(2008-10#3)(2008-5#1)(2008-9#3)
and drinking##14##2##(1990-3#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-9#3)(2009-7#1)(2012-1#1)
and drip irrigation##2##3##(2008-10#2)
and drippy##2##2##(2008-10#2)
and drivers of##2##3##(2012-12#2)
and drivers##3##2##(2012-12#2)(2012-3#1)
and driving##3##2##(2008-4#1)(2008-7#1)(2012-3#1)
and drop##3##2##(2008-10#3)
and droplets##5##2##(2007-5#1)(2008-3#3)(2012-1#1)
and dropped to##2##3##(2008-10#1)(2008-8#1)
and dropped##5##2##(1992-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
and drought on##2##3##(2012-2#1)(2012-6#1)
and drought##6##2##(2008-12#2)(2008-5#1)(2012-2#1)(2012-6#2)
and drug abuse##2##3##(1990-2#1)(2008-5#1)
and drug administration##2##3##(2008-4#1)(2008-8#1)
and drug delivery##3##3##(2008-12#1)(2008-7#1)(2010-5#1)
and drug dependence##2##3##(2008-6#2)
and drug development##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)
and drug discovery##2##3##(2008-4#1)(2013-1#1)
and drug interactions##2##3##(2008-11#1)(2008-8#1)
and drug resistance##6##3##(2007-12#1)(2008-11#3)(2012-2#2)
and drug therapy##4##3##(2007-7#1)(2008-1#1)(2009-10#1)(2010-6#1)
and drug transport##2##3##(2008-11#2)
and drug treatment##4##3##(1992-12#1)(2006-10#1)(2008-3#1)(2009-12#1)
and drug use##5##3##(1996-6#2)(2009-11#1)(2010-9#1)(2011-1#1)
and drug##92##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-6#2)(2006-10#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#3)(2013-1#4)(2013-8#3)
and drug-eluting stents##2##3##(2008-11#1)(2009-5#1)
and drug-eluting##3##2##(2008-11#1)(2009-5#1)(2011-2#1)
and drug-excipient interaction (IR spectroscopy)##2##5##(2010-3#2)
and drug-related##2##2##(2008-12#1)(2008-5#1)
and drugs and##2##3##(2012-2#1)(2013-1#1)
and drugs that##2##3##(2008-4#1)(2013-1#1)
and drugs##20##2##(1990-11#1)(1993-8#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
and dry bean##3##3##(2008-10#3)
and dry cough##5##3##(1997-7#1)(2008-1#2)(2010-2#1)(2011-2#1)
and dry heat treatment##2##4##(2008-10#2)
and dry heat##3##3##(2008-10#3)
and dry mass##2##3##(2008-10#1)(2008-7#1)
and dry matter##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
and dry powder##2##3##(1997-2#1)(2007-11#1)
and dry skin##2##3##(2008-5#1)(2012-3#1)
and dry weight of##3##4##(2008-10#2)(2011-2#1)
and dry weight##4##3##(2008-10#3)(2011-2#1)
and dry weights of leaves and roots were determined##2##9##(2008-10#2)
and dry weights of leaves and roots##3##7##(2008-10#3)
and dry##48##2##(1991-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-10#20)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2012-6#1)(2013-7#2)(2013-8#1)
and drying##10##2##(2008-10#6)(2008-12#3)(2011-2#1)
and dsDNA##4##2##(2008-10#2)(2008-4#1)(2008-8#1)
and dsRNAs from##2##3##(2008-10#2)
and dual##6##2##(1997-2#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#2)
and dual-arc RapidArc were##3##4##(2013-1#3)
and dual-arc##4##2##(2013-1#4)
and dual-fiber##3##2##(2008-3#3)
and dual-ion-beam##2##2##(2008-2#2)
and ducts##2##2##(2010-7#1)(2013-1#1)
and due to its##2##4##(2007-10#1)(2008-10#1)
and due to their##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
and due to##11##3##(1990-5#1)(1991-10#1)(1992-3#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)
and dumping##2##2##(1994-3#1)(2008-10#1)
and duodenal##4##2##(1991-2#1)(1995-2#1)(2006-10#1)(2008-12#1)
and duodenum##3##2##(1994-8#1)(2008-3#1)(2011-2#1)
and duplicate urethra##2##3##(2008-10#2)
and duplication of the##2##4##(1997-3#1)(2008-7#1)
and duplication of##5##3##(1997-3#1)(2008-7#2)(2009-5#1)(2011-2#1)
and duplication##7##2##(1997-3#1)(2008-4#1)(2008-7#3)(2009-5#1)(2011-2#1)
and duplications##5##2##(1995-11#1)(2008-4#3)(2008-6#1)
and durability of##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
and durability##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#2)
and durable##9##2##(1992-1#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
and dural##4##2##(2008-7#3)(2009-3#1)
and duration as##2##3##(1997-6#1)(2008-10#1)
and duration of antibiotic therapy##2##5##(1990-6#1)(2010-6#1)
and duration of stay##2##4##(1992-12#1)(2012-3#1)
and duration of symptoms##3##4##(1997-3#1)(2007-8#1)(2013-1#1)
and duration of the effect##2##5##(1996-2#1)(2008-9#1)
and duration of the##5##4##(1990-12#1)(1992-3#1)(1996-2#1)(2008-6#1)(2008-9#1)
and duration of##53##3##(1990-12#1)(1990-6#1)(1992-12#2)(1992-3#2)(1993-1#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
and duration##69##2##(1990-12#1)(1990-6#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#2)
and during a##5##3##(1994-2#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
and during early##2##3##(1994-12#1)(2012-3#1)
and during pregnancy##2##3##(1995-6#1)(2013-1#1)
and during recovery from exercise in##2##6##(2013-8#2)
and during surgery##2##3##(1993-1#1)(2009-4#1)
and during the course of a##2##6##(2008-10#2)
and during the stress##2##4##(2008-10#1)(2013-8#1)
and during the##22##3##(1991-6#1)(1992-11#1)(1992-12#2)(1994-3#1)(1994-7#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#1)(2013-1#2)(2013-8#1)
and during transport##2##3##(2011-2#1)(2013-1#1)
and during##74##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-6#1)(1992-11#1)(1992-12#4)(1993-1#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-12#2)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#3)
and durum##2##2##(2008-10#2)
and duties##3##2##(1992-6#1)(1996-8#1)(2012-3#1)
and duty##2##2##(2008-3#2)
and dye##11##2##(1994-12#2)(1997-2#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)
and dyes##2##2##(2008-10#1)(2010-12#1)
and dying in##2##3##(1992-5#1)(2012-3#1)
and dying##12##2##(1992-5#1)(1994-1#4)(2007-10#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-3#1)
and dynamic changes##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
and dynamic in##2##3##(2009-7#1)(2009-9#1)
and dynamic processes##2##3##(2008-3#2)
and dynamic range of##2##4##(2008-10#1)(2008-2#1)
and dynamic range##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
and dynamic##81##2##(1990-6#1)(1990-7#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(2007-11#7)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#13)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#3)
and dynamical##2##2##(2009-8#1)(2012-2#1)
and dynamically##6##2##(1990-8#1)(2007-11#1)(2008-1#1)(2012-12#1)(2012-3#2)
and dynamics of a##2##4##(2008-12#1)(2008-8#1)
and dynamics of the##8##4##(1991-5#1)(1991-8#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-11#1)
and dynamics of##22##3##(1991-5#2)(1991-8#1)(1992-3#1)(1992-9#1)(1995-10#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)
and dynamics##37##2##(1991-5#2)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#2)(1994-9#1)(1995-10#1)(1995-5#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#3)(2009-11#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
and dynein##4##2##(2012-2#4)
and dysarthria##3##2##(1997-8#1)(2007-8#1)(2008-12#1)
and dysfunction in##2##3##(2007-10#1)(2010-8#1)
and dysfunction##10##2##(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#2)(2008-8#2)(2010-8#1)(2012-3#1)(2013-1#1)
and dyskeratosis##2##2##(2008-11#1)(2013-1#1)
and dyskinesia##2##2##(2008-7#2)
and dyslexia##2##2##(2008-12#2)
and dyslipidaemia##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
and dyslipidemia##5##2##(2008-3#3)(2010-5#1)(2013-1#1)
and dysmorphic##2##2##(2008-8#1)(2012-12#1)
and dyspeptic symptoms##2##3##(2008-12#1)(2013-1#1)
and dysphagia##2##2##(2012-12#1)(2013-7#1)
and dysplastic##4##2##(1995-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
and dyspnea##9##2##(1992-9#1)(1993-6#1)(2007-2#1)(2008-12#1)(2009-3#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
and dyspnoea##2##2##(2007-8#1)(2008-7#1)
and dysregulation of##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
and dystrophin##2##2##(1992-8#1)(2008-7#1)
and e antigens##2##3##(1993-12#1)(2008-8#1)
and e##4##2##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
and eNOS##2##2##(1996-12#1)(2008-10#1)
and each corresponds to##2##4##(1990-11#1)(1997-4#1)
and each of the##4##4##(1990-8#2)(1996-12#1)(2008-10#1)
and each of##8##3##(1990-8#2)(1991-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
and each other##2##3##(1996-1#1)(2010-5#1)
and each##43##2##(1990-11#1)(1990-8#2)(1991-12#1)(1991-5#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#3)(2008-9#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and ear##8##2##(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-8#1)(2013-8#1)
and earlier onset##2##3##(2008-1#1)(2013-1#1)
and earlier##14##2##(1990-3#1)(1990-8#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#1)
and early HD individuals##2##4##(2011-8#2)
and early adolescent##3##3##(2009-7#2)(2010-4#1)
and early biomarkers##2##3##(2008-2#1)(2012-2#1)
and early childhood##4##3##(2008-1#1)(2010-5#1)(2012-3#1)(2013-8#1)
and early clinical trials##2##4##(2008-11#1)(2008-8#1)
and early clinical##5##3##(1997-3#1)(2008-11#1)(2008-8#1)(2010-11#1)(2012-2#1)
and early death##2##3##(2007-7#1)(2009-4#1)
and early decline##2##3##(2008-11#2)
and early detection and##2##4##(2007-7#1)(2012-3#1)
and early detection of##2##4##(2008-5#1)(2011-2#1)
and early detection##6##3##(1993-2#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
and early diagnosis is##3##4##(2007-10#1)(2008-12#1)(2010-11#1)
and early diagnosis##5##3##(2007-10#1)(2007-7#1)(2008-12#1)(2010-11#1)(2012-2#1)
and early embryonic##2##3##(2012-2#1)(2012-3#1)
and early embryos##2##3##(1993-6#1)(2012-3#1)
and early evolution##2##3##(1993-12#1)(2009-6#1)
and early flowering##2##3##(1997-2#1)(2011-1#1)
and early infancy##3##3##(1996-9#1)(1997-3#1)(2013-1#1)
and early initiation of##2##4##(2009-4#1)(2010-5#1)
and early intervention##3##3##(2007-11#2)(2011-2#1)
and early life##2##3##(2008-10#1)(2009-10#1)
and early morning##2##3##(1997-6#1)(2013-7#1)
and early mortality##2##3##(2008-1#1)(2009-4#1)
and early outcome in##2##4##(2007-10#2)
and early postnatal brain development##2##5##(1994-6#1)(2008-4#1)
and early postnatal##3##3##(1994-6#1)(1997-2#1)(2008-4#1)
and early postoperative##2##3##(2011-2#2)
and early rehabilitation##3##3##(2007-11#1)(2007-8#1)(2013-8#1)
and early results##2##3##(2007-8#1)(2011-2#1)
and early secondary##2##3##(2010-2#1)(2010-9#1)
and early seedling growth##4##4##(2008-12#4)
and early spring##3##3##(2008-10#2)(2011-2#1)
and early surgical##2##3##(2007-8#1)(2013-1#1)
and early treatment of##3##4##(2007-11#1)(2008-6#1)(2010-8#1)
and early treatment##5##3##(2007-11#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-8#1)
and early twentieth##3##3##(2008-10#1)(2010-1#2)
and early##163##2##(1990-6#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#5)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#5)(2008-10#16)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-6#3)(2009-7#3)(2010-1#5)(2010-11#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#13)(2011-3#1)(2011-8#3)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#4)
and early-onset##2##2##(2009-10#1)(2012-3#1)
and early-stage##2##2##(2010-6#1)(2013-1#1)
and earnings in the private health sector##2##7##(1991-2#1)(1992-2#1)
and earnings in the private##3##5##(1991-1#1)(1991-2#1)(1992-2#1)
and earnings##4##2##(1991-1#1)(1991-2#1)(1992-2#1)(2010-12#1)
and ears##2##2##(2008-10#1)(2011-2#1)
and earthworms##2##2##(2008-10#2)
and ease in##2##3##(2008-10#1)(2008-12#1)
and ease of handling##2##4##(2008-10#1)(2008-4#1)
and ease of use##3##4##(2007-12#1)(2008-6#1)(2009-10#1)
and ease of##20##3##(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and ease##26##2##(1997-4#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
and easier to##3##3##(2008-10#1)(2008-4#1)(2009-1#1)
and easier##7##2##(2008-10#4)(2008-4#1)(2009-1#1)(2010-6#1)
and easily available##4##3##(2008-10#3)(2008-5#1)
and easily detected##3##3##(2008-10#1)(2010-6#1)(2012-1#1)
and easily##33##2##(1994-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-7#1)
and east of the##2##4##(1996-4#1)(2008-10#1)
and east##3##2##(1996-4#1)(2008-10#2)
and eastern##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
and easy to perform##4##4##(1990-8#1)(2006-10#1)(2008-4#1)(2008-9#1)
and easy to use##5##4##(1991-9#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
and easy to##22##3##(1990-8#1)(1991-9#1)(1997-3#2)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-7#1)(2011-2#1)
and easy##44##2##(1990-8#1)(1991-9#1)(1992-3#1)(1993-1#1)(1995-5#1)(1996-12#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
and easy-to-use##3##2##(2008-3#2)(2010-2#1)
and eating##9##2##(1993-3#1)(1993-6#1)(1997-8#1)(2007-12#3)(2008-4#1)(2008-9#1)(2011-7#1)
and echocardiographic examination##2##3##(1997-5#1)(2008-4#1)
and echocardiographic##5##2##(1997-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
and echocardiography##7##2##(1992-11#1)(2007-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
and echography##2##2##(1990-3#1)(2010-6#1)
and eco-friendly##2##2##(2008-10#2)
and ecologic##2##2##(2007-2#1)(2011-2#1)
and ecological risk##2##3##(2008-10#1)(2008-8#1)
and ecological systems##2##3##(1995-5#1)(2013-8#1)
and ecological##22##2##(1991-12#1)(1992-11#1)(1994-2#1)(1995-5#1)(2008-10#3)(2008-8#4)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
and ecology and##3##3##(2008-8#2)(2008-9#1)
and ecology##10##2##(2008-10#3)(2008-8#3)(2008-9#2)(2010-8#1)(2013-7#1)
and economic benefits of##2##4##(2008-10#1)(2011-2#1)
and economic benefits##7##3##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#3)(2013-1#1)
and economic burden##2##3##(2007-12#1)(2009-8#1)
and economic consequences of##3##4##(1993-9#1)(1995-1#1)(2007-12#1)
and economic consequences##6##3##(1993-9#1)(1995-1#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-2#1)
and economic cost##2##3##(2008-8#1)(2011-2#1)
and economic costs##2##3##(1994-2#1)(2007-12#1)
and economic data##3##3##(2007-8#2)(2008-6#1)
and economic factors##2##3##(2011-1#1)(2011-2#1)
and economic growth##2##3##(1994-7#1)(2010-5#1)
and economic impact##6##3##(1997-2#1)(2008-7#4)(2011-2#1)
and economic implications##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
and economic losses##3##3##(2007-12#2)(2007-6#1)
and economic method##2##3##(2008-10#2)
and economic problems##2##3##(1995-1#1)(2008-5#1)
and economic realities##4##3##(1992-12#1)(1993-1#2)(2007-5#1)
and economic variables##2##3##(2008-9#1)(2011-2#1)
and economic##100##2##(1990-2#1)(1991-1#2)(1991-3#1)(1992-12#1)(1992-5#1)(1993-1#3)(1993-9#1)(1994-2#3)(1994-7#2)(1994-9#1)(1995-1#2)(1995-2#1)(1996-1#1)(1996-4#1)(1997-2#2)(2007-11#1)(2007-12#9)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
and economical differential pulse polarographic method has been developed for the determination of trace amount of##2##16##(2008-10#2)
and economical differential pulse polarographic##3##5##(2008-10#3)
and economical means of##2##4##(1991-12#1)(2012-2#1)
and economical method##4##3##(2008-10#3)(2008-8#1)
and economical techniques for screening##2##5##(2008-10#2)
and economical##29##2##(1991-12#1)(1994-1#2)(1994-5#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
and economically feasible##2##3##(1996-11#1)(2009-12#1)
and economically##5##2##(1996-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
and economics of health care finance##3##6##(1991-2#1)(1994-3#2)
and economics of##4##3##(1991-2#1)(1994-3#3)
and economics##7##2##(1991-2#1)(1994-3#3)(1994-8#1)(2008-1#1)(2008-10#1)
and economies of scale##2##4##(2010-5#1)(2012-2#1)
and ecosystem productivity##2##3##(2008-8#1)(2010-6#1)
and ecosystem##4##2##(2007-7#1)(2008-7#1)(2008-8#1)(2010-6#1)
and ecotoxicological##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
and ectoparasite load##2##3##(2009-2#2)
and ectoparasite##3##2##(2008-5#1)(2009-2#2)
and ectopic##3##2##(1995-12#1)(1996-5#1)(2012-3#1)
and eczema##2##2##(1994-6#1)(1996-8#1)
and edema##4##2##(1993-9#1)(1994-9#1)(2011-7#1)(2012-2#1)
and edge effects##3##3##(2008-3#1)(2008-6#1)(2008-9#1)
and edge##7##2##(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
and edge-enhanced optical correlation##2##4##(2007-12#2)
and edge-enhanced##4##2##(2007-12#2)(2008-3#2)
and edible##2##2##(2008-8#1)(2010-7#1)
and edited##2##2##(2008-11#1)(2010-1#1)
and editing##4##2##(2008-4#2)(2011-3#1)(2012-2#1)
and educate##5##2##(1992-1#1)(1992-12#1)(1994-1#1)(1994-3#1)(2008-11#1)
and educated##3##2##(2008-11#1)(2008-8#1)(2010-11#1)
and educating##3##2##(1991-1#1)(1992-1#1)(1996-3#1)
and education and##2##3##(2007-8#1)(2008-12#1)
and education in##5##3##(1994-12#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-9#1)
and education level##2##3##(1991-12#1)(2011-1#1)
and education of the##2##4##(1991-12#1)(1995-2#1)
and education of##5##3##(1991-12#1)(1995-2#1)(1995-5#1)(2008-11#1)(2011-2#1)
and education to##2##3##(1994-3#1)(2008-7#1)
and education##60##2##(1990-2#3)(1991-12#2)(1991-2#1)(1992-1#2)(1992-5#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
and educational factors##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
and educational interventions##4##3##(2008-3#1)(2012-2#3)
and educational level##2##3##(1991-6#1)(2013-1#1)
and educational needs##2##3##(1992-3#1)(1995-2#1)
and educational programs##2##3##(1995-1#1)(1996-1#1)
and educational##29##2##(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-2#4)(2013-1#1)
and educationalists##5##2##(2008-11#4)(2008-9#1)
and educators##3##2##(2010-10#1)(2010-4#1)(2012-12#1)
and efavirenz##2##2##(2008-5#2)
and effect of##13##3##(1990-3#1)(1992-6#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)
and effect on##4##3##(1992-11#1)(1994-5#1)(2008-10#1)(2013-1#1)
and effect##23##2##(1990-3#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-5#1)(1997-2#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and effective against##2##3##(2008-5#1)(2009-10#1)
and effective approach to##2##4##(2013-1#1)(2013-8#1)
and effective at##3##3##(1990-5#1)(2008-2#1)(2010-10#1)
and effective clinical##2##3##(1995-5#1)(2008-12#1)
and effective for the##2##4##(2008-10#1)(2008-11#1)
and effective for##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
and effective in promoting##2##4##(2012-1#1)(2012-2#1)
and effective in this##2##4##(2008-11#2)
and effective in##12##3##(1991-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
and effective management##5##3##(2007-5#1)(2008-11#1)(2008-12#1)(2010-1#1)(2012-2#1)
and effective means of##3##4##(1990-8#1)(2008-9#1)(2010-8#1)
and effective means##4##3##(1990-8#1)(2008-11#1)(2008-9#1)(2010-8#1)
and effective measures to##2##4##(2008-8#2)
and effective method for##6##4##(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)
and effective method of##2##4##(1993-1#1)(1993-12#1)
and effective method to##2##4##(2008-10#1)(2008-5#1)
and effective method##11##3##(1993-1#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)
and effective output rates##2##4##(1995-3#2)
and effective strategy for##2##4##(2008-2#1)(2013-1#1)
and effective technique for the##2##5##(2008-4#1)(2009-8#1)
and effective technique for##3##4##(2008-3#1)(2008-4#1)(2009-8#1)
and effective technique to##2##4##(2007-8#1)(2008-10#1)
and effective technique##6##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
and effective therapeutic##2##3##(2007-7#1)(2008-12#1)
and effective therapy##3##3##(1997-5#1)(2008-10#1)(2011-1#1)
and effective tool for##2##4##(1993-12#1)(2008-10#1)
and effective tool##4##3##(1993-12#1)(2008-10#1)(2010-3#1)(2010-5#1)
and effective treatment for patients with##2##6##(1995-4#1)(2008-2#1)
and effective treatment for##4##4##(1993-3#1)(1995-4#1)(2008-2#1)(2008-9#1)
and effective treatment of##2##4##(2008-9#1)(2012-2#1)
and effective treatment##13##3##(1993-3#1)(1995-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#2)
and effective way to##2##4##(2010-12#1)(2012-1#1)
and effective way##3##3##(2008-9#1)(2010-12#1)(2012-1#1)
and effective##186##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-2#2)(1992-6#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#4)(1997-5#1)(2006-12#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#19)(2008-11#12)(2008-12#7)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#3)
and effectively##28##2##(1991-1#2)(1992-2#1)(1993-2#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#2)
and effectiveness in the##2##4##(2008-1#1)(2013-1#1)
and effectiveness in##3##3##(1991-1#1)(2008-1#1)(2013-1#1)
and effectiveness of medigap PPOs##2##5##(1992-2#2)
and effectiveness of telemedicine##2##4##(1996-3#2)
and effectiveness of the##5##4##(1994-2#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-8#1)
and effectiveness of treatment##2##4##(2008-7#1)(2012-2#1)
and effectiveness of##32##3##(1992-12#1)(1992-2#3)(1992-5#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-3#2)(1997-3#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2010-6#1)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
and effectiveness##47##2##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-5#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-3#2)(1997-3#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2010-6#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)
and effector##4##2##(1990-12#1)(1994-5#1)(1997-8#1)(2013-8#1)
and effects of the##2##4##(2008-12#1)(2008-3#1)
and effects of##24##3##(1992-3#1)(1994-2#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
and effects on the##2##4##(1990-12#1)(2008-8#1)
and effects on##12##3##(1990-12#1)(1990-7#1)(1991-12#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)(2012-5#1)
and effects##43##2##(1990-12#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-5#1)(2013-1#2)(2013-7#1)
and efficacies of##2##3##(2008-10#1)(2008-8#1)
and efficacious##10##2##(1990-3#1)(1993-1#1)(1993-5#1)(1995-11#1)(1996-1#1)(1996-9#1)(2008-10#2)(2008-5#1)(2012-3#1)
and efficacy in##3##3##(1995-2#1)(2011-2#1)(2012-12#1)
and efficacy of a##2##4##(2007-7#1)(2008-3#1)
and efficacy of the##6##4##(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#1)
and efficacy of these##3##4##(2008-10#1)(2008-11#1)(2010-6#1)
and efficacy of##56##3##(1991-11#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-5#2)(1995-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-10#3)(2007-7#2)(2008-10#7)(2008-11#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
and efficacy##84##2##(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-2#4)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-10#3)(2007-7#3)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
and efficiency in##4##3##(1992-1#1)(2007-12#1)(2007-5#1)(2012-2#1)
and efficiency of the##2##4##(1994-2#1)(2008-10#1)
and efficiency of##11##3##(1992-2#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-1#1)
and efficiency##46##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#2)(1993-12#2)(1993-3#1)(1994-2#1)(1996-1#1)(1996-12#3)(1996-2#2)(1997-2#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
and efficient alternative to##2##4##(1994-6#1)(1996-5#1)
and efficient approach for##3##4##(1991-12#1)(2008-10#1)(2012-3#1)
and efficient chemical##2##3##(2008-10#1)(2008-4#1)
and efficient computation##2##3##(2009-11#1)(2011-2#1)
and efficient framework##2##3##(2007-12#1)(2013-1#1)
and efficient gene transfer##2##4##(1995-12#1)(2008-9#1)
and efficient method for the separation##2##6##(1995-6#1)(2008-10#1)
and efficient method for the##5##5##(1995-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-3#1)
and efficient method for##8##4##(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)
and efficient method to##2##4##(2007-12#1)(2008-4#1)
and efficient method##12##3##(1990-11#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-3#1)
and efficient patient##2##3##(1992-6#1)(1996-12#1)
and efficient technique for the##2##5##(1994-12#1)(2008-10#1)
and efficient technique for##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
and efficient technique##4##3##(1994-12#1)(2008-10#2)(2008-3#1)
and efficient tool##2##3##(2008-10#1)(2008-2#1)
and efficient way to##3##4##(2008-10#2)(2008-8#1)
and efficient##107##2##(1990-11#1)(1991-12#2)(1991-5#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(2007-11#4)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-11#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and efficiently##15##2##(1993-12#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
and effluent##2##2##(2008-5#1)(2011-2#1)
and effluents of##2##3##(2008-10#1)(2008-11#1)
and effluents##4##2##(2008-10#3)(2008-11#1)
and efflux and##2##3##(1990-2#1)(2008-11#1)
and efflux##9##2##(1990-2#1)(1994-8#4)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
and effort##7##2##(1994-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-5#1)
and efforts to##2##3##(1993-1#1)(2007-8#1)
and efforts##6##2##(1993-1#1)(1995-12#1)(1997-3#1)(2007-7#1)(2007-8#1)(2012-2#1)
and egg##19##2##(1993-6#1)(2008-10#8)(2008-12#2)(2008-8#1)(2008-9#3)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
and eggfish##5##2##(2010-8#5)
and eggs of##2##3##(1994-9#1)(2008-10#1)
and eggs##9##2##(1994-9#1)(2008-10#6)(2010-8#1)(2011-2#1)
and egress from##2##3##(2010-11#2)
and egression##2##2##(2008-10#2)
and eicosanoid##2##2##(1991-8#1)(1993-8#1)
and eight of them##2##4##(2008-5#2)
and eight of##3##3##(1993-12#1)(2008-5#2)
and eight patients##5##3##(1993-1#1)(1995-11#1)(2007-8#1)(2008-7#1)(2011-2#1)
and eight were##2##3##(1997-8#1)(2011-2#1)
and eight years##2##3##(1995-1#1)(2006-10#1)
and eight##45##2##(1992-3#1)(1993-1#2)(1993-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#2)(1997-3#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-9#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-7#1)
and eighteen##3##2##(2007-7#1)(2008-10#1)(2008-7#1)
and either a##2##3##(2008-3#1)(2008-7#1)
and either of##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
and either the##3##3##(1991-9#1)(2008-10#1)(2009-8#1)
and either##36##2##(1991-11#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)
and ejaculatory##5##2##(2007-12#1)(2008-12#3)(2009-5#1)
and ejected##2##2##(2008-10#2)
and elaborated##2##2##(2010-5#1)(2012-12#1)
and elaboration##2##2##(1996-6#1)(2008-10#1)
and elastic fibers##3##3##(1992-12#1)(2007-8#1)(2012-2#1)
and elastic recoil##3##3##(1992-9#1)(2008-7#1)(2009-7#1)
and elastic##17##2##(1992-12#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#2)(2009-7#3)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)
and elasticity##4##2##(2008-5#3)(2008-9#1)
and elastin##5##2##(1991-9#1)(2008-3#1)(2008-5#2)(2008-6#1)
and elderly people##3##3##(1991-11#1)(1995-3#2)
and elderly subjects##3##3##(2008-7#2)(2013-1#1)
and elderly##10##2##(1991-11#1)(1995-3#2)(2008-4#1)(2008-7#3)(2012-12#1)(2013-1#1)(2013-8#1)
and elective##2##2##(1997-8#1)(2008-3#1)
and electric##4##2##(1993-8#1)(2007-12#1)(2008-8#1)(2008-9#1)
and electrical isolation##2##3##(2008-11#1)(2010-6#1)
and electrical properties of##2##4##(2008-10#1)(2013-8#1)
and electrical stimulation##2##3##(2008-3#1)(2010-10#1)
and electrical##23##2##(1992-11#1)(1992-5#1)(1992-6#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-11#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#2)
and electrically evoked##2##3##(1993-12#1)(2008-9#1)
and electrically##4##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-9#1)
and electro-optic##3##2##(2007-11#2)(2008-3#1)
and electroanalytical##2##2##(2008-10#1)(2010-7#1)
and electrocardiographic##6##2##(1991-12#1)(1992-5#1)(2008-12#1)(2008-7#2)(2010-10#1)
and electrocatalysis of##4##3##(2008-10#3)(2008-6#1)
and electrocatalysis##6##2##(2008-10#5)(2008-6#1)
and electrochemical behavior of##2##4##(2008-10#2)
and electrochemical detection##2##3##(1991-5#1)(2008-10#1)
and electrochemical detectors##2##3##(1992-11#1)(2012-1#1)
and electrochemical impedance spectroscopy (EIS)##3##5##(2008-10#3)
and electrochemical impedance spectroscopy##5##4##(2008-10#4)(2010-4#1)
and electrochemical method##3##3##(2008-10#3)
and electrochemical methods##6##3##(1996-2#1)(2008-10#4)(2010-7#1)
and electrochemical properties##3##3##(1994-3#1)(1996-5#1)(2008-8#1)
and electrochemical techniques##2##3##(2008-10#2)
and electrochemical##40##2##(1991-5#1)(1992-11#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#24)(2008-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#2)(2012-1#1)(2012-12#1)(2012-2#2)
and electroconvulsive stimuli##2##3##(1996-12#2)
and electroconvulsive##3##2##(1996-12#2)(2008-7#1)
and electrode##8##2##(1990-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-9#1)
and electrodes##3##2##(2008-10#3)
and electrolysis time##2##3##(2008-10#2)
and electrolysis##3##2##(2008-10#3)
and electrolyte balance and##2##4##(1993-12#1)(1994-6#1)
and electrolyte balance##4##3##(1991-2#1)(1993-12#1)(1994-6#1)(2007-8#1)
and electrolyte leakage##4##3##(2008-10#2)(2008-12#2)
and electrolyte##18##2##(1991-2#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#2)(2009-5#2)
and electrolytes were##2##3##(2008-10#2)
and electrolytes##8##2##(1991-6#1)(2008-10#5)(2011-2#2)
and electrolytic##3##2##(1992-8#1)(2008-10#1)(2009-10#1)
and electromagnetic##9##2##(1992-3#1)(1992-4#1)(2008-2#2)(2008-3#2)(2009-10#1)(2013-1#2)
and electromyography##3##2##(1993-2#1)(2012-2#1)(2012-3#1)
and electron beam##2##3##(2008-3#1)(2009-7#1)
and electron microscopic##9##3##(1990-8#1)(1993-9#1)(1995-6#1)(1996-5#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
and electron microscopy to##2##4##(2008-10#2)
and electron microscopy##27##3##(1991-12#1)(1992-2#1)(1992-9#2)(1993-6#1)(1995-2#1)(1995-6#1)(1997-3#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-1#2)(2012-2#1)
and electron paramagnetic resonance##3##4##(1993-11#1)(2007-12#1)(2008-10#1)
and electron spin##2##3##(1990-5#1)(1993-11#1)
and electron##66##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-9#2)(1993-11#2)(1993-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-3#1)(2006-6#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2009-7#3)(2009-8#1)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
and electron-dense##2##2##(2007-12#1)(2008-10#1)
and electronic##25##2##(1991-5#1)(1992-10#2)(1992-8#1)(1993-11#1)(1995-3#1)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-3#3)(2008-7#1)(2009-11#2)(2009-3#1)(2009-7#1)(2010-7#1)(2012-2#1)
and electrophoresed##3##2##(1992-8#1)(2008-4#2)
and electrophoretic mobility shift##2##4##(1994-9#1)(2011-2#1)
and electrophoretic mobility##4##3##(1994-11#1)(1994-9#1)(2011-2#1)(2013-1#1)
and electrophoretic##7##2##(1990-12#1)(1992-11#1)(1994-11#2)(1994-9#1)(2011-2#1)(2013-1#1)
and electrophysiologic##2##2##(1993-12#1)(2013-1#1)
and electrophysiological##11##2##(1992-6#2)(1992-9#1)(1993-2#1)(1996-5#2)(1997-3#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
and electrophysiologically##2##2##(2008-7#1)(2012-2#1)
and electrophysiology##4##2##(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
and electrospray ionization mass##2##4##(2008-10#2)
and electrospray ionization##3##3##(2008-10#2)(2011-1#1)
and electrospray mass spectrometry detection##3##5##(2008-10#3)
and electrospray mass spectrometry##5##4##(1996-12#1)(2008-10#4)
and electrospray##11##2##(1996-12#1)(1997-2#1)(2008-10#7)(2011-1#2)
and electrostatic##6##2##(1994-12#1)(1997-2#1)(2008-4#1)(2008-7#2)(2010-12#1)
and electrosurgical loop##2##3##(1994-12#2)
and electrothermal atomic absorption spectrometry (ETAAS)##5##6##(2008-10#5)
and electrothermal atomic absorption spectrometry##12##5##(2008-10#12)
and electrothermal##14##2##(2008-10#13)(2008-3#1)
and elemental analyses##2##3##(2007-11#1)(2008-10#1)
and elemental analysis##5##3##(2008-10#3)(2011-1#2)
and elemental carbon##2##3##(2008-10#2)
and elemental##13##2##(2007-11#1)(2008-10#9)(2008-12#1)(2011-1#2)
and elementary school##2##3##(2008-1#1)(2012-12#1)
and elementary##3##2##(1995-12#1)(2008-1#1)(2012-12#1)
and elements of##2##3##(2007-11#1)(2008-4#1)
and elements##8##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2012-12#1)
and elevated levels of##2##4##(1994-9#1)(2012-12#1)
and elevated serum##2##3##(1995-3#1)(2011-2#1)
and elevated##30##2##(1993-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#2)(2013-8#1)
and elevation of the##2##4##(2008-10#1)(2008-8#1)
and elevation of##6##3##(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)
and elevation##9##2##(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)
and eleven##4##2##(2008-4#1)(2010-6#1)(2013-1#1)(2013-7#1)
and elicited##2##2##(1990-2#1)(1991-9#1)
and elicitin##2##2##(2008-10#2)
and eliciting##2##2##(2008-12#1)(2013-1#1)
and eliminate the##5##3##(1994-3#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
and eliminate##10##2##(1990-11#1)(1993-11#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
and eliminated##6##2##(2008-10#3)(2008-11#2)(2012-2#1)
and eliminates the need for##2##5##(2007-11#1)(2008-3#1)
and eliminates the##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
and eliminates##10##2##(1994-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
and eliminating the##2##3##(1995-8#1)(2007-11#1)
and eliminating##5##2##(1993-1#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
and elimination of any##2##4##(1996-3#1)(2007-11#1)
and elimination of interferences##2##4##(2008-10#2)
and elimination of##9##3##(1996-3#1)(1996-5#1)(2007-11#1)(2008-10#4)(2010-5#1)(2011-1#1)
and elimination##14##2##(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2009-8#1)(2010-5#1)(2011-1#1)
and elite##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
and ellipsometric##5##2##(2008-3#5)
and ellipsometry##2##2##(2008-3#2)
and elliptical##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
and elm##3##2##(2008-10#3)
and elongated##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
and elongation of##2##3##(1994-8#1)(2007-11#1)
and elongation##9##2##(1991-12#1)(1994-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#2)
and elsewhere in the##2##4##(1992-2#1)(2008-10#1)
and elsewhere in##3##3##(1992-2#1)(2008-10#2)
and elsewhere##13##2##(1992-2#1)(1994-2#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#6)(2008-4#1)(2013-8#1)
and elucidate the##2##3##(2008-9#1)(2012-12#1)
and elucidate##6##2##(2008-10#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)
and elucidation of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
and eluent flow##2##3##(2008-10#2)
and eluent##17##2##(2008-10#16)(2008-7#1)
and eluted from##2##3##(1990-11#1)(1990-12#1)
and eluted in##2##3##(2008-10#1)(2013-1#1)
and eluted with a##2##4##(2008-10#1)(2008-4#1)
and eluted with##6##3##(2008-10#4)(2008-4#1)(2008-5#1)
and eluted##14##2##(1990-11#1)(1990-12#1)(1990-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2013-1#1)
and eluting##2##2##(2008-10#2)
and elution flow##2##3##(2008-10#2)
and elution of##2##3##(1990-12#1)(2008-10#1)
and elution on##2##3##(2008-10#2)
and elution solvents##2##3##(2008-10#2)
and elution steps##2##3##(2008-10#2)
and elution time##2##3##(2008-10#2)
and elution with##3##3##(1993-11#1)(2008-10#2)
and elution##30##2##(1990-12#1)(1991-12#1)(1993-11#1)(1994-12#1)(2008-10#25)(2008-7#1)
and embarrassment##3##2##(1997-1#1)(2012-1#1)(2013-1#1)
and embedded in paraffin##2##4##(2008-10#1)(2008-11#1)
and embedded in the##2##4##(1990-8#1)(2010-5#1)
and embedded in##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
and embedded##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-5#1)
and embodied##2##2##(2008-12#1)(2009-6#1)
and embolic##2##2##(2008-7#1)(2010-4#1)
and embolism from the heart##2##5##(2007-10#2)
and embolization of##2##3##(2007-7#1)(2009-9#1)
and embolization##4##2##(2007-7#1)(2008-7#1)(2009-9#1)(2012-3#1)
and embryo##6##2##(1995-3#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-9#1)(2013-1#1)
and embryogenesis##2##2##(2008-8#1)(2009-3#1)
and embryology##2##2##(1990-6#1)(2012-2#1)
and embryonic red blood##2##4##(1990-8#2)
and embryonic stem (ES)##2##4##(1994-9#1)(2008-11#1)
and embryonic stem cells##2##4##(2008-11#1)(2009-3#1)
and embryonic stem##4##3##(1994-9#1)(2008-11#2)(2009-3#1)
and embryonic##12##2##(1990-8#2)(1994-9#2)(1996-5#2)(1997-4#1)(2007-12#1)(2008-11#2)(2009-3#2)
and embryos##4##2##(1990-5#1)(2008-4#2)(2009-7#1)
and emerged##2##2##(2008-10#1)(2013-1#1)
and emergence of##4##3##(1990-7#1)(2008-6#1)(2009-4#1)(2013-1#1)
and emergence##9##2##(1990-7#1)(2008-10#3)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
and emergency care##3##3##(1995-2#1)(2008-12#1)(2009-6#1)
and emergency departments##2##3##(1991-3#1)(2007-5#1)
and emergency##16##2##(1990-6#1)(1991-3#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-2#1)(2007-5#1)(2007-9#1)(2008-12#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
and emergent##4##2##(2008-8#1)(2012-12#1)(2013-1#2)
and emerging clinical##2##3##(2009-11#1)(2011-2#1)
and emerging therapies##2##3##(2006-7#1)(2008-7#1)
and emerging##16##2##(1996-1#1)(1996-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and emesis##2##2##(2008-5#1)(2011-2#1)
and emission at##2##3##(1990-8#1)(2008-10#1)
and emission is##2##3##(1993-11#1)(2007-12#1)
and emission maxima##6##3##(2008-10#5)(2008-9#1)
and emission of##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
and emission rate##3##3##(2008-2#1)(2011-10#2)
and emission slit##2##3##(2008-10#2)
and emission spectra of##3##4##(2008-9#2)(2009-10#1)
and emission spectra##7##3##(1992-8#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-10#1)
and emission spectroscopy##2##3##(2008-10#1)(2008-2#1)
and emission wavelength##3##3##(1997-2#1)(2008-10#2)
and emission were##4##3##(2008-10#3)(2011-10#1)
and emission##71##2##(1990-8#2)(1992-8#1)(1993-11#1)(1994-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#41)(2008-2#4)(2008-3#6)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#1)(2010-2#1)(2011-10#3)
and emits##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
and emitted##2##2##(2008-3#2)
and emitting##2##2##(1994-8#1)(2009-6#1)
and emotion##5##2##(1996-3#1)(2007-4#1)(2008-11#3)
and emotional disorders##2##3##(1995-1#1)(1997-2#1)
and emotional effects of listening to favorite music##2##8##(2013-1#2)
and emotional health##2##3##(2008-3#1)(2010-8#1)
and emotional intelligence##2##3##(2008-11#1)(2012-12#1)
and emotional problems##3##3##(2009-7#1)(2013-1#1)(2013-8#1)
and emotional responses##2##3##(2009-10#1)(2010-9#1)
and emotional stability##2##3##(2008-5#1)(2009-7#1)
and emotional state##2##3##(2012-2#1)(2013-1#1)
and emotional##57##2##(1991-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#3)
and emotions##5##2##(1997-3#1)(2008-12#1)(2009-9#1)(2010-1#2)
and empathy##3##2##(1993-12#1)(1995-2#1)(2013-1#1)
and emphasis on##3##3##(1996-2#1)(1997-1#1)(2007-12#1)
and emphasis##4##2##(1995-2#1)(1996-2#1)(1997-1#1)(2007-12#1)
and emphasises the##2##3##(1997-7#1)(2012-1#1)
and emphasize the importance of##2##5##(2009-10#1)(2011-1#1)
and emphasize the##9##3##(1996-3#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
and emphasize##13##2##(1990-9#1)(1992-9#1)(1993-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
and emphasized##3##2##(1991-6#1)(2008-11#1)(2010-3#1)
and emphasizes the need for##2##5##(1991-2#1)(2007-7#1)
and emphasizes the##4##3##(1991-2#1)(2007-7#2)(2013-1#1)
and emphasizes##6##2##(1991-2#1)(1994-12#1)(2007-7#2)(2008-6#1)(2013-1#1)
and emphasizing##2##2##(1993-12#1)(2012-2#1)
and emphysema##2##2##(1992-9#1)(2012-12#1)
and empirical research##4##3##(1996-3#1)(2008-2#1)(2013-1#2)
and empirical results##2##3##(2008-10#1)(2008-8#1)
and empirical studies##3##3##(2012-12#1)(2013-1#2)
and empirical##22##2##(1992-9#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2013-1#4)
and empirically##4##2##(1993-1#1)(2009-9#1)(2010-1#1)(2010-3#1)
and empiricism##2##2##(2008-12#1)(2012-12#1)
and employ##4##2##(1993-12#1)(1994-2#1)(2008-7#1)(2012-12#1)
and employed for##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
and employed##9##2##(1994-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)
and employee##8##2##(1992-3#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-3#1)
and employees##16##2##(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#2)(2008-1#1)(2008-12#1)(2012-3#1)
and employer##5##2##(1992-2#1)(1993-12#2)(1994-12#1)(2008-3#1)
and employers##8##2##(1992-2#1)(1993-2#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-9#1)(2010-10#1)(2013-1#1)
and employing##2##2##(1995-2#1)(2008-10#1)
and employment##14##2##(1991-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-9#1)(1996-3#1)(1997-2#1)(2008-4#1)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#1)
and employs a##2##3##(2008-10#1)(2008-3#1)
and employs##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
and empower##2##2##(2009-12#1)(2010-7#1)
and empowering##3##2##(1993-2#1)(1994-3#1)(2008-7#1)
and empowerment##3##2##(2010-8#1)(2011-2#1)(2012-3#1)
and empty##3##2##(1994-11#1)(2008-10#2)
and emulsified##2##2##(2008-10#2)
and emulsifying activity##2##3##(2013-8#2)
and emulsifying properties of##4##4##(2010-4#1)(2013-8#3)
and emulsifying properties##6##3##(2010-4#2)(2013-8#4)
and emulsifying##8##2##(2010-4#2)(2013-8#6)
and emulsion stability##3##3##(2008-5#3)
and emulsion##7##2##(1992-5#3)(2008-4#1)(2008-5#3)
and enable the##6##3##(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#1)(2011-2#2)
and enable us to##2##4##(1992-2#1)(2008-10#1)
and enable##19##2##(1992-11#1)(1992-2#1)(1995-5#1)(1997-3#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#3)(2013-1#1)
and enabled better##2##3##(2008-10#1)(2010-8#1)
and enabled the##2##3##(1994-1#1)(2008-10#1)
and enabled##6##2##(1994-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)
and enables the##4##3##(2007-7#1)(2008-11#1)(2008-7#1)(2013-8#1)
and enables##14##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2012-3#1)(2013-8#1)
and enabling##8##2##(1990-3#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
and enacted##2##2##(1997-3#1)(2009-5#1)
and enamel##5##2##(1991-2#1)(2008-3#3)(2011-2#1)
and enamel-dentin##2##2##(1990-3#1)(2008-3#1)
and encapsulation/release##2##2##(2009-11#2)
and encoded##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
and encodes a protein of##4##5##(1993-6#1)(1996-6#2)(2008-7#1)
and encodes a protein##5##4##(1993-6#1)(1996-6#2)(2008-10#1)(2008-7#1)
and encodes a##10##3##(1990-11#1)(1992-12#1)(1993-6#1)(1996-10#1)(1996-6#2)(1997-9#1)(2008-10#1)(2008-7#1)(2010-5#1)
and encoding##3##2##(1993-12#1)(2008-2#1)(2008-6#1)
and encourage##5##2##(2008-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-8#1)
and encouraged##2##2##(2008-11#1)(2009-6#1)
and encouragement##3##2##(1992-12#1)(2008-1#1)(2013-1#1)
and encouraging early##2##3##(2008-5#1)(2012-2#1)
and encouraging##8##2##(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
and end of##5##3##(2008-4#1)(2008-5#1)(2011-2#2)(2012-3#1)
and end stage renal##2##4##(1997-8#1)(2011-2#1)
and end users##2##3##(1995-3#1)(1997-1#1)
and end with##2##3##(1992-3#1)(2008-12#1)
and end##14##2##(1992-3#1)(1995-3#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-2#3)(2012-3#1)
and end-diastolic pressure##2##3##(2008-7#2)
and end-of-life##3##2##(2012-12#3)
and end-point##2##2##(2008-10#2)
and end-stage renal disease##7##4##(1994-12#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2011-1#1)
and end-stage##9##2##(1994-12#1)(1994-7#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2010-6#1)(2011-1#1)
and ended in##2##3##(2008-7#1)(2012-2#1)
and ended##4##2##(1993-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
and ending with##4##3##(1994-3#2)(2008-4#1)(2012-2#1)
and ending##6##2##(1994-3#2)(2007-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
and endochitinase##2##2##(2008-10#2)
and endocrine changes in##2##4##(1993-3#1)(2008-5#1)
and endocrine factors##2##3##(1990-6#1)(2012-3#1)
and endocrine##16##2##(1990-6#1)(1991-1#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#2)(2011-1#1)(2012-2#1)(2012-3#4)(2013-8#1)
and endocrinologic##3##2##(2008-10#1)(2008-11#2)
and endocrinological##3##2##(2008-4#1)(2008-6#1)(2012-2#1)
and endocrinologists in##2##3##(2011-2#2)
and endocrinologists##4##2##(2011-2#4)
and endocytosis to polarized growth##2##5##(2009-8#2)
and endocytosis##8##2##(1993-11#2)(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#3)
and endodermal##2##2##(2008-7#1)(2010-11#1)
and endodontic##2##2##(2012-3#1)(2013-8#1)
and endogenous substances##2##3##(2008-10#2)
and endogenous##20##2##(1991-2#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#3)(2012-2#1)
and endometrial biopsy##2##3##(1991-12#1)(2012-2#1)
and endometrial cancer##10##3##(1990-10#1)(1991-12#1)(1994-9#2)(2008-10#2)(2008-4#1)(2011-2#3)
and endometrial##22##2##(1990-10#1)(1991-12#2)(1992-4#1)(1992-8#1)(1994-9#4)(1995-3#2)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#6)(2012-2#1)
and endomorphin 1##2##3##(2012-1#2)
and endophytic##3##2##(2008-10#3)
and endoplasmic reticulum##2##3##(1996-5#1)(2012-2#1)
and endoprosthesis##2##2##(2007-11#1)(2008-10#1)
and endorsement of##2##3##(1994-12#1)(2013-1#1)
and endoscope##2##2##(2008-10#1)(2011-2#1)
and endoscopic evaluation##3##3##(1991-11#1)(2009-12#1)(2013-8#1)
and endoscopic examination##2##3##(2009-1#1)(2011-2#1)
and endoscopic findings##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
and endoscopic##25##2##(1991-11#2)(1991-3#1)(1991-6#1)(1993-2#1)(1995-10#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-5#3)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
and endoscopy##4##2##(1997-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
and endothelial cell##6##3##(1990-4#1)(1994-5#1)(1996-9#1)(2009-11#1)(2012-1#1)(2012-4#1)
and endothelial cells in##2##4##(1996-5#1)(2012-2#1)
and endothelial cells##12##3##(1991-12#1)(1991-5#1)(1992-9#1)(1993-6#1)(1996-5#1)(2009-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
and endothelial dysfunction##4##3##(2008-3#2)(2008-7#1)(2013-8#1)
and endothelial progenitor cells##2##4##(2010-1#2)
and endothelial##30##2##(1990-4#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2010-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#3)
and endothelin receptor mRNA expression##2##5##(1993-3#2)
and endothelin-1##2##2##(1990-2#1)(1995-12#1)
and endotoxin##3##2##(1994-3#1)(1994-7#1)(2008-5#1)
and endovascular embolization##2##3##(2006-12#1)(2008-7#1)
and endovascular##6##2##(1997-6#1)(2006-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
and endpoints##2##2##(2007-4#1)(2013-1#1)
and endrin##2##2##(2008-10#2)
and ends at##2##3##(1994-3#1)(2008-6#1)
and ends in##2##3##(1996-3#1)(2008-7#1)
and ends with##2##3##(2008-10#1)(2010-10#1)
and ends##7##2##(1994-3#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#1)
and endurance training on##2##4##(2010-12#1)(2013-1#1)
and endurance training##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
and endurance##6##2##(2010-12#3)(2011-2#1)(2013-1#1)(2013-8#1)
and energetic efficiency##3##3##(1993-8#1)(2008-7#2)
and energetic##8##2##(1990-8#1)(1993-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2012-3#1)
and energetics of##2##3##(2008-10#1)(2011-1#1)
and energetics##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
and energies##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
and energy balance##2##3##(2008-5#1)(2013-8#1)
and energy content##2##3##(2008-5#2)
and energy dispersive X-ray##2##4##(2008-10#1)(2012-2#1)
and energy efficiency##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
and energy expenditure##5##3##(2008-10#1)(2008-2#2)(2008-4#1)(2013-1#1)
and energy homeostasis##2##3##(2013-1#1)(2013-7#1)
and energy metabolism##3##3##(2008-7#1)(2008-8#2)
and energy minimization##2##3##(1991-5#1)(1993-11#1)
and energy of##2##3##(1995-11#1)(2008-6#1)
and energy to##2##3##(2008-9#1)(2009-4#1)
and energy transfer##3##3##(1992-11#1)(2008-10#1)(2009-2#1)
and energy##72##2##(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-11#1)(1996-11#1)(1997-8#1)(2007-11#4)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-2#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
and energy-dispersive x-ray##2##3##(2008-2#2)
and energy-dispersive##3##2##(2008-10#1)(2008-2#2)
and energy-efficient##2##2##(2011-1#2)
and enforce##5##2##(1993-12#1)(1993-2#1)(1993-3#1)(2008-10#1)(2012-2#1)
and enforced##2##2##(1991-3#1)(2007-5#1)
and engagement in##4##3##(2009-7#2)(2010-5#1)(2013-1#1)
and engagement##11##2##(2008-12#2)(2009-7#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
and engaging##2##2##(2008-11#1)(2013-1#1)
and engineering##3##2##(2008-5#1)(2010-10#1)(2013-1#1)
and engineers##5##2##(2008-3#2)(2009-11#1)(2009-12#1)(2010-10#1)
and enhance motivation##2##3##(1994-9#1)(2008-12#1)
and enhance patient##2##3##(1992-2#1)(2008-11#1)
and enhance the##13##3##(1991-2#1)(1994-9#1)(1996-5#1)(1997-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#1)(2012-2#2)(2013-1#1)
and enhance their##2##3##(2008-6#1)(2010-4#1)
and enhance##42##2##(1991-2#1)(1992-1#1)(1992-2#2)(1993-12#1)(1994-9#2)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
and enhanced by the##2##4##(2008-10#1)(2012-12#1)
and enhanced by##5##3##(1990-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
and enhanced formation of##2##4##(2008-11#1)(2013-1#1)
and enhanced the##5##3##(1992-3#1)(1993-12#1)(1993-8#1)(1997-2#1)(2008-9#1)
and enhanced##47##2##(1990-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-3#1)(1997-2#2)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
and enhancement by##4##3##(2008-10#1)(2008-2#2)(2008-4#1)
and enhancement of the##4##4##(1994-1#1)(1995-1#1)(1997-1#1)(2007-11#1)
and enhancement of##10##3##(1992-6#1)(1994-1#1)(1995-1#1)(1996-9#1)(1997-1#1)(2007-11#1)(2008-11#2)(2008-7#2)
and enhancement##19##2##(1992-6#1)(1994-1#1)(1995-1#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)
and enhancements##2##2##(2010-8#2)
and enhancers##2##2##(1990-12#1)(2008-8#1)
and enhances the##6##3##(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-8#1)(2011-2#1)
and enhances##15##2##(1993-12#1)(1993-8#1)(1996-2#1)(1996-5#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)
and enhancing the##5##3##(1997-3#1)(2008-10#1)(2008-9#1)(2009-12#1)(2012-3#1)
and enhancing##21##2##(1993-5#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-4#1)
and enlarged##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
and enlargement of the##3##4##(1997-5#1)(1997-7#1)(2012-12#1)
and enormous##3##2##(2008-3#1)(2009-4#1)(2013-1#1)
and enriched##2##2##(2008-10#1)(2008-11#1)
and enrichment of the##2##4##(1993-11#1)(2008-10#1)
and enrichment of##9##3##(1993-11#1)(1995-6#1)(2008-10#4)(2008-4#2)(2010-6#1)
and enrichment##14##2##(1990-8#1)(1993-11#1)(1995-6#1)(2008-10#7)(2008-4#2)(2008-6#1)(2010-6#1)
and enrollment##3##2##(1991-3#1)(1994-2#1)(2010-11#1)
and ensiling##2##2##(2008-10#2)
and ensuing##2##2##(2008-10#1)(2009-10#1)
and ensure a##2##3##(2008-3#1)(2011-2#1)
and ensure##8##2##(1994-1#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
and ensured##2##2##(2011-2#2)
and ensures##5##2##(1991-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-12#1)
and ensuring##6##2##(1992-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
and entails##2##2##(2008-10#2)
and enter hair cells##2##4##(2009-8#1)(2012-2#1)
and enter the##3##3##(2011-2#1)(2011-3#1)(2012-3#1)
and enter##6##2##(1990-3#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
and entered into##2##3##(2008-10#1)(2008-12#1)
and entered##4##2##(1993-5#1)(1994-12#1)(2008-10#1)(2008-12#1)
and enteric parasites##2##3##(2008-12#2)
and enteric##3##2##(1994-12#1)(2008-12#2)
and entering the##2##3##(2007-12#1)(2011-2#1)
and entering##4##2##(2007-12#1)(2008-10#1)(2010-9#1)(2011-2#1)
and entertainment##2##2##(2008-1#1)(2010-8#1)
and entitled##2##2##(1995-2#1)(2010-5#1)
and entrapment##2##2##(2008-11#1)(2008-5#1)
and entropy of##4##3##(2007-11#1)(2008-10#2)(2008-4#1)
and entropy##10##2##(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)
and entry##2##2##(1994-12#1)(2011-2#1)
and entry-level groups##3##3##(1995-3#3)
and enucleation##2##2##(2009-4#1)(2011-1#1)
and enumerate##2##2##(2008-4#1)(2010-2#1)
and enumerating##4##2##(2008-10#2)(2008-9#2)
and enumeration of##8##3##(1997-6#1)(2008-10#1)(2008-9#5)(2010-1#1)
and enumeration##9##2##(1997-6#1)(2008-10#1)(2008-9#6)(2010-1#1)
and env##3##2##(1994-12#1)(2008-9#2)
and environment##16##2##(1995-3#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-10#1)(2010-12#2)(2012-2#1)
and environment-friendly##2##2##(2009-10#1)(2010-5#1)
and environmental characteristics##2##3##(1992-12#1)(2011-1#1)
and environmental chemistry##3##3##(2008-10#2)(2008-7#1)
and environmental conditions##7##3##(1990-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)
and environmental determinants##3##3##(2008-1#1)(2010-12#1)(2013-1#1)
and environmental effects on the##2##5##(1994-3#1)(2010-8#1)
and environmental effects##3##3##(1994-3#1)(2010-3#1)(2010-8#1)
and environmental exposure##4##3##(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)
and environmental factors and##2##4##(2008-11#1)(2010-3#1)
and environmental factors are##2##4##(2008-7#1)(2013-7#1)
and environmental factors can all##2##5##(2010-3#1)(2013-8#1)
and environmental factors in the##2##5##(2006-10#1)(2011-1#1)
and environmental factors in##3##4##(2006-10#1)(2008-11#1)(2011-1#1)
and environmental factors may##2##4##(1992-2#1)(2008-8#1)
and environmental factors on##2##4##(2012-2#2)
and environmental factors that##3##4##(2008-11#1)(2008-3#2)
and environmental factors##43##3##(1990-6#1)(1992-12#1)(1992-2#1)(2006-10#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-6#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
and environmental influences##4##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
and environmental interactions of quantitative trait##2##6##(2008-10#2)
and environmental pollution##2##3##(1990-9#1)(2007-7#1)
and environmental relationships##2##3##(2008-7#2)
and environmental risk factors##3##4##(2007-10#1)(2008-11#1)(2012-2#1)
and environmental samples##24##3##(2008-10#24)
and environmental sources##2##3##(2008-2#2)
and environmental stochasticity##2##3##(2008-9#2)
and environmental variables##5##3##(1992-12#1)(2008-10#2)(2008-8#2)
and environmental##175##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#2)(1992-12#3)(1992-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#52)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#4)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
and environmentally friendly##4##3##(2008-10#4)
and environmentally##12##2##(2007-11#1)(2007-12#1)(2008-10#8)(2012-2#2)
and environments##7##2##(1992-2#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
and enzymatic activity##5##3##(1990-12#1)(1992-11#1)(1995-6#1)(2008-7#1)(2013-7#1)
and enzymatic hydrolysis of mixed##2##5##(1990-2#1)(2013-1#1)
and enzymatic hydrolysis##4##3##(1990-2#1)(2008-10#1)(2013-1#2)
and enzymatic methods##3##3##(1990-2#1)(1995-5#1)(1996-12#1)
and enzymatic properties of##2##4##(1995-6#1)(2008-10#1)
and enzymatic##29##2##(1990-12#3)(1990-2#2)(1990-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-2#2)(1997-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#2)
and enzyme activity of##2##4##(2011-2#1)(2012-6#1)
and enzyme activity##9##3##(1994-11#1)(1995-2#1)(1996-12#2)(2009-8#1)(2011-2#1)(2012-6#1)(2013-1#2)
and enzyme immunoassay##2##3##(1990-2#1)(2008-10#1)
and enzyme##32##2##(1990-2#1)(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(2008-1#1)(2008-10#9)(2008-4#1)(2008-6#1)(2009-8#2)(2010-3#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-6#1)(2013-1#3)
and enzyme-linked immunosorbent assay##4##4##(1997-4#1)(2008-10#3)
and enzyme-linked immunosorbent##5##3##(1993-2#1)(1997-4#1)(2008-10#3)
and enzyme-linked##6##2##(1993-2#1)(1995-11#1)(1997-4#1)(2008-10#3)
and enzymes##8##2##(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2011-1#1)(2013-1#1)
and eosin##10##2##(2007-10#2)(2008-9#1)(2010-8#1)(2011-2#3)(2013-1#3)
and eosinophil levels##2##3##(2008-10#1)(2009-5#1)
and eosinophil##5##2##(1997-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)
and eosinophilia##3##2##(1990-3#1)(2007-7#1)(2009-5#1)
and eosinophilic##6##2##(1991-12#2)(2008-11#2)(2010-6#1)(2013-1#1)
and eosinophils are##2##3##(1992-2#1)(2009-5#1)
and eosinophils##10##2##(1990-12#1)(1992-12#1)(1992-2#2)(2008-10#2)(2008-11#1)(2009-5#1)(2010-6#1)(2013-8#1)
and epicotyls##2##2##(2008-10#1)(2008-8#1)
and epidemic##5##2##(1992-8#1)(2008-10#3)(2008-8#1)
and epidemics##5##2##(2008-10#2)(2011-2#2)(2013-8#1)
and epidemiologic##5##2##(1991-12#1)(1995-9#1)(1997-2#1)(1997-4#1)(2011-2#1)
and epidemiological characteristics of##2##4##(2011-2#1)(2013-1#1)
and epidemiological characteristics##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
and epidemiological findings##2##3##(1997-3#2)
and epidemiological profile of tuberculosis##2##5##(2013-1#2)
and epidemiological studies##5##3##(1991-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
and epidemiological surveillance##2##3##(2008-8#2)
and epidemiological##35##2##(1990-6#1)(1991-12#1)(1995-2#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
and epidemiologically##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
and epidemiology of##7##3##(1992-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
and epidemiology##13##2##(1992-6#1)(1996-1#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
and epidermal growth factor receptor##3##5##(2008-10#1)(2008-8#1)(2012-3#1)
and epidermal growth factor##6##4##(1991-12#1)(1991-7#1)(1995-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
and epidermal hyperplasia##4##3##(2008-9#4)
and epidermal necrosis in##2##4##(2008-9#2)
and epidermal##22##2##(1991-12#1)(1991-7#1)(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#6)(2012-3#1)
and epidermis##7##2##(1996-12#1)(2008-10#1)(2008-5#3)(2012-12#2)
and epidermoid cancer of cervix##3##5##(2013-1#3)
and epidural anaesthesia##2##3##(2007-8#1)(2008-7#1)
and epidural anesthesia##5##3##(2012-12#1)(2012-3#4)
and epidural##12##2##(1992-5#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-3#4)(2013-1#1)
and epigallocatechin gallate##2##3##(2008-10#1)(2008-11#1)
and epigenetic mechanisms of##2##4##(2008-7#1)(2012-2#1)
and epigenetic mechanisms##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
and epigenetic##11##2##(1992-3#1)(2008-7#3)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
and epigenetically##2##2##(2008-10#1)(2012-3#1)
and epilepsy##3##2##(2008-2#1)(2008-4#1)(2010-3#1)
and epileptic##3##2##(1995-12#1)(2010-12#1)(2011-1#1)
and epinephrine##10##2##(1994-6#1)(1997-6#2)(1997-7#1)(2008-10#2)(2012-2#3)(2013-1#1)
and episodic memory##2##3##(2008-2#1)(2010-7#1)
and episodic##4##2##(1992-2#1)(2008-2#1)(2009-2#1)(2010-7#1)
and epithelial cell##3##3##(1991-9#1)(1995-9#1)(2008-5#1)
and epithelial cells##9##3##(1990-11#2)(1991-11#2)(1991-9#1)(2007-11#2)(2008-11#1)(2013-1#1)
and epithelial membrane antigen##4##4##(1991-12#1)(1992-2#1)(1994-8#1)(2008-7#1)
and epithelial membrane##5##3##(1991-12#1)(1992-2#1)(1994-8#1)(2007-7#1)(2008-7#1)
and epithelial##21##2##(1990-11#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-9#2)(1992-2#1)(1994-5#1)(1994-8#1)(1995-9#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2013-1#1)
and epitope##2##2##(1993-8#1)(2008-8#1)
and epoxy resins##2##3##(2008-4#1)(2008-9#1)
and epoxy##3##2##(2008-4#1)(2008-9#1)(2010-9#1)
and epsilon and##3##3##(2008-8#3)
and epsilon as well as##2##5##(1995-6#1)(2008-8#1)
and epsilon##21##2##(1990-8#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-8#9)
and equal##10##2##(1993-3#1)(1995-2#1)(2008-10#3)(2009-2#1)(2009-6#1)(2012-1#2)(2013-1#1)
and equally##6##2##(2007-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)
and equations##2##2##(2008-10#1)(2013-8#1)
and equatorial##2##2##(1997-7#1)(2008-3#1)
and equilibrated##2##2##(2008-10#1)(2008-11#1)
and equilibria##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
and equilibrium calculations##2##3##(2008-3#2)
and equilibrium constant##2##3##(1996-2#1)(2008-10#1)
and equilibrium constants##2##3##(2008-10#1)(2008-4#1)
and equilibrium impairments##4##3##(2011-2#4)
and equilibrium studies##2##3##(2008-10#2)
and equilibrium##25##2##(1990-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#9)(2008-3#2)(2008-4#1)(2010-5#2)(2011-2#5)
and equipment and##2##3##(2008-1#1)(2008-11#1)
and equipment necessary for##2##4##(2008-2#1)(2008-9#1)
and equipment necessary##3##3##(2008-2#1)(2008-9#2)
and equipment##19##2##(1991-1#1)(1994-3#1)(1996-11#1)(1996-2#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
and equitable manner##2##3##(1996-1#1)(2011-1#1)
and equity##7##2##(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-3#1)(2010-12#1)(2011-2#1)
and equivalent##3##2##(2008-10#1)(2008-3#2)
and equivocal##2##2##(1994-1#1)(2007-12#1)
and eradicate##2##2##(2009-4#1)(2011-2#1)
and eradication##3##2##(2007-7#1)(2008-10#1)(2010-1#1)
and erectile dysfunction##2##3##(2008-5#1)(2010-10#1)
and erectile function##2##3##(2012-3#2)
and erectile##5##2##(2008-5#1)(2008-7#1)(2010-10#1)(2012-3#2)
and ergosterol##2##2##(2008-10#2)
and erlotinib##2##2##(2012-1#1)(2012-2#1)
and erosion##4##2##(2007-5#2)(2010-5#2)
and erosive##4##2##(2006-10#1)(2008-9#1)(2013-1#2)
and erratic##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
and error##17##2##(1993-6#1)(1995-1#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#1)(2011-1#3)(2012-2#1)
and errors associated with##2##4##(2008-10#1)(2008-3#1)
and errors in##2##3##(2008-2#1)(2008-3#1)
and errors##7##2##(2008-10#2)(2008-2#1)(2008-3#4)
and erythema##7##2##(1991-11#1)(1991-6#1)(1993-8#3)(1997-8#1)(2012-12#1)
and erythroblasts##2##2##(2008-10#1)(2008-11#1)
and erythrocyte fatty acids##2##4##(2013-8#2)
and erythrocyte##12##2##(1993-2#2)(1994-6#1)(2008-10#2)(2008-7#2)(2008-9#2)(2012-12#1)(2013-8#2)
and erythrocytes##7##2##(1990-2#1)(1990-7#2)(1991-12#1)(1993-2#2)(2008-7#1)
and erythroid##2##2##(1991-2#1)(2008-9#1)
and erythromycin##3##2##(1991-8#1)(2007-7#1)(2012-3#1)
and erythropoietin##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
and escalation##2##2##(2009-10#1)(2009-7#1)
and escape##2##2##(2008-10#1)(2010-7#1)
and esophageal cancer##2##3##(2010-6#1)(2013-8#1)
and esophageal pH-metry##2##3##(1996-3#2)
and esophageal varices##3##3##(2013-1#2)(2013-8#1)
and esophageal##17##2##(1990-8#1)(1996-3#2)(2007-8#2)(2008-12#1)(2008-5#2)(2010-6#1)(2010-7#1)(2013-1#3)(2013-8#4)
and esophagitis##2##2##(2011-2#2)
and esophagus##3##2##(1990-8#1)(2008-10#1)(2011-1#1)
and especially for##3##3##(2008-10#2)(2013-8#1)
and especially in the##4##4##(2008-4#1)(2009-10#1)(2009-11#1)(2011-7#1)
and especially in##7##3##(1992-2#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-11#1)(2011-7#1)
and especially of##3##3##(1996-3#1)(2008-1#1)(2013-1#1)
and especially the##7##3##(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#2)(2013-7#1)
and especially to##2##3##(2008-9#1)(2013-8#1)
and especially##44##2##(1990-5#2)(1990-9#1)(1992-2#2)(1994-6#1)(1996-3#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-7#1)(2013-1#1)(2013-7#1)(2013-8#3)
and essential fatty acids##3##4##(2008-3#1)(2008-5#1)(2013-1#1)
and essential oils##3##3##(2007-1#1)(2013-1#2)
and essential##19##2##(1990-12#1)(1996-1#1)(1997-8#1)(2007-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-1#1)(2012-2#2)(2013-1#4)
and essentially##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
and establish the##7##3##(1994-5#1)(1995-3#1)(2007-11#1)(2008-2#1)(2009-5#1)(2010-9#1)(2011-2#1)
and establish##17##2##(1993-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
and established a##2##3##(1990-11#1)(2013-1#1)
and established##15##2##(1990-11#1)(1991-3#1)(1994-1#1)(1995-1#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#1)(2013-1#1)
and establishes the##2##3##(1992-9#1)(2008-7#1)
and establishes##5##2##(1992-9#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
and establishing##6##2##(2008-10#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
and establishment in##2##3##(2008-10#1)(2010-3#1)
and establishment of a##3##4##(2008-10#2)(2009-5#1)
and establishment of##12##3##(2008-10#5)(2008-11#1)(2009-1#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-7#1)
and establishment##15##2##(2008-10#6)(2008-11#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-3#2)(2012-3#1)(2013-7#1)
and esterified##3##2##(1990-7#2)(1990-8#1)
and esters##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
and esthetic##5##2##(2007-12#3)(2008-7#1)(2012-2#1)
and estimate the##6##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)
and estimate##11##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)
and estimated blood loss##2##4##(2008-10#1)(2012-2#1)
and estimated by##3##3##(2008-10#2)(2008-2#1)
and estimated spectrophotometrically##3##3##(2008-10#3)
and estimated the##2##3##(2008-9#1)(2012-3#1)
and estimated with##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
and estimated##26##2##(1990-12#1)(1993-11#1)(2008-10#15)(2008-2#2)(2008-8#1)(2008-9#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and estimates made##2##3##(1994-9#1)(2012-7#1)
and estimates of the##2##4##(1997-7#1)(2008-10#1)
and estimates of##8##3##(1994-3#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-9#1)(2009-5#1)(2011-1#1)
and estimates the##2##3##(2010-1#1)(2011-2#1)
and estimates##15##2##(1994-3#1)(1994-9#2)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-9#1)(2009-5#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-7#1)
and estimating either the##2##4##(2008-10#2)
and estimating##5##2##(1995-3#1)(2008-10#2)(2008-6#1)(2008-9#1)
and estimation of the##2##4##(2008-10#1)(2012-2#1)
and estimation of##10##3##(2008-10#8)(2009-11#1)(2012-2#1)
and estimation##14##2##(1995-9#1)(2008-10#9)(2008-3#2)(2009-11#1)(2012-2#1)
and estradiol levels##2##3##(1995-2#1)(2008-4#1)
and estradiol##4##2##(1992-3#1)(1995-2#1)(2008-11#1)(2008-4#1)
and estrogen and##2##3##(1994-2#1)(1994-5#1)
and estrogen receptor##2##3##(1993-1#1)(1993-11#1)
and estrogen##12##2##(1991-12#1)(1993-1#3)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(2008-11#1)(2008-6#1)(2009-4#1)
and estrogens##2##2##(2008-4#1)(2009-4#1)
and estrone##2##2##(2008-10#2)
and etched##2##2##(2007-12#1)(2008-3#1)
and etching##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
and ethanol extracts of##2##4##(2010-3#1)(2012-2#1)
and ethanol in##4##3##(2008-10#2)(2008-2#1)(2008-6#1)
and ethanol production##3##3##(2011-1#2)(2013-1#1)
and ethanol were##5##3##(1991-5#1)(2008-10#4)
and ethanol yields##2##3##(2008-6#2)
and ethanol##43##2##(1990-2#1)(1991-1#3)(1991-2#1)(1991-5#1)(2008-10#19)(2008-2#3)(2008-3#1)(2008-6#5)(2008-7#1)(2010-3#3)(2011-1#3)(2012-2#1)(2013-1#1)
and ethanolamine##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
and ethene##2##2##(2008-3#1)(2012-12#1)
and ether##5##2##(1994-2#1)(2008-10#1)(2008-5#3)
and ethical aspects of the##2##5##(1991-3#1)(2008-11#1)
and ethical aspects of##3##4##(1991-3#1)(2008-11#1)(2011-2#1)
and ethical aspects##4##3##(1991-3#1)(2008-11#1)(2011-2#1)(2012-12#1)
and ethical challenges##2##3##(2011-1#1)(2012-2#1)
and ethical considerations##2##3##(1996-6#1)(2008-11#1)
and ethical guidelines##2##3##(1992-2#1)(1996-4#1)
and ethical issues##5##3##(1992-3#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#1)
and ethical##30##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
and ethics in##2##3##(1991-3#1)(1997-8#1)
and ethics##12##2##(1991-3#1)(1992-12#1)(1992-5#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-7#2)(2010-3#1)(2012-2#1)
and ethnic differences in##3##4##(2007-12#1)(2013-1#2)
and ethnic differences##4##3##(2007-12#2)(2013-1#2)
and ethnic disparities in##3##4##(2011-2#2)(2012-3#1)
and ethnic disparities##4##3##(2011-2#3)(2012-3#1)
and ethnic groups##6##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#2)(2011-2#1)
and ethnic minorities##4##3##(2008-10#1)(2008-8#2)(2010-4#1)
and ethnic##27##2##(1992-2#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-5#5)(2008-8#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-3#1)(2013-1#2)
and ethnicity##9##2##(2008-1#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
and ethoxyresorufin##2##2##(1994-8#1)(2008-11#1)
and ethyl acetate##8##3##(2008-10#5)(2008-12#2)(2008-5#1)
and ethyl benzene in##2##4##(2008-10#2)
and ethyl cellulose##3##3##(2008-10#1)(2010-5#2)
and ethyl##23##2##(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#2)
and ethylacetoacetate##2##2##(2008-10#1)(2008-11#1)
and ethylene dimethacrylate (EDMA)##2##4##(2008-10#2)
and ethylene glycol dimethacrylate##2##4##(2008-10#2)
and ethylene glycol##5##3##(2008-10#3)(2008-3#1)(2013-8#1)
and ethylene production##2##3##(2008-10#1)(2011-2#1)
and ethylene##15##2##(1992-3#1)(2008-10#10)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
and ethylenediamine##3##2##(1996-2#1)(2007-7#1)(2008-10#1)
and ethylenediaminetetraacetic acid (EDTA)##2##4##(2008-10#2)
and etiological##5##2##(1992-5#1)(2008-10#2)(2008-12#1)(2010-4#1)
and etiologies of##2##3##(2008-1#1)(2010-1#1)
and etiology of##6##3##(1990-3#1)(1994-6#1)(2008-4#1)(2009-10#1)(2009-2#1)(2012-3#1)
and etoposide##14##2##(1992-10#1)(1993-8#1)(1993-9#1)(1994-12#1)(1997-4#2)(2007-10#1)(2007-4#1)(2008-10#1)(2008-6#2)(2009-8#1)(2012-1#1)(2013-1#1)
and eukaryotes##4##2##(1992-12#1)(1996-12#1)(2011-2#1)(2012-3#1)
and eukaryotic##16##2##(1990-5#1)(1995-2#1)(1995-6#1)(1997-4#2)(1997-7#2)(2008-10#1)(2008-11#2)(2008-7#2)(2009-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
and euthanasia##3##2##(1990-6#1)(1995-2#1)(2011-2#1)
and evacuation of##2##3##(1991-11#1)(2012-12#1)
and evacuation##3##2##(1991-11#1)(2008-7#1)(2012-12#1)
and evade##2##2##(2013-1#2)
and evaluate a##6##3##(2008-10#1)(2008-2#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-2#1)
and evaluate its##2##3##(2008-11#2)
and evaluate the impact of the##2##6##(1995-3#1)(2008-10#1)
and evaluate the impact of##3##5##(1994-1#1)(1995-3#1)(2008-10#1)
and evaluate the##18##3##(1994-1#2)(1995-3#1)(1996-9#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
and evaluate their##2##3##(1996-1#1)(2008-5#1)
and evaluate treatment##2##3##(2008-6#1)(2013-8#1)
and evaluate##54##2##(1992-5#1)(1993-1#1)(1994-1#2)(1995-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
and evaluated a##2##3##(1994-3#1)(2009-6#1)
and evaluated as##5##3##(1993-1#1)(1995-3#2)(2008-10#2)
and evaluated at##2##3##(2008-11#1)(2010-4#1)
and evaluated by the##5##4##(1994-3#1)(2008-10#2)(2008-11#1)(2008-4#1)
and evaluated by##13##3##(1990-3#1)(1992-12#1)(1994-3#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2012-1#1)(2013-1#1)
and evaluated for the##2##4##(2008-10#2)
and evaluated for their##3##4##(1991-5#1)(2008-11#1)(2008-12#1)
and evaluated for##19##3##(1991-5#1)(1992-12#1)(1995-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-3#1)
and evaluated in##8##3##(1992-12#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2010-5#1)
and evaluated the##11##3##(1995-11#1)(1995-12#1)(1995-4#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2012-12#1)(2013-7#1)
and evaluated their##5##3##(1991-12#1)(1991-9#1)(2008-10#1)(2012-2#1)(2012-3#1)
and evaluated using##2##3##(2008-10#1)(2011-1#1)
and evaluated with respect to##2##5##(2008-10#1)(2008-2#1)
and evaluated with##4##3##(2008-10#1)(2008-12#1)(2008-2#2)
and evaluated within##2##3##(2008-10#1)(2008-11#1)
and evaluated##108##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-9#1)(1993-1#1)(1993-9#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#40)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and evaluates the##7##3##(1991-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(2008-2#1)(2008-7#1)(2013-1#1)
and evaluates##8##2##(1991-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
and evaluating a##2##3##(1991-12#1)(1995-3#1)
and evaluating the delivery of services under managed care##2##9##(1997-2#2)
and evaluating the##15##3##(1991-1#1)(1992-1#1)(1992-2#1)(1997-2#3)(2008-10#2)(2008-11#2)(2008-12#3)(2008-6#1)(2009-10#1)
and evaluating##35##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-5#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
and evaluation are##2##3##(1993-2#1)(1996-8#1)
and evaluation in##2##3##(2008-10#1)(2008-12#1)
and evaluation of a##19##4##(1994-1#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2012-2#1)(2012-3#1)
and evaluation of an##4##4##(2008-10#3)(2008-12#1)
and evaluation of the##9##4##(1991-1#1)(2007-11#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-3#1)(2012-12#1)
and evaluation of their##4##4##(1995-3#1)(1996-2#1)(2011-2#1)(2012-3#1)
and evaluation of treatment##3##4##(1994-8#1)(2007-8#1)(2010-12#1)
and evaluation of##97##3##(1990-5#1)(1990-8#1)(1991-1#2)(1992-1#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#4)(2010-5#2)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#1)
and evaluation strategies##2##3##(1996-2#1)(1997-2#1)
and evaluation##126##2##(1990-5#1)(1990-8#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#18)(2008-11#6)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2010-12#3)(2010-3#4)(2010-5#4)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
and evaluations of##2##3##(1994-9#1)(1996-2#1)
and evaluations##4##2##(1994-9#1)(1996-2#1)(2008-6#1)(2011-2#1)
and evanescent##4##2##(2007-11#1)(2008-3#3)
and evanescent-wave##2##2##(2010-7#2)
and evaporation##5##2##(2008-10#2)(2008-3#1)(2008-5#2)
and evasion of##2##3##(2013-1#2)
and even a##2##3##(2008-7#1)(2013-1#1)
and even after##2##3##(2008-11#1)(2009-7#1)
and even at##2##3##(1993-8#1)(2008-10#1)
and even cause##2##3##(2008-1#1)(2008-8#1)
and even death##6##3##(1994-12#1)(2007-12#1)(2008-7#2)(2010-12#1)(2013-1#1)
and even distribution of##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
and even distribution##4##3##(1996-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
and even if##3##3##(2008-6#1)(2008-8#1)(2011-3#1)
and even in##5##3##(1997-8#1)(2008-1#2)(2008-9#1)(2010-9#1)
and even induced##2##3##(2008-5#1)(2008-9#1)
and even larger##2##3##(2008-10#1)(2008-9#1)
and even less##2##3##(2007-12#1)(2009-8#1)
and even more##6##3##(1995-12#1)(1995-2#1)(1996-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
and even population##2##3##(2010-5#1)(2012-3#1)
and even the##6##3##(1997-1#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
and even with##2##3##(2010-1#1)(2013-1#1)
and even##126##2##(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#9)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#3)
and evening##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2010-11#1)
and evenness##2##2##(2008-10#2)
and event##2##2##(1992-9#1)(2008-8#1)
and event-free survival (EFS)##2##4##(2011-2#2)
and event-free survival##3##3##(1994-10#1)(2011-2#2)
and events##5##2##(1993-2#1)(1997-3#1)(2008-10#1)(2009-11#1)(2010-5#1)
and eventual##13##2##(1990-5#3)(1992-12#1)(1992-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2010-2#1)(2012-2#2)
and eventually develop##2##3##(1991-1#1)(2008-7#1)
and eventually to##3##3##(1996-3#1)(2008-7#1)(2010-9#1)
and eventually##30##2##(1991-1#1)(1991-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and every 3 days##2##4##(1997-6#1)(2010-12#1)
and every 3##3##3##(1997-6#1)(2007-7#1)(2010-12#1)
and every##13##2##(1992-5#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#2)
and everyday##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
and evidence for the##3##4##(2007-12#1)(2009-6#1)(2013-8#1)
and evidence for##11##3##(1992-3#1)(1995-6#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-8#1)
and evidence of##7##3##(1991-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-7#1)
and evidence that##2##3##(1997-1#1)(2011-2#1)
and evidence##26##2##(1991-8#1)(1992-1#1)(1992-3#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#2)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
and evidence-based##5##2##(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
and evoked##5##2##(1990-3#1)(1996-5#2)(2008-4#1)(2008-9#1)
and evolution and##2##3##(2007-10#1)(2010-1#1)
and evolution in##5##3##(1994-8#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
and evolution of social##2##4##(2008-8#2)
and evolution of the##10##4##(1990-6#1)(1990-7#1)(1994-11#1)(2007-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)
and evolution of##39##3##(1990-6#1)(1990-7#1)(1994-11#1)(1996-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#3)(2010-4#2)(2011-2#2)(2012-3#1)
and evolution##62##2##(1990-6#1)(1990-7#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#10)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-3#5)(2010-4#2)(2011-2#3)(2012-3#1)(2013-1#1)
and evolutionarily##2##2##(2009-3#1)(2012-3#1)
and evolutionary biology##3##3##(2007-12#1)(2009-2#1)(2009-7#1)
and evolutionary consequences of##2##4##(2008-8#1)(2009-2#1)
and evolutionary consequences##3##3##(2008-8#1)(2008-9#1)(2009-2#1)
and evolutionary conservation##2##3##(1991-6#1)(1993-2#1)
and evolutionary history##2##3##(2009-5#1)(2009-6#1)
and evolutionary mechanisms##2##3##(2008-8#1)(2012-12#1)
and evolutionary processes##4##3##(1993-12#1)(1995-5#1)(1996-6#1)(2008-8#1)
and evolutionary psychologists##2##3##(2008-5#1)(2009-12#1)
and evolutionary significance##2##3##(2007-12#1)(2008-7#1)
and evolutionary##42##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#2)(2009-5#4)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
and evolutive##2##2##(1994-9#1)(2008-7#1)
and evolve##2##2##(2012-2#1)(2013-1#1)
and evolved##2##2##(1994-3#1)(2008-9#1)
and evolving##7##2##(1994-2#2)(1995-3#1)(1996-12#1)(2008-11#1)(2010-11#1)(2013-1#1)
and ex vivo##9##3##(1991-8#1)(2008-10#1)(2008-11#5)(2008-9#1)(2010-5#1)
and ex##13##2##(1991-8#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)
and exacerbate##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
and exacerbations##2##2##(2010-5#1)(2011-2#1)
and exact##9##2##(1990-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)
and examination of##3##3##(1997-4#1)(2008-6#1)(2011-2#1)
and examination##14##2##(1991-6#1)(1996-2#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and examinations##3##2##(1990-12#1)(2008-11#1)(2008-12#1)
and examine how##2##3##(2008-2#1)(2008-8#1)
and examine its##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
and examine the##11##3##(1992-2#1)(1995-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)
and examine##26##2##(1992-12#1)(1992-2#1)(1993-12#1)(1995-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#2)
and examined by##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
and examined for##8##3##(1990-3#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-9#1)(2009-7#1)
and examined in a##2##4##(1992-12#1)(2010-6#1)
and examined in##3##3##(1992-12#1)(2008-10#1)(2010-6#1)
and examined its##2##3##(1992-9#1)(1994-12#1)
and examined regarding##2##3##(1991-10#1)(2008-6#1)
and examined the##6##3##(1995-12#1)(1995-5#1)(2008-11#1)(2008-6#1)(2012-1#1)(2013-1#1)
and examined their##3##3##(2008-12#1)(2011-1#1)(2011-2#1)
and examined to##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
and examined##38##2##(1990-3#2)(1991-10#1)(1992-12#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-3#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
and examines the##5##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
and examines##13##2##(1994-2#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-2#1)
and examining the##2##3##(1996-9#1)(2008-11#1)
and examining##4##2##(1996-9#1)(1997-2#1)(2008-11#1)(2008-7#1)
and example##3##2##(2008-10#1)(2008-3#2)
and examples are##3##3##(1997-1#1)(2008-11#1)(2008-3#1)
and examples of##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
and examples##12##2##(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#3)
and exceed##2##2##(1994-2#1)(2008-12#1)
and excellent agreement##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and excellent functional##2##3##(2011-2#1)(2013-1#1)
and excellent response##2##3##(2006-10#1)(2008-10#1)
and excellent stability##2##3##(2008-10#1)(2008-11#1)
and excellent##30##2##(1990-2#1)(1997-3#1)(2006-10#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2009-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
and exceptionally##2##2##(2007-8#1)(2013-8#1)
and excess body##2##3##(2011-2#1)(2012-2#1)
and excess##12##2##(1990-4#1)(1993-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
and excessive##14##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#2)
and exchange of information##4##4##(1991-2#3)(1996-12#1)
and exchange of##6##3##(1990-2#1)(1991-2#3)(1996-12#1)(2011-2#1)
and exchange##13##2##(1990-2#1)(1991-2#3)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-7#2)(2011-2#2)
and exchanging##2##2##(2008-2#1)(2012-12#1)
and excipient concentrations of##2##4##(2013-8#2)
and excipient##4##2##(2008-5#1)(2011-2#1)(2013-8#2)
and excipients in##2##3##(2008-10#2)
and excipients##5##2##(2008-10#4)(2010-5#1)
and excised##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
and excision of the##3##4##(1992-6#1)(2008-10#1)(2008-12#1)
and excision of##4##3##(1992-6#1)(2008-10#1)(2008-12#1)(2009-7#1)
and excision##5##2##(1992-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)
and excisional biopsy##2##3##(2010-11#2)
and excitability##2##2##(1994-12#1)(1995-12#1)
and excitation emission##2##3##(2008-10#2)
and excitation spectra of##2##4##(2008-10#1)(2008-3#1)
and excitation spectra##3##3##(2008-10#2)(2008-3#1)
and excitation wavelength##2##3##(2008-10#1)(2008-9#1)
and excitation##13##2##(2007-11#1)(2008-10#5)(2008-3#1)(2008-9#3)(2012-2#2)(2013-8#1)
and excitatory##3##2##(1996-5#1)(1997-2#1)(2008-11#1)
and excited by##2##3##(2008-2#1)(2008-3#1)
and excited##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#2)(2013-8#1)
and excited-state absorption cross sections##2##5##(2008-3#2)
and excited-state absorption##6##3##(2007-12#1)(2008-3#5)
and excitement##4##2##(1990-3#1)(2007-8#1)(2008-11#1)(2009-3#1)
and exciting##5##2##(1994-12#1)(2010-10#1)(2011-1#2)(2013-1#1)
and excitonic##2##2##(2010-2#2)
and excitotoxic##2##2##(1995-12#2)
and excluded##2##2##(2008-12#1)(2013-1#1)
and exclusion criteria were##2##4##(2012-12#1)(2013-1#1)
and exclusion criteria##9##3##(2007-11#1)(2009-10#1)(2011-2#3)(2012-12#2)(2013-1#2)
and exclusion of##2##3##(1994-2#1)(2011-2#1)
and exclusion##12##2##(1994-2#1)(2007-11#1)(2008-11#1)(2009-10#1)(2011-2#4)(2012-12#2)(2013-1#2)
and exclusive##3##2##(1991-3#1)(2007-8#1)(2008-10#1)
and exclusively##4##2##(1991-3#1)(1993-12#1)(1994-6#1)(2010-10#1)
and excreted##2##2##(2007-7#1)(2013-1#1)
and excretion of##3##3##(2008-11#1)(2010-6#1)(2012-2#1)
and excretion##7##2##(1993-12#1)(1997-7#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#2)
and execution of a##2##4##(1992-3#1)(2009-8#1)
and execution of##10##3##(1992-3#1)(2008-11#3)(2009-8#1)(2011-1#2)(2012-12#2)(2013-1#1)
and execution##16##2##(1991-6#2)(1992-3#1)(2007-8#1)(2008-11#3)(2008-2#2)(2008-3#1)(2009-8#1)(2011-1#2)(2012-12#2)(2013-1#1)
and executive function##4##3##(2008-6#1)(2012-1#2)(2012-2#1)
and executive functions##4##3##(2008-2#1)(2008-6#1)(2009-10#1)(2012-12#1)
and executive##12##2##(1995-2#1)(1996-1#1)(2008-2#1)(2008-6#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
and executives##2##2##(1996-3#1)(2008-11#1)
and exemplify##2##2##(2008-3#1)(2010-3#1)
and exercise are##4##3##(2008-5#1)(2009-3#1)(2013-1#2)
and exercise as well as##2##5##(1994-5#1)(2008-3#1)
and exercise in##4##3##(1992-12#1)(2007-11#1)(2008-12#1)(2012-12#1)
and exercise testing##2##3##(1991-8#1)(1993-2#1)
and exercise therapy##2##3##(1997-3#1)(2008-12#1)
and exercise tolerance##4##3##(1991-3#1)(2010-4#1)(2010-5#1)(2013-8#1)
and exercise##36##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-5#1)(1997-3#1)(2007-11#1)(2007-6#2)(2008-1#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#2)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
and exercises##2##2##(2007-7#1)(2012-12#1)
and exercising##2##2##(2010-7#1)(2011-1#1)
and exert##2##2##(1990-12#1)(2008-4#1)
and exerts##3##2##(1994-9#1)(2008-8#1)(2012-3#1)
and exhaustive##2##2##(2008-10#2)
and exhibit a##4##3##(1994-8#1)(1997-7#1)(2008-3#1)(2008-8#1)
and exhibit the##2##3##(2008-10#1)(2008-8#1)
and exhibit##16##2##(1990-7#1)(1990-8#1)(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)
and exhibited a##6##3##(1992-6#1)(1993-11#1)(1995-5#2)(2008-10#1)(2008-11#1)
and exhibited good reproducibility##2##4##(2008-10#2)
and exhibited good##6##3##(2008-10#4)(2010-4#1)(2013-1#1)
and exhibited significant##2##3##(2008-9#1)(2013-1#1)
and exhibited##35##2##(1990-12#1)(1992-6#2)(1993-11#1)(1994-7#1)(1995-5#2)(1997-4#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-1#3)
and exhibits##15##2##(1992-6#1)(1994-5#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2009-7#1)
and exist##2##2##(2007-4#1)(2008-3#1)
and existential##2##2##(1991-2#1)(2012-3#1)
and existing##8##2##(1997-1#1)(1997-2#1)(2007-2#1)(2008-3#1)(2011-2#1)(2012-3#2)(2013-8#1)
and exit##7##2##(1991-3#1)(1993-9#1)(1994-9#1)(2008-12#1)(2008-3#2)(2008-5#1)
and exocytosis in##3##3##(2008-4#2)(2009-8#1)
and exocytosis of##2##3##(1995-2#1)(1997-7#1)
and exocytosis##7##2##(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#2)(2009-8#1)(2010-11#1)
and exogenous factors##3##3##(2008-10#2)(2008-5#1)
and exogenous##13##2##(1992-5#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
and exogenously added##3##3##(2008-11#1)(2008-4#2)
and exon##6##2##(1991-2#1)(1992-3#1)(1993-11#1)(1996-2#1)(2008-7#1)(2012-3#1)
and exons##2##2##(1990-8#1)(2008-10#1)
and exonuclease##2##2##(1995-5#1)(2010-2#1)
and exotic##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
and expand the##3##3##(1994-2#1)(1996-12#1)(2013-1#1)
and expand##8##2##(1991-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-7#1)(2010-11#1)(2013-1#1)
and expanded in##2##3##(2009-6#1)(2011-2#1)
and expanded to##3##3##(2007-12#1)(2007-5#1)(2008-11#1)
and expanded##13##2##(1996-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#2)(2009-6#1)(2010-10#1)(2011-2#1)(2011-3#1)
and expanding the##2##3##(1994-12#1)(1996-3#1)
and expanding##8##2##(1990-4#1)(1994-12#1)(1996-3#2)(1997-2#1)(2008-1#1)(2008-11#1)(2008-2#1)
and expansion of the##3##4##(2007-5#1)(2008-10#1)(2009-4#1)
and expansion of##11##3##(1994-3#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)
and expansion##15##2##(1994-3#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2012-2#1)
and expect to##2##3##(2008-10#1)(2013-8#1)
and expectations for##2##3##(1991-1#1)(1995-12#1)
and expectations of the##4##4##(1995-1#1)(2008-9#1)(2010-4#1)(2011-1#1)
and expectations of##9##3##(1994-1#1)(1995-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#2)
and expectations regarding##2##3##(1993-6#1)(2011-2#1)
and expectations##22##2##(1991-1#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)
and expected heterozygosity##2##3##(2013-8#2)
and expected outcomes##2##3##(1996-1#1)(2010-6#1)
and expected##14##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#2)
and expedient##2##2##(2010-2#1)(2012-12#1)
and expeditious##2##2##(2008-3#1)(2008-8#1)
and expenditure##7##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(2008-2#1)(2011-1#1)(2012-2#1)
and expenditures for##2##3##(1991-12#1)(1994-12#1)
and expenditures##7##2##(1991-12#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-7#1)
and expense##2##2##(1996-2#1)(2008-11#1)
and expenses##6##2##(1990-11#1)(1992-1#1)(1994-9#1)(2007-4#1)(2010-8#2)
and expensive##9##2##(1992-12#1)(1996-11#1)(2007-5#2)(2008-1#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
and experience in##2##3##(2008-10#1)(2010-10#1)
and experience of##8##3##(1994-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-1#2)(2010-9#1)(2011-1#1)
and experience with##4##3##(1994-2#1)(1996-1#1)(2008-11#1)(2008-7#1)
and experience##40##2##(1990-8#1)(1992-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#2)(1996-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
and experienced nurses##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
and experienced##12##2##(1993-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)
and experiences of##9##3##(1996-6#1)(1997-3#1)(2008-1#2)(2008-12#4)(2013-1#1)
and experiences with##4##3##(1993-3#1)(1997-3#1)(2008-10#1)(2010-8#1)
and experiences##21##2##(1990-6#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-12#5)(2008-6#1)(2010-10#1)(2010-8#1)(2013-1#2)
and experiencing##3##2##(2007-12#1)(2009-12#1)(2012-3#1)
and experiential learning##2##3##(1994-12#2)
and experiential##5##2##(1994-12#2)(1995-2#1)(2008-1#1)(2009-8#1)
and experiment##24##2##(1992-5#1)(1992-6#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)
and experimental conditions##2##3##(2008-10#1)(2008-9#1)
and experimental data are##2##4##(2008-7#1)(2010-10#1)
and experimental data##14##3##(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)
and experimental demonstration##2##3##(2008-3#2)
and experimental design##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
and experimental evidence##5##3##(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
and experimental examples##2##3##(2006-10#1)(2008-3#1)
and experimental group##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
and experimental investigation of the##4##5##(2007-12#1)(2008-3#3)
and experimental investigation of##6##4##(2007-11#1)(2007-12#1)(2008-3#4)
and experimental results are given##3##5##(2008-3#3)
and experimental results are presented that##2##6##(2007-12#2)
and experimental results are presented to##2##6##(2008-2#1)(2008-3#1)
and experimental results are presented##14##5##(2007-12#3)(2008-2#3)(2008-3#8)
and experimental results are##19##4##(2007-12#3)(2008-2#3)(2008-3#13)
and experimental results for a##2##5##(2008-2#1)(2008-3#1)
and experimental results for the##2##5##(2008-3#2)
and experimental results for##5##4##(2008-2#1)(2008-3#3)(2008-7#1)
and experimental results is demonstrated##2##5##(2007-12#1)(2008-3#1)
and experimental results of the##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
and experimental results of##6##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
and experimental results show that the##3##6##(2008-2#1)(2008-3#2)
and experimental results show that##4##5##(2008-2#1)(2008-3#3)
and experimental results was obtained##3##5##(2008-2#2)(2008-7#1)
and experimental results##52##3##(2007-11#2)(2007-12#7)(2008-10#2)(2008-2#10)(2008-3#27)(2008-6#1)(2008-7#2)(2011-2#1)
and experimental spectra##2##3##(2008-3#2)
and experimental studies have shown that##2##6##(2007-10#1)(2009-7#1)
and experimental studies have##4##4##(2007-10#1)(2008-7#1)(2009-7#1)(2010-12#1)
and experimental studies##12##3##(2007-10#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)
and experimental uncertainty##3##3##(2008-10#1)(2008-7#2)
and experimental validation of a##2##5##(2007-12#1)(2011-2#1)
and experimental validation of##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
and experimental validation##7##3##(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
and experimental values##2##3##(1996-5#1)(2008-2#1)
and experimental##169##2##(1993-6#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#12)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#20)(2008-3#51)(2008-4#1)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#4)
and experimentally by##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
and experimentally demonstrate##7##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
and experimentally demonstrated##7##3##(2007-12#5)(2008-3#2)
and experimentally induced##2##3##(1992-6#1)(1995-12#1)
and experimentally investigated##2##3##(1997-2#1)(2008-3#1)
and experimentally measured##3##3##(2008-2#3)
and experimentally realize##2##3##(2007-11#1)(2008-3#1)
and experimentally simple##2##3##(2008-10#1)(2008-4#1)
and experimentally studied##2##3##(2008-2#1)(2008-3#1)
and experimentally that##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
and experimentally the##4##3##(2007-11#1)(2008-3#3)
and experimentally validated##3##3##(2008-3#2)(2011-1#1)
and experimentally verified##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
and experimentally##86##2##(1992-6#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-11#13)(2007-12#15)(2008-10#4)(2008-2#13)(2008-3#31)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-3#1)
and experiments are##2##3##(2007-11#1)(2008-3#1)
and experiments of##2##3##(2008-2#1)(2008-3#1)
and experiments were##2##3##(2008-3#1)(2012-3#1)
and experiments with##3##3##(1991-3#1)(2008-11#1)(2008-3#1)
and experiments##28##2##(1991-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#11)(2008-7#1)(2008-8#2)(2009-5#1)(2010-7#2)(2012-3#1)(2013-8#1)
and expert opinion##3##3##(1996-2#1)(2008-11#1)(2012-3#1)
and expert opinions##2##3##(1995-5#1)(2011-2#1)
and expert##11##2##(1992-2#1)(1993-2#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
and expertise##8##2##(1991-12#1)(1995-1#1)(1995-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)
and experts##3##2##(1995-6#1)(2008-5#1)(2011-8#1)
and explain the##10##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#2)(2011-2#1)(2012-12#1)(2012-3#1)
and explain why##2##3##(2009-8#1)(2011-2#1)
and explain##16##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2009-8#1)(2010-2#2)(2011-2#2)(2012-12#1)(2012-3#1)
and explained in##2##3##(2008-10#1)(2008-9#1)
and explained more than##2##4##(2008-10#1)(2013-1#1)
and explained##20##2##(1993-12#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-2#1)(2013-1#1)
and explains how they##3##4##(1992-12#1)(2009-10#1)(2013-8#1)
and explains how##5##3##(1992-12#1)(2008-4#1)(2009-10#2)(2013-8#1)
and explains the##3##3##(2008-4#1)(2010-3#1)(2011-1#1)
and explains##12##2##(1992-12#1)(1993-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-10#2)(2010-3#1)(2011-1#1)(2013-8#1)
and explicit attitudes toward fatness and thinness##3##7##(2007-12#3)
and explicit attitudes toward##4##4##(2007-12#3)(2009-9#1)
and explicit attitudes##5##3##(2007-12#4)(2009-9#1)
and explicit water##2##3##(2008-10#1)(2012-2#1)
and explicit##9##2##(2007-12#5)(2008-10#1)(2009-9#1)(2010-8#1)(2012-2#1)
and explicitly##2##2##(1994-1#1)(2008-3#1)
and exploitation##2##2##(1995-5#1)(2008-2#1)
and exploiting##2##2##(2008-10#1)(2008-3#1)
and exploits##2##2##(2008-3#1)(2012-2#1)
and exploration##3##2##(2008-8#1)(2010-7#1)(2013-1#1)
and exploratory factor analyses##2##4##(2009-11#1)(2010-11#1)
and exploratory##5##2##(2008-8#1)(2009-11#1)(2010-11#1)(2012-3#1)(2013-1#1)
and explore the effects of##2##5##(2007-12#1)(2012-3#1)
and explore the##4##3##(2007-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
and explore##7##2##(2007-12#1)(2008-11#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
and explored as##3##3##(2008-10#2)(2012-12#1)
and explored the##2##3##(1992-2#1)(2008-11#1)
and explored##12##2##(1992-2#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-9#1)(2012-12#1)
and explores the##5##3##(1992-12#1)(1993-1#1)(1996-2#1)(2008-10#1)(2010-5#1)
and explores##10##2##(1992-12#1)(1992-3#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-7#1)
and exploring##4##2##(2008-10#1)(2008-8#1)(2009-7#1)(2012-3#1)
and explosive##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
and explosives##2##2##(2008-10#2)
and exponential models##4##3##(2008-10#4)
and exponential##6##2##(2008-10#4)(2008-3#2)
and export of##3##3##(1991-2#1)(2008-8#1)(2011-2#1)
and export##9##2##(1991-2#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
and expose the##2##3##(1992-1#1)(2008-9#1)
and expose##4##2##(1992-1#1)(2008-9#1)(2011-1#1)(2012-12#1)
and exposed in##2##3##(2006-6#1)(2008-11#1)
and exposed the##2##3##(1995-6#1)(2008-10#1)
and exposed to a##2##4##(2008-11#1)(2008-9#1)
and exposed to different##2##4##(2008-10#2)
and exposed to natural##2##4##(2008-10#1)(2013-1#1)
and exposed to##17##3##(1992-11#1)(1995-5#1)(1996-9#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and exposed##28##2##(1990-2#1)(1992-11#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-9#1)(2006-6#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and exposure of##3##3##(1991-2#1)(1995-5#1)(2008-10#1)
and exposure periods##3##3##(2008-10#2)(2011-2#1)
and exposure time##4##3##(1990-2#1)(2008-10#3)
and exposure times on the##2##5##(2008-10#2)
and exposure times##4##3##(1996-12#1)(2008-10#2)(2012-2#1)
and exposure to a##2##4##(2010-10#1)(2010-11#1)
and exposure to##14##3##(1990-8#1)(1991-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-11#1)(2011-2#1)
and exposure##36##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)
and exposures##2##2##(2008-12#1)(2010-11#1)
and express the##3##3##(1997-4#2)(2009-8#1)
and express##13##2##(1993-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
and expressed as##3##3##(1997-6#2)(2008-10#1)
and expressed at##2##3##(1990-5#1)(1994-8#1)
and expressed in E##2##4##(1991-5#1)(1997-6#1)
and expressed in Escherichia coli##6##5##(1993-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-9#1)
and expressed in##23##3##(1990-11#1)(1991-5#2)(1991-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)
and expressed sequence##2##3##(2008-10#1)(2008-7#1)
and expressed the##4##3##(1992-3#2)(1993-3#1)(1997-4#1)
and expressed under the##2##4##(2008-10#1)(2008-8#1)
and expressed##54##2##(1990-11#1)(1990-5#2)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2012-1#1)
and expressing##2##2##(1996-3#1)(2007-11#1)
and expression analyses##2##3##(1996-8#1)(2010-5#1)
and expression analysis of##3##4##(2008-7#1)(2008-8#1)(2010-5#1)
and expression analysis##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)
and expression characterization of##2##4##(2008-8#1)(2008-9#1)
and expression in E##2##4##(1991-5#1)(1992-3#1)
and expression in Escherichia coli##2##5##(1991-9#1)(1993-9#1)
and expression in##9##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-8#1)(2008-8#1)(2012-12#1)
and expression level of##2##4##(1997-8#1)(2008-9#1)
and expression level##4##3##(1994-8#1)(1997-8#1)(2008-10#1)(2008-9#1)
and expression levels of##3##4##(1994-12#1)(2008-11#1)(2012-3#1)
and expression levels##6##3##(1993-6#1)(1994-12#1)(2008-11#2)(2012-3#1)(2013-1#1)
and expression of a##13##4##(1990-11#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#2)(1995-6#1)(1997-2#1)(1997-6#1)(2013-1#1)(2013-8#1)
and expression of an##2##4##(1991-2#1)(1997-4#1)
and expression of certain##2##4##(1993-6#2)
and expression of co-stimulatory molecules##2##5##(2008-10#2)
and expression of foreign genes in##2##6##(1995-5#1)(1997-4#1)
and expression of foreign genes##3##5##(1995-5#1)(1997-4#1)(2008-11#1)
and expression of functional##2##4##(1994-12#1)(2008-9#1)
and expression of human##2##4##(2008-11#1)(2008-9#1)
and expression of the##23##4##(1990-11#2)(1990-12#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#3)
and expression of##96##3##(1990-11#4)(1990-12#1)(1990-5#2)(1991-2#2)(1991-9#2)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#4)(1994-12#2)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#7)(2009-8#1)(2010-12#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
and expression pattern##2##3##(1997-7#2)
and expression patterns of##2##4##(1993-12#1)(2012-3#1)
and expression profiling##2##3##(2008-7#1)(2012-3#1)
and expression studies##2##3##(1996-6#1)(2008-8#1)
and expression systems##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
and expression vectors##3##3##(1993-2#1)(1994-12#2)
and expression##156##2##(1990-11#4)(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#3)(1992-10#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#4)(1993-6#5)(1993-9#1)(1994-12#6)(1994-5#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#3)(1997-9#1)(2007-11#1)(2008-1#3)(2008-10#5)(2008-11#14)(2008-2#2)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#8)(2008-9#11)(2009-10#1)(2009-8#2)(2010-12#2)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
and expressions for##2##3##(2007-11#1)(2008-2#1)
and expressive##4##2##(1996-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
and extend the##9##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-6#1)(2011-7#1)(2012-3#1)
and extend##16##2##(1994-3#1)(1995-1#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
and extended X-ray absorption fine structure##2##6##(1996-2#1)(2008-9#1)
and extended from##2##3##(2008-11#1)(2008-7#1)
and extended into the##3##4##(1990-5#1)(2008-8#1)(2008-9#1)
and extended the##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
and extended##25##2##(1990-5#2)(1990-8#1)(1996-2#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-5#1)(2010-7#1)
and extending to the##2##4##(2008-10#1)(2008-11#1)
and extending##6##2##(1992-8#1)(1995-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)
and extends previous##3##3##(1996-2#1)(2008-12#1)(2008-7#1)
and extends the##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
and extends to##2##3##(2008-9#1)(2013-1#1)
and extends##11##2##(1993-6#1)(1994-11#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
and extension of the##5##4##(1990-6#1)(1996-12#1)(1996-6#1)(2007-11#1)(2011-1#1)
and extension of##9##3##(1990-6#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-7#1)(2010-1#1)(2011-1#1)(2012-3#2)
and extension to##3##3##(2007-4#1)(2008-12#1)(2011-1#1)
and extension##21##2##(1990-6#1)(1991-6#1)(1994-2#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-7#1)(2009-10#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-3#2)
and extensive##27##2##(1991-5#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-8#1)(2007-10#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)
and extensively drug-resistant TB##3##4##(2010-5#3)
and extensively drug-resistant##4##3##(2009-4#1)(2010-5#3)
and extensively##7##2##(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-5#3)
and extensor##8##2##(1993-12#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-9#1)(2009-5#1)
and extent of involvement##2##4##(1990-12#1)(1996-12#1)
and extent of the##5##4##(2007-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
and extent of these##2##4##(1997-2#1)(2008-7#1)
and extent of##41##3##(1990-12#1)(1991-12#1)(1992-6#2)(1992-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)
and extent##45##2##(1990-12#1)(1991-12#1)(1992-6#2)(1992-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
and external beam radiotherapy##2##4##(1995-9#1)(2007-11#1)
and external beam##6##3##(1994-3#1)(1995-9#1)(2007-11#1)(2008-2#2)(2008-6#1)
and external calibration##2##3##(2008-10#2)
and external factors##4##3##(1991-2#1)(1991-6#1)(1996-1#1)(2009-10#1)
and external##72##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-5#1)(1993-2#1)(1994-3#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#3)(2007-12#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
and externalizing problems##2##3##(2012-12#1)(2013-1#1)
and externalizing##8##2##(1995-2#1)(2008-12#1)(2012-12#4)(2013-1#2)
and extinction coefficient##5##3##(1995-3#1)(2008-3#4)
and extinction coefficients at##3##4##(2008-3#3)
and extinction coefficients of##3##4##(2008-2#2)(2009-9#1)
and extinction coefficients##6##3##(2008-2#2)(2008-3#3)(2009-9#1)
and extinction##16##2##(1991-12#1)(1992-12#1)(1995-3#1)(2008-2#2)(2008-3#8)(2008-9#2)(2009-9#1)
and extinction-to-backscatter##2##2##(2008-3#2)
and extra##4##2##(1991-6#1)(1994-8#1)(2011-2#1)(2013-8#1)
and extra-articular##2##2##(2013-1#2)
and extra-hepatic##4##2##(1992-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
and extracardiac##2##2##(2010-10#1)(2010-12#1)
and extracellular matrix proteins##4##4##(2008-5#1)(2012-1#2)(2012-12#1)
and extracellular matrix##11##3##(1997-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#1)
and extracellular##30##2##(1994-12#1)(1994-6#1)(1994-8#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
and extracorporeal##2##2##(2013-1#1)(2013-8#1)
and extracranial Lewy body type-degeneration in PD##2##7##(2008-11#2)
and extracranial##3##2##(2008-11#3)
and extractable P##2##3##(2008-5#2)
and extractable organic halogens##2##4##(2008-10#2)
and extractable##5##2##(1992-9#1)(2008-10#2)(2008-5#2)
and extractant##3##2##(2008-10#3)
and extracted with##3##3##(2008-10#2)(2008-5#1)
and extracted##10##2##(2008-10#6)(2008-3#1)(2008-5#1)(2010-7#1)(2013-8#1)
and extracting##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
and extraction chromatographic##2##3##(2008-10#2)
and extraction chromatography##2##3##(2008-10#2)
and extraction efficiency##2##3##(2008-10#1)(2012-2#1)
and extraction of the##4##4##(1996-6#1)(2008-10#2)(2010-3#1)
and extraction of##8##3##(1996-10#1)(1996-6#1)(2008-10#4)(2008-4#1)(2010-3#1)
and extraction time were##2##4##(2008-10#2)
and extraction time##7##3##(2008-10#7)
and extraction time) were##2##4##(2008-10#2)
and extraction##37##2##(1996-10#1)(1996-6#1)(2008-10#29)(2008-2#1)(2008-4#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)
and extractions were##2##3##(1990-12#1)(2011-2#1)
and extractive##3##2##(2008-10#2)(2009-6#1)
and extracts##8##2##(2008-10#6)(2008-5#1)(2012-3#1)
and extraembryonic##2##2##(1995-8#1)(2012-1#1)
and extraintestinal##2##2##(2013-8#2)
and extraordinary##4##2##(2008-2#3)(2008-3#1)
and extrapolate##2##2##(2008-2#1)(2008-6#1)
and extrapolation##2##2##(1992-2#1)(2010-5#1)
and extreme##10##2##(1990-6#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-7#1)
and extremely low##2##3##(1997-3#1)(2010-6#1)
and extremely##9##2##(1993-8#1)(1997-3#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#2)
and extremities##4##2##(2007-7#1)(2010-6#1)(2012-2#1)(2013-8#1)
and extrinsic factors##3##3##(1996-6#1)(2008-11#1)(2010-7#1)
and extrinsic work values##3##4##(2010-10#3)
and extrinsic work##4##3##(1996-1#1)(2010-10#3)
and extrinsic##15##2##(1996-1#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-7#1)(2011-2#1)(2013-1#1)
and eye movements were recorded##2##5##(2008-7#2)
and eye movements were##3##4##(2008-7#3)
and eye movements##5##3##(2008-7#4)(2009-2#1)
and eye##15##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#4)(2009-2#1)(2010-1#1)(2010-8#1)(2011-7#1)(2013-1#2)
and eyebrow##4##2##(2010-3#4)
and eyes##5##2##(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
and fabD##2##2##(1992-4#2)
and fabricate the##2##3##(2008-10#1)(2013-1#1)
and fabricate##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
and fabricated##16##2##(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#1)(2010-2#1)
and fabrication of a##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2009-9#1)
and fabrication of##12##3##(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-9#1)
and fabrication##15##2##(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2009-9#1)
and face##13##2##(1994-1#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
and facial nerve##3##3##(1997-6#2)(2008-9#1)
and facial palsy##2##3##(2007-10#1)(2008-9#1)
and facial##13##2##(1994-9#1)(1996-5#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-8#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-3#1)
and facile##4##2##(2008-2#1)(2008-3#1)(2010-4#1)(2012-2#1)
and facilitate further##2##3##(2009-5#1)(2012-12#1)
and facilitate the##8##3##(1990-7#1)(1995-12#1)(1996-4#1)(2008-10#1)(2008-12#1)(2010-3#1)(2010-5#1)(2010-7#1)
and facilitate##28##2##(1990-7#1)(1991-12#1)(1994-2#1)(1995-12#1)(1996-4#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
and facilitated by##3##3##(1996-2#1)(1996-5#1)(2008-5#1)
and facilitated##8##2##(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2009-12#1)
and facilitates the##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
and facilitates##18##2##(1990-9#1)(1993-3#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
and facilitating##8##2##(1995-1#1)(1995-3#1)(1995-8#1)(1997-3#1)(2007-7#1)(2008-11#2)(2010-9#1)
and facilitation in##2##3##(2008-12#1)(2010-8#1)
and facilitation##5##2##(2008-12#1)(2008-8#3)(2010-8#1)
and facilitators to##5##3##(2012-2#1)(2013-1#4)
and facilitators##7##2##(1995-3#1)(2012-2#1)(2013-1#5)
and facilities##6##2##(1994-3#1)(2008-8#1)(2009-3#2)(2009-8#1)(2011-2#1)
and facility##3##2##(1991-3#1)(1994-12#1)(1995-2#1)
and facing##3##2##(1993-3#1)(2010-7#1)(2011-2#1)
and factor analysis##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
and factor structure##2##3##(2008-1#1)(2010-1#1)
and factor##10##2##(1991-11#1)(1993-12#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2012-12#1)
and factorial design study##2##4##(2008-10#2)
and factors affecting##2##3##(1994-6#1)(2007-7#1)
and factors associated with##9##4##(2007-11#1)(2007-7#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
and factors influencing##5##3##(1991-12#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
and factors predicting##2##3##(2008-10#1)(2013-7#1)
and factors that contribute to##2##5##(2008-10#1)(2011-1#1)
and factors that##6##3##(1993-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-7#1)
and factors##29##2##(1991-12#1)(1993-1#1)(1994-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#2)
and factory workers##3##3##(1991-12#1)(2008-11#2)
and facts##2##2##(2007-4#1)(2008-8#1)
and facultative##2##2##(1990-2#1)(2008-12#1)
and faculty##6##2##(1996-1#2)(2008-11#1)(2008-12#2)(2013-1#1)
and faecal haemoglobin##2##3##(1993-8#2)
and faecal##5##2##(1993-8#2)(2007-5#1)(2008-10#1)(2008-5#1)
and fail to exhibit##2##4##(1994-11#2)
and fail to##7##3##(1990-8#1)(1994-11#2)(1996-9#1)(2007-12#1)(2008-3#1)(2013-1#1)
and failed to##5##3##(1990-5#1)(1996-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
and failed##8##2##(1990-5#1)(1996-6#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-2#1)
and failing##2##2##(2008-5#1)(2010-5#1)
and fails to##2##3##(1994-2#1)(2012-3#1)
and failure of##5##3##(2007-12#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
and failure to##5##3##(1991-12#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
and failure##14##2##(1991-12#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and failures in##2##3##(1991-8#1)(2008-5#1)
and failures##6##2##(1990-11#1)(1991-8#1)(1994-3#1)(2008-10#1)(2008-5#1)(2010-11#1)
and fair to##2##3##(1997-8#2)
and fair##7##2##(1997-8#2)(2007-8#1)(2008-11#3)(2008-2#1)
and fairly##7##2##(2008-10#4)(2008-2#1)(2008-7#1)(2013-1#1)
and fall into##2##3##(2008-2#1)(2008-4#1)
and fall of##2##3##(2008-10#2)
and fall##13##2##(2007-12#1)(2008-10#9)(2008-2#1)(2008-4#1)(2011-2#1)
and falling##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
and falls##2##2##(2010-11#1)(2013-1#1)
and false negative##2##3##(2008-1#1)(2011-2#1)
and false##8##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
and familial adenomatous polyposis##2##4##(2009-12#2)
and familial autosomal dominant##2##4##(1997-8#2)
and familial factors##2##3##(2010-3#1)(2011-2#1)
and familial##14##2##(1993-12#1)(1993-8#1)(1997-8#2)(2007-6#1)(2008-1#1)(2008-4#1)(2009-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#2)
and familiarity with##5##3##(2007-11#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
and familiarity##6##2##(1997-1#1)(2007-11#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
and families are##2##3##(2008-9#1)(2011-2#1)
and families in##3##3##(1992-3#1)(1997-1#2)
and families##35##2##(1990-12#1)(1991-12#3)(1991-2#1)(1992-2#2)(1992-3#2)(1994-1#1)(1996-3#1)(1997-1#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-11#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
and family caregivers##2##3##(1991-1#1)(2006-5#1)
and family communication##2##3##(2009-8#2)
and family decision##2##3##(2008-3#1)(2011-2#1)
and family doctors in the rest of the Netherlands (n = 521)##2##12##(1991-8#2)
and family doctors##3##3##(1991-8#2)(2008-11#1)
and family effects##2##3##(2009-9#2)
and family formation##2##3##(2008-8#1)(2009-10#1)
and family functioning##5##3##(1996-1#1)(2008-6#1)(2008-7#2)(2009-7#1)
and family members##8##3##(1992-12#1)(1993-1#1)(1997-3#1)(2008-6#2)(2008-7#1)(2009-11#1)(2011-1#1)
and family perceptions##2##3##(1996-2#1)(2007-11#1)
and family planning##4##3##(1992-5#1)(1994-3#2)(2010-1#1)
and family practitioners##2##3##(1993-12#1)(2007-11#1)
and family relationships##2##3##(2007-11#1)(2011-1#1)
and family responsibilities##2##3##(2008-11#1)(2012-3#1)
and family satisfaction##2##3##(1997-1#1)(2010-2#1)
and family support##3##3##(1997-2#1)(2007-8#1)(2009-7#1)
and family therapy##3##3##(1996-6#1)(2007-7#1)(2008-9#1)
and family##102##2##(1991-1#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-2#2)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#1)(2006-5#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-11#8)(2008-12#1)(2008-3#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-8#2)
and family-based##2##2##(2008-4#1)(2012-3#1)
and far away from ore body rock##2##7##(2013-8#2)
and far fields##3##3##(2007-12#2)(2008-2#1)
and far from##4##3##(1993-8#1)(2008-11#1)(2008-3#2)
and far##11##2##(1992-8#1)(1993-8#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#2)(2013-8#2)
and far-field intensity##2##3##(2008-2#1)(2008-3#1)
and far-field##9##2##(2007-11#1)(2008-2#3)(2008-3#4)(2012-2#1)
and far-reaching##2##2##(1992-3#1)(2007-11#1)
and farm##3##2##(2008-12#2)(2011-2#1)
and farmers##2##2##(1997-7#1)(2010-1#1)
and fast and##2##3##(2008-3#1)(2011-2#1)
and fast atom bombardment mass##2##5##(1994-3#1)(2008-10#1)
and fast atom bombardment##3##4##(1994-3#1)(1995-3#1)(2008-10#1)
and fast atom##4##3##(1993-11#1)(1994-3#1)(1995-3#1)(2008-10#1)
and fast food##2##3##(2011-2#2)
and fast method for the##4##5##(2008-10#4)
and fast method for##6##4##(2008-10#5)(2008-11#1)
and fast method has been developed for the##2##8##(2008-10#2)
and fast method##10##3##(2008-10#9)(2008-11#1)
and fast procedure for##2##4##(2008-10#1)(2008-6#1)
and fast procedure##3##3##(2008-10#2)(2008-6#1)
and fast response##5##3##(2007-11#1)(2008-10#4)
and fast spectrophotometric determination of##2##5##(2008-10#2)
and fast##67##2##(1993-11#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#38)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#4)(2012-3#1)(2013-8#1)
and fast-twitch##2##2##(1994-9#2)
and faster recovery##2##3##(1996-3#1)(2013-1#1)
and faster##15##2##(1991-5#1)(1996-3#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
and fasting##5##2##(2008-11#1)(2008-3#2)(2008-7#1)(2010-4#1)
and fat##17##2##(1994-5#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
and fat-free##2##2##(2008-10#1)(2012-2#1)
and fatal injury##2##3##(2008-11#2)
and fatal##7##2##(1991-8#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#2)
and fate of the##2##4##(2008-7#1)(2013-1#1)
and fate of##5##3##(1991-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
and fathers##6##2##(1993-6#1)(1994-12#1)(2007-5#1)(2009-5#2)(2009-7#1)
and fatigue##21##2##(1991-6#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-6#3)(2011-2#3)(2012-2#2)(2013-1#1)
and fatty acid composition of##3##5##(1991-12#1)(2010-4#1)(2013-1#1)
and fatty acid composition##4##4##(1991-12#1)(1992-12#1)(2010-4#1)(2013-1#1)
and fatty acid profile##2##4##(2010-11#1)(2013-1#1)
and fatty acid profiles were##2##5##(2010-11#1)(2010-2#1)
and fatty acid profiles##6##4##(2008-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
and fatty acid##22##3##(1991-12#1)(1992-12#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-11#2)(2010-2#4)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
and fatty acids in##2##4##(1992-3#2)
and fatty acids##13##3##(1991-12#1)(1992-3#2)(1994-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)
and fatty##40##2##(1991-12#2)(1992-10#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-11#2)(2010-2#4)(2010-4#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
and fault##4##2##(1996-4#1)(2008-2#2)(2009-10#1)
and favor##3##2##(1996-3#1)(2008-8#1)(2008-9#1)
and favorable##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
and favorably##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
and favoring##2##2##(1997-3#1)(2008-9#1)
and favourable##2##2##(1990-9#1)(2008-1#1)
and fear of##3##3##(1996-6#1)(2011-2#1)(2013-1#1)
and fear##11##2##(1990-10#1)(1996-6#1)(2007-11#1)(2008-11#2)(2008-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
and fears##4##2##(1992-1#1)(2008-11#2)(2010-3#1)
and feasibility of##6##3##(1991-3#1)(2007-10#1)(2008-3#1)(2011-2#1)(2012-12#2)
and feasibility##12##2##(1991-3#1)(2007-10#2)(2008-10#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
and feasible for##2##3##(1995-2#1)(2008-3#1)
and feasible##7##2##(1991-2#1)(1995-2#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
and feather quality##2##3##(2008-9#2)
and feather##6##2##(1992-2#1)(2007-5#1)(2008-5#2)(2008-9#2)
and feature sizes as small as##2##6##(2008-2#2)
and feature##9##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-8#1)
and features of the##3##4##(2008-3#1)(2008-5#2)
and features of##12##3##(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
and features##20##2##(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
and fecal##11##2##(1991-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-5#1)(2009-4#3)(2011-2#2)(2013-8#1)
and feces##8##2##(1993-2#4)(1996-12#1)(2009-4#2)(2009-6#1)
and fecundity rates##4##3##(2008-12#4)
and fecundity##9##2##(2008-10#1)(2008-12#5)(2008-8#1)(2011-2#2)
and fed without or with##2##5##(2010-2#2)
and fed##13##2##(1992-3#1)(1992-9#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#2)(2010-4#1)(2012-2#1)
and fed-batch cultures##5##3##(2008-11#5)
and fed-batch##15##2##(2008-11#9)(2008-7#2)(2011-2#3)(2013-1#1)
and federal governments##2##3##(2007-6#1)(2009-11#1)
and federal health##3##3##(1996-1#1)(1996-3#1)(2009-5#1)
and federal##17##2##(1991-2#1)(1992-1#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#4)(1996-3#1)(1997-1#1)(1997-3#1)(2007-6#1)(2009-11#1)(2009-5#1)(2010-9#1)
and fee-for-service##5##2##(1991-3#1)(1993-12#1)(1994-2#1)(1995-3#1)(1997-2#1)
and feed conversion ratio (p &lt##2##6##(2008-12#2)
and feed conversion ratio##4##4##(2008-12#3)(2013-1#1)
and feed conversion##5##3##(1997-6#1)(2008-12#3)(2013-1#1)
and feed##21##2##(1993-12#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-7#2)(2010-2#1)(2010-4#1)(2013-1#1)
and feedback to##2##3##(1994-12#1)(2012-3#1)
and feedback##18##2##(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
and feeding habits##3##3##(2008-5#3)
and feeding##29##2##(1990-12#2)(1995-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#2)(2013-8#1)
and feel##2##2##(1992-3#1)(2008-5#1)
and feeling##4##2##(2007-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
and feelings about##4##3##(1992-3#1)(1995-12#1)(2009-6#2)
and feelings of##3##3##(1995-1#1)(1995-2#1)(2011-2#1)
and feelings##13##2##(1992-2#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-11#1)(2009-6#2)(2011-2#2)(2012-12#1)(2013-1#1)
and fees##2##2##(1990-9#1)(1995-12#1)
and fell##3##2##(1990-12#1)(1993-12#1)(2008-10#1)
and fellowship##2##2##(1994-3#1)(2010-5#1)
and felt##4##2##(2010-3#2)(2012-2#1)(2013-1#1)
and female Tg##17##3##(2008-8#2)(2008-9#15)
and female components##4##3##(2008-9#4)
and female fitness##2##3##(2008-8#1)(2008-9#1)
and female gender##2##3##(2007-12#1)(2011-2#1)
and female participants##2##3##(2007-12#1)(2008-5#1)
and female patients##5##3##(2008-7#4)(2010-5#1)
and female rats##14##3##(1993-5#1)(1994-2#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-9#1)(2010-1#1)
and female reproductive##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
and female subjects##5##3##(2008-10#1)(2008-5#2)(2010-8#1)(2013-1#1)
and female volunteers##2##3##(2007-11#1)(2008-5#1)
and female##153##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-5#2)(1994-2#1)(1995-11#1)(1995-3#1)(1995-8#2)(1997-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#6)(2008-11#4)(2008-12#9)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#14)(2008-9#37)(2009-10#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#3)(2013-8#5)
and females administered##3##3##(2008-9#3)
and females at##7##3##(1993-6#1)(2008-9#6)
and females for##2##3##(2008-8#1)(2011-1#1)
and females in both studies##4##5##(2008-9#4)
and females in##8##3##(2008-9#7)(2012-3#1)
and females of##5##3##(1995-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2013-7#1)
and females were##9##3##(1997-3#1)(2008-4#1)(2008-9#7)
and females##108##2##(1990-3#1)(1990-8#1)(1991-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#7)(2008-9#54)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#7)(2013-8#1)
and femoral neck BMD##2##4##(2010-1#1)(2011-2#1)
and femoral neck##3##3##(2008-4#1)(2010-1#1)(2011-2#1)
and femoral##8##2##(1991-11#1)(1995-12#1)(2008-4#2)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)
and femur##5##2##(1991-11#1)(1997-4#1)(2007-11#1)(2011-2#2)
and fenitrothion##2##2##(2008-10#2)
and fentanyl##4##2##(1993-1#2)(1996-6#2)
and ferment##2##2##(2008-6#1)(2012-3#1)
and fermentation##14##2##(1997-4#1)(2008-10#2)(2008-6#9)(2013-1#2)
and fermentative##4##2##(2008-7#2)(2011-2#2)
and ferric##2##2##(2008-10#1)(2008-11#1)
and ferricyanide##6##2##(1992-11#1)(1992-6#1)(2008-10#4)
and ferritin##8##2##(1994-11#2)(1996-2#1)(1997-6#2)(2007-7#2)(2008-10#1)
and ferroin##2##2##(2008-10#2)
and ferromagnetic##2##2##(2007-11#1)(2008-7#1)
and fertile##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2013-7#1)
and fertility in##2##3##(1997-6#1)(2008-5#1)
and fertility rate##2##3##(1996-2#1)(2008-8#1)
and fertility rates##2##3##(2008-8#1)(2010-12#1)
and fertility##16##2##(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#3)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
and fertilization##4##2##(2007-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
and fertilizer##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
and ferulic acid and syringic acid##2##6##(2011-1#2)
and ferulic acid##4##3##(1994-5#2)(2011-1#2)
and ferulic acids##2##3##(1994-5#1)(2008-10#1)
and ferulic##6##2##(1994-5#3)(2008-10#1)(2011-1#2)
and fetal heart rate##2##4##(1993-10#1)(1994-3#1)
and fetal liver##2##3##(1990-5#1)(2008-4#1)
and fetal loss##2##3##(2013-1#1)(2013-8#1)
and fetal##29##2##(1990-12#2)(1990-5#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-6#3)(1994-3#1)(1994-7#1)(1995-8#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
and fetid##2##2##(1990-3#1)(2007-6#1)
and fetus##4##2##(1993-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
and fetuses were##2##3##(1993-12#1)(1996-12#1)
and fever##18##2##(1991-2#1)(1995-10#1)(1997-7#2)(2006-10#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
and few studies##2##3##(2008-9#1)(2012-8#1)
and few##18##2##(1991-11#1)(1991-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-9#1)(2009-3#2)(2009-8#1)(2012-1#1)(2012-8#1)(2013-1#2)(2013-7#1)
and fewer long-term##2##3##(2012-1#2)
and fewer side effects##2##4##(2007-10#1)(2008-9#1)
and fewer side##3##3##(1996-5#1)(2007-10#1)(2008-9#1)
and fewer##26##2##(1990-8#1)(1991-3#2)(1993-8#1)(1994-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#2)(2013-1#1)
and fiber quality##2##3##(2011-2#2)
and fiber##15##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#5)(2009-7#1)(2011-2#2)(2012-5#1)
and fiber-optic##2##2##(2008-2#1)(2008-3#1)
and fibers##11##2##(1992-11#2)(1992-12#4)(2008-2#3)(2008-6#1)(2012-2#1)
and fibre##6##2##(2008-10#3)(2008-5#1)(2009-7#1)(2012-2#1)
and fibrillarin are two##2##4##(2008-8#2)
and fibrils##2##2##(2008-11#1)(2012-1#1)
and fibrin glue##3##3##(2006-12#1)(2008-7#1)(2008-9#1)
and fibrin##9##2##(1994-5#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)
and fibrinogen##11##2##(1997-7#1)(2006-6#4)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)
and fibrinolytic##4##2##(1994-5#1)(2008-1#1)(2008-5#1)(2013-1#1)
and fibroadenoma##2##2##(1994-7#1)(2012-1#1)
and fibroblast growth factor##2##4##(1994-12#1)(2011-2#1)
and fibroblast growth##5##3##(1994-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
and fibroblast##9##2##(1990-5#1)(1994-12#1)(1997-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
and fibroblastic##2##2##(2008-5#1)(2010-3#1)
and fibroblasts##7##2##(1990-2#2)(1990-6#1)(1991-6#1)(1992-12#1)(1997-1#1)(1997-7#1)
and fibronectin##8##2##(1990-12#1)(1990-5#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-12#1)(2011-2#1)(2012-1#1)
and fibrosis##7##2##(2007-8#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#2)
and fibrous DNA##3##3##(2008-11#3)
and fibrous##7##2##(2008-11#3)(2008-7#1)(2009-11#1)(2009-7#1)(2010-12#1)
and fidelity##3##2##(2008-2#1)(2008-4#1)(2008-6#1)
and field conditions##5##3##(2008-10#5)
and field data##3##3##(1994-8#1)(2008-3#1)(2008-9#1)
and field experiments were conducted to##2##6##(2008-10#2)
and field experiments##6##3##(2008-10#4)(2008-9#1)(2010-8#1)
and field measurements##3##3##(2008-10#1)(2008-3#2)
and field size##2##3##(1992-10#2)
and field studies##5##3##(2008-10#4)(2009-7#1)
and field testing##2##3##(1993-3#1)(2008-12#1)
and field trials##2##3##(2008-10#1)(2008-12#1)
and field##58##2##(1992-10#2)(1993-3#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#29)(2008-12#3)(2008-3#8)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
and fields##6##2##(2008-10#4)(2008-7#1)(2010-10#1)
and fifteen##5##2##(1995-11#1)(2008-9#1)(2011-1#2)(2013-7#1)
and fifth##13##2##(1997-3#2)(2007-12#1)(2008-10#4)(2008-9#1)(2010-11#2)(2010-3#2)(2012-3#1)
and fifth-order spherical aberration##2##4##(2008-3#2)
and fifth-order##4##2##(2007-11#2)(2008-3#2)
and figures##2##2##(1996-1#1)(2011-2#1)
and filamentous fungi##4##3##(2008-6#2)(2011-2#1)(2013-8#1)
and filamentous##8##2##(1994-6#2)(1996-6#1)(2008-6#2)(2011-2#2)(2013-8#1)
and file format##2##3##(2007-7#1)(2011-1#1)
and file##5##2##(1991-2#1)(1993-2#1)(2007-7#1)(2008-6#1)(2011-1#1)
and filled with##7##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
and filled##8##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
and filler##2##2##(2008-12#1)(2010-4#1)
and filling##2##2##(1991-6#1)(2008-12#1)
and film thickness##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
and film##7##2##(1995-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-9#1)
and films##4##2##(1993-5#1)(2007-12#2)(2010-5#1)
and filopodia##2##2##(1995-11#1)(2008-7#1)
and filter##3##2##(2008-10#1)(2012-3#2)
and filtered##4##2##(1996-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
and filtering method##2##3##(2010-8#1)(2012-2#1)
and filtering of the##2##4##(2008-2#1)(2010-11#1)
and filtering##6##2##(1992-12#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-8#1)(2012-2#1)
and filters##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
and filtrated##2##2##(2008-10#2)
and filtration##5##2##(1995-11#1)(2008-10#3)(2008-7#1)
and final cell##2##3##(2008-11#1)(2008-6#1)
and final diagnosis##2##3##(2008-3#1)(2013-8#1)
and final product##2##3##(1996-5#1)(2008-11#1)
and final##32##2##(1990-11#1)(1991-8#1)(1993-1#1)(1993-12#1)(1996-5#1)(1996-9#1)(2007-7#2)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and finally a##2##3##(2008-11#1)(2008-9#1)
and finally detected by##2##4##(2008-10#2)
and finally detected##3##3##(2008-10#2)(2011-1#1)
and finally the##9##3##(1990-10#1)(1993-11#1)(1993-8#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and finally to Cr3+##2##4##(2008-2#2)
and finally to##7##3##(2008-1#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)
and finally##95##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-6#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-1#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-1#5)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-7#2)(2010-12#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)
and finance##6##2##(1993-3#1)(1994-12#1)(1994-2#1)(1997-3#1)(2008-11#1)(2012-12#1)
and financed by##2##3##(1996-1#1)(2010-4#1)
and financed##3##2##(1996-1#1)(1997-3#1)(2010-4#1)
and financial data##2##3##(1992-1#1)(1995-12#1)
and financial implications##2##3##(1996-1#1)(2007-7#1)
and financial performance##4##3##(1992-12#1)(1993-12#1)(2008-6#1)(2012-3#1)
and financial resources##2##3##(1992-12#1)(1997-7#1)
and financial systems##2##3##(1996-1#1)(1997-3#1)
and financial##45##2##(1990-4#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-12#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-8#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and financing of##6##3##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-1#1)(1997-3#1)
and financing##14##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-3#1)(1997-3#1)
and find excellent agreement between them##2##6##(2007-11#1)(2007-12#1)
and find excellent agreement##3##4##(2007-11#1)(2007-12#1)(2012-2#1)
and find it##2##3##(2008-3#1)(2010-10#1)
and find that the##5##4##(1993-6#1)(2008-11#1)(2008-2#2)(2008-3#1)
and find that this##2##4##(1996-2#1)(2007-11#1)
and find that##10##3##(1993-6#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-9#1)(2010-2#1)
and find##22##2##(1990-11#1)(1991-1#1)(1993-6#1)(1994-12#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#3)(2013-7#1)
and finding##2##2##(1993-5#1)(2008-9#1)
and findings are##2##3##(1993-2#1)(2008-11#1)
and findings from##2##3##(2008-4#1)(2009-9#1)
and findings in##2##3##(1996-3#1)(2008-7#1)
and findings of##3##3##(2008-12#1)(2008-2#1)(2011-3#1)
and findings that##2##3##(2008-10#2)
and findings##16##2##(1993-2#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2011-3#1)(2012-2#1)
and finds##3##2##(1997-3#1)(2009-8#1)(2011-2#1)
and fine motor##2##3##(2008-7#1)(2011-2#1)
and fine##11##2##(1992-8#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
and finely tuned##2##3##(1994-12#2)
and finely##3##2##(1994-12#2)(2007-12#1)
and finger tapping##2##3##(1994-3#1)(2008-7#1)
and finger##6##2##(1994-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
and finished##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
and finishing##9##2##(1990-3#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-2#4)
and finite##3##2##(1995-12#1)(2008-3#1)(2009-7#1)
and finite-element##2##2##(2008-3#1)(2008-8#1)
and fire##4##2##(1990-8#1)(1991-12#1)(2008-11#1)(2012-2#1)
and firing rate##2##3##(2008-11#1)(2008-7#1)
and firing##5##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
and firm stabilization##2##3##(2007-11#2)
and firmness##2##2##(2008-10#1)(2008-5#1)
and first degree relatives##3##4##(2007-7#3)
and first derivative##4##3##(2008-10#4)
and first results##2##3##(2008-3#1)(2013-1#1)
and first##29##2##(1991-8#1)(1995-1#1)(2007-11#2)(2007-12#1)(2007-7#4)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
and first-derivative##2##2##(2008-10#2)
and first-order##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
and fiscal##4##2##(1992-1#1)(1995-3#1)(2008-6#1)(2008-7#1)
and fish from##2##3##(2008-11#1)(2008-3#1)
and fish samples##3##3##(2008-10#3)
and fish##24##2##(1992-10#1)(1992-8#1)(1993-8#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2013-7#1)
and fisheries##2##2##(2010-8#2)
and fishery##2##2##(2008-12#1)(2013-7#1)
and fission products##2##3##(2008-10#1)(2013-1#1)
and fission yeast##3##3##(2009-3#2)(2009-8#1)
and fission##6##2##(1995-6#1)(2008-10#1)(2009-3#2)(2009-8#1)(2013-1#1)
and fistula##3##2##(2008-7#1)(2009-1#2)
and fistulae##2##2##(1990-3#1)(2008-1#1)
and fistulas##4##2##(1997-8#3)(2008-1#1)
and fit##4##2##(2008-11#1)(2008-8#1)(2009-4#1)(2011-2#1)
and fitness##10##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
and fits##2##2##(2008-7#1)(2013-1#1)
and fitted##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
and fitting the##3##3##(2008-10#1)(2008-7#2)
and fitting##5##2##(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)
and five cell##2##3##(2008-11#1)(2012-2#1)
and five in the##2##4##(2007-7#1)(2008-11#1)
and five months##2##3##(1995-9#1)(2013-1#1)
and five new##2##3##(1997-3#1)(2008-8#1)
and five other##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
and five variables##2##3##(2008-10#2)
and five were##2##3##(1994-2#1)(2008-6#1)
and five year graft survival was##2##6##(2008-1#2)
and five year##3##3##(2008-1#3)
and five years##3##3##(1992-4#1)(2008-10#1)(2008-9#1)
and five##99##2##(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#10)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#10)(2009-12#1)(2009-8#1)(2010-4#2)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
and five-color near-infrared optical lymphatic imaging##2##6##(2008-12#2)
and fix##2##2##(1993-3#1)(2011-2#1)
and fixation of##2##3##(2012-2#1)(2013-1#1)
and fixation techniques##2##3##(2008-7#1)(2012-3#1)
and fixation##13##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
and fixed by##2##3##(1993-9#1)(2008-12#1)
and fixed cells##4##3##(2008-10#1)(2008-9#3)
and fixed in##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
and fixed on##5##3##(2008-10#4)(2010-8#1)
and fixed##28##2##(1993-9#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and fixed-analyzer spectroscopic##2##3##(2008-3#2)
and fixed-analyzer##4##2##(2008-3#4)
and flag##2##2##(2008-10#1)(2008-12#1)
and flame atomic absorption spectrometry is presented##2##7##(2008-10#2)
and flame atomic absorption spectrometry were##2##6##(2008-10#2)
and flame atomic absorption spectrometry##13##5##(2008-10#13)
and flame atomic absorption##15##4##(2008-10#15)
and flame##18##2##(1997-3#1)(2008-10#17)
and flank##2##2##(2007-7#1)(2008-7#1)
and flanking##4##2##(1994-12#1)(2008-10#1)(2008-8#2)
and flap problems##2##3##(2008-9#2)
and flap##4##2##(2008-9#2)(2009-8#2)
and flare##2##2##(2008-3#1)(2008-5#1)
and flash##2##2##(2008-3#1)(2013-1#1)
and flask##2##2##(2008-10#1)(2008-12#1)
and flat##2##2##(2008-11#1)(2011-2#1)
and flattened##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
and flavin##3##2##(1994-9#1)(2008-11#1)(2008-8#1)
and flavonoids##2##2##(2008-10#1)(2013-7#1)
and flexibility in##2##3##(2008-10#1)(2008-3#1)
and flexibility of##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
and flexibility to##2##3##(1992-12#1)(1994-2#1)
and flexibility##14##2##(1990-4#1)(1992-12#1)(1992-3#1)(1994-2#1)(2008-10#5)(2008-3#3)(2008-4#1)(2012-3#1)
and flexible##17##2##(1992-3#1)(1993-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
and flexion##4##2##(2008-9#2)(2009-11#1)(2009-3#1)
and flexor##2##2##(2007-11#1)(2009-11#1)
and flies##2##2##(1991-5#1)(2008-8#1)
and flight##2##2##(1996-12#1)(2008-8#1)
and floating##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
and flooding##2##2##(2008-8#1)(2013-1#1)
and floor##6##2##(1994-12#4)(1997-2#1)(2008-7#1)
and floral##2##2##(2008-10#1)(2008-9#1)
and flourish##2##2##(1992-3#1)(1996-1#1)
and flow analysis##2##3##(2008-10#2)
and flow cytometric##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
and flow cytometry have##2##4##(1992-8#1)(2008-9#1)
and flow cytometry##19##3##(1990-8#1)(1992-8#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#5)(2009-6#1)(2011-2#1)(2013-8#1)
and flow injection (FI) methods##2##5##(2008-10#2)
and flow injection (FI)##3##4##(2008-10#3)
and flow injection analysis (FIA)##2##5##(2008-10#2)
and flow injection analysis##4##4##(2008-10#4)
and flow injection atomic##2##4##(2008-10#2)
and flow injection variables were##2##5##(2008-10#2)
and flow injection variables##3##4##(2008-10#3)
and flow injection##21##3##(2008-10#21)
and flow measurements##2##3##(2007-11#1)(2008-11#1)
and flow rate of the##2##5##(2008-10#2)
and flow rate of##4##4##(2008-10#3)(2010-3#1)
and flow rate##14##3##(2008-10#13)(2010-3#1)
and flow rates of##2##4##(2008-10#2)
and flow rates were##2##4##(2008-10#2)
and flow rates##7##3##(2008-10#5)(2008-11#1)(2008-7#1)
and flow variables##6##3##(2008-10#6)
and flow velocity##2##3##(2007-12#1)(2008-3#1)
and flow##97##2##(1990-8#1)(1992-8#1)(1993-6#1)(1993-8#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#59)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
and flow-injection (FI) analysis##2##4##(2008-10#2)
and flow-injection (FI)##3##3##(2008-10#3)
and flow-injection methods##2##3##(2008-10#2)
and flow-injection##8##2##(2008-10#8)
and flow-rate##3##2##(2008-10#2)(2008-9#1)
and flowed through the##2##4##(2008-10#2)
and flower buds##3##3##(2008-10#3)
and flower production##2##3##(2008-8#1)(2011-2#1)
and flower##12##2##(1993-2#1)(2008-10#7)(2008-8#1)(2009-12#1)(2009-5#1)(2011-2#1)
and flowering stages##2##3##(2008-10#1)(2013-8#1)
and flowering time##2##3##(2009-8#1)(2012-3#1)
and flowering##7##2##(2008-10#3)(2009-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
and flowers##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
and flowing##2##2##(2008-10#1)(2008-5#1)
and fluctuating##5##2##(2007-12#1)(2008-9#2)(2010-4#1)(2012-3#1)
and fluctuations in##2##3##(2008-10#1)(2008-7#1)
and fluence rate##2##3##(2008-2#1)(2012-3#1)
and fluence##3##2##(2008-2#2)(2012-3#1)
and fluid##15##2##(1991-12#1)(1995-12#1)(1996-6#1)(2007-7#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-2#1)
and fluorescein##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
and fluorescence behavior of##3##4##(2008-10#3)
and fluorescence detection##7##3##(1991-5#1)(1996-5#1)(2008-10#5)
and fluorescence emission##2##3##(2008-10#2)
and fluorescence emissions##2##3##(2008-10#2)
and fluorescence epi-illumination)##3##3##(2008-4#2)(2008-9#1)
and fluorescence imaging##2##3##(2007-12#1)(2012-2#1)
and fluorescence in situ hybridization (FISH)##4##6##(1993-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
and fluorescence in situ hybridization##7##5##(1993-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)
and fluorescence in##10##3##(1993-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)
and fluorescence intensity##3##3##(2008-10#2)(2013-7#1)
and fluorescence microscopy##7##3##(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#3)
and fluorescence properties of##2##4##(1990-12#1)(2008-8#1)
and fluorescence properties##4##3##(1990-12#1)(2008-4#1)(2008-8#1)(2010-4#1)
and fluorescence signal##2##3##(2008-10#1)(2008-2#1)
and fluorescence spectra##4##3##(1990-5#1)(2008-10#2)(2008-3#1)
and fluorescence spectroscopy##3##3##(2008-11#1)(2009-6#1)(2010-4#1)
and fluorescence##91##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-5#2)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-5#1)(1995-6#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#8)(2009-10#1)(2009-6#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
and fluorescence-activated cell sorting##2##4##(2008-4#1)(2009-11#1)
and fluorescence-detected##2##2##(2006-4#1)(2008-10#1)
and fluorescent detection##2##3##(2008-10#1)(2008-9#1)
and fluorescent dyes##2##3##(2008-3#1)(2008-7#1)
and fluorescent##21##2##(1991-5#1)(1995-2#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#5)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and fluoride using##2##3##(2008-10#2)
and fluoride##13##2##(1994-5#1)(1994-8#1)(2007-12#1)(2008-10#8)(2010-3#1)(2011-2#1)
and fluorimetric detection##6##3##(1991-5#1)(2008-10#5)
and fluorimetric methods##2##3##(2008-10#2)
and fluorimetric##10##2##(1991-5#1)(2008-10#9)
and fluorinated##3##2##(2008-2#2)(2008-3#1)
and fluorine##2##2##(2007-12#1)(2008-10#1)
and fluorography of##2##3##(1990-7#1)(1992-3#1)
and fluorometric detection##2##3##(2008-10#2)
and fluorometric##3##2##(2008-10#3)
and fluorometrically##2##2##(1990-8#1)(2008-10#1)
and fluoroquinolones##2##2##(2008-10#1)(2011-2#1)
and fluoroscopic control##2##3##(2011-2#2)
and fluoroscopy##3##2##(1993-12#1)(2007-8#1)(2008-9#1)
and fluoxetine##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
and fluticasone propionate##3##3##(1996-2#2)(2007-11#1)
and fluvalinate in##2##3##(2008-10#2)
and fluvalinate##3##2##(2008-10#3)
and fluxes##2##2##(2008-10#1)(2008-11#1)
and fly##4##2##(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#1)
and foaming##2##2##(2008-5#1)(2010-4#1)
and foams##2##2##(2008-3#1)(2008-5#1)
and focal position##2##3##(2007-11#1)(2007-12#1)
and focal spot##2##3##(2007-12#1)(2008-3#1)
and focal##15##2##(1996-12#1)(1996-6#1)(1996-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
and focus group interviews##3##4##(2008-11#1)(2008-12#1)(2010-3#1)
and focus group##4##3##(2008-11#1)(2008-12#2)(2010-3#1)
and focus groups##5##3##(1991-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2010-10#1)
and focus of##2##3##(2008-11#1)(2009-6#1)
and focus on a##2##4##(2008-11#1)(2008-8#1)
and focus on the##3##4##(2008-5#1)(2008-7#1)(2012-2#1)
and focus on##8##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)
and focus##23##2##(1991-12#1)(1992-12#1)(1994-11#1)(1996-3#2)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-3#1)(2012-2#1)
and focused on##2##3##(2010-5#1)(2013-1#1)
and focused##10##2##(1995-1#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#1)
and focuses on the##3##4##(1993-3#1)(2008-1#1)(2008-7#1)
and focuses on##8##3##(1992-1#1)(1993-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
and focuses##9##2##(1992-1#1)(1993-3#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
and focusing of##4##3##(2007-11#3)(2008-2#1)
and focusing the##2##3##(1991-1#1)(2008-3#1)
and focusing##13##2##(1991-1#1)(2007-11#5)(2007-12#1)(2007-2#1)(2008-2#3)(2008-3#2)
and foetal outcome##3##3##(2008-7#1)(2010-11#1)(2011-1#1)
and foetal##5##2##(2007-2#1)(2008-7#2)(2010-11#1)(2011-1#1)
and folate##5##2##(1992-9#2)(2008-3#2)(2008-7#1)
and folded##2##2##(2007-12#1)(2008-3#1)
and folding##4##2##(1994-8#1)(2008-4#1)(2008-7#1)(2012-2#1)
and foliar resorption##2##3##(2008-12#2)
and foliar##10##2##(2008-10#6)(2008-12#3)(2011-10#1)
and folic acid##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
and follicular##5##2##(1995-12#1)(2007-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
and follow a##2##3##(1995-5#1)(2010-1#1)
and follow up of##4##4##(1994-7#1)(2007-8#1)(2008-4#1)(2008-7#1)
and follow up##7##3##(1994-7#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
and follow##13##2##(1994-7#1)(1995-5#1)(2007-11#2)(2007-8#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-1#1)(2011-2#1)
and follow-up care##2##3##(1996-1#1)(2013-1#1)
and follow-up of adolescents##2##4##(1990-6#1)(1993-3#1)
and follow-up of patients with##3##5##(2012-2#2)(2013-1#1)
and follow-up of patients##4##4##(2008-1#1)(2012-2#2)(2013-1#1)
and follow-up of pulmonary##2##4##(2011-2#2)
and follow-up of##17##3##(1990-6#1)(1993-3#1)(2007-11#1)(2008-1#2)(2008-6#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
and follow-up until##2##3##(1993-12#1)(2013-1#1)
and follow-up were##2##3##(1996-6#1)(2007-7#1)
and follow-up##58##2##(1990-6#2)(1991-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)
and follow-up]##2##2##(1990-9#1)(2011-1#1)
and followed a##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
and followed by an##2##4##(1996-5#1)(2013-8#1)
and followed by##9##3##(1996-2#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#2)(2013-8#1)
and followed for##4##3##(2007-8#1)(2008-7#1)(2010-3#1)(2012-3#1)
and followed the##3##3##(1991-8#1)(1995-6#1)(2012-12#1)
and followed up for##4##4##(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
and followed up##7##3##(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-12#1)
and followed##35##2##(1991-8#1)(1992-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#5)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
and followed-up##2##2##(2011-2#1)(2013-1#1)
and following a##2##3##(1991-2#1)(2008-10#1)
and following the##5##3##(1996-9#1)(2008-1#1)(2008-10#3)
and following##34##2##(1990-11#1)(1990-5#1)(1991-2#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
and follows a##2##3##(1990-7#1)(1993-8#1)
and follows the##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
and follows##5##2##(1990-7#1)(1993-8#1)(1994-5#1)(1995-6#1)(2008-10#1)
and food and##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
and food choice##2##3##(2012-1#2)
and food consumption##3##3##(1994-2#1)(1995-12#1)(2008-1#1)
and food industries##2##3##(2010-9#1)(2013-8#1)
and food ingredients##2##3##(2011-2#2)
and food intake##4##3##(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
and food preferences##2##3##(2012-12#1)(2012-2#1)
and food products are##2##4##(1992-11#1)(2010-7#1)
and food samples##3##3##(2008-10#3)
and food##62##2##(1990-6#1)(1991-2#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#7)(2012-1#4)(2012-12#2)(2012-2#3)(2013-8#4)
and foodborne##2##2##(2007-12#1)(2011-2#1)
and foods##5##2##(1994-1#1)(2008-10#4)
and foodstuffs##2##2##(2008-10#2)
and foot##9##2##(1994-8#1)(1997-8#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
and footprinting##3##2##(1995-2#2)(2008-2#1)
and for 10##2##3##(2008-10#2)
and for a variety of##3##5##(1997-1#1)(1997-7#1)(2008-3#1)
and for a##17##3##(1994-6#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-5#1)(2009-4#1)
and for all##6##3##(1990-5#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
and for an##3##3##(1992-12#1)(2008-2#1)(2012-12#1)
and for analysis of##2##4##(2008-10#1)(2008-4#1)
and for analysis##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
and for any##2##3##(1995-9#1)(2008-2#1)
and for comparison##2##3##(1996-2#1)(2008-2#1)
and for data acquisition##2##4##(2008-10#2)
and for data##3##3##(2008-10#2)(2008-2#1)
and for determining##2##3##(2008-10#1)(2009-5#1)
and for different##6##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)
and for distinguishing##2##3##(2008-3#1)(2008-4#1)
and for each##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
and for elucidating##2##3##(2009-10#1)(2009-8#1)
and for estimating##2##3##(1994-3#1)(1997-6#1)
and for evaluating the##2##4##(2008-10#1)(2008-4#1)
and for evaluation of##2##4##(1993-1#1)(2008-11#1)
and for every##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and for female##2##3##(2008-7#1)(2012-3#1)
and for free##2##3##(2008-10#1)(2008-5#1)
and for future##2##3##(1992-2#1)(2012-12#1)
and for general##2##3##(1991-12#1)(1995-8#1)
and for identifying##3##3##(2008-1#1)(2009-11#1)(2013-7#1)
and for improving##2##3##(1994-6#1)(2007-11#1)
and for investigating##2##3##(2008-7#1)(2008-9#1)
and for its admixture with##2##5##(2008-10#2)
and for its##5##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
and for long-term##2##3##(2008-7#1)(2008-9#1)
and for low##2##3##(1997-3#1)(2008-3#1)
and for monitoring##2##3##(1990-8#1)(2013-7#1)
and for more than##2##4##(2008-10#1)(2008-3#1)
and for most of the##2##5##(2008-10#2)
and for most##3##3##(2008-10#2)(2008-3#1)
and for one##2##3##(2008-10#2)
and for optical##2##3##(2007-11#1)(2007-12#1)
and for optimizing##2##3##(2008-4#1)(2010-8#1)
and for other##2##3##(1991-2#1)(2008-3#1)
and for pathogenicity on##2##4##(2008-10#2)
and for patients who##2##4##(2008-1#1)(2008-10#1)
and for patients##5##3##(1992-5#1)(2008-1#1)(2008-10#1)(2010-11#1)(2012-3#1)
and for preconcentration##2##3##(2008-10#2)
and for prediction of##2##4##(2008-2#1)(2008-5#1)
and for preparation of##2##4##(2008-1#1)(2008-9#1)
and for preventing##2##3##(2007-8#1)(2013-1#1)
and for providing##3##3##(2008-11#1)(2008-7#1)(2010-4#1)
and for pyramiding##2##3##(2008-10#2)
and for reducing##4##3##(2008-2#1)(2008-3#1)(2008-4#2)
and for reproducibility##2##3##(2008-10#2)
and for research##2##3##(2008-10#1)(2009-7#1)
and for selected##2##3##(1995-12#1)(2011-3#1)
and for setting##2##3##(1996-3#1)(2008-9#1)
and for several##2##3##(2007-12#1)(2008-10#1)
and for severe##2##3##(1990-3#1)(2007-8#1)
and for some##4##3##(1995-12#1)(1995-2#1)(2007-8#1)(2013-1#1)
and for stabilizing##2##3##(2008-10#1)(2008-4#1)
and for studying the##3##4##(1993-11#1)(1997-7#1)(2008-4#1)
and for subsequent##2##3##(1995-3#1)(2008-3#1)
and for suppression of##2##4##(2008-10#2)
and for the control##2##4##(2010-4#1)(2011-2#1)
and for the detection of##2##5##(2008-10#1)(2008-7#1)
and for the determination of the##3##6##(2008-10#1)(2008-12#2)
and for the determination of##5##5##(2008-10#3)(2008-12#2)
and for the development of##3##5##(1990-10#1)(2008-3#1)(2012-12#1)
and for the evaluation##2##4##(2008-9#1)(2011-2#1)
and for the first time##3##5##(1997-2#1)(2008-2#1)(2011-2#1)
and for the first##5##4##(1997-2#1)(2008-2#2)(2008-7#1)(2011-2#1)
and for the latter##2##4##(2008-10#1)(2010-3#1)
and for the maintenance of##2##5##(2008-8#1)(2009-3#1)
and for the presence of##2##5##(1991-3#1)(2011-2#1)
and for the##117##3##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-3#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#26)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-3#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and for their ability to##2##5##(1991-2#1)(2010-4#1)
and for their##11##3##(1991-2#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-7#1)(2009-1#1)(2010-4#1)
and for those that##2##4##(1993-12#1)(2011-2#1)
and for those who##2##4##(1994-2#1)(2013-1#1)
and for those##5##3##(1993-12#1)(1994-2#1)(2011-2#2)(2013-1#1)
and for three##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
and for total##3##3##(1991-2#1)(1994-9#1)(2008-10#1)
and for treatment of##2##4##(1994-9#1)(2010-6#1)
and for two##3##3##(1991-8#1)(1997-7#1)(2008-10#1)
and for understanding the##3##4##(1996-12#1)(2008-3#1)(2012-2#1)
and for understanding##4##3##(1996-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
and for which##5##3##(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
and for##621##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#5)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#3)(1991-8#3)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#7)(2007-6#2)(2007-7#3)(2007-8#5)(2008-1#7)(2008-10#141)(2008-11#24)(2008-12#9)(2008-2#26)(2008-3#55)(2008-4#27)(2008-5#14)(2008-6#5)(2008-7#19)(2008-8#8)(2008-9#19)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#4)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#3)
and foraging##3##2##(2008-9#2)(2012-3#1)
and forbidden##2##2##(2007-12#1)(2008-11#1)
and forbs##2##2##(2008-12#1)(2008-8#1)
and force##7##2##(1992-9#1)(2007-12#1)(2008-2#2)(2010-12#1)(2012-12#1)(2013-1#1)
and forces the##2##3##(1992-11#1)(2007-12#1)
and forces##3##2##(1992-11#1)(2007-12#1)(2008-7#1)
and forcing##2##2##(1990-2#1)(2007-12#1)
and forearm##3##2##(2008-3#1)(2008-5#1)(2009-3#1)
and forecast##2##2##(2012-12#1)(2012-3#1)
and forehead##2##2##(1993-2#1)(1996-6#1)
and foreign ions##4##3##(2008-10#4)
and foreign##17##2##(1992-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#3)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
and foremost##3##2##(1990-11#1)(1995-11#1)(2013-8#1)
and forensic purposes##2##3##(2008-10#2)
and forensic##8##2##(1995-11#1)(2008-10#3)(2008-12#2)(2009-9#1)(2010-4#1)
and forest##8##2##(2008-10#3)(2008-8#1)(2008-9#2)(2012-5#1)(2013-7#1)
and forestry##2##2##(2008-7#1)(2013-8#1)
and forgetting##2##2##(1992-1#1)(1997-4#1)
and form a##8##3##(2007-12#2)(2008-10#4)(2008-7#1)(2011-1#1)
and form an##2##3##(2008-5#1)(2008-9#1)
and form of##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
and form the basis for##2##5##(1996-2#1)(2009-5#1)
and form the##3##3##(1996-2#1)(2008-7#1)(2009-5#1)
and form##31##2##(1993-12#1)(1996-2#1)(1997-7#1)(2007-12#3)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#2)(2009-8#1)(2010-3#3)(2011-1#1)(2012-2#2)(2012-3#1)
and formal##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)
and formaldehyde##4##2##(1995-3#1)(2008-10#2)(2008-2#1)
and formalize##2##2##(2008-10#1)(2008-9#1)
and formalized##2##2##(1994-3#1)(1996-3#1)
and formamide##2##2##(2008-10#2)
and formate##5##2##(1995-2#1)(2008-10#2)(2008-6#1)(2011-1#1)
and formation and##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
and formation constant of##2##4##(2008-10#2)
and formation constant##3##3##(2008-10#3)
and formation constants##2##3##(2008-10#2)
and formation of a##4##4##(1990-8#1)(2009-8#1)(2012-1#1)(2013-1#1)
and formation of lipid##2##4##(2008-7#1)(2013-1#1)
and formation of the eggshell in the tarnished plant bug##2##10##(2007-12#2)
and formation of the##5##4##(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#1)
and formation of##30##3##(1990-8#1)(1991-11#1)(1992-4#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
and formation##45##2##(1990-8#1)(1991-11#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
and formed a##2##3##(2008-10#1)(2008-7#1)
and formed an##2##3##(2008-10#1)(2008-6#1)
and formed the##2##3##(2008-10#1)(2008-12#1)
and formed##25##2##(1997-2#1)(1997-3#1)(2008-10#11)(2008-12#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
and former##5##2##(1995-11#1)(1995-12#2)(1997-6#1)(2010-8#1)
and forming##5##2##(1990-8#1)(2007-12#1)(2008-10#3)
and forms a##7##3##(1993-3#1)(1994-9#1)(2007-12#1)(2008-10#2)(2010-11#1)(2010-12#1)
and forms an##2##3##(1992-11#1)(2008-5#1)
and forms complexes with cdk5##2##5##(1995-5#2)
and forms of##2##3##(2012-2#1)(2013-1#1)
and forms the##2##3##(2007-11#1)(2007-12#1)
and forms##23##2##(1992-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-5#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and formulate##2##2##(2008-11#1)(2008-7#1)
and formulated##2##2##(1994-5#1)(2010-5#1)
and formulating##2##2##(2008-5#1)(2012-12#1)
and formulation##4##2##(2008-10#3)(2008-12#1)
and formulations of##2##3##(2008-10#1)(2011-2#1)
and formulations##4##2##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
and forskolin (10 microM)##2##4##(1997-2#2)
and forskolin and##2##3##(1993-3#2)
and forskolin##16##2##(1993-3#4)(1993-6#1)(1994-11#1)(1994-6#1)(1995-8#1)(1997-2#6)(1997-7#1)(2012-12#1)
and forskolin-stimulated adenylyl cyclase##2##4##(1995-11#1)(1997-1#1)
and forty-two##2##2##(2008-11#1)(2009-6#1)
and forward##7##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
and forward-scattering##3##2##(2008-2#3)
and fos##2##2##(2008-11#2)
and fossa##2##2##(2008-5#2)
and foster##2##2##(1997-2#1)(2008-12#1)
and fostered##2##2##(1992-2#1)(2008-11#1)
and fostering##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
and foul##3##2##(2009-10#1)(2013-1#2)
and fouling##5##2##(2008-11#1)(2008-7#2)(2013-1#2)
and found a significant##2##4##(2008-11#1)(2008-5#1)
and found a##9##3##(1990-5#1)(1994-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
and found good agreement##2##4##(2008-3#2)
and found in##2##3##(1995-2#1)(2008-8#1)
and found it to be##3##5##(1993-8#1)(2008-3#1)(2012-2#1)
and found no##3##3##(1995-2#1)(1995-3#1)(2009-10#1)
and found significant##2##3##(2008-5#1)(2013-1#1)
and found that it##4##4##(1990-12#1)(1996-3#1)(2008-10#1)(2008-5#1)
and found that the##13##4##(1991-5#1)(1994-11#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-8#1)(2011-2#1)(2012-3#1)
and found that there was##2##5##(1996-12#1)(2013-1#1)
and found that there##3##4##(1996-12#1)(2012-3#1)(2013-1#1)
and found that##46##3##(1990-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#4)(2011-2#1)(2012-3#5)(2013-1#3)
and found the##2##3##(2008-7#1)(2008-9#1)
and found them to##2##4##(1990-8#1)(2011-2#1)
and found to be 1##2##5##(2008-10#2)
and found to be accurate##2##5##(2008-10#2)
and found to be effective in##2##6##(1992-3#1)(1997-6#1)
and found to be identical##2##5##(1996-12#1)(2008-11#1)
and found to be in##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
and found to be very##2##5##(1993-9#1)(2007-7#1)
and found to be##33##4##(1991-7#1)(1992-3#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
and found to contain##3##4##(1993-2#1)(1993-8#1)(1994-6#1)
and found to encode##3##4##(1992-10#1)(1993-12#1)(1994-12#1)
and found to have the##2##5##(1992-8#1)(1992-9#1)
and found to have##9##4##(1992-6#1)(1992-8#1)(1992-9#1)(1994-5#1)(2007-11#2)(2010-4#1)(2010-5#1)(2013-1#1)
and found to##64##3##(1991-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#2)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and found##156##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#6)(2007-12#4)(2007-7#1)(2008-10#31)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#7)(2013-1#7)(2013-8#2)
and foundation##2##2##(1997-1#1)(2008-5#1)
and fountain waters) and##2##4##(2008-10#2)
and four additional##2##3##(1995-6#1)(2008-10#1)
and four cases of##2##4##(1994-12#1)(2008-10#1)
and four different##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
and four had##2##3##(2008-12#1)(2008-5#1)
and four isolates of##2##4##(2007-6#1)(2008-10#1)
and four months##2##3##(1992-11#1)(1992-4#1)
and four of##2##3##(2008-10#1)(2011-2#1)
and four open reading frames##2##5##(1997-3#1)(2008-8#1)
and four other##3##3##(2008-10#2)(2009-8#1)
and four patients##5##3##(1990-9#1)(1992-9#1)(1997-8#1)(2008-5#1)(2008-7#1)
and four selected##2##3##(2011-3#1)(2013-8#1)
and four were##4##3##(1993-6#1)(2008-10#1)(2009-3#1)(2010-1#1)
and four with##2##3##(2008-10#1)(2012-1#1)
and four years##2##3##(1991-6#1)(2008-11#1)
and four##139##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#3)(1997-9#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#37)(2008-11#2)(2008-12#6)(2008-2#2)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#2)(2010-8#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#3)
and four-color##2##2##(2008-9#2)
and four-component##2##2##(2008-10#2)
and four-wave mixing##2##3##(2007-11#2)
and fourteen##5##2##(1994-9#1)(1995-12#1)(1995-3#1)(2008-5#1)(2011-2#1)
and fourth##15##2##(1990-8#1)(1994-2#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
and fourth-order##3##2##(2007-12#1)(2008-3#2)
and foveal##3##2##(2011-7#1)(2013-1#2)
and fox##2##2##(1991-9#1)(1994-8#1)
and fractional##4##2##(1995-12#1)(2011-1#1)(2012-2#2)
and fractional-order##2##2##(2008-3#2)
and fractionated by##3##3##(1990-8#1)(1991-12#1)(2008-10#1)
and fractionated on##2##3##(1994-9#1)(2009-8#1)
and fractionated##6##2##(1990-8#1)(1991-12#1)(1994-9#1)(2008-10#1)(2008-11#1)(2009-8#1)
and fractionation of##5##3##(1993-12#1)(1994-12#1)(2008-10#2)(2008-5#1)
and fractionation##9##2##(1993-12#1)(1994-12#1)(2007-4#3)(2008-10#3)(2008-5#1)
and fractions##4##2##(1990-2#1)(1993-6#1)(2008-11#1)(2008-5#1)
and fracture characteristics##2##3##(2008-8#1)(2009-7#1)
and fracture line##2##3##(2013-1#2)
and fracture risk##4##3##(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
and fracture toughness##3##3##(2009-7#3)
and fracture##19##2##(2007-11#1)(2007-8#1)(2008-8#2)(2009-6#1)(2009-7#6)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and fractures##2##2##(1990-6#1)(2009-3#1)
and fragile##2##2##(1995-3#1)(2008-7#1)
and fragility##2##2##(2007-8#1)(2012-12#1)
and fragment##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
and fragmentary##2##2##(2008-1#1)(2008-10#1)
and fragmented##2##2##(1992-12#1)(2012-3#1)
and fragments##3##2##(1995-5#1)(1997-6#1)(2008-8#1)
and frail##4##2##(1991-12#1)(1994-1#1)(1994-2#1)(2013-8#1)
and frame##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
and frameless stereotactic##2##3##(2008-7#2)
and frameless##3##2##(2008-7#3)
and frank##2##2##(2011-2#1)(2012-12#1)
and free amino acids##2##4##(2008-10#1)(2008-6#1)
and free energy##6##3##(1993-11#1)(2008-10#4)(2010-7#1)
and free fatty acid##2##4##(1994-5#1)(2008-11#1)
and free from##2##3##(2008-10#1)(2012-2#1)
and free of##9##3##(1993-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-3#1)
and free radical scavenging##3##4##(2008-12#1)(2008-5#1)(2010-12#1)
and free radical##7##3##(2008-10#1)(2008-12#1)(2008-5#3)(2010-12#1)(2011-2#1)
and free sialic acid##2##4##(1995-12#1)(2008-7#1)
and free##74##2##(1990-8#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-5#2)(1995-12#2)(1996-11#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2009-12#1)(2009-5#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#7)(2013-1#3)(2013-3#1)
and free-radical##3##2##(1997-7#1)(2008-6#1)(2011-1#1)
and free-space optical##2##3##(2008-2#1)(2008-3#1)
and free-space##3##2##(2008-2#1)(2008-3#2)
and freedom##3##2##(2007-8#1)(2008-11#1)(2009-6#1)
and freeze##2##2##(1993-11#1)(2012-12#1)
and freezing##2##2##(2009-2#2)
and freezing-thawing##2##2##(2008-10#2)
and frequencies of##6##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
and frequencies##11##2##(1993-12#1)(1996-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-7#1)
and frequency domains##2##3##(2007-11#2)
and frequency of the##5##4##(1990-8#1)(1995-11#1)(2008-10#2)(2008-7#1)
and frequency of visiting##2##4##(1990-9#1)(2008-12#1)
and frequency of##41##3##(1990-11#1)(1990-8#1)(1990-9#2)(1993-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
and frequency response##3##3##(2007-12#2)(2008-3#1)
and frequency##76##2##(1990-11#1)(1990-8#1)(1990-9#2)(1992-11#1)(1993-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#2)(2008-7#3)(2008-8#3)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#4)
and frequency-conversion##3##2##(2007-12#3)
and frequency-domain##4##2##(2007-12#1)(2008-2#1)(2012-1#1)(2013-1#1)
and frequency-doubled##3##2##(2007-11#1)(2007-12#2)
and frequency-modulated##2##2##(2007-11#1)(2008-3#1)
and frequent contact with##2##4##(2009-5#1)(2010-10#1)
and frequent exacerbations##2##3##(2010-5#1)(2011-2#1)
and frequent##21##2##(1990-5#1)(1992-11#1)(1992-2#1)(1994-12#1)(1996-3#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-8#1)
and frequently is##2##3##(2007-8#1)(2008-9#1)
and frequently used##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
and frequently##14##2##(1990-5#1)(1993-1#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#3)(2012-2#2)
and fresh plasma##2##3##(1995-3#2)
and fresh##12##2##(1990-12#1)(1991-3#1)(1993-6#1)(1995-3#2)(2008-10#2)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-7#1)
and freshwater##7##2##(2008-11#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
and friction##5##2##(1994-9#1)(1996-4#1)(1997-3#2)(2008-5#1)
and frictional##2##2##(2008-5#1)(2011-2#1)
and fringe##2##2##(2008-2#1)(2008-3#1)
and frog##3##2##(1996-5#1)(2008-9#1)(2013-1#1)
and frogs##4##2##(1992-11#1)(1995-2#1)(2008-9#2)
and from 0##15##3##(1993-3#1)(1996-2#1)(2008-10#9)(2008-5#2)(2013-8#2)
and from 1##4##3##(2008-10#4)
and from 10 to##2##4##(2008-10#2)
and from 100 to##2##4##(2008-10#2)
and from 100##3##3##(2008-10#2)(2011-2#1)
and from 2##7##3##(2007-12#2)(2007-6#1)(2008-10#4)
and from 20 to##2##4##(2008-10#2)
and from 20##3##3##(2008-10#3)
and from 3##2##3##(2008-10#2)
and from 30 to##2##4##(2008-10#1)(2009-7#1)
and from 4##3##3##(2007-12#1)(2008-10#2)
and from 5 to##2##4##(2011-1#1)(2013-1#1)
and from 5##5##3##(2008-10#3)(2011-1#1)(2013-1#1)
and from 50##2##3##(1993-1#1)(2007-11#1)
and from 7##4##3##(1991-8#1)(2008-11#1)(2008-7#2)
and from 92##3##3##(2008-10#3)
and from 95 to##2##4##(2008-10#2)
and from 95##3##3##(2008-10#3)
and from P##2##3##(2008-10#2)
and from a##9##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)
and from all##2##3##(1994-9#1)(2008-10#1)
and from different##2##3##(1995-2#1)(2008-7#1)
and from highly mineralised water##2##5##(2008-10#2)
and from other##5##3##(2008-10#2)(2008-8#2)(2010-10#1)
and from patients with##2##4##(1990-2#1)(1996-12#1)
and from soil##3##3##(2008-10#3)
and from the##53##3##(1990-11#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-9#2)(1995-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
and from these data##2##4##(2007-11#1)(2008-10#1)
and from these##3##3##(2007-11#1)(2008-10#2)
and from this##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
and from two##3##3##(1994-6#1)(2008-11#1)(2013-7#1)
and from various##2##3##(1992-6#1)(2009-4#1)
and from which##2##3##(1993-12#1)(2008-3#1)
and from##302##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#110)(2008-11#10)(2008-12#2)(2008-2#8)(2008-3#19)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#3)(2011-2#5)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
and front##2##2##(2007-12#1)(2008-3#1)
and frontal lobes##3##3##(1994-3#1)(1997-3#1)(2008-1#1)
and frontal sinus##4##3##(2006-12#1)(2011-2#3)
and frontal##18##2##(1990-8#1)(1994-3#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#2)(2009-4#1)(2010-8#1)(2011-2#5)
and frozen##2##2##(1996-8#1)(2008-6#1)
and fructose 1##2##3##(1990-12#1)(1996-6#1)
and fructose##14##2##(1990-12#1)(1990-2#1)(1996-2#1)(1996-6#1)(2008-10#6)(2008-6#3)(2010-2#1)
and fruit and##2##3##(2008-10#1)(2008-7#1)
and fruit infections##2##3##(2008-10#2)
and fruit juice samples##2##4##(2008-10#2)
and fruit juice##6##3##(2008-10#6)
and fruit production##2##3##(2008-5#2)
and fruit russet severity##2##4##(2008-10#2)
and fruit scab##2##3##(2008-10#2)
and fruit with##2##3##(2008-10#2)
and fruit yield##3##3##(2008-10#3)
and fruit##50##2##(2008-10#43)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
and fruiting##3##2##(2008-10#1)(2008-12#1)(2012-4#1)
and fruits of##2##3##(2008-10#1)(2008-12#1)
and fruits##11##2##(2008-10#3)(2008-12#5)(2008-5#1)(2008-7#1)(2012-2#1)
and frustrating##3##2##(1993-12#1)(2008-9#1)(2010-6#1)
and frustration##9##2##(1993-5#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-8#1)(2009-10#1)(2009-9#1)(2012-3#2)
and fry survival##2##3##(2010-8#2)
and fry##6##2##(1992-6#2)(2008-6#2)(2010-8#2)
and fuel##4##2##(1990-8#1)(2008-7#1)(2012-2#1)(2013-7#1)
and fulfill##3##2##(1994-2#1)(1996-5#1)(2009-3#1)
and fulfillment##2##2##(1995-1#1)(2008-10#1)
and full bloom##2##3##(2008-10#2)
and full##19##2##(1995-12#1)(1995-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and full-length##2##2##(1995-6#1)(2008-10#1)
and full-swing shots##2##3##(2011-2#2)
and full-swing##3##2##(2011-2#3)
and fully characterized##2##3##(2007-11#1)(2008-12#1)
and fully##9##2##(1990-8#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-7#1)(2011-1#1)
and fulminant##3##2##(1997-8#1)(2007-7#2)
and fulvic acid##3##3##(2008-10#3)
and fulvic acids##4##3##(2008-10#4)
and fulvic##9##2##(2008-10#8)(2008-3#1)
and fumes##2##2##(1991-4#1)(2008-10#1)
and fumonisin contamination##3##3##(2008-10#3)
and fumonisin##6##2##(2008-10#5)(2013-1#1)
and function and##5##3##(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
and function are##6##3##(1991-1#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
and function as##2##3##(1991-2#1)(2008-1#1)
and function in patients with##2##5##(2007-8#1)(2008-12#1)
and function in the##4##4##(1995-2#1)(2007-12#1)(2009-5#2)
and function in##24##3##(1992-12#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#3)(2009-1#1)(2009-5#2)(2010-11#2)(2011-2#1)(2012-12#3)(2013-8#1)
and function is##3##3##(1994-10#1)(2008-5#1)(2008-7#1)
and function of a##2##4##(1993-1#1)(2008-9#1)
and function of each##2##4##(1990-12#1)(2008-7#1)
and function of most##2##4##(2008-1#1)(2011-1#1)
and function of the adrenal##2##5##(1996-5#1)(2008-4#1)
and function of the stratum corneum##2##6##(2008-5#2)
and function of the##27##4##(1994-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#1)(2012-2#1)(2013-1#2)
and function of these##4##4##(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
and function of this##2##4##(1995-8#1)(2009-8#1)
and function of##92##3##(1990-12#1)(1990-7#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-2#2)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#1)
and function words##3##3##(1996-2#1)(2008-10#1)(2008-2#1)
and function##214##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#6)(2008-11#9)(2008-12#3)(2008-2#3)(2008-4#12)(2008-5#11)(2008-6#2)(2008-7#17)(2008-8#6)(2008-9#9)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#6)(2010-12#4)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#12)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#3)
and functional ability##2##3##(2011-8#1)(2013-1#1)
and functional activity##4##3##(1994-5#1)(2008-8#3)
and functional alterations of##2##4##(1997-6#1)(2008-1#1)
and functional analysis of a##3##5##(2008-8#2)(2008-9#1)
and functional analysis of human##2##5##(1992-3#1)(2008-4#1)
and functional analysis of the##2##5##(1993-3#1)(2008-10#1)
and functional analysis of##11##4##(1992-3#1)(1993-3#1)(1997-7#1)(2008-10#1)(2008-4#3)(2008-8#2)(2008-9#2)
and functional analysis##16##3##(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#3)(2012-12#1)
and functional aspects of##2##4##(1992-9#1)(1995-3#1)
and functional assays##2##3##(1994-6#1)(1997-4#1)
and functional assessment##4##3##(2007-11#2)(2010-9#1)(2012-3#1)
and functional brain imaging##2##4##(2007-8#1)(2013-8#1)
and functional capacity##2##3##(2008-7#1)(2012-2#1)
and functional changes in the##2##5##(2012-3#1)(2013-1#1)
and functional changes in##3##4##(2008-5#1)(2012-3#1)(2013-1#1)
and functional changes##5##3##(1994-12#1)(2008-5#2)(2012-3#1)(2013-1#1)
and functional characteristics of##3##4##(1991-3#1)(1995-3#1)(2011-2#1)
and functional characterization of a##2##5##(1993-5#1)(2008-11#1)
and functional characterization of##5##4##(1993-3#1)(1993-5#1)(2008-11#2)(2012-2#1)
and functional complementation##2##3##(2008-9#1)(2009-10#1)
and functional consequences##2##3##(2009-12#1)(2013-1#1)
and functional data##2##3##(2008-11#1)(2008-9#1)
and functional decline##3##3##(2008-7#2)(2013-1#1)
and functional disability##3##3##(2010-12#1)(2012-1#1)(2013-1#1)
and functional disorders##2##3##(2008-4#1)(2012-12#1)
and functional expression of##5##4##(1990-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-4#1)
and functional expression##6##3##(1990-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-4#1)(2008-7#1)
and functional genomics approaches##2##4##(2011-1#1)(2011-2#1)
and functional genomics##7##3##(2008-7#4)(2009-4#1)(2011-1#1)(2011-2#1)
and functional groups##2##3##(2008-10#1)(2008-7#1)
and functional imaging have##2##4##(2007-8#1)(2012-12#1)
and functional imaging##3##3##(2007-8#1)(2012-12#1)(2012-2#1)
and functional impairment##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-12#2)
and functional impairments##2##3##(2007-12#1)(2009-10#1)
and functional magnetic resonance imaging##4##5##(1994-3#1)(2008-2#2)(2010-7#1)
and functional maturation##2##3##(2008-5#1)(2008-8#1)
and functional mechanism of tetrahydroisoquinoline##2##5##(2011-3#2)
and functional organization of##2##4##(1997-6#1)(2008-8#1)
and functional outcome##8##3##(2007-10#2)(2008-11#1)(2008-6#3)(2008-9#1)(2009-8#1)
and functional outcomes after##2##4##(2011-2#1)(2012-1#1)
and functional outcomes in##2##4##(2009-10#1)(2013-1#1)
and functional outcomes of##2##4##(2008-6#1)(2013-1#1)
and functional outcomes##11##3##(2008-11#1)(2008-6#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
and functional parameters of##2##4##(2007-12#1)(2008-11#1)
and functional performance##2##3##(2013-1#2)
and functional plasticity of##2##4##(2008-7#1)(2012-12#1)
and functional plasticity##4##3##(2008-1#1)(2008-7#1)(2012-12#2)
and functional properties of##4##4##(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
and functional properties##8##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#2)(2012-2#1)
and functional recovery##3##3##(1990-5#1)(1994-8#1)(2011-2#1)
and functional responses##2##3##(2008-9#1)(2010-1#1)
and functional results##7##3##(1991-9#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-1#2)
and functional status of##2##4##(1994-12#1)(2008-7#1)
and functional status were##2##4##(2008-6#1)(2008-9#1)
and functional status##8##3##(1994-12#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-7#2)(2008-9#1)
and functional studies of##2##4##(1993-12#1)(2008-2#1)
and functional studies##5##3##(1993-12#1)(2008-2#1)(2009-4#1)(2010-12#1)(2012-12#1)
and functional study##3##3##(1991-6#1)(1994-12#1)(2008-9#1)
and functional##273##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#2)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#3)(1995-6#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-8#5)(2008-1#6)(2008-10#11)(2008-11#10)(2008-2#8)(2008-3#1)(2008-4#11)(2008-5#4)(2008-6#5)(2008-7#23)(2008-8#12)(2008-9#13)(2009-10#6)(2009-11#3)(2009-12#2)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-3#3)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#7)(2011-3#2)(2011-7#1)(2011-8#1)(2012-1#3)(2012-12#11)(2012-2#9)(2012-3#5)(2013-1#17)(2013-8#3)
and functionality of##4##3##(2008-10#2)(2008-9#1)(2009-11#1)
and functionality##7##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)
and functionalization##3##2##(2008-5#1)(2010-12#2)
and functionalized##2##2##(2008-10#1)(2009-8#1)
and functionally distinct##3##3##(1990-12#1)(2008-7#1)(2013-8#1)
and functionally##23##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and functioning of##3##3##(2011-1#1)(2012-2#1)(2012-6#1)
and functioning##12##2##(1991-2#1)(1992-9#1)(2008-7#1)(2009-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-6#1)
and functions as a##2##4##(1990-11#1)(1992-12#1)
and functions of a##2##4##(1994-1#1)(2008-10#1)
and functions of the##2##4##(2007-2#1)(2008-9#1)
and functions of##11##3##(1994-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2012-2#2)
and functions that##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
and functions within##2##3##(1996-12#1)(2010-8#1)
and functions##30##2##(1990-11#1)(1992-11#1)(1992-12#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and fundamental##5##2##(2008-10#2)(2009-12#1)(2010-3#1)(2013-1#1)
and funded##2##2##(1991-1#1)(1994-3#1)
and funding of##2##3##(1997-1#1)(2008-10#1)
and funding##12##2##(1995-1#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
and funds##2##2##(1990-6#1)(1992-12#1)
and fungal growth##2##3##(2008-10#1)(2010-7#1)
and fungal infections##3##3##(2007-8#1)(2011-3#1)(2013-1#1)
and fungal##29##2##(1992-8#1)(2007-8#1)(2008-10#14)(2008-5#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)
and fungi are##3##3##(2006-6#1)(2011-1#1)(2012-2#1)
and fungi##23##2##(1994-2#1)(1994-9#1)(1995-11#1)(2006-5#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-8#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
and fungicide use on asexual development and growth of Phytophthora infestans on potato foliage##3##14##(2008-10#3)
and fungicide##6##2##(2008-10#6)
and furafylline inhibition##2##3##(1994-8#2)
and furan##4##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
and furosemide##3##2##(1992-9#2)(2007-10#1)
and further characterization##2##3##(2008-10#2)
and further characterized##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
and further clinical##2##3##(2010-8#1)(2013-1#1)
and further demonstrated that##2##4##(2008-3#1)(2008-5#1)
and further development##2##3##(2008-10#2)
and further explored##2##3##(2008-5#1)(2008-7#1)
and further improvement##2##3##(2008-3#1)(2012-3#1)
and further into##2##3##(1994-6#1)(2008-8#1)
and further investigation##2##3##(1996-12#1)(2013-1#1)
and further research##4##3##(1993-12#1)(2006-10#1)(2011-2#1)(2012-2#1)
and further studies##2##3##(2008-10#1)(2008-5#1)
and further suggest that##3##4##(1992-2#1)(2007-8#1)(2008-11#1)
and further the##2##3##(1995-1#1)(2008-5#1)
and further##104##2##(1990-12#1)(1991-6#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
and furthermore to##2##3##(2008-10#1)(2013-1#1)
and furthermore##5##2##(1992-4#1)(2008-10#2)(2012-12#1)(2013-1#1)
and fuse##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
and fused silica##3##3##(2008-2#1)(2008-3#2)
and fused to##2##3##(1994-8#1)(1996-6#1)
and fused with the##2##4##(2008-9#2)
and fused##9##2##(1994-8#1)(1996-6#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)
and fusiform##2##2##(2007-8#1)(2013-8#1)
and fusing##2##2##(2008-10#1)(2011-3#1)
and fusion protein GST-IE86##2##4##(2008-9#2)
and fusion protein##3##3##(2007-6#1)(2008-9#2)
and fusion##21##2##(1993-9#1)(1994-12#2)(1997-1#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-12#7)(2012-3#1)
and fusions##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
and future approaches##2##3##(2008-8#1)(2010-5#1)
and future challenges##4##3##(1997-1#1)(2008-11#1)(2009-3#1)(2013-1#1)
and future developments##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
and future directions of the##2##5##(1994-1#1)(2009-5#1)
and future directions of##8##4##(1994-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2012-1#1)
and future directions##24##3##(1991-2#1)(1992-12#1)(1994-1#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
and future expectations##2##3##(2008-8#1)(2011-2#1)
and future implications##2##3##(1994-12#1)(1997-3#1)
and future of reward systems##2##5##(1995-12#1)(1996-3#1)
and future of##9##3##(1993-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#2)
and future opportunities##2##3##(2007-12#1)(2008-10#1)
and future perspective##2##3##(2011-2#1)(2013-8#1)
and future perspectives##7##3##(1994-9#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-3#2)
and future potential##3##3##(1993-12#2)(2007-10#1)
and future prospects for##4##4##(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
and future prospects##13##3##(1997-6#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-3#1)
and future research are discussed##4##5##(2007-12#1)(2007-7#1)(2008-12#1)(2011-2#1)
and future research directions are discussed##3##6##(2007-12#1)(2009-5#1)(2009-9#1)
and future research directions are##5##5##(1994-3#1)(2007-12#1)(2008-1#1)(2009-5#1)(2009-9#1)
and future research##14##3##(1992-12#1)(1994-3#1)(1996-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
and future studies##2##3##(2008-7#1)(2011-2#1)
and future use##2##3##(2008-10#1)(2013-1#1)
and future##156##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-12#3)(1992-4#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2006-9#2)(2007-10#1)(2007-12#4)(2007-4#1)(2007-7#2)(2008-1#6)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#5)
and future-temporal comparison##2##3##(2009-5#2)
and future-temporal##3##2##(2009-5#3)
and fuzzy##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
and g were##2##3##(2008-10#2)
and g##8##2##(1990-5#1)(1992-8#1)(1993-11#2)(2008-10#2)(2008-2#2)
and gain insight into##2##4##(2008-10#1)(2012-3#1)
and gain##19##2##(1995-1#1)(1996-12#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#1)
and gaining##2##2##(2011-2#1)(2013-8#1)
and gait disorders##2##3##(2013-1#2)
and gait##10##2##(2007-10#1)(2008-12#1)(2008-7#3)(2012-12#2)(2013-1#3)
and galactose##9##2##(1990-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#3)
and gallbladder cancer##2##3##(2010-12#2)
and gallbladder size##2##3##(2011-2#2)
and gallbladder##6##2##(1994-2#1)(2008-11#1)(2010-12#2)(2011-2#2)
and gallic acid##2##3##(2008-10#1)(2008-6#1)
and gallic##3##2##(2008-10#2)(2008-6#1)
and galls##2##2##(2008-10#2)
and gametic phase equilibrium##2##4##(2008-10#1)(2012-3#1)
and gametic phase##3##3##(2008-10#2)(2012-3#1)
and gamma camera##2##3##(1994-2#1)(1996-2#1)
and gamma can be##2##4##(2008-3#1)(2008-6#1)
and gamma subunits##2##3##(1995-11#1)(2008-8#1)
and gamma##31##2##(1990-7#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#3)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#5)(2008-7#2)(2008-8#5)
and gamma)##3##2##(1993-3#1)(1994-6#1)(1994-8#1)
and gamma-CD##5##2##(1996-5#2)(2008-10#3)
and gamma-aminobutyric acid (GABA)##3##4##(1992-3#1)(1995-12#1)(1995-2#1)
and gamma-aminobutyric acid##6##3##(1990-7#1)(1992-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)
and gamma-cyclodextrins##5##2##(2008-10#5)
and gamma2)##2##2##(2008-11#2)
and ganoderma lucidum##2##3##(2013-8#2)
and gap junction formation in##2##5##(1994-3#2)
and gap junction##4##3##(1994-3#2)(2012-2#2)
and gap junctional##2##3##(2008-8#2)
and gap junctions##2##3##(2009-10#1)(2012-2#1)
and gap##9##2##(1994-3#2)(2008-4#1)(2008-8#2)(2009-10#1)(2012-2#3)
and gaps in##2##3##(1994-6#1)(2008-3#1)
and gaps##3##2##(1992-12#1)(1994-6#1)(2008-3#1)
and garden##2##2##(2008-10#1)(2008-12#1)
and gas chromatographic analysis##2##4##(1990-7#1)(2008-10#1)
and gas chromatographic##4##3##(1990-7#1)(2008-10#2)(2010-5#1)
and gas chromatography##8##3##(1990-8#1)(1993-1#1)(2008-10#6)
and gas chromatography-mass spectrometry (GC-MS)##5##5##(1993-12#1)(2008-10#4)
and gas chromatography-mass spectrometry##11##4##(1993-12#1)(2008-10#10)
and gas chromatography-mass##12##3##(1993-12#1)(2008-10#11)
and gas chromatography/electron capture##2##4##(2008-10#2)
and gas exchange##3##3##(1994-5#1)(2008-12#1)(2012-3#1)
and gas phase##2##3##(2008-10#1)(2008-11#1)
and gas##47##2##(1990-7#1)(1990-8#1)(1993-1#1)(1993-12#1)(1994-5#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#5)(2008-6#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#1)
and gas-phase##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
and gaseous##2##2##(1996-12#1)(2008-10#1)
and gases##3##2##(1991-4#1)(1996-12#1)(2008-2#1)
and gasoline##2##2##(2008-10#1)(2008-3#1)
and gastric cancer##2##3##(2008-1#1)(2010-12#1)
and gastric ulcer##5##3##(1992-11#2)(2008-12#1)(2008-5#1)(2011-2#1)
and gastric ulcers##2##3##(1992-11#1)(2007-8#1)
and gastric##27##2##(1992-11#3)(1994-8#3)(1995-2#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-8#3)
and gastrin##2##2##(1992-8#1)(2010-6#1)
and gastritis##2##2##(2008-1#1)(2009-10#1)
and gastroduodenal##4##2##(1997-1#1)(1997-4#1)(2011-2#1)(2012-12#1)
and gastrointestinal bleeding##3##3##(2009-8#1)(2012-2#1)(2012-3#1)
and gastrointestinal manifestations##2##3##(2008-11#1)(2011-2#1)
and gastrointestinal reactions##2##3##(2011-2#1)(2013-1#1)
and gastrointestinal tract##5##3##(1991-12#1)(1997-8#2)(2008-1#1)(2012-2#1)
and gastrointestinal##30##2##(1990-2#2)(1991-1#1)(1991-12#1)(1991-6#1)(1996-11#1)(1997-8#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
and gavage studies)##2##3##(2008-9#2)
and gave a##3##3##(1992-8#1)(1996-1#1)(2008-10#1)
and gave an##2##3##(2008-6#1)(2010-12#1)
and gave##16##2##(1992-8#1)(1994-2#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-10#6)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-5#1)
and gel filtration chromatography##4##4##(1991-3#1)(1994-9#1)(2008-10#1)(2010-2#1)
and gel filtration##12##3##(1990-12#2)(1990-7#1)(1991-3#1)(1994-8#1)(1994-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-2#1)
and gel permeation chromatography##3##4##(2008-10#2)(2009-2#1)
and gel##23##2##(1990-12#2)(1990-7#1)(1991-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
and gel-filtration##4##2##(1990-12#1)(1990-2#1)(2008-10#1)(2010-4#1)
and gelatin##5##2##(2008-10#4)(2013-1#1)
and gelbstoff##2##2##(2008-2#1)(2008-3#1)
and gemcitabine##2##2##(2008-11#1)(2011-2#1)
and gemfibrozil##4##2##(2008-10#1)(2011-1#3)
and genQuest##2##2##(2008-4#2)
and gender are##2##3##(2008-11#1)(2012-2#1)
and gender differences in##2##4##(2008-7#1)(2011-1#1)
and gender differences##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#2)
and gender in##2##3##(2011-2#1)(2012-2#1)
and gender on##6##3##(1994-3#1)(2007-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
and gender##49##2##(1990-9#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1996-1#1)(1997-6#1)(2007-10#2)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#3)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#3)
and gender-based##2##2##(2008-10#1)(2009-5#1)
and gender-matched controls##2##3##(2007-10#2)
and gender-matched##5##2##(2007-10#3)(2008-12#1)(2009-8#1)
and genders##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
and gene amplification##3##3##(1995-8#1)(2008-11#2)
and gene diversity##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
and gene expression of##4##4##(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
and gene expression patterns##2##4##(2007-11#1)(2007-12#1)
and gene expression##26##3##(1992-11#1)(1993-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#4)
and gene flow##2##3##(2008-10#1)(2012-3#1)
and gene mapping##2##3##(2008-9#1)(2011-1#1)
and gene networks##3##3##(2008-7#1)(2010-5#1)(2012-2#1)
and gene order##2##3##(1997-2#1)(2010-7#1)
and gene regulation##2##3##(2008-11#1)(2008-7#1)
and gene regulatory##2##3##(2011-2#1)(2013-1#1)
and gene therapy##5##3##(1994-5#1)(1994-8#1)(1997-2#1)(2007-7#1)(2008-4#1)
and gene transcription##2##3##(2008-5#1)(2008-8#1)
and gene transfer##3##3##(2008-11#1)(2008-8#1)(2009-5#1)
and gene##95##2##(1992-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
and general anaesthesia##3##3##(2010-7#1)(2011-1#2)
and general business##2##3##(1996-3#1)(2008-10#1)
and general characteristics was found to be statistically significant for##2##10##(1990-2#2)
and general condition of the patient##2##6##(2007-11#2)
and general conditions##2##3##(1993-3#1)(2007-10#1)
and general hospitals##3##3##(1991-2#1)(1994-1#2)
and general practice##6##3##(1992-2#1)(1995-9#1)(2007-3#1)(2008-3#1)(2008-8#1)(2011-2#1)
and general practice]##2##3##(1994-11#1)(1997-8#1)
and general practitioners##5##3##(1995-5#1)(1996-8#1)(2008-10#2)(2012-2#1)
and general principles##2##3##(2007-5#2)
and general representation factors##3##4##(1993-2#1)(1993-3#1)(1994-1#1)
and general self-esteem##2##3##(2009-7#2)
and general surgery##2##3##(2008-6#1)(2012-3#1)
and general##86##2##(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#2)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-7#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and generalised##4##2##(2008-10#3)(2012-12#1)
and generalist##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
and generalizable##3##2##(2009-4#1)(2011-1#1)(2013-7#1)
and generalized H-point standard additions##2##5##(2008-10#2)
and generalized##14##2##(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
and generalizes##2##2##(2007-11#1)(2011-2#1)
and generally was##2##3##(2008-10#2)
and generally##19##2##(1990-11#1)(1992-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
and generate##10##2##(1993-12#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)
and generated by##2##3##(1994-8#1)(2008-7#1)
and generated##6##2##(1994-8#1)(1997-8#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)
and generates##8##2##(1991-2#1)(1995-2#1)(1995-8#1)(2007-11#1)(2007-12#2)(2012-12#1)(2012-2#1)
and generating##4##2##(1991-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
and generation of##7##3##(1993-12#1)(1997-6#1)(2008-2#1)(2008-4#3)(2011-2#1)
and generation##8##2##(1993-12#1)(1997-6#1)(2008-2#1)(2008-4#3)(2010-6#1)(2011-2#1)
and generic##6##2##(1995-3#2)(2007-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
and genes coding##2##3##(1996-12#1)(2012-12#1)
and genes of##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
and genes##7##2##(1996-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
and genetic analyses##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
and genetic analysis of##2##4##(1996-12#1)(2013-8#1)
and genetic analysis##6##3##(1996-12#1)(2007-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
and genetic characteristics of##2##4##(2011-2#1)(2013-8#1)
and genetic characteristics##3##3##(2011-2#1)(2013-8#2)
and genetic characterization of##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
and genetic counselling##2##3##(1991-3#1)(1997-3#1)
and genetic data##3##3##(1990-5#1)(2008-8#1)(2010-5#1)
and genetic diseases##2##3##(1990-2#1)(2012-12#1)
and genetic diversity in##2##4##(1994-11#1)(2008-8#1)
and genetic diversity of##2##4##(2008-10#2)
and genetic diversity##6##3##(1994-11#1)(2008-10#2)(2008-8#1)(2009-5#2)
and genetic evidence##3##3##(1994-9#1)(2012-12#2)
and genetic exchange##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
and genetic factors##7##3##(2007-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#2)(2013-1#1)
and genetic features of##2##4##(2008-8#1)(2013-1#1)
and genetic linkage##3##3##(1997-3#1)(2008-10#2)
and genetic manipulation##3##3##(2008-11#1)(2008-4#1)(2009-3#1)
and genetic mapping##3##3##(1995-6#1)(1996-8#1)(2008-4#1)
and genetic markers##3##3##(2012-3#1)(2013-1#1)(2013-8#1)
and genetic research##3##3##(2008-2#1)(2010-3#1)(2013-7#1)
and genetic structure of##3##4##(2008-10#2)(2008-9#1)
and genetic studies##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-1#1)
and genetic toxicology##2##3##(1996-12#2)
and genetic traits##2##3##(2008-8#1)(2009-5#1)
and genetic validation##2##3##(2010-2#1)(2010-5#1)
and genetic variability##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
and genetic variation of##2##4##(2011-10#1)(2012-2#1)
and genetic variation within##2##4##(2008-10#1)(2008-12#1)
and genetic variation##7##3##(2008-10#3)(2008-12#1)(2008-5#1)(2011-10#1)(2012-2#1)
and genetic##140##2##(1990-2#1)(1990-5#1)(1991-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#4)(2009-3#1)(2009-5#3)(2009-8#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#6)
and genetical##2##2##(1990-12#1)(2008-10#1)
and genetically distinct from##2##4##(2008-10#2)
and genetically distinct##4##3##(2008-10#2)(2008-8#2)
and genetically modified (FVB Tg##3##5##(2008-9#3)
and genetically##14##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#5)
and genetics in##3##3##(1997-3#1)(2008-8#1)(2012-12#1)
and genetics of crown rust resistance in barley##2##8##(2008-10#2)
and genetics of##9##3##(1994-2#1)(2007-7#1)(2008-10#2)(2008-8#2)(2009-9#1)(2012-2#1)(2012-3#1)
and genetics##19##2##(1990-3#1)(1994-2#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and genistein##8##2##(1992-12#1)(1992-8#2)(1993-12#1)(2008-10#1)(2008-4#3)
and genital##10##2##(1993-3#1)(1996-12#1)(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
and genitalia##3##2##(2008-8#1)(2010-12#1)(2010-4#1)
and genitourinary##3##2##(2007-12#1)(2007-7#1)(2010-8#1)
and genome evolution##2##3##(2008-7#2)
and genome organization of##2##4##(1995-6#1)(2008-8#1)
and genome organization##4##3##(1995-6#1)(2008-10#1)(2008-8#1)(2010-3#1)
and genome replication##2##3##(2008-10#1)(2012-12#1)
and genome structure##2##3##(2007-12#1)(2008-7#1)
and genome##19##2##(1995-6#1)(2007-12#2)(2008-10#4)(2008-7#6)(2008-8#3)(2010-2#1)(2010-3#1)(2012-12#1)
and genome-based##2##2##(2008-10#1)(2011-1#1)
and genome-wide##6##2##(2009-4#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
and genomic DNA##5##3##(1991-9#1)(1996-8#1)(2008-4#1)(2008-9#1)(2013-1#1)
and genomic data##2##3##(2008-11#1)(2008-4#1)
and genomic##32##2##(1991-9#3)(1992-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#1)(2012-3#1)(2013-1#1)
and genomics of##2##3##(2008-7#1)(2008-9#1)
and genomics##6##2##(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)
and genotoxic##2##2##(1993-11#2)
and genotoxicity##2##2##(2008-4#1)(2013-1#1)
and genotype of##4##3##(2008-4#2)(2013-1#2)
and genotype##15##2##(1997-5#1)(2008-10#6)(2008-4#3)(2008-5#2)(2009-7#1)(2013-1#2)
and genotyped##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
and genotypes of##4##3##(2008-10#2)(2008-4#1)(2012-3#1)
and genotypes##11##2##(2007-7#1)(2008-10#5)(2008-4#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
and genotypic diversity##2##3##(2008-10#2)
and genotypic##12##2##(2008-10#8)(2008-12#1)(2008-4#1)(2008-8#2)
and genotyping of##2##3##(2008-10#1)(2012-3#1)
and genotyping##5##2##(2008-10#1)(2008-2#2)(2012-3#2)
and gentamicin##3##2##(2007-7#1)(2009-5#1)(2011-2#1)
and gentamycin##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
and gentle##2##2##(2008-10#1)(2008-9#1)
and genus##2##2##(1991-3#1)(2013-7#1)
and geochemical##3##2##(1997-5#1)(2008-10#2)
and geographic areas##2##3##(1994-1#1)(1996-12#1)
and geographic distance##4##3##(2008-10#4)
and geographic distribution of##3##4##(1996-12#1)(2008-10#1)(2011-2#1)
and geographic distribution##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
and geographic information systems##2##4##(1997-1#1)(2008-10#1)
and geographic locations##2##3##(2008-10#2)
and geographic origin##2##3##(2008-10#2)
and geographic##26##2##(1990-9#1)(1992-1#1)(1994-1#1)(1996-12#2)(1997-1#1)(2008-10#12)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
and geographical distribution of the##2##5##(1997-7#1)(2013-8#1)
and geographical distribution##3##3##(1997-7#1)(2007-7#1)(2013-8#1)
and geographical origin##2##3##(2008-10#2)
and geographical##16##2##(1990-8#1)(1997-7#1)(2007-7#1)(2008-10#7)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-8#1)
and geographically##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2013-7#1)
and geological samples##3##3##(2008-10#3)
and geological##4##2##(1997-5#1)(2008-10#3)
and geometric##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
and geometrical##5##2##(2008-10#1)(2008-3#3)(2008-7#1)
and geometry of##3##3##(1991-12#1)(1993-8#1)(2008-7#1)
and geometry##5##2##(1991-12#1)(1993-8#1)(2008-3#2)(2008-7#1)
and geostatistical##2##2##(2008-10#1)(2008-11#1)
and germ cell##3##3##(2009-10#2)(2009-7#1)
and germ plasm##2##3##(2008-10#2)
and germ tube growth of##4##5##(2008-10#4)
and germ tube##5##3##(2008-10#5)
and germ##13##2##(2008-10#7)(2009-10#5)(2009-7#1)
and germinal##2##2##(2008-4#1)(2008-9#1)
and germinate##3##2##(2008-10#3)
and germination of##3##3##(1993-3#1)(2008-10#2)
and germination were##2##3##(2008-10#2)
and germination##12##2##(1993-3#1)(1995-6#1)(2008-10#9)(2008-12#1)
and germline##2##2##(2008-11#1)(2013-8#1)
and gerontology##2##2##(1995-12#1)(2008-7#1)
and gestational age##5##3##(1996-12#1)(2007-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
and gestational##9##2##(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
and get more##2##3##(1994-1#1)(1996-12#1)
and get##5##2##(1992-12#1)(1994-1#1)(1995-2#1)(1996-12#1)(2008-10#1)
and gfg transcripts##2##3##(1994-11#2)
and ghost talk##2##3##(2008-3#2)
and ghost##3##2##(2007-11#1)(2008-3#2)
and giant cells##2##3##(2007-12#1)(2008-7#1)
and giant##11##2##(1991-8#1)(1992-11#1)(2007-12#2)(2007-7#1)(2008-5#1)(2008-7#2)(2011-2#2)(2013-7#1)
and gills##3##2##(2008-12#2)(2008-7#1)
and ginger##2##2##(2008-10#1)(2008-11#1)
and gingival##3##2##(2008-1#1)(2008-12#1)(2011-2#1)
and ginseng##2##2##(2009-9#1)(2012-3#1)
and girls'##2##2##(2007-12#1)(2009-7#1)
and give a##2##3##(2007-11#1)(2009-8#1)
and give an overview of##2##5##(2010-11#1)(2010-9#1)
and give rise to##3##4##(2009-5#1)(2010-12#1)(2010-4#1)
and give##28##2##(1990-10#1)(1990-3#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-7#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-9#1)(2012-2#2)(2013-1#1)
and given the##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
and given##7##2##(1997-5#1)(1997-6#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and gives a##10##3##(1991-11#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
and gives rise to##2##4##(2008-10#1)(2008-5#1)
and gives the##2##3##(2008-10#1)(2008-11#1)
and gives##27##2##(1990-11#1)(1991-11#1)(1992-2#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2009-7#1)(2010-5#1)(2010-9#1)(2013-1#1)
and giving##6##2##(1992-4#1)(1996-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#1)
and glabellar##2##2##(2008-5#2)
and gland##2##2##(2008-5#1)(2012-1#1)
and glass beads were##2##4##(2008-10#1)(2008-3#1)
and glass beads##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
and glass##14##2##(1995-3#1)(2008-10#4)(2008-3#6)(2009-5#1)(2010-8#1)(2012-2#1)
and glassy carbon##3##3##(2008-10#3)
and glaucoma##3##2##(2011-1#3)
and glenoid##2##2##(2008-7#1)(2008-8#1)
and glia is##3##3##(2007-10#1)(2008-7#1)(2009-9#1)
and glia##6##2##(1995-12#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)
and glial cells in##2##4##(2008-4#1)(2008-7#1)
and glial cells of the##2##5##(1990-7#1)(2008-2#1)
and glial cells##14##3##(1990-11#1)(1990-7#4)(1993-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)
and glial fibrillary acidic protein##2##5##(1996-5#1)(2008-7#1)
and glial##20##2##(1990-11#1)(1990-7#5)(1991-6#1)(1993-12#1)(1994-2#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)
and glibenclamide in##2##3##(1994-8#1)(1996-9#1)
and glibenclamide##8##2##(1992-3#2)(1994-11#1)(1994-8#4)(1996-9#1)
and glioma risk##3##3##(2011-2#3)
and glioma##5##2##(1992-6#1)(2011-2#3)(2012-12#1)
and gliosis##4##2##(1996-5#3)(2013-7#1)
and global analysis##2##3##(1994-11#1)(2010-5#1)
and global health##3##3##(2008-6#2)(2012-12#1)
and global ratings of energy##2##5##(2008-7#2)
and global solar##2##3##(2008-3#1)(2010-1#1)
and global##40##2##(1992-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-8#1)
and globally##3##2##(1996-8#1)(2008-3#1)(2011-2#1)
and globoid cell leukodystrophy##2##4##(2008-11#2)
and globule compressibility##2##3##(2008-10#2)
and globulin##2##2##(2008-10#1)(2008-5#1)
and globulins##3##2##(2008-10#1)(2008-12#1)(2010-4#1)
and globus pallidus##2##3##(1996-12#1)(2008-7#1)
and glomerular filtration rate##4##4##(1995-12#3)(2010-4#1)
and glomerular##5##2##(1995-12#3)(2008-1#1)(2010-4#1)
and glomerulonephritis (GN)##2##3##(1997-8#1)(2011-1#1)
and glomerulonephritis##5##2##(1996-3#1)(1997-8#1)(2007-7#1)(2011-1#1)(2013-8#1)
and gluC##2##2##(2008-10#2)
and glucagon##7##2##(1994-11#1)(1994-8#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)
and glucagon-like peptide-1##2##3##(2011-2#2)
and glucagon-like##3##2##(2011-2#2)(2012-3#1)
and glucocorticoid receptors##4##3##(1995-12#2)(2008-4#1)(2008-6#1)
and glucocorticoid therapy##2##3##(2012-12#2)
and glucocorticoid##13##2##(1992-2#1)(1993-12#1)(1993-5#1)(1995-12#4)(2008-12#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#2)
and glucocorticoids##10##2##(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2012-2#1)
and gluconeogenesis##2##2##(1991-9#1)(2008-1#1)
and gluconic acid##3##3##(1996-5#1)(2008-6#2)
and gluconic##5##2##(1996-5#1)(2008-10#2)(2008-6#2)
and glucose 6-phosphatase##2##3##(1994-8#1)(2010-11#1)
and glucose and##7##3##(1994-5#2)(1995-3#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
and glucose concentration##4##3##(2008-10#2)(2008-6#1)(2010-2#1)
and glucose concentrations##3##3##(1991-9#1)(1993-1#1)(2010-10#1)
and glucose for##2##3##(1990-8#1)(1996-6#1)
and glucose in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
and glucose levels##6##3##(2008-10#3)(2008-11#1)(2012-3#1)(2012-5#1)
and glucose oxidase##7##3##(2008-10#7)
and glucose oxidase)##2##3##(2008-10#2)
and glucose tolerance##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
and glucose uptake##2##3##(1994-6#1)(2008-11#1)
and glucose was##2##3##(1991-9#1)(1993-1#1)
and glucose##89##2##(1990-12#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-9#2)(1993-1#2)(1993-6#1)(1994-5#4)(1994-6#3)(1994-8#3)(1995-3#1)(1996-6#1)(1997-4#2)(1997-6#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#3)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#2)(2011-1#1)(2012-3#3)(2012-4#1)(2012-5#4)(2013-1#3)
and glucose)##2##2##(1992-9#1)(2008-7#1)
and glucose-6-phosphate dehydrogenase##2##3##(1990-3#1)(2008-8#1)
and glucose-stimulated insulin secretion##2##4##(1997-4#1)(2008-11#1)
and glutamate dehydrogenase (GDH)##2##4##(1995-5#1)(2008-11#1)
and glutamate dehydrogenase##4##3##(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)
and glutamate in the##2##4##(1995-12#1)(2008-7#1)
and glutamate release in vivo##2##5##(1995-12#2)
and glutamate transporters##2##3##(2008-7#1)(2008-8#1)
and glutamate##26##2##(1990-11#2)(1990-7#1)(1991-11#1)(1992-11#1)(1995-12#3)(1995-5#2)(1996-12#1)(1997-1#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-1#1)(2012-1#1)
and glutamatergic##6##2##(1993-12#1)(1994-6#2)(2008-7#3)
and glutamic pyruvic transaminase##2##4##(1995-6#1)(2008-7#1)
and glutamic##6##2##(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
and glutamine concentration##2##3##(2008-11#2)
and glutamine synthetase##4##3##(2008-11#2)(2008-7#1)(2009-8#1)
and glutamine##33##2##(1991-2#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-11#22)(2008-7#5)(2009-8#1)
and glutamine)##2##2##(2008-11#2)
and glutaraldehyde##3##2##(2008-10#3)
and glutathione S-transferase##3##3##(1996-12#1)(2008-4#2)
and glutathione determination##2##3##(2008-10#2)
and glutathione disulfide##5##3##(2008-10#4)(2008-11#1)
and glutathione on##2##3##(1991-9#1)(2007-4#1)
and glutathione peroxidase##10##3##(1990-3#2)(1991-12#3)(1991-9#1)(1997-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and glutathione reductase##2##3##(1994-9#1)(2010-5#1)
and glutathione##38##2##(1990-3#2)(1991-12#3)(1991-9#2)(1992-2#1)(1993-8#1)(1994-9#1)(1996-12#1)(1997-5#1)(2007-4#1)(2008-10#15)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
and gluteus muscles##2##3##(1990-8#1)(2006-10#1)
and glycaemic control##2##3##(1993-2#1)(2013-1#1)
and glycan##2##2##(1992-3#1)(2010-11#1)
and glycemic control##2##3##(2009-8#1)(2011-2#1)
and glycemic load##2##3##(2008-1#1)(2013-8#1)
and glycemic##4##2##(2008-1#1)(2009-8#1)(2011-2#1)(2013-8#1)
and glyceraldehyde-3-phosphate dehydrogenase##3##3##(1992-6#1)(1995-11#1)(2010-9#1)
and glycerol which##2##3##(1995-11#2)
and glycerol##8##2##(1995-11#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)
and glycine##14##2##(1990-8#2)(1992-10#1)(1992-6#1)(1993-2#1)(1996-5#2)(1997-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)
and glycogen##6##2##(1990-8#1)(2008-10#3)(2010-4#1)(2010-7#1)
and glycolytic##5##2##(1994-3#1)(1994-8#1)(1997-1#3)
and glycophorin##3##2##(1992-11#1)(1994-12#1)(2008-9#1)
and glycoproteins##2##2##(1990-7#1)(2008-10#1)
and glycosaminoglycan free##2##3##(1991-9#2)
and glycosylated##4##2##(1992-5#1)(1992-6#1)(1993-12#1)(2008-11#1)
and glycosylation of##3##3##(2010-11#1)(2011-2#2)
and glycosylation##6##2##(2008-11#3)(2010-11#1)(2011-2#2)
and glycuronic acids##2##3##(1991-7#2)
and go##5##2##(1992-3#1)(1994-12#1)(2007-2#1)(2007-5#1)(2010-3#1)
and go&quot##2##2##(2008-3#1)(2012-12#1)
and goal re-engagement##2##3##(2010-2#2)
and goal##4##2##(1995-3#1)(2007-12#1)(2010-2#2)
and goal-directed##2##2##(2007-8#1)(2010-10#1)
and goals of the##2##4##(1995-3#1)(2011-2#1)
and goals of##5##3##(1993-3#1)(1995-3#1)(2008-11#1)(2010-6#1)(2011-2#1)
and goals##10##2##(1991-12#1)(1991-8#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-11#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)
and goat##3##2##(1995-2#1)(2011-2#2)
and goats##6##2##(1996-5#1)(2008-12#3)(2011-1#1)(2011-2#1)
and goblet cell##3##3##(1996-7#1)(2013-1#2)
and goes on to describe##2##5##(1994-3#1)(2008-9#1)
and gold##19##2##(1997-3#2)(2008-10#10)(2008-2#2)(2008-3#2)(2009-4#1)(2010-11#1)(2013-1#1)
and goldfish##3##2##(1997-7#1)(2008-12#2)
and gonad##2##2##(2008-12#1)(2009-11#1)
and gonadal##4##2##(2008-10#1)(2008-4#1)(2008-5#2)
and gonadotropin-releasing hormone##2##3##(1990-9#1)(1996-2#1)
and gonadotropin-releasing##3##2##(1990-9#1)(1996-2#2)
and gonads##3##2##(2008-11#1)(2008-4#1)(2009-2#1)
and goniometric##3##2##(2008-12#1)(2008-3#2)
and gonochoristic##2##2##(2008-7#2)
and good agreement is##2##4##(2008-2#1)(2008-3#1)
and good agreement was obtained with the##2##7##(2008-10#2)
and good agreement was obtained##3##5##(2008-10#3)
and good agreement was##4##4##(2008-10#3)(2008-2#1)
and good agreement##8##3##(2008-10#4)(2008-2#2)(2008-3#2)
and good clinical##2##3##(2013-8#2)
and good correlation##2##3##(2008-10#2)
and good functional##2##3##(2007-8#1)(2009-4#1)
and good linearity##4##3##(2008-10#3)(2009-8#1)
and good long-term stability##2##4##(2008-10#2)
and good long-term##3##3##(2007-7#1)(2008-10#2)
and good outcome##2##3##(1996-2#1)(2007-11#1)
and good physical##2##3##(2008-5#1)(2010-5#1)
and good precision (RSD##2##4##(2008-10#2)
and good recoveries##3##3##(2008-10#3)
and good reproducibility##8##3##(2008-10#7)(2012-3#1)
and good response##2##3##(1992-9#1)(2008-10#1)
and good results were obtained##2##5##(2008-10#2)
and good results##7##3##(2007-11#3)(2008-10#3)(2011-2#1)
and good selectivity for##2##4##(2008-10#2)
and good selectivity##5##3##(2008-10#4)(2010-11#1)
and good stability##2##3##(2008-10#1)(2008-5#1)
and good##97##2##(1991-3#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-1#2)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#45)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and goodness-of-fit##2##2##(2011-1#2)
and gout##3##2##(2007-7#1)(2009-10#2)
and governance##7##2##(1991-1#1)(1995-12#2)(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
and governing##3##2##(1991-2#2)(2010-8#1)
and government##20##2##(1991-12#2)(1992-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-6#1)(1996-12#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
and governmental##13##2##(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)
and governments##7##2##(1991-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-11#1)(2012-12#1)
and grabbing##2##2##(2007-8#1)(2008-3#1)
and grade 3##3##3##(2008-6#2)(2013-1#1)
and grade 4##2##3##(1991-8#2)
and grade##17##2##(1991-8#2)(1997-7#1)(2007-10#1)(2008-6#3)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
and graded##2##2##(1990-5#1)(2013-1#1)
and graded-index POF's were##2##4##(2008-3#2)
and gradient##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
and grading##4##2##(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
and gradual##6##2##(1996-3#1)(1997-5#1)(2008-11#1)(2009-7#1)(2010-11#1)(2012-3#1)
and gradually became##2##3##(1997-8#1)(2008-9#1)
and gradually##7##2##(1997-8#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
and graduate medical education##2##4##(2008-11#2)
and graduate##8##2##(1994-12#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
and graduating##2##2##(2009-10#1)(2011-1#1)
and graft survival##2##3##(2008-1#1)(2013-1#1)
and graft##7##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
and grafting##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
and grafts##4##2##(2009-5#3)(2011-3#1)
and grain yield per m2##2##5##(2008-12#2)
and grain yield##4##3##(2008-12#4)
and grain##15##2##(2008-10#6)(2008-12#7)(2008-3#1)(2008-8#1)
and grains##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
and gram negative##4##3##(2007-7#1)(2007-8#1)(2008-11#1)(2010-3#1)
and granular##6##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
and granularity##3##2##(2011-2#3)
and granule##3##2##(1992-6#2)(1993-6#1)
and granulocyte-macrophage colony-stimulating factor##2##4##(1995-6#1)(2008-11#1)
and granulocyte-macrophage##3##2##(1992-3#1)(1995-6#1)(2008-11#1)
and granulocytes##2##2##(2008-9#1)(2009-6#1)
and granuloma##2##2##(2007-7#1)(2008-9#1)
and granulomatous##3##2##(1990-3#1)(1990-8#1)(2012-12#1)
and granulosa##4##2##(1995-2#1)(1995-8#2)(2008-12#1)
and grape##3##2##(2008-10#3)
and graphic method##2##3##(2008-10#1)(2008-5#1)
and graphic##5##2##(2008-10#1)(2008-3#2)(2008-5#1)(2010-3#1)
and graphical##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
and graphics##3##2##(2008-6#1)(2010-8#1)(2012-3#1)
and graphite furnace atomic absorption spectrometric determination of##2##8##(2008-10#2)
and graphite furnace atomic absorption spectrometry (GFAAS)##4##7##(2008-10#4)
and graphite furnace atomic absorption spectrometry##8##6##(2008-10#8)
and graphite furnace atomic absorption##11##5##(2008-10#11)
and graphite##13##2##(2008-10#13)
and grasping##3##2##(1996-2#1)(2007-8#1)(2012-2#1)
and grass##2##2##(1992-3#1)(1996-12#1)
and grasses##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
and grating##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
and gravity##2##2##(1991-12#1)(2008-3#1)
and gray MTA+10%CaO##2##3##(2013-1#2)
and gray leaf spot resistance##2##5##(2008-10#2)
and gray leaf spot##4##4##(2008-10#4)
and gray##11##2##(2008-10#7)(2008-6#1)(2011-2#1)(2013-1#2)
and gray-scale##2##2##(2008-3#2)
and grease##3##2##(2008-5#1)(2013-1#2)
and greater availability of##2##4##(1997-1#1)(2010-11#1)
and greater coverage##2##3##(1994-3#1)(2013-1#1)
and greater than 0##2##4##(2008-10#2)
and greater than##9##3##(1990-12#1)(1992-12#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-6#1)(2013-7#1)
and greater##60##2##(1990-12#1)(1992-12#2)(1993-5#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-8#1)(2010-11#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and greatest##2##2##(2008-11#1)(2008-12#1)
and greatly##6##2##(1993-9#1)(2008-10#1)(2008-3#2)(2009-9#1)(2010-3#1)
and green coffee beans##3##4##(2008-10#3)
and green fluorescent protein##2##4##(2008-11#1)(2008-9#1)
and green##16##2##(2006-12#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-9#1)(2011-2#1)(2013-7#1)
and greenhouse conditions##2##3##(2008-10#2)
and greenhouse experiments##5##3##(2008-10#4)(2008-8#1)
and greenhouse studies##2##3##(2008-10#1)(2013-8#1)
and greenhouse##13##2##(2008-10#11)(2008-8#1)(2013-8#1)
and grew as##2##3##(2008-11#1)(2008-6#1)
and grew##10##2##(1991-6#1)(2008-10#5)(2008-11#2)(2008-6#1)(2012-3#1)
and grey##4##2##(1995-8#1)(2009-12#1)(2011-1#1)(2011-2#1)
and grip##4##2##(2007-12#2)(2008-9#1)(2013-1#1)
and groin##3##2##(1996-12#2)(2011-1#1)
and grooming##2##2##(1991-3#1)(2008-5#1)
and groove##6##2##(2008-2#1)(2008-3#5)
and grooves##3##2##(1991-2#1)(2008-8#1)(2010-5#1)
and gross##7##2##(1994-5#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
and ground water##3##3##(2008-10#3)
and ground##13##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-7#1)(2010-12#1)
and ground-based##4##2##(2008-2#2)(2008-3#2)
and ground-level##2##2##(2008-2#1)(2008-3#1)
and grounded in##2##3##(2008-1#1)(2008-11#1)
and grounded##3##2##(2008-1#1)(2008-11#2)
and groundwater##4##2##(1996-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
and group 3##6##3##(2008-10#1)(2008-7#4)(2010-3#1)
and group B##3##3##(1995-12#1)(2007-9#1)(2008-1#1)
and group II##5##3##(1995-12#1)(2008-10#2)(2010-1#1)(2013-1#1)
and group III##2##3##(2006-6#1)(2009-8#1)
and group interviews##2##3##(2008-11#1)(2009-11#1)
and group##48##2##(1992-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-3#2)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#5)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and grouped into##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
and grouped##8##2##(1993-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2011-2#1)
and groups of##4##3##(1996-12#1)(2008-9#1)(2009-12#1)(2011-1#1)
and groups with##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
and groups##17##2##(1993-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and grow in##2##3##(1994-7#1)(2008-5#1)
and grow##6##2##(1994-7#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#2)
and growing body of##2##4##(2008-5#1)(2012-12#1)
and growing##18##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-6#1)(2012-12#1)
and grown for##2##3##(2008-10#1)(2008-2#1)
and grown in##3##3##(1994-2#1)(2012-2#1)(2013-1#1)
and grown##9##2##(1994-2#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#2)
and growth abnormalities##2##3##(2008-10#2)
and growth behavior##2##3##(2008-11#1)(2008-2#1)
and growth chamber##3##3##(2008-10#3)
and growth conditions on##2##4##(2008-7#1)(2011-2#1)
and growth conditions##5##3##(1994-9#1)(1997-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
and growth factor receptors##2##4##(1992-8#1)(2008-4#1)
and growth factor##8##3##(1992-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#2)
and growth factors##17##3##(1991-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-5#2)(2008-9#2)(2009-12#1)(2011-2#2)(2012-6#1)(2013-1#1)
and growth hormone deficiency##2##4##(2008-5#1)(2011-1#1)
and growth hormone##7##3##(1991-9#1)(1994-8#2)(1996-2#1)(2008-5#1)(2009-9#1)(2011-1#1)
and growth in##8##3##(1991-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
and growth inhibition##2##3##(1994-8#1)(2008-10#1)
and growth mechanism##2##3##(2008-10#2)
and growth of the##4##4##(1994-8#1)(2008-10#3)
and growth of these##2##4##(2008-1#1)(2008-10#1)
and growth of##41##3##(1990-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-3#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
and growth on##2##3##(2008-10#2)
and growth only##2##3##(2009-10#1)(2012-3#1)
and growth parameters##3##3##(2011-1#2)(2012-9#1)
and growth rate##4##3##(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
and growth rates##2##3##(2008-8#1)(2012-12#1)
and growth was##3##3##(2008-10#1)(2008-6#2)
and growth were##2##3##(2008-10#1)(2012-3#1)
and growth##163##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-3#4)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#36)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-9#2)(2010-2#2)(2011-1#6)(2011-2#11)(2012-12#4)(2012-2#2)(2012-3#3)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#4)(2013-7#3)(2013-8#1)
and guanidine##2##2##(1990-12#1)(2012-2#1)
and guanine##4##2##(1992-8#1)(1995-11#1)(2008-10#2)
and guanosine##7##2##(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(2008-4#2)(2009-12#1)
and guanylyl cyclase##3##3##(2008-3#3)
and guarantee##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
and guarantees##2##2##(2008-11#1)(2008-3#1)
and guardians##2##2##(1995-3#1)(2008-9#1)
and guidance##7##2##(1997-8#1)(2007-10#1)(2008-11#1)(2008-12#3)(2013-1#1)
and guide##7##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-6#1)(2012-3#1)
and guided##7##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
and guidelines for##6##3##(1992-3#1)(1996-11#1)(2008-12#2)(2008-5#1)(2010-5#1)
and guidelines##14##2##(1992-3#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-5#1)
and guides the##2##3##(2009-4#1)(2010-8#1)
and guides##3##2##(2008-10#1)(2009-4#1)(2010-8#1)
and guilt##3##2##(1996-11#1)(1997-7#1)(2009-10#1)
and guinea pig##4##3##(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)
and guinea pigs##6##3##(1995-12#5)(2008-10#1)
and guinea##10##2##(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-12#5)(2008-10#1)
and guinea-pig##3##2##(1990-12#3)
and gum##2##2##(2012-2#2)
and gut##5##2##(1991-8#1)(1994-11#2)(2008-5#1)(2010-10#1)
and gynecologic##2##2##(1992-1#1)(2011-2#1)
and hCG levels##2##3##(2011-1#2)
and hCG##5##2##(1996-5#2)(2008-5#1)(2011-1#2)
and hFIX##2##2##(2008-8#1)(2008-9#1)
and hIL-6##2##2##(2008-8#2)
and habitat loss##2##3##(2008-9#1)(2013-7#1)
and habitat##13##2##(2007-5#1)(2008-5#1)(2008-8#5)(2008-9#3)(2010-8#1)(2013-7#2)
and habits##2##2##(2008-5#1)(2011-2#1)
and habituation of motivated##2##4##(2009-8#2)
and habituation##7##2##(1993-5#1)(1997-2#1)(2008-4#2)(2009-8#3)
and had a higher mortality##2##5##(2008-7#1)(2011-2#1)
and had a higher##8##4##(1990-11#1)(1993-6#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
and had a lower##2##4##(2010-11#1)(2013-1#1)
and had a molecular mass of##2##6##(1995-6#1)(2008-10#1)
and had a significant##2##4##(1991-6#1)(2010-4#1)
and had a##38##3##(1990-11#1)(1990-7#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#2)(1995-6#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
and had an unambiguous serostatus##2##5##(1995-9#2)
and had an##8##3##(1995-3#1)(1995-9#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
and had been treated##2##4##(1996-7#1)(2010-3#1)
and had been##9##3##(1993-1#1)(1994-12#1)(1996-7#1)(2008-10#1)(2008-8#1)(2009-3#2)(2010-3#1)(2013-8#1)
and had complete##2##3##(2008-7#1)(2010-5#1)
and had distinct##2##3##(2008-8#1)(2013-1#1)
and had elevated##2##3##(1996-12#1)(2008-10#1)
and had higher##4##3##(2006-10#1)(2012-1#1)(2013-1#1)(2013-7#1)
and had increased##2##3##(2008-2#1)(2011-2#1)
and had less##5##3##(1995-3#1)(1996-2#1)(2008-10#2)(2010-4#1)
and had low##2##3##(2008-2#1)(2008-5#1)
and had lower##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
and had more##6##3##(1993-12#1)(1995-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
and had never##2##3##(1990-6#1)(2010-5#1)
and had no effect on the##3##6##(1992-8#1)(1994-6#1)(2008-7#1)
and had no effect on##4##5##(1992-8#1)(1993-12#1)(1994-6#1)(2008-7#1)
and had no further##2##4##(2008-5#1)(2011-2#1)
and had no history of##2##5##(2010-5#1)(2013-1#1)
and had no##15##3##(1992-8#1)(1993-12#1)(1994-6#1)(1995-5#1)(1995-6#2)(2006-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
and had not been##2##4##(2008-11#1)(2011-3#1)
and had not##4##3##(2008-11#1)(2008-7#1)(2009-1#1)(2011-3#1)
and had the highest##2##4##(2008-10#2)
and had the##9##3##(1992-12#1)(1995-4#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)
and had to##2##3##(1991-6#1)(2008-7#1)
and had##188##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#5)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#4)(2011-1#2)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#5)
and haemagglutination inhibition##2##3##(1997-6#2)
and haematocrit##2##2##(1990-3#1)(1993-3#1)
and haematuria##2##2##(2008-10#1)(2011-2#1)
and haemodialysis patients##2##3##(1990-3#1)(2008-12#1)
and haemodialysis##3##2##(1990-3#1)(2008-12#1)(2011-1#1)
and haemodynamic parameters##2##3##(2010-7#1)(2011-2#1)
and haemodynamic##4##2##(2008-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
and haemolytic##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
and hair samples##8##3##(2008-10#7)(2008-5#1)
and hair##21##2##(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#7)(2008-8#1)(2008-9#2)(2012-2#1)
and hairy root cultures of Lithospermum erythrorhizon##2##7##(1994-11#2)
and hairy root cultures##4##4##(1994-11#4)
and hairy##5##2##(1994-11#4)(2008-10#1)
and half of##2##3##(1997-8#1)(2008-6#1)
and half were##2##3##(1993-12#1)(2007-12#1)
and half years##4##3##(2007-7#1)(2008-1#1)(2010-11#2)
and half##15##2##(1993-12#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
and half-beam block##2##3##(2007-10#2)
and half-strength##2##2##(2008-10#2)
and hallucinations##6##2##(1995-11#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
and hallucinogenic##2##2##(1991-1#1)(2011-2#1)
and halofuginone##3##2##(2007-6#3)
and haloperidol##3##2##(1993-5#2)(2008-7#1)
and halophenols##3##2##(2008-10#3)
and hampered##2##2##(2010-8#1)(2011-2#1)
and hamster##2##2##(1994-12#1)(1996-2#1)
and hand massage##3##3##(2010-7#3)
and hand##15##2##(1997-3#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#2)(2010-7#3)(2011-2#3)
and handle##2##2##(2007-7#1)(2009-5#1)
and handling of##4##3##(1990-2#1)(2008-11#1)(2008-9#2)
and handling##17##2##(1990-2#1)(1992-1#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2012-12#1)
and hands-on##4##2##(1994-12#1)(1994-6#1)(2007-5#1)(2009-2#1)
and handy##3##2##(1991-3#1)(2008-10#1)(2008-2#1)
and haploid segregation analysis##2##4##(2008-10#2)
and haploid##4##2##(2008-10#3)(2012-3#1)
and haplotype##4##2##(1997-5#1)(2008-10#1)(2010-8#1)(2011-2#1)
and haplotypes##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
and happy##2##2##(1996-9#1)(2010-4#1)
and haptoglobin##3##2##(1996-12#2)(2008-1#1)
and hard of hearing children and adolescents##2##7##(2011-2#2)
and hard of hearing##7##4##(2011-2#7)
and hard##18##2##(1990-10#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#9)
and hardly##3##2##(1990-10#1)(1995-11#1)(2011-1#1)
and hardness of##2##3##(2008-10#1)(2010-10#1)
and hardness##6##2##(2007-12#1)(2008-10#2)(2010-10#1)(2010-4#2)
and haricot##2##2##(2008-10#2)
and harm##2##2##(1995-9#1)(2008-11#1)
and harmful##6##2##(1997-4#1)(2008-10#3)(2008-11#1)(2013-8#1)
and harmonic##3##2##(2008-3#3)
and harsh##3##2##(2008-8#1)(2009-7#1)(2010-11#1)
and harvest##4##2##(2008-10#1)(2008-11#2)(2008-4#1)
and harvested##5##2##(1993-3#1)(2008-10#3)(2011-2#1)
and has a calculated##3##4##(1990-7#2)(2008-10#1)
and has a high##4##4##(1996-10#1)(2007-12#1)(2008-3#1)(2012-2#1)
and has a low##2##4##(2007-7#1)(2009-7#1)
and has a very##2##4##(2007-12#1)(2010-3#1)
and has a##53##3##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-2#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-3#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
and has also been##3##4##(2007-12#1)(2009-12#1)(2013-8#1)
and has also##5##3##(2007-12#1)(2008-10#1)(2009-12#1)(2010-1#1)(2013-8#1)
and has an application##2##4##(2007-11#1)(2008-10#1)
and has an##15##3##(1993-12#1)(1993-2#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-10#1)(2010-5#1)
and has become a##2##4##(2008-7#1)(2011-2#1)
and has become an##2##4##(2008-10#1)(2012-2#1)
and has become##6##3##(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
and has been applied successfully to the##2##7##(2008-10#2)
and has been applied to the##3##6##(2008-10#3)
and has been applied to##4##5##(2008-10#3)(2008-9#1)
and has been applied##8##4##(2008-10#7)(2008-9#1)
and has been associated with##2##5##(2010-7#1)(2011-2#1)
and has been considered##2##4##(1994-8#1)(2008-7#1)
and has been demonstrated##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
and has been found in##2##5##(2008-10#1)(2010-3#1)
and has been found##3##4##(2008-10#1)(2010-3#1)(2011-2#1)
and has been implicated in a##2##6##(1996-12#1)(2012-12#1)
and has been implicated in several##2##6##(2006-10#1)(2012-2#1)
and has been implicated in##5##5##(1992-10#1)(1996-12#1)(2006-10#1)(2012-12#1)(2012-2#1)
and has been implicated##6##4##(1992-10#1)(1996-12#1)(2006-10#1)(2012-12#2)(2012-2#1)
and has been proposed##2##4##(2008-3#1)(2008-4#1)
and has been reported##4##4##(1992-8#1)(1995-6#1)(2007-11#1)(2008-1#1)
and has been shown to##8##5##(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-2#1)(2011-2#1)
and has been successfully##3##4##(2008-10#3)
and has been the##2##4##(2008-12#1)(2012-3#1)
and has been used as##2##5##(2008-10#1)(2008-7#1)
and has been used for##3##5##(2007-11#1)(2008-10#1)(2012-3#1)
and has been used to##2##5##(1991-7#1)(2008-10#1)
and has been used##11##4##(1991-7#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-4#1)(2012-3#1)
and has been utilized##2##4##(2007-11#1)(2008-10#1)
and has been validated##2##4##(2008-10#1)(2008-3#1)
and has been##92##3##(1991-7#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-11#1)(1994-8#2)(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#7)(2008-9#3)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
and has facilitated the##2##4##(1996-1#1)(2008-10#1)
and has facilitated##3##3##(1994-5#1)(1996-1#1)(2008-10#1)
and has focused on##2##4##(1994-3#1)(1997-3#1)
and has high##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
and has improved##2##3##(1997-3#1)(2007-12#1)
and has led to##3##4##(1994-12#1)(2009-6#1)(2012-12#1)
and has low##4##3##(2008-10#3)(2011-2#1)
and has maintained##2##3##(1996-1#1)(2012-3#1)
and has no##3##3##(1997-1#1)(2008-6#1)(2010-3#1)
and has not been##3##4##(1995-6#1)(2008-5#1)(2012-3#1)
and has not##7##3##(1995-6#1)(2006-10#1)(2008-1#1)(2008-5#1)(2012-3#1)(2013-1#2)
and has only##2##3##(2008-5#1)(2013-1#1)
and has opened##2##3##(2011-2#1)(2012-3#1)
and has previously##2##3##(1993-2#1)(2008-9#1)
and has produced##2##3##(1996-1#1)(2009-7#1)
and has proved##3##3##(1991-12#1)(1994-3#1)(2007-12#1)
and has provided##4##3##(1995-12#1)(1997-2#1)(2008-10#1)(2012-12#1)
and has recently been shown to##2##6##(1995-6#1)(2008-10#1)
and has recently##4##3##(1995-6#1)(2007-6#1)(2008-10#1)(2011-2#1)
and has required##2##3##(2008-12#1)(2008-9#1)
and has resulted in##2##4##(2008-3#1)(2013-1#1)
and has shown##4##3##(1991-5#1)(2008-10#1)(2008-5#2)
and has since##6##3##(1996-11#1)(2007-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2013-8#1)
and has the advantage of being##2##6##(2008-10#1)(2008-3#1)
and has the advantage of##7##5##(1994-3#1)(2008-10#2)(2008-3#2)(2008-9#1)(2011-2#1)
and has the advantage##8##4##(1994-3#1)(2008-10#3)(2008-3#2)(2008-9#1)(2011-2#1)
and has the advantages of##2##5##(2008-2#1)(2008-7#1)
and has the potential to be used##2##7##(2008-10#1)(2008-3#1)
and has the potential to##9##5##(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)
and has the potential##10##4##(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-3#1)
and has the##26##3##(1994-12#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)
and has##333##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-8#1)(1994-12#3)(1994-3#3)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#4)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(1997-9#1)(2006-10#2)(2007-11#6)(2007-12#9)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#61)(2008-11#8)(2008-12#6)(2008-2#9)(2008-3#19)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#4)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#16)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#8)(2013-1#8)(2013-7#3)(2013-8#2)
and hatching rate##2##3##(2008-12#1)(2008-5#1)
and hatching##5##2##(2008-12#1)(2008-5#2)(2010-8#2)
and haustoria##3##2##(2008-10#3)
and have a##30##3##(1991-2#1)(1991-3#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#1)
and have adapted##2##3##(2011-2#1)(2012-3#1)
and have also been##3##4##(2008-3#1)(2010-1#1)(2010-5#1)
and have an increased##2##4##(2008-7#1)(2011-1#1)
and have an##6##3##(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-7#1)
and have become##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
and have been found to be##3##6##(1993-12#1)(2008-10#1)(2008-2#1)
and have been found##4##4##(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
and have been implicated##2##4##(2008-10#1)(2013-1#1)
and have been linked to##2##5##(2012-12#1)(2013-1#1)
and have been linked##3##4##(2008-5#1)(2012-12#1)(2013-1#1)
and have been reported to##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
and have been shown to##3##5##(2008-5#1)(2010-10#1)(2013-1#1)
and have been##34##3##(1993-12#1)(1993-2#1)(1994-5#2)(1995-1#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#4)
and have begun to##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
and have confirmed the##2##4##(2008-3#1)(2013-8#1)
and have demonstrated##3##3##(2007-11#1)(2008-5#1)(2010-12#1)
and have different##2##3##(2008-8#1)(2011-1#1)
and have expanded##2##3##(1995-3#1)(1996-2#1)
and have experienced##3##3##(2010-3#1)(2010-8#1)(2011-2#1)
and have found##3##3##(2008-11#1)(2008-7#1)(2011-3#1)
and have high##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
and have higher##2##3##(2009-5#1)(2013-1#1)
and have identified a##2##4##(1990-5#1)(1995-6#1)
and have identified two##2##4##(1994-3#1)(1994-9#1)
and have identified##5##3##(1990-5#1)(1994-3#1)(1994-9#1)(1995-6#1)(2008-3#1)
and have implications for##2##4##(1993-2#1)(2010-9#1)
and have important implications for##2##5##(2008-12#1)(2008-8#1)
and have important##3##3##(2008-12#1)(2008-8#1)(2010-11#1)
and have improved##2##3##(2008-4#1)(2011-2#1)
and have increased##2##3##(2007-7#1)(2013-1#1)
and have led to a##2##5##(1993-8#1)(2008-3#1)
and have led to##6##4##(1993-8#1)(2008-3#2)(2009-12#1)(2010-4#1)(2013-1#1)
and have little##2##3##(1992-11#1)(2012-12#1)
and have more##2##3##(1995-1#1)(2013-8#1)
and have not been##4##4##(2008-10#1)(2008-11#1)(2011-2#2)
and have not##5##3##(2008-10#2)(2008-11#1)(2011-2#2)
and have presented##2##3##(1992-3#1)(1994-5#1)
and have proved##2##3##(1997-1#1)(2008-2#1)
and have recently##2##3##(1990-5#1)(2010-8#1)
and have shown that##2##4##(1995-11#1)(2009-5#1)
and have shown##4##3##(1995-11#1)(2008-11#1)(2009-5#1)(2011-2#1)
and have significant##2##3##(2011-1#1)(2012-2#1)
and have similar##4##3##(1991-2#1)(1996-5#1)(2008-7#1)(2010-11#1)
and have the##5##3##(2008-10#1)(2012-12#2)(2013-1#2)
and have to be##3##4##(2007-7#1)(2008-10#1)(2011-2#1)
and have to##6##3##(1996-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#2)
and have used##2##3##(1990-7#1)(2008-10#1)
and have##245##2##(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#3)(1992-3#1)(1992-6#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#16)(2008-12#5)(2008-2#4)(2008-3#12)(2008-4#7)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#5)
and having a##5##3##(1995-8#1)(1997-6#1)(2008-12#2)(2011-2#1)
and having an##2##3##(1992-2#1)(2010-8#1)
and having##26##2##(1992-2#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and hay##2##2##(2008-10#1)(2008-12#1)
and hazard##3##2##(1997-3#1)(2009-3#1)(2011-2#1)
and hazards##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
and he had##3##3##(1992-6#1)(2011-2#1)(2012-2#1)
and he is##4##3##(1990-11#1)(2008-11#1)(2011-1#1)(2011-2#1)
and he was discharged##3##4##(2008-12#1)(2013-1#1)(2013-8#1)
and he was##8##3##(2007-5#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
and he##25##2##(1990-11#2)(1992-6#1)(1993-3#1)(1997-3#1)(2007-5#2)(2008-11#1)(2008-12#3)(2008-8#1)(2009-7#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
and he/she##2##2##(2007-11#1)(2010-3#1)
and head and neck##2##4##(2007-12#1)(2008-3#1)
and head circumference##5##3##(2008-12#1)(2008-2#1)(2011-1#3)
and head length##2##3##(2008-5#2)
and head##21##2##(2007-10#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#3)(2013-8#2)
and headache in##2##3##(2008-7#1)(2013-8#1)
and headache##11##2##(1994-6#1)(2007-7#1)(2008-12#1)(2008-7#2)(2010-12#3)(2011-2#1)(2013-7#1)(2013-8#1)
and healing##12##2##(1992-6#1)(1994-2#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
and health administration##4##3##(1991-2#1)(1992-3#1)(1994-3#1)(1997-3#1)
and health and##2##3##(2008-1#1)(2010-12#1)
and health authorities##2##3##(2008-9#1)(2009-10#1)
and health care are##2##4##(2008-11#1)(2009-5#1)
and health care delivery systems##2##5##(1993-12#1)(1995-1#1)
and health care delivery##6##4##(1993-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-12#2)
and health care expenditures##3##4##(1992-12#1)(2009-5#1)(2013-7#1)
and health care in the##2##5##(1995-2#1)(2008-8#1)
and health care institutions##2##4##(1991-2#1)(1995-2#1)
and health care planners##2##4##(1992-2#1)(1996-3#1)
and health care professionals##3##4##(1991-2#1)(2008-11#1)(2008-7#1)
and health care providers##9##4##(1991-12#1)(1991-3#1)(1995-6#1)(1997-2#1)(2008-8#1)(2013-8#4)
and health care reform##7##4##(1993-12#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-2#1)
and health care services##2##4##(1996-2#1)(2008-7#1)
and health care systems##6##4##(1993-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-2#1)
and health care utilization##7##4##(1996-2#3)(1997-1#2)(2009-5#1)(2010-12#1)
and health care##87##3##(1990-12#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-12#2)(1992-2#1)(1993-12#4)(1993-2#1)(1994-1#2)(1994-12#3)(1994-3#1)(1995-1#2)(1995-12#4)(1995-2#5)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#3)(1997-1#3)(1997-2#2)(1997-8#1)(2007-10#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-7#5)(2008-8#2)(2009-5#6)(2010-12#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-7#1)(2013-8#4)
and health characteristics##2##3##(1991-3#1)(2011-2#1)
and health conditions of##2##4##(2011-2#1)(2013-1#1)
and health conditions##3##3##(2011-2#2)(2013-1#1)
and health control##2##3##(2008-10#1)(2011-1#1)
and health delivery##2##3##(2008-11#1)(2011-2#1)
and health economic##2##3##(2007-10#1)(2011-2#1)
and health education##2##3##(1992-1#1)(2008-1#1)
and health effects of##2##4##(1992-11#1)(1992-9#1)
and health effects##4##3##(1992-11#1)(1992-9#1)(2008-11#1)(2008-7#1)
and health equity##3##3##(1996-3#1)(2010-12#1)(2011-1#1)
and health information systems##2##4##(2008-7#1)(2012-12#1)
and health information##5##3##(1993-3#1)(1996-11#1)(2008-7#1)(2012-12#2)
and health insurance coverage##2##4##(2008-11#1)(2011-2#1)
and health insurance##7##3##(1991-2#1)(1996-12#1)(1997-2#1)(2008-11#1)(2011-2#1)(2013-1#2)
and health literature##2##3##(2010-10#1)(2012-12#1)
and health management##2##3##(1993-12#2)
and health of children##2##4##(2009-5#1)(2012-12#1)
and health of low-income adults using a randomized controlled design##2##10##(2013-1#2)
and health of##6##3##(2008-11#2)(2009-5#1)(2012-12#1)(2013-1#2)
and health organizations##2##3##(1996-1#1)(1997-3#1)
and health outcomes##5##3##(1994-1#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
and health plan##3##3##(1996-3#1)(1997-2#1)(1997-3#1)
and health plans##5##3##(1996-1#1)(1996-2#3)(1997-3#1)
and health policy##5##3##(1991-12#1)(1992-1#1)(1995-2#1)(1996-3#1)(2010-9#1)
and health problems##4##3##(1990-6#1)(2011-2#2)(2012-1#1)
and health professionals##7##3##(1992-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
and health programs##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(2010-12#1)
and health promotion##9##3##(1992-1#1)(1994-1#1)(1994-11#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2010-6#1)(2013-1#1)
and health reform##4##3##(1995-2#2)(1996-12#1)(1996-9#1)
and health sector##3##3##(1997-1#1)(2008-8#1)(2010-5#1)
and health service delivery##2##4##(1996-1#1)(2008-12#1)
and health service##6##3##(1996-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-1#1)
and health services research in Canada##2##6##(1993-3#2)
and health services research##4##4##(1991-1#1)(1993-3#2)(1997-3#1)
and health services##11##3##(1990-12#1)(1990-8#1)(1991-1#1)(1992-1#1)(1993-3#2)(1994-12#1)(1997-3#2)(2008-1#1)(2010-1#1)
and health status##9##3##(1994-3#1)(1996-3#1)(2008-1#1)(2010-2#4)(2011-1#1)(2013-1#1)
and health system reform##2##4##(1996-12#1)(2012-12#1)
and health system##7##3##(1996-12#1)(2008-1#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
and health systems##7##3##(1997-3#1)(2008-11#3)(2010-8#1)(2011-1#1)(2012-12#1)
and health technology assessment##2##4##(2012-12#2)
and health workers##2##3##(2010-1#1)(2010-8#1)
and health##313##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#4)(1991-3#4)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#7)(1993-2#3)(1993-3#4)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#4)(1994-3#5)(1994-6#3)(1995-1#2)(1995-12#4)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#11)(1996-3#9)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#9)(1997-6#1)(1997-8#1)(2007-10#2)(2007-2#2)(2007-7#1)(2008-1#11)(2008-10#5)(2008-11#16)(2008-12#5)(2008-2#1)(2008-4#1)(2008-7#12)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#8)(2009-7#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#19)(2012-1#2)(2012-12#14)(2012-2#3)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#11)
and health-care##4##2##(1993-2#1)(2008-1#1)(2008-4#1)(2011-1#1)
and health-related quality of life in##3##6##(2009-3#1)(2011-1#1)(2013-8#1)
and health-related quality of life##4##5##(2009-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
and health-related##7##2##(2008-7#1)(2009-3#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
and health-seeking behavior##2##3##(2012-12#2)
and health]##6##2##(1990-12#1)(1990-3#1)(1991-6#1)(1993-6#1)(1995-8#1)(1997-4#1)
and healthcare needs##2##3##(2008-4#2)
and healthcare providers##4##3##(1995-1#1)(1997-5#1)(2008-11#1)(2013-8#1)
and healthcare##22##2##(1994-12#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and healthspan##2##2##(2012-2#2)
and healthy control groups were##2##5##(2011-1#2)
and healthy control##5##3##(1990-12#1)(2008-12#1)(2011-1#3)
and healthy controls##10##3##(1990-8#1)(1992-12#1)(1996-5#1)(2007-1#1)(2007-2#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
and healthy leaf area absorption##2##5##(2008-10#2)
and healthy peach seedlings##2##4##(2008-10#2)
and healthy skin##2##3##(2008-5#2)
and healthy subjects##6##3##(1994-1#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
and healthy volunteers##3##3##(1996-7#1)(2008-5#1)(2013-1#1)
and healthy women##2##3##(2010-9#1)(2013-1#1)
and healthy##61##2##(1990-12#1)(1990-8#1)(1991-11#1)(1992-12#1)(1994-1#1)(1996-1#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-1#1)(2007-2#2)(2008-10#11)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2009-4#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
and hearing and equilibrium impairments##3##5##(2011-2#3)
and hearing##10##2##(2008-9#3)(2011-1#1)(2011-2#4)(2012-2#2)
and heart and##2##3##(1990-11#1)(1994-3#1)
and heart disease##6##3##(1991-3#1)(2008-3#1)(2008-8#1)(2009-6#1)(2013-7#1)(2013-8#1)
and heart failure##15##3##(1993-2#1)(1995-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-2#1)(2011-1#1)(2011-2#4)(2012-3#2)
and heart rate (HR)##5##4##(1990-5#1)(1991-2#1)(2008-11#2)(2013-8#1)
and heart rate were##2##4##(1994-5#1)(2008-5#1)
and heart rate##17##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1994-5#1)(1995-12#3)(2008-11#2)(2008-5#3)(2012-12#1)(2013-8#1)
and heart##71##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-11#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-5#1)(1995-12#3)(1995-3#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
and heat capacity##4##3##(1997-2#1)(2008-3#2)(2013-1#1)
and heat shock protein##2##4##(1996-9#1)(2008-11#1)
and heat shock proteins##3##4##(1990-11#1)(1993-8#1)(1996-9#1)
and heat shock##7##3##(1990-11#1)(1993-8#2)(1996-9#2)(1997-4#1)(2008-11#1)
and heat stress##3##3##(1991-12#2)(2012-2#1)
and heat##37##2##(1990-11#1)(1990-12#1)(1991-12#2)(1992-2#1)(1993-8#2)(1994-11#1)(1995-5#1)(1996-12#3)(1996-6#1)(1996-9#2)(1997-2#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2010-11#1)(2012-2#3)(2013-1#2)
and heat-treated##2##2##(2008-11#1)(2010-4#1)
and heated##6##2##(2008-10#4)(2010-9#2)
and heating time##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
and heating##14##2##(1990-2#2)(1997-4#1)(2007-12#1)(2008-10#7)(2008-2#1)(2009-11#1)(2013-1#1)
and heavier##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
and heavily##3##2##(1992-8#1)(1997-5#1)(2008-2#1)
and heavy metal ions##12##4##(2008-10#12)
and heavy metal##16##3##(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#2)
and heavy metals in##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
and heavy metals##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)
and heavy##30##2##(1993-3#1)(1993-8#1)(1994-6#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-7#2)
and height of##7##3##(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and height##16##2##(1993-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)
and heightened##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
and held##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2012-2#1)
and helical##3##2##(1991-11#1)(1995-2#1)(2009-8#1)
and helium##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
and helminths##2##2##(2008-9#1)(2013-1#1)
and help in##2##3##(2008-7#1)(2012-12#1)
and help students##2##3##(2008-11#1)(2009-12#1)
and help to predict##2##4##(2008-11#1)(2011-2#1)
and help to##8##3##(2008-11#2)(2008-2#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
and help##32##2##(1991-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and helped##3##2##(2008-12#1)(2010-8#1)(2011-2#1)
and helper T##2##3##(2012-3#1)(2013-1#1)
and helper##4##2##(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
and helping them##2##3##(1993-12#1)(2008-11#1)
and helping##6##2##(1993-12#1)(2008-11#2)(2008-8#1)(2010-7#1)(2011-2#1)
and helps to##5##3##(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
and helps##9##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and hematocrit##7##2##(1993-2#1)(1996-3#1)(2006-10#1)(2008-1#2)(2008-8#1)(2010-2#1)
and hematologic##3##2##(1990-12#1)(1997-3#1)(2012-12#1)
and hematological##4##2##(2007-2#1)(2008-5#1)(2010-5#2)
and hematopoietic stem##2##3##(2008-11#1)(2012-12#1)
and hematopoietic##4##2##(2008-11#1)(2012-12#2)(2012-2#1)
and hematoporphyrin##2##2##(1992-6#1)(2008-8#1)
and hematuria##5##2##(2008-1#2)(2008-10#2)(2011-2#1)
and heme##2##2##(1992-12#1)(2013-1#1)
and hemianopia##2##2##(2009-2#2)
and hemicellulose##2##2##(2008-6#1)(2011-2#1)
and hemin##4##2##(1991-9#1)(1994-5#1)(2008-10#1)(2008-9#1)
and hemispheric##3##2##(1996-7#1)(2008-1#1)(2009-2#1)
and hemocoagulative##2##2##(2008-7#2)
and hemodialysis##4##2##(2008-1#1)(2008-4#1)(2011-2#2)
and hemodynamic factors##2##3##(2011-2#1)(2012-3#1)
and hemodynamic##14##2##(2007-8#1)(2008-10#1)(2010-6#3)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
and hemodynamics##4##2##(2007-10#1)(2009-9#1)(2010-5#1)(2013-1#1)
and hemoglobin concentration##2##3##(2008-3#1)(2008-9#1)
and hemoglobin were not significantly##2##5##(2011-2#1)(2013-1#1)
and hemoglobin were##5##3##(2007-11#1)(2008-1#1)(2009-12#1)(2011-2#1)(2013-1#1)
and hemoglobin##23##2##(1990-9#1)(1992-9#1)(1994-11#3)(1994-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-5#1)(2013-1#2)
and hemolymph of##3##3##(1995-11#1)(2008-10#2)
and hemolymph##4##2##(1995-11#2)(2008-10#2)
and hemolytic anemia##2##3##(1991-2#1)(1996-3#1)
and hemolytic##6##2##(1991-2#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-5#1)
and hemoptysis##3##2##(2007-8#2)(2008-5#1)
and hemorheological##2##2##(2008-7#1)(2008-9#1)
and hemorrhage##6##2##(1992-2#1)(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
and hemorrhagic##7##2##(1994-8#1)(2007-10#1)(2008-5#1)(2010-6#3)(2013-1#1)
and hemostasis##3##2##(1991-6#1)(2010-8#1)(2011-2#1)
and hence a##4##3##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
and hence could##2##3##(1993-2#1)(1994-9#1)
and hence eliminated##2##3##(2008-10#2)
and hence for##2##3##(1990-7#1)(2008-3#1)
and hence is##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
and hence it##4##3##(1997-1#1)(2008-10#3)
and hence may##3##3##(1997-9#1)(2008-3#1)(2011-1#1)
and hence offers much more information than can be obtained by studying only an isolated protein##2##16##(2008-2#1)(2008-4#1)
and hence offers##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
and hence the##17##3##(1993-11#1)(1996-12#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)
and hence there is##3##4##(2007-7#1)(2008-10#1)(2013-1#1)
and hence this##2##3##(1990-12#1)(2007-7#1)
and hence to the##4##4##(2008-10#2)(2008-3#2)
and hence to##9##3##(2008-10#3)(2008-2#2)(2008-3#4)
and hence were##2##3##(2008-10#1)(2013-8#1)
and hence##115##2##(1990-12#2)(1990-7#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-9#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-9#1)(2007-11#5)(2007-12#4)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#8)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
and heparan sulfate##2##3##(1992-11#1)(1995-6#1)
and heparin##3##2##(1997-4#1)(2007-5#1)(2008-5#1)
and hepatic gene##2##3##(1997-4#1)(2008-10#1)
and hepatic insufficiency##2##3##(2006-10#2)
and hepatic lipid profiles##2##4##(2008-10#2)
and hepatic microsomal##2##3##(1994-8#1)(2008-8#1)
and hepatic profiles##2##3##(2008-1#1)(2008-3#1)
and hepatic##33##2##(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1997-4#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#5)(2011-2#2)(2013-8#2)
and hepatitis B surface##2##4##(2007-7#1)(2009-4#1)
and hepatitis B virus##2##4##(2008-10#1)(2009-5#1)
and hepatitis B##9##3##(1991-6#1)(1995-2#1)(2007-2#2)(2007-7#1)(2008-10#1)(2009-4#2)(2009-5#1)
and hepatitis C virus (HCV)##2##5##(2008-10#1)(2013-8#1)
and hepatitis C virus##8##4##(1994-7#1)(1996-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2013-8#1)
and hepatitis C##13##3##(1990-9#1)(1994-7#1)(1996-9#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#2)(2009-7#1)(2013-8#1)
and hepatitis##28##2##(1990-9#1)(1991-6#1)(1994-7#1)(1995-2#1)(1996-9#1)(1997-3#1)(2007-12#4)(2007-2#2)(2007-7#4)(2008-1#3)(2008-10#3)(2008-6#1)(2009-4#2)(2009-5#1)(2009-7#1)(2013-8#1)
and hepatobiliary disease##2##3##(2010-6#1)(2012-3#1)
and hepatobiliary##3##2##(1990-3#1)(2010-6#1)(2012-3#1)
and hepatocellular carcinoma##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
and hepatocellular##4##2##(1990-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
and hepatocyte##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
and her condition##2##3##(1995-12#1)(2011-2#1)
and her##28##2##(1990-12#1)(1990-3#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
and her-2/neu protein markers##2##4##(2008-10#2)
and herbaceous##2##2##(2008-6#1)(2012-6#1)
and herbal medicine##2##3##(2012-3#2)
and herbal##8##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)(2012-3#2)(2013-1#1)
and herbalism##2##2##(1997-6#2)
and herbarium##3##2##(2008-10#3)
and herbivores##4##2##(2008-8#2)(2008-9#1)(2009-4#1)
and herbs##2##2##(2009-11#1)(2013-1#1)
and herd##2##2##(1992-5#2)
and here we##3##3##(2008-11#1)(2009-7#1)(2010-12#1)
and here##7##2##(1994-11#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-12#1)
and hereditary##5##2##(2007-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
and heritability of##2##3##(2008-10#1)(2008-8#1)
and heritable##2##2##(2008-7#1)(2009-4#1)
and herpes simplex virus##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and herpes##4##2##(1990-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
and heterochromatic##2##2##(2008-2#1)(2009-10#1)
and heterochromatin##2##2##(2008-5#1)(2008-7#1)
and heterocyclic##3##2##(1992-6#1)(1995-3#1)(2009-12#1)
and heterodimer##2##2##(1993-11#2)
and heterodyne##5##2##(2007-11#1)(2007-12#4)
and heterogeneity of the##2##4##(2009-7#1)(2012-1#1)
and heterogeneity of##3##3##(2008-10#1)(2009-7#1)(2012-1#1)
and heterogeneity##8##2##(2008-10#3)(2008-11#2)(2008-8#1)(2009-7#1)(2012-1#1)
and heterogeneous group of##2##4##(2012-2#1)(2012-3#1)
and heterogeneous##13##2##(2007-5#1)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
and heterologous##4##2##(1990-2#1)(1997-2#1)(2008-5#1)(2008-8#1)
and heteromeric receptors##2##3##(1995-11#2)
and heteromeric##4##2##(1995-11#4)
and heteromorphic##2##2##(2008-9#1)(2010-3#1)
and heteronuclear##3##2##(1990-5#1)(1992-4#1)(1993-11#1)
and heterosexual##2##2##(1992-9#2)
and heterosynaptic long-term depression##2##4##(2009-8#2)
and heterosynaptic##3##2##(2009-8#3)
and heterotic gene expression##2##4##(2009-10#2)
and heterozygosity##2##2##(2009-5#2)
and heterozygous##3##2##(1990-8#1)(1992-6#1)(1996-5#1)
and hexadecanoic acid##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
and hexagonal##2##2##(2007-12#1)(2008-3#1)
and hexahydro-1##2##2##(2008-10#1)(2008-3#1)
and hexane##2##2##(2008-10#2)
and hexokinase##3##2##(1990-11#2)(1991-5#1)
and hibernating##3##2##(2008-7#1)(2008-8#2)
and hidden##4##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
and hierarchical##4##2##(1995-2#1)(2008-10#1)(2010-5#1)(2010-7#1)
and high PWV were##2##4##(2007-10#2)
and high accuracy##2##3##(2008-10#1)(2008-3#1)
and high concentration of##2##4##(2008-12#1)(2012-3#1)
and high concentrations of##3##4##(1990-5#1)(2007-5#1)(2008-8#1)
and high concentrations##4##3##(1990-5#1)(2007-5#1)(2008-11#1)(2008-8#1)
and high costs##2##3##(2008-8#1)(2011-2#1)
and high density lipoprotein##2##4##(1991-11#1)(2008-3#1)
and high density##3##3##(1991-11#1)(2008-10#1)(2008-3#1)
and high dependency##2##3##(2006-10#1)(2008-11#1)
and high dose##8##3##(1994-8#1)(2007-11#1)(2008-11#1)(2008-7#2)(2010-11#1)(2013-1#2)
and high doses##2##3##(1997-2#1)(1997-7#1)
and high efficiency##2##3##(2008-10#1)(2008-3#1)
and high frequency##2##3##(1996-12#1)(2010-12#1)
and high genetic##2##3##(2008-8#1)(2013-8#1)
and high humidity##2##3##(2010-4#1)(2013-8#1)
and high level of##2##4##(2011-1#1)(2012-2#1)
and high level##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
and high levels of##5##4##(1996-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)
and high levels##6##3##(1995-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)
and high mobility##2##3##(1994-9#1)(2008-10#1)
and high molecular weight##3##4##(1990-12#2)(2008-5#1)
and high mortality##6##3##(1990-12#1)(1994-7#1)(1996-2#1)(2008-1#1)(2008-7#1)(2013-1#1)
and high multiplicity##2##3##(1995-12#1)(2008-9#1)
and high pH##3##3##(1991-9#1)(2008-10#1)(2009-12#1)
and high performance liquid chromatographic##2##5##(2008-10#2)
and high performance liquid chromatography (HPLC)##2##6##(1997-2#1)(2008-10#1)
and high performance liquid chromatography##5##5##(1994-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)
and high performance liquid##8##4##(1990-5#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)
and high performance##9##3##(1990-5#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)(2012-3#1)
and high plasma digoxin level in the elderly (p &lt##2##10##(1994-6#2)
and high plasma digoxin level in##3##6##(1994-6#3)
and high plasma digoxin level##4##5##(1994-6#4)
and high precision##2##3##(2008-3#1)(2009-7#1)
and high pressure##4##3##(1997-6#1)(1997-7#1)(2008-10#1)(2011-1#1)
and high pressures##2##3##(1996-12#1)(2008-10#1)
and high prevalence of##2##4##(2007-7#1)(2011-2#1)
and high pulse##2##3##(2008-3#1)(2010-1#1)
and high purity##2##3##(2008-10#1)(2008-9#1)
and high quality##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
and high quantum yield##2##4##(2008-10#1)(2008-9#1)
and high reproducibility##2##3##(2008-10#2)
and high resolution##7##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
and high salt##2##3##(1995-5#1)(2008-8#1)
and high sample throughput##2##4##(2008-10#2)
and high sampling rate##2##4##(2008-10#1)(2008-3#1)
and high school financial education##2##5##(2010-10#2)
and high school##5##3##(1990-6#1)(2009-7#2)(2010-10#2)
and high selectivity##7##3##(2008-10#7)
and high sensitivity##10##3##(1997-3#1)(2007-11#1)(2008-10#7)(2013-1#1)
and high spatial resolution##3##4##(2007-11#1)(2007-12#1)(2008-8#1)
and high specificity##3##3##(1993-8#1)(1997-3#1)(2011-1#1)
and high strength##3##3##(2009-6#1)(2013-1#2)
and high temperature##3##3##(1995-6#1)(2008-12#1)(2008-8#1)
and high temperatures##4##3##(2008-10#2)(2008-2#1)(2009-5#1)
and high titer##2##3##(1991-8#1)(2008-11#1)
and high voltage##2##3##(1991-9#1)(2008-11#1)
and high yield##2##3##(1995-12#1)(2008-9#1)
and high##322##2##(1990-12#4)(1990-3#1)(1990-5#2)(1990-6#2)(1991-11#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#4)(2006-10#1)(2007-10#3)(2007-11#8)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#76)(2008-11#11)(2008-12#8)(2008-2#9)(2008-3#17)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#7)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-4#6)(2010-8#2)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#14)(2013-7#1)(2013-8#5)
and high)##2##2##(1992-3#1)(2012-3#1)
and high-density lipoprotein##4##3##(2008-12#1)(2008-3#1)(2008-6#1)(2013-8#1)
and high-density##9##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#1)
and high-dose inhaled corticosteroid##3##4##(2008-1#3)
and high-dose##6##2##(1992-6#1)(1996-11#1)(2008-1#3)(2012-12#1)
and high-frequency##3##2##(2008-2#1)(2008-3#2)
and high-level expression##2##3##(1994-12#1)(2008-4#1)
and high-level##4##2##(1994-1#1)(1994-12#1)(2008-4#1)(2013-1#1)
and high-numerical-aperture##2##2##(2008-2#1)(2008-3#1)
and high-performance liquid chromatography##8##4##(1991-5#2)(1994-3#1)(1996-5#1)(1997-2#1)(2008-10#3)
and high-performance liquid##9##3##(1991-5#2)(1994-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#3)
and high-performance##12##2##(1991-5#2)(1994-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-4#1)(2011-2#2)
and high-quality##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
and high-resolution##6##2##(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
and high-risk##7##2##(1991-8#1)(1992-10#1)(1994-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
and high-sensitivity##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-5#1)
and high-speed##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
and high-throughput screening (HTS)##2##4##(2008-10#1)(2008-9#1)
and high-throughput screening##3##3##(2008-10#2)(2008-9#1)
and high-throughput##11##2##(2008-10#3)(2008-2#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
and higher cell##2##3##(2008-11#1)(2008-5#1)
and higher concentrations##3##3##(1994-11#1)(2007-12#1)(2008-12#1)
and higher education institutions##2##4##(2008-12#2)
and higher education##7##3##(1991-1#2)(2008-12#4)(2013-1#1)
and higher for##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
and higher functional##3##3##(2008-9#1)(2009-9#1)(2013-1#1)
and higher level of##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
and higher level##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
and higher levels of##11##4##(2007-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#4)(2009-7#1)(2013-1#1)
and higher levels##13##3##(1995-12#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#4)(2009-7#1)(2013-1#1)
and higher order##3##3##(2008-11#2)(2008-4#1)
and higher percentage of##2##4##(2009-9#1)(2013-8#1)
and higher quality##2##3##(2008-11#1)(2011-1#1)
and higher than the##2##4##(2008-3#1)(2010-8#1)
and higher than##5##3##(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
and higher##140##2##(1990-11#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#8)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#5)(2009-5#5)(2009-7#3)(2009-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#4)
and higher-order##6##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)
and highest in##2##3##(2007-10#1)(2008-11#1)
and highest##12##2##(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2009-8#1)(2011-2#3)
and highlight recent##2##3##(1992-12#1)(2009-12#1)
and highlight some##3##3##(1995-3#1)(2012-3#1)(2013-1#1)
and highlight the importance of##2##5##(2008-8#1)(2012-3#1)
and highlight the need for##2##5##(2008-9#1)(2013-1#1)
and highlight the role of##2##5##(2009-9#1)(2013-1#1)
and highlight the##18##3##(1992-3#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
and highlight their##2##3##(2007-7#1)(2013-1#1)
and highlight##38##2##(1992-12#1)(1992-3#2)(1993-3#1)(1995-11#1)(1995-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
and highlighted the##2##3##(1996-2#1)(2008-11#1)
and highlighted##3##2##(1996-2#1)(2008-11#1)(2011-2#1)
and highlighting##2##2##(2013-1#1)(2013-8#1)
and highlights some of##2##4##(1991-3#1)(1992-3#1)
and highlights some##3##3##(1991-3#1)(1992-3#1)(2008-6#1)
and highlights the importance of##2##5##(2008-6#1)(2012-2#1)
and highlights the##15##3##(1990-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
and highlights##30##2##(1990-6#1)(1991-3#1)(1992-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-11#1)(2009-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and highly effective##3##3##(1997-4#1)(2008-11#1)(2013-1#1)
and highly efficient##6##3##(1994-5#1)(2007-6#1)(2008-7#1)(2008-9#2)(2012-1#1)
and highly reproducible##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
and highly selective##8##3##(1991-12#1)(2008-10#7)
and highly sensitive##16##3##(1991-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-12#1)(2009-7#1)(2012-2#1)(2012-3#1)
and highly significant##2##3##(2008-10#1)(2010-3#1)
and highly specific##4##3##(1997-2#1)(2008-10#2)(2008-5#1)
and highly variable##2##3##(1995-8#1)(2013-7#1)
and highly virulent##2##3##(2008-10#2)
and highly##102##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#2)(2008-10#29)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
and hilar##2##2##(1996-1#1)(1997-8#1)
and hinder##3##2##(1995-3#1)(2008-10#2)
and hip circumference##3##3##(2011-2#2)(2013-1#1)
and hip##13##2##(1997-8#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#3)(2013-1#2)
and hippocampal formation##2##3##(1996-12#1)(1997-4#1)
and hippocampal##18##2##(1992-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-2#3)(1995-12#1)(1996-12#2)(1997-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-7#1)(2013-8#2)
and hippocampus and##2##3##(1994-2#1)(1997-2#1)
and hippocampus in##2##3##(1994-6#1)(1995-5#1)
and hippocampus of##5##3##(1993-3#1)(1995-12#3)(2013-1#1)
and hippocampus##26##2##(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-6#2)(1995-12#5)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#2)
and his colleagues##2##3##(1992-9#1)(2008-9#1)
and his contribution to##2##4##(2007-5#1)(2013-1#1)
and his emotional##2##3##(1991-6#1)(1996-3#1)
and his or her##2##4##(1992-12#1)(2008-12#1)
and his##54##2##(1990-11#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and his4##2##2##(2008-10#2)
and histamine in##2##3##(1994-2#1)(1995-12#1)
and histamine release##2##3##(2008-4#1)(2009-12#1)
and histamine##11##2##(1990-7#1)(1994-2#3)(1995-12#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2013-7#2)
and histochemical assays##2##3##(1996-12#1)(2008-10#1)
and histochemical methods##2##3##(1991-1#1)(1997-2#1)
and histochemical##7##2##(1991-1#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-7#1)
and histologic findings##2##3##(2006-12#1)(2008-1#1)
and histologic type##2##3##(1990-12#1)(1991-8#1)
and histologic##15##2##(1990-12#2)(1991-2#1)(1991-8#1)(1992-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#2)(2010-3#1)(2013-7#1)
and histological analysis##4##3##(1996-6#1)(2008-5#1)(2010-7#1)(2013-7#1)
and histological aspects##2##3##(2012-2#1)(2013-1#1)
and histological differentiation##2##3##(2008-9#1)(2011-2#1)
and histological examination##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
and histological features of##3##4##(2008-7#1)(2010-8#1)(2012-3#1)
and histological features##8##3##(1991-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-3#1)
and histological findings in##2##4##(1991-3#1)(2008-5#1)
and histological findings##6##3##(1991-3#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-1#1)
and histological methods##2##3##(2007-12#1)(2008-4#1)
and histological study##2##3##(2009-6#1)(2011-2#1)
and histological techniques##2##3##(2008-10#1)(2013-8#1)
and histological##52##2##(1990-6#1)(1991-11#2)(1991-3#1)(1991-8#1)(1993-12#1)(1994-9#1)(1996-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#2)
and histologically##11##2##(1991-9#1)(1995-2#1)(1995-4#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
and histology##9##2##(1992-8#1)(1996-5#3)(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2011-2#1)
and histomorphological##2##2##(1994-5#1)(2007-8#1)
and histomorphometric##2##2##(2008-5#1)(2013-8#1)
and histone deacetylase##2##3##(2008-7#1)(2011-2#1)
and histone degradation##2##3##(1992-8#2)
and histone##13##2##(1990-5#1)(1992-6#2)(1992-8#2)(1994-11#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-4#1)(2011-2#1)
and histones##2##2##(1994-9#1)(2008-4#1)
and histopathologic findings of##2##4##(2006-10#2)
and histopathologic findings##3##3##(2006-10#2)(2007-10#1)
and histopathologic##7##2##(2006-10#2)(2007-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
and histopathological examination##3##3##(2012-2#1)(2013-1#2)
and histopathological features##2##3##(2008-1#1)(2008-7#1)
and histopathological findings in##3##4##(1996-12#1)(2011-2#1)(2013-1#1)
and histopathological findings##12##3##(1996-12#3)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#2)(2013-1#1)
and histopathological lesions##3##3##(1997-6#1)(2008-5#1)(2009-11#1)
and histopathological study in##2##4##(1991-3#1)(2007-7#1)
and histopathological##34##2##(1990-2#1)(1991-3#1)(1996-12#3)(1996-3#1)(1997-6#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#5)(2012-2#1)(2013-1#3)
and histopathologically##2##2##(2007-12#1)(2009-10#1)
and histopathology of##2##3##(2008-10#1)(2012-12#1)
and histopathology study##2##3##(2008-5#2)
and histopathology##14##2##(1994-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#2)(2011-2#3)(2012-12#1)(2012-2#2)
and historical##5##2##(1996-2#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-3#1)
and history of the##2##4##(2008-11#1)(2009-11#1)
and history of##13##3##(1996-3#1)(2007-8#3)(2008-11#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and history##15##2##(1996-3#1)(1997-8#1)(2007-8#3)(2008-11#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and hoarseness##4##2##(1990-12#1)(2007-8#1)(2012-2#1)(2013-7#1)
and hold##8##2##(2007-11#1)(2008-10#1)(2008-6#4)(2008-7#1)(2008-9#1)
and holding##3##2##(1997-1#1)(2008-10#1)(2008-5#1)
and holes##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
and holistic##2##2##(2008-11#1)(2009-8#1)
and hollow##2##2##(2007-12#1)(2008-3#1)
and holometabolous##2##2##(2007-12#1)(2012-2#1)
and holy basil##2##3##(2008-5#2)
and home care##5##3##(1993-12#1)(1993-2#1)(1994-8#1)(2011-2#2)
and home health##2##3##(1994-2#1)(1997-2#1)
and home##12##2##(1993-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2009-6#1)(2010-8#1)(2011-2#2)
and homeostasis##5##2##(1996-2#1)(2008-5#1)(2012-2#1)(2012-5#1)(2013-1#1)
and homeostatic##2##2##(1990-12#1)(2008-8#1)
and homicide##2##2##(1992-2#1)(2008-12#1)
and homocysteine##2##2##(1991-12#1)(2008-8#1)
and homogeneous##10##2##(1992-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#2)(2013-7#1)
and homogenized##2##2##(2008-10#2)
and homogenous##2##2##(2007-8#1)(2008-12#1)
and homologous##6##2##(1991-12#1)(1994-8#2)(1995-11#1)(2008-4#1)(2008-9#1)
and homology##4##2##(1990-7#1)(1993-11#1)(2008-8#1)(2009-6#1)
and homosexuals##2##2##(1990-9#1)(2008-5#1)
and homovanillic acid (HVA)##2##4##(1995-3#1)(2008-3#1)
and honesty in##2##3##(1995-5#1)(2008-9#1)
and honeydew##2##2##(2008-10#1)(2011-2#1)
and honor##2##2##(1997-3#1)(2008-11#1)
and hope##3##2##(1993-2#1)(2008-11#1)(2008-12#1)
and hopes##2##2##(1991-11#1)(2008-10#1)
and horizontal##15##2##(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
and horizontally##5##2##(1994-1#1)(2008-1#2)(2008-2#1)(2008-3#1)
and hormesis##3##2##(1996-6#1)(2008-7#2)
and hormonal regulation##2##3##(1992-3#1)(1995-11#1)
and hormonal responses to##4##4##(1991-8#1)(1994-12#1)(2008-3#1)(2008-4#1)
and hormonal responses##5##3##(1991-8#1)(1994-12#2)(2008-3#1)(2008-4#1)
and hormonal##20##2##(1991-8#1)(1992-3#1)(1994-12#2)(1995-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#2)(2013-7#2)
and hormonally##3##2##(1990-7#1)(1995-2#1)(2008-10#1)
and hormone signals##2##3##(2009-8#2)
and hormone##14##2##(1992-8#1)(1993-11#1)(1993-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-7#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#3)
and hormones##14##2##(1992-8#1)(1995-11#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-3#1)
and horse heart##2##3##(1992-3#1)(2008-7#1)
and horse##8##2##(1990-5#1)(1992-3#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-4#2)
and horse-radish peroxidase##5##3##(2008-10#5)
and horseradish peroxidase (HRP) as##2##5##(1995-12#1)(2008-10#1)
and horseradish peroxidase (HRP) were immobilized##2##6##(2008-10#2)
and horseradish peroxidase (HRP) were##3##5##(2008-10#3)
and horseradish peroxidase (HRP)##8##4##(1995-12#1)(2008-10#6)(2010-5#1)
and horseradish peroxidase##14##3##(1995-12#1)(2007-12#1)(2008-10#11)(2010-5#1)
and horticultural crops##2##3##(2008-10#2)
and horticultural workers##2##3##(2008-12#2)
and horticultural##5##2##(2008-10#3)(2008-12#2)
and hospital care##4##3##(1993-3#1)(2012-1#1)(2013-1#2)
and hospital competition##2##3##(2008-11#2)
and hospital outpatient##2##3##(1990-6#1)(1992-1#1)
and hospital physicians##2##3##(1996-9#2)
and hospital profitability##2##3##(2008-11#2)
and hospital resource use##2##4##(1994-3#1)(1995-3#1)
and hospital security##2##3##(1991-12#1)(1992-2#1)
and hospital stay##4##3##(2007-8#3)(2013-1#1)
and hospital##55##2##(1990-12#1)(1990-6#2)(1991-1#3)(1991-12#2)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-9#3)(2007-8#3)(2008-11#9)(2008-7#1)(2009-10#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
and hospital-based##2##2##(1990-9#1)(1993-1#1)
and hospitalization for##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
and hospitalization##10##2##(1993-1#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
and hospitalizations for##2##3##(2010-8#1)(2011-2#1)
and hospitalizations##4##2##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
and hospitals##24##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#3)(1994-12#1)(1996-12#1)(1996-2#2)(1997-5#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
and host cells##2##3##(2007-10#1)(2008-10#1)
and host colonization was##2##4##(2008-10#2)
and host colonization##3##3##(2008-10#3)
and host encounter##3##3##(2008-9#3)
and host factors##3##3##(2008-10#1)(2008-9#1)(2010-6#1)
and host in##2##3##(2009-2#1)(2011-1#1)
and host range studies##2##4##(2008-10#1)(2010-10#1)
and host range##4##3##(2008-10#3)(2010-10#1)
and host resistance##6##3##(2008-10#4)(2008-8#2)
and host##52##2##(1995-3#1)(2006-10#1)(2007-10#1)(2008-10#28)(2008-8#5)(2008-9#7)(2009-2#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)
and hostility##4##2##(2008-4#3)(2010-7#1)
and hosts##2##2##(2008-4#1)(2010-12#1)
and hot air oven treatments##2##5##(2008-12#2)
and hot##10##2##(1994-3#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
and hot-spring water##2##3##(2008-10#2)
and hours##3##2##(2008-10#2)(2013-1#1)
and house finches##2##3##(2008-8#2)
and house##4##2##(1996-6#1)(2008-10#1)(2008-8#2)
and housing##2##2##(2008-7#1)(2009-7#1)
and how a##4##3##(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
and how best to##3##4##(2006-10#1)(2009-9#1)(2013-1#1)
and how can##2##3##(1997-1#2)
and how different##2##3##(1997-3#1)(2008-10#1)
and how it can be##2##5##(1996-2#1)(2008-2#1)
and how it can##3##4##(1996-2#1)(2007-2#1)(2008-2#1)
and how it has##2##4##(1995-12#1)(2009-6#1)
and how it is##3##4##(2008-11#1)(2008-9#1)(2013-8#1)
and how it may##2##4##(2009-7#1)(2010-3#1)
and how it should be maintained as required to obtain maximum image-forming capacity and resolution##3##15##(2008-4#2)(2008-9#1)
and how it was##4##4##(1992-2#1)(1992-6#1)(2010-3#1)(2011-1#1)
and how it##24##3##(1992-2#1)(1992-6#1)(1993-3#2)(1994-1#1)(1995-12#1)(1996-2#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-3#2)(2010-8#1)(2011-1#1)(2013-8#2)
and how many##2##3##(2007-12#1)(2008-4#1)
and how much##2##3##(1994-3#1)(2010-12#1)
and how postwar psychological adjustment and health mediated the effects of postwar appraisals##2##13##(2013-1#2)
and how rapidly##3##3##(1997-7#1)(2008-10#1)(2011-2#1)
and how such changes##2##4##(1994-1#1)(2008-5#1)
and how such##4##3##(1992-1#1)(1993-2#1)(1994-1#1)(2008-5#1)
and how the##13##3##(1994-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#2)
and how their##5##3##(1991-1#1)(1996-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
and how these relationships##2##4##(1996-2#1)(2008-8#1)
and how these##16##3##(1996-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and how they affect##2##4##(1996-3#1)(2010-3#1)
and how they are##6##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-2#1)
and how they can be##2##5##(1997-2#1)(2010-12#1)
and how they have##2##4##(1996-12#1)(2008-7#1)
and how they interact with##2##5##(2008-8#1)(2009-10#1)
and how they interact##3##4##(2008-8#1)(2009-10#1)(2010-5#1)
and how they may##2##4##(2008-3#1)(2008-7#1)
and how they perceive their own and their##2##8##(2012-3#2)
and how they##33##3##(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
and how this information is##2##5##(2007-12#1)(2010-5#1)
and how this##17##3##(1996-2#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
and how to analyze##2##4##(2008-4#2)
and how to avoid##2##4##(1997-2#1)(1997-3#1)
and how to initiate##2##4##(1991-6#1)(2008-6#1)
and how to make##2##4##(2009-10#1)(2012-2#1)
and how to relate##2##4##(1997-2#1)(2008-12#1)
and how to treat##2##4##(1992-8#1)(1996-3#1)
and how to##42##3##(1990-3#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-2#3)(1997-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
and how well##2##3##(1996-12#1)(2008-11#1)
and how##252##2##(1990-3#2)(1991-1#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#4)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#6)(1996-6#1)(1997-1#4)(1997-2#5)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#3)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#6)(2008-11#11)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#14)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#9)(2008-9#9)(2009-1#1)(2009-10#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#3)(2010-11#3)(2010-12#7)(2010-3#4)(2010-5#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#15)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#8)(2013-8#4)
and how?]##2##2##(1991-2#1)(1992-3#1)
and hs-CRP were##2##3##(2011-2#1)(2012-5#1)
and hs-CRP##7##2##(2011-1#2)(2011-2#3)(2012-3#1)(2012-5#1)
and hsCRP levels##2##3##(2008-3#2)
and hsf1##2##2##(2012-12#2)
and huge##2##2##(2008-1#1)(2008-7#1)
and human beta##3##3##(1990-11#2)(1992-11#1)
and human breast cancer##2##4##(2011-2#2)
and human cell lines##3##4##(1997-7#1)(2008-11#2)
and human cell##5##3##(1997-7#2)(2008-11#2)(2008-9#1)
and human chorionic gonadotropin##2##4##(1993-12#1)(1995-5#1)
and human data##2##3##(2008-7#1)(2011-1#1)
and human evolution##3##3##(1996-5#2)(2008-7#1)
and human fetal##2##3##(1994-6#1)(2008-8#1)
and human fibroblasts##2##3##(1997-7#1)(2012-2#1)
and human genes##3##3##(1991-9#1)(1993-3#1)(1993-6#1)
and human hair##8##3##(2008-10#3)(2011-1#1)(2012-3#3)(2013-8#1)
and human health##5##3##(1991-12#1)(1994-3#1)(2008-11#1)(2008-7#1)(2011-1#1)
and human immunodeficiency virus infection##3##5##(1991-6#1)(1997-7#1)(2006-10#1)
and human immunodeficiency virus##6##4##(1991-6#2)(1996-4#1)(1997-7#1)(2006-10#1)(2007-7#1)
and human immunodeficiency##7##3##(1991-6#2)(1996-4#1)(1997-7#1)(2006-10#1)(2007-7#2)
and human influenza viruses in##2##5##(2013-1#2)
and human liver##4##3##(1991-5#1)(1992-8#1)(1995-2#1)(2008-11#1)
and human lung##2##3##(1995-8#1)(2013-1#1)
and human melanoma cell##3##4##(1992-2#2)(2008-8#1)
and human neutrophils##3##3##(1993-8#1)(1995-6#1)(1996-12#1)
and human papilloma##2##3##(1994-8#1)(2007-12#1)
and human peripheral blood lymphocytes##2##5##(1991-9#1)(2008-11#1)
and human resource##2##3##(1995-2#1)(2012-12#1)
and human rights##3##3##(2008-11#1)(2008-8#1)(2010-3#1)
and human sequences##2##3##(1993-6#1)(1994-11#1)
and human serum albumin (HSA)##2##5##(1997-2#1)(2008-10#1)
and human serum samples##5##4##(2008-10#5)
and human serum##18##3##(1994-6#1)(1997-2#1)(2008-10#16)
and human service##4##3##(1991-3#1)(1994-1#1)(2011-2#2)
and human skin##3##3##(1993-5#1)(2008-5#2)
and human studies##12##3##(1993-11#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-2#2)(2012-3#1)
and human tumor cell lines##3##5##(1992-8#1)(1994-5#1)(2008-7#1)
and human tumor##6##3##(1992-8#1)(1994-12#1)(1994-5#2)(2008-11#1)(2008-7#1)
and human umbilical vein endothelial cells##4##6##(1994-8#1)(2008-7#1)(2008-9#1)(2010-3#1)
and human umbilical vein endothelial##5##5##(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
and human urine by##2##4##(2008-10#2)
and human urine samples##2##4##(2008-10#2)
and human urine##6##3##(2008-10#6)
and human volunteers##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
and human##298##2##(1990-11#3)(1990-12#8)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#4)(1992-11#1)(1992-2#3)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#6)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#3)(1996-12#3)(1996-4#1)(1996-5#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#7)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#4)(2008-1#2)(2008-10#38)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#12)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#12)(2008-9#8)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-3#4)(2010-6#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#5)(2012-5#1)(2012-8#1)(2013-1#5)(2013-8#2)
and humanistic psychology##3##3##(2010-6#3)
and humanistic##4##2##(2010-6#3)(2012-3#1)
and humanitarian##2##2##(1995-2#1)(2011-2#1)
and humans are##3##3##(2008-11#1)(2012-2#2)
and humans##38##2##(1992-11#2)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#3)
and humerus##3##2##(2007-11#1)(2012-1#1)(2012-2#1)
and humic acid##4##3##(2008-10#4)
and humic substances##3##3##(2008-10#3)
and humic##11##2##(2008-10#11)
and humidity on##4##3##(2008-10#1)(2010-4#1)(2011-2#2)
and humidity##16##2##(1992-2#2)(2008-10#2)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#6)(2013-1#1)(2013-7#2)
and humoral immune responses##5##4##(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)
and humoral immune##7##3##(1995-2#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
and humoral immunity in##2##4##(2008-10#1)(2012-3#1)
and humoral immunity##5##3##(2007-7#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
and humoral responses##3##3##(1991-12#2)(2008-10#1)
and humoral##16##2##(1991-12#2)(1995-2#2)(2006-10#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#2)(2012-3#1)
and hyaluronic acid (HA)##2##4##(1996-12#1)(2010-10#1)
and hyaluronic acid##3##3##(1996-12#2)(2010-10#1)
and hybrid density functionals have MUEs of only 0##2##9##(2012-12#2)
and hybrid linear##2##3##(2008-10#2)
and hybrid##22##2##(1992-6#1)(2008-10#8)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
and hybridization of##4##3##(1993-6#1)(2008-10#2)(2008-4#1)
and hybridization with##2##3##(2008-10#2)
and hybridization##16##2##(1993-6#1)(1996-4#1)(2008-10#7)(2008-4#5)(2011-2#2)
and hybridized to##3##3##(1991-2#1)(2008-1#1)(2008-10#1)
and hybridized##4##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-5#1)
and hybridoma cells##3##3##(2008-11#3)
and hybridomas##2##2##(2008-11#2)
and hybrids##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
and hydrated##2##2##(2008-10#1)(2008-5#1)
and hydration##10##2##(1990-11#2)(1991-12#1)(1994-3#2)(1995-11#1)(2008-5#2)(2012-2#1)(2013-8#1)
and hydraulic conductance##3##3##(2009-8#3)
and hydrazine in##4##3##(2008-10#4)
and hydrazine sensor based on##2##5##(2013-1#2)
and hydrazine##11##2##(2008-10#9)(2013-1#2)
and hydride generation atomic absorption spectrometry##2##6##(2008-10#2)
and hydride generation atomic##3##4##(2008-10#3)
and hydride generation##9##3##(2008-10#9)
and hydride##15##2##(2007-11#2)(2008-10#12)(2009-7#1)
and hydrocarbon mixtures##2##3##(2008-10#1)(2008-3#1)
and hydrocarbon##3##2##(2008-10#2)(2008-3#1)
and hydrocarbons##2##2##(1992-3#1)(2008-10#1)
and hydrocephalus##5##2##(1995-5#1)(2011-2#2)(2012-2#2)
and hydrochloric acid##8##3##(1997-2#1)(2008-10#7)
and hydrochloric acids##2##3##(2008-10#2)
and hydrochloric##10##2##(1997-2#1)(2008-10#9)
and hydrocortisone##6##2##(1991-12#1)(1992-5#1)(2008-10#1)(2008-11#1)(2011-2#2)
and hydrodynamic injection##2##3##(2008-10#2)
and hydrodynamic##7##2##(2008-10#3)(2008-2#1)(2009-2#1)(2009-5#1)(2011-1#1)
and hydrofluoric acids##5##3##(2008-10#5)
and hydrogen bonding##5##3##(2008-10#5)
and hydrogen exchange##2##3##(1995-3#1)(2008-4#1)
and hydrogen ions##2##3##(2008-10#2)
and hydrogen peroxide (H(2)O(2))##3##4##(2008-10#2)(2010-5#1)
and hydrogen peroxide (H2O2)##2##4##(1990-5#1)(1997-4#1)
and hydrogen peroxide in the##2##5##(1994-8#1)(2008-10#1)
and hydrogen peroxide in##4##4##(1994-8#1)(2008-10#3)
and hydrogen peroxide##37##3##(1990-5#2)(1990-8#1)(1991-9#2)(1994-8#1)(1997-4#3)(2008-10#23)(2008-11#1)(2009-8#1)(2010-5#1)(2011-2#2)
and hydrogen sulfide##2##3##(2008-6#1)(2009-12#1)
and hydrogen##62##2##(1990-5#2)(1990-8#1)(1991-9#2)(1994-8#1)(1995-3#1)(1996-12#3)(1997-4#4)(2007-11#1)(2008-10#36)(2008-11#1)(2008-4#2)(2008-6#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#2)
and hydrogen-bonding##2##2##(2008-10#2)
and hydrogenase##2##2##(1995-5#2)
and hydrolysis of##3##3##(1993-8#1)(1994-11#1)(2008-10#1)
and hydrolysis products##2##3##(1993-11#1)(2008-10#1)
and hydrolysis reactions##2##3##(2008-7#2)
and hydrolysis##10##2##(1993-11#1)(1993-8#1)(1994-11#1)(2008-10#3)(2008-5#1)(2008-7#3)
and hydrolytic degradation##2##3##(2008-6#2)
and hydrolytic##4##2##(1990-10#1)(2008-10#1)(2008-6#2)
and hydrolyzed##2##2##(2008-6#1)(2013-1#1)
and hydromorphone##2##2##(2008-7#1)(2012-3#1)
and hydrophilic##8##2##(1990-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#2)
and hydrophobic forces##2##3##(2008-10#1)(2008-5#1)
and hydrophobic interaction chromatography##3##4##(1991-5#3)
and hydrophobic interactions between##2##4##(1990-2#1)(2008-10#1)
and hydrophobic interactions in##2##4##(1992-6#1)(2008-5#1)
and hydrophobic interactions##4##3##(1990-2#1)(1992-6#1)(2008-10#1)(2008-5#1)
and hydrophobic##20##2##(1990-2#1)(1991-5#3)(1992-11#1)(1992-6#2)(2008-10#3)(2008-4#1)(2008-5#2)(2009-9#1)(2010-10#3)(2012-1#1)(2012-2#1)(2013-1#1)
and hydrophobicity##4##2##(1995-5#1)(2008-5#1)(2013-1#1)(2013-8#1)
and hydroquinone##3##2##(2008-10#3)
and hydrostatic pressure##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
and hydrothermal##2##2##(2008-10#1)(2013-1#1)
and hydroxyapatite##4##2##(1990-5#1)(1994-3#1)(2008-11#1)(2011-2#1)
and hydroxyethyl##2##2##(2008-5#1)(2012-1#1)
and hydroxyl radical##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
and hydroxyl##4##2##(2008-10#2)(2008-5#1)(2011-1#1)
and hydroxylamine hydrochloride##2##3##(2008-10#2)
and hydroxylamine##10##2##(1991-5#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#5)(2009-11#1)
and hydroxylapatite##2##2##(1990-7#1)(1994-6#1)
and hydroxylation##2##2##(1990-5#1)(2011-1#1)
and hydroxyproline##2##2##(1995-3#1)(2008-10#1)
and hydroxyurea##3##2##(1997-3#1)(2008-7#2)
and hygiene##4##2##(2007-12#1)(2007-2#1)(2009-10#1)(2013-1#1)
and hygienic##3##2##(2008-1#1)(2008-10#1)(2013-8#1)
and hygromycin resistance genes##2##4##(2008-10#2)
and hyper##2##2##(1990-10#1)(2012-3#1)
and hypercalcemia in##2##3##(1991-8#1)(2008-12#1)
and hypercalcemia of malignancy##2##4##(1990-2#1)(2010-10#1)
and hypercalcemia were##2##3##(1991-5#1)(1991-8#1)
and hypercalcemia##7##2##(1990-2#1)(1991-5#1)(1991-8#3)(2008-12#1)(2010-10#1)
and hypercholesteremic##3##2##(2008-10#3)
and hypercoagulable##2##2##(2007-10#1)(2008-3#1)
and hyperesthesia##2##2##(2012-3#1)(2013-1#1)
and hyperglycemia##9##2##(1992-8#1)(2008-1#2)(2008-3#2)(2009-11#1)(2011-1#1)(2012-12#2)
and hyperglycemic##2##2##(2009-11#1)(2010-11#1)
and hyperinsulinemia##5##2##(1990-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
and hyperkeratosis##2##2##(2008-9#2)
and hyperkeratotic##2##2##(2008-5#1)(2010-6#1)
and hyperlipidaemia##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
and hyperlipidemia etc##2##3##(2013-1#2)
and hyperlipidemia##8##2##(1994-5#1)(2007-7#2)(2008-1#1)(2008-3#1)(2009-6#1)(2013-1#2)
and hyperoside##2##2##(2008-10#1)(2009-6#1)
and hyperpigmented##3##2##(2007-7#1)(2008-5#2)
and hyperplasia of the##2##4##(2007-7#1)(2010-11#1)
and hyperplasia of##4##3##(2007-7#1)(2008-10#1)(2009-3#1)(2010-11#1)
and hyperplasia##6##2##(2007-7#1)(2008-10#1)(2008-9#2)(2009-3#1)(2010-11#1)
and hyperplastic##3##2##(1990-12#1)(1992-8#1)(2009-12#1)
and hyperprolactinemia##2##2##(2008-8#1)(2011-2#1)
and hypersensitive##4##2##(2008-10#4)
and hypersensitivity##3##2##(1995-6#1)(2007-12#1)(2008-7#1)
and hypertension are##2##3##(2008-7#1)(2013-1#1)
and hypertension##32##2##(1991-5#1)(1992-8#1)(1994-8#1)(1996-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
and hypertensive##6##2##(1990-2#1)(1997-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
and hyperthyroid##2##2##(1990-8#1)(2007-8#1)
and hyperthyroidism##5##2##(1996-8#1)(2008-4#3)(2011-1#1)
and hypertonic##2##2##(1992-8#1)(2013-7#1)
and hypertriglyceridemia##2##2##(2008-3#1)(2013-8#1)
and hypertrophic##3##2##(2008-5#1)(2008-9#1)(2010-11#1)
and hypertrophied##2##2##(1996-9#1)(1997-3#1)
and hypertrophy of##2##3##(2008-10#1)(2008-8#1)
and hypertrophy##6##2##(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
and hyphal growth of##2##4##(1997-6#1)(2012-2#1)
and hyphal growth##5##3##(1997-6#1)(2008-10#3)(2012-2#1)
and hyphal##7##2##(1991-9#1)(1997-6#1)(2008-10#4)(2012-2#1)
and hyphenated techniques##2##3##(2008-10#2)
and hypnotic##5##2##(1991-8#1)(1993-9#1)(2008-6#1)(2009-10#1)(2011-2#1)
and hypodermal cell##2##3##(1990-11#1)(2008-10#1)
and hypoglossal##4##2##(2008-2#1)(2011-2#2)(2013-1#1)
and hypoglycemia##2##2##(2008-1#1)(2012-3#1)
and hypogonadism##2##2##(1993-2#1)(2012-3#1)
and hypophosphatemia##3##2##(1991-8#3)
and hypoplasia##2##2##(2008-9#1)(2010-11#1)
and hypoplastic##4##2##(2007-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
and hypospadias##2##2##(2008-10#2)
and hypotension##4##2##(1990-9#1)(1993-9#1)(2007-8#1)(2011-1#1)
and hypothalamic##7##2##(1995-11#1)(1995-12#2)(1996-12#1)(1997-2#1)(2008-4#1)(2012-3#1)
and hypothalamus##5##2##(1990-12#1)(1991-9#1)(1993-5#1)(1994-2#1)(1995-2#1)
and hypothesis##2##2##(2009-12#1)(2013-1#1)
and hypothesized that##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
and hypothetical##6##2##(1990-8#1)(1996-6#1)(2008-12#1)(2008-9#1)(2010-6#1)(2012-2#1)
and hypovirulent phenotype##2##3##(2008-10#2)
and hypovirulent##3##2##(2008-10#3)
and hypoxanthine##7##2##(1991-9#1)(1993-12#1)(1994-5#2)(1994-8#1)(2008-10#2)
and hypoxemia##2##2##(1991-9#1)(2008-1#1)
and hypoxia##4##2##(1990-12#1)(1993-6#1)(2011-2#1)(2013-1#1)
and hypoxic##5##2##(1993-12#2)(1997-1#1)(2008-10#1)(2013-1#1)
and hysteresis##2##2##(2008-5#2)
and i##2##2##(1995-12#1)(2008-10#1)
and iNOS##2##2##(2008-9#1)(2009-10#1)
and iatrogenic##4##2##(1990-9#1)(2007-12#1)(2008-9#1)(2012-3#1)
and ibotenic##2##2##(1991-9#1)(1997-2#1)
and ibuprofen##3##2##(1997-5#1)(2008-10#1)(2008-11#1)
and ice crystal##2##3##(2008-2#1)(2008-3#1)
and ice##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
and ideals##2##2##(2007-12#1)(2009-12#1)
and ideas##7##2##(1990-11#1)(1991-3#1)(2007-12#1)(2008-12#1)(2008-9#1)(2010-5#1)(2013-8#1)
and identical##2##2##(2013-1#2)
and identically##2##2##(1995-9#1)(2008-3#1)
and identification of Vibrio cholerae##2##5##(2008-9#2)
and identification of a##10##4##(1990-7#1)(1991-12#1)(1992-8#1)(1997-7#1)(2008-10#1)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#2)
and identification of individual##2##4##(2008-11#1)(2008-7#1)
and identification of its##4##4##(1990-11#1)(1995-5#1)(1995-8#1)(2008-5#1)
and identification of several##3##4##(1993-12#1)(1997-3#1)(2008-10#1)
and identification of the impurities in metolachlor##2##7##(2008-10#2)
and identification of the##6##4##(1990-12#1)(2008-10#4)(2008-11#1)
and identification of##80##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
and identification##89##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
and identified a##2##3##(2008-11#2)
and identified as##11##3##(1994-6#1)(1996-2#1)(1997-3#1)(2008-10#7)(2012-12#1)
and identified at##2##3##(2008-10#2)
and identified by using standard bacteriological methods##2##7##(2008-12#2)
and identified by##8##3##(1990-4#1)(1992-3#1)(2006-12#1)(2008-10#2)(2008-12#2)(2008-7#1)
and identified four##2##3##(2010-3#1)(2013-1#1)
and identified in##2##3##(1995-6#1)(2012-12#1)
and identified the##7##3##(1994-2#1)(1995-11#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
and identified using##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
and identified##72##2##(1990-4#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-3#2)(2006-12#1)(2007-10#2)(2007-11#1)(2007-5#1)(2008-10#20)(2008-11#4)(2008-12#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and identifies key##2##3##(1996-12#1)(1997-3#1)
and identifies some##2##3##(1996-1#1)(2010-7#1)
and identifies the key##2##4##(1993-2#1)(2011-2#1)
and identifies the##4##3##(1993-2#1)(1994-1#1)(2008-10#1)(2011-2#1)
and identifies##16##2##(1993-1#1)(1993-2#1)(1994-1#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)
and identify a##4##3##(1991-12#1)(2008-10#1)(2009-10#1)(2012-3#1)
and identify the##9##3##(1993-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
and identify them as##2##4##(1995-12#1)(2012-3#1)
and identify##54##2##(1991-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(2006-5#1)(2007-11#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2012-4#1)(2013-7#1)(2013-8#3)
and identifying proteins##2##3##(2008-4#1)(2012-3#1)
and identifying the##3##3##(1997-1#1)(1997-2#1)(2008-10#1)
and identifying##14##2##(1996-3#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
and identity of the##2##4##(2007-12#1)(2008-10#1)
and identity of##4##3##(1993-8#1)(2007-12#1)(2008-10#2)
and identity##9##2##(1993-11#1)(1993-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2009-7#2)
and idiopathic dilated cardiomyopathy##2##4##(2007-8#1)(2010-8#1)
and idiopathic hypersomnia##2##3##(2012-2#2)
and idiopathic##10##2##(1991-5#1)(1993-6#1)(2006-10#1)(2007-8#1)(2008-11#1)(2009-8#1)(2010-8#1)(2012-2#2)(2013-8#1)
and idler beams##2##3##(2007-11#1)(2008-2#1)
and idler##14##2##(2007-11#5)(2007-12#6)(2008-2#2)(2008-3#1)
and ie-2##2##2##(1997-3#2)
and if so##11##3##(1990-5#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2012-7#1)
and if the##7##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#2)(2013-8#1)
and if they##4##3##(1997-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
and if##44##2##(1990-5#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-9#1)(2011-2#3)(2012-2#3)(2012-3#2)(2012-7#1)(2013-8#3)
and ifosfamide##6##2##(1994-12#1)(2007-10#1)(2010-3#4)
and ifosphamide##4##2##(2008-10#4)
and ignored##2##2##(1995-11#1)(2008-10#1)
and ii)##6##2##(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-2#1)
and iii)##6##2##(1993-5#1)(2010-8#1)(2012-2#2)(2013-8#2)
and ileal##2##2##(2009-12#2)
and ileum##4##2##(2008-1#1)(2008-5#1)(2012-2#1)(2013-7#1)
and ill##3##2##(2007-8#1)(2008-11#1)(2008-8#1)
and ill-health in agriculture##2##4##(2008-11#2)
and ill-health in##4##3##(2008-11#4)
and ill-health##6##2##(2008-11#6)
and illicit drug use in middle adulthood##2##7##(2009-7#2)
and illicit##3##2##(2009-7#2)(2013-8#1)
and illiteracy##2##2##(1991-12#1)(2008-1#1)
and illness##15##2##(1993-12#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-11#1)(2010-10#1)(2010-2#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
and illnesses##7##2##(1993-12#1)(1993-3#2)(1997-4#1)(2009-10#1)(2010-1#1)(2011-2#1)
and illuminated##2##2##(2008-3#2)
and illumination##4##2##(2008-3#2)(2008-6#1)(2009-6#1)
and illustrate the##7##3##(1994-3#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and illustrate##14##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
and illustrated in##2##3##(2007-12#1)(2012-2#1)
and illustrated with a##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
and illustrated with##7##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-7#1)(2012-2#1)
and illustrated##17##2##(1992-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-8#1)(2011-7#1)(2012-2#2)(2013-1#1)
and illustrates by##2##3##(1992-2#1)(2009-11#1)
and illustrates how this##2##4##(1996-3#1)(2007-12#1)
and illustrates how##5##3##(1991-2#1)(1996-3#1)(2007-12#1)(2008-7#1)(2012-12#1)
and illustrates the##5##3##(1992-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-1#1)
and illustrates##15##2##(1991-2#1)(1992-12#1)(1992-2#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
and illustrating##2##2##(2008-8#2)
and illustrative##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
and image analysis##5##3##(2008-10#2)(2008-4#1)(2008-9#1)(2010-10#1)
and image processing##7##3##(1997-4#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)
and image reconstruction##4##3##(2008-3#3)(2011-1#1)
and image##43##2##(1995-6#2)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#12)(2008-4#3)(2008-7#2)(2008-9#7)(2010-10#1)(2010-8#3)(2011-1#1)(2011-2#2)
and imaged##2##2##(2008-3#2)
and images of##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-10#1)
and images##11##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-3#1)
and imagined##2##2##(1992-11#1)(2013-1#1)
and imaging data##2##3##(2008-9#1)(2009-8#1)
and imaging features##4##3##(1997-8#1)(2009-4#1)(2012-12#1)(2012-2#1)
and imaging findings##4##3##(2008-7#1)(2011-2#2)(2012-12#1)
and imaging in##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
and imaging of##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-6#1)
and imaging techniques##2##3##(1993-5#1)(2008-10#1)
and imaging##45##2##(1993-3#1)(1993-5#1)(1994-5#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
and imipenem##2##2##(2007-7#1)(2010-8#1)
and immature##3##2##(2008-10#2)(2010-3#1)
and immediate##19##2##(1992-4#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2010-12#1)(2010-9#1)(2011-2#3)(2013-1#1)
and immediately after##5##3##(2007-7#1)(2007-8#1)(2008-5#1)(2009-6#1)(2013-1#1)
and immediately##12##2##(1996-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#3)
and immersed in##2##3##(1995-2#1)(2008-10#1)
and immersive##2##2##(2008-6#1)(2013-8#1)
and immigrants from##2##3##(1997-6#1)(2007-12#1)
and immigrants##3##2##(1991-5#1)(1997-6#1)(2007-12#1)
and immigration##6##2##(1990-3#1)(1991-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
and immobilisation##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
and immobilised##2##2##(2008-10#2)
and immobilization##3##2##(1994-8#1)(2010-11#1)(2012-1#1)
and immobilize##2##2##(2008-10#1)(2008-7#1)
and immobilized##10##2##(1990-2#1)(1994-3#1)(1997-2#1)(2008-10#3)(2008-6#2)(2008-7#2)
and immortal##2##2##(1993-11#1)(2008-11#1)
and immortalization of##3##3##(2008-2#3)
and immune cells##7##3##(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
and immune function in##2##4##(2010-1#1)(2011-2#1)
and immune function##4##3##(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
and immune reactions##2##3##(2008-1#1)(2008-5#1)
and immune response of##2##4##(2008-7#1)(2011-2#1)
and immune response##7##3##(1997-8#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
and immune responses in##2##4##(1994-9#1)(1995-12#1)
and immune responses##7##3##(1991-9#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-5#1)(2008-11#1)
and immune system##4##3##(1994-5#1)(1994-6#1)(1995-12#1)(2008-12#1)
and immune##58##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-5#1)(1996-12#1)(1997-8#3)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
and immunity to minor##2##4##(2008-3#2)
and immunity to##3##3##(2008-3#2)(2008-7#1)
and immunity##8##2##(1994-5#1)(2007-5#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)
and immunization##6##2##(1995-12#1)(1995-5#1)(1996-12#2)(1997-6#1)(2007-2#1)
and immunoaffinity column##2##3##(1990-7#1)(2008-10#1)
and immunoaffinity purification of the##2##5##(1993-9#1)(2008-2#1)
and immunoaffinity purification##3##3##(1993-9#1)(2008-2#2)
and immunoaffinity##7##2##(1990-7#1)(1993-9#2)(2008-10#2)(2008-2#2)
and immunoassay##2##2##(2008-10#2)
and immunoblot analysis##3##3##(1990-5#1)(1993-8#1)(2008-11#1)
and immunoblot##7##2##(1990-5#1)(1993-3#1)(1993-8#1)(1997-6#1)(2008-10#2)(2008-11#1)
and immunoblotting assays##2##3##(1991-2#1)(2010-4#1)
and immunoblotting demonstrated the expression of##2##6##(1995-8#1)(1996-5#1)
and immunoblotting##13##2##(1991-12#1)(1991-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-12#1)(2008-4#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
and immunocapture##2##2##(2008-10#2)
and immunochemical##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
and immunocompromised patients##2##3##(1990-12#1)(2011-2#1)
and immunocompromised##3##2##(1990-12#1)(2010-8#1)(2011-2#1)
and immunocytochemical##11##2##(1991-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-7#1)(2009-12#1)
and immunocytochemistry##4##2##(1995-5#1)(1997-7#1)(2008-11#1)(2009-12#1)
and immunofluorescence microscopy##4##3##(1994-8#1)(2007-12#2)(2007-7#1)
and immunofluorescence##14##2##(1994-8#1)(2007-12#2)(2007-7#3)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-12#1)
and immunofluorescent##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
and immunogenic##3##2##(1995-2#1)(2013-1#2)
and immunogenicity of##6##3##(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
and immunogenicity##14##2##(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
and immunoglobulin A (IgA)##2##4##(1991-2#1)(2010-4#1)
and immunoglobulin A##3##3##(1991-2#1)(2010-4#2)
and immunoglobulin G##3##3##(2008-10#2)(2012-3#1)
and immunoglobulin M##2##3##(1994-3#1)(1995-2#1)
and immunoglobulin##12##2##(1991-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2010-4#2)(2012-3#1)(2013-7#1)
and immunoglobulins##2##2##(1990-12#1)(2008-7#1)
and immunohistochemical analyses##3##3##(1996-12#1)(2008-5#1)(2008-6#1)
and immunohistochemical features of##2##4##(1990-8#1)(2007-8#1)
and immunohistochemical features##4##3##(1990-8#1)(2007-8#1)(2008-4#1)(2012-2#1)
and immunohistochemical findings##2##3##(2009-3#1)(2013-8#1)
and immunohistochemical methods##2##3##(2008-7#1)(2011-2#1)
and immunohistochemical staining of##2##4##(2011-2#1)(2013-8#1)
and immunohistochemical staining##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
and immunohistochemical studies##5##3##(1990-10#1)(1994-9#1)(2007-5#1)(2008-12#1)(2011-2#1)
and immunohistochemical study of##2##4##(1991-6#1)(1993-8#1)
and immunohistochemical techniques##2##3##(1990-8#1)(2012-3#1)
and immunohistochemical##36##2##(1990-10#1)(1990-12#1)(1990-8#2)(1991-6#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-12#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#4)
and immunohistochemically##2##2##(1994-12#1)(2008-10#1)
and immunohistochemistry of##2##3##(2008-10#1)(2008-5#1)
and immunohistochemistry using##2##3##(1991-5#1)(1997-6#1)
and immunohistochemistry with##2##3##(1992-8#1)(2011-2#1)
and immunohistochemistry##23##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#2)(2010-11#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
and immunohistological features##2##3##(2007-8#1)(2008-12#1)
and immunohistological##6##2##(1990-6#1)(2007-8#1)(2008-12#1)(2008-5#2)(2010-12#1)
and immunolabeling##2##2##(1992-12#1)(2008-10#1)
and immunologic memory##2##3##(1995-5#1)(2012-3#1)
and immunologic##10##2##(1992-10#1)(1992-2#1)(1993-3#1)(1995-5#2)(1996-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)
and immunological changes##2##3##(1991-2#1)(1994-5#1)
and immunological characterization of##2##4##(1992-6#1)(1993-3#1)
and immunological presentation##2##3##(1990-2#1)(1995-5#1)
and immunological studies##2##3##(1991-9#1)(2011-2#1)
and immunological##21##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-6#2)(1993-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#3)(2012-3#1)
and immunologically##2##2##(1990-11#1)(2007-11#1)
and immunology##10##2##(1994-12#2)(2006-10#2)(2007-8#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-8#1)
and immunomodulatory activities##2##3##(2007-11#1)(2008-10#1)
and immunomodulatory effects##2##3##(1997-4#1)(2012-3#1)
and immunomodulatory##4##2##(1997-4#1)(2007-11#1)(2008-10#1)(2012-3#1)
and immunoperoxidase tests for the detection of antibodies to chicken anaemia agent##2##12##(1991-3#2)
and immunoperoxidase##3##2##(1991-2#1)(1991-3#2)
and immunophenotype##2##2##(2008-11#1)(2009-8#1)
and immunophenotyping##4##2##(2008-12#1)(2008-9#2)(2009-2#1)
and immunoprecipitation of##2##3##(2008-1#1)(2008-11#1)
and immunoprecipitation##5##2##(1993-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-9#1)
and immunoregulation##2##2##(1991-2#1)(2011-3#1)
and immunostaining##4##2##(1993-11#1)(1994-7#1)(2008-10#1)(2008-11#1)
and immunosuppression##3##2##(1991-1#1)(2007-12#1)(2010-12#1)
and immunosuppressive drugs##4##3##(2008-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
and immunosuppressive therapy##4##3##(2006-10#2)(2008-1#1)(2008-7#1)
and immunosuppressive##10##2##(2006-10#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
and immunotherapy##4##2##(1991-11#1)(1991-8#1)(1993-11#1)(2011-2#1)
and immunotoxicity##3##2##(2008-10#2)(2008-4#1)
and impact of these##2##4##(2007-10#1)(2013-1#1)
and impact of this##2##4##(2008-12#1)(2009-5#1)
and impact of##14##3##(1990-6#1)(1996-1#1)(2007-10#1)(2007-12#2)(2008-12#2)(2008-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
and impact on##10##3##(1992-12#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-8#2)(2012-3#1)
and impact##39##2##(1990-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1996-1#1)(1996-11#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#3)(2008-9#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and impacted##2##2##(1997-1#1)(2008-10#1)
and impacts##2##2##(1993-12#1)(2007-7#1)
and impaired glucose tolerance##5##4##(2008-1#1)(2008-3#1)(2008-7#2)(2011-1#1)
and impaired growth##2##3##(1996-6#1)(2010-6#1)
and impaired##27##2##(1991-3#1)(1992-9#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
and impairing##3##2##(2008-3#1)(2010-5#1)(2012-12#1)
and impairment of##8##3##(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#2)(2012-2#1)(2012-6#1)
and impairment##12##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2012-12#1)(2012-2#1)(2012-6#1)
and impairs##3##2##(1997-8#1)(2010-6#1)(2013-8#1)
and impedance##5##2##(2007-11#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
and impending##4##2##(2007-11#3)(2008-7#1)
and implant##4##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
and implantable##2##2##(2008-12#1)(2010-8#1)
and implantation of##6##3##(1991-3#1)(1991-9#1)(2008-4#1)(2011-2#2)(2013-1#1)
and implantation##8##2##(1991-3#1)(1991-9#1)(1994-9#1)(2008-10#1)(2008-4#1)(2011-2#2)(2013-1#1)
and implanted##4##2##(2010-8#2)(2012-2#1)(2013-7#1)
and implement a##9##3##(1991-12#1)(1993-1#1)(1995-2#1)(1996-1#1)(2007-4#1)(2008-9#2)(2012-3#1)(2013-1#1)
and implement an##4##3##(1992-2#1)(1993-2#1)(1997-3#1)(2008-12#1)
and implement##33##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
and implementation are##3##3##(1993-12#1)(1995-2#1)(1996-1#1)
and implementation challenges##2##3##(1997-1#1)(2013-1#1)
and implementation in##2##3##(1994-12#2)
and implementation of a##10##4##(1991-2#1)(1992-2#1)(1993-3#3)(1995-3#1)(1996-2#1)(2008-1#1)(2012-2#1)(2013-1#1)
and implementation of an##4##4##(1992-3#1)(1994-2#1)(1996-1#1)(2008-11#1)
and implementation of health##2##4##(1995-1#1)(2011-1#1)
and implementation of new##2##4##(2008-7#1)(2009-12#1)
and implementation of programs##2##4##(1992-1#1)(2012-3#1)
and implementation of the##9##4##(1993-3#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
and implementation of these programs##2##5##(2011-3#1)(2013-1#1)
and implementation of these##4##4##(2008-10#1)(2009-7#1)(2011-3#1)(2013-1#1)
and implementation of##67##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#5)(1994-2#3)(1994-3#1)(1995-1#1)(1995-3#3)(1996-1#1)(1996-2#2)(1996-4#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
and implementation##97##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#5)(1994-12#3)(1994-2#4)(1994-3#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#5)(1996-1#3)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#3)(2008-9#4)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
and implemented a##5##3##(2008-3#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-1#1)
and implemented by##3##3##(1996-12#1)(2007-11#1)(2013-1#1)
and implemented for##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
and implemented in##7##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)
and implemented##49##2##(1991-12#1)(1992-2#1)(1993-3#2)(1994-3#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#4)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#4)
and implementing a##4##3##(1992-2#1)(1995-12#2)(1997-2#1)
and implementing the##2##3##(2010-8#1)(2012-2#1)
and implementing##23##2##(1990-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-12#1)(2009-12#1)(2010-11#1)(2010-8#2)(2011-1#1)(2012-2#2)
and implicate##2##2##(1990-11#1)(1993-11#1)
and implication of##2##3##(2007-8#1)(2011-2#1)
and implications are discussed##2##4##(2007-12#1)(2010-5#1)
and implications are##3##3##(1992-3#1)(2007-12#1)(2010-5#1)
and implications for disease##2##4##(2008-10#2)
and implications for health care##2##5##(1995-3#1)(2008-12#1)
and implications for health##3##4##(1995-1#1)(1995-3#1)(2008-12#1)
and implications for patient##2##4##(1997-8#1)(2011-2#1)
and implications for treatment and##2##5##(2008-6#1)(2009-12#1)
and implications for##30##3##(1992-9#2)(1994-2#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#2)(2013-1#1)
and implications in##2##3##(1997-4#1)(2007-12#1)
and implications of these findings##2##5##(2009-11#1)(2013-1#1)
and implications of these##3##4##(2009-11#1)(2010-3#1)(2013-1#1)
and implications of this##2##4##(1995-5#1)(2011-2#1)
and implications of##9##3##(1995-5#1)(2008-1#1)(2009-11#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and implications##54##2##(1992-11#1)(1992-3#1)(1992-9#2)(1994-2#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#3)(1997-4#1)(1997-8#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
and implicit##3##2##(1991-5#1)(2008-2#1)(2009-9#1)
and implies that##2##3##(2008-7#1)(2011-2#1)
and implies##5##2##(1996-12#1)(1996-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
and importance of##14##3##(1990-2#1)(1990-5#1)(1991-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
and importance##16##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
and important in##3##3##(1995-2#1)(2007-12#1)(2011-1#1)
and important##26##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
and imported##4##2##(1994-9#1)(2008-10#2)(2008-12#1)
and impression##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
and imprinting##2##2##(2008-10#1)(2008-7#1)
and improve clinical##4##3##(1995-12#1)(1997-2#1)(2008-12#1)(2011-1#1)
and improve health care##2##4##(1997-2#2)
and improve health##3##3##(1997-2#2)(2013-1#1)
and improve its##2##3##(2008-8#1)(2011-2#1)
and improve patient##3##3##(2007-9#1)(2008-7#1)(2013-1#1)
and improve quality of##2##4##(1996-3#1)(2007-12#1)
and improve quality##4##3##(1996-3#2)(2007-12#1)(2012-12#1)
and improve symptoms##2##3##(2008-3#2)
and improve the patient's##2##4##(1993-12#1)(2008-10#1)
and improve the quality of the##2##6##(1996-7#1)(2008-11#1)
and improve the quality of##6##5##(1990-12#1)(1994-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(2008-11#1)
and improve the##29##3##(1990-12#2)(1993-12#1)(1994-1#1)(1996-12#2)(1996-7#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
and improve their##7##3##(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-3#1)(2011-2#1)
and improve##105##2##(1990-12#2)(1991-3#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-1#4)(1994-2#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#4)(2006-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#3)(2011-7#1)(2012-12#4)(2012-3#2)(2013-1#7)(2013-8#2)
and improved accuracy##2##3##(2007-11#1)(2008-3#1)
and improved cardiac##2##3##(2012-12#1)(2012-2#1)
and improved cognitive##2##3##(1994-6#2)
and improved flexibility##2##3##(2008-10#2)
and improved health##2##3##(2008-8#1)(2010-1#1)
and improved in##3##3##(2008-10#1)(2008-7#2)
and improved patient##3##3##(1995-3#1)(1996-1#1)(2013-1#1)
and improved quality of life##4##5##(1992-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
and improved quality of##5##4##(1992-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)
and improved quality##6##3##(1992-3#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)
and improved the quality of##2##5##(1993-3#1)(1995-12#1)
and improved the##9##3##(1991-3#1)(1993-3#1)(1995-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
and improved##97##2##(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-3#2)(1996-1#4)(1996-5#1)(1997-1#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#3)
and improvement in##12##3##(1993-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
and improvement of grip strength were##2##6##(2008-9#2)
and improvement of quality##2##4##(1994-12#1)(2011-2#1)
and improvement of the##2##4##(1993-6#1)(2013-8#1)
and improvement of##17##3##(1993-6#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-1#1)(2010-10#1)(2011-2#2)(2013-8#1)
and improvement##44##2##(1993-2#4)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-1#2)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
and improvements are##2##3##(2008-2#1)(2013-1#1)
and improvements in the##2##4##(1994-1#1)(2011-2#1)
and improvements in##10##3##(1994-1#1)(1995-12#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
and improvements of##2##3##(2007-11#1)(2008-10#1)
and improvements##18##2##(1994-1#1)(1994-3#1)(1995-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and improves the##7##3##(1991-11#1)(1994-9#1)(2007-12#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
and improves##23##2##(1991-11#1)(1994-9#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-2#2)(2013-8#2)
and improving health##2##3##(1996-2#1)(2007-12#1)
and improving quality of##2##4##(2008-1#1)(2008-7#1)
and improving quality##4##3##(1992-11#1)(1996-12#1)(2008-1#1)(2008-7#1)
and improving the efficiency of the##2##6##(1992-2#1)(2010-8#1)
and improving the quality of##3##5##(1996-2#2)(2013-8#1)
and improving the##13##3##(1992-2#1)(1996-2#2)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
and improving their##3##3##(1996-2#1)(2008-7#2)
and improving##50##2##(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1996-12#1)(1996-2#5)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#6)(2009-11#2)(2009-7#1)(2010-11#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
and impulse##3##2##(2008-2#1)(2008-4#1)(2012-3#1)
and impulsivity##2##2##(2008-2#1)(2009-10#1)
and in 0##2##3##(2008-10#2)
and in 1 case a##2##5##(1991-3#1)(2007-10#1)
and in 1##9##3##(1990-11#1)(1991-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2011-1#2)(2013-1#1)
and in 10 of the##2##5##(1996-12#1)(2008-10#1)
and in 11 patients##2##4##(2007-11#1)(2008-5#1)
and in 15##3##3##(1990-2#1)(2009-10#1)(2013-1#1)
and in 16##2##3##(2008-1#1)(2008-10#1)
and in 17##2##3##(2007-11#1)(2008-5#1)
and in 19##3##3##(2007-11#2)(2008-8#1)
and in 2 patients##3##4##(1997-4#1)(2007-11#1)(2008-5#1)
and in 2##7##3##(1991-6#1)(1992-5#1)(1997-4#1)(2007-11#2)(2008-5#1)(2010-2#1)
and in 25##2##3##(1993-12#1)(2008-7#1)
and in 26##2##3##(2007-11#1)(2007-8#1)
and in 29##2##3##(2007-11#1)(2007-8#1)
and in 3 cases##3##4##(2007-11#1)(2011-2#2)
and in 3 of##2##4##(1994-9#1)(2008-12#1)
and in 3##9##3##(1990-9#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
and in 33% of##2##4##(1990-3#1)(1992-9#1)
and in 4##2##3##(1993-9#1)(2008-5#1)
and in 5 of##2##4##(1992-2#1)(2011-2#1)
and in 5##6##3##(1991-11#1)(1991-2#1)(1992-2#1)(2007-10#1)(2011-2#1)(2013-1#1)
and in 50##5##3##(1990-9#1)(1996-6#1)(2007-7#1)(2008-7#1)(2011-2#1)
and in 50% of##2##4##(1997-3#1)(2008-1#1)
and in 6##2##3##(1996-11#1)(2011-2#1)
and in 60% of##2##4##(1996-9#1)(2011-2#1)
and in 7 cases##2##4##(1996-2#1)(2009-6#1)
and in 7 patients##2##4##(2008-5#1)(2012-3#1)
and in 7##5##3##(1996-2#1)(2007-11#1)(2008-5#1)(2009-6#1)(2012-3#1)
and in 8 patients##3##4##(1996-3#1)(1997-8#1)(2013-1#1)
and in 8##5##3##(1993-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2013-1#1)
and in 800 mg/L males##2##5##(2008-9#2)
and in CHO##2##3##(1997-4#1)(2008-11#1)
and in Canada##3##3##(2008-10#2)(2008-11#1)
and in DNA##2##3##(1993-3#1)(2008-10#1)
and in Norway##2##3##(1990-6#1)(1993-3#1)
and in Poland##2##3##(1994-12#1)(2009-5#1)
and in SDCL C/N 30##2##5##(2008-10#2)
and in Xenopus##2##3##(1990-12#1)(1995-3#1)
and in a control group of##2##6##(2008-7#1)(2012-12#1)
and in a few##2##4##(1994-1#1)(1997-2#1)
and in a field##2##4##(2008-10#2)
and in a group of##2##5##(1996-7#1)(2008-7#1)
and in a single##2##4##(2007-12#1)(2008-10#1)
and in a##64##3##(1990-11#1)(1990-2#2)(1990-5#1)(1991-12#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-5#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-8#3)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
and in about##2##3##(2008-11#1)(2008-9#1)
and in accordance with##2##4##(2008-6#1)(2013-7#1)
and in addition##5##3##(1997-4#1)(1997-8#1)(2008-10#1)(2010-3#1)(2012-3#1)
and in adult life##2##4##(1995-12#1)(2009-8#1)
and in adult##4##3##(1995-12#1)(1997-7#1)(2007-12#1)(2009-8#1)
and in adults with##2##4##(1997-4#1)(2012-3#1)
and in adults##4##3##(1997-4#1)(1997-6#1)(2008-7#1)(2012-3#1)
and in agreement with those obtained by##2##7##(2008-10#2)
and in agreement with##7##4##(2008-10#6)(2013-8#1)
and in all##14##3##(1993-6#1)(1995-12#1)(1996-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-7#1)(2011-2#2)(2012-12#1)
and in an##11##3##(1990-3#1)(1995-9#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)(2012-2#1)(2012-3#2)
and in animal models of##3##5##(2008-10#1)(2008-7#1)(2010-5#1)
and in animal models##5##4##(1991-9#1)(2008-10#2)(2008-7#1)(2010-5#1)
and in animals##2##3##(2008-11#1)(2013-1#1)
and in another third##2##4##(1994-9#1)(2008-10#1)
and in another##5##3##(1991-2#1)(1994-6#1)(1994-9#1)(1996-9#1)(2008-10#1)
and in aqueous##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
and in artificial##2##3##(2008-10#2)
and in association with##4##4##(1991-12#1)(2007-12#1)(2008-10#2)
and in blood plasma##3##4##(2008-10#3)
and in blood##6##3##(1997-7#1)(2008-10#4)(2013-1#1)
and in both types of##2##5##(1993-8#1)(2013-7#1)
and in both##7##3##(1993-8#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2013-7#1)
and in brain##3##3##(2008-7#2)(2010-7#1)
and in cancer##4##3##(1991-12#1)(1997-3#1)(2007-10#1)(2010-12#1)
and in case of##3##4##(1991-6#1)(2008-5#1)(2011-2#1)
and in cases with##2##4##(1990-6#1)(2011-2#1)
and in cases##4##3##(1990-6#1)(1991-8#1)(1993-2#1)(2011-2#1)
and in cell##2##3##(1995-5#1)(2008-11#1)
and in cells##3##3##(1992-6#1)(1995-2#1)(2008-4#1)
and in certain##3##3##(1990-7#1)(2008-3#1)(2008-7#1)
and in children with##2##4##(2011-2#1)(2013-8#1)
and in children##5##3##(2007-11#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
and in chloroform##2##3##(2007-11#1)(2008-10#1)
and in clarifying##2##3##(2010-12#1)(2011-2#1)
and in clinical##4##3##(1994-12#1)(1995-1#1)(2008-11#1)(2008-5#1)
and in combination to##4##4##(2008-10#3)(2012-2#1)
and in combination with nitrite##2##5##(1990-6#2)
and in combination with##12##4##(1990-2#1)(1990-6#2)(1991-1#1)(1993-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2009-8#1)(2011-2#1)(2013-1#1)
and in combination##23##3##(1990-2#1)(1990-5#1)(1990-6#2)(1991-1#1)(1993-12#1)(1996-12#1)(2007-7#1)(2008-10#5)(2008-5#3)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#1)
and in commercial##3##3##(2008-10#3)
and in complex with##2##4##(2009-7#1)(2011-1#1)
and in complex##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
and in contrast##2##3##(1997-1#1)(2008-11#1)
and in control##2##3##(1996-1#1)(2008-4#1)
and in controlling##2##3##(1991-9#1)(2008-10#1)
and in coronary##2##3##(2008-4#2)
and in cortical##2##3##(2008-10#2)
and in crop##2##3##(2008-12#1)(2008-7#1)
and in culture##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
and in determining##3##3##(1997-8#1)(2008-11#1)(2008-8#1)
and in developing##2##3##(1997-1#1)(2010-4#1)
and in development of##3##4##(2008-4#1)(2011-1#2)
and in development##5##3##(2008-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
and in different##11##3##(1990-7#1)(1993-11#1)(1993-2#1)(2007-11#1)(2008-10#5)(2008-8#2)
and in differentiating##3##3##(1994-11#1)(2012-2#2)
and in diseased##2##3##(1993-9#1)(2008-10#1)
and in each##2##3##(2008-10#2)
and in early##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
and in eight##2##3##(2008-10#2)
and in establishing##2##3##(1997-1#1)(2008-7#1)
and in experimental##2##3##(1991-12#1)(1997-2#1)
and in females##3##3##(2008-8#1)(2011-2#2)
and in field##2##3##(2008-3#1)(2010-5#1)
and in five##5##3##(1995-12#1)(1997-3#1)(2008-10#2)(2010-4#1)
and in flow##2##3##(2008-10#1)(2012-12#1)
and in four##5##3##(1990-9#1)(2007-8#1)(2008-10#2)(2008-8#1)
and in general##6##3##(1996-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
and in good##4##3##(1991-6#1)(1992-2#1)(1992-3#1)(2008-10#1)
and in health##3##3##(1997-1#1)(2011-2#1)(2012-3#1)
and in healthy controls##2##4##(1990-3#1)(2008-6#1)
and in healthy##4##3##(1990-12#1)(1990-3#1)(1995-11#1)(2008-6#1)
and in human melanoma##2##4##(1992-2#1)(2008-8#1)
and in human##11##3##(1991-12#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1996-2#1)(2007-7#1)(2008-8#1)(2013-1#1)
and in implanted##2##3##(1996-12#1)(2008-8#1)
and in improving the##2##4##(2008-1#1)(2008-3#1)
and in increasing##2##3##(2008-10#1)(2008-4#1)
and in industrial##3##3##(2008-10#2)(2008-11#1)
and in inflammatory##2##3##(1993-3#1)(2013-1#1)
and in intrinsic##2##3##(2008-11#1)(2009-5#1)
and in isolated##4##3##(1994-6#1)(1995-11#1)(1997-6#1)(2008-5#1)
and in its##5##3##(1994-11#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-2#1)
and in keeping with##2##4##(1995-1#1)(2008-10#1)
and in keeping##3##3##(1992-9#1)(1995-1#1)(2008-10#1)
and in less than##2##4##(2008-10#2)
and in less##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
and in living##2##3##(2008-10#1)(2010-12#1)
and in many cases##8##4##(1994-2#1)(2008-10#4)(2008-3#1)(2010-3#1)(2013-1#1)
and in many##11##3##(1991-6#1)(1992-1#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-3#1)(2013-1#1)
and in markets where blood or urine tests are not commonly used in underwriting##2##14##(1993-12#2)
and in matched##2##3##(1995-5#1)(2011-2#1)
and in mitotic##2##3##(2008-11#1)(2012-2#1)
and in mixtures##2##3##(2008-10#1)(2008-2#1)
and in modifying##2##3##(1990-9#1)(2011-3#1)
and in more##3##3##(1994-6#1)(2008-10#1)(2009-2#1)
and in most cases##2##4##(1997-1#1)(2012-1#1)
and in most##7##3##(1997-1#1)(1997-4#1)(2008-3#2)(2008-9#1)(2012-1#1)(2012-2#1)
and in mouse##3##3##(1995-6#1)(1997-7#1)(2008-9#1)
and in need of##2##4##(2010-9#1)(2011-2#1)
and in new##2##3##(1993-12#1)(1996-5#1)
and in no case did the##2##6##(1991-8#1)(2008-9#1)
and in no case##4##4##(1990-2#1)(1991-3#1)(1991-8#1)(2008-9#1)
and in normal##5##3##(1990-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(2012-3#1)
and in older##2##3##(1994-12#1)(2013-8#1)
and in one case the##2##5##(1990-8#1)(1994-9#1)
and in one case##4##4##(1990-8#1)(1992-3#1)(1994-6#1)(1994-9#1)
and in one of the##3##5##(1990-2#1)(1991-6#1)(2008-9#1)
and in one of##4##4##(1990-2#1)(1991-6#1)(1993-12#1)(2008-9#1)
and in one patient##2##4##(1996-9#1)(2007-11#1)
and in one##17##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-6#1)(1994-9#1)(1996-9#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-9#1)(2011-1#1)
and in only##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2013-7#1)
and in order to##5##4##(2008-10#2)(2008-11#1)(2008-12#1)(2011-1#1)
and in other countries##2##4##(2008-5#2)
and in other##16##3##(1990-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-1#1)(1996-2#1)(2006-6#1)(2008-12#1)(2008-5#3)(2008-7#2)(2011-3#1)(2013-8#2)
and in our##3##3##(1993-2#1)(1996-9#1)(2012-3#1)
and in part##2##3##(1990-2#1)(2008-8#1)
and in particular for##2##4##(2008-10#1)(2008-2#1)
and in particular in the##2##5##(2010-5#1)(2011-2#1)
and in particular its##2##4##(1996-12#1)(2007-2#1)
and in particular the##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)
and in particular with##2##4##(1995-1#1)(2008-10#1)
and in particular##38##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-3#1)(1995-1#1)(1995-5#1)(1996-12#2)(1997-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
and in patients with chronic##2##5##(2007-8#1)(2008-1#1)
and in patients with##21##4##(1991-11#1)(1991-8#1)(1993-12#1)(1994-11#1)(2007-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)
and in patients##26##3##(1991-11#1)(1991-8#1)(1993-12#1)(1994-11#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
and in peripheral##2##3##(1991-11#1)(2008-7#1)
and in pharmaceutical formulations##3##4##(2008-10#3)
and in pharmaceutical##6##3##(2008-10#6)
and in phase##2##3##(2008-11#1)(2008-5#1)
and in planta##8##3##(2008-10#7)(2009-12#1)
and in practice##2##3##(1990-2#1)(2008-2#1)
and in pregnancy##2##3##(1990-9#1)(1992-12#1)
and in presence of##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and in prolonging##2##3##(1994-7#1)(2008-3#1)
and in protoplast culture##2##4##(2008-8#2)
and in rats##2##3##(1996-5#1)(1997-2#1)
and in real time##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
and in real##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#1)
and in recognizing##2##3##(2008-10#1)(2012-2#1)
and in reconstructing##2##3##(2008-3#1)(2008-7#1)
and in reducing##3##3##(1992-12#1)(2008-4#1)(2008-5#1)
and in relation to##4##4##(1991-6#1)(2008-10#1)(2008-5#1)(2010-6#1)
and in reported##2##3##(1992-2#1)(2012-12#1)
and in response to a##2##5##(2012-2#1)(2012-3#1)
and in response to##8##4##(1994-3#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-7#2)(2012-2#1)(2012-3#1)
and in rural##2##3##(1994-1#1)(2012-12#1)
and in seedlings##2##3##(2008-10#2)
and in serum##2##3##(1990-8#2)
and in serum-free##2##3##(2008-11#1)(2008-7#1)
and in seven##2##3##(1995-12#1)(2008-3#1)
and in several##5##3##(1992-5#1)(1995-12#1)(1997-2#1)(2007-10#1)(2011-2#1)
and in silico##3##3##(2009-8#1)(2010-11#1)(2011-2#1)
and in situ hybridization (ISH)##2##5##(1992-12#1)(2012-3#1)
and in situ hybridization have##2##5##(2008-6#1)(2009-7#1)
and in situ hybridization histochemistry##4##5##(1992-6#1)(1994-11#1)(1994-2#1)(1995-2#1)
and in situ hybridization of##2##5##(1996-12#2)
and in situ hybridization##22##4##(1990-12#1)(1991-5#2)(1992-12#1)(1992-6#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#3)(1997-1#1)(1997-7#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2012-3#1)
and in situ##47##3##(1990-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#2)(1994-11#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#4)(1997-1#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2012-3#2)(2013-7#2)
and in situations##2##3##(2008-3#1)(2009-8#1)
and in six##3##3##(1990-3#1)(1990-8#1)(2008-8#1)
and in small##2##3##(1991-8#1)(2008-11#1)
and in soil##3##3##(2008-10#2)(2011-2#1)
and in some cases##25##4##(1993-12#2)(1993-8#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
and in some instances##6##4##(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
and in some patients with##2##5##(1992-6#1)(1997-7#1)
and in some##50##3##(1991-12#1)(1992-11#1)(1992-6#1)(1993-12#3)(1993-8#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
and in specific##3##3##(1997-4#1)(2008-10#1)(2008-7#1)
and in spite of##2##4##(1992-9#1)(2013-1#1)
and in studies##2##3##(1997-7#1)(2008-10#1)
and in subjects##2##3##(2008-1#1)(2012-7#1)
and in terms of##4##4##(1996-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
and in that##2##3##(1990-11#1)(2008-10#1)
and in the United States##3##5##(1991-12#1)(1997-3#1)(2008-10#1)
and in the United##4##4##(1991-12#1)(1997-3#1)(2008-10#1)(2008-12#1)
and in the absence of##5##5##(1993-3#1)(1994-5#1)(2008-9#1)(2010-11#1)(2011-1#1)
and in the acrosome of##2##5##(2008-7#2)
and in the adult##3##4##(1994-2#1)(2008-11#1)(2008-7#1)
and in the case of the##2##6##(1993-9#1)(1995-11#1)
and in the case of##5##5##(1993-9#1)(1995-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
and in the control group##2##5##(1994-12#2)
and in the development of##3##5##(2008-4#1)(2009-10#1)(2011-2#1)
and in the different##2##4##(1994-6#1)(1995-6#1)
and in the differential##2##4##(2013-1#1)(2013-8#1)
and in the direction##2##4##(2008-3#1)(2008-6#1)
and in the evaluation of##2##5##(1990-11#1)(2012-2#1)
and in the field##5##4##(2008-10#4)(2008-3#1)
and in the first##3##4##(1991-6#1)(2008-8#1)(2008-9#1)
and in the following##7##4##(1996-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)
and in the future##7##4##(1991-12#1)(1993-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)
and in the hippocampus##3##4##(1994-6#2)(1997-2#1)
and in the intact##2##4##(1994-8#1)(1997-4#1)
and in the light of the##2##6##(2007-12#1)(2008-10#1)
and in the liver##2##4##(2008-12#1)(2013-7#1)
and in the long term##2##5##(2007-8#1)(2008-7#1)
and in the management of##2##5##(1990-2#1)(2007-7#1)
and in the mean##2##4##(2008-10#1)(2013-1#1)
and in the number of##2##5##(2008-12#1)(2013-1#1)
and in the other##5##4##(1992-8#1)(2008-10#2)(2008-9#1)(2009-4#1)
and in the plasma of##2##5##(2008-7#1)(2010-8#1)
and in the presence of ascorbic acid##2##7##(2008-10#2)
and in the presence of the##3##6##(2008-10#3)
and in the presence of##26##5##(1991-2#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)
and in the present work we##2##6##(1990-12#1)(2008-10#1)
and in the production of##2##5##(1993-3#1)(2008-10#1)
and in the range##4##4##(2008-10#4)
and in the remaining##3##4##(1991-3#1)(1993-5#1)(2010-3#1)
and in the rest of##2##5##(1994-2#1)(2008-7#1)
and in the salivary##2##4##(2008-10#2)
and in the same##2##4##(2008-10#1)(2008-8#1)
and in the second##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
and in the third##3##4##(1993-12#1)(1993-3#1)(2013-1#1)
and in the treatment of##2##5##(1992-12#1)(2013-1#1)
and in the treatment##3##4##(1992-12#1)(2008-10#1)(2013-1#1)
and in the urine##2##4##(2008-7#1)(2013-1#1)
and in the##400##3##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#5)(1993-5#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#5)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#7)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#79)(2008-11#11)(2008-12#6)(2008-2#7)(2008-3#15)(2008-4#7)(2008-5#13)(2008-6#5)(2008-7#17)(2008-8#11)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#3)(2009-7#4)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#7)
and in their##13##3##(1992-12#1)(1992-8#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-2#1)
and in these##3##3##(1993-6#1)(2009-8#1)(2013-8#1)
and in this case##2##4##(2008-5#1)(2008-9#1)
and in this respect##2##4##(1992-5#1)(2008-5#1)
and in this way##6##4##(1997-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#1)
and in this##14##3##(1992-5#1)(1996-7#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#2)(2009-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
and in those of##2##4##(2008-10#2)
and in those who had##2##5##(2013-1#2)
and in those with##3##4##(1991-2#1)(1993-9#1)(2008-3#1)
and in those##13##3##(1990-8#2)(1990-9#1)(1991-2#1)(1993-9#1)(1994-12#1)(2008-10#3)(2008-3#1)(2013-1#2)(2013-8#1)
and in three cases##3##4##(1992-11#1)(1995-11#1)(2008-10#1)
and in three##6##3##(1992-11#1)(1995-11#1)(2008-10#2)(2012-3#1)(2013-7#1)
and in time##3##3##(1991-2#2)(2008-10#1)
and in tissue##2##3##(1990-11#1)(2007-12#1)
and in toluene##2##3##(2009-9#2)
and in transfected##2##3##(1992-12#1)(1993-3#1)
and in transmission##2##3##(2008-10#1)(2008-2#1)
and in treatment##2##3##(2008-11#1)(2008-7#1)
and in turn##7##3##(1994-1#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#1)
and in two field##2##4##(2008-10#2)
and in two##15##3##(1990-9#1)(1991-12#1)(1993-2#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2012-2#1)(2012-3#1)
and in understanding the##2##4##(1993-11#1)(2007-12#1)
and in utero##2##3##(1994-8#1)(2007-8#1)
and in various##9##3##(1991-9#1)(1992-5#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-8#1)
and in vitro activity of##2##5##(1995-3#1)(2008-11#1)
and in vitro antimicrobial##2##4##(2008-11#1)(2011-2#1)
and in vitro dispersion time##4##5##(2010-3#4)
and in vitro drug##2##4##(2010-5#1)(2011-1#1)
and in vitro phosphorylation##2##4##(1993-8#1)(1995-5#1)
and in vitro studies##8##4##(1991-9#1)(1992-11#1)(1992-9#1)(1994-8#1)(1995-9#1)(2009-1#1)(2010-5#1)(2013-1#1)
and in vitro transcription##2##4##(1994-8#1)(2008-4#1)
and in vitro##122##3##(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-5#3)(1994-8#5)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-2#1)(2010-3#4)(2010-5#3)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#2)
and in vivo and##3##4##(1992-9#1)(2008-10#1)(2008-11#1)
and in vivo assays##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
and in vivo by##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
and in vivo data##5##4##(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
and in vivo efficacy##2##4##(1995-3#1)(2008-5#1)
and in vivo evaluation of##3##5##(1995-3#1)(2008-5#1)(2011-2#1)
and in vivo evaluation##4##4##(1995-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
and in vivo function##2##4##(1992-3#1)(1996-2#1)
and in vivo gene##2##4##(1994-12#1)(2008-4#1)
and in vivo in##4##4##(1991-9#1)(1994-5#1)(1997-6#1)(2007-8#1)
and in vivo methods##2##4##(2008-10#1)(2008-5#1)
and in vivo skin##2##4##(2008-5#1)(2009-6#1)
and in vivo##179##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#4)(1995-3#5)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-8#1)(1997-6#2)(1997-8#1)(2006-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#12)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#24)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-2#4)(2010-6#1)(2011-1#3)(2011-2#7)(2011-7#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
and in water##4##3##(1995-3#1)(2007-12#1)(2008-10#2)
and in what##2##3##(1994-3#1)(2008-11#1)
and in which##5##3##(1993-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)
and in whom the##2##4##(1992-3#1)(2011-2#1)
and in whom##4##3##(1990-3#1)(1992-3#1)(2010-6#1)(2011-2#1)
and in women##3##3##(2008-4#1)(2011-1#1)(2013-1#1)
and in##2218##2##(1990-11#13)(1990-12#11)(1990-2#19)(1990-3#10)(1990-5#9)(1990-6#7)(1990-7#8)(1990-8#9)(1990-9#11)(1991-1#4)(1991-10#1)(1991-11#8)(1991-12#20)(1991-2#10)(1991-3#9)(1991-4#5)(1991-5#8)(1991-6#12)(1991-8#5)(1991-9#12)(1992-1#2)(1992-10#1)(1992-11#9)(1992-12#14)(1992-2#8)(1992-3#10)(1992-4#2)(1992-5#7)(1992-6#8)(1992-8#5)(1992-9#9)(1993-1#6)(1993-11#10)(1993-12#25)(1993-2#9)(1993-3#13)(1993-5#5)(1993-6#8)(1993-8#10)(1993-9#13)(1994-1#3)(1994-11#10)(1994-12#13)(1994-2#16)(1994-3#8)(1994-5#10)(1994-6#13)(1994-7#3)(1994-8#12)(1994-9#8)(1995-1#4)(1995-11#15)(1995-12#19)(1995-2#8)(1995-3#14)(1995-5#13)(1995-6#10)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#22)(1996-2#11)(1996-3#4)(1996-4#2)(1996-5#10)(1996-6#12)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#11)(1997-2#12)(1997-3#21)(1997-4#13)(1997-5#2)(1997-6#11)(1997-7#10)(1997-8#8)(2006-10#2)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#8)(2007-11#33)(2007-12#24)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#22)(2007-9#2)(2008-1#23)(2008-10#396)(2008-11#80)(2008-12#23)(2008-2#26)(2008-3#58)(2008-4#42)(2008-5#88)(2008-6#16)(2008-7#71)(2008-8#48)(2008-9#49)(2009-1#2)(2009-10#11)(2009-11#4)(2009-12#10)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#5)(2009-6#7)(2009-7#10)(2009-8#16)(2009-9#8)(2010-1#4)(2010-11#10)(2010-12#7)(2010-2#9)(2010-3#13)(2010-4#6)(2010-5#9)(2010-6#6)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#34)(2011-2#75)(2011-3#3)(2011-7#1)(2012-1#4)(2012-12#28)(2012-2#32)(2012-3#36)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#55)(2013-7#11)(2013-8#28)
and in-depth interviews##2##3##(2010-12#1)(2013-1#1)
and in-depth##4##2##(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
and in-hospital##2##2##(2008-3#1)(2012-2#1)
and in-house##2##2##(2008-10#1)(2008-12#1)
and in-line##3##2##(2007-12#2)(2008-10#1)
and in-situ##2##2##(2008-10#2)
and in-vitro##2##2##(1992-3#1)(2010-5#1)
and inability to##3##3##(1992-12#1)(2008-7#1)(2011-3#1)
and inactivated##5##2##(1995-5#1)(2008-4#1)(2011-1#1)(2011-2#2)
and inactivation of the##2##4##(1992-11#1)(1994-3#1)
and inactivation of##5##3##(1992-11#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-4#1)
and inactivation##11##2##(1992-11#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-4#1)
and inadequate##13##2##(1990-12#1)(1994-12#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
and inadvertent##2##2##(2007-8#1)(2008-11#1)
and inappropriate (1-3)##2##3##(2010-12#2)
and inappropriate##6##2##(1993-3#1)(1996-12#1)(2009-4#1)(2010-12#2)(2011-2#1)
and inappropriately##2##2##(1995-8#1)(2008-6#1)
and inbreeding##2##2##(2008-12#1)(2008-9#1)
and incentive##2##2##(1993-6#1)(1997-1#1)
and incentives##5##2##(1992-3#1)(1993-2#1)(1996-12#1)(2008-4#1)(2011-2#1)
and incidence angle##3##3##(2007-11#1)(2008-3#2)
and incidence in##2##3##(1991-3#1)(1993-2#1)
and incidence is##2##3##(2008-7#1)(2008-8#1)
and incidence of infection##2##4##(2008-10#2)
and incidence of latent##2##4##(2008-10#2)
and incidence of##33##3##(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-12#1)(1997-3#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
and incidence rate##2##3##(2012-2#1)(2012-3#1)
and incidence##52##2##(1990-6#1)(1990-8#1)(1991-3#3)(1991-8#1)(1992-12#1)(1993-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#3)
and incident##6##2##(2007-11#1)(2008-3#2)(2009-10#2)(2010-10#1)
and incidentally##3##2##(2009-3#1)(2011-2#1)(2013-1#1)
and inclined##2##2##(1990-3#1)(2008-6#1)
and include a##2##3##(1993-12#1)(2008-10#1)
and include both##2##3##(2008-7#1)(2011-2#1)
and include the##5##3##(1992-12#1)(1995-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
and include##39##2##(1992-12#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
and included in a##2##4##(2008-10#1)(2011-7#1)
and included in##4##3##(2008-10#2)(2011-7#1)(2012-2#1)
and included two##2##3##(2008-10#1)(2009-9#1)
and included##29##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-8#1)(1993-8#1)(1994-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
and includes a##8##3##(1994-12#1)(1996-1#1)(1996-2#1)(2008-12#1)(2009-8#1)(2012-2#1)(2013-1#2)
and includes the##5##3##(1995-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)
and includes##36##2##(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and including the##5##3##(1992-8#1)(2008-1#1)(2008-10#1)(2008-3#2)
and including##10##2##(1992-8#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-4#1)(2012-3#1)
and inclusion of##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
and inclusion##6##2##(1996-2#1)(2007-2#1)(2008-10#2)(2011-1#1)(2012-2#1)
and inclusive##2##2##(1990-4#1)(1996-3#1)
and incoherent##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
and income##10##2##(1991-3#1)(1992-3#1)(1994-1#1)(1994-6#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
and incompatible##4##2##(1992-3#1)(2008-10#3)
and incomplete##12##2##(1992-2#1)(1995-12#2)(1997-3#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
and inconclusive##3##2##(2012-2#2)(2013-1#1)
and inconsistency##2##2##(2008-10#1)(2010-2#1)
and inconsistent##7##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
and inconspicuous##2##2##(2008-10#1)(2008-11#1)
and incorporate a##2##3##(2008-12#1)(2012-2#1)
and incorporate##6##2##(1995-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2011-1#1)(2012-2#1)
and incorporated into##6##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
and incorporated##12##2##(1990-7#1)(1992-3#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
and incorporates##5##2##(1993-12#1)(1993-3#1)(2007-11#1)(2008-4#1)(2009-5#1)
and incorporating##4##2##(1995-2#1)(2007-11#1)(2008-10#2)
and incorporation in##2##3##(2008-10#1)(2009-3#1)
and incorporation of##5##3##(1992-9#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-3#1)
and incorporation##10##2##(1992-9#1)(1993-3#2)(1994-12#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)
and incorrect##2##2##(1991-9#1)(2011-2#1)
and increase in the##5##4##(1990-12#1)(1992-6#1)(1995-4#1)(2008-1#1)(2012-2#1)
and increase in##13##3##(1990-12#1)(1992-6#2)(1994-6#1)(1995-4#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#2)
and increase its referral base##2##5##(1994-3#2)
and increase of the##2##4##(2008-7#1)(2011-1#1)
and increase of##11##3##(1990-12#1)(1992-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#2)(2013-1#2)
and increase the sensitivity of##2##5##(1997-3#1)(2008-10#1)
and increase the##22##3##(1992-9#1)(1993-2#1)(1994-2#2)(1997-3#1)(1997-5#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#3)(2013-8#1)
and increase with##2##3##(1990-12#1)(2008-10#1)
and increase##81##2##(1990-12#3)(1991-3#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-2#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-4#1)(1995-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
and increased again##2##3##(2008-10#1)(2008-2#1)
and increased apoptosis##2##3##(2008-3#1)(2012-4#1)
and increased catabolism of##2##4##(2008-6#2)
and increased cell##2##3##(1995-3#1)(2009-12#1)
and increased exponentially with##2##4##(2008-10#2)
and increased from##2##3##(2008-10#1)(2009-7#1)
and increased health care costs##2##5##(2008-1#2)
and increased in the##2##4##(1996-5#1)(2008-12#1)
and increased in##6##3##(1996-5#2)(2008-10#2)(2008-12#1)(2008-8#1)
and increased intensity of##2##4##(2007-7#1)(2012-2#1)
and increased intensity##3##3##(1996-5#1)(2007-7#1)(2012-2#1)
and increased knowledge of##2##4##(2010-8#1)(2012-12#1)
and increased length of##2##4##(2008-6#1)(2009-7#1)
and increased levels of##3##4##(1992-8#1)(2011-2#1)(2013-1#1)
and increased mortality##4##3##(1996-3#1)(2010-12#1)(2012-3#1)(2013-8#1)
and increased plant##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
and increased plasma##2##3##(2008-6#1)(2011-1#1)
and increased risk of##3##4##(2007-8#1)(2008-9#1)(2012-12#1)
and increased significantly##3##3##(1992-6#1)(1996-2#1)(2008-9#1)
and increased specific##2##3##(2008-11#1)(2013-1#1)
and increased temperature##2##3##(2008-2#1)(2012-1#1)
and increased the percentage of##2##5##(1991-11#1)(1996-3#1)
and increased the##18##3##(1991-11#1)(1993-1#1)(1993-8#1)(1994-11#1)(1996-2#2)(1996-3#1)(2008-10#5)(2008-5#2)(2009-7#1)(2011-1#1)(2012-2#2)
and increased to##3##3##(1990-7#1)(2008-10#2)
and increased with age##3##4##(2011-1#2)(2013-3#1)
and increased with increasing##2##4##(2008-10#1)(2010-8#1)
and increased with##12##3##(2008-10#4)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-3#1)
and increased##240##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#3)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#41)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#6)(2008-7#4)(2008-8#9)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#13)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#4)(2012-4#2)(2013-1#9)(2013-3#1)(2013-7#2)(2013-8#3)
and increases in CRP##2##4##(2008-8#2)
and increases in##11##3##(1990-12#1)(1991-2#1)(1996-4#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-8#2)
and increases the##16##3##(1992-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#2)
and increases to the##2##4##(2009-2#2)
and increases to##3##3##(2008-1#1)(2009-2#2)
and increases with##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
and increases##54##2##(1990-12#2)(1991-2#1)(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-8#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
and increasing costs##2##3##(1995-3#1)(2008-7#1)
and increasing numbers of##3##4##(1993-3#1)(2008-9#1)(2013-1#1)
and increasing the##14##3##(1990-5#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
and increasing##69##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-12#3)(1994-5#1)(1995-3#1)(1997-3#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#2)(2012-12#2)(2013-1#5)
and increasingly##4##2##(1995-2#1)(1995-6#1)(2006-6#1)(2008-6#1)
and incubated at 37 degrees C##2##6##(2008-10#1)(2008-11#1)
and incubated at##10##3##(1992-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)
and incubated for##2##3##(2008-10#2)
and incubated in##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
and incubated with##5##3##(1992-8#1)(1994-8#1)(1996-12#1)(2008-4#1)(2011-1#1)
and incubated##26##2##(1992-3#1)(1992-8#1)(1994-8#1)(1996-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-3#1)(2011-1#1)(2013-1#1)
and incubation period##2##3##(2008-10#2)
and incubation temperature##2##3##(2008-5#1)(2008-8#1)
and incubation temperatures##2##3##(2008-10#1)(2008-5#1)
and incubation time of##3##4##(1996-2#2)(2008-10#1)
and incubation time##7##3##(1996-2#2)(2008-10#2)(2010-5#1)(2011-3#1)(2012-6#1)
and incubation##19##2##(1996-2#2)(2007-2#1)(2008-10#10)(2008-5#2)(2008-8#1)(2010-5#1)(2011-3#1)(2012-6#1)
and indeed##7##2##(1993-11#1)(1995-11#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-6#1)
and independence in##3##3##(2007-11#2)(2007-7#1)
and independence##9##2##(1991-12#1)(1995-3#1)(2007-11#2)(2007-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
and independent contrasts##3##3##(1997-4#1)(2008-9#2)
and independent mechanisms##2##3##(1991-1#1)(1991-9#1)
and independent of##8##3##(1990-2#1)(1990-7#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
and independent##42##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-6#1)(1995-9#1)(1996-2#2)(1997-4#2)(2007-11#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and independently of the##2##4##(2008-5#1)(2008-7#1)
and independently of##3##3##(1994-11#1)(2008-5#1)(2008-7#1)
and independently##11##2##(1994-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and indeterminate##2##2##(1996-2#1)(2008-12#1)
and index mismatch##2##3##(2008-3#2)
and index of##2##3##(2008-10#1)(2012-1#1)
and index##7##2##(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#2)(2012-1#1)
and indexing##2##2##(2009-10#1)(2010-5#1)
and indicate that the##2##4##(1990-11#1)(1992-4#1)
and indicate that##21##3##(1990-11#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-2#1)
and indicate##28##2##(1990-11#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
and indicated that##7##3##(1990-7#1)(1995-2#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-7#1)
and indicated the##3##3##(2008-12#1)(2008-6#1)(2008-8#1)
and indicated##14##2##(1990-7#1)(1994-11#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-12#1)(2011-1#1)
and indicates that the##4##4##(1993-2#2)(2008-3#1)(2010-8#1)
and indicates that##12##3##(1990-5#1)(1993-2#2)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
and indicates##23##2##(1990-5#1)(1993-2#2)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
and indications for##9##3##(1994-11#1)(2006-12#1)(2007-11#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
and indications##11##2##(1991-9#1)(1994-11#1)(2006-12#1)(2007-11#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-8#1)
and indicator##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
and indicators of##2##3##(1991-12#1)(2012-12#1)
and indicators##3##2##(1991-12#1)(2008-1#1)(2012-12#1)
and indices of##3##3##(1992-9#2)(2013-1#1)
and indices##5##2##(1992-9#2)(2008-11#1)(2008-2#1)(2013-1#1)
and indigenous##5##2##(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
and indigo carmine##3##3##(1993-8#1)(2008-10#2)
and indigo##4##2##(1993-8#1)(1996-6#1)(2008-10#2)
and indirect PAD##3##3##(2008-10#3)
and indirect effects of##6##4##(1997-1#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-1#1)
and indirect effects##10##3##(1991-12#1)(1997-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)(2012-2#1)
and indirect methods##2##3##(2008-3#1)(2012-3#1)
and indirect statistical##2##3##(2009-5#1)(2011-1#1)
and indirect##56##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-6#1)(1992-3#1)(1996-2#1)(1997-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and indirectly##15##2##(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#3)(2012-3#2)
and indiscriminate##2##2##(2008-3#1)(2012-12#1)
and indium in##2##3##(2008-1#1)(2008-10#1)
and indium##9##2##(2008-1#1)(2008-10#7)(2010-6#1)
and indium(III)##3##2##(2008-10#3)
and individual case##2##3##(1992-2#1)(1994-3#1)
and individual difference factors in##2##5##(2009-4#2)
and individual differences##2##3##(1992-7#1)(2013-8#1)
and individual##50##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-2#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
and individual-based##3##2##(2008-9#3)
and individual-level##4##2##(1992-6#1)(1994-9#1)(2008-8#1)(2010-7#1)
and individualise##2##2##(2007-11#1)(2008-6#1)
and individualized##6##2##(1992-8#1)(2007-11#1)(2008-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
and individually##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
and individuals are##2##3##(1994-2#1)(1997-8#1)
and individuals with##2##3##(2010-4#1)(2012-3#1)
and individuals##18##2##(1991-2#1)(1992-9#1)(1994-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and indole##2##2##(1994-8#1)(2008-10#1)
and indomethacin##4##2##(1990-11#1)(2008-10#1)(2008-11#2)
and indoor##5##2##(2012-1#1)(2013-1#3)(2013-8#1)
and induce expression of##2##4##(2008-8#1)(2009-4#1)
and induce##20##2##(1993-6#1)(1994-11#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
and induced a##2##3##(2008-4#1)(2013-1#1)
and induced apoptosis##4##3##(2008-9#1)(2011-2#2)(2013-1#1)
and induced changes in##2##4##(2008-9#1)(2012-5#1)
and induced mutations##2##3##(1991-9#1)(2008-7#1)
and induced pluripotent stem cells##3##5##(2012-12#1)(2012-2#2)
and induced resistance##2##3##(2008-10#1)(2008-8#1)
and induced the##2##3##(1994-11#1)(2008-10#1)
and induced tumor##2##3##(2010-1#1)(2010-3#1)
and induced##51##2##(1990-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#4)(2013-8#1)
and inducements##2##2##(1991-1#2)
and inducer##2##2##(1995-8#1)(2010-6#1)
and induces apoptosis##2##3##(2011-2#1)(2013-1#1)
and induces the##2##3##(1994-11#1)(2008-11#1)
and induces##13##2##(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and inducible expression of##3##4##(1990-12#1)(1993-12#1)(1995-5#1)
and inducible##9##2##(1990-12#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-2#1)
and inducing##7##2##(1991-9#1)(1992-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-2#1)
and induction of apoptosis##2##4##(2008-10#1)(2008-12#1)
and induction of##23##3##(1990-12#1)(1992-12#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
and induction##28##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
and inductively coupled plasma atomic emission##3##6##(2008-10#3)
and inductively coupled plasma mass spectrometry (ICP-MS)##4##7##(2008-10#4)
and inductively coupled plasma mass spectrometry##7##6##(2008-10#7)
and inductively coupled plasma mass##8##5##(2008-10#8)
and inductively coupled plasma##13##4##(2008-10#13)
and inductively coupled plasma-mass##2##4##(2008-10#2)
and inductively coupled##16##3##(2008-10#16)
and inductively##17##2##(2008-10#17)
and industrial applications##2##3##(2008-10#1)(2009-7#1)
and industrial processes##2##3##(1991-6#1)(2008-10#1)
and industrial waste water##2##4##(2008-10#2)
and industrial##38##2##(1991-6#1)(1993-3#1)(2008-10#21)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
and industrially##2##2##(2008-11#1)(2012-12#1)
and industry##12##2##(1991-12#1)(1991-3#2)(1992-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
and indwelling##2##2##(1991-11#1)(2012-2#1)
and ineffective##8##2##(1997-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-3#1)(2013-1#3)
and inefficient##3##2##(1992-11#1)(2009-2#1)(2012-2#1)
and inert##5##2##(1997-4#1)(2008-10#3)(2008-8#1)
and inevitably##4##2##(1996-2#1)(1997-1#1)(2008-7#2)
and inexpensive##25##2##(1991-6#1)(1992-11#1)(1994-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-6#1)(2010-9#1)(2011-1#1)(2013-8#1)
and inexpensively##2##2##(1996-11#1)(2008-12#1)
and infancy##2##2##(2008-11#1)(2012-12#1)
and infant formula##2##3##(2008-10#2)
and infant health##3##3##(2007-10#1)(2010-12#1)(2010-5#1)
and infant mortality##3##3##(1994-3#1)(1997-8#1)(2013-1#1)
and infant##25##2##(1991-12#1)(1992-6#1)(1993-3#1)(1994-3#2)(1995-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2013-1#1)
and infantile##3##2##(2007-12#1)(2008-11#1)(2011-1#1)
and infants##8##2##(1994-3#1)(1994-6#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-11#1)(2012-2#1)
and infarct##3##2##(2007-10#1)(2007-8#1)(2013-1#1)
and infarction##4##2##(1991-11#1)(1995-8#1)(2006-10#1)(2008-3#1)
and infect##2##2##(1997-3#1)(2008-5#1)
and infected leaves##2##3##(2008-10#2)
and infected with##8##3##(1995-12#1)(2008-10#7)
and infected##28##2##(1992-8#1)(1993-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-10#19)(2008-8#1)(2011-2#1)(2012-3#2)
and infection are##4##3##(1997-4#1)(2008-10#1)(2009-3#1)(2011-10#1)
and infection control strategies##3##4##(2007-12#1)(2007-7#1)(2011-2#1)
and infection control##6##3##(1995-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2011-2#1)
and infection efficiency##2##3##(2008-10#2)
and infection frequency##3##3##(2008-10#3)
and infection in##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
and infection of##7##3##(2008-10#5)(2011-1#1)(2011-2#1)
and infection rates##2##3##(2008-10#1)(2013-8#1)
and infection with##2##3##(1996-12#1)(2010-8#1)
and infection##62##2##(1991-6#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-12#4)(2007-7#2)(2008-10#31)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-5#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
and infections##11##2##(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and infectious complications##5##3##(2007-11#1)(2008-5#2)(2011-2#1)(2011-3#1)
and infectious diseases##3##3##(1994-11#1)(2008-10#1)(2008-7#1)
and infectious##20##2##(1994-11#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#2)
and infectivity of##3##3##(2008-10#2)(2011-3#1)
and infectivity##5##2##(2008-10#2)(2011-3#1)(2012-2#1)(2013-1#1)
and infer##2##2##(2008-3#1)(2010-10#1)
and inferior##12##2##(1995-12#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
and inferotemporal##2##2##(1997-2#1)(2006-12#1)
and infertility in##3##3##(1995-2#1)(2008-4#1)(2010-11#1)
and infertility##11##2##(1990-3#1)(1995-2#3)(2008-12#1)(2008-4#2)(2010-11#1)(2011-1#3)
and infested with##3##3##(2008-10#3)
and infested##7##2##(1996-12#1)(2008-10#6)
and infiltrated##2##2##(2008-10#2)
and infiltration of##4##3##(2008-10#1)(2010-1#3)
and infinite##4##2##(2008-11#1)(2008-3#2)(2008-8#1)
and inflamed##2##2##(1995-11#1)(2013-1#1)
and inflammation and##4##3##(2008-9#1)(2010-5#1)(2012-12#2)
and inflammation in the##5##4##(2008-4#3)(2010-8#1)(2012-12#1)
and inflammation in##7##3##(2008-4#3)(2010-8#1)(2011-2#2)(2012-12#1)
and inflammation that##2##3##(2008-9#1)(2012-2#1)
and inflammation##34##2##(1995-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and inflammatory bowel##2##3##(2007-10#1)(2013-1#1)
and inflammatory response##3##3##(2008-8#1)(2008-9#1)(2010-11#1)
and inflammatory responses##2##3##(1991-8#1)(2011-2#1)
and inflammatory##32##2##(1990-6#1)(1991-2#1)(1991-8#3)(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1997-5#1)(1997-8#1)(2007-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#1)
and infliximab are##2##3##(2010-12#2)
and infliximab##4##2##(2010-12#4)
and influence of##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
and influence the##6##3##(1992-9#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
and influence##19##2##(1992-6#1)(1992-9#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-1#2)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
and influences##6##2##(2008-11#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-1#2)
and influencing##4##2##(1992-6#1)(1997-1#1)(2008-10#1)(2011-1#1)
and influent##3##2##(2008-10#3)
and influential##3##2##(1995-3#1)(2008-10#1)(2010-12#1)
and influenza A##2##3##(2012-2#1)(2013-1#1)
and influenza B viruses##2##4##(1994-9#1)(1996-6#1)
and influenza virus##4##3##(1994-6#1)(1995-5#1)(2008-10#2)
and influenza##10##2##(1992-4#1)(1992-6#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-6#1)(2008-10#2)(2012-2#1)(2013-1#1)
and influx##2##2##(1991-5#1)(1992-12#1)
and inform efforts to##2##4##(2008-10#1)(2009-5#1)
and inform##3##2##(2008-10#1)(2008-12#1)(2009-5#1)
and informal##6##2##(1992-12#2)(1996-3#1)(2008-11#1)(2008-12#1)(2010-8#1)
and informatics##2##2##(2007-11#1)(2008-10#1)
and information about the##3##4##(2008-2#1)(2008-3#1)(2009-11#1)
and information about##5##3##(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#1)
and information dissemination##2##3##(1990-3#1)(2011-1#1)
and information exchange##2##3##(1995-12#1)(1996-1#1)
and information literacy##3##3##(2008-11#3)
and information management##2##3##(1993-2#1)(2008-10#1)
and information on##3##3##(1993-12#1)(1995-6#1)(2011-2#1)
and information regarding##2##3##(1994-12#1)(2008-7#1)
and information retrieval##2##3##(1996-12#1)(2008-11#1)
and information systems##7##3##(1993-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#3)
and information technology##9##3##(1994-12#1)(2008-11#4)(2008-7#1)(2011-1#1)(2012-2#2)
and information##52##2##(1990-3#1)(1992-11#1)(1993-12#1)(1993-2#2)(1994-12#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#3)(2007-11#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)
and informative##3##2##(1994-9#1)(2009-9#1)(2011-1#1)
and informed consent##3##3##(1995-1#1)(1996-11#1)(2010-11#1)
and informed##11##2##(1991-2#1)(1991-7#1)(1992-12#1)(1995-1#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-11#1)
and infrared (IR)##2##3##(2008-10#1)(2008-5#1)
and infrared radiation##2##3##(2007-11#1)(2008-2#1)
and infrared spectra of##2##4##(1996-2#1)(2008-11#1)
and infrared spectra##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2010-5#1)
and infrared spectral##2##3##(2008-3#2)
and infrared spectroscopy##2##3##(2008-10#1)(2012-2#1)
and infrared##20##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-8#1)
and infrastructure##3##2##(1997-1#1)(2010-12#1)(2012-12#1)
and ingestion##2##2##(2008-10#1)(2008-6#1)
and inguinal##6##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
and inhalation of##2##3##(2012-3#1)(2013-1#1)
and inhalation##5##2##(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
and inhalational##2##2##(2010-7#1)(2012-3#1)
and inhaled##5##2##(1992-3#1)(1997-1#1)(2010-10#2)(2013-1#1)
and inhaler use##2##3##(1996-1#1)(2010-6#1)
and inhaler##3##2##(1996-1#1)(2007-11#1)(2010-6#1)
and inherent##3##2##(1991-12#1)(2008-7#1)(2013-1#1)
and inheritance of##2##3##(2008-10#1)(2009-3#1)
and inheritance##4##2##(1991-3#1)(2008-10#1)(2009-3#1)(2011-2#1)
and inherited##3##2##(1992-9#1)(2008-11#1)(2012-3#1)
and inhibin##4##2##(1992-8#1)(2008-8#3)
and inhibit the##8##3##(1991-9#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
and inhibit##20##2##(1990-5#1)(1991-9#1)(1994-5#1)(1994-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#4)(2009-10#1)(2011-2#1)(2013-1#1)
and inhibited by##5##3##(1990-12#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-7#1)
and inhibited cell growth##2##4##(1994-11#1)(2008-10#1)
and inhibited cell##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
and inhibited growth##2##3##(1990-6#1)(2008-10#1)
and inhibited the##7##3##(1991-6#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
and inhibited##29##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and inhibiting##6##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-10#1)
and inhibition by##2##3##(1990-11#1)(1992-11#1)
and inhibition of the##2##4##(1991-8#1)(2008-11#1)
and inhibition of##31##3##(1990-5#1)(1991-8#2)(1991-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-4#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#2)(2013-1#1)
and inhibition##40##2##(1990-11#1)(1990-5#2)(1991-10#1)(1991-8#2)(1991-9#1)(1992-11#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-4#3)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#2)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
and inhibitor of##2##3##(1991-9#1)(2013-1#1)
and inhibitor##5##2##(1991-9#1)(1995-2#1)(2008-4#1)(2013-1#1)(2013-7#1)
and inhibitors of the##2##4##(1994-3#1)(1994-8#1)
and inhibitors of##4##3##(1994-3#1)(1994-8#1)(1997-4#1)(2008-5#1)
and inhibitors##10##2##(1991-5#1)(1994-3#1)(1994-8#2)(1995-8#1)(1997-4#1)(2006-6#1)(2007-10#1)(2008-5#2)
and inhibitory effects##2##3##(1995-11#1)(2008-10#1)
and inhibitory##18##2##(1990-7#1)(1991-5#1)(1992-6#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)
and inhibits the formation of##2##5##(2008-5#1)(2011-2#1)
and inhibits the##8##3##(1990-11#1)(1990-7#1)(1994-11#1)(1994-5#1)(1995-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
and inhibits##21##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-12#2)(1997-1#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)
and inhomogeneous##4##2##(2008-3#3)(2009-7#1)
and initial characterization of##5##4##(1990-11#1)(1990-7#1)(1991-5#1)(2008-4#1)(2008-9#1)
and initial management of##2##4##(2007-10#1)(2007-12#1)
and initial management##3##3##(2007-10#1)(2007-12#1)(2011-2#1)
and initial rate##4##3##(2008-10#4)
and initial##47##2##(1990-11#1)(1990-7#1)(1991-5#1)(1994-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-8#1)(2013-1#1)
and initially##3##2##(1996-9#1)(2008-10#1)(2011-2#1)
and initiate its##2##3##(1997-4#1)(2013-7#1)
and initiate##9##2##(1992-9#1)(1995-11#1)(1997-4#1)(2008-11#2)(2008-4#1)(2009-8#1)(2011-3#1)(2013-7#1)
and initiated##3##2##(1991-8#1)(2008-10#1)(2010-1#1)
and initiates##2##2##(1990-12#1)(2009-3#1)
and initiating a##2##3##(2008-1#1)(2010-7#1)
and initiating##6##2##(1991-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-7#1)(2011-2#1)
and initiation of##9##3##(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
and initiative##2##2##(1995-2#1)(1997-8#1)
and initiatives##2##2##(2008-12#1)(2010-12#1)
and injected into##4##3##(1993-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
and injected##9##2##(1991-12#1)(1993-8#1)(1997-8#1)(2007-12#1)(2008-10#3)(2011-2#1)(2013-7#1)
and injecting##3##2##(2007-7#1)(2008-10#2)
and injection of##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
and injection##9##2##(1997-8#1)(2008-10#5)(2008-7#1)(2011-2#1)(2013-1#1)
and injections##2##2##(2008-10#1)(2010-5#1)
and injured##3##2##(2008-4#1)(2009-6#1)(2013-8#1)
and injuries##8##2##(1990-6#1)(1995-12#1)(1995-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2010-11#1)(2012-12#1)
and injury to##2##3##(1996-8#1)(2010-9#1)
and injury##17##2##(1990-5#2)(1995-6#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
and inland##8##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2012-1#1)(2013-7#1)
and innate##2##2##(2012-3#1)(2013-1#1)
and inner ear##2##3##(2006-12#1)(2011-2#1)
and inner##16##2##(1990-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-8#1)
and innervation##2##2##(2007-12#2)
and innovation in health care##2##5##(1995-1#2)
and innovation in##3##3##(1995-1#2)(2008-1#1)
and innovation of##2##3##(2012-2#1)(2012-3#1)
and innovation##12##2##(1994-2#1)(1995-1#5)(2008-1#1)(2008-11#1)(2012-2#3)(2012-3#1)
and innovations##2##2##(1992-3#1)(1995-1#1)
and innovative ways##2##3##(1992-12#1)(1997-2#1)
and innovative##16##2##(1992-12#1)(1993-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-11#3)(2012-2#2)(2012-3#1)
and innovativeness##2##2##(2010-11#2)
and inoculated with R##2##4##(2008-10#2)
and inoculated with##8##3##(2008-10#7)(2013-1#1)
and inoculated##17##2##(1990-8#1)(1991-8#1)(2007-12#1)(2008-10#12)(2011-1#1)(2013-1#1)
and inoculation of the##2##4##(2008-10#2)
and inoculation of##3##3##(2008-10#2)(2008-9#1)
and inoculation##10##2##(2008-10#9)(2008-9#1)
and inoculum concentration##2##3##(1994-5#1)(2008-10#1)
and inoculum densities##2##3##(2008-10#2)
and inoculum density of##3##4##(2008-10#3)
and inoculum density##5##3##(1997-6#1)(2008-10#4)
and inoculum size##2##3##(2008-6#2)
and inoculum##18##2##(1994-5#1)(1997-6#1)(2008-10#13)(2008-12#1)(2008-6#2)
and inorganic anions##8##3##(2008-10#8)
and inorganic ions##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
and inorganic mercury##5##3##(2008-10#5)
and inorganic##40##2##(1994-2#1)(1996-7#1)(1997-3#1)(2008-10#28)(2008-11#3)(2008-3#1)(2008-7#2)(2009-7#1)(2010-4#1)(2011-2#1)
and inosine triphosphatase##2##3##(2013-1#2)
and inosine##6##2##(1992-3#1)(1993-12#3)(2013-1#2)
and inositol 1##5##3##(1991-12#2)(1994-8#1)(1995-2#1)(1997-8#1)
and inositol trisphosphate##4##3##(1990-8#1)(1991-12#1)(1992-12#1)(1995-2#1)
and inositol##16##2##(1990-12#1)(1990-8#1)(1991-12#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-8#1)(1995-2#2)(1997-8#1)(2008-10#1)(2008-11#1)
and inotropic support##2##3##(2010-5#1)(2013-1#1)
and inpatient care##2##3##(1991-11#1)(1995-2#1)
and inpatient##5##2##(1991-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-3#1)
and inpatients##2##2##(2011-2#2)
and input from##2##3##(2008-11#1)(2008-7#1)
and input##5##2##(1993-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
and insect vectors##3##3##(2008-10#3)
and insect##12##2##(2008-10#10)(2008-8#1)(2008-9#1)
and insects##7##2##(1995-2#1)(1997-4#1)(2008-10#3)(2009-8#2)
and insensitive to##2##3##(1990-7#1)(2008-10#1)
and insensitive##6##2##(1990-7#1)(2008-10#5)
and insensitivity to##3##3##(1990-11#1)(1995-5#1)(2008-2#1)
and inserted into##5##3##(1997-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
and inserted##9##2##(1990-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)
and insertion of##2##3##(2008-6#1)(2012-2#1)
and insertion polymorphism in##2##4##(1995-3#2)
and insertion##7##2##(1990-11#1)(1995-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
and insertions##5##2##(1995-2#1)(2008-1#1)(2008-4#2)(2008-9#1)
and inshore##2##2##(2007-5#1)(2013-7#1)
and inside the##2##3##(2008-10#1)(2008-3#1)
and inside##7##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)
and inside-out patch recordings##2##4##(1995-11#2)
and inside-out patch##4##3##(1994-12#1)(1995-11#3)
and insight into##3##3##(1991-2#1)(1997-4#1)(2008-7#1)
and insight##5##2##(1991-2#1)(1997-4#1)(2008-6#2)(2008-7#1)
and insights into##2##3##(2008-10#1)(2008-11#1)
and insights##4##2##(2008-10#1)(2008-11#2)(2010-3#1)
and insignificant##5##2##(1996-3#1)(2008-10#3)(2008-6#1)
and insoluble fractions of##2##4##(1994-11#1)(1997-4#1)
and insoluble##12##2##(1990-5#1)(1994-11#2)(1994-3#1)(1996-1#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-4#1)
and insomnia##2##2##(2010-7#1)(2011-2#1)
and instability of the##2##4##(1990-5#1)(1992-12#1)
and instability##8##2##(1990-5#1)(1992-12#1)(2007-11#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
and installation of##2##3##(1996-2#1)(2008-4#1)
and installation##3##2##(1996-2#1)(2008-4#1)(2008-7#1)
and installed##2##2##(2008-11#1)(2009-8#1)
and installing the##2##3##(1994-1#2)
and instead##8##2##(1992-2#1)(1995-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)
and institution of##3##3##(2008-1#1)(2008-3#1)(2011-1#1)
and institution##4##2##(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)
and institutional##12##2##(1991-1#1)(1991-6#1)(1993-12#1)(1995-3#2)(2008-1#1)(2008-3#1)(2009-10#2)(2009-11#1)(2009-4#1)(2011-2#1)
and institutionalised##2##2##(2008-7#1)(2012-12#1)
and institutionalization##3##2##(2007-10#1)(2009-7#1)(2013-1#1)
and institutions##13##2##(1990-6#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-5#1)(2007-8#1)(2008-7#2)(2009-4#1)(2010-3#1)(2010-7#1)(2010-8#1)
and instruction##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
and instructions on##2##3##(1991-2#1)(2009-11#1)
and instructions##3##2##(1991-2#1)(2008-4#1)(2009-11#1)
and instrument##6##2##(1996-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)
and instrumental drift##2##3##(2008-10#2)
and instrumental evaluation##2##3##(2008-5#2)
and instrumental parameters##3##3##(1990-3#1)(2008-10#2)
and instrumental texture##2##3##(2010-4#1)(2011-2#1)
and instrumental variables##5##3##(2008-10#5)
and instrumental##29##2##(1990-3#2)(1990-6#1)(1991-3#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2010-4#2)(2011-2#1)(2012-2#1)
and instrumentation##12##2##(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2013-1#1)
and instruments for##2##3##(2008-9#2)
and instruments##6##2##(2008-10#2)(2008-6#1)(2008-9#2)(2009-7#1)
and insufficient##6##2##(1990-2#1)(1991-6#1)(2008-10#1)(2009-10#2)(2011-3#1)
and insulin are##2##3##(1990-8#1)(2010-6#1)
and insulin levels##6##3##(1992-6#1)(2008-1#1)(2010-8#1)(2012-3#1)(2013-1#2)
and insulin receptors##2##3##(2008-4#1)(2008-5#1)
and insulin resistance as##2##4##(1992-8#1)(2009-11#1)
and insulin resistance in##5##4##(2008-9#1)(2012-2#2)(2013-1#2)
and insulin resistance##23##3##(1992-8#1)(2008-1#3)(2008-3#3)(2008-4#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
and insulin sensitivity##10##3##(1994-12#4)(2008-1#2)(2010-10#1)(2011-1#1)(2012-3#2)
and insulin were##4##3##(1991-2#1)(1991-5#1)(2010-8#1)(2012-2#1)
and insulin##79##2##(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-12#5)(1996-11#2)(2007-10#1)(2008-1#9)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#7)(2013-8#1)
and insulin-dependent diabetes mellitus##2##4##(1996-8#1)(1997-3#1)
and insulin-dependent diabetes##3##3##(1990-5#1)(1996-8#1)(1997-3#1)
and insulin-like growth factor##5##4##(1995-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)
and insulin-like growth factor-I##4##4##(1993-11#1)(1995-12#1)(2007-11#1)(2010-8#1)
and insulin-like growth##12##3##(1990-12#1)(1993-11#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#1)
and insulin-like##13##2##(1990-12#1)(1993-11#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#1)
and insurance companies##3##3##(1994-3#2)(2012-12#1)
and insurance##6##2##(1992-12#1)(1994-3#2)(1996-12#1)(1997-2#1)(2012-12#1)
and insurers##4##2##(1991-12#1)(1995-2#1)(1997-1#1)(2008-7#1)
and intact rats##2##3##(1996-2#1)(2008-7#1)
and intact##9##2##(1991-5#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)
and intake##3##2##(2010-2#1)(2011-1#1)(2011-2#1)
and integral##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
and integrate the##2##3##(1995-2#1)(2008-10#1)
and integrate##10##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-12#1)(2010-1#1)(2010-3#1)(2010-5#1)
and integrated health care systems##3##5##(1997-1#2)(1997-2#1)
and integrated health care##4##4##(1995-2#1)(1997-1#2)(1997-2#1)
and integrated into the##2##4##(1992-3#1)(1994-2#1)
and integrated into##3##3##(1992-3#1)(1994-2#1)(1996-8#1)
and integrated networks##2##3##(1996-3#2)
and integrated to##2##3##(2010-8#1)(2011-2#1)
and integrated with##2##3##(2011-2#1)(2012-12#1)
and integrated##30##2##(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
and integrates##5##2##(1992-12#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-2#1)
and integrating##3##2##(1993-1#1)(1996-12#1)(1997-3#1)
and integration of various##2##4##(1994-7#1)(1997-7#1)
and integration of##11##3##(1992-12#1)(1994-2#2)(1994-7#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-3#1)
and integration##23##2##(1992-12#1)(1992-6#1)(1994-2#2)(1994-7#1)(1995-12#2)(1996-12#2)(1996-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-4#1)(2010-8#1)(2012-3#2)
and integrative##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
and integrin α(v) β(3)##2##4##(2010-12#2)
and integrin##5##2##(2008-11#2)(2010-12#2)(2010-6#1)
and integrins##3##2##(2008-4#1)(2008-7#1)(2009-3#1)
and integrity of the##3##4##(1994-5#1)(2008-7#1)(2012-12#1)
and integrity of##5##3##(1994-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and integrity##12##2##(1994-5#1)(2008-5#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and intellectual##7##2##(1997-5#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)
and intellectually##3##2##(1995-1#1)(2009-8#1)(2013-1#1)
and intelligence##3##2##(2008-4#1)(2008-7#1)(2009-8#1)
and intended##3##2##(1993-3#1)(2008-11#1)(2008-9#1)
and intense##5##2##(1991-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-7#1)
and intensified##2##2##(2008-10#1)(2012-12#1)
and intensifying##2##2##(2008-4#1)(2011-1#1)
and intensity of activity##2##4##(2008-12#1)(2010-11#1)
and intensity of the##8##4##(1990-3#1)(1993-12#2)(1997-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
and intensity of treatment##2##4##(1993-1#1)(2009-11#1)
and intensity of##28##3##(1990-3#1)(1991-2#3)(1993-1#1)(1993-12#2)(1994-3#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
and intensity##48##2##(1990-3#1)(1991-2#4)(1992-12#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#6)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
and intensity-modulated##2##2##(2008-2#2)
and intensive care management##2##4##(2010-10#1)(2010-7#1)
and intensive care##9##3##(1991-3#2)(2006-10#1)(2009-5#2)(2010-10#1)(2010-7#1)(2011-2#2)
and intensive##14##2##(1991-3#2)(1992-3#1)(1994-12#1)(1996-12#1)(2006-10#1)(2008-6#1)(2009-5#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)
and intensively##2##2##(2008-10#1)(2008-7#1)
and intent to use condoms##2##5##(2008-4#2)
and intention to resume tobacco##2##5##(2007-12#2)
and intention to##3##3##(1993-12#1)(2007-12#2)
and intention##4##2##(1993-12#1)(2007-12#2)(2008-7#1)
and intentional##7##2##(1990-3#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)
and intentions##2##2##(1991-3#2)
and inter row spacing##2##4##(2008-12#2)
and inter-assay coefficients of variation were##4##6##(1990-12#1)(2008-10#2)(2010-5#1)
and inter-assay coefficients of variation##5##5##(1990-11#1)(1990-12#1)(2008-10#2)(2010-5#1)
and inter-assay precision##3##3##(1995-2#1)(2008-10#2)
and inter-assay##10##2##(1990-11#1)(1990-12#1)(1995-2#1)(2008-10#5)(2010-5#1)(2011-3#1)
and inter-day accuracy##2##3##(2008-10#2)
and inter-day coefficients of variation##2##5##(2008-10#2)
and inter-day precision##4##3##(2008-10#2)(2011-2#1)(2011-3#1)
and inter-day##13##2##(2008-10#11)(2011-2#1)(2011-3#1)
and inter-individual variations##4##3##(1996-12#2)(2013-8#2)
and inter-observer##2##2##(2008-11#1)(2012-3#1)
and inter-professional##2##2##(2008-11#1)(2010-10#1)
and inter-rater reliability of##3##4##(1993-12#2)(2012-12#1)
and inter-rater reliability##5##3##(1993-12#2)(2008-10#1)(2012-12#2)
and interact with the##2##4##(2008-8#1)(2010-4#1)
and interact with##6##3##(1995-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-4#1)
and interact##7##2##(1995-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-4#1)
and interacting with##2##3##(2008-11#1)(2008-3#1)
and interacting##6##2##(1996-3#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
and interaction effects##2##3##(2008-10#1)(2008-2#1)
and interaction of##5##3##(1992-6#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-2#1)
and interaction with other##2##4##(1997-8#1)(2008-5#1)
and interaction with the##2##4##(1997-1#1)(2007-6#1)
and interaction with##8##3##(1990-8#1)(1995-8#1)(1997-1#1)(1997-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#1)
and interaction##27##2##(1990-8#1)(1992-6#2)(1995-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
and interactions between##2##3##(2007-7#1)(2008-5#1)
and interactions of##3##3##(1992-9#1)(2008-10#2)
and interactions with##2##3##(2008-10#2)
and interactions##17##2##(1991-2#1)(1992-9#1)(1995-5#1)(1995-6#1)(2007-7#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
and interactive effects of##2##4##(2008-10#1)(2012-3#1)
and interactive##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#3)
and interacts with the##3##4##(1995-5#1)(1996-2#1)(2008-10#1)
and interacts with##4##3##(1995-3#1)(1995-5#1)(1996-2#1)(2008-10#1)
and interacts##5##2##(1995-3#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)
and intercellular spaces##2##3##(2008-10#2)
and intercellular##10##2##(1997-2#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2012-1#1)(2013-1#1)
and intercept of##2##3##(2008-10#2)
and intercept##9##2##(2008-10#9)
and interchannel cross talk##2##4##(2008-2#1)(2008-3#1)
and interconnection##2##2##(2008-2#1)(2008-7#1)
and interconnections##2##2##(1994-3#1)(2008-3#1)
and intercostal##4##2##(2007-8#2)(2011-2#2)
and interday##2##2##(2008-10#2)
and interdependent##2##2##(1995-3#1)(2011-1#1)
and interdisciplinary##5##2##(1991-3#1)(1997-3#1)(2008-1#1)(2008-7#1)(2010-10#1)
and interest in##6##3##(2010-8#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and interest of##2##3##(1990-2#1)(2008-5#1)
and interest##11##2##(1990-2#1)(1991-6#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-8#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and interesting##5##2##(1992-5#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
and interests of the##2##4##(1997-1#1)(2012-12#1)
and interests of##4##3##(1995-2#1)(1997-1#1)(1997-3#1)(2012-12#1)
and interests##11##2##(1991-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
and interface##2##2##(2008-2#1)(2010-2#1)
and interfacial tension##2##3##(1997-1#1)(2010-4#1)
and interfacial tensions##2##3##(2008-6#1)(2010-4#1)
and interfacial##8##2##(1997-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-4#2)
and interfere with the##3##4##(2008-1#1)(2008-3#1)(2008-9#1)
and interfere with##4##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
and interfere##6##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-9#1)
and interference effects##2##3##(2008-10#1)(2008-3#1)
and interference free##2##3##(2008-10#2)
and interference of a large number of metal ions##2##9##(2008-10#2)
and interference of a number of metal ions on the determination of##4##12##(2008-10#4)
and interference of a##6##4##(2008-10#6)
and interference of##9##3##(2007-12#1)(2008-10#7)(2008-3#1)
and interference with##4##3##(1996-8#1)(2008-3#1)(2008-5#1)(2010-10#1)
and interference##23##2##(1996-8#1)(2007-12#1)(2008-10#14)(2008-3#5)(2008-5#1)(2010-10#1)
and interferences##7##2##(2008-10#7)
and interferential##2##2##(1995-12#1)(2012-3#1)
and interferents##2##2##(2008-10#2)
and interferes with##2##3##(2008-11#1)(2013-7#1)
and interfering ions on the recoveries of Cr(III)##2##8##(2008-10#2)
and interfering ions on the recovery of the analyte##2##9##(2008-10#2)
and interfering ions on the recovery of the analytes have been##2##11##(2008-10#2)
and interfering ions on the recovery of the##4##8##(2008-10#4)
and interfering ions on the##6##5##(2008-10#6)
and interfering ions##8##3##(2008-10#8)
and interfering with##3##3##(1992-3#1)(2010-12#1)(2011-2#1)
and interfering##15##2##(1991-12#1)(1992-3#1)(2008-10#9)(2008-2#2)(2010-12#1)(2011-2#1)
and interferometric##2##2##(2008-2#1)(2008-3#1)
and interferon regulatory##2##3##(1994-11#1)(2012-3#1)
and interferon##6##2##(1990-8#1)(1994-11#1)(1995-12#1)(2006-10#1)(2007-12#1)(2012-3#1)
and interferon-alpha-2a##2##2##(1990-2#2)
and interferon-gamma##5##2##(1993-3#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-7#1)
and intergenic regions##2##3##(1996-3#1)(2008-4#1)
and intergenic##3##2##(1996-3#1)(1996-6#1)(2008-4#1)
and intergroup##2##2##(2008-10#1)(2008-5#1)
and interior##2##2##(1996-12#1)(2008-10#1)
and interlaboratory##2##2##(2008-4#1)(2008-5#1)
and interleukin 3##2##3##(1990-12#1)(1991-12#1)
and interleukin##10##2##(1990-12#1)(1991-12#1)(1993-6#1)(1995-2#1)(1996-12#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
and interleukin-2 (IL-2)##2##3##(1995-12#1)(2008-5#1)
and interleukin-2##5##2##(1990-12#1)(1994-12#1)(1995-12#1)(2008-11#1)(2008-5#1)
and interleukin-4##2##2##(1997-1#1)(2008-11#1)
and interleukin-6 (IL-6) were##2##4##(1995-12#1)(2008-3#1)
and interleukin-6 (IL-6)##4##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)
and interleukin-6 in##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
and interleukin-6##10##2##(1994-6#1)(1995-12#2)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
and interleukin-8 (IL-8)##2##3##(1994-11#1)(2008-4#1)
and interleukin-8##3##2##(1994-11#1)(2008-4#1)(2012-2#1)
and intermediate density##2##3##(1994-8#1)(1995-6#1)
and intermediate##34##2##(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#2)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
and intermediate/grey zone alleles##2##4##(2009-5#2)
and intermediates##2##2##(1992-6#1)(2008-6#1)
and intermittent high##2##3##(1992-4#1)(2012-4#1)
and intermittent##10##2##(1992-4#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-4#1)
and intermolecular hydrogen##4##3##(2008-10#4)
and intermolecular interactions##5##3##(1992-4#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-9#1)
and intermolecular##14##2##(1992-4#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)
and internal carotid artery##2##4##(2007-8#1)(2011-2#1)
and internal complexity##2##3##(2008-1#2)
and internal consistency##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
and internal damage##2##3##(2011-2#2)
and internal deletions in##2##4##(1995-6#1)(2011-2#1)
and internal organs##2##3##(2007-12#1)(2008-9#1)
and internal standard##6##3##(2008-1#1)(2008-10#3)(2008-9#1)(2011-2#1)
and internal transcribed spacer (ITS)##2##5##(2008-10#2)
and internal transcribed spacer##4##4##(2008-10#4)
and internal transcribed##6##3##(2008-10#5)(2008-8#1)
and internal##78##2##(1993-1#1)(1993-12#1)(1995-1#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-3#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#5)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and internalization of##3##3##(1994-8#1)(1995-11#1)(1997-1#1)
and internalization##6##2##(1991-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-9#1)
and internalizing##5##2##(2008-2#1)(2009-7#1)(2009-9#2)(2012-12#1)
and internally##2##2##(2008-2#1)(2008-7#1)
and international collaboration##2##3##(2008-10#1)(2010-1#1)
and international scientific##2##3##(2008-10#1)(2008-12#1)
and international##36##2##(1990-2#1)(1991-9#1)(1992-12#1)(1994-12#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-2#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and internationally##4##2##(1993-2#1)(2008-12#2)(2011-2#1)
and interneurons##3##2##(1993-12#1)(2007-12#1)(2013-8#1)
and interns##2##2##(1997-5#1)(2010-2#1)
and interobserver##3##2##(1997-8#2)(2008-8#1)
and interpersonal##7##2##(1992-3#1)(1993-12#1)(1996-7#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-7#1)
and interpret the##3##3##(2008-2#1)(2008-9#1)(2011-1#1)
and interpret##14##2##(1992-8#1)(1995-1#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-1#1)(2012-12#2)(2012-3#2)
and interpretable##2##2##(1991-3#1)(2010-6#1)
and interpretation of results##2##4##(2007-2#1)(2007-5#1)
and interpretation of the results##2##5##(1994-2#1)(2008-10#1)
and interpretation of the##9##4##(1994-2#1)(1996-11#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)
and interpretation of various##2##4##(1993-12#1)(2007-7#1)
and interpretation of##28##3##(1993-12#1)(1994-2#1)(1996-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-2#1)
and interpretation##42##2##(1992-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-6#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-8#2)
and interpretations of##2##3##(1991-11#1)(2008-8#1)
and interpretations##3##2##(1991-11#1)(1995-3#1)(2008-8#1)
and interpreted using##2##3##(2008-7#1)(2010-7#1)
and interpreted##6##2##(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-7#1)
and interpreting results##2##3##(2008-4#1)(2012-3#1)
and interpreting##11##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
and interpretive##2##2##(1993-12#1)(2008-10#1)
and interruption of##2##3##(1991-3#1)(2007-12#1)
and interrupts##2##2##(1994-12#1)(2010-8#1)
and intersections##4##2##(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
and interspecies transmission##2##3##(2013-8#2)
and interspecies##4##2##(1992-6#1)(2009-6#1)(2013-8#2)
and interspecific crosses##2##3##(2008-10#2)
and interspecific##6##2##(1996-4#1)(2008-10#3)(2008-8#1)(2008-9#1)
and interstitial fibrosis##3##3##(1990-9#1)(2008-5#1)(2008-7#1)
and interstitial lung disease##2##4##(2006-10#2)
and interstitial##18##2##(1990-9#1)(2006-10#3)(2007-7#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2012-12#2)(2012-2#1)(2013-8#1)
and interval estimates##3##3##(1994-9#2)(2008-11#1)
and interval##5##2##(1994-9#2)(1995-2#1)(2008-11#1)(2009-7#1)
and intervals##2##2##(1997-7#1)(2008-10#1)
and intervention are##2##3##(2008-11#2)
and intervention for##2##3##(2009-6#1)(2011-1#1)
and intervention in##4##3##(1990-9#1)(1996-3#1)(2008-11#1)(2010-10#1)
and intervention needs of##2##4##(2008-12#2)
and intervention of##2##3##(2009-9#1)(2010-12#1)
and intervention studies##2##3##(2010-4#1)(2013-8#1)
and intervention with##2##3##(2008-6#1)(2010-10#1)
and intervention##47##2##(1990-9#1)(1992-12#1)(1996-3#1)(1997-1#1)(2007-8#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#4)(2010-12#3)(2010-4#1)(2010-7#3)(2011-1#3)(2011-2#3)(2012-2#5)(2013-8#2)
and interventional procedures##4##3##(2006-10#1)(2006-8#1)(2011-2#2)
and interventional studies##2##3##(1995-1#1)(2013-1#1)
and interventional##13##2##(1993-12#1)(1993-3#2)(1995-1#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
and interventions and##2##3##(1994-3#1)(1996-2#1)
and interventions for##2##3##(1995-12#1)(2008-12#1)
and interventions in##3##3##(1995-3#1)(2013-1#2)
and interventions that##4##3##(1995-3#1)(2008-11#1)(2013-1#2)
and interventions##28##2##(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#6)
and intervertebral disc##2##3##(2009-12#1)(2010-3#1)
and intervertebral discs##5##3##(2007-8#5)
and intervertebral##8##2##(2007-11#1)(2007-8#5)(2009-12#1)(2010-3#1)
and interview##2##2##(2011-2#1)(2013-1#1)
and interviews with##7##3##(1993-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2012-2#1)(2013-1#1)
and interviews##10##2##(1993-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
and intestinal strains##2##3##(1993-2#2)
and intestinal##29##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-2#2)(1996-12#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-5#3)(2010-1#1)(2011-2#2)(2012-2#2)(2013-1#8)(2013-8#2)
and intestine##16##2##(1991-5#2)(1991-8#1)(1997-7#1)(1997-9#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#2)(2013-8#1)
and intimal hyperplasia##4##3##(1996-8#2)(2009-11#1)(2011-3#1)
and intimal##6##2##(1996-8#2)(2008-3#1)(2009-11#1)(2010-4#1)(2011-3#1)
and intimately##2##2##(1993-8#1)(2010-10#1)
and into a##2##3##(1995-12#1)(1995-6#1)
and into an##2##3##(1994-1#1)(2012-1#1)
and into the##9##3##(1995-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-3#1)
and into##19##2##(1994-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
and intra operative##3##3##(2007-9#1)(2012-2#2)
and intra##6##2##(2007-9#1)(2008-11#1)(2008-7#1)(2012-2#3)
and intra- and##2##3##(2013-7#1)(2013-8#1)
and intra-NAS##2##2##(1993-12#2)
and intra-arterial calcium stimulation##2##4##(2007-5#2)
and intra-arterial##3##2##(2007-10#1)(2007-5#2)
and intra-cardiac##2##2##(2007-8#2)
and intra-day##3##2##(2008-10#2)(2013-8#1)
and intra-day)##2##2##(2008-10#2)
and intraabdominal##2##2##(1990-2#1)(1991-3#1)
and intracavitary##2##2##(2010-12#1)(2010-3#1)
and intracavity##3##2##(2007-12#3)
and intracellular calcium concentration##2##4##(1995-2#1)(2008-8#1)
and intracellular calcium mobilization##3##4##(1993-6#1)(2008-4#1)(2008-8#1)
and intracellular calcium##9##3##(1993-6#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)
and intracellular ions in##2##4##(2010-4#2)
and intracellular localization of##2##4##(1993-8#1)(1994-6#1)
and intracellular localization##4##3##(1993-8#1)(1994-6#1)(1995-2#1)(2011-2#1)
and intracellular pH (pHi)##2##4##(2007-10#1)(2010-8#1)
and intracellular pH##5##3##(1994-2#1)(2007-10#1)(2008-10#1)(2010-8#2)
and intracellular signaling##3##3##(2009-8#1)(2012-2#2)
and intracellular transport of##2##4##(2011-2#1)(2013-1#1)
and intracellular##63##2##(1990-12#3)(1990-2#1)(1990-7#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-2#2)(1995-8#2)(1996-2#2)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-8#1)(2010-10#2)(2010-4#5)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
and intracellularly##3##2##(1997-3#1)(2008-10#2)
and intracerebral hemorrhage##3##3##(1995-5#1)(2007-10#1)(2009-11#1)
and intracoronary##4##2##(1994-11#1)(2007-8#1)(2008-10#1)(2011-1#1)
and intracranial##9##2##(1991-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2012-8#2)(2013-8#2)
and intractable##2##2##(1994-3#1)(2008-10#1)
and intradermal##2##2##(2008-5#1)(2013-1#1)
and intramolecular##3##2##(1991-5#1)(1992-8#1)(1993-3#1)
and intranuclear##3##2##(1991-12#1)(1994-11#1)(2013-1#1)
and intraocular##2##2##(2011-1#2)
and intraoperative digital subtraction angiography##2##5##(2008-7#2)
and intraoperative findings##2##3##(2007-11#1)(2013-8#1)
and intraoperative##20##2##(1992-9#2)(2007-11#1)(2007-8#4)(2008-10#1)(2008-7#3)(2008-9#3)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
and intraperitoneal##4##2##(1994-9#1)(1997-4#2)(2010-5#1)
and intraperitoneally##2##2##(1993-3#1)(2008-8#1)
and intraspecific##7##2##(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#1)
and intrathecal##3##2##(1991-1#1)(2007-11#1)(2009-3#1)
and intrauterine growth retardation##2##4##(1995-8#1)(2010-3#1)
and intrauterine##8##2##(1990-11#1)(1994-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(2008-11#1)(2010-3#1)(2012-3#1)
and intravascular##3##2##(2008-9#1)(2009-5#2)
and intravenous administration are##2##4##(2007-11#1)(2011-1#1)
and intravenous administration##4##3##(2007-11#1)(2011-1#3)
and intravenous antibiotics##2##3##(2008-10#1)(2010-8#1)
and intravenous drug##2##3##(1992-9#1)(2007-7#1)
and intravenous##33##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-9#1)(1994-12#1)(1996-11#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)
and intravenously##3##2##(1991-9#1)(2008-10#1)(2011-1#1)
and intraventricular##5##2##(1993-12#1)(2007-10#2)(2008-8#1)(2011-2#1)
and intravitreal##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
and intriguing changes in provider practice patterns##2##7##(1994-12#2)
and intriguing##4##2##(1994-12#2)(2008-7#1)(2013-1#1)
and intrinsic fluorescence measurement##2##4##(2008-3#2)
and intrinsic fluorescence##4##3##(1994-6#1)(1995-5#1)(2008-3#2)
and intrinsic##20##2##(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#2)(2009-8#1)(2010-2#1)
and introduce##4##2##(1997-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
and introduced directly into the##2##5##(2008-10#2)
and introduced into the##3##4##(2008-10#3)
and introduced into##13##3##(1992-12#2)(1993-12#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-8#1)
and introduced species##2##3##(2008-6#1)(2008-9#1)
and introduced##28##2##(1992-12#2)(1993-12#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-2#1)
and introduces a##2##3##(2008-11#1)(2008-3#1)
and introduces##4##2##(1996-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
and introducing##3##2##(1993-2#1)(2008-3#1)(2013-8#1)
and introduction of##4##3##(1994-5#1)(2008-11#1)(2008-8#1)(2011-1#1)
and introduction to staff was mainly supported by continuing education courses (92##2##12##(2013-1#2)
and introduction to##3##3##(2008-10#1)(2013-1#2)
and introduction##8##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-1#1)(2013-1#2)
and introgression##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
and intron 1 of##2##4##(2008-8#1)(2012-3#1)
and intron##9##2##(1991-6#1)(1993-11#1)(1993-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)
and intron/exon boundaries##2##3##(2008-11#1)(2008-4#1)
and introns##3##2##(1997-6#1)(2008-11#1)(2012-3#1)
and intubation##2##2##(1993-6#2)
and invade the##3##3##(2008-10#2)(2009-7#1)
and invade##4##2##(2008-10#2)(2008-9#1)(2009-7#1)
and invaded##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
and invading##2##2##(2008-10#1)(2013-1#1)
and invariant##2##2##(2007-8#1)(2012-2#1)
and invasion assay##2##3##(2008-11#1)(2013-8#1)
and invasion in##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
and invasion of cancer cells##2##5##(2008-11#1)(2011-1#1)
and invasion of hepatoma##3##4##(2008-11#2)(2013-8#1)
and invasion of the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
and invasion of##16##3##(2008-11#7)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
and invasion##31##2##(2008-11#8)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#7)
and invasive growth##2##3##(1994-11#1)(2008-11#1)
and invasive##17##2##(1990-6#1)(1992-10#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#3)(2009-4#1)(2012-3#2)(2013-1#1)
and invasiveness##3##2##(1995-6#1)(2008-11#1)(2013-1#1)
and inventory##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
and inverse##6##2##(1993-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-12#1)
and inversely correlated with the##3##5##(1990-2#1)(1993-8#1)(2011-2#1)
and inversely##8##2##(1990-2#1)(1993-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
and inversion of##2##3##(1995-3#1)(1996-5#1)
and inversion##7##2##(1995-3#1)(1995-8#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
and inversions##4##2##(1995-2#1)(2008-3#1)(2011-2#2)
and invertase##2##2##(2008-10#1)(2008-12#1)
and invertebrate immunocytes##2##3##(1995-12#2)
and invertebrate species##2##3##(1990-11#1)(2013-7#1)
and invertebrate##11##2##(1990-11#1)(1992-12#1)(1995-12#2)(1997-7#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-9#1)(2013-7#1)
and invertebrates##2##2##(1991-12#1)(2013-1#1)
and inverted##4##2##(1994-12#1)(2007-8#1)(2010-5#1)(2011-2#1)
and investigate its##2##3##(2007-11#1)(2008-11#1)
and investigate the##9##3##(1997-3#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#1)
and investigate##20##2##(1991-1#1)(1994-5#1)(1995-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
and investigated as a##2##4##(2008-10#1)(2010-7#1)
and investigated as##9##3##(2008-10#7)(2008-12#1)(2010-7#1)
and investigated its relationship##2##4##(2008-10#1)(2013-1#1)
and investigated its##4##3##(1993-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
and investigated the effect of##3##5##(2008-11#1)(2011-2#1)(2013-1#1)
and investigated the effects of##2##5##(1991-12#1)(2008-11#1)
and investigated the##9##3##(1991-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and investigated their##2##3##(1997-4#1)(2008-7#1)
and investigated##39##2##(1991-12#1)(1993-8#1)(1997-4#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
and investigates the##3##3##(1994-2#1)(2013-1#1)(2013-8#1)
and investigates##5##2##(1994-2#1)(1995-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
and investigating##2##2##(2008-4#1)(2010-2#1)
and investigation of##7##3##(1990-11#1)(2008-10#4)(2008-3#1)(2008-8#1)
and investigation##10##2##(1990-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-10#1)(2011-3#1)(2012-2#1)
and investigational##4##2##(2007-7#2)(2008-12#1)(2009-12#1)
and investigations##7##2##(1992-3#1)(1995-12#1)(2007-10#2)(2007-7#1)(2012-12#1)(2013-1#1)
and investigative##2##2##(1993-8#1)(1997-8#1)
and investigators to##2##3##(1995-2#1)(1996-12#1)
and investigators##4##2##(1995-2#1)(1996-12#1)(2007-11#1)(2009-11#1)
and investment##2##2##(1994-12#1)(2007-12#1)
and invited##2##2##(2008-11#1)(2008-12#1)
and involve a##2##3##(1994-12#1)(2012-1#1)
and involve##6##2##(1991-9#1)(1994-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2012-1#1)
and involved a##2##3##(1995-11#1)(2008-10#1)
and involved in many##2##4##(2008-8#1)(2013-8#1)
and involved in the##2##4##(2009-5#1)(2011-2#1)
and involved in##6##3##(1995-3#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
and involved only##2##3##(1993-8#1)(2008-10#1)
and involved the##2##3##(2008-10#1)(2011-1#1)
and involved##16##2##(1991-6#1)(1993-8#1)(1995-11#1)(1995-3#1)(2008-10#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
and involvement in the##2##4##(1990-6#1)(1997-3#1)
and involvement in##3##3##(1990-6#1)(1996-5#1)(1997-3#1)
and involvement of the##2##4##(1997-8#1)(2011-2#1)
and involvement of##4##3##(1992-12#1)(1997-8#1)(2011-1#1)(2011-2#1)
and involvement##15##2##(1990-6#2)(1992-12#2)(1996-1#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-8#1)(2008-1#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
and involves a##3##3##(2009-12#1)(2013-1#2)
and involves the##4##3##(1991-5#1)(2008-4#1)(2008-5#1)(2012-12#1)
and involves##19##2##(1990-7#1)(1991-5#1)(1992-6#1)(1995-12#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
and involving the##2##3##(1994-1#1)(2012-12#1)
and involving##6##2##(1990-5#1)(1990-6#1)(1994-1#1)(2007-8#2)(2012-12#1)
and iodate in##2##3##(2008-10#2)
and iodate##6##2##(2008-10#6)
and iodide organification defect##2##4##(2011-1#2)
and iodide##17##2##(1990-2#1)(1992-8#1)(2008-10#13)(2011-1#2)
and iodine in##2##3##(1997-8#2)
and iodine##5##2##(1997-8#3)(2008-10#1)(2009-8#1)
and iodoacetamide##2##2##(2008-5#1)(2010-11#1)
and iodoacetate##2##2##(1990-7#2)
and ion channels##4##3##(1993-9#1)(1995-2#1)(2008-4#1)(2008-8#1)
and ion chromatographic##2##3##(2008-6#1)(2010-4#1)
and ion chromatography##4##3##(1994-9#1)(2008-10#3)
and ion exchange##4##3##(1990-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
and ion permeability##2##3##(2008-8#1)(2008-9#1)
and ion##33##2##(1990-8#1)(1993-11#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
and ion-beam etching##3##3##(2007-11#3)
and ion-beam##4##2##(2007-11#3)(2008-3#1)
and ion-depletion effect##2##3##(2008-10#2)
and ion-exchange chromatography (IEC)##2##4##(2008-10#1)(2008-12#1)
and ion-exchange chromatography##3##3##(1991-9#1)(2008-10#1)(2008-12#1)
and ion-exchange##5##2##(1991-9#1)(2008-10#2)(2008-12#1)(2013-1#1)
and ion-pair liquid chromatography-electrospray-tandem mass spectrometry##2##6##(2008-10#2)
and ion-pair##3##2##(2008-10#3)
and ionic strength of##6##4##(2008-10#6)
and ionic strength on##2##4##(2008-10#2)
and ionic strength##22##3##(1990-12#1)(1992-8#1)(1993-11#1)(1997-2#1)(2008-10#15)(2008-4#1)(2008-7#1)(2013-1#1)
and ionic strengths##3##3##(1995-2#1)(2008-10#2)
and ionic##33##2##(1990-12#1)(1992-8#1)(1993-11#2)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#19)(2008-3#1)(2008-4#1)(2008-7#2)(2010-4#1)(2012-3#1)(2013-1#1)
and ionization##2##2##(2008-10#1)(2010-7#1)
and ionized##3##2##(2008-10#2)(2008-3#1)
and ionizing radiation##5##3##(1990-7#1)(1995-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
and ionomycin in a dose-dependent manner##2##6##(1995-8#2)
and ionomycin##6##2##(1993-3#1)(1994-11#1)(1995-8#3)(2008-11#1)
and ions##2##2##(2008-10#1)(2009-7#1)
and ipsilateral##5##2##(1996-12#1)(1996-5#1)(2008-12#1)(2008-8#1)(2011-2#1)
and iris##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
and iron deficiency##4##3##(1990-11#1)(2011-1#3)
and iron in mixtures##2##4##(2008-10#2)
and iron in##9##3##(1997-8#1)(2008-10#8)
and iron ions##2##3##(2008-10#2)
and iron were##4##3##(2008-10#3)(2010-2#1)
and iron##50##2##(1990-11#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#30)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#3)(2012-2#7)
and iron(II)##7##2##(2008-10#7)
and iron(III)##8##2##(2008-10#8)
and irradiance##3##2##(2007-5#1)(2008-3#2)
and irradiated with a##2##4##(2007-12#1)(2008-3#1)
and irradiated with##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
and irradiated##8##2##(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-12#1)
and irradiation##5##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
and irregular##5##2##(1991-2#1)(1995-6#1)(2007-7#1)(2008-11#1)(2008-5#1)
and irregularity in##2##3##(2008-11#1)(2008-9#1)
and irregularity##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
and irrelevant##4##2##(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
and irreversible loss of##2##4##(2007-12#1)(2008-7#1)
and irreversible##13##2##(1990-2#1)(1995-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
and irreversibly##3##2##(2008-10#3)
and irrigation water##4##3##(2008-10#4)
and irrigation##12##2##(2008-10#11)(2013-8#1)
and irritable##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
and is a component of##2##5##(2008-10#2)
and is a good##2##4##(2008-10#1)(2008-2#1)
and is a key target for##2##6##(2011-1#1)(2012-3#1)
and is a major##2##4##(1990-2#1)(2008-1#1)
and is a member of##2##5##(1993-9#1)(1994-12#1)
and is a promising##2##4##(2010-7#1)(2013-1#1)
and is a useful##2##4##(1996-2#1)(2012-3#1)
and is a##55##3##(1990-2#2)(1991-3#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#3)(2007-10#2)(2007-11#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
and is able to##5##4##(1994-5#1)(2008-10#2)(2008-3#1)(2009-5#1)
and is accompanied by##2##4##(1990-7#1)(2009-8#1)
and is accompanied##3##3##(1990-7#1)(2008-9#1)(2009-8#1)
and is activated by##2##4##(1992-3#1)(1995-6#1)
and is activated##4##3##(1992-12#1)(1992-3#1)(1995-6#1)(2011-2#1)
and is actively##2##3##(1990-5#1)(2007-12#1)
and is also##14##3##(1990-10#1)(1990-11#1)(1992-11#2)(1994-5#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)
and is an excellent##2##4##(2008-10#1)(2008-9#1)
and is an important##2##4##(2008-10#1)(2008-7#1)
and is an##14##3##(1990-2#1)(1990-5#1)(1995-9#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2013-1#2)(2013-8#1)
and is analyzed##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
and is apparently##2##3##(1997-3#1)(2008-10#1)
and is applicable to the analysis of alloy samples##2##9##(2008-10#2)
and is applicable to the analysis of synthetic mixtures and alloys##2##11##(2008-10#2)
and is applicable to the analysis of##4##7##(2008-10#4)
and is applicable to the##5##5##(2008-10#5)
and is applicable to##9##4##(1991-8#1)(2007-11#1)(2008-10#6)(2008-3#1)
and is applicable##11##3##(1991-8#1)(2007-11#1)(2008-10#6)(2008-3#2)(2010-5#1)
and is applied to the##2##5##(2008-10#2)
and is applied to##5##4##(2008-10#2)(2008-3#2)(2008-7#1)
and is applied##6##3##(2008-10#3)(2008-3#2)(2008-7#1)
and is approximately##3##3##(1993-2#1)(1996-5#1)(2007-11#1)
and is associated to##2##4##(2008-10#1)(2008-9#1)
and is associated with a##7##5##(1993-11#1)(1995-5#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-6#1)(2013-1#1)
and is associated with an##2##5##(2007-7#1)(2008-1#1)
and is associated with high##3##5##(2009-10#1)(2009-7#1)(2012-12#1)
and is associated with the##2##5##(1991-5#2)
and is associated with##24##4##(1991-5#2)(1993-11#1)(1995-12#1)(1995-5#1)(2007-7#2)(2008-1#4)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-6#1)(2012-12#2)(2012-3#2)(2013-1#2)
and is associated##26##3##(1991-5#2)(1993-11#1)(1995-12#1)(1995-5#1)(2007-7#2)(2008-1#4)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-6#1)(2012-12#2)(2012-3#2)(2013-1#2)
and is at##2##3##(1991-12#1)(2008-2#1)
and is attributed to##2##4##(2008-10#1)(2008-7#1)
and is available for##2##4##(2008-2#1)(2010-1#1)
and is available##4##3##(2008-2#2)(2010-1#1)(2010-8#1)
and is based on the##7##5##(1991-1#1)(1991-12#1)(2008-10#2)(2008-11#1)(2009-11#1)(2013-1#1)
and is based on##17##4##(1991-1#1)(1991-12#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#2)
and is based##18##3##(1991-1#1)(1991-12#1)(1992-4#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#2)
and is becoming##2##3##(1993-11#1)(2010-7#1)
and is being##4##3##(2007-7#1)(2008-3#1)(2008-7#2)
and is believed to be a##2##6##(2007-7#1)(2008-9#1)
and is believed to be##3##5##(2007-7#1)(2008-9#1)(2010-3#1)
and is believed to##5##4##(2007-7#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-1#1)
and is capable of##9##4##(1991-12#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
and is caused by##3##4##(1990-6#1)(2008-5#1)(2011-2#1)
and is characterised clinically by##2##5##(1991-2#1)(1997-8#1)
and is characterised##3##3##(1991-2#1)(1997-8#1)(2012-12#1)
and is characterized by a##2##5##(1993-11#1)(2011-1#1)
and is characterized by##9##4##(1993-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-11#2)(2011-1#1)(2012-12#2)
and is characterized##10##3##(1993-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-11#2)(2011-1#1)(2012-12#2)
and is coincident with the##2##5##(1991-2#1)(2009-5#1)
and is common##2##3##(1990-2#1)(2013-1#1)
and is comparable##2##3##(2008-10#1)(2008-11#1)
and is composed mainly of##2##5##(1994-5#1)(2010-8#1)
and is composed of##2##4##(2008-8#1)(2008-9#1)
and is composed##4##3##(1994-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
and is considered a major##2##5##(2008-1#1)(2013-8#1)
and is considered a##3##4##(2008-1#1)(2011-2#1)(2013-8#1)
and is considered to be##3##5##(1991-12#1)(2007-2#1)(2008-9#1)
and is considered to##5##4##(1991-12#1)(1996-12#1)(2007-2#1)(2008-5#1)(2008-9#1)
and is considered##8##3##(1991-12#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
and is consistent with the##2##5##(2008-10#2)
and is consistent with##7##4##(1992-12#1)(1993-9#1)(1997-6#1)(2008-10#2)(2010-11#1)(2011-1#1)
and is continuing to##2##4##(2008-6#1)(2011-2#1)
and is coupled##2##3##(2007-12#1)(2008-2#1)
and is currently##6##3##(1996-1#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
and is defined as##2##4##(2008-12#1)(2013-1#1)
and is defined##3##3##(2007-12#1)(2008-12#1)(2013-1#1)
and is demonstrated for##2##4##(2007-12#1)(2008-2#1)
and is demonstrated##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and is described##5##3##(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#1)
and is designed to reduce##2##5##(1991-12#1)(2007-12#1)
and is designed to##5##4##(1991-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2012-1#1)
and is detected##2##3##(2008-2#1)(2008-4#1)
and is difficult to##2##4##(2008-7#1)(2013-7#1)
and is discussed##2##3##(1996-10#1)(2011-2#1)
and is distributed##2##3##(2008-10#1)(2008-4#1)
and is divided##2##3##(2008-4#1)(2008-8#1)
and is doing well##3##4##(2007-7#1)(2008-8#1)(2013-7#1)
and is dominated by the##2##5##(2008-3#1)(2010-2#1)
and is dominated by##3##4##(2007-5#1)(2008-3#1)(2010-2#1)
and is due to##2##4##(1997-7#1)(2007-10#1)
and is due##3##3##(1997-7#1)(2007-10#1)(2008-3#1)
and is easily##4##3##(1996-1#1)(2008-10#2)(2008-3#1)
and is easy to##2##4##(2008-3#1)(2012-2#1)
and is effective##4##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)
and is emerging as##2##4##(1992-1#1)(2008-1#1)
and is encoded##2##3##(2008-3#1)(2013-8#1)
and is especially useful##2##4##(1995-11#1)(2008-10#1)
and is especially##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
and is essential for##3##4##(1995-8#1)(2008-5#1)(2011-2#1)
and is essential##4##3##(1995-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
and is expected to##4##4##(2008-10#2)(2008-11#1)(2008-6#1)
and is expressed in##3##4##(1991-12#1)(1992-3#1)(2012-2#1)
and is expressed only in##2##5##(1994-11#1)(1994-12#1)
and is expressed##8##3##(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(2012-2#1)
and is extremely##2##3##(2008-11#1)(2012-1#1)
and is faster##2##3##(1993-11#1)(2008-10#1)
and is found to accurately and reliably include the free energy contributions of solvent relaxation to hydrolysis##2##17##(2013-1#2)
and is found to##5##4##(2007-11#1)(2008-10#1)(2010-3#1)(2013-1#2)
and is found##9##3##(1996-6#1)(2007-11#1)(2008-10#4)(2010-3#1)(2013-1#2)
and is free from##2##4##(1990-12#1)(2011-2#1)
and is frequently##6##3##(1992-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
and is further##2##3##(2008-8#1)(2010-8#1)
and is generally##2##3##(1993-5#1)(2008-9#1)
and is higher##2##3##(1996-5#1)(2007-12#1)
and is highly expressed in##2##5##(1992-11#1)(1995-6#1)
and is highly##11##3##(1990-7#1)(1992-11#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)
and is illustrated##2##3##(2008-11#1)(2011-2#1)
and is in the##3##4##(1992-3#1)(2008-7#1)(2009-5#1)
and is in##11##3##(1992-3#1)(1993-11#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)
and is increasingly##2##3##(2007-2#1)(2008-12#1)
and is independent of the concentration of##2##7##(2008-10#2)
and is independent of the##5##5##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
and is independent of##7##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-8#1)
and is influenced by##2##4##(2009-8#1)(2013-8#1)
and is involved in many##2##5##(2011-2#1)(2013-8#1)
and is involved in the##4##5##(2008-4#1)(2008-9#1)(2009-8#1)(2013-8#1)
and is involved in##13##4##(1993-11#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-2#2)(2013-8#2)
and is known as##2##4##(2010-7#1)(2013-7#1)
and is known for its##2##5##(2008-10#1)(2009-9#1)
and is known to be##2##5##(1996-2#1)(2008-11#1)
and is known to##4##4##(1993-12#1)(1996-2#1)(2008-11#1)(2012-2#1)
and is known##8##3##(1993-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-7#1)(2012-2#1)(2013-7#1)
and is largely##3##3##(1994-5#1)(2008-7#1)(2010-11#1)
and is less##9##3##(1992-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-7#1)
and is likely to##4##4##(1990-7#1)(2008-3#1)(2008-7#1)(2009-3#1)
and is likely##5##3##(1990-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)
and is limited to##2##4##(2008-3#1)(2013-1#1)
and is limited##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and is linked to##2##4##(1996-3#1)(2010-12#1)
and is located##6##3##(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1997-7#1)(2008-12#1)
and is mainly##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
and is mandatory##2##3##(1997-5#1)(2007-8#1)
and is more sensitive than BLASTN when comparing DNA sequences##2##10##(2008-4#2)
and is more sensitive##3##4##(2008-3#1)(2008-4#2)
and is more##14##3##(1995-2#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2013-1#1)
and is most##3##3##(2008-7#1)(2009-8#1)(2011-1#1)
and is much less##2##4##(1997-4#1)(2008-2#1)
and is much##5##3##(1997-4#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
and is necessary for##3##4##(1991-11#1)(1994-8#1)(2008-8#1)
and is necessary to##2##4##(1994-12#2)
and is necessary##5##3##(1991-11#1)(1994-12#2)(1994-8#1)(2008-8#1)
and is not##28##3##(1990-7#1)(1994-8#1)(1995-5#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#4)(2013-1#2)
and is now##8##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
and is observed in##2##4##(2008-10#1)(2012-2#1)
and is of##7##3##(1995-6#1)(2008-11#1)(2008-12#2)(2011-2#2)(2013-1#1)
and is offering##2##3##(2008-5#1)(2008-7#1)
and is often associated with##3##5##(1995-12#1)(2010-12#1)(2013-1#1)
and is often##9##3##(1995-12#1)(1996-12#1)(2006-10#1)(2008-10#3)(2010-12#1)(2010-5#1)(2013-1#1)
and is one of the major##2##6##(2008-10#1)(2013-1#1)
and is one of the##4##5##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
and is one##5##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
and is only a##2##4##(1994-6#1)(2008-11#1)
and is only##6##3##(1990-8#1)(1994-6#1)(1996-11#1)(2008-11#1)(2008-3#1)(2012-2#1)
and is part of a##2##5##(2007-5#2)
and is part of the##4##5##(2008-7#1)(2011-2#3)
and is part of##6##4##(2007-5#2)(2008-7#1)(2011-2#3)
and is particularly##2##3##(1995-6#1)(2008-12#1)
and is partly##3##3##(1997-7#1)(2007-11#1)(2008-3#1)
and is performed##3##3##(1991-6#1)(2008-12#1)(2012-2#1)
and is possibly a##2##4##(1994-8#1)(1996-12#1)
and is potentially##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
and is preceded by##2##4##(1991-11#1)(2012-3#1)
and is predicted to##2##4##(1990-7#1)(1990-8#1)
and is present in##3##4##(1994-8#1)(1995-2#1)(2008-10#1)
and is present##5##3##(1993-3#1)(1994-8#1)(1995-2#1)(2008-10#1)(2011-2#1)
and is presumed to##2##4##(1993-6#1)(2008-10#1)
and is probably an##2##4##(2008-10#1)(2011-2#1)
and is probably##7##3##(1994-2#1)(1995-5#1)(2008-10#3)(2008-8#1)(2011-2#1)
and is proportional to##2##4##(1995-3#1)(2008-3#1)
and is rapidly##2##3##(1994-9#1)(1996-12#1)
and is rarely##2##3##(1995-1#1)(2008-12#1)
and is recommended for##2##4##(2009-4#1)(2010-8#1)
and is reflected from a##2##5##(2007-11#1)(2008-2#1)
and is reflected##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
and is regulated by##4##4##(1995-2#1)(1996-10#1)(2011-2#1)(2013-1#1)
and is related to the##2##5##(1992-12#1)(2008-10#1)
and is related to##3##4##(1992-12#1)(1995-3#1)(2008-10#1)
and is related##4##3##(1992-12#1)(1995-3#1)(2008-10#2)
and is reported##3##3##(1990-6#1)(2008-10#1)(2009-12#1)
and is reproducible##2##3##(2008-10#2)
and is required for##4##4##(1997-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
and is responsible for the##4##5##(1994-8#1)(1995-6#1)(2009-7#1)(2012-2#1)
and is responsible for##10##4##(1994-8#1)(1995-6#1)(2008-10#2)(2008-12#1)(2009-2#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
and is scalable##3##3##(2008-3#3)
and is seen##3##3##(2008-8#1)(2011-2#1)(2012-1#1)
and is sensitive to##3##4##(1997-2#1)(2007-12#1)(2009-11#1)
and is shown to be##4##5##(2008-2#1)(2008-3#2)(2012-2#1)
and is shown to produce##2##5##(2007-11#1)(2008-3#1)
and is shown to##7##4##(2007-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-2#1)
and is shown##8##3##(2007-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2012-2#1)
and is significantly##4##3##(1991-9#1)(1993-3#1)(2008-10#1)(2008-4#1)
and is similar in##2##4##(1992-2#1)(1994-11#1)
and is similar to##4##4##(1996-3#1)(2008-3#1)(2008-8#1)(2009-10#1)
and is similar##7##3##(1992-2#1)(1994-11#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
and is sometimes##2##3##(1991-11#1)(2007-8#1)
and is specific for##2##4##(1995-2#1)(2008-10#1)
and is specifically##2##3##(1993-12#1)(2008-9#1)
and is stable##2##3##(2011-2#1)(2012-1#1)
and is still##5##3##(1993-8#1)(1996-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
and is stimulated by##2##4##(1992-6#1)(2008-5#1)
and is subsequently##2##3##(2008-11#1)(2008-3#1)
and is suitable for the##2##5##(2008-10#1)(2011-1#1)
and is suitable for##11##4##(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-2#2)(2011-1#1)
and is suitable##12##3##(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-2#2)(2011-1#1)(2011-2#1)
and is superior to##2##4##(1995-12#1)(2008-10#1)
and is surrounded by##3##4##(1993-9#1)(2008-5#1)(2008-7#1)
and is the most common##2##5##(2010-3#1)(2010-5#1)
and is the most##5##4##(2007-8#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
and is the only##4##4##(2007-12#1)(2008-10#3)
and is the preferred##2##4##(2008-9#1)(2010-7#1)
and is the##22##3##(1992-2#1)(1993-11#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
and is then##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
and is theoretically##2##3##(2007-11#1)(2008-3#1)
and is therefore ideally suited##2##5##(1990-12#1)(2008-3#1)
and is therefore particularly##2##4##(2008-7#2)
and is therefore##16##3##(1990-12#1)(1994-11#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2012-3#1)
and is thought to be an##2##6##(1993-3#1)(2012-12#1)
and is thought to be##5##5##(1993-3#1)(2008-4#2)(2011-1#1)(2012-12#1)
and is thought to##7##4##(1993-3#1)(2008-4#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
and is thus##7##3##(1992-12#1)(1995-8#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
and is time##2##3##(2008-10#1)(2012-12#1)
and is typically##2##3##(2007-4#1)(2012-2#1)
and is under the##2##4##(1993-6#1)(2012-12#1)
and is used as##2##4##(2008-3#1)(2008-7#1)
and is used in##2##4##(1995-6#1)(2008-10#1)
and is used to##4##4##(1994-12#1)(2007-11#1)(2008-3#1)(2009-8#1)
and is used##11##3##(1994-12#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2013-7#1)
and is useful for##2##4##(2008-11#1)(2008-3#1)
and is useful in##2##4##(2008-3#1)(2010-8#1)
and is useful##5##3##(2008-11#1)(2008-3#2)(2010-12#1)(2010-8#1)
and is usually##6##3##(1991-11#1)(1992-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)
and is verified by##2##4##(2007-11#1)(2008-10#1)
and is very##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
and is widely##2##3##(1996-2#1)(2008-8#1)
and is##994##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#4)(1990-5#3)(1990-6#3)(1990-7#8)(1990-8#4)(1991-1#1)(1991-11#5)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#3)(1992-3#8)(1992-4#1)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#7)(1993-12#5)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-11#7)(1994-12#7)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#8)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#7)(1995-6#7)(1995-8#4)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#6)(1996-3#4)(1996-5#6)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#1)(2006-10#3)(2006-5#1)(2007-1#1)(2007-10#3)(2007-11#17)(2007-12#29)(2007-2#4)(2007-4#2)(2007-5#4)(2007-7#9)(2007-8#5)(2008-1#18)(2008-10#140)(2008-11#25)(2008-12#16)(2008-2#33)(2008-3#69)(2008-4#17)(2008-5#23)(2008-6#7)(2008-7#38)(2008-8#25)(2008-9#21)(2009-10#6)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#7)(2010-8#9)(2011-1#13)(2011-2#42)(2012-1#6)(2012-12#21)(2012-2#20)(2012-3#7)(2013-1#32)(2013-7#5)(2013-8#10)
and ischaemic heart disease in##2##5##(1990-6#1)(2007-7#1)
and ischaemic heart disease##6##4##(1990-6#1)(1990-9#1)(1997-8#3)(2007-7#1)
and ischaemic##7##2##(1990-6#1)(1990-9#1)(1997-8#3)(2007-7#1)(2012-2#1)
and ischemia of the##2##4##(2008-10#1)(2008-7#1)
and ischemia##5##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#2)
and ischemic heart disease##2##4##(2008-3#1)(2012-3#1)
and ischemic stroke##8##3##(2007-10#2)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)
and ischemic##15##2##(1993-6#1)(1995-5#1)(2007-10#2)(2007-8#2)(2008-3#2)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
and islet##3##2##(1994-12#1)(2010-11#2)
and iso-butylamine##2##2##(2008-10#2)
and isoalantolactone##2##2##(2008-10#2)
and isobutane##2##2##(2008-10#1)(2011-2#1)
and isobutyric acids##2##3##(2008-10#2)
and isocitrate dehydrogenase##2##3##(2008-10#1)(2009-11#1)
and isoelectric focusing##2##3##(2008-11#1)(2010-7#1)
and isoelectric point##2##3##(1992-6#1)(1993-3#1)
and isoelectric##4##2##(1992-6#1)(1993-3#1)(2008-11#1)(2010-7#1)
and isoflurane##4##2##(1991-6#1)(2010-7#1)(2012-12#1)(2012-3#1)
and isoform##3##2##(1993-5#1)(2010-7#1)(2012-2#1)
and isolate the##2##3##(1990-3#1)(1995-1#1)
and isolate##8##2##(1990-3#1)(1991-8#1)(1995-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
and isolated form##2##3##(2009-10#2)
and isolated from##2##3##(1997-2#1)(2008-8#1)
and isolated##32##2##(1990-5#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-9#1)(2011-2#1)
and isolates from the##2##4##(2008-10#2)
and isolates from##7##3##(2008-10#7)
and isolates of##8##3##(2008-10#8)
and isolates##21##2##(2008-10#20)(2008-5#1)
and isolating##3##2##(1996-12#1)(2008-2#1)(2008-9#1)
and isolation frequency##2##3##(2008-10#2)
and isolation of the##3##4##(1993-5#1)(1996-12#1)(2008-2#1)
and isolation of##17##3##(1993-5#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-8#2)(2010-11#1)(2011-7#1)
and isolation##27##2##(1993-5#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-8#2)(2009-7#1)(2010-11#1)(2010-7#1)(2011-7#1)(2012-12#2)
and isoleucine##2##2##(2008-10#2)
and isometric##3##2##(2007-11#1)(2007-8#1)(2011-1#1)
and isoniazid##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
and isooctane##2##2##(2008-10#1)(2013-1#1)
and isopropanol were##2##3##(1991-5#1)(2008-10#1)
and isopropanol##5##2##(1991-5#3)(2008-10#2)
and isopropyl alcohol##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
and isotherm##2##2##(2008-10#1)(2013-8#1)
and isothermal##3##2##(2008-3#3)
and isotonic##2##2##(1990-11#1)(2011-1#1)
and isotopic##3##2##(2008-10#2)(2008-7#1)
and isozyme patterns##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and isozyme##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
and issues related to##3##4##(2007-10#1)(2009-5#1)(2011-2#1)
and issues to be##3##4##(1993-2#1)(1994-12#1)(2013-8#1)
and issues##19##2##(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#2)
and it allowed the##3##4##(1992-12#1)(2008-10#1)(2011-1#1)
and it also showed a##2##5##(2008-10#1)(2011-3#1)
and it also##6##3##(1992-8#1)(2008-10#2)(2008-7#1)(2011-3#1)(2013-8#1)
and it appears##2##3##(1990-11#1)(1993-2#1)
and it became##2##3##(2009-7#1)(2011-3#1)
and it can be used for##2##6##(2008-10#1)(2008-3#1)
and it can be used##3##5##(2008-10#1)(2008-3#1)(2013-7#1)
and it can be##17##4##(1993-3#1)(1996-3#1)(2007-11#2)(2008-10#5)(2008-3#3)(2008-7#1)(2009-4#1)(2010-6#1)(2013-7#1)(2013-8#1)
and it can##20##3##(1991-6#1)(1993-3#1)(1996-3#1)(2007-11#2)(2008-10#6)(2008-3#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2013-7#1)(2013-8#1)
and it cannot##2##3##(2008-10#1)(2008-3#1)
and it contains##2##3##(1996-10#1)(2012-3#1)
and it could be##8##4##(2008-10#5)(2008-11#1)(2010-7#1)(2010-8#1)
and it could##10##3##(2008-10#6)(2008-11#1)(2010-7#1)(2010-8#1)(2013-8#1)
and it did not##2##4##(2008-10#2)
and it did##3##3##(2008-10#2)(2010-1#1)
and it does not##2##4##(2008-3#2)
and it emphasizes##2##3##(2008-7#1)(2010-7#1)
and it enables##2##3##(2007-11#1)(2008-4#1)
and it gave a##2##4##(2008-10#2)
and it has a##4##4##(1991-5#1)(2008-10#2)(2013-8#1)
and it has also##2##4##(2011-2#1)(2011-3#1)
and it has been proposed that the##2##7##(1995-2#1)(2008-1#1)
and it has been proposed that##3##6##(1995-2#1)(2008-1#1)(2008-7#1)
and it has been suggested that##3##6##(1992-8#1)(2007-8#1)(2009-10#1)
and it has been##15##4##(1992-8#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-12#3)(2012-3#1)
and it has##31##3##(1990-11#1)(1991-5#1)(1992-8#1)(1995-2#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-8#1)
and it indicates that##2##4##(2008-10#1)(2011-2#1)
and it is a##5##4##(2008-5#1)(2008-6#1)(2008-7#1)(2011-3#1)(2012-3#1)
and it is able to##2##5##(1997-6#1)(2013-8#1)
and it is also##8##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
and it is associated with##2##5##(2012-2#2)
and it is concluded that##2##5##(1992-11#1)(2008-2#1)
and it is concluded##3##4##(1990-3#1)(1992-11#1)(2008-2#1)
and it is considered##2##4##(2007-7#1)(2011-2#1)
and it is critical##2##4##(2008-11#1)(2013-1#1)
and it is demonstrated that##2##5##(2007-12#1)(2008-3#1)
and it is difficult##2##4##(2008-4#1)(2009-7#1)
and it is especially##2##4##(2013-1#1)(2013-7#1)
and it is estimated that##2##5##(2008-11#1)(2011-2#1)
and it is estimated##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
and it is expected to##2##5##(2007-8#1)(2011-1#1)
and it is expected##3##4##(2007-8#1)(2010-12#1)(2011-1#1)
and it is found that the##2##6##(2008-10#1)(2009-7#1)
and it is found that##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and it is hypothesized that##2##5##(1995-11#1)(2009-5#1)
and it is important that##2##5##(1992-6#1)(1995-2#1)
and it is important##4##4##(1992-6#1)(1995-2#1)(2008-10#1)(2010-10#1)
and it is likely that this##3##6##(1992-12#1)(2007-12#1)(2008-10#1)
and it is likely that##8##5##(1992-12#1)(1994-11#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
and it is necessary to##2##5##(1996-5#1)(2009-12#1)
and it is now widely##2##5##(2008-4#1)(2011-2#1)
and it is now##4##4##(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
and it is only##3##4##(1993-9#1)(2007-7#1)(2008-11#1)
and it is possible that the##2##6##(1997-7#1)(2008-8#1)
and it is possible that##3##5##(1995-3#1)(1997-7#1)(2008-8#1)
and it is possible to##4##5##(2008-10#1)(2008-12#1)(2010-4#1)(2012-3#1)
and it is possible##7##4##(1995-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)
and it is proposed that##3##5##(1993-12#1)(2008-10#1)(2012-12#1)
and it is related to##2##5##(2008-1#1)(2008-5#1)
and it is shown how##2##5##(2008-3#1)(2008-4#1)
and it is shown that the##5##6##(1994-5#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-9#1)
and it is shown that##9##5##(1990-7#1)(1994-5#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)
and it is shown##12##4##(1990-7#1)(1994-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)
and it is still a##2##5##(2010-11#2)
and it is still##3##4##(2010-11#2)(2012-1#1)
and it is suggested that##3##5##(1991-2#1)(2008-11#1)(2008-8#1)
and it is suitable##2##4##(2008-10#1)(2010-12#1)
and it is susceptible##2##4##(2008-10#2)
and it is the##2##4##(2008-10#1)(2008-3#1)
and it is well##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
and it is##174##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-5#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#30)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
and it makes##3##3##(1996-5#1)(2008-3#1)(2010-8#1)
and it may also##2##4##(2009-10#1)(2013-7#1)
and it may be##10##4##(1990-11#1)(1992-8#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
and it may##20##3##(1990-11#1)(1992-8#1)(1995-12#1)(1996-4#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
and it might be##2##4##(1997-8#1)(2008-10#1)
and it must be##2##4##(1996-1#1)(2008-10#1)
and it must##3##3##(1996-1#1)(2008-10#1)(2012-12#1)
and it offers##2##3##(2012-2#1)(2013-8#1)
and it often##2##3##(2007-5#1)(2009-3#1)
and it permits the##2##4##(2008-1#1)(2008-10#1)
and it permits##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
and it provides##3##3##(1996-3#1)(1997-4#1)(2010-10#1)
and it remains##3##3##(1990-12#1)(2008-4#1)(2013-1#1)
and it represents##4##3##(2007-12#1)(2010-6#1)(2011-1#1)(2013-7#1)
and it requires a##2##4##(1995-12#1)(2010-10#1)
and it requires##4##3##(1995-12#1)(2009-12#1)(2010-10#1)(2012-3#1)
and it seems that##2##4##(2008-1#1)(2009-5#1)
and it seems to##2##4##(2010-8#1)(2013-1#1)
and it seems##6##3##(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#1)(2013-1#1)
and it should be possible to##2##6##(1994-12#1)(2010-11#1)
and it should be##6##4##(1994-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-11#2)
and it should##8##3##(1994-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#2)
and it showed##4##3##(2007-11#1)(2008-10#1)(2010-5#1)(2013-8#1)
and it shows##6##3##(1990-12#1)(2008-10#2)(2008-3#2)(2008-8#1)
and it suggests that##3##4##(1990-2#1)(2008-10#2)
and it suggests##4##3##(1990-2#1)(1992-12#1)(2008-10#2)
and it was applied to the##2##6##(2008-10#2)
and it was applied##3##4##(2008-10#3)
and it was concluded that##2##5##(1991-12#1)(2008-10#1)
and it was found that both##2##6##(2008-10#1)(2010-5#1)
and it was found that the##10##6##(1990-8#1)(1994-12#1)(2007-12#1)(2008-10#6)(2008-3#1)
and it was found that##18##5##(1990-12#1)(1990-8#1)(1992-3#1)(1994-12#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-8#1)(2010-5#2)
and it was found##21##4##(1990-12#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-12#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-8#1)(2010-5#2)(2011-2#1)
and it was not##5##4##(1990-6#1)(2008-10#2)(2008-9#2)
and it was possible to##2##5##(1993-8#1)(2008-10#1)
and it was shown that##3##5##(2008-10#2)(2008-3#1)
and it was successfully applied##2##5##(2008-10#2)
and it was the##3##4##(2008-10#1)(2008-6#1)(2012-12#1)
and it was within this##2##5##(2008-10#1)(2009-10#1)
and it was##94##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
and it##508##2##(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#9)(2007-12#10)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#7)(2008-10#115)(2008-11#13)(2008-12#5)(2008-2#14)(2008-3#23)(2008-4#8)(2008-5#12)(2008-6#7)(2008-7#19)(2008-8#11)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#4)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#5)(2011-1#5)(2011-2#14)(2011-3#4)(2011-4#1)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#8)(2013-7#6)(2013-8#12)
and it's##4##2##(2008-10#1)(2010-12#1)(2012-3#2)
and itching##2##2##(2008-11#1)(2012-12#1)
and itchy##3##2##(2012-2#1)(2012-3#1)(2013-8#1)
and item##3##2##(2008-4#1)(2009-12#1)(2011-1#1)
and its 1##2##3##(2008-10#2)
and its 3##3##3##(1996-2#1)(2008-10#1)(2008-9#1)
and its Cu(2+) and Zn(2+) complexes##2##6##(2008-5#2)
and its DNA sequence was determined##2##6##(2008-10#1)(2008-8#1)
and its N-terminal##2##3##(2008-7#1)(2008-8#1)
and its ability to##9##4##(1990-5#1)(1991-6#1)(1994-5#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#2)
and its accuracy is##2##4##(2008-2#1)(2008-3#1)
and its accuracy was##2##4##(2008-10#2)
and its accuracy##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
and its action##2##3##(1995-12#1)(2008-7#1)
and its active##4##3##(1993-8#1)(2008-10#2)(2013-1#1)
and its activities##2##3##(1993-3#1)(2011-2#1)
and its activity##5##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
and its adjacent##2##3##(2008-10#1)(2008-12#1)
and its advantages##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
and its aftermath##2##3##(2007-12#1)(2011-2#1)
and its amperometric##2##3##(2008-10#2)
and its analogs##4##3##(1995-12#1)(1995-3#1)(2008-11#1)(2009-7#1)
and its analogue##3##3##(2008-11#2)(2010-3#1)
and its analogues##7##3##(1994-8#1)(1996-7#3)(2008-10#2)(2010-5#1)
and its analytical application##4##4##(2008-10#4)
and its analytical##8##3##(2008-10#8)
and its antagonists##2##3##(2008-8#2)
and its antibody##2##3##(2008-11#1)(2011-2#1)
and its apparent##3##3##(1990-8#1)(1993-2#1)(1994-12#1)
and its application as a##2##5##(2008-10#2)
and its application as##3##4##(2008-10#3)
and its application for determination of##2##6##(2008-10#2)
and its application for the determination of##2##7##(2008-10#2)
and its application for the##4##5##(2008-10#3)(2008-11#1)
and its application for##11##4##(1992-6#1)(2008-10#8)(2008-11#1)(2008-7#1)
and its application in a##2##5##(2008-10#1)(2008-3#1)
and its application in analytical chemistry##2##6##(2008-10#2)
and its application in environmental##3##5##(2008-10#3)
and its application in optical##2##5##(2008-2#1)(2008-3#1)
and its application in the determination of##2##7##(2008-10#1)(2008-2#1)
and its application in the##7##5##(1993-2#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)
and its application in##27##4##(1993-2#2)(1995-3#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
and its application to a##2##5##(2008-10#1)(2008-2#1)
and its application to simultaneous##2##5##(2007-11#1)(2008-10#1)
and its application to spectroscopy##3##5##(2007-11#1)(2007-12#2)
and its application to the determination of trace##2##8##(2008-10#2)
and its application to the determination of##7##7##(2008-10#7)
and its application to the##12##5##(2008-10#10)(2008-2#1)(2011-2#1)
and its application to water samples##2##6##(2008-10#2)
and its application to##49##4##(1990-5#1)(1990-8#1)(2007-11#4)(2007-12#2)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-8#1)(2011-2#1)
and its application##101##3##(1990-5#1)(1990-8#1)(1992-2#1)(1992-6#1)(1993-2#2)(1995-3#1)(2007-11#4)(2007-12#2)(2008-10#63)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
and its applications in##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)
and its applications##12##3##(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2010-9#1)(2013-1#1)
and its assessment##2##3##(2012-1#1)(2013-7#1)
and its associated cell##2##4##(2009-8#1)(2011-2#1)
and its associated factors among##3##5##(2008-10#2)(2010-12#1)
and its associated factors##4##4##(2008-10#2)(2010-12#1)(2013-8#1)
and its associated piRNAs in somatic cells##2##7##(2009-3#2)
and its associated risk##2##4##(2008-11#1)(2012-1#1)
and its associated##26##3##(1994-8#1)(1994-9#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
and its association with other##2##5##(2008-10#1)(2009-7#1)
and its association with##21##4##(1990-3#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)
and its association##22##3##(1990-3#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)
and its attendant##2##3##(2011-2#1)(2012-3#1)
and its binding was inhibited##2##5##(1992-9#1)(1993-6#1)
and its binding##5##3##(1991-12#1)(1992-9#1)(1993-6#1)(2008-8#2)
and its biological##2##3##(1995-12#1)(2008-9#1)
and its branches##3##3##(1997-8#3)
and its catalytic activity##2##4##(1996-2#1)(2008-10#1)
and its catalytic domain##2##4##(1991-5#2)
and its catalytic##5##3##(1991-5#2)(1996-2#1)(2008-10#2)
and its causes in##2##4##(1996-12#1)(2009-4#1)
and its changes##3##3##(1993-9#1)(2008-10#1)(2012-12#1)
and its characteristics##2##3##(1993-3#1)(2011-2#1)
and its characterization##2##3##(2008-11#2)
and its chemical##6##3##(2008-10#3)(2008-7#2)(2011-2#1)
and its clinical##7##3##(1995-9#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
and its comorbidities##2##3##(2009-10#1)(2009-11#1)
and its comparison with##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
and its complete##2##3##(1991-12#1)(2008-9#1)
and its complex with##2##4##(2008-10#2)
and its complex##3##3##(2008-10#2)(2009-5#1)
and its complexes with##3##4##(1992-9#1)(2008-10#2)
and its complications are##2##4##(2008-1#1)(2010-10#1)
and its complications is##2##4##(2008-7#1)(2010-4#1)
and its complications##11##3##(2007-10#2)(2007-5#1)(2008-1#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
and its components were##2##4##(2008-3#1)(2008-9#1)
and its components##9##3##(1991-2#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
and its compounds##2##3##(2008-10#2)
and its concentration was##2##4##(2008-10#2)
and its concentration##7##3##(2008-10#6)(2010-4#1)
and its conjugate were##2##4##(2008-10#2)
and its conjugate##3##3##(2008-10#3)
and its connections in##2##4##(2011-2#2)
and its connections##4##3##(1993-6#1)(2011-2#2)(2013-8#1)
and its consequences for##3##4##(1990-2#1)(2008-8#1)(2011-2#1)
and its consequences##11##3##(1990-2#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-8#1)
and its constituents##4##3##(2008-10#3)(2008-2#1)
and its content##6##3##(1990-3#1)(1992-3#1)(2008-10#2)(2008-5#1)(2012-2#1)
and its context##2##3##(2008-2#1)(2008-9#1)
and its control##4##3##(1990-11#1)(1993-6#1)(2012-12#1)(2013-8#1)
and its conversion into##2##4##(1991-7#1)(2008-10#1)
and its conversion##3##3##(1991-7#1)(2008-10#1)(2008-5#1)
and its correlation with the##2##5##(2008-10#1)(2013-8#1)
and its correlation with##5##4##(2008-10#1)(2009-10#1)(2009-5#1)(2013-8#2)
and its correlation##6##3##(2008-10#2)(2009-10#1)(2009-5#1)(2013-8#2)
and its corresponding##6##3##(1996-12#1)(2008-10#2)(2008-6#1)(2010-8#1)(2011-1#1)
and its course##2##3##(2009-10#1)(2013-1#1)
and its critical role##2##4##(2008-6#1)(2009-10#1)
and its crystal##2##3##(1997-7#1)(2008-10#1)
and its current##3##3##(1992-2#1)(2008-11#1)(2012-2#1)
and its deduced amino acid sequence##2##6##(1996-10#1)(1996-6#1)
and its degradation product##3##4##(2008-10#2)(2008-5#1)
and its degradation products##3##4##(1997-2#1)(2008-10#2)
and its degradation##6##3##(1997-2#1)(2008-10#4)(2008-5#1)
and its demonstrated##2##3##(2008-11#2)
and its dependence on temperature##2##5##(2007-11#1)(2008-10#1)
and its dependence on the##3##5##(2008-10#1)(2008-3#2)
and its dependence on##10##4##(1990-8#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-3#3)(2008-7#1)
and its derivatives are##3##4##(1993-11#1)(2008-8#1)(2008-9#1)
and its derivatives on##2##4##(2008-10#1)(2008-5#1)
and its derivatives were##2##4##(1990-5#1)(2008-10#1)
and its derivatives with##2##4##(1993-11#1)(2008-11#1)
and its derivatives##31##3##(1990-5#1)(1992-9#1)(1993-11#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-5#3)(2008-8#2)(2008-9#3)(2011-2#1)(2013-1#1)
and its derivatives]##2##3##(1993-11#1)(2011-3#1)
and its detection in##2##4##(2007-7#1)(2008-10#1)
and its detection limit##2##4##(2008-10#2)
and its detection##7##3##(2007-7#1)(2008-10#6)
and its determinants##2##3##(2008-1#1)(2010-3#1)
and its determination by##6##4##(2008-10#5)(2008-11#1)
and its determination in##2##4##(2008-10#2)
and its determination##11##3##(2008-10#10)(2008-11#1)
and its development##3##3##(2007-12#1)(2008-11#1)(2013-1#1)
and its dispersion##2##3##(2007-11#1)(2008-2#1)
and its dissociation##2##3##(2008-10#2)
and its distance from the##2##5##(2013-8#2)
and its distribution##2##3##(2008-10#2)
and its dose##2##3##(2008-12#1)(2008-5#1)
and its downstream##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
and its effect on the##4##5##(1995-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
and its effect on##22##4##(1992-1#1)(1995-11#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
and its effect to##2##4##(2008-10#1)(2008-11#1)
and its effect was##2##4##(2008-10#2)
and its effect##30##3##(1992-1#1)(1995-11#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
and its effectiveness##3##3##(1991-3#1)(2008-3#1)(2008-6#1)
and its effector##3##3##(2008-1#1)(2008-5#1)(2009-8#1)
and its effects in##2##4##(1991-9#1)(2008-1#1)
and its effects on the##3##5##(1990-5#1)(2010-2#1)(2013-1#1)
and its effects on##13##4##(1990-2#1)(1990-5#1)(1992-9#1)(1994-5#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
and its effects##17##3##(1990-2#1)(1990-5#1)(1991-9#1)(1992-9#1)(1994-5#1)(1996-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
and its efficacy is##2##4##(2008-2#1)(2008-3#1)
and its efficacy##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
and its efficiency##2##3##(2008-10#1)(2008-3#1)
and its electrochemical##2##3##(2008-10#2)
and its elimination##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
and its environment##4##3##(1990-8#1)(1992-6#1)(2008-1#1)(2008-10#1)
and its environmental##2##3##(2008-10#1)(2011-2#1)
and its evaluation##2##3##(1994-1#1)(2008-8#1)
and its evolution##4##3##(1991-3#1)(2008-10#2)(2010-6#1)
and its evolutionary consequences##2##4##(2008-9#1)(2009-6#1)
and its experimental##3##3##(2008-3#3)
and its expression in the##3##5##(1996-10#1)(1996-12#1)(1997-2#1)
and its expression in##6##4##(1996-10#1)(1996-12#1)(1997-2#2)(2008-8#2)
and its expression is##3##4##(1992-12#1)(1995-6#1)(2008-9#1)
and its expression was##3##4##(1997-2#1)(2008-12#1)(2008-8#1)
and its expression##16##3##(1992-12#2)(1993-11#1)(1993-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-2#4)(2008-12#1)(2008-8#3)(2008-9#1)
and its extracts##4##3##(2011-1#3)(2013-8#1)
and its fast##2##3##(2008-10#1)(2008-4#1)
and its first##2##3##(2008-10#1)(2008-8#1)
and its flanking regions##4##4##(1990-11#1)(1990-8#1)(1993-8#1)(1997-4#1)
and its four##3##3##(2008-10#2)(2013-1#1)
and its frequency##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
and its function as a##2##5##(1995-2#1)(2011-3#1)
and its function in regulating##2##5##(2008-8#1)(2008-9#1)
and its function in##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
and its function##6##3##(1995-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
and its functional##3##3##(1994-6#1)(1994-8#1)(2012-2#1)
and its future##2##3##(1994-1#1)(2012-3#1)
and its gene expression##2##4##(2008-11#1)(2013-8#1)
and its gene##3##3##(1995-6#1)(2008-11#1)(2013-8#1)
and its genetic##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
and its good##2##3##(2008-10#1)(2008-5#1)
and its health##2##3##(2008-10#1)(2011-1#1)
and its high##4##3##(1994-12#1)(2007-11#1)(2008-10#1)(2010-11#1)
and its homologues##3##3##(1993-11#1)(1995-6#1)(2008-10#1)
and its host##3##3##(1997-1#1)(2008-10#2)
and its hydrolysis products##2##4##(2008-10#2)
and its identification##3##3##(1990-2#1)(1996-4#1)(2013-1#1)
and its imaging##2##3##(2008-11#1)(2008-3#1)
and its immediate##2##3##(2008-2#1)(2008-9#1)
and its impact on clinical outcomes##2##6##(2009-12#1)(2011-2#1)
and its impact on health##2##5##(2012-12#1)(2013-1#1)
and its impact on the##6##5##(1996-1#1)(2006-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
and its impact on##29##4##(1991-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-9#1)(2011-2#4)(2012-12#4)(2013-1#4)
and its impact##33##3##(1991-1#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-1#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-9#1)(2011-2#5)(2012-12#4)(2013-1#4)
and its implementation##2##3##(1995-5#1)(2008-3#1)
and its implication on##4##4##(2008-10#1)(2008-11#2)(2011-2#1)
and its implication##5##3##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
and its implications for##10##4##(1992-9#1)(1993-8#1)(1995-2#1)(1996-4#2)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
and its implications in##5##4##(1993-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2012-3#1)
and its implications on##2##4##(2011-1#1)(2011-2#1)
and its implications to##2##4##(1990-10#1)(2008-11#1)
and its implications##20##3##(1990-10#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-4#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and its importance in the##3##5##(1994-5#1)(2012-1#1)(2013-1#1)
and its importance in##5##4##(1994-5#1)(1997-3#1)(2008-1#1)(2012-1#1)(2013-1#1)
and its importance##7##3##(1994-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2012-1#1)(2013-1#1)
and its improvement##2##3##(2008-11#1)(2008-2#1)
and its inability to##2##4##(1994-12#1)(1996-2#1)
and its incorporation into##2##4##(1990-7#1)(2008-7#1)
and its individual##2##3##(1996-2#1)(2008-1#1)
and its influence on the##2##5##(1994-5#1)(2008-2#1)
and its influence on##6##4##(1994-5#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-1#1)(2013-8#1)
and its influence##8##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-9#1)(2013-1#1)(2013-8#1)
and its influencing factors##2##4##(2008-9#1)(2011-1#1)
and its influential factors]##2##4##(2013-8#2)
and its inhibition by##6##4##(1995-6#2)(2008-11#1)(2008-5#1)(2008-7#2)
and its inhibition##8##3##(1995-6#2)(1997-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
and its initial##2##3##(1992-2#1)(2008-3#1)
and its interaction with##6##4##(1997-1#1)(2007-12#1)(2008-10#3)(2008-5#1)
and its interaction##7##3##(1997-1#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#1)
and its interactions##2##3##(2009-4#1)(2009-9#1)
and its interpretation##2##3##(1990-6#1)(2009-4#1)
and its intracellular##2##3##(1996-2#1)(2011-1#1)
and its inversion##2##3##(2008-3#2)
and its isoelectric##2##3##(1991-2#1)(2008-7#1)
and its isolated##2##3##(1994-11#1)(1995-2#1)
and its keto acid##2##4##(2008-11#2)
and its key##2##3##(1993-3#1)(2012-8#1)
and its kinetic##2##3##(1995-11#1)(2008-10#1)
and its known##2##3##(1997-5#1)(2008-10#1)
and its later##2##3##(2008-4#1)(2010-5#1)
and its level##2##3##(2008-10#2)
and its levels are##2##4##(1993-12#1)(2009-8#1)
and its ligand##2##3##(1994-12#1)(2011-2#1)
and its limitations##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)
and its link to##2##4##(2008-11#1)(2008-8#1)
and its linkage##2##3##(1990-8#1)(2008-10#1)
and its links to##2##4##(2008-9#1)(2010-3#1)
and its location##2##3##(1990-9#1)(2008-7#1)
and its low##4##3##(2008-10#2)(2009-1#1)(2009-11#1)
and its mRNA##6##3##(1990-7#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(2008-9#1)
and its main metabolite##9##4##(2008-10#9)
and its main##18##3##(1997-8#1)(2008-10#14)(2008-2#1)(2010-5#1)(2011-2#1)
and its major metabolite (AM1) in##2##6##(2008-10#2)
and its major metabolite##3##4##(1992-11#1)(2008-10#2)
and its major metabolites in##2##5##(1990-8#1)(1996-5#1)
and its major metabolites##3##4##(1990-8#1)(1996-5#1)(2008-10#1)
and its major transformation product##2##5##(2008-10#2)
and its major##11##3##(1990-8#1)(1992-11#1)(1996-5#1)(1997-8#1)(2008-10#6)(2013-8#1)
and its management in##2##4##(2008-5#1)(2008-7#1)
and its management##8##3##(1995-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#1)
and its mechanism of##3##4##(1992-6#1)(2008-8#2)
and its mechanism##6##3##(1992-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2013-8#1)
and its medication##3##3##(2011-1#3)
and its medicinal preparation by capillary##2##6##(2008-10#2)
and its medicinal preparation##3##4##(2008-10#3)
and its medicinal##5##3##(2008-10#5)
and its mercury##2##3##(1993-11#1)(2008-10#1)
and its messenger RNA##2##4##(1993-11#1)(1994-11#1)
and its metabolic##2##3##(2008-10#1)(2008-3#1)
and its metabolite in##2##4##(2008-10#2)
and its metabolite##9##3##(2008-10#8)(2009-6#1)
and its metabolites are##2##4##(2008-10#1)(2008-11#1)
and its metabolites in##8##4##(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2011-3#1)
and its metabolites were##3##4##(1992-10#1)(2008-11#1)(2008-7#1)
and its metabolites##23##3##(1992-10#1)(1993-3#1)(1996-5#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2011-3#1)
and its methyl##2##3##(1996-7#1)(2007-11#1)
and its microenvironment##2##3##(2008-7#1)(2009-3#1)
and its model##2##3##(2008-10#1)(2012-3#1)
and its modification by##2##4##(1993-5#1)(2009-8#1)
and its modulation by##4##4##(1990-3#2)(1993-2#1)(1994-2#1)
and its modulation##6##3##(1990-3#2)(1993-2#1)(1994-2#1)(2008-2#1)(2013-8#1)
and its molecular##4##3##(1997-4#1)(2008-1#1)(2008-8#1)(2009-4#1)
and its most##2##3##(1990-5#1)(2008-1#1)
and its mutant##3##3##(1995-11#1)(2008-8#2)
and its mutants##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and its natural##2##3##(2008-6#1)(2008-7#1)
and its neighbouring##2##3##(2007-7#1)(2008-1#1)
and its newer modalities##3##4##(2011-2#3)
and its nitroso-metabolites##3##3##(2008-10#3)
and its occurrence##2##3##(2007-2#1)(2008-7#1)
and its operation in##2##4##(2007-12#1)(2008-11#1)
and its operation##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
and its operational##2##3##(2008-2#1)(2009-10#1)
and its optical implementation##2##4##(2008-2#1)(2008-3#1)
and its optical##3##3##(2008-2#1)(2008-3#2)
and its outcome##2##3##(2008-3#1)(2012-3#1)
and its oxidation products##2##4##(2008-10#1)(2008-11#1)
and its oxidation##3##3##(2008-10#2)(2008-11#1)
and its pH##4##3##(1994-12#1)(2008-10#3)
and its participation in the##2##5##(1994-9#1)(2011-2#1)
and its performance##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
and its pharmaceutical formulation##2##4##(2008-10#2)
and its pharmaceutical preparations##2##4##(2008-10#2)
and its pharmaceutical##4##3##(2008-10#4)
and its phosphorylated anabolites##2##4##(2008-7#2)
and its phosphorylation##2##3##(1995-2#2)
and its physicochemical properties##2##4##(2008-10#2)
and its physicochemical##3##3##(2008-10#2)(2008-7#1)
and its physiological##3##3##(1994-3#1)(2007-8#1)(2008-5#1)
and its position in the##2##5##(2008-12#1)(2009-5#1)
and its position##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-5#1)
and its possible impact on##2##5##(2008-3#1)(2012-1#1)
and its possible##9##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-1#1)
and its potency##2##3##(1995-11#1)(2013-1#1)
and its potential application##2##4##(2011-2#1)(2013-1#1)
and its potential effects##2##4##(1991-12#1)(2011-2#1)
and its potential for##4##4##(1992-6#1)(2007-11#1)(2008-10#1)(2010-12#1)
and its potential impact##2##4##(1993-2#1)(2008-11#1)
and its potential##20##3##(1991-12#1)(1992-12#1)(1992-6#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
and its practical##2##3##(2007-12#1)(2010-9#1)
and its precursor##3##3##(1994-6#1)(1995-5#1)(1996-12#1)
and its predictive##2##3##(2011-1#1)(2011-2#1)
and its preliminary##2##3##(2008-8#1)(2012-3#1)
and its presence##3##3##(1990-7#1)(2008-10#1)(2012-1#1)
and its presumed##2##3##(1994-8#1)(2008-10#1)
and its prevention with##2##4##(1991-9#1)(1993-10#1)
and its prevention##8##3##(1991-9#1)(1993-10#1)(1997-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
and its progress##2##3##(1997-2#1)(2013-8#1)
and its properties##3##3##(1991-12#1)(1993-3#1)(2008-10#1)
and its protection##2##3##(1994-8#1)(2008-5#1)
and its receptor in aged##2##5##(2009-5#1)(2013-7#1)
and its receptor in##6##4##(1991-7#1)(1993-3#1)(2008-11#1)(2008-4#1)(2009-5#1)(2013-7#1)
and its receptor##22##3##(1991-7#1)(1993-11#1)(1993-3#2)(1995-12#4)(1997-4#1)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2012-2#1)(2013-7#1)
and its receptors are##2##4##(2011-1#1)(2011-2#1)
and its recognition##2##3##(2008-1#1)(2008-10#1)
and its recombinant##3##3##(1994-8#1)(2008-9#1)(2012-2#1)
and its reduction##2##3##(1994-11#1)(2011-2#1)
and its regulation by##2##4##(1990-8#1)(2008-4#1)
and its regulation##4##3##(1990-8#1)(2008-4#1)(2010-3#1)(2011-1#1)
and its regulator##2##3##(1995-2#1)(1995-5#1)
and its regulatory##2##3##(2012-2#1)(2013-1#1)
and its related compounds##3##4##(2008-11#3)
and its related##15##3##(1992-6#1)(2008-10#2)(2008-11#3)(2008-8#3)(2009-10#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
and its relation to the##5##5##(1992-3#1)(1993-5#1)(1997-6#1)(2011-2#1)(2013-8#1)
and its relation to##15##4##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and its relation##16##3##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
and its relationship to the##5##5##(1995-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
and its relationship to##19##4##(1992-12#2)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-2#2)(2012-2#1)
and its relationship with cigarette##2##5##(2013-1#2)
and its relationship with the known##2##6##(1995-12#1)(2007-11#1)
and its relationship with the##6##5##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
and its relationship with##14##4##(1990-9#1)(1991-12#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-6#1)(2012-12#2)(2013-1#2)
and its relationship##33##3##(1990-9#1)(1991-12#1)(1992-12#2)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#2)(1996-5#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
and its relevance for##2##4##(1994-12#1)(2009-2#1)
and its relevance to the##3##5##(1991-5#1)(2007-12#1)(2007-9#1)
and its relevance to##7##4##(1991-5#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
and its relevance##9##3##(1991-5#1)(1994-12#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
and its removal##2##3##(2008-7#1)(2013-1#1)
and its repair##2##3##(2007-10#1)(2008-10#1)
and its resistance##2##3##(2008-10#1)(2008-3#1)
and its response to##2##4##(2007-11#1)(2008-7#1)
and its response##4##3##(1992-8#1)(1996-9#1)(2007-11#1)(2008-7#1)
and its results##2##3##(2007-2#1)(2008-10#1)
and its risk factors##2##4##(2007-7#1)(2011-1#1)
and its robustness##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and its role as a##3##5##(2008-10#1)(2009-11#1)(2009-7#1)
and its role in the##4##5##(1997-2#1)(2008-12#1)(2008-8#2)
and its role in##19##4##(1990-2#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
and its role##22##3##(1990-2#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
and its sensitivity was##2##4##(1992-6#1)(2007-8#1)
and its sensitivity##3##3##(1992-6#1)(2007-8#1)(2008-3#1)
and its separation##2##3##(2008-10#2)
and its sequence##2##3##(1993-9#1)(1997-7#1)
and its significance##3##3##(2007-7#1)(2009-4#1)(2010-6#1)
and its simplicity##2##3##(2008-11#1)(2008-3#1)
and its social##2##3##(2008-11#1)(2011-1#1)
and its solution##2##3##(2008-10#2)
and its spatial distribution##2##4##(2008-3#1)(2009-10#1)
and its specific receptor##2##4##(1990-5#1)(1993-12#1)
and its specific##5##3##(1990-2#1)(1990-5#1)(1992-12#1)(1993-12#1)(2008-11#1)
and its stability##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
and its stimulation by##2##4##(1990-8#1)(1992-8#1)
and its structure##2##3##(2008-10#1)(2011-2#1)
and its subsequent##12##3##(1993-6#1)(1994-11#2)(1996-5#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-8#1)(2011-2#1)
and its substrate##3##3##(2008-2#1)(2009-7#2)
and its subtypes in##2##4##(1995-12#1)(2008-3#1)
and its subunits##2##3##(1990-5#1)(2008-10#1)
and its suitability for##2##4##(1995-11#1)(2008-10#1)
and its superiority##2##3##(1992-9#1)(1994-6#1)
and its suppression by##5##4##(1992-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2009-9#1)
and its suppression##6##3##(1992-12#1)(1993-8#1)(2008-10#1)(2008-11#2)(2009-9#1)
and its surgical##3##3##(1990-2#1)(1990-8#1)(1993-2#1)
and its surrounding##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2009-12#1)
and its surroundings##2##3##(2008-10#1)(2012-2#1)
and its symptoms##2##3##(2011-1#1)(2012-1#1)
and its synthetic##3##3##(1990-2#1)(1997-3#1)(2009-3#1)
and its therapeutic##3##3##(2008-11#1)(2008-7#2)
and its three major##2##4##(1990-8#1)(1996-6#1)
and its toxic metabolite##3##4##(2008-10#3)
and its transmission##3##3##(2008-10#1)(2008-2#1)(2010-1#1)
and its treatment with##2##4##(1994-5#1)(2008-11#1)
and its treatment##17##3##(1990-6#1)(1991-2#1)(1992-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#1)
and its two##3##3##(1991-2#1)(1992-11#1)(2008-10#1)
and its uncertainty##4##3##(2008-10#3)(2008-3#1)
and its underlying mechanism##2##4##(2008-10#1)(2010-11#1)
and its underlying##6##3##(1990-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-11#1)
and its use as##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
and its use for##4##4##(1997-3#1)(2008-10#2)(2008-3#1)
and its use in the##4##5##(1994-12#1)(1995-12#1)(2008-10#2)
and its use in##8##4##(1994-12#1)(1995-12#1)(2008-10#4)(2011-1#1)(2013-7#1)
and its use is##3##4##(1995-11#1)(2008-11#1)(2010-2#1)
and its use##19##3##(1991-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-7#1)
and its usefulness##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
and its utility##2##3##(2009-6#1)(2013-8#1)
and its value in the##2##5##(2007-2#1)(2007-4#1)
and its value in##3##4##(2007-2#1)(2007-4#1)(2007-8#1)
and its value##4##3##(1994-12#1)(2007-2#1)(2007-4#1)(2007-8#1)
and its variant##2##3##(2008-8#1)(2013-1#1)
and its variants##2##3##(2008-9#1)(2013-1#1)
and its various##3##3##(1994-12#1)(2008-5#1)(2011-2#1)
and its withdrawal##2##3##(1996-12#2)
and its##1957##2##(1990-10#2)(1990-11#4)(1990-2#10)(1990-3#6)(1990-4#1)(1990-5#12)(1990-6#2)(1990-7#3)(1990-8#15)(1990-9#5)(1991-1#1)(1991-12#10)(1991-2#8)(1991-3#3)(1991-5#5)(1991-6#7)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#5)(1992-12#11)(1992-2#4)(1992-3#3)(1992-5#4)(1992-6#11)(1992-8#5)(1992-9#7)(1993-1#4)(1993-10#2)(1993-11#10)(1993-12#4)(1993-2#9)(1993-3#11)(1993-5#5)(1993-6#10)(1993-8#5)(1993-9#5)(1994-1#2)(1994-11#11)(1994-12#16)(1994-2#7)(1994-3#2)(1994-5#10)(1994-6#5)(1994-7#1)(1994-8#11)(1994-9#5)(1995-1#4)(1995-11#11)(1995-12#13)(1995-2#12)(1995-3#5)(1995-5#9)(1995-6#15)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#12)(1996-3#2)(1996-4#4)(1996-5#10)(1996-6#4)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#16)(1997-3#8)(1997-4#5)(1997-5#3)(1997-6#6)(1997-7#5)(1997-8#5)(2006-10#1)(2007-10#7)(2007-11#25)(2007-12#28)(2007-2#3)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#26)(2008-10#454)(2008-11#86)(2008-12#19)(2008-2#40)(2008-3#75)(2008-4#23)(2008-5#45)(2008-6#7)(2008-7#58)(2008-8#54)(2008-9#43)(2009-1#2)(2009-10#18)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#7)(2009-4#7)(2009-5#12)(2009-6#8)(2009-7#12)(2009-8#12)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#7)(2010-6#7)(2010-7#1)(2010-8#5)(2010-9#5)(2011-1#36)(2011-10#1)(2011-2#78)(2011-3#5)(2012-1#10)(2012-12#22)(2012-2#45)(2012-3#22)(2012-6#1)(2012-8#1)(2013-1#52)(2013-7#9)(2013-8#33)
and ivermectin##3##2##(1996-11#1)(1997-3#1)(2010-2#1)
and japonica##4##2##(2008-10#3)(2008-8#1)
and jasmonic acid##2##3##(2008-10#1)(2009-8#1)
and jasmonic##3##2##(2008-10#2)(2009-8#1)
and jatropha##3##2##(2009-3#3)
and jaundice##5##2##(1990-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
and jaw##3##2##(1996-3#1)(2010-3#1)(2013-1#1)
and jeopardizes##2##2##(1996-11#1)(2008-5#1)
and job satisfaction##5##3##(1991-12#1)(1992-1#1)(1996-9#1)(2008-12#1)(2008-9#1)
and job##14##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-3#1)(1994-1#1)(1996-9#1)(2008-12#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
and joining of##2##3##(1997-7#2)
and joining##4##2##(1997-3#2)(1997-7#2)
and joint destruction##2##3##(2008-8#1)(2009-1#1)
and joint##22##2##(1990-6#1)(1992-6#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#3)
and joints##2##2##(1991-11#1)(2012-3#1)
and journals##3##2##(2008-12#1)(2009-6#1)(2010-8#1)
and joy##2##2##(2009-10#1)(2013-1#1)
and judging##2##2##(1992-12#1)(1996-2#1)
and judgment##2##2##(1992-3#1)(2010-8#1)
and judicious use of##2##4##(2008-1#1)(2013-1#1)
and judicious##6##2##(2007-12#1)(2007-7#1)(2008-1#1)(2010-1#1)(2011-2#1)(2013-1#1)
and juice 0##2##3##(2008-10#2)
and juice##6##2##(2008-10#4)(2010-5#2)
and jumping##4##2##(1990-6#1)(1995-2#2)(1996-2#1)
and junctional##2##2##(1994-6#1)(1997-9#1)
and just##8##2##(1994-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
and justice##5##2##(1991-12#1)(1992-2#1)(1997-1#1)(2007-2#1)(2008-10#1)
and justicidin E##2##3##(1996-5#2)
and justify##2##2##(1991-11#1)(2008-3#1)
and juvenile rheumatoid arthritis##2##4##(2012-3#2)
and juvenile##13##2##(1993-11#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#2)(2012-3#3)
and juveniles##3##2##(2008-10#1)(2010-8#2)
and k is##2##3##(2008-3#1)(2008-5#1)
and k##8##2##(1992-9#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)
and k(298) = 2##2##4##(1996-2#2)
and k)##2##2##(2008-10#1)(2008-2#1)
and kainate receptors were##2##4##(1993-12#1)(2012-2#1)
and kainic acid##2##3##(1993-6#1)(1995-12#1)
and kallikrein##2##2##(1990-5#2)
and kappa opioid##2##3##(1993-12#1)(2009-12#1)
and kappa##9##2##(1991-1#1)(1993-12#1)(1995-6#1)(2006-10#1)(2008-3#2)(2009-12#1)(2009-8#1)(2013-8#1)
and kappa-##2##2##(1995-12#1)(2008-10#1)
and karyotype##2##2##(2008-12#1)(2008-9#1)
and kcat##2##2##(1994-5#1)(1995-8#1)
and keep##5##2##(1994-3#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
and keeping them##2##3##(1995-12#1)(2008-9#1)
and keeping##4##2##(1995-12#1)(1996-1#1)(2008-10#1)(2008-9#1)
and keeps##2##2##(2007-12#1)(2008-12#1)
and kept##6##2##(1996-2#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
and keratin##3##2##(2008-11#1)(2012-1#1)(2012-3#1)
and keratinocytes are##2##3##(2008-1#1)(2008-5#1)
and keratinocytes##5##2##(2008-1#1)(2008-5#3)(2012-3#1)
and keratinolytic activity##2##3##(2008-6#2)
and keratinolytic##4##2##(2008-6#4)
and kernel##9##2##(2008-10#8)(2011-2#1)
and ketamine infusions##3##3##(2011-2#3)
and ketamine##9##2##(1991-1#1)(2011-2#5)(2012-2#2)(2012-3#1)
and ketoconazole was##3##3##(2008-5#3)
and ketoconazole##5##2##(2008-11#1)(2008-5#3)(2012-3#1)
and ketone##2##2##(1996-5#1)(2007-11#1)
and key informant interviews##3##4##(2008-12#1)(2008-6#1)(2012-12#1)
and key##20##2##(1991-3#1)(1993-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
and kidney and##3##3##(1994-9#1)(1997-8#1)(2008-5#1)
and kidney disease##4##3##(2007-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
and kidney of##4##3##(2008-5#2)(2008-7#1)(2012-3#1)
and kidney were found to be##2##6##(1995-11#1)(2008-5#1)
and kidney were##4##3##(1992-9#1)(1995-11#1)(2008-5#1)(2009-11#1)
and kidney##62##2##(1990-11#3)(1990-12#2)(1990-3#6)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-9#1)(1993-12#2)(1994-11#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and kidney-derived##2##2##(1991-3#1)(2008-7#1)
and kidneys were##2##3##(1995-11#1)(2012-3#1)
and kidneys##8##2##(1990-2#1)(1991-6#1)(1995-11#1)(1997-6#1)(2008-12#1)(2008-5#1)(2012-3#2)
and kill the##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
and kill##5##2##(2006-10#1)(2007-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
and killed##3##2##(1990-3#1)(1993-12#1)(1996-12#1)
and killing##2##2##(1991-9#1)(2008-7#1)
and kinapses##2##2##(2012-2#2)
and kinase##5##2##(1991-12#1)(1994-11#1)(1994-8#1)(2008-4#1)(2009-8#1)
and kind of##3##3##(1994-6#2)(2008-10#1)
and kinematic##3##2##(1994-3#1)(2007-12#1)(2010-3#1)
and kinematics##5##2##(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#2)
and kinetic analysis of##2##4##(1993-8#1)(2008-10#1)
and kinetic analysis##3##3##(1993-8#1)(1995-3#1)(2008-10#1)
and kinetic and##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
and kinetic characterization of##2##4##(1991-9#1)(1994-6#1)
and kinetic data##2##3##(1990-8#1)(2013-1#1)
and kinetic energy##2##3##(2008-10#2)
and kinetic parameters for##3##4##(1990-9#1)(1993-8#1)(2008-7#1)
and kinetic parameters##4##3##(1990-9#1)(1993-8#1)(2008-4#1)(2008-7#1)
and kinetic properties of these##2##5##(2008-4#1)(2008-5#1)
and kinetic properties of##3##4##(1995-3#1)(2008-4#1)(2008-5#1)
and kinetic studies of##3##4##(1990-7#1)(1991-5#1)(1993-8#1)
and kinetic studies##4##3##(1990-7#1)(1991-5#1)(1993-8#1)(2008-11#1)
and kinetic##35##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#2)(1991-9#1)(1992-3#1)(1993-8#4)(1994-6#1)(1995-3#2)(1997-2#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
and kinetics of##10##3##(1990-2#1)(1994-5#1)(1997-2#1)(2008-10#5)(2012-2#1)(2013-1#1)
and kinetics##17##2##(1990-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and kinetin##2##2##(2008-10#1)(2013-1#1)
and knee flexion##2##3##(2011-2#1)(2013-1#1)
and knee joint##2##3##(1994-8#1)(2011-2#1)
and knee##16##2##(1994-8#1)(1995-12#1)(1995-5#1)(2006-10#2)(2007-8#3)(2009-3#2)(2011-2#2)(2012-2#2)(2013-1#2)
and knirps-related##2##2##(1994-8#2)
and knockout mice##2##3##(2008-4#1)(2009-7#1)
and know how##3##3##(1996-12#1)(2009-11#1)(2011-2#1)
and know##4##2##(1996-12#1)(2009-11#1)(2010-8#1)(2011-2#1)
and knowledge about diabetes##2##4##(1993-12#1)(2011-1#1)
and knowledge about the##3##4##(1995-5#1)(2008-11#1)(2009-8#1)
and knowledge about##10##3##(1993-12#1)(1995-5#1)(1997-1#1)(2008-11#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#2)
and knowledge and##2##3##(1996-3#1)(2009-10#1)
and knowledge management##2##3##(2008-11#1)(2008-8#1)
and knowledge of and##2##4##(2011-1#1)(2012-3#1)
and knowledge of the##8##4##(1992-12#1)(2007-7#1)(2008-10#2)(2009-9#1)(2011-1#1)(2011-2#2)
and knowledge of##26##3##(1992-12#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
and knowledge##65##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)
and known##10##2##(1993-12#2)(1994-11#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-3#1)
and kringle 1##3##3##(1990-5#2)(1995-6#1)
and kringle##5##2##(1990-5#2)(1993-8#2)(1995-6#1)
and kyphoplasty are##3##3##(2007-8#1)(2008-7#2)
and kyphoplasty in##3##3##(2007-8#2)(2008-7#1)
and kyphoplasty##8##2##(2007-8#3)(2008-7#5)
and l-ascorbic acid##2##3##(2008-10#1)(2008-5#1)
and l-cystine##3##2##(2008-10#3)
and l-dopa##7##2##(2008-10#7)
and l-triiodothyronine (l-T(3))##2##3##(2008-10#2)
and lab##2##2##(2008-6#1)(2009-3#1)
and label##3##2##(2008-5#1)(2010-5#1)(2012-2#1)
and label-free##2##2##(2008-10#1)(2008-7#1)
and labeled simultaneously##2##3##(2008-10#2)
and labeled with##3##3##(1992-3#1)(1996-2#1)(2008-4#1)
and labeled##8##2##(1990-12#1)(1992-3#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-4#2)
and labeling of the##2##4##(1995-6#1)(2008-10#1)
and labeling of##5##3##(1995-6#1)(2008-10#1)(2008-4#2)(2012-2#1)
and labeling##11##2##(1991-12#1)(1995-6#1)(2008-10#3)(2008-4#5)(2012-2#1)
and labelled##4##2##(1990-12#1)(1990-8#1)(1992-9#1)(2012-1#1)
and labile##2##2##(1990-12#1)(2008-10#1)
and labor##11##2##(1990-5#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#3)(2013-1#2)
and laboratories##2##2##(1994-5#1)(2012-12#1)
and laboratory analysis##2##3##(2008-10#1)(2012-2#1)
and laboratory data were collected##2##5##(2008-1#1)(2011-2#1)
and laboratory data were##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
and laboratory data##8##3##(1991-3#1)(1994-5#1)(2008-1#1)(2011-2#2)(2013-1#3)
and laboratory evaluations##2##3##(2008-1#1)(2010-1#1)
and laboratory features of##5##4##(1997-7#1)(2008-8#2)(2011-2#2)
and laboratory features##7##3##(1997-7#1)(2008-8#2)(2011-2#3)(2013-1#1)
and laboratory investigations were##2##4##(2008-11#1)(2011-2#1)
and laboratory investigations##5##3##(1990-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
and laboratory parameters##2##3##(1996-1#1)(2011-2#1)
and laboratory studies##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
and laboratory variables##4##3##(2011-1#2)(2011-2#2)
and laboratory##70##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#1)(1996-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#6)(2008-5#1)(2008-7#4)(2008-8#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)
and laborious##7##2##(1995-11#1)(1995-12#1)(2008-10#3)(2008-4#1)(2012-12#1)
and labour##5##2##(1990-11#1)(1992-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
and lacZ##3##2##(1990-5#2)(1997-4#1)
and lack of control##2##4##(1992-3#1)(2013-1#1)
and lack of knowledge##2##4##(2007-2#1)(2011-2#1)
and lack of social##2##4##(2008-5#1)(2011-2#1)
and lack of##46##3##(1990-7#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-1#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and lack##48##2##(1990-7#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#1)(1996-1#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and lacked a##2##3##(1993-3#1)(1997-7#1)
and lacked##6##2##(1993-3#2)(1995-12#1)(1997-7#1)(2008-10#2)
and lacking##4##2##(1991-6#1)(1997-1#1)(2008-10#1)(2011-2#1)
and lacks##4##2##(1990-11#1)(1992-3#1)(1997-4#1)(2007-12#1)
and lactate dehydrogenase (LDH)##2##4##(1994-5#1)(2008-10#1)
and lactate from##2##3##(1992-6#1)(2008-11#1)
and lactate##15##2##(1992-6#1)(1994-5#1)(2008-10#3)(2008-11#5)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#1)
and lactating##4##2##(1990-11#3)(2011-2#1)
and lactic acid##7##3##(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2013-7#1)
and lactic##8##2##(1997-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2013-7#1)
and lactoferrin##3##2##(2008-10#2)(2013-8#1)
and lactose##7##2##(1990-2#2)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
and lag phase##2##3##(2011-2#2)
and lag##7##2##(2007-11#2)(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#2)
and lag-2##2##2##(1994-12#2)
and lake water samples##3##4##(2008-10#3)
and lake water##8##3##(2008-10#8)
and lake##10##2##(2008-10#9)(2012-3#1)
and lamb##3##2##(1991-12#1)(1997-2#1)(2010-4#1)
and lambda = 632##2##4##(2008-3#2)
and lambda =##3##3##(2008-3#3)
and lambda is##2##3##(2008-3#1)(2008-8#1)
and lambda##13##2##(1990-5#1)(1995-6#3)(2007-12#1)(2008-10#2)(2008-3#4)(2008-8#1)(2009-3#1)
and lambda(2)##2##2##(2008-10#1)(2008-3#1)
and lamellar##2##2##(2008-5#1)(2009-7#1)
and laminar##5##2##(1992-6#1)(1992-9#1)(1993-12#2)(2008-9#1)
and laminarinase##3##2##(2008-10#3)
and laminin in##2##3##(1992-6#1)(1993-12#1)
and lamivudine##3##2##(2008-5#2)(2009-8#1)
and land##5##2##(1992-1#1)(2008-10#1)(2008-3#1)(2008-8#2)
and language development in children with cochlear implants##2##8##(2008-9#2)
and language development##4##3##(2008-11#1)(2008-9#2)(2010-4#1)
and language disturbances##5##3##(2007-8#5)
and language skills of##3##4##(2008-9#3)
and language##33##2##(1995-5#1)(1997-3#1)(1997-6#1)(2007-8#6)(2008-11#4)(2008-12#1)(2008-9#6)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
and lansoprazole##5##2##(2012-2#5)
and lanthanides##6##2##(2008-10#6)
and lanthanum##5##2##(2007-11#1)(2008-10#4)
and laparoscopic##6##2##(1993-12#1)(1993-9#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
and laparoscopically assisted vaginal##2##4##(1994-2#1)(2011-2#1)
and large amounts of##2##4##(1992-8#1)(2008-10#1)
and large dose treatments with##2##5##(1994-6#2)
and large effect##2##3##(2007-11#1)(2011-2#1)
and large gamma##2##3##(2008-2#2)
and large numbers of##2##4##(1997-1#1)(2008-10#1)
and large sample##2##3##(1996-3#1)(2013-1#1)
and large scale##2##3##(1996-4#1)(2012-2#1)
and large size##2##3##(2008-10#1)(2010-2#1)
and large##85##2##(1990-11#2)(1990-2#2)(1990-5#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-6#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#6)(2013-1#1)(2013-8#1)
and large-scale production##3##3##(2008-2#1)(2008-4#2)
and large-scale##11##2##(2008-11#3)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
and large-volume##2##2##(2008-10#2)
and largely##6##2##(1996-12#1)(1996-2#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
and larger in##2##3##(2008-3#2)
and larger than##3##3##(1990-5#1)(2007-11#1)(2008-10#1)
and larger##24##2##(1990-5#2)(1990-8#1)(1995-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2012-2#1)
and larvae and##2##3##(2008-8#2)
and larvae##8##2##(1997-4#1)(2008-10#1)(2008-8#3)(2010-8#1)(2011-2#1)(2013-1#1)
and larval density##2##3##(2008-9#1)(2010-8#1)
and larval##6##2##(2007-5#1)(2008-7#1)(2008-9#1)(2010-8#2)(2012-3#1)
and laryngeal##5##2##(1990-9#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
and larynx##2##2##(2008-11#1)(2013-1#1)
and lasalocid##2##2##(2007-6#2)
and laser ablation##2##3##(2008-10#2)
and laser action##2##3##(2007-11#1)(2008-2#1)
and laser capture##2##3##(2010-6#2)
and laser in##2##3##(1993-6#2)
and laser therapy##2##3##(2010-8#1)(2013-1#1)
and laser##43##2##(1991-9#1)(1993-12#1)(1993-6#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#8)(2008-3#10)(2008-8#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and laser-induced fluorescence##4##3##(2008-10#1)(2008-3#3)
and laser-induced##8##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-9#1)(2013-1#1)
and lasers##2##2##(2012-3#2)
and lasing##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
and last but not least##2##5##(1991-3#1)(2007-11#1)
and last##10##2##(1991-3#1)(1992-3#1)(1997-3#1)(2007-11#2)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
and lasted for##2##3##(1991-2#1)(2008-10#1)
and lasted more than##2##4##(2008-9#2)
and lasted##7##2##(1990-5#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-1#1)
and lasting for##2##3##(1992-11#1)(1996-6#1)
and lasting results##2##3##(1990-5#1)(1992-9#1)
and lasting##10##2##(1990-5#1)(1992-11#1)(1992-9#1)(1996-6#1)(2007-11#1)(2011-2#4)(2013-1#1)
and lastly##6##2##(1990-3#1)(1990-8#1)(1992-3#1)(1994-12#1)(2008-10#1)(2011-10#1)
and late colonizers##2##3##(2008-5#2)
and late complications##3##3##(1993-9#1)(2007-11#1)(2011-2#1)
and late in##2##3##(2008-10#2)
and late phases of##2##4##(2008-6#1)(2013-8#1)
and late phases##4##3##(2008-6#1)(2010-12#2)(2013-8#1)
and late season##2##3##(2008-10#2)
and late##57##2##(1992-6#1)(1993-9#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#3)
and late-onset##2##2##(2008-10#1)(2008-7#1)
and late-season##2##2##(2008-10#1)(2011-2#1)
and late-stage myxomatous mitral valves from dogs##2##7##(2010-12#2)
and late-stage##3##2##(2010-12#3)
and latency in##2##3##(2008-10#2)
and latency##3##2##(2008-10#2)(2008-3#1)
and latent period##3##3##(2008-10#3)
and latent##7##2##(1991-11#1)(1995-8#2)(2008-10#3)(2009-8#1)
and latently infected##3##3##(2008-10#3)
and later also in##2##4##(2011-3#1)(2012-2#1)
and later appeared##2##3##(2008-10#1)(2008-7#1)
and later from##3##3##(2008-10#1)(2010-8#1)(2012-1#1)
and later##51##2##(1992-12#1)(1992-4#1)(1994-11#1)(1995-1#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)
and lateral and##2##3##(2007-11#1)(2007-12#1)
and lateral displacement##2##3##(2007-8#1)(2008-2#1)
and lateral regions of##2##4##(1990-9#1)(1996-12#1)
and lateral walls##3##3##(2008-10#1)(2008-7#2)
and lateral##52##2##(1990-12#1)(1990-7#2)(1990-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-2#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)
and lateral)##2##2##(1990-12#1)(2012-8#1)
and laterally##2##2##(2007-12#1)(2011-1#1)
and lauric acid##2##3##(1991-5#1)(2008-10#1)
and law##3##2##(1991-2#1)(1991-3#1)(2008-1#1)
and lawsuits##2##2##(2007-5#1)(2008-11#1)
and laxatives##2##2##(2008-10#1)(2008-7#1)
and layer thickness##2##3##(2008-3#1)(2010-4#1)
and layer##7##2##(1995-9#1)(2008-3#1)(2010-4#1)(2012-1#1)(2013-1#3)
and layer-by-layer##2##2##(2008-10#1)(2010-4#1)
and layered##6##2##(2007-12#4)(2008-9#1)(2010-4#1)
and lead in marine sediment##2##5##(2008-10#2)
and lead in seawater##3##4##(2008-10#3)
and lead in##25##3##(2007-5#1)(2008-10#24)
and lead is##3##3##(2007-5#1)(2008-10#2)
and lead to a##4##4##(2008-10#2)(2008-7#2)
and lead to the##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
and lead to##25##3##(1994-11#1)(1994-9#1)(1995-8#1)(1996-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#5)(2008-3#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
and lead were##2##3##(2008-10#1)(2008-8#1)
and lead##96##2##(1992-3#2)(1993-3#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-11#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#4)(2007-7#3)(2008-10#63)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
and lead(II) in##3##3##(2008-10#3)
and lead(II)##10##2##(2008-10#10)
and leaders##3##2##(2008-1#1)(2008-7#1)(2010-10#1)
and leadership development##3##3##(1993-1#1)(1996-1#1)(1996-12#1)
and leadership in##2##3##(1994-2#2)
and leadership##13##2##(1991-2#1)(1992-2#1)(1993-1#1)(1994-2#2)(1996-1#3)(1996-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-2#1)
and leading to##5##3##(1991-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and leads to a##3##4##(2007-11#1)(2008-12#1)(2008-7#1)
and leads to an##2##4##(1991-3#1)(2010-3#1)
and leads to the##3##4##(2008-7#1)(2009-12#1)(2013-1#1)
and leads to##22##3##(1991-3#1)(1995-8#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#4)(2009-12#2)(2010-3#1)(2010-4#2)(2011-2#1)(2013-1#2)
and leads##23##2##(1991-3#1)(1995-8#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#4)(2009-12#2)(2010-3#1)(2010-4#2)(2011-2#2)(2013-1#2)
and leaf age on infection and lesion development of pecan scab##2##11##(2008-10#2)
and leaf age##5##3##(2008-10#5)
and leaf blight##4##3##(2008-10#4)
and leaf distortion##2##3##(2008-10#2)
and leaf rust##5##3##(2008-10#5)
and leaf spot development##2##4##(2008-10#2)
and leaf spot##6##3##(2008-10#6)
and leaf wetness duration##9##4##(2008-10#9)
and leaf wetness##12##3##(2008-10#12)
and leaf##59##2##(2008-10#53)(2008-5#2)(2008-8#2)(2012-6#1)(2013-1#1)
and leafhopper##2##2##(2008-10#2)
and leaflet##2##2##(2007-8#2)
and leakage of##3##3##(1992-3#2)(1996-2#1)
and leakage##4##2##(1992-3#2)(1996-2#1)(2012-3#1)
and lean mass##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
and lean muscle mass were##2##5##(2013-1#2)
and lean##11##2##(1995-5#2)(1996-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#2)
and learn to##3##3##(1994-1#1)(1996-2#1)(2009-8#1)
and learn##10##2##(1993-2#1)(1994-1#1)(1995-3#1)(1996-2#1)(2008-11#2)(2009-8#1)(2010-12#1)(2013-1#2)
and learned##2##2##(1995-6#1)(2007-11#1)
and learners##2##2##(2008-11#1)(2011-2#1)
and learning and memory##2##4##(1993-12#1)(2012-2#1)
and learning disabilities##2##3##(2008-11#1)(2012-3#1)
and learning in##2##3##(1993-12#1)(1996-1#1)
and learning resources##2##3##(1996-2#1)(2008-12#1)
and learning##63##2##(1992-11#2)(1993-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-11#29)(2008-12#8)(2008-7#2)(2008-9#1)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and least amount of eluent for elution of##3##8##(2008-10#3)
and least amount of eluent for##4##6##(2008-10#4)
and least amount of eluent##5##5##(2008-10#5)
and least amount of##7##4##(2008-10#7)
and least satisfied with##2##4##(1993-3#1)(2009-11#1)
and least##19##2##(1992-12#1)(1993-3#1)(1994-12#1)(2008-10#12)(2008-8#2)(2009-11#1)(2012-12#1)
and leave##2##2##(1993-6#1)(2008-12#1)
and leaves and##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
and leaves of##7##3##(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#1)(2012-7#1)
and leaves that##2##3##(1992-3#1)(2008-12#1)
and leaves##33##2##(1992-3#1)(1993-6#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-12#5)(2008-5#2)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-8#2)
and leaving behind##2##3##(1997-7#1)(2008-12#1)
and leaving##4##2##(1993-6#1)(1997-7#1)(2008-12#1)(2011-2#1)
and lecturers##3##2##(2008-11#3)
and led to a##10##4##(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)
and led to the##5##4##(1992-8#1)(1995-3#1)(2008-10#1)(2010-8#1)(2011-2#1)
and led to##21##3##(1992-2#1)(1992-8#2)(1993-12#1)(1993-8#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and led##22##2##(1992-2#1)(1992-8#2)(1993-12#1)(1993-8#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
and leek##3##2##(2008-10#3)
and left anterior##2##3##(1993-12#1)(2008-7#1)
and left bending##2##3##(2008-8#2)
and left hemiparesis##2##3##(2007-10#1)(2013-8#1)
and left in##2##3##(1990-10#1)(1990-8#1)
and left main##2##3##(2008-11#1)(2011-2#1)
and left parietotemporal##2##3##(1995-2#2)
and left ventricular hypertrophy in patients with##2##7##(2008-12#1)(2012-12#1)
and left ventricular hypertrophy in##3##5##(1995-11#1)(2008-12#1)(2012-12#1)
and left ventricular##13##3##(1990-12#1)(1995-11#2)(1995-3#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and left##65##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1992-2#1)(1993-12#1)(1993-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(2007-10#3)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-4#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#4)
and left-sided##2##2##(2008-12#1)(2011-2#1)
and leg pain##6##3##(1997-2#1)(2007-11#1)(2012-3#3)(2013-1#1)
and leg press##2##3##(2008-5#2)
and leg##16##2##(1996-5#2)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#2)(2010-9#2)(2012-3#3)(2013-1#2)
and legal aspects##3##3##(2011-2#3)
and legal issues##6##3##(1995-12#1)(2008-11#4)(2008-12#1)
and legal##29##2##(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and legislative##3##2##(2008-8#1)(2009-12#1)(2012-12#1)
and legs##3##2##(2007-12#1)(2008-5#2)
and leiomyosarcoma##3##2##(1990-11#1)(1991-4#1)(1992-10#1)
and leisure activities##3##3##(2012-12#2)(2013-8#1)
and leisure##4##2##(1996-11#1)(2012-12#2)(2013-8#1)
and leisure-time##2##2##(1992-8#1)(2011-2#1)
and lemma##3##2##(2008-8#1)(2008-9#2)
and lend##2##2##(2010-4#1)(2011-2#1)
and length but##2##3##(2008-5#1)(2013-8#1)
and length of hospital stay##4##5##(1991-12#2)(2011-2#1)(2013-1#1)
and length of stay##7##4##(1992-2#1)(1992-3#2)(1994-3#1)(1995-1#1)(2012-2#2)
and length of stays are##2##5##(2010-8#2)
and length of stays##3##4##(2010-8#3)
and length of the nauplii##2##5##(2008-5#2)
and length of the##9##4##(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-2#1)
and length of##41##3##(1990-2#1)(1990-5#1)(1991-12#3)(1992-2#1)(1992-3#2)(1993-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2010-10#1)(2010-8#3)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#2)
and length##56##2##(1990-2#1)(1990-5#1)(1991-12#3)(1992-2#2)(1992-3#2)(1993-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#2)(2008-8#2)(2009-3#1)(2010-10#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
and lens##3##2##(1991-6#1)(2008-2#1)(2008-3#1)
and lenses##2##2##(2008-10#1)(2008-3#1)
and lepidopteran##2##2##(2008-10#2)
and leptin##10##2##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and leptomeningeal##2##2##(2012-3#2)
and lesbian##4##2##(1995-6#1)(2008-12#2)(2010-8#1)
and lesbians##3##2##(1996-5#1)(2008-12#2)
and lesion development##3##3##(2008-10#3)
and lesion size##4##3##(2008-10#4)
and lesion##15##2##(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-7#1)(2011-2#1)
and lesions of the##3##4##(1996-11#1)(2007-11#1)(2008-9#1)
and lesions##5##2##(1991-6#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-9#1)
and less efficient##2##3##(2008-12#1)(2012-5#1)
and less expensive than##2##4##(2008-11#1)(2008-9#1)
and less expensive##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
and less frequent##2##3##(1990-5#1)(2008-5#1)
and less frequently##7##3##(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#3)(2012-2#1)
and less low##2##3##(1993-11#1)(2013-8#1)
and less often##2##3##(2008-4#1)(2011-2#1)
and less than 1%##3##4##(2008-10#2)(2008-8#1)
and less than 10%##2##4##(2008-10#1)(2008-2#1)
and less than##14##3##(1991-2#1)(1993-9#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#2)(2012-2#1)
and less time##2##3##(2008-10#1)(2008-5#1)
and less variability##2##3##(2008-10#2)
and less##130##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#3)(1994-2#2)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#6)(2012-5#1)(2012-9#1)(2013-1#2)(2013-8#4)
and lessen##2##2##(1990-4#1)(2013-1#1)
and lessons learned##3##3##(1995-3#1)(2008-11#1)(2008-8#1)
and lessons##7##2##(1993-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-4#1)(2008-11#1)(2008-8#1)
and let##2##2##(2008-8#1)(2011-2#1)
and lethal##6##2##(1990-6#1)(1995-2#1)(2008-5#1)(2011-2#2)(2012-2#1)
and lethality##5##2##(1996-12#2)(1997-6#1)(1997-8#1)(2011-2#1)
and letters##3##2##(1992-2#1)(1992-8#1)(1993-10#1)
and lettuce##6##2##(2008-10#5)(2010-10#1)
and leucine##5##2##(1991-12#1)(1992-6#1)(1993-11#1)(1997-8#1)(2008-12#1)
and leucocytosis##2##2##(1997-8#1)(2008-12#1)
and leucovorin##2##2##(1991-4#2)
and leukaemia##2##2##(2011-2#1)(2012-12#1)
and leukemia inhibitory factor##2##4##(1995-11#1)(2009-5#1)
and leukemia##5##2##(1995-11#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)
and leukemia-inhibitory factor##3##3##(2008-4#2)(2009-3#1)
and leukemic##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
and leukoaraiosis##2##2##(2008-8#2)
and leukocyte##4##2##(1995-2#1)(1996-2#1)(2006-6#2)
and leukopenia##2##2##(1990-12#1)(2008-6#1)
and leukotriene##3##2##(1991-8#1)(2007-11#1)(2008-3#1)
and leukotrienes##2##2##(1990-3#1)(2008-11#1)
and leupeptin and##2##3##(1991-12#1)(1992-9#1)
and leupeptin##3##2##(1991-12#1)(1992-9#1)(1994-10#1)
and level of the##2##4##(2008-5#1)(2008-7#1)
and level of##30##3##(1991-3#1)(1991-5#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
and level##33##2##(1991-3#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#4)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
and levels in maize silage##2##5##(2008-10#2)
and levels of disease##2##4##(2008-10#1)(2008-5#1)
and levels of resistance##2##4##(2008-10#2)
and levels of##29##3##(1990-3#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-11#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-12#1)(2008-5#3)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
and levels##35##2##(1990-3#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-5#3)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)
and leveraging##2##2##(2008-9#1)(2013-1#1)
and levo-norgestrel##2##2##(2008-10#2)
and levodopa##2##2##(1996-3#1)(2008-7#1)
and levofloxacin##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)
and lexical##3##2##(2008-9#1)(2009-2#2)
and liability insurance##2##3##(1992-2#2)
and liability##6##2##(1992-2#2)(1992-3#1)(1994-1#1)(1994-2#1)(1996-12#1)
and liberal##2##2##(1997-6#1)(2013-1#1)
and lichen##4##2##(1992-3#1)(2009-6#1)(2011-2#2)
and lidar##2##2##(2008-2#1)(2008-3#1)
and lidocaine##9##2##(1991-1#2)(1993-1#1)(1996-12#2)(2008-10#2)(2008-5#1)(2009-5#1)
and lie##2##2##(2008-4#1)(2008-7#1)
and life course##2##3##(2011-1#1)(2011-2#1)
and life cycle##2##3##(2007-5#1)(2013-7#1)
and life cycles##2##3##(2008-10#1)(2008-9#1)
and life events##2##3##(2008-11#1)(2009-12#1)
and life expectancy##2##3##(1996-6#1)(2008-12#1)
and life history##4##3##(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
and life satisfaction##3##3##(2007-10#1)(2012-1#1)(2013-1#1)
and life sciences##2##3##(2008-10#1)(2013-1#1)
and life span##3##3##(1991-5#1)(2008-3#2)
and life table##2##3##(1991-3#1)(2008-12#1)
and life threatening complications##2##4##(2011-1#1)(2012-3#1)
and life threatening##5##3##(2007-10#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and life##48##2##(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
and life-history traits##2##3##(2008-8#1)(2008-9#1)
and life-history##6##2##(2008-8#5)(2008-9#1)
and life-style##3##2##(1991-8#1)(2008-8#1)(2012-2#1)
and life-threatening##10##2##(1995-12#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-3#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
and lifelong##2##2##(2008-11#1)(2012-2#1)
and lifestyle and##2##3##(1996-8#1)(2008-6#1)
and lifestyle behaviors are associated with overweight and obesity##2##9##(2013-8#2)
and lifestyle behaviors lead to overweight and obesity and subsequent NCD that are a significant factor in the morbidity and mortality of the population##2##24##(2013-8#2)
and lifestyle behaviors lead to overweight and obesity and subsequent NCD that are##3##13##(2013-8#3)
and lifestyle behaviors lead to overweight and obesity and subsequent NCD that##4##12##(2013-8#4)
and lifestyle behaviors##6##3##(2013-8#6)
and lifestyle changes##3##3##(2008-3#1)(2013-1#2)
and lifestyle factors##2##3##(2008-7#1)(2011-2#1)
and lifestyle##22##2##(1996-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
and lifetime of the##5##4##(2008-10#5)
and lifetime of##7##3##(2008-10#6)(2008-9#1)
and lifetime reproduction##2##3##(2008-3#2)
and lifetime##18##2##(2008-10#10)(2008-3#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-12#1)
and lifting##3##2##(2010-8#1)(2012-12#2)
and ligaments##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
and ligand binding##2##3##(1995-2#1)(1997-7#1)
and ligand##12##2##(1992-11#2)(1994-11#1)(1995-2#2)(1997-7#1)(2008-10#3)(2008-12#1)(2009-10#1)(2010-11#1)
and ligand-binding##2##2##(1993-11#1)(2010-11#1)
and ligand-gated ion##2##3##(2008-4#1)(2008-8#1)
and ligands##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
and ligated##2##2##(2008-8#1)(2008-9#1)
and ligation##2##2##(1993-6#1)(2010-7#1)
and ligation-independent cloning##2##3##(1997-4#2)
and light chain##4##3##(1993-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
and light chains##5##3##(1994-11#1)(1994-5#2)(1996-9#1)(2011-2#1)
and light in##2##3##(1997-6#1)(2007-12#1)
and light intensity##2##3##(2008-3#1)(2013-8#1)
and light microscopy##2##3##(2008-10#1)(2008-4#1)
and light polarization##2##3##(2007-11#1)(2008-3#1)
and light propagation##2##3##(2008-10#1)(2008-3#1)
and light scattering##2##3##(2008-3#1)(2008-8#1)
and light surgical meshes with identical knitted structure##2##8##(2012-1#2)
and light##50##2##(1992-3#1)(1992-8#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#2)(1996-9#1)(1997-1#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
and light-induced##2##2##(2007-11#1)(2007-12#1)
and lighter##3##2##(2008-11#1)(2010-6#1)(2012-12#1)
and lightly##2##2##(1992-8#1)(1996-3#1)
and lignin##5##2##(2008-6#2)(2012-2#2)(2013-8#1)
and like##2##2##(1995-11#1)(2012-3#1)
and likelihood##2##2##(1995-12#1)(2008-9#1)
and likely to##4##3##(2008-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
and likely##16##2##(1992-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-7#1)
and limb salvage##3##3##(2008-6#3)
and limb##9##2##(1997-3#1)(2007-8#1)(2008-6#4)(2008-7#1)(2011-1#1)(2011-2#1)
and limbic systems##2##3##(1997-7#1)(2008-1#1)
and limbic##7##2##(1990-7#1)(1991-1#1)(1995-12#1)(1997-7#1)(2008-1#2)(2009-9#1)
and limbs##5##2##(2007-7#1)(2008-5#1)(2012-12#3)
and limit of detection (LOD)##2##5##(2008-10#2)
and limit of detection for##2##5##(2008-10#2)
and limit of detection of the##3##6##(2008-10#3)
and limit of detection of##6##5##(2008-10#6)
and limit of detection were##2##5##(2008-10#2)
and limit of detection##15##4##(2008-10#15)
and limit of detection)##2##4##(2008-10#2)
and limit of quantitation##2##4##(2008-10#1)(2010-3#1)
and limit of##22##3##(2008-10#20)(2010-3#1)(2012-2#1)
and limit the##5##3##(1992-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
and limit##29##2##(1992-2#1)(2007-8#1)(2008-10#20)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
and limitations are discussed##2##4##(1997-1#1)(2008-10#1)
and limitations are##6##3##(1996-12#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
and limitations for##2##3##(2008-10#1)(2008-4#1)
and limitations in##2##3##(2007-8#1)(2008-12#1)
and limitations of a##2##4##(2008-3#1)(2008-8#1)
and limitations of each##5##4##(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)
and limitations of the various##2##5##(2008-10#1)(2008-9#1)
and limitations of the##14##4##(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
and limitations of these##3##4##(1994-12#1)(2008-11#1)(2012-3#1)
and limitations of this study##2##5##(1993-1#1)(2012-1#1)
and limitations of this##8##4##(1990-6#1)(1993-1#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-1#1)
and limitations of##54##3##(1990-10#1)(1990-6#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-11#2)(1996-12#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-8#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and limitations on##2##3##(2007-12#1)(2008-3#1)
and limitations with##2##3##(2008-10#1)(2011-2#1)
and limitations##94##2##(1990-10#1)(1990-6#1)(1991-11#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#8)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#3)(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)
and limited by##3##3##(1990-3#1)(2008-11#1)(2009-9#1)
and limited field##2##3##(2008-10#1)(2009-8#1)
and limited in##2##3##(2008-7#1)(2011-2#1)
and limited motion##5##3##(2008-5#1)(2008-6#4)
and limited resources##2##3##(1996-3#1)(2009-2#1)
and limited to##3##3##(2008-7#1)(2013-1#2)
and limited##54##2##(1990-3#1)(1992-11#1)(1993-11#2)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
and limiting##5##2##(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
and limits of detection of##2##5##(2008-10#2)
and limits of detection##9##4##(2008-10#9)
and limits of quantification##2##4##(2008-10#2)
and limits of the##3##4##(2008-5#1)(2009-6#1)(2012-2#1)
and limits of##16##3##(1996-7#1)(2008-10#12)(2008-5#1)(2009-6#1)(2012-2#1)
and limits the##3##3##(2008-10#2)(2008-5#1)
and limits##24##2##(1992-11#1)(1993-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2008-10#14)(2008-3#1)(2008-5#2)(2009-6#1)(2012-2#1)
and linalool##4##2##(1992-8#1)(2008-10#3)
and line##10##2##(1997-2#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)
and lineages##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
and linear calibration##2##3##(2008-10#2)
and linear discriminant analysis##2##4##(2008-10#2)
and linear range of##2##4##(1992-8#1)(2008-10#1)
and linear range##4##3##(1992-8#1)(2008-10#3)
and linear ranges of##3##4##(2008-10#2)(2008-4#1)
and linear ranges##4##3##(2008-10#3)(2008-4#1)
and linear regression tests##2##4##(2008-6#2)
and linear regression##4##3##(1993-12#1)(2008-10#1)(2008-6#2)
and linear response##2##3##(2008-10#2)
and linear##44##2##(1990-5#1)(1992-8#1)(1993-12#2)(1996-4#1)(2007-12#2)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2010-5#1)(2010-8#1)
and linearity of##2##3##(1996-2#1)(2008-10#1)
and linearity were##2##3##(2008-10#2)
and linearity##9##2##(1990-2#1)(1996-2#1)(2008-10#7)
and linearly##2##2##(2007-11#1)(2012-2#1)
and linewidth##2##2##(2008-3#1)(2009-11#1)
and linguistic adaptation##3##3##(2007-8#2)(2013-1#1)
and linguistic##9##2##(1997-2#1)(2007-8#2)(2008-11#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#2)
and linguistics##2##2##(2008-9#1)(2013-1#1)
and link##5##2##(1997-3#1)(2008-11#2)(2008-2#1)(2008-8#1)
and linkage disequilibrium in##2##4##(2012-2#1)(2012-3#1)
and linkage disequilibrium##5##3##(1995-6#1)(2008-10#2)(2012-2#1)(2012-3#1)
and linkage##8##2##(1990-8#1)(1995-6#1)(2008-10#3)(2008-4#1)(2012-2#1)(2012-3#1)
and linked to##4##3##(1992-12#1)(2008-10#2)(2008-7#1)
and linked##6##2##(1992-12#1)(1993-6#1)(2008-10#2)(2008-7#1)(2009-12#1)
and linker##3##2##(2008-4#1)(2009-6#1)(2013-7#1)
and linkers##2##2##(1997-4#2)
and linking##7##2##(1994-9#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
and links##2##2##(2008-11#1)(2008-4#1)
and linoleic acid##2##3##(2008-11#1)(2008-12#1)
and lipase##3##2##(2008-10#2)(2008-8#1)
and lipid accumulation##2##3##(1992-3#1)(2013-1#1)
and lipid composition##2##3##(2008-5#1)(2013-7#1)
and lipid droplets##2##3##(2007-12#2)
and lipid hydroperoxides##2##3##(2008-10#1)(2009-8#1)
and lipid lowering##3##3##(1992-7#1)(2008-1#1)(2008-5#1)
and lipid mediators##2##3##(1994-10#2)
and lipid metabolism and##2##4##(1994-12#1)(2008-3#1)
and lipid metabolism##9##3##(1994-12#1)(2008-3#4)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
and lipid peroxidation and##2##4##(1996-2#1)(2008-4#1)
and lipid peroxidation##13##3##(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-2#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
and lipid profile##3##3##(2008-12#1)(2008-3#1)(2008-7#1)
and lipid profiles in##2##4##(2008-12#1)(2008-3#1)
and lipid profiles##4##3##(1991-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
and lipid solutions##2##3##(1990-5#1)(2009-9#1)
and lipid##76##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#2)(1996-2#2)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
and lipids in##3##3##(1993-11#1)(2008-4#2)
and lipids##22##2##(1990-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-11#1)(2008-1#1)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
and lipofuscin##3##2##(1992-12#1)(1994-6#1)(2008-7#1)
and lipophilic anions##2##3##(2008-10#2)
and lipophilic##6##2##(1990-2#1)(1993-12#1)(2008-10#4)
and lipopolysaccharide##2##2##(1990-2#1)(2008-4#1)
and lipoprotein indices in##2##4##(2009-7#1)(2013-1#1)
and lipoprotein lipase##2##3##(1995-6#1)(1996-11#1)
and lipoprotein metabolism##4##3##(1990-2#1)(2008-11#1)(2008-6#2)
and lipoprotein##19##2##(1990-2#1)(1992-2#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#3)
and lipoproteins##4##2##(1993-12#1)(1994-5#1)(1995-5#1)(2008-3#1)
and liposomal##2##2##(2008-5#1)(2013-1#1)
and liposome##2##2##(2008-10#1)(2008-9#1)
and liposome-loaded##2##2##(1993-8#2)
and liposomes##4##2##(1990-2#1)(1994-12#1)(1994-5#1)(2008-5#1)
and liquid chromatography##7##3##(2008-10#6)(2011-2#1)
and liquid flow##2##3##(2008-7#1)(2008-8#1)
and liquid media##2##3##(2008-10#2)
and liquid sampling##2##3##(2008-10#2)
and liquid##37##2##(1991-9#1)(1995-3#1)(1995-6#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-1#1)
and liquid-crystal##2##2##(2008-10#1)(2008-3#1)
and liquid-liquid extraction##2##3##(2008-10#1)(2011-3#1)
and liquid-liquid##5##2##(2008-10#2)(2008-3#1)(2009-8#1)(2011-3#1)
and liquids##3##2##(2008-3#3)
and lists##2##2##(2008-7#1)(2008-9#1)
and literacy skills##3##3##(2010-4#1)(2012-3#2)
and literacy##6##2##(2008-11#1)(2010-4#3)(2012-3#2)
and literary##2##2##(1993-3#1)(2012-3#1)
and literature review##39##3##(1995-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#2)
and literature review]##4##3##(1993-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and literature##54##2##(1993-8#1)(1995-8#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
and lithium##4##2##(1994-3#1)(1996-5#1)(2008-10#1)(2009-8#1)
and lithography##2##2##(2007-12#1)(2008-5#1)
and litter##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
and little evidence##2##3##(2008-5#1)(2009-7#1)
and little is known##2##4##(1993-6#1)(2013-8#1)
and little##23##2##(1993-6#1)(1993-8#1)(1995-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#3)
and live##9##2##(1995-12#1)(1996-1#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-6#2)(2011-2#1)(2013-1#1)
and liver and##2##3##(1993-6#1)(2008-7#1)
and liver cancer in##2##4##(2010-1#1)(2011-2#1)
and liver cirrhosis##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
and liver disease in##2##4##(1991-8#1)(2009-5#1)
and liver disease##3##3##(1991-8#1)(2009-5#1)(2009-8#1)
and liver enzymes##2##3##(2008-5#1)(2008-8#1)
and liver of the##3##4##(1990-7#1)(1995-9#1)(2008-12#1)
and liver of##8##3##(1990-7#1)(1992-9#1)(1995-9#1)(2008-12#2)(2008-5#1)(2008-7#1)(2013-1#1)
and liver size##2##3##(2008-10#1)(2010-8#1)
and liver tissues##4##3##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
and liver weight##3##3##(1992-5#1)(1994-5#1)(2008-12#1)
and liver weights of##2##4##(2008-9#2)
and liver were##3##3##(1996-12#1)(2008-5#1)(2012-3#1)
and liver##95##2##(1990-2#1)(1990-5#1)(1990-7#4)(1990-9#1)(1991-5#4)(1991-6#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#1)(2008-1#5)(2008-10#8)(2008-11#4)(2008-12#5)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#3)(2010-1#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#3)
and livers##3##2##(1994-7#1)(1997-4#1)(2008-11#1)
and lives##2##2##(2008-11#1)(2009-3#1)
and livestock##7##2##(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#2)(2012-3#2)
and living conditions##4##3##(1996-9#1)(2008-2#1)(2008-9#2)
and living in##4##3##(1990-2#1)(2007-10#1)(2008-10#1)(2013-8#1)
and living##15##2##(1990-12#1)(1990-2#1)(1992-4#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2013-8#2)
and load##2##2##(2009-4#1)(2013-7#1)
and loading##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
and loadings##2##2##(2008-10#1)(2008-8#1)
and lobster##3##2##(1991-5#1)(2008-10#2)
and local authorities##2##3##(2008-9#1)(2012-12#1)
and local clays##2##3##(2008-10#2)
and local communities##3##3##(1996-2#1)(1996-3#1)(2011-2#1)
and local control##2##3##(2008-9#1)(2010-3#1)
and local corticosteroid##2##3##(2008-9#2)
and local environmental##3##3##(2008-6#1)(2008-8#1)(2010-6#1)
and local governments##3##3##(1993-2#1)(1995-1#1)(1997-1#1)
and local health departments##2##4##(1996-1#1)(1997-3#1)
and local health system##3##4##(2011-2#3)
and local health##8##3##(1994-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2011-2#3)(2011-9#1)
and local level##5##3##(1996-12#1)(1996-5#1)(1997-2#2)(2011-9#1)
and local population##2##3##(2008-1#1)(2008-9#1)
and local##112##2##(1991-1#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#8)(2009-2#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-9#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
and localization of the##3##4##(1994-12#1)(2009-2#1)(2011-1#1)
and localization of##20##3##(1990-11#1)(1990-3#1)(1992-11#1)(1993-6#2)(1994-12#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
and localization to##3##3##(1992-10#1)(2008-10#1)(2010-11#1)
and localization##30##2##(1990-11#1)(1990-3#1)(1992-10#1)(1992-11#1)(1993-6#2)(1994-12#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
and localize##3##2##(1990-11#1)(1991-6#1)(2011-1#1)
and localized in##2##3##(1995-8#1)(2010-5#1)
and localized to the##2##4##(1992-10#1)(1994-9#1)
and localized##17##2##(1990-5#1)(1990-9#1)(1992-10#1)(1994-9#1)(1995-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#2)
and localizing##2##2##(2007-11#1)(2007-12#1)
and locally##5##2##(2008-1#1)(2008-4#2)(2008-5#1)(2011-2#1)
and locate##2##2##(2008-12#1)(2008-3#1)
and located in##2##3##(1992-12#1)(1992-3#1)
and located on the##4##4##(1991-2#1)(2008-6#1)(2008-8#1)(2010-12#1)
and located##9##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
and locates##2##2##(1993-11#1)(1996-8#1)
and locating##2##2##(2008-3#1)(2010-7#1)
and location in##2##3##(1995-12#1)(2011-2#1)
and location of the##4##4##(1995-2#1)(2007-11#1)(2008-8#1)(2011-2#1)
and location of##19##3##(1992-12#1)(1993-11#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#2)(2011-2#2)
and location##35##2##(1992-12#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#3)(2011-2#4)(2013-1#1)
and locations of genes##2##4##(2008-10#1)(2008-7#1)
and locations of##4##3##(1996-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
and locations##7##2##(1995-1#1)(1996-4#1)(2008-10#3)(2008-3#1)(2008-7#1)
and loci##3##2##(2008-4#1)(2008-8#1)(2012-3#1)
and locomotion##6##2##(1991-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#1)
and locomotor activity##3##3##(1993-6#1)(1995-12#1)(2008-4#1)
and locomotor##6##2##(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-4#1)
and locomotory##3##2##(1991-2#1)(1997-2#1)(2008-8#1)
and locus##2##2##(1994-2#1)(2008-12#1)
and lodgepole pine##2##3##(2008-10#1)(2013-1#1)
and log 5##3##3##(2008-10#3)
and log##12##2##(2007-11#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-11#1)(2009-9#1)
and logarithm of##3##3##(2008-10#2)(2010-5#1)
and logic of##2##3##(2008-7#2)
and logic##4##2##(2008-7#2)(2012-3#2)
and logistic EuroSCORE##3##3##(2007-8#2)(2013-8#1)
and logistic regression models##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
and logistic regression##8##3##(2008-10#2)(2008-8#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and logistic##14##2##(2007-2#1)(2007-8#2)(2008-10#3)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and long lasting##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
and long pulses##2##3##(2008-2#1)(2008-3#1)
and long term##16##3##(1993-1#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#3)(2011-2#1)(2011-3#1)(2013-1#2)
and long##47##2##(1992-11#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#4)(2013-8#1)
and long-distance movement of##2##4##(2008-10#2)
and long-distance##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
and long-lasting##9##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1997-2#1)(2008-3#3)(2008-5#1)
and long-lived##2##2##(1992-12#1)(2008-10#1)
and long-range##5##2##(1990-4#1)(1991-11#1)(1997-4#1)(2008-10#1)(2012-2#1)
and long-stay##2##2##(1993-12#1)(2008-7#1)
and long-term care##8##3##(1991-1#1)(1991-3#2)(1993-12#1)(1994-3#2)(1997-3#1)(2009-4#1)
and long-term cell##2##3##(2008-10#1)(2008-4#1)
and long-term effects of##2##4##(1990-12#1)(2011-2#1)
and long-term effects##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
and long-term factors##2##3##(2008-1#2)
and long-term follow-up##8##3##(1991-2#1)(1994-6#1)(2008-1#2)(2008-11#1)(2008-7#2)(2011-2#1)
and long-term maintenance of##2##4##(2008-10#1)(2008-8#1)
and long-term management##2##3##(2007-5#1)(2013-8#1)
and long-term outcomes##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
and long-term potentiation##2##3##(1991-12#1)(1993-12#1)
and long-term prognosis##2##3##(1996-9#1)(2013-8#1)
and long-term results of##3##4##(1991-6#1)(2012-3#2)
and long-term results##7##3##(1991-6#2)(1995-9#1)(2008-10#1)(2011-2#1)(2012-3#2)
and long-term stability of##2##4##(2008-10#1)(2008-11#1)
and long-term stability##5##3##(2008-10#4)(2008-11#1)
and long-term treatment of##3##4##(2007-8#1)(2010-8#1)(2012-3#1)
and long-term##132##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#3)(1992-11#2)(1993-12#4)(1993-2#1)(1993-5#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#2)(1996-4#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#6)
and longer latent period in a##2##6##(2008-10#2)
and longer##20##2##(1991-1#1)(1995-8#1)(1996-2#1)(1996-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2009-11#2)(2009-8#1)(2012-3#1)(2013-8#1)
and longer-lasting##2##2##(1992-8#1)(1995-12#1)
and longer-term##2##2##(1996-1#1)(2008-11#1)
and longevity##11##2##(1992-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-7#1)
and longitudinal shift##2##3##(2007-12#1)(2008-3#1)
and longitudinal##16##2##(1995-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
and longitudinal-mode linewidth##2##3##(2007-11#2)
and longitudinally##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
and look at##2##3##(2012-3#2)
and look for##2##3##(1995-3#1)(1996-3#1)
and look##5##2##(1991-1#1)(1995-3#1)(1996-3#1)(2012-3#2)
and looks at##2##3##(1994-2#1)(2010-12#1)
and looks##3##2##(1994-2#1)(2008-7#1)(2010-12#1)
and loop##4##2##(2007-11#1)(2008-8#1)(2011-3#1)(2013-8#1)
and loose##5##2##(1993-3#1)(1997-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
and loperamide##2##2##(2008-8#2)
and lorazepam##2##2##(1991-1#1)(1991-12#1)
and lose##2##2##(2008-8#1)(2011-2#1)
and losers##2##2##(1993-3#1)(2007-4#1)
and loss of function##3##4##(2010-11#1)(2011-2#1)(2012-2#1)
and loss of the##7##4##(1991-12#1)(1993-8#1)(1994-8#1)(2007-11#1)(2008-5#2)(2011-2#1)
and loss of##42##3##(1990-7#1)(1991-12#1)(1992-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-6#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
and loss##48##2##(1990-7#1)(1991-12#1)(1992-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-6#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
and losses##7##2##(1993-12#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-6#1)(2011-2#1)
and lossless##2##2##(2008-3#2)
and lost its##2##3##(1991-11#1)(2008-10#1)
and lost##3##2##(1991-11#1)(2007-12#1)(2008-10#1)
and love##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
and low affinity binding##3##4##(1990-5#2)(2009-12#1)
and low affinity for##2##4##(1995-2#1)(1995-6#1)
and low affinity##9##3##(1990-11#1)(1990-5#2)(1991-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(2009-12#1)
and low anterior##2##3##(1990-9#1)(2008-12#1)
and low back pain##5##4##(1990-6#1)(1996-9#1)(1997-4#1)(2009-4#2)
and low back##7##3##(1990-6#1)(1996-9#1)(1997-4#1)(2008-12#2)(2009-4#2)
and low birth weight##9##4##(1991-11#1)(1991-12#2)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
and low birth##10##3##(1991-11#1)(1991-12#2)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and low capacity##3##3##(1993-1#2)(1995-12#1)
and low cell##2##3##(1993-8#1)(2008-11#1)
and low concentrations##2##3##(2008-10#1)(2011-2#1)
and low cost flow injection##2##5##(2008-10#2)
and low cost##16##3##(1994-2#1)(2008-10#12)(2008-3#1)(2011-2#2)
and low costs##2##3##(1997-3#1)(2008-10#1)
and low cross talk##4##4##(2007-11#4)
and low degree of##2##4##(2008-7#1)(2011-1#1)
and low density lipoprotein##5##4##(1991-11#1)(1991-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
and low density lipoproteins##2##4##(1992-11#1)(2008-10#1)
and low density##10##3##(1991-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-5#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
and low detection limit##3##4##(2008-10#2)(2013-1#1)
and low detection##5##3##(2008-10#4)(2013-1#1)
and low dose combination of midazolam and ketamine##2##8##(2012-2#2)
and low dose##6##3##(1995-9#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
and low expression##2##3##(2010-3#1)(2012-12#1)
and low in polar lipids##2##5##(2008-11#2)
and low in##4##3##(2007-12#1)(2008-11#2)(2009-7#1)
and low ionic strength##2##4##(1990-11#1)(1992-8#1)
and low ionic##3##3##(1990-11#1)(1992-8#1)(2008-7#1)
and low levels of##4##4##(1991-12#1)(2008-9#1)(2009-7#1)(2010-5#1)
and low limits of detection##2##5##(2008-10#2)
and low magnesium##2##3##(1992-6#1)(1993-8#1)
and low molecular weight##5##4##(1993-3#1)(1997-2#2)(2008-10#1)(2008-7#1)
and low output##4##3##(1996-9#1)(2007-8#2)(2008-2#1)
and low pH##2##3##(2008-7#1)(2013-8#1)
and low protein##2##3##(1990-8#1)(1996-12#1)
and low reproductive success##3##4##(2009-12#1)(2012-3#2)
and low risk##3##3##(1994-3#1)(2012-12#1)(2012-3#1)
and low serum##3##3##(2008-11#1)(2011-1#2)
and low temperatures##3##3##(2008-10#3)
and low values of##2##4##(2008-10#2)
and low values##3##3##(2008-10#3)
and low##277##2##(1990-11#2)(1990-2#1)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-8#1)(2007-11#7)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#53)(2008-11#9)(2008-12#12)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#5)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#5)(2012-6#1)(2012-7#1)(2013-1#13)(2013-7#2)(2013-8#3)
and low-cost method for the##2##5##(2008-10#2)
and low-cost##10##2##(2008-10#9)(2008-3#1)
and low-density lipoprotein (LDL)##3##4##(1991-8#1)(2008-10#1)(2008-3#1)
and low-density lipoprotein##4##3##(1991-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
and low-dose##5##2##(2008-11#1)(2008-7#1)(2011-2#3)
and low-frequency##3##2##(1991-10#1)(2007-11#1)(2008-2#1)
and low-grade fever##2##3##(2007-8#1)(2008-11#1)
and low-grade##6##2##(1997-6#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-3#1)
and low-income countries##2##3##(2008-8#1)(2012-2#1)
and low-pass filtering##2##3##(2008-2#1)(2008-3#1)
and low-power##2##2##(2007-11#1)(2012-2#1)
and low-temperature##2##2##(2007-11#1)(2008-3#1)
and lower body##2##3##(2010-1#1)(2012-2#1)
and lower costs##4##3##(1994-3#1)(1995-2#1)(2008-11#1)(2011-2#1)
and lower detection limits were##2##5##(2008-10#2)
and lower detection limits##5##4##(2008-10#5)
and lower detection##6##3##(1991-5#1)(2008-10#5)
and lower extremity##8##3##(2007-11#2)(2008-12#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#2)
and lower for##2##3##(2008-10#1)(2011-7#1)
and lower in##2##3##(1991-4#1)(2008-8#1)
and lower levels of##5##4##(1991-1#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
and lower limb##4##3##(1990-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
and lower limbs##2##3##(2008-6#1)(2008-7#1)
and lower morbidity##2##3##(2007-10#1)(2008-10#1)
and lower parts##5##3##(2008-10#2)(2008-12#1)(2013-1#2)
and lower recovery##2##3##(2008-10#2)
and lower socioeconomic##2##3##(2006-10#1)(2010-6#1)
and lower survival##2##3##(2008-10#1)(2008-9#1)
and lower than##4##3##(1994-7#1)(1995-1#1)(2008-10#2)
and lower total dose of##2##5##(2008-6#1)(2013-1#1)
and lower trapezius##2##3##(2010-9#2)
and lower urinary tract##2##4##(2008-1#1)(2012-12#1)
and lower water##2##3##(2008-10#1)(2010-8#1)
and lower##150##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#3)(1992-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-7#2)(1995-1#1)(1995-12#1)(1995-2#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#4)(2007-7#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#4)
and lower-extremity##2##2##(2012-3#1)(2013-1#1)
and lowered##2##2##(1994-11#1)(1996-3#1)
and lowering of glucose-stimulated##2##4##(2008-11#2)
and lowering of##3##3##(1995-2#1)(2008-11#2)
and lowering##4##2##(1993-12#1)(1995-2#1)(2008-11#2)
and lowest for##2##3##(1992-8#1)(2008-10#1)
and lowest in the##2##4##(1996-12#1)(2008-10#1)
and lowest in##12##3##(1995-8#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-7#2)(2013-8#1)
and lowest on##2##3##(2008-10#1)(2009-7#1)
and lowest##27##2##(1992-8#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-10#9)(2008-12#3)(2008-7#2)(2009-11#1)(2009-7#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and lumbar curvature##3##3##(2013-1#3)
and lumbar multifidus muscles##2##4##(2012-12#2)
and lumbar vertebral##2##3##(1997-4#1)(2008-7#1)
and lumbar##22##2##(1994-12#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#5)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
and lumenal##3##2##(1994-8#2)(2008-1#1)
and luminal##2##2##(2007-12#1)(2009-12#1)
and luminance##4##2##(2008-2#2)(2008-3#1)(2008-8#1)
and luminescence##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and luminescent##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
and luminol##5##2##(1995-3#1)(2008-10#4)
and lumpectomy##2##2##(2011-1#1)(2013-8#1)
and lunar##2##2##(2008-2#1)(2011-1#1)
and lung cancer in##3##4##(2008-8#2)(2013-1#1)
and lung cancer##14##3##(1990-2#1)(1991-12#1)(1991-2#1)(1996-3#2)(2007-10#1)(2007-11#1)(2008-8#2)(2009-12#1)(2013-1#4)
and lung consolidation##2##3##(2011-2#1)(2012-3#1)
and lung in##2##3##(1990-12#1)(2012-3#1)
and lung metastases##3##3##(1991-6#2)(1994-12#1)
and lung surgery##2##3##(2008-6#1)(2012-12#1)
and lung tissue##2##3##(1992-11#1)(2008-4#1)
and lung tissues##2##3##(1990-7#1)(1997-4#1)
and lung##58##2##(1990-12#3)(1990-2#1)(1990-7#1)(1991-12#3)(1991-2#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#2)(1993-3#2)(1993-8#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#1)
and lung)##2##2##(2008-10#1)(2008-9#1)
and lungs of##3##3##(1993-8#1)(1997-3#1)(2008-7#1)
and lungs##11##2##(1993-12#1)(1993-8#2)(1996-2#1)(1997-3#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#1)
and luteinizing hormone##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)
and luteolin were##2##3##(2008-4#2)
and luteolin##7##2##(1994-11#1)(2008-10#1)(2008-11#2)(2008-4#3)
and lymph node involvement##2##4##(1990-6#1)(2011-2#1)
and lymph node metastases##2##4##(1990-6#1)(2012-3#1)
and lymph node##11##3##(1990-6#2)(1993-2#1)(1995-1#1)(1996-9#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
and lymph nodes##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
and lymph##14##2##(1990-6#2)(1993-2#1)(1995-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
and lymphadenopathy##2##2##(2006-10#1)(2010-12#1)
and lymphatic##8##2##(1990-9#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
and lymphatics in##2##3##(2011-2#2)
and lymphatics##3##2##(2008-5#1)(2011-2#2)
and lymphocyte##5##2##(1991-9#1)(1993-1#1)(1995-12#1)(1995-2#1)(2008-11#1)
and lymphocytes##15##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2010-6#1)
and lymphoid follicles##2##3##(1997-1#1)(1997-3#1)
and lymphoid tissue##2##3##(2008-4#1)(2008-9#1)
and lymphoid##9##2##(1997-1#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#1)
and lymphoma among young##2##4##(1990-3#1)(1991-3#1)
and lymphoma##12##2##(1990-3#1)(1991-3#1)(1991-8#1)(1992-3#3)(1994-5#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
and lymphomas##3##2##(1991-3#1)(1991-4#1)(2008-7#1)
and lyophilised##2##2##(2008-10#2)
and lysine 9##2##3##(2013-1#2)
and lysine##16##2##(1990-7#1)(1991-2#2)(1993-11#1)(1996-2#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#2)(2013-8#1)
and lysis of##2##3##(1996-1#1)(2008-4#1)
and lysis##3##2##(1996-1#1)(2008-4#1)(2011-2#1)
and lysosomal##5##2##(1990-5#1)(1991-2#1)(1994-11#1)(1994-5#1)(2008-11#1)
and lysozyme##5##2##(1992-8#1)(1997-2#1)(1997-8#1)(2008-7#1)(2011-2#1)
and m can be##2##4##(1992-6#1)(2008-10#1)
and m##9##2##(1992-6#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)
and m-cresol were##2##3##(2008-10#1)(2011-1#1)
and mAb##2##2##(2008-10#1)(2011-2#1)
and mGluR5##2##2##(1996-12#2)
and mRNA are##2##3##(1992-11#1)(1993-5#1)
and mRNA expression of##3##4##(2011-2#1)(2013-1#2)
and mRNA expression##4##3##(1994-11#1)(2011-2#1)(2013-1#2)
and mRNA in the##2##4##(1994-2#1)(1995-2#1)
and mRNA in##3##3##(1994-2#1)(1995-2#1)(2008-8#1)
and mRNA level##4##3##(1992-3#1)(1995-11#1)(1995-2#1)(2008-11#1)
and mRNA levels##5##3##(1991-12#1)(1992-8#1)(1993-3#1)(1995-6#1)(2010-1#1)
and mRNA##29##2##(1991-12#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-2#5)(1995-6#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
and mRNAs##2##2##(2008-10#1)(2009-6#1)
and mTOR##3##2##(2009-7#1)(2011-1#1)(2013-8#1)
and machine vision##3##3##(2008-2#2)(2008-3#1)
and machine##8##2##(1997-8#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#2)
and macromolecules##4##2##(1996-9#1)(2008-10#1)(2008-7#1)(2009-11#1)
and macrophage##4##2##(1991-5#1)(1995-3#1)(2008-10#2)
and macrophages express##2##3##(1993-3#2)
and macrophages in##3##3##(1995-12#1)(1997-8#2)
and macrophages##19##2##(1992-9#1)(1993-3#2)(1993-6#1)(1994-11#1)(1995-12#1)(1997-8#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#2)
and macrophages)##3##2##(2008-4#2)(2012-3#1)
and macroscopic##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#2)(2011-2#1)
and macular##5##2##(2008-10#1)(2011-2#2)(2013-1#2)
and made a##4##3##(1991-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
and made available##3##3##(1994-2#1)(2007-6#1)(2008-2#1)
and made the##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
and made##24##2##(1991-6#1)(1992-3#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
and magic angle##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
and magnesium nitrate##2##3##(2008-10#2)
and magnesium salts##2##3##(1995-3#1)(2008-10#1)
and magnesium were used as##2##5##(2008-10#2)
and magnesium were##4##3##(2008-10#3)(2008-5#1)
and magnesium##39##2##(1991-5#2)(1991-9#1)(1995-3#1)(1997-8#1)(2008-10#26)(2008-3#2)(2008-5#3)(2010-12#1)(2013-1#2)
and magnetic properties##5##3##(2007-11#2)(2008-11#1)(2009-8#1)(2010-6#1)
and magnetic resonance (MR)##2##4##(2007-10#1)(2011-2#1)
and magnetic resonance angiography revealed##2##5##(2008-1#1)(2008-12#1)
and magnetic resonance angiography##4##4##(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#1)
and magnetic resonance imaging (MRI) are##2##6##(2008-1#1)(2012-2#1)
and magnetic resonance imaging (MRI) has##2##6##(2010-8#1)(2011-1#1)
and magnetic resonance imaging (MRI)##9##5##(1996-8#1)(2008-1#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-7#1)
and magnetic resonance imaging demonstrated##2##5##(2011-1#1)(2011-2#1)
and magnetic resonance imaging have##2##5##(2007-10#1)(2008-8#1)
and magnetic resonance imaging in##2##5##(1990-12#1)(2012-12#1)
and magnetic resonance imaging showed a##2##6##(2007-8#1)(2008-7#1)
and magnetic resonance imaging to##2##5##(1990-12#1)(2008-9#1)
and magnetic resonance imaging##39##4##(1990-12#2)(1993-12#1)(1996-8#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
and magnetic resonance##50##3##(1990-12#2)(1993-12#1)(1994-2#1)(1995-9#1)(1996-8#1)(1997-8#1)(2007-10#4)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#5)(2008-8#1)(2008-9#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#2)
and magnetic##63##2##(1990-12#2)(1993-12#1)(1994-2#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-10#4)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#2)
and magneto-optical disks##2##3##(2008-2#1)(2008-3#1)
and magneto-optical##4##2##(2008-2#1)(2008-3#3)
and magnification##2##2##(2007-11#1)(2008-3#1)
and magnitude of shortening##2##4##(2007-8#2)
and magnitude of the##6##4##(1990-8#1)(1996-4#1)(1997-7#1)(2008-10#2)(2008-8#1)
and magnitude of##16##3##(1990-8#1)(1992-2#1)(1993-2#1)(1996-11#1)(1996-4#2)(1997-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)
and magnitude##22##2##(1990-8#1)(1992-2#1)(1993-2#1)(1995-11#1)(1996-11#1)(1996-4#4)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#3)(2008-7#2)(2008-8#1)(2009-11#1)
and magnitudes of##2##3##(2008-10#1)(2010-3#1)
and magnolol##6##2##(2008-10#6)
and main##9##2##(1991-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-1#1)(2010-5#1)(2010-8#1)(2013-8#1)
and mainland##4##2##(1997-5#1)(2008-5#1)(2008-8#1)(2012-2#1)
and mainly due to##2##4##(2007-11#1)(2008-10#1)
and mainly##11##2##(1990-5#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-1#2)(2011-2#2)
and maintain a##4##3##(1990-5#1)(1995-2#1)(2008-10#1)(2008-8#1)
and maintain an##2##3##(1993-1#1)(1995-2#1)
and maintain in##2##3##(2008-1#1)(2008-9#1)
and maintain the##5##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
and maintain##42##2##(1990-5#1)(1993-1#1)(1995-2#2)(1997-1#2)(1997-3#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
and maintained at##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
and maintained by##2##3##(1993-6#1)(2008-7#1)
and maintained for##4##3##(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
and maintained in##3##3##(2008-4#1)(2009-12#1)(2012-3#1)
and maintained using##3##3##(2008-2#1)(2011-2#1)(2012-3#1)
and maintained with##4##3##(1996-6#1)(2010-7#3)
and maintained##39##2##(1993-12#1)(1993-6#2)(1994-12#1)(1994-5#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-3#2)
and maintaining a##5##3##(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-6#1)
and maintaining collaborative capital##2##4##(2011-1#2)
and maintaining the##6##3##(1992-1#1)(1994-12#1)(2008-1#1)(2008-8#2)(2013-8#1)
and maintaining##39##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-3#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-8#1)
and maintains a##2##3##(1993-12#1)(2010-12#1)
and maintains the##2##3##(2008-8#1)(2012-1#1)
and maintains##5##2##(1993-12#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)
and maintenance are##2##3##(2008-7#1)(2009-8#1)
and maintenance of a##3##4##(1992-1#1)(2007-7#1)(2008-7#1)
and maintenance of the##7##4##(1990-8#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)
and maintenance of##44##3##(1990-8#1)(1991-9#1)(1992-1#1)(1993-3#1)(1993-8#1)(1996-11#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#7)(2008-6#2)(2008-7#6)(2008-9#3)(2009-11#1)(2009-12#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and maintenance therapy with##2##4##(2011-2#1)(2011-3#1)
and maintenance##73##2##(1990-8#1)(1991-1#1)(1991-9#1)(1992-1#1)(1993-3#1)(1993-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#8)(2008-6#4)(2008-7#11)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and maize##18##2##(2008-10#8)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#3)
and major complications##2##3##(2009-3#1)(2012-2#1)
and major depression##6##3##(2009-9#1)(2011-2#4)(2013-8#1)
and major depressive disorder##3##4##(2009-9#2)(2011-2#1)
and major##35##2##(1990-5#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#4)(2011-2#6)(2012-2#2)(2013-8#3)
and majority of##3##3##(2008-8#1)(2010-8#1)(2012-2#1)
and make a##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
and make recommendations for##2##4##(1996-2#1)(2008-6#1)
and make recommendations##5##3##(1996-2#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-1#1)
and make the##2##3##(2010-8#1)(2012-12#1)
and make##30##2##(1991-1#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-8#3)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
and makes possible##2##3##(2008-10#1)(2008-7#1)
and makes recommendations for##4##4##(2007-12#1)(2008-11#1)(2012-12#1)(2012-2#1)
and makes recommendations##5##3##(2007-12#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
and makes##18##2##(1993-2#1)(1996-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#2)(2008-8#2)(2009-10#1)(2010-10#1)(2012-12#2)(2012-2#1)
and making a##2##3##(2007-7#1)(2008-8#1)
and making death happen##3##4##(1991-2#3)
and making use of##2##4##(2008-4#1)(2010-10#1)
and making##15##2##(1991-2#3)(1993-1#1)(1993-12#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
and malachite green##3##3##(2008-10#1)(2010-5#2)
and malaria##7##2##(2007-2#1)(2008-7#1)(2010-1#2)(2012-1#1)(2012-2#2)
and malate##3##2##(1993-6#1)(2008-10#2)
and male fertility##6##3##(2008-8#1)(2009-10#2)(2012-2#3)
and male gender##3##3##(2007-10#1)(2008-8#1)(2013-1#1)
and male sexuals)##2##3##(2008-8#2)
and male##47##2##(1990-11#1)(1990-3#2)(1990-6#1)(1992-11#1)(1992-3#1)(1992-8#3)(1994-2#3)(1994-6#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-10#2)(2009-3#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
and males##14##2##(2008-1#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
and malformation##2##2##(1997-4#1)(2008-7#1)
and malignancies##5##2##(1991-5#1)(2011-1#1)(2011-2#2)(2011-3#1)
and malignancy##8##2##(1990-10#1)(1990-2#1)(2008-11#1)(2009-12#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
and malignant disease##4##3##(1990-9#1)(2008-4#1)(2011-2#1)(2012-12#1)
and malignant glioma##2##3##(2008-8#2)
and malignant human##3##3##(1990-12#1)(1994-2#2)
and malignant neoplasms##2##3##(2007-12#2)
and malignant transformation##2##3##(2008-7#1)(2011-2#1)
and malignant##60##2##(1990-11#1)(1990-12#2)(1990-9#3)(1991-3#1)(1992-11#1)(1992-9#1)(1993-11#3)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-3#2)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#5)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2010-12#1)(2010-3#2)(2010-6#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
and malnutrition##6##2##(1990-5#1)(1993-12#1)(1993-9#1)(2008-11#1)(2010-9#1)(2012-2#1)
and malondialdehyde (MDA) levels##2##4##(2008-7#1)(2009-5#1)
and malondialdehyde##4##2##(2008-7#1)(2009-5#1)(2009-8#1)(2013-8#1)
and malonic acid##2##3##(2008-10#2)
and malonic##4##2##(2008-10#4)
and malpractice##2##2##(1996-3#1)(2010-8#1)
and malrotation##2##2##(2007-8#1)(2011-2#1)
and maltohexaitol##2##2##(1990-7#2)
and maltotriose##3##2##(1990-12#1)(1992-12#1)(1995-5#1)
and mammal##2##2##(2008-5#1)(2008-8#1)
and mammalian cells##7##3##(1997-3#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
and mammalian species##2##3##(2008-5#1)(2008-9#1)
and mammalian target of rapamycin (mTOR)##2##6##(2008-7#1)(2013-1#1)
and mammalian##21##2##(1991-6#1)(1994-11#1)(1995-3#1)(1997-3#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2011-2#2)(2013-1#1)
and mammals##12##2##(1994-5#1)(1995-11#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-3#2)(2012-2#1)
and mammary gland are##2##4##(2012-2#2)
and mammary gland##4##3##(2008-9#1)(2012-2#3)
and mammary##8##2##(1992-9#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#3)
and mammography##2##2##(1990-10#1)(1990-6#1)
and man##7##2##(1990-5#1)(1994-11#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-7#1)
and man-made##3##2##(1996-6#1)(2008-11#2)
and manage the##5##3##(1996-3#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
and manage##25##2##(1994-1#2)(1994-3#2)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and manageable##3##2##(2008-1#1)(2008-6#1)(2012-12#1)
and managed by##2##3##(1991-2#1)(2012-2#1)
and managed care organizations##2##4##(1995-2#1)(1996-1#1)
and managed care##16##3##(1991-12#1)(1991-3#1)(1993-12#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-6#1)
and managed mental health##3##4##(1995-1#3)
and managed##28##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-3#2)(1995-1#4)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
and management are##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
and management at##2##3##(2012-2#1)(2013-1#1)
and management challenges##2##3##(1992-2#1)(1996-3#1)
and management considerations##2##3##(2007-12#1)(2008-7#1)
and management development##2##3##(1992-1#1)(1994-1#1)
and management have##2##3##(1997-1#1)(2013-8#1)
and management in the 1990s##2##5##(1991-3#2)
and management in the##3##4##(1991-3#2)(2008-8#1)
and management in##8##3##(1991-3#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
and management of a##5##4##(1991-12#1)(2008-11#1)(2008-12#2)(2008-6#1)
and management of acute##2##4##(2008-3#1)(2008-4#1)
and management of isolated##2##4##(2007-7#1)(2010-1#1)
and management of myocardial infarction##2##5##(1990-2#1)(1991-3#1)
and management of osteoporosis##3##4##(1993-11#1)(2008-7#1)(2008-8#1)
and management of patients with chronic##2##6##(2008-4#1)(2011-2#1)
and management of patients with##7##5##(2007-11#1)(2007-8#1)(2008-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
and management of potential##2##4##(2007-12#1)(2010-12#1)
and management of the patient##2##5##(2008-8#1)(2012-12#1)
and management of the##7##4##(1992-12#1)(1995-2#1)(2006-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-12#1)
and management of these##3##4##(2008-9#1)(2010-9#1)(2013-1#1)
and management of this##5##4##(2007-8#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)
and management of##156##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#7)(2008-11#5)(2008-12#4)(2008-3#13)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-7#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
and management options in##2##4##(2010-8#2)
and management practices##3##3##(2008-11#1)(2008-5#2)
and management skills##2##3##(1992-1#1)(2007-12#1)
and management strategies for##2##4##(2008-6#1)(2013-7#1)
and management strategies##6##3##(2006-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2013-7#1)
and management##317##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#6)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-10#4)(2007-11#3)(2007-12#14)(2007-5#2)(2007-7#3)(2007-8#5)(2008-1#8)(2008-10#17)(2008-11#11)(2008-12#9)(2008-3#15)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#8)(2008-9#2)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#3)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#5)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#6)(2010-9#4)(2011-1#6)(2011-2#18)(2011-7#5)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#14)(2013-7#4)(2013-8#5)
and managerial##4##2##(1994-12#2)(1994-3#2)
and managers in their##2##4##(1996-3#1)(1997-4#1)
and managers in##4##3##(1993-3#1)(1995-1#1)(1996-3#1)(1997-4#1)
and managers of##3##3##(1993-12#1)(1994-3#1)(2008-12#1)
and managers##22##2##(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-3#2)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#3)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
and managing the##4##3##(1995-3#1)(2008-10#1)(2009-10#1)(2013-8#1)
and managing##26##2##(1992-3#1)(1994-3#3)(1995-12#2)(1995-3#1)(1997-8#5)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-8#2)
and mandible##5##2##(2007-12#1)(2008-12#1)(2008-7#2)(2012-12#1)
and mandibular##8##2##(1997-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
and manganese determination##2##3##(2008-10#2)
and manganese in##7##3##(2008-10#6)(2010-8#1)
and manganese peroxidase##2##3##(2008-6#2)
and manganese##30##2##(1991-12#1)(1995-3#1)(1996-2#1)(2008-10#22)(2008-6#2)(2010-11#1)(2010-8#1)(2011-2#1)
and manganese(II)##2##2##(2008-10#1)(2008-5#1)
and mango##4##2##(2008-10#4)
and mangrove##2##2##(2007-5#1)(2011-2#1)
and manifests##3##2##(1995-8#1)(2007-7#1)(2008-1#1)
and manipulate the##2##3##(2008-10#1)(2008-4#1)
and manipulate##5##2##(2008-10#1)(2008-4#1)(2009-12#1)(2009-5#1)(2010-7#1)
and manipulated using##2##3##(2007-6#1)(2012-2#1)
and manipulated##5##2##(1992-11#1)(2007-6#1)(2009-12#1)(2010-9#1)(2012-2#1)
and manipulating##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
and manipulation of low-index##2##4##(2007-11#2)
and manipulation of##7##3##(1991-8#1)(2007-11#2)(2008-2#1)(2009-10#1)(2010-7#1)(2011-2#1)
and manipulation##10##2##(1991-8#1)(2007-11#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)
and mannitol in the##2##4##(2008-10#1)(2012-7#1)
and mannitol##4##2##(1993-8#1)(2008-10#2)(2012-7#1)
and manual therapy##2##3##(2007-11#1)(2008-12#1)
and manual##11##2##(2007-11#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
and manufacture of##3##3##(2008-2#1)(2008-3#2)
and manufacture##4##2##(2008-2#2)(2008-3#2)
and manufacturers##2##2##(1993-3#1)(1996-2#1)
and manufacturing process##2##3##(2008-10#1)(2008-11#1)
and manufacturing##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-10#1)(2010-3#1)(2010-5#1)
and manure##2##2##(2008-10#1)(2010-2#1)
and many countries##3##3##(2008-10#2)(2011-2#1)
and many factors##2##3##(2009-5#1)(2012-2#1)
and many more##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
and many of the##3##4##(1997-1#1)(2008-8#1)(2012-1#1)
and many of them##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)
and many of these##3##4##(2008-10#1)(2009-5#1)(2010-11#1)
and many of##12##3##(1997-1#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2012-1#1)
and many other factors##2##4##(1991-12#1)(1996-3#1)
and many other##7##3##(1991-12#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-9#2)(2013-7#1)
and many others are##2##4##(1991-3#1)(2013-1#1)
and many others##4##3##(1991-3#1)(2009-4#1)(2011-1#1)(2013-1#1)
and many were##3##3##(1991-2#1)(1992-8#1)(2010-1#1)
and many##93##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
and map##2##2##(1993-3#1)(2008-10#1)
and mapped the##2##3##(1997-6#1)(2012-2#1)
and mapped##11##2##(1990-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and mapping of a##2##4##(1991-6#1)(1996-6#1)
and mapping of the##2##4##(1997-9#1)(2008-10#1)
and mapping of##12##3##(1991-6#1)(1996-10#1)(1996-6#1)(1997-9#2)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
and mapping techniques##3##3##(2013-1#3)
and mapping##23##2##(1991-6#1)(1996-10#1)(1996-6#1)(1997-9#2)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
and maps##4##2##(1991-6#1)(1994-11#2)(2008-11#1)
and marbling traits##2##3##(2010-4#2)
and marbling##8##2##(2010-2#1)(2010-4#7)
and marginal##5##2##(1990-9#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#1)
and marginally##2##2##(1994-3#1)(2008-8#1)
and marijuana use##7##3##(2009-5#1)(2009-7#2)(2011-1#1)(2013-7#1)(2013-8#2)
and marijuana##12##2##(1991-4#1)(2008-9#1)(2009-5#2)(2009-7#3)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
and marine##16##2##(1994-9#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-3#1)
and marital dysfunction##3##3##(2007-2#3)
and marital status##3##3##(1991-6#1)(2010-8#1)(2012-2#1)
and marital##10##2##(1991-6#1)(2007-2#4)(2010-8#1)(2011-2#2)(2012-2#2)
and marked##16##2##(1992-6#1)(1994-2#1)(1994-9#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
and markedly##6##2##(1990-12#1)(1993-8#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
and marker##7##2##(2007-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#2)
and marker-assisted selection##2##3##(2008-10#1)(2012-3#1)
and marker-assisted##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
and markers of##6##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and markers##13##2##(1997-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2012-2#1)(2013-1#1)
and market##10##2##(1992-1#1)(1992-3#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)
and marketing of##3##3##(1993-2#1)(1994-3#1)(1995-12#1)
and marketing##8##2##(1993-2#1)(1994-3#3)(1995-12#1)(2008-1#1)(2008-5#1)(2008-6#1)
and markets##2##2##(1997-1#1)(2007-7#1)
and marsupialization##2##2##(2007-12#1)(2012-12#1)
and masked thiol groups##2##4##(2008-4#2)
and masking##4##2##(2008-10#3)(2009-11#1)
and mass of##3##3##(2007-11#1)(2010-11#1)(2012-12#1)
and mass spectral##2##3##(2008-11#1)(2008-5#1)
and mass spectrometric detection##2##4##(2008-5#2)
and mass spectrometric##4##3##(1992-12#1)(2008-5#2)(2008-8#1)
and mass spectrometry (MS)##2##4##(2008-4#1)(2008-8#1)
and mass spectrometry to##2##4##(2008-8#1)(2010-11#1)
and mass spectrometry##27##3##(1991-12#1)(1992-6#1)(1995-11#1)(2008-1#1)(2008-10#6)(2008-4#5)(2008-7#3)(2008-8#3)(2010-11#2)(2010-5#3)(2013-1#1)
and mass spectrometry)##2##3##(2008-12#1)(2008-7#1)
and mass transfer##6##3##(1997-2#1)(2008-10#2)(2008-6#1)(2010-4#1)(2013-1#1)
and mass##71##2##(1991-12#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#5)(2009-5#1)(2010-11#4)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#3)
and massage for##2##3##(2008-10#1)(2013-1#1)
and massage##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
and massive##8##2##(1994-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2011-2#1)(2011-3#1)
and mast cell##2##3##(2008-6#1)(2012-3#1)
and mast##3##2##(2008-6#1)(2012-3#1)(2013-1#1)
and mastoid##2##2##(2008-7#1)(2013-7#1)
and mastoparan##5##2##(1994-11#4)(2008-10#1)
and masu salmon##2##3##(2008-5#2)
and matched controls##4##3##(1996-12#1)(1997-5#1)(2010-6#1)(2013-1#1)
and matched with##2##3##(1995-6#1)(2012-2#1)
and matched##10##2##(1995-6#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-12#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#2)
and matching##4##2##(1996-2#1)(2007-12#1)(2008-6#1)(2013-1#1)
and mate choice in##3##4##(2008-8#2)(2008-9#1)
and material from##2##3##(2008-10#2)
and material properties##2##3##(2009-7#1)(2011-1#1)
and material shrinkage that currently hamper page-oriented holographic storage systems##2##10##(2007-11#2)
and material##25##2##(1991-8#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#3)(2008-9#1)(2009-7#1)(2010-10#2)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#1)
and materials are##2##3##(1997-3#1)(2008-9#1)
and materials##17##2##(1990-5#1)(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#3)(2010-8#1)(2011-2#1)(2012-8#1)
and materiel##2##2##(1991-12#1)(1994-1#1)
and maternal depression##2##3##(2009-12#1)(2012-12#1)
and maternal##21##2##(1992-11#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-8#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2012-12#3)(2013-1#1)
and maternity##4##2##(1995-1#1)(2008-9#1)(2013-1#2)
and mathematical models##2##3##(2008-10#2)
and mathematical##5##2##(2008-10#3)(2008-6#1)(2009-8#1)
and mating success##2##3##(2008-8#1)(2012-3#1)
and mating systems of##2##4##(2012-2#2)
and mating type were##2##4##(2008-10#2)
and mating type##12##3##(2008-10#12)
and mating##25##2##(2008-10#13)(2008-11#1)(2008-12#2)(2008-8#3)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)
and matric potentials##2##3##(2008-10#2)
and matric##3##2##(2008-10#3)
and matrices##4##2##(1990-2#3)(2008-10#1)
and matrix effects are discussed##3##5##(2008-10#3)
and matrix effects for preconcentration were##2##6##(2008-10#2)
and matrix effects##8##3##(2008-10#8)
and matrix elimination##2##3##(2008-10#2)
and matrix metalloproteinase##2##3##(2011-2#1)(2012-3#1)
and matrix proteins##2##3##(2008-11#1)(2012-12#1)
and matrix##34##2##(1990-2#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and maturation in##2##3##(2008-7#1)(2009-12#1)
and maturation of the##4##4##(1992-12#2)(2008-10#1)(2012-2#1)
and maturation of##12##3##(1992-12#2)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-6#2)(2010-4#1)(2012-1#1)(2012-2#1)
and maturation##25##2##(1992-12#2)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-7#1)
and mature##18##2##(1991-7#1)(1994-6#1)(1996-2#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#1)(2008-9#3)(2010-3#1)(2011-2#1)
and matured##2##2##(2008-10#2)
and maturity##2##2##(2008-10#1)(2013-7#1)
and maxillary##6##2##(1993-12#1)(2008-6#1)(2013-1#4)
and maxillofacial surgeons##2##3##(2007-12#2)
and maxillofacial surgery##11##3##(1993-1#2)(2007-12#4)(2008-7#4)(2009-7#1)
and maxillofacial##19##2##(1993-1#2)(2007-12#9)(2008-7#6)(2009-7#1)(2011-2#1)
and maximal##7##2##(1990-8#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)
and maximize the##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
and maximize##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
and maximizing the benefits to editorial board members##3##8##(2010-12#3)
and maximizing the##4##3##(1991-12#1)(2010-12#3)
and maximizing##6##2##(1991-12#1)(1996-12#1)(2008-10#1)(2010-12#3)
and maximum likelihood##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
and maximum temperatures##2##3##(2008-10#1)(2012-2#1)
and maximum##46##2##(1993-8#1)(1994-3#1)(1994-9#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#1)
and may act##2##3##(2008-10#1)(2009-10#1)
and may actually##2##3##(2008-8#1)(2011-3#1)
and may affect the##2##4##(1995-2#1)(2010-5#1)
and may affect##3##3##(1994-5#1)(1995-2#1)(2010-5#1)
and may allow##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
and may also cause##2##4##(2006-6#1)(2008-7#1)
and may also serve as a transformative model for emerging EMR/EHR requirements##2##12##(2010-8#2)
and may also##15##3##(1994-6#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-1#1)(2010-8#3)(2011-2#1)(2013-1#1)
and may assist in##2##4##(2012-2#1)(2013-1#1)
and may assist##3##3##(2010-10#1)(2012-2#1)(2013-1#1)
and may be a useful##2##5##(2008-10#1)(2010-11#1)
and may be a##8##4##(1992-6#1)(1995-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#1)
and may be an##3##4##(1997-8#1)(2008-6#1)(2009-12#1)
and may be applied to other##2##6##(2008-4#2)
and may be applied to##3##5##(2008-11#1)(2008-4#2)
and may be applied##4##4##(2008-10#1)(2008-11#1)(2008-4#2)
and may be associated with##3##5##(2007-7#1)(2008-7#1)(2010-12#1)
and may be caused by##2##5##(1994-12#1)(2011-2#1)
and may be considered##2##4##(2008-10#1)(2008-5#1)
and may be critical for##2##5##(2008-10#1)(2012-7#1)
and may be especially##2##4##(1994-2#1)(2007-10#1)
and may be involved in##3##5##(1997-2#1)(2008-8#1)(2011-1#1)
and may be more##2##4##(1991-6#1)(1995-11#1)
and may be of##6##4##(1995-3#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
and may be part of##2##5##(2008-10#1)(2008-9#1)
and may be related to the##2##6##(1992-9#1)(2008-4#1)
and may be related to##4##5##(1992-9#1)(2008-4#1)(2008-8#1)(2010-1#1)
and may be the##8##4##(1990-7#1)(1991-12#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-8#1)
and may be used as##2##5##(1990-11#1)(2008-11#1)
and may be used for the##3##6##(1990-11#1)(2008-10#1)(2008-12#1)
and may be used##6##4##(1990-11#2)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
and may be useful for##3##5##(1994-3#1)(2008-10#2)
and may be useful in##2##5##(2008-10#2)
and may be useful##6##4##(1994-3#1)(2008-10#4)(2010-3#1)
and may be##105##3##(1990-11#2)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#3)
and may become##2##3##(2007-11#1)(2009-11#1)
and may benefit from##2##4##(2012-2#1)(2012-3#1)
and may cause##3##3##(2007-8#1)(2008-3#1)(2013-7#1)
and may coexist##2##3##(2007-11#1)(2008-12#1)
and may compromise##2##3##(2008-10#1)(2013-1#1)
and may constitute##2##3##(1991-5#1)(2013-8#1)
and may contribute to the##3##5##(1997-4#1)(2008-12#1)(2008-9#1)
and may contribute to##7##4##(1997-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)
and may decrease##2##3##(2007-8#1)(2011-2#1)
and may depend on##3##4##(2008-12#1)(2008-3#1)(2008-9#1)
and may differ##2##3##(1994-8#1)(2008-10#1)
and may directly##2##3##(2006-6#1)(2008-10#1)
and may enhance##2##3##(2008-10#1)(2009-11#1)
and may even produce##2##4##(1991-1#1)(2013-7#1)
and may even##4##3##(1991-1#1)(2007-7#1)(2011-2#1)(2013-7#1)
and may explain the##4##4##(1991-9#1)(2007-7#1)(2008-10#2)
and may explain##5##3##(1991-9#1)(2007-7#1)(2008-10#2)(2008-3#1)
and may extend##2##3##(2008-12#1)(2010-8#1)
and may have a##7##4##(1990-3#1)(1992-2#1)(1993-8#1)(2008-10#2)(2008-5#1)(2013-8#1)
and may have an##3##4##(2008-1#1)(2008-2#1)(2010-3#1)
and may have##21##3##(1990-3#1)(1990-5#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-8#1)
and may help identify##2##4##(2010-10#1)(2011-2#1)
and may help the##2##4##(1991-2#1)(1997-2#1)
and may help##7##3##(1991-2#1)(1997-2#1)(2006-10#1)(2008-12#1)(2010-10#1)(2011-2#2)
and may improve##3##3##(2007-8#1)(2008-3#1)(2010-12#1)
and may in##2##3##(1997-6#1)(2007-11#1)
and may include the##2##4##(2007-8#1)(2010-4#1)
and may include##3##3##(2007-8#1)(2008-9#1)(2010-4#1)
and may increase##5##3##(1996-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
and may indicate##4##3##(1996-8#1)(2007-10#1)(2008-10#1)(2012-2#1)
and may involve##5##3##(1992-11#1)(1992-12#1)(1993-8#1)(1996-8#1)(2013-1#1)
and may lead to##6##4##(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2012-12#1)
and may modulate##2##3##(1995-6#1)(2007-8#1)
and may need##2##3##(2006-10#1)(2011-2#1)
and may negatively affect##2##4##(1995-1#1)(2011-2#1)
and may not be##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
and may not##5##3##(1991-8#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
and may now be##2##4##(2008-11#1)(2008-8#1)
and may occur##2##3##(1995-6#1)(2006-10#1)
and may only be##2##4##(1997-3#1)(2009-3#1)
and may permit##2##3##(2007-12#2)
and may play a role in##3##6##(1992-6#1)(2008-7#1)(2010-10#1)
and may play a##4##4##(1992-6#1)(1995-2#1)(2008-7#1)(2010-10#1)
and may play an important role in the##2##8##(1995-12#1)(2008-9#1)
and may play##6##3##(1992-6#1)(1995-12#1)(1995-2#1)(2008-7#1)(2008-9#1)(2010-10#1)
and may precipitate##2##3##(1996-3#1)(2008-6#1)
and may present##2##3##(2008-1#1)(2008-8#1)
and may prove useful##2##4##(1996-2#1)(2008-10#1)
and may prove##4##3##(1996-2#1)(2007-5#1)(2008-10#1)(2008-7#1)
and may provide a##3##4##(1994-11#1)(2009-8#1)(2013-1#1)
and may provide an##2##4##(2008-1#1)(2008-10#1)
and may provide insight into##2##5##(2008-10#1)(2008-9#1)
and may provide##14##3##(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2013-1#2)
and may reduce the##2##4##(1993-2#1)(2007-8#1)
and may reduce##4##3##(1990-5#1)(1993-2#1)(2007-11#1)(2007-8#1)
and may represent a##8##4##(1990-2#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#2)(2009-8#1)(2013-8#1)
and may represent##11##3##(1990-2#1)(1994-11#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#2)(2009-8#1)(2010-3#1)(2013-8#1)
and may require a##2##4##(2008-11#1)(2009-8#1)
and may require##7##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)
and may result in##6##4##(1992-2#1)(1994-2#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
and may result##7##3##(1992-2#1)(1994-2#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
and may serve to##2##4##(1991-2#1)(2008-1#1)
and may serve##3##3##(1991-2#1)(2008-1#1)(2011-1#1)
and may suggest that##2##4##(1990-3#1)(2008-5#1)
and may suggest##3##3##(1990-3#1)(1991-12#1)(2008-5#1)
and may therefore be##2##4##(1990-11#1)(1993-2#1)
and may therefore##4##3##(1990-11#1)(1993-2#1)(2008-11#1)(2008-4#1)
and may thus##4##3##(1994-2#1)(2008-10#1)(2009-5#1)(2011-2#1)
and may##397##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#2)(1995-6#3)(1996-11#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2006-10#4)(2006-6#2)(2006-7#1)(2007-10#3)(2007-11#7)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#6)(2008-1#6)(2008-10#50)(2008-11#10)(2008-12#8)(2008-2#4)(2008-3#15)(2008-4#8)(2008-5#8)(2008-6#4)(2008-7#16)(2008-8#13)(2008-9#18)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#2)(2012-7#1)(2013-1#12)(2013-7#3)(2013-8#9)
and meals##2##2##(1990-2#1)(2008-1#1)
and mealybug##2##2##(2008-10#2)
and mean SRIF##2##3##(1997-2#2)
and mean arterial blood pressure##2##5##(2013-1#1)(2013-8#1)
and mean arterial##3##3##(1991-5#1)(2013-1#1)(2013-8#1)
and mean body weights of dosed groups were similar to those of the vehicle controls##3##15##(2008-9#3)
and mean body##6##3##(2008-9#5)(2011-2#1)
and mean duration of##2##4##(2008-1#1)(2011-2#1)
and mean incidence##2##3##(2008-10#2)
and mean##57##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-9#1)(1994-12#1)(1997-2#2)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#7)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
and meaning##3##2##(2008-12#1)(2013-1#2)
and meaningful##7##2##(1995-1#1)(2008-1#1)(2008-12#3)(2012-2#2)
and means of##3##3##(1990-2#1)(1994-12#1)(2008-3#1)
and means##5##2##(1990-2#1)(1994-12#1)(1995-5#2)(2008-3#1)
and measurable##4##2##(1994-2#1)(1995-12#1)(1996-2#1)(2008-9#1)
and measure the##3##3##(2008-11#1)(2011-2#2)
and measure##13##2##(2007-12#2)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
and measured a##2##3##(2008-3#1)(2009-11#1)
and measured by the##4##4##(2008-10#4)
and measured by##16##3##(1991-2#1)(1994-5#1)(1995-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-5#1)(2010-4#1)
and measured for##2##3##(2008-10#1)(2008-3#1)
and measured in a##2##4##(1994-3#1)(2008-10#1)
and measured in##3##3##(1994-3#1)(2008-10#2)
and measured its##2##3##(1994-11#1)(1996-5#1)
and measured performance##3##3##(2008-3#3)
and measured the##3##3##(1995-2#1)(2007-11#1)(2008-5#1)
and measured their##2##3##(1990-12#1)(2007-11#1)
and measured using##2##3##(2008-10#1)(2008-7#1)
and measured with##3##3##(2007-5#1)(2008-10#2)
and measured##65##2##(1990-12#1)(1991-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-5#1)(1996-7#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#13)(2008-5#3)(2008-7#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-1#1)(2013-7#1)
and measurement of the##9##4##(1995-8#1)(2008-10#6)(2008-2#1)(2008-3#1)
and measurement of##29##3##(1992-3#1)(1993-2#1)(1995-1#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#2)
and measurement repeatability##2##3##(2008-10#2)
and measurement##49##2##(1992-3#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#2)(2008-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
and measurements in##2##3##(2008-2#1)(2008-6#1)
and measurements of the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and measurements of##11##3##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-11#1)
and measurements were taken##2##4##(1995-12#1)(2013-7#1)
and measurements were##3##3##(1995-12#1)(2008-10#1)(2013-7#1)
and measurements##29##2##(1992-6#1)(1995-12#1)(2006-12#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2013-1#2)(2013-7#1)
and measures of##15##3##(1992-9#1)(1993-3#1)(1994-3#2)(2008-1#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
and measures the##2##3##(2008-2#1)(2008-3#1)
and measures to##2##3##(2008-11#1)(2008-4#1)
and measures##30##2##(1990-12#1)(1991-3#2)(1992-9#1)(1993-3#1)(1994-3#2)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and measuring the##12##3##(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#2)
and measuring##24##2##(1992-11#1)(1993-12#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#3)(2009-5#1)(2012-2#1)
and meat products##5##3##(2008-10#3)(2010-4#1)(2012-12#1)
and meat quality parameters in growing and finishing pigs##3##9##(2010-2#3)
and meat quality##10##3##(2010-2#5)(2010-4#1)(2012-2#3)(2013-1#1)
and meat##19##2##(1992-10#1)(2008-10#4)(2010-2#5)(2010-4#4)(2012-12#1)(2012-2#3)(2013-1#1)
and mebendazole##5##2##(2008-10#5)
and mechanical behavior of##2##4##(2009-7#2)
and mechanical properties of the##2##5##(2008-6#1)(2009-8#1)
and mechanical properties of##9##4##(2007-12#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)
and mechanical properties##17##3##(1995-3#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#1)
and mechanical stability##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
and mechanical support##2##3##(2007-9#1)(2009-8#1)
and mechanical ventilation##2##3##(1991-11#1)(2007-7#1)
and mechanical##64##2##(1991-11#1)(1993-5#1)(1994-3#1)(1995-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
and mechanically flexible##2##3##(2008-7#2)
and mechanically inferior brittle##2##4##(2012-2#2)
and mechanically##11##2##(2008-10#2)(2008-3#1)(2008-7#3)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#2)
and mechanism for##2##3##(1996-12#1)(2008-8#1)
and mechanism of action of##2##5##(2008-4#1)(2010-4#1)
and mechanism of action##3##4##(1991-2#1)(2008-4#1)(2010-4#1)
and mechanism of##16##3##(1991-2#1)(1992-11#1)(1993-11#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)
and mechanism##20##2##(1991-2#1)(1992-11#1)(1993-11#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)
and mechanism-based##2##2##(1995-2#1)(2008-12#1)
and mechanisms of action##2##4##(2008-10#1)(2009-4#1)
and mechanisms of##13##3##(1994-2#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
and mechanisms that##3##3##(1994-1#1)(2008-7#1)(2010-3#1)
and mechanisms##31##2##(1994-1#1)(1994-2#1)(1994-8#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and mechanistic implications of##2##4##(1997-2#1)(2008-10#1)
and mechanistic insight##2##3##(2009-10#1)(2012-12#1)
and mechanistic##9##2##(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2012-12#1)
and meclofenamic acids##2##3##(2008-10#2)
and media reports##2##3##(2007-2#1)(2013-8#1)
and media##14##2##(1992-8#1)(1996-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and medial frontal##2##3##(1994-3#1)(1996-5#1)
and medial prefrontal lesions on##2##5##(1993-3#2)
and medial prefrontal##3##3##(1993-3#2)(1993-6#1)
and medial temporal##2##3##(1996-5#2)
and medial##20##2##(1991-12#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-3#1)(1996-5#3)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
and median survival was##2##4##(1990-8#1)(1991-6#1)
and median##15##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1993-9#1)(1994-3#1)(1996-12#2)(1997-4#1)(2007-8#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)
and mediastinal lymph##2##3##(1990-8#1)(2008-4#1)
and mediastinal##13##2##(1990-8#1)(1992-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#2)
and mediastinum##2##2##(2007-8#1)(2008-12#1)
and mediate the##2##3##(1994-5#1)(1995-2#1)
and mediate##6##2##(1994-5#1)(1995-2#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
and mediated##6##2##(1991-3#1)(2008-10#3)(2013-1#2)
and mediates##5##2##(1995-2#2)(2008-7#1)(2008-8#1)(2008-9#1)
and mediating##3##2##(2008-5#1)(2010-10#1)(2013-8#1)
and mediator##2##2##(2008-10#1)(2009-10#1)
and mediators of##2##3##(2012-3#1)(2013-8#1)
and mediators##6##2##(2007-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
and medical activities##2##3##(1995-2#1)(2008-7#1)
and medical and##2##3##(1995-11#1)(2008-11#1)
and medical care##13##3##(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1995-2#2)(1997-2#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
and medical complications in##2##4##(2008-9#2)
and medical complications##4##3##(1992-5#1)(2008-9#3)
and medical data##3##3##(1990-9#1)(2008-6#1)(2009-5#1)
and medical decision-making##2##3##(1994-1#1)(2012-12#1)
and medical doctors##2##3##(2008-1#1)(2011-2#1)
and medical fields##2##3##(2008-11#1)(2013-1#1)
and medical journals##2##3##(1991-3#1)(2010-2#1)
and medical malpractice##2##3##(1991-12#1)(1994-2#1)
and medical management##5##3##(1997-3#1)(2008-4#1)(2010-6#1)(2011-3#1)(2013-1#1)
and medical practice##3##3##(1994-12#1)(1995-2#2)
and medical records##2##3##(1993-1#1)(1993-11#1)
and medical research##3##3##(1991-6#1)(1996-12#1)(2007-11#1)
and medical schools##2##3##(2007-4#1)(2008-10#1)
and medical services##2##3##(1991-3#1)(2012-3#1)
and medical staff##4##3##(1991-12#1)(1992-2#1)(1994-1#1)(2012-3#1)
and medical students in##2##4##(2008-4#1)(2013-1#1)
and medical students to##2##4##(1992-2#1)(2008-11#1)
and medical students##11##3##(1992-2#1)(2008-11#5)(2008-12#2)(2008-4#1)(2010-9#1)(2013-1#1)
and medical technology##3##3##(1991-12#1)(1993-12#1)(2008-12#1)
and medical therapy##2##3##(2011-3#1)(2012-12#1)
and medical treatment##4##3##(2008-8#1)(2009-9#1)(2010-12#1)(2012-3#1)
and medical##146##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-3#3)(1991-6#5)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#6)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#13)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#1)
and medically##7##2##(1991-3#1)(1992-3#1)(1996-1#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-3#1)
and medication##13##2##(1994-12#1)(1994-2#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#2)
and medications##2##2##(2010-11#1)(2011-2#1)
and medicinal chemistry##2##3##(2006-12#1)(2008-10#1)
and medicinal plants##3##3##(2008-10#1)(2009-10#1)(2011-3#1)
and medicinal##8##2##(2006-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2011-3#1)
and medicine in##2##3##(1995-2#1)(1996-11#1)
and medicine##26##2##(1995-2#5)(1996-11#3)(1996-12#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
and medicines##3##2##(1996-11#1)(1997-6#1)(2012-12#1)
and mediolateral##2##2##(1995-4#1)(2010-9#1)
and medium term##2##3##(2011-2#1)(2013-1#1)
and medium##17##2##(1990-7#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
and medium-chain##2##2##(1991-5#1)(2007-8#1)
and medium-sized vessels##2##3##(1997-8#1)(2006-10#1)
and medium-sized##3##2##(1997-8#1)(2006-10#1)(2011-2#1)
and medium-term##3##2##(2010-11#1)(2011-2#2)
and medroxyprogesterone acetate##2##3##(1993-8#1)(1997-7#1)
and medulla##8##2##(1990-12#1)(1996-5#2)(1997-2#4)(2007-12#1)
and medullary##5##2##(1991-4#1)(1996-9#2)(2008-10#1)(2009-3#1)
and meet##3##2##(1997-3#1)(2007-8#1)(2008-5#1)
and meeting##3##2##(1992-1#1)(1994-2#1)(1996-2#1)
and mefenamic##2##2##(2008-10#2)
and meiosis##2##2##(2008-12#1)(2008-5#1)
and meiotic##13##2##(2007-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2009-10#1)(2010-3#1)
and melanin##5##2##(1991-5#2)(2008-10#1)(2008-5#1)(2010-8#1)
and melanogenic##2##2##(1995-2#2)
and melanoma##8##2##(1990-2#1)(1991-3#1)(1994-6#1)(2008-9#1)(2009-10#2)(2013-1#1)(2013-8#1)
and melasma##2##2##(2007-7#2)
and melatonin##4##2##(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)
and melon##5##2##(2008-10#4)(2011-2#1)
and melting point##2##3##(1990-9#1)(2008-5#1)
and melting##5##2##(1990-9#1)(1992-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
and member of the##2##4##(1995-6#1)(2008-12#1)
and member##4##2##(1995-6#1)(1997-3#1)(2008-12#1)(2012-2#1)
and members of##3##3##(1996-12#1)(2008-10#1)(2010-2#1)
and members##4##2##(1996-12#1)(1997-1#1)(2008-10#1)(2010-2#1)
and membership##2##2##(1993-1#1)(2008-10#1)
and membrane fractions##7##3##(1990-2#1)(1991-2#2)(1992-6#1)(1994-11#1)(1995-8#1)(2008-11#1)
and membrane lipid##2##3##(1995-8#1)(2008-8#1)
and membrane lipids##2##3##(1990-2#1)(2008-8#1)
and membrane potential##4##3##(1994-11#2)(1994-12#1)(2009-6#1)
and membrane transport##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
and membrane##50##2##(1990-2#2)(1991-2#2)(1992-6#2)(1993-12#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#3)(2007-12#1)(2008-10#8)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2012-3#1)
and membrane-associated##2##2##(1990-8#1)(2012-12#1)
and membrane-bound##3##2##(2008-4#1)(2008-7#2)
and membranes##4##2##(1996-2#1)(2008-10#1)(2008-11#2)
and membrano-proliferative glomerulonephritis##2##3##(2007-8#1)(2008-1#1)
and membranous glomerulonephritis##2##3##(2007-7#1)(2013-1#1)
and membranous##8##2##(1993-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
and memory deficits##4##3##(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#1)
and memory formation##2##3##(2008-7#1)(2009-8#1)
and memory in rats##2##4##(2008-7#1)(2011-2#1)
and memory in##10##3##(1993-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#4)(2011-2#1)
and memory performance##2##3##(1994-8#1)(2008-12#1)
and memory processes##4##3##(1992-11#2)(2009-11#1)(2012-12#1)
and memory requirements##2##3##(2008-2#1)(2008-7#1)
and memory##83##2##(1991-11#1)(1992-11#2)(1993-12#2)(1993-3#3)(1994-8#2)(1995-12#1)(1996-5#4)(1997-2#1)(1997-6#2)(2007-12#2)(2007-8#1)(2008-10#7)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#9)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#8)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#9)(2013-1#1)(2013-8#2)
and men are##2##3##(2008-1#1)(2008-10#1)
and men were##2##3##(2008-12#1)(2008-5#1)
and men who##2##3##(1996-5#1)(2009-5#1)
and men##36##2##(1991-6#2)(1991-8#1)(1994-2#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#3)(2009-11#1)(2009-5#2)(2009-7#2)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#3)
and meningeal##2##2##(2006-12#1)(2008-7#1)
and meninges##3##2##(1993-12#2)(2008-1#1)
and meningiomas##2##2##(1995-12#1)(2006-12#1)
and meningitis##8##2##(1995-3#2)(2009-12#4)(2009-6#1)(2012-2#1)
and meningococcal disease##2##3##(1991-8#2)
and meningococcal##3##2##(1991-8#2)(2008-7#1)
and menopausal status##2##3##(1993-1#1)(2009-3#1)
and menopausal##3##2##(1993-1#1)(2008-7#1)(2009-3#1)
and menstrual##4##2##(2008-4#1)(2009-3#1)(2012-2#2)
and menstruation##2##2##(1994-9#1)(2008-5#1)
and mental disability##2##3##(1990-6#1)(1997-5#1)
and mental health care##4##4##(1995-1#1)(1997-5#1)(2006-9#1)(2008-2#1)
and mental health disorders##4##4##(2013-8#4)
and mental health in##5##4##(2010-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
and mental health of##2##4##(2010-1#1)(2011-2#1)
and mental health providers##2##4##(2008-6#1)(2010-10#1)
and mental health services##4##4##(1992-3#1)(1993-2#1)(2008-11#1)(2008-12#1)
and mental health##59##3##(1991-12#3)(1992-1#1)(1992-3#5)(1993-10#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-5#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#6)
and mental illness##3##3##(1996-11#1)(1997-8#1)(2011-3#1)
and mental retardation##4##3##(1995-1#1)(1997-8#1)(2007-11#1)(2008-1#1)
and mental status##2##3##(2007-11#1)(2010-12#1)
and mental training##4##3##(2008-7#1)(2009-11#2)(2012-3#1)
and mental##98##2##(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#5)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-5#2)(1997-8#2)(2006-9#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#4)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#6)
and mentally##5##2##(1990-2#1)(1990-3#1)(1995-11#1)(2008-2#2)
and mentioned##2##2##(1995-1#1)(2008-10#1)
and mentor##2##2##(2008-7#1)(2012-3#1)
and mentors##2##2##(2008-1#1)(2008-11#1)
and meperidine##3##2##(2007-10#2)(2011-2#1)
and mercaptoethanol##2##2##(1991-12#1)(1992-6#1)
and mercaptopicolinate##2##2##(1995-8#2)
and mercury in##5##3##(2008-10#4)(2008-12#1)
and mercury ions##8##3##(1991-9#1)(2008-10#7)
and mercury was##2##3##(2008-10#2)
and mercury##31##2##(1991-9#1)(1994-3#1)(2007-12#1)(2008-10#25)(2008-12#1)(2009-12#1)(2013-1#1)
and mercury(II)##2##2##(2008-10#2)
and merge##2##2##(2007-12#1)(2008-10#1)
and merging of##2##3##(2007-11#1)(2007-12#1)
and merging##4##2##(1995-2#1)(2007-11#1)(2007-12#1)(2010-10#1)
and meristem exclusion of##2##4##(2012-2#2)
and merit##2##2##(1997-1#1)(2012-3#1)
and merits##2##2##(2009-2#1)(2010-12#1)
and meropenem##2##2##(2007-7#1)(2011-1#1)
and mesangial##3##2##(1995-2#1)(2008-1#2)
and mesenchymal##4##2##(1991-9#1)(2010-8#2)(2012-3#1)
and mesenteric##3##2##(1991-6#1)(1997-8#1)(2009-8#1)
and mesoderm##2##2##(2008-10#1)(2008-11#1)
and mesodermal##2##2##(1996-5#1)(2007-7#1)
and mesophyll##2##2##(2008-10#1)(2013-7#1)
and mesothelioma##6##2##(1991-12#4)(1995-12#1)(2010-5#1)
and met##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
and meta-analyses are##2##3##(1996-6#1)(2013-1#1)
and meta-analyses in##2##3##(1993-12#1)(2013-1#1)
and meta-analyses##10##2##(1991-3#1)(1993-12#2)(1996-6#3)(2010-11#1)(2012-1#1)(2013-1#2)
and meta-analytic##2##2##(1996-6#1)(2008-11#1)
and metabolic abnormalities##2##3##(2008-1#1)(2008-4#1)
and metabolic activity##3##3##(2008-10#2)(2008-11#1)
and metabolic complications##2##3##(2008-3#1)(2011-3#1)
and metabolic control##3##3##(1990-7#1)(1995-2#1)(2012-4#1)
and metabolic diseases##2##3##(2011-2#1)(2013-8#1)
and metabolic disorders##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
and metabolic disturbances##3##3##(2008-3#1)(2009-12#1)(2012-1#1)
and metabolic functions##2##3##(1992-9#1)(2012-1#1)
and metabolic imaging##2##3##(2013-1#1)(2013-8#1)
and metabolic markers##2##3##(2008-3#1)(2013-1#1)
and metabolic processes##2##3##(2010-2#1)(2012-2#1)
and metabolic programming##2##3##(2009-9#1)(2012-2#1)
and metabolic responses during supramaximal exercise##2##6##(2013-8#2)
and metabolic responses##5##3##(2008-10#1)(2008-3#1)(2012-2#1)(2013-8#2)
and metabolic stress##2##3##(2010-9#1)(2012-12#1)
and metabolic syndrome in##4##4##(2007-5#1)(2008-3#1)(2009-9#1)(2012-3#1)
and metabolic syndrome##19##3##(2007-5#1)(2008-1#2)(2008-3#5)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
and metabolic##85##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(2007-5#2)(2008-1#3)(2008-10#4)(2008-11#8)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#6)(2009-10#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#8)(2013-7#1)(2013-8#8)
and metabolically##2##2##(1993-3#1)(1994-12#1)
and metabolism in the##4##4##(1991-12#1)(1997-2#1)(2008-3#1)(2011-1#1)
and metabolism of##18##3##(1992-2#1)(1993-11#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-11#7)(2008-5#1)(2008-8#1)(2010-5#1)(2011-3#1)
and metabolism were##2##3##(1995-11#1)(2008-11#1)
and metabolism##46##2##(1991-12#2)(1992-2#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-11#2)(1995-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#9)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-5#1)(2011-1#2)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
and metabolite concentrations##3##3##(1991-3#1)(2008-10#1)(2012-5#1)
and metabolite responses to##2##4##(2008-3#2)
and metabolite##10##2##(1991-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2012-5#2)
and metabolites in##2##3##(2008-10#1)(2010-11#1)
and metabolites##8##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#3)(2010-4#1)(2012-1#1)
and metabolized##3##2##(1990-6#1)(1992-3#1)(2008-12#1)
and metabolomic##2##2##(2008-11#1)(2012-12#1)
and metabolomics##4##2##(2011-2#1)(2012-1#1)(2012-2#2)
and metabotropic##6##2##(1995-12#1)(2008-4#1)(2008-7#4)
and metachronous##3##2##(1992-8#1)(2007-5#1)(2010-3#1)
and metacognitive##2##2##(2008-11#1)(2012-3#1)
and metagenomics##2##2##(2011-2#1)(2012-3#1)
and metal ion##2##3##(2008-10#2)
and metal ions was##2##4##(2008-10#2)
and metal ions##7##3##(2008-10#6)(2008-7#1)
and metal##27##2##(1990-3#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-3#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
and metal-ion##2##2##(2008-10#1)(2013-1#1)
and metal-semiconductor-metal##2##2##(2008-3#2)
and metalaxyl##3##2##(2008-10#3)
and metallic##9##2##(1992-6#1)(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2012-12#1)
and metalloprotease##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
and metalloproteinase##2##2##(1992-9#1)(2009-7#1)
and metallothionein turnover in##2##4##(2008-10#2)
and metallothionein##4##2##(2008-10#2)(2008-7#2)
and metallurgical##2##2##(2008-10#2)
and metals##3##2##(1994-6#1)(2010-5#1)(2013-1#1)
and metamorphosis of##2##3##(1995-11#1)(1995-12#1)
and metapopulation##2##2##(2008-8#2)
and metastable reaction monitoring GC-MS-MS##2##5##(2008-10#2)
and metastable##3##2##(1994-3#1)(2008-10#2)
and metastases were##2##3##(2010-3#2)
and metastases##7##2##(2008-11#1)(2008-6#1)(2009-3#1)(2010-3#3)(2013-1#1)
and metastasis in##3##3##(1994-12#1)(2010-10#1)(2011-2#1)
and metastasis is##2##3##(2008-11#1)(2010-8#1)
and metastasis of##5##3##(1994-12#1)(1996-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
and metastasis to##2##3##(2010-6#1)(2012-3#1)
and metastasis##52##2##(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-9#1)(1996-10#1)(1997-4#1)(2007-10#2)(2007-11#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#3)(2009-4#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
and metastasize##2##2##(1990-8#1)(2011-2#1)
and metastatic disease##4##3##(1997-5#1)(2008-1#1)(2008-6#1)(2008-7#1)
and metastatic potential##2##3##(2008-4#1)(2011-2#1)
and metastatic progression##2##3##(2009-3#1)(2013-1#1)
and metastatic sites##2##3##(1994-7#1)(2012-3#1)
and metastatic spread of##2##4##(1990-11#1)(2010-7#1)
and metastatic tumors##3##3##(2009-9#1)(2010-9#1)(2011-2#1)
and metastatic##39##2##(1990-11#1)(1990-8#1)(1992-6#3)(1992-9#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-9#1)(1997-5#2)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-3#4)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
and metatranscriptomes##2##2##(2011-2#2)
and meteorological##3##2##(2008-2#1)(2009-7#2)
and metformin##4##2##(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
and methacholine##2##2##(1996-1#1)(2008-5#1)
and methamphetamine##3##2##(2008-10#2)(2013-1#1)
and methane utilization##4##3##(2008-6#3)(2008-7#1)
and methane##14##2##(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#5)(2008-7#3)
and methanol are##2##3##(2008-10#1)(2008-3#1)
and methanol as##4##3##(2008-10#2)(2010-12#1)(2011-1#1)
and methanol in the ratio##2##5##(2008-10#1)(2012-12#1)
and methanol in##4##3##(1991-5#2)(2008-10#1)(2012-12#1)
and methanol was##2##3##(1995-2#1)(2008-10#1)
and methanol were##3##3##(1995-2#1)(2007-11#1)(2008-10#1)
and methanol##25##2##(1990-2#1)(1991-5#2)(1993-11#1)(1995-2#2)(1996-5#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
and methanol)##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
and methcathinone##2##2##(1995-2#2)
and methionine##3##2##(1994-9#1)(2008-10#1)(2011-1#1)
and methocarbamol##2##2##(2008-10#2)
and method for##3##3##(1995-1#1)(2007-11#1)(2008-12#1)
and method of##6##3##(1996-12#1)(2007-12#1)(2008-1#1)(2009-9#1)(2010-8#1)(2011-1#1)
and method##21##2##(1995-1#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)
and methodical##2##2##(2008-10#1)(2008-8#1)
and methodological##8##2##(2008-4#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#1)
and methodologies##6##2##(1993-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and methodology for##2##3##(1992-3#1)(2008-10#1)
and methodology to##2##3##(2008-7#1)(2010-8#1)
and methodology##13##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)
and methods The##2##3##(2012-12#2)
and methods are##2##3##(2008-4#1)(2010-11#1)
and methods for determining##2##4##(1992-9#1)(2008-4#1)
and methods for##25##3##(1992-3#1)(1992-9#1)(1997-3#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#5)(2008-9#3)(2009-10#1)(2009-5#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
and methods in surgical##2##4##(2010-8#1)(2012-3#1)
and methods of##24##3##(1991-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-10#4)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
and methods to##11##3##(1991-12#1)(1994-1#1)(1997-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)
and methods used to##4##4##(1991-2#1)(1993-2#1)(2008-2#1)(2008-3#1)
and methods used##8##3##(1991-2#1)(1993-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2013-8#1)
and methods##282##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-1#2)(1997-3#2)(1997-6#1)(2006-10#2)(2006-6#1)(2006-8#3)(2007-10#8)(2007-11#79)(2007-7#2)(2007-8#35)(2008-1#3)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#9)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#28)(2012-3#3)(2013-1#12)(2013-8#3)
and methotrexate (MTX)##2##3##(2008-10#1)(2012-3#1)
and methotrexate##8##2##(1991-8#1)(2006-10#2)(2008-10#2)(2010-3#1)(2012-3#2)
and methyl jasmonate##2##3##(2008-10#2)
and methyl mercury##4##3##(2008-10#4)
and methyl##23##2##(1990-9#1)(1992-12#1)(1994-3#1)(1994-8#2)(1995-11#2)(1995-2#1)(1996-5#1)(2007-1#1)(2007-11#1)(2008-10#10)(2008-5#1)(2009-12#1)
and methylated##4##2##(1991-9#1)(2008-10#3)
and methylation analysis##3##3##(1992-12#1)(1995-11#1)(2008-11#1)
and methylation##10##2##(1990-7#1)(1992-12#1)(1992-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-11#1)(2011-9#1)
and methylation-sensitive##2##2##(1995-2#1)(2008-7#1)
and methylene blue##2##3##(2008-10#1)(2008-3#1)
and methylene chloride##2##3##(2008-10#1)(2011-1#1)
and methylene##5##2##(1997-1#1)(2008-10#2)(2008-3#1)(2011-1#1)
and methylenetetrahydrofolate##2##2##(1990-7#1)(2008-11#1)
and methylglycol chitosan##2##3##(2008-10#2)
and methylmercuric chloride##2##3##(2008-7#2)
and methylmercury chloride##2##3##(2008-10#2)
and methylmercury##9##2##(2008-10#9)
and methylparaben##3##2##(2008-10#2)(2008-5#1)
and methylphenidate##2##2##(2006-10#1)(2008-9#1)
and metoprolol##3##2##(1995-6#1)(1996-3#1)(2012-2#1)
and metribuzin##2##2##(2008-10#2)
and metrology##2##2##(2008-2#1)(2008-3#1)
and metronidazole##4##2##(1996-6#2)(2008-12#1)(2011-2#1)
and miRNA##2##2##(2008-2#1)(2012-12#1)
and mice and##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and mice splenocytes##4##3##(2008-5#4)
and mice##38##2##(1991-1#1)(1991-12#1)(1992-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#4)(2008-7#2)(2008-9#1)(2009-6#1)(2010-6#2)(2012-2#2)
and micellar electrokinetic chromatography##2##4##(1996-5#1)(2008-10#1)
and micellar solutions##2##3##(2008-10#2)
and micellar##9##2##(1993-11#1)(1994-12#1)(1996-5#2)(2008-10#5)
and miconazole##2##2##(1991-5#2)
and micro##6##2##(1990-6#1)(1996-12#1)(2008-11#1)(2008-9#1)(2010-9#1)(2012-2#1)
and micro-optics##4##2##(2007-11#1)(2008-3#3)
and micro-vesiculation##2##2##(2006-6#2)
and microalbuminuria##2##2##(1995-11#1)(2013-1#1)
and microanalysis##2##2##(2008-10#2)
and microarray##3##2##(2008-2#1)(2008-4#1)(2012-2#1)
and microautoradiography##2##2##(1993-11#1)(2008-5#1)
and microbes##3##2##(1996-9#2)(2008-7#1)
and microbial biomass##2##3##(2008-10#2)
and microbial##13##2##(2008-10#8)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
and microbiologic##3##2##(1990-9#1)(2011-2#2)
and microbiological findings##2##3##(1990-6#1)(2008-5#1)
and microbiological##14##2##(1990-6#1)(1990-9#1)(1992-5#1)(1995-11#1)(1996-5#1)(2007-12#2)(2008-5#3)(2012-12#2)(2013-1#2)
and microbiologically##2##2##(1990-9#1)(2008-7#1)
and microbiologists##2##2##(1990-6#1)(2008-5#1)
and microbiology##3##2##(2008-11#2)(2008-9#1)
and microcalorimetric measurements##2##3##(1995-5#1)(2008-10#1)
and microchemical##2##2##(2008-10#1)(2008-5#1)
and microchip solid-state lasers##2##4##(2007-11#2)
and microchip##3##2##(2007-11#2)(2008-10#1)
and microcirculation##2##2##(1992-12#1)(2009-5#1)
and microfluidic##2##2##(2009-2#1)(2011-1#1)
and microglia##7##2##(1996-5#1)(2008-7#3)(2008-8#1)(2010-1#1)(2013-7#1)
and microhybrid##2##2##(2009-8#1)(2012-6#1)
and microinvasive##2##2##(2012-3#2)
and microleakage##2##2##(2013-1#2)
and microlens arrays##2##3##(2008-2#2)
and micromachining##2##2##(2007-12#2)
and micromechanical##2##2##(1997-4#2)
and micrometer##2##2##(2008-10#1)(2009-11#1)
and micronuclei##4##2##(1996-2#1)(2008-9#1)(2010-1#1)(2013-1#1)
and micronutrients##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
and microorganisms##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2010-7#1)
and microparticles##2##2##(2012-1#2)
and microroughness##2##2##(2008-3#2)
and microsatellite markers##6##3##(2008-10#4)(2008-12#1)(2013-8#1)
and microsatellite##7##2##(2008-10#5)(2008-12#1)(2013-8#1)
and microscopic examination of##3##4##(2006-10#1)(2008-10#1)(2012-7#1)
and microscopic examination##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2012-7#1)
and microscopic lesion scores##3##4##(2008-5#3)
and microscopic lesions##3##3##(1997-3#1)(2008-12#1)(2008-5#1)
and microscopic observations##2##3##(2008-10#2)
and microscopic##31##2##(1991-6#1)(1994-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#1)(2009-2#1)(2009-7#2)(2012-7#1)(2013-7#2)
and microscopically##4##2##(2007-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
and microscopy##6##2##(2007-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)
and microsequence analysis##2##3##(1991-8#1)(2008-9#1)
and microsomal b5##3##3##(1992-6#3)
and microsomal fractions##3##3##(1993-6#1)(1993-8#1)(1994-6#1)
and microsomal##9##2##(1992-6#5)(1992-8#1)(1993-6#1)(1993-8#1)(1994-6#1)
and microstructure of##4##3##(1995-6#1)(2008-5#2)(2011-2#1)
and microsurgery for##2##3##(1993-1#1)(2008-7#1)
and microtubule##6##2##(1991-1#1)(1991-5#1)(1994-5#1)(2009-10#1)(2009-12#1)(2011-2#1)
and microvascular endothelial##2##3##(1990-4#1)(2008-5#1)
and microvascular##6##2##(1990-4#1)(1990-9#1)(1992-3#1)(1994-8#1)(1997-1#1)(2008-5#1)
and microvessels##3##2##(1996-5#2)(2008-11#1)
and microwave irradiation##2##3##(2008-12#1)(2013-1#1)
and microwave##12##2##(2007-12#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#2)(2013-1#1)
and microwave-assisted digestion##3##3##(2008-10#3)
and microwave-assisted##5##2##(2008-10#5)
and mid##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
and mid-infrared spectroscopy##2##3##(2008-10#2)
and mid-infrared##3##2##(2008-10#3)
and midazolam##6##2##(1993-1#1)(1995-11#1)(2011-2#1)(2012-2#3)
and midbrain##4##2##(1996-12#1)(2008-6#1)(2013-1#1)(2013-7#1)
and middle ear##3##3##(1994-2#1)(1997-3#1)(2008-7#1)
and middle##25##2##(1992-4#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#2)
and middle-aged##7##2##(1994-6#1)(2008-3#1)(2008-7#3)(2009-12#1)(2011-2#1)
and middle-income countries##6##3##(2008-10#3)(2010-11#1)(2012-12#2)
and middle-income##8##2##(1993-3#1)(2008-10#3)(2010-11#1)(2011-2#1)(2012-12#2)
and midfacial##3##2##(2007-12#1)(2011-2#2)
and midline##2##2##(1994-3#1)(2007-12#1)
and midwife##2##2##(1995-6#1)(2013-1#1)
and might also be##2##4##(1997-3#1)(2009-6#1)
and might also##3##3##(1997-3#1)(2008-7#1)(2009-6#1)
and might be involved in the##3##6##(1993-8#1)(1994-11#1)(2013-1#1)
and might be##13##3##(1991-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#3)(2011-1#1)(2013-1#1)
and might contribute to##2##4##(2008-7#2)
and might play##2##3##(2008-7#1)(2011-2#1)
and might therefore be##2##4##(1991-12#1)(1993-12#1)
and might therefore##3##3##(1991-12#1)(1993-12#1)(1994-8#1)
and might##37##2##(1991-12#1)(1991-9#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#8)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
and migraine without aura##3##4##(2008-9#3)
and migraine##7##2##(2008-5#1)(2008-9#4)(2012-3#2)
and migrant##2##2##(1990-9#1)(2011-2#1)
and migrate##4##2##(1995-12#1)(2006-12#1)(2008-12#1)(2008-7#1)
and migration from##2##3##(2011-2#1)(2013-1#1)
and migration in##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
and migration of##8##3##(1991-12#1)(1993-5#1)(2008-10#2)(2008-4#3)(2010-8#1)
and migration##38##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-5#1)(1994-1#1)(1995-2#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
and migratory##2##2##(2008-7#1)(2010-8#1)
and mild cognitive impairment##3##4##(2008-6#1)(2010-11#1)(2012-3#1)
and mild or##2##3##(2011-1#1)(2012-2#1)
and mild traumatic##2##3##(2009-8#1)(2010-1#1)
and mild##30##2##(1991-2#1)(1993-3#1)(1994-9#1)(1996-7#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
and mildly##3##2##(1997-2#1)(2010-3#1)(2010-4#1)
and military aerosol##2##3##(2008-3#2)
and military##5##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)
and milk samples##5##3##(2008-10#2)(2011-2#1)(2012-2#2)
and milk##17##2##(1991-2#1)(1992-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
and millimeter##2##2##(2008-2#1)(2008-3#1)
and mimic##3##2##(2008-10#2)(2012-12#1)
and mimicking##2##2##(2008-7#1)(2011-1#1)
and mindfulness##2##2##(2013-1#2)
and minds##2##2##(1991-3#1)(2008-7#1)
and mineral oil##2##3##(2008-10#1)(2013-7#1)
and mineral salts##2##3##(2008-10#1)(2008-7#1)
and mineral supplementation##3##3##(1990-3#3)
and mineral water##6##3##(2008-10#6)
and mineral waters##3##3##(2008-10#3)
and mineral##30##2##(1990-3#3)(1997-3#2)(2008-10#20)(2008-11#2)(2008-7#1)(2012-2#1)(2013-7#1)
and mineralization of##2##3##(2008-11#1)(2008-12#1)
and mineralization##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2009-7#2)(2011-1#1)
and mineralocorticoid receptors##2##3##(1993-8#1)(1994-2#1)
and mineralocorticoid##4##2##(1993-8#1)(1994-2#1)(1997-1#1)(2013-1#1)
and minerals##7##2##(1994-6#2)(1996-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
and miniature##2##2##(2008-10#1)(2008-3#1)
and miniaturisation##2##2##(2008-10#1)(2008-12#1)
and miniaturization##3##2##(2008-10#2)(2010-11#1)
and miniaturized##2##2##(2008-10#1)(2013-1#1)
and minima##6##2##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
and minimal change disease##2##4##(2008-1#1)(2013-8#1)
and minimal inhibitory concentration##2##4##(2010-5#1)(2013-8#1)
and minimal residual disease##3##4##(2008-10#1)(2011-2#2)
and minimal##28##2##(1991-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-9#4)(2010-10#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#2)
and minimal-scan fan-beam##2##3##(2008-3#2)
and minimal-scan##3##2##(2008-3#3)
and minimally invasive##4##3##(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
and minimally##5##2##(2007-8#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
and minimising##2##2##(2008-10#2)
and minimization of##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
and minimize the##7##3##(1996-1#1)(1997-1#1)(2008-10#3)(2008-6#1)(2011-2#1)
and minimize##18##2##(1991-3#1)(1992-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)(2013-8#1)
and minimizes the##2##3##(2007-12#1)(2012-1#1)
and minimizes##4##2##(2007-12#1)(2008-10#2)(2012-1#1)
and minimizing risk##2##3##(2008-6#1)(2008-8#1)
and minimizing##7##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-11#1)
and minimum detectable##2##3##(1995-2#1)(2013-7#1)
and minimum of##2##3##(2008-10#1)(2008-3#1)
and minimum##22##2##(1992-9#1)(1995-2#1)(1997-3#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and mining##4##2##(2008-5#1)(2008-7#2)(2010-10#1)
and minocycline##3##2##(2008-7#2)(2010-5#1)
and minor complications in carotid##2##5##(1990-9#2)
and minor complications##4##3##(1990-9#2)(2009-3#1)(2012-2#1)
and minor##26##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-8#1)(1993-12#1)(1994-6#1)(2008-10#10)(2008-4#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
and minority##5##2##(2008-10#1)(2008-2#1)(2010-11#1)(2012-3#1)(2013-1#1)
and mirror##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
and miscarriages in##2##3##(1995-2#1)(2008-9#1)
and miscellaneous##6##2##(1996-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
and misconceptions##2##2##(2010-11#1)(2010-7#1)
and misleading##2##2##(1990-6#1)(2008-8#1)
and misoprostol to terminate##2##4##(1995-8#1)(2013-1#1)
and misoprostol##5##2##(1995-8#2)(2006-10#1)(2012-12#1)(2013-1#1)
and missed clinic##2##3##(1991-1#1)(1996-3#1)
and missed##3##2##(1991-1#1)(1996-3#1)(2008-10#1)
and missing##6##2##(1994-9#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
and mission of##3##3##(1994-2#1)(1995-2#1)(2008-7#1)
and mission##7##2##(1992-3#1)(1993-1#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-7#1)
and mistakes##2##2##(1992-1#1)(2012-3#1)
and misuse##5##2##(1991-12#1)(2008-11#1)(2013-1#3)
and mite##2##2##(2008-11#1)(2008-8#1)
and mites##3##2##(2008-10#2)(2008-8#1)
and mitigate the##2##3##(2008-11#1)(2010-8#1)
and mitigate##5##2##(2008-10#1)(2008-11#2)(2010-8#1)(2012-3#1)
and mitigation##2##2##(2012-2#1)(2012-3#1)
and mitochondria are##2##3##(2009-10#1)(2009-12#1)
and mitochondria##15##2##(1993-6#1)(2007-12#1)(2008-5#1)(2008-7#4)(2009-10#5)(2009-12#1)(2009-8#1)(2012-3#1)
and mitochondrial DNA mutations##2##4##(1996-9#2)
and mitochondrial DNA##7##3##(1996-9#2)(2008-10#4)(2011-1#1)
and mitochondrial isocitrate dehydrogenase subunit α##2##6##(2010-12#2)
and mitochondrial membrane potential##2##4##(2008-9#2)
and mitochondrial membrane##3##3##(2008-11#1)(2008-9#2)
and mitochondrial proteins##3##3##(2008-7#2)(2010-11#1)
and mitochondrial##40##2##(1991-5#4)(1992-10#2)(1993-2#1)(1995-8#1)(1996-2#1)(1996-9#2)(1997-7#1)(2007-10#1)(2008-10#9)(2008-11#2)(2008-7#4)(2008-9#4)(2010-11#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#2)
and mitogenesis##4##2##(1997-7#3)(2008-4#1)
and mitogenic##3##2##(1996-2#1)(2008-9#1)(2010-12#1)
and mitogens##2##2##(1996-2#1)(2009-5#1)
and mitomycin C##4##3##(1990-2#2)(1993-9#1)(1995-8#1)
and mitomycin##6##2##(1990-2#2)(1993-9#1)(1995-5#2)(1995-8#1)
and mitosis##4##2##(1993-6#1)(1995-11#1)(2008-7#1)(2012-2#1)
and mitotic index##2##3##(1995-6#1)(2012-3#1)
and mitotic##10##2##(1990-11#1)(1991-9#1)(1993-9#1)(1995-6#1)(1996-9#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
and mitral valve regurgitation##3##4##(2007-8#3)
and mitral valve surgery##2##4##(2007-8#2)
and mitral valve##6##3##(2007-8#5)(2012-3#1)
and mitral##9##2##(1995-3#1)(2007-8#7)(2012-3#1)
and mixed cultures##4##3##(1997-6#1)(2008-10#1)(2011-1#1)(2013-1#1)
and mixed inflammatory##2##3##(2007-9#1)(2013-8#1)
and mixed pollination systems##2##4##(2009-8#2)
and mixed types##2##3##(1990-2#1)(2009-7#1)
and mixed with a##2##4##(2008-10#1)(2008-8#1)
and mixed with##7##3##(1994-1#1)(2008-10#4)(2008-8#1)(2012-3#1)
and mixed##41##2##(1990-2#1)(1991-9#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-9#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and mixing with##2##3##(2008-10#1)(2008-11#1)
and mixing##6##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#1)
and mixture##4##2##(2008-10#2)(2010-3#2)
and mixtures of##3##3##(2008-10#3)
and mixtures##10##2##(1990-8#1)(2008-10#9)
and mlt2##2##2##(2012-3#2)
and mobile phase B##2##4##(2008-5#1)(2011-1#1)
and mobile phase##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
and mobile##15##2##(1995-6#1)(1996-5#1)(2008-10#2)(2008-5#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-5#1)
and mobilisation##2##2##(1997-7#1)(2008-7#1)
and mobility of##4##3##(1995-12#1)(2008-10#2)(2008-4#1)
and mobility##11##2##(1995-12#1)(2008-10#3)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
and mobilization of the##2##4##(2008-12#1)(2013-8#1)
and mobilization of##4##3##(2008-12#1)(2009-6#1)(2013-1#1)(2013-8#1)
and mobilization##8##2##(1991-6#1)(1992-6#1)(2007-12#1)(2008-12#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
and modal##2##2##(2007-11#1)(2008-2#1)
and modalities of##2##3##(2011-2#1)(2013-8#1)
and modalities##4##2##(1993-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
and mode of action of##2##5##(2008-11#1)(2008-6#1)
and mode of action##3##4##(2008-11#1)(2008-6#2)
and mode of delivery##3##4##(2007-11#1)(2011-2#2)
and mode of speech##2##4##(2011-1#2)
and mode of spread##2##4##(2008-10#2)
and mode of##16##3##(1992-9#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2010-10#1)(2011-1#2)(2011-2#4)
and mode##23##2##(1992-9#1)(1994-6#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#2)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#4)
and model these##2##3##(2008-10#1)(2008-4#1)
and model##33##2##(1994-5#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and model-based##2##2##(2008-3#1)(2008-8#1)
and modeled theoretically##2##3##(2008-2#1)(2008-3#1)
and modeled##6##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)
and modeling of##7##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2011-1#1)
and modeling##17##2##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2011-1#1)(2012-2#1)(2013-8#1)
and modelling##2##2##(2008-11#1)(2008-8#1)
and models in##2##3##(1996-3#1)(2007-11#1)
and models to##2##3##(2008-10#1)(2008-7#1)
and models##11##2##(1993-2#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-1#1)
and moderate deficiency in##2##4##(2011-1#2)
and moderate to##4##3##(1997-8#1)(2008-10#2)(2008-7#1)
and moderate##32##2##(1991-11#1)(1994-11#1)(1995-12#2)(1996-9#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-10#4)(2008-12#2)(2008-3#3)(2008-7#2)(2008-8#3)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
and moderately##9##2##(1994-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
and moderating##4##2##(1995-1#1)(2008-11#1)(2010-1#1)(2010-12#1)
and modern##12##2##(1990-5#1)(1991-2#1)(1991-8#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-9#1)(2013-1#1)
and modes of speciation##2##4##(2010-3#1)(2013-1#1)
and modes of##4##3##(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
and modest##3##2##(1996-3#1)(2008-10#1)(2008-8#1)
and modestly##2##2##(2008-3#2)
and modification of##10##3##(1993-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-6#1)(2013-8#1)
and modification##18##2##(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-8#1)
and modifications##4##2##(1990-8#1)(2008-10#1)(2008-4#1)(2009-4#1)
and modified by##2##3##(1990-8#1)(1995-12#1)
and modified power law##2##4##(2008-10#2)
and modified radical##2##3##(1995-4#1)(2008-9#1)
and modified with##3##3##(1995-2#1)(2008-10#2)
and modified##34##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-4#1)(1997-2#1)(2006-12#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
and modifier##5##2##(2008-10#5)
and modify##7##2##(1994-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-5#1)
and modifying the##4##3##(2008-4#2)(2009-11#1)(2012-1#1)
and modifying##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-11#1)(2011-1#1)(2012-1#1)
and modularity##2##2##(2008-7#1)(2012-3#1)
and modulate##4##2##(1994-8#1)(2008-4#2)(2009-6#1)
and modulated by##3##3##(1994-11#1)(2008-5#1)(2008-7#1)
and modulated##11##2##(1994-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)
and modulates the##3##3##(2008-10#2)(2008-5#1)
and modulates##11##2##(1990-7#1)(1991-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-5#1)(2010-10#1)
and modulating the##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
and modulation of##8##3##(2007-12#2)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
and modulation transfer function##3##4##(2008-2#1)(2008-3#2)
and modulation##17##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
and modulators of##2##3##(2008-8#1)(2011-1#1)
and modulators##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
and moisture resistance##2##3##(2008-2#2)
and moisture##12##2##(1992-2#2)(1997-2#1)(2008-10#4)(2008-2#4)(2008-8#1)
and molar##6##2##(2008-10#6)
and molars##4##2##(2008-12#1)(2009-2#3)
and molds##2##2##(2011-2#1)(2013-1#1)
and mole fraction of##2##4##(2008-10#2)
and mole##3##2##(2008-10#3)
and molecular analyses were##2##4##(2008-10#2)
and molecular analyses##5##3##(1997-7#1)(2008-10#4)
and molecular analysis of##2##4##(1997-4#1)(2012-3#1)
and molecular analysis##4##3##(1997-4#1)(2008-10#1)(2008-8#1)(2012-3#1)
and molecular basis of##2##4##(1993-12#1)(2009-5#1)
and molecular basis##3##3##(1993-12#1)(2008-7#1)(2009-5#1)
and molecular biology##11##3##(1997-1#1)(2006-10#1)(2008-1#2)(2008-4#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-3#1)(2012-3#1)
and molecular changes##3##3##(1997-7#1)(2008-7#2)
and molecular characteristics##3##3##(2007-7#1)(2008-10#2)
and molecular characterization of a##4##5##(1995-6#1)(2008-10#2)(2012-12#1)
and molecular characterization of##8##4##(1995-6#1)(2008-10#5)(2012-12#1)(2012-2#1)
and molecular cloning of the##3##5##(1992-9#1)(1994-11#1)(1997-7#1)
and molecular cloning of##4##4##(1991-2#1)(1992-9#1)(1994-11#1)(1997-7#1)
and molecular data##3##3##(2007-12#1)(2008-6#1)(2010-3#1)
and molecular differences##2##3##(2008-10#1)(2013-1#1)
and molecular dynamics calculations##2##4##(1991-8#1)(1994-3#1)
and molecular dynamics##8##3##(1991-8#2)(1994-11#1)(1994-3#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
and molecular epidemiology of##2##4##(2008-10#1)(2013-1#1)
and molecular epidemiology##4##3##(2007-10#1)(2008-10#1)(2011-1#1)(2013-1#1)
and molecular events of##2##4##(1994-6#1)(2008-9#1)
and molecular events##3##3##(1994-6#1)(2008-9#1)(2010-5#1)
and molecular evolutionary##2##3##(2010-3#2)
and molecular features of##3##4##(2008-7#1)(2011-2#2)
and molecular features##6##3##(2008-10#1)(2008-7#2)(2011-2#3)
and molecular forms of##2##4##(1991-5#2)
and molecular genetic##3##3##(2008-8#1)(2010-3#1)(2011-2#1)
and molecular interactions##3##3##(1995-6#1)(2007-12#1)(2011-2#1)
and molecular levels##5##3##(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)
and molecular mapping of##2##4##(2008-10#2)
and molecular mapping##4##3##(2008-10#4)
and molecular markers were used to##2##6##(2008-10#2)
and molecular markers##4##3##(2008-10#3)(2008-5#1)
and molecular mechanical##2##3##(2008-10#1)(2008-11#1)
and molecular mechanics##4##3##(1994-3#1)(1995-5#2)(1996-5#1)
and molecular mechanism of##3##4##(2011-2#1)(2013-1#2)
and molecular mechanisms of action of agents with neurotrophic and neuroplastic properties##2##12##(2009-8#2)
and molecular mechanisms of##4##4##(1994-5#1)(2009-10#1)(2009-8#2)
and molecular mechanisms##11##3##(1994-5#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
and molecular methods##4##3##(2007-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
and molecular modeling##7##3##(1992-3#1)(1992-4#1)(1994-5#2)(1995-3#2)(1996-5#1)
and molecular modelling##3##3##(1994-11#1)(1995-3#1)(1997-2#1)
and molecular organization of the##2##5##(2008-5#1)(2013-8#1)
and molecular oxygen##2##3##(1994-6#1)(1995-5#1)
and molecular pathology of##2##4##(2007-12#1)(2008-9#1)
and molecular pathways##3##3##(2009-8#1)(2012-1#1)(2012-2#1)
and molecular properties of##4##4##(1994-3#1)(2008-10#2)(2008-2#1)
and molecular size##2##3##(1990-8#1)(2008-10#1)
and molecular structure##2##3##(2007-11#1)(2008-8#1)
and molecular structures of human progastricsin##2##6##(1995-3#2)
and molecular structures##3##3##(1995-3#2)(2012-2#1)
and molecular studies##6##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)
and molecular targets##2##3##(2011-3#1)(2012-1#1)
and molecular techniques##2##3##(2008-10#1)(2011-1#1)
and molecular variation of##2##4##(2008-10#2)
and molecular variation##3##3##(2008-10#3)
and molecular weight of##5##4##(2008-10#2)(2008-6#1)(2008-8#1)(2010-3#1)
and molecular weight##9##3##(1991-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)
and molecular##229##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#3)(1994-3#3)(1994-5#4)(1994-6#2)(1995-3#5)(1995-5#3)(1995-6#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#4)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-1#4)(2008-10#49)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#11)(2008-8#8)(2008-9#9)(2009-10#3)(2009-3#1)(2009-5#3)(2009-8#3)(2010-1#2)(2010-12#2)(2010-3#7)(2010-4#3)(2010-5#3)(2010-6#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
and molecularly##2##2##(1994-9#1)(2013-1#1)
and molecules of##2##3##(1994-2#1)(2011-1#1)
and molecules##11##2##(1994-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#3)(2013-1#1)
and molybdate##5##2##(1990-11#1)(1991-8#1)(1992-3#1)(2008-10#2)
and molybdenum in##7##3##(2008-10#7)
and molybdenum##19##2##(2008-10#19)
and molybdenum(VI) in##3##3##(2008-10#3)
and molybdenum(VI)##7##2##(2008-10#6)(2010-11#1)
and momentum##4##2##(1992-7#1)(2008-10#2)(2008-2#1)
and monensin##3##2##(1992-8#1)(1995-11#1)(2007-6#1)
and monetary##2##2##(2007-4#1)(2009-6#1)
and money to##2##3##(1995-2#1)(1996-9#1)
and money##8##2##(1995-2#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)
and monitor the##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
and monitor##15##2##(1990-3#1)(1992-3#1)(1993-2#1)(1994-1#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)
and monitored at##2##3##(2008-10#2)
and monitored by##2##3##(1993-12#1)(2008-3#1)
and monitored##17##2##(1991-3#1)(1993-12#1)(1995-12#1)(1996-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-3#1)(2012-3#1)
and monitoring in##2##3##(2007-7#1)(2013-7#1)
and monitoring of patients with##2##5##(1990-9#1)(2013-1#1)
and monitoring of the##4##4##(2008-10#1)(2011-3#1)(2012-12#1)(2012-2#1)
and monitoring of##39##3##(1990-6#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-6#2)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)
and monitoring response to##2##4##(2008-7#1)(2010-3#1)
and monitoring the##11##3##(1997-7#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#3)(2012-3#1)
and monitoring##86##2##(1990-6#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-7#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-7#2)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#3)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)
and monkeys##2##2##(1991-1#1)(2008-7#1)
and mono-##2##2##(2009-9#1)(2010-6#1)
and monoclonal antibodies to##2##4##(1992-6#1)(1993-9#1)
and monoclonal antibodies##7##3##(1992-6#1)(1993-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2012-3#1)
and monoclonal antibody production##4##4##(2008-11#3)(2011-2#1)
and monoclonal antibody##10##3##(1990-2#1)(1990-7#1)(1994-5#1)(2008-11#6)(2011-2#1)
and monoclonal##24##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(2008-11#7)(2008-4#4)(2008-5#2)(2009-11#1)(2011-2#1)(2012-3#1)
and monocyte chemoattractant protein-1##2##4##(2012-2#1)(2013-1#1)
and monocyte chemoattractant##3##3##(2010-6#1)(2012-2#1)(2013-1#1)
and monocyte##8##2##(1995-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and monocyte-derived cells##2##3##(2010-3#1)(2011-2#1)
and monocyte/macrophage##2##2##(1995-3#2)
and monocytes##10##2##(1990-5#2)(1990-7#1)(1992-12#2)(2006-6#1)(2008-4#1)(2008-9#2)(2012-1#1)
and monocytes/macrophages##3##2##(2010-1#2)(2013-8#1)
and monocytic##4##2##(1997-7#1)(2013-1#3)
and monodisperse##2##2##(1994-12#1)(2010-5#1)
and monolayer##5##2##(1990-11#1)(2007-6#1)(2008-11#3)
and monolithic##3##2##(2007-11#1)(2008-10#2)
and monomer##4##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#1)
and monomeric##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
and monomethylarsonic acid (MMA) were##2##5##(2008-10#2)
and monomethylarsonic acid##5##3##(2008-10#5)
and mononuclear##2##2##(2008-10#1)(2009-10#1)
and monophasic increase in [Ca2+]i##2##5##(1994-2#1)(1997-2#1)
and monophasic##3##2##(1994-2#1)(1995-12#1)(1997-2#1)
and monosodium glutamate##2##3##(2008-10#1)(2009-11#1)
and monounsaturated##2##2##(2009-5#1)(2013-1#1)
and mood disorders##3##3##(2008-4#1)(2009-7#2)
and mood in##2##3##(1996-7#1)(2010-12#1)
and mood##13##2##(1996-7#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
and mood-related##2##2##(2009-8#2)
and moral##6##2##(1994-9#1)(1996-2#1)(2008-11#3)(2008-12#1)
and morality in##2##3##(1997-2#1)(2009-10#1)
and morbid##2##2##(2013-1#1)(2013-7#1)
and morbidity and##2##3##(2008-7#1)(2012-2#1)
and morbidity are##3##3##(1996-12#1)(2008-7#1)(2011-2#1)
and morbidity in##7##3##(1990-8#1)(1997-4#1)(2007-2#1)(2009-5#1)(2011-2#2)(2012-12#1)
and morbidity##50##2##(1990-8#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
and more accurate##3##3##(2007-12#1)(2008-3#1)(2010-6#1)
and more aggressive##2##3##(1997-8#1)(2008-9#1)
and more and more##2##4##(1991-5#1)(2012-12#1)
and more common##3##3##(1991-5#1)(2008-5#1)(2011-2#1)
and more complex##8##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-4#1)(2012-1#1)(2012-2#1)
and more comprehensive##2##3##(1993-2#1)(1996-2#1)
and more convenient##2##3##(2008-10#1)(2011-2#1)
and more cost effective than##2##5##(2011-2#2)
and more data##2##3##(2007-11#1)(2011-2#1)
and more effective##14##3##(1991-12#3)(1994-1#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
and more efficient##5##3##(1996-3#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-7#1)
and more expensive##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
and more frequent family meals and breakfast consumption##2##8##(2013-1#2)
and more frequent family meals##3##5##(2013-1#3)
and more frequent##8##3##(1996-3#1)(2007-1#1)(2007-12#1)(2007-8#1)(2012-2#1)(2013-1#3)
and more frequently##2##3##(2008-10#1)(2013-7#1)
and more general##2##3##(1996-1#1)(2013-8#1)
and more generally in##2##4##(2008-10#1)(2010-1#1)
and more generally##4##3##(2008-10#1)(2008-9#1)(2010-1#2)
and more hospitals##2##3##(1994-1#1)(1995-2#1)
and more important##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-1#1)
and more importantly##5##3##(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
and more in the##2##4##(2011-3#1)(2013-8#1)
and more in##3##3##(2008-5#1)(2011-3#1)(2013-8#1)
and more interested in##2##4##(1997-8#1)(2011-2#1)
and more likely to be##2##5##(2008-9#1)(2009-5#1)
and more likely to have##2##5##(1992-2#1)(2011-2#1)
and more likely to##7##4##(1992-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)
and more likely##8##3##(1992-2#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)
and more limited##2##3##(1993-1#1)(2012-1#1)
and more of##3##3##(1994-1#1)(1994-2#1)(2011-2#1)
and more often##4##3##(1991-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
and more particularly##2##3##(2008-5#1)(2011-2#1)
and more positive##2##3##(1994-2#1)(2009-6#1)
and more powerful##2##3##(2008-10#1)(2008-3#1)
and more precise##2##3##(2008-10#2)
and more precisely##2##3##(2012-12#1)(2012-2#1)
and more rapid##4##3##(2008-2#1)(2012-2#2)(2013-1#1)
and more rarely##2##3##(1990-3#1)(1996-6#1)
and more realistic##3##3##(1993-12#1)(2008-5#1)(2013-8#1)
and more recent##3##3##(2008-2#1)(2008-8#1)(2010-8#1)
and more recently in##3##4##(1991-12#1)(2008-2#1)(2012-12#1)
and more recently##14##3##(1991-12#1)(1994-5#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
and more reliable than##2##4##(2008-10#1)(2010-6#1)
and more reliable##3##3##(2008-10#1)(2010-6#1)(2010-8#1)
and more reproducible##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and more research##2##3##(2008-12#1)(2012-2#1)
and more satisfied than##2##4##(2009-11#1)(2012-2#1)
and more sensitive##2##3##(1995-5#1)(2006-10#1)
and more severe##2##3##(2008-10#2)
and more sophisticated##2##3##(2007-5#1)(2012-3#1)
and more stable##5##3##(2007-5#2)(2008-10#1)(2008-11#1)(2012-3#1)
and more than 100##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
and more than 20##2##4##(2010-11#1)(2012-2#1)
and more than 4##2##4##(2007-11#1)(2008-10#1)
and more than 60%##2##4##(1996-8#1)(2008-3#1)
and more than 90%##2##4##(1994-6#1)(2008-7#1)
and more than 95% of##2##5##(2008-6#2)
and more than half##5##4##(1994-12#1)(2007-10#1)(2010-8#1)(2010-9#1)(2011-1#1)
and more than##34##3##(1990-2#1)(1990-9#1)(1991-12#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
and more to##3##3##(1996-3#1)(2008-7#1)(2012-2#1)
and more variable##4##3##(1996-2#1)(2007-8#1)(2008-3#1)(2010-8#1)
and more work##2##3##(1992-12#1)(2008-7#1)
and more##371##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#5)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-5#3)(2007-7#2)(2007-8#8)(2008-1#4)(2008-10#50)(2008-11#11)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#11)(2008-8#11)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-3#1)(2010-4#4)(2010-6#3)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#3)(2011-2#20)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#5)(2012-2#11)(2012-3#9)(2012-7#1)(2013-1#17)(2013-7#3)(2013-8#8)
and moreover##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#2)
and morphine##7##2##(1991-1#1)(1994-2#1)(1996-2#2)(2007-11#1)(2008-8#1)(2009-7#1)
and morphogenesis##2##2##(2007-12#1)(2009-5#1)
and morphogenetic##2##2##(1992-6#1)(1993-5#1)
and morpholine##2##2##(1992-8#1)(2007-11#1)
and morphologic##2##2##(2008-5#1)(2012-3#1)
and morphological analysis of##2##4##(2008-9#1)(2012-3#1)
and morphological analysis##4##3##(1997-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
and morphological aspects of##2##4##(2008-7#1)(2009-8#1)
and morphological changes in##4##4##(1991-2#1)(1992-12#1)(2009-2#1)(2013-7#1)
and morphological changes##6##3##(1991-2#1)(1992-12#1)(1997-3#1)(2009-2#1)(2011-2#1)(2013-7#1)
and morphological characters##2##3##(2008-7#1)(2009-8#1)
and morphological criteria##2##3##(2008-1#1)(2009-12#1)
and morphological features##2##3##(2008-10#1)(2008-9#1)
and morphological properties of##2##4##(2011-2#1)(2012-1#1)
and morphological##44##2##(1991-2#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2012-5#2)(2013-1#1)(2013-7#1)
and morphologically similar##2##3##(2008-10#1)(2008-8#1)
and morphologically##6##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
and morphologies##2##2##(1997-3#1)(2010-9#1)
and morphology of the##4##4##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
and morphology of##14##3##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-4#1)
and morphology##28##2##(1993-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
and morphometric traits##2##3##(2013-7#2)
and morphometric##7##2##(1996-5#1)(2008-5#1)(2008-6#1)(2013-7#3)(2013-8#1)
and morphometrical##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
and morphometry of##2##3##(1997-5#1)(2011-2#1)
and morphometry##3##2##(1997-5#1)(2011-2#1)(2013-8#1)
and mortality after##5##3##(2006-10#1)(2007-8#1)(2012-2#1)(2013-1#2)
and mortality among##4##3##(1992-5#1)(2008-1#2)(2010-8#1)
and mortality and##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-8#1)
and mortality associated with##4##4##(1993-9#1)(1996-9#1)(2007-12#1)(2012-2#1)
and mortality at 30 days##2##5##(2007-10#1)(2013-8#1)
and mortality at##4##3##(2007-10#1)(2008-8#2)(2013-8#1)
and mortality can be##3##4##(1993-12#1)(2011-2#1)(2013-1#1)
and mortality data##2##3##(2008-1#1)(2011-2#1)
and mortality due to cardiovascular##2##5##(2009-5#1)(2013-7#1)
and mortality due to##10##4##(1991-6#1)(1992-8#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#3)
and mortality due##11##3##(1991-6#1)(1992-8#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#3)
and mortality for##2##3##(2011-2#1)(2012-3#1)
and mortality from##3##3##(1993-2#1)(2010-4#1)(2011-2#1)
and mortality in these##2##4##(2008-10#1)(2013-1#1)
and mortality in##35##3##(1990-5#1)(1993-3#1)(1993-5#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
and mortality is##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
and mortality of the##12##4##(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#8)
and mortality of##22##3##(1990-2#1)(1990-5#1)(1992-11#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#8)
and mortality rate##4##3##(1994-5#1)(2006-10#1)(2008-1#1)(2008-7#1)
and mortality rates in##2##4##(2006-10#1)(2008-3#1)
and mortality rates of##2##4##(2012-2#1)(2013-1#1)
and mortality rates##8##3##(2006-10#2)(2007-10#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
and mortality risk##2##3##(2008-11#1)(2008-8#1)
and mortality was highest##2##4##(2008-6#1)(2008-7#1)
and mortality was##6##3##(1990-5#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
and mortality were##6##3##(1997-1#1)(2008-1#1)(2008-7#1)(2013-1#3)
and mortality##258##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#2)(1996-7#1)(1996-9#2)(1997-1#4)(1997-3#2)(1997-8#2)(2006-10#7)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#6)(2007-8#4)(2008-1#15)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#4)(2008-7#17)(2008-8#17)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#25)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#15)
and mosquito##2##2##(2007-12#1)(2008-8#1)
and most are##2##3##(1992-12#1)(2009-5#1)
and most important##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
and most importantly##4##3##(1997-2#1)(2008-3#1)(2010-5#1)(2013-8#1)
and most likely##2##3##(2007-2#1)(2008-8#1)
and most of the metal ions##2##6##(2008-10#2)
and most of the##13##4##(1991-11#1)(1994-6#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
and most of them had##2##5##(1990-11#1)(1991-2#1)
and most of them showed##2##5##(1992-12#1)(2010-2#1)
and most of them were##2##5##(2008-5#1)(2012-3#1)
and most of them##9##4##(1990-11#1)(1991-2#1)(1992-12#1)(1993-2#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
and most of##26##3##(1990-11#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-6#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
and most recently##2##3##(2008-10#1)(2010-8#1)
and most successful##2##3##(1994-12#1)(2013-1#1)
and most##111##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-5#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#4)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#4)
and mostly of##2##3##(2009-8#1)(2009-9#1)
and mostly viable myocardium##2##4##(2007-8#2)
and mostly##8##2##(2007-8#2)(2008-11#1)(2009-8#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-7#1)
and mother##6##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
and mother-child##2##2##(1996-1#1)(2010-7#1)
and mothers##3##2##(2009-10#1)(2009-12#1)(2010-5#1)
and motif detection##2##3##(2008-2#1)(2008-4#1)
and motilin##2##2##(1994-11#2)
and motility in vitro##2##4##(1990-4#1)(2008-12#1)
and motility of##2##3##(1992-12#1)(2009-8#1)
and motility##10##2##(1990-4#1)(1992-12#1)(2007-12#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-8#2)(2011-2#1)
and motion##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-12#1)
and motivate##2##2##(2008-11#1)(2008-12#1)
and motivated##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
and motivation of##2##3##(1990-3#1)(1997-5#1)
and motivation to##5##3##(1992-12#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
and motivation##18##2##(1990-3#1)(1992-12#1)(1992-3#1)(1994-1#2)(1997-5#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-8#2)
and motivational##2##2##(1991-1#1)(2013-1#1)
and motor block##2##3##(2012-3#2)
and motor cortex##6##3##(1991-6#4)(2008-7#1)(2011-2#1)
and motor neuron##3##3##(2008-5#1)(2013-1#2)
and motor performance##2##3##(1991-2#1)(2011-2#1)
and motor##40##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#4)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1996-5#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#6)(2009-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and motor-evoked potential##3##3##(2008-7#1)(2011-2#2)
and motor-evoked##4##2##(2008-7#1)(2010-7#1)(2011-2#2)
and motoric##2##2##(1991-6#1)(1993-11#1)
and moulds##2##2##(2008-11#1)(2013-8#1)
and mouse embryonic##2##3##(1997-4#1)(2013-1#1)
and mouse gene nomenclature##2##4##(2008-4#2)
and mouse gene##3##3##(1997-7#1)(2008-4#2)
and mouse liver##3##3##(1991-8#2)(2008-8#1)
and mouse models##2##3##(2009-3#1)(2011-9#1)
and mouse monoclonal antibodies (MAbs)##2##5##(2008-10#2)
and mouse monoclonal antibodies##3##4##(1993-12#1)(2008-10#2)
and mouse##79##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#6)(1991-8#4)(1992-11#1)(1992-6#4)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#4)(1995-6#1)(1996-5#1)(1997-4#1)(1997-7#3)(1997-9#1)(2008-10#3)(2008-3#1)(2008-4#10)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-3#1)(2010-11#1)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
and mouth in##2##3##(2008-5#1)(2010-5#1)
and mouth##15##2##(2008-11#1)(2008-12#5)(2008-5#1)(2009-10#1)(2010-5#3)(2011-2#2)(2013-8#2)
and move##4##2##(1991-9#1)(2007-5#1)(2008-10#1)(2013-8#1)
and movement in##2##3##(2008-8#1)(2010-8#1)
and movement of##4##3##(2008-10#2)(2008-7#1)(2009-10#1)
and movement protein (MP)##2##4##(2008-10#1)(2008-9#1)
and movement protein##4##3##(1997-3#1)(2008-10#1)(2008-9#2)
and movement##23##2##(1993-6#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-7#1)(2010-8#1)(2013-8#1)
and moving##6##2##(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-8#1)
and mtSSU rDNA##3##3##(2008-10#3)
and mtSSU##4##2##(2008-10#4)
and mu =##2##3##(2007-12#1)(2008-10#1)
and mu was##2##3##(1996-5#1)(2008-10#1)
and mu##7##2##(1994-2#1)(1996-5#2)(2007-12#1)(2008-10#3)
and mu(s)' of##2##3##(2008-3#2)
and mu(s)'##7##2##(2008-3#7)
and much better##2##3##(2008-10#1)(2008-2#1)
and much greater than that##2##5##(2008-10#1)(2008-11#1)
and much has been learned##2##5##(1993-12#1)(2010-9#1)
and much less##4##3##(1993-2#1)(1994-11#1)(2008-4#1)(2008-8#1)
and much more##5##3##(1994-7#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-9#1)
and much of the##3##4##(1993-11#1)(2007-12#1)(2008-3#1)
and much of##4##3##(1993-11#1)(2007-12#1)(2008-3#1)(2010-5#1)
and much smaller than##2##4##(2011-2#1)(2013-7#1)
and much##30##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2013-7#1)
and mucinous carcinomas##2##3##(2006-8#1)(2011-2#1)
and mucinous##3##2##(1990-6#1)(2006-8#1)(2011-2#1)
and mucosal##10##2##(1992-6#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-2#1)
and mucous##3##2##(2010-1#1)(2012-12#1)(2013-1#1)
and mucus##2##2##(1996-1#1)(2008-4#1)
and multi-commutation##2##2##(2008-10#2)
and multiangle light scattering##2##4##(2011-2#2)
and multiband##3##2##(2008-3#3)
and multicentre##2##2##(1992-5#1)(2012-3#1)
and multicollinearity##2##2##(1994-12#1)(2008-10#1)
and multicolor##4##2##(2007-12#1)(2008-12#1)(2008-9#1)(2013-8#1)
and multicommutation##3##2##(2008-10#3)
and multicomponent##3##2##(2008-10#3)
and multidetector##3##2##(2008-6#1)(2012-2#2)
and multidimensional##3##2##(1994-1#1)(2008-10#1)(2012-2#1)
and multidisciplinary##8##2##(1993-3#1)(1995-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2009-9#1)(2010-6#1)(2012-3#1)
and multidrug resistance##4##3##(2008-11#3)(2011-2#1)
and multidrug##7##2##(1991-12#1)(2008-11#3)(2010-3#1)(2011-2#1)(2012-2#1)
and multiemission scan##2##3##(2008-10#2)
and multifactorial disease##2##3##(2008-1#1)(2009-10#1)
and multifactorial##3##2##(2008-1#1)(2009-10#1)(2011-2#1)
and multifocal##3##2##(1994-5#1)(2010-3#1)(2011-2#1)
and multifunctional##2##2##(1995-2#1)(2010-7#1)
and multilayer deposition##2##3##(2008-3#2)
and multilayer##8##2##(2007-8#1)(2008-2#2)(2008-3#5)
and multilevel##2##2##(2008-12#1)(2010-1#1)
and multilocus##3##2##(2008-10#2)(2011-2#1)
and multinucleated##2##2##(1991-11#1)(1991-12#1)
and multiphoton laser scanning microscopy##2##5##(2008-9#2)
and multiple antioxidant agents##5##4##(2008-7#5)
and multiple choice##2##3##(1991-12#1)(2012-12#1)
and multiple daily##2##3##(2009-11#2)
and multiple linear regression##3##4##(2008-10#2)(2011-2#1)
and multiple logistic regression analysis##2##5##(2008-11#2)
and multiple myeloma##2##3##(1990-9#1)(2007-11#1)
and multiple nodules##2##3##(2007-12#1)(2011-2#1)
and multiple regression##2##3##(2008-10#1)(2012-1#1)
and multiple scattering##2##3##(2008-3#2)
and multiple sclerosis##5##3##(2010-12#3)(2011-7#1)(2013-1#1)
and multiple system atrophy##4##4##(2008-7#4)
and multiple tumors##2##3##(2007-7#1)(2011-2#1)
and multiple##92##2##(1990-9#1)(1991-12#2)(1991-3#1)(1992-10#1)(1992-3#1)(1992-8#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-5#2)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and multiple-pulse##3##2##(2008-3#3)
and multiple-stage##2##2##(2008-12#1)(2011-2#1)
and multiplex##5##2##(2008-10#4)(2011-2#1)
and multiplication##6##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-7#1)
and multiplicative##3##2##(1994-9#1)(2008-3#1)(2008-7#1)
and multiplicity of##2##3##(2008-9#1)(2012-2#1)
and multiplies##2##2##(1994-12#1)(2008-10#1)
and multiply##3##2##(2008-10#3)
and multipolar##2##2##(1994-2#1)(2007-11#1)
and multistep##2##2##(2007-10#1)(2008-10#1)
and multisyringe##2##2##(2008-10#2)
and multitarget##3##2##(2008-3#3)
and multivalent frequency##2##3##(2008-5#2)
and multivalent##3##2##(2008-10#1)(2008-5#2)
and multivariate analyses indicated##2##4##(2008-9#1)(2009-4#1)
and multivariate analyses##9##3##(2007-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
and multivariate analysis were##2##4##(2012-3#1)(2013-1#1)
and multivariate analysis##5##3##(1991-8#1)(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
and multivariate calibration##15##3##(2008-10#14)(2008-3#1)
and multivariate logistic regression analyses##2##5##(2007-10#1)(2011-2#1)
and multivariate logistic regression##5##4##(2007-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
and multivariate methods##3##3##(2008-10#2)(2008-11#1)
and multivariate statistical analysis##2##4##(2010-5#1)(2012-3#1)
and multivariate statistical process analysis##2##5##(2013-8#2)
and multivariate statistical##6##3##(2008-10#2)(2010-5#1)(2012-3#1)(2013-8#2)
and multivariate statistics##3##3##(2008-10#1)(2009-10#1)(2012-1#1)
and multivariate##62##2##(1991-8#1)(1992-1#1)(1995-12#1)(2007-10#3)(2007-12#1)(2008-10#29)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
and multivitamin##2##2##(2008-10#2)
and multiwavelength##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
and municipal##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
and municipalities##3##2##(2008-7#1)(2012-12#2)
and murine IL-10##2##3##(1993-8#2)
and murine##19##2##(1990-12#1)(1991-5#1)(1992-2#2)(1992-8#1)(1993-2#3)(1993-8#3)(1994-11#1)(1994-8#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
and muscarinic receptor##2##3##(1992-3#1)(1993-12#1)
and muscarinic##5##2##(1992-11#1)(1992-3#1)(1993-12#1)(2010-4#1)(2012-3#1)
and muscle cells of##2##4##(1997-7#1)(2008-10#1)
and muscle cells##5##3##(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#1)
and muscle mass##2##3##(2008-5#1)(2008-7#1)
and muscle strength##2##3##(2008-12#1)(2009-3#1)
and muscle to##2##3##(1993-5#1)(2010-6#1)
and muscle wasting in##2##4##(1994-9#1)(2007-11#1)
and muscle weakness##2##3##(2011-1#1)(2011-2#1)
and muscle##46##2##(1992-11#1)(1992-6#1)(1992-9#2)(1993-5#2)(1994-12#1)(1994-9#1)(1995-12#2)(1996-12#1)(1997-7#2)(2006-6#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-1#1)(2009-3#1)(2010-10#2)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and muscles##11##2##(1992-5#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and muscular endurance##2##3##(2008-12#1)(2008-5#1)
and muscular##10##2##(1992-12#1)(1995-11#1)(1995-3#1)(1996-11#1)(2007-12#2)(2008-12#1)(2008-5#2)(2013-1#1)
and musculoskeletal##2##2##(1994-12#1)(2012-3#1)
and music appreciation##2##3##(2008-9#2)
and music##4##2##(1992-3#1)(1995-1#1)(2008-9#2)
and musical##2##2##(1992-3#1)(2008-9#1)
and mussel##3##2##(2008-10#3)
and mussels##2##2##(1997-4#1)(2008-10#1)
and must be addressed##2##4##(2007-12#1)(2008-11#1)
and must be considered##4##4##(2008-1#1)(2008-7#1)(2012-3#1)(2013-8#1)
and must be##19##3##(1992-5#1)(1995-5#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-8#3)
and must##29##2##(1992-5#1)(1993-1#1)(1993-11#1)(1995-5#1)(1996-3#2)(1997-3#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
and mutagenesis studies##2##3##(1995-6#1)(1996-12#1)
and mutagenesis##5##2##(1990-5#2)(1995-6#1)(1996-12#1)(2007-6#1)
and mutagenic##3##2##(1992-9#1)(1997-2#1)(2008-10#1)
and mutant enzymes##3##3##(1990-12#1)(1990-8#1)(1995-2#1)
and mutant proteins##3##3##(1990-8#1)(1991-6#1)(2008-1#1)
and mutant##28##2##(1990-12#1)(1990-8#2)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#5)
and mutants##6##2##(1990-7#1)(1995-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
and mutated##6##2##(1991-9#1)(1995-6#1)(2008-8#1)(2008-9#2)(2012-2#1)
and mutation analysis##2##3##(2008-1#1)(2008-9#1)
and mutation in the##2##4##(2008-10#1)(2008-7#1)
and mutation##9##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)
and mutational##5##2##(1994-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
and mutations in##2##3##(2011-1#1)(2011-2#1)
and mutations of##2##3##(2008-11#1)(2011-2#1)
and mutations##11##2##(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
and mutual##5##2##(1990-8#1)(1992-3#1)(1992-6#1)(2008-11#1)(2009-9#1)
and mutually##2##2##(2008-3#1)(2008-5#1)
and my##5##2##(2008-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
and myasthenia gravis##2##3##(2007-8#1)(2008-5#1)
and mycelial compatibility##2##3##(2008-10#2)
and mycelial##6##2##(2008-10#5)(2008-6#1)
and mycelium##4##2##(2008-10#4)
and mycobacterial##2##2##(1997-4#1)(2007-12#1)
and mycological##5##2##(2008-5#4)(2009-2#1)
and mycoparasitism##2##2##(2008-10#1)(2013-8#1)
and mycophenolate mofetil##2##3##(2010-12#1)(2012-3#1)
and mycophenolic acid##2##3##(1990-10#1)(2010-3#1)
and mycoses##2##2##(2011-2#2)
and mycotoxin accumulation in barley##2##5##(2008-10#2)
and mycotoxin accumulation in##3##4##(2008-10#3)
and mycotoxin accumulation##4##3##(2008-10#4)
and mycotoxin contamination##2##3##(2008-10#1)(2011-10#1)
and mycotoxin production##2##3##(2008-10#1)(2010-7#1)
and mycotoxin##9##2##(2008-10#7)(2010-7#1)(2011-10#1)
and myelin basic protein##4##4##(1994-6#1)(1996-6#1)(2008-7#1)(2008-8#1)
and myelin##6##2##(1994-6#1)(1996-5#1)(1996-6#1)(2008-7#2)(2008-8#1)
and myelodysplastic disorders##2##3##(1990-8#2)
and myelodysplastic syndromes##3##3##(2009-8#2)(2010-11#1)
and myelodysplastic##6##2##(1990-8#2)(2008-7#1)(2009-8#2)(2010-11#1)
and myeloid##2##2##(2008-10#1)(2008-11#1)
and myeloma##2##2##(1990-12#1)(2007-11#1)
and myeloperoxidase##2##2##(1991-3#1)(2008-8#1)
and myelosuppression##3##2##(1991-2#1)(2008-6#1)(2013-1#1)
and myo-inositol##2##2##(1993-6#1)(1995-6#1)
and myocardial infarction by##2##4##(1991-11#1)(2011-2#1)
and myocardial infarction##6##3##(1991-11#1)(1994-12#1)(2007-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
and myocardial##22##2##(1990-3#1)(1991-11#1)(1991-12#2)(1991-9#1)(1994-12#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-8#3)(2011-2#3)(2012-2#1)(2013-8#1)
and myogenic##2##2##(2010-12#1)(2010-8#1)
and myometrium##2##2##(1990-11#1)(1994-9#1)
and myopathy##2##2##(2008-1#1)(2013-1#1)
and myopia progression##2##3##(2010-1#2)
and myosin##8##2##(1990-5#2)(1991-5#1)(1992-2#1)(1992-9#1)(1995-12#1)(2009-9#1)(2012-3#1)
and mysteries##2##2##(2008-5#1)(2009-1#1)
and n =##2##3##(2008-10#1)(2009-2#1)
and n is##2##3##(1991-8#1)(2007-11#1)
and n##11##2##(1991-8#1)(1992-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2009-2#1)
and n-butyl##2##2##(2008-10#2)
and n-caproic acids##2##3##(2008-10#2)
and n-hexane##3##2##(2008-10#3)
and n-propanol##2##2##(2008-2#2)
and nafion chemically modified electrode##2##5##(2008-10#2)
and nail##4##2##(2007-7#1)(2008-5#1)(2010-6#1)(2011-2#1)
and nails##4##2##(2008-5#2)(2008-7#2)
and nalidixic acid##2##3##(2008-10#1)(2012-3#1)
and name##7##2##(2008-10#1)(2010-8#1)(2012-1#4)(2013-1#1)
and named as##3##3##(1990-7#1)(1996-12#1)(2008-10#1)
and named##6##2##(1990-7#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-8#1)
and names##3##2##(2008-10#1)(2012-1#2)
and nano##4##2##(2009-12#1)(2011-1#1)(2013-1#2)
and nanoindentation techniques##2##3##(2008-10#1)(2008-3#1)
and nanoparticle##3##2##(2008-8#1)(2009-11#1)(2013-1#1)
and nanoparticles##2##2##(1997-1#1)(2008-10#1)
and nanorings##2##2##(2010-4#2)
and nanostructured##3##2##(2008-10#2)(2009-12#1)
and nanotechnology##6##2##(1994-8#1)(2008-10#1)(2008-7#2)(2010-7#1)(2011-2#1)
and nanotubes##3##2##(2008-7#3)
and naphazoline##3##2##(2008-10#3)
and naphthalene##7##2##(2008-10#7)
and naphtho[2##2##2##(1990-7#2)
and narasin##6##2##(2007-6#6)
and narrow##11##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
and narrow-band##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
and narrowing of the##2##4##(1992-5#1)(2008-7#1)
and narrowing of##3##3##(1992-5#1)(2007-11#1)(2008-7#1)
and nasal obstruction##2##3##(2008-2#1)(2011-1#1)
and nasal##15##2##(1993-2#1)(1997-3#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
and nasopharyngeal##2##2##(1995-5#1)(2012-1#1)
and national economic indicators##3##4##(1991-1#1)(1991-2#1)(1992-2#1)
and national guidelines##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
and national##29##2##(1991-1#1)(1991-2#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-8#1)(1997-3#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-1#1)
and nationally##3##2##(1996-5#1)(2012-3#1)(2013-1#1)
and native gel electrophoretic analysis##2##5##(2008-4#2)
and native##11##2##(1993-11#1)(1995-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-8#1)
and natriuretic##2##2##(1994-8#1)(2013-7#1)
and natural forests##2##3##(2008-10#1)(2012-2#1)
and natural history of##4##4##(2007-11#1)(2008-11#2)(2008-7#1)
and natural history##5##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)
and natural killer (NK) cell activity were evaluated in##2##9##(2008-10#2)
and natural killer (NK)##3##4##(2008-10#2)(2012-3#1)
and natural killer cell##4##4##(1995-3#2)(2008-10#2)
and natural killer cells##5##4##(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
and natural killer##13##3##(1995-3#2)(2006-10#1)(2007-8#1)(2008-10#5)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
and natural selection##4##3##(2010-5#1)(2012-3#3)
and natural water samples##2##4##(2008-10#2)
and natural water##3##3##(2008-10#3)
and natural##77##2##(1991-1#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#2)(1996-3#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#29)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
and naturally contaminated##2##3##(2008-10#1)(2011-1#1)
and naturally occurring##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
and naturally##11##2##(2008-10#6)(2008-3#1)(2008-5#2)(2008-9#1)(2011-1#1)
and nature of the##4##4##(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)
and nature of##13##3##(1992-3#1)(1993-11#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
and nature##15##2##(1992-3#1)(1993-11#1)(1993-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
and nausea and vomiting##2##4##(2008-10#2)
and nausea and##3##3##(2008-10#2)(2013-1#1)
and nausea##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2010-2#1)(2012-2#2)(2013-1#1)
and nausea/vomiting##2##2##(1992-8#1)(2007-7#1)
and navigation##3##2##(2007-8#1)(2008-6#1)(2009-12#1)
and near infrared##6##3##(2008-10#2)(2010-4#2)(2011-1#2)
and near normal##2##3##(2008-11#1)(2010-5#1)
and near the##2##3##(1991-5#1)(1996-12#1)
and near##20##2##(1991-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
and near-IR##2##2##(2007-12#1)(2008-2#1)
and near-field##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
and near-infrared spectral regions##2##4##(2008-2#1)(2008-3#1)
and near-infrared spectral##3##3##(2008-2#2)(2008-3#1)
and near-infrared wavelengths##2##3##(2008-2#1)(2008-3#1)
and near-infrared##19##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#5)(2011-1#1)(2013-8#1)
and near-ultraviolet absorption spectrum of liquid water##3##7##(2008-2#1)(2008-3#2)
and near-ultraviolet##5##2##(1995-5#1)(2008-2#1)(2008-3#3)
and nearby##2##2##(1997-5#1)(2008-12#1)
and nearly all##5##3##(1990-7#1)(1990-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
and nearly completely inhibited##2##4##(1991-12#1)(2008-10#1)
and nearly half of##2##4##(1993-6#1)(1996-11#1)
and nearly half##3##3##(1993-6#1)(1996-11#1)(2008-10#1)
and nearly##26##2##(1990-7#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
and nebulizer##2##2##(2008-10#1)(2013-8#1)
and necessary##7##2##(1991-1#1)(1994-1#1)(1995-5#1)(1997-2#1)(2008-2#1)(2008-7#1)(2013-8#1)
and necessity##2##2##(1996-3#1)(2011-2#1)
and neck contrast-enhanced CT##4##4##(2013-1#4)
and neck contrast-enhanced##5##3##(2013-1#5)
and neck dissection##2##3##(2012-3#1)(2013-1#1)
and neck follicular dendritic cell##2##5##(2011-1#2)
and neck pain##2##3##(2008-12#1)(2008-2#1)
and neck squamous cell##4##4##(1997-7#1)(2008-2#2)(2013-8#1)
and neck surgery##3##3##(1991-4#1)(2008-12#1)(2009-7#1)
and neck to##2##3##(1995-6#1)(2008-1#1)
and neck trauma##2##3##(2010-9#2)
and neck##144##2##(1990-12#5)(1990-6#5)(1991-3#1)(1991-4#2)(1992-10#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-6#1)(1995-6#1)(1995-8#4)(1995-9#3)(1996-11#1)(1997-3#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#9)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-7#2)(2010-4#3)(2010-6#1)(2010-9#2)(2011-1#4)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#13)(2013-8#10)
and necrosis of##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
and necrosis##26##2##(1992-6#1)(1994-8#3)(2008-1#3)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2011-2#1)(2013-1#2)
and necrotic lesions that##2##4##(2008-10#2)
and necrotic lesions##3##3##(2008-10#3)
and necrotic##8##2##(2008-10#5)(2008-8#1)(2008-9#1)(2013-8#1)
and need for##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
and need to be##5##4##(2008-10#1)(2008-7#1)(2008-8#2)(2010-11#1)
and need to##6##3##(2008-10#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)
and need##18##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-6#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-1#1)
and needed##3##2##(2008-4#1)(2009-7#1)(2013-8#1)
and needing##2##2##(2008-12#1)(2011-2#1)
and needle and screw-needle biopsies of mammary tissue##2##8##(1994-5#2)
and needle##4##2##(1994-5#2)(2007-11#1)(2008-10#1)
and needles##3##2##(2008-5#1)(2008-7#2)
and needs assessment##3##3##(1994-3#2)(1997-1#1)
and needs for##3##3##(1997-1#1)(2008-6#1)(2013-8#1)
and needs further##2##3##(2011-1#1)(2012-3#1)
and needs in##2##3##(1992-3#1)(2008-7#1)
and needs of the##2##4##(1991-3#1)(1997-2#1)
and needs of##7##3##(1991-3#1)(1992-1#1)(1992-3#1)(1997-2#1)(2008-6#1)(2009-3#1)(2010-11#1)
and needs to be##3##4##(1997-8#1)(2008-10#1)(2012-3#1)
and needs to##4##3##(1997-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
and needs##35##2##(1990-3#1)(1991-3#1)(1992-1#1)(1992-3#2)(1992-4#1)(1993-1#1)(1994-3#2)(1995-1#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
and negative Goos-Hänchen shift near the##2##6##(2007-11#2)
and negative affect##3##3##(2013-8#3)
and negative attributional style##2##4##(2010-10#2)
and negative consequences##2##3##(1997-2#1)(2008-6#1)
and negative for##5##3##(1990-12#1)(2006-12#1)(2007-7#1)(2008-10#1)(2011-1#1)
and negative in##4##3##(1995-4#1)(1996-12#1)(2008-9#2)
and negative predictive value of##5##5##(2007-5#1)(2008-3#1)(2011-2#2)(2013-1#1)
and negative predictive value##9##4##(2007-5#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#4)(2013-1#1)
and negative predictive values were##3##5##(1991-4#1)(2008-12#1)(2008-3#1)
and negative predictive values##7##4##(1991-4#1)(1991-6#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)
and negative predictive##17##3##(1991-4#1)(1991-6#1)(1992-3#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-4#1)(2011-1#1)(2011-2#4)(2013-1#1)
and negative religious coping##2##4##(2008-12#2)
and negative symptoms##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
and negative##136##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-12#1)(1992-3#3)(1992-6#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-8#2)(1996-12#1)(1997-2#2)(1997-7#1)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#5)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#5)
and negatively after abuse##2##4##(2010-3#2)
and negatively charged##2##3##(2008-10#1)(2008-4#1)
and negatively correlated with##7##4##(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#1)
and negatively correlated##8##3##(2008-10#4)(2008-9#1)(2011-2#2)(2013-1#1)
and negatively related to##2##4##(1991-12#1)(2011-2#1)
and negatively to##2##3##(1997-7#1)(2008-7#1)
and negatively with##6##3##(1991-12#1)(1994-6#1)(1996-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
and negatively##32##2##(1990-5#1)(1991-12#2)(1992-9#1)(1994-6#1)(1996-7#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#1)(2010-3#2)(2010-5#1)(2011-2#4)(2013-1#3)(2013-7#1)
and neglect of##2##3##(1991-12#1)(1995-5#1)
and neglect##12##2##(1991-12#1)(1995-5#1)(1996-2#2)(2007-12#1)(2009-7#4)(2009-8#1)(2012-2#1)(2012-3#1)
and neglected##8##2##(1995-5#5)(2009-4#1)(2011-1#1)(2012-3#1)
and negligence##2##2##(1992-1#1)(1992-2#1)
and negligible##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
and negotiating##4##2##(1992-2#1)(1996-12#1)(1996-3#1)(2010-9#1)
and neighborhood frequency##2##3##(2008-11#2)
and neighborhood problems##2##3##(2009-9#2)
and neighborhood##7##2##(2008-11#2)(2009-7#2)(2009-9#2)(2011-2#1)
and neighborhoods##2##2##(1997-5#1)(1997-6#1)
and neighboring##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
and neither the##2##3##(2008-10#1)(2008-3#1)
and neither##9##2##(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-5#1)(2008-10#3)(2008-3#1)
and nematicide##2##2##(2008-10#2)
and nematode##5##2##(2008-10#1)(2008-12#2)(2008-8#1)(2013-1#1)
and nematodes##3##2##(2008-10#2)(2011-2#1)
and neocortical##3##2##(1990-5#1)(1991-10#1)(1991-5#1)
and neomycin##2##2##(1992-3#2)
and neonatal care##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
and neonatal follow-up##2##3##(2008-11#2)
and neonatal intensive care##2##4##(1994-3#1)(2008-11#1)
and neonatal rats##3##3##(1996-5#1)(1997-2#1)(2008-7#1)
and neonatal variables##2##3##(2008-12#2)
and neonatal##44##2##(1990-3#3)(1992-12#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-5#4)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)
and neoplasia##2##2##(1996-8#1)(2013-8#1)
and neoplasm##2##2##(2007-7#1)(2012-12#1)
and neoplasms##2##2##(2007-11#1)(2011-2#1)
and neoplastic cells##3##3##(1992-8#1)(1993-9#1)(2013-7#1)
and neoplastic##17##2##(1990-7#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-2#2)(1995-12#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
and neovascularization##2##2##(1992-3#1)(2010-9#1)
and nephrocalcinosis##2##2##(2008-1#1)(2011-2#1)
and nephrologists##2##2##(2007-7#1)(2008-1#1)
and nephropathy and##2##3##(1990-9#1)(2008-9#1)
and nephropathy in##2##3##(2008-9#2)
and nephropathy##10##2##(1990-9#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-9#3)(2011-2#1)(2012-2#2)
and nephrotic syndrome##2##3##(1990-10#1)(2013-8#1)
and nephrotoxic drugs##2##3##(2008-4#2)
and nerve fibres##2##3##(2008-5#1)(2013-8#1)
and nerve injury##2##3##(2010-8#1)(2011-2#1)
and nerve##16##2##(1995-12#1)(1996-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
and nerves##6##2##(1995-12#1)(1996-3#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
and nervous system##2##3##(1995-8#1)(2008-10#1)
and nervous##5##2##(1990-5#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-7#1)
and nest##3##2##(2007-5#1)(2008-5#1)(2008-9#1)
and nested PCR##2##3##(2008-12#1)(2008-9#1)
and nested##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
and net##9##2##(1990-11#1)(1992-6#3)(1993-1#1)(2008-12#1)(2008-5#1)(2010-5#1)(2012-2#1)
and network##9##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-9#1)(2013-1#1)(2013-8#1)
and network-based##2##2##(2008-10#1)(2011-3#1)
and networking##2##2##(2008-3#1)(2012-2#1)
and networks##6##2##(1994-1#1)(2009-9#1)(2010-10#2)(2012-2#1)(2013-1#1)
and neural networks##5##3##(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)
and neural responses##3##3##(2008-11#2)(2008-7#1)
and neural tube##2##3##(1995-3#1)(2008-8#1)
and neural##30##2##(1990-11#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-12#2)(2007-8#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and neuraminidase##3##2##(1994-11#1)(2008-9#1)(2011-2#1)
and neurite extension##3##3##(1996-12#1)(2008-11#2)
and neurite outgrowth##2##3##(1991-6#1)(2008-11#1)
and neurite##7##2##(1991-6#1)(1996-12#2)(2008-11#3)(2008-7#1)
and neuroactive steroids##2##3##(2008-7#1)(2008-8#1)
and neuroactive##3##2##(2008-7#2)(2008-8#1)
and neuroanatomical##2##2##(2007-12#1)(2008-7#1)
and neurobiological bases of auditory hallucinations in schizophrenia##2##8##(2008-2#2)
and neurobiological##4##2##(2008-12#1)(2008-2#2)(2013-8#1)
and neurobiology of##2##3##(2008-12#1)(2008-6#1)
and neurobiology##3##2##(2008-12#1)(2008-4#1)(2008-6#1)
and neurochemical effects##2##3##(1992-7#1)(1997-2#1)
and neurochemical##10##2##(1992-7#2)(1993-6#1)(1997-2#1)(2008-4#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
and neurocognitive endophenotypes##2##3##(2010-1#2)
and neurocognitive##3##2##(2009-10#1)(2010-1#2)
and neurodegeneration##6##2##(2008-7#1)(2010-11#1)(2010-2#2)(2012-3#1)(2013-8#1)
and neurodegenerative disease##2##3##(2012-2#1)(2013-7#1)
and neurodegenerative diseases##4##3##(1992-12#1)(2009-2#1)(2011-2#1)(2012-1#1)
and neurodegenerative disorders##3##3##(2008-7#1)(2010-2#1)(2012-1#1)
and neurodegenerative##10##2##(1992-12#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-2#1)(2011-9#1)(2012-1#2)(2012-2#1)(2013-7#1)
and neuroendocrine##14##2##(1992-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2011-2#1)
and neurofibromatosis type 1##2##4##(2011-1#1)(2012-3#1)
and neurofibromatosis type##3##3##(2008-9#1)(2011-1#1)(2012-3#1)
and neurofilaments##2##2##(1990-8#1)(1993-9#1)
and neurogenic##7##2##(2007-12#1)(2008-11#3)(2008-5#1)(2012-1#1)(2013-7#1)
and neurohormonal##2##2##(1996-6#1)(2008-3#1)
and neuroimaging##5##2##(2007-10#2)(2008-11#2)(2008-8#1)
and neurologic deficits##3##3##(2007-10#2)(2012-3#1)
and neurologic##7##2##(2007-10#2)(2007-11#1)(2008-7#1)(2010-1#1)(2012-3#2)
and neurological deficits##3##3##(1996-11#1)(2008-12#1)(2011-2#1)
and neurological disorders##4##3##(1994-11#1)(2008-10#1)(2009-3#1)(2011-2#1)
and neurological mechanisms##2##3##(1990-11#1)(2007-8#1)
and neurological##30##2##(1990-11#1)(1992-11#1)(1993-1#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-6#1)(2008-7#4)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
and neurologically##3##2##(1995-12#1)(2009-10#1)(2011-2#1)
and neurologists##3##2##(2006-7#1)(2008-4#1)(2008-6#1)
and neurology##4##2##(2008-1#1)(2008-4#1)(2008-6#1)(2010-12#1)
and neuromedin N##3##3##(1994-8#1)(1996-2#2)
and neuromuscular control##2##3##(2007-11#2)
and neuromuscular disease##2##3##(2008-5#2)
and neuromuscular##5##2##(2007-11#2)(2008-5#2)(2012-3#1)
and neuromyelitis optica##4##3##(2011-1#2)(2012-3#2)
and neuron-glial interactions##2##3##(2008-7#2)
and neuron-specific enolase##4##3##(1996-5#1)(2009-8#1)(2011-2#2)
and neuronal NOS##2##3##(2008-10#1)(2009-10#1)
and neuronal ascorbate##2##3##(2008-2#2)
and neuronal cell##2##3##(1996-12#1)(2008-4#1)
and neuronal networks##2##3##(1990-5#1)(2013-1#1)
and neuronal##26##2##(1990-5#1)(1991-6#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#2)(2009-10#3)(2010-2#1)(2012-2#1)(2013-1#2)
and neurons in##2##3##(1996-12#1)(2008-5#1)
and neurons##11##2##(1996-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)
and neuropathic##3##2##(2008-7#1)(2009-12#2)
and neuropathologic aspects##2##3##(2008-4#1)(2008-7#1)
and neuropathological##2##2##(1996-11#1)(2008-7#1)
and neuropathy has been found to be##2##7##(2012-2#2)
and neuropathy##6##2##(1996-12#1)(2012-2#5)
and neuropeptide Y##4##3##(1990-5#1)(1994-8#1)(1995-11#1)(1997-1#1)
and neuropeptide##5##2##(1990-5#1)(1994-8#2)(1995-11#1)(1997-1#1)
and neuropeptides##4##2##(1995-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
and neurophysiological##3##2##(2007-8#1)(2008-9#1)(2013-8#1)
and neuroprotection##4##2##(2008-1#1)(2008-10#1)(2009-6#1)(2013-8#1)
and neuroprotective effects##2##3##(2012-12#1)(2013-8#1)
and neuroprotective##6##2##(2007-9#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and neuropsychiatric##4##2##(2008-1#1)(2008-2#1)(2012-12#1)(2013-7#1)
and neuropsychological deficits##2##3##(2007-10#1)(2010-12#1)
and neuropsychological##9##2##(1994-6#1)(1996-7#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)
and neuroscience##3##2##(1997-6#1)(2008-11#1)(2013-1#1)
and neurotoxic##3##2##(1993-6#1)(2008-12#1)(2008-7#1)
and neurotransmitter##4##2##(1996-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
and neurotransmitters##3##2##(1995-2#1)(2008-10#2)
and neurotrophic factors##2##3##(2008-7#1)(2013-7#1)
and neurotrophic##4##2##(2008-7#2)(2013-1#1)(2013-7#1)
and neurotrophins##2##2##(1994-8#1)(2008-5#1)
and neurovascular##2##2##(2008-3#1)(2011-2#1)
and neutral markers##2##3##(2008-10#1)(2012-3#1)
and neutral##22##2##(1990-5#2)(1990-8#1)(1992-10#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-2#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-3#3)
and neutron diffraction##2##3##(1991-5#1)(2010-7#1)
and neutron##3##2##(1991-5#1)(2008-10#1)(2010-7#1)
and neutropenia##4##2##(2006-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
and neutrophil##4##2##(1994-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
and neutrophils##6##2##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
and never##6##2##(1992-6#1)(1993-11#1)(2007-7#1)(2008-10#2)(2008-3#1)
and nevoid basal cell carcinoma##2##5##(1997-3#1)(2007-12#1)
and new and##2##3##(2008-3#1)(2012-2#1)
and new applications##2##3##(1992-11#1)(2012-2#1)
and new approaches to##2##4##(1992-3#1)(2012-2#1)
and new approaches##5##3##(1992-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2012-2#1)
and new developments in the##2##5##(1990-6#1)(2008-1#1)
and new methods##2##3##(1994-6#1)(2008-8#1)
and new methylene blue##2##4##(2008-10#2)
and new research##2##3##(1995-6#1)(2009-10#1)
and new surgical##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
and new technologies##2##3##(1993-2#1)(2010-11#1)
and new therapeutic##2##3##(1997-3#1)(2009-8#1)
and new therapies##4##3##(2007-12#1)(2008-7#1)(2009-8#1)(2010-5#1)
and new##115##2##(1990-6#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-4#2)(1997-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#4)(2010-11#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#2)
and newborn infants##2##3##(1990-8#1)(2010-11#1)
and newborn##11##2##(1990-8#2)(1992-8#1)(1993-3#1)(1994-5#1)(1996-2#1)(2008-5#2)(2009-9#1)(2010-11#2)
and newer##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
and newly emerged##2##3##(2008-10#2)
and newly##10##2##(1997-4#1)(2008-10#5)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
and news##3##2##(1991-2#1)(2007-2#1)(2010-8#1)
and newsletter##2##2##(1996-12#1)(2008-4#1)
and next##3##2##(2007-11#1)(2008-4#1)(2011-2#1)
and nicardipine##2##2##(1990-12#1)(1996-2#1)
and nickel by flame atomic absorption##2##6##(2008-10#2)
and nickel by##6##3##(2008-10#4)(2008-12#2)
and nickel in brass##2##4##(2008-10#2)
and nickel in urine##2##4##(2008-10#2)
and nickel in##14##3##(2008-10#14)
and nickel were##4##3##(2008-10#4)
and nickel##46##2##(1996-12#2)(2008-10#39)(2008-12#3)(2009-12#1)(2010-11#1)
and nickel(II)##6##2##(2008-10#6)
and nicotinamide adenine dinucleotide##2##4##(1997-2#1)(2008-5#1)
and nicotinamide adenine##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
and nicotinamide##6##2##(1994-8#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
and nicotine##14##2##(1992-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-6#3)(2009-7#6)(2013-8#1)
and nicotinic acid##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
and nicotinic receptors##2##3##(1994-5#1)(1995-11#1)
and nicotinic##7##2##(1990-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
and nifedipine##3##2##(1994-11#2)(2009-12#1)
and night classes##2##3##(1992-3#1)(2008-9#1)
and night sweats##2##3##(1997-4#1)(2008-11#1)
and night##16##2##(1992-3#1)(1995-10#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-9#1)(2009-5#2)(2010-2#1)(2011-2#2)
and nighttime##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
and nilotinib##2##2##(2011-2#1)(2012-12#1)
and nine healthy##2##3##(2010-12#1)(2013-1#1)
and nine months##2##3##(1992-5#1)(1993-1#1)
and nine of##2##3##(1993-2#1)(2008-10#1)
and nine on##2##3##(2008-5#1)(2008-6#1)
and nine patients with##2##4##(2007-8#1)(2008-7#1)
and nine##37##2##(1990-11#1)(1990-3#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-2#2)(1993-3#2)(1995-11#1)(1995-6#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and ninety##2##2##(1995-6#1)(2008-12#1)
and nioxime##2##2##(2008-10#2)
and nisin##2##2##(2008-6#1)(2011-2#1)
and nitrate ester explosives##2##4##(2008-10#2)
and nitrate in##15##3##(2008-10#15)
and nitrate removal##2##3##(2008-12#2)
and nitrate using##3##3##(2008-10#3)
and nitrate were##2##3##(2008-10#2)
and nitrate##50##2##(1992-6#1)(1993-3#1)(1994-5#1)(2008-10#43)(2008-12#3)(2008-7#1)
and nitrates##3##2##(1994-3#1)(2006-8#1)(2008-10#1)
and nitrendipine##3##2##(1994-8#1)(1996-5#1)(2008-10#1)
and nitric acid##2##3##(2008-10#2)
and nitric acids##2##3##(2008-10#2)
and nitric oxide (NO)##6##4##(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)
and nitric oxide synthase##2##4##(1995-12#1)(1996-5#1)
and nitric oxide##17##3##(1995-12#1)(1996-5#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-3#1)
and nitric##22##2##(1995-12#1)(1996-5#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-6#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-3#1)
and nitrite (NO(2)(-))##3##3##(2008-10#3)
and nitrite anion##2##3##(1996-2#2)
and nitrite in##4##3##(2008-10#4)
and nitrite on##2##3##(1990-6#1)(2008-10#1)
and nitrite production##3##3##(1996-12#3)
and nitrite was##4##3##(1990-6#1)(2008-10#3)
and nitrite were##2##3##(1996-2#1)(2008-10#1)
and nitrite##36##2##(1990-6#4)(1993-8#2)(1996-12#3)(1996-2#3)(2008-10#24)
and nitrite/nitrate##3##2##(2008-10#2)(2010-5#1)
and nitro groups##2##3##(1996-5#1)(2010-11#1)
and nitrogen balance##2##3##(2008-12#1)(2008-3#1)
and nitrogen utilization##2##3##(2012-2#1)(2012-3#1)
and nitrogen##41##2##(1990-5#1)(1991-5#1)(1992-12#1)(1996-12#1)(1996-2#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)
and nitrogen-deficient##2##2##(2008-6#2)
and nitroprusside##2##2##(2008-10#1)(2008-3#1)
and nitrous oxide anaesthesia##2##4##(1996-6#2)
and nitrous oxide##6##3##(1991-6#1)(1992-3#1)(1996-6#3)(2008-7#1)
and nitrous##7##2##(1991-6#1)(1992-3#1)(1996-6#3)(2008-10#1)(2008-7#1)
and nivalenol (NIV)##2##3##(2008-10#2)
and nm23-H2##3##2##(1993-9#3)
and no accumulation##2##3##(2008-11#2)
and no adverse##2##3##(1993-1#1)(2008-7#1)
and no cellular##2##3##(1996-6#1)(2010-6#1)
and no change in the##2##5##(1991-11#1)(2008-5#1)
and no change in##7##4##(1991-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
and no chemical treatment##2##4##(2008-10#2)
and no correlation##2##3##(1990-2#1)(1992-2#1)
and no data##2##3##(2008-10#1)(2013-1#1)
and no detectable##3##3##(1992-11#1)(2013-1#1)(2013-7#1)
and no difference##2##3##(1991-1#1)(2008-10#1)
and no effect##5##3##(1993-11#1)(1995-5#1)(2008-10#2)(2008-11#1)
and no evidence of##9##4##(1992-6#1)(1994-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)
and no evidence##11##3##(1992-6#1)(1994-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)(2012-3#1)
and no further##4##3##(1991-6#1)(1993-12#1)(2008-10#2)
and no genotype##2##3##(2008-10#1)(2013-1#1)
and no history of##2##4##(2007-8#1)(2008-11#1)
and no implant failed##2##4##(2013-1#2)
and no increase in##3##4##(1992-11#1)(1995-8#1)(2011-2#1)
and no maternal effect was present (P = 0##2##9##(2008-10#2)
and no more##3##3##(2008-5#1)(2010-12#1)(2011-1#1)
and no mortality##3##3##(1996-3#1)(2007-7#1)(2008-7#1)
and no obvious##2##3##(2007-10#1)(2012-2#1)
and no other relevant history##2##5##(2008-10#2)
and no other##5##3##(1990-12#1)(1991-12#1)(1997-7#1)(2008-10#2)
and no population##2##3##(2008-10#2)
and no potential for decreasing in vivo phagocytosis by the intact murine immune system##2##14##(2008-10#2)
and no previous##2##3##(1991-2#1)(2012-1#1)
and no recurrence was observed##2##5##(2008-1#1)(2011-1#1)
and no recurrence was##5##4##(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
and no recurrence##8##3##(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-8#1)(2011-1#1)
and no response##3##3##(2007-11#2)(2008-10#1)
and no serious adverse##2##4##(2008-3#1)(2011-2#1)
and no serious##4##3##(1990-11#1)(2008-3#1)(2011-2#2)
and no side##2##3##(1990-3#1)(1991-3#1)
and no significant difference at 95% confidence level##2##8##(2008-10#2)
and no significant difference was##2##5##(1996-12#1)(2011-1#1)
and no significant difference##4##4##(1996-12#1)(2008-10#2)(2011-1#1)
and no significant differences in##2##5##(1994-11#1)(2008-10#1)
and no significant differences##5##4##(1994-11#1)(2008-10#3)(2008-12#1)
and no significant##14##3##(1994-11#1)(1994-2#1)(1996-12#1)(2007-10#1)(2008-10#7)(2008-12#1)(2010-7#1)(2011-1#1)
and no signs of##2##4##(2013-1#2)
and no specific##4##3##(1992-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
and no statistically significant##2##4##(2009-7#1)(2013-1#1)
and no such##2##3##(1992-9#1)(2010-6#1)
and no systematic errors were observed##2##6##(2008-10#2)
and no transmission##2##3##(2008-10#2)
and no##275##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#76)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#10)(2009-2#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#4)
and nocturnal enuresis##2##3##(1997-5#1)(2013-8#1)
and nodes##2##2##(2008-10#2)
and nodular goiter##2##3##(2013-8#2)
and nodular##6##2##(2009-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
and noise current##3##3##(2008-3#3)
and noise suppression##2##3##(2008-7#1)(2011-1#1)
and noise##26##2##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
and noisy##2##2##(2008-3#1)(2008-9#1)
and nominal##2##2##(2008-10#1)(2008-8#1)
and non hepatic cell lines##2##5##(1990-12#2)
and non##29##2##(1990-12#2)(1991-3#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and non-Chinese##2##2##(1996-12#1)(2008-5#1)
and non-Hispanic Whites##3##3##(2009-11#1)(2010-10#2)
and non-Hispanic##5##2##(2009-11#1)(2010-10#2)(2010-12#1)(2010-3#1)
and non-alcoholic##6##2##(2008-10#1)(2013-1#5)
and non-aqueous media##2##3##(2008-10#2)
and non-aqueous##4##2##(2008-10#4)
and non-cardiac##2##2##(2007-8#1)(2012-2#1)
and non-coding regions##3##3##(1991-2#1)(2007-6#1)(2008-7#1)
and non-coding##10##2##(1991-2#1)(2007-12#1)(2007-6#1)(2008-7#4)(2010-7#1)(2011-2#1)(2012-5#1)
and non-compliance##2##2##(1990-6#1)(1997-1#1)
and non-conclusive##2##2##(2008-6#2)
and non-conducting##5##2##(2008-10#1)(2008-7#4)
and non-contact##3##2##(1997-6#1)(2008-10#1)(2009-4#1)
and non-demented##4##2##(1996-12#1)(2008-7#3)
and non-destructive##2##2##(2008-10#2)
and non-diabetic##2##2##(2011-2#1)(2012-2#1)
and non-displaced southern##2##3##(2013-1#2)
and non-displaced##4##2##(1993-11#1)(2013-1#3)
and non-drinkers##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
and non-enzymatic##7##2##(2008-10#2)(2008-5#4)(2011-2#1)
and non-fat##2##2##(2008-10#2)
and non-human primates##2##3##(1993-5#1)(1997-8#1)
and non-human##4##2##(1993-5#1)(1995-5#1)(1997-8#1)(2012-12#1)
and non-identified species##2##3##(2008-5#2)
and non-immunized##2##2##(2008-9#2)
and non-infected##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
and non-insulin-dependent##2##2##(2008-4#1)(2011-1#1)
and non-invasive measurements##2##3##(2008-5#2)
and non-invasive##15##2##(1996-2#1)(2006-6#1)(2008-10#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#2)(2010-5#1)(2010-8#1)(2011-1#1)
and non-involved##3##2##(2009-7#3)
and non-ionic surfactants##4##3##(2008-10#3)(2008-5#1)
and non-ionic##6##2##(1997-7#1)(2008-10#4)(2008-5#1)
and non-ischaemic##2##2##(1994-11#1)(2008-10#1)
and non-lacunar##2##2##(2007-10#2)
and non-linear##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
and non-medical##5##2##(1994-12#3)(2008-11#1)(2008-12#1)
and non-metastatic##4##2##(1992-9#2)(2008-4#1)(2010-3#1)
and non-moral dilemmas##2##3##(2008-11#2)
and non-nucleoside reverse transcriptase##2##4##(2007-12#1)(2011-2#1)
and non-obese##4##2##(2012-12#2)(2012-2#1)(2013-7#1)
and non-overlapping##2##2##(2008-11#1)(2008-7#1)
and non-parametric##3##2##(1997-7#2)(2008-10#1)
and non-pathogenic##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
and non-peripheral heterochromatin##2##3##(1991-12#2)
and non-pharmacological##6##2##(1992-6#1)(1993-2#1)(2009-6#1)(2009-7#1)(2011-2#2)
and non-polar##3##2##(1994-3#1)(2008-10#2)
and non-proteolytic##3##2##(1997-4#1)(2011-2#2)
and non-responders##4##2##(2007-10#1)(2010-12#1)(2012-12#2)
and non-selective##6##2##(2008-10#1)(2008-12#2)(2011-2#3)
and non-self-specific##2##2##(2013-8#2)
and non-significant##2##2##(1993-2#1)(1997-4#1)
and non-smokers##6##2##(2008-10#1)(2008-12#3)(2008-7#1)(2011-2#1)
and non-specific##5##2##(1990-11#1)(2008-10#3)(2011-2#1)
and non-sporulating bacterium##2##3##(2011-2#2)
and non-steroidal anti-inflammatory drugs##3##4##(2008-10#3)
and non-steroidal anti-inflammatory##6##3##(1991-8#1)(1995-5#1)(1995-6#1)(2008-10#3)
and non-steroidal##8##2##(1991-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#4)
and non-storing##2##2##(1994-3#2)
and non-thrust##3##2##(2008-12#3)
and non-toxic##3##2##(1991-12#1)(1996-1#1)(2008-10#1)
and non-transgenic##2##2##(2008-12#2)
and non-treatment##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
and non-union##3##2##(1994-3#2)(2012-2#1)
and non-use of##2##3##(1997-6#1)(2013-8#1)
and non-users##4##2##(2008-11#1)(2013-8#3)
and non-vaccinated##4##2##(1997-3#1)(1997-6#1)(2008-5#2)
and non-verbal##5##2##(1990-3#1)(1997-6#1)(2007-11#2)(2009-2#1)
and non-virulent##3##2##(2008-5#3)
and non-volatile##3##2##(2008-10#3)
and nonamended##2##2##(2008-10#2)
and nonaphasic##2##2##(2009-9#2)
and noncitrus hosts were##2##4##(2008-10#2)
and noncitrus hosts##3##3##(2008-10#3)
and noncitrus##4##2##(2008-10#3)(2011-2#1)
and noncoding sequences##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
and noncoding##5##2##(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
and nonconducting##2##2##(2008-10#2)
and nonconstant##2##2##(2007-12#1)(2008-2#1)
and nondestructive##5##2##(2008-3#3)(2008-8#1)(2013-8#1)
and nondiagnostic##3##2##(2008-11#3)
and none has##3##3##(1991-4#1)(1997-7#1)(2011-2#1)
and none of the##10##4##(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#1)
and none of them##2##4##(2008-12#1)(2008-7#1)
and none of##14##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
and none were##2##3##(2008-10#1)(2011-2#1)
and none##32##2##(1991-4#1)(1992-6#1)(1994-6#1)(1995-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
and nonenzymatic##2##2##(1994-11#1)(1996-9#1)
and nonfatal##2##2##(2008-3#1)(2011-2#1)
and nongenomic##2##2##(1992-12#1)(2008-4#1)
and nonglycosylated##3##2##(1991-9#1)(1992-8#2)
and nongovernmental organizations##2##3##(1996-1#1)(1996-4#1)
and nongovernmental##3##2##(1996-1#1)(1996-4#1)(2009-12#1)
and nonhuman##2##2##(1994-8#1)(1997-8#1)
and noninoculated##2##2##(2008-10#2)
and noninvasive##6##2##(2008-3#1)(2008-4#1)(2008-8#3)(2012-2#1)
and nonionic surfactants##2##3##(2008-10#1)(2008-5#1)
and nonlinear absorption##4##3##(2007-11#3)(2008-3#1)
and nonlinear in##2##3##(2008-2#2)
and nonlinear waveguides induced by optical vortex solitons##2##8##(2007-12#2)
and nonlinear##26##2##(2007-11#7)(2007-12#7)(2008-10#2)(2008-2#2)(2008-3#5)(2009-12#1)(2009-8#2)
and nonlinearity##6##2##(2007-11#1)(2008-2#2)(2008-9#2)(2010-9#1)
and nonmagnetic abrasive particles##2##4##(2008-3#2)
and nonmedical##3##2##(1997-1#2)(2013-1#1)
and nonoperative##2##2##(2009-3#1)(2010-8#1)
and nonparametric##6##2##(1997-5#1)(2008-10#1)(2009-10#3)(2012-1#1)
and nonpathogenic F##2##3##(2008-10#2)
and nonpathogenic##6##2##(2008-10#6)
and nonpathogens##3##2##(2008-10#3)
and nonpharmacological##4##2##(1991-12#1)(1992-12#1)(2008-11#2)
and nonprofit##5##2##(1994-2#1)(1995-1#2)(1995-2#1)(2008-11#1)
and nonprofits##2##2##(1994-12#1)(1994-2#1)
and nonselective##6##2##(2008-10#2)(2008-12#2)(2008-7#1)(2013-1#1)
and nonsmokers##5##2##(2008-1#1)(2008-10#2)(2009-5#1)(2012-12#1)
and nonspecific##6##2##(1991-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#1)
and nonsteroidal anti-inflammatory##3##3##(1997-1#1)(2008-10#1)(2008-7#1)
and nonsteroidal##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2009-12#1)
and nonsustained ventricular tachycardia##2##4##(1995-12#1)(2013-8#1)
and nontoxic##2##2##(1992-10#1)(2009-2#1)
and nontransgenic##2##2##(2008-10#2)
and nontreatment##2##2##(1993-11#1)(2007-12#1)
and nonuniform##2##2##(2008-2#1)(2008-6#1)
and nonwords##2##2##(1990-8#1)(2008-11#1)
and nor##2##2##(2010-10#1)(2011-2#1)
and noradrenaline (NA)##2##3##(1995-3#1)(2008-7#1)
and noradrenaline concentration after active orthostasis in##2##7##(2008-7#2)
and noradrenaline release##2##3##(2008-7#2)
and noradrenaline##7##2##(1994-9#1)(1995-3#1)(2008-7#5)
and norepinephrine##6##2##(1992-8#1)(1993-1#1)(1995-11#1)(2007-8#1)(2008-3#1)(2012-3#1)
and normal breast tissue##2##4##(1991-12#1)(2008-3#1)
and normal cells##3##3##(2008-11#2)(2008-4#1)
and normal control##2##3##(1995-5#1)(2008-1#1)
and normal groups##2##3##(1993-12#1)(2013-1#1)
and normal healthy##4##3##(1992-8#1)(1995-3#1)(2008-5#1)(2011-1#1)
and normal human##3##3##(1992-8#1)(1993-12#1)(2008-3#1)
and normal in##4##3##(1990-2#1)(2008-1#1)(2008-7#2)
and normal intelligence##2##3##(1997-3#2)
and normal plasma cells##2##4##(2010-12#2)
and normal saline##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
and normal skin##3##3##(1992-8#1)(2008-5#2)
and normal subjects##4##3##(1996-7#3)(2008-7#1)
and normal tissue##2##3##(2008-7#1)(2009-10#1)
and normal weight##3##3##(2007-12#2)(2008-6#1)
and normal##93##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-8#3)(1993-12#2)(1993-9#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-7#3)(1997-3#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
and normalization of##5##3##(1992-2#1)(1996-9#1)(2007-4#1)(2012-2#1)(2012-3#1)
and normalization##7##2##(1992-2#1)(1996-9#1)(2007-4#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
and normalized##7##2##(2008-10#1)(2008-2#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and normally##4##2##(1995-12#1)(2008-5#1)(2008-7#1)(2009-12#1)
and normative##2##2##(1997-6#1)(2008-11#1)
and normotensive subjects##3##3##(2008-10#1)(2013-8#2)
and norms##3##2##(1996-12#1)(2007-7#1)(2010-2#1)
and northern Sudanese women##2##4##(2013-1#2)
and northern blot analyses##2##4##(2008-10#2)
and northern blot##4##3##(2008-10#4)
and northern hybridization##2##3##(2008-10#2)
and northern##22##2##(1994-11#1)(2007-1#1)(2008-10#11)(2008-8#3)(2008-9#1)(2010-3#2)(2013-1#3)
and noscapine##3##2##(2008-10#3)
and nose##4##2##(1995-3#1)(2007-12#1)(2008-7#2)
and noses##2##2##(2008-7#1)(2010-4#1)
and nosocomial##2##2##(1997-3#1)(2013-1#1)
and not a##4##3##(1990-2#1)(2008-10#1)(2009-8#1)(2012-3#1)
and not all##2##3##(2012-12#1)(2013-8#1)
and not always##2##3##(1993-9#1)(2011-2#1)
and not an##2##3##(2008-4#1)(2008-6#1)
and not as##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
and not attributable to a##2##5##(2008-10#1)(2008-5#1)
and not be##2##3##(1991-12#1)(2009-11#1)
and not by##5##3##(1990-11#1)(1993-3#1)(1995-6#1)(2007-12#1)(2008-9#1)
and not considered##2##3##(2012-3#1)(2013-1#1)
and not consistent##2##3##(2008-10#2)
and not due to##7##4##(1990-5#1)(1990-8#1)(1993-12#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-5#1)
and not enough##2##3##(2007-7#1)(2013-1#1)
and not for##2##3##(2008-1#1)(2010-7#1)
and not from the##2##4##(2008-5#2)
and not from##3##3##(2008-10#1)(2008-5#2)
and not having##2##3##(2011-2#1)(2012-12#1)
and not in the##3##4##(1991-1#1)(1991-9#1)(2008-10#1)
and not in##6##3##(1991-1#1)(1991-9#1)(1995-6#1)(1997-2#1)(2008-10#2)
and not intrinsic##2##3##(2009-2#1)(2010-10#1)
and not just##2##3##(1990-4#1)(2008-5#1)
and not limited##2##3##(1993-8#1)(2008-10#1)
and not merely##5##3##(1990-8#1)(1995-2#1)(2007-8#1)(2008-7#1)(2012-3#1)
and not on the##2##4##(2008-5#1)(2008-9#1)
and not on##5##3##(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
and not only##3##3##(1994-2#1)(2008-6#1)(2012-1#1)
and not related to##2##4##(1995-11#1)(2008-10#1)
and not related##3##3##(1995-11#1)(2008-10#1)(2010-8#1)
and not require##2##3##(1990-3#1)(2013-1#1)
and not significantly different##2##4##(2008-10#2)
and not significantly##3##3##(2008-10#3)
and not simply##2##3##(1995-8#1)(2008-10#1)
and not so##2##3##(2008-5#1)(2011-2#1)
and not the##13##3##(1990-6#1)(1992-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-3#1)
and not to##9##3##(1992-2#1)(1993-12#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-12#1)
and not using##2##3##(2011-1#1)(2012-6#1)
and not via##2##3##(1992-8#1)(1993-12#1)
and not with##5##3##(1990-5#1)(1991-12#1)(2008-10#2)(2008-11#1)
and not within the##2##4##(1995-12#1)(2009-3#1)
and not##190##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#4)(1991-1#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#40)(2008-11#3)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#5)(2012-6#1)(2013-1#8)(2013-8#2)
and notable##2##2##(2008-10#1)(2009-9#1)
and note##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
and noted##2##2##(2008-5#1)(2011-2#1)
and notification##2##2##(1994-2#1)(2012-12#1)
and notified##2##2##(1991-6#1)(1997-5#1)
and novel radioprotective agent##2##4##(2011-2#2)
and novel therapeutic##3##3##(2007-7#1)(2008-4#1)(2010-10#1)
and novel##34##2##(1993-12#1)(1993-6#1)(1993-9#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#2)(2010-12#3)(2010-5#1)(2011-2#3)(2013-1#2)(2013-8#1)
and novelty##2##2##(1990-11#1)(1994-2#1)
and now we##2##3##(2008-10#1)(2009-3#1)
and now##18##2##(1991-3#1)(1993-2#1)(1996-12#1)(1996-3#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#2)
and nuclear DNA##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
and nuclear Overhauser##2##3##(1990-5#1)(1992-3#1)
and nuclear condensation##2##3##(2008-8#1)(2013-1#1)
and nuclear factor##3##3##(1994-6#2)(2010-10#1)
and nuclear fractions##2##3##(1992-3#1)(1993-8#1)
and nuclear magnetic resonance##3##4##(1990-3#1)(1995-2#1)(2008-4#1)
and nuclear medicine##5##3##(1994-2#1)(1996-2#1)(2008-8#2)(2013-1#1)
and nuclear proteins##3##3##(1993-12#1)(1993-3#1)(2008-11#1)
and nuclear size##2##3##(1993-12#1)(2012-2#1)
and nuclear volume##4##3##(2008-12#2)(2008-7#1)(2010-8#1)
and nuclear##73##2##(1990-3#2)(1990-5#1)(1992-11#1)(1992-3#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#3)(1995-2#2)(1996-2#1)(1997-7#1)(1997-8#2)(2007-4#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-8#2)(2010-10#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
and nucleated##2##2##(1996-12#1)(2011-2#1)
and nuclei##6##2##(1991-9#1)(1992-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
and nucleic acid##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
and nucleic acids##9##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
and nucleic##13##2##(1995-2#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
and nucleocapsid##2##2##(1993-12#1)(2009-7#1)
and nucleoli##2##2##(1991-12#1)(2008-10#1)
and nucleolytic activities##3##3##(1991-9#3)
and nucleoside signaling##2##3##(2008-4#2)
and nucleoside##7##2##(2008-4#5)(2008-7#1)(2010-8#1)
and nucleotide (nt)##2##3##(1993-12#1)(1994-12#1)
and nucleotide analogs##2##3##(2008-4#2)
and nucleotide sequence data##2##4##(1997-6#1)(2008-10#1)
and nucleotide sequence of##2##4##(1991-2#1)(1993-6#1)
and nucleotide sequence##5##3##(1991-2#1)(1993-6#1)(1997-6#1)(2008-10#2)
and nucleotide sequences of the##2##5##(1993-12#1)(2008-10#1)
and nucleotide sequences##4##3##(1991-5#1)(1993-12#1)(1997-3#1)(2008-10#1)
and nucleotide sequencing##2##3##(1994-12#1)(1995-12#1)
and nucleotide##19##2##(1991-2#1)(1991-5#1)(1993-12#2)(1993-6#1)(1994-12#2)(1995-12#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2010-8#1)
and nucleus accumbens##8##3##(1993-12#1)(1993-6#1)(1994-8#5)(1997-2#1)
and nucleus##17##2##(1991-12#2)(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#5)(1997-2#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-8#1)
and number concentrations##4##3##(2008-3#4)
and number of factors##4##4##(2008-10#4)
and number of health##2##4##(1990-6#1)(1992-3#1)
and number of lesions##2##4##(2008-10#2)
and number of repeated extraction with##2##6##(2008-10#2)
and number of##68##3##(1990-6#1)(1990-8#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-8#4)(2008-10#22)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#4)
and number##79##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#23)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#4)
and numbers of##7##3##(1993-8#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#1)
and numbers##10##2##(1993-8#1)(1994-3#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2013-8#2)
and numeric##3##2##(2008-7#2)(2012-2#1)
and numerical aperture##2##3##(2008-2#1)(2008-9#1)
and numerical calculations##2##3##(2007-12#1)(2008-3#1)
and numerical investigations of##2##4##(2007-12#1)(2008-2#1)
and numerical reconstruction##2##3##(2008-3#2)
and numerical responses of Stethorus gilvifrons Mulsant feeding on##2##9##(2008-12#2)
and numerical responses##3##3##(2008-12#2)(2008-8#1)
and numerical results are##3##4##(2008-2#2)(2008-3#1)
and numerical results##12##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#7)
and numerical simulation##2##3##(2007-11#1)(2008-3#1)
and numerical simulations##7##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-12#1)
and numerical##49##2##(2007-11#3)(2007-12#4)(2008-10#4)(2008-12#2)(2008-2#8)(2008-3#19)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-12#1)(2013-8#2)
and numerically analyzed##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
and numerically that##3##3##(2007-11#1)(2007-12#2)
and numerically using##2##3##(2008-10#1)(2011-2#1)
and numerically##16##2##(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#1)
and numerous other##2##3##(2008-10#1)(2011-2#1)
and numerous##19##2##(1992-1#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
and nurse education##4##3##(2008-11#2)(2008-12#2)
and nurse##14##2##(1997-5#1)(2008-1#1)(2008-11#4)(2008-12#5)(2008-3#1)(2010-4#1)(2011-1#1)
and nurse's##4##2##(1993-2#1)(1995-1#1)(2010-10#2)
and nursery##2##2##(1996-12#1)(2008-12#1)
and nurses in##3##3##(1992-12#1)(2010-4#1)(2011-2#1)
and nurses to##3##3##(1993-2#1)(1995-3#1)(2008-11#1)
and nurses who##2##3##(2008-12#1)(2009-11#1)
and nurses##26##2##(1991-2#1)(1992-12#1)(1993-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
and nurses'##5##2##(1992-2#3)(2012-3#1)(2013-8#1)
and nursing care##2##3##(1991-12#1)(2012-3#1)
and nursing home##4##3##(1992-3#1)(1993-12#1)(1994-2#1)(1995-2#1)
and nursing interventions for persons with post-op hemorrhage after tonsillectomy##2##10##(2013-1#2)
and nursing interventions of an adult with a postoperative hemorrhage##2##10##(2013-1#2)
and nursing interventions that guided nursing care during this emergency##2##10##(2013-1#2)
and nursing interventions##6##3##(2013-1#6)
and nursing##46##2##(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-2#2)(1995-9#8)(1996-1#1)(1996-6#1)(1997-3#1)(2007-11#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-7#1)(2009-11#1)(2012-2#1)(2012-3#2)(2013-1#6)
and nurturant##2##2##(1992-3#2)
and nurture##2##2##(1993-12#1)(2008-11#1)
and nutrient consumption##2##3##(2008-7#2)
and nutrient intake##5##3##(1994-12#1)(2009-4#1)(2010-6#3)
and nutrient##24##2##(1993-3#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#4)(2011-1#2)(2013-7#1)(2013-8#1)
and nutrients were##2##3##(2008-3#1)(2013-7#1)
and nutrients##9##2##(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
and nutrition of the##2##4##(2008-5#2)
and nutrition##15##2##(1991-3#1)(1992-5#1)(1993-11#1)(1995-3#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-5#1)(2012-2#1)
and nutritional condition##2##3##(2010-8#1)(2011-1#1)
and nutritional deficiencies##2##3##(1995-3#2)
and nutritional status of##2##4##(1991-12#2)
and nutritional status##5##3##(1991-12#2)(2007-12#1)(2012-12#2)
and nutritional supplement##2##3##(2008-10#1)(2008-5#1)
and nutritional supplements##3##3##(2008-10#2)(2008-5#1)
and nutritional##33##2##(1990-2#1)(1991-12#2)(1994-3#1)(1995-3#2)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)
and nutritive##2##2##(2008-10#2)
and o##2##2##(2008-10#2)
and o-nitrophenyl octyl ether##3##4##(2008-10#3)
and o-nitrophenyloctyl ether##2##3##(2008-10#2)
and o-nitrotoluene##2##2##(2008-10#2)
and o-phenylenediamine##3##2##(2008-10#3)
and oICH##2##2##(2012-3#2)
and oak##4##2##(2008-10#3)(2008-5#1)
and oat##5##2##(2008-10#3)(2011-2#2)
and obese patients##2##3##(2011-2#2)
and obese subjects##2##3##(1997-7#1)(2008-3#1)
and obese women##4##3##(2011-1#2)(2011-2#1)(2013-1#1)
and obese##21##2##(1993-11#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#3)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
and obesity are##5##3##(2008-1#1)(2008-11#1)(2012-2#2)(2013-8#1)
and obesity as##2##3##(2012-3#2)
and obesity in the##2##4##(2009-6#1)(2011-2#1)
and obesity in this##2##4##(2012-3#1)(2013-1#1)
and obesity in young black and white adults##2##8##(2011-2#2)
and obesity in young##3##4##(2011-2#3)
and obesity in##11##3##(2008-3#2)(2009-6#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
and obesity is##3##3##(2010-3#1)(2011-2#1)(2012-2#1)
and obesity of##2##3##(2008-1#1)(2010-4#1)
and obesity on the##2##4##(2010-3#1)(2013-8#1)
and obesity on##5##3##(2007-12#1)(2008-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
and obesity was##2##3##(2011-2#1)(2012-12#1)
and obesity were##4##3##(2012-12#1)(2012-3#1)(2013-8#2)
and obesity##85##2##(2007-12#3)(2008-1#6)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#4)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#15)
and obesity-related##2##2##(2008-4#1)(2011-1#1)
and object##6##2##(1993-11#1)(2008-3#2)(2008-6#1)(2009-2#1)(2013-1#1)
and objective assessments##2##3##(2007-12#1)(2013-1#1)
and objective measures of##2##4##(2007-12#1)(2008-5#1)
and objective measures##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
and objective##31##2##(1990-12#1)(1990-3#1)(1992-9#2)(1994-7#1)(1996-5#1)(1997-6#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)
and objectives##16##2##(1991-12#1)(1994-12#2)(1995-1#1)(1996-3#2)(2006-5#1)(2007-4#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#3)(2011-2#1)
and objects##3##2##(2007-8#1)(2008-11#1)(2009-10#1)
and obligate heterozygotes##2##3##(1990-8#2)
and obligations##4##2##(1997-4#1)(2008-6#2)(2012-12#1)
and oblique##4##2##(2008-3#3)(2008-9#1)
and observation of##2##3##(2007-10#1)(2013-1#1)
and observation##5##2##(2007-10#1)(2007-11#1)(2008-2#1)(2013-1#1)(2013-8#1)
and observational studies##3##3##(2008-6#1)(2009-11#1)(2012-2#1)
and observational##6##2##(2008-6#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
and observations of##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
and observations on##2##3##(2007-12#1)(2008-9#1)
and observations were used to##2##5##(2007-2#1)(2010-4#1)
and observations##13##2##(1992-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#2)(2010-4#1)
and observe##3##2##(2008-11#1)(2010-2#1)(2011-3#1)
and observed for##2##3##(1997-3#1)(2008-10#1)
and observed in##2##3##(2008-3#1)(2008-7#1)
and observed the##4##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
and observed values##3##3##(2008-10#3)
and observed##37##2##(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-2#2)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#2)
and observers##2##2##(2008-10#1)(2009-10#1)
and observing the##2##3##(2007-12#1)(2008-11#1)
and observing##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
and obsessive##2##2##(1997-6#1)(2007-8#1)
and obstacles to##2##3##(1994-2#1)(2010-11#1)
and obstacles##4##2##(1993-12#1)(1994-2#1)(2010-11#1)(2012-2#1)
and obstetric units##2##3##(2008-4#1)(2013-1#1)
and obstetric##4##2##(2008-4#1)(2010-9#1)(2013-1#2)
and obstetricians##2##2##(2008-1#1)(2013-1#1)
and obstetrics##2##2##(1990-3#1)(2007-7#1)
and obstruction##2##2##(1996-5#1)(2008-11#1)
and obstructive uropathy##2##3##(1990-8#1)(2008-1#1)
and obstructive##5##2##(1990-8#1)(2008-1#1)(2010-6#2)(2013-1#1)
and obtain an##2##3##(2008-10#1)(2008-3#1)
and obtain quantitative##2##3##(2008-10#2)
and obtain##15##2##(2008-10#6)(2008-2#2)(2008-3#3)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
and obtained a##3##3##(1990-7#1)(2007-11#1)(2008-9#1)
and obtained##24##2##(1990-7#1)(1991-6#1)(1992-8#1)(1993-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)
and obtaining##6##2##(1995-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
and obturated##2##2##(2013-1#2)
and obvious##2##2##(1997-3#1)(2008-10#1)
and occasional##9##2##(1994-3#1)(1997-3#1)(1997-6#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-11#1)(2013-8#1)
and occasionally in##2##3##(1996-5#2)
and occasionally##17##2##(1996-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
and occipital cortices##2##3##(1996-12#1)(2010-7#1)
and occipital##7##2##(1992-2#1)(1993-12#1)(1996-12#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
and occlusion of the##2##4##(1991-8#1)(2008-7#1)
and occlusion of##3##3##(1991-8#1)(2008-10#1)(2008-7#1)
and occlusion##6##2##(1991-8#1)(1996-2#1)(2008-10#2)(2008-7#1)(2013-1#1)
and occlusions##2##2##(1991-3#1)(2012-2#1)
and occlusivity##2##2##(2008-5#2)
and occupation##4##2##(1995-12#1)(2008-12#1)(2010-12#1)(2012-12#1)
and occupational exposure to##2##4##(1990-8#1)(1996-2#1)
and occupational health##2##3##(1990-6#1)(2011-1#1)
and occupational status##2##3##(1995-3#2)
and occupational therapists##3##3##(1996-2#1)(2008-11#2)
and occupational therapy##4##3##(2008-11#2)(2010-3#1)(2010-9#1)
and occupational##32##2##(1990-6#1)(1990-8#1)(1991-2#1)(1994-2#1)(1995-3#2)(1996-2#2)(1997-1#1)(2007-8#1)(2008-11#4)(2008-12#1)(2009-12#3)(2009-5#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-9#3)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and occur##6##2##(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
and occurred in##5##3##(2007-7#1)(2008-10#2)(2012-2#2)
and occurred##10##2##(1993-8#1)(1997-3#1)(2007-7#1)(2008-10#5)(2012-2#2)
and occurrence of##8##3##(2006-6#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
and occurrence##11##2##(2006-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and occurring##3##2##(1990-11#1)(2008-7#1)(2009-7#1)
and occurs in##5##3##(1996-8#1)(2008-12#1)(2008-4#2)(2012-3#1)
and occurs only in the##2##5##(2008-6#1)(2008-7#1)
and occurs##17##2##(1990-5#1)(1992-10#1)(1994-12#1)(1994-8#1)(1996-8#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#2)(2012-3#1)
and ocean##2##2##(2008-2#1)(2008-9#1)
and oceanic##3##2##(2008-2#1)(2010-8#1)(2011-2#1)
and oceanographic##2##2##(2010-5#1)(2010-8#1)
and octyl salicylate##3##3##(2008-5#3)
and octyl##5##2##(1990-2#1)(2008-5#4)
and octylphenol##3##2##(2008-10#2)(2008-11#1)
and ocular signs##2##3##(2013-1#2)
and ocular##8##2##(1990-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#2)
and odds##2##2##(2011-2#1)(2012-3#1)
and odontoglossum ringspot tobamovirus##2##4##(2008-10#2)
and odour##4##2##(1990-5#1)(2008-10#1)(2008-7#2)
and oedema##4##2##(1996-6#3)(2007-11#1)
and oestrogens##2##2##(1996-11#1)(2008-4#1)
and of 1##3##3##(2008-10#2)(2012-2#1)
and of 25##2##3##(1996-5#1)(2008-10#1)
and of a##17##3##(1990-12#1)(1991-12#1)(1993-2#1)(1993-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
and of all##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
and of an##4##3##(1994-2#1)(2008-10#1)(2008-2#2)
and of available##2##3##(1994-2#1)(2013-1#1)
and of cancer##3##3##(1990-8#1)(2008-7#1)(2010-12#1)
and of different##3##3##(2008-10#3)
and of four##2##3##(1990-6#1)(2008-10#1)
and of glucose##2##3##(1992-12#1)(2008-10#1)
and of health##2##3##(1993-11#1)(2012-3#1)
and of high quality##2##4##(1995-1#1)(2012-12#1)
and of higher##2##3##(2012-3#1)(2013-8#1)
and of human##2##3##(1991-12#1)(2008-3#1)
and of its derivatives##2##4##(2008-10#2)
and of its##11##3##(1990-6#1)(1993-9#1)(2008-10#6)(2008-2#1)(2008-8#1)(2009-12#1)
and of normal##3##3##(1993-1#1)(1993-9#1)(2008-11#1)
and of one##2##3##(2007-11#1)(2008-10#1)
and of other##4##3##(1990-9#1)(2007-10#1)(2008-10#2)
and of protein##3##3##(1993-6#1)(1995-3#1)(2012-2#1)
and of some##4##3##(2008-10#1)(2008-4#1)(2010-4#1)(2012-3#1)
and of synaptic##2##3##(1995-12#1)(2013-8#1)
and of the corresponding##3##4##(1991-6#1)(1997-3#1)(2008-3#1)
and of the effects of the##2##6##(2008-3#1)(2011-2#1)
and of the respective##2##4##(1995-2#1)(1996-5#1)
and of the surrounding##2##4##(2008-3#2)
and of the##145##3##(1990-12#2)(1990-3#1)(1990-5#3)(1990-8#2)(1991-11#4)(1991-12#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
and of their##7##3##(1990-5#2)(1991-5#1)(1991-8#1)(2008-10#1)(2008-2#1)(2009-10#1)
and of these##6##3##(1991-2#1)(1993-1#1)(1996-1#1)(2008-9#1)(2009-12#1)(2012-2#1)
and of two##4##3##(1993-11#1)(2006-6#1)(2008-11#1)(2009-2#1)
and of wild-type##2##3##(1994-5#1)(1995-2#1)
and of##541##2##(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#5)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#6)(1991-11#4)(1991-12#5)(1991-2#2)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#5)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#5)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#13)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#129)(2008-11#13)(2008-12#4)(2008-2#16)(2008-3#27)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#8)(2008-9#12)(2009-10#6)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#10)(2012-12#4)(2012-2#9)(2012-3#8)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#6)
and off##13##2##(2007-11#2)(2007-12#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-8#1)(2011-1#1)
and off-axis##2##2##(2008-3#2)
and off-label##2##2##(2008-9#1)(2010-12#1)
and off-line preconcentration##2##3##(2008-10#2)
and off-line##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
and offer a##2##3##(2007-12#1)(2008-2#1)
and offer an##3##3##(2008-11#1)(2008-6#1)(2012-2#1)
and offer new##2##3##(2012-2#1)(2013-1#1)
and offer some##3##3##(2008-10#1)(2009-12#1)(2012-3#1)
and offer the##2##3##(2008-10#1)(2008-5#1)
and offer##31##2##(1991-12#1)(1992-12#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
and offered##5##2##(1993-12#1)(2008-10#2)(2011-1#1)(2012-12#1)
and offering##3##2##(1995-1#1)(2010-10#1)(2012-2#1)
and offers a##5##3##(1991-5#1)(2007-12#1)(2008-11#1)(2009-8#1)(2010-7#1)
and offers an##3##3##(2008-3#1)(2010-9#1)(2012-3#1)
and offers guidance##2##3##(2008-4#1)(2010-9#1)
and offers some##4##3##(1991-2#1)(1992-2#1)(1993-1#1)(2008-9#1)
and offers suggestions##3##3##(1991-2#1)(1995-1#1)(1995-12#1)
and offers##36##2##(1991-2#2)(1991-5#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-12#2)(1997-3#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-3#1)
and office##2##2##(1992-4#1)(1993-3#1)
and official##4##2##(2008-10#1)(2009-7#1)(2013-1#2)
and offset##3##2##(2008-11#1)(2008-3#2)
and offspring density on offspring##2##5##(2008-9#2)
and offspring fitness components##2##4##(2008-8#2)
and offspring fitness##3##3##(2008-8#3)
and offspring##14##2##(1995-12#1)(1997-5#1)(1997-7#1)(2007-5#1)(2008-8#5)(2008-9#4)(2009-3#1)
and ofloxacin##5##2##(2008-10#5)
and often as sensitive as silver staining##2##7##(2008-2#1)(2008-4#1)
and often as##3##3##(2008-2#1)(2008-4#1)(2010-11#1)
and often in##2##3##(1994-8#1)(2009-12#1)
and often requires##2##3##(2008-3#1)(2011-2#1)
and often the##2##3##(2008-4#1)(2011-2#1)
and often with##2##3##(1997-1#1)(2007-10#1)
and often##68##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-9#1)(1994-8#2)(1995-2#1)(1996-12#1)(1997-1#2)(1997-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
and oil##11##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#6)(2010-3#1)(2011-1#1)
and okadaic acid##6##3##(1992-12#1)(1992-9#2)(1993-8#1)(1995-8#2)
and olanzapine##3##2##(2008-6#2)(2008-7#1)
and old age##3##3##(2008-1#1)(2011-1#1)(2012-3#1)
and old rats##13##3##(1991-12#3)(1994-11#1)(1994-6#3)(1994-8#1)(2008-7#4)(2009-12#1)
and old##40##2##(1990-3#2)(1991-12#3)(1994-11#1)(1994-5#2)(1994-6#5)(1994-8#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#8)(2008-8#1)(2009-12#2)(2010-11#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-7#1)
and older adult##2##3##(2010-10#1)(2013-7#1)
and older adults##7##3##(2008-11#1)(2008-3#1)(2008-4#2)(2009-10#1)(2012-1#1)(2013-1#1)
and older age##5##3##(2007-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
and older and##2##3##(1995-2#1)(2013-8#1)
and older females##2##3##(2008-4#2)
and older in##2##3##(2011-1#1)(2011-2#1)
and older men with##2##4##(2008-4#2)
and older women##4##3##(2008-3#2)(2011-2#2)
and older##65##2##(1990-3#1)(1993-12#1)(1994-2#1)(1995-2#2)(1997-1#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#5)
and older)##3##2##(1991-9#1)(1993-2#1)(2010-12#1)
and oldest##2##2##(2008-7#1)(2013-8#1)
and oleic acid##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
and oleic##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
and olfactory##8##2##(1993-6#1)(1996-12#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-8#1)
and oligodendrocytes##3##2##(1995-5#1)(2008-11#2)
and oligomerization##2##2##(1990-11#1)(1991-5#1)
and oligonucleotide##5##2##(1996-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
and oligonucleotides##5##2##(1997-7#1)(2008-4#4)
and oligoribonucleotides##2##2##(2008-4#2)
and oligosaccharide##2##2##(1997-4#2)
and oligotrophic##4##2##(2008-10#4)
and olive##3##2##(2008-10#2)(2009-5#1)
and omega-conotoxin##2##2##(1993-3#1)(1996-5#1)
and omenta##2##2##(2008-1#2)
and omentum##2##2##(2008-1#1)(2008-12#1)
and omitting##2##2##(2008-3#1)(2009-8#1)
and on 9##2##3##(2008-3#1)(2009-1#1)
and on a##14##3##(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2012-3#1)
and on antiretroviral therapy##2##4##(2012-12#2)
and on apple##2##3##(2008-10#2)
and on both##2##3##(2007-11#1)(2008-10#1)
and on day##2##3##(2006-6#1)(2011-2#1)
and on different##2##3##(2008-10#1)(2012-3#1)
and on factors that affect##2##5##(2006-6#1)(2008-10#1)
and on factors that##3##4##(2006-6#2)(2008-10#1)
and on how##5##3##(1995-3#1)(2007-12#1)(2008-11#1)(2009-7#1)(2013-1#1)
and on human##3##3##(2007-7#1)(2008-11#1)(2008-5#1)
and on in vitro##2##4##(2008-10#1)(2008-8#1)
and on its##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
and on leaves##2##3##(2008-10#2)
and on molecular##2##3##(2008-10#1)(2010-12#1)
and on skin##4##3##(1993-9#1)(2008-5#3)
and on specific##2##3##(2008-5#1)(2008-6#1)
and on the Internet##2##4##(1996-8#1)(2012-2#1)
and on the basis of##3##5##(1990-3#1)(2008-12#1)(2010-1#1)
and on the concentration of##3##5##(2008-5#1)(2008-7#1)(2012-12#1)
and on the first##2##4##(1990-2#1)(2008-1#1)
and on the local##2##4##(2007-4#1)(2008-3#1)
and on the other hand##4##5##(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
and on the other##9##4##(1991-5#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
and on the perceived usefulness and appropriateness of each instrument##2##10##(2013-1#2)
and on the presence of##2##5##(1993-12#1)(2013-1#1)
and on the same##2##4##(1994-3#1)(2008-8#1)
and on the size and##2##5##(2008-1#1)(2008-3#1)
and on the social##2##4##(2008-12#1)(2010-8#1)
and on the stability of##2##5##(1996-5#1)(2008-10#1)
and on the subsequent reaction##2##5##(1993-3#1)(2008-10#1)
and on the subsequent##4##4##(1993-3#1)(1994-8#1)(2008-10#2)
and on the surface of##2##5##(2008-10#2)
and on the surface##4##4##(2008-10#2)(2008-3#1)(2013-8#1)
and on the use of##2##5##(2008-10#1)(2008-3#1)
and on the##141##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-1#3)(2008-10#26)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#18)(2008-4#1)(2008-5#8)(2008-7#5)(2008-8#3)(2008-9#4)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
and on their##5##3##(1990-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-8#1)
and on to##2##3##(2012-1#1)(2012-3#1)
and on who##2##3##(1994-6#2)
and on##357##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#2)(1992-8#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#1)(1995-11#6)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-12#2)(2006-6#3)(2007-10#2)(2007-11#2)(2007-12#9)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#74)(2008-11#7)(2008-12#7)(2008-2#14)(2008-3#32)(2008-4#6)(2008-5#18)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#5)(2009-1#2)(2009-10#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#4)(2011-2#8)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#6)(2013-8#2)
and on-going##3##2##(2007-11#1)(2008-1#1)(2008-6#1)
and on-line##10##2##(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)
and once after the##2##4##(2007-5#1)(2009-9#1)
and once after##3##3##(2007-5#1)(2007-8#1)(2009-9#1)
and once##7##2##(1990-8#1)(1992-6#1)(2007-5#1)(2007-8#1)(2009-7#1)(2009-9#1)(2013-7#1)
and oncologists##2##2##(2008-6#1)(2012-12#1)
and oncology##6##2##(1991-2#1)(1994-3#1)(1994-5#1)(2008-11#1)(2011-2#1)(2012-3#1)
and one (1##2##3##(2007-7#1)(2007-8#1)
and one (1%)##2##3##(1997-3#1)(2008-3#1)
and one additional##2##3##(2008-10#1)(2010-12#1)
and one at##2##3##(2008-10#2)
and one by##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
and one case of##4##4##(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
and one case##7##3##(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)
and one child##3##3##(1993-2#1)(2008-9#1)(2012-2#1)
and one control##2##3##(2013-1#1)(2013-8#1)
and one cultivar##2##3##(2008-10#2)
and one death##2##3##(1997-8#1)(2013-8#1)
and one dominant##2##3##(2008-10#2)
and one each##2##3##(1995-12#1)(2008-10#1)
and one field##2##3##(2008-10#1)(2011-2#1)
and one fistula##2##3##(1993-2#1)(1996-3#1)
and one for the##4##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-2#1)
and one for##12##3##(1992-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2013-1#1)
and one from the##3##4##(2008-1#1)(2008-10#1)(2008-9#1)
and one from##11##3##(1996-6#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-9#1)
and one had##10##3##(1992-6#2)(1997-5#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#1)
and one has##2##3##(1990-6#1)(2008-10#1)
and one in the##5##4##(1990-10#1)(1992-1#1)(1994-8#1)(1995-5#1)(2011-2#1)
and one in which##2##4##(2008-8#1)(2011-2#1)
and one in##11##3##(1990-10#1)(1992-1#1)(1994-8#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#2)
and one isolate of##3##4##(2008-10#3)
and one isolate##4##3##(2008-10#4)
and one line##2##3##(2008-10#2)
and one localized##2##3##(2008-10#1)(2008-5#1)
and one month##2##3##(1991-2#1)(2008-5#1)
and one negative##2##3##(1990-11#1)(2013-7#1)
and one of its##3##4##(1996-5#1)(2008-12#1)(2008-6#1)
and one of the major##3##5##(2008-10#1)(2009-4#1)(2012-2#1)
and one of the two##2##5##(2008-10#1)(2009-10#1)
and one of the##18##4##(1996-1#1)(1996-2#2)(1997-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#2)
and one of them was##2##5##(1994-6#1)(2008-10#1)
and one of them##4##4##(1994-6#1)(2008-10#2)(2008-9#1)
and one of these##2##4##(1990-12#1)(2008-10#1)
and one of##44##3##(1990-12#1)(1992-2#1)(1994-5#1)(1994-6#1)(1996-1#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-3#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
and one on##4##3##(2008-5#2)(2011-2#1)(2013-7#1)
and one or more##3##4##(1994-2#1)(2008-10#2)
and one or##5##3##(1990-5#1)(1994-2#1)(2008-10#3)
and one other##2##3##(2008-3#1)(2008-5#1)
and one patient died from##2##5##(1996-9#1)(2008-10#1)
and one patient died##3##4##(1996-9#1)(2008-10#1)(2008-6#1)
and one patient had##4##4##(1994-11#1)(2007-7#1)(2008-6#2)
and one patient with##2##4##(1990-12#1)(1996-9#1)
and one patient##17##3##(1990-12#1)(1994-11#1)(1996-8#1)(1996-9#2)(2007-7#3)(2008-10#3)(2008-5#1)(2008-6#3)(2011-1#1)(2011-2#1)
and one putative##2##3##(1993-3#1)(1993-6#1)
and one race of##3##4##(2008-10#3)
and one sample##2##3##(2008-10#2)
and one strain of##2##4##(2008-10#1)(2008-8#1)
and one strain##3##3##(2008-10#2)(2008-8#1)
and one that##5##3##(1992-2#1)(1992-9#1)(1997-5#1)(1997-6#1)(2008-3#1)
and one third##3##3##(1990-9#1)(2007-2#1)(2010-8#1)
and one was##9##3##(1990-9#1)(1997-6#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
and one with a##3##4##(1992-1#1)(2008-9#1)(2012-1#1)
and one with##11##3##(1991-11#1)(1992-1#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#3)(2010-3#1)(2012-1#1)(2012-2#1)
and one without##2##3##(2008-7#1)(2008-8#1)
and one year##5##3##(1991-11#2)(2008-10#1)(2009-10#1)(2012-12#1)
and one##448##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#2)(1992-1#2)(1992-2#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#3)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#3)(1997-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#8)(2008-10#105)(2008-11#8)(2008-12#7)(2008-2#8)(2008-3#17)(2008-4#8)(2008-5#24)(2008-6#10)(2008-7#14)(2008-8#10)(2008-9#21)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#15)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#15)(2013-7#4)(2013-8#2)
and one-dimensional##5##2##(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)
and one-half##3##2##(1993-3#1)(1995-1#1)(2013-1#1)
and one-step etching##2##3##(2008-2#2)
and one-step##3##2##(2008-2#2)(2008-3#1)
and one-third##4##2##(1997-7#1)(1997-8#1)(2007-2#1)(2008-4#1)
and one-way ANOVA##2##3##(2008-10#1)(2010-8#1)
and ones##2##2##(2008-11#1)(2008-4#1)
and ongoing##19##2##(1993-12#1)(1995-2#1)(1996-3#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-4#1)(2012-12#2)(2012-2#1)(2013-1#2)
and online##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)
and only 10%##2##3##(1992-9#1)(1996-11#1)
and only 16##2##3##(2008-8#1)(2013-1#1)
and only 2##3##3##(1990-3#1)(2008-10#1)(2010-5#1)
and only 2%##2##3##(2008-7#1)(2008-9#1)
and only 20##2##3##(1993-2#1)(2013-1#1)
and only 3##2##3##(2008-10#1)(2011-2#1)
and only 4%##2##3##(1995-5#1)(1996-1#1)
and only 5##2##3##(1993-8#1)(2008-7#1)
and only 54% of##2##4##(2008-10#1)(2008-5#1)
and only a few cases##2##5##(2013-1#1)(2013-7#1)
and only a few patients##2##5##(2006-10#1)(2013-1#1)
and only a few##10##4##(1995-12#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-6#1)(2013-1#2)(2013-7#1)
and only a small##4##4##(1995-11#1)(2007-11#2)(2008-7#1)
and only a##17##3##(1993-2#1)(1995-11#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-2#1)(2010-6#1)(2013-1#2)(2013-7#1)
and only after##2##3##(2008-10#1)(2008-7#1)
and only eight##2##3##(2008-1#1)(2008-7#1)
and only few cases have been reported##2##7##(1991-8#1)(2007-7#1)
and only few##3##3##(1991-8#1)(2007-7#1)(2008-4#1)
and only four##2##3##(1994-2#1)(2008-8#1)
and only if##6##3##(2008-3#3)(2008-6#1)(2008-7#1)(2010-7#1)
and only in##10##3##(1990-6#1)(1991-11#1)(1992-12#1)(1993-8#1)(1994-5#1)(1996-12#1)(2007-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
and only one of the##2##5##(1991-12#1)(2007-12#1)
and only one##13##3##(1991-12#1)(1991-4#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
and only partially##2##3##(1993-6#1)(2008-10#1)
and only the second genome sequence##2##6##(2011-2#2)
and only the##11##3##(1990-10#1)(1992-3#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#4)
and only those##2##3##(2008-11#1)(2010-8#1)
and only three##2##3##(1997-5#1)(2007-12#1)
and only two##2##3##(1990-12#1)(2008-2#1)
and only##175##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-9#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#3)(2009-2#2)(2009-8#3)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#10)(2011-9#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#4)
and onset of##2##3##(2008-12#1)(2012-1#1)
and onset##3##2##(2008-12#1)(2012-1#1)(2012-3#1)
and onto##2##2##(2008-2#1)(2008-3#1)
and ontological##2##2##(2008-7#1)(2013-1#1)
and onychomycosis##3##2##(2008-5#1)(2009-2#2)
and opaque##2##2##(2012-3#1)(2013-1#1)
and open questions##2##3##(1992-12#1)(1997-3#1)
and open surgical intervention##2##4##(2013-8#2)
and open surgical##3##3##(2011-2#1)(2013-8#2)
and open##29##2##(1992-12#1)(1993-5#1)(1993-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#4)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
and open-ended questions##2##3##(2011-1#1)(2011-2#1)
and open-ended##4##2##(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
and opened##3##2##(1991-8#1)(2008-7#1)(2008-8#1)
and opens##2##2##(2008-11#1)(2011-2#1)
and operant##3##2##(2007-8#1)(2010-2#2)
and operate##4##2##(2008-11#1)(2008-3#2)(2011-7#1)
and operated in the positive ion mode##2##7##(2011-3#2)
and operated on##2##3##(2008-10#1)(2013-1#1)
and operated##6##2##(1992-9#1)(2008-10#2)(2011-3#2)(2013-1#1)
and operates in a##2##4##(2008-10#1)(2008-3#1)
and operates##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
and operating costs##2##3##(1991-12#1)(2008-2#1)
and operating expenses##3##3##(1992-2#1)(1996-12#1)(2008-11#1)
and operating##20##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
and operation of a##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)
and operation of the##2##4##(2007-11#1)(2007-5#1)
and operation of##10##3##(1992-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-2#1)
and operation##21##2##(1992-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
and operational and storage stability##2##5##(2008-10#2)
and operational issues##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
and operational lifetime of##2##4##(2008-10#2)
and operational##31##2##(1990-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2009-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
and operations##12##2##(1992-1#2)(1992-3#1)(1993-3#1)(1994-1#2)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)(2010-12#1)
and operative treatment##2##3##(1994-5#1)(2012-2#1)
and operative##13##2##(1992-10#1)(1993-5#1)(1994-5#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
and operator##4##2##(1992-12#2)(2008-10#1)(2008-9#1)
and operators##6##2##(1990-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#2)
and ophthalmic##2##2##(2011-1#1)(2011-2#1)
and ophthalmologic##2##2##(2011-2#1)(2013-1#1)
and ophthalmology##2##2##(2007-11#1)(2010-10#1)
and opiate##5##2##(1994-8#1)(1997-4#1)(2010-11#3)
and opiates##2##2##(1997-4#1)(2008-5#1)
and opinion##2##2##(1991-12#1)(1994-3#1)
and opinions about##3##3##(1991-3#1)(1995-1#1)(2010-12#1)
and opinions##6##2##(1991-3#1)(1991-9#1)(1995-1#1)(1996-11#1)(1997-3#1)(2010-12#1)
and opioid peptides##2##3##(1991-1#1)(1994-2#1)
and opioid##4##2##(1991-1#1)(1994-2#1)(1995-12#1)(2008-2#1)
and opioids##4##2##(1991-2#1)(2008-7#1)(2009-5#1)(2013-1#1)
and opponents##2##2##(1994-1#1)(2008-11#1)
and opportunities for learning##2##4##(2012-2#1)(2013-8#1)
and opportunities for##9##3##(1993-12#1)(1995-3#1)(2008-12#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and opportunities in##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
and opportunities that##4##3##(1994-3#1)(2008-1#1)(2008-5#1)(2010-3#1)
and opportunities to##3##3##(1993-2#1)(2008-10#1)(2010-4#1)
and opportunities##31##2##(1991-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#2)(1995-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
and opportunity##7##2##(1994-12#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
and opposed-phase pulse sequence##2##4##(1997-8#2)
and opposed-phase##8##2##(1997-8#8)
and opposing##2##2##(2008-8#1)(2012-2#1)
and opposite##2##2##(2008-7#1)(2008-8#1)
and optic nerve##4##3##(2010-8#1)(2011-1#1)(2011-2#2)
and optic neuritis##2##3##(1995-12#1)(2007-7#1)
and optic##9##2##(1995-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)
and optical coherence tomography##2##4##(2007-11#1)(2007-12#1)
and optical computing##2##3##(2007-12#1)(2008-3#1)
and optical constants of thin##2##5##(2008-3#2)
and optical constants of##3##4##(2007-11#1)(2008-3#2)
and optical constants##5##3##(2007-11#1)(2008-3#4)
and optical depth##2##3##(2008-2#2)
and optical efficiency##2##3##(2007-11#1)(2008-3#1)
and optical fiber##2##3##(2008-2#1)(2008-3#1)
and optical fibers##2##3##(2008-2#2)
and optical interconnects##2##3##(2008-3#2)
and optical microscopy##3##3##(2008-3#1)(2009-11#1)(2010-5#1)
and optical parametric oscillation##2##4##(2008-3#2)
and optical parametric##4##3##(2008-2#2)(2008-3#2)
and optical properties of##8##4##(2008-2#1)(2008-3#6)(2013-8#1)
and optical properties##9##3##(2008-2#1)(2008-3#7)(2013-8#1)
and optical spectroscopy##2##3##(2008-10#1)(2010-12#1)
and optical thickness##3##3##(2008-2#2)(2008-3#1)
and optical##108##2##(1993-11#2)(1995-2#1)(2007-11#8)(2007-12#5)(2008-10#5)(2008-12#1)(2008-2#26)(2008-3#43)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and optically active##2##3##(1995-3#1)(1997-7#1)
and optically pumped##2##3##(2008-3#1)(2008-7#1)
and optically##9##2##(1995-3#1)(1997-7#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-7#1)(2011-1#1)
and optimal conditions##2##3##(2007-11#1)(2008-4#1)
and optimal##22##2##(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-2#1)(2011-2#1)(2012-2#1)
and optimisation of##2##3##(2008-10#2)
and optimisation##5##2##(2008-10#3)(2008-2#1)(2010-11#1)
and optimised##7##2##(2008-10#7)
and optimism##3##2##(1995-12#1)(2010-7#2)
and optimistic##2##2##(2010-10#2)
and optimization of a##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
and optimization of peptide separation##2##5##(1994-9#1)(1995-3#1)
and optimization of the##6##4##(2008-10#3)(2008-3#2)(2008-7#1)
and optimization of these##2##4##(2007-12#1)(2013-7#1)
and optimization of##29##3##(1994-9#1)(1995-3#1)(1997-4#1)(2007-12#3)(2008-10#7)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#3)(2011-2#1)(2012-2#1)(2013-7#1)
and optimization##38##2##(1994-9#1)(1995-3#1)(1997-4#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-7#1)
and optimize the##5##3##(1992-5#1)(2007-11#1)(2008-11#1)(2009-11#1)(2013-1#1)
and optimize##13##2##(1992-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and optimized a##2##3##(2008-10#1)(2013-1#1)
and optimized by##2##3##(2008-10#1)(2008-5#1)
and optimized for##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
and optimized to##4##3##(2008-10#3)(2008-5#1)
and optimized##56##2##(1997-2#1)(2007-12#1)(2008-10#38)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#1)
and optimizes the##2##3##(2008-11#1)(2011-2#1)
and optimizes##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
and optimizing the##2##3##(2008-11#1)(2008-5#1)
and optimizing##10##2##(2008-10#1)(2008-11#2)(2008-3#4)(2008-5#1)(2008-9#1)(2010-10#1)
and optimum conditions##3##3##(2008-10#3)
and optimum##11##2##(1994-6#1)(2008-10#9)(2013-1#1)
and option costs##2##3##(2008-8#2)
and optional##2##2##(2008-10#1)(2008-7#1)
and options available##2##3##(2008-4#1)(2008-7#1)
and options for##7##3##(1993-12#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-3#1)
and options##15##2##(1991-3#1)(1993-12#1)(1997-1#2)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)
and optoelectronic##2##2##(2008-2#1)(2008-3#1)
and optosensing##2##2##(2008-10#2)
and or##11##2##(1990-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)
and oral administration##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
and oral health##4##3##(2008-1#1)(2008-9#2)(2013-1#1)
and oral mucosa##2##3##(2008-3#1)(2012-12#1)
and oral##54##2##(1990-12#1)(1992-11#2)(1993-12#2)(1994-12#1)(1994-9#1)(1995-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#4)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
and orally##5##2##(1990-11#1)(1994-6#1)(2008-10#1)(2012-2#1)(2012-3#1)
and orange juice##5##3##(2008-10#2)(2010-5#3)
and orange##8##2##(2008-10#4)(2008-3#1)(2010-5#3)
and orbit##2##2##(2008-11#1)(2011-1#1)
and orbital metastasis##2##3##(1992-2#1)(2007-10#1)
and orbital##6##2##(1992-2#2)(1996-5#1)(2007-10#1)(2007-12#1)(2013-1#1)
and orbitofrontal##2##2##(2007-8#1)(2008-7#1)
and order##10##2##(1996-12#2)(1997-5#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-9#1)(2013-8#2)
and ordered##8##2##(1996-10#1)(1997-4#2)(1997-5#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
and ordering##2##2##(2008-10#1)(2010-3#1)
and orders##2##2##(1995-2#1)(2012-7#1)
and ore samples##2##3##(2008-10#2)
and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1##2##8##(1992-12#2)
and organ weights##2##3##(2008-9#1)(2010-7#1)
and organ##19##2##(1991-2#1)(1992-12#2)(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
and organellar##2##2##(2009-8#1)(2010-4#1)
and organelle##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
and organelles##4##2##(1994-8#1)(2008-5#1)(2008-8#1)(2010-4#1)
and organic acids in##2##4##(2008-10#1)(2008-4#1)
and organic acids##7##3##(1996-12#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)
and organic arsenic##2##3##(2008-10#2)
and organic compounds##5##3##(2008-10#4)(2012-8#1)
and organic loading rate##2##4##(2008-7#1)(2013-1#1)
and organic matter content##2##4##(2008-10#2)
and organic matter were##2##4##(2008-5#1)(2008-6#1)
and organic matter##8##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2013-7#1)
and organic mercury##4##3##(2008-10#4)
and organic phosphates##2##3##(1990-8#1)(1994-3#1)
and organic solvent##9##3##(1990-5#2)(2008-10#4)(2008-6#1)(2010-11#1)(2013-1#1)
and organic solvents##4##3##(2008-10#3)(2008-6#1)
and organic##89##2##(1990-5#2)(1990-8#1)(1992-5#1)(1994-3#1)(1994-9#2)(1996-12#1)(2007-8#1)(2008-10#53)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#3)(2010-11#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
and organic)##2##2##(2008-10#1)(2008-7#1)
and organisation of##2##3##(1993-6#1)(2012-1#1)
and organisational support (OR = 1##2##4##(2011-2#2)
and organisational##4##2##(2008-2#1)(2009-5#1)(2011-2#2)
and organisations##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
and organisms##4##2##(2008-10#1)(2008-5#3)
and organization of##8##3##(1996-12#1)(1997-3#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-4#1)
and organization##21##2##(1991-2#2)(1991-6#1)(1994-1#1)(1996-1#2)(1996-12#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#2)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
and organizational commitment##2##3##(1993-2#1)(1995-12#1)
and organizational impact##2##3##(2008-12#1)(2012-1#1)
and organizational implications of##2##4##(1996-2#1)(2008-12#1)
and organizational structure##4##3##(1991-1#1)(1994-2#1)(2008-11#1)(2013-8#1)
and organizational##36##2##(1991-1#1)(1991-12#1)(1993-12#1)(1993-2#4)(1994-1#2)(1994-2#4)(1995-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-3#1)(2013-8#1)
and organizationally##2##2##(1996-2#1)(2012-1#1)
and organizations in##2##3##(1997-3#1)(2008-7#1)
and organizations##8##2##(1994-2#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-3#2)(2008-7#1)(2010-5#1)
and organize##2##2##(1992-2#1)(1997-2#1)
and organized into##2##3##(2008-4#1)(2012-1#1)
and organized##9##2##(1991-1#1)(1991-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#1)
and organizing##3##2##(2008-1#1)(2008-11#1)(2008-9#1)
and organogenesis##2##2##(2008-12#1)(2010-8#1)
and organotypic##3##2##(2008-4#1)(2009-9#2)
and organs of##2##3##(2008-5#1)(2008-7#1)
and organs were##2##3##(2008-11#1)(2013-1#1)
and organs##20##2##(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#2)(2010-12#1)(2010-4#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and orient in##2##3##(2009-8#2)
and orient##3##2##(2009-8#2)(2011-1#1)
and oriental pickling melon cultivars##2##5##(2008-10#2)
and oriental##4##2##(1997-8#1)(2008-10#3)
and orientation of##7##3##(1993-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-3#1)
and orientation##26##2##(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-5#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#2)(2009-5#1)(2011-1#1)(2011-3#1)(2012-2#1)
and orientations##3##2##(1993-8#1)(2008-10#1)(2009-7#1)
and origin of the##2##4##(2007-5#1)(2008-10#1)
and origin of##3##3##(2007-5#1)(2008-10#2)
and origin##4##2##(2007-5#1)(2008-10#3)
and original##8##2##(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#2)
and originally##2##2##(2008-10#1)(2008-7#1)
and originating from##2##3##(2008-10#1)(2012-3#1)
and origins of##2##3##(2008-10#1)(2008-11#1)
and origins##4##2##(2008-10#2)(2008-11#2)
and ornamental shapes##2##3##(2008-9#2)
and ornamental trees##2##3##(2011-2#2)
and ornamental##5##2##(2008-10#1)(2008-9#2)(2011-2#2)
and ornithine##2##2##(1990-2#1)(2008-10#1)
and orthodontic treatment##2##3##(2007-12#1)(2013-7#1)
and orthodontic##5##2##(2007-12#2)(2010-3#1)(2013-1#1)(2013-7#1)
and orthogonal##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
and orthographic##4##2##(1991-2#2)(2012-1#1)(2013-8#1)
and orthologues##2##2##(2008-7#2)
and orthopaedic##3##2##(1990-9#1)(1991-6#1)(2007-8#1)
and orthopedic##5##2##(1991-6#1)(2007-11#1)(2009-3#1)(2013-1#2)
and orthophosphate##2##2##(2008-10#2)
and oscillations##7##2##(1990-5#1)(1995-5#1)(2008-11#3)(2008-3#1)(2008-7#1)
and oscillatory##2##2##(2008-12#1)(2008-5#1)
and osmolality##4##2##(2008-11#3)(2008-5#1)
and osmolarity##4##2##(2008-1#1)(2008-11#2)(2011-2#1)
and osmotic##4##2##(1997-7#1)(2008-11#1)(2010-7#1)(2012-7#1)
and osteoarthritis##3##2##(1992-3#1)(2008-7#1)(2009-8#1)
and osteoblastic##3##2##(2007-11#1)(2008-11#2)
and osteoblasts##2##2##(2011-2#1)(2012-4#1)
and osteocalcin##4##2##(2011-2#1)(2012-1#1)(2012-4#2)
and osteochondral lesions##3##3##(2011-2#2)(2012-3#1)
and osteochondritis dissecans##2##3##(1992-4#1)(2008-8#1)
and osteoclast##4##2##(2008-11#1)(2008-4#1)(2011-2#2)
and osteoclasts##5##2##(1990-5#1)(1991-5#1)(2008-4#1)(2008-8#1)(2011-2#1)
and osteogenesis##5##2##(2007-8#1)(2008-11#3)(2008-5#1)
and osteoinductive growth factors##2##4##(2008-8#2)
and osteoinductive##3##2##(2008-7#1)(2008-8#2)
and osteomalacia in##3##3##(1991-11#1)(1997-4#1)(2008-4#1)
and osteomyelitis##4##2##(2006-10#1)(2012-8#1)(2013-8#2)
and osteopathic##4##2##(2007-11#3)(2008-12#1)
and osteopathy##4##2##(2007-11#2)(2010-12#2)
and osteopontin##3##2##(2008-11#2)(2012-1#1)
and osteoporosis##14##2##(1991-11#1)(1994-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#3)
and osteoporotic##2##2##(2008-7#1)(2012-2#1)
and osteoprotegerin##4##2##(2007-8#1)(2008-11#1)(2011-1#1)(2013-1#1)
and osteosarcoma##3##2##(2007-5#1)(2008-7#1)(2010-3#1)
and other AGs of R##2##5##(2008-10#2)
and other active##2##3##(1994-6#1)(2008-10#1)
and other additives##2##3##(2009-10#1)(2010-4#1)
and other advances##2##3##(2008-7#1)(2010-9#1)
and other adverse##3##3##(1995-3#1)(2008-7#1)(2010-6#1)
and other agencies##3##3##(1994-2#1)(1996-2#1)(1997-2#1)
and other agents##4##3##(1991-9#1)(1996-3#1)(2007-10#1)(2008-8#1)
and other agricultural##2##3##(2008-12#1)(2013-8#1)
and other analytes##2##3##(2008-10#1)(2008-3#1)
and other animals##4##3##(1991-8#1)(1993-3#1)(1995-2#1)(2008-10#1)
and other applications##6##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#2)
and other areas of##3##4##(1996-3#1)(2008-10#1)(2010-11#1)
and other areas##4##3##(1992-12#1)(1996-3#1)(2008-10#1)(2010-11#1)
and other artificial##2##3##(1990-7#1)(2008-10#1)
and other aspects of##2##4##(1993-2#1)(2012-3#1)
and other biological##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)
and other biomolecules##2##3##(2008-10#2)
and other body##2##3##(1992-9#1)(1996-3#1)
and other cancers##5##3##(1992-5#1)(1993-1#1)(2008-11#1)(2008-7#2)
and other cardiac##3##3##(2010-6#1)(2010-8#1)(2012-2#1)
and other cardiovascular risk factors##3##5##(1991-4#1)(1996-8#1)(2010-4#1)
and other cardiovascular##6##3##(1991-4#1)(1996-8#1)(2008-6#1)(2009-9#1)(2010-4#1)(2011-2#1)
and other cases of##2##4##(2008-2#1)(2008-8#1)
and other causes##2##3##(2008-10#1)(2009-8#1)
and other cell##4##3##(1992-5#1)(1994-3#1)(1995-12#1)(2008-4#1)
and other cells##5##3##(1990-9#1)(1991-9#1)(2008-4#1)(2009-12#1)(2013-8#1)
and other challenges facing##2##4##(1996-3#1)(2008-8#1)
and other chemical##2##3##(2008-10#1)(2008-11#1)
and other chromosomal##2##3##(1995-8#1)(1997-9#1)
and other chronic diseases##5##4##(2009-5#1)(2010-4#1)(2012-1#1)(2013-8#2)
and other chronic##8##3##(1994-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-1#1)(2013-8#2)
and other citrus##2##3##(2008-5#2)
and other clinical##4##3##(1993-11#1)(2008-5#1)(2010-12#2)
and other coexisting##2##3##(2008-10#1)(2013-1#1)
and other cognitive##3##3##(2008-7#1)(2009-10#1)(2009-8#1)
and other community##3##3##(1996-1#1)(1996-12#1)(2012-2#1)
and other complex##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
and other complications##3##3##(2007-10#1)(2008-11#2)
and other components of##3##4##(2008-1#1)(2008-3#1)(2008-4#1)
and other components##6##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
and other compounds##4##3##(1991-5#1)(1991-9#1)(2008-10#2)
and other conditions##3##3##(1991-2#1)(2008-10#1)(2009-5#1)
and other constitutional##2##3##(2010-8#1)(2012-12#1)
and other countries##10##3##(1993-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
and other critical##4##3##(1996-12#1)(2008-11#1)(2009-8#1)(2010-11#1)
and other cytokines##3##3##(1994-9#1)(1996-2#1)(2008-7#1)
and other data##3##3##(1991-1#1)(1997-2#1)(2010-3#1)
and other developing countries##2##4##(2009-4#1)(2011-2#1)
and other devices##2##3##(1991-3#2)
and other diseases##8##3##(1994-5#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
and other disorders##5##3##(1997-2#1)(2008-1#2)(2008-3#1)(2010-1#1)
and other drug use behaviors##2##5##(1996-1#2)
and other drug##3##3##(1996-1#2)(2012-12#1)
and other drugs##7##3##(1991-1#1)(2008-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
and other effects##3##3##(1990-12#1)(1990-9#1)(1994-5#1)
and other elements##2##3##(1996-1#1)(2008-4#1)
and other environmental factors##2##4##(2008-7#1)(2013-7#1)
and other environmental##8##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-5#1)(2013-7#1)
and other ethnic populations##2##4##(2010-8#1)(2011-1#1)
and other experimental##2##3##(1994-8#1)(2008-10#1)
and other factors in the##2##5##(2008-2#1)(2010-11#1)
and other factors##17##3##(1996-3#1)(1996-7#1)(1997-3#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-12#2)(2013-1#1)
and other family members are##2##5##(2011-2#1)(2012-12#1)
and other family##3##3##(2009-11#1)(2011-2#1)(2012-12#1)
and other features##2##3##(2008-3#1)(2013-8#1)
and other findings##2##3##(1997-3#1)(2012-3#1)
and other forms of##7##4##(1991-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-2#1)
and other gases##3##3##(1991-5#1)(2008-2#2)
and other genes##2##3##(1992-12#1)(1992-8#1)
and other genetic##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
and other governmental##2##3##(2008-11#2)
and other health care professionals are##2##6##(2007-2#1)(2008-4#1)
and other health care professionals##5##5##(1994-3#1)(2007-2#1)(2008-4#1)(2010-9#1)(2012-12#1)
and other health care providers##3##5##(1993-1#1)(1994-12#1)(2007-12#1)
and other health care##11##4##(1993-1#2)(1994-12#1)(1994-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-9#1)(2012-12#1)
and other health##21##3##(1991-3#1)(1991-6#1)(1993-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-9#1)(2012-12#2)
and other heavy##3##3##(1995-2#1)(1995-3#1)(2008-10#1)
and other host##2##3##(2008-10#1)(2011-2#1)
and other hosts##2##3##(2008-10#2)
and other imaging##2##3##(1991-2#1)(2009-3#1)
and other important##6##3##(1992-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-4#1)(2013-7#1)
and other infections##3##3##(1995-5#1)(2008-8#1)(2013-1#1)
and other inflammatory##2##3##(2008-7#1)(2010-12#1)
and other information##2##3##(1996-11#1)(2008-11#1)
and other inorganic##2##3##(2008-10#2)
and other institutions##2##3##(1994-3#1)(2007-4#1)
and other interfacial parameters##2##4##(2008-3#2)
and other invasive##2##3##(1990-2#1)(2011-2#1)
and other issues##4##3##(1995-12#1)(1996-2#1)(2008-12#1)(2010-5#1)
and other key##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
and other laboratories##2##3##(2008-11#1)(2008-8#1)
and other laboratory##2##3##(2009-3#1)(2012-3#1)
and other lifestyle behaviors##2##4##(2009-5#1)(2013-8#1)
and other lifestyle##4##3##(1993-11#1)(2009-5#1)(2013-8#2)
and other ligands##4##3##(1996-2#1)(2008-10#1)(2008-7#1)(2009-8#1)
and other locations##2##3##(2007-12#1)(2008-10#1)
and other major##3##3##(1994-8#1)(1997-1#1)(2011-2#1)
and other markers##2##3##(2008-10#1)(2013-8#1)
and other mechanisms of##2##4##(1991-9#1)(1992-8#1)
and other media##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
and other mediators##2##3##(2008-4#1)(2008-5#1)
and other medical conditions##2##4##(2011-2#2)
and other medical##5##3##(1996-3#1)(2008-8#1)(2008-9#1)(2011-2#2)
and other members of the##5##5##(1994-2#1)(1995-3#1)(2008-10#1)(2008-4#1)(2011-2#1)
and other members of##6##4##(1994-2#1)(1995-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
and other men who have sex with men##2##8##(2009-5#2)
and other mental health problems##2##5##(2009-7#1)(2013-8#1)
and other mental##3##3##(1993-12#1)(2009-7#1)(2013-8#1)
and other metabolic parameters##2##4##(1994-12#1)(2013-1#1)
and other metabolic##3##3##(1994-12#1)(2008-4#1)(2013-1#1)
and other minor##2##3##(1990-5#1)(1993-12#1)
and other miscellaneous##2##3##(2008-10#2)
and other model##3##3##(2008-11#1)(2008-4#1)(2012-1#1)
and other motor##2##3##(2008-7#1)(2012-3#1)
and other mu##2##3##(1995-6#1)(2008-10#1)
and other neurodegenerative diseases##2##4##(2008-5#1)(2010-5#1)
and other neurodegenerative##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
and other neurological disorders##2##4##(1996-6#2)
and other neurological##4##3##(1996-6#2)(2008-5#1)(2012-3#1)
and other new##2##3##(1994-3#1)(2008-11#1)
and other nutrients##4##3##(2008-11#1)(2008-7#2)(2012-3#1)
and other occupational diseases##2##4##(2009-12#2)
and other opioid##2##3##(1995-6#1)(2008-2#1)
and other oral##3##3##(2007-12#1)(2008-5#1)(2013-8#1)
and other organelles##2##3##(2008-10#1)(2008-7#1)
and other organisms##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
and other organizations##3##3##(1994-7#1)(1995-1#1)(2007-7#1)
and other organs##2##3##(1994-5#1)(1995-2#1)
and other outcomes##2##3##(1995-2#1)(2008-12#1)
and other parameters of##2##4##(1992-9#1)(2008-10#1)
and other parameters##4##3##(1992-9#1)(2008-10#2)(2008-8#1)
and other pathogens##2##3##(1995-2#1)(2008-5#1)
and other pathological##2##3##(2010-11#1)(2013-1#1)
and other patient##2##3##(1995-12#1)(2008-10#1)
and other physical##3##3##(1990-8#1)(1992-5#1)(2011-2#1)
and other physiological##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
and other phytopathogenic##2##3##(2008-10#2)
and other plant hosts##2##4##(2008-10#2)
and other plant##3##3##(2008-10#2)(2010-3#1)
and other plants##3##3##(2008-10#2)(2009-10#1)
and other possible##3##3##(1992-11#2)(2008-10#1)
and other potential##4##3##(1996-2#1)(2008-4#1)(2010-12#1)(2013-1#1)
and other predictions##2##3##(2007-12#1)(2008-8#1)
and other problems##3##3##(1993-6#1)(2008-3#1)(2008-6#1)
and other procedures##4##3##(1991-2#1)(1995-1#1)(1995-12#1)(1997-7#1)
and other processes##2##3##(2008-10#1)(2011-2#1)
and other products##2##3##(1991-9#1)(2008-10#1)
and other properties of##2##4##(1991-5#1)(2008-9#1)
and other properties##4##3##(1991-5#1)(2008-12#1)(2008-7#1)(2008-9#1)
and other protein##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
and other proteins##3##3##(2008-10#2)(2013-1#1)
and other providers in##2##4##(1995-1#1)(2012-3#1)
and other providers##6##3##(1991-3#1)(1992-12#1)(1995-1#1)(1996-3#1)(2012-3#1)(2013-1#1)
and other psychiatric disorders##2##4##(1991-1#1)(2008-1#1)
and other psychiatric##3##3##(1991-1#1)(1994-2#1)(2008-1#1)
and other rare earth elements##2##5##(2008-10#2)
and other reactions##2##3##(1992-11#1)(1997-7#1)
and other reactive oxygen species##2##5##(2008-10#1)(2008-8#1)
and other reactive##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
and other reasons##2##3##(1992-2#1)(1993-1#1)
and other related##6##3##(1991-6#1)(1992-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)
and other relatives##2##3##(1997-8#1)(2011-2#1)
and other relevant##3##3##(1994-3#1)(2008-8#1)(2008-9#1)
and other resources##4##3##(1993-12#1)(2007-2#1)(2008-10#2)
and other results##2##3##(1995-2#1)(2007-11#1)
and other rheumatic conditions##2##4##(2011-2#2)
and other rheumatic##3##3##(1991-3#1)(2011-2#2)
and other risk factors##2##4##(1992-11#1)(2008-11#1)
and other root##2##3##(2008-10#1)(2008-7#1)
and other sexual##2##3##(1990-6#1)(2011-2#1)
and other sexually transmitted diseases##3##5##(1993-6#1)(1993-9#1)(1997-6#1)
and other sexually transmitted##4##4##(1993-6#1)(1993-9#1)(1997-6#1)(2011-2#1)
and other signaling##3##3##(2008-11#1)(2008-4#1)(2009-6#1)
and other significant##2##3##(1995-6#1)(2012-3#1)
and other similar##3##3##(1997-3#1)(2007-7#1)(2010-4#1)
and other sites##4##3##(1993-2#1)(2007-10#1)(2007-7#1)(2013-1#1)
and other skin##2##3##(1991-6#1)(2007-12#1)
and other small##3##3##(1990-12#1)(2008-10#2)
and other social##3##3##(2008-10#1)(2008-12#1)(2010-12#1)
and other soft##2##3##(2007-11#1)(2008-10#1)
and other solid tumors##3##4##(2008-7#3)
and other solid##5##3##(1994-10#1)(2008-3#1)(2008-7#3)
and other solvents##2##3##(2008-10#1)(2008-7#1)
and other sources of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
and other sources##6##3##(1990-8#1)(1992-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
and other species##6##3##(1992-12#1)(2008-8#2)(2010-3#1)(2013-1#1)(2013-8#1)
and other staff##5##3##(1993-3#1)(1996-2#1)(2008-12#1)(2008-8#1)(2009-3#1)
and other states##2##3##(1992-1#1)(2008-10#1)
and other stimuli##3##3##(2008-4#1)(2009-10#2)
and other structural##3##3##(2008-1#1)(2008-9#1)(2012-12#1)
and other studies##2##3##(1994-3#1)(2008-9#1)
and other substance##2##3##(1991-1#1)(2008-10#1)
and other substances##3##3##(1991-3#1)(1996-1#1)(2008-11#1)
and other such##2##3##(1997-3#1)(2008-5#1)
and other symptoms##2##3##(2008-5#1)(2012-3#1)
and other systemic##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
and other systems##5##3##(1995-2#1)(1996-1#1)(2007-7#1)(2008-7#1)(2008-9#1)
and other techniques in##2##4##(2009-10#1)(2011-2#1)
and other techniques##7##3##(1991-2#1)(2007-10#1)(2007-2#1)(2008-10#2)(2009-10#1)(2011-2#1)
and other tissues of##2##4##(1994-2#1)(2008-4#1)
and other tissues##6##3##(1990-12#1)(1991-2#1)(1994-2#1)(1996-6#1)(1997-2#1)(2008-4#1)
and other topics##2##3##(1992-9#1)(1996-2#1)
and other transcription factors##2##4##(2008-4#1)(2008-8#1)
and other tumors##2##3##(2008-11#1)(2010-12#1)
and other types of##5##4##(1993-12#1)(2008-4#2)(2010-1#1)(2012-2#1)
and other types##6##3##(1993-12#1)(2008-4#2)(2010-1#1)(2011-2#1)(2012-2#1)
and other variables##7##3##(1991-6#1)(2008-10#3)(2011-1#1)(2013-1#2)
and other visceral##2##3##(2008-7#1)(2013-8#1)
and other##1175##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#4)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#9)(1991-11#1)(1991-12#7)(1991-2#6)(1991-3#8)(1991-4#1)(1991-5#4)(1991-6#6)(1991-8#1)(1991-9#7)(1992-1#1)(1992-11#6)(1992-12#8)(1992-2#4)(1992-5#4)(1992-6#2)(1992-8#4)(1992-9#5)(1993-1#10)(1993-11#3)(1993-12#7)(1993-2#6)(1993-3#7)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#7)(1994-3#12)(1994-5#7)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#6)(1995-12#6)(1995-2#14)(1995-3#6)(1995-5#7)(1995-6#4)(1995-8#4)(1996-1#12)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#9)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#7)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#16)(2007-2#10)(2007-3#1)(2007-4#3)(2007-7#10)(2007-8#4)(2008-1#18)(2008-10#186)(2008-11#50)(2008-12#15)(2008-2#22)(2008-3#32)(2008-4#36)(2008-5#34)(2008-6#11)(2008-7#47)(2008-8#34)(2008-9#21)(2009-10#12)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#10)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#4)(2010-3#7)(2010-4#7)(2010-5#7)(2010-6#5)(2010-7#3)(2010-8#14)(2010-9#2)(2011-1#13)(2011-2#48)(2011-3#1)(2012-1#5)(2012-12#20)(2012-2#12)(2012-3#13)(2012-4#1)(2013-1#31)(2013-7#3)(2013-8#16)
and others are##2##3##(2008-10#1)(2013-7#1)
and others as##2##3##(2007-7#1)(2008-5#1)
and others have shown that##2##5##(2008-11#1)(2010-5#1)
and others have##10##3##(1992-3#1)(1994-7#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)
and others having##2##3##(1992-3#1)(2008-10#1)
and others in a##2##4##(1992-3#1)(1994-12#1)
and others in the##2##4##(1996-12#1)(2008-11#1)
and others in##4##3##(1992-3#1)(1994-12#1)(1996-12#1)(2008-11#1)
and others that##3##3##(2010-5#1)(2012-12#1)(2013-8#1)
and others to##3##3##(1993-3#2)(2009-10#1)
and others using##2##3##(1992-2#1)(2008-1#1)
and others which##2##3##(1990-5#1)(1994-8#1)
and others who##2##3##(1992-3#2)
and others##82##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#5)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-7#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
and others)##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
and otherwise normal##2##3##(1992-4#1)(1995-5#1)
and otherwise##4##2##(1992-4#1)(1995-5#1)(2008-5#1)(2013-8#1)
and otitis media##2##3##(1991-3#1)(2008-7#1)
and otolaryngology##2##2##(2008-11#2)
and our present results##2##4##(1991-5#1)(1997-2#1)
and our results##2##3##(2008-10#1)(2011-2#1)
and our##39##2##(1991-5#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
and out of the##7##4##(1996-4#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2011-2#2)
and out of these##2##4##(2011-1#1)(2013-8#1)
and out of##16##3##(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-8#1)
and out##17##2##(1992-2#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-8#1)
and out-migration##2##2##(2011-2#2)
and out-of-plane scattering##2##3##(2008-2#1)(2008-3#1)
and out-of-plane##8##2##(2008-2#3)(2008-3#5)
and out-of-pocket spending##2##3##(1992-3#1)(1997-3#1)
and outbreeding depression##2##3##(2008-8#2)
and outcome data were collected##2##5##(2008-3#1)(2012-2#1)
and outcome data were##3##4##(2008-3#1)(2012-2#1)(2013-1#1)
and outcome for##4##3##(1994-9#1)(2009-4#1)(2009-8#2)
and outcome in a series of 20##2##7##(2008-10#2)
and outcome in high##2##4##(2008-6#1)(2011-1#1)
and outcome in##9##3##(2008-10#2)(2008-6#3)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)
and outcome measures of##2##4##(2006-10#1)(2011-1#1)
and outcome measures##11##3##(1994-2#1)(1996-7#1)(2006-10#2)(2007-11#3)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
and outcome of patients##2##4##(2008-6#1)(2011-2#1)
and outcome of treatment##2##4##(1991-1#1)(2008-11#1)
and outcome of##25##3##(1991-1#1)(1994-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
and outcome were##2##3##(2012-12#1)(2013-1#1)
and outcome##89##2##(1991-1#1)(1991-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1996-7#1)(1997-7#1)(2006-10#3)(2006-7#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
and outcomes after##2##3##(2012-2#1)(2012-3#1)
and outcomes are##2##3##(2008-1#1)(2008-12#1)
and outcomes for the##2##4##(1994-12#1)(2010-6#1)
and outcomes for##7##3##(1994-12#1)(1996-2#1)(2008-12#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
and outcomes in##3##3##(2007-10#1)(2008-9#1)(2013-1#1)
and outcomes is##2##3##(2008-10#1)(2008-12#1)
and outcomes management##3##3##(1994-3#2)(1997-3#1)
and outcomes measurement##2##3##(1994-12#1)(1997-1#1)
and outcomes of care##4##4##(1993-3#2)(1994-2#1)(2008-6#1)
and outcomes of nutrition##2##4##(1994-3#1)(1995-3#1)
and outcomes of patients##2##4##(2008-3#1)(2012-3#1)
and outcomes of the##3##4##(2008-12#1)(2011-1#1)(2012-12#1)
and outcomes of##26##3##(1991-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1995-3#1)(2008-12#4)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and outcomes research##2##3##(1994-3#1)(2009-12#1)
and outcomes were##2##3##(2008-10#1)(2009-9#1)
and outcomes##92##2##(1991-12#2)(1992-1#1)(1993-3#2)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#4)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#9)(2008-3#5)(2008-6#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#3)
and outdoor air##8##3##(2008-10#6)(2010-5#2)
and outdoor##22##2##(1997-2#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-6#1)(2010-5#6)
and outdoors##4##2##(2008-10#2)(2012-12#2)
and outer cortex##5##3##(2008-10#4)(2012-2#1)
and outer dense##2##3##(2008-4#1)(2010-4#1)
and outer sheath cells##2##4##(2010-11#2)
and outer##18##2##(1990-11#2)(1991-10#1)(1996-5#1)(2007-5#1)(2008-10#5)(2008-4#1)(2008-9#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
and outgrowth of##3##3##(2008-9#1)(2011-2#2)
and outgrowth##11##2##(2008-9#1)(2011-2#10)
and outlier##3##2##(1993-3#1)(1997-1#1)(2008-10#1)
and outline##7##2##(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
and outlines the##5##3##(1993-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
and outlines##13##2##(1992-12#1)(1993-12#1)(1994-3#1)(1997-1#2)(1997-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
and outlook##2##2##(1996-2#1)(2008-11#1)
and outpatient services##2##3##(1992-1#1)(1995-2#1)
and outpatient##14##2##(1992-1#2)(1992-12#3)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#3)(2007-10#1)(2013-1#1)
and output power of the##2##5##(2007-12#1)(2008-3#1)
and output power##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
and output powers##2##3##(2008-3#2)
and output##29##2##(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#8)(2008-3#7)(2008-4#1)(2009-12#1)(2010-8#2)
and outputs##6##2##(1992-2#2)(1996-2#1)(1996-3#1)(2008-12#1)(2008-2#1)
and outside a##2##3##(2008-2#1)(2013-7#1)
and outside of##4##3##(1993-1#1)(2008-10#1)(2008-12#1)(2010-9#1)
and outside the##7##3##(1991-2#1)(1997-2#1)(2008-2#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
and outside##20##2##(1991-1#1)(1991-2#1)(1993-1#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#2)(2009-5#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and outstanding##2##2##(2008-10#1)(2008-12#1)
and outward##2##2##(1995-12#1)(1995-3#1)
and ovalbumin##10##2##(1995-2#1)(2008-10#5)(2008-11#2)(2008-7#2)
and ovarian cancer##9##3##(1991-3#1)(1992-9#1)(1993-9#1)(1997-7#4)(2008-10#1)(2013-1#1)
and ovarian##17##2##(1991-3#1)(1992-9#1)(1993-9#1)(1995-2#1)(1995-8#2)(1997-3#1)(1997-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
and ovary##11##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-7#3)(2009-7#1)(2010-5#1)(2011-1#2)
and over a##3##3##(2007-12#1)(2008-3#2)
and over half##2##3##(2012-2#1)(2012-3#1)
and over the##5##3##(1992-2#1)(2008-4#1)(2008-5#2)(2009-12#1)
and over time##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
and over##51##2##(1990-3#2)(1990-6#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-5#3)(1997-1#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-12#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
and overall acceptability##2##3##(2010-2#2)
and overall health##3##3##(2008-7#3)
and overall impression (helpfulness)##2##4##(2010-8#2)
and overall impression##3##3##(2010-8#2)(2012-2#1)
and overall quality of life##2##5##(2008-1#1)(2008-6#1)
and overall survival (OS)##3##4##(1991-8#1)(1992-10#1)(2009-4#1)
and overall survival was##3##4##(1992-12#1)(2008-6#1)(2012-3#1)
and overall survival were##4##4##(1990-12#1)(2008-6#2)(2012-3#1)
and overall survival##16##3##(1990-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1995-4#1)(2007-7#1)(2008-6#4)(2009-4#1)(2010-3#1)(2012-1#1)(2012-3#2)(2013-1#1)
and overall##45##2##(1990-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1995-4#1)(1997-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#5)(2008-7#3)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
and overcome##5##2##(1991-2#1)(1994-11#1)(1994-12#2)(2011-2#1)
and overcomes the##2##3##(2007-11#1)(2008-11#1)
and overexpression of##4##3##(1995-8#1)(1997-4#1)(2008-11#1)(2008-8#1)
and overexpression##5##2##(1995-8#1)(1997-4#1)(2008-11#1)(2008-8#1)(2012-2#1)
and overlap in##2##3##(2008-7#1)(2013-1#1)
and overlap##4##2##(1996-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
and overlapping of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and overlapping##5##2##(1995-5#1)(2008-10#1)(2008-11#2)(2011-2#1)
and overlay##3##2##(2007-5#1)(2008-2#1)(2008-3#1)
and overlay-doped##2##2##(2008-3#2)
and overproduction of##2##3##(1997-7#1)(2013-8#1)
and overseas##2##2##(2008-1#1)(2008-11#1)
and oversee quality##2##3##(1991-12#1)(1996-2#1)
and overt##2##2##(2008-7#1)(2012-1#1)
and overtone bands that are##2##5##(2007-12#2)
and overweight are##2##3##(1995-5#1)(2008-3#1)
and overweight##8##2##(1990-2#1)(1991-12#2)(1995-5#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-2#1)
and oviduct##4##2##(2008-12#3)(2008-2#1)
and ovulation in##2##3##(1990-9#1)(2010-8#1)
and ovulation##3##2##(1990-9#1)(1994-7#1)(2010-8#1)
and own##5##2##(2007-11#5)
and oxalate##6##2##(1992-5#1)(1992-9#1)(2008-10#4)
and oxaliplatin##3##2##(2008-4#1)(2008-8#1)(2010-11#1)
and oxendolone##2##2##(1990-11#2)
and oxidant##3##2##(1996-9#2)(2008-10#1)
and oxidation in##2##3##(2008-1#1)(2008-10#1)
and oxidation index##2##3##(2013-8#2)
and oxidation of the##3##4##(2008-10#1)(2008-8#2)
and oxidation of##9##3##(2008-10#4)(2008-3#1)(2008-8#2)(2013-1#2)
and oxidation##28##2##(1996-2#1)(2008-1#3)(2008-10#11)(2008-3#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
and oxidative damage##4##3##(2009-12#2)(2013-8#2)
and oxidative phosphorylation##4##3##(1991-9#1)(1994-11#1)(1994-8#1)(2008-10#1)
and oxidative stress in##3##4##(2009-10#1)(2011-1#1)(2011-2#1)
and oxidative stress markers##2##4##(2011-2#2)
and oxidative stress were##2##4##(2011-2#1)(2011-3#1)
and oxidative stress##20##3##(1996-9#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-8#1)
and oxidative##33##2##(1990-7#2)(1991-9#1)(1994-11#1)(1994-8#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2013-8#3)
and oxidized LDL##2##3##(1997-8#1)(2010-3#1)
and oxidized##13##2##(1993-11#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
and oxygen consumption##2##3##(1991-9#1)(1996-5#1)
and oxygen delivery##2##3##(1992-2#1)(2012-3#1)
and oxygen for##2##3##(2008-11#1)(2010-8#1)
and oxygen is##2##3##(1990-7#1)(2008-10#1)
and oxygen metabolism##4##3##(2006-7#1)(2007-10#2)(2008-10#1)
and oxygen saturation##6##3##(2008-3#3)(2010-10#2)(2012-2#1)
and oxygen therapy##2##3##(2010-10#1)(2010-6#1)
and oxygen uptake rate##3##4##(2008-11#1)(2008-7#2)
and oxygen uptake##8##3##(2008-11#2)(2008-6#1)(2008-7#2)(2013-8#3)
and oxygen##59##2##(1990-7#1)(1991-9#1)(1992-2#1)(1994-5#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-4#1)(2006-7#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
and oxygen-concentration##2##2##(2007-12#2)
and oxygenation##2##2##(1995-12#1)(1996-3#1)
and oxyhemoglobin##2##2##(1993-1#1)(2008-11#1)
and oxymatrine##2##2##(2008-10#2)
and oxytocin##2##2##(1993-12#1)(1994-9#1)
and oyster##3##2##(1997-4#2)(2008-10#1)
and ozonation##3##2##(1992-5#1)(2008-10#1)(2013-1#1)
and ozone##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
and p &lt##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
and p = 0##10##4##(1997-2#2)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#3)(2013-1#1)
and p =##12##3##(1992-6#1)(1997-2#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#3)(2013-1#1)
and p##29##2##(1990-9#1)(1992-6#1)(1997-2#3)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-5#1)(2009-5#1)(2011-2#5)(2012-12#1)(2013-1#1)
and p&lt##3##2##(2006-8#1)(2007-8#1)(2013-1#1)
and p-cresol##3##2##(1990-8#1)(1991-5#2)
and p-hydroxybenzaldehyde##2##2##(1992-5#1)(2008-10#1)
and p-nitroaniline##3##2##(2008-10#3)
and p10##3##2##(1997-4#3)
and p120##2##2##(1996-2#2)
and p21cip1##2##2##(2013-1#2)
and p27##2##2##(2011-2#2)
and p35##7##2##(1995-6#1)(1997-3#1)(2008-8#5)
and p38 was##2##3##(2010-12#1)(2011-2#1)
and p38##7##2##(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
and p38)##2##2##(1996-2#1)(2009-6#1)
and p53 expression in##3##4##(2008-7#2)(2012-12#1)
and p53##16##2##(1992-3#1)(1993-9#1)(1995-9#1)(2007-5#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#6)(2012-12#1)(2012-2#1)
and p67##2##2##(1991-5#1)(1994-5#1)
and p=0##2##2##(2006-8#1)(2008-12#1)
and pH 12##2##3##(2008-11#2)
and pH 2##2##3##(1994-9#1)(2013-1#1)
and pH 4##2##3##(1997-2#1)(2008-10#1)
and pH 5##5##3##(1994-5#1)(1997-2#1)(2008-10#2)(2008-6#1)
and pH 6##5##3##(1997-2#1)(2008-10#4)
and pH 7##5##3##(1997-2#1)(2008-10#2)(2008-5#1)(2008-8#1)
and pH and##2##3##(2008-10#1)(2008-5#1)
and pH are##2##3##(2008-10#2)
and pH change##2##3##(2008-10#1)(2013-1#1)
and pH changes##2##3##(2013-1#2)
and pH dependence##2##3##(1992-3#1)(2008-4#1)
and pH dependent##2##3##(1993-12#1)(1994-11#1)
and pH for the##2##4##(2008-10#2)
and pH for##3##3##(2008-10#3)
and pH in##5##3##(1990-2#1)(1993-5#1)(2008-10#1)(2008-8#1)(2010-3#1)
and pH measurements##3##3##(1994-7#1)(2008-10#2)
and pH of the mobile phase##2##6##(2008-10#1)(2011-1#1)
and pH of the##9##4##(1990-8#1)(2008-10#6)(2008-6#1)(2011-1#1)
and pH of##20##3##(1990-8#1)(2008-10#17)(2008-6#1)(2011-1#1)
and pH on the##3##4##(2008-10#2)(2008-5#1)
and pH on##6##3##(2008-10#4)(2008-5#1)(2009-12#1)
and pH optima##2##3##(1991-12#1)(2010-3#1)
and pH range##2##3##(2008-10#1)(2008-6#1)
and pH value##2##3##(2008-10#1)(2013-8#1)
and pH values##7##3##(1991-2#1)(2008-10#4)(2008-7#1)(2010-4#1)
and pH was##2##3##(1990-12#1)(2008-10#1)
and pH were##8##3##(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
and pH##137##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-9#2)(1997-2#4)(1997-4#2)(2008-10#73)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#4)(2009-12#2)(2009-9#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#5)(2013-8#2)
and pH)##3##2##(2008-10#2)(2013-8#1)
and pHi##2##2##(1991-5#1)(2007-10#1)
and pI##4##2##(1990-5#1)(1993-8#1)(1994-8#2)
and pK(2)##2##2##(2008-10#2)
and pK(a) values##3##3##(2008-10#3)
and pK(a)##4##2##(2008-10#4)
and pKa2##2##2##(1990-5#1)(2008-10#1)
and pSmad##2##2##(2011-2#2)
and pack##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
and packages##2##2##(2008-3#1)(2010-7#1)
and packaging of##2##3##(1993-2#1)(2008-4#1)
and packaging##7##2##(1993-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)
and packed column##2##3##(2008-10#2)
and packed in##2##3##(2008-10#2)
and packed with##2##3##(1990-8#1)(2008-10#1)
and packed##9##2##(1990-8#1)(2008-10#7)(2012-12#1)
and packing##2##2##(2008-3#1)(2012-3#1)
and packinghouses##2##2##(2008-10#2)
and paclitaxel##4##2##(2007-7#3)(2010-11#1)
and paediatric##3##2##(1990-3#1)(2008-11#1)(2011-2#1)
and paediatricians##2##2##(2008-11#1)(2008-7#1)
and paid##3##2##(1992-3#1)(1996-2#2)
and pain VAS (P = 0##2##6##(2008-10#2)
and pain and##4##3##(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
and pain can be##2##4##(2008-8#2)
and pain for##2##3##(2010-9#1)(2012-12#1)
and pain in both##2##4##(1996-11#1)(2006-10#1)
and pain in the##3##4##(1993-2#1)(2008-9#1)(2012-12#1)
and pain in##7##3##(1993-2#1)(1996-11#1)(2006-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
and pain sensation##2##3##(2008-7#2)
and pain thresholds to argon laser stimulation##2##7##(1993-1#2)
and pain tolerance##2##3##(2008-10#1)(2009-2#1)
and pain was##2##3##(1996-6#1)(2012-12#1)
and pain when##3##3##(2007-8#1)(2009-9#1)(2012-12#1)
and pain##63##2##(1990-9#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-1#4)(1993-2#1)(1994-9#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)
and painful swelling of the##2##5##(1990-11#1)(2008-1#1)
and painful swelling of##3##4##(1990-11#1)(2007-7#1)(2008-1#1)
and painful##12##2##(1990-11#1)(1991-8#1)(1996-12#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2013-7#1)
and painting##4##2##(2008-10#4)
and paired##4##2##(2008-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
and pairwise##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
and palate is##2##3##(2012-12#1)(2013-1#1)
and palate##16##2##(2007-12#3)(2008-10#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#2)(2013-1#5)
and pale##2##2##(2008-5#1)(2012-1#1)
and palisade##2##2##(2008-10#1)(2013-7#1)
and palladium from##2##3##(2008-10#2)
and palladium in##2##3##(2008-10#2)
and palladium on##2##3##(2008-10#2)
and palladium##15##2##(2008-10#15)
and palladium(II)##8##2##(2008-10#6)(2013-1#2)
and palliative care##9##3##(1992-2#1)(2008-7#2)(2010-10#3)(2012-12#1)(2012-3#1)(2013-1#1)
and palliative treatment##2##3##(1996-8#1)(2013-8#1)
and palliative##13##2##(1992-2#1)(1996-8#1)(2008-6#1)(2008-7#2)(2010-10#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and palmitate were##2##3##(1993-8#1)(1994-6#1)
and palmitate##3##2##(1990-2#1)(1993-8#1)(1994-6#1)
and palmitic acid##4##3##(1995-5#2)(2008-12#1)(2010-4#1)
and palpable##3##2##(1992-4#1)(2008-10#1)(2013-1#1)
and palpitations##4##2##(1993-2#1)(1994-11#1)(1997-3#1)(2008-12#1)
and pancreas##13##2##(1990-3#1)(1995-3#3)(1995-6#1)(1996-12#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)
and pancreatic##11##2##(1992-3#1)(1993-3#1)(1994-3#1)(1994-6#1)(2008-5#1)(2008-9#1)(2010-11#2)(2011-2#1)(2013-1#2)
and pancytopenia##2##2##(1990-9#1)(2012-12#1)
and pandemic##2##2##(2010-4#1)(2011-2#1)
and panic disorder##3##3##(1996-7#1)(2007-5#1)(2008-6#1)
and panic##4##2##(1996-7#1)(2007-5#1)(2008-6#1)(2010-2#1)
and panicle##6##2##(2008-10#3)(2008-12#3)
and pannexins##2##2##(2008-7#2)
and panning##2##2##(2008-6#1)(2008-9#1)
and paper##7##2##(1992-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-4#1)
and papilla formation##2##3##(2008-10#2)
and papillary##9##2##(1990-7#1)(1992-2#2)(1993-2#2)(2011-2#4)
and paraaortic node dissection##2##4##(1994-2#2)
and paracetamol by##2##3##(2008-10#2)
and paracetamol##10##2##(1993-2#1)(1995-5#1)(2008-10#8)
and paracrine##11##2##(1992-9#1)(1994-9#1)(1995-8#1)(1996-5#1)(2006-10#1)(2008-4#4)(2013-1#1)(2013-7#1)
and paradigms##3##2##(2008-2#1)(2009-7#1)(2009-8#1)
and paradoxical##3##2##(1992-8#1)(2007-12#1)(2008-9#1)
and paraffin##6##2##(1991-4#1)(2008-1#1)(2008-10#4)
and paraffin-embedded##2##2##(1993-12#1)(2008-9#1)
and parallel efficiency##2##3##(2007-9#2)
and parallel##13##2##(1994-11#1)(1994-6#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and parallelism##3##2##(2007-12#1)(2008-3#1)(2010-11#1)
and parallels##2##2##(2007-12#1)(2008-12#1)
and parameter##3##2##(2008-10#3)
and parameters of##6##3##(2008-10#1)(2008-2#2)(2013-1#3)
and parameters such as##2##4##(2008-3#1)(2008-9#1)
and parameters##20##2##(1990-5#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-1#4)
and parametric##4##2##(2007-12#2)(2008-10#1)(2011-1#1)
and paranasal sinuses##6##3##(1990-6#1)(1992-10#1)(2006-12#1)(2007-4#1)(2008-3#1)(2013-1#1)
and paraplegia##2##2##(2008-12#1)(2010-8#1)
and parasite##12##2##(2007-12#1)(2008-8#7)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
and parasites##9##2##(1994-11#1)(1994-9#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
and parasitic intensity##2##3##(2008-6#2)
and parasitic##5##2##(1996-1#1)(2008-10#1)(2008-6#2)(2012-2#1)
and parasitism##2##2##(1995-3#1)(2008-6#1)
and parasitoid##3##2##(2008-8#3)
and parasitoids##2##2##(2008-8#1)(2009-8#1)
and parasitological##6##2##(1996-12#1)(2008-12#1)(2012-12#3)(2013-1#1)
and parasitology##3##2##(2009-10#1)(2010-1#2)
and parasympathetic##5##2##(2008-10#1)(2008-7#1)(2010-5#1)(2012-2#2)
and parathyroid hormone##2##3##(1990-2#1)(2010-10#1)
and parathyroid##4##2##(1990-2#1)(1995-6#1)(2009-4#1)(2010-10#1)
and paraventricular nucleus##3##3##(1993-12#2)(2008-9#1)
and paraventricular##5##2##(1993-12#2)(1996-12#1)(2008-7#1)(2008-9#1)
and parenchyma##2##2##(2008-10#1)(2013-1#1)
and parenchymal##3##2##(1991-12#1)(1992-3#1)(1993-6#1)
and parenchymatous##3##2##(1992-2#1)(1997-2#1)(2008-6#1)
and parent PAHs##2##3##(2008-11#2)
and parent##16##2##(1992-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(2006-10#1)(2008-11#4)(2008-3#2)(2010-8#1)(2011-2#1)
and parental distress##2##3##(1992-2#1)(1996-2#1)
and parental investment per offspring##2##5##(2008-9#2)
and parental investment##3##3##(2008-8#1)(2008-9#2)
and parental perceptions of##2##4##(2009-7#2)
and parental##18##2##(1991-11#1)(1992-2#2)(1993-1#1)(1994-6#1)(1996-2#1)(2008-12#2)(2008-8#2)(2008-9#2)(2009-7#4)(2010-9#1)(2011-2#1)
and parenteral##7##2##(1991-3#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)
and parenting practices##2##3##(2008-11#1)(2009-7#1)
and parenting skills##2##3##(1992-12#1)(1996-2#1)
and parenting##12##2##(1992-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-11#2)(2009-11#1)(2009-12#1)(2009-7#3)(2010-1#1)
and parents to##2##3##(1993-1#1)(2010-5#1)
and parents##21##2##(1990-9#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-6#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#3)
and parents'##3##2##(2009-7#1)(2009-8#1)(2013-1#1)
and paresis##2##2##(1996-8#1)(2007-11#1)
and parietal cells##3##3##(1997-1#1)(2007-12#2)
and parietal cortex##5##3##(1992-8#1)(1996-5#1)(2008-2#1)(2008-7#2)
and parietal##14##2##(1992-8#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-12#2)(2008-2#2)(2008-7#2)(2010-7#1)(2011-1#1)(2012-1#2)
and parity##3##2##(1990-6#1)(2007-2#1)(2008-3#1)
and part of the first##2##5##(1993-6#1)(1994-12#1)
and part of the##11##4##(1990-5#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
and part of##17##3##(1990-11#2)(1990-5#1)(1991-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
and part##18##2##(1990-11#2)(1990-5#1)(1991-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
and parthenogenesis##2##2##(2010-3#1)(2013-1#1)
and partial characterization of##6##4##(1990-11#1)(1990-12#1)(1992-6#1)(1993-3#1)(1994-6#1)(2008-10#1)
and partial characterization##7##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-6#1)(1993-3#1)(1994-6#1)(2008-10#1)
and partial degradation##2##3##(2008-7#1)(2009-7#1)
and partial least square##5##4##(2008-10#3)(2013-8#2)
and partial least squares (PLS)##5##5##(2008-10#4)(2013-8#1)
and partial least squares regression##3##5##(2008-10#3)
and partial least squares##12##4##(2008-10#11)(2013-8#1)
and partial least##18##3##(2008-10#15)(2013-8#3)
and partial least-squares##2##3##(2008-10#2)
and partial nucleotide##2##3##(1992-11#1)(2008-10#1)
and partial protection##2##3##(1990-6#1)(2013-1#1)
and partial sequencing##2##3##(1992-8#1)(2008-10#1)
and partial##73##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-4#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#25)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
and partially characterized##3##3##(1992-6#1)(1997-6#1)(2008-6#1)
and partially destroyed##2##3##(2007-12#1)(2008-5#1)
and partially overlapping##2##3##(2008-8#1)(2009-10#1)
and partially purified##5##3##(1990-12#1)(1994-11#1)(1996-6#1)(2008-10#2)
and partially##35##2##(1990-12#2)(1990-5#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-10#1)(2010-2#1)(2010-3#1)
and participant characteristics##2##3##(2009-4#1)(2011-2#1)
and participant observation##2##3##(2008-11#1)(2012-12#1)
and participant##7##2##(1997-1#1)(2008-11#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
and participants##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
and participate in the##4##4##(1990-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
and participate in##10##3##(1990-12#1)(1992-12#1)(1992-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
and participation by##2##3##(2008-10#2)
and participation in a##2##4##(1993-11#1)(1996-2#1)
and participation in##13##3##(1990-6#1)(1990-9#1)(1993-11#1)(1993-12#1)(1996-2#1)(2008-1#1)(2008-12#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)
and participation of##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
and participation##23##2##(1990-6#1)(1990-9#1)(1993-11#1)(1993-12#1)(1996-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#3)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#1)
and participatory##2##2##(2009-5#1)(2013-8#1)
and particle size and##2##4##(2008-3#1)(2011-2#1)
and particle size distribution##2##4##(1993-2#1)(2008-3#1)
and particle size##11##3##(1993-2#1)(1995-3#1)(2008-10#4)(2008-3#2)(2009-2#1)(2010-3#1)(2011-2#1)
and particle##18##2##(1993-2#1)(1995-3#1)(1997-2#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)
and particles in the##2##4##(1997-2#1)(2008-10#1)
and particles in##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
and particles##9##2##(1990-12#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-6#1)
and particular##4##2##(1995-8#1)(2007-7#1)(2008-11#1)(2008-6#1)
and particularities of##2##3##(2007-10#1)(2007-8#1)
and particularly for##2##3##(1994-5#1)(2008-8#1)
and particularly in##4##3##(1990-9#1)(1997-8#1)(2009-5#1)(2009-9#1)
and particularly sequences are being generated##2##6##(2008-2#1)(2008-4#1)
and particularly the##6##3##(1992-12#1)(1992-6#1)(1995-11#1)(2008-5#2)(2013-1#1)
and particularly their##2##3##(2012-2#1)(2012-3#1)
and particularly useful##2##3##(2008-11#1)(2009-9#1)
and particularly##42##2##(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
and particulate fractions##4##3##(1996-5#3)(2008-10#1)
and particulate matter##2##3##(2008-10#1)(2008-3#1)
and particulate##9##2##(1995-3#1)(1996-5#3)(1997-4#1)(2008-10#3)(2008-3#1)
and particulates##4##2##(2008-10#3)(2008-11#1)
and partition coefficient##2##3##(1993-1#1)(2007-11#1)
and partitioning##2##2##(1993-8#1)(1993-9#1)
and partly because of##2##4##(1992-2#1)(2012-12#1)
and partly to##2##3##(1997-7#1)(2007-12#1)
and partly with##2##3##(1995-8#1)(2011-2#1)
and partly##13##2##(1992-2#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-12#2)
and partner##4##2##(1993-12#1)(1995-6#1)(2009-5#1)(2010-12#1)
and partnered##2##2##(2010-8#2)
and partners in##2##3##(1997-3#1)(2010-4#1)
and partners##4##2##(1997-3#1)(2009-9#1)(2010-4#1)(2010-5#1)
and partnership##4##2##(1993-3#2)(2008-1#1)(2008-11#1)
and parts of##2##3##(2007-7#1)(2009-4#1)
and parvalbumin##5##2##(1995-5#3)(1996-5#2)
and parvovirus B19##2##3##(2012-3#1)(2013-1#1)
and passage of##2##3##(1991-3#1)(2008-9#1)
and passed through a##3##4##(2007-12#1)(2008-10#2)
and passed through the##3##4##(2008-10#3)
and passed through##6##3##(2007-12#1)(2008-10#5)
and passed##7##2##(2007-11#1)(2007-12#1)(2008-10#5)
and passing through##2##3##(2008-10#1)(2008-3#1)
and passing##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
and passive##17##2##(1995-8#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)
and passively Q-switched##2##3##(2007-11#1)(2008-3#1)
and passively##4##2##(2007-11#2)(2008-3#2)
and past gene##2##3##(2008-8#1)(2012-3#1)
and past##7##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-7#1)
and pasture##2##2##(1996-12#2)
and patch area##2##3##(2008-8#2)
and patch extinction##2##3##(2008-8#2)
and patch##6##2##(2007-8#1)(2008-8#5)
and patches##3##2##(2008-12#1)(2010-6#2)
and patchy##3##2##(2008-2#1)(2010-12#1)(2012-2#1)
and patent ductus arteriosus##2##4##(2008-11#2)
and patent##6##2##(1996-9#1)(2007-12#1)(2008-11#2)(2010-12#1)(2011-2#1)
and paternal care is##2##4##(2008-8#1)(2008-9#1)
and paternal##6##2##(2008-12#1)(2008-8#1)(2008-9#2)(2009-11#2)
and paternally silenced imprinted##2##4##(2008-7#2)
and paternally silenced##3##3##(2008-7#3)
and paternity##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
and path length##4##3##(2008-11#1)(2008-3#3)
and path##6##2##(2008-11#1)(2008-2#1)(2008-3#4)
and pathogen evolution##3##3##(2008-10#2)(2011-10#1)
and pathogen life cycle##2##4##(2008-10#2)
and pathogen population##4##3##(2008-10#4)
and pathogen populations from mixtures##2##5##(2008-10#2)
and pathogen##30##2##(2008-10#25)(2008-8#1)(2008-9#1)(2011-10#2)(2012-2#1)
and pathogen-induced##2##2##(2008-10#2)
and pathogenesis of##11##3##(1990-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
and pathogenesis##15##2##(1990-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and pathogenesis-related##2##2##(2008-10#2)
and pathogenic bacteria##2##3##(2009-5#1)(2012-2#1)
and pathogenic mechanisms##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
and pathogenic##19##2##(2008-10#8)(2008-4#1)(2008-6#1)(2008-9#2)(2009-5#1)(2011-2#3)(2012-2#1)(2012-3#2)
and pathogenicity (hrp) genes##2##4##(2008-10#2)
and pathogenicity assays##2##3##(2008-10#2)
and pathogenicity on##4##3##(2008-10#4)
and pathogenicity tests##4##3##(2008-10#4)
and pathogenicity##23##2##(2008-10#20)(2011-2#1)(2012-3#1)(2013-8#1)
and pathogens##8##2##(1997-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)
and pathologic changes##3##3##(1990-3#1)(1996-6#1)(2010-6#1)
and pathologic conditions##4##3##(1990-12#1)(1993-12#1)(1996-6#1)(2007-11#1)
and pathologic features of##4##4##(1990-6#1)(1991-8#1)(1992-2#1)(2008-1#1)
and pathologic features##5##3##(1990-6#1)(1991-8#1)(1992-2#1)(2008-1#1)(2012-3#1)
and pathologic findings##3##3##(1991-8#1)(1997-8#1)(2012-1#1)
and pathologic##26##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#2)(1991-8#2)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#1)(1996-6#2)(1997-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-6#2)(2012-1#1)(2012-3#2)
and pathological changes##2##3##(1990-6#1)(2008-7#1)
and pathological conditions##3##3##(2008-4#1)(2008-8#1)(2009-8#1)
and pathological development of##2##4##(2012-3#1)(2013-1#1)
and pathological evaluation##2##3##(2010-3#1)(2010-7#1)
and pathological features of the##2##5##(1991-12#1)(2008-7#1)
and pathological features of##7##4##(1991-12#1)(1991-6#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)
and pathological features##9##3##(1991-12#1)(1991-6#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and pathological findings##3##3##(2009-5#1)(2011-1#1)(2012-2#1)
and pathological fracture##3##3##(2007-11#3)
and pathological processes##4##3##(1992-2#1)(2010-12#1)(2010-3#1)(2012-12#1)
and pathological##68##2##(1990-6#1)(1990-9#3)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-3#1)(1997-2#1)(2006-6#1)(2007-11#4)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#5)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#3)
and pathologically##2##2##(2009-1#1)(2010-12#1)
and pathologists##4##2##(1990-10#1)(1991-2#1)(2008-10#1)(2008-11#1)
and pathology of the##2##4##(1997-1#1)(2008-1#1)
and pathology of##4##3##(1990-5#1)(1997-1#1)(2008-1#1)(2008-9#1)
and pathology##13##2##(1990-5#1)(1996-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2013-1#1)
and pathophysiological##11##2##(1994-12#1)(1996-9#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-12#1)
and pathophysiology of the##2##4##(2009-10#1)(2011-1#1)
and pathophysiology of these##2##4##(1992-9#1)(2008-7#1)
and pathophysiology of##9##3##(1992-9#1)(2006-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)
and pathophysiology##17##2##(1992-9#1)(1994-12#1)(2006-12#1)(2008-12#1)(2008-5#3)(2008-7#2)(2009-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2013-8#1)
and pathotypes##2##2##(2008-10#2)
and pathway##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
and pathways involved in##2##4##(2008-11#1)(2012-3#1)
and pathways involved##3##3##(2008-11#1)(2010-6#1)(2012-3#1)
and pathways of##2##3##(2009-8#1)(2013-8#1)
and pathways##14##2##(2008-11#3)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
and patient age##4##3##(1993-12#1)(1996-9#1)(2008-4#1)(2012-3#1)
and patient care##6##3##(1994-1#2)(1995-2#1)(1995-3#1)(2010-12#1)(2010-2#1)
and patient characteristics##2##3##(1993-12#1)(2008-7#1)
and patient compliance##3##3##(1991-6#1)(2008-3#1)(2008-7#1)
and patient education##8##3##(1996-12#1)(1996-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
and patient groups##2##3##(2008-12#1)(2008-4#1)
and patient management##2##3##(2008-10#1)(2008-3#1)
and patient outcome##2##3##(2008-11#1)(2013-8#1)
and patient outcomes##3##3##(2009-8#1)(2011-2#2)
and patient populations##2##3##(1992-12#1)(1992-3#1)
and patient satisfaction with##2##4##(1996-3#1)(2010-8#1)
and patient satisfaction##25##3##(1990-3#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
and patient stratification##2##3##(2008-8#2)
and patient survival##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
and patient##124##2##(1990-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1993-11#3)(1993-12#2)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2009-11#1)(2009-3#3)(2009-8#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#1)
and patient's data##2##3##(2010-8#2)
and patient's##7##2##(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#2)(2010-8#2)
and patient-related factors##2##3##(2011-2#1)(2013-1#1)
and patient-related##4##2##(2007-5#1)(2009-12#1)(2011-2#1)(2013-1#1)
and patient-reported outcomes##2##3##(2008-7#1)(2009-9#1)
and patient-reported##3##2##(2008-7#1)(2009-9#1)(2011-1#1)
and patient-specific##2##2##(1992-3#1)(2012-1#1)
and patients during##2##3##(1993-12#1)(2011-2#1)
and patients have##2##3##(2008-10#1)(2013-1#1)
and patients in the##4##4##(1992-8#1)(1993-1#1)(2009-8#1)(2011-1#1)
and patients in##7##3##(1990-11#1)(1992-8#1)(1993-1#1)(1995-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
and patients is##2##3##(1993-3#1)(1996-1#1)
and patients may##2##3##(2009-5#1)(2012-3#1)
and patients suffering from##2##4##(1991-5#1)(2010-11#1)
and patients to##4##3##(1991-2#1)(1997-3#1)(2009-8#1)(2010-9#1)
and patients under##2##3##(2007-5#1)(2007-7#1)
and patients who had##2##4##(2010-8#1)(2011-2#1)
and patients who have undergone##2##5##(2008-7#1)(2013-8#1)
and patients who##9##3##(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and patients with a##2##4##(2007-8#1)(2011-2#1)
and patients with bilateral##2##4##(2007-10#1)(2012-2#1)
and patients with##41##3##(1990-12#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and patients without MS##2##4##(2012-3#2)
and patients without##3##3##(2007-11#1)(2012-3#2)
and patients##137##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#2)(1996-1#5)(1996-11#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
and patients' social##2##3##(2011-2#2)
and patients'##16##2##(2008-1#1)(2008-11#1)(2008-7#3)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#3)
and patriarchy##2##2##(1991-6#1)(2011-2#1)
and pattern formation##3##3##(1997-3#1)(1997-6#1)(2008-7#1)
and pattern of##7##3##(1990-11#1)(1993-5#1)(1996-5#1)(1997-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
and pattern recognition##3##3##(2008-10#3)
and pattern##17##2##(1990-11#1)(1993-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
and patterns in##3##3##(1991-3#1)(1994-6#1)(2011-2#1)
and patterns of care##2##4##(1991-2#1)(2007-10#1)
and patterns of##12##3##(1990-10#1)(1991-1#1)(1991-2#1)(1992-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
and patterns##17##2##(1990-10#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-5#1)(1994-6#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
and pay for##2##3##(1993-3#1)(1994-3#1)
and pay##4##2##(1993-3#1)(1994-3#1)(2007-11#1)(2008-11#1)
and payer##2##2##(1994-3#1)(2008-12#1)
and payers##5##2##(1991-3#1)(1993-12#1)(1995-3#1)(1997-1#1)(1997-6#1)
and payment systems##2##3##(1996-1#1)(1996-2#1)
and payment##8##2##(1991-1#1)(1992-2#1)(1994-12#1)(1996-1#2)(1996-2#1)(2008-11#1)(2011-1#1)
and payors##5##2##(1992-1#2)(1992-3#1)(1994-1#2)
and pea##5##2##(2008-10#5)
and peach##8##2##(2008-10#8)
and peak area##6##3##(1996-5#1)(2008-10#5)
and peak areas##3##3##(2008-10#3)
and peak current##3##3##(2008-10#3)
and peak flow##2##3##(1990-9#1)(2010-2#1)
and peak height##6##3##(2008-10#6)
and peak inspiratory##2##3##(1994-2#1)(2012-2#1)
and peak power of 0##2##5##(2007-11#1)(2007-12#1)
and peak powers##2##3##(2007-11#1)(2007-12#1)
and peak to##2##3##(2008-10#1)(2008-11#1)
and peak##49##2##(1990-12#1)(1990-9#1)(1991-2#1)(1994-2#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#27)(2008-11#1)(2008-3#2)(2008-5#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
and peaks in##2##3##(1990-7#1)(2011-2#1)
and peanut##3##2##(1994-8#1)(2008-10#2)
and pear##4##2##(2008-10#4)
and pearl##2##2##(1997-4#1)(2008-10#1)
and pectoralis major##2##3##(1992-6#1)(2010-9#1)
and peculiarities of##3##3##(1992-11#1)(2010-9#1)(2012-1#1)
and pedagogical##3##2##(1991-1#1)(2008-11#1)(2012-3#1)
and pediatric##10##2##(1992-1#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#2)
and pediatrics##2##2##(1994-12#1)(1996-9#1)
and pedicle##3##2##(2007-11#2)(2008-7#1)
and pedigree##3##2##(1997-5#1)(2008-10#1)(2008-3#1)
and peer assessment has been##2##5##(2008-11#2)
and peer assessment##6##3##(2008-11#6)
and peer relationships##2##3##(1996-12#1)(2013-1#1)
and peer review##3##3##(1993-1#1)(1993-2#1)(1994-2#1)
and peer##25##2##(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(2007-2#1)(2008-11#7)(2009-12#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#6)
and peers##8##2##(1990-2#3)(1991-2#1)(2009-7#1)(2010-11#1)(2013-1#2)
and pefloxacin##2##2##(2007-7#2)
and pelagic##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
and pellet##4##2##(1997-4#1)(2008-11#1)(2008-6#2)
and pelvic pain##4##3##(1990-6#1)(1992-1#2)(1994-3#1)
and pelvic##13##2##(1990-6#1)(1992-1#2)(1993-1#1)(1994-3#1)(2007-11#2)(2008-5#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
and pelvis and##3##3##(1991-11#1)(2012-2#2)
and pelvis##15##2##(1991-11#1)(2007-10#1)(2007-11#2)(2008-12#5)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#2)
and penetrate the##2##3##(1997-6#1)(2008-8#1)
and penetrate##4##2##(1997-6#1)(2008-10#2)(2008-8#1)
and penetrating##4##2##(1990-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
and penetration of the##2##4##(2008-10#1)(2008-8#1)
and penetration of##4##3##(2008-10#3)(2008-8#1)
and penetration##8##2##(2008-10#5)(2008-5#2)(2008-8#1)
and penicillin##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
and penile length##2##3##(2008-10#1)(2011-1#1)
and penile##5##2##(1991-2#1)(1994-1#1)(2008-10#2)(2011-1#1)
and pension##2##2##(1994-1#1)(2010-12#1)
and pentachlorophenol (PCP)##2##3##(2008-10#2)
and pentachlorophenol##3##2##(2008-10#3)
and pentaerythritol tetranitrate##2##3##(2008-10#2)
and pentagalloylglucose##2##2##(2008-10#2)
and pentavalent##3##2##(2008-10#2)(2009-6#1)
and pentoxyresorufin##2##2##(1994-8#2)
and people in New Zealand##2##5##(1996-12#2)
and people with AIDS##2##4##(1995-12#2)
and people with a##2##4##(2010-12#1)(2012-12#1)
and people with##7##3##(1995-12#2)(1996-12#1)(1997-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
and people##13##2##(1995-12#2)(1996-12#3)(1997-3#1)(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
and pepper##2##2##(2008-10#2)
and peptidase##4##2##(2008-10#3)(2008-9#1)
and peptide##11##2##(1992-8#1)(1993-3#1)(1995-2#2)(1995-5#2)(2008-4#2)(2008-5#1)(2010-7#1)(2013-8#1)
and peptides using##2##3##(1996-5#1)(2008-10#1)
and peptides##19##2##(1990-2#1)(1991-12#1)(1992-11#1)(1995-2#1)(1996-5#3)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-3#1)(2012-2#1)
and peptone after preload##2##4##(1997-4#2)
and peptone after##3##3##(1997-4#3)
and peptone##6##2##(1997-4#4)(2008-10#1)(2012-2#1)
and per capita##3##3##(1991-6#1)(2011-1#1)(2013-7#1)
and per##6##2##(1991-2#1)(1991-6#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-7#1)
and perceived health status##2##4##(2008-6#1)(2013-1#1)
and perceived peer##2##3##(2009-7#2)
and perceived problems##2##3##(1997-7#1)(2008-3#1)
and perceived quality##2##3##(1993-12#1)(1996-3#1)
and perceived##37##2##(1993-12#2)(1994-3#2)(1996-3#4)(1997-1#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#6)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
and percent clay##2##3##(2008-10#2)
and percent of##2##3##(2008-10#1)(2008-4#1)
and percent##16##2##(1997-8#1)(2007-5#1)(2008-10#12)(2008-4#1)(2013-1#1)
and percentage of body fat##2##5##(1997-7#1)(2008-11#1)
and percentage of recovery##2##4##(2008-10#1)(2008-5#1)
and percentage of##17##3##(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)
and percentage##25##2##(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#1)
and percentages##4##2##(2007-11#1)(2008-11#1)(2011-1#1)(2012-12#1)
and perception of##6##3##(1996-3#1)(1996-7#1)(2007-6#1)(2008-7#1)(2010-11#1)(2012-12#1)
and perception##9##2##(1996-3#1)(1996-7#1)(2007-6#1)(2008-7#1)(2010-11#1)(2011-1#2)(2012-12#2)
and perceptions of##23##3##(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
and perceptions##24##2##(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
and perceptual##9##2##(1991-12#1)(1992-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-9#1)(2012-12#1)
and perchlorate##3##2##(2008-10#3)
and perchloric acid##4##3##(2008-10#3)(2008-5#1)
and perchloric##5##2##(2008-10#4)(2008-5#1)
and percutaneous coronary intervention##2##4##(2008-11#1)(2011-2#1)
and percutaneous transluminal coronary angioplasty##2##5##(2007-8#2)
and percutaneous transluminal##3##3##(2007-8#2)(2011-2#1)
and percutaneous##10##2##(1990-8#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#3)
and perennial##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#1)
and perfect##3##2##(2008-2#1)(2008-3#1)(2010-9#1)
and perform##7##2##(1990-12#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)
and performance analysis of##2##4##(2008-3#2)
and performance characteristics of##2##4##(2008-10#1)(2008-3#1)
and performance evaluation##2##3##(1995-1#1)(2008-2#1)
and performance in the##2##4##(1995-12#1)(1996-2#1)
and performance in##7##3##(1995-12#1)(1996-2#2)(2007-10#1)(2008-11#1)(2012-1#1)(2012-12#1)
and performance indicators##4##3##(1992-12#1)(1993-2#1)(2008-11#2)
and performance measurement##2##3##(1996-3#1)(2009-3#1)
and performance of a##9##4##(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2009-11#1)
and performance of the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
and performance of##32##3##(1991-3#1)(1993-12#1)(1996-5#1)(2006-4#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-9#1)(2013-1#1)(2013-8#1)
and performance on##2##3##(2008-8#1)(2012-2#1)
and performance status##2##3##(2007-11#1)(2012-3#1)
and performance##90##2##(1991-3#2)(1992-12#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-3#3)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#12)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#2)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
and performances##2##2##(2008-3#1)(2009-2#1)
and performed a##2##3##(2011-2#1)(2012-3#1)
and performed##21##2##(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2009-1#1)(2009-7#1)(2009-9#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
and performing a##2##3##(1994-12#1)(2008-10#1)
and performing##13##2##(1992-5#1)(1994-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-2#2)(2012-3#1)
and performs##4##2##(1993-3#1)(1994-8#1)(1995-3#1)(2013-8#1)
and perfused##2##2##(1992-6#1)(2012-2#1)
and perfusion will##2##3##(2010-12#1)(2012-2#1)
and perfusion##15##2##(1997-1#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
and perfusion-weighted MRI##2##3##(2007-10#2)
and perfusion-weighted magnetic resonance imaging##3##5##(2007-10#1)(2007-9#2)
and perfusion-weighted##5##2##(2007-10#3)(2007-9#2)
and perhaps other##5##3##(1991-2#1)(1992-2#1)(1995-3#1)(1997-4#1)(2008-8#1)
and perhaps##26##2##(1990-6#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#2)(2012-3#1)
and peri-implantitis##3##2##(2012-2#1)(2013-1#2)
and periampullary##2##2##(1991-3#2)
and pericarditis##2##2##(1995-11#1)(1997-8#1)
and pericytes##2##2##(2011-2#1)(2012-12#1)
and periganglionic injection of##2##4##(2007-10#2)
and perinatal HIV/AIDS in Jamaica##2##5##(2009-7#2)
and perinatal##11##2##(1991-6#1)(1993-6#1)(1996-5#1)(2009-10#1)(2009-7#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and perineal##2##2##(1993-9#1)(2008-10#1)
and perineum##3##2##(1993-1#2)(2008-10#1)
and period of##3##3##(1992-3#1)(2007-11#1)(2011-2#1)
and period##5##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
and periodate##4##2##(1992-9#1)(2008-10#3)
and periodic##10##2##(1993-1#1)(1995-10#1)(1996-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
and periodically##2##2##(2007-12#1)(2009-12#1)
and periodicity of##2##3##(1996-2#1)(2008-4#1)
and periodontal disease##7##3##(1990-3#2)(1995-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2012-3#1)
and periodontal##10##2##(1990-12#1)(1990-3#2)(1995-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2012-3#2)(2013-1#1)
and periodontitis##3##2##(1991-6#1)(2007-7#1)(2012-12#1)
and periods of##5##3##(1994-7#1)(2008-10#1)(2008-3#2)(2010-6#1)
and perioperative complications##2##3##(2006-7#1)(2010-7#1)
and perioperative##8##2##(2006-7#1)(2007-8#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)
and peripancreatic##4##2##(2008-3#2)(2012-2#2)
and peripheral arterial##4##3##(1990-11#1)(1995-2#1)(2008-7#1)(2010-6#1)
and peripheral blood from##2##4##(2008-4#1)(2012-2#1)
and peripheral blood lymphocytes##5##4##(1990-5#1)(1991-12#1)(1994-3#1)(2008-1#1)(2008-9#1)
and peripheral blood##17##3##(1990-5#1)(1991-12#1)(1994-3#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-9#2)(2010-8#1)(2012-2#3)(2012-3#1)
and peripheral nerve##2##3##(1992-6#1)(2008-12#1)
and peripheral nervous system##8##4##(1995-3#1)(1996-12#1)(1996-5#1)(2008-3#1)(2008-7#3)(2013-8#1)
and peripheral nervous##13##3##(1995-3#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2012-2#1)(2013-8#1)
and peripheral neurons##4##3##(1996-12#3)(1997-6#1)
and peripheral neuropathy##2##3##(1990-2#1)(2008-7#1)
and peripheral tissues##3##3##(1991-2#2)(1997-8#1)
and peripheral vascular##2##3##(2008-8#1)(2010-9#1)
and peripheral##87##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-12#4)(1996-5#1)(1997-3#1)(1997-6#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#2)
and peripherally##2##2##(2008-7#1)(2009-4#1)
and periphery##3##2##(1994-8#1)(1996-12#1)(2008-10#1)
and perirenal fat##3##3##(2010-4#3)
and peristaltic##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
and peritoneal dialysis##7##3##(1994-5#1)(2007-12#1)(2007-7#1)(2008-10#4)
and peritoneal tuberculosis##2##3##(2013-1#2)
and peritoneal##16##2##(1991-12#2)(1994-5#1)(1997-4#1)(2007-12#3)(2007-7#1)(2008-10#4)(2012-12#1)(2013-1#3)
and peritoneum##3##2##(1992-8#1)(2008-5#2)
and periurethral##4##2##(1997-7#2)(2008-3#1)(2013-8#1)
and perivascular infiltrating inflammatory cells##3##5##(2012-3#3)
and perivascular##6##2##(1995-12#1)(2008-12#1)(2012-3#3)(2013-1#1)
and periventricular##3##2##(1993-12#1)(2011-2#1)(2012-3#1)
and permanent dentitions##2##3##(2008-12#1)(2012-2#1)
and permanent morbidity was##3##4##(2008-7#3)
and permanent##23##2##(1995-4#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#3)(2013-7#1)
and permanganate##4##2##(2008-10#4)
and permeability of##3##3##(1992-5#3)
and permeability##4##2##(1991-9#1)(1992-5#3)
and permeate##2##2##(2008-10#2)
and permeation of##3##3##(2008-5#3)
and permeation##6##2##(2008-10#1)(2008-5#4)(2011-2#1)
and permethrin)##2##2##(2011-2#2)
and permit##6##2##(1993-12#1)(1995-5#1)(2008-10#2)(2008-9#1)(2012-12#1)
and permits the##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
and permits##19##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#4)(2009-10#1)(2010-6#1)(2012-12#1)
and permitted the##2##3##(2008-10#2)
and permitted##4##2##(1995-12#1)(2008-10#2)(2012-2#1)
and permutation##2##2##(2008-12#1)(2008-7#1)
and peroxidase activities##2##3##(1994-5#1)(2008-10#1)
and peroxidase##13##2##(1991-2#1)(1994-5#2)(2008-10#8)(2008-5#2)
and peroxide##3##2##(2008-10#2)(2008-5#1)
and peroxisome##2##2##(2012-3#1)(2013-8#1)
and peroxisomes##4##2##(2007-12#2)(2008-5#1)(2009-8#1)
and peroxynitrite##4##2##(2008-10#2)(2011-2#2)
and perpendicular to the##3##4##(2008-3#3)
and perpendicular to##4##3##(2008-2#1)(2008-3#3)
and perpendicular##5##2##(2008-2#1)(2008-3#4)
and perpetuation of##4##3##(2008-1#1)(2008-12#3)
and persisted for##4##3##(1993-12#1)(2007-10#2)(2008-10#1)
and persisted in##2##3##(2007-8#1)(2008-10#1)
and persisted##8##2##(1993-12#1)(1997-2#1)(2007-10#2)(2007-8#1)(2008-10#2)(2008-6#1)
and persistence in##2##3##(2008-10#2)
and persistence of the##4##4##(2008-10#1)(2008-8#1)(2011-2#2)
and persistence of##14##3##(1993-8#2)(1995-9#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#3)
and persistence##24##2##(1993-8#2)(1995-5#1)(1995-9#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)
and persistent infections##2##3##(1997-6#1)(2010-1#1)
and persistent mental illness (SPMI)##2##5##(2008-11#1)(2013-1#1)
and persistent mental##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
and persistent##22##2##(1990-3#1)(1991-8#2)(1992-11#1)(1995-12#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2013-1#3)
and persisting##2##2##(1996-5#1)(2008-11#1)
and personal characteristics##3##3##(2007-12#2)(2009-7#1)
and personal digital assistant##2##4##(2008-10#1)(2008-3#1)
and personal equipoise##2##3##(2012-2#2)
and personal experience##3##3##(2007-8#1)(2008-1#1)(2008-8#1)
and personal exposure##3##3##(2008-11#2)(2008-6#1)
and personal health care##2##4##(1996-1#1)(1997-3#1)
and personal health##4##3##(1996-1#1)(1997-3#1)(2008-10#2)
and personal situations##2##3##(1993-12#1)(1993-2#1)
and personal##54##2##(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#3)(1997-3#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
and personality traits##3##3##(1994-2#1)(2009-8#1)(2010-12#1)
and personality##9##2##(1990-2#1)(1994-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
and personality]##2##2##(1994-2#1)(2011-3#1)
and personalized medicine##2##3##(2008-10#1)(2011-1#1)
and personalized##5##2##(2008-10#1)(2009-5#1)(2010-10#2)(2011-1#1)
and personnel##8##2##(1993-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#4)
and persons with##2##3##(1994-9#1)(2007-12#1)
and persons##5##2##(1990-11#1)(1991-5#1)(1994-9#1)(2007-12#2)
and perspective##5##2##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#1)
and perspectives in##4##3##(1991-3#1)(2008-11#1)(2008-5#1)(2009-12#1)
and perspectives##15##2##(1990-12#1)(1991-3#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#2)(2012-12#3)
and perspectives]##2##2##(1990-6#1)(2009-10#1)
and perturbation##3##2##(1993-12#1)(2007-12#1)(2008-2#1)
and perturbed##3##2##(2008-10#2)(2013-1#1)
and pertussis vaccine##3##3##(1992-2#1)(1995-3#1)(1995-5#1)
and pertussis##8##2##(1992-2#3)(1994-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(2007-11#1)
and pervasive##4##2##(2009-11#1)(2012-2#1)(2013-1#2)
and pest##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
and pesticides in##2##3##(2008-10#2)
and pesticides##9##2##(2008-10#8)(2009-8#1)
and petal##2##2##(2008-10#2)
and pethidine##4##2##(2008-10#3)(2010-4#1)
and petioles##2##2##(2008-10#2)
and petroleum##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
and phaC##2##2##(2008-6#2)
and phage##6##2##(1991-9#3)(1993-8#1)(1993-9#1)(2013-1#1)
and phagocytic##2##2##(2012-2#1)(2013-8#1)
and phagocytosis##3##2##(1995-2#1)(2007-10#1)(2008-4#1)
and phantom##2##2##(1995-5#1)(2007-12#1)
and pharmaceutical applications##2##3##(1994-3#1)(2012-2#1)
and pharmaceutical companies##2##3##(2008-5#2)
and pharmaceutical dosage forms##3##4##(2008-10#1)(2011-1#2)
and pharmaceutical dosage##4##3##(2008-10#2)(2011-1#2)
and pharmaceutical formulations##7##3##(2008-10#7)
and pharmaceutical industries##8##3##(2008-10#2)(2008-11#1)(2008-6#2)(2008-9#2)(2009-3#1)
and pharmaceutical preparations##5##3##(2008-10#5)
and pharmaceutical products##3##3##(2008-10#1)(2008-5#2)
and pharmaceutical samples##5##3##(2008-10#4)(2012-2#1)
and pharmaceutical##44##2##(1990-9#1)(1991-6#1)(1994-3#1)(2008-10#23)(2008-11#1)(2008-5#5)(2008-6#2)(2008-9#2)(2009-3#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#2)
and pharmaceuticals##8##2##(2008-10#8)
and pharmacist##2##2##(1994-12#1)(2013-1#1)
and pharmacists##2##2##(1994-12#1)(1995-2#1)
and pharmacodynamic##2##2##(2008-10#1)(2008-8#1)
and pharmacodynamics of##4##3##(1991-1#1)(1991-2#1)(2008-8#1)(2009-11#1)
and pharmacodynamics##9##2##(1991-1#1)(1991-2#1)(1997-4#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-12#1)(2010-6#1)
and pharmacogenomics in oncology##2##4##(2008-10#2)
and pharmacogenomics in##4##3##(2008-10#4)
and pharmacogenomics##5##2##(2008-10#5)
and pharmacokinetic characteristics##2##3##(2008-10#1)(2013-1#1)
and pharmacokinetic##8##2##(1990-6#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)
and pharmacokinetics of##3##3##(1996-1#1)(2008-11#1)(2012-3#1)
and pharmacokinetics##4##2##(1996-1#1)(2008-11#1)(2009-12#1)(2012-3#1)
and pharmacologic treatment##2##3##(2011-2#1)(2013-8#1)
and pharmacologic##8##2##(1990-2#1)(1993-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
and pharmacological approaches##2##3##(1992-9#1)(2009-8#1)
and pharmacological characterization of##2##4##(1996-2#1)(2012-3#1)
and pharmacological inhibition##2##3##(2008-4#1)(2009-3#1)
and pharmacological intervention##2##3##(1991-2#1)(2008-7#1)
and pharmacological properties of##4##4##(1994-11#1)(1995-11#1)(2008-4#1)(2008-7#1)
and pharmacological treatment##4##3##(1991-2#1)(2007-8#1)(2012-2#1)(2012-3#1)
and pharmacological##32##2##(1990-7#1)(1991-2#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-8#1)
and pharmacologically##2##2##(1994-8#1)(2009-7#1)
and pharmacology##6##2##(1994-1#1)(1995-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
and pharmacotherapy of##2##3##(2008-4#1)(2013-8#1)
and pharmacotherapy##5##2##(1991-2#1)(2008-4#1)(2013-1#2)(2013-8#1)
and pharmacy##5##2##(1991-1#1)(1993-3#1)(1994-12#1)(1997-2#1)(2009-6#1)
and pharyngeal##4##2##(2007-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
and pharynx##6##2##(1990-8#2)(1995-5#1)(1997-6#1)(2011-2#1)(2013-1#1)
and phase I trials in##2##5##(2008-5#2)
and phase I##3##3##(2008-5#2)(2008-8#1)
and phase II trials##2##4##(2008-5#2)
and phase II##4##3##(1995-12#1)(2008-5#2)(2008-7#1)
and phase contrast##3##3##(2008-7#1)(2013-3#2)
and phase difference##3##3##(2007-12#2)(2008-3#1)
and phase matching##2##3##(2008-3#2)
and phase modulation with##2##4##(2007-11#1)(2007-12#1)
and phase modulation##5##3##(2007-11#3)(2007-12#2)
and phase transition##3##3##(1990-2#1)(2008-10#1)(2009-11#1)
and phase unwrapping##2##3##(2008-2#1)(2008-3#1)
and phase##79##2##(1990-2#1)(1991-9#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(2007-11#11)(2007-12#12)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#15)(2008-5#5)(2008-7#2)(2008-8#2)(2009-11#1)(2010-4#2)(2012-2#2)(2013-3#2)(2013-8#5)
and phase-matching##2##2##(2007-12#2)
and phase-modulation##2##2##(1995-5#1)(2008-3#1)
and phase-resolved##2##2##(2007-11#1)(2008-3#1)
and phase-shift##2##2##(2008-3#2)
and phenobarbital##2##2##(2008-10#2)
and phenol as##2##3##(2008-10#2)
and phenol in##2##3##(2008-10#2)
and phenol##7##2##(2008-10#6)(2009-12#1)
and phenolic compounds##2##3##(2008-10#1)(2013-1#1)
and phenolic##6##2##(2008-10#3)(2009-7#1)(2012-2#1)(2013-1#1)
and phenology##2##2##(2008-10#1)(2008-8#1)
and phenols in##3##3##(2008-10#3)
and phenols##5##2##(2008-10#5)
and phenomena##2##2##(2008-2#1)(2008-7#1)
and phenotype in##4##3##(2008-10#1)(2008-4#1)(2008-8#2)
and phenotype of arylsulfatase A##2##5##(1997-3#2)
and phenotype of##3##3##(1997-3#2)(2010-7#1)
and phenotype##14##2##(1997-3#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
and phenotypes##8##2##(2008-11#1)(2008-4#2)(2009-10#1)(2010-4#2)(2010-7#1)(2011-1#1)
and phenotypic analyses##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
and phenotypic features##2##3##(2012-3#2)
and phenotypic information##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
and phenotypic plasticity##2##3##(2008-8#2)
and phenotypic##31##2##(1991-6#1)(1992-2#1)(1993-2#1)(1997-3#1)(2007-10#1)(2008-10#8)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#3)
and phenotypically##4##2##(1990-12#1)(2008-10#2)(2011-1#1)
and phenoxyalkanoic##2##2##(2008-10#2)
and phenyl##2##2##(2008-10#2)
and phenylalanine (Phe)##2##3##(2008-10#1)(2013-1#1)
and phenylalanine##7##2##(1990-11#1)(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
and phenylethanolamine N-methyltransferase##2##3##(1991-5#1)(1996-5#1)
and phenylhydrazine##11##2##(1991-12#1)(2008-10#10)
and phenylmercury##5##2##(2008-10#5)
and phenylpropanoids##2##2##(2008-11#2)
and phenytoin##7##2##(2008-10#4)(2008-11#1)(2010-3#1)(2011-1#1)
and pheochromocytoma##2##2##(1992-2#1)(2009-1#1)
and phi##5##2##(1991-11#1)(1991-12#1)(1995-3#1)(2008-10#1)(2011-2#1)
and philanthropic##2##2##(2008-8#1)(2009-4#1)
and philosophers##2##2##(2008-1#1)(2009-6#1)
and philosophical##3##2##(1990-12#1)(2008-11#1)(2008-12#1)
and philosophy##3##2##(2007-3#1)(2008-11#1)(2008-12#1)
and phloem##6##2##(2008-10#2)(2012-8#4)
and phonological awareness skills##2##4##(2008-9#1)(2011-1#1)
and phonological awareness##7##3##(2008-12#3)(2008-9#1)(2011-1#2)(2011-2#1)
and phonological##8##2##(2008-12#3)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)
and phorbol 12-myristate 13-acetate##2##4##(1994-9#1)(1996-2#1)
and phorbol 12-myristate##3##3##(1994-9#1)(1996-2#1)(2013-1#1)
and phorbol ester##4##3##(1990-12#1)(1994-8#1)(1995-6#1)(1996-2#1)
and phorbol ester-stimulated##2##3##(1991-5#1)(1995-6#1)
and phorbol esters##5##3##(1994-8#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-7#1)
and phorbol##19##2##(1990-12#1)(1991-5#1)(1991-9#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-6#3)(1996-2#3)(2008-11#1)(2008-7#1)(2013-1#1)
and phosphatase activity##2##3##(1994-8#1)(2011-1#1)
and phosphatase##3##2##(1994-8#1)(1995-2#1)(2011-1#1)
and phosphatases##3##2##(2009-5#1)(2011-1#1)(2012-12#1)
and phosphate buffer##3##3##(2008-10#2)(2011-3#1)
and phosphate concentration##3##3##(2008-10#2)(2008-6#1)
and phosphate in##2##3##(2008-10#2)
and phosphate metabolism##2##3##(1994-11#1)(2008-4#1)
and phosphate salts##2##3##(2011-2#2)
and phosphate were##2##3##(1996-6#1)(2008-10#1)
and phosphate##30##2##(1992-3#1)(1994-11#2)(1996-6#1)(2008-1#1)(2008-10#14)(2008-4#1)(2008-6#2)(2008-7#2)(2011-2#3)(2011-3#1)(2013-1#2)
and phosphatidic acid##3##3##(1990-12#1)(1994-6#1)(1995-8#1)
and phosphatidyl##2##2##(1992-12#1)(2008-9#1)
and phosphatidylcholine##3##2##(1990-5#1)(1993-11#1)(2012-2#1)
and phosphatidylethanolamine##11##2##(1990-11#1)(1990-2#4)(1992-8#1)(1994-12#2)(2007-11#1)(2008-8#1)(2012-2#1)
and phosphatidylinositol##3##2##(1993-6#1)(1993-8#1)(1994-12#1)
and phosphatidylserine##6##2##(1990-7#1)(1993-11#2)(1994-11#3)
and phosphocholine##3##2##(1990-12#2)(1995-3#1)
and phosphocreatine##2##2##(1993-11#1)(2013-1#1)
and phosphodiesterase##3##2##(1997-7#1)(2010-10#2)
and phosphoenolpyruvate##4##2##(1993-11#1)(1995-3#1)(2008-7#2)
and phosphoglycerate mutase##3##3##(1993-3#1)(2010-12#2)
and phosphoinositide##3##2##(1996-2#2)(1997-1#1)
and phospholipase A2##3##3##(1994-12#1)(1994-6#2)
and phospholipase D##2##3##(1997-6#1)(2011-2#1)
and phospholipase##7##2##(1994-12#1)(1994-3#1)(1994-6#2)(1997-6#1)(2008-5#1)(2011-2#1)
and phospholipid##9##2##(1991-2#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(2009-10#1)(2012-2#1)
and phospholipid-dependent##3##2##(1992-6#1)(1993-8#1)(1997-4#1)
and phospholipids##9##2##(1991-12#1)(1994-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
and phosphomolybdic acid##2##3##(2008-10#2)
and phosphoramidite##2##2##(2008-4#2)
and phosphorescence##2##2##(1992-12#1)(2008-10#1)
and phosphoric##2##2##(2008-10#2)
and phosphorothioate##2##2##(2008-4#2)
and phosphorous##3##2##(2008-10#1)(2008-11#2)
and phosphorus in##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
and phosphorus##19##2##(2007-10#1)(2008-10#7)(2008-12#1)(2008-5#3)(2008-9#2)(2012-2#1)(2013-1#3)(2013-8#1)
and phosphorylated##5##2##(1991-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-2#1)
and phosphorylation of ERK1/2##2##4##(2008-11#1)(2011-2#1)
and phosphorylation of##10##3##(1992-7#1)(1994-8#1)(1995-2#2)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
and phosphorylation##19##2##(1991-12#2)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-6#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)
and photo##2##2##(1995-2#1)(2007-11#1)
and photoacoustic##2##2##(2009-5#1)(2010-2#1)
and photoaffinity##2##2##(1990-12#1)(1994-8#1)
and photoageing##2##2##(2008-5#2)
and photoaging##2##2##(2008-5#1)(2011-2#1)
and photochemical##6##2##(1994-3#1)(1995-2#1)(2008-10#1)(2009-11#1)(2011-3#1)(2012-2#1)
and photochemistry##3##2##(2010-2#2)(2012-8#1)
and photocoagulation##2##2##(1993-1#1)(1993-6#1)
and photodegradation##2##2##(2008-10#1)(2012-3#1)
and photodetectors##2##2##(2008-3#2)
and photodiodes##2##2##(2007-11#1)(2008-3#1)
and photodynamic therapy##5##3##(2009-4#3)(2010-8#1)(2012-3#1)
and photodynamic##7##2##(1991-9#1)(2009-4#4)(2010-8#1)(2012-3#1)
and photographic##2##2##(1996-12#1)(2013-1#1)
and photolithography##2##2##(2008-3#1)(2012-2#1)
and photoluminescence##6##2##(2007-12#1)(2008-10#3)(2008-2#1)(2009-11#1)
and photolytic##2##2##(2011-1#1)(2012-12#1)
and photometric##3##2##(2008-10#3)
and photon##2##2##(2008-2#1)(2008-5#1)
and photonic##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
and photophysical##2##2##(2008-2#1)(2008-3#1)
and photoreceptor##2##2##(1994-5#1)(2010-1#1)
and photosensitive##3##2##(1995-6#1)(2008-8#2)
and photosensitivity##2##2##(2008-5#1)(2012-3#1)
and photostability##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
and photosynthetic pigments##2##3##(2008-12#1)(2011-1#1)
and photosynthetic##5##2##(1994-3#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-7#1)
and photothermal##3##2##(2010-6#1)(2012-12#2)
and phototoxicity##2##2##(2008-11#1)(2008-4#1)
and photovoltaic##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
and phthalic##4##2##(2008-10#4)
and phycocyanin##2##2##(2008-3#1)(2008-8#1)
and phylloplane of creeping bentgrass##2##5##(2008-10#2)
and phylogenetic analyses of##2##4##(2008-10#2)
and phylogenetic analyses##4##3##(2008-10#2)(2013-8#2)
and phylogenetic analysis of##2##4##(1993-12#1)(2008-10#1)
and phylogenetic analysis suggested that##2##5##(2008-10#2)
and phylogenetic analysis##10##3##(1993-12#1)(2008-10#7)(2008-8#2)
and phylogenetic characterization of##2##4##(2008-10#2)
and phylogenetic relationships##5##3##(2008-10#4)(2009-10#1)
and phylogenetic significance of##2##4##(2010-3#1)(2013-1#1)
and phylogenetic##31##2##(1993-12#1)(2008-10#17)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and phylogeny in##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
and phylogeny of##4##3##(2008-10#1)(2008-5#2)(2008-6#1)
and phylogeny##9##2##(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)
and physical activity behaviors##2##4##(2012-2#1)(2013-1#1)
and physical activity in##4##4##(1995-2#1)(2008-7#1)(2013-1#2)
and physical activity on##2##4##(2010-9#1)(2013-8#1)
and physical activity patterns##2##4##(2009-6#1)(2012-2#1)
and physical activity were##2##4##(2008-3#1)(2013-8#1)
and physical activity##26##3##(1995-2#1)(1995-3#1)(1997-1#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-6#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
and physical and mental##2##4##(2009-11#1)(2013-1#1)
and physical and##5##3##(2009-11#2)(2010-11#1)(2010-2#1)(2013-1#1)
and physical changes##2##3##(2008-10#1)(2008-5#1)
and physical characteristics##2##3##(2008-3#1)(2008-5#1)
and physical chemistry##2##3##(2008-5#1)(2009-9#1)
and physical development##2##3##(2008-11#1)(2013-1#1)
and physical disability##2##3##(2007-8#1)(2008-6#1)
and physical disorders##2##3##(1996-7#1)(2013-8#1)
and physical examination are the##2##5##(1997-3#1)(2013-8#1)
and physical examination are##3##4##(1997-3#1)(2010-1#1)(2013-8#1)
and physical examination is##2##4##(1995-11#1)(2008-11#1)
and physical examination to##2##4##(2010-7#1)(2011-2#1)
and physical examination##24##3##(1991-12#1)(1995-11#1)(1995-4#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and physical exercise##2##3##(1996-11#1)(2008-7#1)
and physical function##2##3##(2011-2#1)(2013-1#1)
and physical functioning##2##3##(1995-3#1)(2013-1#1)
and physical health of##2##4##(1996-9#1)(2008-2#1)
and physical health##7##3##(1996-9#1)(2008-2#2)(2009-5#2)(2010-3#1)(2012-2#1)
and physical mapping of##2##4##(2008-10#2)
and physical mapping##5##3##(1995-6#1)(1997-9#1)(2008-10#3)
and physical performance##6##3##(1992-9#1)(1996-3#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
and physical properties of the##2##5##(1990-7#1)(2008-5#1)
and physical properties of##6##4##(1990-7#1)(1992-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
and physical properties##9##3##(1990-7#1)(1992-11#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#2)
and physical self-perceptions##2##3##(2007-12#2)
and physical therapy##3##3##(1997-6#1)(2008-12#1)(2010-6#1)
and physical##171##2##(1990-7#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#5)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#3)(2009-5#3)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#5)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#13)(2013-8#7)
and physically##5##2##(1997-8#1)(2007-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
and physician education##2##3##(1994-12#1)(1997-1#1)
and physician practice##2##3##(1991-12#1)(1994-12#1)
and physician preference##2##3##(2008-10#1)(2009-12#1)
and physician##32##2##(1991-12#1)(1991-3#1)(1992-1#3)(1992-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#2)(1996-1#2)(1996-12#2)(1996-3#2)(1997-1#2)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-3#2)
and physicians and##2##3##(1992-1#1)(2008-11#1)
and physicians are##3##3##(1991-1#1)(1997-4#1)(2008-4#1)
and physicians can##3##3##(1991-3#1)(1996-1#1)(1997-3#1)
and physicians to##2##3##(1996-3#1)(2008-8#1)
and physicians##33##2##(1991-1#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)
and physicians'##2##2##(1996-2#1)(2007-11#1)
and physico-chemical##2##2##(1997-1#1)(2008-5#1)
and physicochemical characteristics##3##3##(2008-10#2)(2008-5#1)
and physicochemical properties of##2##4##(1993-1#1)(2008-10#1)
and physicochemical properties##5##3##(1990-7#1)(1993-1#1)(1994-2#1)(2008-10#1)(2011-2#1)
and physicochemical##12##2##(1990-7#1)(1993-1#1)(1994-2#1)(2008-10#4)(2008-5#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
and physics##2##2##(1994-3#1)(2009-9#1)
and physiologic##10##2##(1990-3#1)(1993-1#1)(1993-6#1)(1996-3#1)(2008-5#2)(2009-12#1)(2010-8#1)(2012-1#1)(2013-7#1)
and physiological aging##2##3##(2010-1#1)(2012-2#1)
and physiological factors##2##3##(1995-6#1)(2008-5#1)
and physiological processes##4##3##(1992-5#1)(1992-8#1)(2008-10#1)(2011-2#1)
and physiological properties of the##2##5##(1997-6#1)(2008-7#1)
and physiological properties##3##3##(1997-6#1)(2008-7#1)(2009-5#1)
and physiological responses##3##3##(2008-9#2)(2013-7#1)
and physiological role of##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
and physiological studies##2##3##(1996-9#1)(2008-7#1)
and physiological##66##2##(1990-6#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-9#1)(1997-4#1)(1997-6#2)(2007-7#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-7#2)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
and physiologically##4##2##(1992-5#1)(2008-5#1)(2008-7#1)(2010-3#1)
and physiology of the##5##4##(1997-1#1)(2007-8#1)(2008-8#1)(2010-9#1)(2012-2#1)
and physiology of this##2##4##(2009-9#1)(2011-1#1)
and physiology of##10##3##(1991-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-2#1)
and physiology##22##2##(1991-12#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
and physiology)##2##2##(2008-9#1)(2010-8#1)
and physiopathological##2##2##(1997-3#1)(2007-10#1)
and physiopathology##4##2##(1992-3#1)(2010-3#1)(2010-6#1)(2013-1#1)
and physiotherapists##2##2##(1991-2#1)(1996-6#1)
and physiotherapy##6##2##(1990-6#1)(1994-9#1)(1996-1#1)(2006-10#1)(2008-3#1)(2012-12#1)
and phytochemical##2##2##(2008-10#1)(2010-5#1)
and phytotoxicity##2##2##(2008-10#1)(2011-1#1)
and pi##2##2##(1991-12#1)(2008-3#1)
and pi-pi##2##2##(2008-10#1)(2009-11#1)
and picosecond##5##2##(1995-2#1)(2007-11#2)(2007-12#2)
and pictorial##4##2##(1992-3#1)(2008-12#1)(2011-2#1)(2012-2#1)
and piezoelectric##3##2##(1992-3#1)(2008-10#1)(2008-2#1)
and pig liver##3##3##(1990-11#1)(1990-2#2)
and pig##9##2##(1990-11#1)(1990-2#2)(1992-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
and pigment##3##2##(1991-5#1)(2008-8#1)(2010-10#1)
and pigmentary##2##2##(1994-12#1)(2013-1#1)
and pigmentation##4##2##(1991-6#1)(2008-10#1)(2008-5#1)(2012-12#1)
and pilot##6##2##(2008-12#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#2)
and pilot-tested##2##2##(2010-3#1)(2011-2#1)
and pimozide##3##2##(1995-12#2)(2010-8#1)
and pindolol##5##2##(2008-10#5)
and pine##2##2##(2008-10#1)(2013-1#1)
and pineal##3##2##(1994-5#2)(2008-9#1)
and piperidine##5##2##(1990-8#2)(2007-11#1)(2008-10#2)
and pipes##2##2##(2008-7#2)
and piriform##2##2##(1996-12#1)(2013-1#1)
and pitch##2##2##(2008-9#1)(2013-8#1)
and pitfalls in##2##3##(1992-1#1)(2012-2#1)
and pitfalls of##3##3##(1994-6#1)(2007-4#1)(2010-8#1)
and pitfalls##11##2##(1992-1#2)(1994-3#1)(1994-6#1)(1997-2#1)(2007-4#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#2)
and pituitary cells##3##3##(2008-4#3)
and pituitary gland##2##3##(1992-3#1)(2008-4#1)
and pituitary##15##2##(1992-3#1)(1993-5#1)(1993-9#1)(1997-3#1)(2008-4#6)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
and pk(a(2))=8##2##2##(2008-10#2)
and pk(a(2))=9##3##2##(2008-10#3)
and place cells##3##3##(2007-8#3)
and place##11##2##(1990-6#1)(1992-11#1)(1993-3#1)(2007-8#5)(2008-10#1)(2010-5#1)(2011-1#1)
and placebo groups##4##3##(1990-3#1)(2008-5#2)(2012-2#1)
and placebo##15##2##(1990-3#1)(1990-6#1)(1994-11#3)(2008-5#2)(2008-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
and placed in a greenhouse##2##5##(2008-10#1)(2008-5#1)
and placed in a##8##4##(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#1)
and placed in the##2##4##(2008-10#1)(2008-2#1)
and placed in##17##3##(1996-11#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2013-1#1)
and placed on##2##3##(2008-5#1)(2008-8#1)
and placed##24##2##(1996-11#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
and placement in##2##3##(2008-10#1)(2008-3#1)
and placement##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
and placenta##6##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
and placental##7##2##(1990-4#1)(1991-9#1)(1995-6#1)(1995-8#1)(2008-9#3)
and places##2##2##(2007-12#1)(2011-2#1)
and placing##2##2##(1993-12#1)(1994-7#1)
and plan##7##2##(1991-12#1)(1993-1#1)(1996-9#1)(1997-3#1)(2007-11#1)(2009-5#1)(2013-8#1)
and planar laser-induced fluorescence##2##4##(2008-2#2)
and planar##7##2##(2007-12#1)(2008-2#4)(2008-3#1)(2008-8#1)
and planned to##2##3##(1992-4#1)(2007-2#1)
and planned##5##2##(1992-4#1)(2007-2#1)(2010-10#2)(2011-1#1)
and planners##2##2##(2011-2#1)(2012-12#1)
and planning for the future##2##5##(1994-2#1)(2008-12#1)
and planning for##3##3##(1994-2#1)(2007-4#1)(2008-12#1)
and planning tools##5##3##(1994-1#2)(1994-2#2)(2007-12#1)
and planning##25##2##(1992-12#1)(1994-1#2)(1994-2#3)(1994-3#1)(1996-2#1)(1996-3#2)(1997-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#4)(2013-8#1)
and plans for##2##3##(1994-2#1)(2008-8#1)
and plans##12##2##(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#4)(2008-8#1)(2013-7#1)
and plant cells##4##3##(2008-11#2)(2008-8#1)(2009-8#1)
and plant death##3##3##(2008-10#3)
and plant disease##2##3##(2008-10#2)
and plant growth##6##3##(2007-11#1)(2008-10#3)(2008-12#1)(2011-2#1)
and plant kingdoms##2##3##(2008-11#1)(2008-8#1)
and plant materials##2##3##(2008-10#1)(2010-5#1)
and plant ontologies##2##3##(2008-7#2)
and plant population##3##3##(2008-12#3)
and plant populations##2##3##(2008-12#2)
and plant resistance##2##3##(2008-10#1)(2008-6#1)
and plant samples were##2##4##(2008-11#1)(2013-7#1)
and plant samples##4##3##(2008-10#2)(2008-11#1)(2013-7#1)
and plant sterol##2##3##(1992-3#1)(1992-6#1)
and plant##82##2##(1990-9#2)(1992-3#1)(1992-6#1)(1992-8#2)(1995-8#1)(1997-4#1)(2007-11#2)(2008-10#31)(2008-11#5)(2008-12#8)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-6#2)(2009-8#4)(2010-5#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
and plantar##2##2##(1997-3#1)(2011-1#1)
and planted with##2##3##(2008-10#1)(2008-12#1)
and planted##4##2##(2008-10#3)(2008-12#1)
and plants and is##2##4##(2008-10#1)(2013-8#1)
and plants were##5##3##(2008-10#1)(2008-12#2)(2008-8#1)(2013-7#1)
and plants with##2##3##(2008-10#2)
and plants##23##2##(1997-3#1)(2008-10#10)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-2#1)(2011-10#1)(2013-1#1)(2013-7#1)(2013-8#1)
and plaque##6##2##(2008-1#1)(2008-2#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-2#1)
and plasma DBH##2##3##(1995-11#2)
and plasma V level and V loss##2##7##(2011-2#2)
and plasma V level and##3##5##(2011-2#3)
and plasma V level##4##4##(2011-2#4)
and plasma and##3##3##(1994-12#1)(1994-8#1)(2008-10#1)
and plasma cell##2##3##(1993-8#1)(2008-7#1)
and plasma cells##2##3##(2008-5#1)(2012-12#1)
and plasma components##2##3##(1990-11#1)(2008-11#1)
and plasma from##3##3##(1995-11#1)(2008-2#1)(2008-4#1)
and plasma is##2##3##(1994-12#1)(2008-10#1)
and plasma membrane##8##3##(1993-1#1)(1993-3#1)(1994-10#1)(1994-11#1)(1996-5#1)(2008-10#1)(2009-4#1)(2013-1#1)
and plasma membranes##4##3##(1990-11#2)(1996-5#1)(2008-10#1)
and plasma nitric oxide levels were##2##6##(2007-10#2)
and plasma nitric oxide levels##3##5##(2007-10#3)
and plasma of##4##3##(1995-12#1)(2013-1#3)
and plasma protein##3##3##(2008-7#1)(2011-1#2)
and plasma samples##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
and plasma##102##2##(1990-11#3)(1990-8#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-11#5)(1995-12#2)(1995-2#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(2007-10#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-2#4)(2010-5#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
and plasma)##2##2##(1992-3#1)(2008-10#1)
and plasmapheresis##4##2##(1993-2#1)(2007-7#1)(2012-3#1)(2013-8#1)
and plasmid##5##2##(1995-8#1)(2008-12#3)(2008-4#1)
and plasminogen activator inhibitor-1 (PAI-1)##2##5##(1994-9#1)(2013-1#1)
and plasminogen activator##5##3##(1992-7#1)(1994-9#1)(2008-11#2)(2013-1#1)
and plasminogen##8##2##(1991-9#1)(1992-3#1)(1992-7#1)(1994-9#1)(2008-11#2)(2013-1#1)(2013-8#1)
and plasmodium##2##2##(1994-11#2)
and plasmon##3##2##(2007-11#1)(2009-11#1)(2009-9#1)
and plastic coverslips##2##3##(2008-10#2)
and plastic##6##2##(1990-3#1)(2008-10#3)(2008-2#1)(2010-8#1)
and plasticity in##2##3##(1996-12#1)(2008-8#1)
and plasticity##13##2##(1996-12#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2012-2#1)
and plasticizer##7##2##(1996-8#2)(2008-10#5)
and plate##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
and plateau##2##2##(1997-2#1)(2012-2#1)
and plateaued##2##2##(2008-6#1)(2010-5#1)
and plated##3##2##(2008-10#1)(2008-11#2)
and platelet aggregation##3##3##(1991-9#1)(1994-8#1)(2008-11#1)
and platelet count##4##3##(1990-3#1)(2007-10#3)
and platelet counts##3##3##(2008-10#2)(2010-5#1)
and platelet levels##2##3##(1991-9#1)(2012-12#1)
and platelet##24##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-3#1)(1994-8#1)(2007-10#4)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-5#1)(2012-12#2)(2013-7#1)
and platelet-activating##3##2##(1992-3#2)(1994-5#1)
and platelet-derived growth factor##2##4##(1997-6#1)(2013-1#1)
and platelets in##2##3##(1991-4#1)(2011-2#1)
and platelets##11##2##(1991-4#2)(1992-12#1)(2006-6#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
and plates##4##2##(2007-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
and plating##2##2##(2008-3#1)(2008-8#1)
and platinum##9##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)
and platinum(II)##2##2##(2008-10#2)
and play a key role in##3##6##(2008-10#1)(2008-5#1)(2012-12#1)
and play a pivotal##2##4##(2008-3#1)(2011-2#1)
and play a role in##3##5##(1997-7#2)(2008-10#1)
and play a significant role in##2##6##(2008-8#1)(2012-2#1)
and play a##13##3##(1997-7#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and play an essential role##2##5##(1992-11#1)(1997-7#1)
and play an important##2##4##(2008-9#1)(2012-12#1)
and play an##4##3##(1992-11#1)(1997-7#1)(2008-9#1)(2012-12#1)
and play important roles in##3##5##(1997-8#1)(2009-5#1)(2012-3#1)
and play important roles##4##4##(1997-8#1)(2009-5#1)(2010-12#1)(2012-3#1)
and play##26##2##(1992-11#1)(1997-6#1)(1997-7#3)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and played##3##2##(1992-12#1)(1997-5#1)(2008-11#1)
and playing surface##2##3##(1990-6#2)
and playing##4##2##(1990-6#2)(2010-8#1)(2012-12#1)
and plays a role in##2##5##(1997-2#1)(2012-2#1)
and plays a##9##3##(1995-8#1)(1997-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
and plays an important role in the##4##7##(1990-9#1)(2008-11#1)(2010-10#1)(2012-1#1)
and plays an important role in##9##6##(1990-9#1)(1996-12#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
and plays an important##10##4##(1990-9#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
and plays##20##2##(1990-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
and pleasantness##4##2##(2008-11#1)(2012-12#3)
and pleural effusion##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
and pleural##6##2##(1991-12#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
and pleurisy##2##2##(2011-2#2)
and ploidy in##2##3##(2008-6#1)(2008-9#1)
and ploidy##3##2##(2008-6#2)(2008-9#1)
and plots##2##2##(1997-8#1)(2008-10#1)
and plotted##2##2##(2008-2#1)(2008-3#1)
and pluralistic##2##2##(2012-12#1)(2012-2#1)
and pneumolysin##3##2##(2008-10#3)
and pneumonia##5##2##(1992-2#1)(1994-6#1)(2008-1#1)(2008-12#1)(2008-3#1)
and pod##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
and pods##2##2##(2008-10#1)(2013-8#1)
and point out##2##3##(2007-11#1)(2007-12#1)
and point to##3##3##(1996-2#1)(2008-11#1)(2012-12#1)
and point##13##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and pointing##2##2##(2008-2#2)
and points of##3##3##(1995-2#1)(2007-6#1)(2010-12#1)
and points out##3##3##(1995-2#1)(1997-5#1)(2008-6#1)
and points to the##2##4##(1995-5#1)(2007-11#1)
and points to##4##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
and points##11##2##(1992-12#1)(1995-2#2)(1995-5#1)(1997-5#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#1)
and polar##11##2##(1990-2#1)(1992-10#1)(1992-5#4)(2008-10#3)(2008-3#1)(2008-5#1)
and polarimetric detectors##2##3##(2008-10#2)
and polarimetric##4##2##(2008-10#2)(2008-3#2)
and polarity##7##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
and polarization characteristics of##3##4##(2007-11#1)(2008-2#2)
and polarization data##2##3##(2008-2#1)(2008-3#1)
and polarization of##5##3##(2008-2#1)(2008-3#3)(2008-4#1)
and polarization properties of##2##4##(2007-12#1)(2008-3#1)
and polarization properties##4##3##(2007-12#3)(2008-3#1)
and polarization##34##2##(1994-6#1)(2007-11#7)(2007-12#6)(2008-10#1)(2008-2#7)(2008-3#10)(2008-4#1)(2013-1#1)
and polarizations of the two##2##5##(2007-11#1)(2007-12#1)
and polarizations of the##3##4##(2007-11#1)(2007-12#1)(2008-4#1)
and polarized##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)
and polarographic##3##2##(2008-10#3)
and police##2##2##(1992-2#1)(2008-7#1)
and policies in##2##3##(2007-2#1)(2010-10#1)
and policies that##2##3##(1995-1#1)(2012-12#1)
and policies##15##2##(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(2007-2#1)(2008-11#2)(2008-7#1)(2010-1#2)(2010-10#1)(2012-12#2)(2013-1#1)
and policy and##2##3##(2010-2#1)(2013-8#1)
and policy implications of##2##4##(1996-1#1)(2008-7#1)
and policy implications on##2##4##(1991-12#1)(2008-11#1)
and policy implications##5##3##(1991-12#2)(1996-1#1)(2008-11#1)(2008-7#1)
and policy makers##6##3##(1994-12#1)(1996-2#1)(2009-7#1)(2010-8#2)(2011-1#1)
and policy options##2##3##(1996-1#1)(1996-12#1)
and policy##36##2##(1991-1#3)(1991-12#2)(1991-2#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-1#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
and policy-makers##4##2##(1995-3#1)(2008-11#1)(2010-8#1)(2013-1#1)
and policymakers##4##2##(1992-3#1)(1995-3#1)(2009-4#1)(2010-4#1)
and poling##2##2##(2007-11#1)(2007-12#1)
and poliomyelitis##2##2##(1991-11#1)(1993-12#1)
and polished##3##2##(2007-11#2)(2009-5#1)
and polishing##6##2##(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-7#1)
and political contexts##2##3##(1991-12#1)(2008-11#1)
and political factors##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
and political issues##2##3##(1996-12#1)(2010-12#1)
and political##35##2##(1991-12#1)(1991-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#1)(2008-1#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
and politics in##3##3##(2008-1#1)(2008-11#1)(2009-7#1)
and politics##7##2##(1995-1#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-7#1)(2013-1#1)
and pollen tubes of Lilium davidii##2##6##(2008-8#2)
and pollen tubes##3##3##(2008-8#3)
and pollen##16##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-8#5)(2008-9#1)(2009-10#3)(2012-7#1)
and pollination and seed dispersal##2##5##(2008-9#2)
and pollination##4##2##(2008-10#1)(2008-9#2)(2009-6#1)
and pollutants##6##2##(2008-10#2)(2008-5#1)(2009-8#1)(2010-11#1)(2011-1#1)
and pollution##5##2##(1990-9#1)(1997-6#1)(2008-3#1)(2008-5#1)(2013-7#1)
and poly##3##2##(1990-12#1)(2008-10#1)(2009-7#1)
and poly(1##2##2##(2008-10#2)
and poly(2-acrylamido-2-methylpropane sulfonate)##2##3##(2008-10#2)
and poly(dimethylsiloxane) (PDMS)##2##3##(2009-11#1)(2009-2#1)
and poly(ethylene glycol)##4##3##(1995-2#1)(2009-7#1)(2013-1#2)
and poly(ethylene##7##2##(1995-2#1)(2008-10#3)(2009-7#1)(2013-1#2)
and poly(methyl methacrylate) (PMMA)##2##4##(2008-3#1)(2010-4#1)
and poly(methyl methacrylate)##3##3##(2008-3#2)(2010-4#1)
and poly(vinyl##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
and poly-deoxyguanosine(11)##2##2##(2008-10#2)
and poly-drug users who used##2##5##(2013-8#2)
and poly-drug users##3##3##(2013-8#3)
and poly-l-aspartic acid##2##3##(2009-8#2)
and polyadenylation of##2##3##(1997-2#1)(1997-7#1)
and polyadenylation##3##2##(1997-2#1)(1997-7#1)(2007-12#1)
and polyamine biosynthesis inhibitors##2##4##(2008-10#2)
and polyamine##6##2##(1993-9#1)(1994-6#1)(1997-3#2)(2008-10#2)
and polyandry in##2##3##(2008-9#2)
and polyaniline##3##2##(2008-10#3)
and polychlorinated biphenyls (PCBs) in##2##5##(2008-10#2)
and polychlorinated biphenyls (PCBs)##3##4##(2008-10#3)
and polychlorinated biphenyls##4##3##(2008-10#4)
and polychlorinated dibenzofurans##4##3##(2008-10#3)(2008-7#1)
and polychlorinated##9##2##(2008-10#8)(2008-7#1)
and polyclonal antibodies##7##3##(1990-5#2)(1992-8#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)
and polyclonal##8##2##(1990-5#2)(1992-8#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)
and polycrystalline##2##2##(1991-1#1)(2008-7#1)
and polycystic ovary##2##3##(2007-7#1)(2008-5#1)
and polycystic##5##2##(1997-1#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-1#1)
and polydipsia##2##2##(1997-3#2)
and polydisperse##2##2##(2008-10#2)
and polydispersity##2##2##(2008-5#1)(2010-2#1)
and polyelectrolytes##2##2##(2008-10#1)(2009-11#1)
and polyethylene##2##2##(2008-10#1)(2008-9#1)
and polygenic##5##2##(1991-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-7#1)
and polyhydramnios##2##2##(2010-4#1)(2012-3#1)
and polyimide##3##2##(2009-7#3)
and polymer concrete structural composites##2##5##(2008-9#2)
and polymer##11##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2012-2#1)
and polymerase chain reaction (PCR) assays##2##6##(2008-10#2)
and polymerase chain reaction (PCR)##10##5##(1992-3#1)(1992-6#1)(1994-1#1)(1996-10#1)(2008-10#5)(2011-2#1)
and polymerase chain reaction and##2##5##(2008-10#1)(2011-2#1)
and polymerase chain reaction in##2##5##(2008-10#2)
and polymerase chain reaction##19##4##(1992-3#1)(1992-6#1)(1994-1#1)(1995-12#2)(1996-10#1)(2007-12#1)(2008-10#10)(2011-2#2)
and polymerase chain reaction-restriction fragment length polymorphism##2##7##(2008-10#2)
and polymerase chain##23##3##(1992-3#1)(1992-6#2)(1994-1#1)(1995-12#2)(1996-10#1)(2007-12#1)(2008-10#13)(2011-2#2)
and polymerase##25##2##(1992-3#1)(1992-6#2)(1994-1#1)(1995-12#2)(1996-10#1)(1996-8#1)(2007-12#1)(2008-10#13)(2008-4#1)(2011-2#2)
and polymeric##6##2##(1990-2#2)(2008-10#2)(2008-5#1)(2012-12#1)
and polymerization##5##2##(1993-8#1)(2008-10#2)(2009-10#1)(2012-2#1)
and polymers##4##2##(2006-12#1)(2008-2#1)(2008-9#1)(2009-2#1)
and polymorphic##7##2##(1992-6#2)(1995-6#1)(2008-10#2)(2008-7#1)(2009-10#1)
and polymorphism of##3##3##(2008-8#1)(2011-1#1)(2012-1#1)
and polymorphism##4##2##(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
and polymorphisms in##2##3##(2008-2#1)(2008-5#1)
and polymorphisms##9##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-5#1)(2010-8#1)
and polymorphonuclear##2##2##(1992-12#1)(2008-7#1)
and polymyalgia rheumatica##2##3##(1994-9#1)(2006-10#1)
and polyparasitism##3##2##(2009-10#1)(2012-12#2)
and polyphenol##2##2##(2008-10#1)(2012-2#1)
and polyphenols##9##2##(2008-10#5)(2009-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
and polyploidization##2##2##(2007-12#1)(2008-7#1)
and polyps##2##2##(1992-5#1)(2012-3#1)
and polysaccharide##2##2##(2008-11#1)(2012-12#1)
and polysaccharides##2##2##(2008-5#1)(2008-6#1)
and polyspermy##4##2##(2008-8#4)
and polystyrene##7##2##(1990-12#1)(2008-10#2)(2008-11#3)(2008-2#1)
and polyunsaturated fatty acids##2##4##(2008-5#1)(2012-2#1)
and polyunsaturated fatty##3##3##(2008-5#1)(2010-2#1)(2012-2#1)
and pons##2##2##(1997-2#1)(2011-1#1)
and pontine##3##2##(1990-12#1)(1993-12#1)(2008-8#1)
and poor availability of##2##4##(2009-4#1)(2013-1#1)
and poor concentration##2##3##(2012-2#1)(2013-8#1)
and poor differentiation##2##3##(2011-2#1)(2012-3#1)
and poor in##2##3##(1991-12#1)(2008-6#1)
and poor outcome##2##3##(2008-12#1)(2008-6#1)
and poor prognosis##2##3##(2009-10#1)(2011-1#1)
and poor school performance##2##4##(2008-11#1)(2009-7#1)
and poor##53##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-5#1)(1995-9#2)(1996-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#2)
and poorer##11##2##(1991-8#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-2#2)
and poorly defined##2##3##(2008-11#1)(2010-8#1)
and poorly differentiated##2##3##(2011-2#1)(2013-7#1)
and poorly managed##2##3##(2008-10#2)
and poorly understood##2##3##(1994-1#1)(2008-8#1)
and poorly##14##2##(1994-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
and popular##4##2##(1994-2#1)(2008-6#1)(2008-7#1)(2010-1#1)
and popularity##2##2##(2009-8#1)(2013-1#1)
and population biology##2##3##(2008-8#1)(2008-9#1)
and population densities of H##3##5##(2008-10#3)
and population densities##5##3##(2008-10#4)(2008-8#1)
and population density##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
and population differentiation##5##3##(2008-10#3)(2012-3#2)
and population dynamics of the##2##5##(2008-10#2)
and population dynamics##4##3##(2008-10#3)(2008-8#1)
and population genetic##3##3##(1995-11#1)(2008-8#1)(2008-9#1)
and population genetics##2##3##(2008-10#1)(2013-1#1)
and population growth##2##3##(2008-8#1)(2011-2#1)
and population levels##2##3##(2008-10#1)(2010-5#1)
and population spike##2##3##(1995-12#2)
and population structure of##4##4##(2008-10#1)(2011-2#2)(2013-8#1)
and population structure##7##3##(2008-10#3)(2011-2#2)(2012-3#1)(2013-8#1)
and population##61##2##(1991-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(1997-2#1)(2007-11#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-8#8)(2008-9#4)(2009-7#1)(2010-5#2)(2010-8#3)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
and population-based##6##2##(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
and population-level##2##2##(2008-8#1)(2013-1#1)
and populations from##2##3##(2008-10#2)
and populations of##2##3##(2008-10#2)
and populations##11##2##(1990-12#1)(1995-11#1)(1996-2#1)(2008-10#5)(2008-7#1)(2008-8#1)(2010-8#1)
and porcine follicular fluid##2##4##(1990-12#2)
and porcine##7##2##(1990-11#1)(1990-12#2)(1993-11#1)(1995-3#1)(1997-7#1)(2008-8#1)
and pore size##4##3##(2008-10#2)(2008-7#1)(2009-11#1)
and pore##7##2##(1994-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-10#1)
and pork quality##2##3##(2010-4#2)
and pork##6##2##(1997-4#1)(2008-10#2)(2010-4#3)
and porosity##5##2##(2008-12#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-2#1)
and porous##3##2##(2009-12#1)(2012-1#1)(2012-2#1)
and porphyrin##2##2##(2008-10#2)
and portability##3##2##(2008-10#2)(2009-12#1)
and portable##8##2##(2008-10#6)(2010-7#1)(2013-8#1)
and portal hypertension##9##3##(1991-5#1)(1991-6#1)(2006-10#2)(2009-8#3)(2010-10#1)(2013-1#1)
and portal##16##2##(1991-5#1)(1991-6#1)(1997-8#2)(2006-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#3)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
and pose a##2##3##(2008-1#1)(2010-3#1)
and pose##3##2##(2008-1#1)(2010-3#1)(2013-1#1)
and poses a##3##3##(1995-2#1)(2008-7#1)(2013-8#1)
and poses##5##2##(1995-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
and position of the##9##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
and position of##12##3##(1990-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
and position##24##2##(1990-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
and positional##6##2##(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
and positioned##3##2##(1994-2#1)(1997-9#1)(2008-10#1)
and positioning of the##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
and positioning of##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
and positioning##8##2##(1997-4#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)(2012-3#1)
and positions of the##2##4##(2008-10#1)(2008-4#1)
and positions of##5##3##(1992-3#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-4#1)
and positions##7##2##(1992-3#1)(1994-8#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
and positive and negative##3##4##(2009-11#1)(2013-1#2)
and positive controls##2##3##(2008-10#2)
and positive family history##2##4##(2008-3#1)(2012-3#1)
and positive predictive values##3##4##(1994-3#1)(2007-10#1)(2012-12#1)
and positive predictive##4##3##(1994-3#1)(2007-10#1)(2008-11#1)(2012-12#1)
and positive samples##2##3##(2008-1#1)(2008-10#1)
and positive##53##2##(1990-12#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
and positively associated with##2##4##(2008-1#1)(2011-2#1)
and positively charged##6##3##(1990-5#1)(1994-9#2)(2008-10#2)(2008-7#1)
and positively correlated with##9##4##(2008-10#7)(2008-5#1)(2011-2#1)
and positively related to##4##4##(1990-8#1)(2007-12#1)(2009-7#1)(2013-1#1)
and positively##29##2##(1990-11#2)(1990-5#1)(1990-8#1)(1994-9#2)(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
and positron emission tomography (PET)##2##5##(1995-12#1)(1996-7#1)
and positron emission tomography##3##4##(1995-12#1)(1996-7#1)(2008-2#1)
and posits##2##2##(2008-11#1)(2008-12#1)
and possess##5##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2012-12#1)
and possesses a##3##3##(1992-6#1)(1994-11#1)(1994-2#1)
and possesses##6##2##(1992-6#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
and possibilities for improving##2##4##(1996-12#1)(2008-1#1)
and possibilities for##3##3##(1996-12#1)(2008-1#1)(2008-10#1)
and possibilities of##7##3##(1990-11#1)(1993-11#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-9#1)(2011-3#1)
and possibilities##14##2##(1990-11#1)(1993-11#1)(1994-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-3#1)(2013-1#1)
and possibility of##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
and possible applications##2##3##(2008-2#1)(2008-7#1)
and possible clinical##2##3##(2008-7#1)(2012-3#1)
and possible complications of orthotic use is essential for appropriate decision making##2##12##(2007-11#1)(2007-8#1)
and possible complications of##4##4##(1993-8#1)(2007-11#1)(2007-8#1)(2012-3#1)
and possible complications##6##3##(1993-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-1#1)(2012-3#1)
and possible contributing factors##2##4##(2008-11#1)(2011-2#1)
and possible future directions##2##4##(1996-12#1)(2008-11#1)
and possible future##3##3##(1996-12#1)(2008-11#1)(2011-7#1)
and possible implications for##2##4##(2007-2#1)(2012-1#1)
and possible implications##3##3##(1991-3#1)(2007-2#1)(2012-1#1)
and possible involvement in##2##4##(1995-12#1)(2008-5#1)
and possible mechanism##2##3##(2007-12#1)(2011-2#1)
and possible mechanisms##2##3##(1991-1#1)(2008-8#1)
and possible phylogenetic implications are discussed##2##6##(2007-12#2)
and possible side effects##2##4##(1995-1#1)(2007-11#1)
and possible solutions##6##3##(1994-12#1)(2007-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)
and possible treatment##4##3##(2008-6#1)(2008-7#2)(2010-12#1)
and possible##91##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#2)(1993-8#2)(1994-12#1)(1995-1#2)(1995-12#1)(1996-12#1)(1997-5#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#2)
and possibly also other##2##4##(1994-8#1)(1995-3#1)
and possibly also##6##3##(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-4#1)(2010-2#1)
and possibly for##3##3##(2008-1#1)(2013-1#1)(2013-8#1)
and possibly in##3##3##(1990-5#1)(1992-8#1)(2008-10#1)
and possibly its##2##3##(2008-8#2)
and possibly other##9##3##(1995-12#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)
and possibly the##3##3##(1992-12#1)(2008-5#1)(2010-7#1)
and possibly##76##2##(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-8#1)(1997-5#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
and post mortem##3##3##(1995-9#1)(2008-7#1)(2011-1#1)
and post registration##3##3##(2008-11#2)(2008-12#1)
and post treatment##2##3##(2010-9#1)(2013-1#1)
and post##28##2##(1990-5#1)(1991-5#1)(1995-9#1)(1996-3#1)(2007-11#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and post-##4##2##(2012-12#4)
and post-column##3##2##(2008-10#3)
and post-genomic##3##2##(2009-5#1)(2009-9#1)(2012-3#1)
and post-implantation loss##2##3##(1996-12#2)
and post-implantation##3##2##(1996-12#2)(2008-9#1)
and post-initiation##2##2##(1992-5#2)
and post-menopausal##2##2##(1994-7#1)(2012-12#1)
and post-mortem##2##2##(1996-12#1)(2008-6#1)
and post-operative management##2##3##(2007-11#1)(2011-2#1)
and post-operative##11##2##(1990-9#1)(1991-5#1)(2007-11#2)(2007-8#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and post-stage##2##2##(2013-8#2)
and post-synaptic##2##2##(2008-10#1)(2012-12#1)
and post-test design##2##3##(1993-1#1)(1996-1#1)
and post-test##9##2##(1993-1#1)(1994-1#3)(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2013-1#1)
and post-traumatic stress##2##3##(1992-9#1)(2013-8#1)
and post-traumatic##6##2##(1990-9#1)(1992-9#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
and post-treatment##9##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-1#1)(2013-1#4)
and postalveolar##2##2##(2009-12#2)
and postdeposition##2##2##(2008-2#1)(2008-3#1)
and poster##2##2##(2008-5#2)
and posterior and##2##3##(2008-12#1)(2008-6#1)
and posterior cingulate cortex/precuneus##2##4##(2008-6#2)
and posterior cingulate##5##3##(2008-11#1)(2008-6#3)(2013-8#1)
and posterior fusion and##2##4##(2008-12#1)(2009-3#1)
and posterior interosseous neurectomy##2##4##(2008-9#2)
and posterior parietal regions##3##4##(1997-2#1)(2008-11#1)(2012-1#1)
and posterior parietal##4##3##(1997-2#2)(2008-11#1)(2012-1#1)
and posterior probability##2##3##(1995-2#1)(2010-4#1)
and posterior surface of the##2##5##(2007-8#1)(2012-1#1)
and posterior##71##2##(1990-12#1)(1990-3#1)(1991-5#2)(1993-1#1)(1993-12#2)(1994-9#1)(1995-2#2)(1997-2#2)(1997-3#2)(2007-11#3)(2007-12#4)(2007-8#2)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#4)(2008-8#8)(2008-9#2)(2009-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-1#3)(2012-3#1)(2013-1#6)(2013-8#1)
and posterolateral##3##2##(2010-3#1)(2013-1#2)
and posters##3##2##(2008-10#2)(2008-7#1)
and postexercise##2##2##(2013-8#2)
and postgraduate##7##2##(1994-12#2)(1997-5#1)(2007-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
and postinfectious##2##2##(2008-10#1)(2010-12#1)
and postmarketing##2##2##(2008-11#1)(2010-5#1)
and postmating##2##2##(2012-12#1)(2012-3#1)
and postmenopausal patients##3##3##(1993-12#1)(1994-12#1)(1994-2#1)
and postmenopausal##6##2##(1993-12#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-3#1)(2013-7#1)
and postnatal day##2##3##(1996-12#1)(1996-5#1)
and postnatal periods##2##3##(1996-5#1)(2008-1#1)
and postnatal##22##2##(1991-9#2)(1993-12#1)(1993-3#2)(1993-5#1)(1994-11#2)(1995-1#1)(1996-12#1)(1996-5#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
and postnatally##2##2##(1996-5#1)(2012-3#1)
and postoperative care##4##3##(2009-5#1)(2010-5#1)(2010-7#2)
and postoperative complications##3##3##(2006-10#1)(2008-9#1)(2011-3#1)
and postoperative evaluation##2##3##(2008-7#1)(2013-8#1)
and postoperative morbidity##4##3##(1994-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
and postoperative pain##3##3##(1994-3#1)(2007-9#1)(2013-1#1)
and postoperative period##2##3##(2007-8#1)(2013-1#1)
and postoperative radiotherapy##3##3##(1990-12#1)(1991-4#1)(1994-2#1)
and postoperative treatment##3##3##(1990-12#1)(1992-9#1)(2013-1#1)
and postoperative##61##2##(1990-12#2)(1990-9#1)(1991-4#1)(1992-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#3)(1996-2#1)(1996-6#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-7#3)(2008-9#7)(2009-10#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#7)(2013-8#1)
and postoperatively##5##2##(2007-8#1)(2008-9#1)(2009-10#2)(2013-8#1)
and postpartum##5##2##(2008-10#1)(2008-8#1)(2008-9#3)
and postprandial plasma##2##3##(2011-1#1)(2012-3#1)
and postprandial##6##2##(2011-1#3)(2012-3#2)(2012-4#1)
and postprocessing##2##2##(2008-2#1)(2008-3#1)
and postsynaptic neurons##2##3##(2008-11#1)(2009-8#1)
and postsynaptic##11##2##(1990-12#1)(1995-12#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#2)(2009-9#2)(2012-12#1)(2012-3#1)
and posttranscriptional##3##2##(1991-5#1)(2008-11#1)(2012-12#1)
and posttranslational##2##2##(1994-8#1)(2008-2#1)
and posttraumatic stress disorder##2##4##(2009-11#1)(2011-2#1)
and posttraumatic stress##5##3##(2009-11#2)(2011-2#1)(2012-3#2)
and posttraumatic##6##2##(2007-8#1)(2009-11#2)(2011-2#1)(2012-3#2)
and posttreatment##3##2##(2008-7#1)(2009-7#1)(2012-2#1)
and postural instability##2##3##(2008-7#2)
and postural reflexes##2##3##(1996-7#2)
and postural stability##2##3##(2008-7#1)(2010-12#1)
and postural thermoregulation##2##3##(2011-2#2)
and postural##11##2##(1994-3#1)(1996-7#2)(2008-12#1)(2008-7#4)(2010-12#1)(2011-2#2)
and posture##2##2##(1992-5#1)(1993-5#1)
and postzygotic##2##2##(2012-3#2)
and potassium bromate in phosphoric acid medium##2##7##(2008-10#2)
and potassium bromate##5##3##(2008-10#4)(2008-9#1)
and potassium chloride##2##3##(2008-10#2)
and potassium concentrations##2##3##(1995-8#1)(2008-10#1)
and potassium gadolinium tungstate##2##4##(2008-10#2)
and potassium in##4##3##(2008-10#3)(2008-12#1)
and potassium ions##2##3##(2008-10#2)
and potassium nitrate##2##3##(2008-10#2)
and potassium##55##2##(1990-7#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
and potato##20##2##(2008-10#18)(2008-12#1)(2008-8#1)
and potatoes##2##2##(1990-8#1)(2008-10#1)
and potency of##3##3##(1994-8#1)(1997-4#1)(2008-5#1)
and potency##6##2##(1994-8#1)(1997-4#2)(2007-10#1)(2008-10#1)(2008-5#1)
and potent##13##2##(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
and potential application in##2##4##(2008-10#1)(2013-1#1)
and potential applications##4##3##(1996-12#1)(2008-11#1)(2009-4#1)(2010-12#1)
and potential clinical##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
and potential for##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
and potential future##4##3##(1997-8#1)(2008-11#1)(2009-4#1)(2012-12#1)
and potential health##2##3##(2008-12#1)(2011-1#1)
and potential impact on##2##4##(2009-11#1)(2010-9#1)
and potential liability##2##3##(1991-12#1)(1993-2#1)
and potential mechanisms##2##3##(2008-4#1)(2012-2#1)
and potential of##7##3##(2008-10#2)(2008-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
and potential pitfalls##2##3##(2008-4#1)(2012-2#1)
and potential pulse amplitude##2##4##(2008-10#2)
and potential solutions##2##3##(1996-12#1)(2010-6#1)
and potential therapeutic##2##3##(1997-1#1)(2008-7#1)
and potential therapy##2##3##(2007-11#1)(2008-5#1)
and potential uses of##2##4##(1996-3#1)(2010-5#1)
and potential##112##2##(1990-12#1)(1991-12#1)(1991-6#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#3)
and potentially dangerous##2##3##(1995-3#1)(1997-7#1)
and potentially fatal##2##3##(2007-8#1)(2012-3#1)
and potentially interfering ions of##2##5##(2008-10#2)
and potentially toxic##2##3##(2008-10#1)(2008-7#1)
and potentially##56##2##(1993-11#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-9#2)(2010-1#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
and potentials on pH##2##4##(2008-10#2)
and potentials##5##2##(1991-11#1)(1995-1#1)(2008-10#3)
and potentiated the##2##3##(1992-11#1)(1995-12#1)
and potentiated##4##2##(1992-11#1)(1995-12#1)(2008-10#1)(2008-11#1)
and potentiates the##2##3##(1997-2#1)(2010-12#1)
and potentiates##4##2##(1997-2#2)(1997-4#1)(2010-12#1)
and potentiation of##3##3##(1996-5#1)(2007-7#1)(2008-12#1)
and potentiometric titration##3##3##(2008-10#3)
and potentiometric##7##2##(2008-10#7)
and potentiometry##3##2##(2008-10#3)
and potyviruses##3##2##(2008-10#3)
and poultry##5##2##(1990-3#1)(2008-10#2)(2011-2#2)
and powder inhalers##2##3##(1992-3#1)(1996-1#1)
and powder##7##2##(1992-3#1)(1996-1#1)(2008-10#2)(2009-7#1)(2010-4#1)(2012-1#1)
and powdery mildew##2##3##(2008-10#2)
and power density##2##3##(2008-3#2)
and power in the##2##4##(1995-2#1)(2008-3#1)
and power of##3##3##(1997-3#1)(2008-2#1)(2008-5#1)
and power spectra##2##3##(2007-11#1)(2008-8#1)
and power spectrum##2##3##(1990-8#1)(2008-11#1)
and power to##2##3##(2007-7#1)(2009-9#1)
and power##33##2##(1990-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-3#3)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2013-1#1)
and power-consumption##2##2##(2008-10#1)(2008-2#1)
and powered##2##2##(2007-9#1)(2012-3#1)
and powerful method##2##3##(2008-3#1)(2013-1#1)
and powerful tool##2##3##(2008-2#1)(2008-9#1)
and powerful##16##2##(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
and practical aspects##2##3##(1991-12#1)(2008-11#1)
and practical challenges##2##3##(2008-7#1)(2010-3#1)
and practical considerations##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
and practical detection##2##3##(2008-3#2)
and practical field##2##3##(2008-10#1)(2008-3#1)
and practical issues regarding##2##4##(1996-6#1)(2008-10#1)
and practical method##4##3##(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
and practical model##2##3##(2008-12#1)(2008-9#1)
and practical problems that##2##4##(2008-7#1)(2010-3#1)
and practical problems##3##3##(2008-2#1)(2008-7#1)(2010-3#1)
and practical training##3##3##(1994-12#3)
and practical##68##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-12#4)(1995-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-12#1)(2010-3#3)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and practically##9##2##(1993-11#1)(1997-6#1)(2008-10#2)(2008-3#2)(2009-12#1)(2011-1#1)(2012-2#1)
and practice among##2##3##(1992-3#1)(2013-1#1)
and practice and##3##3##(1996-9#1)(2011-1#1)(2012-12#1)
and practice are discussed##3##4##(2008-11#1)(2008-12#1)(2009-8#1)
and practice are##4##3##(2008-11#1)(2008-12#1)(2009-8#1)(2010-10#1)
and practice can##2##3##(2008-11#1)(2011-2#1)
and practice guidelines##3##3##(1993-12#1)(1994-3#1)(2010-10#1)
and practice in##5##3##(1991-6#1)(2008-11#1)(2012-3#1)(2013-8#2)
and practice is##4##3##(2008-1#1)(2008-11#1)(2010-10#2)
and practice of cancer pain treatment##2##6##(1997-3#2)
and practice of##19##3##(1993-12#1)(1994-5#1)(1995-1#2)(1995-3#1)(1997-3#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#3)
and practice regarding##2##3##(1990-8#1)(2011-1#1)
and practice##128##2##(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-9#1)(1994-1#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#4)(2006-10#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-11#18)(2008-12#13)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#13)(2010-3#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#5)(2012-12#5)(2012-3#2)(2013-1#9)(2013-8#4)
and practiced##2##2##(2009-10#1)(2013-1#1)
and practices among##2##3##(2008-11#1)(2013-1#1)
and practices are##2##3##(1996-2#1)(2010-9#1)
and practices in the##3##4##(2009-7#1)(2011-2#2)
and practices in##7##3##(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#3)(2012-12#1)
and practices of##10##3##(1990-6#1)(1990-8#1)(2008-1#1)(2008-9#1)(2010-10#1)(2012-2#2)(2013-1#2)(2013-7#1)
and practices regarding##3##3##(2009-9#1)(2010-11#1)(2010-6#1)
and practices that##2##3##(2008-5#1)(2010-7#1)
and practices##55##2##(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#2)(1997-3#1)(2008-1#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)
and practicing##3##2##(1996-1#1)(2008-12#1)(2008-3#1)
and practitioners must##2##3##(2008-12#1)(2008-7#1)
and practitioners to##4##3##(1996-1#1)(2008-11#1)(2010-11#1)(2010-9#1)
and practitioners##17##2##(1993-12#1)(1993-2#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
and pragmatic##3##2##(2008-3#1)(2008-7#1)(2010-4#1)
and pre- and##2##3##(2012-12#1)(2013-1#1)
and pre-concentration of##6##3##(2008-10#6)
and pre-concentration##8##2##(2008-10#8)
and precancerous##5##2##(2011-2#1)(2011-3#4)
and preceding##2##2##(2008-10#1)(2010-12#1)
and precipitated##4##2##(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
and precipitating##3##2##(1991-1#1)(2008-2#1)(2012-3#1)
and precipitation were##2##3##(2008-10#1)(2009-7#1)
and precipitation##10##2##(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#2)(2013-1#1)
and precise analytical procedure##2##4##(2008-10#2)
and precise analytical##4##3##(2008-10#4)
and precise and##2##3##(2008-10#1)(2013-8#1)
and precise determination of uranium in concentrates and##2##8##(2008-10#2)
and precise determination of##4##4##(2008-10#4)
and precise results##4##3##(2008-10#3)(2010-3#1)
and precise spectrophotometric##3##3##(2008-10#3)
and precise##57##2##(1992-12#1)(1996-2#1)(2007-7#1)(2008-10#34)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
and precisely##4##2##(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)
and precision and##2##3##(2008-10#1)(2009-8#1)
and precision associated with this##2##5##(2008-10#2)
and precision at the##2##4##(2008-10#2)
and precision for##5##3##(2008-10#3)(2008-3#1)(2011-2#1)
and precision in the##4##4##(2007-11#1)(2008-10#3)
and precision in##7##3##(2007-11#1)(2008-10#4)(2008-3#1)(2008-8#1)
and precision of the method##5##5##(1990-8#1)(2008-10#4)
and precision of the results##2##5##(2008-10#1)(2008-2#1)
and precision of the##14##4##(1990-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2010-5#1)
and precision of this method##2##5##(2008-10#1)(2011-1#1)
and precision of this##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
and precision of##25##3##(1990-8#1)(1991-3#1)(2008-10#18)(2008-2#2)(2008-3#1)(2010-5#1)(2011-1#1)
and precision was##4##3##(2008-10#4)
and precision were##6##3##(2008-10#3)(2009-8#1)(2011-2#1)(2011-3#1)
and precision##106##2##(1990-2#1)(1990-8#1)(1991-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#74)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-1#4)
and precision)##2##2##(2008-10#2)
and preclinical##2##2##(2010-11#1)(2012-2#1)
and precolumn##2##2##(1991-12#1)(2008-10#1)
and preconcentrate##2##2##(2008-10#2)
and preconcentrated##6##2##(2008-10#6)
and preconcentration for the##3##4##(2008-10#3)
and preconcentration in a##2##4##(2008-10#2)
and preconcentration of Cr(III) and Cr(VI)##2##6##(2008-10#2)
and preconcentration of U(VI)##3##4##(2008-10#3)
and preconcentration of inorganic##3##4##(2008-10#3)
and preconcentration of samples##2##4##(2008-10#2)
and preconcentration of trace##7##4##(2008-10#7)
and preconcentration of##37##3##(2008-10#37)
and preconcentration parameters##2##3##(2008-10#2)
and preconcentration procedures##2##3##(2008-10#2)
and preconcentration time)##2##3##(2008-10#2)
and preconcentration##68##2##(2008-10#68)
and predation risk##2##3##(2008-9#1)(2012-3#1)
and predation##6##2##(2007-7#1)(2008-8#1)(2008-9#3)(2012-3#1)
and predator diversity##2##3##(2008-9#2)
and predator odors##2##3##(2008-4#2)
and predator species##2##3##(2008-9#2)
and predator##10##2##(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#4)(2012-3#1)
and predators##5##2##(2008-8#3)(2008-9#1)(2009-2#1)
and predict the##9##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-6#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-3#1)
and predict##19##2##(1992-11#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-5#2)(2010-7#1)(2011-3#1)(2013-8#2)
and predictable##6##2##(2007-12#2)(2008-10#1)(2008-7#1)(2009-6#1)(2010-7#1)
and predicted amino acid sequence##2##5##(1992-3#1)(2008-9#1)
and predicted amino acid##3##4##(1992-3#1)(2008-10#1)(2008-9#1)
and predicted secondary##2##3##(1990-4#1)(1993-3#1)
and predicted the coding sequences of the corresponding genes##3##9##(1995-8#1)(1996-10#1)(1996-2#1)
and predicted the##4##3##(1995-8#1)(1996-10#1)(1996-2#1)(2008-8#1)
and predicted##31##2##(1990-4#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#2)(2010-8#2)(2011-2#1)(2013-1#2)
and predicting the##4##3##(2007-12#1)(2008-3#2)(2008-8#1)
and predicting##13##2##(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
and prediction ability##2##3##(2008-10#1)(2013-8#1)
and prediction of the##2##4##(2007-8#1)(2008-10#1)
and prediction of##10##3##(1995-9#1)(2007-8#1)(2008-10#3)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
and prediction rates##2##3##(2008-10#2)
and prediction##26##2##(1994-12#1)(1995-9#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
and predictions are##3##3##(2008-7#1)(2008-8#1)(2009-11#1)
and predictions of##3##3##(2008-6#1)(2008-7#1)(2010-4#1)
and predictions##7##2##(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-4#1)(2013-1#1)
and predictive factors of##2##4##(2008-10#1)(2010-7#1)
and predictive factors##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
and predictive models##2##3##(2008-7#2)
and predictive value##2##3##(1991-12#1)(2013-1#1)
and predictive##15##2##(1991-12#1)(1993-2#1)(1997-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
and predictors of response to infliximab##2##6##(2012-2#1)(2013-8#1)
and predictors of##10##3##(1995-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2011-1#1)(2012-2#3)(2013-8#2)
and predictors##11##2##(1995-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-2#3)(2013-8#2)
and predicts the##3##3##(2007-11#2)(2008-3#1)
and predicts##8##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
and prednisolone##6##2##(1992-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
and prednisone in##3##3##(1993-6#1)(2008-1#2)
and prednisone##8##2##(1990-12#1)(1993-6#1)(2006-10#1)(2008-1#2)(2008-12#1)(2010-12#1)(2011-2#1)
and predominance of##2##3##(1990-12#1)(1993-2#1)
and predominant##3##2##(1990-5#2)(2011-2#1)
and predominantly##3##2##(1996-2#1)(2010-8#1)(2013-1#1)
and preeclampsia##4##2##(2008-4#2)(2011-2#2)
and preexisting##3##2##(2009-11#1)(2010-3#1)(2012-1#1)
and preferably##4##2##(1995-2#1)(2009-12#2)(2009-8#1)
and preference tests##2##3##(2008-5#2)
and preference##7##2##(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-5#1)
and preferences for##2##3##(2012-12#1)(2013-1#1)
and preferences of##2##3##(2008-7#1)(2013-1#1)
and preferences##8##2##(2008-7#1)(2009-11#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#2)
and preferentially##6##2##(1993-3#1)(1995-5#1)(2008-3#1)(2009-10#1)(2010-6#1)(2012-2#1)
and preferred provider##3##3##(1993-12#1)(1994-1#1)(2008-4#1)
and preferred##7##2##(1993-12#1)(1994-1#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-10#1)
and prefrontal cortex##3##3##(1994-2#1)(2007-8#1)(2013-1#1)
and prefrontal##9##2##(1994-2#1)(1996-7#3)(1997-2#2)(2007-8#2)(2013-1#1)
and pregnancy outcome##5##3##(1991-12#1)(1992-9#1)(1996-12#1)(2013-1#2)
and pregnancy##20##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-9#1)(1994-9#1)(1996-12#1)(1996-9#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
and pregnancy-associated##2##2##(1994-9#1)(2008-10#1)
and pregnancy]##3##2##(1992-5#1)(1996-11#1)(2013-1#1)
and pregnant women##7##3##(1995-12#1)(1995-2#2)(1995-8#1)(2008-8#1)(2012-2#1)(2013-8#1)
and pregnant##11##2##(1991-12#1)(1993-12#1)(1995-12#1)(1995-2#2)(1995-8#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
and prejudice##2##2##(2011-1#1)(2011-2#1)
and preliminary characterization of##3##4##(1992-8#1)(2007-12#1)(2009-10#1)
and preliminary experiments##2##3##(2007-12#1)(2008-3#1)
and preliminary results are##2##4##(2006-4#1)(2007-11#1)
and preliminary results##6##3##(1991-3#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-12#1)
and preliminary validation of##2##4##(2008-12#1)(2013-1#1)
and preliminary validation##3##3##(2008-12#1)(2010-6#1)(2013-1#1)
and preliminary##31##2##(1991-2#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-2#2)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and premature##13##2##(1995-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
and premises##2##2##(1991-12#1)(2007-10#1)
and prenatal care##2##3##(2008-1#1)(2013-1#1)
and prenatal diagnosis##2##3##(2012-12#1)(2012-3#1)
and prenatal##8##2##(2008-1#2)(2008-4#1)(2012-12#1)(2012-3#2)(2013-1#2)
and preneoplastic##2##2##(1991-12#1)(2011-1#1)
and preoperative##6##2##(1991-2#1)(1994-12#1)(1996-8#1)(2006-10#1)(2010-3#1)(2011-2#1)
and preparation of a##3##4##(2008-11#1)(2008-4#1)(2009-3#1)
and preparation of human##2##4##(2008-9#2)
and preparation of the##2##4##(2008-2#1)(2008-4#1)
and preparation of##18##3##(1992-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#6)(2008-9#4)(2009-3#1)(2011-1#1)(2013-1#1)
and preparation##33##2##(1992-1#1)(1992-3#3)(1994-11#1)(1994-3#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-9#5)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
and preparations##2##2##(2008-10#2)
and preparative##6##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-8#1)(2008-10#1)(2012-2#1)
and prepared##10##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
and preparedness##3##2##(2007-12#1)(2008-11#1)(2010-8#1)
and preparing a##2##3##(2008-12#1)(2008-9#1)
and preparing cells for transport##2##5##(2008-4#1)(2008-9#1)
and preparing##9##2##(1992-2#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#3)
and presbyacusis##2##2##(2008-7#2)
and prescribe##2##2##(2008-12#1)(2008-8#1)
and prescribed##2##2##(2008-1#1)(2010-1#1)
and presence of a##4##4##(1990-8#1)(1995-2#1)(2007-12#1)(2008-10#1)
and presence of##35##3##(1990-2#1)(1990-8#2)(1991-2#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
and presence##37##2##(1990-2#1)(1990-8#2)(1991-2#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
and present a case##2##4##(2010-6#1)(2010-8#1)
and present a##13##3##(1993-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#1)
and present as an##2##4##(2007-8#1)(2013-1#1)
and present as##4##3##(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and present experimental results##3##4##(2007-11#1)(2008-3#1)(2008-6#1)
and present in##3##3##(1995-11#1)(2008-4#1)(2010-3#1)
and present results##2##3##(2008-3#2)
and present significant challenges in##2##5##(2008-7#1)(2010-12#1)
and present some##2##3##(2008-2#1)(2008-3#1)
and present tense/agreement##3##3##(2012-1#3)
and present the results of##3##5##(1996-1#1)(2008-2#1)(2011-2#1)
and present the results##4##4##(1996-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
and present the##11##3##(1994-12#1)(1996-1#1)(2007-12#1)(2008-2#2)(2008-7#2)(2008-9#2)(2011-2#1)(2012-1#1)
and present##78##2##(1993-12#1)(1993-3#1)(1994-12#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#5)(2009-11#2)(2009-3#1)(2009-5#3)(2010-12#2)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#4)(2013-1#2)
and presentation of each epitope##2##5##(2008-8#2)
and presentation of##8##3##(1994-11#2)(1996-12#1)(2008-11#1)(2008-3#1)(2008-8#3)
and presentation##14##2##(1994-11#2)(1995-12#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#4)(2010-7#1)(2011-2#1)
and presentations##2##2##(2008-7#1)(2011-2#1)
and presented a##2##3##(2008-12#1)(2008-5#1)
and presented as##2##3##(1992-3#1)(2011-2#1)
and presented evidence##2##3##(2008-10#1)(2008-11#1)
and presented in##2##3##(1994-2#1)(1995-1#1)
and presented with##2##3##(1996-6#1)(2011-2#1)
and presented##19##2##(1991-10#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
and presenting##8##2##(1992-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-7#1)
and presents a##11##3##(1992-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
and presents an##3##3##(1995-9#1)(1997-2#1)(2008-9#1)
and presents as a##2##4##(2008-7#1)(2009-12#1)
and presents examples of##2##4##(1995-6#1)(2008-8#1)
and presents the##7##3##(1991-12#1)(1991-2#1)(1993-1#1)(1993-2#1)(1997-2#1)(2010-5#1)(2013-8#1)
and presents##40##2##(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-2#2)(1997-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
and preservation of the##2##4##(1992-9#1)(2008-11#1)
and preservation of##11##3##(1992-9#1)(1993-12#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2010-9#1)(2011-2#2)
and preservation##16##2##(1992-9#1)(1993-12#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#3)
and preserve the##2##3##(1994-3#1)(2008-3#1)
and preserve##6##2##(1994-3#1)(2008-10#1)(2008-3#2)(2010-5#1)(2011-2#1)
and preserved with##2##3##(2008-10#2)
and preserved##9##2##(1991-2#1)(1997-4#1)(2008-10#3)(2008-6#1)(2010-5#1)(2011-1#1)(2013-7#1)
and preserves the##2##3##(2007-12#1)(2012-3#1)
and preserves##5##2##(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-3#1)
and preserving##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
and pressure conditions##2##3##(2008-11#2)
and pressure measurements##2##3##(2008-2#1)(2008-3#1)
and pressure on##2##3##(2008-6#1)(2008-9#1)
and pressure##39##2##(1990-5#1)(1991-3#1)(1992-8#1)(1996-3#1)(1997-7#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#6)(2008-3#9)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)
and pressures##8##2##(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2010-8#1)
and presumably##6##2##(1991-8#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-12#1)(2007-12#1)
and presumed##4##2##(1991-3#1)(1994-2#1)(2007-12#1)(2009-4#1)
and preterm birth##2##3##(1995-6#1)(2013-8#1)
and preterm##8##2##(1990-12#2)(1994-3#2)(1995-6#1)(1996-2#1)(2012-3#1)(2013-8#1)
and pretreatment of##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
and pretreatment##7##2##(1993-9#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)
and prevails under##2##3##(2008-10#2)
and prevalence of##21##3##(1991-6#1)(1992-2#1)(1996-11#1)(1997-3#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
and prevalence were##2##3##(2008-10#1)(2010-4#1)
and prevalence##29##2##(1991-6#1)(1992-2#2)(1996-11#1)(1997-3#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)
and prevent the occurrence of##2##5##(1993-12#1)(2007-7#1)
and prevent the##3##3##(1993-12#1)(2007-7#1)(2010-3#1)
and prevent their##2##3##(2008-9#1)(2013-8#1)
and prevent##26##2##(1990-11#1)(1991-1#1)(1991-2#1)(1993-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and preventable##4##2##(1991-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
and preventative##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
and prevented the infection of the##2##6##(2010-10#2)
and prevented the##5##3##(1990-12#1)(2008-7#1)(2010-10#2)(2011-2#1)
and prevented##12##2##(1990-11#1)(1990-12#1)(1990-7#1)(1993-12#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#2)(2011-2#1)
and preventing complications##2##3##(1992-12#1)(2008-8#1)
and preventing or##2##3##(1993-1#1)(2008-10#1)
and preventing the##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
and preventing##19##2##(1992-12#1)(1993-1#1)(1994-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
and prevention and##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
and prevention efforts##3##3##(2008-11#1)(2009-5#1)(2012-2#1)
and prevention of cancer##2##4##(2009-4#2)
and prevention of dental##2##4##(2008-5#1)(2008-7#1)
and prevention of its##2##4##(2008-8#1)(2012-2#1)
and prevention of##48##3##(1990-7#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-8#1)(1997-8#3)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)
and prevention program##2##3##(1990-3#1)(1992-2#1)
and prevention programs##4##3##(1996-3#1)(1996-5#1)(2008-11#1)(2012-2#1)
and prevention strategies##3##3##(2009-5#1)(2011-2#1)(2013-1#1)
and prevention##91##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-2#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-8#3)(2007-10#1)(2007-11#4)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#3)(2009-8#2)(2010-1#2)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#1)
and preventive care##7##3##(1994-12#1)(1994-3#1)(2007-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
and preventive measures##3##3##(2007-2#1)(2008-5#1)(2009-10#1)
and preventive strategies##3##3##(1993-11#1)(1996-12#1)(2008-10#1)
and preventive##23##2##(1991-2#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
and prevents##11##2##(1990-12#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-11#1)(2013-8#1)
and previous history of##2##4##(2007-10#1)(2008-11#1)
and previous neurologic disease##2##4##(2008-7#2)
and previous or##2##3##(1991-12#1)(2012-2#1)
and previous##35##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-1#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
and previously reported##5##3##(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
and previously unreported##2##3##(2011-1#2)
and previously##18##2##(1994-8#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#2)
and prey selection##3##3##(2010-8#3)
and prey##10##2##(2008-8#5)(2008-9#2)(2010-8#3)
and price indicators for the health care industry##3##8##(1995-12#1)(1997-2#1)(1997-3#1)
and price indicators for the health care##4##7##(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)
and price##12##2##(1991-12#1)(1994-12#3)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2012-2#2)(2013-1#1)
and prices##2##2##(1991-2#1)(2007-11#1)
and pricing##2##2##(1996-3#1)(1997-5#1)
and pride##2##2##(2013-8#2)
and primarily##6##2##(1992-6#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-3#1)(2013-8#1)
and primary biliary cirrhosis##3##4##(1990-9#1)(1992-12#2)
and primary biliary##4##3##(1990-9#1)(1992-12#3)
and primary care physicians##3##4##(1996-11#1)(2008-9#1)(2009-9#1)
and primary care##11##3##(1993-12#1)(1996-11#1)(1996-3#2)(1997-2#2)(1997-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)
and primary care]##2##3##(1995-3#1)(1997-3#1)
and primary human##3##3##(1994-5#1)(2008-11#1)(2009-12#1)
and primary structure of the##2##5##(1991-6#1)(1993-6#1)
and primary structure of##3##4##(1991-6#1)(1993-6#1)(1995-3#1)
and primary wound##2##3##(1996-3#1)(2008-9#1)
and primary##67##2##(1990-9#1)(1991-6#1)(1992-12#3)(1992-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-5#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-9#3)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#4)
and primates##5##2##(1990-5#1)(1993-8#1)(2008-1#1)(2008-10#1)(2013-8#1)
and primed##2##2##(2008-11#1)(2012-3#1)
and primer##4##2##(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)
and primers were designed##2##4##(2008-10#2)
and primers were##3##3##(2008-10#3)
and primers##5##2##(2008-10#5)
and primitive##2##2##(1993-8#1)(2013-8#1)
and primordial##3##2##(2008-12#1)(2010-5#1)(2013-1#1)
and principal component analysis (PCA)##2##5##(2008-10#2)
and principal component analysis##6##4##(2008-10#3)(2010-8#2)(2012-2#1)
and principal component regression (PCR)##5##5##(2008-10#5)
and principal component regression methods##2##5##(2008-10#2)
and principal component regression##9##4##(2008-10#9)
and principal component##16##3##(1996-5#1)(2008-10#12)(2010-8#2)(2012-2#1)
and principal components analysis##2##4##(2008-10#1)(2008-4#1)
and principal##21##2##(1996-5#1)(2008-10#14)(2008-3#2)(2008-4#1)(2010-8#2)(2012-2#1)
and principles are##3##3##(1993-3#1)(2008-2#1)(2010-8#1)
and principles of multimodal therapy##2##5##(2010-3#2)
and principles of##5##3##(2007-12#1)(2008-11#1)(2010-3#2)(2011-1#1)
and principles##9##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-3#2)(2010-8#1)(2011-1#1)
and printing##2##2##(2008-3#1)(2008-9#1)
and prior to the##2##4##(2008-10#2)
and prior to##7##3##(1991-12#1)(1997-3#1)(1997-4#1)(2008-10#4)
and prior##16##2##(1991-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#2)(2007-7#1)(2008-10#4)(2009-8#1)(2010-2#1)
and priorities of the##2##4##(1996-1#1)(2008-7#1)
and priorities of##3##3##(1996-1#1)(2008-7#1)(2010-3#1)
and priorities##5##2##(1996-1#2)(2008-10#1)(2008-7#1)(2010-3#1)
and prioritization of##2##3##(1992-11#1)(1996-2#1)
and prioritization##4##2##(1992-11#1)(1996-1#1)(1996-2#1)(2010-8#1)
and prioritized##4##2##(1996-1#1)(2012-12#1)(2013-8#2)
and prioritizing##4##2##(1994-12#1)(2008-11#1)(2010-3#1)(2013-8#1)
and priority##3##2##(1991-11#1)(1991-2#1)(1992-2#1)
and privacy##7##2##(1992-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-7#1)(2010-8#1)(2012-12#1)
and private health insurance##2##4##(1993-3#1)(2013-1#1)
and private health##3##3##(1993-3#1)(1996-3#1)(2013-1#1)
and private physicians' offices providing abortions in states##2##8##(1994-2#2)
and private sector##3##3##(1996-11#1)(1996-12#1)(1996-2#1)
and private sectors##5##3##(1992-12#1)(1996-2#2)(1997-3#1)(2013-1#1)
and private##48##2##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-12#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-4#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and pro-C3##2##2##(1992-12#2)
and pro-apoptotic##4##2##(1995-6#1)(2009-12#1)(2010-10#1)(2013-1#1)
and pro-inflammatory##2##2##(2008-10#1)(2013-7#1)
and pro-opiomelanocortin##2##2##(1992-10#1)(2009-8#1)
and proactive##2##2##(2008-12#1)(2010-11#1)
and probabilistic##4##2##(2008-10#2)(2008-3#1)(2012-12#1)
and probability of##5##3##(1990-5#1)(1993-1#1)(2008-10#1)(2009-8#2)
and probability##6##2##(1990-5#1)(1993-1#1)(2008-10#1)(2009-11#1)(2009-8#2)
and probable cases##2##3##(2006-10#1)(2007-7#1)
and probable##6##2##(1991-12#1)(1992-4#1)(2006-10#1)(2007-7#1)(2008-7#1)(2013-8#1)
and probably a##2##3##(2007-7#1)(2008-9#1)
and probably also##5##3##(1992-6#1)(1993-11#1)(1997-3#1)(2011-2#2)
and probably involves a##2##4##(1991-12#1)(2008-10#1)
and probably the##2##3##(1991-12#1)(2013-1#1)
and probably##37##2##(1990-5#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-3#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-8#4)(2008-9#2)(2009-3#2)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#1)
and probe##9##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)
and probed##4##2##(1990-5#1)(1991-2#1)(2008-10#2)
and probes##6##2##(1994-11#1)(1994-9#1)(2008-10#3)(2008-9#1)
and probing##6##2##(2007-12#1)(2008-10#1)(2008-3#3)(2011-2#1)
and probiotics##6##2##(2009-12#1)(2010-12#1)(2011-2#3)(2013-1#1)
and problem drinking##2##3##(1994-2#2)
and problem solving##3##3##(1994-12#1)(1994-2#1)(2012-12#1)
and problem##9##2##(1994-12#1)(1994-2#3)(1995-12#1)(1997-3#1)(2008-11#1)(2012-12#2)
and problematic##6##2##(1991-3#1)(1994-2#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-12#1)
and problems associated with##2##4##(2008-3#1)(2011-1#1)
and problems encountered##3##3##(2008-7#1)(2009-10#1)(2010-12#1)
and problems in##2##3##(2010-5#1)(2011-1#1)
and problems of the##2##4##(2007-5#2)
and problems of##7##3##(1990-2#1)(1992-6#1)(1993-12#1)(1995-2#1)(2007-5#2)(2008-10#1)
and problems that##3##3##(2008-4#1)(2010-9#1)(2013-8#1)
and problems to##4##3##(2009-10#1)(2013-8#3)
and problems with##4##3##(1995-9#1)(2008-9#2)(2010-6#1)
and problems##41##2##(1990-2#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#5)
and problems]##2##2##(1992-5#1)(1993-11#1)
and procaine##2##2##(2008-10#2)
and procedural##6##2##(1991-12#1)(1996-2#1)(2008-12#1)(2011-2#2)(2012-2#1)
and procedure of##2##3##(1997-2#1)(2009-2#1)
and procedure##9##2##(1995-3#1)(1997-2#1)(2008-10#2)(2009-2#1)(2013-8#4)
and procedures are##2##3##(2008-1#1)(2008-9#1)
and procedures for##9##3##(1993-1#1)(1994-2#1)(2008-12#1)(2008-4#2)(2010-11#1)(2010-3#1)(2010-7#1)(2013-8#1)
and procedures in##2##3##(1994-2#1)(2011-2#1)
and procedures of##3##3##(2008-12#1)(2009-5#1)(2011-3#1)
and procedures that##2##3##(2008-12#1)(2013-8#1)
and procedures##36##2##(1990-3#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-2#3)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-4#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#2)
and proceeds##2##2##(1993-11#1)(1995-8#1)
and process development##2##3##(2008-11#2)
and process improvement##2##3##(1995-2#1)(2011-2#1)
and process of the##2##4##(2008-11#1)(2012-3#1)
and process of##4##3##(1994-12#1)(1996-3#1)(2008-11#1)(2012-3#1)
and process##33##2##(1991-1#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and process-dependent material composition of films##2##6##(2008-2#2)
and processed for##2##3##(2008-5#1)(2008-7#1)
and processed in##2##3##(2008-10#1)(2010-8#1)
and processed to##2##3##(2011-1#1)(2011-2#1)
and processed##16##2##(1991-6#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and processes are##2##3##(1995-1#1)(2008-2#1)
and processes for##2##3##(2008-12#1)(2010-8#1)
and processes of##5##3##(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)
and processes that##3##3##(1996-2#1)(2007-7#1)(2010-12#1)
and processes used in##2##4##(2008-8#1)(2010-3#1)
and processes##32##2##(1995-1#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#2)
and processing by##4##3##(1991-11#1)(1991-9#1)(1997-4#1)(2008-3#1)
and processing conditions##2##3##(2008-2#1)(2010-4#1)
and processing of##16##3##(1990-5#2)(1991-10#1)(1991-5#1)(1993-5#1)(2007-12#1)(2008-2#4)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)(2012-3#1)
and processing##50##2##(1990-5#2)(1991-10#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-5#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-6#1)(2010-10#1)(2010-4#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
and produce a##2##3##(1994-1#1)(2008-3#1)
and produce more##2##3##(2008-2#1)(2009-8#1)
and produce##24##2##(1994-1#1)(1994-12#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2011-1#1)(2012-1#1)(2012-12#1)
and produced a##5##3##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
and produced by##2##3##(1992-3#1)(2011-2#1)
and produced in##3##3##(1994-12#1)(2008-10#1)(2012-2#1)
and produced significantly##2##3##(2008-10#1)(2013-1#1)
and produced substantial##2##3##(2008-12#1)(2008-3#1)
and produced##37##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#4)(2008-9#2)(2009-12#1)(2010-3#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
and producers##3##2##(1996-2#2)(2011-2#1)
and produces a##9##3##(1990-5#1)(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)
and produces an##2##3##(2009-11#1)(2010-8#1)
and produces##31##2##(1990-5#1)(1993-12#1)(1993-9#1)(1994-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-2#2)
and producing a##2##3##(1996-11#1)(2008-10#1)
and producing##6##2##(1996-11#1)(2007-12#1)(2008-10#3)(2008-7#1)
and product of##2##3##(1993-12#1)(2008-10#1)
and product quality##2##3##(2008-11#1)(2013-1#1)
and product##27##2##(1990-8#1)(1992-1#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-5#2)(2008-6#2)(2008-7#2)(2010-7#1)(2012-2#2)(2013-1#1)
and product-related factors##2##3##(2008-10#1)(2011-2#1)
and production of a##5##4##(1993-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
and production of interferon-beta##2##4##(2008-11#2)
and production of the##2##4##(2008-10#1)(2008-11#1)
and production of##35##3##(1991-9#1)(1993-8#1)(1994-11#2)(1995-5#1)(1995-8#1)(1996-9#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)
and production rates##2##3##(2008-11#2)
and production##60##2##(1991-9#1)(1992-12#1)(1993-8#1)(1994-11#2)(1994-3#2)(1995-5#1)(1995-8#1)(1996-9#1)(2008-10#7)(2008-11#18)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#3)
and productive##4##2##(1994-3#1)(1994-8#1)(2008-1#1)(2008-7#1)
and productivities##2##2##(2008-11#1)(2008-6#1)
and productivity are##2##3##(2008-8#1)(2011-2#1)
and productivity in##5##3##(1992-2#1)(2007-5#1)(2008-11#2)(2008-6#1)
and productivity of recombinant##2##4##(2008-11#2)
and productivity of##8##3##(2007-5#1)(2008-11#3)(2008-12#2)(2008-5#2)
and productivity##31##2##(1991-2#1)(1992-2#1)(1993-3#1)(2007-5#3)(2008-10#3)(2008-11#11)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-1#1)
and products of their photodegradation##2##5##(2008-10#2)
and products of##5##3##(1991-3#1)(1996-12#1)(2008-10#2)(2008-7#1)
and products##13##2##(1991-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)
and professional and##2##3##(2008-7#1)(2012-1#1)
and professional associations##3##3##(1996-12#1)(1996-2#1)(2008-12#1)
and professional attitude##4##3##(1990-2#3)(2008-10#1)
and professional development##5##3##(2008-11#2)(2008-12#1)(2010-10#1)(2012-1#1)
and professional issues##3##3##(1991-2#1)(2008-11#1)(2008-12#1)
and professional knowledge##2##3##(2008-11#1)(2010-10#1)
and professional learning##2##3##(2008-12#2)
and professional level##2##3##(1993-3#1)(2008-11#1)
and professional organizations##3##3##(1995-12#1)(1995-3#1)(2012-2#1)
and professional practice settings##2##4##(2008-1#2)
and professional roles##2##3##(2008-11#1)(2012-12#1)
and professional skills##2##3##(2007-8#1)(2013-1#1)
and professional staff##2##3##(1991-12#1)(1995-3#1)
and professional work##2##3##(2011-2#1)(2012-2#1)
and professional##84##2##(1990-10#1)(1990-2#4)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-3#2)(1996-1#3)(1996-12#3)(1996-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#16)(2008-12#9)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#2)(2010-3#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#3)
and professionalization of the field##2##5##(1994-3#2)
and professionals##10##2##(1991-12#1)(1992-3#2)(1996-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
and proficiency testing##2##3##(2008-12#1)(2008-4#1)
and proficiency##3##2##(2008-12#1)(2008-4#1)(2011-2#1)
and profile of##2##3##(2008-9#1)(2011-2#1)
and profile##8##2##(1990-10#1)(1994-11#1)(1994-3#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
and profiles of##3##3##(2007-7#1)(2008-3#1)(2010-3#1)
and profiles##7##2##(1994-2#1)(2007-7#1)(2008-10#1)(2008-3#3)(2010-3#1)
and profit##2##2##(1995-3#1)(1997-2#1)
and profitability of these same fund development programs##2##8##(1995-1#1)(1995-3#1)
and profitability of##5##3##(1991-1#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#1)
and profitability##8##2##(1991-1#1)(1992-3#1)(1995-1#2)(1995-3#2)(2008-11#1)(2008-12#1)
and profits##5##2##(1991-3#2)(1997-2#1)(2007-4#1)(2008-11#1)
and profound##2##2##(1994-1#1)(1997-4#1)
and profoundly##2##2##(1990-8#1)(2008-9#1)
and progenitor cells of##2##4##(2008-9#1)(2011-2#1)
and progenitor cells##8##3##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-12#1)
and progenitor##9##2##(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-12#1)
and progeny isolates##2##3##(2008-10#2)
and progeny virus was##2##4##(2008-10#2)
and progeny virus##3##3##(2008-10#3)
and progeny##7##2##(2008-10#7)
and progesterone (P)##2##3##(1994-9#1)(2008-10#1)
and progesterone receptor##3##3##(1997-7#1)(2008-4#1)(2011-2#1)
and progesterone receptors in##2##4##(1990-11#1)(1994-2#1)
and progesterone receptors##7##3##(1990-11#2)(1991-12#1)(1993-9#1)(1994-2#1)(2013-8#2)
and progesterone##25##2##(1990-11#2)(1991-12#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-5#2)(1997-7#1)(2007-10#2)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#3)
and progestin##4##2##(1992-2#3)(2008-12#1)
and progestins##2##2##(1994-9#1)(2008-11#1)
and prognosis after acute##2##4##(2006-8#1)(2007-10#1)
and prognosis for##2##3##(2011-2#1)(2013-1#1)
and prognosis in##3##3##(1990-5#1)(2012-2#1)(2012-3#1)
and prognosis of breast cancer##2##5##(2008-4#1)(2010-8#1)
and prognosis of these##2##4##(2008-7#1)(2009-5#1)
and prognosis of this##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
and prognosis of##27##3##(1990-8#1)(1992-8#1)(1995-9#1)(1997-3#1)(2006-8#1)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
and prognosis##59##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#4)
and prognostic assessment##3##3##(1991-6#1)(1993-5#1)(2008-3#1)
and prognostic biomarkers##2##3##(2008-7#1)(2011-3#1)
and prognostic factors##5##3##(1990-9#2)(1995-5#1)(1996-8#1)(2008-12#1)
and prognostic impact of##2##4##(2010-3#1)(2011-2#1)
and prognostic implications of##2##4##(2008-10#1)(2008-2#1)
and prognostic implications##4##3##(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)
and prognostic significance##3##3##(2008-11#1)(2008-4#1)(2010-4#1)
and prognostic value of##2##4##(2008-7#1)(2012-2#1)
and prognostic value##4##3##(1994-11#1)(2008-7#2)(2012-2#1)
and prognostic##42##2##(1990-6#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-2#1)(1993-5#1)(1994-11#1)(1995-5#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)
and program evaluation##2##3##(1993-2#1)(1997-1#1)
and program payments##2##3##(1991-3#2)
and program##20##2##(1991-3#3)(1992-1#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
and programmable##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-10#1)
and programmatic##2##2##(1997-3#1)(2012-2#1)
and programmed cell death##4##4##(2007-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
and programmed##6##2##(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
and programmes##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2012-1#1)
and programs and##2##3##(1991-1#1)(1993-2#1)
and programs have##2##3##(1994-3#1)(2013-1#1)
and programs to##6##3##(1996-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2012-12#2)
and programs##24##2##(1991-1#2)(1993-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#1)
and progress in##4##3##(1997-6#1)(2007-11#1)(2008-6#1)(2013-8#1)
and progress of##4##3##(2008-8#1)(2010-3#1)(2012-1#1)(2012-2#1)
and progress##16##2##(1993-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and progresses##2##2##(2009-12#1)(2013-8#1)
and progressing##4##2##(1990-8#1)(1996-3#1)(2007-11#1)(2010-7#1)
and progression free survival (PFS)##2##5##(2008-10#2)
and progression of breast cancer##3##5##(2009-5#1)(2012-2#1)(2012-3#1)
and progression of the##3##4##(1991-11#1)(2010-11#2)
and progression of these##2##4##(2011-2#1)(2013-1#1)
and progression of##35##3##(1991-11#1)(1993-9#2)(1994-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-3#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and progression rates##2##3##(2011-3#1)(2012-12#1)
and progression##59##2##(1991-11#1)(1992-8#1)(1993-9#2)(1994-12#1)(1994-5#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#3)(2011-1#1)(2011-2#8)(2011-3#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
and progressive disease##3##3##(1992-12#1)(1992-9#1)(2010-12#1)
and progressive sensory symptoms##2##4##(2012-12#2)
and progressive sensory##3##3##(1990-3#1)(2012-12#2)
and progressive##30##2##(1990-3#1)(1992-12#1)(1992-9#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-6#3)(2008-7#3)(2009-10#2)(2009-11#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#3)(2013-1#1)
and progressively declined##2##3##(1995-2#1)(2007-8#1)
and progressively##5##2##(1993-2#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-6#1)
and prohibited##2##2##(2008-10#1)(2010-2#1)
and proinflammatory##2##2##(2007-11#1)(2010-5#1)
and project##4##2##(1994-12#1)(2007-12#1)(2008-3#1)(2010-6#1)
and projected##5##2##(1993-11#1)(1994-2#1)(1996-2#1)(2008-10#1)(2009-5#1)
and projection##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
and projections##2##2##(1992-9#1)(1994-2#1)
and prokaryotic##4##2##(1994-12#1)(1996-2#1)(1997-4#1)(2011-2#1)
and prolactin##9##2##(1990-7#1)(1991-3#1)(1993-11#1)(1993-2#3)(1994-12#1)(1994-5#1)(1995-11#1)
and proliferate in##2##3##(2007-12#1)(2008-11#1)
and proliferate##3##2##(2007-12#2)(2008-11#1)
and proliferating cell nuclear antigen (PCNA)##3##6##(1994-7#1)(1995-2#1)(2011-2#1)
and proliferating##9##2##(1992-6#1)(1993-11#1)(1994-7#1)(1995-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
and proliferation and##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
and proliferation in##6##3##(1990-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(2012-12#1)(2013-8#1)
and proliferation kinetics of adapted##2##5##(2013-8#2)
and proliferation of mouse##2##4##(2008-9#2)
and proliferation of the##3##4##(1995-2#1)(1996-3#1)(2008-7#1)
and proliferation of##18##3##(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#2)(1997-3#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-6#1)(2013-7#1)
and proliferation was##2##3##(1996-12#1)(2008-9#1)
and proliferation were##2##3##(2008-11#1)(2008-5#1)
and proliferation##66##2##(1990-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-10#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#3)(1997-3#1)(2006-6#1)(2007-12#1)(2008-11#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2010-3#1)(2011-2#2)(2012-1#5)(2012-12#3)(2012-2#1)(2012-5#1)(2012-6#1)(2013-7#1)(2013-8#4)
and proliferative disorders##2##3##(2006-10#1)(2013-1#1)
and proliferative##9##2##(1994-9#1)(2006-10#1)(2008-11#3)(2008-7#1)(2013-1#3)
and proline accumulation##2##3##(2008-12#2)
and proline##8##2##(1990-5#1)(1992-6#1)(2008-10#1)(2008-12#4)(2010-4#1)
and prolonged exposure to##2##4##(2008-10#2)
and prolonged in##2##3##(1997-3#1)(2008-10#1)
and prolonged##30##2##(1992-12#1)(1993-5#1)(1994-6#2)(1995-12#2)(1997-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
and prolongs survival##2##3##(2007-5#1)(2009-9#1)
and prolongs##3##2##(2007-5#1)(2009-9#1)(2012-2#1)
and prolyl##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
and prominent##5##2##(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
and promise##3##2##(1996-12#2)(2008-8#1)
and promises to##2##3##(1997-5#1)(2007-9#1)
and promises##5##2##(1992-1#1)(1997-5#1)(2007-9#1)(2008-3#1)(2011-2#1)
and promising results##2##3##(2008-7#1)(2010-12#1)
and promising##10##2##(1991-5#1)(1992-5#1)(2007-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2013-1#1)
and promote a##3##3##(1993-1#1)(2007-2#1)(2008-10#1)
and promote the##2##3##(2012-12#1)(2013-8#1)
and promote##23##2##(1993-1#1)(1995-1#1)(1996-2#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#2)
and promoted##6##2##(1990-11#1)(1994-3#1)(2008-11#1)(2008-12#2)(2010-10#1)
and promoter activity##2##3##(1997-8#1)(2010-11#1)
and promoter of##2##3##(1990-11#1)(2009-2#1)
and promoter##11##2##(1990-11#1)(1992-5#2)(1994-6#1)(1995-8#1)(1997-8#1)(1997-9#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)
and promoters##3##2##(2007-11#1)(2008-4#2)
and promotes a##2##3##(1995-3#1)(2009-8#1)
and promotes the##2##3##(2008-5#1)(2008-9#1)
and promotes##16##2##(1991-1#1)(1994-5#1)(1995-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
and promoting the##3##3##(1994-2#1)(2008-9#1)(2012-2#1)
and promoting##12##2##(1994-2#1)(2008-11#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2012-2#2)
and promotion of##5##3##(1992-12#1)(1995-12#1)(1996-11#1)(2010-5#1)(2011-2#1)
and promotion##12##2##(1991-5#1)(1992-12#1)(1992-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-12#1)(2008-9#2)(2009-9#1)(2010-5#1)(2011-2#1)
and promotional##3##2##(1993-12#1)(1994-12#1)(2011-2#1)
and prompt surgical decompression is##2##5##(2011-2#2)
and prompt##11##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
and prone to##3##3##(2008-3#1)(2008-9#1)(2009-8#1)
and pronounced##8##2##(1991-9#1)(1992-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-3#1)
and propagate in the##2##4##(2007-12#1)(2008-9#1)
and propagate##5##2##(2007-12#1)(2008-3#1)(2008-9#2)(2009-6#1)
and propagated##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
and propagation mode reduction##2##4##(2007-11#2)
and propagation of##5##3##(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-1#1)
and propagation##13##2##(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#3)(2008-4#1)(2009-5#1)(2011-1#1)(2012-12#1)
and propagative##2##2##(2008-10#2)
and propamocarb##2##2##(2008-10#2)
and propane##2##2##(2008-3#1)(2011-2#1)
and propeptide##2##2##(1991-9#2)
and proper management of##3##4##(2010-6#1)(2013-1#2)
and proper management##4##3##(2010-11#1)(2010-6#1)(2013-1#2)
and proper treatment##5##3##(2011-1#1)(2011-2#1)(2013-8#3)
and proper##22##2##(1996-2#1)(1997-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
and properly##2##2##(1993-12#1)(2011-2#1)
and properties of a##2##4##(1995-2#1)(2008-6#1)
and properties of an##2##4##(2008-8#1)(2009-7#1)
and properties of concentration and separation of trace##2##8##(2008-10#2)
and properties of new##2##4##(1990-11#1)(2008-10#1)
and properties of the##5##4##(1992-7#1)(1994-5#1)(1995-11#1)(2008-8#1)(2009-9#1)
and properties of##27##3##(1990-11#1)(1992-7#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-4#2)(2008-6#1)(2008-8#3)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
and properties##33##2##(1990-11#1)(1992-7#1)(1992-8#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#3)(2009-7#4)(2009-9#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
and property relationships##2##3##(2007-11#1)(2012-2#1)
and property##4##2##(1992-2#1)(1996-12#1)(2007-11#1)(2012-2#1)
and prophylactic##8##2##(1992-11#1)(1993-3#1)(2007-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2011-2#1)
and prophylaxis of##3##3##(1991-8#1)(2009-5#1)(2010-6#1)
and prophylaxis##6##2##(1990-11#1)(1991-8#1)(1994-6#1)(2009-5#1)(2010-6#2)
and propidium iodide##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
and propidium##6##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)
and propofol##2##2##(2011-2#1)(2012-12#1)
and proportion of##8##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#3)(2013-7#2)
and proportion##10##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#3)(2013-7#2)
and proportional to the##5##4##(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
and proportional##12##2##(1995-2#1)(2007-7#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
and proportions##2##2##(2008-10#1)(2012-3#1)
and proposals for##6##3##(1992-12#1)(2008-11#4)(2013-1#1)
and propose a model##2##4##(2008-10#1)(2009-8#1)
and propose a##12##3##(1990-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#2)
and propose an##3##3##(2010-11#1)(2012-3#1)(2013-1#1)
and propose that##4##3##(1992-3#1)(1992-6#1)(2008-10#1)(2008-11#1)
and propose##30##2##(1990-10#1)(1990-11#1)(1990-9#1)(1992-3#1)(1992-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
and proposed as##2##3##(2008-12#1)(2009-10#1)
and proposed##12##2##(1993-1#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
and proposes a##7##3##(1991-6#1)(1992-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
and proposes possible##2##3##(1992-2#1)(2008-11#1)
and proposes that##2##3##(2007-11#1)(2009-11#1)
and proposes##13##2##(1991-6#1)(1992-1#1)(1992-2#1)(1995-1#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-12#1)(2013-1#1)
and propranolol in##2##3##(1993-5#1)(2008-10#1)
and propranolol##4##2##(1993-5#1)(1995-6#1)(1996-2#1)(2008-10#1)
and proprioceptive##3##2##(1996-5#1)(2009-1#1)(2013-1#1)
and prospective studies##2##3##(1993-11#1)(2008-7#1)
and prospective study was conducted in##2##6##(2011-2#1)(2012-12#1)
and prospective study was##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
and prospective study##4##3##(1992-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
and prospective##15##2##(1991-9#1)(1992-12#1)(1993-11#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and prospectively##5##2##(1996-1#1)(2008-12#1)(2009-7#1)(2011-1#1)(2013-8#1)
and prospects for##5##3##(1992-3#1)(1994-5#1)(1995-1#1)(2009-4#1)(2011-2#1)
and prospects##13##2##(1990-2#1)(1992-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-4#1)(2011-2#2)(2011-7#1)
and prospects]##3##2##(1990-12#1)(1991-3#1)(1992-3#1)
and prostacyclin##3##2##(1994-5#1)(1996-2#1)(2008-3#1)
and prostaglandin E1 (PGE1)##2##4##(1994-2#1)(1997-7#1)
and prostaglandin E2##5##3##(1991-8#1)(1995-6#1)(1997-1#1)(2011-2#2)
and prostaglandin synthesis##2##3##(1997-1#2)
and prostaglandin##16##2##(1991-8#2)(1994-2#1)(1995-6#1)(1996-2#1)(1997-1#4)(1997-7#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#2)
and prostaglandins##3##2##(2008-7#2)(2010-1#1)
and prostate cancer##11##3##(1995-8#1)(2007-11#3)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-3#1)
and prostate were not##2##4##(1992-12#1)(2011-2#1)
and prostate##23##2##(1992-12#1)(1995-12#1)(1995-8#1)(2007-11#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
and prostate-specific##2##2##(1994-3#1)(2008-4#1)
and prosthesis##3##2##(1993-6#1)(2008-1#1)(2012-2#1)
and prosthetic groups##3##3##(2008-7#3)
and prosthetic##13##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#4)(2011-2#2)(2013-1#3)
and prostitution##2##2##(1997-6#1)(2008-1#1)
and protamine##2##2##(1994-9#1)(2008-6#1)
and protease inhibitors##6##3##(1997-4#1)(2008-1#1)(2008-5#1)(2009-8#2)(2011-3#1)
and protease##13##2##(1994-9#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-8#2)(2011-3#1)
and proteases##2##2##(1991-9#1)(1992-6#1)
and protect against##2##3##(2011-2#1)(2012-3#1)
and protect the##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
and protect##11##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and protected from pathogenic organisms through testing of any biological materials##2##11##(2008-4#2)
and protected from##3##3##(2007-11#1)(2008-4#2)
and protected the##2##3##(1996-3#1)(2008-11#1)
and protected##10##2##(1995-5#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-12#1)(2012-3#1)
and protecting the##4##3##(2008-11#1)(2008-5#1)(2010-4#1)(2012-3#1)
and protecting##11##2##(1994-1#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-8#1)
and protection against##8##3##(1990-11#1)(1993-11#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
and protection by##3##3##(1990-12#1)(1992-9#1)(2008-8#1)
and protection in##2##3##(1995-11#1)(1995-5#1)
and protection of the##2##4##(2008-10#1)(2012-1#1)
and protection of##4##3##(1991-9#1)(2008-10#1)(2008-4#1)(2012-1#1)
and protection##25##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
and protective factors##8##3##(2008-2#1)(2008-5#1)(2009-7#4)(2010-5#1)(2011-1#1)
and protective##25##2##(1995-12#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#5)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#2)
and protects it##2##3##(2008-5#2)
and protects the##2##3##(2007-12#2)
and protects##7##2##(1996-9#1)(2007-12#2)(2008-11#1)(2008-5#2)(2008-8#1)
and protein A##2##3##(1996-12#2)
and protein A-Sepharose##2##3##(2008-11#1)(2008-8#1)
and protein and##4##3##(1995-5#1)(2008-10#1)(2008-8#1)(2013-7#1)
and protein binding##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
and protein complexes##2##3##(2008-4#1)(2011-2#1)
and protein composition##3##3##(1990-7#1)(1995-9#1)(2008-9#1)
and protein concentration##2##3##(1995-2#1)(2011-2#1)
and protein concentrations##2##3##(2008-6#1)(2011-1#1)
and protein content of##2##4##(2009-11#1)(2013-1#1)
and protein content##8##3##(1990-7#1)(2009-11#1)(2010-11#1)(2010-4#1)(2012-7#1)(2013-1#3)
and protein disulfide##2##3##(2009-8#1)(2012-2#1)
and protein expression is##2##4##(2008-11#1)(2013-1#1)
and protein expression of##5##4##(2008-11#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-2#1)
and protein expression##16##3##(2008-10#1)(2008-11#5)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-7#1)(2013-1#3)
and protein from the##2##4##(2009-12#1)(2010-2#1)
and protein in##4##3##(1992-7#1)(1995-12#1)(2008-7#1)(2012-3#1)
and protein intake##3##3##(2013-1#1)(2013-8#2)
and protein interaction##2##3##(2011-2#1)(2012-2#1)
and protein interactions can be##2##5##(2008-4#1)(2011-2#1)
and protein interactions##3##3##(1993-11#1)(2008-4#1)(2011-2#1)
and protein kinase A##4##4##(1994-8#1)(1995-6#1)(1997-2#1)(2008-11#1)
and protein kinase B##2##4##(2008-3#2)
and protein kinase C (PKC)##2##5##(2008-10#1)(2008-5#1)
and protein kinase C activation##3##5##(1990-12#1)(1994-3#1)(1995-11#1)
and protein kinase C in##2##5##(1996-9#1)(2008-11#1)
and protein kinase C##17##4##(1990-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)
and protein kinase##26##3##(1990-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-5#1)(2008-9#1)
and protein level##3##3##(1994-8#1)(2008-4#1)(2011-2#1)
and protein levels in##2##4##(2013-8#2)
and protein levels of##4##4##(2011-3#2)(2012-2#1)(2013-8#1)
and protein levels##11##3##(1993-6#1)(1997-7#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#3)
and protein metabolism##2##3##(2008-10#1)(2009-10#1)
and protein phosphorylation##2##3##(1994-2#1)(2008-8#1)
and protein production##3##3##(2008-11#1)(2008-7#2)
and protein productivity##2##3##(2008-11#1)(2008-7#1)
and protein secretion##2##3##(1992-9#1)(2008-7#1)
and protein sequence##2##3##(2008-4#1)(2008-7#1)
and protein sequences##3##3##(2008-10#1)(2008-4#2)
and protein substrates##2##3##(1992-6#1)(2008-4#1)
and protein synthesis in##2##4##(1995-12#1)(2008-12#1)
and protein synthesis##8##3##(1991-5#1)(1991-9#1)(1995-12#2)(1997-8#1)(2007-12#1)(2008-12#1)(2012-2#1)
and protein transformations##2##3##(2013-1#2)
and protein were##5##3##(1993-3#1)(2008-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
and protein##234##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#3)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#10)(2008-11#24)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#3)(2012-1#1)(2012-2#7)(2012-3#5)(2012-7#2)(2013-1#15)(2013-7#1)(2013-8#7)
and protein-bound##7##2##(1991-12#2)(2008-10#5)
and protein-free##2##2##(2008-11#2)
and protein-mediated intermembrane transfer of##2##5##(1992-6#2)
and protein-protein interactions##5##3##(1995-6#1)(2008-1#1)(2008-4#1)(2008-7#2)
and protein-protein##6##2##(1995-6#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-7#1)
and proteins and##2##3##(2008-10#2)
and proteins from##2##3##(1991-8#1)(1994-2#1)
and proteins in the##3##4##(2008-10#1)(2008-7#1)(2012-6#1)
and proteins in##8##3##(1991-6#1)(1992-3#1)(1992-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-6#1)
and proteins involved in the##2##5##(1994-8#1)(2012-2#1)
and proteins involved in##3##4##(1994-8#1)(2008-9#1)(2012-2#1)
and proteins of##5##3##(1991-6#1)(1991-8#1)(1997-4#1)(1997-6#1)(2011-2#1)
and proteins that##2##3##(2008-4#1)(2010-11#1)
and proteins were##3##3##(1990-10#1)(2008-10#1)(2010-3#1)
and proteins which##2##3##(2008-11#1)(2008-5#1)
and proteins##66##2##(1990-10#1)(1990-12#1)(1991-6#2)(1991-8#2)(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(1997-4#1)(1997-6#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#2)(2010-3#1)(2010-7#2)(2011-2#4)(2012-2#1)(2012-3#1)(2012-6#1)
and proteinuria##3##2##(2008-1#1)(2008-7#1)(2012-2#1)
and proteoglycans##2##2##(1991-5#1)(1992-12#1)
and proteolysis##5##2##(1990-5#1)(2008-11#1)(2010-4#1)(2013-1#2)
and proteolytic activities##2##3##(2008-10#1)(2011-2#1)
and proteolytic##9##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
and proteome##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
and proteomic data##2##3##(2008-11#1)(2008-7#1)
and proteomic##7##2##(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2012-12#1)
and proteomics##8##2##(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#2)(2010-7#1)(2011-3#1)
and protocols for##2##3##(2008-4#2)
and protocols##11##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-9#2)(2011-2#3)
and proton NMR##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
and proton magnetic resonance##2##4##(2008-10#1)(2008-5#1)
and proton pump inhibitors##2##4##(2011-2#1)(2012-2#1)
and proton##11##2##(1990-12#1)(1993-11#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
and protonated species##2##3##(2008-10#2)
and protonated##5##2##(1991-9#2)(2008-10#3)
and protoplast##3##2##(2008-10#1)(2008-8#2)
and protoplasts##4##2##(1997-3#1)(2008-8#2)(2008-9#1)
and protoporphyrin##2##2##(1991-5#1)(2012-2#1)
and protostomes##2##2##(2008-7#1)(2010-4#1)
and protozoa##4##2##(1994-11#1)(2008-9#2)(2009-10#1)
and protozoan parasites##2##3##(2011-1#2)
and protozoans##2##2##(2008-11#1)(2008-5#1)
and prove##3##2##(2007-8#1)(2008-3#2)
and proved to be##3##4##(1994-12#1)(2008-10#1)(2012-2#1)
and proved to##4##3##(1994-12#1)(2008-10#2)(2012-2#1)
and proved##11##2##(1990-9#1)(1992-8#1)(1994-12#1)(1994-3#1)(2008-10#6)(2012-2#1)
and proven to##2##3##(1996-2#1)(2010-5#1)
and proven##6##2##(1994-2#1)(1996-2#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-7#1)
and provenances##3##2##(2012-5#2)(2012-9#1)
and provide a basis##2##4##(2008-7#1)(2013-8#1)
and provide a better##2##4##(1995-3#1)(2007-12#1)
and provide a blueprint##2##4##(1993-2#1)(1994-12#1)
and provide a##38##3##(1991-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#1)(1995-12#1)(1995-3#2)(2007-12#1)(2007-5#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-3#2)(2013-8#2)
and provide accurate##2##3##(2010-8#1)(2013-8#1)
and provide additional##2##3##(2011-2#1)(2013-1#1)
and provide adequate##2##3##(1997-2#1)(2012-12#1)
and provide an##4##3##(2008-6#1)(2010-10#1)(2011-7#1)(2012-3#1)
and provide clinical##3##3##(2007-10#1)(2008-11#1)(2011-2#1)
and provide clues##2##3##(1997-6#1)(2008-10#1)
and provide evidence that##2##4##(1997-3#1)(2012-12#1)
and provide evidence##6##3##(1991-12#1)(1997-3#1)(1997-6#1)(2008-11#1)(2012-12#1)(2012-2#1)
and provide further evidence##2##4##(1990-8#1)(1991-8#1)
and provide guidance##4##3##(1993-12#1)(1996-3#1)(2008-11#1)(2008-7#1)
and provide information##2##3##(2007-12#1)(2008-10#1)
and provide insights into##2##4##(2008-7#1)(2012-2#1)
and provide new##3##3##(1997-7#1)(2008-11#1)(2008-8#1)
and provide recommendations for##3##4##(2008-3#1)(2008-4#1)(2008-8#1)
and provide recommendations##4##3##(1992-3#1)(2008-3#1)(2008-4#1)(2008-8#1)
and provide some mechanistic insights into neoplastic responses##2##8##(2008-8#1)(2008-9#1)
and provide some##3##3##(2008-8#1)(2008-9#1)(2010-5#1)
and provide suggestions for future##2##5##(2008-6#1)(2012-12#1)
and provide support to##2##4##(1994-12#1)(2013-8#1)
and provide the##4##3##(1995-9#1)(2008-11#1)(2011-2#1)(2013-8#1)
and provide them##2##3##(1992-12#1)(2011-2#1)
and provide useful##4##3##(2006-6#1)(2007-10#1)(2008-4#1)(2012-3#1)
and provide##136##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-10#2)(2007-12#3)(2007-5#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#6)(2011-7#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#8)
and provided a##7##3##(2008-10#3)(2008-3#2)(2010-11#1)(2010-5#1)
and provided an##2##3##(2007-6#1)(2010-9#1)
and provided evidence of##2##4##(1994-1#1)(2012-2#1)
and provided further##2##3##(1990-7#1)(2008-10#1)
and provided satisfactory results##2##4##(2008-10#2)
and provided that##2##3##(1995-6#1)(2008-8#1)
and provided##45##2##(1990-7#1)(1991-6#1)(1994-1#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-12#4)(2007-6#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
and provider##13##2##(1991-2#2)(1992-3#1)(1993-12#1)(1994-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-11#1)(2011-1#2)
and providers are##2##3##(1991-3#1)(1996-2#1)
and providers in##2##3##(1994-12#1)(2012-12#1)
and providers##30##2##(1991-12#1)(1991-3#1)(1993-12#1)(1994-1#3)(1994-12#5)(1995-1#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-6#1)(2012-12#1)(2013-1#4)
and provides a brief##3##4##(2008-11#1)(2008-9#1)(2010-5#1)
and provides a case study##2##5##(1995-6#1)(2012-12#1)
and provides a detailed##2##4##(2008-10#1)(2008-9#1)
and provides a new##3##4##(2008-5#1)(2008-8#1)(2009-12#1)
and provides a review of the##2##6##(2010-12#1)(2011-7#1)
and provides a summary of##2##5##(1992-3#1)(2011-2#1)
and provides a useful##2##4##(1995-3#1)(2008-9#1)
and provides a##42##3##(1990-12#1)(1990-5#1)(1992-3#1)(1992-4#1)(1993-3#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
and provides an analysis##2##4##(2008-1#1)(2010-10#1)
and provides an excellent##2##4##(2008-10#1)(2008-9#1)
and provides an overview of the##4##6##(1993-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
and provides an overview of##5##5##(1991-1#1)(1993-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
and provides an##21##3##(1991-1#1)(1991-9#1)(1993-3#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
and provides background for the##2##5##(2008-9#1)(2012-12#1)
and provides examples##2##3##(2008-9#1)(2012-2#1)
and provides excellent##2##3##(2008-3#2)
and provides further evidence for##2##5##(2008-10#1)(2008-7#1)
and provides further evidence##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
and provides further##5##3##(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
and provides good##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
and provides information##2##3##(2008-10#1)(2008-9#1)
and provides new##3##3##(2008-10#2)(2009-8#1)
and provides opportunities for##2##4##(1995-1#1)(2008-12#1)
and provides practical recommendations##2##4##(2010-12#1)(2012-12#1)
and provides recommendations##2##3##(2007-12#1)(2010-10#1)
and provides some##3##3##(1994-2#1)(2007-11#1)(2008-12#1)
and provides the##7##3##(1992-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2013-1#1)
and provides useful##3##3##(1992-10#1)(2008-7#1)(2010-3#1)
and provides##151##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-4#1)(1993-3#2)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#2)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#11)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#12)(2009-12#2)(2009-5#1)(2009-8#3)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2011-7#2)(2012-1#1)(2012-12#7)(2012-2#4)(2013-1#4)(2013-8#1)
and providing a##3##3##(2008-10#1)(2008-12#1)(2009-7#1)
and providing support##2##3##(2007-12#1)(2011-2#1)
and providing the##2##3##(1993-12#1)(2008-12#1)
and providing##22##2##(1992-1#1)(1993-11#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
and provincial##3##2##(2007-12#1)(2008-11#1)(2012-12#1)
and proving##2##2##(2008-10#1)(2011-1#1)
and provision of##6##3##(1995-2#1)(1996-1#1)(1997-3#1)(2007-7#1)(2008-10#1)(2009-5#1)
and provision##7##2##(1994-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-7#1)(2008-10#1)(2009-5#1)
and provoked##2##2##(2008-6#1)(2012-12#1)
and proximal anastomotic devices##2##4##(2010-8#2)
and proximal anastomotic##3##3##(2010-8#3)
and proximal femur##3##3##(2006-10#1)(2011-2#2)
and proximal stumps are not available##2##6##(2008-9#2)
and proximal tubular##2##3##(1994-5#2)
and proximal##23##2##(1991-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1997-2#1)(2006-10#1)(2007-8#1)(2008-12#2)(2008-6#1)(2008-9#3)(2009-3#1)(2010-4#1)(2010-8#3)(2011-2#3)(2013-7#1)
and proximity##3##2##(2008-7#1)(2008-9#2)
and proxy##3##2##(2008-7#2)(2010-12#1)
and pruritus##3##2##(2007-7#1)(2013-1#2)
and pseudoephedrine##3##2##(2007-10#1)(2008-10#2)
and pseudogamous##2##2##(2008-5#2)
and pseudouridine##3##2##(1990-8#2)(1997-2#1)
and psi##4##2##(1990-8#1)(1991-6#2)(2008-2#1)
and psoriasis##4##2##(1993-8#1)(2008-8#1)(2012-2#2)
and psychiatric conditions##2##3##(2009-9#1)(2012-3#1)
and psychiatric disorders##9##3##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
and psychiatric##28##2##(1991-1#1)(1991-2#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(2007-1#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
and psychiatrists##3##2##(1996-1#2)(2009-9#1)
and psychiatry had##2##3##(1991-6#1)(1993-6#1)
and psychiatry##7##2##(1991-12#1)(1991-6#1)(1993-6#1)(2008-6#1)(2009-8#1)(2011-1#2)
and psychological adjustment##7##3##(1996-3#1)(2007-12#1)(2009-11#3)(2009-7#1)(2010-2#1)
and psychological and academic adjustment in##2##6##(2010-1#2)
and psychological aspects of##2##4##(2008-4#1)(2010-3#1)
and psychological aspects]##2##3##(1993-6#1)(1997-3#1)
and psychological distress##6##3##(2007-11#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-8#1)
and psychological effects of##2##4##(1992-5#1)(2007-2#1)
and psychological effects##3##3##(1992-5#1)(2007-2#1)(2007-6#1)
and psychological functioning##2##3##(1995-2#1)(2008-2#1)
and psychological invulnerability##3##3##(2010-7#3)
and psychological problems##2##3##(1993-6#1)(2009-11#1)
and psychological treatment##2##3##(2007-11#1)(2009-7#1)
and psychological well-being##10##3##(1992-2#1)(2007-12#1)(2008-11#1)(2009-7#1)(2012-2#2)(2013-1#4)
and psychological wellbeing##2##3##(2009-9#1)(2011-2#1)
and psychological##74##2##(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#2)(1994-3#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#4)(2009-12#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
and psychologists##6##2##(1990-6#1)(1996-1#1)(1996-11#1)(2008-12#2)(2010-12#1)
and psychology##2##2##(1993-2#1)(2013-1#1)
and psychometric evaluation##2##3##(2007-12#2)
and psychometric##5##2##(1994-6#1)(2007-10#1)(2007-12#2)(2008-5#1)
and psychomotor##2##2##(1994-6#1)(2008-11#1)
and psychopathology##5##2##(1995-5#1)(2008-1#2)(2008-6#1)(2009-10#1)
and psychophysical##4##2##(2008-11#1)(2008-9#3)
and psychosis##3##2##(1997-5#1)(2009-9#1)(2011-2#1)
and psychosocial characteristics##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
and psychosocial development##2##3##(2008-11#1)(2008-9#1)
and psychosocial factors##2##3##(1994-6#1)(2010-5#1)
and psychosocial interventions##2##3##(1995-1#1)(2013-1#1)
and psychosocial##34##2##(1994-6#1)(1995-1#1)(1995-5#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#4)
and psychosomatic disorders##2##3##(2011-2#1)(2012-2#1)
and psychosomatic##4##2##(1990-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
and psychotherapeutic##2##2##(2008-1#1)(2009-7#1)
and psychotherapy##7##2##(1991-1#1)(2008-2#1)(2008-4#1)(2010-4#1)(2013-1#2)(2013-8#1)
and psychotic symptoms##2##3##(2008-7#1)(2011-1#1)
and psychotic##4##2##(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
and psychotropic##2##2##(2007-11#1)(2007-7#1)
and pubertal status##3##3##(2011-1#3)
and pubertal##5##2##(2008-3#1)(2011-1#4)
and puberty##6##2##(2011-1#3)(2011-2#3)
and pubescence##2##2##(2013-7#2)
and public and##2##3##(1997-3#1)(2008-5#1)
and public health agencies##3##4##(1995-12#2)(2009-5#1)
and public health implications of##2##5##(2008-7#1)(2011-2#1)
and public health implications##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
and public health issues##2##4##(1993-2#1)(1996-2#1)
and public health professionals##2##4##(2009-3#1)(2013-1#1)
and public health services##2##4##(1994-3#1)(1997-2#1)
and public health staff##2##4##(2013-8#2)
and public health##50##3##(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-1#2)(1996-2#2)(1996-6#2)(1997-2#2)(1997-3#6)(1997-4#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
and public interest##2##3##(2008-8#1)(2009-7#1)
and public officials##2##3##(1996-12#1)(2011-2#1)
and public policy##7##3##(1991-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(2007-5#1)(2008-12#1)(2008-8#1)
and public relations##3##3##(1991-1#1)(1997-3#1)(2008-12#1)
and public reporting of##2##4##(2013-1#2)
and public##90##2##(1991-1#2)(1991-12#1)(1992-9#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#4)(1996-12#3)(1996-2#2)(1996-6#3)(1997-2#2)(1997-3#8)(1997-4#1)(1997-6#1)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
and publication of##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
and publication##7##2##(1993-12#2)(2008-10#2)(2008-12#2)(2008-9#1)
and published by##2##3##(2008-5#1)(2008-8#1)
and published data##2##3##(1993-8#1)(2008-3#1)
and published in##2##3##(2008-10#1)(2012-2#1)
and published##8##2##(1993-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
and publishing##2##2##(1993-12#1)(1994-12#1)
and puerperium##3##2##(1991-3#1)(2008-11#1)(2012-12#1)
and pulmonary arterial##3##3##(2008-11#2)(2011-3#1)
and pulmonary artery##4##3##(1993-12#1)(1995-2#1)(1997-8#2)
and pulmonary complications##2##3##(2007-8#2)
and pulmonary edema##3##3##(1994-8#2)(2011-2#1)
and pulmonary embolism##9##3##(1996-6#3)(1997-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#1)
and pulmonary fibrosis##3##3##(2006-10#3)
and pulmonary hypertension##5##3##(2010-12#1)(2010-6#2)(2011-3#1)(2012-12#1)
and pulmonary metastasis##2##3##(2007-8#1)(2008-7#1)
and pulmonary##62##2##(1990-10#1)(1992-12#1)(1992-5#2)(1993-12#1)(1993-8#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-6#3)(1997-2#1)(1997-8#2)(2006-10#4)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#4)(2010-8#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
and pulp##5##2##(2008-10#3)(2009-12#1)(2013-1#1)
and pulse amplitude##3##3##(2007-12#1)(2008-10#2)
and pulse compression in hollow waveguides##2##6##(2007-11#2)
and pulse compression##4##3##(2007-11#3)(2008-3#1)
and pulse duration##2##3##(2007-11#1)(2008-3#1)
and pulse height##2##3##(2008-10#2)
and pulse##36##2##(1992-12#1)(2007-11#10)(2007-12#4)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#8)(2008-7#2)(2010-4#1)(2013-8#1)
and pulsed##7##2##(2008-2#2)(2008-3#3)(2009-4#1)(2011-2#1)
and pulsed-field gel electrophoresis##3##4##(2008-10#3)
and pump##9##2##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)(2010-6#1)
and pumped by a##2##4##(2007-12#2)
and pumped by##3##3##(2007-12#3)
and pumping##2##2##(2008-3#1)(2012-3#1)
and pumpkin##2##2##(2008-10#2)
and puncture##3##2##(2012-3#3)
and punishment##2##2##(1995-9#1)(2013-8#1)
and pupa##3##2##(2007-12#1)(2008-6#2)
and purchasers of health##2##4##(1996-2#1)(1997-3#1)
and purchasers of##3##3##(1996-2#2)(1997-3#1)
and purchasers##5##2##(1996-12#1)(1996-2#3)(1997-3#1)
and pure##17##2##(2008-10#9)(2008-3#3)(2008-9#2)(2010-5#1)(2011-2#1)(2013-1#1)
and purge##2##2##(1995-6#1)(2008-10#1)
and purging##2##2##(2007-7#1)(2008-10#1)
and purification by##2##3##(2008-4#1)(2012-2#1)
and purification of a##2##4##(2008-10#1)(2008-4#1)
and purification of active serine proteases and their variants from##2##10##(2008-4#2)
and purification of esculetin from the seeds of Euphorbia lathyris L##2##11##(2011-1#2)
and purification of halophilic proteins##2##5##(2011-2#2)
and purification of human##2##4##(2008-11#1)(2008-8#1)
and purification of the##5##4##(1994-5#1)(1994-6#1)(2008-10#1)(2009-9#1)(2011-1#1)
and purification of##45##3##(1990-5#1)(1991-2#1)(1994-5#1)(1994-6#1)(1997-2#2)(1997-4#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-4#8)(2008-6#2)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
and purification steps##3##3##(2008-10#2)(2008-7#1)
and purification##65##2##(1990-5#1)(1991-2#1)(1994-5#1)(1994-6#1)(1997-2#2)(1997-4#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-4#13)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-9#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and purified bovine##2##3##(1992-12#1)(1995-5#1)
and purified by HPLC##2##4##(1992-3#1)(1995-11#1)
and purified by affinity chromatography##2##5##(1995-6#1)(2008-9#1)
and purified by reverse-phase##2##4##(1993-11#1)(2008-6#1)
and purified by##15##3##(1990-12#1)(1990-8#2)(1992-3#1)(1993-11#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#2)(2010-11#1)
and purified from##10##3##(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
and purified in##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
and purified on##2##3##(1995-11#1)(2008-10#1)
and purified to homogeneity by##2##5##(1993-8#1)(2008-8#1)
and purified to homogeneity##6##4##(1993-11#1)(1993-8#1)(1994-9#1)(1995-2#2)(2008-8#1)
and purified to##8##3##(1992-8#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-2#3)(2008-8#1)
and purified##65##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-11#3)(1993-6#1)(1993-8#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#4)(1995-5#2)(1995-6#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-6#1)(2010-11#2)(2011-1#1)(2012-2#2)(2013-8#1)
and purify##10##2##(1993-8#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and purifying##5##2##(2008-2#1)(2008-4#3)(2009-9#1)
and purine nucleotides##2##3##(1996-8#1)(2008-10#1)
and purine##5##2##(1993-12#1)(1996-8#1)(2008-10#2)(2008-3#1)
and purinergic##2##2##(1994-6#1)(2009-3#1)
and purity##3##2##(2008-2#1)(2009-5#2)
and purpose of##4##3##(1993-1#1)(1994-12#1)(1997-3#1)(2013-8#1)
and purpose##7##2##(1993-1#1)(1994-12#1)(1995-12#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
and purposes##2##2##(1991-9#1)(1994-1#1)
and pursuing##2##2##(1994-1#1)(2009-12#1)
and purulent##3##2##(1993-2#1)(2008-1#1)(2013-1#1)
and pustules##2##2##(2010-6#1)(2012-3#1)
and put in##2##3##(1992-12#1)(1995-2#1)
and put##8##2##(1992-12#1)(1994-1#2)(1994-2#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-5#1)
and putamen of##2##3##(1993-12#1)(2008-7#1)
and putamen##6##2##(1993-12#3)(1995-5#1)(2008-7#1)(2012-12#1)
and putative##12##2##(1994-9#1)(2008-10#6)(2008-7#2)(2011-1#1)(2011-2#2)
and putrescine oxidase##2##3##(2008-10#2)
and putrescine##6##2##(1991-12#1)(2008-10#2)(2008-8#2)(2009-8#1)
and puts##4##2##(2008-3#1)(2010-11#1)(2012-2#1)(2012-3#1)
and pyelonephritis##2##2##(1995-2#1)(2008-10#1)
and pyramidal##3##2##(1993-12#1)(1996-5#1)(2013-8#1)
and pyrazinamide##2##2##(2008-1#1)(2008-10#1)
and pyrene##2##2##(2008-10#1)(2008-11#1)
and pyridine##5##2##(1996-2#2)(2008-10#3)
and pyridoxine##3##2##(2008-10#3)
and pyridoxine) in pharmaceutical##2##4##(2008-10#2)
and pyrifenox##2##2##(2008-10#2)
and pyrimidine##5##2##(1992-8#2)(2008-10#3)
and pyrogallol##4##2##(2008-10#4)
and pyrolysis##3##2##(2008-10#3)
and pyruvate carboxylase##2##3##(2008-11#2)
and pyruvate kinase##4##3##(1994-3#1)(1994-8#1)(1995-2#1)(2008-7#1)
and pyruvate stimulate the conversion of glucose to glycogen##2##9##(1995-8#2)
and pyruvate##21##2##(1991-5#2)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#2)(2008-10#5)(2008-11#2)(2008-7#2)(2013-1#1)
and p = 0##2##2##(2013-8#2)
and q##2##2##(2008-11#1)(2010-3#1)
and qPCR##2##2##(2010-4#1)(2010-6#1)
and quadrat size##3##3##(2008-10#3)
and quadrat##4##2##(2008-10#4)
and quadratic discriminant##3##3##(1991-12#2)(2008-10#1)
and quadratic##11##2##(1991-12#3)(2007-11#2)(2008-10#3)(2008-8#1)(2010-2#1)(2012-2#1)
and quadrature##4##2##(2007-11#3)(2009-3#1)
and quadriceps muscle strength in##2##5##(2011-2#2)
and quadruplex##2##2##(1994-11#1)(2008-4#1)
and qualified to##2##3##(2008-3#1)(2008-6#1)
and qualified##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
and qualitative analysis##2##3##(1994-2#1)(2010-10#1)
and qualitative aspects of##2##4##(2009-10#1)(2009-9#1)
and qualitative aspects##3##3##(2009-10#1)(2009-9#1)(2012-12#1)
and qualitative data on##2##4##(1991-8#1)(2012-2#1)
and qualitative data##5##3##(1990-9#1)(1991-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
and qualitative observation##2##3##(2012-2#2)
and qualitative research##2##3##(1992-2#1)(2012-12#1)
and qualitative studies##2##3##(2007-6#1)(2008-10#1)
and qualitative##46##2##(1990-9#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2007-6#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-8#1)
and qualitatively##9##2##(1994-5#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-2#1)
and quality and##3##3##(1995-12#1)(1997-1#1)(2008-10#1)
and quality assessment##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
and quality assurance programs##2##4##(1995-1#1)(2012-2#1)
and quality assurance##11##3##(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-2#2)
and quality control are##2##4##(1995-1#1)(1996-12#1)
and quality control in##3##4##(1994-3#1)(2008-10#1)(2008-4#1)
and quality control##18##3##(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)(2013-1#1)
and quality improvement##6##3##(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-3#1)(2010-8#1)
and quality in##7##3##(1992-2#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-7#1)
and quality management##4##3##(1993-3#1)(1994-2#1)(1997-2#1)(1997-3#1)
and quality of care in##2##5##(1995-12#1)(2008-11#1)
and quality of care##18##4##(1991-1#3)(1993-12#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-2#3)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)
and quality of life among##3##5##(2009-12#1)(2009-5#1)(2010-5#1)
and quality of life for##2##5##(2008-7#1)(2012-12#1)
and quality of life in patients with##6##7##(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-8#2)
and quality of life in patients##7##6##(1991-6#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-8#2)
and quality of life in##14##5##(1991-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and quality of life of the##3##6##(2007-11#1)(2011-2#1)(2011-3#1)
and quality of life of##6##5##(2007-11#1)(2008-7#2)(2011-2#2)(2011-3#1)
and quality of life##57##4##(1991-6#1)(1992-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
and quality of the##7##4##(1991-6#1)(1993-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
and quality of##116##3##(1990-11#1)(1990-2#1)(1991-1#3)(1991-11#1)(1991-6#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#3)
and quality##221##2##(1990-11#1)(1990-2#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-6#2)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#8)(1995-12#5)(1995-2#7)(1995-3#2)(1996-1#6)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#8)(1997-3#3)(1997-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#9)(2013-1#5)(2013-8#3)
and quality-of-life##2##2##(2008-7#1)(2012-2#1)
and quantification have##2##3##(2008-10#1)(2010-7#1)
and quantification limits##12##3##(2008-10#12)
and quantification of the##4##4##(2008-10#2)(2010-9#1)(2011-2#1)
and quantification of##34##3##(1991-5#1)(1992-3#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#3)(2009-7#1)(2010-7#1)(2010-9#2)(2011-2#1)(2013-8#1)
and quantification were##3##3##(2008-10#3)
and quantification##71##2##(1991-5#1)(1992-3#1)(2008-1#1)(2008-10#46)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#3)(2009-7#2)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-8#1)
and quantified by##9##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)
and quantified in##4##3##(1991-11#1)(1993-6#1)(2008-3#1)(2013-8#1)
and quantified on##2##3##(2008-10#1)(2008-5#1)
and quantified using##2##3##(1991-12#1)(2008-2#1)
and quantified##27##2##(1991-11#1)(1991-12#2)(1992-3#1)(1993-6#1)(1994-6#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2011-1#1)(2013-8#1)
and quantify the##9##3##(2008-10#5)(2008-3#2)(2008-9#1)(2010-5#1)
and quantify##39##2##(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-2#3)
and quantifying the##2##3##(2008-4#1)(2008-5#1)
and quantifying##8##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
and quantitate##2##2##(2008-10#1)(2008-4#1)
and quantitated using a##2##4##(1991-2#1)(2008-7#1)
and quantitated using##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
and quantitated##10##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-9#1)(1997-2#1)(2008-10#2)(2008-7#2)
and quantitating##2##2##(2008-4#1)(2008-9#1)
and quantitation of iodotyrosines and iodothyronines##2##6##(2008-10#2)
and quantitation of the##3##4##(1997-2#1)(2008-10#1)(2008-9#1)
and quantitation of##17##3##(1990-12#1)(1992-8#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-4#3)(2008-9#1)(2013-8#1)
and quantitation##28##2##(1990-12#1)(1992-8#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#17)(2008-4#3)(2008-9#1)(2013-8#1)
and quantitative analyses of##2##4##(2008-10#1)(2008-9#1)
and quantitative analyses##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
and quantitative analysis of the##4##5##(2008-2#2)(2008-5#1)(2011-1#1)
and quantitative analysis of##17##4##(2008-10#10)(2008-2#2)(2008-5#2)(2011-1#1)(2012-12#1)(2012-3#1)
and quantitative analysis##24##3##(2008-10#14)(2008-2#2)(2008-5#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
and quantitative approach##2##3##(2008-5#1)(2008-8#1)
and quantitative assessment of##3##4##(2008-2#1)(2008-4#1)(2008-5#1)
and quantitative data##2##3##(2008-12#2)
and quantitative detection##2##3##(2008-10#2)
and quantitative determination of##7##4##(1991-5#1)(2008-10#2)(2008-5#3)(2010-4#1)
and quantitative determination was##3##4##(2008-10#1)(2008-5#2)
and quantitative determination##11##3##(1991-5#1)(2008-10#3)(2008-5#6)(2010-4#1)
and quantitative evaluation of##3##4##(1990-12#1)(1996-5#1)(2013-1#1)
and quantitative measurement of##2##4##(2008-5#1)(2008-9#1)
and quantitative recovery of a##2##5##(2008-10#1)(2011-1#1)
and quantitative recovery##3##3##(2008-10#1)(2011-1#2)
and quantitative resistance of bermudagrass genotypes##2##6##(2008-10#2)
and quantitative resistance##4##3##(2008-10#3)(2008-9#1)
and quantitative studies##2##3##(2008-9#1)(2012-2#1)
and quantitative trait loci##2##4##(2008-12#1)(2008-5#1)
and quantitative trait##3##3##(2008-12#1)(2008-5#1)(2013-8#1)
and quantitative traits##3##3##(2008-4#1)(2012-3#2)
and quantitative##125##2##(1990-12#1)(1991-5#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-5#2)(2008-1#2)(2008-10#39)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#15)(2008-7#1)(2008-8#2)(2008-9#8)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#2)
and quantitatively compared##2##3##(2008-10#1)(2008-11#1)
and quantitatively##23##2##(1991-5#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)(2009-7#1)(2012-2#1)(2013-7#1)
and quantities of##2##3##(2008-10#1)(2009-8#1)
and quantity of the##3##4##(2008-10#2)(2008-7#1)
and quantity of##9##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2011-10#1)(2012-12#1)(2012-2#1)
and quantity##17##2##(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-10#1)(2012-12#5)(2012-2#1)(2013-1#1)
and quantum chemical##2##3##(2008-5#1)(2012-2#1)
and quantum chemistry##2##3##(2011-2#2)
and quantum yield##2##3##(2008-9#2)
and quantum yields##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
and quantum##18##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-2#1)
and quarantine##5##2##(1996-11#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-12#1)
and quarter-wave plates##3##3##(2007-11#1)(2008-3#2)
and quartz##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
and quasi##2##2##(2007-12#1)(2012-2#1)
and quasi-periodic Cantor-like bandgap structures##2##5##(2008-3#2)
and quasi-periodic##3##2##(2008-3#3)
and quasistatic##2##2##(1996-4#1)(2012-2#1)
and quaternary ammonium##2##3##(2008-10#2)
and quaternary mixtures##2##3##(2008-10#1)(2013-8#1)
and quaternary##11##2##(1997-2#3)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2013-8#1)
and quaternized##2##2##(2008-10#1)(2008-5#1)
and queer##2##2##(2009-7#2)
and quenching of##2##3##(1992-12#1)(2008-5#1)
and quenching##3##2##(1992-12#1)(2008-5#1)(2010-4#1)
and quercetin##10##2##(1994-8#1)(1995-11#1)(2008-10#5)(2008-9#2)(2012-1#1)
and question##3##2##(2009-10#1)(2009-6#1)(2010-12#1)
and questionable##2##2##(1990-6#1)(1992-2#1)
and questionnaires were##2##3##(2008-11#1)(2011-1#1)
and questionnaires##9##2##(1992-5#1)(1994-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-1#1)
and questions regarding##2##3##(2010-7#1)(2013-8#1)
and questions##14##2##(1991-6#1)(1993-12#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and queuing##2##2##(2008-8#1)(2008-9#1)
and quick method##2##3##(2012-2#1)(2013-8#1)
and quick##10##2##(1993-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-8#1)
and quicker##2##2##(1993-6#1)(2007-7#1)
and quickly in##2##3##(2008-10#1)(2012-12#1)
and quickly##14##2##(1990-6#1)(1992-12#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-3#1)(2012-12#1)
and quiescent cultures##3##3##(1992-3#2)(2008-3#1)
and quinic acids##4##3##(2008-10#1)(2008-11#3)
and quinic##5##2##(2008-10#2)(2008-11#3)
and quinine and##2##3##(1992-11#1)(2008-10#1)
and quinine##5##2##(1992-11#2)(1997-4#2)(2008-10#1)
and quinoline##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
and quinolone##4##2##(1995-3#1)(2008-10#2)(2011-2#1)
and quinolones##5##2##(2008-10#4)(2011-2#1)
and quite##7##2##(1990-6#1)(1995-5#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
and r = -0##2##4##(1991-2#1)(2008-12#1)
and r = 0##9##4##(1991-2#2)(1991-8#1)(1995-11#2)(1995-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
and r =##11##3##(1991-2#3)(1991-8#1)(1995-11#2)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
and r##15##2##(1991-2#3)(1991-8#1)(1995-11#2)(1995-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
and r(2)##2##2##(2008-10#2)
and r(EO) = 0##2##4##(2012-12#2)
and rCBF##3##2##(2007-10#2)(2008-7#1)
and rRNA##5##2##(1992-6#1)(2008-10#1)(2008-8#2)(2011-2#1)
and rabbit##21##2##(1990-5#1)(1991-12#1)(1991-6#2)(1992-3#1)(1994-8#1)(1995-5#1)(1996-9#1)(1997-7#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#3)
and rabbits##10##2##(1990-11#3)(1994-8#1)(1996-12#1)(1996-9#2)(2008-4#1)(2008-5#1)(2010-4#1)
and race 2##5##3##(2008-10#5)
and race 6##3##3##(2008-10#3)
and race##21##2##(1992-3#1)(1992-8#1)(1995-12#1)(2008-10#17)(2008-8#1)
and racemic naproxen##2##3##(1994-3#2)
and races of F##2##4##(2008-10#2)
and races##4##2##(2008-10#4)
and racial##3##2##(1993-6#1)(1994-12#1)(2011-1#1)
and radial basis##2##3##(2008-10#2)
and radial##9##2##(2008-10#2)(2008-3#2)(2010-6#1)(2011-2#3)(2012-2#1)
and radiance##2##2##(2008-3#2)
and radiating##2##2##(2008-2#1)(2013-8#1)
and radiation therapy##13##3##(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
and radiation treatment for##2##4##(1992-6#1)(1992-7#1)
and radiation##37##2##(1992-10#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-8#1)(1995-9#2)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#3)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
and radiative##3##2##(1992-3#1)(2008-10#1)(2008-2#1)
and radical scavenging##2##3##(2008-12#1)(2008-7#1)
and radical##8##2##(1997-4#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-7#2)(2010-11#1)(2012-12#1)
and radicular##2##2##(2011-2#1)(2012-2#1)
and radio##5##2##(1995-2#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-3#1)
and radioactivity##2##2##(1992-3#1)(2008-8#1)
and radiobiological##2##2##(2008-7#1)(2011-2#1)
and radiofrequency##3##2##(2007-8#2)(2010-12#1)
and radiographic evaluation##3##3##(2007-11#1)(2008-6#1)(2008-9#1)
and radiographic features##4##3##(1993-12#1)(2007-12#1)(2007-7#1)(2008-12#1)
and radiographic findings##3##3##(2008-6#1)(2012-2#1)(2013-8#1)
and radiographic outcomes##3##3##(2011-2#1)(2013-1#2)
and radiographic##26##2##(1993-12#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-12#2)(2008-6#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and radiographs were##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
and radiographs##7##2##(2007-8#2)(2008-11#1)(2008-8#2)(2012-2#1)(2013-1#1)
and radioimmunoassay##2##2##(1992-8#1)(1995-11#1)
and radiologic features and##2##4##(2007-12#1)(2011-2#1)
and radiologic features##3##3##(1991-6#1)(2007-12#1)(2011-2#1)
and radiologic##9##2##(1991-6#1)(2007-12#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
and radiological assessment##2##3##(1990-8#1)(2013-1#1)
and radiological examination##9##3##(1991-3#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
and radiological features##2##3##(2008-7#1)(2013-1#1)
and radiological findings##9##3##(2008-6#1)(2009-5#1)(2012-12#3)(2012-2#2)(2013-1#2)
and radiological investigations##2##3##(1990-12#1)(1991-11#1)
and radiological manifestations##3##3##(1991-11#1)(2012-12#2)
and radiological results##3##3##(2007-11#1)(2007-8#2)
and radiological##59##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-5#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-7#1)(2007-11#4)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#4)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
and radiologically confirmed##2##3##(2007-8#1)(2008-8#1)
and radiologically##6##2##(2007-12#1)(2007-8#2)(2008-12#1)(2008-8#1)(2010-11#1)
and radiologists##7##2##(1992-3#1)(1993-3#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-7#1)(2012-2#1)
and radiology##4##2##(1991-12#1)(1993-1#1)(1994-12#1)(2009-6#1)
and radiometric##3##2##(2007-7#1)(2008-3#2)
and radionuclide##3##2##(1991-2#1)(1993-9#1)(2008-7#1)
and radiopharmaceuticals##2##2##(2012-12#2)
and radiotherapy are##3##3##(1990-2#1)(1990-6#1)(2010-8#1)
and radiotherapy in the management of##2##6##(1991-4#1)(1993-9#1)
and radiotherapy in the##3##4##(1991-4#1)(1993-9#1)(2011-2#1)
and radiotherapy in##5##3##(1991-4#1)(1993-2#1)(1993-9#1)(2007-8#1)(2011-2#1)
and radiotherapy were##2##3##(1992-8#1)(2010-3#1)
and radiotherapy##29##2##(1990-2#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-2#2)(1993-6#1)(1993-9#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-6#3)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
and radish##4##2##(2008-10#4)
and raffinose##4##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
and rain##6##2##(2008-10#5)(2008-5#1)
and rainfall##7##2##(2008-10#4)(2008-5#1)(2008-8#1)(2013-7#1)
and rainwater##3##2##(2008-10#3)
and rainy seasons##3##3##(2008-5#1)(2013-7#2)
and rainy##4##2##(1993-3#1)(2008-5#1)(2013-7#2)
and raise questions about##2##4##(2008-8#1)(2012-2#1)
and raise the possibility that##3##5##(1991-2#1)(1992-3#1)(2008-9#1)
and raise the##4##3##(1991-2#1)(1992-3#1)(2008-9#1)(2012-2#1)
and raise##7##2##(1991-2#1)(1992-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)
and raised##7##2##(1990-2#1)(1991-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
and raises the##3##3##(1995-12#1)(1995-2#1)(2008-8#1)
and raises##8##2##(1990-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-8#1)
and raising##8##2##(1991-12#1)(1991-7#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)
and random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#1)(2013-7#1)
and random amplified polymorphic DNA (RAPD)##5##6##(2008-10#4)(2013-7#1)
and random amplified polymorphic DNA##7##5##(2008-10#6)(2013-7#1)
and random amplified polymorphic##8##4##(2008-10#6)(2008-5#1)(2013-7#1)
and random amplified##9##3##(2008-10#7)(2008-5#1)(2013-7#1)
and random genetic drift##2##4##(1996-6#1)(2008-10#1)
and random orientations##2##3##(2008-2#1)(2008-3#1)
and random sampling##2##3##(1993-11#1)(2008-10#1)
and random##30##2##(1993-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#15)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2011-2#1)(2013-7#1)
and randomized controlled trials##2##4##(2009-12#1)(2009-2#1)
and randomized##5##2##(1995-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)
and randomly assigned to ingest in a double blind manner##2##10##(2008-5#2)
and randomly assigned to##3##4##(2008-4#1)(2008-5#2)
and randomly assigned##4##3##(2008-12#1)(2008-4#1)(2008-5#2)
and randomly##7##2##(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)
and range of motion##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
and range of##10##3##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
and range##15##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#3)
and ranged from##6##3##(1990-6#1)(1992-11#1)(2007-5#1)(2008-10#3)
and ranged##7##2##(1990-6#1)(1992-11#1)(2007-5#1)(2008-10#4)
and ranges##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
and ranging##2##2##(2007-11#1)(2008-10#1)
and ranging) technique##2##3##(2008-2#1)(2008-3#1)
and ranitidine##4##2##(2008-10#2)(2008-11#2)
and rank##4##2##(2008-10#1)(2008-5#2)(2013-1#1)
and ranked in##2##3##(1995-6#1)(2008-8#1)
and ranked##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
and ranking of##2##3##(1993-12#1)(2009-11#1)
and ranking##8##2##(1993-12#1)(2008-11#5)(2008-9#1)(2009-11#1)
and rapamycin##6##2##(1991-9#1)(1993-11#1)(1993-8#3)(1996-2#1)
and rapeseed##2##2##(2008-10#2)
and rapid amplification of cDNA ends##2##6##(2008-5#1)(2010-5#1)
and rapid analytical method is##2##5##(2008-10#2)
and rapid and##2##3##(2007-12#1)(2008-10#1)
and rapid approach##3##3##(1995-6#1)(2008-1#1)(2008-10#1)
and rapid assay for##2##4##(2008-10#1)(2008-11#1)
and rapid detection of##3##4##(1997-3#1)(2008-10#1)(2010-6#1)
and rapid determination of##2##4##(2008-10#2)
and rapid differential##2##3##(2008-10#2)
and rapid eye movement (REM) sleep##4##6##(1991-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
and rapid growth##3##3##(1994-2#1)(2011-2#1)(2012-3#1)
and rapid method for detecting##2##5##(2008-10#2)
and rapid method for the determination of##4##7##(2008-10#4)
and rapid method for the##6##5##(2008-10#6)
and rapid method for##14##4##(1990-11#1)(1995-2#1)(2008-10#11)(2008-4#1)
and rapid method is##2##4##(2008-10#2)
and rapid method of##2##4##(1994-11#1)(2008-4#1)
and rapid method##24##3##(1990-11#1)(1990-7#1)(1990-8#1)(1994-11#1)(1995-2#1)(2008-10#16)(2008-4#2)(2008-5#1)
and rapid response##5##3##(1992-1#1)(2007-11#1)(2008-10#2)(2011-2#1)
and rapid separation of##2##4##(1996-5#1)(2008-10#1)
and rapid separation##3##3##(1996-5#1)(2008-10#2)
and rapid spectrophotometric method is##2##5##(2008-10#2)
and rapid spectrophotometric method##3##4##(2008-10#3)
and rapid spectrophotometric##5##3##(2008-10#5)
and rapid##138##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#63)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
and rapidity and##3##3##(1990-12#1)(2008-10#1)(2009-6#1)
and rapidity of##2##3##(1993-5#1)(2008-10#1)
and rapidity##9##2##(1990-12#1)(1990-7#1)(1993-5#1)(2008-10#5)(2009-6#1)
and rapidly changing##3##3##(1997-3#1)(2008-11#2)
and rapidly growing##2##3##(1992-8#1)(2012-2#1)
and rapidly progressive##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
and rapidly than##2##3##(2008-10#1)(2011-2#1)
and rapidly##35##2##(1992-8#1)(1993-12#1)(1994-11#1)(1995-2#2)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#3)(2008-4#1)(2009-12#1)(2009-3#1)(2011-2#3)(2012-2#3)(2012-8#1)
and rare earth elements##3##4##(2008-10#3)
and rare earth##5##3##(2008-10#5)
and rare##20##2##(2006-10#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
and rarely in##2##3##(2008-5#1)(2013-1#1)
and rarely##9##2##(1991-2#1)(1994-3#1)(1997-3#1)(2007-8#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
and ras##3##2##(1992-11#1)(2008-11#2)
and rash##4##2##(1991-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
and rat brain##5##3##(1993-6#1)(2008-10#3)(2008-2#1)
and rat hepatocytes##2##3##(1990-2#1)(1992-3#1)
and rat kidney##2##3##(1997-7#2)
and rat liver microsomes##5##4##(1990-8#1)(1991-5#1)(1994-8#1)(2011-3#2)
and rat liver##11##3##(1990-8#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-8#2)(2011-3#2)
and rat##73##2##(1990-11#1)(1990-2#3)(1990-6#1)(1990-8#2)(1991-12#5)(1991-2#2)(1991-5#4)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#2)(2012-1#2)(2012-12#1)(2013-1#2)
and rate of growth of##2##5##(1996-3#1)(2011-2#1)
and rate of the##2##4##(1991-12#1)(2008-9#1)
and rate of##17##3##(1991-12#1)(1992-1#1)(1992-9#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
and rate parameters##2##3##(2008-10#1)(2008-11#1)
and rate their##2##3##(2008-7#1)(2010-4#1)
and rate##29##2##(1991-12#1)(1992-1#1)(1992-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#2)(2012-8#1)(2013-1#2)
and rate-limiting##4##2##(1992-8#1)(1993-8#1)(1996-12#1)(2009-9#1)
and rated##4##2##(2008-11#1)(2008-6#1)(2010-8#2)
and rates of death##2##4##(1991-12#1)(2013-1#1)
and rates of##9##3##(1991-12#1)(1992-2#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2013-1#1)
and rates##12##2##(1991-12#1)(1992-2#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
and rather##3##2##(1993-12#1)(2007-12#1)(2008-9#1)
and rating##2##2##(2008-10#2)
and ratings of##3##3##(1991-3#1)(2008-9#1)(2013-8#1)
and ratings##4##2##(1991-3#2)(2008-9#1)(2013-8#1)
and ratio of##2##3##(1995-3#1)(2010-4#1)
and ratio spectra##2##3##(2008-10#1)(2011-1#1)
and ratio##7##2##(1995-3#1)(2008-10#4)(2010-4#1)(2011-1#1)
and ratiometric##2##2##(2008-10#2)
and rational design##2##3##(2008-8#1)(2011-2#1)
and rational##8##2##(1992-5#1)(1993-11#1)(1994-8#1)(2008-8#1)(2011-1#1)(2011-2#2)(2011-3#1)
and rationale for##3##3##(1997-1#1)(2008-6#1)(2008-9#1)
and rationale##5##2##(1994-3#1)(1997-1#1)(2008-12#1)(2008-6#1)(2008-9#1)
and ratios of##2##3##(2008-3#2)
and ratios##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
and rats adapted to##2##4##(2013-1#2)
and rats were##2##3##(1994-6#1)(2008-9#1)
and rats##31##2##(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-5#3)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-9#2)(2010-7#1)(2011-1#1)(2013-1#2)
and raw and treated##2##4##(2008-10#1)(2012-12#1)
and raw##4##2##(1994-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
and ray##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
and ray-optics##2##2##(2008-3#2)
and re-association##2##2##(2008-12#2)
and re-dissolved in##2##3##(2008-10#1)(2008-5#1)
and re-establishment##2##2##(2008-1#1)(2008-11#1)
and re-training##2##2##(2011-1#1)(2013-1#1)
and reach the##2##3##(1996-7#1)(2008-10#1)
and reach##8##2##(1995-2#1)(1996-7#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
and reached a maximum##5##4##(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
and reached a plateau##2##4##(1994-11#1)(2011-2#1)
and reached a##11##3##(1990-6#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
and reached the maximum##2##4##(1997-2#1)(2008-9#1)
and reached the saturated value of 103 (+/-5%) muC cm-2##2##10##(2008-10#2)
and reached the##8##3##(1996-3#1)(1997-2#1)(2008-10#5)(2008-9#1)
and reached##29##2##(1990-6#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
and reaches a maximum##2##4##(2008-3#1)(2012-12#1)
and reaches the##2##3##(1997-1#1)(2008-5#1)
and reaches##6##2##(1993-8#1)(1997-1#1)(2008-3#2)(2008-5#1)(2012-12#1)
and reaching##6##2##(1992-10#1)(1992-11#2)(1992-3#1)(2008-10#1)(2008-9#1)
and react to##2##3##(1990-3#1)(1993-3#1)
and react##4##2##(1990-3#1)(1993-3#1)(2010-4#1)(2013-7#1)
and reacted with the##3##4##(2008-10#3)
and reacted with##11##3##(1993-6#1)(1994-11#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)
and reacted##14##2##(1993-6#1)(1994-11#1)(1996-12#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-5#1)(2012-3#1)
and reaction mechanism##2##3##(2008-10#1)(2008-11#1)
and reaction of##2##3##(1996-5#1)(2008-10#1)
and reaction time##3##3##(1996-7#1)(2008-6#1)(2011-2#1)
and reaction##17##2##(1996-5#1)(1996-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#2)
and reactions##4##2##(1992-3#1)(1996-11#1)(2008-12#1)(2012-2#1)
and reactive ion etching##3##4##(2008-2#1)(2008-3#2)
and reactive nitrogen species##2##4##(2009-8#1)(2011-2#1)
and reactive oxygen species (ROS)##2##5##(2008-1#1)(2008-10#1)
and reactive oxygen species have been##2##6##(2008-10#1)(2009-6#1)
and reactive oxygen species##7##4##(1997-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-6#2)
and reactive##26##2##(1990-6#2)(1997-4#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)
and reactivities##2##2##(2008-10#1)(2010-5#1)
and reactivity of##2##3##(2007-11#1)(2009-9#1)
and reactivity##10##2##(1992-5#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-9#1)(2010-6#1)(2012-12#1)(2012-2#1)
and reactor##4##2##(2008-10#2)(2008-11#1)(2009-2#1)
and reacts with the##2##4##(2008-10#2)
and reacts with##3##3##(2008-10#3)
and reacts##4##2##(1992-8#1)(2008-10#3)
and read##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
and readability##2##2##(2011-2#1)(2012-3#1)
and readers##4##2##(2008-10#1)(2010-12#3)
and readily available##3##3##(1994-3#1)(2008-10#1)(2008-4#1)
and readily##8##2##(1994-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-6#1)(2012-3#1)
and readiness##2##2##(2008-2#1)(2013-8#1)
and reading comprehension##3##3##(2008-12#1)(2011-2#2)
and reading scores##2##3##(2008-12#2)
and reading##15##2##(1992-3#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-12#5)(2008-2#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
and readings##2##2##(1995-1#1)(1997-3#1)
and readout##4##2##(2008-2#2)(2008-3#2)
and reagent consumption##4##3##(2008-10#3)(2011-1#1)
and reagent volumes##3##3##(2008-10#3)
and reagent##22##2##(2008-10#21)(2011-1#1)
and reagentless##2##2##(2008-10#1)(2008-3#1)
and reagents and##3##3##(2008-10#2)(2008-2#1)
and reagents that##2##3##(2008-4#1)(2008-9#1)
and reagents##19##2##(1996-5#1)(2008-10#12)(2008-2#1)(2008-4#3)(2008-9#1)(2010-7#1)
and real data##5##3##(2008-10#2)(2008-3#1)(2009-9#1)(2013-1#1)
and real sample##2##3##(2008-10#2)
and real samples##13##3##(2008-10#12)(2008-5#1)
and real##38##2##(1991-6#1)(2008-10#26)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2012-12#1)(2013-1#1)
and real-data##2##2##(2009-12#1)(2012-1#1)
and real-time PCR to detect helper virus contamination in the preparation##2##11##(2008-2#1)(2008-4#1)
and real-time PCR##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
and real-time imaging##2##3##(2009-7#1)(2011-1#1)
and real-time polymerase chain reaction (PCR)##2##6##(2008-10#2)
and real-time polymerase chain##3##4##(2008-10#3)
and real-time##27##2##(1996-12#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
and real-world##2##2##(2007-11#1)(2009-8#1)
and realistic##4##2##(1991-2#1)(1995-3#1)(2008-3#1)(2008-5#1)
and realities##3##2##(2007-4#1)(2008-1#1)(2008-11#1)
and reality##5##2##(1994-1#1)(1994-12#1)(1996-12#1)(2008-12#1)(2008-9#1)
and realization of##3##3##(1995-1#1)(2007-11#1)(2007-12#1)
and realization##4##2##(1995-1#1)(1995-3#1)(2007-11#1)(2007-12#1)
and realize##2##2##(2009-8#1)(2012-12#1)
and realized##3##2##(2007-12#1)(2008-2#1)(2012-3#1)
and realizing##2##2##(1991-3#1)(2008-3#1)
and really dangerous##2##3##(2012-3#2)
and really##4##2##(1992-2#1)(2012-3#2)(2013-1#1)
and reared##4##2##(1996-5#1)(2008-1#1)(2008-10#1)(2013-8#1)
and rearing##3##2##(1997-2#1)(2010-4#1)(2012-2#1)
and rearranged##2##2##(2008-10#1)(2008-7#1)
and rearrangement to##2##3##(1993-11#1)(2012-12#1)
and rearrangement##6##2##(1993-11#2)(1993-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
and reason##2##2##(2008-8#1)(2010-11#1)
and reasonable##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
and reasonably##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)
and reasoning##3##2##(2008-12#1)(2010-11#1)(2012-12#1)
and reasons for failure##2##4##(2012-12#1)(2013-1#1)
and reasons for##9##3##(1993-12#1)(1994-7#1)(1995-3#1)(2007-10#2)(2012-12#2)(2012-3#1)(2013-1#1)
and reasons##12##2##(1993-12#1)(1994-7#1)(1995-3#1)(2007-10#2)(2009-5#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
and reassessment##2##2##(2010-5#1)(2013-1#1)
and recall##4##2##(1991-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
and receipt of##2##3##(2008-4#1)(2013-1#1)
and receive a##2##3##(1996-3#1)(2008-7#1)
and receive care##2##3##(1994-3#1)(2008-4#1)
and receive##11##2##(1994-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#3)(2013-1#2)
and received a##2##3##(1995-8#1)(2010-4#1)
and received an##2##3##(1992-3#1)(2008-7#1)
and received by##2##3##(2008-10#1)(2008-3#1)
and received##20##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-8#1)(2007-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
and receiver field of view##2##5##(2008-3#2)
and receiver operating##2##3##(2008-10#1)(2011-2#1)
and receiver##15##2##(1995-5#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#6)(2008-9#1)(2011-2#1)
and receivers##3##2##(1995-5#1)(2008-2#1)(2008-3#1)
and receiving##10##2##(1991-12#1)(1994-3#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-10#1)(2010-10#1)(2013-1#1)(2013-8#1)
and recent advances in##3##4##(2008-5#1)(2008-8#1)(2012-2#1)
and recent advances of##2##4##(2008-10#1)(2011-1#1)
and recent advances##7##3##(2008-10#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-7#1)(2012-2#1)
and recent applications##2##3##(1994-9#1)(2010-9#1)
and recent developments##2##3##(2008-10#1)(2008-4#1)
and recent experience##2##3##(2007-8#1)(2008-11#1)
and recent findings##2##3##(2009-10#1)(2012-3#1)
and recent##45##2##(1990-8#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-11#1)(1996-1#1)(1997-6#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
and recently##7##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
and receptacle area##2##3##(2008-10#2)
and reception##2##2##(2008-11#1)(2012-2#1)
and receptor binding assays##2##4##(1994-5#1)(1995-8#1)
and receptor binding##4##3##(1991-1#1)(1991-12#1)(1994-5#1)(1995-8#1)
and receptor cell##2##3##(2007-12#1)(2008-10#1)
and receptor molecules is##2##4##(2008-1#1)(2008-4#1)
and receptor molecules##3##3##(2008-1#2)(2008-4#1)
and receptor signaling##2##3##(2008-4#1)(2012-2#1)
and receptor##20##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#3)(2009-8#1)(2011-2#1)(2012-2#1)
and receptor-binding##2##2##(1991-2#1)(2012-2#1)
and receptor-ligand##2##2##(2008-12#1)(2008-4#1)
and receptors for##2##3##(1990-11#1)(1996-12#1)
and receptors##8##2##(1990-11#1)(1990-5#1)(1992-6#1)(1996-12#1)(2008-4#1)(2012-12#1)(2013-8#2)
and recessive##4##2##(1997-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
and recipes##2##2##(2008-9#1)(2012-2#1)
and recipient##11##2##(1992-3#1)(2007-10#1)(2008-4#2)(2009-10#1)(2011-2#4)(2012-12#1)(2012-2#1)
and recipients##3##2##(1994-12#1)(2007-8#1)(2009-5#1)
and reciprocal##6##2##(1993-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2011-2#1)
and reciprocity##2##2##(1992-3#1)(2008-3#1)
and recognise the##2##3##(2011-2#2)
and recognise##3##2##(2008-8#1)(2011-2#2)
and recognition by##3##3##(1992-11#1)(1993-8#1)(2013-1#1)
and recognition for##2##3##(1991-3#1)(1994-1#1)
and recognition in##2##3##(2008-2#1)(2008-4#1)
and recognition of##8##3##(1994-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
and recognition##23##2##(1991-3#2)(1992-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)(2013-1#2)(2013-8#1)
and recognize the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
and recognize##10##2##(1993-12#1)(1995-12#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
and recognized##2##2##(2008-10#2)
and recognizing##3##2##(1994-3#1)(2008-4#1)(2011-2#1)
and recombinant human##2##3##(1992-8#1)(2008-11#1)
and recombinant inbred lines##2##4##(2008-10#2)
and recombinant protein expression##2##4##(2008-11#2)
and recombinant protein production##6##4##(2008-11#5)(2008-5#1)
and recombinant protein##9##3##(2008-11#7)(2008-5#1)(2008-7#1)
and recombinant##32##2##(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-2#2)(1997-2#1)(2007-6#1)(2008-10#3)(2008-11#11)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#2)
and recombinases##2##2##(2008-11#1)(2012-3#1)
and recombination of##2##3##(1995-2#1)(2008-8#1)
and recombination##14##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#1)
and recommend##3##2##(1991-6#1)(1992-12#1)(2010-9#1)
and recommendations are made##2##4##(1992-12#1)(2008-11#1)
and recommendations are##6##3##(1992-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
and recommendations based on##2##4##(2010-9#1)(2013-1#1)
and recommendations by the##2##4##(1994-12#1)(2007-12#1)
and recommendations for the use of contrast##2##7##(2008-7#1)(2008-9#1)
and recommendations for the##4##4##(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
and recommendations for##20##3##(1992-3#1)(1993-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
and recommendations of the##2##4##(2008-8#1)(2009-10#1)
and recommendations of##3##3##(1994-12#1)(2008-8#1)(2009-10#1)
and recommendations##46##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-12#2)(1995-1#3)(1995-2#1)(1995-3#1)(1996-1#2)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#4)
and recommended##5##2##(1993-3#1)(1995-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
and recommending##2##2##(1994-12#1)(1996-3#1)
and recommends##4##2##(1990-9#1)(1997-2#1)(2008-4#1)(2011-3#1)
and reconstituted##5##2##(1992-8#1)(1993-8#1)(2008-10#2)(2008-8#1)
and reconstitution of##2##3##(1995-8#1)(1997-4#1)
and reconstitution##3##2##(1995-8#1)(1997-4#1)(2008-10#1)
and reconstruct##2##2##(2010-6#1)(2012-2#1)
and reconstructed using##2##3##(2008-7#1)(2013-1#1)
and reconstructed##9##2##(1997-8#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
and reconstruction filter##2##3##(2012-1#2)
and reconstruction of##8##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
and reconstruction with##3##3##(2007-11#2)(2013-1#1)
and reconstruction##35##2##(2007-11#4)(2007-12#3)(2007-8#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
and reconstructive surgery of##2##4##(1992-9#1)(2011-2#1)
and reconstructive surgery##4##3##(1992-9#1)(2008-11#2)(2011-2#1)
and reconstructive##8##2##(1992-9#2)(2007-7#1)(2008-11#2)(2010-3#1)(2011-2#1)(2012-2#1)
and record the##2##3##(2008-3#1)(2008-4#1)
and record their##2##3##(2007-2#1)(2008-12#1)
and record##5##2##(2007-2#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
and recorded the##3##3##(1997-3#1)(2007-7#1)(2012-3#1)
and recorded##11##2##(1990-9#1)(1993-1#1)(1995-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-3#1)
and recording of##2##3##(2008-2#1)(2013-8#1)
and recording##12##2##(2007-12#2)(2008-2#5)(2008-3#3)(2011-2#1)(2013-8#1)
and records##2##2##(2008-9#1)(2012-3#1)
and recoverable##2##2##(1991-9#1)(2008-10#1)
and recovered by##2##3##(1992-8#1)(2008-10#1)
and recovered completely##2##3##(1996-6#1)(2008-1#1)
and recovered from##3##3##(2008-10#2)(2008-3#1)
and recovered##15##2##(1990-7#1)(1992-8#1)(1996-11#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and recoveries between##2##3##(2008-10#2)
and recoveries of##3##3##(2008-10#2)(2008-7#1)
and recoveries##11##2##(1993-2#1)(2008-10#9)(2008-7#1)
and recovering##2##2##(1992-9#1)(2008-3#1)
and recovery from the pharmaceutical##2##5##(2008-10#2)
and recovery from##3##3##(1990-7#1)(2008-10#2)
and recovery in##2##3##(2013-1#1)(2013-8#1)
and recovery is quantitative##2##4##(2008-10#2)
and recovery is##3##3##(2008-10#3)
and recovery of the##4##4##(2008-10#3)(2008-3#1)
and recovery of##27##3##(1991-9#1)(2008-10#17)(2008-11#4)(2008-3#2)(2008-7#1)(2012-12#1)(2013-1#1)
and recovery tests##2##3##(2008-10#2)
and recovery time##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
and recovery to##2##3##(2008-10#1)(2012-2#1)
and recovery was##3##3##(1993-12#1)(2008-10#1)(2011-3#1)
and recovery were##2##3##(1990-8#1)(2008-10#1)
and recovery##82##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-2#1)(2008-10#44)(2008-11#5)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#4)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
and recreation##3##2##(1993-2#1)(1994-3#1)(2012-12#1)
and recreational##4##2##(1991-1#1)(2008-5#1)(2008-9#1)(2012-12#1)
and recruit##3##2##(2008-11#1)(2009-5#1)(2009-8#1)
and recruited##2##2##(2008-3#1)(2009-3#1)
and recruiting##4##2##(1994-1#2)(2011-1#1)(2012-3#1)
and recruitment and retention##2##4##(1995-2#1)(2008-11#1)
and recruitment of##4##3##(1992-1#1)(2008-5#1)(2008-7#1)(2012-2#1)
and recruitment##15##2##(1992-1#1)(1992-6#1)(1995-2#1)(1996-2#1)(2006-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#3)(2012-3#2)(2013-7#1)
and rectal cancer##6##3##(1992-8#1)(1997-8#1)(2010-6#2)(2011-2#2)
and rectal##15##2##(1991-6#1)(1992-2#1)(1992-8#1)(1997-3#1)(1997-8#1)(2007-10#1)(2008-10#2)(2009-10#1)(2010-6#2)(2011-2#3)(2013-1#1)
and rectangular##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
and rectocele##3##2##(1994-3#1)(2011-2#2)
and rectum##14##2##(1991-2#1)(1991-6#3)(1992-5#1)(1992-8#1)(1993-9#1)(2007-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and rectus abdominis##4##3##(2008-4#1)(2012-2#3)
and rectus##5##2##(2008-12#1)(2008-4#1)(2012-2#3)
and recur after##2##3##(2011-2#1)(2013-1#1)
and recurrence of the##2##4##(2008-10#1)(2008-7#1)
and recurrence of##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
and recurrence##16##2##(1997-7#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
and recurrences##3##2##(1995-9#1)(2007-8#2)
and recurrent##24##2##(1990-9#1)(1991-3#2)(1991-6#4)(1992-9#1)(1994-3#1)(1996-11#1)(1997-5#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-3#1)
and recurring##2##2##(2008-11#1)(2008-12#1)
and recursive partitioning##2##3##(1995-2#1)(2008-3#1)
and recursive##3##2##(1995-2#1)(2008-3#1)(2008-6#1)
and recyclability##2##2##(1994-3#1)(2010-12#1)
and recycling##5##2##(1990-11#1)(1993-11#3)(1995-11#1)
and red blood cells##3##4##(1996-12#1)(2008-10#2)
and red cell##4##3##(1991-9#2)(1992-6#1)(2011-3#1)
and red cells##2##3##(1992-12#1)(1993-9#1)
and red wine##3##3##(2008-10#2)(2011-2#1)
and red##36##2##(1990-10#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-9#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-10#11)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#1)
and redesign##4##2##(1993-12#1)(1996-12#1)(1997-2#1)(2008-12#1)
and redesigning the continuum of care##2##6##(1997-3#2)
and redesigning the##3##3##(1997-3#2)(2008-2#1)
and redesigning##6##2##(1997-1#1)(1997-3#3)(1997-7#1)(2008-2#1)
and redistribution##2##2##(1995-6#1)(2008-10#1)
and redox potential##2##3##(1993-11#1)(2008-11#1)
and redox##13##2##(1990-8#1)(1993-11#2)(2008-10#7)(2008-11#1)(2008-7#1)(2012-2#1)
and reduce average##2##3##(1997-2#1)(2008-8#1)
and reduce costs##5##3##(1995-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2009-4#1)
and reduce health##2##3##(1996-2#1)(2012-2#1)
and reduce risk##3##3##(1997-1#1)(2008-12#1)(2011-1#1)
and reduce the adverse##2##4##(2012-3#1)(2013-7#1)
and reduce the incidence of##2##5##(2007-11#1)(2012-3#1)
and reduce the need for##2##5##(2009-11#1)(2010-9#1)
and reduce the number of##3##5##(1997-5#1)(2008-10#1)(2011-2#1)
and reduce the risk of##3##5##(2008-1#1)(2011-2#1)(2013-8#1)
and reduce the##33##3##(1992-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
and reduce##72##2##(1990-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#3)(1997-1#2)(1997-2#3)(1997-5#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#2)
and reduced bone mass##2##4##(1997-8#1)(2013-1#1)
and reduced bone##4##3##(1997-8#1)(2009-7#1)(2013-1#2)
and reduced by##3##3##(1991-5#1)(1995-3#1)(2008-10#1)
and reduced cost##2##3##(2008-3#1)(2008-6#1)
and reduced disease severity##3##4##(2008-10#3)
and reduced disease##4##3##(2008-10#4)
and reduced glutathione (GSH)##3##4##(2008-10#2)(2010-11#1)
and reduced glutathione##6##3##(2008-10#3)(2010-11#1)(2012-2#2)
and reduced in##3##3##(2008-7#2)(2013-8#1)
and reduced morbidity##2##3##(2008-10#1)(2010-6#1)
and reduced quality of life##2##5##(1995-8#1)(2008-7#1)
and reduced quality##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
and reduced root rot severity by##2##6##(2008-10#2)
and reduced scattering coefficients##4##4##(2008-2#1)(2008-3#3)
and reduced scattering##8##3##(2008-2#1)(2008-3#7)
and reduced sporulation##2##3##(2008-10#2)
and reduced survival##4##3##(1993-1#1)(1994-10#1)(2008-7#1)(2012-2#1)
and reduced the number of##2##5##(2008-10#1)(2012-3#1)
and reduced the rate of##2##5##(1991-12#1)(2008-10#1)
and reduced the##24##3##(1990-5#1)(1991-12#1)(1992-11#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-9#1)(2010-11#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
and reduced time##2##3##(2008-10#1)(2013-1#1)
and reduced##161##2##(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#42)(2008-11#5)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#9)(2012-3#1)(2012-6#1)(2013-1#8)(2013-8#1)
and reduces the number of##2##5##(1991-2#1)(1995-9#1)
and reduces the##10##3##(1990-2#1)(1991-2#1)(1991-9#1)(1995-9#1)(1997-1#1)(1997-3#1)(2007-11#2)(2008-3#1)(2008-5#1)
and reduces##25##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-3#2)(1995-12#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and reducing agents##2##3##(2008-10#1)(2008-4#1)
and reducing costs##3##3##(1996-3#1)(1997-2#1)(2008-10#1)
and reducing health##2##3##(1996-3#1)(2012-2#1)
and reducing the##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
and reducing##43##2##(1990-2#1)(1990-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
and reduction coil length##3##4##(2008-10#3)
and reduction in##13##3##(1994-10#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
and reduction of the##4##4##(1990-6#1)(1995-5#1)(2008-10#1)(2008-9#1)
and reduction of##25##3##(1990-6#2)(1995-5#1)(1996-11#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
and reduction##51##2##(1990-6#2)(1994-10#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
and reductions in##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
and reductions of##2##3##(1991-11#1)(1996-5#1)
and reductions##5##2##(1991-11#1)(1996-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
and reductive stress##2##3##(1990-7#1)(2008-11#1)
and reductive##5##2##(1990-7#1)(1992-12#1)(2008-10#2)(2008-11#1)
and redwood##2##2##(2008-10#2)
and reelin##2##2##(2009-8#2)
and reengineering##2##2##(1995-3#2)
and reference memory##2##3##(2008-12#2)
and reference methods##3##3##(2008-10#3)
and reference strains##2##3##(2008-10#2)
and reference values##3##3##(2008-10#2)(2011-2#1)
and reference wave##2##3##(2008-2#1)(2008-3#1)
and reference##36##2##(1996-1#1)(1997-1#1)(2007-12#2)(2008-10#18)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
and references##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
and referral services##2##3##(1994-1#1)(1994-2#1)
and referral to##2##3##(2008-11#1)(2009-8#1)
and referral##10##2##(1990-11#1)(1992-2#1)(1994-1#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)
and referred for##2##3##(1994-6#1)(2010-8#1)
and referred##5##2##(1994-6#1)(2008-10#1)(2010-8#1)(2010-9#2)
and referring##2##2##(1996-3#1)(2007-8#1)
and refined by##2##3##(1992-12#1)(1992-4#1)
and refined to##4##3##(1992-8#1)(1993-8#1)(1995-5#1)(2008-11#1)
and refined using##2##3##(2008-11#1)(2008-8#1)
and refined##13##2##(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2011-1#1)
and refinement of##2##3##(1995-1#1)(2008-7#1)
and refinement##5##2##(1993-8#1)(1995-1#1)(1996-1#1)(2008-7#1)(2011-3#1)
and refining##3##2##(2008-4#1)(2008-6#1)(2011-1#1)
and reflect##4##2##(1990-7#1)(1993-6#1)(2008-8#1)(2009-9#1)
and reflectance##15##2##(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#7)(2013-8#1)
and reflected##5##2##(2007-11#2)(2008-11#1)(2008-3#1)(2009-9#1)
and reflecting##4##2##(2008-12#3)(2013-1#1)
and reflection characteristics##2##3##(2008-3#2)
and reflection from the##2##4##(2008-2#1)(2008-3#1)
and reflection from##3##3##(2008-2#2)(2008-3#1)
and reflection##22##2##(2007-12#2)(2008-11#3)(2008-2#6)(2008-3#11)
and reflections on##2##3##(2008-11#1)(2012-2#1)
and reflective##10##2##(2008-11#4)(2008-2#1)(2008-3#5)
and reflectivity##3##2##(2008-3#3)
and reflects the##2##3##(1997-6#1)(2008-3#1)
and reflects##4##2##(1997-6#1)(2008-12#1)(2008-3#1)(2012-2#1)
and reflex##3##2##(1993-12#1)(2008-10#1)(2008-12#1)
and reflux##3##2##(1992-11#1)(2011-2#1)(2012-12#1)
and refolding of the##2##4##(2008-4#1)(2008-8#1)
and refolding##4##2##(2008-10#1)(2008-4#2)(2008-8#1)
and reform##4##2##(1991-12#1)(1993-12#1)(1994-12#1)(1996-3#1)
and refraction##4##2##(2008-2#3)(2008-7#1)
and refractive index changes##2##4##(2007-12#2)
and refractive index of##3##4##(2008-10#1)(2008-2#2)
and refractive index##15##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#4)(2008-4#1)
and refractive indices##4##3##(2008-2#2)(2008-3#2)
and refractive##22##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#8)(2008-3#7)(2008-4#1)
and refractive-index##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
and refractory##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#3)
and refugee##2##2##(2008-11#1)(2011-2#1)
and regained##2##2##(1994-5#1)(2011-1#1)
and regarding##2##2##(1990-3#1)(2008-4#1)
and regardless of##2##3##(1994-9#1)(2008-9#1)
and regenerated##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
and regenerating liver##2##3##(1990-5#1)(1991-12#1)
and regenerating##4##2##(1990-5#1)(1991-12#1)(2008-2#1)(2010-5#1)
and regeneration of the##2##4##(2008-5#1)(2012-2#1)
and regeneration of##6##3##(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-2#1)
and regeneration##22##2##(1993-12#1)(1993-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
and regenerative medicine##11##3##(2008-11#1)(2008-5#2)(2009-7#1)(2010-10#2)(2010-3#1)(2012-12#1)(2012-5#2)(2012-6#1)
and regenerative##14##2##(1994-5#2)(2008-11#1)(2008-5#2)(2009-10#1)(2009-7#1)(2010-10#2)(2010-3#1)(2012-12#1)(2012-5#2)(2012-6#1)
and region of origin##2##4##(2008-10#2)
and region of##3##3##(2008-10#2)(2012-12#1)
and region##5##2##(2008-10#2)(2011-2#1)(2011-9#1)(2012-12#1)
and regional cerebral##2##3##(1996-5#1)(2007-10#1)
and regional differences##2##3##(1991-6#1)(2007-5#1)
and regional##50##2##(1990-11#2)(1990-6#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-3#4)(1994-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-11#1)(2009-2#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-3#1)
and regions of##2##3##(1990-4#1)(2013-1#1)
and regions##7##2##(1990-4#1)(1995-5#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and registered in the##2##4##(1991-6#1)(2008-12#1)
and registered##3##2##(1991-6#1)(2008-12#1)(2010-5#1)
and registration##9##2##(1992-1#2)(1992-12#1)(1996-2#1)(2008-3#2)(2009-12#1)(2011-1#1)(2012-2#1)
and registries##3##2##(2009-10#1)(2011-2#1)(2012-12#1)
and registry of##2##3##(2008-7#1)(2009-4#1)
and regression analyses were##2##4##(2008-10#2)
and regression analyses##3##3##(2008-10#2)(2011-2#1)
and regression coefficient##2##3##(2008-10#2)
and regression of the##2##4##(2008-12#1)(2008-7#1)
and regression of##4##3##(1990-2#1)(1995-9#1)(2008-12#1)(2008-7#1)
and regression tree##3##3##(2008-10#3)
and regression##17##2##(1990-2#1)(1994-1#1)(1995-9#1)(2008-10#10)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
and regressions##2##2##(2008-8#1)(2013-1#1)
and regrowth of##2##3##(1992-9#1)(2008-7#1)
and regrowth##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
and regular follow-up##2##3##(1996-7#1)(2013-1#1)
and regular use of##3##4##(1990-9#1)(1991-9#1)(2008-9#1)
and regular##13##2##(1990-9#1)(1991-9#1)(1996-7#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2013-1#1)
and regularly##2##2##(1992-9#1)(1997-3#1)
and regulate the##4##3##(1991-11#1)(1994-9#1)(2008-11#1)(2010-1#1)
and regulate their##2##3##(2008-10#1)(2012-2#1)
and regulate##13##2##(1991-11#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-1#1)(2012-2#1)(2013-1#1)
and regulated by##2##3##(2008-4#1)(2011-2#1)
and regulated expression of##2##4##(1992-6#1)(1993-9#1)
and regulated in the##2##4##(1992-3#1)(2010-12#1)
and regulated##10##2##(1992-3#1)(1992-6#1)(1993-9#1)(1994-1#1)(2008-4#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)
and regulates the##3##3##(1997-6#1)(2011-2#1)(2012-2#1)
and regulates##7##2##(1995-6#1)(1997-6#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and regulating cell##2##3##(2009-8#1)(2010-9#1)
and regulating##7##2##(1996-12#1)(2009-5#1)(2009-8#1)(2010-8#2)(2010-9#1)(2013-1#1)
and regulation by##3##3##(1993-6#1)(1995-11#1)(2008-11#1)
and regulation in##3##3##(1995-2#1)(2008-8#1)(2008-9#1)
and regulation of glucose and glutamine metabolism##2##7##(2008-11#2)
and regulation of the##6##4##(1990-5#1)(1991-5#1)(1993-2#1)(1993-5#1)(1995-11#1)(2012-2#1)
and regulation of##30##3##(1990-5#1)(1991-5#2)(1993-12#1)(1993-2#1)(1993-5#1)(1995-11#1)(1997-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
and regulation##51##2##(1990-5#1)(1991-5#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-11#2)(1995-2#1)(1995-6#1)(1997-1#1)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-11#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
and regulations of##2##3##(2009-5#1)(2012-3#1)
and regulations##15##2##(1992-11#1)(1995-3#2)(1996-1#1)(1996-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2012-3#1)
and regulators of##2##3##(2009-7#1)(2011-2#1)
and regulators##3##2##(2009-7#1)(2011-2#1)(2012-3#1)
and regulatory authorities##2##3##(2008-11#1)(2008-8#1)
and regulatory elements##3##3##(2008-8#1)(2012-3#2)
and regulatory mechanisms##3##3##(1993-11#1)(2011-1#1)(2012-3#1)
and regulatory##38##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#3)
and rehabilitation after total knee arthroplasty##2##6##(2007-11#2)
and rehabilitation of the##2##4##(1995-2#1)(1995-5#1)
and rehabilitation of##5##3##(1995-2#1)(1995-5#1)(2007-12#1)(2012-2#1)(2012-3#1)
and rehabilitation##34##2##(1991-12#1)(1993-1#1)(1993-12#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(2007-11#8)(2007-12#1)(2007-8#2)(2008-12#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)
and rehabilitative##4##2##(2009-10#1)(2013-1#3)
and rehydration##2##2##(2008-10#1)(2011-1#1)
and reimbursement guidelines##2##3##(2008-12#2)
and reimbursement##13##2##(1991-12#2)(1992-11#1)(1992-12#1)(1993-3#1)(1995-3#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#3)
and reimplantation##2##2##(2008-9#2)
and reinforce the##2##3##(2007-8#1)(2008-8#1)
and reinforcement of##2##3##(1991-1#1)(2013-1#1)
and reinforcement##5##2##(1991-1#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
and reinforces the##2##3##(2008-10#1)(2011-2#1)
and reinforces##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
and rejected##3##2##(1995-12#2)(2008-10#1)
and rejection of##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
and rejection##5##2##(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)
and relapse##6##2##(1996-11#1)(2008-11#1)(2008-5#1)(2009-9#2)(2011-2#1)
and relapse-free survival##2##3##(1991-4#1)(1994-12#1)
and relapsing##3##2##(1991-2#1)(1995-12#1)(2008-7#1)
and relate their##2##3##(1996-2#1)(2008-9#1)
and relate them to##2##4##(2008-12#1)(2012-2#1)
and relate##9##2##(1996-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
and related aminothiols##2##3##(2008-10#2)
and related complications##2##3##(1996-12#1)(2008-7#1)
and related compounds by micellar electrokinetic chromatography##2##7##(1990-8#2)
and related compounds in##3##4##(2008-10#3)
and related compounds on protein##3##5##(2008-11#3)
and related compounds##18##3##(1990-8#2)(2007-11#1)(2008-10#11)(2008-11#3)(2008-7#1)
and related disorders##11##3##(1992-6#2)(2008-11#1)(2008-12#5)(2008-3#1)(2009-7#1)(2012-2#1)
and related factors##4##3##(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
and related genera##2##3##(2008-10#1)(2008-5#1)
and related indices in##2##4##(2008-10#1)(2010-12#1)
and related inhibitors##2##3##(1992-12#1)(2011-3#1)
and related issues##2##3##(2008-5#1)(2009-9#1)
and related materials##2##3##(1994-3#1)(2009-12#1)
and related phenomena##2##3##(2008-3#2)
and related problems##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
and related processes##2##3##(2008-2#2)
and related proteins##2##3##(1990-5#1)(2008-7#1)
and related research##2##3##(1996-2#1)(2008-10#1)
and related risk factors in the federated States of micronesia##4##10##(2013-8#4)
and related risk factors in the republic of the marshall islands##2##11##(2013-8#2)
and related risk factors in the republic of##3##8##(2013-8#3)
and related risk factors in the territory of##2##8##(2013-8#2)
and related risk factors in the##10##6##(2013-8#10)
and related social##2##3##(1991-3#1)(2012-12#1)
and related species##7##3##(2007-12#1)(2008-10#5)(2008-11#1)
and related to the##9##4##(1992-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-10#1)(2012-2#1)
and related to##16##3##(1992-3#1)(1996-9#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-7#1)
and related##201##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-12#4)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#39)(2008-11#11)(2008-12#9)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#9)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#5)(2013-8#13)
and relatedness##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)
and relates the##2##3##(1995-1#1)(2008-8#1)
and relates##4##2##(1995-1#1)(1996-3#1)(2008-8#1)(2008-9#1)
and relating##4##2##(1990-2#1)(2008-10#1)(2008-7#2)
and relation to##2##3##(2007-10#1)(2008-4#1)
and relation##3##2##(2007-10#1)(2008-4#1)(2011-2#1)
and relational##9##2##(1990-3#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#1)
and relations##2##2##(2013-1#2)
and relationship to##5##3##(1993-8#1)(2008-9#2)(2012-12#1)(2012-3#1)
and relationship with##2##3##(2008-7#1)(2013-7#1)
and relationship##16##2##(1993-8#1)(2008-12#1)(2008-7#2)(2008-9#4)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
and relationships between##2##3##(2008-11#1)(2008-9#1)
and relationships of##3##3##(1991-1#1)(2008-1#1)(2008-8#1)
and relationships within##2##3##(2008-10#1)(2010-6#1)
and relationships##10##2##(1991-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)
and relative abundance of##3##4##(2008-10#1)(2008-5#2)
and relative abundance##6##3##(2008-10#1)(2008-5#3)(2008-8#2)
and relative error##2##3##(2008-10#2)
and relative head weight (0##2##5##(2008-10#2)
and relative humidity on##2##4##(2008-10#1)(2010-10#1)
and relative humidity##13##3##(1995-3#1)(1996-12#1)(2008-10#8)(2008-8#1)(2010-10#1)(2013-1#1)
and relative proportions of##2##4##(2008-7#2)
and relative standard deviation (R##2##5##(2008-10#2)
and relative standard deviation for##2##5##(2008-10#2)
and relative standard deviation of +/-0##2##6##(2008-10#2)
and relative standard deviation of +/-1##2##6##(2008-10#2)
and relative standard deviation of 1##3##6##(2008-10#3)
and relative standard deviation of##13##5##(2008-10#13)
and relative standard deviation was##3##5##(2008-10#3)
and relative standard deviation were##2##5##(2008-10#2)
and relative standard deviation##33##4##(2008-10#33)
and relative standard deviations for##2##5##(2008-10#2)
and relative standard deviations of##2##5##(2008-10#2)
and relative standard deviations were##5##5##(2008-10#5)
and relative standard deviations##12##4##(2008-10#11)(2010-5#1)
and relative standard##47##3##(2008-10#46)(2010-5#1)
and relative weight of##2##4##(1995-3#1)(2008-10#1)
and relative##124##2##(1990-2#1)(1992-3#1)(1994-3#1)(1995-3#2)(1995-9#1)(1996-12#3)(2007-10#2)(2007-11#1)(2008-10#75)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-7#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)
and relatively easy##2##3##(1991-3#1)(2011-2#1)
and relatively effective##2##3##(2008-10#1)(2013-1#1)
and relatively few##2##3##(2008-7#1)(2012-3#1)
and relatively high##3##3##(2008-2#1)(2008-3#1)(2009-3#1)
and relatively inexpensive##3##3##(2008-10#3)
and relatively low##6##3##(2008-10#2)(2008-7#1)(2011-1#1)(2012-2#2)
and relatively simple##4##3##(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)
and relatively##38##2##(1991-3#1)(1992-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#2)(2009-3#2)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
and relatives##7##2##(1990-3#1)(1995-1#1)(1997-3#1)(2007-10#1)(2009-6#1)(2010-8#1)(2012-12#1)
and relaxation rate##2##3##(1994-5#1)(1994-8#1)
and relaxation time of the##2##5##(2007-11#2)
and relaxation##16##2##(1991-12#2)(1992-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-4#2)(1997-7#1)(2007-11#2)(2007-6#1)(2008-3#2)(2011-2#1)(2013-1#1)
and relaxed##3##2##(2007-8#1)(2008-11#1)(2008-9#1)
and relearning of##2##3##(1994-8#1)(1995-12#1)
and relearning##6##2##(1994-8#1)(1995-12#5)
and release by##2##3##(1996-2#1)(2008-10#1)
and release from##2##3##(1995-11#1)(1996-12#1)
and release in##3##3##(1991-1#1)(2008-10#2)
and release of ascospores of Anisogramma anomala##2##7##(2008-10#2)
and release of newly synthesized##2##5##(1996-2#1)(2008-11#1)
and release of the##3##4##(2008-10#3)
and release of##39##3##(1991-9#1)(1992-2#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#2)(2006-10#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
and release properties of the##2##5##(2008-10#1)(2013-1#1)
and release the##4##3##(1992-6#1)(2008-7#1)(2009-11#1)(2010-4#1)
and release##75##2##(1991-1#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-8#2)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#2)(1997-2#2)(2006-10#1)(2007-7#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
and released during##2##3##(1994-5#1)(2008-4#1)
and released from##3##3##(1991-3#1)(1995-12#1)(2009-10#1)
and released in##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
and released##21##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#1)(2009-10#1)(2011-10#1)(2011-2#1)
and releasing##3##2##(1994-5#1)(2009-9#1)(2013-1#1)
and relevance of##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
and relevance##5##2##(1991-5#1)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
and relevant information##3##3##(2008-6#1)(2010-4#1)(2013-8#1)
and relevant##20##2##(1990-11#1)(1990-8#1)(1991-9#1)(1994-12#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#3)(2013-1#2)(2013-8#1)
and reliability for##2##3##(2008-7#1)(2012-12#1)
and reliability of a##2##4##(1995-11#1)(2010-9#1)
and reliability of the##14##4##(1994-2#1)(1994-6#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
and reliability of these##2##4##(2008-4#1)(2012-12#1)
and reliability of this##2##4##(2008-11#1)(2013-8#1)
and reliability of##30##3##(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(2007-10#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
and reliability##45##2##(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
and reliable alternative to##2##4##(2007-12#1)(2008-9#1)
and reliable alternative##3##3##(1993-8#1)(2007-12#1)(2008-9#1)
and reliable analytical method##2##4##(2008-10#2)
and reliable analytical##5##3##(2008-10#5)
and reliable and##2##3##(2008-10#1)(2008-4#1)
and reliable detection of##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
and reliable detection##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
and reliable diagnosis##2##3##(2007-2#1)(2011-3#1)
and reliable diagnostic##3##3##(2007-2#1)(2008-10#1)(2012-3#1)
and reliable for##3##3##(1990-5#1)(2008-10#1)(2008-3#1)
and reliable instrument##2##3##(2008-10#1)(2013-1#1)
and reliable manner##2##3##(1997-1#1)(2010-12#1)
and reliable means of##2##4##(1990-8#1)(1997-7#1)
and reliable means##3##3##(1990-8#1)(1995-2#1)(1997-7#1)
and reliable method for the selective extraction and##2##8##(2008-10#2)
and reliable method for the##4##5##(2008-10#4)
and reliable method for##13##4##(1997-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
and reliable method has been developed##2##6##(2008-10#2)
and reliable method of##2##4##(2008-10#1)(2008-9#1)
and reliable method to##2##4##(2008-10#1)(2008-3#1)
and reliable method was developed for##2##6##(2008-10#2)
and reliable method with##2##4##(2008-5#1)(2012-2#1)
and reliable method##26##3##(1997-7#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-2#1)
and reliable procedure##2##3##(2008-10#1)(2010-8#1)
and reliable##118##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
and reliably##8##2##(1992-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
and reliance on##3##3##(2008-12#1)(2008-6#1)(2011-1#1)
and relief##3##2##(1992-5#1)(1997-2#1)(2006-10#1)
and relies on the##2##4##(2008-11#1)(2008-2#1)
and relies##5##2##(1995-3#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#1)
and relieve##4##2##(1997-6#1)(2007-11#1)(2008-11#1)(2012-3#1)
and relieving##2##2##(2008-11#1)(2010-5#1)
and religion are##3##3##(2008-12#1)(2010-10#1)(2013-1#1)
and religion##7##2##(2008-11#1)(2008-12#2)(2009-8#1)(2010-10#1)(2013-1#2)
and religious beliefs##2##3##(2008-4#1)(2012-12#1)
and religious coping##3##3##(2008-12#1)(2009-11#2)
and religious involvement##3##3##(2009-7#3)
and religious##15##2##(1991-6#1)(2008-10#1)(2008-12#3)(2008-4#2)(2009-11#2)(2009-7#4)(2009-8#1)(2012-12#1)
and remain##10##2##(1992-4#1)(2007-10#2)(2007-5#1)(2008-10#3)(2008-12#1)(2008-9#1)(2013-1#1)
and remainder##2##2##(1994-3#1)(2013-8#1)
and remained an##2##3##(1995-11#1)(2011-1#1)
and remained at##3##3##(1996-5#1)(2007-10#1)(2012-12#1)
and remained elevated##2##3##(1994-11#1)(2007-10#1)
and remained low##2##3##(1997-6#1)(2010-8#1)
and remained so##3##3##(2007-7#1)(2008-10#1)(2010-3#1)
and remained stable##2##3##(2008-7#1)(2011-2#1)
and remained##32##2##(1990-8#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-1#1)
and remains a significant clinical problem##2##6##(2008-7#2)
and remains a##3##3##(2008-7#2)(2013-8#1)
and remains the##2##3##(2007-7#1)(2008-10#1)
and remains##15##2##(1990-7#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
and remarkable stability##3##3##(1990-5#1)(2008-10#2)
and remarkable##7##2##(1990-5#1)(2007-12#1)(2008-10#2)(2008-7#2)(2012-3#1)
and remarkably##2##2##(2008-1#1)(2009-12#1)
and remembered##2##2##(2007-12#1)(2012-2#1)
and remifentanil##2##2##(2008-10#1)(2011-2#1)
and reminder##2##2##(1996-2#1)(2010-8#1)
and remission of##2##3##(1994-12#1)(1995-10#1)
and remission##5##2##(1993-12#1)(1994-12#1)(1995-10#1)(2008-6#1)(2013-8#1)
and remodeling in##2##3##(1994-8#1)(2011-2#1)
and remodeling of the##3##4##(2007-11#1)(2008-7#1)(2009-7#1)
and remodeling of##5##3##(2007-11#1)(2008-7#1)(2009-11#1)(2009-7#2)
and remodeling##14##2##(1994-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#2)(2009-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
and remote sensing data##2##4##(2008-8#2)
and remote sensing of##2##4##(2008-2#1)(2008-3#1)
and remote sensing##8##3##(2008-2#1)(2008-3#1)(2008-8#6)
and remote##22##2##(1990-5#1)(1991-9#1)(1993-6#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#6)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
and remotely##2##2##(2007-12#1)(2008-10#1)
and removal of the##5##4##(1990-2#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and removal of##25##3##(1990-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
and removal##29##2##(1990-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
and remove infected##2##3##(2008-10#2)
and remove the##2##3##(1997-2#1)(2011-2#1)
and remove##10##2##(1994-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-9#1)(2009-12#1)(2011-2#1)
and removed by##3##3##(1991-9#1)(2008-2#1)(2008-9#1)
and removed the##2##3##(1990-9#1)(2007-8#1)
and removed##18##2##(1990-9#1)(1991-9#1)(1997-8#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
and removes##2##2##(2008-7#2)
and removing##6##2##(1991-6#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
and renal biopsy##2##3##(1992-5#1)(2006-10#1)
and renal cell##4##3##(1994-3#1)(2009-4#1)(2011-2#2)
and renal dysfunction##2##3##(1997-4#1)(2008-3#1)
and renal effects of##2##4##(1990-9#1)(2008-1#1)
and renal failure##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
and renal function##2##3##(1991-11#1)(1994-6#1)
and renal insufficiency##5##3##(1990-2#1)(1990-9#1)(2007-12#1)(2008-1#1)(2008-7#1)
and renal or##2##3##(2008-10#1)(2008-8#1)
and renal toxicity of gold sodium thiomalate##2##7##(1994-5#2)
and renal toxicity of gold##3##5##(1994-5#3)
and renal transplant##2##3##(2008-1#1)(2008-3#1)
and renal transplantation##2##3##(2007-7#1)(2008-6#1)
and renal tubule degeneration in 100 mg/kg males were significantly##2##10##(2008-9#2)
and renal tubule degeneration in##3##5##(2008-9#3)
and renal tubule degeneration##4##4##(2008-9#4)
and renal##82##2##(1990-2#1)(1990-9#3)(1991-11#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#9)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#2)
and rendering##3##2##(2008-6#3)
and renders##2##2##(1997-7#1)(2007-12#1)
and renewability##2##2##(2008-10#1)(2008-5#1)
and renewable##2##2##(2008-10#1)(2008-6#1)
and renewal##2##2##(1993-2#1)(2011-2#1)
and renin##5##2##(1990-5#1)(1993-6#3)(2008-11#1)
and renovation of##3##3##(2008-11#1)(2012-3#2)
and reorganization of the##2##4##(1992-2#1)(1997-4#1)
and reorganization of##4##3##(1992-2#1)(1993-8#1)(1997-4#1)(2009-8#1)
and rep-PCR##2##2##(2008-10#2)
and repair in##2##3##(2008-10#1)(2012-2#1)
and repair of##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
and repair##32##2##(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#2)(1995-3#1)(1996-12#1)(1997-2#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#7)(2008-9#3)(2009-12#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
and repairing##2##2##(2008-5#1)(2012-5#1)
and repeat##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
and repeatability of##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
and repeatability##14##2##(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
and repeatable##2##2##(2008-12#1)(2011-2#1)
and repeated##14##2##(1991-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
and reperfused##3##2##(1991-9#1)(1995-12#1)(1996-9#1)
and reperfusion injury##3##3##(1991-8#1)(1996-2#1)(2012-2#1)
and reperfusion##11##2##(1991-8#1)(1991-9#2)(1996-2#1)(1996-9#2)(2009-12#1)(2010-1#2)(2012-2#1)(2013-7#1)
and repetition compulsion##2##3##(2009-11#2)
and repetition##3##2##(2008-2#1)(2009-11#2)
and repetitive extragenic palindromic (REP)##2##5##(2008-10#2)
and repetitive sequence-based polymerase chain reaction##2##6##(2008-10#2)
and repetitive##10##2##(2008-10#7)(2009-10#1)(2009-4#1)(2010-3#1)
and replace##6##2##(2007-12#1)(2009-12#1)(2010-3#4)
and replaced by a##2##4##(1992-6#1)(2009-8#1)
and replaced by##7##3##(1992-6#2)(1993-6#1)(1996-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
and replaced with##3##3##(2008-10#2)(2008-12#1)
and replaced##11##2##(1992-6#2)(1993-6#1)(1996-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
and replacement of##3##3##(2006-12#1)(2008-10#1)(2008-7#1)
and replacement with##2##3##(1991-10#1)(2008-9#1)
and replacement##7##2##(1990-8#1)(1991-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
and replacing##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
and replay##3##2##(1994-3#1)(2007-12#1)(2008-2#1)
and replicated in##3##3##(2008-10#2)(2008-3#1)
and replicated##7##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
and replication##7##2##(1994-8#1)(1997-2#2)(2008-4#1)(2008-7#1)(2011-2#2)
and report a##2##3##(1996-12#1)(2008-3#1)
and report of##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
and report on##3##3##(1993-6#1)(1997-1#1)(2008-3#1)
and report that##2##3##(1992-2#1)(1994-5#1)
and report the results##2##4##(1990-5#1)(2012-12#1)
and report the##5##3##(1990-5#1)(1993-3#1)(1994-12#1)(2012-12#1)(2012-3#1)
and report##25##2##(1990-5#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(2007-11#2)(2008-3#3)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
and reported a##2##3##(2009-5#2)
and reported as##4##3##(1991-12#1)(2008-10#1)(2011-1#1)(2012-2#1)
and reported for the##2##4##(2008-10#1)(2012-2#1)
and reported in##4##3##(1990-11#1)(1990-6#1)(2008-10#1)(2008-11#1)
and reported studies##2##3##(1992-1#1)(2010-6#1)
and reported that##3##3##(2008-12#1)(2008-3#1)(2013-1#1)
and reported the##2##3##(2012-12#1)(2013-1#1)
and reported##34##2##(1990-11#2)(1990-6#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-6#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)
and reporter##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
and reporting as well as identifying the issues that need to be addressed##6##13##(2013-8#6)
and reporting as well as##9##5##(2013-8#9)
and reporting of##6##3##(1991-11#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
and reporting##30##2##(1991-11#1)(1992-12#1)(1993-6#1)(1994-2#2)(1995-3#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#10)
and reports of##3##3##(1996-8#1)(2007-2#1)(2008-5#1)
and reports on the##2##4##(1995-2#1)(1996-2#1)
and reports on##4##3##(1995-2#1)(1996-2#1)(2008-11#1)(2010-1#1)
and reports that##2##3##(2008-10#1)(2008-11#1)
and reports##18##2##(1994-3#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2010-1#1)(2010-5#1)(2010-8#1)(2012-1#1)
and represent a major##2##4##(1990-4#1)(2009-4#1)
and represent a novel##2##4##(1990-5#1)(1991-5#1)
and represent a##9##3##(1990-4#1)(1990-5#1)(1991-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-7#1)(2012-12#1)
and represent important##2##3##(2008-7#1)(2013-8#1)
and represent##19##2##(1990-4#1)(1990-5#1)(1991-5#1)(1992-2#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and representation##2##2##(1995-12#1)(2008-8#1)
and representative isolates##2##3##(2008-10#2)
and representative of the##2##4##(2008-10#2)
and representative of##3##3##(1992-3#1)(2008-10#2)
and representative##7##2##(1992-3#1)(1992-9#1)(2008-10#4)(2013-8#1)
and representativeness of##3##3##(2008-4#1)(2009-11#2)
and representativeness##4##2##(2008-4#1)(2009-11#3)
and representatives from##2##3##(1996-12#1)(2008-7#1)
and representatives of##2##3##(1991-6#1)(2008-10#1)
and representatives##5##2##(1991-6#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-7#1)
and represented##6##2##(1992-6#1)(1993-6#1)(2007-12#1)(2008-10#3)
and representing the##2##3##(2008-10#1)(2009-10#1)
and represents a possible##2##4##(2010-11#1)(2011-2#1)
and represents a##9##3##(1990-2#1)(1994-12#1)(1996-12#1)(2008-4#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-4#1)
and represents an##3##3##(2008-10#2)(2008-3#1)
and represents the only##2##4##(2008-10#1)(2008-5#1)
and represents the##7##3##(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
and represents##23##2##(1990-2#1)(1993-11#1)(1994-12#1)(1996-12#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-4#1)
and repressed##3##2##(2008-11#1)(2008-9#2)
and represses##3##2##(1994-12#1)(2012-2#1)(2013-1#1)
and repression of##2##3##(1995-11#1)(2011-2#1)
and reproduced##2##2##(2007-12#1)(2008-10#1)
and reproducibility (R##2##3##(2008-10#2)
and reproducibility are##2##3##(1991-5#1)(2008-10#1)
and reproducibility of the assay##2##5##(2008-10#1)(2013-8#1)
and reproducibility of the results##2##5##(2008-5#1)(2008-8#1)
and reproducibility of the##10##4##(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-8#1)
and reproducibility of##20##3##(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2013-8#1)
and reproducibility studies##2##3##(2008-10#2)
and reproducibility was##2##3##(1990-2#1)(2008-10#1)
and reproducibility were obtained##2##4##(2008-10#2)
and reproducibility were##3##3##(2008-10#3)
and reproducibility##69##2##(1990-2#1)(1991-5#1)(1992-11#1)(1995-8#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#46)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-2#1)(2010-11#1)(2013-8#2)
and reproducible (RSD 0##2##4##(2008-10#2)
and reproducible HPLC##2##3##(2008-10#1)(2010-5#1)
and reproducible and##3##3##(1991-9#1)(2008-10#2)
and reproducible determination##2##3##(2008-10#2)
and reproducible in##2##3##(2008-7#1)(2009-1#1)
and reproducible method for determining##2##5##(2008-11#1)(2011-2#1)
and reproducible method for##3##4##(2008-11#1)(2010-11#1)(2011-2#1)
and reproducible method to##3##4##(1994-6#1)(2008-10#1)(2008-9#1)
and reproducible method##8##3##(1994-6#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-11#1)(2011-2#1)
and reproducible results##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
and reproducible##87##2##(1990-11#1)(1990-7#2)(1991-9#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-12#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#37)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2010-11#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
and reproducibly##5##2##(1991-11#1)(2008-10#1)(2010-10#1)(2012-2#2)
and reproduction of the##3##4##(2008-10#1)(2008-5#2)
and reproduction of##10##3##(2008-10#1)(2008-11#1)(2008-5#4)(2008-8#2)(2011-1#1)(2013-1#1)
and reproduction##30##2##(1997-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#4)(2008-9#4)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
and reproductive behavior##2##3##(1996-2#1)(2008-5#1)
and reproductive function##4##3##(2008-4#2)(2009-5#1)(2013-8#1)
and reproductive health services##2##4##(2008-11#2)
and reproductive health##14##3##(1994-9#1)(1996-12#1)(2008-11#4)(2008-9#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
and reproductive organs##2##3##(2008-12#1)(2010-1#1)
and reproductive outcome##3##3##(1992-3#2)(2009-5#1)
and reproductive success was##2##4##(2008-10#1)(2008-8#1)
and reproductive success##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and reproductive tract##2##3##(1990-11#1)(2013-1#1)
and reproductive variables##2##3##(1993-9#1)(2010-8#1)
and reproductive##58##2##(1990-11#1)(1992-2#1)(1992-3#2)(1993-9#1)(1994-9#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-12#5)(2012-2#1)(2012-3#2)(2012-8#2)(2013-1#2)(2013-7#2)(2013-8#2)
and repulsion##3##2##(2008-9#1)(2009-8#1)(2012-2#1)
and request##2##2##(1991-3#1)(2010-10#1)
and require a##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
and require considerable##2##3##(2007-11#1)(2008-10#1)
and require further##3##3##(2008-10#2)(2012-3#1)
and require new approaches##2##4##(2007-9#1)(2010-12#1)
and require##26##2##(1993-12#1)(1993-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
and required only##2##3##(1990-2#1)(1991-3#1)
and required##20##2##(1990-2#1)(1991-3#3)(1996-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
and requirements for##3##3##(1991-6#1)(2012-3#1)(2013-1#1)
and requirements##8##2##(1991-6#1)(1992-9#1)(2007-8#1)(2008-8#1)(2012-3#2)(2013-1#2)
and requires a##2##3##(2007-7#1)(2008-10#1)
and requires an##2##3##(2010-2#1)(2012-3#1)
and requires further##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
and requires no##2##3##(2007-12#1)(2008-5#1)
and requires only##2##3##(2008-3#1)(2008-7#1)
and requires surgical##2##3##(1991-6#1)(2008-4#1)
and requires the##5##3##(1993-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
and requires##47##2##(1990-7#1)(1991-5#2)(1991-6#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-1#2)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and requiring##2##2##(2007-11#1)(2008-1#1)
and resampling##4##2##(2008-10#1)(2008-3#2)(2008-6#1)
and rescue of##2##3##(2008-10#1)(2012-2#1)
and rescue##5##2##(2008-10#2)(2008-3#2)(2012-2#1)
and research and##2##3##(1991-1#1)(1995-12#1)
and research are presented##2##4##(1991-2#1)(2012-12#1)
and research are##3##3##(1991-2#1)(2008-11#1)(2012-12#1)
and research challenges##2##3##(1994-12#1)(2009-11#1)
and research data##2##3##(1997-2#1)(2010-8#1)
and research directions##3##3##(2008-12#1)(2008-5#1)(2010-4#1)
and research implications##2##3##(1991-1#1)(2008-12#1)
and research in##12##3##(1991-6#1)(1993-11#1)(1995-9#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-8#2)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
and research into##4##3##(1991-2#1)(1992-8#1)(1995-3#1)(2009-1#1)
and research is##2##3##(1994-3#1)(2011-2#1)
and research must##2##3##(1995-2#1)(2011-2#1)
and research of##2##3##(2008-12#1)(2010-11#1)
and research on the##4##4##(2008-10#2)(2008-5#1)(2009-11#1)
and research on##6##3##(2008-10#2)(2008-5#2)(2009-11#1)(2012-3#1)
and research organisations##2##3##(2010-4#1)(2010-8#1)
and research should##2##3##(2008-1#1)(2008-12#1)
and research studies##4##3##(2013-1#3)(2013-7#1)
and research##116##2##(1991-1#2)(1991-12#2)(1991-2#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#5)(2008-5#6)(2008-6#7)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)
and research]##3##2##(1992-6#2)(1996-11#1)
and researcher##2##2##(2008-1#1)(2011-2#1)
and researchers to##3##3##(2008-7#1)(2010-10#1)(2012-12#1)
and researchers##18##2##(1997-1#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
and researches##2##2##(2011-1#1)(2012-2#1)
and resected##2##2##(2008-10#1)(2013-1#1)
and resection of##3##3##(2008-7#1)(2010-3#1)(2010-8#1)
and resection##6##2##(2008-6#1)(2008-7#2)(2010-3#1)(2010-8#1)(2011-2#1)
and resembled the##2##3##(1994-5#1)(2008-11#1)
and reserpine-induced orofacial dyskinesia##2##4##(2012-2#2)
and reservoir##4##2##(1996-2#1)(2008-10#3)
and reside##2##2##(2010-6#1)(2011-2#1)
and residence time##2##3##(1992-11#1)(2008-10#1)
and residence##6##2##(1991-6#1)(1992-11#1)(1992-3#1)(2008-10#2)(2013-1#1)
and residency training##2##3##(2011-2#1)(2012-3#1)
and residency##3##2##(2010-8#1)(2011-2#1)(2012-3#1)
and resident##4##2##(1990-2#1)(1991-9#1)(2008-5#1)(2009-8#1)
and residential care##3##3##(1997-1#2)(2008-12#1)
and residential##5##2##(1991-1#1)(1997-1#2)(2008-12#1)(2011-2#1)
and residents##6##2##(1993-3#1)(1995-3#1)(2008-8#1)(2011-2#2)(2013-8#1)
and residual stress##2##3##(2008-2#1)(2008-8#1)
and residual##16##2##(1997-1#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-8#2)(2008-9#4)
and residue##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
and residues from##2##3##(2008-10#1)(2008-5#1)
and residues##8##2##(1991-5#1)(1993-11#1)(1997-9#1)(2008-10#3)(2008-5#1)(2008-8#1)
and resilience##3##2##(2009-9#1)(2012-12#1)(2012-2#1)
and resin amount##3##3##(2008-10#3)
and resin##6##2##(1997-3#1)(2008-10#5)
and resins##4##2##(1997-4#1)(2008-4#2)(2008-9#1)
and resistance in##2##3##(1990-6#1)(2008-10#1)
and resistance of##3##3##(2007-6#1)(2008-10#1)(2008-9#1)
and resistance to chemotherapy##2##4##(2010-3#1)(2011-2#1)
and resistance to lodging##2##4##(2008-10#2)
and resistance to the##3##4##(2008-8#1)(2011-10#1)(2013-1#1)
and resistance to##38##3##(1990-5#1)(1991-3#1)(1996-2#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-9#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)
and resistance training on##2##4##(2008-5#2)
and resistance training##6##3##(2008-5#4)(2013-1#2)
and resistance was found##2##4##(2008-10#2)
and resistance was##4##3##(2008-10#4)
and resistance##82##2##(1990-5#1)(1990-6#2)(1991-3#1)(1992-2#1)(1993-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-10#34)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-5#3)(2009-9#1)(2010-3#1)(2010-4#1)(2011-10#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#8)
and resistant (&gt##2##3##(2007-7#1)(2008-10#1)
and resistant cultivars of##2##4##(2008-10#2)
and resistant cultivars##6##3##(2008-10#6)
and resistant isolates##2##3##(2008-10#2)
and resistant to##11##3##(1992-12#1)(1992-2#1)(1992-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-10#1)
and resistant##51##2##(1990-12#1)(1991-12#2)(1991-4#2)(1992-12#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#27)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-10#1)(2012-1#1)
and resisted##2##2##(2009-5#1)(2013-1#1)
and resistivity index (RI) of##2##5##(2008-1#1)(2013-8#1)
and resolution of the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
and resolution of##15##3##(1994-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#2)(2012-3#1)
and resolution##35##2##(1994-12#1)(1995-3#1)(1996-5#1)(2007-11#4)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-7#1)(2012-2#2)(2012-3#1)
and resolutions##4##2##(1994-1#2)(1995-3#1)(2008-2#1)
and resolve##3##2##(1994-1#1)(2008-10#1)(2011-2#1)
and resolved by##2##3##(1996-2#1)(2008-10#1)
and resolved##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
and resolving##2##2##(1994-2#1)(2008-2#1)
and resonance##6##2##(2007-11#1)(2008-10#2)(2009-9#1)(2010-3#1)(2013-8#1)
and resonant##4##2##(2007-11#2)(2008-3#2)
and resorcinol##4##2##(1992-3#1)(2008-10#3)
and resorption##3##2##(1990-7#1)(2008-7#1)(2012-2#1)
and resource allocation##2##3##(1992-1#1)(1995-2#1)
and resource use##2##3##(1991-12#1)(1996-9#1)
and resource utilization##3##3##(1993-3#1)(1994-3#1)(2008-3#1)
and resource##23##2##(1991-12#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-9#2)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#2)(2012-2#1)(2012-3#2)(2013-1#1)
and resources and##4##3##(2008-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
and resources are##4##3##(2008-12#1)(2008-8#1)(2010-8#1)(2013-1#1)
and resources for##5##3##(1992-3#2)(1995-12#1)(1997-3#1)(2013-1#1)
and resources in##3##3##(1990-12#1)(1990-6#1)(1997-3#1)
and resources of##2##3##(1990-2#1)(2008-10#1)
and resources on##2##3##(1997-1#1)(2007-2#1)
and resources to the##2##4##(2011-2#1)(2012-3#1)
and resources to##7##3##(2008-11#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and resources##45##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-3#2)(1994-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#3)(2007-2#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
and respect for##2##3##(1996-1#1)(2009-6#1)
and respect##5##2##(1992-1#1)(1994-1#1)(1996-1#1)(2009-6#1)(2010-5#1)
and respectful##2##2##(1990-6#1)(2011-1#1)
and respective##5##2##(2007-6#1)(2008-10#3)(2013-8#1)
and respectively##2##2##(1994-2#1)(2008-1#1)
and respiration were##2##3##(1991-10#2)
and respiration##5##2##(1991-10#2)(2008-7#1)(2011-2#2)
and respiratory chain##2##3##(1994-11#1)(2011-1#1)
and respiratory changes##2##3##(1991-10#2)
and respiratory depression##4##3##(1992-5#1)(1995-5#1)(1996-2#2)
and respiratory distress##3##3##(1991-9#1)(2007-8#1)(2013-1#1)
and respiratory failure with##2##4##(2006-10#1)(2013-1#1)
and respiratory failure##7##3##(1995-3#1)(2006-10#1)(2007-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
and respiratory function##2##3##(2011-2#1)(2012-2#1)
and respiratory infections##2##3##(1997-6#1)(2010-6#1)
and respiratory outcomes##2##3##(2010-6#2)
and respiratory rate were##2##4##(2007-8#1)(2008-5#1)
and respiratory syncytial virus (RSV)##2##5##(2008-11#1)(2011-2#1)
and respiratory syncytial virus##3##4##(1995-5#1)(2008-11#1)(2011-2#1)
and respiratory tract##4##3##(1991-9#1)(1995-6#1)(1996-12#1)(2008-11#1)
and respiratory##55##2##(1990-2#1)(1991-10#2)(1991-6#1)(1991-9#2)(1992-5#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#3)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#3)
and respond appropriately##2##3##(2008-6#1)(2009-9#1)
and respond to a##3##4##(2008-8#1)(2008-9#1)(2009-6#1)
and respond to the##3##4##(1994-3#1)(1995-1#1)(2009-9#1)
and respond to##19##3##(1990-12#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-2#1)
and respond##22##2##(1990-12#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#3)(2010-11#1)(2012-1#1)(2012-2#1)
and responded##3##2##(1994-2#1)(1995-10#1)(2007-7#1)
and responding to##4##3##(1993-1#1)(1994-2#2)(2009-9#1)
and responding##6##2##(1992-2#1)(1993-1#1)(1994-2#2)(2009-9#2)
and responds to##4##3##(1990-5#1)(2008-11#1)(2010-10#1)(2013-8#1)
and response time of the electrode##2##6##(2008-10#2)
and response time of the##3##5##(2008-10#3)
and response time of##4##4##(2008-10#4)
and response time were##2##4##(2008-10#2)
and response time##8##3##(2008-10#7)(2008-6#1)
and response to chemotherapy##2##4##(1991-4#1)(2012-3#1)
and response to the##3##4##(1995-5#1)(2008-10#1)(2009-8#1)
and response to therapy##2##4##(1997-2#1)(2008-1#1)
and response to treatment##3##4##(2008-7#1)(2010-8#1)(2013-8#1)
and response to##26##3##(1991-4#1)(1992-12#1)(1993-11#1)(1994-10#1)(1994-12#1)(1995-5#1)(1997-2#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and response variables##2##3##(2008-10#1)(2008-7#1)
and response##66##2##(1991-4#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-12#2)(1996-4#1)(1997-2#1)(2006-10#2)(2008-1#3)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
and responses in##2##3##(1993-6#1)(2008-9#1)
and responses to treatment##3##4##(2008-6#1)(2013-1#2)
and responses to##13##3##(1992-2#1)(1995-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and responses##20##2##(1991-6#1)(1992-2#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and responsibilities for##2##3##(2007-5#1)(2012-12#1)
and responsibilities in##2##3##(2008-1#1)(2011-2#1)
and responsibilities of##9##3##(1991-2#1)(1992-12#1)(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-3#1)
and responsibilities##23##2##(1991-2#1)(1992-12#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and responsibility for##2##3##(1995-1#1)(2008-11#1)
and responsibility in the##2##4##(2007-11#1)(2008-3#1)
and responsibility##9##2##(1995-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)
and responsible##3##2##(1992-6#1)(2008-9#1)(2012-3#1)
and responsive to##5##3##(2007-11#1)(2009-7#1)(2013-1#3)
and responsive##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2009-7#1)(2013-1#3)
and responsiveness of##3##3##(1994-11#1)(2007-8#1)(2008-9#1)
and responsiveness to##4##3##(1990-12#1)(1993-2#1)(1994-2#1)(2013-1#1)
and responsiveness##7##2##(1990-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(2007-8#1)(2008-9#1)(2013-1#1)
and responsivity##2##2##(2008-2#1)(2009-10#1)
and rest##2##2##(1992-12#1)(1996-2#1)
and restenosis after##3##3##(1992-9#1)(2008-4#2)
and restenosis##5##2##(1992-9#2)(2008-11#1)(2008-4#2)
and resting##7##2##(1991-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
and restlessness##2##2##(2008-7#1)(2011-2#1)
and restoration of the##2##4##(2008-6#1)(2012-2#1)
and restoration of##11##3##(1995-3#3)(1995-6#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
and restoration##15##2##(1991-5#1)(1995-3#3)(1995-6#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
and restore##8##2##(2007-11#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and restored##8##2##(1993-8#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
and restores##3##2##(2008-3#1)(2010-2#1)(2012-2#1)
and restoring##3##2##(2008-3#1)(2008-8#1)(2009-9#1)
and restraint##2##2##(1990-7#1)(2009-6#1)
and restrict##2##2##(1991-5#1)(2008-10#1)
and restricted activity days##2##4##(2013-1#2)
and restricted gene flow##2##4##(2008-9#1)(2010-8#1)
and restricted to the##3##4##(2008-10#2)(2008-5#1)
and restricted to##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
and restricted##14##2##(1991-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#3)
and restriction analysis##2##3##(1992-8#1)(2008-10#1)
and restriction fragment length polymorphism (RFLP)##3##6##(2008-10#2)(2008-5#1)
and restriction fragment length polymorphism analysis of##2##7##(2008-10#2)
and restriction fragment length polymorphism analysis##3##6##(2008-10#2)(2008-5#1)
and restriction fragment length polymorphism##10##5##(2008-10#7)(2008-5#2)(2013-1#1)
and restriction fragment length polymorphisms##3##5##(2008-10#2)(2008-12#1)
and restriction fragment length##13##4##(2008-10#9)(2008-12#1)(2008-5#2)(2013-1#1)
and restriction##25##2##(1992-8#1)(1993-6#1)(1994-12#1)(1997-2#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-5#2)(2012-12#1)(2013-1#1)
and restrictions on sodium/water##2##4##(1992-6#2)
and restrictions##4##2##(1992-3#1)(1992-6#2)(2008-3#1)
and restrictive##2##2##(1991-12#1)(1997-3#1)
and restricts##2##2##(2008-3#1)(2010-5#1)
and restructuring of##2##3##(1997-2#1)(2011-1#1)
and restructuring##4##2##(1995-12#1)(1997-2#1)(2008-3#1)(2011-1#1)
and result in##9##3##(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-9#1)
and result##11##2##(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)
and resultant##10##2##(1991-3#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and resulted in a##5##4##(2007-11#1)(2008-10#2)(2008-4#1)(2012-12#1)
and resulted in complete##2##4##(1991-8#1)(2007-6#1)
and resulted in increased##2##4##(1994-8#1)(1995-3#1)
and resulted in the##6##4##(1994-9#1)(1997-5#1)(2007-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
and resulted in##29##3##(1991-5#1)(1991-8#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-5#1)(1997-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and resulted##30##2##(1991-5#1)(1991-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-5#1)(1997-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and resulting in##7##3##(1996-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-12#1)
and resulting##12##2##(1994-12#1)(1995-1#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#1)
and results after##2##3##(1995-11#1)(2009-3#1)
and results are discussed##2##4##(1991-3#1)(2008-10#1)
and results are presented for##2##5##(1992-12#1)(2008-10#1)
and results are presented##6##4##(1992-12#1)(2008-10#1)(2008-3#3)(2010-7#1)
and results are reported##2##4##(2008-3#1)(2010-8#1)
and results are##16##3##(1991-3#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
and results from##5##3##(1995-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)
and results in a##7##4##(1991-12#1)(1991-5#1)(1995-6#1)(2008-10#2)(2008-3#1)(2012-2#1)
and results in only##2##4##(2008-3#1)(2013-8#1)
and results in significant##2##4##(2008-10#1)(2011-1#1)
and results in the##5##4##(1994-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2009-7#1)
and results in##27##3##(1991-12#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
and results obtained##3##3##(1992-9#1)(2008-10#1)(2012-1#1)
and results of a##4##4##(1994-1#1)(2007-12#1)(2009-5#1)(2012-1#1)
and results of an##2##4##(2008-5#1)(2008-7#1)
and results of the study##2##5##(2008-10#1)(2008-11#1)
and results of the##6##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
and results of these##2##4##(2007-8#1)(2008-2#1)
and results of##39##3##(1990-11#1)(1990-9#1)(1992-5#1)(1994-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-8#2)(2012-1#1)(2012-3#2)(2013-1#2)
and results presented##2##3##(2008-10#1)(2008-3#1)
and results were compared##2##4##(2008-10#2)
and results were##7##3##(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2013-1#1)
and results##136##2##(1990-11#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#15)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
and results]##3##2##(1990-6#1)(1990-9#1)(1992-5#1)
and resumption of normal##2##4##(1996-12#1)(2008-10#1)
and resurrection##2##2##(2009-7#1)(2010-5#1)
and resveratrol##2##2##(2008-10#1)(2008-7#1)
and retail##4##2##(1993-3#1)(1994-3#1)(2008-10#1)(2010-4#1)
and retain a##2##3##(1994-3#1)(2008-11#1)
and retain##8##2##(1990-12#1)(1991-3#1)(1994-3#1)(1995-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2010-9#1)
and retained in the column##2##5##(2008-10#1)(2008-9#1)
and retained in the##3##4##(2008-10#1)(2008-9#2)
and retained the##2##3##(2008-10#1)(2011-2#1)
and retained##9##2##(1991-5#1)(1993-6#1)(2008-10#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#1)
and retaining##6##2##(1992-3#1)(1996-3#1)(2008-10#2)(2012-2#1)(2013-8#1)
and retentate##2##2##(2008-10#1)(2008-7#1)
and retention initiatives##2##3##(2008-11#2)
and retention of an##2##4##(1993-12#1)(1996-3#1)
and retention of volunteers##2##4##(1993-2#2)
and retention of##19##3##(1991-2#1)(1991-5#1)(1993-12#1)(1993-2#2)(1994-3#2)(1994-8#1)(1996-12#2)(1996-3#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)
and retention strategies##3##3##(1995-2#1)(2007-10#1)(2012-3#1)
and retention##50##2##(1990-2#1)(1991-2#2)(1991-5#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#3)(1997-3#1)(2007-10#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#1)
and reteplase are##2##3##(2007-11#1)(2008-7#1)
and reteplase##3##2##(2007-11#2)(2008-7#1)
and retested##2##2##(1994-3#1)(2012-2#1)
and reticular##3##2##(1991-6#1)(1997-2#1)(2008-4#1)
and retina##3##2##(1997-2#1)(2008-1#1)(2008-4#1)
and retinal##13##2##(2007-11#1)(2007-5#2)(2008-1#3)(2008-12#1)(2008-4#2)(2008-7#1)(2011-2#1)(2013-8#2)
and retinitis##2##2##(2008-9#1)(2011-2#1)
and retinoblastoma##2##2##(1995-11#1)(2008-7#1)
and retinoic acid##5##3##(1994-11#2)(2008-4#1)(2008-7#1)(2012-12#1)
and retinoic##6##2##(1994-11#2)(1997-7#1)(2008-4#1)(2008-7#1)(2012-12#1)
and retinol status in rats with##2##6##(2009-6#2)
and retinol##3##2##(1993-2#1)(2009-6#2)
and retinol-binding protein##2##3##(1990-12#1)(2009-6#1)
and retinopathy##3##2##(2008-1#1)(2008-3#1)(2012-12#1)
and retirement##3##2##(2007-3#1)(2008-10#1)(2008-9#1)
and retraction##2##2##(2009-8#1)(2013-1#1)
and retrieval of##6##3##(1991-8#1)(1994-12#1)(2007-12#2)(2008-11#1)(2008-8#1)
and retrieval##19##2##(1991-8#1)(1994-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-3#2)
and retrieved##4##2##(1994-3#2)(2007-12#1)(2010-8#1)
and retrieving##6##2##(1994-3#2)(1997-2#1)(2007-11#1)(2008-2#1)(2009-12#1)
and retrograde##7##2##(1991-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
and retrogradely transported to the neuronal##2##6##(1991-12#2)
and retrogradely##3##2##(1991-12#3)
and retroperitoneal fibrosis##2##3##(2008-1#1)(2009-8#1)
and retroperitoneal##7##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
and retrospective data##2##3##(1994-6#1)(2011-1#1)
and retrospective##7##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and retroviral##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
and return to the##2##4##(1991-3#1)(2008-1#1)
and return to work##2##4##(2007-11#1)(2012-3#1)
and return to##7##3##(1991-3#1)(1991-6#1)(2007-11#1)(2008-1#1)(2009-3#1)(2009-6#1)(2012-3#1)
and return##11##2##(1991-3#1)(1991-6#1)(1992-12#1)(1993-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-3#1)(2009-6#1)(2012-3#1)(2013-8#1)
and returned to the control level after##2##7##(2008-6#2)
and returned to the##6##4##(1997-7#2)(2007-8#1)(2008-6#2)(2008-8#1)
and returned to##11##3##(1993-1#1)(1993-11#1)(1994-6#1)(1995-3#1)(1997-7#2)(2007-8#1)(2008-10#1)(2008-6#2)(2008-8#1)
and returned##17##2##(1991-5#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2013-1#1)
and returning##2##2##(2008-8#1)(2011-1#1)
and returns the##2##3##(2008-3#1)(2008-5#1)
and returns##5##2##(1997-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
and reusability##2##2##(2008-10#1)(2008-6#1)
and reuse oxalic acid in##2##5##(2013-1#2)
and reused##2##2##(2007-11#1)(2008-10#1)
and revascularization##2##2##(1997-8#1)(2012-3#1)
and reveal a##4##3##(1995-5#1)(2007-8#1)(2011-1#1)(2012-12#1)
and reveal the##3##3##(2008-3#1)(2008-5#1)(2009-8#1)
and reveal##12##2##(1995-2#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
and revealed a##3##3##(2008-10#2)(2012-12#1)
and revealed remarkable consistency over four decades##2##7##(2013-1#2)
and revealed that##3##3##(1990-12#1)(1993-2#1)(2011-2#1)
and revealed the##4##3##(1995-8#2)(1997-4#1)(2008-10#1)
and revealed##26##2##(1990-12#1)(1993-2#1)(1995-8#2)(1997-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)
and reveals some##2##3##(2008-11#1)(2008-7#1)
and reveals the##3##3##(1994-11#1)(2008-10#1)(2009-8#1)
and reveals##10##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-10#1)(2012-3#1)
and revenue##2##2##(1993-12#1)(1996-3#1)
and revenues##2##2##(1992-12#1)(2008-11#1)
and reversal of the formaldehyde cross-linking permits recovery and quantitative analysis of the immunoprecipitated##2##14##(2008-2#2)
and reversal of##5##3##(1990-7#1)(1996-2#1)(2008-2#2)(2008-8#1)
and reversal##9##2##(1990-7#1)(1996-2#1)(2008-10#2)(2008-2#2)(2008-8#1)(2008-9#1)(2013-8#1)
and reverse phase high performance liquid chromatography##2##7##(1990-7#1)(1994-6#1)
and reverse phase##5##3##(1990-7#1)(1992-9#1)(1994-6#1)(1995-3#1)(2008-10#1)
and reverse transcription polymerase chain reaction (RT-PCR)##2##7##(1996-12#1)(2007-6#1)
and reverse transcription##4##3##(1992-8#1)(1996-12#1)(2007-6#1)(2012-12#1)
and reverse transcription-polymerase chain reaction (RT-PCR)##2##6##(1995-12#1)(2008-10#1)
and reverse transcription-polymerase chain reaction##4##5##(1995-12#1)(2008-10#2)(2013-1#1)
and reverse##37##2##(1990-11#2)(1990-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-2#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-2#2)(2013-1#2)
and reverse-transcription polymerase chain reaction (RT-PCR)##2##6##(1993-3#1)(2008-10#1)
and reversed the##2##3##(1990-11#1)(1991-5#1)
and reversed##6##2##(1990-11#1)(1990-12#1)(1991-5#1)(2008-10#3)
and reversed-phase HPLC##10##3##(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
and reversed-phase##14##2##(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(1997-4#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)
and reversibility of##3##3##(2008-10#2)(2009-4#1)
and reversibility##5##2##(2007-2#1)(2008-10#3)(2009-4#1)
and reversible##25##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
and reversibly##5##2##(1990-7#1)(1992-3#1)(1994-6#1)(1997-2#1)(2011-1#1)
and revertant##2##2##(1992-9#1)(1995-5#1)
and review current##2##3##(2013-1#2)
and review of literature##18##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
and review of literature]##2##4##(1996-8#1)(2012-3#1)
and review of the literature##55##5##(1992-12#2)(1994-8#1)(2006-12#1)(2007-12#1)(2007-2#4)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
and review of the literature]##16##5##(1990-5#1)(1990-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-3#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-1#2)
and review of the##76##4##(1990-5#1)(1990-6#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-2#4)(2007-5#2)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#1)
and review of##104##3##(1990-5#1)(1990-6#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#4)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#13)(2013-8#1)
and review process##2##3##(1991-1#1)(2010-5#1)
and review recent##2##3##(2008-1#1)(2011-1#1)
and review the literature on the##2##6##(2009-1#1)(2011-2#1)
and review the literature on##3##5##(2009-1#1)(2010-8#1)(2011-2#1)
and review the literature##7##4##(2007-10#1)(2009-1#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
and review the##14##3##(2007-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)
and review##154##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-5#3)(2007-7#2)(2008-1#5)(2008-10#12)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#5)(2009-1#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#20)(2013-8#1)
and reviewed the##5##3##(2007-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)
and reviewed##10##2##(1993-12#1)(2007-11#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#1)(2013-1#1)
and reviewing##3##2##(2008-11#1)(2010-1#1)(2013-8#1)
and reviews the current##2##4##(2009-8#1)(2012-2#1)
and reviews the##8##3##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#1)
and reviews##20##2##(1991-2#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
and revised##2##2##(1991-2#1)(2008-1#1)
and revision##3##2##(1995-6#1)(2008-11#1)(2010-8#1)
and reward##9##2##(1991-12#1)(1992-11#1)(1994-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2009-5#1)(2013-1#1)
and rewarding##5##2##(1997-2#1)(2008-11#1)(2008-9#1)(2010-7#1)(2012-12#1)
and rewards of##3##3##(1997-2#1)(2010-9#2)
and rewards##5##2##(1996-1#1)(1997-2#1)(2010-4#1)(2010-9#2)
and rhabdomyolysis##2##2##(2007-12#1)(2013-1#1)
and rheological##5##2##(2008-5#4)(2009-11#1)
and rhesus monkey##2##3##(1995-12#1)(2008-9#1)
and rhesus##3##2##(1991-9#1)(1995-12#1)(2008-9#1)
and rheumatoid arthritis (RA)##2##4##(1994-6#1)(2011-2#1)
and rheumatoid arthritis##10##3##(1994-6#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#3)(2011-2#2)(2013-8#1)
and rhinitis##4##2##(2012-3#4)
and rhizoctonia##2##2##(2008-10#2)
and rhizosphere##3##2##(2008-10#3)
and rho##6##2##(1995-8#1)(1996-12#1)(2008-10#2)(2008-2#1)(2010-5#1)
and rhodamine B##2##3##(2008-10#2)
and rhodamine##5##2##(1995-5#1)(2008-10#4)
and rhodium##5##2##(2008-10#5)
and rhythmic##3##2##(1997-7#1)(2012-12#1)(2013-8#1)
and rib cage deformity##2##4##(2007-11#2)
and rib##5##2##(1997-3#1)(2007-11#3)(2010-2#1)
and ribavirin in##2##3##(2011-2#1)(2013-1#1)
and ribavirin therapy##2##3##(2008-6#1)(2013-7#1)
and ribavirin##9##2##(1994-8#1)(2008-6#2)(2010-4#1)(2011-2#2)(2013-1#2)(2013-7#1)
and ribosomal protein##2##3##(2008-10#2)
and ribosomal##4##2##(2008-10#3)(2008-7#1)
and ribosome##2##2##(1993-11#1)(1997-8#1)
and rice (Oryza sativa)##2##4##(2008-10#1)(2008-7#1)
and rice flour##2##3##(2008-10#2)
and rice##12##2##(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)
and rich in##2##3##(1997-8#1)(2010-4#1)
and rich##6##2##(1997-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)
and richness of mollusks and crustaceans associated##2##7##(2011-2#2)
and richness of##6##3##(2008-11#1)(2008-5#1)(2011-2#4)
and richness##9##2##(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#4)
and ridge tillage systems##2##4##(2008-10#2)
and ridge tillage##4##3##(2008-10#4)
and ridge##5##2##(2008-10#4)(2012-12#1)
and ridge-type##2##2##(2008-2#1)(2008-3#1)
and rifampicin##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
and rifampin##4##2##(2007-12#4)
and right adrenal##2##3##(2008-1#1)(2012-12#1)
and right atrium##3##3##(2007-8#2)(2012-2#1)
and right internal thoracic artery (RITA)##2##6##(2007-8#2)
and right internal thoracic artery##3##5##(2007-8#3)
and right internal##4##3##(2007-7#1)(2007-8#3)
and right ventricle##3##3##(2007-8#1)(2008-10#2)
and right ventricular hypertrophy##2##4##(1996-11#1)(2012-12#1)
and right ventricular##3##3##(1996-11#1)(1997-3#1)(2012-12#1)
and right##55##2##(1991-2#1)(1992-12#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#8)(2008-1#2)(2008-10#2)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#4)(2010-12#2)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
and right-handed##4##2##(2006-4#1)(2008-7#2)(2010-12#1)
and rights##4##2##(1991-2#1)(1995-6#1)(1996-5#1)(2008-11#1)
and rightward##3##2##(1990-5#1)(1995-12#1)(2007-8#1)
and rigidity##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
and rigorous##6##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2010-4#1)
and ring##7##2##(1990-3#1)(1991-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)
and ringdown##2##2##(2008-3#2)
and rinsing##2##2##(2008-10#1)(2008-3#1)
and ripening##2##2##(2008-10#1)(2012-2#1)
and rise##5##2##(1990-7#1)(1993-3#1)(2007-11#1)(2008-2#1)(2008-8#1)
and rising##4##2##(1996-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
and risk assessment##10##3##(1995-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
and risk behaviors##3##3##(1997-3#1)(2009-5#1)(2013-8#1)
and risk estimation##2##3##(1990-3#1)(1996-12#1)
and risk factor##4##3##(2007-10#1)(2010-9#1)(2011-2#2)
and risk factors for##13##4##(2007-10#1)(2009-2#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and risk factors in##4##4##(1996-6#1)(2008-10#1)(2012-12#1)(2013-8#1)
and risk factors of##8##4##(1993-5#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
and risk factors were##3##4##(2010-7#2)(2012-2#1)
and risk factors##42##3##(1993-5#1)(1994-2#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
and risk factors) and##2##4##(1990-6#1)(2007-10#1)
and risk for##4##3##(2008-11#1)(2009-9#1)(2010-6#1)(2012-2#1)
and risk management##10##3##(1991-12#1)(1992-12#1)(1993-1#2)(1993-2#1)(1994-12#1)(1994-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
and risk of breast cancer##2##5##(1994-2#2)
and risk of breast##3##4##(1994-2#2)(2008-11#1)
and risk of cardiovascular disease##5##5##(1996-6#3)(1997-8#1)(2011-2#1)
and risk of cardiovascular##6##4##(1993-11#1)(1996-6#3)(1997-8#1)(2011-2#1)
and risk of cervical##3##4##(1994-2#2)(2013-1#1)
and risk of coronary heart disease##2##6##(1991-8#1)(2008-12#1)
and risk of infection##4##4##(2007-12#3)(2013-1#1)
and risk of ischemic##2##4##(2008-3#1)(2011-1#1)
and risk of progression##2##4##(2008-11#1)(2013-1#1)
and risk of stroke##2##4##(1996-11#1)(2008-8#1)
and risk of##46##3##(1990-6#1)(1991-8#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-2#4)(1994-9#1)(1996-11#2)(1996-3#1)(1996-6#3)(1997-8#2)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
and risk reduction##2##3##(2011-2#1)(2013-8#1)
and risk stratification##2##3##(2008-3#1)(2011-1#1)
and risk to##2##3##(1995-12#1)(2008-7#1)
and risk##145##2##(1990-3#1)(1990-6#2)(1991-12#1)(1991-8#1)(1992-12#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#6)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#4)(1997-3#1)(1997-8#2)(2007-10#3)(2007-11#2)(2007-12#3)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#14)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#6)
and risks associated with##2##4##(2008-11#1)(2008-6#1)
and risks of these##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
and risks of##15##3##(1993-1#1)(1993-11#1)(1996-9#1)(2008-10#2)(2008-7#2)(2009-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#3)
and risks##30##2##(1992-3#2)(1993-1#1)(1993-11#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-2#3)(2013-1#3)
and risky behavior##3##3##(1996-2#1)(2009-7#1)(2009-8#1)
and risky sexual behaviors##2##4##(2007-12#2)
and risky##9##2##(1996-2#1)(2007-12#2)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
and rituximab##2##2##(2012-3#1)(2013-1#1)
and river water samples##7##4##(2008-10#7)
and river water##13##3##(2008-10#13)
and river waters##4##3##(2008-10#4)
and river##21##2##(2008-10#20)(2008-8#1)
and road##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
and robots##2##2##(2007-12#2)
and robust solid##2##3##(2008-10#2)
and robust time-based##2##3##(2008-10#2)
and robust##50##2##(1995-11#1)(1995-12#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#5)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
and robusta green coffee varieties##2##5##(2008-10#2)
and robusta##5##2##(2008-10#5)
and robustness of the##5##4##(1993-3#1)(1997-3#1)(2008-10#1)(2008-6#2)
and robustness of this##2##4##(2007-12#1)(2008-11#1)
and robustness of##7##3##(1993-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#2)
and robustness##16##2##(1993-3#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-6#2)(2012-12#1)
and rock samples##3##3##(2008-10#3)
and rock##5##2##(2007-5#1)(2008-10#3)(2013-8#1)
and rocks##2##2##(2008-3#1)(2010-8#1)
and rocuronium##2##2##(2008-10#1)(2009-4#1)
and rodent##10##2##(1992-6#2)(1993-12#1)(1994-12#2)(1994-6#1)(2008-10#1)(2008-4#1)(2008-7#2)
and roentgenographic##2##2##(1993-2#1)(2008-5#1)
and role in human disease##2##5##(1991-9#1)(2008-8#1)
and role in##6##3##(1991-9#1)(1993-12#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
and role limitations due to emotional##2##6##(2007-11#1)(2012-12#1)
and role limitations due to##3##5##(2007-11#2)(2012-12#1)
and role models##3##3##(1996-3#1)(2008-11#1)(2009-8#1)
and role of##9##3##(1993-1#1)(1993-6#1)(1996-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and role##29##2##(1990-12#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-1#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
and roles of##4##3##(1994-8#1)(1995-12#1)(2011-2#2)
and roles##7##2##(1994-8#1)(1995-12#1)(2008-1#1)(2008-8#1)(2011-2#2)(2013-1#1)
and roll##2##2##(2008-3#1)(2010-8#1)
and roller bottles##2##3##(2008-11#2)
and roller##3##2##(2008-11#3)
and rolling of leukocytes##2##4##(2008-11#1)(2008-3#1)
and room temperature fluorimetry##2##4##(2008-10#2)
and room temperature##4##3##(2008-10#4)
and root and##2##3##(2008-10#2)
and root dry##2##3##(2008-10#1)(2008-12#1)
and root growth##4##3##(2008-10#1)(2008-8#1)(2009-8#2)
and root mean square error##2##5##(2011-2#1)(2012-1#1)
and root mean##4##3##(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)
and root rot of tomato##3##5##(2008-10#3)
and root rot of##9##4##(2008-10#9)
and root rot##19##3##(2008-10#19)
and root##69##2##(1996-10#1)(2008-1#1)(2008-10#42)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#7)(2010-11#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-8#1)(2013-8#1)
and root-knot##2##2##(2008-10#2)
and roots of##7##3##(2008-10#5)(2008-12#1)(2011-1#1)
and roots were##4##3##(2008-10#4)
and roots##28##2##(2008-10#15)(2008-12#6)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-10#2)
and rose oil##4##3##(2008-10#4)
and rose to##3##3##(2008-9#1)(2009-6#1)(2011-2#1)
and rose##10##2##(2008-10#7)(2008-9#1)(2009-6#1)(2011-2#1)
and rosette##2##2##(2008-8#1)(2009-8#1)
and rostral##2##2##(1996-5#1)(1997-2#1)
and rosuvastatin##5##2##(2011-1#5)
and rotate##2##2##(1993-11#1)(2008-2#1)
and rotated##5##2##(2008-11#2)(2008-2#1)(2008-3#2)
and rotation in##3##3##(2007-8#1)(2008-6#1)(2008-9#1)
and rotation of##2##3##(2007-12#1)(2008-11#1)
and rotation##8##2##(1995-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)
and rotational##8##2##(1995-5#2)(2007-11#2)(2008-10#1)(2008-2#2)(2012-2#1)
and rotenone##4##2##(1995-11#3)(2008-11#1)
and rough endoplasmic##2##3##(2007-12#1)(2008-7#1)
and rough##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
and roughness of the##2##4##(2007-11#1)(2008-3#1)
and roughness##9##2##(2007-11#1)(2008-3#5)(2008-5#3)
and round##3##2##(1995-9#1)(2008-9#1)(2012-2#1)
and route of transmission##2##4##(1996-11#1)(2007-7#1)
and route of##3##3##(1996-11#1)(2007-7#1)(2008-8#1)
and route##5##2##(1996-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-8#1)
and routes of##2##3##(1993-11#1)(2011-2#1)
and routine laboratory##3##3##(2009-4#1)(2011-2#1)(2012-3#1)
and routine##14##2##(1991-12#2)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and routinely##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
and routines##2##2##(1992-12#1)(2008-9#1)
and routing##4##2##(1993-5#1)(2008-2#2)(2008-3#1)
and rpoD##2##2##(1994-12#2)
and rsp3 genes##2##3##(2008-10#2)
and rub##2##2##(2008-5#1)(2008-8#1)
and rubbery##2##2##(2009-7#1)(2009-9#1)
and rubella##4##2##(1992-5#1)(1995-3#1)(2008-4#1)(2009-5#1)
and rubidium##2##2##(2008-10#2)
and ruggedness##2##2##(2008-10#2)
and rule out##2##3##(1991-12#1)(2009-6#1)
and rules##5##2##(1993-3#1)(1994-2#1)(2008-10#1)(2008-9#1)(2009-2#1)
and rumen##2##2##(2009-4#1)(2011-2#1)
and run##9##2##(1990-11#1)(1992-12#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-4#1)
and running##4##2##(1993-2#1)(2008-11#2)(2008-5#1)
and runs##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
and rupture of##4##3##(2009-4#1)(2009-9#1)(2010-9#1)(2013-1#1)
and rupture##7##2##(1994-8#1)(2006-10#1)(2007-10#1)(2009-4#1)(2009-9#1)(2010-9#1)(2013-1#1)
and rural areas of##2##4##(2009-4#1)(2011-2#1)
and rural areas##9##3##(1991-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(2008-11#1)(2009-4#2)(2011-2#1)(2012-1#1)
and rural veterans##2##3##(2012-1#2)
and rural##34##2##(1991-3#1)(1992-12#3)(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-3#2)(2008-10#3)(2008-11#1)(2008-12#1)(2009-4#2)(2009-7#1)(2010-5#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#5)
and rust##4##2##(2008-10#4)
and ruthenium in##2##3##(2008-10#2)
and ruthenium with##2##3##(2008-10#2)
and ruthenium##10##2##(2008-10#9)(2008-12#1)
and rutin were##2##3##(2008-10#2)
and rutin##4##2##(2008-10#3)(2008-9#1)
and rye##4##2##(1995-8#1)(2008-10#1)(2008-5#2)
and s##4##2##(1991-1#1)(2007-11#1)(2007-12#1)(2008-3#1)
and s(cv) =##3##3##(2007-11#3)
and s(r##2##2##(2008-10#2)
and sacral##3##2##(2010-6#1)(2013-8#2)
and sacrificed at##2##3##(2010-4#1)(2012-3#1)
and sacrificed##4##2##(2008-9#2)(2010-4#1)(2012-3#1)
and saddle##2##2##(2007-11#1)(2009-3#1)
and safe alternative to##2##4##(1990-8#1)(2008-10#1)
and safe alternative##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
and safe and##2##3##(2011-2#1)(2012-2#1)
and safe as##2##3##(1994-3#1)(2008-7#1)
and safe in##6##3##(1995-5#1)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
and safe method##2##3##(1993-1#1)(2007-2#1)
and safe option##2##3##(2008-4#1)(2011-1#1)
and safe procedure##3##3##(1994-9#1)(2011-1#1)(2012-12#1)
and safe technique##2##3##(1996-3#1)(2012-3#1)
and safe##55##2##(1990-12#1)(1990-3#1)(1990-8#1)(1992-5#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
and safely##3##2##(1994-2#1)(2008-9#1)(2011-2#1)
and safer##8##2##(1996-1#1)(1996-9#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
and safety and##3##3##(2008-8#1)(2009-4#1)(2010-7#1)
and safety by##2##3##(2008-12#1)(2012-12#1)
and safety climate strength##2##4##(2010-6#2)
and safety concerns##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
and safety data##3##3##(2008-8#2)(2011-1#1)
and safety in##9##3##(1995-3#3)(2008-11#1)(2008-5#2)(2012-12#2)(2012-2#1)
and safety issues##3##3##(1993-3#1)(2007-2#1)(2008-12#1)
and safety of a##4##4##(1993-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
and safety of abatacept in##2##5##(2012-3#2)
and safety of the##4##4##(1991-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
and safety of this##4##4##(1992-2#1)(1997-3#2)(2008-11#1)
and safety of##63##3##(1990-9#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1997-3#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#2)
and safety profile of##2##4##(2007-8#1)(2010-5#1)
and safety profile##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)
and safety recommendations##2##3##(2009-10#1)(2012-3#1)
and safety##150##2##(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#2)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#7)(2008-12#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#16)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#7)(2013-1#16)(2013-8#4)
and sagittal##4##2##(1993-1#1)(2007-11#1)(2007-12#1)(2013-1#1)
and salaries##3##2##(1992-1#1)(1994-1#1)(1995-1#1)
and salary##10##2##(1991-1#1)(1991-12#1)(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(2008-12#1)(2012-12#1)
and salbutamol##2##2##(1996-1#1)(2013-1#1)
and sales##4##2##(1995-3#1)(2008-11#2)(2009-7#1)
and salicylaldehyde##2##2##(2008-10#2)
and salicylic acid was##2##4##(2008-10#2)
and salicylic acid##7##3##(1993-11#1)(2008-10#3)(2008-5#2)(2009-8#1)
and salicylic acid)##2##3##(1990-8#1)(2008-10#1)
and salicylic acids were##2##4##(2008-5#2)
and salicylic##11##2##(1990-8#1)(1993-11#1)(2008-10#4)(2008-5#4)(2009-8#1)
and saline water##3##3##(2008-10#2)(2012-5#1)
and saline##6##2##(1994-2#1)(2008-10#4)(2012-5#1)
and salinity tolerance##2##3##(1992-8#1)(2011-1#1)
and salinity##4##2##(1992-8#1)(2008-5#2)(2011-1#1)
and salinomycin##2##2##(2007-6#2)
and saliva samples##3##3##(2008-10#2)(2013-1#1)
and saliva##16##2##(1990-5#1)(2008-10#8)(2008-12#1)(2008-3#2)(2009-6#1)(2010-11#1)(2013-1#1)(2013-8#1)
and salivary gland##2##3##(2008-10#2)
and salivary glands##10##3##(1994-5#1)(2008-10#7)(2011-1#2)
and salivary##14##2##(1993-12#1)(1994-5#1)(2006-10#1)(2008-10#9)(2011-1#2)
and salt##6##2##(2008-4#2)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
and same##2##2##(2008-5#1)(2012-3#1)
and sample acidity##2##3##(2008-10#2)
and sample consumption##2##3##(2008-10#2)
and sample flow rate##4##4##(2008-10#4)
and sample flow##5##3##(2008-10#5)
and sample pH##2##3##(2008-10#2)
and sample preparation##3##3##(2008-10#3)
and sample size##5##3##(1992-6#1)(1995-9#1)(2008-10#1)(2010-4#1)(2012-12#1)
and sample throughput of##4##4##(2008-10#4)
and sample throughput##8##3##(2008-10#8)
and sample volume##6##3##(2008-10#6)
and sample volumes##2##3##(2008-10#2)
and sample##73##2##(1992-6#1)(1994-9#1)(1995-9#1)(1997-2#1)(2008-10#56)(2008-2#3)(2008-3#5)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#2)
and sampled##4##2##(2007-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
and samples are##2##3##(2008-10#1)(2012-1#1)
and samples of##5##3##(1993-12#1)(2008-10#3)(2008-7#1)
and samples##12##2##(1993-12#1)(2008-10#8)(2008-12#1)(2008-7#1)(2012-1#1)
and sampling frequencies##2##3##(2008-10#2)
and sampling frequency of##3##4##(2008-10#3)
and sampling frequency##4##3##(2008-10#4)
and sampling rate of##2##4##(2008-10#2)
and sampling rate##3##3##(2008-10#3)
and sampling##23##2##(1993-9#1)(1994-9#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#1)(2012-3#1)(2013-1#1)
and sand##2##2##(2007-5#1)(2008-12#1)
and sanitary institutions##3##3##(2009-7#3)
and sanitary##11##2##(2008-10#1)(2009-12#1)(2009-7#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#2)
and sanitation##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
and saphenous vein##3##3##(1990-9#1)(2006-6#1)(2011-2#1)
and saphenous##5##2##(1990-9#1)(1996-5#1)(2006-6#1)(2011-2#2)
and saprophytic##2##2##(2008-10#2)
and sarcoma##3##2##(2007-8#1)(2008-6#1)(2009-3#1)
and sarcomatous components##3##3##(1991-4#1)(2009-5#1)(2012-1#1)
and sarcomatous##4##2##(1990-12#1)(1991-4#1)(2009-5#1)(2012-1#1)
and sarcoplasmic reticulum##2##3##(1991-2#1)(2008-11#1)
and saruplase##2##2##(2007-11#2)
and satellite##2##2##(2008-8#1)(2009-3#1)
and satellites##2##2##(2008-2#2)
and satisfaction with care##2##4##(1995-2#1)(1997-3#1)
and satisfaction with the##2##4##(1995-2#1)(2008-9#1)
and satisfaction with undergraduate education##2##5##(1993-3#2)
and satisfaction with##11##3##(1993-2#1)(1993-3#2)(1995-2#2)(1996-3#2)(1997-3#1)(2008-12#1)(2008-9#1)(2009-5#1)
and satisfaction within the disabled Medicare population##2##7##(1995-12#2)
and satisfaction##32##2##(1991-3#1)(1993-2#1)(1993-3#2)(1994-3#1)(1995-12#5)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#3)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
and satisfactory precision##2##3##(2008-10#2)
and satisfactory results##4##3##(1992-6#1)(1994-3#1)(2007-11#1)(2008-10#1)
and satisfactory##18##2##(1992-6#1)(1994-3#1)(1996-9#2)(2007-11#1)(2008-10#8)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and satisfies##2##2##(2007-10#1)(2008-4#1)
and satisfying the##2##3##(1993-12#1)(1997-3#1)
and satisfying##3##2##(1993-12#1)(1994-2#1)(1997-3#1)
and saturable binding##2##3##(1991-2#1)(1993-6#1)
and saturable##10##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-6#2)(1993-9#1)(1995-11#1)(2007-12#1)(2008-3#1)
and saturated##7##2##(1990-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#2)
and saturation irradiance values##2##4##(2008-2#1)(2008-3#1)
and saturation irradiance##7##3##(2008-2#3)(2008-3#4)
and saturation##10##2##(1996-2#1)(2008-2#3)(2008-3#4)(2008-5#1)(2009-5#1)
and sauna##2##2##(1991-12#1)(2007-10#1)
and save##2##2##(1996-3#1)(2008-9#1)
and saving of##3##3##(1992-3#1)(1994-5#1)(2008-9#1)
and savings##2##2##(1993-12#1)(1994-12#1)
and scabies##4##2##(1991-2#1)(2008-12#3)
and scaffold##2##2##(2008-5#1)(2013-1#1)
and scalable##2##2##(2008-4#1)(2008-7#1)
and scale up##2##3##(2008-11#1)(2008-2#1)
and scale##9##2##(1995-9#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
and scale-invariant##4##2##(2008-3#4)
and scale-up##4##2##(1992-12#1)(2008-11#2)(2008-7#1)
and scaleable##3##2##(2008-11#2)(2008-8#1)
and scaled##2##2##(1996-4#1)(2008-7#1)
and scales##5##2##(2007-11#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
and scaling of##2##3##(2008-3#1)(2008-8#1)
and scaling##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
and scalp##3##2##(2007-8#1)(2008-7#1)(2012-2#1)
and scan rate##5##3##(2008-10#5)
and scan##7##2##(2008-10#5)(2008-7#2)
and scanned##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)(2012-2#1)
and scanning electron microscope##3##4##(2008-10#2)(2012-3#1)
and scanning electron microscopic##3##4##(1992-12#1)(1995-8#1)(2007-12#1)
and scanning electron microscopy (SEM)##5##5##(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-8#1)
and scanning electron microscopy of##2##5##(2008-10#1)(2010-4#1)
and scanning electron microscopy##19##4##(2007-12#2)(2008-10#9)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2013-1#1)
and scanning electron##27##3##(1992-12#1)(1995-8#1)(2007-12#3)(2008-10#13)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
and scanning microscopy##2##3##(2008-3#1)(2008-9#1)
and scanning tunneling##2##3##(1990-12#1)(2008-10#1)
and scanning##37##2##(1990-12#1)(1992-12#1)(1995-8#1)(2007-12#6)(2008-10#14)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
and scar management##3##3##(2012-3#3)
and scar##4##2##(2010-8#1)(2012-3#3)
and scarce mitochondria##2##3##(2008-7#1)(2009-7#1)
and scarce##3##2##(2008-7#1)(2009-7#1)(2012-12#1)
and scarring##2##2##(1996-1#1)(2008-9#1)
and scatter##5##2##(1991-5#1)(2008-2#1)(2011-1#2)(2013-8#1)
and scattered electromagnetic fields##2##4##(2008-3#2)
and scattered##8##2##(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2013-8#1)
and scatterer##4##2##(1995-9#1)(2008-2#1)(2008-3#2)
and scatterers##2##2##(2007-12#1)(2008-3#1)
and scattering medium##3##3##(2008-2#2)(2008-3#1)
and scattering of##2##3##(2008-3#2)
and scattering parameters##3##3##(2008-3#3)
and scattering properties of##2##4##(2008-3#2)
and scattering##49##2##(2007-11#6)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#30)(2008-7#1)(2009-12#1)
and scavenge##2##2##(1992-9#1)(2008-11#1)
and scavenger##2##2##(1994-6#1)(2008-5#1)
and scavenging##2##2##(2008-11#1)(2012-2#1)
and schedule##2##2##(1992-2#1)(2007-12#1)
and scheduled##2##2##(1992-1#1)(2008-9#1)
and scheduling##3##2##(1996-12#1)(2012-3#2)
and schizoaffective disorder##2##3##(2008-8#2)
and schizoaffective##3##2##(2008-8#3)
and schizophrenia##20##2##(1990-12#1)(1993-9#1)(1996-6#6)(1997-5#3)(2007-8#3)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#1)
and schizophrenic##2##2##(1996-5#1)(2011-2#1)
and scholarly##2##2##(2010-2#1)(2010-4#1)
and scholastic##2##2##(1996-1#1)(2012-2#1)
and school##14##2##(2007-12#1)(2008-11#1)(2009-4#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
and schools of##2##3##(1996-12#1)(2010-3#1)
and schools##5##2##(1992-5#1)(1996-12#1)(2010-3#1)(2012-12#2)
and sciatic nerve##2##3##(1994-8#1)(2008-8#1)
and science##6##2##(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
and scientific as##2##3##(1994-12#1)(2009-11#1)
and scientific issues of##2##4##(2008-9#1)(2013-8#1)
and scientific progress##2##3##(2010-12#1)(2012-2#1)
and scientific research##2##3##(2009-9#1)(2010-4#1)
and scientific##33##2##(1990-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and scientifically##2##2##(2008-5#1)(2011-2#1)
and scientists to##2##3##(2008-7#1)(2009-9#1)
and scientists##7##2##(1993-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-10#1)(2013-8#1)
and scintigraphy##5##2##(1990-6#1)(1991-9#1)(2007-11#1)(2010-6#1)(2013-1#1)
and scintillation##4##2##(1992-5#1)(2007-12#1)(2008-3#2)
and sclerotia formation of##2##4##(2008-10#1)(2008-8#1)
and sclerotia##3##2##(2008-10#2)(2008-8#1)
and scope of practice##4##4##(1996-12#1)(2011-1#3)
and scope of##9##3##(1994-12#1)(1996-12#1)(2007-10#1)(2008-9#1)(2010-3#1)(2011-1#3)(2013-1#1)
and scope##11##2##(1994-12#1)(1996-12#1)(2007-10#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#1)
and score##3##2##(1995-12#1)(1997-5#1)(2008-7#1)
and scored##6##2##(1995-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
and scores##6##2##(1993-3#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
and scoring of##2##3##(2007-11#1)(2008-4#1)
and scoring##7##2##(1994-3#2)(1995-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-11#1)
and screen##4##2##(2008-1#1)(2012-3#1)(2013-1#2)
and screen-printed electrodes##2##3##(2008-10#2)
and screened for the presence of##2##6##(1996-12#1)(2008-10#1)
and screened for the##3##4##(1996-12#1)(2008-10#2)
and screened for##5##3##(1994-12#1)(1996-12#1)(2008-10#3)
and screened with##3##3##(1991-6#1)(1992-8#1)(1994-8#1)
and screened##14##2##(1991-6#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-1#1)
and screening for##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and screening of##6##3##(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-8#1)
and screening##23##2##(1991-6#1)(1994-3#1)(1995-9#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
and screw##3##2##(2007-11#1)(2007-8#1)(2008-9#1)
and screws##3##2##(2007-8#1)(2008-9#1)(2012-2#1)
and scrotum##2##2##(1994-1#1)(2007-9#1)
and scv =##2##3##(2007-11#2)
and sea surface##2##3##(2008-3#2)
and sea urchin##2##3##(1995-3#1)(2011-2#1)
and sea water samples##4##4##(2008-10#4)
and sea water##8##3##(2008-10#7)(2010-12#1)
and sea##17##2##(1995-3#1)(2007-5#1)(2008-10#10)(2008-2#1)(2008-3#2)(2010-12#1)(2011-2#1)
and sea-water##2##2##(2008-10#2)
and seagrass##2##2##(2007-5#2)
and sealed##2##2##(2008-10#1)(2013-1#1)
and sealing##2##2##(1996-8#1)(2011-2#1)
and search for##3##3##(2008-11#1)(2008-5#1)(2011-1#1)
and search##8##2##(1996-7#1)(2008-11#2)(2008-5#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
and searched##3##2##(2008-10#2)(2013-8#1)
and searching for##2##3##(1994-7#1)(2008-8#1)
and searching##4##2##(1994-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
and season##2##2##(1994-2#1)(2008-11#1)
and seasonal changes##2##3##(1993-6#1)(2008-8#1)
and seasonal distribution of##2##4##(2007-10#1)(2008-10#1)
and seasonal variation of##2##4##(2007-2#1)(2013-7#1)
and seasonal variation##4##3##(2007-2#1)(2008-10#1)(2008-5#1)(2013-7#1)
and seasonal##21##2##(1991-8#3)(1993-6#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#3)(2013-7#1)
and seawater samples##3##3##(2008-10#3)
and seawater##15##2##(2008-10#11)(2008-2#3)(2012-5#1)
and sebaceous gland hyperplasia##3##4##(2008-9#3)
and sebaceous##4##2##(2008-9#4)
and second (ED50##2##3##(1995-12#2)
and second dissociation constants of##2##5##(2008-10#2)
and second dissociation constants##4##4##(2008-10#4)
and second dissociation##5##3##(2008-10#5)
and second generation##3##3##(1995-2#1)(2011-2#2)
and second order##4##3##(2008-10#1)(2008-2#1)(2010-5#1)(2011-1#1)
and second##77##2##(1990-3#1)(1990-8#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-3#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-11#3)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-3#1)(2013-8#2)
and second-derivative##4##2##(2008-10#4)
and second-harmonic generation##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
and second-harmonic##11##2##(2007-11#3)(2007-12#5)(2008-3#2)(2008-7#1)
and second-order##7##2##(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#2)
and secondary branching of##2##4##(2008-10#2)
and secondary patency##7##3##(2007-7#5)(2011-3#2)
and secondary prevention##14##3##(1990-12#1)(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
and secondary spread##2##3##(2008-10#2)
and secondary structure of##2##4##(2008-7#1)(2009-7#1)
and secondary structure##3##3##(1993-8#1)(2008-7#1)(2009-7#1)
and secondary structures of##2##4##(1994-12#2)
and secondary structures##3##3##(1994-12#2)(1995-9#1)
and secondary##112##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#6)(2007-8#2)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#5)
and secondly the##2##3##(2008-11#1)(2013-1#1)
and secondly to##4##3##(2008-10#3)(2010-8#1)
and secondly##11##2##(1993-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2010-8#1)(2013-1#2)
and secrete##15##2##(1993-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)(2010-11#1)(2012-2#1)(2013-1#4)
and secreted by the##2##4##(1994-8#1)(2008-5#1)
and secreted by##8##3##(1993-3#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-6#1)
and secreted in##2##3##(1990-12#1)(2012-2#1)
and secreted into the##2##4##(1992-3#1)(1993-9#1)
and secreted##24##2##(1990-12#1)(1990-8#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
and secretes##2##2##(1994-8#1)(2008-7#1)
and secreting##3##2##(2008-4#1)(2008-6#1)(2012-12#1)
and secretion in##2##3##(1995-11#1)(2010-11#1)
and secretion of IL-6##2##4##(1994-6#1)(1995-2#1)
and secretion of the##3##4##(1991-9#1)(1993-11#1)(1997-4#1)
and secretion of##19##3##(1990-11#1)(1991-5#1)(1991-9#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-4#2)(2007-12#1)(2008-11#2)(2008-5#1)(2008-8#2)(2012-12#1)
and secretion##33##2##(1990-11#1)(1990-2#1)(1991-5#1)(1991-9#2)(1993-11#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#2)(2007-12#1)(2008-11#4)(2008-5#1)(2008-8#3)(2010-11#3)(2011-2#3)(2012-12#1)
and secretions##3##2##(1994-12#1)(1994-9#1)(2008-12#1)
and secretory##6##2##(1994-9#1)(1996-5#1)(2006-6#1)(2008-4#1)(2010-11#1)(2010-12#1)
and sectioned##2##2##(1990-2#1)(2009-12#1)
and sectioning##4##2##(1990-8#1)(1997-8#1)(2007-12#1)(2008-4#1)
and sections##2##2##(1992-8#1)(2008-2#1)
and sector##2##2##(2008-10#2)
and secure##8##2##(1992-2#1)(1992-3#1)(1995-2#2)(1996-12#1)(2008-1#1)(2010-10#1)(2012-1#1)
and securing##5##2##(2007-8#1)(2008-11#2)(2009-10#1)(2010-8#1)
and security directors##3##3##(1991-3#1)(1992-2#2)
and security of##3##3##(1992-2#1)(1995-12#1)(1996-12#1)
and security##10##2##(1991-3#2)(1992-2#3)(1995-12#1)(1996-12#2)(2008-10#1)(2008-4#1)
and sedation with intravenous##2##4##(1993-1#1)(1995-11#1)
and sedation##6##2##(1993-1#2)(1995-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
and sedative##3##2##(1996-3#1)(2008-10#1)(2010-4#1)
and sedentary##4##2##(1992-3#1)(2008-11#1)(2008-3#1)(2008-7#1)
and sediment certified reference materials##2##5##(2008-10#2)
and sediment certified##3##3##(2008-10#3)
and sediment extracts##3##3##(2008-10#3)
and sediment samples##10##3##(2008-10#10)
and sediment##26##2##(2008-10#26)
and sedimentation##10##2##(1990-9#1)(1995-11#2)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#2)
and sediments are##2##3##(2008-10#2)
and sediments by##3##3##(2008-10#3)
and sediments##14##2##(2008-10#13)(2013-8#1)
and see##3##2##(2008-4#1)(2008-7#1)(2009-5#1)
and seed coat##4##3##(2008-10#3)(2013-8#1)
and seed production##2##3##(2008-10#1)(2008-8#1)
and seed set##2##3##(2009-12#2)
and seed weight##2##3##(2008-10#1)(2008-12#1)
and seed were##2##3##(2008-10#2)
and seed##27##2##(2008-10#14)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-12#2)(2009-6#1)(2013-1#1)(2013-8#1)
and seeded with##2##3##(2007-11#1)(2008-10#1)
and seeded##3##2##(2007-11#1)(2008-10#1)(2010-9#1)
and seedling growth of V##5##5##(2008-12#5)
and seedling growth of##11##4##(2008-12#9)(2008-5#2)
and seedling growth##12##3##(2008-12#10)(2008-5#2)
and seedling##22##2##(2008-10#5)(2008-12#12)(2008-5#3)(2008-7#1)(2008-8#1)
and seedlings##5##2##(2008-10#5)
and seeds of##2##3##(2008-10#1)(2013-8#1)
and seeds oil##2##3##(2008-10#2)
and seeds##14##2##(2008-10#7)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2013-8#1)
and seek##6##2##(1993-3#1)(1994-1#1)(1996-12#1)(2008-11#1)(2012-12#1)(2013-8#1)
and seeking##5##2##(1990-10#1)(1996-2#1)(2008-11#1)(2008-5#1)(2011-1#1)
and seeks to##3##3##(2007-10#1)(2008-6#1)(2013-8#1)
and seem to be##2##4##(2008-7#1)(2012-4#1)
and seem to##3##3##(1990-5#1)(2008-7#1)(2012-4#1)
and seem##4##2##(1990-5#1)(1992-3#1)(2008-7#1)(2012-4#1)
and seemed to be##2##4##(1995-12#1)(2008-10#1)
and seemed to##3##3##(1994-3#1)(1995-12#1)(2008-10#1)
and seemed##4##2##(1990-9#1)(1994-3#1)(1995-12#1)(2008-10#1)
and seemingly##2##2##(2008-10#1)(2008-4#1)
and seems to be##3##4##(1993-12#1)(1995-6#1)(2010-2#1)
and seems to##4##3##(1993-12#1)(1995-6#1)(2007-12#1)(2010-2#1)
and segment apex##2##3##(2008-5#2)
and segmental glomerulosclerosis (FSGS)##4##4##(2007-7#1)(2008-1#2)(2012-2#1)
and segmental glomerulosclerosis##9##3##(2007-7#3)(2008-1#5)(2012-2#1)
and segmental liver atrophy##2##4##(2012-2#2)
and segmental##20##2##(1990-8#1)(1993-12#1)(1995-11#1)(2007-12#1)(2007-7#3)(2008-1#6)(2011-2#3)(2012-2#4)
and segmentation##5##2##(1995-5#1)(2008-6#1)(2008-9#2)(2011-7#1)
and seismic##2##2##(1996-4#2)
and seismicity is##2##3##(1996-4#2)
and seizure##3##2##(1992-12#1)(2008-2#1)(2011-2#1)
and seizures##8##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and seldom##3##2##(1990-11#1)(1994-3#1)(2007-12#1)
and select the##4##3##(2011-2#1)(2011-3#1)(2013-1#2)
and select##10##2##(1994-12#1)(2008-10#1)(2008-6#2)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
and selected by##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
and selected for##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
and selected with##2##3##(2008-11#2)
and selected##38##2##(1991-1#1)(1991-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
and selecting the structure that persists in all of the trials##2##11##(2008-4#2)
and selecting the##3##3##(2007-12#1)(2008-4#2)
and selecting##8##2##(1995-1#1)(2007-12#2)(2008-4#4)(2011-2#1)
and selection by##2##3##(2008-10#1)(2008-3#1)
and selection of patients##2##4##(2007-8#1)(2010-6#1)
and selection of##14##3##(1990-7#1)(1992-12#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#3)(2011-3#1)(2013-1#1)
and selection on##2##3##(2008-8#1)(2008-9#1)
and selection##34##2##(1990-7#1)(1992-12#1)(1992-3#1)(1993-8#1)(1997-3#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#3)(2013-1#3)
and selective COX-2##2##3##(2008-10#1)(2008-11#1)
and selective agonists##2##3##(2008-4#2)
and selective chemical##2##3##(1993-11#1)(2008-2#1)
and selective detection of##4##4##(1995-6#2)(2008-10#2)
and selective detection##5##3##(1995-6#2)(2008-10#3)
and selective determination of##6##4##(2008-10#6)
and selective determination##8##3##(2008-10#8)
and selective extraction##4##3##(2008-10#4)
and selective flow injection##4##4##(2008-10#4)
and selective flow-injection##2##3##(2008-10#2)
and selective for the##2##4##(2008-10#2)
and selective inhibitor of##3##4##(1990-8#1)(2008-4#1)(2008-5#1)
and selective method for the determination of##5##7##(2008-10#5)
and selective method for the##7##5##(2008-10#7)
and selective method for##9##4##(2008-10#9)
and selective method has been developed for##3##7##(2008-10#3)
and selective method has been##4##5##(2008-10#4)
and selective method is proposed for the##2##7##(2008-10#2)
and selective method is##8##4##(2008-10#8)
and selective method of##2##4##(2008-10#2)
and selective method was developed for the##2##7##(2008-10#2)
and selective method##26##3##(2008-10#25)(2008-5#1)
and selective reagent##2##3##(1996-5#1)(2008-10#1)
and selective square-wave##2##3##(2008-10#2)
and selective##135##2##(1990-5#1)(1990-8#2)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-3#2)(1995-6#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#93)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#4)(2008-8#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
and selectively##12##2##(1996-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-10#1)(2013-1#1)
and selectivities##2##2##(2008-10#1)(2010-7#1)
and selectivity are discussed##2##4##(2008-10#2)
and selectivity are##3##3##(2008-10#3)
and selectivity coefficients##2##3##(2008-10#2)
and selectivity for the##2##4##(2008-10#1)(2008-4#1)
and selectivity for##6##3##(2008-10#5)(2008-4#1)
and selectivity of the sensor##2##5##(2008-10#2)
and selectivity of the##9##4##(2008-10#9)
and selectivity of##20##3##(1990-8#1)(1996-12#1)(2008-10#17)(2010-12#1)
and selectivity to##3##3##(2008-10#3)
and selectivity were##2##3##(2008-10#2)
and selectivity##75##2##(1990-8#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#62)(2008-3#1)(2008-4#2)(2008-9#2)(2010-10#1)(2010-12#2)(2012-2#1)
and selenate (Se(VI))##2##3##(2008-10#2)
and selenate##4##2##(2008-10#3)(2013-8#1)
and selenium in##5##3##(2008-10#5)
and selenium were##3##3##(2008-10#3)
and selenium##26##2##(1993-12#1)(1997-8#1)(2008-10#23)(2009-5#1)
and selenocystine##2##2##(2008-10#1)(2010-11#1)
and selenomethionine##3##2##(2008-10#3)
and self management##2##3##(2011-2#1)(2012-3#1)
and self##10##2##(1992-5#1)(1994-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and self-assembled##2##2##(2008-10#2)
and self-assembly##4##2##(2007-12#1)(2008-10#3)
and self-assessment##4##2##(1993-2#1)(2008-9#2)(2013-1#1)
and self-awareness##4##2##(2008-11#2)(2008-12#1)(2012-3#1)
and self-care##4##2##(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)
and self-concept##3##2##(2009-7#3)
and self-directed##2##2##(1993-12#1)(2008-11#1)
and self-efficacy##5##2##(1993-12#1)(2008-4#1)(2010-9#1)(2013-1#2)
and self-esteem among##2##3##(2009-7#1)(2012-2#1)
and self-esteem##10##2##(1990-2#1)(1992-3#1)(1994-12#1)(2007-12#2)(2008-12#1)(2009-7#1)(2011-2#1)(2012-2#2)
and self-evaluation##2##2##(1994-6#1)(2007-12#1)
and self-harm behaviors##2##3##(2009-7#1)(2009-9#1)
and self-harm##3##2##(2009-7#1)(2009-9#1)(2013-1#1)
and self-help groups##2##3##(1994-12#1)(1995-1#1)
and self-help##4##2##(1994-12#1)(1995-1#1)(1995-3#1)(2010-10#1)
and self-paced##2##2##(1996-3#1)(2013-1#1)
and self-perceived competency##2##3##(2008-8#2)
and self-perceived##3##2##(2008-5#1)(2008-8#2)
and self-perception##2##2##(2007-2#1)(2012-2#1)
and self-phase modulation##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and self-regulation##3##2##(2008-12#2)(2012-3#1)
and self-reported##13##2##(1991-1#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)
and self-reports##2##2##(2008-4#1)(2012-12#1)
and self-stretching##2##2##(2010-9#2)
and sell##2##2##(1997-2#1)(2008-5#1)
and semantic##7##2##(1990-8#1)(1993-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#2)
and semen##2##2##(2008-7#2)
and semi-quantitative##3##2##(1997-3#1)(2008-10#2)
and semi-structured interviews##4##3##(1991-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
and semi-structured##5##2##(1991-6#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#1)
and semi-urban areas##2##3##(1997-4#1)(2008-3#1)
and semi-volatile halogenated compounds##2##4##(2009-8#2)
and semiconductor##5##2##(2007-12#2)(2008-10#3)
and seminal vesicles##3##3##(1997-8#1)(2012-12#2)
and semivolatile##4##2##(2008-10#4)
and send##5##2##(1995-1#1)(2007-12#1)(2008-4#1)(2011-2#2)
and senescence##12##2##(1994-6#2)(1995-2#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#6)
and senescent rats##3##3##(1991-2#2)(2013-7#1)
and senescent##4##2##(1991-2#2)(2008-3#1)(2013-7#1)
and senile##4##2##(2008-7#2)(2011-1#2)
and senior##6##2##(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(2009-4#1)(2012-12#1)
and sensation##2##2##(2008-6#1)(2010-8#1)
and sensation-seeking##2##2##(2008-3#2)
and sense of well-being##2##4##(2008-7#1)(2011-2#1)
and sense of##7##3##(1997-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
and sense organs##2##3##(2007-12#1)(2008-5#1)
and sense##9##2##(1997-1#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
and sensing applications##2##3##(2007-12#1)(2009-2#1)
and sensing of##2##3##(2007-11#1)(2008-10#1)
and sensing##11##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-7#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-1#1)
and sensitisation##2##2##(1990-11#1)(2008-7#1)
and sensitive analysis of##2##4##(2008-10#1)(2012-1#1)
and sensitive and##6##3##(2008-10#6)
and sensitive as##2##3##(2008-10#1)(2008-9#1)
and sensitive assay for##2##4##(2008-10#1)(2008-4#1)
and sensitive assay##4##3##(2008-10#3)(2008-4#1)
and sensitive characterization##2##3##(2008-2#1)(2008-9#1)
and sensitive detection of##2##4##(1990-12#1)(2008-10#1)
and sensitive detection##3##3##(1990-12#1)(2008-10#2)
and sensitive determination of##8##4##(2008-10#8)
and sensitive enough##2##3##(2008-10#2)
and sensitive flow cytometric##3##4##(1990-12#2)(2008-9#1)
and sensitive flow injection##5##4##(2008-10#5)
and sensitive flow##8##3##(1990-12#2)(2008-10#5)(2008-9#1)
and sensitive flow-injection##2##3##(2008-10#2)
and sensitive fluorometric##3##3##(2008-10#3)
and sensitive for##4##3##(1992-2#1)(2008-10#2)(2008-2#1)
and sensitive high-performance liquid##2##4##(2008-10#2)
and sensitive method for the determination of trace##2##8##(2008-10#2)
and sensitive method for the determination of##13##7##(1990-8#1)(2008-10#12)
and sensitive method for the quantitative##2##6##(2008-10#1)(2010-1#1)
and sensitive method for the##24##5##(1990-8#1)(2007-7#1)(2008-10#19)(2008-5#1)(2010-1#1)(2010-4#1)
and sensitive method for##26##4##(1990-8#1)(2007-7#1)(2008-10#21)(2008-5#1)(2010-1#1)(2010-4#1)
and sensitive method has been developed for the determination of##2##10##(1991-5#1)(2008-10#1)
and sensitive method has been developed for the##3##8##(1991-5#1)(2008-10#2)
and sensitive method has been developed for##4##7##(1991-5#1)(2008-10#3)
and sensitive method is described for the determination of##2##9##(2008-10#2)
and sensitive method is described for the##3##7##(2008-10#3)
and sensitive method is##4##4##(2008-10#4)
and sensitive method to determine##2##5##(2008-10#2)
and sensitive method was developed for the spectrophotometric determination of##2##10##(2008-10#2)
and sensitive method was developed for##3##6##(2008-10#3)
and sensitive method was developed##4##5##(2008-10#3)(2011-1#1)
and sensitive method was##5##4##(2008-10#4)(2011-1#1)
and sensitive method##45##3##(1990-8#1)(1991-3#1)(1991-5#1)(2007-7#1)(2008-10#36)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
and sensitive methods##2##3##(2008-1#1)(2008-10#1)
and sensitive on-line##2##3##(2008-10#1)(2008-11#1)
and sensitive procedure for spectrophotometric determination of##2##7##(2008-10#2)
and sensitive procedure for##3##4##(2008-10#3)
and sensitive procedure##4##3##(2008-10#4)
and sensitive sequential injection spectrophotometric##2##5##(2008-10#2)
and sensitive spectrofluorimetric##2##3##(2008-10#2)
and sensitive spectrophotometric method##3##4##(2008-10#3)
and sensitive spectrophotometric methods are described##2##6##(2008-10#2)
and sensitive spectrophotometric methods for the determination of##2##8##(2008-10#2)
and sensitive spectrophotometric methods##4##4##(2008-10#4)
and sensitive spectrophotometric##8##3##(2008-10#8)
and sensitive square-wave voltammetric##2##4##(2008-10#2)
and sensitive strains##3##3##(1997-2#1)(2008-10#2)
and sensitive technique for##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
and sensitive to##9##3##(1990-11#1)(2007-6#1)(2008-10#5)(2008-3#1)(2011-2#1)
and sensitive tool##2##3##(2008-10#1)(2008-9#1)
and sensitive##231##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#167)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#4)(2009-4#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
and sensitively detected##3##3##(1994-9#1)(2008-10#2)
and sensitively##10##2##(1994-9#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-8#1)
and sensitivities##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
and sensitivity analysis##3##3##(1995-12#1)(2011-1#1)(2013-1#1)
and sensitivity and##3##3##(1995-12#1)(2008-10#1)(2012-12#1)
and sensitivity are##3##3##(1996-9#1)(2008-10#2)
and sensitivity for##4##3##(2008-10#4)
and sensitivity in##2##3##(1997-1#1)(2008-10#1)
and sensitivity of the system##2##5##(2007-12#1)(2008-2#1)
and sensitivity of the##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2010-8#1)
and sensitivity of##18##3##(1993-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2010-8#1)(2011-1#1)
and sensitivity than##2##3##(2008-10#1)(2011-2#1)
and sensitivity to##8##3##(1996-12#3)(2007-7#1)(2008-10#3)(2008-7#1)
and sensitivity was found##2##4##(2007-6#1)(2007-8#1)
and sensitivity was##4##3##(1991-2#1)(1992-3#1)(2007-6#1)(2007-8#1)
and sensitivity were satisfactory##2##4##(2008-10#2)
and sensitivity were##4##3##(2008-10#4)
and sensitivity with##2##3##(2009-9#1)(2012-8#1)
and sensitivity##101##2##(1991-2#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-12#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#46)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)
and sensitization##3##2##(1993-8#1)(2008-5#1)(2009-8#1)
and sensor##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)
and sensorial##4##2##(2008-5#2)(2010-4#1)(2012-12#1)
and sensorineural deafness##2##3##(2008-9#1)(2011-1#1)
and sensors for##2##3##(1990-8#1)(2008-10#1)
and sensors##7##2##(1990-8#1)(2007-12#1)(2008-10#3)(2010-12#1)(2012-2#1)
and sensory aspects##2##3##(2008-9#2)
and sensory attributes##2##3##(2010-4#1)(2011-2#1)
and sensory changes##2##3##(2010-4#1)(2012-12#1)
and sensory characteristics##2##3##(2010-4#2)
and sensory deficits##2##3##(2007-10#1)(2008-12#1)
and sensory evaluation##2##3##(2010-4#1)(2011-2#1)
and sensory loss##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
and sensory properties##4##3##(2010-4#3)(2012-2#1)
and sensory##37##2##(1990-12#1)(1994-9#1)(1995-1#2)(1995-5#2)(1997-1#1)(2007-10#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-4#8)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
and sent to all##2##4##(1992-1#1)(2007-7#1)
and sent to##4##3##(1992-1#1)(2007-7#1)(2008-10#1)(2008-7#1)
and sent##6##2##(1992-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)
and sentence##4##2##(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
and separate the##2##3##(1994-3#1)(2008-10#1)
and separate##9##2##(1992-12#1)(1994-3#1)(1997-7#1)(2007-8#1)(2008-10#4)(2011-2#1)
and separated by##7##3##(1990-5#2)(1990-8#1)(1993-9#1)(1994-9#1)(2008-10#1)(2008-6#1)
and separated from the##2##4##(2008-10#2)
and separated from##3##3##(2008-10#3)
and separated into##2##3##(1991-9#1)(1993-11#1)
and separated the##2##3##(2007-8#1)(2008-10#1)
and separated##23##2##(1990-5#2)(1990-8#1)(1991-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-6#1)(2011-1#1)
and separately##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
and separating##3##2##(2008-10#2)(2008-9#1)
and separation conditions##3##3##(1994-9#1)(2008-10#2)
and separation factors##2##3##(2008-10#2)
and separation from##2##3##(1996-3#1)(2008-10#1)
and separation of a##2##4##(2008-10#2)
and separation of the##3##4##(1996-5#1)(2008-10#2)
and separation of total mercury##2##5##(2008-10#2)
and separation of trace##6##4##(2008-10#6)
and separation of##32##3##(1996-5#2)(2008-10#27)(2008-7#1)(2009-6#1)(2012-3#1)
and separation studies##2##3##(2008-10#2)
and separation with##2##3##(2008-10#2)
and separation##64##2##(1993-12#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#2)(2008-1#1)(2008-10#49)(2008-11#2)(2008-7#2)(2009-6#1)(2012-3#1)
and separations##2##2##(1995-1#1)(2008-10#1)
and sepsis##8##2##(1991-3#1)(1993-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-1#1)
and sepsis-induced##2##2##(1995-2#1)(2012-3#1)
and septal thickness##2##3##(1995-3#1)(2012-2#1)
and septal##4##2##(1995-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
and septate junctions##2##3##(2008-7#2)
and septate##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
and septic arthritis##2##3##(1991-3#1)(2011-2#1)
and septic shock##9##3##(1996-9#1)(2007-12#3)(2008-5#1)(2011-2#4)
and septic##11##2##(1991-3#1)(1996-9#1)(2007-12#3)(2008-5#1)(2011-2#5)
and septicemia##2##2##(1994-9#1)(2013-8#1)
and sequence alignment##2##3##(2011-1#2)
and sequence analyses##4##3##(2008-10#3)(2008-11#1)
and sequence analysis of a##3##5##(1992-12#1)(1993-2#1)(1997-4#1)
and sequence analysis of the##5##5##(1990-7#1)(2008-10#2)(2008-6#1)(2009-5#1)
and sequence analysis of##18##4##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1997-4#1)(2008-10#6)(2008-6#1)(2009-5#1)
and sequence analysis##23##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1997-4#1)(1997-9#1)(2008-10#8)(2008-6#1)(2009-3#1)(2009-5#1)(2011-1#1)
and sequence comparison##2##3##(1993-8#1)(2008-10#1)
and sequence determination of the##2##5##(2008-10#1)(2010-6#1)
and sequence determination of##3##4##(2008-10#1)(2010-6#2)
and sequence determination##4##3##(2008-10#1)(2008-8#1)(2010-6#2)
and sequence of a##3##4##(1990-5#1)(1991-6#1)(1993-6#1)
and sequence of the human##3##5##(1994-11#1)(1996-8#1)(2008-7#1)
and sequence of the##9##4##(1991-7#1)(1992-3#1)(1994-11#1)(1994-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
and sequence of##18##3##(1990-5#1)(1990-7#1)(1991-6#2)(1991-7#1)(1992-3#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-7#1)
and sequence similarity##3##3##(1991-6#1)(2009-10#2)
and sequence##77##2##(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1996-8#1)(1997-4#2)(1997-9#1)(2007-6#1)(2008-10#23)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-6#2)(2011-1#3)(2012-1#1)(2013-8#1)
and sequence-dependent##2##2##(2008-4#1)(2012-2#1)
and sequence-tagged site##2##3##(1994-12#1)(1996-12#1)
and sequenced a##5##3##(1990-7#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)
and sequenced the entire##2##4##(1994-11#1)(1994-12#1)
and sequenced the two##2##4##(1991-2#1)(2013-1#1)
and sequenced the##13##3##(1991-2#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#1)(2013-1#1)
and sequenced to##2##3##(2008-2#1)(2008-9#1)
and sequenced##106##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-5#1)(1991-6#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#5)(1993-9#2)(1994-11#2)(1994-12#3)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-6#1)(2007-7#1)(2008-10#26)(2008-12#3)(2008-2#1)(2008-5#3)(2008-8#3)(2008-9#3)(2012-12#1)(2013-1#2)(2013-8#2)
and sequences of the##2##4##(1994-12#1)(2008-10#1)
and sequences of##4##3##(1994-12#1)(2007-7#1)(2008-10#1)(2008-8#1)
and sequences##6##2##(1994-12#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-9#1)
and sequencing analyses##2##3##(1995-8#1)(2008-10#1)
and sequencing of a##8##4##(1994-12#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-9#1)
and sequencing of an##2##4##(1991-6#1)(1997-2#1)
and sequencing of the complete##2##5##(1995-8#1)(1997-7#1)
and sequencing of the genomic##2##5##(1996-12#1)(2008-8#1)
and sequencing of the##13##4##(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
and sequencing of##33##3##(1991-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#3)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#2)
and sequencing the##2##3##(2008-10#1)(2011-2#1)
and sequencing was performed##2##4##(2012-2#1)(2013-8#1)
and sequencing##58##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#3)(1994-12#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#4)(1997-9#1)(2008-10#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#2)
and sequential determination of##4##4##(2008-10#4)
and sequential injection (SI)##2##4##(2008-10#2)
and sequential injection analysis##2##4##(2008-10#2)
and sequential injection##7##3##(2008-10#7)
and sequential##25##2##(1990-7#1)(1993-1#1)(1997-2#1)(2007-6#1)(2008-10#18)(2008-8#1)(2008-9#1)(2011-2#1)
and sequentially##2##2##(1994-6#1)(1995-5#1)
and sera##5##2##(1992-11#1)(1993-1#1)(2007-10#1)(2008-10#1)(2008-11#1)
and serial##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
and serially##3##2##(1992-6#1)(1993-12#1)(2012-2#1)
and series of##2##3##(2008-11#1)(2008-5#1)
and series##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
and serine hydroxymethyltransferase##2##3##(1997-1#2)
and serine##12##2##(1990-7#2)(1992-10#1)(1992-6#1)(1993-11#2)(1997-1#3)(2008-11#3)
and serine/threonine##2##2##(1995-2#1)(2008-10#1)
and serious##10##2##(1992-9#1)(1993-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-8#1)
and seroconversion rate of##2##4##(2007-7#2)
and seroconversion##5##2##(1991-3#1)(2007-7#3)(2011-2#1)
and serologic tests##2##3##(1991-12#1)(2012-3#1)
and serologic##8##2##(1990-3#1)(1991-12#1)(1995-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
and serological changes##2##3##(1995-2#1)(2007-2#1)
and serological characterization of##2##4##(1994-6#1)(2008-10#1)
and serological##14##2##(1990-3#1)(1990-6#2)(1994-6#1)(1995-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-7#1)
and serologically##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
and serology of##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
and serology##11##2##(1992-12#1)(1994-8#1)(1997-6#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2012-2#1)
and seroma##2##2##(2007-7#1)(2012-3#1)
and seropositivity##2##2##(1993-11#1)(2007-12#1)
and serotonergic##5##2##(1991-7#1)(1993-1#1)(1993-5#1)(1996-12#1)(2009-10#1)
and serotonin metabolism in the##2##5##(1997-7#1)(2013-1#1)
and serotonin metabolism##3##3##(1997-7#2)(2013-1#1)
and serotonin release##2##3##(1990-8#1)(1992-12#1)
and serotonin turnover##2##3##(2013-1#2)
and serotonin##22##2##(1990-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-2#1)(1996-12#2)(1996-5#1)(1997-7#3)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#3)
and serotonin-dependent##2##2##(1992-12#2)
and serotype distribution##3##3##(2007-12#1)(2008-5#2)
and serotype##4##2##(2007-12#1)(2008-5#3)
and serous##3##2##(1993-9#1)(1994-9#1)(2007-12#1)
and serpentine##3##2##(2007-9#1)(2008-10#2)
and sertraline##2##2##(2012-2#1)(2012-3#1)
and serum albumin##3##3##(1993-9#1)(2008-7#2)
and serum aluminum concentrations##2##4##(1992-11#2)
and serum amyloid##2##3##(2008-3#1)(2010-12#1)
and serum biochemical##2##3##(2011-1#1)(2012-3#1)
and serum cholesterol##4##3##(2008-12#2)(2008-7#2)
and serum concentration##2##3##(2008-11#1)(2008-7#1)
and serum creatinine##2##3##(1994-6#1)(2013-1#1)
and serum factors that##2##4##(2007-7#2)
and serum free##2##3##(1994-12#1)(2008-11#1)
and serum level of##3##4##(2008-7#2)(2008-9#1)
and serum levels of##3##4##(2008-5#1)(2008-7#1)(2012-1#1)
and serum neopterin concentrations##3##4##(1990-2#3)
and serum of##3##3##(1992-3#1)(1992-8#1)(2008-8#1)
and serum potassium##2##3##(1994-6#1)(1997-8#1)
and serum resistance##2##3##(1991-8#2)
and serum samples##9##3##(1994-12#1)(1995-2#1)(2008-10#6)(2013-1#1)
and serum thiobarbituric acid reactive substances##2##6##(2008-10#2)
and serum thromboxane##2##3##(1990-12#2)
and serum total protein##2##4##(2008-10#1)(2012-2#1)
and serum total##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
and serum triglyceride##2##3##(1991-12#1)(2008-1#1)
and serum was##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
and serum##134##2##(1990-12#2)(1990-2#4)(1990-3#1)(1990-8#4)(1991-12#3)(1991-8#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-8#2)(1993-8#1)(1993-9#1)(1994-12#3)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#3)(1995-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#35)(2008-11#5)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
and serum-free##3##2##(1994-6#1)(2008-11#2)
and serve as a##3##4##(1995-1#1)(1997-3#1)(2009-11#1)
and serve as##9##3##(1995-1#1)(1996-12#1)(1997-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2012-3#1)(2013-8#1)
and serve to##2##3##(1996-12#1)(2012-2#1)
and serve##13##2##(1995-1#1)(1996-12#2)(1997-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-8#1)
and served as a control##3##5##(1992-9#1)(1997-2#1)(2010-11#1)
and served as a##4##4##(1992-9#1)(1996-12#1)(1997-2#1)(2010-11#1)
and served as the control group##2##6##(1993-1#1)(1994-5#1)
and served as##8##3##(1992-9#1)(1993-1#1)(1994-5#1)(1996-12#1)(1997-2#1)(2008-8#1)(2010-11#2)
and served##9##2##(1992-9#1)(1993-1#1)(1994-5#1)(1996-12#1)(1997-2#1)(2008-8#2)(2010-11#2)
and serves as a model##2##5##(2011-2#1)(2012-12#1)
and serves as a##4##4##(1997-8#1)(2007-11#1)(2011-2#1)(2012-12#1)
and serves##6##2##(1991-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-12#1)
and service as##2##3##(1995-1#1)(1995-12#1)
and service delivery##7##3##(1993-1#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(2008-11#1)(2010-10#1)
and service levels##3##3##(1996-1#1)(1996-2#1)(1997-1#1)
and service providers##3##3##(1995-12#1)(2008-11#2)
and service quality##7##3##(1994-12#1)(1994-2#1)(1995-1#3)(1995-2#1)(1995-3#1)
and service to##3##3##(1994-2#1)(2007-2#1)(2009-3#1)
and service##41##2##(1992-2#1)(1993-1#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-2#2)(1995-1#7)(1995-12#5)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and services are discussed##2##4##(1991-2#2)
and services for##3##3##(1996-1#1)(1997-7#1)(2010-12#1)
and services in##2##3##(2012-12#1)(2012-2#1)
and services provided##2##3##(1992-3#1)(1996-2#1)
and services that##3##3##(1993-1#1)(1994-12#1)(1994-3#1)
and services to##4##3##(1993-1#1)(1994-2#1)(1995-3#1)(2009-5#1)
and services will##2##3##(1994-1#1)(1995-12#1)
and services##43##2##(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#3)(1995-12#1)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
and serving##4##2##(1994-3#1)(1996-1#1)(1997-1#1)(2008-5#1)
and sesami##3##2##(2008-10#3)
and set##7##2##(1991-12#1)(2008-3#2)(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
and sets##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
and setting up a##2##4##(2008-10#2)
and setting##8##2##(1996-9#1)(2007-2#1)(2008-10#3)(2008-8#2)(2012-2#1)
and settings##4##2##(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
and settled##2##2##(1992-8#1)(2008-8#1)
and seven days##2##3##(2008-5#1)(2013-1#1)
and seven different##2##3##(1997-3#1)(2008-10#1)
and seven isolates##2##3##(2008-10#2)
and seven patients##3##3##(2007-12#1)(2007-8#1)(2013-8#1)
and seven##46##2##(1992-6#1)(1993-12#1)(1995-9#1)(1997-3#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#2)(2011-2#3)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#1)
and seventh##8##2##(1991-1#1)(1992-1#1)(1995-4#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
and seventy three##2##3##(2008-10#1)(2008-12#1)
and seventy##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
and seventy-two##3##2##(1996-8#1)(2008-9#1)(2012-2#1)
and several animal##2##3##(2008-10#1)(2008-3#1)
and several different##2##3##(1991-2#1)(1997-5#1)
and several environmental##2##3##(2008-10#1)(2012-12#1)
and several of the##2##4##(1993-8#1)(2008-11#1)
and several organic##2##3##(2008-10#1)(2010-4#1)
and several other species##2##4##(1993-12#1)(2008-7#1)
and several other##10##3##(1993-11#1)(1993-12#1)(1994-1#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)
and several recombinant##2##3##(1993-6#1)(2007-2#1)
and several studies have##2##4##(2008-12#1)(2008-3#1)
and several studies##3##3##(2007-12#1)(2008-12#1)(2008-3#1)
and several types of##2##4##(1995-3#1)(2008-8#1)
and several##130##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-3#3)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
and severe bone##2##3##(2008-7#1)(2011-2#1)
and severe fibrosis##2##3##(2013-8#2)
and severe hydronephrosis##2##3##(2007-10#1)(2008-4#1)
and severe nausea##3##3##(1990-12#1)(2007-12#1)(2012-2#1)
and severe pain##4##3##(2007-11#1)(2008-7#1)(2010-12#2)
and severe##87##2##(1990-11#1)(1990-12#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-8#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#4)(2007-10#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#5)
and severely##6##2##(1990-3#1)(1995-2#1)(1995-8#1)(2008-10#2)(2009-7#1)
and severities##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
and severity and##2##3##(2008-10#1)(2008-6#1)
and severity in##2##3##(2008-10#2)
and severity increased with increasing##2##5##(2008-10#2)
and severity increased with##3##4##(2008-10#3)
and severity increased##4##3##(2008-10#4)
and severity of abuse##2##4##(2012-12#2)
and severity of acute viral hepatitis and fulminant hepatitis during pregnancy##2##11##(2007-7#2)
and severity of illness##4##4##(1993-12#1)(1995-2#1)(1995-9#1)(2010-10#1)
and severity of pain##2##4##(2007-11#1)(2010-12#1)
and severity of the disease##2##5##(2008-10#1)(2008-7#1)
and severity of the##8##4##(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
and severity of##59##3##(1990-3#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and severity on##4##3##(1995-2#1)(2008-10#3)
and severity##112##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-12#1)(1994-2#1)(1995-2#3)(1995-5#1)(1995-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#57)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and sew##2##2##(2008-12#1)(2010-8#1)
and sewage##5##2##(1991-7#1)(2008-10#4)
and sex and age##2##4##(1992-2#1)(1993-1#1)
and sex chromosome##2##3##(2010-3#2)
and sex differences in##2##4##(2008-9#1)(2009-7#1)
and sex hormones##2##3##(2010-12#1)(2011-2#1)
and sex influence##2##3##(1997-6#1)(2010-8#1)
and sex on the##2##4##(2008-7#1)(2010-4#1)
and sex on##4##3##(2008-7#1)(2010-2#1)(2010-4#1)(2013-7#1)
and sex ratio##2##3##(2008-8#1)(2008-9#1)
and sex ratios##3##3##(2010-8#1)(2011-2#2)
and sex standardized##2##3##(1995-9#1)(2008-3#1)
and sex steroids##2##3##(1997-6#1)(2008-6#1)
and sex were##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
and sex##66##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-6#2)(2007-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and sex)##2##2##(2010-11#1)(2011-2#1)
and sex-matched healthy controls##2##4##(2008-7#2)
and sex-matched healthy##3##3##(1993-9#1)(2008-7#2)
and sex-matched##14##2##(1992-8#1)(1993-9#1)(1997-7#1)(2006-10#1)(2007-10#2)(2008-3#2)(2008-6#1)(2008-7#4)(2011-2#1)
and sexual abuse##5##3##(1995-5#2)(1996-1#1)(2008-2#1)(2009-7#1)
and sexual behavior##3##3##(2008-12#2)(2008-9#1)
and sexual behaviors in a predominantly Hispanic sample of##2##9##(2009-5#2)
and sexual behaviors##4##3##(2009-5#3)(2013-8#1)
and sexual function##4##3##(2010-8#1)(2011-2#3)
and sexual health##5##3##(1990-12#1)(2008-11#2)(2009-5#2)
and sexual identity##3##3##(2008-12#1)(2009-5#2)
and sexual recombination##3##3##(2008-10#1)(2008-8#2)
and sexual reproduction##3##3##(2008-10#3)
and sexual risk behavior in##2##5##(2010-5#1)(2013-1#1)
and sexual risk behavior##3##4##(2010-5#2)(2013-1#1)
and sexual risk behaviors##2##4##(2008-4#1)(2013-1#1)
and sexual risk##5##3##(2008-4#1)(2010-5#2)(2013-1#2)
and sexual selection##9##3##(2008-8#4)(2008-9#1)(2012-3#4)
and sexual##69##2##(1990-12#1)(1991-3#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-10#1)(2009-5#10)(2009-7#2)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#5)(2013-1#4)(2013-8#2)
and sexuality##3##2##(2008-1#1)(2008-10#1)(2009-5#1)
and sexually transmitted diseases##4##4##(1991-12#1)(1993-2#1)(1995-9#1)(2011-1#1)
and sexually transmitted infections among##2##5##(2008-12#1)(2010-11#1)
and sexually transmitted infections##4##4##(2007-2#1)(2008-12#1)(2009-5#1)(2010-11#1)
and sexually transmitted##9##3##(1991-12#1)(1993-2#1)(1995-9#1)(2007-2#1)(2008-12#2)(2009-5#1)(2010-11#1)(2011-1#1)
and sexually##12##2##(1991-12#1)(1993-2#1)(1995-9#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-1#1)
and shading##3##2##(2008-10#1)(2008-9#2)
and shaking time##3##3##(2008-10#3)
and shallow##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
and sham##4##2##(2007-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
and sham-injured (n = 8)##2##5##(1993-12#2)
and sham-injured##3##2##(1993-12#3)
and sham-irradiated##2##2##(2008-11#2)
and sham-operated##3##2##(1990-5#1)(2012-1#2)
and shame##2##2##(2007-12#1)(2008-11#1)
and shape is##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
and shape memory##2##3##(2009-7#1)(2010-10#1)
and shape of the##9##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#1)(2013-8#1)
and shape of##15##3##(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-12#2)(2013-8#1)
and shape the##3##3##(2007-11#1)(2008-4#2)
and shape##48##2##(1993-9#1)(1995-5#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#3)(2013-8#1)
and shapes##4##2##(1997-2#1)(2008-10#2)(2009-11#1)
and shaping##2##2##(1994-1#1)(2008-7#1)
and share a##3##3##(2008-10#2)(2008-8#1)
and share##9##2##(1991-9#1)(1993-9#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-8#1)
and shared learning##2##3##(2008-11#2)
and shared##18##2##(1992-12#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
and shares##4##2##(1990-11#1)(1991-6#1)(2008-10#1)(2008-12#1)
and sharing of##3##3##(2009-5#1)(2010-8#1)(2013-8#1)
and sharing##4##2##(1994-1#1)(2009-5#1)(2010-8#1)(2013-8#1)
and she died##2##3##(2009-3#1)(2011-2#1)
and she was treated with##2##5##(1992-10#1)(2011-1#1)
and she was##8##3##(1992-10#1)(1994-6#1)(2008-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
and she##13##2##(1992-10#1)(1992-12#1)(1994-6#1)(2008-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
and shear force##3##3##(2009-11#1)(2010-4#1)(2013-1#1)
and shear stress##2##3##(2009-11#1)(2009-6#1)
and shear##13##2##(2008-11#2)(2008-2#1)(2008-5#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-4#1)(2012-2#1)(2013-1#1)
and shear-rate##2##2##(2007-12#2)
and shearographic interferometry##2##3##(2008-3#2)
and shearographic##3##2##(2008-3#3)
and sheath##2##2##(2008-10#1)(2009-5#1)
and shed light on the##2##5##(2008-5#1)(2009-5#1)
and shed##3##2##(2008-5#1)(2009-3#1)(2009-5#1)
and shedding##2##2##(2012-3#1)(2012-9#1)
and sheep##15##2##(1990-11#1)(1990-5#1)(1992-2#1)(1995-6#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
and shelf life of##2##4##(2007-3#1)(2008-10#1)
and shelf##3##2##(2007-3#1)(2008-10#1)(2010-4#1)
and shell##2##2##(2008-12#1)(2012-2#1)
and shellfish##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
and shift of##2##3##(2008-11#1)(2008-7#1)
and shift work##2##3##(1990-2#1)(2008-8#1)
and shift##7##2##(1990-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
and shifted##3##2##(1997-2#1)(1997-7#1)(2008-7#1)
and shifting the##2##3##(2008-2#1)(2008-3#1)
and shifting##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
and shifts##2##2##(1995-3#1)(2008-3#1)
and shikonin production##2##3##(1994-11#2)
and shock##3##2##(2007-8#1)(2008-8#1)(2010-5#1)
and shoot blight##13##3##(2008-10#13)
and shoot##24##2##(2008-10#19)(2008-12#3)(2008-9#1)(2013-1#1)
and shoots##6##2##(2008-10#2)(2008-12#4)
and short arm##2##3##(2008-9#2)
and short half-life##2##3##(2008-4#1)(2010-7#1)
and short supply##2##3##(2007-2#1)(2008-11#1)
and short##35##2##(1991-8#1)(1992-11#1)(1994-11#1)(1996-6#1)(2007-12#3)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
and short-##2##2##(2011-2#1)(2013-8#1)
and short-chain##2##2##(1997-4#1)(2007-12#1)
and short-term results##2##3##(1993-3#1)(2011-2#1)
and short-term##13##2##(1993-3#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#2)
and shortcomings of the##2##4##(2008-3#2)
and shortcomings of##3##3##(1994-3#1)(2008-3#2)
and shortcomings that##2##3##(1991-1#1)(2013-1#1)
and shortcomings##7##2##(1991-1#1)(1994-3#1)(2008-3#2)(2011-2#1)(2013-1#2)
and shorten##3##2##(1992-5#1)(2008-8#1)(2010-8#1)
and shortened##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
and shortening of the##2##4##(1992-5#1)(2012-1#1)
and shortening of##3##3##(1992-5#1)(2007-11#1)(2012-1#1)
and shortening##4##2##(1992-5#1)(2007-11#1)(2012-1#1)(2013-8#1)
and shorter##10##2##(1990-12#1)(1993-2#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)
and shortly##2##2##(1995-8#1)(2010-11#1)
and shortness of breath##3##4##(2008-7#2)(2010-8#1)
and should allow##2##3##(1992-3#1)(2008-10#1)
and should always##2##3##(2010-3#1)(2011-2#1)
and should be applicable to##2##5##(1991-5#1)(2010-12#1)
and should be applicable##3##4##(1991-2#1)(1991-5#1)(2010-12#1)
and should be carefully##2##4##(2008-1#1)(2011-1#1)
and should be combined##2##4##(1992-11#1)(2008-4#1)
and should be confirmed by##2##5##(1996-2#1)(2008-10#1)
and should be confirmed##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
and should be considered a##2##5##(1993-1#1)(1997-3#1)
and should be considered as a treatment##3##7##(2007-11#2)(2008-3#1)
and should be considered as##4##5##(2007-11#2)(2008-3#1)(2011-2#1)
and should be considered in those##2##6##(2007-2#1)(2012-3#1)
and should be considered in##7##5##(2007-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-10#1)(2012-3#1)
and should be considered when##3##5##(1993-6#1)(1996-3#1)(2008-8#1)
and should be considered##21##4##(1993-1#1)(1993-6#2)(1996-3#1)(1997-3#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
and should be evaluated##4##4##(1992-2#1)(2012-3#1)(2013-1#2)
and should be performed##4##4##(2007-4#1)(2007-8#1)(2008-6#1)(2013-1#1)
and should be taken into account##2##6##(2008-2#2)
and should be the##2##4##(2008-10#1)(2011-2#1)
and should be used to##2##5##(2007-8#1)(2013-1#1)
and should be used##3##4##(2007-8#1)(2008-7#1)(2013-1#1)
and should be##86##3##(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#6)(2013-8#1)
and should facilitate the##2##4##(1995-6#1)(2008-7#1)
and should facilitate##4##3##(1992-8#1)(1995-6#1)(2008-10#1)(2008-7#1)
and should have##3##3##(2007-12#1)(2008-5#1)(2013-1#1)
and should help to##2##4##(2008-10#1)(2013-8#1)
and should help##3##3##(1997-1#1)(2008-10#1)(2013-8#1)
and should not be confused with##2##6##(1997-3#1)(1997-8#1)
and should not be##8##4##(1997-3#2)(1997-8#1)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
and should not##9##3##(1997-3#2)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
and should therefore be##2##4##(2009-2#1)(2009-3#1)
and should therefore##3##3##(2009-2#2)(2009-3#1)
and should##145##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#6)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
and shoulder muscles##2##3##(2010-9#2)
and shoulder##11##2##(2007-10#2)(2007-11#2)(2007-8#1)(2008-11#1)(2008-6#1)(2010-9#3)(2012-2#1)
and show a##7##3##(1992-6#1)(1993-11#1)(1993-3#1)(2008-10#2)(2008-7#1)(2012-2#1)
and show an##4##3##(1991-2#1)(1992-10#1)(1993-3#1)(2008-10#1)
and show excellent##2##3##(2008-5#1)(2008-7#1)
and show good agreement##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
and show good##6##3##(2008-10#2)(2008-2#2)(2008-3#2)
and show how a##2##4##(2008-2#1)(2008-3#1)
and show how the##2##4##(2008-3#1)(2012-2#1)
and show how this##2##4##(2008-10#1)(2008-9#1)
and show how to##2##4##(1997-3#1)(2008-10#1)
and show how##12##3##(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
and show increased##2##3##(1997-7#1)(2011-10#1)
and show no evidence of##3##5##(2008-10#1)(2008-2#1)(2010-8#1)
and show no##6##3##(1996-2#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)
and show that if##2##4##(2008-5#1)(2010-7#1)
and show that it can##2##5##(2007-12#1)(2008-3#1)
and show that it is##2##5##(2008-4#1)(2013-1#1)
and show that it##7##4##(1993-9#1)(1995-6#1)(2007-12#1)(2008-3#2)(2008-4#1)(2013-1#1)
and show that its##2##4##(2007-11#1)(2009-5#1)
and show that the##14##4##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#5)(2010-12#1)(2012-3#1)
and show that these##2##4##(1994-12#1)(1994-8#1)
and show that they##3##4##(1997-8#1)(2007-12#1)(2008-2#1)
and show that this##2##4##(2008-2#1)(2008-6#1)
and show that##48##3##(1993-9#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#1)(1997-8#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
and show the results##2##4##(2007-12#1)(2008-3#1)
and show the utility of the##3##6##(2008-3#3)
and show the##14##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#6)(2008-9#1)(2011-1#1)
and show##123##2##(1990-10#1)(1991-2#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#10)(2008-10#17)(2008-11#2)(2008-2#12)(2008-3#19)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
and showed a good##3##4##(1992-10#1)(2007-11#1)(2008-11#1)
and showed a significant##2##4##(2013-1#1)(2013-8#1)
and showed a##18##3##(1990-11#1)(1991-12#1)(1992-10#1)(1993-9#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#2)
and showed an##4##3##(1990-6#1)(2008-2#1)(2008-7#1)(2011-2#1)
and showed excellent##3##3##(1993-1#1)(2007-12#1)(2011-3#1)
and showed good agreement with##2##5##(2008-10#1)(2008-3#1)
and showed good agreement##4##4##(2008-10#3)(2008-3#1)
and showed good correlation##2##4##(1992-11#1)(2008-10#1)
and showed good##10##3##(1992-11#1)(2008-10#7)(2008-11#1)(2008-3#1)
and showed high##3##3##(1994-8#1)(2008-10#1)(2012-2#1)
and showed little##2##3##(2012-12#1)(2012-3#1)
and showed more##2##3##(2009-8#1)(2010-5#1)
and showed no significant##3##4##(2008-11#1)(2008-6#1)(2009-9#1)
and showed no##6##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-9#1)
and showed only##3##3##(1995-11#1)(2008-10#2)
and showed positive##2##3##(1992-3#1)(2007-7#1)
and showed significant##3##3##(2008-5#1)(2010-8#1)(2012-3#1)
and showed similar##2##3##(2008-5#1)(2011-2#1)
and showed strong##2##3##(1995-4#1)(2010-5#1)
and showed that it is##2##5##(1990-2#1)(1995-2#1)
and showed that it##3##4##(1990-2#1)(1990-5#1)(1995-2#1)
and showed that the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
and showed that##14##3##(1990-12#1)(1990-2#1)(1990-5#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)
and showed the##8##3##(1995-11#1)(1996-2#1)(2008-10#2)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
and showed very##2##3##(2007-11#1)(2009-5#1)
and showed##126##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-6#4)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-4#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#23)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#3)(2010-8#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#3)
and showing that the##2##4##(1992-12#1)(2008-2#1)
and showing##4##2##(1992-12#1)(1995-2#1)(2008-2#1)(2011-2#1)
and shown to be a##4##5##(1992-3#1)(1997-2#1)(2008-10#1)(2012-12#1)
and shown to be expressed##2##5##(1995-6#1)(2008-9#1)
and shown to be##16##4##(1991-8#1)(1992-3#1)(1993-11#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
and shown to contain##2##4##(1992-12#1)(2008-10#1)
and shown to induce##2##4##(1994-3#1)(1995-5#1)
and shown to possess##2##4##(1991-12#1)(1993-8#1)
and shown to##36##3##(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
and shown##38##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
and shows a##6##3##(1991-12#1)(1992-6#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
and shows how##2##3##(2008-10#1)(2008-11#1)
and shows no##6##3##(1990-2#1)(1991-2#1)(1994-12#1)(2007-12#1)(2008-3#1)(2008-6#1)
and shows that the##7##4##(1992-3#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2012-3#1)
and shows that##12##3##(1992-3#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2012-3#1)
and shows the##5##3##(1991-9#1)(1992-9#1)(2008-2#1)(2008-8#2)
and shows##58##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#4)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and shutting##2##2##(1993-6#1)(2007-11#1)
and sialic acid##2##3##(2008-12#1)(2008-5#1)
and sialic##3##2##(1994-11#1)(2008-12#1)(2008-5#1)
and sialyl##3##2##(1992-8#1)(1993-8#2)
and sibling##2##2##(1995-12#1)(2008-12#1)
and siblings##2##2##(2006-8#1)(2008-9#1)
and sickle cell anaemia##3##4##(2009-10#1)(2013-8#2)
and side chain##6##3##(2009-7#6)
and side chains##3##3##(1995-5#1)(2008-4#1)(2009-7#1)
and side effect profiles##2##4##(2011-10#2)
and side effect##3##3##(2011-1#1)(2011-10#2)
and side effects of##4##4##(1991-6#1)(1993-1#1)(2008-12#1)(2013-1#1)
and side effects##13##3##(1991-2#1)(1991-6#1)(1993-1#1)(1993-6#1)(1996-5#1)(1996-8#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-11#1)(2012-12#1)(2013-1#1)
and side##35##2##(1991-2#1)(1991-6#1)(1993-1#1)(1993-6#1)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#7)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-10#2)(2012-12#1)(2012-2#1)(2013-1#3)
and side-effects##3##2##(2007-7#1)(2008-5#1)(2008-7#1)
and sidechain##3##2##(2008-2#1)(2008-9#1)(2009-7#1)
and sieved##2##2##(2008-10#2)
and sigma##2##2##(1990-8#1)(1993-12#1)
and sigmoidoscopy##2##2##(1995-10#1)(2010-6#1)
and signal intensities##3##3##(2008-3#2)(2009-11#1)
and signal intensity##3##3##(2008-10#2)(2009-11#1)
and signal processing##2##3##(2008-3#1)(2012-3#1)
and signal pulses##2##3##(2007-12#1)(2008-3#1)
and signal size##2##3##(2008-3#2)
and signal transduction in##2##4##(1996-2#1)(2010-5#1)
and signal transduction pathways##3##4##(2008-4#2)(2008-7#1)
and signal transduction##13##3##(1993-8#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#2)
and signal##42##2##(1991-10#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-2#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#8)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-8#1)(2010-12#1)(2010-5#2)(2012-3#2)(2013-8#1)
and signal-to-noise ratio with##2##4##(2008-2#1)(2008-3#1)
and signal-to-noise ratio##9##3##(1997-8#1)(2008-2#2)(2008-3#4)(2010-9#1)(2013-8#1)
and signal-to-noise ratios##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
and signal-to-noise##12##2##(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2010-9#1)(2013-8#1)
and signaling mechanisms##2##3##(2008-10#1)(2009-3#1)
and signaling of##2##3##(2008-10#1)(2010-5#1)
and signaling pathways##3##3##(2009-11#1)(2010-3#1)(2011-1#1)
and signaling##20##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and signalling##2##2##(1996-2#1)(2009-3#1)
and signals##2##2##(2008-10#1)(2008-8#1)
and significance of the##2##4##(1991-2#1)(2009-5#1)
and significance of##12##3##(1991-11#1)(1991-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and significance##14##2##(1991-11#1)(1991-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and significant changes##2##3##(2008-10#1)(2008-5#1)
and significant correlations with##3##4##(2012-1#1)(2012-12#1)(2013-7#1)
and significant differences were found##3##5##(2008-10#2)(2013-1#1)
and significant differences were##4##4##(2008-10#2)(2013-1#2)
and significant differences##6##3##(2008-10#2)(2011-2#1)(2013-1#2)(2013-7#1)
and significant improvement##2##3##(2010-12#1)(2012-12#1)
and significant increase in##2##4##(1995-12#1)(2008-10#1)
and significant increase##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
and significant relationship between##2##4##(1996-3#1)(2008-10#1)
and significant residual##2##3##(2007-12#1)(2009-4#1)
and significant##64##2##(1991-12#1)(1991-6#1)(1993-12#1)(1993-6#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
and significantly (P##2##3##(2008-10#2)
and significantly decreased##2##3##(2008-9#1)(2010-9#1)
and significantly different##2##3##(2008-5#1)(2008-6#1)
and significantly enhanced##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
and significantly higher##3##3##(1993-12#1)(2008-7#1)(2013-1#1)
and significantly improve##2##3##(2008-10#1)(2013-8#1)
and significantly improved##2##3##(2008-10#2)
and significantly increased##6##3##(1991-5#1)(1992-11#1)(1995-12#2)(2008-10#1)(2010-10#1)
and significantly less##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and significantly lower on the DOF On-Task score##2##8##(2010-8#2)
and significantly lower##8##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#2)(2012-12#1)(2012-2#1)
and significantly reduce the##2##4##(2007-4#1)(2012-2#1)
and significantly reduce##3##3##(2007-4#1)(2008-7#1)(2012-2#1)
and significantly reduced in##2##4##(1990-5#1)(2008-10#1)
and significantly reduced the##3##4##(1991-12#1)(1993-8#1)(2012-2#1)
and significantly reduced##7##3##(1990-5#1)(1991-12#1)(1993-8#1)(1995-12#1)(2008-10#2)(2012-2#1)
and significantly reduces the##2##4##(2007-8#1)(2008-3#1)
and significantly smaller##3##3##(1997-2#1)(2008-5#1)(2013-8#1)
and significantly with age##2##4##(2008-7#2)
and significantly with##3##3##(2008-10#1)(2008-7#2)
and significantly##69##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#3)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#2)
and signs of##13##3##(1990-2#1)(1995-2#1)(1995-3#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)
and signs##28##2##(1990-2#1)(1990-6#1)(1992-4#1)(1994-2#1)(1995-2#2)(1995-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#3)(2010-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
and silencing##2##2##(2011-1#1)(2011-2#1)
and silica gel##2##3##(2008-10#2)
and silica##15##2##(1992-10#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#3)(2009-7#1)(2010-7#1)
and silicas##3##2##(1990-8#2)(2008-1#1)
and silicate##5##2##(2008-10#5)
and silicon were determined##2##4##(2008-10#2)
and silicon##11##2##(2008-10#5)(2008-2#2)(2008-3#3)(2009-5#1)
and silver staining##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
and silver##18##2##(2008-10#10)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)
and silver(I)##3##2##(2008-10#3)
and simazine##6##2##(2008-10#6)
and simian immunodeficiency virus (SIV)##2##5##(1995-2#1)(1997-3#1)
and simian immunodeficiency virus##3##4##(1995-2#1)(1997-3#1)(2013-7#1)
and simian immunodeficiency##4##3##(1995-2#1)(1997-3#1)(1997-6#1)(2013-7#1)
and simian##5##2##(1995-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2013-7#1)
and similar in##2##3##(1997-6#1)(2013-8#1)
and similar levels of##2##4##(1995-8#1)(2008-10#1)
and similar results were obtained##2##5##(2008-10#2)
and similar results##3##3##(2008-10#3)
and similar to that##3##4##(1993-11#1)(1995-8#1)(2008-1#1)
and similar to##7##3##(1993-11#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-6#1)
and similar##41##2##(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-6#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-6#1)(2013-1#1)(2013-8#1)
and similarities in##3##3##(1992-8#1)(2008-10#1)(2008-7#1)
and similarities##9##2##(1992-8#2)(1997-6#1)(2008-10#2)(2008-7#2)(2009-12#1)(2009-7#1)
and similarity of##2##3##(2008-12#1)(2012-3#1)
and similarity##6##2##(1993-2#1)(1996-6#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
and similarly##4##2##(1993-12#1)(1993-5#1)(1994-2#1)(2008-3#1)
and simple analytical##3##3##(2008-10#2)(2008-3#1)
and simple and##3##3##(2007-7#1)(2008-10#2)
and simple determination of##2##4##(1992-3#1)(2008-10#1)
and simple in##2##3##(2008-10#1)(2013-1#1)
and simple means##2##3##(2006-6#1)(2008-10#1)
and simple method for the##3##5##(1995-3#1)(2007-11#1)(2008-10#1)
and simple method for##13##4##(1995-3#1)(2007-11#2)(2008-10#5)(2008-3#2)(2008-6#1)(2010-6#1)(2012-3#1)
and simple method has been developed for the##2##8##(2008-10#2)
and simple method has been##3##5##(1997-7#1)(2008-10#2)
and simple method to##4##4##(2007-12#1)(2008-10#2)(2008-12#1)
and simple method was##2##4##(2008-10#2)
and simple method##24##3##(1995-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-12#1)(2008-3#2)(2008-6#1)(2010-6#1)(2012-3#1)
and simple procedure##3##3##(2008-10#2)(2008-2#1)
and simple way to##2##4##(2008-10#1)(2008-5#1)
and simple way##4##3##(2008-10#3)(2008-5#1)
and simple##107##2##(1990-5#1)(1992-3#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#59)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
and simpler##6##2##(2007-12#1)(2008-10#4)(2008-3#1)
and simplex##2##2##(2008-10#2)
and simplicity of the##2##4##(2008-10#2)
and simplicity of##4##3##(1997-7#1)(2008-10#2)(2009-9#1)
and simplicity##12##2##(1990-5#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-9#1)(2010-8#1)
and simplification##2##2##(2007-11#1)(2008-5#1)
and simplified##5##2##(1990-6#1)(2008-10#2)(2008-4#1)(2008-9#1)
and simplifies##3##2##(1992-2#1)(2007-12#1)(2008-3#1)
and simplify##3##2##(2008-11#2)(2011-2#1)
and simply##3##2##(2008-10#1)(2008-4#1)(2010-8#1)
and simulate##3##2##(2008-2#1)(2010-10#1)(2013-8#1)
and simulated annealing##2##3##(1995-8#1)(2008-4#1)
and simulated data##5##3##(1997-4#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
and simulated epidemics##2##3##(2008-10#2)
and simulated ischemia##3##3##(1994-2#3)
and simulated results##2##3##(2007-12#1)(2008-3#1)
and simulated##30##2##(1990-9#1)(1994-1#1)(1994-2#3)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)
and simulates##2##2##(2008-2#1)(2013-8#1)
and simulation of##9##3##(1993-2#1)(1994-8#1)(2007-12#1)(2008-3#3)(2011-1#3)
and simulation##17##2##(1993-2#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#3)(2013-1#1)
and simulations show that##2##4##(2008-2#1)(2008-8#1)
and simulations##7##2##(1996-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)
and simultaneous addition of##2##4##(2008-11#1)(2008-5#1)
and simultaneous analysis of dichlorvos##2##5##(2008-10#2)
and simultaneous changes##2##3##(1991-9#1)(2008-3#1)
and simultaneous detection of##2##4##(2008-10#1)(2008-9#1)
and simultaneous determination of arsenic##2##5##(2008-10#2)
and simultaneous determination of##10##4##(2008-10#9)(2008-5#1)
and simultaneous saccharification and fermentation##2##5##(2008-6#2)
and simultaneous surface or intracellular antigen expression##2##7##(2008-9#2)
and simultaneous visualization##2##3##(2009-11#1)(2011-2#1)
and simultaneous##48##2##(1991-9#1)(1992-8#1)(1993-5#1)(1995-5#1)(2007-11#4)(2007-12#1)(2008-10#23)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-11#1)(2011-2#2)(2013-1#1)
and simultaneously preserve##2##3##(2009-4#1)(2010-7#1)
and simultaneously##32##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-9#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(2007-11#4)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#1)
and simvastatin##2##2##(1991-6#1)(2011-2#1)
and sinapic acid##2##3##(2013-1#2)
and since##9##2##(1992-6#1)(1993-11#1)(1995-12#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
and single cells##2##3##(1992-12#1)(1993-3#1)
and single diffusion##2##3##(2012-2#2)
and single photon emission computed tomography (SPECT)##2##7##(1996-12#1)(2008-8#1)
and single photon emission computed tomography##3##6##(1996-12#1)(2008-8#1)(2010-12#1)
and single photon emission##4##4##(1996-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
and single port access##2##4##(2012-12#2)
and single positive##2##3##(1997-7#1)(2008-10#1)
and single##37##2##(1992-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-12#2)(2012-2#3)
and single-cell##3##2##(1994-8#1)(2008-8#2)
and single-mode##2##2##(2008-2#1)(2008-3#1)
and single-molecule fluorescence##3##3##(2007-12#1)(2008-10#1)(2009-4#1)
and single-molecule##6##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-9#1)(2012-2#1)
and single-pass##2##2##(2007-12#1)(2008-2#1)
and single-scattering albedo##4##3##(2008-2#1)(2008-3#3)
and single-scattering##5##2##(2008-2#1)(2008-3#4)
and single-shot##3##2##(2007-11#2)(2007-12#1)
and single-strand##3##2##(1993-3#1)(1994-11#1)(2013-1#1)
and single-stranded##3##2##(1990-11#1)(1992-6#1)(1994-8#1)
and single-walled carbon nanotubes##2##4##(2008-7#1)(2013-1#1)
and singlet oxygen##2##3##(1991-9#1)(2009-4#1)
and singly##2##2##(2008-3#1)(2011-3#1)
and sink##2##2##(2007-12#1)(2013-1#1)
and sinking##2##2##(2008-10#1)(2008-8#1)
and sinks##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
and sinus##4##2##(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and sinuses in the##2##4##(2007-12#1)(2010-5#1)
and sinuses##4##2##(1992-10#1)(2007-12#1)(2008-6#1)(2010-5#1)
and sinusitis##2##2##(1990-10#1)(2007-12#1)
and sinusoids##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
and sirolimus##3##2##(2007-11#3)
and sister chromatid exchanges##2##4##(1996-2#1)(2008-11#1)
and sister##6##2##(1990-7#1)(1996-2#1)(2007-7#2)(2008-11#1)(2010-2#1)
and site of##4##3##(1991-6#1)(1994-11#1)(2008-10#1)(2009-4#1)
and site##10##2##(1991-12#1)(1991-6#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-4#1)
and site-directed mutagenesis##4##3##(1992-11#1)(1994-8#1)(1995-8#1)(2008-10#1)
and site-directed mutants of##3##4##(1994-11#1)(1995-6#1)(2008-10#1)
and site-directed##8##2##(1990-7#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#2)
and site-specific##2##2##(2008-10#1)(2008-11#1)
and sites of##3##3##(2008-8#1)(2010-3#1)(2011-2#1)
and sites##8##2##(1997-3#1)(2008-10#3)(2008-8#2)(2010-3#1)(2011-2#1)
and sitting##4##2##(1993-10#1)(2008-11#1)(2011-2#2)
and situation awareness##2##3##(2011-2#2)
and situation##3##2##(2011-2#3)
and situational factors##2##3##(2008-7#2)
and situations in which##2##4##(2008-4#1)(2010-9#1)
and situations that##2##3##(2008-5#1)(2010-11#1)
and situations##5##2##(1996-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-9#1)
and six in##2##3##(2008-10#1)(2011-2#1)
and six isolates from##2##4##(2008-10#2)
and six months after##3##4##(1990-5#1)(1993-3#1)(2011-2#1)
and six months##4##3##(1990-5#1)(1993-3#1)(2008-11#1)(2011-2#1)
and six of##2##3##(1993-12#1)(2011-1#1)
and six other##2##3##(2008-10#1)(2011-2#1)
and six patients##2##3##(2008-1#1)(2011-2#1)
and six were##2##3##(2007-7#1)(2008-1#1)
and six##69##2##(1990-2#1)(1990-3#2)(1990-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-3#2)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-7#1)(2013-8#1)
and sixth##5##2##(1996-1#1)(2007-12#1)(2008-3#1)(2010-1#1)(2013-7#1)
and sixth-order polarization aberrations##2##4##(2007-12#2)
and sixth-order##3##2##(2007-12#2)(2008-3#1)
and sixty##3##2##(2007-10#1)(2011-1#1)(2012-12#1)
and size and##3##3##(2007-5#1)(2008-10#1)(2010-8#1)
and size at##4##3##(2008-8#3)(2013-8#1)
and size distribution of aerosols##3##5##(2008-2#1)(2008-3#2)
and size distribution of##5##4##(2008-2#2)(2008-3#2)(2013-8#1)
and size distribution##10##3##(2008-10#2)(2008-2#4)(2008-3#2)(2011-2#1)(2013-8#1)
and size distributions of##2##4##(2008-2#1)(2008-3#1)
and size distributions##3##3##(2008-2#2)(2008-3#1)
and size exclusion chromatography##2##4##(1991-12#1)(1991-9#1)
and size exclusion##3##3##(1991-12#1)(1991-9#1)(2008-10#1)
and size of the##14##4##(1993-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-2#1)(2007-8#2)(2008-10#2)(2008-5#2)(2009-12#1)(2010-8#1)(2010-9#1)
and size of##35##3##(1990-5#1)(1991-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#2)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2013-7#1)
and size##98##2##(1990-5#1)(1991-12#2)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#14)(2008-2#6)(2008-3#9)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
and size-exclusion chromatography##2##3##(1993-11#1)(1993-8#1)
and size-exclusion##3##2##(1991-9#1)(1993-11#1)(1993-8#1)
and sizes of the##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
and sizes of##5##3##(2007-7#1)(2008-10#1)(2008-3#1)(2009-1#1)(2010-8#1)
and sizes##9##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-8#1)(2010-8#2)
and skeletal muscle##11##3##(1990-5#2)(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)
and skeletal muscle-specific##2##3##(1995-2#1)(2008-8#1)
and skeletal##26##2##(1990-5#2)(1992-6#1)(1992-9#1)(1993-12#2)(1995-11#1)(1995-2#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and skill level##2##3##(1996-12#1)(2007-11#1)
and skill to##2##3##(1995-12#1)(2011-2#1)
and skill##8##2##(1993-2#1)(1995-12#1)(1996-12#1)(2007-11#1)(2008-11#2)(2011-2#2)
and skilled##6##2##(1995-3#2)(2008-11#1)(2008-9#1)(2011-1#2)
and skills and##2##3##(1997-3#1)(2011-2#1)
and skills needed##2##3##(1993-12#1)(2012-12#1)
and skills of##2##3##(1991-12#1)(2012-1#1)
and skills that##2##3##(2008-1#1)(2008-11#1)
and skills##23##2##(1991-1#1)(1991-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(1997-3#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
and skim milk formed the curd##2##6##(2010-2#2)
and skim milk##5##3##(2010-2#5)
and skimmer##2##2##(2008-10#2)
and skin aging##2##3##(2008-5#2)
and skin biopsy##2##3##(1992-2#1)(2011-2#1)
and skin cancer##5##3##(2007-12#1)(2008-8#1)(2010-8#1)(2011-2#2)
and skin defects##2##3##(2008-10#1)(2008-5#1)
and skin of##2##3##(2008-5#1)(2008-6#1)
and skin surface pH are##2##5##(2008-5#2)
and skin surface pH##3##4##(2008-5#3)
and skin surface##5##3##(2008-5#5)
and skin##71##2##(1990-8#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-9#2)(1995-3#2)(1997-3#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#30)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
and skin)##2##2##(2008-9#1)(2011-1#1)
and skinning##2##2##(1997-5#1)(2008-4#1)
and skull base##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
and skull##4##2##(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
and skull-base surgery##2##3##(2008-9#1)(2012-1#1)
and sky##3##2##(2008-2#1)(2008-3#2)
and slag##3##2##(2008-10#3)
and sleep disorders##2##3##(2007-10#1)(2007-8#1)
and sleep duration##2##3##(2011-2#2)
and sleep problems##2##3##(1997-3#1)(2013-1#1)
and sleep##22##2##(1991-1#1)(1993-2#1)(1994-8#1)(1996-7#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-8#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
and sleeve##3##2##(1991-12#2)(2012-1#1)
and sliding##2##2##(2007-8#1)(2009-11#1)
and slightly dried##2##3##(2008-12#2)
and slightly higher than##2##4##(1993-5#1)(2010-8#1)
and slightly higher##3##3##(1993-5#1)(2008-10#1)(2010-8#1)
and slightly less##4##3##(1994-2#1)(1995-2#1)(2008-5#1)(2008-9#1)
and slightly##19##2##(1991-2#1)(1992-8#1)(1993-5#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)
and slips##2##2##(2008-3#1)(2013-1#1)
and slope of the##2##4##(2007-12#1)(2008-10#1)
and slope##11##2##(2007-12#1)(2008-10#8)(2008-2#1)(2008-5#1)
and slopes##2##2##(2008-10#2)
and slot-blot hybridization##2##3##(2008-4#2)
and sloughing##4##2##(1991-8#4)
and slow growth of##2##4##(2010-12#1)(2011-1#1)
and slow growth##3##3##(1997-2#1)(2010-12#1)(2011-1#1)
and slow the##2##3##(2008-10#1)(2012-2#1)
and slow##26##2##(1990-5#1)(1990-7#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-8#1)(2008-9#3)(2009-8#2)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
and slower##4##2##(2008-10#1)(2008-7#2)(2012-1#1)
and slowing##2##2##(2008-7#1)(2013-1#1)
and slowly##6##2##(1993-12#1)(1995-6#2)(2008-7#1)(2009-4#1)(2012-3#1)
and sludge##3##2##(2008-10#2)(2010-12#1)
and slurry##6##2##(2008-10#6)
and small GTPases##2##3##(2011-2#1)(2012-2#1)
and small amounts of##3##4##(1993-8#1)(2007-11#1)(2008-5#1)
and small cell carcinoma##3##4##(1991-6#1)(2008-1#1)(2009-3#1)
and small cell##5##3##(1991-6#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-3#1)
and small dense##2##3##(2008-1#1)(2011-1#1)
and small intestine##6##3##(1990-7#1)(1992-11#3)(1994-11#2)
and small molecules##3##3##(2008-10#1)(2010-11#1)(2011-3#1)
and small sample sizes##2##4##(2008-10#2)
and small vessel vasculitis##3##4##(1997-8#2)(2008-10#1)
and small##95##2##(1990-12#1)(1990-6#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#3)(1992-4#1)(1993-2#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#1)(2013-8#2)
and small-angle##2##2##(2008-10#1)(2008-3#1)
and small-scale##2##2##(2009-8#1)(2011-2#1)
and smaller primates##2##3##(2008-4#1)(2012-3#1)
and smaller##25##2##(1995-1#1)(1995-3#1)(1996-5#2)(1997-1#1)(2007-12#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and smallest##2##2##(1996-5#1)(2008-11#1)
and smoke##3##2##(1996-12#2)(2008-11#1)
and smoked##2##2##(1993-11#1)(1996-6#1)
and smoking behavior##2##3##(2008-8#2)
and smoking status of##2##4##(2008-12#1)(2009-5#1)
and smoking status##4##3##(2008-12#1)(2009-5#1)(2011-2#2)
and smoking##23##2##(1990-12#1)(1991-11#1)(1992-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
and smooth muscle actin##3##4##(2008-11#1)(2011-1#1)(2013-8#1)
and smooth muscle cells##3##4##(1990-2#1)(1995-12#1)(1997-4#1)
and smooth muscle##12##3##(1990-2#1)(1992-6#2)(1993-8#1)(1994-6#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
and smooth septate junctions##3##4##(2008-7#3)
and smooth##26##2##(1990-2#1)(1990-7#1)(1992-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#2)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and smoothly##2##2##(2008-2#1)(2010-3#1)
and smoothness of##2##3##(2007-8#1)(2010-6#1)
and snacks##2##2##(2007-10#1)(2012-1#1)
and snakes##2##2##(2009-9#1)(2010-3#1)
and sniffing##2##2##(2008-10#1)(2012-1#1)
and snow##2##2##(2008-10#1)(2008-3#1)
and so are the##2##4##(1994-11#1)(1997-8#1)
and so are##3##3##(1994-11#1)(1997-8#1)(2013-8#1)
and so far##2##3##(1995-12#1)(2008-12#1)
and so forth##4##3##(1991-2#1)(1995-12#1)(2008-1#1)(2013-7#1)
and so improve##2##3##(2008-10#1)(2008-7#1)
and so is the##2##4##(2008-10#1)(2008-8#1)
and so is##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
and so it is##2##4##(2008-2#1)(2010-6#1)
and so it##4##3##(2007-12#1)(2008-2#1)(2010-6#1)(2013-1#1)
and so on to##2##4##(2008-10#1)(2012-3#1)
and so on##13##3##(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-3#1)(2011-4#1)(2012-3#1)
and so on)##2##3##(2008-10#1)(2008-6#1)
and so the##5##3##(2008-2#1)(2008-3#1)(2009-10#1)(2012-12#1)(2013-1#1)
and so to##3##3##(1990-12#1)(1992-5#1)(2008-10#1)
and so##71##2##(1990-10#1)(1990-12#1)(1991-2#1)(1992-5#1)(1992-6#2)(1993-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#2)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2011-4#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and so-called##3##2##(1990-2#1)(1995-12#1)(2009-2#1)
and social and academic##3##4##(2008-12#3)
and social and##5##3##(1996-12#1)(2008-11#1)(2008-12#3)
and social anxiety disorder##2##4##(2013-1#1)(2013-8#1)
and social aspects of##2##4##(1993-11#1)(2007-10#1)
and social aspects##3##3##(1990-12#1)(1993-11#1)(2007-10#1)
and social behavior##3##3##(2008-10#1)(2008-8#1)(2009-9#1)
and social care##16##3##(1992-11#1)(1992-2#1)(1992-5#1)(1995-11#1)(2008-11#8)(2008-12#3)(2013-8#1)
and social class in##2##4##(1992-8#1)(1996-9#1)
and social class##4##3##(1992-8#2)(1996-9#1)(2010-8#1)
and social consequences##2##3##(1991-12#1)(2012-2#1)
and social context##2##3##(2010-8#2)
and social costs##2##3##(1991-6#1)(2008-11#1)
and social development##2##3##(2011-2#1)(2012-12#1)
and social difficulties##2##3##(1996-3#1)(1997-8#1)
and social environments##2##3##(2008-9#1)(2012-12#1)
and social factors in##3##4##(1991-6#1)(2008-2#1)(2008-7#1)
and social factors##7##3##(1991-6#1)(1995-9#1)(2008-2#1)(2008-7#2)(2008-8#1)(2012-12#1)
and social features##2##3##(2008-6#1)(2011-2#1)
and social function##2##3##(2009-5#1)(2013-1#1)
and social functioning##6##3##(2007-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and social history##2##3##(1997-3#1)(2008-10#1)
and social impact##2##3##(2008-11#1)(2009-5#1)
and social impacts##2##3##(2008-1#1)(2008-10#1)
and social interaction##4##3##(1996-2#1)(2007-12#1)(2012-2#1)(2012-3#1)
and social interactions##2##3##(1996-2#1)(2008-6#1)
and social learning##2##3##(2008-10#1)(2008-4#1)
and social life##2##3##(2010-11#1)(2011-2#1)
and social marketing##2##3##(1997-3#1)(2012-3#1)
and social networks##2##3##(2008-11#1)(2009-12#1)
and social phobia##3##3##(2008-4#2)(2012-2#1)
and social policies##2##3##(1992-1#1)(1994-5#1)
and social policy##2##3##(2008-10#1)(2011-1#1)
and social problem##2##3##(2007-11#2)
and social relationship)##2##3##(1994-12#2)
and social responsibility##3##3##(1995-12#1)(2012-3#1)(2013-1#1)
and social sciences##2##3##(2008-2#1)(2010-11#1)
and social services##15##3##(1991-12#1)(1992-11#1)(1992-12#1)(1994-1#2)(1994-12#1)(1995-3#1)(1996-1#1)(1996-3#3)(2008-1#1)(2008-11#2)(2008-2#1)
and social skills##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
and social status##5##3##(1994-6#1)(1997-2#1)(2008-12#1)(2010-8#1)(2011-2#1)
and social support in##2##4##(2009-7#1)(2009-8#1)
and social support##15##3##(1992-12#1)(1992-3#1)(1996-2#3)(1996-3#2)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and social values##2##3##(2008-1#1)(2008-12#1)
and social variables##2##3##(2008-7#1)(2012-2#1)
and social well-being##3##3##(1994-9#1)(2010-7#1)(2012-3#1)
and social work##7##3##(1992-12#1)(2010-10#1)(2010-3#1)(2012-12#3)(2013-1#1)
and social##229##2##(1990-12#1)(1991-12#2)(1991-6#4)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-2#2)(1994-1#2)(1994-12#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#8)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#4)(2008-10#7)(2008-11#17)(2008-12#14)(2008-2#4)(2008-4#5)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#3)(2009-10#4)(2009-12#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#9)(2013-1#12)(2013-8#5)
and socialization##2##2##(2007-4#1)(2009-7#1)
and socially##4##2##(1995-5#1)(2008-11#2)(2011-2#1)
and societal costs##2##3##(2008-12#1)(2011-1#1)
and societal##9##2##(2007-12#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
and societies##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
and society as a whole##2##5##(1995-5#1)(2007-12#1)
and society##14##2##(1991-6#1)(1993-12#1)(1994-5#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and socio-demographic variables##2##3##(2009-7#1)(2011-1#1)
and socio-economic factors##2##3##(2008-12#1)(2012-12#1)
and socio-economic##7##2##(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#2)(2013-1#1)
and sociocultural##2##2##(1997-7#1)(2007-12#1)
and sociodemographic##2##2##(2012-2#1)(2013-1#1)
and socioeconomic status##9##3##(2010-5#2)(2011-1#3)(2012-12#1)(2013-1#1)(2013-8#2)
and socioeconomic##20##2##(1993-9#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-5#2)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#3)
and sociological##4##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-11#1)
and sociology##2##2##(2008-2#1)(2009-10#1)
and sodium alginate##3##3##(2010-5#2)(2011-1#1)
and sodium azide##2##3##(1990-11#1)(1995-11#1)
and sodium chloride concentration##3##4##(2008-10#2)(2011-2#1)
and sodium chloride##8##3##(2008-10#5)(2008-12#1)(2008-2#1)(2011-2#1)
and sodium citrate in##2##4##(2010-3#1)(2011-2#1)
and sodium citrate##7##3##(2008-10#1)(2010-3#5)(2011-2#1)
and sodium dodecyl sulfate (SDS)##3##5##(2008-10#2)(2008-4#1)
and sodium dodecyl sulfate##6##4##(1991-12#1)(2008-10#4)(2008-4#1)
and sodium dodecyl##11##3##(1991-12#1)(1992-8#1)(2008-10#8)(2008-4#1)
and sodium fluoride (NaF)##2##4##(2008-10#2)
and sodium hydroxide##2##3##(2008-10#2)
and sodium hypochlorite##2##3##(2008-10#2)
and sodium iodide##2##3##(2008-10#2)
and sodium ions##3##3##(2008-10#3)
and sodium nitrate##2##3##(2008-10#2)
and sodium nitroprusside (SNP)##2##4##(2008-10#1)(2008-11#1)
and sodium nitroprusside in##2##4##(1995-8#1)(2008-10#1)
and sodium nitroprusside##7##3##(1990-12#1)(1995-8#3)(2008-10#2)(2008-11#1)
and sodium retention##2##3##(2006-10#1)(2008-7#1)
and sodium sulfite##3##3##(2008-10#3)
and sodium tetraphenylborate (NaTPB) as an##2##6##(2008-10#2)
and sodium tetraphenylborate (NaTPB) as##3##5##(2008-10#3)
and sodium tetraphenylborate##5##3##(2008-10#5)
and sodium valproate##4##3##(1995-12#3)(2008-6#1)
and sodium##103##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-8#1)(1993-12#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-8#4)(1997-4#1)(2006-10#1)(2008-10#55)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#6)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-8#1)
and soft drinks##5##3##(2008-10#5)
and soft independent modelling of class analogy##2##7##(2008-10#2)
and soft independent##3##3##(2008-10#3)
and soft rot##2##3##(2008-10#2)
and soft tissue infections##4##4##(2007-12#1)(2008-10#1)(2009-4#2)
and soft tissue##27##3##(1991-2#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#3)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#1)
and soft tissues of the##2##5##(2007-7#1)(2010-6#1)
and soft tissues##9##3##(2007-11#1)(2007-12#3)(2007-7#1)(2008-6#1)(2010-6#2)(2012-2#1)
and soft##54##2##(1991-2#2)(1993-11#1)(2007-11#1)(2007-12#7)(2007-7#1)(2008-10#15)(2008-2#1)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#3)(2010-5#1)(2010-6#2)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#1)
and soft-tissue reconstruction##2##3##(2010-12#1)(2010-3#1)
and soft-tissue tumours##2##3##(2008-6#2)
and soft-tissue##9##2##(1992-6#1)(2007-8#1)(2008-2#1)(2008-6#3)(2010-12#1)(2010-3#1)(2011-2#1)
and soft-x-ray##4##2##(2008-2#2)(2008-3#2)
and software for##2##3##(1997-4#1)(2008-4#1)
and software tools for##2##4##(2010-11#1)(2011-3#1)
and software tools##3##3##(2008-4#1)(2010-11#1)(2011-3#1)
and software##23##2##(1993-2#1)(1993-5#1)(1994-2#1)(1996-12#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
and soil characteristics##2##3##(2012-2#1)(2013-8#1)
and soil microbial##2##3##(2008-10#2)
and soil moisture content##3##4##(2008-10#1)(2008-12#1)(2013-7#1)
and soil moisture##7##3##(1995-3#1)(2008-10#3)(2008-12#1)(2011-1#1)(2013-7#1)
and soil samples##9##3##(2008-10#8)(2011-1#1)
and soil treatments##3##3##(2008-10#3)
and soil type##2##3##(2012-9#2)
and soil using##2##3##(2008-10#1)(2011-1#1)
and soil were##3##3##(2008-10#1)(2011-1#2)
and soil##86##2##(1991-7#1)(1995-3#1)(2008-10#49)(2008-11#1)(2008-12#2)(2008-5#2)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#8)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2012-9#2)(2013-1#1)(2013-7#6)(2013-8#2)
and soils##5##2##(2008-10#4)(2008-5#1)
and solar angle##2##3##(2008-2#1)(2008-3#1)
and solar radiation##2##3##(2008-10#2)
and solar zenith angles##2##4##(2008-2#1)(2008-3#1)
and solar##19##2##(2008-10#2)(2008-2#6)(2008-3#10)(2008-7#1)
and sole##2##2##(2009-10#1)(2011-2#1)
and soles##3##2##(1997-3#1)(2010-6#1)(2012-3#1)
and soleus##2##2##(1995-12#2)
and solid phase extraction##6##4##(2008-10#6)
and solid phase microextraction##2##4##(2008-10#2)
and solid phase##12##3##(1996-12#1)(2008-10#10)(2008-7#1)
and solid samples##2##3##(2008-10#2)
and solid tumors##2##3##(2008-7#2)
and solid##37##2##(1990-10#1)(1994-6#2)(1996-12#1)(2008-10#20)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#4)(2010-5#1)(2012-1#1)(2013-1#2)
and solid-liquid##2##2##(2008-10#1)(2012-1#1)
and solid-phase extraction##3##3##(1992-11#1)(2008-10#2)
and solid-phase microextraction##2##3##(2008-10#2)
and solid-phase##8##2##(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#5)
and solid-state##4##2##(1996-2#1)(2008-10#2)(2008-2#1)
and solidarity##2##2##(2008-12#1)(2011-2#1)
and solubility of##3##3##(2008-10#3)
and solubility##8##2##(2008-10#6)(2013-1#2)
and solubilization##2##2##(2008-10#1)(2008-4#1)
and soluble fractions##3##3##(1990-11#2)(1997-2#1)
and soluble##24##2##(1990-11#2)(1990-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-7#1)(2013-8#2)
and solute distribution##2##3##(2011-2#2)
and solute##7##2##(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#4)
and solution##15##2##(1992-8#2)(2008-10#7)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)
and solutions in##3##3##(1992-2#1)(2008-7#1)(2010-8#1)
and solutions##18##2##(1991-12#1)(1992-2#2)(1994-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-8#1)(2013-8#1)
and solvation##2##2##(2008-4#1)(2010-2#1)
and solve##2##2##(2006-10#1)(2009-5#1)
and solvent extraction of##2##4##(2008-10#2)
and solvent extraction##6##3##(2008-10#6)
and solvent kinetic isotope##2##4##(1991-9#1)(1992-3#1)
and solvent volume##2##3##(2008-10#2)
and solvent##30##2##(1991-9#1)(1992-3#1)(1994-9#1)(2008-10#22)(2008-11#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
and solvent-based##2##2##(2008-10#1)(2008-9#1)
and solvents##4##2##(2008-10#3)(2008-5#1)
and solves the##2##3##(1992-5#1)(2007-11#1)
and solves##3##2##(1992-5#1)(2007-11#1)(2008-2#1)
and solving##4##2##(1994-2#1)(1995-3#1)(1996-2#1)(2008-2#1)
and somatic complaints##3##3##(1996-2#1)(2008-10#1)(2008-2#1)
and somatic##14##2##(1995-5#1)(1996-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
and somatosensory information##2##3##(1991-2#1)(2008-11#1)
and somatosensory##5##2##(1991-2#1)(1993-12#2)(2008-11#1)(2008-5#1)
and some additional programs##2##4##(2008-4#2)
and some additional##3##3##(2008-10#1)(2008-4#2)
and some applications##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
and some are##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
and some aspects of authorship##3##5##(2008-10#3)
and some aspects of cognitive impairment##2##6##(2008-6#2)
and some aspects of##5##4##(2008-10#3)(2008-6#2)
and some cancers##3##3##(2008-10#1)(2010-1#1)(2012-2#1)
and some common##2##3##(2008-10#1)(2013-1#1)
and some experimental results are##2##5##(2008-2#1)(2008-3#1)
and some experimental##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
and some factors##2##3##(2008-10#1)(2008-4#1)
and some genes##2##3##(2009-10#1)(2011-2#1)
and some have been##2##4##(2010-12#1)(2011-3#1)
and some have##4##3##(1991-9#1)(2010-12#1)(2011-3#2)
and some heavy##2##3##(2008-10#2)
and some in##2##3##(2008-10#1)(2010-3#1)
and some isolates from##2##4##(2008-10#2)
and some members##2##3##(1994-9#1)(2009-10#1)
and some of its##7##4##(1993-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
and some of the##15##4##(1991-12#2)(1992-12#1)(1992-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2012-2#2)(2013-1#1)
and some of them were##2##5##(2007-11#1)(2012-1#1)
and some of them##5##4##(1996-2#1)(2007-11#1)(2011-1#1)(2012-1#1)(2012-2#1)
and some of these##3##4##(2008-10#1)(2008-5#1)(2009-12#1)
and some of##34##3##(1991-12#2)(1992-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2009-12#1)(2011-1#2)(2012-1#1)(2012-2#3)(2013-1#1)
and some organic##2##3##(2008-10#2)
and some other##4##3##(1994-2#1)(2008-10#1)(2008-6#1)(2009-5#1)
and some others##2##3##(2008-10#1)(2011-2#1)
and some patients##2##3##(2010-3#1)(2012-3#1)
and some properties of##2##4##(1997-6#1)(2007-11#1)
and some protonated##2##3##(2008-10#2)
and some related##2##3##(1993-6#1)(2010-7#1)
and some studies##2##3##(2008-1#1)(2011-2#1)
and some transition##2##3##(2008-10#2)
and some types of##2##4##(2008-9#1)(2011-3#1)
and some viruses##2##3##(2008-10#1)(2010-1#1)
and some##261##2##(1990-6#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#5)(1995-1#2)(1995-12#4)(1995-3#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(2007-11#6)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#73)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#4)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#4)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)
and sometimes controversial##2##3##(1993-12#1)(2008-8#1)
and sometimes even##2##3##(1994-1#1)(2008-2#1)
and sometimes two##2##3##(1992-9#1)(2008-7#1)
and sometimes with##2##3##(2008-8#1)(2012-2#1)
and sometimes##42##2##(1992-1#1)(1992-9#1)(1993-12#2)(1994-1#2)(1994-12#1)(1994-6#1)(1996-11#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
and somewhat##7##2##(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2012-3#1)
and son##2##2##(2008-12#1)(2008-7#1)
and song##3##2##(2008-9#2)(2011-1#1)
and sonicated##2##2##(1994-5#1)(2008-10#1)
and sonication##3##2##(2008-10#3)
and sophisticated##8##2##(1994-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
and sorbed onto##2##3##(2008-10#2)
and sorbic acid##5##3##(1996-5#1)(2008-10#4)
and sorbitol dehydrogenase##4##3##(1996-2#3)(2008-11#1)
and sorbitol##7##2##(1996-2#3)(2008-11#1)(2008-6#3)
and sorghum##2##2##(2008-10#1)(2009-10#1)
and sorption capacity##2##3##(2008-10#2)
and sorption on a C-18 bonded silica##2##7##(2008-10#2)
and sorption on##3##3##(2008-10#3)
and sorption##7##2##(2008-10#7)
and sorted##2##2##(2008-10#1)(2008-6#1)
and sorting of##3##3##(2008-9#2)(2013-8#1)
and sorting##9##2##(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2010-6#1)(2013-8#1)
and sought##2##2##(2012-2#1)(2013-1#1)
and sound intensity##2##3##(2008-9#2)
and sound##10##2##(1995-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#3)(2013-7#1)
and source of##4##3##(1993-2#1)(2008-4#1)(2011-2#2)
and source##10##2##(1993-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-2#2)
and sources of##8##3##(1991-11#1)(1993-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)
and sources##10##2##(1991-11#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)
and south of the##2##4##(2008-10#1)(2012-2#1)
and south of##3##3##(2008-10#2)(2012-2#1)
and south##4##2##(2008-10#2)(2012-1#1)(2012-2#1)
and southeast##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
and southeastern##2##2##(2008-4#1)(2011-2#1)
and southern parts##2##3##(1997-6#1)(2007-1#1)
and southern##14##2##(1997-6#1)(2007-1#1)(2008-10#9)(2008-9#1)(2011-2#2)
and soy protein##2##3##(2008-7#1)(2010-4#1)
and soy##5##2##(1996-8#1)(2008-7#2)(2010-4#1)(2013-1#1)
and soya##2##2##(2008-10#1)(2008-5#1)
and soybean plants##2##3##(2008-10#2)
and soybean roots##2##3##(2008-10#2)
and soybean##20##2##(1995-11#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
and space to##2##3##(2008-1#1)(2008-10#1)
and space##14##2##(1996-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2013-1#1)
and space-resolved##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
and space-time##2##2##(2007-12#1)(2008-3#1)
and space-variant operations##2##3##(2008-3#2)
and space-variant##4##2##(2008-3#4)
and spaceborne##2##2##(2008-3#2)
and spaces##2##2##(2008-5#1)(2011-2#1)
and spacings of##2##3##(1997-7#1)(2010-11#1)
and spanned##2##2##(1995-5#1)(2008-10#1)
and spans a##2##3##(1993-3#1)(1997-8#1)
and sparing of##2##3##(1992-11#1)(2007-4#1)
and sparing##5##2##(1992-11#1)(2007-4#1)(2008-10#1)(2012-2#2)
and spastic##3##2##(1996-2#1)(2007-11#1)(2009-11#1)
and spatial arrangement of the##3##5##(2008-3#2)(2013-7#1)
and spatial arrangement##4##3##(2007-12#1)(2008-3#2)(2013-7#1)
and spatial correlation##2##3##(2008-10#1)(2008-2#1)
and spatial distribution of##6##4##(2008-10#1)(2008-8#1)(2009-10#2)(2010-8#1)(2013-7#1)
and spatial distribution patterns of##2##5##(2008-10#1)(2011-2#1)
and spatial distribution##9##3##(2008-10#3)(2008-8#1)(2009-10#2)(2010-8#1)(2011-2#1)(2013-7#1)
and spatial dynamics##4##3##(2008-10#3)(2008-8#1)
and spatial expression of##2##4##(1995-3#1)(2012-2#1)
and spatial expression##3##3##(1995-3#1)(1996-12#1)(2012-2#1)
and spatial filtering##2##3##(2008-2#2)
and spatial information##3##3##(2008-3#2)(2008-9#1)
and spatial memory##3##3##(1993-12#1)(1997-2#1)(2008-7#1)
and spatial patterns##5##3##(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
and spatial relationships##2##3##(1996-5#1)(2008-9#1)
and spatial resolution of##2##4##(2008-3#1)(2008-9#1)
and spatial resolution##17##3##(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-9#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
and spatial scale##2##3##(2008-8#2)
and spatial spread of##3##4##(2008-10#3)
and spatial variation in##2##4##(2010-8#1)(2013-7#1)
and spatial##114##2##(1992-10#2)(1993-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-11#4)(2007-12#7)(2007-5#1)(2007-8#1)(2008-10#21)(2008-11#3)(2008-2#11)(2008-3#14)(2008-4#2)(2008-7#1)(2008-8#11)(2008-9#4)(2009-10#4)(2009-11#2)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-7#4)(2013-8#1)
and spatially by##3##3##(1994-9#1)(2008-2#1)(2013-7#1)
and spatially resolved##3##3##(2007-12#1)(2008-3#2)
and spatially##19##2##(1994-3#1)(1994-9#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#5)(2008-9#1)(2010-4#1)(2012-3#1)(2013-7#1)
and spatio-temporal##2##2##(2011-2#1)(2013-8#1)
and spatiotemporal variables##2##3##(2013-1#2)
and spatiotemporal##6##2##(2008-8#1)(2009-9#2)(2012-2#1)(2013-1#2)
and spawning##3##2##(2008-12#1)(2008-8#1)(2010-8#1)
and speakers who stammer##2##4##(2008-2#2)
and speakers who##3##3##(2008-2#3)
and speakers##6##2##(2008-11#1)(2008-2#3)(2010-5#1)(2012-2#1)
and speaking##4##2##(2008-7#1)(2012-12#1)(2013-1#2)
and special##11##2##(1995-12#1)(1995-2#1)(1996-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
and specialist##6##2##(1992-9#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)
and specialists##4##2##(1996-2#1)(1997-1#1)(2008-5#1)(2012-12#1)
and specialization##3##2##(1995-12#1)(2008-12#1)(2012-3#1)
and specialized equipment##2##3##(2008-4#2)
and specialized##13##2##(1994-5#1)(1995-5#1)(1997-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-5#1)
and specially##3##2##(1991-9#1)(2008-11#1)(2011-2#1)
and specialties##2##2##(1991-6#1)(1993-12#1)
and specialty##5##2##(1995-3#1)(1996-2#1)(1997-1#1)(2008-6#1)(2010-7#1)
and speciation analysis in##2##4##(2008-10#2)
and speciation analysis##3##3##(2008-10#3)
and speciation of arsenic by flow##2##6##(2008-10#2)
and speciation of arsenic by##3##5##(2008-10#3)
and speciation of arsenic in##2##5##(2008-10#2)
and speciation of arsenic##5##4##(2008-10#5)
and speciation of chromium in##3##5##(2008-10#3)
and speciation of chromium##5##4##(2008-10#5)
and speciation of inorganic arsenic##2##5##(2008-10#2)
and speciation of inorganic##4##4##(2008-10#4)
and speciation of##21##3##(2008-10#21)
and speciation##30##2##(1996-6#3)(2008-10#25)(2008-8#2)
and species abundance distributions##2##4##(2008-8#2)
and species composition##3##3##(2008-3#1)(2008-9#1)(2013-7#1)
and species concentrations in##2##4##(2008-10#1)(2008-3#1)
and species differences in##2##4##(2007-12#1)(2008-9#1)
and species diversification##2##3##(2008-8#1)(2010-3#1)
and species diversity##3##3##(2008-5#1)(2013-7#1)(2013-8#1)
and species of##2##3##(2008-10#1)(2011-2#1)
and species richness##4##3##(2008-5#1)(2008-9#1)(2013-7#2)
and species##48##2##(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#6)(2008-9#4)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)(2012-5#1)(2012-6#1)(2013-7#8)(2013-8#1)
and species'##2##2##(2008-8#2)
and species-specific differences##2##3##(1991-1#1)(2011-10#1)
and species-specific##6##2##(1991-1#1)(2008-10#1)(2011-10#1)(2012-2#2)(2013-8#1)
and specific assay##2##3##(1990-2#1)(1996-5#1)
and specific detection of##4##4##(2008-10#3)(2010-5#1)
and specific diagnostic##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
and specific flow##2##3##(2008-10#1)(2008-9#1)
and specific for##3##3##(2008-10#1)(2012-2#2)
and specific inhibitors of##2##4##(2008-5#1)(2008-9#1)
and specific leaf area##2##4##(2008-8#1)(2012-5#1)
and specific method for##5##4##(2008-10#4)(2011-3#1)
and specific productivity##2##3##(2008-11#2)
and specific##129##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#3)(2013-8#1)
and specifically for##3##3##(2008-4#1)(2010-5#1)(2010-6#1)
and specifically into##2##3##(1993-12#1)(2008-5#1)
and specifically##24##2##(1992-11#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-12#1)(2007-2#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-6#1)(2013-1#1)
and specification##2##2##(2007-12#1)(2008-7#1)
and specificities##5##2##(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-9#1)
and specificity 0##2##3##(2011-2#2)
and specificity as well as##2##5##(2008-4#1)(2010-4#1)
and specificity for##6##3##(2008-10#1)(2008-3#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
and specificity in##3##3##(1996-8#1)(2008-11#1)(2008-7#1)
and specificity of a##2##4##(1991-9#1)(2012-3#1)
and specificity of the##17##4##(1990-11#1)(1990-7#1)(1993-6#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)
and specificity of##49##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
and specificity were##3##3##(1990-6#1)(2008-5#1)(2013-1#1)
and specificity##116##2##(1990-11#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#3)(2009-1#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#15)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#1)
and specifies the##2##3##(2009-10#1)(2011-2#1)
and specifies##3##2##(2007-11#1)(2009-10#1)(2011-2#1)
and specifity##2##2##(2007-2#1)(2011-2#1)
and specimen##2##2##(2008-3#1)(2010-9#1)
and speckle noise##2##3##(2008-3#2)
and speckle##5##2##(2008-2#1)(2008-3#4)
and spectra##2##2##(1990-7#1)(2008-10#1)
and spectral characteristics##3##3##(2007-11#1)(2008-12#1)(2013-8#1)
and spectral data##6##3##(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2012-2#1)
and spectral domain optical coherence tomography##2##6##(2011-1#2)
and spectral features of##2##4##(2007-11#1)(2008-2#1)
and spectral properties of##4##4##(1996-2#1)(2008-10#1)(2008-3#2)
and spectral properties##5##3##(1996-2#1)(2008-10#1)(2008-3#2)(2009-8#1)
and spectral purity##2##3##(2008-11#1)(2008-3#1)
and spectral resolution##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
and spectral##59##2##(1994-11#1)(1996-2#1)(2007-11#7)(2007-12#7)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#10)(2008-5#2)(2009-8#1)(2010-11#1)(2011-1#2)(2012-2#1)(2012-8#1)(2013-8#3)
and spectrally narrowed##2##3##(2007-11#1)(2007-12#1)
and spectrally resolved##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
and spectrally##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2011-1#1)
and spectrofluorimetric determination of##4##4##(2008-10#4)
and spectrofluorimetric##6##2##(2008-10#6)
and spectrometer##2##2##(2007-11#1)(2008-2#1)
and spectrometric##2##2##(2008-3#1)(2008-5#1)
and spectrophotometric detection##11##3##(2008-10#11)
and spectrophotometric determination of EDTA##2##5##(2008-10#2)
and spectrophotometric determination of trace##2##5##(2008-10#2)
and spectrophotometric determination of##12##4##(2008-10#12)
and spectrophotometric determination##13##3##(2008-10#13)
and spectrophotometric measurements##3##3##(2008-10#2)(2008-2#1)
and spectrophotometric study##2##3##(2008-10#2)
and spectrophotometric##39##2##(1993-8#1)(2008-10#35)(2008-2#1)(2008-3#1)(2011-2#1)
and spectrophotometrically##2##2##(2008-10#2)
and spectrophotometry##6##2##(2008-10#6)
and spectroscopic study of##2##4##(2008-10#2)
and spectroscopic##13##2##(1994-11#1)(1994-12#1)(1995-5#1)(2008-10#7)(2008-3#1)(2008-4#1)(2012-2#1)
and spectroscopy##9##2##(1992-3#1)(1992-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-5#1)(2012-12#3)
and spectrum##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2013-8#1)
and speculate on##2##3##(2008-11#2)
and speculates on##2##3##(1993-3#1)(2008-9#1)
and speech perception##5##3##(2008-9#2)(2009-9#1)(2012-2#2)
and speech recognition##2##3##(2007-7#1)(2008-9#1)
and speech##19##2##(1993-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-9#5)(2009-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)
and speed of##6##3##(2007-12#1)(2008-10#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#1)
and speed##14##2##(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-12#1)(2010-3#1)(2010-8#2)(2011-1#1)
and spelling development##2##3##(2011-1#2)
and spelling##4##2##(2008-11#1)(2011-1#2)(2012-3#1)
and spend less##2##3##(1992-5#1)(2008-2#1)
and spent##6##2##(1997-2#1)(2008-10#2)(2010-4#2)(2010-8#1)
and sperm cells##2##3##(2007-12#1)(2008-12#1)
and sperm head##2##3##(2008-10#1)(2011-2#1)
and sperm##17##2##(1991-5#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#2)(2009-2#1)(2011-2#1)(2013-1#1)
and spermathecae##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
and spermatids##2##2##(2009-10#1)(2013-1#1)
and spermatocytes##3##2##(2008-5#2)(2009-7#1)
and spermatogenesis##9##2##(2009-10#4)(2009-7#1)(2010-5#1)(2012-1#1)(2012-2#2)
and spermatozoa##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
and spermidine##2##2##(1995-2#1)(2008-10#1)
and spermine##9##2##(1990-7#2)(1992-11#1)(2008-10#3)(2008-8#1)(2009-8#2)
and spermine)##4##2##(1991-5#1)(1994-9#1)(2008-10#1)(2009-8#1)
and spermiogenesis##4##2##(2007-12#1)(2008-9#1)(2011-1#1)(2012-2#1)
and spherical aberration##3##3##(2007-12#1)(2008-3#2)
and spherical##10##2##(2007-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2011-2#1)
and spheroids##2##2##(2008-2#1)(2008-3#1)
and sphingomyelin##2##2##(1995-8#1)(2008-5#1)
and spider##3##2##(2008-5#2)(2012-3#1)
and spike timing##3##3##(2008-11#2)(2009-8#1)
and spike##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2009-8#1)
and spiked samples##3##3##(2008-10#3)
and spiked water##2##3##(2008-10#2)
and spiked##15##2##(2008-10#15)
and spinal cord and##3##4##(1992-1#1)(1996-12#1)(1996-2#1)
and spinal cord injury##2##4##(1993-12#1)(2013-1#1)
and spinal cord of mice##2##5##(1997-2#2)
and spinal cord of##6##4##(1991-1#1)(1997-2#4)(1997-3#1)
and spinal cord were##3##4##(1991-5#1)(1993-12#1)(1995-3#1)
and spinal cord##39##3##(1991-1#1)(1991-5#2)(1992-1#2)(1992-12#2)(1993-11#1)(1993-12#2)(1993-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#5)(1997-3#3)(1997-8#1)(2008-4#1)(2008-5#2)(2008-7#5)(2009-8#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and spinal curvature##2##3##(2008-11#1)(2008-12#1)
and spinal##55##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#2)(1992-1#2)(1992-11#1)(1992-12#2)(1993-11#1)(1993-12#2)(1993-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#5)(1997-3#3)(1997-8#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
and spindle##3##2##(2008-11#1)(2010-5#1)(2013-1#1)
and spine##6##2##(2007-11#2)(2007-5#1)(2007-8#1)(2008-11#1)(2010-12#1)
and spines##2##2##(1996-2#1)(2012-3#1)
and spiral##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
and spirilloxanthin##2##2##(2010-2#2)
and spirit##4##2##(1996-3#1)(2008-12#1)(2009-10#1)(2012-2#1)
and spirits##2##2##(2008-10#1)(2009-7#1)
and spiritual beliefs##2##3##(2009-7#1)(2011-1#1)
and spiritual##21##2##(1995-5#1)(2007-2#1)(2007-5#2)(2008-12#2)(2008-4#1)(2009-7#1)(2010-11#2)(2010-2#3)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#4)
and spirituality##4##2##(1994-1#1)(2010-10#1)(2010-8#1)(2013-8#1)
and spirometry##3##2##(2007-8#1)(2008-1#1)(2013-8#1)
and spleen on##2##3##(1991-8#1)(1995-12#1)
and spleen were##3##3##(1993-3#1)(2008-5#1)(2010-7#1)
and spleen##27##2##(1990-12#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-11#1)(1993-3#1)(1994-11#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)
and spleens##2##2##(1995-2#1)(2008-10#1)
and splenectomy##2##2##(2011-2#1)(2013-1#1)
and splenic##8##2##(1992-11#1)(1993-9#2)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
and splenomegaly##2##2##(2008-5#1)(2011-2#1)
and splice##2##2##(2008-4#1)(2011-1#1)
and split##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
and splitting of##2##3##(2008-10#1)(2008-5#1)
and splitting##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
and spoOA##2##2##(1997-4#2)
and spoilage##2##2##(1997-4#2)
and spondylolisthesis##2##2##(1996-6#1)(2008-11#1)
and spontaneous recurrence of##2##4##(1996-7#2)
and spontaneous##23##2##(1991-11#1)(1995-11#2)(1996-6#1)(1996-7#2)(1997-7#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-2#2)(2013-1#1)
and spontaneously##5##2##(1994-2#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)
and sporadic##7##2##(1993-12#1)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
and sporangia##3##2##(2008-10#3)
and spore dispersal gradient on the spatio-temporal dynamics of plant disease epidemics##2##12##(2008-10#2)
and spore dispersal gradient on##3##5##(2008-10#3)
and spore flux density##2##4##(2008-10#2)
and spore germination in##2##4##(2008-10#2)
and spore germination##3##3##(2008-10#3)
and spore production##3##3##(2008-10#3)
and spore##16##2##(2008-10#15)(2012-2#1)
and spores##2##2##(2008-8#2)
and sport orientation##2##3##(2009-7#2)
and sport##3##2##(2009-7#3)
and sports##11##2##(1996-6#1)(2008-5#5)(2008-9#1)(2010-1#1)(2010-7#1)(2013-1#2)
and sporulated##3##2##(2008-10#2)(2011-2#1)
and sporulation in##2##3##(2008-10#1)(2008-8#1)
and sporulation of the##2##4##(2008-10#1)(2008-6#1)
and sporulation of##3##3##(2008-10#2)(2008-6#1)
and sporulation per##2##3##(2008-10#2)
and sporulation##21##2##(1994-12#1)(2008-10#17)(2008-6#2)(2008-8#1)
and spot##3##2##(2008-10#2)(2008-9#1)
and spotted##2##2##(2008-10#1)(2008-7#1)
and spray##3##2##(2008-10#3)
and spread in##2##3##(1992-8#1)(2008-10#1)
and spread of the pathogen##2##5##(2008-10#2)
and spread of this##2##4##(2008-10#1)(2008-12#1)
and spread of##22##3##(1990-11#1)(1990-3#1)(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
and spread through##2##3##(1992-5#1)(2013-8#1)
and spread##36##2##(1990-11#1)(1990-3#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-9#2)(1994-6#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
and spreading##9##2##(1994-6#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-3#1)
and spreads##2##2##(2008-8#2)
and spring barley##3##3##(2008-10#3)
and spring##16##2##(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#2)(2012-3#1)(2013-7#1)
and sputtered##2##2##(2008-3#2)
and sputum##2##2##(2008-1#1)(2010-5#1)
and squalane##2##2##(1991-5#1)(2008-10#1)
and squamometry##3##2##(2008-5#3)
and squamous cell carcinoma##5##4##(2008-4#2)(2010-8#2)(2012-3#1)
and squamous cell carcinomas##5##4##(1991-11#1)(2008-4#1)(2010-8#1)(2012-3#2)
and squamous cell##11##3##(1991-11#1)(2008-4#3)(2010-8#3)(2012-3#4)
and squamous##12##2##(1991-11#1)(2008-1#1)(2008-4#3)(2010-8#3)(2012-3#4)
and square wave adsorptive stripping voltammetry##2##6##(2008-10#2)
and square wave voltammetric##4##4##(2008-10#4)
and square wave voltammetry (SWV)##3##5##(2008-10#3)
and square wave voltammetry using##3##5##(2008-10#3)
and square wave voltammetry were##2##5##(2008-10#2)
and square wave voltammetry##9##4##(2008-10#8)(2008-8#1)
and square wave##16##3##(2008-10#15)(2008-8#1)
and square-law##2##2##(2007-11#1)(2008-2#1)
and square-wave##4##2##(2008-10#4)
and squash##2##2##(2008-10#2)
and stabilisation of the##2##4##(1997-5#1)(2007-11#1)
and stabilisation of##3##3##(1997-5#1)(2007-11#1)(2012-2#1)
and stabilisation##7##2##(1997-5#1)(2007-11#3)(2007-8#1)(2011-2#1)(2012-2#1)
and stabilised##2##2##(2007-11#2)
and stability analysis##2##3##(2008-2#1)(2008-3#1)
and stability constant##2##3##(2008-10#2)
and stability constants of##2##4##(2008-10#2)
and stability constants##4##3##(2008-10#4)
and stability for the##2##4##(2008-10#2)
and stability for##3##3##(2008-10#3)
and stability in##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2010-11#1)
and stability indicating##2##3##(2008-10#2)
and stability of differentiated phenotype##3##5##(1995-11#3)
and stability of protein##2##4##(1991-6#1)(2008-11#1)
and stability of protonated spermidine and##2##6##(2008-10#2)
and stability of protonated##5##4##(2008-10#5)
and stability of the##15##4##(1990-5#1)(1992-6#1)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)
and stability of##48##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-11#3)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
and stability to##2##3##(1994-11#1)(2008-5#1)
and stability was##2##3##(2008-10#1)(2008-5#1)
and stability##108##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-5#1)(1995-11#3)(1995-3#1)(1996-2#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
and stabilization of the##5##4##(1991-12#1)(1992-5#1)(1994-5#1)(2008-3#1)(2008-9#1)
and stabilization of##9##3##(1991-12#1)(1992-5#1)(1994-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)
and stabilization##14##2##(1991-12#1)(1992-5#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)
and stabilize the##2##3##(1994-12#1)(1994-7#1)
and stabilize##6##2##(1993-11#1)(1994-12#1)(1994-7#1)(2008-5#1)(2009-7#1)(2012-3#1)
and stabilized by the##2##4##(1997-4#1)(2008-4#1)
and stabilized with##2##3##(2007-12#1)(2013-1#1)
and stabilized##7##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-4#1)(2013-1#2)
and stabilizers for polyvinyl chloride (PVC) pipe##2##7##(2008-10#2)
and stabilizers##5##2##(2008-10#3)(2010-8#1)(2011-2#1)
and stabilizes##4##2##(1992-6#1)(2009-2#1)(2009-6#1)(2011-2#1)
and stabilizing##6##2##(1995-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-3#1)
and stable fixation##2##3##(2007-11#1)(2010-3#1)
and stable flow rate##2##4##(2008-10#2)
and stable renal function##2##4##(2008-1#1)(2013-1#1)
and stable##54##2##(1991-5#1)(1992-12#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-8#1)(2009-12#1)(2010-3#1)(2011-3#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
and stably##4##2##(1994-8#2)(2008-10#1)(2008-2#1)
and stacked##2##2##(2008-10#1)(2008-7#1)
and staff in##2##3##(1993-1#1)(2013-1#1)
and staff needs##2##3##(1995-3#1)(2013-1#1)
and staff satisfaction##2##3##(1992-1#1)(1992-3#1)
and staff##40##2##(1992-1#1)(1992-3#1)(1993-1#2)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#2)(1996-7#1)(1997-5#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and staffing##5##2##(1996-1#1)(1996-2#1)(1996-3#2)(2012-3#1)
and stage IV##3##3##(1991-11#1)(2007-8#2)
and stage of the##2##4##(1995-2#1)(2008-8#1)
and stage specific##2##3##(1992-3#1)(2008-11#1)
and stage##23##2##(1991-11#1)(1992-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-8#4)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#2)
and staged##2##2##(2008-7#1)(2012-2#1)
and stages of##2##3##(2012-2#1)(2012-3#1)
and staggered gratings##2##3##(2007-11#2)
and staging of pancreatic##3##4##(2008-1#2)(2009-5#1)
and staging of##5##3##(2008-1#2)(2008-2#1)(2009-5#1)(2010-12#1)
and staging##8##2##(1990-6#1)(2006-10#1)(2008-1#2)(2008-2#1)(2009-5#1)(2010-12#2)
and stained with##2##3##(2008-7#1)(2011-2#1)
and stained##7##2##(1992-6#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-7#1)
and staining of##3##3##(2008-4#1)(2008-9#2)
and staining with##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
and staining##14##2##(2007-12#1)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#5)(2011-1#2)
and stainless steel##9##3##(2008-10#5)(2008-2#1)(2008-7#1)(2013-8#2)
and stand##3##2##(2008-10#3)
and standard addition method##2##4##(2008-10#2)
and standard addition##9##3##(1990-8#1)(2008-10#8)
and standard deviation of##6##4##(1994-11#1)(2008-10#3)(2008-3#2)
and standard deviation##9##3##(1994-11#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)
and standard deviations were calculated##2##5##(2011-2#2)
and standard deviations were##5##4##(2008-10#2)(2011-2#3)
and standard deviations##8##3##(2008-10#3)(2009-8#1)(2011-2#3)(2012-12#1)
and standard length (L(S))##2##4##(2010-8#2)
and standard reference materials##2##4##(2008-10#2)
and standard statistical analyses##2##4##(2008-7#1)(2011-1#1)
and standard therapy##2##3##(2009-4#2)
and standard##62##2##(1990-8#1)(1992-4#1)(1994-11#1)(1996-8#1)(2007-11#2)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and standardization of##2##3##(1993-3#1)(2008-10#1)
and standardization##4##2##(1993-3#1)(1996-12#1)(2008-10#1)(2008-9#1)
and standardize the##2##3##(1997-3#1)(2008-9#1)
and standardized##9##2##(1993-1#1)(1994-12#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
and standardizing##3##2##(1996-12#1)(1997-3#1)(2009-6#1)
and standards for##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
and standards in##2##3##(2008-7#1)(2010-5#1)
and standards of care##3##4##(1991-3#1)(2008-3#1)(2011-1#1)
and standards of##5##3##(1991-3#1)(1996-12#1)(2007-11#1)(2008-3#1)(2011-1#1)
and standards##15##2##(1991-3#3)(1992-3#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)
and standing are used to determine how##2##7##(2009-11#2)
and standing##3##2##(2008-7#1)(2009-11#2)
and starch##5##2##(2008-10#3)(2008-5#1)(2009-5#1)
and start##2##2##(1990-2#1)(2009-5#1)
and started##6##2##(2007-2#1)(2008-10#1)(2008-8#1)(2010-1#2)(2012-3#1)
and starting the##2##3##(2008-1#1)(2008-2#1)
and starting##5##2##(1992-3#1)(2008-1#1)(2008-10#2)(2008-2#1)
and state health care reform##2##5##(1996-1#2)
and state health care##3##4##(1991-12#1)(1996-1#2)
and state health##4##3##(1991-12#1)(1996-1#2)(1997-2#1)
and state of aggregation of##2##5##(1994-5#2)
and state of##8##3##(1994-5#2)(1995-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)
and state##48##2##(1990-11#1)(1991-12#1)(1991-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-1#2)(1995-2#1)(1995-5#1)(1996-1#6)(1996-3#1)(1997-2#3)(1997-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#2)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
and states##5##2##(1990-11#2)(1995-6#1)(2008-10#1)(2013-8#1)
and static headspace gas##2##4##(2008-10#2)
and static##15##2##(1992-3#1)(1992-6#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#2)
and statin therapy##2##3##(2008-3#2)
and statin##4##2##(2008-3#2)(2011-2#1)(2013-1#1)
and statins##2##2##(2008-7#1)(2012-3#1)
and stationary phase##2##3##(1995-8#1)(2008-10#1)
and stationary##5##2##(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
and statistical analysis of##2##4##(2008-10#2)
and statistical analysis was performed##2##5##(2011-2#1)(2013-1#1)
and statistical analysis##10##3##(1995-3#1)(1996-2#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and statistical methods##2##3##(1996-1#1)(2009-5#1)
and statistical parameters##2##3##(2008-10#1)(2008-12#1)
and statistical validation##2##3##(2008-7#2)
and statistical##35##2##(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-10#11)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and statistically evaluated##2##3##(2009-1#1)(2013-1#1)
and statistically significant##6##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-3#1)
and statistically##16##2##(1991-2#1)(1992-10#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-9#2)(2009-1#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
and statisticians##2##2##(2008-10#1)(2012-2#1)
and statistics of##2##3##(1990-9#1)(2008-3#1)
and statistics##4##2##(1990-9#1)(2008-3#2)(2008-7#1)
and status##4##2##(1992-12#1)(1994-11#1)(2009-8#1)(2010-10#1)
and staurosporine##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
and stay on##2##3##(1994-3#1)(1995-12#1)
and stay##4##2##(1993-2#1)(1994-3#1)(1995-12#1)(2013-1#1)
and steady state##2##3##(2008-10#2)
and steady##4##2##(1993-12#1)(2008-10#2)(2013-8#1)
and steady-state levels of##2##4##(1994-6#1)(2008-10#1)
and steady-state##9##2##(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-3#3)(2011-2#1)(2012-3#1)
and steam-pretreated##2##2##(2008-6#1)(2011-2#1)
and stearic acid##3##3##(2008-10#3)
and stearic acids##2##3##(1994-8#1)(2008-10#1)
and stearic##5##2##(1994-8#1)(2008-10#4)
and steel##4##2##(2008-10#3)(2008-4#1)
and steels##2##2##(2008-10#2)
and steepness##2##2##(2008-3#2)
and steering in a##2##4##(2007-11#2)
and steering##3##2##(2007-11#2)(2008-3#1)
and stem cell##3##3##(2009-9#1)(2012-5#2)
and stem diameter##2##3##(2013-7#2)
and stem rot of##2##4##(2008-10#2)
and stem rot##6##3##(2008-10#6)
and stem##26##2##(1992-3#1)(2008-10#17)(2008-12#1)(2009-3#1)(2009-9#1)(2012-5#2)(2013-1#1)(2013-7#2)
and stems of##4##3##(2008-10#2)(2008-11#1)(2010-10#1)
and stems were##3##3##(2008-10#3)
and stems##17##2##(2008-10#14)(2008-11#2)(2010-10#1)
and stenosis##6##2##(1991-8#1)(1992-9#1)(2007-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
and stent##7##2##(1994-11#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)
and stenting##7##2##(2007-7#1)(2008-1#2)(2008-12#1)(2011-2#2)(2012-3#1)
and step##3##2##(1996-3#1)(2007-11#1)(2008-10#1)
and step-by-step##4##2##(2008-4#3)(2008-9#1)
and steps##3##2##(2010-3#1)(2013-1#1)(2013-8#1)
and stepwise##5##2##(1995-6#2)(2008-10#3)
and stereochemistry##2##2##(1995-11#1)(1995-6#1)
and stereoselective##3##2##(1996-5#2)(2010-2#1)
and stereotypes##2##2##(1994-12#1)(2010-11#1)
and steric contributions to##2##4##(1990-8#1)(1994-5#1)
and steric hindrance##2##3##(1990-8#1)(2008-5#1)
and steric##7##2##(1990-8#2)(1994-5#1)(2008-10#2)(2008-5#1)(2012-12#1)
and sterile##2##2##(1996-3#1)(2013-7#1)
and sterilization in##2##3##(2010-7#1)(2012-12#1)
and sterilization of##2##3##(1992-12#1)(2009-5#1)
and sterilization##5##2##(1992-12#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-8#1)
and sternal##5##2##(1994-7#1)(2007-8#1)(2012-2#2)(2013-8#1)
and steroid hormones##2##3##(1994-6#1)(1994-9#1)
and steroid##7##2##(1994-6#1)(1994-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2010-10#1)(2012-2#1)
and steroids##10##2##(1990-8#1)(1994-5#1)(1997-1#2)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-4#1)
and sterol regulatory##2##3##(2008-10#1)(2012-2#1)
and sterol##4##2##(1994-8#1)(2008-10#1)(2009-7#1)(2012-2#1)
and sterols##6##2##(1994-11#2)(2008-10#2)(2009-7#2)
and stethoscope##2##2##(2010-2#1)(2012-3#1)
and stiffness of the##2##4##(2007-12#1)(2008-9#1)
and stiffness##9##2##(1992-5#1)(2006-10#2)(2007-12#1)(2008-9#3)(2011-2#1)(2013-1#1)
and stigma##3##2##(2012-1#1)(2012-2#1)(2012-3#1)
and stilbene##2##2##(2008-10#2)
and still##17##2##(1993-3#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-5#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#1)
and stimulate growth##2##3##(2008-11#1)(2008-3#1)
and stimulate##13##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#1)
and stimulated the##2##3##(1990-7#1)(2011-2#1)
and stimulated##13##2##(1990-7#2)(1991-7#1)(1993-3#1)(1994-11#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
and stimulates the##2##3##(1991-2#1)(2012-12#1)
and stimulates##12##2##(1990-2#1)(1991-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-12#1)(2007-11#2)(2008-11#1)(2008-4#1)(2012-12#1)
and stimulating##6##2##(1997-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#1)
and stimulation of##13##3##(1990-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-7#1)
and stimulation##15##2##(1990-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-7#1)
and stimulatory##4##2##(1992-3#1)(1993-5#1)(1997-7#1)(2008-7#1)
and stimulus##2##2##(1995-5#1)(2008-9#1)
and stirred##2##2##(2008-11#2)
and stirring time##3##3##(2008-10#3)
and stirring##7##2##(2008-10#6)(2008-11#1)
and stochastic##4##2##(1994-5#1)(2008-10#1)(2008-11#1)(2009-12#1)
and stoichiometry of##2##3##(2008-4#1)(2012-2#1)
and stoichiometry##4##2##(2008-10#1)(2008-4#2)(2012-2#1)
and stomach and##2##3##(2010-1#1)(2012-12#1)
and stomach cancer##3##3##(1990-12#1)(2012-12#1)(2012-3#1)
and stomach in##3##3##(2011-2#1)(2013-8#2)
and stomach##23##2##(1990-12#1)(1992-8#2)(1995-11#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-8#2)
and stomatal conductance##2##3##(2008-10#1)(2008-12#1)
and stomatal##3##2##(2008-10#2)(2008-12#1)
and stone##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
and stool samples##2##3##(2009-10#1)(2013-1#1)
and stool##3##2##(1991-12#1)(2009-10#1)(2013-1#1)
and stopped##2##2##(1996-8#1)(2008-10#1)
and stopped-flow##4##2##(2008-10#3)(2008-4#1)
and storage in##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
and storage of the##2##4##(2007-12#1)(2008-9#1)
and storage of##12##3##(1990-2#1)(2007-12#1)(2008-2#1)(2008-9#8)(2010-8#1)
and storage stability were carried out##2##6##(2008-10#2)
and storage stability##10##3##(2008-10#10)
and storage time##2##3##(1993-12#1)(2013-1#1)
and storage##52##2##(1990-2#1)(1993-12#1)(2007-12#4)(2008-10#17)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#14)(2010-12#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#2)
and store the##3##3##(2007-11#1)(2008-10#2)
and store##8##2##(1994-3#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-8#1)
and stored at 37 degrees C##2##6##(2010-3#2)
and stored at##5##3##(2008-10#1)(2010-3#3)(2010-7#1)
and stored for##2##3##(2008-10#1)(2008-9#1)
and stored in a##2##4##(2007-7#1)(2008-7#1)
and stored in the##2##4##(2008-10#1)(2013-1#1)
and stored in##7##3##(1993-12#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
and stored under##2##3##(1993-3#1)(2008-10#1)
and stored##22##2##(1993-12#1)(1993-3#1)(1997-1#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-3#3)(2010-7#1)(2010-8#1)(2013-1#1)
and straightforward##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2010-7#1)
and strain##29##2##(1991-8#1)(1992-11#1)(1993-9#1)(1994-3#1)(1996-4#1)(2007-11#4)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-4#2)(2009-7#1)(2010-6#3)(2013-1#3)
and strain-specific##2##2##(2008-12#1)(2011-2#1)
and strains from##2##3##(1997-3#1)(2008-10#1)
and strains##7##2##(1997-3#1)(2008-10#5)(2013-1#1)
and strategic planning##4##3##(1995-1#2)(1996-2#1)(2008-12#1)
and strategic##11##2##(1991-2#1)(1995-1#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2009-10#1)
and strategies for prevention##2##4##(2008-5#1)(2008-7#1)
and strategies for the##2##4##(2012-12#1)(2013-8#1)
and strategies for##14##3##(1991-9#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
and strategies in##2##3##(2009-12#1)(2010-11#1)
and strategies of##3##3##(2010-3#1)(2010-4#1)(2013-1#1)
and strategies to overcome##2##4##(2008-11#1)(2010-10#1)
and strategies to##4##3##(1995-2#1)(2008-11#1)(2010-10#1)(2013-1#1)
and strategies##35##2##(1991-9#1)(1992-3#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
and strategy##6##2##(1991-3#1)(1995-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)
and stratification of##2##3##(2011-2#2)
and stratification##4##2##(1995-2#1)(2008-2#1)(2011-2#2)
and stratified##6##2##(1994-9#1)(2007-12#2)(2008-3#1)(2009-5#1)(2011-2#1)
and stratify##2##2##(1995-12#1)(2008-11#1)
and stratospheric##4##2##(2008-11#1)(2008-3#3)
and stratum corneum##2##3##(2008-5#2)
and strawberry##6##2##(2008-10#6)
and stray##2##2##(1996-12#2)
and stream##3##2##(2008-10#2)(2009-8#1)
and streamwater##2##2##(2008-10#2)
and strength of the##2##4##(2007-8#1)(2008-10#1)
and strength of##4##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
and strength##17##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
and strengthen the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
and strengthen##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2012-3#1)
and strengthened##2##2##(2009-6#1)(2011-1#1)
and strengthening of the##2##4##(2012-1#2)
and strengthening the##2##3##(1991-3#1)(2009-5#1)
and strengthening##11##2##(1991-3#1)(1995-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#3)
and strengths##2##2##(2008-1#1)(2008-3#1)
and streptavidin##2##2##(1990-12#1)(2008-9#1)
and streptococcal##4##2##(1990-12#2)(2010-12#1)(2011-2#1)
and streptokinase##2##2##(1993-8#1)(1995-6#1)
and stress fibers##2##3##(2008-6#2)
and stress fractures##2##3##(1991-11#2)
and stress response##6##3##(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#2)
and stress responses##3##3##(2008-7#1)(2009-10#1)(2009-6#1)
and stress##46##2##(1991-11#2)(1992-12#1)(1993-12#1)(1994-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#4)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-7#3)(2013-8#2)
and stress)##2##2##(2008-9#1)(2011-2#1)
and stress-induced##5##2##(1990-7#2)(2008-11#2)(2008-4#1)
and stressed##2##2##(2008-11#1)(2012-2#1)
and stresses##2##2##(2008-3#1)(2012-2#1)
and stretch##3##2##(1993-12#1)(2008-1#2)
and stretched##2##2##(2008-9#1)(2012-2#1)
and striatal##2##2##(1994-2#1)(2013-1#1)
and striatum of##3##3##(1993-12#1)(1997-2#2)
and striatum##16##2##(1993-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#2)(1997-2#4)(1997-7#2)(2008-7#1)
and strictly##4##2##(1996-3#1)(2008-10#1)(2009-2#1)(2011-2#1)
and strictures##2##2##(2008-10#1)(2010-12#1)
and stride length##2##3##(1994-12#1)(2010-8#1)
and stride##3##2##(1994-12#1)(2010-8#1)(2013-1#1)
and stripe rust severity##2##4##(2008-10#2)
and stripe rust##8##3##(2008-10#8)
and stripe##9##2##(2008-10#9)
and stripping##9##2##(2008-10#9)
and strive to##2##3##(1994-1#1)(1995-1#1)
and stroke in##4##3##(1991-6#1)(2009-9#3)
and stroke is##2##3##(2008-9#2)
and stroke prevention##2##3##(1993-9#1)(2008-8#1)
and stroke##40##2##(1990-3#1)(1991-6#1)(1993-9#1)(2007-10#8)(2008-1#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-1#1)(2009-4#2)(2009-9#5)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and stroke-like episodes)##2##3##(1990-12#1)(2008-8#1)
and stroma##2##2##(1994-2#1)(2013-1#1)
and stromal cell##3##3##(2008-11#1)(2010-3#1)(2012-3#1)
and stromal cells##5##3##(2008-11#1)(2009-3#1)(2011-2#3)
and stromal##12##2##(2008-11#3)(2009-3#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
and strong##36##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-12#2)(1992-7#1)(1996-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)
and stronger##3##2##(2008-8#2)(2013-1#1)
and strongly correlated##2##3##(2008-4#1)(2008-8#1)
and strongly influenced##2##3##(1993-3#1)(2008-10#1)
and strongly inhibited##2##3##(1991-5#1)(2011-2#1)
and strongly##26##2##(1991-5#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2011-2#2)(2012-2#2)
and strontium##3##2##(2008-10#2)(2012-2#1)
and structural analysis##3##3##(1994-6#1)(2008-4#1)(2013-1#1)
and structural and##3##3##(1996-2#1)(2008-8#1)(2010-11#1)
and structural changes in##2##4##(2008-5#1)(2012-1#1)
and structural changes of##2##4##(2008-10#1)(2008-7#1)
and structural changes##7##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
and structural characteristics of##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
and structural characteristics##5##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#2)
and structural characterization of a##2##5##(1995-2#1)(2008-10#1)
and structural characterization of the##2##5##(1993-8#1)(2008-10#1)
and structural characterization of##5##4##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#2)
and structural characterization##6##3##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#3)
and structural equation modeling##2##4##(2008-12#1)(2010-6#1)
and structural factors##2##3##(1990-9#1)(2009-3#1)
and structural features##2##3##(1990-7#1)(1991-6#1)
and structural information##2##3##(2008-10#1)(2009-9#1)
and structural integrity##3##3##(2008-4#1)(2008-9#2)
and structural properties of##6##4##(2007-8#1)(2008-2#3)(2010-2#2)
and structural properties##8##3##(1990-2#1)(1991-6#1)(2007-8#1)(2008-2#3)(2010-2#2)
and structural relationship##2##3##(1992-3#1)(2008-7#1)
and structural stability##2##3##(2008-10#2)
and structural##95##2##(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-6#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
and structurally different##2##3##(2007-12#1)(2013-7#1)
and structurally related##2##3##(1994-8#1)(1995-3#1)
and structurally##11##2##(1994-8#1)(1995-3#2)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2010-10#1)(2011-1#1)(2013-7#1)
and structure elucidation of##2##4##(2007-11#1)(2008-9#1)
and structure of a##4##4##(1992-2#1)(2008-5#1)(2008-7#1)(2010-5#1)
and structure of the##12##4##(1993-2#1)(1995-1#1)(2008-10#3)(2008-11#2)(2008-7#3)(2009-12#1)(2012-1#1)
and structure of##41##3##(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1995-1#1)(1995-3#1)(1995-5#2)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
and structure##62##2##(1991-11#2)(1991-8#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and structure--activity relationship##3##3##(1995-3#3)
and structure-activity relationships of the##2##5##(1995-3#1)(2008-10#1)
and structure-activity relationships of##3##4##(1992-6#1)(1995-3#1)(2008-10#1)
and structure-activity relationships##4##3##(1992-6#1)(1995-3#1)(2008-10#1)(2008-7#1)
and structure-activity##5##2##(1992-6#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-7#1)
and structured emission and excitation features##2##6##(2012-2#2)
and structured interviews##2##3##(2008-8#1)(2008-9#1)
and structured##8##2##(1992-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-4#1)(2012-2#2)
and structures of##3##3##(1997-3#1)(2008-8#1)(2009-11#1)
and structures that##2##3##(2008-10#1)(2010-10#1)
and structures##17##2##(1991-2#1)(1993-9#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-10#2)(2010-12#1)(2010-8#1)
and student evaluation##2##3##(2008-11#2)
and student nurses##2##3##(2008-11#1)(2008-12#1)
and student support##2##3##(2008-11#2)
and student##12##2##(1995-1#1)(1996-1#1)(2007-5#1)(2008-11#5)(2008-12#2)(2010-12#1)(2012-3#1)
and students from##2##3##(2008-10#1)(2008-12#1)
and students in##2##3##(2008-11#2)
and students with##3##3##(2008-12#1)(2013-1#2)
and students##20##2##(1995-12#1)(1995-3#2)(1996-2#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-12#4)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#2)
and students'##2##2##(2008-12#2)
and studied as a##2##4##(2007-11#1)(2008-10#1)
and studied as##3##3##(1992-8#1)(2007-11#1)(2008-10#1)
and studied by##2##3##(2008-10#1)(2008-5#1)
and studied for##3##3##(2008-10#3)
and studied in##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2009-9#1)
and studied its##6##3##(1991-2#1)(1997-4#1)(2008-9#2)(2012-3#2)
and studied the##7##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
and studied##37##2##(1991-12#1)(1991-2#1)(1992-8#1)(1995-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#3)(2013-8#1)
and studies in##3##3##(2008-7#1)(2009-5#1)(2010-12#1)
and studies of##3##3##(1991-2#1)(2008-10#1)(2010-9#1)
and studies on the##2##4##(1992-3#1)(2008-4#1)
and studies on##5##3##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
and studies that##2##3##(2008-7#1)(2008-9#1)
and studies##18##2##(1991-2#1)(1992-3#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2013-8#2)
and study its##2##3##(1994-9#1)(2010-3#1)
and study of new##2##4##(1991-5#1)(2008-7#1)
and study of the##2##4##(2008-10#1)(2012-3#1)
and study of##9##3##(1991-5#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
and study on its##3##4##(2008-8#3)
and study the##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
and study weaknesses of these papers are tabulated##6##8##(2007-8#6)
and study weaknesses were tabulated##4##5##(2007-8#4)
and study weaknesses##10##3##(2007-8#10)
and study##44##2##(1991-5#1)(1992-2#1)(1994-9#1)(1996-3#1)(1996-9#1)(2007-7#2)(2007-8#10)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-3#5)
and studying the##3##3##(1997-8#1)(2008-2#1)(2008-4#1)
and studying##9##2##(1997-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)
and stunning in##2##3##(1996-9#1)(2011-1#1)
and stunting##2##2##(2008-10#2)
and style of##3##3##(1996-4#1)(2008-11#1)(2013-1#1)
and style##4##2##(1996-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
and styles of##2##3##(2008-10#2)
and stylet##2##2##(2007-12#2)
and styrene##4##2##(1996-5#1)(2008-12#1)(2008-3#1)(2009-9#1)
and sub##2##2##(2008-5#1)(2011-2#1)
and sub-cellular##2##2##(2008-4#1)(2009-12#1)
and sub-clinical##2##2##(1992-5#1)(2008-9#1)
and subacute##5##2##(1990-6#1)(1994-11#1)(2008-3#2)(2013-1#1)
and subadult##3##2##(1997-9#1)(2008-5#1)(2010-4#1)
and subarachnoid##3##2##(2008-7#1)(2008-9#1)(2009-4#1)
and subcellular distribution of##4##4##(1990-2#1)(1995-2#1)(1995-6#1)(2008-10#1)
and subcellular distribution##6##3##(1990-2#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-9#2)
and subcellular localization of##2##4##(1996-2#1)(2008-7#1)
and subcellular localization##5##3##(1996-2#1)(1996-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
and subcellular##16##2##(1990-11#1)(1990-2#1)(1991-2#1)(1994-10#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#3)(2012-12#1)
and subclasses##2##2##(1996-2#1)(2008-4#1)
and subclavian artery##2##3##(2008-7#2)
and subclavian vein##3##3##(2008-1#1)(2008-12#2)
and subclavian##9##2##(2007-7#1)(2008-1#1)(2008-12#3)(2008-7#2)(2011-2#2)
and subcortical white matter##2##4##(1993-12#1)(2007-10#1)
and subcortical##8##2##(1993-12#1)(2007-10#1)(2008-11#3)(2010-9#1)(2013-1#2)
and subcultured##2##2##(1996-5#1)(2010-3#1)
and subculturing##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
and subcutaneous emphysema##2##3##(2011-2#2)
and subcutaneous tissue##2##3##(2008-5#1)(2013-1#1)
and subcutaneous##19##2##(1991-6#1)(1992-9#1)(1993-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#3)
and subdivided into##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
and subdivided##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)
and subendocardial late enhancement##2##4##(2013-7#2)
and subgenotypes##2##2##(2009-3#1)(2013-8#1)
and subgroup II##3##3##(2008-10#3)
and subgroup##6##2##(1995-12#1)(2008-10#5)
and subgroups##5##2##(1993-2#1)(1997-1#1)(1997-2#1)(2008-10#2)
and subject to##2##3##(2008-2#1)(2008-3#1)
and subject##6##2##(1996-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#2)
and subjected to a##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
and subjected to the##2##4##(1993-8#1)(2008-10#1)
and subjected to##25##3##(1990-12#1)(1991-12#1)(1993-8#1)(1995-12#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-3#1)(2012-9#1)(2013-1#2)
and subjective SA##3##3##(2011-2#3)
and subjective and objective##2##4##(2007-12#2)
and subjective effects of##2##4##(1991-1#2)
and subjective health##3##3##(2008-7#2)(2011-1#1)
and subjective ratings of##2##4##(1995-12#1)(2007-12#1)
and subjective well-being##2##3##(2008-12#1)(2008-7#1)
and subjective##44##2##(1991-1#2)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-6#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
and subjectively##2##2##(1995-1#1)(2007-12#1)
and subjects##5##2##(1993-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
and sublethal##2##2##(2008-10#2)
and submaxillary gland##2##3##(1993-11#2)
and submaximal##2##2##(1993-12#1)(2013-8#1)
and submission##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
and submit##2##2##(2008-10#1)(2013-8#1)
and submitted to##4##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
and submitted##5##2##(1992-12#1)(2008-10#2)(2008-12#1)(2008-7#1)
and submucosal##3##2##(1993-8#1)(1997-4#1)(2013-8#1)
and subnormal##3##2##(1990-9#1)(1992-11#1)(2008-1#1)
and suboccipital##2##2##(2008-7#1)(2010-9#1)
and subordinate##5##2##(1997-5#1)(2008-8#1)(2010-8#3)
and subordinates##2##2##(2008-8#1)(2010-8#1)
and subpleural cysts##2##3##(2006-10#2)
and subpleural##5##2##(1991-6#1)(2006-10#2)(2008-1#2)
and subpopulations##2##2##(2008-10#2)
and subscale##3##2##(2007-12#3)
and subscales##2##2##(2007-12#1)(2011-1#1)
and subsequent activation of the##2##5##(2009-8#1)(2012-2#1)
and subsequent administration of##2##4##(1992-5#1)(2007-7#1)
and subsequent amplification of##2##4##(1997-6#1)(2008-9#1)
and subsequent analysis##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and subsequent determination by##2##4##(2008-10#2)
and subsequent determination##3##3##(2008-10#3)
and subsequent development of##4##4##(1994-2#1)(2008-10#3)
and subsequent development##5##3##(1994-11#1)(1994-2#1)(2008-10#3)
and subsequent elution of##2##4##(2008-10#2)
and subsequent evaluation##3##3##(2008-12#1)(2008-4#1)(2012-3#1)
and subsequent infection##2##3##(2007-12#1)(2008-10#1)
and subsequent liver##2##3##(1994-6#1)(2009-7#1)
and subsequent management##3##3##(1994-5#1)(2008-9#1)(2012-2#1)
and subsequent measurement##2##3##(2008-10#2)
and subsequent release##2##3##(1991-9#1)(1995-5#1)
and subsequent ring opening##2##4##(1995-2#1)(2012-12#1)
and subsequent signal##2##3##(2008-10#1)(2011-2#1)
and subsequent transmission##2##3##(2008-8#1)(2012-2#1)
and subsequent treatment##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
and subsequent##221##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#64)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#10)
and subsequently analysed by##2##4##(1993-9#1)(2008-11#1)
and subsequently determined##2##3##(2008-10#2)
and subsequently eluted with##2##4##(2008-10#2)
and subsequently has##2##3##(2008-10#1)(2011-2#1)
and subsequently in##2##3##(2008-10#1)(2008-12#1)
and subsequently measured by##2##4##(2007-11#1)(2008-10#1)
and subsequently measured##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
and subsequently observed for##2##4##(1995-3#1)(2008-9#1)
and subsequently reduce##2##3##(2008-10#1)(2013-8#1)
and subsequently separated##2##3##(2008-10#2)
and subsequently spread to##2##4##(1992-10#1)(2008-8#1)
and subsequently the##4##3##(1993-11#1)(2008-2#1)(2008-8#1)(2010-6#1)
and subsequently to##5##3##(1990-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)
and subsequently treated by##2##4##(1993-8#1)(2008-10#1)
and subsequently treated##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
and subsequently##105##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-3#1)(1995-6#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
and subsets##2##2##(1997-2#1)(1997-7#1)
and subsidies##2##2##(1992-12#1)(2008-1#1)
and substance P##2##3##(1991-12#1)(2007-8#1)
and substance abuse##9##3##(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
and substance misuse##2##3##(2009-9#2)
and substance use disorder##2##4##(2008-6#1)(2012-3#1)
and substance use##10##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)
and substance##26##2##(1991-1#1)(1991-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
and substances##4##2##(2008-10#2)(2008-3#1)(2010-1#1)
and substantial##9##2##(1990-8#1)(1995-2#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2013-8#1)
and substantially##9##2##(2007-11#1)(2007-12#2)(2008-10#2)(2009-12#1)(2009-6#1)(2010-11#1)(2012-12#1)
and substantiated##2##2##(2008-10#1)(2008-5#1)
and substituted##4##2##(1990-5#1)(1996-5#1)(2008-10#1)(2011-2#1)
and substitution##4##2##(1993-3#1)(2008-8#1)(2010-3#1)(2011-1#1)
and substitutive##2##2##(1992-3#1)(1993-2#1)
and substrate concentrations##2##3##(1990-5#1)(2011-1#1)
and substrate refractive indices##2##4##(2008-3#2)
and substrate specificity##5##3##(1990-11#1)(1992-12#1)(1994-11#1)(1996-5#1)(2007-7#1)
and substrate##32##2##(1990-11#1)(1990-5#1)(1991-12#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#5)(2008-5#2)(2008-7#4)(2011-1#1)(2011-2#1)
and substrates##5##2##(2007-11#1)(2008-1#1)(2008-2#1)(2011-1#1)(2013-1#1)
and subsurface drip##2##3##(2008-10#2)
and subsurface##6##2##(2007-11#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
and subsurface-drip irrigation##3##3##(2008-10#3)
and subsurface-drip##4##2##(2008-10#4)
and subtle##5##2##(1994-9#2)(2007-8#1)(2008-4#1)(2009-5#1)
and subtotal##3##2##(2010-12#1)(2011-2#2)
and subtracted##2##2##(2008-3#2)
and subtypes##4##2##(1994-2#1)(1997-5#1)(2008-2#1)(2008-8#1)
and subunit##4##2##(1991-3#1)(1992-11#1)(1997-2#1)(2007-2#1)
and succeeded in##2##3##(1996-8#1)(2008-11#1)
and success in##2##3##(1992-2#1)(2011-1#1)
and success##12##2##(1992-11#1)(1992-2#1)(1995-1#1)(1996-3#1)(1996-8#1)(2008-9#2)(2009-7#1)(2010-3#2)(2011-1#1)(2011-2#1)
and successes##3##2##(2008-6#1)(2009-7#1)(2010-11#1)
and successful thought suppression##2##4##(2012-3#2)
and successful treatment of##2##4##(1993-6#1)(1997-3#1)
and successful treatment##4##3##(1993-6#1)(1997-3#1)(2008-7#1)(2013-7#1)
and successful##28##2##(1992-12#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
and successfully applied to the determination of##2##7##(2008-10#2)
and successfully applied to the##3##5##(2008-10#3)
and successfully applied to##4##4##(2008-10#4)
and successfully applied##5##3##(2008-10#5)
and successfully implement##2##3##(1994-1#1)(2008-10#1)
and successfully treated##2##3##(1993-5#1)(2011-1#1)
and successfully used##2##3##(2008-10#1)(2008-11#1)
and successfully##33##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
and successive##3##2##(1991-3#1)(2008-5#1)(2010-6#1)
and successively##2##2##(1990-8#1)(2007-8#1)
and succinate dehydrogenase##2##3##(1993-11#1)(1996-8#1)
and succinate##3##2##(1993-11#1)(1996-8#1)(2008-7#1)
and succinic acids##2##3##(2008-10#2)
and succinic##4##2##(2008-10#3)(2008-11#1)
and such a##4##3##(1990-11#1)(1992-2#1)(2007-11#1)(2008-3#1)
and such association##2##3##(2008-10#1)(2008-9#1)
and such##19##2##(1990-11#1)(1992-2#1)(1993-3#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
and sucrose synthase##2##3##(2011-2#2)
and sucrose##15##2##(1991-5#1)(1994-8#1)(1995-6#1)(1996-10#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)
and sudden cardiac death##2##4##(2008-12#1)(2009-10#1)
and sudden death##4##3##(2008-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
and sudden##15##2##(1991-11#1)(1991-3#1)(1995-6#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
and suffering from##2##3##(1992-4#1)(2012-3#1)
and suffering##10##2##(1991-1#1)(1992-4#1)(1997-5#1)(2008-10#1)(2012-3#3)(2013-1#3)
and sufficient for##7##3##(1991-2#2)(1995-2#1)(2008-10#1)(2009-10#1)(2012-3#2)
and sufficient##23##2##(1991-2#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#2)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-3#2)(2013-1#1)
and sufficiently##4##2##(1994-3#1)(1996-11#1)(2008-10#1)(2010-4#1)
and sugar beet##6##3##(2008-10#6)
and sugar##13##2##(1993-9#1)(1995-11#1)(1997-8#1)(2008-10#7)(2008-12#1)(2012-12#1)(2013-1#1)
and sugars##7##2##(2008-10#1)(2008-12#1)(2009-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
and suggest a role for##2##5##(1997-1#1)(2008-10#1)
and suggest a##11##3##(1993-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#2)
and suggest an important role for##2##6##(1996-5#1)(2008-10#1)
and suggest an##4##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-9#1)
and suggest directions for##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
and suggest how##2##3##(2008-12#1)(2008-8#1)
and suggest its##2##3##(1993-6#1)(2013-1#1)
and suggest some##2##3##(2008-11#1)(2010-2#1)
and suggest strategies##2##3##(1991-11#1)(2008-12#1)
and suggest that a##3##4##(1990-12#1)(2008-7#1)(2012-12#1)
and suggest that both##2##4##(1995-12#1)(2008-8#1)
and suggest that it may##2##5##(2008-10#1)(2008-2#1)
and suggest that it##4##4##(1990-2#1)(2008-10#2)(2008-2#1)
and suggest that reduced##2##4##(1993-8#1)(1994-6#1)
and suggest that some##2##4##(1995-8#1)(2008-5#1)
and suggest that the mechanisms of##2##6##(2008-5#1)(2010-3#1)
and suggest that the##18##4##(1991-5#1)(1993-12#1)(1995-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
and suggest that there##3##4##(1994-2#1)(1995-12#1)(1996-6#1)
and suggest that these##4##4##(1990-7#1)(1993-5#1)(1994-6#1)(1995-5#1)
and suggest that this##2##4##(2008-4#1)(2008-5#1)
and suggest that##108##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-5#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-5#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#2)(1994-8#5)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#1)(1995-8#3)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-8#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-5#1)(2013-1#5)(2013-8#1)
and suggest the possibility that##2##5##(1991-12#1)(1994-3#1)
and suggest the##6##3##(1990-8#1)(1991-12#1)(1994-3#1)(1994-6#1)(2007-10#1)(2008-9#1)
and suggest##154##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#5)(1995-11#3)(1995-12#5)(1995-2#4)(1995-5#1)(1995-8#3)(1996-12#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#7)(2009-10#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
and suggested a##3##3##(1992-12#1)(2008-10#1)(2009-8#1)
and suggested that the##2##4##(1991-2#1)(2008-11#1)
and suggested that##7##3##(1991-2#1)(1997-8#1)(2008-11#1)(2008-8#2)(2010-2#1)(2011-1#1)
and suggested##22##2##(1991-2#1)(1992-12#1)(1997-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and suggesting that##2##3##(2008-10#1)(2008-6#1)
and suggesting the##2##3##(1991-12#1)(2007-7#1)
and suggesting##6##2##(1991-12#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-1#1)
and suggestions are made for##3##5##(1996-2#1)(2007-11#1)(2008-12#1)
and suggestions are##5##3##(1996-2#1)(2007-11#1)(2008-12#2)(2009-5#1)
and suggestions for future research are##3##6##(2008-12#1)(2008-4#1)(2009-5#1)
and suggestions for future research##4##5##(2008-12#1)(2008-4#1)(2009-11#1)(2009-5#1)
and suggestions for future##5##4##(2008-12#2)(2008-4#1)(2009-11#1)(2009-5#1)
and suggestions for##16##3##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(2006-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-11#2)(2010-2#1)(2012-3#1)
and suggestions on the##2##4##(2008-9#1)(2012-2#1)
and suggestions##31##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
and suggestive##2##2##(2013-8#2)
and suggests a##6##3##(1992-1#1)(1993-8#1)(1995-1#1)(1996-1#1)(2010-3#1)(2010-7#1)
and suggests an##2##3##(1996-2#1)(2008-9#1)
and suggests how##2##3##(1993-12#1)(2009-11#1)
and suggests its##2##3##(2010-10#1)(2010-5#1)
and suggests measures##2##3##(1995-1#1)(2011-2#1)
and suggests strategies##2##3##(1993-2#1)(2008-4#1)
and suggests that the##4##4##(1991-7#1)(1994-2#1)(2008-11#1)(2012-2#1)
and suggests that they##3##4##(1997-2#1)(2008-7#2)
and suggests that##20##3##(1991-7#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-2#1)
and suggests the##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
and suggests ways to##2##4##(1993-12#1)(2008-11#1)
and suggests##59##2##(1991-7#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#3)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
and suicidal behaviors##2##3##(2008-11#1)(2013-1#1)
and suicidal motives##2##3##(1996-3#2)
and suicidal##8##2##(1996-3#2)(2008-11#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
and suicidality##2##2##(2010-7#1)(2011-2#1)
and suicide##7##2##(1991-10#1)(2009-7#2)(2011-1#1)(2013-1#3)
and suitability of the habitat##2##5##(2008-10#2)
and suitability of the##4##4##(2008-10#2)(2008-12#1)(2009-8#1)
and suitable for simultaneous##2##4##(2008-10#1)(2011-1#1)
and suitable for the quality control of##3##7##(2011-1#2)(2012-3#1)
and suitable for the##4##4##(1990-2#1)(2011-1#2)(2012-3#1)
and suitable for##16##3##(1990-12#1)(1990-2#1)(1993-6#1)(2008-10#7)(2008-3#1)(2010-8#1)(2011-1#3)(2012-3#1)
and suitable##23##2##(1990-12#1)(1990-2#1)(1993-6#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#3)(2012-3#1)
and sulcal##2##2##(1996-7#1)(2008-6#1)
and sulfamethoxazole##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
and sulfate ions##2##3##(2008-10#2)
and sulfate##9##2##(1992-12#1)(1992-3#1)(2008-10#4)(2008-6#1)(2008-7#1)(2013-1#1)
and sulfate)##3##2##(2008-10#3)
and sulfated##2##2##(1991-12#1)(1993-12#1)
and sulfatide##2##2##(1996-5#2)
and sulfhydryl groups##4##3##(1992-6#3)(2013-1#1)
and sulfhydryl##6##2##(1992-6#3)(1992-9#1)(2009-8#1)(2013-1#1)
and sulfide##5##2##(2008-10#4)(2011-2#1)
and sulfides##2##2##(2008-10#2)
and sulfite##4##2##(1994-8#1)(2008-10#3)
and sulfo-polysaccharide##2##2##(2008-5#2)
and sulfur dioxide##4##3##(2008-10#3)(2008-2#1)
and sulfur##10##2##(1997-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2010-11#2)(2013-1#2)
and sulfuric acid##4##3##(2008-10#2)(2010-6#1)(2013-1#1)
and sulfuric##5##2##(2008-10#2)(2010-6#1)(2013-1#2)
and sulphate##9##2##(1997-7#5)(2008-10#4)
and sulphonic##3##2##(2008-10#3)
and sulphur##2##2##(2008-10#2)
and sulphuric acids##2##3##(2008-10#2)
and sulphuric##3##2##(2008-10#3)
and sum##4##2##(1994-9#1)(1996-7#1)(2008-10#1)(2009-7#1)
and sum-frequency generation##4##3##(2007-12#4)
and summarize##3##2##(2008-5#1)(2012-12#2)
and summarized in##2##3##(1996-3#1)(2008-4#1)
and summarizes our##2##3##(1993-2#1)(2011-2#1)
and summarizes the##5##3##(1994-11#1)(2007-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
and summarizes##13##2##(1993-2#1)(1994-11#1)(1995-3#2)(1995-6#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#2)
and summarizing the##2##3##(2008-10#1)(2012-3#1)
and summarizing##4##2##(2007-5#2)(2008-10#1)(2012-3#1)
and summary of##3##3##(2007-12#1)(2008-7#1)(2009-11#1)
and summary##8##2##(2007-12#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)
and sun##2##2##(1991-6#1)(2008-4#1)
and sunflower oil##2##3##(2013-1#2)
and sunflower##6##2##(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#2)
and sunset##2##2##(2008-10#2)
and superconducting interconnections##2##3##(2008-3#2)
and superconducting##3##2##(1990-12#1)(2008-3#2)
and superficial##17##2##(1990-6#1)(1993-9#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-9#1)(2011-2#1)(2012-3#1)
and superhelicity in##2##3##(1994-6#2)
and superimposed##2##2##(1996-5#1)(2008-2#1)
and superior cervical##2##3##(1991-12#1)(1996-2#1)
and superior temporal##2##3##(1996-7#1)(2008-11#1)
and superior##15##2##(1991-12#2)(1996-12#1)(1996-2#1)(1996-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and supernumerary##3##2##(2008-5#2)(2010-3#1)
and superoxide anion##4##3##(1990-5#1)(1997-4#1)(2008-10#1)(2008-4#1)
and superoxide dismutase activities were##2##5##(2008-10#2)
and superoxide dismutase##7##3##(1990-2#1)(1990-5#1)(1997-4#1)(2008-10#2)(2008-12#1)(2011-2#1)
and superoxide##13##2##(1990-2#1)(1990-5#2)(1996-2#1)(1997-4#2)(2008-10#4)(2008-12#1)(2008-4#1)(2011-2#1)
and supervised learning methods##2##4##(2008-10#2)
and supervised##3##2##(2008-10#3)
and supervision##3##2##(1991-2#2)(2011-1#1)
and supervisory##2##2##(1992-2#1)(2013-1#1)
and supplemental##2##2##(2008-10#1)(2012-12#1)
and supplementary##3##2##(1996-5#1)(1997-6#1)(2012-3#1)
and supplementation##4##2##(1990-3#1)(2008-11#1)(2008-2#1)(2008-4#1)
and supplemented with##2##3##(2008-7#1)(2013-1#1)
and supplemented##7##2##(2008-10#1)(2008-7#2)(2011-2#2)(2013-1#2)
and supplements##3##2##(2008-10#1)(2010-11#1)(2010-5#1)
and suppliers##2##2##(1994-1#1)(2008-11#1)
and supplies##3##2##(1995-2#1)(1997-6#1)(2011-2#1)
and supply of##3##3##(1993-3#1)(1994-12#1)(2007-4#1)
and supply##8##2##(1993-3#1)(1994-12#1)(1994-3#1)(2007-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and supplying##2##2##(1995-12#1)(2007-10#1)
and support for##10##3##(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
and support groups##2##3##(1992-12#1)(1996-3#1)
and support in##3##3##(2008-12#1)(2009-6#1)(2011-2#1)
and support intervention##5##3##(2011-2#5)
and support of a##2##4##(2008-8#2)
and support of##4##3##(2008-8#2)(2010-5#1)(2012-3#1)
and support services to address these NCD##6##7##(2013-8#6)
and support services to address these NCDs##3##7##(2013-8#3)
and support services to address these##9##6##(2013-8#9)
and support services to address##10##5##(2013-8#10)
and support services##11##3##(2009-5#1)(2013-8#10)
and support staff##3##3##(1995-12#1)(1995-3#1)(1996-1#1)
and support the existence of##2##5##(2008-5#1)(2008-8#1)
and support the##16##3##(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
and support to##5##3##(1995-3#1)(1997-7#1)(2007-7#1)(2009-5#1)(2010-5#1)
and support##102##2##(1991-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-3#4)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#3)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#11)
and supported by##2##3##(1993-2#1)(2008-2#1)
and supported the##2##3##(2008-10#1)(2008-11#1)
and supported##13##2##(1991-11#1)(1993-2#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#1)(2012-12#1)
and supporting electrolyte##4##3##(2008-10#4)
and supporting structures##2##3##(1997-1#1)(2012-3#1)
and supporting the##3##3##(1993-12#1)(1997-3#1)(2008-5#1)
and supporting##23##2##(1991-5#2)(1993-12#1)(1993-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-3#3)
and supportive care is the##2##5##(2008-7#1)(2013-1#1)
and supportive care##7##3##(1994-3#1)(2008-7#3)(2010-9#1)(2011-2#1)(2013-1#1)
and supportive evidence##2##3##(2008-10#1)(2008-8#1)
and supportive therapy##2##3##(1992-10#1)(2012-3#1)
and supportive##20##2##(1992-10#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
and supports a##2##3##(2008-12#1)(2008-3#1)
and supports the hypothesis of##2##5##(1994-3#1)(2008-10#1)
and supports the hypothesis that##2##5##(1993-11#1)(2013-1#1)
and supports the hypothesis##4##4##(1993-11#1)(1994-3#1)(2008-10#1)(2013-1#1)
and supports the##12##3##(1993-11#1)(1994-12#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#3)
and supports##25##2##(1993-11#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
and supposed##2##2##(2008-5#1)(2008-7#1)
and suppress##4##2##(1990-11#1)(1991-9#1)(1993-11#1)(2011-1#1)
and suppressed by##2##3##(1993-3#1)(1993-6#1)
and suppressed the##6##3##(1993-12#1)(1994-8#1)(2008-11#2)(2011-2#2)
and suppressed##20##2##(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(2007-11#1)(2008-10#5)(2008-11#4)(2011-2#3)(2012-2#1)(2013-1#1)
and suppresses##5##2##(1995-2#1)(1997-2#1)(2007-11#1)(2009-10#1)(2012-12#1)
and suppressing##6##2##(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2011-1#1)
and suppression of##13##3##(1990-5#1)(1994-6#1)(1995-2#2)(1997-2#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)
and suppression##16##2##(1990-5#1)(1994-6#1)(1995-2#2)(1995-6#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#2)
and suppressive##2##2##(2008-10#1)(2008-5#1)
and suppurative inflammation##2##3##(2008-9#2)
and suppurative##3##2##(2007-12#1)(2008-9#2)
and supraoptic##4##2##(1995-12#1)(1996-12#2)(2008-8#1)
and surface EMG##2##3##(2011-2#1)(2012-2#1)
and surface albedo##3##3##(2008-2#3)
and surface area of##2##4##(1996-5#1)(2008-5#1)
and surface area##7##3##(1996-5#2)(2008-10#3)(2008-5#1)(2010-5#1)
and surface characteristics##2##3##(1997-2#1)(2013-8#1)
and surface charge##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
and surface immobilized##2##3##(2008-5#1)(2009-3#1)
and surface morphology##3##3##(2008-5#1)(2009-7#1)(2010-4#1)
and surface of##2##3##(2008-10#1)(2010-4#1)
and surface properties##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
and surface roughness##5##3##(2008-2#1)(2008-3#3)(2013-8#1)
and surface tension##2##3##(1996-3#1)(2008-3#1)
and surface water##2##3##(2008-10#2)
and surface##85##2##(1990-4#1)(1991-8#1)(1992-3#2)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-2#10)(2008-3#13)(2008-5#7)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
and surface-enhanced Raman scattering (SERS)##2##5##(2008-10#2)
and surfaces##4##2##(2007-10#1)(2008-3#2)(2011-2#1)
and surfactant##8##2##(1994-3#1)(1996-5#1)(2008-10#3)(2008-5#1)(2010-5#1)(2013-8#1)
and surfactants##3##2##(2008-10#2)(2008-5#1)
and surgeon##7##2##(2008-10#1)(2008-7#3)(2009-4#1)(2011-2#1)(2013-1#1)
and surgeons should##2##3##(2007-8#1)(2008-6#1)
and surgeons##6##2##(1993-6#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-8#1)
and surgery are##2##3##(2011-2#1)(2013-1#1)
and surgery for##5##3##(1994-9#1)(1996-6#1)(1996-9#1)(2008-10#1)(2010-12#1)
and surgery in##2##3##(1995-11#1)(2009-7#1)
and surgery is##2##3##(2010-3#1)(2011-2#1)
and surgery was performed##2##4##(2008-10#1)(2011-2#1)
and surgery was##4##3##(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
and surgery##27##2##(1991-3#1)(1991-6#1)(1993-1#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
and surgical aspects##2##3##(2008-9#1)(2009-8#1)
and surgical debridement##2##3##(2007-11#1)(2010-6#1)
and surgical intervention##5##3##(1995-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and surgical lung biopsy##2##4##(2013-1#2)
and surgical management is##2##4##(2008-7#1)(2011-2#1)
and surgical management of##6##4##(2007-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#2)
and surgical management##8##3##(2007-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-3#2)
and surgical modalities##2##3##(2007-11#1)(2009-8#1)
and surgical operation##2##3##(1993-5#1)(2008-7#1)
and surgical options##2##3##(2008-8#1)(2010-3#1)
and surgical outcomes##2##3##(1993-12#1)(2008-10#1)
and surgical planning##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
and surgical practice##2##3##(2011-2#2)
and surgical technique##2##3##(1990-9#1)(2011-2#1)
and surgical therapy]##2##3##(1997-6#2)
and surgical treatment are##2##4##(1993-6#1)(2007-8#1)
and surgical treatment of##2##4##(2008-7#1)(2013-8#1)
and surgical treatment was##2##4##(2007-11#1)(2012-3#1)
and surgical treatment were##2##4##(1990-9#1)(2007-8#1)
and surgical treatment with##3##4##(2006-12#1)(2007-11#1)(2008-10#1)
and surgical treatment##21##3##(1990-9#1)(1993-6#1)(1994-2#1)(2006-12#1)(2007-11#3)(2007-8#5)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
and surgical treatments##2##3##(2008-5#1)(2012-3#1)
and surgical##124##2##(1990-3#1)(1990-9#2)(1992-12#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#3)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#6)(2009-12#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-3#3)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#2)
and surgically##2##2##(2009-10#1)(2013-1#1)
and surprising##2##2##(2008-8#1)(2010-5#1)
and surprisingly##4##2##(1995-12#1)(1997-9#1)(2007-7#1)(2008-11#1)
and surrogate##3##2##(2008-10#1)(2010-4#1)(2011-7#1)
and surrounded by##2##3##(1997-4#1)(2007-12#1)
and surrounded##3##2##(1997-4#1)(2007-12#1)(2011-2#1)
and surrounding areas##2##3##(1993-6#1)(2008-11#1)
and surrounding solvent molecules)##2##4##(2008-10#2)
and surrounding the##2##3##(1996-8#1)(2007-11#1)
and surrounding tissues##2##3##(1993-9#1)(2008-8#1)
and surrounding##21##2##(1993-6#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-6#1)(2011-2#1)
and surveillance of##6##3##(1991-11#2)(2007-12#1)(2008-10#1)(2012-12#1)(2012-3#1)
and surveillance systems##2##3##(1997-3#2)
and surveillance##17##2##(1991-11#2)(1997-3#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-12#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
and survey results##2##3##(2008-11#2)
and survey##5##2##(1995-2#1)(1996-3#1)(2008-11#2)(2008-12#1)
and surveys##5##2##(2008-4#1)(2009-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
and survival in patients with##2##5##(2011-2#2)
and survival in##7##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#2)(2013-1#1)
and survival of neurons##4##4##(1993-3#1)(1996-2#1)(2008-4#1)(2013-8#1)
and survival of the##6##4##(1994-10#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
and survival of##27##3##(1991-5#1)(1993-3#1)(1994-10#1)(1994-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and survival rate##2##3##(2008-10#1)(2008-5#1)
and survival rates##7##3##(1994-7#1)(1994-9#3)(1995-4#1)(2007-5#1)(2008-6#1)
and survival was##2##3##(1992-12#1)(2012-3#1)
and survival were##2##3##(2012-2#1)(2013-1#1)
and survival##102##2##(1991-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#3)(2006-10#1)(2007-10#2)(2007-11#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#6)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#8)(2011-9#1)(2012-12#4)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#7)(2013-8#3)
and survive##2##2##(2008-10#2)
and survived##5##2##(1994-7#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
and survivin in superficial urothelial carcinoma##2##6##(2011-2#2)
and survivin in##3##3##(2011-2#3)
and survivin##9##2##(2011-2#9)
and survivors##2##2##(2008-7#1)(2011-2#1)
and survivorship of##2##3##(2013-1#2)
and survivorship##4##2##(2008-8#1)(2013-1#3)
and susceptibility in##2##3##(2008-10#1)(2012-2#1)
and susceptibility to##16##3##(1990-2#1)(1992-2#1)(1992-6#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and susceptibility##25##2##(1990-2#1)(1992-2#1)(1992-6#1)(1995-6#1)(1997-8#1)(2008-10#7)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and susceptible cultivars##4##3##(2008-10#4)
and susceptible cv##2##3##(2008-10#2)
and susceptible inbred##2##3##(2008-10#2)
and susceptible to##4##3##(2008-10#3)(2008-11#1)
and susceptible##45##2##(1996-12#1)(2008-10#39)(2008-11#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
and suspected##2##2##(1992-3#1)(2012-3#1)
and suspended##3##2##(1992-12#1)(2008-10#1)(2008-5#1)
and suspension cultures##2##3##(2008-11#1)(2008-2#1)
and suspension##12##2##(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#1)
and suspension)##2##2##(2008-10#2)
and suspensions##2##2##(2008-10#1)(2008-3#1)
and suspicious##2##2##(2011-1#1)(2013-8#1)
and sustain a##2##3##(1993-1#1)(2008-7#1)
and sustain##4##2##(1992-8#1)(1993-1#1)(2008-10#1)(2008-7#1)
and sustainability of##3##3##(1997-3#1)(2008-7#1)(2008-8#1)
and sustainability##5##2##(1997-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
and sustainable development##2##3##(2008-11#2)
and sustainable primary##2##3##(2009-6#1)(2009-9#1)
and sustainable##8##2##(2008-10#1)(2008-11#2)(2008-12#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#1)
and sustained suppression##2##3##(2009-8#1)(2013-1#1)
and sustained##17##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2012-3#1)(2013-1#1)
and sustaining##8##2##(1992-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
and suture##2##2##(1993-12#1)(2008-5#1)
and suturing##2##2##(2007-12#1)(2010-8#1)
and swallow##2##2##(1994-9#1)(2008-7#1)
and swallowing##2##2##(2013-1#1)(2013-8#1)
and sweat##2##2##(2008-5#2)
and sweating##2##2##(1994-3#1)(2008-5#1)
and sweet orange##3##3##(2008-10#3)
and sweet##8##2##(2008-10#7)(2012-12#1)
and swelling in##2##3##(2008-10#1)(2008-8#1)
and swelling of##2##3##(2008-7#1)(2013-1#1)
and swelling##10##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
and swept##2##2##(2008-10#2)
and swim##5##2##(2008-12#4)(2010-5#1)
and switch providers##2##3##(1993-12#2)
and switched##2##2##(1992-3#1)(2008-2#1)
and switches##2##2##(2008-3#1)(2008-9#1)
and switching##8##2##(2007-12#2)(2008-10#1)(2008-3#3)(2012-2#2)
and swollen##4##2##(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#1)
and sycamore##2##2##(2008-10#2)
and syllable##2##2##(2008-8#1)(2013-8#1)
and sylvestrene##2##2##(2008-11#2)
and symbiotic##2##2##(2008-10#1)(2008-8#1)
and symbolic##4##2##(2009-7#2)(2010-4#1)(2013-8#1)
and symmetric##6##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
and symmetrical##2##2##(1993-3#1)(2008-3#1)
and sympathetic##2##2##(2008-4#1)(2008-7#1)
and sympathy##2##2##(2007-11#1)(2012-2#1)
and sympatric##3##2##(2008-8#1)(2010-8#1)(2012-3#1)
and symptom burden##2##3##(2008-7#2)
and symptom development##4##3##(2008-10#3)(2008-9#1)
and symptom expression##2##3##(2008-10#2)
and symptom severity##4##3##(2008-10#2)(2008-3#1)(2013-7#1)
and symptom##19##2##(1996-1#1)(2007-7#1)(2008-10#8)(2008-3#2)(2008-7#2)(2008-9#1)(2009-1#1)(2011-1#1)(2012-3#1)(2013-7#1)
and symptomatic##12##2##(1990-2#1)(1994-12#1)(2007-10#1)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
and symptomatology##6##2##(1990-9#2)(2007-8#1)(2008-10#3)
and symptomless##2##2##(2008-10#2)
and symptoms of the##3##4##(1997-7#1)(2007-11#1)(2007-7#1)
and symptoms of##37##3##(1992-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#5)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-7#1)(2013-1#2)
and symptoms##84##2##(1990-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-9#1)(1997-2#1)(1997-7#1)(1997-8#3)(2006-10#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#8)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#1)
and synapses##3##2##(1997-3#1)(2008-11#1)(2008-4#1)
and synaptic plasticity in the##2##5##(1993-12#1)(1996-12#1)
and synaptic plasticity in##3##4##(1993-12#1)(1996-12#1)(2013-1#1)
and synaptic plasticity##4##3##(1993-12#1)(1996-12#1)(2008-7#1)(2013-1#1)
and synaptic transmission##4##3##(2008-4#1)(2008-7#2)(2009-9#1)
and synaptic##19##2##(1993-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#4)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
and synaptophysin##3##2##(1992-2#1)(1996-5#1)(2011-2#1)
and synchronization of##2##3##(1996-2#1)(2008-3#1)
and synchronization##7##2##(1996-2#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#2)(2010-5#1)
and synchronized##2##2##(2008-4#1)(2011-2#1)
and synchronous chemo-radiotherapy##2##3##(1990-6#2)
and synchronous metastases##4##3##(2008-6#4)
and synchronous scan##2##3##(2008-10#1)(2013-8#1)
and synchronous##11##2##(1990-6#2)(1995-9#1)(2008-10#2)(2008-2#1)(2008-6#4)(2013-8#1)
and synchrony##2##2##(2009-8#1)(2013-8#1)
and syncope##3##2##(1992-9#1)(2008-7#2)
and syndesmotic##2##2##(2009-3#2)
and syndrome##2##2##(2009-8#1)(2011-2#1)
and synergistic##5##2##(1991-4#1)(1995-5#1)(2008-10#1)(2008-8#1)(2009-3#1)
and synovial fluid findings in##2##5##(2006-10#2)
and synovial fluid##5##3##(1992-8#1)(1994-8#1)(2006-10#2)(2013-8#1)
and synovial##13##2##(1990-6#1)(1991-5#2)(1992-4#1)(1992-8#1)(1994-8#1)(2006-10#2)(2008-12#1)(2009-3#2)(2011-2#1)(2013-8#1)
and syntax##4##2##(2008-12#2)(2008-9#1)(2010-4#1)
and synthesis of##17##3##(1990-2#1)(1992-12#1)(1994-12#1)(1994-3#2)(1995-3#2)(1997-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-3#1)(2013-1#1)
and synthesis to exponentially amplify a product of specific size and sequence##2##12##(2008-2#1)(2008-9#1)
and synthesis##26##2##(1990-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#2)(1997-1#3)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2011-3#1)(2013-1#2)
and synthesized a##2##3##(1993-3#1)(2010-6#1)
and synthesized##16##2##(1993-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-6#1)(2011-3#3)(2012-12#1)
and synthesizing##3##2##(2008-4#2)(2008-9#1)
and synthetic compounds##2##3##(2008-11#1)(2013-1#1)
and synthetic mixtures of##2##4##(2008-10#2)
and synthetic mixtures##3##3##(2008-10#3)
and synthetic samples##3##3##(2008-10#3)
and synthetic water##2##3##(2008-10#1)(2008-5#1)
and synthetic##47##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
and syphilis infections in Iranian blood donors##2##7##(2008-12#2)
and syphilis infections##3##3##(2008-12#3)
and syphilis##4##2##(1996-11#1)(2008-12#3)
and syrup##2##2##(2008-10#1)(2012-2#1)
and system requirements##2##3##(1991-1#1)(2010-12#1)
and system##22##2##(1990-12#1)(1991-1#1)(1991-12#1)(1993-2#1)(1994-2#1)(2008-1#3)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
and systematic errors in##2##4##(2007-12#1)(2008-6#1)
and systematic errors##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
and systematic##25##2##(1992-2#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
and systematically analyze##2##3##(2009-5#1)(2010-10#1)
and systematically##7##2##(1996-3#1)(2008-2#2)(2009-5#1)(2010-10#1)(2012-2#2)
and systemic complications##2##3##(2010-3#1)(2011-2#1)
and systemic disease##2##3##(2008-6#1)(2013-8#1)
and systemic diseases##3##3##(2007-8#1)(2008-5#1)(2010-3#1)
and systemic disorders##3##3##(2007-11#1)(2007-7#1)(2008-4#1)
and systemic effects##4##3##(1997-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
and systemic lupus erythematosus##5##4##(1990-9#1)(1991-5#1)(1997-8#1)(2008-1#1)(2008-5#1)
and systemic therapy##4##3##(1991-8#1)(1997-8#1)(2008-6#1)(2012-3#1)
and systemic##77##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#2)(1992-2#2)(1992-3#3)(1994-2#1)(1995-5#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#3)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-2#11)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#1)
and systemically in##2##3##(2008-10#1)(2008-8#1)
and systemically##7##2##(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#2)(2013-8#1)
and systems biological##2##3##(2008-10#1)(2012-2#1)
and systems biology##2##3##(2008-11#1)(2012-2#1)
and systems for##2##3##(1994-1#1)(2010-7#1)
and systems of##3##3##(1992-4#2)(2008-11#1)
and systems to##2##3##(2007-12#1)(2009-8#1)
and systems##34##2##(1992-4#2)(1993-12#1)(1993-3#1)(1994-1#2)(1995-1#1)(1996-12#1)(1997-1#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-8#1)
and systems-driven##2##2##(2013-8#2)
and systolic and##2##3##(2008-12#1)(2008-3#1)
and systolic blood pressure were##2##5##(2008-5#1)(2012-3#1)
and systolic blood pressure##6##4##(2008-10#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-3#1)
and systolic##10##2##(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
and t(0)##2##2##(2008-10#2)
and t(0)=-0##2##2##(2013-7#2)
and t(1/2) values &lt##2##4##(2008-10#2)
and t(1/2)##3##2##(2008-10#3)
and t-test##2##2##(1990-12#1)(2008-10#1)
and tRNA genes##2##3##(1996-6#1)(2012-3#1)
and tRNA##6##2##(1992-6#1)(1993-8#1)(1996-6#1)(2008-4#1)(2008-8#1)(2012-3#1)
and table##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
and tables##2##2##(1994-6#1)(2008-11#1)
and tablet##2##2##(2008-10#1)(2010-5#1)
and tablets##3##2##(2008-10#3)
and tacrolimus##2##2##(2008-3#1)(2011-1#1)
and tactical##2##2##(1997-1#1)(2008-12#1)
and tactics for##2##3##(1993-12#1)(2008-9#1)
and tactics##4##2##(1993-12#1)(1994-12#1)(2008-9#1)(2013-1#1)
and tactile##4##2##(1993-12#3)(2013-1#1)
and tail flick##2##3##(2010-5#1)(2011-1#1)
and tail of##2##3##(2008-7#1)(2010-12#1)
and tail##12##2##(1997-4#1)(1997-7#1)(2007-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#3)
and tailored##2##2##(2009-2#1)(2011-2#1)
and tailoring##5##2##(1994-3#1)(2007-10#1)(2008-6#1)(2010-12#1)(2012-1#1)
and take the lead##2##4##(1995-3#1)(2008-8#1)
and take the##3##3##(1992-11#1)(1995-3#1)(2008-8#1)
and take##13##2##(1992-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
and taken into account in the##2##6##(2008-2#1)(2008-3#1)
and taken into account in##3##5##(2008-2#2)(2008-3#1)
and taken##6##2##(2008-2#2)(2008-3#2)(2008-5#1)(2012-3#1)
and takes a##2##3##(2008-3#1)(2008-7#1)
and takes into account the##2##5##(2007-11#1)(2008-5#1)
and takes into account##3##4##(2007-11#1)(2008-5#1)(2008-9#1)
and takes the##2##3##(1992-6#1)(2007-12#1)
and takes##12##2##(1992-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
and taking a##2##3##(2008-11#1)(2013-1#1)
and taking medication##2##3##(2008-7#2)
and taking##13##2##(1991-11#1)(1991-4#1)(1996-10#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-7#1)(2010-4#1)(2013-1#1)
and talking##2##2##(1992-3#1)(2011-2#1)
and tall fescue##5##3##(2008-10#5)
and tamoxifen##3##2##(1993-11#1)(2011-2#2)
and tan##3##2##(2008-10#2)(2008-3#1)
and tandem MS##2##3##(2008-9#1)(2012-12#1)
and tandem mass spectrometry##3##4##(2008-10#2)(2008-8#1)
and tandem mass##4##3##(2008-10#2)(2008-8#1)(2012-1#1)
and tandem##11##2##(1997-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
and tangential ultrafiltration##2##3##(2008-10#2)
and tangential##4##2##(1995-5#1)(2008-10#3)
and tangerine x grapefruit##2##4##(2008-10#2)
and tangible##3##2##(1991-3#1)(2013-1#2)
and tantalum##3##2##(2008-10#2)(2009-7#1)
and tap water and##4##4##(2008-10#3)(2008-8#1)
and tap water samples##11##4##(2008-10#11)
and tap water##20##3##(2008-10#19)(2008-8#1)
and tap##23##2##(2008-10#22)(2008-8#1)
and tape##2##2##(2008-12#1)(2013-7#1)
and tapered optical fibers##3##4##(2007-11#2)(2007-12#1)
and target organ##2##3##(2008-7#1)(2009-1#1)
and target##29##2##(1990-12#3)(1993-11#1)(1994-2#1)(1994-3#1)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2013-1#1)
and targeted to the##3##4##(2008-10#1)(2010-5#2)
and targeted to##4##3##(2007-12#1)(2008-10#1)(2010-5#2)
and targeted treatment##2##3##(2008-7#1)(2012-12#1)
and targeted##17##2##(1995-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-12#1)(2010-5#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)
and targeting of##2##3##(2011-2#1)(2012-12#1)
and targeting##9##2##(1993-9#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
and targets for##2##3##(2008-8#1)(2011-2#1)
and targets##5##2##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
and tartaric acid##7##3##(2008-10#5)(2010-3#2)
and task##8##2##(1991-3#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-8#2)(2012-3#1)(2013-1#1)
and tasks##4##2##(1992-12#1)(1994-3#1)(1996-11#1)(2009-7#1)
and taste##4##2##(1996-5#1)(2008-10#1)(2008-12#1)(2009-10#1)
and taurine##3##2##(1990-8#2)(2008-10#1)
and taurocholate##2##2##(1992-3#2)
and tax##3##2##(1991-3#1)(1994-3#2)
and taxol##2##2##(1994-5#1)(2008-11#1)
and taxonomic##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
and taxonomy in##2##3##(1995-6#1)(2013-1#1)
and taxonomy##5##2##(1995-6#2)(2008-10#1)(2013-1#1)(2013-7#1)
and tea samples##4##3##(2008-10#4)
and tea##9##2##(2008-10#7)(2008-11#1)(2009-9#1)
and teacher##9##2##(2008-10#2)(2008-12#2)(2008-2#1)(2009-11#1)(2010-8#1)(2012-2#2)
and teachers##13##2##(1993-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2009-11#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
and teachers'##3##2##(1993-1#1)(2009-7#2)
and teachers)##2##2##(2009-7#1)(2010-1#1)
and teaching##14##2##(1995-1#1)(1995-12#1)(2007-12#1)(2007-3#1)(2008-11#4)(2008-12#2)(2008-5#1)(2010-1#1)(2010-10#1)(2010-3#1)
and team##5##2##(1992-5#1)(1994-1#1)(1996-3#1)(2008-5#1)(2010-10#1)
and teams##2##2##(1997-2#1)(2011-2#1)
and teamwork##3##2##(1993-3#1)(1996-1#1)(2012-3#1)
and tears##2##2##(1992-6#1)(2011-2#1)
and tebuconazole##2##2##(2008-10#1)(2008-6#1)
and technical assistance##2##3##(1994-3#1)(2013-1#1)
and technical considerations##2##3##(2011-2#2)
and technical details have been kept to a minimum##2##9##(2007-5#2)
and technical expertise##2##3##(2010-4#1)(2013-1#1)
and technical issues##3##3##(2007-2#1)(2010-4#1)(2011-2#1)
and technical limitations##2##3##(2008-7#1)(2009-8#1)
and technical problems##2##3##(2007-11#1)(2008-1#1)
and technical skills##2##3##(1992-2#1)(1993-12#1)
and technical views##2##3##(2007-12#1)(2008-11#1)
and technical##51##2##(1990-5#1)(1990-8#1)(1991-3#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#2)
and technically##2##2##(2007-8#1)(2009-2#1)
and technicians##2##2##(1994-12#1)(2012-2#1)
and technique##9##2##(1990-3#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-12#1)(2011-2#2)(2013-1#2)
and techniques for##3##3##(1994-6#1)(2008-9#2)
and techniques has##2##3##(2008-10#1)(2008-8#1)
and techniques in##6##3##(1993-2#1)(2007-12#2)(2007-8#1)(2008-12#1)(2009-3#1)
and techniques of##4##3##(1995-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
and techniques that##2##3##(2011-2#2)
and techniques used##2##3##(1994-1#1)(2008-10#1)
and techniques##40##2##(1990-12#3)(1992-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#2)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#2)(2010-3#1)(2010-7#1)(2011-2#3)
and technologic##2##2##(2007-12#1)(2008-7#1)
and technological advances have##2##4##(1995-12#1)(2008-10#1)
and technological advances##6##3##(1995-12#1)(2008-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
and technological##17##2##(1991-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2012-2#2)(2013-1#1)
and technologies##10##2##(1997-1#1)(1997-4#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-10#1)(2012-3#1)(2013-8#1)
and technologists##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
and technology in##2##3##(1994-12#1)(2010-11#1)
and technology##31##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and tedious##3##2##(1991-5#1)(2008-10#1)(2008-9#1)
and teen##4##2##(2008-7#1)(2013-1#3)
and teeth##2##2##(2008-12#1)(2011-1#1)
and teflon##2##2##(2008-10#2)
and teicoplanin##5##2##(2008-10#4)(2013-8#1)
and telecare##2##2##(1996-2#1)(2013-8#1)
and telecommunications##2##2##(1994-3#1)(2008-3#1)
and telemedicine##2##2##(1996-11#1)(1996-2#1)
and telephone survey##2##3##(1996-1#1)(1996-8#1)
and telephone##4##2##(1996-1#1)(1996-8#1)(1997-2#1)(2013-1#1)
and teleradiology##4##2##(1996-2#2)(1997-8#1)(2012-2#1)
and telescope##2##2##(2008-3#2)
and tellurium##2##2##(2007-12#1)(2008-10#1)
and telmisartan##5##2##(2010-3#4)(2011-3#1)
and telomerase activity##3##3##(2008-1#2)(2008-6#1)
and telomerase##10##2##(2006-10#1)(2008-1#3)(2008-11#4)(2008-6#1)(2012-3#1)
and telomere length in##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
and telomere length##4##3##(2008-11#1)(2008-9#1)(2012-3#2)
and telomere##5##2##(2008-11#2)(2008-9#1)(2012-3#2)
and temperament##2##2##(2008-2#1)(2008-9#1)
and temperate##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
and temperature and##2##3##(2008-10#1)(2008-2#1)
and temperature are##4##3##(2008-10#3)(2008-2#1)
and temperature as well as##2##5##(1992-3#1)(2008-3#1)
and temperature can##2##3##(2008-10#1)(2008-11#1)
and temperature conditions##4##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
and temperature control##2##3##(2008-10#1)(2008-2#1)
and temperature dependence##5##3##(1992-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
and temperature dependent##2##3##(1994-8#1)(2008-11#1)
and temperature effects##2##3##(2008-10#1)(2008-11#1)
and temperature for##4##3##(1994-11#1)(2008-10#1)(2008-3#2)
and temperature is##2##3##(2008-3#1)(2008-8#1)
and temperature measurement##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and temperature measurements##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
and temperature of##3##3##(2007-12#1)(2008-10#2)
and temperature on extraction were studied##2##6##(2008-10#2)
and temperature on the##5##4##(1996-5#1)(1997-2#1)(2008-10#3)
and temperature on##15##3##(1996-5#1)(1997-2#1)(2008-10#9)(2008-11#1)(2009-7#1)(2009-8#1)(2010-4#1)
and temperature profiles##2##3##(1996-12#1)(2008-3#1)
and temperature sensitivity##2##3##(1995-8#1)(2008-3#1)
and temperature stability##2##3##(2007-12#1)(2008-3#1)
and temperature to##2##3##(2008-10#1)(2008-3#1)
and temperature variations##2##3##(1990-10#1)(2008-10#1)
and temperature was observed##2##4##(2008-10#2)
and temperature was##5##3##(2007-8#1)(2008-10#3)(2008-7#1)
and temperature were optimized##2##4##(2008-10#2)
and temperature were##9##3##(1991-12#1)(1992-11#1)(2008-10#6)(2008-3#1)
and temperature##162##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#1)(1997-2#2)(2007-11#2)(2007-12#9)(2007-8#1)(2008-10#53)(2008-11#6)(2008-12#1)(2008-2#18)(2008-3#31)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-6#1)
and temperature)##5##2##(1990-8#1)(2008-10#3)(2008-7#1)
and temperature-dependent sex determination##2##4##(2008-8#1)(2010-3#1)
and temperature-dependent##4##2##(1990-2#1)(1994-6#1)(2008-8#1)(2010-3#1)
and temperature-dispersion equations##2##3##(2008-3#2)
and temperatures##11##2##(1994-3#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)(2013-7#2)
and temporal analyses##2##3##(2008-10#2)
and temporal bone##2##3##(2008-9#1)(2011-2#1)
and temporal changes in##4##4##(2008-10#1)(2008-11#1)(2010-4#1)(2013-7#1)
and temporal characteristics of##2##4##(2007-12#1)(2008-10#1)
and temporal characteristics##5##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#2)
and temporal cortices##2##3##(1996-12#1)(1996-5#1)
and temporal development of##3##4##(2007-12#1)(2008-10#2)
and temporal distribution of##5##4##(2007-11#1)(2007-5#1)(2008-10#3)
and temporal distribution##6##3##(2007-11#1)(2007-5#1)(2008-10#4)
and temporal dynamics of##2##4##(2008-10#1)(2009-8#1)
and temporal dynamics##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
and temporal effects on tissue##2##5##(2011-1#2)
and temporal effects on##3##4##(2008-10#1)(2011-1#2)
and temporal expression##3##3##(1992-9#1)(1996-6#1)(2012-12#1)
and temporal features##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
and temporal information##2##3##(2008-3#2)
and temporal pattern of##3##4##(1995-5#1)(2007-12#2)
and temporal patterns of the##3##5##(2008-11#1)(2008-7#2)
and temporal patterns of##5##4##(2008-10#2)(2008-11#1)(2008-7#2)
and temporal patterns##7##3##(2008-10#3)(2008-11#1)(2008-7#3)
and temporal phase##4##3##(2007-12#2)(2008-3#2)
and temporal profile of##2##4##(2008-7#1)(2013-8#1)
and temporal profiles##2##3##(2007-11#1)(2009-8#1)
and temporal resolution of##2##4##(2011-2#2)
and temporal resolution##11##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-1#1)(2013-8#1)
and temporal resolutions##3##3##(2008-10#2)(2008-2#1)
and temporal variability of##3##4##(1992-9#2)(2008-10#1)
and temporal variability##4##3##(1992-9#3)(2008-10#1)
and temporal variations##3##3##(2008-5#2)(2008-6#1)
and temporal##126##2##(1992-9#4)(1993-9#1)(1994-9#3)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-8#5)(2007-11#5)(2007-12#9)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#6)(2008-2#7)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
and temporally resolved##2##3##(2008-2#2)
and temporally varying##2##3##(2008-8#1)(2008-9#1)
and temporally##14##2##(1994-2#1)(1994-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-3#1)(2011-2#1)
and temporary##5##2##(1992-5#1)(1994-8#1)(1994-9#1)(2008-10#1)(2010-6#1)
and ten patients##2##3##(2008-9#1)(2009-4#1)
and ten year patient##2##4##(2008-8#2)
and ten year##3##3##(2008-8#3)
and ten##23##2##(1994-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
and tend to##4##3##(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
and tended to##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
and tendency##3##2##(1990-12#1)(2008-12#1)(2008-5#1)
and tender##2##2##(2008-10#1)(2010-11#1)
and tenderness##3##2##(1992-5#1)(2008-1#1)(2010-2#1)
and tendon##4##2##(1997-3#1)(2008-12#1)(2008-9#1)(2009-7#1)
and tends to be##2##4##(2009-8#1)(2013-1#1)
and tends to##4##3##(1990-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
and tenofovir##2##2##(2008-8#1)(2013-1#1)
and tens of##2##3##(1991-2#1)(2008-10#1)
and tensile properties##2##3##(2008-5#1)(2009-7#1)
and tensile##7##2##(1997-5#1)(2008-5#1)(2008-9#1)(2009-7#3)(2012-2#1)
and tensions##2##2##(1995-3#1)(2011-1#1)
and tenth##2##2##(2007-8#1)(2008-4#1)
and terminal differentiation##3##3##(1992-12#1)(2008-4#1)(2008-7#1)
and terminal##12##2##(1992-12#1)(1993-11#2)(1994-5#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-8#1)
and terminals in the##2##4##(1997-3#1)(2008-7#1)
and terminals##5##2##(1992-3#1)(1997-3#2)(1997-7#1)(2008-7#1)
and terminating##3##2##(1997-4#1)(2011-1#2)
and termination of##2##3##(2008-4#1)(2008-9#1)
and termination##4##2##(2008-11#1)(2008-4#2)(2008-9#1)
and terminology of##2##3##(2007-11#1)(2012-2#1)
and terminology##6##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
and terms##2##2##(1990-3#1)(2008-2#1)
and ternary complexes of##2##4##(2008-10#2)
and ternary complexes##4##3##(2008-10#4)
and ternary mixtures of##2##4##(2008-10#2)
and ternary mixtures##8##3##(2008-10#8)
and ternary##15##2##(1994-3#1)(2008-10#14)
and terpolymers##2##2##(2008-5#1)(2008-9#1)
and terrestrial##2##2##(2008-5#1)(2013-7#1)
and territory##3##2##(2008-8#2)(2011-2#1)
and terror##3##2##(1990-6#1)(2009-10#2)
and tert-butylhydroquinone##2##2##(2008-10#2)
and tertiary care##2##3##(1994-2#1)(1995-1#1)
and tertiary hospitals##2##3##(1993-2#1)(2008-3#1)
and tertiary structural##3##3##(1994-5#2)(1995-5#1)
and tertiary structure##10##3##(1990-5#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#2)
and tertiary##24##2##(1990-5#1)(1990-6#1)(1993-2#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#2)(2013-1#2)
and test its predictions using data from##2##7##(2008-8#2)
and test of##4##3##(1991-5#1)(1992-6#1)(2007-7#1)(2012-3#1)
and test results##2##3##(2008-3#1)(2012-3#1)
and test solution pH##2##4##(2008-10#2)
and test the##4##3##(2008-7#2)(2008-9#1)(2009-3#1)
and test##33##2##(1991-2#1)(1991-5#1)(1992-6#1)(1995-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
and tested a##7##3##(2007-11#1)(2008-10#1)(2008-3#4)(2008-8#1)
and tested as##4##3##(1992-8#1)(1995-3#1)(2008-11#1)(2008-2#1)
and tested by##3##3##(2007-12#2)(2008-8#1)
and tested for the##5##4##(2008-10#4)(2013-8#1)
and tested for their ability to##2##6##(1993-11#1)(1993-3#1)
and tested for their##6##4##(1993-11#1)(1993-3#1)(2007-11#1)(2008-10#1)(2011-2#2)
and tested for##27##3##(1992-3#1)(1993-11#1)(1993-3#1)(1993-9#1)(2007-11#1)(2007-9#1)(2008-10#14)(2008-2#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
and tested in a##3##4##(2008-10#1)(2008-5#1)(2009-11#1)
and tested in vitro##2##4##(2008-3#1)(2008-8#1)
and tested in##12##3##(1993-3#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#2)
and tested on##7##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
and tested the##3##3##(1990-5#1)(2009-12#1)(2012-1#1)
and tested to##4##3##(1992-2#1)(1996-1#1)(2008-10#1)(2010-4#1)
and tested under##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and tested using standard##2##4##(2008-10#1)(2010-8#1)
and tested using##5##3##(2007-12#1)(2008-10#3)(2010-8#1)
and tested with##4##3##(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
and tested##130##2##(1990-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-9#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#4)(2007-12#5)(2007-9#1)(2008-10#36)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#22)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-4#2)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and testes##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
and testicular self-exam##2##3##(2009-5#2)
and testicular spermatogenesis##2##3##(2008-7#2)
and testicular##10##2##(1990-2#1)(1990-9#1)(1992-12#1)(1994-5#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#2)
and testified##2##2##(2008-10#1)(2008-8#1)
and testing a##2##3##(1997-3#1)(2008-10#1)
and testing for##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
and testing of a##6##4##(1996-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
and testing of the##2##4##(2008-10#1)(2010-10#1)
and testing of##21##3##(1992-2#1)(1995-6#1)(1996-2#2)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)
and testing the##3##3##(2008-4#1)(2010-8#2)
and testing##52##2##(1992-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#4)
and testis##13##2##(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1997-8#1)(2008-10#1)(2008-8#3)(2012-2#2)(2013-1#1)(2013-8#1)
and testosterone##14##2##(1990-11#2)(1991-12#1)(1992-8#3)(1994-2#1)(1994-3#1)(1995-12#1)(2008-5#2)(2008-7#2)(2011-2#1)
and tests for##4##3##(1992-6#1)(1996-2#1)(2008-7#1)(2012-3#1)
and tests of##2##3##(1992-6#1)(2008-10#1)
and tests##12##2##(1992-6#2)(1994-9#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
and tetanus##5##2##(1992-2#2)(1995-3#1)(1995-5#1)(2011-2#1)
and tetrabromophthalic anhydride##2##3##(2008-10#2)
and tetrabutylammonium hydroxide##2##3##(1990-5#1)(2008-10#1)
and tetrabutylammonium##3##2##(1990-5#1)(2008-10#1)(2009-5#1)
and tetracycline##6##2##(1991-8#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-3#1)
and tetradecyldimethylbenzylammonium chloride##3##3##(2008-10#3)
and tetraethylammonium##2##2##(1996-5#1)(2008-10#1)
and tetraethylorthosilicate##2##2##(2008-10#1)(2008-5#1)
and tetrahydrofuran##3##2##(1994-9#1)(2008-10#1)(2008-2#1)
and tetraiodofluorescein##2##2##(2008-10#2)
and tetramerization properties##2##3##(1993-8#2)
and tetraploid##2##2##(2008-10#1)(2008-11#1)
and text processing##2##3##(2007-12#1)(2008-10#1)
and text##6##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
and textbooks##2##2##(2011-2#1)(2013-8#1)
and textile##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
and texture information##2##3##(2008-6#2)
and texture##8##2##(2007-10#1)(2008-5#1)(2008-6#3)(2010-4#2)(2011-2#1)
and thalamic##2##2##(1995-8#1)(1997-2#1)
and thalamus##3##2##(1996-12#1)(2008-7#1)(2009-9#1)
and thalassemia##4##2##(2008-10#1)(2013-1#3)
and thallium in##2##3##(1993-9#1)(2008-10#1)
and thallium##12##2##(1993-9#1)(2008-10#11)
and thapsigargin##3##2##(1992-5#1)(1994-3#1)(1996-5#1)
and thapsigargin-sensitive##2##2##(1991-8#2)
and that &quot##2##3##(1991-3#1)(2008-9#1)
and that Cx43 transfection##2##4##(2008-11#2)
and that P##2##3##(2008-10#1)(2008-5#1)
and that T##2##3##(2008-10#1)(2008-6#1)
and that a##23##3##(1990-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#1)
and that activation of##3##4##(1997-7#1)(2008-4#1)(2010-11#1)
and that all three##2##4##(2008-10#1)(2008-8#1)
and that all##4##3##(1992-12#1)(2008-10#1)(2008-8#1)(2010-3#1)
and that allows##2##3##(1997-3#1)(2008-3#1)
and that an##5##3##(1994-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-4#1)
and that any##3##3##(1990-11#1)(2008-10#1)(2008-8#1)
and that appear##2##3##(1993-3#1)(2009-10#1)
and that are##5##3##(2008-3#1)(2009-8#1)(2011-1#2)(2012-3#1)
and that at least##2##4##(1991-8#1)(1995-3#1)
and that at##4##3##(1991-8#1)(1995-3#1)(1995-8#1)(2008-10#1)
and that between##2##3##(1990-6#1)(2008-3#1)
and that both the##2##4##(1991-10#1)(1993-11#1)
and that both##6##3##(1991-10#1)(1992-4#1)(1993-11#1)(2008-10#2)(2009-2#1)
and that can##4##3##(2008-10#1)(2008-9#1)(2010-7#1)(2012-2#1)
and that cell##2##3##(1992-6#1)(2008-11#1)
and that changes in##5##4##(1991-9#1)(1992-6#1)(1994-8#1)(2008-10#1)(2010-5#1)
and that difference was statistically significant##3##6##(2011-2#3)
and that differences##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
and that down-regulation of##2##4##(2008-11#1)(2011-2#1)
and that each##2##3##(1996-1#1)(1997-8#1)
and that exposure##2##3##(2008-7#1)(2011-2#1)
and that expression##2##3##(1993-3#1)(2012-2#1)
and that for the##2##4##(1996-12#1)(2008-10#1)
and that for##7##3##(1990-11#1)(1991-12#1)(1996-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
and that further##2##3##(1997-2#1)(2008-3#1)
and that future##2##3##(2008-8#2)
and that good##2##3##(1993-12#1)(1996-6#1)
and that has been##2##4##(2010-7#1)(2012-12#1)
and that has##3##3##(2008-3#1)(2010-7#1)(2012-12#1)
and that higher doses##2##4##(1993-11#1)(2008-8#1)
and that higher##3##3##(1993-11#1)(2008-8#1)(2009-10#1)
and that in the##4##4##(1994-12#1)(1994-9#1)(2008-12#1)(2013-8#1)
and that in vitro##2##4##(2008-5#2)
and that in##10##3##(1990-12#1)(1991-6#1)(1994-12#2)(1994-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2013-8#1)
and that increased##2##3##(1995-6#1)(2008-11#1)
and that inhibition##3##3##(1993-11#1)(1994-8#1)(2008-11#1)
and that is##6##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
and that it can be useful in##2##7##(1995-11#1)(2008-2#1)
and that it can##4##4##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and that it has##3##4##(1990-12#1)(2008-2#1)(2008-7#1)
and that it is not##3##5##(2008-10#1)(2010-8#1)(2012-2#1)
and that it is##13##4##(1990-3#1)(1991-1#1)(1994-3#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#2)(2012-2#1)
and that it may be##3##5##(1992-8#1)(2008-10#1)(2008-11#1)
and that it may##6##4##(1992-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)
and that it will be##2##5##(1996-8#1)(2008-8#1)
and that it##42##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-3#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
and that its##10##3##(1992-10#1)(1992-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
and that loss of##3##4##(1990-11#1)(2007-12#1)(2012-12#1)
and that low doses actually reduce risk##2##7##(2008-7#2)
and that many of##2##4##(2008-7#1)(2009-8#1)
and that many##5##3##(1990-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
and that most##2##3##(2008-10#1)(2008-11#1)
and that obtained##2##3##(2008-10#2)
and that of a##2##4##(2008-10#1)(2008-3#1)
and that of the##19##4##(1990-2#1)(1990-7#1)(1996-5#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#1)
and that of##58##3##(1990-2#2)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
and that only##2##3##(1991-6#1)(1996-12#1)
and that our##2##3##(1991-12#1)(2008-5#1)
and that phosphorylation of##2##4##(2008-5#1)(2010-12#1)
and that physicians rely primarily on direct experience for the information necessary to make a referral choice##2##17##(1994-1#2)
and that previously##2##3##(1997-7#1)(2008-10#1)
and that reduced##4##3##(1990-2#1)(1992-12#1)(1994-9#1)(2012-2#1)
and that relatively##2##3##(2007-12#1)(2008-11#1)
and that requires##2##3##(1993-2#1)(2011-2#1)
and that sexual recombination##2##4##(2008-10#2)
and that sexual##3##3##(2008-10#2)(2012-3#1)
and that simple##2##3##(1993-9#1)(2008-8#1)
and that some##2##3##(1996-9#1)(2008-10#1)
and that specific##3##3##(1992-3#1)(2008-10#1)(2012-12#1)
and that such##6##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-7#1)(2011-2#1)
and that surgical##2##3##(2008-7#1)(2013-1#1)
and that the affinity##2##4##(1990-8#1)(1994-6#1)
and that the best##2##4##(2008-10#1)(2011-2#1)
and that the different##2##4##(1995-11#1)(2008-10#1)
and that the effects of##2##5##(1994-9#1)(2008-8#1)
and that the experimental##2##4##(1996-2#1)(2008-2#1)
and that the expression##2##4##(1992-3#1)(2008-9#1)
and that the induction of##2##5##(1996-7#1)(1997-2#1)
and that the interaction##2##4##(1991-5#1)(1995-2#1)
and that the key##2##4##(1992-8#1)(2008-7#1)
and that the lack of##2##5##(1994-8#1)(2008-10#1)
and that the majority##2##4##(2008-12#1)(2013-1#1)
and that the male##2##4##(2008-8#1)(2010-5#1)
and that the maximum##2##4##(1990-11#1)(2008-5#1)
and that the mechanism of##2##5##(1990-2#1)(2013-8#1)
and that the most##2##4##(2008-10#1)(2010-8#1)
and that the new##2##4##(2008-11#1)(2009-6#1)
and that the number of##2##5##(2008-7#1)(2010-7#1)
and that the potential##2##4##(1996-2#1)(2008-5#1)
and that the presence of##2##5##(2008-10#1)(2012-12#1)
and that the protein##3##4##(1993-11#1)(1994-3#1)(1996-12#1)
and that the sensitivity##2##4##(2008-3#1)(2008-8#1)
and that the three##2##4##(1995-6#1)(2008-10#1)
and that the two##4##4##(1990-5#1)(1996-2#1)(2008-10#1)(2008-3#1)
and that the use of##2##5##(2008-10#1)(2010-5#1)
and that the##255##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#5)(2007-12#7)(2008-1#2)(2008-10#35)(2008-11#10)(2008-12#3)(2008-2#7)(2008-3#17)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#14)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
and that their##5##3##(1994-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)
and that there are##3##4##(2008-1#1)(2008-5#1)(2013-8#1)
and that there exists##2##4##(1990-12#1)(2008-9#1)
and that there is no##2##5##(1991-3#1)(2011-2#1)
and that there is##6##4##(1991-11#1)(1991-3#1)(1994-9#1)(2008-11#1)(2011-2#1)(2012-2#1)
and that there##16##3##(1990-12#1)(1991-11#1)(1991-3#1)(1994-9#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and that these differences##2##4##(1992-3#1)(1993-3#1)
and that these factors##2##4##(2008-10#1)(2012-3#1)
and that these##32##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
and that they are##2##4##(2008-10#1)(2008-2#1)
and that they could##2##4##(1996-9#1)(2008-9#1)
and that they may##3##4##(2008-5#1)(2009-3#1)(2010-5#1)
and that they were##3##4##(2008-11#2)(2008-9#1)
and that they##23##3##(1994-3#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-5#1)(2012-12#1)
and that this activation##2##4##(1993-12#1)(1994-2#1)
and that this effect is##2##5##(2007-10#1)(2009-4#1)
and that this effect##5##4##(1994-8#1)(2007-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
and that this factor##2##4##(1992-3#1)(1994-12#1)
and that this in turn##2##5##(1990-12#1)(2010-4#1)
and that this increased##3##4##(1994-5#1)(2008-10#1)(2008-7#1)
and that this is not##2##5##(2011-1#1)(2012-12#1)
and that this is##3##4##(1994-8#1)(2011-1#1)(2012-12#1)
and that this may be##2##5##(1991-2#1)(2008-8#1)
and that this may##3##4##(1991-2#1)(2008-7#1)(2008-8#1)
and that this property##2##4##(2008-5#1)(2008-7#1)
and that this##52##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-6#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and that to##2##3##(1993-8#1)(2008-3#1)
and that treatment with##2##4##(1993-3#1)(2008-10#1)
and that treatment##4##3##(1992-9#1)(1993-3#1)(1995-2#1)(2008-10#1)
and that two of##2##4##(2008-10#1)(2012-3#1)
and that two##4##3##(1993-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
and that tyrosine##2##3##(1994-11#1)(1996-5#1)
and that uses##2##3##(1992-6#1)(2008-2#1)
and that various##2##3##(2008-12#2)
and that was##2##3##(1997-8#1)(2008-2#1)
and that we##3##3##(1994-12#1)(2008-8#1)(2010-11#1)
and that when##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
and that which is##2##4##(1993-8#1)(2008-11#1)
and that without##2##3##(1995-4#1)(2008-3#1)
and that##1105##2##(1990-11#9)(1990-12#8)(1990-2#8)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#6)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#15)(1991-2#6)(1991-3#4)(1991-5#5)(1991-6#2)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#7)(1992-4#3)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#5)(1993-2#3)(1993-3#7)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#10)(1994-2#5)(1994-3#8)(1994-5#6)(1994-6#4)(1994-8#9)(1994-9#7)(1995-1#3)(1995-11#5)(1995-12#13)(1995-2#12)(1995-3#5)(1995-4#2)(1995-5#5)(1995-6#8)(1995-8#5)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#11)(1996-2#8)(1996-3#4)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#10)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#9)(1997-8#3)(2006-6#2)(2007-10#8)(2007-11#8)(2007-12#20)(2007-2#3)(2007-4#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#144)(2008-11#55)(2008-12#18)(2008-2#19)(2008-3#61)(2008-4#12)(2008-5#34)(2008-6#10)(2008-7#38)(2008-8#58)(2008-9#27)(2009-10#8)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#14)(2009-9#5)(2010-1#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#6)(2010-8#3)(2011-1#18)(2011-10#1)(2011-2#32)(2011-3#1)(2012-1#5)(2012-12#14)(2012-2#19)(2012-3#23)(2013-1#17)(2013-7#1)(2013-8#10)
and thaumatin##2##2##(1997-4#1)(2008-10#1)
and thaw##2##2##(2008-9#1)(2011-2#1)
and thawing##13##2##(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-3#1)
and the &quot##6##3##(1994-11#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)
and the 1##7##3##(1992-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2012-2#1)
and the 2##4##3##(1990-9#1)(2008-10#2)(2011-2#1)
and the 20##3##3##(2008-10#2)(2011-2#1)
and the 3' NCR##2##4##(2008-9#2)
and the 3' untranslated region##4##5##(1991-9#1)(1997-6#2)(2008-10#1)
and the 3'##13##3##(1991-9#1)(1992-3#1)(1992-9#1)(1996-6#1)(1997-6#3)(2008-10#4)(2008-9#2)
and the 30th##2##3##(1995-8#1)(2008-5#1)
and the 3sigma detection limit##2##5##(2008-10#2)
and the 4##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
and the 5##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
and the 5'##5##3##(1996-8#1)(2008-10#1)(2008-8#3)
and the 5-year disease-free survival rate was##2##7##(1997-7#2)
and the A##3##3##(1996-7#1)(2008-9#1)(2010-7#1)
and the AD cases##2##4##(1991-1#2)
and the AIDS##2##3##(1992-12#1)(1996-6#1)
and the ANN##2##3##(2008-10#2)
and the ARS##2##3##(2008-6#2)
and the ATPase##3##3##(1995-6#1)(1996-9#1)(2006-6#1)
and the Addiction Severity Index##2##5##(2011-1#2)
and the Alb method##2##4##(2008-7#2)
and the American Association##2##4##(1991-1#1)(2008-1#1)
and the American Hospital Association##2##5##(1992-2#1)(1992-3#1)
and the American##10##3##(1991-1#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#2)(1995-6#1)(1996-6#1)(2008-1#1)(2012-12#1)
and the Americas##3##3##(2008-10#3)
and the Ar##2##3##(2008-10#2)
and the Association##2##3##(2008-10#1)(2012-3#1)
and the Bayesian##2##3##(1994-9#1)(2011-1#1)
and the Beck Depression Inventory##3##5##(2011-2#1)(2013-1#1)(2013-8#1)
and the Bragg wavelength##2##4##(2007-11#2)
and the Bragg##3##3##(2007-11#2)(2007-12#1)
and the C-CH(3) mode##2##4##(2007-1#2)
and the C-terminal region##2##4##(1997-2#2)
and the C-terminal##13##3##(1991-12#2)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#2)(1995-5#1)(1995-6#1)(1997-2#2)(2008-10#1)(2008-9#1)
and the CD4##2##3##(1992-6#1)(2012-2#1)
and the CH(3)##2##3##(2008-10#2)
and the CL##3##3##(1991-9#1)(2008-10#2)
and the CP##2##3##(2008-10#1)(2008-8#1)
and the California##2##3##(1995-12#1)(2008-11#1)
and the Canadian##4##3##(1994-11#1)(2007-12#2)(2007-5#1)
and the Caribbean Basin##3##4##(2008-10#3)
and the Caribbean and##3##4##(2008-5#1)(2011-2#2)
and the Caribbean##11##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#5)
and the Carolinas##2##3##(2008-8#2)
and the Caucasus##5##3##(2008-10#5)
and the Centers for Disease Control and Prevention)##2##8##(2008-4#1)(2008-9#1)
and the Centers for##3##4##(2008-4#1)(2008-9#1)(2012-12#1)
and the Central##2##3##(2008-2#1)(2010-4#1)
and the Child Behavior Checklist##2##5##(1993-1#1)(2006-10#1)
and the Child##4##3##(1993-1#1)(2006-10#1)(2008-9#1)(2009-11#1)
and the Chinese##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
and the Czech Republic##2##4##(2008-11#1)(2008-5#1)
and the DNA##9##3##(1991-12#1)(1992-3#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-2#2)(2008-4#1)
and the DNC##2##3##(2010-2#2)
and the Department of##2##4##(2007-8#1)(2008-11#1)
and the District of Columbia##3##5##(1992-3#1)(1997-1#1)(2010-5#1)
and the Dominican Republic##3##4##(2008-10#2)(2008-11#1)
and the Doppler##2##3##(2008-3#2)
and the E2##2##3##(1990-5#1)(1994-8#1)
and the Environmental##2##3##(1992-1#1)(2008-11#1)
and the European Society##2##4##(2008-10#1)(2012-3#1)
and the European##9##3##(1995-6#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
and the Expression of##2##4##(2010-8#2)
and the F##2##3##(2008-3#1)(2013-1#1)
and the F(1)##2##3##(2008-10#2)
and the FLACC##2##3##(2012-2#2)
and the FWHM##2##3##(2007-12#1)(2008-3#1)
and the Fano factor##2##4##(2010-10#2)
and the Federal##4##3##(1995-12#1)(1996-1#1)(1997-5#1)(2011-1#1)
and the Fisher##2##3##(2008-3#1)(2013-7#1)
and the Food and Drug Administration##2##6##(2008-12#1)(2012-2#1)
and the Food##3##3##(2008-12#1)(2010-9#1)(2012-2#1)
and the Fourier##7##3##(2008-2#2)(2008-3#5)
and the G1/G2##2##3##(2008-10#2)
and the GAB##2##3##(2008-10#2)
and the GFP##2##3##(2008-4#1)(2008-9#1)
and the Gibbs##2##3##(1997-2#1)(2008-10#1)
and the Global Assessment##2##4##(2008-11#1)(2011-1#1)
and the Global##6##3##(1991-2#1)(1994-6#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
and the Golgi##3##3##(1990-7#1)(2008-11#1)(2009-8#1)
and the Group Benefit Questionnaire##2##5##(2013-1#2)
and the HR##2##3##(2013-8#2)
and the Health Care Financing Administration##2##6##(1994-2#1)(1997-2#1)
and the Health##4##3##(1994-2#1)(1997-2#1)(2007-12#1)(2012-3#1)
and the IR##2##3##(2007-11#1)(2008-3#1)
and the IRMA##2##3##(1993-2#2)
and the ITA##2##3##(2007-8#2)
and the IgG##2##3##(1994-2#1)(2008-10#1)
and the IgG-binding##2##3##(1990-8#1)(1995-5#1)
and the Indian##2##3##(2009-11#1)(2010-12#1)
and the Infrared##2##3##(1996-2#1)(2008-2#1)
and the Institute of##2##4##(2010-10#1)(2012-2#1)
and the International##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
and the Internet##3##3##(2007-12#1)(2008-11#2)
and the JNK pathway##2##4##(2008-1#2)
and the Japanese##2##3##(2008-11#1)(2008-6#1)
and the LOD##2##3##(2008-10#2)
and the Los##2##3##(2008-5#1)(2013-1#1)
and the MS##2##3##(1994-3#1)(2008-3#1)
and the Massachusetts##2##3##(1993-12#1)(2008-5#1)
and the Medical##5##3##(1993-6#1)(1996-3#1)(1997-2#1)(1997-5#1)(2010-2#1)
and the Medicare##3##3##(1995-12#1)(1996-3#1)(1997-3#1)
and the Mediterranean##2##3##(2008-10#1)(2011-2#1)
and the Middle East##2##4##(1995-3#1)(2008-10#1)
and the Middle##3##3##(1995-3#1)(2008-10#2)
and the Mie##2##3##(2008-3#2)
and the Ministry of Health##3##5##(1991-2#1)(2008-1#1)(2008-10#1)
and the Ministry of##4##4##(1991-2#1)(2008-1#1)(2008-10#1)(2010-4#1)
and the Monte Carlo##3##4##(2008-2#1)(2008-3#2)
and the N##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
and the N-terminal##6##3##(1991-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-6#1)
and the NH2-terminal##2##3##(1990-12#1)(1992-9#1)
and the NHS##2##3##(2008-11#1)(2008-7#1)
and the NO##2##3##(1995-5#1)(1996-2#1)
and the Na+##2##3##(1991-8#1)(1995-11#1)
and the National Health##3##4##(2007-5#1)(2008-10#2)
and the National Institute of##3##5##(1996-4#1)(2008-9#1)(2011-2#1)
and the National Institute##4##4##(1996-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
and the National##14##3##(1994-12#1)(1996-4#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#1)
and the Netherlands##4##3##(1991-4#1)(2008-10#2)(2008-7#1)
and the New##2##3##(1992-12#1)(1996-1#1)
and the Norwegian##3##3##(1992-5#1)(1994-2#1)(1994-9#1)
and the Nursing Interventions Classification were used to identify the appropriate nursing diagnosis##2##13##(2013-1#2)
and the Optimal##2##3##(2008-6#1)(2013-7#1)
and the Pacific##4##3##(2008-1#2)(2008-2#1)(2012-12#1)
and the Patient##2##3##(1992-12#1)(2012-1#1)
and the Philippines##3##3##(2007-5#2)(2012-12#1)
and the Prevention of##2##4##(2008-11#1)(2010-12#1)
and the R##10##3##(1995-3#1)(2008-10#9)
and the RSD of the method 0##2##7##(2008-10#2)
and the RSD of the##3##5##(2008-10#3)
and the RSD was##2##4##(2008-10#2)
and the RSD##7##3##(2008-10#7)
and the Raman scattering##2##4##(2008-10#1)(2008-3#1)
and the Raman##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
and the Republic of the Marshall Islands##2##7##(2008-1#2)
and the Republic of##3##4##(2008-1#2)(2013-8#1)
and the Rey Memory Test##2##5##(2008-7#2)
and the Rhodamine##2##3##(2008-10#1)(2009-11#1)
and the S182##2##3##(1995-8#2)
and the SE systems##2##4##(2008-10#2)
and the SE##3##3##(2008-10#2)(2008-3#1)
and the SMR of##2##4##(2008-10#1)(2009-7#1)
and the SNR##2##3##(2007-12#1)(2008-3#1)
and the SPME##2##3##(2008-10#2)
and the School of##2##4##(2008-11#1)(2010-3#1)
and the Short##2##3##(2008-10#1)(2009-10#1)
and the Society for##2##4##(1996-8#1)(2013-8#1)
and the Society of##2##4##(2008-5#1)(2013-1#1)
and the Society##5##3##(1994-12#1)(1996-8#1)(2008-5#1)(2013-1#1)(2013-8#1)
and the South##3##3##(2008-1#2)(2008-10#1)
and the State-Trait Anxiety Inventory for Children##2##7##(1995-12#1)(2013-8#1)
and the State-Trait Anxiety Inventory##3##5##(1995-12#1)(2010-6#1)(2013-8#1)
and the Stokes##2##3##(2007-11#1)(2008-2#1)
and the Study##2##3##(2008-7#1)(2012-2#1)
and the TSS concentration##3##4##(2013-8#3)
and the U##8##3##(1992-12#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-10#2)(2008-12#1)(2012-3#1)
and the UK##3##3##(1996-1#1)(2008-7#1)(2011-1#1)
and the US##5##3##(1994-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-8#1)
and the USA##2##3##(2007-2#1)(2010-11#1)
and the UV##2##3##(2008-10#1)(2008-3#1)
and the United Kingdom##8##4##(1992-1#1)(1995-1#2)(2008-10#2)(2008-7#2)(2013-8#1)
and the United States and##2##5##(2008-10#2)
and the United States have##2##5##(1993-3#1)(2008-8#1)
and the United States were analyzed##2##6##(2008-10#2)
and the United States were##5##5##(2007-12#1)(2008-10#3)(2008-5#1)
and the United States##40##4##(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#3)(1996-3#1)(2007-12#3)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-12#2)(2012-2#3)(2012-3#1)
and the United##50##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#3)(1995-1#2)(1996-3#1)(2007-12#3)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-8#1)
and the University of##7##4##(1991-2#1)(1992-2#1)(1993-2#1)(1994-11#1)(1996-7#1)(2008-12#1)(2008-7#1)
and the Western countries##2##4##(2010-2#2)
and the Western##3##3##(2008-5#1)(2010-2#2)
and the World##2##3##(1993-11#1)(1996-2#1)
and the X chromosome##2##4##(1995-5#1)(1996-6#1)
and the abdomen##2##3##(1997-5#1)(2008-5#1)
and the abilities of the##2##5##(1992-8#1)(1995-5#1)
and the ability of cells to##2##6##(2008-10#1)(2008-11#1)
and the ability of##12##4##(1992-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#2)
and the ability to accept##2##5##(1995-8#1)(2012-3#1)
and the ability to be##3##5##(2008-2#1)(2008-7#1)(2009-9#1)
and the ability to measure##2##5##(2008-1#1)(2012-2#1)
and the ability to segment language##2##6##(2012-3#2)
and the ability to tune##2##5##(2007-11#1)(2012-12#1)
and the ability to##42##4##(1990-5#1)(1992-8#1)(1995-8#2)(1996-12#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)
and the ability##54##3##(1990-5#1)(1992-12#1)(1992-8#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)
and the abnormal##2##3##(1996-11#1)(2012-2#1)
and the absence of a##2##5##(2007-12#1)(2008-3#1)
and the absence of data on##2##6##(2008-9#2)
and the absence of##22##4##(1993-3#1)(1994-9#1)(1996-1#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the absence##24##3##(1992-2#1)(1993-3#1)(1994-9#1)(1996-1#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
and the absolute##9##3##(1993-8#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-3#1)(2013-1#1)
and the absorbance is##3##4##(2008-10#3)
and the absorbance of the oxidized OPD##2##7##(2008-10#2)
and the absorbance of the##5##5##(2008-10#5)
and the absorbance##13##3##(2007-12#1)(2008-10#12)
and the absorption coefficient of##2##5##(2007-12#1)(2008-3#1)
and the absorption coefficient##5##4##(2007-12#1)(2008-3#4)
and the absorption coefficients of##2##5##(2007-12#1)(2008-3#1)
and the absorption coefficients##3##4##(2007-12#1)(2008-3#2)
and the absorption##17##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#11)
and the abundance of##3##4##(1994-2#1)(2008-11#1)(2008-5#1)
and the academic performance##2##4##(2013-8#2)
and the academic##3##3##(2008-12#1)(2013-8#2)
and the accompanying##5##3##(1995-3#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)
and the accumulation of##7##4##(1990-5#1)(1995-6#1)(1997-3#1)(2008-10#2)(2009-8#1)(2010-3#1)
and the accumulation time##2##4##(2008-10#2)
and the accumulation##10##3##(1990-5#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-11#1)(2009-8#1)(2010-3#1)
and the accuracy of the##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
and the accuracy of##8##4##(1992-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)
and the accuracy##13##3##(1991-8#1)(1992-3#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-6#1)
and the accurate##2##3##(2008-10#1)(2011-2#1)
and the achievement##2##3##(2008-12#1)(2011-2#1)
and the acquired##2##3##(1996-12#1)(2008-10#1)
and the acrophase##2##3##(2010-8#2)
and the action of##2##4##(2008-5#1)(2009-8#1)
and the action##4##3##(1991-3#1)(2008-5#1)(2009-8#1)(2011-3#1)
and the actions of##2##4##(2008-7#1)(2008-9#1)
and the activation of##17##4##(1991-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
and the activation##20##3##(1991-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
and the active site##2##4##(1996-8#1)(2013-1#1)
and the active##12##3##(1991-8#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and the activities of the##2##5##(1991-12#1)(1993-3#1)
and the activities of##10##4##(1991-12#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#1)
and the activities##11##3##(1991-12#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#1)
and the activity of the##4##5##(1994-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
and the activity of##19##4##(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-3#2)(2012-1#1)(2013-1#1)
and the activity##20##3##(1994-11#1)(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-3#2)(2012-1#1)(2013-1#1)
and the actual##7##3##(1993-12#1)(1994-3#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-1#1)
and the actuarial##2##3##(1990-6#1)(1990-9#1)
and the acute phase response##2##5##(1992-9#1)(1993-12#1)
and the acute##3##3##(1992-9#1)(1993-12#1)(1996-3#1)
and the adaptive##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
and the addition of##6##4##(1991-9#1)(2008-10#2)(2008-2#1)(2011-1#2)
and the adenine##2##3##(1990-8#1)(1992-6#1)
and the adenosine receptor##2##4##(1995-8#2)
and the adhesion force##2##4##(2008-10#1)(2008-11#1)
and the adjacent##7##3##(1990-11#1)(1991-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-9#1)
and the adoption of##2##4##(1995-3#1)(2008-12#1)
and the advanced##2##3##(1994-12#1)(2008-3#1)
and the advances made in##2##5##(2009-8#1)(2010-3#1)
and the advantage of##3##4##(2008-10#2)(2012-5#1)
and the advantage##4##3##(2008-10#2)(2012-3#1)(2012-5#1)
and the advantages and disadvantages of##2##6##(1991-1#1)(2008-9#1)
and the advantages and##3##4##(1991-1#1)(2008-3#1)(2008-9#1)
and the advantages of##5##4##(1994-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
and the advantages##10##3##(1991-1#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
and the aerosol##3##3##(1992-3#1)(2008-3#2)
and the affected##4##3##(1997-8#1)(2007-12#1)(2008-7#1)(2013-1#1)
and the affinity##3##3##(1997-7#1)(2008-10#1)(2012-2#1)
and the age of the##2##5##(2007-11#1)(2008-7#1)
and the age of##3##4##(2007-11#1)(2008-7#1)(2008-8#1)
and the age##7##3##(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
and the age-standardised mortality rate##2##5##(2008-8#2)
and the aging##2##3##(2010-2#1)(2012-2#1)
and the agreement between observed and certified##2##7##(2008-10#2)
and the alcohol##2##3##(2007-11#1)(2008-10#1)
and the algorithm##2##3##(2008-2#2)
and the alignment of the##2##5##(2007-11#1)(2008-4#1)
and the alignment##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
and the alternative##2##3##(2008-9#1)(2013-8#1)
and the altitude##2##3##(2008-3#2)
and the amino acid composition of the##2##7##(1990-8#1)(2008-9#1)
and the amino acid sequence of##3##6##(1990-7#3)
and the amino acid sequence##7##5##(1990-7#3)(1991-9#2)(1994-9#1)(2013-8#1)
and the amino acid##12##4##(1990-7#3)(1990-8#1)(1991-2#1)(1991-9#2)(1994-9#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
and the amino##14##3##(1990-7#3)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-6#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
and the amino-terminal sequences##2##4##(1992-8#1)(1996-8#1)
and the amount of the##3##5##(1992-6#1)(1992-8#1)(2008-8#1)
and the amount of##34##4##(1992-6#2)(1992-8#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-6#1)(1997-3#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#4)(2010-5#1)(2011-2#2)(2013-8#1)
and the amount##38##3##(1990-11#1)(1990-12#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#4)(2010-5#1)(2011-2#2)(2013-8#1)
and the amphipathic##2##3##(1994-3#1)(1997-2#1)
and the amplified fragment length polymorphism marker##2##7##(2008-10#2)
and the amplitude of the##2##5##(2007-11#1)(2008-5#1)
and the amplitude of##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
and the amplitude##5##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
and the amplitudes of##2##4##(2008-10#1)(2008-3#1)
and the amygdala##3##3##(1996-5#1)(2008-11#1)(2008-7#1)
and the analysis of the##3##5##(2008-10#2)(2008-11#1)
and the analysis of##12##4##(1990-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2012-12#1)
and the analysis##17##3##(1990-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2012-12#1)(2012-3#1)(2013-8#1)
and the analyte determined##2##4##(2008-10#2)
and the analyte##5##3##(2008-10#5)
and the analytes were##2##4##(2008-10#2)
and the analytes##6##3##(2008-10#6)
and the analytic##2##3##(1995-2#1)(2007-10#1)
and the analytical characteristics##3##4##(2008-10#3)
and the analytical frequency was##2##5##(2008-10#2)
and the analytical performance##2##4##(2008-10#2)
and the analytical results were##3##5##(2008-10#3)
and the analytical results##5##4##(2008-10#3)(2008-3#2)
and the analytical##21##3##(2008-10#16)(2008-3#3)(2010-11#1)(2011-1#1)
and the anatomical##2##3##(1992-12#1)(2008-10#1)
and the anemia##2##3##(2010-12#1)(2011-2#1)
and the angle of incidence##2##5##(2007-12#1)(2008-10#1)
and the angle of the##2##5##(2007-8#1)(2008-3#1)
and the angle of##5##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the angular##4##3##(2007-11#1)(2008-3#3)
and the animal##2##3##(1996-12#1)(2008-10#1)
and the animals were##2##4##(2010-8#1)(2011-2#1)
and the animals##4##3##(1992-3#1)(1995-12#1)(2010-8#1)(2011-2#1)
and the annual##6##3##(1991-6#1)(1992-2#1)(1995-2#1)(2007-7#1)(2011-2#1)(2012-12#1)
and the anomalous diffraction##2##4##(2008-2#2)
and the antagonist##3##3##(1996-2#1)(2008-10#2)
and the anterior##7##3##(1991-6#1)(1994-3#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
and the antibodies were##2##4##(1993-8#1)(2008-9#1)
and the antibodies##4##3##(1993-8#1)(2008-8#1)(2008-9#1)(2009-6#1)
and the antibody was##4##4##(1991-5#1)(1997-2#1)(2008-10#2)
and the antibody##5##3##(1991-5#1)(1997-2#1)(2008-10#2)(2008-11#1)
and the anticancer##2##3##(2009-12#1)(2009-9#1)
and the anticipated##2##3##(1993-12#1)(2008-7#1)
and the antifungal##2##3##(2008-10#1)(2008-5#1)
and the antimalarial##2##3##(1994-12#1)(2010-1#1)
and the antioxidant##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)
and the apparatus##2##3##(2007-12#1)(2008-3#1)
and the apparent molar absorptivity##3##5##(2008-10#3)
and the apparent molar##4##4##(2008-10#4)
and the apparent##9##3##(1990-3#1)(1992-3#1)(1992-6#1)(2008-10#5)(2010-9#1)
and the appearance of##12##4##(1992-12#1)(1994-6#1)(1996-3#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)
and the appearance##13##3##(1992-12#1)(1994-6#1)(1995-6#1)(1996-3#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#1)
and the application of a##2##5##(2008-10#1)(2008-7#1)
and the application of an external##2##6##(2008-7#2)
and the application of it to the determination of##2##9##(2008-10#2)
and the application of the internet of things in##2##9##(2012-3#2)
and the application of the##3##5##(2008-2#1)(2012-3#2)
and the application of##21##4##(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-4#1)(2008-7#4)(2008-8#1)(2012-12#1)(2012-3#2)
and the application##26##3##(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
and the applied##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
and the approach##3##3##(1996-8#1)(2008-9#1)(2010-3#1)
and the appropriate##7##3##(1991-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
and the appropriateness of##2##4##(2007-2#1)(2013-8#1)
and the aprX##2##3##(2008-10#2)
and the aqueous phase##2##4##(1994-12#1)(2008-10#1)
and the aqueous##4##3##(1994-12#1)(2008-10#3)
and the arc discharge composite (1% mass fraction)##2##8##(2008-10#2)
and the area of the##2##5##(1991-2#1)(2008-10#1)
and the area under the##2##5##(2008-10#1)(2008-11#1)
and the area##5##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
and the arm##2##3##(2008-12#1)(2008-7#1)
and the aromatic##2##3##(2008-10#1)(2012-2#1)
and the artery was##2##4##(2008-7#1)(2012-3#1)
and the articles##2##3##(2011-2#1)(2012-3#1)
and the artificial##2##3##(1992-12#1)(2012-1#1)
and the assay of##3##4##(1991-11#1)(1994-7#1)(2008-11#1)
and the assay results were satisfactory##2##6##(2008-10#2)
and the assay##6##3##(1991-11#1)(1994-7#1)(2008-10#3)(2008-11#1)
and the assays##2##3##(2008-4#1)(2011-2#1)
and the assessment of##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
and the associated disturbances##2##4##(2007-11#1)(2008-3#1)
and the associated##23##3##(1993-3#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)
and the association of##2##4##(2012-3#1)(2013-1#1)
and the association with##2##4##(2008-10#2)
and the association##6##3##(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and the asymmetry factor##2##4##(2008-3#2)
and the asymmetry parameter##2##4##(2008-2#1)(2008-3#1)
and the asymmetry##5##3##(2008-2#1)(2008-3#3)(2008-5#1)
and the asymptotic##2##3##(2008-3#1)(2012-1#1)
and the atherogenic##2##3##(2008-12#1)(2013-7#1)
and the atmosphere##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
and the atmospheric##2##3##(2008-2#1)(2008-3#1)
and the atomic number##2##4##(2008-3#2)
and the atomic##5##3##(2008-10#2)(2008-3#2)(2008-7#1)
and the attitudes of##2##4##(2007-7#1)(2008-10#1)
and the authors##4##3##(1996-12#1)(2006-7#1)(2010-10#1)(2013-8#1)
and the authors' experience##2##4##(1990-10#1)(2010-11#1)
and the authors'##5##3##(1990-10#1)(2007-11#1)(2008-7#1)(2010-11#1)(2012-3#1)
and the autocorrelation##2##3##(2008-2#1)(2013-1#1)
and the autophosphorylation##2##3##(1991-12#1)(1993-6#1)
and the autosomal##2##3##(2008-6#1)(2008-8#1)
and the auxiliary##2##3##(1991-2#1)(1995-1#1)
and the availability of##10##4##(1994-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)
and the availability##11##3##(1992-3#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)
and the available##6##3##(1991-6#1)(1992-2#1)(1994-5#1)(2008-8#1)(2010-11#1)(2011-2#1)
and the average duration of##2##5##(2011-2#2)
and the average flow##2##4##(2008-3#1)(2011-2#1)
and the average length##2##4##(2008-7#1)(2009-10#1)
and the average number and length of the introns per gene were##2##12##(1997-6#1)(1997-8#1)
and the average number of##2##5##(1991-12#1)(2008-10#1)
and the average number##4##4##(1991-12#1)(1997-6#1)(1997-8#1)(2008-10#1)
and the average recovery##2##4##(2008-10#2)
and the average size of##4##5##(2008-3#2)(2008-5#1)(2011-1#1)
and the average##46##3##(1991-12#1)(1997-6#1)(1997-8#3)(2007-11#1)(2007-8#2)(2008-10#9)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#2)
and the axial##2##3##(2008-2#1)(2008-3#1)
and the axillary##3##3##(2008-8#1)(2010-6#1)(2012-12#1)
and the azimuth##2##3##(2008-2#1)(2008-3#1)
and the baby##3##3##(1996-11#2)(2011-1#1)
and the background##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
and the backscattering coefficient##4##4##(2008-2#2)(2008-3#2)
and the backscattering##6##3##(2008-2#2)(2008-3#4)
and the backward##2##3##(2008-2#1)(2008-3#1)
and the bacterial##3##3##(1992-5#1)(2008-11#1)(2008-7#1)
and the bacterium##2##3##(2008-10#2)
and the band##3##3##(1993-11#1)(2008-10#1)(2008-9#1)
and the bandwidth of##2##4##(2007-12#1)(2008-3#1)
and the bandwidth##5##3##(1994-8#1)(2007-12#2)(2008-3#2)
and the barriers that##2##4##(1994-12#1)(1996-12#1)
and the basal ES##2##4##(2012-2#2)
and the basal##9##3##(1992-9#1)(1994-12#1)(1995-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#2)
and the bases##2##3##(1994-3#1)(2007-11#1)
and the basic##5##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
and the basis for##2##4##(2008-10#1)(2008-11#1)
and the beam##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
and the beginning of the##3##5##(2007-11#1)(2009-7#1)(2012-2#1)
and the beginning of##7##4##(1996-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
and the behavioral##4##3##(2007-12#1)(2008-4#1)(2008-9#1)(2011-2#1)
and the benefit of##2##4##(1997-6#1)(2008-2#1)
and the benefit##3##3##(1992-3#1)(1997-6#1)(2008-2#1)
and the benefits and##2##4##(1996-3#1)(2010-4#1)
and the benefits of##7##4##(1995-9#1)(1997-1#1)(1997-6#1)(2008-11#2)(2008-3#1)(2008-9#1)
and the benefits##14##3##(1994-2#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-9#2)(2010-4#1)
and the best conditions##2##4##(2008-10#2)
and the best##16##3##(2007-12#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
and the beta##3##3##(1992-3#2)(1994-5#1)
and the beta-tubulin gene were##2##5##(2008-10#2)
and the better##3##3##(2008-11#2)(2008-2#1)
and the bilateral##3##3##(2007-10#1)(2008-7#1)(2012-12#1)
and the binding constant##2##4##(2008-10#2)
and the binding of##3##4##(1991-11#1)(1993-8#1)(1994-5#1)
and the binding to##2##4##(1993-12#1)(1995-6#1)
and the binding##11##3##(1991-11#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-5#1)(2008-10#4)(2009-10#1)
and the biochemical##2##3##(2009-3#1)(2011-1#1)
and the biological activity of##2##5##(2008-9#1)(2012-2#1)
and the biological##8##3##(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#1)
and the biosensor##2##3##(2008-10#2)
and the bladder##2##3##(1996-12#1)(2008-10#1)
and the blood##4##3##(1994-5#1)(1997-1#1)(2008-1#1)(2011-2#1)
and the body##6##3##(1995-12#1)(2008-1#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
and the bone##2##3##(1991-8#1)(2007-12#1)
and the boric acid concentration##2##5##(2008-10#2)
and the bottom##6##3##(2007-9#1)(2008-2#3)(2008-3#2)
and the bound##2##3##(1997-4#1)(2008-10#1)
and the boundary##2##3##(2008-3#1)(2012-2#1)
and the brain##5##3##(1995-11#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-1#1)
and the breeding##2##3##(2008-10#1)(2008-5#1)
and the broader##5##3##(2008-12#1)(2008-8#2)(2010-10#1)(2010-12#1)
and the buffer##4##3##(2007-12#1)(2008-10#2)(2008-4#1)
and the bulk##5##3##(2008-10#3)(2010-7#1)(2012-1#1)
and the burden of##2##4##(2007-12#1)(2008-8#1)
and the burgeoning##2##3##(1992-2#1)(1994-1#1)
and the cDNA##4##3##(1990-12#2)(1994-11#1)(1994-12#1)
and the calculated##10##3##(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2009-7#1)
and the calculation of##3##4##(1994-9#1)(2008-2#1)(2008-4#1)
and the calibration curve is linear over##4##7##(2008-10#4)
and the calibration curve is linear##5##6##(2008-10#5)
and the calibration curve was linear##3##6##(2008-10#3)
and the calibration curve##8##4##(2008-10#8)
and the calibration curves are##2##5##(2008-10#1)(2008-3#1)
and the calibration curves##5##4##(2008-10#4)(2008-3#1)
and the calibration graph was linear##2##6##(2008-10#2)
and the calibration range##2##4##(2008-10#2)
and the calibration##22##3##(2008-10#18)(2008-2#1)(2008-3#3)
and the camera##2##3##(2008-3#1)(2008-9#1)
and the campesterol/sitosterol##2##3##(1992-6#2)
and the capabilities of##2##4##(2008-3#2)
and the capability##2##3##(2008-2#1)(2008-7#1)
and the capacity of the##2##5##(1992-6#1)(2008-12#1)
and the capacity to##2##4##(2007-12#1)(2008-7#1)
and the capacity##4##3##(1992-6#1)(2007-12#1)(2008-12#1)(2008-7#1)
and the capillary##4##3##(2008-10#4)
and the capital##2##3##(1991-1#1)(1994-9#1)
and the carbonyl group of##2##5##(1992-3#1)(2008-5#1)
and the carbonyl group##3##4##(1992-3#1)(1996-2#1)(2008-5#1)
and the carbonyl##4##3##(1990-7#1)(1992-3#1)(1996-2#1)(2008-5#1)
and the cardiac##3##3##(1993-2#2)(1994-11#1)
and the cardiovascular system##3##4##(2009-6#1)(2010-12#1)(2010-8#1)
and the cardiovascular##4##3##(1991-1#1)(2009-6#1)(2010-12#1)(2010-8#1)
and the care##2##3##(2007-10#1)(2009-5#1)
and the carp##2##3##(2008-5#1)(2008-7#1)
and the carrier##2##3##(2008-10#2)
and the case of##2##4##(2011-2#2)
and the case##6##3##(1990-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2011-2#2)
and the catalytic##5##3##(1992-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-4#1)
and the cationic##2##3##(1990-8#1)(2008-5#1)
and the caudal##3##3##(1990-3#1)(1997-3#1)(2011-1#1)
and the causal##3##3##(1990-3#1)(2008-10#2)
and the cause of death##2##5##(2012-2#1)(2013-1#1)
and the causes of##2##4##(2008-10#1)(2012-3#1)
and the causes##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2012-3#1)
and the cavity##4##3##(2008-2#2)(2008-3#2)
and the cell cycle##2##4##(2008-11#1)(2012-1#1)
and the cell death##2##4##(1993-8#1)(2012-3#1)
and the cell line##2##4##(1991-6#1)(2008-11#1)
and the cell##20##3##(1991-6#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-9#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
and the cells##6##3##(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
and the cellular##5##3##(1991-8#1)(1992-12#1)(2008-11#2)(2013-1#1)
and the center of##4##4##(2007-12#1)(2008-2#1)(2008-4#1)(2012-2#1)
and the center##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
and the central nervous system##2##5##(1994-5#1)(2007-8#1)
and the central##9##3##(1993-11#1)(1994-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-5#1)(2013-8#1)
and the cerebral cortex##3##4##(1996-5#1)(2008-7#2)
and the cerebral##5##3##(1994-2#1)(1996-5#1)(2008-7#2)(2013-1#1)
and the chain##3##3##(1993-3#1)(2008-12#2)
and the challenge of##2##4##(2010-1#1)(2012-3#1)
and the challenges that##2##4##(2009-8#1)(2011-2#1)
and the challenges##11##3##(1995-1#1)(1995-2#1)(2007-12#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
and the chance of##2##4##(1995-12#1)(2011-2#1)
and the change in##3##4##(2008-3#1)(2008-7#1)(2009-12#1)
and the change##4##3##(2008-3#1)(2008-7#2)(2009-12#1)
and the changed##2##3##(1997-4#1)(2010-6#1)
and the changes in these##2##5##(2008-10#1)(2011-1#1)
and the changes in##6##4##(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2013-8#1)
and the changes that##2##4##(2007-11#1)(2008-2#1)
and the changes##14##3##(1991-5#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
and the characteristic mass##3##4##(2008-10#3)
and the characteristic##6##3##(1992-6#1)(2008-10#3)(2008-11#1)(2008-2#1)
and the characteristics of the##2##5##(2007-11#1)(2008-7#1)
and the characteristics of##7##4##(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)
and the characterization of##4##4##(1992-6#1)(2008-10#1)(2008-6#1)(2012-3#1)
and the charge##2##3##(2007-12#1)(2008-7#1)
and the chemical variables##2##4##(2008-10#2)
and the chemical##11##3##(1990-7#1)(1997-2#1)(2008-10#8)(2010-10#1)
and the chemokine##2##3##(2008-11#1)(2008-5#1)
and the chest wall##2##4##(2008-6#1)(2012-2#1)
and the chest##4##3##(1991-12#1)(2008-6#1)(2012-2#1)(2013-1#1)
and the chicken##2##3##(2008-5#1)(2013-1#1)
and the child##4##3##(1990-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
and the child's##2##3##(1992-2#1)(2008-10#1)
and the choice of##6##4##(2007-11#2)(2008-10#2)(2008-9#1)(2011-1#1)
and the choice##7##3##(2007-11#2)(2008-10#2)(2008-9#1)(2009-8#1)(2011-1#1)
and the chromogenic##2##3##(1990-2#1)(2008-10#1)
and the chromosome##2##3##(2007-12#1)(2008-8#1)
and the chronic##4##3##(1991-3#1)(1993-2#1)(1994-2#1)(1995-12#1)
and the city of New York##2##6##(2008-8#1)(2013-1#1)
and the city of##5##4##(1995-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)
and the cladding modes increases##2##5##(2008-3#2)
and the classification##2##3##(2007-8#1)(2013-8#1)
and the clinical benefit of##2##5##(1997-7#2)
and the clinical course of##2##5##(1994-7#1)(2011-2#1)
and the clinical evidence##2##4##(2011-2#2)
and the clinical findings##2##4##(1995-5#1)(2013-1#1)
and the clinical implications##2##4##(2008-3#1)(2008-4#1)
and the clinical presentation of##2##5##(1990-6#1)(2009-12#1)
and the clinical response of##2##5##(1991-3#1)(2008-5#1)
and the clinical results of##2##5##(2008-6#1)(2013-7#1)
and the clinical##33##3##(1990-6#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-5#1)(1995-6#1)(1997-7#2)(1997-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
and the clinician##3##3##(1993-2#1)(2012-12#1)(2012-3#1)
and the cloned gene product formation in Streptomyces lividans##2##9##(1994-3#2)
and the cloned##3##3##(1994-3#2)(1996-12#1)
and the closely related##3##4##(1995-8#1)(2008-1#1)(2008-10#1)
and the closest##2##3##(2008-10#1)(2008-9#1)
and the coat protein (CP)##2##5##(2008-10#2)
and the coding##2##3##(1997-4#1)(2008-8#1)
and the coefficient of variation of##2##6##(2008-10#2)
and the coefficient of variation##6##5##(1992-3#1)(2008-10#5)
and the coefficient of##9##4##(1992-3#1)(2008-10#7)(2008-2#1)
and the coefficients of variation were##2##6##(2008-10#2)
and the coefficients of##3##4##(2008-10#2)(2008-3#1)
and the coexistence of##2##4##(2008-10#1)(2008-8#1)
and the coil##2##3##(2010-7#1)(2012-2#1)
and the collagen##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
and the collateral##2##3##(1994-1#1)(2008-10#1)
and the collected##2##3##(2008-10#1)(2008-2#1)
and the collection of##2##4##(2008-12#1)(2009-5#1)
and the collection##3##3##(2008-12#1)(2008-5#1)(2009-5#1)
and the colony##2##3##(1991-12#1)(2008-10#1)
and the color##7##3##(1993-6#2)(2007-10#1)(2008-10#2)(2008-3#2)
and the colored##2##3##(2008-10#2)
and the column##3##3##(2008-10#2)(2008-2#1)
and the combination of the two##2##6##(2008-7#1)(2012-5#1)
and the combination of##9##4##(1990-10#1)(1990-8#1)(1993-3#1)(1995-5#1)(2008-10#1)(2008-12#2)(2008-7#1)(2012-5#1)
and the combination##12##3##(1990-10#1)(1990-8#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2010-3#1)(2012-5#1)
and the combined##3##3##(1994-12#1)(2008-10#1)(2009-2#1)
and the common##8##3##(1992-3#1)(2007-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
and the communication##2##3##(2008-7#1)(2011-2#1)
and the community##11##3##(1992-12#1)(1993-1#1)(1994-1#1)(1995-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
and the comparison of the##2##5##(2008-10#1)(2013-8#1)
and the comparison of##3##4##(2008-10#2)(2013-8#1)
and the comparison##6##3##(1990-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
and the compatibility of##2##4##(2008-2#1)(2008-3#1)
and the competition##2##3##(2008-10#1)(2008-7#1)
and the complementary##2##3##(1993-8#1)(2008-10#1)
and the complete##5##3##(1993-2#1)(2008-10#3)(2008-9#1)
and the complex of##2##4##(1992-3#1)(2008-10#1)
and the complex refractive index##2##5##(2008-3#2)
and the complex refractive##3##4##(2007-11#1)(2008-3#2)
and the complex##16##3##(1992-3#1)(1993-9#1)(1994-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2009-3#1)
and the complexes were##2##4##(2008-10#2)
and the complexes##4##3##(1994-11#1)(2008-10#2)(2009-5#1)
and the complexities of appraisal and retrospection##2##7##(2013-1#2)
and the complexity of##6##4##(2008-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
and the complexity##7##3##(2008-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
and the complication##2##3##(2008-10#1)(2009-3#1)
and the compomer##2##3##(2008-5#1)(2011-2#1)
and the component##2##3##(2008-10#1)(2013-8#1)
and the composition of the##2##5##(2008-10#2)
and the composition of##6##4##(2008-10#3)(2008-5#1)(2011-2#1)(2013-8#1)
and the composition##8##3##(2008-10#3)(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#1)
and the compound was##2##4##(2008-10#1)(2011-1#1)
and the compound##3##3##(2008-10#1)(2011-1#1)(2011-3#1)
and the compounds##2##3##(2008-10#2)
and the computational##2##3##(2008-10#1)(2011-1#1)
and the concentration of each ion in##2##7##(2008-10#2)
and the concentration of free##2##5##(1994-12#1)(2008-2#1)
and the concentration of the##10##5##(1991-5#1)(1994-5#1)(2008-10#6)(2008-5#1)(2013-8#1)
and the concentration of##44##4##(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-5#1)(2008-10#26)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#2)
and the concentration##54##3##(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-5#1)(2008-10#32)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#1)(2013-8#2)
and the concentrations of##8##4##(1993-12#1)(2008-10#7)
and the concentrations##10##3##(1993-12#1)(2008-10#9)
and the concept of a##2##5##(2008-3#1)(2012-2#1)
and the concept of##6##4##(1992-1#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
and the concepts##2##3##(1995-1#1)(2008-10#1)
and the conclusions##2##3##(2010-5#1)(2011-1#1)
and the concomitant##7##3##(1990-8#1)(1992-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-10#1)(2013-1#1)
and the condition##2##3##(2008-5#1)(2011-2#1)
and the conditions for##3##4##(1994-12#1)(2008-10#1)(2008-9#1)
and the conditions of##3##4##(2008-3#1)(2008-4#1)(2011-1#1)
and the conditions under which it is##2##7##(2008-11#1)(2008-3#1)
and the conditions##9##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2011-1#1)
and the conjugate##2##3##(2007-12#1)(2008-3#1)
and the connection##2##3##(2008-3#1)(2013-1#1)
and the consequences of their##2##5##(2008-11#1)(2010-1#1)
and the consequences of##7##4##(1992-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-4#1)
and the consequences##10##3##(1992-12#1)(1992-3#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-4#1)
and the consequent##6##3##(1992-9#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-12#1)
and the conserved##2##3##(2008-10#1)(2008-8#1)
and the constant##3##3##(2008-10#3)
and the constitutive##2##3##(1993-8#1)(1995-8#1)
and the construct##2##3##(1997-6#1)(2007-12#1)
and the construction of##2##4##(1991-12#1)(2008-8#1)
and the consumer##2##3##(1992-1#1)(2008-8#1)
and the consumption of##7##4##(1992-8#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
and the contemporary##2##3##(1997-1#1)(2011-2#1)
and the content and##2##4##(2009-12#1)(2012-12#1)
and the content of the##2##5##(1994-7#1)(2008-6#1)
and the content of##9##4##(1994-7#1)(1994-9#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-2#1)(2013-7#1)
and the content##12##3##(1994-7#1)(1994-9#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
and the contents of##2##4##(1995-5#1)(2008-10#1)
and the contents##3##3##(1995-5#1)(2008-10#1)(2008-12#1)
and the continuous##3##3##(1994-12#1)(2008-10#1)(2009-11#1)
and the contractile##2##3##(1990-12#1)(2008-2#1)
and the contralateral##3##3##(1993-12#1)(2007-10#1)(2013-1#1)
and the contrast##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
and the contribution of##5##4##(1995-12#1)(2007-10#1)(2008-2#1)(2009-2#1)(2010-12#1)
and the contribution##6##3##(1994-3#1)(1995-12#1)(2007-10#1)(2008-2#1)(2009-2#1)(2010-12#1)
and the contributions of##3##4##(2008-12#2)(2011-2#1)
and the contributions##4##3##(2008-12#2)(2008-2#1)(2011-2#1)
and the control group##7##4##(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
and the control of##4##4##(1990-6#1)(1990-9#1)(2011-2#1)(2012-2#1)
and the control##24##3##(1990-12#1)(1990-6#1)(1990-9#1)(1992-11#1)(1997-6#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#2)
and the controls##2##3##(1996-7#1)(2012-3#1)
and the controversies##2##3##(2008-11#1)(2008-9#1)
and the conventional##7##3##(2007-12#1)(2008-10#2)(2010-3#1)(2010-6#1)(2012-3#1)(2013-8#1)
and the coordination of##2##4##(2008-9#1)(2013-7#1)
and the coordination##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-7#1)
and the core##2##3##(2008-8#2)
and the correct##3##3##(1992-9#1)(1994-9#1)(2012-3#1)
and the correction##2##3##(2008-3#1)(2013-8#1)
and the correlation between##2##4##(2008-10#1)(2008-11#1)
and the correlation coefficient##2##4##(2008-10#1)(2013-8#1)
and the correlation coefficients##2##4##(2008-10#1)(2011-1#1)
and the correlation of##4##4##(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
and the correlation##13##3##(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
and the corresponding amino acid sequence##2##6##(1990-2#1)(1995-8#1)
and the corresponding##43##3##(1990-11#1)(1990-2#1)(1991-12#1)(1993-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
and the cortical##3##3##(2008-10#1)(2008-7#1)(2009-10#1)
and the cost of##9##4##(1991-9#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)(2013-1#1)
and the cost to##2##4##(2008-2#1)(2008-9#1)
and the cost##13##3##(1991-9#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)
and the cost-effectiveness##2##3##(1993-2#1)(2011-2#1)
and the costs associated with##3##5##(1994-2#1)(1997-3#1)(2008-11#1)
and the costs of##5##4##(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)
and the costs##8##3##(1994-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-4#1)
and the course of the##2##5##(2008-7#1)(2012-2#1)
and the course of##8##4##(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
and the course##9##3##(1994-12#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
and the creation of##5##4##(1994-12#1)(2008-10#1)(2008-2#1)(2012-1#1)(2012-2#1)
and the criteria used##2##4##(1993-12#1)(2008-1#1)
and the criteria##5##3##(1993-12#1)(1997-8#1)(2008-1#1)(2012-2#1)(2013-1#1)
and the critical##9##3##(1993-3#1)(1994-12#1)(1995-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-8#1)
and the cross correlation##2##4##(2007-12#1)(2008-3#1)
and the cross talk##3##4##(2007-12#1)(2008-2#1)(2009-12#1)
and the cross##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-12#1)
and the crystal structure##3##4##(1991-3#1)(1992-12#1)(1996-5#1)
and the crystal##9##3##(1991-3#1)(1992-12#1)(1995-6#1)(1996-5#1)(2008-2#1)(2008-3#3)(2008-9#1)
and the cultural##2##3##(2008-1#1)(2008-11#1)
and the culture##5##3##(2007-7#1)(2008-1#1)(2008-11#2)(2009-3#1)
and the cumulative##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
and the current status of the##2##6##(1996-8#1)(1997-3#1)
and the current##15##3##(1994-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)(2012-2#1)
and the curvature##5##3##(2007-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-6#1)
and the cyclic##2##3##(1994-11#1)(2008-10#1)
and the cytogenetic##2##3##(2012-3#2)
and the cytoplasm##2##3##(2009-2#1)(2012-2#1)
and the cytotoxicity of the##2##5##(2008-5#1)(2008-8#1)
and the data analysis##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
and the data compared with##2##5##(1997-8#1)(2008-10#1)
and the data obtained##3##4##(1993-8#1)(2008-10#2)
and the data of the FT-IR spectrum##2##7##(2008-10#2)
and the data of##3##4##(2008-10#2)(2008-3#1)
and the data provided##2##4##(1991-5#1)(2008-10#1)
and the data were analyzed by##2##6##(1993-9#1)(2009-8#1)
and the data were analyzed##3##5##(1993-9#1)(2008-12#1)(2009-8#1)
and the data were processed by##2##6##(2008-10#1)(2011-1#1)
and the data were##6##4##(1993-9#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-1#1)
and the data##33##3##(1991-5#2)(1992-2#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1997-8#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
and the date of##2##4##(1991-12#1)(2008-10#1)
and the date##4##3##(1991-11#1)(1991-12#1)(2008-10#1)(2008-7#1)
and the death and dying##2##5##(2011-2#2)
and the death##3##3##(1997-7#1)(2011-2#2)
and the decision##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
and the decline of##2##4##(1995-3#1)(2012-7#1)
and the decrease in the##2##5##(2008-10#1)(2008-11#1)
and the decrease in##6##4##(1990-5#1)(1993-12#1)(2008-10#2)(2008-11#1)(2013-7#1)
and the decrease of##3##4##(1990-2#1)(2008-10#1)(2008-5#1)
and the decrease##10##3##(1990-2#1)(1990-5#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-7#1)(2013-8#1)
and the decreased##2##3##(2008-7#1)(2013-7#1)
and the deduced amino acid sequence of##2##7##(1991-12#1)(1992-12#1)
and the deduced amino acid sequence##3##6##(1991-12#1)(1992-12#1)(1997-2#1)
and the deduced amino acid##5##5##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#1)(1997-2#1)
and the deduced amino-acid##2##4##(1994-12#1)(1996-12#1)
and the deduced##8##3##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-8#1)
and the definition of the##2##5##(1993-1#1)(2010-7#1)
and the definition of##4##4##(1993-1#1)(2008-10#1)(2008-8#1)(2010-7#1)
and the deformation##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
and the degradation of the##2##5##(2007-5#1)(2008-3#1)
and the degradation of##4##4##(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
and the degradation##7##3##(2007-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
and the degree of the##3##5##(2008-11#1)(2008-9#1)(2013-8#1)
and the degree of##36##4##(1990-9#1)(1993-6#1)(1993-8#1)(1995-8#2)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#2)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#2)
and the degree to which they##2##6##(1996-1#1)(2008-3#1)
and the degree to which##3##5##(1996-1#1)(2008-3#1)(2009-11#1)
and the degree##39##3##(1990-9#1)(1993-6#1)(1993-8#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#2)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#2)
and the deletion##2##3##(1990-7#1)(1993-8#1)
and the delivery of##2##4##(1996-2#1)(1996-3#1)
and the delivery##3##3##(1993-3#1)(1996-2#1)(1996-3#1)
and the delta##3##3##(1993-8#1)(1994-12#1)(2008-10#1)
and the demand##2##3##(2008-3#1)(2008-9#1)
and the demands##2##3##(1994-2#1)(2011-2#1)
and the demonstrated##2##3##(1992-6#1)(2007-11#1)
and the demonstration of##4##4##(1997-6#1)(2008-1#1)(2008-2#1)(2008-5#1)
and the density of##5##4##(1995-8#1)(2008-10#1)(2011-1#1)(2012-1#1)(2013-1#1)
and the density##7##3##(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
and the dependence of the##3##5##(1995-11#1)(2008-10#1)(2008-3#1)
and the dependence of##4##4##(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
and the depolarization##4##3##(2008-2#1)(2008-3#3)
and the depolarizer concentration##3##4##(2008-10#3)
and the depth of##3##4##(2008-3#2)(2008-5#1)
and the depth##4##3##(2008-3#3)(2008-5#1)
and the derivation of##2##4##(2008-10#1)(2008-7#1)
and the derived groove##2##4##(2008-3#2)
and the derived##4##3##(2008-10#1)(2008-3#3)
and the dermis##3##3##(2008-1#1)(2008-3#1)(2008-5#1)
and the description of##2##4##(2011-7#1)(2013-8#1)
and the design and##2##4##(2008-2#1)(2008-9#1)
and the design of##6##4##(1995-5#1)(2008-10#1)(2008-3#2)(2012-1#1)(2013-1#1)
and the design##9##3##(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
and the desire of##2##4##(1992-9#1)(2008-10#1)
and the desire to##2##4##(2011-2#1)(2013-1#1)
and the desire##4##3##(1992-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
and the desired##3##3##(1992-4#1)(1996-12#1)(2008-1#1)
and the destruction##2##3##(1994-5#1)(2009-7#1)
and the detailed##2##3##(2008-9#1)(2013-8#1)
and the detection and quantification limits##2##6##(2008-10#2)
and the detection limit (3sigma)##3##5##(2008-10#3)
and the detection limit for##4##5##(2008-10#4)
and the detection limit is 0##5##6##(2008-10#5)
and the detection limit is 1##3##6##(2008-10#3)
and the detection limit is##14##5##(2008-10#13)(2013-1#1)
and the detection limit of##4##5##(2008-10#3)(2011-1#1)
and the detection limit was 0##8##6##(2008-10#8)
and the detection limit was 1##3##6##(2008-10#3)
and the detection limit was 2##4##6##(2008-10#4)
and the detection limit was 4##2##6##(2008-10#2)
and the detection limit was down to 0##2##8##(2008-10#2)
and the detection limit was##32##5##(2008-10#32)
and the detection limit##63##4##(2008-10#61)(2011-1#1)(2013-1#1)
and the detection limits achieved##2##5##(2008-10#2)
and the detection limits for##4##5##(2008-10#4)
and the detection limits of##4##5##(2008-10#4)
and the detection limits##17##4##(2008-10#17)
and the detection of##5##4##(1991-12#1)(1994-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
and the detection##93##3##(1991-12#1)(1994-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#85)(2011-1#1)(2013-1#2)
and the detector array##2##4##(2008-3#2)
and the detector##10##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)
and the determination of the##6##5##(1996-11#1)(1997-1#1)(2008-10#2)(2008-8#1)(2009-7#1)
and the determination of##17##4##(1996-11#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#9)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)
and the determination##21##3##(1996-11#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#13)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)
and the determined values coincided with the certified values very well##2##11##(2008-10#2)
and the determined values obtained were in##2##7##(2008-10#2)
and the determined values##4##4##(2008-10#4)
and the developed##2##3##(2008-10#2)
and the developing##4##3##(1990-7#1)(2008-10#1)(2009-10#1)(2013-1#1)
and the development and##2##4##(1992-2#1)(2008-7#1)
and the development of a##5##5##(2007-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-12#1)
and the development of an##2##5##(1993-3#1)(2008-8#1)
and the development of molecular##2##5##(2008-10#1)(2011-1#1)
and the development of more##4##5##(1994-5#1)(2007-7#1)(2010-11#1)(2011-2#1)
and the development of new##6##5##(1991-12#1)(1994-9#1)(1997-8#1)(2007-10#1)(2008-10#1)(2011-2#1)
and the development of preventive##2##5##(2009-4#1)(2009-6#1)
and the development of the##7##5##(1996-2#1)(1996-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
and the development of##75##4##(1991-1#1)(1991-12#2)(1993-10#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#2)(2013-1#3)(2013-8#3)
and the development##77##3##(1991-1#1)(1991-12#2)(1992-2#1)(1993-10#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#2)(2013-1#3)(2013-8#3)
and the developmental process##2##4##(1993-12#1)(1997-1#1)
and the developmental##5##3##(1993-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2009-12#1)
and the device is##2##4##(2007-12#1)(2008-1#1)
and the diagnosis is##2##4##(1991-2#1)(2013-1#1)
and the diagnosis of##3##4##(1991-12#1)(1992-9#1)(2007-11#1)
and the diagnosis was confirmed by##3##6##(1990-2#1)(1990-6#1)(2008-7#1)
and the diagnosis was confirmed##5##5##(1990-2#1)(1990-6#1)(2008-7#1)(2010-12#1)(2012-12#1)
and the diagnosis was##7##4##(1990-2#1)(1990-6#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)
and the diagnosis##17##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
and the diagnostic##6##3##(1991-8#1)(1995-6#1)(1996-12#1)(2008-6#1)(2010-12#1)(2013-7#1)
and the diameter of the##2##5##(2008-3#1)(2011-1#1)
and the diameter of##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
and the diaphragm##2##3##(1990-2#1)(2010-2#1)
and the dielectric##2##3##(2008-2#1)(2008-3#1)
and the difference between##2##4##(2008-11#1)(2008-3#1)
and the difference in##3##4##(1991-8#1)(1993-11#1)(2008-10#1)
and the difference of##2##4##(2008-3#1)(2013-8#1)
and the difference##9##3##(1991-8#1)(1993-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2013-8#1)
and the differences between##5##4##(1993-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
and the differences in the##2##5##(2008-3#1)(2009-11#1)
and the differences in##3##4##(2008-3#1)(2009-11#1)(2010-8#1)
and the differences##9##3##(1993-2#1)(1996-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-8#1)
and the different types of##2##5##(2008-10#1)(2013-1#1)
and the different##12##3##(1991-9#1)(1995-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2010-9#1)(2011-1#1)(2013-1#1)
and the differential diagnosis##4##4##(1990-12#1)(1993-8#1)(2008-11#1)(2012-2#1)
and the differential##7##3##(1990-12#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
and the differentiation of##2##4##(1993-3#1)(2008-10#1)
and the differentiation##3##3##(1991-3#1)(1993-3#1)(2008-10#1)
and the difficulties encountered##2##4##(1997-3#1)(2008-7#1)
and the difficulties in##4##4##(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)
and the difficulties##11##3##(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
and the difficulty in##6##4##(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
and the difficulty of##2##4##(1990-3#1)(2008-10#1)
and the difficulty##8##3##(1990-3#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
and the diffraction efficiency##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
and the diffraction##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
and the diffusion coefficients##2##4##(1991-5#1)(2007-11#1)
and the diffusion##7##3##(1991-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)
and the digestive system##2##4##(2009-10#1)(2010-5#1)
and the digestive tract##2##4##(2007-12#1)(2009-5#1)
and the digestive##4##3##(2007-12#1)(2009-10#1)(2009-5#1)(2010-5#1)
and the digital darkroom##2##4##(2008-1#1)(2008-4#1)
and the digital##3##3##(2008-1#1)(2008-4#1)(2012-2#1)
and the dilution##2##3##(2008-10#1)(2013-8#1)
and the direct##5##3##(1994-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
and the direction of##3##4##(2008-10#1)(2008-2#1)(2009-2#1)
and the direction##4##3##(2008-10#1)(2008-2#2)(2009-2#1)
and the directional##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
and the discovery of##7##4##(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-3#1)
and the discrete-ordinates##2##3##(1994-3#1)(2007-11#1)
and the discrimination##3##3##(1991-5#1)(2008-12#1)(2008-2#1)
and the disease severity##2##4##(1994-11#1)(2008-10#1)
and the disease##14##3##(1994-11#1)(2008-10#6)(2008-8#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#3)
and the diseases##2##3##(2008-10#1)(2008-11#1)
and the disorganization of the##2##5##(2008-7#1)(2009-10#1)
and the dispersal of##2##4##(2008-10#1)(2010-3#1)
and the displacement##2##3##(1992-9#1)(2008-10#1)
and the display##2##3##(2008-3#2)
and the disruption of##2##4##(2008-10#1)(2010-3#1)
and the dissociation constant##2##4##(1991-8#1)(2008-10#1)
and the dissociation##3##3##(1991-8#1)(1995-11#1)(2008-10#1)
and the distal##2##3##(1995-6#1)(2008-10#1)
and the distance between the##4##5##(1993-12#1)(1997-6#1)(2008-10#1)(2008-3#1)
and the distance between##8##4##(1993-12#1)(1993-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
and the distance##13##3##(1993-12#1)(1993-8#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-8#1)(2010-5#1)(2013-1#1)
and the distances##2##3##(2008-6#1)(2010-10#1)
and the distinct##2##3##(1995-5#1)(2008-10#1)
and the distinction##2##3##(2008-4#1)(2008-9#1)
and the distinctive##4##3##(1991-7#1)(1992-6#1)(1996-12#2)
and the distribution of persons is##2##6##(2012-2#2)
and the distribution of the##3##5##(1992-3#1)(2008-10#1)(2008-11#1)
and the distribution of values##3##5##(2008-7#1)(2013-1#2)
and the distribution of##20##4##(1992-3#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-3#1)(2011-7#1)(2012-2#2)(2013-1#3)(2013-7#1)
and the distribution##25##3##(1991-12#1)(1992-3#1)(1994-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-3#1)(2011-7#1)(2012-2#2)(2013-1#4)(2013-7#1)
and the disturbances of glucose##2##5##(2008-7#2)
and the disturbances##3##3##(2008-3#1)(2008-7#2)
and the diverse##2##3##(1993-5#1)(2010-7#1)
and the diversity of##3##4##(1992-3#1)(2008-10#1)(2013-1#1)
and the diversity##4##3##(1992-3#1)(2008-10#1)(2013-1#1)(2013-7#1)
and the dog##3##3##(1995-11#2)(2013-1#1)
and the donor##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
and the dopamine##2##3##(1995-12#1)(2008-10#1)
and the dorsal##3##3##(1993-6#1)(2013-7#2)
and the downstream##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
and the draining veins##2##4##(2008-7#1)(2012-3#1)
and the driving##2##3##(1991-12#1)(2008-11#1)
and the drug resistant##2##4##(2008-11#1)(2011-2#1)
and the drug##10##3##(1992-2#1)(1995-5#1)(1996-5#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
and the dry##2##3##(2007-5#1)(2008-11#1)
and the duration of the##8##5##(1996-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
and the duration of##18##4##(1990-11#1)(1995-6#1)(1996-2#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
and the duration##22##3##(1990-11#1)(1995-6#1)(1996-2#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and the durations of##2##4##(2008-8#1)(2012-3#1)
and the dye##3##3##(1990-12#1)(2008-10#1)(2010-4#1)
and the dynamic range##3##4##(2007-12#1)(2008-10#2)
and the dynamic##9##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-8#1)(2013-1#1)
and the dynamics of##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
and the dynamics##6##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
and the early##7##3##(2008-10#2)(2008-11#2)(2008-5#1)(2010-8#1)(2013-1#1)
and the ease of##2##4##(2008-2#1)(2013-1#1)
and the ease##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and the economic impact##3##4##(2007-11#1)(2008-10#2)
and the economic##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
and the economy##2##3##(1997-6#1)(2013-8#1)
and the edge##2##3##(2008-2#1)(2008-3#1)
and the education of##2##4##(1992-2#1)(2007-7#1)
and the educational##3##3##(1992-1#1)(1994-2#1)(1994-3#1)
and the effect is##2##4##(1992-3#1)(2008-2#1)
and the effect of a##2##5##(1995-12#1)(2008-11#1)
and the effect of foreign ions##2##6##(2008-10#2)
and the effect of pH on##2##6##(2008-10#1)(2008-6#1)
and the effect of pH##4##5##(2008-10#2)(2008-5#1)(2008-6#1)
and the effect of some##2##5##(2008-5#1)(2008-8#1)
and the effect of the##9##5##(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)(2013-8#2)
and the effect of##72##4##(1992-3#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-10#2)(2008-10#21)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
and the effect on##3##4##(1992-9#1)(1994-2#1)(1996-12#1)
and the effect was##8##4##(1993-12#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)
and the effect##87##3##(1991-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-10#2)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
and the effective dose##2##4##(1995-12#1)(2008-12#1)
and the effective##14##3##(1992-2#1)(1995-12#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-3#2)(2012-2#1)(2013-1#1)
and the effectiveness of the##4##5##(1995-1#1)(1995-3#1)(2008-3#1)(2012-1#1)
and the effectiveness of##12##4##(1995-1#1)(1995-3#1)(1996-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and the effects of GH replacement##2##6##(1997-8#1)(2008-4#1)
and the effects of the##7##5##(1994-6#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-3#3)
and the effects of these##2##5##(1993-3#1)(2008-7#1)
and the effects of##43##4##(1992-1#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-9#1)(1997-2#2)(1997-7#1)(1997-8#2)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
and the effects on the##5##5##(1992-6#1)(2008-5#1)(2010-4#1)(2011-3#2)
and the effects on##11##4##(1992-6#1)(1993-9#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-3#2)(2012-4#1)
and the effects were##2##4##(2008-10#1)(2008-4#1)
and the effects##57##3##(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-7#1)(1997-8#2)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#1)(2011-3#2)(2012-4#1)(2013-1#1)(2013-8#1)
and the efficacy and##2##4##(1996-6#1)(2008-8#1)
and the efficacy of this##2##5##(1997-4#1)(2009-12#1)
and the efficacy of##13##4##(1990-6#1)(1994-12#1)(1995-6#1)(1997-4#1)(2008-5#3)(2008-7#1)(2009-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
and the efficacy##15##3##(1990-6#1)(1994-12#1)(1995-6#1)(1996-6#1)(1997-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
and the efficiency of##3##4##(1997-6#1)(2008-10#2)
and the efficiency##4##3##(1997-6#1)(2008-10#2)(2008-3#1)
and the efficient use of##2##5##(2008-10#1)(2013-1#1)
and the efficient##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
and the efforts of##2##4##(1994-9#1)(2012-2#1)
and the efforts##3##3##(1994-9#1)(1997-7#1)(2012-2#1)
and the ejection fraction##2##4##(2008-7#2)
and the elderly##12##3##(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)
and the electrical##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
and the electrocardiogram##2##3##(1994-6#1)(2008-3#1)
and the electrode surface##2##4##(2008-10#2)
and the electrode##10##3##(2008-10#9)(2008-3#1)
and the electrodes##2##3##(2008-9#1)(2009-8#1)
and the electromagnetic##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and the electron##3##3##(2007-6#1)(2008-10#1)(2008-8#1)
and the electronic coupling##2##4##(1995-2#2)
and the electronic##4##3##(1994-3#1)(1995-2#2)(2011-2#1)
and the electrophoretic##3##3##(1994-11#1)(2008-2#1)(2008-5#1)
and the electrostatic##2##3##(2008-10#2)
and the elements##2##3##(2008-10#1)(2008-9#1)
and the elimination of##2##4##(2008-10#2)
and the eluate##2##3##(1990-8#1)(1994-12#1)
and the elution##2##3##(2008-10#2)
and the embryo##2##3##(2009-8#1)(2011-1#1)
and the emergence of##3##4##(1994-12#1)(2009-3#1)(2010-1#1)
and the emerging##3##3##(1996-3#2)(1997-3#1)
and the emission of##2##4##(1996-2#1)(2008-2#1)
and the emission##9##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)
and the emitted fluorescence was##2##5##(2007-11#1)(2008-10#1)
and the emitted fluorescence##3##4##(2007-11#1)(2008-10#2)
and the employees##2##3##(1992-5#1)(1996-3#1)
and the end of the study##3##6##(1990-9#1)(2007-2#1)(2008-7#1)
and the end of the##4##5##(1990-9#1)(2007-2#1)(2008-11#1)(2008-7#1)
and the end of##8##4##(1990-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
and the end##11##3##(1990-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#1)(2013-8#1)
and the end-point volume of the titrant exists in the##3##10##(2008-10#3)
and the endogenous##2##3##(2008-11#1)(2013-7#1)
and the energetic##2##3##(2008-9#2)
and the energy##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
and the energy-insulating sheath effect of##2##6##(2008-10#2)
and the enhanced##5##3##(2008-10#3)(2009-3#1)(2013-8#1)
and the enhancement of##5##4##(1994-5#1)(1996-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
and the enhancement##7##3##(1994-5#1)(1996-2#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#1)
and the ensuing##6##3##(1996-2#2)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
and the enthalpy##2##3##(1994-5#1)(2008-10#1)
and the entire##8##3##(1992-3#1)(1994-11#1)(1997-2#1)(2007-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
and the entorhinal cortex##3##4##(1994-3#3)
and the entorhinal##4##3##(1992-11#1)(1994-3#3)
and the entry##2##3##(2008-11#1)(2010-5#1)
and the environment in##3##4##(1992-3#2)(2008-12#1)
and the environment##19##3##(1991-11#1)(1992-2#1)(1992-3#2)(1995-11#1)(1996-11#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#2)(2009-5#1)(2009-6#2)(2010-12#1)(2012-2#1)(2012-3#1)
and the environmental and##2##4##(2008-10#1)(2008-7#1)
and the environmental conditions##2##4##(2008-3#1)(2008-8#1)
and the environmental##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)
and the enzymatic activity##2##4##(1992-6#1)(2008-6#1)
and the enzymatic##5##3##(1990-12#1)(1992-6#1)(2008-10#2)(2008-6#1)
and the enzyme was##2##4##(1995-8#1)(1997-2#1)
and the enzyme##9##3##(1994-6#1)(1995-8#1)(1997-2#1)(2006-10#1)(2008-10#5)
and the enzymes##3##3##(1994-5#1)(2008-10#2)
and the epsilon-amino groups of##2##5##(1992-6#2)
and the equilibrium constant##3##4##(1994-8#1)(1995-6#1)(2008-10#1)
and the equilibrium constants##2##4##(2008-10#2)
and the equilibrium##9##3##(1994-8#1)(1995-6#1)(2008-10#5)(2008-8#1)(2008-9#1)
and the equipment##4##3##(1990-5#1)(2007-11#1)(2008-11#1)(2012-12#1)
and the equivalent##2##3##(2008-11#1)(2008-3#1)
and the error##2##3##(2008-2#1)(2008-3#1)
and the errors##2##3##(2008-3#1)(2013-8#1)
and the establishment of##8##4##(1991-9#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-7#1)
and the estimated##9##3##(1997-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#2)
and the estimation of##2##4##(1990-8#1)(2008-10#1)
and the ethical##2##3##(1995-6#1)(2012-2#1)
and the etiology of the##2##5##(2007-11#1)(2008-10#1)
and the etiology of##4##4##(1995-3#1)(2007-11#1)(2008-10#1)(2012-3#1)
and the etiology##5##3##(1995-3#1)(2007-11#1)(2008-10#2)(2012-3#1)
and the evaluation and##2##4##(2008-4#2)
and the evaluation of the##2##5##(1991-6#1)(2008-10#1)
and the evaluation of##6##4##(1991-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
and the evaluation##9##3##(1991-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)
and the events##2##3##(1995-2#1)(2006-10#1)
and the evidence for##2##4##(2008-7#1)(2010-5#1)
and the evidence##6##3##(1992-4#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
and the evolution of its##2##5##(1992-1#1)(2008-10#1)
and the evolution of the##3##5##(2008-2#1)(2011-2#1)(2013-7#1)
and the evolution of##24##4##(1992-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#7)(2008-9#3)(2009-6#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and the evolutionary##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
and the exact##5##3##(2008-10#1)(2008-3#4)
and the excellent##2##3##(1993-6#1)(2009-11#1)
and the exchange of##2##4##(1992-12#1)(2008-11#1)
and the exchange##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
and the excitation##4##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the excited##2##3##(2009-6#1)(2012-12#1)
and the existence of an##2##5##(2008-10#1)(2010-3#1)
and the existence of##11##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
and the existence or not of##2##6##(1993-2#1)(2013-8#1)
and the existence##13##3##(1993-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the existing##2##3##(2008-10#1)(2013-1#1)
and the expansion of##2##4##(1996-2#1)(1997-3#1)
and the expected##5##3##(2008-3#2)(2008-8#1)(2009-10#1)(2012-3#1)
and the experience of the##2##5##(1991-6#1)(1996-12#1)
and the experience of##3##4##(1991-6#1)(1996-12#1)(2008-6#1)
and the experience##5##3##(1991-6#1)(1996-12#1)(2008-1#1)(2008-6#1)(2012-3#1)
and the experiences of##2##4##(1997-7#1)(2010-3#1)
and the experiment##5##3##(2008-3#3)(2008-7#1)(2013-8#1)
and the experimental conditions##2##4##(2008-10#2)
and the experimental data##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
and the experimental results are##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
and the experimental results indicate that##2##6##(1990-12#1)(2008-3#1)
and the experimental results##11##4##(1990-12#1)(2007-11#1)(2008-2#2)(2008-3#6)(2008-6#1)
and the experimental verification##2##4##(2008-3#2)
and the experimental##29##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-3#1)
and the experimentally##2##3##(2007-11#1)(2008-3#1)
and the exposure##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
and the expression level of##3##5##(1995-11#1)(2008-9#1)(2009-12#1)
and the expression of##24##4##(1991-8#1)(1994-3#1)(1995-5#1)(1996-12#2)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)
and the expression##33##3##(1991-8#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#2)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#3)(2009-12#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
and the extent of metastases##2##5##(1992-11#1)(2008-1#1)
and the extent of##16##4##(1990-12#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
and the extent to which the##2##6##(1995-5#1)(2008-5#1)
and the extent to which they##2##6##(2010-7#1)(2012-2#1)
and the extent to which##5##5##(1995-5#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)
and the extent##21##3##(1990-12#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)
and the extents of##2##4##(1990-5#1)(2008-7#1)
and the external##8##3##(1990-11#1)(2008-1#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#1)(2013-8#1)
and the extinction coefficient##3##4##(1991-12#1)(2008-2#1)(2008-3#1)
and the extinction ratio of##2##5##(2008-2#2)
and the extinction ratio##4##4##(2008-1#1)(2008-2#3)
and the extinction##9##3##(1991-12#1)(2008-1#1)(2008-2#4)(2008-3#2)(2008-8#1)
and the extracellular##2##3##(1994-3#1)(2008-9#1)
and the extract##2##3##(2008-10#2)
and the extracted##2##3##(1993-6#1)(2008-2#1)
and the extraction##8##3##(2008-10#8)
and the extracts##2##3##(2008-10#2)
and the extreme##2##3##(2008-10#1)(2008-7#1)
and the extremely##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
and the fabrication of##2##4##(2008-10#1)(2008-3#1)
and the fabrication##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
and the facility with which it promotes the integration of research into EBP##2##13##(2013-1#2)
and the facility##3##3##(1996-2#1)(2013-1#2)
and the fact that both##3##5##(1997-5#1)(2009-10#1)(2009-7#1)
and the fact that it##2##5##(2007-12#1)(2012-12#1)
and the fact that the##5##5##(1991-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
and the fact that##23##4##(1991-8#1)(1992-9#2)(1993-9#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the factors affecting##2##4##(2007-10#1)(2008-10#1)
and the factors involved in##2##5##(1997-6#1)(2008-2#1)
and the factors that##5##4##(2008-4#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#1)
and the factors which##3##4##(1992-1#1)(2008-7#1)(2010-9#1)
and the factors##17##3##(1991-12#1)(1992-1#1)(1994-11#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#2)(2011-2#1)
and the failure to##2##4##(1996-2#1)(2008-11#1)
and the failure##4##3##(1996-2#1)(1997-3#1)(2008-11#1)(2009-7#1)
and the false##3##3##(2008-6#1)(2011-2#1)(2012-3#1)
and the families##2##3##(1992-3#1)(2008-1#1)
and the family##7##3##(1996-9#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-9#1)(2013-1#2)
and the far-field##4##3##(2008-2#2)(2008-3#2)
and the fast##4##3##(1995-3#1)(2007-12#2)(2013-8#1)
and the fate of##3##4##(1996-12#1)(2008-3#1)(2008-8#1)
and the favorable##2##3##(1990-6#1)(2008-10#1)
and the fear of##2##4##(2008-1#1)(2008-8#1)
and the feasibility for##2##4##(2011-2#1)(2013-8#1)
and the feasibility of##2##4##(2008-10#1)(2008-3#1)
and the feasibility##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
and the female##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
and the fertilization##2##3##(2007-12#1)(2008-9#1)
and the fetus##2##3##(1997-8#1)(2011-1#1)
and the fiber##3##3##(2007-11#1)(2008-3#1)(2013-8#1)
and the field distribution of##2##5##(2007-11#1)(2007-12#1)
and the field of practice##2##5##(1994-12#1)(1995-1#1)
and the field of view##2##5##(2008-3#2)
and the field of##5##4##(1993-2#1)(1994-12#1)(1995-1#1)(2008-3#2)
and the field##14##3##(1993-2#1)(1994-12#1)(1995-1#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#2)(2010-7#1)
and the fifth##6##3##(1992-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
and the fifth-order##3##3##(2008-2#1)(2008-3#2)
and the figure of##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
and the figure##4##3##(1992-4#1)(2008-10#1)(2008-3#1)(2012-12#1)
and the film thickness##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
and the film##7##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)
and the filter##2##3##(1992-6#1)(2008-3#1)
and the final reaction that produces the ligand-conjugated oligonucleotide are described elsewhere in the series##2##15##(2008-4#2)
and the final##23##3##(1990-7#2)(1992-4#1)(1995-6#1)(1996-12#1)(2006-10#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-5#1)(2013-1#1)
and the financial##5##3##(1992-12#1)(1995-3#1)(1997-8#1)(2008-2#1)(2008-3#1)
and the finding that the##2##5##(1995-11#1)(2008-10#1)
and the findings of##2##4##(1994-8#1)(2008-3#1)
and the findings##5##3##(1994-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
and the finite-difference time-domain##3##4##(2008-3#3)
and the first derivative##3##4##(2008-10#3)
and the first four##2##4##(1993-8#1)(1994-11#1)
and the first genome sequence of a member of the genus##2##11##(2011-2#2)
and the first line##2##4##(2008-11#1)(2013-8#1)
and the first one##2##4##(2008-2#1)(2011-2#1)
and the first report##2##4##(2008-1#1)(2009-1#1)
and the first##44##3##(1991-5#2)(1991-6#1)(1992-11#2)(1993-8#1)(1994-11#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
and the fitting##2##3##(2013-8#2)
and the flanking##2##3##(2008-10#1)(2008-8#1)
and the flexibility##3##3##(1993-11#1)(2008-2#1)(2011-1#1)
and the flow of##2##4##(1996-6#1)(2008-10#1)
and the flow rate were##2##5##(1990-12#1)(2008-10#1)
and the flow rate##5##4##(1990-12#1)(2008-10#3)(2011-1#1)
and the flow##11##3##(1990-12#1)(1996-6#1)(2008-10#7)(2008-11#1)(2011-1#1)
and the flow-rate##2##3##(1997-2#1)(2008-10#1)
and the fluorescence intensity##2##4##(2008-10#2)
and the fluorescence of##2##4##(1992-8#1)(2008-10#1)
and the fluorescence##15##3##(1990-8#1)(1992-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
and the fluorescent##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and the focal length##2##4##(2008-2#1)(2008-3#1)
and the focal##8##3##(2008-2#3)(2008-3#3)(2008-4#1)(2013-1#1)
and the focus##3##3##(1993-12#1)(1996-3#1)(1997-3#1)
and the focusing##2##3##(2008-10#1)(2008-3#1)
and the follow-up##2##3##(1994-2#1)(2009-10#1)
and the following##15##3##(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)(2013-1#1)
and the food##2##3##(1990-9#1)(2012-2#1)
and the form##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
and the formation constants of##2##5##(2008-10#2)
and the formation constants##3##4##(2008-10#3)
and the formation of apoptotic bodies##3##6##(2008-11#1)(2008-7#1)(2012-3#1)
and the formation of the##4##5##(1991-5#1)(1996-12#1)(2008-10#2)
and the formation of##25##4##(1991-1#1)(1991-5#2)(1994-3#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-3#1)
and the formation##29##3##(1991-1#1)(1991-5#2)(1994-3#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-3#1)
and the four##4##3##(1991-12#1)(1993-3#1)(1997-7#1)(2013-8#1)
and the fourth##4##3##(1992-4#2)(1997-3#1)(2008-5#1)
and the fraction of the##2##5##(1994-3#1)(2008-7#1)
and the fraction of##7##4##(1994-3#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
and the fraction##8##3##(1994-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
and the fractional##7##3##(1996-4#1)(2007-11#1)(2008-3#4)(2008-7#1)
and the fractions##2##3##(2008-10#1)(2012-2#1)
and the free energy of##2##5##(1995-5#1)(1996-6#1)
and the free##11##3##(1990-11#1)(1995-1#1)(1995-5#1)(1996-6#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-2#1)
and the frequency distribution of##2##5##(2008-10#1)(2008-7#1)
and the frequency of the##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
and the frequency of##18##4##(1990-11#1)(1990-8#1)(1994-6#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#3)(2013-7#1)
and the frequency##23##3##(1990-11#1)(1990-8#1)(1994-6#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#3)(2013-7#1)
and the frequent##4##3##(1990-6#1)(2008-1#1)(2008-5#1)(2013-8#1)
and the fringe##2##3##(2008-3#2)
and the full range of##2##5##(2008-10#1)(2008-7#1)
and the full width at half-maximum##2##6##(2008-2#1)(2013-8#1)
and the full##9##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and the function of##3##4##(2008-4#2)(2011-3#1)
and the functional diversity of individual cells##2##7##(2008-2#1)(2008-4#1)
and the functional role of##2##5##(2007-8#1)(2008-4#1)
and the functional##16##3##(1993-2#1)(1993-3#1)(1995-11#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#3)(2008-8#1)(2013-1#1)
and the functions of##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
and the fundamental##2##3##(2007-11#2)
and the fungal pathogen##2##4##(2008-10#2)
and the fungal##3##3##(2008-10#3)
and the fungi##3##3##(2008-10#3)
and the fungicide##2##3##(2008-10#1)(2008-11#1)
and the fungus##5##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-9#1)
and the further##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
and the future of the##2##5##(1996-1#1)(2009-7#1)
and the future of##7##4##(1991-1#1)(1993-2#1)(1996-1#1)(1997-1#2)(2008-2#1)(2009-7#1)
and the future##15##3##(1991-1#1)(1991-3#1)(1993-2#2)(1996-1#1)(1997-1#2)(1997-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-7#1)(2010-4#1)(2013-1#1)
and the gain##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and the gas temperature##2##4##(2008-3#2)
and the gas##4##3##(2008-10#2)(2008-3#2)
and the gel##2##3##(1990-8#1)(2008-8#1)
and the gene conferring resistance to##2##6##(1994-12#2)
and the gene##9##3##(1990-5#1)(1993-3#1)(1994-12#2)(1997-2#1)(2008-6#2)(2008-8#1)(2010-6#1)
and the general public##6##4##(1991-11#1)(1993-2#1)(1996-3#1)(2007-12#2)(2010-12#1)
and the general##15##3##(1990-3#2)(1991-11#1)(1993-2#1)(1993-3#1)(1996-3#1)(1997-4#1)(2007-12#3)(2008-4#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
and the generalized##2##3##(2007-11#1)(2009-9#1)
and the generated##3##3##(1992-6#1)(2007-11#1)(2008-9#1)
and the generation of##7##4##(1992-12#1)(1994-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
and the genes##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
and the genetic diversity##2##4##(2008-10#1)(2008-6#1)
and the genetic##13##3##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-4#1)(2011-1#1)
and the genome##3##3##(1990-11#1)(2008-10#1)(2008-9#1)
and the genotype##2##3##(2008-4#1)(2011-1#1)
and the geographic##2##3##(1991-3#1)(1994-1#1)
and the geometric##2##3##(1991-5#1)(2007-11#1)
and the geometrical##5##3##(2008-2#1)(2008-3#3)(2009-6#1)
and the geometry of the##2##5##(2008-10#1)(2009-9#1)
and the geometry of##4##4##(1991-9#1)(1993-5#1)(2008-10#1)(2009-9#1)
and the geometry##5##3##(1991-9#1)(1993-5#1)(2008-10#1)(2008-2#1)(2009-9#1)
and the germination##2##3##(2008-10#1)(2011-2#1)
and the glass infiltration mode##2##5##(2009-8#2)
and the global##8##3##(1990-8#1)(1990-9#2)(1994-12#1)(1997-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
and the glycemic##3##3##(2008-1#2)(2011-2#1)
and the goal##4##3##(1994-11#1)(2007-12#1)(2007-7#1)(2008-11#1)
and the goals of##2##4##(2008-7#1)(2011-2#1)
and the goals##4##3##(2007-4#1)(2008-12#1)(2008-7#1)(2011-2#1)
and the gold surface##2##4##(2008-10#1)(2013-8#1)
and the good##5##3##(1990-2#1)(1992-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
and the grade##2##3##(2008-10#1)(2008-12#1)
and the gradient##2##3##(2008-10#1)(2008-8#1)
and the granule##2##3##(2008-6#1)(2013-8#1)
and the grating##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
and the gray##2##3##(2008-10#1)(2011-2#1)
and the great##5##3##(1995-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-2#1)
and the greater##3##3##(1993-11#1)(1994-3#1)(2013-1#1)
and the greatest##11##3##(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#7)(2013-1#1)
and the greenhouse effect##2##4##(1991-6#2)
and the greenhouse##3##3##(1991-6#2)(2008-10#1)
and the groove##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
and the group of##2##4##(2008-12#1)(2008-3#1)
and the group##8##3##(1993-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-10#1)(2009-6#1)
and the growing number of##2##5##(1993-12#1)(2011-3#1)
and the growing##8##3##(1993-12#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-8#1)(2011-3#1)(2012-12#1)(2013-8#1)
and the growth of##5##4##(1990-3#1)(1997-1#1)(2008-10#2)(2013-8#1)
and the growth##14##3##(1990-3#1)(1993-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-8#1)(2009-6#1)(2013-8#1)
and the handling of##2##4##(2008-10#1)(2008-4#1)
and the head##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
and the healing##2##3##(2009-5#1)(2010-1#1)
and the health care provider##2##5##(2010-1#1)(2013-1#1)
and the health care provider's liability for improper disclosure##2##9##(1991-12#1)(1992-3#1)
and the health care system##4##5##(1992-12#1)(1993-12#1)(1997-6#1)(2013-1#1)
and the health care##15##4##(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-6#1)(2010-1#1)(2013-1#2)
and the health of##3##4##(2007-2#1)(2008-5#1)(2012-12#1)
and the health##25##3##(1991-12#1)(1991-3#1)(1992-12#3)(1992-3#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-3#1)(2012-12#1)(2013-1#2)
and the heart rate from##2##5##(1991-6#2)
and the heart rate##3##4##(1990-5#1)(1991-6#2)
and the heart##9##3##(1990-5#1)(1991-6#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)
and the heat##2##3##(1992-2#1)(1993-8#1)
and the help##2##3##(1994-3#1)(1995-1#1)
and the hemoglobin##3##3##(2008-3#3)
and the hepatic##2##3##(1991-5#1)(2008-9#1)
and the hepatitis##2##3##(1991-11#1)(1997-7#1)
and the heterologous##2##3##(2008-11#2)
and the hidden##2##3##(2008-10#1)(2008-3#1)
and the high affinity##2##4##(1990-12#1)(2008-7#1)
and the high frequency##2##4##(1990-8#1)(2011-2#1)
and the high level of##3##5##(1997-7#1)(2008-1#1)(2008-8#1)
and the high##25##3##(1990-12#1)(1990-3#1)(1990-8#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and the high-frequency##2##3##(2007-12#1)(2008-3#1)
and the higher##11##3##(1996-2#1)(2008-10#4)(2008-11#2)(2008-7#3)(2013-7#1)
and the highest level of##3##5##(1992-9#1)(2008-12#1)(2008-8#1)
and the highest##19##3##(1990-2#1)(1992-9#1)(1997-5#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
and the highly##6##3##(1993-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
and the hip##2##3##(2009-11#1)(2009-3#1)
and the hippocampus##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
and the histological diagnosis##2##4##(2008-10#1)(2011-1#1)
and the histological findings##2##4##(1990-11#1)(2008-1#1)
and the histological##7##3##(1990-11#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)
and the histopathological##4##3##(1997-8#1)(2008-1#1)(2010-11#1)(2013-8#1)
and the historical##2##3##(2010-8#1)(2011-2#1)
and the history of the##2##5##(2008-12#2)
and the history of##5##4##(1995-12#1)(2008-12#2)(2010-3#1)(2010-8#1)
and the horizontal##2##3##(1994-3#1)(2008-3#1)
and the hormone##2##3##(1991-5#1)(1993-6#1)
and the hospital##12##3##(1990-9#1)(1991-12#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2013-1#2)
and the host##6##3##(1990-7#1)(2008-10#2)(2008-9#1)(2009-4#1)(2012-12#1)
and the human##12##3##(1990-9#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-6#3)(2008-4#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-2#1)
and the humidity##2##3##(2008-10#2)
and the hybrid filter##2##4##(2008-3#2)
and the hybrid##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
and the hybridization##2##3##(2008-10#2)
and the hydration##2##3##(2008-10#1)(2012-2#1)
and the hydrogen##3##3##(2007-11#1)(2008-10#2)
and the hydrolysis of the##2##5##(1993-11#1)(2008-10#1)
and the hydrolysis##3##3##(1993-11#1)(2008-10#2)
and the hydrophilic##2##3##(1995-2#1)(2008-10#1)
and the hydrophobic##2##3##(2008-10#2)
and the hygromycin##2##3##(2008-10#1)(2008-11#1)
and the hyphal##2##3##(1996-6#1)(2008-7#1)
and the identification of a##3##5##(1991-2#1)(1993-12#1)(1994-8#1)
and the identification of##16##4##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#2)(1994-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2011-1#1)(2012-2#1)
and the identification##17##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#2)(1994-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2011-1#1)(2012-2#1)
and the identified##3##3##(1991-8#1)(2008-7#1)(2011-1#1)
and the identity of the##2##5##(2008-10#1)(2013-8#1)
and the identity##3##3##(1997-3#1)(2008-10#1)(2013-8#1)
and the idler##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
and the image##6##3##(1995-6#1)(2007-11#1)(2007-12#2)(2008-12#1)(2010-4#1)
and the images##2##3##(2007-11#1)(2008-4#1)
and the imaginary part to +/-50%##2##6##(2008-3#2)
and the imaginary part##5##4##(2008-3#5)
and the imaginary##18##3##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#10)
and the imaging##4##3##(2007-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
and the immediate##3##3##(2008-3#2)(2010-11#1)
and the immobilized##3##3##(2008-10#2)(2008-11#1)
and the immune system are##2##5##(2008-2#1)(2008-5#1)
and the immune system##9##4##(1997-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#3)(2010-5#1)
and the immune##11##3##(1997-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-9#1)(2010-5#1)
and the immunoglobulin##2##3##(1991-2#1)(2008-4#1)
and the impact of the##5##5##(1992-9#1)(2007-8#1)(2008-3#1)(2012-12#1)(2013-8#1)
and the impact of##24##4##(1992-9#1)(1993-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
and the impact on##5##4##(1991-2#1)(1992-12#1)(2007-10#1)(2008-10#1)(2010-2#1)
and the impact that##2##4##(1992-1#1)(2010-7#1)
and the impact##34##3##(1991-2#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
and the implantation of##2##4##(2011-2#2)
and the implementation of the##3##5##(1992-1#1)(2008-3#1)(2011-1#1)
and the implementation of##10##4##(1992-1#1)(1995-1#1)(1997-2#1)(1997-3#1)(2008-3#2)(2011-1#2)(2012-3#1)(2013-1#1)
and the implementation##11##3##(1992-1#1)(1994-1#1)(1995-1#1)(1997-2#1)(1997-3#1)(2008-3#2)(2011-1#2)(2012-3#1)(2013-1#1)
and the implications for##5##4##(1995-2#1)(2006-12#1)(2008-7#1)(2010-8#1)(2012-3#1)
and the implications of such##2##5##(2008-12#1)(2010-1#1)
and the implications of this##2##5##(2008-10#1)(2008-12#1)
and the implications of##5##4##(1991-2#1)(2008-10#1)(2008-12#2)(2010-1#1)
and the implications##15##3##(1991-1#1)(1991-2#2)(1995-2#1)(2006-12#1)(2008-10#2)(2008-12#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
and the importance of an##2##5##(1991-2#1)(1993-12#1)
and the importance of the##3##5##(2007-2#1)(2010-3#1)(2013-1#1)
and the importance of##35##4##(1990-8#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#2)
and the importance##36##3##(1990-8#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#2)
and the impressive##2##3##(1991-9#1)(1993-12#1)
and the improved##5##3##(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
and the improvement##2##3##(2010-6#1)(2011-2#1)
and the in situ##2##4##(2008-10#1)(2008-6#1)
and the in vitro##3##4##(1993-1#1)(2008-8#1)(2010-5#1)
and the in vivo##3##4##(1990-8#1)(1995-12#1)(2008-5#1)
and the in##8##3##(1990-8#1)(1993-1#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)
and the inability##2##3##(2008-10#1)(2012-12#1)
and the inactivation##2##3##(1990-11#1)(1994-6#1)
and the inactive##2##3##(1992-6#1)(1995-12#1)
and the incidence is##2##4##(2008-2#1)(2013-1#1)
and the incidence of BYDV##2##5##(2008-10#2)
and the incidence of CSF leak was##2##7##(2012-3#2)
and the incidence of complications##2##5##(2008-1#1)(2012-2#1)
and the incidence of flowers with ray blight##2##8##(2008-10#2)
and the incidence of##38##4##(1990-12#1)(1991-3#1)(1991-8#1)(1995-11#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
and the incidence##43##3##(1990-12#1)(1991-3#1)(1991-8#1)(1995-11#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
and the incidences of##4##4##(2008-9#3)(2011-2#1)
and the inclusion of##2##4##(2008-10#2)
and the incoherent##5##3##(2007-12#1)(2008-3#4)
and the incorporation of##2##4##(2008-1#1)(2013-1#1)
and the incorporation##3##3##(2008-1#1)(2008-8#1)(2013-1#1)
and the increase in the rate of##2##7##(1993-11#1)(1995-6#1)
and the increase in the##3##5##(1993-11#1)(1995-6#1)(2008-5#1)
and the increase in##12##4##(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)
and the increase of##6##4##(2008-10#2)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
and the increase##20##3##(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2010-5#1)(2012-12#1)(2013-8#1)
and the increased risk of##3##5##(2008-7#1)(2010-12#1)(2013-1#1)
and the increased##13##3##(1991-9#1)(1992-9#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the increasing##7##3##(1992-1#1)(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
and the incremental##3##3##(2010-8#1)(2012-12#1)(2013-1#1)
and the index of dispersion##2##5##(2008-10#2)
and the index of##5##4##(1990-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
and the index##8##3##(1990-11#1)(1992-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)
and the indirect leucocyte migration inhibition factor (LMIF)##2##8##(1991-12#2)
and the indirect##4##3##(1991-12#2)(1994-2#1)(2008-10#1)
and the individual##12##3##(1992-3#1)(1992-6#1)(1993-5#1)(1994-8#1)(2008-10#3)(2008-8#2)(2009-12#1)(2011-2#1)(2011-3#1)
and the induced##2##3##(2008-10#1)(2008-3#1)
and the induction of##10##4##(1992-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
and the induction period##2##4##(2008-10#2)
and the induction##13##3##(1992-12#1)(1994-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
and the inductively coupled##2##4##(2008-10#2)
and the industry##2##3##(1995-1#1)(1996-2#1)
and the infant##2##3##(2008-11#1)(2008-2#1)
and the infected##2##3##(2008-10#1)(2012-3#1)
and the infection##2##3##(1990-3#1)(2009-7#1)
and the inferior##2##3##(1996-5#1)(2008-8#1)
and the inflammatory##4##3##(1997-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
and the influence of the political and##2##7##(1995-2#1)(2008-2#1)
and the influence of the##13##5##(1993-12#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-11#2)(2011-2#1)
and the influence of##41##4##(1992-2#1)(1993-12#1)(1995-2#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
and the influence on##2##4##(2008-11#1)(2011-2#1)
and the influence##45##3##(1992-2#1)(1993-12#1)(1995-2#1)(2007-11#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-9#2)(2011-2#2)(2013-1#2)(2013-8#1)
and the information and##2##4##(1995-1#1)(1996-3#1)
and the information##8##3##(1993-6#1)(1994-3#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-10#1)
and the infrared##6##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
and the inherent##5##3##(2008-2#1)(2008-3#2)(2009-9#1)(2010-10#1)
and the inhibition of##2##4##(1990-11#1)(2012-2#1)
and the inhibitor##2##3##(1990-2#1)(1993-8#1)
and the inhibitory effect of##2##5##(2008-8#1)(2011-3#1)
and the inhibitory effect##3##4##(2008-8#1)(2008-9#1)(2011-3#1)
and the inhibitory effects##2##4##(1994-8#1)(1995-11#1)
and the inhibitory##6##3##(1992-7#1)(1994-8#1)(1995-11#1)(2008-8#1)(2008-9#1)(2011-3#1)
and the inhomogeneous##2##3##(2008-3#2)
and the initial##9##3##(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#1)
and the initiation of##2##4##(2008-9#1)(2009-3#1)
and the injection##3##3##(1997-3#1)(2008-10#1)(2011-1#1)
and the inner##3##3##(1990-11#1)(2008-2#1)(2012-2#1)
and the innermost##3##3##(1990-3#1)(2007-12#1)(2008-7#1)
and the insertion##2##3##(1991-12#1)(2007-11#1)
and the instantaneous##2##3##(2008-3#2)
and the institution##3##3##(1993-12#1)(2010-3#1)(2011-2#1)
and the instrument##2##3##(2008-3#1)(2009-12#1)
and the insurance##2##3##(1992-3#1)(1993-12#1)
and the integrated##5##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
and the integration of the##2##5##(1997-3#1)(2008-10#1)
and the integration of##4##4##(1994-12#1)(1997-3#1)(2008-10#1)(2010-5#1)
and the integration##5##3##(1994-12#1)(1997-3#1)(2008-10#1)(2010-5#1)(2011-1#1)
and the intensities of the##2##5##(2008-10#1)(2008-8#1)
and the intensity of stereotypy performance##2##6##(2008-11#2)
and the intensity of the##7##5##(1993-3#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
and the intensity of##11##4##(1993-3#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2013-7#1)
and the intensity##17##3##(1993-3#1)(1994-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2013-7#1)
and the interaction between##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
and the interaction of##6##4##(1990-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)
and the interaction with##2##4##(1995-5#1)(1995-6#1)
and the interaction##13##3##(1990-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2009-4#1)(2011-2#1)
and the interactions of##2##4##(2008-10#1)(2008-4#1)
and the interactions##5##3##(2008-10#3)(2008-4#1)(2008-8#1)
and the interests of##2##4##(1992-3#1)(2009-10#1)
and the interference from##2##4##(2008-10#2)
and the interference of other##2##5##(2008-10#1)(2008-6#1)
and the interference of##4##4##(2008-10#2)(2008-5#1)(2008-6#1)
and the interference##10##3##(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2013-8#2)
and the interferometer##2##3##(2007-12#1)(2008-2#1)
and the intergenic region##3##4##(1996-10#1)(2008-10#2)
and the intergenic##4##3##(1996-10#1)(2008-10#3)
and the interior of##2##4##(2008-7#1)(2013-7#1)
and the interior##3##3##(2008-7#1)(2013-7#2)
and the intermediate##2##3##(2008-3#1)(2008-6#1)
and the intermediates##2##3##(2008-10#1)(2008-6#1)
and the internal structure##2##4##(1991-2#1)(2008-3#1)
and the internal transcribed spacer##2##5##(2008-10#2)
and the internal##9##3##(1991-2#1)(1991-3#1)(1992-12#1)(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)
and the internet##3##3##(2008-11#1)(2013-8#2)
and the interpretation of the##2##5##(2008-10#1)(2008-4#1)
and the interpretation of##4##4##(2007-8#1)(2008-10#1)(2008-4#2)
and the interval##2##3##(1991-2#1)(2008-10#1)
and the intervention##2##3##(2008-4#1)(2012-3#1)
and the interventionist##2##3##(2008-12#1)(2011-2#1)
and the intestinal##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
and the intestine##2##3##(1995-9#1)(2008-5#1)
and the intra- and##2##4##(1997-2#1)(2011-2#1)
and the intracellular##9##3##(1990-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#2)
and the intrinsic##4##3##(1992-6#1)(2008-10#3)
and the introduction of##5##4##(1991-3#1)(2008-12#1)(2008-6#1)(2008-7#2)
and the inverse##2##3##(2007-11#1)(2008-3#1)
and the inversion##2##3##(2008-2#1)(2008-3#1)
and the investigation of##3##4##(1991-12#1)(2006-4#1)(2008-10#1)
and the invisible##2##3##(1993-12#1)(2011-2#1)
and the involvement of##5##4##(1994-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)
and the ion##3##3##(2008-10#3)
and the ion-pair##2##3##(2008-10#2)
and the ionic strength##3##4##(2008-10#3)
and the ionic##4##3##(2008-10#4)
and the iron##2##3##(1990-3#2)
and the irradiation time##2##4##(2008-10#2)
and the isolate##3##3##(2008-10#3)
and the isolated##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-6#1)
and the issues##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
and the item##2##3##(2012-2#1)(2013-1#1)
and the iterative##3##3##(2008-2#1)(2008-3#2)
and the joint##2##3##(1993-5#1)(2008-3#1)
and the joints##2##3##(1992-5#1)(2011-1#1)
and the journal##2##3##(1995-5#1)(2013-1#1)
and the judicial system##3##4##(1997-8#1)(2008-12#1)(2011-2#1)
and the jugular##2##3##(2009-6#1)(2011-2#1)
and the key##6##3##(1997-3#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
and the kidney##2##3##(2007-7#1)(2008-9#1)
and the kidneys##3##3##(1993-9#1)(2008-1#1)(2008-5#1)
and the kinetic##4##3##(1997-2#1)(2008-10#2)(2010-10#1)
and the kinetics of##4##4##(1993-3#1)(2008-10#2)(2011-2#1)
and the kinetics##6##3##(1993-3#1)(1995-5#1)(2008-10#2)(2008-8#1)(2011-2#1)
and the knee##3##3##(2010-3#1)(2013-1#2)
and the knowledge of##3##4##(2008-10#2)(2013-1#1)
and the knowledge##7##3##(1993-11#1)(2008-10#2)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
and the known##9##3##(1992-12#1)(1992-6#1)(1994-12#1)(1996-12#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
and the labeled##2##3##(1995-2#1)(2008-2#1)
and the laboratory##7##3##(1993-5#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
and the lack of##22##4##(1991-2#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
and the large size of the##2##6##(1991-3#1)(2009-2#1)
and the large##10##3##(1991-3#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2009-2#1)(2012-3#2)(2013-1#1)
and the larger the##2##4##(2008-10#1)(2008-3#1)
and the larger##7##3##(1994-1#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-1#1)
and the largest##3##3##(1997-2#1)(2007-11#1)(2013-1#1)
and the laser##13##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#2)
and the last one##2##4##(1997-3#1)(2007-11#1)
and the last##13##3##(1990-3#2)(1991-11#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-6#1)(2008-7#1)
and the late##4##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
and the latency##2##3##(1993-12#1)(2008-1#1)
and the lateral resolution##2##4##(2007-11#1)(2008-3#1)
and the lateral##9##3##(1990-7#1)(1993-6#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)
and the latest##2##3##(2008-7#1)(2010-8#1)
and the latter was##3##4##(1994-11#1)(2008-10#1)(2012-2#1)
and the latter##18##3##(1990-8#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2010-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
and the lattice absorption gap at the##2##7##(2008-2#2)
and the law##4##3##(1993-2#1)(1993-3#1)(1996-2#1)(2012-12#1)
and the lead##2##3##(2007-12#1)(2008-5#1)
and the leading##2##3##(2008-1#1)(2009-7#1)
and the leaf##2##3##(2008-10#1)(2008-8#1)
and the learning##5##3##(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)
and the least amount##2##4##(2007-11#1)(2008-7#1)
and the least##6##3##(2007-11#1)(2008-12#3)(2008-5#1)(2008-7#1)
and the left ventricular##4##4##(1993-12#1)(1995-3#1)(2008-12#2)
and the left##12##3##(1990-11#1)(1990-6#1)(1991-3#1)(1993-12#1)(1995-3#1)(1996-6#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
and the legal##3##3##(1991-12#1)(1997-5#1)(2010-7#1)
and the length and##2##4##(2008-2#1)(2008-9#1)
and the length of the##7##5##(1997-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
and the length of##14##4##(1995-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
and the length##17##3##(1995-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
and the lengths of##2##4##(2008-10#1)(2008-3#1)
and the lens aperture?##2##4##(2008-3#2)
and the lesion was##2##4##(2006-10#1)(2007-10#1)
and the lesion##4##3##(2006-10#1)(2007-10#1)(2008-7#1)(2010-6#1)
and the lesions##2##3##(2007-8#1)(2008-5#1)
and the less##2##3##(1997-3#1)(2008-4#1)
and the lessons##4##3##(2010-12#1)(2012-2#1)(2013-1#2)
and the lethality##2##3##(1995-12#1)(2008-10#1)
and the level of##33##4##(1991-2#1)(1992-1#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-8#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
and the level##35##3##(1991-2#1)(1992-1#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
and the levels of##8##4##(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#3)(2012-2#1)(2013-1#1)
and the levels##9##3##(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#3)(2012-2#1)(2013-1#1)
and the lidar##2##3##(2008-3#2)
and the life span##3##4##(2008-10#2)(2013-7#1)
and the life##4##3##(2008-10#2)(2008-8#1)(2013-7#1)
and the lifetime of##2##4##(2008-10#1)(2008-9#1)
and the lifetime##4##3##(2008-10#2)(2008-9#1)(2011-1#1)
and the ligand##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
and the ligation of##2##4##(2008-2#1)(2011-3#1)
and the light##6##3##(1992-8#1)(2008-10#3)(2008-3#1)(2008-9#1)
and the likelihood of##6##4##(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2012-3#1)
and the likelihood##8##3##(2008-4#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2012-3#1)
and the likely##2##3##(2008-8#1)(2012-2#1)
and the limit of detection is 0##3##7##(2008-10#3)
and the limit of detection is##6##6##(2008-10#4)(2011-1#1)(2013-1#1)
and the limit of detection was 0##2##7##(2008-10#2)
and the limit of detection was##5##6##(2008-10#5)
and the limit of detection##16##5##(2008-10#14)(2011-1#1)(2013-1#1)
and the limit of quantification (LOQ)##2##6##(2008-10#2)
and the limit of quantification##8##5##(2008-10#7)(2008-5#1)
and the limit of quantitation##2##5##(2008-10#1)(2010-3#1)
and the limit of##27##4##(2008-10#23)(2008-5#1)(2010-3#1)(2011-1#1)(2013-1#1)
and the limitation of the##3##5##(1991-3#1)(2008-10#1)(2008-2#1)
and the limitation of##4##4##(1991-3#1)(2008-10#2)(2008-2#1)
and the limitation##5##3##(1991-3#1)(2008-10#2)(2008-2#2)
and the limitations of##8##4##(1994-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
and the limitations##10##3##(1994-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2012-12#1)
and the limited##9##3##(1994-12#1)(2007-7#1)(2008-11#2)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
and the limits of detection (LOD)##2##6##(2008-10#2)
and the limits of detection were c(L##2##7##(2008-10#2)
and the limits of detection were##4##6##(2008-10#3)(2008-2#1)
and the limits of detection##8##5##(2008-10#7)(2008-2#1)
and the limits of##11##4##(1995-5#1)(2008-10#7)(2008-2#1)(2009-5#1)(2011-1#1)
and the limits##12##3##(1995-5#1)(2008-10#8)(2008-2#1)(2009-5#1)(2011-1#1)
and the line##2##3##(2008-10#1)(2008-3#1)
and the linear dynamic range##2##5##(2008-10#2)
and the linear dynamic##3##4##(2008-10#3)
and the linear range and the##2##6##(2008-10#2)
and the linear range is##2##5##(2008-10#2)
and the linear range was 0##2##6##(2008-10#1)(2010-5#1)
and the linear range was##3##5##(2008-10#2)(2010-5#1)
and the linear range##13##4##(2008-10#12)(2010-5#1)
and the linear relationship between##2##5##(2008-10#1)(2010-5#1)
and the linear##25##3##(1997-3#1)(2007-12#1)(2008-10#18)(2008-7#2)(2010-5#2)(2012-12#1)
and the linearity is maintained in the concentration range 0##3##10##(2008-10#3)
and the linearity##5##3##(2008-10#5)
and the lipid##5##3##(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-1#1)
and the liquid##6##3##(1992-6#1)(2008-10#4)(2008-3#1)
and the literature##9##3##(1993-6#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-7#2)(2010-12#1)(2013-1#1)
and the liver##9##3##(1990-11#1)(1990-12#1)(1992-11#1)(1993-3#2)(1995-12#1)(1995-2#1)(2008-7#1)(2010-12#1)
and the local oscillator##2##4##(2008-2#1)(2008-3#1)
and the local##13##3##(1991-12#1)(1992-11#1)(1996-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)
and the localization of the##3##5##(1995-6#1)(2008-9#1)(2012-3#1)
and the localization of##4##4##(1994-8#1)(1995-6#1)(2008-9#1)(2012-3#1)
and the localized##3##3##(1993-5#1)(2007-11#1)(2007-12#1)
and the location of the nutrient foramen with respect to the surfaces and the zones##2##15##(2013-8#2)
and the location of the##4##5##(2008-2#1)(2008-3#1)(2013-8#2)
and the location of##6##4##(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#2)
and the location##8##3##(2008-2#2)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#2)
and the locations of##2##4##(1995-2#1)(2008-10#1)
and the locus##2##3##(1991-2#1)(2008-7#1)
and the logarithm of##3##4##(2008-10#3)
and the long##5##3##(1993-3#1)(2007-11#1)(2008-2#1)(2008-3#2)
and the long-term##8##3##(1993-12#1)(1994-2#2)(2006-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)
and the longest##2##3##(1994-3#1)(2008-7#1)
and the longitudinal##3##3##(2008-3#3)
and the loss of the##3##5##(2007-12#1)(2008-10#1)(2013-7#1)
and the loss of##8##4##(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
and the loss##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
and the low##11##3##(1990-2#1)(1994-6#1)(1996-3#1)(1996-4#1)(2007-11#1)(2008-10#3)(2008-7#1)(2010-11#1)(2012-2#1)
and the low-frequency##2##3##(1991-10#1)(2007-11#1)
and the lower limit##2##4##(2008-10#2)
and the lower##8##3##(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
and the lowest was found with T1##2##7##(2008-12#2)
and the lowest was found with##3##6##(2008-12#3)
and the lowest##18##3##(1990-12#1)(1993-2#1)(1993-8#1)(2007-11#1)(2008-10#5)(2008-12#4)(2008-3#3)(2008-5#1)(2008-8#1)
and the luminol solution were sequentially introduced into the flow cell based on an SIA programmed sequence##2##17##(2008-10#2)
and the lung##6##3##(1994-7#2)(2007-12#1)(2008-1#1)(2009-1#1)(2013-7#1)
and the lungs##4##3##(1996-12#1)(2008-1#1)(2008-10#1)(2012-2#1)
and the mRNA expression##2##4##(2008-11#1)(2008-7#1)
and the mRNA##5##3##(1991-12#1)(1992-9#1)(2008-11#1)(2008-4#1)(2008-7#1)
and the magnetic##2##3##(1996-11#1)(2008-10#1)
and the magneto-optic##3##3##(2008-2#1)(2008-3#2)
and the magnitude of the##8##5##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
and the magnitude of##13##4##(1990-12#1)(1994-3#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
and the main cause##2##4##(2008-3#1)(2010-6#1)
and the main##16##3##(1991-9#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#2)
and the maintenance of##7##4##(1995-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the major##11##3##(1994-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#1)(2011-1#2)(2012-12#1)
and the majority of the##2##5##(2009-3#1)(2012-2#1)
and the majority of##11##4##(1995-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2012-2#2)
and the majority##15##3##(1992-5#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2012-2#2)
and the making of##2##4##(2008-7#1)(2009-11#1)
and the mammalian##2##3##(2008-11#1)(2008-9#1)
and the managed care##2##4##(1996-1#1)(1996-12#1)
and the management of##12##4##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
and the management##15##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
and the mandibular##3##3##(2008-9#1)(2013-1#2)
and the manifestation##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
and the manipulation##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
and the manner of##2##4##(1995-11#1)(2008-10#1)
and the manner##4##3##(1990-12#1)(1995-11#1)(2008-10#1)(2010-5#1)
and the manufacturer's##2##3##(2008-3#1)(2008-4#1)
and the many##3##3##(2008-9#1)(2010-2#1)(2012-2#1)
and the mass transfer##2##4##(2008-10#1)(2008-7#1)
and the mass##8##3##(1994-12#1)(1995-3#1)(2008-10#2)(2008-7#2)(2010-6#1)(2012-12#1)
and the mathematical##2##3##(2008-10#1)(2008-3#1)
and the matrix##5##3##(2008-10#1)(2008-7#1)(2009-7#1)(2010-5#1)(2012-1#1)
and the mature##8##3##(1990-11#2)(1990-12#1)(1990-5#1)(1994-8#1)(1995-6#1)(2008-4#1)(2011-2#1)
and the maximal##4##3##(1990-2#1)(2008-11#1)(2008-6#1)(2008-7#1)
and the maximum slope##2##4##(2007-11#1)(2008-10#1)
and the maximum##23##3##(1995-11#1)(1995-12#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-1#1)(2013-1#1)(2013-8#1)
and the mean ages of##2##5##(1997-7#1)(2008-12#1)
and the mean and standard deviation of the##2##8##(1994-11#1)(2008-10#1)
and the mean arterial pressure##2##5##(1994-3#1)(2013-8#1)
and the mean duration of##2##5##(1996-3#1)(2007-8#1)
and the mean insulin level during the last 20 min of the clamp##2##13##(1994-12#2)
and the mean number of##2##5##(1992-3#1)(1997-2#1)
and the mean time of##3##5##(1997-4#1)(2008-11#1)(2009-3#1)
and the mean time##6##4##(1991-6#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-12#1)
and the mean total number of wireworms##2##7##(2011-2#2)
and the mean total number of##3##6##(2010-12#1)(2011-2#2)
and the mean##53##3##(1990-11#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-4#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the meaning of##2##4##(1996-1#1)(2012-3#1)
and the means##2##3##(2008-10#1)(2012-3#1)
and the measured##9##3##(2007-12#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-9#1)(2013-1#1)
and the measurement of the##2##5##(2008-10#1)(2010-5#1)
and the measurement##8##3##(2008-10#4)(2008-2#1)(2008-3#2)(2010-5#1)
and the measures##4##3##(1996-8#1)(2008-8#1)(2009-11#1)(2010-11#1)
and the mechanical properties of##2##5##(2008-5#1)(2009-7#1)
and the mechanical##3##3##(2008-3#1)(2008-5#1)(2009-7#1)
and the mechanism by which##2##5##(1990-11#1)(1992-9#1)
and the mechanism of action of the##2##7##(2008-10#1)(2008-5#1)
and the mechanism of the##2##5##(1995-8#1)(2008-4#1)
and the mechanism of##10##4##(1991-5#1)(1993-11#1)(1995-5#1)(1995-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2012-1#1)
and the mechanism underlying##2##4##(2008-8#1)(2009-5#1)
and the mechanism##19##3##(1990-11#1)(1991-5#1)(1992-9#1)(1993-11#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
and the mechanisms by which##3##5##(2008-11#1)(2011-3#1)(2012-2#1)
and the mechanisms involved##2##4##(2008-7#1)(2010-3#1)
and the mechanisms of##4##4##(1994-10#1)(2007-7#1)(2008-10#1)(2013-8#1)
and the mechanisms##12##3##(1994-10#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-3#1)(2012-2#1)(2013-8#1)
and the media##6##3##(1991-5#1)(1996-2#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
and the median follow-up##2##4##(1990-2#1)(1993-11#1)
and the median##11##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-6#1)(1993-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
and the medical community##2##4##(2008-8#1)(2010-6#1)
and the medical community's##2##4##(2011-2#1)(2013-8#1)
and the medical staff##2##4##(1993-2#2)
and the medical##15##3##(1991-6#1)(1993-2#2)(1995-8#1)(1996-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
and the medications##2##3##(2008-7#1)(2008-8#1)
and the medium##6##3##(2008-11#2)(2008-2#1)(2008-3#2)(2013-1#1)
and the medullary##2##3##(1995-6#1)(2013-1#1)
and the melting##2##3##(2008-2#1)(2008-5#1)
and the membrane can be used for more than 3 months without##2##12##(2008-10#2)
and the membrane surface##2##4##(1991-9#1)(1994-5#1)
and the membrane##10##3##(1991-9#1)(1992-6#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-5#1)
and the mental##2##3##(2009-6#1)(2011-2#1)
and the metabolic syndrome##14##4##(2008-1#4)(2008-10#1)(2008-3#5)(2008-5#1)(2010-5#2)(2012-2#1)
and the metabolic##16##3##(1993-2#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#5)(2008-5#1)(2010-5#2)(2012-2#1)
and the metabolism of##2##4##(2008-5#1)(2008-8#1)
and the metabolites##2##3##(1990-5#1)(2008-11#1)
and the metal ion##2##4##(2008-10#2)
and the metal was determined by##2##6##(2008-10#2)
and the metal##13##3##(1997-7#1)(2008-10#9)(2008-7#1)(2009-11#1)(2010-5#1)
and the metastatic##2##3##(1992-9#1)(2011-2#1)
and the method has been##2##5##(2008-10#2)
and the method is##3##4##(2008-10#3)
and the method of##6##4##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
and the method used for##2##5##(2008-3#1)(2010-5#1)
and the method used##3##4##(2008-3#2)(2010-5#1)
and the method was##2##4##(2008-10#2)
and the method##24##3##(1993-3#1)(2008-10#13)(2008-2#1)(2008-3#3)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the methodology##3##3##(2008-7#1)(2009-9#1)(2011-2#1)
and the methods for##2##4##(2008-9#1)(2009-11#1)
and the methods that##2##4##(2008-8#1)(2011-1#1)
and the methods##9##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2011-1#1)
and the middle##5##3##(1995-6#1)(1996-2#1)(1997-6#1)(2008-3#1)(2010-8#1)
and the migration##5##3##(1996-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2012-1#1)
and the mild##2##3##(2008-10#2)
and the minimal##2##3##(2008-4#1)(2008-9#1)
and the minimization of##2##4##(2006-6#1)(2008-3#1)
and the minimum##8##3##(1995-6#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-5#1)(2013-8#1)
and the minor##4##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
and the mirror##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
and the mismatch##3##3##(2007-12#2)(2010-8#1)
and the mitochondrial small subunit (mtSSU) ribosomal RNA##2##8##(2008-10#2)
and the mitochondrial small subunit (mtSSU)##3##6##(2008-10#3)
and the mitochondrial##5##3##(1992-11#1)(2008-10#3)(2010-4#1)
and the mixed##2##3##(2008-10#1)(2008-3#1)
and the mixing##2##3##(2008-10#1)(2008-7#1)
and the mixture of##2##4##(2008-10#2)
and the mixture##4##3##(2008-10#4)
and the mixtures of crosses##2##5##(2008-10#2)
and the mobile phase##3##4##(2008-10#2)(2011-1#1)
and the mobile##4##3##(1996-5#1)(2008-10#2)(2011-1#1)
and the mode of action of the##2##7##(1997-1#1)(1997-7#1)
and the mode of##5##4##(1993-8#1)(1997-1#1)(1997-7#1)(2008-12#1)(2008-9#1)
and the mode##6##3##(1993-8#1)(1997-1#1)(1997-7#1)(2008-12#1)(2008-7#1)(2008-9#1)
and the model was##2##4##(2008-10#2)
and the model##14##3##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)(2013-8#1)
and the models##3##3##(2008-11#1)(2008-8#1)(2010-2#1)
and the moderating influence of##2##5##(2007-12#1)(2010-1#1)
and the moderating##3##3##(1996-2#1)(2007-12#1)(2010-1#1)
and the modification of##2##4##(1990-8#1)(2008-10#1)
and the modification##3##3##(1990-8#1)(2008-10#2)
and the modified##11##3##(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2013-8#1)
and the modulation of##4##4##(1992-9#1)(2008-4#1)(2008-5#1)(2011-1#1)
and the modulation transfer function##3##5##(2008-2#1)(2008-3#2)
and the modulation##8##3##(1992-9#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2011-1#1)
and the modulatory##2##3##(1991-1#1)(2008-11#1)
and the modulus##2##3##(2008-5#1)(2012-2#1)
and the molar absorptivity##3##4##(2008-10#3)
and the molar ratio of##2##5##(2008-10#1)(2011-2#1)
and the molar##7##3##(2008-10#6)(2011-2#1)
and the mole fraction##2##4##(2008-10#2)
and the molecular weight##3##4##(1997-8#1)(2008-10#1)(2008-3#1)
and the molecular##11##3##(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-11#1)(2013-8#1)
and the molecules##2##3##(1992-9#1)(2008-7#1)
and the momentum##2##3##(2007-8#1)(2008-3#1)
and the monoclonal##2##3##(1995-12#1)(1997-4#1)
and the moral##3##3##(2008-11#2)(2011-2#1)
and the more##11##3##(1990-11#1)(1990-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-2#1)(2013-8#1)
and the morphological##2##3##(1993-9#1)(2007-12#1)
and the mortality rate is##3##5##(1992-9#1)(2008-1#1)(2008-4#1)
and the mortality rate##4##4##(1992-9#1)(2008-1#1)(2008-4#1)(2008-8#1)
and the mortality##7##3##(1992-9#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2013-8#1)
and the most appropriate##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
and the most common##6##4##(2008-12#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
and the most commonly##2##4##(2008-2#1)(2013-1#1)
and the most effective##2##4##(2008-10#2)
and the most frequent##4##4##(1990-6#1)(1991-4#1)(1993-3#1)(2010-1#1)
and the most frequently##3##4##(2008-10#1)(2009-3#1)(2010-4#1)
and the most recent##2##4##(1991-2#1)(2008-1#1)
and the most relevant##2##4##(2008-10#2)
and the most##42##3##(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1993-3#1)(1996-11#1)(1997-3#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
and the mother##3##3##(2008-12#2)(2008-2#1)
and the motion##2##3##(2008-2#1)(2008-3#1)
and the mouse##2##3##(1995-3#1)(1996-5#1)
and the mouth##2##3##(2008-11#1)(2008-5#1)
and the movement##2##3##(1997-3#1)(2008-10#1)
and the multiple##5##3##(1993-12#1)(1997-4#1)(2008-10#1)(2009-7#1)(2013-1#1)
and the multiple-scattering##2##3##(2008-2#2)
and the mutant##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
and the mutation##5##3##(1994-11#1)(1995-5#1)(2008-1#1)(2008-12#2)
and the name##2##3##(2008-10#1)(2008-8#1)
and the nasal##2##3##(2008-11#1)(2010-8#1)
and the national##2##3##(2008-3#1)(2011-2#1)
and the native##6##3##(1992-8#1)(1993-11#2)(1997-8#1)(2008-10#2)
and the natural##9##3##(1997-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)
and the nature of the##9##5##(1992-6#1)(1994-8#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-5#1)(2012-2#1)
and the nature of##15##4##(1991-3#1)(1992-6#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-2#1)
and the nature##17##3##(1991-11#1)(1991-3#1)(1992-6#1)(1994-8#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-2#1)
and the near infrared##3##4##(2008-3#3)
and the near##4##3##(2007-12#1)(2008-3#3)
and the near-infrared regions##2##4##(2008-3#2)
and the near-infrared##4##3##(2007-11#1)(2008-3#3)
and the near-isogenic##3##3##(2008-10#1)(2011-2#2)
and the necessary##3##3##(1994-11#1)(2008-3#1)(2008-4#1)
and the necessity for##2##4##(2009-8#1)(2012-12#1)
and the necessity of##5##4##(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-11#1)
and the necessity##8##3##(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-11#1)(2009-8#1)(2012-12#1)
and the need for a##3##5##(1996-6#1)(1997-3#1)(2007-11#1)
and the need for an##2##5##(1992-8#1)(2011-2#1)
and the need for appropriate##2##5##(2007-2#1)(2008-11#1)
and the need for immediate medical##2##6##(2010-10#2)
and the need for immediate##3##5##(2010-10#2)(2012-2#1)
and the need for research##2##5##(1996-2#1)(1996-3#1)
and the need for##30##4##(1992-8#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and the need to##9##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
and the need##39##3##(1992-8#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
and the needle##2##3##(1992-12#1)(2008-10#1)
and the needs of##5##4##(1992-3#1)(1993-12#1)(2007-10#1)(2008-10#1)(2010-11#1)
and the negative##6##3##(1994-8#2)(1996-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
and the nematode##2##3##(1995-6#1)(2008-10#1)
and the nerve##2##3##(2007-8#1)(2008-9#1)
and the nervous system##6##4##(1996-11#1)(2007-12#1)(2008-5#4)
and the nervous##7##3##(1996-11#1)(2007-12#1)(2008-5#4)(2009-6#1)
and the network##2##3##(2009-10#1)(2013-1#1)
and the neural##2##3##(2007-12#1)(2009-2#1)
and the neurological##4##3##(2008-7#2)(2011-2#2)
and the neuronal##2##3##(1990-7#1)(2009-6#1)
and the new European directive##2##5##(1996-8#2)
and the new##26##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-1#1)(1995-10#1)(1995-2#2)(1996-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-8#1)
and the newer##2##3##(1993-3#1)(2006-10#1)
and the next##6##3##(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2013-8#1)
and the noise##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
and the non-charged##2##3##(2008-10#2)
and the nonlinear##7##3##(2007-12#2)(2008-3#4)(2008-7#1)
and the nonprofit##2##3##(1991-1#1)(1995-2#1)
and the normal allele##2##4##(1994-11#1)(1997-3#1)
and the normal##4##3##(1991-3#1)(1994-11#1)(1996-3#1)(1997-3#1)
and the normalized sporulation curve##2##5##(2008-10#2)
and the novel##5##3##(1994-9#1)(1996-12#1)(1996-5#1)(2008-3#1)(2012-12#1)
and the nuclear##2##3##(1995-3#1)(2008-7#1)
and the nucleation zone##2##4##(1996-4#2)
and the nucleotide sequence was determined##2##6##(1993-9#1)(1997-4#1)
and the nucleotide sequence##3##4##(1993-9#1)(1997-4#1)(2008-10#1)
and the nucleotide sequences##2##4##(1997-8#1)(2009-5#1)
and the nucleotide##5##3##(1993-9#1)(1997-4#1)(1997-8#1)(2008-10#1)(2009-5#1)
and the nucleus accumbens##7##4##(1996-12#2)(1997-3#2)(2008-6#2)(2008-7#1)
and the nucleus##14##3##(1996-12#2)(1997-3#2)(2008-10#1)(2008-11#3)(2008-6#2)(2008-7#2)(2011-2#2)
and the number and##2##4##(1995-8#1)(2008-5#1)
and the number of cases##2##5##(1994-9#2)
and the number of conidia and appressoria were counted##2##9##(2008-10#2)
and the number of conidia##3##5##(2008-10#3)
and the number of embryos##2##5##(1992-3#1)(2008-12#1)
and the number of functional##2##5##(2008-9#1)(2012-2#1)
and the number of layers##2##5##(2008-3#2)
and the number of single cells##2##6##(2008-7#2)
and the number of years of##2##6##(1993-12#2)
and the number of##95##4##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#3)(1994-6#1)(1994-9#2)(1995-12#1)(1996-12#1)(1996-2#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and the number##98##3##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#3)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and the numbers of##4##4##(1997-5#1)(2007-4#1)(2008-10#1)(2008-11#1)
and the numerical aperture##3##4##(2007-11#2)(2013-8#1)
and the numerical##6##3##(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
and the nurse##2##3##(1993-2#1)(2012-3#1)
and the nurses##2##3##(2008-10#1)(2009-5#1)
and the nursing##3##3##(2007-10#1)(2008-11#2)
and the nutritional status##2##4##(2007-12#1)(2011-1#1)
and the object##2##3##(2008-2#2)
and the objective##7##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2012-1#1)
and the observation of##5##4##(1990-6#1)(1994-2#1)(2008-5#1)(2008-7#1)(2010-3#1)
and the observation##8##3##(1990-6#1)(1994-2#1)(1996-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-3#1)
and the observed##7##3##(1993-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
and the obstacles##2##3##(2008-7#1)(2012-12#1)
and the obtained results were##2##5##(2008-10#2)
and the obtained results##6##4##(2008-10#6)
and the obtained##15##3##(2008-10#13)(2008-12#1)(2008-6#1)
and the occasional##3##3##(1992-11#1)(1996-11#1)(2008-7#1)
and the occurrence of##10##4##(1990-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-2#2)(2013-7#1)
and the occurrence##11##3##(1990-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-3#1)(2011-2#2)(2013-7#1)
and the old##2##3##(2008-10#1)(2008-7#1)
and the older##4##3##(1996-12#1)(1997-2#1)(2008-10#2)
and the olfactory##2##3##(1994-2#1)(2008-7#1)
and the one##2##3##(1997-6#1)(2008-10#1)
and the one-step##2##3##(2008-2#1)(2008-3#1)
and the ones##3##3##(1993-11#1)(1997-4#1)(2011-2#1)
and the ongoing##3##3##(1992-2#1)(1993-12#1)(1996-2#1)
and the only one##2##4##(1997-4#1)(2010-12#1)
and the only##10##3##(1997-4#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
and the onset of##8##4##(1990-5#1)(1994-2#1)(1996-2#1)(1996-5#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and the opening of##2##4##(2008-11#1)(2013-1#1)
and the operating##4##3##(1991-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
and the operation##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
and the opportunity to##2##4##(2008-9#1)(2013-8#1)
and the opposite##2##3##(2007-11#1)(2008-3#1)
and the optic##2##3##(2006-12#1)(2008-10#1)
and the optical absorption##2##4##(2008-3#2)
and the optical path##3##4##(2007-11#1)(2008-3#2)
and the optical properties of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
and the optical thickness##2##4##(2008-2#1)(2008-3#1)
and the optical##23##3##(2007-11#3)(2008-10#2)(2008-2#5)(2008-3#13)
and the optimal therapeutic##2##4##(2010-8#1)(2012-2#1)
and the optimal##15##3##(1992-9#1)(1994-11#1)(1997-3#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and the optimization of the##3##5##(2008-10#1)(2008-3#2)
and the optimization of##8##4##(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2011-3#1)
and the optimized##6##3##(1997-7#1)(2008-10#4)(2008-3#1)
and the optimum conditions##2##4##(2008-10#2)
and the optimum pH for##2##5##(1990-2#1)(1990-7#1)
and the optimum pH##3##4##(1990-2#1)(1990-7#1)(2008-10#1)
and the optimum##12##3##(1990-2#1)(1990-7#1)(1997-3#1)(2008-10#5)(2008-12#2)(2008-3#2)
and the order##2##3##(1991-2#1)(2011-2#1)
and the ordinary##2##3##(2007-12#1)(2008-3#1)
and the organic solvent##2##4##(2008-10#2)
and the organic##5##3##(1991-9#1)(1994-9#1)(2008-10#3)
and the organism is##2##4##(2007-11#1)(2008-10#1)
and the organism##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
and the organization of the##2##5##(1992-3#1)(1995-5#1)
and the organization##3##3##(1992-3#1)(1995-2#1)(1995-5#1)
and the organizational##3##3##(1992-12#1)(1992-2#1)(1996-3#1)
and the organs##2##3##(2008-2#1)(2010-12#1)
and the orientation of##5##4##(1991-10#1)(1994-9#1)(2008-2#3)
and the origin and##2##4##(2008-11#1)(2008-9#1)
and the origin of the##3##5##(1996-4#1)(2008-3#1)(2008-7#1)
and the origin of##5##4##(1995-11#1)(1996-4#1)(2008-3#1)(2008-7#1)(2008-8#1)
and the origin##7##3##(1995-11#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
and the original##5##3##(2008-10#2)(2008-3#1)(2009-3#1)(2013-8#1)
and the osteotomy site##2##4##(2011-2#2)
and the osteotomy##3##3##(2009-10#1)(2011-2#2)
and the other 2##2##4##(1995-12#1)(2013-1#1)
and the other a##7##4##(1991-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
and the other as##2##4##(2008-10#2)
and the other at##2##4##(1995-12#1)(2013-1#1)
and the other based on##2##5##(1993-11#1)(2008-2#1)
and the other consisting of##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
and the other for##5##4##(2007-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
and the other four##2##4##(1996-12#1)(2008-10#1)
and the other from the##2##5##(2008-3#1)(2010-8#1)
and the other from##5##4##(2008-10#3)(2008-3#1)(2010-8#1)
and the other group##2##4##(1992-12#1)(2013-8#1)
and the other groups##2##4##(2008-12#1)(2012-5#1)
and the other half##2##4##(1996-1#1)(2008-2#1)
and the other in a##3##5##(2008-10#1)(2009-5#1)(2012-12#1)
and the other in the##3##5##(2007-8#1)(2008-3#1)(2008-8#1)
and the other in##7##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-12#1)
and the other is a##4##5##(2008-3#3)(2010-8#1)
and the other is##8##4##(1992-9#1)(2007-11#1)(2008-3#5)(2010-8#1)
and the other of##3##4##(1992-12#1)(2008-10#1)(2008-6#1)
and the other on##2##4##(2008-9#1)(2010-8#1)
and the other one##3##4##(1997-4#1)(2008-2#1)(2008-4#1)
and the other six##2##4##(2008-10#1)(2008-5#1)
and the other to##7##4##(1990-2#1)(1996-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-6#1)
and the other two##7##4##(1992-8#1)(1995-3#2)(2008-10#2)(2008-3#1)(2010-2#1)
and the other was##4##4##(2007-12#1)(2008-10#1)(2013-1#2)
and the other which##3##4##(1990-5#1)(1990-8#1)(1995-6#1)
and the other with##5##4##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
and the other##201##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1994-11#2)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-3#1)(1997-4#2)(2007-11#4)(2007-12#5)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#18)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#6)(2009-10#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#7)(2013-8#3)
and the others were##2##4##(1994-7#1)(2007-10#1)
and the others##7##3##(1994-12#1)(1994-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
and the outcome of##2##4##(2009-7#1)(2010-6#1)
and the outcome was##2##4##(1997-3#1)(2007-10#1)
and the outcome##7##3##(1991-6#1)(1997-3#1)(2007-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
and the outcomes of##2##4##(2010-5#1)(2011-2#1)
and the outcomes##3##3##(2009-9#1)(2010-5#1)(2011-2#1)
and the outer##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
and the output of a##2##5##(2008-2#1)(2008-3#1)
and the output of##4##4##(2008-2#1)(2008-3#3)
and the output power was##2##5##(2007-11#1)(2008-3#1)
and the output power##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
and the output##20##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#9)(2008-7#1)(2010-8#4)
and the outside##2##3##(2007-12#1)(2008-5#1)
and the ovarian##3##3##(1990-11#1)(1990-9#1)(2008-12#1)
and the ovaries were exposed##2##5##(1992-3#2)
and the overall survival was##2##5##(2011-2#1)(2013-1#1)
and the overall survival##5##4##(1991-4#1)(2008-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
and the overall##27##3##(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1994-6#1)(1996-5#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#1)
and the oxidation peak##2##4##(2008-10#2)
and the oxidation state of##2##5##(1992-8#1)(2008-10#1)
and the oxidation##4##3##(1992-8#1)(2008-10#3)
and the oxidative##2##3##(1993-2#1)(2009-12#1)
and the oxygen##3##3##(1994-11#1)(1995-5#1)(2008-7#1)
and the pH of the solution##2##6##(1990-8#1)(2008-10#1)
and the pH of the##8##5##(1990-8#1)(1994-12#1)(2008-10#4)(2008-5#1)(2008-6#1)
and the pH was adjusted to##2##6##(2008-10#2)
and the pH##13##3##(1990-8#1)(1994-12#1)(1994-5#1)(2008-10#8)(2008-5#1)(2008-6#1)
and the pI##2##3##(1990-5#1)(2008-10#1)
and the pain##2##3##(2008-7#1)(2012-3#1)
and the paired##2##3##(1990-12#1)(2011-2#1)
and the parameters that##2##4##(2008-10#1)(2008-3#1)
and the parameters##6##3##(1994-8#1)(2008-10#4)(2008-3#1)
and the parasitism##2##3##(2008-6#2)
and the parent drug##3##4##(2008-10#2)(2013-1#1)
and the parent##6##3##(1995-9#1)(2008-10#3)(2009-9#1)(2013-1#1)
and the parental##2##3##(2008-8#1)(2011-1#1)
and the part##3##3##(2008-2#2)(2008-3#1)
and the partial sequence of##2##5##(1993-12#1)(2008-10#1)
and the partial##5##3##(1993-12#1)(2008-10#2)(2008-4#1)(2011-3#1)
and the participation##2##3##(2008-11#1)(2009-11#1)
and the particle size##2##4##(1997-2#1)(2007-11#1)
and the particle##5##3##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
and the particular##2##3##(1994-5#1)(2010-2#1)
and the partition##2##3##(1990-11#1)(2012-3#1)
and the passive##2##3##(1992-6#1)(2008-10#1)
and the pathogen##13##3##(2008-10#10)(2008-8#1)(2009-6#1)(2013-1#1)
and the pathogenesis of##3##4##(2008-10#1)(2013-1#2)
and the pathogenesis##4##3##(2006-10#1)(2008-10#1)(2013-1#2)
and the pathologic##3##3##(2008-10#1)(2008-9#1)(2010-6#1)
and the pathological##6##3##(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the pathophysiology of##4##4##(1997-6#1)(2008-4#2)(2008-7#1)
and the pathophysiology##5##3##(1997-6#1)(2008-10#1)(2008-4#2)(2008-7#1)
and the patient died##3##4##(2007-12#1)(2009-8#1)(2011-2#1)
and the patient had an uneventful recovery##2##7##(2010-7#1)(2012-2#1)
and the patient had##4##4##(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
and the patient has been##2##5##(2008-1#1)(2008-9#1)
and the patient has##3##4##(1990-12#1)(2008-1#1)(2008-9#1)
and the patient is now##2##5##(2008-7#1)(2011-2#1)
and the patient is##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
and the patient underwent a##2##5##(2010-12#1)(2012-2#1)
and the patient underwent##5##4##(2007-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
and the patient was discharged##3##5##(1994-9#1)(2011-2#1)(2013-8#1)
and the patient was free##2##5##(2009-1#1)(2013-8#1)
and the patient was referred for##2##6##(2008-8#1)(2011-1#1)
and the patient was referred##3##5##(2008-8#1)(2011-1#2)
and the patient was treated with##2##6##(2006-10#1)(2008-11#1)
and the patient was treated##3##5##(2006-10#1)(2008-11#1)(2008-12#1)
and the patient was##18##4##(1993-1#1)(1994-6#1)(1994-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-1#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#3)
and the patient##67##3##(1990-12#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-6#1)(1997-2#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#3)(2008-1#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
and the patient's age and##2##5##(1996-1#1)(2012-2#1)
and the patient's age##4##4##(1996-1#1)(1996-6#1)(2012-2#1)(2013-1#1)
and the patient's##14##3##(1992-6#1)(1994-2#1)(1996-1#1)(1996-6#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the patients##12##3##(1990-9#1)(1991-1#1)(1995-1#1)(1995-11#1)(1996-2#1)(2007-11#1)(2007-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
and the patients'##3##3##(1991-2#2)(1993-2#1)
and the pattern of##5##4##(1994-5#1)(2008-10#3)(2012-2#1)
and the pattern##7##3##(1990-9#1)(1994-5#1)(2008-10#3)(2008-3#1)(2012-2#1)
and the patterns of##3##4##(1991-12#1)(1997-5#1)(2010-12#1)
and the paucity of##2##4##(1997-2#1)(1997-9#1)
and the peak area##2##4##(2008-10#1)(2011-1#1)
and the peak current##2##4##(2008-10#2)
and the peak height##2##4##(1993-8#1)(2008-10#1)
and the peak power is##2##5##(2007-11#2)
and the peak##20##3##(1990-6#1)(1993-8#1)(1995-8#1)(2007-10#1)(2007-11#3)(2008-10#8)(2008-3#2)(2011-1#2)(2011-2#1)
and the peaks##2##3##(2008-10#1)(2011-2#1)
and the peer##2##3##(2008-11#1)(2008-8#1)
and the pelvis##2##3##(2008-8#1)(2010-3#1)
and the peptide##3##3##(1995-2#1)(2007-11#1)(2009-5#1)
and the perceived##7##3##(1992-1#1)(1992-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
and the percentage of##9##4##(1992-6#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#1)
and the percentage##11##3##(1992-6#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)
and the percentages of##2##4##(1993-8#1)(2008-10#1)
and the perception##3##3##(1994-7#1)(2007-12#1)(2011-2#1)
and the performance of the##5##5##(2008-2#1)(2008-3#3)(2010-4#1)
and the performance of##11##4##(1993-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)(2010-4#1)
and the performance##14##3##(1993-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2010-4#1)(2013-1#1)
and the performances of the##2##5##(2008-10#2)
and the performances##3##3##(2008-10#3)
and the perfusion##2##3##(2009-11#1)(2010-12#1)
and the period of##4##4##(2007-11#1)(2008-8#1)(2011-2#1)(2012-4#1)
and the period##6##3##(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-4#1)
and the perioperative##2##3##(2007-8#1)(2009-5#1)
and the permanent##2##3##(1997-3#1)(2008-12#1)
and the permeability of##2##4##(2008-10#1)(2008-7#1)
and the person##2##3##(1991-12#1)(2012-2#1)
and the personality##2##3##(1996-7#1)(2008-5#1)
and the pertinent##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
and the phage##2##3##(2008-10#1)(2008-11#1)
and the pharmacokinetic parameters of the##2##6##(2012-2#2)
and the pharmacokinetic parameters##3##4##(2008-11#1)(2012-2#2)
and the phase of the##4##5##(2007-11#2)(2007-12#1)(2008-2#1)
and the phase of ultrashort##2##5##(2007-12#1)(2008-3#1)
and the phase of##10##4##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#1)(2009-5#1)
and the phase##27##3##(1991-9#1)(1995-2#1)(2007-11#5)(2007-12#5)(2008-2#6)(2008-3#5)(2008-5#2)(2009-5#1)(2011-1#1)
and the phenotype of##2##4##(1996-5#1)(2008-8#1)
and the phenotype##3##3##(1994-12#1)(1996-5#1)(2008-8#1)
and the phenotypes##2##3##(1997-8#1)(2008-9#1)
and the phloem##2##3##(2008-10#1)(2008-11#1)
and the phosphorylation##2##3##(1993-11#1)(1997-2#1)
and the physical and##2##4##(1994-3#1)(2009-7#1)
and the physical##13##3##(1991-1#1)(1994-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#2)
and the physician##5##3##(1990-9#1)(1991-1#1)(2007-12#1)(2009-5#1)(2012-1#1)
and the physician's##2##3##(1991-2#1)(1996-2#1)
and the physiological##3##3##(2008-6#1)(2011-2#2)
and the physiopathological##2##3##(1992-5#1)(1993-6#1)
and the pineal hormone melatonin##2##5##(1991-6#1)(1992-12#1)
and the plant##4##3##(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#1)
and the plants##3##3##(2008-10#2)(2008-9#1)
and the plasma##4##3##(1993-9#1)(2008-2#1)(2008-7#1)(2011-2#1)
and the plateau##2##3##(1990-7#1)(2008-10#1)
and the platelet##2##3##(2006-6#1)(2008-11#1)
and the platinum group elements##2##5##(2008-10#2)
and the play##2##3##(1992-12#1)(2012-2#1)
and the point-measure##2##3##(2012-2#2)
and the point-spread function##2##4##(2008-2#1)(2008-3#1)
and the point-spread##3##3##(2008-2#1)(2008-3#2)
and the polarization of##3##4##(1991-5#1)(2008-2#1)(2008-3#1)
and the polarization##6##3##(1991-5#1)(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
and the political##2##3##(1992-1#1)(2007-9#1)
and the politics of##2##4##(1994-2#1)(2008-10#1)
and the polycystic ovary syndrome##2##5##(2008-3#1)(2008-4#1)
and the polymer##3##3##(2008-10#2)(2009-11#1)
and the polymerase chain reaction##4##5##(1991-9#1)(1994-12#2)(2008-10#1)
and the polyurethane foam##2##4##(2008-10#2)
and the poor##3##3##(1990-6#1)(1992-2#1)(2008-1#1)
and the population densities of##2##5##(2007-5#1)(2008-10#1)
and the population of##2##4##(1995-1#1)(1996-6#1)
and the population##11##3##(1994-2#1)(1995-1#1)(1996-6#1)(2007-5#1)(2008-10#4)(2008-8#1)(2010-3#1)(2011-2#1)
and the position of the##8##5##(2008-3#2)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
and the position of##12##4##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
and the positioning of##2##4##(1992-6#1)(2010-1#1)
and the positions of##2##4##(2007-11#1)(2008-3#1)
and the positive##7##3##(1990-9#1)(1993-11#1)(1997-1#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
and the possibilities for##2##4##(2008-10#1)(2008-3#1)
and the possibilities of##2##4##(2008-10#1)(2011-3#1)
and the possibilities##4##3##(2008-10#2)(2008-3#1)(2011-3#1)
and the possibility of amelioration by##2##6##(2008-10#2)
and the possibility of##19##4##(1990-5#1)(1991-6#1)(1994-12#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#2)(2013-8#1)
and the possibility that##2##4##(1992-2#1)(2009-1#1)
and the possibility to##3##4##(2010-12#1)(2011-2#1)(2012-1#1)
and the possibility##25##3##(1990-5#1)(1991-6#1)(1992-2#1)(1994-12#1)(1996-4#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
and the possible effects##2##4##(1996-2#1)(2007-12#1)
and the possible mechanism of catalytic reaction is proposed##2##9##(2008-10#2)
and the possible mechanism of catalytic reaction##3##7##(2008-10#3)
and the possible##36##3##(1991-5#1)(1992-12#1)(1993-5#1)(1996-2#2)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-4#1)
and the posterior##5##3##(1991-2#1)(1994-3#1)(1997-8#1)(2007-12#1)(2010-12#1)
and the postoperative course was uneventful##2##6##(1996-8#1)(2007-8#1)
and the postoperative##7##3##(1991-2#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-7#1)(2009-10#1)(2013-1#1)
and the potential benefits of##3##5##(2008-10#1)(2009-5#1)(2010-12#1)
and the potential for future##2##5##(2008-8#1)(2011-2#1)
and the potential for unanticipated##2##5##(2008-10#1)(2012-2#1)
and the potential for##19##4##(1991-6#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
and the potential impact of##2##5##(2008-10#1)(2013-8#1)
and the potential of##12##4##(1994-1#1)(1994-5#1)(2007-12#1)(2008-10#5)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
and the potential role of##2##5##(1994-11#1)(2008-8#1)
and the potential##65##3##(1991-6#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-5#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#3)(2013-1#2)(2013-8#2)
and the potentiation of##2##4##(1992-8#1)(2008-4#1)
and the potentiometric##2##3##(2008-10#2)
and the power of##3##4##(1996-3#1)(2009-5#1)(2009-6#1)
and the power spectrum##3##4##(2007-12#1)(2008-3#2)
and the power##16##3##(1995-12#2)(1996-3#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#1)
and the practical##9##3##(1990-9#1)(1992-5#1)(1993-1#1)(1995-3#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-3#2)
and the practice of##4##4##(1993-12#1)(2008-4#1)(2010-8#1)(2011-1#1)
and the practice##7##3##(1990-3#1)(1993-12#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-3#1)
and the practitioner##2##3##(1991-12#1)(1994-1#1)
and the precipitate##2##3##(2008-11#1)(2008-4#1)
and the precise##3##3##(1991-5#1)(2008-10#2)
and the precision and accuracy of the##2##7##(2008-10#2)
and the precision of the method##2##6##(2008-10#2)
and the precision of the##4##5##(2008-10#3)(2008-3#1)
and the precision was##2##4##(2008-10#2)
and the precision were##2##4##(2008-10#2)
and the precision##17##3##(2008-10#16)(2008-3#1)
and the preconcentration##2##3##(2008-10#2)
and the predicted##3##3##(1991-9#1)(1995-2#1)(2008-10#1)
and the prediction of##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
and the prediction##4##3##(2008-3#2)(2008-9#1)(2011-2#1)
and the predictive value of a##2##6##(1990-3#1)(1992-5#1)
and the predictive##3##3##(1990-3#1)(1992-12#1)(1992-5#1)
and the predictor##2##3##(2011-2#1)(2012-12#1)
and the predictors##2##3##(2006-10#1)(2010-5#1)
and the predominance of##2##4##(1995-2#1)(2007-10#1)
and the preference of##2##4##(1991-6#1)(1992-9#1)
and the preferred##3##3##(1995-6#1)(2008-11#1)(2013-8#1)
and the preoperative##2##3##(2011-2#1)(2012-12#1)
and the preparation of the##2##5##(2008-10#1)(2008-7#1)
and the preparation of##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
and the preparation##4##3##(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
and the prescription##2##3##(2007-12#1)(2012-2#1)
and the presence of PCR inhibitors##2##6##(2008-11#1)(2008-12#1)
and the presence of a##8##5##(1994-5#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
and the presence of abundant##2##5##(2008-7#1)(2009-10#1)
and the presence of an##4##5##(1990-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
and the presence of calcium ions##2##6##(1995-8#1)(2008-10#1)
and the presence of congestive heart failure or weight loss##2##10##(2012-3#2)
and the presence of multiple##2##5##(1992-6#1)(2008-10#1)
and the presence of other##2##5##(2008-7#1)(2010-6#1)
and the presence of proteins##2##5##(2008-10#1)(2008-6#1)
and the presence of small##2##5##(2008-10#1)(2008-7#1)
and the presence of specific##2##5##(2008-10#1)(2008-9#1)
and the presence of the##6##5##(1991-5#1)(1991-8#1)(1994-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
and the presence of##106##4##(1990-9#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-6#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
and the presence or absence of##3##6##(1991-5#1)(2008-10#1)(2011-2#1)
and the presence##110##3##(1990-9#1)(1991-12#1)(1991-5#3)(1991-8#1)(1992-6#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
and the present study##2##4##(1991-8#1)(1994-11#1)
and the present##8##3##(1990-8#1)(1991-11#1)(1991-8#1)(1994-11#1)(1996-2#1)(2007-8#1)(2008-10#1)(2012-12#1)
and the press in##2##4##(2006-10#1)(2009-10#1)
and the press##4##3##(1996-9#1)(1997-6#1)(2006-10#1)(2009-10#1)
and the pretreatment##2##3##(2008-8#1)(2012-3#1)
and the prevailing##2##3##(1994-3#1)(2011-2#1)
and the prevalence and##2##4##(1994-11#1)(2008-10#1)
and the prevalence of the##2##5##(2008-10#1)(2013-1#1)
and the prevalence of##17##4##(1990-12#1)(1994-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
and the prevalence##20##3##(1990-12#1)(1994-11#1)(1994-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#2)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
and the prevention and##2##4##(1997-6#1)(2011-2#1)
and the prevention of##8##4##(1991-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
and the prevention##10##3##(1991-11#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
and the previous##2##3##(2010-10#1)(2012-1#1)
and the previously##2##3##(1997-7#1)(2010-3#1)
and the primary health##2##4##(1995-8#1)(2013-8#1)
and the primary structure of##2##5##(1990-12#1)(1992-8#1)
and the primary##11##3##(1990-12#1)(1990-8#1)(1992-8#2)(1995-8#1)(2007-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
and the principal##4##3##(1991-1#1)(2007-2#1)(2008-11#1)(2008-7#1)
and the principle of##3##4##(2008-10#2)(2008-3#1)
and the principles of##5##4##(2008-3#2)(2009-5#1)(2012-2#1)(2012-3#1)
and the probability of##12##4##(1992-2#1)(1995-12#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
and the probability##13##3##(1992-2#1)(1995-12#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
and the probe##4##3##(2008-10#2)(2008-3#2)
and the probes##2##3##(1994-1#1)(2008-9#1)
and the problem of##5##4##(1997-5#1)(2007-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
and the problem##6##3##(1997-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
and the problems##5##3##(1990-5#1)(1993-1#1)(1997-2#1)(1997-5#1)(2007-11#1)
and the procedure for##2##4##(2008-4#1)(2008-7#1)
and the procedure##8##3##(2008-10#4)(2008-4#1)(2008-7#2)(2012-1#1)
and the process of##6##4##(1991-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)
and the process##11##3##(1991-2#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-8#1)
and the processes##3##3##(2007-10#1)(2010-3#1)(2010-5#1)
and the produced##4##3##(1990-5#1)(2008-10#2)(2008-8#1)
and the product##7##3##(1992-6#1)(2008-10#2)(2011-2#2)(2012-2#1)(2013-1#1)
and the production of cytokines##2##5##(2008-11#1)(2013-1#1)
and the production of reactive oxygen species##2##7##(1994-5#1)(2008-10#1)
and the production of reactive oxygen##3##6##(1994-5#2)(2008-10#1)
and the production of##19##4##(1992-8#1)(1994-2#1)(1994-5#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
and the production##21##3##(1992-8#1)(1994-2#1)(1994-5#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#3)
and the productivity of##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
and the productivity##4##3##(2008-10#1)(2008-11#2)(2008-6#1)
and the products of##2##4##(1991-12#1)(2008-10#1)
and the products were##2##4##(1991-2#1)(2008-4#1)
and the products##8##3##(1991-12#1)(1991-2#2)(2008-10#2)(2008-4#2)(2012-2#1)
and the profile of##3##4##(1991-2#1)(2008-3#1)(2012-12#1)
and the profile##4##3##(1991-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
and the profiles##2##3##(2008-3#1)(2008-5#1)
and the progeny##2##3##(2008-10#2)
and the prognosis is##3##4##(1990-8#1)(1996-9#1)(2007-8#1)
and the prognosis was##2##4##(1990-5#1)(1991-8#1)
and the prognosis##8##3##(1990-5#1)(1990-8#1)(1991-8#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-8#2)
and the program##4##3##(1992-12#1)(2008-2#1)(2010-9#1)(2011-2#1)
and the progress of##2##4##(1996-5#1)(2008-7#1)
and the progress##5##3##(1991-12#1)(1996-5#1)(2007-7#1)(2008-7#2)
and the progression of##4##4##(1990-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
and the promoter##2##3##(1997-7#1)(2008-9#1)
and the promotion of##3##4##(2007-3#1)(2008-1#1)(2012-12#1)
and the propagation##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
and the propensity##2##3##(2008-4#1)(2013-1#1)
and the proper##3##3##(2007-11#1)(2008-3#1)(2009-8#1)
and the properties of the##4##5##(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)
and the properties of##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)
and the properties##8##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)(2012-2#1)
and the proportion of leaflets##2##5##(2008-10#2)
and the proportion of the##2##5##(2008-10#2)
and the proportion of##14##4##(1993-3#1)(1996-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#2)(2013-1#1)
and the proportion##16##3##(1993-3#1)(1996-11#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#2)(2013-1#1)
and the proportional##2##3##(1992-6#1)(2008-10#1)
and the proposed method##5##4##(2008-10#4)(2008-9#1)
and the proposed##14##3##(1991-2#1)(1996-9#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
and the prospects##3##3##(2007-11#1)(2008-3#1)(2011-7#1)
and the protection of the##2##5##(2010-4#1)(2013-7#1)
and the protection of##3##4##(2007-11#1)(2010-4#1)(2013-7#1)
and the protection##4##3##(2007-11#1)(2008-10#1)(2010-4#1)(2013-7#1)
and the protective effects##2##4##(2008-7#1)(2009-7#1)
and the protective##8##3##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-1#2)
and the protein content##2##4##(2010-11#1)(2013-1#1)
and the protein was##2##4##(1990-11#1)(1997-4#1)
and the protein##16##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-6#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2013-1#1)(2013-7#1)
and the proteins##3##3##(1995-2#1)(2008-4#2)
and the provider##2##3##(2007-12#1)(2008-1#1)
and the province of##2##4##(1992-8#1)(2008-10#1)
and the provision of services##2##5##(1990-2#1)(1996-3#1)
and the provision of##8##4##(1990-2#1)(1991-12#1)(1995-12#1)(1996-3#1)(2008-11#2)(2008-7#1)(2013-1#1)
and the proximal##3##3##(1995-2#1)(1996-8#1)(2008-7#1)
and the psychiatric##2##3##(1992-2#1)(1996-11#1)
and the psychological##2##3##(2013-1#2)
and the public at large##2##5##(1997-2#1)(2009-12#1)
and the public to##3##4##(1991-8#1)(1994-1#1)(2008-4#1)
and the public##18##3##(1991-8#1)(1992-1#1)(1994-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#2)(1997-2#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-12#2)
and the public's##2##3##(1995-3#1)(2008-7#1)
and the pulmonary##2##3##(2007-9#1)(2010-8#1)
and the pulse##6##3##(1990-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
and the pump##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
and the pure##3##3##(2008-10#1)(2008-3#2)
and the purification##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
and the purity##2##3##(2008-10#1)(2008-7#1)
and the putative##4##3##(1991-9#1)(1997-2#1)(2008-10#1)(2012-3#1)
and the qualitative##2##3##(2010-8#1)(2012-3#1)
and the qualities##2##3##(2007-12#1)(2008-9#1)
and the quality of life of African American##2##8##(2008-4#2)
and the quality of life of##3##6##(2008-4#2)(2013-1#1)
and the quality of life##7##5##(2007-7#1)(2008-4#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#1)
and the quality of medical##2##5##(1996-12#1)(1996-3#1)
and the quality of the##4##5##(1991-6#1)(2008-3#1)(2008-8#1)(2012-1#1)
and the quality of##21##4##(1991-6#1)(1993-1#1)(1994-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
and the quality##24##3##(1991-6#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the quantification limit##3##4##(2008-10#3)
and the quantification##5##3##(2008-10#5)
and the quantitative determination of##2##5##(2008-10#2)
and the quantitative determination##3##4##(2008-10#3)
and the quantitative##4##3##(2008-10#4)
and the quantity##2##3##(1997-2#1)(2008-10#1)
and the quantum##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
and the quenching##5##3##(1995-8#1)(2008-10#2)(2008-4#1)(2013-8#1)
and the question of whether##2##5##(2008-12#1)(2010-12#1)
and the question of##3##4##(1991-12#1)(2008-12#1)(2010-12#1)
and the question##5##3##(1991-12#1)(1994-5#1)(1995-8#1)(2008-12#1)(2010-12#1)
and the radial##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
and the radiation##3##3##(1996-6#1)(2008-2#1)(2008-3#1)
and the random##5##3##(2008-10#1)(2008-2#1)(2010-8#2)(2012-3#1)
and the range of##6##4##(1994-12#1)(1995-3#1)(2007-11#1)(2008-3#1)(2009-12#1)(2013-8#1)
and the range##7##3##(1994-12#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-3#1)(2009-12#1)(2013-8#1)
and the raphe##2##3##(1991-12#1)(1997-3#1)
and the rapid##2##3##(2011-2#1)(2012-1#1)
and the rat##6##3##(1990-12#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-9#1)
and the rate constant##4##4##(1995-2#2)(2008-10#1)(2008-7#1)
and the rate of##27##4##(1990-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
and the rate##37##3##(1990-6#2)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
and the ratio of the##4##5##(1993-8#1)(2007-12#2)(2008-5#1)
and the ratio of##15##4##(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-12#1)(2012-7#1)
and the ratio##18##3##(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-7#1)
and the ratios of##2##4##(1992-11#1)(1994-9#1)
and the ratios##4##3##(1992-11#1)(1992-3#1)(1994-9#1)(2008-10#1)
and the reactant##2##3##(2008-3#1)(2013-8#1)
and the reaction conditions##2##4##(2008-10#1)(2013-8#1)
and the reaction mechanisms presented##2##5##(2008-10#2)
and the reaction mixture##2##4##(2008-10#2)
and the reaction of##2##4##(2008-10#2)
and the reaction##16##3##(1992-5#1)(2008-10#13)(2008-8#1)(2013-8#1)
and the reactivity of##2##4##(2008-10#2)
and the reading##2##3##(2008-3#2)
and the reagent##7##3##(1990-7#1)(2008-10#5)(2008-5#1)
and the reagents##4##3##(2008-10#3)(2008-11#1)
and the realization of##2##4##(2008-2#1)(2011-2#1)
and the reasons for##2##4##(2007-7#1)(2010-11#1)
and the received##2##3##(2008-3#2)
and the receiver##3##3##(2007-11#2)(2008-2#1)
and the recent##4##3##(1990-5#1)(2008-5#1)(2009-9#1)(2010-5#1)
and the recently##2##3##(2008-10#1)(2010-12#1)
and the receptor##2##3##(2008-11#1)(2010-11#1)
and the receptors##2##3##(1993-2#1)(2011-2#1)
and the recipients##2##3##(2008-6#1)(2011-2#1)
and the reciprocal of the##2##5##(2008-3#2)
and the recognition that##2##4##(1991-12#1)(2008-4#1)
and the recognition##3##3##(1991-12#1)(2008-4#1)(2008-8#1)
and the recombinant##5##3##(1995-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
and the recombination##2##3##(1995-12#1)(2007-11#1)
and the reconstruction of a##2##5##(2007-11#1)(2008-3#1)
and the reconstruction of##4##4##(1994-3#1)(1996-8#1)(2007-11#1)(2008-3#1)
and the reconstruction##8##3##(1994-3#1)(1996-8#1)(2007-11#1)(2008-11#1)(2008-3#4)
and the recoveries are in the range of##3##8##(2008-10#3)
and the recoveries are##4##4##(2008-10#4)
and the recoveries obtained##2##4##(2008-10#2)
and the recoveries of##2##4##(2008-10#2)
and the recoveries were in the range of##2##8##(2008-10#2)
and the recoveries were##5##4##(2008-10#3)(2011-1#2)
and the recoveries##16##3##(2008-10#14)(2011-1#2)
and the recovery of##3##4##(2008-10#3)
and the recovery process##2##4##(2012-2#1)(2013-1#1)
and the recovery was##7##4##(1990-8#2)(2008-10#4)(2013-8#1)
and the recovery##24##3##(1990-8#2)(1995-2#1)(2008-10#17)(2012-2#1)(2013-1#1)(2013-8#2)
and the recruitment of##2##4##(1992-6#1)(2008-4#1)
and the recruitment##3##3##(1992-6#1)(2008-4#1)(2009-5#1)
and the rectum##2##3##(1992-3#1)(2012-12#1)
and the recycling of##2##4##(1994-8#1)(2008-9#1)
and the red##2##3##(2008-4#2)
and the redox##2##3##(1990-8#1)(2008-10#1)
and the reduced scattering##4##4##(2008-2#1)(2008-3#3)
and the reduced##9##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-3#1)(2012-2#1)
and the reduced-scattering##3##3##(2008-2#2)(2008-3#1)
and the reduction in the number of##2##7##(2008-3#1)(2012-3#1)
and the reduction in##4##4##(1995-6#1)(1996-6#1)(2008-3#1)(2012-3#1)
and the reduction of##8##4##(1993-3#1)(1995-3#1)(2008-10#2)(2008-12#1)(2009-6#1)(2011-2#1)(2013-7#1)
and the reduction##15##3##(1991-1#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
and the reference##23##3##(1996-12#1)(2007-12#2)(2008-10#7)(2008-2#3)(2008-3#10)
and the reflectance of##2##4##(2008-3#2)
and the reflectance##4##3##(2008-3#4)
and the reflected##2##3##(2008-3#2)
and the refractive index of the##4##6##(2007-11#2)(2008-2#1)(2008-3#1)
and the refractive index##8##4##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)
and the refractive-index##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and the regeneration of##2##4##(2008-5#1)(2010-7#1)
and the region##2##3##(1996-5#1)(2008-3#1)
and the regional networks (alliances)##2##5##(1996-12#1)(1997-2#1)
and the regional##6##3##(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#2)(2013-8#1)
and the regioselectivity##2##3##(1996-5#1)(2008-8#1)
and the regression equation of working curve is##2##8##(2008-10#2)
and the regression equation##3##4##(2008-10#3)
and the regression##4##3##(2008-10#4)
and the regulating##2##3##(2008-4#1)(2008-7#1)
and the regulation of their expression##2##6##(2008-4#1)(2008-8#1)
and the regulation of##10##4##(1990-5#1)(1994-12#1)(1996-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
and the regulation##11##3##(1990-5#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
and the regulatory gene##2##4##(2008-10#1)(2011-1#1)
and the regulatory##6##3##(1990-7#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#1)(2011-1#1)
and the related species##2##4##(2008-10#1)(2008-9#1)
and the related##11##3##(1990-11#1)(1991-1#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2011-3#1)
and the relation between the##4##5##(1993-5#1)(2007-11#1)(2008-8#1)(2011-1#1)
and the relation between##6##4##(1993-5#1)(1994-2#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
and the relation##7##3##(1993-5#1)(1994-2#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
and the relationship between the two##2##6##(2008-11#1)(2009-8#1)
and the relationship between the##3##5##(2008-11#1)(2008-3#1)(2009-8#1)
and the relationship between##20##4##(1991-12#1)(1994-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the relationship of the##2##5##(1995-9#1)(1997-4#1)
and the relationship of##4##4##(1995-9#1)(1997-4#1)(2008-9#1)(2012-1#1)
and the relationship to##2##4##(2008-6#1)(2013-1#1)
and the relationship with##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
and the relationship##30##3##(1991-12#1)(1992-12#1)(1994-7#1)(1995-9#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and the relationships between##3##4##(1991-12#1)(2008-7#1)(2008-9#1)
and the relationships##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
and the relative power##2##4##(2007-11#1)(2008-3#1)
and the relative standard deviation (R##12##6##(2008-10#12)
and the relative standard deviation (RSD)##3##6##(2008-10#2)(2013-8#1)
and the relative standard deviation for 0##3##7##(2008-10#3)
and the relative standard deviation for eight##2##7##(2008-10#2)
and the relative standard deviation for##8##6##(2008-10#8)
and the relative standard deviation is##5##6##(2008-10#5)
and the relative standard deviation of##2##6##(2008-10#2)
and the relative standard deviation was 4##2##7##(1990-8#1)(2008-10#1)
and the relative standard deviation was##8##6##(1990-8#1)(2008-10#7)
and the relative standard deviation##45##5##(1990-8#1)(2008-10#42)(2008-3#1)(2013-8#1)
and the relative standard deviations (R##3##6##(2008-10#3)
and the relative standard deviations were##3##6##(2008-10#3)
and the relative standard deviations##11##5##(2008-10#9)(2011-1#2)
and the relative standard##57##4##(1990-8#1)(2008-10#52)(2008-3#1)(2011-1#2)(2013-8#1)
and the relative##96##3##(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#61)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
and the relatively low##2##4##(2008-1#1)(2008-3#1)
and the relatively##3##3##(2008-1#1)(2008-3#1)(2009-6#1)
and the relaxation##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
and the release of##9##4##(1995-11#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
and the released##2##3##(1992-8#1)(2008-10#1)
and the relevance##2##3##(2008-10#1)(2011-2#1)
and the relevant##7##3##(1990-8#1)(2008-10#5)(2010-1#1)
and the reliability of##6##4##(1990-3#1)(2007-2#1)(2008-3#2)(2009-1#1)(2010-8#1)
and the reliability##7##3##(1990-3#1)(2007-2#1)(2008-3#3)(2009-1#1)(2010-8#1)
and the remainder had##2##4##(2008-7#1)(2008-9#1)
and the remainder of the##2##5##(2008-10#1)(2011-1#1)
and the remainder##6##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
and the remaining isolates##2##4##(2008-10#2)
and the remaining##33##3##(1991-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-2#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and the removal of##4##4##(1995-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
and the repeatability of the##2##5##(2008-10#1)(2008-3#1)
and the repeatability of##4##4##(2008-10#2)(2008-3#2)
and the repeatability##7##3##(1994-9#1)(2008-10#4)(2008-3#2)
and the repetition rate of the##3##6##(2007-11#1)(2008-3#2)
and the repetition rate##4##4##(2007-11#2)(2008-3#2)
and the reported##3##3##(1992-8#1)(1995-6#1)(2008-7#1)
and the reports##2##3##(1990-10#1)(2007-8#1)
and the representative##2##3##(2008-10#1)(2013-8#1)
and the reproducibility of the##6##5##(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-7#1)
and the reproducibility of##8##4##(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)
and the reproducibility was##2##4##(2008-10#2)
and the reproducibility##14##3##(2008-10#8)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)
and the reproductive##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
and the required##7##3##(2008-10#2)(2008-3#4)(2010-9#1)
and the requirement for##5##4##(1996-1#1)(2008-7#2)(2010-7#1)(2013-8#1)
and the requirement of##2##4##(2007-9#1)(2013-8#1)
and the requirement##9##3##(1992-9#1)(1996-1#1)(2007-9#1)(2008-11#1)(2008-7#2)(2010-7#1)(2013-8#2)
and the requirements of##2##4##(2011-2#1)(2012-3#1)
and the requirements##3##3##(2011-2#1)(2012-3#2)
and the research##2##3##(2008-4#1)(2013-1#1)
and the researcher##2##3##(1992-12#1)(2009-6#1)
and the residual##5##3##(1991-1#1)(2008-10#2)(2008-2#1)(2009-10#1)
and the resin##2##3##(2008-10#2)
and the resin-phase (31)P##2##4##(2008-10#2)
and the resistance##3##3##(2008-10#1)(2008-8#1)(2011-3#1)
and the resistant##7##3##(2008-10#5)(2008-11#1)(2008-6#1)
and the resolution is##2##4##(2008-2#1)(2008-3#1)
and the resolution of the##3##5##(2007-11#1)(2007-12#1)(2010-9#1)
and the resolution of##6##4##(1991-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-9#1)
and the resolution##11##3##(1991-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-9#1)
and the resonance##4##3##(2008-3#3)(2011-1#1)
and the resource##2##3##(1992-2#1)(2008-10#1)
and the resources##2##3##(1995-6#1)(2012-2#1)
and the respective##4##3##(1991-12#1)(2007-11#1)(2008-10#2)
and the respiratory##4##3##(1994-11#1)(2008-5#1)(2011-1#1)(2012-3#1)
and the response of##5##4##(1991-3#1)(2008-10#1)(2008-8#2)(2013-8#1)
and the response surface##2##4##(2008-10#2)
and the response time is##3##5##(2007-12#1)(2008-10#2)
and the response time##4##4##(2007-12#1)(2008-10#3)
and the response to##8##4##(1991-2#1)(1994-3#1)(2007-9#1)(2008-1#2)(2008-8#1)(2009-12#1)(2013-1#1)
and the response was##3##4##(1996-12#1)(2008-11#1)(2011-2#1)
and the response##25##3##(1991-2#1)(1991-3#1)(1991-6#1)(1994-11#1)(1994-3#1)(1996-12#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-8#3)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and the responses of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
and the responses##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
and the rest in##2##4##(1991-11#1)(2008-1#1)
and the rest of the##2##5##(1995-2#1)(2011-1#1)
and the rest of##5##4##(1995-2#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
and the rest to##2##4##(2008-12#1)(2008-9#1)
and the rest##19##3##(1991-1#1)(1991-11#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
and the restenosis rate##2##4##(2008-12#2)
and the restoration of the##2##5##(2008-10#1)(2013-1#1)
and the result is##3##4##(1990-12#1)(2008-3#1)(2008-8#1)
and the result of##2##4##(2007-11#1)(2012-12#1)
and the result was satisfactory##2##5##(2008-10#2)
and the result##9##3##(1990-12#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-8#1)(2012-12#1)
and the resultant##17##3##(1994-2#1)(1995-2#3)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2010-8#1)
and the resulting solution is##3##5##(2008-10#3)
and the resulting solution##4##4##(2008-10#4)
and the resulting##57##3##(1991-2#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#18)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)
and the results agreed with the##2##6##(2008-10#2)
and the results agreed with##4##5##(2008-10#4)
and the results are compared with the##4##7##(2008-10#3)(2008-2#1)
and the results are compared with those##3##7##(2008-10#2)(2008-3#1)
and the results are compared with##9##6##(2008-10#5)(2008-2#1)(2008-3#3)
and the results are compared##11##5##(2008-10#7)(2008-2#1)(2008-3#3)
and the results are used##2##5##(2008-10#1)(2008-3#1)
and the results are##24##4##(1995-5#1)(2007-12#1)(2007-2#1)(2008-10#9)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the results compared with those obtained with##2##8##(2008-10#2)
and the results compared with those obtained##3##7##(2008-10#3)
and the results compared with those##4##6##(2008-10#4)
and the results compared with##5##5##(1996-12#1)(2008-10#4)
and the results demonstrated##2##4##(2008-10#2)
and the results for##3##4##(2008-10#2)(2008-9#1)
and the results from the##2##5##(2008-10#1)(2008-2#1)
and the results from##5##4##(1997-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
and the results indicated a##2##5##(2007-12#1)(2008-10#1)
and the results indicated that the##2##6##(2008-8#1)(2011-3#1)
and the results indicated that##4##5##(2008-8#1)(2011-2#2)(2011-3#1)
and the results indicated##6##4##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#2)(2011-3#1)
and the results obtained by##2##5##(2008-10#2)
and the results obtained in##2##5##(2008-10#1)(2011-2#1)
and the results obtained were##2##5##(2008-10#2)
and the results obtained with the##2##6##(2008-10#2)
and the results obtained##13##4##(2008-10#12)(2011-2#1)
and the results of a##4##5##(1992-1#1)(2008-3#2)(2008-9#1)
and the results of our##2##5##(1990-9#1)(2008-8#1)
and the results of the first##2##6##(1990-2#1)(2008-5#1)
and the results of the##4##5##(1990-2#1)(1995-1#1)(2008-3#1)(2008-5#1)
and the results of##27##4##(1990-2#1)(1990-9#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1997-8#1)(2007-10#2)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
and the results show that the##2##6##(2008-2#1)(2008-8#1)
and the results show that##4##5##(2008-10#2)(2008-2#1)(2008-8#1)
and the results show##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
and the results showed good agreement with##2##7##(2008-10#2)
and the results showed that the##3##6##(2008-10#2)(2011-1#1)
and the results showed that##5##5##(2008-10#4)(2011-1#1)
and the results showed##10##4##(2008-10#8)(2011-1#2)
and the results well agreed with the##2##7##(2008-10#2)
and the results were comparable##2##5##(2008-10#1)(2008-8#1)
and the results were compared to##2##6##(2008-10#2)
and the results were compared with the##2##7##(1996-3#1)(2008-10#1)
and the results were compared with those obtained by##3##9##(2008-10#1)(2008-2#1)(2008-3#1)
and the results were compared with those obtained##5##8##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)
and the results were compared with those##6##7##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)
and the results were compared with##13##6##(1996-3#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)
and the results were compared##18##5##(1994-3#1)(1996-3#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)
and the results were consistent##3##5##(1993-9#1)(2008-10#1)(2013-1#1)
and the results were found to be##4##7##(1997-2#1)(2008-10#3)
and the results were in agreement with those obtained by##2##10##(2008-10#2)
and the results were in agreement with##3##7##(2008-10#3)
and the results were in good agreement with the##2##9##(2008-10#2)
and the results were in good agreement with those##2##9##(2008-10#2)
and the results were in good agreement with##4##8##(2008-10#4)
and the results were in##8##5##(2008-10#8)
and the results were satisfactory##2##5##(2008-10#2)
and the results were statistically compared##2##6##(2008-10#2)
and the results were##51##4##(1990-12#1)(1992-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-7#1)(1996-3#1)(1997-2#1)(2008-10#31)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the results##178##3##(1990-12#2)(1990-2#1)(1990-9#1)(1992-1#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-8#1)(2007-10#2)(2007-12#2)(2007-2#1)(2008-10#87)(2008-2#10)(2008-3#14)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#4)(2008-9#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
and the retention##3##3##(2008-10#2)(2011-2#1)
and the retrieved##3##3##(2008-3#3)
and the reversibility of##2##4##(1993-6#1)(2008-10#1)
and the review##3##3##(1990-6#1)(2008-11#1)(2012-3#1)
and the revised##2##3##(2008-9#1)(2010-11#1)
and the reward##3##3##(2008-1#1)(2009-5#1)(2009-8#1)
and the rhizosphere##2##3##(2008-10#2)
and the right##8##3##(1990-11#1)(1994-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-12#1)
and the rise##2##3##(1990-6#1)(1993-3#1)
and the risk factors##2##4##(2011-2#1)(2013-1#1)
and the risk of cancer##2##5##(1990-8#1)(1994-2#1)
and the risk of colorectal cancer##2##6##(1993-9#1)(2009-8#1)
and the risk of coronary##2##5##(1996-8#1)(2008-12#1)
and the risk of ischemic##2##5##(2008-3#1)(2011-1#1)
and the risk of##42##4##(1990-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#4)(2009-12#2)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
and the risk##46##3##(1990-8#1)(1991-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#4)(2009-12#2)(2009-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
and the risks of##3##4##(1990-5#1)(1996-6#1)(2008-10#1)
and the risks##6##3##(1990-5#1)(1992-3#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-8#1)
and the rms##4##3##(1992-4#1)(2007-11#1)(2008-3#1)(2008-8#1)
and the robustness##2##3##(1997-5#1)(2008-10#1)
and the role it##3##4##(2008-5#1)(2013-1#2)
and the role of adjuvant##2##5##(2008-6#1)(2012-3#1)
and the role of different##2##5##(2007-8#1)(2011-2#1)
and the role of the nurse##2##6##(2008-6#1)(2011-2#1)
and the role of the##15##5##(1992-2#1)(1993-12#1)(1994-2#2)(1995-2#2)(2007-11#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and the role of these##4##5##(1991-2#1)(2008-10#2)(2008-2#1)
and the role of##77##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#2)(1993-11#3)(1993-12#4)(1993-6#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-2#1)(2013-7#1)(2013-8#2)
and the role played by the##2##6##(2008-10#1)(2008-7#1)
and the role that##2##4##(1997-2#1)(2011-2#1)
and the role they##2##4##(1995-2#1)(2008-12#1)
and the role##90##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#2)(1992-6#1)(1993-11#3)(1993-12#4)(1993-6#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#3)(2013-1#4)(2013-2#1)(2013-7#1)(2013-8#2)
and the roles of##5##4##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
and the root##3##3##(2008-10#2)(2008-9#1)
and the roots##2##3##(2008-10#1)(2010-3#1)
and the rostral##2##3##(1990-9#1)(1996-5#1)
and the route of##2##4##(1993-6#1)(2008-9#1)
and the safe##4##3##(1993-1#2)(2008-2#2)
and the safety of##3##4##(1992-5#1)(2008-10#1)(2008-3#1)
and the safety##4##3##(1992-5#1)(1994-6#1)(2008-10#1)(2008-3#1)
and the salivary##2##3##(2008-10#1)(2013-8#1)
and the same##25##3##(1990-12#1)(1990-5#1)(1990-8#1)(1995-6#1)(1996-3#1)(1996-7#2)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2013-8#1)
and the sample size##2##4##(2008-10#2)
and the sample throughput was##2##5##(2008-10#2)
and the sample throughput##6##4##(2008-10#6)
and the sample##22##3##(2008-10#17)(2008-2#1)(2008-3#2)(2008-8#1)(2012-3#1)
and the samples were##2##4##(2008-10#1)(2011-3#1)
and the samples##3##3##(2008-10#2)(2011-3#1)
and the sampling frequency##2##4##(2008-10#2)
and the sampling rate was##2##5##(2008-10#2)
and the sampling##8##3##(2008-10#7)(2008-2#1)
and the satellite##2##3##(2008-10#1)(2008-3#1)
and the satisfaction##2##3##(1992-3#1)(2007-10#1)
and the saturation##2##3##(2008-7#1)(2011-2#1)
and the scaling##2##3##(2008-10#1)(2008-2#1)
and the scattered##2##3##(2008-2#1)(2008-3#1)
and the scattering phase function##3##5##(2008-2#2)(2008-3#1)
and the scattering properties##2##4##(2008-3#2)
and the scattering##11##3##(2008-2#2)(2008-3#9)
and the scientific##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
and the screening##2##3##(2010-10#1)(2012-12#1)
and the search for##3##4##(2007-10#1)(2008-4#1)(2012-2#1)
and the search##5##3##(2007-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
and the seasonal##2##3##(2007-1#1)(2012-2#1)
and the second at##3##4##(1990-7#1)(1994-11#1)(2009-9#1)
and the second group##2##4##(2008-7#1)(2011-2#1)
and the second in##2##4##(2008-12#2)
and the second is##4##4##(2008-3#3)(2008-8#1)
and the second most##2##4##(2008-5#1)(2010-10#1)
and the second one##5##4##(1994-11#1)(1995-6#1)(2008-10#1)(2008-3#1)(2010-11#1)
and the second peak##2##4##(2008-10#1)(2010-3#1)
and the second was##2##4##(2008-10#1)(2009-8#1)
and the second##67##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-6#2)(1996-3#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
and the second-harmonic##3##3##(2007-12#1)(2008-3#2)
and the secondary##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)
and the secreted##3##3##(2008-6#1)(2009-3#1)(2012-12#1)
and the secretion of##3##4##(1993-3#1)(2008-11#2)
and the secretion##5##3##(1993-3#1)(1994-6#1)(2008-11#2)(2008-7#1)
and the secretory##2##3##(1993-5#1)(1995-6#1)
and the security##3##3##(1991-1#1)(1993-3#1)(1995-2#1)
and the selected##2##3##(2013-8#2)
and the selection of##2##4##(2008-3#1)(2012-2#1)
and the selection##3##3##(2008-1#1)(2008-3#1)(2012-2#1)
and the selective##5##3##(1995-12#2)(2008-10#1)(2009-7#1)(2012-3#1)
and the selectivity of##3##4##(2008-10#3)
and the selectivity##12##3##(1996-2#1)(2008-10#10)(2013-7#1)
and the self-assembly of##2##4##(2008-12#1)(2010-4#1)
and the sensing##3##3##(2008-10#2)(2008-3#1)
and the sensitivities##2##3##(2008-3#1)(2011-1#1)
and the sensitivity and specificity of##3##6##(1990-9#1)(2012-2#1)(2012-3#1)
and the sensitivity and##4##4##(1990-9#1)(2009-8#1)(2012-2#1)(2012-3#1)
and the sensitivity in##2##4##(2008-1#1)(2008-10#1)
and the sensitivity of optical##2##5##(2008-3#2)
and the sensitivity of the method##3##6##(1990-12#1)(2008-10#2)
and the sensitivity of the##7##5##(1990-12#1)(2008-10#4)(2008-3#1)(2010-3#1)
and the sensitivity of##14##4##(1990-12#1)(2008-10#7)(2008-3#3)(2008-8#1)(2010-3#1)(2011-1#1)
and the sensitivity to##3##4##(1990-3#1)(2008-10#1)(2008-2#1)
and the sensitivity##28##3##(1990-12#1)(1990-3#1)(1990-9#1)(1992-3#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#4)(2008-8#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
and the sensor##5##3##(2008-10#5)
and the sensors##2##3##(2008-10#2)
and the separation between the##2##5##(2008-10#1)(2009-2#1)
and the separation of##3##4##(2008-10#3)
and the separation##6##3##(2008-10#4)(2008-9#1)(2009-2#1)
and the septum##3##3##(1994-2#1)(1996-12#1)(2008-9#1)
and the sequence of the##2##5##(1990-7#1)(1996-8#1)
and the sequence of##5##4##(1990-7#1)(1994-11#1)(1996-8#1)(2007-12#1)(2008-10#1)
and the sequence##8##3##(1990-7#1)(1992-8#1)(1994-11#1)(1994-12#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
and the sequences##2##3##(2008-10#1)(2008-8#1)
and the sequencing of##2##4##(2008-2#1)(2008-8#1)
and the sequential##2##3##(2008-10#2)
and the serum##3##3##(1993-1#1)(1994-6#1)(2007-2#1)
and the service##2##3##(1991-1#1)(2008-12#1)
and the seven##3##3##(1994-12#1)(1994-2#1)(2009-7#1)
and the seventh##2##3##(2011-2#2)
and the severity of disability##2##5##(2011-2#2)
and the severity of the##4##5##(1990-9#1)(1997-3#1)(1997-6#1)(2008-5#1)
and the severity of##16##4##(1990-9#1)(1992-9#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-5#2)(2010-4#1)(2011-2#3)(2012-12#1)
and the sexual##2##3##(1996-11#1)(2008-10#1)
and the shaking time##2##4##(2008-10#2)
and the shape of the object##2##6##(2008-3#2)
and the shape of the##7##5##(2007-8#1)(2008-2#1)(2008-3#5)
and the shape of##9##4##(2007-8#2)(2008-2#1)(2008-3#6)
and the shape##10##3##(2007-8#2)(2008-2#1)(2008-3#7)
and the shell##2##3##(2008-12#1)(2008-7#1)
and the shift of##2##4##(2008-2#1)(2013-1#1)
and the shift##4##3##(1992-2#1)(2008-2#2)(2013-1#1)
and the short and long term treatment of these##2##9##(2007-12#1)(2008-1#1)
and the short reaction time##2##5##(2008-10#1)(2008-9#1)
and the short time##2##4##(2008-10#1)(2009-4#1)
and the short##10##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
and the shortage of##2##4##(2011-2#2)
and the shortest##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
and the side##4##3##(1997-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
and the sigma##2##3##(1992-5#1)(2012-2#1)
and the sign of the##2##5##(2008-3#1)(2008-8#1)
and the sign##4##3##(2007-11#2)(2008-3#1)(2008-8#1)
and the signal peptide##2##4##(1991-6#1)(2010-6#1)
and the signal##18##3##(1991-6#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2013-8#1)
and the signal-to-noise ratio of##2##5##(2008-10#1)(2008-3#1)
and the signal-to-noise ratio##10##4##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
and the signal-to-noise##11##3##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)
and the signaling pathways activated##2##5##(1997-7#1)(2008-4#1)
and the significance of the##4##5##(1991-9#1)(1995-6#1)(2009-8#1)(2013-8#1)
and the significance of##6##4##(1991-9#1)(1995-6#1)(1996-2#1)(2007-10#1)(2009-8#1)(2013-8#1)
and the significant##3##3##(1997-4#1)(2008-7#1)(2009-11#1)
and the silver##2##3##(2008-10#1)(2008-3#1)
and the similarity##2##3##(1995-6#1)(2008-2#1)
and the simulated##3##3##(2008-3#2)(2009-9#1)
and the simulation##2##3##(2008-3#1)(2008-7#1)
and the simultaneous##7##3##(1990-8#2)(1996-4#1)(2008-10#1)(2008-2#1)(2009-5#1)(2013-1#1)
and the single##2##3##(1995-6#1)(2008-10#1)
and the sink##2##3##(2008-8#1)(2008-9#1)
and the site of##4##4##(1997-4#1)(2007-10#1)(2008-7#1)(2012-2#1)
and the site##6##3##(1997-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
and the situation of##2##4##(2008-2#1)(2009-5#1)
and the situation##3##3##(2008-10#1)(2008-2#1)(2009-5#1)
and the six##4##3##(2008-1#1)(2008-5#2)(2010-8#1)
and the sixth##2##3##(2011-2#2)
and the size distribution of##3##5##(2008-10#1)(2008-2#1)(2009-5#1)
and the size distribution##7##4##(2008-10#1)(2008-2#5)(2009-5#1)
and the size of the calibration##2##6##(2008-10#2)
and the size of the##9##5##(1990-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2010-2#1)(2013-8#1)
and the size of##15##4##(1990-5#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2010-2#1)(2013-7#1)(2013-8#1)
and the size##26##3##(1990-5#1)(1995-5#1)(2008-10#5)(2008-2#9)(2008-3#2)(2008-5#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
and the skill##2##3##(1991-3#1)(2007-11#1)
and the skills##4##3##(1994-2#1)(1995-2#1)(1996-1#1)(2008-6#1)
and the skin##8##3##(2008-10#1)(2008-5#6)(2011-2#1)
and the slip##2##3##(1996-4#1)(2012-2#1)
and the slope efficiency##2##4##(2007-12#1)(2008-2#1)
and the slope of the##4##5##(2008-10#2)(2008-3#1)(2008-8#1)
and the slope was##2##4##(2008-10#2)
and the slope##10##3##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)
and the slow##5##3##(1991-12#2)(2008-10#1)(2008-5#1)(2010-12#1)
and the slowest##2##3##(2008-10#1)(2008-11#1)
and the small##5##3##(1997-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
and the smaller##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
and the smallest##2##3##(2008-10#1)(2011-2#1)
and the so called##2##4##(2008-8#1)(2013-1#1)
and the so-called##3##3##(1993-6#1)(1994-6#1)(2008-3#1)
and the social and##2##4##(1996-2#1)(2011-2#1)
and the social##8##3##(1996-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2011-2#2)
and the society##2##3##(2008-3#1)(2012-12#1)
and the software##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
and the soil microbial community##2##5##(2008-10#2)
and the soil##7##3##(1990-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-10#1)(2011-1#1)
and the solid phase extraction (SPE)##2##6##(2008-10#2)
and the solubility##2##3##(2008-10#1)(2010-4#1)
and the soluble##3##3##(1990-6#1)(1992-3#1)(1994-11#1)
and the solution is##3##4##(2007-12#1)(2008-10#2)
and the solution##6##3##(1991-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
and the solvent extraction##2##4##(1995-2#1)(2008-10#1)
and the solvent##4##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
and the spatial distribution of##2##5##(2008-2#1)(2008-8#1)
and the spatial##11##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)
and the spatiotemporal##2##3##(2008-8#1)(2009-8#1)
and the special##2##3##(2008-2#1)(2008-7#1)
and the specialized##2##3##(1993-1#1)(1994-8#1)
and the specific##16##3##(1990-12#1)(1992-1#1)(1994-3#1)(1994-9#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
and the specificity 84%##2##4##(1990-2#2)
and the specificity of the##3##5##(1996-12#1)(2008-10#1)(2009-12#1)
and the specificity of##5##4##(1996-12#1)(1997-2#1)(2008-10#1)(2009-12#1)(2010-6#1)
and the specificity was##3##4##(1996-12#3)
and the specificity##13##3##(1990-2#2)(1994-8#1)(1996-12#4)(1996-9#1)(1997-2#1)(2008-10#1)(2009-12#1)(2010-6#1)(2011-1#1)
and the spectral phase##2##4##(2007-12#2)
and the spectral##11##3##(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#4)(2008-3#1)(2009-12#1)
and the speed##3##3##(2008-2#1)(2011-2#1)(2012-12#1)
and the spinal cord##2##4##(2010-8#1)(2013-8#1)
and the spinal##3##3##(2008-4#1)(2010-8#1)(2013-8#1)
and the spontaneous##2##3##(1992-6#1)(2008-6#1)
and the spot size##2##4##(2008-3#2)
and the spread of##4##4##(1994-3#1)(2008-10#1)(2008-9#1)(2010-1#1)
and the spreading##2##3##(1997-2#1)(2009-10#1)
and the stability constant##2##4##(2008-10#2)
and the stability of the##9##5##(1991-11#1)(1993-11#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
and the stability of##17##4##(1991-11#1)(1993-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and the stability##23##3##(1990-5#1)(1991-11#1)(1993-11#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and the stable##4##3##(1997-1#1)(2008-3#1)(2008-8#1)(2011-2#1)
and the stacking##2##3##(2008-2#1)(2008-8#1)
and the staff##2##3##(1991-9#1)(2008-12#1)
and the stage of##5##4##(2008-10#1)(2008-7#1)(2010-3#2)(2011-2#1)
and the standard addition##3##4##(2008-10#2)(2013-8#1)
and the standard deviation is##2##5##(2008-10#1)(2008-2#1)
and the standard deviation of the##2##6##(2008-3#2)
and the standard deviation of##3##5##(2008-10#1)(2008-3#2)
and the standard deviation##8##4##(2008-10#3)(2008-2#1)(2008-3#2)(2010-9#1)(2013-8#1)
and the standard reference##2##4##(2008-1#1)(2008-10#1)
and the standard##27##3##(1991-12#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-6#1)(2010-9#1)(2013-8#2)
and the start of treatment##3##5##(2012-12#3)
and the start of##4##4##(1991-6#1)(2012-12#3)
and the start##5##3##(1990-5#1)(1991-6#1)(2012-12#3)
and the state of the##2##5##(2008-5#1)(2010-6#1)
and the state of##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)
and the state##6##3##(1996-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-6#1)
and the stationary##2##3##(2008-10#1)(2008-11#1)
and the statistical##4##3##(1993-11#1)(2010-8#1)(2013-8#2)
and the steady-state##4##3##(1995-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
and the steps##2##3##(2011-2#1)(2012-12#1)
and the stimulation##2##3##(2008-9#2)
and the stimulatory##3##3##(1990-12#1)(2008-11#1)(2008-7#1)
and the stock and drug controller at the pharmacy##2##9##(2010-3#2)
and the storage##2##3##(2008-10#1)(2013-7#1)
and the strain##4##3##(2007-7#1)(2008-10#2)(2011-2#1)
and the strategies of##2##4##(2007-2#1)(2010-8#1)
and the strategies they##2##4##(2008-5#1)(2010-6#1)
and the strategies##5##3##(2007-2#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-8#1)
and the stream##3##3##(2008-10#3)
and the strength of##2##4##(2007-8#1)(2008-10#1)
and the strength##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
and the strengths and##2##4##(2008-11#1)(2011-2#1)
and the strong##2##3##(2008-10#2)
and the structural elements##2##4##(1996-5#1)(2010-4#1)
and the structural##6##3##(1996-5#1)(2008-10#3)(2008-9#1)(2010-4#1)
and the structure of the##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
and the structure of##11##4##(1992-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
and the structure was##2##4##(2007-11#1)(2010-10#1)
and the structure##15##3##(1992-12#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#2)(2010-10#2)(2010-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
and the structures##2##3##(2008-12#1)(2011-2#1)
and the structuring##2##3##(2008-11#1)(2008-3#1)
and the studies##2##3##(2008-8#1)(2010-2#1)
and the study of##5##4##(1991-9#1)(1993-1#1)(1996-5#1)(2008-5#1)(2012-2#1)
and the study##10##3##(1991-9#1)(1992-4#1)(1993-1#1)(1996-5#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
and the submucosa##2##3##(1993-12#1)(1995-3#1)
and the subsequent binding of##2##5##(1991-2#1)(2010-1#1)
and the subsequent derivation##2##4##(2008-10#1)(2008-11#1)
and the subsequent measurement of##2##5##(2008-10#1)(2008-4#1)
and the subsequent##43##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)
and the substance of##2##4##(1993-12#1)(2008-5#1)
and the substance##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
and the substrate##9##3##(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)
and the successful##2##3##(1995-1#1)(2012-3#1)
and the suitability##2##3##(1992-6#1)(2008-11#1)
and the sulfhydryl##2##3##(1992-6#1)(1995-5#1)
and the sum of all##2##5##(1991-12#1)(2008-10#1)
and the sum of the##2##5##(2008-10#2)
and the sum of##5##4##(1991-12#1)(2008-10#4)
and the sum##6##3##(1991-12#1)(2008-10#4)(2008-3#1)
and the superior##4##3##(1996-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
and the support of##2##4##(2008-1#1)(2012-1#1)
and the support##3##3##(2008-1#1)(2008-2#1)(2012-1#1)
and the supporting##2##3##(1996-1#1)(2007-8#1)
and the suppression of##4##4##(2006-12#1)(2008-10#2)(2008-11#1)
and the surface of the##2##5##(2008-3#1)(2008-5#1)
and the surface of##3##4##(2008-3#2)(2008-5#1)
and the surface roughness##2##4##(2007-11#1)(2008-3#1)
and the surface##13##3##(1990-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#2)
and the surgeons##2##3##(2009-7#1)(2013-1#1)
and the surgical##7##3##(1990-6#1)(1991-6#1)(1993-1#1)(2007-8#1)(2008-6#1)(2008-8#1)(2013-1#1)
and the surrounding##11##3##(1993-11#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-7#4)(2008-8#1)(2011-1#1)
and the survival of selected pathogenic bacteria in kenkey's milieu##2##10##(1997-4#2)
and the survival of##4##4##(1997-4#2)(2008-8#1)(2012-12#1)
and the survival rate##2##4##(1995-3#1)(2011-2#1)
and the survival time##2##4##(1997-4#1)(2013-1#1)
and the survival##8##3##(1995-3#1)(1997-4#3)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the susceptibility to##3##4##(2011-1#3)
and the susceptibility##4##3##(2011-1#4)
and the susceptible cultivar##2##4##(2008-10#2)
and the susceptible##9##3##(2008-10#7)(2008-5#1)(2011-2#1)
and the switch##2##3##(1996-7#1)(2009-3#1)
and the swollen##2##3##(2008-5#1)(2011-2#1)
and the symmetrical##3##3##(1997-5#2)(2007-12#1)
and the symmetry##2##3##(2008-3#1)(2013-8#1)
and the sympathetic##2##3##(1994-5#1)(2008-9#1)
and the symptoms##5##3##(1991-6#1)(1992-4#1)(2007-8#1)(2008-7#1)(2010-8#1)
and the syntheses of the##2##5##(2008-10#1)(2009-5#1)
and the synthesis of##4##4##(1996-12#1)(2008-4#2)(2012-2#1)
and the synthesis##5##3##(1996-12#1)(2008-10#1)(2008-4#2)(2012-2#1)
and the synthetic##4##3##(1992-11#1)(1997-3#1)(2008-2#1)(2013-1#1)
and the system has##2##4##(2008-10#1)(2010-8#1)
and the system of##2##4##(1996-4#1)(2012-12#1)
and the system##12##3##(1995-3#1)(1996-2#1)(1996-4#1)(2008-10#3)(2008-3#3)(2010-8#1)(2012-12#1)(2013-8#1)
and the system's##2##3##(1995-1#1)(2008-3#1)
and the systematic##2##3##(2007-12#1)(2008-11#1)
and the systemic##3##3##(2007-9#1)(2008-7#1)(2012-3#1)
and the target##9##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-2#1)
and the targets##2##3##(2008-11#1)(2008-7#1)
and the tau##2##3##(1993-6#1)(1995-2#1)
and the technical##5##3##(1995-5#1)(1997-2#1)(2008-11#1)(2012-12#1)(2012-2#1)
and the technique can be##2##5##(2007-11#1)(2008-2#1)
and the technique##4##3##(2007-11#1)(2008-2#2)(2010-8#1)
and the techniques##5##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
and the temperature and##2##4##(2008-2#1)(2008-5#1)
and the temperature dependence of##3##5##(2008-2#1)(2008-3#2)
and the temperature were##2##4##(2008-10#1)(2008-2#1)
and the temperature##23##3##(1990-5#1)(1990-8#1)(1992-6#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-7#2)
and the template##2##3##(2008-10#2)
and the temporal coherence##2##4##(2007-11#2)
and the temporal##11##3##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#1)(2008-8#1)(2012-2#1)
and the term##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
and the terminal##6##3##(1993-11#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
and the tertiary##2##3##(1995-2#1)(1997-2#1)
and the test##6##3##(1992-6#1)(1995-9#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
and the tetramethylarsonium cation##2##4##(2008-10#2)
and the theoretical##7##3##(1990-5#1)(1991-12#1)(2007-12#1)(2008-2#2)(2008-3#2)
and the therapeutic##6##3##(1991-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
and the thermal##9##3##(2007-11#1)(2008-2#4)(2008-3#3)(2008-6#1)
and the thermodynamic parameters##2##4##(2008-10#2)
and the thermodynamic##6##3##(2008-10#4)(2008-5#1)(2008-8#1)
and the thickness of a##2##5##(2008-3#2)
and the thickness of the##8##5##(1991-5#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)
and the thickness of##11##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#3)
and the thickness##13##3##(1991-5#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)
and the thicknesses of thin absorbing films##3##7##(2008-3#3)
and the thin##2##3##(2007-12#1)(2008-12#1)
and the third group##2##4##(2008-10#1)(2008-5#1)
and the third is##2##4##(2008-2#1)(2008-8#1)
and the third##26##3##(1990-3#1)(1991-12#2)(1992-12#1)(1992-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-3#1)
and the three##16##3##(1991-6#1)(1991-8#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#2)(1997-9#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
and the threshold decreased by 11%##2##6##(2008-3#2)
and the threshold for##2##4##(1994-2#1)(1995-11#1)
and the threshold##6##3##(1994-2#1)(1995-11#1)(2007-12#1)(2008-3#3)
and the throughput##3##3##(2008-10#1)(2008-3#2)
and the tightly associated tRNA##2##5##(1992-6#2)
and the time delay##2##4##(1996-6#1)(2007-12#1)
and the time dependence of the##2##6##(1993-8#1)(2007-12#1)
and the time dependence of##3##5##(1993-8#1)(2007-12#1)(2008-10#1)
and the time for##2##4##(2008-10#2)
and the time of##9##4##(1990-8#1)(1991-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-3#1)(2013-8#1)
and the time required to##2##5##(1995-12#1)(2008-8#1)
and the time spent##2##4##(2011-2#1)(2013-1#1)
and the time to##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
and the time##36##3##(1990-8#1)(1991-5#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#3)(2013-1#2)(2013-8#2)
and the time-averaged##2##3##(2008-3#1)(2012-3#1)
and the timing of##5##4##(1995-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
and the timing##7##3##(1995-5#1)(2008-10#1)(2008-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
and the titer##2##3##(1992-12#1)(2013-8#1)
and the tobacco##2##3##(2008-7#1)(2011-2#1)
and the tolerance##3##3##(2008-10#1)(2008-3#2)
and the tools to##3##4##(1993-12#2)(2011-2#1)
and the top##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
and the total amount of##2##5##(1996-12#1)(2010-4#1)
and the total internal reflection##2##5##(2007-11#1)(2007-12#1)
and the total number of##5##5##(1994-2#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-2#1)
and the total##31##3##(1994-2#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
and the toxic effects of##2##5##(2008-11#1)(2008-7#1)
and the toxic##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
and the traditional##2##3##(1996-2#1)(2008-10#1)
and the training##2##3##(1992-11#1)(2008-3#1)
and the transcription rate##2##4##(1992-9#1)(2008-11#1)
and the transcription start##2##4##(1993-6#1)(1994-12#1)
and the transcription##6##3##(1992-9#1)(1993-6#1)(1994-12#1)(2008-1#1)(2008-11#1)(2010-4#1)
and the transcriptional##3##3##(1996-12#1)(2008-6#1)(2010-1#1)
and the transfer##3##3##(1993-8#1)(1997-6#1)(2008-10#1)
and the transforming##2##3##(1994-11#1)(2008-10#1)
and the transient##2##3##(2008-3#1)(2012-2#1)
and the transition from##3##4##(1990-12#1)(2008-7#1)(2009-6#1)
and the transition to##2##4##(2011-2#1)(2012-3#1)
and the transition##7##3##(1990-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-3#1)
and the transmission is##2##4##(2007-12#1)(2008-3#1)
and the transmission of##2##4##(2008-12#1)(2009-2#1)
and the transmission##7##3##(1991-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)
and the transmitted##2##3##(2008-2#1)(2008-3#1)
and the transplantation##2##3##(2008-6#1)(2011-2#1)
and the transport scattering coefficients##2##5##(2008-2#2)
and the transport scattering##3##4##(2008-2#2)(2008-3#1)
and the transport##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
and the treated##2##3##(2011-1#1)(2013-1#1)
and the treatment of the##2##5##(2008-10#1)(2011-1#1)
and the treatment of##7##4##(1993-11#1)(1995-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#2)
and the treatment options##2##4##(1993-8#1)(2011-2#1)
and the treatment was##2##4##(1994-8#1)(2009-7#1)
and the treatment##21##3##(1991-11#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-9#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
and the treatments##2##3##(2008-10#1)(2008-12#1)
and the trends##2##3##(1991-3#1)(2008-5#1)
and the trp repressor##3##4##(1992-8#3)
and the tumor microenvironment##2##4##(2009-3#1)(2010-11#1)
and the tumor was diagnosed as##2##6##(1995-4#1)(2013-8#1)
and the tumor was##4##4##(1995-4#1)(2006-12#1)(2008-7#1)(2013-8#1)
and the tumor##8##3##(1994-12#1)(1995-4#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-11#1)(2013-8#1)
and the tungsten##2##3##(2008-10#2)
and the twin##2##3##(2007-11#1)(2008-3#1)
and the two are##2##4##(2008-3#1)(2008-4#1)
and the two other##2##4##(1990-5#1)(2008-5#1)
and the two##44##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-6#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#2)(2012-3#1)(2013-7#1)
and the type of##16##4##(1991-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
and the type##19##3##(1991-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
and the types of##4##4##(1991-3#1)(1997-3#1)(2007-7#1)(2010-9#1)
and the types##5##3##(1991-3#1)(1997-3#1)(2007-7#1)(2010-9#1)(2011-2#1)
and the tyrosine##2##3##(2007-12#1)(2008-5#1)
and the ugly##4##3##(2008-7#3)(2011-2#1)
and the ultimate##3##3##(1991-9#1)(1992-6#1)(2008-7#1)
and the underlying##10##3##(1997-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#1)(2012-2#2)(2013-1#1)
and the understanding of the##2##5##(2008-5#1)(2008-7#1)
and the understanding of##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
and the unique##5##3##(1991-3#1)(1992-3#1)(2006-10#1)(2008-3#1)(2011-2#1)
and the unity of##2##4##(2008-4#1)(2010-8#1)
and the unpredictable##2##3##(2007-8#1)(2010-10#1)
and the unreacted##2##3##(2008-10#2)
and the updated##2##3##(2008-3#1)(2012-2#1)
and the upper limit##2##4##(2008-10#2)
and the upper##10##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-6#1)(2011-1#2)(2011-2#1)
and the uptake of##2##4##(1993-3#1)(2008-11#1)
and the uptake##4##3##(1990-2#1)(1993-3#1)(2008-10#1)(2008-11#1)
and the urinary##3##3##(1991-5#1)(1996-12#1)(2013-1#1)
and the use of a##4##5##(1997-2#1)(2008-3#1)(2010-2#1)(2011-1#1)
and the use of an##2##5##(2008-10#1)(2013-1#1)
and the use of medical##2##5##(1993-6#1)(1996-6#1)
and the use of multiple##2##5##(2008-10#1)(2008-4#1)
and the use of oral contraceptives##2##6##(1991-8#1)(2008-11#1)
and the use of the##10##5##(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)
and the use of these##2##5##(2008-2#1)(2008-4#1)
and the use of this##3##5##(2007-7#1)(2007-8#1)(2008-11#1)
and the use of unhealthy weight control methods##2##8##(2012-2#2)
and the use of##101##4##(1990-2#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
and the use##102##3##(1990-2#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
and the usefulness of##3##4##(2007-11#1)(2008-2#1)(2008-7#1)
and the user##2##3##(1991-9#1)(2011-2#1)
and the uses of##3##4##(2007-12#1)(2008-3#1)(2010-12#1)
and the uses##4##3##(1997-3#1)(2007-12#1)(2008-3#1)(2010-12#1)
and the usual##4##3##(1991-3#1)(1996-2#2)(2009-12#1)
and the utility of##2##4##(2008-11#1)(2008-3#1)
and the utilization of##2##4##(2008-10#1)(2008-8#1)
and the vaccine##2##3##(1995-5#1)(1997-6#1)
and the validation##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and the validity of the##4##5##(2008-10#2)(2008-2#1)(2008-6#1)
and the validity of##5##4##(1991-12#1)(2008-10#2)(2008-2#1)(2008-6#1)
and the validity##6##3##(1991-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2012-2#1)
and the value of the##2##5##(2007-12#1)(2008-5#1)
and the value of##14##4##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)
and the value##17##3##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)
and the values for##2##4##(2010-12#1)(2013-1#1)
and the values obtained##3##4##(2008-10#2)(2010-4#1)
and the values of the##2##5##(1994-1#1)(2008-10#1)
and the values of##4##4##(1994-1#1)(1997-3#1)(2008-10#2)
and the values##13##3##(1994-1#1)(1997-3#1)(1997-4#1)(2008-10#5)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#2)
and the vaporization behavior of##2##5##(2008-10#2)
and the variability of##2##4##(2007-6#1)(2011-2#1)
and the variability##3##3##(2007-6#1)(2008-10#1)(2011-2#1)
and the variables##3##3##(2008-10#2)(2010-5#1)
and the variant##2##3##(1990-8#1)(1992-6#1)
and the variation in##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
and the variation of the##4##5##(2008-10#1)(2008-2#2)(2008-5#1)
and the variation of##5##4##(2008-10#1)(2008-2#3)(2008-5#1)
and the variation##13##3##(2008-10#4)(2008-2#4)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)
and the variations in the##2##5##(2008-10#2)
and the variations in##3##4##(1991-11#1)(2008-10#2)
and the various##9##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-9#1)(2010-11#1)(2013-8#1)
and the vascular##2##3##(2008-11#1)(2012-1#1)
and the vastus lateralis##2##4##(2010-4#2)
and the velocity##2##3##(2008-11#1)(2008-3#1)
and the ventral tegmental area (VTA)##2##6##(1996-12#1)(2008-7#1)
and the ventral tegmental area##4##5##(1996-12#2)(1997-3#1)(2008-7#1)
and the ventral##8##3##(1996-12#2)(1997-3#1)(2008-5#2)(2008-7#2)(2009-8#1)
and the verification of##2##4##(2008-3#2)
and the versatility##2##3##(2008-10#1)(2008-3#1)
and the vertebral##2##3##(2008-7#1)(2011-2#1)
and the vertical##5##3##(2008-2#1)(2008-3#4)
and the very low##3##4##(2008-10#2)(2008-2#1)
and the vessel##2##3##(2008-10#1)(2008-7#1)
and the vibration##2##3##(2008-3#2)
and the viewing angle of##2##5##(2007-11#1)(2008-2#1)
and the viewing##3##3##(2007-11#2)(2008-2#1)
and the viral##4##3##(2007-10#1)(2008-10#1)(2008-9#1)(2010-5#1)
and the virus##4##3##(2008-10#3)(2008-11#1)
and the visible##3##3##(2007-12#2)(2008-11#1)
and the visual##4##3##(2008-3#1)(2008-6#1)(2010-9#1)(2013-8#1)
and the volume of##4##4##(1990-12#1)(1995-3#1)(2008-10#1)(2008-3#1)
and the volume##7##3##(1990-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#2)
and the volumes##2##3##(1995-8#1)(2009-11#1)
and the vulva##2##3##(1996-12#1)(1997-7#1)
and the water content of the##2##6##(2008-3#1)(2008-5#1)
and the water content##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
and the water##8##3##(2007-5#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)
and the wave-front##2##3##(2008-3#2)
and the wavelength of the##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
and the wavelength of##6##4##(2007-11#1)(2007-12#2)(2008-3#3)
and the wavelength##10##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-3#4)
and the way in which##2##5##(1997-1#1)(1997-7#1)
and the way##6##3##(1997-1#1)(1997-7#1)(2008-1#1)(2008-12#1)(2009-10#1)(2012-12#1)
and the ways in which##2##5##(2008-8#1)(2012-12#1)
and the ways of##2##4##(1992-11#1)(2011-1#1)
and the ways##5##3##(1992-11#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
and the weak##4##3##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)
and the weed##2##3##(2008-10#1)(2008-12#1)
and the weight##5##3##(1991-2#1)(2008-12#1)(2008-5#2)(2012-12#1)
and the whole##6##3##(1991-8#1)(1993-12#1)(1994-3#2)(2012-12#1)(2012-9#1)
and the wide##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
and the wider##7##3##(2008-11#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#1)
and the widespread##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
and the width of the##4##5##(1993-12#1)(2007-12#1)(2008-10#2)
and the width of##5##4##(1993-12#1)(2007-12#1)(2008-10#3)
and the width##6##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#3)
and the wild type was##2##5##(2008-10#2)
and the wild type##5##4##(2008-10#5)
and the women##2##3##(1996-12#1)(2007-2#1)
and the women's##2##3##(1997-3#1)(2009-12#1)
and the work##3##3##(2007-11#1)(2008-9#1)(2012-2#1)
and the working electrode##3##4##(2008-10#3)
and the working##9##3##(1995-6#1)(2008-10#6)(2008-3#1)(2008-4#1)
and the world##5##3##(1997-1#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-12#1)
and the worst##2##3##(2007-11#1)(2008-11#1)
and the yeast##2##3##(1997-6#1)(2008-5#1)
and the yield of##4##4##(1995-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
and the zebrafish##2##3##(1991-9#1)(2008-7#1)
and the zero-dipole summation method##2##5##(2013-1#2)
and the zero-order##3##3##(2008-3#3)
and the zone##2##3##(2008-10#1)(2008-7#1)
and the##14927##2##(1990-10#7)(1990-11#42)(1990-12#53)(1990-2#29)(1990-3#27)(1990-5#50)(1990-6#28)(1990-7#33)(1990-8#60)(1990-9#29)(1991-1#40)(1991-10#2)(1991-11#23)(1991-12#81)(1991-2#63)(1991-3#44)(1991-4#5)(1991-5#41)(1991-6#38)(1991-7#3)(1991-8#30)(1991-9#41)(1992-1#25)(1992-10#3)(1992-11#21)(1992-12#62)(1992-2#40)(1992-3#76)(1992-4#12)(1992-5#24)(1992-6#70)(1992-7#1)(1992-8#36)(1992-9#38)(1993-1#29)(1993-10#3)(1993-11#42)(1993-12#90)(1993-2#45)(1993-3#68)(1993-5#17)(1993-6#46)(1993-8#48)(1993-9#15)(1994-1#24)(1994-10#2)(1994-11#54)(1994-12#72)(1994-2#69)(1994-3#63)(1994-5#44)(1994-6#33)(1994-7#14)(1994-8#51)(1994-9#27)(1995-1#30)(1995-10#1)(1995-11#33)(1995-12#74)(1995-2#78)(1995-3#72)(1995-4#5)(1995-5#57)(1995-6#89)(1995-8#44)(1995-9#7)(1996-1#26)(1996-10#2)(1996-11#17)(1996-12#88)(1996-2#91)(1996-3#48)(1996-4#14)(1996-5#41)(1996-6#30)(1996-7#9)(1996-8#20)(1996-9#18)(1997-1#22)(1997-2#70)(1997-3#79)(1997-4#54)(1997-5#26)(1997-6#39)(1997-7#57)(1997-8#50)(1997-9#4)(2006-10#22)(2006-12#9)(2006-4#1)(2006-6#6)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#52)(2007-11#274)(2007-12#345)(2007-2#27)(2007-3#2)(2007-4#7)(2007-5#22)(2007-6#11)(2007-7#48)(2007-8#89)(2007-9#8)(2008-1#162)(2008-10#3063)(2008-11#498)(2008-12#176)(2008-2#542)(2008-3#1129)(2008-4#207)(2008-5#363)(2008-6#169)(2008-7#475)(2008-8#378)(2008-9#318)(2009-1#11)(2009-10#65)(2009-11#48)(2009-12#48)(2009-2#18)(2009-3#42)(2009-4#19)(2009-5#52)(2009-6#49)(2009-7#61)(2009-8#62)(2009-9#38)(2010-1#38)(2010-10#41)(2010-11#52)(2010-12#72)(2010-2#39)(2010-3#65)(2010-4#51)(2010-5#63)(2010-6#45)(2010-7#27)(2010-8#94)(2010-9#25)(2011-1#201)(2011-10#3)(2011-2#509)(2011-3#34)(2011-4#2)(2011-7#5)(2012-1#51)(2012-12#158)(2012-2#236)(2012-3#175)(2012-4#3)(2012-5#8)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#343)(2013-2#3)(2013-7#60)(2013-8#270)
and theca cells##2##3##(1990-8#1)(2008-9#1)
and theca##3##2##(1990-8#1)(2008-12#1)(2008-9#1)
and theft##3##2##(1994-12#1)(1996-12#1)(2012-1#1)
and their 1-deoxy##2##3##(1992-12#2)
and their Ca2+##2##3##(1995-2#1)(2009-3#1)
and their N-hydroxy metabolites##2##4##(1992-6#2)
and their Nernstian slopes were##2##5##(2008-10#2)
and their ability to##18##4##(1991-7#1)(1995-11#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-7#1)
and their acridine orange (AO) induced mutants##2##7##(2008-12#2)
and their activities##5##3##(2007-12#1)(2008-9#2)(2009-5#1)(2010-3#1)
and their activity##3##3##(1992-5#1)(2008-5#1)(2010-5#1)
and their adequate##2##3##(2008-10#1)(2011-2#1)
and their age##2##3##(2008-12#1)(2009-7#1)
and their aggregates with##2##4##(2008-1#1)(2008-10#1)
and their amino acid sequences##2##5##(1992-6#1)(1994-11#1)
and their analogs##9##3##(2007-11#3)(2007-5#1)(2008-10#3)(2008-4#2)
and their analysis by##2##4##(2008-9#1)(2013-8#1)
and their analysis##4##3##(1992-12#1)(2008-9#1)(2009-9#1)(2013-8#1)
and their analytical##2##3##(2008-10#2)
and their antibiotic susceptibility##2##4##(2010-8#1)(2011-2#1)
and their antimicrobial sensitivity pattern##2##5##(2007-7#2)
and their antimicrobial##3##3##(2007-7#2)(2012-3#1)
and their applicability##2##3##(2008-10#1)(2008-5#1)
and their application in##5##4##(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)
and their application to the##4##5##(2008-10#3)(2009-12#1)
and their application to##17##4##(1990-7#1)(1994-2#1)(1995-3#2)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#1)
and their application##25##3##(1990-7#1)(1994-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#1)
and their applications in##4##4##(1997-2#1)(2008-12#2)(2008-4#1)
and their applications to##4##4##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
and their applications##15##3##(1992-11#1)(1992-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
and their approach##2##3##(1993-1#1)(1996-8#1)
and their associated##12##3##(1991-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2011-2#1)
and their association with##13##4##(1994-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
and their association##15##3##(1994-11#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
and their behavior##2##3##(2008-7#1)(2008-9#1)
and their binding##3##3##(1995-3#1)(2008-11#1)(2009-5#1)
and their biochemical##2##3##(2008-1#1)(2012-2#1)
and their biological##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
and their biophysical##2##3##(1997-6#1)(2012-3#1)
and their care##2##3##(2008-11#1)(2010-10#1)
and their care-givers##2##3##(2008-11#1)(2008-9#1)
and their caregivers##3##3##(1992-3#1)(1996-3#1)(2013-8#1)
and their carers##4##3##(2008-11#1)(2008-12#1)(2010-12#1)(2013-8#1)
and their causes##2##3##(2007-11#1)(2012-3#1)
and their changes##4##3##(1992-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
and their changing##2##3##(1995-6#1)(2010-12#1)
and their characteristics##2##3##(2008-8#1)(2008-9#1)
and their characterization by##2##4##(2006-12#1)(2008-10#1)
and their characterization##4##3##(1995-3#1)(2006-12#1)(2008-10#2)
and their child##3##3##(1990-12#1)(2008-9#1)(2012-2#1)
and their child's##2##3##(2008-9#1)(2010-9#1)
and their children##5##3##(1991-11#1)(1993-12#1)(2008-12#1)(2008-6#1)(2012-2#1)
and their clinical##3##3##(2008-6#1)(2008-8#1)(2010-5#1)
and their cognate##2##3##(2009-10#1)(2009-9#1)
and their colleagues##3##3##(2007-10#1)(2011-1#1)(2011-2#1)
and their combination##6##3##(1992-2#1)(2009-8#1)(2011-1#1)(2012-5#1)(2012-7#1)(2012-9#1)
and their combinations##3##3##(1996-12#1)(2008-10#1)(2012-3#1)
and their communities##2##3##(1992-12#1)(2009-6#1)
and their community##2##3##(1995-3#1)(2008-7#1)
and their comparative##2##3##(2008-10#1)(2010-7#1)
and their comparison with##2##4##(2008-10#1)(2008-3#1)
and their comparison##4##3##(2008-10#3)(2008-3#1)
and their complete##2##3##(1996-10#1)(2012-1#1)
and their complexes##5##3##(2008-10#4)(2010-7#1)
and their components##4##3##(2008-10#3)(2012-3#1)
and their concentrations##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
and their confidence##2##3##(2008-10#2)
and their consequences##5##3##(2007-11#1)(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
and their contribution to##3##4##(2008-12#1)(2009-8#1)(2011-2#1)
and their contribution##4##3##(2008-12#2)(2009-8#1)(2011-2#1)
and their correlation with##2##4##(2008-12#1)(2011-2#1)
and their correlation##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
and their corresponding##5##3##(1993-6#1)(1996-5#1)(2008-6#1)(2009-6#1)(2010-8#1)
and their current##4##3##(1997-4#1)(2008-10#1)(2008-12#1)(2009-9#1)
and their decision-making##2##3##(1992-2#1)(2011-1#1)
and their degradation products##3##4##(2008-10#1)(2013-1#2)
and their dependence on##2##4##(1996-5#1)(2008-3#1)
and their derivatives are##2##4##(2008-10#1)(2008-5#1)
and their derivatives##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)
and their detection##5##3##(2007-12#1)(2008-10#3)(2012-2#1)
and their determination by##4##4##(2008-10#4)
and their determination##5##3##(2008-10#5)
and their determinations by##2##4##(2008-10#2)
and their development##4##3##(1992-2#1)(2007-12#1)(2008-5#1)(2010-9#1)
and their difference##2##3##(2008-10#1)(2008-12#1)
and their distribution in##3##4##(1996-12#1)(2009-7#1)(2013-1#1)
and their distribution##7##3##(1996-12#1)(2008-10#2)(2008-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
and their diverse##2##3##(2008-10#1)(2013-8#1)
and their dynamics##2##3##(1996-12#1)(2011-3#1)
and their effect on the##2##5##(2008-10#1)(2008-11#1)
and their effect on##8##4##(1991-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
and their effect##10##3##(1991-3#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
and their effectiveness to improve##2##5##(2012-2#2)
and their effectiveness##3##3##(2012-12#1)(2012-2#2)
and their effects on the##6##5##(1990-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#2)
and their effects on##13##4##(1990-11#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
and their effects##16##3##(1990-11#2)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
and their efficacy##2##3##(2008-2#1)(2008-5#1)
and their elimination##2##3##(2008-10#1)(2008-12#1)
and their emerging##2##3##(2008-10#1)(2012-2#1)
and their employees##2##3##(1995-1#1)(1996-12#1)
and their environment##2##3##(1994-3#1)(2010-8#1)
and their evaluation##2##3##(2008-11#1)(2008-5#1)
and their evolution##2##3##(2008-7#1)(2010-5#1)
and their existing##2##3##(2011-3#1)(2013-8#1)
and their experience of##2##4##(1996-9#1)(2009-5#1)
and their experience##3##3##(1996-9#1)(2009-5#2)
and their expression in##2##4##(1993-8#1)(1994-12#1)
and their expression is##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
and their expression##9##3##(1990-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(2008-11#2)(2008-4#1)(2009-10#1)(2011-1#1)
and their extracts##2##3##(2008-10#1)(2011-1#1)
and their families##47##3##(1990-10#1)(1992-1#2)(1992-12#2)(1992-3#3)(1994-1#2)(1994-12#1)(1994-3#2)(1995-2#1)(1995-3#3)(1996-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-11#13)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
and their family##2##3##(1992-2#1)(2007-12#1)
and their first##3##3##(1997-6#1)(2008-10#2)
and their formation##2##3##(1994-12#1)(2012-12#1)
and their function##2##3##(1993-9#1)(2008-8#1)
and their functional##3##3##(1996-2#1)(2008-7#1)(2008-9#1)
and their gene transcripts were##2##5##(2008-5#2)
and their gene##3##3##(1997-4#1)(2008-5#2)
and their healthcare providers##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
and their high##2##3##(2008-10#1)(2008-7#1)
and their host##2##3##(2009-5#1)(2013-1#1)
and their hosts is##2##4##(2008-9#1)(2012-12#1)
and their hosts##5##3##(1997-7#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
and their hybrids##5##3##(2008-10#4)(2008-9#1)
and their hydrodynamic##2##3##(2009-9#1)(2011-1#1)
and their hydrolysis##2##3##(2008-10#1)(2008-6#1)
and their hydroxy/N(4)-acetyl metabolites##2##4##(2008-10#2)
and their impact on the##3##5##(1994-5#1)(1996-12#1)(2008-7#1)
and their impact on##12##4##(1992-1#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)(2013-1#1)
and their impact##14##3##(1992-1#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#2)(2008-10#2)(2008-11#3)(2008-7#1)(2010-11#1)(2013-1#1)
and their implications for the##2##5##(2007-12#1)(2008-8#1)
and their implications for##10##4##(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)
and their implications##15##3##(1995-1#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)
and their importance for##2##4##(2008-10#2)
and their importance in##2##4##(2008-10#1)(2011-1#1)
and their importance##6##3##(1993-3#1)(1995-1#1)(2008-10#3)(2011-1#1)
and their in##2##3##(2008-9#2)
and their individual##2##3##(2008-10#2)
and their influence on the##2##5##(2008-10#1)(2013-8#1)
and their influence on##7##4##(2008-10#2)(2008-2#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
and their influence##9##3##(2008-10#3)(2008-2#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
and their inhibitors##5##3##(2008-1#1)(2008-9#3)(2012-12#1)
and their inhibitory##3##3##(1992-6#1)(1992-8#1)(2013-1#1)
and their interaction on##2##4##(2008-10#2)
and their interaction with##8##4##(1990-2#2)(1995-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
and their interaction##14##3##(1990-2#2)(1993-11#1)(1995-2#1)(1995-5#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
and their interactions on##3##4##(2008-10#2)(2008-7#1)
and their interactions with the##2##5##(2010-2#1)(2012-1#1)
and their interactions with##5##4##(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-1#1)
and their interactions##14##3##(1994-9#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-1#1)
and their ligands##4##3##(2008-11#1)(2008-4#2)(2009-8#1)
and their limitations##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
and their locations##3##3##(2010-10#1)(2013-1#2)
and their long-term##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
and their main metabolites in##2##5##(2008-10#2)
and their main metabolites##3##4##(2008-10#3)
and their main##6##3##(2008-10#4)(2008-11#1)(2008-6#1)
and their management in##2##4##(2008-7#1)(2010-3#1)
and their management##8##3##(2007-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
and their mechanism of##2##4##(2008-4#1)(2012-2#1)
and their mechanisms of action##2##5##(2008-7#2)
and their medical##2##3##(1992-2#1)(2013-8#1)
and their members##3##3##(1991-2#1)(1993-1#1)(2007-4#1)
and their metabolites are##2##4##(2008-11#2)
and their metabolites in radish##2##5##(2008-10#2)
and their metabolites##11##3##(2008-1#1)(2008-10#5)(2008-11#4)(2013-1#1)
and their metal complexes##2##4##(2008-10#2)
and their metal##4##3##(2008-10#4)
and their mixture##2##3##(2008-10#2)
and their mixtures##3##3##(2008-10#3)
and their modes of action##2##5##(2008-11#2)
and their modulation by##2##4##(1993-2#1)(2008-5#1)
and their more##2##3##(2009-12#1)(2012-12#1)
and their morphology##2##3##(2008-11#1)(2013-1#1)
and their mothers##4##3##(1994-6#1)(2009-11#1)(2011-1#1)(2012-12#1)
and their multilayer##2##3##(2008-2#2)
and their negative##2##3##(1995-2#1)(2013-8#1)
and their neonates##4##3##(2011-1#4)
and their newborn##2##3##(2007-12#1)(2007-2#1)
and their newborns##3##3##(2011-1#3)
and their nuclei##2##3##(2008-8#1)(2008-9#1)
and their nucleotide sequences were determined according to##2##8##(1997-6#1)(1997-8#1)
and their nucleotide sequences##3##4##(1990-5#1)(1997-6#1)(1997-8#1)
and their nucleotide##4##3##(1990-5#1)(1997-6#1)(1997-8#1)(2013-8#1)
and their number##2##3##(1992-5#1)(2012-2#1)
and their offspring##6##3##(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
and their optical##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
and their optimal values were##2##5##(2008-10#2)
and their optimal##4##3##(2008-10#3)(2008-3#1)
and their orientation##2##3##(2008-10#1)(2008-3#1)
and their origin##2##3##(2008-5#1)(2008-8#1)
and their origins##2##3##(1991-4#1)(2008-7#1)
and their outcome##2##3##(2010-11#1)(2010-3#1)
and their outcomes##2##3##(1996-4#1)(2011-3#1)
and their outer membrane components##2##5##(1995-12#2)
and their overall##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
and their own##3##3##(1995-1#1)(2008-8#1)(2012-1#1)
and their parasites##2##3##(2008-1#1)(2008-8#1)
and their parasitic##2##3##(2008-8#1)(2013-1#1)
and their parents were##2##4##(1995-2#1)(2008-3#1)
and their parents##14##3##(1990-9#1)(1991-2#1)(1995-12#2)(1995-2#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
and their partial##2##3##(2008-10#1)(2008-8#1)
and their partners in##2##4##(2007-2#1)(2011-2#1)
and their partners##9##3##(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#2)
and their pathogenicity##2##3##(2008-10#1)(2012-3#1)
and their pathogens##2##3##(2008-10#2)
and their patients and##2##4##(1995-3#1)(1997-3#1)
and their patients##7##3##(1990-6#1)(1995-2#1)(1995-3#2)(1997-3#1)(2008-3#1)(2011-1#1)
and their patterns of##2##4##(2010-10#1)(2012-2#1)
and their perceptions##2##3##(2007-10#1)(2007-11#1)
and their performance as##2##4##(2007-11#2)
and their performance##7##3##(1993-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#2)
and their personal##2##3##(1996-9#1)(2007-11#1)
and their phylogenetic##2##3##(1997-6#1)(2010-10#1)
and their physicians##6##3##(1991-1#1)(1996-3#1)(2008-11#2)(2008-6#1)(2012-3#1)
and their place in##2##4##(1994-3#1)(2008-2#1)
and their possible impact on##2##5##(2011-1#1)(2011-2#1)
and their possible##10##3##(2007-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#2)(2011-2#2)(2012-3#1)
and their potential applications##3##4##(2009-4#1)(2013-1#2)
and their potential for##2##4##(2007-12#1)(2010-6#1)
and their potential to##4##4##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
and their potential use for##2##5##(2008-10#1)(2009-8#1)
and their potential##25##3##(1990-6#1)(1993-6#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#4)
and their practical##2##3##(2009-10#1)(2011-2#1)
and their prevalence##2##3##(1991-12#1)(2008-10#1)
and their products##3##3##(2008-10#1)(2009-5#1)(2012-1#1)
and their progeny##2##3##(2008-8#1)(2011-2#1)
and their properties##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
and their quality##2##3##(2011-2#1)(2013-8#1)
and their quantification##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
and their receptors are##2##4##(2008-1#1)(2008-4#1)
and their receptors in human melanocytes##2##6##(2008-5#2)
and their receptors in the##3##5##(1996-12#1)(2008-4#1)(2008-5#1)
and their receptors in##7##4##(1996-12#1)(1997-2#1)(2008-4#1)(2008-5#3)(2013-1#1)
and their receptors##13##3##(1996-12#1)(1997-2#1)(2008-1#1)(2008-4#3)(2008-5#3)(2011-2#2)(2012-12#1)(2013-1#1)
and their regulation##5##3##(1995-12#1)(2008-10#3)(2013-7#1)
and their regulatory##2##3##(2010-1#1)(2011-1#1)
and their related##3##3##(1995-11#1)(2009-10#1)(2013-8#1)
and their relation to##6##4##(1991-6#1)(1993-5#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-3#1)
and their relation##7##3##(1991-6#1)(1993-5#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-3#1)(2011-1#1)
and their relationship to breast##2##5##(1993-1#1)(2011-3#1)
and their relationship to the##3##5##(2008-11#1)(2008-3#1)(2013-8#1)
and their relationship to##12##4##(1990-9#1)(1992-6#1)(1993-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
and their relationship with##7##4##(2007-10#1)(2008-10#2)(2012-2#2)(2012-9#1)(2013-7#1)
and their relationship##21##3##(1990-9#1)(1992-6#1)(1993-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#4)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
and their relationships to##4##4##(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)
and their relationships with##2##4##(1995-9#1)(2008-7#1)
and their relationships##6##3##(1995-9#1)(2008-10#1)(2008-7#2)(2009-4#1)(2011-1#1)
and their relative##8##3##(1990-3#1)(1997-3#1)(2007-8#2)(2008-10#2)(2008-7#1)(2012-2#1)
and their relatives'##2##3##(2010-10#1)(2012-12#1)
and their relevance to##3##4##(2007-7#1)(2008-3#1)(2008-8#1)
and their relevance##4##3##(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)
and their respective control##2##4##(2009-6#1)(2011-2#1)
and their respective##12##3##(1996-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
and their response to##3##4##(1994-5#1)(2008-10#1)(2013-8#1)
and their resulting##2##3##(1996-3#1)(2007-12#1)
and their role in##8##4##(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-2#2)(2012-12#1)(2012-2#1)
and their role##9##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#2)(2012-12#1)(2012-2#1)
and their roles in##2##4##(2009-11#1)(2011-2#1)
and their safe##2##3##(2007-2#1)(2008-3#1)
and their salient##2##3##(2008-11#1)(2009-11#1)
and their satisfaction with##2##4##(1993-3#1)(2010-2#1)
and their sequences##2##3##(2008-10#1)(2008-5#1)
and their severity##2##3##(2008-3#1)(2010-4#1)
and their sex partners##2##4##(1996-4#1)(2008-10#1)
and their sex##3##3##(1996-4#1)(2008-10#1)(2009-5#1)
and their significance for##3##4##(1990-9#1)(2008-12#1)(2008-8#1)
and their significance in##3##4##(1991-11#1)(1993-2#1)(2012-2#1)
and their significance##7##3##(1990-9#1)(1991-11#1)(1993-2#1)(2008-12#2)(2008-8#1)(2012-2#1)
and their simultaneous##3##3##(2008-10#2)(2008-7#1)
and their size##2##3##(2008-10#2)
and their social##2##3##(2008-1#1)(2009-7#1)
and their spatial distribution##2##4##(2013-7#1)(2013-8#1)
and their spatial pattern)##2##4##(2008-10#2)
and their spatial##6##3##(1993-3#1)(1997-4#1)(2008-10#2)(2013-7#1)(2013-8#1)
and their spectral##2##3##(2007-12#1)(2008-10#1)
and their stability is a function of charges involved in the formation reaction##2##13##(2008-10#2)
and their stability##5##3##(2007-11#1)(2008-10#3)(2013-8#1)
and their staff##3##3##(1995-2#1)(1996-1#1)(2009-11#1)
and their standard##2##3##(2008-10#2)
and their statistical##2##3##(2008-10#1)(2009-4#1)
and their structural##3##3##(1991-2#1)(2007-11#1)(2010-1#1)
and their structures##2##3##(1996-2#1)(2007-1#1)
and their subsequent determination##2##4##(2008-10#2)
and their subsequent use##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
and their subsequent##14##3##(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-5#2)(2011-2#1)
and their surrounding##2##3##(2008-12#1)(2008-4#1)
and their susceptibility to##2##4##(2008-11#1)(2008-5#1)
and their susceptibility##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
and their target genes##2##4##(1994-8#1)(2011-2#1)
and their target##3##3##(1994-8#1)(2009-8#1)(2011-2#1)
and their temporal##2##3##(2008-3#1)(2012-1#1)
and their therapeutic##3##3##(1995-4#1)(2008-1#1)(2011-1#1)
and their transcripts##2##3##(1993-2#1)(1994-2#1)
and their transformation products in Tunisian surface water##2##8##(2008-10#2)
and their transformation##3##3##(2008-10#2)(2010-4#1)
and their translation##2##3##(1997-2#1)(2008-9#1)
and their treatment##5##3##(1992-5#1)(1997-6#1)(2007-11#1)(2008-4#1)(2009-9#1)
and their underlying##2##3##(2008-8#1)(2011-1#1)
and their unique##3##3##(1993-3#1)(2010-6#1)(2010-7#1)
and their usage##2##3##(1990-11#1)(2008-2#1)
and their use for##2##4##(1997-4#1)(2008-6#1)
and their use in the##2##5##(2008-10#1)(2008-6#1)
and their use in##6##4##(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2013-1#1)
and their use##15##3##(1997-4#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and their utilization##2##3##(2009-5#1)(2011-1#1)
and their validity##7##3##(1994-12#1)(2008-10#1)(2008-2#1)(2013-1#4)
and their variation##2##3##(1994-12#1)(2008-5#1)
and their various##2##3##(2008-4#1)(2009-11#1)
and their work##2##3##(1994-2#1)(2010-9#1)
and their##1574##2##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#10)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#7)(1992-11#3)(1992-12#8)(1992-2#8)(1992-3#10)(1992-5#6)(1992-6#9)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#7)(1993-2#7)(1993-3#6)(1993-5#2)(1993-6#7)(1993-8#4)(1993-9#4)(1994-1#3)(1994-11#5)(1994-12#7)(1994-2#8)(1994-3#12)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#3)(1995-1#7)(1995-11#5)(1995-12#10)(1995-2#11)(1995-3#20)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#11)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#8)(1997-4#9)(1997-6#8)(1997-7#6)(1997-8#4)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#6)(2007-11#22)(2007-12#28)(2007-2#5)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#16)(2008-10#270)(2008-11#87)(2008-12#32)(2008-2#19)(2008-3#41)(2008-4#33)(2008-5#51)(2008-6#13)(2008-7#36)(2008-8#31)(2008-9#49)(2009-1#1)(2009-10#6)(2009-11#8)(2009-12#9)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#13)(2009-6#5)(2009-7#6)(2009-8#10)(2009-9#9)(2010-1#5)(2010-10#8)(2010-11#7)(2010-12#7)(2010-2#5)(2010-3#9)(2010-4#8)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#13)(2010-9#10)(2011-1#44)(2011-2#56)(2011-3#6)(2012-1#6)(2012-12#24)(2012-2#39)(2012-3#18)(2012-4#1)(2012-5#1)(2012-7#1)(2012-9#2)(2013-1#59)(2013-7#5)(2013-8#32)
and thelytokous populations##2##3##(2008-10#2)
and thematic analysis##2##3##(2010-9#1)(2012-12#1)
and thematic content##2##3##(1994-2#1)(2008-12#1)
and thematic##6##2##(1994-2#1)(2007-2#1)(2008-12#1)(2008-4#1)(2010-9#1)(2012-12#1)
and themes were identified##2##4##(2008-11#1)(2012-2#1)
and themes##3##2##(2008-11#1)(2010-11#1)(2012-2#1)
and then a##6##3##(1990-12#1)(1992-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
and then activated on the membranes##2##6##(1992-6#2)
and then added to##2##4##(1994-2#1)(2008-11#1)
and then adding##3##3##(2008-10#3)
and then after##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
and then allow the##2##4##(2008-4#1)(2010-5#1)
and then an##4##3##(2008-10#3)(2008-3#1)
and then analyzed##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
and then applied to the##4##5##(1996-3#1)(2008-10#3)
and then applied to##8##4##(1996-3#1)(2008-10#6)(2012-2#1)
and then applying##2##3##(2009-9#1)(2013-1#1)
and then at##2##3##(2008-10#1)(2008-3#1)
and then back##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
and then be##2##3##(1993-12#1)(2008-1#1)
and then by##6##3##(1992-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)
and then calculating##2##3##(2008-10#1)(2008-3#1)
and then compared##3##3##(2007-8#1)(2008-2#1)(2009-4#1)
and then completed a##2##4##(2010-8#2)
and then completed##3##3##(1994-3#1)(2010-8#2)
and then declined to##2##4##(2008-10#2)
and then declined##10##3##(1995-3#1)(2008-10#9)
and then decrease##2##3##(2008-8#1)(2013-1#1)
and then decreased significantly##2##4##(2008-10#1)(2008-12#1)
and then decreased##11##3##(1992-5#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)
and then decreases with##2##4##(2013-8#2)
and then decreases##5##3##(1995-3#1)(2008-10#1)(2008-9#1)(2013-8#2)
and then determined by##3##4##(2008-10#3)
and then determined##4##3##(2008-10#4)
and then diffuse##2##3##(1997-1#1)(2007-12#1)
and then directly##3##3##(2007-11#1)(2008-10#2)
and then discuss##3##3##(2008-2#1)(2012-1#1)(2013-8#1)
and then doing a##2##4##(2007-11#1)(2008-2#1)
and then each##2##3##(2008-10#1)(2008-3#1)
and then evaluated##2##3##(2008-11#1)(2012-3#1)
and then exit##2##3##(2008-3#1)(2012-12#1)
and then expanded to##2##4##(2008-12#1)(2008-2#1)
and then exposed to##3##4##(1991-5#1)(2008-10#1)(2009-9#1)
and then extracted by##3##4##(2008-10#2)(2013-1#1)
and then extracted##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#1)
and then fed into##2##4##(2008-3#2)
and then followed##2##3##(2010-1#1)(2012-2#1)
and then from##2##3##(1996-5#1)(2008-4#1)
and then gradually decreased##2##4##(1990-7#1)(2008-7#1)
and then gradually##3##3##(1990-7#1)(2008-10#1)(2008-7#1)
and then had##3##3##(1992-9#1)(2007-8#1)(2008-11#1)
and then identified##3##3##(1995-6#1)(1997-7#1)(2008-4#1)
and then in the##2##4##(2008-10#2)
and then in##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
and then increased again##3##4##(1997-2#1)(1997-3#1)(2008-7#1)
and then increased##11##3##(1992-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-8#1)
and then incubated##5##3##(1992-12#1)(1993-8#1)(1994-8#1)(2008-10#1)(2010-3#1)
and then is##3##3##(2008-10#3)
and then it##2##3##(2008-10#2)
and then its##2##3##(1994-12#1)(2008-10#1)
and then measured##4##3##(1990-12#1)(2008-5#1)(2010-5#1)(2013-1#1)
and then mixed with##2##4##(2008-10#1)(2011-3#1)
and then on##4##3##(1994-2#1)(2007-10#1)(2008-10#1)(2011-1#1)
and then only##2##3##(2008-10#1)(2008-2#1)
and then progressively##2##3##(1993-8#1)(1995-8#1)
and then quantitatively##2##3##(2008-10#2)
and then rapidly##2##3##(2007-12#1)(2008-5#1)
and then reaches##2##3##(2008-10#2)
and then reduced to##2##4##(2008-10#1)(2011-1#1)
and then reduced##3##3##(2008-10#1)(2011-1#2)
and then show##2##3##(1993-12#1)(2008-2#1)
and then spread##2##3##(2008-10#2)
and then spun##2##3##(2007-12#1)(2008-8#1)
and then started to increase##2##5##(1995-3#1)(2010-8#1)
and then started to##3##4##(1995-3#1)(1997-2#1)(2010-8#1)
and then stimulated with##3##4##(1991-2#1)(1992-8#1)(2011-2#1)
and then subjected to a##2##5##(1995-6#1)(2009-4#1)
and then subjected to##5##4##(1991-5#1)(1995-6#2)(2009-4#1)(2011-1#1)
and then submitted to##2##4##(1990-10#1)(2008-12#1)
and then the ratio decreased with increase in the molar ratio of myristic acid to pyrene carboxylic acid##2##18##(2008-10#2)
and then the##31##3##(1992-8#1)(1993-2#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
and then these##2##3##(2008-11#1)(2013-1#1)
and then they were##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
and then they##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#1)
and then to the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and then to##20##3##(1993-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)
and then transferred to a##2##5##(2008-12#1)(2013-1#1)
and then transferred to##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
and then transformed##2##3##(2008-10#1)(2008-4#1)
and then treated with##3##4##(2008-10#2)(2011-2#1)
and then used to##3##4##(2008-2#1)(2008-8#1)(2012-12#1)
and then used##9##3##(1997-1#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)
and then using the##2##4##(2008-10#1)(2008-8#1)
and then was##7##3##(1996-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
and then we##2##3##(2008-2#1)(2012-12#1)
and then were##9##3##(1993-11#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-9#2)
and then with 0##2##4##(2008-10#1)(2008-5#1)
and then with a##2##4##(2007-12#1)(2009-8#1)
and then with##8##3##(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)
and then##568##2##(1990-10#1)(1990-12#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#5)(1993-6#1)(1993-8#3)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#5)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#2)(1997-6#1)(1997-7#4)(1997-8#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-5#1)(2007-8#4)(2008-1#9)(2008-10#153)(2008-11#26)(2008-12#14)(2008-2#13)(2008-3#22)(2008-4#11)(2008-5#15)(2008-6#5)(2008-7#17)(2008-8#23)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-8#6)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#9)(2010-7#1)(2010-8#8)(2011-1#10)(2011-2#10)(2011-3#3)(2012-1#3)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#9)
and theophylline are##2##3##(1990-8#1)(2008-10#1)
and theophylline##6##2##(1990-8#1)(1990-9#1)(2008-10#3)(2010-11#1)
and theoretical considerations##2##3##(2008-10#1)(2010-10#1)
and theoretical data##2##3##(2008-3#1)(2009-11#1)
and theoretical foundations##2##3##(1995-2#1)(2008-12#1)
and theoretical investigations##2##3##(2008-11#1)(2008-2#1)
and theoretical models##2##3##(1990-12#1)(1996-4#1)
and theoretical predictions##6##3##(2007-11#1)(2007-12#2)(2008-3#1)(2010-2#1)(2013-1#1)
and theoretical results##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
and theoretical study##2##3##(1991-9#1)(2007-12#1)
and theoretical values##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
and theoretical##59##2##(1990-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-6#1)(1995-2#2)(1996-4#1)(2007-11#2)(2007-12#5)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#14)(2008-5#2)(2008-6#2)(2008-9#2)(2009-11#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
and theoretically analyzed##2##3##(2008-2#2)
and theoretically##22##2##(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
and theories about##2##3##(2007-8#1)(2008-11#1)
and theories of##2##3##(1995-1#1)(1996-3#1)
and theories##12##2##(1992-3#1)(1995-1#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#4)
and theory are##3##3##(2008-3#1)(2008-8#1)(2012-12#1)
and theory of##3##3##(1993-2#1)(2008-2#1)(2008-3#1)
and theory##16##2##(1993-2#1)(1994-2#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-8#2)(2012-12#1)
and theory-of-mind##2##2##(2008-9#2)
and therapeutic applications of##2##4##(2008-3#1)(2013-1#1)
and therapeutic applications##3##3##(2008-3#1)(2010-5#1)(2013-1#1)
and therapeutic approach##4##3##(1993-5#2)(1996-11#1)(2008-7#1)
and therapeutic approaches to##2##4##(2006-10#1)(2008-1#1)
and therapeutic approaches##5##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
and therapeutic aspects of the##2##5##(1990-9#1)(1993-6#1)
and therapeutic aspects of##6##4##(1990-9#1)(1992-5#1)(1993-6#1)(2007-12#1)(2007-8#1)(2012-3#1)
and therapeutic aspects##7##3##(1990-9#1)(1992-5#1)(1993-6#1)(2007-12#1)(2007-8#2)(2012-3#1)
and therapeutic considerations##3##3##(1990-9#1)(1993-5#1)(2009-3#1)
and therapeutic decision##2##3##(2007-10#1)(2011-2#1)
and therapeutic effectiveness##2##3##(2009-3#1)(2013-8#1)
and therapeutic efficacy of##2##4##(1991-9#1)(2007-11#1)
and therapeutic efficacy##4##3##(1991-9#1)(2007-11#2)(2007-8#1)
and therapeutic features##2##3##(1990-12#1)(2013-1#1)
and therapeutic implications are##2##4##(1991-3#1)(2008-7#1)
and therapeutic implications##6##3##(1991-3#1)(1992-6#1)(2008-7#3)(2013-8#1)
and therapeutic implications]##2##3##(1990-3#1)(2007-8#1)
and therapeutic interventions##2##3##(2008-7#1)(2010-12#1)
and therapeutic modalities##2##3##(1993-1#1)(2008-11#1)
and therapeutic options##4##3##(1992-12#1)(2010-11#1)(2010-8#1)(2011-1#1)
and therapeutic possibilities##2##3##(1990-6#1)(1990-8#1)
and therapeutic potential of##2##4##(2008-11#1)(2008-7#1)
and therapeutic potential##5##3##(2008-11#1)(2008-7#3)(2013-7#1)
and therapeutic reasons##2##3##(2008-9#1)(2012-2#1)
and therapeutic response##2##3##(2010-11#1)(2012-2#1)
and therapeutic results##2##3##(1996-9#1)(2009-5#1)
and therapeutic roles##2##3##(2008-3#1)(2010-5#1)
and therapeutic strategies are##3##4##(1992-3#1)(2008-7#1)(2008-8#1)
and therapeutic strategies##7##3##(1992-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-8#1)
and therapeutic strategy##4##3##(1991-5#1)(2012-2#2)(2012-3#1)
and therapeutic targets##4##3##(2008-4#1)(2010-12#1)(2012-12#2)
and therapeutic value of##2##4##(2012-3#2)
and therapeutic value##3##3##(2009-10#1)(2012-3#2)
and therapeutic##163##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-3#2)(1993-5#4)(1993-6#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-3#4)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#4)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#6)(2013-7#3)(2013-8#5)
and therapeutics to##2##3##(2008-11#2)
and therapeutics##9##2##(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2010-12#1)(2010-5#1)
and therapies##5##2##(2008-11#1)(2008-5#1)(2013-1#3)
and therapists##3##2##(1995-12#1)(2012-12#1)(2013-1#1)
and therapy are discussed##2##4##(1991-8#1)(1993-6#1)
and therapy are##3##3##(1990-5#1)(1991-8#1)(1993-6#1)
and therapy based##2##3##(2010-3#1)(2010-9#1)
and therapy failures (p = 0##2##6##(2011-2#2)
and therapy for##4##3##(2006-10#1)(2013-1#2)(2013-8#1)
and therapy in##2##3##(1996-11#1)(2011-2#1)
and therapy of these##2##4##(2007-5#1)(2008-7#1)
and therapy of this rare##2##5##(1991-5#1)(2012-3#1)
and therapy of this##3##4##(1990-2#1)(1991-5#1)(2012-3#1)
and therapy of##31##3##(1990-2#1)(1990-5#1)(1990-6#2)(1991-5#1)(1991-9#1)(1992-5#2)(1994-11#1)(1995-5#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
and therapy##85##2##(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-5#2)(1993-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#3)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
and therapy-related##2##2##(1997-8#1)(2008-6#1)
and therapy]##5##2##(1990-3#1)(1990-6#1)(1993-3#1)(1995-5#1)(2008-1#1)
and there are a##2##4##(1995-4#1)(2008-5#1)
and there are indications that##2##5##(1993-3#1)(2006-6#1)
and there are many##2##4##(2008-10#1)(2013-1#1)
and there are no##4##4##(2008-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
and there are significant##2##4##(2007-12#1)(2010-8#1)
and there are##26##3##(1993-3#1)(1993-6#1)(1994-3#1)(1995-4#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
and there has been no##4##5##(1994-12#1)(2008-10#1)(2008-7#2)
and there has been##5##4##(1994-12#1)(2008-10#1)(2008-7#2)(2009-10#1)
and there have been##2##4##(2008-8#1)(2012-1#1)
and there is a need for##2##6##(2011-1#1)(2013-1#1)
and there is a need to##2##6##(2007-7#1)(2008-11#1)
and there is a need##4##5##(2007-7#1)(2008-11#1)(2011-1#1)(2013-1#1)
and there is a requirement##2##5##(2008-11#1)(2009-4#1)
and there is a strong##2##5##(2008-3#1)(2011-2#1)
and there is a##16##4##(1993-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
and there is also some##2##5##(1990-2#1)(1991-6#1)
and there is an urgent##2##5##(2008-11#1)(2013-7#1)
and there is an##7##4##(1997-5#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
and there is great##2##4##(2008-11#1)(2009-7#1)
and there is increasing evidence##2##5##(1992-9#1)(2007-12#1)
and there is increasing##3##4##(1992-9#1)(2007-12#1)(2012-2#1)
and there is little##4##4##(1992-6#1)(1997-2#1)(2011-2#1)(2013-8#1)
and there is no clear evidence##2##6##(1996-3#1)(2013-1#1)
and there is no consensus##2##5##(2008-7#1)(2012-2#1)
and there is no##20##4##(1990-11#1)(1991-12#1)(1996-3#1)(2007-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#2)
and there is##69##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#4)
and there may be a##2##5##(1995-1#1)(2008-1#1)
and there may be##4##4##(1995-1#1)(2007-12#1)(2008-1#1)(2010-11#1)
and there was a##11##4##(1992-11#1)(1996-1#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-3#1)(2013-8#1)
and there was little##4##4##(2008-10#3)(2008-8#1)
and there was no evidence of##3##6##(2008-10#2)(2008-7#1)
and there was no recurrence##2##5##(2012-2#1)(2013-1#1)
and there was no significant association with##2##7##(1995-8#2)
and there was no significant difference between##2##7##(2008-8#1)(2008-9#1)
and there was no significant difference##4##6##(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
and there was no significant##8##5##(1995-8#2)(2006-6#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
and there was no##34##4##(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-6#1)(2012-2#1)(2013-1#3)(2013-8#1)
and there was##61##3##(1990-12#1)(1992-11#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-2#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
and there were 3##2##4##(1990-3#1)(2011-2#1)
and there were four##2##4##(2006-12#1)(2008-10#1)
and there were no serious complications##2##6##(2008-5#1)(2012-2#1)
and there were no significant differences in##3##7##(1991-2#1)(1993-1#1)(2008-10#1)
and there were no significant differences##4##6##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)
and there were no significant##7##5##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
and there were no signs of##2##6##(1993-1#1)(1993-6#1)
and there were no##22##4##(1991-2#1)(1991-6#1)(1993-1#2)(1993-6#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)
and there were significant##2##4##(2007-5#1)(2008-10#1)
and there were##33##3##(1990-3#1)(1990-6#1)(1991-2#1)(1991-6#1)(1993-1#2)(1993-6#2)(1995-2#1)(1995-3#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#4)(2012-2#1)
and there##206##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#28)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#9)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#7)
and thereafter the##3##3##(1996-12#1)(2008-3#2)
and thereafter##17##2##(1991-2#1)(1991-8#1)(1993-2#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-6#1)(2012-2#1)
and thereby enable##2##3##(1994-3#1)(2008-3#1)
and thereby functional##2##3##(2009-10#1)(2012-2#1)
and thereby influence##2##3##(1992-11#1)(2008-5#1)
and thereby reduce##2##3##(2013-1#1)(2013-8#1)
and thereby the##5##3##(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
and thereby to##3##3##(1995-2#1)(2009-10#1)(2012-2#1)
and thereby##72##2##(1990-7#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-5#1)(1995-8#3)(1996-4#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
and therefore a##7##3##(1997-2#1)(2008-10#2)(2008-2#2)(2009-2#1)(2011-2#1)
and therefore an##2##3##(1990-10#1)(2008-8#1)
and therefore can be##4##4##(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
and therefore can##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
and therefore cannot be##3##4##(2007-11#1)(2008-3#1)(2012-2#1)
and therefore could be##4##4##(1991-3#1)(2009-5#1)(2010-8#1)(2013-8#1)
and therefore could##7##3##(1991-3#1)(1994-5#1)(1995-12#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-8#1)
and therefore has##3##3##(2008-3#2)(2008-7#1)
and therefore it is##2##4##(2008-7#1)(2012-7#1)
and therefore it##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-7#1)
and therefore its##3##3##(2009-8#2)(2012-6#1)
and therefore little is known##2##5##(1993-1#1)(2013-8#1)
and therefore may##3##3##(1991-6#1)(1994-9#1)(2008-5#1)
and therefore more##2##3##(1995-11#1)(2008-10#1)
and therefore must be##2##4##(1991-3#1)(1992-3#1)
and therefore only##3##3##(2008-11#1)(2012-12#2)
and therefore represent##2##3##(2008-10#2)
and therefore represents##2##3##(1995-6#1)(2008-11#1)
and therefore selective##2##3##(2008-9#1)(2013-1#1)
and therefore should##2##3##(2007-11#1)(2009-4#1)
and therefore the##17##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-3#1)(1992-6#1)(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#2)(2010-3#1)(2013-8#1)
and therefore their##2##3##(2008-10#1)(2008-4#1)
and therefore these##3##3##(2008-10#1)(2008-7#1)(2010-6#1)
and therefore they##3##3##(2008-3#1)(2011-2#2)
and therefore to##2##3##(2008-3#1)(2008-7#1)
and therefore was##2##3##(2008-1#1)(2011-2#1)
and therefore would##2##3##(1993-9#1)(2013-1#1)
and therefore##202##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-8#4)(1991-12#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-5#1)(2006-10#1)(2007-11#6)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#5)(2008-2#9)(2008-3#13)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#3)(2012-6#1)(2012-7#2)(2013-1#5)(2013-8#5)
and thermal analysis of##2##4##(2008-10#2)
and thermal analysis##5##3##(2007-11#1)(2008-10#4)
and thermal data implied that##2##5##(2008-5#2)
and thermal desorption##6##3##(2008-10#5)(2010-5#1)
and thermal lensing in##2##4##(2007-12#1)(2008-3#1)
and thermal lensing of##2##4##(2008-3#2)
and thermal lensing##4##3##(2007-12#1)(2008-3#3)
and thermal stabilities##2##3##(2008-10#1)(2011-1#1)
and thermal stability of the##2##5##(2008-10#1)(2011-2#1)
and thermal stability of##6##4##(1995-8#1)(2008-10#3)(2009-9#1)(2011-2#1)
and thermal stability##10##3##(1995-8#2)(2008-10#4)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
and thermal##65##2##(1991-2#1)(1993-8#1)(1995-8#2)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#4)(2008-10#19)(2008-2#2)(2008-3#15)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and thermally##2##2##(2008-3#1)(2009-11#1)
and thermodynamic characteristics of##2##4##(2008-10#2)
and thermodynamic parameters for##2##4##(2008-10#2)
and thermodynamic parameters of##2##4##(1992-3#1)(2008-10#1)
and thermodynamic parameters##5##3##(1992-3#1)(2008-10#4)
and thermodynamic studies of the##2##5##(1990-9#1)(2008-10#1)
and thermodynamic##18##2##(1990-9#1)(1991-5#2)(1991-6#1)(1992-3#2)(1997-2#1)(2008-10#11)
and thermodynamically favored##2##3##(1993-11#1)(2009-10#1)
and thermodynamics##6##2##(1993-3#1)(1995-11#2)(2008-10#1)(2008-8#2)
and thermogenesis##4##2##(1995-8#1)(2012-12#2)(2012-3#1)
and thermogravimetric analysis##3##3##(1995-11#1)(2008-10#2)
and thermogravimetric##4##2##(1995-11#1)(2008-10#3)
and thermometry##2##2##(1992-8#1)(2008-3#1)
and these are##7##3##(1991-3#1)(1996-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#2)
and these changes##4##3##(1990-3#1)(2008-3#1)(2009-9#1)(2013-8#1)
and these complications##2##3##(2010-12#1)(2013-1#1)
and these compounds##3##3##(2008-10#2)(2010-5#1)
and these differences##7##3##(1994-2#1)(1994-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
and these effects were##2##4##(2008-11#1)(2011-2#1)
and these effects##5##3##(1996-5#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
and these genes are##2##4##(1992-3#1)(2010-3#1)
and these have##2##3##(1993-6#1)(2008-7#1)
and these may##3##3##(2008-11#1)(2010-5#1)(2012-3#1)
and these strains##2##3##(2008-10#2)
and these two##2##3##(1991-9#1)(2008-6#1)
and these values were##4##4##(1990-12#1)(1992-12#1)(1995-5#1)(1996-12#1)
and these values##6##3##(1990-12#1)(1992-12#1)(1992-6#1)(1995-5#1)(1996-12#1)(2008-4#1)
and these were compared##2##4##(2008-9#1)(2012-2#1)
and these were found to be##2##6##(1995-12#1)(2008-10#1)
and these were##13##3##(1991-2#1)(1993-6#1)(1995-12#1)(2007-8#1)(2008-10#6)(2008-9#1)(2009-12#1)(2012-2#1)
and these will be##2##4##(2008-11#1)(2012-2#1)
and these will##3##3##(2008-11#1)(2012-2#2)
and these##141##2##(1990-12#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-6#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#4)
and theta##3##2##(1991-12#1)(2007-12#1)(2013-8#1)
and theta(0)##3##2##(2008-2#3)
and they all increased##2##4##(1995-11#1)(2013-8#1)
and they also##5##3##(1992-11#1)(1996-8#1)(2008-12#1)(2008-5#1)(2008-7#1)
and they are in good agreement with the theoretical##2##9##(2008-3#2)
and they are in good agreement##3##6##(2008-11#1)(2008-3#2)
and they are most##2##4##(2008-8#1)(2009-8#1)
and they are##32##3##(1991-5#1)(1992-11#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#1)
and they can be##6##4##(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
and they can##8##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-8#1)
and they did##2##3##(1993-6#1)(2008-11#1)
and they exhibit a##2##4##(2008-3#1)(2008-6#1)
and they exhibit##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
and they form##2##3##(2007-8#1)(2012-12#1)
and they had##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
and they have a##3##4##(2008-2#1)(2012-12#1)(2013-1#1)
and they have also##2##4##(2008-1#1)(2008-10#1)
and they have been##2##4##(1997-2#1)(2012-2#1)
and they have##13##3##(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
and they may be##3##4##(2007-11#1)(2008-9#1)(2012-2#1)
and they may##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
and they occur##2##3##(1990-9#1)(1994-12#1)
and they suggest##2##3##(2008-4#1)(2011-2#1)
and they underwent##2##3##(1995-4#1)(2007-8#1)
and they usually##2##3##(2008-10#1)(2012-2#1)
and they were also##2##4##(1995-6#1)(2008-10#1)
and they were##28##3##(1991-1#1)(1993-12#3)(1993-8#1)(1995-6#1)(1997-3#1)(2007-7#2)(2008-10#11)(2010-7#2)(2011-2#1)(2013-1#2)(2013-8#3)
and they will##2##3##(1993-3#1)(1994-12#1)
and they##186##2##(1990-2#1)(1990-9#1)(1991-1#4)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#30)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#8)
and thiabendazole##4##2##(2008-10#4)
and thiamine##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
and thick##5##2##(2007-12#2)(2008-10#1)(2009-5#1)(2011-2#1)
and thickening of the##3##4##(1997-5#1)(2008-5#1)(2011-1#1)
and thickening of##4##3##(1997-5#1)(2008-5#1)(2008-9#1)(2011-1#1)
and thicker##2##2##(2011-2#2)
and thickness of the##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#1)
and thickness of##12##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2010-8#1)(2013-8#2)
and thickness were##2##3##(2008-3#1)(2008-5#1)
and thickness##25##2##(2007-11#3)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2009-6#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-8#2)
and thimerosal##3##2##(1997-2#1)(2008-10#2)
and thin films##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
and thin layer chromatography##2##4##(2008-11#1)(2010-5#1)
and thin layer##3##3##(2008-11#1)(2010-5#1)(2013-1#1)
and thin##20##2##(1990-4#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#3)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
and thin-film##3##2##(2008-3#3)
and thinning of##2##3##(2012-2#1)(2013-1#1)
and thiocyanate have##2##3##(2008-10#2)
and thiocyanate ions##2##3##(2008-10#2)
and thiocyanate##5##2##(2008-10#5)
and thioglycolic acid##4##3##(1992-8#1)(2008-10#2)(2012-3#1)
and thiol groups##3##3##(1991-9#1)(2008-10#2)
and thiol##5##2##(1991-9#1)(2008-10#3)(2008-5#1)
and thiols##2##2##(1992-11#1)(2008-8#1)
and thioridazine##2##2##(2008-3#1)(2008-7#1)
and thiosulphate##2##2##(2008-10#2)
and thiourea##3##2##(2008-10#3)
and third line hormonotherapy in advanced post-menopausal breast cancer##2##9##(1993-1#2)
and third line##4##3##(1992-6#1)(1993-1#3)
and third trimester##4##3##(1992-10#1)(1995-8#1)(2013-1#2)
and third##46##2##(1990-3#1)(1990-7#1)(1992-10#1)(1992-6#1)(1993-1#3)(1993-12#2)(1995-2#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-1#5)
and third-harmonic generation##2##3##(2007-12#2)
and third-order dispersion##2##3##(2007-11#2)
and third-order##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
and third-party##3##2##(1991-3#1)(1995-1#1)(2008-7#1)
and thirdly##5##2##(1995-5#1)(2008-11#1)(2008-5#1)(2009-2#1)(2012-12#1)
and thirteen##6##2##(2007-2#2)(2008-5#2)(2008-8#1)(2013-8#1)
and this action##2##3##(1990-8#1)(2012-3#1)
and this also##2##3##(2008-2#1)(2010-3#1)
and this article##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
and this association is##2##4##(1991-5#1)(2009-10#1)
and this binding is##2##4##(1994-12#1)(1995-2#1)
and this binding##3##3##(1994-12#1)(1995-2#1)(1995-6#1)
and this can be##3##4##(1994-12#1)(1996-4#1)(2010-10#1)
and this can##5##3##(1991-11#1)(1994-12#1)(1996-4#1)(2008-3#1)(2010-10#1)
and this case##2##3##(2011-1#1)(2012-12#1)
and this change##2##3##(1993-11#1)(2011-3#1)
and this contributes to##3##4##(1994-11#1)(1996-2#1)(2007-7#1)
and this could##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
and this decline was##2##4##(2008-11#1)(2008-7#1)
and this decline##3##3##(1990-5#1)(2008-11#1)(2008-7#1)
and this directly##2##3##(2007-12#1)(2008-10#1)
and this effect is##3##4##(1990-11#1)(2008-8#1)(2009-5#1)
and this effect was##6##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-9#2)
and this effect##16##3##(1990-11#1)(1990-5#1)(1991-12#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-5#1)
and this event is##2##4##(1994-9#1)(2007-12#1)
and this factor##2##3##(1993-6#1)(2007-12#1)
and this gene was designated as##2##6##(2008-8#2)
and this gene was##3##4##(2008-10#1)(2008-8#2)
and this has##5##3##(2008-6#2)(2008-7#1)(2011-2#2)
and this in turn##2##4##(2008-12#2)
and this increase##4##3##(1990-11#1)(1992-12#1)(1994-11#1)(2006-10#1)
and this inhibition##2##3##(1991-5#1)(1993-8#1)
and this interaction##2##3##(1995-2#1)(2008-9#1)
and this is associated##2##4##(1997-1#1)(2012-12#1)
and this is one##2##4##(1997-6#1)(2013-8#1)
and this is##25##3##(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-10#1)(2011-3#1)(2012-12#1)(2013-8#1)
and this leads to##2##4##(2008-3#1)(2011-2#1)
and this may be##7##4##(1993-8#1)(1995-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
and this may have##2##4##(1990-6#1)(1997-5#1)
and this may result in a##2##6##(1996-4#1)(2008-10#1)
and this may##13##3##(1990-6#1)(1993-8#1)(1995-3#1)(1996-4#1)(1997-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2013-1#1)
and this mechanism may##2##4##(1992-12#1)(1992-9#1)
and this method##4##3##(1991-2#1)(2008-1#1)(2008-10#2)
and this number##2##3##(1990-12#1)(2012-2#1)
and this paper##4##3##(1991-12#1)(1991-5#1)(1996-12#1)(2012-3#1)
and this phenotype##2##3##(2007-2#1)(2012-3#1)
and this requires a##2##4##(2007-7#1)(2008-8#1)
and this resistance##2##3##(2008-10#2)
and this response##2##3##(1992-12#1)(2008-8#1)
and this result##2##3##(1993-6#1)(2008-10#1)
and this results in a##2##5##(1992-5#1)(2008-10#1)
and this review will##3##4##(2008-10#2)(2013-8#1)
and this review##5##3##(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
and this sequence##2##3##(1996-12#1)(2009-10#1)
and this system##2##3##(2008-10#2)
and this technique may##2##4##(2008-11#1)(2010-10#1)
and this type of##2##4##(2008-12#1)(2008-8#1)
and this unit is##2##4##(2008-9#2)
and this unit##4##3##(1990-11#1)(2008-4#1)(2008-9#2)
and this value was##2##4##(1990-7#1)(1997-8#1)
and this was accompanied by##2##5##(1992-9#1)(2009-6#1)
and this was associated with##2##5##(1993-12#1)(1994-8#1)
and this was followed##2##4##(1993-1#1)(2008-8#1)
and this was successfully##2##4##(2008-9#1)(2010-6#1)
and this was##26##3##(1990-5#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-8#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)
and this will be##2##4##(1997-2#1)(2008-6#1)
and this will##4##3##(1995-2#1)(1997-2#1)(2008-6#1)(2008-7#1)
and this##312##2##(1990-11#4)(1990-12#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#4)(1995-2#7)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(1997-9#1)(2006-10#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#48)(2008-11#10)(2008-12#7)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#7)(2008-7#10)(2008-8#10)(2008-9#12)(2009-10#3)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#4)(2011-1#6)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#6)
and thoracic CT##2##3##(1997-8#1)(2007-10#1)
and thoracic aorta##4##3##(1990-2#1)(2007-8#3)
and thoracic spine##3##3##(2008-12#3)
and thoracic surgical##3##3##(1993-12#2)(2010-8#1)
and thoracic##25##2##(1990-2#1)(1993-12#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-8#4)(2008-10#1)(2008-12#5)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
and thorium##2##2##(2008-10#2)
and thorough##7##2##(1991-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2012-3#1)(2013-8#1)
and thoroughly##3##2##(2011-1#1)(2013-1#2)
and those aged##2##3##(1994-5#1)(2013-1#1)
and those at the##2##4##(2008-1#1)(2010-3#1)
and those at##4##3##(1994-3#1)(2008-1#2)(2010-3#1)
and those calculated##2##3##(1990-5#1)(2008-2#1)
and those effects were##2##4##(2011-2#2)
and those for ribulose 1##2##5##(1997-6#2)
and those for##8##3##(1991-11#1)(1997-6#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
and those from the##2##4##(1995-12#1)(2009-11#1)
and those from##13##3##(1993-9#1)(1995-12#1)(1995-5#1)(2008-10#4)(2008-6#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
and those in##4##3##(1996-1#1)(1997-2#1)(2008-10#1)(2008-8#1)
and those involved in##2##4##(2008-7#1)(2010-11#1)
and those not##5##3##(1992-12#1)(1994-2#1)(1997-3#1)(2009-12#1)(2011-1#1)
and those obtained by##3##4##(2008-10#2)(2008-3#1)
and those obtained using a##2##5##(2008-10#2)
and those obtained using##3##4##(2008-10#3)
and those obtained##10##3##(2008-10#7)(2008-3#1)(2008-5#1)(2011-2#1)
and those of a##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
and those of other##3##4##(2008-5#1)(2009-8#1)(2010-8#1)
and those of the##9##4##(1993-8#1)(1994-3#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-2#1)
and those of##39##3##(1990-12#1)(1990-7#1)(1990-9#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-3#1)(1995-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
and those on the##2##4##(2008-9#1)(2011-2#1)
and those on##6##3##(1993-12#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
and those originating##2##3##(2008-10#1)(2008-6#1)
and those reported##3##3##(1995-12#1)(2007-11#1)(2008-10#1)
and those that are##2##4##(2007-2#1)(2012-2#1)
and those that do not##2##5##(1994-2#1)(1997-3#1)
and those that##17##3##(1991-5#1)(1993-11#1)(1993-3#1)(1994-2#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-9#2)(2009-3#1)(2012-2#1)
and those treated with##2##4##(1995-12#1)(2008-3#1)
and those treated##3##3##(1995-12#1)(1997-4#1)(2008-3#1)
and those which##2##3##(2010-2#1)(2013-8#1)
and those who are##4##4##(1991-2#1)(2010-10#1)(2011-2#2)
and those who did not##4##5##(1990-11#1)(2007-7#1)(2008-7#1)(2013-1#1)
and those who do not##2##5##(2007-10#1)(2011-2#1)
and those who had##3##4##(2007-12#1)(2008-9#1)(2010-12#1)
and those who never##2##4##(2009-5#2)
and those who were##3##4##(1992-2#1)(2008-1#1)(2008-6#1)
and those who##33##3##(1990-11#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-12#1)(1995-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and those with a##3##4##(2008-7#1)(2008-9#1)(2013-1#1)
and those with higher##2##4##(1991-1#1)(2012-3#1)
and those with the##2##4##(2008-10#1)(2012-2#1)
and those with##37##3##(1991-1#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-8#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and those##269##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#41)(2008-11#2)(2008-12#7)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#14)(2008-8#3)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2012-9#1)(2013-1#11)(2013-7#1)(2013-8#3)
and thought to be##2##4##(2011-2#1)(2013-1#1)
and thought to##3##3##(2010-8#1)(2011-2#1)(2013-1#1)
and thought##7##2##(2007-12#1)(2007-5#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and thoughtful##2##2##(1992-2#1)(2011-2#1)
and threaten human##2##3##(2008-10#1)(2008-8#1)
and threaten##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
and threats to##2##3##(1991-3#1)(1997-3#1)
and three DNA repair-deficient##2##4##(2008-7#2)
and three cases of##2##4##(2008-8#1)(2011-2#1)
and three different##9##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
and three dimensional##2##3##(2008-10#1)(2008-2#1)
and three distinct##3##3##(2008-10#1)(2008-9#1)(2010-10#1)
and three from##2##3##(1997-4#1)(2008-5#1)
and three groups of##2##4##(2008-8#1)(2008-9#1)
and three had##2##3##(1992-3#1)(2007-8#1)
and three in##2##3##(2008-10#2)
and three irrigation##2##3##(2008-10#1)(2008-12#1)
and three isolates##2##3##(2008-10#2)
and three months after##3##4##(1991-11#1)(1992-9#1)(1996-3#1)
and three months##5##3##(1991-11#2)(1992-9#1)(1996-3#1)(2013-1#1)
and three of the##4##4##(1992-11#1)(1992-2#1)(1997-9#1)(2008-10#1)
and three of##8##3##(1991-12#1)(1992-11#1)(1992-2#1)(1997-9#2)(2008-10#2)(2008-11#1)
and three on##2##3##(2011-2#2)
and three or more##2##4##(2007-7#1)(2008-5#1)
and three patients##2##3##(2007-8#1)(2008-6#1)
and three sets##2##3##(2008-10#2)
and three species of##2##4##(2008-10#1)(2010-8#1)
and three sub-subplots (deficit##2##4##(2008-10#2)
and three themes##2##3##(2010-11#1)(2012-3#1)
and three times higher##2##4##(1993-3#1)(1995-12#1)
and three types of##2##4##(2008-2#1)(2008-7#1)
and three were##7##3##(1993-6#1)(1995-4#1)(1997-8#1)(2008-10#2)(2008-5#1)(2013-8#1)
and three with##4##3##(1992-6#1)(2007-6#1)(2008-7#1)(2012-2#1)
and three women##2##3##(2011-2#2)
and three years##2##3##(2008-1#1)(2010-12#1)
and three##233##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#4)(2008-10#60)(2008-11#4)(2008-12#5)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#14)(2011-3#1)(2012-2#5)(2012-3#6)(2013-1#8)(2013-8#3)
and three-dimensional NMR##2##3##(1995-2#1)(1995-3#1)
and three-dimensional reconstruction##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
and three-dimensional spatial##2##3##(2007-12#1)(2008-3#1)
and three-dimensional##22##2##(1992-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-1#1)
and three-photon confocal fluorescence microscopy##2##5##(2008-3#2)
and three-way##2##2##(2008-10#2)
and threonine##7##2##(1993-3#1)(1994-9#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-5#1)
and threshold##10##2##(1997-2#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#1)(2012-2#1)
and thresholding##2##2##(2008-2#1)(2010-4#1)
and thresholds##4##2##(1992-11#1)(1993-12#1)(2008-10#1)(2008-9#1)
and thrive##3##2##(1994-12#1)(1997-1#1)(2012-2#1)
and throat##6##2##(1993-2#4)(2013-8#2)
and thrombectomy##3##2##(1996-6#1)(2011-2#2)
and thrombin##7##2##(1992-12#2)(1992-4#1)(1994-11#2)(2008-7#1)(2008-9#1)
and thrombin-stimulated##2##2##(1992-8#1)(2008-8#1)
and thrombocytes##2##2##(1990-2#1)(2008-7#1)
and thrombocytopenia##4##2##(1991-4#1)(2007-2#1)(2007-8#1)(2008-8#1)
and thromboses##2##2##(1991-3#1)(1997-5#1)
and thrombosis in##2##3##(2008-1#2)
and thrombosis##12##2##(1991-12#1)(1991-3#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)
and thromboxane##2##2##(2008-10#1)(2008-5#1)
and through a##3##3##(1994-11#1)(1996-3#1)(2013-8#1)
and through artificial##2##3##(1994-3#1)(2008-10#1)
and through breast milk##2##4##(2011-1#1)(2013-1#1)
and through the##2##3##(2008-12#1)(2008-9#1)
and through to##2##3##(1995-3#1)(2010-12#1)
and through##36##2##(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-3#1)(2006-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
and throughout the##6##3##(1992-11#1)(1995-3#1)(2006-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
and throughout##9##2##(1992-11#1)(1995-3#1)(2006-10#1)(2008-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and throughput##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
and thrust##2##2##(1992-6#1)(2009-9#1)
and thumb##4##2##(1996-2#1)(2008-12#1)(2008-9#2)
and thus a##9##3##(1990-12#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-2#1)(2010-8#1)
and thus also##4##3##(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
and thus are##4##3##(1990-12#1)(2008-4#1)(2009-5#1)(2010-4#1)
and thus be used##2##4##(2008-10#2)
and thus both##2##3##(1992-7#1)(2008-11#1)
and thus can be used to##2##6##(2008-2#1)(2012-3#1)
and thus can be used##3##5##(2008-11#1)(2008-2#1)(2012-3#1)
and thus can be##4##4##(2008-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
and thus can##6##3##(1993-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
and thus constitutes##2##3##(2009-6#1)(2012-2#1)
and thus contribute to##2##4##(2008-10#1)(2013-1#1)
and thus could be used##2##5##(2008-10#1)(2008-5#1)
and thus could be##5##4##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
and thus could##6##3##(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
and thus facilitate##2##3##(1996-6#1)(2009-4#1)
and thus have the potential to##2##6##(2008-7#1)(2008-8#1)
and thus have##4##3##(2007-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
and thus improve##4##3##(1997-3#1)(1997-5#1)(2007-12#1)(2008-3#1)
and thus increase##2##3##(1996-1#1)(2008-4#1)
and thus is##7##3##(1992-4#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
and thus it has##2##4##(2008-12#1)(2008-8#1)
and thus it was##2##4##(2008-10#1)(2009-6#1)
and thus it##8##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-1#1)
and thus its##3##3##(1997-7#1)(2008-10#1)(2013-8#1)
and thus likely##2##3##(2008-8#1)(2009-9#1)
and thus may be##2##4##(2008-10#1)(2012-3#1)
and thus may##10##3##(1995-11#2)(1995-3#1)(1995-9#1)(1996-10#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
and thus must be##2##4##(2008-4#1)(2010-4#1)
and thus must##3##3##(2008-4#1)(2010-4#1)(2012-2#1)
and thus not##2##3##(1997-7#1)(2008-5#1)
and thus of the##2##4##(2008-3#1)(2011-2#1)
and thus offer##2##3##(2007-12#1)(2008-8#1)
and thus permit##2##3##(1996-12#1)(2008-3#1)
and thus provide a##2##4##(2008-5#1)(2009-3#1)
and thus provide##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)
and thus provides a##2##4##(1995-6#1)(1996-8#1)
and thus provides##3##3##(1995-6#1)(1996-8#1)(2012-2#1)
and thus reduce##2##3##(2008-5#1)(2013-1#1)
and thus should##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
and thus support the##2##4##(1992-11#1)(1992-9#1)
and thus the##25##3##(1991-3#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-8#2)(2010-6#1)(2013-1#2)(2013-8#1)
and thus to##7##3##(1996-12#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-12#1)(2012-2#1)
and thus was##2##3##(1995-2#1)(2008-10#1)
and thus we##2##3##(2009-2#1)(2009-9#1)
and thus were not##2##4##(1992-2#1)(2008-10#1)
and thus were##5##3##(1992-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
and thus##290##2##(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1994-10#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#10)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#30)(2008-11#11)(2008-12#5)(2008-2#8)(2008-3#18)(2008-4#9)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#15)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#3)(2009-8#4)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#11)(2013-8#6)
and thylakoid##3##2##(1994-11#1)(2008-10#1)(2009-10#1)
and thymic lymphosarcoma##2##3##(1992-8#2)
and thymic##5##2##(1991-12#1)(1992-8#2)(2008-7#1)(2013-1#1)
and thymidine##5##2##(1992-8#1)(1993-3#1)(2008-10#1)(2008-4#1)(2011-1#1)
and thymine##2##2##(2008-10#1)(2008-11#1)
and thymus##6##2##(1990-11#1)(2007-5#1)(2008-10#2)(2008-5#2)
and thyroid autoantibodies##2##3##(1991-8#1)(2008-7#1)
and thyroid cancer##2##3##(2008-4#1)(2012-1#1)
and thyroid function##2##3##(2008-7#2)
and thyroid hormone##6##3##(1991-5#1)(1993-3#2)(2008-7#3)
and thyroid##21##2##(1991-5#1)(1991-8#1)(1993-3#2)(1993-9#3)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#7)(2011-2#1)(2012-1#2)(2013-1#1)
and thyroxine (T(4))##2##3##(2009-12#1)(2010-8#1)
and tibia##4##2##(1992-3#1)(2008-8#1)(2012-1#1)(2013-1#1)
and tibial##5##2##(2007-11#1)(2009-10#1)(2009-3#1)(2009-4#1)(2013-1#1)
and tibialis anterior muscles##2##4##(2012-3#1)(2013-8#1)
and tibialis##3##2##(1995-2#1)(2012-3#1)(2013-8#1)
and tick-borne##2##2##(2013-8#2)
and tickborne disease##2##3##(1997-7#2)
and ticks##2##2##(1997-4#1)(2010-1#1)
and tics##2##2##(2008-4#1)(2008-7#1)
and tidal##4##2##(1991-12#1)(1996-5#1)(2007-5#1)(2013-1#1)
and tie##4##2##(2011-2#4)
and tightly##2##2##(2008-5#1)(2011-2#1)
and tilapia##2##2##(1994-11#2)
and tillage on##2##3##(2008-10#2)
and tillage##3##2##(2008-10#3)
and tilt##5##2##(2008-1#1)(2008-2#1)(2008-3#3)
and tilt-shift errors##2##3##(2008-3#2)
and tilt-shift##3##2##(2008-3#3)
and tilted##3##2##(2007-12#1)(2008-2#1)(2011-7#1)
and time and##3##3##(2008-10#2)(2008-5#1)
and time at##2##3##(2007-12#1)(2008-8#1)
and time constraints##2##3##(1991-12#1)(2008-12#1)
and time consuming##11##3##(1990-2#1)(1994-1#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
and time course of##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
and time course##4##3##(1991-5#1)(2008-10#1)(2008-7#1)(2008-9#1)
and time delay##2##3##(2008-11#1)(2010-10#1)
and time dependent##3##3##(1992-3#2)(2008-10#1)
and time from##2##3##(1995-12#1)(2012-3#1)
and time interval##2##3##(2008-7#1)(2013-1#1)
and time of exposure to##2##5##(1996-12#1)(2008-10#1)
and time of exposure##3##4##(1996-12#1)(2008-10#1)(2012-4#1)
and time of intervention##2##4##(1992-5#1)(2008-10#1)
and time of the year##2##5##(2008-3#1)(2008-5#1)
and time of the##3##4##(2007-11#1)(2008-3#1)(2008-5#1)
and time of##28##3##(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1996-12#1)(1996-7#1)(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#2)(2008-5#3)(2010-2#1)(2011-2#1)(2012-3#1)(2012-4#1)
and time on##4##3##(1994-9#1)(2008-3#1)(2011-1#1)(2013-1#1)
and time perception##2##3##(2009-7#1)(2011-2#1)
and time resolved##2##3##(2008-10#2)
and time resources##2##3##(2010-3#1)(2012-2#1)
and time series##2##3##(2008-10#1)(2008-7#1)
and time spent##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
and time the##2##3##(2008-5#1)(2013-1#1)
and time to progression##2##4##(1991-2#1)(2008-3#1)
and time to##13##3##(1991-2#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#2)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
and time were##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
and time##155##2##(1990-2#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#40)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#11)(2013-8#1)
and time-consuming to##2##3##(2010-8#1)(2011-1#1)
and time-consuming##13##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)
and time-dependent inhibitory##2##3##(2012-3#1)(2013-1#1)
and time-dependent manner##10##3##(1991-5#1)(1994-9#2)(1996-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
and time-dependent manners##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
and time-dependent##29##2##(1990-5#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1996-2#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
and time-of-flight##2##2##(2008-10#1)(2010-4#1)
and time-resolved fluorescence##4##3##(1990-2#1)(2008-10#1)(2008-8#1)(2009-2#1)
and time-resolved measurements##2##3##(2008-10#1)(2008-3#1)
and time-resolved##12##2##(1990-2#1)(1990-8#1)(2008-10#4)(2008-3#3)(2008-8#1)(2009-2#1)(2009-3#1)
and time-saving##4##2##(1990-11#1)(1994-8#1)(1996-7#1)(2008-10#1)
and time-stability##3##2##(2008-10#2)(2008-5#1)
and time-varying##4##2##(2008-2#1)(2008-3#3)
and timeliness of##2##3##(2009-3#1)(2011-2#1)
and timely information##2##3##(1996-1#1)(2008-11#1)
and timely##18##2##(1995-3#1)(1996-1#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-8#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
and times##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
and timing noise added in##2##5##(2007-11#2)
and timing noise##3##3##(2007-11#3)
and timing of the##2##4##(1993-12#1)(2008-11#1)
and timing of##21##3##(1991-8#1)(1993-12#2)(1993-3#1)(1995-5#1)(1996-3#1)(2008-10#3)(2008-11#4)(2010-12#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
and timing##30##2##(1991-8#1)(1993-12#2)(1993-3#1)(1995-5#1)(1996-3#1)(2007-11#6)(2008-10#4)(2008-11#4)(2010-12#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
and tin in##2##3##(2008-10#2)
and tin is##2##3##(2008-10#2)
and tin##10##2##(2008-10#10)
and tinea corporis##2##3##(2007-7#1)(2008-5#1)
and tinea##5##2##(2007-7#1)(2008-5#4)
and tinned fish consumption##2##4##(2008-1#2)
and tinned fish##3##3##(2008-1#3)
and tinnitus##2##2##(2008-7#2)
and tiopronin##2##2##(1994-5#2)
and tip##3##2##(1995-8#1)(2008-5#1)(2010-8#1)
and tips##3##2##(2008-10#1)(2008-4#1)(2010-3#1)
and tiredness##2##2##(1997-6#1)(2013-7#1)
and tissue architecture##2##3##(2008-5#1)(2010-9#1)
and tissue culture##5##3##(2008-11#2)(2008-9#1)(2011-3#1)(2012-3#1)
and tissue damage is##2##4##(2008-7#1)(2013-1#1)
and tissue damage##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#2)
and tissue development##2##3##(1990-4#1)(2011-2#1)
and tissue distribution of##3##4##(1991-2#1)(1993-11#1)(1995-3#1)
and tissue distribution##6##3##(1991-2#1)(1993-11#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-4#1)
and tissue engineering##11##3##(2007-12#1)(2008-11#2)(2008-5#3)(2009-12#1)(2009-5#1)(2012-12#2)(2012-2#1)
and tissue inhibitor of metalloproteinase-1##2##5##(2008-5#1)(2008-9#1)
and tissue inhibitor of metalloproteinases-2##2##5##(1992-2#1)(2013-1#1)
and tissue inhibitor of##5##4##(1992-2#1)(2008-5#2)(2008-9#1)(2013-1#1)
and tissue inhibitors of##2##4##(1992-9#1)(2013-1#1)
and tissue levels##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
and tissue preservation##2##3##(1996-3#1)(2012-2#1)
and tissue repair##3##3##(2008-4#1)(2008-7#1)(2009-12#1)
and tissue samples##2##3##(2009-3#1)(2011-2#1)
and tissue selenium##2##3##(1993-12#2)
and tissue specificity##2##3##(2008-5#1)(2008-9#1)
and tissue##108##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#1)(1995-3#3)(1995-6#1)(1996-12#3)(1996-3#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#7)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#8)(2008-9#5)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#3)
and tissue-specific expression of##4##4##(1990-11#2)(2008-7#1)(2008-9#1)
and tissue-specific##11##2##(1990-11#2)(1993-12#1)(1995-6#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
and tissues are##2##3##(2008-4#1)(2013-1#1)
and tissues by##2##3##(2008-10#2)
and tissues of the##2##4##(1996-2#1)(2008-12#1)
and tissues of##5##3##(1991-8#1)(1993-5#1)(1994-2#1)(1996-2#1)(2008-12#1)
and tissues##52##2##(1990-8#2)(1991-3#2)(1991-8#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
and titanium metal##2##3##(2008-5#2)
and titanium trichloride##2##3##(2008-10#2)
and titanium##13##2##(1994-3#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#2)(2011-2#1)
and titanium(IV)##4##2##(2008-10#4)
and titrated to##2##3##(2010-4#1)(2012-3#1)
and titrated##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
and titration of##5##3##(2008-4#2)(2008-9#1)(2009-8#1)(2013-1#1)
and titration##6##2##(1994-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2013-1#1)
and titrimetry##2##2##(2008-10#2)
and to a lesser degree##3##5##(1991-12#1)(2008-10#1)(2008-6#1)
and to a lesser extent in the##2##7##(1997-2#1)(1997-9#1)
and to a lesser extent on##2##6##(2008-10#2)
and to a lesser extent##28##5##(1990-12#2)(1991-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)
and to a lesser##31##4##(1990-12#2)(1991-12#2)(1992-6#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-12#1)
and to a significant##2##4##(1994-1#1)(2008-4#1)
and to a##59##3##(1990-11#1)(1990-12#2)(1991-12#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and to achieve##5##3##(1991-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
and to address the##2##4##(1994-2#1)(2008-3#1)
and to address##5##3##(1994-2#1)(2008-1#1)(2008-3#2)(2009-5#1)
and to adjust##3##3##(2008-10#1)(2012-3#1)(2013-7#1)
and to affect##2##3##(1995-12#1)(2008-10#1)
and to all##3##3##(1993-2#1)(1997-8#1)(2010-3#1)
and to allow##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
and to an##6##3##(1990-12#1)(1993-6#1)(1997-5#1)(2008-11#1)(2009-10#2)
and to analyse the##2##4##(2009-5#1)(2012-5#1)
and to analyse##3##3##(2009-5#1)(2011-2#1)(2012-5#1)
and to analyze the##4##4##(1996-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
and to analyze##6##3##(1996-9#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
and to ascertain if##2##4##(2007-11#1)(2011-2#1)
and to ascertain##5##3##(1996-9#1)(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
and to assess risk##2##4##(1996-12#1)(2008-12#1)
and to assess the impact of##2##6##(1995-3#1)(2008-4#1)
and to assess the impact##3##5##(1995-3#1)(2008-4#1)(2012-2#1)
and to assess the##13##4##(1990-3#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
and to assess whether##3##4##(2008-1#1)(2008-10#1)(2009-3#1)
and to assess##24##3##(1990-3#1)(1995-3#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
and to assist##2##3##(1991-12#1)(2013-1#1)
and to avoid the##2##4##(2008-8#1)(2011-2#1)
and to avoid##5##3##(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)
and to be able##2##4##(1990-3#1)(2008-11#1)
and to be##20##3##(1990-2#1)(1990-3#1)(1991-9#1)(1992-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1996-1#1)(2007-10#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)
and to better##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
and to bring##3##3##(1991-5#1)(1994-9#1)(2008-10#1)
and to calculate the##2##4##(2008-10#1)(2011-2#1)
and to carry out##4##4##(1992-3#1)(2008-10#2)(2013-8#1)
and to carry##5##3##(1992-3#1)(2008-10#2)(2008-4#1)(2013-8#1)
and to cause##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
and to challenge##4##3##(2007-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
and to changes in##2##4##(2009-7#1)(2013-1#1)
and to characterize the##3##4##(2008-3#2)(2011-1#1)
and to characterize their##2##4##(2008-7#1)(2009-7#1)
and to characterize##6##3##(1997-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-1#1)
and to choose##2##3##(1993-5#1)(2012-1#1)
and to clarify the##3##4##(1994-2#1)(2008-3#1)(2009-9#1)
and to clarify##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
and to classify##2##3##(1991-12#1)(2008-10#1)
and to compare the presence of##2##6##(2013-1#1)(2013-8#1)
and to compare the results with those##2##7##(2007-10#1)(2009-3#1)
and to compare the use of##2##6##(2008-7#1)(2012-3#1)
and to compare the##15##4##(1992-11#1)(1994-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and to compare them with##3##5##(2007-11#1)(2008-10#1)(2011-2#1)
and to compare these results with##2##6##(2008-9#1)(2011-1#1)
and to compare these##4##4##(1992-10#1)(2008-3#1)(2008-9#1)(2011-1#1)
and to compare##31##3##(1990-7#1)(1992-10#1)(1992-11#1)(1994-12#1)(1994-2#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
and to compensate for##2##4##(2007-11#2)
and to compensate##3##3##(2007-11#2)(2008-3#1)
and to confirm the##2##4##(2007-8#1)(2008-10#1)
and to confirm##4##3##(2007-8#1)(2008-10#2)(2008-9#1)
and to consider##3##3##(1994-5#1)(2010-8#1)(2011-1#1)
and to control##2##3##(2008-5#2)
and to correlate these##2##4##(2008-5#1)(2010-8#1)
and to correlate##5##3##(1991-8#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)
and to create##2##3##(2008-10#1)(2008-12#1)
and to date##3##3##(1990-12#1)(2007-12#1)(2009-2#1)
and to decide##2##3##(1991-3#1)(1997-7#1)
and to decrease the##3##4##(1990-6#1)(2008-11#1)(2011-2#1)
and to decrease##6##3##(1990-6#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-2#1)
and to define its role in##2##6##(1994-3#1)(2008-10#1)
and to define its##3##4##(1994-3#1)(2008-10#2)
and to define the##2##4##(1991-5#1)(2008-6#1)
and to define##12##3##(1991-5#1)(1992-9#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-6#2)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
and to demonstrate that##2##4##(1991-3#1)(2008-8#1)
and to demonstrate the feasibility of##2##6##(2008-3#1)(2008-9#1)
and to demonstrate##7##3##(1991-2#1)(1991-3#1)(1992-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
and to describe the##5##4##(2008-11#1)(2008-3#1)(2008-6#1)(2012-1#1)(2013-1#1)
and to describe##9##3##(1992-1#1)(1994-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
and to detail##2##3##(2008-4#1)(2011-2#1)
and to detect##7##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)
and to determine how##3##4##(2008-10#1)(2010-1#1)(2012-2#1)
and to determine if##4##4##(1993-12#1)(2008-10#3)
and to determine its##3##4##(1994-11#1)(2008-1#1)(2012-3#1)
and to determine the mechanism##2##5##(1991-9#1)(2011-1#1)
and to determine the rate at which participating laboratories successfully completed tests initiated##2##13##(2008-10#2)
and to determine the##31##4##(1991-9#1)(1992-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#2)(2010-10#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
and to determine their##5##4##(1995-10#1)(2008-11#2)(2012-2#2)
and to determine where##2##4##(1996-4#1)(2008-10#1)
and to determine whether the##3##5##(1993-12#1)(2008-5#2)
and to determine whether their##2##5##(1993-1#1)(1995-2#1)
and to determine whether this##2##5##(1995-11#1)(2013-1#1)
and to determine whether##11##4##(1993-1#1)(1993-12#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)(2013-1#1)
and to determine##74##3##(1991-9#1)(1992-5#1)(1993-1#1)(1993-12#2)(1994-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and to develop strategies##2##4##(2008-10#1)(2011-1#1)
and to develop##12##3##(2007-4#1)(2008-10#2)(2008-12#1)(2008-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
and to devise##2##3##(2008-10#1)(2013-1#1)
and to differentiate##3##3##(1995-2#1)(2008-2#1)(2010-10#1)
and to direct##2##3##(1995-3#1)(2012-2#1)
and to discuss the##5##4##(1994-11#1)(2008-10#1)(2011-2#1)(2012-3#2)
and to discuss##11##3##(1991-1#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
and to distinguish##2##3##(1994-2#1)(2008-3#1)
and to document the##2##4##(1997-6#1)(2010-6#1)
and to document##4##3##(1997-6#1)(2007-8#1)(2008-10#1)(2010-6#1)
and to each##2##3##(1993-12#1)(1997-3#1)
and to eliminate##4##3##(2007-5#1)(2008-3#1)(2009-4#1)(2011-1#1)
and to elucidate the##2##4##(1997-8#1)(2011-2#1)
and to elucidate##4##3##(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
and to embrace##2##3##(2008-1#1)(2010-8#1)
and to emphasize the##4##4##(1992-3#1)(1995-4#1)(2008-8#1)(2012-12#1)
and to enable##3##3##(2008-12#1)(2010-10#1)(2011-1#1)
and to encourage##4##3##(1995-11#1)(1997-6#1)(2008-9#1)(2013-8#1)
and to enhance the##2##4##(2007-12#1)(2008-3#1)
and to enhance##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
and to ensure the##2##4##(2008-7#1)(2012-2#1)
and to ensure##6##3##(1996-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
and to establish a##6##4##(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
and to establish the##7##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2012-12#1)
and to establish##17##3##(1997-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2010-3#2)(2012-12#2)
and to estimate the##4##4##(1991-5#1)(2008-10#1)(2010-8#2)
and to estimate their##2##4##(2008-3#1)(2013-8#1)
and to estimate##12##3##(1991-5#1)(1995-2#1)(2008-10#2)(2008-3#5)(2010-8#2)(2013-8#1)
and to evaluate potential##2##4##(2008-4#1)(2008-6#1)
and to evaluate the effectiveness##2##5##(2009-6#1)(2013-1#1)
and to evaluate the efficacy of##2##6##(1997-2#1)(2012-3#1)
and to evaluate the##19##4##(1994-6#1)(1995-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2009-6#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
and to evaluate their##2##4##(2008-10#1)(2012-2#1)
and to evaluate whether the##2##5##(1997-3#1)(2013-7#1)
and to evaluate##41##3##(1994-6#1)(1995-3#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
and to examine the relationship between##2##6##(2008-8#1)(2013-1#1)
and to examine the##11##4##(1993-12#1)(1994-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
and to examine whether##2##4##(2010-5#1)(2010-6#1)
and to examine##19##3##(1993-12#1)(1994-7#1)(1994-9#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
and to explore the##6##4##(1994-3#1)(1996-1#1)(2008-9#1)(2011-1#1)(2012-3#2)
and to explore##13##3##(1994-3#1)(1996-1#1)(2007-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
and to express##2##3##(2008-5#1)(2009-9#1)
and to extend the##2##4##(2008-10#1)(2013-1#1)
and to extend##5##3##(1996-12#1)(1997-4#1)(2008-10#1)(2010-2#1)(2013-1#1)
and to facilitate##6##3##(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and to find##3##3##(2011-2#2)(2013-1#1)
and to focus##4##3##(1994-2#1)(2008-10#1)(2009-7#1)(2012-2#1)
and to follow the##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
and to follow##6##3##(1993-5#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
and to formulate##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
and to further##3##3##(1995-2#1)(2008-1#1)(2008-9#1)
and to gain##2##3##(2008-10#1)(2008-9#1)
and to generate##6##3##(1993-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-6#1)(2011-2#1)
and to get##2##3##(2008-5#1)(2010-8#1)
and to give##6##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-7#1)
and to guide##4##3##(1997-8#1)(2008-12#1)(2010-12#1)(2012-12#1)
and to have a##6##4##(1993-5#1)(1996-2#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-7#1)
and to have##17##3##(1990-3#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-5#1)(1996-2#2)(2008-11#2)(2008-3#2)(2008-5#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
and to help prevent##2##4##(2008-12#1)(2010-12#1)
and to help##12##3##(1996-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-12#1)
and to high##2##3##(1995-8#1)(2008-10#1)
and to highlight##5##3##(1995-3#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-2#1)
and to identify and##2##4##(2008-3#1)(2010-11#1)
and to identify factors that##2##5##(2007-10#1)(2008-9#1)
and to identify factors##4##4##(2007-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
and to identify novel targets##2##5##(2008-8#1)(2010-6#1)
and to identify novel##3##4##(2008-10#1)(2008-8#1)(2010-6#1)
and to identify the factors##2##5##(2008-6#1)(2011-2#1)
and to identify the##11##4##(1990-11#1)(1995-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
and to identify##42##3##(1990-11#1)(1991-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
and to illustrate how##2##4##(1994-3#1)(1997-4#1)
and to illustrate the##2##4##(2008-10#1)(2012-2#1)
and to illustrate##5##3##(1994-3#1)(1997-4#1)(2008-10#1)(2010-1#1)(2012-2#1)
and to improve quality of##2##5##(2008-1#1)(2012-2#1)
and to improve the quality of##3##6##(1993-3#1)(2008-12#1)(2010-4#1)
and to improve the##14##4##(1991-12#1)(1993-12#1)(1993-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#1)
and to improve##32##3##(1991-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and to incorporate##2##3##(2008-10#2)
and to increase the efficiency##2##5##(1993-3#1)(2008-7#1)
and to increase the##4##4##(1993-3#1)(2008-10#2)(2008-7#1)
and to increase##12##3##(1993-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2010-11#1)(2012-12#1)(2013-1#1)
and to indicate##4##3##(1993-2#1)(2008-1#1)(2008-2#1)(2013-8#1)
and to induce the##2##4##(2007-5#1)(2008-10#1)
and to induce##9##3##(1990-2#1)(1994-6#1)(2007-11#1)(2007-5#1)(2008-10#4)(2009-12#1)
and to influence the##2##4##(1997-3#1)(2008-10#1)
and to inform##3##3##(1994-1#1)(1996-6#1)(2012-2#1)
and to inhibit the##2##4##(2008-5#1)(2009-2#1)
and to inhibit##6##3##(1993-8#1)(1995-2#2)(2008-1#1)(2008-5#1)(2009-2#1)
and to insulate##2##3##(1991-3#1)(1994-5#1)
and to integrate##2##3##(1995-3#1)(1995-5#1)
and to interrogate##2##3##(2008-7#1)(2011-2#1)
and to introduce the##2##4##(2007-12#1)(2012-12#1)
and to introduce##3##3##(2007-11#1)(2007-12#1)(2012-12#1)
and to investigate the##7##4##(1990-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
and to investigate their##3##4##(2008-3#1)(2008-5#1)(2011-2#1)
and to investigate##15##3##(1990-3#1)(1995-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#1)
and to its##2##3##(1992-12#2)
and to keep##5##3##(1993-6#1)(2008-1#2)(2010-4#1)(2010-8#1)
and to lay the foundation for##2##6##(2008-4#1)(2013-8#1)
and to learn##3##3##(2007-8#1)(2008-11#1)(2009-3#1)
and to limit the##2##4##(2008-10#1)(2008-6#1)
and to link##2##3##(1995-2#1)(2008-6#1)
and to localize the##3##4##(1996-12#1)(2008-1#1)(2008-5#1)
and to localize##4##3##(1996-12#1)(2008-1#1)(2008-5#2)
and to maintain##5##3##(1993-11#1)(1994-8#1)(2008-10#1)(2008-3#1)(2010-12#1)
and to make##10##3##(1995-2#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-11#1)(2009-8#1)
and to map##3##3##(2008-10#2)(2008-2#1)
and to maximize##6##3##(1993-12#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
and to measure the##2##4##(2008-2#1)(2010-8#1)
and to measure##4##3##(1996-12#1)(2007-12#1)(2008-2#1)(2010-8#1)
and to meet##2##3##(1997-3#1)(2010-4#1)
and to model the##2##4##(1995-2#1)(2008-10#1)
and to monitor the##2##4##(2008-1#1)(2008-10#1)
and to monitor their##2##4##(2008-11#1)(2013-1#1)
and to monitor##7##3##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
and to move##2##3##(1993-12#1)(2007-11#1)
and to obtain a##2##4##(2008-10#2)
and to obtain##7##3##(1993-12#1)(1994-9#1)(1996-1#1)(2008-10#2)(2008-12#1)(2010-7#1)
and to offer##4##3##(1991-3#1)(1991-6#1)(1995-12#1)(2012-1#1)
and to one##2##3##(1995-3#1)(2008-10#1)
and to optimize for specificity##2##5##(2008-2#1)(2008-9#1)
and to optimize the##3##4##(2008-3#1)(2011-2#2)
and to optimize##6##3##(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)(2013-8#1)
and to other##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
and to outline the##2##4##(2008-10#1)(2008-11#1)
and to outline##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
and to overcome the##2##4##(2008-10#2)
and to perform##7##3##(1997-4#1)(2007-9#1)(2008-12#2)(2008-3#1)(2009-2#1)(2011-1#1)
and to possess##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
and to predict##4##3##(1993-2#1)(2008-1#1)(2008-2#1)(2010-8#1)
and to prepare##3##3##(1994-2#1)(1996-3#1)(2008-1#1)
and to present the##2##4##(2007-4#1)(2008-11#1)
and to present##5##3##(2007-4#1)(2008-11#1)(2008-9#1)(2012-12#2)
and to prevent##9##3##(1995-5#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
and to produce##4##3##(1992-10#1)(1994-5#1)(2008-8#2)
and to promote the##4##4##(2008-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
and to promote##6##3##(1991-12#1)(1995-11#1)(2008-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
and to propose a##2##4##(1990-7#1)(2007-12#1)
and to propose##3##3##(1990-7#1)(2007-12#1)(2009-8#1)
and to protect##3##3##(1994-2#1)(1994-3#1)(1994-6#1)
and to provide a stable environment for##3##7##(2008-4#2)(2011-2#1)
and to provide a##8##4##(2008-10#1)(2008-11#1)(2008-4#3)(2010-5#1)(2011-2#1)(2013-1#1)
and to provide an##2##4##(2008-8#1)(2011-2#1)
and to provide information##2##4##(1992-2#1)(1996-6#1)
and to provide new##2##4##(2008-3#1)(2013-8#1)
and to provide the##2##4##(1992-6#1)(2008-11#1)
and to provide##41##3##(1990-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#4)
and to put##2##3##(1990-11#1)(2011-2#1)
and to quantify the##4##4##(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)
and to quantify##7##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
and to quantitate##2##3##(1994-8#1)(2008-4#1)
and to rank##2##3##(2008-11#1)(2011-2#1)
and to read##2##3##(2008-5#1)(2009-12#1)
and to real samples##2##4##(2008-10#2)
and to real##3##3##(2008-10#3)
and to recognize the##2##4##(2010-5#1)(2011-2#1)
and to recommend##2##3##(1991-2#1)(2009-10#1)
and to reduce the##5##4##(2008-10#1)(2008-2#1)(2009-8#1)(2010-7#1)(2011-2#1)
and to reduce##12##3##(1994-6#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#2)(2010-7#1)(2011-2#1)
and to regulate##2##3##(2008-6#1)(2013-8#1)
and to relate these##2##4##(2008-8#1)(2010-4#1)
and to relate##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#2)
and to remove##3##3##(2008-10#1)(2013-1#2)
and to result in##3##4##(1996-5#1)(2008-2#1)(2013-1#1)
and to reveal##2##3##(2007-5#1)(2008-10#1)
and to review##2##3##(2008-3#1)(2008-8#1)
and to sample##2##3##(2008-10#1)(2013-7#1)
and to search##2##3##(2008-4#1)(2008-9#1)
and to see##2##3##(1994-9#1)(2011-2#1)
and to seek out##2##4##(1996-3#1)(2008-10#1)
and to seek##3##3##(1992-3#1)(1996-3#1)(2008-10#1)
and to select##4##3##(2007-2#1)(2008-2#1)(2008-4#1)(2010-5#1)
and to shift##2##3##(1997-2#1)(2007-11#1)
and to show the##2##4##(1993-3#1)(1997-8#1)
and to show##5##3##(1993-3#1)(1993-6#1)(1997-8#1)(2008-11#1)(2012-2#1)
and to some extent##3##4##(1996-8#1)(2008-10#1)(2013-1#1)
and to study the effect of##2##6##(1994-5#1)(2008-2#1)
and to study the##8##4##(1990-12#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-3#1)
and to study##15##3##(1990-12#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
and to subsequently##2##3##(2008-4#1)(2009-11#1)
and to suggest possible solutions##2##5##(2008-6#1)(2008-7#1)
and to suggest##7##3##(1991-3#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
and to support##4##3##(2010-11#1)(2012-3#2)(2013-1#1)
and to suppress##6##3##(1995-2#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
and to target##2##3##(2008-10#1)(2008-7#1)
and to test the##2##4##(2008-10#1)(2008-3#1)
and to test##7##3##(1996-6#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)
and to that##2##3##(2008-10#1)(2013-8#1)
and to the best of our knowledge##2##7##(2008-2#1)(2013-1#1)
and to the determination of##2##5##(2008-10#2)
and to the development of##5##5##(1993-2#1)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
and to the##86##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and to their##5##3##(2008-10#3)(2008-9#1)(2010-10#1)
and to try to##2##4##(2008-10#1)(2008-9#1)
and to try##4##3##(1997-3#1)(2008-1#1)(2008-10#1)(2008-9#1)
and to understand the##3##4##(2008-3#1)(2008-6#1)(2011-1#1)
and to understand##5##3##(2008-3#1)(2008-6#1)(2009-3#1)(2010-2#1)(2011-1#1)
and to use##9##3##(1993-9#1)(1996-1#1)(1996-2#2)(2008-10#1)(2009-5#1)(2010-11#1)(2010-3#1)(2012-12#1)
and to validate##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and to verify if the##2##5##(2007-7#1)(2010-3#1)
and to verify if##3##4##(2007-7#1)(2008-10#1)(2010-3#1)
and to verify the##3##4##(2008-7#2)(2011-2#1)
and to verify##9##3##(1990-6#1)(1992-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-3#1)(2011-2#1)
and to visualize##2##3##(2007-7#1)(2011-1#1)
and to what extent##4##4##(1996-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
and to what##6##3##(1996-12#1)(2008-2#1)(2010-8#1)(2011-2#2)(2013-7#1)
and to##1564##2##(1990-10#1)(1990-11#5)(1990-12#7)(1990-2#5)(1990-3#7)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#9)(1991-2#3)(1991-3#6)(1991-5#6)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#4)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#10)(1992-5#3)(1992-6#8)(1992-8#5)(1992-9#1)(1993-1#3)(1993-11#4)(1993-12#14)(1993-2#8)(1993-3#8)(1993-5#5)(1993-6#5)(1993-8#4)(1993-9#1)(1994-1#6)(1994-11#6)(1994-12#7)(1994-2#10)(1994-3#10)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#15)(1995-3#10)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#8)(1996-11#1)(1996-12#7)(1996-2#8)(1996-3#7)(1996-4#2)(1996-5#5)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#10)(1997-3#9)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#7)(1997-8#7)(1997-9#2)(2006-10#1)(2006-12#1)(2007-10#5)(2007-11#24)(2007-12#23)(2007-2#4)(2007-4#3)(2007-5#4)(2007-7#8)(2007-8#12)(2007-9#1)(2008-1#31)(2008-10#235)(2008-11#57)(2008-12#27)(2008-2#33)(2008-3#76)(2008-4#31)(2008-5#38)(2008-6#20)(2008-7#46)(2008-8#31)(2008-9#33)(2009-10#12)(2009-11#5)(2009-12#2)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#9)(2009-6#2)(2009-7#5)(2009-8#10)(2009-9#6)(2010-1#5)(2010-10#12)(2010-11#8)(2010-12#10)(2010-2#2)(2010-3#10)(2010-4#6)(2010-5#11)(2010-6#5)(2010-7#6)(2010-8#19)(2010-9#2)(2011-1#21)(2011-2#72)(2011-3#3)(2011-7#1)(2012-1#7)(2012-12#28)(2012-2#30)(2012-3#27)(2012-5#2)(2013-1#47)(2013-7#12)(2013-8#33)
and tobacco (Nicotiana##2##3##(2008-10#1)(2011-2#1)
and tobacco in the##2##4##(2008-1#1)(2011-2#1)
and tobacco in##3##3##(2008-1#2)(2011-2#1)
and tobacco smoke##3##3##(1992-9#1)(1993-11#1)(2011-1#1)
and tobacco##22##2##(1992-9#1)(1993-11#1)(1994-12#1)(2007-12#1)(2008-1#3)(2008-10#12)(2011-1#1)(2011-2#2)
and tocopherols##4##2##(2008-10#3)(2008-6#1)
and toe##2##2##(2008-5#1)(2013-1#1)
and together with##2##3##(1997-2#1)(2008-10#1)
and together##5##2##(1997-2#1)(2008-10#4)
and tolerability of an##2##4##(1991-2#1)(2008-3#1)
and tolerability of long-term##2##4##(2012-3#1)(2013-1#1)
and tolerability of the##3##4##(1991-2#1)(1996-1#1)(2008-3#1)
and tolerability of##18##3##(1990-3#1)(1991-2#2)(1994-12#1)(1996-1#1)(2007-7#2)(2008-3#5)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
and tolerability##25##2##(1990-3#2)(1990-6#1)(1991-2#2)(1994-12#1)(1996-1#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-3#6)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
and tolerable treatment##2##3##(2008-10#1)(2008-8#1)
and tolerable##6##2##(1992-2#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-8#1)
and tolerance for##2##3##(2007-12#1)(2008-10#1)
and tolerance of##7##3##(1990-6#1)(2008-10#3)(2008-5#2)(2010-3#1)
and tolerance to##7##3##(1996-6#1)(2008-10#1)(2008-12#2)(2009-6#1)(2009-7#1)(2011-10#1)
and tolerance##25##2##(1990-6#1)(1991-11#1)(1995-9#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#2)(2009-6#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-10#4)
and tolerances##3##2##(2007-11#1)(2008-2#1)(2008-7#1)
and tolerant##3##2##(2008-10#3)
and toluene##3##2##(2008-10#3)
and tomato in##2##3##(2008-10#2)
and tomato plants in##2##4##(2008-10#2)
and tomato plants##6##3##(2008-10#6)
and tomato were##2##3##(2008-10#2)
and tomato##42##2##(2008-10#41)(2008-5#1)
and tomatoes##2##2##(2008-10#1)(2008-3#1)
and tomography##2##2##(2006-4#1)(2013-1#1)
and tomorrow##2##2##(1996-12#1)(2011-3#1)
and tone##5##2##(1997-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-3#1)
and tonsillar##2##2##(1995-12#1)(1997-3#1)
and too##2##2##(1997-2#1)(2011-2#1)
and took##6##2##(2008-10#1)(2008-5#2)(2008-9#1)(2009-7#1)(2013-1#1)
and tool use##2##3##(2009-2#2)
and tools for##3##3##(1993-6#1)(2008-7#1)(2008-8#1)
and tools to##4##3##(1995-3#1)(2008-11#1)(2008-5#1)(2012-12#1)
and tools##18##2##(1992-12#1)(1993-12#1)(1993-6#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
and tooth##4##2##(2008-9#1)(2009-7#1)(2012-12#2)
and top##2##2##(2008-10#1)(2009-11#1)
and top-hat##2##2##(2008-2#1)(2008-3#1)
and topical antifungal##2##3##(2011-2#1)(2012-3#1)
and topical##8##2##(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and topographic effects##2##3##(2008-2#1)(2008-3#1)
and topographic##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and topographical##4##2##(1992-5#1)(1995-8#1)(2007-11#1)(2008-2#1)
and topography of the##2##4##(2007-11#1)(2013-8#1)
and topography of##3##3##(2007-10#1)(2007-11#1)(2013-8#1)
and topography##5##2##(2007-10#1)(2007-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
and topological indices##2##3##(2007-11#2)
and topological##4##2##(1991-8#1)(1994-5#1)(2007-11#2)
and torpor##2##2##(2011-2#1)(2013-8#1)
and torque##4##2##(2008-2#1)(2008-3#3)
and torsional##2##2##(1992-9#1)(2008-10#1)
and torso##2##2##(2008-7#1)(2013-1#1)
and tortuous##2##2##(1997-3#2)
and torture##2##2##(1996-3#1)(2013-1#1)
and total IgE##2##3##(1992-9#1)(2009-5#1)
and total arsenic in##3##4##(2008-10#3)
and total arsenic##4##3##(2008-10#4)
and total bilirubin##3##3##(2008-10#1)(2012-3#2)
and total body irradiation##2##4##(1993-9#1)(2008-1#1)
and total body##3##3##(1993-9#1)(2008-1#1)(2009-11#1)
and total cell##3##3##(1994-6#1)(2008-11#1)(2008-7#1)
and total cholesterol in##2##4##(2009-7#1)(2011-1#1)
and total cholesterol##6##3##(1991-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-8#1)
and total clutch mass in##2##5##(1991-5#2)
and total cost##2##3##(1993-12#1)(2011-2#1)
and total disease##2##3##(2008-10#2)
and total dissolved##3##3##(2008-10#3)
and total fresh weight of##2##5##(2008-12#2)
and total fresh weight##3##4##(2008-10#1)(2008-12#2)
and total hip replacement##2##4##(1995-2#1)(2009-3#1)
and total hip##4##3##(1995-2#1)(2007-11#1)(2009-3#1)(2010-3#1)
and total inorganic##6##3##(2008-10#6)
and total ionic##2##3##(2008-10#2)
and total iron in drugs##2##5##(2008-10#2)
and total iron in##3##4##(2008-10#3)
and total iron##8##3##(2008-10#8)
and total knee arthroplasty##6##4##(1994-3#1)(2011-2#4)(2013-1#1)
and total knee##7##3##(1994-3#1)(2009-3#1)(2011-2#4)(2013-1#1)
and total lifespan##2##3##(2009-12#2)
and total linear indices of the##2##6##(2007-11#2)
and total number of##2##4##(2008-4#1)(2009-5#1)
and total number##3##3##(1994-3#1)(2008-4#1)(2009-5#1)
and total phenolic contents##2##4##(2013-8#2)
and total phosphates (inorganic phosphates plus purine nucleotides)##2##8##(2008-10#2)
and total phosphates##3##3##(2008-10#3)
and total phosphorus##2##3##(2008-10#2)
and total protein of##2##4##(2008-12#2)
and total protein##10##3##(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#3)(2011-2#1)(2012-2#1)(2013-8#1)
and total selenium##3##3##(2008-10#3)
and total soluble##2##3##(2008-10#2)
and total sulphur dioxide##4##4##(2008-10#4)
and total vanadium in##2##4##(2008-10#2)
and total vanadium##4##3##(2008-10#4)
and total##211##2##(1991-12#2)(1991-2#1)(1991-5#2)(1991-8#2)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-6#2)(1993-9#1)(1994-3#2)(1994-6#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#85)(2008-11#3)(2008-12#8)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
and total/HDL cholesterol##2##3##(2013-1#2)
and totally##3##2##(2008-10#1)(2011-2#2)
and touch##3##2##(2008-1#1)(2013-1#2)
and toughness##2##2##(1997-4#1)(2010-2#1)
and toward the##2##3##(2008-3#2)
and toward##10##2##(1991-1#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-4#1)
and towards##4##2##(1991-12#1)(1995-12#1)(2008-10#1)(2010-8#1)
and toxic elements##2##3##(2008-10#1)(2008-5#1)
and toxic gases##4##3##(1996-12#4)
and toxic substances for the North American Great Lakes##3##9##(2008-11#3)
and toxic substances##6##3##(2008-10#1)(2008-11#4)(2010-7#1)
and toxic##21##2##(1991-9#1)(1993-6#1)(1994-2#1)(1996-12#4)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#1)(2010-7#1)(2011-2#1)
and toxicants##2##2##(1995-11#1)(2010-4#1)
and toxicities##2##2##(2008-7#1)(2011-2#1)
and toxicity are##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
and toxicity of##12##3##(1990-2#1)(1991-3#1)(1991-8#1)(1994-8#1)(2007-10#1)(2008-1#1)(2008-6#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and toxicity was##2##3##(2008-6#1)(2008-7#1)
and toxicity##46##2##(1990-2#2)(1991-2#1)(1991-3#1)(1991-8#1)(1994-8#1)(1995-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#2)
and toxicological studies##2##3##(2008-11#1)(2008-12#1)
and toxicological##9##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)
and toxicology##3##2##(1995-11#1)(2010-7#1)(2012-1#1)
and toxin production##3##3##(1992-12#1)(2008-10#1)(2011-2#1)
and toxin##5##2##(1992-12#1)(1995-2#1)(2008-10#1)(2011-2#2)
and toxins##3##2##(2008-8#1)(2009-10#1)(2010-10#1)
and trabecular meshwork##2##3##(2008-11#1)(2008-4#1)
and trabecular##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
and trace determination of##2##4##(2008-10#2)
and trace elements##7##3##(2008-10#4)(2008-12#1)(2010-5#1)(2013-8#1)
and trace metal##3##3##(2008-10#3)
and trace##20##2##(1993-6#1)(2008-10#14)(2008-12#1)(2008-8#1)(2009-3#1)(2010-5#1)(2013-8#1)
and traceability##2##2##(2008-10#2)
and trachea##2##2##(1995-12#1)(1996-12#1)
and tracheal##2##2##(2007-8#2)
and tracheitis)##2##2##(1997-3#1)(2010-4#1)
and track patients with diabetes##2##5##(2013-8#2)
and track##6##2##(1996-12#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#2)
and tracked##2##2##(2011-1#1)(2013-8#1)
and tracking of the##2##4##(2011-1#1)(2013-1#1)
and tracking of##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
and tracking systems##2##3##(1995-12#1)(2008-3#1)
and tracking##11##2##(1991-12#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-1#2)(2013-1#1)
and trade##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
and trade-offs##3##2##(2008-8#2)(2010-3#1)
and traditional Chinese medicine##4##4##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and traditional Chinese##7##3##(2008-10#3)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and traditional ones##2##3##(1997-2#1)(2011-3#1)
and traditional##19##2##(1992-3#1)(1995-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2009-11#1)(2010-10#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and traffic##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
and trafficking##5##2##(1991-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
and train##4##2##(1993-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
and trained to##2##3##(1993-12#1)(2008-5#1)
and trained##8##2##(1993-12#1)(2007-7#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#2)
and training are##2##3##(1993-1#1)(1996-6#1)
and training as well as##2##5##(1994-12#1)(2008-10#1)
and training as##3##3##(1991-3#1)(1994-12#1)(2008-10#1)
and training for##5##3##(1993-1#1)(1994-2#1)(2008-11#2)(2012-3#1)
and training in##8##3##(1997-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
and training of##13##3##(1990-3#1)(1994-12#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)
and training programs##3##3##(1992-1#1)(1997-6#1)(2008-11#1)
and training to##2##3##(2010-10#1)(2012-12#1)
and training##75##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-1#2)(1992-12#1)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#3)(1997-6#1)(1997-7#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#11)(2008-12#5)(2008-6#1)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
and trait anxiety##2##3##(1994-12#1)(2010-6#1)
and trait specific##2##3##(2012-3#2)
and trait##7##2##(1994-12#1)(1994-2#1)(2010-6#1)(2012-3#4)
and traits of##2##3##(2008-8#1)(2010-10#1)
and traits##4##2##(1994-9#1)(2008-8#1)(2010-10#1)(2010-5#1)
and tramadol##2##2##(2008-10#1)(2008-9#1)
and trans isomers of##4##4##(2010-2#4)
and trans isomers##5##3##(1990-9#1)(2010-2#4)
and trans##8##2##(1990-9#1)(1991-5#1)(1992-12#1)(1996-2#1)(2010-2#4)
and trans-1##2##2##(1996-5#1)(2007-11#1)
and trans-editing##2##2##(2012-2#2)
and transactivate##2##2##(1995-8#2)
and transcranial Doppler##3##3##(2007-10#1)(2007-8#1)(2008-7#1)
and transcranial##4##2##(2007-10#1)(2007-8#1)(2008-7#1)(2010-7#1)
and transcribed##2##2##(2008-4#1)(2012-2#1)
and transcript##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
and transcription factor##3##3##(2008-11#1)(2012-1#1)(2013-8#1)
and transcription factors##6##3##(1991-1#1)(1994-12#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-4#1)
and transcription of##3##3##(1995-11#1)(1996-6#1)(2010-11#1)
and transcription##29##2##(1991-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-6#1)(2008-10#3)(2008-11#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
and transcriptional activity##2##3##(1995-6#1)(2011-1#1)
and transcriptional regulation##3##3##(1995-2#1)(2007-12#1)(2012-2#1)
and transcriptional##13##2##(1995-11#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-5#1)(2008-9#3)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
and transcriptionally##4##2##(1994-11#1)(1994-8#1)(2009-8#1)(2011-2#1)
and transcriptome##3##2##(2010-3#1)(2011-2#2)
and transcytosis are##2##3##(2008-1#1)(2009-10#1)
and transcytosis in##2##3##(2009-10#1)(2009-12#1)
and transcytosis##6##2##(1995-2#1)(2008-1#1)(2009-10#3)(2009-12#1)
and transduce##2##2##(1993-3#1)(2008-4#1)
and transduced##2##2##(1993-11#1)(2011-2#1)
and transducers##2##2##(1993-12#1)(2009-5#1)
and transduction of##2##3##(1997-3#1)(2008-1#1)
and transduction##5##2##(1997-3#1)(2008-1#1)(2008-5#1)(2009-6#1)(2009-8#1)
and transection of the##2##4##(1992-11#1)(2008-11#1)
and transepidermal water loss (TEWL)##2##5##(2008-5#2)
and transepidermal water loss##4##4##(2008-5#4)
and transepidermal##5##2##(2008-5#5)
and transesophageal echocardiography##2##3##(2007-7#1)(2011-2#1)
and transesophageal##4##2##(2007-7#1)(2009-3#1)(2011-2#2)
and transfected into##6##3##(1992-8#1)(1993-3#1)(1994-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
and transfected##8##2##(1992-8#1)(1993-3#2)(1994-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)
and transfection##5##2##(1995-8#1)(2008-1#1)(2008-2#1)(2008-9#1)(2011-2#1)
and transfer##10##2##(1990-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-5#1)
and transferred into##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
and transferred to a##3##4##(1995-3#1)(2008-10#1)(2008-2#1)
and transferred to the##2##4##(2008-10#1)(2008-2#1)
and transferred to##8##3##(1995-3#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-2#2)(2011-1#1)
and transferred##16##2##(1995-3#1)(1997-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#3)(2009-1#1)(2011-1#1)(2012-2#1)
and transferrin saturation##2##3##(2007-7#2)
and transferrin##12##2##(1990-8#2)(1995-11#3)(1996-5#1)(2007-7#2)(2008-11#4)
and transferring##4##2##(1994-2#1)(1997-2#1)(2008-4#2)
and transform##5##2##(1995-12#1)(1996-1#1)(2008-12#1)(2008-2#1)(2008-4#1)
and transformants were##2##3##(1990-5#1)(1991-9#1)
and transformation of##3##3##(2007-11#1)(2008-4#1)(2009-10#1)
and transformation##10##2##(1994-9#1)(1995-11#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#2)
and transformations##2##2##(2007-11#1)(2013-1#1)
and transformed cell types##2##4##(1997-1#1)(2008-7#1)
and transformed cells##4##3##(1993-8#1)(1994-5#1)(1995-2#1)(2008-11#1)
and transformed into##4##3##(1994-12#1)(1995-8#1)(2008-9#1)(2009-8#1)
and transformed##20##2##(1992-3#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2013-1#2)
and transforming growth factor alpha##3##5##(1992-8#2)(2008-7#1)
and transforming growth factor beta##2##5##(2008-11#1)(2012-2#1)
and transforming growth factor##7##4##(1992-8#2)(2008-11#2)(2008-7#1)(2011-1#1)(2012-2#1)
and transforming growth factor-beta (TGF-beta) signaling##2##6##(2008-11#1)(2009-3#1)
and transforming growth factor-beta (TGF-beta)##3##5##(2008-11#2)(2009-3#1)
and transforming growth factor-β##2##4##(2012-1#1)(2012-12#1)
and transforming growth##13##3##(1992-8#2)(2008-11#4)(2008-7#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and transforming##14##2##(1992-8#2)(2008-11#4)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and transfusion##6##2##(1994-12#1)(1994-9#1)(2006-10#1)(2008-10#1)(2012-2#1)(2012-3#1)
and transgender##3##2##(2008-12#3)
and transgenesis##2##2##(2008-11#1)(2008-4#1)
and transgenic animals##2##3##(1992-8#1)(2008-7#1)
and transgenic mice##4##3##(1995-6#1)(2008-4#1)(2008-9#1)(2009-8#1)
and transgenic plants##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
and transgenic##14##2##(1992-8#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2013-8#1)
and transgressive segregation##2##3##(2008-10#2)
and transient gene expression##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
and transient increases##2##3##(1990-12#1)(2008-9#1)
and transient##39##2##(1990-12#2)(1991-12#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-9#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-7#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and transiently##7##2##(1992-9#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
and transition metal ions##5##4##(2008-10#5)
and transition metals##3##3##(2008-10#3)
and transition to##2##3##(1990-8#1)(1991-12#1)
and transition##20##2##(1990-8#1)(1991-12#1)(1991-6#1)(2008-10#14)(2008-2#1)(2008-3#1)(2011-2#1)
and transitional cell carcinoma##2##4##(1997-4#1)(2009-5#1)
and transitional##4##2##(1993-2#1)(1997-4#1)(2008-10#1)(2009-5#1)
and transitions##2##2##(2008-4#1)(2010-7#1)
and translate the##2##3##(2008-1#1)(2008-7#1)
and translate##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
and translated in##3##3##(1990-12#1)(1993-2#1)(1995-6#1)
and translated##4##2##(1990-12#1)(1993-2#1)(1995-6#1)(2009-10#1)
and translates##2##2##(2007-11#1)(2012-2#1)
and translating them into##2##4##(1991-3#1)(2008-2#1)
and translation of the##4##4##(1990-11#1)(1990-12#1)(1995-6#1)(2007-8#1)
and translation of##6##3##(1990-11#1)(1990-12#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-3#1)
and translation##16##2##(1990-11#1)(1990-12#1)(1991-9#1)(1995-6#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#1)
and translational##11##2##(1990-5#1)(1993-2#1)(1993-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-1#1)
and translocation of the##2##4##(1992-3#1)(1995-6#1)
and translocation of##3##3##(1992-3#1)(1995-6#1)(2008-8#1)
and translocation##6##2##(1992-11#1)(1992-3#1)(1995-6#1)(2008-5#1)(2008-8#2)
and translocations##2##2##(1997-7#1)(2009-10#1)
and translucens##2##2##(2008-10#2)
and transmembrane signaling##2##3##(1993-1#1)(2011-1#1)
and transmembrane##5##2##(1993-1#1)(1993-8#1)(1997-1#1)(2011-1#1)(2013-1#1)
and transmission coefficient##2##3##(2007-12#1)(2008-3#1)
and transmission coefficients##3##3##(2007-12#2)(2008-3#1)
and transmission electron microscope##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
and transmission electron microscopy (TEM)##5##5##(2008-10#1)(2009-7#2)(2011-2#1)(2013-8#1)
and transmission electron microscopy at##2##5##(2008-10#1)(2008-7#1)
and transmission electron microscopy in order to##2##7##(2007-12#1)(2008-7#1)
and transmission electron microscopy showed##2##5##(2007-7#1)(2008-8#1)
and transmission electron microscopy to##2##5##(2008-10#2)
and transmission electron microscopy were used to##2##7##(2007-12#1)(2008-7#1)
and transmission electron microscopy##33##4##(2007-12#9)(2007-7#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-7#2)(2010-11#1)(2011-2#1)(2013-8#2)
and transmission electron##39##3##(2006-10#1)(2007-12#10)(2007-7#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#7)(2008-8#2)(2009-2#1)(2009-7#2)(2010-11#1)(2011-2#1)(2013-8#2)
and transmission losses##2##3##(2008-2#1)(2008-3#1)
and transmission measurements##2##3##(2008-2#1)(2008-3#1)
and transmission of##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-1#1)(2010-8#1)(2012-12#1)
and transmission rates##3##3##(2008-10#2)(2012-2#1)
and transmission spectra##2##3##(2007-11#1)(2007-12#1)
and transmission##85##2##(1996-2#1)(2006-10#1)(2007-11#4)(2007-12#15)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#3)(2008-3#8)(2008-5#2)(2008-7#7)(2008-8#3)(2009-2#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#3)
and transmits##3##2##(2007-12#1)(2008-8#1)(2010-5#1)
and transmittable by##4##3##(2008-10#4)
and transmittance measurements##6##3##(2008-2#3)(2008-3#3)
and transmittance##12##2##(2008-10#1)(2008-2#4)(2008-3#7)
and transmitted by the##2##4##(2008-10#1)(2011-2#1)
and transmitted by##5##3##(2008-10#3)(2011-2#1)(2013-1#1)
and transmitted##9##2##(2008-10#4)(2008-3#3)(2011-2#1)(2013-1#1)
and transparency of##2##3##(2008-4#1)(2013-7#1)
and transparency##7##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-7#1)(2013-8#2)
and transparent##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-3#1)
and transplant patients##2##3##(2006-6#1)(2008-1#1)
and transplant##3##2##(2006-6#1)(2008-1#2)
and transplantation##6##2##(2008-10#2)(2008-11#1)(2010-11#1)(2010-3#1)(2011-2#1)
and transplanted##5##2##(1993-12#1)(2008-9#2)(2011-3#1)(2013-1#1)
and transport mechanism##2##3##(2008-10#2)
and transport of##5##3##(1996-9#1)(2008-10#2)(2008-7#1)(2013-8#1)
and transport properties of##2##4##(1992-8#1)(1997-1#1)
and transport properties##3##3##(1992-8#1)(1997-1#1)(2012-1#1)
and transport were##2##3##(2008-10#1)(2013-1#1)
and transport##32##2##(1992-8#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-8#1)
and transportation##6##2##(2008-10#2)(2012-2#1)(2013-1#3)
and transported out of the system##2##6##(2008-10#2)
and transported to the##3##4##(1994-11#1)(1995-6#1)(2008-10#1)
and transported to##4##3##(1994-11#1)(1995-4#1)(1995-6#1)(2008-10#1)
and transported##11##2##(1990-12#1)(1994-11#1)(1995-4#1)(1995-6#1)(2008-10#6)(2008-4#1)
and transporters##4##2##(1994-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
and transporting##3##2##(2008-9#1)(2013-1#2)
and transposon##4##2##(2008-9#1)(2009-10#2)(2010-5#1)
and transvaginal##3##2##(1995-3#1)(1996-1#2)
and transversal##2##2##(2007-8#1)(2011-3#1)
and transverse load##3##3##(2007-12#3)
and transverse##13##2##(1991-6#1)(1992-2#1)(1995-2#1)(2007-12#4)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
and trap##4##2##(2008-10#3)(2010-11#1)
and trapezium##2##2##(2008-9#2)
and trapped in the flow cell equipped with the##2##9##(2008-10#2)
and trapped in##3##3##(2008-10#3)
and trapped##5##2##(2008-10#5)
and trapping of a##2##4##(2008-10#1)(2008-3#1)
and trapping of##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
and trapping##11##2##(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-3#2)(2010-7#1)
and traps##2##2##(1995-12#1)(2008-10#1)
and trauma centers##2##3##(2008-11#1)(2008-6#1)
and trauma surgery##2##3##(1990-11#1)(2010-9#1)
and trauma##8##2##(1990-11#1)(2007-11#1)(2008-11#2)(2008-6#2)(2010-9#1)(2012-1#1)
and traumatic##6##2##(1991-3#1)(1992-6#1)(2007-12#1)(2010-12#1)(2010-2#1)(2013-8#1)
and traumatology##3##2##(2007-8#2)(2013-1#1)
and travel##7##2##(1990-6#1)(1997-6#1)(2007-2#3)(2008-8#1)(2011-2#1)
and travellers##4##2##(1997-3#1)(2007-2#3)
and treat it##2##3##(2007-7#1)(2012-3#1)
and treat the##3##3##(1995-11#1)(2007-12#1)(2012-12#1)
and treat them##3##3##(2007-12#2)(2013-1#1)
and treat##30##2##(1992-11#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
and treatable disease##3##3##(1991-8#1)(2008-1#1)(2013-8#1)
and treated accordingly and##2##4##(2008-7#1)(2012-2#1)
and treated by##4##3##(1990-6#1)(2007-11#1)(2008-10#1)(2008-8#1)
and treated early##2##3##(2007-12#1)(2012-3#1)
and treated for##3##3##(1996-3#1)(2008-7#1)(2011-1#1)
and treated in our##2##4##(1992-6#1)(2011-2#1)
and treated in##5##3##(1992-6#1)(1993-2#1)(2007-8#1)(2010-10#1)(2011-2#1)
and treated prophylactically with##3##4##(1994-3#1)(2012-2#1)(2012-3#1)
and treated with##18##3##(1992-10#1)(1993-3#1)(1996-12#1)(1996-5#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-1#1)(2012-4#1)(2013-1#2)(2013-7#1)
and treated##60##2##(1990-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-12#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#2)
and treating the##2##3##(2010-3#1)(2011-2#1)
and treating##24##2##(1995-2#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
and treatment are discussed##4##4##(1994-9#1)(2006-12#1)(2008-11#1)(2013-1#1)
and treatment are##9##3##(1990-12#1)(1994-9#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
and treatment can##2##3##(1990-6#1)(2008-4#1)
and treatment efficacy##3##3##(1992-9#1)(1996-2#1)(2007-11#1)
and treatment failure##2##3##(2009-9#1)(2012-12#1)
and treatment for##8##3##(1990-12#1)(1993-1#1)(1993-2#1)(1996-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
and treatment goals##2##3##(2010-5#1)(2013-8#1)
and treatment implications##2##3##(1993-12#1)(2008-2#1)
and treatment in##13##3##(1990-3#1)(1996-8#1)(1997-8#1)(2007-7#2)(2008-10#1)(2008-12#2)(2009-12#1)(2010-5#1)(2011-1#1)(2012-12#2)
and treatment initiated##2##3##(2008-11#1)(2013-7#1)
and treatment is##10##3##(1992-2#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
and treatment issues##3##3##(1993-9#1)(1995-6#1)(2011-2#1)
and treatment modalities of##2##4##(2010-8#1)(2013-1#1)
and treatment modalities##8##3##(1994-7#1)(2008-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
and treatment needs##2##3##(2008-1#1)(2008-7#1)
and treatment of LMM##2##4##(2011-2#2)
and treatment of a##3##4##(1996-6#1)(2008-5#1)(2010-12#1)
and treatment of bacterial##2##4##(2010-12#1)(2013-1#1)
and treatment of cancer##2##4##(1992-3#1)(2008-5#1)
and treatment of chronic hepatitis##2##5##(2007-12#1)(2009-8#1)
and treatment of chronic##3##4##(2007-12#1)(2008-7#1)(2009-8#1)
and treatment of condyloma##2##4##(2012-3#2)
and treatment of depression##2##4##(2008-4#1)(2008-6#1)
and treatment of diabetic##2##4##(2007-7#1)(2008-1#1)
and treatment of human##2##4##(1994-5#1)(2013-1#1)
and treatment of hyperhomocysteinemia in##2##5##(2007-10#2)
and treatment of hyperhomocysteinemia##3##4##(2007-10#2)(2008-3#1)
and treatment of mood disorders##2##5##(2008-7#1)(2013-8#1)
and treatment of osteoporosis##10##4##(1990-11#1)(1993-11#5)(1997-6#2)(2007-8#1)(2008-7#1)
and treatment of pain##3##4##(2007-11#1)(2008-11#1)(2012-3#1)
and treatment of patients with##3##5##(2008-12#1)(2010-10#1)(2011-7#1)
and treatment of pediatric##2##4##(2010-6#1)(2013-1#1)
and treatment of primary##2##4##(2006-10#1)(2007-10#1)
and treatment of prostate cancer##2##5##(2008-4#2)
and treatment of such##2##4##(2007-7#1)(2008-5#1)
and treatment of the most##2##5##(1993-2#1)(1997-3#1)
and treatment of the##17##4##(1993-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#3)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
and treatment of these diseases##2##5##(2010-3#1)(2012-3#1)
and treatment of these##3##4##(2010-3#1)(2010-5#1)(2012-3#1)
and treatment of this disease##3##5##(2008-1#1)(2008-8#1)(2011-7#1)
and treatment of this##9##4##(1992-5#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-7#1)(2013-1#2)
and treatment of various##4##4##(1997-2#1)(2008-7#1)(2013-7#1)(2013-8#1)
and treatment of##228##3##(1990-11#3)(1990-6#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1993-11#5)(1993-2#3)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#4)(1996-6#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-8#2)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#10)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#9)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#13)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#10)(2011-3#1)(2011-7#3)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#6)
and treatment options for##3##4##(2007-2#1)(2012-2#1)(2013-1#1)
and treatment options##10##3##(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
and treatment outcome##5##3##(1991-12#1)(1994-8#1)(2008-11#1)(2013-1#2)
and treatment parameters##2##3##(2008-1#1)(2008-10#1)
and treatment planning##6##3##(1991-12#1)(1993-1#1)(1994-3#1)(2007-11#2)(2008-7#1)
and treatment possibilities##2##3##(1993-11#1)(1997-7#1)
and treatment procedures##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
and treatment programs to##2##4##(2008-1#1)(2010-9#1)
and treatment programs##3##3##(1995-6#1)(2008-1#1)(2010-9#1)
and treatment related##2##3##(2008-7#1)(2011-2#1)
and treatment response in##2##4##(2007-2#1)(2008-9#1)
and treatment response##6##3##(1991-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-9#1)(2009-4#1)
and treatment results of##4##4##(1996-9#1)(1997-3#1)(2008-6#1)(2008-7#1)
and treatment results##5##3##(1996-9#2)(1997-3#1)(2008-6#1)(2008-7#1)
and treatment strategies##7##3##(1994-1#1)(2007-12#1)(2007-2#1)(2010-6#1)(2012-12#2)(2012-2#1)
and treatment were##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
and treatment will##2##3##(2008-8#1)(2010-5#1)
and treatment with##22##3##(1990-2#1)(1990-7#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#2)(2011-2#2)
and treatment##559##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#2)(1992-9#1)(1993-1#3)(1993-11#7)(1993-12#1)(1993-2#4)(1993-9#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-11#3)(1996-2#1)(1996-3#5)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#1)(1997-6#5)(1997-7#2)(1997-8#3)(2006-10#4)(2006-12#3)(2007-10#6)(2007-11#14)(2007-12#18)(2007-2#4)(2007-4#2)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#14)(2008-10#26)(2008-11#16)(2008-12#9)(2008-2#5)(2008-3#10)(2008-4#8)(2008-5#12)(2008-6#8)(2008-7#25)(2008-8#12)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-3#6)(2010-4#7)(2010-5#5)(2010-6#8)(2010-7#3)(2010-8#10)(2010-9#3)(2011-1#20)(2011-2#31)(2011-3#2)(2011-7#3)(2012-1#2)(2012-12#14)(2012-2#18)(2012-3#12)(2013-1#31)(2013-7#4)(2013-8#18)
and treatment-induced##2##2##(1997-2#1)(2012-12#1)
and treatment]##12##2##(1991-2#1)(1991-6#1)(1992-5#1)(1993-2#1)(1994-5#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
and treatments for##2##3##(2008-8#1)(2011-2#1)
and treatments of##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
and treatments##19##2##(1993-12#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-8#1)
and tree##6##2##(1990-8#1)(1996-8#1)(2008-5#3)(2013-1#1)
and trees##4##2##(2008-10#2)(2008-8#2)
and tremor in##2##3##(2008-7#1)(2012-3#1)
and tremor secondary to##2##4##(2008-7#2)
and tremor##7##2##(2008-2#1)(2008-7#5)(2012-3#1)
and trend##2##2##(1997-3#1)(2013-8#1)
and trends in the##2##4##(2008-10#1)(2008-2#1)
and trends in##7##3##(1991-3#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-2#1)(2012-12#2)
and trends of##2##3##(2007-7#1)(2011-1#1)
and trends##22##2##(1991-3#1)(1993-1#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#5)
and triacylglycerols##3##2##(1990-8#2)(1993-6#1)
and trial##4##2##(1993-3#1)(2008-11#1)(2008-5#1)(2010-5#1)
and trialkyl phosphine oxide##2##4##(2008-10#2)
and triamterene in##2##3##(2008-10#2)
and triamterene were##2##3##(2008-10#2)
and triamterene##5##2##(2008-10#5)
and trichloroacetate##2##2##(1995-3#1)(2008-10#1)
and trichloroethylene##3##2##(2008-10#2)(2008-7#1)
and trichrome##2##2##(2010-12#1)(2012-3#1)
and tricyclic antidepressants##4##3##(1991-8#1)(1997-8#3)
and tricyclic##6##2##(1990-8#1)(1991-8#1)(1997-8#3)(2010-11#1)
and tried for##2##3##(1995-12#1)(2008-10#1)
and tried##3##2##(1995-12#2)(2008-10#1)
and tries to##2##3##(1993-3#1)(2008-3#1)
and tries##3##2##(1990-6#1)(1993-3#1)(2008-3#1)
and triethylamine##3##2##(2008-10#2)(2008-7#1)
and trifloxystrobin##2##2##(2008-10#1)(2011-2#1)
and trigger apoptosis##2##3##(2008-4#1)(2009-4#1)
and trigger##3##2##(2008-4#1)(2009-4#1)(2013-1#1)
and triggered##2##2##(2008-7#1)(2012-2#1)
and triggering of##2##3##(2008-10#1)(2009-8#1)
and triggers##2##2##(1995-12#1)(2009-9#1)
and triglyceride (p&lt##2##3##(2008-10#2)
and triglyceride levels##3##3##(1997-7#1)(2008-10#2)
and triglyceride##13##2##(1991-4#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
and triglycerides in##2##3##(1991-12#1)(2013-1#1)
and triglycerides##19##2##(1990-8#3)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-2#1)(2010-5#2)(2013-1#3)
and triglycerides)##3##2##(1992-12#1)(1994-3#1)(2013-1#1)
and triiodothyronine##3##2##(1991-12#1)(2008-11#1)(2008-7#1)
and trimethoprim-sulfamethoxazole##2##2##(1997-3#1)(2009-8#1)
and trimethylarsine oxide (TMAO)##2##4##(2008-10#2)
and trimethylarsine##3##2##(2008-10#2)(2009-6#1)
and trimipramine##3##2##(1995-2#3)
and trioctylphosphine oxide##2##3##(2008-10#2)
and triphenyl phosphate##2##3##(2013-1#2)
and triphosphates##5##2##(1996-5#2)(2008-2#1)(2008-4#2)
and triple helix##4##3##(2013-1#4)
and triple##10##2##(1991-9#1)(1992-8#1)(1996-5#1)(2007-11#1)(2008-5#1)(2009-11#1)(2013-1#4)
and tris(2##4##2##(1996-2#1)(2008-10#3)
and trisomy##2##2##(1995-8#1)(2010-1#1)
and triticale##2##2##(2008-10#1)(2013-1#1)
and triton-treated##3##2##(1994-11#3)
and trivalent cations indicate##2##4##(2008-10#2)
and trivalent cations##4##3##(2008-10#4)
and trivalent metal##2##3##(1990-2#1)(1993-6#1)
and trivalent##7##2##(1990-2#1)(1993-6#1)(1995-5#1)(2008-10#4)
and trkC##2##2##(1996-12#2)
and trkC-like proteins##2##3##(1995-8#2)
and troglitazone##2##2##(2010-11#2)
and trophic##2##2##(2008-1#1)(2010-8#1)
and tropical##12##2##(1992-5#1)(2008-10#10)(2008-5#1)
and troponin I (TnI)##2##4##(2007-8#1)(2008-7#1)
and troponin I##5##3##(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
and troponin##8##2##(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
and troubleshooting##3##2##(2008-4#2)(2008-9#1)
and true##7##2##(1992-9#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
and truly##2##2##(1993-2#1)(1996-12#1)
and truncated##4##2##(1994-5#1)(1995-6#1)(2008-2#1)(2008-4#1)
and trunk of##2##3##(2010-8#1)(2012-12#1)
and trunk##7##2##(1995-8#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
and trust##4##2##(1993-2#1)(2007-10#1)(2008-12#1)(2013-1#1)
and trustees##2##2##(1993-3#1)(2012-2#1)
and trustworthy##2##2##(1992-3#1)(2008-10#1)
and trypsin##5##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
and trypsin)##2##2##(2008-10#2)
and tryptamine##2##2##(1993-6#1)(2008-10#1)
and tryptophan methyl##2##3##(2008-10#2)
and tryptophan##8##2##(1995-3#1)(2008-10#2)(2009-8#1)(2011-3#2)(2012-2#2)
and ts85 cells##2##3##(1995-11#2)
and tubal##3##2##(1991-3#1)(1996-8#1)(2011-2#1)
and tube formation##4##3##(2008-10#3)(2010-6#1)
and tube##6##2##(1994-6#1)(2008-10#3)(2009-6#1)(2010-6#1)
and tuber##4##2##(2008-10#4)
and tuberculin skin##2##3##(2007-2#1)(2011-2#1)
and tuberculosis##8##2##(1991-11#1)(2008-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
and tuberculosis]##2##2##(1996-11#1)(1996-3#1)
and tuberose##2##2##(2010-3#2)
and tubers##3##2##(2008-10#2)(2010-5#1)
and tubes##2##2##(1992-11#1)(2008-5#1)
and tubular##5##2##(1993-12#2)(2011-2#1)(2012-1#1)(2013-8#1)
and tubule formation##2##3##(2008-11#1)(2012-4#1)
and tubule##3##2##(2008-11#1)(2008-5#1)(2012-4#1)
and tubulointerstitial##2##2##(2012-12#1)(2013-1#1)
and tulipae##2##2##(2008-10#2)
and tumor cell##2##3##(2012-1#1)(2012-3#1)
and tumor cells##3##3##(2008-11#2)(2008-8#1)
and tumor formation##2##3##(2008-11#2)
and tumor growth##2##3##(2008-1#1)(2008-7#1)
and tumor metastasis##2##3##(1994-8#1)(2008-8#1)
and tumor necrosis factor (TNF)##2##5##(1992-12#1)(1994-2#1)
and tumor necrosis factor alpha##2##5##(1990-5#1)(2013-8#1)
and tumor necrosis factor##7##4##(1990-5#1)(1992-12#1)(1994-2#1)(1997-2#1)(2008-11#1)(2008-6#1)(2013-8#1)
and tumor necrosis factor-alpha (TNF-alpha)##2##5##(1995-12#1)(2008-7#1)
and tumor necrosis factor-alpha##5##4##(1992-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-7#1)
and tumor necrosis##13##3##(1990-5#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
and tumor progression##2##3##(1994-5#1)(2013-1#1)
and tumor resection##3##3##(2007-11#2)(2013-1#1)
and tumor size##2##3##(1990-12#1)(1990-8#1)
and tumor suppressor##3##3##(2008-11#1)(2008-7#1)(2009-5#1)
and tumor tissue##2##3##(1990-2#1)(2012-2#1)
and tumor##72##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-2#1)(2007-11#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#6)(2009-10#1)(2009-4#1)(2009-5#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
and tumor-associated##3##2##(1995-9#1)(2008-11#2)
and tumorigenesis##8##2##(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)
and tumorigenic##2##2##(1992-9#1)(2009-3#1)
and tumorigenicity##2##2##(2012-12#1)(2013-1#1)
and tumors are##2##3##(2008-3#1)(2013-8#1)
and tumors##5##2##(2007-11#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-8#1)
and tumour lymphocytic infiltration##2##4##(2013-1#2)
and tumour necrosis factor##3##4##(1996-2#2)(2011-2#1)
and tumour necrosis##4##3##(1996-2#2)(2008-6#1)(2011-2#1)
and tumour progression##2##3##(2009-4#1)(2013-1#1)
and tumour promoting##2##3##(1992-2#2)
and tumour##20##2##(1991-5#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-9#1)(1996-2#2)(2007-11#1)(2008-2#1)(2008-6#2)(2008-7#3)(2009-4#1)(2011-2#1)(2013-1#3)
and tumoural progression##2##3##(2013-1#2)
and tumours##2##2##(1993-8#1)(2012-12#1)
and tunability##2##2##(2007-11#2)
and tunable##9##2##(2007-11#2)(2007-12#2)(2008-12#2)(2008-2#1)(2008-3#2)
and tuned##2##2##(2008-3#2)
and tungsten##7##2##(2008-10#7)
and tunic##2##2##(2008-7#2)
and tuning##5##2##(2007-11#3)(2007-12#1)(2008-11#1)
and tunneling##2##2##(2009-9#1)(2011-2#1)
and turbid##3##2##(1994-3#1)(2007-11#1)(2008-3#1)
and turbidity reduction assays##2##4##(2009-6#2)
and turbidity##7##2##(2008-10#5)(2009-6#2)
and turbulence##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
and turkey)##2##2##(2008-10#1)(2010-4#1)
and turned out to be##3##5##(1995-6#1)(1997-8#1)(2010-5#1)
and turnover of##2##3##(2007-12#1)(2008-1#1)
and turnover##8##2##(2007-12#1)(2007-5#1)(2008-1#1)(2008-5#2)(2010-9#1)(2012-2#1)(2013-1#1)
and turns##2##2##(1993-11#1)(2006-12#1)
and twelfth nerve##2##3##(2011-2#2)
and twelfth##3##2##(2008-10#1)(2011-2#2)
and twelve samples##2##3##(2008-10#2)
and twelve##7##2##(1990-2#1)(1992-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-3#1)
and twenty##10##2##(1990-3#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
and twice##2##2##(2008-2#1)(2011-2#1)
and twin studies##2##3##(2008-1#1)(2008-7#1)
and twin##3##2##(2008-1#1)(2008-7#1)(2009-5#1)
and twin-image##2##2##(2007-12#1)(2008-3#1)
and twist##5##2##(2008-3#4)(2013-7#1)
and two additional##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
and two age-matched##2##3##(1997-6#1)(2008-9#1)
and two analogs##2##3##(1993-8#1)(1995-12#1)
and two atypical##2##3##(1993-9#1)(2008-10#1)
and two cases##4##3##(2008-10#1)(2008-5#1)(2008-7#2)
and two control groups##2##4##(1993-12#1)(2009-5#1)
and two control##3##3##(1993-12#1)(1996-1#1)(2009-5#1)
and two days##2##3##(1995-8#1)(1996-3#1)
and two different types of##2##5##(2008-10#1)(2008-7#1)
and two different##10##3##(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#2)
and two distinct##4##3##(1993-6#1)(2008-10#2)(2013-1#1)
and two female patients##2##4##(2007-8#1)(2008-7#1)
and two forms of##4##4##(1991-12#1)(2008-10#1)(2010-5#2)
and two from##2##3##(1995-6#1)(2008-10#1)
and two groups##2##3##(1992-2#1)(1996-12#1)
and two histidine##2##3##(1991-12#1)(1992-8#1)
and two hours##2##3##(2008-12#1)(2008-5#1)
and two human##2##3##(1994-2#1)(1994-6#1)
and two in the##5##4##(1994-12#1)(1995-3#1)(2008-10#1)(2010-8#1)(2013-7#1)
and two in##7##3##(1994-12#1)(1995-3#1)(2008-10#3)(2010-8#1)(2013-7#1)
and two introns##2##3##(1991-2#1)(2010-5#1)
and two isoforms of##2##4##(1991-12#1)(1993-12#1)
and two isolates of##3##4##(2008-10#3)
and two isolates##4##3##(2008-10#4)
and two minor##3##3##(1993-12#1)(1995-6#1)(1997-8#1)
and two natural##2##3##(2008-5#1)(2013-7#1)
and two new##5##3##(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#2)
and two of these##2##4##(1993-11#1)(2008-10#1)
and two of##8##3##(1990-5#1)(1992-2#1)(1993-11#1)(1994-11#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
and two open##3##3##(1990-11#1)(2008-10#2)
and two other##9##3##(1992-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-2#1)(2011-1#1)
and two patients##5##3##(1991-4#1)(1995-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
and two previously##2##3##(2008-10#1)(2012-3#1)
and two related##2##3##(2007-2#1)(2008-10#1)
and two samples##2##3##(2008-10#1)(2010-8#1)
and two sets of##3##4##(2008-10#2)(2008-3#1)
and two sets##4##3##(2008-10#3)(2008-3#1)
and two sites##2##3##(1994-5#1)(2008-10#1)
and two small##2##3##(1997-3#1)(2008-8#1)
and two species of##3##4##(2007-12#1)(2008-11#1)(2008-5#1)
and two species##4##3##(2007-12#1)(2008-11#1)(2008-5#2)
and two strains##2##3##(2008-10#1)(2011-2#1)
and two to five##2##4##(2008-10#2)
and two unknown##2##3##(2008-10#1)(2008-5#1)
and two wavelengths##2##3##(2008-10#1)(2008-3#1)
and two weeks later##3##4##(1991-6#1)(1992-3#2)
and two weeks##4##3##(1991-6#1)(1992-3#2)(1995-12#1)
and two were##5##3##(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
and two with##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
and two yeast##2##3##(2008-4#1)(2008-8#1)
and two##391##2##(1990-11#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-2#3)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#2)(2006-6#1)(2007-11#3)(2007-12#12)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#121)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#17)(2008-6#3)(2008-7#12)(2008-8#13)(2008-9#11)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#3)
and two-component##2##2##(1995-5#1)(1997-7#1)
and two-dimensional gels##2##3##(2008-1#1)(2010-11#1)
and two-dimensional numerical##2##3##(2008-3#1)(2009-6#1)
and two-dimensional##23##2##(1990-11#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-4#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)
and two-layer##2##2##(2008-3#2)
and two-phase##3##2##(2007-5#1)(2008-10#1)(2010-11#1)
and two-photon absorption##5##3##(2007-11#2)(2008-3#1)(2010-7#2)
and two-photon excitation##3##3##(2008-3#3)
and two-photon excited fluorescence##2##4##(2007-11#2)
and two-photon fluorescence##3##3##(2008-3#1)(2011-1#2)
and two-photon microscopy##3##3##(2007-12#2)(2008-11#1)
and two-photon##17##2##(2007-11#4)(2007-12#2)(2008-11#1)(2008-3#6)(2010-7#2)(2011-1#2)
and two-stage##4##2##(2008-10#3)(2010-4#1)
and two-step##2##2##(2008-10#2)
and two-tone frequency-modulation spectroscopy##2##4##(2008-3#2)
and two-tone##3##2##(2008-3#3)
and twofold##2##2##(2008-10#1)(2012-3#1)
and type 2 diabetes has risen substantially##2##7##(2008-3#2)
and type 2 diabetes in##2##5##(2008-7#1)(2010-10#1)
and type 2 diabetes mellitus##5##5##(2008-1#1)(2008-6#1)(2010-11#1)(2011-1#1)(2013-1#1)
and type 2 diabetes##23##4##(2008-1#2)(2008-10#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2012-4#2)(2013-1#3)
and type 2 diabetic patients##3##5##(1993-2#2)(2011-2#1)
and type 2##35##3##(1992-8#1)(1993-2#3)(1997-3#2)(2008-1#2)(2008-10#4)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2012-4#2)(2013-1#3)
and type 2A##2##3##(1990-12#1)(1995-5#1)
and type I##4##3##(1995-12#1)(2007-12#1)(2008-2#1)(2008-7#1)
and type II##10##3##(1994-2#1)(1995-2#2)(1997-3#1)(2008-11#1)(2008-3#2)(2008-5#2)(2010-11#1)
and type III##2##3##(2008-7#1)(2013-8#1)
and type X##2##3##(2008-11#2)
and type and##2##3##(2008-10#2)
and type of surgical##2##4##(2008-2#1)(2009-12#1)
and type of##38##3##(1991-12#2)(1992-1#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-9#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
and type##114##2##(1990-12#1)(1991-12#2)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#4)(1994-2#4)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#3)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2009-12#2)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#3)(2013-1#8)(2013-8#2)
and type-specific##2##2##(2008-10#1)(2013-8#1)
and types of##17##3##(1992-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
and types##21##2##(1992-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and typical##8##2##(1992-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
and typically##7##2##(1996-3#1)(2008-12#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-3#1)
and typing##5##2##(2011-2#2)(2013-8#3)
and tyramine##2##2##(2008-7#2)
and tyrosinase##7##2##(1995-2#1)(1996-9#1)(2008-10#2)(2008-5#1)(2013-1#2)
and tyrosine hydroxylase (TH)##2##4##(2008-11#1)(2011-2#1)
and tyrosine kinase##6##3##(1990-12#1)(1997-7#1)(2008-8#1)(2011-3#1)(2013-1#2)
and tyrosine phosphorylation of NR2B##2##5##(1997-2#2)
and tyrosine phosphorylation of##3##4##(1997-2#3)
and tyrosine phosphorylation##4##3##(1994-6#1)(1997-2#3)
and tyrosine residues##4##3##(1990-11#1)(1991-2#2)(1994-11#1)
and tyrosine##25##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#2)(1994-11#1)(1994-6#2)(1997-2#3)(1997-7#2)(2008-10#3)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#3)
and ulcerative colitis##7##3##(1996-2#1)(2010-11#1)(2010-12#3)(2011-2#1)(2013-1#1)
and ulcerative##10##2##(1991-3#1)(1993-2#1)(1996-2#1)(2010-11#1)(2010-12#4)(2011-2#1)(2013-1#1)
and ulcers##2##2##(1992-6#1)(2007-7#1)
and ultimate##6##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
and ultimately cell##2##3##(1995-12#2)
and ultimately lead to##2##4##(2009-10#1)(2013-1#1)
and ultimately the##3##3##(2008-8#1)(2010-5#1)(2013-1#1)
and ultimately to##4##3##(1994-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
and ultimately##43##2##(1992-12#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
and ultra high##2##3##(2008-10#1)(2009-3#1)
and ultra##7##2##(2007-12#1)(2008-10#3)(2008-7#1)(2009-3#1)(2010-5#1)
and ultra-pure##2##2##(2008-10#2)
and ultra-sensitive##2##2##(2008-10#1)(2009-12#1)
and ultrafast##2##2##(2007-11#2)
and ultrafiltrate##2##2##(2010-5#1)(2011-1#1)
and ultrafiltration##5##2##(1993-12#1)(1993-8#1)(1994-5#1)(2008-10#2)
and ultrasonic method##2##3##(2008-10#1)(2008-5#1)
and ultrasonic##7##2##(1991-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
and ultrasonographic##2##2##(1997-7#1)(2008-10#1)
and ultrasonography##6##2##(2007-11#1)(2008-10#1)(2008-12#1)(2012-2#2)(2012-3#1)
and ultrasound examination##3##3##(1990-9#2)(1996-11#1)
and ultrasound##19##2##(1990-11#1)(1990-5#1)(1990-9#2)(1991-3#1)(1995-5#1)(1996-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and ultrastructural analysis##2##3##(1990-12#1)(2008-7#1)
and ultrastructural changes##5##3##(1994-5#2)(2008-10#2)(2011-1#1)
and ultrastructural features of the##4##5##(1991-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
and ultrastructural features of##6##4##(1991-8#1)(1992-8#1)(2007-12#1)(2008-5#2)(2008-7#1)
and ultrastructural features##7##3##(1991-8#1)(1992-12#1)(1992-8#1)(2007-12#1)(2008-5#2)(2008-7#1)
and ultrastructural studies##7##3##(1992-2#1)(1992-8#1)(1993-11#1)(1994-8#1)(2007-12#1)(2008-5#1)(2008-6#1)
and ultrastructural study of##2##4##(2008-5#1)(2008-7#1)
and ultrastructural study##5##3##(1993-11#1)(2008-5#1)(2008-7#2)(2009-7#1)
and ultrastructural##33##2##(1990-12#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#2)(1992-9#1)(1993-11#2)(1994-5#2)(1994-8#1)(2007-12#3)(2008-10#3)(2008-5#5)(2008-6#1)(2008-7#5)(2009-7#2)(2011-1#1)
and ultrastructurally##3##2##(1994-12#1)(2008-10#1)(2008-6#1)
and ultrastructure of the##2##4##(1994-9#1)(2008-12#1)
and ultrastructure of##5##3##(1994-9#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)
and ultrastructure##8##2##(1994-9#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
and ultrathin##3##2##(1997-2#1)(2008-7#1)(2010-4#1)
and ultratrace##5##2##(2008-10#5)
and ultraviolet detection##7##3##(2008-10#6)(2008-5#1)
and ultraviolet##14##2##(1996-3#1)(1997-7#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
and umbilical A/B ratio##2##4##(1994-3#2)
and umbilical catheter##2##3##(2011-2#2)
and umbilical##9##2##(1994-3#2)(1994-5#2)(2008-9#1)(2011-2#4)
and unacceptable##2##2##(1996-12#1)(2013-1#1)
and unaffected##3##2##(1995-12#1)(2012-5#1)(2013-1#1)
and unambiguous determination of##2##4##(2008-3#2)
and unambiguous##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)
and unbiased##3##2##(1997-3#1)(2008-10#1)(2012-12#1)
and unbound##4##2##(1990-12#1)(1994-8#1)(1996-5#1)(2008-11#1)
and unburned##3##2##(2008-10#2)(2008-3#1)
and uncapped##3##2##(2008-10#3)
and uncertainties##2##2##(1991-12#1)(2008-2#1)
and uncertainty about the##2##4##(2008-10#1)(2011-2#1)
and uncertainty about##3##3##(2008-10#1)(2011-2#2)
and uncertainty in##3##3##(1996-3#1)(2008-2#1)(2012-12#1)
and uncertainty of single-shot##2##4##(2008-3#2)
and uncertainty of##5##3##(2008-10#1)(2008-3#2)(2012-12#2)
and uncertainty##22##2##(1991-2#1)(1993-3#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#4)(2012-3#1)
and unchanged##6##2##(1996-2#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-8#1)
and unclassified##2##2##(2008-1#1)(2008-10#1)
and uncommon##3##2##(1996-11#1)(2007-12#1)(2008-11#1)
and uncomplicated urinary tract infection##2##5##(2009-5#1)(2011-2#1)
and uncomplicated##4##2##(1992-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
and unconjugated##3##2##(1990-11#1)(2008-11#1)(2009-5#1)
and uncontrollable##2##2##(2007-12#1)(2012-12#1)
and uncontrolled##3##2##(1992-5#1)(2008-12#1)(2008-8#1)
and unconventional##2##2##(1991-6#1)(2010-3#1)
and uncovered##2##2##(1991-8#1)(2008-10#1)
and undamaged##4##2##(1995-2#2)(2008-8#2)
and under certain##2##3##(2008-10#1)(2008-9#1)
and under different##2##3##(1991-2#1)(1994-5#1)
and under the##3##3##(2007-12#1)(2008-10#2)
and under what conditions##2##4##(1994-12#1)(2012-3#1)
and under##28##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-2#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2012-3#1)
and underemployment##2##2##(2013-1#2)
and undergo##6##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-9#1)(2011-2#1)
and undergoes##2##2##(1990-2#1)(2008-10#1)
and undergraduate##7##2##(1991-1#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-12#2)(2009-4#1)
and underlines the##3##3##(1990-6#1)(1992-5#1)(1992-6#1)
and underlying mechanisms##3##3##(2008-12#1)(2012-1#1)(2013-1#1)
and underlying##15##2##(1995-1#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
and underscore the importance of##2##5##(2011-2#1)(2013-8#1)
and underscore the##5##3##(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and underscores the##2##3##(1995-2#1)(2013-1#1)
and understand the##9##3##(1995-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
and understand##17##2##(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)
and understandable method##2##3##(1995-12#1)(2008-9#1)
and understandable##3##2##(1995-12#1)(1996-3#1)(2008-9#1)
and understanding of the##9##4##(1991-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-4#1)(2009-7#1)
and understanding of tumour hypoxia and##2##6##(2011-2#2)
and understanding of##22##3##(1991-12#1)(1991-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-8#1)(2009-4#2)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and understanding the##6##3##(1991-2#1)(1992-1#1)(1993-2#1)(2008-12#1)(2012-3#1)(2012-5#1)
and understanding##42##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-2#1)(1994-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#5)(2008-3#2)(2008-8#2)(2009-12#1)(2009-4#3)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)
and understandings##2##2##(2010-10#1)(2013-1#1)
and understood##5##2##(2008-10#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-8#1)
and underwater##3##2##(2008-10#1)(2008-2#1)(2010-2#1)
and underwent a##8##3##(1995-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2009-10#1)(2012-12#1)(2012-2#2)
and underwent##25##2##(1990-6#1)(1993-1#1)(1995-2#1)(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
and undetermined##2##2##(1991-3#1)(2013-8#1)
and undiagnosed##3##2##(2008-5#1)(2009-6#1)(2012-12#1)
and undoped##4##2##(2007-12#1)(2008-3#3)
and unemployment##2##2##(2011-1#1)(2013-1#1)
and unequal##3##2##(2008-3#1)(2008-6#1)(2012-1#1)
and unethical##2##2##(2008-12#1)(2008-7#1)
and uneven##2##2##(2008-10#1)(2011-2#1)
and unexpected##6##2##(1990-11#1)(1996-1#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-11#1)
and unexplained##4##2##(1990-9#1)(1992-11#1)(2007-7#1)(2011-1#1)
and unfiltered##2##2##(2008-10#2)
and unfolding##3##2##(1991-6#1)(1995-5#1)(2009-7#1)
and unhealthy##3##2##(1991-6#1)(2011-2#1)(2012-2#1)
and unheated##2##2##(1990-12#2)
and uniform##16##2##(1990-8#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)
and uniformity##2##2##(2008-3#1)(2010-5#1)
and uniformly##3##2##(1995-12#1)(2008-3#2)
and unify##2##2##(2008-2#1)(2008-9#1)
and unilateral##7##2##(1992-5#1)(1996-2#1)(2007-4#1)(2007-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
and unilaterally in##2##3##(1996-12#2)
and uninfected##5##2##(1994-9#1)(1997-3#1)(2008-10#2)(2012-2#1)
and uninformative variable elimination##2##4##(2008-10#2)
and uninjured fruits##2##3##(1997-6#2)
and uninoculated leaves##2##3##(2008-10#2)
and uninoculated##4##2##(2008-10#4)
and uninsured##3##2##(1997-3#2)(2011-2#1)
and unintended##2##2##(1993-12#1)(2013-1#1)
and unintentional##2##2##(1991-12#1)(2008-11#1)
and unipolar##2##2##(2007-12#1)(2009-9#1)
and unique features##2##3##(1997-2#1)(2008-10#1)
and unique##22##2##(1990-12#1)(1994-2#1)(1995-3#1)(1996-10#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
and uniqueness##4##2##(2008-11#1)(2009-10#1)(2013-8#2)
and unit##3##2##(1990-12#1)(1992-3#1)(1995-12#1)
and united##2##2##(1996-3#1)(2013-1#1)
and units##2##2##(2010-8#1)(2011-2#1)
and univariate calibration##2##3##(2008-10#2)
and univariate##3##2##(2008-10#2)(2010-3#1)
and universal##9##2##(1996-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)(2011-1#1)
and university##6##2##(1990-12#1)(1992-5#1)(1997-8#1)(2007-10#1)(2010-2#1)(2012-12#1)
and unknown##10##2##(1990-6#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-1#1)(2013-1#1)
and unlabeled##2##2##(1990-11#1)(1993-11#1)
and unlike##2##2##(1992-11#1)(2011-2#1)
and unnecessary##3##2##(1994-3#1)(2008-10#1)(2012-12#1)
and unplanned##4##2##(1993-2#1)(2007-11#1)(2010-4#1)(2011-1#1)
and unpleasant##2##2##(1992-2#1)(2008-6#1)
and unpleasantness##5##2##(2008-10#4)(2008-5#1)
and unpolarized##2##2##(2007-11#1)(2008-3#1)
and unprecedented##2##2##(1996-3#1)(2012-3#1)
and unpredictable##3##2##(1996-6#1)(2008-11#1)(2010-3#1)
and unprocessed##6##2##(1997-2#1)(2007-10#1)(2008-12#4)
and unprotected left main##2##4##(2008-3#1)(2011-2#1)
and unpublished##5##2##(1992-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
and unraveling##2##2##(1997-2#1)(2008-11#1)
and unrelated##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
and unrestrained##2##2##(2007-12#2)
and unsafe##3##2##(2008-1#1)(2008-5#1)(2012-12#1)
and unsatisfactory##2##2##(1995-12#1)(2011-2#1)
and unsaturated##4##2##(1992-6#1)(1996-5#1)(2008-10#1)(2008-11#1)
and unstable##15##2##(1993-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
and unsteady##5##2##(2007-12#1)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
and unstructured##3##2##(2008-9#1)(2009-12#1)(2010-8#1)
and unsymmetrical##3##2##(2008-10#3)
and until now##2##3##(1997-7#1)(2008-12#1)
and until##4##2##(1997-7#1)(2008-12#1)(2013-1#1)(2013-8#1)
and untrained##3##2##(1992-8#1)(1997-5#1)(2013-1#1)
and untreated control##2##3##(2008-10#1)(2008-12#1)
and untreated##17##2##(1990-2#2)(1991-6#1)(1995-12#1)(1995-6#1)(1997-4#1)(2007-10#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
and unusual##12##2##(1993-12#1)(1993-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#2)(2013-1#1)
and unusually##2##2##(1991-2#1)(2008-8#1)
and unwanted##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
and up to 11##2##4##(2008-10#1)(2008-3#1)
and up to a##3##4##(1995-11#1)(2007-2#1)(2008-11#1)
and up to##18##3##(1990-8#1)(1995-11#1)(1995-2#1)(1997-6#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2011-1#2)
and up-regulation##2##2##(1990-2#1)(2008-9#1)
and up-to-date information##2##3##(2012-12#1)(2013-8#1)
and up-to-date##4##2##(1995-2#1)(2008-3#1)(2012-12#1)(2013-8#1)
and update##6##2##(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#2)(2013-1#1)
and updated##10##2##(1994-12#1)(1997-3#1)(2008-10#3)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
and updating##4##2##(1994-2#2)(1995-9#2)
and upgrade##2##2##(1996-3#1)(2012-2#1)
and upland rice##2##3##(2008-10#2)
and upland##4##2##(2008-10#4)
and upon##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
and upper gastrointestinal##2##3##(2007-8#1)(2011-2#1)
and upper tropospheric##3##3##(2008-3#3)
and upper##25##2##(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-3#4)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#4)(2012-2#2)(2013-1#3)
and upregulation of##2##3##(2007-11#1)(2008-10#1)
and upstream##4##2##(1991-6#1)(1993-2#1)(1997-4#1)(2008-11#1)
and uptake of##3##3##(1994-5#1)(1996-2#1)(2008-7#1)
and uptake##8##2##(1992-3#1)(1994-5#1)(1996-2#1)(2008-7#1)(2009-9#2)(2011-2#1)(2013-1#1)
and upward##3##2##(2008-2#1)(2008-5#1)(2008-7#1)
and uranium##4##2##(2008-10#3)(2013-8#1)
and uranium(VI)##4##2##(2008-10#4)
and urban and##3##3##(1994-3#1)(2008-6#1)(2010-4#1)
and urban areas##4##3##(1994-2#1)(2009-6#1)(2009-7#1)(2011-2#1)
and urban##24##2##(1994-2#5)(1994-3#1)(1996-3#2)(1997-5#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
and urea production##2##3##(2008-11#2)
and urea were##4##3##(1995-3#1)(2008-11#1)(2011-2#2)
and urea##27##2##(1990-11#1)(1995-2#1)(1995-3#4)(1995-6#1)(2008-10#6)(2008-11#4)(2008-3#5)(2008-7#1)(2011-2#3)(2012-2#1)
and urease##3##2##(1995-3#1)(2008-10#1)(2013-7#1)
and ureteric##2##2##(2008-10#1)(2008-4#1)
and ureteroneocystostomy##2##2##(2009-5#1)(2013-1#1)
and ureters##6##2##(1997-6#5)(2011-2#1)
and urethra##4##2##(1997-7#3)(2008-10#1)
and urethral##3##2##(2008-10#3)
and urgency of##3##3##(1996-1#1)(2008-9#1)(2010-7#1)
and urgency##5##2##(1990-3#1)(1991-6#1)(1996-1#1)(2008-9#1)(2010-7#1)
and urgent##4##2##(1992-2#1)(2008-11#1)(2010-10#1)(2013-8#1)
and uric acid levels##2##4##(1995-12#1)(2008-7#1)
and uric acid were##2##4##(2008-10#1)(2013-1#1)
and uric acid##16##3##(1995-12#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
and uric acid)##2##3##(2008-10#2)
and uric##19##2##(1995-12#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
and uridine##3##2##(1995-8#1)(1996-5#1)(2008-4#1)
and urinalysis##2##2##(2007-12#1)(2010-8#1)
and urinary incontinence##5##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#2)
and urinary tract##3##3##(2008-10#2)(2012-2#1)
and urinary##26##2##(1990-12#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#2)(2011-2#3)(2012-2#2)(2013-1#2)
and urine by##6##3##(1992-11#1)(1993-9#1)(2006-10#1)(2008-7#1)(2013-1#2)
and urine citrulline levels correlated with each other (p &lt##2##10##(2006-10#2)
and urine citrulline levels##5##4##(2006-10#5)
and urine is##2##3##(2008-10#2)
and urine media##2##3##(2008-10#2)
and urine obtained##2##3##(2008-10#1)(2008-7#1)
and urine sample##2##3##(2008-10#2)
and urine samples of##2##4##(2008-10#2)
and urine samples were##2##4##(1993-11#1)(2008-10#1)
and urine samples with##2##4##(2008-10#1)(2010-4#1)
and urine samples##16##3##(1993-11#1)(2008-10#14)(2010-4#1)
and urine using a##2##4##(1991-12#1)(2008-10#1)
and urine##94##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-5#1)(1992-11#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#3)(1997-2#1)(2006-10#8)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#2)(2008-12#1)(2008-7#8)(2009-12#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and urine)##4##2##(2008-10#4)
and urodynamic##3##2##(2008-10#3)
and urodynamics##2##2##(1991-11#1)(2008-1#1)
and urogenital tracts##2##3##(1992-6#1)(2007-7#1)
and urokinase##3##2##(1992-6#1)(1995-6#1)(2007-11#1)
and urokinase-type##2##2##(1994-3#2)
and urologic tumor##3##3##(2007-8#3)
and urology##2##2##(2008-1#1)(2012-12#1)
and urticaria##3##2##(1990-6#1)(1996-11#1)(2008-7#1)
and usability of##2##3##(2008-12#1)(2010-10#1)
and usability##6##2##(2008-12#1)(2008-6#1)(2009-11#1)(2010-10#2)(2011-2#1)
and usable##2##2##(2008-2#1)(2013-7#1)
and usage of##3##3##(1994-12#1)(2008-9#1)(2010-6#1)
and usage##7##2##(1991-12#1)(1994-12#1)(2008-11#1)(2008-9#3)(2010-6#1)
and use a##3##3##(1991-3#1)(2008-3#1)(2012-2#1)
and use are##2##3##(2008-1#1)(2008-5#1)
and use for##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
and use in##5##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-5#1)
and use it to##2##4##(2007-11#1)(2008-7#1)
and use it##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
and use of a##9##4##(1992-4#1)(1993-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)
and use of alcohol among##2##5##(1991-9#2)
and use of an##3##4##(1997-1#1)(2008-2#1)(2009-10#1)
and use of clinical##2##4##(1993-12#1)(2012-12#1)
and use of computer##2##4##(1990-9#1)(2008-12#1)
and use of data##2##4##(1992-12#1)(1996-2#1)
and use of health##5##4##(1993-6#1)(1994-2#1)(1996-9#1)(2012-12#2)
and use of patient##2##4##(1996-3#1)(2010-5#1)
and use of social##2##4##(1997-3#1)(2011-1#1)
and use of the##8##4##(1992-11#1)(1993-3#1)(1996-11#1)(2007-10#1)(2008-10#2)(2008-9#1)(2009-9#1)
and use of these##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
and use of##124##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-8#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#1)
and use the##6##3##(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2010-9#1)(2012-3#1)
and use them##3##3##(2008-1#1)(2008-2#1)(2010-1#1)
and use this to##2##4##(2008-7#1)(2009-12#1)
and use this##5##3##(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)
and use##196##2##(1990-11#1)(1990-6#2)(1990-9#1)(1991-12#3)(1991-3#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-8#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#23)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
and used a##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
and used as a##4##4##(1994-12#1)(2008-10#1)(2008-3#2)
and used as an##5##4##(1992-3#1)(2008-10#2)(2008-11#1)(2011-1#1)
and used as the##2##4##(2008-10#2)
and used as##25##3##(1990-5#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-6#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)
and used for a##3##4##(1993-3#1)(1994-2#1)(2006-10#1)
and used for determination of##3##5##(2008-10#2)(2008-3#1)
and used for determining##2##4##(2008-10#1)(2008-3#1)
and used for the determination of##3##6##(1990-2#1)(2008-10#1)(2008-7#1)
and used for the preconcentration##2##5##(2008-10#2)
and used for the##16##4##(1990-2#1)(1990-5#1)(2008-10#10)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
and used for##55##3##(1990-2#1)(1990-5#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
and used in the##2##4##(2008-10#2)
and used in##13##3##(1991-12#1)(1993-2#1)(1993-6#1)(2008-10#6)(2008-12#1)(2010-5#1)(2012-2#2)
and used it to##3##4##(1991-12#1)(2008-2#1)(2008-9#1)
and used the##5##3##(2008-11#2)(2011-1#1)(2011-2#1)(2013-8#1)
and used them##2##3##(2008-7#1)(2008-8#1)
and used to amplify##2##4##(2008-10#2)
and used to analyze##2##4##(2008-3#2)
and used to calculate the##7##5##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
and used to calculate##8##4##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
and used to characterize the##2##5##(1994-5#1)(2008-10#1)
and used to compute##2##4##(2008-3#1)(2008-6#1)
and used to design##2##4##(2008-10#1)(2008-11#1)
and used to determine##3##4##(2008-10#2)(2013-1#1)
and used to estimate##3##4##(1996-2#1)(2008-10#1)(2008-3#1)
and used to identify##3##4##(1991-5#1)(2008-10#2)
and used to investigate the##2##5##(2008-10#1)(2008-3#1)
and used to investigate##3##4##(1993-8#1)(2008-10#1)(2008-3#1)
and used to measure##2##4##(2007-12#1)(2008-10#1)
and used to monitor##2##4##(2008-10#2)
and used to probe##2##4##(1994-12#1)(1995-8#1)
and used to produce##3##4##(2007-12#1)(2008-10#2)
and used to study the##4##5##(1992-6#1)(2008-10#2)(2008-8#1)
and used to transform##2##4##(1990-5#1)(2008-8#1)
and used to##81##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-8#1)(1996-2#2)(2007-12#2)(2008-10#36)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
and used with##4##3##(1994-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
and used##218##2##(1990-2#1)(1990-5#3)(1991-12#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1994-12#2)(1994-2#2)(1994-5#2)(1994-6#3)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#2)(1996-3#1)(1997-5#1)(2006-10#1)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#84)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#7)(2009-7#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
and useful approach to##2##4##(1997-4#1)(2011-2#1)
and useful approach##3##3##(1997-4#1)(2010-3#1)(2011-2#1)
and useful diagnostic tool##2##4##(2007-11#1)(2008-10#1)
and useful information##4##3##(1996-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
and useful to##3##3##(1996-5#1)(1997-3#1)(2008-10#1)
and useful##35##2##(1990-6#1)(1992-12#1)(1993-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#1)
and usefulness for##2##3##(2008-12#1)(2010-8#1)
and usefulness of the##4##4##(1995-12#1)(1996-1#1)(2013-1#2)
and usefulness of##8##3##(1995-12#1)(1996-1#1)(2008-10#2)(2008-12#1)(2009-9#1)(2013-1#2)
and usefulness##11##2##(1995-12#1)(1996-1#1)(2008-10#3)(2008-12#2)(2009-9#1)(2010-8#1)(2013-1#2)
and user##5##2##(1994-2#1)(2008-10#1)(2011-2#3)
and user-friendly##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
and users of##4##3##(1992-11#1)(1992-5#2)(1993-3#1)
and users##7##2##(1991-3#2)(1992-11#1)(1992-5#2)(1993-3#1)(2008-11#1)
and uses a##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2009-9#1)
and uses of##5##3##(1993-2#1)(1993-3#1)(1996-11#1)(2008-9#1)(2009-5#1)
and uses only##2##3##(2007-12#1)(2008-10#1)
and uses the##5##3##(1997-3#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-6#1)
and uses##25##2##(1993-2#2)(1993-3#1)(1996-11#1)(1996-5#1)(1997-3#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2013-8#1)
and using a##11##3##(1990-12#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and using an##4##3##(2008-10#4)
and using different##2##3##(2008-10#1)(2008-11#1)
and using the##19##3##(1990-2#1)(1991-6#1)(1994-6#1)(1996-2#1)(2008-10#7)(2008-3#1)(2008-4#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and using##82##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-2#2)(1996-12#2)(1996-2#2)(1997-2#2)(1997-3#1)(2007-11#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
and usually are##2##3##(1992-9#1)(2008-10#1)
and usually benign##2##3##(2008-11#1)(2013-1#1)
and usually occurs##2##3##(2007-8#1)(2013-1#1)
and usually##34##2##(1992-3#1)(1992-9#1)(1993-3#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
and uterine cells##2##3##(1994-8#1)(1994-9#1)
and uterine##10##2##(1990-10#1)(1990-6#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-12#1)(2008-3#1)(2013-1#1)
and utilisation##2##2##(2010-8#1)(2010-9#1)
and utilise##4##2##(2007-5#1)(2008-11#2)(2008-4#1)
and utilised##2##2##(1997-3#1)(2008-10#1)
and utilising##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
and utilities##2##2##(2012-3#2)
and utility of a##2##4##(2008-7#1)(2013-1#1)
and utility of our##2##4##(2009-12#1)(2009-5#1)
and utility of##12##3##(1990-12#1)(1993-2#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
and utility##16##2##(1990-12#1)(1993-2#1)(1995-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
and utilization management##2##3##(1995-1#2)
and utilization of health care services##2##6##(1993-2#1)(1994-1#1)
and utilization of the Clearinghouse's services##2##6##(1994-1#2)
and utilization of the##4##4##(1994-1#3)(2008-7#1)
and utilization of##17##3##(1991-12#1)(1992-3#1)(1993-2#2)(1993-9#1)(1994-1#4)(1994-11#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-7#3)(2010-10#1)
and utilization on##2##3##(1992-12#1)(2008-10#1)
and utilization rates##2##3##(1993-1#2)
and utilization review##2##3##(1994-1#1)(1997-3#1)
and utilization##44##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-2#2)(1993-9#1)(1994-1#7)(1994-11#1)(1994-12#2)(1994-2#2)(1995-1#3)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)
and utilize a##2##3##(2007-12#1)(2008-10#1)
and utilize the##2##3##(2008-10#1)(2008-9#1)
and utilize##9##2##(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
and utilized as##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
and utilized for##2##3##(2008-10#1)(2008-3#1)
and utilized in the##2##4##(2008-12#1)(2011-2#1)
and utilized in##5##3##(1996-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
and utilized to##3##3##(2008-10#2)(2008-2#1)
and utilized##16##2##(1991-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
and utilizes##2##2##(2008-10#1)(2012-3#1)
and utilizing##5##2##(1990-2#1)(1994-1#1)(2008-12#1)(2013-1#2)
and uveitis##2##2##(2010-12#1)(2012-3#1)
and v)##2##2##(2007-11#1)(2009-9#1)
and vWF levels##3##3##(2013-8#3)
and vWF##6##2##(2013-8#6)
and vaccination strategies##2##3##(2008-7#1)(2012-2#1)
and vaccination##7##2##(1993-6#1)(1997-8#1)(2008-11#2)(2008-7#1)(2012-2#2)
and vaccinations##2##2##(2011-2#1)(2012-3#1)
and vaccine##7##2##(1996-12#1)(2008-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)
and vaccines##8##2##(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#2)(2012-2#1)
and vacuolar##4##2##(1995-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
and vacuolation of##2##3##(1995-11#1)(2008-10#1)
and vacuolation##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
and vacuum##5##2##(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)
and vagal##2##2##(2008-6#1)(2009-7#1)
and vagina##2##2##(1990-8#1)(2010-11#1)
and vaginal hysterectomy in##2##4##(1993-12#2)
and vaginal hysterectomy##3##3##(1993-12#3)
and vaginal##13##2##(1992-3#1)(1993-12#5)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)(2013-1#1)
and valeric acids##2##3##(1991-5#1)(2008-6#1)
and valeric##3##2##(1991-5#1)(2008-6#2)
and valid##10##2##(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and validate a##6##3##(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
and validate the##6##3##(2006-10#1)(2008-10#1)(2008-11#1)(2010-7#1)(2010-8#1)(2012-1#1)
and validate##18##2##(2006-10#1)(2008-10#6)(2008-11#2)(2008-5#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
and validated by use of##2##5##(2008-3#2)
and validated by##9##3##(2008-10#5)(2008-12#2)(2008-3#2)
and validated for##8##3##(2008-10#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)
and validated in the##2##4##(2008-10#2)
and validated in##4##3##(2008-10#4)
and validated on##2##3##(2008-3#1)(2013-1#1)
and validated the##2##3##(2008-10#1)(2008-2#1)
and validated through##2##3##(1995-12#1)(2008-10#1)
and validated using##4##3##(1990-12#1)(2008-10#3)
and validated with##2##3##(2008-10#2)
and validated##54##2##(1990-12#1)(1992-9#1)(1995-12#1)(2008-10#27)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#4)(2013-8#1)
and validates the##2##3##(2008-10#2)
and validates##3##2##(2008-10#2)(2011-2#1)
and validating##2##2##(2008-10#1)(2013-1#1)
and validation are##2##3##(1997-7#1)(2008-10#1)
and validation of a##16##4##(1992-9#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#1)
and validation of an##4##4##(1990-2#1)(1996-12#1)(2008-10#1)(2009-12#1)
and validation of the##3##4##(2009-3#1)(2011-2#1)(2012-2#1)
and validation of##34##3##(1990-2#1)(1992-9#1)(1996-12#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2009-12#2)(2009-3#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and validation sets##2##3##(2008-10#2)
and validation##66##2##(1990-2#1)(1992-9#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#29)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#4)(2008-7#4)(2009-12#2)(2009-3#1)(2010-11#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
and validity in##2##3##(1993-12#1)(2008-11#1)
and validity of the##11##4##(1993-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#3)(2012-12#1)
and validity of##19##3##(1992-3#1)(1993-11#1)(1993-3#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)
and validity##29##2##(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-3#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
and valine##5##2##(1995-11#3)(1996-2#1)(2008-10#1)
and valuable information##2##3##(2009-11#1)(2012-2#1)
and valuable tools##2##3##(2008-10#1)(2011-2#1)
and valuable##13##2##(1990-3#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
and value of##9##3##(1992-6#1)(1993-1#1)(1993-3#1)(1995-1#2)(1995-3#1)(2008-9#1)(2011-1#1)(2011-2#1)
and value##17##2##(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)
and value-added##2##2##(1993-1#1)(2013-1#1)
and valued##2##2##(2010-5#1)(2011-1#1)
and values for##2##3##(1990-8#1)(1991-3#1)
and values in##2##3##(1996-12#1)(2009-7#1)
and values of##4##3##(1997-3#1)(2008-7#3)
and values##24##2##(1990-8#1)(1991-3#1)(1992-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#4)(2009-4#1)(2009-7#3)(2011-2#1)
and valve function##2##3##(2007-8#2)
and valve##3##2##(2007-8#2)(2012-2#1)
and valvular##5##2##(1990-11#1)(1991-12#1)(2007-8#3)
and van der Waals##3##4##(1993-8#1)(2007-11#1)(2010-4#1)
and van##5##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-4#1)
and vanadate##5##2##(1997-1#5)
and vanadium##9##2##(2008-10#8)(2008-6#1)
and vanadium(V)##6##2##(2008-10#6)
and vancomycin##2##2##(2007-7#1)(2008-12#1)
and vapor##6##2##(1992-3#1)(2007-5#1)(2008-3#4)
and vaporization in a##2##4##(1996-1#1)(2008-3#1)
and vaporization##6##2##(1996-1#1)(2008-10#4)(2008-3#1)
and variability in##2##3##(1993-2#1)(2008-8#1)
and variability of##4##3##(1991-11#1)(2008-6#1)(2011-2#2)
and variability##9##2##(1991-11#1)(1993-2#1)(2008-6#1)(2008-8#3)(2011-2#3)
and variable##27##2##(1992-6#1)(1993-12#1)(1994-11#2)(1997-3#2)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#2)
and variables##4##2##(1996-12#1)(1996-5#1)(2010-10#1)(2012-12#1)
and variably##2##2##(2008-11#1)(2012-3#1)
and variance of##3##3##(1992-9#1)(2007-11#1)(2008-10#1)
and variance##6##2##(1992-9#1)(2007-11#1)(2008-10#2)(2008-3#2)
and variances of##4##3##(1995-5#1)(2012-1#3)
and variant scaffolds##2##3##(2012-2#2)
and variant##3##2##(2008-4#1)(2012-2#2)
and variants##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
and variation in pathogenicity##2##4##(2008-10#2)
and variation in##11##3##(1997-8#1)(2007-12#1)(2008-10#5)(2008-8#1)(2008-9#2)(2013-1#1)
and variation of##6##3##(1994-3#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
and variation##21##2##(1994-3#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and variations in the##2##4##(1993-12#1)(2008-12#1)
and variations in##5##3##(1992-8#1)(1993-12#1)(2008-10#1)(2008-12#1)(2009-4#1)
and variations of##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
and variations##8##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)
and varied from##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
and varied in##2##3##(2008-10#1)(2008-11#1)
and varied with##2##3##(1992-3#1)(2008-10#1)
and varied##16##2##(1992-3#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
and varies##6##2##(1990-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
and variety of##4##3##(1995-5#1)(1997-2#1)(1997-4#1)(2009-1#1)
and variety##5##2##(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2009-1#1)
and various foreign##3##3##(2008-10#3)
and various forms of##2##4##(2008-10#1)(2011-3#1)
and various organs##3##3##(1991-5#1)(1992-9#1)(2008-5#1)
and various other##3##3##(1996-4#1)(2008-7#1)(2013-1#1)
and various types of##3##4##(1993-3#1)(2008-3#1)(2008-7#1)
and various types##4##3##(1993-3#1)(2008-3#1)(2008-7#1)(2012-2#1)
and various##103##2##(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and vary##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
and varying degrees of##2##4##(2008-9#1)(2010-12#1)
and varying##8##2##(1994-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)
and vascular biology##2##3##(2008-1#2)
and vascular dementia##3##3##(2008-7#3)
and vascular disease##2##3##(2006-10#1)(2011-2#1)
and vascular endothelial growth factor##3##5##(1997-7#1)(2008-7#2)
and vascular endothelial##7##3##(1991-5#2)(1997-7#1)(2008-3#1)(2008-7#2)(2008-9#1)
and vascular imaging##2##3##(2008-8#1)(2010-8#1)
and vascular plant##2##3##(2008-11#1)(2008-9#1)
and vascular plants##3##3##(2008-8#3)
and vascular reactivity##3##3##(1995-12#1)(2012-2#2)
and vascular smooth muscle cells##2##5##(2008-11#1)(2009-2#1)
and vascular smooth muscle##4##4##(1991-6#1)(2008-11#2)(2009-2#1)
and vascular tissues##2##3##(2008-3#1)(2008-9#1)
and vascular##60##2##(1991-3#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-1#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-2#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#1)
and vascularity##2##2##(2008-7#1)(2009-5#1)
and vasculature##4##2##(2007-7#1)(2008-9#1)(2012-2#2)
and vasoactive intestinal polypeptide (VIP)##2##5##(1993-9#1)(1995-11#1)
and vasoactive intestinal polypeptide##3##4##(1993-9#1)(1995-11#1)(1997-1#1)
and vasoconstriction##2##2##(1990-5#1)(1994-9#1)
and vasodilatation##2##2##(1990-12#1)(2008-10#1)
and vasodilation##2##2##(1997-7#1)(2013-8#1)
and vasodilator##2##2##(1991-3#1)(1992-5#1)
and vasodilators##2##2##(1997-5#1)(2010-10#1)
and vasopressin##4##2##(1992-8#1)(1995-12#1)(1997-4#2)
and vast##2##2##(1992-2#1)(2008-11#1)
and vector##12##2##(1990-5#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#2)
and vectors##2##2##(1995-2#1)(2008-8#1)
and vegetable consumption##3##3##(2008-7#1)(2009-4#1)(2009-5#1)
and vegetable protein##2##3##(2013-8#2)
and vegetable##16##2##(1992-10#1)(2008-10#5)(2008-7#1)(2009-4#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
and vegetables and##4##3##(1990-8#1)(1994-2#1)(2008-10#1)(2011-1#1)
and vegetables##37##2##(1990-8#3)(1991-2#1)(1994-2#2)(1997-1#1)(2007-12#1)(2008-10#7)(2008-4#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#6)(2013-1#3)(2013-8#1)
and vegetation cover##4##3##(2008-12#4)
and vegetation##14##2##(2008-10#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2013-7#1)
and vegetative buds##2##3##(2008-10#2)
and vegetative compatibility groups (VCGs)##2##5##(2008-10#2)
and vegetative compatibility groups##3##4##(2008-10#3)
and vegetative compatibility##6##3##(2008-10#6)
and vegetative##10##2##(2008-10#10)
and vehicles##2##2##(2008-8#1)(2012-12#1)
and vein##7##2##(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2009-3#1)
and veins are##2##3##(1996-2#1)(2008-3#1)
and veins##11##2##(1995-12#4)(1996-2#1)(1996-8#1)(2006-10#1)(2008-3#1)(2010-4#1)(2010-8#2)
and velocity in##2##3##(2007-12#1)(2008-3#1)
and velocity measurements##3##3##(2008-2#2)(2008-3#1)
and velocity of##3##3##(1991-12#1)(1997-7#1)(2008-7#1)
and velocity##20##2##(1991-12#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#3)(2013-1#1)
and vendor must##2##3##(1991-3#1)(1992-12#1)
and vendors##4##2##(1993-12#1)(1997-3#1)(2007-10#1)(2008-10#1)
and venlafaxine##3##2##(2008-11#1)(2012-2#2)
and venographic##2##2##(2012-3#2)
and venous thromboembolism##6##3##(1997-2#1)(1997-5#4)(2007-2#1)
and venous##23##2##(1990-3#2)(1996-9#2)(1997-2#1)(1997-5#4)(1997-6#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and ventilated##4##2##(1996-3#1)(1997-6#1)(2007-8#1)(2008-7#1)
and ventilation##3##2##(1994-6#1)(2006-10#1)(2010-7#1)
and ventilator##3##2##(2008-10#1)(2012-2#2)
and ventilatory##4##2##(1994-12#1)(1996-2#2)(2008-7#1)
and ventral PFC##2##3##(2008-11#2)
and ventral striatum##2##3##(1994-8#1)(2011-1#1)
and ventral##18##2##(1990-5#1)(1990-7#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#2)(2007-12#2)(2008-11#3)(2008-6#1)(2011-1#1)(2011-2#1)
and ventricles##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
and ventricular fibrillation##3##3##(1995-12#1)(1996-3#2)
and ventricular function in##2##4##(2009-10#1)(2010-4#1)
and ventricular##14##2##(1995-12#1)(1995-8#1)(1996-3#3)(2006-7#1)(2007-8#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)(2012-1#1)
and ventrolateral flagella##2##3##(2007-12#2)
and ventrolateral##3##2##(2007-12#3)
and ventromedial##2##2##(1993-12#1)(2008-4#1)
and venture##2##2##(1993-3#1)(2008-11#1)
and venules##2##2##(1995-12#1)(2007-12#1)
and verapamil##5##2##(1990-7#1)(1991-9#2)(1993-8#1)(2011-2#1)
and verbal##6##2##(2008-10#1)(2009-9#1)(2010-7#2)(2013-1#1)(2013-8#1)
and verbalized##2##2##(2010-6#1)(2011-2#1)
and verification of the##2##4##(2008-9#2)
and verification of##5##3##(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#2)
and verification##8##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)
and verified by direct##2##4##(2007-12#1)(2008-3#1)
and verified by##6##3##(1993-2#1)(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)
and verified experimentally##2##3##(2008-3#2)
and verified that##2##3##(2008-10#1)(2008-9#1)
and verified##14##2##(1993-2#1)(2007-12#1)(2008-10#2)(2008-3#5)(2008-8#1)(2008-9#2)(2009-2#1)(2013-1#1)
and verify the##5##3##(2007-11#1)(2008-12#1)(2008-3#2)(2008-6#1)
and verify##9##2##(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-8#1)
and verifying##3##2##(2008-2#1)(2008-4#2)
and versatile##18##2##(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#1)(2012-2#1)
and versatility of the##2##4##(2007-5#1)(2008-10#1)
and versatility of##5##3##(2007-5#1)(2008-10#2)(2008-7#1)(2010-2#1)
and vertebral rotation##2##3##(2007-8#2)
and vertebral##9##2##(1990-11#1)(1997-4#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
and vertebrate##9##2##(1990-5#1)(1996-6#1)(2007-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)
and vertebrates##14##2##(1991-9#1)(2007-12#9)(2008-11#1)(2008-9#3)
and vertical components of##2##4##(1990-5#1)(2008-9#1)
and vertical components##3##3##(1990-5#1)(2008-11#1)(2008-9#1)
and vertical transmission##5##3##(2008-9#4)(2011-1#1)
and vertical##24##2##(1990-5#1)(1996-1#1)(2007-11#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#5)(2009-11#2)(2010-3#2)(2011-1#1)
and vertically##6##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-3#1)
and very expensive##2##3##(2008-10#1)(2008-11#1)
and very few cases have##2##5##(1990-12#1)(2013-1#1)
and very few##5##3##(1990-12#1)(1990-6#1)(2008-2#1)(2010-10#1)(2013-1#1)
and very good##8##3##(2007-11#3)(2008-10#3)(2011-2#1)(2013-1#1)
and very high##7##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)
and very low density lipoproteins##3##5##(1992-3#1)(1994-3#1)(1995-2#1)
and very low density##4##4##(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)
and very low##9##3##(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-7#1)
and very low-density lipoprotein##2##4##(1994-6#1)(2009-8#1)
and very often##2##3##(2010-3#1)(2011-2#1)
and very promising##2##3##(1996-12#1)(2007-11#1)
and very sensitive method##2##4##(2008-10#2)
and very sensitive##5##3##(2008-10#4)(2012-12#1)
and very simple method was developed for the simultaneous##2##9##(2008-10#2)
and very simple##3##3##(2008-10#2)(2008-2#1)
and very small##2##3##(2008-3#1)(2008-9#1)
and very##80##2##(1990-12#1)(1990-6#2)(1991-3#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and vesicatoria##2##2##(2008-10#2)
and vesicle##5##2##(1992-3#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
and vesicles of##2##3##(2007-12#1)(2009-10#1)
and vesicles##5##2##(1994-5#1)(2007-12#2)(2009-10#1)(2012-2#1)
and vesicular monoamine transporter##2##4##(1996-12#2)
and vesicular##5##2##(1996-12#3)(2008-7#1)(2013-1#1)
and vessel wall##2##3##(2010-12#1)(2012-3#1)
and vessel##6##2##(1990-12#1)(2007-7#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-3#1)
and vessels##2##2##(2007-8#1)(2010-1#1)
and vestibular##6##2##(1995-12#1)(1995-5#2)(1995-8#2)(2012-3#1)
and veterinary##3##2##(1992-8#1)(2010-1#1)(2012-3#1)
and via##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
and viability in##2##3##(2008-11#1)(2013-1#1)
and viability of the##4##4##(2008-11#1)(2008-5#1)(2011-2#2)
and viability of##7##3##(2008-11#2)(2008-5#2)(2011-2#2)(2012-2#1)
and viability##22##2##(1995-9#1)(2007-2#1)(2007-7#1)(2008-11#5)(2008-4#1)(2008-5#2)(2008-9#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
and viable cell density##2##4##(2008-11#2)
and viable cell##3##3##(2008-11#2)(2008-7#1)
and viable counts##3##3##(2008-10#3)
and viable##12##2##(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2010-12#1)(2012-3#1)
and vibration##2##2##(2007-11#1)(2013-8#1)
and vibrational Raman##2##3##(2008-3#2)
and vibrational frequencies##2##3##(1996-2#1)(2013-1#1)
and vibrational##5##2##(1996-2#1)(2008-3#2)(2013-1#2)
and vibrations##2##2##(1994-3#1)(2008-2#1)
and vibratory signaling##2##3##(2009-9#2)
and vice versa##23##3##(1990-5#1)(1991-2#1)(1991-8#1)(1993-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
and vice##24##2##(1990-5#1)(1991-2#1)(1991-8#1)(1993-3#1)(1994-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
and vice-versa##2##2##(2008-12#1)(2010-10#1)
and victim##2##2##(2008-11#1)(2008-3#1)
and victimization among##2##3##(2009-7#1)(2010-1#1)
and victimization##7##2##(2009-7#3)(2010-1#3)(2013-1#1)
and video##6##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
and viewed as##2##3##(2008-10#1)(2008-12#1)
and viewed##7##2##(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-7#1)
and viewing##6##2##(2007-2#1)(2008-11#1)(2008-3#4)
and views##2##2##(1997-2#1)(2008-1#1)
and vigorous##2##2##(2008-7#1)(2013-1#1)
and vigorously##2##2##(1991-1#1)(2010-9#1)
and vimentin##4##2##(1991-6#1)(1993-8#1)(2012-1#1)(2013-1#1)
and vinblastine##3##2##(1993-8#1)(2011-1#2)
and vinclozolin##6##2##(2008-10#6)
and vincristine##3##2##(1991-6#1)(2008-11#1)(2009-11#1)
and vindesine##3##2##(1990-2#1)(1992-12#2)
and vinyl##2##2##(2008-11#1)(2011-2#1)
and violence against##2##3##(2008-12#1)(2011-2#1)
and violence##10##2##(1990-2#1)(1994-9#1)(1996-1#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-8#1)(2011-2#2)
and violent##5##2##(1990-6#1)(1995-2#1)(2009-5#1)(2009-7#1)(2012-2#1)
and viral RNA##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
and viral genes##3##3##(1995-2#1)(2008-8#1)(2010-1#1)
and viral infections##2##3##(2008-5#1)(2013-1#1)
and viral pathogens##3##3##(2008-10#2)(2010-12#1)
and viral##34##2##(1991-2#1)(1993-3#1)(1995-2#2)(1995-5#1)(1996-6#1)(2008-10#5)(2008-11#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
and virion##6##2##(1997-3#4)(2008-10#2)
and virological##2##2##(2007-7#1)(2012-3#1)
and virtual##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
and virtually##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
and virulence genes##2##3##(2008-10#1)(2012-3#1)
and virulence of the##2##4##(2008-10#1)(2008-7#1)
and virulence of##6##3##(2008-10#3)(2008-12#1)(2008-7#1)(2009-2#1)
and virulence phenotypes##2##3##(2008-10#2)
and virulence##32##2##(2007-7#1)(2008-10#20)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#2)(2011-2#2)(2012-3#2)
and virulent to##2##3##(2008-10#2)
and virulent##8##2##(2008-10#7)(2010-12#1)
and virus accumulation##2##3##(2008-10#2)
and virus neutralization##2##3##(1997-3#1)(2008-12#1)
and virus replication##3##3##(1992-12#1)(1994-11#1)(2008-9#1)
and virus##25##2##(1991-2#1)(1992-12#1)(1994-11#1)(1997-3#3)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-8#1)
and virus-induced vesicles##2##3##(2008-10#2)
and virus-infected##3##2##(2008-10#1)(2008-11#2)
and viruses##14##2##(1992-12#1)(1995-12#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-7#1)
and viscera##2##2##(1992-2#1)(2012-12#1)
and visceral leishmaniasis##2##3##(2008-12#1)(2013-1#1)
and visceral##18##2##(1992-6#2)(1995-1#1)(1997-3#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#3)
and viscoelastic##4##2##(2008-5#1)(2009-4#2)(2012-2#1)
and viscoelasticity##2##2##(2008-5#1)(2009-4#1)
and viscosity of the##4##4##(2008-3#1)(2008-5#1)(2009-7#1)(2013-8#1)
and viscosity of##5##3##(2008-3#1)(2008-5#1)(2009-7#1)(2013-8#2)
and viscosity##12##2##(2008-3#1)(2008-5#4)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
and visibility of the##2##4##(2007-11#1)(2008-3#1)
and visibility of##3##3##(2007-11#1)(2008-3#1)(2012-1#1)
and visibility##6##2##(1994-2#1)(2007-11#1)(2008-2#2)(2008-3#1)(2012-1#1)
and visible light##3##3##(2008-10#2)(2008-11#1)
and visible##18##2##(1992-2#1)(1993-12#1)(1995-2#1)(1996-1#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2013-1#1)
and vision##3##2##(1994-1#1)(1996-11#1)(2013-1#1)
and visions##2##2##(1995-11#1)(2008-1#1)
and visitors##4##2##(1992-2#1)(1994-12#1)(1995-2#1)(1996-12#1)
and visual MMN##2##3##(2008-8#2)
and visual cortex##2##3##(1997-2#1)(2008-1#1)
and visual disturbances##2##3##(2008-8#1)(2011-2#1)
and visual field##3##3##(2011-2#3)
and visual##35##2##(1990-3#1)(1991-2#1)(1991-6#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#6)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#2)
and visualization of the##2##4##(2008-6#1)(2011-2#1)
and visualization of##9##3##(2008-1#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#2)
and visualization##21##2##(2008-1#1)(2008-10#2)(2008-4#6)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#3)(2011-7#1)
and visualize##6##2##(1995-11#1)(2008-10#1)(2008-4#2)(2008-7#2)
and visualized##3##2##(1995-6#1)(2006-8#1)(2008-10#1)
and visualizing##4##2##(2008-4#3)(2008-6#1)
and visually##2##2##(2008-12#1)(2008-4#1)
and visuospatial functioning##2##3##(2009-10#1)(2009-6#1)
and visuospatial##3##2##(2008-7#1)(2009-10#1)(2009-6#1)
and vital##8##2##(2008-11#2)(2008-7#1)(2010-8#1)(2012-12#4)
and vitality##4##2##(2007-11#1)(2011-2#1)(2013-1#2)
and vitamin B(6)##2##3##(2007-10#1)(2008-3#1)
and vitamin C##4##3##(1992-9#1)(1997-8#1)(2008-10#1)(2012-12#1)
and vitamin D##6##3##(1993-3#1)(1997-6#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-8#1)
and vitamin E##6##3##(1992-9#1)(1993-2#1)(2008-10#1)(2008-5#2)(2012-2#1)
and vitamin##35##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-9#4)(1993-2#1)(1993-3#1)(1995-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and vitamin-like compounds##2##3##(1995-6#2)
and vitamins##3##2##(1992-9#1)(2008-3#1)(2008-5#1)
and vitiligo##4##2##(1997-8#1)(2007-5#2)(2008-8#1)
and vitronectin##2##2##(2008-11#2)
and vocal##4##2##(2008-9#2)(2009-11#1)(2013-8#1)
and vocational##3##2##(1993-3#1)(2007-12#1)(2009-7#1)
and voice##6##2##(2008-7#1)(2009-10#1)(2011-1#1)(2012-1#3)
and voids##2##2##(2008-3#1)(2012-2#1)
and volar forearm##3##3##(2008-5#3)
and volar##5##2##(2008-5#3)(2008-9#2)
and volatile organic compounds##2##4##(2008-10#1)(2013-1#1)
and volatile##6##2##(1997-1#1)(2008-10#4)(2013-1#1)
and volatilization##2##2##(2008-10#2)
and voltage##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)(2013-1#1)
and voltage-activated##2##2##(2008-8#2)
and voltage-dependent##3##2##(1993-3#2)(1996-2#1)
and voltammetric determination of##3##4##(2008-10#3)
and voltammetric##8##2##(2008-10#8)
and voltammetry##3##2##(2008-10#3)
and volume measurements of##2##4##(2008-3#1)(2009-3#1)
and volume measurements##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
and volume mixing ratio##2##4##(2008-3#2)
and volume of the##4##4##(1990-11#1)(2008-10#3)
and volume of##24##3##(1990-11#1)(1991-2#2)(1995-3#1)(1996-5#1)(2008-10#14)(2008-2#1)(2008-7#1)(2011-1#2)(2011-2#1)
and volume##57##2##(1990-11#3)(1990-8#2)(1991-12#1)(1991-2#3)(1992-12#2)(1995-3#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-10#18)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2013-1#2)
and volumes##7##2##(1994-3#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)
and volumetric##7##2##(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
and voluntary health##2##3##(2008-11#1)(2012-1#1)
and voluntary sector##2##3##(1994-12#1)(1996-3#1)
and voluntary##9##2##(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
and volunteer##4##2##(1991-3#1)(1992-3#1)(1993-12#1)(1996-2#1)
and volunteerism##5##2##(1991-2#1)(2008-12#1)(2008-4#1)(2008-5#2)
and volunteers##5##2##(1991-3#1)(1992-3#2)(1993-2#1)(1996-7#1)
and vomiting in##2##3##(1990-12#1)(1990-6#1)
and vomiting were##3##3##(1991-6#1)(2008-6#1)(2011-2#1)
and vomiting##33##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1995-9#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#4)(2010-12#3)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#4)
and von Willebrand factor##2##4##(1990-5#1)(2013-8#1)
and von Willebrand##3##3##(1990-5#1)(2008-11#1)(2013-8#1)
and von##4##2##(1990-5#1)(2008-11#1)(2008-12#1)(2013-8#1)
and vulnerabilities##2##2##(1995-12#1)(2011-2#1)
and vulnerability to##2##3##(2008-8#1)(2009-10#1)
and vulnerability##10##2##(1996-3#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
and vulnerable##4##2##(1997-1#1)(2009-9#1)(2010-12#1)(2013-7#1)
and vulvovaginal candidiasis##3##3##(2008-5#1)(2011-1#2)
and w##2##2##(2007-2#1)(2010-4#1)
and w/o##3##2##(2008-5#3)
and waist circumference##5##3##(2008-11#1)(2010-8#2)(2011-1#1)(2011-2#1)
and waist##6##2##(2008-11#1)(2010-8#2)(2011-1#1)(2011-2#2)
and waist-to-hip ratio##2##3##(2007-12#1)(2008-11#1)
and waiting##3##2##(1991-11#1)(2007-12#1)(2007-8#1)
and wake##2##2##(1996-7#1)(2007-12#1)
and walking##6##2##(2007-10#1)(2007-12#1)(2008-7#2)(2010-4#1)(2012-1#1)
and wall motion##4##3##(1997-8#2)(2007-8#2)
and wall teichoic acid##2##4##(1995-6#2)
and wall##9##2##(1995-6#2)(1997-8#2)(2007-8#2)(2008-2#1)(2009-10#2)
and ward staff##3##3##(2007-10#1)(2011-1#2)
and warm##3##2##(1990-12#1)(2008-10#1)(2008-7#1)
and warm-acclimated Turkish hamsters##2##4##(1996-5#2)
and warrant further research##2##4##(2010-10#1)(2010-2#1)
and warrant further##3##3##(1992-2#1)(2010-10#1)(2010-2#1)
and warrant##4##2##(1992-2#1)(2010-10#1)(2010-2#1)(2011-2#1)
and warrants further investigation##2##4##(2008-5#1)(2009-8#1)
and warrants further##3##3##(2007-8#1)(2008-5#1)(2009-8#1)
and warrants##5##2##(2007-12#1)(2007-8#1)(2008-5#1)(2009-8#1)(2011-1#1)
and was 1##2##3##(1992-3#1)(2008-11#1)
and was a##4##3##(1992-3#1)(2008-1#1)(2008-11#1)(2008-7#1)
and was able to##4##4##(1993-8#1)(1995-2#1)(2008-10#1)(2013-1#1)
and was abolished by the##2##5##(1994-6#1)(2008-6#1)
and was abolished by##7##4##(1990-2#1)(1992-7#1)(1993-6#1)(1994-6#1)(1997-2#1)(2008-6#1)(2011-2#1)
and was abolished##8##3##(1990-2#1)(1991-12#1)(1992-7#1)(1993-6#1)(1994-6#1)(1997-2#1)(2008-6#1)(2011-2#1)
and was affected by##2##4##(1992-3#1)(2009-7#1)
and was also observed in the 0 AFB(1)##2##8##(2008-10#2)
and was also##4##3##(1993-2#1)(2008-10#3)
and was an##2##3##(2008-12#1)(2008-8#1)
and was applied for##2##4##(2008-10#2)
and was applied to a##2##5##(2008-10#2)
and was applied to the determination of##2##7##(2008-10#2)
and was applied to##5##4##(2008-10#4)(2013-1#1)
and was applied##9##3##(2008-10#8)(2013-1#1)
and was approved by##2##4##(2008-9#1)(2012-3#1)
and was associated with a##3##5##(1997-4#1)(2008-1#1)(2010-5#1)
and was associated with the##3##5##(1993-3#1)(2010-12#2)
and was associated with##10##4##(1993-3#1)(1995-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-12#2)(2010-5#1)(2013-8#1)
and was asymptomatic##2##3##(2013-1#2)
and was at##2##3##(1990-12#1)(1994-8#1)
and was attributed to the##2##5##(1997-4#1)(2008-10#1)
and was based on the##3##5##(2008-10#2)(2008-11#1)
and was based on##5##4##(2008-10#3)(2008-11#1)(2012-12#1)
and was below the##3##4##(1991-11#1)(2008-10#1)(2008-5#1)
and was blocked by##3##4##(1990-5#1)(1992-3#1)(1995-12#1)
and was characterized by##3##4##(1995-2#1)(2008-10#1)(2012-1#1)
and was characterized##5##3##(1994-2#1)(1995-2#1)(2008-10#1)(2012-1#1)(2012-2#1)
and was clearly##2##3##(1996-12#1)(2007-6#1)
and was compared with the##2##5##(1995-2#1)(2008-10#1)
and was compared with##4##4##(1991-12#1)(1995-2#1)(2008-10#1)(2008-8#1)
and was completely##3##3##(1993-11#1)(1994-11#1)(2008-7#1)
and was confirmed##2##3##(2009-1#1)(2012-3#1)
and was consequently##2##3##(2008-10#1)(2008-8#1)
and was considerably##2##3##(2008-10#2)
and was consistent##2##3##(1997-3#1)(2008-8#1)
and was continued##2##3##(2007-8#1)(2011-1#1)
and was correlated with the##2##5##(2008-10#1)(2009-11#1)
and was correlated with##5##4##(1997-6#1)(2008-10#3)(2009-11#1)
and was correlated##6##3##(1997-6#1)(2006-10#1)(2008-10#3)(2009-11#1)
and was deemed##2##3##(2008-10#1)(2008-12#1)
and was described##2##3##(2008-10#2)
and was designated##2##3##(1990-7#1)(2008-10#1)
and was designed to##3##4##(1993-11#1)(1997-6#1)(2008-9#1)
and was detected in##2##4##(1997-8#1)(2008-1#1)
and was detected##3##3##(1997-8#1)(2008-1#1)(2008-7#1)
and was diagnosed as having##2##5##(1996-9#1)(2008-7#1)
and was diagnosed as##4##4##(1996-9#1)(2008-7#2)(2011-2#1)
and was diagnosed with##3##4##(2008-2#1)(2009-12#1)(2010-10#1)
and was diagnosed##9##3##(1996-9#1)(2008-2#1)(2008-7#3)(2009-12#1)(2010-10#2)(2011-2#1)
and was discharged on the##2##5##(2010-5#1)(2011-1#1)
and was discharged##3##3##(2010-12#1)(2010-5#1)(2011-1#1)
and was dissolved##2##3##(1994-11#1)(2008-10#1)
and was distributed##2##3##(1993-6#1)(1996-1#1)
and was due to##3##4##(1992-6#1)(1997-2#1)(2007-11#1)
and was due##4##3##(1992-6#1)(1997-2#1)(2007-11#1)(2007-7#1)
and was eluted##2##3##(1990-8#1)(2008-10#1)
and was expected to##2##4##(2008-10#1)(2008-7#1)
and was expressed in nmol##2##5##(2008-7#2)
and was expressed##3##3##(2006-6#1)(2008-7#2)
and was faster in##2##4##(2007-12#1)(2008-8#1)
and was first##2##3##(2008-10#2)
and was followed by##2##4##(2008-5#1)(2010-8#1)
and was followed##3##3##(1990-5#1)(2008-5#1)(2010-8#1)
and was found in##3##4##(2008-9#1)(2011-2#1)(2012-12#1)
and was found to be a##2##6##(1990-11#1)(1991-11#1)
and was found to be##12##5##(1990-11#1)(1990-7#1)(1991-11#1)(1993-9#1)(2007-12#1)(2008-10#6)(2011-1#1)
and was found to have##4##5##(2008-7#2)(2012-2#1)(2013-8#1)
and was found to##25##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#1)(1993-9#1)(2007-12#1)(2008-10#10)(2008-3#2)(2008-7#2)(2011-1#2)(2012-2#1)(2013-8#1)
and was found##29##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#1)(1993-9#1)(1995-11#1)(2007-12#1)(2008-10#10)(2008-3#2)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and was fully##2##3##(1993-9#1)(2009-3#1)
and was further##4##3##(2008-10#1)(2008-11#1)(2010-3#1)(2012-12#1)
and was generally##3##3##(1991-2#1)(1991-6#1)(2012-2#1)
and was greater for##2##4##(2008-10#1)(2008-9#1)
and was greater##3##3##(2008-10#2)(2008-9#1)
and was greatest##2##3##(2008-10#2)
and was higher##2##3##(2008-9#1)(2011-2#1)
and was highly##4##3##(1991-7#1)(2008-10#3)
and was identified as##2##4##(2008-10#1)(2013-1#1)
and was identified in##2##4##(2008-10#2)
and was identified##5##3##(2008-10#3)(2013-1#2)
and was in##2##3##(2008-2#1)(2010-10#1)
and was increased##5##3##(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#1)(2013-8#1)
and was independent of##2##4##(1991-5#1)(1993-6#1)
and was inhibited by the##3##5##(1992-11#1)(2008-10#1)(2008-4#1)
and was inhibited by##8##4##(1990-12#1)(1992-11#1)(1992-3#1)(2006-6#1)(2008-10#2)(2008-4#1)(2013-1#1)
and was injected##2##3##(2008-10#2)
and was located##2##3##(2008-7#1)(2012-12#1)
and was lost##3##3##(1990-5#1)(1994-5#1)(2012-3#1)
and was lowest##2##3##(2007-5#1)(2008-10#1)
and was mainly##2##3##(1996-5#1)(1997-2#1)
and was maintained##3##3##(2008-11#1)(2008-4#1)(2009-10#1)
and was mapped##2##3##(2008-10#2)
and was more effective##2##4##(2008-10#1)(2011-2#1)
and was more efficient##2##4##(1992-11#1)(2008-10#1)
and was more##9##3##(1992-11#1)(1992-12#1)(1994-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
and was most##2##3##(2008-10#2)
and was much##2##3##(2008-10#1)(2009-2#1)
and was named##3##3##(1990-7#1)(2008-10#2)
and was negatively correlated##2##4##(2008-10#2)
and was negatively##3##3##(2008-10#2)(2013-8#1)
and was not affected by##3##5##(1990-2#1)(1990-7#1)(2008-10#1)
and was not associated with##3##5##(1995-11#1)(2009-10#1)(2009-3#1)
and was not detected##2##4##(1995-11#1)(2008-12#1)
and was not influenced by##3##5##(1990-12#1)(2008-10#1)(2008-11#1)
and was not significantly##4##4##(1995-12#1)(1997-6#1)(2010-5#1)(2010-8#1)
and was not##27##3##(1990-12#1)(1990-2#1)(1990-7#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)
and was observed##3##3##(1992-9#1)(1993-9#1)(2007-12#1)
and was only##3##3##(1992-3#1)(1996-5#1)(2011-2#1)
and was partially##3##3##(1990-2#1)(1994-12#1)(2008-5#1)
and was partly##2##3##(2008-11#1)(2008-3#1)
and was positioned##2##3##(2008-10#1)(2008-6#1)
and was present##2##3##(1996-9#1)(2009-3#1)
and was proved to be##2##5##(1997-1#1)(2008-10#1)
and was purified by##2##4##(2008-10#1)(2008-11#1)
and was reduced##3##3##(1996-5#1)(1997-8#1)(2008-10#1)
and was referred to##2##4##(1995-12#1)(2013-8#1)
and was related to##2##4##(1993-9#1)(2008-10#1)
and was relatively##2##3##(1992-12#1)(2011-1#1)
and was restricted to the##2##5##(2008-10#2)
and was restricted to##3##4##(1997-1#1)(2008-10#2)
and was seen##2##3##(2007-7#1)(2008-11#1)
and was sensitive##2##3##(2008-10#1)(2013-7#1)
and was separated from the aqueous layer by adding sodium chloride##2##11##(2008-10#2)
and was separated##3##3##(2008-10#2)(2010-2#1)
and was shown to be a##3##6##(1993-12#1)(1994-11#1)(2011-2#1)
and was shown to be##5##5##(1993-12#1)(1994-11#1)(2008-10#2)(2011-2#1)
and was shown to##9##4##(1993-12#1)(1994-11#2)(1995-8#1)(2008-10#4)(2011-2#1)
and was shown##10##3##(1993-12#1)(1994-11#2)(1995-8#1)(2008-10#5)(2011-2#1)
and was significantly higher##2##4##(2008-1#1)(2008-10#1)
and was significantly reduced in##2##5##(1993-11#1)(2008-10#1)
and was significantly reduced##3##4##(1993-11#1)(2008-10#1)(2010-10#1)
and was significantly##11##3##(1993-11#1)(2008-1#1)(2008-10#6)(2010-10#1)(2010-3#1)(2011-2#1)
and was similar to##2##4##(2008-10#2)
and was similar##3##3##(2008-10#2)(2008-4#1)
and was slightly##2##3##(2008-10#1)(2010-10#1)
and was statistically significant##2##4##(2008-10#1)(2011-2#1)
and was still##2##3##(1994-9#1)(1995-6#1)
and was strongly associated with##2##5##(2010-12#1)(2010-8#1)
and was subsequently##2##3##(2008-10#1)(2010-7#1)
and was successfully applied to the##4##6##(2008-10#4)
and was successfully treated with##2##5##(2008-10#1)(2010-8#1)
and was successfully treated##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
and was successfully##10##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2010-8#1)
and was sustained##2##3##(1990-10#1)(1993-8#1)
and was the##5##3##(1992-6#1)(2008-10#3)(2010-6#1)
and was then##6##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-12#1)
and was therefore##4##3##(1997-6#1)(1997-7#1)(2008-10#1)(2013-1#1)
and was thus##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
and was treated with##2##4##(2008-11#1)(2011-1#1)
and was treated##5##3##(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
and was under##2##3##(1992-8#1)(2010-12#1)
and was unresponsive to##2##4##(2007-8#1)(2011-2#1)
and was used as a##2##5##(1997-4#1)(2008-10#1)
and was used for##3##4##(1990-11#1)(2008-10#2)
and was used to construct##2##5##(2007-11#1)(2008-10#1)
and was used to##5##4##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
and was used##12##3##(1990-11#1)(1995-1#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)
and was useful##2##3##(2008-10#1)(2010-8#1)
and was very##2##3##(2008-10#1)(2008-7#1)
and was well tolerated##2##4##(2008-3#1)(2011-2#1)
and was##605##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#5)(1990-6#3)(1990-7#4)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#7)(1994-1#1)(1994-11#10)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#5)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#6)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#4)(2008-1#6)(2008-10#163)(2008-11#19)(2008-12#4)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#6)(2008-7#22)(2008-8#10)(2008-9#8)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#6)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#7)(2011-2#15)(2012-1#2)(2012-12#11)(2012-2#6)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#7)
and washed##3##2##(1990-5#1)(2008-10#1)(2011-1#1)
and washing##9##2##(2008-10#8)(2008-7#1)
and waste water samples##2##4##(2008-10#2)
and waste water##7##3##(1994-5#1)(2008-10#6)
and waste waters##5##3##(2008-10#5)
and waste##19##2##(1993-11#1)(1994-5#1)(1997-3#1)(2008-10#14)(2008-11#1)(2012-2#1)
and waste-water##3##2##(2008-10#2)(2008-6#1)
and wastes##4##2##(1992-3#1)(2008-10#3)
and wastewater samples##6##3##(2008-10#6)
and wastewater##12##2##(2008-10#11)(2008-6#1)
and wastewaters##4##2##(2008-10#4)
and wasting##2##2##(1997-8#1)(2008-1#1)
and water agar##2##3##(2008-10#2)
and water by##2##3##(2008-10#2)
and water consumption##2##3##(2008-10#1)(2008-2#1)
and water containing##2##3##(2008-10#2)
and water content##4##3##(2008-12#1)(2008-5#1)(2008-7#2)
and water deficit##2##3##(2009-8#1)(2012-5#1)
and water depth##3##3##(2008-10#1)(2009-11#2)
and water holding capacity##2##4##(2008-5#1)(2010-4#1)
and water in##5##3##(1990-9#1)(2008-10#2)(2008-9#1)(2013-7#1)
and water intake##4##3##(1993-12#1)(2008-1#1)(2011-1#1)(2013-1#1)
and water molecules##2##3##(1997-7#2)
and water potential##3##3##(2008-10#3)
and water retention##4##3##(1997-7#3)(2011-2#1)
and water samples were##2##4##(2008-10#1)(2012-12#1)
and water samples with##2##4##(2008-10#2)
and water samples##15##3##(2008-10#14)(2012-12#1)
and water temperature##3##3##(2008-10#1)(2013-7#2)
and water transport##2##3##(2007-12#1)(2013-1#1)
and water use##2##3##(2008-5#1)(2009-6#1)
and water vapor in##2##4##(2008-2#1)(2008-3#1)
and water vapor##9##3##(1991-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
and water was##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
and water##155##2##(1990-9#1)(1991-2#2)(1991-5#2)(1992-1#1)(1992-9#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-7#5)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#68)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#16)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#4)(2013-7#4)(2013-8#2)
and water)##2##2##(1996-12#1)(2008-5#1)
and water-insoluble##2##2##(1996-5#1)(2008-6#1)
and water-soluble##5##2##(1991-3#1)(1991-5#1)(1992-2#1)(2008-10#2)
and water-vapor##3##2##(2008-3#3)
and watermelon##6##2##(2008-10#6)
and waters by##2##3##(2008-10#2)
and waters##6##2##(2008-10#6)
and watery##3##2##(1997-6#1)(2007-7#1)(2012-3#1)
and wave##2##2##(1992-11#1)(2010-7#1)
and wave-front##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
and waveguide##3##2##(2008-10#1)(2008-3#2)
and waveguides##2##2##(2007-12#1)(2008-3#1)
and wavelength tuning##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
and wavelength##26##2##(1996-2#1)(2007-11#5)(2007-12#5)(2008-10#3)(2008-2#3)(2008-3#4)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#2)
and wavelength-division##2##2##(2007-11#1)(2008-3#1)
and wavelengths##4##2##(2008-10#1)(2008-3#3)
and wavelet##2##2##(2008-2#1)(2008-3#1)
and waviness##2##2##(2008-2#1)(2008-3#1)
and wax##3##2##(2008-10#3)
and waxes##2##2##(2008-5#1)(2012-2#1)
and waxy##3##2##(2007-11#3)
and wayfinding##2##2##(2012-2#2)
and ways in which##2##4##(2008-3#1)(2009-5#1)
and ways to##10##3##(1992-12#1)(1994-2#2)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-1#1)
and ways##15##2##(1991-3#1)(1992-12#1)(1994-2#2)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-8#1)
and we also present##2##4##(2008-3#2)
and we also##6##3##(1994-8#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-6#1)
and we are##2##3##(2008-7#1)(2010-5#1)
and we assume that##2##4##(2008-3#1)(2008-8#1)
and we believe##2##3##(2008-10#1)(2009-5#1)
and we can##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
and we characterize##2##3##(2008-3#1)(2012-2#1)
and we compare##4##3##(1996-3#1)(2008-2#1)(2008-8#2)
and we compared##2##3##(2008-12#1)(2011-2#1)
and we conclude that##3##4##(1990-5#1)(2008-8#1)(2013-1#1)
and we conclude##4##3##(1990-5#1)(2008-8#2)(2013-1#1)
and we consider the##2##4##(2008-9#1)(2011-2#1)
and we demonstrate how##2##4##(2008-6#1)(2008-8#1)
and we demonstrate that##2##4##(2008-2#1)(2008-6#1)
and we demonstrate##7##3##(2008-2#2)(2008-6#2)(2008-8#1)(2010-11#1)(2013-1#1)
and we describe a##2##4##(2008-3#1)(2010-7#1)
and we describe how##2##4##(2007-12#1)(2008-9#1)
and we describe##4##3##(2007-12#1)(2008-3#1)(2008-9#1)(2010-7#1)
and we discuss how##3##4##(2008-3#2)(2010-12#1)
and we discuss the##6##4##(2007-11#1)(2008-2#3)(2008-3#1)(2012-3#1)
and we discuss##13##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2010-12#1)(2012-3#3)
and we evaluated the##2##4##(1995-12#1)(2010-11#1)
and we examined##2##3##(2008-11#1)(2013-8#1)
and we explain##2##3##(2008-10#1)(2008-2#1)
and we focus on##3##4##(2008-1#1)(2008-7#1)(2013-8#1)
and we found evidence that##2##5##(2009-10#1)(2011-2#1)
and we found that##2##4##(1990-6#1)(2007-12#1)
and we found##6##3##(1990-6#1)(2007-12#2)(2008-3#1)(2009-10#1)(2011-2#1)
and we got##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
and we have##9##3##(1990-9#1)(1991-11#1)(1994-12#1)(1995-8#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-7#1)(2008-9#1)
and we highlight##2##3##(2010-5#1)(2013-1#1)
and we illustrate##2##3##(2008-2#1)(2012-1#1)
and we investigated##2##3##(2008-7#1)(2013-7#1)
and we measure##2##3##(2007-12#1)(2008-3#1)
and we need##2##3##(1991-12#1)(2011-2#1)
and we now report##2##4##(1993-2#1)(2008-8#1)
and we observed##2##3##(2008-9#1)(2009-5#1)
and we performed##2##3##(2007-8#1)(2011-2#1)
and we present an##2##4##(2008-8#1)(2013-1#1)
and we present##5##3##(1992-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
and we propose##3##3##(2008-8#1)(2009-4#1)(2013-1#1)
and we review the##2##4##(2011-1#1)(2011-2#1)
and we review##4##3##(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
and we should##3##3##(1997-7#1)(2007-12#1)(2008-9#1)
and we show that the##3##5##(2007-11#1)(2008-2#1)(2008-7#1)
and we show that##9##4##(1995-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-2#1)
and we show##11##3##(1995-11#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
and we speculate that##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
and we speculate##4##3##(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
and we suggest that##3##4##(2008-8#1)(2009-1#1)(2012-2#1)
and we suggest##4##3##(2008-8#1)(2009-1#1)(2010-3#1)(2012-2#1)
and we use##3##3##(2007-11#1)(2008-3#1)(2009-12#1)
and we used##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
and we will##2##3##(2007-6#1)(2013-8#1)
and we##203##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#2)(1992-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-7#2)(2007-11#6)(2007-12#11)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#20)(2008-3#20)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#14)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#4)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#2)(2013-8#6)
and weak##11##2##(1992-6#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)
and weaker##6##2##(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
and weakly absorbing##4##3##(2008-2#1)(2008-3#3)
and weakly ionized##2##3##(2007-11#1)(2008-10#1)
and weakly##17##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#4)(2012-12#1)
and weakness in##2##3##(2008-9#1)(2012-3#1)
and weakness of##4##3##(1991-12#1)(2008-6#1)(2009-1#1)(2012-2#1)
and weakness##9##2##(1991-12#1)(1997-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2012-2#1)(2012-3#1)
and weaknesses of##7##3##(1992-12#2)(1994-1#1)(1997-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
and weaknesses##22##2##(1992-12#2)(1993-1#1)(1993-2#1)(1994-1#2)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-8#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-2#1)
and wealthy##2##2##(2010-11#1)(2012-3#1)
and wear##5##2##(2008-5#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)
and weather conditions##2##3##(2008-10#2)
and weather variables##4##3##(2008-10#4)
and weather##8##2##(2008-10#7)(2008-9#1)
and wedge##4##2##(2007-11#1)(2008-3#2)(2011-2#1)
and weeds##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
and week##3##2##(1993-9#1)(2010-2#1)(2013-1#1)
and weekly##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
and weighed##2##2##(1994-1#1)(2009-4#1)
and weight and##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
and weight gain##5##3##(2008-3#2)(2008-8#1)(2011-1#1)(2013-1#1)
and weight loss##17##3##(1997-3#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#3)(2013-8#3)
and weight of the##2##4##(2008-11#1)(2008-12#1)
and weight of##8##3##(2008-10#2)(2008-11#1)(2008-12#3)(2008-9#1)(2013-7#1)
and weight reduction##3##3##(1996-11#1)(2008-3#2)
and weight##58##2##(1991-12#1)(1991-6#1)(1996-11#1)(1997-3#2)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-3#6)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
and weight-bearing##2##2##(2008-12#1)(2010-5#1)
and weighted##4##2##(2008-2#1)(2009-5#1)(2010-3#1)(2012-1#1)
and weighting##2##2##(1995-2#1)(2013-7#1)
and weights of##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
and weights##5##2##(1996-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
and welfare of##2##3##(1992-3#1)(1995-11#1)
and welfare##8##2##(1992-3#2)(1992-5#1)(1993-3#1)(1995-11#1)(1996-3#2)(1997-2#1)
and well tolerated in##3##4##(1996-1#1)(2008-11#2)
and well tolerated when##3##4##(1994-11#1)(1996-2#1)(2008-7#1)
and well tolerated##16##3##(1990-12#1)(1991-11#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
and well waters##2##3##(2008-10#2)
and well##42##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and well-being among##3##3##(2008-7#1)(2010-4#1)(2013-8#1)
and well-being are##2##3##(1992-3#1)(2009-11#1)
and well-being in##2##3##(2009-7#1)(2011-2#1)
and well-being of##5##3##(2008-11#1)(2010-7#1)(2010-9#2)(2012-2#1)
and well-being##33##2##(1992-3#3)(1994-2#1)(1994-3#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#4)(2009-5#2)(2009-7#3)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
and well-defined##7##2##(1997-4#1)(2008-10#1)(2008-4#3)(2008-6#1)(2009-10#1)
and well-known##3##2##(2007-11#1)(2008-5#2)
and well-tolerated##8##2##(1994-8#1)(1995-5#1)(2008-11#1)(2009-5#1)(2010-5#1)(2012-2#3)
and wellbeing##4##2##(2008-3#1)(2010-10#2)(2011-2#1)
and wellness##7##2##(1994-12#1)(2008-12#2)(2010-12#1)(2010-7#1)(2013-1#1)(2013-7#1)
and went on to##2##4##(2008-10#2)
and went##3##2##(1992-3#1)(2008-10#2)
and were able to##10##4##(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and were all##3##3##(2008-10#2)(2010-11#1)
and were also##6##3##(1996-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
and were analyzed##2##3##(2008-11#1)(2008-5#1)
and were asked to##4##4##(2008-11#3)(2012-12#1)
and were assayed##2##3##(1994-5#1)(2008-8#1)
and were characterized by##4##4##(1992-3#1)(1992-6#1)(2008-10#1)(2013-1#1)
and were chosen##3##3##(2008-8#1)(2009-2#1)(2011-2#1)
and were classified##3##3##(2008-5#1)(2010-4#1)(2011-2#1)
and were compared in##2##4##(2008-10#1)(2008-12#1)
and were compared to##2##4##(2007-8#1)(2008-5#1)
and were compared with those##2##5##(2008-10#2)
and were compared with##3##4##(2008-10#2)(2008-6#1)
and were compared##9##3##(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
and were considered to##2##4##(2008-11#1)(2008-3#1)
and were considered##5##3##(1990-5#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-3#1)
and were cross-resistant to##2##4##(2008-5#2)
and were detected##3##3##(1997-8#1)(2011-1#1)(2012-1#1)
and were determined##2##3##(2008-10#2)
and were distinct from##2##4##(2008-10#2)
and were distributed in##2##4##(1992-8#1)(2008-10#1)
and were divided into five##2##5##(1995-12#1)(2008-10#1)
and were divided into##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
and were divided##5##3##(1995-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
and were equally##2##3##(1995-3#1)(1997-9#1)
and were estimated##2##3##(2008-10#1)(2008-5#1)
and were evaluated##4##3##(2007-10#1)(2008-3#1)(2010-5#1)(2011-1#1)
and were examined by##2##4##(2008-12#1)(2013-1#1)
and were examined##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
and were followed##2##3##(2006-10#1)(2013-1#1)
and were found in##3##4##(1992-12#1)(2008-10#2)
and were found to be 4##2##6##(1994-5#1)(1996-12#1)
and were found to be##9##5##(1994-5#1)(1996-12#2)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#1)
and were found to##12##4##(1994-5#1)(1996-12#2)(1996-5#1)(1997-4#1)(2008-10#5)(2008-2#1)(2008-3#1)
and were found##19##3##(1992-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(1996-12#2)(1996-5#1)(1997-4#1)(2008-10#8)(2008-2#1)(2008-3#1)(2010-5#1)
and were further##2##3##(2008-6#1)(2013-1#1)
and were generally##2##3##(2008-9#1)(2013-8#1)
and were genetically##2##3##(2008-10#2)
and were given the##2##4##(2008-6#1)(2012-3#1)
and were given##4##3##(1991-2#1)(2007-7#1)(2008-6#1)(2012-3#1)
and were highly##4##3##(1995-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
and were identified as##2##4##(2008-10#1)(2010-12#1)
and were identified##3##3##(2008-10#2)(2010-12#1)
and were in##6##3##(1997-2#2)(2008-10#4)
and were included in##3##4##(2009-7#1)(2010-4#1)(2013-1#1)
and were included##4##3##(1994-12#1)(2009-7#1)(2010-4#1)(2013-1#1)
and were increased##2##3##(1995-12#1)(2011-3#1)
and were incubated##2##3##(2008-12#1)(2008-5#1)
and were less than the##2##5##(1996-12#1)(2008-10#1)
and were less than##3##4##(1991-12#1)(1996-12#1)(2008-10#1)
and were less##7##3##(1991-12#1)(1992-9#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
and were localized to##2##4##(1991-5#1)(1997-3#1)
and were localized##3##3##(1991-5#1)(1997-3#1)(2008-10#1)
and were more effective##2##4##(2008-5#1)(2013-1#1)
and were more likely to be##2##6##(1995-3#1)(2011-2#1)
and were more likely to report##2##6##(1995-12#1)(2009-5#1)
and were more likely to##4##5##(1995-12#1)(1995-3#1)(2009-5#1)(2011-2#1)
and were more likely##5##4##(1995-12#1)(1995-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
and were more##15##3##(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
and were most##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and were no longer##2##4##(1993-1#1)(2010-8#1)
and were not pathogenic to##2##5##(2008-10#2)
and were not pathogenic##3##4##(2008-10#3)
and were not##22##3##(1993-9#2)(1997-5#1)(2008-10#8)(2008-12#1)(2008-5#3)(2009-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#2)
and were pathogenic on##3##4##(2008-10#3)
and were pathogenic##4##3##(2008-10#4)
and were positive for##2##4##(1992-2#2)
and were present in##2##4##(1994-2#1)(2008-10#1)
and were randomized to##3##4##(2008-3#1)(2012-2#2)
and were readily##2##3##(2008-10#2)
and were relatively##2##3##(1993-12#1)(2008-5#1)
and were restricted to##2##4##(2008-10#2)
and were screened for##2##4##(2008-10#1)(2013-1#1)
and were screened##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
and were sent##2##3##(1990-6#1)(1997-2#1)
and were separated##3##3##(2008-10#3)
and were significantly higher##2##4##(1996-7#1)(2011-2#1)
and were significantly##7##3##(1996-7#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
and were slightly less##2##4##(2008-10#1)(2009-2#1)
and were stained##2##3##(1997-2#1)(2009-5#1)
and were studied##3##3##(1993-12#1)(2008-11#1)(2008-12#1)
and were subjected to##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
and were subsequently##4##3##(2008-10#3)(2008-6#1)
and were sufficiently##2##3##(2007-12#1)(2008-10#1)
and were the##4##3##(2008-10#3)(2011-2#1)
and were then##5##3##(1990-12#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-9#1)
and were thereafter##2##3##(1993-5#1)(2012-1#1)
and were treated##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
and were unable to##2##4##(1995-5#1)(2008-11#1)
and were unaffected by the presence##2##6##(2008-10#2)
and were used as##2##4##(2008-10#1)(2008-5#1)
and were used for##5##4##(1996-8#1)(2007-10#1)(2008-10#2)(2008-11#1)
and were used over a period of##2##7##(2008-10#2)
and were used to##4##4##(2008-10#1)(2008-7#1)(2011-3#1)(2013-1#1)
and were used##14##3##(1994-2#1)(1996-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#1)
and were##462##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1996-12#6)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#3)(1997-9#1)(2006-10#1)(2007-10#7)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#139)(2008-11#16)(2008-12#9)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#22)(2008-6#4)(2008-7#7)(2008-8#8)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#7)(2011-2#11)(2011-3#2)(2012-1#5)(2012-12#5)(2012-2#8)(2012-3#6)(2012-4#1)(2013-1#22)(2013-7#2)(2013-8#6)
and west##4##2##(1991-4#1)(2008-10#3)
and western North America##3##4##(2008-10#2)(2008-8#1)
and western United States##2##4##(2008-10#2)
and western analysis##2##3##(2008-10#2)
and western blot analysis##3##4##(2008-10#2)(2008-11#1)
and western blotting##4##3##(2008-10#1)(2008-11#2)(2013-1#1)
and western populations##4##3##(2008-10#3)(2008-12#1)
and western white pine##2##4##(2008-10#2)
and western##37##2##(1993-1#1)(1997-6#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
and wet##9##2##(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-8#1)
and wetness duration##5##3##(2008-10#5)
and wetness##8##2##(2008-10#8)
and wettable sulfur##2##3##(2011-2#2)
and what are the##2##4##(1991-6#1)(2010-11#1)
and what are##3##3##(1991-6#1)(2010-11#1)(2012-12#1)
and what can be##2##4##(2008-11#1)(2012-12#1)
and what can##3##3##(2008-11#1)(2012-12#2)
and what do they##2##4##(1994-12#1)(1994-3#1)
and what does not work##2##5##(1992-12#1)(2008-4#1)
and what does not##3##4##(1992-12#1)(2007-7#1)(2008-4#1)
and what factors##2##3##(1995-1#1)(1996-1#1)
and what is##5##3##(1991-12#1)(1996-3#1)(1997-6#1)(2008-9#1)(2010-5#1)
and what it means to##3##5##(1996-12#1)(2008-5#1)(2013-1#1)
and what it means##4##4##(1996-12#1)(2008-5#1)(2013-1#2)
and what it##5##3##(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#2)
and what kind of##2##4##(1994-6#1)(1995-6#1)
and what mixture##2##3##(1997-4#1)(2008-5#1)
and what not to##2##4##(2009-9#1)(2010-5#1)
and what the##4##3##(1990-8#2)(1997-3#1)(2013-1#1)
and what they consider as important##3##6##(2011-2#3)
and what they##5##3##(2010-10#1)(2010-3#1)(2011-2#3)
and what we need to##2##5##(2012-12#1)(2013-1#1)
and what we##6##3##(1994-1#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
and what will##2##3##(1991-12#1)(1997-1#1)
and what##74##2##(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-2#4)(2012-1#1)(2012-12#4)(2013-1#5)
and what's not##2##3##(2007-12#1)(2007-9#1)
and what's##3##2##(1996-11#1)(2007-12#1)(2007-9#1)
and wheat flour##2##3##(2008-10#2)
and wheat germ##2##3##(1994-11#1)(2008-10#1)
and wheat##27##2##(1994-11#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2011-10#1)
and when combined with the Franck-Condon factors##2##7##(2010-2#2)
and when combined with##4##4##(1992-3#1)(2008-1#1)(2010-2#2)
and when it##3##3##(2008-3#1)(2008-6#1)(2008-7#1)
and when the##10##3##(1990-6#1)(1994-3#2)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)
and when there##2##3##(1990-11#1)(1996-11#1)
and when they##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
and when this##2##3##(1992-6#1)(2008-3#1)
and when to##2##3##(1995-5#1)(2008-9#1)
and when##66##2##(1990-11#1)(1990-2#1)(1990-6#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-8#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
and where do##2##3##(2008-8#1)(2010-9#1)
and where the##7##3##(1990-12#1)(2008-10#1)(2008-6#2)(2010-2#1)(2010-7#1)(2012-3#1)
and where they##2##3##(2008-12#1)(2013-1#1)
and where##33##2##(1990-12#1)(1990-6#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
and whereas##2##2##(2010-10#1)(2010-8#1)
and whether a##3##3##(1993-2#1)(2010-7#1)(2013-1#1)
and whether it has##3##4##(2008-8#1)(2008-9#1)(2009-1#1)
and whether it is##2##4##(2008-10#1)(2011-2#1)
and whether it##6##3##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)
and whether or not the##2##5##(1991-7#1)(2011-2#1)
and whether the##17##3##(1990-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-1#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-8#1)
and whether there is##2##4##(2008-11#1)(2008-4#1)
and whether there##4##3##(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
and whether these##6##3##(1996-5#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-1#1)(2013-8#1)
and whether they were##2##4##(1994-1#1)(2008-8#1)
and whether they##6##3##(1990-3#1)(1994-1#1)(1997-1#1)(2008-7#1)(2008-8#1)(2012-12#1)
and whether this##4##3##(1994-6#1)(1995-8#1)(1997-2#1)(2013-1#1)
and whether##75##2##(1990-12#1)(1990-3#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
and which are not##2##4##(2008-5#1)(2011-2#1)
and which are##8##3##(1990-3#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#1)
and which can be##2##4##(1996-5#1)(2008-2#1)
and which has##2##3##(2008-10#1)(2008-9#1)
and which includes##2##3##(1993-2#1)(1996-12#1)
and which is##6##3##(1990-6#1)(1991-5#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
and which was##3##3##(2007-8#1)(2008-10#1)(2009-5#1)
and which were##2##3##(1994-8#1)(2008-9#1)
and which would be##2##4##(1993-6#1)(2013-7#1)
and which##64##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#4)(2011-8#1)(2012-3#1)(2013-7#2)(2013-8#2)
and while the##3##3##(1997-3#1)(1997-7#1)(2008-11#1)
and while##8##2##(1995-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
and whilst##2##2##(2007-8#1)(2008-12#1)
and white adults##3##3##(2011-1#1)(2011-2#2)
and white blood cell##4##4##(1996-12#1)(2007-12#1)(2008-10#2)
and white blood##5##3##(1996-12#1)(2007-12#1)(2008-10#2)(2011-2#1)
and white matter##2##3##(1993-12#1)(1995-8#1)
and white muscle##2##3##(2013-1#2)
and white pine blister rust##2##5##(2008-10#2)
and white##40##2##(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#3)
and white-light##3##2##(2007-12#2)(2008-3#1)
and whites##5##2##(1993-3#1)(1996-3#1)(2007-10#1)(2010-2#1)(2012-3#1)
and who developed##2##3##(2006-10#1)(2007-10#1)
and who had##5##3##(1992-6#1)(1993-9#1)(1996-6#1)(2008-10#1)(2013-1#1)
and who have a##2##4##(1996-2#1)(2011-2#1)
and who have##3##3##(1996-2#1)(2008-8#1)(2011-2#1)
and who is##3##3##(1996-1#1)(1997-4#1)(2008-7#1)
and who underwent##2##3##(2008-5#1)(2012-3#1)
and who was##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
and who were##2##3##(2011-1#1)(2012-3#1)
and who will##2##3##(1993-3#1)(2011-2#1)
and who##38##2##(1991-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-3#3)(2013-1#4)
and whole blood by##2##4##(2008-10#2)
and whole blood##8##3##(2008-10#5)(2008-3#1)(2011-2#2)
and whole body##2##3##(2008-7#1)(2012-3#1)
and whole genome##2##3##(2008-8#1)(2012-3#1)
and whole grains in##2##4##(2012-12#2)
and whole grains##7##3##(2010-1#1)(2012-12#5)(2012-2#1)
and whole##33##2##(1991-12#1)(1991-5#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#1)
and whole-body##2##2##(2008-2#1)(2013-8#1)
and whole-organism##2##2##(2008-10#1)(2010-5#1)
and whole-plant##2##2##(2008-10#1)(2009-8#1)
and wholesome##2##2##(2007-11#1)(2010-6#1)
and whose symptoms##2##3##(2008-6#1)(2013-1#1)
and whose##15##2##(1994-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(2006-6#3)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and why are##2##3##(1997-4#1)(2012-12#1)
and why it is##2##4##(1991-1#1)(2009-9#1)
and why the##3##3##(1994-12#1)(2008-11#1)(2009-5#1)
and why they are##2##4##(2008-4#1)(2009-11#1)
and why they##4##3##(1996-3#1)(2008-11#1)(2008-4#1)(2009-11#1)
and why we##2##3##(1997-2#1)(2012-2#1)
and why##31##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and wide angle##2##3##(2008-3#1)(2008-5#1)
and wide##15##2##(1991-5#1)(1992-9#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)
and widely accepted##2##3##(2008-10#1)(2008-11#1)
and widely applicable##2##3##(2008-10#1)(2011-2#1)
and widely used##7##3##(1996-4#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)
and widely##19##2##(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#3)
and wider##5##2##(2008-10#2)(2009-7#1)(2013-1#1)(2013-8#1)
and widespread##17##2##(1992-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and width of the##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
and width of##7##3##(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
and width##17##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-7#2)
and wild Solanum spp##2##4##(2008-10#2)
and wild Solanum##3##3##(2008-10#3)
and wild type##4##3##(1990-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
and wild##24##2##(1990-12#1)(2007-12#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
and wild-type strains##2##3##(2008-10#2)
and wild-type##16##2##(1994-5#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#1)
and wildlife##4##2##(2008-10#1)(2008-12#2)(2012-2#1)
and wildtype##2##2##(1991-9#1)(2009-11#1)
and will aid in the development of##2##7##(2008-11#1)(2008-7#1)
and will allow##2##3##(2008-2#1)(2008-7#1)
and will also##5##3##(1995-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
and will be reviewed##2##4##(2008-7#1)(2010-3#1)
and will be used##2##4##(2008-7#1)(2013-1#1)
and will be##19##3##(1991-11#1)(1991-12#1)(1995-1#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-7#2)(2008-8#1)(2010-3#1)(2010-4#1)(2012-3#2)(2013-1#3)
and will continue to be##2##5##(1996-3#1)(1997-1#1)
and will continue to do so##2##6##(2008-11#1)(2012-6#1)
and will continue to##8##4##(1996-3#1)(1996-5#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2012-6#1)
and will continue##10##3##(1991-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-6#1)
and will eventually become##2##4##(2008-10#2)
and will eventually##3##3##(1993-12#1)(2008-10#2)
and will facilitate##2##3##(2008-10#1)(2010-6#1)
and will have to be##3##5##(1990-6#1)(1992-11#1)(2009-5#1)
and will have##6##3##(1990-6#1)(1992-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
and will include##2##3##(1996-3#1)(2008-11#1)
and will not##2##3##(2007-11#1)(2011-3#1)
and will provide##3##3##(1996-2#1)(2008-10#1)(2010-1#1)
and will require##3##3##(1994-1#1)(2008-10#1)(2009-9#1)
and will result in an##2##5##(2008-5#1)(2013-7#1)
and will soon be##2##4##(2008-10#1)(2008-7#1)
and will##108##2##(1990-6#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#2)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#2)(1997-2#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#4)(2013-7#1)
and willing to##3##3##(1992-12#1)(2007-2#1)(2008-11#1)
and willingness to recommend##4##4##(1993-12#3)(2011-1#1)
and willingness to##7##3##(1993-12#3)(1994-1#1)(1994-12#1)(2009-5#1)(2011-1#1)
and wilt##4##2##(2008-10#4)
and wilt-resistant##3##2##(2008-10#3)
and wind speed##3##3##(2008-10#2)(2008-3#1)
and wind velocity##2##3##(2008-10#1)(2008-5#1)
and wind##8##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
and wine##6##2##(1997-1#1)(2008-10#5)
and wines##3##2##(2008-10#3)
and winning##2##2##(2009-10#1)(2013-1#1)
and winter wheat genotypes##2##4##(2008-10#2)
and winter wheat##3##3##(2008-10#3)
and winter##22##2##(1994-12#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2012-2#3)(2013-1#1)(2013-8#2)
and wire##2##2##(2008-11#1)(2012-12#1)
and wires##2##2##(1992-3#1)(2012-3#1)
and witches'-broom##2##2##(2008-10#2)
and with 0##2##3##(2008-10#1)(2011-2#1)
and with a higher##2##4##(1990-11#1)(1991-12#1)
and with a history of##2##5##(1997-5#1)(2013-1#1)
and with a large##2##4##(1994-12#1)(2008-12#1)
and with a period##2##4##(2008-2#1)(2009-9#1)
and with a very##2##4##(1990-5#1)(2008-10#1)
and with a##51##3##(1990-11#2)(1990-5#2)(1990-7#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-5#1)(1997-5#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2009-11#1)(2009-9#2)(2011-2#3)(2013-1#3)
and with additional##2##3##(1994-3#1)(2007-11#1)
and with an##14##3##(1993-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
and with and without##2##4##(2008-10#1)(2013-1#1)
and with data##4##3##(1992-9#1)(2008-10#1)(2008-2#1)(2008-8#1)
and with different##5##3##(1995-6#1)(2008-10#2)(2008-5#1)(2009-11#1)
and with experimental##2##3##(2008-3#1)(2010-10#1)
and with focal##2##3##(1997-3#1)(2008-3#1)
and with high##8##3##(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
and with higher##2##3##(2007-10#1)(2011-1#1)
and with increased##2##3##(1993-8#1)(2008-12#1)
and with increasing##2##3##(1995-5#1)(2013-1#1)
and with it##2##3##(1995-2#1)(2008-10#1)
and with its##3##3##(1994-11#1)(2008-2#1)(2011-2#1)
and with less##2##3##(1995-1#1)(1997-3#1)
and with low##4##3##(2007-12#1)(2008-3#1)(2009-1#1)(2010-12#1)
and with minimal##3##3##(1994-3#1)(2013-1#2)
and with no evidence##2##4##(1995-2#1)(2007-8#1)
and with no##8##3##(1992-6#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)
and with normal##3##3##(2009-4#1)(2010-12#1)(2013-1#1)
and with other##11##3##(1993-11#1)(1996-1#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)
and with reduced##2##3##(2008-10#1)(2008-11#1)
and with regard to##2##4##(1991-5#1)(2008-12#1)
and with respect to##4##4##(1990-12#1)(1992-5#1)(1993-12#1)(1994-8#1)
and with shorter##2##3##(2007-8#1)(2008-4#1)
and with that of##2##4##(2008-7#1)(2010-2#1)
and with the aid of##2##5##(2008-10#1)(2008-5#1)
and with the aim##2##4##(2008-11#1)(2008-8#1)
and with the same##2##4##(2008-10#1)(2008-8#1)
and with the use of##3##5##(2008-10#1)(2010-6#1)(2011-2#1)
and with the##78##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#4)(1992-12#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#6)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)
and with their##3##3##(1991-12#1)(1996-5#1)(2008-7#1)
and with this##2##3##(1990-5#1)(2008-2#1)
and with those obtained##2##4##(2008-10#2)
and with those of##3##4##(1993-6#1)(2008-10#1)(2010-8#1)
and with those##7##3##(1993-6#1)(2008-10#4)(2008-9#1)(2010-8#1)
and with two##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
and with yeast##2##3##(1992-8#1)(1995-2#1)
and with##457##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-3#3)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#1)(2006-10#2)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#6)(2007-8#7)(2008-1#3)(2008-10#86)(2008-11#9)(2008-12#7)(2008-2#18)(2008-3#35)(2008-4#7)(2008-5#17)(2008-6#3)(2008-7#11)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#5)(2010-10#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#15)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#17)(2013-8#1)
and withdrawal##13##2##(1991-1#3)(1995-11#2)(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#2)(2010-11#1)(2011-2#1)
and within a##7##3##(1990-12#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-9#1)
and within countries##3##3##(2007-7#1)(2009-7#1)(2011-1#1)
and within each##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
and within populations##2##3##(2008-10#2)
and within single##2##3##(2008-10#1)(2008-5#1)
and within the##10##3##(1990-9#1)(1993-12#1)(1996-3#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
and within##67##2##(1990-12#2)(1990-9#1)(1992-12#2)(1993-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
and without a history of##3##5##(2010-9#1)(2012-3#2)
and without a##17##3##(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-2#1)(2007-12#2)(2008-11#1)(2008-3#4)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
and without anginal symptoms##2##4##(2007-8#2)
and without any##7##3##(1996-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)
and without contrast##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
and without modifier##3##3##(2008-10#3)
and without osteoporosis##4##3##(2010-3#4)
and without previous##6##3##(1992-3#1)(2007-8#2)(2008-10#1)(2010-11#1)(2011-2#1)
and without the effect##2##4##(2008-11#1)(2009-11#1)
and without the need of##2##5##(2008-11#1)(2010-5#1)
and without the need##4##4##(2008-10#2)(2008-11#1)(2010-5#1)
and without the##19##3##(1991-8#1)(1994-11#1)(1995-2#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-11#1)(2010-5#1)
and without trauma##2##3##(2007-5#1)(2009-4#1)
and without##262##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#14)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-10#46)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#21)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#7)(2013-1#20)(2013-7#1)(2013-8#2)
and wives##2##2##(2011-2#2)
and women aged##5##3##(1994-11#2)(1996-8#1)(2009-5#1)(2013-1#1)
and women are##4##3##(1991-6#1)(1995-12#1)(2012-12#1)(2012-2#1)
and women in##4##3##(1991-6#1)(2007-7#1)(2009-9#1)(2010-12#1)
and women were##5##3##(2008-12#1)(2008-9#1)(2010-5#1)(2011-1#2)
and women with##13##3##(1992-12#1)(1992-2#1)(1992-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
and women##126##2##(1990-11#2)(1990-3#1)(1991-11#2)(1991-12#1)(1991-6#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#7)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#10)(2011-2#7)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
and women's health##2##3##(1991-6#1)(1995-6#1)
and women's##4##2##(1991-6#1)(1995-6#1)(2008-7#1)(2012-12#1)
and women)##2##2##(1991-4#1)(2009-10#1)
and women]##2##2##(1991-6#1)(2008-10#1)
and wood##9##2##(2008-10#5)(2008-5#1)(2008-9#3)
and word##3##2##(2008-11#1)(2008-12#2)
and work conditions##3##3##(1995-11#1)(2010-7#1)(2013-1#1)
and work in##2##3##(1990-3#1)(2008-5#1)
and work together##2##3##(1996-2#1)(2013-8#1)
and work within##2##3##(2007-2#1)(2008-2#1)
and work world##2##3##(1995-12#1)(2013-1#1)
and work##34##2##(1990-2#1)(1990-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-3#1)(2007-2#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-5#2)(2008-9#2)(2009-10#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
and work-up##2##2##(2008-10#1)(2008-4#1)
and work]##2##2##(1990-6#1)(2007-8#1)
and worked##5##2##(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
and worker##4##2##(2008-10#1)(2008-8#2)(2010-11#1)
and workers##5##2##(2008-8#5)
and workforce##2##2##(2008-10#1)(2010-10#1)
and working conditions##3##3##(1997-7#1)(2008-10#1)(2010-10#1)
and working groups##2##3##(2008-7#1)(2012-2#1)
and working in##2##3##(2010-9#1)(2012-3#1)
and working memory##2##3##(2007-8#1)(2009-9#1)
and working practice##2##3##(2008-10#1)(2010-12#1)
and working to##2##3##(1995-3#1)(2010-9#1)
and working with##3##3##(1995-12#1)(2008-4#1)(2008-6#1)
and working##36##2##(1995-12#1)(1995-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-9#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
and workload##5##2##(1993-12#1)(2007-10#1)(2010-10#1)(2011-1#1)(2011-2#1)
and workplace##3##2##(1993-12#1)(2008-10#1)(2011-1#1)
and works of art##2##4##(2008-10#2)
and works##3##2##(2008-10#2)(2008-2#1)
and workshops##2##2##(1996-4#1)(2010-11#1)
and world##2##2##(2007-8#1)(2010-7#1)
and worldwide##7##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-1#2)
and worse##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
and worsen##3##2##(2008-2#1)(2008-7#1)(2010-12#1)
and worsened##2##2##(2010-11#1)(2012-12#1)
and worsening of##3##3##(2007-11#1)(2008-1#2)
and worsening##6##2##(2007-11#1)(2008-1#2)(2008-7#1)(2010-10#1)(2013-1#1)
and would also##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
and would be##6##3##(2007-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)
and would##27##2##(1990-2#1)(1990-5#1)(1991-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-5#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-7#1)
and wound complications##2##3##(2008-8#1)(2011-2#1)
and wound healing##9##3##(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-9#2)(2012-12#2)
and wound infection##2##3##(1995-12#1)(2007-7#1)
and wound##19##2##(1995-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-3#1)
and wound-healing complications##2##3##(2008-7#2)
and wounding##2##2##(2008-10#2)
and wrinkles##3##2##(2008-5#3)
and wrist joints##3##3##(1995-6#1)(2007-8#1)(2009-8#1)
and wrist##10##2##(1995-6#1)(2007-8#2)(2008-12#1)(2008-8#1)(2009-8#1)(2012-2#3)(2013-1#1)
and writing##4##2##(2008-11#1)(2008-12#2)(2013-1#1)
and written##7##2##(1991-2#1)(1993-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
and x-ray diffraction (XRD)##2##4##(2008-5#1)(2010-4#1)
and x-ray diffraction##3##3##(2008-3#1)(2008-5#1)(2010-4#1)
and x-ray##11##2##(1992-12#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
and xanthine oxidase (XOD)##2##4##(1993-12#1)(2008-10#1)
and xanthine oxidase##4##3##(1993-12#2)(2008-10#1)(2008-11#1)
and xanthosine##2##2##(2009-12#2)
and xenograft##2##2##(2009-3#1)(2012-3#1)
and xenografts##4##2##(1991-6#1)(2009-3#3)
and xylazine (0##2##3##(2012-3#2)
and xylazine##3##2##(2012-3#3)
and xylem##4##2##(2008-11#1)(2012-5#1)(2012-8#2)
and xylene (BTEX)##2##3##(2008-10#2)
and xylene##7##2##(2008-10#7)
and xylose##5##2##(2008-10#1)(2008-6#2)(2008-7#1)(2013-1#1)
and y##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
and yaw of##2##3##(2008-2#1)(2008-3#1)
and year of##4##3##(2007-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
and year##7##2##(2007-10#1)(2008-10#3)(2008-7#1)(2011-1#1)(2013-1#1)
and years of##2##3##(1996-1#1)(2008-10#1)
and years to##2##3##(1996-1#1)(1996-3#1)
and years##7##2##(1996-1#2)(1996-3#1)(2008-10#3)(2008-11#1)
and yeast cells##4##3##(2008-10#1)(2008-6#2)(2009-6#1)
and yeast extract##2##3##(2008-11#2)
and yeast##35##2##(1993-2#1)(1993-6#3)(1994-6#1)(1997-2#1)(1997-4#2)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-2#1)(2010-4#3)(2012-2#2)(2012-3#1)(2013-8#1)
and yeasts##4##2##(2007-11#1)(2008-5#1)(2013-1#2)
and yellow fluorescent proteins##2##4##(2008-10#1)(2008-9#1)
and yellow##16##2##(1992-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-9#2)(2010-8#1)(2011-1#1)
and yellowing apex and margin on the mature leaves##2##9##(2008-9#2)
and yellowing##4##2##(2008-10#2)(2008-9#2)
and yet##12##2##(1991-12#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-8#1)
and yield components##5##3##(2008-12#4)(2008-4#1)
and yield higher##2##3##(2008-5#1)(2008-7#1)
and yield in the field##2##5##(2008-10#2)
and yield in##3##3##(2008-10#2)(2008-9#1)
and yield loss##2##3##(2008-10#2)
and yield of##3##3##(2008-10#2)(2008-12#1)
and yield was##2##3##(2008-10#2)
and yield were##2##3##(2008-10#2)
and yield##41##2##(1997-6#1)(2008-10#19)(2008-11#1)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2013-1#3)
and yielded the##2##3##(2008-10#2)
and yielded##10##2##(1993-8#1)(1997-7#1)(2008-10#7)(2013-8#1)
and yields a##6##3##(1995-2#1)(2008-10#3)(2008-2#1)(2010-4#1)
and yields##22##2##(1990-11#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-6#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)
and yoga##2##2##(2010-12#2)
and yolk##3##2##(2008-10#2)(2008-12#1)
and you##6##2##(1991-3#1)(1992-1#1)(1993-12#1)(1995-2#1)(1996-2#1)(2007-4#1)
and young adult##3##3##(2008-3#1)(2009-5#1)(2011-1#1)
and young adulthood##2##3##(1993-9#1)(2010-7#1)
and young adults with##2##4##(2008-11#1)(2012-2#1)
and young adults##25##3##(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#4)(2008-7#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#3)
and young child nutrition##3##4##(2010-5#3)
and young child##5##3##(2010-5#5)
and young children##13##3##(1996-2#1)(1997-1#2)(1997-8#1)(2008-11#1)(2010-5#3)(2011-2#1)(2013-1#2)(2013-8#2)
and young men##2##3##(1991-9#1)(2009-5#1)
and young people##4##3##(1991-6#1)(2008-7#1)(2009-5#1)(2013-1#1)
and young women##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
and young##78##2##(1990-6#1)(1991-6#1)(1991-9#1)(1993-9#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-6#4)(2008-7#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#8)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#9)(2013-7#1)(2013-8#6)
and younger##14##2##(1994-6#2)(1995-11#1)(1996-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
and your hospital##2##3##(1994-12#1)(1994-2#1)
and your##11##2##(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
and youth##13##2##(2008-11#4)(2008-12#2)(2009-5#1)(2009-7#3)(2010-1#1)(2011-2#1)(2012-2#1)
and yttrium##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
and z =##2##3##(1995-8#2)
and z##3##2##(1995-8#2)(2009-11#1)
and zenith##2##2##(2008-3#2)
and zero##4##2##(1990-8#1)(1997-6#1)(2008-10#1)(2008-3#1)
and zeta##4##2##(1993-3#2)(1995-11#1)(2012-2#1)
and zidovudine##2##2##(1992-6#1)(2011-3#1)
and zinc (Zn)##2##3##(1995-3#1)(1997-4#1)
and zinc by##4##3##(1997-4#1)(2008-10#3)
and zinc determination##2##3##(2008-10#2)
and zinc from##3##3##(1997-4#1)(2008-10#2)
and zinc in##16##3##(2008-10#15)(2011-2#1)
and zinc ions##3##3##(2008-10#1)(2009-7#1)(2010-11#1)
and zinc on the##2##4##(1994-6#1)(1995-3#1)
and zinc on##4##3##(1994-6#1)(1995-3#1)(2008-10#1)(2013-8#1)
and zinc using##2##3##(2008-10#2)
and zinc were##8##3##(1997-4#1)(2008-10#5)(2008-5#1)(2011-2#1)
and zinc##83##2##(1992-3#1)(1994-6#1)(1995-3#3)(1997-4#5)(2008-10#58)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and zinc(II) by##2##3##(2008-10#2)
and zinc(II)##9##2##(1991-5#2)(2008-10#7)
and zinc)##2##2##(2008-10#1)(2008-11#1)
and zinc-containing##3##2##(1995-6#2)(2008-5#1)
and zirconium oxide##2##3##(2008-2#1)(2008-3#1)
and zirconium##4##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
and zirconium(IV)##3##2##(2008-10#3)
and zona incerta##2##3##(1996-12#2)
and zona##3##2##(1996-12#2)(2008-12#1)
and zone##2##2##(1997-5#1)(2010-8#1)
and zoonotic##4##2##(1997-3#1)(2007-2#1)(2010-4#2)
and zooplankton##3##2##(2009-8#3)
and zoospores##8##2##(2008-10#8)
and zucchini##2##2##(2008-10#2)
and ~0##3##2##(2007-12#1)(2008-2#1)(2010-4#1)
and ~1##2##2##(2008-3#2)
and α##2##2##(2010-11#1)(2011-2#1)
and α-zearalenol##2##2##(2013-1#2)
and β(3)-adrenoceptor agonists##2##3##(2010-12#2)
and β-catenin##2##2##(2012-2#1)(2013-1#1)
and β-cell##6##2##(2010-10#2)(2010-11#4)
and β2-microglobulin##2##2##(2013-7#2)
and ≥3##2##2##(2013-1#2)
and##215794##1##(1990-10#103)(1990-11#647)(1990-12#785)(1990-2#630)(1990-3#412)(1990-4#39)(1990-5#732)(1990-6#427)(1990-7#465)(1990-8#741)(1990-9#340)(1991-1#397)(1991-10#59)(1991-11#320)(1991-12#1142)(1991-2#736)(1991-3#584)(1991-4#98)(1991-5#650)(1991-6#623)(1991-7#71)(1991-8#463)(1991-9#555)(1992-1#312)(1992-10#161)(1992-11#464)(1992-12#911)(1992-2#628)(1992-3#1111)(1992-4#159)(1992-5#372)(1992-6#745)(1992-7#43)(1992-8#637)(1992-9#617)(1993-1#453)(1993-10#19)(1993-11#692)(1993-12#1332)(1993-2#689)(1993-3#881)(1993-5#187)(1993-6#625)(1993-7#3)(1993-8#644)(1993-9#475)(1994-1#419)(1994-10#27)(1994-11#779)(1994-12#1126)(1994-2#971)(1994-3#949)(1994-5#653)(1994-6#674)(1994-7#133)(1994-8#903)(1994-9#572)(1995-1#441)(1995-10#26)(1995-11#731)(1995-12#1345)(1995-2#1289)(1995-3#1077)(1995-4#55)(1995-5#747)(1995-6#920)(1995-8#555)(1995-9#185)(1996-1#517)(1996-10#66)(1996-11#249)(1996-12#1253)(1996-2#1303)(1996-3#791)(1996-4#137)(1996-5#867)(1996-6#396)(1996-7#181)(1996-8#207)(1996-9#287)(1997-1#622)(1997-2#1209)(1997-3#1180)(1997-4#848)(1997-5#353)(1997-6#646)(1997-7#875)(1997-8#729)(1997-9#57)(2006-10#402)(2006-11#4)(2006-12#115)(2006-4#27)(2006-5#18)(2006-6#132)(2006-7#17)(2006-8#37)(2006-9#3)(2007-1#40)(2007-10#905)(2007-11#3068)(2007-12#3821)(2007-2#415)(2007-3#29)(2007-4#123)(2007-5#376)(2007-6#154)(2007-7#1117)(2007-8#1591)(2007-9#117)(2008-1#2322)(2008-10#43193)(2008-11#7764)(2008-12#3891)(2008-2#4205)(2008-3#8570)(2008-4#3600)(2008-5#5508)(2008-6#2298)(2008-7#6995)(2008-8#4874)(2008-9#4875)(2009-1#117)(2009-10#1064)(2009-11#723)(2009-12#704)(2009-2#366)(2009-3#574)(2009-4#556)(2009-5#1046)(2009-6#565)(2009-7#1063)(2009-8#1215)(2009-9#690)(2010-1#529)(2010-10#753)(2010-11#808)(2010-12#1128)(2010-2#549)(2010-3#1178)(2010-4#1057)(2010-5#1099)(2010-6#657)(2010-7#623)(2010-8#1549)(2010-9#436)(2011-1#3055)(2011-10#90)(2011-2#8372)(2011-3#470)(2011-4#7)(2011-5#2)(2011-7#76)(2011-8#10)(2011-9#19)(2012-1#961)(2012-12#2872)(2012-2#4335)(2012-3#3342)(2012-4#59)(2012-5#108)(2012-6#63)(2012-7#63)(2012-8#43)(2012-9#25)(2013-1#7099)(2013-2#4)(2013-3#14)(2013-7#950)(2013-8#3571)
and-9 imagers and sounders##2##4##(2008-2#2)
and/ or##3##2##(1997-3#1)(1997-5#1)(2008-10#1)
and/or CKD##2##2##(2012-3#2)
and/or Ca##2##2##(1997-4#1)(2008-1#1)
and/or DNA##2##2##(1993-8#1)(2013-1#1)
and/or IGF-I##2##2##(2008-11#1)(2013-1#1)
and/or M##4##2##(2008-10#1)(2008-6#1)(2012-3#2)
and/or VFA##2##2##(2008-3#2)
and/or a##8##2##(1996-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-10#1)
and/or activity of##2##3##(2011-2#1)(2012-3#1)
and/or activity##3##2##(2011-2#1)(2012-3#2)
and/or alcohol##2##2##(1991-12#1)(2009-6#1)
and/or an##7##2##(1990-11#1)(1990-2#1)(2008-1#1)(2009-3#1)(2010-5#1)(2012-3#2)
and/or are##2##2##(2008-10#1)(2008-4#1)
and/or at##2##2##(2008-1#1)(2011-2#1)
and/or basal##2##2##(2008-10#1)(2012-4#1)
and/or benefit##2##2##(2008-7#2)
and/or biochemical##2##2##(2008-11#1)(2008-5#1)
and/or blood##2##2##(1992-12#1)(2008-1#1)
and/or bone marrow##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
and/or bone##7##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-3#1)(2012-3#1)
and/or bradycardia##2##2##(1997-6#1)(2008-7#1)
and/or by##7##2##(1993-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)
and/or candidate genes##2##3##(2008-8#2)
and/or catalase##2##2##(1992-12#1)(1994-2#1)
and/or cellular##2##2##(2008-4#1)(2013-1#1)
and/or clinical##2##2##(1991-12#1)(2009-10#1)
and/or cognitive##2##2##(2011-1#1)(2013-7#1)
and/or competitive advantage##2##3##(2009-5#2)
and/or complete##2##2##(2012-2#1)(2013-8#1)
and/or degradation##2##2##(1992-12#1)(1992-3#1)
and/or dendritic cells##2##3##(1997-2#1)(2009-4#1)
and/or diffuse##2##2##(1992-9#1)(2008-3#1)
and/or drug##2##2##(1994-2#1)(2008-8#1)
and/or during##2##2##(2008-1#1)(2008-10#1)
and/or easy##2##2##(1997-4#1)(2008-10#1)
and/or excessive##2##2##(2011-1#1)(2013-1#1)
and/or failed##2##2##(2010-3#1)(2013-1#1)
and/or from##2##2##(2010-7#1)(2011-1#1)
and/or functional##4##2##(1996-12#1)(2008-7#1)(2009-4#1)(2009-5#1)
and/or functionally##2##2##(1991-6#1)(2008-1#1)
and/or genotoxic##2##2##(1997-4#1)(2012-2#1)
and/or glial##2##2##(1994-2#1)(1995-5#1)
and/or hormonal##2##2##(1992-11#1)(2013-1#1)
and/or hydrogen peroxide##2##3##(2008-10#2)
and/or hydrogen##3##2##(2008-10#2)(2013-1#1)
and/or hyperuricosuria##2##2##(2008-10#1)(2008-7#1)
and/or in##3##2##(2008-6#1)(2009-2#1)(2010-12#1)
and/or increasing##2##2##(1996-3#1)(2012-2#1)
and/or inhibition of##4##3##(1992-10#1)(1994-11#1)(1997-4#1)(2008-4#1)
and/or inhibitors##3##2##(1990-8#1)(2009-2#2)
and/or intensity of##2##3##(2008-10#1)(2008-8#1)
and/or its##8##2##(1990-2#1)(1991-7#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
and/or kinetic##2##2##(1997-2#1)(2008-10#1)
and/or limited##2##2##(2008-8#1)(2013-1#1)
and/or maintain##2##2##(2009-8#1)(2010-7#1)
and/or maintenance of##2##3##(1993-6#1)(2008-6#1)
and/or maintenance##3##2##(1993-6#1)(2008-11#1)(2008-6#1)
and/or mature##2##2##(2008-4#1)(2008-7#1)
and/or membrane##2##2##(1993-6#1)(2009-12#1)
and/or mental##2##2##(2008-7#1)(2011-1#1)
and/or multiple##2##2##(2008-4#1)(2011-2#1)
and/or mutations##2##2##(2008-4#1)(2008-5#1)
and/or negatively##2##2##(2008-10#2)
and/or other##5##2##(1992-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
and/or oxidation of##2##3##(1991-9#1)(2008-10#1)
and/or oxidation##3##2##(1991-9#1)(2008-10#2)
and/or pharmacodynamic##2##2##(1991-2#1)(2007-11#1)
and/or prevent##2##2##(2007-7#1)(2013-1#1)
and/or prevention of##2##3##(2008-10#1)(2008-4#1)
and/or progression of##2##3##(1995-6#1)(2008-7#1)
and/or progression##3##2##(1995-6#1)(2008-7#1)(2010-3#1)
and/or protein##2##2##(1992-8#1)(1995-12#1)
and/or reactive##2##2##(1994-8#1)(2008-10#1)
and/or reduced##3##2##(1990-12#1)(1996-9#1)(2010-3#1)
and/or regional##2##2##(2008-10#1)(2012-3#1)
and/or release of##2##3##(1997-3#1)(2008-9#1)
and/or renal##5##2##(1994-5#1)(1997-8#2)(2008-1#1)(2008-8#1)
and/or repair##2##2##(1994-6#1)(1997-2#1)
and/or resection##2##2##(2012-2#1)(2012-3#1)
and/or risk assessment##3##3##(2008-10#2)(2008-11#1)
and/or secondary##2##2##(1990-8#1)(2008-2#1)
and/or separation##2##2##(2008-10#2)
and/or sodium##2##2##(2007-3#1)(2008-4#1)
and/or soft tissue##2##3##(2013-1#2)
and/or spatial##2##2##(2008-3#1)(2013-8#1)
and/or surgical##2##2##(1996-3#1)(2011-2#1)
and/or symptoms##2##2##(2007-6#1)(2008-1#1)
and/or the##22##2##(1990-6#1)(1992-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and/or their##8##2##(1990-9#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2010-7#1)(2011-2#1)
and/or therapeutic##2##2##(1990-6#1)(2008-11#1)
and/or they are##3##3##(2008-4#1)(2012-2#2)
and/or to##4##2##(1994-2#1)(1995-12#1)(2008-11#1)(2008-6#1)
and/or toxicity of##3##3##(1990-2#1)(1991-9#1)(2012-2#1)
and/or training##2##2##(2008-5#2)
and/or trans-acting##2##2##(1993-12#1)(1995-2#1)
and/or treatment of##2##3##(1997-4#1)(2010-10#1)
and/or treatment##3##2##(1997-4#1)(2010-10#1)(2012-2#1)
and/or ultrasound##2##2##(2008-1#1)(2010-8#1)
and/or##979##1##(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-12#11)(1991-2#7)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#8)(1992-10#2)(1992-11#3)(1992-12#10)(1992-2#2)(1992-3#2)(1992-5#4)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#6)(1994-3#3)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#13)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#6)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#11)(1997-3#9)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#7)(2006-10#5)(2006-6#1)(2007-10#5)(2007-11#5)(2007-12#7)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#4)(2008-1#22)(2008-10#117)(2008-11#34)(2008-12#14)(2008-2#10)(2008-3#14)(2008-4#29)(2008-5#33)(2008-6#12)(2008-7#42)(2008-8#23)(2008-9#27)(2009-10#3)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#6)(2009-7#4)(2009-8#4)(2009-9#6)(2010-1#2)(2010-10#9)(2010-11#3)(2010-12#7)(2010-2#5)(2010-3#6)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#7)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#53)(2011-3#2)(2012-1#1)(2012-12#13)(2012-2#33)(2012-3#29)(2012-4#1)(2012-5#1)(2012-9#2)(2013-1#38)(2013-7#2)(2013-8#10)
and15##2##1##(2008-11#2)
andExpansin genes##2##2##(2008-8#2)
andHind III##2##2##(2008-8#2)
andersoni##2##1##(2013-1#2)
andhemadsorption activities##2##2##(2008-11#2)
andin vitro##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
andin vivo##6##2##(2008-11#2)(2008-4#1)(2008-8#3)
andin##10##1##(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#5)
andincreased##2##1##(2008-11#2)
andiyazi##3##1##(2008-10#3)
andoxygen##2##1##(2008-11#2)
andrhoV (alt)##5##2##(2008-9#5)
androgen ablation##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
androgen action##2##2##(1995-12#1)(2008-4#1)
androgen and glucocorticoid receptors##2##4##(1995-12#2)
androgen and glucocorticoid##3##3##(1995-12#3)
androgen binding component##3##3##(1990-11#3)
androgen binding##8##2##(1990-11#6)(2008-11#2)
androgen concentrations##3##2##(2008-4#1)(2010-11#1)(2013-8#1)
androgen deficiency##5##2##(1990-6#1)(1992-12#1)(2008-1#1)(2008-4#1)(2009-2#1)
androgen dependent##2##2##(1993-8#1)(2012-12#1)
androgen deprivation therapy##3##3##(2008-7#2)(2012-3#1)
androgen deprivation##4##2##(2008-1#1)(2008-7#2)(2012-3#1)
androgen excess##3##2##(2008-4#3)
androgen in##2##2##(1995-12#1)(2008-7#1)
androgen levels##4##2##(2009-5#1)(2011-1#2)(2013-1#1)
androgen metabolism in##2##3##(1990-11#2)
androgen metabolism##3##2##(1990-11#2)(1995-8#1)
androgen production##5##2##(1990-5#1)(1990-9#1)(1993-9#1)(2008-7#1)(2012-3#1)
androgen receptor cDNA##2##3##(1991-5#1)(1995-12#1)
androgen receptor expression##4##3##(1991-5#2)(1996-5#1)(2008-4#1)
androgen receptor mRNA##2##3##(1991-5#2)
androgen receptor##31##2##(1990-11#5)(1991-5#6)(1991-9#2)(1995-12#1)(1995-3#2)(1996-5#1)(2007-12#1)(2008-4#6)(2008-9#1)(2009-4#3)(2010-1#1)(2011-2#1)(2012-2#1)
androgen receptor-mediated##2##2##(2010-1#1)(2011-2#1)
androgen receptors##2##2##(1993-8#1)(2008-4#1)
androgen##116##1##(1990-11#16)(1990-5#1)(1990-6#2)(1990-9#1)(1991-5#10)(1991-9#2)(1992-12#1)(1993-8#3)(1993-9#1)(1994-2#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-8#1)(1996-5#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-4#16)(2008-5#4)(2008-6#3)(2008-7#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#1)(2010-1#3)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
androgen-dependent##6##1##(1990-11#2)(1991-5#1)(1991-9#1)(1996-5#1)(2008-4#1)
androgen-mediated##2##1##(1995-12#1)(1996-5#1)
androgen-regulated genes##2##2##(2008-6#1)(2010-1#1)
androgen-regulated##4##1##(1992-3#1)(1996-5#1)(2008-6#1)(2010-1#1)
androgen-sensitive##2##1##(1992-12#1)(1995-3#1)
androgenic alopecia##3##2##(2008-5#3)
androgenic steroid##4##2##(1990-11#3)(1993-1#1)
androgenic##14##1##(1990-11#3)(1991-9#1)(1993-1#1)(1995-12#1)(1996-5#1)(2008-5#3)(2010-1#1)(2011-2#1)(2012-3#2)
androgens and glucocorticoids##2##3##(1995-12#1)(2008-7#1)
androgens and##5##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)
androgens to##4##2##(1990-11#1)(1990-9#1)(2009-7#1)(2011-1#1)
androgens##40##1##(1990-11#4)(1990-5#2)(1990-9#2)(1991-5#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1996-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-4#4)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#2)
andrographolide were##2##2##(2008-10#2)
andrographolide##6##1##(2008-10#6)
android##4##1##(2008-11#3)(2009-7#1)
androids##4##1##(2008-11#4)
androstenedione reduction##2##2##(1994-6#2)
androstenedione##7##1##(1990-11#3)(1994-6#2)(1995-8#1)(2008-1#1)
androstenone##8##1##(2008-5#8)
andthat##2##1##(2008-11#1)(2008-2#1)
anecdotal evidence to support the##2##5##(2007-11#1)(2008-11#1)
anecdotal evidence##5##2##(2007-11#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-7#1)
anecdotal##16##1##(1991-8#1)(1992-12#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
anecdotally##4##1##(1995-3#1)(2007-12#1)(2008-1#1)(2008-9#1)
anemia (10##2##2##(2008-7#1)(2009-8#1)
anemia among##3##2##(2009-10#1)(2011-2#2)
anemia and thrombocytopenia##2##3##(1991-4#1)(2008-8#1)
anemia and##19##2##(1991-4#1)(1994-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
anemia are##2##2##(1991-6#1)(2008-7#1)
anemia associated with##5##3##(1992-9#1)(1995-1#1)(2008-7#1)(2010-9#1)(2012-3#1)
anemia by##2##2##(2008-4#1)(2012-3#1)
anemia due to##3##3##(1992-6#1)(1993-5#1)(1994-6#1)
anemia has##2##2##(2010-9#1)(2013-1#1)
anemia in cancer patients##2##4##(2010-11#2)
anemia in##15##2##(1996-3#1)(2008-1#2)(2008-10#1)(2008-7#2)(2008-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
anemia is##4##2##(2008-7#1)(2010-11#2)(2013-1#1)
anemia of chronic disease##3##4##(2010-12#1)(2013-1#2)
anemia of##6##2##(1992-9#1)(1997-6#1)(2010-12#1)(2012-2#1)(2013-1#2)
anemia on##3##2##(2008-7#2)(2010-11#1)
anemia or##2##2##(1994-3#1)(2012-2#1)
anemia was##4##2##(1994-9#1)(2011-2#2)(2012-12#1)
anemia with##3##2##(2008-7#2)(2008-8#1)
anemia##171##1##(1990-3#3)(1991-2#1)(1991-4#1)(1991-6#2)(1992-3#1)(1992-6#4)(1992-9#4)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#4)(1994-9#2)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-6#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#31)(2008-8#9)(2008-9#3)(2009-10#2)(2009-8#1)(2010-11#6)(2010-12#2)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#7)(2012-9#1)(2013-1#14)(2013-7#1)(2013-8#2)
anemia]##2##1##(1993-3#1)(1996-10#1)
anemic and##2##2##(1991-4#1)(2008-7#1)
anemic patients with cancer##5##4##(2008-7#5)
anemic patients with##6##3##(2008-7#6)
anemic patients##7##2##(2008-7#7)
anemic##16##1##(1990-10#1)(1991-4#2)(2008-7#9)(2011-2#1)(2012-2#3)
anemometry##7##1##(1994-12#1)(2008-2#1)(2008-3#5)
anemone##3##1##(2008-10#3)
anergic##3##1##(1992-6#2)(2008-4#1)
anergy##7##1##(1997-7#1)(2008-11#2)(2008-4#3)(2011-2#1)
anesthesia and##17##2##(1991-2#1)(1992-12#1)(1993-1#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
anesthesia by##2##2##(2007-8#1)(2009-3#1)
anesthesia during##5##2##(2007-8#1)(2011-2#1)(2012-3#3)
anesthesia following##2##2##(1994-2#1)(2012-3#1)
anesthesia for a patient with##2##5##(2012-12#2)
anesthesia for cesarean section##2##4##(2012-12#1)(2012-3#1)
anesthesia for the##2##3##(2007-12#1)(2011-2#1)
anesthesia for##14##2##(1993-1#3)(2007-12#1)(2007-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
anesthesia in the##5##3##(1992-6#1)(2010-8#2)(2011-3#1)(2013-8#1)
anesthesia in##17##2##(1992-11#1)(1992-6#1)(1993-1#1)(2007-11#2)(2007-12#1)(2010-3#1)(2010-8#2)(2011-3#1)(2012-12#1)(2012-3#5)(2013-8#1)
anesthesia is a##2##3##(1992-12#1)(2009-5#1)
anesthesia is##5##2##(1992-12#1)(2007-11#2)(2009-5#1)(2011-2#1)
anesthesia medical information##2##3##(2010-8#2)
anesthesia on##4##2##(1993-1#1)(2007-12#1)(2012-3#1)(2013-8#1)
anesthesia practice##3##2##(2007-5#1)(2011-1#1)(2012-2#1)
anesthesia pre-screening##2##2##(1994-3#2)
anesthesia risk##2##2##(2007-8#1)(2011-2#1)
anesthesia techniques##2##2##(2011-2#2)
anesthesia time##2##2##(1993-12#1)(1994-3#1)
anesthesia to##2##2##(2012-12#1)(2013-1#1)
anesthesia was used##2##3##(1990-11#1)(2007-7#1)
anesthesia was##8##2##(1990-11#1)(1992-11#1)(1993-1#2)(2007-11#1)(2007-7#1)(2012-3#2)
anesthesia were##2##2##(1990-5#1)(2012-3#1)
anesthesia with##13##2##(2007-8#1)(2008-4#1)(2012-12#2)(2012-3#9)
anesthesia without##2##2##(1993-1#1)(2012-2#1)
anesthesia##228##1##(1990-11#3)(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#2)(1992-11#2)(1992-12#7)(1992-6#3)(1993-1#18)(1993-10#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#3)(2007-11#8)(2007-12#4)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#12)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#8)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#7)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#11)(2011-1#2)(2011-2#23)(2011-3#2)(2011-7#1)(2012-12#11)(2012-2#7)(2012-3#39)(2013-1#7)(2013-8#2)
anesthesia]##2##1##(1990-5#1)(1992-11#1)
anesthesiologist##6##1##(1993-1#1)(2007-11#2)(2008-10#1)(2009-4#1)(2012-12#1)
anesthesiologists##4##1##(1993-1#1)(2008-10#1)(2010-8#1)(2012-3#1)
anesthesiology##3##1##(1992-3#1)(2010-8#1)(2013-1#1)
anesthetic agent##5##2##(1993-1#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
anesthetic agents##5##2##(2008-8#1)(2009-5#1)(2012-3#3)
anesthetic and##2##2##(1993-1#1)(2011-2#1)
anesthetic implications##2##2##(2006-10#1)(2011-2#1)
anesthetic induction##2##2##(1991-1#1)(2009-4#1)
anesthetic management of##2##3##(2011-1#1)(2011-2#1)
anesthetic management##6##2##(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#1)
anesthetic technique##3##2##(2007-8#2)(2010-5#1)
anesthetic##72##1##(1990-12#1)(1990-2#1)(1990-5#3)(1991-1#1)(1991-6#1)(1993-1#13)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#1)
anesthetics and##2##2##(1990-2#1)(2010-8#1)
anesthetics on##3##2##(1990-12#1)(1990-2#2)
anesthetics##25##1##(1990-12#1)(1990-2#5)(1993-1#4)(1995-12#3)(1996-12#1)(2007-12#1)(2009-3#3)(2009-8#1)(2010-8#5)(2012-3#1)
anesthetist##3##1##(2006-10#1)(2011-2#2)
anesthetists##4##1##(2011-2#4)
anesthetized by##2##2##(1990-12#1)(2013-1#1)
anesthetized cats##2##2##(2008-8#1)(2012-3#1)
anesthetized dogs##6##2##(1992-3#2)(1994-8#1)(1995-12#1)(1997-1#1)(2008-5#1)
anesthetized guinea##3##2##(1990-9#1)(1992-3#1)(1994-11#1)
anesthetized monkeys##2##2##(1990-7#1)(1994-8#1)
anesthetized rats and##2##3##(1992-3#1)(1997-2#1)
anesthetized rats##15##2##(1990-5#2)(1990-7#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-4#2)(2009-8#1)(2013-7#1)
anesthetized with halothane##2##3##(1991-12#1)(2009-12#1)
anesthetized with##6##2##(1991-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2009-12#1)(2012-12#1)
anesthetized##54##1##(1990-12#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-12#2)(1991-3#1)(1992-3#7)(1992-7#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1997-1#2)(1997-2#2)(1997-7#2)(2008-10#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
aneuploid tumor##2##2##(1994-12#2)
aneuploid##9##1##(1994-12#2)(1997-4#1)(2008-10#2)(2008-6#2)(2008-8#1)(2009-12#1)
aneuploides##2##1##(1996-12#1)(2008-11#1)
aneuploidy in##2##2##(1991-6#1)(2009-7#1)
aneuploidy##22##1##(1990-3#1)(1991-6#1)(1993-9#1)(1994-12#1)(1995-9#1)(1996-12#4)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2012-3#3)(2013-1#2)
aneurysm and a##2##3##(2009-7#1)(2011-2#1)
aneurysm and the##2##3##(2011-2#1)(2013-8#1)
aneurysm and##9##2##(1994-1#1)(1994-11#1)(2008-8#2)(2009-7#2)(2011-2#2)(2013-8#1)
aneurysm arising from fenestrated proximal anterior cerebral artery##2##8##(2013-8#2)
aneurysm arising from##5##3##(2007-8#2)(2010-7#1)(2013-8#2)
aneurysm by##2##2##(1997-6#2)
aneurysm causing##2##2##(2008-7#2)
aneurysm formation##5##2##(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2009-10#1)
aneurysm has##2##2##(1994-11#1)(2010-4#1)
aneurysm in a##3##3##(2007-9#1)(2008-7#1)(2012-12#1)
aneurysm in the##3##3##(1997-8#1)(2008-12#1)(2009-8#1)
aneurysm in##9##2##(1997-8#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#2)(2009-8#1)(2012-12#1)(2013-1#1)
aneurysm involving the##2##3##(2008-12#1)(2009-8#1)
aneurysm is a##2##3##(1997-3#1)(2012-1#1)
aneurysm is##4##2##(1997-3#1)(2008-1#1)(2010-4#1)(2012-1#1)
aneurysm may##2##2##(2008-11#1)(2008-7#1)
aneurysm of a##2##3##(2007-8#1)(2008-7#1)
aneurysm of the ascending aorta##3##5##(2007-8#3)
aneurysm of the extracranial##2##4##(1992-5#1)(2008-7#1)
aneurysm of the middle cerebral artery##3##6##(2008-7#3)
aneurysm of the##19##3##(1991-6#1)(1992-5#1)(1997-8#1)(2007-10#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-7#5)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
aneurysm of##31##2##(1991-6#1)(1992-5#2)(1997-8#1)(2007-10#1)(2007-8#9)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#7)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
aneurysm on##2##2##(2008-7#1)(2010-7#1)
aneurysm repair at##2##3##(2007-8#1)(2008-12#1)
aneurysm repair##11##2##(2007-8#3)(2008-12#1)(2008-3#1)(2010-12#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
aneurysm rupture##4##2##(2008-7#2)(2011-2#2)
aneurysm sac##3##2##(2008-11#1)(2011-3#2)
aneurysm should be##2##3##(1992-5#1)(2008-7#1)
aneurysm surgery and##3##3##(2012-3#3)
aneurysm surgery in##2##3##(2007-8#1)(2008-7#1)
aneurysm surgery##5##2##(2007-8#1)(2008-7#1)(2012-3#3)
aneurysm was successfully treated with##2##5##(2008-1#1)(2008-7#1)
aneurysm was##9##2##(1997-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#4)(2013-1#1)
aneurysm which was##2##3##(2007-8#1)(2013-8#1)
aneurysm which##3##2##(1991-6#1)(2007-8#1)(2013-8#1)
aneurysm with##6##2##(1991-8#1)(2007-8#2)(2008-11#1)(2011-2#2)
aneurysm##231##1##(1990-6#1)(1991-6#2)(1991-8#1)(1992-5#7)(1993-5#1)(1994-1#1)(1994-11#3)(1995-11#3)(1995-5#1)(1996-3#2)(1997-3#4)(1997-5#1)(1997-6#7)(1997-8#3)(2007-10#6)(2007-2#1)(2007-7#1)(2007-8#29)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#9)(2008-12#11)(2008-2#1)(2008-3#1)(2008-7#39)(2008-8#3)(2009-10#2)(2009-4#1)(2009-7#4)(2009-8#2)(2010-12#4)(2010-4#5)(2010-5#3)(2010-7#5)(2010-8#1)(2011-1#1)(2011-2#18)(2011-3#5)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#8)
aneurysm?##2##1##(2007-8#2)
aneurysm]##2##1##(1992-5#1)(1995-5#1)
aneurysmal SAH##2##2##(2012-3#2)
aneurysmal bone cyst##6##3##(2012-12#4)(2013-1#2)
aneurysmal bone##7##2##(2012-12#4)(2013-1#3)
aneurysmal dilatation of the##2##4##(2008-12#1)(2012-2#1)
aneurysmal dilatation of##3##3##(2008-12#1)(2011-3#1)(2012-2#1)
aneurysmal dilatation##4##2##(2008-12#1)(2008-7#1)(2011-3#1)(2012-2#1)
aneurysmal pattern##2##2##(2008-7#2)
aneurysmal protrusion at the##2##4##(2008-12#2)
aneurysmal rupture##3##2##(1997-8#3)
aneurysmal sac##4##2##(1997-3#2)(2008-11#1)(2011-3#1)
aneurysmal subarachnoid hemorrhage##3##3##(1995-11#1)(2012-2#1)(2012-3#1)
aneurysmal##38##1##(1995-11#1)(1997-3#5)(1997-6#1)(1997-8#3)(2007-8#1)(2008-11#1)(2008-12#4)(2008-7#3)(2009-7#1)(2010-4#1)(2010-7#1)(2011-3#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)
aneurysms and##9##2##(1993-5#1)(2007-4#1)(2008-7#4)(2009-9#1)(2012-2#1)(2013-1#1)
aneurysms are##5##2##(2008-11#1)(2008-7#1)(2010-4#1)(2010-5#1)(2013-1#1)
aneurysms arising from the##2##4##(2007-8#1)(2012-3#1)
aneurysms at##2##2##(1991-3#1)(2010-4#1)
aneurysms in the##2##3##(2009-4#1)(2010-8#1)
aneurysms in##7##2##(1995-11#1)(1997-3#2)(2008-7#1)(2009-4#1)(2010-8#1)(2010-9#1)
aneurysms is##4##2##(1997-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
aneurysms of the##6##3##(1990-6#1)(2007-8#1)(2008-7#3)(2010-7#1)
aneurysms of##9##2##(1990-6#1)(2007-8#1)(2008-7#4)(2009-8#1)(2010-7#1)(2012-12#1)
aneurysms that were##2##3##(1997-3#1)(2011-2#1)
aneurysms that##5##2##(1997-3#2)(2006-10#1)(2011-2#1)(2013-1#1)
aneurysms to##2##2##(2011-2#1)(2012-3#1)
aneurysms were located at the##2##5##(1997-3#1)(2008-7#1)
aneurysms were treated##2##3##(1995-11#1)(2008-7#1)
aneurysms were##9##2##(1992-5#1)(1995-11#1)(1997-3#1)(1997-8#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
aneurysms with a##2##3##(2008-7#1)(2012-2#1)
aneurysms with##5##2##(2008-2#1)(2008-7#3)(2012-2#1)
aneurysms##112##1##(1990-6#1)(1991-3#1)(1992-5#1)(1993-5#2)(1995-11#4)(1997-3#8)(1997-6#1)(1997-8#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-8#5)(2008-11#3)(2008-2#1)(2008-7#25)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#12)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#5)(2013-8#9)
aneurysms]##2##1##(1997-3#1)(2011-3#1)
anew##3##1##(2008-10#1)(2008-11#1)(2009-10#1)
angel##2##1##(2007-11#1)(2008-10#1)
angelfish##2##1##(2007-5#2)
anger and##3##2##(2009-8#1)(2010-11#2)
anger expression##5##2##(2008-4#5)
anger intensity and the##3##4##(2010-11#3)
anger or##2##2##(1990-11#1)(2010-11#1)
anger##30##1##(1990-11#1)(1992-3#1)(1995-12#1)(1996-11#1)(2007-7#1)(2008-12#2)(2008-2#1)(2008-4#7)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#8)(2010-7#1)(2012-2#2)
angiitis is##2##2##(2008-7#1)(2010-6#1)
angiitis##6##1##(2008-10#1)(2008-7#3)(2010-6#1)(2012-3#1)
angina and##12##2##(1992-4#1)(1992-9#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-3#5)(2008-5#1)
angina are##3##2##(2008-12#2)(2011-2#1)
angina pectoris and##6##3##(1990-12#1)(1991-9#4)(1992-4#1)
angina pectoris have##2##3##(1990-12#1)(1994-11#1)
angina pectoris##25##2##(1990-12#3)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#5)(1992-4#2)(1992-5#1)(1994-11#1)(1995-11#1)(2007-8#2)(2008-10#2)(2008-12#2)(2010-8#1)(2011-2#1)(2013-1#1)
angina##92##1##(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#6)(1992-4#3)(1992-5#1)(1992-9#2)(1994-11#2)(1995-11#1)(1996-3#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-8#13)(2008-10#5)(2008-12#6)(2008-3#20)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#3)
angina)##4##1##(1992-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
anginal##4##1##(2007-8#2)(2008-12#1)(2008-4#1)
angio-CT##2##1##(1995-11#2)
angioaccess##2##1##(2008-1#1)(2011-3#1)
angioarchitectural##2##1##(1995-11#1)(1997-6#1)
angioarchitecture##4##1##(1995-11#1)(1996-9#1)(2011-2#2)
angiocentric lymphoma##2##2##(2009-1#2)
angiocentric##3##1##(2009-1#3)
angiodysplasia of the##3##3##(2007-8#2)(2010-6#1)
angiodysplasia##5##1##(1997-3#1)(2007-8#2)(2010-6#1)(2012-2#1)
angiodysplasias##5##1##(1992-5#1)(2012-1#3)(2013-1#1)
angioedema following##2##2##(2010-5#1)(2012-2#1)
angioedema##14##1##(1991-9#1)(1996-11#1)(2007-2#2)(2008-8#1)(2010-5#3)(2012-2#1)(2013-1#5)
angiofibroma in##2##2##(1993-6#2)
angiofibromas##2##1##(1991-3#1)(2013-1#1)
angiogenesis and##13##2##(2008-1#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
angiogenesis are##2##2##(2008-1#1)(2008-7#1)
angiogenesis at##2##2##(2011-2#2)
angiogenesis by##2##2##(2008-5#1)(2013-1#1)
angiogenesis factor##2##2##(1990-4#1)(2008-11#1)
angiogenesis in patients with##2##4##(2010-12#1)(2012-12#1)
angiogenesis in vivo and##2##4##(1990-4#2)
angiogenesis in##16##2##(1990-4#2)(1991-12#1)(1994-12#1)(1996-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-1#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
angiogenesis inhibitor##3##2##(1991-12#3)
angiogenesis inhibitors##3##2##(1994-12#1)(1997-1#2)
angiogenesis is a##2##3##(2008-1#1)(2012-2#1)
angiogenesis is##4##2##(2008-1#1)(2010-9#1)(2012-2#1)(2013-8#1)
angiogenesis of##5##2##(2008-11#2)(2011-1#1)(2011-2#2)
angiogenesis through##2##2##(2013-1#2)
angiogenesis##107##1##(1990-4#3)(1991-12#8)(1991-3#1)(1992-9#1)(1994-12#3)(1996-10#1)(1996-8#1)(1997-1#2)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#9)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#5)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#4)(2012-12#4)(2012-2#3)(2013-1#8)(2013-8#3)
angiogenic activity##3##2##(1990-4#1)(2008-1#2)
angiogenic factor##6##2##(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(2008-11#1)(2008-9#1)
angiogenic factors##8##2##(2008-1#2)(2008-11#1)(2009-8#1)(2010-9#2)(2012-12#1)(2012-3#1)
angiogenic inhibitors are##2##3##(2008-1#2)
angiogenic inhibitors in##2##3##(2008-1#2)
angiogenic inhibitors##8##2##(2008-1#8)
angiogenic process##2##2##(1990-4#1)(2010-9#1)
angiogenic properties##2##2##(1992-3#1)(2008-7#1)
angiogenic##47##1##(1990-4#4)(1992-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(2006-10#1)(2008-1#12)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#3)(2010-9#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
angiogenin##9##1##(1992-11#5)(1994-9#4)
angiogram also##2##2##(2008-12#1)(2013-1#1)
angiogram##16##1##(1996-6#1)(2006-12#1)(2007-10#2)(2007-8#2)(2008-12#2)(2008-7#4)(2011-2#1)(2013-1#3)
angiogram-negative##2##1##(2007-10#2)
angiograms and##2##2##(1997-3#1)(2007-10#1)
angiograms in##2##2##(1995-11#1)(2006-12#1)
angiograms##14##1##(1995-11#1)(1997-3#2)(2006-12#1)(2007-10#2)(2007-8#1)(2008-7#3)(2011-2#2)(2013-1#2)
angiographic and##2##2##(1994-11#1)(2011-1#1)
angiographic appearance##2##2##(1994-11#1)(1996-9#1)
angiographic control##2##2##(2007-8#2)
angiographic cure was achieved in##2##5##(2008-7#2)
angiographic evaluation##2##2##(2007-8#1)(2008-7#1)
angiographic findings of##2##3##(1997-8#2)
angiographic findings##4##2##(1997-8#4)
angiographic follow-up##2##2##(1994-11#1)(1994-9#1)
angiographic imaging##2##2##(1996-9#1)(2008-8#1)
angiographic restenosis##2##2##(2008-11#1)(2008-12#1)
angiographic results##2##2##(2007-8#2)
angiographic studies##4##2##(1991-2#1)(2007-7#2)(2012-2#1)
angiographic study##2##2##(1994-11#1)(2008-7#1)
angiographic vasospasm after AVM rupture##2##5##(2012-3#2)
angiographic vasospasm##3##2##(2012-3#3)
angiographic##52##1##(1990-6#2)(1991-2#1)(1991-8#1)(1992-3#1)(1992-9#1)(1994-11#4)(1994-9#1)(1996-6#1)(1996-9#2)(1997-3#3)(1997-8#7)(2007-7#2)(2007-8#5)(2008-11#2)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#4)
angiographically proven##2##2##(1990-8#1)(1997-8#1)
angiographically##10##1##(1990-8#1)(1993-12#1)(1994-11#1)(1995-3#1)(1996-8#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#2)
angiographies##3##1##(2008-7#2)(2011-2#1)
angiography (3D-CTA)##2##2##(2008-7#1)(2012-2#1)
angiography (CTA)##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
angiography (DSA)##5##2##(1993-8#1)(2008-7#2)(2012-2#2)
angiography (P##2##2##(2007-10#1)(2008-3#1)
angiography and angioplasty##3##3##(2011-2#3)
angiography and magnetic resonance##2##4##(2008-12#2)
angiography and##26##2##(1992-9#1)(1993-6#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#2)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#1)
angiography before the second operation##2##5##(2008-7#2)
angiography between##3##2##(2007-8#2)(2012-3#1)
angiography confirmed the diagnosis##2##4##(1995-11#1)(2008-1#1)
angiography confirmed##3##2##(1995-11#1)(2008-1#1)(2013-1#1)
angiography demonstrated##3##2##(2008-7#2)(2013-1#1)
angiography for the##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
angiography for##6##2##(2008-7#4)(2009-4#1)(2011-2#1)
angiography has##3##2##(2007-10#1)(2008-7#1)(2010-12#1)
angiography in patients##2##3##(1990-9#1)(2008-10#1)
angiography in the##3##3##(1990-9#1)(2007-10#1)(2012-2#1)
angiography in##10##2##(1990-9#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
angiography is##5##2##(1996-8#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-4#1)
angiography may##3##2##(1996-9#1)(1997-8#1)(2008-11#1)
angiography of the##3##3##(1997-8#1)(2008-7#1)(2009-5#1)
angiography of##5##2##(1997-8#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
angiography or##3##2##(1993-6#1)(1997-3#1)(2011-2#1)
angiography proved to be##2##4##(2008-12#1)(2008-7#1)
angiography remains the##2##3##(1995-11#1)(2008-7#1)
angiography revealed a##2##3##(2008-12#1)(2008-7#1)
angiography revealed the##2##3##(2008-1#1)(2011-2#1)
angiography revealed##9##2##(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
angiography showed a##3##3##(1996-3#1)(2007-8#1)(2010-10#1)
angiography showed##10##2##(1996-3#1)(1996-9#1)(2007-8#2)(2008-7#3)(2010-10#2)(2013-1#1)
angiography to evaluate##2##3##(1990-9#1)(2008-7#1)
angiography to##6##2##(1990-9#1)(2008-7#2)(2009-11#1)(2009-12#1)(2012-3#1)
angiography was##8##2##(1991-11#1)(1991-6#1)(1994-1#1)(2007-8#2)(2008-7#2)(2011-2#1)
angiography with 3D display##2##4##(1995-11#2)
angiography with##5##2##(1995-11#2)(1997-8#1)(2007-10#1)(2011-2#1)
angiography##231##1##(1990-5#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-6#2)(1993-8#2)(1994-1#3)(1994-3#1)(1995-11#5)(1995-12#1)(1996-3#1)(1996-8#1)(1996-9#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#8)(2006-12#1)(2007-10#11)(2007-7#3)(2007-8#13)(2008-1#4)(2008-10#1)(2008-11#7)(2008-12#14)(2008-2#1)(2008-3#7)(2008-7#49)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#26)(2012-12#1)(2012-2#13)(2012-3#4)(2013-1#9)(2013-8#1)
angioinvasive##3##1##(1990-10#1)(2008-5#1)(2013-1#1)
angiology##2##1##(1991-3#2)
angioma##3##1##(1996-6#1)(2007-8#1)(2011-2#1)
angiomas and##2##2##(2007-11#2)
angiomas of the##2##3##(2007-11#1)(2008-7#1)
angiomas##11##1##(1996-6#1)(2007-11#5)(2007-8#1)(2008-7#3)(2008-9#1)
angiomatosis##2##1##(2013-1#2)
angiomatous##2##1##(1997-6#1)(2013-1#1)
angiomyolipoma and##2##2##(2006-10#1)(2010-6#1)
angiomyolipoma##7##1##(1992-2#1)(2006-10#1)(2010-6#5)
angiopathy in##2##2##(1996-5#1)(2007-10#1)
angiopathy##6##1##(1996-11#1)(1996-5#1)(2007-10#2)(2012-2#1)(2013-1#1)
angioplastic##2##1##(1995-11#1)(2012-2#1)
angioplasties##4##1##(1991-8#1)(2008-3#1)(2011-2#2)
angioplasty and stent placement##2##4##(2007-10#1)(2008-8#1)
angioplasty and stent##4##3##(1994-11#1)(2007-10#1)(2008-11#1)(2008-8#1)
angioplasty and stenting##5##3##(2007-7#1)(2008-1#2)(2008-12#1)(2012-3#1)
angioplasty and##15##2##(1991-3#1)(1994-11#2)(1997-8#2)(2007-10#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-8#2)(2012-3#1)
angioplasty by##2##2##(2008-11#2)
angioplasty for##3##2##(2008-11#1)(2008-7#1)(2009-12#1)
angioplasty has##2##2##(1991-3#1)(2011-2#1)
angioplasty in##6##2##(1990-2#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-3#2)
angioplasty is##3##2##(1991-3#1)(1997-3#1)(2008-1#1)
angioplasty of the##3##3##(1991-5#1)(2007-8#1)(2013-1#1)
angioplasty of##7##2##(1991-3#1)(1991-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#1)
angioplasty or##2##2##(2008-1#1)(2008-5#1)
angioplasty with##3##2##(1991-5#1)(2008-11#1)(2011-2#1)
angioplasty##110##1##(1990-2#1)(1990-9#1)(1991-3#7)(1991-5#2)(1992-4#2)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#5)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-8#4)(1997-3#1)(1997-8#6)(2006-8#1)(2007-10#4)(2007-7#2)(2007-8#6)(2008-1#9)(2008-11#10)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#3)(2009-12#1)(2010-5#1)(2011-2#11)(2012-3#2)(2013-1#1)(2013-8#2)
angioplasty]##4##1##(1990-9#1)(1992-5#1)(1996-8#1)(2013-8#1)
angiosarcoma of the##2##3##(2008-10#1)(2008-11#1)
angiosarcoma##11##1##(1990-2#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-6#3)(2013-7#2)
angioscopy##2##1##(1991-11#1)(2008-10#1)
angiosperm trees##2##2##(2008-10#1)(2012-3#1)
angiosperm##8##1##(2008-10#4)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
angiosperms and##2##2##(2008-7#1)(2008-8#1)
angiosperms##11##1##(1994-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-8#3)
angiotensin AT1 and AT2 receptors##3##5##(1991-9#1)(1995-12#2)
angiotensin AT1 and AT2##4##4##(1991-9#1)(1995-12#3)
angiotensin AT1 receptor in##2##4##(1995-12#2)
angiotensin AT1 receptor##5##3##(1995-12#5)
angiotensin AT1##10##2##(1991-9#1)(1995-12#9)
angiotensin AT2 receptor##2##3##(1991-12#1)(1995-12#1)
angiotensin AT2##3##2##(1991-12#2)(1995-12#1)
angiotensin I to##2##3##(1990-12#1)(1994-8#1)
angiotensin I##6##2##(1990-12#2)(1992-9#1)(1994-8#2)(2008-10#1)
angiotensin II (AII) receptor##2##4##(1991-5#1)(1993-3#1)
angiotensin II (AII)##5##3##(1991-5#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)
angiotensin II (Ang II)##3##4##(1992-9#1)(1996-9#1)(2008-1#1)
angiotensin II and##5##3##(1992-9#1)(1995-12#1)(1997-7#2)(2008-1#1)
angiotensin II in##6##3##(1992-9#2)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#1)
angiotensin II is##2##3##(1992-9#1)(1995-11#1)
angiotensin II receptor antagonists##3##4##(1991-5#1)(1995-12#1)(2008-10#1)
angiotensin II receptor blockers##4##4##(1996-6#2)(2008-11#2)
angiotensin II receptor subtype##2##4##(1992-3#1)(1994-8#1)
angiotensin II receptor##21##3##(1990-11#1)(1991-5#4)(1992-3#2)(1992-9#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1996-5#1)(1996-6#2)(2008-10#1)(2008-11#2)
angiotensin II receptors##2##3##(1990-11#1)(1992-3#1)
angiotensin II type##4##3##(1992-3#1)(1994-11#2)(2008-9#1)
angiotensin II##83##2##(1990-11#2)(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#8)(1992-3#6)(1992-8#2)(1992-9#12)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#4)(1994-9#3)(1995-11#6)(1995-12#6)(1996-2#4)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-7#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)
angiotensin II-induced DNA synthesis##2##4##(1995-11#2)
angiotensin II-induced##5##2##(1994-2#1)(1995-11#3)(1995-12#1)
angiotensin III##3##2##(1993-6#1)(1994-2#2)
angiotensin IV##2##2##(1997-7#2)
angiotensin converting enzyme (ACE)##2##4##(1993-12#1)(2008-1#1)
angiotensin converting enzyme inhibitor##3##4##(1992-9#1)(1995-12#1)(2007-8#1)
angiotensin converting enzyme inhibitors##5##4##(1991-9#1)(1995-12#1)(1996-6#1)(2006-8#1)(2008-1#1)
angiotensin converting enzyme##18##3##(1990-12#1)(1990-5#4)(1991-3#1)(1991-9#1)(1992-9#1)(1993-12#1)(1995-12#2)(1996-6#1)(2006-8#1)(2007-8#1)(2008-1#4)
angiotensin receptor blockers##2##3##(2008-7#1)(2008-8#1)
angiotensin receptor##6##2##(1991-9#2)(1992-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
angiotensin receptors##6##2##(1991-5#1)(1991-9#2)(1994-2#2)(1994-8#1)
angiotensin##165##1##(1990-11#2)(1990-12#5)(1990-5#4)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#11)(1991-9#6)(1992-3#8)(1992-8#2)(1992-9#16)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#3)(1994-8#7)(1994-9#4)(1995-11#10)(1995-12#19)(1996-2#4)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#2)(1997-7#5)(2006-8#1)(2007-8#2)(2008-1#9)(2008-10#2)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-5#1)(2012-1#1)(2012-3#2)(2013-1#2)
angiotensin-I converting enzyme##2##3##(2010-2#2)
angiotensin-converting enzyme (ACE)##3##3##(1990-2#1)(2008-6#1)(2008-7#1)
angiotensin-converting enzyme and##2##3##(2008-11#1)(2008-6#1)
angiotensin-converting enzyme inhibitor##2##3##(2008-3#1)(2012-3#1)
angiotensin-converting enzyme inhibitors##4##3##(2008-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
angiotensin-converting enzyme##16##2##(1990-2#2)(1992-8#1)(1993-8#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
angiotensin-converting-enzyme##4##1##(1994-3#3)(1995-3#1)
angiotensin-immunoreactive cell bodies##2##3##(1993-12#2)
angiotensins##5##1##(1997-7#5)
angle X-ray diffraction##2##3##(2008-5#2)
angle X-ray##3##2##(2008-11#1)(2008-5#2)
angle and the##12##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-3#1)(2012-2#1)
angle and##48##2##(1992-9#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#18)(2008-5#2)(2008-7#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
angle are##4##2##(2008-2#1)(2008-3#3)
angle as##2##2##(2008-2#1)(2008-3#1)
angle at which##2##3##(2008-3#1)(2013-1#1)
angle between the two##2##4##(1997-7#1)(2008-3#1)
angle between the##5##3##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#2)
angle between##11##2##(1997-7#1)(2007-12#1)(2008-2#2)(2008-3#6)(2013-8#1)
angle by use of##2##4##(2008-3#2)
angle by##6##2##(2007-12#2)(2007-8#1)(2008-3#3)
angle can be##2##3##(2008-2#1)(2008-3#1)
angle closure glaucoma##2##3##(2011-2#2)
angle closure##6##2##(2011-2#4)(2013-1#2)
angle decreased##4##2##(2007-8#3)(2008-10#1)
angle deformity##2##2##(2007-11#2)
angle dependence##3##2##(2008-2#2)(2012-2#1)
angle during transparent##2##3##(2009-12#2)
angle during##3##2##(2009-12#2)(2011-2#1)
angle for the##2##3##(2008-2#1)(2009-12#1)
angle for##11##2##(2008-2#2)(2008-3#8)(2009-12#1)
angle from##2##2##(2007-11#1)(2009-11#1)
angle has##2##2##(2007-11#1)(2008-3#1)
angle in the##6##3##(1995-5#1)(2008-3#5)
angle in##10##2##(1995-5#1)(2007-8#2)(2008-3#7)
angle increases##2##2##(2008-2#2)
angle interferometer##4##2##(2008-2#4)
angle is##13##2##(1993-3#1)(2007-11#2)(2007-8#1)(2008-2#4)(2008-3#4)(2012-12#1)
angle measurement based on the##2##5##(2008-2#1)(2008-3#1)
angle measurement##7##2##(2008-2#1)(2008-3#3)(2008-5#1)(2009-7#1)(2010-3#1)
angle measurements##2##2##(1995-2#1)(2007-11#1)
angle medulloblastoma##2##2##(2008-8#2)
angle multiplexed##2##2##(2007-11#1)(2007-12#1)
angle multiplexing##2##2##(2007-12#1)(2008-2#1)
angle of 0##4##3##(1996-2#1)(2008-2#2)(2008-3#1)
angle of a##3##3##(2008-2#1)(2008-3#2)
angle of an##2##3##(2008-2#2)
angle of incidence and the##2##5##(2008-2#1)(2008-3#1)
angle of incidence and##5##4##(2008-2#2)(2008-3#3)
angle of incidence of##9##4##(2008-1#1)(2008-2#5)(2008-3#3)
angle of incidence on##2##4##(2008-2#1)(2008-3#1)
angle of incidence##32##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#17)
angle of reflection##2##3##(2008-2#2)
angle of rotation in##2##4##(2007-12#1)(2008-3#1)
angle of rotation##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
angle of the grating##2##4##(2008-2#1)(2008-3#1)
angle of the reference##2##4##(2007-11#1)(2008-2#1)
angle of the##38##3##(2007-11#6)(2007-12#1)(2007-8#7)(2008-10#2)(2008-2#9)(2008-3#11)(2008-9#1)(2012-2#1)
angle of##139##2##(1993-11#1)(1993-8#2)(1995-3#1)(1996-2#2)(1997-7#1)(2007-11#12)(2007-12#5)(2007-7#1)(2007-8#9)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#37)(2008-3#51)(2008-4#1)(2008-9#2)(2009-11#1)(2012-2#1)(2013-8#1)
angle on the##3##3##(2008-3#3)
angle on##4##2##(2008-3#3)(2012-3#1)
angle only##2##2##(2008-3#2)
angle or##3##2##(2008-3#2)(2011-2#1)
angle range of the c axis and the incident angle##2##10##(2008-3#2)
angle range of the##3##4##(2008-3#2)(2013-8#1)
angle range of##5##3##(2008-2#2)(2008-3#2)(2013-8#1)
angle range##6##2##(2008-2#2)(2008-3#3)(2013-8#1)
angle shift##4##2##(2008-10#4)
angle that is##2##3##(2008-2#1)(2008-3#1)
angle that##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
angle theta##2##2##(2008-3#2)
angle to the##3##3##(2008-2#1)(2008-6#1)(2008-7#1)
angle to##6##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
angle tuning of the##2##4##(2008-3#2)
angle tuning##3##2##(2008-3#3)
angle was##10##2##(1990-11#1)(1992-4#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2012-2#1)
angle were##4##2##(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
angle when##2##2##(2008-3#2)
angle windows##2##2##(2008-3#2)
angle with respect to the##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
angle with##8##2##(2007-11#1)(2008-2#2)(2008-3#4)(2012-2#1)
angle##582##1##(1990-11#2)(1991-9#1)(1992-4#2)(1992-9#2)(1993-11#2)(1993-3#1)(1993-8#3)(1994-12#1)(1994-5#4)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#2)(1997-1#1)(1997-7#2)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#35)(2007-12#22)(2007-4#1)(2007-7#1)(2007-8#32)(2008-1#4)(2008-10#31)(2008-11#2)(2008-12#6)(2008-2#99)(2008-3#208)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#4)(2009-6#1)(2009-7#4)(2009-8#1)(2010-3#3)(2010-8#1)(2011-1#2)(2011-2#20)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#10)(2013-8#8)
angle)##5##1##(1993-12#1)(2007-11#1)(2008-2#2)(2008-3#1)
angle-dependent##2##1##(2008-3#2)
angle-multiplexed holographic##2##2##(2007-11#1)(2008-2#1)
angle-multiplexed##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
angle-of-arrival (AA)##2##2##(2008-3#2)
angle-resolved##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
angled##5##1##(2007-11#4)(2010-3#1)
angles and by##2##3##(2007-12#1)(2008-4#1)
angles and residual strains in##3##5##(2008-9#3)
angles and residual strains##4##4##(2008-9#4)
angles and the##2##3##(2007-11#1)(2008-3#1)
angles and##19##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-9#4)(2010-3#1)(2011-2#1)(2013-1#1)
angles are##9##2##(1992-12#1)(1995-6#1)(2007-11#2)(2008-3#5)
angles around##2##2##(1992-12#1)(2008-3#1)
angles as large as##2##4##(2007-11#1)(2008-3#1)
angles as##5##2##(2007-11#3)(2008-2#1)(2008-3#1)
angles at##2##2##(2007-12#1)(2008-3#1)
angles for the##3##3##(2008-2#1)(2008-3#2)
angles for##5##2##(2008-2#3)(2008-3#2)
angles from##4##2##(2008-2#1)(2008-3#3)
angles greater than the critical angle##2##6##(2008-3#2)
angles greater than##3##3##(2008-3#3)
angles in the##2##3##(1992-12#1)(2008-3#1)
angles in##7##2##(1992-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)
angles is##6##2##(1990-11#1)(2008-2#1)(2008-3#4)
angles less than##4##3##(2008-2#1)(2008-3#3)
angles of incidence of##2##4##(2007-11#1)(2008-3#1)
angles of incidence##10##3##(2007-11#2)(2008-2#1)(2008-3#7)
angles of the##8##3##(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2011-2#1)
angles of##34##2##(1992-4#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#17)(2008-4#1)(2008-6#1)(2011-2#1)(2012-3#1)
angles range from##2##3##(2007-12#1)(2008-3#1)
angles that are##2##3##(2008-3#2)
angles that##3##2##(2008-3#3)
angles to##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
angles were##7##2##(1992-4#1)(2008-3#1)(2009-10#2)(2010-3#1)(2011-2#1)(2012-12#1)
angles with respect to the##2##5##(2008-3#2)
angles with##5##2##(2008-3#4)(2010-3#1)
angles##228##1##(1990-11#1)(1992-12#3)(1992-4#4)(1993-11#2)(1995-5#1)(1995-6#2)(1996-2#1)(1997-4#1)(1997-8#1)(2007-11#17)(2007-12#10)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#39)(2008-3#106)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#2)(2009-6#1)(2010-10#1)(2010-3#3)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
angry behaviors##2##2##(2010-11#2)
angry emotional expressions##2##3##(2008-11#2)
angry face##2##2##(1990-11#1)(2009-4#1)
angry faces##2##2##(2009-4#2)
angry facial expressions##2##3##(2008-11#1)(2009-4#1)
angry##14##1##(1990-11#1)(1991-3#1)(2008-11#4)(2009-4#4)(2010-10#1)(2010-11#3)
angry&quot##3##1##(2008-2#3)
angstrom##2##1##(1991-12#1)(1991-5#1)
angstroms##5##1##(1990-11#1)(1992-9#1)(2013-8#3)
anguibactin##6##1##(2011-2#6)
angular acceptance##3##2##(2008-2#1)(2008-3#2)
angular and##7##2##(2007-11#1)(2008-2#4)(2008-3#1)(2013-1#1)
angular anisoplanatism##2##2##(2008-3#2)
angular correlation##3##2##(1995-5#1)(2008-3#2)
angular correlations##3##2##(2007-11#2)(2008-2#1)
angular deflection logic gates##2##4##(2008-3#2)
angular deflection##4##2##(2008-3#4)
angular dependence of the##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
angular dependence of##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
angular dependence##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)
angular dispersion of##2##3##(2007-11#2)
angular dispersion##3##2##(2007-11#3)
angular displacement of##2##3##(2008-2#1)(2011-2#1)
angular displacement##5##2##(2008-2#1)(2008-3#1)(2011-2#2)(2013-1#1)
angular displacements##3##2##(2009-4#1)(2013-1#2)
angular distribution of the##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
angular distribution of##12##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#2)
angular distribution##22##2##(2007-11#6)(2007-12#1)(2008-10#4)(2008-2#7)(2008-3#3)(2011-1#1)
angular distributions of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
angular distributions##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
angular gyrus##2##2##(2008-11#2)
angular leaf spot##10##3##(2008-10#10)
angular leaf##11##2##(2008-10#11)
angular light-scattering##3##2##(2008-3#3)
angular measurement##2##2##(2012-2#1)(2013-1#1)
angular misalignment##2##2##(2008-3#2)
angular momentum is##3##3##(2007-11#2)(2012-2#1)
angular momentum of##2##3##(2007-11#1)(2008-7#1)
angular momentum##9##2##(2007-11#6)(2008-3#1)(2008-7#1)(2012-2#1)
angular multiplexing##6##2##(2007-12#1)(2008-3#5)
angular observation##2##2##(2008-3#2)
angular optical scattering##2##3##(2008-3#2)
angular optical##3##2##(2008-3#3)
angular orientation##2##2##(2007-11#2)
angular plate##2##2##(2013-1#2)
angular position of##2##3##(2007-11#1)(2008-2#1)
angular positions of##2##3##(2007-12#1)(2008-2#1)
angular positions##3##2##(2007-12#1)(2008-2#2)
angular range of##4##3##(2008-2#1)(2008-3#3)
angular range##9##2##(2007-12#1)(2008-2#1)(2008-3#7)
angular resolution##4##2##(2008-2#2)(2008-3#1)(2012-12#1)
angular response##8##2##(2008-2#5)(2008-3#3)
angular responses of##2##3##(2007-11#2)
angular rotation##2##2##(1996-7#1)(2007-12#1)
angular selectivity of##2##3##(2008-2#2)
angular selectivity##4##2##(2008-2#3)(2008-3#1)
angular sensitivity of##3##3##(2007-11#2)(2008-2#1)
angular separation##2##2##(2007-11#1)(2008-2#1)
angular size of the##4##4##(2006-4#1)(2008-2#1)(2008-3#2)
angular spectrum of##2##3##(2008-3#2)
angular speed##2##2##(2008-3#1)(2011-2#1)
angular spread of the##2##4##(2007-12#2)
angular variation##3##2##(2008-3#2)(2010-3#1)
angular velocity of the##2##4##(2011-2#2)
angular velocity##4##2##(2011-1#1)(2011-2#3)
angular##240##1##(1993-5#1)(1994-5#1)(1995-5#2)(1996-7#1)(2006-4#1)(2007-11#32)(2007-12#15)(2007-8#2)(2008-10#17)(2008-11#3)(2008-2#44)(2008-3#84)(2008-6#1)(2008-7#4)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#12)(2013-7#1)
angulata and##2##2##(2013-7#2)
angulata##3##1##(2013-7#3)
angulated plates fractures##2##3##(2007-11#2)
angulated##5##1##(2007-11#2)(2007-12#1)(2008-9#1)(2012-2#1)
angulation and##3##2##(1995-9#1)(2007-8#1)(2008-9#1)
angulation of##2##2##(2010-3#1)(2011-2#1)
angulation##11##1##(1995-9#1)(2007-8#1)(2008-11#1)(2008-9#3)(2010-3#3)(2011-2#1)(2013-1#1)
angustifolia and E##3##3##(2006-11#3)
angustifolia##6##1##(2006-11#4)(2010-3#1)(2013-8#1)
angustifolia) and##2##2##(2008-10#1)(2010-3#1)
angustifolia)##3##1##(2008-10#2)(2010-3#1)
anharmonicity##2##1##(1995-3#1)(2007-12#1)
anhedonia##3##1##(1993-9#1)(2008-7#2)
anhydride to give##2##3##(1996-5#1)(2008-11#1)
anhydride was##3##2##(1995-11#1)(2008-10#2)
anhydride##42##1##(1991-12#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-11#14)(1996-5#1)(2007-11#4)(2008-10#17)(2008-11#1)(2012-1#1)
anhydrides##5##1##(1994-3#1)(1995-11#4)
anhydrous citric acid##2##3##(2010-3#2)
anhydrous methyl ethyl ketone##2##4##(2008-10#2)
anhydrous theophylline##2##2##(2013-8#2)
anhydrous##23##1##(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#2)(2013-8#2)
aniline and##2##2##(2008-10#2)
aniline from##2##2##(2008-10#2)
aniline in##3##2##(2008-10#3)
aniline mustards##2##2##(1992-11#2)
aniline was##3##2##(2008-10#3)
aniline with##2##2##(2008-10#2)
aniline##30##1##(1991-5#1)(1992-11#2)(1993-3#1)(1995-3#1)(2007-11#1)(2008-10#22)(2010-12#1)(2012-3#1)
anilines and polynuclear##2##3##(1994-9#2)
anilines and##3##2##(1994-5#1)(1994-9#2)
anilines##5##1##(1994-5#1)(1994-9#3)(2008-10#1)
anilino-(1##3##1##(2008-10#3)
animal and cell culture##2##4##(2008-4#1)(2012-2#1)
animal and food##2##3##(2008-10#1)(2013-8#1)
animal and human research##2##4##(2008-5#1)(2009-7#1)
animal and human studies suggests that##2##6##(1996-5#1)(2009-7#1)
animal and human studies##3##4##(1996-5#1)(2008-2#1)(2009-7#1)
animal and human##12##3##(1992-9#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#3)
animal and in##2##3##(1992-3#1)(1992-9#1)
animal and plant cells##3##4##(2008-11#1)(2008-8#1)(2009-8#1)
animal and plant##6##3##(1997-4#1)(2008-11#1)(2008-8#2)(2009-8#1)(2011-2#1)
animal and##33##2##(1991-12#1)(1992-3#1)(1992-9#2)(1996-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-7#3)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
animal as well as##2##4##(1996-2#1)(2008-11#1)
animal behavior##6##2##(2008-11#3)(2008-8#3)
animal bioinformatics##2##2##(2008-7#2)
animal carcasses##3##2##(2008-6#3)
animal care##3##2##(1997-7#1)(2008-4#1)(2008-9#1)
animal cell culture processes##2##4##(2008-11#2)
animal cell culture##17##3##(2008-11#15)(2008-7#2)
animal cell cultures##2##3##(2008-11#1)(2008-7#1)
animal cell##38##2##(1997-3#1)(2008-10#1)(2008-11#27)(2008-4#1)(2008-7#4)(2008-8#1)(2009-8#3)
animal cells and tissues##2##4##(2008-4#1)(2008-7#1)
animal cells and##5##3##(1994-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
animal cells for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
animal cells in##3##3##(2008-11#2)(2013-1#1)
animal cells##33##2##(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#2)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#14)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2013-1#1)
animal contact##4##2##(2007-12#1)(2007-7#1)(2008-12#2)
animal data##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
animal densities##2##2##(2007-6#2)
animal disease##2##2##(2007-7#1)(2011-2#1)
animal diseases##4##2##(2007-6#1)(2008-9#1)(2010-7#1)(2011-2#1)
animal diversity##2##2##(2008-9#2)
animal evolution##2##2##(2010-4#1)(2012-2#1)
animal experiment##2##2##(2008-12#1)(2010-8#1)
animal experimentation##5##2##(1990-12#3)(1991-3#1)(1997-7#1)
animal experiments have##2##3##(1991-2#1)(1996-3#1)
animal experiments##12##2##(1991-12#2)(1991-2#1)(1993-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-7#2)(2010-1#1)(2012-3#1)
animal exposure##3##2##(2008-10#1)(2008-4#2)
animal facilities##2##2##(2008-4#1)(2008-9#1)
animal fat##2##2##(1990-2#1)(1994-2#1)
animal fats##2##2##(2009-3#1)(2011-2#1)
animal feed and##2##3##(2008-10#2)
animal feed##9##2##(2008-10#8)(2010-4#1)
animal feeding##2##2##(2008-10#2)
animal feeds##8##2##(2008-10#6)(2011-2#2)
animal for##2##2##(2008-11#1)(2008-7#1)
animal genome database development##3##4##(2008-7#3)
animal genome##4##2##(2008-7#4)
animal groups##4##2##(1990-7#1)(2007-12#2)(2011-2#1)
animal had##2##2##(2008-9#2)
animal health throughout a research study##2##6##(2008-4#2)
animal health##10##2##(1997-7#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#2)(2011-2#1)(2012-1#1)(2013-1#1)
animal in##3##2##(1995-12#1)(2008-10#1)(2008-4#1)
animal insulin treatment##2##3##(1991-8#2)
animal is misjudged as##2##4##(2013-1#2)
animal is##9##2##(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#1)(2013-1#2)
animal lectins##2##2##(1990-5#2)
animal model and##2##3##(2008-10#1)(2008-9#1)
animal model for human##2##4##(2008-4#1)(2011-2#1)
animal model for multiple sclerosis##2##5##(2007-11#1)(2010-12#1)
animal model for##12##3##(1992-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
animal model of##27##3##(1990-11#1)(1992-11#1)(1992-9#1)(1993-12#3)(1993-2#1)(1995-2#1)(1996-12#1)(1996-7#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#3)(2008-9#2)(2010-1#1)(2012-12#1)(2012-2#4)
animal model system##3##3##(2008-11#2)(2008-4#1)
animal model was##2##3##(2008-10#1)(2008-9#1)
animal model##85##2##(1990-11#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-11#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#2)(2008-4#9)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#2)
animal models and human##4##4##(2008-10#1)(2008-3#1)(2009-2#1)(2012-2#1)
animal models and##8##3##(1992-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
animal models are used to##2##5##(2008-7#2)
animal models are##4##3##(2008-10#1)(2008-7#3)
animal models for##5##3##(1990-9#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#1)
animal models have been##3##4##(2008-9#1)(2010-4#1)(2010-6#1)
animal models have##7##3##(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-6#1)(2013-7#1)
animal models of human disease##2##5##(2008-4#1)(2012-12#1)
animal models of human##5##4##(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#1)
animal models of infection##3##4##(2008-7#3)
animal models of##42##3##(1992-6#1)(1992-9#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#7)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
animal models that##2##3##(2008-2#1)(2008-9#1)
animal models##135##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-9#2)(1992-1#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-7#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#7)(2008-7#15)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-4#4)(2010-5#3)(2010-6#5)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
animal or human##3##3##(2008-11#1)(2008-5#1)(2010-11#1)
animal origin##11##2##(1994-3#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
animal parasites##2##2##(1994-12#1)(2008-8#1)
animal pathogens##2##2##(2011-2#2)
animal populations##2##2##(2008-8#1)(2011-2#1)
animal protein consumed##3##3##(2013-7#3)
animal protein kinase C##2##4##(1993-11#2)
animal protein sources##3##3##(2008-10#2)(2013-7#1)
animal protein##15##2##(1993-11#2)(2008-10#2)(2008-11#2)(2010-4#1)(2011-2#1)(2013-7#7)
animal protein-free##2##2##(2011-2#2)
animal proteins##2##2##(1996-2#1)(1997-4#1)
animal scavenging##2##2##(1995-3#2)
animal shelter##3##2##(1996-12#1)(2013-8#2)
animal species##11##2##(1990-6#1)(1992-6#2)(2007-10#1)(2008-12#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
animal studies and clinical trials##2##5##(1993-11#1)(2008-8#1)
animal studies and##5##3##(1993-11#1)(2008-1#1)(2008-11#1)(2008-8#2)
animal studies for##3##3##(2008-10#2)(2012-12#1)
animal studies have##5##3##(2008-10#3)(2008-2#1)(2009-10#1)
animal studies indicate##2##3##(1991-9#1)(1997-1#1)
animal studies suggest that##2##4##(1992-6#1)(2007-4#1)
animal studies##38##2##(1991-12#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-9#1)(1995-8#1)(1995-9#1)(1997-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2011-2#1)(2012-12#4)(2012-2#1)
animal study##4##2##(1997-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
animal testing##3##2##(2008-10#1)(2008-5#1)(2010-6#1)
animal tests##2##2##(1996-12#1)(2008-4#1)
animal that##4##2##(1994-8#1)(2008-9#2)(2010-3#1)
animal tissue##5##2##(1990-7#1)(1997-4#1)(2008-10#2)(2008-7#1)
animal tissues##6##2##(1994-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
animal tissues)##2##2##(2008-10#1)(2012-12#1)
animal to animal##2##3##(2008-10#2)
animal to##5##2##(1992-12#1)(2008-10#2)(2008-4#1)(2012-12#1)
animal was maintained##2##3##(1997-6#1)(2008-5#1)
animal was##4##2##(1992-8#1)(1997-6#1)(2008-5#1)(2012-2#1)
animal weight##2##2##(1994-8#1)(2008-5#1)
animal were##2##2##(2008-10#1)(2012-3#1)
animal##822##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#6)(1992-8#2)(1992-9#6)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#9)(1994-7#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#10)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#7)(1997-7#11)(1997-8#2)(2006-6#1)(2007-10#3)(2007-11#3)(2007-12#19)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#2)(2007-9#1)(2008-1#8)(2008-10#87)(2008-11#85)(2008-12#13)(2008-2#10)(2008-3#7)(2008-4#42)(2008-5#23)(2008-6#11)(2008-7#48)(2008-8#34)(2008-9#42)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#15)(2010-1#7)(2010-10#2)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#9)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#31)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#18)(2012-2#14)(2012-3#10)(2013-1#15)(2013-7#9)(2013-8#6)
animal's##8##1##(1992-11#1)(1993-12#1)(1996-12#1)(2008-11#2)(2008-4#2)(2009-4#1)
animal-derived##7##1##(2008-11#7)
animal-free medium##2##2##(2008-11#2)
animal-free##4##1##(2008-11#4)
animals (3##2##2##(1996-5#1)(2008-5#1)
animals after##4##2##(1990-3#1)(1995-5#1)(2009-7#1)(2013-1#1)
animals aged##2##2##(1993-12#1)(1995-8#1)
animals also##3##2##(1994-9#1)(2008-7#1)(2009-5#1)
animals and a##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
animals and for##2##3##(2008-11#1)(2013-1#1)
animals and human##5##3##(1995-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
animals and humans in##2##4##(2010-3#1)(2013-1#1)
animals and humans##18##3##(1992-9#1)(1994-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
animals and in##2##3##(1991-2#1)(1996-5#1)
animals and man##4##3##(1996-3#2)(1996-5#1)(1997-7#1)
animals and plants##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
animals and to##5##3##(1994-12#1)(1994-9#1)(2008-10#1)(2008-4#2)
animals and##72##2##(1990-3#1)(1991-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-3#2)(1996-5#3)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#3)
animals are not##2##3##(1994-6#1)(2011-2#1)
animals are##13##2##(1994-5#2)(1994-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)
animals as##7##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#1)(2011-2#2)
animals at##5##2##(1990-5#1)(1992-5#1)(1997-4#1)(2008-8#1)(2010-1#1)
animals but not in##2##4##(1990-7#1)(2008-7#1)
animals but##5##2##(1990-7#1)(1995-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
animals by##7##2##(1992-8#1)(1994-5#1)(2008-12#1)(2009-6#1)(2010-2#1)(2010-6#1)(2013-1#1)
animals can be##3##3##(1993-12#1)(1993-6#1)(1994-5#1)
animals can learn to##2##4##(2009-8#1)(2013-8#1)
animals can##8##2##(1993-12#2)(1993-6#1)(1994-5#1)(2008-8#2)(2009-8#1)(2013-8#1)
animals captured##2##2##(2008-5#1)(2009-4#1)
animals compared to##3##3##(1995-2#1)(1996-12#1)(2012-3#1)
animals compared with##2##3##(1995-2#1)(2008-10#1)
animals compared##5##2##(1995-2#2)(1996-12#1)(2008-10#1)(2012-3#1)
animals correspond##2##2##(1995-12#1)(2007-12#1)
animals could##2##2##(2008-9#1)(2009-8#1)
animals developed##3##2##(1995-12#1)(1995-9#1)(2009-8#1)
animals did not##3##3##(1994-8#1)(2008-5#1)(2009-12#1)
animals did##4##2##(1994-8#1)(1995-12#1)(2008-5#1)(2009-12#1)
animals died or were sacrificed moribund prior to the end of the study##3##13##(2008-9#3)
animals died or were##4##4##(1996-6#1)(2008-9#3)
animals displayed a##2##3##(1992-8#1)(1993-3#1)
animals displayed##4##2##(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)
animals during##3##2##(1997-6#1)(2010-4#1)(2012-2#1)
animals exhibited##4##2##(2008-10#2)(2008-5#2)
animals exposed to##2##3##(1991-2#1)(1994-5#1)
animals failed to##2##3##(1994-3#2)
animals failed##3##2##(1993-12#1)(1994-3#2)
animals for##7##2##(1990-12#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
animals from a##2##3##(1993-5#1)(1996-12#1)
animals from##8##2##(1993-5#2)(1996-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#1)
animals had a##4##3##(1993-5#2)(2008-12#1)(2008-6#1)
animals had higher##2##3##(1990-12#1)(2009-4#1)
animals had##13##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-12#1)(1993-5#2)(1997-8#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-4#1)
animals have been##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
animals have##7##2##(1990-8#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
animals in chemical##2##3##(2008-10#1)(2010-1#1)
animals in the exercise##2##4##(1992-3#2)
animals in the##11##3##(1992-1#1)(1992-3#3)(1993-12#1)(1993-9#1)(2007-10#1)(2007-12#1)(2008-8#2)(2010-4#1)
animals in which##3##3##(1995-12#1)(2008-4#1)(2012-3#1)
animals in##37##2##(1990-3#2)(1992-1#2)(1992-12#1)(1992-3#3)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#2)(2010-4#2)(2011-1#1)(2012-3#3)
animals injected with##2##3##(1993-12#1)(2008-6#1)
animals injected##3##2##(1991-2#1)(1993-12#1)(2008-6#1)
animals is a##2##3##(1993-6#1)(2008-6#1)
animals is also##2##3##(2007-6#1)(2009-2#1)
animals is##9##2##(1990-12#1)(1993-6#1)(1995-12#1)(2007-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-4#1)
animals made more##2##3##(1992-11#1)(2008-6#1)
animals may##4##2##(1990-5#1)(1995-8#1)(1996-12#1)(2009-8#1)
animals must##2##2##(2008-1#1)(2008-4#1)
animals of control##2##3##(2010-1#1)(2013-1#1)
animals of the##2##3##(1994-6#1)(2008-5#1)
animals of this##2##3##(1992-5#1)(2008-12#1)
animals of##10##2##(1991-2#1)(1992-5#1)(1993-5#1)(1994-6#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-1#1)(2013-1#2)
animals on##3##2##(1993-12#1)(1996-5#1)(2008-10#1)
animals or##5##2##(2007-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-7#1)
animals over##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
animals per##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
animals pre-treated##2##2##(1993-12#1)(1995-11#1)
animals pretreated with##6##3##(1993-12#1)(1994-8#1)(1996-9#1)(2010-11#1)(2011-1#2)
animals received an##2##3##(1991-12#1)(1993-12#1)
animals received either##2##3##(1995-12#1)(2009-12#1)
animals received##8##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(2008-7#1)(2009-12#1)
animals recovered##2##2##(2008-11#1)(2013-1#1)
animals remained##2##2##(1992-5#1)(1994-3#1)
animals show##2##2##(2008-11#1)(2009-8#1)
animals showed an##2##3##(1991-2#1)(2010-2#1)
animals showed##12##2##(1991-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
animals studied##3##2##(1996-12#1)(1996-5#1)(2012-2#1)
animals such as##2##3##(2007-11#1)(2012-2#1)
animals than in controls##3##4##(2008-7#1)(2011-2#2)
animals than in##5##3##(1992-8#1)(1997-4#1)(2008-7#1)(2011-2#2)
animals than##6##2##(1992-8#1)(1995-12#1)(1997-4#1)(2008-7#1)(2011-2#2)
animals that are##3##3##(2007-6#1)(2008-10#1)(2008-7#1)
animals that died##2##3##(2008-9#1)(2011-2#1)
animals that had been##2##4##(1993-6#1)(2008-11#1)
animals that have##2##3##(2008-4#1)(2010-7#1)
animals that received BDNF##2##4##(1995-5#2)
animals that received##8##3##(1993-12#2)(1995-5#3)(1997-2#1)(2008-5#1)(2011-1#1)
animals that##27##2##(1993-12#2)(1993-6#2)(1995-5#3)(1997-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#2)
animals the##5##2##(1991-5#1)(1993-12#1)(2008-7#2)(2008-8#1)
animals to detect and##2##4##(2008-4#1)(2008-8#1)
animals to produce##2##3##(2008-5#1)(2008-7#1)
animals to##19##2##(1991-2#3)(1993-3#1)(1994-3#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#2)(2010-4#1)(2012-12#1)(2013-1#2)
animals treated with##4##3##(1992-9#1)(1995-11#1)(1995-3#1)(2013-8#1)
animals treated##6##2##(1992-9#3)(1995-11#1)(1995-3#1)(2013-8#1)
animals under##4##2##(2008-12#1)(2008-5#2)(2013-1#1)
animals underwent##2##2##(1997-6#1)(2008-3#1)
animals using a##2##3##(1994-2#1)(1997-4#1)
animals using##5##2##(1994-2#1)(1997-4#1)(2011-1#1)(2012-3#2)
animals was also##2##3##(1996-5#1)(2008-11#1)
animals was compared with##2##4##(1992-10#1)(1995-8#1)
animals was##21##2##(1990-8#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-2#1)(2011-2#1)
animals were also##3##3##(1991-2#1)(1993-3#1)(2008-9#1)
animals were divided into##2##4##(1992-3#1)(1997-6#1)
animals were housed##2##3##(1993-6#1)(2008-11#1)
animals were killed##4##3##(1991-12#1)(2007-10#1)(2008-9#1)(2009-12#1)
animals were protected##4##3##(1995-5#3)(2008-9#1)
animals were randomly##2##3##(2009-3#1)(2013-1#1)
animals were sacrificed##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
animals were tested for##3##4##(1993-6#1)(1994-2#1)(2011-2#1)
animals were tested##4##3##(1993-6#1)(1994-2#1)(2007-10#1)(2011-2#1)
animals were treated with##2##4##(1996-12#1)(2013-7#1)
animals were treated##3##3##(1996-12#1)(2008-5#1)(2013-7#1)
animals were used##3##3##(1994-6#1)(2006-6#1)(2008-7#1)
animals were##86##2##(1991-12#2)(1991-2#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#4)(1993-3#3)(1993-6#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-5#3)(1996-12#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-9#1)(2006-6#1)(2007-10#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#4)(2008-7#7)(2008-9#3)(2009-12#1)(2009-3#3)(2009-4#2)(2010-2#3)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
animals when##3##2##(1995-2#1)(1996-2#1)(2008-7#1)
animals where##3##2##(1997-2#1)(2008-8#2)
animals which##7##2##(1995-9#1)(1996-12#1)(1996-3#1)(1997-4#2)(2008-5#1)(2013-7#1)
animals while the##2##3##(1991-12#1)(2007-8#1)
animals while##3##2##(1991-12#1)(1993-9#1)(2007-8#1)
animals with a##2##3##(1991-2#1)(1994-11#1)
animals with##27##2##(1991-2#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2011-3#1)(2012-1#1)
animals##1025##1##(1990-11#3)(1990-12#6)(1990-2#1)(1990-3#5)(1990-5#16)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#10)(1991-2#16)(1991-3#1)(1991-5#2)(1991-8#2)(1992-1#4)(1992-10#5)(1992-11#7)(1992-12#3)(1992-2#3)(1992-3#9)(1992-5#7)(1992-6#1)(1992-7#2)(1992-8#9)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#43)(1993-2#1)(1993-3#11)(1993-5#6)(1993-6#15)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#14)(1994-5#16)(1994-6#9)(1994-7#1)(1994-8#8)(1994-9#5)(1995-11#7)(1995-12#23)(1995-2#9)(1995-3#3)(1995-5#11)(1995-6#2)(1995-8#6)(1995-9#2)(1996-12#22)(1996-2#3)(1996-3#4)(1996-5#18)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#2)(1997-4#9)(1997-6#6)(1997-7#2)(1997-8#4)(1997-9#3)(2006-6#4)(2007-10#4)(2007-11#3)(2007-12#10)(2007-3#1)(2007-5#1)(2007-6#6)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#53)(2008-11#23)(2008-12#32)(2008-2#5)(2008-3#12)(2008-4#28)(2008-5#46)(2008-6#6)(2008-7#51)(2008-8#36)(2008-9#34)(2009-12#8)(2009-2#3)(2009-3#6)(2009-4#6)(2009-5#8)(2009-6#7)(2009-7#1)(2009-8#8)(2010-1#5)(2010-11#1)(2010-12#1)(2010-2#11)(2010-3#2)(2010-4#22)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#2)(2011-1#11)(2011-2#36)(2011-3#2)(2012-1#7)(2012-12#5)(2012-2#17)(2012-3#21)(2013-1#29)(2013-7#7)(2013-8#8)
animals'##2##1##(1995-12#1)(2008-7#1)
animals)##3##1##(1996-12#1)(2008-7#1)(2010-4#1)
animate##4##1##(1997-6#1)(2008-11#2)(2008-12#1)
animated agents##2##2##(2008-11#2)
animated##6##1##(2008-11#3)(2009-10#1)(2011-2#1)(2012-2#1)
animation##7##1##(2007-11#1)(2008-6#5)(2010-8#1)
animations##5##1##(2007-12#1)(2008-6#1)(2010-8#1)(2010-9#2)
anion and cation exchange columns##2##5##(2008-10#2)
anion and cation##5##3##(2007-12#1)(2008-10#3)(2012-1#1)
anion and the##3##3##(1990-8#1)(1994-5#1)(2008-10#1)
anion and##19##2##(1990-5#1)(1990-8#1)(1994-5#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#1)(2009-8#1)(2012-1#1)
anion band##2##2##(2008-10#2)
anion binding site##3##3##(1990-5#2)(1993-8#1)
anion binding to##2##3##(1990-5#1)(2011-1#1)
anion binding##11##2##(1990-5#3)(1990-8#3)(1993-8#1)(1996-12#1)(2008-10#1)(2011-1#2)
anion carriers##2##2##(2008-10#2)
anion channel##5##2##(1995-11#1)(2008-4#2)(2008-8#1)(2012-2#1)
anion channels##2##2##(2008-4#2)
anion complex##2##2##(2008-10#2)
anion exchange and##5##3##(1991-5#1)(1991-9#1)(1992-3#1)(2008-10#2)
anion exchange chromatography and##3##4##(1994-6#1)(2008-7#2)
anion exchange chromatography##7##3##(1990-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#3)
anion exchange column##10##3##(1992-12#1)(2008-10#7)(2008-11#2)
anion exchange membranes##2##3##(2008-10#2)
anion exchange resin##6##3##(2008-10#6)
anion exchange##47##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-6#1)(2008-10#27)(2008-11#5)(2008-7#4)(2008-8#1)
anion exchanger##15##2##(2008-10#14)(2013-7#1)
anion excluder and##2##3##(2008-10#2)
anion excluder##6##2##(2008-10#6)
anion film modified carbon paste electrode##2##6##(2008-10#2)
anion form##2##2##(1992-6#1)(1993-11#1)
anion formation##2##2##(1994-8#1)(2008-10#1)
anion has##3##2##(1992-11#1)(1996-2#2)
anion in##4##2##(1992-11#1)(2008-10#2)(2011-1#1)
anion ionophores in##3##3##(2008-10#3)
anion is##2##2##(2012-2#1)(2012-7#1)
anion of##5##2##(1996-5#1)(1997-7#1)(2008-10#3)
anion produced by##2##3##(1996-5#1)(1997-4#1)
anion produced##3##2##(1996-5#1)(1997-4#1)(2008-10#1)
anion radicals##4##2##(1994-11#2)(2010-12#1)(2013-8#1)
anion site##2##2##(1990-5#1)(2008-10#1)
anion to##2##2##(2008-10#2)
anion transport##3##2##(1994-6#1)(2011-2#2)
anion##263##1##(1990-2#1)(1990-5#8)(1990-8#4)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#3)(1994-5#2)(1994-6#3)(1994-8#4)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#6)(1996-5#2)(1996-9#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#142)(2008-11#8)(2008-12#1)(2008-4#7)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#9)(2011-2#4)(2012-1#1)(2012-2#4)(2012-7#1)(2013-7#1)(2013-8#2)
anion-exchange HPLC##3##2##(1992-12#1)(1993-11#1)(2008-4#1)
anion-exchange and##4##2##(2008-10#4)
anion-exchange chromatography##18##2##(1990-11#1)(1991-5#1)(1991-7#2)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(2008-10#7)(2008-4#1)
anion-exchange column in the I(-)-form after the##2##7##(2008-10#2)
anion-exchange column in the##3##4##(2008-10#3)
anion-exchange column##12##2##(1990-8#1)(1991-7#1)(2008-10#10)
anion-exchange conversion column##2##3##(2008-10#2)
anion-exchange disks##2##2##(2008-10#2)
anion-exchange high-performance liquid chromatography##5##4##(1991-2#1)(1991-5#2)(1994-12#2)
anion-exchange high-performance liquid##6##3##(1991-2#2)(1991-5#2)(1994-12#2)
anion-exchange resin##10##2##(2008-10#10)
anion-exchange silica gels##2##3##(2008-10#2)
anion-exchange##75##1##(1990-11#1)(1990-8#2)(1991-2#2)(1991-5#3)(1991-7#3)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#1)(2008-10#48)(2008-4#2)(2008-7#1)(2010-4#1)
anion-selective##3##1##(2008-10#3)
anionic additive on##2##3##(2008-10#2)
anionic additive##6##2##(2008-10#6)
anionic amino acids##2##3##(1990-12#2)
anionic and cationic##4##3##(1990-8#1)(2008-10#2)(2008-5#1)
anionic and##10##2##(1990-8#1)(1992-6#1)(2008-10#7)(2008-5#1)
anionic arsenic##3##2##(2008-10#3)
anionic compounds##2##2##(1990-8#1)(2008-10#1)
anionic detergents##2##2##(1990-5#1)(2012-2#1)
anionic dye##2##2##(2008-10#2)
anionic glycolipids and phospholipids##2##4##(1994-12#2)
anionic molecules##2##2##(2008-10#1)(2009-8#1)
anionic polyelectrolytes##2##2##(2008-10#2)
anionic porphyrin##3##2##(2008-10#3)
anionic resin##3##2##(2008-10#3)
anionic response##2##2##(2008-10#2)
anionic site##3##2##(2008-10#3)
anionic slope of##2##3##(2008-10#2)
anionic species##9##2##(2008-10#9)
anionic surfactant in##2##3##(1996-5#1)(2008-10#1)
anionic surfactant##13##2##(1996-5#1)(2008-10#10)(2008-5#2)
anionic surfactants in##5##3##(2008-10#5)
anionic surfactants##17##2##(2008-10#12)(2008-5#5)
anionic##157##1##(1990-12#2)(1990-5#5)(1990-8#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-12#4)(1994-5#2)(1994-9#1)(1995-2#1)(1995-6#2)(1996-5#2)(1997-7#1)(2008-10#103)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#11)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2012-12#2)(2012-2#2)
anions (bromide##2##2##(2008-10#2)
anions and cations##9##3##(2008-10#9)
anions and complexing agents has been studied at 1##2##9##(2008-10#2)
anions and complexing agents##3##4##(2008-10#3)
anions and the##2##3##(2008-10#2)
anions and##32##2##(1993-12#2)(1997-7#1)(2008-10#26)(2008-7#1)(2010-7#1)(2013-1#1)
anions are##4##2##(2008-10#3)(2010-4#1)
anions at##4##2##(1990-5#1)(2008-10#3)
anions by##2##2##(1990-5#1)(2008-10#1)
anions do not interfere##3##4##(2008-10#3)
anions found in##2##3##(2008-10#2)
anions in the##2##3##(2008-10#2)
anions in##14##2##(2008-10#14)
anions is##5##2##(1990-8#2)(1997-7#1)(2008-10#2)
anions of##2##2##(2008-10#2)
anions on the##5##3##(1990-8#1)(1994-5#1)(2008-10#3)
anions on##7##2##(1990-8#1)(1994-5#1)(2008-10#5)
anions present in##2##3##(2008-10#2)
anions present##3##2##(2008-10#3)
anions such as##4##3##(1994-5#1)(2008-10#3)
anions to##2##2##(1990-5#1)(2008-10#1)
anions was achieved within##2##4##(2008-10#2)
anions was achieved##3##3##(2008-10#3)
anions was##6##2##(1990-5#1)(2008-10#5)
anions were##8##2##(2008-10#7)(2012-7#1)
anions which##3##2##(1990-8#1)(2008-10#2)
anions with a##2##3##(2008-10#2)
anions with the##2##3##(2008-10#1)(2010-4#1)
anions with##8##2##(1995-5#1)(2008-10#5)(2010-4#2)
anions##224##1##(1990-5#6)(1990-8#7)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-12#1)(1994-5#3)(1995-5#2)(1995-6#1)(1996-2#4)(1996-5#1)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#1)(2008-10#171)(2008-11#2)(2008-7#2)(2010-4#7)(2010-7#1)(2011-1#1)(2012-1#1)(2012-7#1)(2013-1#2)
aniracetam##3##1##(1995-12#3)
aniseed drinks by##2##3##(2008-10#2)
aniseed drinks##3##2##(2008-10#3)
anisette samples##4##2##(2008-10#4)
anisodamine##3##1##(2008-9#2)(2010-12#1)
anisometropic amblyopia##2##2##(2013-7#2)
anisometropic##4##1##(2013-7#4)
anisomycin##2##1##(1991-5#1)(1994-11#1)
anisoplanatic effects##2##2##(2008-3#2)
anisoplanatic##3##1##(2008-3#3)
anisoplanatism##6##1##(2007-11#2)(2008-3#4)
anisopliae host infection process##2##4##(2010-10#2)
anisopliae##18##1##(2008-6#8)(2010-10#10)
anisotropic GSM beams##3##3##(2007-11#3)
anisotropic Gaussian-Schell model (GSM) beams##2##5##(2007-11#2)
anisotropic Gaussian-Schell model##3##3##(2007-11#3)
anisotropic actuation##3##2##(2010-4#3)
anisotropic and inhomogeneous##2##3##(2008-3#1)(2009-7#1)
anisotropic and##5##2##(2008-3#4)(2009-7#1)
anisotropic dielectric##2##2##(2008-3#2)
anisotropic diffraction##3##2##(2007-11#2)(2008-3#1)
anisotropic foci with one##2##4##(2008-10#2)
anisotropic foci##3##2##(2008-10#3)
anisotropic grains in##2##3##(2008-2#2)
anisotropic magnetoresistance##2##2##(1990-4#1)(2008-7#1)
anisotropic materials##2##2##(2008-2#1)(2008-3#1)
anisotropic medium##4##2##(2007-11#3)(2008-3#1)
anisotropic molecule##3##2##(2008-3#3)
anisotropic optical##2##2##(2007-11#2)
anisotropic periodic structures##2##3##(2008-3#2)
anisotropic periodic##3##2##(2008-3#3)
anisotropic samples##2##2##(2008-2#1)(2009-7#1)
anisotropic scattering media##5##3##(2008-2#1)(2008-3#4)
anisotropic scattering of##2##3##(2008-10#1)(2008-2#1)
anisotropic scattering planar media##2##4##(2008-3#2)
anisotropic scattering##13##2##(2008-10#1)(2008-2#2)(2008-3#10)
anisotropic self-diffraction in BaTiO(3)##2##4##(2008-2#1)(2008-3#1)
anisotropic self-diffraction in##3##3##(2008-2#1)(2008-3#2)
anisotropic self-diffraction##4##2##(2008-2#1)(2008-3#3)
anisotropic semitransparent substrate##2##3##(2008-3#2)
anisotropic structures##2##2##(2008-3#2)
anisotropic substrate##2##2##(2008-3#2)
anisotropic uniaxial##2##2##(2008-2#2)
anisotropic##124##1##(1990-4#2)(1994-3#1)(1995-3#1)(1997-7#2)(2007-11#16)(2007-12#5)(2008-10#7)(2008-2#15)(2008-3#56)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#3)(2010-4#7)
anisotropies##3##1##(2008-10#2)(2008-3#1)
anisotropy and##2##2##(2008-3#2)
anisotropy as##2##2##(2007-11#1)(2012-2#1)
anisotropy can be##2##3##(2008-10#1)(2008-3#1)
anisotropy can##3##2##(2008-10#2)(2008-3#1)
anisotropy in organic molecular films##2##5##(2008-3#2)
anisotropy in##7##2##(1991-9#1)(2007-12#2)(2008-2#1)(2008-3#3)
anisotropy is##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
anisotropy measurements##3##2##(1990-11#1)(2008-10#2)
anisotropy of the##5##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
anisotropy of##16##2##(1990-2#1)(1993-11#2)(1994-2#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-6#1)(2009-11#1)
anisotropy on##2##2##(2008-2#1)(2008-3#1)
anisotropy ratio##2##2##(2008-10#2)
anisotropy with##2##2##(2008-10#1)(2008-3#1)
anisotropy##95##1##(1990-11#1)(1990-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#2)(1994-2#1)(1995-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#7)(2007-12#4)(2008-10#23)(2008-11#1)(2008-2#8)(2008-3#31)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2012-2#1)
ankle and foot##2##3##(2010-11#1)(2011-2#1)
ankle and##7##2##(2009-11#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#1)
ankle arthrodesis was##2##3##(2008-12#1)(2009-7#1)
ankle arthrodesis with screws##4##4##(2011-2#4)
ankle arthrodesis##8##2##(2008-12#3)(2009-7#1)(2011-2#4)
ankle arthroplasty##2##2##(2009-10#1)(2010-5#1)
ankle arthroscopy##6##2##(2009-1#4)(2010-7#2)
ankle arthrosis##5##2##(2008-12#2)(2011-2#3)
ankle brachial##2##2##(2008-8#2)
ankle fracture with##2##3##(2009-1#1)(2009-3#1)
ankle fracture##4##2##(2009-1#2)(2009-3#1)(2013-1#1)
ankle fractures##5##2##(2009-1#1)(2009-3#2)(2012-3#1)(2013-1#1)
ankle injuries##2##2##(2010-3#1)(2011-2#1)
ankle injury##4##2##(2007-11#2)(2012-3#2)
ankle instability##3##2##(2012-3#1)(2013-1#2)
ankle joint##17##2##(2007-11#1)(2007-8#4)(2009-7#3)(2010-3#1)(2010-5#2)(2011-2#2)(2012-2#3)(2012-3#1)
ankle joints##4##2##(2007-11#3)(2011-2#1)
ankle pain##5##2##(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
ankle range of motion##2##4##(2007-11#2)
ankle sprain##7##2##(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#3)
ankle sprains##3##2##(2013-1#3)
ankle##142##1##(1990-6#1)(1995-12#2)(2007-11#9)(2007-8#4)(2008-12#12)(2008-8#6)(2009-1#10)(2009-10#4)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#8)(2010-11#1)(2010-3#4)(2010-5#8)(2010-7#5)(2011-2#25)(2012-12#1)(2012-2#15)(2012-3#10)(2013-1#12)
ankles and##2##2##(2007-11#1)(2009-4#1)
ankles##5##1##(1996-9#1)(2006-10#1)(2007-11#1)(2009-4#1)(2013-1#1)
ankyloglossia##2##1##(1993-12#2)
ankylosed##3##1##(2007-12#1)(2007-8#1)(2011-2#1)
ankylosing spondylitis (AS)##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
ankylosing spondylitis and##2##3##(2010-12#1)(2010-5#1)
ankylosing spondylitis##18##2##(1990-6#5)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#4)(2010-5#1)(2011-2#2)(2012-3#2)
ankylosing spondylitis]##2##2##(1993-11#1)(2013-8#1)
ankylosing##23##1##(1990-6#5)(1991-8#1)(1993-11#2)(2008-10#2)(2008-5#1)(2008-7#2)(2010-12#4)(2010-5#1)(2011-2#2)(2012-3#2)(2013-8#1)
ankylosis##8##1##(2007-12#2)(2011-2#6)
ankyrin repeat##2##2##(1991-7#1)(2008-8#1)
ankyrin repeats##2##2##(2008-8#1)(2012-1#1)
ankyrin##5##1##(1991-7#1)(1996-12#1)(2008-8#2)(2012-1#1)
anlage and##3##2##(1994-8#1)(1995-8#1)(2011-2#1)
anlage##5##1##(1994-8#1)(1995-8#1)(1997-9#1)(2007-12#1)(2011-2#1)
annals##4##1##(1990-6#3)(1997-4#1)
annealed at##4##2##(2008-2#1)(2009-8#1)(2013-8#2)
annealed to##2##2##(1992-12#1)(1994-12#1)
annealed##12##1##(1992-12#1)(1994-12#1)(2007-11#2)(2008-10#1)(2008-2#4)(2009-8#1)(2013-8#2)
annealing and##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
annealing at##7##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#2)
annealing in##3##2##(2008-2#2)(2008-3#1)
annealing is##2##2##(2008-3#1)(2013-8#1)
annealing of##2##2##(2009-5#2)
annealing step##4##2##(1994-12#2)(2007-11#2)
annealing temperature##3##2##(2007-12#1)(2008-10#2)
annealing to##2##2##(1991-11#1)(2008-11#1)
annealing was##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
annealing##71##1##(1991-11#1)(1994-12#3)(1994-5#4)(1995-5#1)(1995-8#1)(2007-11#9)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#13)(2008-3#16)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#4)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#4)
annelid Platynereis##2##2##(1990-5#2)
annelid##7##1##(1990-5#3)(1995-3#1)(1996-2#1)(2008-5#1)(2008-7#1)
annelids##2##1##(2009-8#2)
annetocin-IR cells##2##2##(2008-5#2)
annetocin-IR##3##1##(2008-5#3)
annetocin-secretory cells were##2##3##(2008-5#2)
annetocin-secretory cells##4##2##(2008-5#4)
annex##2##1##(2008-10#1)(2008-11#1)
annexin II##3##2##(1991-6#3)
annexin V and##2##3##(2008-11#1)(2012-1#1)
annexin V to##2##3##(2008-11#2)
annexin V##18##2##(1994-6#4)(2006-6#3)(2008-1#1)(2008-10#1)(2008-11#7)(2012-1#1)(2012-12#1)
annexin V-FITC/PI staining##2##3##(2008-11#2)
annexin XII hexamer##3##3##(1995-11#3)
annexin##34##1##(1991-6#3)(1992-12#2)(1993-8#1)(1994-6#4)(1995-11#3)(2006-6#3)(2008-1#1)(2008-10#1)(2008-11#10)(2008-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2013-7#1)
annexins I##3##2##(1992-12#2)(1993-8#1)
annexins##7##1##(1992-12#5)(1993-8#2)
annihilation##5##1##(1992-11#1)(1994-12#1)(2008-7#1)(2010-4#1)(2012-12#1)
anniversary of the##2##3##(2008-7#1)(2013-1#1)
anniversary of##9##2##(1992-2#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
anniversary##12##1##(1991-3#1)(1992-2#1)(1995-1#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
annosum##7##1##(2008-10#5)(2010-10#2)
annotate the##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
annotate##6##1##(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-1#1)
annotated bibliography##4##2##(1992-1#1)(1992-12#1)(1993-2#2)
annotated by##2##2##(2010-4#1)(2013-8#1)
annotated##21##1##(1992-1#1)(1992-12#1)(1993-2#2)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-10#1)(2010-3#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
annotating##2##1##(2008-7#1)(2011-2#1)
annotation and##2##2##(2008-4#1)(2010-8#1)
annotation data##3##2##(2008-7#1)(2009-5#1)(2011-2#1)
annotation of RNA motifs##2##4##(2008-7#2)
annotation of##10##2##(2007-11#1)(2008-7#4)(2008-9#2)(2010-11#1)(2011-2#1)(2013-8#1)
annotation transfer##2##2##(2012-2#2)
annotation##71##1##(2007-11#2)(2008-4#6)(2008-7#16)(2008-9#5)(2009-10#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#31)(2012-2#2)(2012-3#1)(2013-8#1)
annotations##13##1##(2008-10#1)(2008-4#2)(2008-7#8)(2012-2#2)
announce##3##1##(2010-11#1)(2011-2#1)(2013-1#1)
announced that##4##2##(1995-1#1)(1996-2#1)(2008-5#1)(2008-7#1)
announced##16##1##(1995-1#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
announcements##3##1##(2008-1#1)(2012-1#1)(2013-1#1)
annoying##3##1##(2008-3#1)(2008-5#1)(2008-7#1)
annual IAHSS##3##2##(1992-2#1)(1994-2#1)(1996-12#1)
annual Norwegian##2##2##(1991-6#2)
annual and perennial##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
annual and##4##2##(2008-10#1)(2008-2#1)(2010-1#1)(2011-2#1)
annual average costs of BYDV##2##5##(2008-10#2)
annual average##3##2##(2007-2#1)(2008-10#2)
annual data for##2##3##(1991-12#1)(1997-2#1)
annual dose##4##2##(1996-6#1)(2008-7#1)(2009-11#2)
annual entomological inoculation rate##3##4##(2012-12#3)
annual health##2##2##(2008-11#1)(2011-2#1)
annual incidence of##4##3##(1996-11#2)(2007-7#1)(2008-4#1)
annual incidence rate was##2##4##(1996-8#1)(2011-2#1)
annual incidence rate##3##3##(1996-8#1)(2011-2#2)
annual incidence##11##2##(1996-11#4)(1996-8#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#2)
annual income##2##2##(2008-12#2)
annual meeting of the European Society of Gastrointestinal and Abdominal Radiology##2##11##(2008-7#2)
annual meeting of the##4##4##(1997-7#1)(2008-7#2)(2008-8#1)
annual meeting of##5##3##(1997-7#1)(2008-7#2)(2008-8#1)(2009-4#1)
annual meeting##18##2##(1990-2#1)(1991-1#1)(1997-7#1)(2008-10#8)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#1)
annual mortality rate##4##3##(1992-9#1)(1995-3#3)
annual mortality##7##2##(1992-9#1)(1995-3#4)(2008-10#1)(2010-12#1)
annual national##2##2##(1992-3#1)(2011-2#1)
annual number of##2##3##(1995-6#1)(2011-2#1)
annual per capita##4##3##(1994-2#1)(1997-1#1)(2007-7#1)(2012-3#1)
annual per##5##2##(1994-2#1)(1997-1#1)(1997-8#1)(2007-7#1)(2012-3#1)
annual plant Arabidopsis thaliana##2##4##(2008-9#2)
annual plant populations##2##3##(2008-8#2)
annual plant##9##2##(2008-8#5)(2008-9#4)
annual precipitation##2##2##(2008-10#2)
annual radiation exposure##2##3##(1996-6#2)
annual rainfall##2##2##(2009-10#2)
annual rate##5##2##(1993-1#1)(1993-3#2)(1996-1#1)(2007-8#1)
annual report of the american phytopathological society##7##7##(2008-10#7)
annual report##11##2##(1996-1#2)(2008-10#7)(2010-3#1)(2012-3#1)
annual reports##3##2##(1990-3#1)(2012-12#1)(2012-3#1)
annual sales##2##2##(2008-5#2)
annual savings of##3##3##(1992-2#1)(2008-1#1)(2008-10#1)
annual scientific meeting##3##3##(2008-7#2)(2009-9#1)
annual screening##2##2##(2010-10#1)(2012-2#1)
annual seroconversion rate##2##3##(2007-7#2)
annual seroconversion rates##2##3##(2007-7#2)
annual seroconversion##4##2##(2007-7#4)
annual survey##3##2##(1994-3#1)(1995-2#1)(2008-11#1)
annual variability in seed##2##4##(2008-9#2)
annual variation##2##2##(2008-5#1)(2008-9#1)
annual volume of##2##3##(1995-2#1)(2007-9#1)
annual volume##3##2##(1992-2#1)(1995-2#1)(2007-9#1)
annual##271##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-6#2)(1992-1#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-9#2)(1995-2#4)(1995-3#4)(1995-6#1)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#5)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-1#1)(2007-10#2)(2007-2#3)(2007-5#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#34)(2008-11#9)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#6)(2008-8#23)(2008-9#11)(2009-10#3)(2009-11#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#5)(2011-2#19)(2012-12#6)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#3)
annually and##3##2##(1995-2#1)(2007-5#1)(2007-9#1)
annually by##2##2##(1995-9#1)(1996-2#1)
annually for##2##2##(1991-12#1)(2008-9#1)
annually in##4##2##(1996-3#1)(2008-1#1)(2008-6#1)(2012-2#1)
annually on the##2##3##(1994-1#1)(2007-2#1)
annually worldwide##2##2##(2010-11#1)(2011-2#1)
annually##43##1##(1990-11#1)(1991-12#1)(1992-1#1)(1993-1#1)(1994-1#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
annualreviews##35##1##(2011-1#15)(2011-2#10)(2012-1#10)
annuals##3##1##(2008-9#3)
annular aperture##2##2##(2007-12#1)(2008-3#1)
annular collagen##3##2##(2008-8#3)
annular##35##1##(1995-5#2)(1996-6#1)(1997-2#2)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#6)(2008-7#2)(2008-8#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#4)(2013-7#1)
annulare##2##1##(1996-3#1)(2010-6#1)
annulata##2##1##(2007-2#1)(2011-1#1)
annulatus##5##1##(2008-5#3)(2011-1#1)(2013-1#1)
annulenes##3##1##(1996-5#3)
annuli##2##1##(2007-12#1)(2008-2#1)
annuloplasty device##2##2##(2007-8#2)
annuloplasty ring##4##2##(2007-8#4)
annuloplasty rings##2##2##(2007-8#2)
annuloplasty##21##1##(2007-8#12)(2008-10#5)(2008-8#3)(2010-9#1)
annulus and##2##2##(1996-6#1)(2007-8#1)
annulus fibrosus##2##2##(2009-3#1)(2012-2#1)
annulus of##2##2##(2008-5#1)(2008-8#1)
annulus or##2##2##(2008-10#1)(2008-9#1)
annulus##20##1##(1990-5#1)(1996-6#3)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)
annuum cv##2##2##(2008-10#2)
annuum##14##1##(2008-10#14)
annuus L##3##2##(2008-10#3)
annuus and##2##2##(2008-10#1)(2008-8#1)
annuus##11##1##(2008-10#8)(2008-8#1)(2009-6#2)
ano-genital examination##3##2##(2009-9#1)(2010-4#2)
ano-genital##5##1##(2009-9#1)(2010-4#4)
anodal##2##1##(1992-11#1)(1992-3#1)
anode and##2##2##(2008-10#1)(2012-12#1)
anode##9##1##(1991-5#1)(2007-11#1)(2008-10#4)(2008-3#1)(2012-12#1)(2013-1#1)
anodes##2##1##(2008-3#2)
anodic and cathodic##3##3##(2008-10#3)
anodic and##4##2##(2008-10#4)
anodic bonding of##2##3##(2008-10#2)
anodic current##2##2##(2008-10#1)(2008-12#1)
anodic electrodissolution##3##2##(2008-10#3)
anodic oxidation of hydrazine##2##4##(2008-10#2)
anodic oxidation of##4##3##(2008-10#4)
anodic oxidation##7##2##(2008-10#7)
anodic peak potential##4##3##(2008-10#4)
anodic peak was##3##3##(2008-10#3)
anodic peak##14##2##(2008-10#14)
anodic peaks of##2##3##(2008-10#2)
anodic peaks##6##2##(2008-10#6)
anodic potential##3##2##(2008-10#3)
anodic slime is determined##2##4##(2008-10#2)
anodic stripping differential pulse##3##4##(2008-10#3)
anodic stripping peak current##2##4##(2008-10#2)
anodic stripping peak##3##3##(2008-10#3)
anodic stripping voltammetric (ASV)##2##4##(2008-10#2)
anodic stripping voltammetric detection##2##4##(2008-10#2)
anodic stripping voltammetric determination of##2##5##(2008-10#2)
anodic stripping voltammetric method##2##4##(2008-10#2)
anodic stripping voltammetric##13##3##(2008-10#13)
anodic stripping voltammetry (ASV)##3##4##(2008-10#3)
anodic stripping voltammetry (SWASV)##3##4##(2008-10#3)
anodic stripping voltammetry and##3##4##(2008-10#3)
anodic stripping voltammetry at##2##4##(2008-10#2)
anodic stripping voltammetry of##2##4##(2008-10#2)
anodic stripping voltammetry using##3##4##(2008-10#3)
anodic stripping voltammetry with##4##4##(2008-10#4)
anodic stripping voltammetry##47##3##(2008-10#46)(2010-2#1)
anodic stripping##72##2##(2008-10#71)(2010-2#1)
anodic##136##1##(1995-6#1)(1996-12#1)(2008-10#130)(2008-12#1)(2008-2#1)(2010-2#1)(2013-1#1)
anodically##4##1##(2008-10#4)
anodisation##2##1##(2008-10#2)
anodised at##2##2##(2008-10#2)
anodised##3##1##(2008-10#3)
anodized BDD electrodes##2##3##(2008-10#2)
anodized BDD##3##2##(2008-10#3)
anodized##8##1##(2008-10#5)(2008-3#1)(2009-7#2)
anodontia##2##1##(2007-12#2)
anogenital##6##1##(1993-9#1)(1994-1#1)(1996-1#3)(2011-1#1)
anomala ascospores##2##2##(2008-10#2)
anomala strain K##3##3##(2008-10#3)
anomala were##3##2##(2008-10#3)
anomala##19##1##(2008-10#19)
anomalies and##5##2##(1997-3#1)(2008-4#1)(2008-9#1)(2010-6#1)(2013-1#1)
anomalies are rare##2##3##(2007-11#1)(2008-9#1)
anomalies are##9##2##(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#2)(2013-1#1)
anomalies in the##4##3##(2008-2#1)(2008-3#1)(2011-1#2)
anomalies in##16##2##(1992-5#1)(1997-3#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)
anomalies of the##5##3##(1990-6#1)(1991-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
anomalies of##12##2##(1990-6#1)(1991-6#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2012-3#1)
anomalies such as##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
anomalies that##4##2##(1995-3#1)(1997-3#1)(2008-10#1)(2012-12#1)
anomalies were##4##2##(1993-12#2)(2008-11#2)
anomalies##121##1##(1990-6#1)(1991-6#2)(1992-5#1)(1992-6#1)(1993-12#3)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#14)(1997-4#2)(1997-5#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#8)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-6#3)(2010-8#3)(2011-1#6)(2011-2#1)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#1)
anomalies)##2##1##(1997-3#1)(2013-1#1)
anomalous branching##2##2##(2008-7#1)(2011-2#1)
anomalous coronary artery##2##3##(2007-8#1)(2008-12#1)
anomalous diffraction approximation##3##3##(2008-2#1)(2008-3#2)
anomalous diffraction theory##3##3##(2008-2#2)(2008-3#1)
anomalous diffraction##8##2##(2008-2#4)(2008-3#3)(2009-11#1)
anomalous dispersion techniques##2##3##(2006-4#2)
anomalous dispersion##7##2##(2006-4#2)(2007-11#2)(2008-2#2)(2010-10#1)
anomalous mole fraction##2##3##(2008-8#2)
anomalous muscles##2##2##(2008-9#1)(2012-2#1)
anomalous origin of the right coronary##2##6##(2007-8#2)
anomalous origin of the##3##4##(2007-8#2)(2011-2#1)
anomalous photovoltaic film##2##3##(2008-2#2)
anomalous photovoltaic##3##2##(2008-2#3)
anomalous pulmonary venous connection to##3##5##(2008-11#3)
anomalous pulmonary venous connection##4##4##(2008-11#4)
anomalous pulmonary venous##5##3##(2007-8#1)(2008-11#4)
anomalous venous drainage##3##3##(2008-7#3)
anomalous##88##1##(1992-6#1)(1992-8#1)(1995-11#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-4#4)(2007-11#8)(2007-12#2)(2007-8#9)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#3)(2009-9#1)(2010-10#1)(2010-11#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-2#1)(2013-8#1)
anomalously small amounts of##2##4##(2012-2#2)
anomalously##8##1##(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#2)
anomaly and##4##2##(1993-9#1)(2008-11#1)(2008-12#1)(2010-3#1)
anomaly in the##3##3##(1991-9#1)(2007-11#1)(2008-10#1)
anomaly in which##2##3##(1991-8#1)(1995-5#1)
anomaly in##9##2##(1991-8#1)(1991-9#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-9#1)
anomaly is##4##2##(1991-6#1)(2007-11#1)(2008-12#1)(2008-7#1)
anomaly of the##4##3##(2012-2#1)(2013-1#2)(2013-2#1)
anomaly of##9##2##(2007-5#1)(2008-7#2)(2010-11#2)(2012-2#1)(2013-1#2)(2013-2#1)
anomaly often##2##2##(1993-9#1)(2012-3#1)
anomaly that##2##2##(2008-10#1)(2008-11#1)
anomaly was##2##2##(1992-2#1)(2008-11#1)
anomaly##80##1##(1990-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#2)(1993-9#3)(1995-5#2)(1997-3#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#11)(2008-11#6)(2008-12#4)(2008-6#2)(2008-7#4)(2008-9#3)(2009-11#1)(2009-5#1)(2010-11#6)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-2#2)
anomer having##2##2##(1990-9#2)
anomer of##2##2##(1990-11#1)(1995-5#1)
anomer##5##1##(1990-11#2)(1990-9#2)(1995-5#1)
anomeric##3##1##(1990-11#1)(1992-7#1)(1995-11#1)
anomerization##2##1##(1990-9#2)
anomers##2##1##(1990-11#1)(1996-5#1)
anonymous DNA##2##2##(1993-3#1)(2008-4#1)
anonymous questionnaire##3##2##(1991-9#1)(1997-4#1)(2008-12#1)
anonymous survey##3##2##(1990-11#1)(1993-11#1)(2008-10#1)
anonymous written##2##2##(1991-8#2)
anonymous##21##1##(1990-11#1)(1991-8#2)(1991-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-9#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2012-3#2)
anonymously##2##1##(1996-11#1)(2011-2#1)
anopheles##2##1##(2011-1#2)
anophthalmia##5##1##(2011-1#5)
anorectal motor function##3##3##(2011-2#3)
anorectal motor##4##2##(2011-2#4)
anorectal##12##1##(1990-6#1)(1991-12#1)(1992-3#1)(2011-2#7)(2012-2#1)(2013-1#1)
anorectic drugs##2##2##(2008-4#2)
anorectic##9##1##(1997-5#1)(1997-7#1)(2007-7#1)(2008-4#4)(2011-2#1)(2012-3#1)
anorexia nervosa (AN)##5##3##(1991-11#1)(2007-7#3)(2013-1#1)
anorexia nervosa and##2##3##(2007-7#1)(2013-1#1)
anorexia nervosa is##2##3##(1992-11#1)(2007-7#1)
anorexia nervosa##26##2##(1991-1#1)(1991-11#2)(1992-11#2)(1993-12#1)(1996-8#1)(1996-9#1)(2007-12#2)(2007-7#7)(2007-8#2)(2011-2#1)(2012-3#3)(2013-1#3)
anorexia when administered##2##3##(1996-12#1)(1996-2#1)
anorexia##53##1##(1991-1#1)(1991-11#2)(1992-11#3)(1993-12#2)(1995-9#1)(1996-12#3)(1996-2#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(2007-12#2)(2007-7#9)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-6#1)(2011-2#1)(2012-3#6)(2013-1#6)(2013-8#1)
another &quot##4##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-9#1)
another 1##2##2##(1990-2#1)(2007-11#1)
another 3##2##2##(1991-2#1)(2010-3#1)
another 4##2##2##(1991-2#1)(2008-10#1)
another 6##2##2##(2008-1#1)(2010-3#1)
another and##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
another approach##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
another as##2##2##(1992-9#1)(2008-10#1)
another at##3##2##(2007-12#1)(2008-3#2)
another by##6##2##(2008-10#2)(2008-2#1)(2008-9#2)(2010-12#1)
another case of##2##3##(2008-6#1)(2011-1#1)
another case##3##2##(2007-7#1)(2008-6#1)(2011-1#1)
another displayed##2##2##(2008-10#1)(2009-11#1)
another drug##2##2##(1991-1#1)(2009-5#1)
another experiment##4##2##(1990-11#1)(1997-6#1)(2008-10#1)(2008-11#1)
another factor##6##2##(1991-5#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
another family of##2##3##(1994-3#1)(2011-2#1)
another five##2##2##(1997-3#1)(2009-5#1)
another for##6##2##(1994-8#1)(1997-7#1)(2008-11#1)(2008-3#2)(2013-8#1)
another four##2##2##(2007-6#1)(2007-7#1)
another gene##3##2##(1992-9#1)(2008-7#1)(2012-2#1)
another general##2##2##(1995-6#1)(2008-11#1)
another group of##7##3##(1990-2#2)(1991-5#1)(1992-12#1)(1994-3#1)(1997-4#1)(2009-8#1)
another group##12##2##(1990-2#2)(1991-5#1)(1992-12#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
another important factor##2##3##(2008-1#1)(2008-10#1)
another important##6##2##(2008-1#2)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
another in a##3##3##(1991-3#1)(1997-7#1)(2009-10#1)
another in the##2##3##(1992-3#1)(1994-2#1)
another in##11##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-10#1)
another is##2##2##(2008-10#1)(2008-2#1)
another island##2##2##(1996-10#1)(2008-8#1)
another isolate of the##2##4##(2008-10#2)
another isolate##5##2##(2008-10#5)
another key##3##2##(2008-11#1)(2010-5#1)(2012-2#1)
another larger##2##2##(2008-10#1)(2008-5#1)
another laser##2##2##(2007-11#1)(2007-12#1)
another locus##2##2##(1997-5#1)(2008-10#1)
another mechanism##2##2##(1991-9#1)(2011-2#1)
another member of the##5##4##(1997-7#1)(2008-10#2)(2012-12#1)(2012-2#1)
another method of##2##3##(1992-12#1)(2008-4#1)
another method##6##2##(1992-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-8#1)
another model##2##2##(2008-10#2)
another nucleoside##2##2##(2008-4#2)
another of##5##2##(1993-6#1)(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
another one is##2##3##(2008-10#2)
another one##12##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-2#1)
another or##2##2##(2008-10#1)(2008-2#1)
another organic##2##2##(2010-4#1)(2013-1#1)
another pain##2##2##(1993-2#1)(2009-12#1)
another pair of##2##3##(1995-6#1)(2008-8#1)
another patient##3##2##(1997-8#1)(2007-8#1)(2008-1#1)
another person to HIV through sexual intercourse##2##7##(1997-5#2)
another person##4##2##(1997-5#2)(2008-11#1)(2008-9#1)
another person's##3##2##(2008-11#2)(2010-5#1)
another possible##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
another primary##3##2##(1993-12#1)(2011-2#1)(2013-7#1)
another protein and##2##3##(2008-4#2)
another protein##5##2##(1994-11#1)(1997-4#1)(2008-4#3)
another putative##2##2##(1996-3#1)(2008-10#1)
another recombinant##2##2##(2008-11#1)(2008-7#1)
another region##4##2##(1993-6#1)(1995-3#1)(1996-4#1)(2012-3#1)
another relative##2##2##(2008-10#1)(2010-4#1)
another resin##2##2##(2008-10#2)
another set of##2##3##(2008-10#1)(2008-6#1)
another simple##2##2##(2008-10#1)(2008-3#1)
another site##2##2##(1991-8#1)(2008-10#1)
another species##7##2##(1994-8#1)(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#1)(2012-3#2)
another strain##2##2##(1997-3#1)(2008-10#1)
another study##2##2##(2008-9#1)(2011-2#1)
another surgical##2##2##(2008-12#1)(2012-3#1)
another to##5##2##(1996-5#1)(2007-12#1)(2008-4#2)(2011-1#1)
another two##6##2##(1996-12#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)
another type of##5##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
another type##7##2##(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2009-9#1)
another unit##2##2##(2008-10#1)(2008-9#1)
another using##3##2##(1993-9#1)(2008-10#2)
another was##2##2##(1992-3#1)(2008-10#1)
another way##3##2##(1991-6#1)(1994-2#1)(2008-8#1)
another wider##2##2##(1991-6#1)(2008-10#1)
another with##4##2##(1995-5#1)(2008-10#1)(2010-8#1)(2011-1#1)
another year##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
another##641##1##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-12#3)(1992-3#3)(1992-4#1)(1992-8#4)(1992-9#6)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#2)(1993-6#4)(1993-9#3)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#7)(1994-9#2)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#6)(1997-6#1)(1997-7#5)(1997-8#5)(2006-10#1)(2007-11#10)(2007-12#15)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#15)(2008-10#119)(2008-11#29)(2008-12#3)(2008-2#9)(2008-3#21)(2008-4#19)(2008-5#23)(2008-6#7)(2008-7#19)(2008-8#12)(2008-9#19)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#3)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#6)(2010-6#3)(2010-8#6)(2010-9#1)(2011-1#7)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#11)(2013-7#2)(2013-8#5)
another's##7##1##(1996-1#1)(2007-4#1)(2008-11#4)(2013-8#1)
anovulation##3##1##(1990-9#1)(2008-4#1)(2010-11#1)
anovulatory infertility##3##2##(2010-11#1)(2011-1#1)(2013-8#1)
anovulatory##5##1##(2008-4#1)(2010-11#1)(2011-1#2)(2013-8#1)
anoxia and##3##2##(1996-9#2)(2008-1#1)
anoxia or##2##2##(1991-2#2)
anoxia##20##1##(1990-7#5)(1991-2#2)(1994-12#3)(1994-8#1)(1996-9#5)(1997-2#3)(2008-1#1)
anoxic encephalopathy##2##2##(2012-3#2)
anoxic injury##2##2##(1990-7#2)
anoxic rats##2##2##(1997-2#2)
anoxic##13##1##(1990-7#2)(1992-3#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-2#2)(2008-11#2)(2012-3#2)
ans##4##1##(2013-1#4)
ansa##2##1##(1990-3#1)(2008-7#1)
ansamycin##2##1##(1994-8#2)
ansochromogenes differentiation##2##2##(2008-8#2)
ansochromogenes##9##1##(2008-8#7)(2008-9#2)
answer is##2##2##(1996-2#1)(2012-2#1)
answer questions##4##2##(1991-3#1)(2007-10#1)(2008-11#1)(2008-5#1)
answer the question of how##2##5##(2008-9#1)(2009-8#1)
answer the question of##3##4##(2008-9#1)(2009-8#1)(2010-4#1)
answer the question##7##3##(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
answer the questions##3##3##(1997-1#1)(2008-7#2)
answer the##27##2##(1994-8#2)(1997-1#1)(1997-3#1)(2007-8#10)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
answer this question##3##3##(1991-12#1)(2009-2#1)(2012-12#1)
answer to the question##2##4##(1995-3#1)(2011-2#1)
answer to the##4##3##(1995-3#1)(1995-8#1)(2008-10#1)(2011-2#1)
answer to this##2##3##(1994-3#1)(2007-7#1)
answer to##8##2##(1992-11#1)(1994-3#1)(1995-3#1)(1995-8#2)(2007-7#1)(2008-10#1)(2011-2#1)
answer##97##1##(1990-8#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-4#1)(2007-7#3)(2007-8#10)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
answer?##2##1##(1995-12#1)(2008-8#1)
answered a questionnaire##3##3##(1997-2#1)(2011-1#1)(2013-1#1)
answered a##6##2##(1997-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
answered by##6##2##(1990-2#1)(1991-7#1)(1992-11#1)(1993-6#1)(1995-1#1)(2012-2#1)
answered correctly##3##2##(1993-2#1)(1996-6#1)(2013-1#1)
answered that they would##3##4##(1990-6#2)(2008-12#1)
answered the questionnaire##5##3##(1992-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
answered the##8##2##(1992-1#1)(1993-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
answered##48##1##(1990-2#1)(1990-6#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-2#3)(1993-6#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#2)
answering a specific clinical question##2##5##(2007-5#2)
answering questions##3##2##(1991-5#1)(1994-12#1)(1997-3#1)
answering the##2##2##(1994-3#1)(2011-2#1)
answering##11##1##(1991-5#1)(1994-12#1)(1994-3#1)(1997-3#1)(2007-5#2)(2008-2#1)(2010-1#1)(2010-12#2)(2011-2#1)
answers and##2##2##(1994-1#1)(1994-12#1)
answers are##2##2##(1995-1#1)(2008-2#1)
answers for##2##2##(1993-12#1)(2011-2#1)
answers in##2##2##(2008-10#1)(2013-8#1)
answers of##2##2##(1993-12#1)(2008-9#1)
answers on##3##2##(2008-11#2)(2012-2#1)
answers that##2##2##(2012-3#1)(2013-1#1)
answers to the##3##3##(1991-1#1)(2008-3#1)(2011-2#1)
answers to these and other questions##2##6##(1992-12#1)(2008-3#1)
answers to these##3##3##(1992-12#1)(2008-3#1)(2008-7#1)
answers to##10##2##(1990-6#1)(1991-1#1)(1992-12#1)(1996-3#1)(2008-3#2)(2008-7#2)(2011-2#1)(2013-1#1)
answers were##2##2##(2008-12#1)(2010-8#1)
answers##52##1##(1990-6#1)(1991-1#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
ant Monomorium pharaonis##2##3##(2007-12#2)
ant Pachycondyla obscuricornis##2##3##(2007-12#2)
ant and fungal##2##3##(2008-8#2)
ant colonies##3##2##(2008-6#2)(2008-8#1)
ant species##2##2##(2008-8#1)(2012-3#1)
ant##33##1##(1992-2#1)(2007-12#6)(2008-10#2)(2008-5#2)(2008-6#5)(2008-8#10)(2012-2#4)(2012-3#2)(2013-1#1)
ant-BA22##2##1##(2008-1#2)
ant-cultivar conflict over##2##3##(2008-8#2)
ant-cultivar conflict##4##2##(2008-8#4)
antacids or H2 receptor antagonists and##2##6##(1995-10#2)
antacids##4##1##(1993-2#1)(1995-10#2)(2008-7#1)
antagonise##3##1##(1992-3#1)(1994-12#1)(1996-5#1)
antagonism against postharvest wound pathogens##2##5##(2008-10#2)
antagonism against##3##2##(2008-10#3)
antagonism at##2##2##(1995-3#1)(2008-11#1)
antagonism between##4##2##(1991-9#1)(1994-11#1)(2008-10#2)
antagonism is##2##2##(2008-10#1)(2013-8#1)
antagonism of##8##2##(1990-2#1)(1992-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-4#1)
antagonism to##2##2##(1997-2#1)(2008-10#1)
antagonism was##4##2##(2007-8#1)(2008-10#2)(2008-8#1)
antagonism##44##1##(1990-2#1)(1991-9#1)(1992-8#2)(1994-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-2#1)(1997-2#3)(1997-7#1)(2007-8#3)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#4)(2012-3#1)(2013-1#1)(2013-8#1)
antagonism)##2##1##(2007-8#1)(2008-10#1)
antagonist 2-hydroxysaclofen##2##2##(1993-12#1)(2008-8#1)
antagonist GR 127935##2##3##(1995-12#2)
antagonist Ulocladium atrum##2##3##(2008-10#2)
antagonist activity##7##2##(1992-3#1)(1995-3#1)(1997-4#1)(2008-7#2)(2012-12#1)(2012-2#1)
antagonist and a##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
antagonist and##17##2##(1991-5#1)(1992-5#1)(1993-12#1)(1995-12#1)(1995-8#1)(2008-10#5)(2008-5#2)(2008-6#2)(2008-7#1)(2012-12#1)(2012-2#1)
antagonist at##4##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
antagonist attenuated##2##2##(1992-3#1)(2008-4#1)
antagonist bicuculline##3##2##(1997-2#2)(2008-8#1)
antagonist binding##3##2##(1993-3#1)(1994-5#1)(1994-6#1)
antagonist decreased##2##2##(1993-8#1)(2008-10#1)
antagonist densities##3##2##(2008-10#3)
antagonist doses##2##2##(2008-10#2)
antagonist effects of naloxonazine##4##4##(1996-2#4)
antagonist effects##5##2##(1994-9#1)(1996-2#4)
antagonist for##3##2##(1993-12#1)(2008-8#1)(2010-8#1)
antagonist in the##3##3##(1994-9#1)(1996-2#1)(2008-10#1)
antagonist in##7##2##(1992-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-4#1)
antagonist inhibits##2##2##(1991-12#1)(1995-11#1)
antagonist is##3##2##(1992-6#1)(1995-12#1)(2008-10#1)
antagonist may##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
antagonist naltrexone##2##2##(1991-1#1)(1993-6#1)
antagonist of 1 alpha##2##4##(1992-12#2)
antagonist of the NMDA##2##4##(2008-7#1)(2012-12#1)
antagonist of the##12##3##(1992-11#1)(1993-3#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-12#1)(2012-3#1)
antagonist of##31##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-3#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2012-12#1)(2012-3#1)
antagonist on##4##2##(1992-3#1)(1995-12#1)(2008-10#2)
antagonist properties of##2##3##(1997-2#1)(2008-7#1)
antagonist propranolol##2##2##(1995-3#1)(2008-2#1)
antagonist tamoxifen##2##2##(2008-11#2)
antagonist that##4##2##(1995-3#1)(1997-6#1)(2008-11#1)(2009-10#1)
antagonist under development by##2##4##(2008-5#2)
antagonist under development##3##3##(1991-5#1)(2008-5#2)
antagonist was##3##2##(1994-11#1)(1995-12#1)(2008-10#1)
antagonist with##7##2##(1995-12#2)(1996-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
antagonist##389##1##(1990-12#2)(1990-5#6)(1990-7#1)(1991-1#3)(1991-12#2)(1991-5#5)(1991-6#2)(1992-11#2)(1992-12#2)(1992-3#10)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#6)(1993-3#6)(1993-5#3)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#4)(1994-2#10)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#6)(1995-11#7)(1995-12#36)(1995-2#3)(1995-3#9)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#18)(1996-5#3)(1996-6#1)(1997-2#14)(1997-4#6)(1997-6#3)(1997-7#9)(2006-6#3)(2007-10#1)(2007-11#2)(2008-1#3)(2008-10#58)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#13)(2008-5#13)(2008-6#9)(2008-7#15)(2008-8#14)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
antagonist)##8##1##(1992-3#2)(1995-12#2)(1996-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
antagonist-pathogen##2##1##(2008-10#2)
antagonistic activities##2##2##(2008-10#2)
antagonistic activity against##2##3##(2008-10#2)
antagonistic activity of##4##3##(2008-10#2)(2008-12#2)
antagonistic activity##14##2##(1990-2#1)(1995-3#1)(2008-10#7)(2008-11#2)(2008-12#3)
antagonistic coevolution##2##2##(2008-8#1)(2008-9#1)
antagonistic effect of##4##3##(1994-6#1)(2008-12#1)(2008-4#1)(2012-12#1)
antagonistic effect on##5##3##(1994-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
antagonistic effect##11##2##(1994-11#1)(1994-6#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#2)
antagonistic effects##6##2##(1996-12#1)(2008-10#4)(2008-12#1)
antagonistic fungus##2##2##(2008-10#2)
antagonistic interaction between##2##3##(2008-10#2)
antagonistic interactions of##2##3##(2008-10#1)(2011-2#1)
antagonistic interactions##6##2##(2008-10#2)(2011-2#1)(2012-3#2)(2013-1#1)
antagonistic isolates##2##2##(2008-10#2)
antagonistic microorganisms in the field##2##5##(2008-10#2)
antagonistic microorganisms##3##2##(2008-10#3)
antagonistic or synergistic##2##3##(2008-10#2)
antagonistic or##3##2##(2008-10#2)(2008-7#1)
antagonistic pleiotropy##3##2##(2008-9#1)(2010-1#2)
antagonistic selection##2##2##(2008-8#2)
antagonistic species##2##2##(2008-8#2)
antagonistic to##3##2##(1995-5#1)(2008-10#2)
antagonistic yeast##2##2##(2008-10#2)
antagonistic##99##1##(1990-2#2)(1990-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(2007-12#3)(2008-10#48)(2008-11#3)(2008-12#7)(2008-4#2)(2008-7#3)(2008-8#9)(2008-9#3)(2009-8#2)(2010-1#2)(2010-3#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
antagonistic)##2##1##(2008-10#2)
antagonistically##4##1##(2008-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
antagonists and##11##2##(1990-2#1)(1990-9#1)(1994-9#1)(1995-10#2)(1995-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-2#1)
antagonists are##6##2##(2007-11#2)(2008-3#2)(2008-7#1)(2010-12#1)
antagonists as##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
antagonists at##2##2##(1991-1#1)(1995-3#1)
antagonists can##2##2##(1994-2#1)(1995-12#1)
antagonists do##3##2##(1994-11#1)(2007-11#1)(2008-6#1)
antagonists for##5##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
antagonists from##2##2##(1993-6#1)(2008-10#1)
antagonists have##4##2##(1993-3#1)(1996-9#1)(2010-12#1)(2012-1#1)
antagonists in aphthous ulceration##4##4##(2012-1#4)
antagonists in the##2##3##(1990-6#1)(2008-10#1)
antagonists in##15##2##(1990-5#1)(1990-6#1)(1992-11#1)(1993-5#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-1#5)(2012-12#1)
antagonists inhibited##3##2##(1992-9#1)(1995-11#1)(1995-12#1)
antagonists is##2##2##(2008-10#1)(2008-4#1)
antagonists may be##2##3##(2007-8#1)(2008-10#1)
antagonists may have##2##3##(1992-3#1)(1995-12#1)
antagonists may##4##2##(1992-3#1)(1995-12#1)(2007-8#1)(2008-10#1)
antagonists might##2##2##(2008-10#1)(2008-4#1)
antagonists of##11##2##(1992-11#1)(1993-1#1)(1993-3#1)(1995-3#2)(1995-6#1)(2006-6#1)(2008-10#3)(2008-8#1)
antagonists on the##3##3##(1993-9#1)(1994-2#1)(2008-8#1)
antagonists on##9##2##(1991-1#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
antagonists or##3##2##(1991-5#1)(2008-10#2)
antagonists that##3##2##(1995-11#1)(2008-10#2)
antagonists to##4##2##(1992-3#1)(1994-11#1)(1995-8#1)(2008-10#1)
antagonists was##2##2##(1992-3#1)(1993-10#1)
antagonists were##4##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
antagonists with##5##2##(1995-3#1)(1996-5#1)(2008-10#1)(2008-4#2)
antagonists##227##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#5)(1991-5#4)(1991-8#3)(1992-11#3)(1992-2#1)(1992-3#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#3)(1994-11#6)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#5)(1995-10#2)(1995-11#8)(1995-12#12)(1995-2#1)(1995-3#7)(1995-6#2)(1995-8#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#5)(2006-6#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#17)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#8)(2008-9#1)(2009-12#2)(2009-7#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#6)(2012-12#2)(2012-2#1)(2013-1#1)
antagonists)##2##1##(2009-6#1)(2011-2#1)
antagonize the effects of##2##4##(1992-6#1)(1997-2#1)
antagonize the##7##2##(1992-6#1)(1994-11#2)(1994-12#1)(1995-12#1)(1997-2#2)
antagonize##20##1##(1992-6#1)(1994-11#2)(1994-12#1)(1994-9#2)(1995-12#3)(1997-2#3)(2008-10#2)(2008-11#1)(2009-4#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
antagonized by a##2##3##(1993-11#1)(1994-8#1)
antagonized by##12##2##(1990-2#1)(1990-5#1)(1991-9#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-8#1)(1995-11#1)(2008-5#1)
antagonized the effects of##2##4##(1990-5#2)
antagonized the##9##2##(1990-5#2)(1991-8#1)(1993-8#1)(1994-11#3)(1996-2#1)(1997-2#1)
antagonized##24##1##(1990-2#1)(1990-5#3)(1991-8#1)(1991-9#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-11#3)(1994-8#1)(1995-11#1)(1995-12#2)(1996-2#2)(1997-2#1)(2008-5#1)
antagonizes the##3##2##(1991-1#1)(1994-3#1)(2008-11#1)
antagonizes##10##1##(1991-1#1)(1991-12#1)(1994-3#2)(1994-5#1)(1997-2#1)(2008-11#1)(2012-12#2)(2012-3#1)
antagonizing the##5##2##(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-9#1)
antagonizing##9##1##(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
antarctica##5##1##(2007-5#1)(2008-4#1)(2011-2#2)(2013-1#1)
antazoline##4##1##(2008-10#4)
ante##4##1##(1992-1#1)(1992-2#1)(1996-3#1)(2008-7#1)
antebrachial fascia##2##2##(2008-9#1)(2009-1#1)
antebrachial##5##1##(2008-9#4)(2009-1#1)
antecedent of##3##2##(2007-12#2)(2011-2#1)
antecedent##9##1##(1992-2#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
antecedents and consequences##5##3##(2007-7#3)(2008-11#1)(2008-6#1)
antecedents of parent's behavior##2##4##(1993-3#2)
antecedents of the##2##3##(2011-2#2)
antecedents of##8##2##(1993-3#3)(1996-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
antecedents##18##1##(1993-1#1)(1993-3#3)(1996-3#1)(2007-7#4)(2008-11#2)(2008-6#1)(2009-12#1)(2010-6#1)(2011-2#3)(2013-1#1)
antefixes##2##1##(2008-10#2)
antegrade and retrograde##2##3##(1991-3#1)(2007-9#1)
antegrade and##3##2##(1991-3#1)(2007-9#2)
antegrade cardioplegia##2##2##(2007-9#2)
antegrade with retrograde delivery of cardioplegic solution##2##7##(2007-9#2)
antegrade##12##1##(1991-3#1)(2007-8#1)(2007-9#6)(2008-11#1)(2008-7#1)(2012-2#1)(2013-7#1)
anteiso-branched fatty acids##2##3##(2011-1#2)
antemortem##5##1##(2008-12#1)(2008-7#2)(2009-3#2)
antenatal attendance##2##2##(2008-7#2)
antenatal care and##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
antenatal care##13##2##(1990-12#1)(1991-3#1)(1991-6#1)(1993-6#1)(1995-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-6#1)(2012-3#1)
antenatal clinic##2##2##(2007-7#1)(2013-1#1)
antenatal clinics##4##2##(1994-6#1)(2009-7#1)(2013-1#2)
antenatal management##2##2##(1991-3#1)(2007-8#1)
antenatal or neonatal seroprevalence data##2##5##(1994-9#2)
antenatal or neonatal##3##3##(1994-9#2)(2008-11#1)
antenatal screening##2##2##(2008-11#1)(2011-2#1)
antenatal##48##1##(1990-12#1)(1991-3#2)(1991-6#2)(1992-12#1)(1993-6#1)(1994-6#1)(1994-9#2)(1995-6#2)(1996-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-11#5)(2008-7#3)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#4)
antenatally diagnosed hydronephrosis##2##3##(2008-10#2)
antenatally diagnosed##5##2##(2008-10#5)
antenatally##7##1##(1996-3#1)(2008-1#1)(2008-10#5)
antenna are##2##2##(2008-10#1)(2008-2#1)
antenna elements##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
antenna in##2##2##(2008-3#1)(2013-8#1)
antenna is##6##2##(2007-12#4)(2008-3#1)(2008-9#1)
antenna of##6##2##(2007-12#3)(2008-10#3)
antenna system##2##2##(1993-11#1)(2008-3#1)
antenna was##2##2##(2008-2#1)(2008-3#1)
antenna with a##2##3##(2008-3#2)
antenna##66##1##(1993-11#1)(2007-12#27)(2008-10#6)(2008-2#6)(2008-3#20)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#3)
antennae in##2##2##(1996-2#1)(2008-7#1)
antennae##6##1##(1996-2#1)(2007-12#3)(2008-7#1)(2008-9#1)
antennal lobe##6##2##(2007-12#6)
antennal sensilla##3##2##(2007-12#3)
antennal##20##1##(1994-8#1)(2007-12#16)(2008-10#1)(2008-7#1)(2008-9#1)
antennas are##2##2##(2007-12#1)(2008-3#1)
antennas##21##1##(2007-12#7)(2008-2#9)(2008-3#5)
antennular flagella##2##2##(2007-12#2)
antennular neuropil##2##2##(2007-12#2)
antennular##6##1##(2007-12#6)
antennule##3##1##(2007-12#2)(2008-5#1)
antepartum##2##1##(1993-12#1)(1994-3#1)
anterior abdominal wall##5##3##(1991-1#2)(2008-11#1)(2011-2#1)(2012-12#1)
anterior abdominal##6##2##(1991-1#2)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
anterior adenoma##2##2##(2012-1#2)
anterior and lateral##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#3)
anterior and posterior intercondylar distances##2##5##(2013-1#2)
anterior and posterior surgery##2##4##(2008-8#2)
anterior and posterior##28##3##(1993-12#1)(1995-2#1)(1997-3#2)(2007-11#2)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-3#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#5)
anterior and##41##2##(1990-7#1)(1992-12#1)(1993-12#1)(1995-2#1)(1997-3#2)(2007-11#3)(2007-12#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#6)(2008-8#6)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#5)
anterior approach with##2##3##(2008-7#1)(2011-2#1)
anterior approach##4##2##(2008-7#1)(2008-8#1)(2011-2#2)
anterior cerebral arteries##3##3##(2008-7#3)
anterior cerebral artery##10##3##(1997-3#1)(1997-6#1)(2007-10#2)(2008-7#3)(2011-2#1)(2013-8#2)
anterior cerebral##14##2##(1997-3#1)(1997-6#1)(2007-10#2)(2008-7#6)(2008-9#1)(2011-2#1)(2013-8#2)
anterior cervical discectomy and fusion (ACDF) in##2##7##(2012-12#2)
anterior cervical discectomy and fusion (ACDF)##4##6##(2012-12#4)
anterior cervical discectomy##7##3##(2008-7#1)(2012-12#4)(2012-3#2)
anterior cervical##9##2##(2008-7#3)(2012-12#4)(2012-3#2)
anterior chamber of##2##3##(2007-11#1)(2008-7#1)
anterior chamber##6##2##(2007-11#1)(2008-7#2)(2011-2#3)
anterior cingulate and##4##3##(1994-3#1)(1996-2#1)(2008-11#1)(2010-2#1)
anterior cingulate cortex##5##3##(1994-3#1)(2008-10#1)(2008-11#3)
anterior cingulate##12##2##(1993-12#1)(1994-3#3)(1996-2#1)(2008-10#1)(2008-11#4)(2010-2#1)(2012-12#1)
anterior clinoidectomy via the##4##4##(2011-2#4)
anterior communicating artery aneurysm rupture##2##5##(2008-7#2)
anterior communicating artery aneurysm##5##4##(1996-3#2)(2008-2#1)(2008-7#2)
anterior communicating artery##10##3##(1996-3#2)(2008-2#1)(2008-7#7)
anterior compartment syndrome following ankle arthroscopy after Maisonneuve fracture##2##9##(2009-1#2)
anterior compartment##3##2##(2007-8#1)(2009-1#2)
anterior cortical##2##2##(1992-8#1)(1995-5#1)
anterior cranial fossa##2##3##(2008-8#1)(2011-1#1)
anterior cranial vault pathology##2##4##(2011-2#2)
anterior cranial vault##3##3##(2011-2#3)
anterior cranial##7##2##(2008-8#1)(2011-1#1)(2011-2#5)
anterior cruciate ligament (ACL) and##3##5##(1997-8#2)(2013-1#1)
anterior cruciate ligament (ACL) reconstruction##2##5##(2013-1#2)
anterior cruciate ligament (ACL)##8##4##(1997-8#2)(2012-2#1)(2013-1#5)
anterior cruciate ligament reconstruction##8##4##(2008-11#3)(2008-12#1)(2013-1#4)
anterior cruciate ligament##26##3##(1990-6#1)(1997-8#2)(2007-8#6)(2008-11#3)(2008-12#1)(2009-1#1)(2012-2#1)(2013-1#11)
anterior descending##14##2##(1991-9#1)(1994-11#1)(1995-12#1)(2007-8#4)(2008-11#3)(2008-7#1)(2013-1#2)(2013-7#1)
anterior dislocation##3##2##(2008-8#1)(2009-3#1)(2011-2#1)
anterior displacement of##3##3##(2013-1#3)
anterior fontanelle and##3##3##(2011-1#3)
anterior horn cells##3##3##(1991-7#1)(1995-12#1)(2008-7#1)
anterior horn##5##2##(1990-9#1)(1991-7#1)(1995-12#1)(2008-7#2)
anterior hypothalamic area##2##3##(1993-12#1)(2013-7#1)
anterior instrumentation##2##2##(2008-8#2)
anterior insula activity##2##3##(2008-11#2)
anterior insula##4##2##(2008-11#4)
anterior intestine##2##2##(2008-7#2)
anterior jugular vein phlebectesia##2##4##(2011-1#2)
anterior knee pain##2##3##(2008-9#1)(2013-1#1)
anterior lamellar keratoplasty##2##3##(2011-1#1)(2013-1#1)
anterior leaflet##5##2##(2007-8#2)(2008-10#1)(2013-1#2)
anterior limb bud##2##3##(1993-12#2)
anterior limb##3##2##(1993-12#3)
anterior lobe##5##2##(1992-12#1)(1992-9#3)(1996-5#1)
anterior maxilla##6##2##(2007-12#2)(2009-8#2)(2013-1#2)
anterior mediastinal masses##2##3##(2007-8#2)
anterior mediastinal##4##2##(2007-8#4)
anterior mediastinum##2##2##(2007-8#1)(2008-6#1)
anterior motion##4##2##(2007-8#2)(2013-1#2)
anterior muscles##3##2##(2010-9#1)(2012-3#1)(2013-8#1)
anterior or##2##2##(2007-11#1)(2008-7#1)
anterior pharynx##2##2##(2007-12#2)
anterior pituitary TRH##2##3##(1994-6#2)
anterior pituitary cells in##2##4##(1990-2#1)(1990-7#1)
anterior pituitary cells##12##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1996-2#4)(1996-5#1)
anterior pituitary concentrations of TRH##2##5##(1994-6#2)
anterior pituitary gland##3##3##(1990-8#1)(1997-2#1)(2008-1#1)
anterior pituitary##34##2##(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#2)(1990-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1993-5#2)(1994-6#7)(1994-9#1)(1996-2#4)(1996-5#3)(1997-2#1)(2008-1#1)(2010-2#1)
anterior portion of the##4##4##(1991-8#1)(2006-12#1)(2008-1#1)(2009-1#1)
anterior posterior##2##2##(2010-12#1)(2012-2#1)
anterior region##6##2##(2007-12#2)(2008-7#1)(2009-1#2)(2013-1#1)
anterior resection##5##2##(1990-9#1)(1992-6#1)(1997-8#1)(2007-8#1)(2008-12#1)
anterior rotation of the##2##4##(2008-9#1)(2011-2#1)
anterior sacral meningocele##2##3##(2009-3#2)
anterior segment##9##2##(2008-2#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-7#4)(2012-12#1)
anterior shoulder dislocation##2##3##(2008-8#2)
anterior shoulder##4##2##(2007-11#2)(2008-8#2)
anterior side of the##2##4##(2007-8#1)(2013-2#1)
anterior side##3##2##(1997-8#1)(2007-8#1)(2013-2#1)
anterior skull base lesions##2##4##(2006-12#1)(2011-2#1)
anterior skull base##7##3##(2006-12#4)(2011-2#3)
anterior spinal##2##2##(1997-6#1)(2008-8#1)
anterior stabilization##3##2##(2007-11#2)(2008-8#1)
anterior superior temporal gyrus##2##4##(2009-2#2)
anterior teeth##3##2##(1990-5#1)(2013-1#2)
anterior temporal##2##2##(1990-5#1)(2008-9#1)
anterior tibial artery##4##3##(1991-8#1)(2008-12#1)(2009-3#2)
anterior tibial##5##2##(1991-8#1)(2008-12#2)(2009-3#2)
anterior to the##4##3##(2008-10#1)(2008-9#1)(2011-2#2)
anterior to##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
anterior urethral##2##2##(2007-9#1)(2008-10#1)
anterior vaginal wall##2##3##(2008-10#1)(2011-2#1)
anterior wall##10##2##(2006-12#2)(2007-8#1)(2011-2#3)(2011-7#1)(2012-12#3)
anterior##486##1##(1990-12#2)(1990-2#1)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#4)(1991-1#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#5)(1993-12#9)(1993-5#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#7)(1994-8#4)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-2#6)(1996-3#2)(1996-5#5)(1996-6#3)(1996-9#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-8#4)(2006-12#10)(2007-10#3)(2007-11#13)(2007-12#26)(2007-8#27)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#18)(2008-12#11)(2008-2#4)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#53)(2008-8#16)(2008-9#8)(2009-1#6)(2009-2#2)(2009-3#7)(2009-4#3)(2009-8#4)(2010-1#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#10)(2011-2#37)(2011-7#5)(2012-1#3)(2012-12#12)(2012-2#10)(2012-3#8)(2013-1#34)(2013-2#1)(2013-7#2)(2013-8#4)
anterior-posterior##4##1##(1993-2#1)(1996-7#1)(2008-5#1)(2011-2#1)
anteriorly##10##1##(1992-9#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2013-1#1)
antero-lateral##2##1##(2008-12#1)(2008-5#1)
antero-posterior##2##1##(1993-12#1)(1997-4#1)
antero-ventral lobes##2##2##(2008-5#2)
anterograde amnesia##2##2##(2008-6#1)(2012-2#1)
anterograde tracer##2##2##(1995-12#1)(2008-7#1)
anterograde tracers##2##2##(1997-3#1)(2008-4#1)
anterograde##16##1##(1990-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-2#3)(1997-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2012-2#1)
anterogradely labeled##2##2##(2008-11#1)(2008-7#1)
anterogradely##4##1##(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#1)
anterolateral approach for##2##3##(2011-2#2)
anterolateral approach was used##2##4##(2009-3#1)(2012-3#1)
anterolateral approach##10##2##(2009-3#2)(2011-2#5)(2012-3#3)
anterolateral thigh flap and vastus lateralis muscle flap##2##8##(2008-5#2)
anterolateral thigh flap##4##3##(2008-5#2)(2011-2#2)
anterolateral thoracotomy##4##2##(2007-8#3)(2008-10#1)
anterolateral##28##1##(2007-8#4)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#2)(2010-5#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-3#4)(2013-8#1)
anteromedial and##2##2##(2010-7#1)(2013-1#1)
anteromedial##5##1##(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
anteroposterior diameter of##3##3##(1995-6#1)(2013-1#2)
anteroposterior diameter##4##2##(1995-6#1)(2013-1#3)
anteroposterior##8##1##(1995-5#1)(1995-6#1)(2008-10#2)(2010-9#1)(2013-1#3)
antetorsion angle##2##2##(2007-8#2)
anteversion##2##1##(2007-11#1)(2010-3#1)
anthelmintic resistance##2##2##(1997-7#2)
anthelmintic##8##1##(1991-8#1)(1996-12#1)(1997-7#4)(2008-10#1)(2012-12#1)
anthelmintics in##2##2##(1991-8#1)(2008-10#1)
anthelmintics##4##1##(1991-8#1)(2008-10#2)(2013-1#1)
anther culture##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
anther was##2##2##(2008-8#2)
anther##16##1##(1997-2#1)(2008-10#3)(2008-4#1)(2008-8#10)(2008-9#1)
antheridia##3##1##(2008-10#2)(2010-3#1)
anthers and##2##2##(1997-2#1)(2008-8#1)
anthers##6##1##(1997-2#1)(1997-8#1)(2008-10#1)(2008-8#3)
anthesis in##4##2##(2008-10#4)
anthesis stage##2##2##(2008-10#1)(2008-12#1)
anthesis to##2##2##(2008-10#1)(2008-12#1)
anthesis##38##1##(2008-10#30)(2008-11#2)(2008-12#4)(2008-8#1)(2008-9#1)
anthocyan##2##1##(2008-10#2)
anthocyanin##5##1##(2008-10#4)(2008-9#1)
anthocyanins isolated from##2##3##(2008-4#2)
anthocyanins##12##1##(2008-10#3)(2008-4#6)(2008-5#1)(2009-6#2)
anthracene and DTPP##2##3##(2008-10#2)
anthracene##14##1##(2008-10#13)(2013-1#1)
anthracene-9-carboxylic acid##2##2##(1992-3#1)(2013-1#1)
anthracis strains##3##2##(2012-2#3)
anthracis to##2##2##(2007-12#1)(2010-1#1)
anthracis##15##1##(1992-12#1)(1992-3#1)(2007-12#2)(2008-10#2)(2010-1#2)(2011-2#3)(2012-2#4)
anthracnose (caused by Colletotrichum##2##4##(2008-10#2)
anthracnose and leaf blight##2##4##(2008-10#2)
anthracnose and##3##2##(2008-10#3)
anthracnose caused by Colletotrichum##2##4##(2008-10#2)
anthracnose caused by##3##3##(2008-10#3)
anthracnose disease##2##2##(2008-10#2)
anthracnose fungus##2##2##(2008-10#2)
anthracnose in the##3##3##(2008-10#3)
anthracnose in##5##2##(2008-10#5)
anthracnose lesions##4##2##(1997-6#2)(2008-10#2)
anthracnose of##3##2##(2008-10#3)
anthracnose on##4##2##(2008-10#4)
anthracnose pathogen##5##2##(2008-10#5)
anthracnose resistance##5##2##(2008-10#5)
anthracnose severity##2##2##(2008-10#2)
anthracnose was##2##2##(2008-10#2)
anthracnose##63##1##(1997-4#1)(1997-6#2)(2008-10#60)
anthracycline##11##1##(1990-7#1)(1993-6#2)(1994-5#1)(1994-8#1)(1997-4#1)(2008-7#1)(2009-4#2)(2009-9#1)(2013-7#1)
anthracycline-based adjuvant chemotherapy in##2##4##(2008-6#2)
anthracycline-based adjuvant chemotherapy##3##3##(2008-6#3)
anthracycline-induced##2##1##(2013-7#2)
anthracyclinecontaining##2##1##(2008-6#2)
anthracyclines and##2##2##(1991-6#1)(2007-5#1)
anthracyclines##6##1##(1991-6#1)(1993-12#1)(1993-6#1)(2007-5#1)(2008-11#1)(2008-5#1)
anthramycin##2##1##(1991-3#2)
anthranilic acid##4##2##(2007-11#1)(2008-10#3)
anthraquinone##6##1##(2008-10#4)(2008-9#1)(2010-3#1)
anthraquinones##3##1##(2008-10#2)(2013-7#1)
anthrarufins##2##1##(2008-8#2)
anthrasteroids##2##1##(1990-11#2)
anthrax and##2##2##(2007-12#2)
anthrax toxin##2##2##(2009-10#2)
anthrax##16##1##(1990-9#2)(1991-6#1)(1992-12#1)(2007-12#2)(2009-10#2)(2011-1#1)(2011-2#1)(2012-2#6)
anthropocentricisms##2##1##(2010-3#2)
anthropogenic activities##2##2##(2008-10#1)(2011-2#1)
anthropogenic and natural##2##3##(2008-11#1)(2008-5#1)
anthropogenic and##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
anthropogenic fulvic acids##2##3##(2008-10#2)
anthropogenic impacts##2##2##(2007-5#1)(2012-2#1)
anthropogenic particle emissions##2##3##(2008-11#2)
anthropogenic platinum-group elements (PGE)##2##4##(2008-11#2)
anthropogenic sources##5##2##(2007-5#3)(2008-10#1)(2010-8#1)
anthropogenic##38##1##(1992-3#1)(1997-4#1)(2007-5#4)(2008-10#10)(2008-11#11)(2008-12#1)(2008-2#1)(2008-5#2)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
anthropogenically##2##1##(2008-11#1)(2008-9#1)
anthropoid primates##2##2##(2011-2#2)
anthropological##7##1##(1991-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#3)
anthropology##2##1##(1995-6#1)(2008-2#1)
anthropometric and##4##2##(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#1)
anthropometric data##4##2##(1993-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
anthropometric indicators##5##2##(2010-6#2)(2011-1#2)(2012-12#1)
anthropometric measurements##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
anthropometric parameters##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
anthropometric##27##1##(1993-12#1)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-6#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#2)
anthropometry and##3##2##(2008-5#2)(2008-7#1)
anthropometry##11##1##(1991-12#1)(2008-10#1)(2008-5#4)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
anthropomorphic phantom##3##2##(1993-9#1)(1997-8#1)(2012-1#1)
anthropomorphism##2##1##(2008-11#2)
anthryl##2##1##(2008-10#2)
anthurium blight##2##2##(2008-10#2)
anthurium##6##1##(2008-10#6)
anti S##2##2##(2008-10#1)(2009-9#1)
anti apo B-100 and##2##4##(1993-12#2)
anti apo##3##2##(1993-12#3)
anti conformation##3##2##(1992-3#1)(1993-11#2)
anti hypertensive##2##2##(2010-1#2)
anti to the##2##3##(1996-5#1)(2011-2#1)
anti tubercular##2##2##(1995-10#1)(2007-7#1)
anti##45##1##(1990-11#1)(1990-6#2)(1991-11#1)(1991-12#1)(1992-3#1)(1993-11#2)(1993-12#3)(1993-3#1)(1995-10#1)(1996-5#4)(1997-1#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-12#2)(2008-5#4)(2009-11#1)(2009-9#1)(2010-1#5)(2010-2#2)(2010-3#1)(2011-2#3)(2012-2#2)
anti-##9##1##(1992-8#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)
anti-A##7##1##(1992-12#4)(1995-12#3)
anti-B##5##1##(1992-12#2)(1992-3#1)(2008-10#1)(2008-9#1)
anti-B19##2##1##(2012-2#2)
anti-C##2##1##(1991-9#1)(1994-12#1)
anti-C3##4##1##(1990-12#3)(1990-2#1)
anti-CCP was##2##2##(2011-2#2)
anti-CCP##8##1##(2011-2#7)(2012-2#1)
anti-CD2 mAb##2##2##(2008-7#2)
anti-CD20 monoclonal##2##2##(2007-10#1)(2010-5#1)
anti-CD20##5##1##(2007-10#2)(2008-10#1)(2008-11#1)(2010-5#1)
anti-CD3##5##1##(1995-12#2)(1995-2#1)(2008-4#2)
anti-CD36 antibodies##2##2##(1991-2#2)
anti-CD36##3##1##(1991-2#3)
anti-CD4 monoclonal##2##2##(1991-8#1)(1997-2#1)
anti-CD4##3##1##(1991-8#1)(1997-2#1)(2008-5#1)
anti-CD8##2##1##(2008-5#1)(2013-1#1)
anti-CJC##2##1##(2008-7#2)
anti-CT##2##1##(2008-10#2)
anti-Candida##2##1##(2013-1#2)
anti-D and##2##2##(1994-12#2)
anti-D##9##1##(1994-12#4)(1994-3#1)(1994-6#2)(2010-11#1)(2013-1#1)
anti-E##3##1##(1993-9#2)(2008-10#1)
anti-E1##2##1##(1994-8#2)
anti-EGF##2##1##(1991-2#1)(1991-7#1)
anti-EGF-R##2##1##(1991-7#1)(1994-9#1)
anti-ErbB2##2##1##(2009-2#2)
anti-FLAG monoclonal antibodies M1##2##4##(1997-3#2)
anti-FLAG##4##1##(1997-3#4)
anti-Fas antibody upon transduction##2##4##(2008-8#2)
anti-Fas antibody was##2##3##(2008-8#2)
anti-Fas antibody##6##2##(2008-8#6)
anti-Fas##8##1##(2008-8#8)
anti-Fya in the##2##3##(1992-6#2)
anti-Fya##6##1##(1992-6#6)
anti-GABA##2##1##(2007-12#2)
anti-GM1##2##1##(2008-7#2)
anti-GM2 mAbs##2##2##(1994-2#2)
anti-GM2##3##1##(1994-2#3)
anti-GPIIb##2##1##(1991-8#1)(1997-7#1)
anti-GalC##2##1##(1996-5#2)
anti-HAV##3##1##(2009-4#2)(2012-12#1)
anti-HBV therapy##3##2##(2009-8#1)(2011-2#1)(2012-12#1)
anti-HBV##4##1##(2009-8#2)(2011-2#1)(2012-12#1)
anti-HBc##5##1##(1990-8#2)(1996-12#1)(1997-8#1)(2008-8#1)
anti-HBe##2##1##(1990-8#1)(1992-5#1)
anti-HBs levels##2##2##(2013-1#2)
anti-HBs##5##1##(1990-8#1)(2013-1#4)
anti-HCMV##2##1##(1996-12#2)
anti-HCV antibodies##5##2##(2008-1#5)
anti-HCV positive##2##2##(2007-7#2)
anti-HCV##23##1##(2007-7#7)(2008-1#6)(2008-12#3)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#4)
anti-HER2##2##1##(2008-10#1)(2009-9#1)
anti-HIV 5-phenyl-1-phenylamino-1H-imidazole##2##2##(2011-3#2)
anti-HIV activities##4##2##(2011-3#4)
anti-HIV activity in##2##3##(1995-3#1)(1996-5#1)
anti-HIV activity of##2##3##(1990-10#1)(2011-2#1)
anti-HIV activity##8##2##(1990-10#1)(1990-8#1)(1991-9#1)(1995-3#2)(1996-5#1)(2009-8#1)(2011-2#1)
anti-HIV agent##4##2##(1990-10#1)(1991-3#2)(1992-9#1)
anti-HIV compounds##2##2##(2011-3#2)
anti-HIV drug##2##2##(1994-11#1)(2011-3#1)
anti-HIV properties##2##2##(2008-5#1)(2013-1#1)
anti-HIV##37##1##(1990-10#2)(1990-8#1)(1991-3#2)(1991-9#1)(1992-8#2)(1992-9#2)(1994-11#1)(1994-12#1)(1995-3#3)(1996-5#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#2)(2011-3#15)(2013-1#1)
anti-HIV-1 activity##2##2##(1992-8#1)(2011-2#1)
anti-HIV-1 drug##2##2##(2011-3#2)
anti-HIV-1 drugs##7##2##(2011-2#3)(2011-3#4)
anti-HIV-1 integrase##2##2##(2011-3#1)(2012-3#1)
anti-HIV-1##16##1##(1992-8#1)(2011-2#5)(2011-3#9)(2012-3#1)
anti-HIV1/2##2##1##(2008-12#2)
anti-HLA-B27##2##1##(2008-9#2)
anti-HSP70##2##1##(1994-11#1)(2010-12#1)
anti-HbPs antibodies##2##2##(1990-12#2)
anti-HbPs##3##1##(1990-12#3)
anti-Hofmeister##3##1##(2008-10#3)
anti-Hu##4##1##(1991-11#1)(1996-11#2)(2009-3#1)
anti-IL-6 mAb##2##2##(2008-10#2)
anti-IL-6 monoclonal##3##2##(1994-2#1)(2008-10#1)(2009-4#1)
anti-IL-6##8##1##(1994-2#1)(1995-2#1)(2008-10#4)(2009-4#1)(2013-1#1)
anti-IRS-1##2##1##(1992-10#1)(1997-6#1)
anti-Ig##3##1##(1991-2#1)(2008-4#2)
anti-IgE antibody##4##2##(2008-10#1)(2008-11#2)(2010-5#1)
anti-IgE##10##1##(1991-12#3)(2008-10#1)(2008-11#2)(2010-5#3)(2012-12#1)
anti-IgG##7##1##(1994-12#1)(1994-3#1)(2008-10#3)(2008-4#2)
anti-Jk3 antibody##2##2##(1995-6#2)
anti-K##2##1##(1992-6#1)(2011-1#1)
anti-K4##3##1##(1994-9#3)
anti-KLH IgG##3##2##(2008-10#3)
anti-KLH IgM and IgG responses were##2##6##(2008-10#2)
anti-KLH IgM and IgG responses##3##5##(2008-10#2)(2008-9#1)
anti-KLH IgM and IgG##4##4##(2008-10#3)(2008-9#1)
anti-KLH IgM##7##2##(2008-10#5)(2008-9#2)
anti-KLH##10##1##(2008-10#8)(2008-9#2)
anti-KS##2##1##(1993-2#1)(2008-6#1)
anti-LAS##3##1##(2008-10#3)
anti-LWa##3##1##(1994-12#3)
anti-Leishmania antibodies##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
anti-OVA##2##1##(2008-11#2)
anti-PAP##2##1##(2008-10#2)
anti-PKC##2##1##(1992-9#1)(1993-11#1)
anti-PRP antibody##3##2##(1995-5#3)
anti-Phl p 1 IgG##2##4##(2012-2#2)
anti-Phl p##3##2##(2012-2#3)
anti-RNS##2##1##(2008-5#2)
anti-Ri##2##1##(1996-11#2)
anti-Ro antibodies##2##2##(2008-7#2)
anti-Ro##3##1##(2008-7#3)
anti-S100 protein and anti-vimentin antisera##2##5##(1991-2#2)
anti-SecY##2##1##(1991-5#2)
anti-Sm antibodies##2##2##(1993-2#1)(2008-1#1)
anti-Sm##6##1##(1993-2#3)(1993-8#1)(2008-1#1)(2011-2#1)
anti-SsEno##2##1##(2009-6#2)
anti-Stokes Raman scattering##12##3##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#2)
anti-Stokes Raman##23##2##(2007-11#5)(2007-12#6)(2008-2#7)(2008-3#5)
anti-Stokes##40##1##(2007-1#4)(2007-11#8)(2007-12#9)(2008-2#9)(2008-3#10)
anti-TB drugs##4##2##(2008-1#1)(2008-8#1)(2011-2#1)(2013-7#1)
anti-TB treatment##5##2##(1996-3#2)(2008-8#1)(2010-8#1)(2011-1#1)
anti-TB##10##1##(1996-3#2)(2008-1#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#2)
anti-TNF antibodies##2##2##(1990-5#1)(1994-2#1)
anti-TNF##10##1##(1990-5#1)(1994-2#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
anti-TNF-alpha mAb treatment##2##3##(2008-10#2)
anti-TNF-alpha mAb##5##2##(1996-12#1)(2008-10#4)
anti-TNF-alpha##9##1##(1996-12#1)(2008-10#6)(2010-12#2)
anti-TNFs##3##1##(2010-12#2)(2012-3#1)
anti-TNP antibody was##3##3##(2008-10#3)
anti-TNP antibody##6##2##(2008-10#6)
anti-TNP##7##1##(2008-10#7)
anti-TSP##2##1##(1991-2#1)(1993-6#1)
anti-Toxoplasma##7##1##(1996-11#1)(2007-10#6)
anti-Vel##3##1##(1994-9#3)
anti-Vg monoclonal antibody##2##3##(2008-10#2)
anti-Vg##3##1##(2008-10#3)
anti-Yo##3##1##(1996-11#2)(1997-8#1)
anti-actin##2##1##(1993-3#1)(2008-7#1)
anti-addictive##2##1##(1997-2#2)
anti-ageing##9##1##(2008-5#9)
anti-aggregatory##3##1##(2008-10#1)(2008-7#2)
anti-aging action##2##2##(1990-3#2)
anti-aging effect##2##2##(1994-5#1)(2011-2#1)
anti-aging##16##1##(1990-3#2)(1994-5#1)(2008-4#1)(2008-5#7)(2008-7#2)(2011-2#1)(2012-2#1)(2013-7#1)
anti-alcohol##2##1##(1996-11#1)(2012-12#1)
anti-allergic##3##1##(2008-11#2)(2008-5#1)
anti-anaphylactic##2##1##(2008-10#2)
anti-androgen##2##1##(2010-1#1)(2011-2#1)
anti-androgenic##2##1##(2008-10#1)(2011-2#1)
anti-angiogenic activity##3##2##(1991-12#2)(2008-11#1)
anti-angiogenic factors##2##2##(2013-1#2)
anti-angiogenic therapies##5##2##(1997-1#1)(2011-3#1)(2013-1#1)(2013-8#2)
anti-angiogenic therapy##3##2##(2008-12#1)(2011-7#1)(2012-1#1)
anti-angiogenic##18##1##(1991-12#2)(1997-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-3#1)(2011-7#1)(2012-1#1)(2013-1#3)(2013-8#3)
anti-apoptotic factor##2##2##(2008-1#1)(2013-1#1)
anti-apoptotic gene##3##2##(2008-11#1)(2010-1#1)(2012-2#1)
anti-apoptotic pathways##2##2##(2009-12#1)(2010-11#1)
anti-apoptotic protein##2##2##(2010-6#1)(2011-2#1)
anti-apoptotic proteins Bcl-2##3##3##(2008-6#1)(2012-12#2)
anti-apoptotic proteins is##2##3##(2008-11#1)(2009-12#1)
anti-apoptotic proteins##7##2##(2008-11#1)(2008-6#1)(2009-12#3)(2012-12#2)
anti-apoptotic##29##1##(1994-10#1)(2008-1#2)(2008-11#5)(2008-6#1)(2009-12#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#1)
anti-arrhythmic agent##3##2##(1993-6#1)(2008-8#2)
anti-arrhythmic drugs##2##2##(2008-1#2)
anti-arrhythmic##5##1##(1993-6#1)(2008-1#2)(2008-8#2)
anti-arthritic##3##1##(2008-10#1)(2008-5#2)
anti-asialo GM1##2##2##(2008-10#1)(2008-7#1)
anti-asialo##3##1##(2008-10#2)(2008-7#1)
anti-asthma##2##1##(1997-1#1)(2010-5#1)
anti-atherogenic potential of losartan##3##4##(2011-2#3)
anti-atherogenic properties##2##2##(2008-3#1)(2013-8#1)
anti-atherogenic##11##1##(2008-1#1)(2008-10#1)(2008-3#3)(2011-2#4)(2013-8#2)
anti-atherosclerotic##4##1##(1991-2#1)(2008-3#1)(2008-6#1)(2009-5#1)
anti-beta2-GPI##6##1##(2008-7#6)
anti-cancer agent##3##2##(1993-2#1)(2008-11#1)(2012-2#1)
anti-cancer agents##4##2##(2008-1#1)(2008-9#1)(2013-1#2)
anti-cancer chemotherapy##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
anti-cancer compound##2##2##(2012-3#1)(2013-1#1)
anti-cancer cytotoxic agents results in a##2##6##(2012-12#2)
anti-cancer cytotoxic##3##2##(2012-12#3)
anti-cancer drug resistance##2##3##(1994-2#1)(2008-11#1)
anti-cancer drug##5##2##(1994-2#1)(2008-11#1)(2009-9#1)(2013-1#2)
anti-cancer drugs##4##2##(2008-11#2)(2008-9#1)(2009-11#1)
anti-cancer therapy##8##2##(1994-12#1)(1997-1#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
anti-cancer treatment##3##2##(2012-12#3)
anti-cancer##41##1##(1993-2#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-9#3)(2009-11#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-12#9)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)
anti-canine IgG##2##2##(2008-10#2)
anti-carbohydrate antibodies##2##2##(1991-5#1)(1992-12#1)
anti-caspase-3##3##1##(2008-9#3)
anti-choice##3##1##(1995-6#3)
anti-chromatin##2##1##(2008-4#2)
anti-citrullinated##2##1##(2012-2#2)
anti-clotting##2##1##(2013-8#2)
anti-coagulant##2##1##(2013-7#2)
anti-coagulation and##2##2##(2013-7#2)
anti-cyclic citrullinated peptides##2##3##(2011-2#2)
anti-cyclic citrullinated##3##2##(2011-2#2)(2012-2#1)
anti-dandruff##4##1##(2008-5#4)
anti-depressant prescribing##2##2##(2008-11#2)
anti-depressant##7##1##(2007-7#1)(2008-1#1)(2008-11#4)(2009-12#1)
anti-diabetic##2##1##(2008-10#2)
anti-doping##2##1##(1993-3#1)(2008-5#1)
anti-drug##2##1##(2008-10#1)(2013-8#1)
anti-dumping##4##1##(1991-2#1)(1993-1#1)(1993-2#2)
anti-e+f##2##1##(1994-12#2)
anti-emetic drugs##2##2##(2008-10#2)
anti-epileptic##2##1##(1997-8#1)(2011-2#1)
anti-estrogen##2##1##(1992-5#1)(1993-6#1)
anti-estrogenic##3##1##(1991-3#1)(2010-5#2)
anti-estrogens##3##1##(2008-2#1)(2008-5#2)
anti-fibrin and##2##2##(1994-3#2)
anti-fibrotic##3##1##(2008-1#1)(2013-8#2)
anti-fluorescein##5##1##(1991-8#1)(1992-6#2)(1995-5#2)
anti-forskolin##2##1##(2008-11#2)
anti-ganglioside##3##1##(1994-2#1)(2008-10#1)(2008-7#1)
anti-glaucoma##2##1##(2008-7#1)(2011-2#1)
anti-glomerular basement membrane##2##3##(2007-7#1)(2011-2#1)
anti-growth##2##1##(1990-12#1)(1996-2#1)
anti-heart antibodies against##2##3##(2008-7#2)
anti-heart antibodies##4##2##(2008-7#4)
anti-heart##6##1##(2008-7#6)
anti-human IgG##3##2##(1990-12#1)(2008-10#2)
anti-human##12##1##(1990-12#1)(1990-7#1)(1994-7#1)(1994-9#2)(1997-5#1)(2008-10#4)(2008-11#1)(2008-9#1)
anti-hypertensive treatment##2##2##(1990-11#1)(2008-7#1)
anti-hypertensive##5##1##(1990-11#1)(1993-11#1)(2007-7#1)(2008-10#1)(2008-7#1)
anti-id 2F10##2##2##(1995-2#2)
anti-idiotype##4##1##(1994-2#1)(1995-2#1)(2008-10#2)
anti-idiotypic##3##1##(2012-2#3)
anti-immunoglobulin (Ig)##2##2##(2007-11#1)(2008-4#1)
anti-infective agents##2##2##(1997-3#1)(2012-3#1)
anti-infective and symptomatic treatments##2##4##(2011-2#2)
anti-infective and##3##2##(2008-8#1)(2011-2#2)
anti-infective##9##1##(1997-3#1)(2008-5#2)(2008-8#1)(2011-2#3)(2012-3#2)
anti-inflammation and##2##2##(2008-5#1)(2011-3#1)
anti-inflammatories##3##1##(2008-10#2)(2008-9#1)
anti-inflammatory action##4##2##(1994-9#1)(2009-6#3)
anti-inflammatory activities##5##2##(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
anti-inflammatory activity and##2##3##(2007-11#1)(2009-12#1)
anti-inflammatory activity of##3##3##(2008-10#2)(2013-7#1)
anti-inflammatory activity##9##2##(2007-11#1)(2008-10#2)(2008-5#1)(2009-12#1)(2011-1#3)(2013-7#1)
anti-inflammatory agent##2##2##(1990-6#1)(2008-9#1)
anti-inflammatory agents and##2##3##(1996-11#1)(2008-9#1)
anti-inflammatory agents##11##2##(1996-11#1)(1997-1#1)(2007-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2013-1#1)(2013-8#1)
anti-inflammatory and analgesic activities##2##4##(2007-11#1)(2013-7#1)
anti-inflammatory and analgesic##3##3##(1990-5#1)(2007-11#1)(2013-7#1)
anti-inflammatory and thus##2##3##(2008-3#2)
anti-inflammatory and##9##2##(1990-5#1)(2007-11#1)(2008-3#3)(2008-5#1)(2013-1#2)(2013-7#1)
anti-inflammatory compounds##2##2##(2008-5#2)
anti-inflammatory cytokines##4##2##(2009-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
anti-inflammatory drug (NSAID)##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
anti-inflammatory drug in##2##3##(1990-6#1)(2008-10#1)
anti-inflammatory drug##16##2##(1990-6#1)(1995-12#2)(1997-1#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#2)(2009-11#1)(2012-12#1)
anti-inflammatory drugs (NSAIDs)##9##3##(1993-2#1)(1995-5#1)(2007-4#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
anti-inflammatory drugs and##4##3##(1990-3#1)(1995-5#1)(1997-6#1)(2008-11#1)
anti-inflammatory drugs are##3##3##(1994-2#1)(1997-1#1)(2008-5#1)
anti-inflammatory drugs can##2##3##(2010-2#1)(2013-1#1)
anti-inflammatory drugs on deaminase adenosine##2##5##(2008-7#2)
anti-inflammatory drugs on##3##3##(1995-5#1)(2008-7#2)
anti-inflammatory drugs##46##2##(1990-3#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-2#1)(1995-5#4)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-4#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
anti-inflammatory effect of##2##3##(1990-6#1)(2008-10#1)
anti-inflammatory effect##6##2##(1990-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)
anti-inflammatory effects in##2##3##(2008-12#1)(2009-8#1)
anti-inflammatory effects of##4##3##(2008-12#1)(2008-3#1)(2009-1#1)(2013-1#1)
anti-inflammatory effects##15##2##(2007-7#1)(2008-1#2)(2008-12#2)(2008-3#4)(2009-1#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
anti-inflammatory medication##3##2##(2008-11#1)(2008-9#1)(2009-3#1)
anti-inflammatory potential of##2##3##(2008-11#1)(2011-1#1)
anti-inflammatory properties##6##2##(1995-11#1)(2008-10#1)(2008-7#2)(2009-6#1)(2012-2#1)
anti-inflammatory protection##2##2##(2009-11#2)
anti-inflammatory therapy##3##2##(1990-5#1)(1991-8#1)(2008-7#1)
anti-inflammatory##183##1##(1990-3#1)(1990-5#2)(1990-6#4)(1990-8#1)(1991-3#1)(1991-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#5)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#25)(2008-11#7)(2008-12#3)(2008-3#10)(2008-5#11)(2008-7#9)(2008-9#4)(2009-1#2)(2009-11#5)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#12)(2013-7#3)(2013-8#4)
anti-insulin receptor##2##2##(1991-12#1)(1997-6#1)
anti-insulin##3##1##(1991-12#1)(1997-6#1)(2008-1#1)
anti-invasive##3##1##(2008-11#3)
anti-keyhole limpet hemocyanin (KLH)##2##4##(2008-10#2)
anti-kickback statute##2##2##(1993-1#1)(1995-12#1)
anti-kickback##4##1##(1992-12#2)(1993-1#1)(1995-12#1)
anti-lamin##2##1##(2008-8#2)
anti-malaria##4##1##(2010-1#2)(2012-3#2)
anti-metastatic activity##2##2##(2008-11#2)
anti-metastatic##4##1##(2008-11#3)(2013-1#1)
anti-metatype antibodies##5##2##(1992-6#5)
anti-metatype##7##1##(1992-6#7)
anti-microbial##3##1##(2008-10#1)(2010-7#1)(2013-1#1)
anti-mouse IgG##4##2##(1995-2#1)(2008-10#3)
anti-mouse##8##1##(1991-5#1)(1993-8#1)(1995-2#1)(2008-10#3)(2008-8#1)(2012-12#1)
anti-mu##2##1##(1990-12#2)
anti-neoplastic##4##1##(2008-10#1)(2008-2#1)(2011-2#2)
anti-nociceptive effects##2##2##(2008-12#1)(2011-2#1)
anti-nociceptive##3##1##(2008-12#1)(2011-2#2)
anti-nuclear##4##1##(1993-3#1)(1995-2#1)(2008-10#2)
anti-obesity##2##1##(1996-6#1)(2008-1#1)
anti-oxidant and##2##2##(2008-1#1)(2013-7#1)
anti-oxidant enzymes##2##2##(2008-7#2)
anti-oxidant##10##1##(2008-1#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#1)(2012-2#1)(2013-7#1)
anti-oxidants##10##1##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#4)(2010-1#1)(2012-2#2)
anti-oxidation##3##1##(2010-12#1)(2011-3#1)(2012-2#1)
anti-oxidative activity##3##2##(2008-5#3)
anti-oxidative##8##1##(1994-2#1)(2008-10#3)(2008-5#4)
anti-oxygen-quenching RTP##2##2##(2008-10#2)
anti-p185HER2 immunoliposomes are##2##3##(1995-2#2)
anti-p185HER2 immunoliposomes##6##2##(1995-2#6)
anti-p185HER2 monoclonal antibody##2##3##(1993-1#1)(1995-2#1)
anti-p185HER2##9##1##(1993-1#1)(1995-2#8)
anti-parallel##2##1##(1992-9#1)(2008-10#1)
anti-parkinsonian##3##1##(1992-3#1)(2008-7#2)
anti-peptide antibody##3##2##(1990-12#2)(1992-12#1)
anti-peptide antisera##3##2##(1990-5#1)(2008-4#2)
anti-peptide##9##1##(1990-12#2)(1990-5#2)(1992-12#1)(1994-8#1)(2008-4#3)
anti-perspirant##3##1##(2008-5#3)
anti-phospholipid antibodies##2##2##(2008-7#1)(2011-2#1)
anti-phospholipid##3##1##(2008-7#2)(2011-2#1)
anti-phosphopeptide antibodies##3##2##(2008-4#3)
anti-phosphotyrosine antibody##3##2##(1992-10#1)(1997-1#1)(2012-3#1)
anti-phosphotyrosine##4##1##(1992-10#1)(1992-12#1)(1997-1#1)(2012-3#1)
anti-platelet and##2##2##(2008-11#1)(2008-3#1)
anti-platelet##5##1##(2008-11#1)(2008-12#1)(2008-3#2)(2012-12#1)
anti-proliferative and##2##2##(2008-8#1)(2013-1#1)
anti-proliferative effects of##2##3##(2009-4#1)(2013-1#1)
anti-proliferative##9##1##(1996-2#1)(2008-1#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2013-1#2)
anti-pseudomonal##2##1##(2012-2#2)
anti-psychotic medication##2##2##(2010-1#1)(2013-8#1)
anti-psychotic##4##1##(2008-10#1)(2010-1#1)(2013-8#2)
anti-rabbit IgG antibody was##2##4##(2008-10#2)
anti-rabbit IgG##5##2##(2008-10#5)
anti-rabbit##9##1##(1991-2#1)(2008-10#6)(2008-4#2)
anti-rabies##2##1##(2012-12#1)(2012-3#1)
anti-ras##2##1##(1991-12#1)(1992-12#1)
anti-receptor##2##1##(1991-12#1)(1994-2#1)
anti-reflux surgery##3##2##(2008-10#2)(2010-12#1)
anti-reflux##4##1##(2008-10#3)(2010-12#1)
anti-retroviral therapy##5##2##(2007-7#1)(2008-1#2)(2010-12#1)(2011-1#1)
anti-retroviral##10##1##(1992-12#1)(1997-3#1)(2007-7#1)(2008-1#3)(2010-12#2)(2011-1#1)(2013-1#1)
anti-sense##5##1##(1993-11#1)(2008-10#1)(2009-12#1)(2012-2#2)
anti-sera##2##1##(2008-8#1)(2011-1#1)
anti-sheep red blood cell##2##4##(1993-12#1)(2008-10#1)
anti-stokes Raman scattering##3##3##(2008-2#1)(2008-3#2)
anti-stokes Raman##4##2##(2008-2#2)(2008-3#2)
anti-thyroglobulin antibodies##2##2##(2008-7#1)(2013-1#1)
anti-thyroglobulin##3##1##(1991-8#1)(2008-7#1)(2013-1#1)
anti-thyrotropin-receptor antibodies##2##2##(2007-8#2)
anti-tolmetin antibodies##2##2##(1992-9#2)
anti-transferrin##2##1##(1993-8#1)(2008-10#1)
anti-trypanozoon antibodies##2##2##(2011-2#2)
anti-tuberculosis##4##1##(2007-8#1)(2008-10#1)(2009-6#1)(2013-1#1)
anti-tuberculous##4##1##(2008-1#1)(2008-7#1)(2008-8#1)(2010-11#1)
anti-tumor F(ab')2##2##2##(1997-2#2)
anti-tumor activity##6##2##(1992-9#1)(2008-11#2)(2010-11#1)(2010-6#1)(2012-12#1)
anti-tumor and##2##2##(2008-10#2)
anti-tumor necrosis factor (TNF) therapies##2##5##(2011-2#2)
anti-tumor necrosis factor##4##3##(2011-2#4)
anti-tumor reactions in##2##3##(2013-1#2)
anti-tumor##35##1##(1992-9#3)(1993-8#1)(1993-9#2)(1997-2#2)(2008-10#3)(2008-11#6)(2008-9#2)(2009-12#1)(2010-11#2)(2010-6#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
anti-tumour##3##1##(1997-6#1)(2008-5#1)(2012-3#1)
anti-tyrosinase and##2##2##(2008-5#2)
anti-tyrosinase##3##1##(2008-5#3)
anti-u-PA antibodies were##2##3##(1994-3#2)
anti-ulcer##2##1##(2008-10#1)(2011-3#1)
anti-viral drugs##2##2##(2012-2#1)(2013-8#1)
anti-viral##10##1##(1992-12#1)(1992-3#1)(1994-8#1)(1995-2#1)(1995-4#1)(2007-12#1)(2012-2#3)(2013-8#1)
anti-wrinkle##2##1##(2008-5#2)
antiadipogenic##3##1##(2008-5#3)
antiaggregating##3##1##(2008-7#3)
antiaging##2##1##(1994-6#1)(2008-3#1)
antiallergic##2##1##(2008-11#1)(2013-1#1)
antiandrogens##2##1##(1990-11#1)(1991-2#1)
antiangiogenesis##2##1##(2008-8#2)
antiangiogenic##6##1##(1994-12#1)(2007-11#1)(2008-6#1)(2010-1#2)(2012-2#1)
antianxiety##2##1##(1994-2#2)
antiapoptotic##7##1##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#2)
antiarrhythmic agents##3##2##(1992-3#1)(2008-5#2)
antiarrhythmic drug amiodarone##2##3##(1990-5#1)(1993-6#1)
antiarrhythmic drug##5##2##(1990-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(2008-5#1)
antiarrhythmic drugs##2##2##(2006-10#1)(2008-7#1)
antiarrhythmic##19##1##(1990-5#1)(1992-3#2)(1992-6#1)(1993-6#1)(1994-8#1)(1996-3#1)(2006-10#1)(2007-8#2)(2008-5#6)(2008-7#1)(2013-1#1)(2013-7#1)
antiarrhythmics##3##1##(1996-3#1)(2006-8#1)(2008-5#1)
antiatherogenic##5##1##(1994-9#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
antiaxillary odour deodorant##2##3##(2008-5#2)
antibacterial activities against##4##3##(2008-12#2)(2010-3#1)(2012-3#1)
antibacterial activities of##2##3##(2008-5#1)(2011-2#1)
antibacterial activities##8##2##(1994-2#1)(2008-12#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#2)
antibacterial activity against Escherichia coli##2##5##(2010-3#1)(2012-3#1)
antibacterial activity against##8##3##(2007-11#1)(2010-3#4)(2012-3#3)
antibacterial activity and##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
antibacterial activity of the##4##4##(2007-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
antibacterial activity of##14##3##(2007-11#4)(2007-7#1)(2008-12#1)(2008-5#2)(2008-8#2)(2010-3#1)(2010-5#2)(2012-3#1)
antibacterial activity##30##2##(1995-3#2)(2007-11#6)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-3#5)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#4)
antibacterial agent##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
antibacterial agents to##2##3##(2008-5#1)(2008-7#1)
antibacterial agents##13##2##(1991-3#1)(1995-3#2)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#2)
antibacterial and antifungal activities##3##4##(2010-3#1)(2011-1#1)(2012-3#1)
antibacterial and antifungal##8##3##(2008-10#3)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#1)
antibacterial drug##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
antibacterial drugs##2##2##(2008-12#2)
antibacterial efficacy##3##2##(2008-5#2)(2012-3#1)
antibacterial peptides##3##2##(1997-8#2)(2012-2#1)
antibacterial properties##2##2##(2008-8#1)(2012-3#1)
antibacterial resistance and plasmid profile##3##5##(2008-12#3)
antibacterial therapy##2##2##(1992-11#1)(1992-5#1)
antibacterial##110##1##(1990-6#1)(1991-3#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-3#4)(1995-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#3)(2007-11#7)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#8)(2008-5#16)(2008-7#3)(2008-8#7)(2008-9#2)(2010-2#1)(2010-3#8)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#15)(2013-1#1)
antibacterials##5##1##(1997-1#1)(2008-10#4)
antibiogram is##2##2##(2008-1#1)(2013-1#1)
antibiogram##7##1##(2007-7#1)(2008-1#1)(2012-3#1)(2013-1#4)
antibiosis by##2##2##(2008-10#2)
antibiosis##15##1##(2008-10#13)(2012-2#2)
antibiotherapy##4##1##(1992-5#1)(2007-8#1)(2010-4#2)
antibiotic 2##7##2##(2008-10#7)
antibiotic activity##2##2##(2009-6#1)(2011-3#1)
antibiotic and##4##2##(1997-3#1)(2008-7#1)(2008-9#1)(2010-10#1)
antibiotic are##2##2##(1991-2#1)(2007-11#1)
antibiotic biosynthesis##2##2##(2008-10#2)
antibiotic consumption in an intensive care burn department]##2##8##(2009-1#1)(2009-5#1)
antibiotic coverage##2##2##(2008-12#1)(2010-6#1)
antibiotic drug##2##2##(1990-2#1)(2008-9#1)
antibiotic drugs##2##2##(1996-11#1)(2008-10#1)
antibiotic in##4##2##(1990-3#2)(1990-6#1)(1991-3#1)
antibiotic mode of action##2##4##(2008-10#2)
antibiotic moenomycin A##2##3##(1997-2#2)
antibiotic peptide gramicidin##2##3##(2010-5#2)
antibiotic prescribing##4##2##(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
antibiotic produced by##2##3##(2008-6#1)(2008-9#1)
antibiotic produced##3##2##(2008-6#2)(2008-9#1)
antibiotic production by##3##3##(2008-10#2)(2010-8#1)
antibiotic production##8##2##(2008-10#4)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
antibiotic prophylaxis have##2##3##(2009-5#1)(2012-2#1)
antibiotic prophylaxis in##5##3##(1990-6#2)(1992-6#1)(2008-7#1)(2009-5#1)
antibiotic prophylaxis##16##2##(1990-11#1)(1990-3#1)(1990-6#2)(1992-6#2)(2008-10#2)(2008-7#1)(2009-5#3)(2011-2#2)(2012-12#1)(2012-2#1)
antibiotic regimen##2##2##(1994-3#1)(2008-11#1)
antibiotic regimens##3##2##(2010-5#1)(2010-6#1)(2011-2#1)
antibiotic resistance in##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
antibiotic resistance of##2##3##(1991-3#1)(2012-12#1)
antibiotic resistance##17##2##(1991-3#1)(1993-11#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
antibiotic resistances##2##2##(1995-3#1)(2012-3#1)
antibiotic seems to##2##3##(1997-2#1)(2008-6#1)
antibiotic selection##2##2##(2010-1#1)(2010-6#1)
antibiotic sensitivity##5##2##(1996-6#1)(2007-7#2)(2008-12#1)(2010-4#1)
antibiotic susceptibility pattern in##2##4##(2010-8#1)(2012-3#1)
antibiotic susceptibility patterns##2##3##(2008-12#1)(2011-2#1)
antibiotic susceptibility##11##2##(2007-12#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
antibiotic therapy and##6##3##(1997-4#1)(2006-10#1)(2007-8#2)(2008-12#1)(2011-2#1)
antibiotic therapy in##3##3##(1993-11#1)(2010-12#1)(2010-6#1)
antibiotic therapy is##3##3##(1990-2#1)(2007-11#1)(2010-12#1)
antibiotic therapy##42##2##(1990-2#2)(1990-5#2)(1990-6#3)(1993-11#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-6#3)(2011-2#6)(2012-1#1)(2012-12#2)
antibiotic treatment and##4##3##(1991-6#1)(1996-3#1)(1996-8#1)(1997-3#1)
antibiotic treatment has##2##3##(1997-4#1)(2009-5#1)
antibiotic treatment of##3##3##(1990-6#1)(1993-8#1)(2011-2#1)
antibiotic treatment##32##2##(1990-2#2)(1990-6#1)(1991-6#1)(1993-2#1)(1993-8#1)(1995-9#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#2)(2010-6#5)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
antibiotic usage##2##2##(1993-2#1)(2011-2#1)
antibiotic use and##4##3##(2009-5#1)(2011-2#1)(2013-1#2)
antibiotic use in a##3##4##(1996-11#1)(2007-12#1)(2013-8#1)
antibiotic use##17##2##(1996-11#4)(2007-12#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#6)(2013-8#2)
antibiotic used to treat##2##4##(2007-12#1)(2012-2#1)
antibiotic used##3##2##(1997-2#1)(2007-12#1)(2012-2#1)
antibiotic was##2##2##(1992-12#1)(2008-8#1)
antibiotic with##2##2##(1997-3#1)(2008-5#1)
antibiotic##321##1##(1990-11#1)(1990-2#6)(1990-3#3)(1990-5#3)(1990-6#7)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-6#1)(1992-12#2)(1992-6#3)(1993-11#3)(1993-2#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-3#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#6)(1996-3#3)(1996-6#7)(1996-8#1)(1997-2#6)(1997-3#3)(1997-4#3)(1997-7#1)(2006-10#1)(2007-11#4)(2007-12#7)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#4)(2008-10#39)(2008-11#7)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#5)(2008-8#11)(2008-9#11)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#3)(2010-5#3)(2010-6#11)(2010-8#2)(2011-1#3)(2011-2#22)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#8)
antibiotic-associated diarrhea##3##2##(1996-3#1)(2007-12#1)(2013-1#1)
antibiotic-associated##4##1##(1996-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
antibiotic-deficient##2##1##(2008-10#2)
antibiotic-impregnated cement##2##2##(2008-6#2)
antibiotic-injured##3##1##(2009-6#3)
antibiotics against##2##2##(1994-11#1)(2007-7#1)
antibiotics alone##5##2##(1991-1#1)(1994-12#1)(2007-7#1)(2010-5#1)(2013-8#1)
antibiotics already##2##2##(1997-4#1)(2012-2#1)
antibiotics and the##2##3##(2007-2#1)(2008-5#1)
antibiotics and##21##2##(1990-11#2)(1990-5#1)(1996-11#2)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
antibiotics are##9##2##(1992-6#3)(1994-11#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
antibiotics as##5##2##(1994-11#1)(1996-8#1)(1997-4#1)(2008-10#1)(2010-8#1)
antibiotics by##2##2##(2010-8#1)(2012-3#1)
antibiotics can be##2##3##(1994-8#1)(2008-5#1)
antibiotics can##3##2##(1994-8#1)(2008-5#1)(2011-2#1)
antibiotics could##2##2##(1991-3#1)(2008-10#1)
antibiotics during##2##2##(2008-7#1)(2011-2#1)
antibiotics for the##5##3##(1996-11#1)(2007-12#2)(2008-3#1)(2009-5#1)
antibiotics for##10##2##(1996-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
antibiotics from##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
antibiotics have been the conventional methods##2##6##(2012-2#1)(2012-3#1)
antibiotics have been##5##3##(1994-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
antibiotics have##6##2##(1994-12#1)(2008-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
antibiotics in children##2##3##(1994-3#1)(2007-12#1)
antibiotics in knee arthroplasty##2##4##(2011-2#2)
antibiotics in pharmaceutical##2##3##(2008-10#2)
antibiotics in the treatment of##3##5##(2007-11#1)(2008-5#1)(2010-6#1)
antibiotics in the##4##3##(2007-11#1)(2008-5#1)(2008-7#1)(2010-6#1)
antibiotics in##31##2##(1994-12#1)(1994-3#1)(1996-3#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-3#2)(2013-8#1)
antibiotics is##4##2##(1990-12#1)(1997-4#1)(2007-11#1)(2009-4#1)
antibiotics must be##2##3##(1992-12#1)(2012-1#1)
antibiotics of##5##2##(1990-11#2)(1990-6#1)(2010-8#1)(2013-8#1)
antibiotics should be##2##3##(2007-11#1)(2008-11#1)
antibiotics such as##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
antibiotics that are##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2009-8#1)
antibiotics that inhibit##2##3##(1995-2#1)(2011-2#1)
antibiotics that##7##2##(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-8#1)(2011-2#1)
antibiotics the##2##2##(1996-9#1)(2009-5#1)
antibiotics to##4##2##(1995-3#1)(1997-3#1)(2008-6#1)(2009-5#1)
antibiotics used##4##2##(1994-11#1)(1994-12#1)(2008-5#1)(2010-5#1)
antibiotics was##5##2##(1990-8#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-11#1)
antibiotics were administered##3##3##(1994-12#1)(2011-2#1)(2013-8#1)
antibiotics were##12##2##(1991-1#2)(1994-12#1)(2008-10#1)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-8#1)(2013-8#2)
antibiotics with the##4##3##(1993-2#1)(1995-3#1)(2008-10#2)
antibiotics with##11##2##(1990-11#1)(1991-11#1)(1993-2#1)(1994-5#1)(1995-3#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-8#1)
antibiotics##315##1##(1990-11#8)(1990-12#1)(1990-5#3)(1990-6#2)(1990-8#1)(1991-1#4)(1991-11#1)(1991-3#2)(1991-4#2)(1992-12#1)(1992-3#1)(1992-6#4)(1993-2#1)(1993-8#1)(1994-11#4)(1994-12#7)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-2#2)(1995-3#3)(1995-8#1)(1996-11#6)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-7#1)(2006-10#4)(2006-5#2)(2007-11#6)(2007-12#6)(2007-2#1)(2007-7#16)(2008-1#4)(2008-10#45)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#3)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-8#12)(2010-9#1)(2011-1#5)(2011-2#21)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#10)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#9)
antibiotics)##2##1##(2011-2#1)(2012-12#1)
antiblastic drugs##2##2##(1991-8#1)(2013-1#1)
antiblastic##3##1##(1991-8#1)(2013-1#2)
antibodies (ADA)##2##2##(2008-10#2)
antibodies (ANA)##4##2##(1991-2#1)(1993-3#1)(2008-10#2)
antibodies (Ab)##2##2##(1997-4#1)(2008-10#1)
antibodies (Abs)##2##2##(2008-11#1)(2011-2#1)
antibodies (MoAbs)##6##2##(1990-7#1)(1993-1#1)(1993-8#1)(1995-12#1)(2008-5#1)(2008-7#1)
antibodies (scFvs)##4##2##(2008-10#3)(2008-4#1)
antibodies MAX##2##2##(1995-6#2)
antibodies after##2##2##(2008-1#1)(2008-5#1)
antibodies against IL-5##2##3##(2008-4#1)(2010-5#1)
antibodies against human##3##3##(1995-12#1)(2008-4#1)(2008-7#1)
antibodies against synthetic##2##3##(1991-9#1)(1994-11#1)
antibodies against the virus##2##4##(1997-5#1)(2008-8#1)
antibodies against the##17##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-9#1)(1995-12#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
antibodies against their##2##3##(2008-5#1)(2009-8#1)
antibodies against this##2##3##(1990-2#1)(2012-2#1)
antibodies against##101##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#3)(1992-12#2)(1992-2#1)(1992-8#2)(1993-3#3)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-11#9)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-8#1)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
antibodies allowed##2##2##(2008-10#2)
antibodies alone were present)##2##4##(1990-12#2)
antibodies among hemodialysis##2##3##(2008-1#2)
antibodies among##3##2##(2008-1#2)(2008-8#1)
antibodies and the##9##3##(1992-12#1)(1993-2#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
antibodies and their##2##3##(2008-10#2)
antibodies and##57##2##(1990-11#1)(1990-12#1)(1991-6#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#12)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
antibodies are associated with##2##4##(2008-7#1)(2010-4#1)
antibodies are available##3##3##(1994-2#1)(2008-4#2)
antibodies are##20##2##(1991-2#1)(1994-2#1)(1995-12#1)(2006-10#1)(2008-10#5)(2008-11#3)(2008-4#3)(2008-7#2)(2010-4#1)(2013-8#2)
antibodies as a##2##3##(1992-12#1)(2012-2#1)
antibodies as##7##2##(1992-12#1)(1995-2#2)(1995-3#1)(2008-10#1)(2009-5#1)(2012-2#1)
antibodies at##2##2##(1992-8#1)(2008-10#1)
antibodies between##2##2##(1990-2#1)(2007-2#1)
antibodies binding##2##2##(2010-12#2)
antibodies but##3##2##(1991-2#1)(2006-10#1)(2008-10#1)
antibodies by ELISA##4##3##(2007-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
antibodies by##14##2##(1990-12#1)(1991-5#1)(1995-2#1)(1995-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
antibodies can be##6##3##(1994-9#1)(1996-11#1)(2008-1#1)(2008-4#1)(2009-2#1)(2011-2#1)
antibodies can##12##2##(1992-2#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-7#1)(2008-1#2)(2008-4#2)(2009-2#1)(2011-2#1)(2012-12#1)
antibodies conjugated to##2##3##(2008-9#2)
antibodies could recognize##2##3##(2008-8#1)(2011-2#1)
antibodies could##3##2##(1996-12#1)(2008-8#1)(2011-2#1)
antibodies coupled to Sepharose##2##4##(1991-8#1)(1993-12#1)
antibodies decreased##2##2##(1995-11#1)(1995-2#1)
antibodies detectable##2##2##(1997-5#1)(1997-6#1)
antibodies detected##6##2##(1991-11#2)(1992-9#2)(2008-10#1)(2008-7#1)
antibodies developed##2##2##(2008-5#1)(2008-8#1)
antibodies did not bind##2##4##(1995-11#2)
antibodies did not##5##3##(1990-2#1)(1995-11#3)(2009-6#1)
antibodies directed against bovine##2##4##(1994-5#1)(1995-9#1)
antibodies directed against the extracellular domain of##2##7##(1992-12#1)(1996-5#1)
antibodies directed against the##7##4##(1992-12#2)(1992-2#1)(1994-8#1)(1996-5#1)(1997-3#1)(2008-7#1)
antibodies directed against##13##3##(1990-12#1)(1992-12#2)(1992-2#1)(1994-5#1)(1994-8#2)(1995-9#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-7#1)(2008-9#1)
antibodies directed to##2##3##(1994-9#1)(2008-9#1)
antibodies directed##15##2##(1990-12#1)(1992-12#2)(1992-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-7#1)(2008-9#2)
antibodies for apo(a)##2##3##(1993-2#2)
antibodies for routine##2##3##(2008-10#2)
antibodies for the##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
antibodies for##20##2##(1990-5#1)(1992-8#1)(1993-2#2)(1994-8#3)(1995-12#2)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
antibodies from a##2##3##(2008-11#1)(2008-9#1)
antibodies from##8##2##(1994-5#1)(2008-11#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
antibodies generated against##3##3##(1990-5#1)(1994-11#1)(1995-6#1)
antibodies had##6##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(2008-10#1)
antibodies has been##2##3##(2008-11#1)(2008-7#1)
antibodies has##5##2##(1994-8#1)(2008-11#1)(2008-7#2)(2008-9#1)
antibodies have been shown to##2##5##(1992-6#1)(2008-7#1)
antibodies have been##4##3##(1992-6#2)(1994-2#1)(2008-7#1)
antibodies have##6##2##(1992-11#1)(1992-6#2)(1994-2#1)(2008-4#1)(2008-7#1)
antibodies immunoreactive##2##2##(2008-9#2)
antibodies in a##2##3##(2008-4#1)(2008-7#1)
antibodies in human serum##2##4##(1991-5#1)(2008-10#1)
antibodies in human##3##3##(1991-5#1)(1993-9#1)(2008-10#1)
antibodies in patients with##3##4##(1992-2#1)(1992-8#1)(2008-7#1)
antibodies in plants##2##3##(2008-10#2)
antibodies in serum##2##3##(2008-10#1)(2011-1#1)
antibodies in the##8##3##(1990-11#1)(1992-5#2)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)
antibodies in##63##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-7#2)(1995-2#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
antibodies indicated##2##2##(1997-9#1)(2008-12#1)
antibodies induced##2##2##(2008-10#1)(2008-8#1)
antibodies is##6##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
antibodies may##2##2##(1995-9#1)(1997-8#1)
antibodies obtained from##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
antibodies obtained##5##2##(1995-2#2)(1997-8#1)(2008-10#1)(2008-4#1)
antibodies of##9##2##(1990-12#2)(1994-8#1)(2008-12#1)(2008-9#3)(2010-5#1)(2011-1#1)
antibodies on the##2##3##(2008-11#2)
antibodies on##10##2##(1992-12#1)(1992-8#2)(1996-5#1)(2008-10#3)(2008-11#3)
antibodies onto the##2##3##(2009-3#2)
antibodies or##14##2##(1991-2#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
antibodies prepared against##2##3##(1993-6#1)(1994-11#1)
antibodies prepared##4##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-9#1)
antibodies raised against the##3##4##(1991-5#1)(1992-8#1)(1996-12#1)
antibodies raised against##14##3##(1990-11#1)(1990-8#1)(1991-5#2)(1992-11#1)(1992-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-6#1)
antibodies raised in##3##3##(1991-9#2)(1997-4#1)
antibodies raised##18##2##(1990-11#1)(1990-8#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-6#1)
antibodies reacted with##2##3##(1992-6#1)(1994-9#1)
antibodies reactive##2##2##(1991-5#1)(1995-9#1)
antibodies recognize##2##2##(1994-9#1)(1995-2#1)
antibodies recognizing the##2##3##(2007-10#1)(2008-10#1)
antibodies recognizing##6##2##(1991-2#1)(1994-9#1)(2007-10#1)(2008-10#2)(2008-4#1)
antibodies revealed that the##3##4##(1994-6#1)(2008-10#1)(2012-12#1)
antibodies revealed that##4##3##(1994-6#1)(1995-2#1)(2008-10#1)(2012-12#1)
antibodies revealed##6##2##(1992-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-10#1)(2012-12#1)
antibodies secreted##2##2##(1994-9#1)(2008-11#1)
antibodies showed that##2##3##(1991-12#1)(2008-10#1)
antibodies showed##3##2##(1991-12#1)(1992-8#1)(2008-10#1)
antibodies significantly##2##2##(2008-1#1)(2009-12#1)
antibodies specific for the##2##4##(1994-8#1)(2008-10#1)
antibodies specific for##17##3##(1991-5#1)(1991-8#1)(1992-9#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)
antibodies specific to##2##3##(1990-7#1)(2008-9#1)
antibodies specific##20##2##(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
antibodies specifically recognized##2##3##(1996-2#1)(2008-11#1)
antibodies than##2##2##(2008-11#1)(2011-1#1)
antibodies that are##2##3##(2008-10#1)(2008-4#1)
antibodies that bind##2##3##(1995-11#1)(2008-10#1)
antibodies that inhibit##2##3##(1996-2#1)(2008-6#1)
antibodies that recognize##8##3##(1990-11#1)(1994-9#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-4#3)
antibodies that recognized##3##3##(1993-9#1)(2008-10#1)(2012-3#1)
antibodies that##30##2##(1990-11#1)(1991-5#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#5)(2008-6#1)(2008-9#1)(2012-12#1)(2012-3#1)
antibodies to CMV##3##3##(1992-6#2)(2010-12#1)
antibodies to be##2##3##(2008-10#2)
antibodies to neurite growth inhibitors##2##5##(1995-11#2)
antibodies to the##10##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-11#1)(1992-6#2)(1993-12#1)(1994-11#1)(1995-12#1)(1996-6#1)
antibodies to##93##2##(1990-11#1)(1990-12#9)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#4)(1992-9#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
antibodies toward##4##2##(1991-12#2)(1991-5#1)(1994-9#1)
antibodies used for##2##3##(2008-9#1)(2011-2#1)
antibodies used##3##2##(1994-2#1)(2008-9#1)(2011-2#1)
antibodies using##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
antibodies was found##2##3##(2008-10#1)(2008-4#1)
antibodies was more##2##3##(1994-7#2)
antibodies was##14##2##(1990-12#1)(1994-7#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-4#2)(2009-2#1)(2012-2#1)
antibodies we##3##2##(1995-6#1)(1996-12#1)(2010-12#1)
antibodies were immobilized on##2##4##(2008-10#2)
antibodies were measured by##2##4##(2007-7#1)(2008-7#1)
antibodies were not##2##3##(2007-7#1)(2012-3#1)
antibodies were obtained##2##3##(2008-10#1)(2008-9#1)
antibodies were positive in##3##4##(2007-7#2)(2008-8#1)
antibodies were positive##4##3##(2007-7#2)(2007-8#1)(2008-8#1)
antibodies were present in##2##4##(1994-7#2)
antibodies were raised##2##3##(1995-3#1)(2008-10#1)
antibodies were used to##3##4##(2008-10#2)(2008-9#1)
antibodies were used##6##3##(1995-12#2)(2008-10#2)(2008-9#1)(2011-2#1)
antibodies were##44##2##(1990-12#3)(1991-5#1)(1991-7#1)(1992-9#1)(1993-8#1)(1994-3#2)(1994-7#2)(1995-12#2)(1995-3#1)(1997-6#1)(2006-6#1)(2007-7#4)(2007-8#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
antibodies which##8##2##(1990-12#1)(1992-6#1)(1993-6#1)(1996-5#1)(1997-1#1)(1997-5#2)(2008-10#1)
antibodies will##2##2##(2007-10#1)(2008-4#1)
antibodies with a##2##3##(1992-9#1)(2008-9#1)
antibodies with##14##2##(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#2)(2013-8#1)
antibodies without##3##2##(2008-7#2)(2013-8#1)
antibodies##1180##1##(1990-11#9)(1990-12#33)(1990-2#7)(1990-3#3)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#7)(1991-12#11)(1991-2#12)(1991-3#3)(1991-5#18)(1991-6#2)(1991-7#2)(1991-8#8)(1991-9#8)(1992-11#4)(1992-12#19)(1992-2#5)(1992-3#3)(1992-5#5)(1992-6#19)(1992-7#1)(1992-8#19)(1992-9#12)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#8)(1993-6#10)(1993-8#8)(1993-9#5)(1994-11#8)(1994-12#7)(1994-2#6)(1994-3#6)(1994-5#6)(1994-6#2)(1994-7#6)(1994-8#15)(1994-9#17)(1995-11#16)(1995-12#22)(1995-2#21)(1995-3#8)(1995-5#5)(1995-6#14)(1995-8#1)(1995-9#6)(1996-11#5)(1996-12#13)(1996-2#6)(1996-5#9)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#8)(1997-4#5)(1997-5#5)(1997-6#8)(1997-7#9)(1997-8#4)(1997-9#4)(2006-10#6)(2006-6#4)(2007-10#7)(2007-11#1)(2007-12#6)(2007-2#3)(2007-5#2)(2007-7#11)(2007-8#4)(2007-9#1)(2008-1#23)(2008-10#151)(2008-11#58)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#70)(2008-5#17)(2008-6#4)(2008-7#45)(2008-8#31)(2008-9#49)(2009-11#3)(2009-12#4)(2009-2#7)(2009-3#6)(2009-5#1)(2009-6#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#8)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#2)(2011-1#13)(2011-2#30)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#10)(2012-3#10)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#9)
antibodies'##4##1##(2011-1#4)
antibodies)##5##1##(1997-8#1)(2008-10#3)(2008-5#1)
antibody (AB)##2##2##(2008-10#2)
antibody (Ab)##5##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#2)
antibody (IgG##2##2##(1991-2#1)(2008-10#1)
antibody (SjAb)##2##2##(2008-10#2)
antibody 4-4-20##6##2##(1991-8#4)(1992-6#2)
antibody ELISA##2##2##(1991-12#1)(2008-10#1)
antibody Fab fragment##2##3##(2011-2#2)
antibody Fab##3##2##(2011-2#3)
antibody Fv fragment##3##3##(1993-8#3)
antibody activity in serum##2##4##(2008-10#2)
antibody activity in##3##3##(1995-5#1)(2008-10#2)
antibody activity##6##2##(1995-5#2)(1996-12#1)(2008-10#3)
antibody after##2##2##(2008-11#1)(2008-12#1)
antibody against IL-6##2##3##(1990-5#2)
antibody against a##3##3##(1995-6#1)(2008-11#1)(2010-6#1)
antibody against the##9##3##(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(2007-10#1)(2008-8#2)
antibody against##52##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#5)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-2#1)(1997-1#2)(1997-4#1)(2007-10#1)(2008-10#2)(2008-11#6)(2008-8#2)(2010-12#1)(2010-6#1)(2012-2#2)(2013-1#1)
antibody aggregates##2##2##(2008-11#2)
antibody alpha##3##2##(1994-5#3)
antibody also##2##2##(1991-9#1)(1995-6#1)
antibody among##2##2##(1994-9#1)(2011-2#1)
antibody and an##2##3##(2008-11#1)(2008-4#1)
antibody and antigen##2##3##(2008-10#1)(2009-11#1)
antibody and indirect##2##3##(2008-9#2)
antibody and the##2##3##(1990-12#1)(1993-12#1)
antibody and##33##2##(1990-12#2)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-8#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#3)(2009-11#1)(2009-3#1)(2011-1#1)(2012-2#2)
antibody are##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
antibody array##3##2##(2010-12#3)
antibody arrays##2##2##(2010-11#2)
antibody at a##2##3##(2008-10#1)(2008-11#1)
antibody at##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
antibody avidity##3##2##(1995-5#3)
antibody binding sites##2##3##(2008-8#1)(2008-9#1)
antibody binding##5##2##(1991-12#1)(1995-6#1)(2008-1#1)(2008-8#1)(2008-9#1)
antibody bound##2##2##(1994-2#1)(2008-8#1)
antibody by##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
antibody can be##2##3##(2008-4#1)(2008-9#1)
antibody can##5##2##(1991-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)
antibody changed in##2##3##(1993-11#1)(2010-12#1)
antibody characterization##2##2##(2008-10#1)(2008-5#1)
antibody chromosome##2##2##(2008-4#2)
antibody compared with##2##3##(1990-12#1)(2008-11#1)
antibody concentration and##2##3##(2008-10#1)(2008-11#1)
antibody concentration##8##2##(2008-10#1)(2008-11#7)
antibody concentrations against##2##3##(1992-2#2)
antibody concentrations##6##2##(1992-2#3)(1995-5#2)(2011-2#1)
antibody conversion rate##2##3##(1995-12#2)
antibody could##2##2##(2008-9#1)(2013-1#1)
antibody detection was##2##3##(2011-1#1)(2011-2#1)
antibody detection##9##2##(1993-6#1)(1994-6#2)(2008-1#1)(2008-10#1)(2011-1#3)(2011-2#1)
antibody did not##2##3##(1993-6#1)(2008-10#1)
antibody directed against##10##3##(1992-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2013-8#1)
antibody directed##11##2##(1992-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2013-8#1)
antibody followed by##3##3##(2008-9#1)(2009-9#1)(2012-3#1)
antibody for a##2##3##(2008-10#1)(2008-11#1)
antibody for the##4##3##(1995-8#1)(2008-10#1)(2008-11#2)
antibody for##13##2##(1991-2#1)(1993-6#1)(1994-2#1)(1995-8#2)(2008-10#2)(2008-11#5)(2008-9#1)
antibody formation##3##2##(1990-5#1)(1995-11#1)(2008-7#1)
antibody fragment (scFv)##2##3##(2008-8#1)(2009-2#1)
antibody fragment##8##2##(1994-12#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-8#1)(2009-2#2)(2011-1#1)
antibody fragments##5##2##(1994-8#1)(1997-2#1)(2008-10#2)(2013-8#1)
antibody from##4##2##(1994-2#1)(1994-8#1)(2008-10#2)
antibody gene##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
antibody genes##2##2##(1994-3#1)(2008-4#1)
antibody had##2##2##(1991-12#1)(1995-2#1)
antibody identification##3##2##(1992-9#1)(1994-9#2)
antibody in a##4##3##(1994-10#1)(2008-10#1)(2008-11#1)(2008-12#1)
antibody in goats##2##3##(2010-4#2)
antibody in the##8##3##(1996-12#1)(1996-5#1)(2008-11#1)(2008-7#3)(2011-1#2)
antibody in##34##2##(1990-2#1)(1991-11#1)(1992-9#1)(1993-2#1)(1994-10#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#2)
antibody inhibited##2##2##(1990-2#1)(1993-8#1)
antibody inhibition##2##2##(1994-8#1)(1995-11#1)
antibody is##12##2##(1990-12#1)(1994-3#1)(1994-8#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
antibody labeled with##2##3##(2008-10#2)
antibody labeling##3##2##(2008-10#2)(2008-9#1)
antibody labelled##3##2##(1992-6#2)(2008-10#1)
antibody leukocyte capture microarray##2##4##(2010-12#2)
antibody levels against##2##3##(2009-5#1)(2012-12#1)
antibody levels in##2##3##(2007-2#1)(2013-1#1)
antibody levels should be##2##4##(1994-9#2)
antibody levels to##3##3##(1991-8#3)
antibody levels##17##2##(1990-12#1)(1991-11#1)(1991-8#3)(1994-9#2)(1996-12#1)(1997-6#2)(2007-2#1)(2007-5#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#2)
antibody library##5##2##(2008-10#4)(2008-8#1)
antibody of##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
antibody on a##2##3##(1991-5#1)(2008-11#1)
antibody on the sensor chip##3##5##(2008-10#3)
antibody on the sensor##4##4##(1997-2#1)(2008-10#3)
antibody on the##8##3##(1991-5#2)(1997-2#1)(2008-10#5)
antibody on##14##2##(1991-5#5)(1997-2#1)(2008-10#5)(2008-11#3)
antibody or##7##2##(1993-8#1)(2008-10#2)(2008-4#3)(2008-7#1)
antibody pairs##3##2##(2008-10#3)
antibody phage display##3##3##(2008-4#1)(2008-8#1)(2010-12#1)
antibody positivity##2##2##(1992-8#1)(2007-7#1)
antibody preparation##3##2##(2008-10#2)(2008-4#1)
antibody prepared against##5##3##(1990-11#1)(1990-8#1)(1993-6#1)(1996-2#2)
antibody prevalence##2##2##(2008-1#1)(2011-2#1)
antibody produced from##2##3##(2008-11#2)
antibody produced##4##2##(1994-2#1)(1995-6#1)(2008-11#2)
antibody production against##2##3##(1990-12#1)(1995-12#1)
antibody production by in vitro immunized peripheral blood mononuclear cells##2##10##(2008-11#2)
antibody production by in vitro immunized##3##6##(2008-11#3)
antibody production by##8##3##(2008-11#7)(2008-4#1)
antibody production from##3##3##(2008-11#3)
antibody production in the##2##4##(2008-11#2)
antibody production in##10##3##(2008-11#8)(2008-4#1)(2008-8#1)
antibody production of##4##3##(1994-2#2)(2008-11#2)
antibody production rate##5##3##(2008-11#5)
antibody production was not##3##4##(2008-11#3)
antibody production was##4##3##(2008-11#4)
antibody production were##2##3##(2008-11#2)
antibody production##78##2##(1990-12#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-12#1)(1994-2#3)(1995-12#1)(1995-5#1)(1997-6#1)(2008-10#3)(2008-11#50)(2008-2#1)(2008-4#5)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
antibody productivity in##2##3##(2008-11#2)
antibody productivity of##2##3##(2008-11#2)
antibody productivity##10##2##(2008-11#10)
antibody products##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
antibody promiscuity##2##2##(2009-3#2)
antibody raised against a##2##4##(1991-8#1)(1997-6#1)
antibody raised against the purified##2##5##(1993-12#1)(2007-12#1)
antibody raised against the##6##4##(1992-12#1)(1993-12#1)(1995-3#1)(1995-6#1)(2007-12#2)
antibody raised against##13##3##(1991-8#1)(1992-11#2)(1992-12#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
antibody raised##15##2##(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
antibody reacted##2##2##(1993-6#1)(1996-5#1)
antibody reaction##2##2##(1991-12#1)(2008-10#1)
antibody recognized##3##2##(1990-12#1)(1994-11#1)(2008-6#1)
antibody recognizing##2##2##(1993-8#1)(1993-9#1)
antibody response (TDAR)##5##3##(2008-10#5)
antibody response and##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
antibody response by##2##3##(1991-3#1)(2008-10#1)
antibody response in##3##3##(1991-1#1)(2007-11#1)(2008-10#1)
antibody response to KLH##3##4##(2008-10#3)
antibody response to a##2##4##(1994-5#1)(2013-8#1)
antibody response to sheep red blood cells##2##7##(1993-12#1)(2008-10#1)
antibody response to sheep##3##4##(1993-12#1)(2008-10#2)
antibody response to##14##3##(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(2007-10#1)(2008-10#6)(2012-3#1)(2013-8#1)
antibody response##42##2##(1991-1#1)(1991-3#1)(1993-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-4#3)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
antibody responses and##2##3##(1995-5#2)
antibody responses in##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
antibody responses to##7##3##(1992-2#1)(1995-5#4)(1997-3#1)(2008-10#1)
antibody responses##25##2##(1992-2#1)(1995-2#1)(1995-5#8)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-6#1)(2012-12#1)
antibody revealed a##2##3##(2008-5#1)(2008-8#1)
antibody revealed##4##2##(1994-12#1)(1994-6#1)(2008-5#1)(2008-8#1)
antibody rituximab##2##2##(2007-10#1)(2010-11#1)
antibody screening on the Olympus PK7100##2##6##(1992-6#2)
antibody screening##3##2##(1992-6#2)(2007-7#1)
antibody secretion##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
antibody seemed to##2##3##(1995-3#1)(2008-11#1)
antibody showed##3##2##(1997-1#1)(2008-10#2)
antibody specific for the##4##4##(1990-12#1)(1994-11#1)(1995-2#2)
antibody specific for##10##3##(1990-12#2)(1991-9#1)(1992-8#1)(1994-11#1)(1995-2#2)(2008-10#2)(2008-11#1)
antibody specific##12##2##(1990-12#2)(1991-9#1)(1992-8#1)(1994-11#1)(1995-2#2)(2008-10#3)(2008-11#1)(2008-7#1)
antibody specifically##2##2##(1995-12#1)(1997-4#1)
antibody staining##2##2##(1991-5#1)(2008-7#1)
antibody status##2##2##(1991-11#1)(1997-6#1)
antibody support##2##2##(2008-10#2)
antibody synthesis##4##2##(1995-5#1)(2008-10#2)(2008-7#1)
antibody test was##2##3##(1991-3#1)(2010-12#1)
antibody test##4##2##(1991-3#1)(2008-5#1)(2010-12#1)(2012-3#1)
antibody testing##3##2##(1994-2#1)(1995-1#2)
antibody tests are##2##3##(1991-11#1)(1995-1#1)
antibody tests##4##2##(1991-11#1)(1995-1#1)(2007-7#2)
antibody that##8##2##(1992-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(2008-11#1)(2008-5#1)(2012-3#1)
antibody titer against##2##3##(2008-12#2)
antibody titer##10##2##(2007-10#2)(2008-11#3)(2008-12#3)(2008-4#2)
antibody titers in##2##3##(2007-10#1)(2008-12#1)
antibody titers##13##2##(1994-8#1)(1995-5#1)(2007-10#1)(2008-11#1)(2008-12#3)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
antibody titre in the##2##4##(2008-11#1)(2012-2#1)
antibody titre was##2##3##(1997-6#2)
antibody titre##4##2##(1997-6#2)(2008-11#1)(2012-2#1)
antibody titres##9##2##(1991-11#1)(1991-12#1)(1994-8#1)(1997-6#4)(2007-7#1)(2011-2#1)
antibody to a##2##3##(1997-1#1)(2008-7#1)
antibody to the enzyme##2##4##(2008-10#2)
antibody to the##15##3##(1991-3#2)(1993-9#2)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)
antibody to##49##2##(1990-12#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#2)(1995-12#3)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2013-8#1)
antibody used##2##2##(1993-9#2)
antibody using a##2##3##(2008-10#1)(2008-11#1)
antibody using##4##2##(1997-4#1)(2008-10#1)(2008-11#2)
antibody was also##2##3##(2007-12#1)(2008-10#1)
antibody was detected##2##3##(1993-6#1)(2008-11#1)
antibody was immobilized on the##2##5##(2008-10#2)
antibody was immobilized on##3##4##(2008-10#3)
antibody was immobilized##5##3##(2008-10#5)
antibody was prepared##2##3##(1990-12#1)(2008-10#1)
antibody was produced against##3##4##(2008-10#3)
antibody was produced that##2##4##(1995-6#1)(2008-10#1)
antibody was produced##6##3##(1995-6#1)(1996-12#1)(2008-10#4)
antibody was purified by##2##4##(1994-3#1)(2008-8#1)
antibody was purified##4##3##(1992-9#1)(1994-2#1)(1994-3#1)(2008-8#1)
antibody was used to##2##4##(1993-6#1)(2008-8#1)
antibody was used##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
antibody was##59##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#21)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2012-2#1)(2012-3#1)
antibody were##12##2##(1991-5#1)(1992-3#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-8#2)(2011-2#1)
antibody which##4##2##(1990-12#1)(1994-5#1)(1995-12#1)(2008-10#1)
antibody with a##2##3##(1992-9#1)(2008-10#1)
antibody with the magnetic beads after##2##6##(2008-10#2)
antibody with the##3##3##(2008-10#3)
antibody with##12##2##(1990-12#2)(1992-9#2)(1995-2#1)(2008-10#5)(2010-12#1)(2013-1#1)
antibody##1227##1##(1990-11#5)(1990-12#24)(1990-2#3)(1990-5#5)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#5)(1991-12#9)(1991-2#7)(1991-3#6)(1991-5#19)(1991-8#9)(1991-9#7)(1992-10#2)(1992-11#7)(1992-12#9)(1992-2#9)(1992-3#9)(1992-6#12)(1992-8#9)(1992-9#11)(1993-1#1)(1993-11#6)(1993-12#12)(1993-2#5)(1993-3#2)(1993-6#10)(1993-8#18)(1993-9#13)(1994-10#1)(1994-11#3)(1994-12#9)(1994-2#16)(1994-3#12)(1994-5#11)(1994-6#8)(1994-7#2)(1994-8#18)(1994-9#11)(1995-1#3)(1995-11#2)(1995-12#14)(1995-2#14)(1995-3#5)(1995-5#33)(1995-6#8)(1995-8#3)(1996-11#2)(1996-12#13)(1996-2#4)(1996-5#7)(1996-8#1)(1997-1#8)(1997-2#9)(1997-3#3)(1997-4#7)(1997-6#13)(1997-7#3)(2006-6#4)(2007-10#8)(2007-11#2)(2007-12#4)(2007-2#6)(2007-5#1)(2007-7#9)(2007-8#1)(2008-1#5)(2008-10#207)(2008-11#175)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#53)(2008-5#16)(2008-6#9)(2008-7#24)(2008-8#46)(2008-9#26)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#11)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#2)(2011-1#9)(2011-2#26)(2012-12#6)(2012-2#10)(2012-3#11)(2013-1#19)(2013-8#10)
antibody)##6##1##(2008-10#5)(2008-4#1)
antibody- and##2##2##(1995-12#1)(2008-5#1)
antibody-##3##1##(1995-12#1)(2008-5#1)(2013-1#1)
antibody-antigen complexes##3##2##(1994-2#1)(2008-4#2)
antibody-antigen interaction##2##2##(2008-4#1)(2008-7#1)
antibody-antigen##8##1##(1994-2#1)(2008-10#2)(2008-4#4)(2008-7#1)
antibody-based##2##1##(2008-10#2)
antibody-binding##2##1##(2008-10#1)(2008-11#1)
antibody-coated##6##1##(1994-8#1)(1995-12#3)(2008-4#1)(2009-3#1)
antibody-dependent cellular cytotoxicity (ADCC)##2##4##(1993-6#1)(2008-11#1)
antibody-dependent cellular cytotoxicity##3##3##(1993-6#1)(2008-1#1)(2008-11#1)
antibody-dependent##5##1##(1993-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
antibody-forming cell response##2##3##(2008-10#2)
antibody-forming cell##7##2##(2008-10#7)
antibody-forming##8##1##(2008-10#8)
antibody-immobilized##4##1##(2008-10#3)(2008-11#1)
antibody-lectin sandwich##2##2##(2010-11#2)
antibody-mediated##3##1##(2007-7#1)(2008-4#1)(2013-8#1)
antibody-producing B cells##3##3##(2008-11#1)(2008-4#2)
antibody-producing##6##1##(1995-6#1)(2008-11#1)(2008-4#4)
antibody-secreting##3##1##(2008-4#3)
antibunching in the##2##3##(2007-12#2)
anticancer PG##3##2##(2008-11#3)
anticancer action of##2##3##(2008-10#1)(2009-9#1)
anticancer activity of##3##3##(2009-4#1)(2013-1#2)
anticancer activity##8##2##(1993-1#1)(1995-5#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-1#3)
anticancer agent##6##2##(1991-2#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-3#2)
anticancer agents##10##2##(1995-5#1)(2008-11#2)(2008-5#4)(2009-9#1)(2010-7#1)(2011-2#1)
anticancer drug##17##2##(1991-9#1)(1992-2#1)(1994-11#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
anticancer drugs in##2##3##(1995-3#1)(2012-12#1)
anticancer drugs##24##2##(1991-8#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#8)(2008-5#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
anticancer properties##2##2##(1992-9#1)(2013-1#1)
anticancer therapies##3##2##(2008-7#1)(2009-12#1)(2012-2#1)
anticancer therapy##5##2##(2008-11#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-2#1)
anticancer treatment##4##2##(2007-5#1)(2008-7#1)(2008-8#1)(2010-11#1)
anticancer treatments##5##2##(2007-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
anticancer##106##1##(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#2)(1997-3#1)(1997-4#3)(2007-5#2)(2008-10#3)(2008-11#19)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#8)(2008-8#2)(2009-11#1)(2009-12#7)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-11#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#1)
anticarcinogenic##6##1##(1991-9#1)(1993-11#1)(2008-10#1)(2008-4#2)(2009-8#1)
anticardiolipin antibodies##3##2##(1991-6#1)(2006-10#1)(2008-7#1)
anticardiolipin##6##1##(1991-6#1)(1994-9#1)(2006-10#1)(2008-7#1)(2011-2#2)
anticellulite products##2##2##(2008-5#2)
anticentromere antibodies##2##2##(2009-8#2)
anticheater adaptations##3##2##(2008-8#3)
anticholinergic spasmolytic##2##2##(1990-12#2)
anticholinergic##8##1##(1990-12#2)(1990-3#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-5#1)
anticholinergics##6##1##(1997-1#1)(2008-3#2)(2011-1#1)(2011-2#2)
anticholinesterase##4##1##(1991-9#1)(2008-10#1)(2013-1#2)
anticipate and##2##2##(2008-11#1)(2008-9#1)
anticipate that##5##2##(1993-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
anticipate this##2##2##(2007-8#1)(2009-12#1)
anticipate##25##1##(1991-3#1)(1993-5#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
anticipated and##2##2##(1995-4#1)(2008-7#1)
anticipated body image dissatisfaction##4##4##(2007-12#4)
anticipated changes in##2##3##(1992-2#1)(1996-12#1)
anticipated in the##2##3##(1992-3#1)(1993-12#1)
anticipated in##6##2##(1992-3#1)(1993-12#1)(1995-12#1)(2008-10#1)(2009-2#1)(2012-2#1)
anticipated that the##2##3##(1991-2#1)(2008-5#1)
anticipated that##8##2##(1991-2#1)(1991-9#1)(1997-7#1)(2007-5#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)
anticipated to be##5##3##(1992-11#1)(1997-7#1)(2008-11#1)(2008-9#1)(2012-2#1)
anticipated to##9##2##(1992-11#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)
anticipated##92##1##(1990-12#2)(1991-2#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#10)(2007-5#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-2#2)(2009-5#1)(2009-8#2)(2010-3#2)(2011-1#2)(2011-2#3)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
anticipates##2##1##(2008-5#2)
anticipating and##3##2##(1993-1#1)(2007-11#2)
anticipating the##3##2##(2008-11#1)(2008-2#1)(2010-10#1)
anticipating##11##1##(1993-1#1)(1995-1#2)(2007-11#2)(2007-7#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-7#1)(2012-12#1)
anticipation of further##2##3##(1993-12#1)(2011-2#1)
anticipation of##8##2##(1993-12#1)(1993-2#1)(1995-1#1)(2007-11#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
anticipation##14##1##(1993-12#1)(1993-2#1)(1994-11#2)(1995-1#1)(1997-5#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
anticipatory guidance##2##2##(2010-8#1)(2011-2#1)
anticipatory##14##1##(1992-1#1)(1992-12#2)(1997-8#1)(2007-2#1)(2008-11#3)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#3)
anticlastogenic effects##2##2##(2008-11#2)
anticoagulant activity##6##2##(1990-12#3)(1993-11#3)
anticoagulant drugs##2##2##(2013-1#2)
anticoagulant for##4##2##(2008-10#3)(2013-8#1)
anticoagulant therapy##11##2##(1997-2#3)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)(2013-8#1)
anticoagulant treatment##2##2##(2008-10#2)
anticoagulant##59##1##(1990-12#3)(1990-5#2)(1992-1#1)(1992-12#2)(1993-11#4)(1994-9#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-2#5)(1997-3#2)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-7#1)(2012-12#1)(2013-1#4)(2013-8#2)
anticoagulants and##4##2##(1990-12#1)(2008-10#1)(2010-1#1)(2010-6#1)
anticoagulants for##3##2##(1996-6#1)(2012-12#2)
anticoagulants have been##2##3##(1993-12#1)(2012-12#1)
anticoagulants have##3##2##(1993-12#1)(2012-12#2)
anticoagulants in##8##2##(1993-12#2)(1994-9#1)(2012-12#4)(2012-3#1)
anticoagulants were##2##2##(1994-3#2)
anticoagulants##28##1##(1990-12#2)(1993-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-6#1)(2010-7#1)(2012-12#10)(2012-3#1)
anticoagulated patient##2##2##(2008-3#1)(2011-2#1)
anticoagulated with##4##2##(2007-8#1)(2008-10#3)
anticoagulated##8##1##(1993-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-2#2)
anticoagulation and##2##2##(1997-2#1)(1997-3#1)
anticoagulation during##2##2##(2008-1#1)(2008-10#1)
anticoagulation in primary##2##3##(1995-11#1)(1995-5#1)
anticoagulation in##3##2##(1992-1#1)(1995-11#1)(1995-5#1)
anticoagulation or##2##2##(1990-12#1)(2011-1#1)
anticoagulation therapy with warfarin##2##4##(2010-8#1)(2012-12#1)
anticoagulation therapy with##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
anticoagulation therapy##8##2##(2007-8#1)(2008-10#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
anticoagulation with warfarin##2##3##(2008-8#1)(2011-1#1)
anticoagulation##49##1##(1990-12#1)(1992-1#2)(1994-9#1)(1995-11#4)(1995-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#2)(2007-10#3)(2007-8#4)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
anticoagulation/antiaggregation##2##1##(2008-8#2)
anticoccidial drugs##3##2##(1997-6#1)(2007-6#2)
anticoccidial##4##1##(1997-6#2)(2007-6#2)
anticodon loop##2##2##(1993-3#1)(1997-3#1)
anticonvulsant activity of##3##3##(1991-1#1)(1992-3#1)(1995-12#1)
anticonvulsant activity##6##2##(1991-1#1)(1992-3#1)(1995-12#2)(2008-5#2)
anticonvulsant agent##2##2##(2008-5#2)
anticonvulsant drug##2##2##(1992-3#1)(1994-8#1)
anticonvulsant drugs##5##2##(1990-5#3)(2008-10#1)(2008-11#1)
anticonvulsant effect of##4##3##(1992-3#1)(2010-2#1)(2010-3#2)
anticonvulsant effects of NBQX##3##4##(1994-2#3)
anticonvulsant effects of##6##3##(1994-2#4)(1995-12#2)
anticonvulsant effects##9##2##(1990-5#2)(1994-2#4)(1995-12#3)
anticonvulsant efficacy of phenytoin##2##4##(1994-2#2)
anticonvulsant efficacy##3##2##(1992-3#1)(1994-2#2)
anticonvulsant##49##1##(1990-5#6)(1991-1#1)(1992-3#5)(1994-2#9)(1994-8#4)(1995-12#8)(1997-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#4)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)
anticonvulsants##8##1##(1995-12#3)(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)(2010-8#1)
anticorrelation between the##2##3##(2007-12#2)
anticyclic citrullinated peptide (CCP##2##4##(2013-1#2)
antidandruff efficacy and antimycotic activity##2##5##(2008-5#2)
antidandruff efficacy##5##2##(2008-5#5)
antidandruff shampoos##4##2##(2008-5#4)
antidandruff##13##1##(2008-10#1)(2008-5#12)
antidepressant drug##6##2##(1995-12#1)(2008-10#2)(2008-6#2)(2012-3#1)
antidepressant drugs##8##2##(1990-5#2)(1990-8#1)(2008-10#3)(2010-7#1)(2012-2#1)
antidepressant efficacy##3##2##(2008-6#1)(2008-7#1)(2012-3#1)
antidepressant fluoxetine##3##2##(2008-10#2)(2013-1#1)
antidepressant medication##3##2##(1996-7#1)(2008-6#1)(2009-8#1)
antidepressant treatment is##2##3##(2009-8#1)(2012-2#1)
antidepressant treatment##3##2##(1997-5#1)(2009-8#1)(2012-2#1)
antidepressant##43##1##(1990-5#2)(1990-8#1)(1995-12#1)(1996-12#1)(1996-7#2)(1997-5#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-6#8)(2008-7#3)(2009-8#2)(2010-1#1)(2010-4#1)(2010-7#1)(2012-2#2)(2012-3#3)(2013-1#4)
antidepressant-like effects##2##2##(2013-1#2)
antidepressants (TCAs)##2##2##(1996-7#1)(2008-6#1)
antidepressants for##2##2##(1993-12#1)(2012-3#1)
antidepressants has##2##2##(2008-9#1)(2012-2#1)
antidepressants have##2##2##(1996-7#1)(2008-2#1)
antidepressants in the##2##3##(1991-11#1)(2008-6#1)
antidepressants in##4##2##(1991-11#1)(2008-11#1)(2008-6#1)(2012-3#1)
antidepressants or##2##2##(1997-6#1)(2008-6#1)
antidepressants was##2##2##(2008-10#1)(2012-3#1)
antidepressants##59##1##(1991-11#2)(1991-8#1)(1993-12#1)(1993-3#1)(1996-7#3)(1997-6#1)(1997-8#4)(2006-10#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#9)(2008-7#2)(2008-9#4)(2009-7#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#8)(2013-1#2)
antidepressive medication##2##2##(1995-5#2)
antidepressive##4##1##(1991-11#1)(1994-6#1)(1995-5#2)
antidiabetic activity##5##2##(2008-12#2)(2011-3#2)(2013-1#1)
antidiabetic and##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
antidiabetic##14##1##(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-3#3)(2013-1#3)
antidiuretic hormone secretion##2##3##(1991-3#1)(2011-2#1)
antidiuretic hormone##6##2##(1991-3#1)(1994-8#1)(1997-3#1)(2008-1#1)(2009-8#1)(2011-2#1)
antidotes for##2##2##(1995-3#2)
antidromic population##2##2##(1995-12#1)(1997-2#1)
antidromic stimulation of##2##3##(1993-12#2)
antidromic##5##1##(1992-6#1)(1993-12#2)(1995-12#1)(1997-2#1)
antidromically##2##1##(1991-2#1)(1993-12#1)
antidrug##2##1##(2008-10#1)(2010-11#1)
antiemetic drug##2##2##(1990-12#1)(2008-7#1)
antiemetic therapy##2##2##(2008-7#1)(2012-3#1)
antiemetic use##2##2##(2010-9#1)(2012-2#1)
antiemetic##15##1##(1990-12#1)(1990-6#1)(2008-10#1)(2008-7#3)(2009-5#2)(2010-12#1)(2010-9#1)(2012-2#4)(2012-3#1)
antiemetics##5##1##(1992-5#1)(2008-7#2)(2010-9#1)(2012-3#1)
antiendometrial antibodies as an indicator for follow-up of##2##8##(1995-2#2)
antiendometrial antibodies##4##2##(1995-2#4)
antiepileptic agents##2##2##(2008-8#1)(2013-1#1)
antiepileptic drug##5##2##(1992-3#1)(2008-11#3)(2011-2#1)
antiepileptic drugs (AEDs)##2##3##(2008-8#1)(2013-1#1)
antiepileptic drugs##12##2##(2007-2#1)(2008-11#1)(2008-3#4)(2008-7#2)(2008-8#2)(2013-1#2)
antiepileptic medication##2##2##(2008-7#1)(2008-8#1)
antiepileptic medications##2##2##(1990-5#1)(2008-1#1)
antiepileptic##27##1##(1990-5#1)(1992-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#4)(2011-2#1)(2013-1#4)
antiepileptics##4##1##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
antiepileptogenic and anticonvulsant##2##3##(1994-2#2)
antiestrogen binding sites in##2##4##(2008-11#2)
antiestrogen binding sites##8##3##(1991-9#1)(2008-11#7)
antiestrogen tamoxifen##2##2##(1993-1#1)(1995-2#1)
antiestrogen therapy##2##2##(2008-10#1)(2008-7#1)
antiestrogen##23##1##(1990-12#1)(1991-9#1)(1992-5#3)(1993-1#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-11#12)(2008-7#1)(2011-1#1)
antiestrogenic activity##3##2##(1991-3#1)(2008-11#2)
antiestrogenic##7##1##(1991-3#1)(2008-10#1)(2008-11#4)(2011-1#1)
antiestrogens##16##1##(1992-5#2)(1994-8#1)(1994-9#1)(2008-10#2)(2008-11#9)(2012-12#1)
antifeedant activity##2##2##(2008-11#1)(2008-12#1)
antifeedant##3##1##(2008-11#1)(2008-12#1)(2013-8#1)
antifeeding and##2##2##(2013-8#2)
antiferromagnetic interactions##2##2##(2007-11#2)
antiferromagnetic##4##1##(2007-11#2)(2008-10#1)(2012-2#1)
antifibrotic##2##1##(2008-5#1)(2013-8#1)
antiflogistics##2##1##(1996-6#1)(2008-10#1)
antifoam agents##3##2##(2008-7#3)
antifoam##7##1##(2008-10#1)(2008-7#6)
antifolate##4##1##(1993-12#1)(2008-11#1)(2008-5#1)(2010-3#1)
antifouling agent##5##2##(2008-10#5)
antifouling agents##2##2##(2008-10#2)
antifouling biocides##3##2##(2008-11#3)
antifouling##13##1##(2008-10#9)(2008-11#4)
antifreeze activity in##2##3##(2008-10#2)
antifreeze activity##3##2##(1994-9#1)(2008-10#2)
antifreeze glycopeptides##2##2##(1990-12#2)
antifreeze is##2##2##(1994-9#2)
antifreeze##11##1##(1990-12#2)(1994-9#5)(2008-10#4)
antifungal PR-5 protein##2##3##(1997-4#2)
antifungal activities in vitro##2##4##(2008-10#1)(2011-1#1)
antifungal activities in##3##3##(2008-10#2)(2011-1#1)
antifungal activities of##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
antifungal activities##13##2##(1994-2#1)(2008-10#5)(2008-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
antifungal activity against##7##3##(1997-6#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-2#1)
antifungal activity in##3##3##(2008-10#2)(2008-11#1)
antifungal activity of a##3##4##(1997-6#1)(2008-10#1)(2009-2#1)
antifungal activity of the##2##4##(2008-11#1)(2013-1#1)
antifungal activity of##10##3##(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-2#1)(2010-5#1)(2013-1#1)
antifungal activity was##2##3##(2008-10#2)
antifungal activity##36##2##(1994-2#1)(1997-6#2)(2007-11#1)(2008-10#15)(2008-11#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#3)(2010-5#4)(2011-2#1)(2012-2#1)(2013-1#1)
antifungal agent##6##2##(1992-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
antifungal agents in##2##3##(2008-3#1)(2008-7#1)
antifungal agents##14##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-3#1)(2010-3#1)(2011-2#3)(2013-8#1)
antifungal compound##2##2##(2008-10#1)(2008-5#1)
antifungal compounds and##2##3##(2008-10#2)
antifungal compounds in the filtrate##2##5##(2008-10#2)
antifungal compounds##8##2##(2008-10#8)
antifungal diene##5##2##(2008-10#5)
antifungal drug##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
antifungal drugs##6##2##(2008-5#5)(2011-2#1)
antifungal enzymes##2##2##(2008-10#2)
antifungal in##2##2##(2008-10#1)(2011-2#1)
antifungal preparations##2##2##(2008-5#1)(2011-2#1)
antifungal protein##3##2##(1992-8#1)(2008-10#2)
antifungal susceptibility testing##5##3##(2008-5#3)(2011-2#2)
antifungal susceptibility##11##2##(2008-5#8)(2011-2#3)
antifungal therapy and##2##3##(2008-5#1)(2011-2#1)
antifungal therapy with a##2##4##(2008-5#1)(2011-2#1)
antifungal therapy##12##2##(2007-12#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2011-2#4)(2012-3#2)
antifungal##172##1##(1992-11#3)(1992-8#2)(1994-2#2)(1997-2#1)(1997-4#2)(1997-6#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#58)(2008-11#8)(2008-12#1)(2008-3#3)(2008-5#31)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#4)(2009-3#2)(2010-3#2)(2010-5#4)(2011-1#1)(2011-2#21)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
antifungals tested##2##2##(2008-5#2)
antifungals##12##1##(1997-1#1)(2007-7#1)(2008-5#9)(2011-2#1)
antigay prejudice##2##2##(2008-12#2)
antigay##3##1##(2008-12#3)
antigen (Ag)##3##2##(1990-8#1)(1991-5#1)(2008-10#1)
antigen (CEA) and##2##3##(2008-11#1)(2009-11#1)
antigen (CEA) in##2##3##(1991-4#1)(2008-10#1)
antigen (CEA)##11##2##(1990-5#1)(1991-4#2)(1992-11#1)(1992-6#1)(1993-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2009-11#1)
antigen (PSA)##9##2##(1990-9#1)(1994-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
antigen (in##2##2##(2008-2#1)(2008-4#1)
antigen 125##3##2##(1997-8#1)(2007-7#1)(2011-2#1)
antigen and its##2##3##(1995-6#1)(2007-2#1)
antigen and the##4##3##(1990-12#1)(1991-8#1)(1992-10#1)(2011-2#1)
antigen and##28##2##(1990-12#2)(1991-12#1)(1991-8#2)(1992-10#1)(1992-2#1)(1993-12#2)(1993-2#1)(1994-11#1)(1995-6#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
antigen are##4##2##(1994-11#1)(1995-2#1)(2008-10#1)(2009-12#1)
antigen as##2##2##(1991-12#1)(2008-10#1)
antigen binding##7##2##(1990-12#1)(1991-8#1)(1994-11#1)(1995-5#3)(2008-11#1)
antigen but##2##2##(2006-10#1)(2008-9#1)
antigen by the##2##3##(1990-12#1)(1993-6#1)
antigen by##8##2##(1990-12#2)(1991-2#1)(1993-6#1)(1994-2#1)(1995-6#1)(2008-11#1)(2008-4#1)
antigen can##3##2##(1993-8#1)(1995-5#1)(2008-4#1)
antigen could be detected##2##4##(2008-5#1)(2008-9#1)
antigen delivery##3##2##(1993-3#2)(1995-5#1)
antigen design##2##2##(2012-12#2)
antigen detection tests##2##3##(2007-2#2)
antigen detection##11##2##(2007-2#2)(2007-7#3)(2008-10#3)(2011-2#2)(2013-8#1)
antigen dose##2##2##(2008-11#2)
antigen encounter##3##2##(1995-2#1)(2013-1#2)
antigen excess##2##2##(2008-10#2)
antigen expression in##2##3##(1993-6#1)(1996-9#1)
antigen expression##15##2##(1993-6#2)(1994-12#2)(1994-3#1)(1995-6#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#5)
antigen for##7##2##(1996-12#2)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
antigen from the##7##3##(1994-2#1)(1994-3#1)(1997-3#1)(2008-4#2)(2008-5#1)(2011-2#1)
antigen from##12##2##(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1997-3#1)(2008-10#1)(2008-4#2)(2008-5#2)(2011-2#1)
antigen gene##3##2##(1990-5#1)(1991-8#1)(2008-9#1)
antigen immobilised membrane##2##3##(2008-10#2)
antigen immobilised##3##2##(2008-10#3)
antigen in the##7##3##(1993-12#1)(1994-3#1)(1996-9#1)(1997-8#1)(2008-10#2)(2010-4#1)
antigen in##28##2##(1991-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#2)(2010-4#1)(2011-2#1)(2011-3#1)(2013-8#2)
antigen is a##2##3##(2008-4#1)(2008-8#1)
antigen is##12##2##(1990-12#3)(1994-11#3)(2008-4#3)(2008-8#2)(2011-2#1)
antigen levels##2##2##(1991-4#1)(1996-12#1)
antigen loss##2##2##(1994-12#1)(1995-11#1)
antigen molecules##2##2##(2008-10#1)(2008-9#1)
antigen of##16##2##(1992-12#1)(1992-9#1)(1996-12#3)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
antigen on the##4##3##(1991-2#2)(1994-12#2)
antigen on##11##2##(1990-8#1)(1991-2#2)(1992-12#2)(1993-9#1)(1994-12#2)(2008-11#1)(2008-8#1)(2008-9#1)
antigen peptides##2##2##(2007-6#1)(2008-9#1)
antigen positive##2##2##(2008-8#1)(2010-11#1)
antigen presentation by##3##3##(1995-5#1)(2008-11#2)
antigen presentation##10##2##(1990-12#1)(1993-8#1)(1995-11#1)(1995-5#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-5#1)
antigen presenting cells (APCs)##2##4##(1995-5#1)(2008-7#1)
antigen presenting cells##14##3##(1993-3#2)(1993-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
antigen presenting##15##2##(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
antigen receptor##9##2##(1991-2#1)(1993-11#1)(1995-6#2)(1997-9#1)(2008-4#2)(2008-7#1)(2013-1#1)
antigen receptors##5##2##(1991-9#1)(1994-3#1)(1997-9#1)(2008-4#1)(2012-2#1)
antigen recognition##2##2##(1990-12#1)(1995-2#1)
antigen recognized by##2##3##(1994-8#1)(2008-8#1)
antigen sampling##2##2##(2011-2#2)
antigen sensitization##3##2##(1992-12#1)(2008-11#2)
antigen specific human##2##3##(2008-11#2)
antigen specific##4##2##(2007-12#1)(2008-11#2)(2012-12#1)
antigen specificity##3##2##(1991-2#1)(2008-11#1)(2008-4#1)
antigen stability##2##2##(1993-12#1)(2008-4#1)
antigen stimulates##2##2##(1995-5#1)(2008-4#1)
antigen test for##2##3##(1994-2#1)(2012-2#1)
antigen test##4##2##(1994-2#2)(2007-12#1)(2012-2#1)
antigen to an##2##3##(1990-12#1)(2008-4#1)
antigen to the##2##3##(1993-12#1)(1993-8#1)
antigen to##11##2##(1990-12#1)(1991-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-4#2)
antigen was detected##4##3##(1993-12#1)(2008-5#1)(2011-2#2)
antigen was expressed by##2##4##(1990-12#1)(2008-7#1)
antigen was expressed##3##3##(1990-12#1)(1992-8#1)(2008-7#1)
antigen was monitored in##2##4##(2008-10#2)
antigen was##21##2##(1990-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
antigen were##3##2##(1995-2#2)(2008-4#1)
antigen when##4##2##(1990-12#1)(1993-8#1)(1994-11#1)(2008-11#1)
antigen with##3##2##(1990-5#1)(2008-4#1)(2010-6#1)
antigen##620##1##(1990-11#2)(1990-12#23)(1990-5#5)(1990-6#1)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#7)(1991-4#6)(1991-5#1)(1991-8#8)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#6)(1992-9#4)(1993-11#3)(1993-12#12)(1993-2#3)(1993-3#9)(1993-6#4)(1993-8#12)(1993-9#2)(1994-11#15)(1994-12#10)(1994-2#6)(1994-3#8)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#7)(1994-9#1)(1995-11#10)(1995-12#3)(1995-2#14)(1995-4#1)(1995-5#14)(1995-6#7)(1995-9#1)(1996-11#1)(1996-12#12)(1996-2#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#10)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#4)(1997-9#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#5)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#63)(2008-11#60)(2008-12#4)(2008-2#2)(2008-4#28)(2008-5#16)(2008-7#7)(2008-8#19)(2008-9#20)(2009-11#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#23)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#12)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#10)
antigen) and##2##2##(1990-12#1)(1990-7#1)
antigen)##8##1##(1990-12#2)(1990-7#2)(1990-8#1)(1992-5#1)(1992-6#1)(1997-7#1)
antigen- and##2##2##(1995-12#1)(2009-6#1)
antigen-##3##1##(1992-9#1)(1995-12#1)(2009-6#1)
antigen-1##2##1##(1994-2#1)(2008-11#1)
antigen-antibody complex##4##2##(1991-2#1)(2008-10#2)(2008-4#1)
antigen-antibody interaction##3##2##(1997-2#2)(2009-11#1)
antigen-antibody##14##1##(1991-2#1)(1992-8#2)(1997-2#2)(2008-10#6)(2008-4#1)(2008-9#1)(2009-11#1)
antigen-binding fragment (Fab)##2##3##(1995-5#2)
antigen-binding fragment##4##2##(1995-5#4)
antigen-binding##8##1##(1992-8#1)(1994-8#1)(1995-5#4)(1997-2#1)(2008-10#1)
antigen-coated EIA##2##2##(1995-12#2)
antigen-coated##5##1##(1990-12#1)(1995-12#3)(2008-9#1)
antigen-combining##6##1##(1995-5#5)(2008-4#1)
antigen-dose dependent changes in##2##4##(2008-11#2)
antigen-dose dependent##3##2##(2008-11#3)
antigen-induced airway hyperreactivity to i##2##5##(1992-3#2)
antigen-induced airway hyperreactivity to##3##4##(1992-3#3)
antigen-induced airway##4##2##(1992-3#3)(2011-1#1)
antigen-induced##15##1##(1991-9#1)(1992-11#1)(1992-3#6)(1995-6#1)(1997-7#2)(2008-4#2)(2008-5#1)(2011-1#1)
antigen-mediated##2##1##(1995-6#1)(2008-10#1)
antigen-positive cells##2##2##(2008-5#1)(2008-7#1)
antigen-positive##5##1##(1990-9#1)(1997-7#1)(2008-5#1)(2008-7#1)(2013-1#1)
antigen-presenting activities##3##2##(1995-12#2)(2008-8#1)
antigen-presenting cell##2##2##(2008-10#1)(2012-2#1)
antigen-presenting cells (APC)##2##3##(2008-4#2)
antigen-presenting cells (APCs)##3##3##(1997-4#1)(2008-11#1)(2012-3#1)
antigen-presenting cells and##2##3##(1995-5#1)(2011-2#1)
antigen-presenting cells of##2##3##(2006-10#1)(2008-4#1)
antigen-presenting cells that##3##3##(2008-5#1)(2010-5#2)
antigen-presenting cells##17##2##(1991-8#1)(1995-5#3)(1997-4#1)(2006-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2010-5#2)(2011-2#1)(2012-3#2)
antigen-presenting##24##1##(1991-8#1)(1995-12#2)(1995-5#3)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-5#1)(2008-8#2)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)
antigen-pulsed macrophages##3##2##(2008-8#3)
antigen-specific B cells##3##3##(2008-11#2)(2008-4#1)
antigen-specific B##4##2##(2008-11#3)(2008-4#1)
antigen-specific IgE production##2##3##(2008-11#2)
antigen-specific T cell##2##3##(2008-4#2)
antigen-specific T cells##9##3##(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
antigen-specific T##11##2##(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
antigen-specific antibodies##2##2##(2008-10#2)
antigen-specific antibody##2##2##(2008-10#1)(2008-9#1)
antigen-specific human##3##2##(2008-11#3)
antigen-specific immune responses##3##3##(2006-10#1)(2008-11#2)
antigen-specific immune##4##2##(2006-10#2)(2008-11#2)
antigen-specific##47##1##(1993-8#1)(1995-2#1)(2006-10#2)(2008-10#3)(2008-11#17)(2008-4#9)(2008-5#2)(2008-8#2)(2008-9#4)(2010-5#1)(2012-12#2)(2012-2#2)(2013-8#1)
antigen-stimulated production of inositol phosphates##2##5##(1990-8#2)
antigen-stimulated##5##1##(1990-8#3)(2008-8#2)
antigenemia##2##1##(2007-12#1)(2008-1#1)
antigenic analysis##2##2##(2007-12#1)(2007-6#1)
antigenic and nonantigenic sites##2##4##(1994-8#2)
antigenic and##7##2##(1992-9#1)(1994-8#2)(1995-12#1)(1995-2#1)(2012-2#1)(2013-8#1)
antigenic determinants##6##2##(2008-10#1)(2008-4#1)(2008-8#4)
antigenic difference##2##2##(2011-1#1)(2011-2#1)
antigenic differences##2##2##(2008-5#1)(2008-9#1)
antigenic diversity##2##2##(2008-10#1)(2008-5#1)
antigenic effect##2##2##(1995-2#1)(1996-3#1)
antigenic exposure##3##2##(1990-11#1)(2008-4#1)(2012-2#1)
antigenic heterogeneity##2##2##(1996-12#1)(2008-10#1)
antigenic peptide##6##2##(1991-2#1)(1994-11#1)(2008-11#1)(2008-4#3)
antigenic peptides to the##2##4##(1997-4#1)(2008-4#1)
antigenic peptides##7##2##(1991-2#1)(1994-11#1)(1995-11#2)(1995-5#1)(1997-4#1)(2008-4#1)
antigenic properties##2##2##(1996-3#1)(2011-2#1)
antigenic proteins##2##2##(2012-3#1)(2013-8#1)
antigenic residues can##2##3##(2012-2#2)
antigenic site residues##3##3##(2012-2#3)
antigenic site##7##2##(1991-2#1)(1995-2#1)(2012-2#4)(2013-8#1)
antigenic sites##3##2##(1993-12#1)(1994-8#2)
antigenic stimulation##3##2##(1997-1#1)(2008-11#1)(2008-4#1)
antigenic stimulus##3##2##(1991-6#1)(2010-4#1)(2010-6#1)
antigenic structure##2##2##(1997-6#1)(2008-4#1)
antigenic variants##2##2##(1991-2#1)(1994-8#1)
antigenic variations##2##2##(1992-8#1)(2007-6#1)
antigenic##119##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-6#1)(1991-9#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-11#2)(1994-8#6)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-6#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#11)(2008-5#12)(2008-8#5)(2008-9#2)(2010-4#3)(2010-6#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#3)
antigenically distinct##4##2##(2008-5#1)(2011-2#3)
antigenically known##2##2##(2008-10#2)
antigenically related##5##2##(1991-3#3)(2008-5#2)
antigenically##21##1##(1991-3#3)(1992-6#2)(1996-1#1)(1996-6#1)(1997-6#2)(2008-10#3)(2008-4#1)(2008-5#4)(2011-2#3)(2013-8#1)
antigenicity and immunogenicity##3##3##(1994-8#1)(1996-12#1)(2012-12#1)
antigenicity and##7##2##(1994-11#1)(1994-8#1)(1996-12#1)(2008-5#1)(2008-8#2)(2012-12#1)
antigenicity of the##2##3##(1997-6#1)(2008-10#1)
antigenicity of##6##2##(1994-9#1)(1997-6#2)(2008-10#1)(2008-8#1)(2009-3#1)
antigenicity was##2##2##(1997-6#1)(2013-8#1)
antigenicity##29##1##(1991-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-12#3)(1997-6#7)(2008-10#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#1)(2012-12#1)(2013-8#2)
antigenotoxic activity##2##2##(2008-11#1)(2013-1#1)
antigenotoxic##4##1##(2008-11#3)(2013-1#1)
antigens after##3##2##(1994-6#1)(2008-11#1)(2010-12#1)
antigens against##2##2##(1993-2#1)(2008-7#1)
antigens and the##6##3##(1990-12#1)(1992-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2013-8#1)
antigens and their##2##3##(1997-7#1)(2011-2#1)
antigens and##20##2##(1990-11#1)(1990-12#3)(1991-3#1)(1992-9#1)(1994-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
antigens are##5##2##(1990-12#2)(2008-4#1)(2011-1#1)(2013-1#1)
antigens as##3##2##(1994-5#1)(1994-9#1)(2008-5#1)
antigens at##2##2##(1992-9#1)(2008-10#1)
antigens by##6##2##(1993-12#1)(1997-8#1)(2008-4#2)(2008-5#1)(2012-2#1)
antigens can##3##2##(2008-4#1)(2008-5#1)(2013-8#1)
antigens during##2##2##(2008-10#1)(2011-2#1)
antigens expressed on##3##3##(1994-9#1)(2010-11#1)(2011-1#1)
antigens failed to##2##3##(1991-6#1)(1995-5#1)
antigens following##2##2##(1992-12#1)(1995-12#1)
antigens for##4##2##(1997-7#1)(2008-5#1)(2008-8#1)(2010-2#1)
antigens from a##2##3##(2008-10#1)(2008-4#1)
antigens from##12##2##(1992-12#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-4#4)
antigens have been##7##3##(1990-6#1)(1995-5#2)(2008-9#2)(2010-6#1)(2012-3#1)
antigens have##8##2##(1990-6#1)(1995-5#2)(2008-10#1)(2008-9#2)(2010-6#1)(2012-3#1)
antigens in a##2##3##(1995-5#1)(2012-12#1)
antigens in the##4##3##(1992-9#1)(1993-11#1)(1994-7#1)(2008-10#1)
antigens in various##2##3##(1992-12#1)(2008-4#1)
antigens in##27##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-2#1)(1994-7#1)(1995-11#1)(1995-5#1)(1997-3#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
antigens including##2##2##(1997-4#1)(2011-2#1)
antigens is##8##2##(1990-12#1)(1991-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#2)(2011-2#1)
antigens may##2##2##(2008-5#1)(2012-3#1)
antigens of the##2##3##(1995-5#1)(2009-5#1)
antigens of##19##2##(1991-5#1)(1992-12#1)(1992-8#2)(1992-9#2)(1994-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#5)(2008-9#1)(2009-5#1)
antigens on##5##2##(1991-2#1)(1992-12#1)(1994-5#1)(2008-11#1)(2010-11#1)
antigens or##3##2##(1995-12#1)(1996-1#1)(1997-4#1)
antigens recognized by the##2##4##(2008-4#1)(2008-5#1)
antigens recognized by##5##3##(2008-4#4)(2008-5#1)
antigens that are expressed##2##4##(2008-2#1)(2011-2#1)
antigens that are##6##3##(1995-6#1)(2008-2#1)(2008-4#3)(2011-2#1)
antigens that##11##2##(1992-9#1)(1994-11#1)(1994-6#1)(1995-6#1)(2008-2#1)(2008-4#4)(2011-2#1)(2012-12#1)
antigens to##6##2##(1990-5#1)(1993-2#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-9#1)
antigens using a##2##3##(2008-4#1)(2008-9#1)
antigens was##4##2##(1990-12#2)(1995-5#1)(2008-11#1)
antigens were seen##2##3##(2010-1#1)(2011-2#1)
antigens were significantly lower##2##4##(2011-2#2)
antigens were##13##2##(1990-12#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#2)(1996-12#1)(2008-10#1)(2010-1#1)(2011-2#4)
antigens when##3##2##(1993-12#1)(1994-5#1)(2008-11#1)
antigens with##3##2##(1990-5#1)(1995-12#1)(2008-4#1)
antigens##344##1##(1990-11#3)(1990-12#20)(1990-5#4)(1990-6#2)(1990-7#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#7)(1992-2#3)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#8)(1993-11#1)(1993-12#9)(1993-2#5)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#5)(1994-2#2)(1994-3#6)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#16)(1995-6#3)(1996-1#1)(1996-12#5)(1997-1#2)(1997-3#2)(1997-4#6)(1997-7#3)(1997-8#3)(1997-9#1)(2006-10#2)(2006-6#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#25)(2008-11#12)(2008-12#1)(2008-2#2)(2008-4#41)(2008-5#16)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#19)(2009-3#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#15)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
antigens'##2##1##(2011-2#2)
antigens)##2##1##(2008-4#1)(2008-9#1)
antigliadin antibodies##3##2##(1990-9#1)(1991-12#1)(2008-10#1)
antiglobulin test##16##2##(1992-3#1)(1992-6#2)(1992-9#2)(1994-12#4)(1994-3#3)(1994-6#1)(1994-9#3)
antiglobulin##19##1##(1992-3#1)(1992-6#2)(1992-9#2)(1994-12#4)(1994-3#4)(1994-6#3)(1994-9#3)
antiguide structure##3##2##(2007-11#3)
antihistamine##5##1##(2008-10#1)(2008-3#1)(2010-5#2)(2013-1#1)
antihistamines##14##1##(1990-3#1)(2007-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#4)(2011-2#1)(2013-8#1)
antihistaminic##4##1##(2008-10#1)(2008-7#2)(2010-4#1)
antihuman##2##1##(1991-2#1)(2011-2#1)
antihyperglycemic activity##2##2##(2012-3#2)
antihyperglycemic##5##1##(1995-11#1)(2012-2#1)(2012-3#3)
antihyperlipidemic therapy##2##2##(1991-8#2)
antihyperlipidemic##10##1##(1990-2#1)(1991-4#1)(1991-8#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
antihypertensive agent in##2##3##(1991-5#1)(2008-1#1)
antihypertensive agent##8##2##(1990-7#1)(1990-8#2)(1991-5#1)(1992-8#1)(2008-1#1)(2008-8#1)(2010-7#1)
antihypertensive agents##9##2##(1992-6#1)(1992-8#3)(1995-2#1)(2008-3#1)(2009-1#1)(2010-4#1)(2011-1#1)
antihypertensive drug##5##2##(1992-5#1)(1997-8#1)(2008-10#3)
antihypertensive drugs and##3##3##(1990-9#1)(2008-3#1)(2012-12#1)
antihypertensive drugs in##3##3##(2008-3#2)(2008-7#1)
antihypertensive drugs##17##2##(1990-9#1)(1992-11#1)(1992-2#1)(1993-2#1)(1996-6#1)(2008-3#6)(2008-7#1)(2008-8#2)(2010-5#1)(2012-12#2)
antihypertensive effect##2##2##(1993-2#1)(2010-4#1)
antihypertensive efficacy##2##2##(2008-3#2)
antihypertensive medication in##2##3##(2008-1#1)(2008-11#1)
antihypertensive medication##5##2##(1992-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-4#1)
antihypertensive medications##6##2##(1992-8#1)(2008-1#2)(2008-11#1)(2008-8#1)(2012-12#1)
antihypertensive therapies##4##2##(2008-3#3)(2012-3#1)
antihypertensive therapy##22##2##(1990-8#1)(1992-8#7)(1996-6#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-8#3)(2010-1#2)(2011-1#2)(2013-8#3)
antihypertensive treatment for##2##3##(2011-1#1)(2013-8#1)
antihypertensive treatment to##2##3##(2008-1#1)(2008-8#1)
antihypertensive treatment##14##2##(1993-2#2)(1994-11#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
antihypertensive##108##1##(1990-7#1)(1990-8#3)(1990-9#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#15)(1993-2#5)(1994-11#1)(1995-12#1)(1995-2#1)(1996-6#2)(1997-5#1)(1997-8#3)(2007-10#1)(2008-1#7)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#12)(2008-7#1)(2008-8#9)(2009-1#1)(2009-9#1)(2010-1#2)(2010-4#5)(2010-5#3)(2010-7#1)(2011-1#5)(2011-2#1)(2012-12#4)(2012-3#2)(2013-8#4)
antihypertensives##4##1##(2008-10#1)(2008-11#2)(2008-8#1)
antiinflammatory activity##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
antiinflammatory agents##4##2##(2007-11#1)(2008-7#2)(2010-5#1)
antiinflammatory drugs (NSAIDs)##3##3##(2008-11#1)(2008-3#2)
antiinflammatory drugs for##2##3##(1990-9#1)(1996-6#1)
antiinflammatory drugs##10##2##(1990-9#1)(1996-6#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-12#1)(2012-2#1)
antiinflammatory properties##2##2##(1993-11#2)
antiinflammatory##25##1##(1990-9#1)(1991-8#1)(1993-11#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2009-12#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-8#1)
antileishmanial##2##1##(2008-10#1)(2009-10#1)
antileukemic##2##1##(2010-11#1)(2011-2#1)
antillarum oscillated between##2##3##(2008-5#1)(2011-2#1)
antillarum##9##1##(2008-5#6)(2011-2#3)
antimalarial activity against##2##3##(2008-10#1)(2009-10#1)
antimalarial control##2##2##(2010-1#2)
antimalarial drug##5##2##(1994-8#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-2#1)
antimalarial drugs##2##2##(1997-5#1)(2007-2#1)
antimalarial treatment##2##2##(2011-2#1)(2012-12#1)
antimalarial##24##1##(1991-8#1)(1994-12#1)(1994-8#1)(1996-8#1)(1997-5#1)(2007-2#1)(2008-10#3)(2009-10#3)(2009-4#1)(2010-1#5)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
antimalarials##4##1##(2006-10#1)(2007-2#1)(2010-2#1)(2012-12#1)
antimesenteric to mesenteric##2##3##(1996-2#2)
antimesenteric##4##1##(1996-2#3)(2010-12#1)
antimetabolite##2##1##(1995-3#1)(2008-7#1)
antimetabolites##2##1##(2008-11#1)(2008-5#1)
antimetastatic effects of##2##3##(1994-12#1)(1997-7#1)
antimetastatic##3##1##(1994-12#2)(1997-7#1)
antimicrobial activities##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2012-2#1)
antimicrobial activity against##5##3##(1994-11#1)(2008-11#1)(2010-2#1)(2010-5#2)
antimicrobial activity of some##2##4##(2007-11#2)
antimicrobial activity of the essential oils of##2##7##(2008-11#1)(2008-5#1)
antimicrobial activity of the##5##4##(2008-11#3)(2008-5#1)(2012-3#1)
antimicrobial activity of##15##3##(2007-11#2)(2008-11#3)(2008-5#4)(2010-5#2)(2012-3#1)(2013-1#3)
antimicrobial activity was##2##3##(2008-10#1)(2013-1#1)
antimicrobial activity##36##2##(1994-11#1)(1994-5#1)(2007-11#2)(2008-10#4)(2008-11#5)(2008-5#4)(2010-2#2)(2010-4#1)(2010-5#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)
antimicrobial agent##2##2##(2008-8#1)(2010-8#1)
antimicrobial agents against##3##3##(1991-8#1)(2008-7#1)(2011-2#1)
antimicrobial agents in##3##3##(1990-6#1)(2006-10#1)(2008-7#1)
antimicrobial agents##31##2##(1990-6#1)(1991-2#2)(1991-8#2)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#9)(2008-9#1)(2011-2#4)(2012-12#1)(2013-1#3)
antimicrobial agents]##2##2##(1990-6#1)(1990-9#1)
antimicrobial and##4##2##(1994-3#1)(2008-11#1)(2012-12#1)(2012-3#1)
antimicrobial clothes##3##2##(2012-3#3)
antimicrobial compounds##3##2##(2008-11#1)(2009-6#1)(2012-2#1)
antimicrobial drug##2##2##(1991-3#1)(2013-1#1)
antimicrobial drugs##2##2##(2007-7#1)(2008-10#1)
antimicrobial effect##4##2##(2008-5#4)
antimicrobial evaluation of##4##3##(2007-11#1)(2012-3#3)
antimicrobial evaluation##5##2##(2007-11#2)(2012-3#3)
antimicrobial peptide##5##2##(1994-5#2)(2011-2#3)
antimicrobial peptides##7##2##(1993-3#2)(1994-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
antimicrobial products##2##2##(2008-10#1)(2008-12#1)
antimicrobial properties of##2##3##(2010-4#1)(2013-1#1)
antimicrobial properties##3##2##(2010-4#1)(2013-1#2)
antimicrobial protein##2##2##(2008-9#1)(2013-8#1)
antimicrobial resistance and##3##3##(2011-2#2)(2013-1#1)
antimicrobial resistance in bacteria##5##4##(2010-4#4)(2013-8#1)
antimicrobial resistance is##2##3##(1997-3#1)(2007-7#1)
antimicrobial resistance patterns of##3##4##(1991-8#1)(2007-7#1)(2013-8#1)
antimicrobial resistance patterns##4##3##(1991-8#1)(2007-7#1)(2012-2#1)(2013-8#1)
antimicrobial resistance##25##2##(1991-8#1)(1996-11#1)(1997-3#1)(2007-12#1)(2007-7#4)(2009-5#1)(2010-4#5)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
antimicrobial sensitivity##4##2##(2007-7#3)(2008-12#1)
antimicrobial spectrum##2##2##(2010-2#1)(2011-2#1)
antimicrobial stewardship in##2##3##(2013-1#2)
antimicrobial stewardship programs##4##3##(2013-1#4)
antimicrobial stewardship##13##2##(2013-1#13)
antimicrobial substances##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
antimicrobial susceptibility of##2##3##(2008-9#1)(2011-2#1)
antimicrobial susceptibility testing data##3##4##(2013-1#3)
antimicrobial susceptibility##8##2##(2007-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#4)
antimicrobial therapy and##2##3##(2007-11#1)(2013-8#1)
antimicrobial therapy in##3##3##(2010-6#1)(2011-2#2)
antimicrobial therapy is##3##3##(2008-10#1)(2009-4#1)(2011-2#1)
antimicrobial therapy##24##2##(1992-7#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#8)(2012-3#1)(2013-1#1)(2013-8#2)
antimicrobial treatment should be##2##4##(2008-10#2)
antimicrobial treatment##3##2##(1997-3#1)(2008-10#2)
antimicrobial treatments##5##2##(1991-3#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
antimicrobial##261##1##(1990-6#3)(1990-9#1)(1991-2#2)(1991-3#2)(1991-8#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#3)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#3)(2006-10#1)(2006-12#1)(2007-11#7)(2007-12#9)(2007-7#13)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#10)(2008-12#3)(2008-5#15)(2008-7#11)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#2)(2010-2#3)(2010-4#10)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#26)(2012-12#7)(2012-2#5)(2012-3#18)(2013-1#38)(2013-8#7)
antimicrobial-based deodorant##2##2##(2008-5#2)
antimicrobial-resistant##2##1##(2011-2#1)(2013-1#1)
antimicrobials in##3##2##(2010-4#3)
antimicrobials used in##2##3##(2008-5#1)(2010-4#1)
antimicrobials was##2##2##(1990-6#2)
antimicrobials with##2##2##(1990-6#1)(2008-12#1)
antimicrobials##23##1##(1990-6#4)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2010-4#5)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
antimitotic agent##2##2##(1993-1#1)(1997-2#1)
antimitotic##3##1##(1993-1#1)(1997-2#1)(2008-11#1)
antimonial##3##1##(2007-7#2)(2008-10#1)
antimonials##2##1##(1990-7#1)(2008-10#1)
antimonide##2##1##(2008-2#1)(2008-3#1)
antimony and##6##2##(2008-10#6)
antimony by##7##2##(2008-10#7)
antimony content##2##2##(2008-10#2)
antimony determination##3##2##(2008-10#3)
antimony in##19##2##(2008-10#19)
antimony is##2##2##(2008-10#1)(2008-3#1)
antimony##62##1##(2007-7#1)(2008-10#58)(2008-3#1)(2010-5#1)(2012-12#1)
antimony(III)##11##1##(2008-10#11)
antimony(III)-pyrogallol complex##2##2##(2008-10#2)
antimony(V)##4##1##(2008-10#4)
antimouse##2##1##(2008-10#1)(2008-11#1)
antimutagenic and anticarcinogenic##3##3##(1991-9#1)(1993-11#1)(2008-4#1)
antimutagenic##10##1##(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#1)(2008-4#2)(2008-7#4)
antimycin A and##2##3##(1995-11#1)(2010-12#1)
antimycin A##6##2##(1990-2#1)(1992-11#2)(1995-11#1)(2010-12#2)
antimycin A-induced cardiomyocytes apoptosis##2##4##(2010-12#2)
antimycin##8##1##(1990-2#1)(1992-11#2)(1995-11#1)(2010-12#4)
antimycotic##6##1##(2008-1#1)(2008-5#3)(2011-2#2)
antimycotics##3##1##(2008-5#1)(2008-8#2)
antinatriuretic##2##1##(1991-3#1)(1997-7#1)
antineoplastic agents and##2##3##(1994-5#1)(2013-7#1)
antineoplastic agents##5##2##(1990-2#1)(1994-5#1)(2008-3#1)(2011-2#1)(2013-7#1)
antineoplastic drug##2##2##(2007-11#1)(2010-8#1)
antineoplastic drugs and##2##3##(2007-11#2)
antineoplastic drugs##8##2##(2007-11#5)(2013-1#3)
antineoplastic therapy##2##2##(1994-7#1)(2012-3#1)
antineoplastic##29##1##(1990-10#1)(1990-2#3)(1991-6#1)(1994-5#1)(1994-7#1)(1995-3#1)(1996-5#1)(2007-11#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
antineutrophil cytoplasmic##2##2##(1992-2#1)(2006-10#1)
antineutrophil##3##1##(1992-2#1)(2006-10#1)(2008-6#1)
antinociception and respiratory depression##2##4##(1996-2#2)
antinociception and##6##2##(1991-1#1)(1996-2#3)(1997-2#2)
antinociception in##3##2##(1991-1#2)(1997-2#1)
antinociception##19##1##(1991-1#5)(1993-1#1)(1996-2#7)(1997-2#5)(2008-3#1)
antinociceptive action##2##2##(1992-3#1)(2011-2#1)
antinociceptive and anti-inflammatory activity##2##4##(2011-1#2)
antinociceptive and##6##2##(1996-2#2)(2008-11#1)(2008-7#1)(2011-1#2)
antinociceptive effect of##5##3##(1995-12#1)(1996-2#2)(2008-11#2)
antinociceptive effect##7##2##(1995-12#1)(1996-2#3)(2008-11#2)(2010-5#1)
antinociceptive effects##4##2##(1992-3#1)(2010-5#3)
antinociceptive##23##1##(1992-3#2)(1992-8#2)(1993-5#1)(1995-12#1)(1996-2#5)(2008-11#3)(2008-7#1)(2010-5#4)(2011-1#3)(2011-2#1)
antinuclear antibodies (ANA)##3##3##(1991-2#1)(2008-10#2)
antinuclear antibodies##6##2##(1991-2#2)(1995-11#1)(2008-10#2)(2012-3#1)
antinuclear antibody (ANA)##2##3##(2013-1#2)
antinuclear antibody##3##2##(2012-2#1)(2013-1#2)
antinuclear##10##1##(1991-2#2)(1995-11#1)(2006-10#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#2)
antinutrient substances##2##2##(2010-2#2)
antinutrient##3##1##(2010-2#3)
antiobesity effect of Safoof Mohazzil##2##5##(2013-1#2)
antiobesity##3##1##(2013-1#3)
antiopiates##3##1##(1991-1#3)
antioxidant abilities##2##2##(2009-8#2)
antioxidant activities of the##2##4##(2013-1#2)
antioxidant activities of##5##3##(2007-11#1)(2008-10#2)(2013-1#2)
antioxidant activities##11##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
antioxidant activity and##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
antioxidant activity in the##2##4##(2008-10#1)(2013-1#1)
antioxidant activity in##11##3##(1995-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
antioxidant activity of milk from##2##5##(2013-1#2)
antioxidant activity of pure compounds##2##5##(2008-10#2)
antioxidant activity of##16##3##(1992-9#1)(1994-9#1)(2008-10#10)(2009-6#1)(2012-2#1)(2013-1#2)
antioxidant activity than##4##3##(2008-10#1)(2013-8#3)
antioxidant activity were##2##3##(2008-10#1)(2009-3#1)
antioxidant activity##62##2##(1991-2#1)(1991-9#2)(1992-9#1)(1994-9#2)(1995-12#1)(1996-9#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#6)(2013-8#5)
antioxidant agent##2##2##(2011-2#1)(2012-12#1)
antioxidant and anti-inflammatory##2##3##(2009-12#1)(2009-6#1)
antioxidant and free radical##2##4##(2008-10#1)(2008-12#1)
antioxidant and nutritional##2##3##(2011-2#2)
antioxidant and##20##2##(1995-6#2)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#2)
antioxidant capacities##3##2##(2008-7#2)(2013-1#1)
antioxidant capacity and##2##3##(2008-10#1)(2012-2#1)
antioxidant capacity determination##2##3##(2008-10#2)
antioxidant capacity in##3##3##(2008-10#2)(2008-7#1)
antioxidant capacity of the##2##4##(2009-8#1)(2012-1#1)
antioxidant capacity of##8##3##(2008-10#5)(2009-6#1)(2009-8#1)(2012-1#1)
antioxidant capacity##27##2##(2008-10#18)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-1#2)(2012-2#1)
antioxidant compounds##4##2##(2008-11#1)(2008-5#2)(2010-5#1)
antioxidant defence##4##2##(2009-6#1)(2011-1#1)(2012-12#1)(2012-6#1)
antioxidant defense in##2##3##(1996-9#1)(2012-2#1)
antioxidant defense system in##3##4##(1994-6#1)(2008-10#1)(2013-1#1)
antioxidant defense system##6##3##(1994-6#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)
antioxidant defense##15##2##(1994-6#1)(1996-9#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
antioxidant defenses and##2##3##(1993-2#1)(2012-2#1)
antioxidant defenses##3##2##(1991-9#1)(1993-2#1)(2012-2#1)
antioxidant effect in##2##3##(2011-2#2)
antioxidant effect of##3##3##(1995-12#1)(1996-9#1)(2008-10#1)
antioxidant effect##9##2##(1994-9#1)(1995-12#1)(1996-9#2)(2008-10#2)(2011-2#3)
antioxidant enzyme activities##2##3##(1991-12#1)(1994-6#1)
antioxidant enzyme##7##2##(1991-12#1)(1994-6#1)(1996-9#1)(2008-10#1)(2011-2#1)(2012-6#1)(2013-8#1)
antioxidant enzymes (SOD##2##3##(2008-5#1)(2013-8#1)
antioxidant enzymes in##3##3##(1990-3#1)(1996-9#1)(2011-1#1)
antioxidant enzymes##20##2##(1990-3#1)(1994-6#1)(1996-9#1)(2008-5#2)(2008-7#3)(2009-12#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
antioxidant functions##2##2##(1992-9#2)
antioxidant genes##2##2##(2008-7#1)(2011-2#1)
antioxidant glutathione##2##2##(1992-3#1)(2013-1#1)
antioxidant in##3##2##(1994-2#1)(2008-10#2)
antioxidant is##3##2##(1991-9#1)(2009-12#2)
antioxidant models of screening like scavenging of 1##2##8##(2010-5#1)(2011-1#1)
antioxidant network##4##2##(2008-2#4)
antioxidant potential of##2##3##(2008-10#2)
antioxidant potential##6##2##(2008-10#5)(2012-2#1)
antioxidant power##3##2##(2008-5#1)(2012-2#2)
antioxidant properties of##11##3##(1994-8#1)(1995-5#1)(2008-10#5)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
antioxidant properties##16##2##(1994-8#1)(1994-9#1)(1995-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
antioxidant property##4##2##(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
antioxidant response element##2##3##(2008-7#2)
antioxidant status in hypercholesteremic##2##4##(2008-10#2)
antioxidant status in##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
antioxidant status is##2##3##(1991-12#1)(2008-12#1)
antioxidant status of##2##3##(1991-9#1)(2008-12#1)
antioxidant status##11##2##(1991-12#1)(1991-9#1)(2008-10#3)(2008-12#3)(2008-7#1)(2009-8#1)(2009-9#1)
antioxidant substances##2##2##(1992-9#1)(2008-10#1)
antioxidant supplementation##4##2##(2008-1#2)(2009-8#2)
antioxidant system in##2##3##(2008-7#1)(2010-5#1)
antioxidant system##8##2##(1991-9#1)(2008-1#1)(2008-7#2)(2010-5#1)(2012-6#1)(2013-1#2)
antioxidant systems##2##2##(2008-10#1)(2008-5#1)
antioxidant therapy##3##2##(1991-9#2)(2011-1#1)
antioxidant treatment##2##2##(2008-10#1)(2008-5#1)
antioxidant values##2##2##(2008-11#2)
antioxidant vitamins on##2##3##(1992-9#1)(2008-5#1)
antioxidant vitamins##5##2##(1992-9#3)(2008-12#1)(2008-5#1)
antioxidant##370##1##(1990-3#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#10)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#9)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#4)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#8)(2006-10#1)(2007-11#1)(2008-1#4)(2008-10#92)(2008-11#13)(2008-12#9)(2008-2#7)(2008-5#23)(2008-7#29)(2008-8#1)(2009-12#10)(2009-3#3)(2009-6#7)(2009-8#9)(2009-9#2)(2010-4#2)(2010-5#10)(2010-7#2)(2011-1#12)(2011-2#16)(2012-1#2)(2012-12#2)(2012-2#13)(2012-3#1)(2012-6#3)(2013-1#24)(2013-7#1)(2013-8#12)
antioxidant/radical scavenger activity##2##3##(2008-5#2)
antioxidants 3-tert-butyl-4-hydroxyanisole##2##2##(2008-10#2)
antioxidants activities##2##2##(2009-12#1)(2013-1#1)
antioxidants and##16##2##(1992-9#1)(1994-6#1)(1996-9#2)(2008-10#4)(2008-2#1)(2008-5#3)(2011-1#1)(2011-2#2)(2013-1#1)
antioxidants are##3##2##(2008-5#1)(2013-8#2)
antioxidants at##2##2##(2008-10#1)(2008-5#1)
antioxidants by##3##2##(2008-10#2)(2008-5#1)
antioxidants can be##2##3##(1992-12#1)(2008-10#1)
antioxidants can##3##2##(1992-12#1)(2008-10#2)
antioxidants from##4##2##(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
antioxidants has been##2##3##(1993-2#1)(2008-5#1)
antioxidants has##3##2##(1993-2#1)(2008-5#1)(2009-6#1)
antioxidants have##2##2##(1991-9#1)(1993-2#1)
antioxidants in complex matrices##2##4##(2008-10#2)
antioxidants in##14##2##(1992-11#2)(1996-9#1)(2008-10#5)(2008-5#1)(2010-5#1)(2011-2#3)(2013-8#1)
antioxidants is##3##2##(1991-9#1)(1992-9#1)(2008-5#1)
antioxidants on##3##2##(1992-5#1)(1992-9#1)(2008-10#1)
antioxidants such as##6##3##(1991-9#1)(1993-2#1)(2008-11#1)(2008-5#2)(2013-1#1)
antioxidants that may##2##3##(2008-5#1)(2011-2#1)
antioxidants that##5##2##(1991-9#1)(1992-9#1)(2008-5#1)(2009-8#1)(2011-2#1)
antioxidants to##3##2##(1992-9#1)(2008-5#1)(2013-8#1)
antioxidants was##2##2##(2008-10#1)(2009-3#1)
antioxidants were##5##2##(1995-6#1)(2008-4#1)(2009-12#1)(2011-2#1)(2013-8#1)
antioxidants which##3##2##(1992-12#1)(2008-10#1)(2008-5#1)
antioxidants within##2##2##(1991-9#1)(2008-10#1)
antioxidants##149##1##(1991-2#1)(1991-9#9)(1992-11#3)(1992-12#2)(1992-5#3)(1992-9#6)(1993-2#4)(1994-6#3)(1994-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-9#3)(1997-4#1)(2008-1#1)(2008-10#37)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#23)(2008-7#4)(2009-12#2)(2009-3#1)(2009-6#2)(2009-8#2)(2010-5#3)(2011-1#1)(2011-2#10)(2012-1#3)(2013-1#6)(2013-8#7)
antioxidative action##2##2##(2008-11#1)(2009-8#1)
antioxidative activities##2##2##(2008-10#1)(2013-1#1)
antioxidative activity of calcium antagonists##2##5##(1994-9#2)
antioxidative activity of##5##3##(1994-9#2)(2008-10#2)(2008-5#1)
antioxidative activity##6##2##(1994-9#2)(2008-10#2)(2008-5#1)(2013-7#1)
antioxidative and antiapoptotic##2##3##(2008-7#1)(2013-7#1)
antioxidative and##3##2##(1994-6#1)(2008-7#1)(2013-7#1)
antioxidative defense##2##2##(2008-12#1)(2009-8#1)
antioxidative enzyme##2##2##(1991-12#1)(2013-7#1)
antioxidative enzymes##2##2##(1991-12#1)(2008-10#1)
antioxidative potential##3##2##(2008-11#2)(2008-5#1)
antioxidative properties##2##2##(2008-5#1)(2009-8#1)
antioxidative property##3##2##(2008-11#3)
antioxidative##31##1##(1991-12#2)(1994-6#2)(1994-9#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#4)(2008-7#1)(2009-8#3)(2011-2#1)(2013-1#2)(2013-7#3)
antiparallel beta-sheet##2##2##(1993-11#1)(2008-9#1)
antiparallel##9##1##(1990-5#1)(1992-4#1)(1993-11#1)(1993-8#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-9#1)(2011-2#1)
antiparasitic drug##2##2##(1996-2#1)(1997-7#1)
antiparasitic drugs##2##2##(1997-7#2)
antiparasitic##5##1##(1996-12#1)(1996-2#1)(1997-7#3)
antiparkinson##2##1##(2008-7#2)
antiparkinsonian##6##1##(1993-11#1)(1997-2#2)(2008-7#1)(2011-2#1)(2012-12#1)
antipeptide antibody##2##2##(1995-5#1)(1995-6#1)
antiperspirancy##2##1##(2008-5#2)
antiperspirant (AP)##2##2##(2008-5#2)
antiperspirant salts##2##2##(2008-5#2)
antiperspirant##15##1##(2008-5#15)
antiperspirants##4##1##(2008-5#4)
antiphase##4##1##(1990-11#1)(2007-12#1)(2008-3#2)
antiphospholipid antibodies##11##2##(1992-5#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-7#4)(2010-6#1)(2011-1#1)
antiphospholipid antibody##2##2##(2007-11#1)(2012-12#1)
antiphospholipid syndrome##11##2##(1997-8#1)(2006-10#6)(2008-8#1)(2012-3#2)(2013-1#1)
antiphospholipid##28##1##(1992-5#1)(1997-8#1)(2006-10#8)(2007-10#1)(2007-11#1)(2007-9#1)(2008-7#5)(2008-8#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#3)
antiplasmodial activity##2##2##(2008-10#2)
antiplasmodial##3##1##(2008-10#3)
antiplatelet agent##2##2##(2008-5#1)(2008-8#1)
antiplatelet agents and##3##3##(2007-8#1)(2008-8#2)
antiplatelet agents##11##2##(1993-9#1)(2007-8#1)(2008-11#1)(2008-8#4)(2011-1#1)(2011-2#1)(2013-8#2)
antiplatelet and##2##2##(2008-3#2)
antiplatelet drug##2##2##(1990-12#1)(2008-8#1)
antiplatelet drugs##6##2##(1990-11#1)(2007-8#1)(2008-5#1)(2008-8#3)
antiplatelet therapies##6##2##(2006-7#2)(2009-5#2)(2011-2#1)(2012-3#1)
antiplatelet therapy after drug-eluting stents##4##5##(2009-12#4)
antiplatelet therapy after##5##3##(2008-11#1)(2009-12#4)
antiplatelet therapy and##2##3##(2011-2#2)
antiplatelet therapy in infective##2##4##(2011-2#2)
antiplatelet therapy in##5##3##(2008-8#1)(2011-2#4)
antiplatelet therapy##19##2##(2006-7#1)(2008-11#1)(2008-3#2)(2008-8#4)(2009-12#4)(2011-2#7)
antiplatelet treatment##2##2##(2007-8#1)(2008-8#1)
antiplatelet##56##1##(1990-11#1)(1990-12#1)(1991-11#1)(1993-6#1)(1993-9#1)(2006-7#3)(2007-8#3)(2008-11#3)(2008-3#4)(2008-5#2)(2008-8#14)(2009-12#4)(2009-5#2)(2011-1#1)(2011-2#12)(2012-3#1)(2013-8#2)
antiport activity##4##2##(1990-2#2)(1992-5#2)
antiport##11##1##(1990-2#3)(1992-10#2)(1992-5#5)(2008-6#1)
antiporter of##2##2##(1992-5#2)
antiporter##5##1##(1992-10#1)(1992-5#3)(2008-11#1)
antipredator##3##1##(2008-9#1)(2010-8#2)
antiproliferative action of##2##3##(1990-2#1)(1990-6#1)
antiproliferative actions##2##2##(1995-2#1)(2008-4#1)
antiproliferative activity in##2##3##(2008-4#1)(2010-11#1)
antiproliferative activity of##2##3##(1991-4#1)(1997-1#1)
antiproliferative activity##9##2##(1990-12#1)(1991-4#1)(1995-3#1)(1997-1#2)(2008-4#1)(2008-8#1)(2010-11#1)(2013-1#1)
antiproliferative agent and##2##3##(1997-1#1)(2011-3#1)
antiproliferative and immunomodulating##2##3##(1995-12#1)(1997-5#1)
antiproliferative and##3##2##(1995-12#1)(1997-5#1)(2007-11#1)
antiproliferative effect##8##2##(1990-11#2)(1990-12#1)(1995-2#2)(1997-1#2)(2013-1#1)
antiproliferative effects of LHRH##2##4##(2008-4#2)
antiproliferative effects of##4##3##(1992-5#1)(2008-4#2)(2012-3#1)
antiproliferative effects##6##2##(1992-5#1)(1994-11#1)(2008-10#1)(2008-4#2)(2012-3#1)
antiproliferative properties##3##2##(1992-5#1)(1995-2#1)(2013-1#1)
antiproliferative##42##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-6#1)(1991-4#1)(1992-5#2)(1992-8#1)(1994-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1997-1#5)(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-8#1)(2010-11#1)(2011-3#1)(2012-3#2)(2013-1#3)
antipsychotic activity##4##2##(1995-2#1)(1995-3#1)(1996-7#1)(2011-1#1)
antipsychotic agents##6##2##(1992-12#3)(2008-4#1)(2008-7#1)(2008-8#1)
antipsychotic drug##5##2##(1995-2#1)(1997-7#1)(2008-3#1)(2008-4#1)(2011-10#1)
antipsychotic drugs##8##2##(1992-6#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2011-2#1)
antipsychotic medication##5##2##(2008-6#2)(2009-7#1)(2012-2#1)(2013-8#1)
antipsychotic medications##3##2##(2008-6#2)(2009-6#1)
antipsychotic profile##3##2##(1995-3#1)(2008-6#2)
antipsychotic treatment##2##2##(2010-1#2)
antipsychotic##52##1##(1992-12#3)(1992-6#1)(1993-9#1)(1995-2#3)(1995-3#3)(1996-7#1)(1997-7#1)(2008-11#3)(2008-3#3)(2008-4#2)(2008-6#11)(2008-7#3)(2008-8#2)(2009-6#1)(2009-7#1)(2010-1#4)(2010-2#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
antipsychotic-like##3##1##(1995-3#1)(2008-6#2)
antipsychotics are##2##2##(2012-2#1)(2013-8#1)
antipsychotics##19##1##(1996-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#2)
antipyretic##2##1##(2008-10#2)
antipyretica##3##1##(2008-11#3)
antipyrine##2##1##(2008-10#2)
antiquity##6##1##(1990-6#1)(1991-11#1)(1996-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
antiradical activity##2##2##(2008-11#2)
antiradical##4##1##(2008-11#3)(2008-5#1)
antireflection (AR) coatings##2##3##(2008-2#2)
antireflection coated##2##2##(2008-3#2)
antireflection coating and##2##3##(2008-2#1)(2008-3#1)
antireflection coating##5##2##(2008-2#2)(2008-3#3)
antireflection coatings for the##2##4##(2008-2#1)(2008-3#1)
antireflection coatings for##3##3##(2008-2#2)(2008-3#1)
antireflection coatings##5##2##(2008-2#2)(2008-3#3)
antireflection##18##1##(2007-12#1)(2008-2#7)(2008-3#10)
antireflection-coated##7##1##(2007-12#3)(2008-2#1)(2008-3#3)
antireflective##5##1##(2008-3#5)
antireflux procedure##2##2##(1992-9#2)
antireflux##6##1##(1992-9#2)(2007-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
antirescue effect##3##2##(2008-8#3)
antiresonant reflecting optical waveguide##2##4##(2007-11#1)(2007-12#1)
antiresonant reflecting waveguides##2##3##(2007-11#1)(2007-12#1)
antiresonant reflecting##5##2##(2007-11#3)(2007-12#2)
antiresorptive agents##2##2##(1993-11#1)(2010-4#1)
antiresorptive##6##1##(1993-11#2)(1997-7#1)(2008-8#2)(2010-4#1)
antiretroviral agents##3##2##(1990-8#1)(2008-8#1)(2011-3#1)
antiretroviral drug therapy in##2##4##(2009-7#2)
antiretroviral drug##8##2##(2008-11#5)(2009-7#2)(2011-1#1)
antiretroviral drugs are##2##3##(2007-7#2)
antiretroviral drugs##9##2##(2007-7#2)(2009-4#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
antiretroviral therapies##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
antiretroviral therapy (ART) for##2##4##(2008-6#1)(2011-2#1)
antiretroviral therapy (ART) in##2##4##(2012-12#2)
antiretroviral therapy (ART)##5##3##(2008-6#1)(2011-2#2)(2012-12#2)
antiretroviral therapy and##2##3##(2010-8#1)(2012-2#1)
antiretroviral therapy in##8##3##(2008-8#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-8#1)(2012-12#1)
antiretroviral therapy is##2##3##(2007-12#1)(2010-8#1)
antiretroviral therapy##46##2##(2006-10#2)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)
antiretroviral treatment (ART)##2##3##(2009-10#1)(2010-4#1)
antiretroviral treatment##4##2##(2009-10#1)(2009-4#1)(2010-4#1)(2012-12#1)
antiretroviral##85##1##(1990-8#1)(1992-6#2)(2006-10#2)(2007-12#3)(2007-7#5)(2008-1#1)(2008-10#2)(2008-11#6)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#6)(2009-5#2)(2009-7#6)(2009-8#2)(2010-11#3)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#6)(2011-3#3)(2012-12#6)(2012-2#3)(2013-1#1)
antiretrovirals##4##1##(2007-7#2)(2011-2#1)(2013-8#1)
antirheumatic drugs (DMARDs)##3##3##(1990-6#1)(2010-5#1)(2012-3#1)
antirheumatic drugs##9##2##(1990-6#1)(1991-8#1)(2006-10#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
antirheumatic##13##1##(1990-6#2)(1991-8#1)(1995-3#1)(1997-2#1)(2006-10#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#2)
antisense EDRF1##3##2##(2008-8#1)(2008-9#2)
antisense PDS##2##2##(1995-2#2)
antisense RNA transcript##4##3##(1992-8#2)(1994-11#1)(1995-2#1)
antisense RNA was##2##3##(1992-12#1)(2008-10#1)
antisense RNA##21##2##(1991-9#6)(1992-12#2)(1992-8#3)(1994-11#2)(1995-2#1)(1997-6#1)(2008-10#1)(2008-8#4)(2011-1#1)
antisense RNAs##3##2##(1991-9#1)(2008-8#2)
antisense c-jun##2##2##(2008-11#2)
antisense expression plasmid##2##3##(2008-9#2)
antisense expression##4##2##(1994-11#1)(2008-8#1)(2008-9#2)
antisense oligodeoxynucleotide##4##2##(1993-6#1)(1995-12#1)(2008-11#1)(2011-2#1)
antisense oligodeoxynucleotides to##2##3##(1995-11#1)(2008-11#1)
antisense oligodeoxynucleotides##7##2##(1992-6#2)(1993-6#1)(1995-11#1)(1996-7#1)(2008-11#1)(2011-2#1)
antisense oligonucleotide##8##2##(1995-11#2)(1996-7#1)(2008-11#4)(2008-4#1)
antisense oligonucleotides##8##2##(1991-9#1)(1994-12#1)(1995-2#3)(2008-11#1)(2008-6#1)(2011-2#1)
antisense or##2##2##(1997-6#1)(2011-2#1)
antisense orientation##2##2##(1994-10#1)(2008-10#1)
antisense peptides##2##2##(2008-1#2)
antisense technology##2##2##(2008-11#1)(2008-5#1)
antisense transcript##4##2##(1992-8#1)(1994-11#1)(1995-2#1)(2011-2#1)
antisense transcription##3##2##(1992-8#1)(2008-7#1)(2012-3#1)
antisense transcripts##2##2##(2008-7#2)
antisense transgenic##2##2##(1996-12#2)
antisense##128##1##(1991-2#1)(1991-9#8)(1992-12#4)(1992-6#3)(1992-8#8)(1993-3#3)(1993-6#2)(1994-10#2)(1994-11#5)(1994-12#1)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#7)(1995-9#1)(1996-12#4)(1996-2#1)(1996-7#2)(1996-9#1)(1997-6#2)(1997-7#1)(2008-1#3)(2008-10#10)(2008-11#12)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#13)(2008-9#6)(2009-10#1)(2011-1#1)(2011-2#8)(2012-3#1)
antisense-TGFbeta##2##1##(2008-11#2)
antisense-TNFalpha##2##1##(2008-11#2)
antisenseabp transgenic tobacco protoplasts##2##4##(2008-8#2)
antisenseabp transgenic tobacco##3##3##(2008-8#3)
antiseptic agents have##2##3##(2007-12#2)
antiseptic and##2##2##(2012-12#1)(2012-2#1)
antiseptic##9##1##(2007-11#1)(2007-12#2)(2008-10#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
antiseptics##2##1##(2007-12#1)(2013-7#1)
antisera against the##2##3##(2008-10#2)
antisera against##8##2##(1990-8#1)(1991-12#1)(1991-6#1)(1994-6#1)(1996-12#1)(2008-10#3)
antisera directed against##2##3##(1990-8#1)(1994-6#1)
antisera for##3##2##(1995-8#1)(1997-4#1)(2008-10#1)
antisera generated against##2##3##(1994-6#1)(2008-5#1)
antisera in##5##2##(1996-5#1)(2008-10#4)
antisera raised##3##2##(1990-5#1)(1992-9#1)(2008-10#1)
antisera recognized##2##2##(1990-5#1)(2008-10#1)
antisera showed##2##2##(1995-8#1)(1997-6#1)
antisera to CIPs of##2##4##(2008-10#2)
antisera to##9##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-9#1)(2008-10#5)
antisera were##2##2##(2008-10#1)(2008-5#1)
antisera##73##1##(1990-5#4)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#3)(1991-6#1)(1992-3#3)(1992-9#3)(1993-9#1)(1994-3#1)(1994-6#4)(1994-8#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-5#1)(1997-4#1)(1997-6#3)(2008-10#27)(2008-4#2)(2008-5#4)(2010-6#1)
antiserum against##6##2##(1993-11#1)(1993-12#1)(1993-3#1)(1997-1#1)(2008-10#2)
antiserum and##3##2##(2008-10#2)(2008-4#1)
antiserum and/or##3##2##(2008-4#2)(2008-5#1)
antiserum in##2##2##(1992-9#1)(2008-10#1)
antiserum raised against the##4##4##(1996-2#1)(1997-4#1)(2008-10#2)
antiserum raised against##8##3##(1993-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#4)
antiserum raised##9##2##(1993-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#5)
antiserum showed##3##2##(1992-9#1)(2008-10#2)
antiserum specific##2##2##(1991-8#1)(1997-6#1)
antiserum that##3##2##(1994-12#1)(2008-10#2)
antiserum to a##2##3##(1991-9#1)(2008-10#1)
antiserum to##11##2##(1990-11#1)(1991-1#3)(1991-9#1)(1994-2#1)(2008-10#5)
antiserum was raised##2##3##(1994-8#1)(2008-8#1)
antiserum was##3##2##(1994-8#1)(2008-10#1)(2008-8#1)
antiserum were identified as##2##4##(2008-10#2)
antiserum were##3##2##(2008-10#2)(2008-5#1)
antiserum##80##1##(1990-11#4)(1990-5#1)(1991-1#3)(1991-8#1)(1991-9#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-12#2)(2008-10#33)(2008-11#3)(2008-4#4)(2008-5#4)(2008-8#1)(2012-3#1)
antishivering regimen##2##2##(2007-10#2)
antisocial and##2##2##(2008-11#1)(2009-5#1)
antisocial behavior##10##2##(1994-2#1)(2008-11#4)(2009-5#1)(2010-4#1)(2012-12#1)(2013-7#2)
antisocial behaviour##2##2##(2013-8#2)
antisocial personality and##3##3##(1994-2#3)
antisocial personality disorder##4##3##(1991-1#1)(1994-2#2)(2011-2#1)
antisocial personality##8##2##(1991-1#1)(1994-2#5)(2011-2#2)
antisocial##27##1##(1991-1#1)(1994-2#7)(2007-9#1)(2008-11#8)(2009-5#2)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#2)(2013-8#2)
antisolar agent##2##2##(2008-5#2)
antisolar##4##1##(2008-2#1)(2008-5#3)
antisperm monoclonal antibody 6B10##2##4##(2008-8#2)
antistaling##2##1##(2010-7#2)
antistress##2##1##(1994-6#1)(2010-5#1)
antisymmetric stretching##2##2##(2008-10#2)
antisymmetric##7##1##(1995-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
antitank mine##2##2##(2008-10#2)
antitheses in##2##2##(2009-10#1)(2012-2#1)
antithrombin III##12##2##(1990-5#1)(1992-10#1)(1995-2#7)(2008-7#3)
antithrombin agents##2##2##(2008-3#1)(2009-5#1)
antithrombin##21##1##(1990-5#1)(1992-10#2)(1995-2#7)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-5#1)(2010-11#2)(2010-3#2)
antithromboembolic##2##1##(2008-7#1)(2010-8#1)
antithrombotic activity in vivo##2##4##(1997-7#1)(2006-6#1)
antithrombotic activity##6##2##(1997-7#1)(2006-6#5)
antithrombotic agent##4##2##(1991-9#1)(1994-6#2)(2008-5#1)
antithrombotic drugs##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
antithrombotic prophylaxis##2##2##(1992-9#1)(2007-11#1)
antithrombotic##21##1##(1991-9#1)(1992-9#1)(1994-6#2)(1997-2#1)(1997-7#1)(2006-6#6)(2007-11#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
antithrombotics##2##1##(2007-10#1)(2008-8#1)
antithymocyte globulin##2##2##(2007-7#1)(2012-12#1)
antithyroid autoantibodies##2##2##(2008-6#2)
antithyroid drugs##3##2##(2008-10#2)(2012-3#1)
antithyroid##5##1##(2008-10#2)(2008-6#2)(2012-3#1)
antitopoisomerase 1 antibodies##3##3##(2009-8#3)
antitopoisomerase 1##5##2##(2009-8#5)
antitopoisomerase##7##1##(2008-11#2)(2009-8#5)
antitoxin##5##1##(1996-11#1)(1996-8#1)(2008-10#3)
antitrust laws##5##2##(1992-12#1)(1993-1#2)(1994-2#1)(1995-12#1)
antitrust liability##4##2##(1992-3#2)(1993-1#2)
antitrust problems##2##2##(1993-1#2)
antitrust risk##3##2##(1992-12#2)(1993-12#1)
antitrust##29##1##(1991-1#2)(1991-9#1)(1992-12#3)(1992-3#2)(1993-1#8)(1993-12#1)(1994-1#1)(1994-2#3)(1994-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
antitrypsin Pittsburgh##3##2##(1993-2#3)
antitrypsin##8##1##(1993-2#4)(1993-6#2)(1997-3#1)(2008-12#1)
antitubercular drugs in##2##3##(1997-8#1)(2008-10#1)
antitubercular drugs##3##2##(1997-8#1)(2008-10#2)
antitubercular##8##1##(1997-8#1)(2008-10#2)(2008-7#2)(2012-12#2)(2012-3#1)
antituberculosis##3##1##(2008-5#1)(2008-7#1)(2008-9#1)
antituberculous drugs##2##2##(2008-8#2)
antituberculous regimen##2##2##(2007-8#1)(2008-11#1)
antituberculous therapy##4##2##(1996-3#1)(2007-12#1)(2008-1#1)(2011-2#1)
antituberculous##12##1##(1991-6#1)(1996-3#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-8#1)(2011-2#1)
antitumor action##2##2##(2008-10#2)
antitumor activities##2##2##(2008-5#1)(2012-3#1)
antitumor activity in##3##3##(1990-2#1)(2008-5#1)(2011-1#1)
antitumor activity of##3##3##(1991-8#1)(2007-11#1)(2008-4#1)
antitumor activity##16##2##(1990-2#1)(1991-8#1)(1994-5#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2011-1#2)
antitumor agent##3##2##(1990-2#1)(1993-11#1)(1995-2#1)
antitumor agents##9##2##(1992-3#1)(1995-3#1)(1995-6#1)(2008-11#3)(2008-5#3)
antitumor and antimetastatic##2##3##(1994-12#2)
antitumor antibiotics##2##2##(1995-2#1)(2008-9#1)
antitumor drug##3##2##(1991-6#1)(1993-8#1)(1995-6#1)
antitumor drugs##3##2##(1994-5#1)(2008-9#1)(2009-2#1)
antitumor effect on##2##3##(1997-7#2)
antitumor effect##5##2##(1994-5#1)(1997-7#2)(2008-8#2)
antitumor effects and##2##3##(1992-8#1)(2013-7#1)
antitumor effects in##2##3##(2010-4#1)(2013-1#1)
antitumor effects of##3##3##(1991-12#1)(1991-5#1)(1992-5#1)
antitumor effects##7##2##(1991-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(2010-4#1)(2013-1#1)(2013-7#1)
antitumor immunity##3##2##(1997-4#2)(2008-11#1)
antitumor response##5##2##(1992-12#2)(1994-5#2)(2012-12#1)
antitumor##79##1##(1990-2#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-5#6)(1995-2#2)(1995-3#2)(1995-6#2)(1997-4#3)(1997-7#2)(2007-11#2)(2008-10#3)(2008-11#7)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#6)(2009-2#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-3#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#1)
antitumoral##6##1##(1991-3#1)(1991-8#1)(1992-5#1)(1995-12#1)(2008-11#1)(2011-2#1)
antitumour activity##2##2##(2008-5#2)
antitumour##9##1##(1992-3#1)(1994-8#1)(1996-3#1)(1997-4#1)(2008-4#1)(2008-5#3)(2011-2#1)
antitussive drug##2##2##(1990-6#1)(1991-2#1)
antitussive##4##1##(1990-6#2)(1991-2#2)
antiulcer agent##3##2##(1993-3#2)(2008-11#1)
antiulcer##5##1##(1993-3#2)(1997-7#1)(2008-11#1)(2012-12#1)
antivenoms##5##1##(2008-5#5)
antiviral activities##5##2##(1991-2#2)(2008-11#1)(2011-2#1)(2011-3#1)
antiviral activity against##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
antiviral activity in##2##3##(1994-11#1)(2008-8#1)
antiviral activity of the##2##4##(1990-2#1)(2007-8#1)
antiviral activity of##7##3##(1990-2#2)(1994-11#1)(2007-8#2)(2008-10#1)(2008-5#1)
antiviral activity##20##2##(1990-2#2)(1994-11#2)(1997-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
antiviral agent##5##2##(2008-10#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-3#1)
antiviral agents##6##2##(1992-12#1)(1995-9#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
antiviral and##2##2##(2008-10#1)(2011-2#1)
antiviral compounds##2##2##(2011-2#2)
antiviral drug##6##2##(1994-6#1)(1995-6#1)(2008-10#1)(2009-8#1)(2011-3#1)(2012-2#1)
antiviral drugs##3##2##(1994-11#1)(1995-2#1)(2011-2#1)
antiviral immunity##2##2##(2013-1#2)
antiviral protein from##2##3##(1990-11#1)(2008-8#1)
antiviral protein##4##2##(1990-11#1)(2008-10#1)(2008-8#2)
antiviral signaling##2##2##(2013-1#2)
antiviral therapies##3##2##(2006-10#1)(2008-11#1)(2013-8#1)
antiviral therapy for##2##3##(2007-12#1)(2009-8#1)
antiviral therapy in##2##3##(2013-1#2)
antiviral therapy##11##2##(1994-8#1)(2007-12#2)(2008-5#1)(2009-8#3)(2011-2#2)(2013-1#2)
antiviral treatment##6##2##(1995-5#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
antiviral##98##1##(1990-10#1)(1990-11#1)(1990-2#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-8#1)(1994-11#5)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#5)(2009-7#1)(2009-8#5)(2010-2#1)(2011-1#1)(2011-2#8)(2011-3#5)(2012-2#3)(2012-3#3)(2013-1#13)(2013-8#1)
antivirals##3##1##(1997-1#1)(2009-8#1)(2012-12#1)
antiwrinkle activity##2##2##(2008-5#2)
antiwrinkle agent##3##2##(2008-5#3)
antiwrinkle##6##1##(2008-5#6)
antixenosis##2##1##(2011-2#2)
antral follicles##10##2##(1995-12#2)(2008-11#1)(2008-8#4)(2008-9#3)
antral gastritis in peptic ulcer disease patients and##2##8##(2008-5#2)
antral gastritis##6##2##(1997-1#1)(2008-5#5)
antral wall##2##2##(2008-7#1)(2013-1#1)
antral##27##1##(1992-6#1)(1995-11#1)(1995-12#2)(1997-1#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#3)(2011-2#1)(2013-1#3)
antrum##7##1##(1994-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-8#1)
ants (Hymenoptera##3##2##(2008-5#2)(2008-6#1)
ants for##2##2##(2008-10#2)
ants was##2##2##(2008-10#2)
ants were##4##2##(2008-10#1)(2008-6#3)
ants##41##1##(2007-12#2)(2008-10#10)(2008-5#6)(2008-6#11)(2008-8#9)(2012-2#3)
anucleate AML##2##2##(2008-6#2)
anucleate axonal segment of an##2##5##(2008-6#2)
anucleate##4##1##(2008-6#4)
anulatus##2##1##(2008-5#2)
anuran##6##1##(1996-5#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-7#1)
anurans##10##1##(1996-5#1)(1997-3#2)(2008-5#3)(2008-7#2)(2008-8#2)
anuria##6##1##(1991-11#1)(1993-9#1)(2008-1#1)(2008-10#2)(2008-12#1)
anuric patients with##2##3##(2008-4#1)(2011-2#1)
anuric patients##4##2##(2008-4#1)(2011-2#3)
anuric##7##1##(2008-4#1)(2011-2#6)
anus##13##1##(2007-2#1)(2008-10#1)(2009-5#5)(2010-4#1)(2011-2#1)(2013-1#4)
anxieties and fears##2##3##(1992-1#1)(2008-11#1)
anxieties and##3##2##(1992-1#1)(2008-11#1)(2009-10#1)
anxieties##14##1##(1991-3#1)(1992-1#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#2)(2011-2#6)
anxiety (negatively)##2##2##(2008-12#2)
anxiety about##4##2##(1993-1#1)(1995-1#1)(2007-7#1)(2008-1#1)
anxiety among##3##2##(1995-1#1)(2010-2#1)(2011-2#1)
anxiety and affective lability##3##4##(2008-6#3)
anxiety and anger##2##3##(2008-12#2)
anxiety and coping##2##3##(2007-10#1)(2007-6#1)
anxiety and depression in##2##4##(2010-8#1)(2012-1#1)
anxiety and depression were##2##4##(2012-1#2)
anxiety and depression##13##3##(1992-3#1)(1995-12#1)(2007-6#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-8#1)(2012-1#4)(2012-12#1)
anxiety and depressive disorders##4##4##(2009-10#3)(2010-5#1)
anxiety and depressive symptoms##3##4##(2009-10#1)(2010-8#2)
anxiety and depressive##7##3##(2009-10#4)(2010-5#1)(2010-8#2)
anxiety and muscle tension##2##4##(2010-12#2)
anxiety and##58##2##(1990-10#1)(1991-1#1)(1991-6#1)(1992-3#1)(1995-1#2)(1995-12#2)(1996-10#1)(1996-2#1)(2007-10#1)(2007-6#4)(2008-1#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#4)(2008-9#1)(2009-10#5)(2009-3#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-5#2)(2010-8#3)(2011-2#1)(2012-1#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
anxiety as##2##2##(2008-5#1)(2012-1#1)
anxiety can##2##2##(1990-6#1)(2008-7#1)
anxiety class (n =##2##4##(2009-7#2)
anxiety disorder and##2##3##(2013-8#2)
anxiety disorder that##2##3##(2008-4#1)(2008-6#1)
anxiety disorder##19##2##(2008-4#3)(2008-6#2)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#7)
anxiety disorders and##3##3##(2008-11#1)(2009-6#1)(2013-8#1)
anxiety disorders as well as##2##5##(2008-7#1)(2012-2#1)
anxiety disorders in##3##3##(1991-2#1)(2009-6#1)(2013-8#1)
anxiety disorders##33##2##(1991-2#3)(1993-2#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-6#4)(2010-2#1)(2010-7#1)(2012-2#3)(2013-8#9)
anxiety disorders]##2##2##(1994-3#1)(2013-7#1)
anxiety for##3##2##(1990-12#1)(1993-3#1)(2008-6#1)
anxiety in mice##3##3##(1994-3#2)(2008-8#1)
anxiety in##18##2##(1991-2#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-2#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
anxiety levels of##2##3##(1994-2#2)
anxiety levels reached##2##3##(2007-6#2)
anxiety levels##7##2##(1994-2#3)(2007-6#3)(2013-7#1)
anxiety may##3##2##(2008-2#1)(2012-1#2)
anxiety on the##2##3##(1994-12#1)(2011-2#1)
anxiety or depression##2##3##(2008-11#1)(2010-3#1)
anxiety or##3##2##(1995-1#1)(2008-11#1)(2010-3#1)
anxiety states##2##2##(2008-7#2)
anxiety symptoms in infants and toddlers with##2##7##(2012-2#2)
anxiety symptoms##6##2##(2012-2#5)(2013-1#1)
anxiety than##5##2##(2007-12#2)(2007-6#2)(2011-2#1)
anxiety that##3##2##(2009-7#2)(2012-12#1)
anxiety to##4##2##(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
anxiety were##5##2##(1991-12#1)(1994-12#1)(2007-6#1)(2010-8#1)(2013-1#1)
anxiety##304##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#2)(1991-12#2)(1991-2#5)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#5)(1994-12#2)(1994-2#5)(1994-3#3)(1994-6#1)(1995-1#10)(1995-12#2)(1995-2#2)(1996-1#1)(1996-10#1)(1996-2#3)(1996-7#1)(1996-9#1)(2007-10#3)(2007-12#2)(2007-6#11)(2007-7#2)(2008-1#11)(2008-10#1)(2008-11#16)(2008-12#11)(2008-2#8)(2008-3#1)(2008-4#10)(2008-5#3)(2008-6#9)(2008-7#14)(2008-8#2)(2008-9#1)(2009-10#9)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#10)(2009-9#4)(2010-1#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#4)(2011-10#1)(2011-2#10)(2012-1#12)(2012-12#3)(2012-2#16)(2012-3#1)(2013-1#12)(2013-7#3)(2013-8#22)
anxiety)##2##1##(2008-6#1)(2013-1#1)
anxiety-like behavior in##2##3##(2008-8#1)(2013-1#1)
anxiety-related##2##1##(2008-6#1)(2010-7#1)
anxiety/depression##2##1##(2008-12#1)(2010-8#1)
anxiogenic##2##1##(1994-3#1)(2008-11#1)
anxiolytic drug##2##2##(2008-10#1)(2008-8#1)
anxiolytic drugs##4##2##(1990-11#1)(1993-3#1)(1994-3#1)(2008-7#1)
anxiolytic effect of##2##3##(1991-12#1)(2008-10#1)
anxiolytic effects##6##2##(1992-7#1)(1993-12#1)(1993-3#2)(1994-2#1)(2012-2#1)
anxiolytic##22##1##(1990-11#1)(1991-12#1)(1992-7#2)(1993-12#3)(1993-3#3)(1994-2#2)(1994-3#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
anxiolytics and##2##2##(1995-11#1)(2008-11#1)
anxiolytics##3##1##(1995-11#1)(2008-11#1)(2013-8#1)
anxious and##3##2##(1993-12#1)(2008-4#1)(2013-8#1)
anxious coping##2##2##(2009-12#2)
anxious symptoms##2##2##(1992-2#2)
anxious##25##1##(1990-11#1)(1991-1#1)(1992-2#2)(1993-12#1)(2007-4#1)(2007-6#3)(2008-1#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#3)(2009-6#1)(2010-5#1)(2012-2#3)(2013-8#1)
any abnormalities##2##2##(2008-8#1)(2011-2#1)
any absorption##3##2##(1992-4#1)(2008-10#1)(2008-2#1)
any accidental##2##2##(2008-11#1)(2008-9#1)
any action##2##2##(1991-6#1)(2012-2#1)
any additional##7##2##(2007-11#1)(2008-10#2)(2008-3#2)(2011-1#1)(2011-2#1)
any additives and##2##3##(2009-11#1)(2011-2#1)
any additives##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
any advantage over##3##3##(1991-2#1)(1994-3#1)(2009-1#1)
any advantages##2##2##(1992-11#1)(2008-7#1)
any adverse effect on the##2##5##(2008-11#1)(2008-3#1)
any adverse effect##4##3##(1991-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
any adverse effects##4##3##(1997-2#1)(2008-11#1)(2012-2#2)
any adverse##10##2##(1991-1#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-12#1)(2012-2#2)
any age group##3##3##(1992-8#1)(1993-11#1)(1996-12#1)
any age##7##2##(1990-5#1)(1991-4#2)(1992-8#1)(1993-11#1)(1996-12#1)(2010-3#1)
any alteration in##2##3##(1994-6#1)(2012-3#1)
any alteration##6##2##(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
any analytical##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
any animal##3##2##(2008-11#1)(2009-1#1)(2013-7#1)
any antitumor##2##2##(1997-7#1)(2010-4#1)
any anxiety disorder##2##3##(2013-8#2)
any apparent##10##2##(1994-5#1)(1995-2#1)(1996-12#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
any appreciable##3##2##(2008-10#2)(2008-9#1)
any arbitrary##2##2##(2008-2#1)(2008-3#1)
any associated##2##2##(2008-3#1)(2011-2#1)
any association between##2##3##(2007-2#1)(2008-8#1)
any association##3##2##(2007-2#1)(2008-8#2)
any assumption##2##2##(2007-11#1)(2008-3#1)
any assumptions about##2##3##(2008-3#1)(2011-2#1)
any attempt##3##2##(1997-8#1)(2007-12#1)(2008-11#1)
any available##2##2##(2008-10#1)(2008-11#1)
any behavioural changes##2##3##(2007-7#2)
any beneficial effect##2##3##(1992-9#1)(2010-2#1)
any beneficial##4##2##(1992-9#1)(1997-6#1)(2008-11#1)(2010-2#1)
any benefit##2##2##(1990-6#1)(1993-9#1)
any better##3##2##(1996-12#1)(2008-2#2)
any blood##2##2##(1992-12#1)(2008-1#1)
any case is##2##3##(1990-12#1)(1994-2#1)
any case with##2##3##(1995-3#1)(2009-2#1)
any case##14##2##(1990-12#1)(1990-6#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#2)
any cause##3##2##(2007-12#1)(2008-1#1)(2008-6#1)
any cell type##3##3##(1995-2#1)(2008-4#1)(2008-9#1)
any cell##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
any change in the##3##4##(1992-1#1)(2010-8#1)(2011-2#1)
any change in##12##3##(1990-10#1)(1990-5#1)(1992-1#1)(1992-9#1)(1994-8#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#2)
any change##16##2##(1990-10#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#3)(2013-8#1)
any changes in the##3##4##(1994-10#1)(1995-12#1)(2008-10#1)
any changes in##9##3##(1992-9#1)(1994-10#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#1)
any changes##12##2##(1992-9#1)(1994-10#1)(1995-12#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
any chemical##6##2##(1997-3#1)(2008-10#4)(2008-3#1)
any clear##2##2##(1993-11#1)(2012-12#1)
any clinical signs of##2##4##(2007-11#1)(2013-8#1)
any clinical symptoms##2##3##(2007-8#1)(2013-7#1)
any clinical##14##2##(1991-2#1)(1993-2#1)(1995-2#1)(2006-12#1)(2007-11#3)(2007-7#1)(2007-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
any clinically##2##2##(2010-7#1)(2012-2#1)
any combination of the##2##4##(2008-1#1)(2013-1#1)
any combination of##7##3##(1990-7#1)(1991-8#1)(1992-12#1)(1995-9#1)(2008-1#1)(2008-3#1)(2013-1#1)
any combination##11##2##(1990-7#1)(1991-8#1)(1992-12#1)(1995-11#1)(1995-9#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2013-1#1)
any complete##2##2##(1996-11#1)(2008-3#1)
any complex##3##2##(1993-3#1)(2008-11#1)(2008-3#1)
any complication##4##2##(2007-7#1)(2008-7#1)(2012-2#1)(2013-8#1)
any complications##8##2##(1991-12#1)(1992-6#1)(1994-9#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
any compound that could##2##4##(2008-5#2)
any concentration##2##2##(1991-3#1)(1993-6#1)
any condition##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
any conformational##2##2##(1990-11#1)(1995-2#1)
any considerable change in##3##4##(2008-10#3)
any considerable##7##2##(2008-10#7)
any consistent##5##2##(1991-8#1)(1992-11#1)(2008-10#1)(2008-6#1)(2009-9#1)
any conventional##2##2##(2007-11#1)(2008-2#1)
any correction for##2##3##(2007-12#2)
any correlation between enzymatic activity and##2##6##(2010-12#2)
any correlation between##6##3##(2008-1#1)(2008-10#1)(2010-12#2)(2010-8#1)(2012-3#1)
any correlation##10##2##(1994-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-3#1)
any cross section of##2##4##(2008-2#1)(2008-3#1)
any cross##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
any cutaneous##2##2##(2008-10#1)(2012-3#1)
any cystic##2##2##(2006-10#1)(2008-7#1)
any damage##2##2##(1995-6#1)(2007-11#1)
any data##3##2##(1991-12#1)(2008-2#1)(2013-8#1)
any decision##2##2##(2009-12#1)(2013-1#1)
any decrease in##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
any decrease##5##2##(1993-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
any desired##11##2##(1993-8#1)(1994-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)
any detectable amount##2##3##(1992-6#1)(1992-9#1)
any detectable##5##2##(1992-6#1)(1992-9#1)(1995-2#1)(1997-4#1)(2010-10#1)
any developmental##2##2##(1997-3#1)(2008-4#1)
any device##2##2##(2007-11#1)(2008-2#1)
any difference between##2##3##(1990-12#1)(2008-10#1)
any difference in##3##3##(1995-11#1)(2008-5#1)(2011-2#1)
any difference##6##2##(1990-12#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
any differences resulting from##2##4##(1993-2#1)(2008-11#1)
any differences##5##2##(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
any different##2##2##(1995-2#1)(2008-11#1)
any direct##5##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-7#1)
any direction##4##2##(2008-12#1)(2008-3#3)
any discernible##2##2##(2008-2#1)(2008-5#1)
any divergence in##4##3##(2008-10#4)
any divergence##5##2##(2008-10#5)
any drug##3##2##(1990-3#1)(1995-12#1)(2006-10#1)
any effect on the##12##4##(1991-11#1)(1991-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
any effect on##21##3##(1991-11#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
any effect##26##2##(1990-11#1)(1991-11#1)(1991-3#2)(1991-7#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
any effects##5##2##(1991-12#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
any electron##2##2##(2008-10#2)
any element of##2##3##(2006-10#1)(2008-5#1)
any emergency##3##2##(1993-2#1)(1994-2#1)(2012-12#1)
any ethical##2##2##(2011-2#1)(2012-2#1)
any event##2##2##(1996-2#1)(2008-10#1)
any evidence of##6##3##(1990-7#1)(1991-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
any evidence that##2##3##(1991-4#1)(2008-3#1)
any evidence##8##2##(1990-7#1)(1991-3#1)(1991-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)
any existing##2##2##(1997-7#1)(2008-1#1)
any external##3##2##(1996-6#1)(2007-12#1)(2008-3#1)
any fluorescence##2##2##(2008-10#1)(2008-9#1)
any form of##2##3##(1990-3#1)(2008-1#1)
any form##3##2##(1990-3#1)(2008-1#1)(2008-7#1)
any formal##2##2##(2007-10#1)(2010-11#1)
any further##12##2##(1991-5#1)(1993-9#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
any future##5##2##(1992-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)
any gene##2##2##(1993-3#1)(2011-2#1)
any general##2##2##(2012-2#2)
any genetic##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
any genotype##2##2##(2008-10#2)
any given wavelength##2##3##(2007-11#1)(2008-2#1)
any given year##4##3##(1993-12#1)(1994-3#1)(2008-10#1)(2013-1#1)
any given##44##2##(1992-6#2)(1993-12#1)(1994-3#1)(1994-7#1)(1995-6#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2010-11#1)(2010-8#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
any group of##3##3##(1993-1#1)(1995-2#1)(2007-8#1)
any group##6##2##(1993-1#1)(1995-2#1)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)
any growth##2##2##(2008-11#1)(2011-2#1)
any health care setting##3##4##(1994-1#1)(1994-3#1)(2008-1#1)
any health care##5##3##(1991-12#1)(1994-1#1)(1994-3#1)(2008-1#2)
any health##7##2##(1991-12#1)(1994-1#1)(1994-3#1)(2008-1#2)(2008-12#1)(2012-12#1)
any hormonal##2##2##(2007-7#1)(2010-11#1)
any hospital##2##2##(1996-12#1)(1997-2#1)
any impact##2##2##(2007-11#1)(2011-2#1)
any implant##2##2##(2008-9#1)(2013-8#1)
any improvement##3##2##(2008-5#1)(2008-6#1)(2011-2#1)
any increase in##5##3##(1997-7#1)(2008-11#1)(2008-6#3)
any individual##5##2##(1994-11#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-7#1)
any influence of##2##3##(2007-12#1)(2008-10#1)
any influence on##2##3##(1993-8#1)(2009-9#1)
any influence##4##2##(1993-8#1)(2007-12#1)(2008-10#1)(2009-9#1)
any information##4##2##(1993-12#1)(1994-8#1)(2012-1#1)(2013-1#1)
any inhibition##2##2##(1991-9#1)(2011-2#1)
any inhibitory activity##2##3##(1994-12#1)(2012-2#1)
any inhibitory##3##2##(1991-9#1)(1994-12#1)(2012-2#1)
any instrument##3##2##(2008-9#1)(2013-1#2)
any interaction between##2##3##(1997-6#1)(2010-5#1)
any interference##8##2##(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)
any kind of##6##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
any known##12##2##(1996-12#1)(2008-10#5)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
any laboratory##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
any large-scale##2##2##(2008-4#2)
any level of misalignment##2##4##(2008-3#2)
any level of##6##3##(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#2)
any level##7##2##(2008-10#1)(2008-3#2)(2009-4#1)(2011-1#1)(2011-2#2)
any lipid##2##2##(1990-2#1)(2008-11#1)
any major##16##2##(1990-6#1)(1992-2#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
any malignant##2##2##(1990-10#1)(2008-10#1)
any masking##2##2##(2008-10#2)
any material##2##2##(2008-2#1)(2008-3#1)
any measurable##3##2##(1993-8#1)(2008-10#2)
any medical##3##2##(1996-1#1)(2008-7#1)(2012-3#1)
any mental##2##2##(2009-9#1)(2010-6#1)
any model##4##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-8#1)
any modifications##2##2##(1993-12#1)(2007-11#1)
any more##2##2##(2009-10#1)(2013-7#1)
any multivariate##2##2##(1997-4#1)(2008-12#1)
any need for##2##3##(2008-12#1)(2011-2#1)
any need##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
any negative effects##2##3##(2008-6#1)(2011-2#1)
any negative##4##2##(1994-11#1)(2008-6#1)(2010-2#1)(2011-2#1)
any new##5##2##(2007-8#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
any normal##3##2##(1992-12#1)(2007-12#1)(2008-11#1)
any number of##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
any observable##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
any obvious##4##2##(1997-4#1)(2007-7#1)(2008-10#1)(2008-9#1)
any occupational##2##2##(1996-9#1)(2009-12#1)
any of a number of##2##5##(2008-9#2)
any of our patients##2##4##(2007-8#1)(2013-1#1)
any of several##2##3##(1992-12#1)(2008-10#1)
any of the following##2##4##(2008-6#1)(2008-7#1)
any of the genes examined##2##5##(2008-7#1)(2012-3#1)
any of the genes##3##4##(1996-2#1)(2008-7#1)(2012-3#1)
any of the groups##3##4##(1994-11#1)(1997-8#1)(2013-7#1)
any of the interventions##2##4##(2009-11#1)(2013-1#1)
any of the other##5##4##(1990-5#1)(2008-10#2)(2010-12#1)(2012-3#1)
any of the patients##3##4##(1991-3#1)(1996-12#1)(2008-1#1)
any of the peptides##2##4##(1990-11#1)(2008-6#1)
any of the reported##2##4##(2007-7#1)(2008-10#1)
any of the sequences##2##4##(1992-9#1)(1997-3#1)
any of the seven##2##4##(2008-10#1)(2008-6#1)
any of the three##10##4##(1995-4#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-4#1)(2009-2#1)(2010-8#1)
any of the two##2##4##(1997-8#1)(2008-6#1)
any of the##117##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-3#1)(1991-8#2)(1992-11#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#3)(1993-6#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-12#1)(2006-8#1)(2007-12#4)(2007-7#3)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
any of them##3##3##(1990-10#1)(2011-2#1)(2012-1#1)
any of these##21##3##(1990-7#1)(1991-2#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
any of##161##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-12#1)(2006-8#1)(2007-12#5)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#35)(2008-11#3)(2008-12#3)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
any one of the following##3##5##(1993-1#1)(2008-10#1)(2012-2#1)
any one of the##6##4##(1993-1#1)(1994-1#1)(1996-10#1)(1996-2#1)(2008-10#1)(2012-2#1)
any one of these##3##4##(1991-8#1)(1996-1#1)(2011-2#1)
any one of##10##3##(1991-8#1)(1993-1#1)(1994-1#1)(1996-1#1)(1996-10#1)(1996-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
any one##30##2##(1991-1#1)(1991-8#1)(1993-1#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
any optical##4##2##(2007-11#1)(2008-3#3)
any or all##2##3##(2008-10#1)(2008-3#1)
any order##3##2##(2007-11#1)(2008-2#1)(2010-3#1)
any organism##2##2##(2008-10#1)(2008-9#1)
any other country##3##3##(1991-6#1)(1995-12#1)(2008-10#1)
any other disease##2##3##(1993-11#1)(2012-12#1)
any other form##2##3##(2008-10#1)(2010-6#1)
any other group##3##3##(1991-2#2)(2011-2#1)
any other known##4##3##(1995-2#1)(1995-8#1)(2008-10#1)(2008-6#1)
any other type of##2##4##(2008-10#1)(2013-1#1)
any other##91##2##(1990-8#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#1)(2010-6#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
any pain##2##2##(2008-10#1)(2012-12#1)
any pair of##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
any particular cell##2##3##(2008-11#1)(2008-4#1)
any particular##9##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
any patient##4##2##(1997-3#1)(2008-7#1)(2009-10#1)(2010-4#1)
any photorefractive##2##2##(2007-12#1)(2008-2#1)
any population##2##2##(2008-8#1)(2010-4#1)
any positive##2##2##(2008-10#1)(2009-8#1)
any possible##7##2##(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
any postoperative complications##2##3##(2008-12#1)(2009-3#1)
any postoperative##3##2##(2008-12#1)(2009-3#1)(2011-2#1)
any potential##4##2##(1994-11#1)(2008-10#1)(2009-4#1)(2011-1#1)
any potyvirus##2##2##(2008-10#2)
any practice##3##2##(1992-3#1)(1993-3#1)(2008-7#1)
any pre-treatment##6##2##(1991-5#1)(2008-10#5)
any preferential##2##2##(1993-3#1)(2008-7#1)
any preliminary##3##2##(2008-10#3)
any pretreatment of##2##3##(2008-10#1)(2008-11#1)
any pretreatment##9##2##(2008-10#7)(2008-11#1)(2008-9#1)
any previous##10##2##(2008-10#5)(2008-2#2)(2008-8#1)(2009-10#1)(2012-2#1)
any previously##4##2##(1990-11#1)(1990-7#1)(2008-2#1)(2008-6#1)
any prior knowledge##2##3##(2008-10#1)(2008-9#1)
any prior##6##2##(2008-10#4)(2008-9#1)(2012-2#1)
any procedure##2##2##(1992-12#1)(2009-9#1)
any protection in vivo##2##4##(1995-11#2)
any protection##4##2##(1995-11#3)(2008-10#1)
any protective##2##2##(1997-6#1)(2009-5#1)
any protein##3##2##(1994-6#1)(2008-7#2)
any publication##2##2##(2008-11#1)(2008-9#1)
any reason##3##2##(1993-12#1)(1994-1#1)(2008-1#1)
any reduction in##3##3##(1994-2#1)(1996-9#1)(2008-10#1)
any reduction##5##2##(1994-2#1)(1996-9#1)(2008-10#3)
any region##3##2##(1995-6#1)(1997-2#1)(2008-10#1)
any relapse##3##2##(2007-8#1)(2009-11#1)(2010-12#1)
any relapses##2##2##(2007-7#1)(2011-2#1)
any relationship between the##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
any relationship between##4##3##(1996-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
any relationship##6##2##(1996-3#1)(2007-6#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
any relevant##2##2##(2008-5#1)(2008-7#1)
any relief of##2##3##(1996-9#2)
any remaining##2##2##(1996-12#1)(2007-11#1)
any reported##6##2##(1993-12#1)(1993-6#1)(1995-8#2)(1996-10#1)(1996-2#1)
any reptile##2##2##(2010-3#1)(2012-3#1)
any requirement##2##2##(2008-2#1)(2010-4#1)
any research##3##2##(2007-7#1)(2008-1#1)(2008-9#1)
any residual##3##2##(2008-2#1)(2010-3#1)(2013-1#1)
any resistance genes##2##3##(2008-10#2)
any risk factor##2##3##(2006-10#1)(2007-10#1)
any risk##4##2##(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)
any risks##2##2##(1991-11#1)(2008-10#1)
any role in##2##3##(2008-2#1)(2011-1#1)
any role##5##2##(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
any sample##11##2##(1997-6#1)(2008-10#7)(2008-12#1)(2008-3#1)(2010-5#1)
any scientific##2##2##(2008-3#1)(2008-7#1)
any separation##6##2##(2008-10#6)
any sequence##2##2##(1996-3#1)(2008-4#1)
any sequenced genome##2##3##(2008-2#2)
any serious interference##3##3##(2007-12#1)(2008-10#2)
any set##2##2##(2008-3#1)(2013-1#1)
any side effects##3##3##(1992-11#1)(1993-6#1)(2008-10#1)
any side-effects##2##2##(2008-5#1)(2008-7#1)
any significant change in##3##4##(1996-9#1)(2009-5#1)(2011-2#1)
any significant change##5##3##(1996-9#1)(2008-10#2)(2009-5#1)(2011-2#1)
any significant changes in##2##4##(1995-6#1)(2011-2#1)
any significant difference in##2##4##(2007-8#1)(2008-10#1)
any significant difference##5##3##(2007-8#1)(2008-10#2)(2009-10#1)(2013-1#1)
any significant differences##6##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
any significant effect on the##6##5##(1993-11#1)(1995-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
any significant effect on##8##4##(1993-11#1)(1995-3#1)(2008-10#1)(2008-12#2)(2011-2#1)(2011-3#1)(2013-1#1)
any significant effect##10##3##(1993-11#1)(1995-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
any significant side effects##2##4##(1993-11#1)(2007-7#1)
any significant##62##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#3)(2013-8#1)
any signs of##2##3##(2008-10#1)(2008-11#1)
any signs##5##2##(1990-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
any single##11##2##(1994-9#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-9#1)(2007-8#1)(2008-11#1)(2009-9#1)(2010-11#1)(2012-3#1)
any site of##2##3##(2008-11#1)(2011-2#1)
any site##5##2##(1997-8#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
any size##3##2##(1995-1#1)(2008-2#1)(2008-9#1)
any spatial##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
any special##3##2##(2008-10#2)(2008-7#1)
any species and##2##3##(1995-6#1)(1995-8#1)
any species##5##2##(1995-6#1)(1995-8#1)(2008-10#2)(2008-8#1)
any specific##7##2##(1996-1#1)(1997-3#1)(2008-1#2)(2008-11#1)(2008-3#2)
any state of##4##3##(2007-11#2)(2007-12#2)
any statistical##3##2##(1991-2#1)(2008-7#1)(2008-8#1)
any statistically significant effect on the##2##6##(1994-6#1)(2009-1#1)
any statistically significant##4##3##(1994-6#1)(2009-1#1)(2013-1#2)
any step of##2##3##(1995-8#1)(2008-11#1)
any strain##2##2##(1993-5#1)(1996-5#1)
any strong##2##2##(1997-3#1)(2008-9#1)
any study##2##2##(2009-6#1)(2013-1#1)
any substantial##2##2##(2010-3#1)(2012-1#1)
any such##6##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
any surgical##3##2##(2008-11#1)(2011-2#2)
any survival##2##2##(1993-1#1)(2009-4#1)
any symptom##4##2##(1990-3#1)(1991-8#1)(1994-7#1)(2008-9#1)
any symptoms##5##2##(1991-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
any system##3##2##(2008-10#2)(2013-8#1)
any systemic##4##2##(2007-7#1)(2008-10#1)(2013-1#2)
any tested##3##2##(1997-5#1)(2008-10#2)
any therapeutic##4##2##(1990-12#1)(1990-2#1)(1993-5#1)(1996-11#1)
any tissue##3##2##(1995-6#1)(2007-8#1)(2008-1#1)
any toxic##2##2##(1992-6#1)(2008-10#1)
any toxicity##5##2##(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#2)
any treatment and##2##3##(1997-3#1)(2008-5#1)
any treatment##11##2##(1990-2#1)(1993-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
any two##9##2##(1990-11#1)(1990-7#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
any type of##7##3##(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-1#1)
any type##9##2##(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-4#1)(2011-1#1)(2012-1#1)
any unusual##3##2##(1992-5#1)(1995-3#1)(2008-12#1)
any value##3##2##(1991-3#1)(2008-3#2)
any variation##2##2##(2008-2#1)(2011-2#1)
any vector##3##2##(1994-12#1)(2008-4#2)
any vessel##2##2##(1991-8#1)(2007-8#1)
any violence##2##2##(2013-8#2)
any visible##4##2##(2008-10#2)(2008-2#1)(2009-1#1)
any visual##2##2##(1994-8#1)(2012-3#1)
any##2090##1##(1990-10#3)(1990-11#13)(1990-12#5)(1990-2#10)(1990-3#5)(1990-5#7)(1990-6#7)(1990-7#7)(1990-8#2)(1991-1#3)(1991-11#3)(1991-12#6)(1991-2#10)(1991-3#12)(1991-4#5)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#9)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#11)(1992-2#10)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#11)(1992-8#5)(1992-9#8)(1993-1#7)(1993-11#11)(1993-12#15)(1993-2#10)(1993-3#13)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#6)(1994-1#4)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#6)(1994-3#15)(1994-5#10)(1994-6#8)(1994-7#2)(1994-8#9)(1994-9#4)(1995-1#4)(1995-11#7)(1995-12#12)(1995-2#19)(1995-3#11)(1995-4#1)(1995-5#5)(1995-6#13)(1995-8#8)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#3)(1996-12#21)(1996-2#9)(1996-3#6)(1996-4#2)(1996-5#4)(1996-6#6)(1996-7#2)(1996-9#7)(1997-1#2)(1997-2#8)(1997-3#13)(1997-4#12)(1997-5#7)(1997-6#11)(1997-7#5)(1997-8#10)(2006-10#6)(2006-12#5)(2006-6#1)(2006-8#1)(2007-10#8)(2007-11#43)(2007-12#47)(2007-2#3)(2007-4#1)(2007-6#3)(2007-7#16)(2007-8#18)(2008-1#23)(2008-10#353)(2008-11#78)(2008-12#31)(2008-2#60)(2008-3#93)(2008-4#45)(2008-5#56)(2008-6#34)(2008-7#63)(2008-8#36)(2008-9#61)(2009-1#5)(2009-10#11)(2009-11#3)(2009-12#9)(2009-2#2)(2009-3#9)(2009-4#7)(2009-5#10)(2009-6#2)(2009-7#5)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#14)(2010-2#5)(2010-3#13)(2010-4#6)(2010-5#7)(2010-6#9)(2010-7#7)(2010-8#9)(2011-1#22)(2011-2#84)(2011-3#7)(2012-1#11)(2012-12#16)(2012-2#48)(2012-3#25)(2012-4#1)(2013-1#59)(2013-7#9)(2013-8#29)
anybody##2##1##(2008-12#1)(2013-1#1)
anymore##3##1##(1996-5#1)(2008-10#1)(2008-9#1)
anyone##10##1##(1992-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-6#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2012-3#1)
anything##10##1##(1990-10#1)(1992-5#1)(1993-12#1)(1994-2#1)(1996-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
anyway##2##1##(1992-6#1)(1995-6#1)
anyway?##3##1##(1995-12#1)(1996-1#1)(2007-11#1)
anywhere along##2##2##(2007-11#1)(2007-5#1)
anywhere in the##4##3##(1993-11#1)(2008-11#1)(2011-2#1)(2013-8#1)
anywhere##12##1##(1993-11#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
análisis##2##1##(1994-12#1)(2013-1#1)
aoEBA##3##1##(2012-3#3)
aonidiae##2##1##(2008-9#2)
aoronymphium##6##1##(2008-8#5)(2008-9#1)
aorta and##23##2##(1990-3#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-8#7)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-3#2)
aorta at##4##2##(1991-9#2)(1997-5#1)(2008-7#1)
aorta compared to##2##3##(2007-8#1)(2013-8#1)
aorta from##3##2##(1997-6#1)(2007-8#1)(2013-3#1)
aorta in##5##2##(1992-9#1)(2007-8#2)(2009-8#1)(2013-1#1)
aorta lesion##2##2##(1997-8#2)
aorta of##6##2##(1991-9#2)(1994-7#1)(2009-11#1)(2009-7#1)(2013-8#1)
aorta or##3##2##(1997-1#1)(2008-4#1)(2013-8#1)
aorta to##9##2##(2007-12#2)(2007-8#3)(2008-3#1)(2008-7#2)(2010-12#1)
aorta using##3##2##(1990-2#1)(2007-8#1)(2012-2#1)
aorta was##7##2##(1994-7#1)(1997-5#1)(2007-8#4)(2008-7#1)
aorta were##2##2##(2007-11#1)(2008-3#1)
aorta with##2##2##(2007-8#2)
aorta without##3##2##(1994-11#1)(2007-8#1)(2011-1#1)
aorta##197##1##(1990-12#3)(1990-2#6)(1990-3#1)(1991-12#1)(1991-6#1)(1991-9#7)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#3)(1994-11#4)(1994-7#2)(1995-11#1)(1995-12#5)(1996-11#1)(1997-1#1)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#20)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#41)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#4)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-3#5)(2013-8#6)
aorta) in##3##2##(1997-8#3)
aorta)##4##1##(1997-8#3)(2010-8#1)
aorta]##2##1##(1990-6#1)(2008-10#1)
aortae##2##1##(1993-3#1)(1995-12#1)
aortas##5##1##(2008-3#5)
aortic PWV##2##2##(2013-3#2)
aortic and mitral valve regurgitation##2##5##(2007-8#2)
aortic and mitral##4##3##(1995-3#1)(2007-8#3)
aortic and pulmonary artery##2##4##(1993-12#1)(1995-2#1)
aortic and##6##2##(1993-12#1)(1995-2#1)(1995-3#1)(2007-8#3)
aortic aneurysm repair##4##3##(2008-3#1)(2012-1#1)(2012-2#2)
aortic aneurysm with##2##3##(1991-8#1)(2007-8#1)
aortic aneurysm##32##2##(1990-6#1)(1991-8#1)(1992-5#4)(1993-5#1)(1994-1#1)(2007-8#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
aortic aneurysms and##2##3##(1993-5#1)(2007-4#1)
aortic aneurysms##8##2##(1993-5#2)(2007-4#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
aortic arch and its##2##4##(1997-8#2)
aortic arch and##4##3##(1997-8#2)(2007-8#1)(2008-8#1)
aortic arch aneurysm and coronary artery bypass grafting via a modified clamshell incision##2##13##(2008-8#2)
aortic arch aneurysm##4##3##(2007-8#1)(2008-8#2)(2011-2#1)
aortic arch in##3##3##(2007-8#2)(2008-12#1)
aortic arch or##2##3##(2007-8#1)(2010-8#1)
aortic arch surgery##2##3##(2007-8#2)
aortic arch##42##2##(1997-8#3)(2007-8#19)(2008-12#1)(2008-8#6)(2009-7#1)(2010-7#2)(2010-8#1)(2011-2#6)(2013-1#1)(2013-8#2)
aortic atherosclerosis##3##2##(2007-8#2)(2009-12#1)
aortic bi-iliac##2##2##(2011-2#2)
aortic bypass##3##2##(2007-8#3)
aortic characteristic impedance##3##3##(2008-3#3)
aortic clamping##4##2##(1992-6#2)(1996-9#1)(2007-8#1)
aortic coarctation##3##2##(2007-8#1)(2011-2#2)
aortic connector##2##2##(2007-8#2)
aortic cross clamp##2##3##(1996-9#1)(2007-9#1)
aortic cross##3##2##(1996-9#1)(2007-8#1)(2007-9#1)
aortic disease##2##2##(2010-8#1)(2012-2#1)
aortic dissection in##2##3##(2013-1#2)
aortic dissection##29##2##(1991-2#1)(2007-2#1)(2007-7#2)(2007-8#8)(2008-11#1)(2009-6#1)(2010-3#1)(2011-2#4)(2012-1#7)(2013-1#3)
aortic dissections##2##2##(2012-1#2)
aortic endothelial cell##2##3##(1993-6#1)(1995-11#1)
aortic endothelial cells that##2##4##(1990-2#1)(1992-12#1)
aortic endothelial cells##19##3##(1990-12#3)(1990-2#4)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
aortic endothelial##22##2##(1990-12#3)(1990-2#4)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
aortic injury during##2##3##(2007-8#1)(2008-12#1)
aortic injury##5##2##(2007-8#1)(2008-12#3)(2010-12#1)
aortic or mitral##2##3##(1990-12#1)(1995-3#1)
aortic or##3##2##(1990-12#1)(1995-3#1)(2007-8#1)
aortic pressure##3##2##(2008-3#1)(2009-12#2)
aortic regurgitation##16##2##(1995-3#1)(1997-5#1)(1997-8#5)(2007-8#3)(2008-11#2)(2008-7#1)(2009-10#1)(2012-3#2)
aortic replacement using##2##3##(2007-8#1)(2012-2#1)
aortic replacement##3##2##(2007-8#1)(2012-2#2)
aortic rings##5##2##(1990-12#2)(1994-5#1)(2008-11#2)
aortic root and##3##3##(2007-8#2)(2012-2#1)
aortic root##8##2##(2007-8#3)(2009-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
aortic rupture##3##2##(2007-8#1)(2008-12#1)(2012-3#1)
aortic smooth muscle cell##2##4##(1990-7#1)(1995-12#1)
aortic smooth muscle cells##7##4##(1990-7#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#1)
aortic smooth muscle##11##3##(1990-7#2)(1991-5#1)(1992-8#1)(1993-3#2)(1994-6#1)(1995-11#1)(1995-12#2)(2008-6#1)
aortic stenosis and##2##3##(2012-2#2)
aortic stenosis##11##2##(1996-9#1)(2007-8#1)(2008-5#1)(2011-2#2)(2012-2#5)(2013-8#1)
aortic stiffness##2##2##(2013-3#2)
aortic strips##2##2##(1990-8#1)(1991-5#1)
aortic surgery##4##2##(2007-8#1)(2010-8#3)
aortic tissue##3##2##(1990-12#1)(2009-7#2)
aortic valve and##4##3##(2007-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
aortic valve disease##2##3##(2008-12#1)(2009-5#1)
aortic valve implantation##3##3##(2009-12#2)(2011-2#1)
aortic valve replacement##11##3##(1996-9#1)(1997-5#1)(2007-8#4)(2009-12#1)(2009-5#1)(2012-2#1)(2013-8#2)
aortic valve stenosis##3##3##(2007-7#1)(2007-8#1)(2009-5#1)
aortic valve with##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
aortic valve##50##2##(1990-11#1)(1992-6#1)(1996-9#1)(1997-5#3)(2007-7#1)(2007-8#7)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#2)(2008-8#3)(2009-12#3)(2009-2#1)(2009-5#3)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#5)(2013-8#2)
aortic wall##4##2##(1997-8#1)(2009-7#2)(2010-8#1)
aortic##378##1##(1990-11#1)(1990-12#8)(1990-2#4)(1990-3#1)(1990-6#3)(1990-7#2)(1990-8#1)(1991-2#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-5#5)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-5#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1996-2#1)(1996-9#4)(1997-5#4)(1997-6#1)(1997-8#13)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#77)(2007-9#2)(2008-10#3)(2008-11#12)(2008-12#10)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#10)(2009-10#2)(2009-12#6)(2009-2#1)(2009-5#3)(2009-6#1)(2009-7#7)(2009-8#1)(2010-12#8)(2010-3#1)(2010-7#4)(2010-8#10)(2010-9#1)(2011-2#35)(2011-3#1)(2012-1#11)(2012-2#21)(2012-3#8)(2013-1#8)(2013-3#7)(2013-8#6)
aortitis syndrome##2##2##(2008-7#2)
aortitis##12##1##(1997-5#4)(2007-7#4)(2007-8#2)(2008-7#2)
aorto-caval##2##1##(1993-5#2)
aorto-femoral bypass##2##2##(2010-5#2)
aorto-iliac##7##1##(1990-5#2)(1997-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
aorto-ilio-femoral##2##1##(2011-3#2)
aortoarteritis##3##1##(1997-8#1)(2008-12#1)(2012-12#1)
aortocoronary bypass##3##2##(1992-6#1)(2012-3#2)
aortomitral angle##3##2##(2008-10#3)
aortopulmonary artery##2##2##(2008-11#2)
apart and##5##2##(1994-11#1)(1995-3#1)(2007-12#1)(2008-2#1)(2012-3#1)
apart from a##2##3##(1991-6#1)(2008-10#1)
apart from the##9##3##(1990-9#1)(1991-8#1)(1992-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2012-12#1)
apart from##29##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-8#2)(1995-12#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
apart##60##1##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-3#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
apartment##3##1##(1996-5#2)(2011-2#1)
apartments##2##1##(2008-7#2)
apathogenic##3##1##(1993-3#1)(1995-2#2)
apathy##4##1##(1995-11#1)(1995-6#1)(2008-2#1)(2012-2#1)
apatite##19##1##(2008-10#11)(2009-7#4)(2013-1#4)
ape chromosomes##3##2##(1997-6#3)
ape##7##1##(1994-3#1)(1997-6#5)(2011-2#1)
aperiodic##8##1##(2007-11#2)(2007-12#4)(2008-3#1)(2008-4#1)
aperiodically poled crystals##2##3##(2007-11#2)
aperiodically poled nonlinear crystals##2##4##(2007-11#2)
aperiodically poled##6##2##(2007-11#4)(2007-12#2)
aperture (NA)##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
aperture and the##2##3##(2008-2#1)(2008-3#1)
aperture and##6##2##(2008-2#3)(2008-3#3)
aperture are##2##2##(2008-2#1)(2008-3#1)
aperture by use of##2##4##(2007-12#1)(2008-3#1)
aperture by##3##2##(2007-12#1)(2008-3#2)
aperture dimension##2##2##(2008-3#2)
aperture field##3##2##(2011-2#3)
aperture for##3##2##(2007-11#1)(2008-3#2)
aperture frames##2##2##(2008-3#2)
aperture imaging##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2009-12#1)
aperture in a##2##3##(2007-12#2)
aperture in##5##2##(2007-11#1)(2007-12#3)(2008-10#1)
aperture into the##2##3##(2007-11#1)(2007-12#1)
aperture into##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
aperture is##13##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2013-8#1)
aperture of 1##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
aperture of the##14##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#7)
aperture of##29##2##(2007-11#6)(2007-12#5)(2008-2#4)(2008-3#14)
aperture on the##2##3##(2008-2#2)
aperture on##4##2##(2007-12#1)(2008-2#3)
aperture plane##2##2##(2007-11#1)(2008-3#1)
aperture radar image##2##3##(2007-12#1)(2008-3#1)
aperture radar##10##2##(2007-12#2)(2008-2#1)(2008-3#6)(2008-6#1)
aperture shape and##2##3##(2008-2#1)(2008-3#1)
aperture shape##4##2##(2008-2#1)(2008-3#3)
aperture size and##2##3##(2007-12#1)(2008-2#1)
aperture size of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
aperture size##10##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#2)
aperture sizes##2##2##(2008-2#1)(2008-3#1)
aperture synthesis in##2##3##(2008-3#2)
aperture that##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
aperture to reduce##2##3##(2008-2#1)(2008-3#1)
aperture to##7##2##(2008-2#1)(2008-3#6)
aperture was##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
aperture with##2##2##(2008-2#2)
aperture##249##1##(2007-11#28)(2007-12#35)(2008-10#7)(2008-2#54)(2008-3#112)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#4)(2012-2#2)(2013-8#1)
aperture-interface distance##3##2##(2008-3#3)
aperture-interface##4##1##(2008-3#4)
apertureless scanning near-field optical##2##4##(2007-12#2)
apertureless##3##1##(2007-11#1)(2007-12#2)
apertures and##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
apertures in##2##2##(2007-12#1)(2008-3#1)
apertures of##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
apertures##47##1##(2007-11#7)(2007-12#6)(2008-10#1)(2008-2#8)(2008-3#24)(2009-6#1)
aperturing##2##1##(2007-12#1)(2008-3#1)
apes##6##1##(1990-11#1)(1997-6#1)(2007-12#2)(2009-8#1)(2012-12#1)
apex and##6##2##(2008-9#2)(2009-2#1)(2009-6#1)(2010-5#1)(2011-2#1)
apex meningiomas##2##2##(2008-7#2)
apex of first gonopod##2##4##(2008-5#2)
apex of the curve##2##4##(2007-11#2)
apex of the##4##3##(2007-11#2)(2008-7#1)(2012-2#1)
apex of##9##2##(2007-11#2)(2007-12#1)(2007-8#2)(2008-5#2)(2008-7#1)(2012-2#1)
apex point and##2##3##(2009-2#2)
apex point##3##2##(2009-2#3)
apex was##2##2##(2009-6#1)(2010-12#1)
apex##67##1##(1996-2#1)(2007-11#3)(2007-12#2)(2007-8#3)(2008-10#5)(2008-2#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-9#3)(2009-2#8)(2009-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#9)(2012-12#3)(2012-2#4)(2013-1#4)(2013-7#1)
apexification material##2##2##(2012-12#2)
aphakia##3##1##(2008-1#1)(2010-9#2)
aphakic##2##1##(2011-2#2)
aphanidermatum in##3##2##(2008-10#3)
aphanidermatum##17##1##(2008-10#17)
aphasia and##6##2##(2007-10#1)(2007-8#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
aphasia as##2##2##(2007-10#1)(2012-3#1)
aphasia rehabilitation##2##2##(2012-3#1)(2013-1#1)
aphasia##41##1##(1990-3#1)(1993-9#2)(1995-12#1)(1997-3#1)(2007-10#5)(2007-8#6)(2008-4#4)(2008-9#1)(2009-9#2)(2011-1#1)(2012-3#10)(2013-1#6)(2013-8#1)
aphasic##5##1##(1993-9#1)(1997-3#1)(2007-10#1)(2008-10#1)(2013-1#1)
apheresis in##3##2##(1994-12#2)(2011-2#1)
apheresis system##2##2##(2011-2#2)
apheresis was##2##2##(1990-12#1)(2012-12#1)
apheresis##23##1##(1990-12#3)(1991-11#2)(1994-12#6)(2008-9#1)(2011-2#10)(2012-12#1)
aphid Schizaphis graminum##3##3##(1996-12#2)(2008-10#1)
aphid host##2##2##(1996-12#1)(2008-6#1)
aphid species##6##2##(2008-10#6)
aphid transmission##11##2##(2008-10#11)
aphid vector##4##2##(2008-10#4)
aphid vectors and##2##3##(2008-10#2)
aphid vectors##4##2##(2008-10#4)
aphid##70##1##(1996-12#6)(2007-12#3)(2008-10#46)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#3)(2009-8#3)(2011-2#2)(2012-2#2)
aphid-transmitted viruses in snap bean##2##5##(2008-10#2)
aphid-transmitted##6##1##(2008-10#6)
aphidicola##3##1##(1996-12#3)
aphids (Myzus persicae)##3##3##(2008-10#2)(2012-2#1)
aphids and##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
aphids by##2##2##(2008-10#1)(2009-8#1)
aphids that##2##2##(2008-10#1)(2008-8#1)
aphids was##2##2##(2008-10#2)
aphids were##4##2##(2008-10#3)(2011-2#1)
aphids##33##1##(1996-12#1)(2007-12#2)(2008-10#16)(2008-12#2)(2008-8#3)(2009-8#4)(2011-2#1)(2012-2#4)
aphids' population##2##2##(2008-12#2)
aphrodisiac##2##1##(2008-11#1)(2012-2#1)
aphthosis##4##1##(2008-5#1)(2012-1#1)(2012-3#2)
aphthous ulceration##8##2##(2008-5#1)(2012-1#7)
aphthous##10##1##(2007-12#1)(2008-5#1)(2010-1#1)(2012-1#7)
apical and basal dendrites##2##4##(2007-8#2)
apical and basal##8##3##(1994-6#1)(2007-12#1)(2007-8#3)(2009-10#1)(2012-1#1)(2012-2#1)
apical and##11##2##(1994-6#1)(2007-12#1)(2007-8#3)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#2)
apical ballooning##3##2##(2009-6#1)(2010-5#1)(2011-2#1)
apical bullae##3##2##(2008-10#3)
apical cells##2##2##(2008-7#2)
apical dendrites of deep##2##4##(1993-12#2)
apical dendrites of##3##3##(1993-12#2)(2007-8#1)
apical dendrites##5##2##(1993-12#2)(2007-8#2)(2008-4#1)
apical end##2##2##(2008-6#1)(2008-7#1)
apical infolding system##2##3##(2008-7#2)
apical leaves##2##2##(2008-10#2)
apical membrane##6##2##(1992-5#1)(2008-4#3)(2008-6#1)(2012-12#1)
apical membranes##7##2##(1990-11#5)(2009-8#1)(2012-2#1)
apical meristem explants##3##3##(2008-12#3)
apical meristem##11##2##(2008-10#1)(2008-12#4)(2009-8#5)(2012-2#1)
apical muscular##2##2##(2007-8#2)
apical necrosis##3##2##(2008-10#3)
apical or##2##2##(2008-1#1)(2013-1#1)
apical periodontitis with a##2##4##(2013-8#2)
apical periodontitis##5##2##(2013-1#2)(2013-8#3)
apical pleurectomy##3##2##(1991-6#1)(2008-10#2)
apical plug was##2##3##(2013-1#2)
apical plug##3##2##(2013-1#3)
apical portion of the##3##4##(2007-12#1)(2008-9#1)(2013-1#1)
apical portion of##4##3##(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
apical portion##5##2##(2007-12#1)(2008-7#2)(2008-9#1)(2013-1#1)
apical region##5##2##(1995-11#2)(2008-10#1)(2008-7#1)(2013-1#1)
apical seal##3##2##(1991-3#2)(2013-1#1)
apical stem loop of the epsilon##2##6##(2009-7#2)
apical stem loop of##3##4##(2009-7#3)
apical stem loop##4##3##(2009-7#4)
apical stem##5##2##(2008-10#1)(2009-7#4)
apical surgery##3##2##(2009-8#3)
apical third##2##2##(2013-1#2)
apical##172##1##(1990-11#6)(1991-12#1)(1991-3#2)(1991-6#1)(1992-5#1)(1993-12#2)(1994-6#2)(1994-9#2)(1995-11#2)(1995-8#1)(1997-1#1)(1997-7#1)(2007-12#12)(2007-8#9)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#5)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#6)(2009-10#4)(2009-6#1)(2009-7#4)(2009-8#10)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#21)(2013-1#17)(2013-7#2)(2013-8#3)
apical+basal##2##1##(1994-6#2)
apical-basal##3##1##(2009-5#1)(2012-1#2)
apically##4##1##(1990-12#1)(2008-7#2)(2012-12#1)
apices of##2##2##(2008-8#1)(2009-6#1)
apices##6##1##(2008-10#1)(2008-8#1)(2009-6#2)(2012-2#1)(2013-1#1)
apicidin or HC-toxin##2##3##(2008-10#2)
apicidin##7##1##(2008-10#7)
apicoplast##2##1##(2012-2#2)
apigenin##4##1##(2008-10#1)(2008-11#3)
apii and C##2##3##(2008-10#2)
apii sensu lato##2##3##(2008-10#2)
apii##6##1##(2008-10#6)
apiospermum external otitis##2##3##(2008-5#2)
aplanatic##3##1##(2008-3#3)
aplasia and##2##2##(2008-9#1)(2010-8#1)
aplasia is very##2##3##(2013-1#2)
aplasia of the##5##3##(2008-9#1)(2011-1#3)(2013-1#1)
aplasia of##6##2##(2008-9#1)(2011-1#4)(2013-1#1)
aplasia##18##1##(2007-10#2)(2008-10#1)(2008-12#1)(2008-9#3)(2010-8#1)(2011-1#5)(2012-2#1)(2013-1#4)
aplastic anaemia##3##2##(2012-2#3)
aplastic anemia##3##2##(2008-4#1)(2012-3#2)
aplastic##9##1##(2008-4#2)(2009-2#1)(2011-1#1)(2012-2#3)(2012-3#2)
apnea syndrome##6##2##(2007-12#2)(2010-5#3)(2013-1#1)
apnea##34##1##(1992-5#1)(1993-2#1)(1994-3#1)(1997-8#1)(2007-12#10)(2007-2#2)(2009-4#1)(2009-9#2)(2010-5#5)(2012-2#5)(2013-1#2)(2013-7#3)
apnoea of central origin##2##4##(2008-7#2)
apnoea##16##1##(1992-11#2)(1996-5#4)(1997-5#1)(1997-8#1)(2007-11#1)(2008-7#3)(2008-9#1)(2010-6#2)(2012-2#1)
apo A-I##4##2##(1993-12#4)
apo A-I/DMPC complexes##2##3##(1990-12#2)
apo A1##2##2##(1992-6#2)
apo B containing lipoproteins##2##4##(1994-12#2)
apo B in##3##3##(1990-8#2)(1994-11#1)
apo B mRNA editing##2##4##(1990-11#1)(1990-7#1)
apo B mRNA was found to be##2##7##(1990-11#2)
apo B mRNA##5##3##(1990-11#3)(1990-7#2)
apo B##28##2##(1990-11#3)(1990-7#2)(1990-8#5)(1992-6#1)(1993-12#2)(1994-11#4)(1994-12#2)(1994-3#2)(1994-9#4)(1995-8#1)(1997-8#2)
apo B-100 and apo##2##4##(1990-8#1)(1993-12#1)
apo B-100 and##3##3##(1990-8#1)(1993-12#2)
apo B-100##6##2##(1990-11#1)(1990-8#2)(1993-12#3)
apo B-48##6##2##(1990-8#6)
apo B-containing lipoproteins##2##3##(1995-2#1)(1995-8#1)
apo B-containing##3##2##(1995-2#1)(1995-8#2)
apo C##2##2##(1993-6#2)
apo CII##3##2##(1993-6#3)
apo E##2##2##(1994-6#1)(2008-3#1)
apo E-deficient mice##4##3##(1994-6#3)(2008-1#1)
apo and##3##2##(1991-12#1)(2009-7#1)(2012-2#1)
apo##77##1##(1990-11#4)(1990-12#4)(1990-7#2)(1990-8#13)(1991-12#5)(1992-6#3)(1993-12#10)(1993-6#6)(1993-8#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-6#4)(1994-9#4)(1995-2#1)(1995-8#3)(1997-8#2)(2008-1#1)(2008-3#1)(2009-7#2)(2010-10#2)(2012-2#1)
apo(a) and##3##2##(1992-3#1)(1995-6#2)
apo(a) have##2##2##(1992-3#2)
apo(a) isoforms##4##2##(1993-3#2)(1995-2#2)
apo(a)##19##1##(1992-3#5)(1993-2#5)(1993-3#2)(1995-2#2)(1995-6#3)(1995-8#1)(1996-8#1)
apo-E##6##1##(2008-10#6)
apoA-I gene##2##2##(1991-12#2)
apoA-I mRNA##2##2##(1991-12#2)
apoA-I synthesis##3##2##(1991-12#3)
apoA-I##14##1##(1991-12#9)(2008-6#4)(2012-12#1)
apoA-IV-0 and##2##2##(1990-8#1)(1991-8#1)
apoA-IV-0##5##1##(1990-8#3)(1991-8#2)
apoA-IV-1 and##3##2##(1990-8#1)(1991-8#2)
apoA-IV-1##5##1##(1990-8#2)(1991-8#3)
apoA-IV-2##2##1##(1990-8#1)(1991-8#1)
apoA-IV-3##5##1##(1990-8#3)(1991-8#2)
apoB mRNA editing protein##4##4##(1994-8#4)
apoB mRNA editing##5##3##(1994-8#5)
apoB mRNA##10##2##(1992-11#3)(1994-8#7)
apoB##23##1##(1990-7#1)(1992-11#4)(1992-3#9)(1994-8#7)(2008-6#1)(2012-12#1)
apoB-100 mRNA##3##2##(1990-11#1)(1992-11#2)
apoB-100##8##1##(1990-11#1)(1992-11#5)(1995-2#1)(2008-6#1)
apoB-48 mRNA##3##2##(1990-11#1)(1992-11#2)
apoB-48##6##1##(1990-11#1)(1992-11#5)
apoB100##2##1##(2008-6#2)
apoE gene##3##2##(1995-6#3)
apoE homology##2##2##(1995-6#2)
apoE##28##1##(1991-12#4)(1995-6#11)(1996-2#3)(1996-6#5)(2008-6#1)(2008-9#1)(2009-8#3)
apoE4##2##1##(2008-9#2)
apochromatic##2##1##(2008-3#2)
apocrine carcinoma##3##2##(2008-10#3)
apocrine cysts##2##2##(1993-1#2)
apocrine secretion##2##2##(2008-5#2)
apocrine##18##1##(1993-1#4)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#6)
apocytochrome P450cam##2##2##(1993-8#2)
apocytochrome b##2##2##(1991-12#2)
apocytochrome c##3##2##(2008-8#3)
apocytochrome##7##1##(1991-12#2)(1993-8#2)(2008-8#3)
apodization and##2##2##(2008-3#2)
apodization function##2##2##(2008-10#1)(2008-3#1)
apodization of##2##2##(2008-3#2)
apodization on the##3##3##(2008-2#3)
apodization on##4##2##(2008-2#3)(2008-3#1)
apodization##19##1##(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#10)
apodized fiber Bragg grating##2##4##(2007-12#1)(2008-2#1)
apodized##8##1##(2007-12#1)(2008-2#3)(2008-3#4)
apodizer##2##1##(2008-3#2)
apodizing##2##1##(2008-2#2)
apoenzyme##5##1##(1990-11#1)(1993-6#3)(1994-5#1)
apolar##6##1##(1990-2#2)(2008-10#4)
apolipoprotein (apo) E##2##3##(1995-6#1)(2008-6#1)
apolipoprotein (apo)##7##2##(1990-8#1)(1991-8#1)(1993-2#1)(1995-6#1)(2008-6#3)
apolipoprotein A-I##3##2##(1991-12#1)(1993-8#1)(2010-12#1)
apolipoprotein A1##2##2##(1997-8#1)(2010-6#1)
apolipoprotein AI##5##2##(1991-12#1)(1993-12#2)(1995-5#1)(2008-4#1)
apolipoprotein B gene##4##3##(1990-7#1)(1995-2#2)(1997-8#1)
apolipoprotein B in##2##3##(1992-12#1)(2013-1#1)
apolipoprotein B knockout##2##3##(1995-2#2)
apolipoprotein B mRNA editing##2##4##(1990-7#1)(1994-8#1)
apolipoprotein B mRNA##3##3##(1990-7#1)(1992-11#1)(1994-8#1)
apolipoprotein B##30##2##(1990-11#1)(1990-12#1)(1990-7#3)(1992-11#1)(1992-12#1)(1993-12#1)(1993-9#3)(1994-8#1)(1995-12#1)(1995-2#11)(1995-6#1)(1997-8#2)(2008-7#2)(2013-1#1)
apolipoprotein CII##3##2##(1993-6#3)
apolipoprotein E and##2##3##(1995-6#1)(2012-2#1)
apolipoprotein E gene##3##3##(1995-6#1)(2008-4#1)(2009-12#1)
apolipoprotein E##20##2##(1991-12#1)(1994-8#2)(1995-5#1)(1995-6#2)(1996-2#1)(2008-10#3)(2008-4#3)(2008-7#2)(2009-12#1)(2009-8#2)(2012-2#1)(2013-1#1)
apolipoprotein##87##1##(1990-11#1)(1990-12#1)(1990-7#3)(1990-8#2)(1991-12#3)(1991-8#2)(1992-11#2)(1992-12#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#4)(1994-11#2)(1994-8#3)(1995-12#1)(1995-2#11)(1995-5#3)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#3)(2008-10#3)(2008-4#4)(2008-6#4)(2008-7#4)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
apolipoprotein(a) [apo(a)]##2##2##(1992-3#1)(2008-6#1)
apolipoprotein(a) levels##2##2##(1992-9#2)
apolipoprotein(a)##12##1##(1992-3#1)(1992-9#6)(1993-3#2)(1995-6#1)(1996-8#1)(2008-6#1)
apolipoproteins A-I##2##2##(1993-12#2)
apolipoproteins##20##1##(1990-12#1)(1990-2#1)(1990-8#3)(1991-12#1)(1993-12#8)(1993-6#3)(1995-2#3)
apologies##3##1##(2008-10#1)(2012-3#2)
apomictic##5##1##(2008-5#5)
apomorphine (0##4##2##(1995-12#3)(1997-2#1)
apomorphine were##2##2##(1995-12#1)(2008-7#1)
apomorphine##23##1##(1992-10#1)(1992-11#4)(1993-12#1)(1995-12#4)(1995-2#1)(1996-5#5)(1997-2#2)(2008-7#5)
apomorphine-induced##9##1##(1992-12#1)(1993-12#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-2#1)
apomyoglobin##5##1##(1992-3#4)(1994-8#1)
aponeuroses##2##1##(2013-1#2)
aponeurotic fibroma##2##2##(2012-3#2)
aponeurotic##3##1##(2009-9#1)(2012-3#2)
apoprotein B##5##2##(1990-3#1)(1991-2#1)(1991-5#2)(1991-6#1)
apoprotein##16##1##(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-11#1)
apoproteins##2##1##(1991-12#1)(2013-7#1)
apoptic##2##1##(2010-8#2)
apoptosis (programmed cell death)##4##4##(1993-2#1)(1993-9#1)(1995-8#1)(2009-11#1)
apoptosis after exposure##2##3##(2008-10#1)(2008-9#1)
apoptosis after stimulation with IFNγ##2##5##(2011-2#2)
apoptosis after##5##2##(1995-2#1)(2008-10#1)(2008-9#1)(2011-2#2)
apoptosis and cell##3##3##(1994-9#1)(2011-2#1)(2012-1#1)
apoptosis and necrosis in##3##4##(2008-11#2)(2013-1#1)
apoptosis and necrosis of##2##4##(2008-9#1)(2013-1#1)
apoptosis and necrosis##12##3##(1994-8#2)(2008-1#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
apoptosis and proliferation markers in thyroid##2##6##(2012-1#2)
apoptosis and proliferation##7##3##(1994-10#3)(2008-6#1)(2012-1#3)
apoptosis and the##6##3##(1991-12#1)(1994-10#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
apoptosis and##77##2##(1991-12#3)(1994-10#4)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-11#7)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#5)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#5)(2013-7#3)(2013-8#2)
apoptosis as a##3##3##(1994-9#1)(1995-2#1)(2006-10#1)
apoptosis as##6##2##(1994-9#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
apoptosis but##2##2##(1997-8#1)(2008-7#1)
apoptosis by a##2##3##(1993-9#1)(2008-11#1)
apoptosis by##17##2##(1992-9#1)(1993-9#2)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-3#1)
apoptosis can be##2##3##(2008-11#2)
apoptosis can##4##2##(2008-11#2)(2008-7#1)(2009-3#1)
apoptosis could not##2##3##(1994-11#1)(2008-7#1)
apoptosis could##4##2##(1993-9#1)(1994-11#1)(2008-11#1)(2008-7#1)
apoptosis detection##3##2##(2008-11#3)
apoptosis did not##3##3##(2008-10#2)(2013-8#1)
apoptosis during##2##2##(2008-12#1)(2011-1#1)
apoptosis followed##2##2##(2008-11#2)
apoptosis following##2##2##(2008-10#1)(2008-11#1)
apoptosis in HL-60 cells##2##4##(2008-8#1)(2011-2#1)
apoptosis in Parkinson's disease##3##4##(2008-7#3)
apoptosis in WEHI 231##2##4##(1994-10#2)
apoptosis in a##2##3##(1994-10#1)(2013-1#1)
apoptosis in human quiescent##3##4##(1994-6#3)
apoptosis in human##11##3##(1993-9#1)(1994-10#1)(1994-6#3)(1995-2#1)(2008-9#3)(2010-6#1)(2011-2#1)
apoptosis in inflammatory##2##3##(2010-12#1)(2013-1#1)
apoptosis in malignant cells##2##4##(2012-2#2)
apoptosis in rPCNs##2##3##(2008-4#2)
apoptosis in response to##2##4##(2011-2#1)(2013-1#1)
apoptosis in the pancreas##2##4##(2008-7#2)
apoptosis in the##16##3##(1992-3#1)(1993-8#1)(1995-12#1)(1997-7#1)(2008-11#2)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#2)(2013-1#3)(2013-8#1)
apoptosis in vitro##2##3##(2008-10#2)
apoptosis in##100##2##(1992-3#1)(1993-8#1)(1993-9#4)(1994-10#7)(1994-11#1)(1994-6#3)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#2)(1997-7#1)(2008-10#6)(2008-11#9)(2008-12#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#1)
apoptosis induced by##6##3##(1994-11#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)
apoptosis induced##7##2##(1994-11#1)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#1)
apoptosis induction by anti-Fas antibody##2##5##(2008-8#2)
apoptosis induction by##3##3##(2008-11#1)(2008-8#2)
apoptosis induction##13##2##(1995-2#2)(2007-8#1)(2008-11#2)(2008-12#2)(2008-8#4)(2008-9#1)(2009-3#1)
apoptosis inhibition##2##2##(2008-11#1)(2009-6#1)
apoptosis inhibitor##2##2##(2008-11#1)(2012-1#1)
apoptosis inhibitors##2##2##(2008-11#1)(2008-5#1)
apoptosis is##17##2##(1992-3#1)(1992-9#1)(1994-10#1)(1994-3#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#2)
apoptosis occurred in##3##3##(2008-10#1)(2008-8#2)
apoptosis occurred##4##2##(1994-11#1)(2008-10#1)(2008-8#2)
apoptosis occurs##3##2##(1994-11#1)(1995-6#1)(2008-4#1)
apoptosis of HMV-1 cells##2##4##(2008-11#2)
apoptosis of cancer##2##3##(2008-9#2)
apoptosis of human##2##3##(2008-8#1)(2011-2#1)
apoptosis of the##7##3##(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
apoptosis of tumor cells##2##4##(2008-9#1)(2009-3#1)
apoptosis of vascular endothelial cells##2##5##(1996-12#2)
apoptosis of##37##2##(1993-3#2)(1995-2#1)(1996-12#2)(1997-8#1)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-3#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)
apoptosis or##6##2##(2008-10#2)(2008-11#1)(2008-7#2)(2012-12#1)
apoptosis pathway##2##2##(2013-1#2)
apoptosis plays a##2##3##(1994-11#1)(2008-8#1)
apoptosis plays##3##2##(1994-11#1)(2007-10#1)(2008-8#1)
apoptosis regulators##2##2##(2008-11#1)(2009-12#1)
apoptosis through activation of##3##4##(2008-1#1)(2008-4#1)(2010-12#1)
apoptosis through##6##2##(2008-1#1)(2008-4#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
apoptosis to##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
apoptosis triggered by##2##3##(2008-11#1)(2012-2#1)
apoptosis triggered##3##2##(1995-2#1)(2008-11#1)(2012-2#1)
apoptosis under##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
apoptosis via##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
apoptosis was observed##5##3##(1992-3#1)(1993-9#1)(1994-10#1)(2008-11#1)(2008-9#1)
apoptosis was##22##2##(1992-3#1)(1993-9#1)(1994-10#1)(1994-6#2)(1995-2#2)(2008-10#4)(2008-11#4)(2008-9#2)(2009-4#1)(2011-2#2)(2011-3#1)(2012-2#1)
apoptosis were##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
apoptosis when##5##2##(1993-8#1)(1995-2#1)(2009-12#2)(2009-9#1)
apoptosis which is##2##3##(1993-3#1)(2008-11#1)
apoptosis with##4##2##(2008-8#3)(2013-8#1)
apoptosis within 24 h##2##4##(2008-7#1)(2008-9#1)
apoptosis##691##1##(1991-12#4)(1992-3#3)(1992-9#2)(1993-2#4)(1993-3#4)(1993-8#6)(1993-9#12)(1994-10#20)(1994-11#7)(1994-12#2)(1994-3#1)(1994-6#7)(1994-8#2)(1994-9#4)(1995-12#3)(1995-2#18)(1995-6#4)(1995-8#3)(1996-10#1)(1996-12#6)(1996-2#1)(1997-7#4)(1997-8#3)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#8)(2008-10#36)(2008-11#96)(2008-12#11)(2008-3#3)(2008-4#14)(2008-5#10)(2008-6#8)(2008-7#35)(2008-8#50)(2008-9#45)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#9)(2009-2#1)(2009-3#5)(2009-4#7)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#10)(2010-12#11)(2010-2#2)(2010-3#4)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#49)(2011-3#2)(2012-1#15)(2012-12#11)(2012-2#22)(2012-3#8)(2012-4#3)(2013-1#44)(2013-7#8)(2013-8#8)
apoptosis)##6##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#1)
apoptosis-inducing activity##3##2##(2008-11#2)(2008-9#1)
apoptosis-inducing gene##3##2##(2008-8#2)(2008-9#1)
apoptosis-inducing ligand (TRAIL)##3##3##(2009-3#2)(2012-2#1)
apoptosis-inducing ligand##4##2##(2009-3#2)(2012-2#2)
apoptosis-inducing properties##2##2##(2008-10#1)(2009-3#1)
apoptosis-inducing##13##1##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-3#3)(2011-2#1)(2012-2#2)
apoptosis-mediated##3##1##(2008-7#2)(2011-2#1)
apoptosis-related genes##2##2##(2008-9#1)(2010-11#1)
apoptosis-related##3##1##(2008-9#2)(2010-11#1)
apoptotic bodies##8##2##(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
apoptotic cell death in##5##4##(1994-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
apoptotic cell death of##2##4##(1995-8#1)(2008-8#1)
apoptotic cell death##21##3##(1994-10#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
apoptotic cell##24##2##(1994-10#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
apoptotic cells by##2##3##(1995-2#1)(2008-12#1)
apoptotic cells in##2##3##(2010-1#1)(2012-1#1)
apoptotic cells##29##2##(1995-12#1)(1995-2#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#6)(2010-1#3)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
apoptotic changes in##2##3##(2008-10#1)(2008-7#1)
apoptotic changes##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
apoptotic death##4##2##(1995-6#1)(1996-12#1)(2008-11#1)(2011-2#1)
apoptotic effects of##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
apoptotic effects##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
apoptotic index was##2##3##(1995-6#1)(2008-7#1)
apoptotic indices##2##2##(2008-6#1)(2008-9#1)
apoptotic nuclei##2##2##(2008-7#1)(2008-8#1)
apoptotic pathway##9##2##(1995-12#1)(2008-4#1)(2008-9#1)(2009-12#2)(2009-9#1)(2010-11#1)(2011-2#2)
apoptotic pathways##2##2##(2008-6#1)(2008-8#1)
apoptotic process##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
apoptotic processes##3##2##(2008-9#1)(2013-8#2)
apoptotic signal##2##2##(2008-11#1)(2008-9#1)
apoptotic signals##2##2##(2008-11#1)(2010-3#1)
apoptotic stimuli##2##2##(2008-11#1)(2008-9#1)
apoptotic suppressor gene##2##3##(1997-9#2)
apoptotic volume decrease##2##3##(2008-8#1)(2013-8#1)
apoptotic##153##1##(1992-9#1)(1994-10#4)(1995-11#1)(1995-12#3)(1995-2#6)(1995-6#6)(1995-8#2)(1996-12#4)(1996-2#1)(1997-2#1)(1997-9#3)(2008-1#3)(2008-10#8)(2008-11#17)(2008-12#4)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#10)(2008-8#10)(2008-9#16)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
aposklesis##3##1##(2008-7#3)
apothecia as##2##2##(2008-10#2)
apothecia developed##2##2##(2008-10#2)
apothecia from##2##2##(2008-10#2)
apothecia in##2##2##(2008-10#2)
apothecia of T##2##3##(2008-10#2)
apothecia of##4##2##(2008-10#4)
apothecia produced##2##2##(2008-10#2)
apothecia to##3##2##(2008-10#3)
apothecia were##4##2##(2008-10#4)
apothecia##44##1##(2008-10#44)
apothecial emergence##2##2##(2008-10#2)
apothecial##5##1##(2008-10#5)
apothecium development##3##2##(2008-10#3)
apothecium##6##1##(2008-10#6)
apotheosis##2##1##(2009-10#2)
app(ATP) values##2##2##(1992-6#2)
app)##3##1##(2011-2#2)(2012-12#1)
appalling##4##1##(1995-6#1)(2008-6#1)(2009-10#2)
apparatus and the##2##3##(2009-3#1)(2012-3#1)
apparatus and##10##2##(1990-8#1)(1992-12#1)(1997-3#1)(2007-7#1)(2009-10#1)(2009-3#1)(2010-8#1)(2012-3#1)(2012-6#1)(2013-1#1)
apparatus are##3##2##(1991-2#1)(2008-3#1)(2008-6#1)
apparatus as##3##2##(2008-10#2)(2008-11#1)
apparatus designed##2##2##(1991-9#1)(2008-10#1)
apparatus for##7##2##(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
apparatus in##7##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-3#1)
apparatus is##9##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-8#1)(2012-2#1)
apparatus made##2##2##(1990-8#1)(2008-10#1)
apparatus of the##2##3##(1997-3#1)(2010-2#1)
apparatus of##5##2##(1990-5#1)(1997-3#1)(2008-4#1)(2008-6#1)(2010-2#1)
apparatus or##3##2##(1990-5#1)(1995-5#1)(2008-4#1)
apparatus to##6##2##(1990-2#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
apparatus used##3##2##(1990-8#1)(1994-8#1)(2008-10#1)
apparatus was##5##2##(1990-2#1)(2008-10#3)(2008-12#1)
apparatus were##4##2##(1997-7#1)(2007-8#1)(2008-10#2)
apparatus with##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
apparatus##175##1##(1990-12#1)(1990-2#3)(1990-5#4)(1990-7#5)(1990-8#3)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-12#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(2007-11#8)(2007-12#11)(2007-7#2)(2007-8#1)(2008-10#34)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#6)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#1)
apparatus)##3##1##(1992-7#1)(2008-10#1)(2008-6#1)
apparent &quot##2##2##(1995-5#1)(2011-1#1)
apparent K(m) for##4##3##(2008-7#4)
apparent K(m)##8##2##(1997-2#1)(2008-7#7)
apparent Kd of##4##3##(1990-5#3)(1994-6#1)
apparent Kd##5##2##(1990-5#3)(1994-5#1)(1994-6#1)
apparent Km for##4##3##(1990-11#2)(1990-2#1)(1992-3#1)
apparent Km of##5##3##(1992-3#2)(1992-6#1)(1995-11#1)(2008-11#1)
apparent Km value##3##3##(1990-8#1)(1994-12#1)(2008-8#1)
apparent Km values for##4##4##(1990-10#1)(1991-11#1)(1992-3#2)
apparent Km values##5##3##(1990-10#1)(1991-11#1)(1992-3#2)(1995-8#1)
apparent Km##20##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-8#1)(1991-11#1)(1992-3#5)(1992-6#2)(1994-12#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-8#1)
apparent M(r)##2##2##(1992-6#1)(1994-6#1)
apparent Mr of##3##3##(1990-12#1)(1996-2#1)(2010-11#1)
apparent Mr##4##2##(1990-12#1)(1990-7#1)(1996-2#1)(2010-11#1)
apparent ability##2##2##(1992-5#1)(2008-5#1)
apparent absorption##2##2##(2010-2#2)
apparent activation energy##2##3##(1992-3#2)
apparent activation of##2##3##(1990-12#1)(1991-2#1)
apparent activation##4##2##(1990-12#1)(1991-2#1)(1992-3#2)
apparent affinity of##4##3##(1990-7#1)(1995-11#1)(1995-12#1)(1996-12#1)
apparent affinity##7##2##(1990-7#1)(1993-6#2)(1995-11#1)(1995-12#2)(1996-12#1)
apparent after##3##2##(1994-11#1)(2008-5#1)(2010-5#1)
apparent among##2##2##(2008-10#1)(2009-10#1)
apparent and##2##2##(1990-5#1)(2009-12#1)
apparent as##2##2##(1997-2#1)(2007-8#1)
apparent association##2##2##(2008-10#1)(2008-8#1)
apparent between##3##2##(1993-12#1)(1994-12#1)(1994-9#1)
apparent binding constants##3##3##(2008-10#3)
apparent binding##8##2##(1991-5#1)(1994-3#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-3#1)
apparent by##2##2##(1993-8#1)(1994-9#1)
apparent change in the##2##4##(1994-8#1)(2013-8#1)
apparent change in##3##3##(1992-11#1)(1994-8#1)(2013-8#1)
apparent change##4##2##(1992-11#1)(1994-8#1)(2008-11#1)(2013-8#1)
apparent changes in##5##3##(1992-7#1)(1996-12#1)(1997-2#2)(2008-11#1)
apparent changes##6##2##(1992-7#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-5#1)
apparent competition between##2##3##(2008-9#2)
apparent competition##8##2##(2007-7#1)(2008-8#1)(2008-9#6)
apparent complexation constants##2##3##(2008-10#2)
apparent contradiction can be##2##4##(2007-12#1)(2008-8#1)
apparent coordination##2##2##(2008-10#1)(2008-9#1)
apparent differences##3##2##(1990-7#1)(1996-12#1)(1997-2#1)
apparent diffusion coefficient (ADC) and##2##5##(2008-11#1)(2009-11#1)
apparent diffusion coefficient (ADC)##4##4##(1996-5#1)(2008-11#1)(2009-11#1)(2012-2#1)
apparent diffusion coefficient##8##3##(1996-5#1)(2008-10#2)(2008-11#1)(2009-11#2)(2010-12#1)(2012-2#1)
apparent diffusion##9##2##(1996-5#1)(2008-10#3)(2008-11#1)(2009-11#2)(2010-12#1)(2012-2#1)
apparent digestibility of##2##3##(2008-10#1)(2008-12#1)
apparent discrepancies between##2##3##(1990-6#1)(1997-2#1)
apparent discrepancies##4##2##(1990-6#1)(1997-2#1)(2008-8#1)(2013-8#1)
apparent dissociation constant (Kd)##2##4##(1990-11#1)(1990-12#1)
apparent dissociation constant of##3##4##(1993-9#1)(1996-3#1)(2008-9#1)
apparent dissociation constant##7##3##(1990-11#1)(1990-12#1)(1993-8#1)(1993-9#1)(1996-3#1)(2008-10#1)(2008-9#1)
apparent dissociation constants##3##3##(1991-5#1)(1995-2#1)(2008-10#1)
apparent dissociation##11##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-9#1)
apparent effect on##2##3##(1993-8#1)(1995-2#1)
apparent effect##3##2##(1993-8#1)(1995-2#1)(2008-9#1)
apparent effects on##2##3##(2008-11#1)(2012-1#1)
apparent effects##4##2##(1994-9#1)(2008-11#2)(2012-1#1)
apparent following##2##2##(1994-2#1)(1995-5#1)
apparent for##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)
apparent from the##2##3##(1994-8#1)(2008-10#1)
apparent from##5##2##(1994-8#1)(1996-2#1)(2008-10#2)(2008-3#1)
apparent heterogeneous electron transfer rate##2##5##(2008-10#2)
apparent heterogeneous##3##2##(2008-10#3)
apparent homogeneity from##3##3##(1990-12#1)(1994-5#1)(1996-5#1)
apparent homogeneity##7##2##(1990-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-2#1)
apparent in any##2##3##(1991-6#1)(2008-9#1)
apparent in the##7##3##(1993-8#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
apparent in##23##2##(1991-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-5#1)(1997-3#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)
apparent increase in##6##3##(1991-12#1)(1991-9#1)(1994-12#1)(1995-5#1)(2008-10#2)
apparent increase##7##2##(1991-12#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(2008-10#2)
apparent infection rate##8##3##(2008-10#8)
apparent inhibition constant##2##3##(1995-5#1)(2008-10#1)
apparent inhibition##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
apparent ionization##2##2##(1990-8#1)(2008-10#1)
apparent life-threatening events##2##3##(1992-4#1)(2008-11#1)
apparent loss of##2##3##(1991-8#1)(2008-10#1)
apparent mass of##3##3##(1990-7#2)(1992-8#1)
apparent mass##4##2##(1990-7#2)(1992-12#1)(1992-8#1)
apparent molar absorption coefficient##2##4##(2008-10#2)
apparent molar absorptivity is 1##2##5##(2008-10#2)
apparent molar absorptivity is##6##4##(2008-10#6)
apparent molar absorptivity of##4##4##(2008-10#4)
apparent molar absorptivity##12##3##(2008-10#12)
apparent molar##17##2##(2008-10#17)
apparent molecular mass of##12##4##(1990-5#1)(1990-7#1)(1992-10#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-6#2)(1996-12#1)(1997-2#2)(1997-4#1)
apparent molecular mass##16##3##(1990-5#1)(1990-7#1)(1992-10#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-6#2)(1996-12#1)(1997-2#2)(1997-4#1)(2008-10#1)
apparent molecular masses of##2##4##(1990-5#1)(2008-10#1)
apparent molecular masses##3##3##(1990-5#1)(1997-2#1)(2008-10#1)
apparent molecular weight of##8##4##(1990-11#1)(1991-2#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-9#2)(1997-2#1)
apparent molecular weight##16##3##(1990-11#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-11#2)(1994-8#1)(1994-9#2)(1997-2#1)(2008-11#2)
apparent molecular weights of##2##4##(1990-5#1)(1997-7#1)
apparent molecular weights##4##3##(1990-12#1)(1990-5#1)(1992-6#1)(1997-7#1)
apparent molecular##41##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#1)(1991-2#2)(1991-5#1)(1992-10#1)(1992-11#1)(1992-6#3)(1992-7#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#2)(1996-12#1)(1997-2#4)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#2)
apparent nutrient digestibility##3##3##(2012-2#3)
apparent on##3##2##(2007-5#2)(2008-5#1)
apparent only##2##2##(1992-9#1)(2008-10#1)
apparent optical properties of##3##4##(2008-2#2)(2008-3#1)
apparent optical properties##5##3##(2008-2#4)(2008-3#1)
apparent optical##6##2##(2008-2#4)(2008-3#2)
apparent over the##2##3##(2008-10#1)(2012-3#1)
apparent pK##2##2##(1990-8#1)(1994-5#1)
apparent pKa##2##2##(1990-5#1)(1990-8#1)
apparent paradox##4##2##(1994-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
apparent permeability coefficient##4##3##(1990-11#3)(2011-3#1)
apparent permeability##6##2##(1990-11#4)(2008-5#1)(2011-3#1)
apparent protection##2##2##(1994-11#1)(2010-4#1)
apparent rate constants of##2##4##(1992-6#1)(2008-10#1)
apparent recovery##2##2##(2008-10#2)
apparent relationship between##2##3##(2008-11#1)(2011-2#1)
apparent relationship##3##2##(2008-11#2)(2011-2#1)
apparent similarity##4##2##(1995-8#1)(1996-6#1)(2008-10#1)(2008-4#1)
apparent specific volume##2##3##(2008-10#2)
apparent specific##5##2##(2008-10#5)
apparent than##2##2##(1995-1#1)(2008-10#1)
apparent that the##4##3##(2006-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
apparent that##29##2##(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-1#1)
apparent using##2##2##(1996-12#1)(2013-1#1)
apparent viscosity and##3##3##(2008-5#2)(2011-2#1)
apparent viscosity##5##2##(2008-5#4)(2011-2#1)
apparent##614##1##(1990-10#2)(1990-11#10)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#10)(1990-6#5)(1990-7#7)(1990-8#8)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#3)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#8)(1993-9#2)(1994-1#1)(1994-11#9)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#4)(1994-8#5)(1994-9#6)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#6)(1995-6#4)(1995-8#2)(1996-12#9)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#17)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#2)(2006-6#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#8)(2008-10#124)(2008-11#23)(2008-12#3)(2008-2#12)(2008-3#14)(2008-4#6)(2008-5#16)(2008-6#3)(2008-7#17)(2008-8#12)(2008-9#22)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#2)
apparently allosteric##2##2##(1992-8#2)
apparently because of##2##3##(1992-3#1)(2008-9#1)
apparently been##2##2##(2008-10#1)(2008-4#1)
apparently by##4##2##(1991-2#1)(1992-12#1)(1995-6#1)(2013-1#1)
apparently caused by Mycoplasma gallisepticum##2##5##(1997-6#2)
apparently contradictory##2##2##(1993-12#1)(2009-8#1)
apparently dependent on the##2##4##(1995-6#1)(2008-8#1)
apparently developed##2##2##(1997-8#1)(2008-10#1)
apparently did not##2##3##(2008-10#1)(2008-4#1)
apparently does not##2##3##(1993-8#1)(1995-6#1)
apparently due to##2##3##(1994-5#1)(1995-11#1)
apparently had##2##2##(1993-11#1)(1994-5#1)
apparently healthy adults##2##3##(2008-7#1)(2012-2#1)
apparently healthy subjects##2##3##(1991-5#1)(1996-12#1)
apparently healthy young##2##3##(2009-7#1)(2010-3#1)
apparently healthy##15##2##(1991-5#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-7#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
apparently higher##2##2##(2007-7#1)(2008-4#1)
apparently independent of##2##3##(2010-3#1)(2012-3#1)
apparently independent##3##2##(1990-3#1)(2010-3#1)(2012-3#1)
apparently no##3##2##(1993-12#1)(2008-5#1)(2013-8#1)
apparently normal##6##2##(1993-12#3)(1994-12#1)(2008-1#1)(2008-8#1)
apparently not a##2##3##(1991-8#1)(2007-5#1)
apparently not due to##2##4##(1991-10#1)(1994-8#1)
apparently not##10##2##(1991-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1994-8#1)(2007-5#1)(2008-10#1)(2008-8#1)(2013-1#2)
apparently occurred##2##2##(1991-8#1)(2008-10#1)
apparently paradoxical##2##2##(1997-1#1)(2013-1#1)
apparently reflecting the##2##3##(1997-6#1)(2007-11#1)
apparently unrelated##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2010-12#1)
apparently was not##2##3##(1992-3#1)(2008-10#1)
apparently was##3##2##(1992-3#1)(1997-3#1)(2008-10#1)
apparently without##3##2##(1995-6#1)(2008-5#1)(2010-4#1)
apparently##218##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-7#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#3)(1991-9#2)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#6)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#4)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#36)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#3)
appeal for##2##2##(2008-8#1)(2012-2#1)
appeal to the##4##3##(1991-1#1)(1991-2#1)(1996-5#1)(2012-2#1)
appeal to##7##2##(1991-1#1)(1991-2#1)(1992-2#1)(1996-5#1)(2012-2#2)(2013-1#1)
appeal##32##1##(1990-2#1)(1991-1#5)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-5#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
appealed the##2##2##(1995-12#1)(1997-5#1)
appealed to##2##2##(2008-2#1)(2009-7#1)
appealed##6##1##(1990-4#1)(1995-12#1)(1996-12#1)(1997-5#1)(2008-2#1)(2009-7#1)
appealing for##3##2##(2007-11#2)(2008-9#1)
appealing to##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
appealing##21##1##(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
appeals court agreed##2##3##(1995-12#1)(1996-5#1)
appeals court##9##2##(1995-12#3)(1995-6#3)(1996-5#2)(1997-5#1)
appeals of PRO##2##3##(1991-1#1)(1991-3#1)
appeals process##2##2##(1996-1#1)(2008-6#1)
appeals to##2##2##(1994-7#1)(2008-2#1)
appeals##19##1##(1991-1#1)(1991-3#1)(1994-7#1)(1995-12#3)(1995-6#4)(1996-1#1)(1996-5#2)(1997-5#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-8#1)
appear a##2##2##(1994-5#1)(2007-7#1)
appear after##3##2##(2007-7#1)(2008-10#1)(2008-7#1)
appear and##2##2##(1996-6#1)(2007-12#1)
appear as a##2##3##(1990-12#1)(1991-11#1)
appear as an##2##3##(2010-11#1)(2010-5#1)
appear as##17##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-5#1)(1994-5#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
appear at different##2##3##(2008-2#1)(2009-10#1)
appear at##6##2##(1993-8#1)(1994-8#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-8#1)
appear clinically##4##2##(2007-7#1)(2008-11#1)(2010-6#1)(2011-1#1)
appear during the##2##3##(1994-9#1)(2008-10#1)
appear during##4##2##(1994-9#1)(2008-10#1)(2009-3#1)(2013-7#1)
appear for##2##2##(2008-10#1)(2008-2#1)
appear important##2##2##(2008-5#1)(2013-8#1)
appear in a##2##3##(1993-1#1)(2009-7#1)
appear in the##14##3##(1992-3#1)(1993-2#1)(1995-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#1)
appear in##34##2##(1990-12#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-1#1)(1994-9#1)(1995-1#1)(1997-8#1)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-8#1)
appear more##4##2##(1993-12#2)(1994-2#1)(2010-12#1)
appear morphologically##3##2##(2008-10#1)(2011-2#2)
appear normal##2##2##(1991-7#1)(2008-10#1)
appear not to##2##3##(2007-12#1)(2009-9#1)
appear not##3##2##(2007-12#1)(2008-8#1)(2009-9#1)
appear particularly##2##2##(2008-10#1)(2008-4#1)
appear promising##3##2##(1991-1#2)(2008-7#1)
appear related to##2##3##(2008-10#1)(2009-10#1)
appear similar to##3##3##(1995-6#1)(2008-10#1)(2008-4#1)
appear that##7##2##(1991-11#1)(1991-12#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-2#1)(2011-2#1)
appear to affect##4##3##(1994-3#1)(2008-2#1)(2008-7#1)(2008-9#1)
appear to alter##2##3##(2010-8#1)(2012-3#1)
appear to arise##2##3##(2007-11#1)(2011-1#1)
appear to be a##9##4##(1993-12#1)(1995-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2010-5#1)(2010-8#1)
appear to be an##3##4##(2008-7#2)(2011-1#1)
appear to be associated with##5##5##(1994-2#1)(1995-6#1)(2007-6#1)(2008-7#1)(2013-1#1)
appear to be associated##6##4##(1994-2#1)(1995-6#1)(2007-6#1)(2008-4#1)(2008-7#1)(2013-1#1)
appear to be at##2##4##(1996-11#1)(2007-12#1)
appear to be derived from##2##5##(1994-3#1)(2008-10#1)
appear to be distinct##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
appear to be dominated by##2##5##(1992-9#1)(2011-2#1)
appear to be essential for the##2##6##(1994-6#1)(1995-12#1)
appear to be highly##2##4##(1991-4#1)(2008-8#1)
appear to be important in the##2##6##(2008-10#1)(2008-4#1)
appear to be important##3##4##(2007-11#1)(2008-10#1)(2008-4#1)
appear to be in##2##4##(1996-12#1)(2009-6#1)
appear to be independent##2##4##(1994-7#1)(2010-5#1)
appear to be involved in the##4##6##(1992-3#1)(1995-12#1)(2008-10#2)
appear to be involved in##5##5##(1992-3#1)(1995-12#1)(2008-10#3)
appear to be involved##8##4##(1992-3#1)(1993-5#1)(1995-12#1)(2008-10#4)(2010-5#1)
appear to be less##2##4##(1994-3#1)(2009-6#1)
appear to be mediated by##2##5##(2009-5#1)(2013-8#1)
appear to be more##3##4##(2008-11#1)(2008-3#1)(2012-12#1)
appear to be of##5##4##(1994-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
appear to be particularly##2##4##(1990-2#1)(2008-10#1)
appear to be present##2##4##(1994-8#1)(2008-7#1)
appear to be promising##2##4##(2008-11#1)(2008-5#1)
appear to be related to##2##5##(2008-9#1)(2009-2#1)
appear to be related##3##4##(1993-11#1)(2008-9#1)(2009-2#1)
appear to be required##2##4##(2008-10#1)(2010-5#1)
appear to be restricted to##2##5##(1991-6#1)(2008-7#1)
appear to be significantly##2##4##(1990-8#1)(2008-3#1)
appear to be similar##2##4##(2008-10#1)(2011-2#1)
appear to be superior to the##3##6##(2008-2#1)(2008-8#1)(2013-1#1)
appear to be the first##2##5##(2007-8#1)(2011-1#1)
appear to be the##8##4##(1992-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)
appear to be very##3##4##(1991-6#1)(1995-5#1)(2008-10#1)
appear to be well##2##4##(1996-2#1)(2008-3#1)
appear to be##183##3##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-2#2)(1991-4#3)(1991-6#3)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#8)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
appear to change##2##3##(1991-12#1)(2008-5#1)
appear to disrupt##2##3##(1990-7#1)(1994-9#1)
appear to enhance##2##3##(2008-5#1)(2012-3#1)
appear to exist##2##3##(1994-5#1)(2008-10#1)
appear to function##2##3##(2007-8#1)(2009-6#1)
appear to have a##8##4##(1991-11#1)(1992-5#1)(1994-5#1)(2006-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2013-7#1)
appear to have an##2##4##(2008-10#1)(2008-7#1)
appear to have been##4##4##(1996-6#1)(2008-10#3)
appear to have no##3##4##(1990-11#1)(1996-3#1)(2007-11#1)
appear to have the##4##4##(1995-2#1)(2008-11#1)(2008-8#1)(2009-5#1)
appear to have##48##3##(1990-11#1)(1990-3#1)(1991-11#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#2)(1996-3#1)(1996-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#2)(2011-2#2)(2012-3#1)(2013-7#1)
appear to improve##3##3##(2007-11#1)(2007-2#1)(2013-7#1)
appear to increase##2##3##(2007-10#1)(2008-10#1)
appear to induce##3##3##(1991-5#1)(1997-4#1)(2008-5#1)
appear to involve a##2##4##(1992-9#1)(1994-5#1)
appear to involve##3##3##(1992-9#1)(1994-5#1)(2008-2#1)
appear to offer##2##3##(2008-10#1)(2008-11#1)
appear to operate##2##3##(1995-6#1)(2008-8#1)
appear to play a##2##4##(1994-12#1)(2008-10#1)
appear to play an important role in##2##7##(1997-8#1)(2008-4#1)
appear to play##5##3##(1994-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
appear to provide##3##3##(1994-8#1)(2010-6#1)(2012-1#1)
appear to reflect##2##3##(1993-12#1)(2008-2#1)
appear to represent a##3##4##(1991-2#1)(2008-7#1)(2011-2#1)
appear to require##2##3##(2008-11#1)(2009-10#1)
appear to result from##2##4##(2008-11#2)
appear to result##4##3##(1997-1#1)(2008-11#2)(2012-3#1)
appear to share##3##3##(1992-6#1)(2008-1#1)(2013-1#1)
appear to underlie##2##3##(1995-8#1)(2010-2#1)
appear to use##2##3##(2008-11#1)(2010-8#1)
appear to##375##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#3)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#3)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#36)(2008-11#13)(2008-12#3)(2008-2#8)(2008-3#8)(2008-4#7)(2008-5#11)(2008-6#6)(2008-7#19)(2008-8#14)(2008-9#9)(2009-10#4)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#2)
appear when##2##2##(2007-11#1)(2008-3#1)
appear##579##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#3)(1991-1#3)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#2)(1992-11#2)(1992-12#1)(1992-3#5)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#6)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#4)(1995-12#8)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#5)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#4)(1996-5#4)(1996-6#3)(1997-1#4)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#16)(2007-2#2)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#56)(2008-11#19)(2008-12#3)(2008-2#16)(2008-3#13)(2008-4#12)(2008-5#17)(2008-6#7)(2008-7#29)(2008-8#15)(2008-9#15)(2009-10#8)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#4)(2010-8#5)(2011-1#7)(2011-2#18)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#9)(2013-7#3)(2013-8#6)
appearance and behavior##2##3##(2008-11#2)
appearance and the##4##3##(1996-3#1)(1997-8#1)(2008-12#1)(2008-5#1)
appearance and##32##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
appearance comparison##3##2##(2007-12#3)
appearance dynamics##2##2##(1995-6#1)(2008-10#1)
appearance for##3##2##(1996-11#1)(2008-11#1)(2012-3#1)
appearance from##2##2##(1993-2#1)(2008-2#1)
appearance in a##2##3##(2008-10#1)(2012-3#1)
appearance in the##3##3##(2008-12#1)(2008-7#1)(2010-3#1)
appearance in##11##2##(1992-2#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
appearance investment##2##2##(2007-12#2)
appearance is##6##2##(1990-8#1)(1994-10#1)(1996-6#1)(2008-2#1)(2008-5#1)(2011-2#1)
appearance of a single##2##4##(1993-11#1)(2008-10#1)
appearance of a##21##3##(1991-2#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-5#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2012-2#1)(2012-3#1)
appearance of local##2##3##(1990-6#1)(2011-1#1)
appearance of mutant##2##3##(1991-2#1)(1995-6#1)
appearance of new##5##3##(2007-11#1)(2008-10#3)(2011-2#1)
appearance of signs of##2##4##(1995-3#1)(2013-1#1)
appearance of signs##3##3##(1995-3#1)(2010-12#1)(2013-1#1)
appearance of the hand##2##4##(2007-11#1)(2008-9#1)
appearance of the##35##3##(1990-6#1)(1990-8#1)(1991-6#1)(1992-6#1)(1993-12#1)(1994-11#2)(1996-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#4)(2008-6#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)
appearance of these##3##3##(2008-11#2)(2012-2#1)
appearance of this##3##3##(1992-5#1)(2008-10#1)(2008-7#1)
appearance of##194##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#2)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#2)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#11)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#1)
appearance on the##2##3##(1991-11#1)(1995-4#1)
appearance on##4##2##(1991-11#1)(1995-4#1)(2008-10#1)(2010-6#1)
appearance self-concept##2##2##(2009-7#2)
appearance time of##2##3##(2008-10#2)
appearance was##5##2##(1992-9#1)(1993-6#1)(1997-8#1)(2007-12#1)(2010-6#1)
appearance were##2##2##(1992-8#1)(2007-12#1)
appearance which##2##2##(2008-7#1)(2011-1#1)
appearance with##5##2##(1990-8#1)(1990-9#1)(2008-2#1)(2010-6#1)(2013-1#1)
appearance##365##1##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#5)(1991-9#1)(1992-10#1)(1992-12#4)(1992-2#3)(1992-5#2)(1992-6#4)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#4)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#5)(2007-11#2)(2007-12#22)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#54)(2008-11#11)(2008-12#6)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#22)(2008-6#7)(2008-7#15)(2008-8#3)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#6)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#12)(2012-12#6)(2012-2#9)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#3)
appearance)##3##1##(2008-10#1)(2011-2#2)
appearances of the##4##3##(1997-8#2)(2012-2#2)
appearances of##11##2##(1991-8#1)(1997-8#2)(2008-1#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#3)(2013-8#1)
appearances##21##1##(1991-8#1)(1997-8#2)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-2#6)(2013-8#1)
appeared a##2##2##(2008-7#1)(2010-8#1)
appeared after##3##2##(1993-11#1)(2008-10#2)
appeared and##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
appeared as a##7##3##(1994-2#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)
appeared as an##3##3##(2008-10#1)(2012-12#2)
appeared as the##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
appeared as##24##2##(1990-5#1)(1991-6#1)(1994-2#1)(1995-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
appeared at 0##3##3##(2008-10#1)(2008-8#2)
appeared at the##3##3##(1992-9#1)(2008-5#1)(2011-2#1)
appeared at##16##2##(1992-9#1)(1993-8#2)(1995-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2011-2#1)(2011-3#1)(2013-7#1)
appeared between##3##2##(1990-9#1)(1996-11#1)(2008-5#1)
appeared earlier##2##2##(1992-11#1)(2008-10#1)
appeared from##2##2##(1997-3#1)(2008-7#1)
appeared highly##3##2##(2008-10#2)(2008-9#1)
appeared in a##2##3##(1995-3#1)(2013-8#1)
appeared in the##15##3##(1990-3#1)(1993-12#2)(1994-9#1)(1995-2#1)(1995-3#1)(1997-6#3)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)
appeared in##46##2##(1990-12#1)(1990-3#2)(1991-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-5#1)(1996-9#1)(1997-6#3)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
appeared more##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
appeared necrotic##2##2##(2008-10#2)
appeared not to be##3##4##(1992-11#1)(1992-12#1)(2008-5#1)
appeared not##4##2##(1992-11#1)(1992-12#1)(1994-8#1)(2008-5#1)
appeared on the##3##3##(2008-10#3)
appeared on##6##2##(1993-12#1)(1997-5#1)(2008-10#3)(2008-5#1)
appeared only in##2##3##(1994-6#1)(1996-10#1)
appeared only##3##2##(1994-6#1)(1996-10#1)(1996-2#1)
appeared similar to that##2##4##(2008-10#1)(2008-7#1)
appeared similar to##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
appeared similar##4##2##(1996-12#1)(2008-10#2)(2008-7#1)
appeared suddenly##2##2##(2008-5#1)(2010-7#1)
appeared that the##8##3##(1993-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-3#1)
appeared that##13##2##(1990-7#1)(1993-8#1)(1995-9#1)(1996-5#1)(1997-6#1)(2008-10#4)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
appeared to act##2##3##(1993-1#1)(1995-11#1)
appeared to affect the##2##4##(1990-5#1)(2008-11#1)
appeared to arise##2##3##(1990-6#1)(2008-5#1)
appeared to be a sensitive##2##5##(1994-8#1)(2008-5#1)
appeared to be a useful##3##5##(1995-11#1)(2008-10#1)(2010-8#1)
appeared to be a##21##4##(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
appeared to be an##3##4##(1995-11#1)(1995-3#1)(2007-8#1)
appeared to be associated with##4##5##(1994-7#1)(2008-10#2)(2009-12#1)
appeared to be due to##2##5##(1995-8#1)(2011-2#1)
appeared to be due##3##4##(1995-8#1)(2008-8#1)(2011-2#1)
appeared to be high##2##4##(1990-5#1)(2011-1#1)
appeared to be mainly##2##4##(2008-10#1)(2008-11#1)
appeared to be no##2##4##(1992-11#1)(2008-12#1)
appeared to be of##2##4##(1995-12#1)(2008-10#1)
appeared to be related to##4##5##(1997-4#1)(2008-10#2)(2008-8#1)
appeared to be related##5##4##(1997-4#1)(2007-11#1)(2008-10#2)(2008-8#1)
appeared to be significantly##2##4##(1995-12#1)(2013-1#1)
appeared to be stimulatory##2##4##(1993-12#2)
appeared to be the most##2##5##(2008-10#1)(2008-7#1)
appeared to be the##5##4##(1994-3#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
appeared to be##127##3##(1990-2#2)(1990-3#1)(1990-5#3)(1991-12#3)(1991-3#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#33)(2008-11#6)(2008-12#2)(2008-5#4)(2008-7#3)(2008-8#4)(2009-10#2)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
appeared to cause##2##3##(1995-12#1)(2008-6#1)
appeared to contain##3##3##(1993-6#1)(1997-3#1)(2008-10#1)
appeared to decrease##2##3##(2008-10#1)(2011-2#1)
appeared to depend on##2##4##(1994-8#1)(1995-2#1)
appeared to facilitate##2##3##(2008-11#1)(2008-6#1)
appeared to have a##5##4##(1991-6#1)(1995-11#1)(2009-3#1)(2011-1#1)(2012-2#1)
appeared to have had##2##4##(1995-8#1)(1996-1#1)
appeared to have##17##3##(1990-2#1)(1991-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(2007-7#1)(2008-11#2)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-2#1)
appeared to increase with##2##4##(2008-3#1)(2010-5#1)
appeared to increase##5##3##(1993-6#1)(1995-11#1)(2008-12#1)(2008-3#1)(2010-5#1)
appeared to induce##4##3##(1990-5#1)(1993-3#1)(2008-11#1)(2008-5#1)
appeared to label##2##3##(2007-12#2)
appeared to lose the ability to##2##6##(2008-10#2)
appeared to occur##2##3##(1990-7#1)(2008-10#1)
appeared to reduce##2##3##(1995-12#1)(2010-8#1)
appeared to remain##2##3##(1996-6#1)(2008-10#1)
appeared to result in##2##4##(1994-3#1)(2008-10#1)
appeared to show##3##3##(1993-3#1)(1995-2#1)(2008-5#1)
appeared to##239##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#6)(1995-12#7)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#53)(2008-11#17)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
appeared unaffected by##2##3##(1993-12#1)(1996-3#1)
appeared when##4##2##(1991-12#1)(1992-3#1)(2008-12#1)(2008-5#1)
appeared with##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
appeared within##2##2##(1994-6#1)(1994-8#1)
appeared##494##1##(1990-12#4)(1990-2#3)(1990-3#3)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#5)(1991-3#2)(1991-6#2)(1991-8#2)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#5)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#10)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#4)(1994-7#2)(1994-8#7)(1994-9#2)(1995-11#6)(1995-12#10)(1995-2#7)(1995-3#3)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#1)(1997-8#4)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-10#114)(2008-11#26)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#24)(2008-6#6)(2008-7#16)(2008-8#11)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#7)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#6)
appearence##3##1##(1995-4#1)(1997-9#1)(2008-2#1)
appearing as##2##2##(2007-12#1)(2009-6#1)
appearing at##2##2##(2008-10#1)(2008-9#1)
appearing in all##2##3##(2008-11#1)(2008-3#1)
appearing in the##3##3##(1992-2#1)(1997-7#1)(2007-11#1)
appearing in##19##2##(1990-6#1)(1992-2#2)(1995-12#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#2)(2012-1#1)
appearing more##2##2##(1993-2#1)(2008-12#1)
appearing##52##1##(1990-6#1)(1992-2#3)(1992-6#2)(1993-2#1)(1993-5#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
appears a##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
appears as a##9##3##(1991-12#1)(1992-9#1)(1995-12#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#1)
appears as the##3##3##(1990-11#1)(2008-3#1)(2009-11#1)
appears as##16##2##(1990-11#1)(1991-12#1)(1992-9#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
appears at##4##2##(1993-8#1)(2008-10#1)(2008-3#2)
appears beneficial##2##2##(2008-10#1)(2011-2#1)
appears due to##2##3##(1995-3#1)(2013-1#1)
appears in the##12##3##(1990-2#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)
appears in this issue##2##4##(2008-6#1)(2010-5#1)
appears in##27##2##(1990-2#1)(1992-8#1)(1994-6#1)(1994-9#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-5#1)
appears less##2##2##(1992-2#1)(1996-11#1)
appears limited##2##2##(2009-5#1)(2013-1#1)
appears more##3##2##(2006-6#1)(2011-2#1)(2012-2#1)
appears not to be essential for##2##6##(1990-5#1)(1995-11#1)
appears not to be##3##4##(1990-5#1)(1992-11#1)(1995-11#1)
appears not to##5##3##(1990-5#1)(1992-11#1)(1993-9#1)(1995-11#1)(2009-8#1)
appears on##2##2##(2009-3#1)(2013-1#1)
appears particularly##2##2##(2011-2#1)(2012-2#1)
appears promising##3##2##(1995-5#1)(2008-2#1)(2009-10#1)
appears that a##5##3##(1992-11#1)(1994-11#1)(2008-5#1)(2010-4#1)(2011-1#1)
appears that about##2##3##(1990-11#1)(2007-4#1)
appears that in##2##3##(1992-6#1)(1997-4#1)
appears that individual##2##3##(2008-7#1)(2012-12#1)
appears that the##24##3##(1990-11#1)(1991-6#1)(1991-8#1)(1992-6#2)(1993-11#1)(1993-8#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#1)(2013-1#1)
appears that these##2##3##(1994-11#1)(2009-5#1)
appears that this##4##3##(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
appears that##92##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
appears to act##2##3##(2008-10#1)(2008-2#1)
appears to affect##3##3##(1994-5#1)(2008-5#1)(2012-2#1)
appears to be a consensus##2##5##(1993-11#1)(2008-10#1)
appears to be a novel##2##5##(2008-10#1)(2011-2#1)
appears to be a practical##2##5##(1997-2#1)(2008-3#1)
appears to be a promising##2##5##(1997-4#1)(2008-3#1)
appears to be a reasonable##2##5##(1993-1#1)(2012-2#1)
appears to be a relatively##2##5##(2012-2#1)(2013-1#1)
appears to be a safe##2##5##(1992-2#1)(1996-9#1)
appears to be a specific##2##5##(1992-11#1)(1992-6#1)
appears to be a useful tool##2##6##(1990-2#1)(2008-2#1)
appears to be a very promising##2##6##(1990-9#1)(2007-11#1)
appears to be a very##3##5##(1990-9#1)(1994-12#1)(2007-11#1)
appears to be a##65##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-2#3)(2013-1#1)
appears to be an effective##2##5##(1991-4#1)(2007-10#1)
appears to be an important##3##5##(1990-12#1)(1993-2#1)(2008-9#1)
appears to be an increase in##2##6##(1992-2#1)(2008-5#1)
appears to be an integral membrane protein##2##7##(1990-11#1)(1990-12#1)
appears to be an##18##4##(1990-11#1)(1990-12#2)(1991-4#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-11#1)(2007-10#2)(2008-10#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
appears to be as effective as##2##6##(1996-1#1)(2007-7#1)
appears to be as##3##4##(1996-1#1)(2007-7#1)(2008-5#1)
appears to be associated with a poor##2##7##(1994-12#1)(2007-10#1)
appears to be associated with a##3##6##(1994-12#1)(2007-10#1)(2011-2#1)
appears to be associated with##7##5##(1990-2#1)(1993-8#1)(1994-12#1)(1997-4#1)(2007-10#1)(2011-2#2)
appears to be characterized by##2##5##(1990-3#1)(2013-8#1)
appears to be correlated with##2##5##(1993-5#1)(2008-10#1)
appears to be decreased##2##4##(2012-2#2)
appears to be dependent on##2##5##(1994-10#1)(1995-5#1)
appears to be dependent upon##2##5##(2010-11#1)(2011-2#1)
appears to be dependent##4##4##(1994-10#1)(1995-5#1)(2010-11#1)(2011-2#1)
appears to be due to the##2##6##(1994-8#1)(1996-2#1)
appears to be due to##3##5##(1992-8#1)(1994-8#1)(1996-2#1)
appears to be feasible##2##4##(2008-11#1)(2008-3#1)
appears to be important##2##4##(1997-4#1)(2008-4#1)
appears to be in a##2##5##(1994-8#1)(2007-12#1)
appears to be in##3##4##(1994-8#1)(1995-12#1)(2007-12#1)
appears to be inconsistent##2##4##(2008-10#1)(2008-12#1)
appears to be increased##2##4##(2008-1#1)(2008-3#1)
appears to be increasing##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
appears to be independent of##2##5##(1990-2#1)(1991-11#1)
appears to be induced by##2##5##(1996-9#1)(2008-10#1)
appears to be induced##3##4##(1996-9#1)(2008-10#1)(2013-8#1)
appears to be influenced by the##2##6##(1996-12#1)(2010-6#1)
appears to be influenced by##3##5##(1994-5#1)(1996-12#1)(2010-6#1)
appears to be involved in the##3##6##(1994-2#1)(2008-1#1)(2011-2#1)
appears to be involved in##5##5##(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
appears to be linked to##2##5##(2008-5#1)(2010-3#1)
appears to be mediated by##2##5##(1991-5#1)(2012-1#1)
appears to be mediated##3##4##(1991-5#1)(2009-8#1)(2012-1#1)
appears to be more##4##4##(1990-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
appears to be no##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
appears to be of##4##4##(1992-1#1)(2008-10#2)(2013-1#1)
appears to be one##3##4##(1993-5#1)(2008-10#1)(2008-6#1)
appears to be regulated by##2##5##(1997-1#1)(2008-10#1)
appears to be related to the##3##6##(1992-3#1)(2006-10#1)(2008-3#1)
appears to be related to##4##5##(1992-3#1)(1997-1#1)(2006-10#1)(2008-3#1)
appears to be safe##2##4##(2007-7#1)(2011-2#1)
appears to be similar##2##4##(1995-5#2)
appears to be sufficient##2##4##(1997-4#1)(2008-3#1)
appears to be the best##2##5##(1994-5#1)(2008-7#1)
appears to be the first##3##5##(1992-12#1)(1992-8#1)(2009-3#1)
appears to be the most##5##5##(1990-5#1)(1993-3#1)(2009-11#1)(2009-12#1)(2009-8#1)
appears to be the##28##4##(1990-5#2)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
appears to be##301##3##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#5)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-8#2)(2006-10#3)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#3)(2007-7#2)(2008-1#5)(2008-10#33)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#4)
appears to cause##2##3##(2008-11#1)(2012-2#1)
appears to confer##2##3##(1991-1#1)(2008-7#1)
appears to contain##2##3##(1993-11#1)(1993-6#1)
appears to correlate with##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
appears to correspond##2##3##(1991-11#1)(2008-11#1)
appears to exert a##2##4##(2008-4#1)(2009-8#1)
appears to exhibit##2##3##(2008-12#1)(2009-12#1)
appears to follow##2##3##(1990-5#1)(2012-2#1)
appears to function as##2##4##(1993-12#1)(2007-12#1)
appears to function##5##3##(1993-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)
appears to have a##11##4##(1990-5#1)(1992-8#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2006-10#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)
appears to have been##5##4##(1990-3#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
appears to have occurred##2##4##(1995-2#1)(2009-8#1)
appears to have the##2##4##(2008-9#1)(2010-8#1)
appears to have##39##3##(1990-3#1)(1990-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
appears to increase the##3##4##(1990-2#1)(1997-3#1)(2009-8#1)
appears to increase##4##3##(1990-2#1)(1997-3#1)(1997-6#1)(2009-8#1)
appears to influence the##2##4##(2008-9#1)(2013-8#1)
appears to influence##3##3##(1994-6#1)(2008-9#1)(2013-8#1)
appears to involve##2##3##(2008-10#1)(2012-12#1)
appears to modulate##2##3##(1991-9#1)(2008-11#1)
appears to occur##2##3##(1994-8#1)(2008-7#1)
appears to play a crucial role##2##6##(1992-10#1)(2008-6#1)
appears to play a##7##4##(1990-5#1)(1992-10#1)(1992-9#1)(1994-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
appears to play an important role in##2##7##(1995-12#1)(2013-1#1)
appears to play an important##3##5##(1992-8#1)(1995-12#1)(2013-1#1)
appears to play##10##3##(1990-5#1)(1992-10#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#1)
appears to prevent the##2##4##(1997-2#1)(2007-8#1)
appears to provide##5##3##(2008-10#1)(2008-3#2)(2008-5#1)(2012-3#1)
appears to reflect the##2##4##(2008-7#1)(2010-3#1)
appears to reflect##3##3##(1995-12#1)(2008-7#1)(2010-3#1)
appears to regulate##2##3##(1992-12#1)(2012-12#1)
appears to represent a##3##4##(1991-12#1)(2008-10#1)(2008-5#1)
appears to require##3##3##(1994-8#1)(1995-6#1)(2008-7#1)
appears to result from##2##4##(1992-3#1)(2008-7#1)
appears to stimulate##2##3##(1994-11#1)(2008-7#1)
appears to vary##2##3##(1992-12#1)(1995-2#1)
appears to##467##2##(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#7)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#6)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#4)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#3)(1994-5#6)(1994-6#5)(1994-8#6)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-5#6)(1995-6#4)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#7)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#4)(1997-8#2)(2006-10#4)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#47)(2008-11#17)(2008-12#5)(2008-2#3)(2008-3#12)(2008-4#5)(2008-5#18)(2008-6#3)(2008-7#21)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#14)(2012-1#3)(2012-12#4)(2012-2#16)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#5)
appears##714##1##(1990-11#8)(1990-12#4)(1990-2#5)(1990-3#3)(1990-5#8)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#6)(1992-2#5)(1992-3#9)(1992-5#1)(1992-6#5)(1992-8#5)(1992-9#5)(1993-1#2)(1993-11#7)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#3)(1993-6#4)(1993-8#6)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#4)(1994-2#4)(1994-5#8)(1994-6#6)(1994-8#6)(1994-9#3)(1995-11#4)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#7)(1995-6#4)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#4)(2006-10#4)(2006-6#1)(2007-10#4)(2007-11#7)(2007-12#8)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#11)(2008-10#74)(2008-11#25)(2008-12#9)(2008-2#11)(2008-3#25)(2008-4#7)(2008-5#27)(2008-6#7)(2008-7#30)(2008-8#15)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#10)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#23)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#24)(2012-3#4)(2013-1#18)(2013-7#2)(2013-8#6)
appellate court##2##2##(1992-12#1)(1995-6#1)
appellate##3##1##(1992-12#1)(1994-1#1)(1995-6#1)
appendage is##3##2##(2007-8#3)
appendage of the##2##3##(2007-12#2)
appendage##18##1##(2007-12#5)(2007-8#8)(2008-11#2)(2008-7#1)(2010-12#1)(2011-2#1)
appendages and##3##2##(1990-12#1)(2007-12#1)(2008-5#1)
appendages are##2##2##(2007-12#1)(2008-8#1)
appendages in the##3##3##(2007-12#2)(2010-5#1)
appendages in##5##2##(2007-12#2)(2007-8#1)(2010-5#1)(2011-2#1)
appendages##23##1##(1990-12#1)(2007-12#10)(2007-2#1)(2007-8#1)(2008-5#2)(2008-8#3)(2010-5#1)(2011-2#3)(2012-3#1)
appendectomies##2##1##(1992-2#2)
appendectomy##15##1##(1991-1#1)(1991-8#1)(1992-2#2)(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#4)(2011-2#3)(2012-12#1)
appendiceal neoplasm##2##2##(2011-2#2)
appendiceal##10##1##(1990-3#1)(2008-12#2)(2009-7#1)(2011-2#6)
appendicectomies##2##1##(2011-2#1)(2013-1#1)
appendicitis in children##3##3##(2013-1#3)
appendicitis is##2##2##(1991-12#1)(2011-2#1)
appendicitis##31##1##(1991-12#3)(1992-2#1)(1993-6#2)(1997-8#3)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#8)(2013-1#9)
appendiculaires##2##1##(2011-2#2)
appendicular##10##1##(1991-11#1)(2007-12#4)(2010-3#2)(2011-2#2)(2012-12#1)
appendix and##2##2##(1997-8#2)
appendix presents##5##2##(1991-2#1)(2008-2#2)(2008-4#1)(2008-9#1)
appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis##2##12##(2012-12#2)
appendix to the##3##3##(2011-2#1)(2012-12#2)
appendix was##2##2##(1993-6#1)(2009-7#1)
appendix##51##1##(1990-8#1)(1991-2#1)(1992-2#1)(1993-12#2)(1993-6#1)(1997-8#4)(2008-10#2)(2008-12#6)(2008-2#2)(2008-4#9)(2008-7#1)(2008-9#7)(2009-7#5)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
appetite and feeding problems in##2##5##(2011-1#2)
appetite and##9##2##(2007-11#1)(2007-12#1)(2007-7#1)(2011-1#2)(2011-2#1)(2013-8#3)
appetite regulation##4##2##(2009-8#3)(2012-1#1)
appetite##33##1##(1990-10#1)(1993-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#4)(2011-1#2)(2011-2#5)(2012-1#1)(2013-1#1)(2013-8#5)
appetitive##4##1##(2007-8#2)(2008-4#2)
applanation##7##1##(2008-3#5)(2008-7#2)
apple (Malus domestica##2##3##(2008-9#2)
apple (Malus domestica)##3##3##(2008-10#2)(2009-8#1)
apple (Malus##5##2##(2008-10#2)(2008-9#2)(2009-8#1)
apple and pear##3##3##(2008-10#3)
apple and##8##2##(2008-10#8)
apple blossoms##6##2##(2008-10#6)
apple caused by the##2##4##(2008-10#2)
apple cultivars were##2##3##(2008-10#2)
apple cultivars##7##2##(2008-10#5)(2011-10#2)
apple cv##2##2##(2008-10#2)
apple domains##2##2##(2009-7#2)
apple flowers were##3##3##(2008-10#3)
apple flowers##6##2##(2008-10#6)
apple fruit against##2##3##(2008-10#2)
apple fruit##11##2##(2008-10#9)(2008-9#2)
apple fruits##5##2##(2008-10#4)(2008-9#1)
apple growth in##5##3##(2008-10#5)
apple in the##2##3##(2008-10#2)
apple in##7##2##(2008-10#7)
apple juice##5##2##(2008-10#5)
apple juices by##2##3##(2008-10#2)
apple leaves##8##2##(2008-10#8)
apple orchards##5##2##(2008-10#5)
apple pectin##5##2##(1990-9#2)(2008-10#3)
apple pomace##3##2##(1997-2#3)
apple production systems##2##3##(2008-10#2)
apple production##4##2##(2008-10#4)
apple proliferation phytoplasma##3##3##(2008-10#3)
apple proliferation##5##2##(2008-10#5)
apple replant disease##8##3##(2008-10#8)
apple root infection by##3##4##(2008-10#3)
apple roots##4##2##(2008-10#4)
apple samples##2##2##(2008-10#2)
apple scab##16##2##(2008-10#16)
apple seedling##2##2##(2008-10#2)
apple seedlings grown in##4##4##(2008-10#4)
apple seedlings##9##2##(2008-10#9)
apple sooty blotch##3##3##(2008-10#3)
apple stem##3##2##(2008-10#3)
apple tissue##5##2##(2008-10#5)
apple trees in the##2##4##(2008-10#2)
apple trees in##4##3##(2008-10#4)
apple trees infected with##2##4##(2008-10#2)
apple trees##18##2##(2008-10#18)
apple varieties##4##2##(2008-10#4)
apple was perceived as##2##4##(1996-2#2)
apple was##5##2##(1996-2#2)(2008-10#3)
apple wounds by##2##3##(2008-10#2)
apple wounds##5##2##(2008-10#5)
apple##259##1##(1990-9#2)(1996-2#2)(1997-2#3)(2008-10#232)(2008-11#2)(2008-8#1)(2008-9#5)(2009-7#2)(2009-8#1)(2010-2#3)(2011-10#4)(2012-2#2)
apple)##2##1##(2008-10#2)
apples and##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
apples treated with##2##3##(2008-10#2)
apples were##2##2##(2008-10#2)
apples##34##1##(1996-3#1)(2008-10#29)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
appliance##9##1##(1990-5#1)(2007-12#1)(2008-10#1)(2009-7#2)(2013-1#4)
appliances is##2##2##(2007-12#1)(2009-7#1)
appliances##11##1##(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
applicability for##11##2##(1991-1#1)(1992-12#1)(2008-10#4)(2008-3#2)(2010-5#1)(2011-1#1)(2012-2#1)
applicability in the##4##3##(1991-1#1)(1994-3#1)(2008-10#1)(2012-3#1)
applicability in##12##2##(1991-1#1)(1991-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#4)(2010-12#1)(2011-1#1)(2012-3#1)
applicability limits of the##2##4##(2008-10#1)(2008-3#1)
applicability of HIA##2##3##(2013-1#2)
applicability of a##3##3##(1994-1#1)(2008-10#1)(2011-2#1)
applicability of an##2##3##(1997-4#1)(2008-10#1)
applicability of such##3##3##(1993-6#1)(2007-8#1)(2008-10#1)
applicability of the derived##2##4##(2008-2#1)(2008-3#1)
applicability of the developed##3##4##(2008-10#3)
applicability of the method for##3##5##(2008-10#2)(2008-3#1)
applicability of the method was demonstrated by the##3##8##(2008-10#3)
applicability of the method was demonstrated by##4##7##(2008-10#4)
applicability of the method was##6##5##(2008-10#6)
applicability of the method##17##4##(2008-10#12)(2008-3#4)(2010-3#1)
applicability of the model##2##4##(2008-10#1)(2008-7#1)
applicability of the proposed method was##2##6##(2008-10#2)
applicability of the proposed method##4##5##(2008-10#4)
applicability of the proposed##8##4##(1997-8#1)(2008-10#7)
applicability of the technique##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
applicability of the##54##3##(1993-1#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-10#33)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-3#1)(2011-2#1)
applicability of these##3##3##(1993-12#1)(2010-11#1)(2013-8#1)
applicability of this method##4##4##(2008-10#3)(2009-12#1)
applicability of this##12##3##(1995-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-12#1)(2011-1#2)(2011-2#1)
applicability of##115##2##(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#55)(2008-2#6)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-2#4)(2013-1#3)(2013-8#2)
applicability to real##2##3##(2008-10#2)
applicability to the##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
applicability to##19##2##(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#2)
applicability##176##1##(1991-1#2)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#74)(2008-2#10)(2008-3#18)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#3)(2009-4#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#2)(2011-1#7)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
applicable across##2##2##(1991-2#1)(2008-10#1)
applicable also to##2##3##(2008-2#1)(2009-5#1)
applicable also##3##2##(2008-2#1)(2008-7#1)(2009-5#1)
applicable and##2##2##(2008-3#1)(2013-1#1)
applicable as an##2##3##(2007-12#1)(2012-3#1)
applicable as##3##2##(1994-3#1)(2007-12#1)(2012-3#1)
applicable concentration range##2##3##(2008-10#2)
applicable for routine##2##3##(2008-10#2)
applicable for the##9##3##(1991-12#1)(1993-9#1)(2008-10#5)(2008-4#1)(2013-8#1)
applicable for##40##2##(1991-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-2#2)(2013-8#1)
applicable in a##2##3##(2010-5#1)(2011-2#1)
applicable in the concentration range##2##5##(2008-10#2)
applicable in the treatment of##2##5##(2008-7#1)(2010-10#1)
applicable in the##6##3##(1993-12#1)(1997-6#1)(2008-10#2)(2008-7#1)(2010-10#1)
applicable in##14##2##(1993-12#1)(1994-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
applicable only to a subset of##2##6##(1997-8#2)
applicable only to##3##3##(1997-8#2)(2008-8#1)
applicable only##4##2##(1997-8#2)(2006-5#1)(2008-8#1)
applicable target for##2##3##(2008-11#1)(2011-2#1)
applicable to a broad range of##2##6##(2008-11#1)(2008-8#1)
applicable to a large##2##4##(2007-11#1)(2008-10#1)
applicable to a wide range of##2##6##(1994-6#1)(2008-3#1)
applicable to a wide##4##4##(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
applicable to a##11##3##(1994-6#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)
applicable to any##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
applicable to automated##2##3##(2008-10#2)
applicable to human##2##3##(2008-8#1)(2010-12#1)
applicable to in vitro##2##4##(2008-11#1)(2008-9#1)
applicable to large##2##3##(1991-8#1)(1996-4#1)
applicable to many different##2##4##(2008-11#1)(2008-9#1)
applicable to many##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2008-9#1)
applicable to more##2##3##(2008-10#1)(2008-8#1)
applicable to other##13##3##(1993-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-2#1)
applicable to studies of##2##4##(2008-4#1)(2008-9#1)
applicable to the analysis of##7##5##(2008-10#6)(2010-11#1)
applicable to the determination of##4##5##(2008-10#4)
applicable to the development of##2##5##(2008-1#1)(2011-1#1)
applicable to the study of##2##5##(1997-7#1)(2006-6#1)
applicable to the##36##3##(1990-5#1)(1991-12#1)(1994-12#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
applicable to their##2##3##(1996-7#1)(2008-11#1)
applicable to##156##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#21)(2008-4#8)(2008-5#5)(2008-7#5)(2008-8#8)(2008-9#5)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
applicable##274##1##(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-8#1)(1992-12#3)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#5)(2007-9#1)(2008-1#5)(2008-10#70)(2008-11#16)(2008-12#2)(2008-2#14)(2008-3#30)(2008-4#9)(2008-5#6)(2008-7#8)(2008-8#11)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
applicant##9##1##(1991-11#1)(1991-12#1)(1992-5#1)(1993-1#3)(1995-5#1)(2010-12#1)(2010-3#1)
applicants and users of##2##4##(1992-5#2)
applicants and##3##2##(1992-5#2)(2012-3#1)
applicants for a##2##3##(1991-11#1)(1995-5#1)
applicants for mobile facilities##2##4##(1992-5#2)
applicants for##6##2##(1991-11#1)(1992-5#2)(1994-9#1)(1995-5#2)
applicants to##3##2##(1992-3#1)(1993-2#1)(2012-3#1)
applicants with##2##2##(1995-5#1)(1997-3#1)
applicants##36##1##(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-7#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-1#4)(1995-5#5)(1997-1#2)(1997-3#3)(2012-2#2)(2012-3#8)
applicated##2##1##(2008-10#1)(2008-11#1)
application and the##4##3##(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
application and##19##2##(1996-5#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#3)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
application are discussed##2##3##(2008-10#1)(2009-11#1)
application are presented##2##3##(2008-2#1)(2010-9#1)
application are##10##2##(1997-7#1)(2008-10#2)(2008-2#2)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
application area##4##2##(2008-3#2)(2008-8#1)(2008-9#1)
application as a##11##3##(1996-9#2)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)
application as##26##2##(1992-3#1)(1993-9#1)(1996-9#2)(1997-6#1)(2007-11#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)(2013-1#2)
application at 1##2##3##(2008-10#1)(2011-2#1)
application at##8##2##(1992-2#1)(2007-12#2)(2008-10#3)(2011-1#1)(2011-2#1)
application by##2##2##(2008-10#1)(2010-8#1)
application can be##2##3##(2010-12#1)(2012-2#1)
application can##4##2##(1995-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
application conditions##2##2##(2008-5#2)
application did not##2##3##(2008-6#1)(2012-2#1)
application domain##2##2##(2008-3#1)(2008-7#1)
application for a##3##3##(2007-7#1)(2008-11#1)(2008-9#1)
application for determination of##3##4##(2008-10#3)
application for the determination of##4##5##(2008-10#3)(2008-3#1)
application for the##12##3##(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-3#1)
application for##50##2##(1992-5#1)(1992-6#1)(2007-7#1)(2008-10#21)(2008-11#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#5)(2009-3#1)(2012-3#1)(2013-1#2)
application has been##5##3##(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
application has##6##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
application have##3##2##(1993-11#1)(2008-11#1)(2009-4#1)
application in a##7##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
application in drug##2##3##(2008-10#2)
application in flow##2##3##(2008-10#1)(2008-9#1)
application in optical##3##3##(2008-2#2)(2008-3#1)
application in quantitative##2##3##(2008-10#1)(2008-7#1)
application in skin##3##3##(2008-5#3)
application in the design of##2##5##(1997-6#1)(2012-2#1)
application in the determination of##4##5##(2008-10#3)(2008-2#1)
application in the field of##3##5##(2008-2#1)(2008-7#1)(2009-6#1)
application in the health care##2##5##(1993-2#1)(2008-11#1)
application in the separation##2##4##(2008-10#2)
application in the##45##3##(1990-2#1)(1991-5#1)(1992-8#1)(1993-2#2)(1995-6#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
application in various##2##3##(2008-11#1)(2013-8#1)
application in##166##2##(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#47)(2008-11#7)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#16)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
application is demonstrated##2##3##(2007-11#1)(2008-2#1)
application is discussed##2##3##(1995-5#1)(2008-2#1)
application is the##3##3##(1995-8#1)(2008-3#1)(2008-9#1)
application is##19##2##(1992-3#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#1)
application may be##2##3##(2008-10#1)(2008-8#1)
application method##2##2##(2008-10#1)(2008-12#1)
application of &quot##3##3##(2008-7#1)(2013-1#2)
application of 0##3##3##(2008-10#1)(2008-5#2)
application of 1##3##3##(1991-9#1)(1997-3#1)(2008-12#1)
application of 12-O-tetradecanoylphorbol-13-acetate##2##3##(1992-8#2)
application of 2##4##3##(1990-7#1)(2008-12#2)(2011-2#1)
application of B##2##3##(2008-10#2)
application of CTBG to the##2##5##(1996-5#2)
application of N fertilizers##2##4##(2008-10#1)(2012-1#1)
application of NMDA##2##3##(1995-5#1)(1997-2#1)
application of Raman spectroscopy##2##4##(2013-8#2)
application of SA##2##3##(2008-10#2)
application of a combination of##2##5##(2008-10#1)(2009-5#1)
application of a fast##2##4##(2008-10#1)(2009-12#1)
application of a novel##2##4##(2008-10#1)(2008-3#1)
application of a numerical##2##4##(2008-2#1)(2008-3#1)
application of a problem-solving approach##2##5##(1993-2#2)
application of a voltage##2##4##(2007-11#1)(2008-2#1)
application of a##84##3##(1992-2#1)(1993-2#3)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#28)(2008-11#3)(2008-2#8)(2008-3#10)(2008-5#6)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#1)(2010-4#1)(2011-2#2)(2011-3#2)(2012-2#2)(2013-8#1)
application of aluminum##2##3##(1992-12#2)
application of ammonium molybdate##2##4##(2008-10#2)
application of an electric field##3##5##(2007-11#1)(2008-11#1)(2008-3#1)
application of an electrical##2##4##(2007-12#1)(2012-1#1)
application of an instrument##2##4##(1997-1#1)(2008-3#1)
application of an##28##3##(1993-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#3)(2009-10#1)(2009-11#1)(2012-1#1)
application of antioxidants##2##3##(2008-5#1)(2009-6#1)
application of artificial##2##3##(2007-8#1)(2008-10#1)
application of bacterial##2##3##(2008-10#2)
application of both##6##3##(1996-12#1)(2008-10#5)
application of broad-spectrum##2##3##(2008-10#1)(2008-7#1)
application of chemical##2##3##(1991-12#1)(2008-10#1)
application of chemometrics##2##3##(2008-10#2)
application of continuous##2##3##(2007-8#1)(2008-7#1)
application of data mining##2##4##(2008-9#2)
application of data##5##3##(1992-2#1)(2008-10#1)(2008-9#2)(2012-12#1)
application of different##4##3##(2008-10#3)(2010-3#1)
application of diffractive##3##3##(2008-3#3)
application of either##2##3##(2010-7#1)(2013-1#1)
application of evolved gas analysis-mass spectrometry (EGA-MS) with##2##8##(2008-10#2)
application of flow cytometry##2##4##(2008-9#2)
application of flow##3##3##(2008-10#1)(2008-9#2)
application of fungicide##2##3##(2008-10#2)
application of fungicides##4##3##(2008-10#4)
application of gene##2##3##(2008-7#1)(2008-8#1)
application of genetic##3##3##(1994-9#1)(2007-7#1)(2008-3#1)
application of genomics##2##3##(2010-12#1)(2010-4#1)
application of geographical information systems##2##5##(2008-8#2)
application of high##2##3##(2007-12#1)(2013-1#1)
application of high-performance liquid##2##4##(1991-5#1)(2008-10#1)
application of high-performance##3##3##(1991-5#1)(2008-10#2)
application of insecticides##2##3##(1997-7#1)(2008-11#1)
application of iprodione##3##3##(2008-10#3)
application of it##3##3##(1996-6#1)(2008-10#2)
application of light##2##3##(1992-8#1)(2008-10#1)
application of modern##2##3##(2008-12#1)(2012-12#1)
application of molecular##3##3##(2008-10#1)(2009-11#1)(2011-1#1)
application of multivariate##2##3##(2008-1#1)(2008-10#1)
application of near-infrared##2##3##(2008-10#1)(2008-3#1)
application of neurobehavioral and neuromolecular##2##5##(1996-12#2)
application of neutral fluoride gel##2##5##(2013-1#2)
application of new##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2010-11#1)
application of optical##2##3##(2007-11#1)(2008-3#1)
application of our##5##3##(1997-1#1)(2007-12#1)(2008-8#1)(2013-1#2)
application of partial##2##3##(2008-10#1)(2011-2#1)
application of pendimethalin at##2##4##(2011-1#2)
application of pharmacogenetics and pharmacogenomics in developing##2##7##(2008-10#2)
application of polymer##2##3##(2008-10#1)(2010-7#1)
application of pulsed##2##3##(2008-10#1)(2008-3#1)
application of putrescine##2##3##(2011-2#2)
application of quality##2##3##(1992-12#1)(2010-9#1)
application of research##2##3##(1995-1#1)(2008-11#1)
application of sewage sludge in China##3##6##(1997-4#3)
application of sewage sludge##5##4##(1997-4#4)(2007-12#1)
application of silane and adhesive##2##5##(2008-12#2)
application of silicon (Si)##2##4##(2008-10#2)
application of single##2##3##(2008-10#1)(2008-7#1)
application of small##3##3##(1990-5#1)(2008-10#1)(2010-3#1)
application of sodium deoxycholate##2##4##(2011-2#2)
application of solid##2##3##(2008-10#2)
application of some##2##3##(1995-5#1)(2008-7#1)
application of standard##4##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
application of such a##2##4##(1994-12#1)(2008-2#1)
application of such##8##3##(1994-12#1)(2008-2#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
application of the analytical##2##4##(2008-10#1)(2008-3#1)
application of the combination of##3##5##(1997-7#1)(2008-9#1)(2013-8#1)
application of the drug##2##4##(1997-2#1)(1997-4#1)
application of the method for##2##5##(2007-10#1)(2008-10#1)
application of the method to the analysis of##2##8##(2008-10#1)(2008-3#1)
application of the method to the##3##6##(2008-10#2)(2008-3#1)
application of the method to##5##5##(2008-10#2)(2008-2#1)(2008-3#2)
application of the method##14##4##(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#6)(2008-2#1)(2008-3#3)(2013-8#1)
application of the new##4##4##(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
application of the pathogen##2##4##(2008-10#2)
application of the proposed method to##2##6##(2008-10#2)
application of the proposed method##3##5##(2008-10#3)
application of the proposed##7##4##(2008-10#5)(2008-2#1)(2008-3#1)
application of the protocol##2##4##(2008-9#1)(2013-8#1)
application of the same##2##4##(2008-11#2)
application of the technique##2##4##(2008-10#1)(2008-4#1)
application of the##170##3##(1990-12#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#53)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#21)(2008-4#3)(2008-5#5)(2008-7#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#6)(2013-1#5)(2013-8#3)
application of these methods to##2##5##(2008-10#1)(2008-8#1)
application of these methods##4##4##(2008-10#2)(2008-8#1)(2008-9#1)
application of these models##2##4##(2008-5#1)(2008-8#1)
application of these techniques to##4##5##(2008-3#2)(2008-8#1)(2010-9#1)
application of these techniques##5##4##(2008-3#2)(2008-7#1)(2008-8#1)(2010-9#1)
application of these##26##3##(1991-12#1)(1992-3#1)(1994-11#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-9#1)(2012-2#1)
application of this approach##2##4##(1994-5#1)(2010-11#1)
application of this method##6##4##(2008-10#4)(2008-2#1)(2008-8#1)
application of this methodology##4##4##(2008-10#2)(2009-11#1)(2009-8#1)
application of this model to##2##5##(2008-2#1)(2011-2#1)
application of this new##3##4##(1990-3#1)(2006-12#1)(2008-10#1)
application of this technique as a##2##6##(2007-12#1)(2008-10#1)
application of this technique in##4##5##(1993-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
application of this technique##8##4##(1993-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)
application of this##54##3##(1990-3#1)(1990-8#1)(1993-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-1#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
application of topical##2##3##(1997-8#1)(2007-11#1)
application of treatments##3##3##(2008-10#2)(2012-12#1)
application of two##3##3##(2007-12#1)(2008-10#2)
application of ultrafiltration##2##3##(2008-10#2)
application of using##2##3##(2008-10#1)(2008-7#1)
application of various##2##3##(2008-5#2)
application of##1021##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#6)(1992-2#5)(1992-3#4)(1992-8#6)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#10)(1995-2#2)(1995-3#4)(1995-5#7)(1995-6#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#9)(1996-2#3)(1996-3#4)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#6)(1997-4#9)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#2)(2006-12#1)(2007-10#2)(2007-11#15)(2007-12#16)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#12)(2007-9#1)(2008-1#11)(2008-10#287)(2008-11#41)(2008-12#20)(2008-2#35)(2008-3#71)(2008-4#22)(2008-5#41)(2008-6#5)(2008-7#30)(2008-8#15)(2008-9#21)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#5)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#12)(2011-2#31)(2011-3#2)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#17)(2013-1#23)(2013-7#3)(2013-8#12)
application on the##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
application on##14##2##(2008-10#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#2)
application onto##2##2##(1997-2#1)(2008-4#1)
application opportunities##2##2##(2007-12#1)(2008-10#1)
application or##2##2##(2008-10#1)(2008-6#1)
application potential##2##2##(1991-5#1)(2007-12#1)
application potentials##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
application process##2##2##(1996-3#1)(1997-1#1)
application range##4##2##(2008-10#2)(2008-3#2)
application rate and plant##2##4##(2008-12#2)
application rate##8##2##(2008-12#6)(2008-8#1)(2011-2#1)
application rates##2##2##(2008-10#1)(2008-12#1)
application site##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
application technique##3##2##(1994-9#1)(2007-8#1)(2008-5#1)
application that##6##2##(2007-12#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)
application thickness##2##2##(2008-5#2)
application times##4##2##(1992-12#1)(2008-5#1)(2012-3#2)
application to a##10##3##(1996-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2009-4#1)(2011-2#1)
application to amperometric detection of##2##5##(2008-10#2)
application to an##2##3##(2007-11#1)(2008-3#1)
application to coherent##2##3##(2007-11#1)(2007-12#1)
application to determination of##2##4##(2008-10#2)
application to environmental##2##3##(2008-10#1)(2011-2#1)
application to in vivo##2##4##(2008-3#1)(2010-7#1)
application to model##2##3##(2008-5#1)(2012-3#1)
application to other##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
application to particle sizing##2##4##(2008-3#2)
application to spectrophotometric determination of##2##5##(2008-10#2)
application to the analysis of##4##5##(2008-10#4)
application to the detection of##2##5##(2008-10#1)(2008-2#1)
application to the determination of##9##5##(2008-10#9)
application to the direct##2##4##(2008-10#2)
application to the health care environment##2##6##(1995-1#2)
application to the optical##3##4##(2008-2#1)(2008-3#2)
application to the pulmonary##2##4##(1992-3#1)(2011-2#1)
application to the skin surface##2##5##(2008-5#2)
application to the study of##3##5##(2008-10#1)(2008-9#1)(2009-12#1)
application to the##51##3##(1990-2#1)(1992-3#1)(1993-5#1)(1995-1#2)(2007-11#2)(2008-1#1)(2008-10#25)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)
application to water samples##3##4##(2008-10#3)
application to##214##2##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-3#2)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#1)(2007-11#12)(2007-12#13)(2007-6#1)(2008-1#1)(2008-10#74)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#31)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#3)(2012-3#3)(2012-4#1)(2012-8#1)(2013-1#1)(2013-7#2)
application was 0##2##3##(2008-10#2)
application was##12##2##(2007-11#1)(2008-10#8)(2008-9#1)(2011-2#1)(2013-1#1)
application with##6##2##(1994-2#1)(1995-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)
application within the##2##3##(1993-2#1)(1996-12#1)
application would##2##2##(1991-2#1)(2009-4#1)
application##1993##1##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#4)(1990-7#6)(1990-8#4)(1990-9#2)(1991-1#3)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#2)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#8)(1992-2#7)(1992-3#8)(1992-5#2)(1992-6#3)(1992-8#9)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#6)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#6)(1995-11#3)(1995-12#15)(1995-2#3)(1995-3#8)(1995-5#8)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#15)(1996-2#5)(1996-3#8)(1996-5#5)(1996-6#3)(1996-8#3)(1996-9#3)(1997-1#8)(1997-2#7)(1997-3#9)(1997-4#11)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#2)(2006-12#1)(2007-10#5)(2007-11#36)(2007-12#40)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#20)(2007-9#1)(2008-1#14)(2008-10#557)(2008-11#72)(2008-12#45)(2008-2#62)(2008-3#157)(2008-4#30)(2008-5#91)(2008-6#13)(2008-7#50)(2008-8#25)(2008-9#88)(2009-1#1)(2009-10#7)(2009-11#10)(2009-12#7)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#1)(2009-6#9)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#7)(2010-12#8)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#11)(2010-6#2)(2010-7#7)(2010-8#14)(2010-9#5)(2011-1#25)(2011-10#4)(2011-2#61)(2011-3#4)(2012-1#6)(2012-12#15)(2012-2#20)(2012-3#31)(2012-4#1)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#50)(2013-7#6)(2013-8#21)
application)##2##1##(2008-10#1)(2008-5#1)
application-specific##4##1##(2008-10#1)(2008-2#2)(2009-11#1)
applications (e##4##2##(2008-3#1)(2008-4#2)(2008-9#1)
applications a##2##2##(2008-10#1)(2008-3#1)
applications and future##4##3##(2007-7#1)(2008-10#3)
applications and##31##2##(1995-8#1)(1996-12#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#6)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2013-8#1)
applications are also described##2##4##(2008-2#1)(2008-4#1)
applications are also##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
applications are described##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
applications are discussed##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
applications are given##2##3##(2008-2#1)(2008-5#1)
applications are identified##2##3##(2007-12#1)(2008-6#1)
applications are more##2##3##(2008-10#1)(2008-7#1)
applications are##35##2##(1992-11#1)(1993-3#1)(1994-11#1)(1996-1#1)(1997-6#1)(2007-12#2)(2008-10#5)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)
applications as a##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
applications as well as for##2##5##(2008-11#1)(2008-3#1)
applications as well as##3##4##(2008-11#1)(2008-3#1)(2008-9#1)
applications as well##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
applications as##17##2##(2007-11#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
applications at##3##2##(1996-1#1)(1996-12#1)(2008-3#1)
applications based on##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
applications because##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
applications but##2##2##(2008-2#1)(2008-5#1)
applications by##10##2##(2007-12#2)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)
applications demand##3##2##(1994-3#1)(2007-11#1)(2008-3#1)
applications discussed##2##2##(1997-6#1)(2008-10#1)
applications for the##7##3##(1997-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
applications for##46##2##(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-8#2)(2011-7#1)(2012-2#3)(2012-4#1)(2013-1#1)
applications from##5##2##(1992-5#1)(1997-2#1)(2008-1#1)(2008-2#1)(2010-10#1)
applications has been##2##3##(1996-3#1)(1997-8#1)
applications has##5##2##(1996-3#1)(1997-8#1)(2008-3#1)(2010-10#1)(2013-1#1)
applications have been##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
applications in a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
applications in associative memories and multitarget classification##2##7##(2008-3#2)
applications in biotechnology##2##3##(1995-11#1)(1997-4#1)
applications in both##3##3##(2008-3#1)(2008-5#1)(2011-7#1)
applications in cardiovascular##2##3##(2010-5#1)(2010-9#1)
applications in health##3##3##(1993-12#1)(1994-2#1)(1997-3#1)
applications in medicine##4##3##(1992-12#1)(2008-4#1)(2008-7#1)(2010-4#1)
applications in optical communication##2##4##(2007-11#1)(2007-12#1)
applications in optical##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
applications in other##2##3##(2008-10#1)(2008-3#1)
applications in quantitative##2##3##(2008-2#1)(2013-1#1)
applications in regenerative medicine##2##4##(2008-9#1)(2010-10#1)
applications in research##2##3##(2008-10#1)(2010-11#1)
applications in the context of acute##2##6##(2008-3#1)(2010-9#1)
applications in the treatment of##2##5##(1997-4#1)(2011-2#1)
applications in the##22##3##(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
applications in various##2##3##(2008-7#1)(2008-9#1)
applications in which high##2##4##(2008-3#1)(2012-12#1)
applications in which the##2##4##(2008-2#1)(2008-3#1)
applications in which##9##3##(2007-12#2)(2008-2#4)(2008-3#2)(2012-12#1)
applications in##174##2##(1992-12#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#5)(2007-12#8)(2008-10#27)(2008-11#3)(2008-12#4)(2008-2#15)(2008-3#31)(2008-4#8)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
applications include the##3##3##(1990-8#1)(2008-7#1)(2012-2#1)
applications include##6##2##(1990-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
applications including##4##2##(1997-4#1)(2008-10#1)(2010-4#1)(2012-2#1)
applications involving##3##2##(2008-10#2)(2010-4#1)
applications is discussed##2##3##(1992-2#1)(2008-10#1)
applications is examined##2##3##(2007-11#1)(2008-3#1)
applications is proposed##2##3##(2007-11#1)(2008-3#1)
applications is the##2##3##(2008-8#1)(2011-1#1)
applications is##15##2##(1992-2#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#3)(2008-8#1)(2010-10#2)(2010-12#1)(2011-1#1)
applications it is##2##3##(2007-12#1)(2008-11#1)
applications of CMR##2##3##(2010-11#2)
applications of Pseudomonas putida 06909-rif/nal##6##5##(2008-10#6)
applications of Raman##2##3##(2008-10#1)(2009-12#1)
applications of a##7##3##(1991-2#1)(2008-10#3)(2008-2#1)(2011-1#2)
applications of confocal microscopy##3##4##(2008-9#3)
applications of diffractive##2##3##(2007-11#1)(2008-3#1)
applications of electrogenerated chemiluminescence##2##4##(2008-10#2)
applications of molecular##2##3##(1997-7#1)(2010-9#1)
applications of protein##2##3##(1994-8#1)(2008-5#1)
applications of statistical##2##3##(1997-6#1)(2008-10#1)
applications of stripping##2##3##(2008-10#2)
applications of the alkaline##2##4##(1997-4#2)
applications of the fungicide metalaxyl and the nematicide phenamiphos##2##9##(2008-10#2)
applications of the method##2##4##(2008-9#1)(2010-9#1)
applications of the##38##3##(1993-12#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
applications of these##9##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)
applications of this method##3##4##(1994-5#1)(2012-3#2)
applications of this technique##2##4##(2007-11#1)(2008-2#1)
applications of this##12##3##(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#2)
applications of various##2##3##(2008-10#1)(2008-4#1)
applications of##238##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#9)(2007-12#8)(2008-1#1)(2008-10#69)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#6)(2008-7#8)(2008-8#6)(2008-9#10)(2009-12#2)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#2)(2011-7#3)(2012-1#1)(2012-12#1)(2012-2#10)(2012-3#5)(2012-8#1)(2013-1#7)
applications on##4##2##(1992-12#1)(2008-10#3)
applications only##2##2##(2008-10#1)(2008-3#1)
applications range from##2##3##(2008-10#1)(2012-12#1)
applications requires##3##2##(2008-7#1)(2009-9#1)(2012-1#1)
applications requiring##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
applications resulted in##2##3##(2008-10#2)
applications such as affinity##2##4##(1995-11#1)(2008-2#1)
applications such as the##2##4##(2008-10#1)(2008-2#1)
applications such as##25##3##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)
applications that have##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
applications that use##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
applications that##21##2##(1992-12#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#2)(2009-12#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
applications the##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
applications to NASA##2##3##(2007-12#2)
applications to cancer##2##3##(2008-11#1)(2010-6#1)
applications to molecular##4##3##(2013-1#4)
applications to the analysis of##2##5##(2008-10#1)(2008-9#1)
applications to the##4##3##(2008-10#1)(2008-2#1)(2008-9#2)
applications to various##2##3##(2008-12#1)(2008-2#1)
applications to##52##2##(1992-12#1)(1992-5#2)(1993-2#1)(1994-9#2)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#5)
applications using##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
applications was##2##2##(1992-5#1)(2008-10#1)
applications were##6##2##(1991-2#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
applications when##2##2##(1991-2#1)(2008-10#1)
applications where the##2##3##(2008-10#1)(2010-4#1)
applications where##4##2##(1997-4#1)(2008-10#2)(2010-4#1)
applications which##2##2##(2008-10#1)(2011-2#1)
applications will##2##2##(2008-10#1)(2008-8#1)
applications with##5##2##(2008-10#2)(2008-3#2)(2008-6#1)
applications##1351##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-2#4)(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#6)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-2#4)(1994-3#5)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#7)(1997-3#3)(1997-4#8)(1997-6#4)(1997-7#4)(1997-8#7)(2006-4#1)(2007-10#2)(2007-11#48)(2007-12#49)(2007-5#2)(2007-7#1)(2008-1#6)(2008-10#251)(2008-11#47)(2008-12#13)(2008-2#97)(2008-3#177)(2008-4#39)(2008-5#43)(2008-6#9)(2008-7#52)(2008-8#23)(2008-9#42)(2009-10#6)(2009-11#6)(2009-12#14)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#7)(2009-6#1)(2009-7#7)(2009-8#5)(2009-9#6)(2010-1#4)(2010-10#11)(2010-11#9)(2010-12#24)(2010-2#6)(2010-3#2)(2010-4#7)(2010-5#9)(2010-6#3)(2010-7#11)(2010-8#18)(2010-9#4)(2011-1#14)(2011-2#13)(2011-3#2)(2011-7#6)(2012-1#3)(2012-12#7)(2012-2#47)(2012-3#10)(2012-4#1)(2012-5#1)(2012-6#1)(2012-8#2)(2013-1#27)(2013-7#2)(2013-8#6)
applicator##7##1##(1992-1#2)(1996-3#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-1#1)
applicators##3##1##(2008-10#1)(2008-12#1)(2009-11#1)
applied (up to 12##2##4##(1990-7#1)(2008-10#1)
applied 0##2##2##(2008-10#1)(2008-5#1)
applied a##16##2##(1993-12#1)(1993-2#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-8#1)(2009-3#1)(2010-6#1)(2012-3#2)(2013-1#1)
applied across a##2##3##(1990-8#1)(2008-10#1)
applied across##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
applied after##4##2##(2007-8#1)(2008-5#1)(2012-3#1)(2012-8#1)
applied alone##4##2##(2008-10#4)
applied along the##2##3##(2007-12#1)(2007-5#1)
applied along##3##2##(2007-12#1)(2007-5#1)(2012-1#1)
applied also##4##2##(1990-9#1)(1995-5#1)(2008-10#2)
applied and found to##2##4##(2008-10#1)(2008-11#1)
applied and then##3##3##(1992-9#1)(2008-3#1)(2008-5#1)
applied and##21##2##(1992-9#1)(1993-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#5)(2010-7#1)(2011-2#2)(2013-1#1)
applied as a spray##3##4##(2008-10#3)
applied as a##21##3##(2008-10#17)(2008-11#1)(2008-3#1)(2009-12#1)(2009-3#1)
applied as an analytical##2##4##(2008-10#2)
applied as an indicator electrode##3##5##(2008-10#3)
applied as an##8##3##(2008-10#5)(2008-11#1)(2008-6#1)(2010-4#1)
applied as the##2##3##(2008-10#2)
applied as##46##2##(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#2)(2012-5#1)
applied at a rate of##2##5##(2008-10#2)
applied at a##4##3##(2008-10#3)(2008-12#1)
applied at different##6##3##(2008-10#2)(2008-3#1)(2009-10#1)(2012-8#1)(2013-1#1)
applied at the##8##3##(2008-10#6)(2008-6#1)(2008-8#1)
applied at##33##2##(2008-10#20)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#1)
applied before##5##2##(1992-2#1)(1997-4#1)(2008-10#3)
applied bias##2##2##(2008-3#2)
applied by a##2##3##(2008-10#1)(2008-7#1)
applied by the##2##3##(1995-12#1)(2013-1#1)
applied by##18##2##(1992-4#1)(1993-6#1)(1995-12#1)(1996-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
applied cosmetic products can be helpful in improving##2##8##(2008-5#2)
applied cosmetic products##3##3##(2008-5#3)
applied current##11##2##(2008-10#9)(2009-10#1)(2009-12#1)
applied currents##2##2##(2008-10#1)(2009-12#1)
applied daily for##3##3##(2007-7#1)(2008-5#1)(2012-12#1)
applied dc field##2##3##(2007-11#2)
applied dc##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
applied directly to##3##3##(2008-10#3)
applied directly##6##2##(1996-5#1)(2008-10#4)(2011-2#1)
applied during the##5##3##(2008-10#3)(2008-2#1)(2012-2#1)
applied during##12##2##(1991-12#1)(1994-3#1)(1994-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2009-4#1)(2012-2#1)
applied either##5##2##(2008-10#2)(2008-12#2)(2008-3#1)
applied electric current##2##3##(2007-12#1)(2013-1#1)
applied electric field##7##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-7#1)(2009-12#1)
applied electric fields##2##3##(2008-2#1)(2008-3#1)
applied electric##11##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
applied electrical##3##2##(2008-7#1)(2009-5#1)(2010-1#1)
applied energy##3##2##(1993-1#3)
applied field##4##2##(2007-12#1)(2008-3#2)(2008-7#1)
applied fields##2##2##(1994-9#1)(2008-3#1)
applied for a##5##3##(1990-2#1)(1992-5#1)(2008-10#2)(2008-8#1)
applied for analysis of##3##4##(2008-10#2)(2008-11#1)
applied for determination of##10##4##(2008-10#9)(2008-3#1)
applied for each##2##3##(2008-10#1)(2012-1#1)
applied for monitoring the##2##4##(1996-12#1)(2008-10#1)
applied for qualitative##2##3##(2008-10#1)(2008-5#1)
applied for quantitative analysis##2##4##(2007-12#1)(2008-10#1)
applied for simultaneous determination of##3##5##(2008-10#3)
applied for simultaneous##4##3##(2008-10#3)(2008-2#1)
applied for studying##3##3##(2008-10#3)
applied for the analysis of##9##5##(2008-10#9)
applied for the classification##2##4##(2007-11#1)(2009-6#1)
applied for the determination of cobalt in synthetic mixtures##2##9##(2008-10#2)
applied for the determination of cobalt##3##6##(2008-10#3)
applied for the determination of copper##2##6##(2008-10#2)
applied for the determination of nitrite##2##6##(2008-10#2)
applied for the determination of pyrimethamine##2##6##(2008-10#2)
applied for the determination of the##6##6##(1991-7#1)(2008-10#5)
applied for the determination of total##2##6##(2008-10#2)
applied for the determination of trace##3##6##(2008-10#3)
applied for the determination of##60##5##(1991-7#1)(2008-10#59)
applied for the direct determination of##2##6##(2008-10#2)
applied for the direct##3##4##(2008-10#3)
applied for the quantification of##2##5##(2008-10#1)(2009-8#1)
applied for the resolution of##2##5##(2008-10#2)
applied for the simultaneous determination of nitrite and nitrate in##2##10##(2008-10#2)
applied for the simultaneous determination of##5##6##(2008-10#5)
applied for the simultaneous spectrophotometric determination of##2##7##(2008-10#2)
applied for the simultaneous##7##4##(2008-10#7)
applied for the##124##3##(1991-7#1)(2007-11#2)(2008-10#115)(2008-11#1)(2008-3#1)(2009-11#1)(2009-6#2)(2009-8#1)
applied for##245##2##(1990-2#1)(1991-7#1)(1992-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#188)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#10)(2008-5#3)(2008-8#3)(2009-11#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)
applied force##2##2##(2008-10#1)(2009-9#1)
applied here##2##2##(2008-10#2)
applied in a##9##3##(2008-10#6)(2008-3#1)(2008-7#1)(2009-6#1)
applied in an##2##3##(2008-10#2)
applied in any##3##3##(2008-10#2)(2008-9#1)
applied in clinical practice##2##4##(2007-12#1)(2008-10#1)
applied in clinical##4##3##(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
applied in combination with##3##4##(2008-10#2)(2008-7#1)
applied in determination of##2##4##(2008-10#2)
applied in different##2##3##(2008-10#1)(2012-8#1)
applied in many other##2##4##(1997-2#1)(2008-10#1)
applied in many##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
applied in order to##6##4##(1996-5#1)(2008-10#3)(2008-5#1)(2012-2#1)
applied in other medical##2##4##(1996-7#1)(2011-2#1)
applied in other##3##3##(1996-7#1)(2011-2#1)(2013-8#1)
applied in pharmacokinetic study##2##4##(2011-3#2)
applied in pharmacokinetic##3##3##(2008-10#1)(2011-3#2)
applied in studies##3##3##(2008-10#3)
applied in the analysis of##2##5##(2008-10#2)
applied in the determination of##4##5##(2008-10#4)
applied in the early##2##4##(2007-8#1)(2012-2#1)
applied in the field##2##4##(2008-10#2)
applied in the##38##3##(1991-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#2)(2007-8#3)(2008-10#19)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
applied in this##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2009-11#1)
applied in##156##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#67)(2008-11#3)(2008-2#3)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#5)
applied individually##3##2##(1990-5#1)(2008-10#1)(2008-4#1)
applied into##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
applied irrigation water##3##3##(2008-12#3)
applied is##2##2##(1991-8#1)(2007-11#1)
applied it to##3##3##(2007-11#1)(2008-3#2)
applied magnetic field##4##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
applied method##2##2##(2008-10#1)(2008-11#1)
applied normal##3##2##(2008-5#2)(2010-10#1)
applied not only to##2##4##(2008-5#1)(2008-6#1)
applied on the skin##3##4##(2008-5#1)(2008-6#1)(2011-3#1)
applied on the##14##3##(1996-1#1)(2008-10#4)(2008-5#4)(2008-6#1)(2009-11#1)(2010-8#1)(2011-3#1)(2013-1#1)
applied on##27##2##(1993-1#1)(1996-1#1)(1996-12#1)(2008-10#9)(2008-4#1)(2008-5#6)(2008-6#2)(2009-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
applied onto##2##2##(2008-10#1)(2008-5#1)
applied our##3##2##(2008-11#1)(2010-10#2)
applied over a##2##3##(1996-3#1)(2008-10#1)
applied over the range 0##2##5##(2008-10#2)
applied over the##4##3##(2008-10#2)(2008-9#1)(2009-1#1)
applied over##9##2##(1996-3#1)(2008-10#6)(2008-9#1)(2009-1#1)
applied potential and##2##3##(2008-10#2)
applied potential was##2##3##(2008-10#2)
applied potential##25##2##(2007-12#1)(2008-10#23)(2010-5#1)
applied pressure##3##2##(2010-12#1)(2010-4#1)(2012-2#1)
applied prior to##2##3##(1995-12#1)(2008-10#1)
applied public health##2##3##(1997-2#2)
applied quantity##2##2##(2008-5#2)
applied research##4##2##(2008-10#2)(2008-11#1)(2010-3#1)
applied satisfactorily to the determination of##8##6##(2008-10#8)
applied satisfactorily to the##10##4##(2008-10#10)
applied satisfactorily to##15##3##(2008-10#15)
applied satisfactorily##19##2##(2008-10#19)
applied showed##2##2##(2007-11#1)(2008-5#1)
applied simultaneously with##2##3##(1991-3#1)(2007-8#1)
applied simultaneously##4##2##(1991-3#1)(2007-8#1)(2008-10#1)(2010-12#1)
applied strategies##2##2##(2008-9#1)(2013-1#1)
applied stress##2##2##(2007-12#1)(2011-2#1)
applied successfully for the determination of the##2##7##(2008-10#2)
applied successfully for the determination of##4##6##(2008-10#4)
applied successfully in##3##3##(2008-10#3)
applied successfully to determination of##2##5##(2008-10#2)
applied successfully to the analysis of##3##6##(2008-10#3)
applied successfully to the determination of trace##2##7##(2008-10#2)
applied successfully to the determination of##19##6##(2008-10#19)
applied successfully to the##24##4##(2008-10#24)
applied successfully to##34##3##(1991-5#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)
applied successfully##41##2##(1991-5#1)(2008-10#36)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)
applied tension##3##2##(2013-1#3)
applied the model##2##3##(2008-5#1)(2008-8#1)
applied the##24##2##(1992-2#1)(1992-5#1)(1993-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)(2013-7#1)
applied theoretical##2##2##(2008-6#1)(2009-6#1)
applied these##3##2##(2008-3#1)(2010-8#1)(2013-1#1)
applied this technique to##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
applied this##10##2##(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
applied through##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
applied to As##2##3##(2008-10#2)
applied to DNA##3##3##(1991-9#1)(1997-4#1)(2008-10#1)
applied to a multimode##2##4##(2008-3#2)
applied to a specific##2##4##(2008-4#1)(2008-6#1)
applied to a system##2##4##(2008-10#2)
applied to a variety of##4##5##(2008-10#1)(2008-9#2)(2009-9#1)
applied to a##64##3##(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-7#1)(1995-2#2)(1997-4#2)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#5)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
applied to achieve##2##3##(2008-3#1)(2010-12#1)
applied to all##5##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
applied to an##14##3##(1991-2#1)(1992-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-12#1)(2011-2#1)(2012-2#1)
applied to analyse##4##3##(2008-10#4)
applied to analysis of##7##4##(2007-12#1)(2008-10#5)(2012-12#1)
applied to analyze##6##3##(2008-10#6)
applied to assay the##2##4##(2008-10#2)
applied to assay##4##3##(2008-10#4)
applied to assess the##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
applied to bacterial classification based on##2##6##(2008-10#2)
applied to blood##2##3##(2009-7#1)(2011-2#1)
applied to both##9##3##(1995-2#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)
applied to characterize##4##3##(1996-2#1)(2008-10#2)(2008-3#1)
applied to commercial##5##3##(2008-10#5)
applied to create##2##3##(2008-10#1)(2009-6#1)
applied to data from##2##4##(2008-3#1)(2009-7#1)
applied to data##6##3##(1995-5#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
applied to describe##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
applied to detect the##5##4##(2008-10#2)(2008-2#1)(2009-10#1)(2011-1#1)
applied to detect##12##3##(2008-10#7)(2008-2#1)(2009-10#1)(2011-1#2)(2013-1#1)
applied to determination of##13##4##(2008-10#13)
applied to determine the##20##4##(1994-9#1)(1996-12#1)(2008-10#14)(2008-3#2)(2009-12#1)(2011-1#1)
applied to determine trace##3##4##(2008-10#3)
applied to determine##55##3##(1994-9#1)(1996-12#1)(2008-10#47)(2008-3#2)(2009-12#1)(2011-1#2)(2013-1#1)
applied to determining##2##3##(2008-10#2)
applied to develop a##2##4##(2008-11#1)(2012-1#1)
applied to develop##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
applied to different##11##3##(2008-10#8)(2008-7#1)(2010-4#1)(2010-9#1)
applied to differential##2##3##(2008-10#2)
applied to direct glucose determination in##2##6##(2008-10#2)
applied to drugs##2##3##(2008-8#1)(2009-6#1)
applied to environmental##3##3##(2008-10#3)
applied to estimate the##3##4##(2008-10#2)(2008-3#1)
applied to estimate##6##3##(2008-10#4)(2008-3#1)(2012-2#1)
applied to evaluate the##2##4##(2008-1#1)(2008-10#1)
applied to evaluate##5##3##(2008-1#1)(2008-10#3)(2010-8#1)
applied to every##2##3##(1995-3#1)(2008-10#1)
applied to flow##2##3##(2008-10#1)(2008-9#1)
applied to generate##2##3##(2010-12#1)(2013-1#1)
applied to human##2##3##(1994-8#1)(1997-2#1)
applied to identify the##2##4##(2008-10#1)(2011-3#1)
applied to identify##5##3##(2008-10#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
applied to in##2##3##(2008-2#1)(2009-9#1)
applied to investigate the effect of##2##6##(2008-2#1)(2008-9#1)
applied to investigate the##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2011-3#1)
applied to large##2##3##(2008-11#1)(2010-11#1)
applied to large-scale##2##3##(2008-4#1)(2008-9#1)
applied to lead##2##3##(2008-10#1)(2008-2#1)
applied to make##2##3##(2008-3#1)(2008-7#1)
applied to many##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
applied to measure the##2##4##(2011-2#1)(2012-2#1)
applied to measure##9##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
applied to measurements of##3##4##(2008-10#1)(2008-3#2)
applied to measuring##3##3##(2008-2#1)(2008-3#2)
applied to model##2##3##(2008-10#1)(2008-11#1)
applied to monitor##5##3##(1992-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
applied to obtain##5##3##(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
applied to on-line##4##3##(2008-10#4)
applied to other##14##3##(1991-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-11#2)(2011-2#1)
applied to our##2##3##(2007-5#1)(2008-10#1)
applied to patients with##3##4##(1994-3#1)(2008-1#1)(2008-12#1)
applied to pharmaceutical formulations##3##4##(2008-10#3)
applied to real biological##2##4##(1996-5#1)(2012-3#1)
applied to real data##2##4##(2008-2#1)(2013-8#1)
applied to real samples##3##4##(2008-10#3)
applied to real water##2##4##(2008-10#2)
applied to real##11##3##(1996-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
applied to remove##2##3##(2008-3#2)
applied to river water##2##4##(2008-10#2)
applied to roots##2##3##(2008-10#2)
applied to sea water##2##4##(2008-10#2)
applied to several##6##3##(1990-5#1)(2008-10#5)
applied to simulated##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
applied to sodium##2##3##(2007-12#1)(2008-10#1)
applied to soil##2##3##(2008-10#2)
applied to some##3##3##(2008-10#2)(2008-2#1)
applied to spiked##2##3##(2008-10#2)
applied to standard##2##3##(2008-10#1)(2008-7#1)
applied to studies of##2##4##(2008-10#1)(2008-5#1)
applied to study the##10##4##(1997-7#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-5#1)(2011-3#1)
applied to study##12##3##(1997-7#1)(2007-12#1)(2008-10#6)(2008-3#2)(2010-5#1)(2011-3#1)
applied to sugarcane##2##3##(2013-1#2)
applied to tap water and##2##5##(2008-10#2)
applied to tap water##4##4##(2008-10#4)
applied to the analyses of##4##5##(2008-10#4)
applied to the analysis of a##2##6##(1996-5#1)(2008-10#1)
applied to the analysis of certified reference##2##7##(2008-10#2)
applied to the analysis of certified##3##6##(2008-10#3)
applied to the analysis of natural water samples##2##8##(2008-10#2)
applied to the analysis of natural##3##6##(2008-10#3)
applied to the analysis of real##3##6##(2008-10#3)
applied to the analysis of some##3##6##(2008-10#3)
applied to the analysis of spiked##2##6##(2008-10#2)
applied to the analysis of the##5##6##(2008-10#4)(2008-6#1)
applied to the analysis of these##2##6##(2008-10#2)
applied to the analysis of##65##5##(1995-3#1)(1996-5#1)(2008-10#60)(2008-6#1)(2010-4#1)(2013-1#1)
applied to the assay of##3##5##(1992-11#1)(2008-10#2)
applied to the behavior of##2##5##(2008-3#1)(2008-8#1)
applied to the calculation of##2##5##(2007-11#1)(2009-11#1)
applied to the characterization of##2##5##(2008-3#2)
applied to the classification of##2##5##(2008-10#1)(2008-7#1)
applied to the data##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
applied to the design of##5##5##(2008-12#1)(2008-2#1)(2008-3#3)
applied to the design##6##4##(2008-12#2)(2008-2#1)(2008-3#3)
applied to the detection of##5##5##(1994-9#1)(2008-10#4)
applied to the determination of As(III)##3##6##(2008-10#3)
applied to the determination of Captopril in##2##7##(2008-10#2)
applied to the determination of Ni##2##6##(2008-10#2)
applied to the determination of anionic##2##6##(2008-10#2)
applied to the determination of boron in##2##7##(2008-10#2)
applied to the determination of both##3##6##(2008-10#3)
applied to the determination of bromide in seawater##2##8##(2008-10#2)
applied to the determination of chloride in##2##7##(2008-10#2)
applied to the determination of chromium in##3##7##(2008-10#3)
applied to the determination of chromium(VI) in##2##7##(2008-10#2)
applied to the determination of chromium(VI)##3##6##(2008-10#3)
applied to the determination of cobalt in##2##7##(2008-10#2)
applied to the determination of cobalt##3##6##(2008-10#3)
applied to the determination of copper in river##2##8##(2008-10#2)
applied to the determination of copper in##5##7##(2008-10#5)
applied to the determination of epinephrine##2##6##(2008-10#2)
applied to the determination of fluoride in##2##7##(2008-10#2)
applied to the determination of free##2##6##(2008-10#2)
applied to the determination of hydrazine in water##3##8##(2008-10#3)
applied to the determination of iron in##2##7##(2008-10#2)
applied to the determination of iron##3##6##(2008-10#3)
applied to the determination of lead in##8##7##(2008-10#8)
applied to the determination of lead##10##6##(2008-10#10)
applied to the determination of lithium##2##6##(2008-10#2)
applied to the determination of magnesium in##2##7##(2008-10#2)
applied to the determination of nickel in##4##7##(2008-10#4)
applied to the determination of nickel##5##6##(2008-10#5)
applied to the determination of nitrite in##3##7##(2008-10#3)
applied to the determination of paracetamol in##2##7##(2008-10#2)
applied to the determination of rhodium##2##6##(2008-10#2)
applied to the determination of silver in##3##7##(2008-10#3)
applied to the determination of sulfide in##2##7##(2008-10#2)
applied to the determination of the drug in##4##8##(2008-10#4)
applied to the determination of the drugs in##2##8##(2008-10#2)
applied to the determination of the##14##6##(2008-10#13)(2009-8#1)
applied to the determination of these compounds in##4##8##(2008-10#4)
applied to the determination of these metal ions in##2##9##(2008-10#2)
applied to the determination of these metals in##2##8##(2008-10#2)
applied to the determination of these##14##6##(2008-10#14)
applied to the determination of total##7##6##(2008-10#7)
applied to the determination of trace amounts of##5##8##(2008-10#5)
applied to the determination of trace levels of##2##8##(2008-10#2)
applied to the determination of trace##25##6##(2008-10#25)
applied to the determination of tungsten in##2##7##(2008-10#2)
applied to the determination of vanadium in##5##7##(2008-10#5)
applied to the determination of##293##5##(1994-9#1)(1996-5#2)(1997-2#1)(2008-10#285)(2008-3#2)(2009-8#1)(2010-5#1)
applied to the determination##299##4##(1994-9#1)(1996-5#2)(1997-2#1)(2008-10#291)(2008-3#2)(2009-8#1)(2010-5#1)
applied to the development of a capillary##2##7##(2008-10#2)
applied to the development of##3##5##(2007-10#1)(2008-10#2)
applied to the direct determination and potentiometric titration of##2##9##(2008-10#2)
applied to the direct determination of the##4##7##(2008-10#3)(2008-2#1)
applied to the direct determination of##10##6##(2008-10#9)(2008-2#1)
applied to the direct determination##12##5##(2008-10#11)(2008-2#1)
applied to the direct##13##4##(2008-10#12)(2008-2#1)
applied to the dorsal##2##4##(1993-12#1)(2008-4#1)
applied to the ear##2##4##(2008-9#2)
applied to the evaluation of##2##5##(1996-12#1)(2008-10#1)
applied to the extraction and determination of##6##7##(2008-10#6)
applied to the extraction of##3##5##(2008-10#2)(2012-1#1)
applied to the extraction##9##4##(2008-10#8)(2012-1#1)
applied to the field of##2##5##(2007-4#1)(2008-10#1)
applied to the field##3##4##(2007-4#1)(2008-10#2)
applied to the first##2##4##(2007-11#1)(2008-10#1)
applied to the full##2##4##(2010-5#1)(2011-1#1)
applied to the identification of##2##5##(2008-10#1)(2008-7#1)
applied to the measurement of##6##5##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
applied to the monitoring of##4##5##(2008-10#3)(2008-2#1)
applied to the preconcentration of##3##5##(2008-10#3)
applied to the problem of##5##5##(2007-12#1)(2008-2#1)(2008-3#2)(2009-11#1)
applied to the quantification of##3##5##(2008-10#3)
applied to the quantitation of##2##5##(2008-10#2)
applied to the recovery and determination of copper in##2##9##(2008-10#2)
applied to the recovery and determination of##3##7##(2008-10#3)
applied to the recovery##5##4##(2008-10#5)
applied to the results##2##4##(2008-10#2)
applied to the separation and##2##5##(2008-10#2)
applied to the separation##3##4##(1996-5#1)(2008-10#2)
applied to the simple##2##4##(2008-10#2)
applied to the simulated##2##4##(2008-10#2)
applied to the simultaneous determination of hydrazine and phenylhydrazine##2##9##(2008-10#2)
applied to the simultaneous determination of the##2##7##(2008-10#2)
applied to the simultaneous determination of three##2##7##(2008-10#2)
applied to the simultaneous determination of##19##6##(2008-10#19)
applied to the simultaneous##28##4##(2008-10#27)(2008-5#1)
applied to the skin##2##4##(2008-5#1)(2008-7#1)
applied to the speciation of antimony in##2##7##(2008-10#2)
applied to the speciation of chromium in##2##7##(2008-10#2)
applied to the speciation of##6##5##(2008-10#6)
applied to the speciation##8##4##(2008-10#8)
applied to the spectra##2##4##(2008-10#2)
applied to the spectrophotometric determination of chromium(VI)##2##7##(2008-10#2)
applied to the spectrophotometric determination of##3##6##(2008-10#3)
applied to the spectrophotometric##4##4##(2008-10#4)
applied to the study of##5##5##(2008-2#1)(2008-3#3)(2011-1#1)
applied to the system##2##4##(2007-12#1)(2008-10#1)
applied to the trace##2##4##(2008-10#2)
applied to the##707##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-3#2)(1993-12#2)(1993-3#2)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-3#2)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#7)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#526)(2008-11#6)(2008-12#2)(2008-2#17)(2008-3#33)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#6)(2013-8#1)
applied to this##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
applied to three##4##3##(2008-10#3)(2012-2#1)
applied to tomato##2##3##(2008-10#2)
applied to treat##3##3##(2008-12#1)(2008-9#1)(2011-1#1)
applied to trees##2##3##(2008-10#1)(2010-4#1)
applied to two##15##3##(2008-10#6)(2008-3#5)(2008-4#1)(2008-7#1)(2009-11#1)(2013-1#1)
applied to various##4##3##(2008-10#3)(2008-2#1)
applied to water samples##3##4##(2008-10#3)
applied to water##5##3##(2008-10#4)(2010-3#1)
applied to##1542##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-5#3)(1991-8#3)(1991-9#3)(1992-11#4)(1992-12#2)(1992-3#5)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#5)(1993-3#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-12#1)(1995-2#7)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#7)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#6)(1997-6#4)(1997-7#2)(1997-8#4)(2006-10#1)(2007-10#2)(2007-11#22)(2007-12#27)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#898)(2008-11#22)(2008-12#7)(2008-2#57)(2008-3#123)(2008-4#15)(2008-5#20)(2008-6#7)(2008-7#27)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#5)(2009-12#5)(2009-2#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#7)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#15)(2011-2#18)(2011-3#3)(2012-1#5)(2012-12#2)(2012-2#14)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#18)(2013-7#2)(2013-8#9)
applied together with##2##3##(2008-10#1)(2009-12#1)
applied topically##2##2##(1993-1#1)(2008-5#1)
applied treatment##4##2##(2007-8#1)(2008-10#2)(2013-1#1)
applied twice daily for##2##4##(2008-5#2)
applied twice##3##2##(2008-5#3)
applied two##2##2##(2007-8#1)(2008-3#1)
applied under##2##2##(2008-3#1)(2008-5#1)
applied using a##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
applied using##5##2##(1994-2#1)(2008-11#1)(2011-2#1)(2013-1#2)
applied very##2##2##(2008-10#1)(2010-8#1)
applied via##2##2##(2008-10#2)
applied voltage and##3##3##(2008-10#2)(2008-2#1)
applied voltage of##2##3##(2008-10#1)(2008-2#1)
applied voltage##27##2##(2007-11#1)(2007-12#1)(2008-10#16)(2008-2#4)(2008-3#1)(2010-4#1)(2013-1#1)(2013-8#2)
applied was##2##2##(2008-10#1)(2012-2#1)
applied water##2##2##(2008-10#2)
applied were##2##2##(2008-10#2)
applied widely##2##2##(2008-10#1)(2008-4#1)
applied with satisfactory results to##2##5##(2008-10#2)
applied with##17##2##(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#1)(2009-7#1)(2013-1#1)
applied##2831##1##(1990-11#2)(1990-12#2)(1990-2#4)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#8)(1991-2#2)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#5)(1992-9#1)(1993-1#5)(1993-12#8)(1993-2#3)(1993-3#6)(1993-6#4)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#10)(1995-1#1)(1995-12#6)(1995-2#10)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#7)(1996-5#12)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#7)(1997-4#9)(1997-6#8)(1997-7#5)(1997-8#7)(2006-10#1)(2007-10#3)(2007-11#49)(2007-12#50)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#20)(2008-1#9)(2008-10#1506)(2008-11#50)(2008-12#26)(2008-2#90)(2008-3#180)(2008-4#25)(2008-5#87)(2008-6#15)(2008-7#42)(2008-8#26)(2008-9#27)(2009-1#1)(2009-10#9)(2009-11#10)(2009-12#12)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#5)(2009-6#9)(2009-7#7)(2009-8#5)(2009-9#8)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#9)(2010-2#1)(2010-3#9)(2010-4#13)(2010-5#8)(2010-6#2)(2010-7#6)(2010-8#21)(2010-9#2)(2011-1#24)(2011-10#1)(2011-2#40)(2011-3#6)(2012-1#10)(2012-12#9)(2012-2#24)(2012-3#8)(2012-5#2)(2012-7#1)(2012-8#3)(2012-9#1)(2013-1#52)(2013-7#5)(2013-8#21)
applies for##2##2##(2008-11#1)(2008-8#1)
applies the##8##2##(1996-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)
applies to a##2##3##(2008-3#1)(2008-8#1)
applies to all##2##3##(2007-12#1)(2008-2#1)
applies to the##3##3##(1995-2#1)(2007-11#1)(2008-3#1)
applies to##30##2##(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#5)(2008-9#1)(2010-11#1)(2010-3#1)
applies##58##1##(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#4)(2008-8#8)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-7#1)
appliqué##4##1##(2008-3#4)
appliqués in the##3##3##(2008-3#3)
appliqués##11##1##(2008-3#11)
apply a##17##2##(1991-1#1)(1996-4#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)
apply an##5##2##(1995-9#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
apply and##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
apply for##8##2##(1991-3#1)(1994-12#1)(1994-3#1)(2007-12#2)(2012-2#1)(2013-1#2)
apply in##2##2##(1996-11#1)(2009-1#1)
apply it to the##4##4##(1997-1#1)(1997-8#1)(2007-11#1)(2008-3#1)
apply it to##8##3##(1997-1#1)(1997-8#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
apply it##9##2##(1997-1#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
apply legal##2##2##(1995-1#1)(2010-7#1)
apply or##3##2##(2008-10#2)(2013-1#1)
apply our method to##2##4##(2008-2#2)
apply our##3##2##(2008-2#2)(2008-7#1)
apply the method to##3##4##(1995-12#1)(1997-3#1)(2008-8#1)
apply the model to##3##4##(2008-8#2)(2013-8#1)
apply the new##2##3##(1997-3#1)(1997-8#1)
apply the results to##3##4##(1997-2#1)(2008-3#2)
apply the results##4##3##(1997-2#1)(2008-3#2)(2009-4#1)
apply the##42##2##(1992-3#1)(1995-12#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
apply them to##2##3##(1991-1#1)(1995-3#1)
apply them##6##2##(1990-12#1)(1991-1#1)(1993-12#1)(1995-3#1)(2008-3#1)(2013-8#1)
apply these methods##3##3##(2008-3#1)(2009-10#1)(2012-3#1)
apply these results to##2##4##(2008-3#1)(2013-7#1)
apply these##11##2##(1994-3#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-3#3)(2009-10#1)(2012-3#1)(2013-7#1)
apply this method to##3##4##(2008-10#2)(2012-2#1)
apply this method##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
apply this technique to the##3##5##(1995-2#1)(2008-3#1)(2011-1#1)
apply this technique to##5##4##(1995-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
apply this technique##6##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2011-1#1)
apply this##21##2##(1993-9#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
apply to a##2##3##(2008-3#1)(2011-2#1)
apply to an##2##3##(2008-10#1)(2008-6#1)
apply to other##3##3##(1995-2#1)(2010-10#1)(2010-8#1)
apply to patients with##2##4##(2008-6#1)(2011-2#1)
apply to patients##3##3##(2008-6#2)(2011-2#1)
apply to the##6##3##(1995-2#2)(2008-2#1)(2008-4#2)(2013-7#1)
apply to##50##2##(1992-2#1)(1993-2#1)(1995-12#2)(1995-2#4)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
apply##243##1##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-5#1)(1997-7#2)(1997-8#3)(2007-11#4)(2007-12#9)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#14)(2008-12#3)(2008-2#13)(2008-3#24)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#3)
apply?##2##1##(1993-1#1)(1994-2#1)
applying a##32##2##(1995-5#1)(2008-10#17)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#4)(2009-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
applying an external##3##3##(2008-10#1)(2008-3#2)
applying an##14##2##(1997-2#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)
applying artificial neural networks##3##4##(2008-10#3)
applying correction##2##2##(2008-10#2)
applying different##3##2##(2008-10#2)(2008-11#1)
applying external##2##2##(2008-8#1)(2009-12#1)
applying for##3##2##(1991-12#1)(1996-8#1)(2013-8#1)
applying it to the##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
applying it to##12##3##(1997-2#1)(2008-10#8)(2008-3#1)(2009-11#1)(2013-1#1)
applying multivariate##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
applying our##2##2##(2008-10#1)(2012-2#1)
applying physico-chemical##2##2##(2008-10#1)(2010-12#1)
applying spiritual care##3##3##(2010-11#3)
applying the method to##2##4##(2008-10#2)
applying the method##4##3##(2007-11#1)(2008-10#3)
applying the theory##3##3##(2008-10#1)(2008-3#2)
applying the##55##2##(1992-2#1)(1993-12#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#20)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#1)(2008-9#2)(2009-3#2)(2009-8#1)(2009-9#1)(2010-8#3)(2011-1#1)(2013-1#2)(2013-8#1)
applying their##2##2##(1994-12#1)(2008-5#1)
applying them to##4##3##(2008-6#1)(2008-7#1)(2013-1#2)
applying them##5##2##(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)
applying these##6##2##(1993-12#1)(1994-1#2)(2008-10#1)(2008-5#1)(2013-1#1)
applying this knowledge to##2##4##(2009-5#1)(2011-2#1)
applying this##5##2##(2008-11#2)(2009-3#1)(2009-5#1)(2011-2#1)
applying to##2##2##(1994-3#1)(2008-12#1)
applying two##2##2##(2008-10#1)(2008-11#1)
applying##267##1##(1990-7#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#3)(1994-1#2)(1994-12#2)(1994-3#3)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#89)(2008-11#14)(2008-12#4)(2008-2#6)(2008-3#15)(2008-4#5)(2008-5#15)(2008-6#4)(2008-7#5)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-7#3)(2010-8#4)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#4)
appoint##2##1##(1990-11#1)(2013-8#1)
appointed a##2##2##(1993-6#1)(1997-6#1)
appointed##25##1##(1991-9#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-8#2)(2009-4#1)(2010-1#1)(2011-1#1)(2012-3#1)
appointment breaking##2##2##(1996-1#2)
appointment of##3##2##(1992-12#1)(1997-8#1)(2007-12#1)
appointment roles##2##2##(2008-11#1)(2008-12#1)
appointment slots##2##2##(1996-3#2)
appointment##35##1##(1990-3#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-1#3)(1996-3#3)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
appointments and##2##2##(1991-2#1)(2013-8#1)
appointments for##2##2##(1991-2#1)(1991-6#1)
appointments in##5##2##(1992-2#2)(1997-2#1)(2008-4#1)(2013-8#1)
appointments##25##1##(1990-9#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-1#3)(1996-3#1)(1997-2#1)(2008-11#1)(2008-4#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-8#3)
appointments]##2##1##(1990-10#1)(2013-1#1)
apportionment of##3##2##(2008-10#2)(2008-8#1)
apportionment##4##1##(2008-10#3)(2008-8#1)
apposed##4##1##(1991-5#1)(1996-5#1)(2008-7#2)
apposition were##2##2##(2008-10#1)(2009-5#1)
apposition##7##1##(2007-12#1)(2008-10#4)(2009-5#1)(2012-3#1)
appositions##16##1##(2008-10#15)(2011-2#1)
appraisal and##6##2##(1991-12#1)(2008-2#1)(2008-5#1)(2012-3#1)(2013-1#2)
appraisal in##2##2##(2008-9#1)(2012-1#1)
appraisal of the##5##3##(1991-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-8#1)
appraisal of##17##2##(1991-1#2)(1993-6#1)(1994-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
appraisal process##2##2##(2008-11#2)
appraisal skills and##2##3##(2008-11#1)(2008-12#1)
appraisal skills##4##2##(2008-11#2)(2008-12#2)
appraisal##48##1##(1991-1#2)(1991-12#1)(1992-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-3#5)(2013-1#2)(2013-8#1)
appraisals of daily##3##3##(2012-1#3)
appraisals of fit##2##3##(2009-10#2)
appraisals of##9##2##(1994-12#1)(2009-10#3)(2012-1#3)(2013-1#2)
appraisals##34##1##(1992-12#1)(1994-12#1)(1996-2#1)(2008-4#1)(2008-7#1)(2009-10#3)(2010-1#1)(2012-1#7)(2013-1#18)
appraise and##2##2##(2008-11#1)(2012-12#1)
appraise the##5##2##(1991-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
appraise##12##1##(1991-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
appraised as##2##2##(1994-12#1)(2011-2#1)
appraised##15##1##(1994-12#2)(1994-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2011-2#1)(2013-1#3)
appraising##5##1##(2007-5#2)(2008-12#1)(2009-3#1)(2012-3#1)
appreciable amount of##2##3##(1990-11#1)(2007-11#1)
appreciable amount##4##2##(1990-11#1)(1991-12#1)(2007-11#1)(2008-10#1)
appreciable effect on the##2##4##(1992-2#1)(2008-10#1)
appreciable effect##4##2##(1990-12#1)(1992-2#1)(2008-10#1)(2008-11#1)
appreciable lag##2##2##(2008-5#2)
appreciable levels of##2##3##(1991-12#1)(2008-9#1)
appreciable loss##2##2##(2008-11#1)(2012-2#1)
appreciable##43##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
appreciably modified##2##2##(1993-9#1)(2008-8#1)
appreciably##16##1##(1992-5#1)(1992-6#1)(1993-9#2)(1994-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-10#1)(2012-3#1)
appreciate the##11##2##(1991-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
appreciate##17##1##(1991-12#1)(1992-1#1)(1995-12#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
appreciated and##3##2##(1990-11#1)(2010-8#1)(2011-1#1)
appreciated but##2##2##(1994-1#1)(2009-5#1)
appreciated by##2##2##(2008-8#1)(2010-10#1)
appreciated in##4##2##(1991-6#1)(2008-8#1)(2009-10#1)(2011-1#1)
appreciated that##3##2##(2008-8#1)(2009-5#1)(2012-12#1)
appreciated the##3##2##(1997-4#1)(2008-12#1)(2008-5#1)
appreciated##36##1##(1990-11#1)(1991-3#1)(1991-6#2)(1993-11#1)(1994-1#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-5#2)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
appreciation for the##2##3##(2008-8#1)(2012-12#1)
appreciation for##3##2##(2008-8#1)(2009-8#1)(2012-12#1)
appreciation of the##14##3##(1991-12#1)(1993-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
appreciation of their##2##3##(2008-8#1)(2009-5#1)
appreciation of this##2##3##(2008-1#1)(2008-8#1)
appreciation of##33##2##(1991-12#2)(1991-6#1)(1993-12#2)(1993-3#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
appreciation to##2##2##(1991-3#1)(2008-11#1)
appreciation##46##1##(1991-12#3)(1991-3#1)(1991-6#1)(1993-12#2)(1993-3#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
apprehension and##2##2##(1993-2#1)(2010-12#1)
apprehension##7##1##(1993-2#1)(1995-1#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#2)
apprenticeship##2##1##(1997-2#1)(2008-11#1)
appressed to the agar surface##2##5##(2008-10#2)
appressed##3##1##(2008-10#3)
appressoria and##5##2##(2008-10#5)
appressoria formation##3##2##(2008-10#2)(2010-10#1)
appressoria formed on##2##3##(2008-10#2)
appressoria formed##4##2##(2008-10#4)
appressoria of##7##2##(2008-10#7)
appressoria on##4##2##(2008-10#4)
appressoria was##4##2##(2008-10#4)
appressoria were##4##2##(2008-10#4)
appressoria with##2##2##(2008-10#2)
appressoria##61##1##(2008-10#60)(2010-10#1)
appressorial development##2##2##(2008-10#2)
appressorial formation##2##2##(2008-10#2)
appressorial germ tubes##2##3##(2008-10#2)
appressorial##13##1##(2008-10#13)
appressorium development##2##2##(2008-10#2)
appressorium formation and##2##3##(2008-10#2)
appressorium formation in C##2##4##(2008-10#2)
appressorium formation in##3##3##(2008-10#3)
appressorium formation of##3##3##(2008-10#3)
appressorium formation##26##2##(2008-10#26)
appressorium##37##1##(2008-10#36)(2009-8#1)
appressorium-forming##2##1##(2008-10#2)
approach (TRA)##2##2##(2011-2#2)
approach a##2##2##(2008-3#1)(2010-10#1)
approach aimed##2##2##(2009-10#1)(2013-1#1)
approach allowed the##2##3##(2008-10#2)
approach allowed##10##2##(1996-2#1)(2007-8#1)(2008-10#5)(2011-2#2)(2012-12#1)
approach allows a##2##3##(2008-10#1)(2009-10#1)
approach allows for##4##3##(1996-12#1)(2009-5#1)(2009-8#1)(2012-2#1)
approach allows one to##3##4##(1990-12#1)(2008-10#1)(2008-7#1)
approach allows rapid##2##3##(2008-9#2)
approach allows the##3##3##(2008-10#2)(2008-4#1)
approach allows##21##2##(1990-12#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-2#1)
approach also##6##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
approach an##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
approach and a##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
approach and indicate that##2##4##(2008-10#1)(2008-2#1)
approach and its##3##3##(2007-11#2)(2008-10#1)
approach and review of the literature##2##6##(1992-12#1)(2008-10#1)
approach and the##10##3##(1991-3#1)(2008-10#4)(2008-8#1)(2010-1#1)(2010-8#1)(2013-1#1)(2013-8#1)
approach and then##2##3##(1994-12#1)(2008-2#1)
approach and##77##2##(1990-2#1)(1990-3#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#17)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
approach appears to##2##3##(2008-7#1)(2013-1#1)
approach appears##4##2##(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
approach applied to##2##3##(1997-8#1)(2007-12#1)
approach applied##3##2##(1997-8#1)(2007-12#1)(2009-11#1)
approach are discussed##2##3##(1996-11#1)(2008-10#1)
approach are outlined##2##3##(1994-3#1)(2008-10#1)
approach are the##2##3##(2007-11#1)(2011-2#1)
approach are##26##2##(1991-5#1)(1992-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-8#1)(2009-1#1)(2010-11#1)(2010-3#2)(2010-5#1)(2011-2#1)(2013-1#1)
approach as well as##3##4##(1991-2#1)(2008-10#1)(2012-12#1)
approach as##7##2##(1991-2#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)
approach assumes##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
approach at##4##2##(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)
approach based on a##2##4##(2008-3#1)(2009-12#1)
approach based on the##11##4##(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
approach based on##35##3##(1990-8#1)(1994-11#1)(1995-2#1)(2008-1#2)(2008-10#4)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
approach based##36##2##(1990-8#1)(1994-11#1)(1995-2#1)(2008-1#2)(2008-10#5)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
approach between##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
approach both##2##2##(1991-5#1)(1992-1#1)
approach but##2##2##(1996-1#1)(2008-3#1)
approach by##7##2##(1992-5#1)(2008-2#3)(2009-8#1)(2010-3#1)(2012-3#1)
approach bypasses the need##2##4##(2008-11#1)(2008-3#1)
approach called##3##2##(1996-1#1)(2008-4#1)(2013-8#1)
approach can be applied to a##2##6##(2008-2#1)(2008-9#1)
approach can be successfully applied##2##5##(2008-10#2)
approach can be used for##2##5##(2008-11#1)(2008-4#1)
approach can be used in##2##5##(2008-3#1)(2008-8#1)
approach can be used to##3##5##(1996-12#1)(2008-10#1)(2008-2#1)
approach can be used with##2##5##(2008-10#1)(2008-9#1)
approach can be used##11##4##(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
approach can be##26##3##(1996-12#2)(1997-1#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-2#2)
approach can help##2##3##(2010-7#1)(2010-8#1)
approach can improve the##2##4##(2008-10#1)(2008-6#1)
approach can improve##3##3##(2008-10#1)(2008-6#2)
approach can provide##4##3##(1995-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
approach can##51##2##(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-8#1)
approach combining##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
approach compared to##2##3##(2008-3#1)(2008-4#1)
approach consisting of##2##3##(1991-3#1)(2008-10#1)
approach consisting##3##2##(1991-3#1)(2008-10#1)(2008-7#1)
approach could be##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
approach could##9##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2010-12#1)(2011-1#1)(2011-2#1)
approach coupled with mass spectrometry##2##5##(1997-4#1)(2012-2#1)
approach described here##2##3##(2008-3#1)(2009-7#1)
approach described##3##2##(2007-11#1)(2008-3#1)(2009-7#1)
approach developed##5##2##(1994-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
approach differs##2##2##(1990-12#1)(2008-6#1)
approach does not require complete##2##5##(2007-11#1)(2008-2#1)
approach does not##4##3##(1991-9#1)(2007-11#1)(2008-2#1)(2008-9#1)
approach enabled##3##2##(2007-10#1)(2008-10#1)(2009-10#1)
approach enables one to##3##4##(2008-3#3)
approach enables##6##2##(1993-2#1)(2008-3#3)(2008-6#2)
approach extends the##3##3##(1994-11#1)(2007-11#1)(2010-2#1)
approach fails in##2##3##(2008-3#1)(2010-11#1)
approach fails##3##2##(1995-2#1)(2008-3#1)(2010-11#1)
approach focusing on##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
approach followed by##2##3##(1990-9#1)(2006-12#1)
approach for Aboriginal##2##3##(2008-12#1)(2008-4#1)
approach for SNP##2##3##(2012-3#1)(2013-1#1)
approach for a##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#2)
approach for assessing##2##3##(2008-5#1)(2009-10#1)
approach for controlling##2##3##(2008-10#1)(2009-11#1)
approach for designing##2##3##(2008-2#2)
approach for determination of##3##4##(2008-10#3)
approach for determination##4##3##(2008-10#3)(2010-8#1)
approach for determining##2##3##(2007-12#1)(2008-10#1)
approach for evaluating##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
approach for improving the##2##4##(1994-12#1)(2008-5#1)
approach for improving##3##3##(1994-12#1)(2008-3#1)(2008-5#1)
approach for large##2##3##(2008-4#1)(2011-2#1)
approach for management of##2##4##(2008-10#1)(2012-2#1)
approach for modeling##2##3##(2009-11#1)(2010-3#1)
approach for monitoring access##2##4##(1997-2#2)
approach for monitoring##3##3##(1995-2#1)(1997-2#2)
approach for optimal##2##3##(2008-3#1)(2011-2#1)
approach for predicting##2##3##(1992-9#1)(2008-10#1)
approach for preparing MAP systems##2##5##(2008-4#2)
approach for preparing##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
approach for prevention and##2##4##(2008-7#1)(2008-8#1)
approach for quantifying the##2##4##(1994-11#1)(2008-10#1)
approach for quantifying##3##3##(1994-11#1)(2008-10#2)
approach for resection of##2##4##(2011-2#2)
approach for screening##3##3##(2008-10#2)(2013-1#1)
approach for studying##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
approach for testing##2##3##(2012-3#1)(2013-1#1)
approach for the analysis of##5##5##(2008-10#3)(2010-11#1)(2012-3#1)
approach for the assessment of##2##5##(2008-5#1)(2010-3#1)
approach for the determination of##2##5##(1995-3#1)(2008-10#1)
approach for the development of##3##5##(2008-3#1)(2009-6#1)(2010-4#1)
approach for the management of##4##5##(2008-1#1)(2010-11#1)(2010-5#1)(2011-2#1)
approach for the prevention of##2##5##(2008-10#1)(2009-10#1)
approach for the synthesis of##2##5##(1995-2#1)(2012-3#1)
approach for the treatment of##6##5##(1992-8#1)(1994-5#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
approach for the treatment##7##4##(1992-8#1)(1994-5#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#2)
approach for the##67##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
approach for these##2##3##(2008-5#1)(2009-10#1)
approach for this##3##3##(1996-2#1)(2008-5#1)(2012-3#1)
approach for##282##2##(1990-5#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-1#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#4)(2006-12#1)(2007-11#1)(2007-12#7)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#47)(2008-11#4)(2008-12#7)(2008-2#10)(2008-3#16)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#12)(2009-10#4)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#23)(2012-12#1)(2012-2#10)(2012-3#9)(2012-7#1)(2013-1#12)(2013-8#4)
approach given by##2##3##(2008-2#1)(2011-2#1)
approach gives##6##2##(2006-12#1)(2008-3#2)(2009-8#1)(2010-5#1)(2012-2#1)
approach greatly##2##2##(2007-12#1)(2008-3#1)
approach had the##2##3##(2013-1#2)
approach had##3##2##(2013-1#3)
approach has a##2##3##(2008-3#1)(2012-2#1)
approach has been applied to##2##5##(2008-10#1)(2009-10#1)
approach has been applied##3##4##(2008-10#2)(2009-10#1)
approach has been developed for##2##5##(2008-4#1)(2009-12#1)
approach has been developed##6##4##(2006-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-12#1)
approach has been shown##2##4##(2008-10#1)(2012-3#1)
approach has been to##2##4##(2008-6#1)(2010-3#1)
approach has been used##4##4##(1995-12#1)(2008-10#2)(2011-2#1)
approach has been##30##3##(1994-5#1)(1995-12#1)(1995-3#1)(2006-4#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
approach has broad applications##2##4##(2008-4#1)(2010-11#1)
approach has proven to be##2##5##(2008-5#1)(2009-3#1)
approach has the potential to##2##5##(2008-3#1)(2012-2#1)
approach has the potential##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
approach has the##6##3##(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#2)
approach has##58##2##(1990-7#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
approach have been##3##3##(1994-3#1)(2008-10#1)(2011-1#1)
approach identifies##2##2##(2008-11#1)(2008-7#1)
approach improved##2##2##(2008-10#2)
approach improves##2##2##(2008-3#1)(2011-3#1)
approach in a patient##2##4##(1996-3#1)(2008-11#1)
approach in a##5##3##(1996-3#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
approach in an##2##3##(2008-11#1)(2012-3#1)
approach in order to##3##4##(2008-10#2)(2008-9#1)
approach in patients with##3##4##(1990-6#1)(2007-8#1)(2012-3#1)
approach in terms of##2##4##(1992-1#1)(2008-3#1)
approach in the context of##2##5##(2008-10#1)(2008-5#1)
approach in the treatment of##3##5##(1990-9#1)(1993-6#1)(2007-12#1)
approach in the treatment##4##4##(1990-9#1)(1993-6#1)(2007-12#1)(2008-4#1)
approach in the##17##3##(1990-9#1)(1991-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)
approach in##78##2##(1990-6#2)(1990-9#1)(1991-3#1)(1991-6#1)(1992-1#4)(1992-5#1)(1992-6#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-3#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#4)(2008-10#7)(2008-11#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#5)(2013-1#2)(2013-8#1)
approach include##3##2##(1993-12#1)(2008-7#1)(2011-1#1)
approach including##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
approach increases##2##2##(2009-8#1)(2013-8#1)
approach into a##2##3##(2008-2#1)(2013-1#1)
approach involves the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
approach involves##6##2##(1994-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
approach involving##6##2##(1993-8#1)(1994-6#1)(2007-5#1)(2008-10#2)(2013-1#1)
approach is a##5##3##(2006-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)
approach is also##2##3##(2008-2#1)(2008-4#1)
approach is applicable##3##3##(1997-2#1)(2008-2#1)(2008-4#1)
approach is applied to##3##4##(2008-3#1)(2012-1#1)(2012-2#1)
approach is based on a##2##5##(2008-10#1)(2008-3#1)
approach is based on the##2##5##(2008-2#1)(2008-3#1)
approach is based on##11##4##(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)
approach is capable of##2##4##(2008-10#1)(2013-1#1)
approach is clearly##2##3##(1992-1#1)(2010-10#1)
approach is demonstrated by##2##4##(2008-3#2)
approach is demonstrated##3##3##(2008-10#1)(2008-3#2)
approach is described##5##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-2#1)
approach is difficult##2##3##(2008-10#1)(2008-9#1)
approach is illustrated by##2##4##(2008-2#1)(2013-1#1)
approach is illustrated##6##3##(1995-12#1)(2008-2#1)(2009-7#1)(2009-9#1)(2012-1#1)(2013-1#1)
approach is introduced for##2##4##(2008-2#1)(2008-7#1)
approach is introduced in##2##4##(2008-10#2)
approach is introduced##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
approach is limited to##2##4##(2007-12#1)(2012-3#1)
approach is limited##4##3##(2007-12#1)(2008-3#1)(2012-3#2)
approach is more##3##3##(2008-10#2)(2008-8#1)
approach is necessary to##2##4##(1995-5#1)(2008-4#1)
approach is necessary##3##3##(1995-5#1)(2008-12#1)(2008-4#1)
approach is needed##2##3##(1995-6#1)(2011-2#1)
approach is not##7##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
approach is now##3##3##(1992-11#1)(2007-6#1)(2008-7#1)
approach is of##2##3##(1994-2#1)(2007-12#1)
approach is outlined##2##3##(1991-8#1)(1997-4#1)
approach is presented##8##3##(1992-3#1)(1993-5#1)(2008-10#2)(2008-2#3)(2008-5#1)
approach is proposed for##2##4##(2008-10#1)(2008-3#1)
approach is proposed##3##3##(2008-10#2)(2008-3#1)
approach is provided##2##3##(2008-4#2)
approach is required##3##3##(2009-4#1)(2010-11#1)(2010-5#1)
approach is shown to##2##4##(2008-3#2)
approach is similar to that##2##5##(2008-7#1)(2008-9#1)
approach is still##3##3##(1990-12#1)(1992-8#1)(2008-5#1)
approach is superior##2##3##(2010-12#1)(2012-2#1)
approach is taken##2##3##(1996-3#1)(2008-10#1)
approach is technically##2##3##(1990-5#1)(2006-12#1)
approach is that it##4##4##(2008-2#1)(2008-4#1)(2009-8#1)(2012-1#1)
approach is that##12##3##(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#2)
approach is the##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
approach is then##2##3##(1997-4#1)(2008-6#1)
approach is to##10##3##(1991-2#1)(1992-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
approach is used in##2##4##(2008-3#1)(2008-9#1)
approach is used to##8##4##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
approach is used##12##3##(1992-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)
approach is verified##2##3##(2008-2#2)
approach is##214##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#3)(2006-12#2)(2007-11#4)(2007-12#8)(2007-6#1)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#5)(2008-2#16)(2008-3#22)(2008-4#12)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#6)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#11)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#1)
approach it##2##2##(2008-11#1)(2008-3#1)
approach leads to##2##3##(2008-4#1)(2010-12#1)
approach makes##3##2##(2010-4#1)(2011-2#1)(2012-2#1)
approach may be considered##2##4##(2009-10#1)(2010-5#1)
approach may be##9##3##(1993-2#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)
approach may not##2##3##(1993-1#1)(1997-4#1)
approach may offer##2##3##(2008-11#1)(2011-2#1)
approach may##22##2##(1991-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
approach might##2##2##(1994-5#1)(2009-9#1)
approach must be##2##3##(1997-3#1)(2008-3#1)
approach not##2##2##(1996-12#1)(2010-3#1)
approach of breast cancer##3##4##(1991-12#1)(1993-8#2)
approach of the##11##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-3#1)(2012-2#2)(2012-3#1)
approach of##55##2##(1991-12#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1995-12#1)(1995-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#9)(2008-11#5)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2010-3#1)(2010-4#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
approach offers a##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
approach offers##6##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
approach on a##2##3##(2008-10#1)(2008-7#1)
approach on the##3##3##(2008-10#2)(2012-3#1)
approach on##13##2##(2008-10#3)(2008-3#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
approach over##2##2##(2011-2#2)
approach particularly##2##2##(2009-1#1)(2012-1#1)
approach permits one to##2##4##(2008-2#1)(2008-9#1)
approach permits##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
approach permitted##2##2##(2007-8#1)(2008-10#1)
approach presented##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
approach produces##2##2##(2008-3#1)(2009-10#1)
approach proposed##2##2##(2008-3#1)(2010-3#1)
approach provides a##10##3##(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-8#1)
approach provides##17##2##(1994-8#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#2)(2013-8#1)
approach reduces the##2##3##(2007-12#1)(2010-11#1)
approach reduces##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2010-11#1)
approach remains controversial##2##3##(2007-8#1)(2008-12#1)
approach represents a##2##3##(2007-11#1)(2008-3#1)
approach represents##3##2##(2006-12#1)(2007-11#1)(2008-3#1)
approach requires##4##2##(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
approach revealed##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
approach should be##8##3##(2007-8#1)(2008-10#2)(2010-11#1)(2010-7#1)(2011-2#3)
approach should##12##2##(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2010-11#1)(2010-7#1)(2011-2#3)(2013-1#1)
approach starts##2##2##(1994-5#1)(2009-7#1)
approach suggested##2##2##(2008-11#1)(2008-12#1)
approach suitable for##2##3##(1995-2#1)(2008-2#1)
approach supports the##2##3##(1997-2#1)(2008-11#1)
approach supports##3##2##(1992-3#1)(1997-2#1)(2008-11#1)
approach taken in##2##3##(1995-11#1)(2008-11#1)
approach taken##5##2##(1991-12#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-12#1)
approach than##2##2##(1996-1#1)(2010-12#1)
approach that allows##2##3##(2008-11#1)(2012-2#1)
approach that combines##4##3##(1994-6#1)(2009-6#1)(2010-5#1)(2012-2#1)
approach that included##2##3##(2008-12#2)
approach that includes##2##3##(2007-10#1)(2009-8#1)
approach that is##5##3##(2007-12#1)(2008-1#1)(2008-6#1)(2011-2#1)(2013-8#1)
approach that##41##2##(1994-6#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
approach the ideal##2##3##(1990-7#1)(2008-10#1)
approach the##20##2##(1990-7#1)(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
approach their##2##2##(1997-7#1)(2008-8#1)
approach through##2##2##(2007-8#1)(2008-10#1)
approach to a##11##3##(1990-6#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
approach to achieve##3##3##(2007-12#1)(2008-8#1)(2009-4#1)
approach to achieving a##2##4##(1996-3#1)(2008-3#1)
approach to achieving##3##3##(1996-3#1)(2007-12#1)(2008-3#1)
approach to address this##2##4##(2008-11#1)(2012-3#1)
approach to address##3##3##(2008-11#1)(2009-9#1)(2012-3#1)
approach to addressing these##2##4##(1997-2#1)(2008-7#1)
approach to addressing##3##3##(1997-2#1)(2008-7#1)(2012-2#1)
approach to aging##2##3##(1994-5#2)
approach to analysis of##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
approach to analyze##2##3##(1997-3#1)(2008-6#1)
approach to analyzing##4##3##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
approach to assess##2##3##(1997-4#1)(2012-12#1)
approach to automated##2##3##(2008-9#2)
approach to be##2##3##(1995-11#1)(2012-2#1)
approach to biological##2##3##(2008-4#1)(2010-2#1)
approach to bone##2##3##(2007-12#1)(2008-1#1)
approach to care##3##3##(1992-1#1)(2011-2#1)(2012-12#1)
approach to complex##2##3##(1990-2#1)(2008-7#1)
approach to construct a##2##4##(1995-3#1)(2008-10#1)
approach to construct##3##3##(1995-3#1)(2008-10#2)
approach to continuous##2##3##(1995-3#1)(1996-1#1)
approach to control of##2##4##(2008-10#2)
approach to control##4##3##(2008-10#3)(2012-3#1)
approach to cost##2##3##(1993-5#1)(2008-7#1)
approach to data analysis##2##4##(1996-6#1)(2008-12#1)
approach to data collection##3##4##(1994-3#1)(2008-11#2)
approach to data##7##3##(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-12#1)
approach to dealing with##2##4##(1995-2#2)
approach to define##3##3##(1996-12#1)(1996-2#1)(2013-1#1)
approach to describing the properties of##2##6##(2007-11#1)(2008-2#1)
approach to detect##2##3##(2008-10#1)(2012-2#1)
approach to determine the##2##4##(1995-12#1)(2008-10#1)
approach to determine##4##3##(1995-12#1)(2008-10#1)(2009-4#1)(2011-2#1)
approach to determining the##2##4##(2008-8#1)(2010-11#1)
approach to developing##2##3##(1992-3#1)(2010-8#1)
approach to diagnosis and##2##4##(2008-11#1)(2008-7#1)
approach to diagnosis##5##3##(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)
approach to discover##2##3##(2009-9#1)(2010-5#1)
approach to distributed fiber-optic Brillouin sensing##2##6##(2007-11#2)
approach to education##3##3##(1995-2#1)(2007-6#1)(2008-12#1)
approach to enhance##2##3##(2008-11#1)(2013-1#1)
approach to estimate the##4##4##(2008-10#2)(2008-3#1)(2009-9#1)
approach to estimate##6##3##(2008-10#2)(2008-3#1)(2009-2#1)(2009-9#1)(2013-1#1)
approach to estimating##3##3##(1994-11#1)(1995-9#1)(2008-3#1)
approach to ethics##2##3##(2008-11#2)
approach to evaluate##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
approach to examine##2##3##(2008-7#1)(2009-5#1)
approach to financing##2##3##(1993-2#1)(2008-1#1)
approach to generate random##2##4##(2008-10#1)(2013-1#1)
approach to health##7##3##(1993-12#2)(1994-12#2)(1994-3#1)(2012-12#1)(2012-2#1)
approach to hospital##2##3##(1993-2#1)(1996-12#1)
approach to identify##6##3##(1992-2#1)(1993-8#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
approach to identifying##4##3##(2008-11#1)(2008-4#1)(2010-7#1)(2012-3#1)
approach to improve##2##3##(2008-10#1)(2008-9#1)
approach to improving the##2##4##(1996-2#1)(2007-11#1)
approach to improving##9##3##(1991-2#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#2)(2008-7#1)
approach to integrating##2##3##(1994-2#1)(2008-11#1)
approach to investigate the##4##4##(1993-12#1)(1997-1#1)(2008-10#2)
approach to investigate##5##3##(1993-12#1)(1997-1#1)(2008-10#2)(2012-2#1)
approach to investigation and##3##4##(2008-11#3)
approach to laboratory automation##2##4##(2008-10#2)
approach to managed care##2##4##(1994-12#1)(1994-3#1)
approach to management of##2##4##(2008-7#1)(2010-12#1)
approach to management##5##3##(1992-12#1)(1993-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
approach to managing##2##3##(1994-2#1)(2008-10#1)
approach to measure##5##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
approach to measuring##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
approach to medical##2##3##(1996-1#1)(2010-8#1)
approach to medicine##2##3##(1995-6#1)(2008-1#1)
approach to modeling##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
approach to nurse##2##3##(1994-2#1)(2008-11#1)
approach to nursing##3##3##(1993-12#1)(2007-10#1)(2010-3#1)
approach to obtain##2##3##(2007-11#1)(2008-3#1)
approach to optical##3##3##(2008-2#2)(2008-7#1)
approach to optimize##2##3##(2007-12#1)(2008-4#1)
approach to optimizing the##2##4##(2008-3#1)(2012-1#1)
approach to optimizing##4##3##(2008-1#1)(2008-3#2)(2012-1#1)
approach to overcome these##2##4##(2009-10#1)(2010-5#1)
approach to patient care##4##4##(1997-2#1)(2007-10#1)(2008-11#1)(2008-8#1)
approach to patients with##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
approach to patients##5##3##(1992-3#1)(2008-3#1)(2008-7#1)(2011-2#2)
approach to performance##2##3##(1995-3#1)(2007-4#1)
approach to pest management##2##4##(2008-10#2)
approach to prepare##3##3##(2008-10#1)(2009-12#1)(2010-5#1)
approach to public##3##3##(1996-12#1)(1996-3#1)(2008-12#1)
approach to quality##3##3##(1994-3#1)(1995-1#2)
approach to quantify##3##3##(2008-10#2)(2008-8#1)
approach to reduce##2##3##(1990-6#1)(2008-10#1)
approach to reducing the##2##4##(2008-3#1)(2012-3#1)
approach to reducing##3##3##(2007-11#1)(2008-3#1)(2012-3#1)
approach to rehabilitation##2##3##(2008-6#1)(2010-3#1)
approach to restructuring##2##3##(1994-3#1)(1995-2#1)
approach to selectively##2##3##(2008-10#1)(2009-8#1)
approach to separate##2##3##(2008-10#1)(2008-11#1)
approach to service##2##3##(1993-1#1)(1996-12#1)
approach to site identification using##2##5##(2008-11#2)
approach to solve##3##3##(2007-12#1)(2009-10#1)(2012-2#1)
approach to strategic planning##4##4##(1994-2#2)(1994-3#1)(2012-3#1)
approach to study the##5##4##(2008-10#2)(2008-4#1)(2009-12#1)(2010-11#1)
approach to study##8##3##(2008-10#3)(2008-4#2)(2009-12#1)(2010-11#1)(2011-2#1)
approach to supporting##2##3##(1995-12#1)(2008-11#1)
approach to teaching##6##3##(2008-11#4)(2013-1#1)(2013-8#1)
approach to test for##2##4##(2008-11#1)(2008-4#1)
approach to the analysis of the##2##6##(1992-12#1)(1995-8#1)
approach to the analysis of##7##5##(1992-12#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-3#2)(2009-10#1)
approach to the craniocervical junction##2##5##(2011-2#2)
approach to the design of the##2##6##(2008-11#1)(2012-1#1)
approach to the design of##3##5##(2007-11#1)(2008-11#1)(2012-1#1)
approach to the determination of##2##5##(2008-10#1)(2012-4#1)
approach to the development##2##4##(1997-1#1)(2008-11#1)
approach to the diagnosis of##2##5##(1991-3#1)(2009-9#1)
approach to the management of##9##5##(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2010-3#1)(2013-1#1)
approach to the management##10##4##(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2010-3#2)(2013-1#1)
approach to the prevention of##2##5##(2009-10#1)(2009-4#1)
approach to the problem##2##4##(1991-6#1)(1997-3#1)
approach to the solution of the##2##6##(2007-12#1)(2008-2#1)
approach to the study of the##2##6##(2007-11#1)(2007-12#1)
approach to the study of##7##5##(1994-8#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#3)
approach to the synthesis of##3##5##(2008-11#1)(2009-9#1)(2011-2#1)
approach to the treatment of early##2##6##(2008-7#2)
approach to the treatment of##10##5##(1991-11#1)(1992-2#1)(1992-8#1)(1996-3#2)(1996-7#1)(2007-12#1)(2008-7#2)(2012-2#1)
approach to the treatment##11##4##(1991-11#1)(1992-2#1)(1992-8#1)(1996-3#2)(1996-7#1)(2007-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
approach to the use of##2##5##(2008-10#1)(2008-2#1)
approach to the##119##3##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-5#7)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#2)(2009-4#1)(2009-7#2)(2009-9#2)(2010-3#2)(2010-5#2)(2011-2#10)(2012-1#1)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#1)
approach to their##2##3##(2008-3#1)(2012-3#1)
approach to these patients##2##4##(2008-1#1)(2010-8#1)
approach to these##3##3##(2008-1#1)(2010-8#1)(2012-12#1)
approach to this##7##3##(1994-3#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#2)
approach to treat##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
approach to treatment of##2##4##(1994-5#1)(2008-3#1)
approach to treatment##3##3##(1994-5#1)(2008-3#1)(2012-3#1)
approach to understand##2##3##(2009-2#1)(2012-3#1)
approach to understanding the##2##4##(1993-12#1)(2007-11#1)
approach to understanding##7##3##(1992-2#1)(1993-12#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)
approach to venous##2##3##(2008-3#1)(2011-2#1)
approach to##727##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#2)(1992-1#3)(1992-12#5)(1992-2#6)(1992-3#5)(1992-5#1)(1992-8#3)(1992-9#2)(1993-1#4)(1993-12#6)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#4)(1994-2#11)(1994-3#9)(1994-5#5)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#7)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#11)(1996-2#5)(1996-3#9)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#4)(2006-10#1)(2006-12#1)(2006-5#7)(2007-10#2)(2007-11#20)(2007-12#17)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#6)(2008-1#11)(2008-10#70)(2008-11#48)(2008-12#8)(2008-2#16)(2008-3#39)(2008-4#14)(2008-5#4)(2008-6#15)(2008-7#29)(2008-8#25)(2008-9#17)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#5)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#7)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#36)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#22)(2012-3#20)(2012-4#1)(2013-1#15)(2013-7#2)(2013-8#8)
approach toward the##2##3##(2007-11#1)(2008-7#1)
approach toward##5##2##(2007-11#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-1#1)
approach towards the##4##3##(2008-10#1)(2009-5#1)(2012-2#1)(2013-1#1)
approach towards##19##2##(1991-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#1)
approach used for##2##3##(1990-5#1)(1997-2#1)
approach used here##2##3##(1994-8#1)(2012-2#1)
approach used in##5##3##(1994-3#1)(1996-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
approach used to##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
approach used##14##2##(1990-5#1)(1991-6#1)(1994-3#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
approach uses a##2##3##(2008-2#1)(2008-3#1)
approach uses three##2##3##(2008-10#1)(2008-2#1)
approach uses##9##2##(1992-3#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)
approach using a##5##3##(1996-2#1)(2008-10#2)(2011-1#1)(2012-2#1)
approach using the##2##3##(1997-2#1)(2009-5#1)
approach using##19##2##(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
approach utilizes##2##2##(2008-3#1)(2009-12#1)
approach utilizing##3##2##(2008-3#1)(2012-2#1)(2012-3#1)
approach was adopted for the##2##5##(2008-10#2)
approach was adopted to##2##4##(2008-10#1)(2011-1#1)
approach was adopted##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2011-1#1)(2013-1#1)
approach was also used##2##4##(1994-2#1)(2008-10#1)
approach was also##4##3##(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#1)
approach was applied##2##3##(2008-10#1)(2008-11#1)
approach was demonstrated by##2##4##(2008-10#1)(2013-1#1)
approach was demonstrated##5##3##(1996-12#1)(2008-10#3)(2013-1#1)
approach was developed for##3##4##(1994-12#1)(2008-10#1)(2009-11#1)
approach was developed to##2##4##(2008-10#1)(2013-1#1)
approach was developed##7##3##(1994-12#1)(1994-3#1)(2008-10#3)(2009-11#1)(2013-1#1)
approach was evaluated by##3##4##(2008-10#2)(2010-5#1)
approach was evaluated##4##3##(2006-12#1)(2008-10#2)(2010-5#1)
approach was not##2##3##(2008-10#1)(2008-11#1)
approach was performed in##2##4##(2007-11#1)(2013-1#1)
approach was performed##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
approach was proposed to##2##4##(2008-10#1)(2011-2#1)
approach was proposed##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
approach was taken##2##3##(2008-10#1)(2008-8#1)
approach was then##2##3##(2008-8#1)(2012-2#1)
approach was to##4##3##(1990-12#1)(2007-5#1)(2008-10#1)(2008-11#1)
approach was used for the##2##5##(2008-11#1)(2008-7#1)
approach was used for##3##4##(2008-11#1)(2008-7#1)(2009-11#1)
approach was used to##7##4##(2008-10#3)(2008-12#1)(2008-3#1)(2012-3#1)(2013-8#1)
approach was used with##2##4##(2009-8#1)(2013-1#1)
approach was used##17##3##(2006-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
approach was##94##2##(1990-12#1)(1991-1#1)(1991-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#30)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-11#2)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#2)(2011-9#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
approach we have##3##3##(1995-2#1)(2008-5#1)(2009-2#1)
approach we present##2##3##(1995-12#1)(2007-8#1)
approach we##11##2##(1995-12#1)(1995-2#1)(2007-8#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-2#1)(2012-2#1)
approach were##10##2##(1997-6#1)(2007-11#1)(2008-10#4)(2012-1#3)(2012-12#1)
approach when##2##2##(2008-4#2)
approach where##4##2##(1994-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
approach which##7##2##(1990-6#1)(1992-6#1)(1994-9#1)(1995-9#1)(1997-7#1)(2008-5#1)(2010-7#1)
approach will be##2##3##(2007-11#1)(2008-11#1)
approach will##9##2##(1991-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-3#1)
approach with a##7##3##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
approach with potential##2##3##(2008-8#1)(2012-12#1)
approach with the aim of##2##5##(2008-9#1)(2011-1#1)
approach with the##5##3##(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#1)
approach with##46##2##(1990-12#1)(1994-9#1)(1995-2#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)
approach would be##2##3##(2008-7#1)(2012-2#1)
approach would##6##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
approach yields an##2##3##(1996-3#2)
approach yields##8##2##(1996-3#2)(2007-11#1)(2008-3#3)(2008-9#1)(2012-2#1)
approach##3106##1##(1990-10#1)(1990-12#9)(1990-2#5)(1990-3#4)(1990-5#6)(1990-6#6)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#11)(1991-2#11)(1991-3#9)(1991-5#5)(1991-6#9)(1991-8#1)(1991-9#2)(1992-1#14)(1992-11#1)(1992-12#10)(1992-2#11)(1992-3#10)(1992-5#4)(1992-6#4)(1992-8#7)(1992-9#6)(1993-1#9)(1993-11#6)(1993-12#13)(1993-2#11)(1993-3#9)(1993-5#4)(1993-6#3)(1993-8#5)(1993-9#3)(1994-1#9)(1994-11#8)(1994-12#11)(1994-2#23)(1994-3#20)(1994-5#12)(1994-6#6)(1994-8#3)(1994-9#5)(1995-1#8)(1995-11#3)(1995-12#16)(1995-2#22)(1995-3#12)(1995-5#6)(1995-6#8)(1995-8#4)(1995-9#3)(1996-1#18)(1996-11#4)(1996-12#23)(1996-2#15)(1996-3#26)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#12)(1997-2#16)(1997-3#18)(1997-4#6)(1997-5#1)(1997-6#10)(1997-7#6)(1997-8#10)(2006-10#5)(2006-12#10)(2006-4#1)(2006-5#7)(2006-6#1)(2007-10#8)(2007-11#55)(2007-12#60)(2007-2#1)(2007-4#1)(2007-5#5)(2007-6#5)(2007-7#6)(2007-8#34)(2008-1#26)(2008-10#419)(2008-11#131)(2008-12#53)(2008-2#124)(2008-3#190)(2008-4#67)(2008-5#48)(2008-6#46)(2008-7#110)(2008-8#85)(2008-9#67)(2009-1#2)(2009-10#25)(2009-11#12)(2009-12#15)(2009-2#4)(2009-3#16)(2009-4#6)(2009-5#19)(2009-6#8)(2009-7#16)(2009-8#18)(2009-9#18)(2010-1#4)(2010-10#12)(2010-11#20)(2010-12#16)(2010-2#5)(2010-3#24)(2010-4#11)(2010-5#28)(2010-6#3)(2010-7#9)(2010-8#27)(2010-9#5)(2011-1#37)(2011-2#201)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#28)(2012-12#45)(2012-2#89)(2012-3#78)(2012-4#1)(2012-7#2)(2012-8#1)(2013-1#103)(2013-7#8)(2013-8#38)
approach) versus##3##2##(2011-2#2)(2013-1#1)
approach)##13##1##(1995-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-9#2)(2011-2#2)(2012-3#1)(2013-1#3)
approach]##11##1##(1991-6#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
approachable##3##1##(2007-7#1)(2012-2#1)(2013-1#1)
approached 1##3##2##(2008-10#2)(2008-9#1)
approached by##4##2##(1992-9#1)(1993-12#1)(1995-11#1)(2008-11#1)
approached for##2##2##(2007-12#1)(2008-10#1)
approached from##2##2##(2008-7#1)(2012-12#1)
approached in##5##2##(1991-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2009-12#1)
approached significance##2##2##(2008-4#1)(2008-5#1)
approached the##6##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2013-1#1)
approached through##4##2##(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
approached to##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
approached##54##1##(1991-12#1)(1991-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-1#1)
approaches a##3##2##(2008-2#2)(2013-8#1)
approaches across##2##2##(2010-8#1)(2013-1#1)
approaches aimed at##2##3##(2007-11#1)(2011-2#1)
approaches allow##2##2##(2008-9#1)(2009-5#1)
approaches also##2##2##(1997-5#1)(2008-4#1)
approaches and some##2##3##(1992-12#1)(2008-10#1)
approaches and their##5##3##(1996-4#1)(1997-2#1)(2008-11#1)(2013-1#2)
approaches and treatment##2##3##(2010-7#1)(2013-8#1)
approaches and##44##2##(1991-3#1)(1992-12#1)(1994-1#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
approaches are available for##2##4##(2007-12#1)(2008-10#1)
approaches are being##2##3##(2008-4#1)(2012-1#1)
approaches are discussed##3##3##(1994-8#1)(2010-8#1)(2013-1#1)
approaches are employed for##2##4##(2008-3#1)(2013-1#1)
approaches are essential##2##3##(2008-10#1)(2008-11#1)
approaches are needed##2##3##(2008-10#1)(2011-1#1)
approaches are not##2##3##(2007-12#1)(2008-3#1)
approaches are suggested##2##3##(2008-8#1)(2010-11#1)
approaches are##48##2##(1993-12#1)(1994-3#1)(1994-8#1)(1996-9#1)(2007-12#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-3#3)(2013-1#4)
approaches as well as##3##4##(2008-9#2)(2012-3#1)
approaches as well##4##3##(2008-9#2)(2012-3#1)(2013-1#1)
approaches as##6##2##(2008-1#1)(2008-11#1)(2008-9#2)(2012-3#1)(2013-1#1)
approaches available##2##2##(2008-7#1)(2008-9#1)
approaches based on##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
approaches can be##4##3##(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#1)
approaches can provide##2##3##(2009-12#1)(2012-3#1)
approaches can##9##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
approaches continue to##2##3##(2008-11#1)(2010-3#1)
approaches described##4##2##(2008-4#2)(2008-9#1)(2011-1#1)
approaches discussed##2##2##(2008-10#1)(2008-11#1)
approaches for a##2##3##(2008-6#1)(2010-10#1)
approaches for control of##2##4##(2008-10#1)(2009-4#1)
approaches for determining the##2##4##(2008-3#1)(2008-7#1)
approaches for molecular##2##3##(2008-12#1)(2008-4#1)
approaches for the management of##2##5##(2008-10#1)(2008-2#1)
approaches for the##12##3##(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-3#1)
approaches for##89##2##(1990-5#1)(1991-9#1)(1992-1#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#5)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)
approaches has##4##2##(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#1)
approaches have been described to##2##5##(2008-11#1)(2010-8#1)
approaches have been developed for##2##5##(2008-10#1)(2011-3#1)
approaches have been developed to##3##5##(2008-11#1)(2008-8#1)(2011-2#1)
approaches have been developed##6##4##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)
approaches have been proposed for##3##5##(2007-8#1)(2010-12#1)(2012-3#1)
approaches have been proposed##4##4##(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#1)
approaches have been used to##2##5##(2007-7#1)(2013-1#1)
approaches have been used##3##4##(2007-7#1)(2008-11#1)(2013-1#1)
approaches have been##19##3##(1994-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
approaches have##38##2##(1992-12#1)(1994-9#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
approaches in the management of##2##5##(2008-7#1)(2010-5#1)
approaches in the##13##3##(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#2)(2010-5#1)(2011-1#2)(2012-2#2)
approaches in theoretical population##2##4##(2008-9#2)
approaches in this##2##3##(2008-9#1)(2009-3#1)
approaches in##44##2##(1990-6#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2009-4#1)(2009-7#1)(2010-3#3)(2010-5#1)(2011-1#4)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
approaches include##4##2##(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)
approaches including##2##2##(1995-12#1)(2011-2#1)
approaches involving##4##2##(2007-11#2)(2007-5#1)(2008-6#1)
approaches is##6##2##(2008-10#2)(2008-9#2)(2010-12#1)(2013-1#1)
approaches may be used##2##4##(1991-6#1)(2008-11#1)
approaches may be##4##3##(1991-6#1)(1992-1#1)(2008-11#1)(2012-2#1)
approaches may##10##2##(1991-6#1)(1992-1#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-2#1)(2012-3#1)
approaches of##7##2##(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-6#1)(2012-3#1)
approaches on##2##2##(2008-6#1)(2012-3#1)
approaches should be##2##3##(1993-3#1)(2009-8#1)
approaches such as##4##3##(2008-10#1)(2008-4#1)(2010-2#2)
approaches taken##2##2##(1997-3#1)(2008-11#1)
approaches that are##2##3##(2008-7#1)(2008-9#1)
approaches that can be##4##4##(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)
approaches that can##5##3##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)
approaches that have been##3##4##(2008-3#1)(2009-11#1)(2010-7#1)
approaches that have##6##3##(1995-6#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-7#1)
approaches that may##3##3##(2008-11#1)(2010-12#1)(2010-8#1)
approaches that modify##2##3##(1994-5#1)(2008-8#1)
approaches that of##2##3##(2007-11#1)(2008-2#1)
approaches that target##2##3##(2008-8#1)(2012-1#1)
approaches that utilize##2##3##(2008-10#1)(2009-7#1)
approaches that##39##2##(1994-1#1)(1994-12#1)(1994-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
approaches the##6##2##(1992-4#1)(2007-12#1)(2008-3#2)(2010-8#1)(2012-2#1)
approaches they##2##2##(2008-11#1)(2012-1#1)
approaches to a##4##3##(1995-5#1)(2010-3#1)(2012-1#1)(2013-1#1)
approaches to address##2##3##(1996-1#1)(2010-12#1)
approaches to analyzing##2##3##(2008-3#1)(2009-4#1)
approaches to assess##2##3##(2011-2#1)(2013-1#1)
approaches to be##2##3##(2008-11#1)(2008-9#1)
approaches to caring##2##3##(2009-5#2)
approaches to characterize##2##3##(2008-11#1)(2009-8#1)
approaches to clinical##2##3##(1994-1#1)(1996-1#1)
approaches to couple therapy##4##4##(2012-2#4)
approaches to developing##3##3##(2008-4#2)(2010-8#1)
approaches to drug##2##3##(2009-3#1)(2013-1#1)
approaches to enhance##3##3##(2008-11#1)(2010-11#1)(2013-1#1)
approaches to flow cytometry##2##4##(2008-4#1)(2008-8#1)
approaches to health##3##3##(1996-12#1)(1996-7#1)(2008-4#1)
approaches to identify##2##3##(2008-4#1)(2012-3#1)
approaches to improve##2##3##(1991-12#1)(2011-1#1)
approaches to improving##2##3##(2012-2#1)(2013-1#1)
approaches to learning##4##3##(2011-1#3)(2011-2#1)
approaches to management in##2##4##(2011-2#2)
approaches to management##3##3##(1992-2#1)(2011-2#2)
approaches to optimizing##2##3##(1993-3#1)(2008-2#1)
approaches to prevention and##2##4##(1996-3#1)(2011-1#1)
approaches to prevention##3##3##(1996-3#1)(2008-7#1)(2011-1#1)
approaches to promote##2##3##(1996-2#1)(2013-1#1)
approaches to study##2##3##(1994-9#1)(2008-8#1)
approaches to studying##2##3##(2012-2#1)(2013-8#1)
approaches to teaching##2##3##(2011-2#2)
approaches to test##2##3##(1995-2#1)(1997-5#1)
approaches to the development of##2##5##(2008-11#1)(2009-6#1)
approaches to the diagnosis##2##4##(2007-10#1)(2007-12#1)
approaches to the treatment of##6##5##(1992-3#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-1#1)
approaches to the##36##3##(1990-9#1)(1992-3#2)(1993-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-11#1)(2009-6#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-1#2)(2013-7#1)
approaches to these##4##3##(1995-6#1)(2006-10#1)(2008-3#1)(2008-4#1)
approaches to this problem##2##4##(1994-9#1)(2010-11#1)
approaches to this##3##3##(1994-9#1)(2008-3#1)(2010-11#1)
approaches to tobacco use##2##4##(1997-1#2)
approaches to treatment##4##3##(1997-3#1)(2007-11#1)(2008-9#1)(2013-1#1)
approaches to understand##2##3##(2008-7#1)(2009-2#1)
approaches to use##2##3##(2008-1#1)(2008-7#1)
approaches to##257##2##(1990-9#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#3)(1994-1#3)(1994-2#4)(1994-5#1)(1994-9#2)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#9)(2008-5#5)(2008-6#3)(2008-7#16)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#4)(2010-12#4)(2010-3#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#19)(2012-1#3)(2012-12#2)(2012-2#13)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#1)
approaches toward##2##2##(2008-6#1)(2011-2#1)
approaches towards##2##2##(2011-1#1)(2013-1#1)
approaches unity##2##2##(1994-5#1)(2008-2#1)
approaches used by##2##3##(2010-8#1)(2013-1#1)
approaches used in the##2##4##(1994-6#1)(2008-1#1)
approaches used in##4##3##(1994-6#1)(1997-1#1)(2008-1#1)(2009-4#1)
approaches used to##6##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-6#1)(2013-1#1)
approaches used##14##2##(1994-6#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-8#1)(2013-1#2)
approaches using##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)
approaches was##2##2##(2008-9#1)(2013-8#1)
approaches were##10##2##(2008-10#8)(2008-7#1)(2010-8#1)
approaches when##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
approaches will be##4##3##(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#1)
approaches will##8##2##(1997-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
approaches with a##2##3##(2008-1#1)(2008-2#1)
approaches with##4##2##(2008-1#1)(2008-2#1)(2008-6#1)(2010-4#1)
approaches##1006##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#7)(1994-1#7)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#5)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#2)(1996-1#3)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#2)(1996-9#2)(1997-1#10)(1997-2#4)(1997-3#5)(1997-5#4)(1997-7#3)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#8)(2007-12#17)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#15)(2008-10#101)(2008-11#49)(2008-12#17)(2008-2#25)(2008-3#34)(2008-4#42)(2008-5#18)(2008-6#22)(2008-7#50)(2008-8#25)(2008-9#35)(2009-1#1)(2009-10#2)(2009-11#9)(2009-12#6)(2009-2#3)(2009-3#6)(2009-4#6)(2009-5#12)(2009-6#4)(2009-7#8)(2009-8#5)(2010-10#4)(2010-11#12)(2010-12#13)(2010-2#3)(2010-3#20)(2010-4#3)(2010-5#10)(2010-6#6)(2010-7#4)(2010-8#14)(2010-9#2)(2011-1#20)(2011-2#60)(2011-3#4)(2012-1#8)(2012-12#10)(2012-2#35)(2012-3#29)(2012-5#1)(2013-1#54)(2013-7#1)(2013-8#10)
approaching 50%##2##2##(1994-6#1)(2007-4#1)
approaching a##3##2##(1993-8#1)(2008-2#1)(2008-7#1)
approaching cellular senescence##2##3##(2008-11#2)
approaching the##7##2##(2007-12#2)(2008-3#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
approaching those##3##2##(1995-5#1)(2008-10#2)
approaching##44##1##(1993-12#1)(1993-8#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#4)(2008-9#2)(2009-6#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
appropriate (7-9)##2##2##(2010-12#2)
appropriate action##2##2##(2008-10#1)(2012-2#1)
appropriate addition of##2##3##(2008-10#1)(2009-8#1)
appropriate administration##2##2##(1996-11#1)(2008-7#1)
appropriate administrative##3##2##(1991-12#1)(1994-3#1)(1997-3#1)
appropriate analysis of##2##3##(2008-10#1)(2009-8#1)
appropriate analytical##3##2##(2008-10#3)
appropriate and useful##2##3##(1993-2#1)(2007-11#1)
appropriate and##14##2##(1993-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
appropriate animal model in##2##4##(2008-10#2)
appropriate animal model##3##3##(1995-2#1)(2008-10#2)
appropriate animal##4##2##(1995-2#1)(2008-10#2)(2008-4#1)
appropriate antibiotic therapy##3##3##(1996-6#1)(2007-7#1)(2012-12#1)
appropriate antibiotic##6##2##(1994-12#1)(1996-6#1)(2007-7#2)(2011-2#1)(2012-12#1)
appropriate antibodies##2##2##(2008-1#1)(2008-4#1)
appropriate application##2##2##(2008-10#1)(2008-5#1)
appropriate approach##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
appropriate atmospheric##3##2##(2008-2#1)(2008-3#2)
appropriate candidates for##2##3##(1993-3#1)(2013-1#1)
appropriate care for##2##3##(2008-11#1)(2012-12#1)
appropriate care to##2##3##(1991-3#1)(2013-8#1)
appropriate care##8##2##(1991-3#1)(1996-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-8#2)
appropriate cases##2##2##(2008-9#1)(2013-1#1)
appropriate cell lines##2##3##(2008-9#2)
appropriate cell##3##2##(2008-7#1)(2008-9#2)
appropriate choice of the##2##4##(1995-12#1)(2007-11#1)
appropriate choice of##10##3##(1990-8#1)(1995-12#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#2)
appropriate chromogenic##2##2##(2008-10#1)(2008-4#1)
appropriate clinical management##2##3##(2012-2#1)(2013-1#1)
appropriate clinical##6##2##(1995-9#1)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
appropriate cognitive exercises##2##3##(2009-10#2)
appropriate combination of##5##3##(1991-9#1)(1993-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
appropriate combination##6##2##(1991-9#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
appropriate conditions##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-10#1)
appropriate control strategy##2##3##(2008-10#1)(2008-8#1)
appropriate control##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
appropriate controls##2##2##(1995-6#1)(2008-9#1)
appropriate correction##2##2##(2008-10#2)
appropriate course##2##2##(1993-12#1)(1997-2#1)
appropriate design##2##2##(2010-11#1)(2010-5#1)
appropriate devices##2##2##(2007-12#1)(2010-8#1)
appropriate diagnosis and##2##3##(2008-8#2)
appropriate diagnostic##5##2##(1990-9#1)(1995-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
appropriate diet##4##2##(1992-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
appropriate dilution##2##2##(2008-10#1)(2008-4#1)
appropriate dose##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
appropriate drugs##3##2##(2006-10#1)(2009-6#1)(2011-2#1)
appropriate education##3##2##(1997-7#1)(2007-10#1)(2008-6#1)
appropriate evaluation and##2##3##(1997-2#1)(2008-9#1)
appropriate experimental conditions##2##3##(2008-10#1)(2009-12#1)
appropriate experimental##3##2##(2008-10#1)(2009-12#1)(2012-3#1)
appropriate first-line##2##2##(1992-8#1)(2008-6#1)
appropriate flow##2##2##(2008-10#1)(2008-7#1)
appropriate for a##3##3##(1990-2#1)(2008-4#1)(2008-6#1)
appropriate for all##2##3##(2007-11#1)(2008-8#1)
appropriate for gestational age##2##4##(1990-12#1)(2011-1#1)
appropriate for modeling##2##3##(2008-10#2)
appropriate for small##2##3##(2008-2#1)(2010-12#1)
appropriate for the purpose##2##4##(2008-1#1)(2008-10#1)
appropriate for the##13##3##(1994-8#1)(1996-4#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)
appropriate for their age##2##4##(2011-2#1)(2012-12#1)
appropriate for use by##2##4##(1992-3#1)(2009-3#1)
appropriate for use##3##3##(1992-3#1)(2008-5#1)(2009-3#1)
appropriate for##84##2##(1990-12#1)(1990-2#1)(1991-1#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-5#2)(1996-4#1)(1996-7#1)(1997-1#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
appropriate form of##2##3##(1993-6#1)(2008-10#1)
appropriate genetic##2##2##(1997-3#1)(2008-8#1)
appropriate imaging##3##2##(2008-8#1)(2012-1#1)(2013-1#1)
appropriate in order to##2##4##(2008-10#2)
appropriate in vitro##2##3##(1990-3#1)(1994-9#1)
appropriate in##10##2##(1990-3#1)(1994-9#1)(2007-12#1)(2008-10#3)(2010-12#3)(2010-6#1)
appropriate information##6##2##(1995-12#1)(1996-1#1)(2007-2#1)(2008-1#1)(2008-5#1)(2010-5#1)
appropriate initial##3##2##(2007-12#2)(2008-7#1)
appropriate intervention strategies##2##3##(2008-12#1)(2012-3#1)
appropriate intervention##3##2##(2007-7#1)(2008-12#1)(2012-3#1)
appropriate inversion##2##2##(2008-3#2)
appropriate knowledge##2##2##(2007-12#1)(2013-1#1)
appropriate length##2##2##(1996-4#1)(2013-8#1)
appropriate level##3##2##(1991-3#1)(2008-3#1)(2013-1#1)
appropriate levels##2##2##(1997-1#1)(1997-7#1)
appropriate location of##2##3##(2007-12#1)(2008-11#1)
appropriate management of##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
appropriate management##12##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
appropriate manner##2##2##(2008-5#1)(2008-9#1)
appropriate measure##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
appropriate measures to##2##3##(1996-1#1)(2011-1#1)
appropriate measures##5##2##(1992-11#1)(1996-1#1)(2008-6#1)(2011-1#2)
appropriate medical##2##2##(1993-1#1)(2011-3#1)
appropriate medication##2##2##(2012-2#1)(2013-1#1)
appropriate medications##2##2##(2008-11#1)(2010-12#1)
appropriate method##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)
appropriate methods for##4##3##(1990-5#1)(2008-11#1)(2008-9#1)(2009-11#1)
appropriate methods##7##2##(1990-12#1)(1990-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)
appropriate model to##2##3##(2008-10#1)(2008-3#1)
appropriate model##5##2##(1997-4#1)(2008-10#3)(2008-3#1)
appropriate molecular##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
appropriate multidisciplinary##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
appropriate nursing##3##2##(1990-10#1)(2013-1#2)
appropriate nutrition##3##2##(1997-3#1)(2008-1#1)(2010-9#1)
appropriate of##2##2##(1996-1#1)(2009-6#1)
appropriate patient selection and##2##4##(2007-12#1)(2008-5#1)
appropriate patient##4##2##(1991-3#1)(2007-12#1)(2008-5#1)(2009-12#1)
appropriate pharmacological therapies##2##3##(2008-3#1)(2010-10#1)
appropriate pharmacological##3##2##(2008-3#1)(2008-4#1)(2010-10#1)
appropriate position##2##2##(1996-8#1)(1997-8#1)
appropriate practice##2##2##(2008-11#1)(2011-1#1)
appropriate preventive measures##2##3##(1995-3#1)(2007-2#1)
appropriate primary##2##2##(2008-11#1)(2012-2#1)
appropriate procedures##3##2##(1997-4#1)(2008-3#1)(2008-8#1)
appropriate reconstruction##2##2##(2011-2#1)(2012-2#1)
appropriate referral##2##2##(2009-10#1)(2011-1#1)
appropriate regression##2##2##(2007-12#1)(2008-10#1)
appropriate response to##2##3##(2008-1#1)(2008-7#1)
appropriate response##3##2##(1997-3#1)(2008-1#1)(2008-7#1)
appropriate sample##4##2##(1995-3#1)(2008-10#2)(2008-9#1)
appropriate scale##4##2##(2008-10#4)
appropriate screening##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
appropriate selection of the##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
appropriate selection of##5##3##(2007-7#1)(2008-10#2)(2008-3#1)(2009-4#1)
appropriate selection##7##2##(1993-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-1#1)
appropriate separation##2##2##(2007-11#1)(2011-1#1)
appropriate services##2##2##(1991-1#1)(1995-9#1)
appropriate setting##3##2##(1994-12#2)(2010-12#1)
appropriate source##2##2##(1997-4#1)(2008-11#1)
appropriate spectral##2##2##(2008-2#1)(2008-3#1)
appropriate statistical##2##2##(2008-6#1)(2012-2#1)
appropriate strategic##2##2##(1996-1#1)(1996-3#1)
appropriate strategies##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
appropriate studies##2##2##(1995-8#1)(2008-3#1)
appropriate surgery##2##2##(2007-8#1)(2008-6#1)
appropriate surgical treatment##2##3##(1992-5#1)(2008-9#1)
appropriate surgical##6##2##(1990-9#1)(1992-5#1)(2008-7#2)(2008-9#1)(2012-3#1)
appropriate system##2##2##(2008-2#2)
appropriate targeting of##2##3##(1995-2#1)(2012-3#1)
appropriate technique for the determination of##2##6##(2008-10#1)(2012-1#1)
appropriate technique##3##2##(2008-10#2)(2012-1#1)
appropriate techniques##4##2##(1990-3#1)(2008-1#1)(2008-4#2)
appropriate temperature##2##2##(2006-10#1)(2008-11#1)
appropriate test##2##2##(2008-4#1)(2008-5#1)
appropriate therapeutic##3##2##(1994-10#1)(1997-3#1)(2008-4#1)
appropriate therapy##9##2##(1993-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2013-1#1)(2013-8#1)
appropriate thickness##2##2##(2007-12#1)(2008-3#1)
appropriate time##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
appropriate timing of##3##3##(2008-7#1)(2010-10#1)(2013-8#1)
appropriate to study##2##3##(2008-10#1)(2008-9#1)
appropriate to the##3##3##(2007-12#1)(2008-10#2)
appropriate to their##3##3##(1994-2#1)(2008-2#1)(2009-11#1)
appropriate to##26##2##(1990-5#1)(1991-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)
appropriate tools##2##2##(1994-3#1)(2009-11#1)
appropriate training and##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
appropriate training##4##2##(1996-2#1)(2007-12#1)(2008-11#1)(2008-6#1)
appropriate treatment and##2##3##(2008-11#1)(2013-1#1)
appropriate treatment for##2##3##(2010-12#1)(2013-1#1)
appropriate treatment options##2##3##(2010-8#1)(2013-8#1)
appropriate treatment strategy##2##3##(2007-12#1)(2009-6#1)
appropriate treatment##32##2##(1990-6#1)(1991-2#1)(1991-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
appropriate type of anesthesia##2##4##(2007-11#2)
appropriate type of##5##3##(2007-11#2)(2008-4#1)(2010-12#1)(2010-8#1)
appropriate uncertainty##2##2##(2009-12#2)
appropriate use of##9##3##(1993-3#1)(1994-2#2)(1996-2#1)(2007-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
appropriate use##13##2##(1993-3#1)(1994-2#2)(1996-2#1)(2007-12#1)(2007-2#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#3)
appropriate utilization of##4##3##(1994-1#1)(1994-12#1)(1995-1#1)(2008-3#1)
appropriate utilization##5##2##(1994-1#1)(1994-12#1)(1995-1#1)(2008-3#1)(2008-6#1)
appropriate values of##2##3##(2008-3#1)(2013-8#1)
appropriate volume##2##2##(1991-5#1)(2008-11#1)
appropriate wavelength##2##2##(2008-3#1)(2012-3#1)
appropriate weight##3##2##(2008-3#2)(2012-12#1)
appropriate when the##2##3##(1994-2#1)(2008-3#1)
appropriate when##5##2##(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)
appropriate##1021##1##(1990-10#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#3)(1990-9#3)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#6)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#9)(1995-2#5)(1995-3#3)(1995-5#8)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#5)(1996-11#2)(1996-2#5)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#5)(1997-2#3)(1997-3#8)(1997-4#4)(1997-5#1)(1997-7#5)(1997-8#2)(2006-10#4)(2007-10#4)(2007-11#27)(2007-12#29)(2007-2#6)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#17)(2008-10#128)(2008-11#47)(2008-12#10)(2008-2#32)(2008-3#65)(2008-4#35)(2008-5#16)(2008-6#19)(2008-7#25)(2008-8#22)(2008-9#36)(2009-1#1)(2009-10#5)(2009-11#8)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#9)(2009-6#4)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#21)(2010-2#2)(2010-3#7)(2010-4#1)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#11)(2010-9#2)(2011-1#20)(2011-2#40)(2011-3#1)(2012-1#3)(2012-12#15)(2012-2#19)(2012-3#13)(2012-5#1)(2012-9#1)(2013-1#26)(2013-7#1)(2013-8#20)
appropriate-sized##2##1##(2009-5#1)(2012-12#1)
appropriate?##2##1##(1992-9#1)(1995-3#1)
appropriated##3##1##(1997-1#1)(2008-5#1)(2010-1#1)
appropriately and##2##2##(2008-3#1)(2011-1#1)
appropriately designed##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
appropriately in##2##2##(1996-6#1)(2008-12#1)
appropriately monitor##2##2##(1996-3#1)(2008-3#1)
appropriately scaled##2##2##(2007-12#1)(2010-10#1)
appropriately selected##2##2##(2008-10#1)(2008-3#1)
appropriately selecting##3##2##(2008-4#2)(2013-8#1)
appropriately to##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2010-5#1)
appropriately trained##2##2##(2007-12#1)(2008-11#1)
appropriately with##2##2##(2008-1#2)
appropriately##92##1##(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-2#1)(1996-12#2)(1996-3#2)(1996-6#1)(2007-11#3)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
appropriateness criteria for##2##3##(2008-1#1)(2010-12#1)
appropriateness criteria##4##2##(2008-1#1)(2009-4#1)(2010-12#2)
appropriateness for##2##2##(1993-1#1)(2010-4#1)
appropriateness of the##5##3##(1991-12#1)(1992-1#1)(1993-1#1)(1996-3#1)(2007-2#1)
appropriateness of##25##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2013-1#3)(2013-8#1)
appropriateness##40##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#2)(2013-1#5)(2013-8#1)
appropriation for##2##2##(1995-6#2)
appropriation##3##1##(1995-6#3)
appropriations##2##1##(1990-6#1)(1996-5#1)
approval and##3##2##(1991-3#1)(1995-5#1)(2008-10#1)
approval by the##5##3##(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#2)
approval for##7##2##(1992-3#1)(1995-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-12#2)
approval in Japan##2##3##(2008-5#2)
approval in##4##2##(1996-5#1)(2008-5#2)(2008-7#1)
approval is##2##2##(1991-12#1)(2008-5#1)
approval of##18##2##(1991-12#1)(1992-8#1)(1993-12#1)(1993-9#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#2)(2012-12#2)(2013-1#1)
approval process##2##2##(1991-3#1)(2008-10#1)
approval to##3##2##(1991-3#1)(1995-12#1)(2010-6#1)
approval##62##1##(1991-12#2)(1991-3#5)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-5#2)(2007-10#2)(2008-10#2)(2008-3#1)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-12#6)(2012-3#2)(2013-1#3)(2013-8#1)
approved a##7##2##(1991-1#1)(1996-5#2)(1997-2#1)(1997-5#1)(2007-10#1)(2013-1#1)
approved and other drugs##2##4##(2012-2#2)
approved and##8##2##(1992-3#1)(1995-12#1)(2006-7#1)(2012-2#3)(2013-1#2)
approved as##3##2##(1990-2#1)(2008-12#1)(2011-3#1)
approved by FDA##3##3##(2011-2#1)(2011-3#1)(2012-3#1)
approved by regulatory agencies##2##4##(2008-1#1)(2008-8#1)
approved by the FDA for this indication##2##7##(2008-3#1)(2008-9#1)
approved by the FDA##3##4##(2008-3#1)(2008-9#1)(2010-12#1)
approved by the Food and Drug Administration##2##7##(2008-4#1)(2009-9#1)
approved by the US Food and Drug Administration##2##8##(2008-9#1)(2012-12#1)
approved by the US##3##4##(2008-9#1)(2011-2#1)(2012-12#1)
approved by the##16##3##(2007-9#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)
approved by##24##2##(1994-12#1)(1996-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#1)
approved contrast##2##2##(2010-11#1)(2012-3#1)
approved for the treatment of chronic##2##6##(2009-8#1)(2010-5#1)
approved for the treatment of##6##5##(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)
approved for the##7##3##(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)(2012-3#1)
approved for use in##3##4##(2007-11#1)(2010-5#1)(2013-1#1)
approved for use##5##3##(2007-11#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
approved for##25##2##(1992-8#1)(1993-11#1)(1993-12#1)(1995-6#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-8#1)(2010-12#1)(2010-5#3)(2010-6#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
approved in##5##2##(2006-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
approved medications##3##2##(2009-7#1)(2010-12#2)
approved of##3##2##(2008-10#1)(2012-12#2)
approved standard##2##2##(2008-10#1)(2009-12#1)
approved the##2##2##(1990-6#1)(1996-5#1)
approved to##2##2##(2011-2#1)(2012-3#1)
approved treatment##2##2##(2008-8#2)
approved visits##2##2##(1992-3#2)
approved##135##1##(1990-2#1)(1990-6#1)(1991-1#1)(1992-3#4)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#3)(1996-11#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-2#2)(1997-5#2)(1997-8#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#5)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#10)(2013-1#7)(2013-8#1)
approves##6##1##(1992-8#1)(1994-2#1)(1995-6#2)(1996-8#1)(2009-2#1)
approving##4##1##(1995-12#1)(2008-11#1)(2010-5#1)(2010-6#1)
approx 2##3##2##(2008-6#3)
approx 3##2##2##(2008-6#2)
approx##56##1##(1990-11#2)(1990-2#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-6#4)(1992-11#1)(1993-12#3)(1993-2#2)(1993-6#2)(1994-12#3)(1994-8#3)(1995-8#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#14)(2011-2#1)
approximant##3##1##(2007-11#3)
approximate analytical##2##2##(2008-2#1)(2008-3#1)
approximate formula for the##3##4##(1992-9#1)(1995-9#1)(2008-2#1)
approximate linear##2##2##(1997-2#1)(2008-3#1)
approximate methods##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
approximate mirror plane##2##3##(1997-7#2)
approximate molecular weight of##5##4##(1990-12#1)(1990-2#1)(1994-6#1)(2008-10#1)(2008-8#1)
approximate molecular##6##2##(1990-12#2)(1990-2#1)(1994-6#1)(2008-10#1)(2008-8#1)
approximate results##2##2##(2008-3#2)
approximate size##2##2##(2008-3#1)(2008-4#1)
approximate the##8##2##(1993-11#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#1)
approximate theory##2##2##(2008-2#1)(2008-3#1)
approximate values##2##2##(1997-2#1)(2008-10#1)
approximate##89##1##(1990-12#3)(1990-2#1)(1990-8#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-9#2)(1997-2#2)(1997-4#2)(1997-7#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#13)(2008-3#17)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
approximate)##2##1##(1990-8#1)(1993-5#1)
approximated as##3##2##(2008-3#1)(2008-8#1)(2009-9#1)
approximated by a##4##3##(2008-3#4)
approximated by the##3##3##(1992-9#1)(2008-10#1)(2009-5#1)
approximated by##10##2##(1992-2#1)(1992-9#1)(2008-10#1)(2008-3#6)(2009-5#1)
approximated the##3##2##(1992-5#1)(2007-12#1)(2008-10#1)
approximated##25##1##(1992-2#1)(1992-5#1)(1992-9#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#9)(2008-8#1)(2009-5#1)(2009-9#1)(2013-8#1)
approximately $1##2##2##(1995-6#1)(2008-11#1)
approximately $2##2##2##(1994-2#1)(1994-9#1)
approximately -18##2##2##(1993-8#1)(2010-3#1)
approximately 0##80##2##(1990-12#1)(1991-11#3)(1991-8#1)(1992-8#1)(1994-6#1)(1995-6#1)(1996-2#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#8)(2008-3#25)(2009-6#1)(2010-1#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-3#1)
approximately 1 h##2##3##(1996-12#1)(2010-3#1)
approximately 1 in##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
approximately 1 km##2##3##(1997-5#1)(2008-3#1)
approximately 1 m(2)##2##3##(2008-10#2)
approximately 1 mSv##2##3##(1996-6#1)(2011-2#1)
approximately 1 microM##3##3##(1990-5#1)(1990-8#1)(1995-2#1)
approximately 1 mm##2##3##(2008-2#1)(2008-3#1)
approximately 1 nm##2##3##(2008-10#1)(2008-3#1)
approximately 1 to##4##3##(1995-6#1)(2008-10#1)(2008-3#2)
approximately 1##111##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#3)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#2)(2007-11#3)(2007-12#3)(2007-5#1)(2008-10#36)(2008-11#3)(2008-2#5)(2008-3#12)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
approximately 1% of##2##3##(2008-2#1)(2009-11#1)
approximately 1%##11##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-11#1)(2009-3#1)(2011-2#1)
approximately 1-1##2##2##(1997-2#1)(2008-3#1)
approximately 10 degrees C##2##4##(1995-3#1)(2008-10#1)
approximately 10 min##2##3##(2008-11#1)(2008-2#1)
approximately 10 mug##2##3##(2008-10#1)(2008-7#1)
approximately 10 nm##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
approximately 10 pM##2##3##(1991-2#1)(1995-6#1)
approximately 10 times##2##3##(1991-12#1)(1997-6#1)
approximately 10 to##2##3##(1991-8#1)(2008-10#1)
approximately 10##43##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-6#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-5#1)(2012-3#1)
approximately 10% for a##2##4##(2008-2#2)
approximately 10% in##2##3##(2008-2#1)(2008-3#1)
approximately 10% of the##2##4##(1995-11#1)(2008-7#1)
approximately 10% of##8##3##(1990-2#1)(1991-2#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
approximately 10%##20##2##(1990-2#1)(1991-2#1)(1992-6#1)(1995-11#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)
approximately 10(-2)##2##2##(2007-12#1)(2008-3#1)
approximately 10(-4)##2##2##(2008-3#2)
approximately 10(10)##3##2##(1994-8#1)(2007-6#1)(2008-3#1)
approximately 10(5)##2##2##(1995-2#1)(2008-10#1)
approximately 10(6)##2##2##(2008-10#2)
approximately 10-fold higher##2##3##(1991-9#1)(2008-10#1)
approximately 10-fold##7##2##(1991-9#1)(1993-3#1)(1995-6#1)(1995-8#1)(2008-10#3)
approximately 100 mg of##2##4##(1994-5#1)(2012-3#1)
approximately 100 times faster than##2##5##(2008-10#1)(2008-3#1)
approximately 100 times##3##3##(2008-10#2)(2008-3#1)
approximately 100##26##2##(1992-11#1)(1993-9#1)(1994-5#1)(1996-10#1)(1997-5#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)
approximately 100%##2##2##(1993-12#1)(2008-10#1)
approximately 100%)##2##2##(2008-10#1)(2008-7#1)
approximately 1000##5##2##(1991-10#1)(2008-3#3)(2008-5#1)
approximately 1000-1200##2##2##(1995-6#1)(2008-3#1)
approximately 11 kb##3##3##(1996-3#1)(1996-8#1)(1997-7#1)
approximately 11##6##2##(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-9#1)
approximately 110##3##2##(1992-3#1)(1993-6#1)(2008-3#1)
approximately 12##16##2##(1993-11#1)(1993-8#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-10#1)(2010-6#1)(2013-1#1)
approximately 120##2##2##(1992-6#1)(2008-3#1)
approximately 13##7##2##(1995-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-12#1)
approximately 130##4##2##(1992-12#1)(1995-6#1)(1997-5#1)(2007-12#1)
approximately 140##2##2##(1995-12#1)(2012-12#1)
approximately 15 microM##2##3##(1990-2#1)(1995-6#1)
approximately 15 to 20% of##2##5##(2009-12#1)(2013-1#1)
approximately 15##19##2##(1990-2#1)(1993-8#1)(1995-6#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2009-12#1)(2011-2#1)(2013-1#1)
approximately 15% in##2##3##(2008-10#1)(2013-1#1)
approximately 15% of the##2##4##(2008-9#1)(2013-7#1)
approximately 15%##9##2##(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-7#1)
approximately 15-20% of##2##3##(2008-7#1)(2011-1#1)
approximately 150##5##2##(1995-11#1)(1995-6#2)(1997-5#1)(2008-3#1)
approximately 16##2##2##(2008-8#1)(2008-9#1)
approximately 17##5##2##(1995-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
approximately 170##2##2##(1993-11#1)(2008-2#1)
approximately 18##7##2##(1997-7#1)(2008-10#3)(2008-9#2)(2009-11#1)
approximately 19##2##2##(1992-4#1)(2008-5#1)
approximately 2 in##2##3##(1996-2#1)(2008-3#1)
approximately 2 kb##2##3##(1993-6#1)(1996-10#1)
approximately 2##57##2##(1990-8#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#2)(1995-2#4)(1996-10#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-12#5)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#4)(2011-2#2)(2012-2#2)
approximately 2%##6##2##(1993-6#1)(2007-12#1)(2008-10#3)(2008-2#1)
approximately 2%)##2##2##(2008-10#2)
approximately 2- and##2##3##(2008-11#1)(2008-3#1)
approximately 2-fold##6##2##(1991-5#1)(1994-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2011-3#1)
approximately 20 kDa##2##3##(1995-12#1)(1997-7#1)
approximately 20 times##2##3##(2008-10#2)
approximately 20##30##2##(1990-11#1)(1990-5#1)(1991-1#1)(1992-11#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(1995-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-9#2)(2009-5#1)(2009-9#2)(2012-1#1)(2013-8#1)
approximately 20% of##4##3##(1995-6#1)(2008-1#1)(2010-4#1)(2013-1#1)
approximately 20%##11##2##(1992-11#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
approximately 200 m##2##3##(2008-3#1)(2010-3#1)
approximately 200 nm##2##3##(2008-3#1)(2009-7#1)
approximately 200##23##2##(1990-12#1)(1991-2#1)(1994-12#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-5#1)
approximately 2000##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
approximately 21##2##2##(1995-12#1)(1997-1#1)
approximately 210##3##2##(1990-2#1)(1995-2#1)(2008-4#1)
approximately 22##3##2##(1992-11#1)(2008-10#1)(2008-12#1)
approximately 23##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
approximately 24##2##2##(2008-10#1)(2008-2#1)
approximately 25 kDa##2##3##(1993-2#1)(1995-12#1)
approximately 25##12##2##(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#1)
approximately 25% of the##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
approximately 25% of##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
approximately 25%##9##2##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)
approximately 25%)##2##2##(2006-4#1)(2008-7#1)
approximately 250##4##2##(1995-3#1)(2007-2#1)(2008-3#1)(2009-5#1)
approximately 27##2##2##(2008-10#2)
approximately 28##3##2##(1994-12#1)(2008-1#1)(2008-10#1)
approximately 3 days##3##3##(2008-10#1)(2008-7#2)
approximately 3 times##2##3##(2008-2#1)(2008-3#1)
approximately 3 to##2##3##(2008-10#2)
approximately 3 weeks##2##3##(2008-10#2)
approximately 3 x 10(-5)##2##4##(2008-2#1)(2008-3#1)
approximately 3 x##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
approximately 3 years##2##3##(1997-5#1)(2010-1#1)
approximately 3##49##2##(1990-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1997-4#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#11)(2008-11#6)(2008-2#5)(2008-3#7)(2008-7#4)(2009-6#1)(2010-1#1)(2013-1#1)
approximately 3% of##2##3##(2007-11#1)(2008-1#1)
approximately 3%##8##2##(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)
approximately 3-6##2##2##(2007-12#1)(2008-2#1)
approximately 30 mM##2##3##(1992-4#1)(2008-10#1)
approximately 30 ns##2##3##(2008-3#2)
approximately 30 to##2##3##(2008-10#1)(2012-2#1)
approximately 30##21##2##(1991-8#1)(1992-12#1)(1992-4#1)(1997-5#1)(2007-11#2)(2008-10#4)(2008-2#2)(2008-3#4)(2008-7#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
approximately 30% of the##4##4##(1992-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
approximately 30% of##8##3##(1992-12#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
approximately 30% to##2##3##(2008-7#1)(2010-12#1)
approximately 30%##16##2##(1991-11#1)(1992-12#1)(1992-3#1)(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
approximately 300 and##2##3##(2008-10#2)
approximately 300##9##2##(1991-3#1)(1992-1#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)
approximately 3000 K)##2##3##(2008-10#2)
approximately 3000##3##2##(2008-10#2)(2008-3#1)
approximately 31##2##2##(1996-5#1)(2008-3#1)
approximately 32##2##2##(2008-10#1)(2008-12#1)
approximately 330##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
approximately 35##5##2##(1991-8#1)(1992-8#1)(1995-2#1)(2008-10#1)(2008-5#1)
approximately 35%##3##2##(1992-8#1)(2008-1#1)(2008-3#1)
approximately 350##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
approximately 36##2##2##(2007-12#1)(2008-10#1)
approximately 37 degrees##2##3##(2008-2#2)
approximately 37##3##2##(1991-9#1)(2008-2#2)
approximately 38##2##2##(1992-5#1)(2008-10#1)
approximately 4 percent##2##3##(1994-1#1)(1996-3#1)
approximately 4 x##2##3##(1992-5#1)(2008-3#1)
approximately 4##26##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-8#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2009-7#1)(2010-2#1)
approximately 4% of##3##3##(1993-9#1)(2008-4#1)(2009-9#1)
approximately 4%##4##2##(1993-9#1)(2008-3#1)(2008-4#1)(2009-9#1)
approximately 4-fold##2##2##(1995-6#1)(1997-1#1)
approximately 40 kDa##4##3##(1992-10#1)(1995-11#1)(1997-4#1)(2009-7#1)
approximately 40 mg##2##3##(2008-11#2)
approximately 40##20##2##(1990-11#1)(1992-10#1)(1992-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-11#4)(2008-3#3)(2008-8#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-8#1)
approximately 40% of the##3##4##(2008-3#1)(2008-5#1)(2013-8#1)
approximately 40% of##4##3##(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
approximately 40%##8##2##(1997-3#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
approximately 400 nm##2##3##(2008-1#1)(2009-12#1)
approximately 400##5##2##(1997-6#1)(2008-1#1)(2008-5#1)(2009-12#1)(2012-3#1)
approximately 43##2##2##(1992-8#1)(2008-10#1)
approximately 45##6##2##(1992-3#1)(1993-3#1)(1995-6#1)(2008-3#1)(2008-4#1)(2008-9#1)
approximately 45%##3##2##(1992-11#1)(2008-3#1)(2008-9#1)
approximately 450##2##2##(1992-1#1)(1996-2#1)
approximately 46##2##2##(2008-10#2)
approximately 47%##2##2##(1993-6#1)(1997-1#1)
approximately 475##2##2##(1990-2#1)(2008-9#1)
approximately 480##2##2##(2008-11#1)(2009-10#1)
approximately 5 degrees##3##3##(2008-2#1)(2008-3#2)
approximately 5 kb##2##3##(1993-3#1)(1994-11#1)
approximately 5 min##2##3##(1991-2#1)(1995-2#1)
approximately 5 to##2##3##(1995-3#1)(2008-2#1)
approximately 5 x##3##3##(2008-11#1)(2008-3#2)
approximately 5##41##2##(1991-2#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#11)(2008-7#1)(2011-2#1)(2013-8#1)
approximately 5% of the##2##4##(2008-7#1)(2010-5#1)
approximately 5% of##4##3##(2008-7#1)(2010-5#1)(2011-2#2)
approximately 5%##9##2##(2008-3#4)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#2)
approximately 50 mum##2##3##(2008-10#1)(2009-5#1)
approximately 50 nm##2##3##(2008-3#1)(2008-8#1)
approximately 50 ns##2##3##(2008-3#2)
approximately 50##23##2##(1992-6#1)(1993-11#1)(1993-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
approximately 50% as##2##3##(1992-11#1)(2008-10#1)
approximately 50% in##2##3##(1995-11#1)(2008-11#1)
approximately 50% of the##5##4##(1993-11#1)(1997-5#1)(2008-10#1)(2008-4#1)(2009-10#1)
approximately 50% of##9##3##(1991-12#1)(1993-11#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-4#2)(2009-10#1)(2011-3#1)
approximately 50%##28##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#3)(1995-11#1)(1995-2#1)(1995-5#1)(1997-5#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-3#1)
approximately 500##4##2##(1990-12#1)(1993-8#1)(2008-10#1)(2009-12#1)
approximately 52##2##2##(2008-11#1)(2008-2#1)
approximately 55##3##2##(1992-8#1)(1995-6#1)(2008-10#1)
approximately 55%##2##2##(1995-6#1)(2008-3#1)
approximately 56##2##2##(2008-6#1)(2009-10#1)
approximately 58%##3##2##(1994-2#1)(2013-1#1)(2013-8#1)
approximately 6##22##2##(1990-12#1)(1991-9#1)(1993-1#1)(1994-6#1)(1995-2#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
approximately 60 minutes##2##3##(1991-12#1)(2010-5#1)
approximately 60##20##2##(1991-12#1)(1992-5#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
approximately 60% of##6##3##(1991-9#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
approximately 60%##14##2##(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
approximately 600 bp##2##3##(1993-6#2)
approximately 600##6##2##(1990-8#1)(1993-6#2)(2008-10#1)(2008-9#1)(2012-12#1)
approximately 62 degrees##2##3##(2007-12#1)(2008-2#1)
approximately 63 kDa##2##3##(1995-2#1)(2008-11#1)
approximately 65##6##2##(1992-8#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
approximately 65%##2##2##(1992-11#1)(2008-2#1)
approximately 650##2##2##(2008-10#1)(2008-11#1)
approximately 66##2##2##(1990-8#1)(2008-5#1)
approximately 7##19##2##(1990-12#1)(1991-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-9#1)(2011-2#2)(2013-1#1)
approximately 7%##4##2##(2008-10#2)(2011-2#2)
approximately 70 kDa complex##3##4##(1990-8#3)
approximately 70 kDa##4##3##(1990-8#3)(1993-3#1)
approximately 70##12##2##(1990-11#1)(1990-8#3)(1991-5#1)(1993-3#1)(2008-10#3)(2008-3#1)(2010-11#1)(2011-2#1)
approximately 70% of##3##3##(1991-5#1)(2010-10#1)(2012-12#1)
approximately 70%##8##2##(1991-5#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-2#1)(2008-10#1)(2010-10#1)(2012-12#1)
approximately 70-fold##2##2##(1996-3#1)(2008-10#1)
approximately 700##2##2##(2008-10#1)(2008-6#1)
approximately 75##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#2)
approximately 75%##5##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
approximately 78%##2##2##(1997-6#1)(2008-3#1)
approximately 8 months##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
approximately 8##15##2##(1990-5#1)(1991-2#1)(1995-2#1)(1996-10#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)
approximately 8%##2##2##(2008-7#1)(2013-8#1)
approximately 80 mug##2##3##(2008-10#1)(2008-11#1)
approximately 80##10##2##(1992-12#1)(1992-9#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)(2009-9#1)
approximately 80% of##3##3##(1996-10#1)(1996-4#1)(1997-9#1)
approximately 80%##11##2##(1990-3#1)(1994-9#1)(1996-10#1)(1996-4#1)(1997-9#1)(2008-10#3)(2008-3#2)(2009-3#1)
approximately 800##2##2##(1997-4#1)(2007-12#1)
approximately 82%##2##2##(2008-2#1)(2008-7#1)
approximately 85% homology##2##3##(1992-8#2)
approximately 85% of##3##3##(2008-11#1)(2008-3#1)(2010-3#1)
approximately 85%##6##2##(1992-8#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-3#1)
approximately 850##2##2##(1995-6#1)(1997-6#1)
approximately 86##2##2##(2008-10#2)
approximately 870##2##2##(2008-10#1)(2008-3#1)
approximately 9##7##2##(1991-12#1)(1992-3#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)
approximately 90##8##2##(1990-3#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)
approximately 90% of the##4##4##(1996-2#1)(2008-11#1)(2008-3#1)(2010-8#1)
approximately 90% of##8##3##(1994-11#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-8#1)
approximately 90%##13##2##(1994-11#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-3#1)
approximately 93##2##2##(2008-10#2)
approximately 94%##2##2##(2008-10#1)(2008-2#1)
approximately =##2##2##(2008-2#1)(2008-3#1)
approximately a factor of##2##4##(2008-2#1)(2008-5#1)
approximately a##7##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-12#1)
approximately along##3##2##(2007-11#1)(2008-3#2)
approximately an order of magnitude##3##5##(1991-5#1)(1995-8#1)(2008-2#1)
approximately an##4##2##(1991-5#1)(1994-9#1)(1995-8#1)(2008-2#1)
approximately at##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
approximately constant##6##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)
approximately double##2##2##(1991-3#1)(2008-10#1)
approximately eight##2##2##(2008-11#2)
approximately equal to 0##2##4##(1991-5#1)(1994-5#1)
approximately equal to the sum of the genes in##2##9##(2008-10#2)
approximately equal to the##7##4##(1993-9#1)(2008-10#2)(2008-11#1)(2008-3#3)
approximately equal to##17##3##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#3)(1993-9#1)(1994-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#4)
approximately equal##27##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#3)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-3#6)(2008-4#1)(2008-8#1)(2010-12#1)
approximately every 2##2##3##(1994-9#1)(2008-10#1)
approximately every##3##2##(1994-9#1)(2008-10#1)(2008-3#1)
approximately five##5##2##(2008-10#3)(2012-12#1)(2012-2#1)
approximately four times##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
approximately four##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-9#1)
approximately from##3##2##(2008-10#1)(2010-3#2)
approximately half of the##4##4##(1990-9#1)(1994-2#1)(1995-11#1)(2008-3#1)
approximately half of##5##3##(1990-9#1)(1994-2#1)(1995-11#1)(2008-3#1)(2012-3#1)
approximately half the##5##3##(1990-7#1)(1992-9#1)(2008-11#1)(2008-3#1)(2012-12#1)
approximately half##14##2##(1990-7#1)(1990-9#1)(1992-9#1)(1993-1#1)(1994-2#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-12#1)(2012-3#1)
approximately high##2##2##(2008-12#2)
approximately one third##3##3##(1993-10#1)(2008-2#1)(2009-1#1)
approximately one year after##2##4##(1992-4#1)(2008-11#1)
approximately one year##3##3##(1992-4#1)(2008-11#1)(2010-8#1)
approximately one##13##2##(1992-4#1)(1993-10#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
approximately one-half##3##2##(1990-8#1)(1991-12#1)(1995-3#1)
approximately one-quarter of the##2##4##(2007-11#1)(2008-9#1)
approximately one-third of##3##3##(1994-12#1)(2008-1#1)(2008-7#1)
approximately one-third##4##2##(1994-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
approximately parallel##2##2##(2007-11#1)(2007-12#1)
approximately proportional to the number of##2##6##(2008-10#2)
approximately proportional to the##3##4##(2008-10#2)(2008-3#1)
approximately six##4##2##(1990-6#1)(1992-6#1)(2008-10#1)(2008-8#1)
approximately the same##16##3##(1990-11#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)
approximately the##21##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2011-2#1)
approximately three times more##2##4##(1991-12#1)(2008-11#1)
approximately three times the##2##4##(2008-2#2)
approximately three times##4##3##(1991-12#1)(2008-11#1)(2008-2#2)
approximately three##7##2##(1991-12#1)(1995-5#1)(1996-3#1)(2008-11#1)(2008-2#2)(2011-1#1)
approximately twice as many##2##4##(1994-6#1)(2008-10#1)
approximately twice as##7##3##(1993-1#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
approximately twice the##6##3##(1993-6#1)(2007-10#1)(2008-2#1)(2008-3#2)(2009-7#1)
approximately twice##15##2##(1993-1#1)(1993-6#1)(1994-6#1)(1995-3#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-7#1)
approximately two times##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
approximately two##14##2##(1991-6#1)(1995-5#2)(1997-5#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2010-9#1)(2013-1#1)
approximately two-fold##3##2##(1995-9#1)(1996-2#1)(2009-9#1)
approximately two-thirds##2##2##(2008-10#1)(2012-12#1)
approximately twofold##4##2##(1994-2#1)(2008-10#2)(2008-3#1)
approximately##1727##1##(1990-11#5)(1990-12#8)(1990-2#5)(1990-3#3)(1990-5#7)(1990-6#2)(1990-7#2)(1990-8#9)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#6)(1991-12#9)(1991-2#9)(1991-3#3)(1991-5#9)(1991-6#1)(1991-8#6)(1991-9#9)(1992-1#4)(1992-10#2)(1992-11#10)(1992-12#13)(1992-2#2)(1992-3#7)(1992-4#4)(1992-5#7)(1992-6#12)(1992-8#15)(1992-9#3)(1993-1#4)(1993-10#1)(1993-11#13)(1993-12#7)(1993-2#2)(1993-3#8)(1993-6#12)(1993-8#9)(1993-9#4)(1994-1#1)(1994-11#12)(1994-12#5)(1994-2#9)(1994-3#3)(1994-5#5)(1994-6#5)(1994-8#6)(1994-9#10)(1995-1#1)(1995-11#8)(1995-12#5)(1995-2#30)(1995-3#10)(1995-5#7)(1995-6#29)(1995-8#5)(1995-9#3)(1996-1#1)(1996-10#5)(1996-12#4)(1996-2#9)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-4#6)(1997-5#14)(1997-6#5)(1997-7#8)(1997-8#5)(1997-9#2)(2006-10#2)(2006-4#3)(2006-6#1)(2007-10#4)(2007-11#22)(2007-12#52)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#16)(2008-10#373)(2008-11#78)(2008-12#14)(2008-2#91)(2008-3#238)(2008-4#11)(2008-5#26)(2008-6#11)(2008-7#50)(2008-8#20)(2008-9#33)(2009-1#1)(2009-10#9)(2009-11#2)(2009-12#6)(2009-3#5)(2009-5#7)(2009-6#4)(2009-7#5)(2009-8#3)(2009-9#11)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#8)(2010-4#7)(2010-5#7)(2010-6#3)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#29)(2011-3#2)(2012-1#2)(2012-12#13)(2012-2#7)(2012-3#10)(2012-8#1)(2013-1#18)(2013-7#2)(2013-8#9)
approximates a##2##2##(2008-3#2)
approximates the##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
approximates##6##1##(2008-10#1)(2008-3#3)(2008-8#1)(2011-1#1)
approximating the##7##2##(2007-6#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
approximating##15##1##(1990-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
approximation (such as##2##3##(2008-10#2)
approximation and the##4##3##(2008-2#2)(2010-12#1)(2012-1#1)
approximation and##18##2##(2007-11#3)(2008-2#7)(2008-3#5)(2009-2#1)(2010-12#1)(2012-1#1)
approximation are##2##2##(2008-2#1)(2008-3#1)
approximation based on##2##3##(2008-3#2)
approximation based##3##2##(2008-3#2)(2010-2#1)
approximation can be##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
approximation can##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
approximation for the##6##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
approximation for##12##2##(2007-11#3)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)
approximation in##9##2##(2007-12#2)(2008-2#3)(2008-3#1)(2009-12#1)(2010-12#1)(2012-1#1)
approximation is developed##2##3##(2008-3#1)(2010-12#1)
approximation is used to##2##4##(2007-12#1)(2008-2#1)
approximation is used##3##3##(1996-2#1)(2007-12#1)(2008-2#1)
approximation is valid only for##2##5##(2008-3#2)
approximation is##19##2##(1996-2#1)(2007-12#3)(2008-2#5)(2008-3#8)(2008-7#1)(2010-12#1)
approximation levels##2##2##(2008-3#2)
approximation method##5##2##(2008-2#1)(2008-3#3)(2008-8#1)
approximation models##2##2##(2008-3#2)
approximation of a##3##3##(2008-10#1)(2013-8#2)
approximation of the radiative transfer theory##2##6##(2008-3#2)
approximation of the##14##3##(1992-3#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-8#1)(2009-12#1)
approximation of##24##2##(1992-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#6)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#1)(2013-8#2)
approximation properties of##2##3##(2008-6#2)
approximation technique##3##2##(2008-10#1)(2008-3#2)
approximation that##5##2##(1990-8#1)(2008-2#1)(2008-3#2)(2012-3#1)
approximation the##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
approximation to the radiative transport equation is##2##7##(2007-12#1)(2008-3#1)
approximation to the##7##3##(1990-7#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
approximation to##18##2##(1990-7#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#9)(2008-6#1)(2012-1#1)
approximation##245##1##(1990-5#1)(1990-7#1)(1990-8#2)(1992-3#1)(1994-2#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-4#1)(2007-11#20)(2007-12#15)(2008-10#14)(2008-2#61)(2008-3#91)(2008-6#5)(2008-7#2)(2008-8#3)(2009-12#2)(2009-2#2)(2009-5#1)(2009-9#2)(2010-12#4)(2010-2#1)(2012-1#4)(2012-3#3)(2013-1#2)(2013-8#2)
approximations and##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)
approximations are##2##2##(2008-3#2)
approximations for##4##2##(2008-3#4)
approximations in##2##2##(2008-2#1)(2008-3#1)
approximations made##2##2##(2008-2#1)(2008-3#1)
approximations that##2##2##(2008-3#1)(2008-6#1)
approximations to the exact##2##4##(1990-8#1)(2007-11#1)
approximations to the##3##3##(1990-8#1)(2007-11#1)(2010-12#1)
approximations to##5##2##(1990-8#1)(2007-11#2)(2008-2#1)(2010-12#1)
approximations##36##1##(1990-8#1)(1994-2#1)(2007-11#2)(2008-10#1)(2008-2#9)(2008-3#16)(2008-6#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#2)
aprV5##2##1##(1993-12#2)
apraxia##7##1##(2008-4#1)(2009-2#3)(2009-6#1)(2011-1#2)
aprepitant for##3##2##(2008-7#3)
aprepitant##8##1##(2008-7#7)(2010-12#1)
apricot and Japanese plum##2##4##(2008-10#2)
apricot and##3##2##(2008-10#3)
apricot kernel extract##2##3##(2008-5#2)
apricot pollen##3##2##(2008-10#3)
apricot##18##1##(2008-10#9)(2008-5#2)(2011-2#1)(2012-8#6)
april##2##1##(1997-4#1)(2008-7#1)
apropos of##3##2##(1990-9#1)(1991-11#1)(1996-8#1)
aprotic solvents##2##2##(2008-10#2)
aprotic##8##1##(1995-5#1)(2008-10#5)(2009-9#2)
aprotinin and##4##2##(1991-12#1)(1994-6#1)(2006-10#1)(2008-10#1)
aprotinin##14##1##(1990-3#1)(1991-12#1)(1992-8#1)(1994-6#1)(1995-6#1)(1996-9#2)(2006-10#1)(2007-8#3)(2008-10#1)(2010-7#1)(2012-12#1)
après consentement##2##2##(2013-1#2)
après le##2##2##(2011-2#1)(2013-1#1)
après##7##1##(2011-2#1)(2013-1#6)
apt to##2##2##(1990-3#1)(2008-7#1)
apt##4##1##(1990-3#1)(2008-7#1)(2009-3#1)(2012-3#1)
aptamer arrays##2##2##(2009-12#2)
aptamer##10##1##(2007-11#4)(2009-12#3)(2010-12#1)(2010-7#1)(2013-1#1)
aptameric##2##1##(2009-12#2)
aptamers are##3##2##(2007-11#1)(2010-5#1)(2010-7#1)
aptamers as##2##2##(2010-11#1)(2010-7#1)
aptamers can be##4##3##(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#1)
aptamers to##2##2##(2008-4#1)(2013-1#1)
aptamers##33##1##(2007-11#6)(2008-1#1)(2008-4#2)(2008-7#1)(2008-9#6)(2009-12#4)(2010-11#1)(2010-5#4)(2010-7#4)(2012-2#2)(2013-1#2)
aptera aptera##2##2##(2008-12#2)
aptera##4##1##(2008-12#4)
aptitude to##2##2##(1991-2#1)(2008-12#1)
aptitude##5##1##(1991-2#1)(2008-11#1)(2008-12#1)(2010-3#2)
aptly##2##1##(2008-7#1)(2009-10#1)
apyrase conserved region##2##3##(2008-4#2)
apyrase##8##1##(1993-11#1)(1994-11#2)(2007-12#1)(2008-4#4)
aqua regia and##2##3##(2008-10#2)
aqua regia extraction##4##3##(2008-10#4)
aqua regia##15##2##(2008-10#15)
aqua-regia extractable content of the##2##5##(2008-10#2)
aquaculture and##2##2##(2008-10#1)(2008-5#1)
aquaculture species##2##2##(2008-7#1)(2013-8#1)
aquaculture##16##1##(2008-10#1)(2008-5#6)(2008-7#2)(2010-11#1)(2010-5#2)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
aquajogging##2##1##(2010-8#2)
aquaporin 1##2##2##(2008-7#2)
aquaporin##4##1##(2008-5#1)(2008-7#2)(2012-12#1)
aquaporin-2##2##1##(2013-8#2)
aquaporins##4##1##(2007-12#2)(2008-8#1)(2013-1#1)
aquarium##4##1##(2007-5#1)(2008-10#2)(2008-11#1)
aquatic HS##4##2##(2008-10#4)
aquatic and##2##2##(2009-3#1)(2013-7#1)
aquatic bodies##2##2##(2008-5#2)
aquatic environment##7##2##(2008-10#4)(2008-11#1)(2008-6#1)(2010-8#1)
aquatic environments were##3##3##(2008-3#1)(2008-5#2)
aquatic environments##12##2##(2008-10#6)(2008-3#1)(2008-5#2)(2008-9#2)(2009-4#1)
aquatic food webs##2##3##(2008-8#2)
aquatic food##3##2##(2008-8#3)
aquatic humic matter##2##3##(2008-10#2)
aquatic humic##11##2##(2008-10#11)
aquatic insects##2##2##(2008-12#1)(2008-5#1)
aquatic media##3##2##(2008-10#1)(2008-11#2)
aquatic organisms##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
aquatic plant Lemna minor##2##4##(2008-10#1)(2008-7#1)
aquatic plant##7##2##(2008-10#4)(2008-5#2)(2008-7#1)
aquatic plants##2##2##(2008-10#1)(2008-12#1)
aquatic realm##2##2##(2008-9#1)(2010-6#1)
aquatic systems##4##2##(2008-10#3)(2008-7#1)
aquatic##108##1##(1992-5#1)(1995-12#1)(2008-10#51)(2008-11#5)(2008-12#5)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#11)(2009-3#1)(2009-4#1)(2010-6#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#5)(2013-8#1)
aquaticus##9##1##(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-12#3)(2008-5#2)
aquation##4##1##(1996-2#1)(2008-10#3)
aqueduct##6##1##(2008-7#2)(2008-9#3)(2012-3#1)
aqueductal stenosis##2##2##(2008-7#1)(2012-2#1)
aqueductal##3##1##(2008-7#2)(2012-2#1)
aqueous acidic##3##2##(2008-10#3)
aqueous alkaline##2##2##(2008-10#2)
aqueous ammonia##3##2##(2008-10#2)(2013-1#1)
aqueous and ethanol leaf extracts of##2##6##(2010-3#2)
aqueous and ethanol##3##3##(2010-3#3)
aqueous and micellar##2##3##(2008-10#2)
aqueous and organic phases##3##4##(2008-10#2)(2010-4#1)
aqueous and organic solvent##2##4##(1990-5#1)(2008-6#1)
aqueous and organic##7##3##(1990-5#1)(2008-10#3)(2008-6#1)(2010-4#2)
aqueous and solid surfaces##2##4##(1994-6#2)
aqueous and##32##2##(1990-5#1)(1994-5#1)(1994-6#2)(2008-10#21)(2008-6#1)(2010-3#4)(2010-4#2)
aqueous and/or organic drops##2##4##(2008-10#2)
aqueous buffer solution##2##3##(2008-10#1)(2009-9#1)
aqueous buffer##9##2##(1992-12#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-6#2)(2009-12#1)(2009-9#1)
aqueous buffers##2##2##(2008-10#1)(2008-6#1)
aqueous conditions##2##2##(1995-3#1)(2008-10#1)
aqueous detergent concentration using##2##4##(1994-12#2)
aqueous diffusion##3##2##(1992-3#1)(1995-5#1)(2008-10#1)
aqueous dilution##2##2##(2008-10#2)
aqueous dilutions##2##2##(2008-10#1)(2010-7#1)
aqueous dispersions of##3##3##(1990-7#2)(1994-5#1)
aqueous dispersions prepared from##2##4##(1990-7#2)
aqueous dispersions##7##2##(1990-7#4)(1994-12#1)(1994-5#1)(2008-5#1)
aqueous electrolytes##2##2##(2008-10#2)
aqueous environment##10##2##(1992-6#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2013-1#2)
aqueous environmental##2##2##(2008-10#2)
aqueous ethanol##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
aqueous exposure##3##2##(2008-5#3)
aqueous extract of Azadirachta indica##2##5##(2008-12#2)
aqueous extract of Nigella sativa##2##5##(2008-12#2)
aqueous extract of##15##3##(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#2)(2010-3#1)(2011-1#3)(2012-2#2)(2013-1#1)
aqueous extract##21##2##(2008-10#3)(2008-11#2)(2008-12#7)(2008-5#2)(2010-3#1)(2011-1#3)(2012-2#2)(2013-1#1)
aqueous extraction##2##2##(2008-10#2)
aqueous extracts of the##2##4##(2008-10#2)
aqueous extracts of##11##3##(1992-2#1)(1992-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)
aqueous extracts##15##2##(1992-2#1)(1992-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2012-2#1)(2013-1#1)
aqueous food simulants##2##3##(2008-10#2)
aqueous glucose##4##2##(2008-2#4)
aqueous humor##7##2##(1996-2#1)(2008-12#5)(2011-3#1)
aqueous humour##2##2##(2008-4#1)(2008-5#1)
aqueous ion-pair formation (K(MLA)) of##2##5##(2008-10#2)
aqueous ion-pair formation (K(MLA))##3##4##(2008-10#3)
aqueous ionisation constant of##2##4##(2008-10#2)
aqueous leaves extracts of##3##4##(2008-12#3)
aqueous leaves extracts##5##3##(2008-12#5)
aqueous matrix##3##2##(2008-10#3)
aqueous media was##2##3##(2008-10#2)
aqueous media##37##2##(1990-2#2)(2008-10#28)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-7#1)(2012-2#1)
aqueous medium at##2##3##(2008-10#2)
aqueous medium in##3##3##(1997-2#1)(2008-10#2)
aqueous medium using##3##3##(2008-10#3)
aqueous medium##32##2##(1990-11#1)(1997-2#2)(2008-10#29)
aqueous methanol##5##2##(2008-10#5)
aqueous micellar solutions of octyl-beta-D-thioglucoside##2##5##(2008-7#2)
aqueous micellar solutions of##3##4##(2008-10#1)(2008-7#2)
aqueous micellar solutions##4##3##(2008-10#2)(2008-7#2)
aqueous micellar##9##2##(2008-10#7)(2008-7#2)
aqueous mobile phases##2##3##(1996-5#1)(2008-10#1)
aqueous mobile##3##2##(1996-5#1)(2008-10#2)
aqueous organic solvent##2##3##(2008-10#2)
aqueous organic##3##2##(2008-10#2)(2011-2#1)
aqueous ozone##3##2##(2008-10#3)
aqueous pKa of##2##3##(1995-5#2)
aqueous phase and##12##3##(2008-10#11)(2010-4#1)
aqueous phase as##3##3##(2008-10#2)(2008-7#1)
aqueous phase could be##2##4##(2008-10#2)
aqueous phase in##2##3##(2008-10#2)
aqueous phase on##2##3##(2008-10#2)
aqueous phase to##2##3##(2008-10#2)
aqueous phase using##2##3##(2008-10#2)
aqueous phase was##3##3##(2008-10#2)(2008-5#1)
aqueous phase##64##2##(1990-5#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-2#1)(2008-10#50)(2008-5#5)(2008-7#3)(2010-4#1)
aqueous phases##5##2##(1990-8#1)(1991-5#1)(2008-10#2)(2008-12#1)
aqueous pore (i##2##3##(1990-2#2)
aqueous pore##6##2##(1990-2#5)(1994-2#1)
aqueous potassium##2##2##(2008-10#2)
aqueous salt solutions##2##3##(2008-10#1)(2009-10#1)
aqueous sample extraction (RASE)##2##4##(2008-10#2)
aqueous sample extraction##4##3##(2008-10#4)
aqueous sample is##2##3##(2008-10#2)
aqueous sample solution##5##3##(2008-10#5)
aqueous sample##22##2##(2008-10#21)(2008-3#1)
aqueous samples and##2##3##(2008-10#2)
aqueous samples for##3##3##(2008-10#3)
aqueous samples is demonstrated##2##4##(2008-10#2)
aqueous samples is##4##3##(2008-10#4)
aqueous samples using##2##3##(2008-10#2)
aqueous samples was##2##3##(2008-10#2)
aqueous samples##37##2##(2008-10#34)(2008-5#1)(2012-1#2)
aqueous sodium##8##2##(2007-12#1)(2008-10#5)(2008-2#1)(2009-5#1)
aqueous solubility##2##2##(1995-3#1)(2007-11#1)
aqueous solution after##2##3##(1991-12#1)(2008-10#1)
aqueous solution and##16##3##(1990-2#1)(1990-5#1)(2008-10#12)(2008-3#1)(2008-5#1)
aqueous solution as##3##3##(2008-10#2)(2008-9#1)
aqueous solution at pH##4##4##(2008-10#4)
aqueous solution at##9##3##(1995-11#1)(1995-2#1)(2008-10#7)
aqueous solution by##4##3##(2008-10#4)
aqueous solution containing##7##3##(2008-10#4)(2008-8#1)(2008-9#1)(2011-2#1)
aqueous solution for##4##3##(2008-10#3)(2008-11#1)
aqueous solution in the presence of##2##6##(2008-10#2)
aqueous solution in##3##3##(2008-10#3)
aqueous solution of 0##2##4##(2008-10#2)
aqueous solution of a##3##4##(1995-2#2)(2008-10#1)
aqueous solution of the##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
aqueous solution of##19##3##(1995-2#2)(1996-2#1)(1997-2#1)(2007-11#2)(2008-10#10)(2008-5#1)(2010-5#1)(2011-2#1)
aqueous solution on##2##3##(2013-1#1)(2013-8#1)
aqueous solution to##5##3##(1990-5#1)(2008-10#2)(2008-5#1)(2008-6#1)
aqueous solution using##3##3##(1992-8#1)(2008-10#2)
aqueous solution was 0##2##4##(2008-10#2)
aqueous solution was##9##3##(2008-10#7)(2008-11#1)(2009-8#1)
aqueous solution were##6##3##(2008-10#4)(2008-5#1)(2008-8#1)
aqueous solution with##6##3##(1992-3#1)(2008-10#5)
aqueous solution##216##2##(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#3)(1992-3#1)(1992-8#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#5)(1997-7#1)(2007-11#4)(2007-3#1)(2007-7#2)(2008-10#142)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#2)(2011-2#2)(2013-1#4)(2013-8#1)
aqueous solutions and its##2##4##(2008-10#1)(2013-1#1)
aqueous solutions and##9##3##(2008-10#7)(2008-11#1)(2013-1#1)
aqueous solutions are##4##3##(2008-10#3)(2008-3#1)
aqueous solutions by##3##3##(2008-10#3)
aqueous solutions containing other##2##4##(2008-10#2)
aqueous solutions containing the##2##4##(2008-10#1)(2011-2#1)
aqueous solutions containing##12##3##(2008-10#10)(2008-5#1)(2011-2#1)
aqueous solutions in##4##3##(2008-10#2)(2008-6#1)(2010-3#1)
aqueous solutions into##3##3##(2008-10#3)
aqueous solutions of the##2##4##(2008-10#2)
aqueous solutions of##17##3##(1990-12#1)(1990-8#1)(2008-10#13)(2008-2#1)(2008-7#1)
aqueous solutions was studied##4##4##(2008-10#3)(2008-6#1)
aqueous solutions was##7##3##(2008-10#6)(2008-6#1)
aqueous solutions were##4##3##(2008-10#4)
aqueous solutions##132##2##(1990-12#1)(1990-8#1)(1992-8#1)(2007-12#1)(2007-5#1)(2008-10#103)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#3)
aqueous solvent##3##2##(2008-10#3)
aqueous solvents##6##2##(1990-7#1)(2008-10#5)
aqueous standard solutions##3##3##(2008-10#3)
aqueous standard##5##2##(2008-10#5)
aqueous standards calibration##2##3##(2008-10#2)
aqueous standards for##2##3##(2008-10#2)
aqueous standards##21##2##(2008-10#21)
aqueous surfactant##2##2##(2008-10#1)(2008-5#1)
aqueous suspensions of##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)
aqueous systems##3##2##(2008-10#2)(2008-3#1)
aqueous to##3##2##(2008-10#3)
aqueous two-phase extraction##5##3##(2008-6#4)(2012-1#1)
aqueous two-phase system of tetrabutylammonium bromide##2##6##(2008-10#2)
aqueous two-phase system of##4##4##(2008-10#4)
aqueous two-phase system##11##3##(2008-10#7)(2008-6#1)(2011-2#2)(2012-1#1)
aqueous two-phase systems##4##3##(2008-6#1)(2008-7#3)
aqueous two-phase##21##2##(2008-10#7)(2008-6#6)(2008-7#3)(2011-2#2)(2012-1#2)(2012-3#1)
aqueous##982##1##(1990-11#1)(1990-12#2)(1990-2#9)(1990-5#5)(1990-7#5)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#5)(1991-8#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#4)(1996-12#1)(1996-2#3)(1996-5#2)(1997-2#7)(1997-7#1)(2007-11#12)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#645)(2008-11#13)(2008-12#23)(2008-2#10)(2008-3#14)(2008-4#5)(2008-5#35)(2008-6#17)(2008-7#14)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#4)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#2)
aqueous-based##3##1##(1997-2#2)(2008-11#1)
aqueous-methanolic solvents##2##2##(1996-5#2)
aqueous-organic mobile phases##3##3##(1996-5#2)(2010-11#1)
aqueous-organic##5##1##(1990-8#1)(1996-5#3)(2010-11#1)
aqueous/ethanolic solutions##2##2##(2008-10#2)
aquifer##4##1##(2008-10#2)(2013-8#2)
aquifers##2##1##(2008-10#2)
aquired##2##1##(1995-6#1)(2013-8#1)
arNOX activity##2##2##(2009-9#2)
ara-C##6##1##(1990-2#1)(1992-5#5)
arab countries##2##2##(2007-7#1)(2008-4#1)
arab##5##1##(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)
arabic##2##1##(2008-1#1)(2009-11#1)
arabica and robusta##4##3##(2008-10#4)
arabica extracts##2##2##(2013-8#2)
arabica##9##1##(2008-10#4)(2008-5#1)(2013-8#4)
arabiensis##5##1##(2008-8#5)
arabinogalactan##4##1##(1995-11#4)
arabinose##10##1##(2008-10#1)(2008-6#8)(2011-1#1)
arabinoside##4##1##(1991-2#1)(1997-2#2)(2008-5#1)
arachidic##2##1##(1995-11#1)(2008-10#1)
arachidonate release from##4##3##(1994-11#1)(2008-11#3)
arachidonate release##8##2##(1991-2#1)(1994-11#2)(2008-11#5)
arachidonate##20##1##(1990-2#5)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#2)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#5)
arachidonic acid (20##3##3##(1990-7#1)(1992-3#1)(1994-12#1)
arachidonic acid (AA)##5##3##(1991-2#1)(1992-12#1)(1993-8#1)(2008-11#1)(2010-9#1)
arachidonic acid and U-46619##2##4##(1997-7#2)
arachidonic acid and##9##3##(1990-12#1)(1992-6#1)(1993-8#1)(1996-2#1)(1996-7#1)(1997-7#2)(2008-7#1)(2013-1#1)
arachidonic acid in##2##3##(1990-2#1)(1991-12#1)
arachidonic acid liberation##5##3##(1994-3#2)(1995-11#3)
arachidonic acid metabolism##6##3##(1994-8#3)(2008-11#3)
arachidonic acid metabolites##3##3##(1995-12#1)(1997-1#1)(2008-4#1)
arachidonic acid oxidation##2##3##(1994-5#1)(2009-8#1)
arachidonic acid release and##2##4##(1997-1#1)(2009-12#1)
arachidonic acid release##5##3##(1990-2#1)(1997-1#1)(2008-11#1)(2009-12#1)(2011-2#1)
arachidonic acid to##4##3##(1991-8#1)(1992-8#2)(1994-12#1)
arachidonic acid##92##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#2)(1991-2#2)(1991-8#4)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#5)(1993-8#5)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#7)(1994-8#3)(1995-11#12)(1995-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-7#3)(2007-10#1)(2008-11#7)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2013-1#1)
arachidonic acid-induced##3##2##(1991-8#1)(1996-2#1)(2011-1#1)
arachidonic and##3##2##(1994-5#1)(1996-7#1)(2008-7#1)
arachidonic##106##1##(1990-12#1)(1990-2#4)(1990-7#1)(1991-12#2)(1991-2#2)(1991-8#6)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#5)(1993-8#5)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#8)(1994-8#3)(1995-11#12)(1995-12#1)(1995-5#1)(1996-2#2)(1996-7#2)(1997-1#2)(1997-7#3)(2007-10#1)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#1)
arachnoid cyst##8##2##(1991-11#3)(2008-2#1)(2008-7#1)(2009-9#1)(2012-12#2)
arachnoid##13##1##(1991-11#3)(2008-2#1)(2008-7#3)(2009-9#1)(2011-2#1)(2012-12#3)(2012-3#1)
aragonite crystal##2##2##(2008-7#2)
aragonite##14##1##(1990-11#1)(2008-10#7)(2008-7#6)
araneophagy##2##1##(2012-3#2)
arbiter##2##1##(1992-6#1)(2008-1#1)
arbitrarily complex##2##2##(2009-5#2)
arbitrarily defined##2##2##(1993-12#1)(2008-3#1)
arbitrarily large##2##2##(2007-11#1)(2008-7#1)
arbitrarily misaligned##2##2##(2007-11#1)(2008-3#1)
arbitrarily oriented##6##2##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
arbitrarily primed polymerase chain reaction##2##5##(2008-10#1)(2008-11#1)
arbitrarily shaped##3##2##(2007-12#1)(2008-2#2)
arbitrarily##39##1##(1990-12#1)(1993-12#2)(2007-11#6)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#9)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-9#1)
arbitrary and##3##2##(1996-6#1)(2008-2#1)(2008-6#1)
arbitrary complex##6##2##(2007-11#3)(2008-3#3)
arbitrary constant##3##2##(2008-2#1)(2008-3#2)
arbitrary decisions##2##2##(1994-11#1)(1996-4#1)
arbitrary geometries##5##2##(2007-11#3)(2008-3#2)
arbitrary grating##2##2##(2007-12#2)
arbitrary illumination##2##2##(2008-3#2)
arbitrary large##2##2##(2008-3#2)
arbitrary orientation##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
arbitrary polarization##2##2##(2007-12#2)
arbitrary primer##2##2##(2008-10#2)
arbitrary shape##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
arbitrary time##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
arbitrary turbidity##2##2##(2008-2#2)
arbitrary units##2##2##(2008-10#1)(2008-3#1)
arbitrary values of##2##3##(2008-2#2)
arbitrary waveform generation##2##3##(2007-11#2)
arbitrary waveform##3##2##(2007-11#2)(2007-12#1)
arbitrary wavelengths##2##2##(2007-12#1)(2008-3#1)
arbitrary##158##1##(1991-3#1)(1992-12#1)(1992-9#1)(1994-11#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-11#18)(2007-12#19)(2008-10#7)(2008-11#1)(2008-2#35)(2008-3#50)(2008-5#1)(2008-6#7)(2008-8#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#1)
arborea##2##1##(2008-10#1)(2013-7#1)
arboreal##4##1##(1994-5#1)(2009-10#1)(2011-2#1)(2012-9#1)
arborescens##6##1##(2008-10#6)
arboreum##3##1##(2008-8#3)
arboricola pv##5##2##(2008-10#5)
arboricola##8##1##(2008-10#8)
arborization##2##1##(1997-1#1)(2012-2#1)
arborization)##2##1##(2008-10#1)(2012-2#1)
arborizations##3##1##(2007-12#3)
arbors##4##1##(1994-2#3)(1997-3#1)
arbovirus##2##1##(1992-8#1)(2013-8#1)
arbuscular mycorrhizae##2##2##(2008-10#1)(2010-10#1)
arbuscular mycorrhizal fungi on##2##4##(2008-12#1)(2013-8#1)
arbuscular mycorrhizal fungi##4##3##(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
arbuscular mycorrhizal fungus##3##3##(2008-10#1)(2008-12#2)
arbuscular mycorrhizal##10##2##(2008-10#3)(2008-11#2)(2008-12#3)(2008-8#1)(2013-8#1)
arbuscular##12##1##(2008-10#4)(2008-11#2)(2008-12#3)(2008-8#1)(2010-10#1)(2013-8#1)
arbutin##2##1##(2008-6#2)
arbutine##2##1##(2008-5#2)
arc discharge##5##2##(2008-10#5)
arc furnace flue##2##3##(2008-10#2)
arc furnace##3##2##(2008-10#2)(2013-1#1)
arc lamp source##2##3##(2008-3#2)
arc lamp##5##2##(2007-11#1)(2008-3#3)(2008-9#1)
arc min##4##2##(2008-2#3)(2008-3#1)
arc plasma##4##2##(2008-2#2)(2013-8#2)
arc sec##6##2##(2008-2#3)(2008-3#3)
arc that##3##2##(2008-2#2)(2012-12#1)
arc##54##1##(1994-8#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-2#16)(2008-3#12)(2008-5#2)(2008-9#1)(2009-4#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
arced##2##1##(2008-10#1)(2008-7#1)
arch and##5##2##(1997-8#2)(2007-8#1)(2008-8#1)(2012-2#1)
arch atheroma##5##2##(2008-8#5)
arch is##2##2##(2010-7#1)(2011-2#1)
arch of##4##2##(2007-11#1)(2011-2#1)(2013-1#2)
arch reconstruction##2##2##(2007-8#2)
arch##73##1##(1993-9#1)(1997-8#5)(2007-11#2)(2007-12#1)(2007-8#21)(2008-11#2)(2008-12#3)(2008-8#10)(2008-9#3)(2009-7#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#12)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
archaea##7##1##(2008-11#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)
archaeal species##2##2##(2008-7#1)(2011-2#1)
archaeal##6##1##(1993-9#1)(2008-7#3)(2011-2#1)(2012-2#1)
archaebacteria##8##1##(1990-2#3)(1990-5#1)(1993-11#1)(1995-8#1)(2008-8#2)
archaebacterial##2##1##(1992-8#1)(1993-11#1)
archaeological ceramic##2##2##(2008-10#2)
archaeological glass##2##2##(2008-10#2)
archaeological samples##2##2##(2008-10#2)
archaeological##29##1##(1991-2#2)(1995-6#1)(2006-4#1)(2008-10#23)(2012-9#2)
archaeometric study##2##2##(2008-10#2)
archaeon in##2##2##(2011-2#2)
archaeon##6##1##(1993-9#2)(1995-5#1)(2008-9#1)(2011-2#2)
archaic##2##1##(1994-3#1)(2008-10#1)
archeological##2##1##(2008-5#2)
arches##12##1##(1990-5#1)(1995-3#1)(2007-8#2)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
archetypal##5##1##(1990-8#1)(1993-2#1)(2008-11#1)(2008-7#1)(2010-9#1)
archetype##4##1##(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)
archetypes##2##1##(2010-8#2)
archipelago##5##1##(1996-4#1)(1996-6#2)(2008-8#1)(2010-4#1)
architects##5##1##(1994-3#1)(2012-3#4)
architectural distortion##2##2##(2009-12#2)
architectural terracotta##2##2##(2008-10#2)
architectural##24##1##(1991-11#1)(1991-12#1)(1995-8#3)(1996-2#1)(1997-3#1)(2007-12#3)(2008-10#6)(2008-3#5)(2008-9#1)(2009-12#2)
architecture and##16##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-2#1)
architecture as##3##2##(2009-11#1)(2010-3#1)(2011-2#1)
architecture for##13##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#1)(2010-8#2)(2011-1#1)
architecture has been##2##3##(2008-11#1)(2008-3#1)
architecture in##7##2##(1996-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
architecture is also##2##3##(2008-2#1)(2008-3#1)
architecture is based on##3##4##(2008-3#3)
architecture is characteristic##2##3##(1991-2#1)(2008-11#1)
architecture is presented##3##3##(2008-2#2)(2008-3#1)
architecture is##23##2##(1991-2#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-2#4)(2008-3#10)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
architecture of a##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
architecture of the##16##3##(1993-5#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
architecture of##34##2##(1990-8#1)(1993-5#1)(1994-2#1)(1994-8#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#3)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
architecture on the##2##3##(2008-10#1)(2008-8#1)
architecture that##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)
architecture with##2##2##(2008-10#1)(2009-12#1)
architecture##194##1##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-2#2)(1997-1#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#8)(2008-12#1)(2008-2#17)(2008-3#32)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#12)(2008-9#5)(2009-11#5)(2009-12#6)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#9)(2010-9#1)(2011-1#3)(2011-2#11)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
architectures and##3##2##(1997-6#1)(2008-2#1)(2008-3#1)
architectures are##7##2##(1990-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
architectures can be##2##3##(2008-2#1)(2009-3#1)
architectures for##3##2##(2008-2#1)(2008-3#2)
architectures of##3##2##(2007-8#1)(2008-8#2)
architectures that##2##2##(2008-3#2)
architectures##45##1##(1990-11#4)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#13)(2008-3#10)(2008-4#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
archival and##2##2##(2008-10#1)(2008-9#1)
archival paraffin##2##2##(2012-12#1)(2013-8#1)
archival##16##1##(1992-1#2)(1994-11#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
archive##5##1##(1990-3#1)(1997-1#1)(2008-10#2)(2012-2#1)
archived##10##1##(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)
archives of##2##2##(2008-10#2)
archives##7##1##(1992-1#2)(1992-10#1)(2008-10#2)(2008-7#1)(2009-12#1)
archiving and communications systems (PACS)##2##5##(1996-2#2)
archiving and##3##2##(1996-2#2)(1997-8#1)
archiving##7##1##(1994-3#2)(1996-2#2)(1997-8#1)(2008-10#1)(2011-2#1)
archosaurs##3##1##(2008-8#3)
archus##2##1##(2007-8#2)
arcjet plume##6##2##(2008-2#1)(2008-3#5)
arcjet##13##1##(2008-2#6)(2008-3#7)
arcs are##2##2##(2008-2#2)
arcs##15##1##(1991-8#4)(2008-12#1)(2008-2#6)(2008-3#2)(2008-7#1)(2009-9#1)
arcsine transform##2##2##(1991-2#1)(1992-11#1)
arcsine##4##1##(1991-2#3)(1992-11#1)
arctangent function##2##2##(2008-3#2)
arctic##7##1##(1990-8#1)(1991-5#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-3#1)
arcuate neurones##5##2##(1992-8#5)
arcuate nucleus##8##2##(1993-12#1)(1993-5#5)(1994-2#1)(1996-12#1)
arcuate##16##1##(1992-8#5)(1993-12#1)(1993-5#5)(1994-2#1)(1996-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
arcus senilis##3##2##(2008-7#3)
arcus##4##1##(1997-8#1)(2008-7#3)
arduous##5##1##(1993-3#1)(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#1)
are &lt##2##2##(2009-12#1)(2010-3#1)
are &quot##16##2##(1990-2#3)(1992-2#1)(1994-12#1)(1994-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
are (1) the##3##3##(2008-2#1)(2008-3#2)
are (1)##6##2##(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-1#1)
are (a)##2##2##(2007-8#1)(2010-7#1)
are (i)##4##2##(1992-8#1)(1997-8#1)(2008-10#1)(2008-3#1)
are 0##56##2##(1993-8#1)(1994-12#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-10#46)(2008-11#1)(2008-3#3)(2008-9#1)
are 1##24##2##(1990-7#1)(1994-5#1)(2008-10#20)(2008-3#2)
are 10##2##2##(2008-7#1)(2011-2#1)
are 100##2##2##(2008-10#1)(2008-11#1)
are 100%##2##2##(1993-3#1)(2008-10#1)
are 12##3##2##(1992-6#1)(2008-9#1)(2013-1#1)
are 13##3##2##(2008-3#1)(2008-9#2)
are 14##2##2##(2008-10#1)(2013-1#1)
are 15##4##2##(1992-8#1)(1997-5#1)(2008-10#1)(2008-7#1)
are 18##4##2##(1995-5#1)(2007-12#1)(2008-10#2)
are 2##19##2##(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#12)(2008-3#1)(2009-10#1)(2010-8#1)(2012-2#1)
are 20 to 30 times##2##5##(1993-8#1)(2008-1#1)
are 20##4##2##(1993-8#1)(2007-11#1)(2008-1#1)(2008-3#1)
are 24##2##2##(2008-3#1)(2010-8#1)
are 3##16##2##(1990-5#1)(1993-11#1)(1994-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
are 33##2##2##(2008-10#1)(2008-9#1)
are 4##12##2##(1991-1#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)
are 40##2##2##(1994-11#1)(2008-10#1)
are 5##7##2##(1991-2#1)(1997-7#1)(2008-10#4)(2010-8#1)
are 6##8##2##(1992-6#1)(2008-10#6)(2008-11#1)
are 7##4##2##(1992-8#1)(1994-8#1)(2008-10#1)(2013-1#1)
are 76##2##2##(1994-1#1)(2008-3#1)
are 79##2##2##(1992-10#1)(1995-6#1)
are 80##2##2##(1991-5#1)(2008-10#1)
are 9##2##2##(2008-10#2)
are DNA##4##2##(1992-11#1)(1995-5#1)(2008-10#1)(2008-4#1)
are HIV##2##2##(2010-7#1)(2011-2#1)
are HIV-positive##2##2##(1995-6#2)
are K##2##2##(2008-12#1)(2008-2#1)
are UV##2##2##(2007-11#1)(2008-3#1)
are a broad##2##3##(2008-2#1)(2010-6#1)
are a class of##8##4##(1992-2#1)(1994-12#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
are a common and serious##2##5##(1993-11#1)(2010-12#1)
are a common and##3##4##(1991-8#1)(1993-11#1)(2010-12#1)
are a common feature of##2##5##(1995-6#1)(2008-8#1)
are a common problem##2##4##(2010-8#1)(2011-2#1)
are a common##15##3##(1991-6#1)(1991-8#1)(1993-11#1)(1993-2#1)(1995-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
are a complex##2##3##(2008-9#1)(2009-9#1)
are a concern for##2##4##(2007-11#1)(2008-9#1)
are a consequence of the##2##5##(2007-12#1)(2008-10#1)
are a consequence of##4##4##(2007-12#1)(2008-10#3)
are a consequence##5##3##(2007-12#1)(2008-10#3)(2008-4#1)
are a daily occurrence in##2##5##(1994-12#1)(1995-5#1)
are a family of##12##4##(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-5#1)(2010-11#1)(2010-8#1)(2010-9#1)
are a few reports of##2##5##(2007-12#1)(2013-1#1)
are a few reports##3##4##(2007-12#1)(2012-1#1)(2013-1#1)
are a few##8##3##(1993-12#1)(1995-1#1)(1997-2#1)(2007-12#1)(2010-10#1)(2010-11#1)(2012-1#1)(2013-1#1)
are a form of##2##4##(2007-10#1)(2009-9#1)
are a function of both##2##5##(2008-10#1)(2008-12#1)
are a function of##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
are a good alternative##2##4##(2010-4#1)(2013-7#1)
are a good##5##3##(1994-5#1)(2007-8#1)(2010-4#1)(2012-2#1)(2013-7#1)
are a group of##8##4##(1991-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
are a growing##2##3##(2008-5#1)(2013-1#1)
are a hallmark of##2##4##(2008-7#1)(2008-9#1)
are a heterogeneous group of##5##5##(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
are a heterogeneous group##6##4##(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
are a heterogeneous##8##3##(2008-10#1)(2008-7#2)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
are a key##2##3##(2011-2#1)(2012-3#1)
are a large group of##2##5##(2008-10#1)(2008-12#1)
are a large##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
are a leading cause of##2##5##(1997-3#1)(2011-2#1)
are a lot of##3##4##(2007-4#1)(2008-9#1)(2012-2#1)
are a major cause of morbidity##2##6##(2008-11#1)(2008-7#1)
are a major cause of##5##5##(2008-11#2)(2008-7#1)(2009-4#1)(2010-5#1)
are a major source of##2##5##(2008-11#1)(2013-1#1)
are a major##17##3##(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-7#3)(2009-11#1)(2009-4#1)(2010-12#1)(2010-5#2)(2010-8#1)(2012-12#1)(2013-1#1)
are a much##2##3##(1993-9#1)(1997-5#1)
are a necessary##2##3##(1991-9#1)(2007-2#1)
are a new class of##3##5##(2008-9#1)(2011-3#1)(2012-3#1)
are a new##5##3##(1993-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
are a novel class of##3##5##(2008-10#2)(2012-2#1)
are a novel##5##3##(2008-10#2)(2008-3#1)(2012-1#1)(2012-2#1)
are a number of advantages##2##5##(2008-9#1)(2012-12#1)
are a number of disadvantages##2##5##(1991-3#1)(2009-5#1)
are a number of factors##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
are a number of possible##2##5##(1995-3#1)(2008-10#1)
are a number of reports##2##5##(2007-8#1)(2008-7#1)
are a number of##31##4##(1991-3#1)(1992-1#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
are a potential##3##3##(2008-10#2)(2011-2#1)
are a powerful##2##3##(2007-11#1)(2008-9#1)
are a promising approach##2##4##(2012-2#2)
are a promising##5##3##(1995-2#1)(2008-4#1)(2009-11#1)(2012-2#2)
are a rare occurrence##2##4##(2010-12#1)(2011-2#1)
are a rare##9##3##(2008-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-3#1)
are a reality##2##3##(2008-10#1)(2008-11#1)
are a relatively##3##3##(2007-12#1)(2008-3#1)(2012-3#1)
are a result of##2##4##(2009-5#1)(2012-2#1)
are a risk factor for##2##5##(2011-1#1)(2013-1#1)
are a serious problem##2##4##(1996-12#1)(2013-1#1)
are a significant cause of##2##5##(2008-11#1)(2008-3#1)
are a significant##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-8#2)
are a source of##4##4##(1997-3#1)(2007-12#1)(2008-11#1)(2010-1#1)
are a type of##3##4##(1995-5#1)(1996-3#1)(2011-2#1)
are a unique##2##3##(1992-2#1)(1996-2#1)
are a useful##3##3##(2008-4#1)(2009-2#1)(2011-2#1)
are a valuable tool for##3##5##(2008-1#1)(2008-7#2)
are a valuable tool##4##4##(2008-1#1)(2008-5#1)(2008-7#2)
are a valuable##5##3##(2008-1#1)(2008-5#1)(2008-7#2)(2012-3#1)
are a variety of##3##4##(1997-1#1)(2008-10#1)(2012-3#1)
are a very##2##3##(1994-2#1)(2009-12#1)
are a well known complication in##2##6##(1991-11#1)(2008-7#1)
are a well-established##2##3##(2013-7#1)(2013-8#1)
are a widely used##2##4##(1993-1#1)(2008-1#1)
are a##335##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-4#1)(2007-8#4)(2008-1#4)(2008-10#32)(2008-11#17)(2008-12#7)(2008-2#7)(2008-3#7)(2008-4#10)(2008-5#7)(2008-6#1)(2008-7#19)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#22)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#17)(2012-3#10)(2013-1#7)(2013-7#3)(2013-8#5)
are aberrant##2##2##(2009-3#1)(2009-6#1)
are able to alter##3##4##(1994-11#1)(2009-7#1)(2013-1#1)
are able to bind##2##4##(2008-10#1)(2011-2#1)
are able to cause##2##4##(2006-6#1)(2008-10#1)
are able to confer##3##4##(1992-7#1)(1993-8#2)
are able to control##2##4##(2007-11#1)(2008-2#1)
are able to convert##2##4##(1990-12#2)
are able to decrease the##2##5##(2008-5#1)(2008-8#1)
are able to deliver##3##4##(2007-12#1)(2008-7#1)(2010-10#1)
are able to detect##3##4##(2008-10#2)(2011-1#1)
are able to differentiate in##2##5##(2008-11#1)(2013-1#1)
are able to form##3##4##(1994-5#1)(1994-6#1)(2008-4#1)
are able to generate##2##4##(2008-3#1)(2010-7#1)
are able to induce##3##4##(2008-10#1)(2008-9#1)(2011-1#1)
are able to infect##2##4##(2008-10#2)
are able to inhibit##2##4##(2008-5#1)(2010-4#1)
are able to maintain##3##4##(1991-8#1)(2007-7#1)(2008-10#1)
are able to modify##2##4##(2008-7#2)
are able to obtain##3##4##(1995-5#1)(1997-2#1)(2008-7#1)
are able to overcome##2##4##(2008-12#1)(2008-8#1)
are able to perform##2##4##(2008-7#1)(2008-9#1)
are able to provide##2##4##(2008-11#2)
are able to reduce##2##4##(2009-5#1)(2012-3#1)
are able to replace##2##4##(1990-7#2)
are able to stimulate the##2##5##(1993-8#1)(2008-9#1)
are able to stimulate##4##4##(1993-8#2)(2008-9#1)(2012-2#1)
are able to survive##2##4##(1996-12#1)(2011-2#1)
are able to use##3##4##(2007-11#1)(2009-7#1)(2011-2#1)
are able to##136##3##(1990-12#2)(1990-7#3)(1991-8#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#2)(2006-12#2)(2006-6#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-10#13)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#1)
are able##137##2##(1990-12#2)(1990-7#3)(1991-8#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#2)(2006-12#2)(2006-6#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-10#13)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#1)
are abnormally##2##2##(1990-8#1)(1995-5#1)
are abolished##2##2##(1990-7#1)(1991-2#1)
are about 150##2##3##(2008-7#1)(2010-8#1)
are about to##2##3##(1991-2#1)(2008-5#1)
are about##21##2##(1990-3#1)(1990-8#1)(1991-2#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
are above##2##2##(1992-9#1)(2008-10#1)
are absent from the##2##4##(2008-8#1)(2008-9#1)
are absent in##2##3##(2008-8#1)(2011-2#1)
are absent##12##2##(1990-8#1)(1991-12#1)(1993-12#1)(1996-11#1)(2008-2#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-7#1)
are absolute##2##2##(2007-12#1)(2013-1#1)
are absorbed##3##2##(2008-3#2)(2012-2#1)
are abundant in the##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
are abundant in##7##3##(1990-5#1)(1991-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)
are abundant##14##2##(1990-5#1)(1991-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
are abused##2##2##(2008-10#1)(2010-3#1)
are acceptable##7##2##(1991-2#1)(1994-3#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
are accepted##5##2##(2007-8#1)(2008-7#3)(2008-8#1)
are accessible to##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
are accessible##12##2##(1991-9#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-7#1)(2012-3#1)
are accompanied by changes in##3##5##(2008-4#1)(2008-9#1)(2009-6#1)
are accompanied by##15##3##(1990-7#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#4)(2009-6#1)(2010-12#1)(2011-1#1)(2013-8#1)
are accompanied##16##2##(1990-7#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#5)(2009-6#1)(2010-12#1)(2011-1#1)(2013-8#1)
are accomplished##5##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)
are accounted for##3##3##(1995-1#1)(2008-3#1)(2013-8#1)
are accumulated in##3##3##(1994-3#1)(2008-7#1)(2010-8#1)
are accumulated##4##2##(1994-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
are accumulating##2##2##(2008-7#1)(2011-2#1)
are accurate and##3##3##(1993-12#1)(2008-2#1)(2008-9#1)
are accurate##6##2##(1993-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
are accurately##4##2##(1997-8#1)(2008-3#2)(2012-12#1)
are achievable##5##2##(2007-12#1)(2008-12#1)(2008-2#1)(2010-6#1)(2011-1#1)
are achieved by use of##2##5##(2007-12#1)(2008-3#1)
are achieved by##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
are achieved for##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
are achieved in##2##3##(1994-6#1)(2008-2#1)
are achieved##28##2##(1991-11#1)(1994-11#1)(1994-6#1)(2007-11#3)(2007-12#6)(2008-10#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2011-1#1)
are achieving##2##2##(1997-1#1)(2008-6#1)
are acquired and stored##2##4##(2008-3#1)(2008-9#1)
are acquired and##3##3##(2008-3#2)(2008-9#1)
are acquired in##2##3##(2008-10#1)(2008-11#1)
are acquired##10##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)(2013-8#1)
are activated by##10##3##(1990-2#1)(1991-2#1)(1993-12#1)(1993-3#1)(1996-2#1)(2008-11#2)(2008-8#1)(2009-7#1)(2011-2#1)
are activated in##3##3##(1995-11#1)(2012-12#1)(2013-8#1)
are activated##26##2##(1990-2#1)(1991-2#1)(1993-12#2)(1993-3#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
are activators##2##2##(1994-5#1)(1995-5#1)
are active against##2##3##(2011-2#1)(2012-12#1)
are active at##2##3##(2008-11#1)(2011-2#1)
are active in the##2##4##(2008-4#1)(2009-2#1)
are active in##5##3##(1990-11#1)(1993-11#1)(2008-4#1)(2009-11#1)(2009-2#1)
are active##15##2##(1990-11#1)(1993-11#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-2#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
are actively involved in##2##4##(2009-11#1)(2011-2#1)
are actively involved##3##3##(1994-8#1)(2009-11#1)(2011-2#1)
are actively##7##2##(1990-2#1)(1992-6#1)(1994-8#1)(1997-7#1)(2008-4#1)(2009-11#1)(2011-2#1)
are actually based on##2##4##(2008-10#1)(2008-11#1)
are actually##8##2##(1995-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)
are adapted to the##2##4##(1995-11#1)(2008-3#1)
are adapted to##4##3##(1995-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
are adapted##5##2##(1995-11#1)(2008-10#2)(2008-3#1)(2008-9#1)
are adaptive##2##2##(2008-9#1)(2009-11#1)
are added to the mixture##2##5##(1995-8#1)(2008-10#1)
are added to the##4##4##(1995-8#1)(2007-11#1)(2008-10#2)
are added to##6##3##(1995-8#1)(2007-11#1)(2008-10#3)(2012-2#1)
are added##16##2##(1992-8#2)(1993-1#1)(1994-1#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#1)
are addicted to##2##3##(2009-9#1)(2011-2#1)
are addicted##3##2##(2008-6#1)(2009-9#1)(2011-2#1)
are additional##7##2##(2006-6#1)(2008-10#2)(2008-12#1)(2008-9#2)(2010-5#1)
are addressed in##3##3##(2009-8#1)(2012-3#1)(2013-1#1)
are addressed##27##2##(1991-12#2)(1992-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
are addressing##4##2##(1994-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
are adequate for##2##3##(2008-10#1)(2008-11#1)
are adequate##6##2##(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2013-1#1)
are adequately##2##2##(2008-8#1)(2012-1#1)
are adjacent##3##2##(1994-12#1)(1995-5#1)(1997-7#1)
are adjusted to##3##3##(1992-12#1)(2008-10#2)
are adjusted##4##2##(1992-12#1)(2008-10#2)(2009-12#1)
are administered to##2##3##(1991-3#1)(2008-9#1)
are administered##8##2##(1990-9#1)(1991-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
are admitted to##3##3##(1994-2#1)(1997-5#1)(2008-3#1)
are adopted##2##2##(1992-1#1)(2008-3#1)
are adsorbed on##2##3##(2008-10#2)
are adsorbed##10##2##(2007-12#1)(2008-10#8)(2008-5#1)
are advised to##4##3##(1993-1#1)(1997-4#1)(2011-2#1)(2012-2#1)
are advised##6##2##(1992-11#1)(1993-1#1)(1997-4#1)(2011-2#2)(2012-2#1)
are advocated##3##2##(2007-7#1)(2008-7#1)(2012-2#1)
are aesthetically##2##2##(2008-4#1)(2010-8#1)
are affected by the##11##4##(1990-6#1)(1991-12#1)(1991-8#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)(2013-1#1)
are affected by##27##3##(1990-6#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#2)(2012-3#1)(2013-1#1)
are affected more often##2##4##(2008-1#1)(2011-2#1)
are affected##44##2##(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
are afraid##2##2##(1995-12#1)(2011-2#1)
are age dependent##2##3##(1996-5#1)(2012-12#1)
are age##4##2##(1991-12#1)(1996-5#1)(2008-2#1)(2012-12#1)
are aggregated##5##2##(1992-6#1)(2007-5#1)(2008-6#1)(2010-8#2)
are aggressive##2##2##(2008-1#1)(2008-6#1)
are aimed at##2##3##(2008-3#1)(2013-8#1)
are aiming to##2##3##(1995-2#1)(2008-4#1)
are aiming##3##2##(1995-2#1)(1996-6#1)(2008-4#1)
are aligned with##2##3##(1996-1#1)(2007-12#1)
are aligned##4##2##(1996-1#1)(1997-2#1)(2007-12#1)(2008-3#1)
are alive with no evidence of disease##2##7##(2007-5#1)(2008-10#1)
are alive with##3##3##(2007-5#1)(2008-10#1)(2008-6#1)
are alive##14##2##(1990-2#1)(1990-8#1)(1992-5#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-6#2)(2010-3#1)(2011-2#4)
are all highly##2##3##(2008-7#1)(2011-2#1)
are all important##4##3##(1996-3#1)(2007-12#1)(2010-11#1)(2012-2#1)
are all in##2##3##(1996-3#1)(2008-11#1)
are all located##2##3##(1997-4#1)(2010-4#1)
are all shown to##2##4##(1995-12#1)(2008-9#1)
are all##69##2##(1990-6#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-10#7)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#5)
are allelic##3##2##(1992-8#1)(2007-7#1)(2011-1#1)
are allocated##3##2##(1997-3#1)(2006-10#1)(2008-6#1)
are allowed to##7##3##(1992-6#1)(1993-6#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)
are allowed##14##2##(1990-6#1)(1992-6#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
are allowing##2##2##(2009-3#1)(2012-2#1)
are almost always##3##3##(1992-2#1)(2008-12#1)(2008-8#1)
are almost certainly##2##3##(2007-11#1)(2008-8#1)
are almost identical##2##3##(1997-8#1)(2010-7#1)
are almost the same##2##4##(2008-10#1)(2008-2#1)
are almost##21##2##(1992-12#2)(1992-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-8#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#2)
are already a##2##3##(1991-11#1)(2009-5#1)
are already in##3##3##(1992-10#1)(2009-7#1)(2012-1#1)
are already present##2##3##(2007-12#2)
are already used in##2##4##(2012-1#1)(2012-3#1)
are already##27##2##(1990-9#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-8#1)(2006-12#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-3#1)
are also a##2##3##(2008-10#1)(2011-4#1)
are also able to produce##2##5##(1992-9#1)(2008-5#1)
are also able to##3##4##(1992-9#1)(1995-8#1)(2008-5#1)
are also addressed##11##3##(1994-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
are also affected##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
are also among the##2##4##(2008-9#1)(2013-1#1)
are also applicable to##2##4##(2007-9#1)(2008-4#1)
are also associated with##5##4##(2008-12#1)(2008-5#1)(2010-3#1)(2010-4#1)(2012-3#1)
are also at##3##3##(2008-11#1)(2009-12#1)(2009-8#1)
are also available##3##3##(1995-11#1)(1996-2#1)(2008-7#1)
are also becoming##2##3##(2008-11#2)
are also being##3##3##(1996-3#1)(2007-8#1)(2008-10#1)
are also calculated##2##3##(2008-3#2)
are also called##3##3##(2007-7#1)(2013-1#2)
are also capable of##2##4##(1992-2#1)(2007-10#1)
are also characterized##2##3##(2007-10#1)(2013-8#1)
are also common##3##3##(1991-12#1)(2008-1#1)(2010-10#1)
are also compared##2##3##(2008-2#1)(2008-3#1)
are also considered##7##3##(1991-6#1)(1995-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)
are also correlated with##2##4##(1991-8#1)(2007-12#1)
are also covered##2##3##(2011-2#1)(2012-2#1)
are also critical for##2##4##(2012-12#2)
are also critical##3##3##(2012-12#2)(2013-7#1)
are also crucial##2##3##(2008-5#1)(2009-12#1)
are also demonstrated##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
are also derived##2##3##(2008-2#1)(2008-3#1)
are also described in##2##4##(2008-9#1)(2013-1#1)
are also described##32##3##(1993-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#9)(2008-9#2)(2009-9#2)(2010-6#1)(2012-3#2)(2013-1#1)
are also detailed##3##3##(2008-4#2)(2008-9#1)
are also determined##2##3##(2008-11#1)(2008-8#1)
are also developing##2##3##(1996-9#1)(2008-5#1)
are also discussed and##2##4##(1991-5#1)(1995-3#1)
are also discussed in the##2##5##(2008-10#1)(2008-6#1)
are also discussed in this##2##5##(2008-11#1)(2010-7#1)
are also discussed in##7##4##(2008-10#4)(2008-11#1)(2008-6#1)(2010-7#1)
are also discussed##82##3##(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#9)(2008-6#1)(2008-7#4)(2008-9#3)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
are also effective against##2##4##(1997-4#1)(2008-10#1)
are also effective in##2##4##(2007-11#1)(2008-3#1)
are also effective##5##3##(1990-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)
are also estimated##2##3##(2008-3#1)(2008-8#1)
are also evaluated##3##3##(2008-3#2)(2010-3#1)
are also examined##4##3##(1991-3#1)(1991-5#1)(2008-11#1)(2008-3#1)
are also explored##5##3##(1992-1#1)(1992-12#1)(1995-2#1)(2007-8#1)(2010-9#1)
are also exposed##2##3##(2008-2#1)(2008-3#1)
are also found in the##2##5##(1994-6#1)(1996-5#1)
are also found in##4##4##(1994-6#1)(1996-5#1)(1997-7#1)(2009-8#1)
are also found to##2##4##(1990-12#1)(2007-12#1)
are also found##9##3##(1990-12#1)(1994-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)
are also given for##2##4##(2008-4#2)
are also given##8##3##(2007-7#1)(2008-10#3)(2008-4#3)(2011-2#1)
are also highlighted##2##3##(2008-7#1)(2011-1#1)
are also implicated##2##3##(1991-4#1)(1996-11#1)
are also important##3##3##(1997-4#1)(2008-2#1)(2008-3#1)
are also in##2##3##(2008-3#1)(2010-5#1)
are also included##11##3##(1991-1#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-3#1)(2009-8#1)
are also increasingly##2##3##(2006-12#1)(2008-4#1)
are also investigated##9##3##(2008-10#2)(2008-2#1)(2008-3#5)(2010-6#1)
are also involved in the##5##5##(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
are also involved in##9##4##(1996-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
are also involved##10##3##(1995-2#1)(1996-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
are also known to##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
are also known##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
are also likely to be##2##5##(2008-5#1)(2013-8#1)
are also likely to##4##4##(1994-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
are also made##2##3##(2008-3#1)(2009-5#1)
are also more##3##3##(1992-2#1)(1997-4#1)(2011-2#1)
are also necessary##2##3##(2007-12#1)(2008-3#1)
are also needed##4##3##(1992-12#1)(1997-7#1)(2011-1#1)(2012-2#1)
are also not##2##3##(2007-10#1)(2008-10#1)
are also noted##2##3##(1990-3#1)(1996-11#1)
are also observed in##2##4##(2008-7#1)(2009-7#1)
are also observed##4##3##(1991-2#1)(1994-5#1)(2008-7#1)(2009-7#1)
are also of interest##2##4##(2008-10#1)(2008-11#1)
are also present in the##2##5##(2007-12#1)(2008-8#1)
are also present in##6##4##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)
are also present##9##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2012-3#1)
are also presented and##2##4##(1995-5#1)(2008-10#1)
are also presented for##4##4##(1991-2#1)(1993-8#1)(1994-12#1)(2008-5#1)
are also presented to##2##4##(2007-12#1)(2008-10#1)
are also presented##54##3##(1991-2#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-5#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#11)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)
are also proposed##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
are also provided for##5##4##(2007-9#1)(2008-4#3)(2010-10#1)
are also provided##16##3##(1991-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-9#1)(2010-10#1)(2012-2#1)
are also relevant to##2##4##(2007-11#1)(2012-2#1)
are also relevant##3##3##(2007-11#1)(2008-12#1)(2012-2#1)
are also reported in##2##4##(1990-9#1)(2008-10#1)
are also reported##13##3##(1990-5#1)(1990-9#1)(1994-12#1)(1997-4#1)(2008-10#6)(2008-11#1)(2011-1#1)(2012-2#1)
are also required##2##3##(2008-7#1)(2010-11#1)
are also reviewed##11##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)
are also seen##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
are also shown to##2##4##(2008-2#1)(2012-3#1)
are also shown##3##3##(2008-2#1)(2008-5#1)(2012-3#1)
are also simulated##3##3##(2008-2#2)(2008-3#1)
are also some##5##3##(1990-5#1)(1995-3#1)(2008-12#2)(2008-5#1)
are also stimulated##2##3##(2008-10#1)(2012-2#1)
are also studied##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
are also suggested##3##3##(2008-12#1)(2008-6#1)(2010-5#1)
are also suitable for##2##4##(1992-6#1)(2008-4#1)
are also summarized##6##3##(1991-12#1)(1996-1#1)(2008-11#2)(2008-9#1)(2012-3#1)
are also taken into account##2##5##(1991-5#1)(2008-6#1)
are also used for##2##4##(2008-10#1)(2010-8#1)
are also used to##6##4##(2008-2#1)(2008-3#3)(2008-7#2)
are also used##11##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2010-8#1)(2012-3#1)
are also useful in##5##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)
are also useful##7##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-3#1)
are also very##5##3##(1990-8#1)(1992-8#1)(2008-10#2)(2012-2#1)
are also well##2##3##(2009-12#2)
are also##634##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#7)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-6#3)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-5#1)(1997-7#4)(1997-8#1)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#11)(2007-12#15)(2007-4#2)(2007-7#6)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#76)(2008-11#32)(2008-12#9)(2008-2#35)(2008-3#58)(2008-4#55)(2008-5#12)(2008-6#4)(2008-7#26)(2008-8#13)(2008-9#21)(2009-10#1)(2009-12#5)(2009-3#4)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#15)(2011-3#3)(2011-4#1)(2011-7#1)(2012-12#8)(2012-2#9)(2012-3#14)(2013-1#11)(2013-7#1)(2013-8#6)
are altered during##2##3##(2008-3#1)(2013-1#1)
are altered in##4##3##(1993-3#1)(1996-12#1)(2008-1#1)(2008-7#1)
are altered##16##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)(2013-1#1)
are alternative##2##2##(2010-11#1)(2011-1#1)
are always present##2##3##(2007-11#1)(2011-1#1)
are always the##2##3##(1997-7#1)(2008-10#1)
are always##19##2##(1992-3#1)(1995-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
are amenable to##7##3##(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)
are amenable##8##2##(1992-9#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)
are among the highest in the world##2##7##(2008-7#1)(2010-12#1)
are among the most common##5##5##(1993-1#1)(2008-12#2)(2010-8#1)(2012-3#1)
are among the most difficult##2##5##(2008-4#1)(2008-9#1)
are among the most##20##4##(1993-1#1)(1996-3#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
are among the##42##3##(1992-11#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-9#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
are among##45##2##(1992-11#1)(1992-3#2)(1993-1#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-3#1)(1997-9#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
are amongst##2##2##(2007-12#1)(2008-11#1)
are amplified##4##2##(1995-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
are an accepted##2##3##(1994-3#1)(2008-9#1)
are an attractive alternative##2##4##(2008-10#2)
are an attractive##3##3##(2008-10#2)(2012-3#1)
are an effective##4##3##(2007-11#1)(2008-3#1)(2011-3#1)(2013-1#1)
are an essential##2##3##(1994-3#1)(2011-2#1)
are an important class of##2##5##(2008-1#1)(2012-12#1)
are an important component##2##4##(2008-7#1)(2009-9#1)
are an important part of##3##5##(2009-6#1)(2010-11#1)(2013-7#1)
are an important tool for##2##5##(2008-6#1)(2008-9#1)
are an important tool##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
are an important##23##3##(1992-3#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2012-12#1)(2013-7#1)(2013-8#1)
are an integral component##2##4##(2008-10#1)(2008-5#1)
are an integral part of a##2##6##(2008-8#1)(2010-2#1)
are an integral part of the##2##6##(1992-6#1)(2008-8#1)
are an integral part of##5##5##(1992-6#1)(2008-8#2)(2008-9#1)(2010-2#1)
are an integral##7##3##(1992-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)
are an unusual cause##2##4##(2009-8#1)(2013-8#1)
are an unusual##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
are an##72##2##(1992-3#1)(1992-6#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-6#1)(1996-3#2)(2006-12#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
are analogous to##4##3##(2008-2#1)(2008-3#2)(2012-2#1)
are analysed by##2##3##(2008-10#2)
are analysed in terms of##2##5##(2006-4#1)(2008-10#1)
are analysed in##5##3##(1990-3#1)(1991-6#1)(2006-4#1)(2008-10#2)
are analysed##18##2##(1990-3#2)(1991-6#1)(1992-3#1)(1994-2#1)(1996-2#1)(2006-4#1)(2007-6#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-11#1)
are analytically##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
are analyzed and compared##2##4##(2008-3#1)(2011-1#1)
are analyzed and discussed##2##4##(2008-3#2)
are analyzed and##10##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2011-1#1)
are analyzed by a##2##4##(2008-2#1)(2008-3#1)
are analyzed by use of the##3##6##(2007-12#1)(2008-3#2)
are analyzed by use of##4##5##(2007-12#1)(2008-3#3)
are analyzed by##16##3##(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#2)(2008-8#1)(2010-7#1)
are analyzed critically by use of a##2##7##(2008-2#2)
are analyzed for##4##3##(1993-3#1)(1995-1#1)(2008-3#2)
are analyzed in terms of the##2##6##(2007-11#1)(2008-3#1)
are analyzed in terms of##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
are analyzed in##10##3##(1991-3#1)(1993-12#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
are analyzed on the basis of##3##6##(2008-2#2)(2009-4#1)
are analyzed to determine the##2##5##(2007-12#1)(2013-1#1)
are analyzed to obtain##2##4##(1992-5#1)(2008-2#1)
are analyzed to##7##3##(1992-5#1)(1997-1#1)(2007-12#1)(2008-2#2)(2011-1#1)(2013-1#1)
are analyzed using a##2##4##(1992-11#1)(2008-10#1)
are analyzed using##5##3##(1992-11#1)(2008-10#3)(2008-8#1)
are analyzed when##2##3##(2008-3#2)
are analyzed with##3##3##(1991-3#1)(1997-2#1)(2013-1#1)
are analyzed##124##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#6)(2007-4#1)(2008-10#14)(2008-12#1)(2008-2#21)(2008-3#34)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
are anchored##2##2##(1996-5#1)(2008-12#1)
are and how they are##2##5##(2008-1#1)(2008-9#1)
are and how##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
are and will continue to##2##5##(1997-1#1)(2008-1#1)
are and##6##2##(1997-1#1)(2008-1#2)(2008-5#1)(2008-9#1)(2013-1#1)
are anomalous##2##2##(2008-6#1)(2008-9#1)
are another##2##2##(1992-12#1)(2012-1#1)
are antagonistic##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
are antibiotics##3##2##(1997-4#2)(2007-7#1)
are anticipated##4##2##(1992-1#1)(1997-3#1)(2008-11#1)(2008-9#1)
are antiemetic medications an effective adjunct to fluid and electrolyte therapy?##2##11##(2009-5#2)
are any##3##2##(1990-11#1)(2008-10#1)(2012-2#1)
are apparent##4##2##(1993-5#1)(2008-11#1)(2008-7#2)
are apparently##8##2##(1990-2#1)(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-3#1)
are appear##2##2##(2007-11#1)(2007-2#1)
are applicable to other##5##4##(1993-11#1)(2008-3#1)(2008-4#1)(2008-8#2)
are applicable to the##3##4##(2007-11#1)(2008-1#1)(2011-2#1)
are applicable to##23##3##(1993-11#1)(1993-8#1)(1995-2#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)
are applicable##25##2##(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)
are applied and##2##3##(2008-10#1)(2008-11#1)
are applied as##2##3##(2008-10#1)(2010-4#1)
are applied at##2##3##(2008-10#1)(2008-3#1)
are applied for##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
are applied in the##2##4##(2007-8#1)(2008-5#1)
are applied in##5##3##(2007-8#1)(2008-10#2)(2008-5#1)(2009-6#1)
are applied to a##2##4##(1997-4#1)(2008-4#1)
are applied to the##9##4##(1990-11#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-5#1)
are applied to##28##3##(1990-11#1)(1993-3#1)(1996-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#6)(2008-4#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)
are applied##50##2##(1990-11#1)(1991-8#1)(1993-3#1)(1996-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
are appropriate for##6##3##(1991-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-2#1)
are appropriate##12##2##(1990-5#1)(1991-1#1)(1993-3#1)(1994-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-2#1)(2011-1#1)
are appropriately##2##2##(2008-2#1)(2008-7#1)
are approved##3##2##(1997-8#1)(2008-3#1)(2011-1#1)
are approximately##17##2##(1991-9#1)(1992-5#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-12#1)
are arbitrary##2##2##(2008-2#1)(2008-3#1)
are around 0##2##3##(2007-12#1)(2008-10#1)
are around##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
are arranged in a##5##4##(1991-6#1)(1996-2#1)(2007-12#2)(2008-3#1)
are arranged in##9##3##(1991-6#1)(1996-2#1)(2007-12#2)(2008-3#3)(2008-7#1)(2012-1#1)
are arranged##14##2##(1991-6#1)(1996-2#1)(2007-12#3)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)
are artificially##2##2##(1995-2#1)(2013-8#1)
are as effective##2##3##(1997-7#1)(2008-8#1)
are as follows##12##3##(1992-10#1)(1994-5#1)(1996-2#3)(1997-7#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)
are as low as##2##4##(1993-8#1)(2008-8#1)
are as yet##2##3##(2009-9#1)(2010-12#1)
are as##37##2##(1992-10#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-2#3)(1997-7#2)(1997-8#1)(2007-11#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#2)
are asked to##3##3##(1991-12#1)(1993-1#1)(2008-7#1)
are asked##4##2##(1991-12#1)(1993-1#1)(2008-7#1)(2012-2#1)
are aspirated##2##2##(2008-10#2)
are assembled into##2##3##(1993-8#1)(2011-2#1)
are assembled##6##2##(1991-2#1)(1993-8#1)(2008-3#2)(2008-4#1)(2011-2#1)
are assessed and##2##3##(1992-1#1)(2008-10#1)
are assessed by##2##3##(2008-2#1)(2010-6#1)
are assessed for##2##3##(2008-11#1)(2008-3#1)
are assessed##17##2##(1992-1#1)(1995-11#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#1)
are assigned for##2##3##(2008-4#1)(2009-6#1)
are assigned to the##2##4##(1992-3#1)(2007-12#1)
are assigned to##6##3##(1992-3#1)(1994-6#1)(2007-12#3)(2008-12#1)
are assigned##10##2##(1992-3#1)(1993-11#1)(1994-6#1)(2007-12#3)(2008-12#1)(2008-4#1)(2009-6#1)(2012-2#1)
are associated to##2##3##(1990-2#1)(2007-8#1)
are associated with a greater##2##5##(2008-11#1)(2010-6#1)
are associated with a low##2##5##(1993-6#1)(2008-4#1)
are associated with a poor##2##5##(2011-2#1)(2012-3#1)
are associated with a##20##4##(1993-11#1)(1993-6#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
are associated with adverse##2##4##(2008-7#1)(2011-2#1)
are associated with an increased##2##5##(2008-7#1)(2009-10#1)
are associated with better##2##4##(2008-6#1)(2010-2#1)
are associated with both##2##4##(2007-12#1)(2012-12#1)
are associated with certain##2##4##(1996-2#1)(2008-11#1)
are associated with considerable##2##4##(2010-10#1)(2012-3#1)
are associated with different forms of##2##6##(1992-2#1)(2008-12#1)
are associated with different##5##4##(1992-2#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
are associated with elevated##3##4##(2008-7#3)
are associated with high##3##4##(1990-2#1)(2009-10#1)(2010-8#1)
are associated with higher##4##4##(2007-12#1)(2008-7#1)(2009-8#1)(2013-8#1)
are associated with improved##2##4##(2008-7#1)(2009-11#1)
are associated with increased##6##4##(2008-1#1)(2008-10#1)(2008-8#2)(2012-12#2)
are associated with poor prognosis##2##5##(1994-11#1)(2011-2#1)
are associated with poor##4##4##(1993-9#1)(1994-11#1)(1994-12#1)(2011-2#1)
are associated with quantitative##2##4##(2012-3#2)
are associated with risk of##2##5##(2008-11#1)(2008-12#1)
are associated with significant morbidity##2##5##(2008-7#1)(2011-2#1)
are associated with spontaneous##2##4##(2012-12#1)(2012-2#1)
are associated with the use of##2##6##(2007-12#1)(2008-10#1)
are associated with the##34##4##(1991-12#1)(1991-6#1)(1992-5#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
are associated with these##3##4##(2009-8#1)(2010-9#1)(2011-2#1)
are associated with various##2##4##(1995-2#1)(2013-8#1)
are associated with##229##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-10#5)(2007-11#2)(2007-12#6)(2007-7#2)(2008-1#2)(2008-10#17)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#21)(2008-8#8)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#8)
are associated##233##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-10#5)(2007-11#2)(2007-12#6)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#21)(2008-8#8)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#8)
are assumed to be in##2##5##(1991-8#1)(2008-2#1)
are assumed to be##10##4##(1991-8#1)(1992-6#2)(1992-9#1)(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
are assumed to reflect##2##4##(1991-2#1)(2012-2#1)
are assumed to represent##2##4##(1993-5#1)(2008-3#1)
are assumed to##19##3##(1991-2#1)(1991-8#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-5#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2010-8#2)(2012-2#1)
are assumed##22##2##(1991-2#1)(1991-8#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-5#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-8#2)(2012-2#1)
are asymptomatic and are##2##4##(2013-1#1)(2013-7#1)
are asymptomatic##8##2##(1993-1#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2013-1#2)(2013-7#1)
are at a high risk##2##5##(2010-11#1)(2013-8#1)
are at a higher risk##2##5##(2008-4#1)(2011-2#1)
are at a##12##3##(1991-5#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
are at an increased risk of##2##6##(2012-2#1)(2013-1#1)
are at an increased risk##4##5##(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
are at an##8##3##(1997-7#1)(2008-1#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
are at best only##2##4##(2009-8#1)(2011-3#1)
are at best##4##3##(1997-3#1)(2009-8#1)(2011-3#1)(2013-1#1)
are at greater risk for##2##5##(2007-10#1)(2009-8#1)
are at greater risk##4##4##(2007-10#1)(2008-8#1)(2009-8#1)(2010-10#1)
are at high risk for##4##5##(1997-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
are at high risk of##5##5##(1992-5#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-1#1)
are at high risk##10##4##(1992-5#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
are at higher risk for##3##5##(1993-1#1)(1996-3#1)(2011-2#1)
are at higher risk##6##4##(1993-1#1)(1996-3#1)(2006-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
are at increased risk for##7##5##(1990-5#1)(1994-12#1)(2008-10#1)(2008-11#2)(2010-10#1)(2013-8#1)
are at increased risk of developing##3##6##(2011-2#1)(2012-3#2)
are at increased risk of##9##5##(2006-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#2)
are at increased risk##16##4##(1990-5#1)(1994-12#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
are at least three##3##4##(1992-8#1)(1993-2#1)(2011-2#1)
are at least two##4##4##(2007-6#1)(2008-8#1)(2012-2#2)
are at least##19##3##(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
are at odds with##2##4##(1995-8#1)(2009-4#1)
are at present in##2##4##(1992-3#1)(2008-7#1)
are at present##6##3##(1991-12#1)(1992-3#1)(2008-10#2)(2008-7#2)
are at risk for developing##3##5##(2008-1#1)(2008-12#1)(2008-2#1)
are at risk for##13##4##(1990-5#1)(1991-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2011-2#1)
are at risk of##11##4##(1997-4#1)(2007-2#1)(2008-12#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
are at risk##28##3##(1990-5#1)(1990-9#1)(1991-12#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
are at the##9##3##(1990-11#1)(1990-8#1)(1991-9#1)(1994-1#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)
are at##144##2##(1990-11#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2006-5#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
are attached to a##2##4##(2008-10#1)(2009-11#1)
are attached to the cuticle##2##5##(2007-12#2)
are attached to the##8##4##(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-1#1)(2013-1#1)(2013-8#1)
are attached to##11##3##(1997-2#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2009-1#1)(2009-11#1)(2013-1#1)(2013-8#1)
are attached##16##2##(1997-2#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-11#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
are attainable##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
are attained##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
are attempting to##4##3##(1991-3#1)(1995-3#1)(2008-11#1)(2008-5#1)
are attended by##2##3##(1995-12#1)(1996-12#1)
are attracted by##2##3##(2008-10#1)(2011-2#1)
are attractive##7##2##(1994-2#1)(2008-2#1)(2008-7#2)(2010-7#1)(2011-2#2)
are attributable to##8##3##(1991-2#1)(1992-9#1)(1994-11#1)(1995-12#1)(2008-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
are attributed to different##2##4##(2008-7#1)(2013-8#1)
are attributed to the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
are attributed to##12##3##(1992-11#1)(1992-6#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
are attributes##2##2##(2008-12#1)(2010-8#1)
are automatically##12##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2010-5#1)
are autosomal##3##2##(2008-6#1)(2008-7#1)(2008-8#1)
are available and##4##3##(1997-5#1)(2009-7#1)(2010-3#1)(2013-1#1)
are available as##3##3##(1992-3#1)(2008-10#2)
are available at##2##3##(2007-12#1)(2009-12#1)
are available for managing##2##4##(2008-7#1)(2010-11#1)
are available for the##6##4##(1993-6#1)(1997-2#1)(2008-4#1)(2008-7#1)(2013-8#2)
are available for these##2##4##(2008-10#1)(2008-7#1)
are available for use in##2##5##(2007-11#1)(2012-8#1)
are available for use##3##4##(2007-11#1)(2008-10#1)(2012-8#1)
are available for##38##3##(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-8#2)
are available from##7##3##(1990-3#1)(1992-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
are available in the##5##4##(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#1)
are available in##15##3##(1993-1#1)(1994-12#1)(1997-5#1)(2008-10#5)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-10#1)
are available on the##5##4##(1995-3#1)(2008-1#1)(2008-9#1)(2011-2#2)
are available on##7##3##(1995-3#1)(1997-5#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-2#2)
are available online##2##3##(2010-12#1)(2012-3#1)
are available only##2##3##(2008-10#1)(2008-3#1)
are available to the##2##4##(2008-10#1)(2008-5#1)
are available to treat##2##4##(2007-7#1)(2008-8#1)
are available to##24##3##(1993-12#1)(1993-2#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-10#1)(2013-7#1)
are available today##3##3##(1994-1#1)(1997-2#1)(2010-12#1)
are available via the##2##4##(2008-4#1)(2008-7#1)
are available via##3##3##(2008-4#1)(2008-7#2)
are available##200##2##(1990-2#1)(1990-3#2)(1990-6#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1997-2#2)(1997-3#1)(1997-5#4)(1997-6#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#15)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
are averaged to##2##3##(1991-2#1)(2008-3#1)
are averaged##3##2##(1991-2#1)(2007-11#1)(2008-3#1)
are avirulent to##2##3##(2008-10#2)
are avirulent##3##2##(2008-10#2)(2008-9#1)
are avoided##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
are awaited##2##2##(1997-8#1)(2009-5#1)
are awaiting##2##2##(1996-5#1)(1997-7#1)
are aware of the##3##4##(2007-10#1)(2008-3#1)(2010-12#1)
are aware of##7##3##(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-2#1)
are aware##13##2##(1993-6#1)(1995-8#1)(2007-10#1)(2007-12#2)(2008-3#2)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)
are based on a single##2##5##(1997-3#1)(2009-8#1)
are based on a##14##4##(1992-2#1)(1992-3#1)(1992-5#1)(1994-12#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
are based on data##4##4##(1990-12#1)(1993-12#1)(2008-11#1)(2008-8#1)
are based on few##2##4##(2011-2#1)(2012-12#1)
are based on in vitro##2##5##(2008-10#1)(2010-11#1)
are based on the assumption that##3##6##(2008-2#1)(2008-7#1)(2009-7#1)
are based on the clinical##2##5##(2007-12#1)(2008-11#1)
are based on the concept of##2##6##(2008-2#1)(2011-2#1)
are based on the concept##4##5##(1997-4#1)(2008-2#1)(2011-2#1)(2012-2#1)
are based on the formation##3##5##(2008-10#3)
are based on the hypothesis that##2##6##(2008-11#1)(2010-8#1)
are based on the oxidation of##4##6##(2008-10#4)
are based on the use of##4##6##(2008-10#3)(2012-3#1)
are based on the##60##4##(1990-5#2)(1992-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
are based on##155##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#3)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
are based primarily on##2##4##(2008-3#1)(2008-8#1)
are based primarily##3##3##(1993-6#1)(2008-3#1)(2008-8#1)
are based upon the##2##4##(2008-12#1)(2011-1#1)
are based upon##9##3##(1991-1#1)(1996-2#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-1#1)
are based##178##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#31)(2008-11#5)(2008-12#5)(2008-2#6)(2008-3#16)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#3)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#5)(2013-8#2)
are basic##5##2##(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)
are basically identical##2##3##(2008-9#1)(2011-2#1)
are basically##5##2##(1993-11#1)(1994-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
are becoming a##3##3##(2008-10#1)(2008-4#1)(2010-11#1)
are becoming an##2##3##(2008-11#1)(2008-8#1)
are becoming available##2##3##(2008-10#1)(2008-6#1)
are becoming increasingly##7##3##(1994-6#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
are becoming more common##2##4##(2008-9#1)(2013-8#1)
are becoming more##7##3##(1992-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)(2013-8#1)
are becoming##35##2##(1991-2#1)(1992-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-2#2)(1996-8#1)(2007-4#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
are beginning to be##2##4##(2008-10#1)(2008-8#1)
are beginning to emerge##2##4##(2007-12#2)
are beginning to##10##3##(1992-1#2)(1993-2#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#2)
are beginning##11##2##(1992-1#2)(1993-2#1)(1996-2#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#2)
are being applied to both##2##5##(2006-10#1)(2010-5#1)
are being applied to##3##4##(2006-10#1)(2009-12#1)(2010-5#1)
are being applied##4##3##(2006-10#1)(2008-3#1)(2009-12#1)(2010-5#1)
are being assessed##2##3##(2008-11#1)(2011-1#1)
are being considered##3##3##(1994-11#1)(2008-1#1)(2008-7#1)
are being designed to##2##4##(2008-8#2)
are being designed##4##3##(1991-12#1)(2008-4#1)(2008-8#2)
are being developed and##2##4##(2008-10#1)(2008-7#1)
are being developed for##2##4##(2008-5#1)(2008-6#1)
are being developed that##2##4##(1994-12#1)(2011-1#1)
are being developed to##4##4##(2007-9#1)(2008-7#1)(2009-12#1)(2012-2#1)
are being developed##16##3##(1992-3#1)(1994-12#1)(1994-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)
are being discussed##2##3##(2008-12#1)(2013-1#1)
are being elucidated##4##3##(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
are being evaluated in a##2##5##(2007-10#1)(2008-5#1)
are being evaluated in##3##4##(2007-10#1)(2008-5#1)(2013-1#1)
are being evaluated##5##3##(2007-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
are being exploited##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
are being explored as##2##4##(2008-11#1)(2010-4#1)
are being explored##4##3##(2008-11#1)(2009-12#1)(2010-4#1)(2010-7#1)
are being identified##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
are being increasingly recognized as##2##5##(2007-7#1)(2008-9#1)
are being increasingly##5##3##(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)
are being investigated for##2##4##(2008-5#1)(2010-12#1)
are being investigated in##2##4##(2008-4#1)(2012-3#1)
are being investigated##7##3##(1996-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-3#1)
are being made to##2##4##(1992-12#1)(2008-5#1)
are being made##4##3##(1992-12#1)(1995-1#1)(2008-1#1)(2008-5#1)
are being opened##2##3##(1995-6#1)(1997-8#1)
are being performed##2##3##(2010-1#1)(2013-1#1)
are being planned##2##3##(2008-1#1)(2009-6#1)
are being produced##2##3##(2008-3#1)(2008-9#1)
are being reported##4##3##(2007-7#1)(2008-5#1)(2010-3#1)(2012-12#1)
are being studied and used to##2##6##(1994-2#1)(1994-5#1)
are being studied and##3##4##(1994-2#1)(1994-5#1)(2008-7#1)
are being studied##4##3##(1994-2#1)(1994-5#1)(2008-5#1)(2008-7#1)
are being taken##2##3##(2008-4#1)(2009-3#1)
are being tested##4##3##(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
are being treated##3##3##(1997-1#1)(2008-4#1)(2011-1#1)
are being undertaken##2##3##(1995-5#1)(2010-11#1)
are being used as##2##4##(1990-9#1)(2011-2#1)
are being used in##4##4##(2007-12#1)(2010-8#1)(2012-2#2)
are being used to##6##4##(1997-6#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
are being used##17##3##(1990-9#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
are being##177##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#4)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#6)(2008-10#6)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#12)(2008-5#11)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#4)(2009-12#3)(2009-3#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
are believed to be a##2##5##(2008-3#1)(2011-2#1)
are believed to be the##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
are believed to be##13##4##(1992-10#1)(1994-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#1)
are believed to play##2##4##(1991-9#1)(2008-11#1)
are believed to##27##3##(1990-8#1)(1991-3#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)
are below the##2##3##(2008-10#2)
are below##7##2##(1993-9#1)(2008-10#4)(2008-3#2)
are beneficial for##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
are beneficial in the##2##4##(2008-5#1)(2010-10#1)
are beneficial to##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
are beneficial##12##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#3)
are benign neoplasms##2##3##(1991-2#1)(2009-3#1)
are benign tumors##2##3##(2008-8#1)(2012-3#1)
are benign##11##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are best depicted##2##3##(2008-7#2)
are best explained##2##3##(2008-10#1)(2009-6#1)
are best for##2##3##(1995-9#1)(2008-3#1)
are best suited for##3##4##(1990-11#1)(2008-4#1)(2008-9#1)
are best##26##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
are better prepared to##2##4##(1993-2#1)(2013-7#1)
are better suited##3##3##(1991-12#1)(2008-3#1)(2010-9#1)
are better than the##2##4##(2007-11#1)(2012-2#1)
are better than those obtained by##2##6##(2008-11#1)(2008-7#1)
are better than those##4##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)
are better than##9##3##(1995-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
are better##28##2##(1991-12#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
are between 0##2##3##(2008-10#1)(2008-2#1)
are between##12##2##(1996-12#1)(2008-10#7)(2008-2#2)(2008-6#1)(2008-9#1)
are beyond the##2##3##(2007-12#1)(2008-5#1)
are biased##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
are bilateral##2##2##(2007-12#1)(2008-10#1)
are binding##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
are bioactive##2##2##(2008-12#1)(2013-8#1)
are biologically and genetically distinct##2##5##(2008-8#2)
are biologically##11##2##(1992-12#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-3#1)
are biotransformed##2##2##(1993-8#1)(1995-3#1)
are blocked by##5##3##(1992-6#1)(1994-12#1)(1994-2#1)(2008-4#2)
are blocked##6##2##(1992-6#1)(1994-12#1)(1994-2#1)(2008-1#1)(2008-4#2)
are born in##2##3##(1996-5#1)(1997-6#1)
are born##5##2##(1990-6#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-11#1)
are both highly##2##3##(1994-2#1)(2011-2#1)
are both in##2##3##(1996-7#1)(2008-7#1)
are both located##2##3##(1992-8#1)(2008-10#1)
are both##56##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
are bound by##2##3##(1990-12#1)(2008-9#1)
are bound to the##3##4##(2008-4#2)(2008-9#1)
are bound to##9##3##(1994-11#1)(2008-10#1)(2008-4#4)(2008-7#1)(2008-9#1)(2011-2#1)
are bound##15##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-5#1)(1994-11#1)(2008-10#2)(2008-4#4)(2008-7#1)(2008-9#2)(2011-2#1)
are bounded##2##2##(2008-3#1)(2011-2#1)
are bridged by##2##3##(1997-7#2)
are briefly described##8##3##(1991-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)
are briefly discussed##10##3##(1990-9#1)(1992-6#1)(1993-8#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)
are briefly presented##2##3##(1996-3#1)(2008-3#1)
are briefly reviewed and##2##4##(2008-11#1)(2010-8#1)
are briefly reviewed##6##3##(1991-12#1)(1996-11#1)(1996-7#1)(2008-11#1)(2008-2#1)(2010-8#1)
are briefly summarized##3##3##(1995-12#1)(2008-10#1)(2009-6#1)
are briefly##33##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-6#1)(2009-9#1)(2010-8#1)
are broadened##2##2##(1994-5#1)(2008-10#1)
are broadly##4##2##(2007-7#1)(2008-12#1)(2008-9#1)(2010-12#1)
are brought in##2##3##(2008-10#1)(2008-11#1)
are brought into contact with##2##5##(2008-7#1)(2009-5#1)
are brought to bear on the##2##6##(1992-1#1)(1994-2#1)
are brought to##4##3##(1992-1#1)(1994-2#1)(2008-10#1)(2008-3#1)
are brought##11##2##(1992-1#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2012-2#1)
are built##7##2##(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-4#1)
are bulky##2##2##(2008-3#2)
are buried##2##2##(1992-3#1)(2007-11#1)
are but##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
are by far the##2##4##(2007-12#1)(2008-3#1)
are by far##3##3##(2007-12#1)(2008-3#2)
are by no means##2##4##(1996-5#1)(2008-3#1)
are by##7##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-9#1)
are ca##4##2##(2008-10#4)
are calculated and##3##3##(2008-1#1)(2008-3#2)
are calculated as##2##3##(2008-3#1)(2009-11#1)
are calculated by use of##3##5##(2008-3#3)
are calculated by##5##3##(2007-11#1)(2008-3#3)(2010-2#1)
are calculated for a##2##4##(2008-2#2)
are calculated for##11##3##(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)
are calculated from the##3##4##(1995-2#1)(2007-11#1)(2008-2#1)
are calculated from##8##3##(1995-2#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#2)
are calculated to##3##3##(2008-10#2)(2008-3#1)
are calculated using##3##3##(1994-12#1)(2008-7#1)(2011-1#1)
are calculated with##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
are calculated##62##2##(1993-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#10)(2008-3#25)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
are called##9##2##(1994-11#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)
are candidate##2##2##(1994-8#1)(1995-2#1)
are candidates for the##3##4##(1990-11#1)(1993-9#1)(1995-12#1)
are candidates for##8##3##(1990-11#1)(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#1)
are candidates##9##2##(1990-11#1)(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-4#1)
are capable of causing##4##4##(1993-9#1)(1994-11#1)(2006-6#1)(2008-11#1)
are capable of converting##2##4##(1994-11#1)(2008-5#1)
are capable of differentiating into##2##5##(2008-9#2)
are capable of generating##3##4##(2008-1#1)(2008-10#1)(2010-2#1)
are capable of measuring##2##4##(2008-10#1)(2008-3#1)
are capable of##61##3##(1990-11#1)(1990-2#2)(1992-12#1)(1992-9#4)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)
are capable##63##2##(1990-11#1)(1990-2#3)(1992-12#1)(1992-9#4)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)
are captured on##2##3##(2007-12#1)(2008-4#1)
are captured##3##2##(2007-12#1)(2008-4#1)(2008-7#1)
are carcinogenic##2##2##(2008-10#1)(2008-12#1)
are cardinal##2##2##(1996-2#1)(1997-6#1)
are carefully##8##2##(1991-5#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
are caring for##2##3##(2010-11#1)(2012-3#1)
are carried by##2##3##(1990-12#1)(1995-6#1)
are carried in##2##3##(2008-10#1)(2013-8#1)
are carried out in##4##4##(2008-10#3)(2009-12#1)
are carried out on##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
are carried out to demonstrate##2##5##(2007-12#1)(2010-11#1)
are carried out to##4##4##(2007-12#1)(2008-3#2)(2010-11#1)
are carried out with##3##4##(2008-10#3)
are carried out##28##3##(1994-5#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#3)(2008-3#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-12#1)(2013-1#1)
are carried##35##2##(1990-12#1)(1994-5#1)(1995-6#1)(1996-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#12)(2008-2#3)(2008-3#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
are catalytically##3##2##(1992-3#2)(2008-7#1)
are categorized as##2##3##(1992-1#1)(2008-10#1)
are categorized##4##2##(1991-11#1)(1992-1#1)(1995-3#1)(2008-10#1)
are causal##2##2##(2009-6#1)(2012-12#1)
are causally##2##2##(2013-1#2)
are caused by a##3##4##(1990-11#1)(1997-3#1)(2010-12#1)
are caused by the##2##4##(2007-11#1)(2011-2#1)
are caused by##37##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-9#1)(1994-11#1)(1994-5#1)(1997-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
are caused##40##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-9#1)(1994-11#1)(1994-5#1)(1997-3#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
are cellular##2##2##(2006-10#1)(2011-2#1)
are centered on##2##3##(2010-3#1)(2013-1#1)
are central to many##2##4##(1995-2#1)(2009-12#1)
are central to the##2##4##(2008-10#1)(2008-11#1)
are central to##12##3##(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-1#1)
are central##16##2##(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-12#1)
are certain##7##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
are challenged by##3##3##(1996-3#1)(1996-6#1)(2010-7#1)
are challenged to##5##3##(1990-6#1)(1995-12#1)(2008-12#1)(2010-12#1)(2010-3#1)
are challenged with##2##3##(2008-12#1)(2013-8#1)
are challenged##11##2##(1990-6#1)(1993-6#1)(1995-12#1)(1996-3#1)(1996-6#1)(2008-12#2)(2010-12#1)(2010-3#1)(2010-7#1)(2013-8#1)
are challenging##2##2##(2009-8#1)(2012-3#1)
are changed##3##2##(1994-5#1)(2008-2#2)
are changes in##2##3##(2008-10#1)(2008-4#1)
are changes##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
are changing our##2##3##(2008-4#1)(2012-2#1)
are changing##8##2##(1996-2#2)(1997-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
are characterised by##7##3##(2007-12#1)(2008-1#1)(2008-10#3)(2009-8#1)(2012-2#1)
are characterised##8##2##(2007-12#1)(2008-1#1)(2008-10#4)(2009-8#1)(2012-2#1)
are characteristic for##4##3##(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)
are characteristic of the##3##4##(1992-9#1)(1996-3#1)(2008-2#1)
are characteristic of##15##3##(1992-9#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)
are characteristic##23##2##(1992-9#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-3#1)
are characteristics of##4##3##(1991-12#1)(2008-10#2)(2008-11#1)
are characteristics##6##2##(1991-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
are characterized as##2##3##(2008-2#1)(2008-9#1)
are characterized by a##11##4##(1993-9#1)(1994-2#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)
are characterized by an##2##4##(2008-1#1)(2008-7#1)
are characterized by high##2##4##(2008-3#1)(2010-5#1)
are characterized by the##6##4##(1992-12#1)(1992-3#1)(1997-1#1)(2007-12#1)(2008-3#1)(2013-1#1)
are characterized by their##3##4##(1992-3#1)(2008-3#1)(2010-10#1)
are characterized by##67##3##(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#6)(2008-8#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#2)
are characterized in terms of##3##5##(1996-2#1)(2007-8#1)(2008-2#1)
are characterized in##5##3##(1996-2#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-9#1)
are characterized with##2##3##(2008-10#1)(2008-8#1)
are characterized##81##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
are checked##3##2##(2008-10#1)(2008-3#2)
are chemically and##2##3##(2007-11#1)(2008-10#1)
are chemically similar##2##3##(2008-10#2)
are chemically##7##2##(1992-8#1)(2007-11#1)(2008-10#4)(2008-11#1)
are chlorinated to avoid excessive biofouling##2##6##(2008-10#2)
are chosen##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
are chronically infected with##2##4##(2009-7#1)(2013-1#1)
are chronically infected##3##3##(2009-5#1)(2009-7#1)(2013-1#1)
are chronically##4##2##(2006-10#1)(2009-5#1)(2009-7#1)(2013-1#1)
are claimed##2##2##(1991-11#1)(2008-8#1)
are clarified##2##2##(1993-12#1)(2007-12#1)
are classically##2##2##(2011-2#1)(2012-3#1)
are classified according to the##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
are classified according to##4##4##(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
are classified as##9##3##(1995-1#1)(1996-6#1)(2008-10#2)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
are classified into##4##3##(1997-6#1)(2008-6#1)(2010-12#1)(2011-2#1)
are classified##21##2##(1995-1#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#1)
are clear##4##2##(1995-1#1)(2010-3#1)(2013-8#2)
are cleared##2##2##(1995-8#1)(2010-3#1)
are clearly##26##2##(1990-5#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-3#2)(1994-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
are clinical##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2013-1#1)
are clinically and##2##3##(2011-1#1)(2011-2#1)
are clinically significant##2##3##(2010-8#1)(2011-1#1)
are clinically##16##2##(1994-9#1)(1995-11#1)(1997-1#1)(2006-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#2)
are clonal##2##2##(2008-10#2)
are close enough to DNA##2##5##(1991-8#2)
are close enough to##3##4##(1991-8#2)(1994-5#1)
are close relatives##2##3##(2008-10#1)(2008-9#1)
are close to the##2##4##(2007-11#1)(2007-12#1)
are close to##7##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)
are close together##3##3##(2006-4#1)(2008-3#1)(2012-2#1)
are close##16##2##(1991-8#2)(1994-5#1)(1996-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-9#1)(2012-2#1)
are closed##2##2##(1993-11#1)(2008-11#1)
are closely associated with the##3##5##(2008-10#2)(2008-9#1)
are closely associated with##4##4##(2008-10#2)(2008-9#1)(2009-6#1)
are closely linked##2##3##(2008-10#1)(2008-4#1)
are closely related to the##5##5##(1990-11#1)(1991-8#1)(2007-12#2)(2013-1#1)
are closely related to##13##4##(1990-11#1)(1991-8#1)(1996-12#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
are closely related##20##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-3#1)(1995-6#1)(1996-12#1)(2007-12#3)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
are closely##33##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
are clustered in the##2##4##(1997-6#1)(2008-10#1)
are clustered in##5##3##(1990-5#1)(1993-9#1)(1997-6#1)(2008-10#1)(2012-3#1)
are clustered##11##2##(1990-5#1)(1993-9#1)(1994-11#1)(1996-10#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
are coated with##2##3##(2008-2#1)(2010-8#1)
are coated##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
are coexpressed in##3##3##(1994-8#1)(2008-4#1)(2009-6#1)
are coherent with##2##3##(2007-11#1)(2008-3#1)
are coherent##3##2##(2007-11#1)(2008-3#2)
are coincident##2##2##(1990-7#1)(2009-10#1)
are coinfected with##2##3##(2006-10#1)(2011-2#1)
are collagens##2##2##(1994-12#1)(2008-11#1)
are collected and##3##3##(2007-5#1)(2008-10#2)
are collected at##3##3##(2008-1#1)(2008-10#1)(2009-9#1)
are collected by##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
are collected from##2##3##(1993-5#1)(2007-5#1)
are collected in this review##2##5##(2008-10#2)
are collected in this##3##4##(2007-5#1)(2008-10#2)
are collected in##5##3##(2007-5#1)(2008-10#4)
are collected on##2##3##(2008-10#1)(2013-8#1)
are collected##28##2##(1993-12#1)(1993-5#1)(1996-3#1)(2007-12#1)(2007-5#4)(2008-1#1)(2008-10#10)(2008-3#1)(2008-8#2)(2008-9#3)(2009-9#1)(2011-2#1)(2013-8#1)
are collectively##3##2##(1991-11#1)(2011-2#2)
are combinations of two##2##4##(1992-12#1)(2007-11#1)
are combined in one##2##4##(1992-9#1)(2008-10#1)
are combined in##4##3##(1991-2#1)(1992-9#1)(2008-10#1)(2008-12#1)
are combined to##4##3##(2007-11#1)(2008-3#2)(2009-11#1)
are combined with##6##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)
are combined##24##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#4)(2008-7#1)(2009-11#2)
are comfortable with##2##3##(1995-3#1)(1997-2#1)
are comfortable##3##2##(1995-3#1)(1996-3#1)(1997-2#1)
are coming##7##2##(1992-2#1)(1992-5#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
are commented##2##2##(1991-8#1)(2008-8#1)
are commercially available##4##3##(1996-5#1)(2008-10#2)(2010-8#1)
are commercially##6##2##(1996-5#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-2#1)
are committed to##5##3##(1991-3#1)(1992-1#1)(1994-2#1)(2012-2#1)(2012-3#1)
are committed##6##2##(1991-3#1)(1992-1#1)(1994-2#1)(2008-4#1)(2012-2#1)(2012-3#1)
are common among##2##3##(2008-4#1)(2009-11#1)
are common and##12##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
are common complications##2##3##(1991-2#1)(1992-2#1)
are common features of##2##4##(1996-10#1)(2008-6#1)
are common in children and##2##5##(2011-2#1)(2013-7#1)
are common in patients##2##4##(2008-7#1)(2009-5#1)
are common in the##3##4##(2008-7#1)(2009-12#1)(2010-12#1)
are common in##28##3##(1991-11#1)(1996-12#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
are common symptoms##2##3##(1996-6#1)(2008-6#1)
are common to both##3##4##(1991-5#1)(2008-10#1)(2012-2#1)
are common to##8##3##(1991-5#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
are common##100##2##(1991-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
are commonly considered as##2##4##(2012-7#1)(2013-8#1)
are commonly encountered in##3##4##(2007-7#1)(2008-10#1)(2011-2#1)
are commonly found in the##2##5##(2008-10#1)(2011-2#1)
are commonly found in##3##4##(2008-10#2)(2011-2#1)
are commonly found##5##3##(2008-10#2)(2008-5#1)(2011-2#1)(2013-7#1)
are commonly measured##2##3##(2008-3#1)(2013-3#1)
are commonly prescribed##2##3##(2007-11#1)(2012-12#1)
are commonly present##2##3##(2007-6#1)(2008-11#1)
are commonly seen in##2##4##(2007-12#1)(2008-10#1)
are commonly used as##4##4##(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)
are commonly used for##3##4##(2008-10#1)(2010-1#1)(2011-2#1)
are commonly used in the analysis of##2##7##(2008-4#1)(2008-6#1)
are commonly used in the##5##5##(1997-8#1)(2008-10#1)(2008-4#2)(2008-6#1)
are commonly used in##11##4##(1995-12#1)(1997-8#1)(2007-7#2)(2008-10#1)(2008-4#3)(2008-6#1)(2009-3#1)(2011-1#1)
are commonly used to##7##4##(1995-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2012-5#1)
are commonly used##29##3##(1995-1#1)(1995-12#1)(1997-8#1)(2007-7#2)(2008-10#6)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-5#1)
are commonly##77##2##(1991-2#2)(1991-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#2)(2013-3#1)(2013-7#1)(2013-8#1)
are commonplace in##3##3##(2008-2#1)(2008-7#1)(2010-10#1)
are commonplace##4##2##(2008-2#1)(2008-7#1)(2010-10#1)(2011-1#1)
are communicated via##2##3##(1991-5#2)
are communicated##5##2##(1990-8#1)(1991-5#2)(2008-1#1)(2008-7#1)
are compact and##2##3##(1994-2#1)(2007-11#1)
are comparable in##2##3##(1993-11#1)(2012-2#1)
are comparable to the##2##4##(2008-10#1)(2008-2#1)
are comparable to those obtained in##2##6##(2007-8#1)(2008-10#1)
are comparable to those obtained##3##5##(2007-8#1)(2008-10#2)
are comparable to those of##2##5##(2007-12#1)(2008-10#1)
are comparable to those##7##4##(2007-12#1)(2007-8#1)(2008-10#5)
are comparable to##17##3##(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-8#2)(2010-6#1)
are comparable with the##2##4##(2008-3#2)
are comparable with those of##2##5##(2007-12#1)(2008-7#1)
are comparable with those##4##4##(1991-2#1)(1991-3#1)(2007-12#1)(2008-7#1)
are comparable with##8##3##(1991-2#1)(1991-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-1#1)
are comparable##36##2##(1991-2#1)(1991-3#1)(1993-11#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#3)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
are comparatively##2##2##(2008-3#1)(2008-5#1)
are compared and contrasted##4##4##(1996-6#1)(2008-10#2)(2008-3#1)
are compared and##8##3##(1996-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-2#1)
are compared at##2##3##(1992-3#1)(2008-10#1)
are compared based on##2##4##(2007-12#1)(2010-8#1)
are compared by##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
are compared for the##3##4##(1996-5#1)(2008-3#1)(2008-7#1)
are compared for##9##3##(1995-2#1)(1996-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)
are compared in a##3##4##(1995-9#1)(2007-12#1)(2008-5#1)
are compared in terms of##3##5##(1996-5#1)(2008-10#1)(2008-3#1)
are compared in##8##3##(1991-2#1)(1995-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
are compared over time##2##4##(1990-12#1)(1991-2#1)
are compared to other##2##4##(2007-12#1)(2011-2#1)
are compared to previous##2##4##(1991-8#1)(1993-8#1)
are compared to the##4##4##(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
are compared to those obtained with##2##6##(2008-10#2)
are compared to those##6##4##(1994-5#1)(2008-10#3)(2012-12#2)
are compared to##27##3##(1991-8#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
are compared using##3##3##(2008-1#1)(2008-10#1)(2008-6#1)
are compared with a##7##4##(2007-12#2)(2008-3#3)(2008-9#1)(2009-3#1)
are compared with experimental data##5##5##(2008-10#1)(2008-2#3)(2008-3#1)
are compared with experimental results##2##5##(2008-3#2)
are compared with experimental##9##4##(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)
are compared with measurements##2##4##(2008-2#1)(2008-3#1)
are compared with predictions##4##4##(2008-2#1)(2008-3#3)
are compared with previously##2##4##(2007-12#1)(2008-2#1)
are compared with results##2##4##(2008-3#2)
are compared with similar##2##4##(2007-12#1)(2008-11#1)
are compared with that of##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
are compared with that##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
are compared with the findings##2##5##(1991-2#1)(2008-11#1)
are compared with the measured##2##5##(2008-2#1)(2008-3#1)
are compared with the parabolic##2##5##(2007-11#1)(2008-3#1)
are compared with the predictions##2##5##(2007-12#1)(2008-3#1)
are compared with the results of##3##6##(2008-3#3)
are compared with the results##4##5##(2008-10#1)(2008-3#3)
are compared with the standard##2##5##(2008-10#1)(2008-3#1)
are compared with the##38##4##(1991-2#1)(1992-1#1)(1993-6#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#17)(2009-5#1)
are compared with their##2##4##(1992-8#1)(2008-10#1)
are compared with theoretical calculations##2##5##(2008-3#2)
are compared with theoretical results##2##5##(2008-3#2)
are compared with theoretical##8##4##(2008-2#1)(2008-3#7)
are compared with those determined by##2##6##(2008-10#1)(2008-3#1)
are compared with those determined##3##5##(2008-10#2)(2008-3#1)
are compared with those obtained by##4##6##(2008-10#1)(2008-3#3)
are compared with those obtained with a##2##7##(2008-2#1)(2008-3#1)
are compared with those obtained with##4##6##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
are compared with those obtained##15##5##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#6)
are compared with those of##8##5##(1996-7#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)
are compared with those##39##4##(1996-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#10)(2008-2#4)(2008-3#15)(2008-5#1)(2008-6#1)(2009-7#1)
are compared with##152##3##(1991-2#1)(1992-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-8#1)(2007-11#5)(2007-12#10)(2008-10#20)(2008-11#3)(2008-2#23)(2008-3#66)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-7#1)
are compared##254##2##(1990-12#1)(1991-2#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-8#1)(2007-11#5)(2007-12#17)(2008-1#1)(2008-10#42)(2008-11#5)(2008-12#1)(2008-2#32)(2008-3#85)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#3)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#2)
are compartmentalized##2##2##(2008-7#1)(2009-8#1)
are compatible with the##8##4##(1990-5#1)(1990-7#1)(1991-2#1)(1993-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
are compatible with##20##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
are compatible##22##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
are compelling##2##2##(2010-7#1)(2012-12#1)
are compensated for by##2##4##(2008-3#1)(2013-1#1)
are compensated##5##2##(1995-1#1)(2008-3#2)(2008-7#1)(2013-1#1)
are competent##2##2##(1992-3#1)(2008-1#1)
are competing##3##2##(1995-2#1)(1996-1#1)(2009-8#1)
are competitive inhibitors of the##2##5##(1995-5#2)
are competitive inhibitors of##3##4##(1995-5#3)
are competitive##5##2##(1991-1#1)(1995-5#3)(2008-10#1)
are compiled##2##2##(1993-2#1)(2008-10#1)
are complementary and##3##3##(1990-3#1)(2008-8#1)(2012-3#1)
are complementary to the##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
are complementary##14##2##(1990-3#1)(1995-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
are completed##4##2##(1995-12#1)(1997-6#1)(2007-12#1)(2008-3#1)
are completely blocked##2##3##(1994-8#1)(2008-10#1)
are completely##15##2##(1992-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)
are complex and##3##3##(1996-3#2)(2008-9#1)
are complex##17##2##(1991-12#1)(1993-11#1)(1995-1#1)(1995-5#1)(1996-3#2)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
are complexed with##4##3##(2008-10#4)
are complicated and time consuming##2##5##(2008-12#1)(2008-8#1)
are complicated by the##3##4##(1994-9#1)(1997-3#1)(2008-8#1)
are complicated by##5##3##(1991-6#1)(1994-9#1)(1997-3#1)(2008-2#1)(2008-8#1)
are complicated##7##2##(1991-6#1)(1994-9#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-8#2)
are components of##2##3##(1991-1#1)(2011-2#1)
are composed of both##2##4##(2008-10#2)
are composed of##20##3##(1993-2#1)(1993-8#1)(1994-12#1)(1996-4#1)(1997-4#1)(2007-12#5)(2008-10#3)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-12#1)
are composed##21##2##(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-4#1)(2007-12#5)(2008-10#3)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-12#1)
are comprehensive and provide a resource for readers seeking further information##2##11##(2007-5#2)
are comprehensive##3##2##(1996-3#1)(2007-5#2)
are compressed##4##2##(1991-3#1)(1992-12#1)(2007-11#1)(2007-12#1)
are comprised of##4##3##(2008-9#2)(2012-2#2)
are comprised##5##2##(2008-10#1)(2008-9#2)(2012-2#2)
are compromised by##2##3##(2008-5#1)(2009-11#1)
are compromised##4##2##(2008-10#2)(2008-5#1)(2009-11#1)
are computationally##3##2##(2008-6#1)(2008-7#1)(2012-2#1)
are computed by##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
are computed from##3##3##(1990-11#1)(2008-3#1)(2008-6#1)
are computed##14##2##(1990-11#1)(2007-11#1)(2008-2#1)(2008-3#6)(2008-6#4)(2009-3#1)
are conceived to##2##3##(2008-11#2)
are concentrated in the##2##4##(1993-11#1)(1993-6#1)
are concentrated in##4##3##(1993-11#1)(1993-6#1)(2008-7#1)(2009-10#1)
are concentrated to##2##3##(2008-10#2)
are concentrated##12##2##(1992-11#1)(1993-11#1)(1993-5#1)(1993-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)
are concerned about##6##3##(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-5#1)(2008-12#1)
are concerned that##2##3##(1996-2#1)(2008-1#1)
are concerned with the##3##4##(1992-3#1)(1995-6#1)(2007-12#1)
are concerned with##7##3##(1992-3#1)(1994-3#1)(1995-6#1)(2007-12#2)(2008-11#1)(2009-12#1)
are concerned##25##2##(1990-3#1)(1990-6#1)(1991-2#2)(1991-9#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-1#1)(2012-2#1)(2013-1#1)
are concerns##6##2##(1997-1#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-6#1)(2012-3#1)
are concomitant##2##2##(1997-5#1)(2007-10#1)
are conducive to##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
are conducted to##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
are conducted##13##2##(1992-12#1)(1994-7#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
are confined to a##2##4##(2007-7#1)(2008-3#1)
are confined to##5##3##(1992-3#1)(1993-9#1)(2007-7#1)(2008-3#1)(2008-7#1)
are confined##7##2##(1992-3#1)(1993-9#1)(1996-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)
are confirmed by##3##3##(2008-10#1)(2008-2#2)
are confirmed in##2##3##(2008-10#1)(2012-3#1)
are confirmed##11##2##(1993-11#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
are conflicting and##2##3##(2007-7#1)(2013-1#1)
are conflicting##3##2##(2007-7#1)(2008-5#1)(2013-1#1)
are confronted with##2##3##(2007-11#1)(2009-7#1)
are confronted##4##2##(1996-2#1)(2007-11#1)(2008-11#1)(2009-7#1)
are congenital##2##2##(1997-8#1)(2010-8#1)
are congruent with those of##2##5##(2008-8#2)
are congruent with##3##3##(2008-8#3)
are connected by##5##3##(1993-11#1)(2007-11#1)(2008-7#1)(2010-10#1)(2013-1#1)
are connected to##5##3##(2007-12#1)(2008-2#1)(2008-9#2)(2012-5#1)
are connected with the##2##4##(2009-8#1)(2012-12#1)
are connected with##7##3##(1991-9#1)(1996-4#1)(1997-3#1)(2007-11#1)(2009-8#1)(2012-1#1)(2012-12#1)
are connected##19##2##(1991-9#1)(1993-11#1)(1995-1#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-7#1)
are consecutively##2##2##(2008-10#1)(2010-12#1)
are conservative##2##2##(1992-2#1)(1993-12#1)
are conserved among the##2##4##(1996-8#1)(2008-5#1)
are conserved among##4##3##(1996-8#1)(2007-12#1)(2008-5#1)(2010-9#1)
are conserved between##2##3##(1992-8#1)(2010-9#1)
are conserved in iso I##3##5##(1992-8#3)
are conserved in the##2##4##(1994-11#1)(1995-8#1)
are conserved in##9##3##(1992-8#3)(1993-12#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-7#1)(2010-4#1)
are conserved##22##2##(1992-8#4)(1993-12#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-9#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-9#2)(2012-2#1)
are considerable##6##2##(1997-8#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-4#1)(2013-8#1)
are considerably different from##2##4##(1994-12#1)(2008-5#1)
are considerably less##2##3##(2008-10#1)(2011-2#1)
are considerably more##2##3##(2008-10#1)(2008-2#1)
are considerably##9##2##(1992-3#1)(1994-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)
are considered a##4##3##(1994-9#1)(2008-12#1)(2009-4#1)(2013-1#1)
are considered and##2##3##(2008-10#1)(2008-7#1)
are considered as a##2##4##(2008-3#1)(2012-3#1)
are considered as the##3##4##(1996-7#1)(1997-8#1)(2008-10#1)
are considered as##18##3##(1991-6#1)(1996-7#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
are considered for the##2##4##(2008-3#2)
are considered for##3##3##(2008-3#3)
are considered important in##2##4##(1994-3#1)(2008-10#1)
are considered in detail##2##4##(2007-4#1)(2008-10#1)
are considered in relation to##3##5##(2007-12#1)(2008-10#2)
are considered in the light of##2##6##(1993-3#1)(2008-7#1)
are considered in the##5##4##(1993-3#1)(2008-3#2)(2008-7#1)(2012-2#1)
are considered in##13##3##(1993-3#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)
are considered normal##2##3##(2008-5#1)(2010-1#1)
are considered the most important##2##5##(2008-10#1)(2008-5#1)
are considered the##6##3##(2007-7#1)(2008-10#3)(2008-5#1)(2010-1#1)
are considered to be a##2##5##(1990-11#1)(2008-9#1)
are considered to be important##2##5##(1994-8#1)(1995-6#1)
are considered to be the##2##5##(1994-6#1)(2007-11#1)
are considered to be##25##4##(1990-11#1)(1992-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
are considered to##30##3##(1990-11#1)(1991-3#1)(1992-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
are considered while##2##3##(2009-11#1)(2013-8#1)
are considered##211##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#4)(2008-2#10)(2008-3#35)(2008-4#1)(2008-5#7)(2008-7#10)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#3)
are considering##3##2##(1993-2#1)(2007-11#1)(2008-11#1)
are consistent with a gene-for-gene##2##5##(2008-10#2)
are consistent with a model in which##3##7##(1990-2#1)(1992-2#1)(2008-10#1)
are consistent with a model##5##5##(1990-2#1)(1992-2#1)(1992-6#1)(2007-1#1)(2008-10#1)
are consistent with a role in##2##6##(2009-10#1)(2012-3#1)
are consistent with a role##3##5##(1990-3#1)(2009-10#1)(2012-3#1)
are consistent with a##27##4##(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-1#1)(2008-10#7)(2008-11#1)(2009-10#1)(2009-12#1)(2009-5#1)(2012-3#1)
are consistent with an earlier##2##5##(1991-5#1)(2008-10#1)
are consistent with an##6##4##(1991-5#1)(1992-3#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-2#1)
are consistent with current##2##4##(2008-3#1)(2008-4#1)
are consistent with earlier##2##4##(1992-10#1)(2008-10#1)
are consistent with numerical##2##4##(2007-11#1)(2007-12#1)
are consistent with other studies##2##5##(1997-9#1)(2008-12#1)
are consistent with other##4##4##(1996-12#1)(1997-9#1)(2008-12#1)(2008-6#1)
are consistent with previous findings##2##5##(1994-8#1)(2011-2#1)
are consistent with previous reports##2##5##(2008-8#1)(2012-3#1)
are consistent with previous##9##4##(1992-9#1)(1994-8#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
are consistent with the concept that##2##6##(1992-3#1)(1992-6#1)
are consistent with the concept##3##5##(1992-3#1)(1992-6#1)(1997-1#1)
are consistent with the conclusion that##2##6##(1991-12#1)(1996-5#1)
are consistent with the existence##2##5##(1994-8#1)(2008-8#1)
are consistent with the formation of##2##6##(2007-12#1)(2008-5#1)
are consistent with the hypothesis that the##6##7##(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2012-1#1)
are consistent with the hypothesis that##19##6##(1992-12#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#3)(2008-8#2)(2010-12#1)(2012-1#1)(2013-1#1)
are consistent with the hypothesis##20##5##(1992-12#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#3)(2008-8#2)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
are consistent with the idea that##5##6##(1990-10#1)(1990-11#1)(1991-9#1)(1995-3#1)(2008-10#1)
are consistent with the idea##6##5##(1990-10#1)(1990-11#1)(1991-9#1)(1995-3#1)(2008-10#2)
are consistent with the involvement of the##2##7##(1995-11#1)(2008-8#1)
are consistent with the involvement of##3##6##(1994-3#1)(1995-11#1)(2008-8#1)
are consistent with the model##2##5##(1991-1#1)(2012-3#1)
are consistent with the notion that##4##6##(1990-8#1)(2007-8#1)(2009-5#1)(2011-2#1)
are consistent with the##84##4##(1990-10#1)(1990-11#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#4)(1992-6#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#3)
are consistent with those obtained##4##5##(2008-10#2)(2008-3#1)(2008-7#1)
are consistent with those of##4##5##(1993-3#1)(2008-3#1)(2008-7#1)(2013-8#1)
are consistent with those##10##4##(1990-9#1)(1991-11#1)(1993-3#1)(2008-10#2)(2008-3#2)(2008-7#2)(2013-8#1)
are consistent with##199##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#5)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#4)(1997-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#1)(2009-9#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#6)(2013-1#1)(2013-8#4)
are consistent##207##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-8#1)(1991-9#3)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#5)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#4)(1997-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#29)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#6)(2013-1#1)(2013-8#4)
are consistently##7##2##(2008-10#2)(2008-5#1)(2008-6#1)(2009-9#1)(2012-3#1)(2013-7#1)
are consonant with##3##3##(1995-12#1)(2008-9#1)(2012-3#1)
are constant##2##2##(2008-6#1)(2012-2#1)
are constantly undergoing##2##3##(1995-3#1)(2008-9#1)
are constantly##8##2##(1991-9#1)(1992-3#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
are constitutively expressed in##2##4##(2007-12#1)(2008-5#1)
are constitutively##6##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-12#1)
are constrained by the##2##4##(2008-6#1)(2009-7#1)
are constrained by##4##3##(1996-3#1)(2008-6#1)(2008-8#1)(2009-7#1)
are constrained to##2##3##(2008-1#1)(2008-3#1)
are constrained##8##2##(1995-1#1)(1996-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)
are constructed and##2##3##(2008-9#1)(2011-1#1)
are constructed by means of##2##5##(2008-10#1)(2008-3#1)
are constructed by##5##3##(1992-11#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
are constructed for##2##3##(2008-10#1)(2010-8#1)
are constructed in##3##3##(1990-5#1)(2007-12#1)(2008-4#1)
are constructed##16##2##(1990-5#1)(1992-11#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
are consumed##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
are contained in##2##3##(2008-3#2)
are contemplating##2##2##(1991-1#1)(1994-1#1)
are continually##3##2##(2008-3#1)(2008-8#1)(2009-3#1)
are continuing to##3##3##(1996-1#1)(2007-8#1)(2008-11#1)
are continuing##5##2##(1993-8#1)(1996-1#1)(1996-5#1)(2007-8#1)(2008-11#1)
are continuous##2##2##(2008-7#1)(2012-1#1)
are continuously exposed to##2##4##(1994-5#1)(2008-12#1)
are continuously##10##2##(1991-12#1)(1994-5#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-9#1)(2013-8#1)
are contraindicated##2##2##(2008-3#1)(2008-7#1)
are contrasted with the##2##4##(1991-12#1)(2007-12#1)
are contrasted with##4##3##(1991-12#1)(2007-12#1)(2008-11#1)(2012-2#1)
are contrasted##7##2##(1991-12#1)(1992-1#1)(1994-1#1)(2007-12#1)(2008-11#1)(2009-11#1)(2012-2#1)
are contributing to the##2##4##(2008-7#1)(2009-12#1)
are contributing to##4##3##(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
are contributing##7##2##(1994-11#1)(1996-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
are controlled and##2##3##(2008-10#1)(2008-3#1)
are controlled by distinct##2##4##(1990-5#1)(2007-12#1)
are controlled by the##3##4##(2007-11#1)(2007-8#1)(2011-2#1)
are controlled by##16##3##(1990-5#2)(1991-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#3)(2008-8#2)(2011-2#1)
are controlled##25##2##(1990-5#2)(1991-5#1)(1992-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2011-2#2)
are controversial##6##2##(2006-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
are convenient##2##2##(2007-11#1)(2012-2#1)
are converted by##2##3##(2008-10#1)(2008-3#1)
are converted into a##2##4##(2008-1#1)(2008-3#1)
are converted into##9##3##(1993-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2011-2#1)
are converted to##6##3##(2008-10#3)(2009-11#2)(2011-2#1)
are converted##17##2##(1993-12#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2009-11#2)(2011-2#2)
are convinced that##2##3##(1996-2#1)(2008-10#1)
are convinced##3##2##(1996-2#1)(2008-10#1)(2010-12#1)
are coordinated to the##2##4##(2007-11#1)(2008-10#1)
are coordinated##6##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
are copied and##2##3##(1993-12#1)(2008-7#1)
are copied##3##2##(1993-12#1)(2008-7#1)(2008-9#1)
are corrected for##2##3##(1996-12#2)
are corrected##3##2##(1996-12#2)(2008-3#1)
are correlated in##2##3##(2008-10#1)(2008-3#1)
are correlated to##2##3##(2008-11#1)(2010-8#1)
are correlated with the##5##4##(1996-4#1)(2008-2#2)(2008-7#1)(2009-11#1)
are correlated with##14##3##(1990-7#1)(1996-4#2)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
are correlated##21##2##(1990-7#1)(1995-3#1)(1996-4#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-3#2)
are corresponding##2##2##(2008-5#1)(2008-8#1)
are corrupted##2##2##(2008-2#1)(2008-3#1)
are costly##5##2##(1994-2#1)(1995-5#1)(1996-8#1)(2008-10#1)(2008-7#1)
are coupled into##2##3##(2007-11#1)(2008-3#1)
are coupled to the##2##4##(2008-10#1)(2008-7#1)
are coupled to##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-8#1)
are coupled##12##2##(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-11#1)(2010-8#1)
are covalently attached to##2##4##(1991-3#1)(1995-3#1)
are covalently##7##2##(1991-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
are covered by a##2##4##(2008-5#1)(2008-7#1)
are covered by##5##3##(2008-10#1)(2008-5#2)(2008-7#2)
are covered in##2##3##(1995-1#1)(1996-2#1)
are covered with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
are covered##14##2##(1991-5#1)(1995-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-9#1)(2012-3#1)
are created and##2##3##(2008-2#1)(2009-11#1)
are created by##2##3##(2007-11#1)(2008-3#1)
are created##10##2##(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-5#1)
are creating##2##2##(1996-12#1)(1997-2#1)
are critical components of##5##4##(1996-2#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
are critical elements##2##3##(1993-12#1)(2008-11#1)
are critical factors##2##3##(2010-10#1)(2013-7#1)
are critical for the##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
are critical for##21##3##(1993-8#1)(1994-1#1)(1994-5#1)(1997-7#1)(2007-12#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
are critical in the##4##4##(1995-8#1)(2008-11#1)(2008-9#1)(2010-5#1)
are critical in##5##3##(1995-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-5#1)
are critical issues for##2##4##(2013-8#2)
are critical to patient##2##4##(2011-2#1)(2012-2#1)
are critical to the##3##4##(2008-3#1)(2009-10#1)(2010-6#1)
are critical to##15##3##(1993-1#1)(1996-2#2)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
are critical##62##2##(1993-1#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-5#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-7#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
are critically discussed##3##3##(2008-10#3)
are critically important##2##3##(2008-9#1)(2009-7#1)
are critically##12##2##(1992-3#1)(1997-7#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
are criticized##2##2##(1996-2#1)(2009-6#1)
are cross-linked##3##2##(1993-11#1)(2008-2#1)(2013-8#1)
are crucial for the##2##4##(2007-12#1)(2012-2#1)
are crucial for their##2##4##(2007-8#1)(2009-7#1)
are crucial for##19##3##(1993-3#1)(1993-9#1)(1994-8#1)(1996-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#2)
are crucial in##3##3##(2008-10#1)(2008-9#1)(2009-4#1)
are crucial to the##3##4##(1990-6#1)(2008-3#1)(2008-9#1)
are crucial to##9##3##(1990-6#1)(1993-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
are crucial##35##2##(1990-6#1)(1993-3#2)(1993-9#1)(1994-8#1)(1996-12#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
are crucially##2##2##(1995-2#1)(2010-9#1)
are cultivated##2##2##(2008-10#2)
are culturally##2##2##(2008-11#1)(2011-1#1)
are cultured##5##2##(1991-2#1)(2008-11#2)(2008-4#1)(2013-1#1)
are cured##2##2##(2010-3#1)(2013-1#1)
are currently available for the##3##5##(2008-5#1)(2009-1#1)(2011-2#1)
are currently available for##5##4##(2008-5#1)(2009-1#1)(2010-3#1)(2011-2#2)
are currently available##11##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
are currently being explored##2##4##(2008-7#1)(2013-8#1)
are currently being used for##2##5##(2008-10#1)(2008-3#1)
are currently being used##4##4##(1990-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
are currently being##18##3##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#3)(2009-6#1)(2010-12#1)(2010-5#1)(2011-3#2)(2013-8#1)
are currently in clinical##2##4##(2008-5#2)
are currently in development##2##4##(2008-10#1)(2008-11#1)
are currently in progress##2##4##(1997-4#1)(2008-5#1)
are currently in##9##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#4)
are currently no##4##3##(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
are currently of##2##3##(2008-10#1)(2008-3#1)
are currently taking##2##3##(2008-10#1)(2008-7#1)
are currently tested in##2##4##(1995-8#1)(2011-2#1)
are currently the subject of##2##5##(2008-5#1)(2008-7#1)
are currently the##5##3##(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
are currently under##3##3##(2007-11#1)(2007-12#2)
are currently undergoing##2##3##(2007-12#1)(2010-3#1)
are currently underway##2##3##(1992-1#1)(2008-4#1)
are currently used as##3##4##(2008-4#1)(2008-5#1)(2012-2#1)
are currently used in##5##4##(1993-10#1)(2008-10#1)(2010-1#1)(2010-11#1)(2011-2#1)
are currently used##11##3##(1993-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
are currently working##2##3##(2008-10#1)(2008-7#1)
are currently##119##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-2#2)(1993-10#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-5#2)(2006-6#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#8)(2008-7#10)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#5)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
are cut##3##2##(1995-12#1)(2008-3#1)(2011-2#1)
are damaged##3##2##(2008-4#1)(2011-2#1)(2013-7#1)
are data##2##2##(1991-2#1)(2008-11#1)
are deaf##3##2##(2008-9#1)(2011-2#2)
are dealing with##2##3##(1991-6#1)(1993-12#1)
are decisive##2##2##(2007-8#1)(2008-10#1)
are decreased in##3##3##(1991-9#1)(2008-7#1)(2013-8#1)
are decreased##6##2##(1991-9#1)(1992-3#1)(1993-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
are decreasing##3##2##(1997-8#1)(2007-11#1)(2011-2#1)
are deduced from the##3##4##(2008-2#1)(2008-3#1)(2009-8#1)
are deduced##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-8#1)
are deemed##2##2##(2009-4#1)(2009-8#1)
are deeply##4##2##(1991-5#1)(1995-9#1)(2008-10#1)(2012-2#1)
are defective in##2##3##(1990-5#1)(1995-8#1)
are deficient in##4##3##(1997-1#1)(1997-7#1)(2008-7#1)(2012-2#1)
are deficient##5##2##(1992-3#1)(1997-1#1)(1997-7#1)(2008-7#1)(2012-2#1)
are defined and##2##3##(2008-11#1)(2013-7#1)
are defined as##8##3##(1996-11#1)(1996-12#1)(2008-2#1)(2008-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
are defined by their##2##4##(2010-9#1)(2012-2#1)
are defined by##6##3##(2008-10#2)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)
are defined for##2##3##(2008-3#1)(2009-8#1)
are defined in##2##3##(2008-2#1)(2011-1#1)
are defined##30##2##(1991-2#1)(1992-9#1)(1995-9#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are definitely##2##2##(1995-3#1)(2008-7#1)
are degraded in the endoplasmic reticulum##2##6##(1995-2#2)
are degraded##6##2##(1995-2#2)(2007-12#1)(2008-11#1)(2008-5#1)(2010-4#1)
are delayed##3##2##(1996-2#1)(2007-12#1)(2010-12#1)
are deleterious##2##2##(2008-8#2)
are delineated and##2##3##(1991-12#1)(1994-12#1)
are delineated##3##2##(1991-12#1)(1993-3#1)(1994-12#1)
are delivered by##3##3##(2008-11#2)(2009-11#1)
are delivered##9##2##(2008-11#2)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#2)
are demanding##2##2##(1993-12#1)(2008-11#1)
are demonstrated and##5##3##(1996-6#1)(2008-10#1)(2008-2#2)(2012-3#1)
are demonstrated at##2##3##(2007-12#1)(2008-3#1)
are demonstrated by##8##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-12#1)
are demonstrated for##3##3##(1991-5#1)(2007-11#1)(2008-3#1)
are demonstrated from##2##3##(2007-11#1)(2007-12#1)
are demonstrated in##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
are demonstrated to be##2##4##(2008-10#1)(2008-2#1)
are demonstrated to##3##3##(2008-10#1)(2008-2#2)
are demonstrated with##8##3##(2007-12#2)(2008-10#1)(2008-3#3)(2010-12#1)(2012-1#1)
are demonstrated##75##2##(1991-1#1)(1991-5#1)(1992-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-11#7)(2007-12#12)(2008-10#11)(2008-2#8)(2008-3#22)(2008-7#2)(2009-11#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
are dependent on the nature of the##2##7##(1994-5#1)(2008-10#1)
are dependent on the nature of##3##6##(1993-3#1)(1994-5#1)(2008-10#1)
are dependent on the##13##4##(1993-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#1)
are dependent on##22##3##(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
are dependent upon the##2##4##(1990-5#1)(2012-2#1)
are dependent upon##4##3##(1990-5#1)(1991-5#1)(2012-2#2)
are dependent##27##2##(1990-5#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
are depending on##2##3##(2008-5#1)(2009-1#1)
are depleted##2##2##(2008-9#1)(2012-3#1)
are deployed##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
are deposited in the##2##4##(2008-6#1)(2008-7#1)
are deposited in##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
are deposited on##2##3##(2008-10#1)(2008-2#1)
are deposited onto##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
are deposited##11##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)
are depressed##3##2##(1990-11#1)(1993-8#1)(2010-4#1)
are derived analytically##2##3##(2008-3#2)
are derived and##4##3##(2008-2#1)(2008-3#3)
are derived for the##9##4##(1990-8#1)(2007-12#2)(2008-2#2)(2008-3#3)(2013-8#1)
are derived for##15##3##(1990-8#1)(1994-9#1)(2007-12#2)(2008-2#3)(2008-3#6)(2008-9#1)(2013-8#1)
are derived from a##2##4##(1995-6#1)(2010-10#1)
are derived from the##13##4##(1994-9#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-8#1)(2012-2#1)
are derived from##42##3##(1990-5#1)(1991-3#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-3#2)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-6#2)(2008-8#2)(2010-10#2)(2012-1#1)(2012-2#2)
are derived in##2##3##(2008-2#1)(2008-3#1)
are derived that##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
are derived##107##2##(1990-5#1)(1990-8#2)(1991-3#1)(1993-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-3#2)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#20)(2008-3#31)(2008-6#3)(2008-8#4)(2008-9#1)(2009-11#1)(2010-10#2)(2012-1#2)(2012-2#2)(2013-1#2)(2013-8#1)
are described according to##2##4##(1990-8#1)(2008-3#1)
are described along with##5##4##(1996-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)
are described and compared according to the##2##7##(2008-10#2)
are described and compared with##2##5##(2007-11#1)(2008-2#1)
are described and compared##5##4##(2007-11#1)(2008-10#2)(2008-2#1)(2010-12#1)
are described and discussed##4##4##(1990-9#1)(1995-11#1)(2008-11#1)(2008-5#1)
are described and illustrated on##2##5##(2008-10#1)(2008-5#1)
are described and illustrated##4##4##(2007-12#1)(2008-10#1)(2008-5#2)
are described and possible##2##4##(2008-7#1)(2010-6#1)
are described and the##6##4##(1990-9#1)(1997-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)
are described and their##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
are described and##33##3##(1990-12#1)(1990-9#2)(1991-3#1)(1992-4#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#3)(2010-6#1)
are described as well as the##2##6##(1992-3#1)(1995-3#1)
are described as##4##3##(1992-3#1)(1995-3#1)(2007-5#1)(2008-10#1)
are described based on the##2##5##(2008-10#2)
are described by a##2##4##(2007-12#1)(2008-10#1)
are described by##6##3##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)
are described elsewhere in the series##4##6##(2008-4#4)
are described elsewhere in the##5##5##(2008-4#5)
are described for measurement of##2##5##(2008-10#1)(2008-2#1)
are described for the first time##2##6##(2008-10#1)(2013-1#1)
are described for the##11##4##(2008-10#6)(2008-3#1)(2008-4#1)(2008-9#2)(2013-1#1)
are described for##27##3##(1991-5#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#6)(2008-8#1)(2008-9#7)(2013-1#1)
are described from##2##3##(2008-6#1)(2010-8#1)
are described here for the first time##2##7##(2008-10#2)
are described here for##3##4##(2008-1#1)(2008-10#2)
are described here##14##3##(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2010-3#1)(2011-2#1)
are described in detail##12##4##(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-9#1)
are described in the##5##4##(1995-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-3#1)
are described in this article##6##5##(1991-12#1)(1992-1#1)(1996-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
are described in this paper##2##5##(2008-11#1)(2008-12#1)
are described in this unit##13##5##(2008-2#1)(2008-4#11)(2008-9#1)
are described in this##23##4##(1991-12#1)(1992-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#12)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
are described in which##3##4##(1991-9#1)(1997-4#1)(2008-3#1)
are described in##49##3##(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#14)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-2#1)(2011-3#1)
are described that are##2##4##(2008-3#1)(2008-4#1)
are described that##7##3##(2008-2#1)(2008-3#1)(2008-4#3)(2011-1#1)(2012-2#1)
are described which##2##3##(1997-4#1)(2008-11#1)
are described with a##2##4##(1997-3#1)(2008-8#1)
are described with##5##3##(1995-5#1)(1997-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
are described##446##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#7)(1990-9#3)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#4)(2006-12#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-5#1)(2007-8#3)(2008-1#5)(2008-10#82)(2008-11#12)(2008-12#4)(2008-2#30)(2008-3#42)(2008-4#48)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#24)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
are designated as##4##3##(1993-9#1)(1995-11#1)(2007-5#1)(2008-10#1)
are designated##7##2##(1993-9#1)(1995-11#1)(2007-5#1)(2008-10#3)(2013-8#1)
are designed and fabricated##2##4##(2008-2#2)
are designed and##5##3##(1996-3#1)(2008-2#2)(2008-3#1)(2010-8#1)
are designed for##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)
are designed to be##2##4##(2009-7#1)(2009-9#1)
are designed to determine##2##4##(1994-9#1)(2008-8#1)
are designed to##25##3##(1990-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1997-4#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#3)
are designed with##3##3##(2008-3#1)(2008-9#1)(2010-2#1)
are designed##46##2##(1990-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#1)
are desirable##5##2##(1996-11#1)(1997-4#1)(2008-2#1)(2008-3#1)(2011-1#1)
are desired##4##2##(1995-3#1)(2008-5#1)(2008-8#2)
are desperately needed##2##3##(2008-1#1)(2008-4#1)
are destroyed##2##2##(1994-8#1)(2013-1#1)
are detached by##2##3##(2008-11#1)(2008-7#1)
are detached##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
are detailed for##2##3##(2007-12#1)(2008-4#1)
are detailed##17##2##(1992-1#1)(1992-3#1)(1993-3#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2009-9#1)
are detectable in##2##3##(1990-12#1)(2011-1#1)
are detectable##6##2##(1990-12#1)(1994-8#1)(1996-5#1)(2008-11#1)(2011-1#1)(2013-1#1)
are detected at##5##3##(1992-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
are detected by a##3##4##(2008-3#2)(2012-12#1)
are detected by##12##3##(2007-12#2)(2008-10#3)(2008-3#4)(2008-9#1)(2011-2#1)(2012-12#1)
are detected early##2##3##(2008-10#1)(2008-4#1)
are detected even##2##3##(2008-10#2)
are detected for##2##3##(1990-7#1)(2008-10#1)
are detected in human##2##4##(1994-8#1)(2013-1#1)
are detected in the##4##4##(1993-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
are detected in##11##3##(1993-12#1)(1993-3#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2013-1#1)
are detected on##2##3##(2008-3#1)(2008-9#1)
are detected with##3##3##(2008-10#1)(2008-3#2)
are detected##51##2##(1990-7#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#3)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
are determinants##3##2##(1997-4#1)(2009-8#1)(2012-12#1)
are determined as a function of##2##6##(2008-2#1)(2008-5#1)
are determined as##3##3##(2008-12#1)(2008-2#1)(2008-5#1)
are determined both##2##3##(2008-10#1)(2011-2#1)
are determined by a##2##4##(2008-11#1)(2008-3#1)
are determined by the##13##4##(1991-5#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2013-7#1)
are determined by##31##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#2)(2010-4#1)(2013-7#1)
are determined for##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
are determined from the##5##4##(2008-2#1)(2008-3#3)(2011-2#1)
are determined from##10##3##(1990-8#1)(2008-10#2)(2008-2#1)(2008-3#5)(2011-2#1)
are determined in##5##3##(2008-10#1)(2008-12#1)(2008-3#3)
are determined simultaneously using##2##4##(2008-10#1)(2008-3#1)
are determined through##2##3##(2007-12#1)(2008-9#1)
are determined to be##2##4##(1995-2#1)(2008-10#1)
are determined to##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
are determined using##2##3##(2008-10#2)
are determined with a##2##4##(2008-10#1)(2008-3#1)
are determined with##8##3##(2008-10#2)(2008-2#2)(2008-3#4)
are determined##112##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-11#6)(2007-12#5)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#3)(2008-2#14)(2008-3#29)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-7#1)
are developed and##4##3##(1997-1#1)(2007-5#1)(2008-10#1)(2013-1#1)
are developed as##2##3##(2008-12#1)(2010-8#1)
are developed by##2##3##(2008-10#1)(2008-3#1)
are developed for the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
are developed for##8##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2011-2#1)
are developed from##3##3##(1994-12#1)(2008-3#1)(2008-5#1)
are developed in##3##3##(1993-1#1)(2007-12#1)(2009-4#1)
are developed to##5##3##(2007-12#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#1)
are developed##54##2##(1991-12#1)(1992-11#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-12#1)(1997-1#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
are developing##13##2##(1991-12#1)(1991-3#1)(1992-4#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2013-1#1)
are developmental##2##2##(1991-12#1)(2010-3#1)
are developmentally regulated##2##3##(1993-6#1)(1997-1#1)
are devised##4##2##(1994-12#1)(2008-3#3)
are devoted to##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
are diagnosed at##2##3##(2008-1#1)(2010-7#1)
are diagnosed in##2##3##(2008-10#1)(2012-3#1)
are diagnosed with##2##3##(2008-4#1)(2011-2#1)
are diagnosed##15##2##(1994-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
are diagnostic##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
are differences in the##4##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
are differences in##8##3##(1990-5#1)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
are differences##9##2##(1990-5#1)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-7#1)(2013-1#1)
are different from other##2##4##(1993-12#1)(2008-11#1)
are different from the##3##4##(2007-12#1)(2010-8#1)(2011-2#1)
are different from those in the##2##6##(1997-8#1)(2008-5#1)
are different from those in##3##5##(1997-8#1)(2008-10#1)(2008-5#1)
are different from those of##2##5##(1992-12#1)(2010-4#1)
are different from those##8##4##(1992-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)
are different from##18##3##(1992-12#1)(1993-12#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
are different in the##3##4##(1996-5#1)(2008-10#1)(2010-5#1)
are different in##7##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-5#1)(2013-7#1)
are different##63##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-8#2)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#4)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
are differentially expressed in the##2##5##(2008-11#1)(2008-5#1)
are differentially expressed in##5##4##(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
are differentially expressed##8##3##(1992-6#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)
are differentially regulated by##2##4##(1996-12#1)(2008-8#1)
are differentially regulated##5##3##(1991-9#1)(1996-12#1)(2008-8#1)(2008-9#2)
are differentially##21##2##(1991-9#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#1)
are differentiated by##2##3##(1996-1#1)(2008-10#1)
are differentiated##6##2##(1996-1#1)(2008-10#3)(2008-4#1)(2010-12#1)
are differently##5##2##(1991-12#1)(1995-2#1)(2007-11#1)(2008-10#2)
are difficult because of the##3##5##(2008-10#1)(2008-3#1)(2009-7#1)
are difficult because##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
are difficult to access##2##4##(2008-3#1)(2011-2#1)
are difficult to analyze##2##4##(2008-4#1)(2008-8#1)
are difficult to detect##5##4##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
are difficult to diagnose##3##4##(1994-2#1)(1997-4#1)(2011-2#1)
are difficult to distinguish##2##4##(2008-10#1)(2010-3#1)
are difficult to implement##3##4##(2012-2#2)(2012-3#1)
are difficult to interpret##6##4##(1991-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
are difficult to obtain##2##4##(2008-3#1)(2008-5#1)
are difficult to##46##3##(1990-3#1)(1991-11#1)(1993-2#1)(1994-2#1)(1994-9#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
are difficult##56##2##(1990-3#1)(1991-11#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
are diffraction limited with##2##4##(2008-2#1)(2008-3#1)
are digested with##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
are digested##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2013-1#1)
are diluted##2##2##(1994-9#1)(2008-10#1)
are direct##2##2##(2008-10#1)(2008-9#1)
are directed against##2##3##(1994-2#1)(2008-8#1)
are directed into##2##3##(2008-3#2)
are directed to##3##3##(1990-5#1)(1990-8#1)(2008-11#1)
are directed##12##2##(1990-5#1)(1990-8#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)
are directly correlated with##2##4##(2008-4#1)(2013-8#1)
are directly involved in##2##4##(1995-6#1)(1996-12#1)
are directly proportional to the##2##5##(2008-10#2)
are directly related to the##2##5##(1996-2#1)(2010-9#1)
are directly related to##4##4##(1996-2#1)(2008-1#1)(2008-9#1)(2010-9#1)
are directly##28##2##(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-6#1)(2010-9#1)(2012-2#4)(2013-8#1)
are disappointing##4##2##(1994-2#1)(2008-11#1)(2009-4#1)(2011-3#1)
are discarded##4##2##(2008-10#3)(2008-3#1)
are discovered##3##2##(2007-3#1)(2011-2#1)(2013-8#1)
are discrete##2##2##(1996-12#1)(2008-12#1)
are discriminated##2##2##(1992-5#1)(2008-10#1)
are discussed along with##4##4##(2008-4#1)(2008-8#2)(2011-2#1)
are discussed and a##2##4##(1997-1#1)(2011-7#1)
are discussed and compared to other##2##6##(2007-12#1)(2010-3#1)
are discussed and compared with those of##3##7##(1993-11#1)(2008-10#1)(2008-3#1)
are discussed and compared with##4##5##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
are discussed and compared##7##4##(1993-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)
are discussed and demonstrated##2##4##(2008-3#2)
are discussed and illustrated##2##4##(2008-10#1)(2012-2#1)
are discussed and suggestions##2##4##(1996-2#1)(2008-2#1)
are discussed and the##5##4##(1993-5#1)(1996-3#1)(2008-10#3)
are discussed and##39##3##(1991-12#1)(1991-3#1)(1993-11#1)(1993-5#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-2#5)(2008-3#4)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
are discussed as they##2##4##(1991-2#1)(2008-1#1)
are discussed as well as the##2##6##(2008-10#2)
are discussed as well as##3##5##(1991-1#1)(2008-10#2)
are discussed as well##4##4##(1991-1#1)(2008-10#2)(2008-8#1)
are discussed as##17##3##(1990-6#1)(1991-1#1)(1991-2#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
are discussed briefly herein##2##4##(2008-7#2)
are discussed briefly##4##3##(2008-1#1)(2008-3#1)(2008-7#2)
are discussed for##5##3##(1991-9#1)(2007-11#1)(2008-3#2)(2013-1#1)
are discussed from##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
are discussed here##6##3##(1993-8#1)(1994-5#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-12#1)
are discussed herein##3##3##(1993-2#1)(2008-3#1)(2011-2#1)
are discussed in an##3##4##(1996-1#1)(2007-12#1)(2008-1#1)
are discussed in connection with its##2##6##(1994-6#2)
are discussed in connection with##3##5##(1994-6#2)(2008-10#1)
are discussed in detail in##2##5##(2008-4#1)(2008-7#1)
are discussed in detail##21##4##(1990-2#1)(1992-6#1)(1994-2#1)(2008-10#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
are discussed in light of the##5##6##(1997-8#1)(2008-1#1)(2010-7#1)(2013-1#2)
are discussed in light of##12##5##(1994-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#2)
are discussed in order to##2##5##(1990-8#1)(2013-7#1)
are discussed in relation to the##10##6##(1990-12#1)(1992-12#1)(1994-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2012-2#1)
are discussed in relation to##21##5##(1990-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)
are discussed in relation##22##4##(1990-12#1)(1990-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)
are discussed in terms of health##2##6##(2008-11#1)(2010-2#1)
are discussed in terms of the##19##6##(1990-11#1)(1990-7#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-1#1)
are discussed in terms of their##3##6##(1991-2#1)(1992-11#1)(1997-2#1)
are discussed in terms of##42##5##(1990-11#1)(1990-7#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
are discussed in the article##2##5##(1994-12#1)(2011-3#1)
are discussed in the context of previous research##2##8##(2008-9#1)(2012-2#1)
are discussed in the context of the##2##7##(2007-11#1)(2007-12#1)
are discussed in the context of##14##6##(1990-11#1)(1993-11#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-2#2)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)
are discussed in the light of recent##2##7##(1990-9#1)(1991-4#1)
are discussed in the light of the##2##7##(1990-8#1)(2012-2#1)
are discussed in the light of##6##6##(1990-8#1)(1990-9#1)(1991-4#1)(1995-6#1)(2008-10#1)(2012-2#1)
are discussed in the present review##2##6##(1995-8#1)(2008-8#1)
are discussed in the##29##4##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-4#1)(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
are discussed in this article##3##5##(1997-5#1)(2008-10#1)(2008-9#1)
are discussed in this overview##2##5##(2008-4#2)
are discussed in this paper##4##5##(1992-1#1)(2008-10#2)(2012-2#1)
are discussed in this review##5##5##(2009-10#1)(2010-5#2)(2010-7#1)(2010-8#1)
are discussed in this##19##4##(1992-1#1)(1993-6#1)(1997-5#1)(2008-10#3)(2008-4#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
are discussed in##166##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#3)(1993-6#4)(1994-12#1)(1994-2#3)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2006-4#1)(2007-11#3)(2007-12#5)(2007-4#1)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
are discussed including##2##3##(2008-10#2)
are discussed on the basis of the##2##7##(1994-6#1)(2009-6#1)
are discussed on the basis of##4##6##(1993-12#1)(1994-6#1)(1997-2#1)(2009-6#1)
are discussed relative to the##2##5##(1996-3#1)(2008-10#1)
are discussed that##3##3##(1996-2#1)(2008-3#1)(2011-1#1)
are discussed theoretically and experimentally##2##5##(2008-10#1)(2008-3#1)
are discussed theoretically and##3##4##(2008-10#1)(2008-3#2)
are discussed to##5##3##(2008-3#1)(2009-12#1)(2009-2#1)(2012-2#1)(2013-1#1)
are discussed together with##4##4##(1990-12#1)(1990-6#1)(2008-3#1)(2009-12#1)
are discussed which##2##3##(2008-11#1)(2013-1#1)
are discussed with a##3##4##(1995-12#1)(2008-4#1)(2008-8#1)
are discussed with an##2##4##(1993-3#1)(2010-3#1)
are discussed with emphasis on##2##5##(1997-2#1)(2008-5#1)
are discussed with regard to##3##5##(1993-3#1)(2008-11#1)(2008-3#1)
are discussed with respect to the##2##6##(1992-6#1)(1996-2#1)
are discussed with respect to their##2##6##(1994-8#1)(2008-7#1)
are discussed with respect to##7##5##(1992-3#1)(1992-6#1)(1993-8#1)(1994-8#1)(1996-2#1)(2008-3#1)(2008-7#1)
are discussed with some##2##4##(1993-2#1)(2008-10#1)
are discussed with##24##3##(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)
are discussed within the##2##4##(2008-3#1)(2013-1#1)
are discussed##1051##2##(1990-11#3)(1990-12#3)(1990-2#4)(1990-5#1)(1990-6#7)(1990-7#2)(1990-8#8)(1990-9#7)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#6)(1991-3#7)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#5)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#5)(1992-5#5)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#5)(1993-12#13)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#9)(1993-8#8)(1993-9#3)(1994-1#5)(1994-11#5)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#4)(1995-1#4)(1995-11#5)(1995-12#6)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#10)(1996-3#8)(1996-5#2)(1996-6#3)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#25)(2007-12#40)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#6)(2008-1#13)(2008-10#151)(2008-11#39)(2008-12#20)(2008-2#52)(2008-3#81)(2008-4#24)(2008-5#15)(2008-6#6)(2008-7#32)(2008-8#18)(2008-9#16)(2009-10#4)(2009-11#10)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#10)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#6)(2010-3#6)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#4)(2011-1#8)(2011-2#18)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#5)(2012-2#14)(2012-3#3)(2013-1#30)(2013-7#2)(2013-8#6)
are discussing the##2##3##(1990-9#1)(2011-2#1)
are disease free##3##3##(1990-6#1)(2008-10#1)(2008-6#1)
are diseases##2##2##(1993-2#1)(2012-3#1)
are disordered##2##2##(1994-5#1)(1997-2#1)
are dispersed by##2##3##(2008-8#1)(2013-1#1)
are dispersed in##2##3##(2008-3#1)(2009-11#1)
are dispersed##5##2##(1992-9#1)(2008-3#1)(2008-8#1)(2009-11#1)(2013-1#1)
are displaced##2##2##(1995-2#1)(1997-2#1)
are displayed##8##2##(2008-10#2)(2008-3#4)(2012-2#1)(2012-3#1)
are disproportionately represented##2##3##(2008-1#2)
are disproportionately##4##2##(2008-1#2)(2012-12#2)
are disrupted##2##2##(1995-12#1)(2010-7#1)
are dissociable##2##2##(2008-11#1)(2011-1#1)
are dissolved in##3##3##(1992-12#1)(2008-10#2)
are dissolved##4##2##(1992-12#1)(2008-10#3)
are distinct and##2##3##(2008-10#1)(2011-2#1)
are distinct from other##2##4##(2008-10#2)
are distinct from the##3##4##(1991-2#1)(2008-11#1)(2008-4#1)
are distinct from those##3##4##(1993-6#1)(2007-12#1)(2008-10#1)
are distinct from##14##3##(1991-12#1)(1991-2#1)(1993-6#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-8#1)(2010-6#1)
are distinct molecules##2##3##(1990-5#1)(1990-8#1)
are distinct##31##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#3)
are distinctly different from##2##4##(1990-11#1)(2008-9#1)
are distinctly different##3##3##(1990-11#1)(2008-9#2)
are distinguishable##2##2##(2007-11#1)(2010-10#1)
are distinguished from##5##3##(1991-12#1)(2007-9#2)(2009-4#1)(2010-12#1)
are distinguished in##2##3##(2008-10#1)(2011-1#1)
are distinguished##14##2##(1991-12#1)(1993-12#1)(2007-9#2)(2008-10#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
are distorted##4##2##(1993-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
are distributed over a##2##4##(1993-11#1)(2008-9#1)
are distributed##11##2##(1992-3#1)(1993-11#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)
are disturbed##2##2##(2008-3#1)(2008-9#1)
are diverse and##2##3##(2009-12#1)(2011-2#1)
are diverse##9##2##(2007-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
are diverted to##2##3##(1990-5#1)(2008-9#1)
are divided in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
are divided into two##6##4##(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2010-8#1)
are divided into##15##3##(1995-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-8#1)(2013-8#1)
are divided##20##2##(1995-5#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-3#1)(2010-8#1)(2013-8#1)
are documented##5##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
are doing##5##2##(1990-4#1)(1993-1#1)(1994-1#1)(1996-1#1)(2008-10#1)
are dominant in##2##3##(2009-12#1)(2010-4#1)
are dominant##9##2##(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#2)(2012-3#1)
are dominated by a##2##4##(1990-8#1)(2007-12#1)
are dominated by##6##3##(1990-5#1)(1990-8#1)(2007-12#1)(2009-10#1)(2009-6#1)(2009-9#1)
are done##5##2##(1992-2#1)(1997-8#1)(2008-3#1)(2008-4#1)(2010-8#1)
are dose-dependent##2##2##(1997-3#1)(2008-9#1)
are double##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
are down-regulated in##2##3##(2008-1#1)(2009-5#1)
are down-regulated##3##2##(2008-1#1)(2008-7#1)(2009-5#1)
are dramatically##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
are drawing##3##2##(2010-8#2)(2012-3#1)
are drawn for##2##3##(1992-3#1)(1993-12#1)
are drawn from a##2##4##(2011-2#1)(2012-2#1)
are drawn from##5##3##(1996-12#1)(2008-12#1)(2009-11#1)(2011-2#1)(2012-2#1)
are drawn##15##2##(1991-2#1)(1992-3#1)(1993-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
are drinking water##2##3##(2008-10#2)
are drinking##3##2##(2008-10#3)
are driven by##4##3##(1995-1#1)(2008-11#1)(2008-7#1)(2012-12#1)
are driven##6##2##(1993-12#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
are driving a##2##3##(2008-10#1)(2008-11#1)
are driving##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
are due to a##2##4##(2008-4#1)(2012-2#1)
are due to refraction##2##4##(2008-2#1)(2008-3#1)
are due to the same##3##5##(1995-8#1)(2008-10#1)(2012-3#1)
are due to the##26##4##(1990-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#8)(2011-1#1)(2012-3#1)
are due to their##2##4##(1990-3#1)(1991-9#1)
are due to##96##3##(1990-12#2)(1990-2#1)(1990-3#1)(1991-2#1)(1991-9#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#2)(2007-11#4)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#27)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
are due##98##2##(1990-12#3)(1990-2#1)(1990-3#1)(1991-2#1)(1991-9#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#2)(2007-11#4)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#27)(2008-4#2)(2008-5#2)(2008-7#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
are dying##2##2##(1993-12#1)(2011-2#1)
are dynamic and##3##3##(2009-7#1)(2010-11#1)(2013-8#1)
are dynamic##6##2##(1996-6#1)(2007-10#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
are dynamically##3##2##(2008-6#1)(2008-9#1)(2012-3#1)
are each##7##2##(1992-6#2)(1995-2#1)(2008-7#1)(2009-10#1)(2010-11#2)
are eagerly##2##2##(2008-8#1)(2011-1#1)
are early##2##2##(1992-12#1)(1994-5#1)
are easier to use than##2##5##(1992-3#1)(2012-2#1)
are easier to##4##3##(1992-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
are easily performed##2##3##(2008-10#1)(2010-11#1)
are easily recovered##2##3##(1997-8#1)(2007-11#1)
are easily##31##2##(1992-11#1)(1994-9#1)(1997-8#1)(2007-11#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
are easy to##9##3##(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
are easy##10##2##(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
are economically important##4##3##(2008-10#2)(2008-12#1)(2013-7#1)
are economically##7##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-7#1)
are edited##2##2##(1990-7#1)(2012-2#1)
are educated##2##2##(1994-3#1)(2008-11#1)
are effective against##3##3##(1991-11#1)(1993-2#1)(2008-10#1)
are effective and##3##3##(1990-8#1)(1996-6#1)(2013-8#1)
are effective for##3##3##(1993-2#1)(2007-12#1)(2012-12#1)
are effective in preventing##2##4##(2008-3#1)(2013-1#1)
are effective in reducing##2##4##(2008-10#1)(2013-1#1)
are effective in the treatment of allergic rhinitis##2##8##(2007-11#2)
are effective in the treatment of##4##6##(2007-11#3)(2008-3#1)
are effective in the##5##4##(2007-11#3)(2008-3#1)(2010-4#1)
are effective in##17##3##(1994-12#1)(2007-11#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2010-4#1)(2013-1#4)
are effective##48##2##(1990-8#1)(1991-11#1)(1991-6#1)(1993-2#2)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-4#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#5)(2013-8#1)
are efficacious##2##2##(2008-11#1)(2011-2#1)
are efficient and##2##3##(2008-12#1)(2008-4#1)
are efficient##6##2##(1994-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)
are efficiently##6##2##(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
are eight##3##2##(2007-7#1)(2008-1#1)(2012-2#1)
are either absent##2##3##(2008-7#2)
are either not##2##3##(1992-3#1)(2007-7#1)
are either##20##2##(1992-3#1)(1992-7#1)(1993-11#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#4)(2012-3#1)
are elaborated upon##2##3##(2010-12#1)(2012-2#1)
are elaborated##7##2##(1990-2#1)(1994-8#1)(2007-11#1)(2010-12#1)(2010-8#2)(2012-2#1)
are electrophoresed in##2##3##(2008-2#1)(2008-4#1)
are electrophoresed##3##2##(2008-2#1)(2008-4#2)
are elevated in##5##3##(1993-12#1)(1993-9#1)(1995-12#1)(2007-10#1)(2011-2#1)
are elevated##11##2##(1993-12#1)(1993-9#1)(1995-12#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
are elicited##3##2##(1995-3#1)(2008-4#2)
are eliminated by##3##3##(1992-6#1)(1996-12#1)(2008-10#1)
are eliminated##10##2##(1991-12#1)(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-7#1)
are elongate and##2##3##(2008-5#1)(2008-7#1)
are elongated##2##2##(1997-6#1)(2011-2#1)
are elucidated##2##2##(1995-1#1)(2008-10#1)
are eluted with##3##3##(2008-10#3)
are embedded in##3##3##(2008-11#2)(2008-3#1)
are embedded##9##2##(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-8#1)(2013-8#2)
are emerging as an important##2##5##(1996-12#1)(2008-7#1)
are emerging as##5##3##(1996-12#1)(2007-12#1)(2008-7#3)
are emerging in##2##3##(2007-2#1)(2012-3#1)
are emerging##12##2##(1996-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-7#3)(2011-2#1)(2012-3#1)
are emphasized##10##2##(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
are employed as##3##3##(1995-1#1)(2008-10#2)
are employed for##5##3##(1991-3#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
are employed in the##2##4##(2008-2#1)(2010-12#1)
are employed in##4##3##(1997-2#1)(2008-2#1)(2008-7#1)(2010-12#1)
are employed to##9##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-12#1)
are employed##29##2##(1990-5#1)(1991-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#4)(2008-7#1)(2009-9#2)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
are empowered##2##2##(1996-7#1)(2008-1#1)
are enclosed by##2##3##(2007-11#1)(2010-11#1)
are encoded by##8##3##(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-8#1)(2008-4#2)(2009-10#1)
are encoded in##4##3##(1993-11#1)(1997-7#1)(2008-4#1)(2008-7#1)
are encoded##16##2##(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-2#1)(2008-4#4)(2008-7#2)(2009-10#1)
are encountered in the##3##4##(2008-4#1)(2009-8#1)(2010-4#1)
are encountered in##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)
are encountered##8##2##(2008-10#1)(2008-3#2)(2008-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
are encouraged to develop##2##4##(1994-2#1)(2008-1#1)
are encouraged to##10##3##(1991-3#1)(1993-3#1)(1994-2#2)(1995-3#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)
are encouraged##11##2##(1991-3#1)(1993-3#1)(1994-2#2)(1995-3#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
are encouraging for##3##3##(1995-12#1)(2008-1#1)(2008-11#1)
are encouraging##11##2##(1994-2#1)(1995-12#1)(1996-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
are encrypted by##3##3##(2007-11#1)(2008-3#2)
are encrypted##4##2##(2007-11#1)(2008-3#3)
are endemic in##3##3##(2007-12#1)(2008-1#1)(2012-12#1)
are endemic##6##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
are endogenous##3##2##(1994-2#1)(2008-7#1)(2010-11#1)
are endowed with a##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
are energetically##2##2##(2008-7#1)(2008-9#1)
are enforced##2##2##(2008-11#1)(2010-4#1)
are engaged in##4##3##(2011-2#1)(2012-2#2)(2013-8#1)
are engaged##7##2##(1995-2#1)(1996-2#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
are enhanced by##5##3##(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
are enhanced##9##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
are enriched in the##2##4##(2009-10#1)(2012-3#1)
are enriched in##5##3##(1995-3#1)(2008-10#1)(2009-10#1)(2012-2#1)(2012-3#1)
are enriched##7##2##(1995-3#1)(2008-10#1)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
are enrolled in the##2##4##(1995-12#1)(2008-9#1)
are ensheathed successively##2##3##(2007-12#1)(2010-11#1)
are entering##2##2##(2007-4#1)(2012-3#1)
are entirely##3##2##(2008-8#1)(2008-9#1)(2010-3#1)
are entitled to##3##3##(1991-8#1)(1992-2#2)
are entropically stabilized##2##3##(2008-10#2)
are enumerated##2##2##(2008-10#1)(2008-11#1)
are envisaged##4##2##(2008-3#2)(2009-9#1)(2013-1#1)
are enzymatically##4##2##(1991-6#1)(1993-6#1)(1995-2#1)(2009-9#1)
are enzymes that##2##3##(2009-2#1)(2013-1#1)
are equal to those##3##4##(1990-5#1)(1992-3#1)(2008-2#1)
are equal to##4##3##(1990-5#1)(1992-12#1)(1992-3#1)(2008-2#1)
are equal##7##2##(1990-5#1)(1992-12#1)(1992-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
are equally effective##2##3##(2011-1#1)(2012-2#1)
are equally important##3##3##(2008-12#1)(2008-7#1)(2009-5#1)
are equally likely##2##3##(2008-9#2)
are equally susceptible to##2##4##(1990-11#1)(2007-12#1)
are equally##15##2##(1990-11#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2011-1#2)(2012-2#1)
are equipped to##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
are equipped with##2##3##(2007-12#2)
are equipped##6##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
are equivalent in##2##3##(1990-11#1)(2011-2#1)
are equivalent to those##2##4##(2008-11#1)(2008-2#1)
are equivalent to##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
are equivalent##10##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
are equivocal##2##2##(1997-8#1)(2008-1#1)
are especially likely to##2##4##(2008-8#1)(2010-4#1)
are especially useful in##3##4##(2007-11#1)(2008-4#1)(2012-2#1)
are especially useful##4##3##(2007-11#1)(2008-4#1)(2010-7#1)(2012-2#1)
are especially##17##2##(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
are essential cofactors for##2##4##(1997-7#1)(2011-2#1)
are essential for a##2##4##(2008-5#1)(2011-2#1)
are essential for its##4##4##(1994-8#1)(2009-7#2)(2011-3#1)
are essential for the##17##4##(1990-2#1)(1990-5#1)(1992-5#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#3)(2010-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
are essential for##56##3##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#6)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
are essential in the##2##4##(2008-10#1)(2010-9#1)
are essential in##9##3##(1992-11#1)(1992-3#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-9#1)(2013-7#1)
are essential to achieve##2##4##(2008-3#1)(2009-2#1)
are essential to the##5##4##(1995-5#1)(1997-3#1)(2007-2#1)(2008-2#1)(2012-3#1)
are essential to##20##3##(1992-1#2)(1994-11#1)(1994-5#1)(1995-5#1)(1997-3#2)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-3#1)
are essential tools##2##3##(1996-1#1)(2008-12#1)
are essential##116##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-11#2)(1992-3#3)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#6)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
are essentially identical##2##3##(1992-8#1)(1997-8#1)
are essentially the same##2##4##(2008-10#1)(2008-12#1)
are essentially the##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
are essentially##13##2##(1991-9#1)(1992-8#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#1)
are established by##2##3##(2008-10#2)
are established during##2##3##(2010-9#2)
are established for##3##3##(2008-10#2)(2009-11#1)
are established##30##2##(1991-6#1)(1991-9#1)(1996-5#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
are establishing##2##2##(1994-12#1)(2007-12#1)
are estimated and##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
are estimated by##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2012-1#1)
are estimated from##2##3##(2008-2#1)(2008-3#1)
are estimated to be##2##4##(1993-3#1)(2008-3#1)
are estimated to##6##3##(1993-3#1)(1995-3#1)(1996-10#1)(1997-6#1)(2008-3#1)(2012-2#1)
are estimated using##3##3##(2008-6#1)(2008-7#1)(2010-3#1)
are estimated with##2##3##(2008-10#1)(2008-2#1)
are estimated##29##2##(1993-3#1)(1995-3#1)(1996-10#1)(1997-6#1)(2007-12#2)(2008-10#5)(2008-2#5)(2008-3#5)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
are estrogenic##2##2##(2008-11#1)(2012-2#1)
are eukaryotic##2##2##(1997-6#1)(2009-9#1)
are evaluated and##7##3##(2008-10#4)(2008-8#1)(2010-8#1)(2011-1#1)
are evaluated as functions of##2##5##(2008-2#2)
are evaluated as##7##3##(1990-8#1)(1993-2#1)(2008-10#2)(2008-2#2)(2009-8#1)
are evaluated by comparing##2##4##(2008-10#1)(2008-11#1)
are evaluated by##6##3##(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)
are evaluated for##6##3##(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
are evaluated from##2##3##(2008-2#2)
are evaluated in##4##3##(1992-2#1)(1996-2#1)(2008-10#1)(2012-2#1)
are evaluated on the##2##4##(2007-2#1)(2008-5#1)
are evaluated to##3##3##(2008-10#1)(2009-7#1)(2013-8#1)
are evaluated using##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
are evaluated with##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
are evaluated##66##2##(1990-8#1)(1991-12#1)(1992-2#1)(1993-2#1)(1994-2#2)(1994-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#2)(2009-8#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
are evaluating##2##2##(2008-10#1)(2013-1#1)
are even##7##2##(2007-12#1)(2008-10#2)(2008-11#2)(2010-12#1)(2012-2#1)
are eventually##2##2##(1990-2#1)(2008-5#1)
are evidence for##2##3##(1996-2#1)(1997-2#1)
are evidence##3##2##(1993-2#1)(1996-2#1)(1997-2#1)
are evidenced by##2##3##(2008-10#1)(2008-3#1)
are evident in##2##3##(1997-3#1)(2008-10#1)
are evident##5##2##(1993-12#2)(1997-3#1)(2008-10#1)(2011-1#1)
are evolutionarily conserved##5##3##(1991-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
are evolutionarily##7##2##(1991-6#1)(1993-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
are evolving##7##2##(1993-1#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-6#1)(2008-7#1)
are exacerbated##2##2##(1992-3#1)(2008-9#1)
are exactly##2##2##(2008-10#1)(2008-2#1)
are examined and discussed##3##4##(1991-5#1)(2008-3#1)(2008-7#1)
are examined and the##2##4##(1991-3#1)(2008-10#1)
are examined and##10##3##(1991-3#1)(1991-5#1)(1994-2#1)(2006-4#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-6#1)
are examined as##2##3##(1991-3#1)(2008-2#1)
are examined by##6##3##(1997-8#1)(2007-12#1)(2008-2#1)(2010-2#1)(2012-3#1)(2013-8#1)
are examined for the##2##4##(2008-10#1)(2008-2#1)
are examined for##4##3##(1991-1#1)(2008-10#1)(2008-2#1)(2010-2#1)
are examined from##2##3##(1990-11#1)(2008-3#1)
are examined in the context of##3##6##(1993-3#1)(2008-11#1)(2009-11#1)
are examined in this article##2##5##(1991-3#1)(1995-12#1)
are examined in this##3##4##(1991-3#1)(1995-12#1)(2008-3#1)
are examined in##12##3##(1990-3#1)(1991-3#1)(1992-5#1)(1993-3#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)
are examined to##3##3##(1993-3#1)(1995-1#1)(2013-1#1)
are examined using##4##3##(1997-2#1)(2008-10#3)
are examined##93##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-3#5)(1991-5#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2006-4#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#12)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
are examples of##7##3##(1993-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
are exceedingly rare##2##3##(2011-2#1)(2013-1#1)
are excellent for##2##3##(1995-2#1)(2008-10#1)
are excellent##12##2##(1994-3#1)(1994-9#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-3#1)(2009-10#2)(2009-5#1)(2010-7#1)
are exceptional##4##2##(1995-2#1)(1997-3#1)(2008-10#1)(2012-2#1)
are exceptionally diverse##3##3##(2008-8#3)
are exceptionally##5##2##(2008-8#4)(2012-1#1)
are excitatory##2##2##(1995-12#1)(2008-11#1)
are excited##2##2##(2007-12#2)
are excluded from##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
are excluded##7##2##(1992-11#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-2#1)
are exclusively##3##2##(1995-5#1)(2008-11#1)(2012-3#1)
are expanded in##2##3##(2008-2#2)
are expanded##3##2##(2008-2#3)
are expanding##2##2##(1996-3#1)(2008-9#1)
are expected to arise##2##4##(2008-4#1)(2012-3#1)
are expected to be important in##2##6##(2008-3#1)(2009-5#1)
are expected to be more##2##5##(2007-11#1)(2008-10#1)
are expected to be##10##4##(1993-6#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-5#1)
are expected to form##2##4##(2008-3#1)(2008-6#1)
are expected to have##2##4##(2008-5#1)(2008-9#1)
are expected to produce##2##4##(1993-11#1)(1994-5#1)
are expected to promote##2##4##(2008-4#1)(2009-12#1)
are expected to provide##2##4##(2008-3#1)(2012-3#1)
are expected to remain##2##4##(1994-5#1)(2010-5#1)
are expected to##51##3##(1991-3#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#2)
are expected##59##2##(1991-3#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#2)
are expensive and##2##3##(2008-10#2)
are expensive##4##2##(2008-10#3)(2010-12#1)
are experienced by##2##3##(1993-3#1)(2009-8#1)
are experienced##3##2##(1993-3#1)(2008-11#1)(2009-8#1)
are experiencing##5##2##(2008-11#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-7#1)
are experimentally demonstrated##2##3##(2007-12#1)(2008-3#1)
are experimentally##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
are explained by##5##3##(1992-12#1)(2007-11#2)(2008-10#2)
are explained in terms of the##2##6##(2007-12#1)(2008-12#1)
are explained in terms of##3##5##(1992-12#1)(2007-12#1)(2008-12#1)
are explained using##2##3##(2008-10#1)(2008-7#1)
are explained##20##2##(1990-2#1)(1992-12#2)(1994-5#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2011-1#1)(2012-12#1)
are explicitly given##2##3##(2007-12#1)(2008-3#1)
are explicitly##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
are exploited in##2##3##(2008-1#1)(2008-10#1)
are exploited##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
are explored and##2##3##(1992-2#1)(2008-10#1)
are explored in this##2##4##(1990-8#1)(1992-1#1)
are explored in##5##3##(1990-8#1)(1992-1#1)(2008-12#1)(2008-2#1)(2010-6#1)
are explored##37##2##(1990-8#1)(1991-2#2)(1992-1#1)(1992-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#2)(2010-6#1)(2012-12#2)(2012-3#1)
are exploring##3##2##(1994-6#1)(2008-5#1)(2013-1#1)
are exposed to a##2##4##(1995-8#1)(2013-8#1)
are exposed to the##4##4##(1991-11#1)(1991-5#1)(1995-3#1)(2013-1#1)
are exposed to##26##3##(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2009-12#2)(2009-7#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
are exposed##32##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2009-12#2)(2009-7#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
are expressed as a##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
are expressed as##6##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)
are expressed at##4##3##(1993-6#1)(1996-2#1)(2008-1#1)(2008-9#1)
are expressed by##3##3##(1993-12#1)(2008-1#1)(2008-3#1)
are expressed in a##5##4##(1994-5#1)(1996-2#1)(1996-5#2)(2010-7#1)
are expressed in terms of##2##5##(1996-12#1)(2008-2#1)
are expressed in the##12##4##(1992-9#1)(1995-3#1)(1995-5#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
are expressed in##47##3##(1990-5#1)(1992-6#1)(1992-9#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
are expressed intracellularly##2##3##(2008-2#1)(2008-5#1)
are expressed on##3##3##(2008-4#2)(2008-7#1)
are expressed##79##2##(1990-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#3)(1996-2#3)(1996-5#2)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#3)(2011-2#5)(2012-3#2)(2013-1#1)
are extended by##2##3##(2008-7#1)(2013-8#1)
are extended to##4##3##(1995-11#1)(2008-2#1)(2008-3#2)
are extended##8##2##(1995-11#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2013-8#1)
are extensively##5##2##(1990-8#1)(1991-5#1)(1996-2#1)(2008-4#1)(2009-10#1)
are extracellular##3##2##(2008-4#2)(2011-2#1)
are extracted and##2##3##(2008-10#1)(2008-6#1)
are extracted by##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
are extracted from##3##3##(2008-3#1)(2010-8#1)(2013-8#1)
are extracted in##4##3##(2007-12#1)(2008-10#3)
are extracted into chloroform##2##4##(2008-10#2)
are extracted into the##2##4##(2008-10#2)
are extracted into##7##3##(2008-10#7)
are extracted##26##2##(2007-12#1)(2008-10#17)(2008-3#2)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#2)(2013-8#1)
are extraordinarily##2##2##(2007-12#1)(2008-11#1)
are extreme##2##2##(1993-2#1)(2008-10#1)
are extremely heterogeneous##3##3##(1997-4#1)(2011-2#1)(2012-2#1)
are extremely high##2##3##(2008-10#1)(2011-3#1)
are extremely rare and##3##4##(2008-7#1)(2009-5#1)(2013-7#1)
are extremely rare in##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
are extremely rare lesions and##2##5##(2012-2#1)(2012-3#1)
are extremely rare tumors##2##4##(1997-8#1)(2012-3#1)
are extremely rare##17##3##(1995-5#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
are extremely sensitive to##2##4##(1995-5#1)(2008-3#1)
are extremely sensitive##3##3##(1995-5#1)(2008-3#1)(2008-4#1)
are extremely uncommon##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
are extremely well##2##3##(1990-11#1)(2008-8#1)
are extremely##48##2##(1990-11#2)(1990-9#1)(1995-5#2)(1997-4#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2010-3#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
are fabricated by##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
are fabricated##8##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-7#1)
are faced with a##3##4##(1990-11#1)(1995-3#1)(2013-1#1)
are faced with the challenge of finding##2##7##(1996-1#1)(2008-12#1)
are faced with the##5##4##(1995-12#1)(1996-1#1)(1996-12#1)(2008-12#1)(2008-7#1)
are faced with##14##3##(1990-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)
are faced##15##2##(1990-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)
are facing significant##2##3##(1992-2#1)(1994-12#1)
are facing##9##2##(1991-3#1)(1991-9#1)(1992-2#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)
are factors that##2##3##(1993-6#1)(2011-1#1)
are factors##6##2##(1990-5#1)(1993-6#1)(2008-3#1)(2010-10#1)(2011-1#2)
are failing##2##2##(2008-7#1)(2010-6#1)
are failure##2##2##(2007-10#1)(2009-6#1)
are fairly##8##2##(1990-2#1)(1994-2#1)(2008-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
are familiar with the##2##4##(1997-8#1)(2008-11#1)
are familiar##5##2##(1997-8#1)(2008-11#2)(2008-9#1)(2013-1#1)
are far better##2##3##(2008-10#2)
are far from being##4##4##(2007-7#1)(2008-2#1)(2008-4#1)(2009-5#1)
are far from ideal##2##4##(2008-3#1)(2008-6#1)
are far from##7##3##(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)
are far less##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
are far more##2##3##(2008-6#1)(2008-9#1)
are far##16##2##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
are faring in##2##3##(2009-7#1)(2013-1#1)
are fast##7##2##(1994-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)
are faster##2##2##(1996-5#2)
are fastidious##2##2##(2008-9#2)
are favorable for##3##3##(1990-11#1)(2008-10#1)(2008-3#1)
are favorable##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
are favorably compared with##2##4##(2007-11#1)(2008-10#1)
are favored##3##2##(2008-10#1)(2008-8#2)
are favoured##3##2##(1994-3#1)(1997-7#1)(2010-12#1)
are feasible and##2##3##(2008-4#1)(2013-8#1)
are feasible in the##2##4##(2008-11#1)(2008-9#1)
are feasible##12##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2013-1#1)(2013-8#2)
are featured##2##2##(1995-3#1)(2010-7#1)
are features of##3##3##(1991-3#1)(2008-10#1)(2012-2#1)
are features that##2##3##(1995-11#1)(2013-7#1)
are features##5##2##(1991-3#1)(1995-11#1)(2008-10#1)(2012-2#1)(2013-7#1)
are fed back into##2##4##(2008-3#2)
are fed##5##2##(1992-3#1)(2008-10#1)(2008-3#2)(2008-9#1)
are feeling the pressure##2##4##(1994-12#1)(2012-2#1)
are feeling##3##2##(1994-12#1)(2011-1#1)(2012-2#1)
are female##2##2##(1997-3#1)(2013-1#1)
are few and##2##3##(1990-8#1)(2008-7#1)
are few data##5##3##(1992-3#1)(2009-10#1)(2009-9#1)(2010-12#1)(2012-3#1)
are few reports##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
are few##36##2##(1990-8#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
are fewer##5##2##(1990-11#1)(1997-3#1)(2008-3#1)(2012-2#1)(2012-3#1)
are filiform and flagellate##2##4##(2007-12#2)
are filiform and##3##3##(2007-12#2)(2008-7#1)
are filiform##4##2##(2007-12#2)(2008-7#2)
are filled with a##4##4##(2007-12#1)(2008-3#2)(2008-5#1)
are filled with##5##3##(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)
are filled##7##2##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)
are filtered and##2##3##(2008-10#2)
are finally given##2##3##(2008-2#2)
are finally##3##2##(2008-2#2)(2011-2#1)
are finding that##2##3##(1990-4#1)(2008-11#1)
are finding##4##2##(1990-4#1)(2008-11#1)(2008-4#1)(2010-7#1)
are first##11##2##(1990-12#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-6#1)(2013-1#1)
are first-order processes##2##3##(2008-10#1)(2008-5#1)
are fit for practice##2##4##(2008-11#2)
are fit to a##2##4##(2007-1#1)(2008-10#1)
are fit to##3##3##(2007-1#1)(2008-10#1)(2008-3#1)
are fit##5##2##(2007-1#1)(2008-10#1)(2008-11#2)(2008-3#1)
are fitted to the##2##4##(2008-3#2)
are fitted to##4##3##(2008-2#1)(2008-3#2)(2010-8#1)
are five##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
are fixed##5##2##(1990-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)
are flawed##3##2##(1991-3#1)(1996-8#1)(1996-9#1)
are flexible and##2##3##(2007-12#1)(2008-9#1)
are flexible enough##2##3##(2009-8#1)(2011-1#1)
are flexible##4##2##(2007-12#1)(2008-9#1)(2009-8#1)(2011-1#1)
are focal##2##2##(1990-9#1)(1992-11#1)
are focused on##11##3##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-2#1)
are focused##13##2##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-2#1)
are followed by##6##3##(1990-8#1)(1991-3#1)(2008-10#1)(2008-3#2)(2008-4#1)
are followed##13##2##(1990-8#1)(1991-3#1)(1993-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#1)
are for the##5##3##(1992-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
are for##13##2##(1992-1#1)(1992-12#1)(1994-9#1)(1996-1#1)(2008-10#3)(2008-2#2)(2008-4#1)(2010-6#1)(2011-3#1)(2012-2#1)
are forced to##3##3##(1995-5#1)(1996-3#1)(2008-10#1)
are forced##4##2##(1995-5#1)(1996-3#2)(2008-10#1)
are forcing##2##2##(1992-1#1)(1997-8#1)
are formed and##3##3##(2008-10#2)(2008-3#1)
are formed as##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
are formed at##4##3##(2008-10#3)(2010-11#1)
are formed between the##2##4##(1994-8#1)(1997-7#1)
are formed by flat cells with rare organelles##2##8##(2007-12#2)
are formed by##12##3##(1992-4#1)(1994-2#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)
are formed in both##2##4##(2008-10#2)
are formed in the##3##4##(2007-11#1)(2008-10#2)
are formed in##11##3##(1994-2#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-9#1)
are formed inside the##2##4##(2007-12#1)(2008-10#1)
are formed when the##2##4##(2007-11#1)(2008-10#1)
are formed##61##2##(1991-6#1)(1992-4#2)(1994-2#3)(1994-8#2)(1995-5#1)(1996-5#3)(1997-7#1)(2007-11#2)(2007-12#6)(2008-10#24)(2008-12#1)(2008-2#2)(2008-3#5)(2008-9#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
are formidable##3##2##(1995-1#1)(1996-3#1)(2008-7#1)
are forming##3##2##(1994-12#1)(2008-9#1)(2010-12#1)
are formulated for the##2##4##(2008-10#1)(2008-2#1)
are formulated##7##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-4#1)
are found and##2##3##(2008-3#1)(2011-3#1)
are found at##4##3##(1994-9#1)(2008-10#1)(2008-5#2)
are found exclusively##2##3##(1992-6#1)(2008-7#1)
are found for##8##3##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
are found in a number of##2##6##(1997-7#1)(2008-10#1)
are found in a wide variety of##2##7##(1994-9#1)(2008-9#1)
are found in a##4##4##(1994-9#1)(1997-7#1)(2008-10#1)(2008-9#1)
are found in all##3##4##(2008-9#1)(2011-2#2)
are found in many##2##4##(1995-12#1)(2008-11#1)
are found in most##2##4##(1992-5#1)(2008-4#1)
are found in the##18##4##(1990-12#1)(1991-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
are found in##55##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
are found not##2##3##(2008-10#1)(2008-8#1)
are found on the##2##4##(1993-3#1)(2007-12#1)
are found on##3##3##(1993-3#1)(2007-12#1)(2008-5#1)
are found to be 3##2##5##(2008-10#1)(2008-3#1)
are found to be extracted as##2##6##(2008-10#2)
are found to be in##4##5##(2008-2#2)(2009-9#1)(2012-2#1)
are found to be more##4##5##(1991-9#1)(1993-12#1)(2008-1#1)(2008-3#1)
are found to be stable##2##5##(1996-2#1)(2007-11#1)
are found to be##44##4##(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#6)(2009-10#1)(2009-5#1)(2009-9#1)(2012-2#1)
are found to correspond to##3##5##(2008-11#1)(2008-3#1)(2009-11#1)
are found to exhibit a##2##5##(2008-10#2)
are found to have##6##4##(2006-4#1)(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
are found to increase##2##4##(1994-8#1)(2008-12#1)
are found to##68##3##(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#9)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-2#1)
are found with##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
are found##182##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#1)(2008-1#3)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#6)(2008-7#10)(2008-8#6)(2008-9#3)(2009-10#6)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#1)
are four##7##2##(1990-3#1)(1993-8#1)(1995-3#1)(2007-12#1)(2008-1#1)(2012-2#1)(2012-3#1)
are fragile##3##2##(2012-12#1)(2013-1#2)
are framed##3##2##(1995-1#1)(2011-1#1)(2012-12#1)
are free from##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
are free of##3##3##(1993-9#1)(2008-11#1)(2008-4#1)
are free to##2##3##(1992-3#1)(2008-4#1)
are free##8##2##(1992-3#1)(1993-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)
are freely available##2##3##(2010-12#1)(2012-12#1)
are freely##4##2##(1995-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
are frequency##2##2##(2007-12#2)
are frequent in##4##3##(1991-12#1)(1996-12#1)(2010-8#1)(2011-2#1)
are frequent##11##2##(1990-2#2)(1991-12#1)(1996-12#1)(2008-10#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#2)
are frequently associated with##4##4##(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
are frequently detected##2##3##(2012-2#1)(2013-1#1)
are frequently encountered in##2##4##(1997-8#1)(2011-2#1)
are frequently encountered##3##3##(1997-8#1)(2011-2#2)
are frequently involved in##3##4##(2006-7#1)(2009-5#1)(2013-1#1)
are frequently observed##2##3##(2007-12#1)(2008-7#1)
are frequently seen in##2##4##(1993-11#1)(2011-2#1)
are frequently seen##4##3##(1993-11#1)(1996-6#1)(2008-7#1)(2011-2#1)
are frequently studied in##2##4##(2008-7#1)(2013-7#1)
are frequently treated by##2##4##(1995-9#1)(2009-10#1)
are frequently treated##4##3##(1995-9#1)(2008-6#1)(2009-10#1)(2009-3#1)
are frequently used in##2##4##(2008-12#1)(2008-3#1)
are frequently used to##2##4##(2008-9#1)(2010-5#1)
are frequently used##5##3##(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
are frequently##64##2##(1992-3#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-6#2)(1997-7#1)(1997-8#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)
are from an##2##3##(2010-9#1)(2012-1#1)
are from the##3##3##(1994-1#1)(2008-10#1)(2013-1#1)
are from##16##2##(1993-6#1)(1994-1#1)(2008-10#6)(2008-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
are fully automated##2##3##(2008-10#1)(2008-4#1)
are fully##18##2##(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#2)(2011-2#1)
are functional in##2##3##(1993-2#1)(2008-10#1)
are functional##10##2##(1992-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
are functionally##8##2##(1995-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-1#1)
are functions of the##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
are fundamental to##2##3##(2007-11#1)(2008-10#1)
are fundamental##9##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
are fundamentally different from##2##4##(1995-1#1)(2008-2#1)
are fundamentally different in##2##4##(2007-7#1)(2008-11#1)
are fundamentally different##5##3##(1990-5#1)(1995-1#1)(2007-7#1)(2008-11#1)(2008-2#1)
are fundamentally##6##2##(1990-5#1)(1995-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
are further complicated by##2##4##(1994-2#1)(2009-5#1)
are further discussed in this addendum##2##6##(2009-8#2)
are further discussed##4##3##(2008-8#1)(2009-8#3)
are further##17##2##(1994-2#1)(1995-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#1)(2011-1#1)(2011-2#1)
are fused to##2##3##(2008-5#1)(2013-8#1)
are fused##4##2##(2008-5#1)(2008-7#2)(2013-8#1)
are gaining tremendous##2##3##(1991-3#1)(2008-10#1)
are gaining##8##2##(1991-3#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)
are gaps in the##2##4##(2007-12#1)(2012-2#1)
are gastrointestinal##2##2##(1992-5#1)(2012-1#1)
are gender##2##2##(2008-7#1)(2013-1#1)
are general##3##2##(1994-3#1)(1995-3#1)(2008-11#1)
are generalized##4##2##(2008-10#1)(2008-3#2)(2012-1#1)
are generally applicable to##2##4##(1997-7#1)(2008-10#1)
are generally applicable##3##3##(1997-6#1)(1997-7#1)(2008-10#1)
are generally associated with##2##4##(2010-1#1)(2010-12#1)
are generally associated##3##3##(1997-1#1)(2010-1#1)(2010-12#1)
are generally benign##2##3##(1996-8#1)(2011-2#1)
are generally carried out##2##4##(1995-9#1)(2008-2#1)
are generally considered##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
are generally consistent with##2##4##(1997-5#1)(2013-8#1)
are generally found to be##2##5##(2008-3#1)(2013-8#1)
are generally found##3##3##(1990-12#1)(2008-3#1)(2013-8#1)
are generally less than##2##4##(2008-2#1)(2008-3#1)
are generally less##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
are generally lower than those##2##5##(1995-12#1)(2008-10#1)
are generally lower than##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
are generally more##3##3##(1994-2#1)(2008-7#1)(2011-2#1)
are generally not##8##3##(1992-1#1)(1992-5#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-12#1)
are generally of##2##3##(1997-4#1)(2008-10#1)
are generally regarded to##2##4##(1994-9#1)(2007-12#1)
are generally##105##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
are generated and##2##3##(2008-3#1)(2008-8#1)
are generated at##3##3##(2007-11#2)(2008-2#1)
are generated by the##5##4##(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)
are generated by##16##3##(1992-9#1)(1993-8#2)(1994-11#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#1)(2009-10#1)
are generated from the##2##4##(2008-10#1)(2008-6#1)
are generated from##6##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-10#1)
are generated in a##2##4##(2007-11#2)
are generated in the##2##4##(1996-5#1)(2008-9#1)
are generated in##5##3##(1994-11#1)(1996-5#1)(2007-11#2)(2008-9#1)
are generated to##2##3##(2008-3#1)(2010-12#1)
are generated with##3##3##(1996-12#1)(2007-12#1)(2008-2#1)
are generated##45##2##(1992-9#1)(1993-8#2)(1994-11#2)(1996-12#2)(1996-5#1)(2007-11#7)(2007-12#7)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-12#1)(2011-1#1)
are genes##4##2##(1994-9#1)(2008-9#3)
are genetically distinct from##3##4##(2008-10#3)
are genetically distinct##5##3##(2008-10#5)
are genetically identical##2##3##(2008-2#1)(2008-8#1)
are genetically linked##2##3##(1997-3#1)(2012-2#1)
are genetically similar##3##3##(1991-11#1)(1997-8#1)(2008-10#1)
are genetically##25##2##(1991-11#1)(1992-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-8#4)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
are gently##2##2##(2008-8#2)
are geographically##2##2##(1997-3#1)(2011-2#1)
are given and##3##3##(1991-12#1)(2008-10#2)
are given as##2##3##(2008-10#1)(2008-8#1)
are given by##2##3##(2008-3#2)
are given for both##6##4##(2008-3#2)(2008-4#2)(2008-9#2)
are given for each##2##4##(2008-10#1)(2013-1#1)
are given for the##7##4##(2007-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)
are given for##43##3##(1990-5#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#8)(2008-3#11)(2008-4#6)(2008-8#1)(2008-9#4)(2013-1#2)
are given from##2##3##(2007-10#1)(2008-3#1)
are given in the##4##4##(2008-10#3)(2008-3#1)
are given in this paper##2##5##(2008-10#2)
are given in this##3##4##(2008-10#2)(2008-9#1)
are given in##12##3##(1992-9#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-9#1)
are given of the##2##4##(1992-1#1)(2008-2#1)
are given of##4##3##(1992-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
are given on##2##3##(2008-3#1)(2008-4#1)
are given that##2##3##(2008-2#2)
are given to demonstrate the##2##5##(1995-5#1)(2008-10#1)
are given to##7##3##(1993-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)
are given##166##2##(1990-2#1)(1990-5#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#3)(2008-10#28)(2008-11#2)(2008-2#26)(2008-3#35)(2008-4#10)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2013-1#7)(2013-7#1)
are giving##3##2##(1992-1#1)(1996-9#1)(2007-2#1)
are glycoproteins##2##2##(1990-11#1)(1995-12#1)
are glycosylated##3##2##(1990-5#1)(1992-6#1)(2010-12#1)
are going through##2##3##(1991-12#1)(2013-1#1)
are going to be available##4##5##(2008-12#3)(2011-3#1)
are going to be##9##4##(1991-12#1)(1996-3#1)(2008-10#1)(2008-12#3)(2008-6#1)(2010-4#1)(2011-3#1)
are going to##13##3##(1991-12#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-12#3)(2008-6#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#2)
are going##18##2##(1991-12#2)(1994-12#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-12#3)(2008-6#1)(2009-5#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#4)
are good candidates for##3##4##(1993-11#1)(2008-3#1)(2013-8#1)
are good candidates to##2##4##(2010-11#1)(2012-3#1)
are good candidates##5##3##(1993-11#1)(2008-3#1)(2010-11#1)(2012-3#1)(2013-8#1)
are good##20##2##(1992-3#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
are governed by##3##3##(2008-10#2)(2012-3#1)
are gradually##2##2##(2008-5#1)(2013-8#1)
are great##4##2##(1995-12#1)(1995-2#1)(2008-10#1)(2012-3#1)
are greater than##7##3##(1997-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
are greater##9##2##(1995-12#1)(1997-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
are greatest##2##2##(1992-4#1)(2013-1#1)
are greatly affected by##2##4##(2008-3#1)(2011-2#1)
are greatly dependent on##2##4##(1991-6#1)(1993-9#1)
are greatly improved##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
are greatly influenced by##3##4##(2009-5#1)(2010-12#1)(2011-3#1)
are greatly reduced##2##3##(1996-12#1)(2007-12#1)
are greatly##19##2##(1990-12#1)(1991-6#1)(1993-12#1)(1993-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2009-5#2)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
are grouped under the##3##4##(1996-3#1)(2009-10#1)(2011-2#1)
are grouped##8##2##(1996-3#2)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
are growing in##2##3##(2008-9#1)(2012-3#1)
are growing##9##2##(1992-12#1)(1994-3#3)(1996-3#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
are grown in##3##3##(1990-7#1)(2008-10#1)(2008-4#1)
are grown##15##2##(1990-7#1)(2008-10#9)(2008-4#2)(2008-7#2)(2009-11#1)
are guided##2##2##(1993-12#1)(2007-12#1)
are hampered by a lack of##2##6##(2008-7#2)
are hampered by##3##3##(2008-3#1)(2008-7#2)
are handled##5##2##(1990-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-8#1)
are hard to##5##3##(1990-3#1)(1995-12#1)(1995-9#1)(2008-11#1)(2008-12#1)
are harmful to humans and##2##5##(2008-10#1)(2008-8#1)
are harvested by##2##3##(1990-10#1)(2010-11#1)
are harvested##3##2##(1990-10#1)(2010-11#1)(2012-2#1)
are having##5##2##(1994-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
are health##6##2##(1995-1#1)(1996-1#2)(1996-2#1)(2011-2#1)(2012-12#1)
are healthy##4##2##(1997-3#1)(2007-11#1)(2010-5#1)(2011-2#1)
are heavier than##2##3##(2008-1#1)(2008-8#1)
are heavily##5##2##(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-7#1)
are held in##2##3##(2007-5#1)(2013-1#1)
are held together by##2##4##(1997-7#1)(2008-11#1)
are held##5##2##(1996-3#1)(1997-7#1)(2007-5#1)(2008-11#1)(2013-1#1)
are helpful in##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
are helpful##5##2##(1991-3#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-8#1)
are helping##2##2##(2008-7#1)(2013-1#1)
are here##6##2##(2008-10#4)(2008-11#1)(2013-8#1)
are hereby##3##2##(2011-1#2)(2012-12#1)
are herein##2##2##(2008-10#1)(2008-6#1)
are heterogeneous##2##2##(2010-1#1)(2011-2#1)
are heterogeneously##2##2##(1997-2#1)(2008-11#1)
are heterozygous for##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
are high and##2##3##(2007-8#1)(2013-8#1)
are high##30##2##(1993-12#1)(1994-5#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#3)(2012-12#1)(2013-8#1)
are higher for##4##3##(1991-6#1)(1992-12#1)(1996-12#2)
are higher in##6##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
are higher than the##5##4##(2007-11#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-2#1)
are higher than those##2##4##(2008-10#2)
are higher than##10##3##(2007-11#1)(2008-10#5)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
are higher##32##2##(1991-2#1)(1991-6#1)(1992-12#1)(1996-12#2)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
are highest##2##2##(1993-6#1)(2012-2#1)
are highlighted and##2##3##(2007-8#1)(2008-2#1)
are highlighted in the##3##4##(2008-1#2)(2008-10#1)
are highlighted in##4##3##(2008-1#2)(2008-10#1)(2008-2#1)
are highlighted##40##2##(1991-12#1)(1992-1#1)(1992-12#1)(1995-1#1)(1995-2#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
are highly absorbing##2##3##(2008-3#2)
are highly conserved among##3##4##(1990-8#1)(1993-3#1)(1997-7#1)
are highly conserved and##2##4##(2008-4#1)(2012-2#1)
are highly conserved between##3##4##(1990-12#1)(1991-6#1)(1992-8#1)
are highly conserved##18##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-6#1)(1994-8#2)(1997-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
are highly correlated##3##3##(1990-5#1)(1997-2#1)(2008-9#1)
are highly dependent on the##2##5##(1992-8#1)(2013-1#1)
are highly dependent on##3##4##(1992-8#1)(2009-5#1)(2013-1#1)
are highly desirable##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
are highly effective##4##3##(1995-5#1)(1997-4#1)(2008-3#1)(2013-1#1)
are highly expressed in##4##4##(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)
are highly expressed##5##3##(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)
are highly heterogeneous##2##3##(2008-9#1)(2012-3#1)
are highly homologous to##2##4##(1993-9#1)(2008-8#1)
are highly immunogenic##2##3##(1994-8#1)(2009-5#1)
are highly infectious##2##3##(2008-5#1)(2012-2#1)
are highly regulated and##2##4##(2009-8#1)(2010-9#1)
are highly related##2##3##(1996-2#1)(2007-2#1)
are highly resistant to##3##4##(2009-10#1)(2011-2#2)
are highly resistant##4##3##(2009-10#1)(2011-2#3)
are highly selective for##3##4##(1990-8#1)(1991-5#1)(1994-12#1)
are highly selective##4##3##(1990-8#1)(1991-5#1)(1994-12#1)(2008-10#1)
are highly sensitive to the##2##5##(2008-3#2)
are highly sensitive to##12##4##(1992-8#1)(1994-12#1)(1994-8#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)
are highly similar##2##3##(1991-6#2)
are highly specialized##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
are highly specific##3##3##(1990-12#1)(2008-10#1)(2013-8#1)
are highly susceptible to##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
are highly variable##2##3##(1996-4#1)(2013-1#1)
are highly vulnerable to##2##4##(2011-9#1)(2012-2#1)
are highly##151##2##(1990-12#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-11#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#4)(1995-5#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#18)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-9#1)(2012-2#8)(2012-3#2)(2013-1#6)(2013-8#2)
are hindered by##2##3##(2008-11#1)(2009-9#1)
are hindered##3##2##(2007-12#1)(2008-11#1)(2009-9#1)
are homologous to known##2##4##(1994-12#1)(2008-10#1)
are homologous to the##2##4##(1996-6#1)(2010-3#1)
are homologous to##7##3##(1994-12#1)(1994-6#1)(1996-6#2)(2008-10#2)(2010-3#1)
are homologous##13##2##(1990-5#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-6#2)(2008-10#2)(2008-7#1)(2010-3#2)(2012-12#1)(2013-8#1)
are homozygous for the##2##4##(1995-2#1)(2008-10#1)
are homozygous for##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
are homozygous##4##2##(1995-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
are hospitalized##2##2##(1992-1#1)(2013-8#1)
are human##4##2##(1994-12#1)(2007-12#1)(2009-5#1)(2010-12#1)
are hydrochloric acid##2##3##(2008-10#2)
are hydrolyzed##2##2##(1990-11#1)(2008-10#1)
are hypothesized to be##2##4##(2008-8#1)(2010-3#1)
are hypothesized##3##2##(2008-10#1)(2008-8#1)(2010-3#1)
are ideal for##5##3##(1992-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
are ideal##7##2##(1992-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)
are ideally suited##2##3##(2009-10#1)(2012-3#1)
are ideally##3##2##(2009-10#1)(2010-5#1)(2012-3#1)
are identical in##2##3##(1992-11#1)(1992-9#1)
are identical or##3##3##(1995-3#1)(1996-6#1)(2008-10#1)
are identical to each other##2##5##(1993-11#1)(2010-5#1)
are identical to the##6##4##(1992-12#1)(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
are identical to those in##2##5##(1992-11#1)(2008-9#1)
are identical to those of##3##5##(2007-5#1)(2008-10#1)(2008-7#1)
are identical to those##6##4##(1992-11#1)(2007-5#1)(2008-10#2)(2008-7#1)(2008-9#1)
are identical to##16##3##(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1997-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)
are identical with##2##3##(1992-6#1)(1997-7#1)
are identical##38##2##(1990-5#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-5#1)(2011-2#1)
are identified and explored##2##4##(1996-3#1)(2008-9#1)
are identified and##14##3##(1992-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
are identified as##11##3##(1991-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-8#1)
are identified by##5##3##(1996-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
are identified for##2##3##(2008-2#1)(2008-3#1)
are identified in##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
are identified through##4##3##(1992-1#1)(1996-3#1)(2008-3#1)(2013-1#1)
are identified to##2##3##(2008-3#1)(2008-6#1)
are identified with##4##3##(1997-2#1)(2008-3#1)(2008-4#2)
are identified##84##2##(1991-12#2)(1992-1#2)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-11#1)(2007-12#6)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#2)
are ill##3##2##(1994-9#1)(1995-12#1)(2007-10#1)
are illegal##2##2##(1991-6#1)(1996-8#1)
are illuminated by a##3##4##(2007-11#1)(2008-3#2)
are illuminated##4##2##(1994-8#1)(2007-11#1)(2008-3#2)
are illustrated and##2##3##(1995-1#1)(2013-8#1)
are illustrated by##7##3##(1992-6#1)(1994-11#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-4#1)
are illustrated in##2##3##(1990-5#1)(2008-10#1)
are illustrated through##2##3##(1997-4#1)(2013-8#1)
are illustrated with##7##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
are illustrated##28##2##(1990-5#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-8#2)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
are imaged##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
are immature##2##2##(2008-11#1)(2012-1#1)
are immediate##2##2##(1994-12#1)(2008-9#1)
are immersed in##2##3##(2008-3#1)(2013-8#1)
are immobilized on the##2##4##(2008-10#1)(2008-4#1)
are immobilized on##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
are immobilized##6##2##(2008-10#4)(2008-11#1)(2008-4#1)
are immune to##2##3##(2007-11#1)(2008-3#1)
are immune##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
are impacted by##2##3##(2009-7#1)(2009-9#1)
are impaired##6##2##(1993-3#1)(1997-1#1)(2008-11#1)(2008-7#2)(2013-7#1)
are imperative##3##2##(2007-4#1)(2008-11#1)(2011-2#1)
are implanted##2##2##(2009-11#1)(2012-2#1)
are implemented and##2##3##(2008-1#1)(2008-3#1)
are implemented##14##2##(1991-12#1)(1994-1#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2011-1#1)(2012-12#1)
are implementing##4##2##(1994-1#1)(1994-2#1)(2012-2#1)(2013-1#1)
are implicated as##2##3##(1990-3#1)(2010-4#1)
are implicated in the##3##4##(1995-5#1)(2009-5#1)(2010-5#1)
are implicated in##11##3##(1994-9#1)(1995-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2013-8#1)
are implicated##13##2##(1990-3#1)(1994-9#1)(1995-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-5#1)(2013-8#1)
are important and##3##3##(2008-12#1)(2009-7#1)(2013-1#1)
are important because##3##3##(1992-4#1)(2008-5#1)(2010-2#1)
are important components of##5##4##(1992-12#1)(2008-6#1)(2009-6#1)(2010-8#1)(2013-1#1)
are important components##6##3##(1992-12#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-8#1)(2013-1#1)
are important determinants of##2##4##(2010-2#1)(2011-2#1)
are important determinants##3##3##(1992-2#1)(2010-2#1)(2011-2#1)
are important diagnostic##2##3##(2007-12#1)(2008-12#1)
are important factors that##2##4##(2008-7#1)(2010-8#1)
are important factors to consider##2##5##(2009-12#1)(2009-8#1)
are important factors to##5##4##(2008-11#1)(2009-12#1)(2009-8#1)(2013-1#2)
are important factors##12##3##(1992-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-8#1)(2013-1#2)
are important for normal##3##4##(1997-7#1)(2008-6#1)(2009-10#1)
are important for regulation of##2##5##(1991-6#1)(2009-2#1)
are important for the##14##4##(1990-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
are important for understanding the##2##5##(2007-5#1)(2008-10#1)
are important for understanding##3##4##(2007-5#1)(2008-10#1)(2009-7#1)
are important for##54##3##(1990-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
are important in the##8##4##(1992-11#1)(1994-8#1)(1995-5#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-2#1)
are important in these##2##4##(1991-11#1)(2008-10#1)
are important in##30##3##(1991-11#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
are important regulators of the##2##5##(2008-4#1)(2013-1#1)
are important regulators of##3##4##(2008-4#2)(2013-1#1)
are important risk##2##3##(2007-8#1)(2008-7#1)
are important to consider##2##4##(2006-10#1)(2008-8#1)
are important to the##2##4##(2008-11#1)(2011-3#1)
are important to##12##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-3#1)(2012-2#1)
are important tools for##2##4##(2010-8#1)(2013-1#1)
are important tools##4##3##(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
are important##208##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-4#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#7)(2008-2#6)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#6)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-10#3)(2010-11#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#2)(2011-10#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#1)
are imposed in the##2##4##(2007-11#1)(2008-3#1)
are imposed##3##2##(2007-11#1)(2008-3#2)
are impractical##2##2##(2008-10#1)(2008-3#1)
are improved by##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
are improved##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2010-8#1)(2012-3#1)
are in a better position to##2##6##(2008-11#1)(2008-3#1)
are in a good agreement with the##2##7##(2007-11#1)(2008-10#1)
are in a position to##2##5##(1994-3#1)(2008-11#1)
are in a range##2##4##(1993-9#1)(2008-3#1)
are in a unique position to##6##6##(1995-3#1)(1996-1#1)(1997-1#1)(2008-11#1)(2009-11#1)(2011-1#1)
are in a##24##3##(1993-9#1)(1994-1#1)(1994-3#1)(1995-3#2)(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
are in accord with the##2##5##(1991-9#1)(2008-3#1)
are in accord with##8##4##(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-3#1)(2009-5#1)
are in accordance with the##3##5##(1994-8#1)(1995-11#1)(2008-4#1)
are in accordance with##4##4##(1994-8#1)(1995-11#1)(2008-10#1)(2008-4#1)
are in agreement at a 95% confidence level##2##8##(2008-10#2)
are in agreement at the 95% confidence level and within an acceptable range of error##2##15##(2008-10#2)
are in agreement at the 95% confidence level##3##8##(2008-10#3)
are in agreement at##5##4##(2008-10#5)
are in agreement with a##3##5##(1990-12#1)(1991-9#1)(1995-3#1)
are in agreement with previous##6##5##(1994-5#1)(2008-10#3)(2008-7#1)(2010-11#1)
are in agreement with the certified##2##6##(2008-10#2)
are in agreement with the##9##5##(2007-8#1)(2008-10#5)(2008-3#2)(2013-1#1)
are in agreement with##27##4##(1990-12#1)(1991-9#1)(1994-5#1)(1995-3#1)(2006-6#1)(2007-8#1)(2008-10#11)(2008-3#5)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
are in agreement##33##3##(1990-12#1)(1991-9#1)(1994-5#1)(1995-3#1)(2006-6#1)(2007-8#1)(2008-10#17)(2008-3#5)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
are in an##2##3##(2008-10#1)(2013-1#1)
are in close agreement with those obtained using a Pharmacopoeia procedure##2##11##(2008-10#2)
are in close##6##3##(2008-10#2)(2008-2#2)(2008-3#1)(2009-10#1)
are in contact with##4##4##(1995-2#1)(2008-10#1)(2008-3#1)(2013-7#1)
are in control##2##3##(2008-12#1)(2008-9#1)
are in development##2##3##(2008-5#1)(2011-2#1)
are in excellent agreement with OH absorption measurements##2##8##(2008-3#2)
are in excellent agreement with the##5##6##(1990-8#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
are in excellent agreement with##10##5##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2009-5#1)(2011-2#1)
are in excellent agreement##12##4##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#4)(2009-5#1)(2011-2#1)
are in excellent##13##3##(1990-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#4)(2009-5#1)(2011-2#1)
are in fact##5##3##(1993-12#1)(2008-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
are in good agreement with the experimental results##2##8##(2007-11#1)(2008-2#1)
are in good agreement with the theoretical##5##7##(2008-3#5)
are in good agreement with the##18##6##(1991-11#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#7)(2010-7#1)(2013-8#1)
are in good agreement with theoretical predictions##2##7##(2007-11#1)(2007-12#1)
are in good agreement with those obtained by the##2##9##(2008-10#2)
are in good agreement with those obtained by##5##8##(2008-10#5)
are in good agreement with those obtained##6##7##(2008-10#5)(2008-3#1)
are in good agreement with those of the##2##8##(2008-3#2)
are in good agreement with those##12##6##(2008-10#7)(2008-2#1)(2008-3#4)
are in good agreement with##46##5##(1991-11#1)(1992-12#1)(1996-2#1)(2007-11#4)(2007-12#5)(2008-10#12)(2008-2#6)(2008-3#14)(2010-7#1)(2013-8#1)
are in good agreement##58##4##(1991-11#1)(1992-12#1)(1994-5#1)(1996-2#1)(2007-11#4)(2007-12#6)(2008-10#16)(2008-11#1)(2008-2#7)(2008-3#18)(2010-7#1)(2013-8#1)
are in good##61##3##(1991-11#1)(1992-12#1)(1994-5#1)(1996-2#1)(2007-11#4)(2007-12#6)(2008-10#17)(2008-11#1)(2008-2#8)(2008-3#18)(2010-7#1)(2013-8#2)
are in line with the hypothesis that##2##7##(1990-12#1)(1996-5#1)
are in line with the##3##5##(1990-12#1)(1996-5#1)(2009-11#1)
are in need of##4##4##(1994-3#2)(2010-10#1)(2013-1#1)
are in place for##2##4##(1992-9#1)(1996-2#1)
are in place to##2##4##(2010-9#1)(2012-12#1)
are in place##6##3##(1992-9#1)(1996-2#2)(2010-9#1)(2012-12#2)
are in progress or##2##4##(1997-8#1)(2008-10#1)
are in progress##7##3##(1993-11#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
are in reasonable agreement##2##4##(2007-11#1)(2008-3#1)
are in short supply##2##4##(1996-8#1)(2008-10#1)
are in such##2##3##(1997-6#1)(2008-11#1)
are in the early stages of development##2##7##(1993-2#1)(2011-2#1)
are in the early stages of##4##6##(1993-2#1)(1996-3#1)(2008-10#1)(2011-2#1)
are in the process of##4##5##(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
are in the range of 0##4##6##(2008-10#3)(2013-8#1)
are in the range of 1##2##6##(2008-10#2)
are in the range of those##2##6##(2007-11#1)(2007-12#1)
are in the range of##16##5##(2007-11#1)(2007-12#1)(2008-10#12)(2010-10#1)(2013-8#1)
are in the range##23##4##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#18)(2010-10#1)(2013-8#1)
are in the same##2##4##(1992-12#1)(1997-5#1)
are in the##55##3##(1990-12#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-8#1)(1994-2#1)(1994-3#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-8#2)
are in their##3##3##(2012-3#1)(2013-1#2)
are in turn##2##3##(2010-12#1)(2013-7#1)
are in use##2##3##(2007-11#1)(2011-2#1)
are in widespread use##3##4##(1991-12#1)(2007-12#1)(2008-4#1)
are in##315##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-8#1)(2006-6#1)(2007-11#10)(2007-12#14)(2007-8#3)(2008-1#1)(2008-10#78)(2008-11#11)(2008-12#2)(2008-2#14)(2008-3#38)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#4)(2009-6#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#6)
are inactivated##3##2##(1997-3#2)(2008-6#1)
are inadequate##4##2##(1992-9#1)(2008-3#1)(2008-5#1)(2012-2#1)
are inappropriate##2##2##(1992-2#1)(2008-1#1)
are inappropriately##2##2##(1997-8#1)(2008-5#1)
are incapable of##4##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)
are incident upon the##2##4##(2007-12#1)(2008-3#1)
are included and##2##3##(2008-2#1)(2011-2#1)
are included as##2##3##(2007-12#1)(2008-9#1)
are included for the##3##4##(2008-1#1)(2008-3#1)(2008-9#1)
are included for##11##3##(1997-2#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-9#1)(2010-5#1)
are included in the##14##4##(1992-3#1)(1995-5#1)(2006-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2013-1#2)
are included in this##4##4##(1993-12#1)(1994-12#1)(2008-4#1)(2010-8#1)
are included in##22##3##(1992-3#1)(1993-12#1)(1994-12#2)(1995-2#1)(1995-5#1)(1996-3#1)(2006-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#1)(2009-4#1)(2010-8#1)(2013-1#2)
are included that describe##2##4##(2008-9#2)
are included that##4##3##(2008-3#1)(2008-4#1)(2008-9#2)
are included within##2##3##(2008-12#1)(2013-8#1)
are included##77##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#3)(1994-3#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#6)(2008-3#9)(2008-4#12)(2008-5#1)(2008-8#1)(2008-9#6)(2009-4#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
are incompatible with##2##3##(2012-2#1)(2013-8#1)
are incompatible##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
are incomplete##3##2##(1995-1#1)(2007-10#1)(2008-10#1)
are inconclusive##3##2##(1994-9#1)(2008-1#1)(2012-12#1)
are inconsistent with the##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
are inconsistent with##5##3##(1990-8#1)(2008-10#2)(2012-12#1)(2012-3#1)
are inconsistent##8##2##(1990-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
are incorporated in##2##3##(1991-9#1)(2008-6#1)
are incorporated into the##2##4##(2008-3#2)
are incorporated into##9##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)
are incorporated##13##2##(1991-9#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2011-1#1)
are incorporating##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
are increased in patients with##2##5##(2008-5#1)(2011-1#1)
are increased in##7##3##(1991-12#1)(1992-1#1)(1994-11#1)(1995-12#1)(2006-10#1)(2008-5#1)(2011-1#1)
are increased to##2##3##(1992-3#1)(1994-3#1)
are increased##20##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
are increasing in##2##3##(1994-2#1)(2009-5#1)
are increasing##14##2##(1991-2#2)(1993-1#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-1#1)
are increasingly being##5##3##(1990-11#1)(1995-2#1)(2007-11#1)(2008-12#1)(2012-2#1)
are increasingly common##2##3##(2008-2#1)(2013-8#1)
are increasingly popular##2##3##(2008-2#1)(2008-8#1)
are increasingly recognized##2##3##(2007-10#1)(2013-1#1)
are increasingly required to##2##4##(1995-2#1)(2008-12#1)
are increasingly turning to##2##4##(1993-3#1)(2009-9#1)
are increasingly used in##2##4##(1995-2#1)(2008-3#1)
are increasingly used to##2##4##(1994-3#1)(2008-3#1)
are increasingly used##6##3##(1994-3#1)(1995-2#1)(2008-2#1)(2008-3#2)(2013-8#1)
are increasingly using##3##3##(2008-12#2)(2010-8#1)
are increasingly##49##2##(1990-11#1)(1991-3#1)(1993-2#3)(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-9#1)(2010-8#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
are incubated with##2##3##(1992-10#1)(2008-4#1)
are incubated##4##2##(1991-2#1)(1992-10#1)(2008-4#1)(2008-5#1)
are indeed associated with##2##4##(1994-2#1)(2011-2#1)
are indeed##11##2##(1992-3#1)(1994-2#1)(1995-2#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)
are independent and##2##3##(2008-7#1)(2013-1#1)
are independent from##2##3##(1990-2#1)(2012-2#1)
are independent of the##6##4##(1990-5#1)(1993-11#1)(1996-2#1)(2008-3#1)(2008-7#2)
are independent of##15##3##(1990-5#1)(1990-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-3#2)(2008-4#1)(2008-7#4)(2010-5#1)
are independent##27##2##(1990-2#1)(1990-5#1)(1990-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#7)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
are independently##5##2##(1991-3#1)(1992-9#1)(2008-3#1)(2008-7#1)(2012-2#1)
are indicated by##2##3##(1992-2#1)(1993-9#1)
are indicated for##2##3##(2008-3#1)(2010-11#1)
are indicated to##2##3##(2008-10#1)(2013-1#1)
are indicated##16##2##(1992-2#1)(1993-9#1)(1994-3#1)(1996-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
are indication for RT##2##4##(2010-3#2)
are indications that##5##3##(1993-3#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-4#1)
are indications##6##2##(1993-3#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
are indicative of a##3##4##(1994-3#1)(2009-12#1)(2009-4#1)
are indicative of the##2##4##(1996-1#1)(2007-12#1)
are indicative of##12##3##(1991-12#1)(1993-8#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)
are indicators of##3##3##(2008-5#2)(2011-2#1)
are indices of##2##3##(1990-3#1)(2008-8#1)
are indispensable for##4##3##(1993-6#1)(1994-8#1)(2008-4#1)(2012-2#1)
are indispensable to##2##3##(1994-2#1)(2007-8#1)
are indispensable##9##2##(1993-6#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-4#1)(2010-11#1)(2010-8#1)(2012-2#2)
are indispensible##2##2##(2008-2#1)(2013-3#1)
are indistinguishable by##2##3##(1990-11#1)(1992-8#1)
are indistinguishable from##2##3##(2008-10#2)
are indistinguishable##7##2##(1990-11#1)(1992-5#1)(1992-8#1)(2008-10#2)(2008-9#1)(2012-3#1)
are individually##3##2##(1994-2#1)(2010-1#1)(2013-1#1)
are induced by the##3##4##(2008-3#1)(2008-6#1)(2012-1#1)
are induced by##13##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
are induced in the##2##4##(1995-12#1)(2007-11#1)
are induced in##4##3##(1994-8#1)(1995-12#1)(2007-11#1)(2008-4#1)
are induced to##4##3##(1994-9#1)(1995-6#1)(2008-2#1)(2011-2#1)
are induced##25##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-1#1)
are ineffective against##2##3##(2007-11#1)(2011-1#1)
are ineffective##4##2##(1993-8#1)(2007-11#1)(2010-6#1)(2011-1#1)
are inexpensive##3##2##(2008-2#1)(2009-10#1)(2011-2#1)
are infected with##2##3##(1997-6#1)(2008-1#1)
are infected##8##2##(1990-3#1)(1993-3#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
are inferior to##2##3##(2007-11#1)(2008-8#1)
are inferred from the##2##4##(2007-12#1)(2008-3#1)
are inferred##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
are inflammatory##2##2##(2009-8#1)(2011-2#1)
are influenced by both##2##4##(1992-12#1)(1995-3#1)
are influenced by genetic predisposition##2##5##(2008-3#1)(2012-2#1)
are influenced by the##4##4##(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
are influenced by various factors##2##5##(2008-11#1)(2008-2#1)
are influenced by##32##3##(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
are influenced##34##2##(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
are informative##2##2##(2008-7#1)(2008-8#1)
are infrequent##3##2##(1990-2#1)(2008-1#1)(2012-3#1)
are inherent in##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
are inherently##4##2##(2008-3#3)(2008-7#1)
are inherited##2##2##(2008-1#1)(2011-2#1)
are inhibited by##3##3##(1990-11#1)(1993-8#1)(2008-8#1)
are inhibited##5##2##(1990-11#1)(1993-8#1)(1995-8#1)(2008-8#1)(2009-10#1)
are inhibitors of##4##3##(1995-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
are initialized as##2##3##(2008-10#2)
are initially present##2##3##(2008-10#1)(2008-8#1)
are initially##11##2##(1996-2#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)
are initiated by##2##3##(2008-8#1)(2012-2#1)
are initiated##6##2##(1992-2#1)(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
are injected into a##3##4##(2008-10#3)
are injected into the##2##4##(2008-1#1)(2008-10#1)
are injected into##5##3##(2008-1#1)(2008-10#4)
are injected##7##2##(2007-11#1)(2008-1#1)(2008-10#5)
are innervated by##2##3##(1994-9#1)(1997-3#1)
are inoculated##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
are insensitive to the##2##4##(2008-3#2)
are insensitive to##11##3##(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-12#1)
are inserted in##2##3##(1991-7#1)(2009-4#1)
are inserted into the##2##4##(2007-12#1)(2011-2#1)
are inserted into##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
are inserted##5##2##(1991-7#1)(2007-12#1)(2008-11#1)(2009-4#1)(2011-2#1)
are insignificant##2##2##(2008-2#1)(2008-3#1)
are instrumental in##2##3##(1995-1#1)(2012-1#1)
are insufficient to##5##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
are insufficient##11##2##(1990-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-5#1)(2011-2#2)(2013-7#1)
are insulin resistant and##2##4##(2008-1#1)(2008-3#1)
are insulin##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
are integral to##2##3##(1992-12#1)(2008-11#1)
are integral##4##2##(1992-12#1)(2008-11#2)(2011-2#1)
are integrated in a##3##4##(2008-3#2)(2008-5#1)
are integrated in the##2##4##(2007-11#1)(2007-12#1)
are integrated in##8##3##(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-11#1)(2012-1#1)(2012-2#1)
are integrated into##2##3##(2008-10#1)(2008-4#1)
are integrated with##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
are integrated##18##2##(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2012-1#1)(2012-2#1)
are intended for##2##3##(2008-3#1)(2013-1#1)
are intended to help##3##4##(1993-6#1)(2008-8#1)(2009-7#1)
are intended to##7##3##(1993-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-9#1)
are intended##9##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-9#1)(2013-1#1)
are intensity##2##2##(2007-12#1)(2008-3#1)
are interconnected##4##2##(1992-8#1)(2008-11#1)(2008-3#1)(2010-8#1)
are interested in##7##3##(1995-12#1)(2007-11#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-5#1)(2012-3#1)
are interested##8##2##(1995-12#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-5#1)(2012-3#1)
are interesting##4##2##(1994-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
are intermediate##4##2##(1995-5#1)(2008-11#1)(2013-8#2)
are internalized##2##2##(1991-12#1)(1995-8#1)
are interpreted as due to vinca##2##6##(1995-5#2)
are interpreted as##7##3##(1991-5#1)(1992-8#1)(1994-6#1)(1995-5#2)(2007-12#1)(2011-2#1)
are interpreted in terms of##7##5##(1992-6#1)(1994-11#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
are interpreted in##8##3##(1992-6#1)(1994-11#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
are interpreted##21##2##(1991-5#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-6#1)(1995-5#3)(1997-3#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2011-2#2)
are interrelated##3##2##(1992-2#1)(2010-8#1)(2013-1#1)
are intimately linked##2##3##(2008-11#1)(2008-2#1)
are intimately##4##2##(1995-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
are intrinsic##2##2##(1996-12#1)(1996-2#1)
are intrinsically##5##2##(1993-12#1)(1994-8#1)(2008-9#1)(2010-5#1)(2010-8#1)
are introduced and compared##2##4##(2008-11#1)(2011-7#1)
are introduced and their##2##4##(1990-8#1)(2010-9#1)
are introduced and##7##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-7#1)
are introduced by the##2##4##(2008-2#1)(2008-3#1)
are introduced by##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
are introduced for##3##3##(1990-5#1)(1995-5#1)(2008-3#1)
are introduced in this##2##4##(2007-11#1)(2008-10#1)
are introduced into the##4##4##(2008-3#1)(2008-7#2)(2008-9#1)
are introduced into##7##3##(1994-3#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-9#1)
are introduced to##4##3##(1990-11#1)(1991-3#1)(2008-10#1)(2009-4#1)
are introduced##51##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-8#1)(1994-3#1)(1995-5#1)(1996-1#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-7#1)(2013-1#2)(2013-7#1)
are introducing##2##2##(1995-2#1)(2008-2#1)
are intronless##2##2##(1992-6#1)(2009-10#1)
are invalid##2##2##(1997-1#1)(2008-9#1)
are invariant##2##2##(2008-2#1)(2009-10#1)
are inversely related to the##2##5##(1990-7#1)(2009-3#1)
are inversely related to##4##4##(1990-7#1)(2008-7#1)(2008-9#1)(2009-3#1)
are inversely##6##2##(1990-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)
are investigated and compared##4##4##(2007-11#1)(2008-2#3)
are investigated and the##2##4##(2008-10#1)(2008-3#1)
are investigated and##9##3##(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#1)
are investigated as##3##3##(2008-10#2)(2008-2#1)
are investigated both theoretically and experimentally##2##6##(2008-3#2)
are investigated by a##2##4##(1992-9#1)(2010-11#1)
are investigated by numerical simulations##2##5##(2007-11#1)(2008-3#1)
are investigated by use of##2##5##(2007-11#1)(2008-3#1)
are investigated by##10##3##(1991-8#1)(1992-9#1)(1996-11#1)(2007-11#2)(2008-10#2)(2008-3#2)(2010-11#1)
are investigated experimentally##2##3##(2008-2#1)(2008-3#1)
are investigated for the##2##4##(2008-10#2)
are investigated for##3##3##(2008-10#2)(2008-2#1)
are investigated in detail##2##4##(2008-3#2)
are investigated in terms of##2##5##(2008-3#1)(2010-6#1)
are investigated in##10##3##(1993-3#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#4)(2010-6#1)(2010-7#1)
are investigated with##5##3##(2007-11#1)(2008-10#2)(2008-2#2)
are investigated##98##2##(1990-3#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-11#1)(2007-11#9)(2007-12#4)(2008-10#20)(2008-11#1)(2008-2#16)(2008-3#28)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#2)(2012-12#1)
are invisible to##2##3##(2008-2#1)(2010-5#1)
are invited to##2##3##(2008-11#1)(2008-4#1)
are invited##3##2##(2008-11#1)(2008-4#2)
are involved in a##4##4##(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
are involved in cell##2##4##(2008-10#1)(2008-6#1)
are involved in controlling##2##4##(1997-8#1)(2010-10#1)
are involved in its##2##4##(1995-2#1)(2006-6#1)
are involved in regulating##3##4##(1993-5#1)(2008-9#1)(2010-1#1)
are involved in the biosynthesis of##2##6##(1996-12#1)(2008-10#1)
are involved in the development of##5##6##(1996-5#1)(1997-8#1)(2008-10#1)(2010-5#1)(2013-8#1)
are involved in the development##6##5##(1996-5#1)(1997-8#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
are involved in the etiology of##4##6##(1992-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
are involved in the formation of##2##6##(1992-6#1)(2008-10#1)
are involved in the genesis of##2##6##(1991-12#1)(1991-4#1)
are involved in the induction of##2##6##(2008-10#2)
are involved in the induction##3##5##(2008-10#3)
are involved in the maintenance of##2##6##(2008-5#1)(2008-9#1)
are involved in the modulation of##2##6##(1990-7#1)(1997-3#1)
are involved in the pathogenesis of##3##6##(1993-12#1)(2008-10#1)(2008-7#1)
are involved in the regulation of##5##6##(1993-12#2)(1995-2#1)(2006-6#1)(2010-12#1)
are involved in the##67##4##(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-10#13)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
are involved in this process##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
are involved in this##8##4##(1993-5#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
are involved in##156##3##(1990-7#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#4)(1993-5#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-6#4)(2007-12#5)(2008-1#2)(2008-10#25)(2008-11#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#9)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
are involved##183##2##(1990-7#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-12#5)(1993-5#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#2)(2006-6#5)(2007-10#1)(2007-11#1)(2007-12#6)(2008-1#4)(2008-10#29)(2008-11#6)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#9)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#2)
are irradiated with##3##3##(2008-3#2)(2008-7#1)
are isolated by##5##3##(2008-10#1)(2008-2#2)(2008-4#2)
are isolated from##5##3##(2008-10#1)(2008-4#1)(2008-5#2)(2010-5#1)
are isolated##15##2##(1990-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2010-5#1)(2013-1#2)
are isostructural##2##2##(1997-7#2)
are issues of##2##3##(2008-5#1)(2009-5#1)
are issues##3##2##(2008-5#1)(2009-5#1)(2011-2#1)
are its simplicity and##2##4##(1990-7#1)(2008-5#1)
are its simplicity##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
are its##17##2##(1990-7#1)(1991-5#1)(1994-12#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-11#1)(2012-12#1)(2013-1#2)
are joined by##2##3##(2008-11#1)(2008-7#1)
are joined together##2##3##(1997-4#1)(2008-3#1)
are joined##5##2##(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
are jointly##3##2##(1992-1#1)(2007-12#1)(2008-3#1)
are judged##2##2##(2007-8#1)(2008-7#1)
are just beginning to##2##4##(1997-7#1)(2009-8#1)
are just##9##2##(1991-12#1)(1994-2#1)(1995-5#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)
are kept in##2##3##(2008-9#1)(2013-8#1)
are kept##8##2##(1990-2#1)(1994-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#1)
are key components of the##4##5##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
are key components##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
are key enzymes##2##3##(2011-2#1)(2012-5#1)
are key parameters##2##3##(1992-3#1)(2008-10#1)
are key players in##2##4##(2008-4#1)(2013-7#1)
are key regulators of##2##4##(2008-5#1)(2010-4#1)
are key to success##2##4##(1996-12#1)(2011-2#1)
are key to the##2##4##(1995-12#1)(2010-10#1)
are key to##8##3##(1995-12#1)(1996-12#1)(2008-1#1)(2008-7#1)(2010-10#1)(2011-2#2)(2011-3#1)
are key##41##2##(1992-3#1)(1995-12#1)(1995-2#1)(1996-12#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)
are keys to##2##3##(2008-10#2)
are killed##3##2##(1990-12#1)(2008-8#1)(2012-3#1)
are known and##5##3##(1995-9#1)(1997-5#1)(2008-10#1)(2008-3#1)(2011-3#1)
are known as##12##3##(1993-3#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#2)
are known causes of##2##4##(2008-10#1)(2009-5#1)
are known for##2##3##(2008-10#1)(2012-5#1)
are known from##3##3##(2008-5#1)(2010-3#1)(2011-2#1)
are known in##2##3##(1991-12#1)(2011-1#1)
are known to be a##3##5##(2008-11#1)(2008-5#1)(2012-2#1)
are known to be expressed in##2##6##(2011-1#1)(2012-3#1)
are known to be involved in##5##6##(1991-8#1)(1993-12#1)(2008-11#1)(2008-4#1)(2012-1#1)
are known to be relatively##2##5##(2008-1#1)(2008-7#1)
are known to be##36##4##(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
are known to cause##2##4##(1991-12#1)(2008-11#1)
are known to contain##4##4##(1992-8#1)(1997-3#1)(2008-10#1)(2008-11#1)
are known to enhance##2##4##(2008-4#1)(2010-11#1)
are known to exhibit##3##4##(1994-3#1)(2008-10#1)(2012-2#1)
are known to exist##2##4##(1990-11#1)(2008-5#1)
are known to form##2##4##(2008-10#1)(2008-8#1)
are known to function##2##4##(1995-12#1)(2007-12#1)
are known to have##6##4##(1990-2#1)(1992-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
are known to induce##6##4##(1991-2#1)(1994-10#1)(1994-12#1)(1995-9#1)(2008-7#2)
are known to influence##3##4##(2008-5#1)(2009-6#1)(2013-7#1)
are known to mediate##3##4##(2009-8#1)(2010-11#1)(2010-7#1)
are known to occur##2##4##(1990-11#1)(2011-2#1)
are known to play a##3##5##(1995-12#1)(1997-4#1)(2008-5#1)
are known to play##4##4##(1994-2#1)(1995-12#1)(1997-4#1)(2008-5#1)
are known to produce##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
are known to regulate##4##4##(1995-11#1)(1995-2#1)(2011-1#1)(2012-2#1)
are known to##121##3##(1990-11#2)(1990-2#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#10)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#7)(2008-8#2)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)
are known##173##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#3)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#3)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#11)(2008-12#3)(2008-3#7)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#9)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#1)
are labeled by##2##3##(2007-12#1)(2008-7#1)
are labeled with##2##3##(2008-10#1)(2008-9#1)
are labeled##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
are lacking for##2##3##(2010-5#1)(2011-2#1)
are lacking in soldiers##2##4##(2007-12#2)
are lacking in##3##3##(2007-12#2)(2012-2#1)
are lacking##31##2##(1993-12#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
are large and##3##3##(1996-9#1)(2008-7#2)
are large##15##2##(1995-2#1)(1995-3#1)(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
are largely asymptomatic##2##3##(2011-2#2)
are largely consistent with##2##4##(1994-3#1)(2008-7#1)
are largely determined by##2##4##(2007-11#1)(2008-7#1)
are largely due to##2##4##(2008-8#1)(2012-2#1)
are largely explained by##2##4##(1996-3#1)(2008-8#1)
are largely independent of##2##4##(1992-8#1)(2008-3#1)
are largely resistant to##2##4##(1995-2#1)(2011-3#1)
are largely responsible for##3##4##(1993-2#1)(1997-7#1)(2008-10#1)
are largely unknown##9##3##(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)
are largely##49##2##(1990-8#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#2)
are larger than the lidar##2##5##(2008-2#1)(2008-3#1)
are larger than##6##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
are larger##9##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)
are launched in##2##3##(2007-11#2)
are launched##3##2##(2007-11#2)(2008-3#1)
are leading to##5##3##(1994-1#1)(1995-3#1)(1996-1#1)(2008-2#1)(2012-5#1)
are learned##3##2##(2007-8#1)(2010-5#1)(2012-12#1)
are left with a##2##4##(1992-5#1)(2008-2#1)
are left with##3##3##(1992-5#1)(2008-11#1)(2008-2#1)
are left##6##2##(1992-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-3#1)(2012-12#1)
are less common##2##3##(1993-6#1)(2011-1#1)
are less commonly##2##3##(2011-2#1)(2012-3#1)
are less confusion and more clarity##2##6##(2013-1#2)
are less effective##4##3##(1993-12#1)(2007-12#1)(2012-2#1)(2012-3#1)
are less efficient##2##3##(1995-2#1)(2008-11#1)
are less expensive##2##3##(2008-10#1)(2008-9#1)
are less likely to##5##4##(1991-11#1)(1992-2#1)(2008-12#2)(2011-2#1)
are less likely##6##3##(1991-11#1)(1992-2#1)(2008-12#2)(2009-5#1)(2011-2#1)
are less pronounced##2##3##(2008-10#1)(2008-7#1)
are less resistant to##2##4##(1995-3#1)(1996-2#1)
are less sensitive to##2##4##(2008-2#2)
are less severe##4##3##(2008-10#2)(2008-8#1)(2009-4#1)
are less stable in##2##4##(1990-2#1)(1992-6#1)
are less stable##3##3##(1990-2#1)(1992-6#1)(2008-9#1)
are less than 1##2##4##(2008-10#1)(2008-3#1)
are less than 2##2##4##(2008-10#1)(2008-3#1)
are less than 4%##2##4##(1991-11#1)(2008-3#1)
are less than approximately##2##4##(2008-2#1)(2008-3#1)
are less than##22##3##(1990-5#1)(1991-11#1)(1992-2#1)(1995-5#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2013-8#2)
are less well##3##3##(2008-1#1)(2008-8#1)(2009-2#1)
are less##84##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#2)(1992-2#3)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#8)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
are level##2##2##(1992-12#1)(2009-4#1)
are liable to##2##3##(1997-8#1)(2008-7#1)
are liberated##2##2##(1994-9#1)(2008-10#1)
are ligand-activated transcription factors##2##4##(2008-4#1)(2013-7#1)
are likely a##2##3##(2008-8#1)(2009-9#1)
are likely due to##2##4##(2008-3#1)(2009-8#1)
are likely the##2##3##(1995-12#1)(2008-10#1)
are likely to act as##2##5##(1995-8#1)(2013-8#1)
are likely to be associated with##2##6##(2008-7#1)(2013-7#1)
are likely to be important in##2##6##(1996-2#1)(2010-3#1)
are likely to be important##4##5##(1992-6#1)(1996-2#1)(2008-4#1)(2010-3#1)
are likely to be involved in##2##6##(1990-6#1)(2008-4#1)
are likely to be more##2##5##(2007-12#1)(2008-8#1)
are likely to be related to##2##6##(2008-10#1)(2011-2#1)
are likely to be useful##3##5##(1993-12#1)(2008-8#1)(2013-1#1)
are likely to be##48##4##(1990-6#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#2)(1994-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#6)(2008-9#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
are likely to become##2##4##(1991-3#1)(2009-3#1)
are likely to benefit##2##4##(2009-8#1)(2011-2#1)
are likely to change##2##4##(2009-12#1)(2011-1#1)
are likely to continue to##2##5##(1996-1#1)(2009-5#1)
are likely to continue##4##4##(1993-2#2)(1996-1#1)(2009-5#1)
are likely to experience##3##4##(1994-3#1)(2008-6#1)(2012-3#1)
are likely to face##2##4##(2008-11#1)(2011-2#1)
are likely to have a##2##5##(2008-7#1)(2013-1#1)
are likely to have##7##4##(1994-2#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
are likely to increase##2##4##(1992-12#1)(2009-5#1)
are likely to influence##2##4##(1997-1#1)(2010-5#1)
are likely to occur##2##4##(1997-3#1)(2008-2#1)
are likely to play a role in##2##7##(1992-12#1)(1992-6#1)
are likely to play a##5##5##(1992-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
are likely to provide##2##4##(2009-7#1)(2010-11#1)
are likely to represent##2##4##(2008-4#1)(2009-8#1)
are likely to serve as##2##5##(1997-2#1)(2012-1#1)
are likely to##123##3##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#3)(1993-12#2)(1993-2#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#6)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
are likely##148##2##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#4)(1993-12#2)(1993-2#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
are limitations to##3##3##(2008-7#1)(2009-5#1)(2009-8#1)
are limited and##3##3##(2008-11#1)(2009-10#1)(2010-10#1)
are limited as##2##3##(1996-3#1)(2011-2#1)
are limited by the##7##4##(1994-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
are limited by##12##3##(1994-6#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-9#3)(2011-2#1)(2013-8#1)
are limited for##3##3##(1996-12#1)(2008-10#1)(2009-7#1)
are limited in##4##3##(2008-1#1)(2008-9#1)(2013-8#2)
are limited to##6##3##(2008-10#2)(2008-9#2)(2009-10#1)(2012-12#1)
are limited##53##2##(1992-8#1)(1994-6#1)(1996-12#1)(1996-3#2)(1997-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#2)(2008-8#2)(2008-9#6)(2009-10#2)(2009-11#1)(2009-7#1)(2010-10#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#4)
are limiting##2##2##(2008-8#1)(2010-12#1)
are linear in the range##2##5##(2008-10#2)
are linear in the##4##4##(2008-10#3)(2008-2#1)
are linear up to 50##2##5##(2008-10#2)
are linear up to##3##4##(2008-10#3)
are linear##17##2##(2008-10#13)(2008-2#1)(2008-4#1)(2010-1#1)(2012-3#1)
are linearly##5##2##(2007-11#1)(2008-10#4)
are linked at##2##3##(1992-3#1)(2008-10#1)
are linked to the##6##4##(1994-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)
are linked to##27##3##(1990-8#1)(1991-6#1)(1994-12#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
are linked##35##2##(1990-8#1)(1991-6#1)(1992-3#1)(1994-12#1)(1994-8#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-7#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#2)
are listed in##3##3##(1991-3#1)(1996-1#1)(2010-3#1)
are listed##11##2##(1991-3#1)(1993-8#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-1#1)(2012-3#1)
are little different##2##3##(2008-10#1)(2008-2#1)
are little##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
are living##4##2##(1997-6#1)(2008-11#1)(2009-7#1)(2011-1#1)
are local##4##2##(1993-8#1)(2008-2#2)(2008-6#1)
are localised##2##2##(2007-11#1)(2007-8#1)
are localized in##6##3##(1990-8#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
are localized##10##2##(1990-8#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-4#1)(2009-10#1)(2013-1#1)
are locally##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
are located along##2##3##(1993-5#1)(2008-10#1)
are located at##8##3##(1991-8#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-8#1)(1997-7#1)(1997-8#1)(2012-12#1)
are located in the cytoplasmic##2##5##(1993-3#1)(2011-2#1)
are located in the same##2##5##(1995-1#1)(2008-3#1)
are located in the##17##4##(1990-8#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
are located in two##2##4##(1994-6#1)(2009-10#1)
are located in##31##3##(1990-8#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
are located mostly##2##3##(2008-2#1)(2011-2#1)
are located on the##5##4##(1995-11#1)(2007-12#1)(2008-5#1)(2009-9#1)(2012-2#1)
are located on##13##3##(1992-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
are located within or##2##4##(1995-8#1)(1996-8#1)
are located within the##3##4##(1994-12#1)(1994-5#1)(1995-8#1)
are located within##5##3##(1994-12#1)(1994-5#1)(1995-8#2)(1996-8#1)
are located##77##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#7)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
are long##3##2##(1992-6#1)(2008-5#1)(2013-1#1)
are long-term##3##2##(1990-9#1)(1995-12#1)(2009-9#1)
are longer than##2##3##(2007-11#1)(2008-3#1)
are longer##3##2##(1991-11#1)(2007-11#1)(2008-3#1)
are looking for ways to##2##5##(1996-12#1)(1997-3#1)
are looking for##3##3##(1996-12#1)(1997-3#1)(2007-8#1)
are looking##6##2##(1996-12#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)
are loosely##2##2##(2008-11#1)(2008-4#1)
are lost to the##4##4##(1991-2#1)(1992-12#1)(1993-12#1)(1996-1#1)
are lost when##2##3##(2008-2#1)(2008-6#1)
are lost##15##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#2)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-4#1)(2013-1#1)
are low##13##2##(1994-1#1)(1997-4#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-8#4)(2010-10#1)(2011-1#1)(2011-2#1)
are lower for##4##3##(1995-2#1)(2008-10#3)
are lower in##3##3##(1993-8#1)(1996-5#1)(2008-3#1)
are lower than the##2##4##(2008-10#1)(2011-2#1)
are lower than those in the##2##6##(2010-8#1)(2011-2#1)
are lower than those in##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
are lower than those##5##4##(2006-10#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
are lower than##11##3##(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2010-8#1)(2011-2#2)
are lower##22##2##(1991-6#1)(1993-8#1)(1995-2#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#3)(2010-8#1)(2011-2#3)(2012-3#1)
are lowered##2##2##(1995-5#1)(1996-9#1)
are lysed##2##2##(2008-4#2)
are made at the##2##4##(1992-11#1)(2008-10#1)
are made at##5##3##(1992-11#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
are made between##3##3##(1990-5#1)(2008-10#1)(2008-3#1)
are made by##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
are made clear##2##3##(2007-4#1)(2008-3#1)
are made for future research##2##5##(1992-3#1)(2008-12#1)
are made for future##3##4##(1992-3#1)(2008-11#1)(2008-12#1)
are made for the##2##4##(1991-8#1)(2008-2#1)
are made for##16##3##(1991-1#1)(1991-8#1)(1992-12#1)(1992-3#1)(1996-2#1)(1996-4#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2013-8#1)
are made from##2##3##(2008-4#1)(2010-7#1)
are made in##3##3##(2008-4#1)(2012-12#1)(2013-1#1)
are made of the##2##4##(1993-2#1)(1994-2#1)
are made of##7##3##(1993-2#2)(1994-12#1)(1994-2#1)(1995-3#1)(2007-11#1)(2008-7#1)
are made on##3##3##(1991-3#1)(1991-6#1)(2011-3#1)
are made that##2##3##(1992-12#1)(1997-1#1)
are made to the##2##4##(1991-12#1)(2008-2#1)
are made to##6##3##(1991-12#1)(1992-12#1)(1995-9#1)(2008-2#1)(2008-3#1)(2013-1#1)
are made with##2##3##(1991-3#1)(2007-12#1)
are made##90##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#2)(2013-8#2)
are mainly due to##3##4##(1990-12#1)(1995-12#1)(2008-2#1)
are mainly localized##3##3##(1994-11#1)(1994-12#1)(1997-7#1)
are mainly related to##2##4##(2010-5#1)(2010-7#1)
are mainly used to##2##4##(2012-2#1)(2013-1#1)
are mainly used##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
are mainly##35##2##(1990-12#1)(1990-8#1)(1991-5#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
are maintained at##3##3##(2007-12#2)(2008-6#1)
are maintained in##3##3##(1994-3#1)(2008-11#2)
are maintained##20##2##(1991-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-6#1)(2008-8#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)
are major causes of##3##4##(1997-4#1)(2008-1#1)(2010-11#1)
are major factors##2##3##(1995-12#1)(2012-3#1)
are major problems##2##3##(2007-7#1)(2013-1#1)
are major public health concerns##2##5##(2012-12#1)(2012-2#1)
are major sources of##2##4##(2010-5#1)(2011-2#1)
are major targets of##2##4##(2007-12#1)(2008-10#1)
are major targets##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
are major##36##2##(1993-3#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
are making##3##2##(1996-3#1)(2007-4#1)(2010-10#1)
are malignant##2##2##(2008-2#1)(2010-12#1)
are managed with##2##3##(2011-1#1)(2012-3#1)
are managed##5##2##(1995-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
are mandated##2##2##(1997-3#1)(2013-1#1)
are mandatory in##3##3##(1992-9#1)(2008-3#1)(2012-12#1)
are mandatory to##2##3##(2010-12#1)(2011-2#1)
are mandatory##10##2##(1990-6#1)(1992-9#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
are manifested##2##2##(2007-12#1)(2008-7#1)
are manipulated##2##2##(2007-11#1)(2008-11#1)
are many considerations##2##3##(1994-3#1)(2007-12#1)
are many different##2##3##(2007-12#1)(2008-8#1)
are many reports of##2##4##(1991-5#1)(2008-10#1)
are many times##2##3##(2008-6#1)(2008-7#1)
are many##60##2##(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-1#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
are mapped##3##2##(1997-8#1)(2007-12#1)(2008-3#1)
are marked by a##2##4##(1996-12#1)(2008-8#1)
are marked by##3##3##(1991-4#1)(1996-12#1)(2008-8#1)
are markedly affected by##2##4##(1992-3#1)(2007-10#1)
are markedly different##2##3##(1992-3#1)(2008-10#1)
are markedly##10##2##(1992-3#2)(1995-11#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-12#1)
are markers of##3##3##(1996-9#1)(2008-10#2)
are marketed##2##2##(2008-1#1)(2012-12#1)
are matched to##2##3##(2008-3#2)
are matched##4##2##(2008-2#1)(2008-3#3)
are mathematically##3##2##(2008-10#1)(2008-3#2)
are meant to##3##3##(2007-2#1)(2008-9#1)(2011-1#1)
are measurable##3##2##(1992-9#1)(1994-1#1)(2008-3#1)
are measured and##2##3##(2008-3#1)(2009-12#1)
are measured as a function of##5##6##(1996-7#1)(2007-12#2)(2008-3#2)
are measured as##8##3##(1996-7#1)(2007-12#2)(2008-2#1)(2008-3#3)(2009-6#1)
are measured at##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
are measured by means of the##2##6##(2008-2#1)(2008-3#1)
are measured by##12##3##(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-7#1)
are measured directly##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
are measured for##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
are measured in a##3##4##(1996-7#1)(2008-2#1)(2008-3#1)
are measured in##9##3##(1996-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2010-11#1)
are measured simultaneously##3##3##(2008-3#1)(2008-9#2)
are measured to be##2##4##(2007-11#1)(2009-7#1)
are measured to##3##3##(2007-11#1)(2008-11#1)(2009-7#1)
are measured with a##4##4##(2007-11#1)(2008-3#3)
are measured with##6##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#3)
are measured##72##2##(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-7#2)(1997-8#1)(2007-11#6)(2007-12#6)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#27)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)
are mechanically##2##2##(2007-12#2)
are mediated by a##2##4##(2008-4#1)(2012-1#1)
are mediated by the##4##4##(1991-2#1)(1996-3#1)(2008-1#1)(2010-12#1)
are mediated by two##2##4##(2007-11#1)(2008-9#1)
are mediated by##27##3##(1991-2#1)(1991-5#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#1)
are mediated through##4##3##(1990-11#1)(1991-12#1)(1992-3#1)(2013-8#1)
are mediated via##2##3##(1991-2#1)(2008-4#1)
are mediated##39##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-5#1)(2011-2#5)(2012-1#1)(2013-8#1)
are medical##2##2##(1992-5#1)(1996-12#1)
are medically##5##2##(1993-11#1)(1995-8#1)(1997-1#2)(2007-12#1)
are members of a##4##4##(1993-6#1)(1995-8#1)(1996-12#1)(2012-2#1)
are members of the nuclear receptor##2##6##(2008-3#1)(2008-4#1)
are members of the superfamily of##2##6##(1992-11#1)(2008-1#1)
are members of the##14##4##(1991-5#1)(1992-11#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-2#1)
are members of##23##3##(1991-5#1)(1992-11#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2012-2#4)
are mentioned##6##2##(1997-7#1)(2008-1#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
are met with##2##3##(1996-2#1)(2008-1#1)
are met##8##2##(1992-1#1)(1994-3#1)(1994-7#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2013-1#1)
are metabolized##2##2##(1990-11#1)(2008-3#1)
are methods for##4##3##(2008-4#2)(2008-9#1)(2010-7#1)
are methods##8##2##(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#2)(2010-7#1)(2012-2#1)
are methylated##3##2##(1990-8#1)(1994-12#1)(2008-10#1)
are mild and##2##3##(2013-1#1)(2013-8#1)
are mild##6##2##(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
are minimal##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
are minimally##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
are minimized##5##2##(1990-10#1)(2008-10#2)(2008-2#2)
are minor##2##2##(1997-2#1)(2008-12#1)
are missed##2##2##(2013-1#2)
are missing at random##2##4##(1995-12#1)(2009-5#1)
are missing completely at random##2##5##(1997-8#1)(2009-12#1)
are missing##8##2##(1995-12#1)(1997-8#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-2#2)
are mixed and##2##3##(2010-10#1)(2013-1#1)
are mixed in##2##3##(2008-3#1)(2008-4#1)
are mixed with a##2##4##(2007-5#1)(2008-2#1)
are mixed with##4##3##(2007-5#1)(2008-2#1)(2008-4#1)(2008-9#1)
are mixed##14##2##(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#3)(2008-9#1)(2010-10#1)(2013-1#2)
are mobile##2##2##(1991-5#1)(2008-10#1)
are modeled and##2##3##(2008-3#2)
are modeled using##2##3##(2008-7#1)(2009-11#1)
are modeled with##2##3##(2007-12#1)(2008-3#1)
are modeled##11##2##(2007-12#1)(2008-11#2)(2008-3#6)(2008-7#1)(2009-11#1)
are modelled##2##2##(1997-8#1)(2008-7#1)
are moderately##3##2##(1995-2#1)(2008-1#1)(2008-10#1)
are modified by the##2##4##(1991-5#1)(2008-3#1)
are modified by##6##3##(1990-5#1)(1991-5#1)(1994-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
are modified##13##2##(1990-5#1)(1991-5#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-1#1)
are modulated by##4##3##(1990-2#1)(1994-5#1)(2008-8#1)(2013-8#1)
are modulated in##2##3##(2008-3#1)(2013-1#1)
are modulated##7##2##(1990-2#1)(1994-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
are molecules##2##2##(2008-10#1)(2009-6#1)
are monitored##4##2##(1996-12#1)(1997-6#1)(2008-10#1)(2008-4#1)
are monoclinic##3##2##(1996-2#3)
are more active##2##3##(2008-7#1)(2012-2#1)
are more and more##2##4##(1991-6#1)(2009-7#1)
are more and##3##3##(1991-6#1)(2008-7#1)(2009-7#1)
are more appropriate##2##3##(2008-1#1)(2008-2#1)
are more closely related to each other##2##7##(2008-8#1)(2011-2#1)
are more closely related to##5##5##(2008-10#2)(2008-8#1)(2011-2#2)
are more closely##7##3##(1992-11#1)(1995-12#1)(2008-10#2)(2008-8#1)(2011-2#2)
are more common in males##2##5##(1997-3#1)(2008-10#1)
are more common in##6##4##(1990-2#1)(1996-12#1)(1997-3#1)(2008-10#1)(2010-3#1)(2013-1#1)
are more common##14##3##(1990-2#1)(1993-11#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#3)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
are more commonly used##2##4##(2007-12#1)(2009-5#1)
are more complex than##2##4##(1994-3#1)(2008-2#1)
are more complicated than##3##4##(1993-8#1)(2007-12#1)(2012-2#1)
are more difficult to##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
are more diverse##2##3##(2007-10#1)(2008-10#1)
are more easily##2##3##(2008-3#1)(2008-5#1)
are more effective in##2##4##(1993-8#1)(1994-5#1)
are more effective than the##3##5##(1995-2#1)(1996-5#1)(2010-4#1)
are more effective than##7##4##(1993-2#1)(1995-2#1)(1996-5#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
are more effective##14##3##(1991-2#1)(1991-3#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-1#1)(2007-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
are more efficient##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2009-9#1)
are more enhanced##2##3##(2007-11#1)(2008-10#1)
are more evenly##2##3##(1995-2#1)(2007-12#1)
are more favorable for##2##4##(1992-3#2)
are more frequent than##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
are more frequent##6##3##(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
are more frequently##4##3##(1997-3#1)(2008-5#1)(2013-1#2)
are more fully understood##2##4##(2008-8#1)(2010-8#1)
are more important than the##2##5##(1995-1#1)(2008-11#1)
are more important than##4##4##(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
are more likely than##2##4##(2008-4#1)(2011-2#1)
are more likely to be##7##5##(1993-12#1)(1995-2#1)(2008-3#1)(2008-7#1)(2013-1#2)(2013-8#1)
are more likely to develop##2##5##(2008-4#1)(2010-12#1)
are more likely to experience##2##5##(2008-10#1)(2008-9#1)
are more likely to suffer##2##5##(2009-6#1)(2013-8#1)
are more likely to##38##4##(1991-12#1)(1993-11#1)(1993-12#2)(1995-1#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#2)
are more likely##40##3##(1991-12#1)(1993-11#1)(1993-12#2)(1995-1#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#2)
are more often##5##3##(1992-3#1)(1994-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
are more potent##2##3##(2008-12#1)(2009-9#1)
are more prevalent in##3##4##(2008-11#1)(2008-7#1)(2009-5#1)
are more prevalent##4##3##(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#1)
are more pronounced##3##3##(1991-12#1)(2007-12#1)(2008-11#1)
are more related to the##2##5##(1991-5#1)(2008-8#1)
are more resistant than##2##4##(2008-10#1)(2013-1#1)
are more resistant to##5##4##(1993-12#1)(1997-4#1)(2008-11#1)(2009-10#1)(2009-8#1)
are more resistant##7##3##(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2013-1#1)
are more responsive to##2##4##(1993-12#1)(2012-2#1)
are more selective##2##3##(1995-11#1)(2008-11#1)
are more sensitive than##3##4##(2008-10#2)(2008-5#1)
are more sensitive to##2##4##(1991-10#1)(2013-1#1)
are more sensitive##5##3##(1991-10#1)(2008-10#2)(2008-5#1)(2013-1#1)
are more significant##2##3##(2008-3#2)
are more similar to each other##2##6##(1993-6#1)(2008-10#1)
are more stable than##3##4##(1995-5#1)(2007-12#1)(2008-8#1)
are more stable##5##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
are more suitable for##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
are more suited to##2##4##(2006-10#1)(2008-9#1)
are more susceptible to##4##4##(2008-6#1)(2009-5#1)(2012-1#1)(2013-1#1)
are more susceptible##5##3##(2008-6#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
are more than##11##3##(1992-12#1)(1993-12#2)(1996-12#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
are more useful##2##3##(2009-3#1)(2010-12#1)
are more vulnerable to##2##4##(2008-4#1)(2013-1#1)
are more vulnerable##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
are more##279##2##(1990-2#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#2)(2008-1#4)(2008-10#26)(2008-11#12)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#10)(2008-5#10)(2008-6#2)(2008-7#9)(2008-8#15)(2008-9#7)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#3)(2010-10#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#3)(2011-2#15)(2012-1#1)(2012-2#10)(2012-3#2)(2013-1#12)(2013-8#2)
are morphologically similar to##2##4##(2008-10#1)(2010-3#1)
are morphologically similar##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
are morphologically##10##2##(1995-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2010-4#1)(2012-3#1)
are most abundant##2##3##(2008-5#1)(2008-8#1)
are most appropriate##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
are most common##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
are most commonly##5##3##(2007-5#1)(2008-1#1)(2008-2#1)(2009-8#1)(2012-3#1)
are most effective##2##3##(1996-11#1)(2008-10#1)
are most frequently##6##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2012-3#1)
are most important in##2##4##(1994-9#1)(2007-8#1)
are most important##3##3##(1994-9#1)(2007-8#1)(2008-9#1)
are most likely to have##2##5##(2008-1#1)(2008-5#1)
are most likely to##7##4##(1993-12#1)(1994-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
are most likely##15##3##(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-10#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)
are most often##6##3##(1992-8#1)(1994-2#1)(2006-10#1)(2010-11#1)(2010-12#1)(2012-12#1)
are most pronounced in the##2##5##(2008-2#1)(2008-3#1)
are most suitable for##2##4##(2008-10#2)
are most##85##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#1)
are mostly found in##2##4##(1996-12#1)(1997-8#1)
are mostly used##2##3##(1995-5#1)(2010-8#1)
are mostly##22##2##(1991-6#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-8#2)(2012-3#2)(2013-1#1)
are motile##2##2##(2008-5#1)(2011-2#1)
are motivated##2##2##(2009-5#1)(2012-12#1)
are moved##3##2##(2008-3#2)(2012-1#1)
are moving toward##2##3##(1995-2#1)(2010-9#1)
are moving##5##2##(1993-12#1)(1995-2#1)(2008-10#1)(2009-7#1)(2010-9#1)
are much better##2##3##(1995-2#1)(1997-3#1)
are much larger than##2##4##(2008-10#1)(2008-3#1)
are much less common##2##4##(2008-5#1)(2009-1#1)
are much less likely than##2##5##(1994-2#1)(2011-2#1)
are much less sensitive to##3##5##(2008-2#1)(2008-5#1)(2009-9#1)
are much less##10##3##(1994-2#1)(1996-1#1)(2007-11#1)(2008-2#1)(2008-5#2)(2009-1#1)(2009-9#1)(2010-4#1)(2011-2#1)
are much lower than##2##4##(2008-10#1)(2010-8#1)
are much lower##3##3##(2008-10#1)(2010-6#1)(2010-8#1)
are much more likely to##2##5##(2008-12#1)(2009-12#1)
are much more##17##3##(1990-11#1)(1993-3#1)(1995-2#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-8#1)(2012-12#1)
are much smaller than##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
are much##45##2##(1990-11#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#3)(1996-1#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
are multidisciplinary##2##2##(1994-12#1)(2013-1#1)
are multifaceted##2##2##(1994-9#1)(1996-12#1)
are multifactorial##2##2##(1990-2#1)(2008-4#1)
are multiple and##3##3##(2008-5#1)(2011-2#2)
are multiple##16##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-2#4)(2013-1#1)
are multiplexed##3##2##(2008-3#3)
are multiply##2##2##(2008-2#1)(2008-3#1)
are multipotent and##2##3##(2012-12#2)
are mutagenic##2##2##(1991-12#1)(2008-10#1)
are mutually exclusive##3##3##(1995-9#1)(2006-10#1)(2011-2#1)
are mutually##5##2##(1994-12#1)(1995-9#1)(2006-10#1)(2008-9#1)(2011-2#1)
are narrow##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
are narrower than##2##3##(2007-12#1)(2008-10#1)
are native##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
are natural##8##2##(1991-3#1)(1992-3#1)(1997-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#2)
are naturally occurring##2##3##(2008-10#1)(2009-2#1)
are naturally##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)
are near##3##2##(1997-8#1)(2007-12#1)(2008-10#1)
are nearly identical to those##2##5##(1992-3#1)(2008-3#1)
are nearly identical##4##3##(1992-3#1)(1994-8#1)(2007-11#1)(2008-3#1)
are nearly independent of the##2##5##(1997-7#1)(2008-2#1)
are nearly##13##2##(1992-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)
are necessary for an##2##4##(2008-1#1)(2008-10#1)
are necessary for efficient##2##4##(2008-11#1)(2008-2#1)
are necessary for expression of##2##5##(1995-2#1)(2008-7#1)
are necessary for the##8##4##(1990-9#1)(1991-7#1)(1991-9#1)(1994-8#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-5#1)
are necessary for##40##3##(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-2#2)(1995-5#1)(1996-4#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-5#1)(2010-7#1)(2011-2#1)
are necessary in order to##2##5##(2007-10#1)(2012-3#1)
are necessary in##5##3##(1996-3#1)(2007-10#2)(2012-3#1)(2013-8#1)
are necessary to confirm##3##4##(2008-4#1)(2012-12#1)(2013-1#1)
are necessary to determine##4##4##(2008-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
are necessary to ensure##2##4##(1996-11#1)(2013-8#1)
are necessary to further##2##4##(2008-10#1)(2011-2#1)
are necessary to improve##2##4##(2009-5#1)(2009-6#1)
are necessary to support##3##4##(2008-10#1)(2012-2#2)
are necessary to verify##2##4##(2007-8#1)(2008-10#1)
are necessary to##40##3##(1996-11#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
are necessary##101##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-8#2)(1995-2#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-4#2)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
are needed across##2##3##(2012-12#1)(2012-3#1)
are needed and##2##3##(2008-10#1)(2008-5#1)
are needed for the##2##4##(2008-10#2)
are needed for##18##3##(1993-12#1)(1995-11#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#1)
are needed if##2##3##(2008-4#1)(2008-5#1)
are needed in order to##6##5##(1997-6#1)(2008-1#1)(2008-10#2)(2010-9#1)(2013-1#1)
are needed in the##3##4##(1991-3#1)(1992-3#1)(2011-2#1)
are needed in##13##3##(1991-3#1)(1992-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2009-8#1)(2010-9#1)(2011-2#3)(2013-1#1)
are needed on##2##3##(1997-3#1)(2011-1#1)
are needed that##2##3##(1991-2#1)(2012-12#1)
are needed to address##2##4##(2010-9#1)(2012-12#1)
are needed to better##2##4##(2011-2#1)(2013-1#1)
are needed to confirm the##3##5##(1991-12#1)(2010-12#1)(2011-2#1)
are needed to confirm this##2##5##(2008-8#1)(2013-1#1)
are needed to confirm##8##4##(1991-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
are needed to define##2##4##(2008-4#1)(2011-2#1)
are needed to determine the##3##5##(2008-2#1)(2013-1#1)(2013-8#1)
are needed to determine whether##3##5##(1992-8#1)(1993-8#1)(2012-2#1)
are needed to determine##8##4##(1992-8#1)(1993-8#1)(1997-3#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
are needed to elucidate the##3##5##(1995-6#1)(2009-8#1)(2012-12#1)
are needed to ensure##2##4##(1995-6#1)(2008-8#1)
are needed to evaluate the##4##5##(2008-7#1)(2009-5#1)(2009-8#1)(2013-1#1)
are needed to evaluate##5##4##(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2013-1#1)
are needed to fully explore##2##5##(2008-10#1)(2013-1#1)
are needed to fully##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
are needed to further##2##4##(2007-12#1)(2010-12#1)
are needed to identify the##2##5##(2007-11#1)(2008-3#1)
are needed to identify##6##4##(2007-10#1)(2007-11#1)(2008-3#1)(2009-12#1)(2010-11#1)(2013-8#1)
are needed to improve the##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
are needed to improve##6##4##(1995-5#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
are needed to investigate##2##4##(2006-10#1)(2008-10#1)
are needed to understand the##2##5##(1997-3#1)(2012-2#1)
are needed to##93##3##(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-3#2)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-9#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#7)(2013-8#4)
are needed##198##2##(1990-3#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-10#2)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-2#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2008-1#4)(2008-10#20)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#10)(2013-8#4)
are needs##2##2##(1996-3#1)(2008-10#1)
are negative##7##2##(1997-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
are negatively correlated with##2##4##(2012-2#1)(2013-8#1)
are negatively correlated##3##3##(1993-12#1)(2012-2#1)(2013-8#1)
are negatively##6##2##(1992-2#1)(1993-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
are neglected##3##2##(1995-12#1)(2008-2#1)(2008-3#1)
are negligible##4##2##(2007-12#1)(2008-3#3)
are neither##5##2##(1991-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
are neurons##2##2##(2007-12#2)
are never##2##2##(2008-5#1)(2010-12#1)
are nevertheless##2##2##(2008-5#1)(2008-9#1)
are new for##2##3##(2008-5#2)
are new records for the##4##5##(2008-5#4)
are new reports for##3##4##(2008-5#3)
are new to##2##3##(1993-3#1)(2008-11#1)
are new##26##2##(1990-3#1)(1990-9#1)(1991-12#1)(1993-3#1)(1996-3#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#9)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
are newly##2##2##(2008-10#1)(2008-7#1)
are nine##3##2##(2008-5#2)(2008-8#1)
are no clear##2##3##(2008-10#1)(2008-8#1)
are no clinical##2##3##(2008-4#1)(2010-5#1)
are no common standards##2##4##(2008-7#1)(2013-8#1)
are no definitive##4##3##(2008-10#1)(2008-12#1)(2010-12#1)(2010-5#1)
are no longer##11##3##(1992-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#1)
are no more##3##3##(1994-2#1)(1997-6#1)(2010-6#1)
are no reports of##2##4##(2008-5#1)(2011-1#1)
are no reports##5##3##(2008-1#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
are no significant differences between the##2##6##(1993-8#1)(2008-10#1)
are no significant differences between##3##5##(1993-8#1)(2008-10#2)
are no significant##5##3##(1993-8#1)(2008-10#2)(2008-11#1)(2010-3#1)
are no signs##4##3##(1994-6#1)(1994-9#1)(2008-6#1)(2011-2#1)
are no specific##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
are no statistically significant differences between##2##6##(2008-5#1)(2013-1#1)
are no sufficient##2##3##(2007-2#1)(2013-1#1)
are no##102##2##(1990-11#1)(1990-2#2)(1990-6#1)(1990-9#1)(1992-10#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
are non-toxic##2##2##(2008-10#1)(2008-5#1)
are nonreactive##2##2##(1994-12#1)(2008-8#1)
are nonspecific##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
are normal##7##2##(1991-2#1)(1993-12#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)
are normalized##2##2##(2008-2#1)(2008-9#1)
are normally distributed##2##3##(1997-3#1)(2008-3#1)
are normally formed in##2##4##(2008-4#1)(2009-12#1)
are normally present in##2##4##(1990-12#1)(1992-9#1)
are normally##17##2##(1990-12#1)(1990-5#1)(1992-9#1)(1994-9#1)(1995-2#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-3#1)
are not a substitute for##2##5##(2007-10#1)(2008-5#1)
are not a##15##3##(1993-2#1)(1994-2#1)(1994-8#1)(1997-1#1)(2006-10#1)(2007-10#2)(2008-10#2)(2008-5#1)(2008-7#3)(2008-9#1)(2013-1#1)
are not able to##8##4##(1992-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
are not adequately##3##3##(1990-11#1)(2010-12#1)(2012-3#1)
are not affected by the##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
are not affected by##8##4##(1992-3#1)(1994-10#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)
are not affected##10##3##(1990-2#1)(1992-3#1)(1994-10#1)(1995-11#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)
are not always adequate##2##4##(1997-8#1)(2011-2#1)
are not always##14##3##(1993-1#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2011-3#1)
are not applicable##2##3##(1991-11#1)(2007-12#1)
are not appropriate for##4##4##(1996-7#1)(2008-8#1)(2010-3#2)
are not as##8##3##(1992-12#1)(1992-5#1)(1995-4#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-3#1)
are not associated with##7##4##(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-8#1)
are not available for##2##4##(2007-7#1)(2008-10#1)
are not available in##2##4##(2008-11#1)(2008-12#1)
are not available##14##3##(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-9#3)(2010-5#1)(2011-2#1)
are not based##2##3##(1994-3#1)(2008-7#1)
are not being##3##3##(1992-9#1)(2013-1#1)(2013-7#1)
are not capable of##2##4##(1992-6#1)(2009-5#1)
are not clear##4##3##(1992-12#1)(2007-7#1)(2011-2#1)(2012-2#1)
are not clearly understood##2##4##(1992-2#1)(1997-2#1)
are not clearly##6##3##(1990-7#1)(1992-2#1)(1997-2#1)(1997-4#1)(2008-11#1)(2011-2#1)
are not commonly##4##3##(1993-12#2)(2008-5#1)(2008-8#1)
are not compatible with##4##4##(2008-3#1)(2008-5#1)(2008-7#2)
are not completely clear##2##4##(2008-7#1)(2013-1#1)
are not completely##8##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
are not compromised##2##3##(1995-2#1)(2008-1#1)
are not conclusive##2##3##(1997-4#1)(2012-2#1)
are not considered##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
are not consistent with##9##4##(1994-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
are not consistent##10##3##(1994-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-5#1)
are not consistently##4##3##(1993-2#1)(1994-3#1)(2008-2#1)(2008-8#1)
are not correlated##2##3##(1990-12#1)(2008-10#1)
are not covered##2##3##(1994-3#1)(2010-11#1)
are not critical for##2##4##(1992-6#1)(2008-12#1)
are not cured##2##3##(1990-5#1)(2010-3#1)
are not currently##2##3##(1993-2#1)(2008-11#1)
are not defined##3##3##(1995-12#1)(1997-4#1)(2008-7#1)
are not designed to##3##4##(1994-3#1)(2008-7#1)(2008-9#1)
are not detectable##3##3##(1990-2#1)(2007-12#1)(2013-1#1)
are not detectably##2##3##(1992-11#1)(2008-9#1)
are not detected##2##3##(2008-10#1)(2008-4#1)
are not directly##6##3##(1994-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
are not distinct##2##3##(2011-2#2)
are not due to##3##4##(1991-12#1)(1992-8#1)(1994-2#1)
are not easy##2##3##(1993-11#1)(2013-1#1)
are not effective in##3##4##(2008-10#1)(2008-2#1)(2012-1#1)
are not effective##6##3##(1994-9#1)(1997-1#1)(2008-10#2)(2008-2#1)(2012-1#1)
are not equal##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
are not equivalent##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
are not essential for##4##4##(1991-2#1)(1993-2#1)(1993-9#1)(1994-6#1)
are not essential##5##3##(1991-2#1)(1993-2#1)(1993-9#1)(1994-6#1)(2008-2#1)
are not expected to##2##4##(1997-4#1)(2008-7#1)
are not expected##3##3##(1992-3#1)(1997-4#1)(2008-7#1)
are not exploited##2##3##(2009-6#1)(2012-2#1)
are not familiar with##3##4##(2008-4#1)(2010-8#1)(2013-8#1)
are not far##2##3##(1997-7#1)(2008-7#1)
are not feasible##3##3##(2008-10#2)(2008-5#1)
are not formed##2##3##(1994-12#1)(2008-10#1)
are not found in the##2##5##(2008-4#1)(2012-3#1)
are not found in##4##4##(1993-6#1)(2008-4#1)(2008-5#1)(2012-3#1)
are not found##7##3##(1993-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
are not free##2##3##(2013-1#1)(2013-8#1)
are not fully known##2##4##(2008-10#1)(2012-2#1)
are not fully understood##10##4##(1993-12#1)(2008-10#1)(2008-4#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
are not fully##18##3##(1991-6#1)(1992-11#1)(1993-12#1)(2008-10#2)(2008-4#2)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
are not generally##2##3##(2007-5#1)(2008-7#1)
are not high enough to##2##5##(1993-9#1)(2009-4#1)
are not identical to##2##4##(1990-2#1)(2012-2#1)
are not identical##4##3##(1990-2#1)(1990-3#1)(1993-11#1)(2012-2#1)
are not identified##2##3##(1994-9#1)(2008-10#1)
are not important##2##3##(1992-8#1)(1994-12#1)
are not in##8##3##(1991-12#1)(1996-2#1)(2007-12#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#1)
are not independent and##2##4##(2007-12#1)(2008-10#1)
are not independent##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
are not influenced by##2##4##(2008-10#1)(2011-1#1)
are not involved in the##2##5##(1992-8#1)(2008-4#1)
are not involved##4##3##(1991-2#1)(1992-8#1)(1995-12#1)(2008-4#1)
are not known##12##3##(1993-12#1)(1995-11#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-2#1)(2012-3#1)
are not likely to be##4##5##(1995-9#1)(2008-10#1)(2008-11#1)(2009-6#1)
are not likely to##5##4##(1995-9#1)(2008-10#1)(2008-11#2)(2009-6#1)
are not limited to##6##4##(1991-6#1)(1995-8#1)(2008-3#1)(2008-4#1)(2009-11#2)
are not linear##2##3##(2008-10#2)
are not major##2##3##(2008-10#1)(2009-6#1)
are not mediated by##3##4##(1992-8#1)(1994-3#1)(1994-8#1)
are not met##2##3##(2010-3#1)(2013-8#1)
are not mutually exclusive##6##4##(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2013-1#1)
are not necessarily##11##3##(1991-1#1)(1992-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2013-8#1)
are not necessary for##3##4##(2008-10#2)(2013-1#1)
are not necessary##7##3##(2008-10#3)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
are not needed for##3##4##(1994-8#1)(1995-2#1)(2007-12#1)
are not new##4##3##(1994-12#1)(1994-3#1)(2008-12#1)(2010-2#1)
are not observed##6##3##(1991-12#1)(1992-11#1)(1992-6#1)(1997-2#1)(2008-3#1)(2013-8#1)
are not obvious##2##3##(1990-7#1)(2012-1#1)
are not only important##2##4##(1992-8#1)(2013-1#1)
are not only the##2##4##(2008-8#1)(2012-12#1)
are not only##19##3##(1992-11#1)(1992-8#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
are not ordinarily##2##3##(1991-12#1)(2008-3#1)
are not possible##4##3##(1993-3#1)(1996-3#1)(1997-3#1)(2008-3#1)
are not precisely known##2##4##(1994-5#1)(2010-6#1)
are not present in the##2##5##(1993-6#1)(1994-12#1)
are not present in##6##4##(1993-6#1)(1994-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-4#1)
are not present##10##3##(1991-5#1)(1993-6#1)(1994-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-8#1)(2010-4#1)
are not principal##2##3##(2007-12#1)(2008-10#1)
are not produced##2##3##(2008-10#1)(2008-5#1)
are not readily##7##3##(1991-5#1)(1993-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
are not recommended##2##3##(1997-4#1)(2009-5#1)
are not related to##4##4##(1995-2#1)(1996-8#1)(2008-2#1)(2008-7#1)
are not required##5##3##(1991-6#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
are not rescued by##2##4##(1995-9#1)(2008-8#1)
are not restricted to##2##4##(2008-10#1)(2008-6#1)
are not routinely##2##3##(1996-11#1)(2008-11#1)
are not satisfactory##2##3##(2008-7#1)(2008-9#1)
are not satisfied##2##3##(1990-6#1)(2012-3#1)
are not seen##3##3##(1995-5#1)(2008-5#1)(2012-2#1)
are not sensitive##2##3##(2008-10#2)
are not significant##5##3##(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
are not significantly different from##2##5##(1990-12#1)(2008-10#1)
are not significantly different##3##4##(1990-12#1)(2008-10#2)
are not simply##3##3##(2008-8#1)(2009-4#1)(2012-12#1)
are not so##2##3##(2008-4#1)(2013-8#1)
are not specific##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
are not standardized##2##3##(1992-3#1)(1993-12#1)
are not statistically significant##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
are not statistically##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
are not strictly##2##3##(1992-11#1)(2008-3#1)
are not subject##2##3##(1991-3#1)(2010-8#1)
are not sufficient for##2##4##(1992-6#1)(2008-4#1)
are not sufficient to##5##4##(1991-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
are not sufficient##9##3##(1991-3#1)(1992-3#1)(1992-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
are not suitable for##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
are not suitable to##2##4##(2007-7#1)(2013-8#1)
are not suitable##7##3##(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#2)(2013-8#1)
are not the cause of##2##5##(1992-12#1)(1995-5#1)
are not the same##2##4##(1997-2#1)(2008-7#1)
are not the##12##3##(1990-12#1)(1991-12#1)(1992-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
are not to be##3##4##(1991-3#1)(1994-9#1)(2010-3#1)
are not totally##2##3##(1991-12#1)(1996-11#1)
are not uncommon in##2##4##(1992-5#1)(2008-4#1)
are not uncommon##8##3##(1992-5#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#2)(2012-2#1)
are not understood##2##3##(1997-3#1)(2010-5#1)
are not uniform##2##3##(1994-9#1)(2011-2#1)
are not uniformly##2##3##(1990-8#1)(1994-8#1)
are not universally##3##3##(1991-11#1)(2008-10#1)(2008-12#1)
are not useful##4##3##(1994-2#1)(2010-11#1)(2013-1#1)(2013-8#1)
are not usually##4##3##(1991-3#1)(2008-1#1)(2011-2#1)(2012-3#1)
are not very effective in##2##5##(2007-11#1)(2010-9#1)
are not very##5##3##(2007-11#1)(2007-5#1)(2008-10#1)(2009-5#1)(2010-9#1)
are not visible in##2##4##(2007-12#1)(2008-5#1)
are not visible##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
are not well defined##3##4##(1990-2#1)(1993-12#1)(2011-2#1)
are not well understood##14##4##(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#2)
are not well##23##3##(1990-2#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
are not yet available##4##4##(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
are not yet fully understood##3##5##(1994-8#1)(2008-7#1)(2009-11#1)
are not yet fully##4##4##(1994-8#1)(2008-7#1)(2009-11#1)(2009-6#1)
are not yet well defined##2##5##(2008-10#1)(2008-4#1)
are not yet##18##3##(1991-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
are not##795##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#2)(1991-11#3)(1991-12#9)(1991-2#2)(1991-3#5)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#6)(1992-12#7)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#6)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#6)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#8)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#7)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#4)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#4)(2007-12#17)(2007-2#4)(2007-5#4)(2007-7#5)(2007-8#2)(2008-1#6)(2008-10#91)(2008-11#28)(2008-12#11)(2008-2#18)(2008-3#31)(2008-4#27)(2008-5#24)(2008-6#8)(2008-7#33)(2008-8#19)(2008-9#27)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#4)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#35)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#9)(2012-2#22)(2012-3#8)(2013-1#22)(2013-7#2)(2013-8#15)
are notable for##2##3##(1997-2#1)(2013-1#1)
are notable##3##2##(1997-2#1)(2011-2#1)(2013-1#1)
are noted in##2##3##(2009-9#1)(2010-12#1)
are noted##16##2##(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1995-1#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
are noticeable##2##2##(2008-10#1)(2008-6#1)
are notorious for##2##3##(2008-7#1)(2008-8#1)
are notoriously##2##2##(2008-8#1)(2009-9#1)
are novel##6##2##(1990-5#1)(1997-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-7#1)
are now available for##3##4##(2007-8#1)(2008-5#1)(2008-7#1)
are now available##8##3##(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)
are now becoming available##2##4##(2008-3#1)(2008-6#1)
are now becoming##3##3##(1997-2#1)(2008-3#1)(2008-6#1)
are now beginning to##3##4##(1991-3#1)(2011-2#2)
are now being used to##3##5##(2008-7#1)(2010-3#1)(2011-2#1)
are now being used##4##4##(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
are now being##18##3##(1991-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)
are now emerging##2##3##(2008-11#1)(2010-10#1)
are now generally accepted##2##4##(1996-4#1)(2008-5#1)
are now generally##3##3##(1995-12#1)(1996-4#1)(2008-5#1)
are now in operation##2##4##(1997-5#1)(2008-10#1)
are now in##4##3##(1997-2#1)(1997-5#1)(2008-10#1)(2011-2#1)
are now known to##2##4##(2006-10#1)(2009-4#1)
are now more##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
are now part of##2##4##(1996-3#1)(2011-2#1)
are now possible##2##3##(2008-10#1)(2008-7#1)
are now rapidly##2##3##(1993-12#1)(1995-1#1)
are now recognized as being##2##5##(2008-4#2)
are now recognized##5##3##(2008-1#1)(2008-4#2)(2008-7#1)(2012-12#1)
are now reported##2##3##(1994-8#1)(2011-2#1)
are now required##2##3##(1996-12#1)(2008-11#1)
are now routinely##2##3##(2010-5#1)(2013-1#1)
are now several##2##3##(2008-4#1)(2013-1#1)
are now surviving into##2##4##(2008-7#1)(2010-10#1)
are now widely used##2##4##(1990-2#1)(1993-2#1)
are now widely##5##3##(1990-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(2009-3#1)
are now##134##2##(1990-2#2)(1991-11#1)(1991-12#1)(1991-3#2)(1992-2#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
are nowadays##4##2##(2008-10#1)(2010-11#1)(2010-6#1)(2011-2#1)
are nuclear##2##2##(1991-2#1)(2008-5#1)
are numerically reconstructed##2##3##(2008-3#2)
are numerically##3##2##(2008-3#3)
are numerous and##2##3##(1993-12#1)(1995-1#1)
are numerous##18##2##(1993-12#1)(1994-11#1)(1995-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#2)
are obese##5##2##(2008-1#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-1#1)
are objectively##2##2##(2008-5#1)(2012-2#1)
are obligate intracellular pathogens that cause a##2##7##(2009-8#1)(2012-3#1)
are obligate intracellular##4##3##(2008-9#2)(2009-8#1)(2012-3#1)
are obligate##5##2##(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)
are obliged to##2##3##(1996-3#1)(2008-7#1)
are observed and##2##3##(2008-2#1)(2008-3#1)
are observed at the##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
are observed at##6##3##(1991-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
are observed between the##3##4##(1992-4#1)(2007-11#1)(2008-10#1)
are observed between##4##3##(1992-4#1)(1993-3#1)(2007-11#1)(2008-10#1)
are observed due to the strong##2##6##(1993-8#1)(2009-5#1)
are observed during##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
are observed for##9##3##(1991-8#1)(1994-5#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2011-2#1)
are observed in patients with##3##5##(2007-11#1)(2008-3#1)(2008-7#1)
are observed in the##9##4##(1990-5#1)(1995-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-12#1)
are observed in various##2##4##(1997-8#1)(2008-10#1)
are observed in##34##3##(1990-5#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#3)(2010-12#1)(2012-12#1)(2012-3#1)
are observed on##2##3##(1990-8#1)(2008-10#1)
are observed only##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
are observed to be##2##4##(1996-4#1)(2008-3#1)
are observed to##5##3##(1996-4#1)(2007-12#1)(2008-3#2)(2010-2#1)
are observed under##2##3##(1991-11#1)(2007-12#1)
are observed when##3##3##(2007-11#2)(2008-4#1)
are observed with a##2##4##(1990-5#1)(2008-10#1)
are observed with##5##3##(1990-5#1)(1992-3#1)(1995-11#1)(2008-10#1)(2008-5#1)
are observed##109##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-8#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-8#3)(1994-5#3)(1995-11#2)(1995-6#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#11)(2007-12#7)(2008-1#1)(2008-10#13)(2008-12#2)(2008-2#6)(2008-3#15)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-5#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
are obtainable##2##2##(2007-12#1)(2011-1#1)
are obtained after##2##3##(1992-8#1)(2008-3#1)
are obtained and used##2##4##(2008-3#1)(2011-1#1)
are obtained and##5##3##(1994-11#1)(2007-1#1)(2007-12#1)(2008-3#1)(2011-1#1)
are obtained at##3##3##(2008-10#2)(2008-2#1)
are obtained by means of##2##5##(2008-3#2)
are obtained by the##4##4##(2008-10#1)(2008-2#2)(2011-1#1)
are obtained by use of##3##5##(2008-3#3)
are obtained by##24##3##(1990-6#1)(1995-2#1)(1996-2#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#12)(2009-11#1)(2011-1#1)
are obtained following##2##3##(2007-11#2)
are obtained for a##2##4##(2008-10#1)(2008-3#1)
are obtained for each##2##4##(2008-10#1)(2010-8#1)
are obtained for the##5##4##(1990-8#1)(2008-10#1)(2008-3#2)(2013-1#1)
are obtained for##16##3##(1990-8#1)(2008-10#5)(2008-3#7)(2008-4#1)(2010-8#1)(2013-1#1)
are obtained from the##4##4##(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)
are obtained from##13##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#1)
are obtained in the##5##4##(2008-10#2)(2008-2#2)(2008-3#1)
are obtained in##14##3##(1990-12#1)(1996-6#1)(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#1)(2012-8#1)(2013-7#1)
are obtained only##2##3##(2008-10#1)(2008-2#1)
are obtained that##2##3##(2007-11#1)(2008-3#1)
are obtained through##2##3##(2008-10#1)(2008-3#1)
are obtained using##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
are obtained when the##2##4##(2007-11#1)(2007-12#1)
are obtained when##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
are obtained with a##2##4##(2008-2#2)
are obtained with##11##3##(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)
are obtained##160##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-8#1)(1993-3#1)(1994-11#2)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(2007-1#1)(2007-11#14)(2007-12#14)(2008-1#1)(2008-10#36)(2008-2#14)(2008-3#47)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
are obvious##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
are obviously##4##2##(1994-5#1)(1996-3#1)(2008-5#1)(2009-12#1)
are occasional##2##2##(2007-11#1)(2008-10#1)
are occasionally##4##2##(2008-2#2)(2010-12#1)(2010-3#1)
are occupied by##4##3##(1991-5#1)(1997-6#1)(1997-7#2)
are occurring in##3##3##(1995-1#1)(1996-2#1)(2008-10#1)
are occurring##4##2##(1992-6#1)(1995-1#1)(1996-2#1)(2008-10#1)
are of a##9##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
are of concern##3##3##(2008-10#2)(2008-5#1)
are of considerable importance##2##4##(2007-11#1)(2011-1#1)
are of considerable##4##3##(2007-11#2)(2008-10#1)(2011-1#1)
are of crucial importance##2##4##(2008-9#1)(2010-5#1)
are of doubtful##2##3##(2008-1#1)(2008-10#1)
are of fundamental importance##2##4##(2008-10#1)(2008-7#1)
are of fundamental##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
are of great importance for##2##5##(1991-2#1)(1992-12#1)
are of great importance##5##4##(1991-2#1)(1992-12#1)(2008-9#1)(2013-1#2)
are of great interest for##2##5##(2008-10#1)(2008-5#1)
are of great interest##3##4##(2008-10#1)(2008-5#2)
are of great##15##3##(1991-2#1)(1992-12#1)(1994-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
are of high##2##3##(1993-6#1)(2011-1#1)
are of importance in the##2##5##(1992-9#1)(2010-12#1)
are of importance in##3##4##(1992-4#1)(1992-9#1)(2010-12#1)
are of importance to##2##4##(1995-6#1)(2008-10#1)
are of importance##8##3##(1992-4#1)(1992-9#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
are of interest for##4##4##(1993-9#1)(1997-7#1)(2008-3#1)(2013-8#1)
are of interest in developing##2##5##(2007-7#1)(2009-12#1)
are of interest to##4##4##(2007-10#1)(2008-10#1)(2010-5#1)(2011-2#1)
are of interest##11##3##(1993-9#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-5#1)(2011-2#2)(2013-8#1)
are of limited##3##3##(1996-11#1)(1997-2#1)(2008-5#1)
are of major importance##4##4##(1991-2#1)(2008-1#1)(2008-5#1)(2010-8#1)
are of major##5##3##(1991-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-8#1)
are of no##3##3##(1996-6#1)(2007-12#2)
are of normal##2##3##(1997-8#1)(2009-3#1)
are of particular concern##2##4##(1991-4#1)(2013-1#1)
are of particular importance##2##4##(1993-3#1)(2011-2#1)
are of particular interest for##3##5##(2008-2#1)(2008-7#1)(2008-9#1)
are of particular interest##8##4##(1993-3#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
are of particular##13##3##(1991-4#1)(1993-3#2)(1994-8#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
are of special interest for their ability to degrade##2##9##(2011-2#2)
are of special interest##3##4##(1990-9#1)(2011-2#2)
are of the order of##5##5##(2007-11#1)(2008-2#1)(2008-3#3)
are of the same##6##4##(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
are of the##23##3##(1991-2#1)(1991-3#1)(1992-6#1)(1994-5#2)(1995-8#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-10#2)(2012-2#1)
are of two##3##3##(1996-2#1)(2007-12#1)(2008-9#1)
are of utmost importance##2##4##(1993-3#1)(2008-5#1)
are of##171##2##(1990-9#1)(1991-2#4)(1991-3#1)(1991-4#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-9#3)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-5#3)(1994-8#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#9)(2007-7#2)(2008-1#3)(2008-10#16)(2008-11#4)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#4)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
are off##4##2##(2008-3#1)(2008-4#2)(2012-2#1)
are offered for##2##3##(1992-12#1)(2008-10#1)
are offered on how##2##4##(1996-1#1)(2008-12#1)
are offered to##3##3##(1992-12#1)(2008-4#1)(2012-3#1)
are offered which##2##3##(2008-11#1)(2008-12#1)
are offered##26##2##(1991-2#1)(1992-12#3)(1992-2#2)(1993-12#1)(1994-2#1)(1995-6#1)(1996-1#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
are often a##3##3##(1995-1#1)(2008-10#1)(2010-4#1)
are often assumed to be##2##5##(2008-9#1)(2013-1#1)
are often assumed##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
are often at##2##3##(1990-11#1)(2011-2#1)
are often based on##2##4##(2008-11#1)(2008-8#1)
are often called upon to##2##5##(2008-1#1)(2012-12#1)
are often called##3##3##(2008-1#1)(2011-7#1)(2012-12#1)
are often carried out##2##4##(1992-11#1)(2010-11#1)
are often employed##2##3##(2008-3#2)
are often found in##2##4##(2008-10#1)(2008-5#1)
are often found##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
are often hampered by##2##4##(2008-10#1)(2008-2#1)
are often in##2##3##(1994-2#1)(1996-11#1)
are often limited by##3##4##(1995-5#1)(2008-10#1)(2011-2#1)
are often limited##7##3##(1994-12#1)(1995-5#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-7#1)
are often made##3##3##(1997-2#1)(2010-3#1)(2012-12#1)
are often manifested##2##3##(1995-5#1)(1997-4#1)
are often more##2##3##(1990-5#1)(2008-5#1)
are often neglected##2##3##(1995-2#1)(2013-1#1)
are often not##8##3##(1991-1#1)(1992-3#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)
are often obtained##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)
are often overlooked##5##3##(2009-6#1)(2010-4#1)(2012-2#1)(2012-5#1)(2013-7#1)
are often performed##2##3##(1990-12#1)(2008-7#1)
are often present in##2##4##(2007-12#1)(2008-10#1)
are often present##5##3##(2007-12#1)(2008-10#3)(2008-9#1)
are often reported##2##3##(1997-3#1)(2010-2#1)
are often required to##2##4##(2008-11#1)(2013-1#1)
are often required##4##3##(2006-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
are often seen in##4##4##(1995-8#1)(1997-8#1)(2008-1#1)(2008-7#1)
are often seen on##2##4##(2008-1#1)(2009-9#1)
are often seen##8##3##(1995-8#1)(1996-11#1)(1997-8#1)(2008-1#2)(2008-7#1)(2009-9#1)(2010-3#1)
are often the##8##3##(2007-11#1)(2008-10#1)(2008-2#2)(2011-1#1)(2012-2#1)(2012-5#1)(2013-1#1)
are often uncomfortable##2##3##(2007-12#1)(2010-5#1)
are often used as##3##4##(1992-3#1)(2008-10#1)(2008-4#1)
are often used for##2##4##(2008-9#1)(2013-1#1)
are often used in##4##4##(2006-4#1)(2008-3#2)(2010-6#1)
are often used to##4##4##(1997-6#1)(2009-2#1)(2011-2#1)(2012-1#1)
are often used##15##3##(1992-3#1)(1995-11#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
are often weak##2##3##(1992-3#1)(2008-9#1)
are often##230##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-1#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#4)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-6#1)(2008-1#6)(2008-10#17)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#14)(2008-9#9)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-9#4)(2010-11#2)(2010-2#3)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#11)(2011-7#3)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#4)(2012-5#2)(2013-1#11)(2013-7#1)(2013-8#1)
are older than##2##3##(2008-4#1)(2012-3#1)
are older##3##2##(1991-11#1)(2008-4#1)(2012-3#1)
are on a##3##3##(2008-11#2)(2012-2#1)
are on the rise##2##4##(1993-5#1)(2008-11#1)
are on the same##2##4##(1991-11#1)(2007-12#1)
are on the##8##3##(1991-11#1)(1992-3#1)(1993-5#1)(2007-12#3)(2008-11#1)(2011-2#1)
are on##18##2##(1991-11#1)(1992-3#1)(1992-6#1)(1993-5#1)(1997-5#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-2#1)(2011-2#1)(2012-2#1)
are on-line##2##2##(2008-10#2)
are oncogenic##3##2##(2009-5#1)(2011-2#1)(2012-12#1)
are one of the major##3##5##(2008-2#1)(2009-5#1)(2012-2#1)
are one of the most common##2##6##(2007-8#1)(2011-2#1)
are one of the most##7##5##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#4)
are one of the##19##4##(1991-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2009-5#1)(2010-3#1)(2011-2#5)(2012-2#2)
are one##23##2##(1991-3#1)(1994-5#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-5#1)(2009-5#1)(2010-3#1)(2011-2#6)(2012-2#2)(2012-3#1)
are ongoing to##2##3##(2007-9#1)(2008-7#1)
are ongoing##5##2##(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)
are only a few##7##4##(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
are only a##8##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
are only available##2##3##(1993-11#1)(2008-8#1)
are only beginning to be##2##5##(2007-12#2)
are only beginning to##3##4##(2007-12#2)(2008-4#1)
are only moderately##2##3##(2008-11#1)(2010-4#1)
are only now##2##3##(1990-5#1)(2012-2#1)
are only part of##2##4##(2008-1#1)(2008-6#1)
are only present in##2##4##(1991-11#1)(2011-1#1)
are only present##3##3##(1991-11#1)(2008-5#1)(2011-1#1)
are only some of the##2##5##(1997-2#1)(2008-11#1)
are only two##3##3##(1991-12#1)(1995-6#1)(2008-5#1)
are only##67##2##(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
are open##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
are operated##4##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
are operating##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2009-5#1)
are operationally##2##2##(2008-10#1)(2012-12#1)
are operative##2##2##(1995-5#1)(2008-10#1)
are optical##4##2##(2007-11#1)(2008-3#3)
are optically##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
are optimal##3##2##(1997-4#1)(2007-12#1)(2011-2#1)
are optimally##2##2##(1992-8#1)(1993-11#1)
are optimised by##2##3##(2008-10#2)
are optimised##7##2##(2008-10#5)(2008-7#1)(2013-1#1)
are optimized by##2##3##(2008-10#2)
are optimized for##2##3##(2007-12#1)(2013-1#1)
are optimized to maximize the##2##5##(2007-12#1)(2008-10#1)
are optimized to##3##3##(2007-12#1)(2008-10#2)
are optimized##16##2##(2007-12#2)(2008-10#11)(2008-7#1)(2010-5#1)(2013-1#1)
are or##2##2##(2008-4#1)(2012-2#1)
are ordered##2##2##(1993-2#1)(2006-10#1)
are organic##2##2##(2008-10#1)(2013-8#1)
are organised##2##2##(1994-12#1)(1995-6#1)
are organized and##2##3##(1992-3#1)(1993-12#1)
are organized as##3##3##(1993-12#1)(1994-5#1)(2008-9#1)
are organized in##2##3##(1993-2#1)(2008-8#1)
are organized into##3##3##(1992-9#1)(2008-6#1)(2008-7#1)
are organized##15##2##(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
are oriented in##2##3##(2008-10#1)(2008-11#1)
are oriented##6##2##(1990-11#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
are orthorhombic##2##2##(1996-2#1)(1997-7#1)
are other##11##2##(1994-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
are otherwise##8##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
are our##4##2##(1996-2#1)(1997-1#1)(2006-10#1)(2012-12#1)
are out of##3##3##(1995-9#1)(2008-11#1)(2008-6#1)
are outlined and##2##3##(2008-10#1)(2008-11#1)
are outlined in##3##3##(2008-4#1)(2009-4#1)(2012-2#1)
are outlined##37##2##(1991-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
are outweighed by##2##3##(2008-9#1)(2011-1#1)
are over##4##2##(1990-6#1)(2007-2#1)(2008-10#1)(2011-2#1)
are over-represented in##2##3##(2008-12#1)(2010-6#1)
are overcome##2##2##(1996-11#1)(1996-12#1)
are overexpressed in##4##3##(1992-9#1)(2008-4#1)(2009-10#1)(2012-1#1)
are overweight or obese##3##4##(2013-8#3)
are overweight or##4##3##(2008-3#1)(2013-8#3)
are overweight##5##2##(2008-3#1)(2012-3#1)(2013-8#3)
are oxidized##4##2##(1990-8#1)(1991-9#1)(2008-10#1)(2008-4#1)
are pH##2##2##(2008-10#1)(2008-8#1)
are packed##3##2##(1990-7#2)(2008-6#1)
are paid by##2##3##(1992-12#1)(1994-2#1)
are paid##7##2##(1992-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-2#1)(2008-11#1)(2009-11#1)
are paired##2##2##(2007-12#2)
are parallel to the##2##4##(1996-4#1)(2008-3#1)
are parallel to##3##3##(1996-4#1)(2008-3#1)(2008-5#1)
are parallel##4##2##(1996-2#1)(1996-4#1)(2008-3#1)(2008-5#1)
are parameters##2##2##(1990-8#1)(2008-2#1)
are parasites of##2##3##(2011-2#1)(2012-2#1)
are parents##2##2##(2009-11#1)(2010-5#1)
are part of a##6##4##(1990-2#1)(1993-6#1)(2008-11#2)(2011-2#1)(2012-3#1)
are part of the##8##4##(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-7#1)
are part of##19##3##(1990-2#1)(1993-2#1)(1993-6#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
are partially responsible for the##2##5##(1993-2#1)(1994-12#1)
are partially##11##2##(1993-2#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-9#1)(2009-10#1)(2013-8#1)
are particularly abundant##2##3##(2007-12#1)(2008-10#1)
are particularly important during##2##4##(2008-11#1)(2013-1#1)
are particularly important##4##3##(1992-4#1)(2008-11#1)(2012-2#1)(2013-1#1)
are particularly prone to##2##4##(2008-5#1)(2012-3#1)
are particularly suited for##2##4##(2008-10#1)(2008-3#1)
are particularly useful for##7##4##(1990-11#1)(1996-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)
are particularly useful in##2##4##(1997-1#1)(2008-3#1)
are particularly useful##12##3##(1990-11#1)(1993-12#1)(1996-12#1)(1997-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)
are particularly well suited##2##4##(2008-4#1)(2013-1#1)
are particularly##52##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1992-4#1)(1993-12#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#3)(2013-7#1)
are partly explained by the##2##5##(2010-12#1)(2012-3#1)
are partly explained by##3##4##(2010-12#1)(2012-1#1)(2012-3#1)
are partly##6##2##(1990-3#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-3#1)
are parts of##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
are passed##2##2##(2008-10#2)
are pathogenic to##2##3##(2008-10#2)
are pathogenic##4##2##(2008-10#4)
are pathogens of##3##3##(2008-10#3)
are pathogens##4##2##(2008-10#4)
are pathognomonic##2##2##(2011-1#1)(2012-3#1)
are patients in##2##3##(1990-12#1)(2011-2#1)
are patients##6##2##(1990-12#1)(1992-5#1)(2010-12#1)(2011-2#2)(2013-8#1)
are pending##2##2##(1990-6#1)(2008-3#1)
are perceived as##4##3##(1996-12#1)(2008-11#1)(2010-3#1)(2010-4#1)
are perceived##8##2##(1995-1#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-4#1)(2013-1#1)
are perfectly##5##2##(2008-10#2)(2008-3#1)(2008-4#2)
are performed at##2##3##(2008-3#1)(2008-7#1)
are performed by a##2##4##(1993-2#1)(2008-2#1)
are performed by##4##3##(1993-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
are performed for a##2##4##(2008-2#1)(2008-3#1)
are performed for##7##3##(2007-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2011-2#1)
are performed in a##2##4##(2008-2#1)(2008-3#1)
are performed in order to##2##5##(1992-12#1)(2008-10#1)
are performed in the##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
are performed in##11##3##(1992-12#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2010-11#1)(2011-3#1)
are performed on a##3##4##(2007-11#1)(2008-3#2)
are performed on##5##3##(2007-11#1)(2008-3#3)(2008-9#1)
are performed to test##2##4##(2008-3#2)
are performed to##8##3##(1995-3#1)(2008-2#1)(2008-3#6)
are performed with a##3##4##(2008-3#3)
are performed with##7##3##(1995-3#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#3)
are performed##69##2##(1991-11#1)(1992-12#1)(1993-2#2)(1993-3#1)(1994-3#2)(1995-3#2)(1997-3#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#10)(2008-3#19)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2010-11#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
are performing##2##2##(2007-10#1)(2011-2#1)
are perfused##2##2##(1990-7#1)(2009-12#1)
are perhaps##3##2##(1997-2#1)(2010-7#1)(2012-2#1)
are persistent##2##2##(2007-12#1)(2008-10#1)
are perspective##2##2##(2008-10#1)(2009-9#1)
are perturbed##4##2##(1990-7#1)(2008-2#1)(2008-5#1)(2013-8#1)
are phase##2##2##(1994-5#1)(2008-3#1)
are phosphorylated at##2##3##(1994-11#1)(1995-3#1)
are phosphorylated in##2##3##(1997-2#1)(2008-6#1)
are phosphorylated##9##2##(1991-2#1)(1994-11#2)(1995-3#1)(1995-6#1)(1997-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
are phylogenetically##4##2##(1995-6#1)(2008-10#1)(2008-6#1)(2012-2#1)
are physically active##2##3##(1994-3#1)(2013-1#1)
are physically##8##2##(1992-3#1)(1994-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2010-9#1)(2013-1#1)(2013-8#1)
are physiologically##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)
are pivotal in the##2##4##(2006-10#2)
are pivotal in##3##3##(2006-10#2)(2008-12#1)
are pivotal##5##2##(2006-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
are placed in the##2##4##(1996-2#1)(2008-9#1)
are placed in##7##3##(1991-3#1)(1996-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)
are placed##14##2##(1991-3#1)(1994-3#1)(1996-2#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-8#1)
are placing##3##2##(1992-3#1)(1996-2#1)(1996-3#1)
are planar##2##2##(1996-2#1)(2007-12#1)
are planned to##4##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-6#1)
are planned##7##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)
are planning##3##2##(1992-8#1)(1995-1#1)(2008-9#1)
are plated##2##2##(1994-6#1)(2008-10#1)
are playing a role in##2##5##(2008-7#1)(2009-1#1)
are playing an##2##3##(2008-8#1)(2010-12#1)
are playing##4##2##(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)
are plotted##2##2##(1990-7#1)(2007-12#1)
are pluripotent##2##2##(2008-10#1)(2008-9#1)
are pointed out##7##3##(1990-10#1)(1990-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
are pointed##8##2##(1990-10#1)(1990-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
are polygynous##2##2##(1995-6#1)(2009-2#1)
are polymorphic for##2##3##(2008-5#1)(2008-9#1)
are polymorphic##3##2##(1996-8#1)(2008-5#1)(2008-9#1)
are poor and##2##3##(1994-1#1)(2008-10#1)
are poor substrates##2##3##(1993-8#1)(1994-9#1)
are poor##11##2##(1993-8#1)(1994-1#1)(1994-9#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)
are poorer##2##2##(2007-11#1)(2011-1#1)
are poorly understood and##2##4##(2008-10#1)(2008-5#1)
are poorly understood##17##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
are poorly##26##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-1#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
are popular##5##2##(1992-3#1)(1997-6#1)(2007-2#1)(2008-3#1)(2010-3#1)
are positioned within##2##3##(1993-8#1)(2012-12#1)
are positioned##8##2##(1991-2#1)(1993-8#2)(1995-8#1)(2008-10#1)(2008-3#2)(2012-12#1)
are positive##4##2##(1992-8#1)(1995-6#1)(2008-3#1)(2010-4#1)
are positively related##3##3##(1992-2#1)(2008-8#1)(2010-12#1)
are positively##4##2##(1992-2#1)(2008-8#1)(2008-9#1)(2010-12#1)
are possible for##2##3##(2008-2#1)(2008-4#1)
are possible in##6##3##(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
are possible with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
are possible##47##2##(1991-2#1)(1991-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
are possibly involved in##2##4##(1995-5#1)(2008-10#1)
are possibly##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
are postsynaptic targets of##2##4##(1992-3#2)
are postsynaptic##3##2##(1992-3#2)(1992-8#1)
are potent inhibitors of the##4##5##(1990-12#1)(1992-12#1)(1994-11#1)(2010-12#1)
are potent inhibitors of##8##4##(1990-12#1)(1990-8#1)(1992-12#1)(1994-11#2)(1995-11#2)(2010-12#1)
are potent##15##2##(1990-12#1)(1990-8#1)(1992-12#1)(1993-9#1)(1994-11#3)(1994-6#1)(1995-11#2)(1995-3#1)(2008-4#1)(2008-5#2)(2010-12#1)
are potential##20##2##(1992-8#1)(1993-12#1)(1995-6#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
are potentially at risk##2##4##(1991-12#1)(2013-1#1)
are potentially life-threatening##2##3##(1995-8#1)(2012-8#1)
are potentially useful for##5##4##(1993-9#2)(2008-10#2)(2008-2#1)
are potentially useful##8##3##(1993-9#2)(2008-10#2)(2008-2#1)(2009-5#1)(2009-7#1)(2012-2#1)
are potentially##30##2##(1991-12#1)(1992-3#1)(1993-9#2)(1994-12#1)(1995-8#1)(2007-2#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#1)
are potentiated##3##2##(1990-8#1)(1995-11#1)(2008-11#1)
are powerful tools for##2##4##(1997-6#1)(2008-4#1)
are powerful tools##3##3##(1997-6#1)(2008-4#2)
are powerful##6##2##(1997-6#1)(2008-10#1)(2008-4#2)(2012-3#2)
are practically##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
are preceded by##2##3##(1997-1#1)(2008-4#1)
are precise##5##2##(2008-10#5)
are precisely##2##2##(2008-10#1)(2008-3#1)
are preconcentrated##3##2##(2008-10#3)
are predictable##2##2##(2008-10#1)(2008-9#1)
are predicted as##2##3##(2008-10#1)(2013-1#1)
are predicted by the##2##4##(1991-2#1)(1993-3#1)
are predicted by##6##3##(1991-1#1)(1991-2#1)(1993-3#1)(2008-8#1)(2011-2#2)
are predicted for the##2##4##(1993-11#1)(2012-5#1)
are predicted for##3##3##(1993-11#1)(2008-9#1)(2012-5#1)
are predicted to be##6##4##(1990-11#1)(1995-8#1)(2008-2#2)(2009-5#1)(2011-1#1)
are predicted to##16##3##(1990-11#1)(1992-12#1)(1992-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)
are predicted##34##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)
are predictive of##2##3##(2008-8#1)(2010-8#1)
are predisposed to##4##3##(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#1)
are predominant##2##2##(2008-7#1)(2013-8#1)
are predominantly##11##2##(1992-3#2)(1992-8#1)(1995-5#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-2#2)
are preferable because of##2##4##(1997-8#1)(2011-2#1)
are preferable to##2##3##(2008-10#1)(2008-7#1)
are preferable##5##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
are preferentially##5##2##(1990-5#1)(1992-8#1)(2008-1#1)(2008-3#1)(2013-8#1)
are preferred##5##2##(1996-3#1)(2007-7#1)(2008-1#1)(2009-8#1)(2011-2#1)
are pregnant##2##2##(2007-2#1)(2008-3#1)
are preliminary##2##2##(1991-9#1)(2008-7#1)
are prepared as##2##3##(2008-10#1)(2008-4#1)
are prepared by##9##3##(2007-8#1)(2008-10#5)(2009-5#1)(2010-8#1)(2012-2#1)
are prepared for the##2##4##(1997-1#1)(2008-11#1)
are prepared for##3##3##(1992-2#1)(1997-1#1)(2008-11#1)
are prepared in##2##3##(1992-11#1)(2008-4#1)
are prepared to##4##3##(1994-12#1)(2008-11#2)(2013-8#1)
are prepared##26##2##(1990-12#1)(1992-11#1)(1992-2#1)(1994-12#1)(1997-1#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-4#3)(2009-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
are preparing and##2##3##(1993-12#1)(1994-1#1)
are preparing##3##2##(1993-12#1)(1994-1#1)(2008-12#1)
are prerequisites for##3##3##(1995-5#1)(2007-8#1)(2008-11#1)
are prerequisites##4##2##(1995-5#1)(2007-8#1)(2008-11#1)(2008-9#1)
are prescribed in##2##3##(1991-11#1)(2012-12#1)
are prescribed##6##2##(1991-11#1)(1996-4#1)(2008-5#1)(2012-12#1)(2013-1#2)
are present and##4##3##(1991-5#1)(1991-7#1)(1994-5#1)(2008-10#1)
are present at the artifact locations##2##6##(2008-3#2)
are present at the##4##4##(1997-2#1)(2007-12#1)(2008-3#2)
are present at##13##3##(1990-5#1)(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-7#1)
are present during##2##3##(2008-11#1)(2010-3#1)
are present for##2##3##(2008-8#1)(2011-2#1)
are present in a##9##4##(1994-2#1)(1994-8#1)(1996-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2012-12#2)
are present in all##6##4##(1992-12#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
are present in each##2##4##(1990-2#1)(2012-3#1)
are present in human##3##4##(1992-3#1)(2008-6#1)(2013-1#1)
are present in many##2##4##(1997-2#1)(2008-5#1)
are present in the human##3##5##(1993-11#1)(2008-5#1)(2012-2#1)
are present in the##50##4##(1990-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#3)(1994-11#1)(1994-8#2)(1995-12#1)(1996-12#1)(1997-1#2)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
are present in##116##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#5)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#3)(1995-12#3)(1995-2#1)(1996-12#2)(1997-1#2)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#21)(2008-11#7)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
are present on##5##3##(1997-8#1)(2007-12#2)(2008-10#1)(2008-5#1)
are present which##2##3##(1996-3#1)(2008-10#1)
are present within##2##3##(1990-7#1)(1992-12#1)
are present##184##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#5)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#8)(2008-1#5)(2008-10#31)(2008-11#10)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
are presented along with##3##4##(2008-10#1)(2008-12#1)(2008-2#1)
are presented and a##2##4##(1995-12#1)(2011-1#1)
are presented and analyzed##2##4##(2008-2#1)(2008-3#1)
are presented and are found to be in good agreement with##2##11##(2008-2#2)
are presented and are##4##4##(2008-2#2)(2008-3#2)
are presented and compared with##4##5##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
are presented and discussed##16##4##(1990-5#1)(1991-12#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)
are presented and the##2##4##(2008-10#1)(2009-9#1)
are presented and used to##2##5##(1993-3#1)(2008-12#1)
are presented and##38##3##(1990-5#1)(1991-12#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#1)(2009-9#1)(2011-1#1)(2013-1#1)
are presented as a##2##4##(1991-12#1)(2008-3#1)
are presented as an##4##4##(1994-2#1)(2013-1#2)(2013-8#1)
are presented as new##2##4##(1996-12#1)(2008-5#1)
are presented as well##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
are presented as##21##3##(1991-12#1)(1994-2#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#1)(2010-9#1)(2013-1#2)(2013-8#1)
are presented by##2##3##(2008-11#1)(2008-3#1)
are presented demonstrating##2##3##(2008-2#1)(2010-10#1)
are presented for a##4##4##(2007-11#1)(2008-3#2)(2011-1#1)
are presented for all##2##4##(2008-12#1)(2008-7#1)
are presented for both##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
are presented for the determination of##3##6##(2008-10#2)(2008-3#1)
are presented for the##20##4##(1991-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)
are presented for two##2##4##(2007-12#1)(2008-3#1)
are presented for##69##3##(1991-3#1)(1992-12#1)(1993-1#1)(1996-4#1)(1997-7#2)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#22)(2008-4#5)(2008-7#3)(2008-9#3)(2009-5#1)(2009-7#2)(2011-1#1)
are presented from##5##3##(1993-6#1)(2008-10#1)(2008-12#2)(2011-2#1)
are presented here for##2##4##(1990-8#1)(1992-2#1)
are presented here##5##3##(1990-8#1)(1992-2#1)(2008-11#1)(2008-5#1)(2010-7#1)
are presented in a##2##4##(1990-9#1)(2008-3#1)
are presented in the light of##2##6##(1990-3#1)(2008-5#1)
are presented in the##10##4##(1990-3#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-10#1)(2010-9#1)(2012-3#1)
are presented in this article##6##5##(1991-2#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
are presented in this paper##6##5##(2007-11#2)(2008-10#2)(2008-3#1)(2013-1#1)
are presented in this unit##3##5##(2008-4#1)(2008-9#2)
are presented in this##18##4##(1991-2#1)(1992-2#1)(1997-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
are presented in which##2##4##(2008-3#1)(2008-7#1)
are presented in##41##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-2#2)(1997-2#1)(2007-11#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#2)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
are presented of##3##3##(1996-4#1)(2008-2#1)(2008-3#1)
are presented on health##2##4##(1993-2#2)
are presented on the##2##4##(2007-11#1)(2008-3#1)
are presented on##7##3##(1991-3#1)(1993-2#2)(1997-3#1)(2007-11#2)(2008-3#1)
are presented showing that##2##4##(2008-2#1)(2008-9#1)
are presented showing##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
are presented that allow##2##4##(2008-3#1)(2008-9#1)
are presented that confirm the##3##5##(2007-12#2)(2008-2#1)
are presented that demonstrate the##9##5##(2007-12#2)(2008-2#2)(2008-3#5)
are presented that demonstrate##10##4##(2007-12#2)(2008-2#2)(2008-3#6)
are presented that illustrate the##2##5##(2008-11#1)(2012-2#1)
are presented that illustrate##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
are presented that show##2##4##(2007-11#1)(2009-12#1)
are presented that##26##3##(1993-12#1)(2007-11#2)(2007-12#6)(2008-11#1)(2008-2#4)(2008-3#8)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)
are presented to demonstrate the##3##5##(2008-3#1)(2009-12#1)(2011-2#1)
are presented to demonstrate##5##4##(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
are presented to help##2##4##(2007-2#1)(2008-12#1)
are presented to illustrate the##5##5##(1996-12#1)(1996-9#1)(2008-3#3)
are presented to illustrate##7##4##(1996-12#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-3#3)
are presented to show the##2##5##(1992-1#1)(2008-3#1)
are presented to show##3##4##(1992-1#1)(2008-3#2)
are presented to##35##3##(1990-9#1)(1992-1#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#16)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
are presented together with a##2##5##(2008-2#1)(2011-2#1)
are presented together with##4##4##(1990-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
are presented together##6##3##(1990-2#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
are presented using##2##3##(1993-3#1)(2008-7#1)
are presented which##7##3##(1991-5#1)(1992-6#1)(1993-1#1)(1997-6#1)(2007-8#1)(2008-10#1)(2009-3#1)
are presented with##7##3##(2008-2#2)(2008-3#1)(2009-11#1)(2012-3#2)(2013-1#1)
are presented##684##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#3)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#4)(1992-12#3)(1992-2#9)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-6#3)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-12#1)(2007-11#39)(2007-12#32)(2007-2#2)(2007-8#3)(2008-1#3)(2008-10#68)(2008-11#14)(2008-12#11)(2008-2#87)(2008-3#176)(2008-4#19)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#10)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#5)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#6)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#1)
are presenting a case##2##4##(2011-2#1)(2012-3#1)
are presenting a##6##3##(1992-11#1)(1996-7#1)(2008-10#2)(2011-2#1)(2012-3#1)
are presenting the case of##3##5##(2008-4#1)(2008-5#1)(2013-8#1)
are presenting the##5##3##(2007-8#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
are presenting##13##2##(1992-11#1)(1996-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are presently being##2##3##(1993-2#1)(1997-1#1)
are presently under##3##3##(1997-3#1)(2008-9#1)(2012-2#1)
are presently##12##2##(1992-9#1)(1993-2#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
are preserved##3##2##(1994-3#1)(2008-2#1)(2008-3#1)
are presumably##2##2##(1993-6#1)(2007-12#1)
are presumed to be##3##4##(1992-6#1)(1995-6#1)(2007-11#1)
are presumed to##7##3##(1990-7#1)(1992-6#1)(1995-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-7#1)
are prevalent in##6##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-3#1)
are prevalent##12##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
are preventable##2##2##(2010-8#1)(2011-2#1)
are prevented by##3##3##(1994-8#1)(1995-3#1)(2007-11#1)
are prevented##5##2##(1994-8#1)(1995-3#1)(2007-11#1)(2008-4#1)(2012-12#1)
are primarily influenced by##2##4##(2008-3#1)(2008-9#1)
are primarily##13##2##(1991-1#1)(1993-11#1)(1997-7#1)(2008-10#2)(2008-3#2)(2008-8#2)(2008-9#2)(2009-7#1)(2011-1#1)
are primary##6##2##(1992-1#1)(2008-12#1)(2008-7#1)(2009-6#1)(2012-2#2)
are prime##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
are principally##2##2##(2007-12#1)(2009-2#1)
are printed##2##2##(2008-10#1)(2008-3#1)
are private##2##2##(1997-8#1)(2011-2#1)
are probably involved in##2##4##(2008-8#1)(2009-8#1)
are probably involved##3##3##(2008-5#1)(2008-8#1)(2009-8#1)
are probably related to##3##4##(2008-5#1)(2008-9#1)(2009-8#1)
are probably responsible for the##3##5##(1997-2#1)(1997-7#1)(2008-10#1)
are probably the most##2##4##(2008-7#1)(2008-9#1)
are probably the##5##3##(1992-8#1)(1994-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
are probably##37##2##(1990-12#3)(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#2)(2012-3#1)(2013-7#1)
are probed##2##2##(2008-3#1)(2009-12#1)
are problematic##3##2##(1996-1#1)(2008-9#1)(2012-1#1)
are problems##2##2##(2008-10#1)(2013-1#1)
are procedures##3##2##(2008-2#1)(2008-4#1)(2012-3#1)
are processed by##4##3##(1996-2#1)(2008-10#1)(2008-3#2)
are processed to##3##3##(2007-11#1)(2008-3#2)
are processed##13##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#6)(2010-7#1)(2013-1#1)
are produced at##2##3##(2007-11#1)(2008-10#1)
are produced by a##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
are produced by multiple##2##4##(2008-2#1)(2010-10#1)
are produced by the##2##4##(1992-9#1)(1995-11#1)
are produced by##25##3##(1990-11#1)(1992-9#1)(1993-12#1)(1995-11#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#3)(2008-8#3)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-3#1)
are produced from##2##3##(1993-5#1)(2008-2#1)
are produced in##4##3##(1990-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
are produced##51##2##(1990-11#2)(1992-2#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-11#1)(1996-12#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
are products of##4##3##(1991-12#1)(1995-2#1)(2008-7#1)(2009-12#1)
are progressing##2##2##(1991-1#1)(2009-12#1)
are progressively##6##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
are projected onto a##2##4##(2008-2#1)(2008-3#1)
are projected onto##3##3##(2008-2#1)(2008-3#2)
are projected to##4##3##(1995-12#1)(1996-2#1)(1997-2#1)(2010-8#1)
are projected##9##2##(1995-12#2)(1996-2#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#2)(2010-8#1)
are prominent##3##2##(1994-12#1)(2007-12#1)(2008-4#1)
are promising and##3##3##(2007-12#1)(2008-9#1)(2012-2#1)
are promising for##6##3##(1995-2#1)(2008-3#3)(2009-2#1)(2009-7#1)
are promising in##2##3##(2008-2#1)(2013-1#1)
are promising to##2##3##(2007-12#1)(2013-8#1)
are promising##25##2##(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
are promoting##2##2##(1992-8#1)(2011-1#1)
are prone to##13##3##(1995-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are pronounced##3##2##(1992-9#1)(2008-11#1)(2008-5#1)
are properly assessed##3##3##(2008-3#1)(2008-5#1)(2012-12#1)
are properly##8##2##(1995-12#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-12#1)
are proportional to the##3##4##(2007-12#1)(2008-10#2)
are proportional to##5##3##(1997-7#1)(2007-12#1)(2008-10#3)
are proposed and tested##2##4##(2008-3#1)(2012-12#1)
are proposed and##8##3##(2008-10#4)(2008-2#1)(2008-3#1)(2010-11#1)(2012-12#1)
are proposed as##4##3##(1993-3#1)(2008-10#2)(2008-7#1)
are proposed for the##3##4##(2008-10#1)(2010-5#1)(2012-12#1)
are proposed for##15##3##(1992-2#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#2)
are proposed in##2##3##(2008-10#1)(2008-3#1)
are proposed of##2##3##(1996-6#1)(2008-3#1)
are proposed that##3##3##(1996-4#1)(2008-3#1)(2011-2#1)
are proposed to be##2##4##(1997-7#1)(2008-9#1)
are proposed to play a##2##5##(2008-1#1)(2008-9#1)
are proposed to predict##2##4##(2008-2#2)
are proposed to##17##3##(1990-8#1)(1991-12#1)(1992-5#1)(1992-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#3)(2012-3#1)(2013-1#1)(2013-8#1)
are proposed which##2##3##(1995-6#1)(2009-12#1)
are proposed##92##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-6#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#8)(2008-3#14)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
are protected against##2##3##(1992-9#1)(2012-3#1)
are protected from the##2##4##(2009-3#1)(2013-1#1)
are protected from##6##3##(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2013-1#1)
are protected##9##2##(1992-9#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#1)
are protective##2##2##(2008-7#1)(2011-1#1)
are proteolytically##2##2##(1995-6#1)(2008-1#1)
are protocols for##6##3##(2008-2#1)(2008-4#3)(2008-9#2)
are proved##4##2##(2007-11#1)(2008-3#2)(2011-2#1)
are proven for the##2##4##(1996-5#1)(2013-8#1)
are proven##3##2##(1996-5#1)(2010-2#1)(2013-8#1)
are provided as##2##3##(2008-4#2)
are provided by the##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
are provided by##9##3##(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#4)(2013-1#1)(2013-7#1)
are provided for both##2##4##(2007-9#1)(2008-4#1)
are provided for the preparation of##2##6##(2008-4#2)
are provided for the##4##4##(2008-4#3)(2008-7#1)
are provided for##31##3##(1993-2#1)(1995-3#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#13)(2008-7#1)(2008-9#7)(2009-5#1)
are provided in the##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
are provided in this unit for##3##6##(2008-2#1)(2008-4#2)
are provided in##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#2)
are provided that##4##3##(1994-3#1)(2008-2#1)(2008-3#1)(2008-7#1)
are provided to##13##3##(1995-2#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
are provided with##8##3##(1994-6#1)(1995-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-2#1)
are provided##136##2##(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#12)(2008-3#11)(2008-4#30)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#13)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-11#2)(2010-8#5)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
are providing##5##2##(1993-12#1)(2008-1#1)(2009-12#1)(2010-8#1)(2011-1#1)
are proving##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
are published in##2##3##(1991-5#1)(1993-12#1)
are published##7##2##(1991-5#2)(1993-12#1)(2007-2#1)(2008-11#1)(2012-12#1)(2012-2#1)
are pumped##2##2##(2007-12#1)(2008-10#1)
are purely##3##2##(1996-4#1)(2008-3#1)(2012-3#1)
are purified##4##2##(2008-1#2)(2008-2#1)(2008-6#1)
are pursuing##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
are put forward##2##3##(2007-12#1)(2008-3#1)
are put##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
are putative##4##2##(1993-12#1)(1994-12#1)(1995-9#1)(2008-7#1)
are putatively##2##2##(1996-5#1)(2008-10#1)
are qualitatively consistent with##3##4##(2008-3#1)(2009-10#1)(2013-1#1)
are qualitatively similar##2##3##(1990-7#1)(1993-5#1)
are qualitatively##7##2##(1990-7#1)(1993-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
are quantified by##2##3##(1993-12#1)(2008-2#1)
are quantified in##2##3##(1995-11#1)(2008-7#1)
are quantified##9##2##(1993-12#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)
are quantitative##3##2##(2008-10#3)
are quantitatively extracted##2##3##(2008-10#2)
are quantitatively##8##2##(1995-2#1)(1995-5#1)(2008-10#6)
are questionable##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
are questioned##2##2##(1994-11#1)(2009-12#1)
are questions about##2##3##(2008-11#2)
are quick and##2##3##(2008-10#1)(2008-4#1)
are quite different##5##3##(1993-12#1)(1993-8#1)(1994-1#1)(2008-7#1)(2008-8#1)
are quite similar##2##3##(2008-10#1)(2008-4#1)
are quite stable and##2##4##(2008-10#1)(2008-2#1)
are quite stable##3##3##(2008-10#2)(2008-2#1)
are quite suitable for##2##4##(1991-2#1)(2008-3#1)
are quite##29##2##(1991-2#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
are raised##5##2##(1992-3#1)(1995-2#2)(2010-10#1)(2012-1#1)
are randomly distributed##2##3##(2008-7#1)(2013-8#1)
are randomly##4##2##(2008-11#1)(2008-7#2)(2013-8#1)
are ranged##2##2##(2008-10#1)(2008-5#1)
are rapid##7##2##(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
are rapidly changing##3##3##(1993-2#1)(1996-3#1)(2012-2#1)
are rapidly emerging as##2##4##(1992-1#1)(2010-8#1)
are rapidly induced##2##3##(1991-5#1)(1991-7#1)
are rapidly##20##2##(1991-5#1)(1991-7#1)(1992-1#1)(1993-2#1)(1994-12#2)(1996-2#1)(1996-3#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
are rare and##13##3##(1990-9#1)(1991-11#2)(1992-12#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
are rare benign##3##3##(2007-8#1)(2012-12#1)(2013-8#1)
are rare but they##2##4##(2007-6#1)(2008-8#1)
are rare but##3##3##(2007-6#1)(2008-8#1)(2009-10#1)
are rare events##2##3##(2008-6#1)(2008-9#1)
are rare in childhood##2##4##(2008-10#1)(2008-7#1)
are rare in the##2##4##(2008-6#1)(2012-2#1)
are rare in##9##3##(2008-10#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
are rare lesions##2##3##(1991-5#1)(2008-1#1)
are rare tumors##4##3##(1990-6#1)(2012-1#1)(2013-1#2)
are rare tumours##4##3##(2008-7#1)(2012-2#2)(2013-7#1)
are rare##103##2##(1990-10#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
are rarely reported##3##3##(2013-1#3)
are rarely seen##2##3##(2007-5#1)(2007-7#1)
are rarely##12##2##(1996-11#1)(1996-6#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#3)(2013-1#3)
are rather rare in##2##4##(2008-9#1)(2011-2#1)
are rather resistant to##2##4##(1996-2#1)(2009-9#1)
are rather##10##2##(1993-12#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
are reached##2##2##(1992-5#1)(2008-3#1)
are reaching##4##2##(1993-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
are reactive oxygen species (ROS)##2##5##(2008-5#1)(2011-2#1)
are reactive##4##2##(2006-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
are readily accessible##2##3##(2008-7#1)(2012-3#1)
are readily available##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
are readily##21##2##(1992-3#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2012-3#1)
are ready##2##2##(2008-4#2)
are realistic##2##2##(1993-2#1)(1995-1#1)
are realized by##2##3##(2007-11#2)
are realized with##2##3##(2007-12#1)(2008-2#1)
are realized##7##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#1)
are really##3##2##(1995-1#1)(2011-2#1)(2013-8#1)
are rearranged##2##2##(1996-6#1)(2008-2#1)
are reasonable##3##2##(1994-5#1)(2008-10#2)
are reasonably##6##2##(1990-8#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
are receiving##7##2##(1992-5#1)(1993-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2013-1#2)
are recent##6##2##(2008-10#1)(2008-2#2)(2008-7#2)(2012-12#1)
are receptors##2##2##(2008-1#1)(2008-4#1)
are recognised and##2##3##(2008-11#1)(2011-1#1)
are recognised##3##2##(1992-6#1)(2008-11#1)(2011-1#1)
are recognized as##5##3##(2008-10#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
are recognized by##7##3##(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-3#1)
are recognized##24##2##(1990-8#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are recommendations##2##2##(2008-12#1)(2008-4#1)
are recommended for patients with##2##5##(2012-12#1)(2012-3#1)
are recommended for the##2##4##(2011-2#1)(2012-3#1)
are recommended for##6##3##(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)
are recommended to##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
are recommended##27##2##(1990-8#2)(1991-2#1)(1993-1#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)
are reconciled with##2##3##(2008-2#1)(2008-3#1)
are reconstructed by##3##3##(2007-12#2)(2008-3#1)
are reconstructed from##3##3##(2008-2#1)(2008-3#2)
are reconstructed##11##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2010-10#1)
are recorded at##2##3##(2007-12#1)(2008-11#1)
are recorded by use of##2##5##(2008-10#1)(2008-2#1)
are recorded by##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
are recorded for##2##3##(2012-2#1)(2013-1#1)
are recorded in a##3##4##(2007-11#1)(2008-3#2)
are recorded in the##4##4##(2007-12#1)(2008-3#2)(2010-8#1)
are recorded in##8##3##(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#4)(2010-8#1)
are recorded with##3##3##(2007-12#1)(2008-2#1)(2009-3#1)
are recorded##32##2##(1997-2#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#8)(2009-3#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
are recovered by##3##3##(1995-8#1)(2007-11#1)(2008-2#1)
are recovered from the##2##4##(2008-10#1)(2008-2#1)
are recovered from##3##3##(2008-10#2)(2008-2#1)
are recovered quantitatively##3##3##(2008-10#3)
are recovered##10##2##(1995-8#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#1)
are recruited to##2##3##(2008-5#1)(2011-1#1)
are recruited##5##2##(2008-11#1)(2008-5#2)(2011-1#1)(2012-12#1)
are redirected##2##2##(2008-10#1)(2008-3#1)
are reduced by##3##3##(1991-5#1)(1993-3#1)(2008-8#1)
are reduced in##5##3##(1993-12#1)(1994-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
are reduced to the##3##4##(1995-3#1)(2007-12#1)(2008-7#1)
are reduced to##6##3##(1995-3#1)(2007-12#2)(2008-3#2)(2008-7#1)
are reduced##30##2##(1990-11#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-4#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2011-2#1)(2012-2#2)(2012-7#1)
are referred for##2##3##(2011-2#2)
are referred to as &quot##4##5##(1997-6#1)(2009-12#1)(2010-3#2)
are referred to as##11##4##(1997-6#1)(2008-10#4)(2008-9#1)(2009-12#1)(2010-3#2)(2012-2#2)
are referred to##14##3##(1997-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-3#2)(2012-2#2)
are referred##19##2##(1993-2#1)(1995-2#1)(1996-9#1)(1997-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-2#2)
are refined##2##2##(2008-10#1)(2008-3#1)
are reflected by##4##3##(1994-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
are reflected in the##3##4##(1992-3#2)(1994-2#1)
are reflected in##6##3##(1992-3#2)(1994-2#1)(2008-1#1)(2010-10#1)(2010-5#1)
are reflected off the##2##4##(2008-2#1)(2008-3#1)
are reflected##15##2##(1992-3#2)(1993-2#1)(1994-2#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)
are reflective of##2##3##(2010-11#1)(2011-2#1)
are reflective##4##2##(2007-12#1)(2008-12#1)(2010-11#1)(2011-2#1)
are refractory to##4##3##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
are regarded as a##2##4##(2010-5#1)(2012-2#1)
are regarded as important##2##4##(2007-12#1)(2008-11#1)
are regarded as the most##2##5##(1993-2#1)(1994-11#1)
are regarded as##12##3##(1991-9#1)(1992-6#1)(1993-2#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-5#1)(2012-2#2)
are regarded##13##2##(1991-3#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-5#1)(2012-2#2)
are regular##2##2##(2008-5#1)(2012-3#1)
are regularly##5##2##(1992-3#1)(1995-6#1)(2008-1#1)(2008-11#2)
are regulated by a##2##4##(1994-12#1)(2009-9#1)
are regulated by##22##3##(1990-8#1)(1991-12#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#2)(2013-1#1)
are regulated in a##2##4##(1995-2#1)(1997-2#1)
are regulated in##6##3##(1995-2#1)(1996-2#2)(1997-2#1)(2009-3#1)(2011-2#1)
are regulated##38##2##(1990-8#1)(1991-12#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-2#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#3)
are rejected##2##2##(2008-10#1)(2008-8#1)
are related by a##3##4##(1991-12#1)(2008-4#1)(2008-6#1)
are related by##4##3##(1991-12#1)(2007-12#1)(2008-4#1)(2008-6#1)
are related to the##28##4##(1990-8#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-6#1)(1994-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
are related to##62##3##(1990-8#1)(1991-12#1)(1991-3#3)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#2)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
are related with##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
are related##81##2##(1990-8#1)(1991-12#2)(1991-3#3)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#2)(1997-2#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
are relatively easy to##4##4##(1996-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
are relatively few##3##3##(1996-2#1)(2008-6#1)(2008-7#1)
are relatively low##2##3##(2008-1#1)(2008-10#1)
are relatively rare in##2##4##(2007-8#1)(2009-3#1)
are relatively rare##6##3##(1993-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-11#1)
are relatively resistant to##2##4##(1990-12#1)(1995-8#1)
are relatively stable and##3##4##(2008-5#1)(2008-6#1)(2013-8#1)
are relatively uncommon##3##3##(2009-1#1)(2009-5#1)(2013-1#1)
are relatively##44##2##(1990-12#2)(1991-6#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
are released during##2##3##(1992-12#1)(1993-2#1)
are released from the##2##4##(2008-5#1)(2011-2#1)
are released from##7##3##(2008-4#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
are released##13##2##(1992-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
are relevant for##12##3##(1994-5#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
are relevant in##2##3##(2010-6#1)(2012-1#1)
are relevant to all##2##4##(2008-11#1)(2008-3#1)
are relevant to our##2##4##(2008-7#1)(2012-3#1)
are relevant to the##2##4##(2008-3#1)(2010-12#1)
are relevant to##19##3##(1992-12#1)(1993-12#1)(1994-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
are relevant##36##2##(1990-6#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
are reliable protocols for disulfide conjugation##2##6##(2008-4#2)
are reliable##12##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#3)(2012-12#1)(2012-2#1)(2013-1#1)
are reliably##2##2##(2008-10#1)(2008-3#1)
are reluctant to##3##3##(1991-2#1)(1997-5#1)(2010-8#1)
are remarkably similar to those##2##5##(1993-3#1)(2008-9#1)
are remarkably similar##4##3##(1993-3#1)(1995-11#1)(2007-12#1)(2008-9#1)
are remarkably##7##2##(1993-3#1)(1995-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
are removed from the##3##4##(2007-11#1)(2008-11#2)
are removed from##4##3##(2007-11#1)(2008-11#2)(2008-2#1)
are removed##12##2##(1995-2#2)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2012-2#1)
are remunerated##2##2##(1994-12#2)
are repaired##2##2##(2008-11#1)(2011-2#1)
are repeated##4##2##(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#1)
are repetitive##2##2##(2007-12#1)(2008-9#1)
are replaced by##2##3##(2008-11#1)(2008-3#1)
are replaced with##2##3##(2007-11#1)(2008-2#1)
are replaced##5##2##(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
are reported and compared with those##2##6##(2008-10#1)(2008-5#1)
are reported and compared with##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
are reported and##10##3##(1997-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
are reported as##7##3##(1993-9#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#1)
are reported by##2##3##(1993-9#1)(2008-11#1)
are reported for the first time##4##6##(1992-3#1)(1994-11#1)(2006-4#1)(2008-5#1)
are reported for the##11##4##(1992-3#1)(1994-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)
are reported for##30##3##(1990-9#1)(1992-3#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(2006-4#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
are reported from##2##3##(1996-2#1)(2008-6#1)
are reported here for the first time##2##7##(2008-10#1)(2012-12#1)
are reported here for##3##4##(2008-10#2)(2012-12#1)
are reported here##9##3##(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
are reported in the literature##3##5##(2008-3#1)(2011-1#1)(2012-3#1)
are reported in the##5##4##(2008-1#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
are reported in this##2##4##(1992-12#1)(2008-10#1)
are reported in##13##3##(1992-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
are reported only##2##3##(1991-5#1)(2008-10#1)
are reported that show##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
are reported that##4##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
are reported to be##6##4##(1990-7#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-2#1)
are reported to have##3##4##(2010-5#1)(2013-8#2)
are reported to##16##3##(1990-7#1)(1995-9#1)(2008-10#5)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-8#4)
are reported which##2##3##(2008-2#1)(2008-7#1)
are reported with their##2##4##(2007-12#1)(2008-4#1)
are reported with##4##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
are reported##256##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#4)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-11#2)(1996-2#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#2)(2007-11#9)(2007-12#9)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#64)(2008-11#5)(2008-12#4)(2008-2#14)(2008-3#26)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#6)
are reportedly##4##2##(1991-12#1)(2010-8#1)(2012-12#2)
are reporting a case of bilateral##2##6##(2008-7#1)(2010-5#1)
are reporting a case of##8##5##(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
are reporting a##10##3##(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
are reporting##24##2##(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
are reports of##4##3##(1991-2#1)(2008-10#1)(2009-11#1)(2013-1#1)
are reports##5##2##(1991-2#1)(2008-10#1)(2008-2#1)(2009-11#1)(2013-1#1)
are representative of the##4##4##(2008-2#2)(2008-3#1)(2008-4#1)
are representative of##5##3##(2008-2#2)(2008-3#2)(2008-4#1)
are representative##6##2##(2008-2#2)(2008-3#3)(2008-4#1)
are represented as##2##3##(1996-2#1)(2008-2#1)
are represented by a##2##4##(2008-4#1)(2010-8#1)
are represented by the##4##4##(1992-6#1)(2008-3#1)(2009-1#1)(2011-2#1)
are represented by##14##3##(1992-6#1)(1994-2#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2009-1#1)(2010-8#1)(2011-2#1)(2012-3#1)
are represented in the##3##4##(2008-2#1)(2009-8#1)(2013-1#1)
are represented in this##2##4##(1997-3#1)(2010-8#1)
are represented in##6##3##(1997-3#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-8#1)(2013-1#1)
are represented well by##2##4##(2008-2#2)
are represented##26##2##(1992-6#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-7#2)(2009-1#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
are representing##2##2##(1994-3#1)(2012-2#1)
are reproduced##4##2##(2008-2#1)(2008-3#2)(2008-4#1)
are reproducible and##2##3##(2008-10#1)(2008-7#1)
are reproducible from##2##3##(2008-10#1)(2008-3#1)
are reproducible within##3##3##(2008-10#3)
are reproducible##8##2##(2008-10#6)(2008-3#1)(2008-7#1)
are requested##3##2##(1991-11#1)(2008-10#1)(2008-5#1)
are required at##2##3##(2009-3#1)(2011-2#1)
are required by the##2##4##(2008-12#1)(2012-3#1)
are required by##8##3##(1990-5#1)(1994-11#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
are required due to the##2##5##(2008-10#1)(2012-3#1)
are required for both##2##4##(1994-9#2)
are required for the production of##2##6##(1991-5#1)(1991-9#1)
are required for the##12##4##(1991-5#1)(1991-9#1)(1992-6#2)(1993-12#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2012-3#1)
are required for##49##3##(1991-5#2)(1991-9#1)(1992-6#2)(1993-12#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#3)
are required if##2##3##(1993-3#1)(1997-6#1)
are required in the##2##4##(2010-12#1)(2012-12#1)
are required in##9##3##(1992-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
are required that##2##3##(2008-3#1)(2008-5#1)
are required to be##2##4##(1992-2#1)(2008-6#1)
are required to confirm the##2##5##(2008-10#1)(2008-11#1)
are required to confirm##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
are required to determine the##3##5##(2008-1#1)(2008-4#1)(2012-12#1)
are required to enable##2##4##(1997-4#1)(2008-11#1)
are required to establish##3##4##(2007-11#1)(2008-12#1)(2012-3#1)
are required to provide##2##4##(2007-11#1)(2008-7#1)
are required to##56##3##(1990-6#1)(1990-8#1)(1992-1#2)(1992-2#1)(1993-1#2)(1993-11#2)(1993-2#2)(1994-2#1)(1994-9#1)(1995-2#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)
are required with##2##3##(1997-1#1)(2010-11#1)
are required##178##2##(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-5#3)(1991-9#1)(1992-1#2)(1992-2#1)(1992-6#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#4)(2008-2#8)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#12)(2012-4#1)(2013-1#4)(2013-8#4)
are resistant to##24##3##(1991-8#1)(1992-3#1)(1994-11#1)(1995-12#1)(1995-5#1)(2008-10#7)(2008-11#2)(2008-3#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
are resistant##26##2##(1991-8#1)(1992-3#1)(1994-11#1)(1995-12#2)(1995-5#1)(2008-10#8)(2008-11#2)(2008-3#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
are resolved##7##2##(1991-11#1)(1992-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)
are respiratory##2##2##(2013-1#1)(2013-8#1)
are responding##4##2##(2008-10#1)(2008-6#1)(2012-2#2)
are responsible for a significant##2##5##(1992-6#1)(2008-1#1)
are responsible for a##6##4##(1992-6#1)(1997-3#1)(2008-1#1)(2011-2#3)
are responsible for severe##2##4##(1994-5#1)(2008-4#1)
are responsible for the##35##4##(1991-2#3)(1992-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-9#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
are responsible for these##5##4##(1993-3#1)(1995-12#1)(1995-5#1)(1997-7#1)(2008-11#1)
are responsible for##90##3##(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#3)(1992-10#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-5#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#3)(2009-8#3)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are responsible##93##2##(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#3)(1992-10#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#3)(2009-8#3)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are responsive to##4##3##(1995-8#1)(1996-2#1)(2008-11#1)(2008-7#1)
are responsive##5##2##(1995-8#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
are restored##3##2##(1995-5#1)(2008-6#1)(2009-8#1)
are restricted to a##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
are restricted to the##2##4##(1995-2#1)(2008-10#1)
are restricted to##9##3##(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-10#1)(2013-1#1)
are restricted##12##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-1#1)
are results of##2##3##(1997-1#1)(2013-1#1)
are results on the##2##4##(1991-10#1)(1991-2#1)
are results##5##2##(1991-10#1)(1991-2#1)(1997-1#1)(2008-2#1)(2013-1#1)
are retained in the##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
are retained on a##2##4##(2008-10#2)
are retained on##3##3##(2008-10#3)
are retained##9##2##(1992-3#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-9#1)(2012-12#1)
are retrieved from##2##3##(2008-2#1)(2008-3#1)
are retrieved##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
are revealed by##4##3##(1994-5#1)(1995-6#1)(1996-11#1)(2008-3#1)
are revealed##7##2##(1994-5#1)(1995-6#1)(1996-11#1)(1996-9#1)(2008-2#1)(2008-3#1)(2009-10#1)
are revealing the##2##3##(1997-8#1)(2013-8#1)
are reversed##2##2##(1990-7#1)(2009-10#1)
are reversible##6##2##(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#1)(2009-5#1)(2012-12#1)
are reviewed and the##2##4##(1993-3#1)(2008-7#1)
are reviewed and##13##3##(1991-3#1)(1992-2#1)(1993-3#1)(1994-11#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)
are reviewed as to##2##4##(1995-3#1)(2010-9#1)
are reviewed as well as##2##5##(2008-10#1)(2008-8#1)
are reviewed as well##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
are reviewed as##5##3##(1995-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-9#1)
are reviewed briefly##2##3##(2007-12#1)(2007-2#1)
are reviewed for##2##3##(2008-3#1)(2008-8#1)
are reviewed here##4##3##(2008-10#1)(2008-4#2)(2011-2#1)
are reviewed in terms of##2##5##(1991-2#1)(2008-10#1)
are reviewed in this article##4##5##(2008-11#1)(2008-7#1)(2009-12#1)(2012-2#1)
are reviewed in this##5##4##(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-2#1)
are reviewed in##11##3##(1991-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-2#1)
are reviewed with emphasis on##2##5##(2008-10#1)(2008-2#1)
are reviewed##161##2##(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#3)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#19)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#5)(2008-7#9)(2008-8#9)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-9#5)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
are revised##3##2##(1995-1#1)(1995-5#1)(2008-8#1)
are rich in##4##3##(2008-7#1)(2010-3#1)(2012-12#1)(2013-8#1)
are risk factors for##4##4##(2007-11#1)(2009-6#1)(2011-2#1)(2011-3#1)
are risk##6##2##(2007-11#1)(2008-8#1)(2009-6#1)(2011-2#2)(2011-3#1)
are robust to##2##3##(2008-8#1)(2012-3#1)
are robust##4##2##(2008-4#1)(2008-8#1)(2011-1#1)(2012-3#1)
are roughly##2##2##(1996-2#1)(2007-12#1)
are routed##2##2##(2008-3#2)
are routine##2##2##(2008-6#1)(2010-10#1)
are routinely used to##2##4##(1994-5#1)(2008-4#1)
are routinely used##6##3##(1994-5#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)
are routinely##12##2##(1992-5#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-6#1)
are run##3##2##(2008-4#2)(2012-2#1)
are safe and effective##2##4##(2008-11#1)(2012-2#1)
are safe and##5##3##(1991-12#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
are safe##7##2##(1991-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-2#1)
are safety##2##2##(2008-4#1)(2008-5#1)
are said to be##2##4##(1996-6#1)(2013-8#1)
are said to##4##3##(1996-2#1)(1996-6#1)(2013-8#2)
are sampled from##2##3##(2007-12#1)(2008-3#1)
are sampled##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
are satisfactorily##2##2##(1993-3#1)(1996-5#1)
are satisfactory for##2##3##(1992-3#1)(2008-10#1)
are satisfactory##8##2##(1992-3#1)(2008-10#5)(2008-2#1)(2013-8#1)
are satisfied with the##2##4##(1996-2#1)(2008-9#1)
are satisfied##6##2##(1990-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-8#1)
are scanned##3##2##(2008-10#1)(2008-3#2)
are scarce and##2##3##(2008-9#1)(2012-3#1)
are scarce in##2##3##(2008-9#1)(2013-8#1)
are scarce##11##2##(1994-2#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-9#3)(2012-3#1)(2013-8#1)
are scenarios##2##2##(2008-10#1)(2008-11#1)
are scheduled for##2##3##(1996-2#1)(2008-5#1)
are scheduled##4##2##(1993-3#1)(1996-2#1)(2007-8#1)(2008-5#1)
are scoring##2##2##(2008-9#2)
are screened for##4##3##(1996-11#1)(2008-10#1)(2010-8#1)(2011-1#1)
are screened##6##2##(1991-6#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)
are secondary metabolites##2##3##(1991-12#1)(2008-10#1)
are secondary to##2##3##(2008-6#1)(2008-7#1)
are secondary##5##2##(1991-12#1)(1992-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
are secreted##4##2##(1990-7#1)(1997-2#1)(2007-12#1)(2008-7#1)
are secretory##2##2##(2007-12#1)(2012-2#1)
are sedentary##2##2##(2008-10#1)(2013-1#1)
are seeking to##3##3##(2008-11#1)(2008-6#1)(2008-9#1)
are seeking##4##2##(1994-2#1)(2008-11#1)(2008-6#1)(2008-9#1)
are seen as a##2##4##(1992-3#1)(2008-3#1)
are seen as##6##3##(1992-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
are seen in##10##3##(1997-7#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-8#1)(2013-7#1)
are seen to##4##3##(1990-11#1)(1992-1#1)(2008-11#1)(2011-1#1)
are seen with##2##3##(2008-11#1)(2013-8#1)
are seen##29##2##(1990-11#1)(1992-1#1)(1992-3#1)(1992-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-8#1)(2013-7#1)(2013-8#1)
are seldom##7##2##(1992-11#1)(1995-2#1)(1996-2#1)(2007-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
are selected and##2##3##(2008-10#1)(2008-11#1)
are selected by##6##3##(1991-7#1)(1994-12#1)(2008-3#1)(2008-4#1)(2012-12#2)
are selected for the##2##4##(2008-3#2)
are selected for##4##3##(2008-10#1)(2008-3#2)(2011-2#1)
are selected from##2##3##(1995-6#1)(2008-9#1)
are selected to##3##3##(1991-12#1)(2008-3#1)(2008-8#1)
are selected##25##2##(1990-5#1)(1991-12#1)(1991-7#2)(1994-12#1)(1995-6#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
are selective for specific##2##4##(1997-2#1)(2008-11#1)
are selective for##3##3##(1997-2#1)(2008-11#1)(2008-5#1)
are selective##7##2##(1993-6#1)(1994-8#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
are selectively##12##2##(1993-11#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-12#1)
are sensitive to aminoglycosides##2##4##(1995-2#2)
are sensitive to the##7##4##(1990-12#1)(1994-11#1)(1994-6#1)(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
are sensitive to##35##3##(1990-12#1)(1990-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#2)(1996-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
are sensitive##37##2##(1990-12#1)(1990-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#2)(1996-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
are sent to##2##3##(2008-3#1)(2011-2#1)
are sent##4##2##(2008-3#2)(2011-2#2)
are separable##2##2##(1990-4#1)(2008-5#1)
are separate but##2##3##(2008-11#1)(2008-4#1)
are separate##6##2##(1990-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
are separated and##3##3##(1994-9#1)(1995-2#1)(2008-10#1)
are separated by##16##3##(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#2)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2013-8#1)
are separated from the##2##4##(2008-10#2)
are separated from##6##3##(1992-11#1)(1992-6#1)(2008-10#2)(2008-9#1)(2010-8#1)
are separated into##2##3##(2008-10#1)(2008-4#1)
are separated on a reversed-phase##2##5##(1990-8#1)(2008-10#1)
are separated on a##5##4##(1990-8#1)(2008-10#3)(2008-4#1)
are separated on##6##3##(1990-8#1)(2008-10#3)(2008-4#2)
are separated##41##2##(1990-11#1)(1990-8#1)(1992-11#1)(1992-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#2)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
are sequentially##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
are serious and##2##3##(2008-12#1)(2013-7#1)
are serious complications##2##3##(2008-4#1)(2009-3#1)
are serious problems##2##3##(2008-10#1)(2013-1#1)
are serious##9##2##(1993-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2009-3#1)(2013-1#1)(2013-7#1)
are serving as##2##3##(1994-2#1)(2010-8#1)
are set to##2##3##(2007-11#1)(2013-1#1)
are set##5##2##(1992-2#1)(2007-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
are seven##4##2##(1996-1#1)(2008-1#1)(2011-2#1)(2012-2#1)
are several approaches##2##3##(2008-7#1)(2008-9#1)
are several methods##4##3##(1997-4#1)(2008-3#1)(2011-2#2)
are several reasons##3##3##(2008-2#1)(2011-2#1)(2012-1#1)
are several##53##2##(1991-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
are severe and##2##3##(2012-3#1)(2013-1#1)
are severe##6##2##(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#3)
are severely##6##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)
are sexually##3##2##(1992-4#1)(2009-9#1)(2012-12#1)
are shaped by##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
are shaped##5##2##(2008-1#1)(2008-11#1)(2009-5#1)(2011-2#2)
are shared by##2##3##(1997-4#1)(2007-12#1)
are shared##8##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-12#1)
are sharply##2##2##(2008-6#1)(2009-9#1)
are shed##3##2##(2008-11#1)(2009-9#2)
are shifted##4##2##(1995-8#1)(2008-10#1)(2008-2#1)(2009-4#1)
are shorter than##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
are shorter##5##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
are showed##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
are showing##2##2##(1996-12#1)(2007-4#1)
are shown for a##2##4##(1996-3#1)(2008-3#1)
are shown for the##2##4##(2008-2#1)(2008-3#1)
are shown for##8##3##(1992-9#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-3#2)
are shown in the##2##4##(2007-12#1)(2008-3#1)
are shown in##4##3##(2007-12#1)(2008-3#2)(2012-1#1)
are shown to agree well with##2##6##(2008-3#2)
are shown to agree##3##4##(2008-3#3)
are shown to be in good agreement with##3##8##(2007-11#1)(2008-3#1)(2008-8#1)
are shown to be special##2##5##(2008-2#1)(2008-6#1)
are shown to be useful##2##5##(2007-11#1)(2008-10#1)
are shown to be##31##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1995-6#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
are shown to have##2##4##(1992-8#1)(2008-3#1)
are shown to provide##2##4##(2007-11#1)(2008-2#1)
are shown to##65##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-4#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-2#1)(2007-11#7)(2007-12#6)(2008-10#5)(2008-2#6)(2008-3#14)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)
are shown##120##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-8#2)(2007-11#10)(2007-12#11)(2008-10#11)(2008-2#15)(2008-3#30)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
are sick##2##2##(1994-6#1)(2012-3#1)
are significant challenges##4##3##(1995-12#1)(2007-12#1)(2008-12#1)(2009-12#1)
are significant differences between##3##4##(1992-2#1)(2008-4#1)(2008-5#1)
are significant differences##6##3##(1992-2#1)(1995-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
are significant factors##4##3##(2008-10#2)(2013-8#2)
are significant for##2##3##(2007-12#1)(2008-3#1)
are significant##39##2##(1992-2#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-4#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
are significantly associated with##2##4##(2007-7#1)(2008-1#1)
are significantly better##3##3##(2008-10#2)(2008-2#1)
are significantly different from##2##4##(1993-2#1)(1995-3#1)
are significantly different##5##3##(1992-3#1)(1993-2#1)(1995-3#1)(2008-10#1)(2012-3#1)
are significantly greater##3##3##(1995-1#1)(1997-2#1)(2010-4#1)
are significantly higher##5##3##(2008-10#1)(2009-7#1)(2010-2#2)(2013-8#1)
are significantly larger##2##3##(1991-8#1)(2008-2#1)
are significantly less##3##3##(1995-12#1)(2008-10#1)(2009-5#1)
are significantly lower##3##3##(2008-11#1)(2010-7#1)(2013-8#1)
are significantly more common##2##4##(2010-12#1)(2011-1#1)
are significantly more##10##3##(1995-3#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
are significantly reduced##5##3##(1990-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
are significantly related to##2##4##(1996-1#1)(2008-11#1)
are significantly##66##2##(1990-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1997-2#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
are silenced##2##2##(2011-2#1)(2013-8#1)
are similar because##2##3##(1997-4#1)(2010-6#1)
are similar but##2##3##(1991-9#1)(2007-12#1)
are similar for##3##3##(1992-3#1)(2010-12#1)(2012-12#1)
are similar in both##3##4##(2007-8#1)(2009-6#1)(2010-12#1)
are similar in the##2##4##(1991-11#1)(2010-12#1)
are similar in##13##3##(1991-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#2)(2011-2#1)
are similar to other##3##4##(1994-9#1)(2008-7#1)(2010-8#1)
are similar to that##3##4##(1991-3#1)(2008-10#1)(2008-8#1)
are similar to the##7##4##(1993-12#1)(1995-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
are similar to those observed in##2##6##(1993-11#1)(2008-7#1)
are similar to those observed##4##5##(1992-12#1)(1993-11#1)(2008-5#1)(2008-7#1)
are similar to those obtained in##2##6##(1990-8#1)(2007-12#1)
are similar to those of##15##5##(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2009-8#1)(2010-4#1)
are similar to those previously described##2##6##(1991-6#1)(2011-2#1)
are similar to those reported in##2##6##(1997-2#1)(2007-12#1)
are similar to those reported##3##5##(1997-2#1)(2007-12#1)(2013-1#1)
are similar to those##34##4##(1990-8#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
are similar to##67##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
are similar with##2##3##(1993-5#1)(2008-10#1)
are similar##100##2##(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#8)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#2)(2009-6#2)(2009-8#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
are similarly##8##2##(1990-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-8#1)
are simple and##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)
are simple##9##2##(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)
are simpler##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
are simplicity of##2##3##(2007-12#1)(2008-10#1)
are simply##3##2##(1995-1#1)(2008-6#1)(2011-2#1)
are simulated by##4##3##(2008-10#2)(2008-3#2)
are simulated with##2##3##(2008-3#2)
are simulated##11##2##(1991-12#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-3#5)(2009-8#1)
are simultaneously observed##2##3##(2007-12#1)(2008-3#1)
are simultaneously present in##2##4##(1994-5#1)(2008-10#1)
are simultaneously recorded##3##3##(2007-12#1)(2008-2#1)(2010-8#1)
are simultaneously##20##2##(1994-5#1)(1997-3#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#6)(2010-12#1)(2010-8#1)(2013-1#1)
are single##3##2##(2007-11#1)(2007-12#1)(2011-2#1)
are single-stranded##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
are situated in the##2##4##(1997-9#1)(2008-6#1)
are situated##5##2##(1996-8#1)(1997-9#1)(2007-12#1)(2008-3#1)(2008-6#1)
are six##3##2##(1994-2#1)(1995-12#1)(2010-1#1)
are slight##2##2##(2008-10#2)
are slightly larger##2##3##(2008-7#1)(2012-3#1)
are slightly##7##2##(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2012-3#1)
are slow##2##2##(2007-11#1)(2008-9#1)
are slowly##2##2##(2007-7#1)(2008-3#1)
are small and##2##3##(2008-3#1)(2013-8#1)
are small for##2##3##(1991-12#1)(2008-3#1)
are small in##3##3##(1991-12#1)(2008-3#1)(2008-7#1)
are small##32##2##(1990-11#1)(1991-12#2)(1991-8#1)(1992-9#1)(1994-1#1)(1994-8#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
are smaller than the##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
are smaller than##6##3##(1995-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-3#1)(2013-8#1)
are smaller##11##2##(1991-9#1)(1993-3#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
are smooth##2##2##(2008-3#2)
are so different##2##3##(1996-1#2)
are so##16##2##(1993-12#1)(1994-3#1)(1996-1#2)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
are socially##2##2##(1993-6#1)(2008-8#1)
are soft##2##2##(2008-12#1)(2013-1#1)
are solely##4##2##(2007-11#1)(2009-8#1)(2010-8#1)(2013-1#1)
are solid##2##2##(2007-11#1)(2010-4#1)
are solved by use of a##2##6##(2008-3#2)
are solved using##2##3##(2008-10#1)(2009-6#1)
are solved##9##2##(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-6#1)(2010-10#1)
are some of the most##4##5##(2008-10#3)(2009-12#1)
are some of the##10##4##(1996-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#2)(2009-12#1)
are some of##12##3##(1996-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-12#1)
are some##41##2##(1991-1#2)(1992-3#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-1#1)(2010-3#1)(2010-8#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are sometimes difficult to##3##4##(2010-10#1)(2011-2#1)(2012-2#1)
are sometimes difficult##4##3##(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
are sometimes##11##2##(1990-3#1)(1992-11#1)(1996-2#1)(1997-2#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
are somewhat##8##2##(1994-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-5#1)(2013-1#1)
are sought##3##2##(1993-1#1)(2008-1#1)(2008-3#1)
are spared##2##2##(1994-8#1)(2009-10#1)
are sparse##3##2##(2008-11#1)(2013-1#2)
are spatially and temporally##2##4##(2008-10#1)(2009-3#1)
are spatially##4##2##(1995-11#1)(2008-10#1)(2008-9#1)(2009-3#1)
are special##2##2##(2007-11#1)(2012-12#1)
are specialized##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
are specific for the##2##4##(2008-10#1)(2013-8#1)
are specific for##12##3##(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-11#1)(2013-8#4)
are specific to the##5##4##(1992-6#1)(1995-12#1)(2008-12#1)(2009-8#1)(2009-9#1)
are specific to##10##3##(1992-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2012-3#1)
are specific##32##2##(1992-6#1)(1994-5#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2009-11#2)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#4)
are specifically described for##2##4##(2008-4#2)
are specifically expressed##3##3##(1991-5#1)(1996-10#1)(2010-7#1)
are specifically##10##2##(1991-5#1)(1992-11#1)(1996-10#1)(1997-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-7#1)
are specified##2##2##(2008-10#1)(2013-1#1)
are spent##3##2##(1990-2#1)(1996-2#1)(2011-2#1)
are spherical##4##2##(1990-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
are spiked##2##2##(2008-10#2)
are split##2##2##(2008-3#1)(2008-7#1)
are spontaneous##2##2##(1992-3#1)(1994-8#1)
are spontaneously##2##2##(1990-5#1)(1996-6#1)
are sporadic and##2##3##(2009-12#1)(2013-1#1)
are stabilized by##4##3##(1991-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
are stabilized##5##2##(1991-9#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
are stable and##5##3##(2007-11#1)(2008-10#3)(2008-5#1)
are stable for##4##3##(2008-10#2)(2008-5#1)(2009-12#1)
are stable in##4##3##(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)
are stable##25##2##(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-11#2)(2008-10#9)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
are staged##2##2##(2007-12#1)(2012-3#1)
are stained##5##2##(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)
are standard##3##2##(1994-11#1)(2011-1#1)(2011-2#1)
are standardized##3##2##(2008-5#1)(2010-8#1)(2011-2#1)
are starved for##2##3##(1995-8#2)
are statistically significant##4##3##(1990-5#1)(2008-10#2)(2008-5#1)
are statistically##6##2##(1990-5#1)(2008-10#3)(2008-5#1)(2008-8#1)
are still a matter of##2##5##(1990-8#1)(2011-1#1)
are still a##5##3##(1990-8#1)(2007-10#1)(2007-2#1)(2009-5#1)(2011-1#1)
are still alive##8##3##(1990-6#1)(1990-9#1)(1992-6#1)(1992-9#1)(1995-2#1)(1997-5#1)(2011-2#1)(2013-8#1)
are still awaited##2##3##(1995-8#1)(2008-5#1)
are still being##4##3##(1991-5#1)(1997-5#1)(2008-7#1)(2010-1#1)
are still considered##2##3##(1993-2#1)(1995-5#1)
are still controversial##2##3##(1992-6#1)(2012-2#1)
are still discussed##2##3##(2008-8#1)(2009-1#1)
are still highly##2##3##(1993-6#1)(2007-7#1)
are still in##3##3##(1990-2#1)(2009-5#1)(2010-10#1)
are still insufficient##2##3##(2009-7#1)(2012-2#1)
are still lacking##4##3##(1992-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
are still largely##5##3##(1990-6#1)(2008-9#1)(2010-12#1)(2010-6#1)(2012-1#1)
are still missing##2##3##(2008-8#1)(2011-2#1)
are still not clear##3##4##(2007-8#1)(2008-5#1)(2011-2#1)
are still not##12##3##(1996-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#4)
are still poorly understood##2##4##(2008-5#1)(2013-8#1)
are still present##3##3##(2006-10#1)(2008-11#2)
are still relatively##2##3##(2008-4#1)(2008-9#1)
are still scarce##2##3##(2008-1#1)(2012-2#1)
are still some##3##3##(2008-10#1)(2008-7#1)(2011-3#1)
are still subject to##2##4##(2010-10#1)(2013-1#1)
are still unclear##5##3##(2007-7#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
are still under investigation##2##4##(2012-3#1)(2013-1#1)
are still unknown##5##3##(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
are still very##2##3##(2011-2#1)(2013-8#1)
are still widely##2##3##(2008-10#1)(2008-7#1)
are still##144##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#4)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#3)(2009-1#1)(2009-3#2)(2009-5#3)(2009-7#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#4)
are stimulated by##4##3##(1995-5#1)(2008-4#1)(2009-2#1)(2010-10#1)
are stimulated to proliferate##2##4##(1990-12#1)(2008-7#1)
are stimulated##9##2##(1990-12#1)(1991-5#1)(1995-5#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)
are stirred##2##2##(2008-10#1)(2008-11#1)
are stored in a##2##4##(2007-11#1)(2008-3#1)
are stored in the##2##4##(1992-4#1)(2007-12#1)
are stored in##4##3##(1992-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
are stored##10##2##(1990-2#1)(1992-12#1)(1992-4#1)(1993-12#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-9#1)
are stressed##5##2##(1990-2#1)(1991-2#1)(2008-10#1)(2008-9#2)
are strictly##4##2##(1995-12#1)(1997-4#1)(2006-4#1)(2008-2#1)
are strikingly similar##2##3##(2008-5#1)(2009-9#1)
are strikingly##3##2##(1992-8#1)(2008-5#1)(2009-9#1)
are strong predictors of##3##4##(1992-4#1)(1993-1#1)(2008-7#1)
are strong##6##2##(1992-4#1)(1993-1#1)(2008-10#1)(2008-7#2)(2010-2#1)
are stronger than##3##3##(1993-5#1)(2008-8#1)(2012-2#1)
are stronger##4##2##(1993-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
are strongly affected by##2##4##(2008-11#1)(2008-3#1)
are strongly associated with##3##4##(1995-2#1)(2008-1#1)(2008-11#1)
are strongly correlated##3##3##(2008-10#1)(2008-8#1)(2009-3#1)
are strongly dependent on##2##4##(1990-8#1)(2008-3#1)
are strongly influenced by##8##4##(1991-9#1)(1996-4#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-4#1)
are strongly needed to##2##4##(2007-10#1)(2010-11#1)
are strongly needed##4##3##(2007-10#1)(2010-11#1)(2010-5#1)(2011-2#1)
are strongly##40##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-4#1)(1994-9#1)(1995-2#1)(1996-4#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#5)(2008-8#4)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
are structural##4##2##(1993-11#1)(2008-4#1)(2009-6#1)(2012-2#1)
are structurally and##2##3##(1996-2#1)(2010-10#1)
are structurally related##2##3##(1993-12#1)(1997-8#1)
are structurally similar to##2##4##(1993-8#1)(2011-1#1)
are structurally##11##2##(1993-12#1)(1993-8#1)(1996-2#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)
are structured##2##2##(1992-2#1)(2011-1#1)
are structures##2##2##(2008-11#1)(2011-2#1)
are struggling to##2##3##(1995-12#1)(2011-2#1)
are studied and##3##3##(2008-10#1)(2008-3#2)
are studied as##3##3##(2008-3#2)(2010-4#1)
are studied at##2##3##(2007-11#1)(2009-11#1)
are studied by##6##3##(2008-10#3)(2008-4#2)(2008-9#1)
are studied for##7##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)
are studied in detail##3##4##(2008-10#2)(2008-3#1)
are studied in##6##3##(2008-10#3)(2008-11#1)(2008-3#2)
are studied to##3##3##(2008-10#2)(2008-3#1)
are studied with##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
are studied##68##2##(1990-3#1)(1992-3#2)(1995-2#1)(2007-11#8)(2007-12#3)(2008-10#19)(2008-11#2)(2008-2#7)(2008-3#15)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
are subdivided into##2##3##(2008-12#1)(2008-9#1)
are subject to a##2##4##(1991-6#1)(2007-12#1)
are subject to##26##3##(1991-6#2)(1992-11#1)(1995-12#2)(1996-10#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#2)(2012-2#2)
are subject##27##2##(1991-6#2)(1992-11#1)(1992-12#1)(1995-12#2)(1996-10#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#2)(2012-2#2)
are subjected to electrical##2##4##(1991-5#1)(1994-8#1)
are subjected to##13##3##(1991-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
are subjected##14##2##(1991-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
are submitted to##2##3##(2008-5#1)(2010-6#1)
are subsequently##13##2##(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2012-12#1)
are substantial##4##2##(1992-8#1)(1995-6#1)(2008-8#1)(2009-10#1)
are substantially higher than those##2##5##(2008-6#1)(2011-1#1)
are substantially higher##3##3##(1993-12#1)(2008-6#1)(2011-1#1)
are substantially##13##2##(1990-8#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#1)
are substituted##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
are substrates for phosphorylation##2##4##(1991-2#2)
are substrates for##3##3##(1991-2#2)(1992-6#1)
are substrates##4##2##(1991-2#2)(1992-3#1)(1992-6#1)
are subtle##2##2##(1996-12#1)(2009-5#1)
are subtracted##2##2##(2008-3#2)
are successful in##2##3##(2008-10#1)(2012-2#1)
are successful##6##2##(1990-6#1)(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
are successfully##10##2##(1990-9#1)(1993-3#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2013-8#1)
are such that##2##3##(2008-9#1)(2012-12#1)
are such##6##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
are suffering from##3##3##(1994-6#1)(2008-10#1)(2009-11#1)
are sufficient for##8##3##(1993-8#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
are sufficient to determine##2##4##(2008-2#1)(2008-3#1)
are sufficient to##12##3##(1990-7#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)
are sufficient##21##2##(1990-11#1)(1990-7#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-9#1)
are sufficiently small##2##3##(2008-3#1)(2009-5#1)
are sufficiently##16##2##(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-5#1)(2010-7#1)
are suggested as##2##3##(1992-11#1)(1994-9#1)
are suggested by##2##3##(1990-3#1)(2008-6#1)
are suggested for##6##3##(1992-3#1)(1993-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
are suggested to be##4##4##(1993-11#1)(2011-2#2)(2013-8#1)
are suggested to##8##3##(1993-11#1)(1993-3#1)(1996-2#1)(2008-2#1)(2011-2#3)(2013-8#1)
are suggested##42##2##(1990-3#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
are suggestive of##3##3##(2008-10#1)(2008-7#1)(2010-6#1)
are suggestive##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)
are suitable for a##2##4##(2008-10#1)(2008-4#1)
are suitable for influenza virus cultivation##2##6##(2008-11#2)
are suitable for the##4##4##(1996-12#1)(2008-10#3)
are suitable for##32##3##(1994-12#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
are suitable hosts##2##3##(2008-10#1)(2008-6#1)
are suitable to##2##3##(2008-10#1)(2012-2#1)
are suitable##45##2##(1994-12#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
are summarised##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
are summarized and##3##3##(2008-10#1)(2008-7#2)
are summarized for a##2##4##(2008-3#1)(2011-1#1)
are summarized in the next section##2##6##(2008-8#1)(2009-4#1)
are summarized in this##2##4##(2008-10#1)(2008-5#1)
are summarized in##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
are summarized##34##2##(1991-12#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
are superimposed on the##2##4##(2008-2#1)(2008-3#1)
are superimposed on##3##3##(2008-2#1)(2008-3#1)(2009-12#1)
are superimposed##5##2##(2008-12#1)(2008-2#1)(2008-3#2)(2009-12#1)
are superior to the##2##4##(1995-5#1)(2008-5#1)
are superior to those of##3##5##(2007-12#1)(2007-8#1)(2008-10#1)
are superior to##13##3##(1994-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-3#1)
are supersensitive to##2##3##(1990-11#1)(1990-5#1)
are supplied for##2##3##(2008-9#2)
are supplied##6##2##(2008-9#3)(2011-1#2)(2011-2#1)
are supported by the##2##4##(1992-3#1)(2012-2#1)
are supported by##9##3##(1992-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
are supported to##2##3##(1997-1#1)(2008-4#1)
are supported##13##2##(1992-3#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
are supposed to be##3##4##(1997-6#1)(2009-5#1)(2012-3#1)
are supposed to##9##3##(1990-12#1)(1990-6#1)(1995-6#1)(1997-6#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
are suppressed by##2##3##(2007-11#1)(2012-3#1)
are suppressed##5##2##(2007-11#1)(2007-12#2)(2012-3#1)(2013-8#1)
are surgical##3##2##(2010-10#1)(2013-1#2)
are surrounded by an##2##4##(2008-10#1)(2011-2#1)
are surrounded by##6##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
are surveyed##3##2##(1997-4#1)(1997-6#1)(2008-4#1)
are susceptible to fungal##2##4##(2008-10#1)(2011-10#1)
are susceptible to infection##2##4##(2008-10#2)
are susceptible to##15##3##(1991-3#1)(1995-3#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-5#1)(2011-10#1)(2012-2#1)
are suspected to##2##3##(2006-6#1)(2008-7#1)
are suspected##9##2##(1991-12#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
are suspended##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
are sustained##2##2##(1997-8#1)(2013-1#1)
are swept##2##2##(1994-2#1)(2008-10#1)
are symmetrical##2##2##(2010-3#1)(2011-2#1)
are symptomatic##2##2##(2007-2#1)(2013-1#1)
are synchronized##2##2##(1993-9#1)(2007-12#1)
are synchronously##2##2##(2008-10#1)(2010-5#1)
are synergistic with##2##3##(2008-10#1)(2008-2#1)
are synonymous##2##2##(2008-1#1)(2012-2#1)
are synthesized as##2##3##(2008-10#1)(2008-4#1)
are synthesized by##7##3##(1991-9#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2013-1#1)
are synthesized from##2##3##(1997-8#1)(2008-4#1)
are synthesized in##2##3##(1996-9#1)(2011-1#1)
are synthesized using##3##3##(2008-4#2)(2008-6#1)
are synthesized##20##2##(1991-9#1)(1994-5#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
are synthetic##2##2##(1993-11#1)(2007-11#1)
are systematic##2##2##(1996-6#1)(2008-2#1)
are systematically##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
are tabulated##11##2##(2007-8#7)(2008-10#2)(2008-2#1)(2008-8#1)
are tailored for##2##3##(2008-9#1)(2010-2#1)
are tailored##3##2##(2008-9#1)(2009-11#1)(2010-2#1)
are taken as##6##3##(1990-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-7#1)
are taken into account in the##2##6##(2007-12#1)(2008-2#1)
are taken into account in##3##5##(1992-2#1)(2007-12#1)(2008-2#1)
are taken into account##14##4##(1992-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#5)(2011-3#1)
are taken into consideration##3##4##(2007-11#1)(2008-3#1)(2009-4#1)
are taken into##17##3##(1992-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#6)(2009-4#1)(2011-3#1)
are taken to##4##3##(1993-12#1)(1994-8#1)(1997-6#1)(2009-11#1)
are taken up by##4##4##(1995-4#1)(1995-6#1)(2008-11#1)(2008-7#1)
are taken up##6##3##(1993-11#1)(1995-4#1)(1995-6#1)(2008-11#1)(2008-7#1)(2008-9#1)
are taken##41##2##(1990-12#1)(1992-2#1)(1993-11#2)(1993-12#2)(1994-2#1)(1994-8#1)(1995-4#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
are taking place##3##3##(1990-2#1)(2008-10#1)(2008-2#1)
are taking##8##2##(1990-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#2)
are taller##2##2##(2008-6#1)(2008-8#1)
are targeted by##2##3##(2007-8#1)(2009-8#1)
are targeted to##3##3##(1994-5#1)(2009-7#1)(2010-10#1)
are targeted##12##2##(1992-12#1)(1994-2#1)(1994-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)
are targets of##2##3##(2007-12#1)(2013-8#1)
are taught##5##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
are temporally##6##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-11#2)
are tentative and##2##3##(1996-2#1)(2007-11#1)
are tentatively##2##2##(1993-12#1)(2008-10#1)
are termed##7##2##(1993-5#1)(1995-2#1)(1996-11#1)(1996-5#1)(2008-2#1)(2010-5#1)(2013-8#1)
are tested against##2##3##(2008-7#1)(2013-1#1)
are tested by##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
are tested for##5##3##(2008-10#1)(2008-2#1)(2008-4#2)(2011-1#1)
are tested in##2##3##(2009-12#1)(2011-2#1)
are tested to##2##3##(2008-10#2)
are tested using##2##3##(2008-10#1)(2011-1#1)
are tested##26##2##(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#2)(2009-11#2)(2009-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
are testing##2##2##(1990-11#1)(2008-6#1)
are that it##2##3##(2008-10#1)(2008-11#1)
are that the##7##3##(1990-11#1)(1991-6#1)(1992-2#1)(1993-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
are that there is##2##4##(2008-8#1)(2008-9#1)
are that##22##2##(1990-11#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1995-2#2)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
are the absorption##2##3##(2008-3#2)
are the basis for##3##4##(1990-8#1)(1997-1#1)(1997-5#1)
are the basis of a##2##5##(1990-7#1)(2010-6#1)
are the basis of##3##4##(1990-7#1)(2009-8#1)(2010-6#1)
are the basis##6##3##(1990-7#1)(1990-8#1)(1997-1#1)(1997-5#1)(2009-8#1)(2010-6#1)
are the benefits##2##3##(1994-1#1)(2007-8#1)
are the best##3##3##(2007-7#1)(2008-11#1)(2009-12#1)
are the building blocks of##3##5##(1992-11#1)(2008-11#1)(2009-5#1)
are the cause of##2##4##(2008-1#1)(2012-1#1)
are the cells##2##3##(2009-8#1)(2013-1#1)
are the central##2##3##(2011-2#1)(2013-1#1)
are the clinical##2##3##(2007-11#1)(2008-4#1)
are the common##2##3##(2008-7#1)(2009-8#1)
are the commonest##3##3##(1993-9#1)(2008-7#1)(2013-1#1)
are the core of##2##4##(1993-2#1)(2012-3#1)
are the customers##2##3##(1994-12#1)(2008-12#1)
are the dominant##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
are the drivers behind##2##4##(2008-5#1)(2008-7#1)
are the earliest##2##3##(1995-2#1)(2008-8#1)
are the early##2##3##(1990-6#1)(1991-11#1)
are the first cause##2##4##(1996-2#1)(2008-10#1)
are the first to##5##4##(1992-12#1)(1994-2#1)(2007-12#1)(2008-3#1)(2010-11#1)
are the first##31##3##(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-8#1)
are the following##7##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)
are the goals##2##3##(1994-1#1)(2008-9#1)
are the highest##2##3##(2008-11#1)(2008-2#1)
are the implications##2##3##(1993-11#1)(1994-2#1)
are the key elements##2##4##(2009-3#1)(2010-8#1)
are the key factors##3##4##(1995-5#1)(2008-3#1)(2011-2#1)
are the key features##2##4##(1994-9#1)(1997-6#1)
are the key to##5##4##(1991-1#1)(2008-6#1)(2008-7#3)
are the key##20##3##(1991-1#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-6#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
are the largest##5##3##(2008-11#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
are the least##2##3##(2008-4#1)(2008-7#1)
are the loss of##2##4##(2008-10#1)(2012-3#1)
are the lowest##2##3##(2008-10#2)
are the main advantages##2##4##(2008-10#2)
are the main causes##2##4##(2012-2#1)(2013-1#1)
are the main components of##2##5##(1997-2#1)(2008-10#1)
are the main determinants of##2##5##(2012-3#1)(2013-8#1)
are the main factors in determining##2##6##(2008-10#1)(2010-8#1)
are the main factors##5##4##(1991-6#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)
are the main obstacles to##2##5##(1997-4#1)(2009-10#1)
are the main source of primary##2##6##(2008-10#1)(2008-8#1)
are the main source of##4##5##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
are the main sources of##2##5##(2008-10#1)(2008-3#1)
are the main##40##3##(1990-3#1)(1991-6#1)(1993-8#1)(1994-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(2007-8#2)(2008-10#11)(2008-2#1)(2008-3#1)(2008-8#2)(2009-10#1)(2010-11#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
are the mainstay of treatment##2##5##(2008-11#1)(2009-4#1)
are the mainstay of##4##4##(2008-11#1)(2009-4#1)(2010-12#2)
are the mainstays of##2##4##(1993-9#1)(2008-11#1)
are the mainstays##3##3##(1993-9#1)(2008-11#1)(2008-9#1)
are the major cause of##2##5##(2008-10#1)(2008-4#1)
are the major causes##2##4##(1990-8#1)(2008-12#1)
are the major source of##2##5##(1991-2#1)(2008-3#1)
are the major source##4##4##(1991-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
are the major##30##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-4#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
are the majors)##2##3##(2008-11#2)
are the maximum##2##3##(2008-10#1)(2008-3#1)
are the most abundant##5##4##(1992-9#1)(1996-8#1)(1997-2#1)(2008-1#1)(2011-1#1)
are the most common cause of##2##6##(2008-9#1)(2009-5#1)
are the most common causes of##2##6##(2010-4#1)(2011-2#1)
are the most common form of##3##6##(2007-11#1)(2008-11#1)(2013-1#1)
are the most common type of##2##6##(2008-9#1)(2013-1#1)
are the most common##33##4##(1991-6#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-5#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#4)
are the most commonly##4##4##(2007-8#1)(2008-4#1)(2008-6#1)(2013-1#1)
are the most effective##4##4##(1992-11#1)(1997-1#2)(2008-7#1)
are the most frequent##3##4##(2008-1#1)(2008-4#1)(2012-3#1)
are the most frequently##4##4##(1992-5#1)(1997-4#1)(2007-11#1)(2011-1#1)
are the most important factors in##3##6##(1994-1#2)(2008-7#1)
are the most important factors##4##5##(1994-1#2)(2008-7#1)(2013-8#1)
are the most important##17##4##(1991-3#1)(1994-1#2)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2011-7#1)(2013-1#1)(2013-8#1)
are the most likely##2##4##(1990-2#1)(2008-7#1)
are the most potent##3##4##(1991-3#1)(2008-5#1)(2011-2#1)
are the most prevalent##2##4##(1995-6#1)(2011-1#1)
are the most promising##2##4##(2008-10#1)(2008-5#1)
are the most reliable##2##4##(1996-6#1)(2008-5#1)
are the most sensitive##3##4##(1992-9#1)(2006-10#1)(2008-1#1)
are the most serious complication of##3##6##(2007-11#1)(2007-8#1)(2011-2#1)
are the most serious##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
are the most significant##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
are the most widely used##5##5##(1997-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
are the most##121##3##(1990-2#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-1#2)(1995-1#1)(1995-5#1)(1995-6#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-8#3)(2008-1#4)(2008-10#10)(2008-11#6)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-5#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#8)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
are the natural##2##3##(1995-2#1)(1995-3#1)
are the new##2##3##(2012-2#2)
are the ones##3##3##(1992-3#1)(1992-4#1)(1997-6#1)
are the only##8##3##(1990-11#1)(1991-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
are the other##2##3##(2008-10#1)(2008-5#1)
are the patients##2##3##(1993-3#1)(2008-10#1)
are the predominant##3##3##(1996-12#1)(2008-10#1)(2010-11#1)
are the preferred##2##3##(2008-10#1)(2008-9#1)
are the presence of##2##4##(2007-8#1)(2008-7#1)
are the primary driving force##2##5##(1994-5#1)(1995-3#1)
are the primary##15##3##(1992-6#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
are the principal##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
are the principle##2##3##(2008-5#1)(2008-9#1)
are the product of##3##4##(1993-8#1)(2011-2#1)(2012-2#1)
are the result of a##2##5##(2007-11#1)(2012-12#1)
are the result of the##4##5##(1997-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
are the result of##21##4##(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
are the results of the##2##5##(1992-2#1)(1997-3#1)
are the results of##4##4##(1991-2#1)(1992-2#1)(1997-3#1)(2008-3#1)
are the results##7##3##(1990-12#1)(1991-2#1)(1992-2#1)(1997-3#1)(2008-3#1)(2008-7#1)(2013-8#1)
are the risk factors##2##4##(2008-4#1)(2013-8#1)
are the rule##3##3##(1997-3#1)(2008-10#1)(2010-7#1)
are the same as the##2##5##(1995-2#1)(2008-2#1)
are the same as those##2##5##(2008-10#1)(2011-2#1)
are the same as##8##4##(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-12#1)
are the same##22##3##(1993-11#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#2)(2011-2#3)(2012-12#1)
are the second##3##3##(1996-11#1)(2011-3#1)(2012-2#1)
are the significant##2##3##(2007-11#1)(2008-10#1)
are the site of##2##4##(1993-9#1)(2008-11#1)
are the smallest##2##3##(2007-12#1)(2008-9#1)
are the social##2##3##(2009-9#1)(2011-1#1)
are the sole##2##3##(1991-12#1)(2008-10#1)
are the source of##2##4##(2008-4#1)(2008-9#1)
are the standard##2##3##(2007-2#1)(2012-2#1)
are the tumors##2##3##(2011-2#1)(2013-1#1)
are the two major##2##4##(2008-3#1)(2008-5#1)
are the two most##5##4##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
are the two##14##3##(1991-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
are the ultimate##2##3##(2009-3#1)(2012-2#1)
are the use of##3##4##(1995-2#1)(1995-5#1)(2007-12#1)
are the values##2##3##(1994-11#1)(2007-11#1)
are the workhorse flaps##2##4##(2012-2#2)
are the##754##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#5)(1991-5#3)(1991-6#7)(1991-8#2)(1991-9#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#2)(1993-8#3)(1993-9#4)(1994-1#7)(1994-11#1)(1994-12#2)(1994-2#9)(1994-3#2)(1994-5#5)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#8)(1995-3#2)(1995-5#7)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#4)(1996-5#2)(1996-6#4)(1996-8#1)(1997-1#5)(1997-2#5)(1997-3#9)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#13)(2007-12#19)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#9)(2008-1#12)(2008-10#85)(2008-11#31)(2008-12#5)(2008-2#16)(2008-3#34)(2008-4#20)(2008-5#23)(2008-6#10)(2008-7#24)(2008-8#16)(2008-9#21)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#4)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#7)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#11)(2011-2#35)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#12)(2012-2#17)(2012-3#10)(2013-1#17)(2013-7#5)(2013-8#15)
are their##11##2##(1994-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
are themselves##4##2##(1990-8#1)(1994-12#1)(2008-9#2)
are then analyzed##2##3##(2008-2#1)(2008-3#1)
are then applied to##3##4##(2008-2#1)(2008-3#2)
are then combined##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
are then compared##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
are then evaluated##2##3##(2008-2#1)(2009-5#1)
are then presented##2##3##(2006-12#1)(2008-3#1)
are then used as##2##4##(2008-3#1)(2008-4#1)
are then used to calculate##2##5##(2008-10#1)(2008-2#1)
are then used##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)
are then##80##2##(1990-12#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#15)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#10)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
are theoretically##4##2##(2008-3#3)(2010-8#1)
are therapeutic##2##2##(1997-4#1)(2010-8#1)
are there differences##2##3##(2008-5#1)(2012-12#1)
are there##6##2##(1994-3#1)(1996-1#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-12#1)
are therefore likely to be##2##5##(1991-6#1)(2008-8#1)
are therefore likely to##4##4##(1991-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
are therefore of##3##3##(1990-9#1)(2008-3#1)(2010-11#1)
are therefore##26##2##(1990-5#1)(1990-9#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
are thermally desorbed##2##3##(2008-10#2)
are thermally##3##2##(2008-10#2)(2008-3#1)
are thermodynamically##2##2##(1993-11#1)(2008-7#1)
are these##3##2##(2008-9#1)(2010-5#1)(2013-8#1)
are they##14##2##(1990-2#1)(1992-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-10#1)(2012-12#2)
are they?##3##2##(2008-4#1)(2008-7#1)(2009-3#1)
are thin##3##2##(2008-3#1)(2008-5#1)(2010-9#1)
are thoroughly##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
are those between##2##3##(2009-10#2)
are those of##4##3##(1995-9#1)(1997-7#1)(2008-6#1)(2009-10#1)
are those that have##3##4##(1996-2#1)(2008-10#1)(2009-3#1)
are those that occur##2##4##(2008-11#1)(2008-5#1)
are those that##8##3##(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)
are those who##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
are those with##2##3##(1991-9#1)(2011-1#1)
are those##26##2##(1991-4#1)(1991-9#1)(1992-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#4)(2009-3#1)(2010-2#1)(2011-1#1)(2012-3#1)
are thought of##2##3##(2008-10#1)(2009-10#1)
are thought to be at##2##5##(2008-7#1)(2011-2#1)
are thought to be important##2##5##(1990-11#1)(2008-8#1)
are thought to be involved##2##5##(2008-8#1)(2009-10#1)
are thought to be##18##4##(1990-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
are thought to contribute to##2##5##(2008-10#1)(2012-2#1)
are thought to influence the##2##5##(2008-12#1)(2008-8#1)
are thought to play a##2##5##(1995-12#1)(2008-6#1)
are thought to play an important role in##3##8##(2008-4#1)(2008-5#1)(2010-11#1)
are thought to play important roles in##2##7##(2010-11#1)(2011-2#1)
are thought to play important##3##5##(2010-11#1)(2011-2#1)(2013-1#1)
are thought to play##8##4##(1995-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#2)(2011-2#1)(2013-1#1)
are thought to represent##2##4##(2007-8#1)(2011-2#1)
are thought to result from##2##5##(1995-6#1)(2011-2#1)
are thought to result##3##4##(1995-6#1)(1997-8#1)(2011-2#1)
are thought to##53##3##(1990-11#1)(1990-8#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-9#1)(2010-11#2)(2011-2#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
are thought##55##2##(1990-11#1)(1990-8#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2009-9#1)(2010-11#2)(2011-2#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
are threatened##2##2##(1990-2#1)(2009-4#1)
are three main##2##3##(2008-2#1)(2009-5#1)
are three times##2##3##(1990-2#1)(2008-2#1)
are three##21##2##(1990-2#1)(1991-3#1)(1992-9#1)(1993-12#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-5#1)(2012-2#1)(2013-7#2)
are threefold##2##2##(1993-12#1)(2009-5#1)
are thus likely##2##3##(1995-5#1)(2011-2#1)
are thus more##2##3##(1992-3#1)(2008-8#1)
are thus##21##2##(1992-1#1)(1992-3#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-5#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
are tightly controlled by##2##4##(2012-2#2)
are tightly coupled##2##3##(1995-6#1)(2008-8#1)
are tightly packed and##3##4##(1994-5#1)(2008-9#2)
are tightly regulated##2##3##(2008-10#1)(2008-4#1)
are tightly##11##2##(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-2#2)(2013-7#1)
are tilted##2##2##(1996-2#1)(2008-3#1)
are time-consuming##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
are timely and##2##3##(1997-3#1)(2011-1#1)
are timely##3##2##(1997-3#1)(2008-7#1)(2011-1#1)
are times##3##2##(1996-3#1)(2006-10#1)(2008-3#1)
are titrated##2##2##(2008-10#2)
are to advance##2##3##(2012-12#1)(2013-1#1)
are to be expected##3##4##(1991-3#1)(2007-12#1)(2008-6#1)
are to be identified##2##4##(1997-7#1)(2008-1#1)
are to be obtained##2##4##(2008-4#2)
are to be##39##3##(1990-12#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
are to describe##4##3##(2007-8#1)(2008-12#1)(2012-12#1)(2013-1#1)
are to develop a##2##4##(1992-1#1)(1992-9#1)
are to develop##3##3##(1992-1#1)(1992-9#1)(2008-8#1)
are to establish##2##3##(2008-3#1)(2009-8#1)
are to give##2##3##(1996-3#1)(2008-7#1)
are to have##3##3##(1994-9#1)(1995-3#1)(1997-8#1)
are to make##2##3##(1996-1#1)(2012-12#1)
are to our knowledge the##5##5##(2007-11#2)(2007-12#3)
are to provide##5##3##(1990-11#1)(2007-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
are to relieve##2##3##(2008-2#1)(2008-9#1)
are to the##2##3##(2007-12#1)(2008-2#1)
are to##117##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-2#5)(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#6)(2013-8#1)
are today##4##2##(1993-11#1)(1996-1#1)(2008-4#1)(2010-5#1)
are tolerated##4##2##(2008-10#3)(2013-1#1)
are too costly to be##2##5##(2008-10#1)(2008-9#1)
are too large to##2##4##(2008-6#1)(2008-9#1)
are too small to be##2##5##(1991-3#1)(2008-3#1)
are too small##4##3##(1991-3#1)(2008-3#2)(2008-9#1)
are too##24##2##(1991-3#1)(1992-12#1)(1994-3#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#3)(2012-3#2)(2013-1#5)
are tools that##2##3##(2007-4#1)(2012-2#1)
are tools##3##2##(2007-4#1)(2008-7#1)(2012-2#1)
are total##2##2##(2013-1#2)
are toxic to##4##3##(1996-3#1)(2008-10#1)(2008-5#2)
are toxic##7##2##(1992-12#1)(1996-3#1)(2008-10#3)(2008-5#2)
are tracked##2##2##(2008-2#2)
are traditionally based on##2##4##(1994-3#1)(1994-9#1)
are traditionally determined by##2##4##(2008-10#1)(2012-1#1)
are traditionally used##2##3##(2008-10#1)(2008-3#1)
are traditionally##10##2##(1993-3#1)(1994-3#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-1#1)
are trained##3##2##(1992-3#1)(2008-11#1)(2013-1#1)
are trans-spliced##2##2##(2007-12#2)
are transcribed from##3##3##(1990-5#1)(2007-12#1)(2012-3#1)
are transcribed in##2##3##(1990-8#1)(2012-3#1)
are transcribed to##2##3##(1992-11#1)(1997-7#1)
are transcribed##16##2##(1990-5#1)(1990-8#1)(1992-11#1)(1995-6#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
are transcription factors##2##3##(2008-3#1)(2012-2#1)
are transcriptional##2##2##(2008-7#1)(2008-9#1)
are transferred to the##2##4##(2008-4#1)(2009-7#1)
are transferred to##4##3##(1990-10#1)(2008-11#1)(2008-4#1)(2009-7#1)
are transferred##10##2##(1990-10#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-7#1)
are transformed to##3##3##(2008-6#1)(2010-10#1)(2013-1#1)
are transformed##7##2##(1990-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2013-1#1)
are transforming##2##2##(1991-3#1)(2013-8#1)
are transient and##2##3##(1992-4#1)(2007-11#1)
are transient##4##2##(1992-4#1)(2007-11#1)(2009-11#1)(2013-1#1)
are transiently##2##2##(1994-11#1)(2013-1#1)
are translated into##2##3##(2010-4#1)(2012-2#1)
are transmitted by##3##3##(2008-10#3)
are transmitted over the##2##4##(1992-3#1)(2009-9#1)
are transmitted##15##2##(1992-2#1)(1992-3#1)(1994-12#1)(1995-5#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-10#1)(2009-9#1)
are transparent##2##2##(2008-3#2)
are transplanted##4##2##(1995-2#1)(2007-8#1)(2009-5#1)(2013-1#1)
are transported by a##2##4##(1994-8#1)(2010-4#1)
are transported from the##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
are transported from##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
are transported##10##2##(1994-11#1)(1994-8#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)
are trapped##2##2##(2008-10#1)(2012-2#1)
are treated as##4##3##(1997-3#1)(2008-3#3)
are treated by##3##3##(1995-11#1)(2008-7#1)(2013-1#1)
are treated in##2##3##(1997-2#1)(2008-10#1)
are treated with##14##3##(1990-11#1)(1990-7#1)(1992-8#1)(1996-6#1)(2008-10#2)(2008-2#2)(2008-7#2)(2008-8#1)(2010-3#2)(2013-1#1)
are treated##35##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-8#2)(2008-10#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#1)(2010-3#2)(2013-1#2)(2013-8#1)
are treatment##2##2##(1993-12#1)(2011-2#1)
are triggered by##4##3##(2007-11#1)(2007-12#1)(2009-8#1)(2012-1#1)
are triggered##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-8#1)(2012-1#1)
are true##5##2##(1990-8#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#1)
are trying to##5##3##(1990-4#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-11#1)
are tumors##2##2##(2008-10#1)(2011-2#1)
are tuned##4##2##(2007-11#1)(2007-12#1)(2008-4#1)(2009-10#1)
are turned##2##2##(2008-10#1)(2008-4#1)
are turning##2##2##(1990-4#1)(2008-11#1)
are two different##4##3##(1990-12#1)(2008-10#2)(2008-9#1)
are two distinct entities##2##4##(1991-8#1)(1994-9#1)
are two forms of##3##4##(2008-5#1)(2010-5#1)(2011-2#1)
are two forms##4##3##(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
are two genes encoding##2##4##(2008-9#1)(2009-10#1)
are two important##3##3##(2009-8#1)(2011-1#1)(2013-1#1)
are two kinds of##3##4##(1993-3#1)(2008-2#1)(2011-3#1)
are two main##6##3##(1995-5#1)(1997-6#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-2#1)
are two major##9##3##(1994-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-6#1)(2012-2#2)
are two methods##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
are two of the##2##4##(2008-9#1)(2012-2#1)
are two reasons##2##3##(1994-6#1)(2008-3#1)
are two types of##9##4##(1991-2#1)(1994-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2012-2#1)
are two types##10##3##(1991-2#1)(1993-12#1)(1994-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2012-2#1)
are two##107##2##(1990-12#1)(1990-5#1)(1991-2#2)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#6)(2008-9#5)(2009-10#2)(2009-2#1)(2009-6#3)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#2)
are twofold##2##2##(2007-11#1)(2008-3#1)
are type##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
are typical for##2##3##(1996-2#1)(2008-10#1)
are typical of##8##3##(1990-12#1)(1992-6#1)(1993-2#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
are typical##15##2##(1990-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#2)(2011-2#1)(2013-7#2)
are typically based on##2##4##(2008-3#1)(2009-11#1)
are typically generated by##2##4##(2008-10#1)(2008-2#1)
are typically managed##2##3##(2011-2#1)(2012-2#1)
are typically not##2##3##(2008-1#1)(2008-12#1)
are typically performed##2##3##(1994-3#1)(2008-10#1)
are typically used in##2##4##(2008-9#1)(2010-12#1)
are typically##42##2##(1992-2#1)(1994-3#2)(1994-8#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)
are ubiquitous in the##2##4##(2010-6#1)(2011-2#1)
are ubiquitous in##6##3##(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#2)
are ubiquitous##15##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#2)(2011-2#3)(2013-7#1)(2013-8#1)
are unable to afford##2##4##(1994-12#1)(2008-11#1)
are unable to form##2##4##(1990-5#1)(2008-10#1)
are unable to provide##3##4##(2011-1#1)(2012-2#2)
are unable to##25##3##(1990-5#1)(1991-11#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#3)(2013-1#1)
are unaffected by##2##3##(1991-12#1)(1996-8#1)
are unattainable##2##2##(2009-6#1)(2010-2#1)
are unavailable##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
are uncertain##7##2##(1991-5#1)(1992-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
are unclear##8##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-1#1)(2012-2#1)
are uncommon and##2##3##(1990-6#1)(2013-1#1)
are uncommon lesions##3##3##(2007-8#1)(2008-6#1)(2011-2#1)
are uncommon##18##2##(1990-6#1)(1993-12#1)(1993-9#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#3)
are uncommonly##2##2##(2007-7#1)(2012-2#1)
are under control##2##3##(2008-1#1)(2008-10#1)
are under development##7##3##(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#2)
are under investigation##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
are under the control of the##2##6##(2008-11#1)(2008-5#1)
are under the##5##3##(1991-11#1)(2008-11#1)(2008-5#2)(2012-3#1)
are under##40##2##(1991-11#1)(1994-3#2)(1995-2#1)(1995-9#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
are underestimated##3##2##(1995-2#1)(2008-3#1)(2012-2#1)
are undergoing clinical evaluation for##2##5##(2008-7#2)
are undergoing clinical##3##3##(2008-7#2)(2012-12#1)
are undergoing##11##2##(2008-5#2)(2008-7#3)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
are underlined##3##2##(1990-9#1)(1992-9#1)(2008-10#1)
are underrepresented##2##2##(2008-10#1)(2010-8#1)
are understood##5##2##(1996-4#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-5#1)
are undertaken to##2##3##(2011-2#1)(2012-2#1)
are undertaken##4##2##(1994-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
are underway to##5##3##(1993-11#1)(1994-10#1)(2008-8#1)(2009-1#1)(2012-2#1)
are underway##11##2##(1993-11#1)(1994-10#1)(1997-3#1)(2008-11#1)(2008-5#2)(2008-8#2)(2009-1#1)(2012-2#2)
are undesirable##2##2##(2011-2#1)(2012-12#1)
are undoubtedly##2##2##(1991-8#1)(2009-10#1)
are unequal##2##2##(2008-10#1)(2008-2#1)
are unfamiliar with##2##3##(1994-2#1)(2008-4#1)
are uniformly##2##2##(2008-6#1)(2009-8#1)
are unimportant##2##2##(1997-3#1)(2008-8#1)
are uninsured##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
are unique and##3##3##(2008-3#1)(2008-8#1)(2009-10#1)
are unique in their ability to##2##6##(2008-3#1)(2013-8#1)
are unique in##5##3##(1996-12#1)(2007-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
are unique to##4##3##(1991-6#1)(2008-3#1)(2008-7#1)(2008-8#1)
are unique##24##2##(1991-12#1)(1991-6#1)(1992-11#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are uniquely positioned to##2##4##(1992-1#1)(2007-5#1)
are uniquely##7##2##(1992-1#1)(1993-11#1)(1994-9#1)(2007-12#1)(2007-5#1)(2008-3#1)(2013-8#1)
are universal##4##2##(2008-7#1)(2009-10#1)(2010-12#1)(2013-8#1)
are universally present in##2##4##(2008-10#1)(2009-4#1)
are unknown and##2##3##(2012-12#1)(2012-3#1)
are unknown##28##2##(1993-2#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-4#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
are unlikely to affect##2##4##(2008-10#1)(2010-11#1)
are unlikely to be##10##4##(1994-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-10#1)(2013-1#1)
are unlikely to##25##3##(1994-9#1)(1996-12#2)(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#2)
are unlikely##26##2##(1994-9#1)(1996-12#2)(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-1#2)
are unrelated##2##2##(1990-8#1)(2008-11#1)
are unresponsive to##2##3##(1997-1#1)(2008-7#1)
are unstable##3##2##(1992-5#1)(2008-10#1)(2012-3#1)
are unsuitable##2##2##(2008-10#1)(2008-7#1)
are unusual and##2##3##(2007-10#1)(2007-12#1)
are unusual##7##2##(1990-5#1)(1994-2#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-7#2)
are up to##5##3##(2007-12#1)(2008-10#1)(2008-11#2)(2013-8#1)
are up-regulated in##2##3##(2008-4#2)
are urged to##3##3##(1995-2#1)(1996-2#1)(2008-11#1)
are urgently needed to##3##4##(2007-10#1)(2008-8#1)(2011-2#1)
are urgently needed##5##3##(1993-11#1)(2007-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
are urgently required in##2##4##(2010-6#1)(2011-2#1)
are urgently required to##2##4##(1995-5#1)(2010-3#1)
are urgently required##4##3##(1995-5#1)(2010-3#1)(2010-6#1)(2011-2#1)
are urgently##9##2##(1993-11#1)(1995-5#1)(2007-10#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-7#1)
are used and##3##3##(1990-2#1)(2008-10#1)(2012-2#1)
are used as a basis for##2##6##(1991-6#1)(1994-2#1)
are used as a model##2##5##(1997-2#1)(2008-10#1)
are used as a##6##4##(1991-6#1)(1994-2#1)(1997-2#1)(2008-10#2)(2010-8#1)
are used as an##2##4##(2007-12#1)(2008-10#1)
are used as polarization##2##4##(2008-3#2)
are used as the##7##4##(1995-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2011-1#1)
are used as##54##3##(1991-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-12#3)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#1)
are used by##8##3##(1990-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2013-8#2)
are used extensively in##2##4##(2008-5#1)(2009-11#1)
are used extensively##4##3##(1992-3#1)(2008-11#1)(2008-5#1)(2009-11#1)
are used for the fabrication of##2##6##(2008-2#1)(2008-3#1)
are used for the##11##4##(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-12#1)(2010-5#1)(2010-8#1)
are used for their##2##4##(2007-8#1)(2008-12#1)
are used for##57##3##(1990-3#1)(1991-12#1)(1993-11#1)(1996-1#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#3)(2008-9#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
are used frequently##3##3##(2008-12#1)(2013-1#2)
are used here##2##3##(2008-3#1)(2012-12#1)
are used in a##4##4##(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
are used in clinical##2##4##(2008-8#1)(2009-3#1)
are used in combination##2##4##(2007-11#1)(2010-7#1)
are used in the treatment of##2##6##(2008-3#1)(2009-8#1)
are used in the##15##4##(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-8#1)(2010-8#1)
are used in this study##2##5##(1995-6#1)(2008-3#1)
are used in##59##3##(1991-11#1)(1993-3#2)(1995-6#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#3)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-8#1)
are used instead of##2##4##(2007-11#1)(2011-2#1)
are used is##3##3##(2008-3#3)
are used more##2##3##(2008-9#1)(2012-12#1)
are used primarily to##2##4##(1991-6#1)(2008-10#1)
are used primarily##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
are used therapeutically##2##3##(1995-2#1)(2008-1#1)
are used to achieve##2##4##(2008-3#1)(2012-3#1)
are used to analyze##4##4##(1990-11#1)(2007-11#1)(2008-12#1)(2008-3#1)
are used to assess the##3##5##(1992-2#1)(2008-3#1)(2008-5#1)
are used to calculate the##3##5##(2008-3#2)(2011-1#1)
are used to calculate##4##4##(1995-9#1)(2008-3#2)(2011-1#1)
are used to characterize the##3##5##(2008-1#2)(2008-2#1)
are used to characterize##4##4##(2008-1#2)(2008-2#1)(2008-4#1)
are used to compare the##2##5##(2008-10#1)(2008-6#1)
are used to construct##2##4##(1992-11#1)(2008-9#1)
are used to control the##2##5##(2008-10#1)(2008-5#1)
are used to correct the##2##5##(2008-3#2)
are used to correct##3##4##(2008-3#3)
are used to create##2##4##(1991-9#1)(2012-3#1)
are used to define##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
are used to derive##3##4##(2008-2#2)(2008-3#1)
are used to describe##3##4##(1996-2#1)(1997-2#1)(2008-11#1)
are used to detect##3##4##(2008-11#1)(2008-4#1)(2008-9#1)
are used to determine the##5##5##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
are used to determine##9##4##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-11#2)
are used to develop a##2##5##(2008-3#2)
are used to discriminate##2##4##(2008-10#1)(2010-6#1)
are used to draw##2##4##(1990-9#1)(2008-9#1)
are used to eliminate the##2##5##(2008-8#1)(2009-12#1)
are used to establish##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
are used to estimate the##4##5##(1991-3#1)(1994-3#1)(2008-11#1)(2008-2#1)
are used to evaluate the##4##5##(2008-2#1)(2008-4#1)(2010-11#1)(2010-8#1)
are used to evaluate##7##4##(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#1)
are used to examine the##3##5##(2009-12#1)(2010-3#1)(2010-6#1)
are used to find##2##4##(2008-2#2)
are used to generate##2##4##(2008-3#1)(2010-3#1)
are used to guide##2##4##(2013-1#2)
are used to identify the##2##5##(2009-12#1)(2011-3#1)
are used to identify##5##4##(1997-1#1)(2008-9#2)(2009-12#1)(2011-3#1)
are used to illustrate the##5##5##(1995-11#1)(1995-12#1)(2008-10#1)(2008-4#2)
are used to illustrate##7##4##(1995-11#1)(1995-12#1)(2008-10#2)(2008-4#3)
are used to improve##2##4##(1995-2#1)(2008-7#1)
are used to investigate the##4##5##(1992-2#1)(1995-2#1)(2008-4#1)(2008-7#1)
are used to investigate##5##4##(1992-2#1)(1995-2#1)(2008-4#1)(2008-7#1)(2009-8#1)
are used to make##3##4##(2008-2#1)(2008-7#1)(2012-3#1)
are used to measure the##6##5##(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-12#1)
are used to measure##10##4##(2008-1#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-12#1)
are used to monitor##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
are used to obtain##4##4##(2008-3#2)(2008-4#1)(2008-8#1)
are used to optimize the##2##5##(2007-12#1)(2008-5#1)
are used to provide##2##4##(1992-6#1)(1996-3#1)
are used to quantify the##2##5##(2008-2#1)(2008-7#1)
are used to quantify##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
are used to study the##2##5##(1993-11#1)(2008-2#1)
are used to study##4##4##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
are used to treat##7##4##(1994-5#1)(2008-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
are used to validate the##2##5##(2008-3#1)(2008-7#1)
are used to verify##3##4##(2008-4#1)(2008-9#1)(2010-5#1)
are used to##202##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-6#2)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#7)(2008-1#5)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#49)(2008-4#12)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#11)(2009-10#1)(2009-11#4)(2009-12#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
are used with the##2##4##(2008-3#1)(2011-2#1)
are used##517##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-2#2)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#3)(1997-3#5)(1997-6#2)(2007-10#1)(2007-11#10)(2007-12#16)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#14)(2008-10#52)(2008-11#12)(2008-12#4)(2008-2#35)(2008-3#110)(2008-4#22)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#19)(2009-10#1)(2009-11#5)(2009-12#6)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#3)(2010-12#6)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#9)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#5)
are useful analytical tools for##2##5##(2008-10#2)
are useful as##5##3##(1990-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
are useful for studies##2##4##(2008-1#1)(2008-7#1)
are useful for studying the##2##5##(2008-10#1)(2008-8#1)
are useful for studying##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
are useful for the##2##4##(2008-3#1)(2008-4#1)
are useful for##28##3##(1990-2#1)(1993-12#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#7)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
are useful in the##3##4##(1993-2#1)(1995-4#1)(2012-2#1)
are useful in##21##3##(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-4#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2010-7#1)(2011-2#1)(2012-2#1)
are useful markers##2##3##(2008-11#1)(2009-8#1)
are useful predictors of##2##4##(2011-1#1)(2012-2#1)
are useful to determine##2##4##(2008-10#1)(2010-8#1)
are useful to##11##3##(1996-6#1)(1997-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
are useful tools for##2##4##(1995-12#1)(2007-4#1)
are useful tools in##2##4##(2007-4#1)(2010-11#1)
are useful tools##5##3##(1995-12#1)(2007-4#2)(2008-8#1)(2010-11#1)
are useful when##3##3##(2008-2#2)(2008-4#1)
are useful##97##2##(1990-2#1)(1990-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-4#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-4#1)(1997-5#1)(2007-11#3)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#11)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#3)(2012-3#2)(2013-8#2)
are using##9##2##(1992-1#2)(1994-12#1)(1995-12#1)(1997-1#1)(2009-10#1)(2010-11#1)(2010-7#1)(2012-2#1)
are usually associated##2##3##(2007-8#1)(2012-2#1)
are usually characterised##2##3##(2008-10#1)(2010-11#1)
are usually detected##2##3##(2008-10#1)(2012-2#1)
are usually found in the##2##5##(2009-3#1)(2010-12#1)
are usually found in##3##4##(2007-7#1)(2009-3#1)(2010-12#1)
are usually less##2##3##(2008-3#1)(2008-9#1)
are usually mild##2##3##(1997-3#1)(2008-6#1)
are usually more##3##3##(1995-5#1)(1996-4#1)(2008-10#1)
are usually normal in##2##4##(2008-3#1)(2008-4#1)
are usually not##5##3##(1992-3#1)(1993-6#1)(2008-3#1)(2008-8#1)(2009-6#1)
are usually performed on##2##4##(1993-6#1)(2008-10#1)
are usually performed##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2011-2#1)
are usually present##3##3##(1995-11#1)(2010-4#1)(2012-3#1)
are usually required##2##3##(1995-3#1)(2011-2#1)
are usually studied##2##3##(2008-10#1)(2012-12#1)
are usually transferred from##2##4##(1994-6#1)(2008-10#1)
are usually used##2##3##(2008-10#1)(2008-4#1)
are usually##106##2##(1990-11#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
are utilized as##4##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
are utilized to##7##3##(1994-1#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-8#1)(2013-1#1)
are utilized##17##2##(1994-1#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-8#1)(2013-1#1)
are valid for##6##3##(1994-5#1)(2008-2#2)(2008-3#2)(2009-5#1)
are valid##10##2##(1994-5#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)
are validated##3##2##(2008-10#2)(2009-10#1)
are valuable for##4##3##(2008-12#1)(2010-3#1)(2012-2#1)(2012-5#1)
are valuable in the##2##4##(2008-10#1)(2008-11#1)
are valuable in##6##3##(1992-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-8#1)
are valuable tools for##4##4##(1995-6#1)(2008-4#1)(2008-7#1)(2012-3#1)
are valuable tools##7##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#1)
are valuable##22##2##(1992-2#1)(1993-2#1)(1995-11#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2012-5#1)
are variable##5##2##(2007-7#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-3#1)
are variables##2##2##(1993-1#1)(2012-2#1)
are varied and##2##3##(1996-2#1)(2007-2#1)
are varied##11##2##(1996-2#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-2#1)
are various##6##2##(1991-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
are vectors##2##2##(2008-10#1)(2008-12#1)
are verified by##6##3##(2007-12#1)(2008-3#4)(2010-12#1)
are verified in##2##3##(2008-10#1)(2008-3#1)
are verified##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#5)(2010-12#1)
are versatile##2##2##(1996-5#1)(2008-10#1)
are very attractive##2##3##(2008-10#1)(2008-2#1)
are very closely related##3##4##(2008-10#3)
are very common in the##2##5##(2009-4#1)(2009-8#1)
are very common##3##3##(2009-4#1)(2009-8#1)(2012-2#1)
are very complex##2##3##(1996-12#1)(2012-2#1)
are very different in##2##4##(1991-3#1)(2008-10#1)
are very different##6##3##(1990-5#1)(1991-3#1)(1997-8#1)(2008-10#2)(2010-8#1)
are very difficult to##2##4##(1996-4#1)(2008-10#1)
are very effective to##2##4##(2011-2#1)(2013-7#1)
are very effective##5##3##(1990-12#1)(1995-5#1)(2007-7#1)(2011-2#1)(2013-7#1)
are very few##5##3##(1996-12#1)(1996-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
are very good##3##3##(1991-3#1)(2007-11#2)
are very heterogeneous with##2##4##(2010-4#1)(2011-2#1)
are very high##4##3##(1996-5#1)(2008-1#1)(2008-10#2)
are very important factors in##2##5##(2007-11#1)(2007-8#1)
are very important in##3##4##(1990-9#1)(1994-5#1)(2008-1#1)
are very important##11##3##(1990-9#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)(2010-7#1)(2012-3#2)
are very interesting##2##3##(1993-9#1)(2010-11#1)
are very limited##4##3##(2007-11#1)(2008-7#1)(2010-4#1)(2012-7#1)
are very low##2##3##(2008-10#1)(2009-4#1)
are very much##2##3##(1996-11#1)(2009-7#1)
are very promising for##2##4##(2008-7#1)(2011-2#1)
are very promising##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
are very rare##8##3##(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
are very sensitive to##4##4##(2008-10#1)(2008-4#2)(2008-6#1)
are very sensitive##5##3##(2008-10#1)(2008-4#3)(2008-6#1)
are very significantly##2##3##(2008-12#2)
are very similar for##2##4##(1995-3#1)(2008-10#1)
are very similar in##3##4##(1990-11#1)(2007-11#1)(2008-4#1)
are very similar to those of##5##6##(1992-3#1)(1992-8#1)(1994-8#1)(2008-2#1)(2008-7#1)
are very similar to those##7##5##(1992-3#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(2008-2#1)(2008-7#1)
are very similar to##11##4##(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)
are very similar##22##3##(1990-11#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)
are very small##3##3##(2008-10#2)(2008-3#1)
are very stable and##2##4##(2008-10#1)(2008-11#1)
are very stable##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
are very uncommon##2##3##(1991-6#1)(2013-8#1)
are very useful for##2##4##(2007-12#1)(2008-12#1)
are very useful in##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
are very useful##9##3##(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#2)
are very valuable##3##3##(2007-2#1)(2008-9#1)(2011-2#1)
are very##160##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#38)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#6)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-7#1)(2013-8#2)
are viable##5##2##(1993-12#1)(2008-10#2)(2008-9#1)(2010-10#1)
are video films that continuously and dynamically display anatomic structures in 3D space at different velocities##2##16##(2012-3#2)
are viewed as##5##3##(1994-9#1)(1996-5#1)(2009-7#1)(2012-2#1)(2012-3#1)
are viewed##6##2##(1994-9#1)(1996-5#1)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#1)
are virtually##4##2##(1992-6#1)(1992-8#1)(1995-5#1)(2008-3#1)
are virulent to##3##3##(2008-10#3)
are virulent##4##2##(2008-10#4)
are visible at##2##3##(2008-3#1)(2008-7#1)
are visible in the##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
are visible##7##2##(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#1)
are visualized##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)
are vital for##3##3##(2008-2#1)(2009-8#1)(2011-1#1)
are vital##8##2##(1996-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-1#1)(2012-2#1)
are vulnerable to##4##3##(2008-8#1)(2013-1#3)
are vulnerable##5##2##(2008-8#1)(2009-6#1)(2013-1#3)
are waiting for##3##3##(1995-1#1)(1995-5#1)(2010-8#1)
are warning##2##2##(1992-8#1)(2008-12#1)
are warranted in##2##3##(1990-10#1)(2007-11#1)
are warranted to##7##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#3)(2011-2#1)
are warranted##18##2##(1990-10#1)(1991-4#1)(1992-12#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
are wavelength##2##2##(2008-10#1)(2008-2#1)
are we and where are we##2##6##(1990-6#1)(2013-1#1)
are we doing##2##3##(1991-3#1)(2012-12#1)
are we doing?##4##3##(1991-3#1)(1996-2#1)(2011-2#1)(2012-12#1)
are we going##2##3##(1996-12#1)(2008-1#1)
are we there yet?##2##4##(2008-3#1)(2008-8#1)
are we to##3##3##(1990-9#1)(2008-1#1)(2008-10#1)
are we##32##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#2)(1992-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
are we?##2##2##(2007-12#1)(2008-7#1)
are weaker##2##2##(1993-3#1)(2008-8#1)
are weighted##2##2##(2008-10#1)(2008-7#1)
are well above##2##3##(1990-12#1)(1994-1#1)
are well approximated as##2##4##(2008-3#1)(2009-9#1)
are well below##2##3##(2008-5#1)(2012-2#1)
are well conserved##4##3##(1990-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
are well correlated##2##3##(2008-10#2)
are well defined##3##3##(2008-7#1)(2009-9#1)(2011-1#1)
are well described by a##2##5##(1990-7#1)(2007-11#1)
are well described by##3##4##(1990-7#1)(2007-11#1)(2008-3#1)
are well described##5##3##(1990-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-12#1)
are well documented##7##3##(1990-6#1)(1993-11#1)(1994-9#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
are well established##3##3##(1992-3#1)(2008-4#1)(2013-8#1)
are well known for##3##4##(2008-1#1)(2012-12#1)(2012-2#1)
are well known in##2##4##(1995-2#1)(1996-3#1)
are well known to be##3##5##(1994-11#1)(2008-11#1)(2010-3#1)
are well known to##8##4##(1994-11#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
are well known##23##3##(1990-2#1)(1994-11#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are well recognized##2##3##(1990-2#1)(2009-9#1)
are well represented##2##3##(1992-9#1)(2008-1#1)
are well separated##2##3##(2008-10#2)
are well suited for##5##4##(2007-12#1)(2008-10#1)(2008-4#2)(2010-8#1)
are well suited to##5##4##(1993-11#1)(1993-2#1)(1996-5#1)(2008-11#1)(2008-2#1)
are well suited##11##3##(1993-11#1)(1993-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2010-8#1)
are well tolerated##3##3##(1996-9#1)(2008-5#1)(2013-1#1)
are well##98##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#1)(2009-10#1)(2009-12#2)(2009-9#3)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
are well-conserved##3##2##(1995-3#1)(2008-7#1)(2009-8#1)
are well-documented##2##2##(2008-11#1)(2013-1#1)
are well-known##3##2##(1993-12#1)(1996-6#1)(2008-5#1)
are widely acknowledged##2##3##(1993-12#1)(1997-5#1)
are widely available##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
are widely considered##2##3##(2009-4#1)(2012-3#1)
are widely distributed in##3##4##(2008-10#1)(2009-12#1)(2011-2#1)
are widely distributed##6##3##(2008-10#1)(2008-12#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
are widely expressed in##3##4##(2008-3#1)(2009-5#1)(2012-3#1)
are widely used as##3##4##(2010-1#1)(2010-5#1)(2012-3#1)
are widely used for##6##4##(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
are widely used in the##2##5##(2008-11#1)(2010-11#1)
are widely used in##5##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#2)
are widely used to##4##4##(2008-3#2)(2008-7#1)(2010-5#1)
are widely used##21##3##(1994-8#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-11#2)(2010-5#2)(2011-1#1)(2012-3#1)
are widely##49##2##(1993-12#2)(1994-8#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-5#3)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
are widespread among##2##3##(2007-12#1)(2012-12#1)
are widespread##9##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
are willing to##5##3##(1994-1#1)(1996-2#1)(2007-12#1)(2012-12#1)(2012-2#1)
are within 0##2##3##(2008-3#1)(2011-2#1)
are within 3##2##3##(2008-10#2)
are within the range of##3##5##(1990-7#1)(2008-6#1)(2013-1#1)
are within the##9##3##(1990-7#1)(1993-6#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#1)
are within##21##2##(1990-7#1)(1993-11#1)(1993-6#1)(1996-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
are without##3##2##(1991-8#1)(1994-11#1)(2008-11#1)
are working to##2##3##(1993-2#1)(1996-1#1)
are working##10##2##(1993-2#2)(1995-6#1)(1996-1#1)(2008-10#1)(2008-7#3)(2008-8#1)(2011-2#1)
are worth##3##2##(1991-3#1)(1995-3#1)(2008-8#1)
are yet available##2##3##(2008-11#1)(2008-8#1)
are yet to be##6##4##(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
are yet##12##2##(1994-5#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#2)(2009-3#1)(2012-1#1)
are you##3##2##(2008-12#1)(2009-12#1)(2012-3#1)
are you?##3##2##(1992-9#1)(1996-2#1)(2008-4#1)
are young##3##2##(2008-11#1)(2010-3#1)(2011-2#1)
are##29173##1##(1990-10#12)(1990-11#86)(1990-12#77)(1990-2#88)(1990-3#45)(1990-4#7)(1990-5#82)(1990-6#56)(1990-7#48)(1990-8#108)(1990-9#49)(1991-1#44)(1991-10#4)(1991-11#52)(1991-12#159)(1991-2#108)(1991-3#102)(1991-4#10)(1991-5#76)(1991-6#77)(1991-7#10)(1991-8#49)(1991-9#65)(1992-1#65)(1992-10#16)(1992-11#64)(1992-12#133)(1992-2#91)(1992-3#177)(1992-4#31)(1992-5#50)(1992-6#112)(1992-7#3)(1992-8#88)(1992-9#91)(1993-1#44)(1993-10#3)(1993-11#106)(1993-12#192)(1993-2#111)(1993-3#128)(1993-5#22)(1993-6#90)(1993-8#88)(1993-9#58)(1994-1#57)(1994-10#3)(1994-11#85)(1994-12#144)(1994-2#153)(1994-3#118)(1994-5#104)(1994-6#61)(1994-7#4)(1994-8#110)(1994-9#82)(1995-1#84)(1995-10#2)(1995-11#66)(1995-12#143)(1995-2#211)(1995-3#117)(1995-4#6)(1995-5#134)(1995-6#108)(1995-8#73)(1995-9#35)(1996-1#83)(1996-10#10)(1996-11#42)(1996-12#145)(1996-2#208)(1996-3#128)(1996-4#35)(1996-5#77)(1996-6#57)(1996-7#21)(1996-8#23)(1996-9#38)(1997-1#97)(1997-2#123)(1997-3#149)(1997-4#108)(1997-5#45)(1997-6#82)(1997-7#122)(1997-8#113)(1997-9#7)(2006-10#47)(2006-12#23)(2006-4#11)(2006-5#4)(2006-6#15)(2006-7#4)(2006-8#1)(2007-1#4)(2007-10#89)(2007-11#588)(2007-12#894)(2007-2#63)(2007-3#1)(2007-4#26)(2007-5#41)(2007-6#16)(2007-7#102)(2007-8#165)(2007-9#15)(2008-1#373)(2008-10#3734)(2008-11#1031)(2008-12#359)(2008-2#1192)(2008-3#2331)(2008-4#910)(2008-5#668)(2008-6#295)(2008-7#1057)(2008-8#722)(2008-9#736)(2009-1#13)(2009-10#171)(2009-11#113)(2009-12#130)(2009-2#42)(2009-3#84)(2009-4#72)(2009-5#184)(2009-6#89)(2009-7#113)(2009-8#195)(2009-9#124)(2010-1#40)(2010-10#113)(2010-11#147)(2010-12#191)(2010-2#68)(2010-3#155)(2010-4#118)(2010-5#137)(2010-6#81)(2010-7#89)(2010-8#233)(2010-9#60)(2011-1#318)(2011-10#6)(2011-2#996)(2011-3#64)(2011-4#1)(2011-7#12)(2011-9#1)(2012-1#105)(2012-12#326)(2012-2#633)(2012-3#418)(2012-4#2)(2012-5#12)(2012-6#1)(2012-7#4)(2012-8#4)(2013-1#713)(2013-3#2)(2013-7#102)(2013-8#384)
area (BA)##2##2##(2008-11#1)(2012-2#1)
area (mm(2))##2##2##(2011-2#1)(2012-3#1)
area 37##2##2##(1996-2#2)
area CA1 and##3##3##(2008-9#3)
area CA1##13##2##(1995-2#1)(1996-2#1)(1996-5#4)(2008-9#7)
area CA1)##2##2##(2008-9#1)(2010-7#1)
area V4##3##2##(1992-11#2)(2008-11#1)
area affected by the##2##4##(1992-6#1)(2008-5#1)
area affected by##5##3##(1992-6#1)(2008-10#3)(2008-5#1)
area after##2##2##(2008-10#1)(2012-1#1)
area along##2##2##(2008-10#2)
area among##2##2##(1992-5#1)(2007-12#1)
area and a##2##3##(2008-7#1)(2009-4#1)
area and also##2##3##(2008-11#1)(2011-2#1)
area and are##2##3##(2008-6#1)(2008-9#1)
area and is##2##3##(2008-10#1)(2008-9#1)
area and number of##2##4##(2008-9#1)(2010-3#1)
area and perimeter##2##3##(1995-6#1)(2012-5#1)
area and surface##2##3##(2008-10#1)(2010-4#1)
area and the##8##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)
area and were##2##3##(2008-10#1)(2012-1#1)
area and##90##2##(1990-5#1)(1990-8#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-7#1)(1996-8#1)(2007-12#2)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#8)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
area are also##2##3##(2008-10#1)(2008-2#1)
area are not##2##3##(2007-5#1)(2008-7#1)
area are presented##2##3##(2008-12#1)(2008-2#1)
area are##14##2##(1991-3#1)(1991-6#1)(1994-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-12#3)
area around the##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
area around##4##2##(1992-1#1)(2008-10#2)(2008-5#1)
area as a##2##3##(2008-2#1)(2008-5#1)
area as compared to##2##4##(2007-12#1)(2011-2#1)
area as compared##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
area as well as##4##4##(1992-5#1)(1993-9#1)(2008-10#1)(2008-9#1)
area as##11##2##(1992-5#1)(1993-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)
area at a##3##3##(2007-12#1)(2013-1#1)(2013-8#1)
area at##9##2##(2007-12#1)(2008-10#3)(2008-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
area because##2##2##(2008-10#2)
area between##4##2##(1995-3#1)(1997-8#1)(2007-11#1)(2010-9#1)
area but##3##2##(1993-12#1)(2008-11#1)(2008-2#1)
area by##11##2##(1995-11#1)(2008-10#1)(2008-3#2)(2008-9#2)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
area can be##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
area can##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
area compared with##2##3##(2008-10#2)
area contains##2##2##(2010-6#1)(2013-8#1)
area corresponding to the##2##4##(2008-12#1)(2010-10#1)
area could be##2##3##(2008-2#1)(2013-7#1)
area counts for most##2##4##(2008-10#2)
area covered by##3##3##(1994-3#1)(2008-10#2)
area covered##4##2##(1994-3#1)(2008-10#2)(2008-11#1)
area due to##2##3##(2008-10#1)(2008-8#1)
area during##3##2##(1991-12#1)(1995-12#1)(2010-11#1)
area easily##2##2##(2008-5#1)(2011-2#1)
area effects##3##2##(2008-8#1)(2008-9#2)
area estimates##6##2##(1997-3#6)
area for future research##3##4##(1991-9#1)(2010-2#1)(2011-2#1)
area for future##4##3##(1991-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
area for the##2##3##(1992-6#1)(2008-12#1)
area for##29##2##(1990-6#1)(1991-9#1)(1992-6#1)(1994-3#1)(1994-6#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-3#2)(2008-5#2)(2008-7#2)(2009-4#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-3#1)
area free of##2##3##(2007-8#1)(2011-2#1)
area from the##2##3##(2008-10#1)(2010-9#1)
area from##7##2##(2008-10#3)(2008-11#1)(2008-2#1)(2010-9#1)(2011-2#1)
area had##4##2##(1993-6#1)(1995-12#1)(1995-9#1)(2008-10#1)
area has been##2##3##(2008-10#2)
area has##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
area have##4##2##(1993-1#1)(1993-12#1)(2008-10#1)(2008-2#1)
area health boards##2##3##(1992-1#2)
area in the rat##2##4##(1993-12#1)(1994-8#1)
area in the##28##3##(1991-12#1)(1992-3#1)(1993-12#2)(1993-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-5#1)(2007-10#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-7#1)(2010-10#1)(2011-2#2)
area in which the##3##4##(1992-11#1)(2008-10#2)
area in which##7##3##(1992-11#1)(1996-12#1)(1997-1#1)(2008-10#4)
area in##66##2##(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-7#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
area includes##2##2##(2008-1#1)(2010-10#1)
area increased##4##2##(2007-5#1)(2008-12#1)(2012-1#1)(2012-5#1)
area increases##2##2##(2008-10#1)(2008-7#1)
area index##2##2##(2008-10#1)(2008-12#1)
area into##3##2##(2008-10#2)(2008-2#1)
area involved in##2##3##(2008-7#1)(2008-9#1)
area is a##3##3##(1991-3#1)(1996-3#1)(2008-3#1)
area is of##2##3##(2008-10#1)(2008-5#1)
area is proportional to the##2##5##(2008-10#1)(2008-3#1)
area is the##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
area is##45##2##(1991-12#2)(1991-3#1)(1994-1#1)(1994-3#1)(1996-11#2)(1996-3#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-9#1)
area it is##2##3##(1993-8#1)(2008-2#1)
area may have##2##3##(1995-12#1)(2007-12#1)
area may##5##2##(1992-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2012-12#1)
area measurements##7##2##(1991-12#1)(2008-10#6)
area method##3##2##(2008-10#2)(2008-3#1)
area modulation grating##4##3##(2008-3#4)
area modulation##5##2##(2008-3#5)
area near the##2##3##(2008-3#1)(2012-2#1)
area near##3##2##(1990-11#1)(2008-3#1)(2012-2#1)
area network##3##2##(1993-2#1)(2008-3#2)
area networks##2##2##(2008-7#1)(2010-8#1)
area occupied by##3##3##(1994-12#1)(2008-4#1)(2012-1#1)
area of 0##2##3##(2008-10#1)(2008-11#1)
area of 1##2##3##(2008-10#1)(2008-11#1)
area of 2##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
area of Argentina##2##3##(2008-10#2)
area of Health##2##3##(2012-2#1)(2012-3#1)
area of Southern##2##3##(2008-7#1)(2013-8#1)
area of West Bengal##2##4##(2010-4#2)
area of a##6##3##(2008-10#2)(2008-2#1)(2010-12#1)(2013-1#2)
area of application##2##3##(2008-3#1)(2011-1#1)
area of approximately##2##3##(2008-8#1)(2011-2#1)
area of care##2##3##(1991-12#1)(2008-12#1)
area of clinical practice##2##4##(2007-11#1)(2008-11#1)
area of clinical##3##3##(2007-11#1)(2008-11#1)(2010-11#1)
area of each##4##3##(1996-5#1)(2008-10#2)(2008-6#1)
area of foci##2##3##(1992-3#2)
area of health##3##3##(1991-2#1)(1991-6#1)(2012-12#1)
area of influence##4##3##(2008-10#4)
area of intensive##3##3##(2007-5#1)(2008-10#1)(2013-8#1)
area of interest##6##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)
area of malignant##2##3##(1991-2#1)(2012-3#1)
area of practice##2##3##(1995-12#1)(2008-11#1)
area of public health##2##4##(1996-1#1)(2013-1#1)
area of research and##3##4##(1995-8#1)(2007-7#1)(2008-11#1)
area of research##16##3##(1995-8#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)
area of significant##2##3##(2008-9#1)(2010-6#1)
area of source##2##3##(2008-10#2)
area of study is##2##4##(2012-2#1)(2013-7#1)
area of study##5##3##(1990-12#1)(1995-9#1)(2008-9#1)(2012-2#1)(2013-7#1)
area of the brain##2##4##(2008-11#1)(2008-5#1)
area of the cornea##2##4##(2008-3#2)
area of the hippocampus##2##4##(1995-12#1)(2009-12#1)
area of the middle frontal gyrus##2##6##(1994-8#2)
area of the rat##5##4##(1992-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)
area of the resonator##2##4##(2008-3#2)
area of the##88##3##(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-12#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2007-11#1)(2007-12#3)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#8)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-6#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
area of##383##2##(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-7#1)(1994-8#3)(1995-12#7)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#1)(1997-6#4)(1997-8#2)(2007-11#9)(2007-12#6)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#65)(2008-11#24)(2008-12#9)(2008-2#7)(2008-3#20)(2008-4#2)(2008-5#14)(2008-6#6)(2008-7#13)(2008-8#7)(2008-9#9)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#12)(2012-1#5)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#7)(2013-8#6)
area on the##7##3##(1990-8#1)(1991-2#1)(2007-5#1)(2008-10#2)(2008-2#1)(2011-1#1)
area on##11##2##(1990-8#2)(1991-2#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-1#1)
area or##5##2##(2008-10#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-2#1)
area participated in##2##3##(1992-3#1)(1996-2#1)
area per unit##2##3##(1994-3#1)(2008-10#1)
area percentages of fiber type IIB##2##6##(2010-4#2)
area previously##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
area ranged from##2##3##(2008-10#1)(2013-1#1)
area rather than the##2##4##(2008-10#1)(2008-3#1)
area ratio##4##2##(2008-10#1)(2008-7#2)(2013-8#1)
area ratios##5##2##(2008-10#4)(2008-6#1)
area should##2##2##(2008-7#1)(2010-8#1)
area showed##2##2##(2008-5#1)(2011-2#1)
area than##4##2##(1991-3#1)(2007-5#1)(2008-11#1)(2012-12#1)
area that has##5##3##(1995-1#1)(2008-11#2)(2009-8#1)(2013-1#1)
area that is##4##3##(1990-8#1)(2007-12#1)(2008-9#2)
area that##22##2##(1990-8#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
area the##5##2##(1991-12#1)(1995-2#1)(2007-11#1)(2008-10#2)
area there##2##2##(1991-6#1)(1994-12#1)
area they##2##2##(1997-3#1)(2008-5#1)
area to study##2##3##(2008-11#1)(2013-7#1)
area to the##7##3##(1992-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-8#1)
area to##24##2##(1992-2#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
area under curve##2##3##(2008-7#1)(2012-1#1)
area under disease progress curve##2##5##(2008-10#2)
area under the ROC curve##5##5##(2008-10#1)(2010-8#1)(2010-9#1)(2012-1#2)
area under the curve (AUC)##4##5##(1994-12#1)(2008-11#1)(2012-12#1)(2012-3#1)
area under the curve of##3##5##(2008-10#1)(2012-3#1)(2013-8#1)
area under the curve values##2##5##(2007-10#1)(2013-7#1)
area under the curve##14##4##(1992-9#1)(1994-12#2)(2007-10#1)(2008-10#3)(2008-11#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
area under the disease progress curve (AUDPC)##9##7##(2008-10#9)
area under the disease progress curve and##2##7##(2008-10#2)
area under the disease progress curve##19##6##(2008-10#19)
area under the disease progress##20##5##(2008-10#20)
area under the plasma concentration-time curve##2##6##(1996-5#1)(2008-8#1)
area under the##58##3##(1990-7#1)(1992-9#1)(1994-12#2)(1994-9#1)(1996-5#1)(2007-10#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-8#2)(2010-9#1)(2012-1#2)(2012-12#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
area under##69##2##(1990-7#1)(1992-9#1)(1994-12#2)(1994-9#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#37)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-8#2)(2010-9#1)(2012-1#3)(2012-12#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
area using##2##2##(2008-5#1)(2008-7#1)
area ventralis telencephali##2##3##(2008-6#2)
area was assessed##2##3##(2008-5#1)(2008-6#1)
area was evaluated##2##3##(1992-3#1)(2010-7#1)
area was##37##2##(1990-8#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
area were compared##2##3##(1997-1#1)(2009-3#1)
area were##16##2##(1996-1#1)(1997-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2012-2#1)(2013-8#2)
area when compared##2##3##(2008-10#1)(2013-7#1)
area where the##2##3##(2008-10#1)(2008-2#1)
area where##9##2##(1993-6#1)(1995-1#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)
area which##5##2##(1991-12#1)(2009-12#1)(2011-2#2)(2013-7#1)
area with a##6##3##(2007-11#1)(2007-12#1)(2008-3#2)(2011-1#1)(2013-1#1)
area with the##2##3##(1990-6#1)(2008-10#1)
area with##16##2##(1990-6#1)(1992-10#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
area within the##2##3##(1994-9#1)(2009-5#1)
area within##4##2##(1994-9#1)(2008-10#1)(2008-3#1)(2009-5#1)
area##1781##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#4)(1990-6#3)(1990-7#4)(1990-8#10)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#12)(1991-2#6)(1991-3#6)(1991-5#3)(1991-6#7)(1991-8#2)(1991-9#1)(1992-1#8)(1992-10#3)(1992-11#4)(1992-12#4)(1992-2#7)(1992-3#10)(1992-5#9)(1992-6#5)(1992-8#3)(1992-9#2)(1993-1#4)(1993-12#14)(1993-2#3)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#3)(1994-1#3)(1994-11#2)(1994-12#5)(1994-2#8)(1994-3#12)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#10)(1994-9#2)(1995-1#6)(1995-11#4)(1995-12#16)(1995-2#4)(1995-3#11)(1995-5#6)(1995-6#2)(1995-8#4)(1995-9#4)(1996-1#7)(1996-11#6)(1996-12#14)(1996-2#14)(1996-3#10)(1996-4#7)(1996-5#16)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#10)(1997-3#27)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#4)(2006-10#1)(2006-12#1)(2007-10#7)(2007-11#20)(2007-12#33)(2007-2#1)(2007-5#13)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#10)(2008-10#345)(2008-11#79)(2008-12#44)(2008-2#42)(2008-3#80)(2008-4#10)(2008-5#71)(2008-6#23)(2008-7#63)(2008-8#51)(2008-9#53)(2009-10#6)(2009-11#6)(2009-12#7)(2009-3#7)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-10#12)(2010-11#6)(2010-12#7)(2010-2#7)(2010-3#4)(2010-4#12)(2010-5#4)(2010-6#13)(2010-7#12)(2010-8#19)(2010-9#6)(2011-1#11)(2011-2#63)(2011-9#1)(2012-1#14)(2012-12#24)(2012-2#23)(2012-3#21)(2012-5#2)(2012-9#3)(2013-1#41)(2013-3#1)(2013-7#31)(2013-8#31)
area) and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
area) in##2##2##(2008-10#1)(2013-8#1)
area) was##2##2##(2008-10#1)(2011-2#1)
area)##20##1##(1990-2#1)(1995-8#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
area-based##3##1##(2008-12#2)(2011-3#1)
area-distributed##2##1##(2008-2#2)
area-pad##2##1##(2008-2#2)
area-restricted##2##1##(2008-9#2)
area]##7##1##(1993-10#1)(1993-5#1)(1994-6#1)(1996-9#1)(1997-3#1)(2009-5#1)(2013-1#1)
areal density of##2##3##(2007-11#2)
areal##5##1##(1994-3#1)(2007-11#2)(2007-12#1)(2008-7#1)
areas 17 and 18 of the##2##6##(2008-8#2)
areas 17 and 18 of##3##5##(2008-8#3)
areas activated by##2##3##(2008-5#1)(2008-9#1)
areas adjacent to##2##3##(2008-10#1)(2008-8#1)
areas affected by##2##3##(2008-10#1)(2012-3#1)
areas and are##3##3##(1993-6#1)(1997-3#1)(2010-9#1)
areas and in##2##3##(2007-2#1)(2012-3#1)
areas and is##2##3##(1992-2#1)(2008-10#1)
areas and that##2##3##(1996-1#1)(2008-10#1)
areas and the##4##3##(1994-11#1)(2007-7#1)(2008-11#1)(2010-3#1)
areas and to##2##3##(1994-2#1)(2007-8#1)
areas and was##2##3##(1993-12#1)(2008-10#1)
areas and with##2##3##(2008-7#1)(2013-1#1)
areas and##63##2##(1990-2#1)(1990-8#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#7)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
areas are often##2##3##(2008-9#1)(2013-1#1)
areas are##21##2##(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-11#1)(1996-11#1)(1997-8#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)(2012-12#1)(2013-1#2)
areas as well as##2##4##(2008-11#2)
areas as##10##2##(1991-12#1)(1993-1#1)(1994-1#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-10#1)(2010-7#1)
areas associated with##4##3##(1997-2#1)(2008-10#2)(2008-2#1)
areas at##5##2##(1994-3#1)(2007-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
areas between##2##2##(2008-10#1)(2013-7#1)
areas burn after##2##3##(1990-8#2)
areas but##2##2##(1993-9#1)(2008-12#1)
areas by##7##2##(1990-8#1)(1992-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)
areas can be##2##3##(1992-12#2)
areas can##5##2##(1992-12#2)(1996-3#1)(2010-10#1)(2013-1#1)
areas characterized by##2##3##(2008-10#1)(2011-2#1)
areas containing##2##2##(1997-8#1)(2013-1#1)
areas could be##2##3##(1994-8#1)(1996-12#1)
areas could##4##2##(1994-8#1)(1996-12#1)(2007-8#1)(2008-10#1)
areas discussed##2##2##(1994-1#1)(2008-10#1)
areas during##2##2##(2008-11#1)(2008-6#1)
areas examined##2##2##(1997-2#2)
areas for future research##2##4##(2008-11#1)(2012-2#1)
areas for future##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
areas for improvement##6##3##(1996-2#2)(2007-8#1)(2008-11#1)(2008-4#1)(2010-12#1)
areas for the##3##3##(1994-3#1)(1995-5#1)(1997-2#1)
areas for##31##2##(1990-8#1)(1992-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-8#4)(2010-12#1)(2010-8#1)(2012-2#2)(2013-8#1)
areas from##6##2##(1992-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
areas had##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
areas have##3##2##(1991-5#1)(2008-2#1)(2008-5#1)
areas if##3##2##(1996-12#1)(1996-4#1)(2007-2#1)
areas in China##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
areas in both##2##3##(1996-5#1)(2010-12#1)
areas in need of##2##4##(2008-11#1)(2013-1#1)
areas in the dorsal##2##4##(1997-3#1)(2007-12#1)
areas in the left##3##4##(1990-8#1)(2008-1#1)(2008-7#1)
areas in the##27##3##(1990-3#1)(1990-8#1)(1993-12#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
areas in which##8##3##(1996-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
areas in##79##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-3#2)(1996-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
areas including##2##2##(1996-1#1)(2008-1#1)
areas into##4##2##(1996-3#1)(1997-3#1)(2010-12#1)(2012-12#1)
areas involved in##2##3##(1993-12#1)(2010-6#1)
areas involves##2##2##(1994-3#1)(2010-10#1)
areas is##8##2##(1992-12#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-6#1)(2010-12#1)(2010-7#1)
areas it##2##2##(1996-3#1)(2013-8#1)
areas like the##2##3##(2010-3#1)(2010-6#1)
areas like##3##2##(2010-3#1)(2010-6#1)(2012-12#1)
areas located##2##2##(2008-10#1)(2013-7#1)
areas might be##2##3##(2007-2#1)(2008-10#1)
areas of Africa##2##3##(1997-4#1)(2008-10#1)
areas of China##2##3##(2012-3#1)(2013-8#1)
areas of Italy##3##3##(1993-2#1)(2008-10#1)(2008-7#1)
areas of Spain##2##3##(2008-10#2)
areas of Yunnan province that##2##5##(2011-1#2)
areas of active##2##3##(2007-5#1)(2010-9#1)
areas of acute##3##3##(2008-11#1)(2011-2#2)
areas of all##2##3##(1995-6#1)(2008-10#1)
areas of biological##2##3##(2008-10#1)(2008-9#1)
areas of cell##2##3##(1994-11#1)(2008-9#1)
areas of concern in##2##4##(1993-2#1)(2008-6#1)
areas of concern##3##3##(1993-2#1)(2008-1#1)(2008-6#1)
areas of controversy##2##3##(2008-2#1)(2012-1#1)
areas of cortex##2##3##(1990-11#1)(2008-11#1)
areas of different##2##3##(2008-3#1)(2013-7#1)
areas of high##6##3##(1994-8#1)(2007-5#1)(2008-8#2)(2010-5#2)
areas of increased##2##3##(2009-9#1)(2012-12#1)
areas of interest##3##3##(1997-5#1)(2008-11#1)(2013-1#1)
areas of investigation##2##3##(1992-9#1)(2011-1#1)
areas of low##6##3##(1994-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2012-12#1)
areas of nursing##3##3##(2007-11#1)(2008-11#1)(2008-12#1)
areas of potential##4##3##(1991-1#1)(1991-2#1)(2008-8#1)(2012-2#1)
areas of rat brain##4##4##(1990-7#1)(1991-12#2)(2008-10#1)
areas of research that##5##4##(2008-10#1)(2008-11#1)(2009-10#1)(2011-3#1)(2013-1#1)
areas of research##9##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-3#1)(2013-1#1)
areas of responsibility##3##3##(1995-3#1)(1996-1#1)(1996-2#1)
areas of risk##2##3##(1993-2#1)(2007-12#1)
areas of skin##3##3##(1996-12#1)(2008-5#2)
areas of the Cerrado##2##4##(2008-6#1)(2010-3#1)
areas of the Pacific##2##4##(2008-1#1)(2008-10#1)
areas of the United States where##2##6##(1992-8#1)(2011-2#1)
areas of the United States##3##5##(1992-8#1)(2011-2#2)
areas of the body##3##4##(1995-12#1)(2008-4#1)(2010-8#1)
areas of the brain##8##4##(1991-5#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)
areas of the country##4##4##(1994-6#1)(1996-1#1)(2008-7#1)(2012-12#1)
areas of the dorsal horn##2##5##(1997-3#2)
areas of the face##2##4##(2008-5#1)(2010-6#1)
areas of the same##3##4##(1994-5#2)(1996-1#1)
areas of the world##11##4##(1992-9#1)(2008-10#8)(2008-2#1)(2013-1#1)
areas of the##91##3##(1990-10#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
areas of uncertainty##2##3##(1993-12#1)(2012-3#1)
areas of work##2##3##(2008-11#1)(2012-12#1)
areas of##371##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#4)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#2)(1997-5#2)(2006-10#2)(2007-10#5)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#6)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#53)(2008-11#18)(2008-12#10)(2008-2#8)(2008-3#10)(2008-4#6)(2008-5#15)(2008-6#5)(2008-7#12)(2008-8#10)(2008-9#8)(2009-10#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#7)(2011-1#9)(2011-2#18)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#4)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#4)
areas on the##4##3##(2008-10#3)(2008-3#1)
areas on##7##2##(1997-8#1)(2008-10#4)(2008-3#1)(2008-7#1)
areas or##5##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
areas over##2##2##(1996-4#1)(2008-3#1)
areas pertaining to##2##3##(1996-1#1)(2013-8#1)
areas presents##2##2##(1991-2#1)(2008-12#1)
areas previously##2##2##(1995-2#1)(2008-10#1)
areas related to##3##3##(2008-3#1)(2013-1#2)
areas relating to##2##3##(2010-11#1)(2013-1#1)
areas requires##3##2##(1994-11#1)(2008-4#1)(2008-9#1)
areas responsible##2##2##(2008-7#1)(2011-1#1)
areas revealed##2##2##(1996-5#1)(2008-10#1)
areas should be##2##3##(2008-10#1)(2012-5#1)
areas should##3##2##(1994-3#1)(2008-10#1)(2012-5#1)
areas such as##12##3##(1994-3#1)(1995-11#1)(1997-2#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
areas suitable for##2##3##(2008-8#2)
areas than in##2##3##(2008-10#2)
areas than##7##2##(1994-3#1)(2008-10#2)(2008-3#1)(2009-4#1)(2012-1#1)(2012-3#1)
areas that are##4##3##(2008-1#2)(2009-4#1)(2010-10#1)
areas that could##2##3##(2008-3#1)(2008-6#1)
areas that have been##2##4##(1996-5#1)(2008-5#1)
areas that have##3##3##(1996-5#1)(2007-6#1)(2008-5#1)
areas that require##2##3##(2008-4#1)(2011-1#1)
areas that were##2##3##(2008-10#2)
areas that would##2##3##(2008-3#2)
areas that##26##2##(1990-9#1)(1994-1#1)(1996-1#1)(1996-5#2)(1997-7#1)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-2#1)
areas the##2##2##(1993-3#1)(2008-10#1)
areas to control##2##3##(2008-10#2)
areas to##12##2##(1994-3#1)(1994-9#1)(1996-5#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
areas under the##2##3##(2007-8#1)(2011-2#1)
areas under##4##2##(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
areas was found##2##3##(1996-12#1)(2008-10#1)
areas was##14##2##(1996-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#1)(2009-6#1)(2013-1#1)
areas were more##2##3##(1996-3#1)(2010-4#1)
areas were##33##2##(1990-8#1)(1991-6#1)(1992-12#2)(1993-12#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-8#2)(2008-10#6)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)
areas where the##4##3##(1991-12#1)(1993-2#1)(2007-2#1)(2008-5#1)
areas where##31##2##(1990-8#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#2)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2012-3#1)
areas which##4##2##(1994-3#1)(1996-2#1)(2008-5#1)(2011-2#1)
areas with a##2##3##(2008-10#2)
areas with different##3##3##(2008-10#2)(2008-3#1)
areas with##25##2##(1990-11#1)(2008-10#11)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-6#1)(2011-2#3)(2013-1#2)(2013-8#1)
areas within##2##2##(1994-2#1)(2008-10#1)
areas without##3##2##(1997-7#1)(2011-2#1)(2012-1#1)
areas##1397##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#6)(1990-7#1)(1990-8#10)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#6)(1991-5#3)(1991-6#3)(1991-8#1)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#14)(1992-2#6)(1992-3#4)(1992-8#3)(1992-9#3)(1993-1#5)(1993-11#2)(1993-12#19)(1993-2#5)(1993-3#8)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#8)(1994-11#7)(1994-12#4)(1994-2#10)(1994-3#20)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#3)(1995-1#4)(1995-11#5)(1995-12#10)(1995-2#5)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#2)(1995-8#3)(1996-1#9)(1996-11#7)(1996-12#17)(1996-2#17)(1996-3#24)(1996-4#2)(1996-5#8)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#23)(1997-3#16)(1997-4#2)(1997-5#3)(1997-7#2)(1997-8#4)(2006-10#5)(2007-10#9)(2007-11#3)(2007-12#11)(2007-2#13)(2007-4#2)(2007-5#11)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#1)(2008-1#15)(2008-10#215)(2008-11#59)(2008-12#29)(2008-2#20)(2008-3#47)(2008-4#13)(2008-5#39)(2008-6#14)(2008-7#43)(2008-8#47)(2008-9#16)(2009-10#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#11)(2009-5#2)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#9)(2010-11#4)(2010-12#10)(2010-3#6)(2010-4#6)(2010-5#9)(2010-6#10)(2010-7#4)(2010-8#16)(2010-9#9)(2011-1#24)(2011-2#54)(2011-3#1)(2011-7#1)(2012-1#11)(2012-12#21)(2012-2#15)(2012-3#27)(2012-5#3)(2013-1#49)(2013-7#19)(2013-8#21)
areas'##2##1##(1997-3#1)(2011-2#1)
areas) was##2##2##(2008-10#1)(2011-2#1)
areas)##7##1##(1994-3#1)(1996-2#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#1)
areas]##2##1##(1993-9#1)(2012-3#1)
arecaidine##2##1##(1997-7#2)
arecoline##3##1##(1992-10#2)(1997-7#1)
areflexia##3##1##(2011-2#1)(2012-3#2)
aren't##5##1##(1992-8#1)(1994-2#1)(1997-3#1)(2010-12#1)(2011-2#1)
arena and##3##2##(2008-11#1)(2008-7#1)(2009-5#1)
arena for##2##2##(1997-1#1)(2011-2#1)
arena has##2##2##(1993-12#1)(2008-10#1)
arena of##5##2##(1994-2#1)(2007-5#1)(2008-10#1)(2009-3#1)(2012-3#1)
arena##25##1##(1993-12#1)(1994-2#1)(1995-2#1)(1997-1#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)
arenaria##7##1##(2008-10#7)
arenas in which##2##3##(1991-2#1)(2008-1#1)
arenas in##3##2##(1991-2#1)(2008-1#2)
arenas##4##1##(1991-2#1)(2008-1#2)(2008-12#1)
arenes##3##1##(2007-11#2)(2012-3#1)
areola##2##1##(2011-2#2)
areolar##5##1##(1991-3#1)(1993-11#1)(2011-2#3)
aresult of##2##2##(2008-10#1)(2008-11#1)
argali by##2##2##(2009-4#2)
argali##7##1##(2009-4#7)
argan oil samples##2##3##(2011-2#2)
argan oil##4##2##(2011-2#4)
argan##5##1##(2011-2#5)
arginase activity in##2##3##(1992-5#2)
arginase##8##1##(1992-5#3)(2008-7#1)(2013-8#4)
arginine and calcium carbonate##2##4##(2011-2#2)
arginine and##9##2##(1995-3#1)(1996-2#1)(1997-4#1)(2009-4#1)(2010-4#1)(2011-2#3)(2013-7#1)
arginine at##5##2##(1990-11#1)(1991-8#1)(1995-12#1)(1995-2#1)(2008-9#1)
arginine in##2##2##(1991-6#1)(2008-10#1)
arginine residues##3##2##(1995-2#3)
arginine to##4##2##(1994-6#1)(2008-10#2)(2009-4#1)
arginine vasopressin (AVP)##2##3##(1992-8#1)(2008-4#1)
arginine vasopressin##5##2##(1992-8#1)(1997-3#1)(2007-9#1)(2008-4#1)(2010-1#1)
arginine##85##1##(1990-11#2)(1990-5#3)(1991-12#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#3)(2008-9#1)(2009-4#3)(2009-7#4)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#8)(2012-3#1)(2013-7#3)(2013-8#1)
arginine-128##3##1##(1995-5#3)
arginine-glycine-aspartic acid##3##2##(2008-11#1)(2010-12#2)
arginine-specific##2##1##(1991-12#2)
arginine-vasopressin in the ventral hippocampus##2##5##(1995-12#2)
arginine-vasopressin##8##1##(1995-12#7)(2008-11#1)
arginyl##3##1##(1990-11#1)(1990-2#1)(2006-6#1)
arginyl-##2##1##(1994-8#2)
argon and##7##2##(1993-3#2)(2008-10#3)(2008-3#1)(2013-8#1)
argon beam coagulator (ABC)##2##4##(1993-12#1)(1994-3#1)
argon beam coagulator##5##3##(1993-12#2)(1994-3#2)(2010-8#1)
argon content##3##2##(2013-8#3)
argon emission##2##2##(2008-3#2)
argon flow delivers the##2##4##(2008-10#2)
argon flow rate##2##3##(2008-10#1)(2013-8#1)
argon flow##6##2##(2008-10#5)(2013-8#1)
argon gas flow##2##3##(2008-10#1)(2012-1#1)
argon gas##5##2##(2008-10#2)(2008-3#1)(2012-1#1)(2013-1#1)
argon laser##10##2##(1990-11#1)(1990-12#1)(1993-1#2)(2008-3#4)(2008-9#2)
argon plasma coagulation##3##3##(2008-7#1)(2010-12#1)(2013-1#1)
argon plasma is##2##3##(2008-1#1)(2008-10#1)
argon plasma##9##2##(2008-1#1)(2008-10#3)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#1)
argon to##2##2##(2008-10#1)(2008-3#1)
argon##72##1##(1990-11#1)(1990-12#1)(1993-1#2)(1993-12#2)(1993-3#2)(1994-3#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#22)(2008-2#4)(2008-3#12)(2008-7#2)(2008-9#2)(2009-11#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#5)
argon-ion laser##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
argon-ion##8##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
arguably the most##2##3##(2008-10#1)(2010-5#1)
arguably the##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
arguably##7##1##(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
argue against the##4##3##(1996-5#1)(2008-4#1)(2008-8#1)(2008-9#1)
argue against##7##2##(1991-7#1)(1995-5#1)(1996-5#1)(2008-4#1)(2008-8#1)(2008-9#2)
argue for a##2##3##(1993-8#1)(2008-1#1)
argue for the##5##3##(1993-6#1)(1997-1#1)(2007-12#1)(2009-8#1)(2010-3#1)
argue for##7##2##(1993-6#1)(1993-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2009-8#1)(2010-3#1)
argue strongly##2##2##(1997-2#1)(2008-7#1)
argue that a##7##3##(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)
argue that current##2##3##(2008-8#1)(2010-9#1)
argue that only a##2##4##(1991-12#1)(1993-6#1)
argue that the##25##3##(1991-12#1)(1991-2#1)(1992-2#2)(1993-11#1)(1993-6#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-11#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#1)
argue that there is##2##4##(1996-2#1)(2007-7#1)
argue that these##3##3##(1997-2#1)(2011-2#1)(2013-8#1)
argue that this##4##3##(1997-3#1)(2008-11#1)(2009-2#1)(2010-7#1)
argue that##92##2##(1991-12#2)(1991-2#1)(1992-11#1)(1992-2#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1995-11#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#10)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#8)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
argue##116##1##(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-2#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#10)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#9)(2008-9#10)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#3)
argued for##2##2##(1994-11#1)(2008-4#1)
argued in##4##2##(1995-2#1)(2008-7#1)(2009-10#1)(2010-6#1)
argued that a##2##3##(1994-5#1)(2009-11#1)
argued that the##15##3##(1990-7#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-9#2)(2009-11#1)(2010-3#2)(2012-2#1)(2013-1#2)
argued that this##4##3##(1991-3#1)(1995-5#1)(2008-10#1)(2009-2#1)
argued that##53##2##(1990-7#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#2)(2011-1#1)(2012-2#1)(2013-1#4)(2013-8#2)
argued to##2##2##(2008-11#1)(2008-8#1)
argued##67##1##(1990-7#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#4)(2013-8#2)
argues against an##2##3##(1990-5#1)(1995-6#1)
argues against the##2##3##(2008-7#1)(2008-8#1)
argues against##9##2##(1990-5#1)(1994-9#1)(1995-6#1)(1996-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
argues for a##2##3##(1992-10#1)(1996-3#1)
argues for the##3##3##(2008-12#1)(2008-7#1)(2008-9#1)
argues for##9##2##(1990-11#1)(1992-10#1)(1996-3#1)(2007-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#1)
argues that the##5##3##(1992-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2011-2#1)
argues that there##2##3##(1991-2#1)(2008-6#1)
argues that##32##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#2)(2010-10#1)(2011-2#3)(2013-1#1)(2013-8#2)
argues##53##1##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-3#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#2)
arguing that##4##2##(1995-6#1)(2010-9#1)(2011-1#1)(2012-2#1)
arguing##7##1##(1995-6#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
argument against the##2##3##(2008-9#2)
argument by##2##2##(1995-6#1)(2007-10#1)
argument for the##2##3##(1994-2#1)(2007-10#1)
argument for##8##2##(1991-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-1#2)(2007-10#1)(2012-12#1)
argument is##2##2##(1995-5#1)(2008-1#1)
argument that##9##2##(1995-12#1)(1995-6#1)(1997-1#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-8#2)(2010-3#1)
argument were##2##2##(1995-2#1)(2008-8#1)
argument##43##1##(1991-2#1)(1991-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-1#2)(1997-1#1)(1997-5#1)(2007-10#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2012-12#2)(2012-3#1)
arguments against##2##2##(1996-5#1)(2012-12#1)
arguments for a##2##3##(2008-4#2)
arguments for##11##2##(1994-1#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#2)(2010-3#1)(2011-2#1)(2012-2#1)
arguments in##2##2##(2008-7#1)(2009-6#1)
arguments of##3##2##(1994-1#1)(2008-9#1)(2009-10#1)
arguments that##3##2##(2008-3#1)(2008-5#1)(2009-11#1)
arguments to##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
arguments##47##1##(1991-6#1)(1994-1#3)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
argyritarsis##2##1##(2007-12#1)(2012-12#1)
argyrophilia##2##1##(1997-3#2)
argyrophilic##3##1##(2007-12#1)(2008-7#1)(2013-1#1)
ariakensis##4##1##(2010-8#4)
arid##9##1##(2008-10#2)(2008-12#2)(2008-8#2)(2012-7#1)(2012-9#1)(2013-7#1)
aridity##2##1##(2009-2#1)(2012-9#1)
aries)##2##1##(1995-2#1)(2008-8#1)
aripiprazole##2##1##(2008-3#1)(2011-3#1)
arise about##2##2##(2006-10#1)(2010-9#1)
arise and##3##2##(1993-1#1)(1997-4#1)(2008-11#1)
arise as a consequence of##2##5##(2008-9#1)(2013-1#1)
arise as a result of##3##5##(1997-2#1)(2008-11#1)(2008-3#1)
arise as a##7##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
arise as##11##2##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#1)
arise at##2##2##(2008-10#1)(2012-2#1)
arise by##4##2##(1994-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
arise due to##4##3##(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
arise during##6##2##(1992-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
arise for##2##2##(2008-3#1)(2008-7#1)
arise from a##5##3##(1992-8#1)(1994-11#1)(1994-9#1)(2008-8#1)(2012-12#1)
arise from an##2##3##(1995-8#1)(2007-8#1)
arise from differences in##2##4##(2008-9#1)(2011-1#1)
arise from different##3##3##(1997-3#1)(1997-7#1)(2011-1#1)
arise from the##18##3##(1991-2#1)(1991-8#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
arise from##59##2##(1990-7#2)(1991-2#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-7#2)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
arise if##2##2##(2008-11#1)(2008-9#1)
arise in a##2##3##(2008-6#1)(2013-8#1)
arise in the##8##3##(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
arise in##29##2##(1990-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#2)(2009-6#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
arise through##5##2##(1992-6#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#1)
arise when a##2##3##(1993-12#1)(1997-3#1)
arise when the##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
arise when##13##2##(1991-12#1)(1993-12#1)(1997-3#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
arise with##3##2##(1991-3#1)(1996-11#1)(2012-3#1)
arise##186##1##(1990-6#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#11)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#5)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#3)
arisen in the##2##3##(2008-6#1)(2008-8#1)
arisen in##5##2##(2008-3#1)(2008-6#1)(2008-8#2)(2009-11#1)
arisen independently##5##2##(1997-7#1)(2008-10#3)(2009-6#1)
arisen##23##1##(1994-11#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-6#1)(2008-8#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)
arises and##2##2##(2008-11#1)(2008-7#1)
arises as a##3##3##(1992-6#1)(1997-7#1)(2008-11#1)
arises as##4##2##(1992-6#1)(1997-7#1)(2008-11#1)(2011-2#1)
arises because of##2##3##(2008-3#1)(2008-8#1)
arises because##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
arises by##2##2##(2008-3#1)(2008-8#1)
arises from a##4##3##(1994-8#1)(1995-6#1)(1996-2#1)(2011-2#1)
arises from the##16##3##(1995-6#2)(1995-8#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
arises from##37##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-4#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
arises in the##2##3##(2010-3#1)(2010-4#1)
arises in##6##2##(2007-12#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
arises primarily from##2##3##(2007-11#1)(2011-2#1)
arises through##2##2##(2008-2#1)(2011-2#1)
arises when the##2##3##(2007-12#1)(2008-3#1)
arises when##7##2##(1996-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
arises##89##1##(1990-12#1)(1990-8#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#2)(2007-12#5)(2007-5#1)(2008-10#3)(2008-11#4)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-1#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
arising as##2##2##(1991-12#1)(2008-7#1)
arising at the##2##3##(1996-9#1)(2008-9#1)
arising at##5##2##(1994-9#1)(1996-9#1)(2007-11#1)(2008-3#1)(2008-9#1)
arising from a##8##3##(1993-2#1)(2006-4#1)(2008-10#2)(2008-7#1)(2010-7#1)(2012-3#2)
arising from an##2##3##(1995-2#1)(2008-9#1)
arising from the anterior##2##4##(2008-10#1)(2012-2#1)
arising from the complex##3##4##(1993-11#1)(2008-11#1)(2008-3#1)
arising from the inferior vena cava##4##6##(2008-11#3)(2013-1#1)
arising from the left##2##4##(2007-7#1)(2008-6#1)
arising from the right##2##4##(1996-9#1)(2007-8#1)
arising from the superior##2##4##(2007-8#1)(2008-7#1)
arising from the##73##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#2)(1996-5#1)(1996-9#1)(1997-6#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
arising from thyroid##2##3##(2008-7#1)(2013-7#1)
arising from two##2##3##(1993-2#1)(2012-2#1)
arising from##163##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1995-11#2)(1995-2#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#2)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#24)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#5)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
arising in a bone infarct##2##5##(2008-6#2)
arising in a##6##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#2)
arising in association with a bone infarct##2##7##(2008-6#2)
arising in the retroperitoneum##2##4##(2008-6#1)(2009-1#1)
arising in the##10##3##(1990-2#1)(1991-6#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
arising in##33##2##(1990-2#1)(1991-2#1)(1991-6#1)(1994-12#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#7)(2009-1#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
arising on the##3##3##(1993-8#1)(2008-6#1)(2011-3#1)
arising out of medical##2##4##(1994-1#1)(1995-2#1)
arising out of##4##3##(1994-1#1)(1995-2#1)(1996-7#1)(2008-10#1)
arising the##2##2##(2007-2#1)(2008-9#1)
arising time##4##2##(2012-12#4)
arising##231##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-6#1)(1997-7#2)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#29)(2008-11#8)(2008-12#2)(2008-2#10)(2008-3#13)(2008-5#2)(2008-6#10)(2008-7#10)(2008-8#5)(2008-9#8)(2009-1#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#7)
arithmetic average and##2##3##(2008-10#2)
arithmetic average##4##2##(2008-10#4)
arithmetic mean##3##2##(2008-10#2)(2009-11#1)
arithmetic means##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
arithmetic of##2##2##(2007-12#2)
arithmetic##24##1##(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-3#2)
arm (p &lt##2##3##(1993-11#2)
arm and leg##3##3##(1996-5#1)(2010-9#2)
arm and##10##2##(1995-5#1)(1996-5#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-5#2)(2010-9#2)
arm as a##2##3##(2008-7#1)(2009-10#1)
arm as##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
arm circumference (inverse)##2##3##(2008-7#2)
arm circumference##3##2##(1997-4#1)(2008-7#2)
arm entries##2##2##(1993-6#1)(2011-2#1)
arm fat area##2##3##(2008-5#2)
arm for##3##2##(2007-11#1)(2009-3#1)(2011-2#1)
arm in##4##2##(2007-10#2)(2010-8#1)(2012-12#1)
arm is##2##2##(1992-9#1)(2008-3#1)
arm maze##4##2##(1992-12#1)(1994-3#1)(2008-4#1)(2012-2#1)
arm movements in##2##3##(1990-11#1)(2008-7#1)
arm movements##4##2##(1990-11#1)(2008-7#3)
arm number##2##2##(2008-12#2)
arm of Saccharomyces cerevisiae chromosome VII##5##6##(1995-9#1)(1996-3#1)(1997-3#3)
arm of Saccharomyces cerevisiae chromosome##7##5##(1995-9#1)(1996-3#2)(1997-3#4)
arm of a##3##3##(1993-2#1)(2007-12#1)(2008-3#1)
arm of an##3##3##(1993-11#1)(2007-11#1)(2008-3#1)
arm of barley chromosome 3H##2##5##(2008-10#2)
arm of barley chromosome##3##4##(2008-10#3)
arm of chromosome 1##2##4##(2008-10#1)(2012-3#1)
arm of chromosome IV##2##4##(1996-3#1)(1996-6#1)
arm of chromosome IX##4##4##(1995-6#3)(1995-9#1)
arm of chromosome VII##8##4##(1995-6#5)(1995-9#1)(1996-3#1)(1996-6#1)
arm of chromosome XI##3##4##(1993-9#1)(1996-6#2)
arm of chromosome##49##3##(1990-12#1)(1991-6#1)(1993-9#1)(1995-6#9)(1995-9#4)(1996-3#3)(1996-6#5)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#12)(2008-4#1)(2008-7#1)(2008-9#2)(2010-3#1)(2012-12#3)(2012-3#2)
arm of human chromosome##2##4##(1996-2#1)(1997-8#1)
arm of the chromosome##2##4##(1996-6#1)(2008-10#1)
arm of the##14##3##(1990-12#1)(1995-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-10#1)(2012-1#1)(2013-1#1)
arm of wheat chromosome##3##4##(2008-10#3)
arm of wheat##4##3##(2008-10#4)
arm of yeast chromosome##3##4##(1996-3#1)(1996-6#1)(1997-3#1)
arm of##96##2##(1990-12#2)(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-3#1)(1995-6#9)(1995-9#5)(1996-2#1)(1996-3#6)(1996-6#7)(1997-2#1)(1997-3#7)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-3#2)(2010-7#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#1)
arm or hand##2##3##(2007-10#2)
arm port##2##2##(2007-7#2)
arm veins##2##2##(2007-7#1)(2008-7#1)
arm was##4##2##(1993-6#1)(2007-11#1)(2008-5#1)(2013-8#1)
arm with a##2##3##(2008-10#1)(2010-3#1)
arm with##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
arm##257##1##(1990-11#2)(1990-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#9)(1995-9#5)(1996-2#1)(1996-3#6)(1996-5#3)(1996-6#8)(1997-2#2)(1997-3#7)(1997-4#3)(1997-5#1)(1997-8#1)(2007-10#8)(2007-11#6)(2007-12#6)(2007-7#5)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#1)(2008-12#10)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#13)(2008-7#11)(2008-8#2)(2008-9#10)(2009-1#1)(2009-10#2)(2009-3#1)(2010-12#1)(2010-3#5)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#4)
arm)##3##1##(1994-11#2)(2007-8#1)
arm-depleted axonemes##2##2##(1991-2#2)
armadillo##4##1##(2008-5#3)(2008-9#1)
armadillo)##3##1##(2008-5#3)
armadillos##3##1##(2008-5#1)(2008-9#2)
armament##2##1##(2008-11#1)(2013-1#1)
armamentarium for##4##2##(1991-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
armamentarium of the##4##3##(2007-12#3)(2011-2#1)
armamentarium of##6##2##(2007-12#3)(2009-5#1)(2011-2#1)(2012-3#1)
armamentarium##17##1##(1991-12#1)(1996-1#1)(1996-12#1)(2007-12#4)(2008-7#2)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-3#2)
armature of##2##2##(2008-5#2)
armature##5##1##(1991-9#1)(2008-5#4)
armatus##2##1##(1990-8#1)(2008-5#1)
armed crown##2##2##(2008-10#2)
armed##6##1##(2008-10#4)(2008-12#1)(2012-12#1)
armeniacae and E##3##3##(2008-10#3)
armeniacae##6##1##(2008-10#6)
armeniacum##5##1##(2008-10#5)
armeniacum-derived genes##2##2##(2008-10#2)
armies##2##1##(1991-3#1)(2009-7#1)
armigera and##2##2##(2008-8#2)
armigera##16##1##(2008-11#1)(2008-12#2)(2008-8#5)(2011-2#8)
armor##6##1##(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#3)
armoraciae##5##1##(2008-10#5)
arms and##4##2##(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
arms of the##4##3##(1991-2#1)(1997-8#1)(2008-2#1)(2008-4#1)
arms of##15##2##(1991-2#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
arms race##3##2##(1993-2#2)(2013-1#1)
arms that##4##2##(1994-8#1)(1995-2#1)(2008-2#1)(2008-5#1)
arms were##2##2##(1994-8#1)(2008-10#1)
arms##71##1##(1991-2#2)(1991-3#1)(1992-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#3)(1995-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-2#1)(2010-3#3)(2010-6#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
army recruits##2##2##(2008-12#2)
army##6##1##(1991-3#1)(2008-12#3)(2013-1#2)
armyworm##4##1##(1992-6#1)(1994-9#2)(2008-10#1)
arnobia##2##1##(2008-5#2)
aroma compound##2##2##(2008-10#2)
aroma compounds in##3##3##(2008-10#3)
aroma compounds##9##2##(2008-10#9)
aroma of##2##2##(2008-10#2)
aroma profile of cooked beef##2##5##(2008-10#2)
aroma release##3##2##(2008-10#3)
aroma rice varieties##2##3##(2011-1#2)
aroma rice##6##2##(2011-1#6)
aroma##36##1##(2008-10#24)(2008-5#1)(2010-7#1)(2011-1#6)(2011-2#3)(2012-2#1)
aromas##4##1##(2008-10#2)(2010-4#1)(2011-2#1)
aromatase activity in##6##3##(1991-5#5)(1993-8#1)
aromatase activity##10##2##(1991-5#5)(1993-8#2)(1994-2#2)(2013-1#1)
aromatase cytochrome P-450##2##3##(1994-2#1)(1995-8#1)
aromatase inhibition##2##2##(2010-10#1)(2010-2#1)
aromatase inhibitor##2##2##(2008-5#2)
aromatase inhibitors##5##2##(1990-11#1)(1991-5#1)(1995-8#1)(1996-11#1)(2013-8#1)
aromatase mRNA##5##2##(1993-8#5)
aromatase##42##1##(1990-11#1)(1991-5#11)(1993-8#9)(1994-2#5)(1995-8#3)(1996-11#1)(2008-4#2)(2008-5#2)(2009-7#2)(2010-10#1)(2010-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
aromatherapy massage in##2##3##(2008-10#2)
aromatherapy massage##8##2##(2008-10#8)
aromatherapy##10##1##(2008-10#10)
aromatic L-amino acid decarboxylase##2##4##(1991-5#1)(1997-3#1)
aromatic acids##2##2##(2008-10#2)
aromatic aldehydes##7##2##(1996-5#2)(2008-10#2)(2010-4#1)(2011-3#1)(2012-3#1)
aromatic amine##3##2##(1995-5#1)(1997-2#1)(2008-10#1)
aromatic amines in##3##3##(2008-10#3)
aromatic amines is described##2##4##(2008-10#2)
aromatic amines##16##2##(1990-8#4)(1992-6#2)(1997-2#1)(2007-11#2)(2008-10#7)
aromatic amino acid##2##3##(1990-5#1)(1991-12#1)
aromatic amino acids##9##3##(1995-3#1)(2008-10#7)(2008-11#1)
aromatic amino##11##2##(1990-5#1)(1991-12#1)(1995-3#1)(2008-10#7)(2008-11#1)
aromatic and##5##2##(1992-6#1)(1995-3#1)(1996-5#1)(2009-5#1)(2011-2#1)
aromatic carboxylic acids##5##3##(2008-10#5)
aromatic cations##3##2##(2008-10#3)
aromatic compounds on##2##3##(2008-10#2)
aromatic compounds were##2##3##(2008-10#1)(2011-10#1)
aromatic compounds##23##2##(2008-10#16)(2008-11#2)(2008-3#1)(2011-1#1)(2011-10#1)(2012-2#1)(2013-1#1)
aromatic fraction##3##2##(2008-10#3)
aromatic hydrocarbon##9##2##(1994-6#1)(2008-10#5)(2008-7#1)(2011-1#2)
aromatic hydrocarbons (PAH) and##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
aromatic hydrocarbons (PAH) in the##2##5##(2008-10#2)
aromatic hydrocarbons (PAH) in##3##4##(2008-10#3)
aromatic hydrocarbons (PAH)##6##3##(1995-11#1)(2008-10#4)(2008-11#1)
aromatic hydrocarbons (PAHs) and##2##4##(2008-10#2)
aromatic hydrocarbons (PAHs) by##2##4##(2008-10#2)
aromatic hydrocarbons (PAHs) in##11##4##(2008-10#10)(2010-5#1)
aromatic hydrocarbons (PAHs)##32##3##(1990-7#1)(1992-3#1)(1994-3#1)(2008-10#26)(2010-5#3)
aromatic hydrocarbons and##8##3##(1994-9#1)(1995-11#1)(2008-10#4)(2008-11#1)(2010-7#1)
aromatic hydrocarbons in water samples##6##5##(2008-10#6)
aromatic hydrocarbons in water##7##4##(2008-10#7)
aromatic hydrocarbons in##15##3##(2008-10#15)
aromatic hydrocarbons##91##2##(1990-7#2)(1992-3#2)(1994-3#1)(1994-9#2)(1995-11#2)(2008-10#74)(2008-11#3)(2010-5#3)(2010-7#1)(2011-1#1)
aromatic index##2##2##(2008-10#2)
aromatic iodination##3##2##(2007-11#3)
aromatic nitrile##2##2##(1996-5#2)
aromatic or aliphatic##2##3##(2008-4#1)(2012-3#1)
aromatic or##3##2##(2008-4#1)(2010-7#1)(2012-3#1)
aromatic residues##6##2##(1990-11#1)(1994-8#1)(1995-5#2)(2008-11#2)
aromatic ring system and##2##4##(1993-12#2)
aromatic ring system##3##3##(1993-12#3)
aromatic ring##10##2##(1993-12#3)(2008-10#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
aromatic rings##6##2##(1993-3#1)(1996-5#1)(2007-11#1)(2008-10#1)(2010-11#1)(2011-1#1)
aromatic side chains##2##3##(1992-8#1)(1995-2#1)
aromatic solvent-aqueous solution##2##3##(2008-10#2)
aromatic structures##2##2##(2008-10#2)
aromatic##267##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#5)(1991-12#1)(1991-5#1)(1992-3#3)(1992-6#3)(1992-8#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#1)(1996-5#9)(1997-2#2)(1997-3#1)(2007-11#7)(2008-10#151)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#2)(2011-1#7)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
aromatica##5##1##(2008-5#1)(2011-1#3)(2013-8#1)
aromaticity##4##1##(1996-5#1)(2008-10#3)
aromatics##5##1##(1994-9#1)(2008-10#3)(2008-11#1)
aromatisation##2##1##(2008-10#2)
aromatization of the##2##3##(1995-5#1)(2009-5#1)
aromatization of##3##2##(1990-9#1)(1995-5#1)(2009-5#1)
aromatization##6##1##(1990-9#1)(1994-2#1)(1995-5#1)(1996-5#1)(2008-6#1)(2009-5#1)
arose approximately##2##2##(1995-3#1)(1997-4#1)
arose as a##4##3##(1994-1#2)(1996-6#1)(2008-10#1)
arose as##6##2##(1994-1#2)(1994-2#1)(1996-6#1)(2008-10#1)(2011-1#1)
arose because##2##2##(1994-3#1)(1997-3#1)
arose by duplication##2##3##(1995-6#2)
arose by single mutations within##2##5##(2008-10#2)
arose by##6##2##(1990-7#2)(1995-6#2)(2008-10#2)
arose from a##2##3##(2011-2#2)
arose from the##10##3##(1995-2#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-9#1)(2013-1#2)(2013-2#1)
arose from##20##2##(1995-2#1)(1997-3#1)(2007-10#1)(2007-8#3)(2008-10#3)(2008-12#3)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#2)(2013-2#1)
arose in a##2##3##(2008-6#1)(2008-9#1)
arose in the##3##3##(1995-2#1)(1997-1#1)(1997-2#1)
arose in##8##2##(1991-2#1)(1992-9#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-6#1)(2008-9#1)(2010-1#1)
arose on the##2##3##(2008-11#2)
arose through the##2##3##(2008-10#1)(2012-3#1)
arose through##4##2##(2008-10#2)(2010-8#1)(2012-3#1)
arose##57##1##(1990-12#1)(1990-7#2)(1991-2#1)(1992-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-2#1)
arotinoid Ro 40-8757##2##3##(1993-9#2)
arotinoid##5##1##(1993-9#5)
around +/-2%##3##2##(2008-10#3)
around -0##7##2##(2008-10#5)(2008-9#2)
around 0##16##2##(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
around 1##12##2##(1992-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
around 1-2##2##2##(1992-3#1)(1995-5#1)
around 10##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)
around 10%##2##2##(2008-10#1)(2008-12#1)
around 100##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
around 17##2##2##(1994-3#1)(2011-2#1)
around 20##5##2##(1992-6#1)(2008-10#4)
around 200##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
around 2000##2##2##(1990-3#1)(2010-1#1)
around 250##2##2##(1997-6#1)(2008-10#1)
around 3##3##2##(2008-11#1)(2008-6#1)(2008-9#1)
around 3%##6##2##(1996-5#1)(2008-10#4)(2008-2#1)
around 30%##2##2##(2008-6#1)(2013-8#1)
around 4##3##2##(1992-4#1)(1994-8#1)(2009-7#1)
around 40##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
around 6##2##2##(2008-6#1)(2009-5#1)
around 600##2##2##(1997-2#1)(2012-3#1)
around 80##2##2##(1991-5#1)(2007-11#1)
around 90%##2##2##(2008-10#1)(2008-5#1)
around Cu(1) and Cu(2)##2##4##(1997-7#2)
around a##35##2##(1992-1#1)(1993-9#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
around an axis##2##3##(2008-3#1)(2008-6#1)
around an##12##2##(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#2)(2013-8#1)
around and between##2##3##(1996-5#1)(2009-12#1)
around and##4##2##(1996-5#1)(2008-9#1)(2009-12#1)(2010-4#1)
around birth##2##2##(1997-2#1)(2008-12#1)
around blood##2##2##(1991-6#1)(2008-9#1)
around each##3##2##(2008-5#3)
around genes##2##2##(1996-8#1)(1997-4#1)
around health##2##2##(2009-8#1)(2010-2#1)
around in##2##2##(2008-5#1)(2008-8#1)
around infection##2##2##(2008-10#2)
around it##2##2##(2007-12#1)(2008-10#1)
around its##2##2##(2008-3#1)(2008-7#1)
around neurons##2##2##(2008-7#2)
around one##2##2##(2008-3#1)(2012-3#1)
around or through##2##3##(1996-5#2)
around pH##8##2##(2008-10#7)(2010-5#1)
around soils##2##2##(2008-12#2)
around the backscattering direction##2##4##(2008-3#2)
around the cell periphery##2##4##(2012-2#2)
around the center of##2##4##(2007-12#1)(2008-10#1)
around the central##3##3##(1995-5#1)(1996-12#1)(2008-5#1)
around the clock##2##3##(1991-12#1)(2008-9#1)
around the country##3##3##(1994-1#1)(1995-2#1)(1996-2#1)
around the equilibrium##2##3##(2009-5#2)
around the extremity to cover##2##5##(2011-2#2)
around the foot and ankle##2##5##(2010-3#1)(2012-2#1)
around the globe##4##3##(1990-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
around the implants##3##3##(2013-1#3)
around the infection##3##3##(2008-10#3)
around the inoculation site##2##4##(2008-10#2)
around the inoculation##3##3##(2008-10#3)
around the left##2##3##(1995-12#1)(2007-8#1)
around the lesion##2##3##(1996-9#1)(2008-10#1)
around the mean##3##3##(2009-11#2)(2010-10#1)
around the mouth##2##3##(2008-5#1)(2011-2#1)
around the osmium##2##3##(1996-2#2)
around the periphery of the##2##5##(2008-10#1)(2008-9#1)
around the polypropylene and human hair##2##6##(2012-3#2)
around the putative##2##3##(1990-11#1)(2010-10#1)
around the small##2##3##(1995-11#1)(2007-9#1)
around the solute##2##3##(2008-10#2)
around the time of##4##4##(1992-11#1)(1992-3#1)(1994-11#1)(2008-11#1)
around the world and##3##4##(2007-7#1)(2008-1#1)(2008-11#1)
around the world to##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
around the world##37##3##(1991-9#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
around the world)##2##3##(2011-3#2)
around the##271##2##(1990-11#3)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-5#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#3)(1996-1#1)(1996-12#2)(1996-2#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#3)(2006-12#2)(2007-11#3)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#40)(2008-11#12)(2008-12#5)(2008-2#5)(2008-3#13)(2008-5#15)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#4)(2013-1#15)(2013-8#4)
around their##2##2##(2008-11#1)(2008-7#1)
around these##5##2##(1992-12#1)(1994-11#1)(2008-10#1)(2008-2#1)(2010-5#1)
around this##3##2##(2010-12#1)(2012-1#1)(2012-12#1)
around three##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
around two##2##2##(2008-11#1)(2008-5#1)
around##677##1##(1990-11#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#3)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-3#5)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#3)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#5)(2006-10#2)(2006-12#2)(2007-11#8)(2007-12#17)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#146)(2008-11#28)(2008-12#17)(2008-2#18)(2008-3#25)(2008-4#1)(2008-5#34)(2008-6#10)(2008-7#18)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#7)(2009-6#4)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#23)(2011-3#2)(2012-1#4)(2012-12#5)(2012-2#18)(2012-3#11)(2013-1#23)(2013-7#1)(2013-8#13)
around-the-clock##4##1##(2008-11#2)(2008-2#1)(2013-1#1)
arousal and PLM indexes##2##4##(2012-3#2)
arousal and##4##2##(1993-5#1)(2008-5#1)(2012-3#2)
arousal phase##2##2##(2008-8#2)
arousal states##2##2##(1995-12#2)
arousal##22##1##(1993-5#2)(1994-2#1)(1994-3#1)(1995-12#2)(1996-5#1)(2008-1#1)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#2)(2012-1#1)(2012-3#3)
arousal&quot##2##1##(1994-2#2)
aroused from long-term coma##3##4##(2007-8#3)
aroused##7##1##(2007-8#3)(2009-10#1)(2009-7#2)(2013-7#1)
arrange the##3##2##(1992-6#1)(2007-11#1)(2008-3#1)
arrange##8##1##(1990-12#1)(1992-6#1)(1994-3#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
arranged around an##2##3##(2008-6#1)(2011-2#1)
arranged around##3##2##(2008-6#1)(2010-6#1)(2011-2#1)
arranged by the##2##3##(2008-4#1)(2010-11#1)
arranged by##4##2##(2007-12#1)(2008-4#1)(2009-8#1)(2010-11#1)
arranged for##2##2##(2008-10#1)(2008-3#1)
arranged in a manner##2##4##(2008-10#2)
arranged in a split-split-plot design##2##5##(2008-10#2)
arranged in a##21##3##(1991-6#1)(1992-6#1)(1996-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
arranged in parallel##4##3##(2008-10#1)(2008-3#1)(2008-7#2)
arranged in the##2##3##(2008-10#1)(2008-3#1)
arranged in two##2##3##(2007-12#1)(2008-12#1)
arranged in##43##2##(1990-5#1)(1991-6#2)(1992-12#1)(1992-6#1)(1996-2#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#4)(2008-7#4)(2008-8#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
arranged to##2##2##(1997-2#1)(2008-10#1)
arranged##88##1##(1990-5#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-1#2)(1993-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-12#7)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2009-1#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
arrangement and the##2##3##(1996-3#1)(2009-7#1)
arrangement and##5##2##(1992-2#1)(1996-3#1)(2007-12#1)(2009-7#1)(2013-7#1)
arrangement between the##2##3##(1993-12#1)(2008-11#1)
arrangement between##3##2##(1992-6#1)(1993-12#1)(2008-11#1)
arrangement for##4##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
arrangement in relation to##2##4##(1995-6#1)(2013-1#1)
arrangement in the##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
arrangement in which##2##3##(1997-7#1)(2008-3#1)
arrangement in##10##2##(1995-6#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
arrangement is##11##2##(1992-1#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)
arrangement of a##2##3##(2008-2#1)(2009-8#1)
arrangement of collagen fibrils##2##4##(2008-7#2)
arrangement of molecules##2##3##(1996-5#1)(2008-7#1)
arrangement of the four##3##4##(1992-4#1)(2007-11#1)(2008-3#1)
arrangement of the##18##3##(1990-5#1)(1990-8#1)(1992-4#1)(1993-6#1)(1994-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#2)(2010-2#1)(2011-1#1)(2013-7#2)
arrangement of these##2##3##(1994-5#1)(2008-5#1)
arrangement of##56##2##(1990-11#1)(1990-4#1)(1990-5#3)(1990-8#2)(1992-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#3)
arrangement that##5##2##(2008-3#4)(2008-5#1)
arrangement was##2##2##(2008-10#1)(2008-2#1)
arrangement with a hospital##2##4##(1996-3#2)
arrangement with a##3##3##(1996-3#2)(2009-8#1)
arrangement with##8##2##(1996-3#2)(1996-8#1)(2008-10#2)(2008-3#2)(2009-8#1)
arrangement##168##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-8#2)(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#3)(1995-8#1)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#3)(2007-11#5)(2007-12#6)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#31)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-2#3)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#4)
arrangements and##4##2##(1990-8#1)(1991-3#1)(1993-3#1)(2010-10#1)
arrangements are##2##2##(1996-3#1)(1997-7#1)
arrangements between##2##2##(1993-1#1)(2008-11#1)
arrangements for##3##2##(1990-2#1)(2008-11#1)(2011-2#1)
arrangements is##2##2##(1991-12#1)(2008-3#1)
arrangements may##2##2##(1996-3#2)
arrangements of##8##2##(1990-11#1)(1991-10#1)(1994-6#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
arrangements on the##2##3##(1992-1#1)(2010-10#1)
arrangements than##2##2##(1991-3#1)(2013-1#1)
arrangements that##2##2##(1992-2#1)(1994-5#1)
arrangements with##5##2##(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)
arrangements##72##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-3#3)(1991-9#1)(1992-1#1)(1992-2#2)(1993-1#4)(1993-2#1)(1993-3#3)(1994-1#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#8)(1997-2#2)(1997-3#3)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-6#1)(2010-10#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
arranges##2##1##(2010-3#1)(2010-8#1)
array (IDA)##2##2##(2008-10#2)
array (PDA) and##2##3##(2008-10#2)
array (i##2##2##(2007-11#1)(2008-3#1)
array CGH##3##2##(2008-4#1)(2008-9#1)(2012-3#1)
array analysis##7##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
array and a##8##3##(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#2)
array and its application##2##4##(2007-11#1)(2008-10#1)
array and the##6##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
array and##30##2##(1994-11#1)(2007-11#5)(2007-12#3)(2008-10#9)(2008-2#4)(2008-3#6)(2012-1#1)(2012-3#1)
array are##3##2##(2008-2#3)
array as an##2##3##(2007-12#1)(2008-3#1)
array as##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
array at##2##2##(2008-2#2)
array based##3##2##(2008-10#2)(2008-3#1)
array biosensor##2##2##(2008-10#2)
array by means of##2##4##(2008-3#2)
array by##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
array can be##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
array can##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
array comparative genomic hybridization##2##4##(2008-4#1)(2012-1#1)
array comprising##2##2##(2008-10#1)(2010-10#1)
array data##4##2##(2008-3#1)(2008-7#2)(2009-7#1)
array design (OAD)##2##3##(2008-10#2)
array design##5##2##(2008-10#4)(2012-3#1)
array detection##15##2##(1997-2#1)(2008-10#14)
array detector (DAD)##4##3##(2008-10#4)
array detector##22##2##(2008-10#19)(2008-3#2)(2010-5#1)
array detectors##2##2##(2008-10#1)(2008-3#1)
array element##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
array elements##2##2##(2008-3#2)
array for a##2##3##(2008-3#1)(2013-1#1)
array for the##4##3##(2008-10#1)(2008-3#2)(2008-9#1)
array for##21##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#1)(2013-1#3)
array format##2##2##(2008-4#2)
array formed by##2##3##(2007-11#1)(2008-3#1)
array generator##2##2##(2008-3#2)
array generators##2##2##(2007-11#1)(2008-3#1)
array has a##2##3##(2008-2#1)(2008-3#1)
array has been##3##3##(2008-10#1)(2008-3#2)
array has##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
array illuminator is##2##3##(2008-2#1)(2008-3#1)
array illuminator with##2##3##(2008-2#2)
array illuminator##14##2##(2008-2#8)(2008-3#6)
array illuminators##3##2##(2008-2#2)(2008-3#1)
array in a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
array in##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)
array is presented##3##3##(2008-2#1)(2008-3#2)
array is proposed##2##3##(2007-11#1)(2008-2#1)
array is##18##2##(1994-11#1)(2007-11#1)(2008-10#2)(2008-2#6)(2008-3#8)
array of 20##2##3##(2008-3#2)
array of commercial##2##3##(2008-10#1)(2012-2#1)
array of factors##2##3##(2008-4#1)(2012-2#1)
array of five##2##3##(2008-3#2)
array of hexagonal##2##3##(2008-2#2)
array of services##2##3##(1991-3#1)(1997-3#1)
array of six##2##3##(2008-10#2)
array of square##2##3##(2008-2#2)
array of vertical-cavity surface-emitting lasers##3##5##(2008-3#3)
array of##166##2##(1990-8#1)(1991-3#1)(1992-12#1)(1992-8#1)(1995-1#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#11)(2007-12#8)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#3)(2008-2#19)(2008-3#35)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#5)(2013-1#4)(2013-7#2)(2013-8#2)
array provides##4##2##(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)
array sensor##2##2##(2008-10#1)(2010-2#1)
array sources##2##2##(2008-3#2)
array spectrophotometer##7##2##(2008-10#7)
array technologies##2##2##(2008-4#2)
array technology##6##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-10#1)
array that uses##2##3##(2008-2#1)(2008-3#1)
array to be used in##2##5##(2008-2#1)(2012-3#1)
array to##10##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
array was##8##2##(2008-10#4)(2008-9#3)(2011-2#1)
array which##2##2##(1991-2#1)(2008-9#1)
array with a##2##3##(2008-2#1)(2008-3#1)
array with an##2##3##(2008-10#1)(2008-3#1)
array with##11##2##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2012-3#1)
array##631##1##(1990-8#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-11#3)(1995-1#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#39)(2007-12#31)(2007-8#1)(2007-9#2)(2008-10#135)(2008-11#3)(2008-2#81)(2008-3#156)(2008-4#18)(2008-5#8)(2008-6#2)(2008-7#22)(2008-8#1)(2008-9#21)(2009-10#1)(2009-11#5)(2009-12#3)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#5)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#5)(2011-9#1)(2012-1#3)(2012-12#1)(2012-2#9)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#3)
array)##3##1##(1997-8#1)(2009-5#2)
array-based##6##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)
arrayed in##4##2##(1990-5#1)(2007-11#1)(2008-3#1)(2008-8#1)
arrayed on##2##2##(2008-9#2)
arrayed##14##1##(1990-5#2)(1993-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#3)(2010-12#1)
arrayed-waveguide##2##1##(2008-3#2)
arrays and a##2##3##(2008-3#2)
arrays and##12##2##(1990-4#1)(2007-11#1)(2008-10#1)(2008-3#5)(2008-7#2)(2009-5#1)(2011-2#1)
arrays are used##3##3##(2008-2#2)(2008-3#1)
arrays are##10##2##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2009-5#1)
arrays as##2##2##(2008-11#1)(2008-8#1)
arrays by##2##2##(2007-11#1)(2009-7#1)
arrays can##3##2##(2008-7#1)(2009-11#1)(2012-2#1)
arrays combined with##2##3##(2008-7#1)(2010-11#1)
arrays composed of##2##3##(2008-10#1)(2010-4#1)
arrays containing##5##2##(2008-10#2)(2008-4#2)(2008-7#1)
arrays fabricated##2##2##(2008-2#1)(2008-3#1)
arrays for the##2##3##(2009-12#1)(2010-11#1)
arrays for##10##2##(2007-11#1)(2008-3#4)(2008-9#1)(2009-12#3)(2010-11#1)
arrays have##4##2##(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
arrays in the##2##3##(2008-11#1)(2012-3#1)
arrays in##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-8#1)(2012-3#1)
arrays is##5##2##(2007-11#2)(2008-3#2)(2010-2#1)
arrays of droplets##3##3##(2007-5#3)
arrays of electrodes##2##3##(2008-10#2)
arrays of nanoparticles##2##3##(2008-3#1)(2008-7#1)
arrays of optical##2##3##(2007-11#1)(2008-2#1)
arrays of vertical-cavity surface-emitting##2##4##(2007-12#1)(2008-3#1)
arrays of vertical-cavity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
arrays of##57##2##(1990-11#1)(1992-9#1)(2007-11#2)(2007-12#3)(2007-5#3)(2008-10#10)(2008-2#6)(2008-3#9)(2008-5#2)(2008-7#11)(2008-9#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
arrays on##3##2##(2008-10#1)(2009-11#2)
arrays that##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
arrays to##6##2##(2008-3#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
arrays were##8##2##(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)
arrays with a##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
arrays with good##2##3##(2008-2#1)(2008-3#1)
arrays with perfect##3##3##(2008-2#2)(2008-3#1)
arrays with polymer-network liquid crystals##2##5##(2008-3#2)
arrays with##30##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#10)(2008-3#13)(2008-7#2)
arrays##287##1##(1990-11#1)(1990-4#1)(1992-9#1)(2007-11#14)(2007-12#14)(2007-5#4)(2008-10#36)(2008-11#3)(2008-2#41)(2008-3#65)(2008-4#9)(2008-5#2)(2008-7#31)(2008-8#3)(2008-9#14)(2009-10#2)(2009-11#8)(2009-12#7)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#4)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
arrays)##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
arrest after the##2##3##(1995-3#1)(2007-8#1)
arrest after##4##2##(1995-3#3)(2007-8#1)
arrest and DNA damage##3##4##(1994-12#1)(2008-7#1)(2009-7#1)
arrest and DNA repair##2##4##(2008-5#1)(2008-9#1)
arrest and DNA##5##3##(1994-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)
arrest and apoptosis##4##3##(2007-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
arrest and##26##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-10#1)(1994-12#1)(1997-7#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
arrest are##2##2##(1996-9#1)(2008-3#1)
arrest at##6##2##(1990-9#1)(1991-9#1)(1997-7#3)(2008-11#1)
arrest before##2##2##(1997-1#1)(2008-10#1)
arrest cell growth##2##3##(1997-3#2)
arrest in a##2##3##(2007-8#1)(2012-12#1)
arrest in human##2##3##(1997-7#1)(2011-1#1)
arrest in the##2##3##(1993-9#1)(2011-1#1)
arrest in##18##2##(1990-11#1)(1990-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-3#2)(1997-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#2)(2012-12#1)(2012-3#1)
arrest induced by##4##3##(1995-2#1)(2008-11#1)(2008-9#1)(2010-6#1)
arrest is##2##2##(1995-3#1)(2008-3#1)
arrest of the##2##3##(2011-1#1)(2012-12#1)
arrest of##22##2##(1990-11#1)(1992-6#1)(1994-11#2)(1994-8#3)(1995-5#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#3)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
arrest or##6##2##(1992-2#1)(1995-2#1)(2006-6#1)(2008-7#1)(2011-2#2)
arrest phenotype##2##2##(1997-3#2)
arrest rates##2##2##(2010-7#1)(2013-8#1)
arrest the cell##3##3##(2008-9#2)(2012-12#1)
arrest the##6##2##(1996-12#1)(2007-7#1)(2008-11#1)(2008-9#2)(2012-12#1)
arrest were##2##2##(1997-7#1)(2008-7#1)
arrest##199##1##(1990-11#2)(1990-12#3)(1990-9#4)(1991-3#2)(1991-5#1)(1991-9#6)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-6#2)(1994-8#5)(1995-2#5)(1995-3#7)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-3#7)(1997-7#9)(2006-6#1)(2007-10#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#14)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#7)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#13)(2013-8#2)
arrested and##3##2##(1995-12#1)(2011-2#2)
arrested as##2##2##(1990-5#1)(2007-8#1)
arrested at the##3##3##(1993-3#1)(2007-12#1)(2008-10#1)
arrested at##5##2##(1993-3#1)(1994-8#1)(2007-12#1)(2008-10#2)
arrested by##2##2##(1992-3#1)(1994-8#1)
arrested cells##3##2##(1991-2#1)(1992-3#1)(1996-12#1)
arrested heart##4##2##(2007-8#4)
arrested in the##6##3##(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-1#1)
arrested in##8##2##(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2011-1#1)
arrested with##2##2##(1995-2#1)(2008-11#1)
arrested##41##1##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#3)(1993-3#2)(1993-6#1)(1994-8#5)(1995-12#1)(1995-2#1)(1996-12#2)(2007-12#2)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#3)(2013-1#1)
arrestin did not##2##3##(1992-3#1)(1992-5#1)
arrestin##14##1##(1992-3#3)(1992-5#10)(1996-5#1)
arresting the##4##2##(1990-11#1)(1991-3#1)(1991-9#1)(2008-8#1)
arresting##8##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1995-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
arrests transcription##2##2##(1995-3#2)
arrests##9##1##(1993-6#1)(1995-3#2)(2008-10#1)(2008-5#1)(2009-7#1)(2012-2#2)(2013-1#1)
arrests)##2##1##(2008-1#1)(2008-12#1)
arrhenomanes and P##2##3##(2008-10#2)
arrhenomanes##7##1##(2008-10#7)
arrhenotokous##3##1##(2008-10#3)
arrhizus lipase##2##2##(2008-7#2)
arrhizus##3##1##(2008-7#3)
arrhythmia and##2##2##(2007-8#1)(2012-3#1)
arrhythmia in##2##2##(2010-5#1)(2012-12#1)
arrhythmia induced##2##2##(2008-7#1)(2011-2#1)
arrhythmia risk##2##2##(2008-8#2)
arrhythmia##37##1##(1990-9#2)(1991-3#1)(1991-6#1)(1992-11#1)(1995-11#1)(1996-8#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-7#4)(2008-8#3)(2009-3#1)(2009-4#2)(2010-12#1)(2010-5#1)(2010-8#5)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
arrhythmias and##8##2##(1996-8#1)(2008-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-7#1)
arrhythmias as##3##2##(1994-6#1)(2013-1#2)
arrhythmias in##9##2##(1992-3#2)(1992-6#1)(2008-10#1)(2009-5#2)(2012-12#1)(2013-8#2)
arrhythmias of##2##2##(1990-9#1)(2008-10#1)
arrhythmias that##2##2##(1995-12#1)(2012-12#1)
arrhythmias was##2##2##(1992-5#1)(2013-1#1)
arrhythmias##81##1##(1990-6#1)(1990-9#5)(1991-11#1)(1991-8#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-2#2)(1994-6#2)(1995-11#4)(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#4)(2007-8#3)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#3)(2009-4#2)(2009-5#6)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#2)
arrhythmogenesis##2##1##(2006-10#1)(2009-5#1)
arrhythmogenic right ventricular dysplasia##6##4##(1996-3#3)(2008-12#1)(2012-2#1)(2012-3#1)
arrhythmogenic##9##1##(1996-3#3)(2008-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
arrival at the##3##3##(2009-4#1)(2011-1#1)(2013-1#1)
arrival at##5##2##(2008-1#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
arrival in the##3##3##(2010-7#1)(2012-2#1)(2013-1#1)
arrival in##5##2##(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
arrival of##3##2##(2008-9#1)(2009-8#1)(2010-3#1)
arrival to the##2##3##(2008-1#1)(2010-11#1)
arrival to##3##2##(2008-1#1)(2010-11#1)(2011-2#1)
arrival##24##1##(1997-7#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
arrivals##5##1##(2010-8#4)(2011-2#1)
arrive at the##4##3##(1995-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
arrive at##14##2##(1994-9#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
arrive##18##1##(1994-9#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-7#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
arrived at by##3##3##(1992-2#1)(2008-11#1)(2009-5#1)
arrived at##13##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-5#1)
arrived in##2##2##(2007-10#1)(2008-10#1)
arrived##23##1##(1990-3#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-5#2)(2010-1#2)(2012-3#1)
arrives##3##1##(1994-3#1)(2008-2#1)(2009-8#1)
arriving at##3##2##(1997-7#1)(2007-8#1)(2009-8#1)
arriving on##2##2##(2009-7#1)(2011-2#1)
arriving##9##1##(1994-7#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2011-2#1)
arrow##2##1##(1996-1#1)(2008-6#1)
arrows in line drawings##2##4##(2008-6#2)
arrows##3##1##(2008-6#2)(2009-8#1)
arsenal of##7##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)
arsenal##9##1##(1993-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-3#2)(2011-2#1)
arsenate (As(V))##3##2##(2008-10#3)
arsenate [As(V)]##2##2##(2008-10#2)
arsenate and##4##2##(2008-10#3)(2008-11#1)
arsenate determination##2##2##(2008-10#2)
arsenate is##3##2##(2008-10#3)
arsenate##39##1##(1991-8#3)(1997-7#1)(2008-10#31)(2008-11#1)(2008-3#2)(2010-11#1)
arsenazo III##3##2##(2008-10#3)
arsenazo##4##1##(2008-10#4)
arsenazo(III)##3##1##(2008-10#3)
arsenazo-DBC-Al(3+) in the##2##3##(2008-10#2)
arsenazo-DBC-Al(3+)##3##1##(2008-10#3)
arsenic (As)##5##2##(2008-10#4)(2013-1#1)
arsenic (the##2##2##(2008-10#2)
arsenic acid##5##2##(2008-10#5)
arsenic and antimony in##3##4##(2008-10#3)
arsenic and antimony##4##3##(2008-10#4)
arsenic and selenium species##4##4##(2008-10#4)
arsenic and selenium##11##3##(2008-10#11)
arsenic and##24##2##(1995-11#1)(2008-10#21)(2008-12#1)(2010-11#1)
arsenic as##2##2##(1995-11#1)(2008-10#1)
arsenic at##4##2##(2008-10#4)
arsenic based on##2##3##(2008-10#2)
arsenic by##7##2##(2008-10#7)
arsenic compound##2##2##(2008-10#2)
arsenic compounds in##6##3##(2008-10#6)
arsenic compounds present in##2##4##(2008-10#2)
arsenic compounds##21##2##(2008-10#19)(2008-11#2)
arsenic concentration##3##2##(2008-10#3)
arsenic concentrations in the##2##4##(2008-10#1)(2009-7#1)
arsenic concentrations##4##2##(2008-10#3)(2009-7#1)
arsenic contaminated##4##2##(2008-10#2)(2011-2#2)
arsenic content in##2##3##(2008-10#2)
arsenic content##6##2##(2008-10#6)
arsenic determination in##4##3##(2008-10#4)
arsenic determination##11##2##(2008-10#11)
arsenic exposed and##2##3##(2011-2#2)
arsenic exposed##5##2##(2011-2#5)
arsenic exposure##3##2##(2008-10#1)(2011-2#2)
arsenic have##2##2##(2008-10#1)(2011-2#1)
arsenic in ambient##2##3##(2008-10#2)
arsenic in groundwater##3##3##(2008-10#3)
arsenic in samples of##2##4##(2008-10#2)
arsenic in the##3##3##(1995-11#1)(2008-10#2)
arsenic in these##3##3##(2008-10#3)
arsenic in water samples##2##4##(2008-10#2)
arsenic in water##5##3##(2008-10#5)
arsenic in##57##2##(1995-11#2)(2008-10#53)(2010-5#1)(2013-1#1)
arsenic is determined##2##3##(2008-10#2)
arsenic is##7##2##(2008-10#6)(2008-2#1)
arsenic metabolites by C57 BL/6J mice##2##6##(1995-11#2)
arsenic metabolites in the##2##4##(2008-10#2)
arsenic metabolites##8##2##(1995-11#6)(2008-10#2)
arsenic or##2##2##(1995-11#1)(1995-3#1)
arsenic solution##2##2##(2008-10#2)
arsenic speciation in fish##2##4##(2008-10#2)
arsenic speciation in##9##3##(2008-10#9)
arsenic speciation pattern##3##3##(2008-10#3)
arsenic speciation##16##2##(2008-10#16)
arsenic species from##2##3##(2008-10#2)
arsenic species in the extracts##2##5##(2008-10#2)
arsenic species in the##3##4##(2008-10#3)
arsenic species in##19##3##(2008-10#18)(2010-5#1)
arsenic species present##2##3##(2008-10#2)
arsenic species using##3##3##(2008-10#3)
arsenic species was##4##3##(2008-10#4)
arsenic species##58##2##(2008-10#57)(2010-5#1)
arsenic trioxide##6##2##(2008-10#1)(2008-8#2)(2010-8#1)(2011-2#2)
arsenic using##5##2##(2008-10#5)
arsenic via##2##2##(2008-10#2)
arsenic was determined##2##3##(2008-10#2)
arsenic was##7##2##(2008-10#7)
arsenic were##4##2##(1995-11#1)(2008-10#3)
arsenic##397##1##(1995-11#15)(1995-3#2)(2008-10#336)(2008-11#3)(2008-12#1)(2008-2#3)(2008-8#2)(2009-7#1)(2010-1#2)(2010-11#2)(2010-5#9)(2010-8#1)(2011-2#13)(2013-1#7)
arsenic(III##3##1##(2008-10#3)
arsenic(III) and##6##2##(2008-10#5)(2010-5#1)
arsenic(V) in##4##2##(2008-10#4)
arsenic(V)##9##1##(2008-10#9)
arsenic)##5##1##(2008-10#5)
arsenic-contaminated##2##1##(2008-10#2)
arsenical in##2##2##(2008-10#2)
arsenical##3##1##(2008-10#3)
arsenicals in##2##2##(2008-10#2)
arsenicals##9##1##(2008-10#3)(2009-6#6)
arsenicosis patients##2##2##(2011-2#2)
arsenics##6##1##(1993-3#3)(2008-10#3)
arsenite (As(III))##3##2##(2008-10#3)
arsenite [As(III)]##2##2##(2008-10#2)
arsenite and##3##2##(2008-10#3)
arsenite oxidation##2##2##(2008-10#2)
arsenite##29##1##(1994-11#4)(1995-11#1)(2008-10#23)(2008-11#1)
arsenite-exposed##2##1##(1994-11#2)
arsenobetaine (AB)##2##2##(2008-10#2)
arsenobetaine (AsB) and arsenocholine (AsC)##2##5##(2008-10#2)
arsenobetaine (AsB)##7##2##(2008-10#7)
arsenobetaine was##2##2##(2008-10#2)
arsenobetaine##16##1##(2008-10#16)
arsenocholine (AsC)##3##2##(2008-10#3)
arsenocholine##5##1##(2008-10#5)
arsenomolybdate##3##1##(2008-10#1)(2008-6#2)
arsenosugars##6##1##(2008-10#6)
arsenous acid##2##2##(2008-10#2)
arsine generation##2##2##(2008-10#2)
arsine##10##1##(1995-11#1)(2008-10#8)(2009-6#1)
arsines##4##1##(2008-10#4)
arson##3##1##(1994-2#1)(1995-6#1)(1996-12#1)
art and##7##2##(1993-2#2)(1993-3#1)(2008-11#3)(2010-11#1)
art are##2##2##(2010-7#1)(2011-2#1)
art for##3##2##(1995-2#1)(2008-12#1)(2008-4#1)
art music##3##2##(1992-3#3)
art of medicine##2##3##(1993-11#1)(2012-12#1)
art of##21##2##(1990-2#1)(1992-12#1)(1992-9#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#2)
art therapy##4##2##(1993-2#1)(1995-1#2)(1995-2#1)
art##105##1##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-2#4)(1993-3#3)(1994-8#1)(1995-1#6)(1995-2#2)(1995-5#2)(1996-3#1)(1997-1#1)(1997-7#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#2)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
art]##3##1##(1996-11#1)(2013-8#2)
artefact##2##1##(2008-7#1)(2010-8#1)
artefacts##6##1##(1990-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-2#1)
artemether##5##1##(1994-8#4)(2007-2#1)
artemisinic acid##2##2##(2007-1#2)
artemisinin and quinine##2##3##(1997-4#2)
artemisinin and##3##2##(1997-4#2)(2008-10#1)
artemisinin is##2##2##(1995-3#2)
artemisinin##13##1##(1995-3#6)(1997-4#3)(2007-1#1)(2008-10#3)
arteria lusoria##4##2##(2008-11#4)
arteria##6##1##(2008-11#4)(2008-3#1)(2011-3#1)
arterial administration of##2##3##(1997-8#1)(2013-1#1)
arterial adventitia##2##2##(1997-8#1)(2008-11#1)
arterial and portal venous embolization##2##5##(1997-8#2)
arterial and portal venous##3##4##(1997-8#2)(2008-7#1)
arterial and venous##10##3##(1990-3#2)(1997-6#1)(2008-12#1)(2008-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2013-1#2)
arterial and##23##2##(1990-11#1)(1990-2#1)(1990-3#2)(1994-3#1)(1997-6#1)(1997-8#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#1)(2013-1#3)
arterial autograft model##2##3##(2006-6#2)
arterial autograft##3##2##(2006-6#3)
arterial autografts and##2##3##(2006-6#2)
arterial blood flow##3##3##(1990-3#2)(2008-3#1)
arterial blood gas##2##3##(1990-8#1)(2012-12#1)
arterial blood pressure and##2##4##(1996-5#1)(2012-3#1)
arterial blood pressure##32##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-1#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-3#2)(2008-5#2)(2008-7#2)(2009-5#1)(2011-2#2)(2012-3#5)(2013-1#2)(2013-8#2)
arterial blood supply to the##2##5##(2007-8#1)(2012-1#1)
arterial blood supply##3##3##(2007-8#1)(2008-7#1)(2012-1#1)
arterial blood##47##2##(1990-3#3)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#2)(2008-7#3)(2009-11#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#2)
arterial bypass##4##2##(2007-8#4)
arterial calcification##3##2##(2009-11#2)(2009-12#1)
arterial disease (PAD)##2##3##(2008-8#2)
arterial disease in##4##3##(2008-8#2)(2011-2#2)
arterial disease##14##2##(1990-11#1)(1991-6#1)(1992-11#1)(1995-2#1)(1996-8#1)(2007-7#1)(2008-8#4)(2011-2#2)(2012-2#2)
arterial duct##2##2##(2012-12#2)
arterial elasticity##5##2##(2013-8#5)
arterial enhancement##2##2##(2008-7#2)
arterial feeder embolization##2##3##(2006-12#2)
arterial feeders##2##2##(2008-7#1)(2011-2#1)
arterial flow##2##2##(1991-5#1)(1995-12#1)
arterial graft holder##2##3##(2007-8#2)
arterial graft##4##2##(2007-8#4)
arterial grafts##3##2##(2007-8#3)
arterial hyper-enhancement##2##2##(2010-12#2)
arterial hypertension (PAH)##7##3##(2009-10#1)(2010-10#5)(2010-5#1)
arterial hypertension and##6##3##(1990-6#1)(1991-3#1)(1991-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
arterial hypertension in##6##3##(2010-10#2)(2011-1#1)(2011-2#2)(2013-1#1)
arterial hypertension is##3##3##(2007-8#1)(2008-11#1)(2010-10#1)
arterial hypertension or##3##3##(2008-3#1)(2008-7#1)(2010-10#1)
arterial hypertension was##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
arterial hypertension##52##2##(1990-6#1)(1991-3#1)(1991-8#1)(1993-9#1)(1996-3#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-7#4)(2008-8#1)(2009-10#1)(2010-10#12)(2010-5#2)(2011-1#1)(2011-2#8)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
arterial hypertension]##11##2##(1992-6#1)(1993-11#1)(1993-2#2)(1994-2#1)(1996-3#2)(1997-4#1)(2008-10#2)(2013-1#1)
arterial hypotension and##2##3##(1990-5#1)(1995-12#1)
arterial inflow##3##2##(2008-9#2)(2010-8#1)
arterial injury##2##2##(2007-8#1)(2009-3#1)
arterial insufficiency##3##2##(1995-8#1)(1997-3#1)(2008-2#1)
arterial lesion##2##2##(1997-8#1)(2006-6#1)
arterial lesions##3##2##(1997-8#1)(2008-7#1)(2013-1#1)
arterial ligation##2##2##(1990-6#1)(2008-8#1)
arterial line##2##2##(1990-11#2)
arterial lines were##2##3##(1990-11#2)
arterial lines##3##2##(1990-11#3)
arterial load compliance##2##3##(2008-3#2)
arterial muscle##3##2##(1990-11#2)(1991-6#1)
arterial occlusion (n =##2##4##(1997-8#2)
arterial occlusion of the##2##4##(2006-10#1)(2013-8#1)
arterial occlusion##10##2##(1997-8#4)(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
arterial occlusions##5##2##(1994-11#1)(2008-7#3)(2011-2#1)
arterial or venous##3##3##(1997-6#1)(2008-3#1)(2008-7#1)
arterial oxygen tension (PaO2)##2##4##(1997-3#1)(2011-2#1)
arterial oxygen tension##3##3##(1997-3#1)(2006-10#1)(2011-2#1)
arterial oxygen##5##2##(1993-1#1)(1996-3#1)(1997-3#1)(2006-10#1)(2011-2#1)
arterial perfusion##3##2##(1997-1#1)(2008-7#1)(2012-2#1)
arterial phase##4##2##(2008-1#1)(2008-7#1)(2012-1#1)(2013-1#1)
arterial pressure (MAP)##4##3##(1991-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
arterial pressure and##3##3##(1991-6#1)(1993-10#1)(1995-12#1)
arterial pressure during##2##3##(1990-6#1)(2008-7#1)
arterial pressure in##2##3##(1990-12#1)(2009-1#1)
arterial pressure was##2##3##(1990-8#1)(1995-12#1)
arterial pressure##30##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-5#3)(1991-6#1)(1993-10#1)(1993-12#1)(1994-3#1)(1995-12#3)(1996-3#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#2)(2009-8#1)(2011-2#2)(2013-8#1)
arterial remodelling##2##2##(1996-8#1)(2013-8#1)
arterial revascularization##3##2##(2007-8#3)
arterial rupture##2##2##(2012-12#1)(2013-8#1)
arterial smooth muscle##5##3##(1990-11#1)(1990-7#1)(1994-11#1)(1995-8#1)(1997-4#1)
arterial smooth##6##2##(1990-11#1)(1990-7#1)(1994-11#1)(1995-8#1)(1997-4#2)
arterial spin labeling MRI##2##4##(2011-1#2)
arterial spin labeling##3##3##(2009-10#1)(2011-1#2)
arterial stenosis##2##2##(2008-12#1)(2013-1#1)
arterial stiffness##8##2##(2008-1#1)(2009-7#1)(2010-7#1)(2013-7#4)(2013-8#1)
arterial system##8##2##(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2013-2#1)
arterial tension and##2##3##(2008-11#1)(2013-1#1)
arterial tension##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
arterial thrombosis##8##2##(1990-9#1)(1992-3#1)(1993-9#1)(2006-6#1)(2008-7#1)(2010-6#1)(2011-2#2)
arterial tissue##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
arterial vasodilatation##3##2##(1997-7#3)
arterial vessels##3##2##(1992-5#1)(2008-8#1)(2011-2#1)
arterial wall##17##2##(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
arterial##454##1##(1990-11#10)(1990-12#1)(1990-2#1)(1990-3#6)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#5)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#3)(1991-5#4)(1991-6#4)(1991-8#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#6)(1995-2#2)(1995-8#4)(1996-3#8)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#3)(1997-8#14)(2006-10#2)(2006-12#3)(2006-6#9)(2007-10#2)(2007-12#3)(2007-7#3)(2007-8#29)(2007-9#4)(2008-1#11)(2008-10#16)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#18)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#37)(2008-8#11)(2008-9#7)(2009-1#3)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#12)(2010-12#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#31)(2011-3#4)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#18)(2013-2#1)(2013-7#5)(2013-8#14)
arterial-venous##2##1##(1992-1#1)(2013-1#1)
arteries after##2##2##(1990-3#1)(2013-7#1)
arteries and the##6##3##(1992-2#1)(2007-12#1)(2007-8#1)(2008-7#2)(2013-7#1)
arteries and veins##6##3##(1996-8#1)(2006-10#1)(2008-3#1)(2010-4#1)(2010-8#2)
arteries and was##2##3##(2008-7#1)(2010-8#1)
arteries and##35##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#5)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
arteries and/or##2##2##(1990-9#1)(2011-1#1)
arteries are##3##2##(1990-2#1)(2008-3#1)(2013-8#1)
arteries as##2##2##(2008-7#2)
arteries by##2##2##(1996-2#1)(2008-10#1)
arteries from cyclosporine-treated rats##2##4##(1992-3#2)
arteries from##6##2##(1992-3#3)(1993-8#1)(2009-1#1)(2009-11#1)
arteries in the##5##3##(1991-3#1)(2008-11#1)(2011-3#1)(2012-3#2)
arteries in vivo##2##3##(1994-5#1)(2008-7#1)
arteries in##16##2##(1991-3#1)(1992-9#1)(1993-8#1)(1994-5#1)(2007-10#1)(2008-11#1)(2008-7#2)(2010-8#2)(2011-1#1)(2011-3#1)(2012-3#4)
arteries is##5##2##(1997-8#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
arteries may##3##2##(1995-3#1)(2008-1#1)(2008-3#1)
arteries of the lower##2##4##(1997-8#1)(2012-2#1)
arteries of the##5##3##(1991-3#1)(1997-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
arteries of##10##2##(1991-3#1)(1992-3#1)(1997-8#1)(2008-2#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
arteries supplying the##2##3##(2008-7#2)
arteries to##3##2##(1991-12#1)(1995-12#1)(1997-4#1)
arteries was##6##2##(1995-3#1)(1997-8#1)(2007-8#1)(2008-7#2)(2011-2#1)
arteries were not##2##3##(1996-6#1)(2006-12#1)
arteries were##15##2##(1993-8#1)(1994-11#1)(1996-6#2)(1996-9#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-3#2)
arteries which##2##2##(1990-9#1)(2011-1#1)
arteries who##2##2##(2008-7#1)(2010-10#1)
arteries with##3##2##(1994-11#2)(2009-10#1)
arteries##259##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#4)(1991-5#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-9#3)(1993-3#3)(1993-8#3)(1994-11#9)(1994-5#1)(1994-8#1)(1994-9#4)(1995-12#3)(1995-3#4)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-8#10)(2006-10#1)(2006-12#4)(2007-10#3)(2007-12#4)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#11)(2008-7#45)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#2)(2009-8#5)(2010-10#2)(2010-4#1)(2010-5#2)(2010-6#4)(2010-8#8)(2010-9#1)(2011-1#6)(2011-2#16)(2011-3#1)(2012-2#4)(2012-3#11)(2013-1#1)(2013-7#2)(2013-8#1)
arteries)##2##1##(1990-6#1)(2008-1#1)
arteries]##2##1##(2010-8#1)(2011-5#1)
arterio-venous fistula##4##2##(2007-7#2)(2008-1#1)(2013-1#1)
arterio-venous fistulas##3##2##(2007-7#1)(2008-1#1)(2008-7#1)
arterio-venous##9##1##(2007-7#4)(2008-1#2)(2008-7#2)(2013-1#1)
arterioarterial graft##3##2##(2008-1#3)
arteriography##14##1##(1990-2#1)(1990-3#2)(1991-5#2)(1991-9#1)(1993-5#1)(1996-6#1)(2007-9#1)(2008-1#1)(2010-6#3)(2012-2#1)
arteriolar and##2##2##(1995-12#1)(2008-3#1)
arteriolar##8##1##(1993-2#1)(1995-12#1)(2008-3#3)(2008-8#1)(2012-12#1)(2012-2#1)
arteriole##2##1##(2007-10#1)(2008-8#1)
arterioles and##2##2##(1995-12#1)(2013-1#1)
arterioles##12##1##(1992-2#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-10#1)(2008-7#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
arteriopathy##9##1##(1997-3#1)(2007-10#3)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-1#1)
arterioportal shunts##2##2##(2008-2#1)(2009-9#1)
arteriosclerosis and##2##2##(2007-11#1)(2008-1#1)
arteriosclerosis##5##1##(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-5#1)
arteriosclerotic##8##1##(1991-3#1)(1993-11#1)(1994-11#5)(1997-3#1)
arteriosus and##2##2##(2007-8#1)(2008-5#1)
arteriosus##16##1##(1994-3#1)(1996-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#3)(2008-5#2)(2010-10#2)(2012-3#1)(2013-1#1)
arteriovenous (AV)##2##2##(1997-6#1)(2007-7#1)
arteriovenous fistula (AVF)##4##3##(2007-7#3)(2008-7#1)
arteriovenous fistula in##4##3##(1993-6#1)(2007-7#2)(2008-11#1)
arteriovenous fistula is##2##3##(2007-7#1)(2007-8#1)
arteriovenous fistula was##2##3##(1994-9#1)(2007-7#1)
arteriovenous fistula##29##2##(1991-6#1)(1993-6#1)(1994-9#1)(1996-9#3)(2007-10#1)(2007-7#9)(2007-8#3)(2008-1#3)(2008-11#1)(2008-7#2)(2012-2#2)(2013-8#2)
arteriovenous fistulae (AVF)##3##3##(1996-9#2)(2008-7#1)
arteriovenous fistulae##14##2##(1991-6#1)(1996-9#7)(2007-7#2)(2008-11#1)(2008-7#3)
arteriovenous fistulas##13##2##(1991-3#1)(1991-5#1)(1995-11#1)(1996-3#2)(2007-7#4)(2008-7#4)
arteriovenous grafts##4##2##(2007-7#4)
arteriovenous malformation (AVM)##7##3##(1991-3#1)(2008-7#5)(2013-1#1)
arteriovenous malformation in##2##3##(2008-7#1)(2010-10#1)
arteriovenous malformation##28##2##(1991-3#1)(1992-2#1)(2008-1#1)(2008-7#22)(2010-10#1)(2013-1#2)
arteriovenous malformations (AVM)##3##3##(1996-6#1)(2008-7#1)(2012-2#1)
arteriovenous malformations (AVMs) were evaluated##2##5##(2008-7#2)
arteriovenous malformations (AVMs) were##4##4##(2008-7#4)
arteriovenous malformations (AVMs)##14##3##(1997-3#1)(2008-7#11)(2008-9#1)(2012-3#1)
arteriovenous malformations and##2##3##(1991-2#1)(2008-2#1)
arteriovenous malformations in the##2##4##(2008-7#2)
arteriovenous malformations of the##4##4##(2008-7#4)
arteriovenous malformations with##3##3##(2008-7#3)
arteriovenous malformations##54##2##(1991-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-6#2)(2006-12#2)(2007-10#1)(2008-1#3)(2008-2#1)(2008-7#29)(2008-9#7)(2011-2#1)(2012-2#1)(2012-3#1)
arteriovenous shunt##2##2##(1996-9#2)
arteriovenous shunts##7##2##(1995-11#1)(1996-3#1)(1996-9#4)(2008-7#1)
arteriovenous##170##1##(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1992-2#1)(1992-5#1)(1993-6#1)(1994-9#1)(1995-11#3)(1996-3#5)(1996-6#2)(1996-9#16)(1997-3#3)(1997-6#3)(2006-12#2)(2007-10#2)(2007-7#22)(2007-8#3)(2008-1#7)(2008-11#3)(2008-2#1)(2008-7#61)(2008-9#7)(2010-10#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
arteritis and##7##2##(1997-8#6)(2012-12#1)
arteritis in Mexico##2##3##(1997-8#2)
arteritis in##12##2##(1997-8#12)
arteritis is##4##2##(1994-9#1)(1997-8#3)
arteritis##72##1##(1990-8#1)(1994-9#4)(1996-9#1)(1997-8#64)(2011-1#1)(2012-12#1)
artery (ICA)##7##2##(2006-12#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
artery (LAD)##3##2##(2007-8#2)(2013-1#1)
artery (RA)##3##2##(2007-8#2)(2011-2#1)
artery Doppler flow velocimetry##2##4##(2011-2#2)
artery Doppler velocimetry##3##3##(1994-3#2)(2011-2#1)
artery Doppler##5##2##(1994-3#2)(2011-2#3)
artery actually##2##2##(2007-8#2)
artery after##3##2##(2008-7#1)(2010-7#1)(2012-12#1)
artery and other##2##3##(2008-3#1)(2008-7#1)
artery and the##6##3##(2007-10#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-2#1)
artery and their##2##3##(1997-8#1)(2012-12#1)
artery and vein##2##3##(2008-10#1)(2009-3#1)
artery and##34##2##(1995-6#1)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-3#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-2#1)(2013-8#2)
artery aneurysm##24##2##(1991-6#1)(1992-5#1)(1996-3#2)(1997-6#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-2#1)(2008-7#3)(2010-4#1)(2010-5#3)(2011-2#4)(2013-1#1)
artery aneurysms##7##2##(2008-11#1)(2010-5#1)(2011-2#4)(2013-8#1)
artery approach##2##2##(2007-7#1)(2011-2#1)
artery are##2##2##(1991-6#1)(2008-7#1)
artery arises##2##2##(2008-11#1)(2011-2#1)
artery arising from the##4##4##(2007-8#1)(2010-5#1)(2012-2#2)
artery arising from##6##3##(2007-8#1)(2008-7#1)(2010-5#2)(2012-2#2)
artery associated with##2##3##(1991-6#1)(2008-7#1)
artery at the##2##3##(1996-9#1)(1997-6#1)
artery at##3##2##(1996-9#1)(1997-6#1)(2008-7#1)
artery before##2##2##(2007-10#1)(2013-1#1)
artery by a##2##3##(2008-3#1)(2008-7#1)
artery by##6##2##(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#2)
artery bypass graft surgery##9##4##(1994-2#1)(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2012-12#1)(2013-8#1)
artery bypass graft##15##3##(1992-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-11#2)(2008-12#1)(2012-12#1)(2013-8#1)
artery bypass grafting was##2##4##(2007-8#2)
artery bypass grafting##49##3##(1993-12#1)(2006-8#1)(2007-8#35)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#1)
artery bypass surgery##13##3##(1990-2#1)(1990-6#1)(2006-10#1)(2006-6#1)(2007-8#4)(2008-11#3)(2010-8#1)(2012-12#1)
artery bypass##94##2##(1990-2#2)(1990-6#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#49)(2007-9#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-8#2)(2010-8#5)(2011-2#4)(2012-12#2)(2012-3#4)(2013-1#1)(2013-8#1)
artery calcification##2##2##(2009-4#1)(2013-8#1)
artery can##2##2##(1991-8#1)(2007-8#1)
artery cannulation##3##2##(1990-8#1)(2007-8#1)(2013-1#1)
artery catheter##2##2##(1990-8#1)(2008-11#1)
artery catheters##2##2##(1990-8#1)(1996-5#1)
artery disease (CAD) is##3##4##(2008-12#1)(2008-7#1)(2012-3#1)
artery disease (CAD)##17##3##(1991-8#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#4)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
artery disease (OR##3##3##(2007-10#2)(2008-3#1)
artery disease and##9##3##(1990-3#1)(2007-10#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
artery disease at##2##3##(2008-7#1)(2011-2#1)
artery disease in##7##3##(1996-3#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
artery disease was##2##3##(1990-3#1)(1996-6#1)
artery disease##127##2##(1990-12#1)(1990-3#2)(1991-8#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#1)(1994-11#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#5)(2007-5#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#10)(2008-12#3)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#3)(2009-10#2)(2009-12#1)(2009-4#3)(2010-11#2)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#10)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
artery dissection after##2##3##(2007-10#1)(2013-1#1)
artery dissection is a##2##4##(2008-7#1)(2010-10#1)
artery dissection is##4##3##(1991-8#1)(2008-7#1)(2010-10#1)(2011-2#1)
artery dissection##21##2##(1991-8#2)(2007-10#1)(2008-7#5)(2010-10#3)(2011-1#2)(2011-2#4)(2013-1#2)(2013-8#2)
artery distal to the occlusion##2##5##(1993-3#1)(1997-6#1)
artery elasticity##3##2##(2008-10#1)(2013-8#2)
artery embolization##7##2##(1992-9#4)(2008-1#1)(2012-3#2)
artery following##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
artery for##7##2##(1990-8#1)(1995-12#1)(2007-8#1)(2008-1#1)(2009-12#1)(2011-1#1)(2013-1#1)
artery from the##6##3##(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
artery from##7##2##(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
artery function##2##2##(2009-1#1)(2009-5#1)
artery graft##4##2##(1990-3#1)(2007-8#2)(2008-7#1)
artery grafting##3##2##(2007-8#3)
artery grafts##2##2##(2007-8#1)(2011-2#1)
artery in a##5##3##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
artery in##17##2##(1990-8#1)(1995-12#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#4)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
artery injury##2##2##(2007-8#1)(2012-1#1)
artery involvement##2##2##(1997-8#2)
artery is a##2##3##(2011-2#1)(2013-1#1)
artery is##16##2##(1990-3#1)(1990-8#1)(1991-3#1)(1993-3#2)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
artery lesion##5##2##(1991-11#1)(1997-8#3)(2013-1#1)
artery lesions in##3##3##(2007-10#1)(2008-11#1)(2008-3#1)
artery lesions##8##2##(1997-8#1)(2007-10#3)(2008-11#1)(2008-3#2)(2008-7#1)
artery ligation procedure##2##3##(2009-2#2)
artery ligation##11##2##(1994-1#3)(1996-5#2)(1997-2#1)(2007-8#1)(2009-2#3)(2012-12#1)
artery obstruction##2##2##(2008-7#1)(2011-2#1)
artery occlusion and##6##3##(1992-6#1)(2011-2#3)(2013-1#2)
artery occlusion by##4##3##(2007-10#2)(2008-10#1)(2009-2#1)
artery occlusion following##2##3##(2007-10#1)(2008-7#1)
artery occlusion is##2##3##(2008-8#1)(2011-2#1)
artery occlusion##41##2##(1991-8#1)(1992-6#1)(1993-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-8#2)(2007-10#12)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#4)(2008-8#3)(2009-2#1)(2011-2#5)(2013-1#3)(2013-7#1)
artery of the##4##3##(2008-4#3)(2008-7#1)
artery of##10##2##(1991-9#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#4)(2008-7#1)
artery on##2##2##(2007-8#1)(2008-7#1)
artery or##7##2##(1994-11#1)(1997-1#1)(2007-10#2)(2007-9#1)(2008-11#1)(2011-3#1)
artery ostium##2##2##(2007-8#1)(2010-12#1)
artery preparations##2##2##(1991-5#1)(2007-10#1)
artery pressure##8##2##(1991-8#1)(1992-2#1)(1997-5#1)(2007-9#1)(2010-10#1)(2010-4#2)(2010-8#1)
artery pseudoaneurysm##6##2##(2008-12#1)(2008-7#1)(2009-7#1)(2012-2#3)
artery reconstruction with a##2##4##(2008-7#2)
artery reconstruction##3##2##(2008-7#3)
artery should be##2##3##(2007-7#1)(2011-2#1)
artery smooth muscle cells##3##4##(1990-8#1)(1995-2#1)(2011-3#1)
artery smooth muscle##4##3##(1990-8#1)(1995-2#1)(2010-12#1)(2011-3#1)
artery spasm and##3##3##(2008-7#2)(2011-2#1)
artery spasm##11##2##(2007-8#1)(2008-7#4)(2011-2#6)
artery starting from the##2##4##(2007-7#1)(2010-10#1)
artery stenoses##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
artery stenosis in##3##3##(2008-1#1)(2008-11#1)(2009-10#1)
artery stenosis was##2##3##(1997-8#1)(2008-7#1)
artery stenosis##46##2##(1990-2#1)(1994-11#2)(1997-8#3)(2007-10#1)(2007-7#1)(2007-8#5)(2008-1#4)(2008-11#2)(2008-12#7)(2008-7#6)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
artery stenting##8##2##(1992-4#1)(2008-11#2)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
artery syndrome##2##2##(2007-10#1)(2008-7#1)
artery system##2##2##(1994-11#1)(2008-7#1)
artery testing##2##2##(2008-12#2)
artery thrombosis##5##2##(2007-8#1)(2012-12#2)(2013-1#2)
artery to artery##2##3##(2007-10#1)(2008-7#1)
artery to the##3##3##(2007-8#3)
artery to##11##2##(1990-8#1)(1992-9#1)(2007-10#1)(2007-8#4)(2008-7#2)(2009-1#1)(2011-2#1)
artery using##3##2##(2007-10#1)(2008-7#1)(2012-12#1)
artery wall##2##2##(2011-1#1)(2012-2#1)
artery was##17##2##(1995-12#2)(1996-3#1)(1997-1#1)(2007-8#1)(2008-4#1)(2008-7#5)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
artery were##5##2##(1995-11#1)(2006-12#1)(2008-7#2)(2012-3#1)
artery with a##3##3##(2007-8#2)(2008-9#1)
artery with an##2##3##(2008-12#1)(2010-4#1)
artery with##12##2##(1997-6#1)(2007-8#5)(2008-12#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)
artery##1094##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#5)(1990-6#1)(1990-8#8)(1991-11#1)(1991-3#5)(1991-5#3)(1991-6#6)(1991-8#6)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#8)(1993-12#7)(1993-2#1)(1993-3#9)(1993-6#2)(1993-8#2)(1994-1#4)(1994-11#9)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#5)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#7)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#7)(1997-1#3)(1997-2#5)(1997-3#6)(1997-5#2)(1997-6#14)(1997-7#1)(1997-8#22)(2006-10#3)(2006-12#3)(2006-6#3)(2006-7#2)(2006-8#1)(2007-10#57)(2007-11#2)(2007-2#1)(2007-5#2)(2007-7#9)(2007-8#143)(2007-9#8)(2008-1#20)(2008-10#10)(2008-11#50)(2008-12#43)(2008-2#2)(2008-3#16)(2008-4#12)(2008-5#3)(2008-6#2)(2008-7#132)(2008-8#16)(2008-9#16)(2009-1#3)(2009-10#4)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#1)(2009-7#4)(2009-8#1)(2010-10#9)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#10)(2010-5#10)(2010-7#3)(2010-8#12)(2010-9#2)(2011-1#7)(2011-2#90)(2011-3#3)(2012-1#4)(2012-12#14)(2012-2#22)(2012-3#23)(2013-1#42)(2013-2#4)(2013-7#5)(2013-8#31)
artery)##3##1##(2008-7#1)(2011-2#2)
artery]##4##1##(1991-3#1)(1991-6#1)(1991-8#1)(2013-8#1)
arthralgia and##2##2##(2011-2#2)
arthralgia##4##1##(2008-10#1)(2010-12#1)(2011-2#2)
arthralgia/arthritis##3##1##(1995-11#1)(2008-8#1)(2011-2#1)
arthralgias##3##1##(1992-5#1)(1993-8#1)(2012-3#1)
arthritic##4##1##(2008-11#2)(2010-5#1)(2013-1#1)
arthritides are##2##2##(1990-6#1)(2008-9#1)
arthritides##4##1##(1990-6#3)(2008-9#1)
arthritis (CIA)##2##2##(1990-6#1)(2008-11#1)
arthritis (RA)##18##2##(1994-6#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-8#1)
arthritis a##3##2##(1993-11#1)(2013-1#2)
arthritis and degenerative##3##3##(2011-2#1)(2013-1#2)
arthritis and osteomyelitis##2##3##(2013-8#2)
arthritis and##28##2##(1990-3#1)(1990-6#2)(1991-5#2)(1992-5#1)(1994-8#1)(1997-5#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
arthritis are##3##2##(1990-6#1)(2008-5#1)(2008-7#1)
arthritis as##3##2##(1990-6#1)(1991-8#1)(2006-10#1)
arthritis caused by##4##3##(1990-6#1)(1991-11#1)(2006-10#2)
arthritis has##3##2##(1990-6#1)(2006-10#1)(2008-12#1)
arthritis in a##2##3##(2011-2#1)(2012-3#1)
arthritis in##11##2##(1992-5#1)(1995-11#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
arthritis is##9##2##(1990-6#4)(2007-11#2)(2007-12#1)(2012-3#2)
arthritis often##2##2##(2006-10#1)(2010-12#1)
arthritis or##3##2##(1990-6#1)(2007-8#1)(2008-9#1)
arthritis patients##8##2##(1991-5#2)(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#2)
arthritis should be##3##3##(1990-6#1)(2008-8#1)(2013-8#1)
arthritis that##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
arthritis with##3##2##(2006-10#2)(2011-2#1)
arthritis##271##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#29)(1991-11#1)(1991-3#1)(1991-5#4)(1991-8#3)(1992-5#2)(1993-1#1)(1993-11#1)(1993-2#3)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#26)(2007-1#1)(2007-11#13)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#11)(2008-8#15)(2008-9#9)(2009-1#1)(2009-10#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-11#3)(2010-12#5)(2010-5#2)(2010-8#2)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#17)(2013-1#11)(2013-8#13)
arthritis?##2##1##(2007-11#2)
arthritis]##7##1##(1990-6#4)(1991-11#2)(1991-3#1)
arthrodesis from the##2##3##(2008-8#1)(2012-3#1)
arthrodesis from##3##2##(2008-8#2)(2012-3#1)
arthrodesis in##2##2##(2008-6#1)(2011-2#1)
arthrodesis of the##4##3##(2008-8#1)(2010-3#1)(2010-5#1)(2012-3#1)
arthrodesis was##3##2##(2008-12#1)(2009-7#1)(2013-8#1)
arthrodesis with##6##2##(2011-2#4)(2012-3#1)(2013-1#1)
arthrodesis##44##1##(2008-12#5)(2008-6#9)(2008-8#8)(2009-10#1)(2009-7#1)(2010-3#1)(2010-5#4)(2011-2#5)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
arthrography##6##1##(1996-9#1)(2007-11#4)(2007-8#1)
arthrogryposis multiplex congenita]##2##3##(2008-10#1)(2009-5#1)
arthrogryposis##6##1##(1996-12#2)(2008-10#3)(2009-5#1)
arthropathies##7##1##(1990-6#1)(1997-6#1)(2008-8#1)(2010-12#4)
arthropathy##9##1##(1992-5#3)(1994-6#1)(2008-12#2)(2009-10#1)(2012-2#2)
arthroplasties##6##1##(1996-9#2)(2007-11#1)(2008-11#1)(2009-7#1)(2013-1#1)
arthroplasty and##6##2##(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#3)
arthroplasty for##3##2##(2007-11#1)(2008-9#1)(2010-11#1)
arthroplasty from##2##2##(2008-9#1)(2011-2#1)
arthroplasty has##2##2##(2007-8#1)(2010-11#1)
arthroplasty in##9##2##(2007-11#2)(2007-8#2)(2008-8#1)(2009-3#1)(2012-2#2)(2013-1#1)
arthroplasty is##4##2##(1997-6#1)(2007-11#3)
arthroplasty of the##2##3##(2008-9#1)(2013-1#1)
arthroplasty of##4##2##(2008-9#1)(2011-2#2)(2013-1#1)
arthroplasty or##2##2##(2008-9#1)(2011-2#1)
arthroplasty patients##2##2##(2008-8#1)(2012-2#1)
arthroplasty through##2##2##(2007-8#1)(2011-2#1)
arthroplasty to##2##2##(2010-5#1)(2011-2#1)
arthroplasty using##2##2##(2007-8#1)(2008-8#1)
arthroplasty were##3##2##(1996-9#1)(2007-8#1)(2008-9#1)
arthroplasty with##4##2##(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
arthroplasty##172##1##(1994-3#3)(1996-9#1)(1997-2#1)(1997-6#1)(2007-11#14)(2007-12#1)(2007-8#12)(2008-11#3)(2008-6#2)(2008-7#1)(2008-8#30)(2008-9#12)(2009-10#1)(2009-3#8)(2009-4#1)(2010-11#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#33)(2012-12#11)(2012-2#8)(2012-3#2)(2013-1#20)
arthroplasy##2##1##(2011-2#2)
arthropod diversity##2##2##(2008-9#2)
arthropod gap and##2##3##(2008-7#2)
arthropod incidence##2##2##(2011-2#2)
arthropod pests##2##2##(2008-10#1)(2010-10#1)
arthropod species richness##3##3##(2008-9#3)
arthropod species##4##2##(2008-9#4)
arthropod##36##1##(1991-5#1)(2007-12#11)(2008-10#1)(2008-6#3)(2008-7#2)(2008-9#10)(2009-2#1)(2009-7#1)(2010-10#1)(2011-2#4)(2013-8#1)
arthropod-borne##2##1##(2008-10#1)(2011-2#1)
arthropod-dominated##2##1##(2008-8#2)
arthropods of##2##2##(2008-9#1)(2011-2#1)
arthropods##24##1##(1997-7#1)(2007-12#6)(2008-6#4)(2008-7#1)(2008-9#3)(2011-2#9)
arthroscopic ankle##2##2##(2008-12#1)(2009-1#1)
arthroscopic excision##3##2##(2009-3#2)(2013-1#1)
arthroscopic procedures##2##2##(2007-11#1)(2013-1#1)
arthroscopic reconstruction of the anterior cruciate ligament##3##7##(2007-8#2)(2013-1#1)
arthroscopic reconstruction of the##4##4##(2007-8#2)(2013-1#2)
arthroscopic reconstruction of##5##3##(2007-8#2)(2013-1#3)
arthroscopic repair of##2##3##(2007-11#1)(2008-8#1)
arthroscopic subacromial decompression##2##3##(2007-11#2)
arthroscopic techniques##3##2##(2007-11#2)(2008-8#1)
arthroscopic treatment of shoulder##2##4##(2007-11#2)
arthroscopic treatment of##5##3##(2007-11#4)(2008-8#1)
arthroscopic treatment##8##2##(2007-11#6)(2008-8#2)
arthroscopic##43##1##(2007-11#16)(2007-8#2)(2008-12#1)(2008-8#7)(2008-9#1)(2009-1#1)(2009-3#3)(2011-2#4)(2012-12#1)(2013-1#7)
arthroscopical##2##1##(1993-11#1)(2013-1#1)
arthroscopically##6##1##(2007-11#1)(2008-11#1)(2008-9#2)(2009-3#1)(2012-12#1)
arthroscopies##4##1##(2007-11#4)
arthroscopy and##3##2##(2008-10#1)(2008-8#1)(2009-1#1)
arthroscopy are##2##2##(2007-11#1)(2013-1#1)
arthroscopy has become a##2##4##(2007-11#2)
arthroscopy in##5##2##(1990-3#1)(2007-11#3)(2013-1#1)
arthroscopy is##2##2##(2007-11#1)(2008-10#1)
arthroscopy of the##2##3##(1990-11#1)(2012-3#1)
arthroscopy##43##1##(1990-11#1)(1990-3#1)(2007-11#16)(2008-10#4)(2008-8#4)(2008-9#5)(2009-1#4)(2010-7#2)(2011-2#1)(2012-3#2)(2013-1#3)
arthrosis##14##1##(1991-3#1)(1996-6#1)(1997-6#2)(2007-11#1)(2007-8#2)(2008-12#2)(2008-7#1)(2011-2#3)(2013-1#1)
arthrosporioides##3##1##(2008-10#3)
arthrotic##2##1##(2007-11#1)(2007-8#1)
artichoke and cotton##3##3##(2008-10#3)
artichoke isolates##3##2##(2008-10#3)
artichoke##24##1##(1991-5#1)(2008-10#19)(2013-1#4)
article &quot##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
article (Capps##2##2##(2008-12#2)
article about##2##2##(2010-9#1)(2012-3#1)
article addressed##2##2##(1992-1#1)(2010-3#1)
article addresses the##8##3##(1992-2#1)(1994-3#1)(1995-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
article addresses##16##2##(1991-12#2)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)
article advocates##3##2##(1996-3#1)(1997-3#1)(2008-7#1)
article aims to##7##3##(2007-6#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
article aims##11##2##(1991-6#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#2)
article also provides##2##3##(1991-12#1)(1995-12#1)
article also##22##2##(1991-12#2)(1993-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#2)
article analyzes the##11##3##(1991-1#1)(1991-12#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
article analyzes##15##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
article and##5##2##(1991-1#1)(1992-1#2)(1992-2#1)(2008-2#1)
article are##10##2##(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
article attempts to##6##3##(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-5#1)
article briefly discusses##3##3##(1997-2#1)(2008-12#1)(2013-8#1)
article briefly reviews the##2##4##(2009-12#1)(2013-1#1)
article briefly##14##2##(1991-2#1)(1992-12#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-4#1)(2013-1#2)(2013-8#1)
article by##6##2##(1990-8#1)(1992-12#1)(1995-1#1)(1995-2#1)(2007-4#1)(2010-12#1)
article can##3##2##(2006-5#1)(2008-6#1)(2008-7#1)
article concludes with recommendations for##2##5##(1996-12#1)(2008-11#1)
article concludes with##11##3##(1992-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)
article concludes##22##2##(1992-3#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)
article considers the##6##3##(1991-6#1)(2008-10#1)(2009-4#1)(2009-7#1)(2013-1#2)
article considers##13##2##(1991-6#1)(1995-1#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#1)(2013-1#3)
article contains a##3##3##(1993-6#1)(2007-8#1)(2008-10#1)
article contains the##2##3##(1997-3#1)(2007-11#1)
article contains##8##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-6#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)
article deals with the##3##4##(1990-12#1)(2008-9#1)(2013-1#1)
article deals with##5##3##(1990-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
article describes a##28##3##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#4)(1996-3#2)(1996-7#1)(1997-1#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2013-1#1)(2013-7#1)
article describes an innovative##2##4##(2008-11#1)(2008-12#1)
article describes an##10##3##(1990-11#1)(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
article describes in detail the##2##5##(1997-3#1)(2013-1#1)
article describes one##4##3##(1994-2#1)(1997-3#1)(2007-8#1)(2008-12#1)
article describes our##2##3##(1990-11#1)(2008-10#1)
article describes recent##2##3##(1993-3#1)(2007-8#1)
article describes the experiences of##2##5##(1992-3#1)(1997-3#1)
article describes the recent##2##4##(2008-11#2)
article describes the use of##4##5##(1996-3#2)(1997-2#1)(2008-5#1)
article describes the##89##3##(1990-11#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1997-1#1)(1997-2#4)(1997-3#3)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#2)
article describes##189##2##(1990-11#3)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#4)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#1)(1995-1#5)(1995-12#3)(1995-2#2)(1995-3#6)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#9)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#12)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
article discusses several##2##3##(1992-3#1)(2012-2#1)
article discusses the changes##2##4##(1993-2#1)(1994-1#1)
article discusses the current##2##4##(1996-12#1)(2008-7#1)
article discusses the role of##3##5##(1990-12#1)(2009-4#1)(2013-1#1)
article discusses the role##4##4##(1990-12#1)(2009-10#1)(2009-4#1)(2013-1#1)
article discusses the##58##3##(1990-11#1)(1990-12#2)(1991-12#4)(1991-8#1)(1992-1#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#2)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
article discusses various##2##3##(1994-6#1)(2011-2#1)
article discusses ways##2##3##(1992-2#1)(1994-3#1)
article discusses##112##2##(1990-11#1)(1990-12#2)(1991-1#1)(1991-12#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#4)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#1)(1994-1#5)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1997-2#3)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
article emphasizes the laboratory fabrication##2##5##(2008-7#2)
article emphasizes##3##2##(1997-3#1)(2008-7#2)
article employs##2##2##(1996-3#1)(2008-10#1)
article evaluates##7##2##(1996-2#1)(2007-12#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
article examines a##2##3##(1992-2#1)(2012-2#1)
article examines the##36##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-12#2)(1996-2#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-4#1)(2009-7#1)(2011-2#4)(2012-12#2)(2013-1#1)
article examines##67##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#3)(1995-12#3)(1995-2#4)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-1#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#2)
article expands##2##2##(2008-1#1)(2012-12#1)
article explains how##2##3##(1995-1#1)(1997-3#1)
article explains##9##2##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-2#1)
article explores how##2##3##(2008-12#1)(2011-2#1)
article explores the##23##3##(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-8#1)
article explores##42##2##(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#3)(1995-12#2)(1996-12#2)(1996-2#3)(1996-3#2)(1997-1#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2009-10#2)(2011-1#1)(2011-2#7)(2012-2#1)(2013-8#3)
article extends##2##2##(2008-5#1)(2010-5#1)
article focuses on the##20##4##(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)
article focuses on##33##3##(1991-1#1)(1991-2#2)(1991-6#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-6#1)(1996-12#2)(1997-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)
article focuses##34##2##(1991-1#1)(1991-2#2)(1991-6#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-6#1)(1996-12#2)(1997-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
article for the##2##3##(2009-4#1)(2010-7#1)
article gives an overview of##2##5##(1994-1#1)(1996-1#1)
article gives an##4##3##(1994-1#1)(1996-1#1)(2008-11#1)(2008-12#1)
article gives##8##2##(1991-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
article has been withdrawn##5##4##(2008-10#1)(2008-11#3)(2013-1#1)
article has been##10##3##(2008-10#5)(2008-11#4)(2013-1#1)
article has##30##2##(1991-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-3#1)(2006-5#1)(2008-1#1)(2008-10#5)(2008-11#11)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
article highlights some of the##2##5##(2009-10#1)(2013-1#1)
article highlights some##3##3##(2009-10#1)(2009-11#1)(2013-1#1)
article highlights the##8##3##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-11#2)(2009-5#1)(2013-1#1)
article highlights##15##2##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#2)
article identifies##5##2##(1991-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)
article illustrates##6##2##(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2011-1#1)
article in##2##2##(2010-7#1)(2012-2#1)
article includes a##3##3##(1991-11#1)(1997-6#1)(2008-12#1)
article includes an##2##3##(1991-6#1)(1994-1#1)
article includes##10##2##(1991-1#1)(1991-11#1)(1991-6#1)(1992-12#1)(1994-1#2)(1997-6#1)(2008-1#1)(2008-12#2)
article introduces a##5##3##(1996-12#1)(1996-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
article introduces the##3##3##(1991-2#1)(1996-3#1)(2012-3#1)
article introduces##13##2##(1991-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
article is a##13##3##(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#1)(1994-12#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-2#2)
article is an attempt to##2##5##(1990-12#1)(2008-4#1)
article is an overview of##4##5##(1992-1#1)(1997-3#1)(2010-12#1)(2012-2#1)
article is an##16##3##(1990-12#1)(1992-1#1)(1997-3#1)(2008-11#5)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#3)(2012-3#1)
article is based on##3##4##(1996-2#1)(2008-8#1)(2010-5#1)
article is extracted from##2##4##(2009-4#1)(2010-3#1)
article is intended as##2##4##(1991-2#1)(1994-6#1)
article is intended##3##3##(1991-2#1)(1994-6#1)(2008-11#1)
article is the##11##3##(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)
article is to discuss the##2##5##(2007-4#1)(2008-7#1)
article is to discuss##4##4##(1995-1#1)(1996-2#1)(2007-4#1)(2008-7#1)
article is to draw attention to##2##6##(2007-11#1)(2007-8#1)
article is to provide a##6##5##(1997-3#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
article is to provide an overview of##2##7##(2008-11#1)(2010-12#1)
article is to provide the##2##5##(2009-5#1)(2010-9#1)
article is to provide##13##4##(1994-3#1)(1997-3#1)(2008-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
article is to use##2##4##(2008-3#1)(2012-2#1)
article is to##85##3##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#4)
article is##158##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#3)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-2#5)(1997-1#1)(1997-3#2)(1997-8#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#12)(2012-3#12)(2013-1#5)(2013-8#4)
article lays##2##2##(1995-12#1)(1997-3#1)
article offers a##4##3##(1992-3#1)(1994-3#1)(2008-1#1)(2010-6#1)
article offers##7##2##(1992-12#1)(1992-3#2)(1994-3#1)(1996-12#1)(2008-1#1)(2010-6#1)
article on the##3##3##(1994-1#1)(2007-2#1)(2008-9#1)
article on##25##2##(1990-12#1)(1991-1#1)(1993-3#1)(1994-1#1)(1997-1#1)(2007-2#1)(2008-11#3)(2008-7#5)(2008-9#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
article outlines##21##2##(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#2)(2010-4#1)
article present##2##2##(2007-11#1)(2007-8#1)
article presents a brief##2##4##(1990-12#1)(1991-9#1)
article presents a comprehensive overview of the##2##7##(1993-12#1)(2013-1#1)
article presents a detailed##2##4##(1996-1#1)(2010-5#1)
article presents a review of##3##5##(2011-2#1)(2011-7#1)(2013-8#1)
article presents a series of##2##5##(1992-12#1)(2008-7#1)
article presents a##55##3##(1990-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1996-1#2)(1997-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#8)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
article presents an analysis of##3##5##(1993-6#1)(1996-2#1)(2011-1#1)
article presents an overview of##8##5##(1991-12#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-5#3)(2013-8#1)
article presents an##14##3##(1991-12#2)(1993-6#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-7#1)(2011-1#1)(2013-8#1)
article presents the findings of##4##5##(1994-2#1)(1996-2#1)(1997-7#1)(2013-8#1)
article presents the first##2##4##(1992-12#1)(1996-2#1)
article presents the results of a##3##6##(1994-3#1)(1997-3#1)(2013-1#1)
article presents the results of##7##5##(1994-1#1)(1994-3#1)(1997-3#1)(2007-11#1)(2013-1#2)(2013-8#1)
article presents the##33##3##(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#2)(1997-3#2)(1997-7#1)(2007-11#6)(2007-8#5)(2008-10#2)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
article presents##136##2##(1990-12#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#4)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-7#1)(2007-11#8)(2007-12#1)(2007-4#1)(2007-8#7)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#8)(2009-5#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#5)
article proposes a new##2##4##(2008-5#1)(2012-3#1)
article proposes a##5##3##(1992-3#1)(1997-2#1)(2008-2#1)(2008-5#1)(2012-3#1)
article proposes##11##2##(1991-12#1)(1992-3#1)(1993-1#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-3#2)
article provides a brief overview of the##3##7##(2010-12#1)(2010-7#1)(2010-8#1)
article provides a brief overview of##4##6##(1993-2#1)(2010-12#1)(2010-7#1)(2010-8#1)
article provides a brief##5##4##(1993-2#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)
article provides a##27##3##(1993-2#1)(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
article provides an overview of the##14##6##(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-3#1)(2013-8#1)
article provides an overview of##26##5##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-2#2)(2007-12#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
article provides an##28##3##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-2#2)(2007-12#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
article provides examples of how##2##5##(1997-3#1)(2008-12#1)
article provides information##2##3##(1991-6#1)(2010-7#1)
article provides some##2##3##(2008-7#1)(2009-10#1)
article provides##75##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#2)(1994-3#2)(1995-12#2)(1996-1#3)(1996-12#2)(1996-3#1)(1997-1#3)(1997-2#4)(1997-3#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
article questions##3##2##(1990-12#1)(1991-3#1)(1995-1#1)
article reports findings of a##2##5##(1996-7#1)(2011-2#1)
article reports on a##6##4##(1993-3#1)(1995-1#1)(1996-12#1)(2008-12#1)(2008-7#1)(2009-5#1)
article reports on##15##3##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
article reports the results of a study##2##7##(1992-1#1)(1996-1#1)
article reports the results of a##5##6##(1992-1#1)(1992-3#1)(1996-1#2)(1996-12#1)
article reports the##9##3##(1992-1#1)(1992-3#1)(1995-1#1)(1996-1#2)(1996-12#1)(1997-2#1)(2008-9#1)(2013-1#1)
article reports##38##2##(1992-1#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#2)(1996-7#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#2)(2009-5#2)(2010-1#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
article reviewed##2##2##(2008-12#1)(2008-8#1)
article reviews existing literature and##2##5##(1996-2#1)(2008-11#1)
article reviews research on##2##4##(1995-2#1)(2012-3#1)
article reviews some of the##7##5##(1993-1#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
article reviews the current state of##2##6##(1997-4#1)(2008-6#1)
article reviews the current##7##4##(1997-4#1)(2007-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-7#1)
article reviews the evidence supporting##3##5##(2007-10#1)(2008-7#1)(2011-2#1)
article reviews the factors##2##4##(2008-1#1)(2008-4#1)
article reviews the##91##3##(1990-2#1)(1992-2#1)(1993-12#1)(1994-2#3)(1995-2#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#6)(2008-1#4)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#4)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2009-12#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#6)(2013-8#3)
article reviews these##2##3##(2008-11#1)(2008-6#1)
article reviews##144##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#4)(1994-1#1)(1994-2#4)(1994-9#1)(1995-2#4)(1996-12#1)(1996-2#5)(1996-3#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#9)(2008-1#6)(2008-10#4)(2008-11#12)(2008-12#1)(2008-2#5)(2008-4#8)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#7)
article selection##2##2##(1991-12#1)(2010-2#1)
article sets out##3##3##(2010-11#1)(2012-12#1)(2013-8#1)
article sets##4##2##(1992-3#1)(2010-11#1)(2012-12#1)(2013-8#1)
article shows how##3##3##(1996-3#1)(1997-2#1)(2013-8#1)
article shows##6##2##(1994-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2011-2#1)(2013-8#1)
article stresses##2##2##(1995-12#1)(2011-2#1)
article suggests a##2##3##(1991-3#1)(2007-11#1)
article suggests that##3##3##(1994-12#1)(1994-2#1)(2013-1#1)
article suggests##10##2##(1991-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-1#1)(2010-8#1)(2013-1#2)
article summarises##4##2##(1997-7#1)(2007-5#2)(2011-2#1)
article summarizes the literature##2##4##(2009-5#1)(2011-2#1)
article summarizes the##20##3##(1992-12#2)(1992-3#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-5#1)(2011-2#2)
article summarizes##32##2##(1990-11#1)(1990-8#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#3)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)
article surveys##2##2##(2008-11#1)(2008-12#1)
article takes a##4##3##(1991-1#1)(1997-3#1)(2008-8#1)(2013-8#1)
article takes##8##2##(1991-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2013-8#1)
article that##9##2##(2008-11#7)(2008-7#1)(2012-3#1)
article the##9##2##(1990-3#2)(1992-3#1)(1993-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-12#1)(2012-3#1)
article there##2##2##(2012-3#1)(2013-1#1)
article to##2##2##(1991-1#1)(2008-10#1)
article uses##12##2##(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-3#1)
article was to##10##3##(2007-12#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#2)(2013-1#1)
article was##24##2##(1991-2#1)(1992-3#1)(1993-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#4)(2012-2#2)(2013-1#1)
article we present the##2##4##(2012-2#2)
article we present##8##3##(1990-9#1)(1995-6#1)(2008-11#2)(2009-1#1)(2010-12#1)(2012-2#2)
article we##43##2##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1994-1#1)(1995-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#1)
article were##2##2##(2010-9#1)(2013-1#1)
article will address the##2##4##(1995-3#1)(1996-1#1)
article will address##5##3##(1993-11#1)(1995-3#1)(1996-1#1)(2007-10#1)(2008-1#1)
article will convey a case history of actual foodservice recycling practice from a healthcare facility##2##15##(1996-12#1)(1996-3#1)
article will focus on the##3##5##(1995-12#1)(1997-8#1)(2008-5#1)
article will provide an overview of the##3##7##(1991-1#1)(2011-2#1)(2013-8#1)
article will provide an overview of##4##6##(1991-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
article will provide##8##3##(1991-1#1)(1994-2#1)(1997-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
article will review##9##3##(1994-3#2)(1995-2#1)(1996-1#1)(1997-1#1)(2008-7#2)(2009-12#1)(2012-2#1)
article will##55##2##(1991-1#2)(1991-12#2)(1992-4#1)(1993-1#1)(1993-11#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#5)(2013-1#2)(2013-8#2)
article##2178##1##(1990-11#7)(1990-12#7)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#24)(1991-11#1)(1991-12#31)(1991-2#26)(1991-3#13)(1991-6#7)(1991-8#1)(1991-9#3)(1992-1#22)(1992-11#3)(1992-12#30)(1992-2#26)(1992-3#27)(1992-4#2)(1992-6#2)(1992-9#1)(1993-1#20)(1993-11#3)(1993-12#27)(1993-2#20)(1993-3#31)(1993-6#6)(1993-9#1)(1994-1#38)(1994-11#4)(1994-12#26)(1994-2#31)(1994-3#26)(1994-6#2)(1994-9#3)(1995-1#32)(1995-11#1)(1995-12#32)(1995-2#29)(1995-3#28)(1995-5#2)(1995-6#6)(1995-8#2)(1996-1#26)(1996-11#2)(1996-12#32)(1996-2#49)(1996-3#44)(1996-6#3)(1996-7#3)(1996-9#4)(1997-1#22)(1997-2#31)(1997-3#34)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#4)(2006-10#3)(2006-12#1)(2006-5#2)(2007-10#11)(2007-11#26)(2007-12#30)(2007-2#7)(2007-4#5)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#23)(2007-9#1)(2008-1#38)(2008-10#73)(2008-11#133)(2008-12#37)(2008-2#23)(2008-3#12)(2008-4#24)(2008-5#22)(2008-6#18)(2008-7#73)(2008-8#39)(2008-9#36)(2009-1#2)(2009-10#18)(2009-11#7)(2009-12#10)(2009-2#1)(2009-3#11)(2009-4#10)(2009-5#19)(2009-6#2)(2009-7#9)(2009-8#10)(2009-9#16)(2010-1#8)(2010-10#5)(2010-11#10)(2010-12#17)(2010-2#6)(2010-3#11)(2010-4#8)(2010-5#12)(2010-6#9)(2010-7#15)(2010-8#16)(2010-9#18)(2011-1#29)(2011-2#82)(2011-3#3)(2011-7#4)(2012-1#5)(2012-12#37)(2012-2#70)(2012-3#46)(2013-1#68)(2013-7#5)(2013-8#52)
article]##2##1##(1996-9#1)(2013-1#1)
articles and##4##2##(1992-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
articles based on##2##3##(2011-1#1)(2012-12#1)
articles dealing with##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
articles describing the##2##3##(1997-1#1)(2006-10#1)
articles describing##4##2##(1997-1#1)(2006-10#1)(2010-12#1)(2012-12#1)
articles for##4##2##(1991-6#1)(1994-3#1)(2010-5#1)(2013-8#1)
articles found##2##2##(2013-1#1)(2013-8#1)
articles from##3##2##(1994-12#1)(2009-5#1)(2011-2#1)
articles have been##2##3##(1991-3#1)(2009-5#1)
articles have##4##2##(1991-2#1)(1991-3#1)(2009-5#1)(2012-2#1)
articles in English##2##3##(2012-3#1)(2013-1#1)
articles in the literature regarding##2##5##(2012-2#2)
articles in the literature##3##4##(1993-2#1)(2012-2#2)
articles in the##4##3##(1993-2#1)(2009-8#1)(2012-2#2)
articles in this##4##3##(1993-1#1)(1993-2#1)(1994-3#1)(1997-1#1)
articles in##14##2##(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1997-1#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
articles met the criteria for question##2##6##(2013-1#2)
articles on##18##2##(1991-11#1)(1992-6#1)(1993-12#2)(1997-1#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-7#1)
articles published between##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
articles published in this issue of the##5##7##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)
articles published in##9##3##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2006-10#1)(2012-2#1)(2013-8#1)
articles published##19##2##(1994-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2006-10#1)(2008-7#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
articles reporting##2##2##(2011-2#1)(2012-3#1)
articles retrieved##2##2##(2008-11#1)(2012-2#1)
articles that included##2##3##(2011-2#1)(2013-1#1)
articles that##9##2##(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#2)(2012-12#3)(2013-1#1)
articles to##4##2##(2008-5#3)(2010-12#1)
articles was##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
articles were also reviewed##2##4##(2013-1#1)(2013-8#1)
articles were analyzed##2##3##(2012-3#2)
articles were found##2##3##(2009-6#1)(2012-12#1)
articles were identified##4##3##(2007-12#1)(2009-7#1)(2012-12#1)(2013-1#1)
articles were included##2##3##(2011-2#2)
articles were##26##2##(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#3)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
articles##216##1##(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#3)(1993-2#2)(1994-12#6)(1994-3#6)(1995-1#2)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#4)(1997-1#4)(1997-2#3)(1997-3#2)(1997-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#9)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#17)(2011-7#1)(2012-1#1)(2012-12#25)(2012-2#8)(2012-3#15)(2013-1#22)(2013-7#1)(2013-8#7)
articular capsule##2##2##(2007-11#2)
articular cartilage in##2##3##(2009-10#1)(2012-2#1)
articular cartilage of##2##3##(1993-12#1)(2008-9#1)
articular cartilage##14##2##(1993-12#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
articular chondrocalcinosis##3##2##(1991-11#2)(1993-2#1)
articular chondrocytes##2##2##(2007-11#1)(2008-11#1)
articular membranes##3##2##(2008-7#3)
articular reduction##2##2##(2008-8#2)
articular surface##3##2##(2008-8#1)(2011-2#2)
articular surfaces##7##2##(2007-11#4)(2012-3#1)(2013-1#2)
articular##52##1##(1990-6#1)(1991-11#2)(1992-5#1)(1993-12#1)(1993-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#10)(2007-8#1)(2008-11#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#7)(2013-1#3)
articulate a##2##2##(1993-1#1)(2008-12#1)
articulate the##8##2##(1992-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
articulate##18##1##(1992-3#2)(1993-1#1)(1993-12#1)(1994-12#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
articulated##15##1##(1993-1#1)(2007-12#4)(2008-1#2)(2008-11#2)(2008-12#3)(2009-7#1)(2012-2#2)
articulates some of the##2##4##(2008-1#1)(2008-11#1)
articulates##6##1##(1994-1#1)(1996-2#1)(2008-1#1)(2008-11#2)(2011-2#1)
articulating the##3##2##(2008-1#2)(2013-8#1)
articulating##9##1##(2008-1#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
articulation of the##2##3##(2007-12#1)(2012-12#1)
articulation of##5##2##(2007-11#1)(2007-12#1)(2008-12#2)(2012-12#1)
articulation##17##1##(2007-11#1)(2007-12#3)(2008-12#3)(2008-9#2)(2009-11#1)(2012-12#1)(2013-1#4)(2013-8#2)
articulations##2##1##(2007-12#1)(2008-12#1)
articulatory##4##1##(2009-11#3)(2009-12#1)
artiellia isolates than##2##3##(2008-10#2)
artiellia##11##1##(2008-10#11)
artifact in##2##2##(1994-12#1)(2008-3#1)
artifact is##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
artifact reduction in##2##3##(2008-2#1)(2008-3#1)
artifact reduction##3##2##(2008-2#2)(2008-3#1)
artifact##29##1##(1990-5#2)(1994-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#9)(2008-7#2)(2008-8#3)(2009-7#2)(2009-8#2)
artifact?##2##1##(2008-11#1)(2010-6#1)
artifacts and##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
artifacts are##2##2##(2008-3#1)(2012-12#1)
artifacts caused by##2##3##(2007-12#1)(2012-1#1)
artifacts due to##2##3##(2010-5#1)(2011-1#1)
artifacts in optical coherence tomography##2##5##(2008-3#2)
artifacts in##12##2##(2007-12#1)(2008-3#6)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#2)
artifacts of##2##2##(2008-8#2)
artifacts that##4##2##(1990-3#1)(2008-2#1)(2008-3#1)(2008-4#1)
artifacts with##2##2##(1997-2#1)(2008-10#1)
artifacts##67##1##(1990-3#1)(1994-9#1)(1997-2#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#19)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-6#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#4)(2012-12#3)
artifactual##3##1##(1997-5#1)(2008-7#1)(2008-9#1)
artificial DNA##2##2##(2008-7#2)
artificial and natural##2##3##(2008-10#1)(2010-5#1)
artificial and##4##2##(2008-10#2)(2008-5#1)(2010-5#1)
artificial beta##2##2##(1990-7#1)(1992-3#1)
artificial cerebrospinal fluid##3##3##(1994-8#1)(1995-12#1)(2008-10#1)
artificial chromosome (YAC) clones##3##4##(1996-10#1)(1996-12#1)(1997-8#1)
artificial chromosome (YAC)##6##3##(1994-12#1)(1996-10#1)(1996-12#1)(1997-8#1)(2008-4#1)(2008-5#1)
artificial chromosome##22##2##(1991-9#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-8#5)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-10#1)(2010-10#1)(2011-2#1)
artificial chromosomes (BACs)##3##3##(2008-2#1)(2008-4#2)
artificial chromosomes spanning##2##3##(1995-6#1)(2008-10#1)
artificial chromosomes##9##2##(1991-9#1)(1995-6#1)(1996-10#2)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#2)
artificial diet##6##2##(2008-10#1)(2011-2#5)
artificial disc replacement (C-ADR)##5##4##(2012-12#5)
artificial disc replacement##12##3##(2012-12#12)
artificial electron acceptor##2##3##(1995-2#1)(2008-11#1)
artificial electron##3##2##(1995-2#1)(2008-11#2)
artificial enzymes##2##2##(2010-12#2)
artificial evolution##3##2##(2008-8#3)
artificial feeding##2##2##(1997-7#1)(2008-10#1)
artificial grammar learning##2##3##(2008-5#1)(2012-12#1)
artificial grammar##3##2##(2008-5#2)(2012-12#1)
artificial heart valves##2##3##(1991-3#1)(2008-8#1)
artificial heart##5##2##(1991-3#1)(2008-8#2)(2010-8#2)
artificial inoculation of##2##3##(2008-10#2)
artificial inoculation##11##2##(2008-10#10)(2008-8#1)
artificial inoculations##2##2##(2008-10#2)
artificial insemination##4##2##(2008-12#1)(2009-4#1)(2012-1#1)(2013-1#1)
artificial intelligence based##2##3##(2007-11#2)
artificial intelligence##8##2##(2007-11#3)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#2)
artificial intervention##2##2##(2008-10#2)
artificial lens##2##2##(2011-1#1)(2011-2#1)
artificial light##2##2##(2008-10#1)(2008-5#1)
artificial liver support##2##3##(2008-11#1)(2010-12#1)
artificial liver##7##2##(2008-11#5)(2010-12#2)
artificial medium##4##2##(1992-12#4)
artificial mouth system and##2##4##(2008-10#2)
artificial mouth system##3##3##(2008-10#3)
artificial mouth##6##2##(2008-10#6)
artificial nests##3##2##(2008-8#1)(2008-9#2)
artificial neural network (ANN) model##4##5##(2008-10#4)
artificial neural network (ANN)##15##4##(2008-10#13)(2010-8#1)(2013-1#1)
artificial neural network for the##2##5##(2008-10#1)(2008-11#1)
artificial neural network for##3##4##(2008-10#2)(2008-11#1)
artificial neural network is##3##4##(2008-10#1)(2010-8#2)
artificial neural network##42##3##(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#6)(2013-1#2)
artificial neural networks (ANN)##5##4##(2008-10#4)(2010-8#1)
artificial neural networks (ANNs)##6##4##(2008-10#6)
artificial neural networks and##3##4##(2008-10#3)
artificial neural networks for##2##4##(2008-10#2)
artificial neural networks in##2##4##(2008-10#2)
artificial neural networks to##2##4##(2008-10#1)(2008-4#1)
artificial neural networks##46##3##(1995-5#2)(1996-2#1)(2008-10#40)(2008-4#1)(2009-3#1)(2010-8#1)
artificial neural##89##2##(1995-5#2)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#69)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-8#7)(2013-1#2)
artificial nutrition and hydration##2##4##(1990-11#2)
artificial pancreas##3##2##(2009-11#3)
artificial photoperiods##2##2##(2008-7#2)
artificial regulatory circuit##2##3##(1997-4#2)
artificial retinas##3##2##(2008-3#3)
artificial saliva##2##2##(2008-10#1)(2008-11#1)
artificial salivas##2##2##(2008-10#2)
artificial samples##3##2##(2008-10#2)(2008-5#1)
artificial sea water and##2##4##(2008-10#2)
artificial seawater##5##2##(2008-10#5)
artificial selection on##3##3##(2008-8#1)(2008-9#2)
artificial selection##7##2##(2008-8#4)(2008-9#2)(2010-4#1)
artificial surface##2##2##(2012-1#2)
artificial surfaces##8##2##(1990-2#1)(2008-10#3)(2008-8#1)(2013-1#3)
artificial sweeteners##2##2##(2008-10#2)
artificial systems##2##2##(2007-12#1)(2009-5#1)
artificial tear##2##2##(2006-10#1)(2011-3#1)
artificial textures##2##2##(2008-5#2)
artificial turf##3##2##(2013-1#3)
artificial urinary sphincter##3##3##(2008-10#3)
artificial vascular grafts##2##3##(2010-8#2)
artificial water##2##2##(2008-10#1)(2012-7#1)
artificial##433##1##(1990-11#3)(1990-2#2)(1990-7#3)(1991-3#1)(1991-9#6)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#5)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#8)(2007-6#1)(2007-8#5)(2008-1#1)(2008-10#144)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#4)(2008-5#19)(2008-7#8)(2008-8#23)(2008-9#10)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#3)(2010-10#2)(2010-12#7)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#17)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#5)(2012-12#16)(2012-2#3)(2012-3#1)(2012-7#2)(2013-1#14)(2013-7#4)
artificially and naturally##2##3##(2008-10#1)(2011-1#1)
artificially coloured hair##2##3##(2008-5#2)
artificially increased##2##2##(2012-2#1)(2013-8#1)
artificially induced##2##2##(1993-12#1)(2008-11#1)
artificially infected##6##2##(2008-10#5)(2008-8#1)
artificially infested soil##3##3##(2008-10#3)
artificially infested with##2##3##(2008-10#2)
artificially infested##6##2##(2008-10#5)(2011-2#1)
artificially inoculated chickpea##2##3##(2008-10#2)
artificially inoculated with a##2##4##(2008-10#2)
artificially inoculated with##6##3##(2008-10#6)
artificially inoculated##16##2##(2008-10#15)(2010-4#1)
artificially introduced##2##2##(1992-8#2)
artificially ventilated##4##2##(1993-12#1)(1994-11#1)(1996-9#2)
artificially##73##1##(1990-9#1)(1991-9#1)(1992-8#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#33)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
artisanal fleet##2##2##(2013-7#2)
artisanal##7##1##(2008-5#1)(2011-2#2)(2013-7#4)
artist with##2##2##(1995-1#1)(2008-10#1)
artist##7##1##(1995-1#1)(2007-6#1)(2008-10#5)
artistic##4##1##(2008-10#1)(2008-12#1)(2008-3#2)
artochamins##2##1##(2009-5#2)
arts in##2##2##(2009-10#1)(2010-11#1)
arts##15##1##(1990-2#1)(1991-12#1)(1994-12#1)(1995-1#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-3#4)(2011-2#3)(2012-3#1)
artwork##6##1##(1992-1#2)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
artworks##2##1##(2008-10#2)
artérielle##2##1##(2011-2#2)
arundinis##2##1##(2008-10#2)
arvalis)##4##1##(1991-8#2)(2012-3#2)
arvense L##2##2##(2008-12#1)(2008-5#1)
arvense##7##1##(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)
arvensis##4##1##(2008-10#2)(2013-1#2)
arvicoline rodents##2##2##(2008-9#2)
aryl chloride##2##2##(2010-5#1)(2010-8#1)
aryl hydrocarbon (Ah) receptor##2##4##(1993-12#1)(1995-11#1)
aryl hydrocarbon receptor##7##3##(2008-10#4)(2008-7#2)(2013-1#1)
aryl hydrocarbon##10##2##(1993-12#1)(1995-11#1)(2008-10#4)(2008-7#2)(2013-1#2)
aryl substituents##3##2##(1995-5#1)(1996-5#1)(2009-9#1)
aryl sulfotransferase cDNAs##2##3##(1993-8#2)
aryl sulfotransferase##4##2##(1993-12#1)(1993-8#3)
aryl##41##1##(1990-11#3)(1992-6#2)(1993-12#3)(1993-8#3)(1995-11#1)(1995-5#1)(1996-5#2)(1997-4#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#2)(2009-9#1)(2010-5#1)(2010-8#3)(2012-2#1)(2013-1#2)(2013-8#1)
arylacetamide deacetylase##2##2##(1991-5#2)
arylalkylamine N-acetyltransferase##3##2##(1994-2#1)(1995-11#1)(2008-5#1)
arylamine##5##1##(1991-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)
arylamines##2##1##(2008-10#2)
arylating quinones##3##2##(2009-9#3)
arylating##4##1##(2009-9#4)
arylation##2##1##(1992-3#1)(2009-9#1)
arylhydrocarbon##5##1##(1990-7#1)(2008-10#1)(2008-11#3)
arylsulfatase A##4##2##(1991-12#2)(1997-3#2)
arylsulfatase##5##1##(1990-2#1)(1991-12#2)(1997-3#2)
arylsulphatase A activity in##2##4##(1991-3#1)(1994-3#1)
arylsulphatase A##4##2##(1991-3#1)(1994-3#3)
arylsulphatase##5##1##(1991-3#1)(1994-3#3)(2008-7#1)
as &gt##4##2##(1992-9#1)(1995-6#1)(2008-1#1)(2008-12#1)
as &quot##107##2##(1990-2#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-5#2)(1994-1#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-3#3)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#6)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
as 'active oxygen'##2##3##(2008-10#2)
as 'acute##2##2##(2008-11#1)(2011-2#1)
as (1)##2##2##(2008-11#1)(2012-2#1)
as (i)##2##2##(2008-10#1)(2010-5#1)
as +/- 1##2##3##(2008-10#2)
as +/-##3##2##(2008-10#3)
as 0##75##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-1#2)(1994-8#1)(1995-3#1)(2007-11#2)(2007-12#2)(2008-10#40)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)(2011-1#4)(2012-2#2)
as 1 m##2##3##(2008-10#1)(2008-3#1)
as 1 mM##2##3##(1990-7#1)(2008-10#1)
as 1##72##2##(1990-7#1)(1992-6#1)(1993-8#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-11#6)(2007-12#5)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-6#1)(2011-1#4)(2012-1#1)(2013-1#4)
as 1%##3##2##(2007-12#1)(2008-10#1)(2010-2#1)
as 10 nm##2##3##(2007-12#1)(2008-2#1)
as 10 years##2##3##(1994-8#1)(2008-1#1)
as 10##23##2##(1991-8#1)(1994-8#1)(1995-2#1)(1995-3#2)(1997-4#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-7#1)(2013-1#1)
as 10% of##3##3##(1995-2#1)(2007-12#1)(2010-11#1)
as 10%##5##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-11#1)
as 10(-4)##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
as 10(-5) M##3##3##(1991-9#1)(2008-10#2)
as 10(-5)##4##2##(1991-9#1)(2008-10#2)(2008-2#1)
as 100##14##2##(1996-12#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)(2010-7#1)(2013-1#1)(2013-8#1)
as 100%##2##2##(2008-10#1)(2008-12#1)
as 12##6##2##(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#3)
as 120##4##2##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)
as 13##3##2##(2007-11#1)(2007-12#1)(2010-8#1)
as 14##3##2##(1994-12#1)(2007-11#1)(2012-2#1)
as 140##2##2##(2007-11#1)(2007-12#1)
as 15 min##2##3##(1994-11#1)(2008-10#1)
as 15##8##2##(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)
as 150##4##2##(2007-11#1)(2007-12#2)(2009-12#1)
as 16##2##2##(2008-3#1)(2012-2#1)
as 17##2##2##(2007-12#1)(2011-2#1)
as 18##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
as 19##5##2##(1992-8#1)(1995-1#1)(2008-3#2)(2011-1#1)
as 1x10(-8)M##2##2##(2008-10#2)
as 2 and##2##3##(2008-10#1)(2013-1#1)
as 2##32##2##(1990-8#1)(1992-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-2#3)(2008-3#5)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
as 20 days after##2##4##(2008-10#1)(2012-3#1)
as 20##11##2##(1990-4#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
as 20% of##2##3##(2008-7#1)(2013-1#1)
as 20%##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
as 200##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2012-2#1)
as 21%##2##2##(1991-3#1)(2007-12#1)
as 24 hours##2##3##(2008-5#1)(2011-1#1)
as 24##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
as 25##7##2##(1991-9#1)(2008-10#4)(2008-3#2)
as 28##2##2##(2008-2#1)(2008-3#1)
as 3 times##2##3##(2008-10#1)(2008-3#1)
as 3##23##2##(1992-12#1)(1993-8#1)(1995-3#1)(1995-8#1)(2007-11#7)(2008-10#4)(2008-2#1)(2008-3#5)(2011-1#1)(2011-2#1)
as 30##12##2##(1992-3#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2012-3#1)
as 300##5##2##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
as 32##3##2##(1994-8#1)(2008-2#1)(2008-3#1)
as 350##2##2##(2007-11#1)(2008-3#1)
as 36##2##2##(2007-11#1)(2008-10#1)
as 38##2##2##(2008-6#1)(2011-1#1)
as 39##2##2##(2007-11#1)(2011-1#1)
as 4 h after##2##4##(2008-10#2)
as 4##13##2##(1992-12#1)(1993-9#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2009-5#1)(2013-1#1)
as 40##9##2##(1994-11#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
as 40% of##2##3##(2008-7#1)(2009-5#1)
as 40%##3##2##(1991-5#1)(2008-7#1)(2009-5#1)
as 400##3##2##(1997-6#1)(2007-12#1)(2008-10#1)
as 45##2##2##(1995-3#1)(2008-10#1)
as 5 mum##2##3##(2008-10#1)(2008-2#1)
as 5 x##2##3##(2008-10#2)
as 5##24##2##(1990-11#1)(1990-3#1)(1990-8#1)(1992-12#1)(1993-11#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#2)(2008-8#1)(2013-1#1)
as 5%##2##2##(1994-6#1)(2013-8#1)
as 5-Br-PADAP chelates##2##3##(2008-10#2)
as 50##15##2##(1994-2#1)(1994-6#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-7#1)(2009-11#1)
as 50%##5##2##(1992-5#1)(2008-10#2)(2008-3#1)(2012-1#1)
as 500##5##2##(2007-12#1)(2008-11#1)(2008-2#2)(2012-12#1)
as 6 x##2##3##(2008-3#2)
as 6##15##2##(1990-3#1)(1992-3#1)(1995-12#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2013-1#1)
as 60 degrees##2##3##(2008-2#1)(2008-3#1)
as 60##8##2##(1995-3#1)(1995-5#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
as 60% of##2##3##(2008-1#1)(2008-2#1)
as 60%##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
as 600##3##2##(1994-2#1)(2007-11#1)(2008-10#1)
as 61##2##2##(2007-11#1)(2008-10#1)
as 65##3##2##(1990-2#1)(2007-12#1)(2008-3#1)
as 7##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
as 70##2##2##(1994-9#1)(2008-8#1)
as 75##2##2##(2007-11#1)(2008-10#1)
as 76##2##2##(1993-8#1)(2009-11#1)
as 79%##2##2##(1996-9#1)(2008-10#1)
as 8##9##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2009-12#1)(2011-1#1)
as 80##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
as 80% of##2##3##(1990-11#1)(2012-12#1)
as 80%##6##2##(1990-11#1)(1991-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2012-12#1)
as 800##2##2##(2007-12#1)(2008-10#1)
as 9##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
as 90##6##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
as 90%##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
as 900##3##2##(2008-2#2)(2008-3#1)
as 93%##3##2##(1997-4#1)(2008-2#1)(2011-2#1)
as A##6##2##(1994-12#1)(2008-10#1)(2008-12#1)(2009-2#1)(2011-1#1)(2013-8#1)
as AAF##2##2##(1991-5#2)
as ATP##3##2##(1997-7#1)(2013-1#2)
as African American men##2##4##(2009-5#2)
as African##3##2##(2008-1#1)(2009-5#2)
as Ag##2##2##(1991-2#1)(2008-10#1)
as AgL and##2##3##(2008-10#2)
as Ancestry Informative##2##3##(2009-5#2)
as Aspergillus##2##2##(1997-3#1)(2011-2#1)
as B##4##2##(1994-12#1)(2007-12#1)(2011-2#1)(2013-7#1)
as BNP-45##2##2##(1991-5#2)
as BP##2##2##(1994-8#1)(2009-4#1)
as BSA##2##2##(2008-10#2)
as Bacillus anthracis##2##3##(2011-2#2)
as Bacillus##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
as Bloch##2##2##(2009-10#2)
as C##17##2##(2008-10#12)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#2)
as CD4##2##2##(1995-2#1)(2010-12#1)
as CHO##2##2##(1994-3#1)(2008-11#1)
as CL##2##2##(2008-10#2)
as CaF(2) and##2##3##(2007-12#1)(2008-10#1)
as Colletotrichum acutatum##2##3##(2008-10#2)
as Crohn's disease##3##3##(2007-12#1)(2008-11#1)(2009-8#1)
as Cryptococcus neoformans##2##3##(2008-5#1)(2009-2#1)
as Cu##2##2##(2008-10#1)(2013-1#1)
as DNA topoisomerase##2##3##(2008-9#1)(2009-8#1)
as DNA##18##2##(1992-3#1)(1992-9#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#2)(2010-8#1)
as E##4##2##(1990-12#1)(1990-5#1)(2008-10#2)
as Escherichia coli##6##3##(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
as European wheat mosaic virus##2##5##(2008-8#2)
as F##7##2##(2008-10#6)(2013-1#1)
as FK506##2##2##(1993-8#1)(2008-9#1)
as Fe##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
as Fourier##3##2##(2008-10#2)(2008-3#1)
as G##3##2##(2008-10#1)(2008-12#1)(2010-3#1)
as GC##2##2##(2008-10#1)(2011-1#1)
as Gaussian##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
as HIV-1##2##2##(1992-8#1)(2011-3#1)
as HPLC##3##2##(2008-10#3)
as I##3##2##(1993-8#2)(2008-8#1)
as JPEG##2##2##(2008-12#1)(2008-2#1)
as Japanese##2##2##(2012-12#1)(2013-1#1)
as L##2##2##(2008-10#2)
as LOP for##2##3##(2008-8#2)
as MMN and##2##3##(1995-5#1)(2008-7#1)
as MR##3##2##(2009-8#1)(2010-12#2)
as MX(3)##2##2##(2008-10#2)
as Markers of##2##3##(1994-12#1)(2012-3#1)
as Markers##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
as Medicare##2##2##(1992-12#1)(1994-12#1)
as Mg2+##3##2##(1995-2#1)(1995-6#1)(2008-6#1)
as Munchausen's syndrome##2##3##(2010-12#2)
as N##2##2##(2007-11#1)(2008-12#1)
as NA##2##2##(2008-10#2)
as Na(+) and##2##3##(2008-10#2)
as Na(+)##3##2##(2008-10#3)
as P##14##2##(2008-10#11)(2008-4#1)(2008-8#1)(2012-1#1)
as PDL increased##2##3##(2008-11#2)
as PKC delta##2##3##(1994-2#2)
as PKC##3##2##(1992-12#1)(1994-2#2)
as Phytophthora##2##2##(2008-10#1)(2010-3#1)
as Potential Inhibitors of HIV##2##5##(1996-5#2)
as Potential Inhibitors of##3##4##(1996-5#3)
as Potential##5##2##(1996-5#3)(2009-10#1)(2012-2#1)
as Predictors of##3##3##(2007-10#1)(2012-3#1)(2013-1#1)
as President##2##2##(1995-1#1)(1995-6#1)
as Pseudomonas spp##2##3##(2008-10#2)
as Pseudomonas syringae pv##2##4##(2008-10#2)
as Pseudomonas##7##2##(2007-7#1)(2008-10#4)(2010-4#1)(2012-2#1)
as R##10##2##(1995-12#1)(2008-10#7)(2010-8#1)(2012-2#1)
as RNA##5##2##(1990-7#1)(1995-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
as RSD##3##2##(2008-10#3)
as Revealed by##2##3##(2008-10#1)(2012-3#1)
as S##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
as SPE##2##2##(2008-10#2)
as Saccharomyces cerevisiae##2##3##(2008-10#1)(2008-7#1)
as Se##2##2##(2008-10#2)
as Serratia##2##2##(2008-10#2)
as Standard##2##2##(2008-2#1)(2012-3#1)
as Streptococcus pneumoniae##2##3##(1995-5#1)(2007-12#1)
as T##7##2##(1996-12#1)(2008-10#3)(2008-9#1)(2010-3#2)
as TNF##2##2##(1990-5#1)(1997-2#1)
as Th(PBI)(4)##2##2##(2008-10#2)
as Tools##2##2##(2008-10#2)
as Trolox##2##2##(2008-10#1)(2008-11#1)
as Type##3##2##(1994-2#1)(2008-10#1)(2010-5#1)
as UV##3##2##(2008-2#1)(2008-5#1)(2011-2#1)
as X##6##2##(2008-10#6)
as Xanthomonas##2##2##(2008-10#2)
as Y##2##2##(2008-10#1)(2008-3#1)
as [Formula##3##2##(2008-10#1)(2012-2#1)(2012-7#1)
as a &quot##18##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-12#1)(1994-2#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)
as a 'dual action'##2##4##(2012-2#2)
as a 0##2##3##(1996-6#1)(2011-2#1)
as a 1##2##3##(1993-2#1)(2008-10#1)
as a 20%##2##3##(1994-5#1)(2008-7#1)
as a 4##3##3##(1990-11#1)(2007-8#1)(2008-2#1)
as a DNA##4##3##(1990-5#1)(1991-5#1)(2011-2#1)(2013-7#1)
as a Function of##2##4##(2008-10#1)(2008-2#1)
as a Maisonneuve fracture##2##4##(2009-1#2)
as a Majocchi granuloma##2##4##(2012-3#2)
as a Tool for##2##4##(2010-6#1)(2011-1#1)
as a backbone for##2##4##(2008-10#1)(2008-8#1)
as a background##2##3##(2008-10#1)(2009-11#1)
as a bait##2##3##(2008-9#1)(2013-1#1)
as a band of##2##4##(1994-2#1)(2008-10#1)
as a barrier to##5##4##(2008-10#1)(2008-11#1)(2012-1#2)(2012-12#1)
as a barrier##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#2)(2012-12#1)
as a base catalyst in the##2##6##(1993-8#2)
as a base##5##3##(1990-6#1)(1993-8#2)(1996-2#1)(2008-5#1)
as a baseline##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
as a basic##4##3##(1992-1#1)(2008-2#1)(2008-3#1)(2010-12#1)
as a basis for a##2##5##(1991-6#1)(2009-6#1)
as a basis for the##5##5##(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
as a basis for##28##4##(1991-6#1)(1993-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#2)(2008-8#2)(2009-6#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
as a basis##32##3##(1991-6#1)(1993-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-8#4)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
as a better##5##3##(1994-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
as a binder##2##3##(2008-10#2)
as a binding##2##3##(1992-6#1)(2008-10#1)
as a biochemical##3##3##(1993-12#1)(2008-10#1)(2008-12#1)
as a biocontrol agent of##2##5##(2008-10#2)
as a biocontrol agent##3##4##(2008-10#2)(2008-12#1)
as a biological control agent##4##5##(2008-10#4)
as a biological##11##3##(1991-5#1)(1997-4#1)(2008-10#7)(2008-9#1)(2011-2#1)
as a biomarker for##3##4##(2008-10#1)(2010-5#1)(2013-8#1)
as a biomarker of##6##4##(1994-5#1)(2008-10#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-8#1)
as a biomarker##12##3##(1994-5#1)(2008-10#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-5#1)(2012-2#2)(2013-8#3)
as a biosensor##3##3##(2008-10#3)
as a blocking##2##3##(2008-10#1)(2008-8#1)
as a bridge between##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
as a bridge therapy##2##4##(2008-10#2)
as a bridge to surgery##2##5##(2011-2#2)
as a bridge to transplantation##2##5##(2011-2#2)
as a bridge to##7##4##(2008-11#1)(2011-2#5)(2013-1#1)
as a bridge##16##3##(2008-10#5)(2008-11#1)(2008-4#1)(2011-2#6)(2012-3#1)(2013-1#2)
as a brief##3##3##(1991-2#1)(1993-12#1)(2008-10#1)
as a broad##2##3##(1993-8#1)(2008-11#1)
as a broadband light source##2##5##(2007-11#1)(2007-12#1)
as a broadband##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
as a buffer##2##3##(1996-5#1)(2007-12#1)
as a building##2##3##(2008-3#2)
as a by-product of##3##4##(1994-3#2)(2008-9#1)
as a calibration##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
as a cancer treatment##2##4##(2007-10#1)(2011-2#1)
as a cancer##3##3##(2007-10#1)(2008-11#1)(2011-2#1)
as a candidate for a##2##5##(2008-11#1)(2008-12#1)
as a candidate gene for##2##5##(1993-11#1)(2010-2#1)
as a candidate gene##3##4##(1993-11#1)(2010-2#1)(2012-3#1)
as a candidate##14##3##(1992-12#1)(1993-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-1#1)(2010-2#1)(2012-2#1)(2012-3#2)
as a carbon source##8##4##(1994-3#1)(1997-2#2)(2008-10#1)(2008-6#2)(2008-7#1)(2011-1#1)
as a career##3##3##(1996-1#1)(2007-4#2)
as a carrier and##2##4##(2008-10#2)
as a carrier for##2##4##(1994-11#1)(1996-12#1)
as a carrier of##2##4##(2007-12#1)(2008-8#1)
as a carrier solution##2##4##(2008-10#2)
as a carrier##19##3##(1990-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#9)(2008-5#1)(2008-8#1)(2011-2#2)
as a case example##3##4##(1997-2#1)(2008-11#1)(2008-7#1)
as a case of##5##4##(1994-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
as a case study##8##4##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-7#1)
as a case##17##3##(1993-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
as a catalyst for the##2##5##(2008-10#2)
as a catalyst to##2##4##(1996-5#1)(2008-10#1)
as a catalyst##12##3##(1996-5#1)(2008-10#9)(2008-7#1)(2012-3#1)
as a causative##2##3##(2008-8#1)(2013-1#1)
as a cause for##2##4##(1997-6#1)(2008-7#1)
as a cause of the##3##5##(1992-8#1)(2008-1#1)(2012-2#1)
as a cause of##29##4##(1991-12#1)(1992-12#2)(1992-8#1)(1994-2#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
as a cause##32##3##(1991-12#1)(1992-12#2)(1992-8#1)(1994-2#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#3)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
as a cell##5##3##(1993-12#1)(1994-2#1)(2008-10#1)(2008-5#1)(2009-2#1)
as a cellular##4##3##(1995-2#1)(2008-1#1)(2008-11#1)(2012-12#1)
as a central##8##3##(1996-12#1)(2008-10#2)(2008-11#2)(2009-7#1)(2012-1#1)(2013-1#1)
as a challenge to##2##4##(1993-6#1)(2012-2#1)
as a characteristic of##2##4##(1990-11#1)(2008-12#1)
as a charge##2##3##(2008-10#1)(2008-7#1)
as a cheap##2##3##(2008-10#1)(2008-11#1)
as a chelating agent##4##4##(2008-10#4)
as a chelating##8##3##(1996-2#1)(2008-10#7)
as a chemical modifier##4##4##(2008-10#4)
as a chemical##8##3##(2008-10#6)(2008-11#1)(2009-12#1)
as a chiral mobile phase additive##2##6##(2008-10#1)(2010-4#1)
as a chiral selector##3##4##(2008-10#3)
as a chiral##10##3##(2008-10#8)(2008-7#1)(2010-4#1)
as a chromogenic reagent for the##2##6##(2008-10#2)
as a chromogenic reagent for##3##5##(2008-10#3)
as a chromogenic reagent##4##4##(2008-10#4)
as a chronic##3##3##(1991-4#1)(2008-2#1)(2013-1#1)
as a classification##2##3##(2008-10#1)(2013-8#1)
as a clean-up##2##3##(2008-10#2)
as a clinical entity##3##4##(1996-11#1)(2008-12#1)(2013-1#1)
as a clinical tool in##2##5##(2008-5#1)(2012-3#1)
as a clinical tool##4##4##(1995-2#1)(1995-3#1)(2008-5#1)(2012-3#1)
as a clinical##13##3##(1991-4#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2009-9#1)(2012-3#1)(2013-1#1)
as a clinically##2##3##(1990-9#1)(2013-1#1)
as a coating##2##3##(2008-10#1)(2008-5#1)
as a cofactor in##3##4##(1993-8#1)(2008-10#1)(2012-2#1)
as a collection of##2##4##(1996-12#1)(2008-10#1)
as a color##3##3##(2008-10#3)
as a colored reagent##2##4##(2008-10#2)
as a combination of##4##4##(2008-3#3)(2009-10#1)
as a combination##5##3##(1990-8#1)(2008-3#3)(2009-10#1)
as a common##12##3##(1992-6#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
as a commonly##2##3##(2012-3#1)(2013-1#1)
as a communication##2##3##(1990-12#1)(2008-11#1)
as a community##2##3##(2010-9#1)(2012-2#1)
as a comparative##2##3##(2008-10#1)(2012-2#1)
as a comparison with##2##4##(1997-6#1)(2008-10#1)
as a comparison##7##3##(1995-2#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-2#1)
as a competitive##4##3##(1990-8#1)(1991-12#1)(1993-8#1)(1995-12#1)
as a competitor of##2##4##(1995-2#1)(2008-10#1)
as a competitor##3##3##(1995-2#1)(2008-10#2)
as a complement to##4##4##(1996-3#1)(1996-5#1)(2007-12#1)(2011-2#1)
as a complementary treatment for##2##5##(2008-10#1)(2012-12#1)
as a complementary##7##3##(1990-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2012-12#1)
as a complete##2##3##(1992-2#1)(1995-8#1)
as a complex with##2##4##(1997-6#1)(2012-2#1)
as a complex##8##3##(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
as a complexing agent##2##4##(2008-10#2)
as a complexing##4##3##(2008-10#4)
as a complication of##13##4##(1990-6#1)(1993-5#1)(1995-11#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
as a complication##14##3##(1990-6#1)(1993-5#1)(1995-11#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
as a component in the##2##5##(1990-12#1)(2011-1#1)
as a component of a##2##5##(1990-8#1)(2013-8#1)
as a component of photopolymer and flexographic printing##2##8##(2008-9#2)
as a component of the##5##5##(1991-9#1)(1994-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
as a component of##17##4##(1990-8#1)(1991-9#1)(1992-11#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
as a component##19##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-11#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
as a composite graft##2##4##(2007-8#1)(2008-12#1)
as a composite##5##3##(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)
as a compromise between##2##4##(2008-10#2)
as a computer-generated hologram##2##4##(2008-3#2)
as a computer-generated##3##3##(2007-11#1)(2008-3#2)
as a condition##2##3##(1994-12#1)(1995-12#1)
as a conducting##2##3##(2008-5#1)(2013-1#1)
as a conduit##3##3##(1992-8#1)(2007-8#1)(2011-2#1)
as a confirmatory##2##3##(2008-10#2)
as a congenital##2##3##(1996-11#1)(2010-5#1)
as a consequence of a##6##5##(1995-12#1)(2006-10#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
as a consequence of the##13##5##(1990-2#1)(1992-6#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
as a consequence of##46##4##(1990-2#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(2006-10#2)(2007-11#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#5)
as a consequence##60##3##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(2006-10#2)(2007-11#3)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#6)
as a constant ionic medium##2##5##(2008-10#2)
as a constant##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
as a constrained optimization problem for the field of integer##2##10##(2008-2#2)
as a constraint##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
as a content##2##3##(2008-11#1)(2008-12#1)
as a continuation of##2##4##(2008-3#1)(2012-2#1)
as a continuous##3##3##(1992-8#1)(1994-11#1)(2010-11#1)
as a contraindication##2##3##(1990-8#1)(2011-2#1)
as a contrast##2##3##(1993-3#1)(2008-5#1)
as a contributing##3##3##(1994-5#1)(1995-3#1)(2011-2#1)
as a control group##7##4##(1990-8#1)(1993-12#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-10#1)(2009-5#1)
as a control##33##3##(1990-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#4)(2008-6#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-7#1)
as a convolution between the##2##5##(2008-2#1)(2008-3#1)
as a core##3##3##(1993-12#1)(1995-2#1)(2009-3#1)
as a cost##2##3##(1996-12#1)(2008-10#1)
as a counter##2##3##(2008-10#1)(2008-5#1)
as a covariate##3##3##(2009-12#1)(2012-1#1)(2013-8#1)
as a criterion for##3##4##(1991-9#1)(2008-3#1)(2013-7#1)
as a criterion##5##3##(1991-9#1)(2008-3#2)(2008-7#1)(2013-7#1)
as a critical##8##3##(1994-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
as a cross-linking agent##2##4##(2008-10#2)
as a crucial##4##3##(1994-11#1)(2008-11#1)(2008-7#1)(2013-7#1)
as a cue for##3##4##(1995-5#2)(2009-9#1)
as a culture substratum##2##4##(2008-11#2)
as a cure for##2##4##(2007-7#1)(2008-10#1)
as a cutaneous##3##3##(2010-6#1)(2013-8#2)
as a cylindrical##2##3##(2008-2#1)(2008-7#1)
as a cyst##2##3##(2012-12#1)(2013-1#1)
as a cytoplasmic##2##3##(1994-11#1)(2012-12#1)
as a danger##2##3##(1990-11#1)(2008-10#1)
as a decision support##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
as a defense##2##3##(2008-10#1)(2008-8#1)
as a definitive##3##3##(1996-3#1)(2013-1#2)
as a delay CS##2##4##(2008-5#2)
as a delayed##3##3##(2008-8#2)(2009-11#1)
as a demonstration##2##3##(2008-3#1)(2008-7#1)
as a design##4##3##(2008-2#1)(2008-3#3)
as a detection##2##3##(2008-10#1)(2008-3#1)
as a detector for##4##4##(2008-10#4)
as a detector##11##3##(2007-12#1)(2008-10#10)
as a determinant of##2##4##(2008-6#1)(2012-12#1)
as a developmental##2##3##(1993-12#1)(1997-9#1)
as a device##2##3##(2008-3#1)(2008-4#1)
as a diagnostic test for##3##5##(1995-3#1)(1997-3#1)(2008-4#1)
as a diagnostic tool for##2##5##(2008-7#1)(2013-8#1)
as a diagnostic tool in##4##5##(1991-12#1)(2007-7#1)(2008-8#1)(2008-9#1)
as a diagnostic tool##11##4##(1991-12#1)(1997-4#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2012-3#1)(2013-8#1)
as a diagnostic##21##3##(1991-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-8#1)(2012-3#2)(2013-8#3)
as a dietary supplement##2##4##(1992-9#1)(2008-10#1)
as a dietary##4##3##(1992-9#1)(2008-10#1)(2008-6#1)(2009-4#1)
as a diffusive##2##3##(2008-10#2)
as a dimer##4##3##(1992-3#1)(1994-8#1)(1997-7#1)(2013-1#1)
as a direct##13##3##(1990-5#1)(1991-9#1)(1992-12#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)
as a disease##5##3##(2007-5#1)(2008-10#3)(2011-1#1)
as a dispersive##2##3##(2007-12#1)(2008-10#1)
as a distinct species##2##4##(2008-10#1)(2008-5#1)
as a distinct##9##3##(1991-1#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
as a dominant##5##3##(1997-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
as a donor##2##3##(1994-3#1)(1995-11#1)
as a downstream effector of##2##5##(1997-2#1)(2008-11#1)
as a downstream target for##2##5##(1992-12#1)(1995-2#1)
as a downstream target##3##4##(1992-12#1)(1995-2#1)(2011-2#1)
as a downstream##6##3##(1992-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
as a drug##5##3##(1990-2#1)(1994-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
as a dual##2##3##(2008-10#1)(2010-11#1)
as a dynamic##3##3##(2008-8#1)(2009-7#1)(2010-10#1)
as a facilitator##3##3##(1991-2#1)(1996-12#1)(2008-7#1)
as a factor in##2##4##(2007-8#1)(2008-7#1)
as a factor of##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
as a factor##11##3##(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-8#1)
as a family##2##3##(1992-3#1)(2008-9#1)
as a fast##6##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2011-2#1)
as a feature##3##3##(2008-2#1)(2012-3#1)(2013-7#1)
as a few##7##3##(1990-5#1)(1991-2#1)(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
as a field##4##3##(2008-10#2)(2009-7#1)(2010-5#1)
as a filter##3##3##(2008-2#1)(2008-3#2)
as a final diagnosis##2##4##(2010-12#2)
as a fingerprint##2##3##(1993-8#1)(2008-10#1)
as a firm##2##3##(1995-3#1)(2012-3#1)
as a first choice##2##4##(1996-3#1)(2008-4#1)
as a first step in##2##5##(1993-11#1)(2012-2#1)
as a first step toward##2##5##(2007-5#1)(2012-12#1)
as a first step##8##4##(1991-2#1)(1993-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
as a first##18##3##(1991-2#1)(1993-11#1)(1994-1#1)(1996-3#2)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
as a first-line treatment in##2##5##(2011-2#2)
as a first-line treatment##3##4##(2008-10#1)(2011-2#2)
as a first-line##8##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#2)(2013-1#1)
as a flexible##3##3##(2007-11#1)(2009-11#1)(2012-2#1)
as a fluorescence probe for##2##5##(1994-8#1)(2008-10#1)
as a fluorescence probe##3##4##(1994-8#1)(2008-10#2)
as a fluorescence##4##3##(1994-8#1)(2008-10#2)(2008-2#1)
as a fluorescent probe##2##4##(1991-5#2)
as a fluorescent##8##3##(1990-2#1)(1991-5#2)(2008-1#1)(2008-10#3)(2008-11#1)
as a fluorimetric##2##3##(2008-10#2)
as a focus##2##3##(2008-12#1)(2008-2#1)
as a foliar spray##2##4##(2008-10#1)(2011-2#1)
as a foliar##3##3##(2008-10#2)(2011-2#1)
as a follow-up##2##3##(1995-2#1)(2011-2#1)
as a food additive##2##4##(1993-11#1)(2008-6#1)
as a food##4##3##(1993-11#1)(2008-11#1)(2008-6#1)(2012-2#1)
as a form of##5##4##(2007-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
as a form##6##3##(2006-10#1)(2007-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
as a forum for##2##4##(2007-5#1)(2008-4#1)
as a forum##3##3##(2007-5#1)(2008-4#1)(2013-1#1)
as a foundation for##7##4##(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-1#1)
as a fraction of the##2##5##(2008-5#1)(2008-9#1)
as a fraction of##4##4##(1991-9#1)(2008-3#1)(2008-5#1)(2008-9#1)
as a framework for##9##4##(1991-1#1)(1992-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)
as a framework##11##3##(1991-1#1)(1992-2#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)
as a full agonist##2##4##(1995-11#1)(2009-8#1)
as a full##3##3##(1995-11#1)(2008-10#1)(2009-8#1)
as a function of a##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
as a function of age##4##5##(1990-3#1)(1995-8#2)(2007-8#1)
as a function of both temperature and##2##7##(1994-5#1)(2008-10#1)
as a function of both the##3##6##(2008-10#1)(2008-3#1)(2008-7#1)
as a function of both##9##5##(1994-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
as a function of concentration##4##5##(1992-8#1)(2008-10#3)
as a function of depth##3##5##(2007-12#2)(2008-3#1)
as a function of different##2##5##(2008-3#1)(2013-1#1)
as a function of exposure##3##5##(2007-12#2)(2008-3#1)
as a function of gas pressure##2##6##(2008-2#2)
as a function of incidence##2##5##(2008-10#1)(2008-2#1)
as a function of inhalation flow rate##2##7##(1994-2#1)(1997-2#1)
as a function of its##2##5##(1994-5#1)(2008-3#1)
as a function of laser fluence##2##6##(2008-2#1)(2008-3#1)
as a function of laser##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
as a function of ligand##2##5##(1993-11#1)(2008-10#1)
as a function of pH and ionic strength##2##8##(1993-11#1)(2013-1#1)
as a function of pH and##6##6##(1993-11#1)(1996-12#1)(2008-10#3)(2013-1#1)
as a function of pH have been##3##7##(2008-10#3)
as a function of pH in##2##6##(2008-10#2)
as a function of pH##18##5##(1990-5#1)(1990-8#1)(1993-11#1)(1995-5#1)(1996-12#1)(2008-10#12)(2013-1#1)
as a function of parameters##2##5##(2008-3#1)(2009-8#1)
as a function of particle size##4##6##(2008-10#3)(2008-3#1)
as a function of pump##2##5##(2008-3#2)
as a function of resonator##2##5##(2008-3#2)
as a function of scattering##2##5##(2008-3#2)
as a function of temperature and##2##6##(2008-10#2)
as a function of temperature for##2##6##(1997-7#1)(2012-2#1)
as a function of temperature##19##5##(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
as a function of the angle of incidence##2##8##(2008-2#1)(2008-3#1)
as a function of the concentration of##2##7##(1996-5#1)(2008-10#1)
as a function of the cylinder rotation angle##2##8##(2008-3#2)
as a function of the degree of##3##7##(2007-12#2)(2008-3#1)
as a function of the distance between the##2##8##(2007-11#1)(2008-2#1)
as a function of the incident##2##6##(2007-12#1)(2008-3#1)
as a function of the intracavity##2##6##(2007-11#1)(2008-3#1)
as a function of the laser##2##6##(2008-3#2)
as a function of the length##2##6##(1992-8#1)(2007-12#1)
as a function of the location of##2##7##(2008-3#1)(2009-8#1)
as a function of the number of extinction trials##2##9##(2008-5#2)
as a function of the number of##6##7##(2008-2#2)(2008-3#1)(2008-5#3)
as a function of the optical##3##6##(2008-3#3)
as a function of the particle##2##6##(2008-10#1)(2008-2#1)
as a function of the polarization##2##6##(2008-3#2)
as a function of the scattering angle##2##7##(2008-3#2)
as a function of the time##2##6##(2008-10#2)
as a function of the##113##5##(1990-12#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-7#2)(2007-11#4)(2007-12#8)(2008-10#14)(2008-2#17)(2008-3#35)(2008-5#6)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
as a function of their##4##5##(2008-10#2)(2008-3#1)(2012-12#1)
as a function of this##2##5##(2007-11#1)(2008-10#1)
as a function of time##21##5##(1990-8#1)(1991-5#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2010-4#1)(2010-7#1)
as a function of tissue##2##5##(2008-3#1)(2009-12#1)
as a function of wavelength##9##5##(2007-11#2)(2008-3#7)
as a function of##396##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-4#1)(1997-7#5)(1997-8#1)(2007-11#16)(2007-12#17)(2007-8#1)(2008-1#2)(2008-10#86)(2008-11#8)(2008-12#1)(2008-2#37)(2008-3#83)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#7)(2012-4#1)(2013-1#5)(2013-8#2)
as a function##399##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-4#1)(1997-7#5)(1997-8#1)(2007-11#16)(2007-12#17)(2007-8#1)(2008-1#2)(2008-10#88)(2008-11#9)(2008-12#1)(2008-2#37)(2008-3#83)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#7)(2012-4#1)(2013-1#5)(2013-8#2)
as a functional##14##3##(1991-11#1)(1992-9#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-7#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2013-1#1)
as a fundamental##5##3##(2008-11#1)(2008-3#1)(2009-9#1)(2010-4#1)(2012-12#1)
as a fungal##2##3##(2008-10#2)
as a further step##2##4##(1995-2#1)(2008-10#1)
as a further##5##3##(1995-2#1)(2007-2#1)(2008-10#1)(2009-12#1)(2011-1#1)
as a fusion protein##2##4##(1990-11#1)(2009-9#1)
as a fusion##5##3##(1990-11#1)(1994-8#1)(2008-2#2)(2009-9#1)
as a gas##2##3##(2008-3#1)(2010-12#1)
as a gauge##2##3##(2008-5#1)(2012-3#1)
as a gene carrier##2##4##(2008-10#2)
as a gene transfer vector##2##5##(1997-3#2)
as a gene##7##3##(1997-3#2)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
as a general guide for the##2##6##(2008-3#1)(2008-9#1)
as a general prophylactic##2##4##(2008-10#2)
as a general##17##3##(1993-2#1)(1994-5#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
as a genetic marker##2##4##(1993-8#1)(2008-12#1)
as a genetic##3##3##(1993-8#1)(2008-12#1)(2009-5#1)
as a global##2##3##(2008-10#1)(2010-5#1)
as a good candidate##2##4##(1992-3#1)(2008-11#1)
as a good##7##3##(1992-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
as a green##2##3##(2008-5#1)(2012-2#1)
as a group have##2##4##(1991-12#1)(1995-12#1)
as a group##6##3##(1991-12#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)
as a growth factor##3##4##(1990-11#1)(1994-11#1)(2008-4#1)
as a growth##5##3##(1990-11#1)(1991-12#1)(1994-11#1)(2008-4#1)(2010-8#1)
as a guide for##6##4##(1991-12#1)(1996-2#1)(2007-2#1)(2008-4#1)(2010-8#1)(2012-2#1)
as a guide in##3##4##(1990-9#1)(1992-11#1)(2011-1#1)
as a guide of##2##4##(1996-3#1)(2008-10#1)
as a guide to##4##4##(1990-8#1)(2009-10#1)(2010-5#1)(2011-2#1)
as a guide##18##3##(1990-8#1)(1990-9#1)(1991-12#1)(1992-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
as a hapten##2##3##(2008-10#2)
as a health care##2##4##(1994-1#1)(2008-3#1)
as a health##11##3##(1994-1#1)(2008-3#1)(2013-8#9)
as a heterogeneous##5##3##(2008-10#3)(2012-2#1)(2012-3#1)
as a high throughput##2##4##(2008-10#1)(2008-7#1)
as a high##10##3##(1991-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-8#1)
as a highly efficient##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
as a highly selective and sensitive fluorescence probe for##2##9##(2008-12#2)
as a highly selective##3##4##(2008-12#2)(2012-3#1)
as a highly##14##3##(1993-11#1)(1995-8#1)(1997-2#1)(1997-4#2)(2007-12#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-2#1)(2012-3#1)
as a homodimer##2##3##(1994-8#1)(1995-6#1)
as a homogeneous##3##3##(1990-9#1)(1993-11#1)(2008-10#1)
as a host##8##3##(1991-9#1)(1997-2#1)(2008-11#2)(2008-3#2)(2008-8#1)(2011-2#1)
as a human pathogen##2##4##(1990-11#1)(2007-12#1)
as a human##3##3##(1990-11#1)(2007-12#1)(2010-10#1)
as a hybridization probe##4##4##(1991-9#1)(1992-10#1)(1997-4#1)(2008-5#1)
as a hybridization##5##3##(1991-9#1)(1992-10#1)(1997-4#1)(2008-10#1)(2008-5#1)
as a hydrophilic-interaction chromatographic##2##4##(2008-10#2)
as a just##2##3##(1993-11#1)(1994-12#1)
as a key component##2##4##(2008-11#1)(2010-3#1)
as a key factor in##2##5##(2008-5#1)(2008-8#1)
as a key##23##3##(1992-12#1)(1993-2#1)(1994-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-11#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
as a kind of##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
as a labor admission test##2##5##(1994-3#2)
as a laboratory##2##3##(2009-11#1)(2013-8#1)
as a large##8##3##(1997-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
as a late complication of Kirschner wire##2##7##(2007-8#2)
as a late complication of##5##5##(2007-8#3)(2012-2#1)(2013-7#1)
as a laxative##2##3##(1991-6#1)(2011-2#1)
as a leading cause of##2##5##(2010-3#1)(2012-3#1)
as a leading##3##3##(2007-11#1)(2010-3#1)(2012-3#1)
as a learning strategy##2##4##(2008-11#1)(2008-12#1)
as a learning##8##3##(1997-6#1)(2008-11#6)(2008-12#1)
as a legitimate##2##3##(1994-2#1)(2008-6#1)
as a lesion##3##3##(1990-5#1)(1996-3#1)(2012-12#1)
as a less##5##3##(1992-6#1)(2008-10#1)(2011-2#1)(2013-8#2)
as a ligand##8##3##(1991-6#1)(1993-12#1)(1995-2#1)(2008-10#4)(2008-11#1)
as a light detector##2##4##(2008-10#2)
as a light source##7##4##(2007-12#1)(2008-10#2)(2008-2#3)(2012-3#1)
as a light##11##3##(2007-12#2)(2008-10#4)(2008-2#4)(2012-3#1)
as a likely##2##3##(1993-3#1)(2008-3#1)
as a limited##2##3##(2008-10#1)(2009-9#1)
as a linear combination of##2##5##(2008-2#1)(2008-3#1)
as a linear function of##2##5##(2008-3#1)(2013-8#1)
as a linear##10##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2013-1#1)(2013-8#1)
as a linker##2##3##(1997-4#1)(2011-2#1)
as a liquid##2##3##(1996-1#1)(2008-2#1)
as a local mediator in##2##5##(1991-2#1)(1994-9#1)
as a local probe##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
as a local regulator##2##4##(1993-11#1)(1994-2#1)
as a local##12##3##(1991-2#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)
as a long##3##3##(1992-3#1)(2008-1#1)(2008-9#1)
as a long-term##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
as a loss##2##3##(2007-12#1)(2013-1#1)
as a low##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
as a lung##2##3##(1992-3#1)(2012-1#1)
as a main##6##3##(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)
as a major cause of##4##5##(1990-8#1)(1991-6#1)(1997-1#1)(2007-12#1)
as a major factor##2##4##(1993-9#1)(2008-10#1)
as a major health##2##4##(2012-2#1)(2013-8#1)
as a major risk##2##4##(1997-8#1)(2008-12#1)
as a major source of##2##5##(2008-3#1)(2013-8#1)
as a major##39##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-7#1)(1997-1#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
as a management tool##2##4##(1994-3#1)(2008-10#1)
as a management##3##3##(1992-12#1)(1994-3#1)(2008-10#1)
as a manifestation of##2##4##(2013-1#1)(2013-8#1)
as a marker for##11##4##(1994-2#1)(1995-1#1)(1996-6#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-2#1)(2011-2#1)
as a marker of RA##2##5##(2012-2#2)
as a marker of the##4##5##(1992-6#1)(1996-7#1)(2007-10#1)(2009-12#1)
as a marker of##30##4##(1990-11#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-10#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-12#1)(2010-5#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#2)
as a marker##44##3##(1990-11#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-2#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-7#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#3)(2009-10#1)(2009-12#1)(2009-2#1)(2010-5#1)(2011-2#4)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#2)
as a mask##2##3##(2008-3#1)(2008-7#1)
as a masking agent for the determination of##2##8##(2008-10#2)
as a masking agent for##3##5##(2008-10#3)
as a masking agent##6##4##(2008-10#6)
as a mass##2##3##(2008-10#1)(2010-11#1)
as a master regulator of##2##5##(2010-11#1)(2013-1#1)
as a matrix for the##2##5##(2008-10#1)(2008-11#1)
as a matrix modifier##2##4##(2008-10#2)
as a matrix##6##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
as a matter of##4##4##(1997-5#1)(2008-1#1)(2008-7#2)
as a mean##2##3##(1990-11#1)(2008-3#1)
as a means for##2##4##(2008-7#1)(2012-2#1)
as a means of assessing##2##5##(2008-1#1)(2008-11#1)
as a means of capturing and summarizing current evidence on a topic or##2##13##(2007-5#2)
as a means of detecting##2##5##(2008-2#1)(2011-1#1)
as a means of image##2##5##(2011-1#2)
as a means of improving the##2##6##(2008-11#1)(2008-7#1)
as a means of improving##4##5##(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
as a means of investigating##3##5##(1994-8#1)(1997-4#1)(2008-2#1)
as a means of understanding##2##5##(1993-11#1)(2008-11#1)
as a means of##50##4##(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)
as a means to improve##2##5##(2007-8#1)(2008-10#1)
as a means to increase##3##5##(2008-3#1)(2008-5#1)(2010-11#1)
as a means to##25##4##(1994-3#1)(1995-1#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
as a means##77##3##(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#3)(2013-1#2)
as a measure for##2##4##(1992-10#1)(2007-7#1)
as a measure of N nutrition##2##6##(2012-8#1)(2012-9#1)
as a measure of cellular cytotoxicity##2##6##(1991-4#2)
as a measure of disease##2##5##(2008-10#1)(2008-9#1)
as a measure of distress tolerance##2##6##(2013-8#2)
as a measure of health##2##5##(1995-12#1)(1996-1#1)
as a measure of the##12##5##(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)
as a measure of treatment##2##5##(1997-3#1)(2008-9#1)
as a measure of##45##4##(1990-2#1)(1990-9#1)(1991-3#2)(1991-4#2)(1994-11#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-6#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-8#1)(2012-9#1)(2013-8#2)
as a measure to##2##4##(2008-10#1)(2008-6#1)
as a measure##50##3##(1990-2#1)(1990-9#1)(1991-3#2)(1991-4#2)(1992-10#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-6#1)(2007-7#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#2)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-8#1)(2012-9#1)(2013-8#2)
as a measurement##2##3##(2008-10#1)(2008-11#1)
as a measuring device##2##4##(2008-10#1)(2008-3#1)
as a mechanism for##2##4##(1996-3#1)(2008-11#1)
as a mechanism of##5##4##(2006-10#1)(2008-10#1)(2008-8#1)(2010-5#1)(2013-8#1)
as a mechanism##9##3##(1996-12#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-5#1)(2013-8#1)
as a mediating##3##3##(1992-3#1)(1994-2#1)(2008-10#1)
as a mediator between##2##4##(2008-9#1)(2009-10#1)
as a mediator for the##2##5##(2008-10#2)
as a mediator for##3##4##(2008-10#3)
as a mediator of the##2##5##(1994-2#1)(2010-1#1)
as a mediator of##8##4##(1991-9#1)(1992-9#1)(1994-2#1)(1995-2#1)(2008-11#1)(2010-1#1)(2010-8#1)(2012-2#1)
as a mediator##18##3##(1991-9#1)(1992-9#1)(1994-2#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)
as a medical specialty##2##4##(1994-3#1)(2010-10#1)
as a medical##4##3##(1994-3#2)(2009-10#1)(2010-10#1)
as a medium for the##2##5##(2008-10#1)(2008-5#1)
as a medium for##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
as a medium##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
as a member of a##3##5##(1993-3#1)(1994-2#1)(2008-12#1)
as a member of the##5##5##(1992-8#1)(1994-12#1)(1995-2#1)(1997-2#1)(2008-5#1)
as a member of##9##4##(1992-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2011-1#1)
as a membrane##4##3##(1990-5#1)(2008-10#2)(2013-1#1)
as a metal##2##3##(2007-11#1)(2008-10#1)
as a method for the##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
as a method for##13##4##(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-3#1)(2012-3#1)
as a method of assessing##2##5##(1997-3#1)(2008-11#1)
as a method of##19##4##(1994-2#1)(1997-3#1)(2007-11#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)
as a method to##10##4##(1993-11#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-3#1)(2013-8#1)
as a method##46##3##(1993-11#1)(1994-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-11#6)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
as a metric##2##3##(2008-3#1)(2009-10#1)
as a microtubule protein##2##4##(1993-6#2)
as a middle##2##3##(1995-2#1)(2011-2#1)
as a miniaturized##2##3##(2008-3#1)(2009-11#1)
as a minimally invasive##2##4##(2012-12#1)(2013-1#1)
as a minor##4##3##(2008-10#3)(2012-1#1)
as a mirror of##3##4##(2012-3#1)(2013-8#2)
as a mirror##4##3##(2008-2#1)(2012-3#1)(2013-8#2)
as a mixture of##4##4##(2008-10#3)(2012-12#1)
as a mixture##5##3##(1992-6#1)(2008-10#3)(2012-12#1)
as a mobile phase##8##4##(2008-10#7)(2008-11#1)
as a mobile##10##3##(1993-11#1)(2008-10#8)(2008-11#1)
as a mode of##3##4##(2008-1#1)(2008-4#1)(2013-1#1)
as a mode##4##3##(2008-1#1)(2008-4#1)(2013-1#2)
as a model analyte##2##4##(2008-10#2)
as a model compound##4##4##(1993-8#1)(1994-9#1)(1995-12#1)(2008-6#1)
as a model for the##3##5##(1990-7#1)(2007-10#1)(2008-11#1)
as a model for##28##4##(1990-2#1)(1990-7#1)(1991-9#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
as a model of##9##4##(1991-5#1)(1994-5#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2013-1#1)
as a model organism to understand the##2##7##(2008-8#1)(2009-9#1)
as a model organism to##3##5##(2008-8#1)(2009-9#1)(2011-2#1)
as a model sample##2##4##(2008-10#2)
as a model system for##7##5##(1994-9#1)(2008-10#2)(2008-7#1)(2009-11#1)(2011-1#1)(2012-1#1)
as a model system to##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
as a model system##21##4##(1994-9#1)(2008-10#6)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
as a model to study the##2##6##(1993-9#1)(1994-5#1)
as a model to study##4##5##(1993-9#1)(1994-5#1)(2008-10#1)(2012-2#1)
as a model to##7##4##(1990-7#1)(1993-12#1)(1993-9#1)(1994-5#1)(2008-10#2)(2012-2#1)
as a model##106##3##(1990-2#1)(1990-7#2)(1991-5#2)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-5#2)(1994-9#3)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#21)(2008-11#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
as a moderator##5##3##(2007-12#1)(2009-11#1)(2009-7#1)(2010-1#2)
as a modified##2##3##(2008-3#1)(2008-9#1)
as a modifier for##2##4##(2008-10#1)(2008-9#1)
as a modifier##6##3##(2008-10#5)(2008-9#1)
as a modulator of##2##4##(1990-12#1)(2008-7#1)
as a molecular marker of##2##5##(2013-1#1)(2013-8#1)
as a molecular marker##5##4##(2007-10#1)(2008-10#2)(2013-1#1)(2013-8#1)
as a molecular##9##3##(2007-10#1)(2008-10#3)(2008-11#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-8#1)
as a monitor of##2##4##(2008-3#1)(2010-8#1)
as a monitor##3##3##(2008-3#1)(2008-7#1)(2010-8#1)
as a monolayer##2##3##(2008-11#1)(2008-4#1)
as a monomer##5##3##(1990-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)
as a more##8##3##(1994-3#1)(1995-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#2)
as a multidimensional##2##3##(2008-10#1)(2012-2#1)
as a multifunctional##2##3##(2008-10#1)(2008-8#1)
as a multimetal continuous-emission monitor##2##5##(2008-2#2)
as a multivariate##2##3##(2008-10#1)(2010-11#1)
as a mycoherbicide##2##3##(2008-10#2)
as a national model for##2##5##(1995-2#1)(2013-1#1)
as a national##3##3##(1995-2#1)(2009-5#1)(2013-1#1)
as a natural##8##3##(1990-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
as a naturally occurring##2##4##(1990-7#1)(1993-11#1)
as a necessary##5##3##(1992-1#1)(1992-3#1)(1993-8#1)(2009-8#1)(2013-1#1)
as a necrotrophic##2##3##(2008-10#2)
as a negative regulator of##5##5##(1990-11#1)(1995-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
as a negative regulator##6##4##(1990-11#1)(1991-12#1)(1995-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
as a negative##9##3##(1990-11#1)(1991-12#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
as a neoplastic##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
as a network of##3##4##(1992-12#1)(2008-7#1)(2012-12#1)
as a network##4##3##(1990-12#1)(1992-12#1)(2008-7#1)(2012-12#1)
as a neuromodulator##2##3##(2008-6#1)(2008-7#1)
as a neurotransmitter in##2##4##(1991-12#1)(1991-5#1)
as a neurotransmitter##5##3##(1991-12#1)(1991-5#1)(1996-12#1)(2008-5#1)(2012-3#1)
as a neutral carrier##4##4##(2008-10#4)
as a neutral##5##3##(2008-10#4)(2009-7#1)
as a new and##3##4##(1991-5#1)(2007-12#1)(2008-3#1)
as a new anticoagulant##2##4##(2008-10#2)
as a new biosorbent for the##2##6##(2008-10#2)
as a new biosorbent##3##4##(2008-10#3)
as a new genus##2##4##(2008-12#1)(2008-5#1)
as a new host for##2##5##(2012-2#2)
as a new paradigm of inquiry##2##6##(2008-8#2)
as a new paradigm##3##4##(2008-8#2)(2013-1#1)
as a new source of##2##5##(2008-10#1)(2012-2#1)
as a new source##3##4##(2008-10#2)(2012-2#1)
as a new species##2##4##(2008-10#1)(2008-5#1)
as a new strategy of##2##5##(2008-10#1)(2008-8#1)
as a new therapeutic##2##4##(2007-7#1)(2010-6#1)
as a new tool##2##4##(2008-2#1)(2008-3#1)
as a new type of##2##5##(1990-7#1)(2008-10#1)
as a new##82##3##(1990-7#1)(1991-5#1)(1991-8#1)(1996-5#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#6)(2013-1#3)(2013-8#1)
as a nidus##2##3##(2008-7#1)(2011-2#1)
as a non##2##3##(2007-7#1)(2008-7#1)
as a non-invasive##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
as a noninvasive##7##3##(2007-10#1)(2007-12#1)(2009-10#1)(2010-8#1)(2012-1#1)(2013-1#2)
as a nonlinear optical crystal##2##5##(2007-11#1)(2007-12#1)
as a nonlinear##10##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)
as a nonspecific##2##3##(1990-11#1)(2012-12#1)
as a normal##2##3##(2008-5#2)
as a novel and##3##4##(1992-11#1)(2007-11#1)(2008-10#1)
as a novel approach for##2##5##(2009-6#1)(2013-1#1)
as a novel approach##3##4##(2008-10#1)(2009-6#1)(2013-1#1)
as a novel carrier##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
as a novel ionophore for potentiometric##2##6##(2008-10#2)
as a novel ionophore for##4##5##(2008-10#4)
as a novel ionophore##6##4##(2008-10#6)
as a novel method##2##4##(2007-12#1)(2009-8#1)
as a novel therapeutic##2##4##(2012-2#1)(2013-7#1)
as a novel##51##3##(1992-11#1)(1992-9#1)(1993-6#1)(2007-11#2)(2007-12#4)(2008-10#19)(2008-12#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-2#2)(2010-5#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
as a nuclear##2##3##(1994-8#1)(2007-12#1)
as a nucleophile##2##3##(1995-2#1)(2008-7#1)
as a nucleotide##2##3##(1990-7#1)(2008-4#1)
as a number of##6##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2013-1#1)
as a pH-sensitive##2##3##(2008-10#2)
as a palliative treatment##3##4##(1997-3#1)(2007-11#1)(2012-2#1)
as a paracrine##2##3##(1996-5#1)(2008-7#1)
as a paradigm for##2##4##(2011-2#1)(2012-12#1)
as a paradigm##6##3##(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
as a parameter for##3##4##(1994-7#1)(2008-5#1)(2008-7#1)
as a parameter of##3##4##(1990-7#1)(1991-10#1)(1991-2#1)
as a parameter##6##3##(1990-7#1)(1991-10#1)(1991-2#1)(1994-7#1)(2008-5#1)(2008-7#1)
as a parametric##2##3##(2007-12#1)(2009-9#1)
as a part of a##4##5##(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
as a part of hormone##2##5##(2008-11#1)(2012-3#1)
as a part of the##5##5##(1990-12#1)(1992-1#1)(1997-3#1)(2008-10#1)(2008-11#1)
as a part of##24##4##(1990-12#1)(1991-12#1)(1992-1#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
as a particular##2##3##(2008-2#1)(2010-12#1)
as a partner##2##3##(1991-12#1)(1992-3#1)
as a passive##3##3##(2008-10#2)(2008-2#1)
as a pathogenetic##2##3##(1991-3#1)(2006-12#1)
as a pathogenicity factor##2##4##(2008-10#2)
as a pathway##2##3##(1996-12#1)(2008-6#1)
as a patient education tool among##2##6##(2009-5#2)
as a patient##6##3##(1990-6#1)(1993-3#1)(1995-8#1)(2008-4#1)(2009-5#2)
as a peptide##3##3##(1993-6#1)(2008-4#1)(2008-6#1)
as a percent##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
as a percentage of the##4##5##(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
as a percentage of##9##4##(1993-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2010-8#2)
as a period of##2##4##(1995-5#1)(2008-6#1)
as a permanent chemical modifier##3##5##(2008-10#3)
as a permanent modifier for the determination of##2##8##(2008-10#2)
as a permanent modifier##5##4##(2008-10#5)
as a permanent##8##3##(2008-10#8)
as a personal##2##3##(2008-12#2)
as a phase##5##3##(2007-12#1)(2007-7#1)(2008-3#2)(2008-7#1)
as a phosphodiesterase inhibitor##2##4##(2008-5#2)
as a physical##2##3##(2007-12#1)(2012-12#1)
as a physician##3##3##(2007-11#1)(2009-7#1)(2010-1#1)
as a pilot project##2##4##(2008-7#1)(2012-12#1)
as a pilot##4##3##(2008-10#1)(2008-7#1)(2011-9#1)(2012-12#1)
as a plasticizer##3##3##(2008-10#3)
as a platform for the competitive immuno-reaction of HRP-SjAb and SjAb with SjAg##2##13##(2008-10#2)
as a platform for##8##4##(2008-10#2)(2010-12#3)(2010-5#2)(2012-2#1)
as a platform##10##3##(2008-10#2)(2008-7#1)(2010-12#3)(2010-5#2)(2012-2#2)
as a plausible##2##3##(2008-4#1)(2012-2#1)
as a player in the##2##5##(2008-11#1)(2013-8#1)
as a point in##2##4##(1997-6#1)(2008-9#1)
as a point##4##3##(1994-6#1)(1997-6#1)(2008-11#1)(2008-9#1)
as a polarization##2##3##(2007-11#1)(2007-12#1)
as a polarizing beam splitter##2##5##(2008-3#2)
as a policy tool##2##4##(1996-1#2)
as a policy##3##3##(1996-1#2)(2008-7#1)
as a popular##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)
as a population of spatially referenced##2##6##(2008-10#2)
as a population of##3##4##(2008-10#2)(2012-12#1)
as a positive control##4##4##(1992-12#1)(1997-4#1)(2008-10#1)(2008-5#1)
as a positive regulator of insulin##2##6##(1996-2#1)(2010-11#1)
as a positive##10##3##(1992-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)
as a possible cause of##5##5##(1995-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
as a possible cause##7##4##(1992-11#1)(1995-2#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)
as a possible diagnosis##2##4##(2010-3#1)(2012-12#1)
as a possible etiology##2##4##(2008-6#1)(2008-7#1)
as a possible mechanism##3##4##(2007-8#1)(2008-5#1)(2010-4#1)
as a possible reason for##2##5##(2012-12#2)
as a possible##40##3##(1991-11#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-12#4)(2013-1#1)(2013-8#1)
as a post-mortem tool##2##4##(2009-3#2)
as a potent antioxidant##2##4##(2008-10#1)(2009-12#1)
as a potent##14##3##(1990-2#1)(1990-5#1)(1994-11#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
as a potential alternative##3##4##(1996-1#1)(2008-2#1)(2012-8#1)
as a potential model for##2##5##(2008-11#1)(2008-6#1)
as a potential model##3##4##(2008-11#1)(2008-6#1)(2013-1#1)
as a potential protective##2##4##(1990-12#1)(2009-11#1)
as a potential source##2##4##(2008-5#1)(2012-2#1)
as a potential target for##2##5##(1995-9#1)(2012-2#1)
as a potential therapeutic target##2##5##(2011-2#1)(2012-12#1)
as a potential therapeutic##4##4##(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
as a potential tool for##2##5##(2008-10#2)
as a potential treatment for epilepsy##2##6##(2008-5#2)
as a potential treatment for##10##5##(2008-5#7)(2008-7#2)(2012-2#1)
as a potential treatment##11##4##(2008-5#8)(2008-7#2)(2012-2#1)
as a potential##68##3##(1990-12#1)(1991-9#1)(1992-12#1)(1993-12#2)(1994-5#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#13)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#2)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-8#1)(2013-1#1)(2013-8#1)
as a potentially important##5##4##(1993-11#1)(1993-8#1)(2008-2#1)(2008-9#1)(2010-11#1)
as a potentially##8##3##(1993-11#1)(1993-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)(2010-5#1)
as a potentiometric sensor##3##4##(2008-10#3)
as a potentiometric##5##3##(2008-10#5)
as a power##2##3##(2007-12#1)(2008-8#1)
as a powerful diagnostic##2##4##(2010-8#1)(2011-2#1)
as a powerful tool of##2##5##(1993-12#1)(2010-8#1)
as a powerful tool##5##4##(1993-12#1)(2007-11#1)(2008-10#2)(2010-8#1)
as a powerful##13##3##(1993-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#2)(2010-8#2)(2011-2#1)
as a practicable##2##3##(1990-5#1)(2008-3#1)
as a practical##9##3##(1990-5#1)(1991-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)
as a pre-column chelating##2##4##(2008-10#2)
as a pre-column derivatizing reagent##2##5##(2008-10#2)
as a pre-column##5##3##(2008-10#5)
as a pre-plant##2##3##(2008-10#2)
as a precolumn derivatizing reagent##2##5##(2008-10#2)
as a preconcentration##2##3##(2008-10#2)
as a precursor of activated carbon##2##6##(2008-6#2)
as a precursor of##6##4##(1994-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-6#2)
as a precursor to##4##4##(1995-3#1)(2007-11#1)(2010-4#1)(2013-1#1)
as a precursor##12##3##(1990-8#1)(1993-12#1)(1994-5#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-4#1)(2013-1#1)
as a predictive##3##3##(1996-12#1)(2008-5#1)(2010-12#1)
as a predictor of prostate cancer risk##2##7##(2012-12#2)
as a predictor of##14##4##(1990-2#1)(2007-10#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
as a predictor##15##3##(1990-2#1)(2007-10#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
as a preliminary step##2##4##(1990-5#1)(2008-4#1)
as a preliminary##7##3##(1990-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2013-8#1)
as a preoperative##3##3##(1990-11#1)(1990-9#1)(1993-1#1)
as a presentation of##3##4##(1996-3#1)(2008-1#1)(2011-2#1)
as a presenting feature of##4##5##(2007-7#1)(2007-8#1)(2008-9#2)
as a presenting##5##3##(2007-7#1)(2007-8#1)(2008-9#2)(2011-2#1)
as a preservation agent##2##4##(2008-10#2)
as a preservative##3##3##(1990-2#1)(2008-5#1)(2011-2#1)
as a preventive for##2##4##(1995-9#1)(2008-10#1)
as a preventive##4##3##(1992-5#1)(1995-9#1)(2007-12#1)(2008-10#1)
as a previously##2##3##(2008-10#2)
as a primary cause for##2##5##(2008-1#1)(2011-1#1)
as a primary##21##3##(1990-6#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-12#1)
as a principal##2##3##(2009-9#1)(2013-1#1)
as a prior step to its determination by flame atomic spectroscopy##2##11##(2008-10#2)
as a priority##4##3##(1993-3#1)(2008-1#1)(2013-1#2)
as a pro-drug##2##3##(1996-3#1)(2012-2#1)
as a probe to investigate the##2##6##(1991-2#1)(1991-9#1)
as a probe to screen##2##5##(1994-12#1)(1996-6#1)
as a probe to##8##4##(1991-2#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-1#1)
as a probe##45##3##(1990-12#1)(1990-2#1)(1991-2#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-6#3)(1997-1#1)(1997-2#2)(1997-4#4)(2008-10#4)(2008-5#2)(2008-8#4)
as a procedure##3##3##(1994-11#1)(2008-4#1)(2010-8#1)
as a process##2##3##(2008-3#1)(2011-1#1)
as a product of##2##4##(1997-4#1)(2009-10#1)
as a product##4##3##(1997-4#1)(2008-6#2)(2009-10#1)
as a profession##4##3##(1991-3#1)(2008-1#1)(2008-5#1)(2012-2#1)
as a professional##4##3##(1996-12#1)(2008-12#1)(2012-1#1)(2013-1#1)
as a prognostic factor in##3##5##(1996-8#1)(2007-5#1)(2011-2#1)
as a prognostic factor##7##4##(1994-5#1)(1996-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-4#1)(2011-2#1)
as a prognostic indicator in##2##5##(1994-12#1)(1997-4#1)
as a prognostic indicator##4##4##(1994-10#1)(1994-12#1)(1997-4#1)(2008-7#1)
as a prognostic##12##3##(1994-10#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-8#1)(1997-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
as a promising approach##2##4##(2008-11#1)(2010-5#1)
as a promising candidate for##2##5##(2008-9#1)(2011-2#1)
as a promising target for##2##5##(2009-6#1)(2011-1#1)
as a promising##16##3##(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#1)
as a promoter of##2##4##(2008-9#1)(2009-2#1)
as a promoter##5##3##(1991-6#1)(1997-8#1)(2008-8#1)(2008-9#1)(2009-2#1)
as a prophylactic agent for##2##5##(2008-5#1)(2008-7#1)
as a prophylactic##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
as a proportion of patients with##2##6##(2007-7#2)
as a proportion of##5##4##(1996-9#1)(2007-12#1)(2007-7#2)(2008-7#1)
as a proportion##6##3##(1996-9#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-7#1)
as a prospective##2##3##(2011-2#1)(2012-3#1)
as a protective agent##2##4##(2008-10#1)(2008-12#1)
as a protective factor against##4##5##(1995-12#1)(2009-11#1)(2009-7#1)(2013-1#1)
as a protective factor for##3##5##(2009-12#1)(2009-7#1)(2013-8#1)
as a protective factor##8##4##(1995-12#1)(2009-11#2)(2009-12#1)(2009-7#2)(2013-1#1)(2013-8#1)
as a protective##12##3##(1995-12#1)(2008-10#1)(2008-12#1)(2009-11#2)(2009-12#1)(2009-7#2)(2012-2#1)(2013-1#2)(2013-8#1)
as a protein tyrosyl phosphatase##2##5##(1992-12#2)
as a protein##6##3##(1991-12#1)(1992-12#2)(1992-6#1)(2008-11#1)(2012-6#1)
as a prototype for##2##4##(2008-12#1)(2009-11#1)
as a prototype of a##3##5##(2008-10#2)(2011-2#1)
as a prototype##7##3##(1992-3#1)(1994-8#1)(2008-10#2)(2008-12#1)(2009-11#1)(2011-2#1)
as a proxy for##4##4##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
as a proxy##5##3##(2008-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
as a pseudostationary##2##3##(2008-10#2)
as a public health issue##2##5##(2008-9#2)
as a public health problem##3##5##(1995-6#1)(2009-5#1)(2010-9#1)
as a public health##7##4##(1995-6#1)(2007-12#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-9#1)
as a public##9##3##(1995-6#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-9#1)
as a pulsed##2##3##(2008-2#2)
as a pump source##3##4##(2007-11#1)(2007-12#2)
as a pump##6##3##(2007-11#2)(2007-12#4)
as a pure##2##3##(2008-1#1)(2008-3#1)
as a putative##2##3##(1993-12#1)(2012-2#1)
as a quadratic##2##3##(2008-2#1)(2008-3#1)
as a quality control##2##4##(1996-12#1)(2008-10#1)
as a quality##7##3##(1993-12#2)(1996-12#1)(1997-1#2)(2008-10#1)(2008-12#1)
as a quantitative trait and##2##5##(2008-9#1)(2009-4#1)
as a quantitative##3##3##(1996-6#1)(2008-9#1)(2009-4#1)
as a radiation sensitizer##2##4##(1995-8#1)(2007-11#1)
as a radiation##3##3##(1995-8#1)(2007-11#1)(2008-11#1)
as a radioactive##2##3##(1995-2#1)(2008-10#1)
as a radioligand##2##3##(1992-11#1)(1994-8#1)
as a radiosensitizer##2##3##(1990-6#1)(1991-2#1)
as a rallying point##2##4##(1996-12#1)(2008-10#1)
as a rapid and simple##2##5##(2008-10#2)
as a rapid and##6##4##(1996-5#1)(2008-10#4)(2008-3#1)
as a rapid method##2##4##(2008-10#1)(2008-7#1)
as a rapid screening##2##4##(1997-4#1)(2008-10#1)
as a rapid##16##3##(1996-5#1)(1997-4#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#1)
as a rapidly##2##3##(1990-12#1)(2007-11#1)
as a rare and##2##4##(2009-8#1)(2011-2#1)
as a rare cause of##4##5##(2008-12#1)(2009-4#2)(2011-2#1)
as a rare complication of##3##5##(2012-12#1)(2012-3#1)(2013-1#1)
as a rare complication##4##4##(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
as a rare##12##3##(1996-8#1)(2008-12#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
as a ratio of##2##4##(2008-3#1)(2009-6#1)
as a ratio##3##3##(2008-3#1)(2009-6#1)(2011-2#1)
as a reaction##3##3##(2008-10#1)(2008-6#1)(2012-1#1)
as a readout system for##2##5##(2007-12#2)
as a reagent##3##3##(2008-10#2)(2008-9#1)
as a real-time##2##3##(2007-11#2)
as a reason for##2##4##(1991-12#1)(1994-3#1)
as a receptor for##5##4##(1992-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-4#1)
as a recognition element##2##4##(2008-10#2)
as a redox##3##3##(2008-10#2)(2008-11#1)
as a reducing agent##3##4##(2008-10#3)
as a reduction in the##3##5##(1993-3#1)(2008-10#2)
as a reduction in##4##4##(1993-3#1)(2008-10#2)(2008-9#1)
as a reduction##5##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-9#1)
as a reference electrode##2##4##(2008-10#2)
as a reference method##3##4##(2008-10#2)(2013-1#1)
as a reference to##2##4##(2008-10#1)(2008-2#1)
as a reference##30##3##(1993-8#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)
as a reflection##3##3##(1996-9#1)(2008-1#1)(2013-1#1)
as a regulator of##6##4##(1992-12#1)(1994-12#1)(1995-12#1)(2008-8#1)(2009-8#1)(2010-11#1)
as a regulatory##3##3##(1991-9#1)(2008-10#2)
as a reliable##5##3##(1991-12#1)(2008-10#3)(2010-12#1)
as a remedy to##2##4##(1996-12#1)(2008-11#1)
as a replacement for the##2##5##(1992-3#1)(2008-10#1)
as a replacement for##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
as a replacement of##2##4##(2008-4#1)(2012-6#1)
as a replacement##8##3##(1991-12#1)(1992-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-6#1)
as a reporter for the##2##5##(1997-8#1)(2008-4#1)
as a reporter gene to##2##5##(1991-5#1)(1991-9#1)
as a reporter gene##6##4##(1991-5#1)(1991-9#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-11#1)
as a reporter molecule##2##4##(2008-7#1)(2008-9#1)
as a reporter##20##3##(1991-5#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)
as a repository##2##3##(2008-7#1)(2010-10#1)
as a representation of##2##4##(1990-8#1)(2009-6#1)
as a representative chemical##2##4##(2008-7#1)(2008-9#1)
as a representative of##2##4##(2011-2#1)(2013-1#1)
as a representative##12##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
as a reproducible##2##3##(1991-3#1)(1991-5#1)
as a rescue therapy##2##4##(2012-12#2)
as a rescue##3##3##(2007-8#1)(2012-12#2)
as a research##2##3##(1992-6#1)(2013-8#1)
as a reservoir for##3##4##(1997-5#1)(2008-10#1)(2011-2#1)
as a reservoir##5##3##(1995-2#1)(1997-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
as a resource for##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
as a resource##5##3##(2007-12#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
as a response to##8##4##(1990-2#1)(1995-2#1)(2008-10#2)(2009-5#2)(2011-1#1)(2012-7#1)
as a response##9##3##(1990-2#1)(1995-2#1)(2008-10#2)(2009-5#2)(2009-8#1)(2011-1#1)(2012-7#1)
as a result of a##21##5##(1991-11#1)(1994-1#2)(1995-12#1)(1995-6#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
as a result of aggregation##2##5##(2008-3#1)(2012-12#1)
as a result of an##8##5##(1993-12#1)(1994-2#1)(1994-5#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-1#1)
as a result of both##3##5##(1992-9#1)(2008-11#1)(2011-2#1)
as a result of cell##2##5##(2008-4#1)(2011-3#1)
as a result of changes in the##2##7##(2008-11#1)(2008-3#1)
as a result of enzymatic##2##5##(2008-10#2)
as a result of higher##2##5##(2008-8#1)(2012-5#1)
as a result of insufficient##3##5##(2010-5#1)(2011-2#2)
as a result of its##5##5##(1995-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
as a result of long##2##5##(2008-12#1)(2008-4#1)
as a result of low##3##5##(2007-11#1)(2007-12#1)(2013-1#1)
as a result of mining##2##5##(2008-12#2)
as a result of nonlinear##2##5##(2007-11#1)(2008-3#1)
as a result of oxidative##2##5##(1994-8#1)(2010-4#1)
as a result of pulmonary##2##5##(2007-8#1)(2008-7#1)
as a result of refraction##2##5##(2007-11#2)
as a result of replication##2##5##(1995-5#1)(2012-3#1)
as a result of technological##2##5##(2008-9#1)(2013-8#1)
as a result of the continuous##2##6##(2008-10#1)(2008-11#1)
as a result of the passage of##2##7##(1996-11#1)(2011-2#1)
as a result of the##62##5##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-9#1)(1997-2#1)(2007-11#2)(2007-12#4)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#6)(2013-1#2)(2013-7#1)
as a result of their##7##5##(1992-9#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#1)
as a result of these##2##5##(2008-3#1)(2013-8#1)
as a result of##293##4##(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#12)(2007-12#18)(2007-8#4)(2008-1#2)(2008-10#34)(2008-11#16)(2008-12#8)(2008-2#8)(2008-3#17)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#12)(2008-8#7)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#5)
as a result##313##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#3)(1991-2#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-5#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#12)(2007-12#18)(2007-8#4)(2008-1#2)(2008-10#39)(2008-11#16)(2008-12#8)(2008-2#9)(2008-3#17)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#7)(2008-9#9)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#11)(2013-7#4)(2013-8#8)
as a review of the literature##2##6##(2009-3#1)(2011-2#1)
as a review of##3##4##(2008-5#1)(2009-3#1)(2011-2#1)
as a ribosomal protein##2##4##(1996-6#1)(2013-8#1)
as a right to##2##4##(1995-12#2)
as a right##5##3##(1995-12#2)(2008-7#2)(2013-8#1)
as a risk factor for development of##2##7##(2007-10#1)(2011-2#1)
as a risk factor for##12##5##(1990-8#1)(2007-10#3)(2008-12#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
as a risk factor##16##4##(1990-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
as a risk management tool##2##5##(1992-12#1)(1994-12#1)
as a risk##23##3##(1990-8#1)(1990-9#1)(1992-12#1)(1994-12#1)(2006-10#1)(2007-10#3)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a robust##2##3##(2008-3#1)(2008-5#1)
as a route to##3##4##(2008-11#1)(2008-8#1)(2010-12#1)
as a routine in##2##4##(1991-6#1)(1992-11#1)
as a routine procedure##3##4##(1990-10#1)(1996-9#1)(2011-1#1)
as a routine##17##3##(1990-10#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-9#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-9#1)(2007-8#1)(2008-10#3)(2011-1#2)
as a rule##5##3##(1991-6#1)(1995-5#1)(1996-1#1)(2008-3#1)(2008-7#1)
as a safe and effective##2##5##(2008-3#1)(2012-2#1)
as a safe and##3##4##(2008-3#1)(2012-2#1)(2013-1#1)
as a safe##8##3##(1990-6#1)(1991-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
as a sample introduction##2##4##(2008-10#2)
as a sample##9##3##(1996-1#1)(2008-10#7)(2010-5#1)
as a satellite##3##3##(2008-10#1)(2008-5#2)
as a saturable absorber##5##4##(2007-11#2)(2008-2#1)(2008-3#2)
as a scaffold for##3##4##(1997-3#1)(2010-2#1)(2012-2#1)
as a scaffold to##2##4##(1997-3#1)(2012-8#1)
as a scaffold##7##3##(1997-3#2)(2008-7#1)(2010-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
as a scientific##5##3##(1992-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2012-12#1)
as a screen for##2##4##(1997-4#1)(2008-7#1)
as a screening tool for##4##5##(1993-12#1)(2008-10#1)(2013-1#2)
as a screening tool##5##4##(1993-12#1)(1997-4#1)(2008-10#1)(2013-1#2)
as a screening##12##3##(1991-12#1)(1993-12#1)(1993-3#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#2)
as a second line therapy##2##5##(1990-2#1)(2008-5#1)
as a second messenger##2##4##(1992-3#1)(1995-11#1)
as a second##10##3##(1990-2#1)(1992-3#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
as a second-line##2##3##(1992-12#2)
as a secondary##2##3##(2008-4#1)(2012-2#1)
as a secretory##2##3##(1994-9#1)(2007-12#1)
as a seed treatment##2##4##(2008-10#2)
as a seed##4##3##(1994-11#1)(2007-11#1)(2008-10#2)
as a selectable marker##2##4##(1997-8#1)(2008-10#1)
as a selection##2##3##(2008-11#1)(2008-4#1)
as a selective fluorescence quenching##2##5##(2008-10#2)
as a selective##15##3##(1990-2#1)(1991-12#1)(1992-5#1)(1995-11#1)(2008-10#8)(2008-7#1)(2009-2#1)(2010-12#1)
as a sensing##2##3##(2008-10#1)(2008-3#1)
as a sensitive and##2##4##(1997-7#1)(2008-10#1)
as a sensitive##9##3##(1990-2#1)(1993-6#1)(1997-7#1)(2007-11#1)(2008-10#5)
as a sensitizer##2##3##(1992-8#1)(2008-10#1)
as a sensor element##2##4##(2008-10#1)(2011-2#1)
as a sensor for the##2##5##(2008-10#2)
as a sensor for##4##4##(2008-10#3)(2010-8#1)
as a sensor##12##3##(1994-12#1)(2008-10#7)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
as a separate##3##3##(1994-12#1)(2008-10#1)(2012-1#1)
as a separation##2##3##(2008-10#1)(2012-1#1)
as a sequel of##2##4##(2008-7#1)(2012-3#1)
as a sequence of##2##4##(1996-4#1)(2013-1#1)
as a series of##4##4##(2008-4#1)(2009-4#1)(2009-7#1)(2012-2#1)
as a serious complication of##2##5##(2010-5#2)
as a serious##9##3##(1994-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2010-5#2)(2012-3#2)(2013-1#1)
as a serum##2##3##(2008-11#1)(2012-3#1)
as a set of##4##4##(2008-10#2)(2008-12#1)(2010-4#1)
as a short##2##3##(2008-10#1)(2010-6#1)
as a sign of##2##4##(2008-7#2)
as a signal transducer##2##4##(1997-4#1)(2008-8#1)
as a signal##6##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-8#1)
as a signaling##2##3##(2009-6#1)(2012-2#1)
as a significant component of the##2##6##(2008-10#1)(2008-12#1)
as a significant risk factor for##2##6##(2008-2#1)(2012-3#1)
as a significant##17##3##(1994-3#1)(1994-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-3#1)
as a simple and##5##4##(2008-10#3)(2008-11#1)(2010-5#1)
as a simple model system##2##5##(1997-6#1)(2008-10#1)
as a simple model##3##4##(1997-6#1)(2008-10#2)
as a simple##23##3##(1991-12#1)(1994-6#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
as a single agent in##3##5##(1991-6#2)(1994-8#1)
as a single agent##5##4##(1991-6#2)(1994-8#2)(2009-12#1)
as a single band##4##4##(1991-12#1)(1992-12#1)(1992-8#1)(1993-3#1)
as a single copy in the##3##6##(1992-3#1)(1995-8#1)(1997-4#1)
as a single copy##7##4##(1992-3#1)(1993-2#1)(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-8#1)
as a single dose##2##4##(1992-12#2)
as a single##56##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#3)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#2)
as a single-copy##2##3##(1993-9#1)(1995-6#1)
as a site of##2##4##(2008-6#1)(2013-7#1)
as a site##3##3##(2008-6#1)(2011-2#1)(2013-7#1)
as a small##7##3##(1992-9#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-8#1)
as a smooth##2##3##(2007-8#1)(2008-3#1)
as a social##8##3##(1992-2#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-12#1)(2012-1#1)
as a software##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
as a sole carbon source by##2##6##(2008-10#1)(2008-6#1)
as a sole carbon source##8##5##(2008-10#3)(2008-11#1)(2008-6#2)(2012-2#1)(2012-3#1)
as a sole##15##3##(1991-12#1)(1992-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
as a solid catalyst for the determination of##2##8##(2008-10#2)
as a solid catalyst##3##4##(2008-10#3)
as a solid phase reagent for##2##6##(2008-10#2)
as a solid phase##6##4##(2008-10#6)
as a solid substrate##2##4##(2008-10#2)
as a solid support in##2##5##(2008-10#2)
as a solid support##5##4##(2008-10#5)
as a solid##21##3##(1996-2#1)(2008-10#17)(2008-5#1)(2012-2#1)(2013-1#1)
as a solid-state##2##3##(2008-10#2)
as a soluble##2##3##(1992-12#1)(1993-8#1)
as a solution to##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
as a solution##4##3##(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
as a solvent##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
as a sorbent##2##3##(2008-10#2)
as a source for##2##4##(2008-10#1)(2011-3#1)
as a source of carbon##2##5##(2008-10#1)(2011-2#1)
as a source of energy##3##5##(2008-6#3)
as a source of resistance to##5##6##(2008-10#5)
as a source of the##2##5##(1996-5#1)(2011-2#1)
as a source of##43##4##(1991-11#1)(1991-2#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#15)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
as a source##47##3##(1991-11#1)(1991-2#1)(1991-8#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#16)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
as a special case##3##4##(2008-3#1)(2008-8#1)(2012-3#1)
as a special##7##3##(1995-2#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
as a specialty##3##3##(1997-4#1)(2011-1#1)(2012-2#1)
as a species##2##3##(2010-10#1)(2011-2#1)
as a specific inhibitor of##2##5##(1992-9#1)(1995-2#1)
as a specific##13##3##(1991-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)
as a spectrophotometric##3##3##(2008-10#3)
as a spin##2##3##(1990-12#1)(2008-10#1)
as a spray##4##3##(1992-2#1)(2008-10#3)
as a stability indicating##3##4##(2008-10#3)
as a stabilizing##3##3##(1992-6#1)(2008-9#2)
as a stable and##2##4##(2008-4#1)(2012-3#1)
as a stable##6##3##(1994-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-3#1)
as a stand-alone##3##3##(2008-11#1)(2008-4#1)(2010-8#1)
as a standard for##2##4##(2010-8#2)
as a standard##15##3##(1991-12#1)(1992-9#1)(1995-9#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-8#2)(2012-12#1)(2013-1#1)
as a starting point for the##2##6##(2008-10#1)(2012-2#1)
as a starting point for##4##5##(1994-2#1)(2008-10#1)(2010-11#1)(2012-2#1)
as a starting point##6##4##(1994-2#1)(1996-5#1)(2008-10#2)(2010-11#1)(2012-2#1)
as a starting##8##3##(1993-8#1)(1994-2#1)(1996-5#1)(2008-10#2)(2008-2#1)(2010-11#1)(2012-2#1)
as a stationary phase and the##2##6##(2008-10#2)
as a stationary phase in##2##5##(1990-8#2)
as a stationary phase##7##4##(1990-8#2)(1991-5#1)(2008-10#4)
as a statistically##2##3##(2008-11#1)(2009-8#1)
as a step towards##2##4##(2008-10#1)(2011-1#1)
as a stimulus##2##3##(2008-11#1)(2008-8#1)
as a stochastic process##2##4##(2008-2#1)(2010-8#1)
as a storage##2##3##(2008-3#1)(2013-1#1)
as a strain##2##3##(2007-12#1)(2008-3#1)
as a strategic##4##3##(1996-2#1)(1996-3#1)(2008-12#1)(2010-8#1)
as a strategy for enrichment of##2##6##(2013-7#2)
as a strategy for##4##4##(2008-1#1)(2013-7#3)
as a strategy in##2##4##(2008-5#1)(2011-3#1)
as a strategy to improve##3##5##(1996-12#1)(2007-8#1)(2008-3#1)
as a strategy to##9##4##(1996-12#1)(1997-3#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
as a strategy##18##3##(1994-2#1)(1996-12#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-3#1)(2012-2#1)(2013-7#3)(2013-8#1)
as a strong##6##3##(1993-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
as a structural analog of##2##5##(1997-6#2)
as a structural##6##3##(1995-8#1)(1997-1#1)(1997-6#2)(2008-10#2)
as a subject of##2##4##(2008-1#1)(2008-10#1)
as a subject##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
as a subset##3##3##(1994-12#1)(2008-10#1)(2010-7#1)
as a subspecialty##2##3##(1994-12#1)(2007-12#1)
as a substantial##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
as a substitute for##7##4##(1995-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
as a substitute##8##3##(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
as a substrate and##2##4##(1991-5#1)(1992-3#1)
as a substrate for the##2##5##(2008-10#2)
as a substrate for##13##4##(1991-9#1)(1992-8#2)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(2008-10#3)(2008-5#1)(2009-9#1)
as a substrate in##2##4##(1997-8#1)(2011-2#1)
as a substrate of##2##4##(1990-11#1)(2008-11#1)
as a substrate to##2##4##(2008-10#1)(2008-4#1)
as a substrate##40##3##(1990-11#2)(1990-2#1)(1990-7#1)(1990-9#2)(1991-5#2)(1991-9#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
as a successful##2##3##(2008-10#1)(2011-1#1)
as a suitable alternative##2##4##(2008-5#1)(2012-3#1)
as a suitable model##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
as a suitable##12##3##(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#2)(2012-3#1)(2013-1#1)
as a summary##2##3##(2006-7#1)(2013-1#1)
as a sunscreen##3##3##(2008-10#1)(2008-5#2)
as a superposition of##4##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)
as a supplement to##3##4##(1990-9#1)(1991-6#1)(1993-11#1)
as a supplement##5##3##(1990-9#1)(1991-6#1)(1993-11#1)(2008-11#1)(2010-2#1)
as a support##5##3##(1990-6#1)(2008-10#3)(2008-11#1)
as a surface##2##3##(2008-10#1)(2008-2#1)
as a surfactant##4##3##(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
as a surgical##2##3##(2008-4#1)(2008-7#1)
as a surrogate for##5##4##(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
as a surrogate##13##3##(2007-10#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
as a symptom of##2##4##(2007-10#1)(2011-2#1)
as a synthetic##3##3##(2007-11#2)(2008-10#1)
as a system##3##3##(1993-12#1)(1995-2#1)(2013-1#1)
as a target for cancer##2##5##(2011-2#2)
as a target for the##2##5##(1995-5#1)(2013-1#1)
as a target for##10##4##(1995-5#1)(1996-1#1)(1997-7#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#2)(2013-1#1)
as a target of##3##4##(1993-8#1)(2008-12#1)(2011-2#1)
as a target##18##3##(1993-8#1)(1994-2#1)(1995-5#1)(1996-1#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-2#1)(2011-2#3)(2013-1#2)
as a tau##2##3##(1993-6#2)
as a teacher##5##3##(2009-7#1)(2012-1#4)
as a teaching and learning strategy##3##6##(2008-11#3)
as a teaching and##4##4##(2008-11#3)(2008-12#1)
as a teaching method##4##4##(2008-11#3)(2008-12#1)
as a teaching strategy##2##4##(2008-11#1)(2008-12#1)
as a teaching##11##3##(1995-12#1)(2008-11#7)(2008-12#3)
as a team##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
as a technical##2##3##(2007-7#1)(2008-10#1)
as a technique for the##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
as a technique for##5##4##(2008-10#3)(2008-2#1)(2008-7#1)
as a technique to##3##4##(2008-3#1)(2009-9#1)(2011-3#1)
as a technique##8##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-3#1)
as a technology##2##3##(2008-10#1)(2008-9#1)
as a template for##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
as a template##7##3##(1992-6#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
as a temporary##4##3##(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
as a test analyte##2##4##(2008-10#2)
as a test case##4##4##(1991-1#1)(2008-11#1)(2008-3#1)(2010-2#1)
as a test of##3##4##(1994-2#1)(2008-10#1)(2008-8#1)
as a test sample##2##4##(2007-12#1)(2008-10#1)
as a test##13##3##(1991-1#1)(1992-12#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)
as a theoretical##4##3##(1995-1#1)(1996-9#1)(2008-10#1)(2008-12#1)
as a therapeutic agent in##3##5##(2007-11#1)(2008-6#1)(2008-7#1)
as a therapeutic approach in##2##5##(2012-12#1)(2012-3#1)
as a therapeutic option##2##4##(2009-5#1)(2013-8#1)
as a therapeutic target for##2##5##(2008-1#1)(2010-11#1)
as a therapeutic target##4##4##(2008-1#1)(2008-11#1)(2010-11#1)(2010-3#1)
as a therapeutic tool##2##4##(2008-6#1)(2009-9#1)
as a therapeutic##20##3##(1991-12#1)(1992-12#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
as a therapy##4##3##(2009-7#2)(2010-7#1)(2012-2#1)
as a thin film##2##4##(2007-12#1)(2008-3#1)
as a thin layer##2##4##(2008-10#2)
as a thin##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
as a third##2##3##(1990-7#1)(2008-10#1)
as a threat to##3##4##(2007-2#1)(2008-10#1)(2008-11#1)
as a threat##5##3##(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
as a threshold value for##2##5##(2008-10#2)
as a threshold##7##3##(1994-5#1)(1997-5#1)(2008-10#4)(2012-1#1)
as a thrombolytic agent##2##4##(2008-7#2)
as a time##2##3##(2007-12#1)(2010-8#1)
as a titrant##4##3##(2008-10#4)
as a tool for studying##2##5##(2008-11#1)(2008-4#1)
as a tool for the##4##5##(1995-6#1)(2008-10#2)(2010-11#1)
as a tool for##34##4##(1990-11#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-2#2)(2010-3#1)(2011-1#2)
as a tool in the##2##5##(2007-10#1)(2008-5#1)
as a tool in##6##4##(2007-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)
as a tool to measure##2##5##(2008-3#1)(2009-4#1)
as a tool to study##3##5##(1996-6#1)(2010-6#1)(2010-8#1)
as a tool to##26##4##(1990-7#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-4#1)(2010-6#2)(2010-8#1)(2013-1#1)
as a tool##68##3##(1990-11#1)(1990-7#1)(1994-12#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#7)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#2)(2010-11#2)(2010-2#2)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#2)(2013-1#1)
as a topical##3##3##(2008-10#1)(2008-5#2)
as a trace CS##2##4##(2008-5#2)
as a trace##3##3##(2008-5#3)
as a tracer for##2##4##(1997-7#1)(2008-11#1)
as a tracer in##2##4##(1990-5#1)(2008-10#1)
as a tracer##6##3##(1990-11#1)(1990-5#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
as a training##2##3##(1995-6#1)(2008-10#1)
as a trait##2##3##(1996-7#1)(2010-1#1)
as a transcription factor##3##4##(1993-12#1)(2010-5#1)(2011-2#1)
as a transcription##4##3##(1993-12#1)(2010-10#1)(2010-5#1)(2011-2#1)
as a transcriptional##5##3##(1992-12#1)(1994-12#1)(1997-4#1)(2009-8#1)(2011-2#1)
as a transducer for##2##4##(2007-11#1)(2008-3#1)
as a transducer##4##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
as a transient intermediate which undergoes a subsequent Diels-Alder cycloaddition with##2##11##(1996-5#2)
as a transient##3##3##(1996-5#2)(2008-7#1)
as a transition from##2##4##(1991-1#1)(2010-6#1)
as a transition##4##3##(1991-1#1)(1991-5#1)(2008-3#1)(2010-6#1)
as a transmitter##2##3##(1992-6#1)(2008-3#1)
as a transparent##2##3##(2008-3#1)(2008-5#1)
as a treatable##2##3##(2008-1#1)(2010-1#1)
as a treatment for the##3##5##(2007-12#1)(2008-11#1)(2008-3#1)
as a treatment for##11##4##(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
as a treatment modality##2##4##(2007-12#1)(2013-1#1)
as a treatment of##3##4##(1994-7#1)(2008-3#1)(2011-1#1)
as a treatment option for##2##5##(2008-4#1)(2008-7#1)
as a treatment option##4##4##(2007-11#2)(2008-4#1)(2008-7#1)
as a treatment##24##3##(1993-11#1)(1994-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
as a trigger for##2##4##(2008-11#2)
as a trigger##4##3##(1992-3#1)(2008-1#1)(2008-11#2)
as a trophic factor in##2##5##(1996-12#1)(1997-6#1)
as a true##4##3##(1997-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
as a tumor marker for##2##5##(1992-3#1)(1993-1#1)
as a tumor marker##4##4##(1992-3#1)(1993-1#2)(2008-4#1)
as a tumor suppressor##7##4##(1995-2#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
as a tumor##15##3##(1990-7#1)(1992-3#1)(1993-1#2)(1995-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
as a tunable##3##3##(2007-11#2)(2008-3#1)
as a two-dimensional##2##3##(2008-3#2)
as a two-stage##2##3##(2008-11#1)(2008-7#1)
as a type of##3##4##(2008-4#2)(2012-12#1)
as a type##4##3##(1995-2#1)(2008-4#2)(2012-12#1)
as a typical##8##3##(1990-8#1)(2008-10#4)(2011-2#1)(2012-2#1)(2013-8#1)
as a unified##2##3##(1993-12#1)(2008-3#1)
as a unique##13##3##(1991-12#1)(1993-8#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
as a universal##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2009-6#1)
as a useful and##3##4##(1993-12#1)(2008-1#1)(2013-1#1)
as a useful biomarker##2##4##(2009-11#1)(2010-1#1)
as a useful framework for##2##5##(2007-4#1)(2009-4#1)
as a useful tool for##3##5##(1991-3#1)(2008-3#1)(2010-8#1)
as a useful tool##4##4##(1991-3#1)(2008-3#1)(2010-8#1)(2011-2#1)
as a useful vascular access site for##2##7##(2011-2#2)
as a useful##27##3##(1991-3#1)(1993-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-11#1)(2009-4#2)(2010-1#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
as a usual##2##3##(1995-12#1)(2008-6#1)
as a vaccine candidate##2##4##(2008-12#1)(2009-6#1)
as a vaccine##8##3##(1995-5#2)(1996-9#1)(1997-6#1)(2008-12#1)(2009-6#1)(2011-2#2)
as a valid##2##3##(1996-12#1)(2008-7#1)
as a valuable tool for##2##5##(1991-6#1)(2009-10#1)
as a valuable tool in##2##5##(1997-4#1)(2008-10#1)
as a valuable tool##4##4##(1991-6#1)(1997-4#1)(2008-10#1)(2009-10#1)
as a valuable##10##3##(1991-12#1)(1991-6#1)(1997-4#1)(2008-10#2)(2008-12#1)(2009-1#1)(2009-10#1)(2009-9#1)(2012-2#1)
as a variable##2##3##(2008-9#1)(2011-2#1)
as a vector for##3##4##(1997-4#1)(2008-10#1)(2011-2#1)
as a vector##6##3##(1997-4#1)(2008-10#3)(2008-3#1)(2011-2#1)
as a vehicle for##4##4##(1992-1#1)(2008-2#1)(2009-10#1)(2010-6#1)
as a vehicle##7##3##(1992-1#1)(1996-2#1)(1997-4#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-6#1)
as a versatile##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
as a very##6##3##(1992-9#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-7#1)
as a viable alternative##2##4##(1997-4#1)(2007-11#1)
as a viable option for##3##5##(2011-2#2)(2012-2#1)
as a viable##9##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
as a viral##2##3##(2008-10#1)(2010-5#1)
as a virus##2##3##(2008-10#2)
as a viscosity##2##3##(2008-5#1)(2011-1#1)
as a visual cue##2##4##(2008-8#2)
as a visual##3##3##(2008-11#1)(2008-8#2)
as a vital##3##3##(1996-6#1)(1997-3#1)(2008-11#1)
as a water##2##3##(2008-10#2)
as a wave-front##2##3##(2007-12#1)(2008-3#1)
as a wavelength##2##3##(2008-10#1)(2008-3#1)
as a way of reducing the##2##6##(2006-10#1)(2011-1#1)
as a way of##10##4##(1992-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-1#1)
as a way to make##2##5##(2008-8#1)(2009-7#1)
as a way to##9##4##(1995-2#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-7#1)
as a way##19##3##(1992-3#1)(1995-2#1)(1995-3#1)(1997-2#2)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#2)(2009-6#1)(2009-7#1)(2011-1#1)
as a weak initiator##2##4##(1991-8#1)(1995-9#1)
as a weak##7##3##(1991-8#1)(1992-2#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-9#1)
as a weaning pap##2##4##(1997-4#2)
as a weaning##3##3##(1997-4#3)
as a well##2##3##(1990-9#1)(2013-7#1)
as a whole and##8##4##(1993-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)
as a whole can##2##4##(1990-8#1)(2008-8#1)
as a whole is##2##4##(1992-3#1)(2007-10#1)
as a working electrode##6##4##(2008-10#6)
as a working##11##3##(1992-11#1)(1995-12#1)(2008-10#6)(2008-12#2)(2013-1#1)
as a wound dressing material##2##5##(2008-5#2)
as a##5945##2##(1990-10#2)(1990-11#17)(1990-12#18)(1990-2#20)(1990-3#5)(1990-4#1)(1990-5#19)(1990-6#8)(1990-7#15)(1990-8#23)(1990-9#12)(1991-1#11)(1991-10#4)(1991-11#11)(1991-12#40)(1991-2#16)(1991-3#12)(1991-4#4)(1991-5#20)(1991-6#16)(1991-8#6)(1991-9#19)(1992-1#6)(1992-10#3)(1992-11#17)(1992-12#36)(1992-2#10)(1992-3#38)(1992-4#2)(1992-5#5)(1992-6#28)(1992-8#17)(1992-9#21)(1993-1#8)(1993-10#1)(1993-11#27)(1993-12#34)(1993-2#11)(1993-3#20)(1993-5#2)(1993-6#18)(1993-8#28)(1993-9#8)(1994-1#8)(1994-10#3)(1994-11#22)(1994-12#33)(1994-2#28)(1994-3#27)(1994-5#22)(1994-6#13)(1994-7#3)(1994-8#26)(1994-9#14)(1995-1#10)(1995-11#15)(1995-12#27)(1995-2#54)(1995-3#22)(1995-4#3)(1995-5#24)(1995-6#26)(1995-8#16)(1995-9#6)(1996-1#14)(1996-10#2)(1996-11#6)(1996-12#29)(1996-2#22)(1996-3#23)(1996-4#2)(1996-5#18)(1996-6#16)(1996-7#5)(1996-8#4)(1996-9#10)(1997-1#11)(1997-2#39)(1997-3#23)(1997-4#43)(1997-5#10)(1997-6#20)(1997-7#19)(1997-8#12)(1997-9#1)(2006-10#13)(2006-12#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#24)(2007-11#122)(2007-12#135)(2007-2#7)(2007-3#1)(2007-4#5)(2007-5#6)(2007-6#2)(2007-7#23)(2007-8#45)(2007-9#2)(2008-1#61)(2008-10#1105)(2008-11#253)(2008-12#95)(2008-2#168)(2008-3#332)(2008-4#91)(2008-5#179)(2008-6#82)(2008-7#191)(2008-8#136)(2008-9#106)(2009-1#4)(2009-10#38)(2009-11#26)(2009-12#29)(2009-2#9)(2009-3#24)(2009-4#16)(2009-5#18)(2009-6#22)(2009-7#32)(2009-8#25)(2009-9#24)(2010-1#15)(2010-10#17)(2010-11#22)(2010-12#30)(2010-2#14)(2010-3#21)(2010-4#24)(2010-5#35)(2010-6#18)(2010-7#13)(2010-8#44)(2010-9#8)(2011-1#61)(2011-10#1)(2011-2#178)(2011-3#6)(2011-7#3)(2011-9#1)(2012-1#32)(2012-12#70)(2012-2#122)(2012-3#89)(2012-4#2)(2012-5#2)(2012-6#2)(2012-7#1)(2012-8#3)(2012-9#2)(2013-1#165)(2013-7#27)(2013-8#90)
as abnormal##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
as about##2##2##(2008-1#1)(2008-10#1)
as above##6##2##(1995-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
as absolute##4##2##(2007-12#1)(2008-3#1)(2008-7#1)(2010-8#1)
as absorbance##2##2##(2008-10#1)(2011-1#1)
as acceptable##3##2##(2008-10#2)(2008-11#1)
as acceptor##4##2##(2008-10#3)(2009-8#1)
as acceptors##2##2##(1992-12#1)(2008-10#1)
as access##3##2##(1997-2#1)(2007-7#1)(2008-12#1)
as accuracy##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
as accurate as##2##3##(2008-10#1)(2012-2#1)
as accurate##3##2##(1997-3#1)(2008-10#1)(2012-2#1)
as accurately##2##2##(2008-3#2)
as actin##5##2##(1993-3#2)(1993-8#1)(2008-9#1)(2012-2#1)
as actinomycosis##2##2##(2008-1#1)(2009-5#1)
as activated##2##2##(2011-2#1)(2012-2#1)
as activators##2##2##(1994-9#1)(1996-2#1)
as active as##3##3##(1991-8#1)(1997-4#1)(2008-7#1)
as active ingredient##2##3##(2008-5#2)
as active##23##2##(1990-3#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#6)(2008-7#1)(2009-5#1)(2010-12#1)(2013-1#1)
as activity##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
as acute pancreatitis##2##3##(2010-6#1)(2013-8#1)
as acute##10##2##(2008-11#1)(2008-4#1)(2008-7#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
as added##2##2##(2008-10#2)
as additional##15##2##(1992-8#1)(1994-2#1)(1997-5#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2012-3#1)
as additive##6##2##(1990-3#1)(2008-10#4)(2008-2#1)
as adenosine##2##2##(1997-2#1)(2008-4#1)
as adjunct##2##2##(1992-5#1)(2008-1#1)
as adjunctive therapy in##2##4##(1994-12#1)(2011-2#1)
as adjunctive therapy##4##3##(1994-12#1)(2011-10#1)(2011-2#2)
as adjunctive treatment of##2##4##(2011-1#1)(2011-2#1)
as adjunctive treatment##4##3##(2011-1#1)(2011-2#2)(2013-8#1)
as adjunctive##8##2##(1994-12#1)(2011-1#1)(2011-10#1)(2011-2#4)(2013-8#1)
as adjuvant##5##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
as adjuvants to##2##3##(1990-11#1)(1990-3#1)
as adjuvants##3##2##(1990-11#1)(1990-3#1)(2008-5#1)
as administrators##2##2##(1992-2#1)(1993-12#1)
as adsorbent##5##2##(2008-10#3)(2013-1#1)(2013-8#1)
as adsorbents##2##2##(2008-10#2)
as adult##6##2##(1994-3#2)(2008-10#2)(2012-12#1)(2013-1#1)
as adults##11##2##(1994-2#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
as advanced##4##2##(1992-5#1)(1994-3#1)(2009-5#1)(2013-8#1)
as advances##2##2##(1991-2#1)(2009-12#1)
as adverse##4##2##(2007-10#1)(2008-10#1)(2009-7#1)(2011-2#1)
as advocated by##2##3##(2008-11#1)(2009-2#1)
as affected by##8##3##(1997-4#1)(2008-10#2)(2008-12#3)(2008-9#1)(2013-8#1)
as affinity##3##2##(1995-11#1)(1997-3#1)(2008-2#1)
as after##5##2##(1990-12#1)(1990-8#1)(1995-3#1)(2007-11#1)(2013-7#1)
as against the##2##3##(2008-12#1)(2008-5#1)
as against##5##2##(1991-6#1)(1992-11#1)(2007-9#1)(2008-12#1)(2008-5#1)
as age and##5##3##(1990-3#1)(1994-3#1)(2009-8#1)(2012-12#1)(2013-8#1)
as age##16##2##(1990-3#1)(1990-8#1)(1992-8#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
as aggressive##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
as aging##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
as agricultural##2##2##(2008-10#1)(2008-6#1)
as alanine##2##2##(2008-12#1)(2008-7#1)
as alcohol##4##2##(2008-11#1)(2010-4#1)(2010-5#1)(2013-8#1)
as alignment##2##2##(2008-2#1)(2008-4#1)
as alkaline phosphatase##2##3##(2008-10#1)(2008-11#1)
as alkaline##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
as all the##3##3##(1997-3#1)(2007-11#1)(2008-7#1)
as all##8##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
as alpha##4##2##(1990-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
as alpha- and##2##3##(1995-3#1)(2008-12#1)
as already##2##2##(2008-7#1)(2009-11#1)
as also their##2##3##(1993-11#1)(2008-11#1)
as also##13##2##(1990-5#1)(1991-5#1)(1992-11#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
as alterations in##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-6#1)
as alternative##10##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#1)
as alternatives to##9##3##(1993-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-7#1)
as amino acids##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
as amino##4##2##(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
as among##3##2##(1993-6#1)(2008-5#1)(2009-11#1)
as amounts##2##2##(2009-6#1)(2012-2#1)
as amperometric detector##2##3##(2008-10#2)
as amperometric##3##2##(2008-10#3)
as amplified##2##2##(2008-3#1)(2008-9#1)
as amplitude##4##2##(2008-2#2)(2008-3#2)
as amyloid##2##2##(1992-9#1)(2010-8#1)
as an &quot##5##3##(1992-2#1)(1992-6#1)(2008-8#1)(2009-5#1)(2013-8#1)
as an AC suspension##2##4##(2008-10#2)
as an Entry##2##3##(1996-5#1)(2010-10#1)
as an ability to##2##4##(2008-9#1)(2012-3#1)
as an ability##3##3##(1992-5#1)(2008-9#1)(2012-3#1)
as an absorbing solution##2##4##(2008-10#2)
as an absorbing##4##3##(2008-10#2)(2008-2#2)
as an academic##2##3##(2008-1#1)(2008-10#1)
as an acceptor##3##3##(1995-11#1)(1996-5#1)(2008-11#1)
as an accurate##2##3##(2007-10#1)(2008-11#1)
as an activator in the##2##5##(1995-2#1)(2008-10#1)
as an activator of##2##4##(2008-5#1)(2011-2#1)
as an activator##10##3##(1995-2#1)(2008-10#7)(2008-5#1)(2011-2#1)
as an active##7##3##(1992-3#1)(1994-9#1)(1995-6#1)(2008-10#2)(2008-11#1)(2012-3#1)
as an acute##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
as an adaptive##4##3##(1997-4#1)(2007-11#1)(2008-3#1)(2012-12#1)
as an add-on##2##3##(2008-7#1)(2013-8#1)
as an additional source of##2##5##(2009-9#1)(2010-6#1)
as an additional source##3##4##(2008-5#1)(2009-9#1)(2010-6#1)
as an additional tool##2##4##(2011-2#1)(2013-8#1)
as an additional##21##3##(1991-3#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-8#1)
as an additive in##2##4##(2008-10#1)(2011-2#1)
as an additive##5##3##(1996-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
as an address##2##3##(2008-11#1)(2009-11#1)
as an adequate##2##3##(2008-9#1)(2012-12#1)
as an adjunct therapy##2##4##(2008-7#2)
as an adjunct to the##2##5##(1995-2#1)(2013-1#1)
as an adjunct to##18##4##(1991-8#1)(1992-1#1)(1995-2#1)(1995-9#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
as an adjunct##23##3##(1991-8#1)(1992-1#1)(1995-2#1)(1995-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
as an adjunctive treatment##2##4##(1994-11#1)(2008-7#1)
as an adjunctive##3##3##(1994-11#1)(2008-5#1)(2008-7#1)
as an adjuvant for##2##4##(1991-5#1)(2011-2#1)
as an adjuvant to##4##4##(1990-2#1)(2008-10#1)(2008-5#1)(2010-7#1)
as an adjuvant##11##3##(1990-2#2)(1991-5#2)(1991-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
as an adult##3##3##(1994-6#1)(2008-10#1)(2010-4#1)
as an adverse##2##3##(2008-10#1)(2009-4#1)
as an agent##5##3##(2008-10#1)(2009-5#1)(2011-2#2)(2013-8#1)
as an agonist##7##3##(1992-12#1)(1993-6#2)(1994-2#1)(1994-9#1)(2008-6#1)(2008-7#1)
as an aid for##2##4##(2008-10#1)(2008-5#1)
as an aid in the##2##5##(1994-6#1)(2008-4#1)
as an aid in##5##4##(1991-11#1)(1991-12#1)(1994-6#1)(1997-8#1)(2008-4#1)
as an aid to##5##4##(1994-7#1)(1996-1#1)(1996-12#1)(2008-12#1)(2010-4#1)
as an aid##12##3##(1991-11#1)(1991-12#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)
as an alternative and##2##4##(2008-10#2)
as an alternative biocatalyst##2##4##(2008-10#2)
as an alternative for the##2##5##(2008-10#1)(2008-3#1)
as an alternative for##6##4##(1991-1#1)(2008-10#1)(2008-3#2)(2010-8#1)(2013-1#1)
as an alternative health care financing mechanism to the community##2##10##(2008-7#2)
as an alternative method to##3##5##(2008-10#2)(2008-5#1)
as an alternative method##6##4##(1994-9#1)(2007-5#1)(2008-10#3)(2008-5#1)
as an alternative natural reagent for##2##6##(2008-10#2)
as an alternative technique##2##4##(1991-12#1)(2008-10#1)
as an alternative to conventional##5##5##(1996-9#1)(2008-10#2)(2009-4#1)(2013-7#1)
as an alternative to more##2##5##(1996-2#1)(2012-3#1)
as an alternative to the classic##2##6##(1990-8#1)(2011-2#1)
as an alternative to the##12##5##(1990-8#1)(1995-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2010-5#1)(2011-2#1)
as an alternative to traditional##4##5##(1990-5#1)(1992-1#1)(2012-12#1)(2012-2#1)
as an alternative to##55##4##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-5#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-7#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
as an alternative##99##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-5#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-5#1)(2007-7#2)(2008-10#29)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#6)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)
as an amendment##2##3##(2008-10#2)
as an amperometric detector for flow injection analysis##2##8##(2008-10#2)
as an amperometric detector for the##2##6##(2008-10#2)
as an amperometric detector for##6##5##(2008-10#6)
as an amperometric sensor for##3##5##(2008-10#3)
as an amperometric##9##3##(2008-10#9)
as an analytical reagent##2##4##(2008-10#1)(2008-9#1)
as an analytical tool for##2##5##(1992-11#1)(2012-1#1)
as an analytical tool##4##4##(1992-11#1)(2008-10#1)(2008-7#1)(2012-1#1)
as an analytical##12##3##(1992-11#1)(2008-10#7)(2008-7#1)(2008-9#1)(2009-12#1)(2012-1#1)
as an animal model of##4##5##(1993-12#1)(1996-8#1)(2008-4#1)(2008-6#1)
as an animal model##7##4##(1993-12#1)(1996-2#1)(1996-8#1)(2008-4#1)(2008-6#1)(2013-1#2)
as an anion excluder##2##4##(2008-10#2)
as an anticoagulant##3##3##(1995-2#1)(1997-2#1)(2008-10#1)
as an antigen##9##3##(1993-3#1)(1994-11#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)
as an antioxidant##4##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
as an antiulcer agent##2##4##(1993-3#2)
as an application of##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
as an application##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
as an approach to##3##4##(1991-2#1)(1995-2#1)(2008-6#1)
as an appropriate##2##3##(2008-1#1)(2008-9#1)
as an area##2##3##(2008-10#1)(2013-7#1)
as an array##2##3##(2008-2#2)
as an assessment strategy##2##4##(2008-11#2)
as an assessment##4##3##(2008-11#4)
as an association##2##3##(1996-11#1)(2008-10#1)
as an attractive##4##3##(2008-11#1)(2009-7#1)(2010-11#1)(2012-12#1)
as an autocrine growth factor in##2##6##(1990-7#1)(1993-9#1)
as an autocrine##4##3##(1990-2#1)(1990-7#1)(1993-9#1)(2012-2#1)
as an autosomal dominant##2##4##(1997-3#1)(2007-7#1)
as an autosomal##3##3##(1994-9#1)(1997-3#1)(2007-7#1)
as an average##2##3##(2008-11#1)(2013-1#1)
as an early warning##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
as an early##11##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
as an editor##2##3##(2008-11#1)(2009-10#1)
as an effect##2##3##(2008-10#1)(2011-2#1)
as an effective and##2##4##(2008-5#1)(2009-6#1)
as an effective research tool for estimation of##2##8##(2008-11#2)
as an effective tool to##2##5##(1992-2#1)(2012-7#1)
as an effective treatment for##2##5##(2008-2#1)(2008-7#1)
as an effective treatment##3##4##(1997-6#1)(2008-2#1)(2008-7#1)
as an effective##32##3##(1992-2#1)(1993-3#1)(1996-9#1)(1997-2#2)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
as an effector##2##3##(1997-4#1)(2012-2#1)
as an efficient##8##3##(2008-10#3)(2008-11#1)(2008-3#2)(2011-2#1)(2011-3#1)
as an elective##2##3##(1996-12#1)(2008-10#1)
as an electroactive material##3##4##(2008-10#3)
as an electroactive##4##3##(2008-10#4)
as an electrocatalyst for##2##4##(2008-10#2)
as an electrochemical##5##3##(2008-10#5)
as an electron##2##3##(1991-5#1)(1996-3#1)
as an element of##3##4##(1991-3#1)(1992-12#1)(2013-1#1)
as an element##4##3##(1991-3#1)(1992-12#1)(2012-2#1)(2013-1#1)
as an elicitor##2##3##(1994-11#1)(2008-10#1)
as an emergency##3##3##(1993-9#2)(2008-7#1)
as an emergent##3##3##(2010-8#1)(2010-9#1)(2013-8#1)
as an emerging##4##3##(2007-7#1)(2009-5#1)(2010-10#1)(2010-11#1)
as an emission##2##3##(2008-10#2)
as an enabling##2##3##(1994-11#1)(1997-3#1)
as an end point##4##4##(1990-6#1)(2008-10#3)
as an end##5##3##(1990-6#1)(1991-9#1)(2008-10#3)
as an endocrine##3##3##(2008-10#1)(2008-4#1)(2009-6#1)
as an endogenous##2##3##(1996-12#1)(2008-11#1)
as an endpoint##2##3##(1992-9#1)(2008-10#1)
as an energy source for##2##5##(2008-4#1)(2011-2#1)
as an energy-dependent##2##3##(1994-5#1)(2008-11#1)
as an enhancer of##2##4##(2008-10#2)
as an enhancer##3##3##(2008-10#2)(2008-9#1)
as an entity##2##3##(1991-12#1)(2008-6#1)
as an enzymatic##3##3##(2008-10#2)(2012-2#1)
as an enzyme##4##3##(1995-12#1)(2008-10#2)(2008-5#1)
as an epidemic##4##3##(1992-2#2)(2008-10#1)(2010-12#1)
as an episome##2##3##(1995-2#1)(2008-8#1)
as an essential component##2##4##(2007-10#1)(2013-8#1)
as an essential##14##3##(1991-2#1)(1992-6#1)(1993-6#1)(1996-11#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
as an estimate##2##3##(1990-5#1)(2009-12#1)
as an evaluation##2##3##(1996-7#1)(2007-11#1)
as an evolutionary##2##3##(2008-8#1)(2008-9#1)
as an example for##2##4##(2013-8#2)
as an example of the##8##5##(1992-11#1)(1994-2#1)(1995-6#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-12#1)
as an example of##16##4##(1992-11#1)(1994-2#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#2)
as an example to show##2##5##(2008-11#1)(2008-8#1)
as an example to##4##4##(2008-11#1)(2008-8#1)(2012-3#2)
as an example with##2##4##(1997-8#1)(2008-10#1)
as an example##58##3##(1992-11#2)(1994-12#1)(1994-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2013-8#2)
as an excellent##9##3##(1991-2#1)(1996-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)
as an excisional##2##3##(1991-1#1)(1994-12#1)
as an excitation source##2##4##(2008-10#2)
as an excitation##3##3##(2008-10#2)(2008-5#1)
as an exemplar of a##2##5##(2008-10#1)(2008-7#1)
as an exemplar##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
as an exogenous##2##3##(2008-11#1)(2008-5#1)
as an experimental model##4##4##(1996-12#1)(2008-10#2)(2008-8#1)
as an experimental##7##3##(1994-2#1)(1996-12#1)(2008-10#4)(2008-8#1)
as an expert##3##3##(1994-12#1)(2010-10#1)(2012-2#1)
as an explanation for##4##4##(2008-7#1)(2008-8#2)(2008-9#1)
as an explanatory variable##2##4##(1997-7#1)(2008-8#1)
as an exploratory##2##3##(2008-10#1)(2012-3#1)
as an expression of the##2##5##(2008-10#1)(2008-4#1)
as an expression of##3##4##(2007-7#1)(2008-10#1)(2008-4#1)
as an expression##4##3##(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
as an extension of the##4##5##(1992-3#1)(2008-2#1)(2008-3#2)
as an extension of##9##4##(1991-12#1)(1992-11#1)(1992-3#1)(2007-11#1)(2008-2#2)(2008-3#2)(2010-7#1)
as an external##2##3##(1992-1#1)(2008-10#1)
as an extracellular##3##3##(2008-5#2)(2008-9#1)
as an extractant for##2##4##(2008-10#2)
as an extractant in##2##4##(2008-10#2)
as an extractant##10##3##(2008-10#10)
as an extraction##3##3##(2008-10#3)
as an extremely##2##3##(2008-2#1)(2008-8#1)
as an ideal##2##3##(2009-12#1)(2009-4#1)
as an illustration##2##3##(1994-2#1)(2008-3#1)
as an illustrative example##2##4##(2008-10#1)(2011-2#1)
as an illustrative##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
as an immobilized##2##3##(2008-10#2)
as an immunogen##2##3##(1991-9#1)(2008-11#1)
as an important aspect of##3##5##(1997-4#1)(2008-10#1)(2008-8#1)
as an important cause of##2##5##(2007-7#1)(2012-2#1)
as an important component of##2##5##(2008-11#1)(2008-3#1)
as an important component##4##4##(1992-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
as an important element in the##2##6##(1996-12#1)(2012-3#1)
as an important element in##3##5##(1992-2#1)(1996-12#1)(2012-3#1)
as an important factor in##3##5##(1997-8#1)(2008-5#1)(2010-3#1)
as an important factor##4##4##(1997-8#1)(2008-4#1)(2008-5#1)(2010-3#1)
as an important means of##2##5##(1992-2#1)(2011-1#1)
as an important mediator##2##4##(2008-6#1)(2010-9#1)
as an important method##2##4##(2008-11#1)(2013-3#1)
as an important part of the##3##6##(1990-6#1)(1993-12#1)(2008-9#1)
as an important part of##4##5##(1990-6#1)(1993-12#1)(2008-11#1)(2008-9#1)
as an important tool##3##4##(2008-11#1)(2008-2#1)(2010-3#1)
as an important##59##3##(1990-6#1)(1992-2#2)(1992-5#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-3#1)(2013-8#1)
as an improved##2##3##(2008-10#2)
as an improvement in##2##4##(1995-11#1)(2011-2#1)
as an in situ##3##4##(2007-12#2)(2008-3#1)
as an in vitro##2##4##(2008-11#2)
as an in vivo##2##4##(2008-1#1)(2008-5#1)
as an in##7##3##(2007-12#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)
as an incidental finding##3##4##(1993-5#1)(2007-8#1)(2008-7#1)
as an increase in the##2##5##(2008-10#1)(2008-11#1)
as an increase in##9##4##(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
as an increase##11##3##(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
as an increased##2##3##(2008-9#1)(2011-2#1)
as an independent check##2##4##(1993-3#1)(2008-2#1)
as an independent risk factor for##4##6##(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)
as an independent##13##3##(1993-3#1)(1994-12#3)(1994-7#1)(1996-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
as an index for##4##4##(1990-2#1)(1993-12#1)(2008-11#2)
as an index of anxiety in mice##2##7##(1994-3#2)
as an index of##16##4##(1990-6#1)(1992-6#1)(1993-6#1)(1994-3#3)(1995-12#3)(2008-11#2)(2008-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
as an index##21##3##(1990-2#1)(1990-6#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#3)(1995-12#3)(2008-10#1)(2008-11#4)(2008-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
as an indication for##2##4##(1990-2#1)(2011-2#1)
as an indication of the##2##5##(1990-5#1)(2008-4#1)
as an indication of##5##4##(1990-5#1)(1994-7#1)(2008-10#1)(2008-4#2)
as an indication##7##3##(1990-2#1)(1990-5#1)(1994-7#1)(2008-10#1)(2008-4#2)(2011-2#1)
as an indicator electrode for##2##5##(2008-10#2)
as an indicator electrode in potentiometric titration of##9##8##(2008-10#9)
as an indicator electrode in potentiometric##10##6##(2008-10#10)
as an indicator electrode in the potentiometric titration of##4##9##(2008-10#4)
as an indicator electrode in the potentiometric##5##7##(2008-10#5)
as an indicator electrode in##15##5##(2008-10#15)
as an indicator electrode##20##4##(2008-10#20)
as an indicator for##7##4##(1994-5#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
as an indicator of the##6##5##(2008-10#4)(2008-5#1)(2012-12#1)
as an indicator of##25##4##(1992-3#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-12#1)
as an indicator##60##3##(1992-3#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-11#1)(1996-12#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-12#1)
as an indirect##4##3##(1997-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
as an inducible##2##3##(1994-11#1)(2008-10#1)
as an infection##3##3##(1992-9#1)(2009-10#1)(2011-2#1)
as an inflammatory##2##3##(1996-7#1)(2012-3#1)
as an ingredient##3##3##(2008-9#2)(2010-4#1)
as an inhibitor of##7##4##(1990-11#1)(1991-8#1)(1995-3#1)(1995-6#1)(2008-11#3)
as an inhibitor##9##3##(1990-11#1)(1991-5#1)(1991-8#1)(1995-3#1)(1995-6#1)(2008-11#3)(2008-8#1)
as an inhibitory neurotransmitter of##2##5##(1991-5#2)
as an initial screening##2##4##(2008-10#2)
as an initial##13##3##(1994-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#2)
as an initiator##3##3##(1995-9#1)(2008-12#1)(2009-8#1)
as an input##2##3##(2008-2#1)(2008-3#1)
as an instrument for##2##4##(2011-1#1)(2012-2#1)
as an instrument##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
as an integral component of##3##5##(1996-3#1)(2008-4#1)(2012-2#1)
as an integral part of the##3##6##(1993-12#1)(2011-1#1)(2012-2#1)
as an integral part of##9##5##(1993-11#1)(1993-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
as an integral part##10##4##(1993-11#1)(1993-12#1)(1995-5#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
as an integral##13##3##(1993-11#1)(1993-12#1)(1995-5#1)(1996-3#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#2)
as an integrated part##2##4##(1994-2#1)(2008-7#1)
as an integrated##4##3##(1994-2#1)(2008-2#1)(2008-7#1)(2008-8#1)
as an integrator##2##3##(2009-8#1)(2011-2#1)
as an interdialytic##2##3##(2010-3#2)
as an interesting##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
as an interim##2##3##(1992-12#1)(1997-3#1)
as an intermediate layer promoted##2##5##(2008-12#2)
as an intermediate##5##3##(1992-2#1)(2008-12#2)(2008-4#1)(2009-11#1)
as an internal control##5##4##(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)
as an internal standard (IS)##2##5##(2008-10#2)
as an internal standard to correct for##2##7##(2008-1#1)(2008-10#1)
as an internal standard was##2##5##(2008-10#2)
as an internal standard##21##4##(1993-3#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-1#1)(2008-10#14)(2008-11#1)(2010-4#1)
as an internal##34##3##(1991-5#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)
as an interposition##3##3##(2007-8#1)(2008-9#1)(2011-2#1)
as an interpretation##3##3##(2008-10#1)(2013-1#2)
as an intervention##2##3##(1994-3#1)(2008-6#1)
as an intestinal##2##3##(2008-11#1)(2009-9#1)
as an intracavity##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
as an intracellular##6##3##(1990-7#1)(1992-9#1)(2008-1#1)(2008-10#2)(2013-1#1)
as an intraoperative##2##3##(2008-6#1)(2010-7#1)
as an intravenous bolus##2##4##(1992-12#1)(2008-6#1)
as an intravenous##4##3##(1992-12#1)(2008-1#1)(2008-6#1)(2012-2#1)
as an intrinsic##4##3##(1994-3#1)(2008-11#1)(2010-11#1)(2011-2#1)
as an ion carrier##2##4##(2008-10#2)
as an ion discriminator##2##4##(2008-10#2)
as an ion pair##2##4##(2008-10#2)
as an ion##9##3##(2008-10#8)(2008-11#1)
as an ion-pair##2##3##(2008-10#2)
as an ion-pairing reagent##2##4##(2008-10#1)(2010-3#1)
as an ionic##2##3##(2008-10#2)
as an ionization##2##3##(2008-10#2)
as an ionophore for##3##4##(2008-10#3)
as an ionophore in##2##4##(2008-10#2)
as an ionophore was prepared##2##5##(2008-10#2)
as an ionophore was##3##4##(2008-10#3)
as an ionophore##11##3##(2008-10#11)
as an isolated##8##3##(2007-7#1)(2008-10#1)(2008-7#2)(2012-3#1)(2013-1#3)
as an object of##2##4##(2012-3#1)(2013-1#1)
as an object##3##3##(2008-2#1)(2012-3#1)(2013-1#1)
as an objective##6##3##(1994-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
as an occupational##2##3##(2008-11#1)(2013-8#1)
as an oligomeric##2##3##(2010-9#2)
as an on-line##2##3##(2008-10#1)(2008-7#1)
as an open##2##3##(2009-12#1)(2011-2#1)
as an operational##2##3##(2008-3#1)(2008-4#1)
as an opportunity to##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
as an optical diode##2##4##(2007-11#2)
as an optical##17##3##(1996-5#1)(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#8)
as an optimal##2##3##(1992-9#1)(2008-10#1)
as an option for the control of##2##7##(2007-6#2)
as an option for##3##4##(2007-6#2)(2007-7#1)
as an optoelectronic##2##3##(2008-2#1)(2008-3#1)
as an oral##2##3##(2008-5#2)
as an organic modifier##4##4##(2008-10#4)
as an organic##6##3##(1995-12#1)(2008-10#5)
as an outcome measure##2##4##(1996-3#1)(2008-6#1)
as an outcome##3##3##(1996-3#1)(2008-6#1)(2011-2#1)
as an outpatient##3##3##(2008-5#1)(2008-7#1)(2010-8#1)
as an output coupler##2##4##(2008-2#2)
as an ovarian##2##3##(1992-9#1)(2011-2#1)
as an oxidant##3##3##(2008-10#3)
as an ultrafast optical##2##4##(2007-12#2)
as an untreatable##2##3##(2008-1#1)(2008-10#1)
as an unusual##4##3##(2006-10#1)(2007-7#1)(2008-9#1)(2013-7#1)
as an##1434##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#6)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#4)(1991-5#12)(1991-6#1)(1991-8#4)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#11)(1992-3#4)(1992-5#3)(1992-6#5)(1992-9#8)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#9)(1993-5#1)(1993-6#6)(1993-9#6)(1994-11#9)(1994-12#9)(1994-2#12)(1994-3#7)(1994-5#4)(1994-6#2)(1994-7#5)(1994-8#2)(1994-9#7)(1995-1#1)(1995-11#5)(1995-12#8)(1995-2#14)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#12)(1996-2#4)(1996-3#7)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#6)(1997-6#4)(1997-7#2)(1997-8#5)(2006-10#2)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#9)(2007-5#5)(2007-6#2)(2007-7#12)(2007-8#4)(2008-1#18)(2008-10#330)(2008-11#82)(2008-12#16)(2008-2#51)(2008-3#47)(2008-4#29)(2008-5#47)(2008-6#18)(2008-7#46)(2008-8#28)(2008-9#21)(2009-10#7)(2009-11#7)(2009-12#6)(2009-3#3)(2009-4#5)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#10)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#10)(2010-12#4)(2010-2#4)(2010-3#8)(2010-4#7)(2010-5#5)(2010-6#7)(2010-7#5)(2010-8#7)(2010-9#4)(2011-1#9)(2011-2#51)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#18)(2012-2#32)(2012-3#21)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#34)(2013-3#1)(2013-7#5)(2013-8#19)
as analysis of##2##3##(2008-10#1)(2013-8#1)
as analyte##2##2##(2008-10#2)
as analytes##4##2##(2008-10#3)(2008-4#1)
as analytical method for##2##4##(2008-10#1)(2008-5#1)
as analytical method##3##3##(2008-10#2)(2008-5#1)
as analytical signal##5##3##(2008-10#5)
as analytical tools##2##3##(2008-10#2)
as analytical##17##2##(1993-12#1)(2008-10#14)(2008-5#1)(2013-1#1)
as anchor##2##2##(2008-10#2)
as androgen##2##2##(2009-5#1)(2011-2#1)
as anemia##2##2##(2007-7#1)(2012-2#1)
as animal##5##2##(1992-9#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-12#1)
as anion##4##2##(2008-10#4)
as anionic##3##2##(2008-10#3)
as another cause of##2##4##(2006-10#1)(2011-2#1)
as another possible##2##3##(2008-10#1)(2008-7#1)
as another##12##2##(1991-2#1)(1994-11#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#2)
as antagonists##2##2##(1990-5#1)(2011-2#1)
as anterior##2##2##(1993-12#1)(2011-1#1)
as antibacterial agents##3##3##(1995-3#1)(2012-2#1)(2012-3#1)
as antibiotics##5##2##(1992-3#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-3#1)
as antibodies##4##2##(1990-2#1)(1992-6#1)(2008-11#1)(2008-4#1)
as anticipated##2##2##(1995-4#1)(2009-2#1)
as anticoagulant during the HD sessions##2##6##(2008-1#2)
as anticoagulant##3##2##(2008-1#2)(2013-1#1)
as anticonvulsant##2##2##(1995-12#1)(2008-11#1)
as antigen and##2##3##(2007-2#1)(2013-8#1)
as antigen##6##2##(1995-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
as antigens in##2##3##(1995-11#1)(2012-12#1)
as antigens##4##2##(1990-5#1)(1995-11#1)(1995-12#1)(2012-12#1)
as antioxidant##2##2##(2008-11#1)(2013-1#1)
as antioxidants##4##2##(1992-9#2)(2008-4#1)(2011-2#1)
as antitumor##3##2##(2008-11#1)(2011-3#1)(2012-3#1)
as any##7##2##(1991-11#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-4#1)
as apoptosis##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
as apparent##2##2##(2008-10#1)(2011-3#1)
as application##2##2##(1997-2#1)(2008-3#1)
as applied in##2##3##(1997-8#1)(2008-9#1)
as applied to the##5##4##(1997-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
as applied to##11##3##(1997-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-2#1)(2009-5#1)(2011-1#1)(2013-8#1)
as applied##18##2##(1997-4#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
as appropriate##9##2##(1997-1#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
as approximately 200##2##3##(2008-2#1)(2008-3#1)
as approximately##12##2##(1993-6#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2011-2#1)(2013-1#1)
as aptamers##2##2##(2009-12#1)(2010-11#1)
as aqueous solution##2##3##(2008-10#1)(2013-1#1)
as aqueous##5##2##(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
as arachidonic acid##2##3##(1992-6#1)(1993-8#1)
as are the##7##3##(1991-2#1)(1992-3#1)(1994-5#1)(1997-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
as are their##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
as are##25##2##(1991-2#1)(1992-3#2)(1994-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#2)(2012-12#1)
as arising from##2##3##(1995-2#1)(2009-5#1)
as arterial##2##2##(1997-6#1)(2008-11#1)
as artificial##5##2##(2008-10#3)(2009-5#1)(2012-12#1)
as ascospores##3##2##(2008-10#3)
as assayed by##6##3##(1991-12#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-10#2)
as assayed##8##2##(1991-12#1)(1993-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#2)
as assessed by fluorescence##2##4##(1992-6#1)(1995-6#1)
as assessed by the##13##4##(1990-5#1)(1992-3#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#1)
as assessed by##43##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
as assessed in##3##3##(1994-6#1)(1996-2#1)(2012-3#1)
as assessed on##3##3##(2008-7#2)(2008-9#1)
as assessed##53##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-9#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
as associated with##3##3##(1993-12#1)(2008-9#1)(2011-2#1)
as associated##4##2##(1993-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
as asthma##5##2##(1994-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
as asthmatics##2##2##(1994-3#1)(1997-4#1)
as asymptomatic##3##2##(1990-8#1)(2010-6#1)(2011-3#1)
as at least##2##3##(1997-1#1)(2013-1#1)
as at present##2##3##(1990-11#1)(2008-5#1)
as at the##6##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
as at##20##2##(1990-11#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
as atherosclerosis##9##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)
as atmospheric##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
as atrial##2##2##(2012-12#1)(2013-1#1)
as attention##2##2##(2008-4#1)(2013-1#1)
as attractive as##2##3##(2008-10#1)(2011-2#1)
as attractive##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
as autocrine and/or paracrine##2##4##(1992-9#1)(2008-4#1)
as autocrine##3##2##(1992-9#1)(2008-4#2)
as auxiliary##2##2##(2008-10#2)
as available##4##2##(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
as average##4##2##(1990-9#1)(1992-6#1)(2008-10#1)(2008-5#1)
as awareness of##2##3##(1994-1#1)(1996-9#1)
as background##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
as bacterial##2##2##(2008-7#1)(2009-3#1)
as bait##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
as barriers to invasion##2##4##(2007-7#2)
as basal##3##2##(1997-1#2)(2007-12#1)
as base##2##2##(2007-11#1)(2008-10#1)
as based on##2##3##(2011-2#1)(2013-1#1)
as baseline##2##2##(2008-10#1)(2008-7#1)
as basic##3##2##(1990-11#1)(1997-6#1)(1997-8#1)
as basis for##2##3##(1992-3#1)(2008-10#1)
as basis##3##2##(1992-3#1)(1993-2#1)(2008-10#1)
as beam##3##2##(2007-12#1)(2008-3#2)
as before##3##2##(2008-1#1)(2010-11#1)(2013-8#1)
as being a##5##3##(1991-8#1)(1997-4#1)(2008-11#2)(2008-5#1)
as being due to the combined##2##6##(2007-11#1)(2007-12#1)
as being due to##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
as being in the##2##4##(1992-3#1)(2013-1#1)
as being involved in the##2##5##(2008-4#1)(2008-9#1)
as being involved in##3##4##(1993-3#1)(2008-4#1)(2008-9#1)
as being more##3##3##(1996-9#1)(2009-9#1)(2010-10#1)
as being of##3##3##(1997-7#1)(2008-11#1)(2008-5#1)
as being one##2##3##(2008-1#1)(2012-2#1)
as being the most effective##2##5##(1995-5#1)(2013-1#1)
as being the most##3##4##(1995-5#1)(2011-2#1)(2013-1#1)
as being the##6##3##(1995-5#1)(2007-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
as being##73##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#8)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
as belonging to##4##3##(2008-10#4)
as benign##8##2##(2007-8#1)(2008-12#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
as berries aged##2##3##(2008-10#2)
as berries##4##2##(2008-10#3)(2012-12#1)
as best##5##2##(1991-6#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
as beta-lactamase##2##2##(1992-6#1)(2008-11#1)
as better##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
as between##8##2##(1992-12#1)(1994-6#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
as big##2##2##(1996-11#1)(2008-3#1)
as bile##2##2##(1990-8#1)(2008-11#1)
as binary##2##2##(2008-10#1)(2008-3#1)
as binder##3##2##(2008-1#1)(2008-10#2)
as binding##3##2##(1993-12#1)(2008-10#1)(2009-7#1)
as biochemical##3##2##(1991-12#1)(2007-11#1)(2008-10#1)
as biocontrol agents against##2##4##(2008-10#2)
as biocontrol agents of##2##4##(2008-10#2)
as biocontrol agents##4##3##(2008-10#4)
as biofilms##2##2##(2008-9#2)
as bioindicators##2##2##(1994-9#1)(2008-10#1)
as biological control agents##2##4##(2008-10#2)
as biological response##2##3##(2008-5#2)
as biological##16##2##(1994-5#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2010-8#1)(2011-3#1)
as biomarkers for##4##3##(2008-10#1)(2010-5#2)(2012-2#1)
as biomarkers of##3##3##(2008-10#1)(2010-5#2)
as biomarkers##11##2##(2008-10#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#4)(2012-12#1)(2012-2#1)
as biomass##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
as biosensors##2##2##(2007-12#1)(2008-10#1)
as bisexual##3##2##(2008-12#3)
as blood##7##2##(2008-10#3)(2010-11#1)(2010-4#1)(2012-2#2)
as board##2##2##(1994-12#1)(1994-2#1)
as body mass index##3##4##(2008-7#3)
as body##5##2##(2008-7#3)(2009-4#1)(2010-5#1)
as bone##6##2##(1991-11#1)(2007-11#1)(2008-9#1)(2011-7#1)(2012-12#1)(2012-2#1)
as both a##10##3##(1993-2#1)(1995-2#1)(1995-8#1)(2008-10#3)(2009-11#1)(2009-8#1)(2012-5#1)(2013-1#1)
as both the##6##3##(1992-9#1)(1997-2#1)(2008-10#1)(2008-3#2)(2013-1#1)
as both##45##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#14)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)
as bound##2##2##(2007-11#1)(2008-10#1)
as bovine serum albumin##2##4##(2008-10#2)
as bovine##5##2##(1994-8#1)(2008-10#2)(2008-11#1)(2010-2#1)
as brain##7##2##(2007-12#1)(2008-10#1)(2008-6#1)(2009-7#1)(2011-2#2)(2012-12#1)
as breast carcinoma##2##3##(1994-6#1)(1994-7#1)
as breast##6##2##(1994-6#1)(1994-7#1)(1997-3#1)(1997-8#1)(2010-6#1)(2012-2#1)
as bridge##2##2##(2008-10#1)(2010-6#1)
as broadband##2##2##(2008-2#1)(2008-3#1)
as buffer##2##2##(2008-10#2)
as built##2##2##(2008-3#2)
as bulk##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
as business##3##2##(1991-12#1)(1992-1#1)(2012-3#1)
as by increasing##2##3##(2008-10#1)(2008-6#1)
as by##48##2##(1990-12#1)(1990-8#1)(1991-12#1)(1993-6#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as c-Myc##2##2##(2008-11#1)(2011-2#1)
as calcite##2##2##(2008-10#2)
as calculated from the##2##4##(1996-2#1)(2008-10#1)
as calculated##5##2##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
as calibration##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
as calmagite##2##2##(2008-10#2)
as can be##3##3##(2008-1#1)(2008-12#1)(2008-3#1)
as can##6##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#2)(2011-2#1)
as cancer therapy##2##3##(1993-3#1)(2009-12#1)
as cancer vaccines##2##3##(1997-4#2)
as cancer##13##2##(1992-3#1)(1993-3#1)(1997-4#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-12#2)(2010-11#1)(2011-2#1)(2012-2#1)
as candidate genes##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
as candidate##6##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
as candidates for##4##3##(1990-4#1)(1996-5#1)(2007-5#1)(2009-5#1)
as capsaicin##2##2##(2008-11#1)(2008-7#1)
as capturing##2##2##(1993-2#1)(2009-10#1)
as carbohydrate##3##2##(1990-11#1)(1994-3#1)(2010-7#1)
as carbon and##2##3##(2008-6#1)(2012-3#1)
as carbon source##6##3##(1995-8#1)(2008-6#4)(2011-2#1)
as carbon##12##2##(1992-3#1)(1995-8#1)(2008-10#1)(2008-6#6)(2011-2#1)(2012-12#1)(2012-3#1)
as cardiovascular##5##2##(1991-11#1)(1993-2#1)(2008-10#1)(2008-7#1)(2010-7#1)
as caregivers##2##2##(2009-5#1)(2011-1#1)
as carrier for##3##3##(2008-10#2)(2012-2#1)
as carrier##17##2##(1994-3#1)(2008-10#14)(2008-7#1)(2012-2#1)
as carriers in##2##3##(2008-10#2)
as carriers##10##2##(1994-8#1)(1995-9#1)(2008-10#7)(2008-7#1)
as cartilage replacement materials##2##4##(2009-9#2)
as case##2##2##(1992-1#1)(1995-1#1)
as cases##6##2##(1990-10#1)(1991-9#1)(2007-12#1)(2008-12#1)(2010-4#1)(2011-1#1)
as catalyst in##2##3##(2011-2#1)(2013-1#1)
as catalyst##14##2##(1996-5#1)(2008-10#8)(2008-6#2)(2011-2#1)(2013-1#2)
as catalysts for##3##3##(1996-12#1)(2007-11#2)
as catalysts to##2##3##(2007-2#1)(2009-9#1)
as catalysts##9##2##(1992-8#1)(1994-12#1)(1996-12#1)(2007-11#2)(2007-2#1)(2008-12#1)(2009-9#1)(2013-1#1)
as cathode##3##2##(2008-10#3)
as cationic##2##2##(2008-10#2)
as causal##2##2##(2008-5#1)(2010-5#1)
as causative##2##2##(1997-4#1)(2008-1#1)
as cause of##3##3##(1991-4#1)(1992-5#1)(2009-4#1)
as cause##4##2##(1991-4#1)(1992-5#1)(2009-4#1)(2013-1#1)
as caused by rotational Raman scattering##2##6##(2008-3#2)
as caused by##4##3##(1996-3#1)(2008-10#1)(2008-3#2)
as causes of##5##3##(1996-6#1)(1997-4#1)(2007-7#1)(2013-1#1)(2013-8#1)
as cell surface##2##3##(2009-9#1)(2011-2#1)
as cell##23##2##(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#3)(2012-3#1)(2012-5#1)(2013-8#1)
as cells##11##2##(1993-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
as cellular##8##2##(1994-6#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
as central##4##2##(1990-7#1)(2007-8#1)(2008-10#1)(2011-1#1)
as cerebral##3##2##(2008-7#1)(2008-8#1)(2010-12#1)
as certain##8##2##(1991-3#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
as change##2##2##(1991-12#1)(1994-2#1)
as changes in##15##3##(1990-5#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-6#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
as changes##18##2##(1990-5#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-6#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-3#1)
as characteristic##3##2##(1994-9#1)(2007-8#1)(2008-7#1)
as characterized by##5##3##(1994-5#1)(1995-2#1)(2008-10#1)(2009-12#1)(2013-7#1)
as chelate extraction solvent##2##4##(2008-10#2)
as chelate##3##2##(2008-10#3)
as chelating agents in##2##4##(2008-10#2)
as chemical descriptors##6##3##(2008-10#6)
as chemical detectors##2##3##(2008-10#2)
as chemical modifier##13##3##(2008-10#13)
as chemical modifiers##4##3##(2008-10#4)
as chemical##36##2##(1990-7#1)(1994-5#1)(1995-11#1)(2008-10#29)(2008-11#2)(2008-3#1)(2009-2#1)
as chemiluminescent##2##2##(2008-10#2)
as chemopreventive##2##2##(2008-10#1)(2009-12#1)
as chemotherapy##2##2##(1990-11#1)(2008-7#1)
as chicken##2##2##(1995-6#1)(2008-5#1)
as chief##2##2##(2009-10#1)(2009-7#1)
as children but##2##3##(1990-5#1)(2011-2#1)
as children##5##2##(1990-5#1)(1992-3#1)(1994-6#1)(1996-11#1)(2011-2#1)
as chimeric##3##2##(1992-6#1)(2008-4#1)(2008-8#1)
as chiral selector##3##3##(2008-10#3)
as chiral selectors for the assay of##2##7##(2008-10#2)
as chiral selectors##6##3##(1995-6#1)(1996-5#2)(2008-10#3)
as chiral stationary phase##2##4##(2008-10#2)
as chiral##17##2##(1990-8#1)(1995-6#2)(1996-5#2)(2008-10#10)(2011-1#1)(2011-2#1)
as chloride##3##2##(1994-5#2)(2008-10#1)
as chlorophyll content##2##3##(2008-12#2)
as chlorophyll##4##2##(2008-11#1)(2008-12#3)
as cholera##2##2##(1993-6#1)(1994-9#1)
as cholesterol##2##2##(1990-12#1)(2008-10#1)
as chondrosarcoma##2##2##(2008-8#1)(2012-1#1)
as chromogenic reagent for##2##4##(2008-10#2)
as chromogenic reagent##6##3##(2008-10#6)
as chromogenic##7##2##(2008-10#7)
as chronic##8##2##(1991-12#1)(1992-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2013-1#1)
as cigarette##2##2##(2008-7#1)(2010-12#1)
as ciliary##2##2##(1995-11#1)(2008-3#1)
as cis-acting transcriptional regulators##2##4##(1997-4#2)
as cis-acting##3##2##(1997-4#3)
as classical##4##2##(1994-11#1)(2008-10#1)(2010-7#1)(2012-2#1)
as clean-up##2##2##(2008-10#2)
as clinical##15##2##(1991-3#1)(1994-11#1)(1994-12#3)(1995-12#1)(1997-4#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#1)
as clinicians##3##2##(1997-1#1)(2013-1#2)
as cloning##2##2##(2008-9#2)
as close as possible to the##6##6##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
as close as possible to##7##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-5#1)(2011-2#1)
as close as##9##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2010-5#1)(2011-2#1)
as close to##2##3##(2008-9#1)(2012-2#1)
as close##11##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
as closed##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
as closely##2##2##(1993-12#1)(2009-6#1)
as cluster##4##2##(2007-7#1)(2008-10#2)(2009-11#1)
as co-infection##2##2##(2008-8#1)(2011-2#1)
as coating##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
as coatings on##2##3##(2008-2#1)(2010-4#1)
as coenzyme##2##2##(2013-8#2)
as cofactors##4##2##(1994-11#1)(1995-5#1)(2008-4#1)(2012-12#1)
as cognitive##5##2##(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
as cold##2##2##(2009-8#1)(2010-3#1)
as collagen##4##2##(1992-6#1)(2008-5#1)(2008-9#1)(2012-2#1)
as combined##2##2##(1991-1#1)(2007-10#1)
as commercial##4##2##(2008-10#2)(2009-7#1)(2012-2#1)
as common as##6##3##(1992-11#1)(2008-1#2)(2008-7#1)(2008-8#1)(2010-6#1)
as common##11##2##(1992-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2011-4#1)
as commonly##2##2##(2008-6#1)(2008-7#1)
as compact##2##2##(2007-12#1)(2008-2#1)
as comparable##2##2##(2009-2#1)(2013-8#1)
as compared to 0##2##4##(2008-10#1)(2008-8#1)
as compared to a##4##4##(1991-6#1)(2008-5#1)(2008-6#1)(2008-7#1)
as compared to control##4##4##(1991-2#1)(1997-6#1)(2008-12#1)(2012-2#1)
as compared to controls##3##4##(1994-6#1)(1997-8#1)(2008-7#1)
as compared to conventional##2##4##(2008-7#1)(2010-3#1)
as compared to its##3##4##(1992-9#1)(2009-8#1)(2013-7#1)
as compared to natural##2##4##(1994-9#1)(2008-10#1)
as compared to other plants##2##5##(2013-1#2)
as compared to other##12##4##(1993-2#1)(1996-3#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-9#1)(2010-8#1)(2013-1#2)
as compared to parent##2##4##(1991-4#1)(2008-12#1)
as compared to patients##3##4##(2009-5#1)(2010-2#1)(2013-1#1)
as compared to rabeprazole and lansoprazole##2##6##(2012-2#2)
as compared to sham##3##4##(1993-6#1)(1996-12#1)(1996-9#1)
as compared to standard##2##4##(1990-8#1)(2013-1#1)
as compared to that of the##4##6##(1992-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
as compared to that of##10##5##(1992-6#1)(1993-8#1)(1997-4#2)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
as compared to that##12##4##(1992-6#1)(1993-8#1)(1997-4#2)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
as compared to the control##3##5##(1993-12#1)(1994-8#1)(2008-11#1)
as compared to the controls##3##5##(1992-12#1)(1994-5#1)(2008-7#1)
as compared to the other yeast strains##3##7##(2008-10#3)
as compared to the other##4##5##(1994-6#1)(2008-10#3)
as compared to the parent##2##5##(1997-4#1)(2008-10#1)
as compared to the standard##2##5##(2008-10#1)(2010-5#1)
as compared to the traditional##2##5##(2007-8#1)(2008-3#1)
as compared to the##65##4##(1990-11#1)(1990-7#3)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-12#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#14)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2010-3#1)(2010-5#3)(2011-2#4)(2012-2#3)(2013-8#1)
as compared to their control##2##5##(2008-12#1)(2012-2#1)
as compared to their##4##4##(1994-2#1)(2008-12#1)(2009-6#1)(2012-2#1)
as compared to those in##4##5##(2008-10#1)(2009-4#1)(2012-2#1)(2013-8#1)
as compared to those of##3##5##(1990-5#1)(2012-3#1)(2013-8#1)
as compared to those##11##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
as compared to vehicle##2##4##(1996-12#1)(2010-5#1)
as compared to young##3##4##(1991-12#2)(2008-7#1)
as compared to##256##3##(1990-11#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#3)(1995-8#4)(1996-12#3)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#3)(1997-4#4)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#2)(2007-7#6)(2007-8#3)(2008-1#2)(2008-10#35)(2008-11#12)(2008-12#6)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#14)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#6)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#14)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#9)
as compared with a single##2##5##(2008-10#1)(2008-2#1)
as compared with a##5##4##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
as compared with control##5##4##(1993-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-2#1)
as compared with controls (p##2##5##(2006-10#1)(2008-7#1)
as compared with controls##7##4##(1992-6#1)(1995-12#1)(2006-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
as compared with conventional##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
as compared with healthy##2##4##(1990-11#1)(2012-1#1)
as compared with intravenous##2##4##(1993-11#1)(1997-7#1)
as compared with normal##2##4##(1993-6#1)(2012-2#1)
as compared with other##8##4##(1992-11#2)(2007-1#1)(2008-10#2)(2008-3#1)(2011-2#2)
as compared with parental##2##4##(1992-8#1)(2008-10#1)
as compared with patients##2##4##(1996-3#2)
as compared with that of the control rats##2##8##(1993-11#1)(1995-12#1)
as compared with that of the##4##6##(1992-6#1)(1993-11#1)(1995-12#1)(1997-6#1)
as compared with that of##7##5##(1992-6#1)(1993-11#1)(1995-12#1)(1997-6#1)(2007-10#1)(2008-3#1)(2011-1#1)
as compared with that##10##4##(1992-6#1)(1993-11#1)(1995-12#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)
as compared with the control##6##5##(1993-1#1)(1993-12#2)(2008-10#2)(2008-9#1)
as compared with the controls##2##5##(2008-7#2)
as compared with the conventional##2##5##(2007-11#1)(2008-10#1)
as compared with the##44##4##(1990-2#1)(1991-2#1)(1993-1#1)(1993-12#4)(1995-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
as compared with those in##2##5##(1996-3#1)(2008-11#1)
as compared with those of##2##5##(2008-10#1)(2008-9#1)
as compared with those with##2##5##(1991-2#1)(1996-12#1)
as compared with those##10##4##(1991-2#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
as compared with untreated##2##4##(1993-8#1)(2010-11#1)
as compared with values##2##4##(1991-8#1)(2008-10#1)
as compared with##160##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-11#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2006-10#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#1)
as compared##416##2##(1990-11#2)(1990-2#1)(1990-5#5)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#5)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#4)(1993-12#7)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#8)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#4)(1996-12#4)(1996-2#1)(1996-3#5)(1996-5#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#2)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#69)(2008-11#13)(2008-12#7)(2008-2#1)(2008-3#11)(2008-4#5)(2008-5#10)(2008-6#9)(2008-7#20)(2008-8#3)(2008-9#5)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#6)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#3)(2012-12#4)(2012-2#16)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#10)
as competing##2##2##(1990-6#1)(2008-4#1)
as competitive inhibitors##2##3##(1992-9#1)(1997-2#1)
as competitive##5##2##(1992-9#1)(1996-3#2)(1997-2#1)(2008-8#1)
as competitors##2##2##(1990-12#1)(1993-12#1)
as complementary##6##2##(1990-12#1)(1992-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
as complete as##2##3##(1990-6#1)(2008-2#1)
as complete##5##2##(1990-6#1)(1992-10#1)(2008-10#2)(2008-2#1)
as complex as##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
as complex##9##2##(1991-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
as complexes with##2##3##(2008-10#1)(2008-5#1)
as complexes##4##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
as complexing agent##6##3##(2008-10#6)
as complexing agents for##2##4##(2008-10#2)
as complexing##10##2##(2008-10#10)
as complications of##3##3##(1990-6#1)(2007-7#1)(2012-12#1)
as components of the##2##4##(1994-5#1)(2010-1#1)
as components of##7##3##(1994-5#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-6#1)
as components##8##2##(1994-5#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-1#1)(2010-6#1)
as composite##2##2##(2008-2#1)(2008-9#1)
as comprehensive##3##2##(1994-3#1)(1994-8#1)(2011-2#1)
as comprising##2##2##(2008-9#1)(2011-1#1)
as concentrated##2##2##(2008-10#2)
as concentration of##3##3##(2008-10#2)(2008-11#1)
as concentration##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
as concentrations##2##2##(2008-10#1)(2009-6#1)
as concerns##2##2##(1990-9#1)(1997-6#1)
as concomitant##4##2##(2007-8#1)(2008-10#2)(2008-2#1)
as conditions##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
as confidence##2##2##(2008-10#1)(2009-10#1)
as confirmed by##10##3##(1990-8#1)(1991-2#1)(1992-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
as confirmed on##2##3##(1993-9#1)(2008-7#1)
as confirmed##14##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
as congenital##2##2##(2008-11#1)(2011-1#1)
as conidial##2##2##(2008-10#1)(2008-6#1)
as constituents of##2##3##(1994-9#1)(2008-2#1)
as constitutive##2##2##(1995-11#1)(2010-3#1)
as constraints##2##2##(1993-11#1)(2008-9#1)
as consultants##2##2##(1995-5#1)(2012-2#1)
as consumption##2##2##(2008-11#1)(2013-1#1)
as contaminant in##3##3##(2008-10#3)
as contaminants in##2##3##(2008-10#2)
as contaminants##4##2##(1990-12#1)(2008-10#2)(2008-5#1)
as continuous##4##2##(1996-1#1)(1997-7#1)(2007-12#1)(2011-1#1)
as contrast##3##2##(2007-11#1)(2008-7#1)(2013-8#1)
as contributing factors to##2##4##(2008-4#1)(2012-2#1)
as contributing factors##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
as contributing to##2##3##(2008-7#2)
as contributing##7##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
as contributors to##2##3##(2009-7#1)(2013-1#1)
as control group##2##3##(2008-12#1)(2011-2#1)
as control##32##2##(1993-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-9#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
as controlled##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
as controls for##4##3##(1992-2#1)(1997-9#1)(2008-10#1)(2008-3#1)
as controls##35##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-9#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)
as conventional agents##2##3##(2008-7#1)(2008-8#1)
as conventional##11##2##(1991-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
as conversion to an##2##4##(2008-3#1)(2010-3#1)
as conversion##3##2##(2008-3#1)(2008-7#1)(2010-3#1)
as cooking##2##2##(1992-10#1)(2010-4#1)
as coordinator##2##2##(2008-3#1)(2010-11#1)
as copper##2##2##(2008-10#1)(2013-1#1)
as copper(II)##3##2##(2008-10#3)
as core##3##2##(1996-1#1)(2008-8#1)(2010-8#1)
as cosmetic##4##2##(1997-3#1)(2008-5#2)(2012-2#1)
as could##4##2##(1991-12#1)(1992-3#1)(2008-10#1)(2008-7#1)
as counter##4##2##(1995-6#1)(2008-10#2)(2012-12#1)
as couplers##2##2##(1990-3#1)(2008-3#1)
as covariates in a##2##4##(2012-1#1)(2013-1#1)
as covariates##3##2##(1990-8#1)(2012-1#1)(2013-1#1)
as creatine##2##2##(1990-11#1)(1994-12#1)
as criteria for##2##3##(1996-12#1)(2008-10#1)
as criteria##7##2##(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2013-1#1)
as critical##11##2##(1995-2#1)(1995-5#1)(1996-5#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)
as crucial##5##2##(1996-5#1)(2008-2#1)(2008-5#1)(2009-3#1)(2013-1#1)
as cues##2##2##(2008-1#1)(2009-5#1)
as culture##2##2##(1995-2#1)(1996-12#1)
as cultures aged##2##3##(2008-10#2)
as cultures##3##2##(2008-10#2)(2008-7#1)
as cumulative##3##2##(2008-11#2)(2008-5#1)
as current##4##2##(1994-6#1)(1996-2#1)(2008-11#1)(2008-2#1)
as currently##2##2##(2008-3#1)(2008-9#1)
as customers##2##2##(1992-3#1)(1994-1#1)
as cutaneous##3##2##(2008-5#1)(2008-6#1)(2009-10#1)
as cutoff##2##2##(1993-11#1)(1994-7#1)
as cystic pulmonary##2##3##(2012-1#2)
as cystic##4##2##(2008-5#1)(2011-3#1)(2012-1#2)
as cytogenetic##2##2##(2010-3#1)(2013-8#1)
as cytokines##3##2##(1994-11#1)(2011-2#2)
as dangerous##2##2##(1991-6#1)(2012-12#1)
as data collection##2##3##(2008-3#1)(2010-8#1)
as data of##2##3##(2008-2#1)(2012-3#1)
as data##11##2##(1991-12#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-5#1)(2010-8#1)(2012-3#1)
as day##4##2##(1991-5#1)(1994-12#1)(2007-8#1)(2008-11#1)
as death##4##2##(1992-2#1)(1995-1#1)(1997-4#1)(2008-9#1)
as decreased##3##2##(2011-2#2)(2013-1#1)
as decreasing##3##2##(2008-9#1)(2012-2#1)(2012-3#1)
as deduced from the##2##4##(1991-2#1)(1993-6#1)
as deduced from##3##3##(1991-2#1)(1993-12#1)(1993-6#1)
as deep##3##2##(1994-3#1)(1996-2#1)(2012-3#1)
as defense##2##2##(2009-10#1)(2011-2#1)
as defined by the##7##4##(1992-5#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
as defined by##17##3##(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#1)(1995-2#2)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)
as defined##20##2##(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)
as degradation##2##2##(2008-10#2)
as degree of##2##3##(2007-7#1)(2008-7#1)
as delivery##3##2##(1995-5#1)(2010-10#1)(2010-8#1)
as demographic##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
as demonstrated by the##3##4##(1991-5#1)(2008-10#1)(2013-1#1)
as demonstrated by##25##3##(1991-5#1)(1993-11#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-10#7)(2008-5#2)(2009-12#1)(2009-9#1)(2011-2#2)(2013-1#1)
as demonstrated in##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
as demonstrated##32##2##(1991-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-12#1)(2007-7#1)(2008-10#7)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
as dependent variables the##2##4##(1990-3#1)(2008-10#1)
as dependent variables##4##3##(1990-3#1)(2008-10#1)(2010-4#1)(2012-2#1)
as dependent##5##2##(1990-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#1)
as depressed##2##2##(1995-12#1)(2008-12#1)
as depression##7##2##(1992-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
as derivatizing reagent##3##3##(1995-6#1)(2008-10#2)
as derived from##4##3##(1990-8#1)(1997-7#1)(2008-12#1)(2010-8#1)
as dermal##2##2##(2008-10#1)(2012-3#1)
as described above##3##3##(1995-12#1)(1996-2#1)(2011-2#1)
as described by##16##3##(1990-3#1)(1990-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1995-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-10#1)
as described for##4##3##(1991-2#1)(1995-6#1)(2008-5#1)(2011-10#1)
as described here##4##3##(2008-4#4)
as described in a##2##4##(2008-10#1)(2008-4#1)
as described in alternate protocols##2##5##(2008-4#2)
as described in the##8##4##(1997-3#1)(2008-2#1)(2008-4#3)(2008-7#1)(2011-7#1)(2012-1#1)
as described in this unit##3##5##(2008-4#3)
as described in this##5##4##(1997-1#1)(2008-4#3)(2008-8#1)
as described in##22##3##(1996-5#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#10)(2008-7#2)(2008-8#1)(2011-7#1)(2012-1#1)
as described previously in##2##4##(1995-12#2)
as described previously##4##3##(1990-11#1)(1994-11#1)(1995-12#2)
as described to##2##3##(2008-4#2)
as described##65##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1994-11#1)(1995-12#3)(1995-6#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-5#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#21)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2011-10#1)(2011-2#1)(2011-7#1)(2012-1#1)
as desired##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
as detailed in##2##3##(1992-3#1)(2008-4#1)
as detailed##5##2##(1992-3#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-9#1)
as detected by PCR##2##4##(1992-3#1)(2008-10#1)
as detected by the##2##4##(1994-3#2)
as detected by##14##3##(1992-3#2)(1994-3#2)(1995-2#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-9#2)(2012-2#1)(2012-3#1)
as detected##17##2##(1992-3#2)(1994-3#2)(1995-2#1)(1995-6#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#1)(2012-3#1)
as detecting##2##2##(2008-10#1)(2010-7#1)
as detection limit##3##3##(2008-10#3)
as detection system##2##3##(2008-10#2)
as detection##11##2##(2008-10#9)(2008-7#1)(2010-5#1)
as detector##12##2##(2008-10#10)(2008-2#1)(2011-3#1)
as detectors##6##2##(2008-10#6)
as determinants of##6##3##(1991-6#1)(1996-3#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)
as determinants##7##2##(1991-6#1)(1996-3#1)(2008-7#2)(2011-2#1)(2011-3#1)(2012-1#1)
as determination of##2##3##(2008-4#2)
as determined by ELISA##2##4##(1997-6#1)(2008-11#1)
as determined by SDS-PAGE##4##4##(1990-5#1)(1994-9#1)(1997-4#1)(2008-11#1)
as determined by a##4##4##(1994-8#1)(1995-2#1)(2009-2#1)(2010-9#1)
as determined by both##3##4##(1990-7#1)(1992-12#1)(1992-3#1)
as determined by circular dichroism##2##5##(1990-5#1)(1993-11#1)
as determined by in##2##4##(1997-6#1)(2008-7#1)
as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##4##8##(2008-10#4)
as determined by sodium dodecyl##5##5##(1990-7#1)(2008-10#4)
as determined by the number of##2##6##(1993-12#1)(1997-3#1)
as determined by the##18##4##(1990-8#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-7#1)(1994-8#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
as determined by##113##3##(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#3)(2008-10#25)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
as determined from the##2##4##(1990-11#1)(2008-10#1)
as determined from##5##3##(1990-11#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
as determined using##3##3##(1991-6#1)(1993-8#1)(2013-1#1)
as determined##126##2##(1990-11#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#4)(1993-6#1)(1993-8#3)(1994-11#2)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#3)(2007-11#1)(2008-10#28)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-9#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#2)(2013-1#3)
as developed##5##2##(1997-7#1)(2008-10#2)(2009-5#1)(2009-8#1)
as diabetes##7##2##(1995-2#1)(1996-12#1)(2007-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
as diabetic##5##2##(1994-8#1)(2007-8#1)(2008-1#2)(2012-2#1)
as diagnosis##2##2##(2008-5#1)(2013-1#1)
as diagnostic markers for##2##4##(2008-7#1)(2013-8#1)
as diagnostic markers##3##3##(2008-6#1)(2008-7#1)(2013-8#1)
as diagnostic tool##3##3##(2008-10#3)
as diagnostic##13##2##(2008-10#6)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2013-7#1)(2013-8#1)
as dialysis##2##2##(2007-7#1)(2011-1#1)
as did antigens from##2##4##(2008-10#2)
as did the##5##3##(1990-5#1)(1992-4#1)(1995-2#1)(1997-3#1)(2008-10#1)
as did##32##2##(1990-5#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#10)(2008-5#1)(2008-6#3)(2008-7#2)(2009-4#1)(2012-12#1)
as dietary supplements##2##3##(2008-5#1)(2008-7#1)
as dietary##3##2##(2008-5#2)(2008-7#1)
as differences in the##3##4##(2008-10#1)(2009-10#1)(2012-1#1)
as differences in##5##3##(1992-2#1)(1997-3#1)(2008-10#1)(2009-10#1)(2012-1#1)
as differences##8##2##(1992-2#1)(1997-3#1)(2008-10#2)(2009-10#1)(2010-1#1)(2012-1#1)(2012-12#1)
as different##10##2##(1990-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)
as different-sized##2##2##(1992-3#1)(2010-8#1)
as differential##3##2##(1997-4#1)(2008-10#1)(2008-4#1)
as differentiating##2##2##(2012-3#2)
as differentiation##4##2##(1991-12#1)(1991-5#1)(2008-12#1)(2008-8#1)
as difficult##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
as diffusion##2##2##(1993-12#1)(2010-12#1)
as digital##2##2##(2007-11#1)(2008-3#1)
as dimers##2##2##(1990-2#1)(1996-2#1)
as dimethyl##2##2##(2008-10#1)(2008-11#1)
as diploid##4##2##(1993-3#1)(2008-9#1)(2009-12#1)(2010-3#1)
as direct##10##2##(1994-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-12#2)
as directional##2##2##(2010-7#1)(2012-1#1)
as directly##4##2##(1993-11#1)(2009-8#1)(2011-1#1)(2011-2#1)
as discrete##5##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
as discriminant##2##2##(2008-10#2)
as discussed in this##2##4##(1990-11#1)(2008-12#1)
as discussed in##4##3##(1990-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
as discussed##8##2##(1990-11#1)(1992-2#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#1)
as disease incidence increased##2##4##(2008-10#2)
as disease incidence##3##3##(2008-10#3)
as disease##14##2##(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#7)(2008-7#1)(2009-7#1)(2011-2#1)
as disposable##3##2##(2008-10#3)
as distinct from##2##3##(1996-5#1)(2007-7#1)
as distinct species##2##3##(2008-10#2)
as distinct##8##2##(1996-5#1)(2007-7#1)(2008-10#2)(2008-6#1)(2010-10#1)(2010-8#1)(2012-12#1)
as diverse as##3##3##(2010-4#1)(2012-2#2)
as do the##3##3##(1990-8#1)(1991-12#1)(1995-5#1)
as do##9##2##(1990-8#1)(1991-12#1)(1994-3#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-6#1)
as docking##2##2##(1995-2#1)(1995-6#1)
as doctors##2##2##(1996-11#1)(2010-8#1)
as documented by##2##3##(2007-11#1)(2008-4#1)
as does its##2##3##(1995-11#1)(1997-7#1)
as does the##6##3##(2008-10#1)(2008-3#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
as does##15##2##(1992-6#1)(1994-9#1)(1995-11#1)(1997-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
as done##2##2##(2009-11#1)(2012-2#1)
as donor##6##2##(1996-5#1)(1997-7#1)(2008-10#1)(2008-9#2)(2009-8#1)
as dorsal##2##2##(2008-10#1)(2011-2#1)
as double##2##2##(2008-10#1)(2008-2#1)
as driving##2##2##(2008-10#1)(2011-1#1)
as drought##3##2##(1997-2#1)(2008-12#1)(2011-2#1)
as drug or##2##3##(2008-11#1)(2011-2#1)
as drug targets##2##3##(2008-5#1)(2012-1#1)
as drug##13##2##(1992-3#1)(1994-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
as dual##3##2##(2008-1#1)(2013-8#2)
as due to##5##3##(1995-5#2)(2007-12#1)(2008-1#1)(2008-2#1)
as duration of##5##3##(1991-12#1)(2008-10#2)(2012-12#1)(2013-1#1)
as during the##2##3##(1995-6#1)(2008-7#1)
as during##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
as dye##2##2##(2008-2#1)(2008-5#1)
as dynamic##3##2##(2007-8#1)(2008-7#1)(2008-9#1)
as each##6##2##(1991-5#1)(1994-1#1)(1994-6#1)(2008-7#1)(2008-9#1)(2012-1#1)
as early as 1##2##4##(1997-3#1)(2008-10#1)
as early as 2##2##4##(1997-3#1)(2008-10#1)
as early as 6 h##2##5##(1995-12#1)(1997-4#1)
as early as 8 h##2##5##(2008-10#1)(2009-12#1)
as early as day 3##2##5##(1991-5#1)(2007-8#1)
as early as day##3##4##(1991-5#1)(1994-12#1)(2007-8#1)
as early as possible to##3##5##(2007-2#1)(2012-12#1)(2013-1#1)
as early as possible##9##4##(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-8#1)(2012-12#1)(2013-1#2)
as early as the first##2##5##(2008-10#1)(2008-3#1)
as early as the##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
as early as##48##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
as early diagnosis and##2##4##(2007-7#1)(2010-5#1)
as early##58##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
as ecological##3##2##(2008-9#2)(2013-7#1)
as educating##2##2##(1995-12#1)(2008-10#1)
as education and##2##3##(2008-12#1)(2011-1#1)
as education##5##2##(2008-12#1)(2008-9#1)(2011-1#3)
as effective and##3##3##(1991-8#1)(1994-3#1)(1997-7#1)
as effective as possible##2##4##(2008-10#2)
as effective as that##2##4##(1993-9#1)(1994-3#1)
as effective as the##3##4##(1992-12#1)(2008-10#1)(2013-1#1)
as effective as their##2##4##(2008-5#2)
as effective as##31##3##(1990-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
as effective in reducing##2##4##(2008-10#1)(2011-2#1)
as effective in##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
as effective##54##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-7#2)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#11)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-7#1)(2011-2#3)(2013-1#3)
as effectively as the##3##4##(2008-10#2)(2013-1#1)
as effectively as##11##3##(1990-5#1)(1991-12#1)(1994-2#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-12#1)(2013-1#1)
as effectiveness##2##2##(1990-3#1)(2008-10#1)
as effector cells##2##3##(2008-4#1)(2008-8#1)
as effects##2##2##(2008-3#1)(2011-2#1)
as efficacious##2##2##(2008-7#1)(2008-8#1)
as efficiency##2##2##(2008-10#1)(2008-2#1)
as efficient as##6##3##(1990-12#1)(1991-9#1)(1994-2#1)(1997-3#1)(2008-10#2)
as efficient##10##2##(1990-12#1)(1991-9#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)
as efficiently as##3##3##(1990-5#1)(1994-8#1)(1995-12#1)
as efficiently in##2##3##(1991-12#1)(1997-4#1)
as efficiently##6##2##(1990-5#1)(1991-12#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-12#1)
as eight##2##2##(2008-12#1)(2008-3#1)
as either a##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
as either an##2##3##(2008-5#1)(2010-8#1)
as either##29##2##(1991-8#1)(1992-11#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
as electroactive material##3##3##(2008-10#3)
as electroactive##5##2##(2008-10#5)
as electrocatalysts for the##2##4##(2008-10#2)
as electrochemical##2##2##(2008-10#1)(2010-2#1)
as electrode##2##2##(2008-10#1)(2013-1#1)
as electrolyte##3##2##(2008-10#3)
as electron exchanger##2##3##(2008-10#2)
as electron##9##2##(1991-5#1)(1994-11#1)(2007-11#1)(2008-10#5)(2011-2#1)
as electronic##2##2##(1994-12#1)(2013-1#1)
as elemental##3##2##(1995-6#1)(2008-10#1)(2010-11#1)
as elements##2##2##(1994-12#1)(2011-2#1)
as elevated##5##2##(2007-9#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
as elsewhere in the##2##4##(2007-12#1)(2008-10#1)
as elsewhere##4##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
as eluent and##3##3##(2008-10#3)
as eluent##14##2##(2008-10#14)
as embryonic development##2##3##(2008-5#1)(2012-1#1)
as embryonic##3##2##(2008-5#1)(2008-7#1)(2012-1#1)
as emerging##4##2##(2008-6#1)(2011-2#1)(2012-2#2)
as emotion-focused##2##2##(2011-2#2)
as emulsifying##2##2##(2008-10#1)(2008-5#1)
as encoding a##2##3##(1991-6#1)(1991-9#1)
as encoding##4##2##(1991-6#1)(1991-9#1)(1996-10#1)(2008-10#1)
as endogenous##7##2##(1991-1#2)(1991-12#1)(1995-1#1)(1995-5#1)(2008-4#1)(2008-7#1)
as endothelial##3##2##(2008-9#1)(2009-10#1)(2011-2#1)
as endpoints##4##2##(1992-9#1)(1994-2#1)(2007-11#1)(2008-7#1)
as energy##7##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#1)
as enhanced##4##2##(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)
as enriched##2##2##(2008-7#1)(2008-9#1)
as entry##2##2##(1997-5#1)(2007-12#1)
as environmental##6##2##(1994-2#1)(1994-6#1)(2008-10#2)(2010-11#1)(2012-3#1)
as environmentally##2##2##(2008-10#2)
as enzymatic##3##2##(2008-10#3)
as enzyme immobilization##2##3##(2008-10#2)
as enzyme##8##2##(1990-5#1)(1993-3#1)(2008-10#5)(2011-2#1)
as eosinophils##2##2##(1992-2#1)(1992-3#1)
as epidemiological##2##2##(2007-7#1)(2008-10#1)
as epidermal##2##2##(1994-12#1)(2008-10#1)
as episomes##3##2##(1991-6#1)(2008-1#1)(2008-11#1)
as equal to##2##3##(1992-6#1)(1995-3#1)
as equal##4##2##(1990-8#1)(1992-6#1)(1995-3#1)(2013-1#1)
as equilibrium##2##2##(2008-10#2)
as essential##7##2##(1995-1#1)(1996-11#1)(2008-10#1)(2008-12#1)(2009-6#1)(2012-2#1)(2013-1#1)
as established##3##2##(1994-5#1)(1996-12#1)(2009-10#1)
as estimated by the##3##4##(1993-9#1)(1997-2#1)(2008-10#1)
as estimated by##8##3##(1993-9#1)(1995-3#1)(1997-2#2)(2008-10#2)(2008-3#1)(2009-11#1)
as estimated from##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
as estimated##13##2##(1991-6#1)(1993-9#1)(1995-3#1)(1997-2#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)
as estimation of##2##3##(2008-10#1)(2012-2#1)
as ethanol##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
as eukaryotic##2##2##(2008-9#1)(2011-2#1)
as evaluated by the##2##4##(1993-12#1)(2008-10#1)
as evaluated by##6##3##(1993-12#1)(1994-9#1)(1996-9#1)(2007-8#1)(2008-10#2)
as evaluated from##2##3##(1992-12#1)(2008-10#1)
as evaluated##11##2##(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-9#1)(1996-9#1)(2007-8#1)(2008-10#3)(2008-11#1)
as even##2##2##(2008-5#1)(2010-6#1)
as ever##2##2##(1992-9#1)(2008-6#1)
as evidence for##6##3##(1994-5#2)(1996-2#1)(2008-10#1)(2008-8#1)(2010-11#1)
as evidence of##7##3##(1991-5#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
as evidence that the##2##4##(1991-5#1)(2007-12#1)
as evidence that##6##3##(1991-5#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
as evidence##20##2##(1991-5#2)(1993-9#1)(1994-5#2)(1996-2#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
as evidenced by a decrease in number of##2##8##(1991-2#2)
as evidenced by a decrease in##4##6##(1991-2#2)(1997-3#1)(2008-8#1)
as evidenced by a##9##4##(1991-2#2)(1992-8#1)(1993-3#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
as evidenced by increased##3##4##(1997-3#1)(2009-4#1)(2011-2#1)
as evidenced by reoperation##2##4##(2012-12#2)
as evidenced by the fact that##2##6##(2008-10#1)(2008-11#1)
as evidenced by the##9##4##(1992-3#1)(1994-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
as evidenced by##47##3##(1991-2#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#2)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
as evidenced from the##2##4##(2008-3#1)(2008-7#1)
as evidenced from##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
as evidenced##52##2##(1991-2#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-3#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
as evident##2##2##(1994-11#1)(2008-10#1)
as evolutionary##2##2##(2007-12#1)(2008-10#1)
as examined by##2##3##(1994-2#1)(2007-12#1)
as examined##3##2##(1990-3#1)(1994-2#1)(2007-12#1)
as example##2##2##(2008-10#1)(2008-9#1)
as examples for##2##3##(1990-12#1)(2008-2#1)
as examples##8##2##(1990-12#1)(1995-3#1)(2008-2#3)(2009-6#1)(2010-11#1)(2012-2#1)
as excellent and good##2##4##(2008-5#1)(2012-1#1)
as excellent or good##2##4##(2008-3#1)(2012-1#1)
as excellent or##3##3##(1990-6#1)(2008-3#1)(2012-1#1)
as excellent##8##2##(1990-6#1)(1992-2#1)(1993-2#1)(2008-3#1)(2008-5#1)(2012-1#2)(2012-2#1)
as excitation and emission##2##4##(2008-10#2)
as excitation and##3##3##(2008-10#3)
as excitation source is##2##4##(2008-10#2)
as excitation source##4##3##(2008-10#4)
as excitation##7##2##(2008-10#7)
as exclusive##2##2##(1994-1#1)(2010-3#1)
as exemplified by the formation of##2##6##(2008-10#2)
as exemplified by the##3##4##(2008-10#2)(2008-5#1)
as exemplified by##5##3##(1997-1#1)(2008-10#2)(2008-5#2)
as exercise##4##2##(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
as exerting##2##2##(2008-11#1)(2008-7#1)
as expected for a##2##4##(2008-11#1)(2009-2#1)
as expected for##6##3##(1994-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)
as expected from the##2##4##(1992-12#2)
as expected from##7##3##(1992-12#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)
as expected in##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
as expected to##4##3##(1994-5#1)(2007-12#3)
as expected##51##2##(1990-5#1)(1990-8#1)(1992-10#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-8#2)(2007-12#7)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
as expensive##3##2##(1991-2#1)(2007-7#1)(2013-7#1)
as experience##2##2##(1994-2#1)(2009-5#1)
as experimental##11##2##(1993-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2012-3#1)(2013-1#1)
as exposure to##2##3##(2008-11#1)(2012-3#1)
as exposure##3##2##(1993-8#1)(2008-11#1)(2012-3#1)
as expressed by##4##3##(1990-2#1)(1997-4#1)(2008-10#2)
as expressed in##3##3##(2008-10#3)
as expressed##8##2##(1990-2#1)(1997-4#1)(2008-10#5)(2012-12#1)
as expression of##2##3##(1990-6#1)(1996-11#1)
as expression##5##2##(1990-6#1)(1996-11#1)(2008-10#1)(2012-12#1)(2012-3#1)
as extensive##2##2##(1997-1#1)(2006-12#1)
as external##9##2##(1995-1#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2013-8#1)
as extra##2##2##(2008-10#1)(2012-3#1)
as extracellular##7##2##(1990-5#1)(1993-3#1)(1995-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-12#1)
as extractant##8##2##(2008-10#8)
as extractants##4##2##(2008-10#4)
as extraction solvent##2##3##(2008-10#2)
as extraction solvent)##2##3##(2008-10#2)
as extraction##6##2##(2008-10#6)
as extremely##2##2##(1995-12#1)(2008-10#1)
as facial nerve##2##3##(2007-8#1)(2008-9#1)
as facial##3##2##(2007-8#1)(2008-12#1)(2008-9#1)
as facilitators##2##2##(1995-3#1)(2012-3#1)
as factors in the optimization##4##5##(2008-10#4)
as factors in the##5##4##(2008-10#5)
as factors in##6##3##(2008-10#5)(2010-8#1)
as factors that##2##3##(1996-2#1)(2008-8#1)
as factors##14##2##(1992-12#1)(1994-8#1)(1996-2#1)(2008-10#7)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
as fair and##3##3##(2007-11#1)(2008-7#1)(2009-3#1)
as familial##2##2##(1990-3#1)(1994-11#1)
as family##4##2##(1992-1#1)(2008-11#1)(2011-1#1)(2012-2#1)
as family's##2##2##(1994-2#1)(2010-11#1)
as far as possible##4##4##(1990-2#1)(1997-7#1)(2008-11#1)(2011-2#1)
as far as the##7##4##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)
as far as we know##4##5##(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
as far as we##6##4##(1994-1#1)(1994-7#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
as far as##35##3##(1990-2#1)(1990-3#1)(1991-2#2)(1991-9#1)(1994-1#1)(1994-7#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
as far##38##2##(1990-2#1)(1990-3#1)(1991-2#2)(1991-6#1)(1991-9#1)(1993-2#1)(1994-1#1)(1994-7#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
as fast and accurate##2##4##(2007-12#1)(2008-3#1)
as fast as##5##3##(1994-3#1)(1996-2#1)(2008-3#2)(2012-2#1)
as fast##10##2##(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#1)(2012-2#1)
as fat##2##2##(1997-8#1)(2007-12#1)
as fatigue##3##2##(2008-10#1)(2009-1#1)(2012-1#1)
as feasible##2##2##(2012-12#1)(2013-1#1)
as feeding##3##2##(2008-10#1)(2008-9#1)(2009-9#1)
as female##3##2##(1997-2#1)(2008-5#1)(2008-9#1)
as females##3##2##(1995-2#1)(2008-1#1)(2012-3#1)
as fever##4##2##(2008-1#1)(2009-4#1)(2011-2#1)(2012-2#1)
as few as 100##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
as few as##10##3##(1995-3#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
as few of the##2##4##(1991-12#1)(2008-9#1)
as few##14##2##(1991-12#1)(1995-3#1)(2008-10#4)(2008-3#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
as fiber##2##2##(2008-10#1)(2008-2#1)
as fibroblasts##2##2##(1994-8#1)(2012-3#1)
as filter##2##2##(2008-10#1)(2013-1#1)
as final product##2##3##(2008-10#2)
as first choice##3##3##(1990-6#1)(1991-6#1)(2008-3#1)
as first line therapy for##2##5##(1992-6#1)(1993-12#1)
as first line##3##3##(1992-6#1)(1993-12#1)(2011-1#1)
as first##14##2##(1990-6#1)(1991-6#1)(1992-6#1)(1993-12#2)(1997-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#1)(2011-1#2)(2011-2#1)
as first-line chemotherapy##2##3##(2008-6#1)(2013-8#1)
as first-line therapy##4##3##(1992-8#1)(1994-12#1)(2007-2#1)(2013-8#1)
as first-line treatment##2##3##(1997-3#1)(2008-3#1)
as first-line##11##2##(1992-8#1)(1993-2#1)(1994-12#1)(1997-3#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#1)(2013-8#2)
as fish##2##2##(2008-9#1)(2012-1#1)
as fixed anionic##2##3##(2008-10#2)
as fixed##3##2##(2008-10#2)(2008-8#1)
as flavonoids##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
as flow rate##2##3##(2008-10#2)
as flow##11##2##(2008-10#7)(2008-9#2)(2010-7#1)(2011-1#1)
as fluorescein##2##2##(2008-4#1)(2008-9#1)
as fluorescence probe to##2##4##(2013-8#2)
as fluorescence##10##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)(2013-8#3)
as fluorescent##8##2##(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)
as fluorophore##2##2##(2008-10#2)
as foliar##2##2##(2008-10#2)
as folk##2##2##(2009-12#1)(2011-1#1)
as follow-up##4##2##(1992-5#1)(1992-8#1)(2007-8#1)(2010-1#1)
as following##4##2##(2008-12#2)(2011-2#1)(2012-12#1)
as follows (in ng##2##4##(2008-10#2)
as follows##109##2##(1990-10#2)(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#4)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-2#3)(1996-8#1)(1997-2#3)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-7#1)(2013-1#6)(2013-8#2)
as food additives##2##3##(1994-3#1)(2011-2#1)
as food preservative##2##3##(2008-8#2)
as food##13##2##(1994-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
as for a##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
as for other##6##3##(1995-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-12#1)
as for the##24##3##(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-12#1)(2013-1#2)
as for##103##2##(1990-11#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#3)(1994-12#3)(1995-12#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
as foreshocks##2##2##(1996-4#2)
as formal##2##2##(1996-1#1)(2008-11#1)
as forms of##2##3##(1997-3#1)(2012-3#1)
as found by##2##3##(1993-9#1)(2008-10#1)
as found in##2##3##(1991-2#1)(1992-9#1)
as found##6##2##(1991-2#1)(1992-9#1)(1993-9#1)(1997-6#1)(2008-10#1)(2008-3#1)
as four##8##2##(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)
as fragile##2##2##(1997-5#1)(2011-2#1)
as free radical scavenger##2##4##(1995-11#1)(2008-5#1)
as free radical##3##3##(1995-11#1)(2008-5#2)
as free##11##2##(1991-9#1)(1992-4#1)(1994-8#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2011-1#1)
as freezing##2##2##(2008-11#1)(2008-7#1)
as frequency and##2##3##(2008-3#1)(2012-1#1)
as frequency##4##2##(2007-11#1)(2008-3#2)(2012-1#1)
as frequent as##2##3##(1990-12#1)(1997-3#1)
as frequent##5##2##(1990-12#1)(1997-3#1)(2008-1#1)(2011-2#1)(2011-3#1)
as frequently as##2##3##(2007-4#1)(2008-11#1)
as frequently##3##2##(2007-4#1)(2008-10#1)(2008-11#1)
as freshly##4##2##(1995-11#1)(2008-10#2)(2008-7#1)
as fringe##2##2##(2008-2#1)(2008-3#1)
as from##29##2##(1990-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
as fuel##3##2##(1997-6#1)(2008-10#1)(2009-8#1)
as full term infants##2##4##(1990-11#2)
as full##6##2##(1990-11#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
as fully##3##2##(1993-6#1)(2008-10#2)
as function of##4##3##(1993-3#1)(2008-10#3)
as functional##8##2##(1995-3#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
as functions of the##15##4##(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-8#1)(2011-2#1)(2013-8#1)
as functions of time##3##4##(1990-8#1)(2007-11#1)(2008-2#1)
as functions of##31##3##(1990-8#1)(1991-12#1)(1994-2#1)(1994-3#1)(2007-11#3)(2008-10#1)(2008-2#7)(2008-3#10)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
as fundamental##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
as fusion proteins with##2##4##(1994-12#1)(1997-4#1)
as fusion proteins##5##3##(1994-12#1)(1995-11#1)(1997-4#2)(2008-10#1)
as futile##2##2##(1996-3#1)(2010-12#1)
as future##3##2##(1994-12#1)(2012-12#1)(2012-3#1)
as gas##2##2##(2008-10#1)(2008-11#1)
as gatekeepers##3##2##(1996-1#1)(2009-6#1)(2012-2#1)
as gay or lesbian##3##4##(2008-12#3)
as gay##5##2##(1997-5#1)(2008-12#4)
as gender##3##2##(1993-12#1)(2007-7#1)(2008-11#1)
as gene expression##5##3##(1996-6#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-3#1)
as gene##16##2##(1994-11#1)(1996-6#1)(1996-9#1)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#1)
as general##4##2##(1993-1#1)(2008-4#1)(2008-7#1)(2010-6#1)
as generalized##2##2##(2008-10#2)
as generally##2##2##(2008-5#1)(2010-7#1)
as genes##3##2##(2008-5#1)(2009-11#1)(2010-11#1)
as genetic analyses##2##3##(2008-8#1)(2013-1#1)
as genetic##13##2##(1995-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2013-1#1)
as genetically##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
as genomic##3##2##(1994-11#1)(2010-10#1)(2010-3#1)
as geographical##2##2##(2008-11#1)(2008-8#1)
as given by##3##3##(1997-4#1)(2008-2#1)(2008-3#1)
as given##5##2##(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
as global##2##2##(2009-7#1)(2011-1#1)
as glucose##10##2##(1990-5#1)(1992-12#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2011-1#1)
as glutamic##2##2##(1995-6#2)
as glutathione##4##2##(1992-9#1)(2008-5#2)(2010-5#1)
as good as or better than the##2##7##(2008-2#1)(2008-9#1)
as good as or better than##3##6##(1996-3#1)(2008-2#1)(2008-9#1)
as good as the##4##4##(1996-11#1)(1997-8#1)(2009-11#1)(2011-1#1)
as good as those##2##4##(2009-6#1)(2011-2#1)
as good as##16##3##(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
as good##28##2##(1994-8#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#3)
as governments##2##2##(1994-2#1)(2008-1#1)
as graduate##2##2##(1996-2#1)(2012-3#1)
as grafted##2##2##(2008-10#1)(2013-1#1)
as granular##2##2##(2008-3#1)(2008-7#1)
as great as 0##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
as great as 6##2##4##(2008-3#2)
as great as that##2##4##(1992-5#1)(2012-2#1)
as great as the##3##4##(1992-11#1)(1995-12#1)(2008-3#1)
as great as##28##3##(1992-11#1)(1992-5#1)(1995-12#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#12)(2008-5#1)(2012-2#1)
as great for##2##3##(1991-8#1)(2013-8#1)
as great##33##2##(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1995-12#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
as greater##4##2##(2007-10#1)(2007-2#1)(2008-4#1)(2012-3#1)
as green##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
as group##4##2##(1994-12#1)(2006-6#1)(2008-12#1)(2008-4#1)
as growth factors##2##3##(1993-5#1)(2008-5#1)
as growth in##2##3##(1993-1#1)(1994-1#1)
as growth##9##2##(1991-12#1)(1992-12#1)(1993-1#1)(1993-5#1)(1994-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
as guidance for##2##3##(2012-12#1)(2013-1#1)
as guidance##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
as guidelines for##2##3##(1992-12#1)(1996-2#1)
as guidelines##3##2##(1992-12#1)(1996-2#1)(1996-6#1)
as guides##2##2##(1995-1#1)(1996-12#1)
as habitat##2##2##(2008-5#1)(2008-8#1)
as habitats for the##2##4##(1992-6#1)(2011-2#1)
as habitats for##3##3##(1992-6#1)(2011-2#1)(2012-2#1)
as half the##2##3##(2007-11#1)(2008-7#1)
as hard##3##2##(2008-2#1)(2010-8#1)(2011-1#1)
as has been##10##3##(1990-12#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(2006-10#1)(2008-10#3)
as has the role of training to implement pain assessment##2##10##(2013-1#2)
as has the##3##3##(2008-10#1)(2013-1#2)
as has##17##2##(1990-12#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#2)
as have been##2##3##(2007-2#1)(2007-8#1)
as have##4##2##(2007-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
as having a key role in##2##6##(2008-11#1)(2010-6#1)
as having a significant##2##4##(2008-5#1)(2011-2#1)
as having a##19##3##(1992-11#1)(1992-7#1)(1994-2#1)(1994-9#1)(1996-9#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#4)(2012-2#1)
as having either##2##3##(2008-10#1)(2008-3#1)
as having high##2##3##(1993-1#1)(2009-5#1)
as having the##5##3##(1991-11#1)(1995-11#2)(2008-11#1)(2008-3#1)
as having##77##2##(1990-2#1)(1991-11#2)(1991-4#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#2)(2009-5#1)(2010-3#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#2)
as he was##2##3##(2008-10#1)(2010-7#1)
as he##5##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)
as head##3##2##(2007-12#1)(2009-5#1)(2011-2#1)
as health advocates for##2##4##(1992-2#1)(2007-5#1)
as health advocates##4##3##(1992-2#1)(2007-5#2)(2008-11#1)
as health care##4##3##(1993-12#1)(1995-1#2)(2008-11#1)
as health policy##2##3##(1993-12#1)(1997-1#1)
as health##22##2##(1990-10#1)(1991-12#1)(1992-2#1)(1993-12#2)(1993-3#2)(1995-1#2)(1996-12#2)(1996-3#1)(1997-1#2)(1997-3#1)(2007-5#2)(2008-11#2)(2010-12#1)(2010-9#1)(2011-1#1)
as healthcare##2##2##(2008-9#1)(2011-2#1)
as healthy as##2##3##(2008-11#1)(2008-8#1)
as healthy leaf area duration##2##5##(2008-10#2)
as healthy##9##2##(1991-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
as heart##6##2##(2008-5#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-8#1)
as heat and##2##3##(1996-12#1)(2008-2#1)
as heat##6##2##(1996-12#1)(1996-2#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
as heavy atom##2##3##(2008-10#2)
as heavy##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
as helper##2##2##(2008-10#1)(2008-8#1)
as hemoglobin##4##2##(1990-8#1)(1994-11#1)(2008-1#1)(2008-7#1)
as hemorrhage##2##2##(2008-4#1)(2011-2#1)
as hepatic##2##2##(1995-3#1)(2013-1#1)
as her##2##2##(2008-11#1)(2008-8#1)
as heterodimers##2##2##(1995-8#1)(2011-1#1)
as heterologous probes##2##3##(2008-10#2)
as heterologous##3##2##(2008-10#2)(2008-11#1)
as high as 0##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
as high as 1##12##4##(1990-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2012-1#1)
as high as 10##2##4##(1995-2#1)(2008-2#1)
as high as 100##2##4##(2008-10#1)(2010-7#1)
as high as 19##3##4##(1992-8#1)(2008-3#2)
as high as 2##3##4##(2008-3#2)(2008-7#1)
as high as 3##4##4##(1993-8#1)(1995-8#1)(2007-11#2)
as high as 30##3##4##(1992-3#1)(2008-3#1)(2008-5#1)
as high as 30%##2##4##(2008-2#1)(2012-12#1)
as high as 300##2##4##(2007-11#1)(2008-11#1)
as high as 5##2##4##(2008-10#1)(2013-1#1)
as high as 50##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
as high as 500##2##4##(2008-11#1)(2008-2#1)
as high as 6##2##4##(2007-12#1)(2008-3#1)
as high as 80##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
as high as 80%##2##4##(1991-12#1)(2007-10#1)
as high as 90##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
as high as 90%##5##4##(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
as high as 93%##2##4##(1997-4#1)(2011-2#1)
as high as a##3##4##(1994-5#1)(2008-2#2)
as high as in the##3##5##(2008-11#2)(2008-8#1)
as high as possible##2##4##(2007-12#1)(2008-10#1)
as high as that##2##4##(2007-8#1)(2008-11#1)
as high as the##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
as high as##130##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-8#1)(2008-10#17)(2008-11#9)(2008-2#13)(2008-3#21)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
as high in##2##3##(1990-2#1)(2013-1#1)
as high levels of##2##4##(1997-2#1)(2010-1#1)
as high##166##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#12)(2008-12#2)(2008-2#14)(2008-3#21)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
as high-risk##3##2##(2007-10#1)(2009-8#1)(2010-8#1)
as higher##7##2##(1992-2#1)(1994-3#1)(2008-10#2)(2008-8#1)(2009-7#1)(2012-2#1)
as highly concentrated##2##3##(2008-10#1)(2011-2#1)
as highly##7##2##(2008-10#3)(2008-4#2)(2011-2#1)(2013-1#1)
as his##3##2##(2009-10#1)(2010-3#1)(2012-12#1)
as histamine##2##2##(1991-12#1)(1997-1#1)
as histone##2##2##(1991-5#1)(2008-7#1)
as homogeneous as possible##2##4##(1995-12#1)(2008-10#1)
as homogeneous##3##2##(1995-12#1)(2008-10#1)(2008-6#1)
as hospital##8##2##(1993-2#1)(1994-2#2)(1995-3#1)(1996-3#1)(2008-11#1)(2010-12#1)(2012-12#1)
as hospitals##4##2##(1991-2#1)(1992-3#1)(2007-12#1)(2012-12#1)
as host differentials##2##3##(2008-10#2)
as host##7##2##(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
as hosts for##2##3##(2008-11#1)(2012-2#1)
as hosts##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
as hot##2##2##(1991-6#1)(2009-10#1)
as household##3##2##(1997-4#1)(2008-5#1)(2012-12#1)
as how the##2##3##(1993-11#1)(2008-6#1)
as how to##3##3##(1995-2#1)(2008-9#1)(2010-11#1)
as how##11##2##(1992-3#1)(1993-11#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-11#1)
as human##20##2##(1992-10#1)(1992-12#1)(1993-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
as humans##2##2##(2007-8#1)(2010-4#1)
as hybridization probes##3##3##(2008-10#3)
as hybridization##4##2##(2008-10#4)
as hydrogen sulfide##2##3##(2008-10#2)
as hydrogen##9##2##(2007-11#1)(2008-10#4)(2008-4#1)(2010-12#1)(2010-5#1)(2010-7#1)
as hydrophobic##3##2##(2008-10#3)
as hydrotropic##2##2##(2010-5#2)
as hydroxides##3##2##(2008-10#3)
as hypertension##12##2##(1996-11#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-5#1)(2011-1#1)(2012-2#1)
as hyphae##2##2##(2008-10#2)
as ideal##4##2##(2007-12#1)(2008-10#1)(2009-10#1)(2009-8#1)
as identical##2##2##(2008-10#1)(2008-8#1)
as identified by##5##3##(1991-8#1)(1995-6#1)(2008-10#1)(2009-5#1)(2012-12#1)
as identified##9##2##(1991-8#1)(1995-6#1)(2008-10#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#2)
as idiopathic##4##2##(2006-10#1)(2010-10#1)(2010-6#1)(2013-8#1)
as if it were##2##4##(1995-12#1)(2008-8#1)
as if it##3##3##(1992-9#1)(1995-12#1)(2008-8#1)
as if the##2##3##(1993-9#1)(2008-8#1)
as if they were##4##4##(1995-12#1)(2008-3#1)(2009-1#1)(2011-2#1)
as if they##6##3##(1995-12#1)(1995-5#1)(2008-3#1)(2009-1#1)(2011-2#2)
as if##14##2##(1992-9#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-5#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-1#1)(2011-2#2)
as illness##2##2##(2009-9#1)(2013-1#1)
as illustrated by a##3##4##(1991-6#1)(2008-10#1)(2010-8#1)
as illustrated by the##5##4##(1994-11#1)(1994-2#1)(2008-4#1)(2012-12#1)(2012-2#1)
as illustrated by##9##3##(1991-6#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
as illustrated##10##2##(1991-6#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
as illustrations##2##2##(2008-10#1)(2008-11#1)
as image##3##2##(2007-12#1)(2008-6#2)
as imaging##3##2##(1994-5#1)(2010-6#1)(2012-2#1)
as immune##2##2##(2008-10#1)(2009-2#1)
as immunogens##3##2##(2008-10#2)(2008-5#1)
as immunological##4##2##(1994-9#1)(2008-5#1)(2012-2#1)(2013-7#1)
as impaired##2##2##(2009-8#1)(2012-2#1)
as implemented by##2##3##(1994-2#1)(1997-5#1)
as implemented for##2##3##(2008-3#1)(2009-12#1)
as implemented##4##2##(1994-2#1)(1997-5#1)(2008-3#1)(2009-12#1)
as important as the##2##4##(2008-11#2)
as important as##8##3##(1990-12#1)(1992-12#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-1#1)
as important aspects##2##3##(2011-2#2)
as important components##2##3##(2007-2#1)(2008-7#1)
as important in##6##3##(1991-6#1)(1995-5#1)(1996-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
as important##41##2##(1990-12#1)(1991-6#1)(1992-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
as improved##7##2##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
as in a##11##3##(1990-11#1)(1993-11#1)(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-11#1)(2012-12#2)
as in acute##2##3##(1997-4#1)(2008-7#1)
as in adults##2##3##(1992-4#1)(2010-3#1)
as in all##2##3##(1996-11#1)(1997-1#1)
as in an##2##3##(1994-3#1)(2008-10#1)
as in epilepsy##2##3##(1995-5#1)(2008-8#1)
as in human##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
as in intact plants##2##4##(2008-10#1)(2008-11#1)
as in intact##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
as in mammals##2##3##(1997-7#2)
as in many other##3##4##(1993-12#1)(2008-10#1)(2010-8#1)
as in many##4##3##(1993-12#1)(2008-10#2)(2010-8#1)
as in normal##3##3##(2008-7#2)(2008-8#1)
as in other##12##3##(1991-12#1)(1991-9#1)(1993-6#1)(1994-9#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-2#1)
as in our case##2##4##(2006-10#1)(2008-2#1)
as in our##4##3##(1990-2#1)(1990-8#1)(2006-10#1)(2008-2#1)
as in pharmaceutical##2##3##(2008-10#1)(2008-5#1)
as in several##2##3##(2008-3#1)(2009-3#1)
as in soil##2##3##(2008-10#2)
as in solutions##2##3##(1991-8#1)(2008-10#1)
as in the case of the##6##6##(1991-5#1)(1995-3#1)(1996-2#1)(2008-10#2)(2013-1#1)
as in the case of##17##5##(1991-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#1)(2009-6#1)(2009-7#1)(2013-1#1)
as in the general population##2##5##(1997-3#1)(2008-1#1)
as in the other##2##4##(1993-12#1)(2008-10#1)
as in the rest of the##2##6##(1990-3#1)(2008-2#1)
as in the rest of##3##5##(1990-3#1)(1992-9#1)(2008-2#1)
as in the##121##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#2)(2008-10#22)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-7#2)
as in their##3##3##(2008-10#1)(2010-8#1)(2012-12#1)
as in this##2##3##(2006-10#1)(2012-1#1)
as in vitro##5##3##(1993-3#1)(1993-8#1)(1995-3#1)(1997-7#1)(2008-10#1)
as in vivo##5##3##(2007-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
as in##379##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#4)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#5)(1997-8#3)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-7#1)(2008-1#9)(2008-10#61)(2008-11#18)(2008-12#5)(2008-2#6)(2008-3#13)(2008-4#5)(2008-5#14)(2008-6#5)(2008-7#12)(2008-8#15)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#3)(2010-8#2)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#1)
as in-patient##2##2##(2011-2#2)
as inappropriate##2##2##(2009-5#1)(2013-8#1)
as incidence of##3##3##(2007-4#1)(2008-10#1)(2012-12#1)
as incidence##4##2##(2007-4#1)(2008-10#1)(2008-11#1)(2012-12#1)
as incidental findings##2##3##(1990-9#1)(1993-9#1)
as incidental##3##2##(1990-9#1)(1993-9#1)(2008-1#1)
as increase in##2##3##(1995-12#1)(2011-1#1)
as increased##17##2##(1992-8#1)(1993-2#1)(1994-6#1)(1996-2#1)(1997-4#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
as increases in##2##3##(2008-4#1)(2008-7#1)
as increases##3##2##(1992-6#1)(2008-4#1)(2008-7#1)
as independent factors##2##3##(2011-2#1)(2013-8#1)
as independent of##2##3##(2008-10#1)(2012-12#1)
as independent variables##7##3##(1990-3#1)(1993-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)
as independent##24##2##(1990-3#1)(1990-9#1)(1993-8#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
as indicated by a##4##4##(1994-5#1)(1995-8#1)(2008-8#1)(2012-7#1)
as indicated by an##2##4##(1996-12#1)(2012-9#1)
as indicated by low##3##4##(1992-9#1)(2008-10#2)
as indicated by the##15##4##(1991-2#1)(1991-5#1)(1992-6#1)(1995-3#1)(1996-12#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-5#1)(2013-1#1)
as indicated by their##4##4##(1990-5#1)(1995-3#2)(2008-10#1)
as indicated by##52##3##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-10#1)(1994-5#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#2)(1997-1#1)(2007-12#3)(2007-5#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2012-2#1)(2012-7#1)(2012-9#1)(2013-1#1)
as indicated in##2##3##(1997-3#1)(2008-10#1)
as indicated##55##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-10#1)(1994-5#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-3#1)(2007-12#3)(2007-5#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#2)(2012-2#1)(2012-7#1)(2012-9#1)(2013-1#1)
as indicating##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
as indicative of their##2##4##(1990-8#1)(2010-3#1)
as indicative of##4##3##(1990-8#1)(2008-5#1)(2008-7#1)(2010-3#1)
as indicator electrode##2##3##(2008-10#2)
as indicator of tumor##2##4##(2011-2#2)
as indicator of##3##3##(2008-10#1)(2011-2#2)
as indicator##9##2##(1990-7#1)(2008-10#4)(2009-12#1)(2011-2#2)(2013-8#1)
as indicators of##10##3##(1991-5#1)(1992-3#2)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
as indicators##11##2##(1991-5#1)(1992-3#2)(1996-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
as indices of##4##3##(1992-3#1)(1996-12#1)(1996-7#1)(2008-7#1)
as indices##5##2##(1992-3#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-7#1)
as indirect##3##2##(1996-12#1)(2008-9#1)(2011-2#1)
as individual##12##2##(1992-6#1)(1993-6#1)(1995-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2011-2#1)
as individuals##2##2##(2008-11#1)(2011-1#1)
as infants##2##2##(2007-2#1)(2008-11#1)
as infected##2##2##(2008-10#1)(2012-2#1)
as infection##6##2##(1994-11#1)(2008-10#2)(2008-6#1)(2012-12#1)(2012-2#1)
as infectious mononucleosis##2##3##(1992-2#1)(2008-9#1)
as infectious##6##2##(1990-8#1)(1992-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
as inferred by##2##3##(1991-2#1)(2008-10#1)
as inferred from the##2##4##(1996-5#1)(2010-8#1)
as inferred from##6##3##(1995-6#2)(1996-5#1)(2008-7#1)(2010-3#1)(2010-8#1)
as inferred##8##2##(1991-2#1)(1995-6#2)(1996-5#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-8#1)
as inflammatory##2##2##(2008-6#1)(2008-7#1)
as influenced by##2##3##(2008-10#1)(2011-2#1)
as influencing##3##2##(2007-10#2)(2008-11#1)
as information##5##2##(1997-1#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
as inhibitor of##2##3##(2009-4#1)(2013-7#1)
as inhibitors of human 5##2##5##(1995-3#2)
as inhibitors of##19##3##(1991-11#1)(1991-9#1)(1992-12#1)(1992-8#3)(1992-9#1)(1993-3#1)(1995-2#1)(1995-3#4)(1996-2#1)(1997-4#1)(2008-11#1)(2009-9#1)(2012-3#1)(2013-1#1)
as inhibitors##24##2##(1990-11#2)(1991-11#1)(1991-9#1)(1992-12#1)(1992-8#3)(1992-9#1)(1993-3#1)(1995-2#1)(1995-3#5)(1996-2#1)(1997-4#1)(1997-7#1)(2008-11#1)(2009-9#1)(2012-3#2)(2013-1#1)
as inhibitory##3##2##(1997-2#1)(2008-11#1)(2008-7#1)
as initial manifestation of##2##4##(1991-3#1)(2008-10#1)
as initial##9##2##(1991-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
as inoculum sources for##2##4##(2008-10#2)
as inoculum##8##2##(1997-6#1)(2008-10#7)
as input data##2##3##(2007-12#1)(2008-10#1)
as input variables to##2##4##(2008-10#1)(2013-8#1)
as input variables##5##3##(2008-10#4)(2013-8#1)
as input##17##2##(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#4)(2012-12#1)(2013-7#1)(2013-8#1)
as inputs for the##2##4##(2008-10#2)
as inputs for##3##3##(2008-10#3)
as inputs##4##2##(2008-10#4)
as insensitivity to##2##3##(2008-10#1)(2009-8#1)
as insoluble chromolytic substrates for the determination of proteolytic activity##2##10##(1990-2#2)
as insoluble##3##2##(1990-2#2)(1991-7#1)
as institutional##2##2##(1996-3#1)(2012-3#1)
as insulin##8##2##(1990-8#1)(1992-11#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
as insurance##2##2##(1991-3#1)(1995-12#1)
as intact##2##2##(2008-10#1)(2008-4#1)
as integral##2##2##(1991-6#1)(1995-12#1)
as integrated##3##2##(1996-3#1)(2008-10#1)(2008-8#1)
as intense##2##2##(1995-3#1)(2008-5#1)
as intensity##2##2##(2007-11#1)(2008-3#1)
as interacting##2##2##(1997-7#1)(2013-1#1)
as interference##2##2##(2008-10#2)
as interferon-gamma##2##2##(2008-4#1)(2013-1#1)
as intermediaries##3##2##(1996-12#1)(1997-8#1)(2010-5#1)
as intermediate hosts##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
as intermediate##5##2##(2007-8#1)(2008-8#1)(2011-2#2)(2013-8#1)
as intermediates in##2##3##(1990-11#1)(1996-5#1)
as intermediates##4##2##(1990-11#1)(1995-6#1)(1996-5#1)(2008-4#1)
as internal reference##2##3##(2008-10#2)
as internal standard (IS)##2##4##(2008-10#2)
as internal standard for##2##4##(2008-10#2)
as internal standard to compensate##2##5##(2008-10#2)
as internal standard to##3##4##(2008-10#3)
as internal standard##28##3##(2008-10#22)(2008-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
as internal standards in reversed-phase high-performance liquid chromatography##2##8##(1990-8#2)
as internal standards##6##3##(1990-8#2)(2008-10#3)(2008-9#1)
as internal##43##2##(1990-8#2)(1994-12#1)(2008-10#29)(2008-12#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
as interpreted##2##2##(1997-6#1)(2008-8#1)
as intestinal##3##2##(2009-8#1)(2013-1#1)(2013-8#1)
as intracellular##5##2##(1995-8#1)(2008-2#1)(2008-4#1)(2010-7#1)(2012-6#1)
as intravenous##3##2##(1993-1#2)(2010-7#1)
as introducing##3##2##(2008-9#1)(2010-10#1)(2012-2#1)
as intron##2##2##(1993-2#2)
as ion associates##2##3##(2008-10#2)
as ion##8##2##(2008-10#7)(2010-11#1)
as ionic strength##2##3##(2008-10#2)
as ionophore with##2##3##(2008-10#2)
as ionophore##12##2##(2008-10#12)
as ionophores##5##2##(2008-10#5)
as iron##5##2##(1995-3#1)(2008-10#3)(2008-11#1)
as irritable##2##2##(2012-12#1)(2013-8#1)
as is a##3##3##(1994-2#1)(1996-5#1)(2008-9#1)
as is common in the##2##5##(2008-3#1)(2010-7#1)
as is necessary##2##3##(1990-9#1)(2008-2#1)
as is often##2##3##(2008-11#1)(2011-2#1)
as is reflected##2##3##(1995-9#1)(2012-12#1)
as is seen in##3##4##(2008-9#1)(2013-8#2)
as is the case for##4##5##(1990-5#1)(1991-6#1)(1994-5#1)(1995-6#1)
as is the case in##4##5##(1993-11#1)(2008-8#1)(2009-10#1)(2011-2#1)
as is the case with##3##5##(1990-5#1)(2008-4#1)(2013-7#1)
as is the case##14##4##(1990-5#2)(1991-6#1)(1993-11#1)(1994-5#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
as is the##26##3##(1990-10#1)(1990-11#1)(1990-5#2)(1991-6#1)(1992-1#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
as is typical##2##3##(2007-11#1)(2007-12#1)
as is well##2##3##(2008-3#1)(2012-12#1)
as is##67##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-9#1)(1991-6#1)(1992-1#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
as ischemic##4##2##(1992-9#1)(2008-1#1)(2008-7#1)(2011-1#1)
as isolated##9##2##(1993-11#1)(1993-8#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#1)(2013-1#1)
as isolates##2##2##(2008-10#2)
as isotope##2##2##(2008-10#2)
as it accumulates##2##3##(1994-9#1)(2013-8#1)
as it allows##2##3##(2010-10#1)(2010-4#1)
as it appears##2##3##(1994-9#1)(2008-7#1)
as it applies to##2##4##(2008-1#1)(2010-11#1)
as it applies##3##3##(2008-1#1)(2010-11#1)(2012-7#1)
as it can be##3##4##(2008-11#2)(2008-9#1)
as it can##7##3##(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
as it causes##2##3##(2008-8#1)(2011-2#1)
as it determines##2##3##(2008-10#1)(2013-1#1)
as it did##2##3##(2008-12#1)(2008-7#1)
as it does in##2##4##(1991-12#1)(2010-10#1)
as it does##4##3##(1991-12#1)(2008-3#1)(2010-10#1)(2012-12#1)
as it evolves##2##3##(1997-3#1)(2008-6#1)
as it had##2##3##(2009-7#1)(2013-1#1)
as it has##6##3##(1991-1#1)(1997-4#1)(2007-2#1)(2008-10#1)(2011-2#2)
as it is a##3##4##(2008-7#1)(2009-2#1)(2009-4#1)
as it is for##2##4##(2008-3#2)
as it is in the##4##5##(1990-5#1)(1991-1#1)(1995-11#1)(2008-7#1)
as it is in##5##4##(1990-5#1)(1991-1#1)(1995-11#1)(2007-12#1)(2008-7#1)
as it is known##2##4##(1992-2#1)(2011-2#1)
as it is more##2##4##(2008-10#1)(2008-8#1)
as it is of##2##4##(2011-1#1)(2013-7#1)
as it is the case##2##5##(2008-10#1)(2008-5#1)
as it is the##3##4##(1990-8#1)(2008-10#1)(2008-5#1)
as it is##44##3##(1990-5#1)(1990-8#1)(1991-1#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)
as it may##3##3##(1992-8#1)(2007-8#1)(2008-10#1)
as it normally##2##3##(1992-3#1)(2008-5#1)
as it offers##2##3##(2007-7#1)(2012-3#1)
as it often##2##3##(1990-9#1)(2013-1#1)
as it passes through##2##4##(2008-2#1)(2008-3#1)
as it penetrates##2##3##(2009-8#1)(2013-8#1)
as it permits##2##3##(1995-6#1)(1997-8#1)
as it propagates##3##3##(2008-3#2)(2009-6#1)
as it provides##3##3##(2008-10#2)(2010-6#1)
as it related to##4##4##(2008-11#1)(2008-12#3)
as it relates to##11##4##(1994-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
as it requires##3##3##(2007-11#1)(2008-9#1)(2009-8#1)
as it was##16##3##(1990-5#1)(1990-8#1)(1997-1#1)(2007-12#2)(2008-10#4)(2008-12#2)(2008-4#1)(2008-7#2)(2010-12#1)(2010-2#1)
as it would##2##3##(2008-2#1)(2013-8#1)
as it##197##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#7)(2008-12#11)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#3)(2009-1#1)(2009-2#3)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#3)(2012-2#3)(2012-3#6)(2012-7#1)(2013-1#10)(2013-7#3)(2013-8#3)
as it's##2##2##(2008-10#1)(2008-9#1)
as its 1##2##3##(2008-10#2)
as its##94##2##(1990-10#1)(1991-12#2)(1991-3#1)(1992-3#2)(1993-3#1)(1993-6#5)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#5)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#3)
as judged by electrophoretic##2##4##(1991-2#1)(1995-11#1)
as judged by the##8##4##(1991-3#1)(1992-3#1)(1993-2#1)(1993-8#1)(1995-2#1)(2008-11#1)(2010-6#1)(2013-1#1)
as judged by##24##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#2)(1995-11#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-5#1)(2010-6#1)(2013-1#1)
as judged from the##2##4##(1991-5#1)(1993-3#1)
as judged from##4##3##(1991-5#1)(1993-12#2)(1993-3#1)
as judged##28##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#2)(1995-11#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-5#1)(2010-6#1)(2013-1#1)
as juvenile##2##2##(2012-2#1)(2012-3#1)
as key elements##2##3##(2010-4#2)
as key mediators of##2##4##(2008-11#1)(2012-3#1)
as key players in the##2##5##(2009-10#1)(2011-1#1)
as key players in##3##4##(2009-10#1)(2009-3#1)(2011-1#1)
as key##17##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
as knowledge##3##2##(2008-7#2)(2011-8#1)
as laboratory##2##2##(2008-11#1)(2008-8#1)
as lactate dehydrogenase##2##3##(2008-7#1)(2010-12#1)
as lactate##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
as lamellae##2##2##(1994-5#1)(2008-7#1)
as large as 10##3##4##(2007-11#1)(2008-2#2)
as large as 3##2##4##(2007-11#1)(2008-3#1)
as large as the##4##4##(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)
as large as##24##3##(1990-7#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(2007-11#4)(2007-12#4)(2008-2#5)(2008-3#4)(2009-11#1)
as large##31##2##(1990-7#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)
as larger##2##2##(1995-6#1)(2008-10#1)
as laser##3##2##(2007-12#1)(2008-3#2)
as late as##2##3##(1992-12#1)(2008-7#1)
as latent##2##2##(2008-10#1)(2008-5#1)
as lead##4##2##(1995-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
as leads for##2##3##(2008-10#1)(2013-1#1)
as learning##4##2##(1995-1#1)(2008-10#1)(2012-3#2)
as leaves##2##2##(2008-10#1)(2009-8#1)
as lecturers##2##2##(2008-11#2)
as less than##2##3##(2007-11#1)(2008-10#1)
as less##9##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
as leukoaraiosis##2##2##(2007-10#1)(2010-12#1)
as lifestyle##2##2##(2008-3#1)(2011-2#1)
as ligand##5##2##(2008-10#3)(2008-4#1)(2008-5#1)
as ligands##2##2##(2008-10#1)(2010-5#1)
as light source and##2##4##(2008-10#2)
as light source##3##3##(2008-10#2)(2008-3#1)
as light##9##2##(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)
as likely as##2##3##(2008-11#2)
as likely coding sequences##2##4##(1995-12#2)
as likely to be##3##4##(1990-2#1)(2008-2#1)(2010-10#1)
as likely to have##4##4##(1994-12#1)(1995-2#1)(2008-1#1)(2011-2#1)
as likely to##12##3##(1990-2#1)(1994-12#1)(1995-2#2)(2007-10#1)(2008-1#2)(2008-2#1)(2010-10#1)(2011-2#2)(2013-1#1)
as likely##18##2##(1990-2#1)(1994-12#1)(1995-12#3)(1995-2#2)(2007-10#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-1#1)
as limit of detection##4##4##(2008-10#3)(2012-1#1)
as limit##5##2##(2008-10#3)(2011-2#1)(2012-1#1)
as limiting##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
as linear##5##2##(1995-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
as linearity##3##2##(2008-10#2)(2009-8#1)
as linkage##2##2##(2007-7#1)(2008-10#1)
as linked to##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
as lipophilic additive##2##3##(2008-10#2)
as lipophilic##3##2##(2008-10#3)
as liquid##3##2##(2008-10#2)(2008-2#1)
as little as 0##7##4##(1991-2#1)(2008-10#4)(2008-6#1)(2010-4#1)
as little as 1##2##4##(2008-11#1)(2008-4#1)
as little as 10##3##4##(1997-4#1)(2008-10#1)(2013-1#1)
as little as 100##3##4##(1996-12#1)(2008-10#1)(2013-1#1)
as little as 5##3##4##(1990-8#1)(1993-11#1)(2008-10#1)
as little as one##2##4##(2008-10#1)(2008-11#1)
as little as##35##3##(1990-8#1)(1991-2#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
as little##37##2##(1990-8#1)(1991-2#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
as living##2##2##(2008-10#1)(2010-12#1)
as local##12##2##(1990-11#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-3#1)(2010-3#1)(2013-1#1)(2013-7#1)
as log##2##2##(1992-9#1)(2008-10#1)
as logbeta##2##2##(2008-10#2)
as logistic##2##2##(1992-9#1)(1994-2#1)
as long as 1##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
as long as 100##2##4##(2008-2#1)(2008-3#1)
as long as a##2##4##(1996-6#1)(2009-3#1)
as long as possible##3##4##(1991-8#1)(1997-4#1)(2010-7#1)
as long as the corrected##2##5##(1993-12#1)(2007-11#1)
as long as the total distance from the aperture to the focal point exceeds##2##14##(2008-3#2)
as long as the total##3##5##(1996-12#1)(2008-3#2)
as long as the##25##4##(1993-12#2)(1994-11#1)(1994-12#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-9#1)
as long as there is##2##5##(1997-1#1)(2008-8#1)
as long as there##4##4##(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
as long as##59##3##(1990-2#1)(1991-8#1)(1992-4#1)(1993-1#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-7#1)(2012-12#1)(2012-3#1)
as long##66##2##(1990-2#1)(1991-8#1)(1992-4#1)(1993-1#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
as long-term##3##2##(1995-2#1)(2009-7#1)(2012-3#1)
as loss##3##2##(2008-11#2)(2008-3#1)
as low as 0##24##4##(1992-3#1)(1992-8#1)(1994-8#1)(2008-10#17)(2008-11#2)(2008-5#1)(2012-2#1)
as low as 1 x##2##5##(1993-8#1)(2007-11#1)
as low as 1##12##4##(1993-8#1)(1996-12#1)(2007-11#1)(2008-10#7)(2008-2#1)(2011-1#1)
as low as 10##2##4##(1995-3#1)(2008-10#1)
as low as 10(-5)##2##4##(2008-10#1)(2008-2#1)
as low as 10(-8) M##2##5##(2008-10#2)
as low as 100##2##4##(2008-10#2)
as low as 12##2##4##(1992-6#1)(2008-10#1)
as low as 2 x##2##5##(1990-8#1)(2007-12#1)
as low as 2##7##4##(1990-8#1)(1992-3#1)(2007-12#1)(2008-10#3)(2008-3#1)
as low as 20##2##4##(1990-4#1)(2008-10#1)
as low as 22##2##4##(2007-11#1)(2008-2#1)
as low as 30##2##4##(1993-6#1)(2008-3#1)
as low as 4##3##4##(2007-11#1)(2008-10#1)(2009-5#1)
as low as 5##2##4##(2008-10#1)(2008-3#1)
as low as a single##2##5##(1993-12#1)(2008-9#1)
as low as a##3##4##(1993-12#1)(2008-3#1)(2008-9#1)
as low as approximately##2##4##(2008-10#1)(2008-2#1)
as low as that of##2##5##(2007-11#1)(2009-7#1)
as low as that##3##4##(2007-11#1)(2008-7#1)(2009-7#1)
as low as those##2##4##(1993-8#1)(2008-10#1)
as low as##114##3##(1990-4#1)(1990-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#2)(1997-2#1)(2007-11#7)(2007-12#7)(2008-10#55)(2008-11#2)(2008-2#9)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)
as low##126##2##(1990-4#1)(1990-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#2)(1996-9#1)(1997-2#1)(2007-11#7)(2007-12#7)(2008-1#1)(2008-10#58)(2008-11#2)(2008-2#10)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-2#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
as lower##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
as mRNA##2##2##(1995-11#1)(2011-2#1)
as magnesium##2##2##(1995-3#1)(2008-10#1)
as main##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
as maintaining##4##2##(2008-5#1)(2008-7#1)(2009-9#1)(2012-3#1)
as major##10##2##(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#1)
as making##2##2##(2008-11#1)(2012-12#1)
as male parents##3##3##(2008-5#1)(2008-8#2)
as male##6##2##(2007-7#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)
as males##4##2##(1996-5#1)(2007-7#1)(2008-12#1)(2012-12#1)
as malignant##7##2##(1991-9#1)(1994-7#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
as managed care##3##3##(1993-12#1)(1994-3#1)(2008-7#1)
as managed##4##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-7#1)
as management##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
as manganese##3##2##(1991-12#1)(2008-10#2)
as manifestations of##2##3##(1995-3#1)(2008-7#1)
as many as 20##2##4##(2008-10#1)(2013-1#1)
as many as##24##3##(1995-1#1)(1995-2#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
as many patients##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
as many##62##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#3)
as marker##2##2##(2008-12#2)
as markers for the##2##4##(2008-10#1)(2008-3#1)
as markers for##9##3##(1991-11#1)(1991-5#1)(1993-12#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
as markers in##2##3##(1995-12#1)(2008-10#1)
as markers of##7##3##(1990-3#1)(1997-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-8#1)
as markers##21##2##(1990-3#1)(1991-11#1)(1991-5#1)(1993-12#1)(1995-12#1)(1996-5#1)(1997-6#1)(2007-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
as marketing##3##2##(1992-2#1)(1993-3#1)(2008-11#1)
as masking agents##3##3##(2008-10#3)
as masking##5##2##(2008-10#5)
as mass##3##2##(2008-10#1)(2011-2#2)
as massive##3##2##(2008-12#2)(2012-12#1)
as maternal##5##2##(1992-12#1)(1996-12#1)(2008-9#2)(2010-6#1)
as mating##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
as matrix metalloproteinases##2##3##(2008-9#2)
as matrix##5##2##(2008-10#3)(2008-9#2)
as may##2##2##(1992-9#1)(1996-2#1)
as mean relative##2##3##(2008-10#2)
as mean##9##2##(1991-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
as means of##3##3##(2007-12#1)(2008-10#2)
as means##5##2##(2007-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
as measured by Cibacron blue binding##2##6##(2008-4#2)
as measured by ELISA##2##4##(1997-2#1)(2008-8#1)
as measured by MRI##2##4##(2007-8#1)(2010-12#1)
as measured by a##2##4##(1995-6#1)(2007-11#1)
as measured by an##3##4##(1994-11#1)(1994-6#1)(2008-10#1)
as measured by bacterial populations in##2##6##(2008-10#2)
as measured by both##2##4##(1993-12#1)(2011-2#1)
as measured by in##3##4##(1995-12#1)(1997-2#1)(2008-11#1)
as measured by microdialysis##2##4##(1995-12#1)(1997-7#1)
as measured by the##23##4##(1990-7#1)(1992-8#2)(1993-6#1)(1994-3#1)(1995-3#1)(2007-10#2)(2007-12#2)(2008-10#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-9#2)(2011-2#1)(2012-12#1)
as measured by time to##2##5##(2008-5#1)(2013-1#1)
as measured by##113##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-7#2)(2006-6#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-9#2)(2011-2#2)(2012-12#2)(2013-1#2)
as measured in a##2##4##(1992-9#1)(2008-10#1)
as measured in the##2##4##(1993-12#1)(2008-7#1)
as measured in##7##3##(1992-9#1)(1993-12#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-7#1)
as measured with a##7##4##(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)
as measured with the##2##4##(1994-6#1)(2009-8#1)
as measured with##12##3##(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-5#3)(2009-8#1)
as measured##140##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#5)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#4)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-9#2)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
as measurement##2##2##(1995-2#1)(2011-2#1)
as measures of##3##3##(1993-12#1)(2008-3#1)(2011-2#1)
as measures##4##2##(1993-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
as mechanical##3##2##(1994-3#1)(2009-12#1)(2012-12#1)
as mechanically##2##2##(2008-3#1)(2009-8#1)
as mechanisms##3##2##(1996-3#1)(2010-3#1)(2013-1#1)
as media##3##2##(2008-12#1)(2008-2#1)(2008-6#1)
as mediated by##3##3##(2008-9#1)(2010-2#1)(2012-1#1)
as mediator of##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
as mediator##5##2##(1994-2#1)(2008-10#3)(2008-4#1)
as mediators of##2##3##(1994-11#1)(2009-11#1)
as mediators##3##2##(1994-11#1)(2009-11#1)(2013-7#1)
as medical##8##2##(1994-12#1)(1996-12#1)(2008-11#2)(2008-3#1)(2009-5#1)(2011-3#1)(2013-1#1)
as medicine##2##2##(2010-1#1)(2011-1#1)
as medium##4##2##(2008-10#3)(2008-11#1)
as meiotic##2##2##(2008-10#1)(2012-3#1)
as members of the##6##4##(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)
as members of##10##3##(1993-1#1)(1993-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)
as membrane carrier was prepared##2##5##(2008-10#2)
as membrane carrier##4##3##(2008-10#4)
as membrane matrix##2##3##(2008-10#2)
as membrane##11##2##(1990-7#1)(1994-2#1)(2008-10#9)
as memory##3##2##(2008-1#1)(2011-2#1)(2013-8#1)
as merely##3##2##(1991-9#1)(2008-2#1)(2012-2#1)
as mesenchymal##2##2##(2008-10#1)(2008-9#1)
as metabolic##7##2##(1992-10#1)(1994-8#1)(2008-10#1)(2008-7#1)(2010-1#1)(2011-2#2)
as metabolites of##2##3##(2008-10#1)(2010-9#1)
as metabolites##3##2##(1994-8#1)(2008-10#1)(2010-9#1)
as metal extractant##2##3##(2008-10#2)
as metal##8##2##(2007-11#1)(2008-10#7)
as metastatic##2##2##(1993-12#1)(2010-6#1)
as methanol and##2##3##(1994-9#1)(2008-10#1)
as methanol##5##2##(1994-9#1)(2008-10#4)
as methods for##6##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-9#2)
as methods##9##2##(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#3)(2010-10#1)
as methyl##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
as methylation##2##2##(1993-11#1)(2008-10#1)
as microwave##2##2##(2008-10#2)
as mild##3##2##(2007-10#1)(2008-10#1)(2008-8#1)
as minimum##2##2##(2008-10#1)(2008-3#1)
as minor and##2##3##(2008-10#2)
as minor##8##2##(1994-5#1)(1996-12#1)(2008-10#4)(2008-11#1)(2009-5#1)
as missing##2##2##(2009-10#1)(2012-3#1)
as mixed##5##2##(1994-12#2)(2007-12#1)(2008-10#2)
as mobile carrier##2##3##(2008-10#2)
as mobile phase and##6##4##(2008-10#4)(2010-5#1)(2011-1#1)
as mobile phase in##3##4##(2008-10#3)
as mobile phase##30##3##(2008-10#23)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
as mobile phases##2##3##(2008-10#2)
as mobile##34##2##(2008-10#27)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
as mode##2##2##(2007-11#1)(2012-12#1)
as model analytes##2##3##(2008-10#2)
as model compounds##3##3##(2008-10#3)
as model examples##2##3##(2008-10#1)(2011-1#1)
as model systems for##2##4##(2008-10#1)(2008-4#1)
as model##22##2##(1990-12#1)(1997-6#1)(2008-10#15)(2008-4#2)(2008-9#1)(2011-1#2)
as models for##6##3##(1995-12#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-4#1)(2008-7#1)
as models##10##2##(1991-5#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
as modern##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
as modified##2##2##(2008-3#1)(2008-5#1)
as modifier##6##2##(2008-10#6)
as modifiers##2##2##(2008-1#1)(2008-10#1)
as modulation##3##2##(2008-3#2)(2011-2#1)
as modulator of##2##3##(1992-6#1)(2011-2#1)
as modulators##2##2##(2008-2#1)(2008-9#1)
as molecular markers##2##3##(1997-8#1)(2012-5#1)
as molecular sensors##2##3##(2008-10#2)
as molecular##18##2##(1997-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-10#1)(2010-4#3)(2010-7#1)(2012-12#1)(2012-2#1)(2012-5#1)
as molybdoarsenate##2##2##(2008-10#2)
as monitored by##6##3##(1991-12#1)(1992-1#1)(1992-6#1)(1995-8#1)(1997-4#1)(2008-10#1)
as monitored##8##2##(1990-12#1)(1991-12#1)(1992-1#1)(1992-6#1)(1995-8#1)(1997-4#1)(2008-10#2)
as monoclonal antibodies##2##3##(2008-5#1)(2012-12#1)
as monoclonal##3##2##(2008-5#1)(2011-1#1)(2012-12#1)
as monotherapy or in combination with other##2##7##(2008-3#1)(2010-8#1)
as monotherapy or in combination##3##5##(2008-3#1)(2010-5#1)(2010-8#1)
as monotherapy##9##2##(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-10#2)(2012-12#1)
as more or less##2##4##(2008-11#1)(2013-1#1)
as more supportive##2##3##(2009-7#1)(2010-1#1)
as more than##2##3##(2011-2#1)(2012-2#1)
as more##35##2##(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#3)(2009-9#2)(2010-1#1)(2010-12#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
as morphological##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
as most##13##2##(1991-2#1)(1992-2#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
as motion##3##2##(2007-2#1)(2010-8#1)(2011-1#1)
as mouse##2##2##(1991-5#1)(1995-3#1)
as much a##2##3##(2008-7#1)(2009-4#1)
as much as 0##5##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
as much as 1##8##4##(1992-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
as much as 10##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
as much as 10% of the##2##6##(1995-2#1)(2007-12#1)
as much as 10%##3##4##(1995-2#1)(2007-11#1)(2007-12#1)
as much as 100##2##4##(2007-11#2)
as much as 13##2##4##(2007-11#1)(2007-12#1)
as much as 2##2##4##(2011-2#1)(2012-2#1)
as much as 20##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
as much as 20%##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
as much as 3##4##4##(2007-11#2)(2008-3#2)
as much as 30##2##4##(2007-12#1)(2008-3#1)
as much as 4##2##4##(1992-12#1)(1995-8#1)
as much as 40##3##4##(2007-11#1)(2007-12#2)
as much as 40%##2##4##(1991-5#1)(2009-5#1)
as much as 50##4##4##(2008-3#2)(2008-7#1)(2009-11#1)
as much as 50%##3##4##(2008-10#2)(2008-3#1)
as much as 500 mW##2##5##(2007-12#1)(2008-2#1)
as much as 6##3##4##(2008-2#1)(2008-3#2)
as much as 60##3##4##(1995-3#1)(2007-12#1)(2008-3#1)
as much as 7##2##4##(2007-12#1)(2008-3#1)
as much as 70%##2##4##(1990-3#1)(2008-3#1)
as much as 8##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
as much as 80%##2##4##(1990-11#1)(2008-10#1)
as much as 900 mW of##2##6##(2008-2#2)
as much as a factor##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
as much as a##8##4##(1994-8#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#4)
as much as an order of magnitude##2##7##(2008-10#1)(2008-2#1)
as much as possible##6##4##(1993-1#1)(1994-3#1)(1995-5#1)(2008-4#1)(2009-7#1)(2011-1#1)
as much as the##2##4##(1997-8#1)(2012-2#1)
as much as##155##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#25)(2007-12#27)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#32)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
as much##172##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#25)(2007-12#27)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#11)(2008-3#33)(2008-4#1)(2008-5#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
as multiple erythematous macules and patches##2##6##(2010-6#2)
as multiple sclerosis##5##3##(2007-10#1)(2008-12#1)(2011-2#2)(2012-3#1)
as multiple##26##2##(1990-2#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
as multiples of##2##3##(1993-2#1)(2008-9#1)
as muscle##5##2##(1992-9#1)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
as muscles##2##2##(2007-11#1)(2008-8#1)
as myocardial##4##2##(1997-5#1)(2007-11#1)(2008-10#1)(2013-8#1)
as n =##2##3##(2008-10#2)
as narrow as##2##3##(2007-12#1)(2008-10#1)
as national##2##2##(1996-12#1)(2008-1#1)
as native human endonexin II##2##5##(1994-11#2)
as natural##13##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
as naturally##3##2##(1997-3#1)(2008-10#1)(2010-12#1)
as necessary for##4##3##(1995-3#1)(2007-4#1)(2008-11#1)(2009-8#1)
as necessary##11##2##(1991-12#1)(1995-1#1)(1995-3#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-3#1)(2011-2#1)
as needed##10##2##(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2013-1#2)
as negative controls##2##3##(1993-3#1)(2012-3#1)
as negative regulators of##2##4##(2008-7#1)(2009-8#1)
as negative regulators##3##3##(2008-7#1)(2009-8#2)
as negative##14##2##(1992-12#1)(1992-8#1)(1993-3#1)(1996-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-8#3)(2010-3#1)(2010-7#1)(2012-3#1)
as neoanal sphincter for##2##4##(2011-1#2)
as neonatal morbidity and##2##4##(1994-12#1)(2012-3#1)
as nephropathy##2##2##(2010-12#1)(2012-2#1)
as neuroimaging##2##2##(2008-6#1)(2010-5#1)
as neuronal##2##2##(2008-4#1)(2010-11#1)
as neurons##6##2##(1992-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-2#1)
as neutral carrier##5##3##(2008-10#5)
as neutral carriers for##2##4##(2008-10#2)
as neutral carriers##7##3##(2008-10#7)
as neutral ionophores##4##3##(2008-10#4)
as neutral species##2##3##(2008-10#2)
as neutral##23##2##(2008-10#23)
as never before##2##3##(1991-2#1)(2008-11#1)
as new markers of##2##4##(1994-12#1)(1996-12#1)
as new members of the##2##5##(2008-10#1)(2013-8#1)
as new techniques and##2##4##(2008-10#1)(2010-5#1)
as new##33##2##(1991-2#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-12#2)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
as next-generation##3##2##(2011-3#3)
as nicotine##2##2##(2008-8#1)(2011-2#1)
as nitrate##3##2##(2008-10#3)
as nitrite##4##2##(2008-10#4)
as no significant##2##3##(2008-10#1)(2011-2#1)
as no##8##2##(1995-11#1)(1996-12#1)(2008-10#2)(2010-6#1)(2011-2#1)(2013-1#2)
as non-allergic##2##2##(2011-1#2)
as non-insulin dependent##2##3##(1996-11#1)(2008-4#1)
as non-smokers by both systems##2##5##(1993-8#2)
as non-specific##2##2##(2008-7#1)(2009-2#1)
as nonlinear##4##2##(2007-11#2)(2008-10#1)(2008-2#1)
as normal##14##2##(1991-6#1)(1992-11#1)(1993-11#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
as normalization of##2##3##(2008-10#1)(2008-7#1)
as not only##2##3##(2008-10#1)(2008-7#1)
as not##9##2##(1992-6#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)
as novel pathways##2##3##(2010-6#1)(2011-2#1)
as novel##14##2##(1995-3#1)(2008-10#4)(2008-4#2)(2008-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
as nuclear##5##2##(1995-11#1)(1995-2#1)(2008-4#1)(2008-9#1)(2011-1#1)
as nuclei##2##2##(1992-5#1)(2008-2#1)
as number of##8##3##(1990-11#1)(1991-3#1)(1993-12#1)(1994-9#1)(2008-10#2)(2008-9#1)(2012-9#1)
as numbers of##2##3##(1995-12#1)(2008-10#1)
as numerous##8##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-6#1)
as nutrients##3##2##(2008-10#1)(2008-6#1)(2009-8#1)
as nutrition##2##2##(1992-12#1)(2007-11#1)
as nutritional##2##2##(2007-11#1)(2010-12#1)
as obese##3##2##(1993-2#1)(2008-10#1)(2012-12#1)
as obesity##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
as object##3##2##(1992-11#1)(1994-8#1)(2008-3#1)
as observed by##2##3##(2008-6#1)(2010-1#1)
as observed for the##2##4##(1992-6#1)(1995-8#1)
as observed for##3##3##(1990-7#1)(1992-6#1)(1995-8#1)
as observed in many##2##4##(2008-8#2)
as observed in other##2##4##(1991-6#1)(2008-5#1)
as observed in the##2##4##(1996-12#1)(2007-12#1)
as observed in##15##3##(1991-6#1)(1993-11#1)(1994-6#1)(1994-8#2)(1996-12#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-1#1)
as observed##27##2##(1990-7#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-6#1)(1994-8#2)(1995-8#1)(1996-12#2)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2010-1#1)(2011-1#1)(2013-1#1)
as observer##2##2##(1996-2#2)
as obtained by##2##3##(1990-5#1)(2008-6#1)
as obvious##2##2##(2007-5#1)(2008-7#1)
as occupational##2##2##(1990-3#1)(2008-10#1)
as occurring##2##2##(2010-11#1)(2010-5#1)
as occurs during##2##3##(1995-2#1)(2012-2#1)
as occurs in##3##3##(1990-2#1)(1995-2#1)(2009-12#1)
as occurs##6##2##(1990-2#1)(1995-2#2)(2009-12#1)(2010-4#1)(2012-2#1)
as of 1988##2##3##(1994-2#1)(2008-10#1)
as of November##2##3##(1991-3#1)(2013-1#1)
as of a##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
as of the end of##2##5##(1992-9#1)(2011-1#1)
as of the##10##3##(1992-9#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2011-1#1)
as of##44##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#2)(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
as often as##2##3##(1994-3#1)(2006-10#1)
as often##8##2##(1994-3#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)
as oil##2##2##(2008-2#1)(2008-6#1)
as old##2##2##(1991-12#1)(2008-9#1)
as oligonucleotides containing##2##3##(2008-4#2)
as on the##24##3##(1990-5#1)(1995-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#3)
as on their##3##3##(2008-10#2)(2011-1#1)
as on##58##2##(1990-5#1)(1995-12#2)(1997-1#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#2)
as on-line##4##2##(2008-10#4)
as oncogenes##3##2##(1995-2#1)(2011-2#2)
as one major##2##3##(2008-10#1)(2008-2#1)
as one mechanism##2##3##(1990-2#1)(2008-9#1)
as one month##2##3##(2007-2#1)(2008-8#1)
as one of the differential##2##5##(2008-7#1)(2011-1#1)
as one of the factors##2##5##(2007-11#1)(2009-5#1)
as one of the important##2##5##(2008-10#1)(2011-2#1)
as one of the main##4##5##(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)
as one of the major##5##5##(1994-12#1)(1997-6#1)(2008-10#2)(2008-12#1)
as one of the many##2##5##(2008-12#2)
as one of the mechanisms##2##5##(2008-11#1)(2012-12#1)
as one of the most important##4##6##(2007-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
as one of the most##11##5##(1994-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#4)(2009-8#1)(2011-2#1)(2013-7#1)
as one of the primary##2##5##(1994-5#1)(2008-11#1)
as one of the##54##4##(1990-8#1)(1991-4#1)(1992-11#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#13)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
as one of##59##3##(1990-8#1)(1991-4#1)(1992-11#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
as one way to##2##4##(1994-2#1)(1997-2#1)
as one##92##2##(1990-2#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-4#1)(2008-10#17)(2008-11#8)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2009-8#2)(2010-10#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
as only a##2##3##(2008-10#1)(2008-11#1)
as only##6##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
as onset of##2##3##(2008-1#1)(2010-3#1)
as open-chain analogues of neplanocin A##2##6##(2008-11#2)
as operational##3##2##(2008-10#3)
as opposed to a##5##4##(1992-8#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-11#1)
as opposed to an##2##4##(1995-6#1)(2009-4#1)
as opposed to its##2##4##(1994-3#1)(2008-7#1)
as opposed to most##2##4##(2011-2#2)
as opposed to the##11##4##(1990-2#1)(1990-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-3#2)(2008-4#1)(2009-11#1)
as opposed to##47##3##(1990-2#1)(1990-3#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
as optical##14##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#7)(2008-7#1)(2009-12#1)(2010-5#1)(2012-2#1)
as optimal##5##2##(1996-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
as optimization##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
as optimum##2##2##(2007-12#1)(2008-10#1)
as or##5##2##(1996-3#1)(2008-2#2)(2008-9#1)(2009-1#1)
as oral##4##2##(2008-7#2)(2008-9#1)(2011-1#1)
as organelles##2##2##(2007-12#1)(2008-4#1)
as organic modifier##2##3##(2008-10#2)
as organic solvent##4##3##(2008-10#3)(2008-7#1)
as organic##12##2##(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
as organized##2##2##(2009-7#1)(2012-2#1)
as orientation##2##2##(2008-10#1)(2008-11#1)
as original##2##2##(2008-10#2)
as osteoporotic fractures##2##3##(2007-11#1)(2007-8#1)
as other##55##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
as others##3##2##(2008-3#1)(2008-4#1)(2010-10#1)
as our##11##2##(1992-5#1)(1994-5#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
as out-patients##3##2##(1990-6#1)(1991-6#1)(1992-5#1)
as outcome measures##6##3##(2007-11#2)(2007-12#1)(2007-8#1)(2008-9#1)(2011-1#1)
as outgroups##4##2##(1995-11#2)(1995-3#1)(2008-10#1)
as outpatients##4##2##(1994-2#1)(2007-8#1)(2008-5#1)(2011-1#1)
as output##3##2##(2008-11#1)(2008-3#1)(2013-7#1)
as over##2##2##(2008-2#1)(2012-2#1)
as overall##4##2##(2008-2#1)(2008-6#2)(2011-1#1)
as overweight and##2##3##(1993-2#1)(2008-10#1)
as overweight##4##2##(1993-2#1)(2008-10#2)(2012-2#1)
as oxidant##8##2##(2008-10#6)(2011-2#1)(2013-1#1)
as oxidants##2##2##(1990-5#1)(2008-10#1)
as oxidative stress##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
as oxidative##4##2##(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
as oxidizing agent##2##3##(2008-10#2)
as oxidizing reagent##2##3##(2008-10#2)
as oxidizing##4##2##(2008-10#4)
as oxygen##5##2##(1992-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
as p53##2##2##(2008-7#1)(2012-2#1)
as pH##34##2##(1995-11#1)(2008-10#29)(2008-6#2)(2008-8#1)(2011-1#1)
as pain##2##2##(2007-11#1)(2009-12#1)
as palliative##2##2##(2010-3#1)(2012-1#1)
as palpable##3##2##(1997-4#1)(2008-7#1)(2013-1#1)
as pancreas##2##2##(1995-2#2)
as pancreatic##3##2##(1990-2#1)(1995-11#1)(2013-7#1)
as parallel##2##2##(1995-2#1)(2009-10#1)
as parameters of##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
as parameters##4##2##(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
as paraneoplastic syndromes##2##3##(1994-9#1)(2012-3#1)
as parasites of##2##3##(2008-10#1)(2013-1#1)
as parasites##4##2##(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
as parents##2##2##(2010-5#1)(2011-1#1)
as part of a strategy##2##5##(2008-1#1)(2008-7#1)
as part of a study of##2##6##(2008-6#1)(2009-4#1)
as part of a study##3##5##(2008-11#1)(2008-6#1)(2009-4#1)
as part of a wider##2##5##(1996-11#1)(2008-12#1)
as part of a##50##4##(1990-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
as part of an integrated##3##5##(2008-10#2)(2008-11#1)
as part of an##15##4##(1990-10#1)(1994-3#1)(1994-5#1)(1996-12#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#2)
as part of its##2##4##(2007-10#1)(2008-8#1)
as part of the diagnostic##3##5##(1993-1#1)(2013-1#1)(2013-8#1)
as part of the research##2##5##(2008-11#1)(2011-1#1)
as part of the routine##2##5##(1994-6#1)(2008-9#1)
as part of the treatment##2##5##(2012-12#1)(2013-8#1)
as part of the##54##4##(1990-4#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
as part of their##14##4##(1992-10#1)(1992-3#1)(1995-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#2)(2012-2#1)
as part of##168##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#2)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#9)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#4)
as part##169##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#2)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#9)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#4)
as partial##7##2##(1992-1#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
as partially##2##2##(1995-2#1)(2008-10#1)
as participant##2##2##(1996-2#1)(2013-1#1)
as participants in##2##3##(2008-12#2)
as participants##3##2##(1993-12#1)(2008-12#2)
as particulate##3##2##(2008-10#2)(2008-5#1)
as partners##3##2##(1992-1#1)(2008-6#1)(2013-1#1)
as parts of##2##3##(2006-6#1)(2008-11#1)
as passive##6##2##(2008-12#1)(2008-3#1)(2008-8#2)(2009-1#1)(2012-2#1)
as pathogens##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
as pathologic##2##2##(2012-3#2)
as pathovars##3##2##(2008-10#3)
as patient##5##2##(2007-7#1)(2009-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
as patients##8##2##(1992-3#1)(1993-11#1)(1996-2#1)(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#2)
as peak height##3##3##(2008-10#3)
as peak##6##2##(1992-3#1)(2008-10#4)(2008-2#1)
as pendant##2##2##(1997-7#1)(2008-10#1)
as penetration##3##2##(2008-10#1)(2008-5#2)
as people age##2##3##(2008-7#1)(2009-12#1)
as people##4##2##(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)
as per ICH guidelines##3##4##(2011-1#2)(2012-12#1)
as per the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
as per##12##2##(1993-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
as perceived by the clinical nurses and chief nurses##2##9##(2013-1#2)
as perceived by the##4##4##(2008-3#1)(2009-6#1)(2013-1#2)
as perceived by##9##3##(1993-2#1)(1994-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-9#1)(2013-1#2)
as percent##2##2##(2008-10#2)
as percentage of##4##3##(1996-12#1)(2008-10#3)
as percentage##7##2##(1996-12#1)(2008-10#6)
as performed##3##2##(2008-11#1)(2008-7#1)(2012-1#1)
as peripheral arthritis##2##3##(1990-6#1)(2010-12#1)
as peripheral##5##2##(1990-6#1)(1991-3#1)(2007-10#1)(2007-8#1)(2010-12#1)
as permanent##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2011-3#1)
as persistent##2##2##(2008-10#1)(2008-8#1)
as personal##5##2##(1993-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-11#1)
as personality##3##2##(1994-2#1)(2007-11#1)(2009-10#1)
as persons##2##2##(1993-2#1)(2008-1#1)
as pesticides and##2##3##(2008-10#1)(2010-7#1)
as pesticides##3##2##(2008-10#2)(2010-7#1)
as phage##2##2##(2008-7#1)(2012-2#1)
as pharmaceutical##4##2##(1994-3#1)(2008-10#1)(2010-5#1)(2010-7#1)
as phase##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
as phenol##2##2##(2008-10#2)
as phenotypic##2##2##(2008-10#1)(2008-4#1)
as phosphomolybdenum blue##2##3##(2008-10#2)
as photonic##3##2##(2007-11#1)(2009-12#1)(2012-2#1)
as phylogenetic##2##2##(2011-2#1)(2013-7#1)
as physical activity##3##3##(2008-1#1)(2008-11#2)
as physical and##3##3##(1991-3#1)(2008-2#1)(2011-2#1)
as physical##13##2##(1991-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#2)
as physician##3##2##(1993-2#1)(1996-1#1)(1997-3#1)
as physicians##2##2##(1990-10#1)(2012-3#1)
as physiological##4##2##(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
as pigmented##2##2##(2008-11#1)(2010-6#1)
as planned##3##2##(1992-11#1)(1995-1#1)(2010-3#1)
as plant growth##2##3##(2008-10#2)
as plant##8##2##(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)
as plasma##3##2##(1991-9#1)(2007-10#1)(2008-7#1)
as plasticizer in##2##3##(2008-10#2)
as plasticizer##8##2##(2008-10#8)
as plasticizers##2##2##(2008-10#2)
as plasticizing solvent mediators were prepared and investigated as##2##9##(2008-10#2)
as plasticizing solvent mediators were prepared and##3##7##(2008-10#3)
as plasticizing solvent##5##3##(2008-10#5)
as platforms for##3##3##(1994-8#1)(2008-3#1)(2013-1#1)
as pleasant##2##2##(1997-3#1)(2008-5#1)
as points##2##2##(2008-6#1)(2011-2#1)
as polarization##4##2##(2007-12#1)(2008-3#3)
as policy##2##2##(1991-1#1)(2008-10#1)
as polymerase chain reaction##2##4##(2008-10#2)
as polymeric##2##2##(1997-4#1)(2008-5#1)
as polymorphic##3##2##(2008-10#2)(2008-5#1)
as poor##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)
as poorly##2##2##(2011-1#1)(2013-7#1)
as populations##2##2##(2008-10#1)(2008-8#1)
as pore##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
as positional##3##2##(2008-2#1)(2008-4#2)
as positive and negative##2##4##(1997-7#1)(2008-11#1)
as positive and##3##3##(1997-7#1)(2008-11#1)(2008-7#1)
as positive control##2##3##(2008-5#1)(2010-7#1)
as positive controls##6##3##(2008-10#1)(2008-4#1)(2008-9#3)(2013-1#1)
as positive for the##2##4##(1994-12#1)(2008-5#1)
as positive for##4##3##(1993-3#1)(1994-12#1)(2008-5#2)
as positive##23##2##(1990-5#1)(1990-6#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-4#1)(1995-8#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#3)(2010-7#1)(2013-1#1)
as possibilities for##2##3##(2008-11#2)
as possible and to##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
as possible and##10##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)
as possible candidates##2##3##(2008-7#2)
as possible for##2##3##(1994-3#1)(2008-3#1)
as possible in##3##3##(1991-6#1)(1995-12#1)(2007-5#1)
as possible mechanisms##2##3##(1992-8#1)(2010-7#1)
as possible regulators of##2##4##(1995-12#1)(1995-8#1)
as possible to prevent##2##4##(2009-7#1)(2013-1#1)
as possible to the##7##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
as possible to##13##3##(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
as possible ways of##2##4##(1992-11#1)(1992-9#1)
as possible##111##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-3#3)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
as possibly##2##2##(1991-9#1)(2008-12#1)
as post##3##2##(1996-8#1)(2010-12#1)(2012-3#1)
as post-treatment##2##2##(1997-7#1)(2008-6#1)
as potassium##7##2##(1996-12#1)(2006-4#1)(2008-10#5)
as potent as##4##3##(1990-2#1)(1991-12#1)(1995-12#1)(2008-5#1)
as potent##14##2##(1990-2#1)(1991-12#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
as potential anticancer drugs##2##4##(1995-3#1)(1997-3#1)
as potential atypical antipsychotic agents##2##5##(1992-12#2)
as potential diagnostic##2##3##(2011-2#1)(2012-12#1)
as potential new##2##3##(2008-11#1)(2008-9#1)
as potential sources of##2##4##(2008-10#1)(2008-11#1)
as potential##70##2##(1990-8#1)(1991-3#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-2#2)(1994-11#1)(1994-3#1)(1995-3#2)(1996-5#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-6#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)
as potentially##5##2##(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
as potentiometric##3##2##(2008-10#3)
as powerful tools for##2##4##(2007-11#1)(2011-2#1)
as powerful tools##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
as powerful##10##2##(1994-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-7#1)(2011-2#1)(2012-3#1)
as practical##7##2##(1994-12#1)(2008-10#3)(2008-3#1)(2008-4#2)
as pre-##2##2##(1997-7#1)(2007-11#1)
as precipitant##5##2##(2008-10#3)(2008-8#2)
as precisely as##2##3##(2012-2#1)(2013-1#1)
as preconcentration##4##2##(2008-10#4)
as precursor##3##2##(1995-6#1)(2008-7#1)(2008-9#1)
as precursors for##3##3##(1995-3#1)(2010-12#1)(2013-1#1)
as precursors to##2##3##(1992-6#1)(2011-2#1)
as precursors##9##2##(1990-3#1)(1992-6#1)(1995-3#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
as predicted by the##6##4##(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
as predicted by##8##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#1)(2009-8#1)
as predicted from##3##3##(1994-11#1)(1996-2#1)(2008-9#1)
as predicted##18##2##(1994-11#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-6#1)(2013-1#1)
as prediction##3##2##(1997-8#1)(2008-11#1)(2009-6#1)
as predictive##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
as predictor##2##2##(2012-2#1)(2013-1#1)
as predictors of mortality in patients##2##6##(1993-9#1)(2011-2#1)
as predictors of mortality in##4##5##(1993-9#1)(2011-2#3)
as predictors of##13##3##(1993-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-1#1)(2011-2#4)(2012-12#2)
as predictors##16##2##(1993-9#1)(1996-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-1#1)(2011-2#4)(2012-12#2)(2013-1#1)
as predominant##2##2##(1991-4#1)(2011-2#1)
as premature##2##2##(2008-10#1)(2008-11#1)
as preparation##2##2##(1995-1#1)(2012-3#1)
as presence of##5##3##(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
as presence##6##2##(2008-3#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
as presented in##3##3##(1993-2#1)(1996-2#1)(2012-12#1)
as presented##5##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
as presenting##2##2##(2007-8#1)(2011-2#1)
as president##2##2##(2008-5#1)(2008-8#1)
as prevention of##4##3##(2007-11#1)(2013-7#2)(2013-8#1)
as prevention##6##2##(2007-11#1)(2007-5#1)(2013-7#2)(2013-8#2)
as preventive##3##2##(1997-5#1)(2008-10#1)(2011-1#1)
as previous##5##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
as previously described##2##3##(1992-8#1)(1994-2#1)
as previously reported##3##3##(1991-5#1)(2008-10#2)
as previously##13##2##(1990-11#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
as price##3##2##(1992-1#1)(1996-3#1)(2008-12#1)
as primary therapy for##2##4##(2011-2#2)
as primary therapy##3##3##(1990-11#1)(2011-2#2)
as primary treatment##2##3##(2010-8#1)(2011-2#1)
as primary##38##2##(1990-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#2)
as primer##2##2##(2008-8#1)(2008-9#1)
as primers##4##2##(1991-5#1)(1993-3#1)(1995-6#1)(1997-7#1)
as private##2##2##(1995-12#1)(1996-3#1)
as probable##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
as probe for##2##3##(1990-12#1)(2008-9#1)
as probe indicated that##2##4##(1995-6#1)(2008-8#1)
as probe##13##2##(1990-12#1)(1991-5#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-8#4)(2008-9#2)(2013-8#1)
as probed by##2##3##(1994-6#1)(1994-9#1)
as probes and##2##3##(1996-10#1)(2008-8#1)
as probes for##6##3##(2008-10#3)(2008-9#1)(2009-5#1)(2011-1#1)
as probes to##3##3##(1993-11#1)(1994-11#1)(2008-10#1)
as probes##21##2##(1993-11#1)(1993-2#1)(1994-11#1)(1996-10#1)(2008-10#7)(2008-5#1)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#1)(2011-1#1)
as probiotics##4##2##(2011-2#2)(2012-2#1)(2013-7#1)
as problems##2##2##(1994-8#1)(2008-7#1)
as procalpain I##2##3##(1992-6#2)
as product of##2##3##(2008-10#2)
as product##5##2##(1994-9#1)(2008-10#4)
as production##3##2##(2011-2#1)(2013-8#2)
as products of##2##3##(2008-10#1)(2008-3#1)
as professional##2##2##(2007-11#1)(2008-12#1)
as prognostic indicators##2##3##(2008-11#1)(2012-2#1)
as prognostic##4##2##(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#1)
as programmed##2##2##(1996-12#1)(2008-11#1)
as progression##2##2##(2008-6#1)(2008-9#1)
as promising candidates##2##3##(2007-11#1)(2008-7#1)
as promising##14##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-7#1)(2013-1#2)(2013-8#1)
as promoter##2##2##(1993-12#1)(2008-9#1)
as promoters##2##2##(1990-5#1)(2008-7#1)
as promoting##3##2##(2008-6#1)(2010-10#1)(2011-2#1)
as proof##2##2##(2008-5#1)(2010-4#1)
as proper##2##2##(1996-1#1)(2007-8#1)
as prophylactic##4##2##(2007-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
as prophylaxis against##3##3##(2008-7#2)(2009-8#1)
as prophylaxis for postoperative##2##4##(2006-10#1)(2012-1#1)
as prophylaxis##8##2##(1996-11#1)(2006-10#1)(2007-11#1)(2008-7#2)(2009-8#1)(2012-1#1)(2012-2#1)
as proposed##4##2##(1992-12#1)(1995-2#1)(2007-12#1)(2008-5#1)
as prostaglandin##2##2##(1992-3#1)(2013-8#1)
as protecting##4##2##(1991-12#1)(1994-12#1)(1994-9#1)(2008-7#1)
as protection##3##2##(1994-11#1)(2008-9#1)(2011-2#1)
as protective##2##2##(1994-11#1)(2013-8#1)
as protein kinase C##2##4##(1992-9#1)(1993-8#1)
as protein kinase##4##3##(1992-9#1)(1993-8#1)(2008-5#1)(2010-4#1)
as protein##17##2##(1992-9#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2009-8#1)(2010-4#2)(2012-2#1)
as proteins or##2##3##(2008-12#1)(2008-5#1)
as proteins##9##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)
as proton##2##2##(1990-11#1)(1990-7#1)
as prototype##2##2##(2008-10#1)(2013-1#1)
as proven##3##2##(1991-4#1)(2008-11#1)(2011-2#1)
as providers of##2##3##(1996-3#1)(1997-2#1)
as providers##3##2##(1996-3#1)(1997-2#1)(2012-3#1)
as providing a##2##3##(2008-11#1)(2008-9#1)
as providing##13##2##(1990-6#1)(1991-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
as public policies##2##3##(2009-9#1)(2013-1#1)
as public##8##2##(1991-12#1)(1996-1#1)(1996-3#1)(2008-12#1)(2009-9#1)(2010-12#1)(2013-1#2)
as published in##2##3##(2008-10#1)(2012-12#1)
as published##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
as pulmonary##6##2##(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
as pure stands##2##3##(2008-10#2)
as pure##5##2##(2008-10#2)(2008-5#1)(2008-9#2)
as purified##3##2##(1991-9#1)(1992-6#1)(1992-9#1)
as putative##5##2##(1995-3#1)(1996-12#1)(2008-10#2)(2008-8#1)
as qualified##2##2##(1994-1#1)(2012-3#1)
as quality of##2##3##(1995-2#1)(2008-3#1)
as quality##9##2##(1992-11#2)(1994-2#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#1)
as quantified##2##2##(2008-10#1)(2010-8#1)
as quantitative##5##2##(1993-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
as query##2##2##(2008-7#1)(2008-8#1)
as quickly as possible##5##4##(1990-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2013-8#1)
as quickly as##6##3##(1990-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
as quickly##7##2##(1990-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-8#1)
as race 1##3##3##(2008-10#3)
as race 2##6##3##(2008-10#6)
as race##11##2##(2008-10#11)
as radiation source##2##3##(2008-10#2)
as radiation##3##2##(2007-4#1)(2008-10#2)
as radioligand##2##2##(1994-12#1)(1995-11#1)
as random##3##2##(2008-10#2)(2010-5#1)
as rapid as##2##3##(2007-2#1)(2008-9#1)
as rapid##5##2##(2007-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
as rapidly as##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
as rapidly##6##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
as rare##2##2##(2008-5#2)
as rate of##2##3##(2008-10#1)(2008-9#1)
as rate##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
as rated by parents##2##4##(2008-2#1)(2012-2#1)
as rates of##3##3##(2007-12#1)(2008-7#1)(2009-8#1)
as rational##2##2##(2008-7#1)(2012-12#1)
as rats##4##2##(1994-2#1)(2009-10#2)(2012-1#1)
as raw material and##2##4##(2008-10#2)
as raw material##6##3##(2008-10#4)(2008-5#1)(2009-8#1)
as raw##7##2##(2008-10#4)(2008-5#1)(2009-8#1)(2013-8#1)
as reaction medium##2##3##(2008-10#1)(2013-1#1)
as reaction products##2##3##(1994-11#1)(1996-12#1)
as reaction##5##2##(1994-11#1)(1996-12#1)(2008-10#2)(2013-1#1)
as read-out for##2##3##(2013-8#2)
as readily as##3##3##(2008-10#2)(2008-11#1)
as reagent##6##2##(2008-10#6)
as reagents##3##2##(1995-6#1)(1996-2#1)(2008-10#1)
as real##4##2##(1992-6#1)(2008-10#2)(2008-3#1)
as reasons for##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
as receivers##2##2##(1995-5#1)(2008-2#1)
as recent experiences##2##3##(2007-12#1)(2009-10#1)
as recent##4##2##(2007-12#1)(2008-4#1)(2009-10#1)(2011-1#1)
as recently##3##2##(1991-5#1)(2008-10#1)(2013-8#1)
as receptor##5##2##(1994-11#1)(1995-6#1)(2008-7#1)(2009-9#1)(2011-3#1)
as receptors for##4##3##(1994-9#1)(2007-8#1)(2008-4#2)
as receptors##6##2##(1994-9#1)(2007-8#1)(2008-4#3)(2011-2#1)
as recipient##2##2##(2008-8#1)(2008-9#1)
as recognition##2##2##(2008-10#2)
as recombinant vaccines##2##3##(1997-4#2)
as recombinant##3##2##(1997-4#2)(2008-10#1)
as recommended by the##3##4##(1990-6#1)(2011-2#2)
as recommended by##6##3##(1990-6#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
as recorded in##2##3##(2008-11#1)(2013-8#1)
as recorded##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
as recruitment of##2##3##(1993-1#1)(2009-6#1)
as recurrence##3##2##(2006-10#1)(2009-4#1)(2010-4#1)
as recurrent##5##2##(2008-10#1)(2008-7#1)(2008-8#2)(2011-3#1)
as red##3##2##(2008-7#2)(2012-12#1)
as redox##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
as reduced##8##2##(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
as reducing##3##2##(2008-10#2)(2012-12#1)
as reductant##5##2##(1992-3#1)(2008-10#3)(2008-8#1)
as reduction of##3##3##(1991-12#1)(2008-11#1)(2008-2#1)
as reduction##4##2##(1991-12#1)(2008-11#2)(2008-2#1)
as reductions##2##2##(2008-10#1)(2011-2#1)
as reference compounds in##2##4##(2007-11#1)(2008-11#1)
as reference compounds##3##3##(2007-11#1)(2008-11#1)(2009-5#1)
as reference method##5##3##(2008-10#5)
as reference value pH standard##2##5##(2008-10#2)
as reference values##2##3##(2008-10#1)(2013-1#1)
as reference##29##2##(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2009-5#1)(2010-10#1)(2012-3#1)(2013-1#2)
as reflected by##6##3##(1990-8#1)(1992-12#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#1)
as reflected in##3##3##(2008-7#1)(2010-9#1)(2011-1#1)
as reflected##11##2##(1990-8#1)(1991-12#1)(1992-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-4#1)(2010-9#1)(2011-1#1)(2013-1#1)
as regard##2##2##(2007-7#1)(2008-11#1)
as regards life expectancy##2##4##(1992-8#1)(1996-3#1)
as regards the##5##3##(1990-2#1)(1995-5#1)(1995-8#1)(2008-10#1)(2011-2#1)
as regards their##2##3##(2007-10#1)(2010-12#1)
as regards##27##2##(1990-2#2)(1990-6#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-3#2)(1997-2#1)(2007-10#1)(2008-10#2)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
as regional##2##2##(1994-3#1)(2011-1#1)
as registered nurses##2##3##(1994-3#1)(2008-11#1)
as registered##4##2##(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
as regulators of##2##3##(1995-8#1)(2012-12#1)
as regulators##3##2##(1993-5#1)(1995-8#1)(2012-12#1)
as regulatory##4##2##(1994-12#1)(2008-10#1)(2010-5#1)(2012-12#1)
as relapse##2##2##(2009-10#1)(2009-9#1)
as related to##8##3##(1990-11#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
as related##10##2##(1990-11#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
as relative standard deviation (R##8##5##(2008-10#8)
as relative standard deviation (RSD)##3##5##(2008-10#2)(2009-8#1)
as relative standard deviation##28##4##(2008-10#27)(2009-8#1)
as relative standard##30##3##(2008-10#29)(2009-8#1)
as relative##36##2##(2008-10#32)(2008-11#1)(2008-3#2)(2009-8#1)
as release##2##2##(2008-5#1)(2008-7#1)
as relevant to##2##3##(2009-12#1)(2011-2#1)
as relevant##3##2##(2009-12#1)(2011-2#1)(2013-1#1)
as reliable##3##2##(1995-11#1)(2008-4#1)(2010-8#1)
as renal insufficiency##2##3##(1990-9#1)(2008-7#1)
as renal##7##2##(1990-9#1)(1992-8#1)(2007-7#3)(2008-1#1)(2008-7#1)
as reported by Gu et al##2##6##(2008-9#2)
as reported by the##2##4##(1991-2#1)(2008-10#1)
as reported by##4##3##(1991-2#1)(2008-10#1)(2008-9#2)
as reported from other##2##4##(1995-8#1)(2008-10#1)
as reported from##3##3##(1995-8#1)(2008-10#1)(2011-3#1)
as reported in the literature##2##5##(2008-10#1)(2009-7#1)
as reported in the##3##4##(1992-9#1)(2008-10#1)(2009-7#1)
as reported in##6##3##(1992-9#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-1#1)(2013-1#1)
as reported previously##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
as reported##18##2##(1991-2#1)(1992-9#1)(1993-8#1)(1995-12#1)(1995-8#1)(2008-10#5)(2008-11#2)(2008-9#2)(2009-7#1)(2011-3#1)(2012-1#1)(2013-1#1)
as reporter gene##2##3##(2008-8#1)(2011-3#1)
as reporter##3##2##(1990-5#1)(2008-8#1)(2011-3#1)
as reporters of##2##3##(2007-12#1)(2012-2#1)
as representative of the##2##4##(2008-10#1)(2009-7#1)
as representative of##3##3##(2008-10#1)(2008-6#1)(2009-7#1)
as representative##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)
as represented##2##2##(2008-10#1)(2011-2#1)
as reproducible##2##2##(2008-10#1)(2008-9#1)
as reproductive##3##2##(2008-1#1)(2008-7#1)(2008-8#1)
as required for##2##3##(2007-11#1)(2008-9#1)
as required to##4##3##(2008-4#2)(2008-9#1)(2010-10#1)
as required##12##2##(1996-1#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-9#2)(2010-10#1)(2010-5#1)(2012-12#1)
as research##3##2##(1996-12#1)(2010-1#1)(2013-1#1)
as researchers##6##2##(1995-1#3)(1996-3#1)(2008-12#2)
as reservoirs for the##2##4##(1997-4#1)(2008-10#1)
as reservoirs for##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
as reservoirs of##2##3##(2008-10#1)(2010-6#1)
as reservoirs##5##2##(1997-4#1)(2008-10#2)(2008-5#1)(2010-6#1)
as resistance##2##2##(2008-9#1)(2011-2#1)
as resistant##5##2##(2008-10#1)(2008-7#1)(2011-2#3)
as resources##2##2##(1997-2#1)(2011-1#1)
as respiratory##3##2##(1997-8#1)(2011-1#1)(2012-2#1)
as response##2##2##(2008-10#2)
as responses##3##2##(2008-5#1)(2008-8#1)(2010-5#1)
as responsible for the##2##4##(1991-6#1)(2008-6#1)
as responsible for##3##3##(1990-8#1)(1991-6#1)(2008-6#1)
as responsible##4##2##(1990-8#1)(1991-6#1)(2008-5#1)(2008-6#1)
as restoration##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
as restriction##3##2##(2008-10#2)(2008-2#1)
as result of##3##3##(1997-8#1)(2008-7#1)(2011-2#1)
as resulting##3##2##(2008-3#1)(2008-5#1)(2010-5#1)
as results of##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
as results##6##2##(1991-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-3#1)
as retina##2##2##(1990-11#1)(2010-8#1)
as retinopathy##2##2##(1990-5#1)(2008-1#1)
as revealed by in##2##4##(1995-6#1)(2008-11#1)
as revealed by the##3##4##(1992-3#1)(1997-2#1)(2008-7#1)
as revealed by##28##3##(1990-5#1)(1991-10#1)(1992-3#2)(1992-9#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
as revealed in##3##3##(1994-3#1)(2008-7#1)(2009-10#1)
as revealed##31##2##(1990-5#1)(1991-10#1)(1992-3#2)(1992-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
as reversible##2##2##(2008-10#2)
as rich##2##2##(2008-5#1)(2010-3#1)
as risk factor##2##3##(1994-5#1)(1996-8#1)
as risk factors for ovarian cancer##2##6##(1993-9#2)
as risk factors for##5##4##(1993-9#2)(2008-4#1)(2010-4#1)(2013-8#1)
as risk factors##8##3##(1993-9#2)(1996-6#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
as risk##13##2##(1993-9#2)(1994-5#1)(1995-5#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
as risks##2##2##(1991-12#1)(1996-2#1)
as role models##2##3##(1991-2#1)(2012-3#1)
as root##2##2##(2008-10#1)(2009-4#1)
as running buffer##2##3##(2008-10#2)
as running##3##2##(2008-10#3)
as s##2##2##(1992-6#1)(1994-6#1)
as safe and##2##3##(2008-7#1)(2012-12#1)
as safe for##3##3##(2008-3#1)(2009-6#1)(2013-1#1)
as safe##8##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-12#1)(2013-1#1)
as safety##3##2##(1997-5#1)(2008-9#1)(2009-10#1)
as salicylate##2##2##(2008-10#2)
as salicylic acid##3##3##(2008-10#1)(2008-5#2)
as salient##2##2##(1997-3#1)(2008-1#1)
as salt##4##2##(2008-12#3)(2009-8#1)
as salvage##3##2##(1991-6#1)(2011-2#1)(2012-12#1)
as sample matrix##2##3##(2008-10#2)
as sample volume##3##3##(2008-10#3)
as sample##14##2##(2008-10#12)(2008-2#1)(2008-3#1)
as samples##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-5#1)
as sampling##3##2##(2008-5#1)(2010-5#1)(2012-3#1)
as satellites##2##2##(2008-2#2)
as satisfactory##3##2##(2008-10#2)(2008-12#1)
as saturable absorbers##3##3##(2007-11#1)(2008-3#2)
as scaffolds for##3##3##(2008-7#1)(2010-10#1)(2012-8#1)
as scaffolds##5##2##(2008-11#1)(2008-7#1)(2010-10#2)(2012-8#1)
as scan rate##2##3##(2008-10#2)
as scanning##5##2##(2008-10#4)(2009-7#1)
as schizophrenia##5##2##(1991-2#1)(1997-5#2)(2008-5#1)(2009-6#1)
as scientific##2##2##(1994-12#1)(2007-12#1)
as screening method##2##3##(2008-10#2)
as screening tests##2##3##(1993-2#1)(1994-2#1)
as screening##9##2##(1993-2#1)(1994-2#1)(2008-10#5)(2011-1#1)(2011-3#1)
as second line##2##3##(1994-2#1)(1997-7#1)
as second##6##2##(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-7#1)(2008-12#1)
as secondary ligands##2##3##(2008-10#2)
as secondary prevention##3##3##(2007-11#1)(2008-5#1)(2010-1#1)
as secondary prophylaxis after cerebrovascular##2##5##(1991-11#2)
as secondary##18##2##(1991-11#2)(2007-11#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-1#1)(2011-2#2)
as seed treatments##2##3##(2008-10#2)
as seed##6##2##(2008-10#3)(2008-6#1)(2008-9#1)(2013-1#1)
as seeking##2##2##(2008-9#1)(2010-2#1)
as seen by the##6##4##(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)
as seen by##10##3##(1990-7#1)(1992-12#1)(1994-6#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)
as seen from##2##3##(2006-4#1)(2008-3#1)
as seen in the##2##4##(2008-3#1)(2008-7#1)
as seen in##18##3##(1990-9#1)(1991-12#1)(1994-8#1)(1995-11#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
as seen on##2##3##(2008-9#1)(2012-2#1)
as seen with the##2##4##(2008-10#1)(2008-2#1)
as seen with##3##3##(1990-2#1)(2008-10#1)(2008-2#1)
as seen##38##2##(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(2006-10#3)(2006-4#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
as segmentation##2##2##(1997-3#1)(2008-6#1)
as segmented##2##2##(2008-10#1)(2008-3#1)
as selection of##2##3##(2008-10#2)
as selection##4##2##(1992-12#1)(2008-10#2)(2008-7#1)
as selective##15##2##(1990-3#1)(1995-3#1)(2007-12#1)(2008-10#9)(2008-12#1)(2012-12#1)(2012-2#1)
as seminal##2##2##(2008-10#1)(2010-7#1)
as sensed##2##2##(2008-8#1)(2010-2#1)
as sensing material##3##3##(2008-10#3)
as sensing materials##2##3##(2008-10#2)
as sensing##8##2##(2008-10#6)(2008-3#1)(2009-11#1)
as sensitive as##6##3##(1992-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
as sensitive probes##2##3##(1991-3#1)(2008-10#1)
as sensitive to##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
as sensitive##15##2##(1990-8#1)(1991-3#2)(1992-3#1)(2007-2#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2011-2#1)
as sensitivity and specificity##2##4##(1991-9#1)(1995-6#1)
as sensitivity to##2##3##(2008-5#1)(2013-1#1)
as sensitivity##7##2##(1991-9#1)(1995-6#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
as sensitizer##2##2##(2008-10#2)
as sensitizing##2##2##(2008-10#2)
as sensor##2##2##(2008-10#2)
as sensors in##2##3##(2008-10#2)
as sensors##6##2##(2008-10#4)(2008-8#1)(2010-7#1)
as separate##6##2##(2008-10#3)(2008-11#1)(2008-6#1)(2013-7#1)
as separation##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
as sequelae of##2##3##(2008-8#1)(2013-1#1)
as sequencing##2##2##(1990-12#1)(2012-3#1)
as serious##4##2##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
as serum##9##2##(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
as service##4##2##(1992-1#1)(1993-1#1)(1993-3#1)(2008-12#1)
as services##2##2##(1991-1#1)(1996-1#1)
as set forth in the##2##5##(1991-2#1)(1997-5#1)
as set##3##2##(1991-2#1)(1997-5#1)(2007-11#1)
as several##14##2##(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-3#1)(2010-10#2)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
as severe as##2##3##(2008-10#2)
as severe##11##2##(2007-12#1)(2008-10#3)(2008-11#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
as sexual##5##2##(1996-11#1)(2009-12#1)(2009-9#1)(2011-2#2)
as sexually transmitted##2##3##(1996-9#1)(2011-2#1)
as sham##2##2##(2012-3#1)(2012-7#1)
as shapes##2##2##(2008-10#1)(2008-2#1)
as sharp##2##2##(2007-11#1)(2008-2#1)
as she##3##2##(1995-11#1)(2008-4#1)(2008-7#1)
as short as 15##2##4##(2007-11#1)(2008-3#1)
as short as 2##2##4##(2007-12#1)(2008-2#1)
as short as 3##2##4##(2007-11#2)
as short as##21##3##(2007-11#8)(2007-12#6)(2008-2#4)(2008-3#3)
as short##24##2##(1993-12#1)(1997-2#1)(2007-11#8)(2007-12#6)(2008-2#4)(2008-3#3)(2008-9#1)
as show##3##2##(2008-10#3)
as showing##3##2##(1991-2#1)(2008-9#2)
as shown by electron##2##4##(1990-2#1)(2008-5#1)
as shown by the presence##2##5##(1995-12#1)(2011-2#1)
as shown by the##17##4##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1995-12#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-6#1)
as shown by##50##3##(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-8#1)
as shown in a##2##4##(2008-10#1)(2008-2#1)
as shown in the##2##4##(1995-3#1)(2008-10#1)
as shown in##9##3##(1990-5#1)(1995-3#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
as shown##63##2##(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-8#1)
as sick##3##2##(1991-9#2)(1996-1#1)
as side effects##2##3##(2011-2#1)(2011-3#1)
as signal##6##2##(2008-3#1)(2008-7#4)(2010-9#1)
as signaling##4##2##(1990-11#1)(2008-10#1)(2008-9#1)(2009-2#1)
as signalling molecules##2##3##(2012-6#2)
as signalling##3##2##(2008-11#1)(2012-6#2)
as signals##2##2##(1996-11#1)(2008-9#1)
as significant##12##2##(1993-9#1)(1994-2#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#2)(2010-6#1)(2010-7#1)(2012-3#1)
as significantly more##2##3##(1992-2#1)(2007-7#1)
as significantly##5##2##(1992-11#1)(1992-2#1)(2007-7#1)(2008-5#1)(2011-2#1)
as similar to##2##3##(2008-10#1)(2010-4#1)
as similar##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
as simple as##2##3##(2008-10#1)(2008-4#1)
as simple##8##2##(1990-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-3#1)(2012-3#1)
as simultaneous##2##2##(2008-7#1)(2008-9#1)
as single##13##2##(1990-5#1)(1994-8#1)(1997-7#1)(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
as single-chain##2##2##(1993-8#1)(1995-3#1)
as single-photon##2##2##(2008-3#1)(2012-2#1)
as size##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
as sleeping##2##2##(1992-11#1)(2011-1#1)
as slow##2##2##(2009-8#1)(2010-3#1)
as small as 0##5##4##(2008-2#2)(2008-3#3)
as small as 2##2##4##(2007-11#1)(2008-3#1)
as small as 5 microm##2##5##(2008-3#2)
as small as 5##4##4##(2008-2#2)(2008-3#2)
as small as a##3##4##(2008-10#1)(2008-3#2)
as small as##33##3##(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#9)(2008-3#14)(2009-12#1)(2010-11#1)(2011-1#1)
as small##43##2##(1991-9#1)(1994-2#1)(1994-5#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#9)(2008-3#15)(2009-12#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-10#1)
as smart##2##2##(2008-2#1)(2012-12#1)
as smokers by the 'König' reaction##2##6##(1993-8#2)
as smokers##3##2##(1993-8#2)(2007-12#1)
as smoking##4##2##(1992-9#1)(2008-3#1)(2009-5#1)(2013-1#1)
as smooth as##2##3##(1996-1#1)(2008-10#1)
as smooth##3##2##(1996-1#1)(2008-10#1)(2008-6#1)
as social and##2##3##(2007-7#1)(2008-11#1)
as social##5##2##(2007-7#1)(2008-11#1)(2009-7#1)(2012-2#1)(2012-3#1)
as sodium##16##2##(1990-8#1)(1995-11#1)(2008-10#7)(2008-11#2)(2008-5#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
as soft tissue##2##3##(2008-12#1)(2008-7#1)
as soft##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
as soil##7##2##(2008-10#5)(2008-11#1)(2011-2#1)
as solar background##3##3##(2008-2#1)(2008-3#2)
as solar##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
as sole carbon source##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
as sole##8##2##(1990-5#1)(1994-3#1)(1995-5#1)(1997-5#1)(2008-10#2)(2008-6#1)(2008-9#1)
as solid phase extractant##2##4##(2008-10#2)
as solid phase##10##3##(1992-9#1)(2008-10#9)
as solid support##3##3##(2008-10#2)(2008-5#1)
as solid##23##2##(1992-1#1)(1992-9#1)(2008-10#19)(2008-5#1)(2010-4#1)
as solid-state##2##2##(2008-10#2)
as soluble##3##2##(1995-2#1)(2008-10#1)(2009-2#1)
as solution##5##2##(1991-11#1)(2008-10#4)
as solvent mediator and##3##4##(2008-10#3)
as solvent##12##2##(2008-10#8)(2008-11#1)(2011-1#1)(2012-2#2)
as solvents##3##2##(2008-10#1)(2008-2#1)(2010-6#1)
as somatic##2##2##(2008-9#1)(2011-2#1)
as some##29##2##(1990-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-7#1)
as sometimes##3##2##(1993-12#1)(2008-10#2)
as soon as possible and to##2##6##(2007-11#1)(2011-2#1)
as soon as possible and##4##5##(2007-11#1)(2008-10#1)(2010-10#1)(2011-2#1)
as soon as possible##12##4##(1990-9#1)(1991-6#1)(1994-3#1)(1996-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)
as soon as the diagnosis##2##5##(1990-9#1)(2010-6#1)
as soon as the##5##4##(1990-9#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-6#1)
as soon as their##2##4##(1991-12#2)
as soon as##33##3##(1990-5#1)(1990-9#2)(1991-12#3)(1991-6#1)(1994-3#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-8#1)(2013-1#2)
as sorbent material##2##3##(2008-10#2)
as sorbent##7##2##(2008-10#7)
as sorbents for##2##3##(2008-10#2)
as source of##3##3##(1990-3#1)(1990-5#1)(2010-3#1)
as source##6##2##(1990-3#1)(1990-5#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-6#1)
as sources of##9##3##(1992-6#1)(1993-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2012-2#1)
as sources##11##2##(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2012-2#1)
as spatial##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2010-9#1)
as special cases##2##3##(2007-11#1)(2008-7#1)
as special##3##2##(2007-11#1)(2008-7#1)(2010-12#1)
as specialized##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
as species##2##2##(2008-9#1)(2013-1#1)
as specific inhibitors of##2##4##(1993-3#1)(1995-3#1)
as specific##17##2##(1991-5#1)(1992-8#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2013-1#2)
as spectral##2##2##(2007-11#1)(2008-10#1)
as spectrophotometric##3##2##(2008-10#3)
as speed##2##2##(1994-8#1)(2008-10#1)
as spontaneous##3##2##(2008-1#1)(2008-11#1)(2012-12#1)
as stabiliser##2##2##(2008-10#2)
as stabilizer##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
as stable##3##2##(1995-5#1)(2008-11#1)(2008-3#1)
as stage##2##2##(1994-10#1)(2008-7#1)
as standard##13##2##(1990-2#1)(1992-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
as standards##4##2##(1992-12#1)(2008-10#3)
as starting##5##2##(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
as state##2##2##(1995-3#2)
as stated##3##2##(1991-6#1)(2008-10#2)
as stationary phase##3##3##(1991-5#1)(2008-10#2)
as stationary phases##3##3##(2008-10#2)(2011-1#1)
as stationary##6##2##(1991-5#1)(2008-10#4)(2011-1#1)
as statistically##2##2##(2009-9#1)(2011-2#1)
as steady state##2##3##(1996-3#1)(2008-10#1)
as steps##2##2##(1994-7#1)(2008-11#1)
as stimulation of##2##3##(1995-11#1)(2008-5#1)
as stimulation##3##2##(1993-6#1)(1995-11#1)(2008-5#1)
as storage##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
as stores##2##2##(1996-5#1)(2008-9#1)
as straightforward as##2##3##(2008-7#1)(2012-2#1)
as strain##2##2##(2008-10#1)(2013-1#1)
as strains##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
as stress##3##2##(1993-6#1)(2007-12#1)(2008-11#1)
as stressful##4##2##(1994-12#3)(2011-2#1)
as strictly##2##2##(1993-1#1)(2008-3#1)
as stroke##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
as strong##8##2##(1993-8#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)
as structural##4##2##(2008-10#1)(2008-8#1)(2012-1#1)(2013-1#1)
as students##3##2##(1991-3#1)(2007-10#1)(2008-12#1)
as studied by##5##3##(1992-6#1)(1993-5#1)(1996-5#1)(2008-10#2)
as studied##7##2##(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1996-5#1)(2008-10#2)
as studies of##2##3##(2008-11#1)(2008-8#1)
as studies##6##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2013-1#1)
as study object##2##3##(2011-3#1)(2013-8#1)
as study##4##2##(2010-5#1)(2011-3#1)(2013-8#2)
as subcutaneous##2##2##(1997-8#1)(2013-1#1)
as subgroup##2##2##(2008-10#2)
as subjective##4##2##(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)
as subjects##8##2##(1993-2#1)(1994-3#1)(1997-5#1)(2007-12#1)(2008-5#2)(2008-6#1)(2009-6#1)
as subplots##2##2##(2008-12#2)
as subsequent##2##2##(2008-10#1)(2008-7#1)
as substituents##2##2##(2007-11#1)(2011-1#1)
as substitutes for##4##3##(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#1)
as substrate and##2##3##(1990-5#1)(1992-12#1)
as substrate for##2##3##(1991-9#1)(2008-10#1)
as substrate##32##2##(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-2#2)(1997-2#2)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-10#1)(2012-2#2)(2013-1#2)
as substrates for protein##2##4##(2009-2#1)(2010-7#1)
as substrates for the##2##4##(1994-5#1)(2010-1#1)
as substrates for##11##3##(1991-5#1)(1992-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-7#1)
as substrates in##3##3##(1991-5#1)(2009-10#1)(2011-1#1)
as substrates##32##2##(1990-11#1)(1991-5#4)(1991-8#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-8#1)(1994-5#4)(1994-6#1)(1994-8#3)(1995-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-1#1)
as successful condom users##2##4##(2008-11#2)
as successful##3##2##(2008-11#3)
as such a##2##3##(2008-3#2)
as such an##2##3##(2008-7#1)(2010-12#1)
as such by##3##3##(1995-12#1)(2009-3#1)(2009-6#1)
as such##52##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#3)
as sucrose##2##2##(2008-5#2)
as sudden infant death syndrome##2##5##(1991-11#1)(1991-9#1)
as sudden##3##2##(1991-11#1)(1991-9#1)(2008-10#1)
as suffering from##2##3##(1995-2#1)(2008-10#1)
as suggested by the##2##4##(1992-12#1)(2008-10#1)
as suggested by##9##3##(1990-8#2)(1992-12#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-10#1)(2012-1#1)(2012-4#1)
as suggested##12##2##(1990-8#2)(1992-12#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-11#1)(2012-1#1)(2012-4#1)
as suicide##3##2##(1997-4#1)(2011-2#1)(2013-1#1)
as suitable##8##2##(1991-5#1)(1992-3#1)(2007-11#1)(2008-10#4)(2008-11#1)
as sulphate ion##2##3##(2008-10#2)
as sulphate##3##2##(2008-10#3)
as superficial##2##2##(2007-10#1)(2012-3#1)
as superior##2##2##(2007-11#1)(2011-2#1)
as superoxide dismutase (SOD)##3##4##(1991-9#1)(2008-10#1)(2008-7#1)
as superoxide dismutase##5##3##(1991-9#1)(1992-9#1)(2008-10#2)(2008-7#1)
as superoxide##7##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(2008-10#2)(2008-7#1)
as support for the##2##4##(2007-12#1)(2008-5#1)
as support to##2##3##(2008-11#1)(2008-7#1)
as support##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
as supported by the##3##4##(2008-10#1)(2008-2#1)(2009-10#1)
as supporting electrolyte and##2##4##(2008-10#2)
as supporting electrolyte##7##3##(2008-10#7)
as supporting electrolytes##2##3##(2008-10#2)
as supporting##11##2##(1996-5#1)(2008-10#9)(2013-8#1)
as supportive##2##2##(1990-2#1)(2009-7#1)
as surface##5##2##(1995-3#1)(2007-11#1)(2008-2#1)(2010-4#1)(2012-1#1)
as surfactant##4##2##(2008-10#4)
as surgery##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
as surgical##2##2##(2007-11#1)(2008-9#1)
as surrogate biomarkers##2##3##(2008-12#1)(2010-1#1)
as surrogate markers for##2##4##(2009-6#1)(2013-1#1)
as surrogate markers of NO production##2##6##(2006-10#1)(2008-7#1)
as surrogate markers of##3##4##(2006-10#1)(2008-2#1)(2008-7#1)
as surrogate markers##5##3##(2006-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2013-1#1)
as surrogate##13##2##(1993-2#1)(1994-9#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-1#1)(2012-1#1)(2012-3#3)(2013-1#1)
as surrogates for##2##3##(2008-10#1)(2009-2#1)
as surveillance##2##2##(1990-12#1)(2009-5#1)
as survival##2##2##(2009-9#1)(2011-2#1)
as susceptible as the##2##4##(2007-10#1)(2008-10#1)
as susceptible to##2##3##(1993-9#1)(2011-2#1)
as susceptible##7##2##(1993-9#1)(2007-10#1)(2008-10#2)(2008-5#2)(2011-2#1)
as symmetry##2##2##(2008-3#1)(2013-1#1)
as symptoms##2##2##(2011-2#1)(2013-1#1)
as synaptic##2##2##(2009-3#1)(2009-9#1)
as synthetic##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
as systemic##4##2##(1997-5#1)(2008-12#1)(2010-1#1)(2013-1#1)
as take-all decline##2##3##(2008-10#2)
as taking##3##2##(2010-10#1)(2011-2#2)
as target cell##2##3##(2008-12#1)(2008-9#1)
as target cells##2##3##(1993-3#1)(2008-8#1)
as target for##2##3##(1992-2#1)(2012-3#1)
as target##13##2##(1990-11#1)(1992-2#1)(1993-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
as targets for##6##3##(1997-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
as targets of##3##3##(1994-8#1)(2008-4#1)(2013-8#1)
as targets##10##2##(1994-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
as taxonomic##2##2##(2008-10#1)(2008-12#1)
as teachers##2##2##(2012-1#1)(2013-8#1)
as teaching##2##2##(1995-1#1)(2012-3#1)
as technical##2##2##(2008-10#1)(2008-12#1)
as technology##3##2##(1996-1#1)(2008-6#1)(2011-1#1)
as temperature and##3##3##(2008-10#1)(2008-5#1)(2009-5#1)
as temperature##16##2##(1994-12#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-3#1)(2013-7#1)(2013-8#1)
as temperatures increased##2##3##(2008-10#2)
as template##12##2##(1993-9#1)(1997-7#2)(2008-10#4)(2008-4#1)(2008-8#3)(2008-9#1)
as templates for##5##3##(1996-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-11#1)
as templates##11##2##(1995-6#2)(1996-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)
as temporary##2##2##(2008-9#1)(2009-12#1)
as ten##2##2##(1993-12#1)(2008-10#1)
as terminal electron acceptor##2##4##(1990-7#1)(2009-8#1)
as terminal##3##2##(1990-7#1)(2009-8#1)(2009-9#1)
as ternary complexes##2##3##(2008-10#2)
as test##8##2##(1992-8#1)(1995-6#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
as tested using##2##3##(2009-5#1)(2011-1#1)
as tested##4##2##(1995-2#1)(2008-7#1)(2009-5#1)(2011-1#1)
as testing##2##2##(2008-10#1)(2010-7#1)
as testosterone##2##2##(2008-8#1)(2013-8#1)
as that for##4##3##(1993-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
as that found##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
as that in the##2##4##(1990-7#1)(2007-8#1)
as that in##7##3##(1990-7#1)(1991-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)
as that observed in the##2##5##(1991-2#1)(2008-10#1)
as that observed##5##3##(1991-2#1)(1995-3#1)(2008-10#2)(2012-2#1)
as that obtained with##2##4##(2008-12#1)(2008-2#1)
as that obtained##4##3##(1993-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
as that of a##4##4##(2007-12#1)(2008-7#1)(2008-8#1)(2009-10#1)
as that of the##20##4##(1990-12#1)(1992-5#1)(1993-9#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
as that of##54##3##(1990-12#1)(1990-5#2)(1990-7#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-9#1)(1994-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
as that with##2##3##(1990-6#1)(2008-10#1)
as that##100##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#3)(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#4)(2009-10#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
as the &quot##18##3##(1991-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-3#2)
as the BGE##3##3##(1996-5#1)(2008-10#2)
as the C##3##3##(2008-6#3)
as the CB##2##3##(2008-11#1)(2008-2#1)
as the DNA##2##3##(1993-3#1)(2008-10#1)
as the Hospital for the Ruptured and Crippled (R&amp##2##9##(2008-8#2)
as the Laboratory##2##3##(1990-11#1)(2008-5#1)
as the NaCl rate increased##2##5##(2008-10#2)
as the National##2##3##(2008-3#1)(2011-1#1)
as the Sun##3##3##(2008-2#2)(2008-3#1)
as the TNF##2##3##(1994-2#1)(1997-2#1)
as the ability of##2##4##(2007-9#1)(2008-8#1)
as the ability to##4##4##(1992-11#1)(2007-11#1)(2011-1#1)(2013-1#1)
as the ability##6##3##(1992-11#1)(2007-11#1)(2007-9#1)(2008-8#1)(2011-1#1)(2013-1#1)
as the absorbent##2##3##(2008-10#2)
as the accuracy##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
as the activation##2##3##(2008-10#1)(2008-7#1)
as the activator##2##3##(2008-10#1)(2008-4#1)
as the active ingredient##2##4##(2008-10#1)(2008-5#1)
as the active part##3##4##(2008-10#3)
as the active site nucleophile of##2##6##(1995-2#1)(1995-6#1)
as the active##13##3##(1993-6#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)
as the acyl##2##3##(1990-7#1)(1996-5#1)
as the age##2##3##(2008-11#1)(2013-1#1)
as the air##2##3##(2008-6#2)
as the amount of##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
as the analytical signal##2##4##(2008-10#2)
as the analytical##6##3##(2008-10#6)
as the anionic additive##2##4##(2008-10#2)
as the antibiotic##2##3##(1991-12#1)(2008-10#1)
as the apparent##3##3##(1992-5#2)(1995-12#1)
as the assessment##2##3##(2007-11#1)(2008-8#1)
as the authors##4##3##(1991-1#1)(2008-12#1)(2011-2#2)
as the availability of##4##4##(1996-12#1)(2007-7#1)(2008-1#2)
as the availability##5##3##(1996-12#1)(2007-7#1)(2008-1#2)(2008-9#1)
as the average##8##3##(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)
as the basal ganglia##2##4##(1995-3#1)(2013-8#1)
as the base##3##3##(2008-10#2)(2011-2#1)
as the basic##6##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
as the basis for a##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
as the basis for the##2##5##(2008-10#1)(2008-11#1)
as the basis for their##2##5##(2008-12#1)(2010-3#1)
as the basis for##20##4##(1992-6#1)(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-3#2)(2010-7#1)(2013-8#1)
as the basis of the##2##5##(1991-3#1)(2013-1#1)
as the basis of##8##4##(1991-3#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
as the basis##28##3##(1991-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#2)(2010-3#2)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
as the beam##2##3##(2007-11#1)(2008-3#1)
as the benchmark##2##3##(2008-5#1)(2013-1#1)
as the best for##2##4##(2008-10#2)
as the best predictor of##2##5##(2009-8#1)(2013-7#1)
as the best##20##3##(1990-12#1)(1991-12#2)(1993-3#1)(1995-3#1)(1996-12#1)(1996-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-3#1)(2013-7#1)
as the binding##2##3##(2008-10#1)(2010-4#1)
as the biological##2##3##(2008-1#1)(2008-10#1)
as the buffer##3##3##(2008-10#3)
as the building blocks##2##4##(1996-2#1)(2008-11#1)
as the carbon source##4##4##(1995-8#1)(2008-10#2)(2008-7#1)
as the carbon##5##3##(1995-8#1)(2008-10#2)(2008-6#1)(2008-7#1)
as the carrier buffer and background absorbance provider##2##8##(1996-5#1)(2008-10#1)
as the carrier gas##3##4##(2008-10#2)(2008-6#1)
as the carrier##9##3##(1996-5#1)(1997-2#1)(2008-10#5)(2008-6#1)(2011-1#1)
as the case##3##3##(1993-3#1)(2008-1#1)(2011-2#1)
as the catalyst and##2##4##(2008-10#1)(2008-12#1)
as the catalyst for##2##4##(2008-10#1)(2008-7#1)
as the catalyst##8##3##(1995-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
as the causal agent of##2##5##(2008-10#2)
as the causative agent of##2##5##(1992-8#1)(2008-10#1)
as the cause for the##2##5##(1991-2#1)(2010-1#1)
as the cause for##4##4##(1991-2#1)(2007-10#1)(2010-1#2)
as the cause of the##2##5##(1995-5#1)(1996-6#1)
as the cause of##12##4##(1990-6#1)(1991-2#1)(1994-12#1)(1995-5#1)(1996-6#1)(2008-11#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-2#1)
as the cause##19##3##(1990-6#1)(1991-2#2)(1994-12#1)(1995-5#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-1#2)(2010-10#1)(2011-1#2)(2011-2#3)(2012-2#1)
as the cell##5##3##(1993-3#1)(2008-11#2)(2013-1#2)
as the cells##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
as the cellular##4##3##(1992-8#1)(1996-2#1)(2008-10#1)(2008-7#1)
as the center##4##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
as the central##7##3##(1990-7#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-2#1)
as the change in##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
as the change##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
as the chemical##9##3##(1991-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)
as the child##2##3##(2007-8#1)(2012-2#1)
as the chiral##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
as the choice##2##3##(1995-12#1)(1995-5#1)
as the chromogenic reagent##2##4##(2008-10#2)
as the class##2##3##(2008-6#1)(2008-8#1)
as the clinical studies##2##4##(2008-11#1)(2010-5#1)
as the clinical##6##3##(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)
as the coating##2##3##(1995-12#1)(2008-3#1)
as the common##4##3##(1991-9#1)(2008-11#1)(2008-7#1)(2009-12#1)
as the community##2##3##(1995-1#1)(2007-10#1)
as the complex##2##3##(2008-3#1)(2008-6#1)
as the complexing##2##3##(2008-10#2)
as the complexities##2##3##(1994-1#1)(2008-10#1)
as the components##2##3##(1996-12#1)(2008-11#1)
as the composition of##2##4##(2008-10#1)(2008-3#1)
as the concentration of PEDOT##2##5##(2009-11#2)
as the concentration of the##3##5##(2008-10#1)(2008-12#2)
as the concentration of##13##4##(1992-11#1)(1994-8#1)(1995-2#2)(2008-10#4)(2008-11#1)(2008-12#2)(2009-11#2)
as the concentration##18##3##(1992-11#1)(1994-8#1)(1995-2#2)(2008-10#9)(2008-11#1)(2008-12#2)(2009-11#2)
as the concentrations##2##3##(2008-10#1)(2013-1#1)
as the continuous##2##3##(2008-10#2)
as the contrast##2##3##(1993-9#1)(2008-7#1)
as the control group##6##4##(1991-8#1)(1993-1#1)(1994-5#1)(2007-10#1)(2008-4#1)(2011-2#1)
as the control##12##3##(1991-8#1)(1993-1#1)(1994-5#1)(1995-11#1)(1996-5#1)(2007-10#1)(2008-4#1)(2008-5#3)(2009-11#1)(2011-2#1)
as the conventional##5##3##(1997-8#1)(2007-11#1)(2008-10#2)(2009-5#1)
as the core of the##2##5##(2008-10#1)(2008-3#1)
as the core of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
as the core##8##3##(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-3#2)
as the correct##3##3##(1990-12#1)(2008-11#1)(2008-6#1)
as the corrected##3##3##(1993-12#1)(2007-11#1)(2008-3#1)
as the corresponding##4##3##(1992-11#1)(1994-6#1)(2011-1#1)(2011-2#1)
as the costs of##2##4##(1994-2#1)(1995-3#1)
as the coupler##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
as the criterion for##2##4##(2007-8#1)(2012-9#1)
as the critical##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
as the current##4##3##(2008-3#3)(2011-2#1)
as the data##3##3##(2008-3#1)(2010-5#1)(2013-1#1)
as the decision##2##3##(2008-10#1)(2009-5#1)
as the definitive##2##3##(1993-2#1)(2008-6#1)
as the degree of##4##4##(1990-11#1)(1994-12#1)(2007-12#1)(2008-6#1)
as the degree##5##3##(1990-11#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-6#1)
as the density of##2##4##(2008-2#1)(2013-1#1)
as the detection of##6##4##(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#2)
as the detection system##2##4##(2008-10#2)
as the detection##11##3##(1992-11#1)(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-2#3)
as the detector of##2##4##(2008-10#2)
as the detector##6##3##(2008-10#6)
as the development of##5##4##(1994-8#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
as the diagnosis is made##2##5##(1992-11#1)(2010-6#1)
as the diagnosis##5##3##(1990-9#1)(1992-11#1)(2008-1#1)(2008-7#1)(2010-6#1)
as the diameter of##2##4##(2008-3#1)(2008-5#1)
as the difference between##7##4##(1991-11#1)(2008-10#4)(2009-11#1)(2011-2#1)
as the difference in disease##2##5##(2008-10#2)
as the difference in##5##4##(1992-12#1)(2008-10#3)(2009-8#1)
as the difference of##2##4##(2008-3#1)(2011-1#1)
as the difference##14##3##(1991-11#1)(1992-12#1)(2008-10#7)(2008-3#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)
as the direct##2##3##(1990-11#1)(2008-5#1)
as the direction of##2##4##(2008-7#1)(2013-1#1)
as the disease##3##3##(1997-5#1)(2008-2#1)(2008-4#1)
as the distance between##2##4##(2008-10#1)(2008-2#1)
as the distance##3##3##(2008-10#2)(2008-2#1)
as the domain##2##3##(1997-4#1)(2009-6#1)
as the dominant##5##3##(1995-3#1)(1997-8#1)(2008-1#1)(2011-3#1)(2013-8#1)
as the dose##2##3##(2008-10#1)(2008-4#1)
as the driving##2##3##(2008-3#1)(2012-3#1)
as the drug##3##3##(2008-7#2)(2011-2#1)
as the dynamic##2##3##(2008-2#1)(2008-9#1)
as the effect of##13##4##(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
as the electroosmotic flow##2##4##(1994-9#1)(1997-2#1)
as the eluent##4##3##(2008-10#4)
as the elution##2##3##(1996-5#1)(2008-10#1)
as the energy##2##3##(2007-12#1)(2008-3#1)
as the enzyme##5##3##(1995-12#2)(1995-2#1)(1997-1#1)(2010-5#1)
as the epidemic##2##3##(2008-10#2)
as the error##2##3##(2008-10#2)
as the etiological##2##3##(2008-9#1)(2011-2#1)
as the etiology##2##3##(2007-8#1)(2011-2#1)
as the evaluation##3##3##(2008-3#1)(2010-3#1)(2011-2#1)
as the excitation source##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
as the excitation##6##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
as the existence of##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
as the expected##3##3##(1993-12#1)(1994-5#1)(2008-3#1)
as the experimental##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
as the exposure##2##3##(2011-2#1)(2013-1#1)
as the extent of##6##4##(1992-3#1)(1997-8#1)(2008-10#1)(2010-4#1)(2010-5#1)(2011-2#1)
as the extractants##3##3##(2008-10#3)
as the extracting##2##3##(2008-10#2)
as the extraction##4##3##(2008-10#4)
as the factors that##3##4##(1991-11#1)(2008-12#1)(2008-3#1)
as the features of##2##4##(1991-8#1)(2012-2#1)
as the feedstock for##2##4##(2008-6#1)(2009-3#1)
as the feedstock##3##3##(2008-6#1)(2009-3#1)(2011-2#1)
as the fiber##2##3##(2007-11#1)(2007-12#1)
as the field##4##3##(2008-3#3)(2011-1#1)
as the fifth##2##3##(1991-9#1)(1992-12#1)
as the film##2##3##(1996-1#1)(2007-12#1)
as the first choice of##2##5##(1992-9#1)(2012-2#1)
as the first choice##3##4##(1992-9#1)(2012-2#1)(2013-1#1)
as the first line##2##4##(1994-8#1)(1996-7#1)
as the first step in the##2##6##(1995-2#1)(2008-6#1)
as the first step##5##4##(1995-2#1)(2008-10#2)(2008-6#1)(2012-2#1)
as the first to##2##4##(2008-3#1)(2008-9#1)
as the first woman doctor##2##5##(2011-2#2)
as the first##40##3##(1990-12#1)(1991-5#1)(1992-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#1)
as the first-line##3##3##(2010-11#1)(2010-12#1)(2012-3#1)
as the fluid##2##3##(2008-10#1)(2009-11#1)
as the fluorescence##2##3##(1990-8#1)(2008-10#1)
as the fluorophore##2##3##(2007-12#1)(2008-10#1)
as the focal##2##3##(2008-3#1)(2013-8#1)
as the formation of a##2##5##(2007-12#1)(2008-4#1)
as the formation of##7##4##(1992-12#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-10#1)(2012-2#1)
as the free radical##2##4##(2008-11#1)(2009-8#1)
as the free##3##3##(1995-2#1)(2008-11#1)(2009-8#1)
as the fully##2##3##(1994-11#1)(1996-3#1)
as the function of##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
as the functional##6##3##(1997-4#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-10#1)
as the fungus##2##3##(2008-10#2)
as the gain##2##3##(2007-12#1)(2010-8#1)
as the general##2##3##(1992-1#1)(2008-3#1)
as the generator##2##3##(2007-12#1)(2008-10#1)
as the genetic##2##3##(2008-8#1)(2011-1#1)
as the glucose##2##3##(2008-10#2)
as the gold standard##7##4##(2008-12#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-2#1)
as the gross##2##3##(1995-5#1)(2008-2#1)
as the group##2##3##(2007-11#1)(2008-6#1)
as the growth##2##3##(2008-5#1)(2011-2#1)
as the health##3##3##(1996-1#1)(2010-4#1)(2012-12#1)
as the highest##2##3##(1994-2#1)(2007-11#1)
as the host##6##3##(2008-10#3)(2008-2#1)(2008-5#2)
as the human##3##3##(1993-6#1)(1994-6#1)(2010-5#1)
as the imaging##2##3##(2007-12#1)(2010-8#1)
as the immune##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)
as the impact of##2##4##(1994-3#1)(2012-9#1)
as the importance of##2##4##(2008-10#1)(2012-2#1)
as the importance##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
as the incidence of##2##4##(2008-10#1)(2011-2#1)
as the incident##2##3##(2008-2#1)(2008-3#1)
as the increased stability##2##4##(1993-11#1)(2008-4#1)
as the independent variable##2##4##(2008-10#2)
as the index of##2##4##(1996-3#1)(2010-2#1)
as the indicator electrode##3##4##(2008-10#3)
as the indicator##8##3##(2008-10#6)(2008-4#1)(2011-1#1)
as the induction of##4##4##(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
as the industry##2##3##(1991-3#1)(1994-2#1)
as the initial manifestation of##2##5##(1991-6#1)(2006-10#1)
as the initial manifestation##3##4##(1991-6#1)(1993-2#1)(2006-10#1)
as the initial presentation of##4##5##(2006-10#1)(2007-5#1)(2008-6#1)(2012-12#1)
as the initial presentation##5##4##(2006-10#1)(2007-5#1)(2008-1#1)(2008-6#1)(2012-12#1)
as the initial##18##3##(1990-11#1)(1991-6#1)(1993-2#1)(1997-8#1)(2006-10#2)(2007-5#2)(2008-1#2)(2008-3#2)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
as the input##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
as the intensity of##2##4##(1993-3#1)(1995-8#1)
as the intensity##3##3##(1993-3#1)(1995-8#1)(2008-3#1)
as the interference##3##3##(2008-10#2)(2008-3#1)
as the internal standard##8##4##(2008-1#1)(2008-10#7)
as the internal##9##3##(2008-1#1)(2008-10#8)
as the interval between##2##4##(2008-2#1)(2008-7#1)
as the intracellular##3##3##(1995-11#1)(1995-3#1)(2011-2#1)
as the intrinsic##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
as the ion##2##3##(2008-10#2)
as the ionic strength was increased##2##6##(1997-2#2)
as the ionic##3##3##(1990-2#1)(1997-2#2)
as the joint##2##3##(2008-3#1)(2009-7#1)
as the key to##2##4##(1996-1#1)(2010-5#1)
as the key##13##3##(1991-12#2)(1992-11#1)(1992-3#1)(1994-5#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-2#1)
as the knowledge##2##3##(2008-10#1)(2011-1#1)
as the known##2##3##(2008-2#1)(2010-3#1)
as the laser##4##3##(1992-12#1)(2007-12#1)(2008-3#2)
as the leading cause of##2##5##(1997-1#1)(2009-4#1)
as the leading##7##3##(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)
as the leg##2##3##(1995-2#1)(2007-12#1)
as the length of##2##4##(2008-10#1)(2011-3#1)
as the lesion##2##3##(2010-12#1)(2012-3#1)
as the less##2##3##(2008-10#1)(2012-2#1)
as the level of##7##4##(1997-1#1)(2010-4#2)(2010-8#1)(2011-1#1)(2013-1#2)
as the ligand##3##3##(1990-11#1)(2008-10#1)(2010-12#1)
as the light source and the other##2##7##(2008-10#2)
as the light source and the##3##6##(2008-10#3)
as the light source##13##4##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#3)
as the light##14##3##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#3)(2010-5#1)
as the linear##2##3##(1994-12#1)(2008-3#1)
as the local##2##3##(2008-3#1)(2010-12#1)
as the lowest##2##3##(1996-2#1)(2007-11#1)
as the main focus##2##4##(1995-12#1)(2008-1#1)
as the main##24##3##(1990-5#1)(1992-8#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
as the major product##5##4##(1990-2#1)(1990-5#1)(1996-5#1)(2007-11#1)(2009-2#1)
as the major##30##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1994-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
as the mammalian##2##3##(2008-10#1)(2010-2#1)
as the matrix##4##3##(1990-8#1)(2008-10#1)(2009-7#1)(2010-5#1)
as the maximum##3##3##(2008-10#1)(2010-3#1)(2012-3#1)
as the mean##5##3##(1992-2#1)(2008-3#2)(2008-5#1)(2010-3#1)
as the measure##2##3##(2007-8#1)(2008-10#1)
as the mechanism of##3##4##(2008-8#1)(2008-9#1)(2009-9#1)
as the mechanism##6##3##(1990-11#1)(1992-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)
as the medium##2##3##(2008-11#1)(2008-2#1)
as the metabolic##2##3##(1992-2#1)(2011-3#1)
as the method is##2##4##(2008-10#1)(2008-11#1)
as the method of choice for##2##6##(2008-9#1)(2010-12#1)
as the method of##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
as the method##8##3##(1996-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#1)(2010-12#1)
as the minimum##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
as the mobile phase##15##4##(1990-8#2)(1991-7#1)(1993-11#1)(1994-9#1)(2008-10#5)(2011-1#4)(2012-3#1)
as the mobile##17##3##(1990-8#2)(1991-7#1)(1993-11#1)(1994-9#1)(2008-10#6)(2011-1#5)(2012-3#1)
as the mode-locking##2##3##(2007-11#2)
as the model##9##3##(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
as the models##2##3##(1997-5#1)(2008-10#1)
as the molecular##5##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
as the molecule##2##3##(2008-10#1)(2010-5#1)
as the more##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
as the most abundant##2##4##(2009-6#1)(2012-12#1)
as the most appropriate##3##4##(2008-10#2)(2011-2#1)
as the most common cause##2##5##(2011-2#2)
as the most common##6##4##(2008-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
as the most critical##2##4##(2012-3#1)(2013-8#1)
as the most effective##5##4##(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2010-10#1)
as the most important##12##4##(1990-6#1)(1994-11#1)(1995-1#2)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
as the most suitable##2##4##(2008-10#2)
as the most useful##3##4##(1991-3#1)(1991-6#1)(2010-4#1)
as the most##59##3##(1990-6#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#2)(1997-2#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
as the motor##2##3##(1994-9#1)(2008-11#1)
as the name##2##3##(2008-10#1)(2010-5#1)
as the national##2##3##(2008-3#1)(2012-1#1)
as the natural##2##3##(1995-12#1)(2011-3#1)
as the need for##5##4##(1991-2#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-1#1)
as the need##7##3##(1991-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)
as the negative##3##3##(2007-12#1)(2008-8#1)(2013-1#1)
as the new##3##3##(2008-1#1)(2008-3#1)(2010-6#1)
as the nonlinear##2##3##(2007-12#1)(2008-3#1)
as the normal##2##3##(2006-12#1)(2010-1#1)
as the nuclear##2##3##(1991-12#1)(1995-8#1)
as the nucleus##3##3##(2008-2#3)
as the number and##3##4##(1994-2#1)(1996-12#1)(2008-5#1)
as the number of##22##4##(1993-12#1)(1995-12#1)(1995-3#1)(1996-8#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#1)
as the number##26##3##(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#1)
as the numerical##2##3##(2008-2#1)(2008-3#1)
as the older##2##3##(1994-5#1)(2008-10#1)
as the one##4##3##(1990-8#1)(1994-1#1)(2007-12#1)(2008-2#1)
as the only active##2##4##(2008-10#2)
as the only means of##2##5##(1991-2#1)(2008-11#1)
as the only##22##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-4#1)(1993-6#1)(1994-11#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-6#2)(2012-3#1)(2013-1#1)(2013-7#1)
as the operating##2##3##(2008-10#1)(2008-9#1)
as the optical##5##3##(2008-2#3)(2008-3#2)
as the optimal##5##3##(2008-10#2)(2008-6#1)(2009-7#1)(2012-3#1)
as the optimum##5##3##(2008-10#4)(2013-1#1)
as the organic phase##2##4##(1994-3#1)(2008-10#1)
as the organic##5##3##(1994-3#1)(1995-6#1)(2008-10#3)
as the origin of##5##4##(1990-3#1)(2007-12#2)(2008-10#1)(2008-3#1)
as the original##4##3##(1994-3#1)(2008-10#1)(2008-9#2)
as the other##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
as the outcome of##4##4##(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
as the outcome##5##3##(1993-1#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
as the outcomes##2##3##(1994-11#1)(2008-4#1)
as the output##4##3##(2008-2#2)(2008-3#2)
as the overall##5##3##(2008-1#1)(2008-3#2)(2008-7#1)(2010-3#1)
as the oxidant##5##3##(2007-11#3)(2008-10#1)(2008-5#1)
as the oxidants##2##3##(2007-11#1)(2011-2#1)
as the pH increased##2##4##(2008-10#1)(2008-6#1)
as the pH of the##2##5##(1990-5#1)(1995-6#1)
as the pH##9##3##(1990-5#1)(1995-6#1)(2008-10#6)(2008-6#1)
as the parameter##2##3##(2007-11#1)(2008-10#1)
as the parental##3##3##(1992-3#1)(1995-5#1)(2009-6#1)
as the patient##2##3##(1991-6#1)(2012-12#1)
as the patient's##2##3##(1991-9#1)(2008-11#1)
as the patients##3##3##(1990-12#1)(1995-12#1)(2007-8#1)
as the percentage of##5##4##(2006-6#1)(2008-10#3)(2011-2#1)
as the percentage##6##3##(2006-6#1)(2008-10#3)(2008-9#1)(2011-2#1)
as the phantom##2##3##(2008-3#1)(2008-5#1)
as the physical##2##3##(1990-10#1)(2007-12#1)
as the physiological##2##3##(1994-5#1)(2008-1#1)
as the plant##3##3##(2008-10#2)(2008-9#1)
as the plasma##2##3##(1994-12#1)(2011-2#1)
as the polarization##3##3##(2008-2#1)(2008-3#2)
as the position##2##3##(2008-3#2)
as the potential##8##3##(1991-12#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-4#1)(2009-12#1)(2013-8#1)
as the power##2##3##(2007-11#1)(2007-12#1)
as the precursor##5##3##(2008-10#2)(2008-2#1)(2009-6#1)(2012-1#1)
as the predicted##2##3##(2007-12#1)(2008-8#1)
as the predominant##7##3##(1990-11#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
as the preferred##2##3##(2007-7#1)(2008-2#1)
as the presence of the##2##5##(1996-3#1)(2008-12#1)
as the presence of##9##4##(1994-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#2)
as the presence##10##3##(1994-6#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#2)
as the present##2##3##(2007-12#1)(2008-10#1)
as the presenting sign of##3##5##(2007-2#1)(2010-10#1)(2012-12#1)
as the presenting##5##3##(1990-3#1)(2007-2#1)(2010-10#1)(2010-6#1)(2012-12#1)
as the prevalence of##2##4##(1990-6#1)(1990-9#1)
as the primary search tool##2##5##(2008-3#2)
as the primary##26##3##(1990-11#1)(1990-12#1)(1992-3#1)(1993-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
as the prime##2##3##(1995-3#1)(1996-1#1)
as the principal##7##3##(1990-7#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)
as the probe##7##3##(2007-11#2)(2008-10#2)(2008-2#1)(2008-8#2)
as the procedures##2##3##(2010-6#1)(2012-3#1)
as the process##2##3##(2008-2#1)(2012-3#1)
as the product of##3##4##(2008-10#2)(2008-3#1)
as the products of##2##4##(1997-8#1)(2007-12#1)
as the professional##2##3##(1991-1#1)(2012-3#1)
as the propellant##2##3##(1996-1#1)(1996-2#1)
as the proportion of total##3##5##(1995-3#1)(2008-10#1)(2010-12#1)
as the proportion of##6##4##(1995-3#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-2#1)
as the proposed##2##3##(2008-11#1)(2011-1#1)
as the protection##2##3##(2013-1#2)
as the provision of##2##4##(1995-5#1)(2007-4#1)
as the proximal##2##3##(1994-12#1)(2011-2#1)
as the pulse duration##2##4##(1991-2#2)
as the pulse##5##3##(1991-2#2)(2007-12#2)(2008-2#1)
as the pump source##3##4##(2008-2#1)(2008-3#2)
as the pump##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
as the putative##2##3##(1995-2#1)(2008-1#1)
as the quality of the##2##5##(2008-7#1)(2008-8#1)
as the quality of##4##4##(1996-2#1)(1997-4#1)(2008-7#1)(2008-8#1)
as the quantity of##2##4##(2008-9#1)(2011-1#1)
as the quotient of##2##4##(2012-3#1)(2012-6#1)
as the range of##5##4##(1997-3#2)(2008-12#1)(2008-8#1)(2013-1#1)
as the range##6##3##(1997-3#2)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
as the ratio between the##2##5##(2008-10#1)(2008-6#1)
as the ratio between##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
as the ratio of the##6##5##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
as the ratio of##12##4##(1991-6#1)(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-2#1)(2012-1#1)(2013-1#1)
as the ratio##16##3##(1991-6#1)(1994-5#1)(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#2)
as the reagent##2##3##(2008-10#2)
as the reciprocal##2##3##(2008-2#1)(2008-9#1)
as the recognition##3##3##(1990-11#1)(1992-10#1)(2008-10#1)
as the recording medium##2##4##(2007-11#1)(2008-3#1)
as the recording##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
as the reducing##2##3##(2008-10#1)(2011-2#1)
as the reference light##2##4##(2007-11#2)
as the reference##12##3##(1991-5#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
as the regulation##2##3##(2008-9#2)
as the relationship##3##3##(1990-11#1)(1994-8#1)(2011-1#1)
as the relative standard deviation##4##5##(2008-10#4)
as the relative standard##6##4##(2008-10#6)
as the relative##10##3##(1996-5#1)(2008-10#6)(2008-8#1)(2010-11#1)(2011-2#1)
as the reporter##2##3##(1990-12#1)(2008-11#1)
as the residue##2##3##(2007-12#1)(2008-10#1)
as the response##4##3##(1995-12#1)(2008-10#3)
as the result of a##4##5##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
as the result of##12##4##(1992-8#1)(1994-3#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)
as the result##14##3##(1992-8#1)(1994-3#1)(1994-8#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)
as the results##7##3##(1992-9#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-5#1)
as the risk##2##3##(1997-4#1)(2008-2#1)
as the role of##10##4##(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
as the rupture##2##3##(2007-7#1)(2008-6#1)
as the same##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
as the sample##6##3##(1992-11#1)(2008-10#2)(2008-3#2)(2008-7#1)
as the samples##3##3##(2008-10#2)(2012-2#1)
as the saturable absorber##2##4##(2008-3#2)
as the scale##3##3##(2008-11#2)(2008-3#1)
as the scan##2##3##(2008-10#2)
as the scatterer concentration increases##2##5##(2007-12#2)
as the scientific community##3##4##(2008-12#1)(2012-2#2)
as the screening##3##3##(1996-12#1)(2008-10#1)(2011-1#1)
as the second##6##3##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
as the selection##4##3##(1997-6#1)(2008-10#1)(2008-8#1)(2009-8#1)
as the selective##2##3##(2008-10#1)(2013-1#1)
as the sensing material##2##4##(2008-10#2)
as the sensing##3##3##(2008-10#3)
as the sensor##3##3##(2007-11#1)(2008-2#1)(2010-8#1)
as the separation##2##3##(1994-9#1)(2008-10#1)
as the signal##5##3##(1993-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
as the significance of##2##4##(2008-10#1)(2010-5#1)
as the simultaneous##2##3##(2008-10#1)(2009-8#1)
as the single entry##2##4##(2012-2#2)
as the single##3##3##(2008-12#1)(2012-2#2)
as the site##2##3##(2012-12#2)
as the size of a##2##5##(2008-2#1)(2008-3#1)
as the size of the##4##5##(1992-8#1)(2007-10#1)(2008-5#1)(2011-1#1)
as the size of##6##4##(1992-8#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
as the size parameter##2##4##(2008-3#2)
as the size##8##3##(1992-8#1)(2007-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#1)
as the slope##2##3##(2008-3#1)(2009-8#1)
as the small##2##3##(1994-11#1)(2008-9#1)
as the smallest units of##2##5##(2008-10#2)
as the social##2##3##(2008-9#1)(2010-5#1)
as the sole carbon source##5##5##(2008-10#2)(2008-6#2)(2011-1#1)
as the sole nitrogen source##2##5##(1995-8#1)(2008-10#1)
as the sole source of##3##5##(2008-10#1)(2008-6#1)(2008-7#1)
as the sole##19##3##(1991-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-10#6)(2008-6#3)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)
as the solid##4##3##(1990-6#1)(2008-10#3)
as the solution##4##3##(1995-1#1)(2008-10#1)(2008-7#1)(2010-8#1)
as the solvent##10##3##(2008-10#5)(2008-11#1)(2008-2#2)(2012-2#1)(2013-8#1)
as the source of##7##4##(1991-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-1#1)
as the source##12##3##(1991-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2010-3#1)(2012-1#1)
as the spacing##2##3##(2008-2#1)(2008-3#1)
as the specific##4##3##(1996-6#1)(2008-10#2)(2008-11#1)
as the speed of##2##4##(1992-2#1)(2008-8#1)
as the stabilizer##2##3##(2008-5#1)(2013-8#1)
as the standard##12##3##(1991-1#1)(2007-8#1)(2008-10#3)(2008-2#2)(2010-12#2)(2010-3#1)(2011-1#1)(2012-2#1)
as the starting material##2##4##(2007-11#1)(2008-2#1)
as the starting##4##3##(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#1)
as the stationary phase##7##4##(1997-2#1)(2008-10#4)(2011-1#2)
as the stimulus intensity is increased##2##6##(2008-7#2)
as the stimulus##3##3##(2008-7#2)(2008-8#1)
as the strain##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
as the strength of##2##4##(2008-2#1)(2008-8#1)
as the study##3##3##(1991-12#1)(2008-11#1)(2012-12#1)
as the substrate##12##3##(1990-12#1)(1995-2#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)
as the substrates##4##3##(1992-3#1)(1993-6#1)(1994-6#1)(2008-10#1)
as the sum of##2##4##(2007-11#1)(2008-3#1)
as the supporting electrolyte##3##4##(2008-10#3)
as the supporting##4##3##(2008-10#4)
as the surface##2##3##(2008-2#1)(2008-3#1)
as the surfactant##2##3##(2008-10#1)(2013-8#1)
as the symptoms##2##3##(2010-8#1)(2013-1#1)
as the system##3##3##(1997-4#1)(2007-12#1)(2013-1#1)
as the target##5##3##(1994-12#1)(2008-10#3)(2012-2#1)
as the targets for##3##4##(2008-4#2)(2011-3#1)
as the targets##4##3##(2008-4#2)(2011-3#1)(2012-2#1)
as the temperature is##2##4##(1995-2#1)(1997-7#1)
as the temperature##4##3##(1995-2#1)(1997-7#1)(2008-10#1)(2009-12#1)
as the template##4##3##(2008-10#3)(2008-2#1)
as the terminal##2##3##(1990-7#1)(1997-4#1)
as the test##8##3##(1992-3#1)(2008-10#4)(2008-3#2)(2008-5#1)
as the testing##2##3##(2008-10#1)(2009-11#1)
as the theoretical##2##3##(2008-11#1)(2008-4#1)
as the therapeutic##4##3##(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
as the thickness of the##3##5##(2008-3#1)(2008-7#1)(2012-2#1)
as the thickness of##5##4##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
as the thickness##6##3##(1994-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
as the third##6##3##(1993-9#1)(1995-5#1)(2008-10#3)(2009-7#1)
as the three##2##3##(1997-8#1)(2008-10#1)
as the time of##3##4##(2008-10#2)(2008-4#1)
as the time##6##3##(1997-6#1)(2008-10#3)(2008-4#2)
as the timing##2##3##(2007-12#1)(2008-8#1)
as the titrant##3##3##(2008-10#3)
as the topic##2##3##(1992-2#1)(1996-12#1)
as the total concentration of##2##5##(2008-10#2)
as the total##6##3##(1996-12#1)(2008-10#3)(2008-3#2)
as the transient##3##3##(1992-6#1)(1994-11#1)(2008-4#1)
as the transition##2##3##(1996-5#1)(2009-12#1)
as the tumor##3##3##(1990-6#1)(2011-2#1)(2013-1#1)
as the two##5##3##(1997-2#1)(2007-12#2)(2008-10#2)
as the type of##2##4##(1996-12#1)(2007-12#1)
as the type species##2##4##(2011-2#2)
as the type##5##3##(1996-12#1)(2007-12#1)(2008-6#1)(2011-2#2)
as the ultrasonic power##2##4##(2008-10#1)(2013-8#1)
as the underlying mechanism##2##4##(2008-2#1)(2009-12#1)
as the underlying##9##3##(1991-9#1)(1992-1#1)(1995-5#1)(1997-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-3#1)
as the unique##3##3##(2007-12#1)(2010-8#1)(2012-2#1)
as the unit of analysis##3##5##(1996-3#1)(1997-1#1)(2012-2#1)
as the unit of##4##4##(1995-2#1)(1996-3#1)(1997-1#1)(2012-2#1)
as the university considers that there are grounds for such action##3##11##(2008-10#3)
as the unwanted##2##3##(1992-1#1)(1997-2#1)
as the upper##2##3##(2008-10#1)(2008-2#1)
as the use of##12##4##(1993-6#1)(2008-10#5)(2008-11#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
as the use##13##3##(1993-6#1)(2008-10#5)(2008-11#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-3#1)
as the usual##2##3##(1991-12#1)(1997-3#1)
as the variable substrate##3##4##(1992-3#3)
as the variable##5##3##(1992-3#4)(2008-7#1)
as the vehicle##2##3##(2008-5#1)(2010-10#1)
as the viewing##2##3##(2008-1#1)(2008-3#1)
as the volume##2##3##(2008-10#1)(2008-2#1)
as the water##2##3##(2008-10#1)(2008-7#1)
as the wavelength##2##3##(2008-3#2)
as the weighted##3##3##(2008-10#2)(2008-3#1)
as the wild type##5##4##(1993-3#1)(2008-10#3)(2008-9#1)
as the wild-type##2##3##(1992-6#1)(2008-10#1)
as the women##3##3##(1995-2#1)(1996-1#1)(2009-4#1)
as the working electrode##5##4##(2008-10#5)
as the working##6##3##(2008-10#6)
as the##3100##2##(1990-10#1)(1990-11#17)(1990-12#12)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#6)(1990-7#6)(1990-8#9)(1990-9#7)(1991-1#5)(1991-11#4)(1991-12#21)(1991-2#12)(1991-3#9)(1991-5#7)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#9)(1992-1#5)(1992-10#1)(1992-11#9)(1992-12#13)(1992-2#8)(1992-3#14)(1992-4#1)(1992-5#3)(1992-6#10)(1992-8#11)(1992-9#9)(1993-1#6)(1993-11#5)(1993-12#21)(1993-2#6)(1993-3#12)(1993-5#1)(1993-6#10)(1993-8#5)(1993-9#6)(1994-1#6)(1994-11#16)(1994-12#15)(1994-2#7)(1994-3#13)(1994-5#10)(1994-6#8)(1994-8#16)(1994-9#9)(1995-1#7)(1995-11#6)(1995-12#20)(1995-2#26)(1995-3#16)(1995-5#15)(1995-6#17)(1995-8#6)(1995-9#1)(1996-1#15)(1996-11#2)(1996-12#21)(1996-2#15)(1996-3#14)(1996-4#2)(1996-5#14)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#8)(1997-2#22)(1997-3#15)(1997-4#12)(1997-5#4)(1997-6#11)(1997-7#12)(1997-8#11)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#9)(2007-11#56)(2007-12#76)(2007-2#4)(2007-4#1)(2007-5#5)(2007-7#8)(2007-8#15)(2007-9#2)(2008-1#41)(2008-10#669)(2008-11#99)(2008-12#37)(2008-2#130)(2008-3#203)(2008-4#43)(2008-5#83)(2008-6#43)(2008-7#93)(2008-8#55)(2008-9#59)(2009-1#2)(2009-10#9)(2009-11#13)(2009-12#10)(2009-2#8)(2009-3#5)(2009-4#7)(2009-5#14)(2009-6#13)(2009-7#14)(2009-8#19)(2009-9#2)(2010-1#8)(2010-10#8)(2010-11#10)(2010-12#13)(2010-2#7)(2010-3#17)(2010-4#7)(2010-5#25)(2010-6#9)(2010-7#5)(2010-8#14)(2010-9#6)(2011-1#51)(2011-2#100)(2011-3#13)(2011-4#2)(2011-7#2)(2012-1#7)(2012-12#24)(2012-2#62)(2012-3#37)(2012-6#1)(2012-9#2)(2013-1#66)(2013-7#7)(2013-8#39)
as their alditol derivatives##2##4##(1994-9#2)
as their first##2##3##(2009-5#1)(2013-1#1)
as their most##2##3##(1991-3#1)(1996-3#1)
as their own##6##3##(1993-2#1)(1995-1#1)(1995-2#1)(2007-12#1)(2008-8#1)(2012-3#1)
as their primary##3##3##(1991-1#1)(2008-4#1)(2011-2#1)
as their spatial##2##3##(2008-10#1)(2008-2#1)
as their##106##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-3#2)(1997-2#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-3#4)(2013-1#3)(2013-8#1)
as therapeutic agents for##2##4##(1992-12#1)(2012-2#1)
as therapeutic agents##6##3##(1990-9#1)(1992-12#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#1)
as therapeutic drugs##2##3##(2008-11#1)(2011-1#1)
as therapeutic##15##2##(1990-9#2)(1992-12#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
as therapeutics##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
as there are no##2##4##(2008-9#1)(2012-3#1)
as there are##7##3##(1992-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
as there is a##2##4##(1997-1#1)(2011-2#1)
as there is enough##2##4##(2007-2#1)(2008-7#1)
as there is no##3##4##(2008-3#1)(2010-3#1)(2013-1#1)
as there is##10##3##(1997-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
as there was##3##3##(1990-5#1)(2008-10#2)
as there##22##2##(1990-5#1)(1992-2#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
as these are##4##3##(2008-10#2)(2010-11#1)(2012-2#1)
as these cells##2##3##(2009-3#1)(2013-1#1)
as these new##2##3##(2012-12#1)(2012-2#1)
as these patients##2##3##(2008-7#1)(2011-1#1)
as these##29##2##(1991-12#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
as they age##4##3##(2008-10#1)(2008-12#1)(2010-1#1)(2011-2#1)
as they allow##3##3##(2008-5#1)(2009-4#1)(2013-1#1)
as they apply to##5##4##(1992-2#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-7#1)
as they are not##3##4##(2011-2#1)(2011-7#1)(2013-1#1)
as they are quite##2##4##(2008-10#1)(2010-12#1)
as they are##25##3##(1995-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
as they arise##2##3##(2012-1#1)(2012-2#1)
as they can##2##3##(2008-7#1)(2012-2#1)
as they could##2##3##(2008-10#1)(2011-2#1)
as they do in##2##4##(1993-12#1)(1994-9#1)
as they do not##3##4##(1992-4#1)(2008-10#1)(2011-1#1)
as they do##5##3##(1992-4#1)(1993-12#1)(1994-9#1)(2008-10#1)(2011-1#1)
as they have##2##3##(2008-2#1)(2012-2#1)
as they increase##2##3##(1990-12#1)(2007-12#1)
as they may be##2##4##(1990-3#1)(2009-5#1)
as they may##4##3##(1990-3#1)(2008-11#1)(2009-5#1)(2012-2#1)
as they occur##3##3##(1996-5#1)(2008-4#1)(2008-5#1)
as they provide##2##3##(2008-9#1)(2010-9#1)
as they relate to the##4##5##(1991-2#1)(1997-2#1)(2008-5#1)(2008-9#1)
as they relate to##9##4##(1991-2#1)(1993-3#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)
as they were to##2##4##(2008-9#1)(2013-1#1)
as they were##7##3##(1994-8#1)(2008-5#2)(2008-7#2)(2008-9#1)(2013-1#1)
as they##147##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#1)(2008-1#4)(2008-10#13)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#2)
as thiocyanate complexes##2##3##(2008-10#2)
as thiocyanate##3##2##(2008-10#3)
as this is##3##3##(1991-12#1)(1992-6#1)(2012-2#1)
as this may##2##3##(2012-2#1)(2013-1#1)
as this population##3##3##(2008-7#1)(2011-2#2)
as this was##2##3##(2008-1#1)(2011-2#1)
as this##39##2##(1991-12#1)(1992-6#1)(1993-3#1)(1995-12#2)(1995-2#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
as those described##2##3##(1992-6#1)(2011-2#1)
as those for##2##3##(1990-5#1)(2008-10#1)
as those found in##2##4##(2008-10#1)(2008-3#1)
as those having##2##3##(2007-7#1)(2008-8#1)
as those in the##4##4##(1991-12#1)(2008-4#1)(2010-1#1)(2012-12#1)
as those in##8##3##(1991-12#1)(1995-6#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-12#1)
as those induced by##3##4##(1992-8#1)(1993-3#1)(2008-3#1)
as those normally##2##3##(1994-9#1)(2010-1#1)
as those occurring##2##3##(2009-12#1)(2012-12#1)
as those of the##3##4##(1994-11#1)(1997-8#1)(2008-2#1)
as those of##18##3##(1991-9#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2009-6#1)(2013-1#1)
as those on##3##3##(1996-11#1)(2008-10#1)(2008-3#1)
as those that are##2##4##(1997-3#1)(2011-2#1)
as those that##5##3##(1997-3#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
as those with##7##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2013-1#1)
as those##93##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
as though##2##2##(1993-12#1)(1995-3#1)
as three times the standard deviation of the##4##8##(2008-10#4)
as three times the standard deviation of##6##7##(2008-10#6)
as three times##7##3##(2008-10#6)(2010-8#1)
as three##12##2##(1995-3#1)(2007-12#1)(2008-10#8)(2009-2#1)(2010-8#1)
as three-dimensional##2##2##(1996-2#1)(2011-1#1)
as three-grating moiré systems##2##4##(2008-3#2)
as threshold##2##2##(1992-11#1)(2007-11#1)
as thumb##2##2##(1995-12#1)(2008-9#1)
as tillage##2##2##(2008-10#2)
as time##9##2##(1997-8#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)
as time-dependent##2##2##(1996-7#1)(2008-3#1)
as time-series##2##2##(1995-12#1)(2008-2#1)
as tissue##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)
as titrant##2##2##(2008-10#2)
as to &quot##2##3##(2008-8#1)(2009-11#1)
as to a##4##3##(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
as to assess##3##3##(1993-3#1)(1994-8#1)(2012-2#1)
as to become##2##3##(2008-9#1)(2010-10#1)
as to control##2##3##(1994-8#1)(2011-1#1)
as to develop##4##3##(2009-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
as to establish##2##3##(2008-10#1)(2013-1#1)
as to how the##3##4##(2007-8#1)(2008-10#1)(2008-8#1)
as to how they##2##4##(2010-9#2)
as to how##15##3##(1992-12#1)(1994-2#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-9#2)
as to increase##2##3##(2008-10#1)(2008-7#1)
as to inform##2##3##(2007-10#1)(2012-2#1)
as to its##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
as to obtain##3##3##(1995-5#1)(1997-7#1)(2008-8#1)
as to perform##3##3##(2008-10#1)(2010-8#1)(2013-7#1)
as to provide##7##3##(1995-3#1)(1996-12#3)(2009-9#1)(2011-1#1)(2012-3#1)
as to the##61##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-3#2)(1996-5#1)(1996-9#3)(1997-3#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#3)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
as to their##7##3##(1990-7#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-7#1)(2010-10#1)
as to what##7##3##(1993-1#1)(1993-12#1)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#1)
as to whether the##3##4##(1991-1#1)(2008-11#1)(2008-2#1)
as to whether##17##3##(1990-11#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-4#1)(1994-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
as to why##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
as to##280##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-2#5)(1994-3#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#3)(1997-8#1)(2006-6#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#33)(2008-11#10)(2008-12#6)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#10)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#8)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#9)(2013-1#9)(2013-7#2)(2013-8#7)
as tobacco##5##2##(1991-4#1)(1992-9#1)(2008-10#1)(2012-12#1)(2013-1#1)
as tolerant##2##2##(2008-11#1)(2008-12#1)
as toluene##3##2##(1994-8#1)(2008-10#1)(2010-11#1)
as too##2##2##(1995-6#1)(2010-8#1)
as tools for monitoring##2##4##(2008-11#2)
as tools for##5##3##(2008-11#3)(2008-4#1)(2008-7#1)
as tools to##3##3##(1991-2#1)(2008-9#1)(2011-2#1)
as tools##10##2##(1991-2#1)(2008-11#3)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#1)
as topical antioxidant##2##3##(2009-6#2)
as topical##5##2##(1993-1#1)(2008-5#1)(2008-8#1)(2009-6#2)
as total##7##2##(1995-5#1)(1996-7#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
as toxic##3##2##(2008-10#2)(2011-2#1)
as toxicity##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
as traditional##2##2##(2008-2#1)(2010-8#1)
as training in##2##3##(1992-12#1)(2012-3#1)
as training##4##2##(1992-12#1)(2008-10#1)(2010-8#1)(2012-3#1)
as transcription##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)
as transcriptional##2##2##(1991-12#1)(2009-3#1)
as transducers##3##2##(2008-10#2)(2008-8#1)
as transgenes##2##2##(1995-8#1)(2008-2#1)
as treatment for##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
as treatment of##6##3##(1994-12#1)(2008-12#1)(2009-7#1)(2010-12#1)(2011-2#2)
as treatment options##2##3##(2008-3#1)(2010-4#1)
as treatment with##2##3##(1994-3#1)(2009-4#1)
as treatment##20##2##(1994-12#1)(1994-3#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
as treatments for spatial##2##4##(1993-3#2)
as tree##2##2##(2008-5#1)(2011-2#1)
as triple##2##2##(2008-10#1)(2010-4#1)
as true##6##2##(1991-5#1)(1993-2#1)(2008-10#2)(2008-7#1)(2013-7#1)
as tryptic##2##2##(1992-3#1)(2013-1#1)
as tryptophan##3##2##(1995-3#1)(2008-4#1)(2010-6#1)
as tumor necrosis factor##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
as tumor##10##2##(1991-12#1)(1991-4#1)(1992-3#1)(1993-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
as tumour##5##2##(1995-12#1)(1996-12#1)(1997-2#1)(2007-11#2)
as twice##2##2##(1997-4#1)(2008-3#1)
as two distinct##2##3##(1993-11#1)(2008-2#1)
as two##37##2##(1990-12#1)(1991-8#1)(1991-9#1)(1993-11#1)(1994-6#1)(1995-11#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#2)(2013-1#1)
as two-dimensional##7##2##(1996-2#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)
as type##7##2##(1995-6#1)(2008-10#1)(2008-4#2)(2009-11#1)(2009-3#1)(2010-8#1)
as types of##6##3##(1994-12#2)(2008-10#4)
as typical##6##2##(1994-9#1)(1996-4#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-7#1)
as ultrasound markers##2##3##(1996-12#2)
as unacceptable##2##2##(1992-2#1)(2007-5#1)
as unchanged##2##2##(2008-3#1)(2008-6#1)
as unclear##2##2##(1993-7#1)(2013-1#1)
as under##2##2##(2008-5#1)(2012-2#1)
as underlying##2##2##(1991-12#1)(2010-8#1)
as underweight##2##2##(2008-12#1)(2013-1#1)
as undifferentiated##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
as undiluted##2##2##(2008-10#2)
as unique reagents in##2##4##(2008-10#1)(2010-7#1)
as unique##7##2##(1993-5#1)(2008-10#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-3#1)
as universal##4##2##(2008-10#3)(2008-4#1)
as unsafe##2##2##(2008-11#1)(2008-12#1)
as urinary##2##2##(1996-12#1)(2009-3#1)
as use of a##2##4##(1991-2#1)(2010-2#1)
as use of##3##3##(1991-2#1)(2008-10#1)(2010-2#1)
as used for##2##3##(1995-12#1)(1995-5#1)
as used in##4##3##(2007-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
as used##6##2##(1995-12#1)(1995-5#1)(2007-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
as useful markers##2##3##(1994-9#1)(2009-6#1)
as useful##10##2##(1994-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-6#1)(2010-3#1)(2012-1#1)(2012-2#1)
as using##2##2##(2008-10#2)
as usual##5##2##(1996-2#1)(2008-10#2)(2010-10#1)(2011-2#1)
as usually##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
as vaccine##2##2##(1997-6#1)(2011-2#1)
as valuable##3##2##(1997-6#1)(2009-10#1)(2013-8#1)
as variable##2##2##(2007-11#1)(2013-1#1)
as various##8##2##(1994-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-2#2)
as varying##4##2##(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
as vascular endothelial##4##3##(1991-2#1)(2008-1#2)(2010-7#1)
as vascular##7##2##(1991-2#1)(1992-9#1)(2008-1#2)(2008-4#1)(2008-9#1)(2010-7#1)
as vector##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
as vectors for##3##3##(1994-12#1)(2008-11#1)(2011-3#1)
as vectors##9##2##(1994-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2011-3#1)(2012-2#1)
as vehicles for##2##3##(1995-5#1)(2008-10#1)
as vehicles##3##2##(1995-5#1)(2008-10#1)(2012-2#1)
as ventricular##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)(2010-8#1)(2012-3#1)
as very high##2##3##(2008-10#1)(2012-3#1)
as very##7##2##(1991-3#1)(1996-12#1)(2008-10#2)(2008-12#1)(2012-3#1)(2013-1#1)
as via##2##2##(2008-11#1)(2009-11#1)
as viable##2##2##(2008-10#1)(2008-11#1)
as victims##2##2##(1993-3#1)(2009-7#1)
as viewed by a##2##4##(2008-1#1)(2009-7#1)
as viewed by##4##3##(2008-1#1)(2008-7#1)(2009-7#1)(2013-1#1)
as viral##3##2##(1996-2#1)(2008-10#2)
as virulent##2##2##(2008-10#2)
as virus##3##2##(2008-10#2)(2013-8#1)
as visual##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
as visualized by##2##3##(2008-12#1)(2008-5#1)
as visualized##3##2##(1996-12#1)(2008-12#1)(2008-5#1)
as vital##3##2##(1994-7#1)(1995-3#1)(2012-3#1)
as vitamin##5##2##(1991-9#1)(1992-9#1)(2008-1#2)(2011-2#1)
as volatile##2##2##(1994-3#1)(2008-10#1)
as volume##2##2##(2008-3#1)(2008-7#1)
as volunteer##2##2##(1996-3#2)
as volunteers and##2##3##(1994-3#1)(1995-12#1)
as volunteers##8##2##(1991-12#2)(1994-3#1)(1995-12#1)(1996-3#2)(2008-12#1)(2012-3#1)
as was reported##2##3##(1995-2#1)(2008-3#1)
as was seen in##2##4##(1994-8#1)(2008-8#1)
as was seen##3##3##(1993-6#1)(1994-8#1)(2008-8#1)
as was the case for##2##5##(1991-7#1)(2013-1#1)
as was the case in the##2##6##(1995-6#1)(2008-10#1)
as was the case##4##4##(1991-7#1)(1995-6#1)(2008-10#1)(2013-1#1)
as was the##14##3##(1990-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-11#1)(2012-12#1)(2013-1#1)
as was##40##2##(1990-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#3)
as waste##2##2##(2008-10#1)(2008-9#1)
as water##9##2##(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#2)
as wavelength##3##2##(2007-11#2)(2008-2#1)
as ways##2##2##(1991-2#1)(2008-11#1)
as we are##2##3##(1993-6#1)(2008-9#1)
as we have##4##3##(1996-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
as we increase##2##3##(2008-5#1)(2008-8#1)
as we know##10##3##(1994-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)
as we show##3##3##(1993-3#1)(2008-2#1)(2008-8#1)
as we would##2##3##(1995-5#1)(2012-12#1)
as we##38##2##(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-6#1)(1997-4#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2012-12#1)(2012-3#1)(2012-8#1)
as weight gain##2##3##(2007-12#1)(2008-10#1)
as weight##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
as well as 11##2##4##(2008-10#2)
as well as 5##3##4##(1990-11#1)(1990-3#1)(2008-7#1)
as well as 6##2##4##(1992-3#1)(2013-1#1)
as well as CHA's accentuation of ethanol's motor impairment##2##9##(1997-2#2)
as well as DNA##2##4##(1992-3#1)(2008-4#1)
as well as F##2##4##(2008-10#1)(2013-1#1)
as well as P##3##4##(2008-10#2)(2008-4#1)
as well as RNA##2##4##(1995-2#1)(2008-10#1)
as well as a brief##2##5##(1993-12#1)(2008-10#1)
as well as a combination##2##5##(1990-8#1)(2008-3#1)
as well as a few##2##5##(1990-5#1)(2007-12#1)
as well as a glutamine to##2##6##(1996-5#1)(2008-10#1)
as well as a high##2##5##(2008-11#1)(2012-1#1)
as well as a large##2##5##(2008-10#1)(2012-12#1)
as well as a long##2##5##(1992-3#1)(2008-1#1)
as well as a number of##4##6##(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)
as well as a plan##2##5##(1991-1#1)(1993-2#1)
as well as a protocol for##2##6##(2008-4#2)
as well as a reduction in the##2##7##(2008-10#2)
as well as a review of##2##6##(2008-5#1)(2009-3#1)
as well as a significant##3##5##(1994-6#1)(2008-11#2)
as well as a small##2##5##(1992-9#1)(1997-2#1)
as well as a##111##4##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#3)(2006-10#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
as well as abiotic##2##4##(2009-10#1)(2011-2#1)
as well as activities##2##4##(1994-6#1)(2012-2#1)
as well as additional##6##4##(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)
as well as after##2##4##(2007-11#1)(2013-7#1)
as well as age##2##4##(2009-7#1)(2009-8#1)
as well as all human-derived materials##2##6##(2008-4#1)(2008-9#1)
as well as all##5##4##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
as well as all-cause mortality##2##5##(1993-12#2)
as well as alpha##3##4##(1990-7#1)(2008-10#1)(2008-7#1)
as well as alterations in##4##5##(2008-10#1)(2008-12#1)(2008-9#1)(2010-6#1)
as well as alternative##3##4##(1997-7#1)(2008-4#1)(2008-6#1)
as well as amino##2##4##(1995-6#1)(2011-2#1)
as well as among##2##4##(2008-5#1)(2009-11#1)
as well as an important##2##5##(2008-10#1)(2008-7#1)
as well as an increase in##6##6##(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2012-2#1)(2013-1#1)
as well as an increase##7##5##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2012-2#1)(2013-1#1)
as well as an##29##4##(1992-2#1)(1995-2#2)(1996-5#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
as well as another##3##4##(1997-7#1)(2008-8#1)(2011-2#1)
as well as any##3##4##(1991-11#1)(2008-1#1)(2009-4#1)
as well as apoptosis##2##4##(2008-5#1)(2011-2#1)
as well as aqueous##2##4##(2008-2#1)(2008-7#1)
as well as artificial##2##4##(2008-10#2)
as well as at the##5##5##(1995-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
as well as at##10##4##(1995-11#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-2#1)
as well as background##2##4##(2008-3#1)(2008-4#1)
as well as because##2##4##(2009-12#1)(2012-3#1)
as well as being a##3##5##(2008-11#2)(2008-5#1)
as well as being##7##4##(1993-3#1)(2008-11#2)(2008-5#2)(2009-10#1)(2009-6#1)
as well as better##2##4##(2010-10#1)(2011-2#1)
as well as between the##3##5##(1994-6#1)(1994-8#1)(2013-1#1)
as well as between##6##4##(1994-6#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
as well as binding##2##4##(1993-12#1)(2009-7#1)
as well as biochemical##2##4##(1991-12#1)(2007-11#1)
as well as blood##2##4##(2010-11#1)(2012-2#1)
as well as body##2##4##(2008-7#1)(2009-4#1)
as well as both the##2##5##(1997-2#1)(2013-1#1)
as well as both##3##4##(1990-8#1)(1997-2#1)(2013-1#1)
as well as by a##2##5##(2007-11#1)(2008-10#1)
as well as by the##7##5##(1990-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)
as well as by their##3##5##(1995-12#1)(2007-11#1)(2010-2#1)
as well as by using##2##5##(2008-10#2)
as well as by##41##4##(1990-12#1)(1990-8#1)(1991-12#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as well as cases of##2##5##(1991-9#1)(2007-12#1)
as well as cell##2##4##(2011-2#1)(2012-12#1)
as well as certain##6##4##(1991-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-2#1)
as well as changes in the##3##6##(1991-2#1)(1993-3#1)(1994-6#1)
as well as changes in##7##5##(1990-5#1)(1991-2#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
as well as changes##9##4##(1990-5#1)(1991-2#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-11#2)(2010-4#1)(2012-3#1)
as well as characteristic##2##4##(2007-8#1)(2008-7#1)
as well as chimeric##2##4##(1992-6#1)(2008-4#1)
as well as clinical##6##4##(1994-11#1)(1995-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
as well as cognitive##2##4##(2008-2#1)(2013-8#1)
as well as common##2##4##(2011-2#1)(2011-4#1)
as well as conditions##2##4##(2008-10#1)(2012-2#1)
as well as control##3##4##(2012-1#1)(2012-3#1)(2013-8#1)
as well as controls##2##4##(1995-3#1)(2008-7#1)
as well as current##2##4##(1996-2#1)(2008-11#1)
as well as cutaneous##2##4##(2008-6#1)(2009-10#1)
as well as data##4##4##(1991-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
as well as decreased##2##4##(2011-2#1)(2013-1#1)
as well as decreasing##2##4##(2012-2#1)(2012-3#1)
as well as demographic##2##4##(2007-10#1)(2013-1#1)
as well as development and##2##5##(2008-10#1)(2010-10#1)
as well as development##3##4##(1997-6#1)(2008-10#1)(2010-10#1)
as well as diabetic##2##4##(1994-8#1)(2012-2#1)
as well as differences between the two##2##7##(2010-1#1)(2012-12#1)
as well as differences##4##4##(2008-10#1)(2010-1#1)(2012-1#1)(2012-12#1)
as well as different##4##4##(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
as well as differentiation of##2##5##(1991-5#1)(2008-12#1)
as well as diploid##2##4##(2008-9#1)(2009-12#1)
as well as direct##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
as well as directly##3##4##(2009-8#1)(2011-1#1)(2011-2#1)
as well as distant##2##4##(2008-1#1)(2008-6#1)
as well as disturbances of##2##5##(2008-1#1)(2008-12#1)
as well as each##2##4##(1994-6#1)(2008-9#1)
as well as education##2##4##(2008-12#1)(2008-9#1)
as well as electrospray##2##4##(2008-10#2)
as well as environmental##3##4##(1994-2#1)(1994-6#1)(2012-3#1)
as well as enzyme##2##4##(1990-5#1)(2011-2#1)
as well as enzymes##4##4##(2008-10#1)(2010-7#1)(2010-9#1)(2011-2#1)
as well as experimental results are presented##2##7##(2008-2#1)(2008-3#1)
as well as experimental results are##3##6##(2008-2#1)(2008-3#2)
as well as experimental results##4##5##(2008-2#1)(2008-3#3)
as well as experimental##5##4##(2008-2#1)(2008-3#4)
as well as explore##2##4##(1995-8#1)(2011-1#1)
as well as external##5##4##(1995-1#1)(2007-8#1)(2008-10#2)(2008-12#1)
as well as extracorporeal##2##4##(2007-7#1)(2012-3#1)
as well as factors##2##4##(1996-2#1)(2013-1#1)
as well as features##2##4##(2007-11#1)(2013-1#1)
as well as fine##3##4##(1996-10#1)(1997-2#1)(2008-10#1)
as well as fluorescent##2##4##(2008-8#1)(2008-9#1)
as well as follow-up##2##4##(1992-5#1)(2010-1#1)
as well as for other##2##5##(2008-2#1)(2009-2#1)
as well as for the key role of Mg(2+) in the reaction##2##12##(2013-1#2)
as well as for the##19##5##(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-12#1)(2013-1#2)
as well as for##72##4##(1992-8#1)(1993-3#2)(1994-12#3)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
as well as four##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
as well as free##2##4##(1994-8#1)(1997-7#1)
as well as from other##2##5##(1992-2#1)(2008-7#1)
as well as from the##5##5##(1994-12#1)(2008-4#2)(2012-2#2)
as well as from##25##4##(1990-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#2)
as well as further##2##4##(2011-2#1)(2012-2#1)
as well as gene expression##2##5##(1996-6#1)(2008-11#1)
as well as gene##4##4##(1996-6#1)(1996-9#1)(2008-11#1)(2013-7#1)
as well as genetic##2##4##(2011-1#1)(2013-1#1)
as well as good##2##4##(2008-5#1)(2013-1#1)
as well as having##2##4##(2008-11#1)(2008-8#1)
as well as high##6##4##(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-1#1)
as well as high-frequency##2##4##(2008-2#2)
as well as higher##3##4##(2008-10#2)(2012-2#1)
as well as hormonal##2##4##(1991-2#1)(2012-2#1)
as well as how to##2##5##(1995-2#1)(2008-9#1)
as well as how##6##4##(1992-3#1)(1994-11#1)(1995-2#1)(2008-12#1)(2008-4#1)(2008-9#1)
as well as human##4##4##(1997-6#1)(2008-6#1)(2012-2#1)(2012-3#1)
as well as important##2##4##(2011-1#1)(2012-2#1)
as well as improved##2##4##(2008-11#1)(2010-12#1)
as well as improving the##3##5##(2008-11#1)(2010-3#1)(2011-2#1)
as well as improving##4##4##(2008-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
as well as in a##6##5##(1990-11#1)(1993-11#1)(1994-3#1)(2008-10#1)(2012-12#2)
as well as in brain##2##5##(1993-11#1)(2008-2#1)
as well as in comparison to##2##6##(1996-7#1)(2009-12#1)
as well as in experimental##2##5##(1995-5#1)(2011-2#1)
as well as in human##2##5##(2008-11#1)(2008-7#1)
as well as in many##2##5##(1993-12#1)(2008-10#1)
as well as in monitoring##2##5##(1994-12#1)(2008-5#1)
as well as in other##4##5##(2007-11#1)(2008-1#1)(2008-11#1)(2012-2#1)
as well as in patients with##4##6##(1992-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
as well as in some##2##5##(2008-1#1)(2008-11#1)
as well as in the liver##2##6##(2008-5#1)(2008-7#1)
as well as in the morning of the third and fourth days##2##12##(2008-5#2)
as well as in the total##2##6##(2009-6#1)(2009-8#1)
as well as in the##58##5##(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#2)
as well as in their##2##5##(2008-10#1)(2010-8#1)
as well as in vitro##2##5##(1993-3#1)(1993-8#1)
as well as in vivo##3##5##(2008-3#1)(2009-5#1)(2013-1#1)
as well as in##193##4##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#1)(1996-7#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#33)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
as well as incidence of##2##5##(2007-4#1)(2012-12#1)
as well as increased##6##4##(1992-8#1)(1993-2#1)(1994-6#1)(2008-1#2)(2008-6#1)
as well as increases##2##4##(1992-6#1)(2008-7#1)
as well as infectious##2##4##(2008-9#1)(2012-2#1)
as well as introducing##2##4##(2008-9#1)(2012-2#1)
as well as investigation of##2##5##(2008-10#1)(2008-4#1)
as well as it##2##4##(2008-10#1)(2013-1#1)
as well as its potential##2##5##(2007-12#1)(2008-10#1)
as well as its##48##4##(1991-12#1)(1992-3#1)(1993-3#1)(1993-6#3)(1994-11#2)(1994-8#1)(1995-11#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
as well as lactate##2##4##(2008-10#1)(2008-7#1)
as well as less##4##4##(2008-1#1)(2009-11#1)(2012-2#1)(2013-1#1)
as well as limiting##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
as well as many##8##4##(1992-12#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
as well as maternal##2##4##(1992-12#1)(2008-9#1)
as well as mating##2##4##(2008-10#1)(2011-2#1)
as well as mean##2##4##(2008-3#1)(2012-1#1)
as well as measures##2##4##(1993-12#1)(2008-11#1)
as well as membrane fluidity##2##5##(1990-7#1)(1994-2#1)
as well as metabolic##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
as well as metabolism##2##4##(1992-9#1)(1994-6#1)
as well as methods for##5##5##(2008-1#1)(2008-2#2)(2008-9#2)
as well as methods##6##4##(2008-1#1)(2008-2#2)(2008-9#3)
as well as modern##2##4##(2008-10#1)(2008-8#1)
as well as modulation of##2##5##(2008-3#1)(2011-2#1)
as well as molecular##3##4##(2008-10#1)(2008-4#1)(2010-4#1)
as well as monoclonal##2##4##(2008-5#1)(2011-1#1)
as well as mononuclear##2##4##(1994-11#1)(2012-2#1)
as well as more##6##4##(1995-1#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#2)
as well as morphological##2##4##(2008-12#1)(2009-8#1)
as well as most##2##4##(1993-12#1)(1995-1#1)
as well as multiple##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
as well as natural killer##2##5##(2008-10#1)(2008-4#1)
as well as natural##3##4##(2008-10#2)(2008-4#1)
as well as negative##2##4##(2009-8#1)(2010-3#1)
as well as neurons##2##4##(2008-7#1)(2009-2#1)
as well as new##2##4##(2008-4#1)(2011-2#1)
as well as normal##3##4##(1995-2#1)(1996-12#1)(2008-4#1)
as well as novel##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
as well as nuclear##2##4##(1995-2#1)(2011-1#1)
as well as numerous##4##4##(1991-2#1)(2008-11#1)(2009-12#1)(2010-6#1)
as well as objective##2##4##(2007-12#2)
as well as of a##2##5##(2007-12#1)(2008-10#1)
as well as of the##8##5##(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)
as well as of##28##4##(1990-7#1)(1991-8#1)(1992-8#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2013-8#1)
as well as on how##3##5##(2008-12#1)(2012-2#1)(2013-1#1)
as well as on the##23##5##(1990-5#1)(1995-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#2)
as well as on their##2##5##(2008-10#1)(2011-1#1)
as well as on##52##4##(1990-5#1)(1995-12#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#2)
as well as one##4##4##(1997-7#1)(2007-2#1)(2008-10#1)(2008-9#1)
as well as operational##2##4##(2008-10#2)
as well as optical experiments##2##5##(2008-3#2)
as well as optical##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
as well as optimization##2##4##(2008-3#1)(2012-2#1)
as well as other cellular##3##5##(2008-7#1)(2008-8#1)(2009-7#1)
as well as other factors##3##5##(1992-5#1)(2008-2#1)(2009-2#1)
as well as other##45##4##(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
as well as others##2##4##(2008-4#1)(2010-10#1)
as well as our##4##4##(2008-3#1)(2008-6#2)(2008-8#1)
as well as overall##3##4##(2008-6#2)(2011-1#1)
as well as patient##2##4##(2007-7#1)(2012-3#1)
as well as patients##3##4##(1992-3#1)(1993-11#1)(2010-5#1)
as well as peptide##2##4##(1990-2#1)(2008-3#1)
as well as personal##2##4##(1993-2#1)(2008-12#1)
as well as pharmaceutical##2##4##(1994-3#1)(2008-10#1)
as well as physical activity##2##5##(2008-1#1)(2008-11#1)
as well as physical##5##4##(2008-1#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-7#1)
as well as plant##2##4##(2008-10#2)
as well as plasma##2##4##(1991-9#1)(2008-7#1)
as well as possible##6##4##(2006-10#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
as well as postoperative##2##4##(2008-8#1)(2008-9#1)
as well as potent##2##4##(2008-5#1)(2011-2#1)
as well as potential##7##4##(2007-10#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
as well as practical considerations##3##5##(2008-3#1)(2008-4#2)
as well as practical##4##4##(1994-12#1)(2008-3#1)(2008-4#2)
as well as prediction of##2##5##(1997-8#1)(2009-6#1)
as well as prevention##2##4##(2007-5#1)(2013-7#1)
as well as previous##2##4##(2008-11#1)(2011-2#1)
as well as primary##2##4##(2008-2#1)(2008-5#1)
as well as proliferation##2##4##(1990-7#1)(2008-11#1)
as well as promoting##2##4##(2010-10#1)(2011-2#1)
as well as protein kinase##2##5##(1993-8#1)(2010-4#1)
as well as protein##5##4##(1993-8#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
as well as protocols for##3##5##(2008-2#1)(2008-9#2)
as well as provide a##2##5##(1992-8#1)(2008-3#1)
as well as provide##3##4##(1992-8#1)(2008-3#1)(2009-4#1)
as well as providing##3##4##(2008-10#1)(2008-9#1)(2010-6#1)
as well as quantitative##4##4##(1993-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
as well as recent##2##4##(2007-12#1)(2008-4#1)
as well as recently##2##4##(1991-5#1)(2013-8#1)
as well as receptors##2##4##(2008-4#2)
as well as recommendations for long-term##2##6##(2008-9#2)
as well as recommendations for##4##5##(2008-2#1)(2008-9#2)(2010-3#1)
as well as recurrence##2##4##(2006-10#1)(2010-4#1)
as well as reduce##2##4##(2008-5#1)(2008-7#1)
as well as reduced##3##4##(2008-10#1)(2011-2#1)(2013-7#1)
as well as reduction##2##4##(2008-11#1)(2008-2#1)
as well as regulation of##2##5##(2008-4#1)(2009-6#1)
as well as related##2##4##(1996-5#1)(1997-7#1)
as well as renal##2##4##(2007-7#1)(2008-1#1)
as well as reporting##2##4##(1995-12#1)(1997-2#1)
as well as research##2##4##(1996-12#1)(2010-1#1)
as well as restoration##2##4##(2008-1#1)(2012-2#1)
as well as resulting##2##4##(2008-3#1)(2010-5#1)
as well as results##3##4##(2008-10#1)(2008-7#1)(2011-3#1)
as well as safety##2##4##(2008-9#1)(2009-10#1)
as well as samples##2##4##(2008-10#1)(2008-9#1)
as well as schizophrenia##2##4##(1997-5#2)
as well as serious##2##4##(2011-2#1)(2013-8#1)
as well as serum##5##4##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
as well as several##10##4##(1995-6#1)(2008-10#2)(2008-2#1)(2009-3#1)(2010-10#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
as well as sexual##2##4##(1996-11#1)(2011-2#1)
as well as show##2##4##(2008-10#2)
as well as significant##3##4##(1994-2#1)(2007-2#1)(2010-6#1)
as well as simple##2##4##(2008-10#1)(2008-8#1)
as well as small##2##4##(2008-11#1)(2008-3#1)
as well as smoking##2##4##(1992-9#1)(2013-1#1)
as well as social##2##4##(2007-7#1)(2009-7#1)
as well as some of the##6##6##(1993-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)
as well as some of##7##5##(1993-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)
as well as some##25##4##(1990-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-4#2)(2008-9#1)(2009-10#1)(2011-2#1)(2013-7#1)
as well as sound##2##4##(2008-12#1)(2012-2#1)
as well as spatial##2##4##(2007-11#1)(2010-9#1)
as well as specific##2##4##(2013-1#2)
as well as storage##3##4##(2008-10#2)(2008-9#1)
as well as studies##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
as well as subjective##2##4##(2008-7#1)(2011-2#1)
as well as suggestions to##2##5##(1992-1#1)(2008-10#1)
as well as support##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
as well as surface##2##4##(1995-3#1)(2008-2#1)
as well as synthetic##2##4##(1992-11#1)(2008-11#1)
as well as taking##2##4##(2011-2#2)
as well as technological##3##4##(1991-3#1)(1994-12#1)(2008-1#1)
as well as temperature sensitivity##2##5##(1994-12#1)(2010-3#1)
as well as temperature##3##4##(1994-12#1)(2008-10#1)(2010-3#1)
as well as that of the##4##6##(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
as well as that of##12##5##(1990-5#1)(1992-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
as well as that##14##4##(1990-5#1)(1992-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
as well as the abundance##2##5##(2008-10#1)(2010-12#1)
as well as the accuracy of the##2##7##(2008-10#1)(2008-2#1)
as well as the advantages and disadvantages##2##7##(2007-5#1)(2008-10#1)
as well as the advantages##3##5##(1996-3#1)(2007-5#1)(2008-10#1)
as well as the anatomical##2##5##(2011-1#1)(2013-8#1)
as well as the apparent##2##5##(1992-5#1)(1995-12#1)
as well as the application of##2##6##(2008-8#1)(2010-5#1)
as well as the associated##2##5##(2008-7#1)(2008-9#1)
as well as the availability of##2##6##(1996-12#1)(2008-1#1)
as well as the average##2##5##(2008-10#1)(2009-7#1)
as well as the best##2##5##(1996-12#1)(2008-2#1)
as well as the central##2##5##(1990-7#1)(2008-3#1)
as well as the change in##2##6##(2008-2#1)(2008-3#1)
as well as the characteristics of##2##6##(2008-11#1)(2008-7#1)
as well as the chemical##3##5##(1991-5#1)(2008-10#1)(2008-5#1)
as well as the common##2##5##(1991-9#1)(2009-12#1)
as well as the conditions for##2##6##(2008-10#1)(2008-9#1)
as well as the conditions##3##5##(2008-10#2)(2008-9#1)
as well as the degree of##2##6##(1994-12#1)(2007-12#1)
as well as the determination of##2##6##(1990-12#1)(2008-10#1)
as well as the development of##3##6##(1994-8#1)(2008-11#1)(2011-2#1)
as well as the different##2##5##(2007-10#1)(2013-1#1)
as well as the effect of the##2##7##(2008-10#1)(2011-2#1)
as well as the effect of##6##6##(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
as well as the effects of##5##6##(1992-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
as well as the effects##6##5##(1992-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
as well as the evaluation of##2##6##(2010-3#1)(2011-2#1)
as well as the expected##2##5##(1993-12#1)(2008-3#1)
as well as the extent of##3##6##(1992-3#1)(2008-10#1)(2011-2#1)
as well as the factors that##2##6##(1991-11#1)(2008-12#1)
as well as the formation of##2##6##(1994-8#1)(2008-4#1)
as well as the functional##3##5##(1997-4#1)(2008-6#1)(2008-7#1)
as well as the fundamentals of##2##6##(1994-12#2)
as well as the generation##2##5##(2008-2#1)(2008-7#1)
as well as the identification of##3##6##(1995-9#1)(2008-10#1)(2008-6#1)
as well as the importance##2##5##(2012-2#1)(2012-3#1)
as well as the inclusion of##2##6##(2008-11#1)(2008-9#1)
as well as the induction of##2##6##(2008-11#1)(2012-3#1)
as well as the influence of##3##6##(2008-10#2)(2008-11#1)
as well as the intrinsic##2##5##(2008-10#1)(2008-3#1)
as well as the level of##2##6##(2011-1#1)(2013-1#1)
as well as the location##2##5##(2008-10#1)(2008-8#1)
as well as the major##2##5##(2008-2#1)(2009-7#1)
as well as the mean complex refractive index##2##8##(2008-3#2)
as well as the mean##3##5##(2008-3#2)(2010-3#1)
as well as the most##2##5##(2008-11#1)(2010-8#1)
as well as the nature of the##3##7##(1993-5#1)(2008-10#1)(2012-12#1)
as well as the need for##4##6##(1991-2#1)(2007-11#1)(2008-10#1)(2009-4#1)
as well as the number of##3##6##(2008-1#1)(2008-10#2)
as well as the number##4##5##(2008-1#1)(2008-10#2)(2008-5#1)
as well as the original##2##5##(1994-3#1)(2008-10#1)
as well as the other##2##5##(2008-7#1)(2008-8#1)
as well as the polarization##2##5##(2008-3#2)
as well as the possibility##2##5##(2008-10#1)(2008-3#1)
as well as the possible##5##5##(2008-10#4)(2013-1#1)
as well as the potential##3##5##(1991-12#1)(2008-10#1)(2008-4#1)
as well as the presence of##5##6##(1994-6#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-2#1)
as well as the principles of##3##6##(2008-10#1)(2010-7#1)(2012-2#1)
as well as the principles##4##5##(1993-6#1)(2008-10#1)(2010-7#1)(2012-2#1)
as well as the processes##2##5##(2008-11#1)(2009-5#1)
as well as the quality of##2##6##(1996-2#1)(1997-4#1)
as well as the reduction of##2##6##(2007-12#1)(2008-7#1)
as well as the reduction##3##5##(2007-12#1)(2008-11#1)(2008-7#1)
as well as the related##2##5##(1995-6#1)(2012-12#1)
as well as the relationship between##2##6##(1990-11#1)(1994-8#1)
as well as the relative##3##5##(1996-5#1)(2008-8#1)(2010-11#1)
as well as the repeatability##2##5##(2008-10#2)
as well as the results of a##3##7##(1995-2#1)(2008-10#1)(2008-5#1)
as well as the results of##6##6##(1992-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
as well as the role of military service in their life course##2##12##(2013-1#2)
as well as the role of##8##6##(2007-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
as well as the roles of##2##6##(2008-1#1)(2009-2#1)
as well as the signal##2##5##(1997-4#1)(2008-5#1)
as well as the size of the##2##7##(2007-10#1)(2011-1#1)
as well as the specific##3##5##(1996-6#1)(2008-10#1)(2008-11#1)
as well as the stability of##2##6##(1990-2#1)(2008-11#1)
as well as the structure and##2##6##(2008-10#1)(2008-7#1)
as well as the technical##2##5##(2007-8#1)(2008-3#1)
as well as the therapeutic##2##5##(2008-6#1)(2008-7#1)
as well as the thickness of##2##6##(2008-10#1)(2008-3#1)
as well as the time##2##5##(1997-6#1)(2008-4#1)
as well as the tissue##3##5##(1992-6#1)(2008-11#1)(2012-3#1)
as well as the transient##2##5##(1992-6#1)(1994-11#1)
as well as the type##2##5##(1996-12#1)(2008-6#1)
as well as the unique##2##5##(2010-8#1)(2012-2#1)
as well as the use of##5##6##(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
as well as the use##6##5##(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#2)
as well as the wider##2##5##(2010-2#1)(2010-8#1)
as well as the##612##4##(1990-11#2)(1990-12#3)(1990-2#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#4)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#6)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#6)(2007-12#15)(2007-2#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#98)(2008-11#24)(2008-12#6)(2008-2#12)(2008-3#35)(2008-4#10)(2008-5#21)(2008-6#10)(2008-7#27)(2008-8#14)(2008-9#16)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#4)(2009-7#7)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#14)(2011-2#25)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#15)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#6)
as well as their implications##2##5##(2008-5#1)(2009-8#1)
as well as their possible##2##5##(2008-10#1)(2009-8#1)
as well as their##52##4##(1990-11#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-7#1)(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
as well as therapeutic##2##4##(1990-9#1)(2007-10#1)
as well as those of##2##5##(1994-11#1)(2008-10#1)
as well as those with##2##5##(2008-6#1)(2009-8#1)
as well as those##13##4##(1992-8#1)(1993-2#1)(1994-11#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
as well as through##2##4##(2010-1#1)(2012-3#1)
as well as tissue##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
as well as to a##3##5##(2011-1#1)(2012-12#1)(2013-1#1)
as well as to assess##2##5##(1994-8#1)(2012-2#1)
as well as to develop##3##5##(2009-11#1)(2012-12#1)(2013-8#1)
as well as to identify##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
as well as to investigate the##2##6##(2008-7#1)(2011-1#1)
as well as to investigate##3##5##(2008-7#1)(2010-3#1)(2011-1#1)
as well as to make##2##5##(1995-2#1)(2011-1#1)
as well as to obtain##2##5##(1995-5#1)(2008-8#1)
as well as to other##2##5##(2008-11#1)(2008-4#1)
as well as to perform##2##5##(2008-10#1)(2013-7#1)
as well as to provide##3##5##(1996-12#3)
as well as to that##2##5##(1994-2#1)(1996-12#1)
as well as to the development##2##6##(2008-10#1)(2011-2#1)
as well as to the##18##5##(1991-6#1)(1992-3#1)(1994-9#1)(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)(2013-1#1)
as well as to##96##4##(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#2)(2006-6#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#1)(2010-10#4)(2010-3#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
as well as total##4##4##(1995-5#1)(1996-7#1)(2008-1#1)(2008-3#1)
as well as treatment##7##4##(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
as well as tumor##2##4##(1992-3#1)(2012-12#1)
as well as two##8##4##(1994-6#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
as well as two-dimensional##4##4##(2008-3#3)(2009-11#1)
as well as use of##2##5##(1991-2#1)(2008-10#1)
as well as various##5##4##(1994-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-5#1)
as well as varying##2##4##(2008-10#1)(2008-3#1)
as well as ventricular##2##4##(2008-10#1)(2008-4#1)
as well as very##2##4##(1996-12#1)(2013-1#1)
as well as visual##2##4##(2008-11#1)(2013-1#1)
as well as with the##8##5##(1990-2#1)(1993-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
as well as with their##2##5##(1992-9#1)(1996-3#1)
as well as with those##2##5##(1991-12#1)(2008-10#1)
as well as with two other##2##6##(2010-4#1)(2012-2#1)
as well as with##33##4##(1990-2#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-3#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#2)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#1)
as well as within the##2##5##(1991-12#1)(2008-8#1)
as well as within##7##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-1#1)(2012-3#1)
as well as yeast##2##4##(1993-8#1)(1997-8#1)
as well as##3151##3##(1990-10#1)(1990-11#9)(1990-12#9)(1990-2#6)(1990-3#3)(1990-5#8)(1990-6#1)(1990-7#9)(1990-8#10)(1990-9#6)(1991-1#7)(1991-11#6)(1991-12#20)(1991-2#13)(1991-3#8)(1991-4#1)(1991-5#7)(1991-6#9)(1991-7#2)(1991-8#4)(1991-9#8)(1992-1#7)(1992-11#4)(1992-12#13)(1992-2#4)(1992-3#23)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#18)(1993-1#2)(1993-11#8)(1993-12#17)(1993-2#7)(1993-3#15)(1993-5#2)(1993-6#11)(1993-8#12)(1993-9#6)(1994-1#8)(1994-11#16)(1994-12#18)(1994-2#11)(1994-3#12)(1994-5#5)(1994-6#16)(1994-7#1)(1994-8#16)(1994-9#5)(1995-1#4)(1995-11#15)(1995-12#13)(1995-2#26)(1995-3#11)(1995-5#17)(1995-6#18)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#24)(1996-2#19)(1996-3#10)(1996-5#11)(1996-6#4)(1996-7#4)(1996-9#5)(1997-1#5)(1997-2#22)(1997-3#4)(1997-4#13)(1997-5#4)(1997-6#11)(1997-7#18)(1997-8#7)(1997-9#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#15)(2007-11#48)(2007-12#51)(2007-2#6)(2007-4#2)(2007-5#5)(2007-7#11)(2007-8#13)(2007-9#1)(2008-1#43)(2008-10#466)(2008-11#139)(2008-12#46)(2008-2#90)(2008-3#131)(2008-4#85)(2008-5#93)(2008-6#35)(2008-7#104)(2008-8#70)(2008-9#98)(2009-10#23)(2009-11#13)(2009-12#15)(2009-2#9)(2009-3#11)(2009-4#14)(2009-5#14)(2009-6#13)(2009-7#23)(2009-8#28)(2009-9#8)(2010-1#8)(2010-10#17)(2010-11#14)(2010-12#19)(2010-2#5)(2010-3#21)(2010-4#18)(2010-5#17)(2010-6#18)(2010-7#8)(2010-8#14)(2010-9#12)(2011-1#47)(2011-2#142)(2011-3#4)(2011-4#1)(2011-7#2)(2011-8#1)(2012-1#16)(2012-12#46)(2012-2#84)(2012-3#44)(2012-6#1)(2013-1#97)(2013-7#15)(2013-8#44)
as well asforpolicy makers##2##4##(2013-8#2)
as well at##2##3##(1995-3#1)(2008-2#1)
as well the##3##3##(2008-11#1)(2009-4#1)(2011-4#1)
as well to##2##3##(2008-10#1)(2013-3#1)
as well)##2##2##(1991-6#1)(2008-1#1)
as were isolates##2##3##(2008-10#2)
as were the##3##3##(1991-12#1)(1995-1#1)(2008-2#1)
as were##16##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-3#1)(1994-1#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#2)
as what is##2##3##(1994-3#1)(2007-12#1)
as what##4##2##(1994-3#1)(1995-1#1)(2007-12#1)(2008-3#1)
as when the##2##3##(1991-5#1)(2013-1#1)
as when##5##2##(1991-12#1)(1991-5#1)(1996-1#1)(2008-7#1)(2013-1#1)
as white##2##2##(2008-10#2)
as whole##5##2##(1995-12#1)(1996-5#1)(2008-4#1)(2009-11#1)(2010-1#1)
as wild##2##2##(1991-9#1)(2008-8#1)
as wild-type##4##2##(1993-11#1)(1994-6#1)(1995-2#1)(2008-10#1)
as with any##2##3##(2008-10#1)(2012-2#1)
as with the##10##3##(1990-2#1)(1991-5#1)(1993-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
as with##49##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-3#2)(2006-10#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2010-4#2)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#3)(2013-1#2)
as withdrawal symptoms##2##3##(2009-7#1)(2011-1#1)
as withdrawal##4##2##(2008-6#2)(2009-7#1)(2011-1#1)
as within##8##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2012-1#1)(2012-3#1)
as women of##2##3##(1996-5#1)(2011-2#1)
as women##4##2##(1996-5#1)(2007-7#1)(2008-1#1)(2011-2#1)
as working electrode##5##3##(2008-10#5)
as working##9##2##(1991-12#1)(2008-10#8)
as would be expected in##2##5##(2008-10#1)(2011-1#1)
as would be expected##3##4##(1992-11#1)(2008-10#1)(2011-1#1)
as would be##4##3##(1992-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
as would##6##2##(1991-10#1)(1992-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
as x-ray mirrors##2##3##(2007-11#2)
as yeast##4##2##(1991-9#1)(1993-8#1)(1997-8#1)(2008-7#1)
as yet no##3##3##(1991-11#1)(2010-12#1)(2012-12#1)
as yet undefined##2##3##(2008-10#2)
as yet undescribed##2##3##(2008-10#2)
as yet unidentified##4##3##(1994-6#1)(2007-12#1)(2008-9#1)(2009-9#1)
as yet unknown##9##3##(1990-12#1)(1993-9#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-10#1)
as yet##45##2##(1990-12#1)(1990-7#1)(1991-11#2)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-6#2)(1994-9#1)(1996-11#2)(1996-9#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#2)(2012-12#1)
as young##2##2##(2008-10#1)(2008-3#1)
as your##2##2##(1995-2#1)(2012-3#1)
as zinc##3##2##(2008-10#2)(2013-7#1)
as ~1##2##2##(2007-11#1)(2008-2#1)
as##32313##1##(1990-10#16)(1990-11#111)(1990-12#85)(1990-2#89)(1990-3#53)(1990-4#9)(1990-5#113)(1990-6#53)(1990-7#79)(1990-8#119)(1990-9#57)(1991-1#44)(1991-10#9)(1991-11#45)(1991-12#187)(1991-2#118)(1991-3#78)(1991-4#19)(1991-5#113)(1991-6#85)(1991-7#9)(1991-8#46)(1991-9#102)(1992-1#41)(1992-10#16)(1992-11#78)(1992-12#154)(1992-2#71)(1992-3#179)(1992-4#13)(1992-5#46)(1992-6#116)(1992-7#4)(1992-8#96)(1992-9#131)(1993-1#55)(1993-10#1)(1993-11#112)(1993-12#179)(1993-2#85)(1993-3#127)(1993-5#21)(1993-6#92)(1993-7#1)(1993-8#114)(1993-9#64)(1994-1#54)(1994-10#7)(1994-11#138)(1994-12#162)(1994-2#150)(1994-3#139)(1994-5#109)(1994-6#96)(1994-7#20)(1994-8#139)(1994-9#96)(1995-1#66)(1995-10#1)(1995-11#112)(1995-12#172)(1995-2#232)(1995-3#152)(1995-4#6)(1995-5#130)(1995-6#137)(1995-8#76)(1995-9#20)(1996-1#79)(1996-10#9)(1996-11#42)(1996-12#200)(1996-2#143)(1996-3#115)(1996-4#13)(1996-5#115)(1996-6#47)(1996-7#23)(1996-8#23)(1996-9#44)(1997-1#72)(1997-2#178)(1997-3#142)(1997-4#155)(1997-5#43)(1997-6#98)(1997-7#118)(1997-8#84)(1997-9#5)(2006-10#56)(2006-12#13)(2006-4#4)(2006-5#3)(2006-6#12)(2006-7#3)(2007-1#8)(2007-10#135)(2007-11#590)(2007-12#627)(2007-2#52)(2007-3#1)(2007-4#23)(2007-5#43)(2007-6#15)(2007-7#138)(2007-8#167)(2007-9#9)(2008-1#376)(2008-10#6400)(2008-11#1284)(2008-12#520)(2008-2#891)(2008-3#1464)(2008-4#570)(2008-5#952)(2008-6#375)(2008-7#1054)(2008-8#703)(2008-9#697)(2009-1#14)(2009-10#158)(2009-11#119)(2009-12#125)(2009-2#64)(2009-3#95)(2009-4#90)(2009-5#150)(2009-6#113)(2009-7#155)(2009-8#197)(2009-9#89)(2010-1#75)(2010-10#120)(2010-11#124)(2010-12#167)(2010-2#65)(2010-3#164)(2010-4#154)(2010-5#190)(2010-6#127)(2010-7#105)(2010-8#202)(2010-9#64)(2011-1#409)(2011-10#6)(2011-2#1128)(2011-3#63)(2011-4#6)(2011-7#16)(2011-8#2)(2011-9#1)(2012-1#141)(2012-12#400)(2012-2#688)(2012-3#456)(2012-4#5)(2012-5#8)(2012-6#12)(2012-7#10)(2012-8#8)(2012-9#6)(2013-1#874)(2013-3#2)(2013-7#124)(2013-8#440)
as-deposited BDD and glassy carbon electrodes##2##6##(2008-10#2)
as-deposited BDD and##3##3##(2008-10#3)
as-prepared BN whiskers##2##3##(2008-10#2)
as-prepared catalyst##2##2##(2013-1#2)
as-prepared catalysts##2##2##(2013-1#2)
as-prepared##9##1##(2008-10#2)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#4)
as-synthesized##2##1##(2008-10#1)(2008-7#1)
as-yet##2##1##(1995-8#1)(2008-2#1)
as5##2##1##(2008-5#2)
as6##2##1##(2008-5#2)
asFP595 and##3##2##(2009-9#3)
asFP595##4##1##(2009-9#4)
asa##2##1##(2008-11#1)(2008-2#1)
asahii##3##1##(2009-4#3)
asbestiform##2##1##(1991-12#1)(1991-3#1)
asbestos abatement##6##2##(1991-12#4)(1992-2#2)
asbestos exposure in##2##3##(1991-12#2)
asbestos exposure was##3##3##(1991-12#1)(1992-11#2)
asbestos exposure##15##2##(1991-12#9)(1992-11#2)(1993-9#1)(2008-12#1)(2010-12#1)(2010-5#1)
asbestos fibers from##2##3##(1991-12#2)
asbestos fibers in##2##3##(1991-12#2)
asbestos fibers##11##2##(1990-12#1)(1991-12#9)(1991-3#1)
asbestos fibres##3##2##(2013-8#3)
asbestos in place##3##3##(1991-12#3)
asbestos in##9##2##(1991-12#7)(1992-11#1)(1997-5#1)
asbestos is##3##2##(1991-12#2)(1995-2#1)
asbestos was##3##2##(1991-12#2)(1992-11#1)
asbestos##79##1##(1990-12#1)(1991-12#57)(1991-3#1)(1992-1#1)(1992-11#6)(1992-2#2)(1993-9#1)(1995-2#2)(1997-5#1)(2008-12#1)(2010-12#1)(2010-5#1)(2013-8#4)
asbestos-containing building materials##2##3##(1991-12#2)
asbestos-containing materials in##2##3##(1991-12#2)
asbestos-containing materials##4##2##(1991-12#4)
asbestos-containing##6##1##(1991-12#6)
asbestos-induced pleural fibrosis##3##3##(1991-12#3)
asbestos-induced pleural##4##2##(1991-12#4)
asbestos-induced##7##1##(1991-12#7)
asbestos-related disease##3##2##(1991-12#3)
asbestos-related diseases in the##2##4##(1995-2#1)(2013-8#1)
asbestos-related##11##1##(1991-12#9)(1995-2#1)(2013-8#1)
asbestosis##10##1##(1991-12#10)
ascended##2##1##(1997-3#1)(2008-7#1)
ascendency##2##1##(2008-5#2)
ascending and##2##2##(1991-6#1)(2013-1#1)
ascending aorta and##2##3##(2009-7#1)(2012-2#1)
ascending aorta##34##2##(1997-5#4)(1997-8#2)(2007-8#21)(2008-11#1)(2008-3#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
ascending colon##7##2##(1991-6#1)(1993-9#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-8#1)
ascending##59##1##(1990-2#1)(1991-6#2)(1993-9#1)(1996-5#1)(1996-9#1)(1997-5#4)(1997-8#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#22)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-3#2)(2013-8#1)
ascent for##2##2##(2013-1#2)
ascent##7##1##(1992-2#2)(2007-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
ascertain the##27##2##(1990-5#1)(1991-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
ascertain whether or not##2##4##(1993-3#1)(2007-8#1)
ascertain whether##9##2##(1992-8#1)(1993-3#2)(1995-5#1)(1997-4#1)(2006-6#1)(2007-8#1)(2008-11#1)(2010-8#1)
ascertain##57##1##(1990-5#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
ascertained by##7##2##(2008-10#5)(2008-12#1)(2011-1#1)
ascertained in##2##2##(1990-5#1)(2013-1#1)
ascertained the##2##2##(1990-3#1)(1996-12#1)
ascertained through##2##2##(1993-9#1)(1997-5#1)
ascertained##28##1##(1990-3#1)(1990-5#1)(1991-2#2)(1993-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-5#3)(2008-10#6)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
ascertaining that##2##2##(2008-9#1)(2012-12#1)
ascertaining the##3##2##(1994-1#1)(2008-10#1)(2008-9#1)
ascertaining##8##1##(1994-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2011-1#1)(2012-12#1)
ascertainment and assessment##2##3##(1997-5#2)
ascertainment bias##2##2##(2012-3#2)
ascertainment##7##1##(1994-12#1)(1997-5#2)(1997-8#1)(2007-6#1)(2012-3#2)
asci##9##1##(1997-3#1)(2008-10#8)
ascidian Styela canopus##2##3##(2008-7#2)
ascidian eggs##3##2##(1993-6#2)(2008-6#1)
ascidian##8##1##(1993-6#4)(2008-6#2)(2008-7#2)
ascidians##2##1##(2008-5#1)(2008-9#1)
ascites and##7##2##(1992-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
ascites are##2##2##(2007-12#1)(2013-1#1)
ascites cell##2##2##(2008-4#2)
ascites hepatoma cell line of AH109A##3##6##(2008-11#3)
ascites hepatoma cell line##4##4##(2008-11#4)
ascites hepatoma##10##2##(1993-8#3)(2008-11#7)
ascites in##2##2##(1997-6#1)(2013-1#1)
ascites incidence##3##2##(1997-3#2)(1997-6#1)
ascites mortality##3##2##(1997-3#2)(1997-6#1)
ascites of##4##2##(1991-4#3)(1993-9#1)
ascites retention##3##2##(2013-8#3)
ascites tumor##3##2##(1992-3#2)(2008-8#1)
ascites tumour##4##2##(1990-5#2)(1990-6#2)
ascites was##3##2##(2010-10#1)(2013-1#2)
ascites without##2##2##(1991-12#1)(2007-12#1)
ascites##98##1##(1990-5#2)(1990-6#2)(1991-11#1)(1991-12#3)(1991-4#4)(1991-5#1)(1992-3#6)(1993-8#4)(1993-9#1)(1994-12#1)(1997-3#4)(1997-6#8)(1997-7#1)(2007-12#14)(2008-10#3)(2008-11#10)(2008-4#5)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#7)(2012-1#1)(2012-3#3)(2013-1#10)(2013-8#3)
ascites]##2##1##(1991-4#1)(1995-3#1)
ascitic fluid aspirated from##2##4##(1992-2#2)
ascitic fluid volume##2##3##(2007-12#2)
ascitic fluid##19##2##(1992-2#2)(2007-12#9)(2008-1#3)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-12#1)
ascitic fluids##2##2##(1990-2#2)
ascitic##27##1##(1990-2#2)(1992-2#2)(1994-3#2)(1995-11#1)(2007-12#9)(2008-1#3)(2008-10#2)(2008-11#1)(2008-9#3)(2009-8#1)(2010-12#1)
ascitis##3##1##(1993-6#2)(1997-3#1)
ascocarps as a percentage of M##2##6##(2008-10#2)
ascocarps on##3##2##(2008-10#3)
ascocarps##9##1##(2008-10#9)
ascomycete fungi##2##2##(2008-10#2)
ascomycete##15##1##(1995-6#1)(2008-10#10)(2010-3#2)(2011-1#1)(2012-3#1)
ascomycetes##3##1##(2008-10#2)(2010-7#1)
ascomycetous fungi##2##2##(2008-10#1)(2010-6#1)
ascomycetous##3##1##(2008-10#2)(2010-6#1)
ascorbate and##10##2##(1990-2#1)(1992-11#2)(1992-6#1)(1993-2#1)(1994-11#1)(1995-2#1)(2008-10#3)
ascorbate concentration##2##2##(1993-8#2)
ascorbate concentrations##3##2##(1993-8#2)(2012-2#1)
ascorbate in##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
ascorbate is##3##2##(1992-6#1)(2012-2#2)
ascorbate oxidase##5##2##(2008-10#5)
ascorbate peroxidase##2##2##(2008-10#2)
ascorbate to##3##2##(1990-9#1)(2008-11#1)(2008-5#1)
ascorbate using##2##2##(2008-10#1)(2009-9#1)
ascorbate was##3##2##(1992-12#1)(1994-9#1)(1995-6#1)
ascorbate##91##1##(1990-2#1)(1990-9#8)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#4)(1993-11#1)(1993-2#1)(1993-8#7)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#3)(1995-6#2)(1996-9#1)(1997-4#4)(2008-10#21)(2008-11#3)(2008-2#3)(2008-5#3)(2009-9#6)(2011-1#4)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
ascorbic Acid on##2##3##(2008-11#1)(2008-5#1)
ascorbic acid (AA) and uric acid (UA)##2##7##(2008-10#2)
ascorbic acid (AA) and##5##4##(1993-3#1)(2008-10#4)
ascorbic acid (AA) in##3##4##(2008-10#3)
ascorbic acid (AA) is##2##4##(2008-10#1)(2008-5#1)
ascorbic acid (AA)##15##3##(1992-12#1)(1993-3#1)(2008-10#12)(2008-5#1)
ascorbic acid (AsA)##4##3##(1992-3#1)(2008-10#2)(2008-11#1)
ascorbic acid (Vitamin C)##2##4##(2008-10#2)
ascorbic acid (vitamin C)##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
ascorbic acid (vitamin##4##3##(1992-9#1)(2008-10#2)(2008-7#1)
ascorbic acid and copper##2##4##(2008-10#2)
ascorbic acid and sorbic acid in fruit juices##2##8##(2008-10#2)
ascorbic acid and sorbic acid##3##5##(2008-10#3)
ascorbic acid and uric acid##5##5##(2008-10#5)
ascorbic acid and##30##3##(1993-2#1)(1993-3#1)(2008-10#26)(2008-5#1)(2012-2#1)
ascorbic acid as##4##3##(2008-10#2)(2008-5#1)(2009-10#1)
ascorbic acid at##4##3##(2008-10#4)
ascorbic acid based on##5##4##(2008-10#5)
ascorbic acid concentration##3##3##(2008-10#3)
ascorbic acid in pharmaceuticals##2##4##(2008-10#2)
ascorbic acid in the##2##4##(2008-10#2)
ascorbic acid in##23##3##(1992-12#1)(1997-4#1)(2008-10#21)
ascorbic acid is##2##3##(2008-10#1)(2008-5#1)
ascorbic acid or##2##3##(2008-10#1)(2008-5#1)
ascorbic acid oxidation##2##3##(2008-10#1)(2011-2#1)
ascorbic acid pretreatment##3##3##(1993-12#3)
ascorbic acid provided##2##3##(2008-11#2)
ascorbic acid to##2##3##(2008-10#2)
ascorbic acid was linear##2##4##(2008-10#2)
ascorbic acid was##13##3##(2008-10#12)(2008-5#1)
ascorbic acid##230##2##(1990-5#2)(1990-9#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(1996-2#1)(1997-4#1)(2007-4#1)(2008-10#179)(2008-11#3)(2008-12#1)(2008-5#13)(2008-7#2)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#3)
ascorbic acid&gt##2##2##(2008-10#2)
ascorbic##240##1##(1990-5#2)(1990-9#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(1996-2#1)(1997-4#1)(2007-4#1)(2008-10#187)(2008-11#4)(2008-12#1)(2008-5#14)(2008-7#2)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#3)
ascorbyl palmitate and##2##3##(2008-5#2)
ascorbyl phosphate##4##2##(2008-5#4)
ascorbyl##6##1##(2008-5#6)
ascosphaerosis##2##1##(2008-5#2)
ascospore discharge##5##2##(2008-10#5)
ascospore dispersal##2##2##(2008-10#2)
ascospore germination and##2##3##(2008-10#1)(2008-8#1)
ascospore germination in##2##3##(2008-10#2)
ascospore germination##7##2##(2008-10#6)(2008-8#1)
ascospore infection##3##2##(2008-10#3)
ascospore maturation##2##2##(2008-10#2)
ascospore populations##2##2##(2008-10#2)
ascospore production and##3##3##(2008-10#2)(2008-8#1)
ascospore production was##2##3##(2008-10#2)
ascospore production were greatest##2##4##(2008-10#2)
ascospore production were##3##3##(2008-10#3)
ascospore production##13##2##(2008-10#11)(2008-8#2)
ascospore progeny##4##2##(2008-10#4)
ascospore release##22##2##(2008-10#22)
ascospore showers##5##2##(2008-10#5)
ascospore##76##1##(2008-10#73)(2008-8#3)
ascospores also##2##2##(2008-10#2)
ascospores and conidia##3##3##(2008-10#3)
ascospores and##7##2##(2008-10#7)
ascospores are##2##2##(2008-10#2)
ascospores at##3##2##(2008-10#3)
ascospores collected##2##2##(2008-10#2)
ascospores discharged from##2##3##(2008-10#2)
ascospores discharged##3##2##(2008-10#3)
ascospores in the##5##3##(2008-10#5)
ascospores in##12##2##(2008-10#11)(2008-8#1)
ascospores may be##2##3##(2008-10#2)
ascospores of Venturia inaequalis##2##4##(2008-10#2)
ascospores of##8##2##(2008-10#8)
ascospores per##3##2##(2008-10#3)
ascospores was studied##2##3##(2008-10#2)
ascospores was##6##2##(2008-10#6)
ascospores were captured##2##3##(2008-10#2)
ascospores were detectable##2##3##(2008-10#2)
ascospores were detected##3##3##(2008-10#3)
ascospores were released##2##3##(2008-10#2)
ascospores were##14##2##(2008-10#14)
ascospores##115##1##(1993-3#1)(2008-10#110)(2008-8#2)(2010-10#1)(2010-3#1)
ascosporic##4##1##(2008-10#4)
ascribable##3##1##(1992-9#1)(2008-10#1)(2008-5#1)
ascribe##4##1##(2008-7#1)(2011-2#2)(2012-2#1)
ascribed to a##6##3##(1994-5#1)(1996-11#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-1#1)
ascribed to the##16##3##(1991-2#1)(1993-8#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#2)
ascribed to##41##2##(1991-2#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#1)
ascribed##51##1##(1991-12#1)(1991-2#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#1)
ascribes to##2##2##(1991-6#1)(2008-10#1)
asd gene##2##2##(2008-9#2)
aseptic bone necroses##3##3##(2007-11#3)
aseptic loosening##6##2##(2007-11#1)(2008-8#1)(2009-4#1)(2013-1#3)
aseptic meningitis##3##2##(1992-9#1)(2007-2#1)(2007-5#1)
aseptic##23##1##(1992-9#1)(1994-7#1)(2006-10#1)(2007-11#5)(2007-2#1)(2007-5#1)(2008-11#1)(2008-8#2)(2009-4#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#5)
aseptically##4##1##(2007-11#1)(2008-11#1)(2008-12#1)(2011-2#1)
asexual development##5##2##(2008-10#4)(2010-2#1)
asexual endophytes##2##2##(2008-8#2)
asexual form##2##2##(2008-10#2)
asexual genetic exchange##2##3##(2008-10#2)
asexual propagules##2##2##(2008-10#2)
asexual reproduction in##2##3##(2008-10#1)(2009-5#1)
asexual reproduction of##3##3##(2008-10#2)(2008-5#1)
asexual reproduction##20##2##(2008-10#11)(2008-5#5)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
asexual reproductive##2##2##(2009-5#1)(2013-8#1)
asexual##67##1##(2008-10#44)(2008-5#6)(2008-7#1)(2008-8#3)(2009-5#2)(2010-12#1)(2010-2#2)(2010-3#3)(2012-3#1)(2013-1#3)(2013-8#1)
asexually##4##1##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
ash and##8##2##(2008-10#7)(2008-3#1)
ash content of##3##3##(2008-10#2)(2010-4#1)
ash content##4##2##(2008-10#3)(2010-4#1)
ash deriving from a solid waste incinerator and##2##8##(2008-10#2)
ash samples##11##2##(2008-10#11)
ash were##2##2##(2008-10#1)(2010-2#1)
ash##60##1##(1991-2#1)(2008-10#47)(2008-3#6)(2010-11#1)(2010-2#2)(2010-4#2)(2012-2#1)
ashed at 550 degrees C##2##5##(2008-10#2)
ashed##3##1##(2008-10#3)
ashes were##3##2##(2008-10#3)
ashes##12##1##(2008-10#10)(2008-11#1)(2012-2#1)
ashing at##2##2##(2008-10#2)
ashing method##4##2##(2008-10#3)(2013-8#1)
ashing procedure##4##2##(2008-10#4)
ashing##29##1##(2008-10#27)(2008-5#1)(2013-8#1)
asialo-orosomucoid##5##1##(1995-6#5)
asialofetuin##3##1##(2008-9#3)
asialoglycoprotein receptor##6##2##(1993-11#3)(1995-11#1)(1995-2#1)(2008-8#1)
asian american##2##2##(2010-8#1)(2013-1#1)
asian##12##1##(2008-10#2)(2008-3#2)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
asiatica were##2##2##(2008-10#2)
asiatica##10##1##(2008-10#8)(2008-5#1)(2009-8#1)
asiaticus##4##1##(2008-10#2)(2011-2#2)
aside##6##1##(1994-1#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
asignificant##2##1##(2008-11#2)
ask how##4##2##(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)
ask the##2##2##(1993-12#1)(1997-1#1)
ask whether##4##2##(2008-12#1)(2008-7#1)(2009-2#1)(2012-2#1)
ask##28##1##(1990-5#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
asked about the##2##3##(2012-12#2)
asked about##4##2##(2008-10#1)(2008-9#1)(2012-12#2)
asked by##4##2##(1991-5#1)(1993-2#1)(1995-2#1)(2008-11#1)
asked for##12##2##(1990-2#1)(1991-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#3)(2012-12#1)
asked how##3##2##(1994-2#1)(2007-10#1)(2012-2#1)
asked of##2##2##(1995-12#1)(2008-9#1)
asked participants to##2##3##(2008-6#1)(2010-2#1)
asked the following questions##2##4##(2008-12#1)(2008-5#1)
asked the##5##2##(1995-6#1)(1996-5#1)(2008-12#1)(2008-5#1)(2009-6#1)
asked them##2##2##(2008-1#1)(2012-12#1)
asked to be##4##3##(1991-12#1)(2010-11#2)(2010-9#1)
asked to complete the##3##4##(2008-11#2)(2008-8#1)
asked to complete##8##3##(1993-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)
asked to give##3##3##(1990-11#1)(2008-11#1)(2009-11#1)
asked to identify the##2##4##(2008-11#2)
asked to identify##3##3##(2008-11#2)(2013-8#1)
asked to provide##2##3##(1990-11#1)(1993-12#1)
asked to rate the##3##4##(1995-3#1)(1996-2#1)(2008-10#1)
asked to rate##10##3##(1991-6#1)(1993-1#1)(1993-2#1)(1995-3#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)
asked to take##2##3##(2007-6#1)(2008-6#1)
asked to view the##2##4##(1993-1#1)(2008-5#1)
asked to view##3##3##(1993-1#1)(1996-2#1)(2008-5#1)
asked to##86##2##(1990-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-6#2)(1993-1#3)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#4)(1996-3#1)(1997-1#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#5)(2008-11#13)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#4)
asked what##2##2##(2008-11#1)(2012-3#1)
asked which of##2##3##(1994-3#1)(2008-8#1)
asked##161##1##(1990-11#3)(1990-2#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-6#2)(1993-1#3)(1993-12#4)(1993-2#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#6)(1996-3#1)(1996-5#2)(1997-1#1)(1997-4#1)(2007-10#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#19)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#2)(2009-2#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#8)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#8)(2013-8#5)
asking for##2##2##(1994-5#1)(1996-1#1)
asking patients##2##2##(1995-2#1)(1996-8#1)
asking whether##2##2##(2007-3#1)(2008-8#1)
asking##15##1##(1992-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-8#1)(2007-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-8#2)
asks for##2##2##(1994-12#1)(2008-1#1)
asks what##2##2##(2008-11#1)(2009-11#1)
asks##12##1##(1992-3#1)(1993-3#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-11#3)(2008-8#1)(2009-11#1)(2010-7#1)(2012-3#1)
asleep##9##1##(1990-5#1)(2007-6#7)(2012-2#1)
asp##4##1##(1992-12#1)(1997-3#2)(2010-8#1)
asparagi##5##1##(2008-10#5)
asparagine 43##2##2##(1994-11#2)
asparagine and glutamine##3##3##(2008-11#3)
asparagine and##5##2##(1992-6#1)(1993-6#1)(2008-11#3)
asparagine residues##3##2##(1993-6#1)(1997-6#1)(2008-1#1)
asparagine##28##1##(1991-12#1)(1991-9#1)(1992-6#2)(1993-6#4)(1994-11#2)(1994-6#1)(1995-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-7#4)
asparagine-linked glycosylation sites##3##3##(1993-6#1)(2008-11#1)(2008-8#1)
asparagine-linked glycosylation##5##2##(1992-3#1)(1993-6#1)(2008-11#1)(2008-8#2)
asparagine-linked oligosaccharides##2##2##(1992-10#1)(2008-1#1)
asparagine-linked##11##1##(1990-12#1)(1992-10#3)(1992-3#1)(1993-11#1)(1993-6#1)(2008-1#1)(2008-11#1)(2008-8#2)
asparagines##2##1##(1992-6#1)(2012-12#1)
asparagus plantations##3##2##(2008-10#3)
asparagus##17##1##(2008-10#17)
aspartame and##2##2##(2011-1#2)
aspartame in##3##2##(2008-8#3)
aspartame##21##1##(2008-4#2)(2008-8#16)(2010-9#1)(2011-1#2)
aspartase##3##1##(1991-5#2)(1992-11#1)
aspartate amino transferase (AST)##2##4##(2008-10#2)
aspartate aminotransferase (AST) and##2##4##(2008-10#1)(2012-2#1)
aspartate aminotransferase (AST)##6##3##(1994-5#1)(1997-3#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
aspartate aminotransferase##28##2##(1990-7#4)(1992-6#2)(1993-2#2)(1994-5#1)(1994-6#4)(1995-3#1)(1996-10#2)(1996-12#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-12#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
aspartate aminotransferases##2##2##(1992-6#1)(2008-10#1)
aspartate and glutamate##3##3##(1990-11#2)(2012-1#1)
aspartate and##8##2##(1990-11#2)(1995-6#4)(2011-2#1)(2012-1#1)
aspartate complex##5##2##(1991-12#3)(1995-6#2)
aspartate efflux##2##2##(1991-3#2)
aspartate formation in##2##3##(1991-3#2)
aspartate formation##4##2##(1991-3#4)
aspartate in the##3##3##(1995-5#1)(1995-6#2)
aspartate production##2##2##(1991-3#2)
aspartate receptor and##3##3##(1991-12#1)(1992-8#2)
aspartate receptor##9##2##(1991-12#2)(1992-8#6)(1992-9#1)
aspartate residues##2##2##(2008-1#1)(2008-4#1)
aspartate to##2##2##(1991-12#1)(1995-5#1)
aspartate transcarbamoylase##3##2##(1990-8#1)(1995-6#2)
aspartate were##2##2##(1990-11#1)(2012-1#1)
aspartate##92##1##(1990-11#3)(1990-7#4)(1990-8#2)(1991-12#6)(1991-3#8)(1992-6#4)(1992-8#8)(1992-9#1)(1993-11#1)(1993-2#2)(1994-5#1)(1994-6#4)(1995-3#1)(1995-5#2)(1995-6#16)(1995-8#1)(1996-10#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
aspartic acid and##4##3##(1991-12#1)(1995-2#1)(1997-2#1)(2008-5#1)
aspartic acid at position##2##4##(1994-3#1)(1997-3#1)
aspartic acid at##3##3##(1993-8#1)(1994-3#1)(1997-3#1)
aspartic acid##21##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
aspartic peptidases##2##2##(2008-4#2)
aspartic protease##2##2##(1990-2#1)(1991-9#1)
aspartic proteinase from##2##3##(1990-8#1)(1995-6#1)
aspartic proteinase zymogens##2##3##(1995-3#2)
aspartic proteinase##4##2##(1990-8#1)(1995-3#2)(1995-6#1)
aspartic proteinases##2##2##(1990-5#1)(1995-3#1)
aspartic##37##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-6#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-4#5)(2008-5#2)(2008-7#1)(2011-2#1)
aspartyl protease is##2##3##(1994-5#1)(1995-8#1)
aspartyl protease##7##2##(1990-2#1)(1994-5#2)(1995-8#4)
aspartyl residues##2##2##(1991-9#2)
aspartyl##13##1##(1990-2#1)(1991-9#3)(1994-5#2)(1995-6#1)(1995-8#4)(2006-6#1)(2008-5#1)
aspartylglucosaminuria##2##1##(1991-7#2)
aspecific##4##1##(1990-5#1)(1993-9#1)(1997-3#1)(2008-11#1)
aspect appears##2##2##(2008-5#1)(2013-1#1)
aspect for##2##2##(2008-10#1)(2013-7#1)
aspect from##2##2##(1990-8#1)(2007-12#1)
aspect is the assay of##2##5##(1991-5#2)
aspect is the##3##3##(1991-5#3)
aspect is##4##2##(1991-5#3)(1997-5#1)
aspect of a##8##3##(1992-2#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-12#1)(2013-1#1)
aspect of care##2##3##(2007-9#1)(2008-1#1)
aspect of life##2##3##(1993-3#1)(2011-2#1)
aspect of the##37##3##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-12#1)(1996-9#2)(1997-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
aspect of these##2##3##(1992-11#1)(2008-9#1)
aspect of this is##2##4##(2008-7#2)
aspect of this##7##3##(1991-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-12#1)
aspect of wellbeing##2##3##(2008-10#2)
aspect of##105##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#3)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-9#2)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
aspect on##2##2##(2008-11#1)(2011-2#1)
aspect ratio and##2##3##(2008-7#2)
aspect ratio of the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
aspect ratio of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)
aspect ratio##19##2##(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#2)(2009-11#1)(2010-1#1)(2011-2#1)
aspect ratios##9##2##(1991-12#2)(2007-11#2)(2008-2#1)(2008-3#3)(2009-11#1)
aspect that##2##2##(2008-8#1)(2013-1#1)
aspect was##3##2##(1991-8#1)(2008-10#1)(2011-1#1)
aspect were##2##2##(1993-2#1)(2008-10#1)
aspect##181##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1995-12#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-3#1)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#2)
aspects and clinical##2##3##(1997-2#1)(2007-7#1)
aspects and##25##2##(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-6#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2009-5#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
aspects are discussed in##2##4##(1997-5#1)(2006-4#1)
aspects are discussed##5##3##(1990-6#1)(1993-5#1)(1997-5#1)(2006-4#1)(2008-11#1)
aspects are##13##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-5#1)(1993-5#1)(1997-5#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
aspects as##4##2##(1996-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
aspects associated with##3##3##(1990-12#1)(1995-5#1)(2008-4#1)
aspects based on##2##3##(1990-8#1)(2008-11#1)
aspects beyond##2##2##(2008-11#1)(2012-2#1)
aspects concerning the##2##3##(1997-4#1)(2008-11#1)
aspects for which##2##3##(2008-10#2)
aspects for##5##2##(2008-10#3)(2008-6#1)(2012-12#1)
aspects have to be##2##4##(2011-2#1)(2012-12#1)
aspects in the##9##3##(1992-2#1)(1995-8#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#3)(2012-12#1)
aspects in##19##2##(1992-2#1)(1995-8#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-8#2)(2009-10#1)(2010-6#3)(2011-2#6)(2012-12#1)
aspects include##2##2##(2008-11#1)(2008-6#1)
aspects including##3##2##(2008-10#2)(2013-1#1)
aspects is presented##2##3##(2008-10#1)(2008-11#1)
aspects is##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
aspects may##2##2##(2008-12#1)(2010-12#1)
aspects not##2##2##(2012-12#1)(2013-8#1)
aspects of Patient Focused care team##2##6##(1994-2#2)
aspects of Patient Focused##3##4##(1993-12#1)(1994-2#2)
aspects of QoL##2##3##(2008-10#1)(2013-1#1)
aspects of a hospital##2##4##(1992-2#1)(1992-9#1)
aspects of a##8##3##(1992-2#1)(1992-9#1)(1994-2#1)(1996-6#1)(1997-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
aspects of adult##2##3##(1992-1#1)(2007-8#1)
aspects of an##3##3##(1993-1#1)(1995-3#1)(2008-8#1)
aspects of autoimmune##2##3##(2007-5#1)(2012-3#1)
aspects of body image##2##4##(2007-12#2)
aspects of care##8##3##(1991-3#1)(1992-3#1)(1993-2#3)(1995-12#1)(1997-1#1)(2008-11#1)
aspects of cell##2##3##(2008-7#1)(2010-10#1)
aspects of cellular##3##3##(2009-3#1)(2009-8#1)(2011-2#1)
aspects of chromosome##2##3##(2010-3#1)(2013-1#1)
aspects of chronic##2##3##(2008-11#1)(2008-4#1)
aspects of cognition##2##3##(1996-11#1)(2008-4#1)
aspects of cognitive##3##3##(2008-4#1)(2008-6#2)
aspects of data##2##3##(2008-4#1)(2010-1#1)
aspects of dental##2##3##(2008-8#1)(2013-1#1)
aspects of diabetes mellitus##2##4##(1996-11#1)(2008-1#1)
aspects of diabetes##3##3##(1996-11#1)(2008-1#1)(2008-4#1)
aspects of disease##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
aspects of drug##3##3##(1997-6#1)(2009-7#1)(2013-1#1)
aspects of early##2##3##(2008-7#1)(2009-3#1)
aspects of flow cytometry##2##4##(2008-4#1)(2008-9#1)
aspects of functional##3##3##(2008-7#1)(2010-10#1)(2013-1#1)
aspects of gestational diabetes##2##4##(1996-11#2)
aspects of global##2##3##(1993-1#1)(2008-8#1)
aspects of health care##3##4##(1991-3#1)(1993-3#1)(2010-11#1)
aspects of health##5##3##(1991-3#1)(1992-5#1)(1993-3#1)(2010-11#1)(2011-2#1)
aspects of human##4##3##(1994-5#1)(1994-9#1)(2010-8#1)(2012-12#1)
aspects of information##2##3##(1997-3#1)(2012-12#1)
aspects of inpatient##2##3##(1992-2#1)(2009-11#1)
aspects of its##4##3##(2008-4#1)(2008-5#1)(2013-7#1)(2013-8#1)
aspects of legged locomotion##2##4##(2007-12#2)
aspects of living-donor kidney transplantation]##2##5##(2011-2#2)
aspects of lung##2##3##(2010-7#1)(2012-3#1)
aspects of male##2##3##(2009-10#1)(2009-9#1)
aspects of medical care##2##4##(2008-11#1)(2010-3#1)
aspects of metabolism##2##3##(1995-12#1)(2008-2#1)
aspects of music##2##3##(2007-6#1)(2013-8#1)
aspects of non-invasive##2##3##(1996-12#1)(2012-2#1)
aspects of pathogenesis##2##3##(2008-5#1)(2010-5#1)
aspects of peripheral##3##3##(1995-5#1)(2007-12#1)(2012-3#1)
aspects of phage therapy##2##4##(2012-2#2)
aspects of plant##2##3##(2007-12#1)(2008-7#1)
aspects of program evaluation##3##4##(1993-12#3)
aspects of road traffic##2##4##(2010-11#2)
aspects of routine##2##3##(1994-6#1)(2008-10#1)
aspects of sedimentation levels##2##4##(2008-7#2)
aspects of service##3##3##(1994-2#1)(2013-1#2)
aspects of skin##2##3##(2008-5#1)(2010-8#1)
aspects of systemic##2##3##(1992-9#1)(2013-1#1)
aspects of the ICU##2##4##(1992-2#2)
aspects of the development of##2##5##(1993-11#1)(2011-2#1)
aspects of the disease##5##4##(1991-12#1)(1991-5#1)(1993-6#1)(2010-12#1)(2011-2#1)
aspects of the disorder##2##4##(2008-4#1)(2012-12#1)
aspects of the management of##2##5##(2008-11#1)(2013-1#1)
aspects of the method##2##4##(2008-10#2)
aspects of the molecular##2##4##(1994-11#1)(2010-1#1)
aspects of the organization of##2##5##(1995-11#1)(1995-5#1)
aspects of the present##2##4##(2008-10#1)(2008-11#1)
aspects of the project##2##4##(2012-2#2)
aspects of the use of##2##5##(2008-10#1)(2011-2#1)
aspects of the vaccine##2##4##(2008-11#2)
aspects of the work##2##4##(2008-12#1)(2008-9#1)
aspects of the##146##3##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#4)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#1)(1995-1#3)(1995-11#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
aspects of their##11##3##(1991-3#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2010-5#1)(2013-1#1)
aspects of these##9##3##(1991-12#1)(1992-5#1)(2007-5#1)(2008-11#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
aspects of this condition##2##4##(2008-4#1)(2012-2#1)
aspects of this##18##3##(1990-3#1)(1992-6#1)(1994-3#1)(1994-6#1)(1996-5#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-7#1)(2012-2#1)(2013-1#1)
aspects of treatment##4##3##(1996-11#1)(2007-11#1)(2007-12#1)(2010-12#1)
aspects of tumour hypoxia##2##4##(2009-4#2)
aspects of vascular##2##3##(1990-10#1)(2008-7#1)
aspects of visceral leishmaniasis in##2##5##(2007-12#1)(2012-2#1)
aspects of##626##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#6)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#2)(1992-5#2)(1992-6#3)(1992-9#3)(1993-1#4)(1993-11#3)(1993-12#9)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#4)(1994-6#2)(1994-9#4)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#1)(1996-1#4)(1996-11#5)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#22)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#56)(2008-11#29)(2008-12#11)(2008-2#5)(2008-3#12)(2008-4#20)(2008-5#19)(2008-6#5)(2008-7#28)(2008-8#12)(2008-9#24)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#3)(2010-3#7)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#9)(2010-9#4)(2011-1#4)(2011-2#28)(2011-7#1)(2012-1#3)(2012-12#11)(2012-2#18)(2012-3#15)(2013-1#25)(2013-7#6)(2013-8#7)
aspects on the##2##3##(2008-7#1)(2013-1#1)
aspects on##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
aspects regarding##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
aspects related to the##2##4##(2008-9#1)(2011-2#1)
aspects related to##8##3##(1991-9#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
aspects related##9##2##(1991-9#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
aspects such as##2##3##(2008-5#1)(2012-5#1)
aspects that##10##2##(1994-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
aspects to##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
aspects were##3##2##(1990-10#1)(1991-8#1)(2008-10#1)
aspects which##2##2##(2011-2#1)(2013-1#1)
aspects##884##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#3)(1990-9#8)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#8)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#8)(1992-3#3)(1992-5#2)(1992-6#4)(1992-9#3)(1993-1#4)(1993-11#3)(1993-12#9)(1993-2#6)(1993-3#2)(1993-5#2)(1993-6#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#5)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#7)(1995-6#2)(1995-8#1)(1996-1#5)(1996-11#6)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#6)(2007-12#24)(2007-2#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#12)(2008-10#81)(2008-11#54)(2008-12#14)(2008-2#7)(2008-3#16)(2008-4#23)(2008-5#29)(2008-6#11)(2008-7#36)(2008-8#17)(2008-9#33)(2009-10#7)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#6)(2010-12#5)(2010-3#8)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#11)(2010-9#5)(2011-1#7)(2011-2#46)(2011-7#1)(2012-1#5)(2012-12#23)(2012-2#23)(2012-3#19)(2012-5#2)(2013-1#38)(2013-7#7)(2013-8#14)
aspects]##14##1##(1990-5#1)(1990-6#1)(1990-9#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
asper##10##1##(2008-10#5)(2008-5#2)(2010-8#3)
aspera and S##2##3##(2008-10#2)
aspera and##3##2##(2008-10#3)
aspera##5##1##(2008-10#4)(2012-2#1)
asperata##3##1##(2008-10#3)
aspergilloma##5##1##(1996-8#1)(2008-1#2)(2008-5#2)
aspergillosis in patients##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
aspergillosis in##7##2##(1997-3#1)(2007-8#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
aspergillosis is a rare##2##4##(2009-4#1)(2011-2#1)
aspergillosis is a##3##3##(2009-4#1)(2011-2#2)
aspergillosis is##4##2##(2009-2#1)(2009-4#1)(2011-2#2)
aspergillosis should be##2##3##(2008-5#1)(2009-4#1)
aspergillosis was##3##2##(1997-3#1)(2008-1#1)(2011-2#1)
aspergillosis with##3##2##(2013-1#1)(2013-8#2)
aspergillosis##43##1##(1994-3#1)(1995-9#1)(1997-3#3)(2007-8#2)(2008-1#4)(2008-10#3)(2008-5#5)(2008-7#2)(2009-2#2)(2009-3#3)(2009-4#4)(2010-5#2)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#3)
aspergillus##2##1##(2007-8#1)(2013-8#1)
asperities##2##1##(1996-4#2)
asphaltene aggregation##2##2##(2008-3#2)
asphaltene##3##1##(2008-3#3)
asphaltenes##4##1##(2008-6#4)
asphere##3##1##(2007-11#2)(2008-3#1)
aspheres##5##1##(2008-2#1)(2008-3#4)
aspheric corrector##3##2##(2008-3#3)
aspheric plate##2##2##(2008-3#2)
aspheric surfaces##6##2##(2008-2#1)(2008-3#5)
aspheric##20##1##(2008-2#3)(2008-3#17)
aspherical lens for##2##3##(2008-2#1)(2008-3#1)
aspherical lens##5##2##(2008-2#3)(2008-3#2)
aspherical particles##2##2##(2008-2#2)
aspherical##17##1##(2008-2#7)(2008-3#10)
aspherics##2##1##(2008-3#2)
asphyxia at birth##2##3##(1994-3#2)
asphyxia due to##2##3##(1995-11#1)(2012-12#1)
asphyxia##14##1##(1991-6#1)(1992-11#2)(1992-5#1)(1993-3#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#3)(2012-12#1)
asphyxiation##2##1##(1992-2#1)(2008-4#1)
aspirate revealed##3##2##(2007-12#1)(2008-12#1)(2009-6#1)
aspirate##14##1##(2007-12#1)(2007-4#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)
aspirated and the##2##3##(1993-10#1)(2008-10#1)
aspirated and##3##2##(1993-10#1)(2008-10#2)
aspirated from the##2##3##(1992-2#1)(2012-12#1)
aspirated from##5##2##(1992-2#2)(2008-4#1)(2008-9#1)(2012-12#1)
aspirated in##2##2##(2008-10#2)
aspirated into a##2##3##(2008-10#2)
aspirated into the holding coil##2##5##(2008-10#2)
aspirated into##5##2##(2008-10#5)
aspirated sample##2##2##(2008-10#2)
aspirated to##2##2##(2008-10#2)
aspirated##30##1##(1992-2#2)(1993-10#1)(1993-3#1)(2006-10#2)(2007-7#1)(2008-10#17)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-12#1)
aspirates and##3##2##(1990-9#1)(1996-2#1)(2008-11#1)
aspirates were##3##2##(2007-7#1)(2008-10#1)(2008-6#1)
aspirates with##4##2##(2008-10#1)(2008-11#2)(2012-2#1)
aspirates##27##1##(1990-9#1)(1992-5#1)(1994-7#2)(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-6#5)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
aspirates)##3##1##(2008-12#2)(2008-6#1)
aspirating##2##1##(1990-8#1)(2008-10#1)
aspiration (FNA)##4##2##(2007-5#2)(2008-6#1)(2008-7#1)
aspiration and##8##2##(1994-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
aspiration biopsy (FNAB)##5##3##(1997-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
aspiration biopsy in##2##3##(2011-1#1)(2012-3#1)
aspiration biopsy of##2##3##(1994-2#1)(2008-6#1)
aspiration biopsy##16##2##(1990-2#1)(1990-6#1)(1991-6#1)(1992-8#1)(1994-2#1)(1994-7#1)(1997-2#1)(2008-1#1)(2008-6#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
aspiration cytology (FNAC)##4##3##(1990-6#1)(2007-5#1)(2008-7#1)(2009-7#1)
aspiration cytology of##3##3##(1993-12#1)(2008-6#1)(2012-2#1)
aspiration cytology##22##2##(1990-10#1)(1990-6#2)(1993-12#1)(2007-5#1)(2008-10#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#4)
aspiration during##3##2##(2007-10#2)(2007-8#1)
aspiration into##3##2##(2008-10#3)
aspiration lesions of the##3##4##(1992-11#1)(1993-12#1)(1997-3#1)
aspiration lesions##5##2##(1992-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1997-3#1)
aspiration may##2##2##(1993-10#1)(2008-2#1)
aspiration of the##5##3##(2008-10#3)(2008-2#1)(2012-2#1)
aspiration of##17##2##(1991-3#1)(1993-10#1)(1993-12#1)(1993-3#1)(1997-8#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#3)
aspiration or##4##2##(1993-5#1)(1994-9#1)(1996-9#1)(2010-7#1)
aspiration pneumonia or##2##3##(2007-6#1)(2011-1#1)
aspiration pneumonia##5##2##(1991-11#1)(2007-6#1)(2010-12#1)(2011-1#2)
aspiration prophylaxis during##2##3##(1993-10#1)(2010-11#1)
aspiration prophylaxis##3##2##(1993-10#2)(2010-11#1)
aspiration##130##1##(1990-10#2)(1990-2#1)(1990-6#3)(1991-11#1)(1991-3#4)(1991-6#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-10#8)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-5#4)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#3)(2009-6#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#6)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-8#4)
aspirations for their children##3##4##(2009-7#3)
aspirations for their children's educational attainment##3##6##(2009-7#3)
aspirations for their##6##3##(2009-7#6)
aspirations of##2##2##(2008-7#1)(2008-8#1)
aspirations##20##1##(1990-9#1)(1995-2#1)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#8)(2010-3#1)(2010-5#1)(2013-8#1)
aspires to##2##2##(1992-3#1)(2008-7#1)
aspirin alone##2##2##(2006-10#1)(2008-8#1)
aspirin and clopidogrel therapy##2##4##(2008-3#2)
aspirin and heat stress##2##4##(1991-12#2)
aspirin and##15##2##(1991-12#3)(1997-6#1)(2006-10#2)(2006-8#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
aspirin as##2##2##(1991-11#1)(1993-11#1)
aspirin for##2##2##(2007-10#1)(2007-8#1)
aspirin in the##3##3##(1990-3#1)(2007-10#1)(2008-11#1)
aspirin in##9##2##(1990-3#1)(1991-11#1)(2007-10#2)(2008-10#1)(2008-11#2)(2008-8#2)
aspirin is##5##2##(1991-11#1)(2006-7#1)(2008-3#1)(2008-8#1)(2011-2#1)
aspirin or##5##2##(1992-6#1)(1996-11#1)(2008-11#1)(2009-5#2)
aspirin was##3##2##(1997-6#1)(2007-10#1)(2008-11#1)
aspirin##95##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#9)(1991-12#3)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#4)(1996-11#1)(1997-5#1)(1997-6#3)(2006-10#4)(2006-6#2)(2006-7#2)(2006-8#2)(2007-10#5)(2007-8#1)(2008-10#4)(2008-11#11)(2008-12#2)(2008-3#7)(2008-5#2)(2008-8#12)(2009-5#2)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#3)
aspirin-treated##4##1##(1991-11#2)(1992-8#1)(1993-3#1)
aspiring to##3##2##(2010-3#1)(2011-2#1)(2012-3#1)
aspiring##6##1##(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
asplenic##2##1##(2012-12#2)
aspoxicillin##3##1##(1990-8#3)
aspx for revised estimates##35##4##(2011-1#15)(2011-2#10)(2012-1#10)
assailant##2##1##(2008-10#1)(2008-12#1)
assassination##2##1##(1994-9#1)(2008-10#1)
assault and##2##2##(1994-2#1)(2009-5#1)
assault on##2##2##(1991-9#1)(1994-2#1)
assault with##2##2##(2009-7#1)(2010-7#1)
assault##30##1##(1991-9#1)(1994-2#2)(1996-12#4)(1996-2#1)(1996-5#2)(1997-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-5#2)(2009-7#1)(2010-3#3)(2010-7#1)(2011-2#2)(2012-3#4)(2013-8#1)
assaulted##2##1##(2009-5#1)(2010-3#1)
assaults##4##1##(1991-12#1)(1991-3#1)(2008-2#2)
assay (0##2##2##(2008-10#2)
assay (ELISA) and the##2##4##(2008-10#2)
assay (ELISA) and##9##3##(1992-3#1)(1992-5#1)(1997-6#1)(2008-1#1)(2008-10#5)
assay (ELISA) based##2##3##(2008-10#1)(2008-4#1)
assay (ELISA) for##8##3##(1990-2#1)(1994-3#1)(2008-10#4)(2008-11#1)(2011-2#1)
assay (ELISA) is##3##3##(2008-10#2)(2008-4#1)
assay (ELISA) using##2##3##(2008-10#2)
assay (ELISA) was used to##3##5##(2007-2#1)(2008-1#1)(2010-4#1)
assay (ELISA) was##5##3##(1995-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-4#1)
assay (ELISA)##62##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-11#2)(1996-9#1)(1997-4#2)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#30)(2008-11#2)(2008-4#5)(2008-5#1)(2008-6#1)(2010-4#2)(2010-5#1)(2011-2#1)(2011-3#1)(2013-7#1)
assay allows##3##2##(1993-9#1)(2007-7#1)(2008-10#1)
assay also##4##2##(1992-3#1)(2008-10#3)
assay and ELISA##2##3##(2008-10#2)
assay and a##2##3##(1997-3#1)(2011-2#1)
assay and by a##2##4##(2008-10#1)(2008-5#1)
assay and for##2##3##(1997-4#1)(2008-10#1)
assay and real-time##2##3##(2010-11#1)(2012-2#1)
assay and the##6##3##(1994-8#2)(1996-12#1)(2008-10#1)(2012-3#1)(2013-8#1)
assay and western##2##3##(2008-10#2)
assay and##64##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-8#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-11#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
assay are described##2##3##(1991-9#1)(1992-9#1)
assay are discussed##2##3##(1997-4#1)(2008-4#1)
assay are##6##2##(1991-9#1)(1992-9#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
assay as a##4##3##(1992-10#1)(1997-4#3)
assay as well as##3##4##(1994-3#1)(2010-4#1)(2013-1#1)
assay as##8##2##(1992-10#1)(1994-3#1)(1997-4#3)(2008-10#1)(2010-4#1)(2013-1#1)
assay at##5##2##(1990-12#1)(2008-10#2)(2011-1#1)(2011-2#1)
assay based on the##2##4##(1991-12#1)(2008-10#1)
assay based on##12##3##(1991-12#1)(1993-11#1)(2008-10#5)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
assay based##13##2##(1990-6#1)(1991-12#1)(1993-11#1)(2008-10#5)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
assay buffer##2##2##(1990-8#1)(1995-12#1)
assay by the##2##3##(1992-10#1)(2008-12#1)
assay by##11##2##(1990-12#1)(1992-10#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
assay can be performed##2##4##(2008-11#1)(2008-4#1)
assay can be used to detect##2##6##(2008-4#2)
assay can be used to##4##5##(2008-10#1)(2008-4#2)(2008-9#1)
assay can be##14##3##(1991-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-9#1)(2010-2#1)(2010-5#1)
assay can##19##2##(1991-4#1)(1992-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#4)(2008-5#2)(2008-9#1)(2010-2#1)(2010-5#1)
assay capable of detecting##2##4##(1994-11#1)(2009-8#1)
assay condition##2##2##(1991-5#1)(1995-11#1)
assay conditions##11##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-9#2)(1993-11#1)(1993-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
assay confirmed that##2##3##(1991-12#1)(2008-8#1)
assay confirmed##3##2##(1991-12#1)(2008-8#2)
assay could be useful##2##4##(1995-12#1)(2013-1#1)
assay could be##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
assay could##4##2##(1995-12#1)(1996-5#1)(2008-10#1)(2013-1#1)
assay demonstrated that##3##3##(1992-11#1)(2008-9#1)(2010-6#1)
assay demonstrated##4##2##(1992-11#1)(2008-9#2)(2010-6#1)
assay described##5##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2010-4#1)
assay designed to test##2##4##(1991-12#1)(1992-12#1)
assay designed to##3##3##(1991-12#1)(1992-12#1)(1994-2#1)
assay detected##7##2##(2007-6#1)(2008-10#4)(2008-12#1)(2012-2#1)
assay developed##2##2##(1990-12#1)(2008-10#1)
assay development and##4##3##(2008-10#2)(2010-11#1)(2010-6#1)
assay development##6##2##(2008-10#4)(2010-11#1)(2010-6#1)
assay employing##2##2##(1995-2#1)(2008-10#1)
assay enables##5##2##(1996-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)
assay explains##2##2##(1993-12#1)(2013-8#1)
assay for DNA##2##3##(1991-5#1)(2008-1#1)
assay for anti-cancer drug##2##4##(2013-1#2)
assay for detecting##5##3##(1991-9#1)(2008-10#3)(2008-4#1)
assay for detection of##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
assay for detection##4##3##(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
assay for determination of##3##4##(1990-7#1)(2008-10#2)
assay for human##3##3##(1995-11#1)(2008-1#1)(2008-4#1)
assay for monitoring##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
assay for protein##3##3##(2008-10#2)(2010-11#1)
assay for rapid##2##3##(2008-10#1)(2010-4#1)
assay for simultaneous##2##3##(2008-4#1)(2013-8#1)
assay for the detection of##4##5##(1996-12#1)(2008-10#2)(2008-11#1)
assay for the determination of##4##5##(1990-12#2)(1993-12#1)(2008-10#1)
assay for the determination##5##4##(1990-12#2)(1993-12#1)(2008-10#2)
assay for the diagnosis of##2##5##(1990-2#1)(2007-7#1)
assay for the measurement of apoptosis##2##6##(2008-11#2)
assay for the measurement of##3##5##(1994-2#1)(2008-11#2)
assay for the quantification of##2##5##(2008-12#1)(2010-1#1)
assay for the simultaneous##2##4##(2008-10#1)(2008-12#1)
assay for the##32##3##(1990-12#2)(1990-2#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-4#2)(2009-12#1)(2010-1#1)(2012-2#1)
assay for##141##2##(1990-12#2)(1990-2#5)(1990-7#2)(1991-12#2)(1991-5#5)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#3)(1992-9#3)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-5#3)(1997-2#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#5)(2008-10#36)(2008-11#6)(2008-12#3)(2008-4#17)(2008-7#2)(2008-9#6)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#2)
assay format##4##2##(2008-10#3)(2010-11#1)
assay formats##3##2##(2008-10#3)
assay from##2##2##(1990-7#1)(2008-10#1)
assay had a##2##3##(2008-10#2)
assay had##4##2##(2007-7#1)(2008-10#2)(2011-2#1)
assay has a linearity interval between 0##2##7##(2008-10#2)
assay has a##5##3##(1991-2#1)(1992-12#1)(2008-10#3)
assay has been developed to##2##5##(1991-9#1)(2008-10#1)
assay has been developed##5##4##(1991-9#1)(2008-10#3)(2010-4#1)
assay has been##8##3##(1990-2#1)(1991-9#1)(2008-10#4)(2010-4#1)(2011-3#1)
assay has##17##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1995-8#1)(1997-4#1)(2008-10#7)(2009-12#1)(2010-4#1)(2011-3#1)
assay in a##4##3##(1990-11#1)(1991-3#1)(2008-10#1)(2010-8#1)
assay in human##3##3##(1991-6#1)(1992-9#1)(1996-2#1)
assay in order to##2##4##(1990-11#1)(1995-2#1)
assay in pharmaceutical preparations##2##4##(2008-10#2)
assay in pharmaceutical##3##3##(2008-10#3)
assay in the presence##2##4##(1993-11#1)(2011-1#1)
assay in the##8##3##(1991-5#1)(1992-10#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#2)(2011-1#1)
assay in which##3##3##(1990-12#1)(2008-10#2)
assay in##48##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
assay incorporating##2##2##(2008-10#1)(2009-6#1)
assay indicated that the##3##4##(1993-12#1)(1995-2#1)(2013-1#1)
assay indicated that##5##3##(1993-12#1)(1995-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
assay indicated##7##2##(1992-12#1)(1993-12#1)(1995-2#1)(2008-11#1)(2008-9#2)(2013-1#1)
assay indicates that##2##3##(1994-8#1)(2010-2#1)
assay involves##2##2##(2008-10#1)(2008-4#1)
assay is a##6##3##(2007-7#1)(2008-11#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
assay is based on the##7##5##(1990-12#2)(1992-9#1)(2008-10#4)
assay is based on##8##4##(1990-12#2)(1992-9#1)(2008-10#5)
assay is described##2##3##(2008-4#1)(2008-8#1)
assay is designed for##2##4##(2007-2#1)(2008-9#1)
assay is designed##3##3##(2007-2#1)(2008-9#2)
assay is performed##3##3##(2008-10#2)(2008-9#1)
assay is proposed for##2##4##(2008-10#2)
assay is sensitive##3##3##(1990-12#1)(1996-12#1)(2011-3#1)
assay is simple##3##3##(1990-12#2)(2008-4#1)
assay is the##2##3##(2008-10#1)(2008-9#1)
assay is useful for##2##4##(2008-11#1)(2008-4#1)
assay is##70##2##(1990-12#5)(1991-12#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#24)(2008-11#7)(2008-12#1)(2008-4#6)(2008-6#2)(2008-8#1)(2008-9#6)(2010-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
assay kit##2##2##(2008-10#2)
assay may be##6##3##(1990-12#1)(1997-4#1)(2008-10#4)
assay may##7##2##(1990-12#1)(1997-4#2)(2008-10#4)
assay measures the##2##3##(1992-9#1)(2008-11#1)
assay medium##4##2##(1990-12#1)(1996-5#1)(2008-10#2)
assay method for##2##3##(1993-12#1)(2008-5#1)
assay method##6##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-5#2)(2011-1#1)
assay methods for##2##3##(2008-6#1)(2012-2#1)
assay methods##5##2##(1994-12#1)(1995-2#2)(2008-6#1)(2012-2#1)
assay of AZT##2##3##(2008-10#2)
assay of Drosophila melanogaster##2##4##(1996-2#2)
assay of S-perindopril##3##3##(2008-10#3)
assay of ascorbic acid##2##4##(2008-10#2)
assay of bromazepam##2##3##(2008-10#2)
assay of cholesterol##2##3##(1993-12#1)(2008-10#1)
assay of creatinine in urine##2##5##(1992-11#2)
assay of creatinine##4##3##(1992-11#3)(2008-10#1)
assay of enzymatic##2##3##(1991-5#2)
assay of fleroxacin in##2##4##(2008-10#2)
assay of glucose##2##3##(2008-10#2)
assay of l-2-HGA##2##3##(2008-10#2)
assay of l-lactate and pyruvate in##2##6##(2008-10#2)
assay of lead in##2##4##(2008-10#2)
assay of perphenazine##5##3##(2008-10#5)
assay of promethazine hydrochloride##2##4##(2008-10#2)
assay of proteins in##2##4##(2008-10#2)
assay of proteins##5##3##(2008-10#5)
assay of the##5##3##(1995-12#1)(2008-10#2)(2008-4#1)(2010-5#1)
assay of these##3##3##(1991-5#1)(1992-3#1)(2008-8#1)
assay of various##2##3##(2008-10#2)
assay of##172##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#9)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-6#2)(1993-12#4)(1993-2#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-2#2)(1997-4#1)(2008-1#2)(2008-10#109)(2008-11#2)(2008-12#1)(2008-4#8)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)
assay offers##3##2##(1997-4#1)(2008-1#2)
assay on a##3##3##(2008-10#2)(2008-4#1)
assay on##9##2##(1992-9#1)(2008-10#4)(2008-11#2)(2008-4#1)(2013-8#1)
assay or##6##2##(1997-4#1)(1997-8#1)(2008-10#4)
assay performed##3##2##(1997-4#1)(2008-11#1)(2013-8#1)
assay performs##2##2##(2008-10#1)(2008-12#1)
assay plates##3##2##(2008-10#3)
assay procedure##7##2##(1991-5#1)(1993-9#1)(1997-4#2)(2008-10#2)(2008-11#1)
assay procedures##3##2##(1990-2#1)(1991-5#1)(2008-10#1)
assay produced##3##2##(1991-5#1)(1997-2#1)(2008-10#1)
assay protocol##2##2##(1996-12#1)(2008-4#1)
assay proved to be##2##4##(2008-10#1)(2008-11#1)
assay provides a##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
assay provides##5##2##(1990-12#1)(2008-10#2)(2008-4#1)(2013-8#1)
assay requires##2##2##(2008-10#1)(2008-9#1)
assay results##6##2##(1997-4#1)(2008-10#4)(2008-6#1)
assay revealed that##3##3##(1994-3#1)(2008-11#2)
assay revealed##7##2##(1994-3#1)(1995-12#1)(2008-11#3)(2011-1#1)(2013-8#1)
assay showed that laminin 332##2##5##(2013-8#2)
assay showed that the##6##4##(1994-8#1)(2008-8#2)(2008-9#2)(2010-6#1)
assay showed that##16##3##(1994-8#1)(1996-12#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#5)(2010-6#1)(2011-2#1)(2013-8#2)
assay showed the##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
assay showed##25##2##(1994-8#1)(1996-12#2)(2007-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#5)(2010-6#1)(2011-2#1)(2013-8#6)
assay shows##2##2##(1992-9#1)(2008-7#1)
assay suggested that the##2##4##(1993-11#1)(2008-9#1)
assay suggested that##3##3##(1993-11#1)(2008-9#1)(2011-3#1)
assay suitable for##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
assay system for##3##3##(1990-12#1)(1990-8#1)(1992-12#1)
assay system to##2##3##(1990-12#1)(2008-4#1)
assay system was##2##3##(1991-2#1)(2008-11#1)
assay system##22##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-11#1)(2008-10#4)(2008-11#3)(2008-4#1)
assay systems##11##2##(1990-5#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)
assay targeting##2##2##(2008-10#1)(2013-1#1)
assay techniques##2##2##(2008-10#2)
assay technologies##2##2##(2008-4#1)(2009-6#1)
assay technology##2##2##(2013-1#2)
assay that can##2##3##(1991-9#1)(2008-1#1)
assay that measures##2##3##(1995-3#1)(2008-10#1)
assay that##15##2##(1991-9#1)(1995-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2009-10#1)(2010-12#1)(2013-1#1)
assay the##9##2##(1995-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2010-2#1)
assay time of##2##3##(2008-10#1)(2010-5#1)
assay time##7##2##(1996-12#1)(2008-10#4)(2010-5#2)
assay to be##3##3##(1995-12#1)(2008-2#1)(2012-3#1)
assay to detect##8##3##(1991-5#1)(1992-12#1)(1996-11#1)(1996-5#1)(1996-6#1)(2008-10#2)(2011-2#1)
assay to determine##5##3##(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
assay to identify##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
assay to measure##2##3##(2008-12#1)(2008-4#1)
assay to quantify##3##3##(1996-12#1)(2008-10#2)
assay to study the##2##4##(2008-4#1)(2008-7#1)
assay to study##3##3##(1995-2#1)(2008-4#1)(2008-7#1)
assay to##39##2##(1990-12#1)(1991-5#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-7#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#7)(2008-7#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
assay used in this##2##4##(2010-4#2)
assay used in##4##3##(1995-12#1)(2008-4#1)(2010-4#2)
assay used##8##2##(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#2)
assay useful for##2##3##(1996-5#1)(2008-4#1)
assay using a##4##3##(1996-11#1)(2008-10#3)
assay using the##7##3##(1994-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2009-10#1)
assay using##45##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)
assay utilizes a##2##3##(2008-10#1)(2008-12#1)
assay utilizes##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
assay utilizing##2##2##(1990-12#1)(2008-10#1)
assay values##2##2##(2008-10#1)(2010-11#1)
assay was 1##2##3##(2008-10#2)
assay was a##2##3##(2008-10#2)
assay was able to detect##2##5##(2012-2#1)(2013-1#1)
assay was able to##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
assay was also used to##2##5##(2008-10#1)(2008-5#1)
assay was also used##3##4##(2008-10#2)(2008-5#1)
assay was also##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
assay was applied to##2##4##(1991-12#1)(2008-10#1)
assay was carried out##2##4##(1992-12#1)(2008-8#1)
assay was developed for the##2##5##(1990-12#1)(2008-10#1)
assay was developed to simultaneously##3##5##(2008-10#1)(2008-12#1)(2013-8#1)
assay was developed to##6##4##(2008-10#4)(2008-12#1)(2013-8#1)
assay was developed using##2##4##(2008-10#1)(2008-11#1)
assay was developed##13##3##(1990-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2013-8#1)
assay was done to##2##4##(2008-5#1)(2008-9#1)
assay was found to##2##4##(2008-10#2)
assay was highly specific and sensitive##2##6##(1991-11#1)(2008-10#1)
assay was not##2##3##(1995-2#1)(2008-10#1)
assay was performed on##2##4##(1997-6#1)(2008-10#1)
assay was performed##9##3##(1990-12#1)(1991-11#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2012-3#2)(2013-1#1)
assay was used to determine##2##5##(1993-8#1)(2008-10#1)
assay was used to measure##3##5##(1990-2#1)(1992-3#1)(2011-1#1)
assay was used to##11##4##(1990-2#1)(1992-3#1)(1993-8#1)(1997-4#1)(1997-6#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-8#1)
assay was used##12##3##(1990-2#1)(1992-3#1)(1993-8#1)(1997-4#1)(1997-6#1)(2008-10#3)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
assay was##90##2##(1990-12#4)(1990-2#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-6#2)(2008-10#36)(2008-11#4)(2008-12#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
assay we have##2##3##(1992-12#1)(1992-6#1)
assay we##4##2##(1992-12#1)(1992-6#1)(2008-10#1)(2008-5#1)
assay were compared##2##3##(2008-10#1)(2008-5#1)
assay were determined##2##3##(1990-9#1)(2008-10#1)
assay were evaluated##2##3##(2008-10#1)(2013-8#1)
assay were##13##2##(1990-9#1)(1991-5#1)(2008-10#7)(2008-5#2)(2008-9#1)(2013-8#1)
assay where the##2##3##(1990-2#1)(1994-12#1)
assay which can##2##3##(1997-6#1)(2008-11#1)
assay which##5##2##(1992-9#1)(1993-2#1)(1996-5#1)(1997-6#1)(2008-11#1)
assay will be##2##3##(2008-10#1)(2008-11#1)
assay will##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
assay with a##7##3##(1992-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-7#1)
assay with an##2##3##(2008-10#1)(2013-1#1)
assay with the##2##3##(1997-4#1)(2010-12#1)
assay with##22##2##(1992-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
assay yielded##3##2##(1995-2#1)(1996-2#1)(2008-5#1)
assay##1787##1##(1990-10#1)(1990-11#4)(1990-12#40)(1990-2#18)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#2)(1991-11#5)(1991-12#21)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#27)(1991-6#1)(1991-8#1)(1991-9#9)(1992-10#5)(1992-11#11)(1992-12#11)(1992-2#3)(1992-3#9)(1992-5#4)(1992-6#15)(1992-8#2)(1992-9#16)(1993-1#1)(1993-11#5)(1993-12#17)(1993-2#7)(1993-3#4)(1993-6#3)(1993-8#11)(1993-9#9)(1994-11#7)(1994-12#6)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#8)(1994-9#3)(1995-11#9)(1995-12#11)(1995-2#23)(1995-3#12)(1995-5#3)(1995-6#3)(1995-8#8)(1995-9#2)(1996-11#4)(1996-12#23)(1996-2#10)(1996-3#1)(1996-5#15)(1996-6#1)(1996-9#1)(1997-2#6)(1997-3#3)(1997-4#49)(1997-6#5)(1997-7#7)(1997-8#2)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#7)(2008-1#23)(2008-10#608)(2008-11#91)(2008-12#21)(2008-2#3)(2008-3#1)(2008-4#105)(2008-5#36)(2008-6#13)(2008-7#18)(2008-8#16)(2008-9#54)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#6)(2009-8#3)(2009-9#4)(2010-1#2)(2010-11#8)(2010-12#6)(2010-2#11)(2010-3#1)(2010-4#13)(2010-5#13)(2010-6#3)(2010-8#2)(2011-1#16)(2011-2#32)(2011-3#10)(2012-1#5)(2012-12#3)(2012-2#19)(2012-3#18)(2013-1#37)(2013-7#3)(2013-8#26)
assay) and the##2##3##(2008-10#1)(2008-5#1)
assay) and##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
assay)##22##1##(1991-12#1)(1993-2#1)(1993-9#1)(1994-5#2)(1997-4#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#2)
assayed against##3##2##(2007-11#1)(2008-11#1)(2012-12#1)
assayed as##2##2##(2008-10#2)
assayed at the##2##3##(1994-8#1)(2010-2#1)
assayed at##7##2##(1990-11#1)(1990-7#2)(1993-3#1)(1994-11#1)(1994-8#1)(2010-2#1)
assayed by ELISA##3##3##(1992-11#1)(1992-6#1)(2008-5#1)
assayed by PCR##2##3##(2008-10#1)(2008-5#1)
assayed by the##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
assayed by##27##2##(1991-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-5#1)
assayed for their##5##3##(1990-2#1)(1992-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
assayed for##32##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#14)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
assayed in the##6##3##(1990-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-6#1)(2008-10#1)
assayed in vitro##2##3##(1991-10#1)(1995-11#1)
assayed in##23##2##(1990-10#1)(1990-12#2)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-11#2)(1995-2#2)(1995-6#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
assayed on##5##2##(2007-11#2)(2008-10#2)(2008-7#1)
assayed the##6##2##(1991-12#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
assayed using##7##2##(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
assayed with##9##2##(1990-12#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)
assayed##164##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#5)(1990-7#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-11#4)(2007-2#2)(2008-10#54)(2008-11#5)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)
assaying antibody##3##2##(2008-4#3)
assaying for##3##2##(2008-4#1)(2008-8#1)(2010-5#1)
assaying the##2##2##(1993-8#1)(2008-10#1)
assaying##25##1##(1991-5#2)(1992-2#1)(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#5)(2008-2#1)(2008-4#11)(2008-8#1)(2010-5#1)
assays (ELISAs)##2##2##(2008-10#2)
assays able to##2##3##(1992-9#1)(2008-1#1)
assays aiming##2##2##(2008-5#1)(2010-11#1)
assays also##2##2##(2008-10#2)
assays and##33##2##(1990-5#1)(1991-12#1)(1992-12#1)(1995-3#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-4#2)(2008-7#2)(2009-12#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)
assays are also##2##3##(2008-1#1)(2008-4#1)
assays are described for##2##4##(1991-5#1)(2008-9#1)
assays are described##3##3##(1991-5#1)(2008-4#1)(2008-9#1)
assays are most##2##3##(2007-12#1)(2008-1#1)
assays are not##3##3##(2008-10#2)(2008-4#1)
assays are used for##2##4##(2008-1#1)(2008-9#1)
assays are used to measure the##2##6##(2008-1#1)(2008-9#1)
assays are used##4##3##(2008-1#2)(2008-9#2)
assays are##34##2##(1991-5#1)(2007-12#1)(2008-1#4)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#8)(2008-5#1)(2008-9#6)
assays as well as##2##4##(2008-10#1)(2008-8#1)
assays as##5##2##(2008-10#2)(2008-8#1)(2013-1#2)
assays at concentrations##2##3##(2008-10#1)(2008-9#1)
assays at the##2##3##(2008-1#1)(2009-6#1)
assays at##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-11#1)
assays based on the##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
assays based on##6##3##(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)
assays based##7##2##(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
assays but##3##2##(1993-12#1)(2008-10#1)(2009-6#1)
assays by##2##2##(1990-12#1)(2008-10#1)
assays can be performed##3##4##(2008-10#2)(2008-9#1)
assays can be##7##3##(1992-3#1)(2008-1#3)(2008-10#2)(2008-9#1)
assays can##9##2##(1992-3#1)(1994-12#1)(2008-1#3)(2008-10#2)(2008-4#1)(2008-9#1)
assays could be##2##3##(2008-10#1)(2011-2#1)
assays could##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
assays demonstrate that the##2##4##(1995-2#1)(2008-9#1)
assays demonstrate##3##2##(1995-2#1)(1996-5#1)(2008-9#1)
assays demonstrated the##3##3##(1992-11#1)(2008-4#1)(2011-2#1)
assays demonstrated##6##2##(1992-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)
assays described##2##2##(2008-10#1)(2008-9#1)
assays designed##2##2##(2008-10#2)
assays developed##3##2##(2008-10#2)(2008-8#1)
assays enable##2##2##(2008-10#1)(2008-7#1)
assays failed to detect##2##4##(1997-3#1)(2008-10#1)
assays failed to##3##3##(1997-3#1)(2008-10#2)
assays for a##2##3##(1997-2#1)(2008-10#1)
assays for both##2##3##(1993-12#1)(2008-3#1)
assays for monitoring##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
assays for rapid detection of##2##5##(2008-10#1)(2012-2#1)
assays for rapid##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
assays for the detection of##3##5##(2008-10#2)(2011-1#1)
assays for the##11##3##(1990-2#1)(1993-12#1)(1995-8#1)(2008-10#4)(2008-4#1)(2011-1#2)(2011-2#1)
assays for##52##2##(1990-2#1)(1991-5#1)(1992-6#1)(1993-12#2)(1995-11#1)(1995-8#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#6)(2008-7#1)(2008-9#4)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
assays from##4##2##(1997-3#1)(2008-10#1)(2009-12#1)(2011-2#1)
assays had##2##2##(2008-10#2)
assays have been developed##2##4##(2008-10#2)
assays have been##4##3##(2008-10#2)(2008-4#1)(2009-6#1)
assays have##12##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#2)(2010-7#1)
assays in the##4##3##(1990-8#1)(1997-2#1)(2008-1#1)(2008-10#1)
assays in which##2##3##(2008-10#1)(2008-4#1)
assays in##25##2##(1990-12#1)(1990-8#1)(1991-5#1)(1993-11#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
assays include##2##2##(2008-1#1)(2008-10#1)
assays indicated that##4##3##(1995-2#1)(2008-5#1)(2008-9#1)(2010-4#1)
assays indicated##6##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)
assays is##6##2##(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#2)
assays it##2##2##(1992-9#1)(2008-6#1)
assays may##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
assays measure##2##2##(2008-10#1)(2008-4#1)
assays of##44##2##(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-6#2)(2007-11#1)(2008-1#1)(2008-10#10)(2008-4#4)(2008-9#5)(2009-12#1)(2010-11#2)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
assays on##11##2##(1992-6#1)(1994-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
assays or##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
assays performed##2##2##(1995-6#1)(2008-10#1)
assays provide a##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
assays provide##7##2##(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#2)
assays revealed that the##2##4##(2007-12#1)(2008-4#1)
assays revealed that##3##3##(1992-2#1)(2007-12#1)(2008-4#1)
assays revealed the##2##3##(2008-10#2)
assays revealed##6##2##(1992-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2013-1#1)
assays showed that##5##3##(1993-9#1)(1994-11#1)(1995-8#1)(1996-12#1)(2009-9#1)
assays showed##11##2##(1993-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-9#1)(2013-1#1)
assays since they##2##3##(2008-10#1)(2008-4#1)
assays such as##4##3##(1995-5#1)(2007-2#1)(2008-10#1)(2008-5#1)
assays than##2##2##(2008-10#1)(2008-8#1)
assays that allow##2##3##(2008-1#1)(2008-4#1)
assays that can##2##3##(2008-10#1)(2008-4#1)
assays that measure##2##3##(2008-4#1)(2008-9#1)
assays that##19##2##(1993-8#1)(1995-8#1)(2008-1#1)(2008-10#7)(2008-4#7)(2008-9#1)(2010-4#1)
assays to detect##3##3##(2008-10#2)(2008-4#1)
assays to measure##3##3##(2008-10#2)(2008-8#1)
assays to quantitate##2##3##(2008-4#1)(2008-9#1)
assays to##22##2##(1995-2#1)(2008-10#9)(2008-11#2)(2008-4#3)(2008-8#3)(2008-9#2)(2010-5#1)(2013-1#1)
assays used for##2##3##(2008-10#1)(2013-1#1)
assays used to analyze##2##4##(2008-9#2)
assays used to##3##3##(2008-4#1)(2008-9#2)
assays used##6##2##(1995-5#1)(2008-10#1)(2008-4#1)(2008-9#2)(2013-1#1)
assays using a##2##3##(1995-6#1)(2008-9#1)
assays using##17##2##(1993-3#1)(1995-6#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#2)(2011-1#1)(2012-2#1)
assays was evaluated##3##3##(2007-7#1)(2008-10#2)
assays was##10##2##(1994-11#1)(1994-8#1)(2007-7#1)(2008-10#4)(2011-2#1)(2012-2#1)(2013-1#1)
assays we found that##2##4##(1995-2#1)(2012-2#1)
assays we##4##2##(1995-2#1)(2008-12#1)(2012-2#1)(2012-3#1)
assays were also##3##3##(2008-10#3)
assays were carried out##2##4##(2008-10#2)
assays were conducted##2##3##(2008-10#2)
assays were developed to##2##4##(2008-10#2)
assays were developed##6##3##(2008-10#5)(2012-3#1)
assays were employed##2##3##(1997-7#1)(2008-10#1)
assays were performed using##2##4##(1995-12#1)(2008-10#1)
assays were performed with##2##4##(1995-2#1)(1997-7#1)
assays were performed##9##3##(1991-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-2#1)(2008-10#2)(2011-2#1)
assays were used to investigate the##3##6##(2008-10#1)(2009-5#1)(2011-2#1)
assays were used to##7##4##(2008-10#4)(2008-4#1)(2009-5#1)(2011-2#1)
assays were used##8##3##(2008-10#4)(2008-4#1)(2009-5#1)(2010-5#1)(2011-2#1)
assays were##50##2##(1991-12#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-7#2)(2007-2#1)(2008-10#27)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)
assays which##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
assays will##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
assays with a##2##3##(1994-6#1)(2008-10#1)
assays with the##2##3##(1993-6#1)(2008-10#1)
assays with##17##2##(1990-12#1)(1992-8#1)(1993-6#1)(1994-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2012-3#1)
assays##856##1##(1990-11#1)(1990-12#6)(1990-2#1)(1990-5#4)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-5#4)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#11)(1995-3#5)(1995-5#8)(1995-6#10)(1995-8#4)(1995-9#3)(1996-12#6)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#5)(1997-3#3)(1997-4#5)(1997-6#2)(1997-7#5)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-7#2)(2008-1#23)(2008-10#294)(2008-11#23)(2008-12#6)(2008-3#6)(2008-4#64)(2008-5#14)(2008-6#2)(2008-7#13)(2008-8#21)(2008-9#57)(2009-10#2)(2009-12#10)(2009-4#2)(2009-5#1)(2009-6#9)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#10)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#4)(2011-1#12)(2011-2#19)(2012-1#1)(2012-12#8)(2012-2#23)(2012-3#6)(2012-4#1)(2013-1#17)(2013-8#2)
assemblage of species##2##3##(2008-9#1)(2011-2#1)
assemblage of##7##2##(1990-8#1)(2007-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
assemblage##21##1##(1990-8#1)(2007-11#1)(2007-12#1)(2008-8#2)(2008-9#5)(2010-8#3)(2011-1#2)(2011-2#1)(2012-2#5)
assemblages in the##2##3##(1990-8#1)(2007-12#1)
assemblages of##5##2##(1990-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
assemblages##11##1##(1990-8#2)(2007-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)
assemble a laboratory population##2##4##(2008-10#2)
assemble a##5##2##(1993-8#1)(2008-10#2)(2008-9#1)(2012-3#1)
assemble and##3##2##(2008-1#1)(2008-10#1)(2009-11#1)
assemble into##5##2##(1994-3#1)(1994-8#1)(2008-8#2)(2013-8#1)
assemble onto##2##2##(1995-2#1)(2012-2#1)
assemble their##2##2##(2008-7#1)(2009-7#1)
assemble to##2##2##(2007-12#1)(2009-2#1)
assemble##31##1##(1993-8#1)(1994-3#2)(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#2)(2009-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
assembled and##2##2##(2008-8#1)(2013-1#1)
assembled as a##2##3##(2008-3#1)(2012-12#1)
assembled as##3##2##(2008-3#1)(2008-4#1)(2012-12#1)
assembled by##4##2##(2007-11#1)(2008-10#3)
assembled from##2##2##(1992-5#1)(1996-6#1)
assembled in a##3##3##(2008-10#2)(2008-3#1)
assembled in vitro##4##3##(1993-8#1)(2008-2#1)(2008-5#1)(2008-8#1)
assembled in##13##2##(1990-2#1)(1993-6#1)(1993-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
assembled into a##2##3##(2009-12#1)(2011-1#1)
assembled into##10##2##(1993-8#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-2#1)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#1)
assembled on a##3##3##(2008-10#1)(2008-3#2)
assembled on the##2##3##(2008-10#2)
assembled on##8##2##(1994-12#1)(1997-3#1)(2008-10#4)(2008-3#2)
assembled onto##2##2##(1995-2#1)(2008-10#1)
assembled sequences##2##2##(2008-4#1)(2010-4#1)
assembled to a##2##3##(1996-2#1)(2008-2#1)
assembled to##9##2##(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-12#1)(2012-2#1)
assembled using##2##2##(2008-4#1)(2010-4#1)
assembled with##10##2##(1991-2#1)(1997-4#1)(1997-9#2)(2008-10#3)(2008-4#1)(2008-7#1)(2009-11#1)
assembled##109##1##(1990-11#1)(1990-2#2)(1991-2#1)(1992-5#1)(1993-6#2)(1993-8#4)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#3)(1997-3#1)(1997-4#1)(1997-9#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#28)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#2)(2010-4#6)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
assembles into a##2##3##(1994-3#1)(2010-10#1)
assembles##4##1##(1991-5#1)(1994-3#1)(2008-3#1)(2010-10#1)
assemblies are##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
assemblies in##3##2##(2008-1#1)(2011-1#1)(2012-2#1)
assemblies of##3##2##(1990-2#1)(2008-11#1)(2009-11#1)
assemblies on##2##2##(2008-10#1)(2008-7#1)
assemblies were##3##2##(2008-10#3)
assemblies with##2##2##(2008-7#2)
assemblies##46##1##(1990-2#1)(1992-9#1)(1996-2#2)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#3)(2008-7#8)(2009-11#2)(2009-8#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)
assembling and##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
assembling the##2##2##(2008-9#1)(2010-8#1)
assembling##18##1##(1993-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-8#2)(2010-8#1)
assembly and##26##2##(1990-5#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-8#2)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-3#2)
assembly are##2##2##(1993-11#1)(2008-10#1)
assembly at##2##2##(2008-1#2)
assembly by##4##2##(1996-5#1)(2008-10#1)(2008-4#1)(2010-11#1)
assembly composed##2##2##(2011-2#2)
assembly dynamics##2##2##(2008-1#1)(2009-2#1)
assembly errors##2##2##(2011-2#2)
assembly for##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
assembly from##4##2##(1991-5#1)(2008-3#1)(2008-6#1)(2011-2#1)
assembly in vitro##3##3##(2008-8#3)
assembly in##11##2##(1990-2#1)(1990-8#1)(1997-2#1)(2008-10#1)(2008-8#5)(2010-12#1)(2011-2#1)
assembly is the##2##3##(1995-2#1)(2008-4#1)
assembly is##8##2##(1995-2#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)
assembly of carbon nanotubes##2##4##(2009-11#2)
assembly of covalently anchored phospholipid supported membranes##2##7##(1994-12#2)
assembly of nuclear lamina##2##4##(2008-8#2)
assembly of nuclear##4##3##(2008-8#4)
assembly of nucleosomes##2##3##(2008-8#2)
assembly of the##14##3##(1990-8#1)(1991-10#1)(1993-12#1)(1993-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2012-2#1)(2013-1#1)
assembly of this##2##3##(1990-8#1)(2012-3#1)
assembly of##67##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-10#1)(1991-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#2)(1997-2#2)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-4#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-11#4)(2009-12#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
assembly on the##2##3##(2008-10#2)
assembly on##5##2##(1995-6#1)(2008-10#2)(2008-4#2)
assembly or function##2##3##(1994-11#1)(1997-3#1)
assembly process is##2##3##(2010-4#1)(2011-2#1)
assembly process##10##2##(1991-5#2)(1994-11#1)(1994-2#2)(1997-4#2)(2009-11#1)(2010-4#1)(2011-2#1)
assembly processes##2##2##(1994-11#1)(2008-8#1)
assembly system##3##2##(2008-2#2)(2008-8#1)
assembly that##2##2##(2008-10#1)(2011-2#1)
assembly through a##3##3##(2012-12#3)
assembly through##4##2##(2012-12#4)
assembly which##2##2##(1990-8#1)(2012-2#1)
assembly with the##2##3##(1995-12#1)(2008-10#1)
assembly without##2##2##(2008-6#1)(2008-7#1)
assembly##302##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#8)(1991-10#1)(1991-5#7)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#6)(1995-8#5)(1995-9#1)(1996-5#1)(1997-2#12)(1997-3#2)(1997-4#5)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#10)(2008-10#46)(2008-11#6)(2008-2#8)(2008-3#7)(2008-4#14)(2008-6#5)(2008-7#19)(2008-8#23)(2008-9#6)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#1)(2009-7#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#13)(2011-3#3)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#5)(2013-1#4)(2013-8#1)
assembly/disassembly##2##1##(2008-1#1)(2012-12#1)
assert##4##1##(1992-2#1)(1994-1#1)(1997-5#1)(2008-11#1)
asserted that##3##2##(2007-12#1)(2009-9#1)(2013-1#1)
asserted##5##1##(1990-3#1)(1993-1#1)(2007-12#1)(2009-9#1)(2013-1#1)
assertion that##6##2##(1993-12#1)(1994-6#1)(1995-12#1)(2007-12#1)(2009-9#1)(2013-1#1)
assertion##12##1##(1993-12#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
assertions##4##1##(2008-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
assertive##4##1##(2008-11#3)(2008-12#1)
assertiveness##3##1##(2008-11#3)
asserts that the##2##3##(2008-11#1)(2008-2#1)
asserts that##5##2##(1991-3#1)(1993-3#1)(1995-2#1)(2008-11#1)(2008-2#1)
asserts##7##1##(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-2#1)(2008-11#1)(2008-2#1)
asses the##4##2##(2007-11#2)(2008-12#1)(2008-7#1)
asses##8##1##(1996-12#1)(2007-11#3)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
assesed by##2##2##(2007-11#2)
assesed##8##1##(2007-11#7)(2008-7#1)
assesment of##4##2##(2007-11#2)(2007-8#2)
assesment##6##1##(1994-7#1)(2007-11#2)(2007-8#2)(2013-1#1)
assess a##6##2##(1996-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)
assess and compare##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
assess and##9##2##(1992-3#1)(1996-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
assess cell##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
assess for##4##2##(2007-10#1)(2009-7#1)(2012-12#1)(2012-3#1)
assess genetic##4##2##(2008-10#4)
assess how##6##2##(1997-2#1)(2010-6#1)(2010-8#3)(2011-2#1)
assess in##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
assess its##13##2##(1991-2#1)(1992-12#1)(1992-2#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)
assess learning##2##2##(2008-11#1)(2008-12#1)
assess long-term##2##2##(2006-10#1)(2008-11#1)
assess myocardial##2##2##(1997-8#1)(2008-7#1)
assess risk##4##2##(1996-12#1)(2008-12#1)(2008-4#1)(2009-7#1)
assess risks##2##2##(2008-11#2)
assess severity of##4##3##(1997-1#1)(2008-9#2)(2010-8#1)
assess soils and##2##3##(2008-10#2)
assess the ability##6##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
assess the accuracy of the technique##2##6##(2008-2#1)(2008-3#1)
assess the accuracy of the##5##5##(1992-2#1)(2008-10#1)(2008-2#2)(2008-3#1)
assess the accuracy of##6##4##(1992-2#1)(1994-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
assess the accuracy##7##3##(1992-2#1)(1994-3#1)(2008-10#2)(2008-2#2)(2008-3#1)
assess the advantages and##2##4##(2008-10#1)(2008-3#1)
assess the applicability of##3##4##(1995-1#1)(1995-11#1)(2008-3#1)
assess the consequences of##2##4##(1990-2#1)(2008-10#1)
assess the contribution of##3##4##(2008-10#1)(2013-1#2)
assess the degree of##9##4##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
assess the degree##10##3##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-2#1)
assess the effect of##17##4##(1994-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
assess the effect##18##3##(1994-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
assess the effectiveness of##11##4##(1990-2#1)(1993-1#1)(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
assess the effects of##14##4##(1990-12#1)(1990-8#1)(1991-5#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
assess the effects##15##3##(1990-12#1)(1990-8#1)(1991-5#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
assess the efficacy of a##3##5##(2009-2#1)(2012-3#1)(2013-1#1)
assess the efficacy of the##3##5##(2008-1#1)(2010-4#1)(2013-1#1)
assess the efficacy of##9##4##(1992-9#1)(2008-1#1)(2009-2#1)(2010-4#1)(2012-3#2)(2013-1#3)
assess the efficacy##12##3##(1992-9#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-4#1)(2012-3#2)(2013-1#3)
assess the extent and##2##4##(1993-12#1)(2009-5#1)
assess the extent to which##2##5##(1995-3#1)(2008-8#1)
assess the extent##7##3##(1992-6#1)(1993-12#1)(1995-3#1)(2008-8#2)(2009-5#1)(2013-1#1)
assess the function of##2##4##(1994-3#1)(2008-4#1)
assess the functional##4##3##(1995-2#1)(1996-5#1)(2008-10#1)(2008-9#1)
assess the genetic diversity##3##4##(2008-10#2)(2008-7#1)
assess the genetic##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
assess the health##2##3##(1994-9#1)(2013-8#1)
assess the impact of a##2##5##(1992-1#1)(2008-8#1)
assess the impact of##20##4##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
assess the impact##22##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
assess the involvement of##2##4##(1991-9#1)(2008-10#1)
assess the level of##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
assess the long-term##3##3##(1996-7#1)(2011-2#1)(2012-3#1)
assess the mechanisms##2##3##(2008-9#1)(2009-8#1)
assess the occurrence of##2##4##(1997-4#1)(2011-2#1)
assess the perceived##3##3##(1994-2#2)(2013-8#1)
assess the potential benefit of this##2##6##(2007-8#1)(2009-11#1)
assess the potential of##3##4##(2008-10#1)(2008-3#1)(2012-1#1)
assess the potential##15##3##(2007-10#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-1#1)(2012-3#1)
assess the predictive value of##3##5##(2011-1#1)(2012-12#1)(2013-1#1)
assess the predictive##4##3##(2011-1#1)(2012-12#2)(2013-1#1)
assess the presence of##3##4##(2008-2#1)(2008-5#1)(2010-1#1)
assess the presence##5##3##(2008-2#1)(2008-5#2)(2010-1#1)(2012-2#1)
assess the prevalence##10##3##(2007-7#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
assess the prognostic value##2##4##(2008-11#1)(2012-12#1)
assess the quality of the##2##5##(1996-9#1)(2008-3#1)
assess the quality of##8##4##(1991-3#1)(1993-6#1)(1996-9#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
assess the relative##13##3##(1993-2#1)(1995-12#1)(1996-2#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2012-3#1)
assess the reliability of##2##4##(1992-12#1)(2008-10#1)
assess the reproducibility of##2##4##(2008-10#1)(2009-8#1)
assess the risk of##8##4##(1996-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
assess the risk##9##3##(1996-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
assess the role of##7##4##(1990-7#1)(1990-8#1)(1995-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2011-1#1)
assess the safety##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2009-12#1)
assess the severity##3##3##(1995-11#1)(2011-2#1)(2013-1#1)
assess the technical##3##3##(1996-1#1)(2013-8#2)
assess the usefulness of##4##4##(1990-5#1)(1991-3#1)(1996-3#1)(2013-1#1)
assess the usefulness##5##3##(1990-5#1)(1991-3#1)(1996-3#1)(2011-2#1)(2013-1#1)
assess the##480##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#3)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#72)(2008-11#14)(2008-12#8)(2008-2#10)(2008-3#16)(2008-4#11)(2008-5#28)(2008-6#5)(2008-7#14)(2008-8#13)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#22)(2011-3#1)(2012-1#5)(2012-12#9)(2012-2#9)(2012-3#20)(2012-8#1)(2013-1#28)(2013-7#5)(2013-8#14)
assess their##25##2##(1992-6#1)(1992-8#1)(1993-12#2)(1993-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
assess these##3##2##(1995-9#1)(1996-3#1)(2011-1#1)
assess this##6##2##(2007-10#1)(2008-11#2)(2008-8#1)(2013-7#2)
assess tissue##2##2##(2011-2#1)(2013-1#1)
assess total##2##2##(2008-12#1)(2010-5#1)
assess various##2##2##(2008-10#1)(2008-12#1)
assess whether the##7##3##(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)
assess whether##31##2##(1991-6#1)(1993-12#1)(1994-11#1)(1994-3#2)(1995-11#1)(1997-4#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
assess##912##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#6)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#11)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#8)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#6)(1995-12#5)(1995-2#5)(1995-3#7)(1995-5#2)(1995-9#1)(1996-1#4)(1996-12#6)(1996-2#8)(1996-3#6)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#7)(1997-7#2)(1997-8#4)(2006-10#4)(2007-10#11)(2007-11#9)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#8)(2008-10#127)(2008-11#39)(2008-12#20)(2008-2#12)(2008-3#21)(2008-4#20)(2008-5#44)(2008-6#9)(2008-7#33)(2008-8#28)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#15)(2011-2#46)(2011-3#1)(2011-8#1)(2012-1#8)(2012-12#19)(2012-2#21)(2012-3#28)(2012-8#1)(2013-1#56)(2013-7#7)(2013-8#22)
assessable patients##2##2##(1997-6#1)(2008-5#1)
assessable##5##1##(1991-7#1)(1997-6#1)(2007-2#1)(2008-5#1)(2010-11#1)
assessed 8##2##2##(1995-12#1)(2008-10#1)
assessed a##2##2##(1993-12#1)(2008-8#1)
assessed according to##3##3##(1993-8#1)(2012-3#1)(2013-8#1)
assessed after##7##2##(1990-12#1)(1991-5#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
assessed against##2##2##(1996-12#1)(2011-2#1)
assessed and##11##2##(1992-1#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2011-2#1)(2012-12#1)
assessed as the##2##3##(2008-7#1)(2009-11#1)
assessed as##13##2##(1995-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#2)
assessed at a##3##3##(2008-12#1)(2008-3#1)(2008-6#1)
assessed at the##2##3##(1995-8#1)(2008-10#1)
assessed at various##2##3##(2008-10#1)(2008-5#1)
assessed at##21##2##(1990-9#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
assessed before and after the##2##5##(2007-9#1)(2010-12#1)
assessed before##4##2##(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#1)
assessed both##2##2##(1996-12#1)(1996-6#1)
assessed by ELISA##2##3##(2008-10#1)(2012-3#1)
assessed by a##5##3##(1992-12#1)(1996-5#1)(1996-7#1)(2008-10#1)(2013-1#1)
assessed by analyzing##2##3##(1992-2#1)(1997-2#1)
assessed by calculating##2##3##(2008-10#1)(2008-5#1)
assessed by clinical##2##3##(2008-11#1)(2013-1#1)
assessed by comparing the##3##4##(1991-6#1)(2008-10#2)
assessed by comparing##7##3##(1991-6#1)(1994-1#1)(1997-3#1)(2008-10#3)(2010-4#1)
assessed by evaluating##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
assessed by fibrin##2##3##(1994-5#1)(1997-4#1)
assessed by flow cytometry##3##4##(2008-4#1)(2012-4#1)(2013-7#1)
assessed by fluorescent##2##3##(2008-10#2)
assessed by histological##2##3##(1992-9#1)(2008-11#1)
assessed by means of the##2##5##(1990-11#1)(2008-7#1)
assessed by means of##5##4##(1990-11#1)(2007-11#1)(2008-7#1)(2009-1#1)(2010-6#1)
assessed by measuring the##5##4##(1990-5#1)(1995-3#1)(2008-3#1)(2008-5#1)(2009-12#1)
assessed by measuring##8##3##(1990-5#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-2#1)
assessed by quantitative##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
assessed by studying##2##3##(1990-12#1)(2011-2#1)
assessed by subjective##2##3##(2007-12#1)(2012-1#1)
assessed by the optical##2##4##(2013-1#2)
assessed by the##39##3##(1990-10#1)(1990-11#1)(1990-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-3#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#2)(2009-3#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#5)
assessed by use of##7##4##(1995-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
assessed by##221##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-3#1)(1994-5#2)(1994-6#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#4)(1996-3#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#45)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#7)
assessed changes in##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
assessed during##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
assessed either by##3##3##(1992-1#1)(1993-11#1)(1995-6#1)
assessed every##2##2##(2013-1#1)(2013-8#1)
assessed following##4##2##(2008-10#1)(2010-6#1)(2013-7#1)(2013-8#1)
assessed for a##2##3##(1993-12#1)(2008-3#1)
assessed for the presence##2##4##(2008-10#1)(2012-3#1)
assessed for the##5##3##(2007-7#1)(2008-10#3)(2012-3#1)
assessed for their ability to act##2##6##(1990-11#1)(2008-10#1)
assessed for their ability to##3##5##(1990-11#1)(1995-11#1)(2008-10#1)
assessed for their##7##3##(1990-11#1)(1995-11#1)(2008-10#4)(2012-2#1)
assessed for##56##2##(1990-11#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)
assessed from the##4##3##(1997-4#1)(2008-10#1)(2009-11#1)(2010-7#1)
assessed from##9##2##(1996-5#1)(1997-4#1)(2008-10#3)(2009-11#1)(2010-3#1)(2010-7#1)(2011-1#1)
assessed immune function in##3##4##(2008-10#2)(2008-8#1)
assessed in 20##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
assessed in a##10##3##(1990-3#1)(1993-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2013-1#1)
assessed in an##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
assessed in relation to the##2##5##(1995-11#1)(2012-12#1)
assessed in terms of the##3##5##(1994-2#1)(2008-11#1)(2011-1#1)
assessed in terms of##9##4##(1991-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
assessed in the##10##3##(1990-8#1)(1996-2#1)(2008-10#3)(2008-5#1)(2009-11#1)(2012-12#1)(2012-5#1)(2013-1#1)
assessed in this retrospective##2##4##(2007-11#1)(2008-1#1)
assessed in this##3##3##(2007-11#1)(2008-1#1)(2008-10#1)
assessed in two##4##3##(1992-8#1)(1993-11#1)(2007-8#1)(2008-10#1)
assessed in vitro##2##3##(1992-11#1)(2008-5#1)
assessed in##103##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#4)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-4#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#2)(2013-1#3)
assessed its##3##2##(1993-3#1)(2008-10#1)(2010-12#1)
assessed knowledge of##2##3##(2007-10#1)(2012-3#1)
assessed on a##4##3##(1992-8#1)(2008-2#1)(2008-7#1)(2013-8#1)
assessed on the basis of##2##5##(2007-8#1)(2008-3#1)
assessed on the##8##3##(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)
assessed on##26##2##(1990-12#1)(1990-6#1)(1992-8#1)(1997-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
assessed over an##2##3##(2008-9#1)(2011-2#1)
assessed over##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
assessed prior to##2##3##(2008-11#1)(2013-8#1)
assessed quality of##2##3##(2008-10#1)(2008-12#1)
assessed separately##3##2##(1993-9#1)(2008-5#2)
assessed the association between##2##4##(2008-8#1)(2013-1#1)
assessed the effect of##5##4##(1992-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
assessed the effectiveness of##3##4##(2007-10#1)(2008-7#1)(2009-4#1)
assessed the effects of the##2##5##(1992-2#1)(1996-2#1)
assessed the effects of##10##4##(1992-2#1)(1993-3#1)(1996-2#1)(2007-10#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#2)
assessed the efficacy of##4##4##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
assessed the efficacy##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
assessed the impact of##2##4##(2011-2#2)
assessed the relationship between##3##4##(2007-12#1)(2008-12#1)(2011-1#1)
assessed the relationships between##2##4##(2008-10#1)(2013-1#1)
assessed the reliability##2##3##(1992-10#1)(2008-12#1)
assessed the results##2##3##(1991-3#1)(2007-8#1)
assessed the safety##2##3##(2008-7#1)(2009-5#1)
assessed the##91##2##(1990-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
assessed through##10##2##(2008-10#6)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
assessed to be##2##3##(2008-11#1)(2012-2#1)
assessed to##9##2##(1995-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
assessed under##2##2##(2008-6#1)(2008-8#1)
assessed using a modified##2##4##(2008-1#1)(2008-7#1)
assessed using a##14##3##(1994-12#1)(1995-4#1)(1997-7#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-3#2)(2012-3#1)(2013-1#2)
assessed using the##25##3##(1990-11#1)(1993-12#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
assessed using##77##2##(1990-11#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-4#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#4)
assessed via##2##2##(2009-7#1)(2009-9#1)
assessed visually##2##2##(2008-10#1)(2008-3#1)
assessed was##2##2##(2008-4#1)(2013-1#1)
assessed were##2##2##(1994-12#1)(2013-8#1)
assessed when##2##2##(2008-10#1)(2013-1#1)
assessed whether##4##2##(1994-7#1)(2008-12#1)(2010-11#1)(2013-7#1)
assessed with a##5##3##(1993-12#1)(2008-10#1)(2008-5#2)(2010-7#1)
assessed with the##12##3##(1994-2#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2012-2#2)(2013-8#2)
assessed with this##2##3##(2008-4#1)(2010-6#1)
assessed with##32##2##(1993-12#1)(1994-2#1)(1995-11#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-6#1)(2010-7#1)(2012-2#3)(2013-1#3)(2013-8#2)
assessed##1022##1##(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-6#1)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#6)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#9)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#7)(1994-3#3)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#5)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-12#12)(1996-2#5)(1996-3#5)(1996-5#6)(1996-6#1)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#9)(1997-4#7)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#5)(2006-10#3)(2006-6#2)(2007-1#1)(2007-10#11)(2007-11#10)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#6)(2008-10#196)(2008-11#30)(2008-12#21)(2008-2#11)(2008-3#37)(2008-4#8)(2008-5#40)(2008-6#14)(2008-7#41)(2008-8#17)(2008-9#24)(2009-1#2)(2009-10#6)(2009-11#7)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#7)(2010-7#7)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#38)(2012-1#10)(2012-12#9)(2012-2#21)(2012-3#27)(2012-4#2)(2012-5#3)(2012-6#1)(2013-1#52)(2013-7#7)(2013-8#28)
assesses a##2##2##(2009-3#1)(2011-2#1)
assesses how##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
assesses the effect of##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
assesses the extent to which##2##5##(1997-2#1)(2012-2#1)
assesses the role##2##3##(2009-10#1)(2009-7#1)
assesses the##30##2##(1993-3#1)(1997-2#2)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-5#1)(2012-2#2)(2013-8#9)
assesses##46##1##(1991-1#1)(1993-3#1)(1995-6#1)(1997-2#3)(1997-3#3)(1997-8#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#9)
assessing a##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
assessing and treating##2##3##(2008-8#1)(2013-1#1)
assessing and##6##2##(1990-2#1)(1996-2#1)(1997-2#1)(2008-8#1)(2009-10#1)(2013-1#1)
assessing aortic valvular insufficiency##2##4##(1994-3#2)
assessing balance##3##2##(2010-12#3)
assessing body image##2##3##(2007-12#1)(2009-5#1)
assessing cardiovascular##2##2##(2010-12#1)(2013-8#1)
assessing cell##2##2##(1997-7#1)(2013-7#1)
assessing changes in##2##3##(2008-11#1)(2012-2#1)
assessing educational outcomes##2##3##(1991-1#1)(2007-4#1)
assessing genetic##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
assessing learning and##2##3##(2008-10#1)(2008-11#1)
assessing model##2##2##(2008-7#1)(2011-1#1)
assessing pain##2##2##(1990-12#1)(2008-5#1)
assessing patients with##2##3##(2008-1#1)(2008-11#1)
assessing patients##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
assessing performance##2##2##(1997-1#1)(2008-11#1)
assessing the effect of##2##4##(2007-10#1)(2008-7#1)
assessing the effects of##7##4##(1994-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2013-1#1)
assessing the efficacy of##2##4##(2008-3#1)(2008-7#1)
assessing the impact of periodontal diseases on##2##7##(2013-1#2)
assessing the impact##3##3##(2008-2#1)(2013-1#2)
assessing the percentage of##2##4##(2008-10#1)(2008-4#1)
assessing the performance of##2##4##(1996-12#1)(2009-11#1)
assessing the potential##3##3##(1997-2#1)(2007-10#1)(2008-10#1)
assessing the practice of##2##4##(2008-11#2)
assessing the presence of##2##4##(2007-8#1)(2013-8#1)
assessing the quality of##3##4##(2007-12#1)(2010-2#1)(2010-4#1)
assessing the relationship between##2##4##(2008-7#1)(2012-1#1)
assessing the reliability##2##3##(2009-11#1)(2012-12#1)
assessing the risk of##3##4##(2007-11#1)(2008-10#2)
assessing the risk##4##3##(2007-11#1)(2007-2#1)(2008-10#2)
assessing the state of##2##4##(2010-9#1)(2013-1#1)
assessing the##107##2##(1990-3#1)(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
assessing their##3##2##(1990-11#1)(2008-11#1)(2008-9#1)
assessing these##2##2##(1995-11#1)(2008-11#1)
assessing this##2##2##(2008-11#1)(2009-5#1)
assessing whether##3##2##(2008-4#1)(2008-8#1)(2010-2#1)
assessing##303##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#2)(1991-1#4)(1991-11#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#4)(1993-12#3)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#2)(1995-3#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#2)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#29)(2008-11#22)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#11)(2008-5#12)(2008-6#1)(2008-7#18)(2008-8#5)(2008-9#8)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#10)(2011-7#1)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#6)
assessment -##2##2##(2008-11#2)
assessment activities##3##2##(1996-1#1)(1997-3#2)
assessment alone##2##2##(2008-9#1)(2010-11#1)
assessment also##2##2##(1996-12#1)(2009-9#1)
assessment and adjustment##2##3##(2008-8#2)
assessment and advice##2##3##(2011-2#2)
assessment and care##2##3##(2008-11#1)(2009-11#1)
assessment and improvement##12##3##(1993-2#4)(1993-3#1)(1996-1#1)(1996-2#3)(1997-1#2)(1997-2#1)
assessment and intervention##3##3##(2008-7#1)(2009-9#1)(2010-7#1)
assessment and management of##8##4##(2007-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#1)
assessment and management##16##3##(2007-10#1)(2007-11#1)(2008-10#1)(2009-11#1)(2009-2#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
assessment and prevention of##2##4##(1996-8#1)(2009-4#1)
assessment and quality##2##3##(1996-12#1)(2008-10#1)
assessment and the##6##3##(1992-12#1)(1993-3#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-7#1)
assessment and treatment of##5##4##(1995-3#1)(2008-10#1)(2008-6#1)(2010-9#2)
assessment and treatment##15##3##(1991-12#1)(1992-1#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-6#1)(2009-9#1)(2010-9#2)(2011-1#1)(2011-3#1)(2013-8#1)
assessment and##132##2##(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#5)(1993-3#4)(1994-1#1)(1994-11#1)(1994-3#2)(1995-3#1)(1996-1#2)(1996-12#4)(1996-2#5)(1996-8#1)(1997-1#3)(1997-2#1)(1997-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#8)(2011-3#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
assessment approach##2##2##(2008-11#2)
assessment are discussed##2##3##(1997-3#1)(2008-11#1)
assessment are outlined##2##3##(2008-10#1)(2008-11#1)
assessment are##12##2##(1992-2#1)(1994-2#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-9#1)(2010-12#1)(2011-1#2)
assessment as a##2##3##(1997-1#1)(2009-12#1)
assessment as well as##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
assessment as##10##2##(1996-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-12#1)(2012-1#1)(2013-1#1)
assessment at##7##2##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#2)
assessment based on##3##3##(2008-12#1)(2008-5#1)(2012-3#1)
assessment batteries##2##2##(1996-12#1)(2010-9#1)
assessment battery##2##2##(1996-12#1)(2008-9#1)
assessment before##4##2##(2007-8#1)(2013-8#3)
assessment by##11##2##(1997-8#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
assessment can be##2##3##(1992-3#1)(2008-5#1)
assessment can##4##2##(1992-12#1)(1992-3#1)(2008-5#1)(2008-6#1)
assessment conducted##2##2##(1991-12#1)(2008-9#1)
assessment data##6##2##(1995-2#1)(1996-2#2)(1997-1#1)(2007-9#1)(2008-10#1)
assessment during##3##2##(2012-12#1)(2013-1#2)
assessment for a##2##3##(1992-9#1)(2013-1#1)
assessment for the##5##3##(1997-3#1)(1997-6#1)(2008-10#2)(2010-9#1)
assessment for##36##2##(1992-9#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
assessment framework##3##2##(2011-1#1)(2013-1#2)
assessment from##3##2##(1994-2#1)(2008-7#1)(2008-8#1)
assessment has##3##2##(1996-3#1)(2008-11#2)
assessment have##2##2##(2008-10#1)(2008-6#1)
assessment in a##2##3##(1992-12#1)(1996-1#1)
assessment in all##2##3##(2011-2#1)(2013-8#1)
assessment in the##11##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2012-3#1)
assessment in##38##2##(1990-2#1)(1992-12#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
assessment included##3##2##(1996-7#2)(2013-1#1)
assessment information##3##2##(1992-3#1)(1994-12#1)(2009-11#1)
assessment instruments##5##2##(2008-9#1)(2010-9#2)(2011-2#1)(2012-2#1)
assessment involves##2##2##(2008-12#1)(2011-2#1)
assessment is a##3##3##(1990-2#1)(1994-2#1)(1997-3#1)
assessment is##14##2##(1990-2#1)(1992-5#1)(1994-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)
assessment made##2##2##(1994-2#1)(1997-2#1)
assessment may be##2##3##(1992-12#1)(2013-7#1)
assessment may##4##2##(1990-8#1)(1992-12#1)(1996-8#1)(2013-7#1)
assessment method##5##2##(1990-8#1)(2007-11#1)(2008-12#1)(2008-9#2)
assessment methods##5##2##(2008-10#2)(2008-11#1)(2010-11#1)(2013-7#1)
assessment model for##2##3##(2008-10#1)(2008-8#1)
assessment model##4##2##(2008-10#3)(2008-8#1)
assessment models##5##2##(2008-10#4)(2008-12#1)
assessment needs##2##2##(1996-11#1)(2008-12#1)
assessment of &quot##2##3##(1997-2#1)(2012-3#1)
assessment of CAN##2##3##(2012-2#2)
assessment of National Aluminum Company##2##5##(2012-1#2)
assessment of a patient's##2##4##(2008-7#1)(2012-1#1)
assessment of a##13##3##(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
assessment of accuracy##2##3##(2008-2#1)(2009-5#1)
assessment of acute##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
assessment of adolescent##2##3##(2008-6#1)(2011-2#1)
assessment of airway##2##3##(2008-10#1)(2010-5#1)
assessment of all##2##3##(2008-11#1)(2011-2#1)
assessment of an##3##3##(2007-7#1)(2008-12#1)(2008-3#1)
assessment of areas##2##3##(2008-10#1)(2010-12#1)
assessment of atherosclerotic plaque##2##4##(2010-9#2)
assessment of biological activity of##2##5##(2008-12#2)
assessment of biological##4##3##(2008-10#1)(2008-12#2)(2010-11#1)
assessment of body##2##3##(1996-8#1)(2008-3#1)
assessment of bone##3##3##(1993-11#1)(2008-7#1)(2009-7#1)
assessment of both the##2##4##(2008-10#1)(2008-12#1)
assessment of both##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
assessment of cardiac##4##3##(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)
assessment of chronic##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
assessment of citrus tristeza virus incidence##2##6##(2008-10#2)
assessment of clinical##4##3##(1993-9#1)(1995-2#1)(1996-2#1)(2008-11#1)
assessment of cognitive functions##2##4##(2009-10#1)(2012-12#1)
assessment of competence##2##3##(2008-11#1)(2008-8#1)
assessment of cosmetic##2##3##(2008-5#2)
assessment of current##2##3##(1996-1#1)(2008-2#1)
assessment of development##2##3##(1992-12#1)(2008-8#1)
assessment of disease severity##2##4##(2008-10#1)(2008-9#1)
assessment of disease##5##3##(1992-9#1)(2008-10#2)(2008-7#1)(2008-9#1)
assessment of efficacy##2##3##(2008-7#2)
assessment of estrogenicity##2##3##(2008-10#2)
assessment of feeding##2##3##(2008-11#2)
assessment of gene copy number##2##5##(1996-12#2)
assessment of gene##4##3##(1996-12#3)(2008-9#1)
assessment of health##3##3##(1994-12#1)(2009-12#1)(2013-8#1)
assessment of hearing##2##3##(2008-4#1)(2011-2#1)
assessment of immunogenicity##2##3##(1995-5#1)(2008-10#1)
assessment of indications for##2##4##(2007-11#2)
assessment of individual##2##3##(1993-11#1)(2013-8#1)
assessment of its##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
assessment of myocardial##4##3##(1992-5#1)(2011-2#3)
assessment of new cosmetic ingredients##2##5##(2008-5#2)
assessment of new##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
assessment of novel##2##3##(1991-6#1)(2010-6#1)
assessment of nutritional status##2##4##(2012-12#1)(2013-1#1)
assessment of opioid##2##3##(1991-1#2)
assessment of oral##2##3##(1993-1#1)(2012-1#1)
assessment of pain##3##3##(1993-12#1)(1997-8#1)(2010-6#1)
assessment of patient##3##3##(2013-1#3)
assessment of patients after##2##4##(2008-1#1)(2013-8#1)
assessment of patients with##3##4##(2007-8#1)(2008-4#2)
assessment of patients##8##3##(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2012-12#1)(2013-1#1)(2013-8#1)
assessment of patients'##2##3##(1992-5#1)(2008-3#1)
assessment of potential##3##3##(1992-3#1)(2008-10#1)(2010-12#1)
assessment of practical##2##3##(2008-11#2)
assessment of quality##2##3##(1992-9#1)(2008-4#1)
assessment of renal##2##3##(2008-1#1)(2013-1#1)
assessment of respiratory exposure to outdoor air pollutants##2##8##(1996-3#2)
assessment of risk factors for##3##5##(1992-11#1)(1995-6#1)(2011-2#1)
assessment of risk##4##3##(1992-11#1)(1995-6#1)(2008-5#1)(2011-2#1)
assessment of sexual##2##3##(1995-6#1)(2008-8#1)
assessment of skin##5##3##(2008-5#5)
assessment of surface and##2##4##(1996-12#1)(2008-9#1)
assessment of surface##4##3##(1996-12#1)(2008-3#1)(2008-9#2)
assessment of surgical##2##3##(1995-4#1)(2010-6#1)
assessment of the accuracy##2##4##(2008-2#1)(2008-8#1)
assessment of the cervical##2##4##(2007-11#1)(2010-12#1)
assessment of the effects of##3##5##(1994-5#1)(2008-10#2)
assessment of the efficacy of the##2##6##(1991-12#1)(1997-3#1)
assessment of the efficacy of##5##5##(1991-12#1)(1997-3#1)(2008-5#3)
assessment of the efficacy##6##4##(1991-12#1)(1997-3#1)(2008-5#4)
assessment of the method##2##4##(2008-10#2)
assessment of the patients##2##4##(2007-6#1)(2012-3#1)
assessment of the performance of the##3##6##(2008-2#1)(2008-5#1)(2009-8#1)
assessment of the performance of##5##5##(2008-2#1)(2008-5#3)(2009-8#1)
assessment of the risk##2##4##(2007-7#1)(2009-10#1)
assessment of the treatment##2##4##(1996-4#1)(2008-8#1)
assessment of the true##2##4##(1992-3#1)(2013-1#1)
assessment of the viability##2##4##(1992-2#1)(2008-5#1)
assessment of the##134##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#12)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
assessment of their##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
assessment of these##2##3##(2008-7#1)(2008-8#1)
assessment of this##3##3##(1991-6#1)(2008-6#1)(2011-2#1)
assessment of thyroid function in psychiatric patients##2##7##(2008-4#2)
assessment of thyroid function##4##4##(2008-4#2)(2008-6#1)(2013-1#1)
assessment of tissue##2##3##(2009-3#1)(2012-2#1)
assessment of total##3##3##(2008-10#2)(2008-12#1)
assessment of treatment outcomes##2##4##(2010-12#1)(2011-2#1)
assessment of treatment##5##3##(1996-6#1)(2010-12#1)(2011-2#3)
assessment of two##2##3##(2007-11#1)(2013-7#1)
assessment of unwanted immunogenicity##3##4##(2008-10#3)
assessment of vascular##2##3##(1997-8#1)(2013-8#1)
assessment of whether##2##3##(2010-11#1)(2013-7#1)
assessment of##676##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#5)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#3)(1994-1#2)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#8)(1996-2#5)(1996-3#5)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#2)(1997-8#6)(2006-10#3)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#15)(2007-12#7)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#7)(2008-1#4)(2008-10#87)(2008-11#38)(2008-12#13)(2008-2#7)(2008-3#18)(2008-4#23)(2008-5#32)(2008-6#6)(2008-7#28)(2008-8#15)(2008-9#21)(2009-1#5)(2009-10#9)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#6)(2010-12#6)(2010-3#5)(2010-4#1)(2010-5#4)(2010-6#7)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#8)(2011-2#36)(2011-8#1)(2012-1#12)(2012-12#8)(2012-2#12)(2012-3#15)(2012-5#1)(2013-1#21)(2013-7#4)(2013-8#23)
assessment performed##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
assessment practices##11##2##(1991-12#1)(2008-10#1)(2008-12#3)(2010-11#6)
assessment procedures to##2##3##(1992-2#1)(2010-5#1)
assessment procedures##5##2##(1992-2#1)(1996-2#1)(2008-7#1)(2009-11#1)(2010-5#1)
assessment process for##3##3##(2008-10#1)(2008-11#2)
assessment process is##2##3##(1996-1#1)(2008-5#1)
assessment process##8##2##(1996-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2013-8#1)
assessment processes used##2##3##(2008-11#2)
assessment program##2##2##(1993-12#1)(1996-3#1)
assessment protocols##2##2##(1994-3#1)(2008-10#1)
assessment revealed that##2##3##(1991-2#1)(1993-12#1)
assessment revealed##4##2##(1991-2#1)(1993-12#1)(1994-2#1)(2008-6#1)
assessment should be##3##3##(2008-11#1)(2013-1#2)
assessment should##5##2##(2008-11#1)(2012-2#1)(2013-1#3)
assessment showed##3##2##(2007-8#1)(2008-6#1)(2009-6#1)
assessment situation##2##2##(2008-11#2)
assessment strategies in##2##3##(2008-11#2)
assessment strategies##5##2##(2008-11#3)(2009-9#2)
assessment strategy##9##2##(2008-11#8)(2009-11#1)
assessment survey##3##2##(1994-3#1)(2013-1#2)
assessment system##3##2##(1996-2#2)(2008-11#1)
assessment systems##4##2##(1994-12#2)(1995-3#1)(2008-10#1)
assessment techniques##2##2##(1992-3#1)(2010-7#1)
assessment tests##2##2##(2008-12#1)(2013-1#1)
assessment that##5##2##(1991-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-8#1)
assessment time##2##2##(2008-10#2)
assessment times##3##2##(2008-10#3)
assessment to identify##3##3##(2008-1#1)(2009-3#1)(2011-2#1)
assessment to##9##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
assessment tool for##2##3##(2008-3#1)(2011-2#1)
assessment tool##15##2##(1993-12#3)(2007-12#1)(2008-11#5)(2008-3#1)(2008-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
assessment tools can##2##3##(2008-10#1)(2008-12#1)
assessment tools that are##2##4##(1994-12#1)(2010-11#1)
assessment tools##14##2##(1991-3#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
assessment using the##2##3##(2008-1#1)(2008-5#1)
assessment using##6##2##(2008-1#1)(2008-5#2)(2008-7#1)(2010-6#1)(2012-2#1)
assessment was carried out##2##4##(2012-1#1)(2013-1#1)
assessment was performed##4##3##(1992-12#1)(2008-12#1)(2013-1#2)
assessment was undertaken##2##3##(2012-12#1)(2013-1#1)
assessment was##13##2##(1992-12#1)(1995-12#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#6)
assessment were##6##2##(1996-12#1)(1997-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
assessment will be##2##3##(2008-10#1)(2008-3#1)
assessment will##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
assessment with the##2##3##(2010-8#1)(2011-2#1)
assessment with##7##2##(2007-2#1)(2008-12#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
assessment##1559##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#3)(1990-8#5)(1991-1#5)(1991-11#2)(1991-12#9)(1991-2#4)(1991-3#6)(1991-5#1)(1991-6#4)(1992-1#1)(1992-11#1)(1992-12#14)(1992-2#6)(1992-3#6)(1992-5#4)(1992-6#2)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#14)(1993-2#8)(1993-3#5)(1993-5#1)(1993-8#1)(1993-9#3)(1994-1#5)(1994-11#1)(1994-12#9)(1994-2#16)(1994-3#5)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#3)(1995-9#1)(1996-1#13)(1996-11#1)(1996-12#21)(1996-2#20)(1996-3#10)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#3)(1997-1#9)(1997-2#8)(1997-3#9)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#12)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#5)(2007-11#22)(2007-12#15)(2007-2#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#17)(2007-9#2)(2008-1#10)(2008-10#163)(2008-11#121)(2008-12#33)(2008-2#11)(2008-3#38)(2008-4#29)(2008-5#58)(2008-6#18)(2008-7#64)(2008-8#29)(2008-9#41)(2009-1#6)(2009-10#12)(2009-11#13)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#10)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#4)(2009-9#11)(2010-1#2)(2010-10#3)(2010-11#23)(2010-12#16)(2010-3#8)(2010-4#4)(2010-5#6)(2010-6#9)(2010-7#9)(2010-8#4)(2010-9#14)(2011-1#23)(2011-2#80)(2011-3#4)(2011-8#1)(2012-1#17)(2012-12#21)(2012-2#36)(2012-3#23)(2012-5#2)(2013-1#76)(2013-7#8)(2013-8#55)
assessment&quot##2##1##(1996-3#1)(2009-9#1)
assessment)##3##1##(2007-10#1)(2009-9#2)
assessment?##2##1##(1996-1#1)(1997-3#1)
assessment]##2##1##(1995-2#1)(2013-1#1)
assessments and##13##2##(1996-6#2)(2008-10#4)(2008-11#1)(2008-12#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
assessments are also##2##3##(2008-11#1)(2008-3#1)
assessments are##12##2##(1992-6#1)(1993-2#1)(1997-1#1)(1997-8#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-3#1)
assessments at##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
assessments for##2##2##(2011-2#2)
assessments have been##2##3##(2008-10#1)(2011-2#1)
assessments have##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
assessments in##2##2##(2008-10#1)(2008-5#1)
assessments indicate##2##2##(2008-6#1)(2008-9#1)
assessments of overall service quality##2##5##(1995-3#2)
assessments of patients##2##3##(2010-6#1)(2012-1#1)
assessments of the##7##3##(1994-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2013-8#1)
assessments of their##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
assessments of##51##2##(1991-3#1)(1992-6#1)(1994-2#2)(1994-6#1)(1995-3#4)(1995-5#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
assessments were conducted##2##3##(2008-5#1)(2008-6#1)
assessments were made##3##3##(2008-10#2)(2008-5#1)
assessments were##13##2##(1996-1#1)(2007-6#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#3)
assessments with##2##2##(2008-10#2)
assessments##168##1##(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#4)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-12#3)(2007-6#2)(2007-7#1)(2008-10#28)(2008-11#10)(2008-12#6)(2008-3#1)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#2)(2010-4#1)(2010-6#2)(2010-8#3)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#4)
assessor##2##1##(2008-11#1)(2008-5#1)
assessors was##2##2##(2008-10#1)(2008-5#1)
assessors##8##1##(2008-10#4)(2008-11#1)(2008-5#2)(2013-1#1)
asset allocation##2##2##(2011-2#1)(2012-12#1)
asset to##5##2##(1992-1#1)(1993-3#1)(1994-9#1)(2008-11#2)
asset##18##1##(1992-1#1)(1993-3#1)(1994-2#3)(1994-3#3)(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
assets and##2##2##(2012-12#2)
assets for##2##2##(1992-12#1)(2008-12#1)
assets in##3##2##(1992-5#1)(2011-2#2)
assets of##5##2##(1992-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1995-2#1)
assets to##2##2##(1994-2#1)(2008-11#1)
assets##28##1##(1992-12#4)(1992-2#2)(1992-5#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#3)(2012-12#3)(2012-2#1)
assign a##2##2##(1994-9#1)(1995-3#1)
assign##26##1##(1991-5#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-3#1)(1996-2#3)(1996-5#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-3#1)
assignable##2##1##(1994-6#1)(2008-3#1)
assignation##2##1##(2008-10#1)(2010-9#1)
assigned a##8##2##(1991-8#1)(1993-6#1)(1996-6#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)
assigned and##2##2##(2008-11#1)(2009-5#1)
assigned as##2##2##(1992-8#1)(1997-5#1)
assigned by the##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
assigned by##11##2##(1992-3#1)(1995-2#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
assigned for##4##2##(1993-8#1)(2008-11#1)(2008-4#1)(2009-6#1)
assigned higher ratings with the##2##5##(2008-9#2)
assigned into two groups##3##4##(2010-7#1)(2012-3#1)(2013-8#1)
assigned into two##4##3##(2008-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
assigned into##9##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
assigned on the genome##4##4##(1996-6#1)(1996-8#2)(1997-6#1)
assigned on the##6##3##(1993-11#1)(1995-6#1)(1996-6#1)(1996-8#2)(1997-6#1)
assigned on##7##2##(1993-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-6#1)
assigned randomly##6##2##(1991-1#1)(1992-1#1)(1995-3#1)(2008-1#1)(2008-8#1)(2009-6#1)
assigned the##5##2##(1993-11#1)(1997-8#1)(2008-10#3)
assigned to a##11##3##(1994-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
assigned to chromosome##4##3##(1991-2#1)(1994-6#1)(1995-6#1)(1997-4#1)
assigned to chromosomes##3##3##(1993-12#1)(1996-12#1)(2008-10#1)
assigned to each##4##3##(1990-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
assigned to either a##4##4##(1991-12#1)(2008-12#1)(2008-4#1)(2013-1#1)
assigned to either##6##3##(1991-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
assigned to four##3##3##(2008-12#1)(2010-2#1)(2010-8#1)
assigned to one of the two##2##6##(2008-12#1)(2010-4#1)
assigned to one of the##5##5##(2007-6#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-8#1)
assigned to one of three##2##5##(1994-3#1)(2008-4#1)
assigned to one of##10##4##(1994-3#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#2)(2011-2#2)(2013-8#1)
assigned to one##11##3##(1994-3#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#2)(2011-2#2)(2013-8#1)
assigned to receive##8##3##(1990-9#1)(1993-1#1)(1994-2#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#2)
assigned to six##3##3##(2008-10#3)
assigned to the intervention##2##4##(2008-12#1)(2012-2#1)
assigned to the same##2##4##(2008-10#1)(2012-1#1)
assigned to the##26##3##(1991-12#2)(1991-3#1)(1991-8#1)(1992-3#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-6#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
assigned to this##2##3##(1994-6#1)(2008-9#1)
assigned to three experimental##2##4##(2008-12#1)(2010-10#1)
assigned to three##5##3##(2008-12#2)(2009-3#1)(2010-10#1)(2011-2#1)
assigned to two##4##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
assigned to various##2##3##(2008-10#1)(2008-8#1)
assigned to##148##2##(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-12#5)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#12)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#2)
assigned treatment##2##2##(1995-3#1)(2012-12#1)
assigned using##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
assigned##266##1##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#3)(1992-1#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-6#4)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#4)(1996-8#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-8#3)(2007-10#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#39)(2008-11#7)(2008-12#14)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#8)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#4)
assigning a##3##2##(1992-2#1)(2008-7#1)(2013-8#1)
assigning functions##2##2##(2008-7#2)
assigning the##5##2##(1995-6#1)(2007-4#1)(2008-12#1)(2008-4#1)(2010-11#1)
assigning##19##1##(1992-2#2)(1994-12#1)(1995-6#1)(1996-12#1)(2007-4#2)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
assignment and##6##2##(1991-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)
assignment are##2##2##(2008-12#2)
assignment for the##3##3##(1991-9#1)(1992-12#1)(2009-7#1)
assignment for##5##2##(1990-8#1)(1991-9#1)(1992-12#1)(2009-7#2)
assignment in##2##2##(2008-12#1)(2008-9#1)
assignment is##2##2##(1994-12#1)(2010-2#1)
assignment of Rv1567c##2##3##(2009-7#2)
assignment of a##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
assignment of human##2##3##(1991-2#1)(2009-7#1)
assignment of the N-terminal##4##4##(2009-7#4)
assignment of the human##2##4##(1991-9#2)
assignment of the##26##3##(1991-12#1)(1991-2#1)(1991-9#2)(1993-2#1)(1995-5#1)(1995-9#1)(2008-10#1)(2009-7#16)(2013-1#1)(2013-8#1)
assignment of##68##2##(1991-12#1)(1991-2#2)(1991-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-6#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#29)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
assignment test##3##2##(2013-1#3)
assignment to a##3##3##(1991-3#1)(2008-11#2)
assignment to the##2##3##(1990-8#1)(2013-7#1)
assignment to##5##2##(1990-8#1)(1991-3#1)(2008-11#2)(2013-7#1)
assignment was##2##2##(1995-6#1)(2007-10#1)
assignment##127##1##(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#3)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#7)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-7#35)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
assignments and##2##2##(1993-8#1)(2008-10#1)
assignments are##3##2##(1993-11#1)(2009-7#2)
assignments for the##8##3##(1990-5#1)(1994-5#1)(2009-7#6)
assignments for##12##2##(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(2008-12#1)(2009-7#7)
assignments of a##3##3##(2009-7#3)
assignments of an engineered intein based on Mycobacterium tuberculosis RecA##2##10##(2009-7#2)
assignments of human##2##3##(2009-7#2)
assignments of the 34 kDa ketopantoate reductase##2##7##(2009-7#2)
assignments of the 34 kDa##4##5##(2009-7#4)
assignments of the##21##3##(1990-9#1)(2008-9#1)(2009-7#19)
assignments of##44##2##(1990-9#1)(1991-5#1)(1993-11#1)(2008-8#1)(2008-9#2)(2009-7#37)(2013-1#1)
assignments to##3##2##(2008-10#2)(2008-12#1)
assignments were determined##2##3##(2009-7#2)
assignments##82##1##(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-11#2)(1993-8#2)(1994-5#1)(1995-2#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#50)(2010-3#1)(2012-12#1)(2013-1#1)
assigns##4##1##(1996-4#1)(1997-1#1)(2008-3#1)(2010-10#1)
assimilate the##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
assimilate##7##1##(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
assimilated##6##1##(2008-3#1)(2008-9#1)(2010-4#2)(2011-1#1)(2013-1#1)
assimilation in##3##2##(1991-9#1)(1997-1#1)(2011-2#1)
assimilation is##2##2##(1992-10#1)(1997-1#1)
assimilation of##5##2##(1991-9#1)(1992-10#1)(2008-10#1)(2009-2#1)(2009-8#1)
assimilation rate##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2012-5#1)
assimilation theory##3##2##(2009-7#1)(2011-2#2)
assimilation##38##1##(1991-9#2)(1992-10#2)(1993-12#2)(1997-1#4)(2007-2#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2011-2#5)(2012-1#1)(2012-3#1)(2012-5#1)
assimilative##3##1##(2008-10#2)(2012-2#1)
assimilis##5##1##(2008-9#5)
assist a##2##2##(1993-2#1)(2010-8#1)
assist clinical##2##2##(2008-11#1)(2010-11#1)
assist clinicians and##2##3##(2010-10#1)(2013-1#1)
assist clinicians##4##2##(2007-12#1)(2010-10#1)(2012-12#1)(2013-1#1)
assist device in##3##3##(2007-8#2)(2010-8#1)
assist device##10##2##(2007-8#4)(2008-11#1)(2010-8#2)(2011-2#2)(2012-3#1)
assist devices (VADs)##4##3##(2010-6#2)(2011-2#1)(2012-3#1)
assist devices and##2##3##(2011-2#2)
assist devices have##2##3##(2010-6#1)(2010-8#1)
assist devices##16##2##(2006-10#1)(2008-8#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-2#6)(2012-3#1)
assist efforts##2##2##(1997-7#1)(2008-10#1)
assist health care providers##2##4##(1995-3#1)(1996-12#1)
assist health care##3##3##(1995-2#1)(1995-3#1)(1996-12#1)
assist in determining##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
assist in the choice of##2##5##(1995-5#1)(2008-12#1)
assist in the development of##2##5##(2008-10#1)(2008-4#1)
assist in the diagnosis of##2##5##(1991-12#1)(2010-3#1)
assist in the diagnosis##3##4##(1991-12#1)(2010-3#1)(2011-2#1)
assist in the early##2##4##(2008-7#1)(2010-12#1)
assist in the identification of##2##5##(2010-10#1)(2012-3#1)
assist in the treatment of##2##5##(2008-3#1)(2012-2#1)
assist in the##28##3##(1991-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
assist in##76##2##(1990-9#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
assist individuals##2##2##(2010-10#1)(2013-8#1)
assist physicians in##2##3##(2008-10#1)(2010-6#1)
assist radiologists##2##2##(1993-1#1)(1993-3#1)
assist the development of##4##4##(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)
assist the pediatric nurse practitioner in##2##6##(2009-9#1)(2010-10#1)
assist the##27##2##(1991-12#1)(1993-12#1)(1993-2#1)(1995-1#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-7#1)(2012-12#1)
assist them##3##2##(1992-1#1)(1995-1#1)(1995-12#1)
assist with the##2##3##(2008-8#1)(2011-2#1)
assist with##6##2##(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
assist##222##1##(1990-9#1)(1991-12#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#5)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-2#2)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#5)(2008-1#7)(2008-10#24)(2008-11#10)(2008-12#10)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#3)(2011-2#18)(2011-7#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#4)
assistance and##3##2##(1996-1#1)(2007-7#1)(2012-3#1)
assistance by##2##2##(1990-12#1)(2008-10#1)
assistance for##2##2##(1995-1#1)(2008-1#1)
assistance from##4##2##(1990-3#1)(1991-12#1)(2010-12#1)(2012-12#1)
assistance in##9##2##(1991-12#1)(1991-5#1)(1991-6#1)(1995-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)
assistance needed to##2##3##(1991-1#1)(1993-3#1)
assistance of##9##2##(1993-1#1)(1993-3#1)(1993-8#1)(1995-12#1)(2008-1#1)(2008-12#1)(2009-5#1)(2011-1#2)
assistance provided by##2##3##(1990-5#1)(2008-3#1)
assistance to##9##2##(1991-6#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-11#1)(2009-7#2)(2012-12#1)(2012-3#1)
assistance with##2##2##(1996-3#1)(2008-9#1)
assistance##78##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-5#1)(1991-6#2)(1991-9#1)(1993-1#1)(1993-3#4)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-9#2)(2009-3#2)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-3#8)(2013-1#2)
assistant medical##2##2##(2009-11#2)
assistant professors##2##2##(2012-2#1)(2012-3#1)
assistant##24##1##(1992-1#3)(1992-4#2)(1993-6#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#2)(2010-11#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
assistant's##3##1##(1992-1#1)(2009-4#2)
assistants and##3##2##(1995-2#1)(1997-3#1)(2008-11#1)
assistants##18##1##(1992-1#1)(1992-4#1)(1995-2#1)(1997-3#2)(2006-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2009-4#2)(2010-11#2)(2010-5#1)(2013-1#1)
assisted acid##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
assisted by NSBAs##3##3##(2011-1#3)
assisted by a##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
assisted by the##2##3##(2008-7#1)(2008-9#1)
assisted by##26##2##(1994-11#1)(1994-2#1)(1994-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#6)(2012-2#1)(2013-8#1)
assisted closure##4##2##(2007-8#2)(2008-11#2)
assisted conception##6##2##(1990-6#1)(1991-11#2)(1991-3#1)(1994-9#1)(1996-9#1)
assisted digestion procedure##2##3##(2008-10#2)
assisted digestion##4##2##(2008-10#4)
assisted eruption##2##2##(2007-12#2)
assisted extraction##5##2##(2008-10#3)(2012-1#2)
assisted hemodialysis##2##2##(2009-11#2)
assisted in##3##2##(1993-9#1)(2009-1#1)(2011-3#1)
assisted living##14##2##(2007-6#1)(2008-12#10)(2010-8#2)(2013-8#1)
assisted mechanical ventilation##2##3##(2010-5#2)
assisted pseudo-digestion of##2##3##(2008-10#2)
assisted pseudo-digestion##4##2##(2008-10#4)
assisted reproduction##4##2##(1991-3#1)(2007-7#1)(2011-1#2)
assisted reproductive techniques##2##3##(1996-9#1)(2012-3#1)
assisted reproductive technologies##3##3##(1992-2#1)(2008-11#1)(2011-1#1)
assisted reproductive technology##2##3##(2007-2#1)(2012-3#1)
assisted reproductive##7##2##(1992-2#1)(1996-9#1)(2007-2#1)(2008-11#1)(2011-1#1)(2012-3#2)
assisted suicide##18##2##(1991-8#8)(1996-2#1)(2010-12#9)
assisted vaginal hysterectomies##3##3##(1993-12#1)(1995-1#2)
assisted vaginal hysterectomy (LAVH)##4##4##(1994-2#1)(1995-3#1)(1996-2#1)(2010-3#1)
assisted vaginal hysterectomy##19##3##(1993-12#6)(1994-2#3)(1995-3#2)(1996-2#2)(2010-3#1)(2011-2#5)
assisted vaginal##24##2##(1993-12#7)(1994-2#5)(1995-1#2)(1995-3#2)(1996-2#2)(2010-3#1)(2011-2#5)
assisted ventilation##2##2##(1992-3#1)(2008-7#1)
assisted with##4##2##(2008-10#1)(2012-1#1)(2012-2#2)
assisted##191##1##(1990-6#1)(1991-11#2)(1991-3#2)(1991-8#8)(1992-2#1)(1992-3#1)(1993-12#7)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#4)(1996-2#3)(1996-9#4)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#40)(2008-11#5)(2008-12#11)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-6#1)(2010-11#1)(2010-12#9)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#9)(2011-3#1)(2012-1#3)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#6)
assisted-acid##2##1##(2008-10#2)
assisted-primary and secondary patency rates##2##5##(2007-7#2)
assisted-primary patency rates##2##3##(2007-7#2)
assisted-primary##4##1##(2007-7#4)
assisting in##2##2##(2008-10#2)
assisting the##3##2##(1994-3#1)(1996-3#1)(2012-2#1)
assisting##23##1##(1991-12#1)(1992-8#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
assistive device##3##2##(2008-12#1)(2012-2#2)
assistive devices##2##2##(1992-3#1)(2012-2#1)
assistive##7##1##(1991-12#1)(1992-3#1)(2008-12#1)(2010-12#1)(2012-2#3)
assists the##2##2##(2008-10#1)(2008-9#1)
assists##9##1##(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-7#1)(2013-1#1)
associate formation##3##2##(2008-10#3)
associate formed##3##2##(2008-10#3)
associate of##4##2##(2008-10#4)
associate with different##2##3##(2008-10#1)(2008-12#1)
associate with the##8##3##(1992-8#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-6#2)(1996-5#1)(2008-10#1)
associate with##27##2##(1991-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-8#3)(1994-11#1)(1994-8#1)(1995-6#3)(1996-2#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)
associate##74##1##(1990-11#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-11#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-8#2)(1995-2#1)(1995-6#4)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
associated (r(2) = 0##2##4##(2008-10#2)
associated abnormalities##3##2##(2011-1#2)(2012-3#1)
associated and##3##2##(2008-11#2)(2011-2#1)
associated anomalies of thumb hypoplasia##2##5##(2008-9#2)
associated anomalies##3##2##(2008-9#2)(2011-1#1)
associated antigen##2##2##(2008-5#1)(2010-12#1)
associated antral gastritis##2##3##(2008-5#2)
associated as a##2##3##(1995-12#1)(2012-2#1)
associated as##3##2##(1995-12#1)(1995-5#1)(2012-2#1)
associated benefits##3##2##(1994-2#1)(1997-3#1)(2013-8#1)
associated cardiac##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)
associated cell death##2##3##(1990-7#1)(2009-8#1)
associated cell##4##2##(1990-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
associated changes in##3##3##(1997-1#1)(2008-7#1)(2010-11#1)
associated chronic##2##2##(2008-1#1)(2008-2#1)
associated comorbidities##2##2##(2013-1#2)
associated complications##3##2##(2007-10#1)(2007-12#1)(2012-2#1)
associated costs##3##2##(1994-2#1)(1994-3#1)(2010-12#1)
associated disease##2##2##(1996-12#1)(2006-10#1)
associated diseases##4##2##(1990-2#1)(1996-6#2)(1997-7#1)
associated disorders##5##2##(1990-7#1)(2008-11#1)(2008-5#2)(2009-6#1)
associated exonuclease activity##2##3##(1995-2#2)
associated factors among##4##3##(1996-2#1)(2008-10#2)(2010-12#1)
associated factors in##3##3##(2009-10#1)(2013-1#1)(2013-8#1)
associated factors were##2##3##(2013-1#2)
associated factors##17##2##(1996-2#1)(2007-7#1)(2008-10#4)(2009-10#1)(2010-12#1)(2012-12#2)(2013-1#5)(2013-8#2)
associated factors]##2##2##(1991-3#1)(1996-3#1)
associated fracture##2##2##(2008-7#1)(2008-8#1)
associated genes##3##2##(2008-1#1)(2010-11#1)(2011-2#1)
associated in patients##2##3##(2007-8#1)(2012-2#1)
associated in##8##2##(1993-12#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)
associated incidence##2##2##(2008-7#1)(2011-2#1)
associated increase##2##2##(1994-8#1)(2011-2#1)
associated inflammation##2##2##(1997-8#1)(2012-2#1)
associated intensity modulation##2##3##(2008-3#2)
associated intensity##3##2##(2008-3#3)
associated kinase activity##2##3##(1993-3#1)(2009-8#1)
associated lesions##2##2##(2010-4#1)(2011-1#1)
associated liver##2##2##(2009-3#1)(2013-1#1)
associated lymphoid tissue (MALT) tumors##2##5##(1991-6#1)(2008-1#1)
associated lymphoid tissue (MALT)##3##4##(1991-6#1)(1997-1#1)(2008-1#1)
associated lymphoid##4##2##(1991-6#1)(1997-1#1)(2008-1#1)(2011-2#1)
associated malformations##3##2##(1995-11#1)(2012-3#2)
associated medical##2##2##(1997-8#1)(2008-11#1)
associated metabolic##3##2##(2007-7#1)(2008-11#1)(2012-2#1)
associated metal ions##3##3##(2008-10#3)
associated minimum tillage##2##3##(2008-10#2)
associated molecular patterns##2##3##(2009-6#1)(2012-2#1)
associated morbidity##4##2##(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)
associated more##2##2##(2008-7#1)(2009-5#1)
associated muscle##2##2##(2010-5#1)(2010-9#1)
associated myositis##3##2##(2008-8#1)(2013-1#2)
associated only##2##2##(2008-10#1)(2011-2#1)
associated or not with##2##4##(1991-2#1)(2009-3#1)
associated or##3##2##(1991-12#1)(1991-2#1)(2009-3#1)
associated primarily with##2##3##(2008-3#1)(2010-2#1)
associated problems##3##2##(2008-11#1)(2008-7#1)(2009-5#1)
associated production##7##2##(2008-11#7)
associated protein##6##2##(1991-8#1)(1992-10#1)(2008-11#2)(2008-4#1)(2013-1#1)
associated proteins with##2##3##(1996-12#1)(2008-7#1)
associated proteins##9##2##(1991-1#1)(1994-9#1)(1996-12#1)(2008-7#2)(2008-9#1)(2009-8#2)(2012-12#1)
associated renal##3##2##(2008-1#1)(2012-12#2)
associated risk factors in##3##4##(2012-1#1)(2012-2#1)(2013-8#1)
associated risk factors##10##3##(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
associated risk of##4##3##(2008-10#1)(2008-11#1)(2009-4#1)(2013-1#1)
associated risk##15##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
associated risks##3##2##(1995-6#1)(2011-2#1)(2012-2#1)
associated side effects##3##3##(2009-7#2)(2013-8#1)
associated significantly with##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
associated species##2##2##(2008-5#1)(2012-3#1)
associated specifically with##2##3##(1995-12#1)(1995-2#1)
associated subunit##2##2##(1993-8#1)(1995-12#1)
associated systemic##2##2##(1995-6#1)(2008-1#1)
associated to a shallow reef in Morrocoy National Park##2##9##(2011-2#2)
associated to a##12##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-2#4)
associated to flow injection (FI) was studied##2##7##(2008-10#2)
associated to the##21##3##(1990-3#1)(1990-9#1)(1992-6#2)(2008-1#1)(2008-10#7)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
associated to##89##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#2)(1991-2#1)(1991-6#2)(1992-6#2)(1994-12#1)(1994-5#1)(1996-12#1)(1996-2#1)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#2)
associated together##2##2##(1992-6#1)(2012-12#1)
associated tuberculosis##2##2##(1995-10#2)
associated variables##2##2##(2008-11#1)(2008-2#1)
associated virus##3##2##(1993-6#1)(2008-10#2)
associated with &quot##2##3##(2008-5#1)(2011-2#1)
associated with AD##3##3##(1996-2#1)(2008-5#1)(2009-12#1)
associated with Alzheimer##2##3##(1992-6#1)(1994-8#1)
associated with Alzheimer's disease##3##4##(1991-7#1)(1997-2#1)(2007-6#1)
associated with BMI##2##3##(2013-1#2)
associated with BRAF mutations##2##4##(2009-4#2)
associated with BRAF##3##3##(2009-4#3)
associated with CRF##2##3##(2008-1#1)(2009-3#1)
associated with CVD##2##3##(2009-9#1)(2012-3#1)
associated with D##3##3##(2008-10#2)(2008-3#1)
associated with DNA modification by##2##5##(1990-11#2)
associated with DNA##3##3##(1990-11#2)(2012-2#1)
associated with DNAbeta##3##3##(2008-10#3)
associated with EBV##2##3##(1993-9#1)(1995-2#1)
associated with GLS##3##3##(2008-10#3)
associated with HCC##2##3##(1993-2#1)(2013-8#1)
associated with HIV##4##3##(1991-1#1)(2007-7#1)(2009-5#1)(2011-2#1)
associated with HIV-1 infection##2##4##(2008-2#2)
associated with HIV-1##3##3##(1997-3#1)(2008-2#2)
associated with Helicobacter pylori##2##4##(1997-1#1)(2013-8#1)
associated with Leigh syndrome##2##4##(1994-8#2)
associated with MMD##2##3##(2008-10#2)
associated with MS##2##3##(2008-3#1)(2012-3#1)
associated with Mycoplasma##2##3##(2012-3#1)(2013-1#1)
associated with PAD##2##3##(2008-8#2)
associated with PD##3##3##(1990-6#1)(2012-12#1)(2013-8#1)
associated with Rayleigh##2##3##(2008-2#1)(2008-3#1)
associated with Rsp2##2##3##(2008-10#2)
associated with SIDS##2##3##(1992-4#1)(2011-1#1)
associated with Triton##2##3##(1991-8#2)
associated with a 10% increase in##2##6##(1990-3#1)(2008-4#1)
associated with a better outcome##3##5##(2008-11#1)(2008-7#1)(2009-10#1)
associated with a better##6##4##(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)
associated with a decrease in the##4##6##(1994-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
associated with a decrease in##11##5##(1990-12#1)(1994-11#1)(1996-2#1)(2007-9#1)(2008-4#1)(2008-7#3)(2009-9#1)(2012-2#1)(2013-7#1)
associated with a decrease##12##4##(1990-12#1)(1994-11#1)(1996-2#1)(1996-6#1)(2007-9#1)(2008-4#1)(2008-7#3)(2009-9#1)(2012-2#1)(2013-7#1)
associated with a decreased likelihood of##3##6##(2010-11#1)(2011-2#1)(2013-1#1)
associated with a decreased risk##3##5##(2007-4#1)(2011-2#1)(2013-7#1)
associated with a decreased##10##4##(1990-2#1)(1992-8#1)(2007-4#1)(2008-11#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-7#1)
associated with a defective##2##4##(1995-2#1)(2008-9#1)
associated with a great##2##4##(2008-7#1)(2012-12#1)
associated with a greater risk of##2##6##(2008-11#1)(2011-2#1)
associated with a greater##7##4##(2007-5#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
associated with a high incidence of##2##6##(2007-10#2)
associated with a high mortality rate##3##6##(2008-4#1)(2008-6#1)(2010-7#1)
associated with a high prevalence of##2##6##(2008-1#2)
associated with a high##18##4##(1993-11#1)(1995-6#1)(1996-9#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
associated with a higher risk of##4##6##(2012-2#1)(2013-1#2)(2013-8#1)
associated with a higher risk##5##5##(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
associated with a higher##9##4##(1996-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
associated with a history of##3##5##(1992-10#1)(1996-8#1)(2013-8#1)
associated with a history##4##4##(1992-10#1)(1996-8#1)(2013-8#2)
associated with a large##2##4##(1993-11#1)(1997-4#1)
associated with a loss of##2##5##(1992-3#1)(2011-2#1)
associated with a low##8##4##(1993-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
associated with a lower frequency of##2##6##(2007-5#1)(2008-10#1)
associated with a lower##5##4##(2007-5#1)(2008-10#1)(2013-1#2)(2013-8#1)
associated with a marked##2##4##(2008-10#1)(2008-3#1)
associated with a metastatic##2##4##(2007-5#1)(2008-4#1)
associated with a more favorable##2##5##(1990-8#1)(2013-1#1)
associated with a more##5##4##(1990-8#1)(2008-6#2)(2008-8#1)(2013-1#1)
associated with a nonlinear optical##2##5##(2007-12#2)
associated with a number of##6##5##(1990-8#1)(1994-3#1)(1997-4#1)(2008-6#1)(2009-5#1)(2012-1#1)
associated with a poor outcome##5##5##(1990-9#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
associated with a poor prognosis##7##5##(1994-12#1)(2008-6#1)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
associated with a poor##13##4##(1990-9#1)(1994-12#1)(2007-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
associated with a range of##4##5##(2008-10#1)(2013-1#3)
associated with a rapid##3##4##(2008-3#1)(2010-12#1)(2013-1#1)
associated with a reduction in the##2##6##(2008-10#1)(2011-2#1)
associated with a reduction in##9##5##(1993-11#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
associated with a reduction of##3##5##(2008-4#1)(2009-7#1)(2013-1#1)
associated with a reduction##12##4##(1993-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
associated with a rise in##2##5##(2008-10#2)
associated with a significant increase in##5##6##(1994-6#1)(1995-12#1)(2008-1#1)(2008-3#1)(2012-1#1)
associated with a significant increase of##2##6##(1990-9#1)(2008-8#1)
associated with a significant increase##7##5##(1990-9#1)(1994-6#1)(1995-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-1#1)
associated with a significant reduction##6##5##(1997-4#1)(2007-10#1)(2007-2#1)(2008-3#1)(2010-5#1)(2010-6#1)
associated with a significant##18##4##(1990-9#1)(1994-6#1)(1995-12#1)(1997-4#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
associated with a significantly increased risk of##2##7##(1992-10#1)(2008-1#1)
associated with a single##2##4##(1992-9#1)(2008-5#1)
associated with a slight##2##4##(1994-12#1)(2008-7#1)
associated with a substantial##3##4##(1991-8#1)(1993-11#1)(1997-3#1)
associated with a sustained##2##4##(1995-5#1)(2009-8#1)
associated with a transient##2##4##(2007-10#1)(2010-12#1)
associated with a variety of##8##5##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#2)
associated with a very##2##4##(2008-10#1)(2009-12#1)
associated with a wide spectrum of##2##6##(2008-7#1)(2013-1#1)
associated with a##316##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-10#3)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-2#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#3)(2006-12#1)(2007-10#6)(2007-11#2)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#3)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#31)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#8)(2008-5#4)(2008-6#8)(2008-7#13)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#5)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#18)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#21)(2013-7#3)(2013-8#13)
associated with abdominal##2##3##(1995-12#1)(2013-1#1)
associated with abnormal##8##3##(1990-8#1)(1995-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
associated with abnormalities in##2##4##(1995-12#1)(2011-2#1)
associated with abnormalities##3##3##(1995-12#1)(2008-6#1)(2011-2#1)
associated with academic##2##3##(2008-2#1)(2011-2#1)
associated with activation and##2##4##(1992-2#1)(2008-7#1)
associated with activation of##2##4##(2010-12#1)(2012-3#1)
associated with activation##5##3##(1992-2#1)(1995-8#1)(2008-7#1)(2010-12#1)(2012-3#1)
associated with active##3##3##(2008-1#1)(2008-7#1)(2013-1#1)
associated with acute renal failure##2##5##(2008-4#1)(2012-3#1)
associated with acute renal##3##4##(2008-4#1)(2011-2#1)(2012-3#1)
associated with acute##7##3##(1996-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
associated with adherence##3##3##(1996-3#1)(2010-11#1)(2012-3#1)
associated with adjacent##2##3##(2008-3#1)(2011-2#1)
associated with adverse effects##2##4##(2008-7#1)(2008-9#1)
associated with adverse##11##3##(1994-9#1)(2008-1#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
associated with aerosols##2##3##(2008-10#1)(2008-3#1)
associated with aflatoxin##2##3##(2008-10#2)
associated with age for the##2##5##(2011-2#2)
associated with age##10##3##(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
associated with agenesis of corpus callosum##2##6##(2008-7#2)
associated with agenesis of##3##4##(2008-7#3)
associated with aggressive##2##3##(2008-10#1)(2011-1#1)
associated with aging##4##3##(1994-8#1)(2008-3#1)(2008-7#1)(2013-7#1)
associated with alendronate##2##3##(2008-11#2)
associated with all##5##3##(1997-2#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-1#1)
associated with alterations in##2##4##(1996-5#1)(2008-1#1)
associated with alterations##3##3##(1995-12#1)(1996-5#1)(2008-1#1)
associated with altered##5##3##(1995-11#1)(2008-10#1)(2008-2#1)(2009-9#2)
associated with an abnormal##4##4##(1990-5#1)(1993-11#1)(1994-11#1)(1997-3#1)
associated with an altered##2##4##(1996-5#1)(2008-10#1)
associated with an effect on##2##5##(1994-8#2)
associated with an elevated##2##4##(1990-5#1)(2009-10#1)
associated with an important##2##4##(1993-8#1)(2008-5#1)
associated with an improvement##2##4##(2008-6#1)(2012-1#1)
associated with an increase in the percentage of##2##8##(2011-2#2)
associated with an increase in the##3##6##(2010-6#1)(2011-2#2)
associated with an increase in##12##5##(1990-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
associated with an increase of##2##5##(1990-8#1)(1994-3#1)
associated with an increase##14##4##(1990-7#1)(1990-8#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
associated with an increased incidence of##3##6##(2008-1#1)(2008-10#1)(2013-7#1)
associated with an increased likelihood of##3##6##(2010-11#1)(2013-1#2)
associated with an increased prevalence of##3##6##(2008-1#1)(2008-7#1)(2012-5#1)
associated with an increased risk for##8##6##(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
associated with an increased risk of##15##6##(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-3#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
associated with an increased risk##24##5##(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-3#3)(2009-10#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)
associated with an increased##42##4##(1990-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-12#1)(2007-10#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#6)(2013-7#1)
associated with an isolated hydronephrosis##2##5##(2008-10#2)
associated with an outbreak##2##4##(1997-4#1)(2012-12#1)
associated with an##114##3##(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#1)
associated with anemia##4##3##(1992-6#1)(2009-10#1)(2011-2#2)
associated with angiocentric##2##3##(2009-1#2)
associated with antihypertensive##2##3##(2008-3#1)(2010-5#1)
associated with antiretroviral therapy##3##4##(2008-3#1)(2008-8#1)(2009-5#1)
associated with anxiety and##2##4##(1996-10#1)(2008-12#1)
associated with any of the##2##5##(2008-10#1)(2012-3#1)
associated with any##6##3##(2008-10#3)(2008-12#1)(2008-9#1)(2012-3#1)
associated with apoptosis##3##3##(1994-10#1)(2008-10#1)(2008-9#1)
associated with apposed##2##3##(2008-7#2)
associated with approximately##2##3##(1991-2#1)(2008-10#1)
associated with asthma##3##3##(1993-9#1)(2007-11#1)(2008-12#1)
associated with at least##2##4##(1990-3#1)(2013-1#1)
associated with atmospheric##2##3##(1995-11#1)(2008-3#1)
associated with autoimmune hepatitis##2##4##(2011-1#2)
associated with autoimmune##3##3##(2011-1#2)(2011-2#1)
associated with automation##2##3##(2008-10#2)
associated with avian##3##3##(1997-3#1)(2008-5#2)
associated with bacterial##2##3##(1997-3#1)(2008-4#1)
associated with bay laurel##2##4##(2008-10#2)
associated with being##2##3##(2012-2#1)(2013-8#1)
associated with better outcomes##2##4##(2008-7#1)(2011-1#1)
associated with better prognosis##2##4##(2008-6#1)(2012-2#1)
associated with better##11##3##(1993-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#1)(2012-2#2)
associated with bilateral##3##3##(2007-10#1)(2010-11#1)(2012-2#1)
associated with biological control##2##4##(2008-10#2)
associated with biological##4##3##(1997-6#1)(2008-10#3)
associated with bisphosphonate therapy##2##4##(2008-11#1)(2008-7#1)
associated with bleeding had##2##4##(2011-1#2)
associated with bleeding##5##3##(1991-9#1)(2011-1#4)
associated with bone##2##3##(2007-11#1)(2008-1#1)
associated with both the##4##4##(1991-10#1)(2008-5#1)(2010-7#1)(2012-3#1)
associated with both##20##3##(1990-8#1)(1991-10#1)(1991-5#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
associated with cancer##8##3##(1991-12#1)(1997-7#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-8#1)
associated with cardiac##2##3##(2008-10#1)(2012-12#1)
associated with cardiovascular disease##3##4##(1993-12#1)(2010-4#1)(2013-8#1)
associated with cardiovascular##6##3##(1993-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2013-8#2)
associated with carotid##2##3##(2007-10#1)(2008-1#1)
associated with cell wall##3##4##(2008-10#2)(2008-5#1)
associated with cell##9##3##(1992-10#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)
associated with central##2##3##(2010-11#1)(2011-1#1)
associated with cerebral##5##3##(1997-8#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#1)
associated with certain characteristics of##2##5##(1996-7#1)(2007-10#1)
associated with certain##6##3##(1994-2#1)(1996-2#1)(1996-7#1)(2007-10#1)(2008-11#1)(2013-1#1)
associated with cervical##2##3##(2006-10#1)(2011-2#1)
associated with changes in the##2##5##(1994-7#1)(2007-12#1)
associated with changes in##8##4##(1990-2#1)(1991-12#1)(1994-7#1)(2007-12#1)(2008-1#1)(2008-12#2)(2012-2#1)
associated with chronic##9##3##(1990-6#1)(1997-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-1#2)(2012-3#1)(2013-8#1)
associated with citrus##2##3##(2008-10#2)
associated with clavulanic acid##2##4##(1990-3#2)
associated with cleft##3##3##(2007-12#1)(2010-11#1)(2012-12#1)
associated with clinical symptoms##2##4##(2008-12#1)(2013-1#1)
associated with clinical##7##3##(2008-12#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#2)
associated with closantel##2##3##(2011-1#2)
associated with colonic polyposis -##2##5##(2009-12#2)
associated with common##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
associated with complex##2##3##(2008-5#1)(2010-10#1)
associated with complications such as##2##5##(2007-12#1)(2012-12#1)
associated with complications##4##3##(2007-11#1)(2007-12#1)(2010-12#1)(2012-12#1)
associated with components of##2##4##(1994-12#1)(2012-12#1)
associated with conditions##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
associated with congenital##3##3##(1992-6#1)(2011-2#1)(2012-3#1)
associated with considerable morbidity##2##4##(2011-2#1)(2012-3#1)
associated with considerable##4##3##(1992-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
associated with coronary bypass##2##4##(1996-9#2)
associated with coronary##3##3##(1996-9#2)(2008-7#1)
associated with corticosteroid##2##3##(2006-10#1)(2007-11#1)
associated with current##9##3##(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#2)
associated with death pathways##2##4##(2008-11#2)
associated with decreased expression of##3##5##(2008-10#1)(2009-5#1)(2012-1#1)
associated with decreased##18##3##(1996-5#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
associated with decreasing##2##3##(2008-11#1)(2008-7#1)
associated with defects in##2##4##(1991-7#1)(2012-3#1)
associated with deficits in##2##4##(1993-12#1)(2011-2#1)
associated with deficits##3##3##(1993-12#1)(2007-10#1)(2011-2#1)
associated with degenerative##2##3##(2013-1#1)(2013-8#1)
associated with delivering##2##3##(2008-12#2)
associated with dendritic##2##3##(1996-5#1)(2008-9#1)
associated with depressive##2##3##(1992-2#1)(2012-2#1)
associated with diabetes##6##3##(2008-1#2)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#1)
associated with differences in##4##4##(2008-10#1)(2008-9#1)(2009-12#1)(2011-2#1)
associated with different##11##3##(1992-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
associated with disclosure##3##3##(2009-4#3)
associated with disease progression##2##4##(2010-4#1)(2013-1#1)
associated with disease##6##3##(1995-3#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-4#1)(2013-1#1)
associated with diseased##4##3##(2008-10#4)
associated with dopaminergic##2##3##(1993-2#1)(1997-2#1)
associated with dry skin##3##4##(2008-5#3)
associated with dynamic##2##3##(2010-10#1)(2012-2#1)
associated with each##10##3##(1995-6#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2013-7#1)
associated with early sexual activity##2##5##(2013-8#2)
associated with early sexual##3##4##(2013-8#3)
associated with early##6##3##(2007-8#1)(2009-4#1)(2010-11#1)(2013-8#3)
associated with either##5##3##(1990-11#1)(2007-11#1)(2009-10#1)(2010-1#1)(2012-12#1)
associated with electrical##3##3##(1994-5#3)
associated with elevated concentrations of##2##5##(1992-3#1)(2013-1#1)
associated with elevated levels of##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
associated with elevated plasma##2##4##(2008-11#1)(2008-7#1)
associated with elevated serum##2##4##(1991-8#1)(2012-5#1)
associated with elevated##16##3##(1991-1#1)(1991-8#1)(1992-3#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-7#1)(2012-5#1)(2013-1#1)
associated with end-stage PDR##3##4##(2013-1#3)
associated with end-stage##4##3##(2013-1#4)
associated with enhanced##5##3##(1991-12#1)(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#1)
associated with enteropathogenicity##2##3##(2007-10#2)
associated with epileptic##2##3##(2008-7#1)(2010-4#1)
associated with evidence of##2##4##(1991-12#1)(2009-10#1)
associated with exercise##3##3##(2007-6#1)(2010-12#1)(2010-5#1)
associated with exposure to##4##4##(2007-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
associated with exposure##5##3##(2007-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)
associated with extension##2##3##(2007-10#1)(2013-8#1)
associated with facial##3##3##(2007-12#1)(2008-9#1)(2010-4#1)
associated with failure of##2##4##(1993-9#1)(2010-12#1)
associated with failure##3##3##(1993-9#1)(2010-12#1)(2010-6#1)
associated with familial amyloidotic polyneuropathy##2##5##(1992-8#2)
associated with familial##3##3##(1992-8#2)(2010-12#1)
associated with fewer##6##3##(2007-7#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
associated with fiber##2##3##(1992-11#1)(2008-2#1)
associated with food##3##3##(1993-6#1)(2011-2#1)(2012-1#1)
associated with four##3##3##(2008-10#2)(2013-8#1)
associated with frontal##2##3##(2008-4#1)(2009-6#1)
associated with further##2##3##(2008-1#1)(2008-7#1)
associated with gastric cancer##2##4##(1996-5#1)(2011-2#1)
associated with gastric##3##3##(1996-5#1)(2008-12#1)(2011-2#1)
associated with gene##4##3##(1997-4#1)(2007-11#1)(2008-8#1)(2012-3#1)
associated with generalized##4##3##(2008-1#2)(2013-1#1)(2013-8#1)
associated with genetic##2##3##(2008-8#1)(2012-12#1)
associated with good response in##2##5##(2011-2#2)
associated with good##3##3##(1990-6#1)(2011-2#2)
associated with greater##19##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
associated with growth##2##3##(1992-12#1)(1994-5#1)
associated with having##3##3##(2008-6#1)(2009-4#1)(2013-1#1)
associated with health and##3##4##(1997-2#1)(2008-7#1)(2012-1#1)
associated with health##5##3##(1993-2#1)(1997-2#1)(2008-7#1)(2010-5#1)(2012-1#1)
associated with heavy##3##3##(1991-12#1)(1995-3#1)(2013-1#1)
associated with hepatic##3##3##(1991-5#1)(1993-2#1)(2013-1#1)
associated with hepatitis C##3##4##(2010-4#1)(2013-1#2)
associated with hepatitis##4##3##(2007-12#1)(2010-4#1)(2013-1#2)
associated with hepatocellular carcinoma##2##4##(2009-9#1)(2013-8#1)
associated with hereditary##4##3##(1992-3#1)(1997-3#1)(2008-1#1)(2008-12#1)
associated with high blood##2##4##(1995-11#1)(1997-7#1)
associated with high disease severity##2##5##(2008-10#2)
associated with high morbidity and mortality##5##6##(2008-1#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
associated with high morbidity##6##4##(2007-7#1)(2008-1#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
associated with high mortality rate##2##5##(2007-7#1)(2012-3#1)
associated with high mortality##4##4##(2007-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
associated with high##32##3##(1990-2#1)(1990-3#1)(1991-4#1)(1992-5#1)(1994-8#1)(1995-11#1)(1997-7#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
associated with high-risk sexual behavior##2##5##(2013-1#2)
associated with high-risk sexual##3##4##(2009-5#1)(2013-1#2)
associated with higher body-focused anxiety than viewing no##2##8##(2007-12#2)
associated with higher levels of##3##5##(1994-2#1)(2008-11#1)(2009-5#1)
associated with higher mortality##3##4##(2013-1#3)
associated with higher rates of##3##5##(2008-11#1)(2009-8#1)(2013-1#1)
associated with higher risk##2##4##(1996-6#1)(2013-1#1)
associated with higher##31##3##(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-6#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
associated with hilar##2##3##(2007-8#1)(2012-2#1)
associated with host##4##3##(2008-10#3)(2008-8#1)
associated with human##5##3##(1997-8#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-1#1)
associated with hypercholesterolemia##2##3##(2008-1#1)(2013-1#1)
associated with hypertension and##2##4##(2008-7#1)(2009-9#1)
associated with hypertension##6##3##(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)
associated with hypospadias##2##3##(2008-10#2)
associated with immune dysfunction##2##4##(2008-10#1)(2008-12#1)
associated with immune##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
associated with immunity##2##3##(2008-8#1)(2012-3#1)
associated with impaired##4##3##(2008-1#1)(2008-4#1)(2008-7#1)(2013-8#1)
associated with impairment of##2##4##(1994-12#1)(2008-7#1)
associated with implementing##3##3##(1991-1#1)(1993-12#1)(1994-1#1)
associated with improved treatment response and##2##6##(2009-11#2)
associated with improved##11##3##(1997-1#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-11#2)(2010-4#1)(2012-2#1)
associated with improvements in##4##4##(2008-2#1)(2008-7#3)
associated with increased cancer risk##3##5##(1995-9#1)(2012-6#2)
associated with increased cardiovascular risk##2##5##(2008-6#1)(2012-3#1)
associated with increased cell##2##4##(1992-8#1)(2008-7#1)
associated with increased lipid peroxidation##2##5##(1994-6#1)(2012-2#1)
associated with increased morbidity and mortality##2##6##(2006-10#1)(2011-2#1)
associated with increased morbidity##3##4##(2006-10#1)(2010-12#1)(2011-2#1)
associated with increased mortality##2##4##(2011-2#2)
associated with increased rates of##2##5##(2008-10#1)(2008-2#1)
associated with increased risk for bladder cancer##2##7##(2008-4#2)
associated with increased risk for##7##5##(1993-12#2)(1993-3#1)(2007-10#1)(2008-4#2)(2010-10#1)
associated with increased risk of##7##5##(2006-5#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
associated with increased risk##16##4##(1993-12#2)(1993-3#1)(1993-9#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
associated with increased risks of##2##5##(2008-1#1)(2008-8#1)
associated with increased use of##2##5##(2007-10#1)(2008-8#1)
associated with increased##88##3##(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2012-6#2)(2013-1#6)(2013-7#1)(2013-8#1)
associated with increases in the##2##5##(1991-5#1)(2008-10#1)
associated with increases in##5##4##(1991-5#1)(1993-3#1)(1997-7#1)(2008-10#1)(2009-9#1)
associated with increasing##6##3##(1996-2#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#2)
associated with individual change in##2##5##(2008-12#2)
associated with individual##3##3##(2008-12#2)(2013-1#1)
associated with indoor##2##3##(1991-3#2)
associated with induction of##2##4##(1991-12#1)(2008-6#1)
associated with infection by##2##4##(2008-10#2)
associated with infection##4##3##(2008-10#3)(2011-2#1)
associated with infections##2##3##(2011-2#2)
associated with inflammation##3##3##(2008-3#1)(2012-12#1)(2013-1#1)
associated with inflammatory bowel disease (IBD)##3##6##(2010-12#1)(2011-2#1)(2013-8#1)
associated with inflammatory bowel##5##4##(2010-12#2)(2011-2#2)(2013-8#1)
associated with ingestion of a cloperastine containing##2##7##(2008-7#2)
associated with ingestion##3##3##(1993-12#1)(2008-7#2)
associated with inhibition of##2##4##(2012-2#1)(2013-7#1)
associated with injection##2##3##(2013-1#1)(2013-8#1)
associated with insulin resistance and##2##5##(2008-4#1)(2013-1#1)
associated with insulin resistance##5##4##(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
associated with insulin##6##3##(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
associated with intense##2##3##(2008-5#1)(2008-7#1)
associated with intensive##2##3##(2008-10#2)
associated with internal##2##3##(1990-5#1)(2008-10#1)
associated with intracranial##2##3##(2008-7#1)(2012-12#1)
associated with ischemic stroke##3##4##(2007-10#2)(2008-9#1)
associated with it##5##3##(1991-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2011-2#1)
associated with its##9##3##(1990-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#2)
associated with lack of##2##4##(2009-10#1)(2013-1#1)
associated with late##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
associated with left##3##3##(1991-8#1)(2008-12#1)(2009-5#1)
associated with leprosy##4##3##(2012-12#4)
associated with less##10##3##(2008-10#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-9#1)(2013-1#2)
associated with limb##2##3##(1991-8#1)(2012-2#1)
associated with lineage##2##3##(2010-8#2)
associated with liver##2##3##(1994-6#1)(2013-8#1)
associated with local##2##3##(1991-9#1)(2008-9#1)
associated with locomotion##2##3##(1990-8#1)(2008-9#1)
associated with long##2##3##(2008-10#1)(2012-2#1)
associated with longer##3##3##(2007-7#1)(2007-8#1)(2012-3#1)
associated with loss of##5##4##(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#2)
associated with loss##6##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
associated with low##9##3##(1990-5#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)(2012-6#1)
associated with lower levels of##4##5##(1995-3#1)(2009-5#2)(2012-2#1)
associated with lower##25##3##(1990-3#1)(1993-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-7#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-7#2)(2011-1#3)(2012-1#2)(2012-2#1)(2013-1#4)
associated with lung##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
associated with magnetic resonance imaging##2##5##(1992-3#1)(1995-12#1)
associated with major gene controlling litter size in commercial pig breeds##2##11##(2008-8#2)
associated with major##6##3##(1996-7#1)(2008-8#2)(2011-2#2)(2012-12#1)
associated with male##3##3##(1993-5#1)(2008-8#1)(2013-1#1)
associated with malignancy##5##3##(2007-5#1)(2008-7#1)(2009-12#1)(2013-8#2)
associated with many##4##3##(2008-1#1)(2008-12#1)(2008-2#1)(2010-8#1)
associated with marked##4##3##(1991-5#1)(1994-8#1)(1996-2#1)(2008-10#1)
associated with massive##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
associated with maternal##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)
associated with mating##2##3##(2007-12#1)(2008-9#1)
associated with medical procedures##2##4##(2009-9#1)(2010-4#1)
associated with medical##3##3##(1990-11#1)(2009-9#1)(2010-4#1)
associated with membranes##2##3##(1994-6#1)(2009-10#1)
associated with metabolic syndrome##3##4##(2008-3#1)(2011-1#1)(2013-8#1)
associated with metabolic##5##3##(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
associated with metronidazole resistance##2##4##(1997-7#2)
associated with microvascular decompression for trigeminal neuralgia##2##7##(2011-2#2)
associated with migration##2##3##(2008-3#1)(2008-7#1)
associated with mild##3##3##(1994-6#1)(2007-10#1)(2007-7#1)
associated with minimal##2##3##(2013-1#2)
associated with minimally invasive##2##4##(2011-2#2)
associated with mitochondrial##2##3##(1994-11#1)(2009-9#1)
associated with moderate##3##3##(1991-6#1)(2008-11#1)(2012-3#1)
associated with moral##2##3##(2008-11#1)(2013-8#1)
associated with more negative##2##4##(2008-12#1)(2010-1#1)
associated with more than##3##4##(2008-10#2)(2012-3#1)
associated with more##19##3##(1995-3#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
associated with mortality##2##3##(2008-7#1)(2013-1#1)
associated with multiple myeloma in##3##5##(2011-2#3)
associated with multiple myeloma##4##4##(2011-2#4)
associated with multiple##11##3##(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#5)(2011-7#1)
associated with myocardial infarction and##2##5##(2008-8#1)(2009-9#1)
associated with myocardial infarction##4##4##(1994-3#1)(2008-8#1)(2009-9#2)
associated with natural##2##3##(2008-7#1)(2012-12#1)
associated with negative##2##3##(2009-12#1)(2010-2#1)
associated with neoplastic##2##3##(1992-3#1)(2012-2#1)
associated with neurofibromatosis##3##3##(1997-3#1)(2008-6#1)(2009-1#1)
associated with neuronal##2##3##(2008-7#1)(2009-6#1)
associated with neuropathic pain##2##4##(2008-6#1)(2008-9#1)
associated with nitrogen fixation##2##4##(2009-7#2)
associated with no##3##3##(1995-12#2)(1996-12#1)
associated with non-acceptance of hepatitis B##2##6##(2008-9#2)
associated with normal##4##3##(1996-2#1)(2008-10#2)(2011-1#1)
associated with obesity##3##3##(2010-5#1)(2011-1#1)(2013-1#1)
associated with obstructive##2##3##(2008-7#1)(2012-2#1)
associated with one##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
associated with only##2##3##(2008-8#1)(2012-2#1)
associated with oral##4##3##(2007-10#1)(2008-1#1)(2013-1#2)
associated with osteoarthritis of the knee##2##6##(2007-11#1)(2010-12#1)
associated with other##17##3##(1992-12#1)(1993-6#1)(1996-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
associated with outcomes##2##3##(2008-12#2)
associated with oxidative stress##2##4##(1991-9#1)(2008-5#1)
associated with pain and##2##4##(2012-12#1)(2013-1#1)
associated with pain##7##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
associated with partial resistance to##3##5##(2008-10#3)
associated with partial resistance##6##4##(2008-10#6)
associated with partial##7##3##(1992-6#1)(2008-10#6)
associated with particular##3##3##(1993-9#1)(2008-5#1)(2008-8#1)
associated with past##3##3##(2010-9#1)(2012-1#2)
associated with pathogenicity##3##3##(2008-10#2)(2008-5#1)
associated with peripheral##2##3##(2011-1#1)(2013-8#1)
associated with peroxisome proliferation##2##4##(1995-3#2)
associated with pharmacological##2##3##(1997-6#1)(2012-3#1)
associated with physical##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)
associated with physician##2##3##(1993-1#1)(2013-1#1)
associated with plant##2##3##(2007-12#1)(2008-10#1)
associated with plants##3##3##(2008-10#3)
associated with plasma##3##3##(1991-2#1)(1997-8#1)(2008-7#1)
associated with pneumonia##2##3##(2008-7#1)(2011-2#1)
associated with poor outcome##5##4##(1994-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
associated with poor prognosis##5##4##(1994-11#1)(2009-5#2)(2011-2#1)(2011-3#1)
associated with poor survival##2##4##(1991-2#1)(2008-7#1)
associated with poor##23##3##(1990-6#1)(1991-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1997-7#1)(2007-2#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-5#3)(2011-2#4)(2011-3#1)(2012-12#2)(2013-8#1)
associated with poorer performance##2##4##(2011-2#1)(2012-1#1)
associated with poorer##8##3##(2007-12#1)(2008-1#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
associated with positive discography in patients with lumbar discogenic pain are caused by##2##13##(2012-12#2)
associated with positive##6##3##(1992-12#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#2)
associated with postoperative##2##3##(1995-2#1)(2009-3#1)
associated with previous##2##3##(2008-1#1)(2012-3#1)
associated with primary##4##3##(2006-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
associated with prior##2##3##(2009-9#1)(2013-8#1)
associated with proliferation##2##3##(2008-10#1)(2011-2#1)
associated with protein##2##3##(1994-5#1)(2008-11#1)
associated with pulmonary hypertension##2##4##(2010-12#1)(2012-3#1)
associated with pulmonary##5##3##(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
associated with putting##2##3##(2010-12#1)(2013-1#1)
associated with quantitative##3##3##(2008-5#1)(2012-3#2)
associated with raised##2##3##(1990-5#1)(1991-12#1)
associated with rapid##4##3##(1997-3#1)(2007-7#1)(2010-6#1)(2012-2#1)
associated with rebleeding##2##3##(2008-7#1)(2013-1#1)
associated with reduced risk of##2##5##(2010-1#1)(2012-1#1)
associated with reduced##14##3##(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
associated with reduction of##2##4##(2008-10#1)(2013-1#1)
associated with reductions in##5##4##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
associated with relapse##2##3##(1993-11#1)(2010-4#1)
associated with relatively##2##3##(2008-10#2)
associated with renal disease##2##4##(2007-12#1)(2007-7#1)
associated with renal##8##3##(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
associated with repeat prescriptions##3##4##(2008-11#3)
associated with repeat##4##3##(2008-11#4)
associated with repetitive##2##3##(1991-5#1)(2012-3#1)
associated with resistance to##11##4##(2008-10#10)(2009-5#1)
associated with resistance were##2##4##(2008-10#2)
associated with resistance##18##3##(2008-10#16)(2008-9#1)(2009-5#1)
associated with respiratory##2##3##(1991-8#1)(2012-12#1)
associated with response##2##3##(2012-2#1)(2013-1#1)
associated with right##2##3##(2008-2#1)(2012-12#1)
associated with risk of##7##4##(1993-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)
associated with risk##9##3##(1993-9#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)
associated with rupture##2##3##(1990-11#1)(2010-7#1)
associated with sCysC in SLE##2##5##(2013-1#2)
associated with schistosomiasis##2##3##(2008-8#2)
associated with schizophrenia##3##3##(1996-5#1)(1997-5#1)(2009-12#1)
associated with seasonal influenza##2##4##(2011-2#2)
associated with seasonal##3##3##(2008-8#1)(2011-2#2)
associated with seizure##2##3##(2008-2#1)(2010-1#1)
associated with selected##3##3##(2008-8#1)(2010-4#1)(2013-8#1)
associated with senescence##2##3##(1994-5#1)(1995-8#1)
associated with serious complications##2##4##(1992-2#1)(2013-1#1)
associated with serious##5##3##(1992-2#1)(2009-6#1)(2010-8#1)(2013-1#2)
associated with several other##2##4##(2011-1#1)(2012-2#1)
associated with several##10##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
associated with severe enterorrhagia##2##4##(1990-9#2)
associated with severe periodontitis in rural##2##6##(2008-10#2)
associated with severe periodontitis in##3##5##(2008-10#3)
associated with severe periodontitis##4##4##(2008-10#4)
associated with severe##19##3##(1990-9#2)(1996-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
associated with severity of##2##4##(1996-7#1)(2013-1#1)
associated with severity##3##3##(1996-7#1)(2007-10#1)(2013-1#1)
associated with sex##2##3##(2010-3#1)(2011-2#1)
associated with sexual##6##3##(1995-12#1)(2009-5#2)(2009-7#1)(2010-4#1)(2013-1#1)
associated with shortened##2##3##(2007-2#1)(2008-1#1)
associated with shorter##3##3##(1993-10#1)(1995-4#1)(2013-1#1)
associated with shoulder##3##3##(1996-9#1)(2007-11#1)(2008-12#1)
associated with side effects##2##4##(2008-8#1)(2012-1#1)
associated with side-effects##2##3##(2008-5#1)(2008-7#1)
associated with significant increases in##2##5##(2008-1#1)(2010-12#1)
associated with significant morbidity and mortality##4##6##(2006-10#1)(2008-7#1)(2012-1#1)(2013-8#1)
associated with significant morbidity##8##4##(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-8#1)
associated with significant reductions in##3##5##(1995-1#1)(2008-10#2)
associated with significant##24##3##(1990-5#1)(1990-6#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-4#2)(2008-7#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
associated with significantly##6##3##(1993-9#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
associated with similar##2##3##(1994-8#1)(2007-10#1)
associated with six##2##3##(1993-1#1)(2008-10#1)
associated with skeletal##3##3##(2008-7#2)(2013-8#1)
associated with skin##2##3##(1994-6#1)(2007-12#1)
associated with small cell carcinoma of the gallbladder##2##8##(2009-3#2)
associated with small cell##3##4##(1996-2#1)(2009-3#2)
associated with smoking##7##3##(1990-9#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#2)
associated with social##2##3##(1991-12#1)(2008-4#1)
associated with some##7##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
associated with specific##8##3##(1990-6#1)(2008-10#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
associated with spinal##3##3##(2007-8#2)(2011-2#1)
associated with spontaneous clearance of##2##5##(2012-2#2)
associated with spontaneous##5##3##(2008-10#1)(2012-12#1)(2012-2#3)
associated with squamous cell carcinoma##2##5##(1993-8#1)(2007-7#1)
associated with statistically##2##3##(1994-2#1)(2010-7#1)
associated with stress##2##3##(1994-6#1)(2012-2#1)
associated with stroke and##2##4##(1995-3#1)(2007-10#1)
associated with stroke##5##3##(1995-3#1)(2007-10#4)
associated with stronger##2##3##(2009-11#1)(2010-6#1)
associated with substance##2##3##(1994-2#1)(2008-5#1)
associated with substantial##3##3##(1993-3#1)(2011-2#1)(2013-8#1)
associated with successful##5##3##(1990-3#1)(1994-3#1)(2007-4#1)(2008-10#1)(2013-1#1)
associated with such a##2##4##(1993-11#1)(2008-2#1)
associated with such##5##3##(1993-11#1)(1994-2#1)(2008-2#1)(2008-3#1)(2011-2#1)
associated with survival##2##3##(2007-11#1)(2009-12#1)
associated with susceptibility to##4##4##(1995-5#1)(2008-1#1)(2008-10#1)(2013-1#1)
associated with susceptibility##5##3##(1995-5#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
associated with symptoms of##4##4##(1996-7#1)(2007-8#1)(2008-2#1)(2012-1#1)
associated with symptoms##5##3##(1990-3#1)(1996-7#1)(2007-8#1)(2008-2#1)(2012-1#1)
associated with systemic##5##3##(1995-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-7#1)
associated with tall##2##3##(2008-10#2)
associated with the Airy caustics of##2##6##(2008-2#2)
associated with the ability of##2##5##(2009-9#2)
associated with the activation of##2##5##(2009-12#1)(2012-2#1)
associated with the aetiology of##2##5##(1997-4#1)(2013-8#1)
associated with the analysis of##2##5##(2008-10#1)(2010-11#1)
associated with the appearance of##3##5##(1995-8#1)(2011-2#1)(2012-12#1)
associated with the best##2##4##(1995-5#1)(2011-2#1)
associated with the contribution from the downward path##2##8##(2008-3#2)
associated with the course##2##4##(2008-10#1)(2008-11#1)
associated with the crown of Mauritia flexuosa (Arecaceae)##2##8##(2008-6#2)
associated with the crown of##3##5##(2008-6#2)(2013-1#1)
associated with the cytoplasmic##2##4##(1990-8#1)(2009-11#1)
associated with the degree of##3##5##(1996-4#1)(2008-8#2)
associated with the development and##2##5##(2007-11#1)(2011-2#1)
associated with the development of##13##5##(1995-2#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
associated with the development##15##4##(1995-2#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
associated with the disease##8##4##(1991-2#1)(1994-9#1)(2008-10#2)(2013-1#3)(2013-8#1)
associated with the distribution##2##4##(2008-2#1)(2010-8#1)
associated with the emergence##2##4##(2008-11#1)(2012-3#1)
associated with the enzyme##2##4##(1991-12#1)(2008-3#1)
associated with the expression of##4##5##(1990-7#1)(1994-9#1)(2008-3#1)(2009-9#1)
associated with the formation of##2##5##(1992-2#1)(2013-8#1)
associated with the full##2##4##(2007-12#1)(2008-10#1)
associated with the genetic##2##4##(2008-4#1)(2008-9#1)
associated with the health##2##4##(1994-12#1)(2013-7#1)
associated with the high##2##4##(1990-8#1)(2007-10#1)
associated with the higher##3##4##(2010-2#2)(2011-2#1)
associated with the host##2##4##(2008-10#1)(2008-5#1)
associated with the identification of##3##5##(1993-12#1)(2008-10#1)(2009-8#1)
associated with the implementation of this##3##6##(1996-1#1)(1996-2#1)(2008-11#1)
associated with the implementation of##4##5##(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
associated with the importance##2##4##(1995-1#1)(2009-8#1)
associated with the incidence##2##4##(2007-8#1)(2013-1#1)
associated with the increase##4##4##(2008-11#1)(2011-1#2)(2011-2#1)
associated with the induction of##4##5##(1991-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
associated with the injection of##2##5##(2011-2#2)
associated with the introduction of##3##5##(1990-12#1)(1993-1#1)(2008-11#1)
associated with the loss of##2##5##(2008-11#1)(2011-3#1)
associated with the low##2##4##(1990-8#1)(1996-12#1)
associated with the membranes in a##2##6##(1990-7#1)(1991-10#1)
associated with the metabolic syndrome##6##5##(2008-1#1)(2010-4#2)(2011-2#2)(2012-2#1)
associated with the new##2##4##(2007-9#1)(2008-4#1)
associated with the nucleus##2##4##(1993-8#1)(1997-1#1)
associated with the number##2##4##(2008-3#1)(2013-1#1)
associated with the observed##3##4##(1993-3#1)(2008-12#1)(2011-2#1)
associated with the occurrence of pain##2##6##(2010-12#2)
associated with the occurrence of##4##5##(1995-2#1)(2010-12#2)(2013-1#1)
associated with the onset of##2##5##(1995-12#1)(2007-5#1)
associated with the presence of##12##5##(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1996-12#1)(1996-7#1)(2008-10#3)(2011-2#2)(2013-1#1)
associated with the prevalence of##2##5##(1993-5#1)(2008-3#1)
associated with the production of##3##5##(2006-6#1)(2007-12#1)(2008-8#1)
associated with the progression of##2##5##(1993-12#1)(2008-1#1)
associated with the rare##2##4##(2008-10#1)(2012-3#1)
associated with the reaction of##2##5##(1995-6#1)(2010-4#1)
associated with the release##2##4##(2008-10#1)(2011-2#1)
associated with the risk of RA##2##6##(2010-12#2)
associated with the risk of##6##5##(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#2)(2010-4#1)
associated with the surgical##2##4##(1996-9#1)(2011-2#1)
associated with the synthesis##2##4##(2008-10#1)(2011-2#1)
associated with the transition##2##4##(2007-11#1)(2007-7#1)
associated with the two##2##4##(2006-6#1)(2007-11#1)
associated with the use of##16##5##(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
associated with the##502##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#4)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#7)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#3)(2006-6#3)(2007-10#4)(2007-11#6)(2007-12#13)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#73)(2008-11#18)(2008-12#4)(2008-2#15)(2008-3#25)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#19)(2008-8#7)(2008-9#10)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#2)(2009-8#5)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#27)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#10)(2012-3#5)(2013-1#19)(2013-7#1)(2013-8#9)
associated with their use##5##4##(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
associated with their##16##3##(1993-12#1)(1995-3#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2011-3#2)(2013-1#1)
associated with them##3##3##(2008-10#2)(2008-11#1)
associated with therapeutic##2##3##(2008-12#1)(2012-12#1)
associated with these changes##2##4##(1993-2#1)(2009-8#1)
associated with these disorders##2##4##(1997-3#1)(2012-3#1)
associated with these events##3##4##(2009-6#1)(2011-2#1)(2012-12#1)
associated with these##32##3##(1990-11#1)(1993-10#1)(1993-2#2)(1994-2#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
associated with this disease##5##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)
associated with this procedure##2##4##(2007-7#1)(2008-11#1)
associated with this##42##3##(1991-12#1)(1991-3#1)(1994-2#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
associated with thoracic##2##3##(2008-8#1)(2009-8#1)
associated with three##4##3##(2007-8#1)(2008-10#2)(2010-12#1)
associated with thyroid##5##3##(1990-6#2)(2008-4#1)(2013-1#2)
associated with tolerance##3##3##(2008-10#2)(2011-10#1)
associated with tooth##2##3##(2008-12#1)(2013-1#1)
associated with transcriptional##2##3##(1991-2#1)(2011-2#1)
associated with traumatic##2##3##(2008-7#2)
associated with treatment##7##3##(1997-3#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#1)
associated with tremolite##2##3##(1991-12#2)
associated with tumor##6##3##(1991-8#1)(1994-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
associated with two distinct##2##4##(1991-11#1)(2012-12#1)
associated with two##5##3##(1991-11#1)(2008-10#2)(2008-3#1)(2012-12#1)
associated with type 2 diabetes##2##5##(2008-1#1)(2008-3#1)
associated with typical##3##3##(1997-2#1)(2013-1#2)
associated with tyrosine##2##3##(1994-8#1)(2008-4#1)
associated with unintentional injury in a##2##6##(2013-1#2)
associated with urinary flow impairment##2##5##(2008-10#2)
associated with use of osteoporosis drugs##3##6##(2010-3#3)
associated with use of##6##4##(1996-8#1)(2008-11#1)(2010-3#3)(2013-8#1)
associated with using the traditional##2##5##(2008-10#1)(2008-11#1)
associated with using##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)
associated with variation in##2##4##(2007-12#1)(2007-8#1)
associated with various##9##3##(1992-8#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-8#2)(2010-2#1)(2012-3#1)(2013-8#1)
associated with varying levels of##2##5##(1994-2#1)(2007-12#1)
associated with vascular disease##2##4##(2008-3#1)(2009-4#1)
associated with vascular##5##3##(2008-3#1)(2009-4#1)(2010-10#1)(2013-1#1)(2013-8#1)
associated with venous##2##3##(1996-6#1)(2008-9#1)
associated with very##3##3##(1993-3#1)(2008-3#1)(2010-1#1)
associated with victimization##3##3##(2009-5#3)
associated with viral contaminations in##2##5##(2008-11#2)
associated with viral##4##3##(2008-11#2)(2008-8#1)(2013-1#1)
associated with visual imagery##2##4##(2008-11#2)
associated with vitamin##2##3##(2007-9#1)(2012-2#1)
associated with von##2##3##(2008-10#1)(2008-12#1)
associated with yellow##2##3##(2008-10#2)
associated with##3861##2##(1990-10#1)(1990-11#11)(1990-12#9)(1990-2#4)(1990-3#11)(1990-5#16)(1990-6#11)(1990-7#8)(1990-8#14)(1990-9#13)(1991-1#6)(1991-10#4)(1991-11#8)(1991-12#21)(1991-2#7)(1991-3#16)(1991-4#4)(1991-5#12)(1991-6#6)(1991-7#2)(1991-8#17)(1991-9#9)(1992-1#2)(1992-10#4)(1992-11#6)(1992-12#13)(1992-2#14)(1992-3#19)(1992-4#1)(1992-5#7)(1992-6#9)(1992-8#15)(1992-9#10)(1993-1#8)(1993-10#2)(1993-11#13)(1993-12#20)(1993-2#11)(1993-3#13)(1993-5#2)(1993-6#11)(1993-8#12)(1993-9#12)(1994-1#5)(1994-10#1)(1994-11#12)(1994-12#14)(1994-2#16)(1994-3#10)(1994-5#10)(1994-6#14)(1994-7#3)(1994-8#18)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#25)(1995-2#18)(1995-3#17)(1995-4#1)(1995-5#12)(1995-6#12)(1995-8#13)(1995-9#4)(1996-1#9)(1996-10#4)(1996-11#2)(1996-12#14)(1996-2#19)(1996-3#8)(1996-4#1)(1996-5#8)(1996-6#8)(1996-7#6)(1996-8#3)(1996-9#9)(1997-1#10)(1997-2#10)(1997-3#19)(1997-4#9)(1997-5#9)(1997-6#8)(1997-7#17)(1997-8#12)(2006-10#8)(2006-12#3)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#49)(2007-11#35)(2007-12#77)(2007-2#7)(2007-4#3)(2007-5#8)(2007-6#6)(2007-7#29)(2007-8#34)(2007-9#5)(2008-1#68)(2008-10#446)(2008-11#110)(2008-12#61)(2008-2#55)(2008-3#93)(2008-4#55)(2008-5#72)(2008-6#47)(2008-7#178)(2008-8#79)(2008-9#70)(2009-1#7)(2009-10#17)(2009-11#15)(2009-12#25)(2009-2#5)(2009-3#14)(2009-4#17)(2009-5#49)(2009-6#9)(2009-7#25)(2009-8#25)(2009-9#29)(2010-1#14)(2010-10#21)(2010-11#26)(2010-12#38)(2010-2#11)(2010-3#15)(2010-4#28)(2010-5#27)(2010-6#24)(2010-7#15)(2010-8#20)(2010-9#8)(2011-1#78)(2011-10#1)(2011-2#208)(2011-3#5)(2011-7#2)(2012-1#31)(2012-12#91)(2012-2#110)(2012-3#81)(2012-5#4)(2012-6#4)(2013-1#217)(2013-7#19)(2013-8#103)
associated##4513##1##(1990-10#2)(1990-11#15)(1990-12#9)(1990-2#7)(1990-3#12)(1990-5#16)(1990-6#13)(1990-7#10)(1990-8#14)(1990-9#15)(1991-1#9)(1991-10#4)(1991-11#8)(1991-12#24)(1991-2#11)(1991-3#19)(1991-4#4)(1991-5#12)(1991-6#9)(1991-7#2)(1991-8#18)(1991-9#10)(1992-1#2)(1992-10#6)(1992-11#6)(1992-12#13)(1992-2#14)(1992-3#23)(1992-4#1)(1992-5#7)(1992-6#15)(1992-8#16)(1992-9#15)(1993-1#9)(1993-10#2)(1993-11#13)(1993-12#21)(1993-2#13)(1993-3#16)(1993-5#2)(1993-6#12)(1993-8#16)(1993-9#15)(1994-1#5)(1994-10#1)(1994-11#12)(1994-12#17)(1994-2#19)(1994-3#15)(1994-5#13)(1994-6#15)(1994-7#3)(1994-8#21)(1994-9#7)(1995-1#7)(1995-10#3)(1995-11#7)(1995-12#31)(1995-2#22)(1995-3#17)(1995-4#1)(1995-5#13)(1995-6#14)(1995-8#14)(1995-9#5)(1996-1#9)(1996-10#4)(1996-11#2)(1996-12#17)(1996-2#21)(1996-3#10)(1996-4#1)(1996-5#10)(1996-6#10)(1996-7#6)(1996-8#3)(1996-9#9)(1997-1#15)(1997-2#10)(1997-3#21)(1997-4#11)(1997-5#9)(1997-6#8)(1997-7#18)(1997-8#14)(2006-10#9)(2006-12#3)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#52)(2007-11#40)(2007-12#84)(2007-2#7)(2007-4#3)(2007-5#9)(2007-6#7)(2007-7#37)(2007-8#43)(2007-9#6)(2008-1#81)(2008-10#533)(2008-11#141)(2008-12#66)(2008-2#63)(2008-3#108)(2008-4#66)(2008-5#93)(2008-6#51)(2008-7#211)(2008-8#94)(2008-9#85)(2009-1#8)(2009-10#24)(2009-11#16)(2009-12#26)(2009-2#5)(2009-3#20)(2009-4#18)(2009-5#56)(2009-6#13)(2009-7#29)(2009-8#32)(2009-9#31)(2010-1#15)(2010-10#23)(2010-11#31)(2010-12#43)(2010-2#12)(2010-3#15)(2010-4#29)(2010-5#33)(2010-6#26)(2010-7#16)(2010-8#23)(2010-9#9)(2011-1#90)(2011-10#2)(2011-2#247)(2011-3#5)(2011-7#2)(2012-1#32)(2012-12#106)(2012-2#132)(2012-3#93)(2012-5#4)(2012-6#4)(2013-1#257)(2013-7#21)(2013-8#118)
associated)##2##1##(1990-2#1)(2011-2#1)
associated?##2##1##(2006-10#1)(2008-8#1)
associates and##3##2##(2008-10#1)(2008-7#2)
associates for the##2##3##(1990-2#1)(2012-3#1)
associates for##4##2##(1990-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
associates of##8##2##(1997-4#1)(2008-10#5)(2008-7#1)(2010-6#1)
associates specifically with##2##3##(1994-12#1)(1994-8#1)
associates with the##7##3##(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1997-1#1)(2008-10#1)
associates with##19##2##(1990-5#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-2#2)(1997-1#1)(2007-10#1)(2008-10#3)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)
associates##52##1##(1990-2#1)(1990-5#1)(1991-1#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#4)(1995-12#1)(1995-2#2)(1996-2#1)(1997-1#1)(1997-4#2)(2007-10#1)(2008-10#15)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
associating with##6##2##(1994-6#1)(1997-3#1)(2008-8#1)(2009-9#2)(2012-2#1)
associating##16##1##(1990-3#1)(1991-12#1)(1994-6#1)(1997-3#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#2)(2012-2#1)(2013-7#1)(2013-8#1)
association (GWA)##2##2##(2011-2#1)(2012-3#1)
association (OR=4##2##2##(2012-12#2)
association among##7##2##(1992-6#1)(1994-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-7#1)
association analyses##2##2##(2008-10#1)(2008-4#1)
association analysis of##4##3##(2012-3#4)
association analysis##8##2##(1997-5#1)(2011-2#1)(2012-3#6)
association and dissociation##3##3##(1991-5#1)(1993-1#1)(2008-10#1)
association and the##3##3##(1992-6#2)(2008-8#1)
association and##15##2##(1991-5#1)(1991-8#1)(1992-6#2)(1993-1#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-8#3)(2009-10#1)
association approach##2##2##(2008-9#1)(2012-12#1)
association are##3##2##(1991-12#1)(2008-7#1)(2011-1#1)
association areas##3##2##(1997-2#2)(2011-2#1)
association as a##2##3##(2008-10#2)
association as##3##2##(2008-10#3)
association at##2##2##(1996-5#1)(2008-10#1)
association between H##3##3##(2008-5#1)(2013-1#1)(2013-7#1)
association between IBS and##2##4##(2013-1#2)
association between IMT##2##3##(2012-3#2)
association between a##3##3##(1997-4#1)(2008-8#1)(2010-11#1)
association between age##2##3##(2008-8#1)(2011-2#1)
association between clinical##2##3##(2008-1#1)(2012-12#1)
association between different types of exercise training##2##7##(2013-1#2)
association between different##4##3##(1993-8#1)(2008-9#1)(2013-1#2)
association between expression of##2##4##(1992-2#1)(1993-1#1)
association between family##2##3##(2011-2#1)(2013-8#1)
association between food##2##3##(2008-1#1)(2012-12#1)
association between gender and##2##4##(2012-12#2)
association between instrument type and##2##5##(2012-12#2)
association between interparental conflict and##3##5##(2010-1#3)
association between low birth weight and##2##6##(2012-2#2)
association between low##3##3##(2008-3#1)(2012-2#2)
association between manic-depressive illness and##2##5##(1997-5#2)
association between maternal##2##3##(2009-7#1)(2011-2#1)
association between migraine##3##3##(2008-9#3)
association between obesity and##2##4##(2009-2#1)(2009-7#1)
association between p53##2##3##(1994-7#1)(2013-8#1)
association between perceived##2##3##(2011-2#1)(2012-2#1)
association between polymorphisms in##2##4##(1997-5#1)(2008-10#1)
association between polymorphisms##3##3##(1997-5#1)(2008-10#1)(2011-1#1)
association between positive##2##3##(1990-3#1)(2007-10#1)
association between prenatal care and birth##2##6##(1992-2#1)(1995-2#1)
association between prenatal##3##3##(1992-2#1)(1995-2#1)(2008-2#1)
association between religion and under-five mortality##2##6##(2009-6#2)
association between serum uric acid levels##2##6##(2011-1#2)
association between serum uric acid##3##5##(2011-1#3)
association between serum##4##3##(2011-1#4)
association between sex##2##3##(2008-1#1)(2008-10#1)
association between sexual behavior and##2##5##(2009-7#2)
association between sleep##2##3##(1996-7#1)(2013-1#1)
association between the frequency of family dinners and positive and negative dimensions of##2##13##(2013-1#2)
association between the##34##3##(1990-2#1)(1990-8#1)(1990-9#1)(1995-2#1)(1995-5#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-2#1)(2010-3#1)(2011-2#4)(2012-2#3)(2013-1#4)(2013-8#4)
association between these two##3##4##(1993-12#1)(2011-1#1)(2012-3#1)
association between these##7##3##(1993-12#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
association between this##3##3##(2008-6#1)(2012-12#1)(2013-1#1)
association between two##2##3##(2008-10#1)(2012-12#1)
association between##287##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-3#1)(1991-8#2)(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#4)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#5)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#6)(2008-10#17)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#3)(2009-7#8)(2009-8#2)(2009-9#1)(2010-1#6)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#15)(2011-2#25)(2012-12#18)(2012-2#11)(2012-3#7)(2013-1#30)(2013-7#1)(2013-8#10)
association complex of##2##3##(2008-10#2)
association complex##9##2##(2008-10#9)
association complexes##2##2##(2008-10#2)
association constant for##3##3##(2008-10#3)
association constant of the##2##4##(2008-10#2)
association constant of##4##3##(2008-10#4)
association constant##11##2##(1996-5#1)(2008-10#10)
association constants of##3##3##(2008-10#3)
association constants vary##2##3##(2008-10#2)
association constants were##3##3##(2008-10#3)
association constants##21##2##(2008-10#20)(2008-8#1)
association cortex##3##2##(1997-2#3)
association could be##2##3##(1993-12#1)(2011-2#1)
association emerged between##2##3##(1991-12#1)(2012-12#1)
association for##3##2##(1990-12#1)(1994-2#1)(2008-10#1)
association from##2##2##(2008-10#1)(2008-8#1)
association has been##3##3##(1993-8#1)(1996-1#1)(2010-6#1)
association has##6##2##(1993-8#2)(1996-1#1)(2008-10#2)(2010-6#1)
association in##10##2##(1997-8#1)(2008-10#4)(2008-7#1)(2009-5#1)(2012-3#2)(2012-5#1)
association is made##2##3##(1990-6#1)(1997-7#1)
association is##23##2##(1990-2#1)(1990-6#1)(1991-5#1)(1991-8#1)(1994-5#1)(1997-1#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
association of 125I-calmodulin with##2##4##(1991-12#2)
association of 125I-calmodulin##3##3##(1991-12#3)
association of Borrelia burgdorferi##2##4##(2011-2#2)
association of PtdIns 3-kinase##2##4##(1992-12#2)
association of a##4##3##(1993-3#1)(1997-5#1)(2008-10#1)(2009-7#1)
association of both##2##3##(2008-10#1)(2009-2#1)
association of genotype##2##3##(2008-10#1)(2008-7#1)
association of low##2##3##(2007-10#1)(2013-7#1)
association of protein 4##2##4##(1994-12#2)
association of rare##2##3##(2012-3#2)
association of the##15##3##(1990-2#1)(1991-8#1)(1992-12#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-12#1)
association of these##6##3##(1991-3#1)(1996-2#1)(2008-10#3)(2008-3#1)
association of this##5##3##(1995-6#1)(2008-10#2)(2009-8#1)(2012-12#1)
association of two##6##3##(1990-2#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-2#1)
association of vasectomy##2##3##(1990-9#1)(2008-8#1)
association of##210##2##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-8#2)(1992-12#5)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#1)(1995-2#5)(1995-6#2)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#43)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#7)(2012-12#5)(2012-2#12)(2012-3#6)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
association particles##3##2##(2008-10#3)
association process##2##2##(2008-10#2)
association rate constant##3##3##(1993-3#1)(2008-10#2)
association rate##7##2##(1993-1#1)(1993-3#1)(1993-8#2)(2008-10#3)
association reaction##4##2##(1990-8#2)(1995-2#1)(2008-10#1)
association structures##3##2##(2008-5#3)
association studies (GWAS)##2##3##(2010-12#1)(2011-2#1)
association studies and##3##3##(2008-8#1)(2009-5#1)(2012-12#1)
association studies##29##2##(1994-9#1)(1997-5#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#12)(2013-8#1)
association study##11##2##(1997-5#2)(2008-10#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#3)
association test##2##2##(2008-10#1)(2012-3#1)
association through##2##2##(2008-8#1)(2008-9#1)
association time and##2##3##(2009-8#1)(2009-9#1)
association to##4##2##(1990-8#1)(2009-1#1)(2010-3#1)(2012-3#1)
association was found between the##6##5##(1990-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2012-12#1)
association was found between##11##4##(1990-8#1)(1993-10#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
association was found##13##3##(1990-8#1)(1993-10#1)(1993-9#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-12#1)
association was not##3##3##(2011-1#1)(2012-12#2)
association was observed between##4##4##(1991-12#1)(2008-12#1)(2013-1#2)
association was observed##5##3##(1991-12#1)(1991-6#1)(2008-12#1)(2013-1#2)
association was##37##2##(1990-7#1)(1990-8#1)(1991-12#2)(1991-6#1)(1993-10#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)
association were##2##2##(2008-12#1)(2013-1#1)
association which##2##2##(1990-2#1)(1990-6#1)
association with a##19##3##(1991-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1995-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)
association with adverse##2##3##(2008-11#1)(2012-2#1)
association with an##3##3##(2011-2#2)(2012-2#1)
association with both##3##3##(1995-8#1)(2007-10#1)(2007-5#1)
association with clinical##2##3##(1991-6#1)(2008-8#1)
association with coronary##2##3##(2008-11#1)(2012-2#1)
association with development##2##3##(2011-1#2)
association with each other##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
association with human##2##3##(1994-11#1)(1997-8#1)
association with increased##4##3##(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
association with malignant##3##3##(2010-3#1)(2011-2#2)
association with multiple##2##3##(2011-2#1)(2012-3#1)
association with obesity##2##3##(2008-1#1)(2011-2#1)
association with other##5##3##(1997-1#1)(2008-10#2)(2009-7#1)(2013-1#1)
association with protein##2##3##(1993-11#1)(1994-11#1)
association with risk factors##2##4##(2011-2#1)(2012-12#1)
association with spliced##2##3##(2012-2#2)
association with the development of##2##5##(2008-10#1)(2011-2#1)
association with the level of##2##5##(2008-8#1)(2012-12#1)
association with the##39##3##(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#4)(1994-3#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
association with total##2##3##(2012-2#1)(2013-1#1)
association with traditional##2##3##(1991-2#1)(2011-1#1)
association with##279##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#6)(1994-3#2)(1994-6#2)(1995-10#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#29)(2008-11#8)(2008-12#8)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#13)(2011-2#19)(2012-12#7)(2012-2#19)(2012-3#6)(2013-1#8)(2013-8#3)
association##1174##1##(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#10)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#14)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#6)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-1#9)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#7)(1993-9#6)(1994-11#4)(1994-12#10)(1994-2#7)(1994-3#3)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#7)(1995-2#18)(1995-5#2)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#3)(1996-5#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#16)(1997-6#2)(1997-7#2)(1997-8#7)(2006-10#6)(2006-5#1)(2006-6#1)(2007-10#8)(2007-11#2)(2007-12#6)(2007-2#4)(2007-5#4)(2007-6#2)(2007-7#9)(2007-8#4)(2007-9#1)(2008-1#19)(2008-10#194)(2008-11#19)(2008-12#18)(2008-2#6)(2008-3#17)(2008-4#11)(2008-5#15)(2008-6#11)(2008-7#38)(2008-8#33)(2008-9#21)(2009-1#3)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#5)(2009-7#14)(2009-8#10)(2009-9#5)(2010-1#9)(2010-10#1)(2010-11#6)(2010-12#8)(2010-2#7)(2010-3#4)(2010-4#3)(2010-5#7)(2010-6#5)(2010-7#1)(2010-8#9)(2011-1#38)(2011-2#69)(2012-1#2)(2012-12#43)(2012-2#46)(2012-3#59)(2012-5#2)(2013-1#52)(2013-7#6)(2013-8#15)
association&quot##2##1##(2008-11#2)
association'##2##1##(2008-7#2)
association)##2##1##(1990-2#1)(2008-10#1)
association?##6##1##(2007-7#1)(2008-1#2)(2008-7#1)(2008-8#1)(2012-2#1)
associations among##5##2##(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
associations and that##2##3##(1993-6#1)(2009-7#1)
associations and##15##2##(1993-3#1)(1993-6#1)(1995-12#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)
associations are##7##2##(1990-3#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-8#1)(2013-8#1)
associations between school connectedness and early adolescent adjustment##2##8##(2009-7#2)
associations between the presence of##2##5##(2008-8#1)(2011-2#1)
associations between the##9##3##(1990-9#1)(1994-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
associations between these##3##3##(2008-7#1)(2009-5#1)(2013-8#1)
associations between weight-related##2##3##(2007-12#1)(2011-2#1)
associations between##77##2##(1990-9#1)(1994-12#2)(1994-2#1)(1995-2#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#3)(2009-7#5)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#7)(2012-1#6)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
associations can##2##2##(1992-2#1)(1996-12#1)
associations for##4##2##(1995-2#1)(2007-12#1)(2008-10#1)(2010-1#1)
associations have been##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
associations have##4##2##(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
associations in the##3##3##(2008-7#1)(2008-8#1)(2009-7#1)
associations in##11##2##(1996-6#1)(2007-2#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-8#1)(2012-2#2)
associations is##3##2##(1997-2#1)(2012-12#1)(2012-3#1)
associations of Mhc##2##3##(2008-8#2)
associations of the##4##3##(1990-3#1)(1997-8#1)(2008-8#1)(2012-2#1)
associations of##32##2##(1990-3#3)(1994-7#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#2)
associations or##2##2##(2009-10#1)(2012-3#1)
associations to##5##2##(1996-3#1)(2008-10#3)(2010-12#1)
associations were found between##3##4##(1997-4#1)(2010-2#1)(2012-5#1)
associations were found with##3##4##(1993-9#1)(2008-7#1)(2009-5#1)
associations were found##7##3##(1993-9#1)(1997-4#2)(2008-7#1)(2009-5#1)(2010-2#1)(2012-5#1)
associations were noted##2##3##(1993-9#2)
associations were##17##2##(1993-9#3)(1997-4#2)(2008-10#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-5#1)(2013-1#2)(2013-8#1)
associations with atherosclerosis-related##2##3##(2013-8#2)
associations with##29##2##(1991-12#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
associations##302##1##(1990-3#5)(1990-8#1)(1990-9#1)(1991-12#2)(1992-1#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-9#5)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#5)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-8#3)(2007-12#2)(2007-2#2)(2007-7#2)(2008-1#3)(2008-10#39)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#14)(2008-9#8)(2009-10#3)(2009-2#1)(2009-5#5)(2009-7#12)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#12)(2011-2#12)(2011-4#1)(2012-1#14)(2012-12#16)(2012-2#10)(2012-3#13)(2012-5#1)(2012-6#1)(2013-1#15)(2013-7#2)(2013-8#9)
associative learning##6##2##(2008-1#1)(2008-8#1)(2009-8#2)(2012-2#2)
associative recognition##3##2##(2009-8#3)
associative##29##1##(1990-11#1)(1991-9#1)(1996-2#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#5)(2012-2#4)(2013-1#5)
associé à##2##2##(2013-1#2)
associée à##2##2##(2013-1#2)
assortative mating##9##2##(2008-10#2)(2008-8#5)(2008-9#1)(2013-1#1)
assortative##10##1##(2008-10#2)(2008-8#5)(2008-9#1)(2013-1#2)
assorted psychiatric and pain##2##4##(1993-1#2)
assorted psychiatric and##3##3##(1993-1#3)
assorted##6##1##(1992-2#1)(1993-1#3)(1994-3#1)(2008-9#1)
assortment (required for the evolution of##2##6##(2008-8#2)
assortment of##3##2##(2008-4#1)(2008-8#1)(2009-5#1)
assortment##8##1##(2008-4#1)(2008-8#6)(2009-5#1)
assulta##5##1##(2008-8#5)
assume a##13##2##(1992-1#1)(1992-2#1)(1992-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
assume an##2##2##(2007-11#1)(2008-8#1)
assume different##2##2##(1995-12#1)(2007-11#1)
assume increasing##2##2##(1993-3#1)(2008-4#1)
assume responsibility for the##2##4##(1992-3#1)(2009-10#1)
assume responsibility for##3##3##(1992-3#1)(1995-12#1)(2009-10#1)
assume that a##2##3##(1990-7#1)(2008-3#1)
assume that individuals##2##3##(1995-2#1)(2008-8#1)
assume that the##11##3##(1991-6#1)(1995-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)
assume that##42##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#2)(1992-12#2)(1993-2#1)(1995-2#2)(1996-2#1)(1997-8#1)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)
assume the##7##2##(1992-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-7#1)
assume##88##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#5)(2009-10#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)
assumed a##2##2##(1994-9#1)(2008-8#1)
assumed and##3##2##(1995-11#1)(2008-2#1)(2010-4#1)
assumed as##4##2##(1990-2#1)(1990-6#1)(1993-5#1)(2008-7#1)
assumed by the##3##3##(1995-2#1)(2008-9#1)(2010-3#1)
assumed by##7##2##(1992-3#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-3#1)
assumed for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
assumed for##5##2##(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
assumed from##3##2##(2008-10#2)(2013-8#1)
assumed in##4##2##(2008-2#3)(2008-3#1)
assumed proportional to the##2##4##(2008-10#1)(2008-5#1)
assumed scattering phase function##2##4##(2008-2#1)(2008-3#1)
assumed that the##12##3##(1990-3#1)(1993-11#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#1)
assumed that this##2##3##(1994-11#1)(2009-1#1)
assumed that##47##2##(1990-3#1)(1990-7#1)(1991-1#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-3#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
assumed to be a##6##4##(1991-12#1)(1991-2#1)(2008-11#1)(2008-2#2)(2008-7#1)
assumed to be negligible##2##4##(1997-7#1)(2008-3#1)
assumed to be the result of##2##6##(2007-12#1)(2008-9#1)
assumed to be the same##2##5##(2008-10#1)(2010-11#1)
assumed to be the##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
assumed to be##44##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#8)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#2)
assumed to consist of##2##4##(2008-10#1)(2008-3#1)
assumed to have##5##3##(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#2)
assumed to occur##3##3##(1992-12#1)(1995-3#1)(2008-10#1)
assumed to reflect##5##3##(1991-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
assumed to##75##2##(1990-5#2)(1991-12#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#10)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
assumed##221##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-2#1)(1996-4#1)(1996-6#2)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#38)(2008-11#8)(2008-12#3)(2008-2#24)(2008-3#24)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
assumes a##6##2##(1992-12#1)(1992-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
assumes that the##10##3##(1992-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)
assumes that##28##2##(1992-12#1)(1992-2#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-6#1)
assumes the##5##2##(2008-3#2)(2008-4#1)(2008-9#1)(2013-1#1)
assumes##49##1##(1992-12#2)(1992-2#1)(1992-5#1)(1994-1#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#5)(2010-6#1)(2012-2#1)(2013-1#2)
assuming a constant##2##3##(1995-3#1)(2007-12#1)
assuming a##18##2##(1991-3#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2011-1#1)
assuming an##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
assuming that a##4##3##(1996-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
assuming that the##9##3##(1995-9#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
assuming that##24##2##(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
assuming the formation of the##2##5##(2008-10#2)
assuming the##11##2##(2008-10#5)(2008-3#2)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
assuming##84##1##(1991-3#2)(1993-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#9)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)
assumption about##2##2##(2008-3#2)
assumption and the##2##3##(2008-3#1)(2008-9#1)
assumption and##5##2##(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
assumption by##3##2##(1996-7#1)(2008-3#2)
assumption for the##2##3##(1997-8#1)(2009-7#1)
assumption for##3##2##(1997-3#1)(1997-8#1)(2009-7#1)
assumption in##2##2##(1995-2#1)(2008-3#1)
assumption is##7##2##(1994-11#1)(1996-5#1)(2008-11#1)(2008-2#2)(2008-8#1)(2011-2#1)
assumption may be##2##3##(2008-3#1)(2012-3#1)
assumption of Cox's model##2##4##(1997-3#2)
assumption of a##7##3##(1997-2#1)(2008-3#1)(2008-7#3)(2010-8#1)(2011-2#1)
assumption of an##2##3##(1997-6#1)(2008-3#1)
assumption of the model##2##4##(1997-3#1)(2008-2#1)
assumption of the##5##3##(1995-12#1)(1997-3#1)(2008-2#1)(2012-3#1)(2013-8#1)
assumption of##39##2##(1994-2#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
assumption on the##2##3##(2008-10#1)(2008-2#1)
assumption regarding the##3##3##(2007-11#1)(2008-2#2)
assumption that the##20##3##(1990-11#1)(1992-6#2)(1992-8#1)(1995-3#1)(1996-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
assumption that##60##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-12#2)(1992-6#2)(1992-8#1)(1993-12#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#9)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
assumption##165##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#3)(1992-12#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#7)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#16)(2008-3#30)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#6)(2009-2#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
assumptions about response bias##2##4##(2011-2#2)
assumptions about the##10##3##(1996-12#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2010-10#1)(2011-2#1)
assumptions about##19##2##(1993-12#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-10#1)(2010-8#1)(2011-2#3)
assumptions and predictions##2##3##(2008-7#2)
assumptions and##15##2##(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-8#1)
assumptions are violated##2##3##(2008-10#1)(2012-2#1)
assumptions are##7##2##(1995-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-2#1)
assumptions concerning##3##2##(1993-12#1)(2008-3#1)(2008-7#1)
assumptions for##4##2##(1995-12#1)(2008-8#1)(2009-12#1)(2010-8#1)
assumptions in##2##2##(2008-10#1)(2010-1#1)
assumptions lead to a##2##4##(1992-6#1)(2008-10#1)
assumptions made in##4##3##(1991-2#1)(1993-9#1)(1995-12#1)(2008-3#1)
assumptions made##6##2##(1991-2#1)(1993-9#1)(1995-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
assumptions of normality##2##3##(1996-3#1)(2008-10#1)
assumptions of the##11##3##(1995-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-3#1)(2010-9#2)(2013-7#1)(2013-8#1)
assumptions of##30##2##(1994-11#1)(1995-8#1)(1996-3#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#6)(2008-8#2)(2008-9#2)(2010-3#1)(2010-9#2)(2012-2#2)(2013-7#1)(2013-8#1)
assumptions on##3##2##(1997-7#1)(2008-8#2)
assumptions regarding##2##2##(2009-6#1)(2013-1#1)
assumptions that are unlikely to be##2##6##(2008-8#1)(2009-9#1)
assumptions that##7##2##(1994-9#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#1)
assumptions to##2##2##(1997-4#1)(1997-8#1)
assumptions underlying the##2##3##(2008-9#2)
assumptions underlying##4##2##(2007-11#1)(2008-12#1)(2008-9#2)
assumptions used##2##2##(2008-3#1)(2010-10#1)
assumptions were made##2##3##(2008-2#1)(2012-12#1)
assumptions were##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
assumptions##165##1##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-3#4)(1997-4#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#16)(2008-6#1)(2008-7#10)(2008-8#13)(2008-9#11)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-3#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
assurance (QA)##7##2##(1994-2#3)(1995-3#3)(2007-7#1)
assurance and quality control##3##4##(2008-10#2)(2008-4#1)
assurance and quality of care##2##5##(1991-1#2)
assurance and quality##5##3##(1991-1#2)(2008-10#2)(2008-4#1)
assurance and##12##2##(1991-1#2)(1994-1#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2012-2#1)
assurance as##2##2##(1996-1#1)(2008-9#1)
assurance for##2##2##(1991-12#1)(1994-2#1)
assurance in##14##2##(1990-6#1)(1990-9#1)(1991-12#2)(1992-1#1)(1992-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
assurance is##5##2##(1991-12#1)(1992-11#2)(1992-9#1)(1995-2#1)
assurance of medical##2##3##(1992-9#2)
assurance of##10##2##(1992-11#1)(1992-9#2)(1994-3#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
assurance schemes##2##2##(1996-11#1)(2007-7#1)
assurance that##2##2##(2008-4#1)(2013-1#1)
assurance to continuous quality improvement##4##5##(1993-3#2)(1994-2#1)(1994-3#1)
assurance to##6##2##(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#1)(2008-9#1)
assurance##130##1##(1990-6#1)(1990-9#2)(1991-1#4)(1991-12#5)(1992-1#1)(1992-11#6)(1992-5#1)(1992-9#5)(1993-2#3)(1993-3#6)(1993-9#1)(1994-1#1)(1994-2#7)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#7)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#2)(1997-8#1)(2007-4#1)(2007-7#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#7)(2008-9#3)(2010-12#2)(2012-12#3)(2012-2#5)(2013-1#2)
assurances##2##1##(1993-12#1)(2011-2#1)
assure a##4##2##(1992-11#1)(2010-11#1)(2010-9#1)(2011-1#1)
assure the##8##2##(1993-12#1)(1994-12#1)(2008-4#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
assure##35##1##(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-7#1)
assured by##2##2##(2007-11#1)(2008-5#1)
assured##9##1##(1992-9#1)(1993-1#1)(1996-2#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
assures##3##1##(1991-12#1)(2008-12#1)(2011-1#1)
assuring that these##2##3##(2006-10#1)(2008-11#1)
assuring that##6##2##(1994-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-11#1)
assuring the##6##2##(1995-3#1)(2008-10#2)(2008-7#1)(2010-11#1)(2012-2#1)
assuring##21##1##(1990-3#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
astaxanthin from##3##2##(2008-10#3)
astaxanthin##13##1##(2008-10#4)(2008-12#2)(2010-10#3)(2013-8#4)
astaxanthin-overproduction mutant##2##2##(2010-10#2)
astemizole overdose##2##2##(1991-8#2)
astemizole##8##1##(1991-8#3)(2007-11#2)(2008-10#3)
aster formation##2##2##(2008-6#2)
aster yellows (AY)##2##3##(2008-10#2)
aster yellows phytoplasma##2##3##(2008-10#2)
aster yellows subgroups##2##3##(2008-10#2)
aster yellows##12##2##(2008-10#12)
aster##20##1##(2008-10#18)(2008-6#2)
asteroids and comets##2##3##(1997-5#2)
asters##2##1##(2008-10#1)(2008-6#1)
asthenia and##2##2##(2011-2#1)(2012-3#1)
asthenia##5##1##(2008-7#1)(2011-2#1)(2012-3#3)
asthma (EIA)##3##2##(1995-6#1)(2010-5#1)(2012-3#1)
asthma and AR##2##3##(2012-12#2)
asthma and allergic rhinitis##2##4##(2008-10#1)(2011-2#1)
asthma and atopy in children##2##5##(2008-10#2)
asthma and atopy##5##3##(2008-10#5)
asthma and chronic obstructive pulmonary disease (COPD)##2##7##(1992-3#1)(1996-1#1)
asthma and chronic##3##3##(1992-3#1)(1996-1#1)(2008-7#1)
asthma and rhinitis##3##3##(2012-3#3)
asthma and the##3##3##(2007-6#2)(2008-1#1)
asthma and to##2##3##(1997-1#1)(2008-11#1)
asthma and##40##2##(1992-3#1)(1993-12#1)(1994-6#1)(1996-1#1)(1996-7#1)(1997-1#2)(2007-11#1)(2007-6#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#4)(2013-1#1)
asthma are##6##2##(2007-11#1)(2011-1#1)(2011-2#2)(2012-12#2)
asthma attack##2##2##(1993-2#1)(2013-1#1)
asthma by##2##2##(1992-3#1)(2010-6#1)
asthma can##2##2##(1992-3#1)(1996-7#1)
asthma care##5##2##(1997-2#2)(2010-9#2)(2011-1#1)
asthma control##9##2##(2008-3#3)(2009-9#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#2)
asthma education##5##2##(1997-1#2)(2008-10#1)(2010-9#1)(2013-1#1)
asthma exacerbation##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
asthma exacerbations in##2##3##(2010-8#2)
asthma exacerbations##8##2##(2007-11#1)(2008-11#2)(2008-3#1)(2010-5#2)(2010-8#2)
asthma for##2##2##(2008-7#1)(2010-6#1)
asthma guidelines##2##2##(2008-11#1)(2010-5#1)
asthma had##3##2##(2007-2#1)(2007-8#1)(2013-1#1)
asthma has##4##2##(1996-7#1)(2007-11#1)(2009-6#2)
asthma in the##2##3##(2008-10#1)(2008-11#1)
asthma in##16##2##(1990-9#1)(1991-6#1)(1993-12#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#1)(2009-7#1)(2010-6#1)(2012-12#1)
asthma intervention##2##2##(1997-2#1)(2013-1#1)
asthma is increasing##2##3##(1996-7#1)(2008-3#1)
asthma is the most##2##4##(1990-3#1)(2007-8#1)
asthma is##11##2##(1990-3#1)(1996-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-5#1)(2013-1#1)
asthma management in##2##3##(2012-1#1)(2013-1#1)
asthma management##8##2##(1992-2#1)(1994-1#1)(1997-1#1)(2008-3#1)(2010-9#1)(2012-1#1)(2013-1#2)
asthma medication in##2##3##(2008-3#1)(2010-5#1)
asthma or chronic obstructive pulmonary disease##2##6##(2010-12#1)(2010-2#1)
asthma or##6##2##(1997-6#1)(2007-11#1)(2007-6#1)(2008-11#1)(2010-12#1)(2010-2#1)
asthma patients##7##2##(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
asthma pharmacotherapy##2##2##(2008-3#2)
asthma risk##3##2##(2008-12#3)
asthma severity##5##2##(2007-11#1)(2007-5#1)(2010-5#2)(2013-1#1)
asthma symptoms##6##2##(1995-6#1)(1997-1#1)(2007-11#2)(2009-6#1)(2012-12#1)
asthma treated##2##2##(1990-9#1)(2008-8#1)
asthma treatment##3##2##(2008-7#1)(2008-8#1)(2010-5#1)
asthma was##4##2##(1995-6#1)(2007-8#1)(2008-12#1)(2008-5#1)
asthma were##2##2##(1995-6#1)(2008-11#1)
asthma with##5##2##(2007-6#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-12#1)
asthma##392##1##(1990-2#1)(1990-3#3)(1990-9#4)(1991-11#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#7)(1992-3#6)(1992-8#1)(1993-1#3)(1993-12#4)(1993-2#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#5)(1996-1#6)(1996-2#4)(1996-6#1)(1996-7#9)(1997-1#11)(1997-2#4)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#11)(2007-2#4)(2007-5#1)(2007-6#6)(2007-8#7)(2008-1#7)(2008-10#20)(2008-11#21)(2008-12#11)(2008-3#21)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#20)(2008-8#6)(2009-1#1)(2009-6#14)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-5#36)(2010-6#5)(2010-8#3)(2010-9#13)(2011-1#3)(2011-2#8)(2012-1#7)(2012-12#24)(2012-2#4)(2012-3#11)(2013-1#20)(2013-8#1)
asthma-related outcomes##2##2##(2008-11#1)(2012-12#1)
asthma-related##3##1##(2008-11#1)(2009-6#1)(2012-12#1)
asthma?##4##1##(2007-11#1)(2008-10#1)(2010-5#1)(2012-3#1)
asthma]##11##1##(1991-11#1)(1993-9#1)(1995-6#1)(1996-7#1)(2007-6#1)(2008-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
asthmatic children##4##2##(1992-1#1)(1993-12#1)(2008-1#1)(2008-11#1)
asthmatic individuals##4##2##(1992-3#2)(2010-1#2)
asthmatic patients##9##2##(1990-9#1)(1997-1#1)(2007-2#2)(2007-6#1)(2008-10#2)(2008-3#1)(2012-12#1)
asthmatic response##2##2##(2008-10#2)
asthmatic##35##1##(1990-9#2)(1992-1#1)(1992-3#5)(1993-12#1)(1997-1#1)(2007-2#3)(2007-6#6)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-1#3)(2012-12#1)(2013-1#2)
asthmatics and##2##2##(1997-4#1)(2007-6#1)
asthmatics##14##1##(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-4#2)(2007-6#2)(2008-3#1)(2008-7#1)(2009-1#1)(2010-5#1)(2013-1#2)
astigmatic and##2##2##(2008-2#1)(2008-3#1)
astigmatic beam##3##2##(2007-11#2)(2008-3#1)
astigmatic beams##2##2##(2008-3#2)
astigmatic##11##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#5)
astigmatism and coma##2##3##(2007-12#1)(2008-3#1)
astigmatism and##3##2##(2007-12#1)(2008-3#2)
astigmatism of the##4##3##(2008-2#1)(2008-3#3)
astigmatism of##7##2##(2008-2#1)(2008-3#6)
astigmatism##26##1##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#20)
astigmatism)##2##1##(1991-9#1)(2008-3#1)
astonishing##5##1##(1991-3#1)(1992-1#1)(2007-5#1)(2009-4#1)(2009-6#1)
astonishingly##2##1##(2010-3#1)(2011-2#1)
astounding##2##1##(1996-6#1)(2011-1#1)
astragaloi##2##1##(2008-10#2)
astringinin##5##1##(2013-1#5)
astringinin-mediated##2##1##(2013-1#2)
astrocyte Ca2+##2##2##(2009-3#2)
astrocyte cell lines and##4##4##(2008-11#4)
astrocyte cell lines##6##3##(2008-11#6)
astrocyte cultures##4##2##(2008-11#4)
astrocyte migration##2##2##(1992-6#1)(2013-1#1)
astrocyte processes##2##2##(1992-12#1)(2008-7#1)
astrocyte response to##2##3##(1990-7#2)
astrocyte##34##1##(1990-7#5)(1992-12#1)(1992-6#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-11#11)(2008-7#3)(2009-3#3)(2009-5#1)(2013-1#1)
astrocyte-neurone interaction in##2##3##(1995-5#2)
astrocytes and C6##2##3##(1992-6#2)
astrocytes and##12##2##(1992-6#2)(1994-2#1)(1995-5#1)(2008-4#1)(2008-7#3)(2009-3#2)(2013-7#2)
astrocytes are##3##2##(2007-10#1)(2008-7#1)(2013-7#1)
astrocytes by##2##2##(1992-12#1)(2008-4#1)
astrocytes cultured##2##2##(1996-2#1)(1997-1#1)
astrocytes in a##2##3##(2008-4#1)(2009-3#1)
astrocytes in culture##3##3##(1996-5#1)(2008-7#1)(2009-3#1)
astrocytes in denervated neuropil regions in##2##6##(1997-3#2)
astrocytes in the##5##3##(1992-8#1)(1993-12#1)(1995-12#1)(1997-3#1)(2009-3#1)
astrocytes in##17##2##(1992-8#1)(1993-12#1)(1995-12#1)(1996-5#1)(1997-3#3)(2008-4#1)(2008-7#1)(2009-3#4)(2009-5#1)(2009-6#1)(2012-12#1)(2013-1#1)
astrocytes is##4##2##(2008-11#1)(2008-12#1)(2008-7#2)
astrocytes number in##3##3##(2008-12#3)
astrocytes or##2##2##(1992-6#1)(1993-12#1)
astrocytes produce erythropoietin (Epo) and neurons express its receptor##2##9##(2008-11#2)
astrocytes to##3##2##(1995-12#1)(2008-7#1)(2009-5#1)
astrocytes was##5##2##(1994-6#1)(1996-5#1)(2008-11#1)(2008-4#1)(2009-3#1)
astrocytes were##3##2##(1992-6#1)(1992-8#1)(1995-12#1)
astrocytes##137##1##(1992-12#1)(1992-6#4)(1992-8#2)(1993-12#3)(1994-2#3)(1994-6#1)(1995-12#7)(1995-2#2)(1995-5#8)(1996-12#5)(1996-2#1)(1996-5#7)(1997-1#2)(1997-3#3)(2007-10#1)(2008-1#1)(2008-11#14)(2008-12#4)(2008-4#13)(2008-5#1)(2008-7#24)(2009-3#16)(2009-5#4)(2009-6#1)(2012-12#1)(2013-1#4)(2013-7#4)
astrocytic ATP##3##2##(2008-4#3)
astrocytic processes##2##2##(1994-5#1)(1995-12#1)
astrocytic##28##1##(1994-11#2)(1994-5#2)(1995-12#3)(1996-5#2)(2008-11#1)(2008-4#3)(2008-7#7)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#2)(2012-2#1)(2013-1#2)
astrocytoma cells##7##2##(1993-6#1)(1993-8#1)(1995-12#4)(1997-7#1)
astrocytoma##19##1##(1993-6#2)(1993-8#1)(1995-12#5)(1997-7#1)(2008-7#2)(2012-2#4)(2013-1#4)
astrocytomas and##2##2##(2008-12#1)(2008-7#1)
astrocytomas in adults##2##3##(2008-7#2)
astrocytomas##9##1##(1994-8#1)(2008-12#1)(2008-7#7)
astroglia##2##1##(2008-7#1)(2013-7#1)
astroglial cells##2##2##(1993-5#1)(1995-5#1)
astroglial##7##1##(1990-7#1)(1993-5#1)(1995-5#1)(2008-7#2)(2008-8#1)(2012-1#1)
astrogliosis and##2##2##(2009-8#2)
astrogliosis##9##1##(2008-7#1)(2009-8#8)
astrology and##2##2##(2008-11#2)
astronomical data##2##2##(1997-5#2)
astronomical observations##2##2##(1997-5#1)(2008-2#1)
astronomical spectrographs##2##2##(2008-2#2)
astronomical telescope##2##2##(2008-2#1)(2008-3#1)
astronomical##16##1##(1991-8#1)(1997-5#3)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#4)
astronomy##6##1##(1995-6#1)(2008-2#1)(2008-3#4)
astute practitioner##2##2##(2007-11#2)
astute##3##1##(1991-12#1)(2007-11#2)
asy##2##1##(2008-8#1)(2008-9#1)
asylum for##2##2##(2009-10#1)(2009-7#1)
asylum##6##1##(1993-6#1)(2009-10#3)(2009-7#1)(2012-3#1)
asylums##4##1##(1990-6#1)(2009-10#1)(2009-7#1)(2010-6#1)
asymmetric PCR##2##2##(2008-10#1)(2008-2#1)
asymmetric and##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
asymmetric cell##2##2##(2009-3#1)(2012-2#1)
asymmetric dispersal rates##3##3##(2008-8#3)
asymmetric distribution##3##2##(1994-2#2)(2012-2#1)
asymmetric divisions##3##2##(2007-12#1)(2009-5#1)(2009-8#1)
asymmetric expansion##2##2##(1995-2#1)(2008-11#1)
asymmetric flow field-flow fractionation##2##4##(2011-2#2)
asymmetric fusion##6##2##(2008-8#6)
asymmetric interdigitated##2##2##(2007-12#2)
asymmetric modulation##2##2##(2007-12#2)
asymmetric molecules##2##2##(1993-8#1)(2009-10#1)
asymmetric multiple-quantum-well##2##2##(2008-3#2)
asymmetric stretching##4##2##(1990-2#1)(2008-10#3)
asymmetric synapses##3##2##(1995-12#2)(2008-7#1)
asymmetric synthesis of alpha-amino##2##4##(1996-5#1)(2007-11#1)
asymmetric synthesis of##6##3##(1996-5#1)(2007-11#3)(2008-11#2)
asymmetric transformation##2##2##(1992-11#1)(1996-2#1)
asymmetric unit and##2##3##(1992-4#1)(1992-9#1)
asymmetric unit are##2##3##(1992-4#1)(2008-9#1)
asymmetric unit in##2##3##(2008-8#2)
asymmetric unit of##2##3##(1995-2#1)(1997-7#1)
asymmetric unit##20##2##(1992-4#4)(1992-9#2)(1993-8#1)(1995-2#2)(1997-7#1)(2008-4#1)(2008-8#4)(2008-9#5)
asymmetric##181##1##(1990-2#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-4#4)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#5)(1994-2#2)(1994-9#1)(1995-12#3)(1995-2#4)(1995-3#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-4#2)(2007-10#1)(2007-11#11)(2007-12#12)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#22)(2008-9#7)(2009-10#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#5)(2013-1#1)(2013-8#1)
asymmetrical scattering##2##2##(2008-3#2)
asymmetrical##23##1##(1991-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-2#6)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
asymmetrically##12##1##(1990-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2011-2#1)
asymmetries in##5##2##(1990-12#1)(1993-3#1)(2007-12#1)(2008-8#2)
asymmetries##9##1##(1990-12#1)(1993-12#2)(1993-3#1)(2007-12#1)(2008-8#2)(2010-4#1)(2010-9#1)
asymmetry and in##2##3##(2008-2#1)(2009-2#1)
asymmetry and##11##2##(1992-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-8#1)(2012-12#1)
asymmetry as a##2##3##(2008-8#2)
asymmetry can be##2##3##(2007-12#1)(2008-8#1)
asymmetry in the##11##3##(1992-3#1)(1993-12#1)(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)(2012-12#1)
asymmetry in##24##2##(1992-2#1)(1992-3#1)(1993-12#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#3)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#1)
asymmetry is##5##2##(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
asymmetry of interactions##2##3##(2008-8#2)
asymmetry of the##6##3##(1997-6#1)(2008-3#3)(2011-2#1)(2012-12#1)
asymmetry of##17##2##(1997-6#1)(2008-2#1)(2008-3#5)(2008-8#7)(2011-2#2)(2012-12#1)
asymmetry on##2##2##(1994-8#2)
asymmetry parameter##8##2##(2008-2#6)(2008-3#2)
asymmetry parameter)##2##2##(2008-2#2)
asymmetry parameters and##2##3##(2008-2#1)(2008-3#1)
asymmetry parameters##4##2##(2008-2#2)(2008-3#2)
asymmetry was present in##2##4##(2010-4#1)(2011-2#1)
asymmetry was##9##2##(2008-10#4)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#1)(2011-2#1)
asymmetry##126##1##(1992-11#1)(1992-2#4)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-6#2)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#7)(2008-2#16)(2008-3#18)(2008-5#5)(2008-6#1)(2008-8#22)(2008-9#5)(2009-2#1)(2009-6#3)(2009-8#1)(2010-12#1)(2010-4#4)(2010-9#1)(2011-2#4)(2012-12#3)(2012-7#1)(2013-1#1)
asymptomatic Japanese##2##2##(2012-12#1)(2012-3#1)
asymptomatic after##3##2##(1995-11#1)(2008-10#2)
asymptomatic and are##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
asymptomatic and incidentally##2##3##(2009-3#1)(2013-1#1)
asymptomatic and symptomatic##2##3##(2008-10#1)(2012-12#1)
asymptomatic and the##2##3##(1993-5#1)(2011-2#1)
asymptomatic and##17##2##(1993-11#1)(1993-5#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
asymptomatic at##3##2##(1990-8#1)(2012-2#1)(2013-1#1)
asymptomatic bacteriuria##5##2##(2007-12#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
asymptomatic but is##2##3##(1991-11#1)(1991-4#1)
asymptomatic but##7##2##(1991-11#1)(1991-4#1)(1993-9#1)(1996-3#1)(2007-8#1)(2008-10#1)(2012-2#1)
asymptomatic carotid##3##2##(2007-8#1)(2007-9#1)(2008-8#1)
asymptomatic carriers##2##2##(1990-2#2)
asymptomatic essential hypertension##2##3##(2012-2#2)
asymptomatic female##2##2##(2008-2#2)
asymptomatic for##5##2##(1991-5#1)(2008-1#1)(2008-9#1)(2011-2#2)
asymptomatic healthy##2##2##(2008-5#1)(2011-2#1)
asymptomatic hepatitis##2##2##(2008-12#1)(2008-4#1)
asymptomatic in the##2##3##(1997-3#1)(2012-3#1)
asymptomatic in##3##2##(1997-3#1)(2012-3#1)(2013-1#1)
asymptomatic individuals##2##2##(1995-2#1)(2012-3#1)
asymptomatic infections##3##2##(1991-11#1)(1996-12#1)(2008-8#1)
asymptomatic leaves##3##2##(2008-10#3)
asymptomatic lesions##2##2##(2008-5#1)(2011-1#1)
asymptomatic mutant##2##2##(2008-10#2)
asymptomatic obese subjects##3##3##(2012-2#3)
asymptomatic obese##4##2##(2011-1#1)(2012-2#3)
asymptomatic ones##2##2##(2009-4#1)(2011-1#1)
asymptomatic or##5##2##(1990-8#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
asymptomatic patient##3##2##(1991-11#1)(2007-7#1)(2012-12#1)
asymptomatic patients with##3##3##(1991-12#1)(2009-5#1)(2011-2#1)
asymptomatic patients##11##2##(1990-9#1)(1991-12#1)(1992-9#1)(1994-11#1)(2007-10#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
asymptomatic plants##7##2##(2008-10#7)
asymptomatic pregnant women##3##3##(2008-10#1)(2010-8#2)
asymptomatic significant carotid artery stenosis##2##5##(2007-8#2)
asymptomatic smokers##4##2##(1991-4#1)(1991-9#1)(2013-8#2)
asymptomatic subjects##9##2##(2008-12#4)(2008-3#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
asymptomatic ventricular##2##2##(1996-3#1)(1996-6#1)
asymptomatic with##2##2##(2008-12#1)(2013-8#1)
asymptomatic women##4##2##(1995-2#1)(1995-4#2)(2007-7#1)
asymptomatic##261##1##(1990-2#2)(1990-3#3)(1990-6#1)(1990-8#5)(1990-9#2)(1991-11#5)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#2)(1996-1#1)(1996-12#1)(1996-3#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-3#8)(1997-4#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#9)(2008-10#26)(2008-11#1)(2008-12#10)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#4)(2010-11#1)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#18)(2011-3#2)(2012-12#9)(2012-2#10)(2012-3#13)(2013-1#18)(2013-7#2)(2013-8#4)
asymptote of##2##2##(1990-8#1)(2013-7#1)
asymptote##7##1##(1990-8#1)(2008-10#5)(2013-7#1)
asymptotes at##2##2##(1995-11#1)(2008-10#1)
asymptotes##3##1##(1994-11#1)(1995-11#1)(2008-10#1)
asymptotic absorption##3##2##(2008-3#3)
asymptotic analysis is##2##3##(2007-12#1)(2008-7#1)
asymptotic analysis##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
asymptotic at##2##2##(2008-10#2)
asymptotic distribution##2##2##(1994-9#1)(2010-1#1)
asymptotic expansion##2##2##(2008-2#1)(2009-5#1)
asymptotic properties of the##5##4##(2010-11#1)(2012-1#3)(2012-12#1)
asymptotic properties of##6##3##(2008-2#1)(2010-11#1)(2012-1#3)(2012-12#1)
asymptotic properties##8##2##(2008-2#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-1#3)(2012-12#1)
asymptotic results for##2##3##(2008-3#2)
asymptotic results##3##2##(2007-12#1)(2008-3#2)
asymptotic solution##2##2##(2008-3#2)
asymptotic techniques##2##2##(2008-3#2)
asymptotic theory##2##2##(2008-10#1)(2008-3#1)
asymptotic##73##1##(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1996-3#2)(2007-11#2)(2007-12#4)(2008-10#8)(2008-2#5)(2008-3#18)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#3)(2009-5#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-1#5)(2012-12#2)(2013-8#1)
asymptotically efficient##2##2##(2008-10#1)(2008-7#1)
asymptotically normal##2##2##(2008-8#1)(2012-1#1)
asymptotically##15##1##(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-1#5)(2013-8#3)
asynaptic mutant##2##2##(2008-5#2)
asynchronous##17##1##(1995-9#1)(1996-2#2)(1996-8#2)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)
asynchronously##4##1##(1995-9#1)(2007-12#2)(2008-7#1)
asynchrony of left ventricular contraction##2##5##(2008-10#2)
asynchrony of##3##2##(2008-10#3)
asynchrony##16##1##(1996-2#1)(2007-12#1)(2008-10#10)(2008-2#1)(2010-5#3)
asystole##3##1##(1992-5#1)(1995-3#1)(2010-1#1)
at &gt##14##2##(1995-8#1)(1997-2#1)(2008-10#8)(2008-3#1)(2008-7#2)(2009-2#1)
at &lt##10##2##(1995-8#2)(2008-10#6)(2008-2#1)(2008-7#1)
at &quot##6##2##(1990-3#1)(1994-6#1)(2007-5#1)(2008-10#1)(2012-3#2)
at +0##19##2##(2008-10#19)
at +20 degrees C##2##4##(1995-3#1)(1996-4#1)
at +5##2##2##(2008-9#2)
at -0##42##2##(1990-5#1)(2008-10#39)(2008-8#1)(2013-1#1)
at -1##19##2##(2008-10#18)(2011-2#1)
at -10##2##2##(2008-10#1)(2008-2#1)
at -1010mV##3##2##(2008-10#3)
at -150 degrees C##2##4##(1996-2#2)
at -150mV##2##2##(2008-10#2)
at -20 degrees C##6##4##(1996-2#1)(2008-10#3)(2008-11#1)(2010-3#1)
at -20 degrees##7##3##(1996-2#2)(2008-10#3)(2008-11#1)(2010-3#1)
at -20##12##2##(1996-2#2)(2008-10#3)(2008-11#1)(2010-3#1)(2011-2#1)(2013-7#4)
at -200##2##2##(2008-10#2)
at -3##3##2##(2008-10#2)(2009-5#1)
at -40 degrees C##3##4##(1997-4#3)
at -40##5##2##(1992-8#1)(1997-4#3)(2008-10#1)
at -5 degrees C##3##4##(2008-10#3)
at -5##4##2##(2008-10#4)
at -50##2##2##(2008-10#2)
at -592##2##2##(1991-11#2)
at -7##2##2##(1992-9#1)(2008-10#1)
at -70 degrees C##2##4##(1992-3#1)(1996-12#1)
at -78 degrees C##5##4##(1996-5#5)
at -80##3##2##(1993-12#1)(2008-10#1)(2008-8#1)
at 0 and##2##3##(2008-10#1)(2008-5#1)
at 0 degree C##2##4##(1992-9#1)(1993-11#1)
at 0 degree##3##3##(1992-9#1)(1993-11#1)(1995-2#1)
at 0 degrees C##12##4##(1992-8#2)(1997-4#2)(2008-10#4)(2008-6#1)(2008-7#1)(2011-2#2)
at 0 degrees##14##3##(1992-8#2)(1997-4#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#2)
at 0 h and##2##4##(1995-12#2)
at 0 to 25 degrees C##2##6##(2008-10#2)
at 0 to##4##3##(2008-10#3)(2008-7#1)
at 0##179##2##(1990-3#2)(1991-11#3)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-12#3)(1995-2#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#63)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#5)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#8)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#3)
at 0800 h##3##3##(2008-10#3)
at 1 and 2##2##4##(2007-8#1)(2008-10#1)
at 1 and 3 months##3##5##(1993-12#1)(2011-2#1)(2013-1#1)
at 1 and 3##4##4##(1993-12#1)(1997-6#1)(2011-2#1)(2013-1#1)
at 1 and 5##2##4##(1994-9#1)(2008-10#1)
at 1 and##10##3##(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(1997-6#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
at 1 day in vitro##2##5##(1996-12#2)
at 1 day old##2##4##(1997-3#1)(2007-6#1)
at 1 day##7##3##(1990-11#1)(1996-12#2)(1997-3#1)(2007-6#1)(2008-10#1)(2008-11#1)
at 1 degrees C followed by##2##6##(2008-10#2)
at 1 degrees C##6##4##(2008-10#6)
at 1 g liter(-1) for##2##5##(2008-10#2)
at 1 h by##2##4##(1993-1#1)(1997-6#1)
at 1 h##7##3##(1992-3#1)(1993-1#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-6#1)(2008-10#1)
at 1 kHz##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
at 1 mM##2##3##(2008-10#1)(2011-2#1)
at 1 microM##2##3##(1995-11#1)(1995-12#1)
at 1 microg##2##3##(2008-10#2)
at 1 min##2##3##(1990-2#1)(2008-4#1)
at 1 month##2##3##(1995-2#1)(2008-12#1)
at 1 week##4##3##(1990-11#1)(1996-5#1)(2008-10#1)(2013-1#1)
at 1 x##3##3##(1991-8#1)(1993-8#1)(2009-6#1)
at 1 year (P =##3##5##(2013-1#3)
at 1 year follow-up##2##4##(1991-2#1)(2007-8#1)
at 1 year##17##3##(1991-2#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#3)
at 1##271##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#3)(1992-4#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2007-11#23)(2007-12#25)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#38)(2008-11#4)(2008-12#2)(2008-2#17)(2008-3#43)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#3)(2011-2#14)(2011-3#2)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#9)
at 1%##2##2##(2008-10#1)(2008-5#1)
at 1-day-old##2##2##(2007-6#2)
at 1-h Post##2##3##(2013-1#2)
at 1-s intervals##2##3##(2008-3#2)
at 10 Gbits/s##3##3##(2007-12#3)
at 10 Hz##2##3##(2007-11#1)(2008-2#1)
at 10 and 20##2##4##(1996-5#1)(2008-10#1)
at 10 and 30##3##4##(2008-11#1)(2009-12#1)(2012-3#1)
at 10 and 50##2##4##(2008-10#2)
at 10 and##12##3##(1996-5#1)(1997-9#1)(2008-10#5)(2008-11#1)(2009-12#1)(2012-3#2)(2013-1#1)
at 10 days##5##3##(1997-3#1)(1997-6#1)(2008-10#2)(2013-1#1)
at 10 degrees C##4##4##(2008-10#2)(2008-8#1)(2010-4#1)
at 10 mM##6##3##(1990-11#1)(1990-7#1)(1992-7#2)(1995-8#1)(2008-6#1)
at 10 mg/animal##3##3##(2008-10#3)
at 10 microM##2##3##(1990-7#1)(1997-2#1)
at 10 min##3##3##(1993-1#1)(1996-5#1)(2013-1#1)
at 10 mug##2##3##(2008-10#2)
at 10 mug/ml##2##3##(2008-10#2)
at 10 s##3##3##(1993-11#1)(1996-5#1)(2008-10#1)
at 10 to##2##3##(2008-10#1)(2008-11#1)
at 10 years##5##3##(1993-9#1)(2008-6#1)(2011-2#2)(2013-1#1)
at 10##97##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-8#1)(1992-12#1)(1992-7#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-10#30)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
at 10(-6) M##2##3##(1993-9#1)(2008-4#1)
at 10(-6)##4##2##(1990-11#1)(1990-12#1)(1993-9#1)(2008-4#1)
at 10(-7) mol##2##3##(2008-10#2)
at 10(-7)##3##2##(1990-11#1)(2008-10#2)
at 10(-8)##2##2##(1993-9#2)
at 10(-9) M##2##3##(1993-9#1)(1994-6#1)
at 10-13 weeks' gestation##3##4##(1995-8#3)
at 10-13##4##2##(1995-8#3)(2013-1#1)
at 100 and##2##3##(2008-10#1)(2013-7#1)
at 100 cm##3##3##(2008-10#3)
at 100 degrees C for##2##5##(1995-2#1)(2007-11#1)
at 100 degrees C##12##4##(1994-11#4)(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2010-2#1)
at 100 degrees##13##3##(1994-11#4)(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2010-2#1)
at 100 kHz##2##3##(2007-11#1)(2007-12#1)
at 100 mug/ml##3##3##(2008-10#3)
at 100 nM##5##3##(1992-12#1)(1994-11#1)(1994-8#1)(1995-12#2)
at 100##46##2##(1992-12#1)(1992-7#1)(1994-11#5)(1994-8#1)(1995-12#3)(1995-2#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#1)(2013-7#1)
at 100% RH but##2##4##(2008-10#2)
at 100% RH##3##3##(1996-12#1)(2008-10#2)
at 100% relative humidity##2##4##(2008-10#2)
at 100%##6##2##(1996-12#1)(2008-10#5)
at 1000 degrees C##2##4##(1995-6#1)(2007-12#1)
at 1000##8##2##(1990-3#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-5#1)
at 102##3##2##(1994-11#1)(2008-3#1)(2008-9#1)
at 1030 nm##2##3##(2007-11#1)(2007-12#1)
at 105 degrees C##2##4##(2008-10#2)
at 105##7##2##(1990-11#1)(1995-12#1)(2008-10#3)(2010-2#1)(2011-3#1)
at 1060 nm##2##3##(2007-12#2)
at 1064 nm and##2##4##(2007-12#1)(2008-3#1)
at 1064 nm##15##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#5)
at 1064##20##2##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#7)
at 1064- and##2##3##(2008-3#2)
at 10mLmin(-1)##2##2##(2008-10#2)
at 10°C##5##2##(2011-2#5)
at 11##11##2##(1991-8#1)(1993-12#1)(1994-8#1)(1995-8#1)(2008-11#2)(2008-12#2)(2008-3#3)
at 110##3##2##(1995-12#1)(2008-10#1)(2013-8#1)
at 1100 degrees C##3##4##(2008-10#1)(2010-4#2)
at 110°C##3##2##(2012-3#1)(2013-1#2)
at 115##3##2##(1990-8#1)(2008-10#1)(2009-4#1)
at 12 and##4##3##(1992-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
at 12 degrees C##3##4##(2008-10#3)
at 12 months was##2##4##(2007-7#2)
at 12 months were##2##4##(2007-7#1)(2013-1#1)
at 12 months##16##3##(2007-7#3)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#6)(2012-3#2)(2013-1#2)
at 12 to 24##2##4##(2007-10#1)(2008-11#1)
at 12 to##5##3##(2007-10#1)(2008-10#3)(2008-11#1)
at 12 weeks##9##3##(1992-12#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-10#2)(2008-9#1)
at 12##57##2##(1991-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-11#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#4)(2010-3#2)(2011-2#3)(2012-2#6)(2012-3#4)(2013-1#2)
at 120 degrees C##2##4##(1995-2#1)(2008-6#1)
at 120##7##2##(1993-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-6#1)(2013-1#2)
at 125 degrees C##2##4##(2008-10#1)(2008-2#1)
at 125##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
at 12°C##2##2##(2011-1#2)
at 13 degrees C##2##4##(2008-10#2)
at 13##14##2##(1990-6#1)(1993-12#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#4)(2010-10#1)(2012-3#1)
at 1319 nm##2##3##(2007-11#1)(2008-2#1)
at 133##2##2##(1990-7#1)(2010-2#1)
at 135 degrees C##2##4##(2008-10#2)
at 136##2##2##(2008-1#1)(2008-10#1)
at 14 and##2##3##(2008-10#2)
at 14 days##2##3##(1996-2#1)(2008-10#1)
at 14 dpi and##2##4##(2008-10#2)
at 14 dpi##5##3##(2008-10#5)
at 14##20##2##(1991-2#1)(1994-12#2)(1996-2#1)(2008-10#9)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2010-8#1)
at 140 degrees C##2##4##(2007-12#1)(2011-1#1)
at 140 mm Hg##3##4##(2008-11#3)
at 140##6##2##(1997-7#1)(2007-12#1)(2008-11#3)(2011-1#1)
at 14MPa and 45 degrees C for 40min##2##8##(2010-4#2)
at 15 and##2##3##(2008-10#1)(2008-12#1)
at 15 days after freeze-drying##2##5##(2008-10#2)
at 15 days##5##3##(1992-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
at 15 degrees C##12##4##(2008-10#12)
at 15 degrees##13##3##(2008-10#12)(2009-3#1)
at 15 min##2##3##(2006-6#1)(2012-3#1)
at 15 months of age##2##5##(2010-6#2)
at 15 months##5##3##(2010-6#5)
at 15 to 25##2##4##(2007-6#1)(2008-10#1)
at 15 to##5##3##(2007-6#1)(2008-10#3)(2008-3#1)
at 15 years##2##3##(1993-9#1)(2008-1#1)
at 15##57##2##(1992-11#1)(1992-9#1)(1993-9#1)(1996-2#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2009-3#1)(2010-6#5)(2010-7#1)(2011-2#1)(2012-3#2)(2013-7#1)
at 150 J/cm2##2##3##(1992-9#2)
at 150 degrees C and##2##5##(2008-10#1)(2013-8#1)
at 150 degrees C for##2##5##(2008-10#1)(2013-8#1)
at 150 degrees C##5##4##(2007-11#1)(2008-10#2)(2013-8#2)
at 150 mOsm kg(-1)##2##4##(2008-11#2)
at 150##16##2##(1992-9#2)(1993-8#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2010-12#1)(2013-8#2)
at 150W of microwave##2##4##(2008-10#2)
at 150W##3##2##(2008-10#2)(2013-1#1)
at 1525cm(-1)##2##2##(2008-10#2)
at 1540 nm##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
at 155##2##2##(2008-10#2)
at 1550 nm##7##3##(2007-11#4)(2008-3#3)
at 16 weeks##5##3##(1995-3#2)(2007-7#1)(2008-10#1)(2011-1#1)
at 16##13##2##(1993-9#1)(1995-3#2)(2007-7#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)
at 160##2##2##(1993-11#1)(1993-12#1)
at 1600 nm##2##3##(2007-12#2)
at 1600##3##2##(2007-12#3)
at 16p13##2##2##(1993-12#1)(1997-5#1)
at 17##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
at 170 degrees C for##2##5##(2008-10#2)
at 175 degrees C##2##4##(2008-2#2)
at 18 degrees C in##2##5##(2008-10#2)
at 18 degrees C##8##4##(1990-7#1)(1994-3#2)(2008-10#5)
at 18 h##2##3##(1994-6#1)(1995-11#1)
at 18 hours##2##3##(1991-12#1)(2008-12#1)
at 18 months##7##3##(1990-6#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#3)
at 18 to##2##3##(2008-10#1)(2008-7#1)
at 18##29##2##(1990-6#1)(1990-7#1)(1991-12#1)(1994-3#2)(1994-6#1)(1995-11#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#4)
at 180 degrees##2##3##(1991-12#1)(2009-11#1)
at 180 mg/liter##3##3##(2008-10#3)
at 180##7##2##(1991-12#1)(2008-10#3)(2009-11#1)(2012-3#1)(2013-1#1)
at 180°C##3##2##(2012-1#1)(2013-1#2)
at 185 nm##3##3##(1994-9#2)(2008-10#1)
at 19##2##2##(2008-10#1)(2013-8#1)
at 192##2##2##(2008-2#1)(2008-3#1)
at 193 nm##8##3##(2008-2#1)(2008-3#7)
at 195 mm Hg##2##4##(2008-11#2)
at 196##2##2##(2008-3#2)
at 1mM##2##2##(2008-10#1)(2012-2#1)
at 2 and 24 h following##2##6##(1994-8#1)(2009-8#1)
at 2 and 24 h##3##5##(1994-8#1)(1995-12#1)(2009-8#1)
at 2 and 24##4##4##(1992-9#1)(1994-8#1)(1995-12#1)(2009-8#1)
at 2 and 6##2##4##(2007-11#1)(2007-8#1)
at 2 and##12##3##(1992-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-1#1)
at 2 cases##2##3##(2007-11#2)
at 2 days##3##3##(2007-10#1)(2008-11#1)(2010-4#1)
at 2 degrees C##3##4##(2007-3#1)(2008-10#1)(2012-2#1)
at 2 h##4##3##(1995-2#1)(2008-12#1)(2008-7#1)(2010-8#1)
at 2 months##9##3##(2008-10#1)(2010-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
at 2 or##2##3##(1991-6#1)(2013-1#1)
at 2 to 4##2##4##(2008-10#2)
at 2 to##3##3##(2007-10#1)(2008-10#2)
at 2 weeks##3##3##(1995-3#1)(2007-11#1)(2008-10#1)
at 2 x 10(6)##4##4##(2008-10#3)(2008-7#1)
at 2 x##6##3##(2008-10#5)(2008-7#1)
at 2 years (P =##2##5##(2013-1#2)
at 2 years and##2##4##(2008-6#1)(2008-7#1)
at 2 years##9##3##(1991-11#1)(1997-2#1)(1997-4#1)(2008-6#1)(2008-7#2)(2012-1#1)(2013-1#2)
at 2##145##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-4#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-8#4)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2007-10#3)(2007-11#7)(2007-12#7)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#3)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#1)
at 2-3 and##2##3##(2008-12#2)
at 2-4 days##2##3##(1997-3#2)
at 2-4##4##2##(1995-11#1)(1997-3#2)(2008-4#1)
at 2-week intervals##3##3##(1995-12#1)(2008-10#1)(2010-4#1)
at 20 and##5##3##(1997-6#1)(2007-10#1)(2008-10#3)
at 20 days##3##3##(1997-9#1)(2010-4#1)(2013-8#1)
at 20 degrees C and##4##5##(1995-2#1)(2008-12#1)(2008-7#1)(2010-4#1)
at 20 degrees C##31##4##(1990-7#1)(1991-5#1)(1994-3#1)(1995-2#3)(1995-8#1)(1997-2#1)(2008-10#18)(2008-12#2)(2008-3#1)(2008-7#1)(2010-4#1)
at 20 degrees C)##2##4##(2008-10#2)
at 20 degrees##33##3##(1990-7#1)(1991-5#1)(1994-3#1)(1995-2#3)(1995-8#1)(1997-2#1)(2008-10#20)(2008-12#2)(2008-3#1)(2008-7#1)(2010-4#1)
at 20 mg/day##2##3##(1994-7#1)(2006-10#1)
at 20 mg/kg##2##3##(1993-3#1)(2008-10#1)
at 20 months##2##3##(2012-12#1)(2012-2#1)
at 20 or##3##3##(2008-10#3)
at 20 to 25 degrees C##3##6##(2008-10#3)
at 20 to##4##3##(2008-10#4)
at 20##75##2##(1990-7#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-9#1)(2006-10#1)(2007-10#1)(2008-10#35)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2009-1#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
at 20%##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
at 20+/-1 degrees C##2##4##(2008-10#2)
at 20-30##2##2##(1991-12#1)(1996-11#1)
at 200 and##2##3##(2008-10#1)(2012-3#1)
at 200 degrees C##3##4##(2008-10#3)
at 200 mg/kg##3##3##(1991-12#2)(1991-6#1)
at 200 nm##4##3##(1996-5#1)(2008-10#3)
at 200##19##2##(1990-7#1)(1991-12#2)(1991-6#1)(1993-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-3#1)(2012-3#1)
at 200-300##2##2##(1994-12#1)(1997-5#1)
at 2000 Hz and 250 Hz##2##6##(2006-12#2)
at 2000##3##2##(1992-11#1)(2006-12#2)
at 200°C##4##2##(2013-1#4)
at 205 nm##4##3##(2008-1#1)(2008-10#3)
at 205nm##2##2##(2008-10#2)
at 208##3##2##(1990-5#1)(2008-2#1)(2008-3#1)
at 2097##2##2##(2007-12#2)
at 21 days and##2##4##(1994-6#2)
at 21 days##6##3##(1994-6#2)(1997-3#1)(2008-12#1)(2008-5#1)(2012-3#1)
at 21 degrees C##4##4##(1995-5#1)(2008-10#3)
at 21 h##2##3##(1995-12#2)
at 21##19##2##(1990-8#1)(1994-6#2)(1994-7#1)(1995-12#2)(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#2)
at 210 nm##4##3##(1991-12#1)(2008-10#1)(2008-4#1)(2010-3#1)
at 211 nm##2##3##(2007-12#2)
at 211##3##2##(2007-12#2)(2008-3#1)
at 215 nm##3##3##(2008-10#3)
at 215nm##2##2##(2008-10#2)
at 22 and##2##3##(1993-12#1)(1995-11#1)
at 22 days##2##3##(2007-6#2)
at 22 degrees C##8##4##(1991-2#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)
at 22 degrees##10##3##(1991-2#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-9#1)
at 22 weeks##2##3##(2013-1#2)
at 22##21##2##(1991-2#1)(1993-12#1)(1994-8#1)(1995-11#2)(2007-2#1)(2007-6#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2013-1#2)
at 220 nm##4##3##(1995-5#1)(2008-10#2)(2010-5#1)
at 220##6##2##(1995-5#1)(2008-10#3)(2008-3#1)(2010-5#1)
at 222 nm##3##3##(1993-11#1)(1996-5#1)(2008-4#1)
at 222nm##2##2##(2008-10#2)
at 224 nm##2##3##(1992-6#1)(2008-5#1)
at 2249##2##2##(1996-2#1)(2010-8#1)
at 225 kg ha(-1)##2##4##(2008-12#2)
at 225##5##2##(2008-10#3)(2008-12#2)
at 226 nm##2##3##(2008-10#2)
at 226##3##2##(2008-10#2)(2008-3#1)
at 226nm##2##2##(2008-10#2)
at 23 degrees C##8##4##(1990-7#1)(1992-3#2)(1993-9#2)(2007-11#1)(2008-10#2)
at 23##13##2##(1990-7#1)(1990-8#1)(1992-3#2)(1993-9#2)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)
at 230 and 294 K##2##5##(2008-3#2)
at 230 nm##3##3##(2008-10#3)
at 230##7##2##(2008-10#4)(2008-2#1)(2008-3#2)
at 230nm##3##2##(2008-10#3)
at 235 nm##2##3##(1994-3#1)(2008-10#1)
at 24 +/-##2##3##(2008-12#1)(2011-2#1)
at 24 degrees C##11##4##(1997-1#1)(2008-10#10)
at 24 h after##3##4##(1997-7#1)(2008-10#2)
at 24 h and##2##4##(1991-9#1)(1995-2#1)
at 24 h##12##3##(1991-9#1)(1992-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-6#1)(2008-7#2)
at 24 hours##2##3##(1990-12#1)(2008-7#1)
at 24 months##3##3##(1993-11#1)(1994-6#1)(2011-2#1)
at 24 weeks##3##3##(2010-4#1)(2011-2#1)(2012-3#1)
at 24##41##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-4#1)(2011-2#4)(2012-3#1)(2012-6#1)
at 24-h##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
at 24-hour intervals##2##3##(1992-6#1)(2010-3#1)
at 240##4##2##(1995-2#1)(2008-7#1)(2011-2#2)
at 2400 ppm##2##3##(1990-5#2)
at 242##2##2##(1995-2#1)(2008-10#1)
at 244##2##2##(2007-12#1)(2008-10#1)
at 247##2##2##(1993-11#1)(2008-3#1)
at 248 nm##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
at 25 +/-##2##3##(2008-10#1)(2011-2#1)
at 25 and 37 degrees C##2##6##(1992-6#1)(2008-10#1)
at 25 degrees C and constant ionic strength##2##8##(2008-10#2)
at 25 degrees C and continuous wetness##2##7##(2008-10#2)
at 25 degrees C and in##4##6##(2008-10#4)
at 25 degrees C and##19##5##(1995-5#1)(2008-10#16)(2008-5#1)(2008-6#1)
at 25 degrees C are##3##5##(2008-10#3)
at 25 degrees C at##2##5##(2008-10#2)
at 25 degrees C by##3##5##(2008-10#3)
at 25 degrees C for##4##5##(2006-11#1)(2008-10#2)(2008-6#1)
at 25 degrees C in the##3##6##(1990-7#1)(1995-11#1)(2008-10#1)
at 25 degrees C in##6##5##(1990-7#1)(1995-11#1)(2008-10#4)
at 25 degrees C is##2##5##(1991-3#1)(2008-10#1)
at 25 degrees C were##4##5##(1993-8#1)(2008-10#2)(2008-11#1)
at 25 degrees C with##3##5##(2008-10#2)(2009-6#1)
at 25 degrees C##124##4##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-8#1)(1995-11#1)(1995-5#4)(1996-5#1)(1997-7#1)(2006-11#1)(2008-10#89)(2008-11#2)(2008-5#4)(2008-6#2)(2008-8#6)(2009-6#1)(2009-7#1)(2010-4#1)(2013-8#1)
at 25 degrees C)##2##4##(1995-5#1)(2008-10#1)
at 25 degrees##129##3##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#1)(1992-5#1)(1993-8#1)(1995-11#1)(1995-5#5)(1996-5#1)(1997-7#1)(2006-11#1)(2008-10#90)(2008-11#3)(2008-5#4)(2008-6#2)(2008-8#6)(2009-6#1)(2009-7#1)(2010-4#1)(2013-8#1)
at 25 kGy##2##3##(2008-10#2)
at 25##149##2##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-5#5)(1996-2#2)(1996-5#1)(1997-3#1)(1997-7#1)(2006-11#1)(2008-10#99)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-8#6)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
at 25%##3##2##(1990-8#1)(2010-5#1)(2011-2#1)
at 25+/-0##2##2##(2008-10#1)(2008-5#1)
at 250 degrees C##2##4##(2007-12#1)(2008-10#1)
at 250 nm##2##3##(1996-2#1)(2008-10#1)
at 250##14##2##(1994-6#1)(1994-8#1)(1996-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
at 251 nm##2##3##(2008-3#2)
at 251##3##2##(2008-10#1)(2008-3#2)
at 254 nm##8##3##(1995-2#1)(1996-5#1)(2008-10#4)(2009-8#1)(2011-1#1)
at 254##9##2##(1995-2#1)(1996-5#1)(2008-10#5)(2009-8#1)(2011-1#1)
at 254nm##4##2##(2008-10#3)(2011-2#1)
at 256 nm##2##3##(2008-10#1)(2012-12#1)
at 257##2##2##(2008-10#1)(2008-2#1)
at 25°C##2##2##(2011-2#2)
at 26 degrees C##2##4##(1997-6#1)(2008-10#1)
at 26 weeks and in all##2##6##(2008-9#2)
at 26 weeks##7##3##(2007-10#1)(2008-9#6)
at 26##14##2##(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-9#7)
at 260 nm##3##3##(1992-12#1)(1992-8#1)(2008-10#1)
at 263##2##2##(2008-10#2)
at 265##2##2##(1993-3#1)(2008-3#1)
at 266 nm##2##3##(2008-3#2)
at 267 nm##2##3##(2007-12#1)(2008-10#1)
at 27 degrees C##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
at 27 weeks##7##3##(1994-12#1)(2008-9#6)
at 27##13##2##(1992-11#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-9#6)(2011-2#1)
at 270 nm##2##3##(2008-10#1)(2008-2#1)
at 278 nm##2##3##(2008-10#1)(2008-2#1)
at 279##2##2##(2008-10#2)
at 28 days after##2##4##(1992-2#1)(2008-10#1)
at 28 days##5##3##(1992-2#2)(1997-3#1)(2008-10#1)(2010-4#1)
at 28 degrees C and##2##5##(2008-10#1)(2008-5#1)
at 28 degrees C##5##4##(2008-10#3)(2008-5#1)(2008-6#1)
at 28 dpi##2##3##(2008-10#2)
at 28 to##2##3##(2008-10#2)
at 28 weeks of gestation##3##5##(2007-7#1)(2011-1#1)(2013-1#1)
at 28##21##2##(1992-2#2)(1992-4#1)(1994-3#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
at 280 and##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
at 280 nm##7##3##(2008-1#1)(2008-10#5)(2008-7#1)
at 280##12##2##(1994-5#1)(2008-1#1)(2008-10#8)(2008-7#1)(2008-8#1)
at 282 nm##2##3##(2008-10#2)
at 282##4##2##(2007-11#1)(2008-10#3)
at 285 nm##4##3##(1996-12#1)(2008-10#3)
at 285##5##2##(1996-12#1)(2008-10#4)
at 287 nm##3##3##(2008-10#2)(2008-4#1)
at 29 hpm##2##3##(2013-1#2)
at 29##6##2##(1994-3#1)(1997-3#1)(2011-2#1)(2013-1#3)
at 290##3##2##(1994-5#1)(1995-2#1)(2008-10#1)
at 293 and 100 K##2##5##(1996-2#2)
at 293 nm##3##3##(1995-5#3)
at 293##7##2##(1995-5#3)(1996-2#4)
at 295 K##2##3##(2008-10#1)(2008-3#1)
at 295##4##2##(1992-12#2)(2008-10#1)(2008-3#1)
at 295K##2##2##(2008-10#2)
at 298 K and##2##4##(2008-10#2)
at 298 K for the##2##5##(1996-2#2)
at 298 K##8##3##(1994-8#1)(1996-2#2)(2008-10#5)
at 298##13##2##(1994-8#1)(1996-2#2)(2008-10#10)
at 2min##2##2##(2008-10#2)
at 3 T##2##3##(2010-8#1)(2011-2#1)
at 3 X 10(-7) M##2##5##(1990-5#2)
at 3 X##3##3##(1990-5#3)
at 3 and 12 months##2##5##(1991-2#1)(2013-1#1)
at 3 and 6 months##3##5##(2008-10#1)(2009-11#1)(2013-1#1)
at 3 and##7##3##(1991-2#1)(2008-10#1)(2008-3#1)(2009-11#2)(2013-1#2)
at 3 days##2##3##(2008-10#1)(2008-5#1)
at 3 h##4##3##(1993-11#1)(1994-5#1)(1995-5#1)(2008-10#1)
at 3 kHz##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
at 3 m##2##3##(2007-5#2)
at 3 months and##2##4##(1997-3#1)(2012-12#1)
at 3 months follow-up##2##4##(2008-7#1)(2010-12#1)
at 3 months of age##2##5##(1995-8#2)
at 3 months were##2##4##(2007-10#1)(2011-2#1)
at 3 months##17##3##(1991-3#1)(1993-3#1)(1994-1#1)(1995-8#2)(1997-3#1)(2007-10#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
at 3 to##3##3##(2007-10#2)(2008-10#1)
at 3 weeks##3##3##(1990-7#1)(2008-9#1)(2012-2#1)
at 3 years and##2##4##(1994-1#1)(2007-8#1)
at 3 years of##2##4##(1994-1#1)(2012-2#1)
at 3 years##8##3##(1994-1#2)(2007-8#3)(2008-7#1)(2012-2#1)(2013-1#1)
at 3##113##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-3#2)(1994-1#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#2)(1997-3#1)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#10)(2007-5#2)(2007-8#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#2)(2009-6#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
at 3-4 days##2##3##(1994-2#1)(2008-8#1)
at 3-month intervals##2##3##(2008-10#1)(2011-1#1)
at 3-month##4##2##(2008-10#2)(2009-11#1)(2011-1#1)
at 30 and 70% bloom##2##5##(2008-10#2)
at 30 and##5##3##(2007-10#1)(2008-10#2)(2008-6#1)(2008-7#1)
at 30 cm##2##3##(2008-12#1)(2011-1#1)
at 30 days and##2##4##(2008-11#2)
at 30 days##10##3##(2007-10#2)(2008-10#2)(2008-11#2)(2008-5#1)(2009-11#1)(2013-8#2)
at 30 degrees C and##4##5##(1994-3#2)(2008-10#1)(2008-6#1)
at 30 degrees C or##2##5##(1994-3#1)(2008-10#1)
at 30 degrees C##31##4##(1990-7#1)(1990-8#1)(1992-8#1)(1994-3#4)(1995-12#1)(1997-2#1)(1997-8#2)(2008-10#14)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
at 30 degrees##33##3##(1990-7#2)(1990-8#1)(1992-8#1)(1994-3#4)(1995-12#1)(1997-2#1)(1997-8#2)(2008-10#14)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
at 30 microM##2##3##(1993-6#1)(1995-8#1)
at 30 min incubation with dexamethasone##2##6##(1994-3#2)
at 30 min was##2##4##(1994-3#1)(2008-7#1)
at 30 min##10##3##(1990-7#1)(1990-8#1)(1994-3#3)(1995-2#1)(1996-12#1)(2008-7#2)(2013-8#1)
at 30 min)##2##3##(2009-9#1)(2012-3#1)
at 30 minutes##3##3##(1994-3#1)(2007-11#1)(2012-2#1)
at 30##79##2##(1990-7#3)(1990-8#2)(1991-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#8)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-8#2)(2007-10#3)(2007-11#2)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#3)
at 30% of##2##3##(2008-10#1)(2011-1#1)
at 30-minute intervals##2##3##(1994-3#1)(2010-5#1)
at 300 K##3##3##(2008-2#1)(2008-3#2)
at 300 degrees C for##3##5##(2008-10#1)(2008-2#1)(2011-1#1)
at 300 degrees C##6##4##(2008-10#3)(2008-2#1)(2010-4#1)(2011-1#1)
at 300 mOsm kg(-1)##2##4##(2008-11#2)
at 300 nm##2##3##(1993-11#1)(2008-3#1)
at 300##22##2##(1993-11#1)(1997-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#5)(2010-4#1)(2011-1#1)
at 303 K##2##3##(2008-10#2)
at 304 A##2##3##(2008-3#2)
at 305 and##2##3##(2008-2#1)(2008-3#1)
at 306 nm##2##3##(2008-10#2)
at 309##3##2##(2008-10#2)(2008-5#1)
at 30°C##3##2##(2011-2#3)
at 31 degrees C##4##4##(2008-10#1)(2008-11#1)(2008-5#2)
at 31##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-11#1)
at 310 nm##4##3##(2008-10#2)(2008-5#2)
at 312##2##2##(1994-6#1)(2008-10#1)
at 315##2##2##(1992-9#1)(2008-10#1)
at 32 degrees C and##2##5##(2008-10#1)(2008-11#1)
at 32 degrees C##9##4##(1991-2#2)(2008-10#5)(2008-11#1)(2008-5#1)
at 32 degrees C)##2##4##(2008-11#2)
at 32 degrees##11##3##(1991-2#2)(2008-10#5)(2008-11#3)(2008-5#1)
at 32##13##2##(1991-2#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2013-1#1)
at 320 nm##2##3##(2008-10#1)(2012-2#1)
at 320##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
at 325 nm##3##3##(2007-12#2)(2008-2#1)
at 33 degrees C##5##4##(1991-8#1)(2008-11#2)(2011-2#2)
at 33##12##2##(1991-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2011-2#3)(2013-1#1)
at 330 nm##2##3##(2008-10#2)
at 333nm##2##2##(2008-10#2)
at 335##2##2##(1992-12#1)(2008-10#1)
at 336##2##2##(1992-10#1)(2008-2#1)
at 34##5##2##(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
at 340 nm##4##3##(1990-5#1)(1993-3#1)(2008-10#1)(2008-5#1)
at 340##5##2##(1990-5#1)(1990-8#1)(1993-3#1)(2008-10#1)(2008-5#1)
at 346 nm##2##3##(2008-10#2)
at 348##2##2##(2008-10#1)(2008-3#1)
at 35 degrees C and pH##2##6##(2008-10#1)(2008-6#1)
at 35 degrees C and##4##5##(2008-10#2)(2008-5#1)(2008-6#1)
at 35 degrees C##14##4##(2008-10#11)(2008-5#1)(2008-6#2)
at 35 weeks' gestation##2##4##(1993-3#1)(2012-8#1)
at 35##25##2##(1993-3#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2012-12#1)(2012-8#1)
at 35-69##3##2##(1992-6#3)
at 350 nm##2##3##(1991-5#1)(1992-6#1)
at 350##3##2##(1991-5#1)(1992-6#1)(2007-12#1)
at 3500##2##2##(2008-2#1)(2008-5#1)
at 350nm##3##2##(2008-10#3)
at 352 and 500 nm##2##5##(2008-10#2)
at 352##3##2##(2007-12#1)(2008-10#2)
at 355 and 532 nm##2##5##(2008-3#2)
at 355 and##4##3##(2008-3#4)
at 355 nm##11##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#5)(2011-1#1)
at 355##18##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#12)(2011-1#1)
at 36 degrees C##6##4##(1995-8#1)(2008-10#5)
at 36##10##2##(1991-12#1)(1995-8#1)(2008-10#7)(2013-1#1)
at 360 nm and##2##4##(2007-11#1)(2008-10#1)
at 360 nm##4##3##(1993-2#1)(2007-11#1)(2008-10#2)
at 360##6##2##(1993-2#1)(2007-11#1)(2008-10#3)(2008-6#1)
at 360nm##2##2##(2008-10#2)
at 361nm##2##2##(2008-10#2)
at 365 nm##3##3##(1993-8#2)(2008-10#1)
at 367 nm##2##3##(1994-6#1)(2008-10#1)
at 367##4##2##(1994-6#3)(2008-10#1)
at 37 degrees C and##8##5##(1990-12#1)(1996-5#1)(2008-11#2)(2008-5#2)(2008-6#1)(2010-1#1)
at 37 degrees C but not at##2##7##(1991-2#1)(1992-9#1)
at 37 degrees C but##3##5##(1991-2#2)(1992-9#1)
at 37 degrees C for 18##2##6##(1993-8#1)(1997-4#1)
at 37 degrees C for##8##5##(1992-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1997-4#1)(2009-8#1)(2010-2#1)(2010-3#1)
at 37 degrees C in a##2##6##(1993-11#1)(2008-10#1)
at 37 degrees C in##6##5##(1993-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(2008-10#1)(2010-3#1)
at 37 degrees C or##2##5##(1995-8#1)(1997-6#1)
at 37 degrees C under a 5% CO(2) atmosphere##2##9##(2008-11#2)
at 37 degrees C under##3##5##(1994-8#1)(2008-11#2)
at 37 degrees C was##2##5##(2008-4#1)(2008-5#1)
at 37 degrees C with##2##5##(1994-3#1)(2010-3#1)
at 37 degrees C##74##4##(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#4)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#8)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#4)
at 37 degrees C) and##2##5##(1990-12#1)(1992-3#1)
at 37 degrees##79##3##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#4)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#8)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#6)
at 37##85##2##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#4)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-3#6)
at 370 nm##2##3##(2008-10#1)(2008-3#1)
at 370##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
at 375 nm##4##3##(2007-11#1)(2008-10#3)
at 377 nm##3##3##(2007-11#1)(2008-10#2)
at 37 °C##2##2##(2012-2#2)
at 37°C##3##2##(2013-1#3)
at 38 degrees C##2##4##(2008-12#1)(2008-4#1)
at 38##5##2##(1992-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)
at 380##2##2##(2008-2#1)(2008-8#1)
at 384 nm in periodically poled lithium tantalate by use of a visible##2##13##(2007-12#2)
at 39 degrees C##2##4##(1991-8#1)(1994-12#1)
at 39 weeks##6##3##(2008-9#6)
at 39##10##2##(1991-8#1)(1994-11#1)(1994-12#1)(2008-9#7)
at 390 nm##2##3##(2007-12#1)(2008-10#1)
at 390##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
at 395 nm##2##3##(2008-10#2)
at 395##3##2##(2008-10#2)(2008-2#1)
at 3M##2##2##(1995-1#2)
at 4 and##4##3##(1990-8#1)(2008-10#3)
at 4 degrees C and##3##5##(2008-10#2)(2008-11#1)
at 4 degrees C for##7##5##(1990-12#1)(1991-11#1)(1991-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
at 4 degrees C in the##2##6##(2008-10#2)
at 4 degrees C or##2##5##(2008-10#1)(2008-8#1)
at 4 degrees C was##3##5##(2008-10#3)
at 4 degrees C##56##4##(1990-11#3)(1990-12#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#29)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#2)
at 4 degrees##57##3##(1990-11#3)(1990-12#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#29)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#2)
at 4 h##3##3##(1993-8#1)(1995-11#1)(2008-10#1)
at 4 months##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
at 4 to 5 years##2##5##(2012-12#2)
at 4 to 5##3##4##(2007-6#1)(2012-12#2)
at 4 to##4##3##(2007-6#1)(2008-5#1)(2012-12#2)
at 4 weeks and##2##4##(2011-2#2)
at 4 weeks##8##3##(2007-7#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#3)(2012-12#1)
at 4 years##2##3##(2007-8#1)(2008-7#1)
at 4##108##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#40)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#2)(2010-3#1)(2010-5#1)(2011-2#5)(2012-12#4)(2012-2#2)(2012-4#1)(2013-1#2)
at 4-6##2##2##(1995-3#1)(2008-10#1)
at 4-amino-2##2##2##(1994-5#2)
at 40 degrees C for##3##5##(1997-2#2)(2008-10#1)
at 40 degrees C##19##4##(1997-2#2)(2007-11#1)(2008-10#9)(2008-4#4)(2008-5#3)
at 40 degrees##21##3##(1997-2#2)(2007-11#1)(2008-10#9)(2008-4#4)(2008-5#4)(2010-3#1)
at 40 weeks##3##3##(1995-8#1)(2012-12#2)
at 40##32##2##(1995-12#1)(1995-8#1)(1997-2#2)(2007-11#1)(2008-10#12)(2008-4#4)(2008-5#5)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
at 40%##4##2##(1995-12#1)(2008-12#1)(2008-5#1)(2013-1#1)
at 400 MHz and##2##4##(2007-11#1)(2008-10#1)
at 400 degrees C##2##4##(2007-11#1)(2008-10#1)
at 400 nm with##2##4##(2007-11#1)(2008-10#1)
at 400 nm##9##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)
at 400##19##2##(1997-6#1)(2007-11#4)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2010-1#2)
at 4000##2##2##(2008-3#1)(2010-2#1)
at 400nm##2##2##(2008-10#2)
at 405##2##2##(2008-3#1)(2013-8#1)
at 409##2##2##(1993-11#1)(2008-10#1)
at 41##7##2##(1993-8#1)(1994-12#1)(1997-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
at 410 nm##2##3##(1990-11#1)(2008-10#1)
at 410##5##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
at 413##2##2##(1993-11#2)
at 415 nm##2##3##(2008-10#2)
at 415##3##2##(2008-10#3)
at 418 nm##2##3##(2008-2#1)(2009-2#1)
at 42 degrees C##3##4##(1990-11#1)(1994-12#1)(2008-5#1)
at 42##8##2##(1990-11#1)(1994-11#2)(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
at 420 nm##6##3##(2008-10#5)(2008-2#1)
at 420##8##2##(2008-10#6)(2008-2#2)
at 420nm##3##2##(2008-10#3)
at 423 nm##2##3##(2008-10#1)(2008-3#1)
at 425 nm##2##3##(2008-10#2)
at 43 degrees C##2##4##(2008-12#2)
at 43 weeks##8##3##(2008-9#8)
at 43##12##2##(2008-12#3)(2008-9#9)
at 430 nm##2##3##(2007-11#1)(2008-10#1)
at 430##3##2##(2007-11#1)(2008-10#2)
at 430nm##2##2##(2008-10#2)
at 435 nm##3##3##(2008-10#3)
at 44 Hz##2##3##(2008-2#2)
at 440 nm##6##3##(1990-8#1)(2008-10#3)(2008-3#2)
at 440##9##2##(1990-8#1)(2008-10#5)(2008-11#1)(2008-3#2)
at 442##2##2##(1995-5#1)(2008-2#1)
at 443 nm##2##3##(2008-2#2)
at 443##3##2##(2008-2#2)(2008-3#1)
at 45 days##2##3##(2008-10#1)(2008-7#1)
at 45 degrees C and##2##5##(1997-2#1)(2008-10#1)
at 45 degrees C for##5##5##(1994-8#2)(2008-10#1)(2008-5#2)
at 45 degrees C##12##4##(1994-8#2)(1997-2#1)(2008-10#6)(2008-5#2)(2011-1#1)
at 45 degrees and##2##4##(2008-2#1)(2011-2#1)
at 45 degrees##20##3##(1994-8#2)(1997-2#1)(2007-11#1)(2008-10#6)(2008-2#4)(2008-5#2)(2011-1#1)(2011-2#2)(2012-3#1)
at 45 min and##2##4##(1994-11#2)
at 45 min##3##3##(1994-11#2)(2010-11#1)
at 45##29##2##(1993-11#1)(1994-11#2)(1994-8#2)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
at 45%##2##2##(2011-2#1)(2013-8#1)
at 450 nm##2##3##(1993-8#1)(2010-5#1)
at 450##5##2##(1993-8#1)(2008-10#1)(2008-12#2)(2010-5#1)
at 450nm##3##2##(2008-10#3)
at 455nm##3##2##(2008-10#3)
at 458 nm##2##3##(2008-10#1)(2008-9#1)
at 46##4##2##(1997-6#1)(2007-12#1)(2008-3#1)(2012-1#1)
at 460 nm##3##3##(2007-12#1)(2008-10#2)
at 463 nm##3##3##(2007-12#2)(2008-10#1)
at 465 nm##5##3##(1994-3#1)(2007-12#3)(2008-10#1)
at 47##5##2##(1992-5#1)(1996-5#1)(2008-10#2)(2012-2#1)
at 470 nm##8##3##(1997-2#1)(2008-10#5)(2008-11#2)
at 470##11##2##(1997-2#1)(2008-10#6)(2008-11#3)(2008-3#1)
at 470nm##4##2##(2008-10#4)
at 473 nm##2##3##(2007-12#1)(2008-2#1)
at 473##3##2##(2007-12#1)(2008-2#2)
at 475 nm##3##3##(2008-10#2)(2013-8#1)
at 479 nm##2##3##(2008-10#2)
at 48 days vs##2##4##(1994-6#2)
at 48 h after##2##4##(1996-12#1)(2008-10#1)
at 48 h##6##3##(1996-12#1)(2008-10#3)(2008-5#1)(2009-9#1)
at 48 hours##6##3##(2007-10#6)
at 48##17##2##(1994-6#2)(1995-8#1)(1996-12#1)(2007-10#6)(2008-10#5)(2008-5#1)(2009-9#1)
at 480 nm##2##3##(2008-10#2)
at 480##4##2##(2008-10#3)(2008-3#1)
at 480nm##2##2##(2008-10#2)
at 487##2##2##(2008-10#1)(2008-3#1)
at 488 nm##5##3##(2008-2#2)(2008-3#2)(2008-9#1)
at 490 nm##6##3##(1993-11#1)(2008-10#5)
at 490##8##2##(1993-11#1)(2007-12#1)(2008-10#5)(2008-11#1)
at 4 h post exercise##2##4##(2013-1#2)
at 5 K for##2##4##(2007-12#1)(2008-10#1)
at 5 and 15##2##4##(2008-10#1)(2011-2#1)
at 5 and 25 cm##2##5##(2008-10#2)
at 5 and##9##3##(1996-5#1)(2006-10#1)(2008-10#3)(2008-12#1)(2011-2#2)(2013-1#1)
at 5 days after##2##4##(2008-10#1)(2009-3#1)
at 5 days##3##3##(2008-10#1)(2009-3#1)(2010-4#1)
at 5 degrees C and##3##5##(2008-10#2)(2010-4#1)
at 5 degrees C##10##4##(1993-2#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-12#1)(2010-4#1)(2011-2#1)
at 5 g##2##3##(2008-11#2)
at 5 kHz##4##3##(2007-12#2)(2008-3#2)
at 5 mg##2##3##(2007-10#1)(2008-10#1)
at 5 microM##3##3##(1990-2#1)(1993-11#1)(2008-8#1)
at 5 min##2##3##(1990-2#1)(1997-1#1)
at 5 minutes##2##3##(1995-6#1)(1996-9#1)
at 5 weeks of age##3##5##(1992-3#1)(1997-6#1)(2011-2#1)
at 5 weeks##4##3##(1992-3#1)(1997-6#1)(2010-6#1)(2011-2#1)
at 5 years and##2##4##(1991-8#1)(1993-9#1)
at 5 years##20##3##(1990-2#1)(1991-2#1)(1991-4#1)(1991-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(2007-8#2)(2008-11#1)(2008-6#4)(2008-7#1)(2010-3#2)(2013-1#2)
at 5##90##2##(1990-2#3)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-12#3)(2007-8#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-3#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
at 5% significance##2##3##(2008-8#1)(2013-1#1)
at 5%##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
at 5-HT2A receptors##2##3##(1995-3#2)
at 5-HT2A##3##2##(1995-3#3)
at 50 and 200##2##4##(1991-12#1)(2008-10#1)
at 50 and##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
at 50 degrees C and##3##5##(2008-10#3)
at 50 degrees C for##3##5##(1993-11#1)(2008-5#1)(2008-6#1)
at 50 degrees C##16##4##(1993-11#1)(1994-11#1)(1994-5#1)(2007-11#1)(2008-10#7)(2008-5#1)(2008-6#2)(2009-9#2)
at 50 mg/kg##3##3##(1991-12#2)(2008-10#1)
at 50 microM##4##3##(1992-12#1)(1992-9#1)(1993-11#1)(1995-3#1)
at 50##42##2##(1991-12#3)(1992-12#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#2)
at 50% of##3##3##(1990-7#1)(1992-11#1)(2008-1#1)
at 50%##8##2##(1990-7#1)(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-3#1)
at 500 Mbits/s per channel##2##5##(2008-2#2)
at 500 nm##3##3##(2008-10#3)
at 500 rpm##3##3##(2008-11#2)(2008-6#1)
at 500##17##2##(1990-3#1)(1993-3#1)(1995-3#1)(1996-5#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-1#1)
at 500nm##2##2##(2008-10#2)
at 505 nm##5##3##(2008-10#4)(2008-5#1)
at 50°C##2##2##(2013-1#2)
at 510 nm##4##3##(2008-10#3)(2008-11#1)
at 514 nm##2##3##(2008-10#1)(2008-11#1)
at 514##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
at 515 nm##3##3##(1996-4#1)(2008-10#2)
at 52 degrees C##3##4##(1993-3#1)(1997-2#1)(2008-10#1)
at 52##5##2##(1993-3#1)(1997-2#1)(2007-12#1)(2008-10#2)
at 520 nm##5##3##(2008-10#5)
at 520##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
at 523 nm##3##3##(2007-12#1)(2008-10#2)
at 525 nm##6##3##(2008-10#6)
at 525##7##2##(2008-10#6)(2008-2#1)
at 530 and##2##3##(2008-10#1)(2008-5#1)
at 530 nm with##2##4##(1997-2#1)(2008-3#1)
at 530 nm##4##3##(1997-2#1)(2008-10#2)(2008-3#1)
at 530##6##2##(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#1)
at 532 and##2##3##(2008-2#1)(2008-3#1)
at 532 nm for##2##4##(2008-2#1)(2008-3#1)
at 532 nm from a##2##5##(2007-12#1)(2008-2#1)
at 532 nm from##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
at 532 nm in##2##4##(2007-12#2)
at 532 nm##23##3##(2007-11#2)(2007-12#7)(2008-2#4)(2008-3#10)
at 532 nm)##2##3##(2008-2#2)
at 532##27##2##(2007-11#2)(2007-12#7)(2008-2#7)(2008-3#11)
at 540 nm##6##3##(2008-10#5)(2008-5#1)
at 543##2##2##(2008-10#1)(2008-3#1)
at 546 nm##2##3##(2008-10#2)
at 546##3##2##(2008-10#2)(2008-2#1)
at 55 degrees C and##2##5##(2008-12#1)(2008-6#1)
at 55 degrees C##4##4##(2008-10#1)(2008-12#2)(2008-6#1)
at 55 degrees##5##3##(1990-9#1)(2008-10#1)(2008-12#2)(2008-6#1)
at 55##7##2##(1990-9#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-6#1)
at 550 and##2##3##(2008-10#1)(2008-2#1)
at 550 nm##3##3##(1990-11#1)(2008-10#2)
at 550##7##2##(1990-11#1)(2008-10#5)(2008-2#1)
at 550nm##2##2##(2008-10#2)
at 551 nm##2##3##(2008-10#2)
at 555 nm##3##3##(2008-10#3)
at 555##4##2##(2008-10#4)
at 56 degrees C for 30 min##2##7##(1992-9#1)(2008-7#1)
at 56##7##2##(1992-9#1)(2008-10#5)(2008-7#1)
at 560 nm##6##3##(1992-6#1)(2008-10#5)
at 560##7##2##(1992-6#1)(2008-10#6)
at 562 nm##3##3##(2008-10#3)
at 562##4##2##(2008-10#3)(2011-2#1)
at 57##2##2##(1997-2#1)(2009-10#1)
at 570nm##3##2##(2008-10#3)
at 58##2##2##(1993-12#1)(2008-10#1)
at 580 nm##5##3##(2008-10#4)(2008-8#1)
at 580##6##2##(2008-10#5)(2008-8#1)
at 580nm##2##2##(2008-10#2)
at 585##2##2##(2008-10#2)
at 589 nm##2##3##(2008-2#1)(2008-8#1)
at 590##2##2##(2008-10#2)
at 595 nm##5##3##(1990-12#1)(2008-10#4)
at 5M##2##2##(2008-10#2)
at 5mM##2##2##(1990-11#2)
at 5mugl(-1)##2##2##(2008-10#2)
at 6 and 12 months##4##5##(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
at 6 and 12 weeks##2##5##(2006-10#1)(2007-11#1)
at 6 and 12##6##4##(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
at 6 and##10##3##(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
at 6 degrees C##4##4##(2008-10#3)(2008-2#1)
at 6 h following antigen##2##5##(1992-3#2)
at 6 h##6##3##(1992-3#2)(1995-11#2)(1995-8#1)(2008-10#1)
at 6 hours##3##3##(1994-11#1)(2008-7#1)(2013-8#1)
at 6 months and 2 years##4##6##(2007-10#4)
at 6 months and##5##4##(2007-10#4)(2013-1#1)
at 6 months compared with##3##5##(2008-7#1)(2013-1#2)
at 6 months of age##3##5##(2012-12#1)(2012-3#2)
at 6 months of##4##4##(2007-10#1)(2012-12#1)(2012-3#2)
at 6 months##24##3##(1991-2#1)(2007-10#7)(2007-8#1)(2008-7#2)(2008-8#2)(2010-10#1)(2012-12#3)(2012-3#3)(2013-1#4)
at 6 or##2##3##(1996-11#1)(2009-5#1)
at 6 weeks##10##3##(1991-2#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#2)(2011-1#2)
at 6 years##5##3##(1995-4#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
at 6##99##2##(1991-2#2)(1992-3#2)(1993-12#1)(1994-11#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(2006-10#2)(2007-10#7)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#16)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#5)(2013-1#7)(2013-8#1)
at 6-month follow-up##5##3##(2008-8#1)(2008-9#3)(2010-10#1)
at 60 days##3##3##(1992-1#1)(2008-9#2)
at 60 degrees C and##2##5##(2008-10#1)(2008-6#1)
at 60 degrees C for##5##5##(2008-10#3)(2008-6#2)
at 60 degrees C##11##4##(1996-2#1)(2008-10#6)(2008-6#4)
at 60 degrees##13##3##(1996-2#1)(2008-10#7)(2008-6#4)(2013-1#1)
at 60 min and##2##4##(1991-5#1)(2011-2#1)
at 60 min##4##3##(1991-5#1)(1993-6#1)(1997-1#1)(2011-2#1)
at 60 months##2##3##(1991-8#1)(2012-12#1)
at 60##31##2##(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-11#1)(2008-6#4)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
at 600 degrees C##2##4##(1995-6#1)(2008-2#1)
at 600 mg##2##3##(1990-5#1)(2008-12#1)
at 600 mg/day##2##3##(1994-7#2)
at 600 nm##4##3##(1993-11#1)(1993-12#1)(2008-10#2)
at 600##14##2##(1990-5#1)(1990-8#1)(1993-11#1)(1993-12#1)(1994-7#2)(1995-6#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-9#1)
at 605 nm##2##3##(2008-10#2)
at 606 nm##2##3##(2007-12#1)(2008-2#1)
at 610 nm##4##3##(1990-2#1)(2008-10#2)(2008-2#1)
at 612##3##2##(2008-10#3)
at 616 nm##2##3##(2008-10#2)
at 62##2##2##(2007-11#1)(2013-8#1)
at 620 nm##2##3##(2008-10#1)(2008-8#1)
at 620##3##2##(2008-10#2)(2008-8#1)
at 630 nm##2##3##(2007-8#1)(2008-10#1)
at 632##3##2##(2007-12#1)(2008-2#2)
at 633 nm##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
at 633##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
at 635 nm##2##3##(2008-10#2)
at 640 and##2##3##(2008-10#2)
at 640 nm##2##3##(2008-10#1)(2008-3#1)
at 640##4##2##(2008-10#3)(2008-3#1)
at 648##2##2##(1992-8#1)(2008-10#1)
at 65 degrees C##3##4##(2008-10#2)(2008-6#1)
at 65 degrees##4##3##(1992-6#1)(2008-10#2)(2008-6#1)
at 65##7##2##(1990-12#1)(1992-6#1)(2008-10#4)(2008-6#1)
at 650 degrees C##2##4##(2008-10#2)
at 655nm##2##2##(2008-10#2)
at 665 nm##2##3##(2008-10#2)
at 670##3##2##(2008-2#1)(2008-3#1)(2010-9#1)
at 672##2##2##(2008-3#1)(2008-7#1)
at 675##2##2##(2008-2#1)(2008-3#1)
at 690 nm after reduction of phosphomolybdate##2##7##(2008-10#2)
at 6p24-22##2##2##(1997-5#2)
at 7 and##2##3##(2008-10#1)(2008-7#1)
at 7 days after##4##4##(1992-2#1)(1994-5#1)(2007-10#1)(2008-10#1)
at 7 days of##2##4##(1996-5#1)(2008-5#1)
at 7 days##10##3##(1992-2#1)(1994-5#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#2)(2009-6#1)
at 7 months##3##3##(1995-8#2)(1997-3#1)
at 7 years##3##3##(1991-8#1)(2007-7#1)(2012-12#1)
at 7##37##2##(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-6#2)(2012-12#1)(2012-2#2)(2013-1#1)
at 7- to 10-day intervals##2##5##(2008-10#2)
at 70 degrees C##2##4##(2008-10#1)(2008-11#1)
at 70##8##2##(1995-6#1)(2008-10#4)(2008-11#2)(2012-2#1)
at 700 degrees C##2##4##(2008-10#1)(2008-3#1)
at 700 ppm##2##3##(2008-10#2)
at 700##8##2##(1991-2#1)(2008-10#6)(2008-3#1)
at 700nm##2##2##(2008-10#2)
at 71##2##2##(2008-10#1)(2008-12#1)
at 713 cm(-1)##3##3##(2008-10#3)
at 72 h##5##3##(1997-4#1)(2008-10#2)(2011-2#1)(2012-2#1)
at 72##7##2##(1992-5#1)(1997-4#1)(2008-10#3)(2011-2#1)(2012-2#1)
at 720##2##2##(2007-11#1)(2008-10#1)
at 723##2##2##(2008-10#1)(2008-3#1)
at 74##3##2##(1990-11#1)(1993-9#1)(1995-11#1)
at 745 nm##2##3##(2008-2#2)
at 745##3##2##(2008-10#1)(2008-2#2)
at 75##8##2##(1992-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
at 750 nm##2##3##(2007-12#1)(2008-10#1)
at 76##2##2##(2008-10#1)(2008-3#1)
at 765 and 865 nm##3##5##(2008-2#2)(2008-3#1)
at 77 K##7##3##(1993-11#1)(1994-8#1)(2008-10#1)(2009-11#2)(2010-2#2)
at 77##9##2##(1993-11#1)(1994-8#1)(2008-10#3)(2009-11#2)(2010-2#2)
at 770 nm##2##3##(2008-2#2)
at 780 nm##4##3##(2007-12#1)(2008-3#3)
at 780##5##2##(2007-12#1)(2008-10#1)(2008-3#3)
at 785 nm##2##3##(2007-11#1)(2008-3#1)
at 790 nm##2##3##(2007-12#2)
at 792 nm##2##3##(2007-11#1)(2008-2#1)
at 8 and##2##3##(1997-6#1)(2007-12#1)
at 8 days after##2##4##(1992-8#1)(2008-10#1)
at 8 keV##2##3##(2008-3#2)
at 8 months##3##3##(1995-4#1)(2008-4#1)(2010-3#1)
at 8 weeks (P&lt##3##4##(2009-3#3)
at 8 weeks##13##3##(1993-12#1)(1994-3#1)(2007-7#3)(2008-10#2)(2008-5#1)(2009-3#3)(2009-5#1)(2011-2#1)
at 8##42##2##(1991-6#2)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-4#1)(1997-6#1)(2007-11#3)(2007-12#4)(2007-7#4)(2008-10#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#3)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#2)
at 8%##2##2##(2009-7#1)(2013-1#1)
at 80 and 100 degrees C##2##6##(1995-5#1)(2008-5#1)
at 80 and 180°C##2##4##(2012-1#2)
at 80 and##4##3##(1995-5#1)(2008-5#1)(2012-1#2)
at 80 degrees C for##3##5##(2008-10#2)(2011-1#1)
at 80 degrees C##14##4##(2007-12#1)(2008-10#9)(2008-7#1)(2009-9#2)(2011-1#1)
at 80 mumol/kg##2##3##(1993-12#2)
at 80##32##2##(1993-12#3)(1995-5#1)(2007-12#4)(2008-1#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-7#4)(2009-9#2)(2011-1#1)(2012-1#2)(2013-8#2)
at 800 degrees C##2##4##(2008-10#2)
at 800 nm##8##3##(2007-11#3)(2007-12#3)(2008-3#1)(2010-1#1)
at 800##11##2##(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#1)(2010-1#1)(2010-4#1)
at 800nm##2##2##(2007-11#1)(2007-12#1)
at 80°C##2##2##(2012-1#2)
at 810##2##2##(2007-12#1)(2008-3#1)
at 814 nm##2##3##(2008-10#2)
at 84##2##2##(2008-10#2)
at 85 degrees C##3##4##(2008-2#2)(2008-7#1)
at 85##6##2##(1993-3#1)(2007-11#1)(2008-2#2)(2008-7#1)(2013-8#1)
at 850 degrees C##2##4##(2013-8#2)
at 850##6##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#2)
at 852 nm##2##3##(2008-2#1)(2008-3#1)
at 865 nm and##2##4##(2008-2#2)
at 88##2##2##(1992-8#1)(2013-1#1)
at 89##2##2##(2008-10#1)(2012-3#1)
at 890 mmol * kg(-1)##2##5##(2008-8#2)
at 9 hours##2##3##(1994-6#1)(2008-7#1)
at 9 weeks##2##3##(2007-7#1)(2008-11#1)
at 9##22##2##(1992-5#1)(1992-9#1)(1994-6#1)(1994-9#1)(2007-11#3)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)(2013-1#1)
at 90 days##2##3##(2008-8#1)(2009-11#1)
at 90 degrees C##3##4##(1990-2#1)(2008-10#1)(2008-7#1)
at 90 degrees##5##3##(1990-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
at 90 min##2##3##(1992-12#1)(1993-6#1)
at 90##14##2##(1990-2#1)(1990-8#1)(1992-12#1)(1993-6#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
at 90%##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
at 90°C##3##2##(2011-1#2)(2013-1#1)
at 93 K##2##3##(1996-2#2)
at 93##3##2##(1996-2#2)(2009-4#1)
at 946 nm##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
at 95##4##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
at 95% confidence level##18##4##(2008-10#18)
at 95% confidence##20##3##(2008-10#19)(2008-3#1)
at 95%##22##2##(2008-10#20)(2008-3#1)(2008-7#1)
at 96 h after##3##4##(2008-10#3)
at 96 h##5##3##(2008-10#4)(2010-3#1)
at 96 hours##2##3##(1994-5#1)(2011-2#1)
at 96##12##2##(1994-11#1)(1994-5#1)(1995-2#1)(2008-10#5)(2008-8#2)(2010-3#1)(2011-2#1)
at 975 nm##4##3##(2007-11#2)(2007-12#2)
at 980 nm##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
at 985 nm##2##3##(2007-12#2)
at A1 receptors##2##3##(1995-3#2)
at A2a receptors##2##3##(1995-3#2)
at AD and PD affects the##2##6##(2011-2#2)
at AD and PD##4##4##(2011-2#4)
at AD##6##2##(2008-12#2)(2011-2#4)
at AR##4##2##(2013-8#4)
at Ac##3##2##(1991-3#3)
at Alliant Health System##2##4##(1994-2#1)(1995-12#1)
at Alliant##3##2##(1994-2#2)(1995-12#1)
at Army##2##2##(2012-2#2)
at Asn402##2##2##(1991-9#2)
at Ayub Teaching Hospital Abbottabad##2##5##(2010-11#2)
at Bodie##2##2##(2008-8#2)
at Boston##2##2##(2007-7#1)(2008-3#1)
at Brigham and Women's Hospital##3##5##(1994-3#1)(2010-5#2)
at British##2##2##(2011-1#1)(2013-1#1)
at Brown University##2##3##(2008-1#1)(2008-5#1)
at C##2##2##(1990-5#2)
at C-2##6##2##(1996-5#5)(2008-5#1)
at C-3 of the##2##4##(1993-11#1)(2008-11#1)
at C-3 of##3##3##(1993-11#1)(1996-5#1)(2008-11#1)
at C-4 and##3##3##(1992-11#1)(1996-5#2)
at C-4 of##3##3##(1993-8#2)(1996-5#1)
at C-4##8##2##(1992-11#1)(1993-8#3)(1996-5#3)(2009-5#1)
at C2##2##2##(1990-5#1)(2010-9#1)
at C3##3##2##(2008-11#2)(2010-8#1)
at CA3-CA1 synapses##2##3##(2009-8#2)
at CE##2##2##(2008-12#2)
at CNTs##2##2##(2008-10#2)
at CT##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
at Cahuita National Park##2##4##(2008-5#2)
at Children's Hospital##2##3##(1993-12#1)(2008-3#1)
at Cinzana##2##2##(2008-10#2)
at City University##2##3##(2008-11#2)
at Clinical##2##2##(2008-4#1)(2013-8#1)
at Córdoba##2##2##(2008-10#2)
at DNA level##3##3##(1992-3#1)(2008-8#2)
at Different##3##2##(2008-10#1)(2008-2#2)
at Discovery Bay##2##3##(2007-5#2)
at Dunedin Hospital##2##3##(2008-7#2)
at E(cell)=1##2##2##(2008-10#2)
at ED 15##2##3##(1993-3#2)
at ED##3##2##(1993-3#3)
at East Chapman##2##3##(2008-10#2)
at East##3##2##(1997-3#1)(2008-10#2)
at Elevated##2##2##(2008-10#1)(2008-2#1)
at Emory University##2##3##(1997-2#1)(2010-5#1)
at Fiji##2##2##(2008-1#2)
at Fletcher Allen Health Care##2##5##(1995-12#2)
at G1 phase##2##3##(1991-9#1)(2010-6#1)
at G1##3##2##(1991-9#1)(2010-6#1)(2012-3#1)
at Gaustad Hospital##2##3##(1993-6#2)
at Grande Riviere Beach##2##4##(2007-5#2)
at HIV##2##2##(2008-1#1)(2009-5#1)
at HMDE##2##2##(2008-10#2)
at Harvard##3##2##(1990-11#1)(1992-3#1)(2010-5#1)
at High##2##2##(1995-6#1)(2008-10#1)
at His-56##2##2##(1994-8#2)
at Hospital##4##2##(2008-8#3)(2011-1#1)
at I=0##2##2##(2008-10#2)
at IC50##2##2##(1992-5#1)(1995-8#1)
at Isla##2##2##(2008-5#1)(2011-2#1)
at Janelia is##2##3##(2008-9#2)
at Janelia##6##2##(2008-9#6)
at Johns Hopkins University##2##4##(1997-5#1)(2011-2#1)
at Johns Hopkins##5##3##(1994-12#1)(1997-5#1)(2008-1#1)(2011-2#1)(2012-3#1)
at KE##2##2##(2008-12#2)
at Kaiser Permanente##2##3##(1995-2#1)(2010-8#1)
at Kathmandu Medical##2##3##(2008-7#2)
at King##3##2##(2008-1#3)
at L2-3 and L3-4##2##4##(2013-1#2)
at L2-3##4##2##(2012-3#1)(2013-1#3)
at L5-S1##2##2##(2009-3#1)(2012-2#1)
at LSP compared with##2##4##(2006-8#2)
at LSP##5##2##(2006-8#5)
at La##5##2##(1994-9#1)(1995-3#1)(2008-2#1)(2008-3#1)(2013-7#1)
at Lariboisiere Hospital##2##3##(2011-2#2)
at Lawrence Berkeley National Laboratory##3##5##(2008-3#3)
at Lawrence Berkeley National##4##4##(2008-3#4)
at Loma Linda##3##3##(1993-2#3)
at Loop7##2##2##(2008-9#2)
at Los##2##2##(2008-2#1)(2008-5#1)
at Madinah##2##2##(2008-1#2)
at Mayo##2##2##(2008-9#1)(2012-3#1)
at Medical College##2##3##(2007-7#2)
at Medical University##2##3##(2008-9#2)
at Medical##4##2##(2007-7#2)(2008-9#2)
at Mount Barker and##2##4##(2008-10#2)
at Mount##4##2##(1994-2#1)(2008-10#2)(2008-9#1)
at NASA##3##2##(2008-2#1)(2008-3#2)
at NB##2##2##(2013-8#2)
at NBS1 rs1805794 site##2##4##(2011-1#2)
at NBS1##3##2##(2011-1#3)
at NPS##2##2##(2008-10#2)
at National Public Health Laboratory##2##5##(2012-3#2)
at National##3##2##(2008-10#1)(2012-3#2)
at New York##2##3##(2008-5#2)
at New##3##2##(1992-8#1)(2008-5#2)
at North##2##2##(1997-6#1)(2010-5#1)
at Northumbria##2##2##(2008-11#2)
at Northwestern##2##2##(1996-12#1)(1997-2#1)
at Norwegian##3##2##(1992-4#1)(1997-2#1)(1997-8#1)
at P &lt##4##3##(2008-10#2)(2008-5#1)(2010-1#1)
at P&lt##4##2##(1993-9#1)(2008-12#2)(2008-7#1)
at P21##2##2##(1996-5#1)(2012-12#1)
at P4##3##2##(1996-5#3)
at PMI##2##2##(2009-10#2)
at Palmyra Atoll##2##3##(2010-8#2)
at Palmyra##3##2##(2010-8#3)
at Parque##2##2##(2008-5#1)(2008-6#1)
at Playuela##2##2##(2008-5#2)
at R stage##2##3##(1990-5#2)
at R##3##2##(1990-5#2)(2008-10#1)
at RH &gt##2##3##(2008-10#2)
at RH##3##2##(2008-10#3)
at Recovery 1 and 2##2##5##(1994-2#2)
at Resolute Bay##3##3##(2008-2#1)(2008-3#2)
at Risk##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
at Rush-Presbyterian-St##2##2##(1994-1#1)(1994-3#1)
at S##2##2##(2008-7#1)(2012-1#1)
at SS##2##2##(2008-12#2)
at Samanko##2##2##(2008-10#2)
at Serine 133##2##3##(2008-11#2)
at Shifa##2##2##(2013-7#2)
at Southern##2##2##(2009-6#1)(2010-8#1)
at Sri Venkateswara University##6##4##(2008-10#6)
at St##8##2##(1993-2#1)(1994-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-5#1)(2008-7#1)
at Stanford University##2##3##(1993-12#2)
at Stanford##3##2##(1993-12#2)(2008-11#1)
at Sunnybrook Health Science Centre##2##5##(1996-12#1)(1996-2#1)
at T less than Tm##2##5##(1990-7#2)
at T##6##2##(1990-7#2)(1991-3#1)(2008-3#2)(2008-7#1)
at T1 and T2##3##4##(2008-5#1)(2009-10#2)
at T1##10##2##(1997-2#2)(2007-8#1)(2008-5#1)(2009-10#3)(2009-7#2)(2013-1#1)
at T2##6##2##(2007-8#1)(2009-10#1)(2009-7#3)(2013-1#1)
at T4 middle promoters##2##4##(1995-2#2)
at The Johns Hopkins##3##4##(1993-3#1)(1997-1#1)(2008-3#1)
at The Queen Elizabeth Hospital##2##5##(1994-3#2)
at The##17##2##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-3#2)(1997-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
at Thr160##3##2##(1997-1#3)
at Time 1 and Time 2##2##6##(2007-12#2)
at Time 1##4##3##(2007-12#2)(2008-12#1)(2010-4#1)
at Time 2##2##3##(2010-4#2)
at Time##7##2##(2007-12#2)(2008-12#1)(2010-10#1)(2010-4#3)
at Ts##2##2##(2008-3#2)
at Ullevål##3##2##(1990-9#1)(1992-4#1)(1997-2#1)
at University##2##2##(1992-2#1)(1997-2#1)
at Urbana##2##2##(2008-10#2)
at Warsaw Bielany Hospital##2##4##(2009-5#2)
at Warsaw##3##2##(2008-10#1)(2009-5#2)
at Wave 1 were##3##4##(2013-8#3)
at Week##2##2##(2012-2#2)
at West##2##2##(1993-12#1)(2009-10#1)
at Xq28##4##2##(2008-12#3)(2012-3#1)
at Yale University##3##3##(1996-1#1)(1996-9#1)(2008-11#1)
at Yale##4##2##(1996-1#1)(1996-9#2)(2008-11#1)
at a 0##2##3##(2008-2#1)(2008-3#1)
at a 1##5##3##(1995-5#1)(2008-3#4)
at a 1-kHz repetition rate by##2##6##(2007-12#1)(2008-3#1)
at a 1-kHz repetition rate##8##5##(2007-11#1)(2007-12#4)(2008-3#3)
at a 1-kHz##9##3##(2007-11#1)(2007-12#4)(2008-3#4)
at a 10-Hz repetition rate##2##5##(2007-12#1)(2008-2#1)
at a 2##2##3##(2007-12#1)(2008-10#1)
at a 95% confidence level##8##5##(2008-10#8)
at a 95%##9##3##(2008-10#9)
at a MOI of##2##4##(2008-11#1)(2008-9#1)
at a boron-doped diamond##2##4##(2008-10#2)
at a broad##2##3##(2006-6#1)(2012-2#1)
at a carbon fiber microdisk electrode##2##6##(2008-10#2)
at a carbon paste electrode modified##2##6##(2008-10#2)
at a carbon paste electrode##5##5##(2008-10#5)
at a carbon##9##3##(2008-10#9)
at a cellular##2##3##(2008-4#1)(2008-9#1)
at a center wavelength of##7##5##(2007-11#2)(2007-12#4)(2008-3#1)
at a center##8##3##(1997-8#1)(2007-11#2)(2007-12#4)(2008-3#1)
at a central wavelength of##2##5##(2007-11#2)
at a central##3##3##(2007-11#2)(2008-10#1)
at a certain##7##3##(2007-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2013-1#1)
at a common##2##3##(2008-2#1)(2008-3#1)
at a community level on a statewide basis##2##8##(1996-3#2)
at a community##4##3##(1996-3#2)(2008-1#1)(2012-12#1)
at a comparatively##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
at a concentration as low as##4##6##(1993-6#1)(1993-8#1)(2008-10#2)
at a concentration greater than##2##5##(1997-4#2)
at a concentration level of##3##5##(2008-10#3)
at a concentration level##4##4##(2008-10#4)
at a concentration of 0##5##5##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
at a concentration of 1##8##5##(1992-3#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)
at a concentration of 10##2##5##(1991-2#1)(2008-10#1)
at a concentration of 10(-9) mol/l and##2##7##(2011-2#2)
at a concentration of 100 µg/mL##2##6##(2011-1#2)
at a concentration of 100##4##5##(1997-4#1)(2008-10#1)(2011-1#2)
at a concentration of 20##3##5##(1995-2#1)(2008-10#1)(2008-11#1)
at a concentration of 3##2##5##(1990-5#1)(2008-10#1)
at a concentration of approximately##3##5##(2008-11#2)(2008-8#1)
at a concentration of##44##4##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#8)(2008-11#8)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#1)
at a concentration##62##3##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-5#1)(1997-1#1)(1997-4#3)(2008-10#14)(2008-11#9)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#1)
at a constant flow rate##2##5##(2008-10#2)
at a constant rate##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
at a constant speed##2##4##(2007-11#1)(2008-6#1)
at a constant temperature in##2##5##(2007-12#1)(2008-10#1)
at a constant temperature##3##4##(2007-12#1)(2008-10#2)
at a constant##24##3##(1993-12#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
at a controlled rate##2##4##(2008-10#1)(2008-7#1)
at a cost of##5##4##(1994-9#1)(1996-12#1)(2008-10#1)(2008-7#2)
at a cost##8##3##(1994-3#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-7#2)
at a crime scene##2##4##(2008-10#1)(2008-12#1)
at a critical##5##3##(2008-2#1)(2008-3#2)(2012-2#1)(2012-3#1)
at a crosshead speed of##3##5##(2008-12#2)(2013-1#1)
at a defined##2##3##(2008-10#1)(2008-11#1)
at a density##2##3##(1997-3#1)(2008-10#1)
at a dental hygiene school in Japan##2##7##(2009-5#2)
at a depth of##6##4##(1990-11#1)(1996-2#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-5#1)
at a depth##8##3##(1990-11#1)(1996-2#1)(1996-4#1)(2008-11#1)(2008-3#3)(2008-5#1)
at a diagnosis##2##3##(2007-8#1)(2013-8#1)
at a different frequency##3##4##(2007-9#1)(2008-2#1)(2009-8#1)
at a different##9##3##(1991-8#1)(1996-1#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
at a dilution rate of 0##3##6##(2008-6#2)(2008-7#1)
at a dilution rate of##4##5##(2008-6#2)(2008-7#2)
at a dilution##5##3##(2008-2#1)(2008-6#2)(2008-7#2)
at a distance from the##3##5##(1996-5#1)(2007-11#1)(2008-3#1)
at a distance of approximately##2##5##(2008-10#1)(2008-3#1)
at a distance of##17##4##(1992-1#1)(1994-9#1)(2007-11#2)(2008-10#7)(2008-3#5)(2008-8#1)
at a distance##26##3##(1992-1#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#3)(2008-10#8)(2008-12#2)(2008-3#6)(2008-8#2)
at a distinct##2##3##(2008-11#1)(2012-3#1)
at a dosage of##4##4##(1994-2#1)(1994-6#1)(2008-7#1)(2008-9#1)
at a dose of 0##7##5##(1994-6#1)(1995-12#2)(1995-3#1)(1996-12#1)(2008-12#1)(2013-1#1)
at a dose of 1##3##5##(1995-12#1)(2008-10#1)(2013-1#1)
at a dose of 10##4##5##(1991-6#1)(1994-8#1)(2007-10#1)(2008-6#1)
at a dose of 2##2##5##(2008-11#1)(2008-12#1)
at a dose of 3##2##5##(1990-12#1)(2012-2#1)
at a dose of 40##3##5##(1991-2#1)(2008-6#1)(2008-8#1)
at a dose of##36##4##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-12#3)(1995-3#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
at a dose##41##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1992-3#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-12#5)(1995-3#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
at a fast##2##3##(1996-3#1)(2008-9#1)
at a faster rate than##3##5##(1991-3#1)(2008-2#1)(2008-3#1)
at a faster rate##4##4##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
at a few##3##3##(2008-3#2)(2012-5#1)
at a fixed concentration of##2##5##(1992-3#1)(2008-10#1)
at a fixed potential of##2##5##(2008-10#2)
at a fixed##20##3##(1991-1#1)(1992-3#2)(1996-3#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#4)(2008-7#1)(2011-1#1)(2012-3#1)
at a flow rate of 0##5##6##(2008-10#4)(2011-1#1)
at a flow rate of 1##13##6##(2008-10#8)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
at a flow rate of 2##4##6##(2008-10#4)
at a flow rate of##34##5##(2008-10#27)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
at a flow rate##35##4##(2008-10#28)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
at a flow-rate of 1##4##5##(1991-5#1)(1996-5#1)(2008-10#2)
at a flow-rate of##5##4##(1991-5#1)(1996-5#1)(2008-10#3)
at a fluence of approximately 0##2##6##(2008-3#2)
at a frequency of 0##3##5##(2008-10#1)(2011-2#2)
at a frequency of##9##4##(1995-3#1)(1995-8#1)(2008-10#4)(2008-6#1)(2011-2#2)
at a frequency##12##3##(1993-12#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-2#2)
at a fundamental##2##3##(1996-1#1)(2007-12#1)
at a given point in time##2##6##(2007-2#1)(2008-1#1)
at a given point##3##4##(2007-2#1)(2008-1#1)(2008-3#1)
at a given time##2##4##(1995-3#1)(2008-9#1)
at a given torque level##2##5##(1993-12#2)
at a given wavelength##2##4##(2008-10#1)(2008-3#1)
at a given##19##3##(1992-6#1)(1993-12#2)(1995-3#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-9#1)(2010-6#1)
at a glassy carbon electrode##7##5##(2008-10#7)
at a glassy carbon##9##4##(2008-10#9)
at a global##3##3##(2008-8#1)(2010-2#1)(2010-5#1)
at a gold electrode modified with##2##6##(2008-10#2)
at a gold##4##3##(1991-7#1)(2008-10#3)
at a grazing angle##2##4##(2008-2#1)(2008-7#1)
at a group of##3##4##(1992-12#1)(1992-2#1)(1994-11#1)
at a hanging mercury drop electrode (HMDE)##2##7##(2008-10#2)
at a hanging mercury drop electrode##6##6##(2008-10#6)
at a health center##2##4##(1996-3#1)(1997-6#1)
at a health center]##6##4##(1991-11#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-11#1)(1997-4#1)
at a health##8##3##(1991-11#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-6#1)
at a high concentration##2##4##(1997-6#1)(2008-8#1)
at a high density##2##4##(2008-10#1)(2008-11#1)
at a high frequency##3##4##(2008-11#1)(2008-5#2)
at a high level in the##2##6##(1993-3#1)(1994-5#1)
at a high level##8##4##(1993-3#1)(1993-6#1)(1994-5#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
at a high rate##3##4##(2008-4#1)(2008-5#1)(2013-1#1)
at a high temperature##2##4##(2009-11#1)(2012-2#1)
at a high##32##3##(1990-12#1)(1990-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
at a higher frequency##2##4##(2008-10#2)
at a higher level##2##4##(2010-6#1)(2010-9#1)
at a higher rate than##4##5##(1990-8#1)(1995-5#1)(2008-11#2)
at a higher rate##7##4##(1990-8#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-12#1)
at a higher risk of##2##5##(2009-3#1)(2012-12#1)
at a higher risk##6##4##(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#1)
at a higher##25##3##(1990-8#1)(1994-11#1)(1995-5#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)
at a highly boron-doped diamond electrode##2##6##(2008-10#2)
at a holding potential##2##4##(1995-12#1)(2008-8#1)
at a hospital##2##3##(1994-1#1)(2007-10#1)
at a kilohertz repetition rate##2##5##(2007-12#2)
at a known##3##3##(1993-11#1)(1995-2#1)(2008-2#1)
at a large##7##3##(1991-3#1)(1995-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-2#2)
at a larger size##2##4##(2008-8#1)(2009-10#1)
at a later date##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
at a later stage of##2##5##(2008-11#1)(2010-1#1)
at a later stage##9##4##(2007-11#1)(2008-11#3)(2008-5#1)(2010-1#2)(2012-1#1)(2013-8#1)
at a later time##5##4##(1991-12#1)(1993-11#1)(1997-2#1)(2008-3#1)(2012-2#1)
at a later##19##3##(1991-12#1)(1993-11#1)(1995-6#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2010-1#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
at a level 1##2##4##(2008-10#1)(2012-3#1)
at a level as##2##4##(1992-6#1)(2008-10#1)
at a level of##10##4##(1990-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2012-2#2)
at a level that would##2##5##(2008-10#1)(2009-3#1)
at a level that##4##4##(1996-12#1)(2008-10#1)(2008-12#1)(2009-3#1)
at a level##23##3##(1990-8#1)(1991-12#1)(1992-6#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2009-5#1)(2012-2#2)(2012-3#2)
at a linear##2##3##(2008-10#2)
at a liquid-solid interface##3##4##(2008-3#1)(2008-7#2)
at a local##5##3##(1993-6#2)(2008-8#1)(2013-1#2)
at a location##2##3##(2008-3#1)(2010-2#1)
at a low concentration##2##4##(1994-12#1)(2012-3#1)
at a low frequency##2##4##(2008-10#2)
at a low level##6##4##(1992-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)
at a low temperature##4##4##(2007-12#1)(2008-10#2)(2008-11#1)
at a low##25##3##(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
at a lower concentration##2##4##(1993-6#1)(2008-11#1)
at a lower dose##2##4##(1995-5#1)(2008-1#1)
at a lower extent##2##4##(1990-12#2)
at a lower##18##3##(1990-12#2)(1993-6#1)(1995-3#1)(1995-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2012-12#1)
at a maximum##6##3##(1997-5#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
at a mean age of##5##5##(1992-2#1)(1993-6#1)(1997-3#3)
at a mean follow-up##2##4##(1994-2#1)(2008-6#1)
at a mean temperature of##2##5##(2008-10#2)
at a mean##9##3##(1992-2#1)(1993-6#1)(1994-2#1)(1997-3#3)(2008-10#2)(2008-6#1)
at a median follow up of##2##6##(1992-6#1)(2008-6#1)
at a median of##3##4##(2007-10#1)(2008-6#1)(2008-7#1)
at a median time of##2##5##(2010-3#1)(2013-1#1)
at a median##10##3##(1990-12#1)(1992-6#1)(2007-10#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
at a medium##2##3##(2008-10#1)(2013-1#1)
at a mercury electrode##5##4##(2008-10#5)
at a mercury##6##3##(2008-10#6)
at a midwestern##2##3##(1994-2#1)(2007-12#1)
at a minimum##4##3##(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
at a moderate level##2##4##(1993-12#1)(2008-10#1)
at a moderate##4##3##(1990-5#1)(1993-12#1)(2007-12#1)(2008-10#1)
at a molecular level##3##4##(1990-2#1)(1993-9#1)(2013-1#1)
at a molecular weight of##2##5##(1992-12#1)(1993-11#1)
at a molecular##6##3##(1990-2#1)(1992-12#1)(1993-11#1)(1993-9#1)(1997-7#1)(2013-1#1)
at a more##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
at a much higher##2##4##(1994-6#1)(2008-10#1)
at a much lower##3##4##(1990-5#1)(2008-10#2)
at a much##8##3##(1990-5#1)(1992-12#1)(1994-6#1)(2008-10#3)(2008-2#1)(2009-4#1)
at a multidisciplinary##2##3##(2008-6#2)
at a nafion-loaded carbon paste electrode##2##6##(2008-10#2)
at a near##2##3##(2011-1#1)(2012-3#1)
at a nearby##2##3##(2008-3#1)(2011-2#1)
at a net flux of##2##5##(2008-7#2)
at a nominal resolution of##2##5##(2008-10#2)
at a nominal##6##3##(1996-12#1)(2008-10#3)(2012-1#2)
at a nuclear##2##3##(1994-6#1)(2008-8#1)
at a number of##3##4##(1991-2#1)(2008-11#1)(2008-5#1)
at a pH of##3##4##(2008-10#3)
at a pH range of##2##5##(2008-10#1)(2008-7#1)
at a pH range##4##4##(2008-10#3)(2008-7#1)
at a pH value##2##4##(2008-10#2)
at a pH##15##3##(1990-2#1)(2008-10#11)(2008-7#2)(2011-2#1)
at a pH&gt##2##3##(2008-10#1)(2009-11#1)
at a paediatric##2##3##(2008-11#1)(2011-2#1)
at a pair of##2##4##(2007-12#1)(2008-3#1)
at a particular time##2##4##(2008-1#1)(2008-2#1)
at a particular##6##3##(1993-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)
at a peak potential of##2##5##(2008-10#2)
at a peak##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
at a perfusion rate of##2##5##(2008-10#2)
at a platinum electrode in##2##5##(2008-10#2)
at a platinum electrode##3##4##(1991-5#1)(2008-10#2)
at a point in##2##4##(2008-2#1)(2008-6#1)
at a point##3##3##(2007-11#1)(2008-2#1)(2008-6#1)
at a poly(3-methylthiophene)##2##3##(2008-10#2)
at a polypyrrole electrode modified##2##5##(2008-10#2)
at a position##5##3##(1990-5#1)(1993-6#1)(2008-10#2)(2008-3#1)
at a potential of -0##4##5##(2008-10#4)
at a potential of##5##4##(2008-10#4)(2012-2#1)
at a potential##6##3##(2008-10#5)(2012-2#1)
at a precision##2##3##(2008-10#1)(2010-12#1)
at a preconcentration time of##2##5##(2008-10#2)
at a pressure of##2##4##(2008-10#1)(2008-6#1)
at a pressure##3##3##(1996-4#1)(2008-10#1)(2008-6#1)
at a primary care center]##2##5##(1994-3#1)(1994-6#1)
at a primary care##3##4##(1994-3#1)(1994-6#1)(2008-8#1)
at a private psychiatric hospital##2##5##(1991-2#1)(1992-3#1)
at a public hospital in##2##5##(2013-1#1)(2013-8#1)
at a public##4##3##(1993-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
at a pump##4##3##(2007-11#1)(2007-12#3)
at a range of##6##4##(1996-2#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-7#1)
at a range##7##3##(1996-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)(2012-7#1)
at a rapid pace##2##4##(1994-2#1)(1997-3#1)
at a rate of 0##5##5##(1992-12#1)(2007-12#1)(2008-10#2)(2013-7#1)
at a rate of 1##3##5##(1990-9#1)(1992-12#1)(2008-10#1)
at a rate of 2##2##5##(1992-12#1)(2011-2#1)
at a rate of 2% (vol/vol)##2##6##(2008-10#2)
at a rate of 5##2##5##(2008-10#1)(2010-3#1)
at a rate of up to##2##6##(2007-11#1)(2008-10#1)
at a rate of##28##4##(1990-11#1)(1990-9#1)(1992-12#3)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
at a rate similar to that##2##6##(1993-8#1)(1995-2#1)
at a rate##40##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-12#3)(1992-6#1)(1993-6#1)(1993-8#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-11#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
at a ratio of 1##5##5##(1994-11#1)(1994-3#1)(1995-2#1)(2008-10#1)(2013-1#1)
at a ratio of##7##4##(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-10#1)(2013-1#1)
at a reasonable cost##3##4##(1992-1#1)(2008-10#2)
at a reduced##2##3##(2008-3#1)(2008-6#1)
at a regional##2##3##(1995-5#1)(2008-10#1)
at a regulatory##2##3##(1994-9#1)(2008-10#1)
at a relatively high frequency##2##5##(2008-10#1)(2008-11#1)
at a relatively high##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
at a relatively low##5##4##(2008-10#3)(2008-11#1)(2012-12#1)
at a relatively##9##3##(1993-12#1)(2008-10#4)(2008-11#2)(2008-8#1)(2012-12#1)
at a repetition frequency##2##4##(2007-11#1)(2008-3#1)
at a repetition rate of 10##2##6##(2007-12#1)(2008-3#1)
at a repetition rate of 100 Hz##2##7##(2008-3#2)
at a repetition rate of 100##3##6##(2007-12#1)(2008-3#2)
at a repetition rate of 50##2##6##(2007-11#1)(2007-12#1)
at a repetition rate of##16##5##(2007-11#4)(2007-12#6)(2008-2#2)(2008-3#4)
at a repetition##18##3##(2007-11#5)(2007-12#6)(2008-2#2)(2008-3#5)
at a resolution of##6##4##(2008-10#2)(2008-3#3)(2011-1#1)
at a retention time of##2##5##(1990-8#1)(2008-10#1)
at a retention##3##3##(1990-8#1)(2008-10#2)
at a rural##2##3##(1993-3#1)(2008-3#1)
at a sample flow rate of##2##6##(2008-10#2)
at a sample##3##3##(2008-10#3)
at a sampling frequency of##3##5##(2008-10#2)(2013-1#1)
at a sampling rate of 30 h(-1)##2##7##(2008-10#2)
at a sampling rate of 60##2##6##(2008-10#2)
at a sampling rate of 90 h(-1)##2##7##(2008-10#2)
at a sampling rate of 90##3##6##(2008-10#3)
at a sampling rate of##11##5##(2008-10#10)(2008-3#1)
at a sampling##15##3##(2008-10#13)(2008-3#1)(2013-1#1)
at a scale##3##3##(2008-10#2)(2008-11#1)
at a second##3##3##(1992-3#1)(1996-9#1)(2008-3#1)
at a selected##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
at a separation voltage of##5##5##(2008-10#5)
at a series of##2##4##(2008-8#1)(2010-5#1)
at a set of##2##4##(2008-3#1)(2009-2#1)
at a signal-to-noise ratio of 3##5##6##(1990-8#1)(1991-5#1)(2008-10#2)(2013-1#1)
at a signal-to-noise ratio of##7##5##(1990-8#1)(1991-5#1)(2008-10#3)(2008-3#1)(2013-1#1)
at a signal-to-noise ratio##8##4##(1990-8#1)(1991-5#1)(2008-10#4)(2008-3#1)(2013-1#1)
at a significant##2##3##(2008-12#1)(2012-12#1)
at a significantly higher frequency on##2##6##(2008-10#2)
at a significantly higher##4##4##(2008-10#2)(2008-7#2)
at a significantly##7##3##(1995-11#1)(2008-10#2)(2008-2#2)(2008-7#2)
at a silver electrode##2##4##(2008-10#2)
at a similar position##2##4##(1993-8#1)(2007-12#1)
at a similar##9##3##(1990-8#1)(1990-9#1)(1991-8#1)(1993-8#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-10#1)
at a single institution##3##4##(2007-8#1)(2008-6#1)(2011-2#1)
at a single locus##3##4##(2008-10#2)(2008-8#1)
at a single point##2##4##(2008-2#1)(2008-6#1)
at a single position##2##4##(1990-8#1)(1992-11#1)
at a single site##4##4##(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#1)
at a single time point##2##5##(1995-12#1)(2011-2#1)
at a single wavelength##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
at a single##35##3##(1990-8#2)(1992-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-6#2)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#3)
at a site##11##3##(1991-11#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-2#2)(1995-5#1)(2008-9#1)(2009-8#1)(2013-1#1)
at a slaughterhouse##2##3##(1994-7#1)(2008-12#1)
at a slightly##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
at a slower##2##3##(1995-2#1)(2008-7#1)
at a small##7##3##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-3#1)
at a spatial resolution of##2##5##(2008-3#2)
at a specific growth rate##3##5##(1994-3#1)(2008-6#1)(2008-7#1)
at a specific site##4##4##(1991-9#1)(1992-2#1)(1994-8#1)(2013-8#1)
at a specific##18##3##(1991-9#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2013-8#1)
at a spectral##2##3##(1991-5#1)(2008-3#1)
at a speed of##3##4##(2008-10#1)(2008-3#2)
at a static mercury drop electrode##2##6##(2008-10#2)
at a static##3##3##(2008-10#2)(2008-12#1)
at a steady##2##3##(2008-11#1)(2010-11#1)
at a step##2##3##(1997-3#1)(2008-8#1)
at a strongly##2##3##(2008-3#1)(2008-9#1)
at a subregional neonatal unit##2##5##(1995-5#2)
at a teaching hospital in##2##5##(2007-2#1)(2008-8#1)
at a temperature around##2##4##(2008-7#2)
at a temperature of 25 degrees C##2##7##(2008-11#1)(2008-12#1)
at a temperature of##10##4##(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)
at a temperature##21##3##(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#3)(2009-7#1)
at a tertiary care hospital in##2##6##(2013-1#1)(2013-8#1)
at a tertiary care hospital##4##5##(2013-1#1)(2013-8#3)
at a tertiary care##6##4##(2008-6#1)(2013-1#1)(2013-8#4)
at a tertiary##10##3##(2008-4#1)(2008-6#1)(2012-2#2)(2013-1#2)(2013-8#4)
at a time for##2##4##(1994-3#1)(2008-10#1)
at a time of##2##4##(2010-12#1)(2013-1#1)
at a time when##8##4##(1992-9#1)(1995-5#1)(1995-8#1)(2008-10#4)(2012-3#1)
at a time##29##3##(1992-9#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#8)(2008-3#3)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
at a total initiator dose of 1##3##7##(1990-7#3)
at a total initiator dose of##4##6##(1990-7#4)
at a total of##2##4##(1991-11#1)(2008-10#1)
at a total pressure of 650 mbar##2##7##(2007-12#2)
at a total##13##3##(1990-7#4)(1991-11#1)(1992-3#1)(2007-12#2)(2007-8#1)(2008-10#3)(2013-1#1)
at a unique site in##2##5##(1990-7#1)(1995-6#1)
at a unique##3##3##(1990-7#2)(1995-6#1)
at a university##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
at a variety of##2##4##(2008-11#1)(2008-8#1)
at a velocity of##3##4##(2008-3#3)
at a very low##3##4##(2008-10#2)(2008-5#1)
at a very##6##3##(2008-10#4)(2008-5#1)(2012-3#1)
at a video rate##2##4##(2008-2#1)(2008-3#1)
at a wavelength mixing ratio of##2##6##(2013-1#2)
at a wavelength near##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
at a wavelength of 1##10##5##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#3)
at a wavelength of 10##7##5##(2007-11#4)(2007-12#2)(2008-3#1)
at a wavelength of 11##2##5##(2007-11#1)(2008-3#1)
at a wavelength of 2##3##5##(2007-12#2)(2008-2#1)
at a wavelength of 514##2##5##(2007-11#1)(2008-3#1)
at a wavelength of 633 nm##2##6##(2008-3#2)
at a wavelength of 780 nm and##2##7##(2008-2#1)(2008-3#1)
at a wavelength of##55##4##(1990-12#1)(2007-11#13)(2007-12#13)(2008-10#2)(2008-2#11)(2008-3#15)
at a wavelength##63##3##(1990-12#1)(2007-11#14)(2007-12#14)(2008-10#3)(2008-2#12)(2008-3#17)(2013-1#2)
at a wide range of##2##5##(2008-10#1)(2008-5#1)
at a young age##3##4##(1992-2#1)(1994-9#1)(2011-2#1)
at a younger age##5##4##(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
at a younger##6##3##(1994-8#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
at a##1586##2##(1990-11#2)(1990-12#8)(1990-2#5)(1990-5#7)(1990-6#3)(1990-7#7)(1990-8#8)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#3)(1991-2#7)(1991-3#4)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#5)(1992-3#12)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#9)(1993-2#2)(1993-3#7)(1993-6#9)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#8)(1994-3#12)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#10)(1994-9#4)(1995-1#1)(1995-11#9)(1995-12#12)(1995-2#13)(1995-3#9)(1995-5#10)(1995-6#5)(1995-8#2)(1996-1#2)(1996-12#8)(1996-2#5)(1996-3#7)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#9)(1997-4#6)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#4)(2007-11#52)(2007-12#80)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#406)(2008-11#64)(2008-12#25)(2008-2#66)(2008-3#143)(2008-4#7)(2008-5#18)(2008-6#29)(2008-7#42)(2008-8#29)(2008-9#13)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#6)(2010-1#5)(2010-10#4)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#5)(2010-5#6)(2010-6#4)(2010-8#4)(2010-9#2)(2011-1#13)(2011-2#30)(2012-1#4)(2012-12#17)(2012-2#19)(2012-3#17)(2012-5#2)(2012-7#1)(2013-1#36)(2013-7#2)(2013-8#17)
at abdominal hysterectomy##2##3##(1991-12#2)
at about -1##2##3##(2008-10#2)
at about 0##6##3##(2008-10#5)(2008-6#1)
at about 1##2##3##(2008-11#1)(2008-4#1)
at about##38##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-6#1)(2007-12#3)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
at above##2##2##(1994-9#1)(2012-3#1)
at achieving a##3##3##(1991-6#1)(2008-3#1)(2008-4#1)
at achieving##5##2##(1991-6#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)
at acidic pH and##2##4##(1991-12#1)(2013-8#1)
at acidic pH##7##3##(1991-12#2)(1991-5#1)(1992-11#1)(1994-5#1)(2008-10#1)(2013-8#1)
at acidic##9##2##(1991-12#2)(1991-5#1)(1992-11#1)(1994-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
at acupoints##2##2##(2010-7#1)(2013-1#1)
at adjacent##2##2##(2012-12#1)(2012-3#1)
at admission and at discharge##2##5##(1991-2#1)(2011-2#1)
at admission and##3##3##(1991-2#1)(2011-2#2)
at admission were##2##3##(1994-12#1)(2012-3#1)
at admission##10##2##(1991-2#1)(1993-5#1)(1994-12#1)(1996-12#1)(2007-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
at adolescence##2##2##(1990-12#1)(2008-4#1)
at advanced stage##2##3##(2010-7#1)(2011-2#1)
at age 25##2##3##(1997-3#1)(2012-2#1)
at age 4##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
at age fourteen years##2##4##(2012-3#2)
at age of##2##3##(2008-7#1)(2010-8#1)
at age##35##2##(1990-4#1)(1990-6#1)(1995-4#1)(1995-8#2)(1997-3#3)(2006-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#1)(2010-8#3)(2011-1#4)(2012-2#1)(2012-3#5)(2013-1#1)
at age-2##2##2##(2011-2#2)
at ages##8##2##(1991-12#1)(1994-1#2)(1995-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-9#1)
at air-water interface##2##3##(2008-10#2)
at alkaline pH##4##3##(1990-7#1)(1992-6#1)(2008-11#1)(2008-9#1)
at alkaline##5##2##(1990-7#1)(1992-6#1)(2008-11#1)(2008-9#1)(2009-7#1)
at all ages##8##3##(1991-3#1)(1994-11#1)(1996-12#1)(1996-5#2)(2008-3#1)(2008-9#1)(2012-1#1)
at all airway levels##2##4##(1992-3#2)
at all angles of##2##4##(2007-11#1)(2008-3#1)
at all angles##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
at all concentration##2##3##(2008-10#2)
at all concentrations studied##2##4##(2008-10#2)
at all concentrations##6##3##(2008-10#4)(2008-11#1)(2013-7#1)
at all developmental##2##3##(1995-12#1)(2011-2#1)
at all doses##4##3##(1993-6#1)(2008-11#1)(2008-12#2)
at all exposure times##2##4##(2008-5#2)
at all field locations##2##4##(2008-10#1)(2011-2#1)
at all for##2##3##(1996-1#1)(2008-10#1)
at all four##2##3##(1991-2#1)(2008-4#1)
at all growth stages##2##4##(2008-10#2)
at all in##8##3##(1990-11#1)(1995-11#1)(1995-12#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
at all levels of the##6##5##(1992-12#1)(1993-12#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)
at all levels of##10##4##(1992-12#1)(1993-12#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
at all levels##18##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-9#1)
at all loci##2##3##(2008-10#1)(2008-11#1)
at all possible##2##3##(1991-6#1)(2008-8#1)
at all sites##3##3##(1990-2#1)(2008-10#2)
at all stages of##2##4##(1990-7#1)(2008-10#1)
at all stages##5##3##(1990-7#1)(2006-10#1)(2008-10#2)(2008-9#1)
at all temperatures and##2##4##(2008-10#2)
at all temperatures##10##3##(1990-9#1)(2008-10#8)(2011-2#1)
at all tested##2##3##(2008-12#1)(2013-1#1)
at all the##6##3##(1994-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
at all three##9##3##(1991-2#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)(2012-12#1)
at all time##2##3##(2007-12#1)(2012-1#1)
at all times##6##3##(1990-12#1)(1997-2#1)(2007-6#1)(2009-11#1)(2010-10#1)(2010-8#1)
at all treatment##2##3##(2008-10#1)(2013-1#1)
at all wavelengths and##2##4##(1995-6#1)(2008-3#1)
at all wavelengths##5##3##(1995-6#1)(2007-12#1)(2008-3#3)
at all##240##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#5)(1992-8#1)(1993-11#1)(1993-12#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#51)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#15)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-3#4)(2010-8#3)(2010-9#1)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#1)
at almost all##2##3##(2008-10#1)(2013-1#1)
at almost##4##2##(1994-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
at alpha##7##2##(1994-6#1)(1995-11#6)
at altitudes##5##2##(1990-8#1)(1991-5#1)(2008-2#2)(2008-8#1)
at ambient and##2##3##(1995-3#1)(2008-10#1)
at ambient pressure in##2##4##(2008-10#1)(2008-3#1)
at ambient pressure##7##3##(1996-5#1)(2008-10#4)(2008-3#1)(2012-2#1)
at ambient temperature and pressure##2##5##(2008-10#1)(2010-12#1)
at ambient temperature##19##3##(1995-3#1)(1997-7#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)
at ambient##31##2##(1995-3#3)(1996-5#1)(1997-7#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
at amino acid##5##3##(1990-12#1)(1991-8#1)(1993-8#1)(1994-11#1)(1997-3#1)
at an ATP##2##3##(1990-7#1)(1991-9#1)
at an HIV##2##3##(2009-4#1)(2009-5#1)
at an MOI of 0##2##5##(2008-11#1)(2008-9#1)
at an N concentration of##2##5##(2008-10#2)
at an RPE that corresponded to##2##6##(2013-8#2)
at an academic medical##2##4##(1991-1#1)(2011-1#1)
at an academic##4##3##(1991-1#1)(1995-2#1)(2011-1#1)(2012-3#1)
at an accelerated##2##3##(2008-12#1)(2013-8#1)
at an acceptable level##2##4##(1991-2#1)(2009-8#1)
at an acid pH##2##4##(1990-2#1)(2009-7#1)
at an acute angle##2##4##(2007-12#1)(2008-2#1)
at an acute##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
at an advanced stage##3##4##(1997-3#1)(2008-1#1)(2008-10#1)
at an age##2##3##(2008-12#1)(2010-8#1)
at an alarming rate##3##4##(2008-4#1)(2008-7#1)(2012-3#1)
at an analytical##3##3##(2008-10#3)
at an angle of##5##4##(2008-2#3)(2008-3#2)
at an angle##11##3##(1992-9#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#3)(2013-1#1)
at an applied potential of 0##2##6##(2008-10#2)
at an applied potential of##4##5##(2008-10#4)
at an applied##5##3##(2008-10#5)
at an appropriate##4##3##(1996-11#1)(1997-8#1)(2008-3#2)
at an arbitrarily##2##3##(2008-3#2)
at an arbitrary##2##3##(2007-12#1)(2010-5#1)
at an average follow-up of##2##5##(2008-8#1)(2011-2#1)
at an average of##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
at an average##15##3##(1993-1#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
at an earlier age##2##4##(1993-12#1)(2008-3#1)
at an earlier stage of development##2##6##(1997-7#1)(2008-10#1)
at an earlier stage##6##4##(1992-3#1)(1994-11#1)(1994-7#1)(1997-7#1)(2008-1#1)(2008-10#1)
at an earlier##9##3##(1992-3#1)(1993-12#1)(1994-11#1)(1994-7#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)
at an early age##5##4##(1992-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
at an early stage in##3##5##(1990-9#1)(1991-9#1)(2009-8#1)
at an early stage of development##2##6##(2008-10#1)(2010-3#1)
at an early stage of##7##5##(1992-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-3#1)
at an early stage##28##4##(1990-9#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
at an early##38##3##(1990-9#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
at an electrochemically##2##3##(2008-10#2)
at an elevated level in##2##5##(1991-7#1)(1996-12#1)
at an elevated##3##3##(1991-7#1)(1996-12#1)(2013-1#1)
at an emergency##2##3##(1994-3#1)(1994-8#1)
at an emission wavelength of##2##5##(2008-10#2)
at an emission wavelength##3##4##(2008-10#3)
at an energy of##2##4##(2007-12#1)(2008-8#1)
at an energy##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
at an equitoxic##2##3##(1994-2#1)(2008-8#1)
at an estimated##2##3##(2008-11#1)(2008-5#1)
at an even higher##2##4##(2008-11#1)(2008-7#1)
at an excitation wavelength of##2##5##(2008-10#2)
at an incident##2##3##(2008-2#1)(2008-3#1)
at an increased risk for##3##5##(2008-1#1)(2012-12#1)(2012-2#1)
at an increased risk of##3##5##(1990-7#1)(2012-2#1)(2013-1#1)
at an increased risk##7##4##(1990-7#1)(2008-1#1)(2008-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
at an increased vertical dimension##2##5##(2009-8#2)
at an increased##10##3##(1990-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-8#2)(2012-12#1)(2012-2#2)(2013-1#1)
at an increasing rate##2##4##(1995-12#1)(2008-7#1)
at an institutional level##2##4##(2008-7#1)(2013-1#1)
at an intensity of##2##4##(2008-9#1)(2013-8#1)
at an intensity##5##3##(1990-7#2)(1994-6#1)(2008-9#1)(2013-8#1)
at an interim analysis##2##4##(2012-2#2)
at an intermediate##3##3##(2008-3#1)(2008-8#2)
at an internal##2##3##(1990-7#1)(1996-3#1)
at an ionic strength of##2##5##(1990-12#1)(1997-7#1)
at an operating##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
at an optical##2##3##(2007-11#1)(2008-2#1)
at an optimum##2##3##(2008-10#2)
at an overall##2##3##(2007-11#1)(2008-5#1)
at an unprecedented##2##3##(2008-4#1)(2010-12#1)
at an##261##2##(1990-12#1)(1990-2#1)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#10)(2007-12#4)(2007-8#1)(2008-1#4)(2008-10#43)(2008-11#6)(2008-12#6)(2008-2#11)(2008-3#23)(2008-4#2)(2008-5#6)(2008-7#10)(2008-8#7)(2008-9#6)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#9)(2012-3#8)(2013-1#9)(2013-8#7)
at anaphase##3##2##(2008-5#2)(2009-12#1)
at and above##2##3##(1993-6#1)(2012-2#1)
at and##9##2##(1990-8#1)(1993-6#1)(1995-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
at angles of##2##3##(2008-3#2)
at angles##4##2##(2008-3#4)
at annual##2##2##(1991-12#1)(1991-2#1)
at another institution##2##3##(2007-12#1)(2008-12#1)
at another##9##2##(1991-8#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)
at antagonist densities of##2##4##(2008-10#2)
at antagonist##3##2##(2008-10#3)
at anthesis##6##2##(2008-10#5)(2008-12#1)
at any given temperature##2##4##(2008-10#2)
at any given##13##3##(1992-6#2)(1995-6#1)(2007-11#1)(2008-10#3)(2008-4#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#1)
at any level of##2##4##(2011-1#1)(2011-2#1)
at any of the##4##4##(1995-11#1)(2008-10#1)(2008-6#1)(2010-1#1)
at any one time##3##4##(2008-11#1)(2008-2#1)(2008-6#1)
at any pH##2##3##(2008-10#2)
at any point in##3##4##(2007-11#1)(2008-10#1)(2008-12#1)
at any point##6##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
at any single##2##3##(1994-9#1)(1995-12#1)
at any site##3##3##(1997-8#1)(2009-5#1)(2013-1#1)
at any stage of the disease##2##6##(1993-2#1)(2012-2#1)
at any stage of the##6##5##(1993-2#2)(2008-5#1)(2012-12#1)(2012-2#2)
at any stage of##8##4##(1993-2#2)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
at any stage##10##3##(1993-2#2)(2008-10#1)(2008-5#2)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
at any temperature##2##3##(1993-9#1)(2008-10#1)
at any time during##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
at any time##14##3##(1991-3#1)(1994-5#2)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)
at any##94##2##(1991-3#2)(1992-12#1)(1992-6#2)(1993-2#2)(1993-9#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-5#1)(2010-1#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)
at appropriate##6##2##(1990-10#1)(1991-9#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
at approx##2##2##(1990-11#1)(2008-6#1)
at approximately 12##2##3##(1993-8#1)(2010-10#1)
at approximately 3##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
at approximately the same rate##2##5##(1993-6#1)(1995-8#1)
at approximately the same##3##4##(1991-5#1)(1993-6#1)(1995-8#1)
at approximately the##4##3##(1991-5#1)(1993-6#1)(1995-8#1)(2008-10#1)
at approximately##48##2##(1991-12#2)(1991-5#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-3#1)(1995-8#2)(1996-2#2)(1997-5#1)(2007-11#2)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-3#1)
at arbitrary##5##2##(2007-12#2)(2008-2#2)(2008-5#1)
at arginine##2##2##(1994-6#1)(2013-8#1)
at around pH 5-6##2##4##(2008-10#2)
at around pH##4##3##(2008-10#4)
at around##16##2##(1992-11#1)(1993-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)
at as##4##2##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
at atmospheric pressure and 24 degrees C##2##7##(2008-3#2)
at atmospheric pressure and##3##4##(2008-2#1)(2008-3#2)
at atmospheric pressure##12##3##(1990-7#1)(2008-10#1)(2008-2#6)(2008-3#4)
at atmospheric##13##2##(1990-7#1)(2008-10#1)(2008-2#6)(2008-3#4)(2010-5#1)
at atomic resolution##2##3##(2008-7#1)(2009-11#1)
at autopsy##11##2##(1994-7#2)(1995-11#2)(1995-12#1)(1996-11#1)(1996-9#1)(2008-7#2)(2008-9#2)
at average##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
at avoiding##2##2##(2008-11#1)(2008-6#1)
at b =##3##3##(2009-11#3)
at b##4##2##(2008-10#1)(2009-11#3)
at bare##2##2##(2008-10#2)
at bars##2##2##(2008-12#2)
at base##2##2##(1991-11#1)(1995-2#1)
at baseline and 6##2##4##(2011-2#1)(2013-1#1)
at baseline and after##4##4##(2006-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
at baseline and at the##2##5##(2008-10#1)(2008-3#1)
at baseline and at##7##4##(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)
at baseline and during##3##4##(1996-5#1)(2008-3#1)(2013-8#1)
at baseline and then##2##4##(2007-10#1)(2008-3#1)
at baseline and##29##3##(1993-12#1)(1996-5#1)(2006-12#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-7#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
at baseline##70##2##(1992-9#1)(1993-12#2)(1994-2#1)(1995-9#1)(1996-1#1)(1996-5#2)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#5)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#3)
at basic pH##4##3##(2008-10#4)
at basic##5##2##(2008-10#4)(2008-9#1)
at bedtime##6##2##(2007-6#1)(2007-7#1)(2008-5#1)(2010-6#1)(2012-12#2)
at being##3##2##(2009-10#1)(2010-1#1)(2012-3#1)
at best##23##2##(1990-5#1)(1991-3#1)(1994-2#1)(1997-3#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#2)(2009-8#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at between##2##2##(2008-10#1)(2008-11#1)
at bilateral##3##2##(2010-7#1)(2012-2#2)
at birth and##3##3##(2008-1#2)(2009-4#1)
at birth##41##2##(1990-7#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-5#1)(2007-11#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)
at birth?##2##2##(2006-9#1)(2008-7#1)
at bismuth film electrodes##2##4##(2008-10#2)
at bismuth film screen-printed##2##4##(2008-10#2)
at bismuth film##5##3##(2008-10#5)
at blood##2##2##(1995-3#1)(2006-6#1)
at bloom and fruit developmental stages##2##6##(2008-10#2)
at bloom stage##2##3##(2008-10#2)
at bloom##6##2##(2008-10#6)
at booting and panicle exsertion stages##3##6##(2008-10#3)
at booting##4##2##(2008-10#3)(2008-12#1)
at both 5 and 10 years##2##6##(2010-3#2)
at both 5 and##3##4##(2008-10#1)(2010-3#2)
at both bays##2##3##(2007-5#2)
at both doses##3##3##(1991-3#1)(1994-12#1)(2006-10#1)
at both ends of##2##4##(2008-1#1)(2008-8#1)
at both ends##5##3##(1995-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
at both local and##2##4##(1996-5#1)(2009-2#1)
at both locations##2##3##(2008-10#2)
at both mRNA and protein levels##2##6##(2008-5#1)(2008-9#1)
at both pH##2##3##(1997-2#1)(2008-10#1)
at both sides of##2##4##(1991-2#1)(2008-3#1)
at both sites##5##3##(1996-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
at both temperatures##2##3##(2010-8#1)(2012-12#1)
at both the transcriptional and##2##5##(1991-6#1)(1993-8#1)
at both the##27##3##(1991-6#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#2)(2010-5#1)(2012-2#1)
at both time points##4##4##(2009-10#1)(2011-2#1)(2013-1#2)
at both types of##2##4##(1992-3#1)(1993-6#1)
at both wavelengths##2##3##(1995-6#1)(2008-2#1)
at both##119##2##(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-5#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#32)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-2#1)(2009-8#2)(2010-1#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
at branching##2##2##(2012-12#2)
at budbreak##2##2##(2008-10#2)
at by##4##2##(1992-2#1)(2008-11#1)(2008-2#1)(2009-5#1)
at ca##3##2##(2008-10#2)(2008-11#1)
at cancer##2##2##(2013-1#1)(2013-8#1)
at carbon nanotube##4##3##(2008-10#4)
at carbon paste electrode##3##4##(2008-10#3)
at carbon paste##5##3##(2008-10#5)
at carbon##13##2##(2008-10#12)(2010-6#1)
at cell densities of 5##2##5##(2008-10#1)(2008-7#1)
at cell##3##2##(2008-10#1)(2008-7#2)
at cell-cell##2##2##(2009-8#2)
at cellular and##2##3##(2008-5#1)(2008-9#1)
at central wavelengths of##2##4##(2007-11#1)(2007-12#1)
at central##3##2##(1995-8#1)(2007-11#1)(2007-12#1)
at certain##10##2##(1994-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-6#1)(2011-2#1)
at chain lengths##2##3##(1990-5#1)(1997-6#1)
at chain##3##2##(1990-5#1)(1997-6#1)(2008-10#1)
at chance##3##2##(1993-3#1)(1994-3#1)(1996-2#1)
at chemical vapor##2##3##(2007-11#2)
at chemical##3##2##(1994-9#1)(2007-11#2)
at children##2##2##(2009-4#1)(2013-1#1)
at chromosomal##2##2##(2008-11#1)(2011-2#1)
at chromosome I##2##3##(1995-6#2)
at chromosome##7##2##(1995-6#3)(1996-12#2)(2009-5#1)(2010-2#1)
at clinical follow-up##2##3##(2011-1#2)
at clinical level##2##3##(2008-11#2)
at clinical##9##2##(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#2)(2012-12#1)(2013-1#1)
at clinically relevant levels in human urine##2##7##(2008-10#2)
at close##4##2##(1995-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
at cloud##4##2##(2008-10#2)(2008-3#2)
at coarse##2##2##(2008-8#1)(2013-7#1)
at codon##14##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-2#2)(2012-12#1)
at codons##2##2##(1996-5#1)(2008-11#1)
at cold##2##2##(2008-8#2)
at collapsed replication forks##2##4##(2012-3#2)
at community##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
at comparable levels of##2##4##(1993-11#1)(2009-4#1)
at comparable##6##2##(1993-11#1)(1995-8#1)(2008-3#1)(2009-4#1)(2011-7#1)(2012-2#1)
at comparing##2##2##(2008-2#1)(2008-4#1)
at concentration level##2##3##(2008-10#2)
at concentration levels between##3##4##(2008-10#3)
at concentration levels from##2##4##(2008-10#2)
at concentration levels##10##3##(2008-10#10)
at concentration of##5##3##(2008-10#2)(2008-12#1)(2012-2#1)(2013-8#1)
at concentration##23##2##(1990-2#1)(1992-9#1)(1995-8#1)(2008-10#17)(2008-12#1)(2012-2#1)(2013-8#1)
at concentrations &gt##2##3##(1994-8#1)(2008-10#1)
at concentrations above 1##2##4##(2008-10#1)(2008-9#1)
at concentrations above##4##3##(1994-6#1)(2008-10#2)(2008-9#1)
at concentrations as high as 200##2##6##(2008-10#1)(2012-2#1)
at concentrations as high as##8##5##(1990-7#1)(1991-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2012-2#1)
at concentrations as low as 0##3##6##(2008-10#1)(2008-11#2)
at concentrations as low as##6##5##(2008-10#4)(2008-11#2)
at concentrations as##14##3##(1990-7#1)(1991-9#1)(2008-10#5)(2008-11#5)(2008-5#1)(2012-2#1)
at concentrations below##4##3##(1992-12#1)(2008-10#2)(2012-12#1)
at concentrations between 0##4##4##(2008-10#2)(2008-7#2)
at concentrations between##9##3##(1993-9#1)(2008-10#5)(2008-3#1)(2008-7#2)
at concentrations from 0##2##4##(1993-6#2)
at concentrations from##3##3##(1993-6#2)(1995-12#1)
at concentrations greater than##2##4##(2008-10#1)(2008-5#1)
at concentrations higher than##3##4##(1991-5#1)(1993-9#1)(2008-11#1)
at concentrations in the range##2##5##(1990-12#1)(2008-11#1)
at concentrations in the##4##4##(1990-12#1)(1990-8#1)(2008-11#1)(2008-5#1)
at concentrations lower than##2##4##(2008-10#1)(2008-2#1)
at concentrations lower##3##3##(2008-10#2)(2008-2#1)
at concentrations of 0##3##4##(2008-10#1)(2008-9#2)
at concentrations of 1##2##4##(1990-7#1)(2008-10#1)
at concentrations of 10##2##4##(1993-11#1)(1994-9#1)
at concentrations of 50##2##4##(2008-5#1)(2012-3#1)
at concentrations of##26##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-5#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2012-3#1)(2013-1#1)
at concentrations over##2##3##(1993-12#1)(1993-9#1)
at concentrations ranging from##5##4##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
at concentrations ranging##6##3##(1991-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
at concentrations that are##2##4##(2008-10#1)(2010-4#1)
at concentrations that##10##3##(1990-11#1)(1992-9#1)(1995-2#1)(2008-10#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)
at concentrations up to##8##4##(1990-2#1)(1994-11#1)(1995-5#1)(2008-10#3)(2008-5#1)(2013-1#1)
at concentrations##117##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#2)(1990-8#1)(1991-2#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#3)(1993-9#3)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#3)(2007-12#1)(2008-10#43)(2008-11#9)(2008-2#3)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
at conception##2##2##(2008-10#1)(2010-12#1)
at conditions##2##2##(1990-11#1)(1990-8#1)
at conducting and electrogenerated polymer modified electrodes##2##7##(2008-10#2)
at conducting##3##2##(2008-10#3)
at conserved##3##2##(1993-12#1)(1995-8#1)(2010-5#1)
at considerably##2##2##(2008-10#1)(2009-10#1)
at constant pH##2##3##(2008-10#1)(2008-11#1)
at constant temperatures##2##3##(2008-10#2)
at constant total volume##2##4##(2008-10#2)
at constant##17##2##(1992-11#1)(1996-5#1)(2008-10#12)(2008-11#1)(2008-5#1)(2011-2#1)
at contributing to##2##3##(2009-12#1)(2011-2#1)
at controlling##6##2##(1993-3#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-11#1)(2013-1#1)
at cool temperatures##2##3##(2008-10#1)(2008-8#1)
at critical##4##2##(1994-12#1)(1996-3#1)(2008-2#1)(2008-4#1)
at crop anthesis##2##3##(2008-10#2)
at cysteine##2##2##(2008-4#1)(2008-8#1)
at dT+4##2##2##(1992-6#2)
at daily##2##2##(2007-11#1)(2010-10#1)
at day 1 and##2##4##(2007-10#1)(2010-6#1)
at day 1##5##3##(2007-10#1)(2008-5#1)(2010-6#2)(2013-1#1)
at day 125##2##3##(2008-10#2)
at day 14##3##3##(1991-8#1)(1993-12#1)(2008-7#1)
at day 3##3##3##(1993-8#1)(2007-2#1)(2008-5#1)
at day 4##2##3##(1993-9#1)(2011-1#1)
at day 5##2##3##(1995-2#1)(2008-11#1)
at day 63 after sowing##2##5##(2008-12#2)
at day 7##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
at day 8##2##3##(2008-12#1)(2010-10#1)
at day##40##2##(1991-8#2)(1993-12#2)(1993-8#2)(1993-9#1)(1994-9#1)(1995-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-5#4)(2008-6#1)(2008-7#1)(2010-10#1)(2010-6#2)(2011-1#1)(2013-1#3)
at days 0##2##3##(2008-10#1)(2008-7#1)
at days 14 and 21 p##5##6##(2008-5#5)
at days 7##2##3##(2008-7#2)
at days##14##2##(1990-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#3)(2010-6#2)
at defined time points##2##4##(2012-2#1)(2012-3#1)
at defined##5##2##(2007-12#1)(2008-3#1)(2012-2#1)(2012-3#2)
at defining##3##2##(1991-5#1)(2008-11#1)(2012-2#1)
at densities##3##2##(2008-10#2)(2008-12#1)
at depth##2##2##(2008-10#1)(2008-3#1)
at depths of 0 to##2##5##(2008-10#2)
at depths of##8##3##(2007-5#1)(2008-10#4)(2008-3#1)(2012-2#1)(2013-8#1)
at depths##12##2##(1992-3#1)(2007-5#1)(2008-10#5)(2008-3#2)(2012-2#1)(2013-8#2)
at describing the##2##3##(2008-12#1)(2010-11#1)
at detecting##2##2##(1996-3#1)(2008-2#1)
at determining the##2##3##(2008-5#1)(2013-8#1)
at determining##3##2##(1994-8#1)(2008-5#1)(2013-8#1)
at developing a##2##3##(1996-3#1)(2009-11#1)
at developing##5##2##(1996-3#1)(2008-10#2)(2008-12#1)(2009-11#1)
at diagnosis and at relapse##2##5##(2011-2#2)
at diagnosis and##6##3##(1990-12#1)(1992-12#1)(2008-6#1)(2011-2#3)
at diagnosis was##9##3##(1990-12#1)(1992-2#1)(1992-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)
at diagnosis##40##2##(1990-12#5)(1990-8#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-10#1)(1995-8#1)(1997-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-6#3)(2008-7#1)(2010-3#2)(2011-1#3)(2011-2#7)(2012-3#2)(2013-1#4)
at different ages##9##3##(1990-5#1)(1993-12#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
at different altitudes##2##3##(2008-2#1)(2008-3#1)
at different angles##3##3##(2008-2#2)(2008-3#1)
at different concentrations and##2##4##(2008-10#2)
at different concentrations to##2##4##(2008-10#2)
at different concentrations was##2##4##(2008-11#1)(2012-2#1)
at different concentrations##13##3##(1994-3#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2012-2#2)
at different degrees##2##3##(1990-5#1)(2011-3#1)
at different densities##2##3##(2008-10#1)(2013-1#1)
at different depths of##2##4##(2008-2#1)(2008-3#1)
at different depths##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
at different developmental stages##5##4##(1993-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
at different distances from the##3##5##(2008-3#1)(2008-6#2)
at different distances##4##3##(2008-10#1)(2008-3#1)(2008-6#2)
at different doses##2##3##(2008-10#1)(2008-9#1)
at different electrodes##2##3##(2008-10#2)
at different experimental conditions##2##4##(2008-10#2)
at different frequencies##2##3##(1996-12#1)(2013-8#1)
at different growth stages##2##4##(2008-10#2)
at different heights##2##3##(2007-12#1)(2008-10#1)
at different incubation##2##3##(2008-10#1)(2011-2#1)
at different inoculation##2##3##(2008-10#2)
at different intensities##2##3##(1992-3#1)(2012-12#1)
at different intervals##2##3##(2010-3#1)(2013-7#1)
at different ionic strengths in##2##5##(2008-10#2)
at different ionic strengths##6##4##(1992-5#1)(1994-5#1)(2008-10#4)
at different levels of##5##4##(2008-10#2)(2008-11#2)(2009-10#1)
at different levels##15##3##(1991-9#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
at different locations in##4##4##(1992-6#1)(2008-10#2)(2008-5#1)
at different locations on the##2##5##(2008-10#1)(2008-3#1)
at different locations##8##3##(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
at different loci##3##3##(1990-11#1)(1995-2#1)(2008-10#1)
at different operating##3##3##(1992-12#1)(2008-2#2)
at different pH values and##2##5##(1993-11#1)(2008-10#1)
at different pH values##11##4##(1992-8#3)(1993-11#1)(1994-11#2)(2008-10#4)(2008-5#1)
at different pH##19##3##(1992-8#3)(1993-11#1)(1994-11#2)(2008-10#9)(2008-5#2)(2010-11#1)(2011-2#1)
at different periods##2##3##(1992-8#1)(1996-12#1)
at different phases of the cell cycle##2##7##(2008-11#2)
at different points##2##3##(2008-3#1)(2010-2#1)
at different positions in##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
at different positions of the##2##5##(1990-2#1)(1995-3#1)
at different positions##5##3##(1990-2#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
at different rates##4##3##(1994-3#1)(1996-2#1)(1997-6#1)(2008-10#1)
at different scales##3##3##(2008-8#2)(2010-7#1)
at different situations##2##3##(1994-12#1)(2008-3#1)
at different spatial scales##6##4##(2008-10#1)(2008-8#2)(2009-2#1)(2012-12#1)(2013-7#1)
at different spatial##7##3##(2008-10#1)(2008-2#1)(2008-8#2)(2009-2#1)(2012-12#1)(2013-7#1)
at different stage of##2##4##(2008-9#1)(2013-1#1)
at different stages of development##2##5##(2008-8#1)(2012-12#1)
at different stages of the process##2##6##(2008-10#1)(2008-2#1)
at different stages of the##7##5##(1993-9#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
at different stages of their development##2##6##(2009-10#1)(2009-8#1)
at different stages of##19##4##(1990-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#1)(2012-12#1)
at different stages##28##3##(1990-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)
at different steps of the##2##5##(2008-10#1)(2008-8#1)
at different temperature and##2##4##(2008-10#2)
at different temperature##4##3##(2008-10#3)(2009-8#1)
at different temperatures and##9##4##(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
at different temperatures with##2##4##(2008-10#1)(2008-6#1)
at different temperatures##31##3##(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#2)
at different time intervals##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
at different time points##2##4##(1990-7#1)(2011-3#1)
at different time##9##3##(1990-7#1)(2008-10#2)(2010-3#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
at different times after##2##4##(1994-5#1)(2008-10#1)
at different times during##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
at different times from##2##4##(2008-8#1)(2013-1#1)
at different times to##2##4##(2008-10#1)(2012-1#1)
at different times##20##3##(1994-5#2)(1994-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
at different values of##2##4##(2008-3#2)
at different wavelengths are##2##4##(2008-3#1)(2011-1#1)
at different wavelengths in the##2##5##(2007-11#1)(2008-3#1)
at different wavelengths##15##3##(1990-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2011-1#1)
at different##350##2##(1990-11#1)(1990-2#1)(1990-5#5)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#6)(2008-10#93)(2008-11#10)(2008-12#3)(2008-2#22)(2008-3#35)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#16)(2008-9#8)(2009-10#4)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#5)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#12)(2013-7#2)(2013-8#1)
at dilution rates of##2##4##(2008-11#1)(2008-6#1)
at dilution rates##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
at dilution##5##2##(2008-11#1)(2008-6#3)(2008-7#1)
at dilutions##2##2##(1990-12#1)(2008-10#1)
at direct##2##2##(2007-5#1)(2008-3#1)
at discharge##12##2##(1990-2#1)(1991-2#2)(2006-8#1)(2007-8#1)(2008-12#1)(2009-3#1)(2011-2#5)
at discontinuities##2##2##(2008-3#1)(2012-2#1)
at discrete##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
at disease onset##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
at disease##5##2##(2008-10#2)(2012-12#1)(2012-3#1)(2013-8#1)
at disproportionately higher concentrations in humans than in##2##8##(2010-11#2)
at distal##2##2##(2008-5#1)(2011-2#1)
at distance##2##2##(1996-4#1)(2008-10#1)
at distances of##5##3##(1990-7#1)(1995-2#1)(2008-10#3)
at distant##2##2##(2008-8#1)(2009-10#1)
at distinct##5##2##(1993-11#1)(1994-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
at dose level 100##2##4##(2013-1#2)
at dose levels of##2##4##(1994-5#1)(2010-1#1)
at dose##5##2##(1994-5#1)(2009-2#1)(2010-1#1)(2013-1#2)
at doses of 0##3##4##(1995-11#2)(2008-10#1)
at doses of 100##3##4##(2007-7#1)(2008-5#1)(2012-2#1)
at doses of 2##2##4##(2008-7#2)
at doses of 4##2##4##(1997-4#1)(1997-7#1)
at doses of up to 10##2##6##(1992-11#1)(2008-5#1)
at doses of##20##3##(1992-11#1)(1992-6#2)(1995-11#2)(1995-2#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#4)(2008-7#4)(2012-2#1)
at doses that did not##2##5##(1996-2#1)(2008-5#1)
at doses that##4##3##(1996-12#1)(1996-2#1)(2008-5#1)(2009-3#1)
at doses##36##2##(1990-4#1)(1990-5#1)(1992-11#1)(1992-6#2)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#6)(2009-3#1)(2012-2#1)
at each end##2##3##(2008-4#1)(2010-10#1)
at each level##3##3##(1992-6#1)(1996-3#1)(2008-8#1)
at each location##2##3##(2008-10#2)
at each locus##3##3##(2008-5#1)(2009-2#1)(2013-1#1)
at each look##2##3##(1997-3#2)
at each of the three##2##5##(2008-11#1)(2013-8#1)
at each of the##8##4##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-8#1)
at each of these##2##4##(2008-3#1)(2009-12#1)
at each of three##3##4##(2008-10#2)(2008-2#1)
at each of##19##3##(1993-12#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2012-1#1)(2013-8#1)
at each point##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
at each position##2##3##(2008-10#1)(2008-9#1)
at each scan##2##3##(2008-3#1)(2011-2#1)
at each site##2##3##(1994-3#1)(2008-10#1)
at each stage of##3##4##(2008-12#1)(2008-4#1)(2013-8#1)
at each stage##5##3##(2008-12#2)(2008-2#1)(2008-4#1)(2013-8#1)
at each step##4##3##(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#1)
at each temperature##2##3##(1995-5#1)(2008-10#1)
at each time point##5##4##(2008-5#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-2#1)
at each time##6##3##(2008-3#1)(2008-5#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-2#1)
at each visit##3##3##(1995-6#1)(2007-11#1)(2011-2#1)
at each wavelength##2##3##(2007-11#1)(2008-3#1)
at each##109##2##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-6#1)(1993-12#2)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-2#3)(1997-3#4)(2007-11#7)(2007-12#5)(2007-5#1)(2007-6#1)(2007-9#2)(2008-10#16)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
at earlier time points##3##4##(1997-2#1)(2008-10#1)(2012-4#1)
at earlier##6##2##(1993-6#2)(1997-2#1)(2008-10#1)(2011-2#1)(2012-4#1)
at early and late##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
at early bloom##2##3##(2008-10#2)
at early stages of##3##4##(2007-8#1)(2008-10#2)
at early stages##4##3##(2007-8#1)(2008-10#2)(2013-8#1)
at early times##2##3##(2007-12#1)(2008-1#1)
at early##18##2##(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-4#1)(2013-8#1)
at eight wavelengths##2##3##(2007-12#1)(2008-2#1)
at eight##6##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)
at either end of the##2##5##(2008-3#1)(2008-8#1)
at either end##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
at either the##6##3##(1990-5#1)(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
at either##30##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-11#1)(1995-11#2)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
at ejaculation/orgasm##2##2##(2010-11#2)
at electrode##2##2##(2008-10#1)(2008-9#1)
at elevated iron##2##3##(2008-10#2)
at elevated levels in##2##4##(1991-9#1)(2008-10#1)
at elevated temperature##3##3##(2008-10#1)(2010-5#1)(2012-1#1)
at elevated temperatures##13##3##(1990-5#1)(1990-7#1)(1991-9#1)(1994-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-7#1)
at elevated##25##2##(1990-5#1)(1990-7#1)(1991-9#2)(1994-12#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-1#1)
at embryonic##2##2##(1996-12#1)(2013-1#1)
at encouraging##2##2##(1997-3#1)(2010-10#1)
at end of##3##3##(2007-2#1)(2009-11#1)(2011-2#1)
at end##5##2##(1996-2#1)(2007-2#1)(2009-11#1)(2010-5#1)(2011-2#1)
at energies below##2##3##(2007-11#1)(2012-2#1)
at energies##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
at entry and##2##3##(1990-5#1)(2008-4#1)
at entry to the##2##4##(2007-7#1)(2008-7#1)
at entry##8##2##(1990-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)
at environmentally relevant##2##3##(1994-8#1)(2008-10#1)
at equal##9##2##(1991-9#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-12#1)(2013-7#1)
at equilibrium##16##2##(1990-7#1)(1990-8#2)(1992-6#2)(1995-5#1)(2008-10#2)(2008-12#3)(2008-8#3)(2008-9#1)(2013-1#1)
at equimolar concentration##2##3##(1995-3#1)(2008-10#1)
at equimolar##3##2##(1993-6#1)(1995-3#1)(2008-10#1)
at equitoxic doses##2##3##(1992-11#1)(2009-4#1)
at equitoxic##3##2##(1992-11#1)(2009-4#1)(2012-2#1)
at equivalent levels##3##3##(1995-11#1)(2008-11#1)(2013-1#1)
at equivalent##7##2##(1991-9#1)(1995-11#1)(1996-1#1)(2008-11#1)(2008-8#1)(2012-1#1)(2013-1#1)
at establishing the##2##3##(2008-10#1)(2011-1#1)
at establishing##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
at estimating##3##2##(2008-7#1)(2012-12#1)(2013-8#1)
at evaluating the##8##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#2)(2012-3#1)(2012-4#1)(2013-1#1)
at evaluating##10##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#3)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
at every point##2##3##(2007-12#1)(2008-10#1)
at every##10##2##(1990-2#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
at excitation and emission wavelengths of##2##6##(2008-10#1)(2008-3#1)
at excitatory synapses##3##3##(2008-7#2)(2012-3#1)
at excitatory##5##2##(1997-2#1)(2008-7#3)(2012-3#1)
at exercise##2##2##(2008-7#1)(2013-7#1)
at expression rates##2##3##(2008-11#2)
at expression##3##2##(2008-11#3)
at extended SSDS##4##3##(2008-3#4)
at extended##7##2##(2007-4#1)(2008-3#6)
at extremely low##2##3##(2008-10#1)(2008-11#1)
at extremely##3##2##(2008-10#2)(2008-11#1)
at fast rates##2##3##(1992-2#1)(2008-8#1)
at fast##4##2##(1992-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
at faster##2##2##(1992-11#1)(2008-2#1)
at femtogram levels##2##3##(2008-10#2)
at femtomolar concentrations##2##3##(2008-10#1)(2010-1#1)
at fertilization##5##2##(1994-5#1)(2008-6#1)(2009-12#1)(2009-8#1)(2013-1#1)
at final##2##2##(1992-9#1)(2008-7#1)
at finding##5##2##(1992-5#1)(1994-6#1)(2008-2#1)(2008-6#1)(2013-8#1)
at finite frequencies##2##3##(2007-11#2)
at first attempt in all the patients within##2##8##(2010-7#2)
at first birth##4##3##(1993-9#1)(2009-5#3)
at first glance##2##3##(1995-12#1)(2013-8#1)
at first intercourse was significantly associated with##2##7##(1990-9#2)
at first intercourse was##3##4##(1990-9#3)
at first intercourse##6##3##(1990-9#6)
at first sexual##3##3##(1991-6#1)(2010-8#1)(2013-7#1)
at first##45##2##(1990-6#2)(1990-9#6)(1991-6#1)(1992-1#1)(1992-5#1)(1993-9#1)(1995-12#2)(1995-3#1)(1997-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#6)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#3)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-7#2)(2013-8#1)
at five Canadian pediatric##3##4##(1993-6#1)(1994-2#1)(2010-7#1)
at five different##3##3##(2008-12#1)(2010-5#1)(2012-5#1)
at five years##2##3##(1996-11#1)(2012-3#1)
at five##21##2##(1993-6#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
at fixed##8##2##(1992-3#1)(1993-11#1)(1995-3#1)(2008-10#4)(2008-3#1)
at flow rate of##4##4##(2008-10#4)
at flow rate##5##3##(2008-10#5)
at flow rates of##2##4##(1991-9#1)(2008-10#1)
at flow rates##3##3##(1991-9#1)(1996-2#1)(2008-10#1)
at flow##9##2##(1991-9#1)(1996-2#1)(2008-10#7)
at flow-rate of##2##3##(2008-10#2)
at flowering##6##2##(2008-10#3)(2008-12#1)(2012-3#1)(2013-8#1)
at fluences##5##2##(2007-12#2)(2008-3#2)(2011-2#1)
at follow up##2##3##(1997-6#1)(2011-2#1)
at follow-up for##2##3##(1990-6#1)(1993-11#1)
at follow-up##28##2##(1990-11#1)(1990-6#1)(1993-11#1)(2007-10#2)(2007-12#2)(2007-8#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#3)(2012-12#1)(2012-2#1)(2012-5#2)(2013-8#3)
at follow-ups of 4 to##2##5##(2012-12#2)
at forest##2##2##(2008-11#1)(2010-5#1)
at four and five weeks)##2##5##(2012-2#2)
at four concentration levels##2##4##(2008-10#1)(2008-5#1)
at four different temperatures##2##4##(2008-10#1)(2008-5#1)
at four different##7##3##(1997-4#1)(2008-10#4)(2008-5#1)(2013-1#1)
at four locations##3##3##(2008-10#2)(2008-3#1)
at four points in time##2##5##(2008-12#1)(2010-5#1)
at four sites##2##3##(1992-3#1)(2008-11#1)
at four temperatures (20##2##4##(2008-5#1)(2011-2#1)
at four temperatures##3##3##(2008-5#1)(2010-4#1)(2011-2#1)
at four##46##2##(1992-3#1)(1994-3#1)(1996-3#1)(1997-4#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#4)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-3#1)
at fracture##7##2##(2008-7#7)
at fragile sites##3##3##(2011-2#3)
at frequencies of##2##3##(1994-2#1)(2007-12#1)
at frequencies##9##2##(1993-12#1)(1994-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
at frequency##2##2##(2008-3#1)(2013-1#1)
at frequent time points and##2##5##(2009-9#1)(2011-2#1)
at frequent time##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
at frequent##4##2##(1992-5#1)(2008-10#1)(2009-9#1)(2011-2#1)
at full bloom##3##3##(2008-10#3)
at full##8##2##(1996-2#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-6#1)
at functionally##2##2##(2008-7#2)
at further##2##2##(1990-11#1)(2007-7#1)
at gathering##3##2##(1995-12#1)(2009-10#1)(2011-2#1)
at gene##2##2##(1995-9#1)(2008-11#1)
at genetic##2##2##(1996-6#1)(2012-3#1)
at germination and early seedling growth##2##6##(2008-12#2)
at gestational##3##2##(1995-11#1)(1996-11#1)(2011-1#1)
at glassy carbon##2##3##(2008-10#2)
at gold electrode##2##3##(2008-10#2)
at gold##6##2##(2008-10#6)
at grazing##3##2##(2007-11#2)(2008-3#1)
at great##2##2##(2008-12#1)(2010-11#1)
at greater risk for##5##4##(2007-10#1)(2008-11#2)(2009-8#1)(2012-12#1)
at greater risk##10##3##(1996-11#1)(2007-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
at greater than##8##3##(1990-7#1)(1992-3#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-12#1)
at greater##20##2##(1990-7#1)(1992-3#1)(1993-1#1)(1993-2#1)(1996-11#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#2)
at greatest risk##3##3##(2008-7#1)(2011-1#1)(2013-8#1)
at ground level##2##3##(2008-2#1)(2008-3#1)
at ground##3##2##(2008-2#1)(2008-3#2)
at group level##2##3##(2008-1#1)(2012-2#1)
at group##3##2##(1995-12#1)(2008-1#1)(2012-2#1)
at guinea-pig##3##2##(1997-7#3)
at habitat##2##2##(2008-8#1)(2013-1#1)
at half the##2##3##(2008-10#1)(2008-3#1)
at hand##7##2##(1997-1#1)(1997-3#1)(2007-4#1)(2008-11#2)(2008-4#1)(2010-3#1)
at harvest and after##2##4##(2008-10#2)
at harvest##14##2##(2007-8#1)(2008-10#12)(2008-7#1)
at hatch##2##2##(1997-6#1)(2010-8#1)
at hatching##2##2##(2007-12#1)(2010-8#1)
at health care reform##2##4##(1994-12#1)(2008-7#1)
at health care##3##3##(1994-12#1)(1997-1#1)(2008-7#1)
at health##6##2##(1994-12#1)(1997-1#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)
at healthcare facilities##4##3##(2010-5#1)(2013-8#3)
at healthcare##6##2##(1993-2#1)(1995-1#1)(2010-5#1)(2013-8#3)
at hearing##2##2##(2008-9#1)(2010-4#1)
at heart##2##2##(1991-11#1)(2010-12#1)
at high RH (96%)##2##4##(2008-10#2)
at high RH##3##3##(2008-10#3)
at high altitude##2##3##(2012-2#1)(2013-1#1)
at high and low##5##4##(1990-2#1)(1990-8#1)(2007-12#1)(2008-7#1)(2012-1#1)
at high cell densities of##2##5##(2008-11#1)(2008-7#1)
at high cell density were##2##5##(1993-9#1)(1994-5#1)
at high cell density##3##4##(1993-9#2)(1994-5#1)
at high cell##5##3##(1993-9#2)(1994-5#1)(2008-11#1)(2008-7#1)
at high concentration in##3##4##(1990-9#1)(1994-12#1)(1997-3#1)
at high concentration##7##3##(1990-9#1)(1991-9#1)(1994-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-9#1)
at high concentrations of##3##4##(1992-6#1)(1995-12#1)(2011-2#1)
at high concentrations##22##3##(1990-8#1)(1991-8#1)(1992-12#1)(1992-6#2)(1995-11#1)(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-12#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
at high density##2##3##(2008-10#1)(2008-8#1)
at high doses of##2##4##(2008-11#1)(2008-7#1)
at high doses##9##3##(1990-8#1)(1993-11#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-6#1)(2013-1#1)
at high field##2##3##(1996-2#1)(1997-6#1)
at high frame rates##2##4##(2009-6#2)
at high frequencies##2##3##(2008-10#2)
at high frequency##7##3##(1995-8#1)(2008-10#1)(2008-8#2)(2008-9#2)(2010-1#1)
at high ionic strength##2##4##(1992-4#1)(1995-2#1)
at high level##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
at high levels in the##5##5##(1992-11#1)(1993-3#1)(1995-2#1)(1996-2#1)(2008-1#1)
at high levels in##11##4##(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-2#2)(1996-2#1)(1997-6#1)(2008-1#1)
at high levels##21##3##(1990-12#1)(1991-11#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-7#1)
at high or low##2##4##(1994-2#1)(2008-10#1)
at high pH##8##3##(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-6#1)(2008-10#2)(2008-8#1)
at high pressure and##3##4##(1995-6#2)(2008-10#1)
at high pressure##6##3##(1995-6#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
at high pressures##2##3##(2008-2#1)(2010-12#1)
at high proportions in##2##4##(2008-10#1)(2008-5#1)
at high risk for##18##4##(1992-9#1)(1993-11#1)(1994-2#1)(1995-1#1)(1997-7#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#6)
at high risk of acute##2##5##(2009-12#1)(2013-1#1)
at high risk of developing##2##5##(1992-6#1)(2008-7#1)
at high risk of recurrence##3##5##(1993-9#1)(2008-5#1)(2008-8#1)
at high risk of##20##4##(1990-2#1)(1991-11#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
at high risk##54##3##(1990-2#1)(1991-11#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#2)(2009-9#1)(2010-10#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#7)
at high salt concentrations and##2##5##(1990-12#1)(2011-2#1)
at high salt concentrations##4##4##(1990-12#1)(1990-5#1)(2008-10#1)(2011-2#1)
at high salt##5##3##(1990-12#1)(1990-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
at high sampling##2##3##(2008-10#1)(2008-3#1)
at high social##2##3##(1993-3#2)
at high speed##4##3##(2008-3#2)(2008-4#1)(2008-7#1)
at high substrate##2##3##(1992-3#1)(1997-2#1)
at high temperature with hydrochloric acid##2##6##(2008-10#2)
at high temperature##9##3##(1997-3#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-8#1)(2013-1#1)
at high temperatures (25##2##4##(2008-10#2)
at high temperatures##18##3##(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(2008-10#6)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#3)
at high##290##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-8#3)(1990-9#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#6)(1994-11#2)(1994-12#3)(1994-2#3)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#4)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#3)(2007-8#3)(2008-1#2)(2008-10#45)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#16)(2008-8#16)(2008-9#4)(2009-12#2)(2009-3#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#13)(2013-7#1)
at higher NaCl concentrations##2##4##(1990-5#1)(2008-10#1)
at higher NaCl##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
at higher angles##2##3##(2008-3#1)(2012-3#1)
at higher concentrations##17##3##(1990-11#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-8#1)
at higher dose##2##3##(1994-5#1)(2011-1#1)
at higher doses with##2##4##(1992-5#1)(2008-3#1)
at higher doses##6##3##(1992-5#1)(1993-1#1)(1997-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
at higher elevations##2##3##(1996-12#1)(2008-8#1)
at higher energies##2##3##(2008-1#2)
at higher flow rates##2##4##(2008-10#1)(2008-7#1)
at higher frequencies##5##3##(1993-8#1)(2008-10#2)(2008-3#1)(2011-1#1)
at higher initial##2##3##(2008-5#1)(2011-2#1)
at higher levels of##2##4##(2008-12#1)(2010-6#1)
at higher levels##6##3##(1994-1#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-6#1)
at higher pH##2##3##(2008-10#2)
at higher risk for##6##4##(1992-2#1)(1993-1#1)(1996-3#1)(2007-11#1)(2011-2#1)(2013-8#1)
at higher risk of##3##4##(2006-10#1)(2009-5#1)(2012-3#1)
at higher risk##13##3##(1992-2#2)(1993-1#1)(1996-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
at higher spatial resolution##2##4##(2008-7#1)(2009-5#1)
at higher temperatures##9##3##(2008-10#8)(2008-6#1)
at higher trophic levels##2##4##(2008-8#1)(2008-9#1)
at higher values##3##3##(2008-10#3)
at higher##135##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-3#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#33)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#2)(2009-5#3)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
at highest risk for##2##4##(2009-5#1)(2011-2#1)
at highest risk of##3##4##(1996-5#1)(2007-2#1)(2011-2#1)
at highest risk##7##3##(1996-5#1)(2007-10#1)(2007-2#1)(2009-5#1)(2010-9#1)(2011-2#2)
at highest##8##2##(1991-12#1)(1996-5#1)(2007-10#1)(2007-2#1)(2009-5#1)(2010-9#1)(2011-2#2)
at hippocampal##2##2##(2008-7#1)(2013-8#1)
at his hospital##3##3##(1991-1#1)(1993-12#1)(1994-2#1)
at his or her##2##4##(1994-3#1)(2012-2#1)
at his##11##2##(1991-1#2)(1993-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(2008-12#1)(2009-5#1)(2010-8#1)(2012-2#1)
at home and at##2##4##(1996-11#1)(2008-9#1)
at home and##6##3##(1991-8#1)(1992-4#1)(1996-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
at home during##2##3##(2008-12#2)
at home for a##2##4##(1993-3#1)(2008-9#1)
at home for##5##3##(1993-3#2)(2008-9#1)(2012-2#1)(2013-1#1)
at home in the##2##4##(2007-11#1)(2008-4#1)
at home with##2##3##(1992-3#1)(2010-5#1)
at hospital discharge##2##3##(2007-10#1)(2008-11#1)
at hospital##5##2##(1994-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)
at hospitals with off-site##2##4##(2008-3#2)
at hospitals with##3##3##(1995-2#1)(2008-3#2)
at hospitals##8##2##(1990-3#1)(1994-3#1)(1995-2#2)(2008-11#1)(2008-3#2)(2011-2#1)
at hours##2##2##(1994-3#1)(2013-8#1)
at how the##2##3##(2008-7#1)(2013-8#1)
at http##11##2##(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#1)
at human and rat##2##4##(2008-4#2)
at human chromosome##2##3##(1995-6#1)(1996-10#1)
at human##7##2##(1992-8#2)(1995-6#1)(1996-10#1)(2008-4#2)(2009-12#1)
at hypothermic temperatures##3##3##(1990-12#3)
at identical##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
at identifying##9##2##(1991-9#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
at impact##4##2##(2011-2#4)
at implantation##7##2##(1991-12#1)(2008-11#1)(2008-9#3)(2010-10#2)
at improving the##4##3##(2008-3#1)(2011-1#1)(2012-3#2)
at improving##12##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
at in situ##2##3##(2008-10#2)
at in vitro##2##3##(1997-2#1)(1997-8#1)
at in##5##2##(1997-2#1)(1997-8#1)(2008-10#2)(2009-7#1)
at incidence##3##2##(2008-10#1)(2008-3#2)
at increased risk for the##2##5##(1992-8#1)(2008-11#1)
at increased risk for##15##4##(1990-5#1)(1992-8#1)(1994-12#1)(2008-10#1)(2008-11#5)(2008-8#1)(2010-10#1)(2011-2#1)(2013-7#1)(2013-8#2)
at increased risk of##15##4##(1996-8#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#2)
at increased risk##30##3##(1990-5#1)(1992-8#1)(1994-12#1)(1996-8#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
at increased##35##2##(1990-5#1)(1992-1#1)(1992-8#1)(1992-9#1)(1994-12#1)(1996-8#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
at increasing doses##2##3##(1991-6#1)(2011-2#1)
at increasing##12##2##(1991-6#1)(1991-9#1)(1992-6#1)(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#2)
at individual boutons##2##3##(1997-7#2)
at individual level##2##3##(1997-4#1)(2008-8#1)
at individual##9##2##(1992-3#1)(1996-4#1)(1997-4#1)(1997-7#2)(1997-9#1)(2008-10#1)(2008-8#1)(2010-10#1)
at inducing##2##2##(2008-10#1)(2013-8#1)
at industrial##2##2##(2008-11#1)(2011-2#1)
at infection##2##2##(2008-10#1)(2008-11#1)
at infinite##3##2##(1993-8#1)(2008-10#1)(2008-2#1)
at infrared wavelengths##2##3##(2008-2#1)(2008-3#1)
at infrared##3##2##(2008-2#2)(2008-3#1)
at inhibiting the growth##2##4##(2008-10#1)(2008-11#1)
at inhibiting##7##2##(1992-3#1)(1992-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
at initial presentation##2##3##(2009-8#2)
at initial##9##2##(2008-10#1)(2008-6#2)(2008-7#1)(2009-8#2)(2010-5#1)(2011-2#2)
at initiation##2##2##(2008-11#1)(2008-3#1)
at inoculation##11##2##(2008-10#10)(2008-5#1)
at input##2##2##(1992-12#1)(2007-12#1)
at insertion##2##2##(2007-7#1)(2008-3#1)
at intake##4##2##(2008-9#1)(2009-11#1)(2013-8#2)
at integrating##2##2##(1991-9#1)(1992-1#1)
at interfaces##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
at intermediate levels of##3##4##(2008-8#2)(2012-2#1)
at intermediate to high##3##4##(1993-8#1)(1996-6#1)(2008-7#1)
at intermediate##16##2##(1993-8#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
at interphase##2##2##(1990-3#2)
at intervals of 5##3##4##(1992-11#1)(2008-10#2)
at intervals of five minutes##2##5##(2008-1#2)
at intervals of##15##3##(1990-5#1)(1990-6#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-1#2)(2008-10#5)(2011-1#1)
at intervals##21##2##(1990-5#1)(1990-6#1)(1991-2#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
at investigating the##8##3##(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
at investigating##10##2##(1990-6#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
at ionic strength##2##3##(1995-2#1)(2008-10#1)
at irregular##2##2##(2009-12#1)(2009-9#1)
at its C-terminus##4##3##(1996-6#1)(1997-6#1)(2008-11#1)(2011-2#1)
at its border##2##3##(1997-4#1)(2007-12#1)
at its optimum##2##3##(2008-6#1)(2011-1#1)
at its origin##2##3##(1991-12#1)(2008-7#1)
at its second##2##3##(2007-12#1)(2008-8#1)
at its two##2##3##(1994-5#1)(1995-2#1)
at its##53##2##(1991-12#2)(1993-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-6#2)(1997-7#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2009-2#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2013-8#1)
at key##2##2##(2008-7#1)(2010-3#1)
at known##2##2##(1995-8#1)(2008-10#1)
at laboratory##2##2##(2008-12#1)(2008-6#1)
at lambda = 1##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
at lambda = 100 nm##2##5##(2008-3#2)
at lambda = 633 nm##2##5##(2008-3#2)
at lambda =##13##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#7)
at lambda##21##2##(1994-5#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#10)
at lambda(max)##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
at lambda=532 nm##2##3##(2007-12#2)
at laparoscopy for##2##3##(1994-9#1)(2008-10#1)
at laparoscopy##3##2##(1994-9#1)(2008-10#2)
at laparotomy##2##2##(1993-12#1)(2013-1#1)
at large angles##2##3##(2008-2#2)
at large distances##3##3##(2008-10#2)(2008-3#1)
at large scale##2##3##(2008-11#1)(2008-7#1)
at large##30##2##(1992-12#1)(1992-2#2)(1993-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2011-1#1)(2012-2#2)(2013-1#2)
at larger distances##2##3##(2008-3#2)
at larger##3##2##(2008-3#2)(2010-8#1)
at laser wavelengths of 442##2##5##(2008-2#1)(2008-3#1)
at laser##4##2##(2008-2#2)(2008-3#2)
at last follow-up##2##3##(2008-10#1)(2008-6#1)
at last##8##2##(1990-12#1)(1992-12#1)(1996-3#1)(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
at late##8##2##(1990-6#1)(1993-6#1)(1993-9#1)(2008-10#3)(2009-8#1)(2010-4#1)
at later stages##2##3##(2008-3#1)(2009-2#1)
at later time points##2##4##(1993-11#1)(2008-8#1)
at later##8##2##(1993-11#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-8#1)
at least 1 month##2##4##(2008-10#2)
at least 1 of##2##4##(1994-12#1)(1995-2#1)
at least 1 year##4##4##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
at least 1##20##3##(1990-6#1)(1991-8#1)(1994-12#1)(1995-2#2)(2007-10#2)(2007-7#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
at least 1% of##2##4##(1993-12#1)(2008-11#1)
at least 10 days##3##4##(2007-6#2)(2010-12#1)
at least 10 times##2##4##(2008-10#1)(2008-7#1)
at least 10##11##3##(2007-6#3)(2007-7#1)(2008-10#3)(2008-7#2)(2010-12#1)(2013-7#1)
at least 10-fold##5##3##(1992-6#1)(1995-12#1)(1995-6#1)(1997-3#2)
at least 100##7##3##(1995-6#1)(1997-3#1)(2008-10#4)(2008-7#1)
at least 11##3##3##(1990-2#1)(1995-8#1)(1996-5#1)
at least 12##3##3##(2008-1#1)(2008-10#2)
at least 15 minutes##2##4##(1994-7#1)(2010-5#1)
at least 15##6##3##(1990-12#1)(1994-3#1)(1994-7#1)(2007-11#1)(2008-11#1)(2010-5#1)
at least 150##3##3##(2007-11#1)(2010-8#1)(2011-2#1)
at least 18##3##3##(2008-10#2)(2012-2#1)
at least 2##19##3##(1992-8#1)(1996-12#1)(2006-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#1)
at least 20##7##3##(1991-12#1)(1992-3#1)(1995-12#1)(2008-10#2)(2008-6#1)(2012-2#1)
at least 20%##2##3##(1996-3#1)(2008-11#1)
at least 200##2##3##(2008-7#1)(2011-1#1)
at least 21##2##3##(1990-12#1)(2010-7#1)
at least 24##7##3##(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-6#1)
at least 3 months##14##4##(2008-10#12)(2008-8#1)(2010-5#1)
at least 3 of##2##4##(2012-12#1)(2013-1#1)
at least 3##26##3##(2007-10#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
at least 30 days##2##4##(1995-2#1)(2011-2#1)
at least 30##5##3##(1991-6#1)(1995-2#1)(2008-2#1)(2008-3#1)(2011-2#1)
at least 300##3##3##(1990-9#1)(1993-8#1)(2008-9#1)
at least 33##3##3##(1996-6#1)(2007-11#1)(2007-2#1)
at least 35%##2##3##(2008-10#2)
at least 4 years##4##4##(1993-11#1)(1996-1#1)(2008-8#1)(2012-12#1)
at least 4##12##3##(1990-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
at least 40 days##3##4##(1990-11#1)(2008-10#2)
at least 40##5##3##(1990-11#1)(1994-11#1)(2008-10#2)(2008-7#1)
at least 400##2##3##(1995-2#1)(2008-10#1)
at least 43##2##3##(1991-2#1)(2008-10#1)
at least 45##2##3##(2008-10#1)(2008-3#1)
at least 5 days##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
at least 5##14##3##(1990-5#1)(1991-12#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
at least 50##8##3##(1990-7#1)(1991-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)
at least 50% of##2##4##(2008-9#1)(2011-2#1)
at least 50%##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
at least 6 months and##2##5##(1990-12#1)(2008-10#1)
at least 6 months of##3##5##(1991-8#1)(2010-5#2)
at least 6 months##11##4##(1990-12#1)(1991-2#1)(1991-8#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-8#1)(2010-5#2)
at least 6 weeks##3##4##(1990-9#1)(1991-11#1)(2008-10#1)
at least 6##17##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-5#2)
at least 60##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
at least 7##4##3##(1990-11#1)(2007-11#1)(2007-12#1)(2008-1#1)
at least 70##4##3##(1994-2#1)(2008-1#2)(2008-10#1)
at least 75%##2##3##(2008-6#1)(2011-2#1)
at least 8##5##3##(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)
at least 80%##2##3##(2009-6#1)(2010-3#1)
at least 90##4##3##(1996-12#1)(2008-10#3)
at least 90% of##2##4##(2008-10#1)(2008-9#1)
at least 96##2##3##(1990-5#1)(2010-3#1)
at least a##15##3##(1991-3#1)(1993-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-1#1)(2013-1#1)(2013-8#1)
at least an order of magnitude##2##6##(2008-10#1)(2008-3#1)
at least an##5##3##(1993-11#1)(1993-3#1)(2008-10#1)(2008-3#1)(2010-11#1)
at least as good as##5##5##(1996-12#1)(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
at least as good##6##4##(1996-12#1)(1997-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
at least as many##2##4##(2008-1#1)(2012-12#1)
at least as##22##3##(1990-7#1)(1990-8#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
at least at the##2##4##(1991-3#1)(2008-7#1)
at least at##7##3##(1991-3#2)(1994-3#1)(1994-9#1)(2008-11#1)(2008-7#1)(2013-8#1)
at least eight##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
at least equal##2##3##(1993-12#1)(2008-11#1)
at least five##10##3##(1993-6#1)(2008-10#4)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
at least for 3 months##2##5##(2008-10#2)
at least for 5##2##4##(1995-4#1)(2008-10#1)
at least for patients##2##4##(2008-7#1)(2009-7#1)
at least for##16##3##(1995-4#1)(1996-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
at least four distinct##2##4##(2007-7#1)(2008-8#1)
at least four##17##3##(1990-11#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
at least from##2##3##(1994-2#1)(2007-12#1)
at least half of the##2##5##(1992-3#1)(2010-5#1)
at least in part by##2##5##(1994-6#1)(2008-4#1)
at least in part through##2##5##(1990-12#1)(1997-1#1)
at least in part##61##4##(1990-12#1)(1990-2#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#3)(1994-6#3)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
at least in some##3##4##(1993-8#1)(1997-3#1)(2008-3#1)
at least in the context of##2##6##(2008-10#1)(2012-2#1)
at least in the##8##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-4#1)(2012-2#2)
at least in those##2##4##(2008-10#1)(2011-2#1)
at least in##84##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-2#3)(1994-6#3)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#1)(2010-4#1)(2011-2#5)(2012-2#4)(2013-1#2)
at least nine##7##3##(1993-8#1)(1995-2#1)(2008-10#4)(2011-1#1)
at least once a week##3##5##(2009-3#1)(2010-11#1)(2011-2#1)
at least once a##5##4##(1991-9#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)
at least once##9##3##(1991-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
at least one 24-hour quit attempt##2##6##(2013-1#2)
at least one cigarette##2##4##(1991-9#1)(2013-1#1)
at least one component##2##4##(2008-11#1)(2012-12#1)
at least one criterion##2##4##(1993-8#2)
at least one episode of##4##5##(1994-6#1)(2008-10#1)(2008-6#2)
at least one functional##2##4##(1991-5#1)(1992-3#1)
at least one hour##2##4##(2008-7#1)(2010-8#1)
at least one in##2##4##(2008-1#1)(2008-10#1)
at least one month##2##4##(1996-3#1)(1997-8#1)
at least one of the##10##5##(1993-2#1)(2007-10#1)(2008-3#1)(2010-11#2)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
at least one of these##2##5##(1994-6#1)(2008-3#1)
at least one of##14##4##(1993-2#1)(1994-6#1)(2007-10#1)(2008-10#1)(2008-3#2)(2009-2#1)(2010-11#2)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
at least one other##4##4##(1990-11#1)(1994-6#1)(2012-3#1)(2013-8#1)
at least one viable##3##4##(2012-12#3)
at least one year##7##4##(1993-12#1)(2008-11#2)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
at least one##136##3##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#7)(2012-2#1)(2012-3#7)(2013-1#10)(2013-8#3)
at least part of the##4##5##(1991-9#1)(1994-6#1)(2008-10#2)
at least part of##5##4##(1991-5#1)(1991-9#1)(1994-6#1)(2008-10#2)
at least partially##14##3##(1991-4#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
at least partly due to##2##5##(1997-7#1)(2008-8#1)
at least partly##11##3##(1993-12#1)(1994-8#2)(1997-7#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-10#1)(2012-2#1)
at least seven##6##3##(1990-12#1)(1992-5#1)(1996-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
at least several##2##3##(2008-10#2)
at least similar##3##3##(2008-11#2)(2012-12#1)
at least six months##3##4##(2008-5#2)(2013-8#1)
at least six##8##3##(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2013-8#1)
at least small##2##3##(2008-10#1)(2008-3#1)
at least some of the##6##5##(1990-12#1)(1990-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
at least some of them##2##5##(2008-7#1)(2012-2#1)
at least some of these##4##5##(1990-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
at least some of##13##4##(1990-11#1)(1990-12#1)(1990-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#1)
at least some specific##2##4##(1990-6#1)(1995-9#1)
at least some##33##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1996-9#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
at least the following##2##4##(1990-11#1)(1996-12#1)
at least the##10##3##(1990-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-8#1)
at least three different##7##4##(1993-2#1)(1995-2#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-9#1)
at least three distinct##4##4##(1992-8#1)(1994-5#1)(2008-10#1)(2008-5#1)
at least three major##2##4##(2011-2#2)
at least three times##9##4##(1991-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)
at least three types of##2##5##(2007-12#1)(2008-10#1)
at least three##52##3##(1990-7#1)(1990-8#2)(1991-2#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-2#3)(1996-3#1)(1997-3#1)(1997-4#3)(2007-12#3)(2007-5#1)(2008-10#12)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)
at least to##4##3##(1992-3#1)(1996-3#1)(2008-10#1)(2008-3#1)
at least twice as##2##4##(2008-11#1)(2008-5#1)
at least twice##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
at least two active##2##4##(2008-10#1)(2008-5#1)
at least two affected members##2##5##(1997-5#1)(2008-7#1)
at least two binding##2##4##(1994-6#1)(2008-9#1)
at least two different##6##4##(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
at least two distinct##3##4##(1990-8#1)(2010-10#1)(2012-2#1)
at least two genes##4##4##(2008-10#2)(2008-5#1)(2009-10#1)
at least two groups of##2##5##(2007-6#1)(2008-10#1)
at least two groups##3##4##(2007-6#1)(2008-10#2)
at least two months##4##4##(2008-10#2)(2008-6#2)
at least two of these##2##5##(1997-8#1)(2008-7#1)
at least two of##3##4##(1997-8#1)(2008-7#1)(2012-3#1)
at least two orders of magnitude##3##6##(1995-8#1)(2008-10#2)
at least two other##2##4##(2008-10#1)(2009-9#1)
at least two pathways##2##4##(2008-7#1)(2012-3#1)
at least two to##2##4##(2008-10#1)(2008-2#1)
at least two types of##3##5##(1990-12#1)(1992-12#1)(1995-11#1)
at least two##90##3##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-8#1)(1992-10#2)(1992-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)
at least up to##2##4##(2008-10#1)(2011-1#1)
at least when it comes to##2##6##(2009-11#1)(2011-2#1)
at least when##4##3##(1992-3#1)(2008-10#1)(2009-11#1)(2011-2#1)
at least within the##2##4##(2008-11#1)(2010-8#1)
at least within##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
at least##975##2##(1990-11#7)(1990-12#10)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#4)(1990-8#9)(1990-9#3)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#6)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#5)(1993-1#3)(1993-11#2)(1993-12#9)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#6)(1993-8#12)(1993-9#4)(1994-11#3)(1994-12#4)(1994-2#10)(1994-3#4)(1994-5#1)(1994-6#10)(1994-7#1)(1994-8#4)(1994-9#3)(1995-11#5)(1995-12#8)(1995-2#15)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#7)(1995-8#5)(1995-9#1)(1996-1#4)(1996-10#3)(1996-12#9)(1996-2#2)(1996-3#5)(1996-5#3)(1996-6#4)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#10)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#5)(2006-10#2)(2007-10#8)(2007-11#8)(2007-12#9)(2007-2#4)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#3)(2008-1#15)(2008-10#188)(2008-11#42)(2008-12#6)(2008-2#10)(2008-3#25)(2008-4#9)(2008-5#27)(2008-6#18)(2008-7#28)(2008-8#23)(2008-9#21)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#7)(2011-1#8)(2011-2#32)(2012-1#2)(2012-12#17)(2012-2#18)(2012-3#14)(2012-4#1)(2012-5#1)(2013-1#27)(2013-7#3)(2013-8#7)
at less cost##2##3##(1994-1#2)
at less than##7##3##(1992-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2013-7#1)
at less##11##2##(1992-2#1)(1994-1#2)(2007-8#1)(2008-10#5)(2008-11#1)(2013-7#1)
at level##7##2##(2008-10#2)(2008-11#1)(2008-7#2)(2009-6#2)
at levels above##3##3##(1996-1#1)(2008-10#2)
at levels as low as##2##5##(2008-10#2)
at levels comparable to##2##4##(1991-12#1)(1995-2#1)
at levels greater than##2##4##(2008-10#1)(2008-11#1)
at levels near the detection limits up to at least##4##10##(2008-10#4)
at levels near the detection limits##5##6##(2008-10#5)
at levels observed in##2##4##(2008-10#2)
at levels of 0##4##4##(2008-10#3)(2012-2#1)
at levels of##14##3##(1997-4#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#2)
at levels similar to##2##4##(1993-3#1)(2008-10#1)
at levels that##3##3##(1996-12#1)(2008-11#1)(2008-3#1)
at levels up to##4##4##(1994-8#1)(2008-10#1)(2010-4#1)(2011-2#1)
at levels which could be##2##5##(1993-9#1)(2008-10#1)
at levels##52##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-4#1)(2008-10#27)(2008-11#3)(2008-3#2)(2008-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#2)
at light##5##2##(1992-6#1)(1993-9#1)(2008-10#2)(2008-4#1)
at limiting##4##2##(1990-11#1)(1990-5#1)(2008-10#1)(2008-11#1)
at liquid helium temperature##2##4##(1993-11#1)(2008-10#1)
at local and regional scales##3##5##(2008-8#3)
at local levels##2##3##(2008-2#1)(2012-12#1)
at local##11##2##(1991-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2011-2#1)(2012-12#2)
at locations in##2##3##(2008-10#2)
at locations##4##2##(2007-5#1)(2008-10#3)
at long range##2##3##(1996-4#1)(2008-9#1)
at long term##2##3##(1997-2#1)(2008-4#1)
at long##10##2##(1993-3#1)(1995-11#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
at long-term follow-up##3##3##(1991-12#1)(2011-2#1)(2012-12#1)
at long-term##5##2##(1991-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
at longer wavelengths##4##3##(2007-12#1)(2008-3#3)
at longer##6##2##(1995-11#1)(2007-12#1)(2008-12#1)(2008-3#3)
at low CBS concentrations##3##4##(1993-8#3)
at low and high##6##4##(1991-9#1)(1992-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
at low and##7##3##(1991-9#1)(1992-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
at low cell##2##3##(1993-9#1)(1995-6#1)
at low cholesterol concentrations##2##4##(1992-6#2)
at low cholesterol##3##3##(1992-6#3)
at low concentration levels##2##4##(2008-10#2)
at low concentration of##2##4##(1996-2#1)(2008-10#1)
at low concentration##13##3##(1996-2#1)(2008-10#7)(2008-11#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
at low concentrations (0##3##4##(1995-3#1)(2006-6#1)(2008-10#1)
at low concentrations and##3##4##(2007-12#1)(2008-10#1)(2010-4#1)
at low concentrations by##2##4##(2008-10#2)
at low concentrations in##3##4##(2008-10#1)(2008-12#2)
at low concentrations of##9##4##(1990-11#1)(1990-12#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-9#1)(1996-4#1)(2008-11#1)
at low concentrations##38##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1994-8#1)(1995-3#2)(1996-4#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-7#1)
at low cost##6##3##(1996-3#1)(2008-3#3)(2008-6#1)(2008-8#1)
at low dose##5##3##(1996-6#1)(2008-7#3)(2012-2#1)
at low doses of##4##4##(2008-7#4)
at low doses##9##3##(1994-8#1)(2008-7#7)(2010-6#1)
at low dye##2##3##(2008-3#1)(2010-4#1)
at low enzyme##2##3##(2011-2#2)
at low exposure levels##2##4##(1995-3#1)(2008-10#1)
at low frequencies##7##3##(2007-12#1)(2008-10#4)(2008-3#1)(2008-9#1)
at low frequency##5##3##(1996-5#2)(2008-3#1)(2008-4#1)(2008-8#1)
at low glucose concentrations##3##4##(1994-8#1)(1996-2#1)(2010-11#1)
at low glucose##4##3##(1994-8#1)(1996-2#1)(2010-11#2)
at low ionic strength##2##4##(1990-2#1)(1992-3#1)
at low ionic##3##3##(1990-2#1)(1992-3#1)(1995-2#1)
at low laser##2##3##(2007-11#1)(2008-2#1)
at low level during##2##4##(1993-9#1)(2008-8#1)
at low level##3##3##(1993-9#1)(2008-8#2)
at low levels in a##2##5##(2008-10#1)(2008-6#1)
at low levels in the##2##5##(1994-9#1)(2008-10#1)
at low levels in##9##4##(1990-12#1)(1992-12#1)(1993-2#1)(1994-9#1)(2008-10#3)(2008-6#1)(2012-12#1)
at low levels##14##3##(1990-12#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-6#1)(2008-7#1)(2012-12#1)
at low light levels##3##4##(2007-12#2)(2008-3#1)
at low or high##2##4##(2008-11#1)(2008-9#1)
at low or##4##3##(2007-11#1)(2008-11#1)(2008-9#1)(2010-12#1)
at low pH (D)##2##4##(1991-9#2)
at low pH in##2##4##(1995-5#1)(2010-4#1)
at low pH##17##3##(1990-5#1)(1990-8#2)(1991-9#2)(1993-8#2)(1994-8#1)(1995-2#2)(1995-5#1)(2008-10#4)(2008-6#1)(2010-4#1)
at low population##3##3##(1990-11#1)(2008-10#1)(2008-8#1)
at low potentials##3##3##(2008-10#2)(2008-8#1)
at low risk for##2##4##(2008-10#1)(2008-3#1)
at low risk of##2##4##(2008-10#1)(2010-7#1)
at low risk##5##3##(1991-11#1)(2008-10#2)(2008-3#1)(2010-7#1)
at low room##2##3##(1996-1#1)(2008-5#1)
at low substrate concentrations##2##4##(1992-8#1)(1993-8#1)
at low substrate##3##3##(1992-8#1)(1993-8#1)(2008-3#1)
at low temperature##15##3##(1993-6#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#5)(2012-2#1)
at low temperatures##21##3##(1990-3#1)(1993-8#2)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#3)(2011-2#1)(2013-1#1)
at low to moderate##2##4##(1997-6#1)(2008-2#1)
at low##288##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#6)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#11)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#11)(2008-1#1)(2008-10#54)(2008-11#9)(2008-12#3)(2008-2#8)(2008-3#19)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#19)(2008-8#12)(2008-9#3)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#3)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#2)(2013-1#4)(2013-8#1)
at lower and higher temperatures##2##5##(2008-10#2)
at lower and higher##3##4##(2008-10#2)(2008-3#1)
at lower concentrations##9##3##(1990-12#1)(1992-8#1)(1995-3#1)(1997-2#1)(2008-10#4)(2008-8#1)
at lower dose##2##3##(2008-9#1)(2012-3#1)
at lower doses##5##3##(1990-11#1)(1991-10#1)(1997-2#1)(2008-7#2)
at lower frequencies##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
at lower frequency##2##3##(2008-10#1)(2008-9#1)
at lower levels of##2##4##(1993-6#1)(2010-6#1)
at lower levels than##2##4##(2012-1#1)(2012-2#1)
at lower levels##8##3##(1990-12#1)(1992-10#1)(1993-6#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
at lower rates##2##3##(2008-10#1)(2008-6#1)
at lower risk##2##3##(1990-5#1)(2009-8#1)
at lower temperatures##5##3##(1994-3#1)(1995-5#1)(2008-10#1)(2008-9#2)
at lower##68##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-10#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-3#1)(2008-10#24)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-7#1)(2009-8#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
at lysine##3##2##(2009-12#1)(2013-1#2)
at m/z##5##2##(2008-10#3)(2008-11#1)(2009-12#1)
at mRNA and##2##3##(1994-6#1)(2013-8#1)
at mRNA level##2##3##(1993-8#2)
at mRNA##5##2##(1992-8#1)(1993-8#2)(1994-6#1)(2013-8#1)
at major##3##2##(1993-3#1)(2008-6#1)(2010-5#1)
at making##2##2##(1996-3#1)(2012-12#1)
at many levels##2##3##(1993-6#1)(1994-12#1)
at many##9##2##(1993-6#1)(1994-12#1)(1995-1#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
at matched##2##2##(1991-7#1)(2009-5#1)
at maturity and##6##3##(2008-8#2)(2008-9#4)
at maturity##14##2##(2007-8#1)(2008-10#2)(2008-8#5)(2008-9#6)
at maximizing##2##2##(2008-3#1)(2008-7#1)
at maximum coherence##2##3##(2007-11#2)
at maximum##12##2##(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#6)(2010-10#1)(2012-12#1)
at mean##2##2##(2007-7#1)(2012-3#1)
at measuring##2##2##(1996-11#1)(2008-3#1)
at medical##4##2##(1992-6#1)(1993-3#1)(1994-2#1)(2009-5#1)
at medium##3##2##(1992-12#1)(2008-3#1)(2008-5#1)
at membrane##4##2##(1991-5#1)(1994-11#1)(2008-10#1)(2011-2#1)
at menarche##5##2##(1993-9#1)(2013-1#4)
at menopause##2##2##(1993-9#1)(2008-2#1)
at mercury##4##2##(2008-10#4)
at metaphase##2##2##(2008-3#1)(2009-12#1)
at microdisk gold##2##3##(2008-10#2)
at micromolar concentrations##3##3##(1993-11#1)(1995-11#1)(1996-5#1)
at micromolar##5##2##(1993-11#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-11#1)
at microwave##2##2##(2008-3#1)(2012-2#1)
at mid-embryogenesis##2##2##(2007-12#2)
at midcycle##2##2##(2008-7#2)
at mild##2##2##(2008-9#2)
at milking##2##2##(2008-12#2)
at minimal cost##2##3##(2008-11#1)(2012-2#1)
at minimal##3##2##(2008-11#2)(2012-2#1)
at minimum##2##2##(1991-12#1)(2008-10#1)
at mitochondria and##2##3##(2008-9#1)(2011-2#1)
at mitochondria##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
at mitral##2##2##(1993-3#1)(2011-1#1)
at moderate##8##2##(1992-3#1)(1994-9#1)(1995-5#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#1)
at modest##2##2##(2007-12#1)(2008-3#1)
at molecular level##2##3##(1997-6#1)(2012-5#1)
at monitoring sites##2##3##(2008-10#2)
at monitoring##3##2##(2008-10#2)(2008-11#1)
at monthly intervals##2##3##(1997-4#1)(2010-10#1)
at more negative potentials##2##4##(2008-10#2)
at more than##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
at more##12##2##(1990-5#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-6#2)(2011-1#1)(2012-2#1)
at most 1% of the##2##5##(2008-3#1)(2012-3#1)
at most 2##2##3##(2008-10#1)(2008-11#1)
at most of the##2##4##(2008-3#1)(2008-5#1)
at most sites##2##3##(2008-10#2)
at most##19##2##(1992-2#1)(1992-9#1)(1994-3#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2012-3#1)
at much lower cost##2##4##(1993-8#1)(2008-10#1)
at much lower levels##2##4##(1995-2#1)(2008-11#1)
at much lower##5##3##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
at much slower rates##2##4##(1992-2#1)(2008-6#1)
at much##10##2##(1990-8#1)(1992-2#1)(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2013-1#1)
at mug l(-1)##2##3##(2008-10#2)
at multiple APs##2##3##(2008-10#2)
at multiple levels##6##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-7#1)
at multiple scales##3##3##(2008-10#1)(2009-12#1)(2009-5#1)
at multiple sites##8##3##(1990-7#1)(1994-9#1)(2008-10#5)(2008-8#1)
at multiple wavelengths##4##3##(2008-2#1)(2008-3#3)
at multiple##42##2##(1990-7#1)(1991-1#1)(1992-12#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-4#2)(2010-7#1)(2013-1#1)
at muscarinic##2##2##(1997-7#1)(2008-3#1)
at nadir##3##2##(2008-2#1)(2008-3#2)
at naming##3##2##(2007-12#3)
at nanogram level by##2##4##(2008-10#2)
at nanogram levels by##2##4##(2008-10#2)
at nanogram per milliliter##2##4##(2008-10#2)
at nanogram##6##2##(2008-10#6)
at nanomolar concentrations##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
at nanomolar##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
at national and##2##3##(2008-11#1)(2010-4#1)
at national##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
at natural abundance##2##3##(1992-4#1)(2012-8#1)
at natural##3##2##(1992-4#1)(1992-5#1)(2012-8#1)
at near##7##2##(1992-3#1)(1992-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)
at near-infrared wavelengths##3##3##(2007-11#1)(2008-3#2)
at near-neutral pH##2##3##(2010-4#2)
at near-normal##2##2##(2008-3#2)
at nearly##4##2##(1993-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
at necropsy##6##2##(1990-12#1)(1991-8#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)
at negative##2##2##(1990-7#1)(2008-10#1)
at neighboring##2##2##(2008-2#1)(2008-7#1)
at neutral pH and##4##4##(1992-9#1)(1993-11#1)(1994-5#1)(2008-10#1)
at neutral pH in the##2##5##(1995-2#1)(1997-2#1)
at neutral pH##29##3##(1990-12#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#3)(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#2)(2009-10#1)(2013-8#1)
at neutral##33##2##(1990-12#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#3)(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-4#2)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
at new##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
at ng##2##2##(2008-10#2)
at ng/g levels##2##3##(1997-2#2)
at night and##2##3##(2008-3#1)(2009-3#1)
at night##17##2##(1990-5#1)(1990-6#1)(1992-5#1)(1995-6#1)(1997-4#2)(1997-6#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#2)(2009-3#1)(2013-1#1)
at nine different##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
at nine##8##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)
at no##4##2##(1996-2#1)(1997-1#1)(2008-3#1)(2008-6#1)
at nonsynonymous sites##2##3##(1994-8#2)
at normal incidence##10##3##(2007-12#2)(2008-3#8)
at normal levels##2##3##(1990-5#1)(1996-6#1)
at normal##21##2##(1990-5#1)(1990-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-3#10)(2010-4#1)
at novel##3##2##(1990-5#1)(1993-2#1)(1995-6#1)
at nt 8993##2##3##(1994-8#2)
at nt##7##2##(1993-2#1)(1994-8#3)(1995-8#2)(2013-1#1)
at nuclear##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
at nucleotide position##9##3##(1992-9#2)(1993-3#2)(1994-11#2)(2008-10#1)(2008-11#2)
at nucleotide##23##2##(1990-12#1)(1990-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#3)(1993-6#1)(1994-11#4)(1997-3#1)(2007-6#1)(2008-10#2)(2008-11#2)(2012-12#1)(2012-3#1)
at nucleotides##2##2##(2008-10#2)
at nutrition risk##2##3##(1992-12#2)
at nutritional risk##2##3##(1992-12#1)(1997-3#1)
at oblique incidence##9##3##(2008-2#3)(2008-3#6)
at oblique##14##2##(1990-11#1)(2008-2#3)(2008-3#10)
at obtaining##3##2##(2007-10#1)(2008-7#1)(2009-10#1)
at odds with the##2##4##(1995-11#1)(1995-8#1)
at odds with##3##3##(1995-11#1)(1995-8#1)(2009-4#1)
at older age##2##3##(1993-12#1)(2008-1#1)
at older ages##2##3##(1992-6#2)
at older##4##2##(1992-6#2)(1993-12#1)(2008-1#1)
at once##10##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#2)
at one and two##2##4##(2008-5#1)(2010-10#1)
at one and##4##3##(1997-8#1)(2008-1#1)(2008-5#1)(2010-10#1)
at one angle##2##3##(2008-3#2)
at one end and##2##4##(2008-10#1)(2008-5#1)
at one end to##2##4##(2008-10#1)(2008-7#1)
at one end##6##3##(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
at one hospital##2##3##(1993-12#1)(1993-3#1)
at one location##2##3##(2008-10#2)
at one month##3##3##(1996-3#1)(2008-11#1)(2008-5#1)
at one of five##2##4##(2008-10#1)(2008-4#1)
at one of the##2##4##(1996-2#1)(2008-10#1)
at one of##7##3##(1996-2#1)(2008-10#3)(2008-4#1)(2010-3#1)(2011-2#1)
at one or##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2012-3#1)
at one site##2##3##(1990-11#1)(2008-10#1)
at one time##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)
at one wavelength##2##3##(2008-2#1)(2008-3#1)
at one year was##2##4##(2008-10#1)(2010-8#1)
at one year##9##3##(1991-6#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-8#2)(2012-12#1)(2012-3#1)
at one##80##2##(1990-11#1)(1991-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2010-10#2)(2010-3#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#4)
at one-year##2##2##(1991-6#1)(2010-8#1)
at only two##2##3##(2008-10#1)(2008-3#1)
at only##8##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#4)(2010-6#1)
at onset of##7##3##(1994-11#1)(2007-7#1)(2008-7#3)(2008-9#1)(2011-2#1)
at onset##15##2##(1994-11#1)(2007-7#2)(2008-1#1)(2008-7#5)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
at open circuit##5##3##(2008-10#5)
at operation##5##2##(1991-6#1)(1994-7#1)(2007-11#1)(2008-10#2)
at opiate receptors##2##3##(1991-1#2)
at optical##3##2##(1996-12#1)(2007-12#2)
at optimal concentrations##2##3##(1994-8#1)(2007-2#1)
at optimal conditions##2##3##(2008-10#1)(2008-6#1)
at optimal##8##2##(1994-8#1)(1995-8#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-6#1)
at optimum conditions##2##3##(2008-10#2)
at optimum ratio of##2##4##(2010-5#1)(2012-2#1)
at optimum##5##2##(2008-10#3)(2010-5#1)(2012-2#1)
at or above a specified##2##5##(1996-12#2)
at or above##7##3##(1996-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2013-7#1)
at or before##2##3##(2008-8#1)(2012-2#1)
at or below##4##3##(1990-12#1)(2008-10#2)(2008-3#1)
at or close to the##2##5##(2008-5#1)(2008-6#1)
at or near the##10##4##(1990-11#2)(1990-7#1)(1993-3#1)(1994-11#1)(1995-5#1)(1996-8#1)(2008-10#2)(2008-2#1)
at or near##16##3##(1990-11#2)(1990-7#1)(1992-5#1)(1993-3#1)(1994-11#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-10#3)(2008-2#1)(2008-8#1)
at or##35##2##(1990-11#2)(1990-12#1)(1990-7#1)(1992-5#1)(1993-3#1)(1994-11#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-1#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
at oral hyperkeratosis and##2##4##(2012-3#2)
at ordinary##2##2##(2008-9#1)(2013-1#1)
at other locations##3##3##(1995-11#1)(2008-10#1)(2010-8#1)
at other sites##4##3##(1994-3#1)(2007-12#2)(2008-6#1)
at other times##3##3##(1993-3#1)(2008-10#1)(2009-8#1)
at other##24##2##(1993-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-1#1)(1997-5#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
at others##2##2##(2008-8#1)(2010-3#1)
at our Institute##2##3##(1995-10#1)(2010-3#1)
at our center##4##3##(2008-1#1)(2011-2#3)
at our centre##3##3##(2007-11#1)(2008-6#1)(2013-1#1)
at our clinic##2##3##(2008-1#1)(2012-2#1)
at our department##3##3##(1990-9#1)(1997-3#1)(2013-1#1)
at our facility##2##3##(1992-6#2)
at our hospital##8##3##(1990-6#1)(1993-11#1)(1994-7#1)(1995-1#1)(1997-2#1)(2007-10#1)(2008-1#1)(2013-8#1)
at our institute##2##3##(2008-11#2)
at our institution from##2##4##(1994-1#1)(2012-3#1)
at our institution##10##3##(1994-1#1)(2007-11#1)(2007-8#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
at our institutions##2##3##(2007-10#1)(2008-9#1)
at our laboratory for##2##4##(1991-8#1)(2008-10#1)
at our##49##2##(1990-6#1)(1990-9#1)(1991-8#1)(1992-6#3)(1993-11#1)(1994-1#1)(1994-7#1)(1995-1#1)(1995-10#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#4)(2008-6#1)(2008-7#2)(2008-9#2)(2010-3#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
at over##4##2##(1992-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
at oxygen##2##2##(2009-10#1)(2010-8#1)
at pH &gt##3##3##(1994-12#1)(2008-10#1)(2009-12#1)
at pH 1##12##3##(1990-5#1)(1992-12#1)(2008-10#10)
at pH 10##11##3##(1996-12#1)(2008-10#7)(2008-5#2)(2013-1#1)
at pH 11##2##3##(1990-5#1)(1992-12#1)
at pH 12 and##2##4##(1990-8#1)(2008-8#1)
at pH 12##10##3##(1990-8#1)(2008-10#8)(2008-8#1)
at pH 2##22##3##(1993-11#1)(1997-2#3)(2008-10#17)(2008-5#1)
at pH 3 was##2##4##(1995-5#1)(2008-10#1)
at pH 3##39##3##(1990-12#1)(1991-2#1)(1992-12#3)(1994-3#1)(1995-5#1)(2008-10#27)(2008-5#1)(2008-6#2)(2010-5#2)
at pH 4##41##3##(1990-2#1)(1991-12#1)(1994-5#1)(2008-10#28)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
at pH 5##76##3##(1991-12#1)(1991-8#2)(1992-12#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#53)(2008-11#5)(2008-5#1)(2008-6#2)(2009-10#1)(2009-6#1)(2011-2#1)
at pH 6 in##2##4##(1990-8#1)(2011-2#1)
at pH 6##50##3##(1990-5#1)(1990-8#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-6#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#23)(2008-11#1)(2008-5#2)(2008-6#1)(2009-11#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
at pH 6-8##2##3##(1994-8#1)(2008-10#1)
at pH 7 and##3##4##(1992-4#1)(2008-10#1)(2013-1#1)
at pH 7##88##3##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#3)(1992-3#2)(1992-4#1)(1993-8#6)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#3)(1997-2#2)(1997-7#1)(2008-10#45)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#2)(2011-3#1)(2013-1#1)
at pH 8##31##3##(1992-9#1)(1993-11#1)(1993-8#1)(1995-6#2)(2008-10#23)(2008-11#2)(2008-8#1)
at pH 9 and##3##4##(1990-8#1)(2008-10#2)
at pH 9##23##3##(1990-5#1)(1990-8#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#14)(2008-9#1)(2009-3#2)(2013-1#1)
at pH =##2##3##(2008-5#1)(2009-11#1)
at pH approximately 0##2##4##(2008-10#2)
at pH approximately##3##3##(2008-10#3)
at pH close to##2##4##(2008-10#1)(2008-5#1)
at pH higher than##3##4##(2008-10#3)
at pH less than##2##4##(1990-5#1)(1990-7#1)
at pH of##4##3##(2008-10#4)
at pH range##2##3##(2008-10#2)
at pH values of##2##4##(2008-10#2)
at pH values ranging from##3##5##(2008-10#2)(2010-4#1)
at pH values##8##3##(1994-11#1)(2008-10#6)(2010-4#1)
at pH##452##2##(1990-12#2)(1990-2#1)(1990-5#7)(1990-7#2)(1990-8#5)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#7)(1991-9#1)(1992-11#1)(1992-12#10)(1992-3#2)(1992-4#2)(1992-6#1)(1992-9#1)(1993-11#3)(1993-8#9)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#3)(1995-2#2)(1995-5#5)(1995-6#4)(1996-12#1)(1996-2#1)(1997-2#6)(1997-4#2)(1997-6#1)(1997-7#2)(2006-6#1)(2008-10#289)(2008-11#10)(2008-12#2)(2008-5#12)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-2#6)(2011-3#2)(2013-1#6)(2013-8#1)
at pH&gt##3##2##(2008-10#3)
at pH&lt##2##2##(2008-10#2)
at pHs below##2##3##(2008-10#2)
at pHs##3##2##(2008-10#3)
at pachytene##3##2##(2008-5#3)
at palpation##2##2##(1990-12#1)(2008-10#1)
at particle##2##2##(2008-3#1)(2012-1#1)
at particular risk##2##3##(2008-10#1)(2011-2#1)
at particular##4##2##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
at particularly high##2##3##(2007-12#1)(2008-8#1)
at passage 10##2##3##(2011-3#2)
at passage##5##2##(2008-11#1)(2011-3#4)
at pathogen##2##2##(2008-10#1)(2009-8#1)
at peak##10##2##(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-8#1)(2010-3#3)(2012-12#1)
at percentages##2##2##(2008-10#2)
at performing##2##2##(2007-12#1)(2013-1#1)
at phase##2##2##(2008-3#2)
at phosphorus##3##2##(1992-6#2)(1996-2#1)
at photon energies##2##3##(2008-2#2)
at physiologic##2##2##(1990-12#1)(2007-7#1)
at physiological concentrations##3##3##(1993-6#1)(1993-9#1)(2013-8#1)
at physiological ionic strength##3##4##(1990-7#1)(1994-5#2)
at physiological ionic##5##3##(1990-7#1)(1994-5#3)(1995-2#1)
at physiological levels##3##3##(2008-10#2)(2013-1#1)
at physiological pH##7##3##(2008-10#5)(2008-4#1)(2009-11#1)
at physiological temperature##3##3##(2008-10#1)(2013-8#2)
at physiological temperatures##2##3##(1994-3#2)
at physiological##31##2##(1990-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2013-1#1)(2013-8#3)
at physiologically##2##2##(2008-4#1)(2009-7#1)
at pilot scale##3##3##(2008-11#2)(2010-4#1)
at pilot##4##2##(1995-3#1)(2008-11#2)(2010-4#1)
at pit hardening stage##2##4##(2008-10#2)
at platinum electrode##2##3##(2008-10#2)
at play##4##2##(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#1)
at point##2##2##(2008-10#1)(2010-8#1)
at population##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
at ports##2##2##(2011-2#2)
at position -11377C &gt##2##4##(2011-1#2)
at position -4##2##3##(1991-9#2)
at position 127##2##3##(1997-6#2)
at position 13##2##3##(1990-2#1)(1991-12#1)
at position 143##2##3##(2008-10#2)
at position 153##2##3##(1994-8#1)(1997-8#1)
at position 2##3##3##(1991-2#1)(1993-11#1)(1994-3#1)
at position 30##2##3##(1992-8#2)
at position 4 of##2##4##(1990-8#1)(1995-3#1)
at position 4##3##3##(1990-8#1)(1995-3#1)(1996-5#1)
at position 52##2##3##(1995-5#2)
at position 545##2##3##(1992-8#2)
at position 6##5##3##(1994-3#2)(1994-8#1)(1995-5#2)
at position 68*##2##3##(2011-2#2)
at position 72##2##3##(1991-12#1)(2008-10#1)
at position 9##3##3##(1993-8#1)(1994-11#1)(1995-6#1)
at position a##3##3##(1992-6#3)
at position d##3##3##(1992-6#3)
at position##95##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-9#4)(1992-10#1)(1992-3#4)(1992-6#9)(1992-8#6)(1993-11#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-8#3)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-6#2)(2008-1#2)(2008-10#10)(2008-12#5)(2008-2#1)(2008-8#1)(2011-1#4)(2011-2#3)(2012-2#1)
at positions 2 and##2##4##(1992-3#1)(1994-3#1)
at positions A2 and A3##2##5##(1992-3#2)
at positions A2##3##3##(1992-3#3)
at positions of codons 153 and 191##2##7##(1997-8#2)
at positions of##3##3##(1990-12#1)(1997-8#2)
at positions##21##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#4)(1992-6#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#4)(1995-2#1)(1997-8#2)(2008-10#2)
at post-mortem examination##2##3##(1997-3#2)
at post-mortem##3##2##(1997-3#2)(2011-2#1)
at post-test##3##2##(1992-1#1)(2013-1#2)
at postnatal day##2##3##(1993-5#1)(1996-5#1)
at postnatal days##2##3##(1996-5#2)
at postnatal##4##2##(1993-5#1)(1996-5#3)
at postoperative##2##2##(2012-12#1)(2013-1#1)
at potential of##3##3##(2008-10#2)(2013-1#1)
at potential penetration sites##2##4##(2008-10#2)
at potential##7##2##(2008-10#5)(2012-12#1)(2013-1#1)
at potentials##7##2##(1990-8#1)(1995-12#1)(1997-2#2)(2008-10#3)
at ppb level##3##3##(2008-10#3)
at ppb levels##3##3##(2008-10#3)
at ppb##7##2##(2008-10#7)
at practical##2##2##(1996-5#1)(2008-3#1)
at pre- and postgermination stages##2##5##(2008-10#2)
at pre-##4##2##(2008-10#2)(2008-4#1)(2011-1#1)
at precise##2##2##(2008-10#1)(2008-3#1)
at predicting the##2##3##(1995-3#1)(2010-8#1)
at predicting##6##2##(1995-3#1)(2007-10#1)(2008-10#1)(2008-12#2)(2010-8#1)
at preselected points##2##3##(2008-3#2)
at present little##2##3##(1991-2#1)(2007-11#1)
at present remains##2##3##(1990-3#1)(2011-1#1)
at present to##2##3##(1997-6#1)(2010-7#1)
at present we##2##3##(1995-6#1)(2010-8#1)
at present##41##2##(1990-11#2)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-2#2)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)
at presentation and##2##3##(2008-6#1)(2013-1#1)
at presentation in##2##3##(2008-1#1)(2008-10#1)
at presentation or##2##3##(2008-6#2)
at presentation##15##2##(1992-6#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#3)(2010-5#1)(2011-1#1)(2013-1#3)
at preserving##2##2##(1994-3#1)(2011-2#1)
at pressures of##3##3##(1996-5#1)(2008-2#1)(2008-3#1)
at pressures##6##2##(1996-5#1)(2008-2#2)(2008-3#3)
at preventing##8##2##(1996-1#1)(1996-8#1)(1997-3#1)(2008-10#2)(2012-2#1)(2013-1#2)
at previous##2##2##(1990-11#1)(1996-5#1)
at primary and##2##3##(1994-2#1)(1994-7#1)
at primary care##2##3##(1993-6#1)(2011-1#1)
at primary diagnosis##2##3##(2010-3#2)
at primary sites##2##3##(1994-7#2)
at primary##9##2##(1993-6#1)(1994-2#1)(1994-6#1)(1994-7#3)(2010-3#2)(2011-1#1)
at producing##6##2##(1990-5#1)(1994-6#2)(2008-4#1)(2009-2#1)(2013-1#1)
at program##2##2##(2011-2#1)(2012-3#1)
at promoting##3##2##(1991-8#1)(1993-11#1)(2008-11#1)
at proposing##2##2##(2008-2#1)(2010-7#1)
at protein##2##2##(2008-7#1)(2011-1#1)
at providing##7##2##(2008-1#1)(2008-4#2)(2010-8#1)(2012-12#2)(2013-1#1)
at railroad crossings##2##3##(2012-12#2)
at random from the##2##4##(1995-2#1)(1996-12#1)
at random from##5##3##(1995-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
at random in the##2##4##(1997-8#1)(2010-8#1)
at random##32##2##(1990-11#2)(1990-7#1)(1991-8#2)(1992-5#1)(1994-5#1)(1995-12#1)(1995-2#3)(1996-12#1)(1997-3#1)(1997-8#3)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
at range##2##2##(1991-2#1)(2008-5#1)
at ranges of the order of##2##6##(2008-3#2)
at ranges##4##2##(2008-2#1)(2008-3#3)
at rates as##2##3##(2008-10#1)(2008-8#1)
at rates of##3##3##(1995-8#1)(2008-3#1)(2008-9#1)
at rates##12##2##(1995-8#1)(1996-3#1)(1997-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
at ratios##2##2##(1990-2#1)(2008-12#1)
at reasonable cost##3##3##(1991-1#1)(1996-3#1)(2008-10#1)
at reasonable##4##2##(1991-1#1)(1996-3#1)(2008-10#2)
at reconstructing##2##2##(2008-12#1)(2012-12#1)
at recurrent##2##2##(1992-5#1)(2010-3#1)
at reduced##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
at reducing##13##2##(1995-1#1)(1996-8#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)
at refrigeration##2##2##(1997-4#1)(2010-7#1)
at regular intervals for##2##4##(2008-11#1)(2008-4#1)
at regular intervals##8##3##(1992-2#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-4#2)
at regular time intervals##2##4##(2008-10#2)
at regular##10##2##(1992-2#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-4#2)
at relapse##7##2##(1994-5#1)(2007-4#1)(2008-6#1)(2011-2#4)
at relative humidities##4##3##(2008-10#4)
at relatively high##2##3##(2008-2#1)(2008-3#1)
at relatively low concentrations##2##4##(2008-10#2)
at relatively low##6##3##(1996-2#1)(2008-10#4)(2008-4#1)
at relatively##12##2##(1992-3#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2013-1#1)
at removing##4##2##(1995-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
at repetition rates of##2##4##(2007-11#1)(2008-3#1)
at repetition rates##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
at residue##8##2##(1990-7#1)(1993-6#1)(1995-2#1)(1995-6#2)(1995-8#1)(2008-9#1)(2012-12#1)
at residues##6##2##(1990-8#1)(1993-8#1)(1994-8#2)(1995-5#1)(2008-11#1)
at rest and during exercise##2##5##(2008-3#1)(2008-7#1)
at rest and during##7##4##(2007-8#1)(2008-3#3)(2008-7#2)(2013-1#1)
at rest and##18##3##(1995-3#1)(1996-8#1)(2007-8#1)(2008-3#4)(2008-7#6)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
at rest##47##2##(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-3#6)(2008-5#1)(2008-7#14)(2009-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#3)
at right angles##2##3##(2008-3#1)(2008-4#1)
at risk and##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
at risk due to##2##4##(2008-12#1)(2011-2#1)
at risk for HIV##3##4##(1996-5#1)(1997-5#1)(2009-12#1)
at risk for developing##5##4##(2008-1#1)(2008-12#2)(2008-2#1)(2008-7#1)
at risk for familial Alzheimer disease##2##6##(1990-3#2)
at risk for poor##2##4##(1996-12#1)(2010-5#1)
at risk for tumor lysis syndrome##2##6##(2008-7#2)
at risk for vision loss from age-related macular degeneration##2##9##(2007-11#2)
at risk for##62##3##(1990-3#2)(1990-5#2)(1991-1#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1996-12#3)(1996-5#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#4)
at risk from##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
at risk in##2##3##(1997-5#1)(2012-12#1)
at risk of being##2##4##(1991-3#1)(1997-4#1)
at risk of developing##7##4##(1991-9#1)(1992-12#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-3#2)
at risk of infection##2##4##(1990-3#1)(2009-12#1)
at risk of##50##3##(1990-2#1)(1990-3#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
at risk to##3##3##(1990-9#1)(2008-2#1)(2012-12#1)
at risk##172##2##(1990-2#1)(1990-3#5)(1990-5#5)(1990-9#2)(1991-1#2)(1991-12#4)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#7)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#8)(2012-2#5)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#3)
at risk&quot##2##2##(1993-9#1)(2012-3#1)
at risk?##5##2##(1992-2#1)(1994-12#1)(1997-1#1)(2008-11#1)(2009-12#1)
at room temperature and at##2##5##(2008-10#1)(2008-5#1)
at room temperature and can##2##5##(2008-5#1)(2009-12#1)
at room temperature and in##2##5##(2007-11#1)(2008-3#1)
at room temperature and##16##4##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
at room temperature are reported##2##5##(2007-11#1)(2008-3#1)
at room temperature as##2##4##(2008-10#1)(2008-2#1)
at room temperature by##2##4##(2008-10#1)(2008-3#1)
at room temperature for 5min##2##5##(2008-10#2)
at room temperature for 72##2##5##(2008-5#1)(2012-12#1)
at room temperature for##9##4##(1995-2#3)(1997-7#1)(2008-10#3)(2008-5#1)(2012-12#1)
at room temperature in##5##4##(1996-5#1)(2008-10#3)(2008-3#1)
at room temperature is##3##4##(1995-2#1)(2007-11#1)(2008-10#1)
at room temperature on##2##4##(1996-2#1)(2012-2#1)
at room temperature or at 45 degrees C for##2##9##(2008-5#2)
at room temperature or at##3##5##(2008-10#1)(2008-5#2)
at room temperature to##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
at room temperature were##4##4##(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
at room temperature with##2##4##(2008-10#1)(2008-3#1)
at room temperature##149##3##(1990-3#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-7#1)(1995-11#2)(1995-2#5)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#10)(2007-12#14)(2008-10#49)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#2)(2009-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#3)
at room##151##2##(1990-3#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-7#1)(1995-11#2)(1995-2#5)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#10)(2007-12#14)(2008-10#51)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#2)(2009-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#3)
at room-temperature##3##2##(2007-11#1)(2012-2#2)
at round##2##2##(1995-9#2)
at same##2##2##(2008-2#1)(2013-1#1)
at satellite##2##2##(2008-2#1)(2008-3#1)
at saturation by S1##3##4##(1992-3#3)
at saturation##5##2##(1991-5#1)(1992-3#3)(1994-5#1)
at school than##2##3##(1994-6#1)(2008-2#1)
at school##18##2##(1994-6#1)(1996-11#1)(1996-9#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#3)(2013-1#2)
at scientific##2##2##(1992-12#1)(2010-4#1)
at screening##2##2##(2008-8#1)(2012-3#1)
at sea##3##2##(2008-2#1)(2008-4#1)(2011-2#1)
at second##4##2##(2007-11#1)(2008-12#1)(2009-5#1)(2012-2#1)
at selected wavelengths##3##3##(2008-2#1)(2008-3#2)
at selected##8##2##(1994-9#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)
at serine residues 434 and 463##2##6##(2011-2#2)
at serine residues##3##3##(1990-12#1)(2011-2#2)
at serine##4##2##(1990-11#1)(1990-12#1)(2011-2#2)
at settlement##5##2##(2007-5#5)
at seven wavelengths##2##3##(2008-2#1)(2008-3#1)
at seven##11##2##(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-11#1)(2010-2#1)(2011-2#2)
at several intracellular sites##2##4##(1994-10#2)
at several levels to##2##4##(1991-6#1)(2012-3#1)
at several levels##7##3##(1991-6#1)(1992-2#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
at several locations##2##3##(2008-10#1)(2009-10#1)
at several stages##3##3##(1992-12#1)(1996-2#1)(2010-8#1)
at several steps##3##3##(1994-8#1)(2008-5#1)(2012-12#1)
at several time##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
at several wavelengths##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
at several##55##2##(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-10#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
at sexual debut##3##3##(2011-1#3)
at sexual##5##2##(2008-8#2)(2011-1#3)
at short and long##2##4##(1992-11#1)(1993-12#1)
at short##14##2##(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-2#1)(2011-1#1)(2013-1#1)
at shorter##3##2##(1993-12#1)(1996-12#1)(2008-3#1)
at significant##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)
at significantly greater risk##2##4##(2008-11#1)(2009-8#1)
at significantly lower##2##3##(1992-11#1)(2011-2#1)
at significantly##7##2##(1992-11#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#2)
at similar levels in##2##4##(1991-6#1)(2008-10#1)
at similar point in course of##3##6##(2012-12#3)
at similar rates##2##3##(1994-11#1)(1995-6#1)
at similar speeds##3##3##(2007-10#3)
at similar##19##2##(1991-6#1)(1992-10#1)(1992-9#1)(1993-6#1)(1994-11#2)(1995-6#1)(2007-10#3)(2008-10#3)(2008-11#1)(2010-4#1)(2010-7#1)(2012-12#3)
at single##7##2##(1991-12#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#2)
at site##2##2##(1991-5#1)(2008-10#1)
at site(s)##2##2##(1990-5#1)(1995-11#1)
at sites containing##2##3##(1995-8#1)(2008-10#1)
at sites corresponding to##2##4##(1993-11#1)(2008-10#1)
at sites of potential antagonist##2##5##(2008-10#2)
at sites of potential##4##4##(2008-10#4)
at sites of##12##3##(1990-5#1)(1992-2#1)(1997-3#1)(2006-10#1)(2008-10#6)(2009-10#1)(2011-2#1)
at sites that##2##3##(1993-8#1)(2008-10#1)
at sites where##3##3##(1996-10#1)(2008-10#2)
at sites##31##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-2#1)(1993-11#2)(1993-8#1)(1995-5#1)(1995-8#2)(1996-10#1)(1997-3#1)(2006-10#1)(2008-10#13)(2008-9#2)(2009-10#1)(2011-2#2)
at six different temperatures (ranging from 30 to 55 degrees C at intervals of 5 degrees C)##2##17##(2008-10#2)
at six different##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
at six months##7##3##(1991-11#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)
at six wavelengths##2##3##(2008-3#2)
at six##21##2##(1991-11#2)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
at slaughter##6##2##(1990-3#2)(1993-2#1)(2008-5#1)(2010-4#1)(2012-2#1)
at slightly##2##2##(2007-12#1)(2007-8#1)
at slow##3##2##(2007-10#1)(2008-8#2)
at small angles##2##3##(2007-12#1)(2008-3#1)
at small grazing angles##2##4##(2007-11#2)
at small sounded volume##2##4##(2008-3#2)
at small source-detector separations##2##4##(2008-2#1)(2008-3#1)
at small##14##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#8)(2008-9#1)
at sn-2##2##2##(1994-12#2)
at solar##2##2##(2008-3#2)
at solid##2##2##(1990-4#1)(2012-2#1)
at solvent-exposed locations##2##3##(1997-2#2)
at some distance from the##2##5##(1997-5#1)(2013-1#1)
at some point in their##2##5##(2008-9#1)(2009-5#1)
at some point in##3##4##(2008-9#1)(2009-5#1)(2013-1#1)
at some point##5##3##(2008-9#1)(2009-5#2)(2013-1#2)
at some##27##2##(1991-1#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-6#1)(1995-9#1)(1997-5#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
at specialist##2##2##(1994-11#2)
at specific locations##2##3##(2008-7#1)(2011-1#1)
at specific points in time##2##5##(1992-1#1)(2008-11#1)
at specific sites##2##3##(1995-11#1)(2012-2#1)
at specific time##2##3##(2008-10#1)(2010-4#1)
at specific##23##2##(1990-5#1)(1991-2#1)(1992-1#1)(1994-5#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-2#2)(2012-3#1)
at spine##2##2##(2011-2#2)
at stage VIII of the epithelial cycle##2##7##(2009-10#1)(2012-2#1)
at stage VT##3##3##(2011-2#3)
at stage##16##2##(1992-8#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#7)(2012-2#2)
at stages##7##2##(2008-10#3)(2008-6#2)(2009-10#1)(2012-2#1)
at stake##3##2##(1992-4#1)(1995-2#1)(2009-10#1)
at standard temperature and pressure##2##5##(2007-12#2)
at standard##3##2##(2007-12#2)(2008-11#1)
at state level##2##3##(2008-6#1)(2008-8#1)
at steady state and##2##4##(2008-1#1)(2008-7#1)
at steady state##5##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)
at streaming rate##2##3##(2008-12#2)
at stroke onset##2##3##(2007-10#2)
at strong##4##2##(2008-2#2)(2008-3#1)(2011-2#1)
at structurally##2##2##(2008-4#1)(2008-5#1)
at study##2##2##(2007-7#1)(2011-1#1)
at sub-micromolar##2##2##(2008-10#2)
at sub-mug l(-1)##2##3##(2008-10#2)
at sub-nanogram levels##2##3##(2008-10#2)
at sub-nanogram##3##2##(2008-10#3)
at sub-picomolar level##2##3##(2008-10#2)
at submicromolar levels##2##3##(2008-10#2)
at subsequent time points##2##4##(2008-10#1)(2008-5#1)
at subsequent##4##2##(1991-2#1)(2008-10#2)(2008-5#1)
at subwavelength##2##2##(2007-12#1)(2008-3#1)
at subzero temperatures##2##3##(2008-10#2)
at successive##2##2##(2007-12#1)(2008-10#1)
at such a low level##2##5##(2008-10#2)
at such a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
at such##6##2##(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
at sufficient##3##2##(1997-7#1)(2008-3#1)(2010-10#1)
at surface##3##2##(2010-6#1)(2013-8#2)
at surfaces##3##2##(1990-8#1)(2008-2#2)
at surgery was##6##3##(2007-8#1)(2009-10#1)(2009-3#2)(2012-3#1)(2013-1#1)
at surgery##13##2##(1990-3#1)(2007-8#2)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#2)(2010-3#1)(2012-3#1)(2013-1#1)
at synapses##4##2##(1997-2#1)(2008-7#1)(2009-8#1)(2009-9#1)
at synonymous sites##2##3##(1994-8#2)
at synonymous##3##2##(1994-8#3)
at t =##2##3##(2008-10#2)
at t=25 degrees C##2##4##(2008-10#2)
at teaching##2##2##(1994-3#1)(2008-10#1)
at temperature of##4##3##(2008-10#1)(2008-5#1)(2008-6#2)
at temperature##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)
at temperatures above##4##3##(1990-2#1)(2008-10#2)(2013-1#1)
at temperatures as high as##2##5##(1994-9#1)(2008-10#1)
at temperatures as##3##3##(1992-6#1)(1994-9#1)(2008-10#1)
at temperatures below##2##3##(2007-12#1)(2008-10#1)
at temperatures between##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-8#1)
at temperatures from 20 to##2##5##(2008-10#2)
at temperatures from 6 to##2##5##(2008-10#2)
at temperatures from##12##3##(1990-3#1)(2008-10#9)(2008-2#1)(2008-3#1)
at temperatures lower than##2##4##(1990-2#1)(1996-5#1)
at temperatures of##8##3##(2008-10#3)(2008-11#1)(2008-3#3)(2009-8#1)
at temperatures ranging from 25 to##2##6##(1995-5#1)(2008-10#1)
at temperatures ranging from##7##4##(1995-5#1)(2008-10#5)(2008-2#1)
at temperatures up to##4##4##(2008-10#2)(2008-2#1)(2009-7#1)
at temperatures##60##2##(1990-2#2)(1990-3#1)(1992-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#29)(2008-11#2)(2008-2#4)(2008-3#8)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#2)(2013-8#1)
at ten##2##2##(1991-8#1)(2008-3#1)
at term and##3##3##(1993-10#1)(1994-3#2)
at term pregnancy##2##3##(1990-12#2)
at term was##2##3##(1995-8#1)(2012-12#1)
at term##22##2##(1990-11#2)(1990-12#2)(1990-3#1)(1993-10#1)(1993-3#1)(1994-3#5)(1995-8#3)(1996-11#1)(1997-4#1)(2009-5#1)(2012-12#1)(2013-1#3)
at tertiary care##2##3##(2008-11#1)(2012-12#1)
at that level##2##3##(1996-5#1)(2008-10#1)
at that location##2##3##(2008-10#1)(2008-11#1)
at that moment##3##3##(2010-8#3)
at that point##2##3##(2007-12#1)(2012-12#1)
at that position##2##3##(1992-6#1)(2008-9#1)
at that time##10##3##(1994-3#1)(1996-6#1)(2008-10#3)(2009-1#1)(2009-10#1)(2012-3#2)(2013-8#1)
at that##31##2##(1991-6#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-5#1)(1996-5#1)(1996-6#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-9#3)(2009-1#1)(2009-10#1)(2010-8#3)(2012-12#1)(2012-3#2)(2013-8#1)
at the &quot##4##3##(1990-3#1)(2008-11#1)(2008-8#1)(2010-7#1)
at the 0##14##3##(2008-10#14)
at the 1##6##3##(2007-12#1)(2008-10#4)(2010-4#1)
at the 1-year##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
at the 10##5##3##(1997-7#1)(2008-10#4)
at the 15th##2##3##(1995-8#1)(2008-7#1)
at the 193-nm wavelength##3##4##(2008-3#3)
at the 1989##2##3##(1992-1#1)(1993-3#1)
at the 1998##2##3##(2008-10#1)(2008-11#1)
at the 1999##8##3##(2008-10#2)(2008-11#6)
at the 1st##2##3##(1992-5#1)(1993-12#1)
at the 2 and##2##4##(1994-12#1)(1994-9#1)
at the 2##10##3##(1994-12#1)(1994-9#1)(1996-5#1)(2007-11#2)(2008-10#4)(2008-3#1)
at the 20 mug##2##4##(2008-10#2)
at the 2000 APS Annual Meeting##2##6##(2008-11#2)
at the 2000##9##3##(2008-10#1)(2008-11#8)
at the 2001 APS/MSA/SON Joint Meeting##4##6##(2008-11#4)
at the 2001##10##3##(2008-10#2)(2008-11#8)
at the 2002 APS Annual Meeting##2##6##(2008-11#2)
at the 2002##8##3##(2008-10#2)(2008-11#6)
at the 2003 APS Annual Meeting##2##6##(2008-11#2)
at the 2003##10##3##(2008-11#8)(2008-6#1)(2008-7#1)
at the 2004 APS Annual Meeting##2##6##(2008-11#2)
at the 2004##7##3##(2008-11#7)
at the 2005 APS Annual Meeting##2##6##(2008-11#2)
at the 2005##8##3##(2008-11#8)
at the 2006 APS Annual Meeting##2##6##(2008-11#2)
at the 2006##9##3##(2008-10#1)(2008-11#8)
at the 2007 APS Annual Meeting##2##6##(2008-11#2)
at the 2007##4##3##(2008-11#4)
at the 25##2##3##(2008-10#2)
at the 3' end of the##4##6##(1992-8#1)(1995-8#1)(2008-10#2)
at the 3' end of##8##5##(1992-8#1)(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#4)
at the 3' end##11##4##(1992-8#1)(1993-2#1)(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#5)(2013-8#1)
at the 3'##16##3##(1990-7#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-8#2)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-8#1)(2013-8#1)
at the 3'-end of##3##4##(1993-9#1)(2013-1#2)
at the 3rd##2##3##(1994-6#1)(2011-1#1)
at the 4-cell stage##2##4##(1993-3#2)
at the 4th##3##3##(2008-4#1)(2011-1#1)(2013-1#1)
at the 5 microg##2##4##(2008-10#2)
at the 5##8##3##(2008-10#6)(2008-12#1)(2008-4#1)
at the 5' and 3'##3##5##(2008-10#3)
at the 5' end of the##3##6##(1994-8#1)(2007-12#1)(2008-7#1)
at the 5' end##4##4##(1994-8#1)(2007-12#1)(2008-7#1)(2013-8#1)
at the 5' terminus##3##4##(1991-2#1)(2008-4#2)
at the 5'##14##3##(1991-2#1)(1993-3#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-8#1)
at the 5'-terminus##2##3##(1991-1#2)
at the 7##2##3##(2008-10#1)(2008-4#1)
at the 8th##4##3##(1992-3#1)(2008-10#1)(2011-4#1)(2013-1#1)
at the 95% confidence level##22##5##(1995-5#1)(2008-10#21)
at the 95%##25##3##(1995-5#1)(2008-10#24)
at the AM1##2##3##(1996-5#1)(2008-10#1)
at the ATP##2##3##(1991-9#1)(2008-5#1)
at the Agricultural##2##3##(2008-12#2)
at the American##4##3##(1995-2#1)(2008-3#1)(2008-5#1)(2009-6#1)
at the BBB##2##3##(1996-5#2)
at the BTB during the##2##5##(2009-10#1)(2012-2#1)
at the BTB##7##3##(2009-10#3)(2012-2#4)
at the Bragg##3##3##(2007-11#1)(2008-3#2)
at the Brewster angle##2##4##(2008-3#2)
at the C terminus of the##2##6##(1991-6#1)(1995-6#1)
at the C terminus##4##4##(1991-6#1)(1994-12#1)(1995-2#1)(1995-6#1)
at the C##6##3##(1991-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-6#1)
at the C-terminal end##2##4##(1996-12#1)(1997-4#1)
at the C-terminal##6##3##(1992-8#1)(1994-12#1)(1996-12#1)(1997-4#1)(2008-7#1)(2012-2#1)
at the C-terminus of the##2##5##(1994-12#1)(2008-10#1)
at the C-terminus##7##3##(1990-7#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
at the C1##2##3##(1990-8#2)
at the Carter Center##2##4##(1991-12#1)(1993-12#1)
at the Center for Diabetes Research##2##6##(1990-11#2)
at the Center for##6##4##(1990-11#2)(2007-11#1)(2008-11#1)(2008-2#1)(2010-5#1)
at the Center of##2##4##(2008-10#1)(2008-12#1)
at the Center##8##3##(1990-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)
at the Central##2##3##(1991-9#1)(2011-2#1)
at the Centre##3##3##(1993-12#1)(2007-12#1)(2008-6#1)
at the Children##2##3##(2008-9#2)
at the Clinical Hospital##2##4##(2011-2#1)(2013-1#1)
at the Clinical##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
at the DNA##5##3##(1990-11#1)(1991-6#1)(1994-6#1)(2008-4#2)
at the Dammam Central Hospital##2##5##(2008-1#2)
at the Department of##18##4##(1990-9#1)(1991-9#1)(1992-2#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#5)(2013-1#3)
at the Department##19##3##(1990-9#1)(1991-9#1)(1992-2#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#5)(2013-1#3)
at the ED(50)##2##3##(2008-11#2)
at the Emergency##2##3##(1992-6#1)(2007-10#1)
at the European##4##3##(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
at the Faculty of##2##4##(2008-12#1)(2010-1#1)
at the First##2##3##(1994-2#1)(2008-7#1)
at the G(2)/M##2##3##(2008-11#2)
at the Haversian level##2##4##(2013-1#2)
at the Health##3##3##(1993-12#1)(1994-3#1)(2010-3#1)
at the Hg electrode##2##4##(2008-10#2)
at the Hospital for##2##4##(2008-8#1)(2013-8#1)
at the Hospital##3##3##(1990-9#1)(2008-8#1)(2013-8#1)
at the IAT##3##3##(1994-9#3)
at the ICPD##2##3##(1994-9#2)
at the Institut Pasteur##2##4##(2010-1#2)
at the Institut##3##3##(1990-10#1)(2010-1#2)
at the Institute for##2##4##(2008-3#1)(2011-2#1)
at the Institute of##3##4##(1997-8#1)(2008-3#2)
at the Institute##6##3##(1997-8#1)(2008-3#3)(2008-7#1)(2011-2#1)
at the Istituto Nazionale Tumori in Milan##2##7##(1991-4#1)(1991-6#1)
at the Istituto Nazionale Tumori of##2##6##(1990-12#1)(2011-2#1)
at the Istituto Nazionale Tumori##4##5##(1990-12#1)(1991-4#1)(1991-6#1)(2011-2#1)
at the Istituto##5##3##(1990-12#1)(1991-4#1)(1991-6#1)(2008-10#1)(2011-2#1)
at the Jeddah Kidney Center##2##5##(2008-1#2)
at the King Abdulaziz University Hospital##2##6##(2007-7#2)
at the King##4##3##(2007-7#3)(2008-1#1)
at the L4-5 level##2##4##(2008-3#1)(2012-3#1)
at the L4-L5##3##3##(1996-6#3)
at the L5-S1##3##3##(1996-6#2)(2012-2#1)
at the LSPV-LA-J##2##3##(2011-2#2)
at the Laboratory##2##3##(2008-10#1)(2008-3#1)
at the Lagos University Teaching Hospital##2##6##(2010-9#2)
at the Laser Interferometer##2##4##(2008-3#2)
at the MCA bifurcation##2##4##(2008-12#2)
at the MDR1##2##3##(2011-2#2)
at the MER##2##3##(2008-10#2)
at the Mayo Clinic##2##4##(2008-5#1)(2009-5#1)
at the Medical University##4##4##(2007-11#1)(2007-8#1)(2008-9#2)
at the Medical##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-9#2)
at the Metropolitan##3##3##(1997-6#1)(2007-8#1)(2008-5#1)
at the Mexican Institute of Social Security##2##7##(2011-2#2)
at the Montreal Biodome##2##4##(2009-4#2)
at the Mount Sinai##2##4##(1995-8#1)(1996-3#1)
at the Mount##3##3##(1995-8#1)(1996-3#1)(2008-8#1)
at the N terminus of##2##5##(1990-5#1)(2008-10#1)
at the N-terminal end##3##4##(1993-8#1)(1995-11#1)(1995-8#1)
at the N-terminal##8##3##(1991-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-7#1)(2008-10#2)
at the N-terminus of the##2##5##(1992-6#1)(1997-3#1)
at the N-terminus of##3##4##(1992-6#1)(1995-12#1)(1997-3#1)
at the N-terminus##7##3##(1990-5#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-3#1)(2008-9#1)
at the NASA##2##3##(2008-3#2)
at the NEE##2##3##(2008-10#2)
at the NH2 terminus##4##4##(1992-12#1)(1992-9#1)(1993-3#1)(1995-6#1)
at the NH2-terminus##3##3##(1992-12#1)(1992-8#2)
at the National Cancer Institute##2##5##(2008-10#1)(2008-11#1)
at the National Cancer##4##4##(2007-8#1)(2008-10#1)(2008-11#2)
at the National Hospital##2##4##(1997-2#2)
at the National Institute of Standards and Technology##3##8##(2008-2#1)(2008-3#2)
at the National Institute of##4##5##(1994-7#1)(2008-2#1)(2008-3#2)
at the National##17##3##(1994-12#1)(1994-7#1)(1997-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-12#1)(2013-7#1)
at the Nordic School of Public Health##2##7##(1991-2#2)
at the Norwegian Institute of##2##5##(1996-6#1)(2010-6#1)
at the Norwegian##3##3##(1991-2#1)(1996-6#1)(2010-6#1)
at the Orthopedic##2##3##(1997-6#1)(2007-11#1)
at the Parque Nacional Cahuita##2##5##(2011-2#2)
at the Parque Nacional##3##4##(2008-5#1)(2011-2#2)
at the Pavillon Albert-Prévost##5##4##(2008-2#5)
at the Pavillon Roland-Saucier##2##4##(2008-2#2)
at the Pavillon##8##3##(2008-2#8)
at the Pediatric##2##3##(1990-2#1)(2011-1#1)
at the Pi-ta##2##3##(2008-10#2)
at the Pik##2##3##(2008-10#2)
at the Pointe-St-Charles##2##3##(2008-2#2)
at the Q/R site of##2##5##(1995-5#2)
at the RNA level##2##4##(1990-5#1)(1993-6#1)
at the Regional Hospital##2##4##(1990-2#2)
at the Riyadh Armed Forces Hospital##2##6##(2008-1#2)
at the Royal##3##3##(1992-12#1)(2007-12#1)(2008-6#1)
at the S phase##2##4##(1993-8#2)
at the SLCO1B1##2##3##(2011-2#2)
at the School of##3##4##(2008-10#1)(2012-12#1)(2013-8#1)
at the Second##2##3##(1996-5#1)(2007-12#1)
at the Sertoli##2##3##(2012-2#2)
at the Si bandgap energy##2##5##(2007-11#2)
at the Sixth##2##3##(1996-1#1)(2008-5#1)
at the Starfire Optical Range##2##5##(2007-12#1)(2008-2#1)
at the Surgical Department of##2##5##(1993-3#1)(2008-10#1)
at the Surgical Department##3##4##(1992-4#1)(1993-3#1)(2008-10#1)
at the Surgical##4##3##(1992-4#1)(1993-3#1)(1997-8#1)(2008-10#1)
at the São João de Deus##2##6##(2009-10#2)
at the São Paulo##2##4##(1990-12#1)(2013-7#1)
at the São##4##3##(1990-12#1)(2009-10#2)(2013-7#1)
at the TG##2##3##(2012-2#2)
at the Translocator Protein (TSPO) (18##2##6##(2012-2#2)
at the University Clinic##2##4##(1991-11#1)(1995-5#1)
at the University Hospital of the West Indies##3##8##(2011-2#3)
at the University Hospital of##6##5##(1993-3#1)(1996-6#1)(2009-5#1)(2011-2#3)
at the University of Alberta##2##5##(1995-12#1)(1995-3#1)
at the University of Bergen in 1990##2##7##(1992-6#2)
at the University of California##3##5##(1997-5#1)(2008-10#1)(2010-10#1)
at the University of Cincinnati##2##5##(1993-1#1)(2012-3#1)
at the University of Dundee##2##5##(2008-11#2)
at the University of Manchester##2##5##(2008-7#2)
at the University of Michigan##3##5##(1991-3#1)(1995-1#1)(2008-11#1)
at the University of New South Wales##2##7##(1996-1#1)(2008-2#1)
at the University of New##4##5##(1993-1#1)(1994-11#1)(1996-1#1)(2008-2#1)
at the University of Oslo were asked to assess##2##9##(1992-6#2)
at the University of Pennsylvania##2##5##(1996-12#1)(2012-12#1)
at the University of Texas##2##5##(2007-12#1)(2011-2#1)
at the University of Tromsø##2##5##(1993-6#1)(1996-9#1)
at the University of Washington##3##5##(1996-1#1)(2008-5#1)(2012-12#1)
at the University of Wisconsin##2##5##(1995-2#1)(2010-11#1)
at the University of##61##4##(1990-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#4)(1993-1#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
at the University##69##3##(1990-11#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#4)(1993-1#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
at the active site of the enzyme##2##7##(1990-9#1)(1992-6#1)
at the active site of the##3##6##(1990-9#1)(1992-6#1)(1993-11#1)
at the active site of##8##5##(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-6#2)(1993-11#1)(1994-5#1)
at the active site##16##4##(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-5#1)(1992-6#3)(1993-11#2)(1994-5#1)(1995-2#1)(1995-8#1)(1997-2#1)
at the active sites of##2##5##(1992-8#1)(1994-12#1)
at the active##21##3##(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-5#1)(1992-6#3)(1992-8#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-8#1)(1997-2#1)(2008-5#1)
at the adult plant stage in##2##6##(2008-10#2)
at the adult plant stage##4##5##(2008-10#4)
at the adult##5##3##(2008-10#5)
at the age of 40##2##5##(2008-5#1)(2012-3#1)
at the age of 6##2##5##(1994-6#1)(2008-7#1)
at the age of one##3##5##(1992-11#2)(1997-3#1)
at the age of##33##4##(1991-11#1)(1991-6#1)(1992-11#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-3#3)(2007-11#1)(2007-7#3)(2008-10#1)(2008-5#3)(2008-7#5)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at the age##34##3##(1991-11#1)(1991-6#1)(1992-11#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-3#3)(2007-11#2)(2007-7#3)(2008-10#1)(2008-5#3)(2008-7#5)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at the ages of 6##2##5##(2008-3#2)
at the ages of##3##4##(1995-8#1)(2008-3#2)
at the air##2##3##(2008-10#1)(2008-3#1)
at the air-liquid interface##7##4##(2008-10#2)(2008-3#1)(2008-5#4)
at the airway##3##3##(1992-2#2)(1996-12#1)
at the alpha##5##3##(1990-12#1)(1992-3#1)(1996-12#1)(1996-5#1)(2008-6#1)
at the amino acid level##2##5##(1992-12#1)(2008-8#1)
at the amino acid position##2##5##(1991-11#1)(2013-8#1)
at the amino acid##6##4##(1991-11#1)(1992-12#1)(1993-6#1)(2008-8#1)(2009-3#1)(2013-8#1)
at the amino terminus##5##4##(1992-8#1)(1996-12#2)(1997-8#1)(2008-10#1)
at the amino##11##3##(1991-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2013-8#1)
at the ankle and##2##4##(2009-11#1)(2011-2#1)
at the ankle##4##3##(2007-11#1)(2009-11#1)(2011-2#1)(2012-2#1)
at the annual##3##3##(1993-12#1)(2008-5#1)(2011-2#1)
at the antenna##2##3##(2007-12#2)
at the anterior pole of the##2##6##(1994-12#1)(2007-12#1)
at the anterior pole##4##4##(1994-12#1)(2007-12#3)
at the anterior##10##3##(1994-12#2)(2007-12#6)(2008-7#1)(2011-2#1)
at the aperture##2##3##(2008-3#2)
at the apex##3##3##(2007-12#1)(2012-12#2)
at the apical ES##4##4##(2012-2#4)
at the apical##9##3##(1995-8#1)(2008-7#1)(2012-2#6)(2013-1#1)
at the appropriate##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
at the area##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
at the argon/water interface##3##4##(1994-3#3)
at the arterial##2##3##(2008-7#1)(2008-9#1)
at the atomic##2##3##(2008-11#1)(2008-7#1)
at the authors'##2##3##(2007-11#1)(2008-11#1)
at the back of##3##4##(2008-3#2)(2008-5#1)
at the back##5##3##(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
at the basal ES##3##4##(2012-2#3)
at the basal##6##3##(1997-1#1)(2008-7#1)(2012-2#3)(2012-3#1)
at the base and##3##4##(2008-5#3)
at the base of a##2##5##(2008-3#1)(2008-8#1)
at the base of the##9##5##(1991-3#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
at the base of##13##4##(1991-3#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
at the base recognition and catalytic sites##2##7##(1992-4#2)
at the base##20##3##(1991-3#1)(1992-4#2)(1992-8#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
at the baseline##3##3##(1997-8#1)(2012-4#1)(2013-1#1)
at the basic##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
at the bedside##4##3##(1993-3#1)(1996-1#1)(1996-2#1)(2007-7#1)
at the beginning and at the##2##6##(1990-9#1)(2008-11#1)
at the beginning and end of the##2##7##(2008-4#1)(2012-3#1)
at the beginning and end of##3##6##(2008-4#1)(2011-2#1)(2012-3#1)
at the beginning and the end of the study##2##9##(1990-9#1)(2007-2#1)
at the beginning and##7##4##(1990-9#2)(2007-2#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
at the beginning of an##2##5##(1990-2#1)(2008-7#1)
at the beginning of each##5##5##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
at the beginning of the 20th century##2##7##(2009-7#2)
at the beginning of the##23##5##(1990-12#1)(1992-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#2)(2011-1#1)(2012-12#1)(2013-7#1)
at the beginning of their##2##5##(2007-12#1)(2010-2#1)
at the beginning of##47##4##(1990-12#1)(1990-2#1)(1990-6#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
at the beginning##62##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#2)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-7#1)
at the blood-brain barrier##2##4##(2011-2#1)(2012-3#1)
at the blood-testis barrier##2##4##(2009-10#1)(2012-2#1)
at the border##4##3##(2008-7#1)(2012-2#3)
at the bottom of the##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
at the bottom of##5##4##(1992-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
at the bottom##9##3##(1992-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
at the boundary between the##2##5##(2008-2#1)(2009-9#1)
at the boundary between##3##4##(1995-6#1)(2008-2#1)(2009-9#1)
at the boundary##5##3##(1995-6#1)(2007-11#1)(2008-2#2)(2009-9#1)
at the capillary level##2##4##(2011-2#2)
at the carbon paste electrode##3##5##(2008-10#3)
at the carbon##4##3##(2008-10#3)(2008-11#1)
at the carbonyl##3##3##(1993-11#1)(1995-5#1)(1995-6#1)
at the carboxyl terminus##3##4##(1992-8#1)(1992-9#2)
at the carboxyl##5##3##(1992-8#2)(1992-9#2)(2008-10#1)
at the catalytic site of##2##5##(1990-11#1)(1995-2#1)
at the catheter exit site##2##5##(2007-12#1)(2007-7#1)
at the cell periphery##3##4##(1990-8#1)(2007-12#1)(2009-8#1)
at the cell surface##13##4##(1990-8#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-9#1)(2012-12#2)
at the cell##21##3##(1990-8#2)(1991-12#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#1)(2012-12#2)
at the cellular and##2##4##(2008-7#1)(2013-1#1)
at the cellular level##19##4##(1993-11#1)(1995-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#2)(2013-1#1)
at the cellular##24##3##(1993-11#1)(1995-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-8#1)(2012-12#2)(2012-2#3)(2013-1#2)
at the center of origin##2##5##(2008-10#2)
at the center of the##10##5##(1993-8#1)(2008-10#1)(2008-3#6)(2009-7#1)(2011-2#1)
at the center of##17##4##(1993-5#1)(1993-8#1)(2007-12#1)(2008-10#3)(2008-3#7)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
at the center##22##3##(1991-8#1)(1993-5#1)(1993-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#10)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
at the centers##2##3##(1994-3#1)(2009-7#1)
at the central##5##3##(1990-11#1)(1990-8#1)(2008-3#1)(2008-9#2)
at the centre of##3##4##(1996-11#1)(1997-4#1)(2012-7#1)
at the centre##4##3##(1991-11#1)(1996-11#1)(1997-4#1)(2012-7#1)
at the cervical##3##3##(1993-12#1)(2008-12#1)(2008-7#1)
at the chelating##2##3##(1996-2#2)
at the cleavage##2##3##(1995-11#1)(2008-5#1)
at the clinic##3##3##(1995-2#1)(2008-10#1)(2012-12#1)
at the clinical##2##3##(1993-3#1)(2012-3#1)
at the clonal level##2##4##(1992-9#1)(2008-11#1)
at the community level##11##4##(1994-8#1)(1996-12#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#3)
at the community##12##3##(1994-8#1)(1996-12#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#2)(2012-3#1)(2013-1#3)
at the completion of the##2##5##(2008-10#1)(2011-2#1)
at the concentration level of##2##5##(2008-10#1)(2012-1#1)
at the concentration level##3##4##(2008-10#2)(2012-1#1)
at the concentration levels##2##4##(2008-10#2)
at the concentration of 1##2##5##(2008-11#1)(2008-5#1)
at the concentration of 5##2##5##(2008-10#1)(2011-1#1)
at the concentration of##9##4##(1990-12#1)(1991-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-1#1)(2012-3#1)
at the concentration range of 0##2##6##(2008-10#2)
at the concentration range of##4##5##(2008-10#3)(2008-12#1)
at the concentration range##5##4##(2008-10#4)(2008-12#1)
at the concentration##19##3##(1990-12#1)(1991-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
at the concentrations tested##3##4##(2008-10#2)(2008-7#1)
at the concentrations##6##3##(2007-2#1)(2008-10#3)(2008-4#1)(2008-7#1)
at the conclusion of a##2##5##(1994-1#1)(1994-11#1)
at the conclusion of the##3##5##(2008-11#2)(2008-3#1)
at the conclusion of##6##4##(1994-1#1)(1994-11#1)(2008-11#2)(2008-3#1)(2010-12#1)
at the confluence##2##3##(2008-11#1)(2008-7#1)
at the contact##2##3##(1997-3#1)(2008-10#1)
at the control site##2##4##(2007-5#1)(2008-5#1)
at the core of the##4##5##(2008-10#2)(2010-2#1)(2011-2#1)
at the core of##8##4##(1991-2#1)(1993-3#1)(2008-10#2)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
at the core##11##3##(1991-2#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
at the correct##6##3##(1991-12#1)(1992-5#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
at the cost of the##2##5##(2008-11#1)(2008-7#1)
at the cost of##9##4##(1990-6#1)(1993-2#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)
at the county level##2##4##(2008-8#1)(2011-1#1)
at the craniospinal junction##2##4##(2007-10#2)
at the critical##2##3##(1990-5#1)(1997-2#1)
at the crystal##3##3##(2007-11#1)(2008-3#2)
at the dawn of the##2##5##(1991-11#1)(2007-12#1)
at the day##2##3##(2012-2#1)(2013-1#1)
at the department of##2##4##(1991-3#1)(2008-1#1)
at the desired##2##3##(1996-9#1)(2008-4#1)
at the detection##6##3##(2007-11#1)(2008-10#5)
at the detector##3##3##(2008-10#1)(2008-3#2)
at the determination of##2##4##(2008-10#2)
at the developmental##2##3##(1991-9#1)(2008-2#1)
at the diazepam-insensitive sites##3##4##(1992-3#3)
at the different##9##3##(1995-9#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
at the disease##2##3##(2008-10#1)(2008-4#1)
at the disk##2##3##(2008-2#1)(2008-5#1)
at the distal end of the##3##6##(1991-7#1)(2008-10#1)(2008-9#1)
at the distal end of##4##5##(1991-7#1)(1992-12#1)(2008-10#1)(2008-9#1)
at the distal##9##3##(1991-7#1)(1992-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-12#1)
at the distance##2##3##(1993-6#1)(2008-5#1)
at the district##2##3##(2008-1#1)(2011-2#1)
at the dome of the##2##5##(2008-10#1)(2008-5#1)
at the dorsal##2##3##(2007-12#1)(2011-2#1)
at the dosage of##2##4##(1991-2#1)(2007-8#1)
at the dose of 10##2##5##(2012-3#1)(2013-1#1)
at the dose of 30##2##5##(1996-2#1)(2011-2#1)
at the dose of##15##4##(1990-9#2)(1991-2#1)(1992-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#3)
at the dose##16##3##(1990-9#2)(1991-2#1)(1992-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#4)
at the doses of##3##4##(2013-1#3)
at the doses##7##3##(1994-11#1)(1995-12#1)(2008-9#1)(2013-1#4)
at the dough stage##3##4##(2008-10#3)
at the dough##4##3##(2008-10#4)
at the dropping mercury electrode##2##5##(2008-10#2)
at the duodeno-jejunal flexure##2##4##(2008-12#2)
at the dura##2##3##(1996-9#1)(2008-7#1)
at the earliest stage##2##4##(1994-8#1)(2012-2#1)
at the earliest##6##3##(1990-2#1)(1994-8#1)(1997-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
at the early control##2##4##(2013-1#2)
at the early stage of infection##2##6##(2008-10#2)
at the early stage of##6##5##(1997-3#1)(2008-10#4)(2013-1#1)
at the early stages of##3##5##(2008-11#1)(2008-5#1)(2008-6#1)
at the early##18##3##(1992-9#1)(1993-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#3)
at the eastern section of the beach##2##7##(2007-5#2)
at the ectatic area##2##4##(1997-3#2)
at the edge of the##4##5##(1992-3#1)(2008-10#2)(2008-3#1)
at the edge of##9##4##(1992-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
at the edge##10##3##(1992-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)(2013-1#1)
at the edges of##2##4##(1997-3#1)(2008-2#1)
at the edges##3##3##(1997-3#1)(2008-2#1)(2008-5#1)
at the elbow and wrist##2##5##(1995-6#1)(2008-12#1)
at the elbow##10##3##(1995-6#1)(2008-1#3)(2008-12#1)(2008-9#4)(2013-1#1)
at the electrode surface##12##4##(2008-10#11)(2009-12#1)
at the electrode##17##3##(2008-10#16)(2009-12#1)
at the electron microscope level##3##5##(2008-10#3)
at the electron microscopic level##2##5##(1991-9#1)(1995-3#1)
at the electron##5##3##(1991-9#1)(1995-3#1)(2008-10#3)
at the elite level##2##4##(2007-11#2)
at the elite##3##3##(2007-11#3)
at the emergency department##3##4##(2008-10#2)(2011-1#1)
at the emergency##5##3##(1993-12#1)(2007-12#1)(2008-10#2)(2011-1#1)
at the end face of##2##5##(2008-3#2)
at the end of 1th month##2##6##(2011-2#2)
at the end of a capillary tip##4##7##(2008-10#4)
at the end of a##9##5##(1996-6#1)(2008-10#6)(2008-3#1)(2008-8#1)
at the end of each experiment##2##6##(1994-3#1)(2008-10#1)
at the end of each##12##5##(1994-3#1)(1997-4#3)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-9#1)(2011-1#1)
at the end of surgery##2##5##(1990-2#1)(2010-3#1)
at the end of the Early Bronze Age##3##8##(2008-10#3)
at the end of the Pleistocene##2##6##(2008-8#1)(2008-9#1)
at the end of the course##3##6##(2008-11#1)(2012-12#1)(2013-8#1)
at the end of the experiment##3##6##(2008-5#1)(2010-2#1)(2013-1#1)
at the end of the first year##2##7##(1996-12#1)(2011-1#1)
at the end of the first##4##6##(1996-12#1)(1996-3#1)(2008-10#1)(2011-1#1)
at the end of the follow-up period##2##7##(2008-3#1)(2008-7#1)
at the end of the follow-up##4##6##(1992-6#1)(2008-3#1)(2008-7#1)(2008-8#1)
at the end of the growing season##2##7##(2008-10#2)
at the end of the growth phase##2##7##(2008-11#2)
at the end of the growth##3##6##(2007-8#1)(2008-11#2)
at the end of the operation##3##6##(1993-9#1)(2007-8#1)(2009-10#1)
at the end of the second##3##6##(1996-12#1)(2008-8#1)(2013-1#1)
at the end of the stress##2##6##(1994-2#1)(2008-11#1)
at the end of the study (P&lt##2##7##(2007-7#2)
at the end of the study##10##6##(1990-9#1)(2007-7#2)(2008-1#1)(2008-6#1)(2008-9#4)(2011-2#1)
at the end of the therapy##2##6##(1992-12#1)(2013-7#1)
at the end of the treatment##5##6##(1990-9#1)(1991-8#1)(1997-3#1)(2008-5#1)(2013-1#1)
at the end of the trial##3##6##(1994-6#2)(1994-9#1)
at the end of the year##2##6##(2008-1#1)(2008-12#1)
at the end of the##100##5##(1990-9#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-6#2)(1994-9#2)(1996-12#3)(1996-3#1)(1997-3#2)(1997-5#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
at the end of their##3##5##(2008-11#1)(2008-5#1)(2012-12#1)
at the end of therapy##4##5##(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
at the end of this##2##5##(2008-10#1)(2008-4#1)
at the end of##186##4##(1990-2#1)(1990-9#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-3#1)(1995-8#1)(1996-12#4)(1996-3#1)(1996-6#2)(1997-2#3)(1997-3#3)(1997-4#11)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#30)(2008-11#7)(2008-12#7)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#12)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#4)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#8)(2013-7#2)(2013-8#1)
at the end##189##3##(1990-2#1)(1990-9#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-3#1)(1995-8#1)(1996-12#4)(1996-3#1)(1996-6#2)(1997-2#3)(1997-3#3)(1997-4#11)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#30)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#12)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#4)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#8)(2013-7#2)(2013-8#1)
at the end-point were##2##4##(2008-10#2)
at the ends of##2##4##(2008-11#1)(2008-9#1)
at the ends##4##3##(2008-11#1)(2008-9#1)(2009-9#1)(2013-1#1)
at the entrance of##2##4##(2008-10#1)(2008-3#1)
at the entrance##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
at the entry##2##3##(1994-9#1)(2012-2#1)
at the enzyme##2##3##(2008-6#1)(2009-8#1)
at the equivalence point##2##4##(2008-10#2)
at the estrogen##2##3##(1992-6#1)(2008-11#1)
at the evaluated##2##3##(2012-2#1)(2013-1#1)
at the executive##2##3##(1993-2#1)(2008-11#1)
at the exit site##2##4##(2011-2#2)
at the exit##5##3##(2008-2#1)(2008-3#2)(2011-2#2)
at the expected##2##3##(1995-2#1)(2008-11#1)
at the expense of a##2##5##(2008-2#1)(2008-3#1)
at the expense of the##6##5##(1990-9#1)(1994-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-3#1)
at the expense of##24##4##(1990-9#1)(1994-8#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
at the experimental##4##3##(2008-10#3)(2011-1#1)
at the exponential##2##3##(2008-11#2)
at the extremes of##2##4##(1997-3#1)(2008-8#1)
at the family##2##3##(1997-2#1)(2013-7#1)
at the far##2##3##(2007-11#1)(2008-3#1)
at the farm##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
at the fastest##2##3##(1994-3#1)(2008-10#1)
at the fiber input##3##4##(2007-12#2)(2008-3#1)
at the fiber output##2##4##(2007-12#1)(2008-3#1)
at the fiber##6##3##(2007-12#3)(2008-3#3)
at the field scale##3##4##(2008-10#3)
at the field##6##3##(2008-10#6)
at the fifth day##2##4##(1993-12#1)(2007-11#1)
at the fifth##3##3##(1993-12#1)(2007-11#1)(2008-12#1)
at the final harvest##2##4##(2008-10#2)
at the final##7##3##(1991-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
at the first order##2##4##(2007-12#1)(2008-3#1)
at the first time##2##4##(1993-11#1)(2008-3#1)
at the first##22##3##(1990-6#1)(1991-2#1)(1993-11#1)(1995-5#1)(1997-2#1)(1997-6#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-3#3)(2008-4#1)(2009-12#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-1#1)
at the flow rate of##4##5##(2008-10#4)
at the flow rate##5##4##(2008-10#5)
at the focal plane of##2##5##(2007-12#1)(2008-3#1)
at the focal point of##2##5##(2007-12#1)(2008-3#1)
at the focal point##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
at the focal##9##3##(2007-11#3)(2007-12#3)(2008-3#3)
at the focus of##2##4##(2007-11#1)(2008-2#1)
at the focus##4##3##(2007-11#2)(2008-10#1)(2008-2#1)
at the follow-up##2##3##(1997-3#1)(2008-12#1)
at the following##6##3##(1995-8#1)(1997-5#1)(2008-10#2)(2008-12#1)(2011-1#1)
at the forefront of##3##4##(2008-7#1)(2010-4#1)(2013-1#1)
at the four##4##3##(1997-2#1)(2008-10#1)(2008-4#1)(2013-3#1)
at the four-leaf stage##2##4##(2008-10#2)
at the fourth##5##3##(1990-8#1)(1997-2#1)(2007-12#2)(2012-1#1)
at the frequencies##2##3##(2008-4#1)(2013-1#1)
at the frequency of##2##4##(2007-12#1)(2008-9#1)
at the frog neuromuscular junction##2##5##(2008-4#2)
at the front line##2##4##(2008-11#1)(2011-2#1)
at the front##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
at the fundamental##6##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
at the future##3##3##(2009-10#1)(2011-2#2)
at the gene level##2##4##(2008-10#1)(2008-11#1)
at the gene##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
at the genetic level##2##4##(2012-2#1)(2012-3#1)
at the genetic##3##3##(2011-10#1)(2012-2#1)(2012-3#1)
at the genome##2##3##(1995-5#1)(2009-6#1)
at the genomic level##5##4##(1991-12#1)(1991-6#1)(2008-10#1)(2009-10#1)(2011-2#1)
at the genomic##6##3##(1991-12#1)(1991-6#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
at the geometric focus##2##4##(2008-3#2)
at the glassy carbon electrode##2##5##(2008-10#2)
at the glucose-6-phosphate isomerase and peptidase loci##2##7##(2008-10#2)
at the gold electrode##2##4##(2008-10#2)
at the gonads##3##3##(2009-11#3)
at the greatest risk##3##4##(1997-3#1)(2008-7#1)(2013-8#1)
at the group##3##3##(2008-10#2)(2013-1#1)
at the growing##2##3##(2008-3#1)(2009-9#1)
at the hanging mercury drop electrode (HMDE)##4##7##(2008-10#4)
at the hanging mercury drop electrode was##2##7##(2008-10#2)
at the hanging mercury drop electrode##7##6##(2008-10#7)
at the hanging##8##3##(2008-10#8)
at the head-neck junction##2##4##(2013-1#2)
at the heart of the##3##5##(2007-8#1)(2008-11#1)(2012-3#1)
at the heart of##8##4##(2007-4#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)(2012-3#1)
at the heart##9##3##(2007-4#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
at the hexane-water interface##3##4##(2008-10#3)
at the high dose##2##4##(1995-11#1)(2008-10#1)
at the high##7##3##(1993-9#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
at the high-frequency##2##3##(2008-2#1)(2008-3#1)
at the higher dose##3##4##(1997-4#1)(2008-5#1)(2012-3#1)
at the higher##11##3##(1997-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
at the highest concentration##5##4##(1996-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
at the highest concentrations##2##4##(2008-12#1)(2013-7#1)
at the highest dose##6##4##(1992-3#1)(1993-6#1)(2008-10#2)(2008-5#2)
at the highest level##3##4##(1993-3#1)(2008-10#2)
at the highest rate##2##4##(2006-6#1)(2008-10#1)
at the highest risk##2##4##(1996-6#1)(2008-9#1)
at the highest##29##3##(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-7#1)
at the hip##5##3##(1993-11#1)(2008-10#1)(2010-10#1)(2010-3#1)(2011-2#1)
at the histological level##3##4##(2008-10#2)(2008-5#1)
at the horizontal##2##3##(2008-3#1)(2008-9#1)
at the hospital##12##3##(1991-2#1)(1993-3#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-11#2)(2009-4#1)(2010-7#2)(2012-2#2)
at the human##6##3##(1992-8#1)(1997-4#1)(2008-4#3)(2008-5#1)
at the image##2##3##(2008-2#2)
at the implant##2##3##(2012-3#1)(2013-1#1)
at the implanted##2##3##(2008-9#1)(2009-3#1)
at the individual level##3##4##(2008-10#1)(2008-8#1)(2009-4#1)
at the individual##9##3##(2008-10#1)(2008-11#1)(2008-8#3)(2009-4#1)(2010-10#1)(2010-4#1)(2010-9#1)
at the infusion site##2##4##(1992-5#1)(2012-3#1)
at the inhibitory site##2##4##(1990-11#1)(1993-2#1)
at the initial stages of##2##5##(2006-12#1)(2008-1#1)
at the initial visit##2##4##(2008-12#1)(2008-9#1)
at the initial##11##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#1)
at the initiation of##6##4##(2008-11#1)(2011-2#4)(2012-2#1)
at the injection site##6##4##(1990-6#1)(1994-5#1)(2007-11#1)(2009-9#1)(2011-2#2)
at the injection##7##3##(1990-6#1)(1993-1#1)(1994-5#1)(2007-11#1)(2009-9#1)(2011-2#2)
at the inlet and##2##4##(2008-7#2)
at the inner surface##2##4##(2007-12#1)(2008-3#1)
at the inner##6##3##(1991-5#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-8#2)
at the input and the Fourier planes##2##7##(2008-2#1)(2008-3#1)
at the input and the##3##5##(2008-2#1)(2008-3#2)
at the input plane and##2##5##(2007-11#1)(2008-3#1)
at the input##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
at the insertion##2##3##(1995-8#1)(2013-8#1)
at the interface between the##6##5##(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
at the interface between two##3##5##(2008-10#2)(2008-3#1)
at the interface between##13##4##(1995-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)
at the interface of the##4##5##(1991-12#1)(2008-10#3)
at the interface of##10##4##(1991-12#1)(2008-10#5)(2008-3#2)(2009-12#1)(2010-10#1)
at the interface##33##3##(1991-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2013-8#1)
at the interfaces##2##3##(2008-3#2)
at the intermediate##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
at the internal##2##3##(1995-5#1)(1997-3#1)
at the international level##2##4##(2007-10#1)(2008-12#1)
at the intersection of the##2##5##(2009-5#1)(2011-2#1)
at the intersection of##5##4##(2008-11#1)(2009-5#2)(2011-1#1)(2011-2#1)
at the isosbestic point with##2##5##(2008-10#2)
at the junction between the##3##5##(2007-12#1)(2012-12#1)(2012-3#1)
at the junction of the##2##5##(2007-12#1)(2008-10#1)
at the junction of##4##4##(1990-5#1)(2007-12#2)(2008-10#1)
at the junction##9##3##(1990-5#1)(1996-12#1)(2007-12#3)(2007-4#1)(2008-10#1)(2012-12#1)(2012-3#1)
at the junctions##2##3##(2008-10#2)
at the large##2##3##(2008-3#1)(2009-8#1)
at the larval stage##3##4##(2008-6#1)(2008-8#2)
at the lasing wavelength##2##4##(2007-12#1)(2008-2#1)
at the lasing##3##3##(2007-12#2)(2008-2#1)
at the last admission##2##4##(2011-2#2)
at the last##8##3##(1991-2#1)(1993-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-6#1)(2011-2#2)
at the late stage of##2##5##(2008-11#1)(2008-9#1)
at the late stages##2##4##(2008-10#1)(2012-3#1)
at the late##8##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
at the lateral##2##3##(1996-9#1)(2007-12#1)
at the latest##2##3##(1993-6#1)(2013-7#1)
at the leaf##2##3##(2008-10#2)
at the leaflet and leaf levels##2##6##(2008-10#2)
at the leaflet and leaf##3##5##(2008-10#3)
at the leaflet##5##3##(2008-10#5)
at the left##4##3##(1991-3#1)(2007-8#1)(2008-6#1)(2013-1#1)
at the lens##2##3##(2008-2#1)(2008-3#1)
at the lesion site##2##4##(1992-9#1)(1996-5#1)
at the level of 0##3##5##(2008-10#1)(2008-12#1)(2008-2#1)
at the level of 1##2##5##(1996-5#1)(2008-10#1)
at the level of a##3##5##(1990-8#1)(1993-11#1)(2008-4#1)
at the level of both##2##5##(2008-11#1)(2008-8#1)
at the level of individual##3##5##(1997-7#1)(2010-10#1)(2011-2#1)
at the level of mRNA##3##5##(1990-12#1)(1992-3#1)(2011-1#1)
at the level of single##3##5##(2007-12#1)(2008-8#1)(2012-3#1)
at the level of the knee##2##6##(2012-2#2)
at the level of the##32##5##(1990-3#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-5#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
at the level of transcription##7##5##(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(2008-11#1)(2012-12#1)
at the level of##99##4##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#2)(1992-3#2)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
at the level##100##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#2)(1992-3#2)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
at the levels of##6##4##(1992-5#1)(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
at the levels##7##3##(1992-5#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)
at the light and electron##3##5##(2008-4#1)(2008-7#2)
at the light and##4##4##(2008-4#1)(2008-7#3)
at the limit of##3##4##(2007-11#1)(2008-2#1)(2009-9#1)
at the local level##4##4##(1992-2#1)(1994-2#1)(1996-1#1)(2008-10#1)
at the local##8##3##(1992-2#1)(1994-2#1)(1996-1#1)(1997-3#2)(2008-10#2)(2008-2#1)
at the location##3##3##(1990-12#2)(2010-8#1)
at the long##2##3##(2007-11#1)(2008-12#1)
at the low mug l(-1)##2##5##(2008-10#2)
at the low mug##3##4##(2008-10#3)
at the low nanomolar level##2##5##(2008-10#2)
at the low##10##3##(1994-6#1)(2008-10#7)(2008-3#1)(2012-2#1)
at the lower end of the##2##6##(2008-10#1)(2011-2#1)
at the lower temperature##2##4##(2008-10#1)(2008-11#1)
at the lower##10##3##(1996-4#1)(2008-10#4)(2008-11#2)(2011-2#2)(2012-3#1)
at the lowest concentration##3##4##(1991-9#1)(1994-11#1)(2010-10#1)
at the lowest dose##2##4##(1996-5#1)(2012-1#1)
at the lowest##11##3##(1991-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2009-6#1)(2010-10#1)(2012-1#1)
at the lumbar spine##3##4##(1993-11#1)(2010-3#2)
at the m-RNA level of cyclooxygenase-2##2##6##(1997-1#2)
at the mRNA level##6##4##(1994-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-7#1)(2008-8#1)
at the mRNA##7##3##(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-7#1)(2008-8#1)
at the main##3##3##(1990-2#1)(2008-12#1)(2013-7#1)
at the manufacturer's facility to##2##5##(2008-3#2)
at the manufacturer's##3##3##(2008-3#3)
at the margin of##2##4##(2008-10#2)
at the margin##3##3##(1995-4#1)(2008-10#2)
at the margins##2##3##(1997-7#1)(2008-10#1)
at the mature##2##3##(1996-10#1)(2008-10#1)
at the maximum absorption wavelength of##2##6##(2008-10#2)
at the maximum absorption wavelength##3##5##(2008-10#3)
at the maximum of the##2##5##(2008-2#1)(2008-3#1)
at the maximum##6##3##(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
at the medial##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
at the medium##3##3##(2008-10#2)(2008-3#1)
at the meeting##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
at the membrane level##2##4##(1990-2#1)(1997-2#1)
at the membrane##5##3##(1990-2#1)(1992-12#2)(1997-2#1)(2012-2#1)
at the membrane/solution interface##2##4##(2008-10#2)
at the mercury electrode and##4##5##(2008-10#4)
at the mercury electrode surface##3##5##(2008-10#3)
at the mercury electrode##8##4##(2008-10#8)
at the mercury##9##3##(2008-10#9)
at the metabolite level##2##4##(2008-8#1)(2009-12#1)
at the microbiological laboratory##2##4##(2010-6#2)
at the middle of the##2##5##(1997-7#1)(2008-3#1)
at the middle##3##3##(1997-7#1)(2008-3#1)(2013-1#1)
at the midpoint between the maximum and the minimum values of the open-loop TES##2##14##(2008-2#2)
at the midpoint##3##3##(2008-12#1)(2008-2#2)
at the minimum##2##3##(2008-11#1)(2008-8#1)
at the mitochondrial##2##3##(1994-8#1)(2012-2#1)
at the modified electrode are##2##5##(2008-10#2)
at the modified electrode##4##4##(1995-6#1)(2008-10#3)
at the modified##5##3##(1995-6#1)(2008-10#3)(2008-4#1)
at the molecular and cellular levels##2##6##(1997-6#1)(2008-2#1)
at the molecular and##3##4##(1997-6#1)(2008-2#1)(2009-7#1)
at the molecular level is##2##5##(1993-11#1)(2008-10#1)
at the molecular level##22##4##(1992-6#1)(1993-11#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
at the molecular##28##3##(1992-6#1)(1993-11#1)(1995-2#1)(1997-6#2)(1997-8#1)(2008-10#4)(2008-2#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
at the moment of##6##4##(1990-3#1)(1990-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-1#1)
at the moment##13##3##(1990-3#1)(1990-9#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2009-10#1)(2013-1#1)
at the monolayer/water interface##2##4##(1991-3#2)
at the more##2##3##(1990-5#1)(2008-12#1)
at the most##4##3##(1995-12#1)(1996-3#1)(2008-10#1)(2008-8#1)
at the mu##2##3##(1992-3#1)(2008-11#1)
at the mug##3##3##(2008-10#3)
at the muscular portion##2##4##(2008-9#2)
at the nanogram level is##2##5##(2008-10#2)
at the nanogram level##3##4##(2008-10#3)
at the nanometer level##2##4##(2008-3#1)(2008-7#1)
at the nanometer scale##2##4##(2009-11#1)(2009-12#1)
at the nanometer##5##3##(2008-3#1)(2008-7#1)(2009-11#2)(2009-12#1)
at the nanoscale##8##3##(2007-12#1)(2008-7#3)(2009-11#2)(2009-5#1)(2012-2#1)
at the national and##3##4##(2008-11#1)(2010-8#1)(2013-1#1)
at the national level in##2##5##(2007-11#2)
at the national##6##3##(1994-12#1)(2007-11#2)(2008-11#1)(2010-8#1)(2013-1#1)
at the needle##2##3##(1991-12#1)(2008-10#1)
at the neonatal##2##3##(1993-12#1)(1995-5#1)
at the nest##2##3##(2008-8#2)
at the neuromuscular junction##3##4##(2008-7#1)(2009-11#1)(2009-8#1)
at the neuromuscular##4##3##(2008-7#1)(2009-11#1)(2009-8#1)(2012-12#1)
at the new##2##3##(2008-11#1)(2008-8#1)
at the nonreducing terminal were used as substrates##2##8##(1994-5#2)
at the nonreducing##3##3##(1994-5#2)(2008-7#1)
at the normal##2##3##(1997-7#1)(2008-2#1)
at the nuclear level##2##4##(2008-4#1)(2008-6#1)
at the nuclear pore##2##4##(1995-2#1)(2011-2#1)
at the nuclear##6##3##(1995-2#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-2#2)
at the nucleic acid##2##4##(1993-6#1)(1994-11#1)
at the nucleotide and amino acid levels##2##7##(1995-8#1)(2008-10#1)
at the nucleotide and##3##4##(1991-9#1)(1995-8#1)(2008-10#1)
at the nucleotide level##3##4##(1994-12#1)(1997-4#1)(1997-6#1)
at the nucleotide##7##3##(1991-9#1)(1993-6#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-6#1)(2008-10#1)
at the ocean##2##3##(1990-8#1)(2008-8#1)
at the oil-water##2##3##(2008-10#1)(2008-5#1)
at the onset of the##5##5##(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
at the onset of##24##4##(1993-12#1)(1994-11#2)(1996-4#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
at the optical##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
at the optimal##3##3##(1991-5#1)(2008-6#1)(2008-7#1)
at the optimum temperature for##2##5##(2008-10#1)(2008-6#1)
at the optimum temperature##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
at the optimum##7##3##(1994-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)
at the origin of the##2##5##(2008-2#1)(2013-8#1)
at the origin of##3##4##(2008-2#1)(2013-1#1)(2013-8#1)
at the origin##5##3##(2008-2#2)(2010-8#1)(2013-1#1)(2013-8#1)
at the other##6##3##(2008-10#4)(2008-12#1)(2009-6#1)
at the outer##6##3##(1992-3#1)(1997-7#1)(2007-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
at the outlet of the##2##5##(2008-10#2)
at the output of a##2##5##(2007-11#1)(2008-3#1)
at the output of the device##2##6##(2008-2#2)
at the output of the##8##5##(2007-11#2)(2008-2#5)(2008-3#1)
at the output of##10##4##(2007-11#3)(2008-2#5)(2008-3#2)
at the output plane##4##4##(2008-2#2)(2008-3#2)
at the output port##2##4##(2007-12#1)(2008-3#1)
at the output##23##3##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#7)(2008-3#9)
at the outset of##2##4##(1995-1#1)(1995-12#1)
at the outset##5##3##(1995-1#1)(1995-12#1)(2008-12#1)(2011-1#1)(2012-3#1)
at the p53 locus##2##4##(1995-9#1)(1997-7#1)
at the pH##3##3##(1991-8#1)(1993-3#1)(2008-10#1)
at the para position##2##4##(2008-10#1)(2013-1#1)
at the parts-per-trillion level##2##4##(2008-10#2)
at the peak of the##2##5##(1995-11#1)(2008-10#1)
at the peak##6##3##(1995-11#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
at the periphery of the##3##5##(1991-2#1)(2008-10#1)(2009-2#1)
at the periphery of##4##4##(1991-2#1)(2008-10#1)(2008-8#1)(2009-2#1)
at the periphery##8##3##(1991-2#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2013-8#1)
at the phase##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
at the phenotypic level##3##4##(2008-7#2)(2010-2#1)
at the photodiode##2##3##(2008-3#2)
at the pituitary##2##3##(1995-11#1)(1996-2#1)
at the plant##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
at the plasma membrane##6##4##(1994-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)
at the platinum##2##3##(2008-10#2)
at the point of care##2##5##(1997-3#1)(2008-11#1)
at the point of##8##4##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-2#1)
at the point where##3##4##(2007-12#1)(2008-5#1)(2008-8#1)
at the point##11##3##(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)
at the points##2##3##(2008-3#2)
at the population level##8##4##(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#2)
at the population##10##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#2)(2011-2#1)
at the position corresponding to##2##5##(1991-12#1)(1996-5#1)
at the position of##3##4##(1997-7#1)(2008-8#2)
at the position##8##3##(1991-12#1)(1992-6#1)(1996-5#1)(1997-7#1)(2008-8#2)(2009-6#1)(2011-1#1)
at the post-translational level##2##4##(2008-8#1)(2013-1#1)
at the posterior##5##3##(1993-12#1)(2007-12#3)(2008-9#1)
at the posttranscriptional level##3##4##(1994-11#1)(2008-7#1)(2008-8#1)
at the potential of##4##4##(2008-10#4)
at the potential##6##3##(1992-12#1)(2008-10#4)(2009-2#1)
at the preclinical##2##3##(2008-10#1)(2010-10#1)
at the present time##7##4##(1992-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-6#2)
at the present##8##3##(1990-10#1)(1992-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-6#2)
at the previous##2##3##(1995-3#1)(2013-1#1)
at the primary care##2##4##(1993-9#1)(2011-1#1)
at the primary##11##3##(1993-2#1)(1993-9#1)(1994-5#1)(1995-3#1)(2008-10#2)(2011-1#1)(2011-2#2)(2012-2#2)
at the problem##2##3##(2008-7#1)(2013-8#1)
at the promoter##3##3##(2008-11#1)(2011-2#2)
at the proper##3##3##(1994-9#1)(2007-12#2)
at the protein level##5##4##(1990-5#1)(1994-11#1)(2008-10#1)(2011-10#1)(2013-1#1)
at the protein##9##3##(1990-5#1)(1992-3#1)(1994-11#1)(1996-10#1)(2008-10#1)(2008-7#1)(2011-10#1)(2011-2#1)(2013-1#1)
at the provincial level##4##4##(1994-12#1)(2008-8#1)(2012-12#2)
at the proximal##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
at the putative active site of XcTcmJ##2##7##(2010-10#2)
at the putative##4##3##(1990-10#1)(1991-9#1)(2010-10#2)
at the radial##2##3##(2008-10#1)(2009-6#1)
at the range of##3##4##(2008-10#3)
at the rate of 0##2##5##(2008-12#1)(2012-2#1)
at the rate of##8##4##(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
at the rate##9##3##(2007-10#1)(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
at the rates##2##3##(2008-10#1)(2008-9#1)
at the receiver##2##3##(2007-11#1)(2008-3#1)
at the receptor level##2##4##(1993-6#1)(2008-7#1)
at the receptor site##2##4##(1995-3#1)(2007-11#1)
at the receptor##5##3##(1993-6#1)(1995-3#1)(2007-11#1)(2008-7#1)(2012-2#1)
at the recommended##3##3##(2007-11#1)(2008-10#2)
at the recording wavelength##2##4##(2007-12#1)(2008-3#1)
at the recording##3##3##(2007-12#1)(2008-3#2)
at the records of##2##4##(1995-6#1)(2006-10#1)
at the red##2##3##(2008-2#1)(2008-3#1)
at the reducing end of##2##5##(1992-10#1)(1995-11#1)
at the reducing end##3##4##(1992-10#1)(1995-11#2)
at the reducing##4##3##(1992-10#1)(1994-5#1)(1995-11#2)
at the region##2##3##(1990-12#1)(2008-10#1)
at the regional and##2##4##(1992-5#1)(2008-4#1)
at the regional level##2##4##(1990-11#1)(2009-7#1)
at the regional scale##2##4##(2008-10#2)
at the regional##9##3##(1990-11#1)(1992-5#1)(1994-9#1)(1995-5#1)(2008-10#2)(2008-4#2)(2009-7#1)
at the regulatory##2##3##(2008-10#1)(2008-5#1)
at the relatively low##2##4##(2008-6#1)(2008-7#1)
at the relatively##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
at the remote site##3##4##(1990-5#1)(1997-4#2)
at the replication fork##2##4##(1991-12#2)
at the replication##3##3##(1991-12#2)(2012-3#1)
at the request of the##6##5##(1990-11#1)(1997-4#1)(2008-10#4)
at the request of##7##4##(1990-11#1)(1997-4#1)(2008-10#4)(2012-1#1)
at the research station##2##4##(2008-10#1)(2008-11#1)
at the research##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
at the resorptive##3##3##(1991-12#3)
at the retention time##2##4##(2008-10#1)(2008-11#1)
at the right middle cerebral artery##2##6##(2008-12#1)(2013-8#1)
at the right middle##3##4##(2008-12#1)(2013-1#1)(2013-8#1)
at the right time##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
at the right##14##3##(1990-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
at the root of##3##4##(1990-11#1)(2007-12#1)(2009-6#1)
at the root##5##3##(1990-11#1)(2007-12#1)(2008-10#2)(2009-6#1)
at the same age##3##4##(1990-11#1)(1991-11#1)(2012-2#1)
at the same concentration##6##4##(1992-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
at the same concentrations##4##4##(1994-8#1)(2008-10#2)(2008-11#1)
at the same dose##3##4##(1992-5#1)(1992-6#1)(2008-6#1)
at the same frequency##3##4##(1995-12#1)(2008-10#1)(2008-3#1)
at the same institution##3##4##(1990-6#1)(2008-9#1)(2011-2#1)
at the same level as control##2##6##(2008-9#1)(2012-12#1)
at the same level as##3##5##(2008-10#1)(2008-9#1)(2012-12#1)
at the same level in the##2##6##(2008-6#1)(2008-7#1)
at the same level of##2##5##(1993-12#1)(2008-1#1)
at the same level##9##4##(1993-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#1)
at the same location##3##4##(2008-3#2)(2011-1#1)
at the same locus##3##4##(1997-8#1)(2008-10#2)
at the same point##2##4##(1992-2#1)(1993-12#1)
at the same position##2##4##(1993-2#1)(2008-8#1)
at the same rate as##2##5##(1995-6#1)(2008-10#1)
at the same rate##4##4##(1991-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
at the same site as rotenone##2##6##(1990-5#2)
at the same site as##3##5##(1990-5#3)
at the same site##11##4##(1990-5#3)(1993-11#1)(1995-12#1)(1995-5#1)(2007-6#1)(2008-10#2)(2008-12#1)(2011-2#1)
at the same temperature##2##4##(2008-8#1)(2012-2#1)
at the same temperatures##2##4##(2008-10#1)(2008-6#1)
at the same time as the sample parameters##2##8##(2008-3#2)
at the same time as the##5##6##(1993-12#1)(2008-10#1)(2008-3#2)(2012-3#1)
at the same time as##7##5##(1993-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-3#1)
at the same time by##2##5##(2008-2#1)(2008-3#1)
at the same time that##3##5##(1990-4#1)(1995-3#1)(2010-3#1)
at the same time the##3##5##(2007-12#1)(2008-5#1)(2011-2#1)
at the same time to##5##5##(2008-1#1)(2008-10#3)(2013-1#1)
at the same time##102##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
at the same wavelength##2##4##(2008-10#1)(2008-3#1)
at the same##197##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#14)(2008-5#7)(2008-6#8)(2008-7#3)(2008-8#11)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
at the sample##2##3##(2008-3#1)(2011-2#1)
at the sampling unit scale##2##5##(2008-10#2)
at the sampling##5##3##(2008-10#4)(2008-3#1)
at the sampling-unit##2##3##(2008-10#2)
at the scale of the##3##5##(2008-10#2)(2008-7#1)
at the scale of##5##4##(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
at the scene##2##3##(1995-3#1)(2011-2#1)
at the scissile bond##2##4##(1990-5#1)(1995-5#1)
at the second base##2##4##(1992-8#1)(1994-11#1)
at the second##11##3##(1992-2#1)(1992-8#1)(1994-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2012-3#1)
at the secondary##2##3##(1992-11#1)(2010-3#1)
at the seedling and##3##4##(2008-10#2)(2008-12#1)
at the seedling stage and##2##5##(2008-10#2)
at the seedling stage##8##4##(2008-10#7)(2008-12#1)
at the seedling##12##3##(2008-10#10)(2008-12#2)
at the selected##3##3##(2008-10#2)(2008-8#1)
at the self-assembled electrode##2##4##(2008-10#2)
at the sensor surface##2##4##(2008-10#2)
at the separation##3##3##(2008-10#2)(2008-3#1)
at the seventh##2##3##(1993-8#1)(1994-11#1)
at the shelf-edge##2##3##(2011-2#2)
at the shortest##2##3##(1991-2#1)(2013-8#1)
at the single cell level and##2##6##(1997-4#1)(2011-2#1)
at the single cell level##4##5##(1990-12#1)(1997-4#1)(2007-12#1)(2011-2#1)
at the single##8##3##(1990-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)
at the single-cell level##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
at the site most distant from commercial potato production##2##9##(2008-10#2)
at the site of application in 3 mg/kg and greater males and##2##12##(2008-9#2)
at the site of application in dosed mice included##2##9##(2008-9#2)
at the site of application in dosed##3##7##(2008-9#3)
at the site of application in male##2##7##(2008-9#2)
at the site of application in##13##6##(2008-9#13)
at the site of application included##4##6##(2008-9#4)
at the site of application occurred in##6##7##(2008-9#6)
at the site of application##39##5##(2007-7#1)(2008-9#38)
at the site of implantation##2##5##(2010-10#1)(2012-1#1)
at the site of infection##6##5##(1996-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)
at the site of injection##3##5##(1992-6#1)(2011-1#2)
at the site of the##6##5##(1991-3#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-4#1)
at the site of##74##4##(1991-3#1)(1992-12#1)(1992-6#1)(1996-5#2)(1996-8#1)(1997-4#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#41)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-9#1)
at the site##80##3##(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1996-5#2)(1996-8#1)(1997-4#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#41)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-9#1)
at the sites of##4##4##(1990-5#1)(1994-5#1)(1996-12#1)(2013-7#1)
at the sites##8##3##(1990-5#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-5#2)(2011-1#1)(2013-7#1)
at the skin surface##3##4##(2008-5#3)
at the skin##5##3##(2008-10#1)(2008-5#3)(2012-2#1)
at the skull base##2##4##(2011-2#2)
at the solar##2##3##(2008-2#1)(2008-3#1)
at the source##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
at the species level##7##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-6#1)
at the species##9##3##(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-6#1)
at the specific##4##3##(1997-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
at the stage of##8##4##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-1#1)
at the stage##9##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
at the start of a##3##5##(1996-1#1)(2008-11#1)(2009-12#1)
at the start of the epidemic##2##6##(1990-6#1)(2008-10#1)
at the start of the study##2##6##(2008-5#1)(2010-3#1)
at the start of the##10##5##(1990-6#1)(1991-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
at the start of treatment##3##5##(1990-9#1)(2007-12#1)(2008-10#1)
at the start of##20##4##(1990-6#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-9#1)(1996-1#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
at the state and local level##3##6##(1996-12#1)(1997-2#1)(2011-9#1)
at the state and##5##4##(1996-12#1)(1997-1#1)(1997-2#1)(2010-9#1)(2011-9#1)
at the state level##2##4##(1994-12#1)(2008-8#1)
at the state##7##3##(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-8#1)(2010-9#1)(2011-9#1)
at the static mercury drop electrode##2##6##(2008-10#2)
at the structural level##2##4##(1994-2#1)(2008-5#1)
at the structure##2##3##(1994-1#1)(2008-3#1)
at the study site##2##4##(2008-10#2)
at the study##3##3##(1994-11#1)(2008-10#2)
at the surface of a##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
at the surface of the##8##5##(1990-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)
at the surface of##25##4##(1990-12#1)(1991-12#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2010-12#2)(2011-1#1)
at the surface##38##3##(1990-12#1)(1991-12#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#7)(2008-7#2)(2009-7#1)(2010-12#2)(2011-1#1)
at the surfaces of the##2##5##(2008-2#1)(2008-3#1)
at the surgical##2##3##(2010-3#1)(2010-6#1)
at the symposium##3##3##(2008-5#3)
at the synapse##3##3##(1991-12#1)(2009-8#1)(2009-9#1)
at the tail##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
at the target##9##3##(1990-11#1)(1995-1#1)(1997-2#1)(2007-11#2)(2008-11#1)(2008-3#2)(2010-10#1)
at the terminal##5##3##(2008-10#1)(2008-12#1)(2008-7#2)(2012-3#1)
at the test##2##3##(1992-2#1)(2008-9#1)
at the thalami##2##3##(2012-3#2)
at the third##3##3##(1990-12#1)(2007-11#1)(2008-6#1)
at the three##8##3##(1990-3#1)(1991-2#1)(1995-5#1)(2008-10#2)(2008-3#1)(2010-7#1)(2010-8#1)
at the tight##2##3##(1990-7#1)(2009-10#1)
at the time of admission##2##5##(1991-8#1)(1992-3#1)
at the time of colposcopy##2##5##(1992-3#2)
at the time of diagnosis##9##5##(1990-10#1)(1993-1#1)(1994-10#1)(1994-12#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)
at the time of discharge##2##5##(2008-11#1)(2008-3#1)
at the time of examination##2##5##(1991-12#1)(1997-8#1)
at the time of follow-up##2##5##(1997-2#1)(2013-1#1)
at the time of implantation##2##5##(2008-9#1)(2010-6#1)
at the time of initial presentation and##2##7##(2008-6#1)(2012-3#1)
at the time of initial##3##5##(1992-2#1)(2008-6#1)(2012-3#1)
at the time of inoculation##2##5##(2008-10#2)
at the time of presentation##5##5##(1995-10#1)(1997-8#1)(2007-7#1)(2010-12#1)(2012-3#1)
at the time of reperfusion##2##5##(1990-3#1)(1996-9#1)
at the time of sampling##2##5##(1992-12#1)(2008-5#1)
at the time of surgery##6##5##(1990-8#1)(1991-3#1)(1993-11#1)(2007-11#2)(2008-7#1)
at the time of the diagnosis##3##6##(1996-9#1)(2007-8#1)(2011-2#1)
at the time of the original##2##6##(2008-9#1)(2009-1#1)
at the time of the survey##4##6##(1991-2#1)(2009-2#1)(2013-1#2)
at the time of the##29##5##(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
at the time of their##4##5##(1995-6#1)(1996-12#1)(2010-1#1)(2012-3#1)
at the time of this##2##5##(1991-12#1)(1991-3#1)
at the time of transplantation##2##5##(2008-4#1)(2008-9#1)
at the time of##131##4##(1990-10#2)(1990-11#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#3)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-1#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#5)
at the time the##5##4##(1992-11#1)(1993-12#1)(1993-6#1)(1996-5#1)(2013-8#1)
at the time when##2##4##(2008-9#1)(2011-2#1)
at the time##148##3##(1990-10#2)(1990-11#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-10#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-9#3)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#6)(2009-1#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-9#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#5)(2013-8#1)
at the tip of a##4##5##(2007-12#1)(2008-10#1)(2008-3#2)
at the tip of the##8##5##(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2010-12#1)
at the tip of##12##4##(1994-12#1)(1995-3#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-5#1)(2010-12#1)
at the tip##13##3##(1994-12#1)(1995-3#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-5#2)(2010-12#1)
at the tips of##3##4##(2008-10#1)(2008-7#1)(2010-3#1)
at the tips##4##3##(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
at the tissue level##2##4##(1992-1#1)(2008-7#1)
at the tissue##5##3##(1992-1#1)(1992-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
at the titration end-point##2##4##(2008-10#2)
at the top of the##2##5##(1995-6#1)(2007-12#1)
at the top of##4##4##(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
at the top##9##3##(1994-6#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
at the transcript##2##3##(1990-5#1)(2013-8#1)
at the transcriptional level by##3##5##(2008-10#1)(2009-8#1)(2013-1#1)
at the transcriptional level##14##4##(1991-12#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
at the transition between##2##4##(2008-7#1)(2009-7#1)
at the transition##3##3##(2008-7#2)(2009-7#1)
at the translational level##3##4##(1991-12#2)(1992-8#1)
at the triangle##2##3##(2008-6#2)
at the turn of the##4##5##(1997-3#1)(2008-7#1)(2010-1#1)(2011-2#1)
at the turn of##6##4##(1997-3#2)(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)
at the two CO(2) concentrations in##2##6##(2008-10#2)
at the two##13##3##(1996-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
at the ultrastructural level##3##4##(1995-6#1)(2008-10#1)(2008-7#1)
at the university of##3##4##(2008-11#2)(2013-1#1)
at the university##4##3##(2008-11#2)(2010-5#1)(2013-1#1)
at the upper limit of the##2##6##(2008-2#1)(2013-1#1)
at the upper##7##3##(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#2)
at the upstream##4##3##(1995-2#1)(1996-3#1)(2008-1#1)(2008-9#1)
at the use of##2##4##(2008-7#1)(2013-8#1)
at the various##3##3##(2007-11#1)(2008-10#1)(2009-10#1)
at the ventral side of the##2##6##(1991-5#1)(2008-5#1)
at the ventral##3##3##(1991-5#1)(2007-12#1)(2008-5#1)
at the very least##2##4##(1992-12#1)(2008-9#1)
at the very##4##3##(1992-12#1)(1994-2#1)(2008-7#1)(2008-9#1)
at the vinylic positions##2##4##(2009-6#2)
at the water##3##3##(1990-7#2)(2008-10#1)
at the waveguide surface##2##4##(2008-10#2)
at the waveguide##3##3##(2007-9#1)(2008-10#2)
at the wavelength of##7##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
at the wavelength##9##3##(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
at the wavelengths##2##3##(2008-10#1)(2008-3#1)
at the whole##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
at the work place##2##4##(1995-2#1)(2009-12#1)
at the working##2##3##(2008-10#1)(2008-11#1)
at the workplace##2##3##(1997-4#1)(2012-3#1)
at the workshop##4##3##(2008-10#1)(2012-2#1)(2013-8#2)
at the wound site##4##4##(2008-10#3)(2008-9#1)
at the wound##5##3##(2008-10#4)(2008-9#1)
at the wrist##5##3##(2007-7#1)(2008-1#4)
at the young##3##3##(1997-6#2)(1997-8#1)
at the##4643##2##(1990-10#7)(1990-11#17)(1990-12#16)(1990-2#15)(1990-3#12)(1990-4#1)(1990-5#23)(1990-6#11)(1990-7#12)(1990-8#15)(1990-9#13)(1991-1#3)(1991-10#1)(1991-11#10)(1991-12#39)(1991-2#23)(1991-3#22)(1991-4#2)(1991-5#11)(1991-6#20)(1991-7#2)(1991-8#6)(1991-9#15)(1992-1#7)(1992-10#3)(1992-11#9)(1992-12#23)(1992-2#11)(1992-3#37)(1992-4#5)(1992-5#8)(1992-6#21)(1992-8#19)(1992-9#13)(1993-1#10)(1993-10#1)(1993-11#18)(1993-12#29)(1993-2#9)(1993-3#20)(1993-5#4)(1993-6#17)(1993-8#17)(1993-9#11)(1994-1#5)(1994-10#1)(1994-11#19)(1994-12#23)(1994-2#14)(1994-3#21)(1994-5#16)(1994-6#12)(1994-7#5)(1994-8#22)(1994-9#21)(1995-1#5)(1995-10#1)(1995-11#17)(1995-12#25)(1995-2#24)(1995-3#27)(1995-4#1)(1995-5#21)(1995-6#20)(1995-8#18)(1995-9#3)(1996-1#12)(1996-10#2)(1996-11#2)(1996-12#24)(1996-2#17)(1996-3#11)(1996-4#6)(1996-5#26)(1996-6#11)(1996-7#1)(1996-8#2)(1996-9#14)(1997-1#8)(1997-2#23)(1997-3#45)(1997-4#36)(1997-5#10)(1997-6#20)(1997-7#15)(1997-8#15)(2006-10#5)(2006-12#1)(2006-6#3)(2006-8#3)(2007-1#1)(2007-10#14)(2007-11#82)(2007-12#117)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#12)(2007-6#1)(2007-7#25)(2007-8#36)(2007-9#3)(2008-1#44)(2008-10#823)(2008-11#212)(2008-12#78)(2008-2#124)(2008-3#265)(2008-4#62)(2008-5#134)(2008-6#46)(2008-7#142)(2008-8#102)(2008-9#136)(2009-1#1)(2009-10#19)(2009-11#15)(2009-12#14)(2009-2#5)(2009-3#9)(2009-4#11)(2009-5#9)(2009-6#20)(2009-7#15)(2009-8#20)(2009-9#13)(2010-1#16)(2010-10#18)(2010-11#8)(2010-12#16)(2010-2#6)(2010-3#21)(2010-4#12)(2010-5#11)(2010-6#14)(2010-7#11)(2010-8#19)(2010-9#10)(2011-1#43)(2011-10#2)(2011-2#176)(2011-3#1)(2011-4#2)(2011-9#1)(2012-1#9)(2012-12#41)(2012-2#103)(2012-3#57)(2012-4#1)(2012-6#1)(2012-7#2)(2012-9#2)(2013-1#121)(2013-3#1)(2013-7#21)(2013-8#57)
at their disposal##2##3##(1994-3#1)(2012-12#1)
at their first##3##3##(1990-6#1)(1994-2#1)(2010-1#1)
at their own##2##3##(1993-3#1)(2009-4#1)
at their surface##2##3##(2008-1#1)(2012-2#1)
at their##52##2##(1990-6#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#5)(1994-2#1)(1994-3#1)(1995-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
at therapeutic concentrations##2##3##(1994-8#1)(2010-3#1)
at therapeutic##3##2##(1994-8#1)(2008-3#1)(2010-3#1)
at thermal##3##2##(1993-8#1)(2007-12#1)(2008-11#1)
at these concentrations##2##3##(2008-11#2)
at these loci##3##3##(1993-6#1)(1995-2#1)(2008-10#1)
at these low##2##3##(2008-10#1)(2008-7#1)
at these receptors##2##3##(2008-8#2)
at these sites##6##3##(1992-6#1)(1995-8#1)(2007-12#1)(2008-10#2)(2012-2#1)
at these two##4##3##(1991-9#1)(2007-12#1)(2007-6#1)(2008-4#1)
at these wavelengths##2##3##(2007-11#1)(2008-3#1)
at these##50##2##(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at this age##3##3##(2007-8#1)(2008-7#1)(2009-5#1)
at this concentration##3##3##(1992-12#1)(2008-10#1)(2008-6#1)
at this dose##3##3##(1990-6#1)(1992-12#1)(2013-1#1)
at this electrode##2##3##(2008-10#2)
at this hospital##4##3##(1990-11#1)(1990-3#1)(1995-3#1)(2011-2#1)
at this institution##2##3##(2008-6#1)(2008-8#1)
at this level##5##3##(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
at this location##2##3##(2008-10#1)(2008-5#1)
at this locus##5##3##(1993-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)
at this meeting##3##3##(2008-5#2)(2011-2#1)
at this modified electrode##3##4##(2008-10#3)
at this pH##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
at this point to##2##4##(2008-10#1)(2008-11#1)
at this point##6##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
at this position was##2##4##(2008-4#1)(2009-8#1)
at this position##9##3##(1990-12#1)(1994-5#1)(1995-2#1)(2008-12#1)(2008-4#2)(2008-8#2)(2009-8#1)
at this site##10##3##(1990-11#1)(1993-3#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-2#1)
at this stage##7##3##(1994-2#1)(2007-8#2)(2008-11#2)(2008-8#1)(2008-9#1)
at this task##2##3##(2008-7#1)(2009-9#1)
at this time##17##3##(1990-12#1)(1991-1#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-3#2)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2013-1#1)
at this wavelength##3##3##(2007-12#2)(2008-10#1)
at this##131##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#1)(1991-1#2)(1991-3#1)(1992-12#2)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#4)(1994-2#2)(1994-5#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#3)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#6)
at those##6##2##(1995-1#1)(1996-2#1)(2008-3#2)(2008-5#1)(2008-9#1)
at three concentration levels##2##4##(2008-10#2)
at three different concentration levels##2##5##(2008-10#2)
at three different sites in##2##5##(2008-10#1)(2008-8#1)
at three different##20##3##(1995-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
at three levels##4##3##(1994-12#1)(1997-7#1)(2008-11#1)(2011-1#1)
at three months##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
at three or##2##3##(2008-10#1)(2008-3#1)
at three sites##2##3##(2008-10#1)(2008-5#1)
at three years of##2##4##(1991-4#1)(2012-3#1)
at three years was##2##4##(2007-8#2)
at three years##4##3##(1991-4#1)(2007-8#2)(2012-3#1)
at three##84##2##(1991-4#1)(1991-9#1)(1993-2#1)(1993-6#2)(1994-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#4)(2008-8#3)(2008-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
at time 3##2##3##(2008-11#2)
at time of##10##3##(1992-12#1)(1992-5#1)(1995-11#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)
at time points##2##3##(1994-11#1)(2008-4#1)
at time##20##2##(1992-12#1)(1992-5#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)
at times of##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
at times##19##2##(1991-12#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
at total##2##2##(1990-7#1)(1996-2#1)
at trace concentration levels##3##4##(2008-10#3)
at trace concentrations##2##3##(2008-10#2)
at trace level##5##3##(2008-10#5)
at trace levels by##2##4##(2008-10#2)
at trace levels in##5##4##(2008-10#5)
at trace levels##22##3##(2008-10#22)
at trace##33##2##(2008-10#33)
at transcriptional##3##2##(1992-8#1)(2008-4#1)(2008-9#1)
at translational level##3##3##(2008-8#3)
at treatment##3##2##(1996-11#1)(2007-1#1)(2013-1#1)
at twice the##4##3##(1994-8#1)(2007-11#1)(2008-2#2)
at twice##5##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#2)
at two and##2##3##(2008-1#1)(2008-11#1)
at two angles##2##3##(2008-2#2)
at two concentrations of##2##4##(2008-10#1)(2008-5#1)
at two concentrations##3##3##(2008-10#2)(2008-5#1)
at two different concentrations##2##4##(2008-10#2)
at two different levels##2##4##(1991-6#1)(2008-7#1)
at two different##17##3##(1990-12#1)(1991-6#1)(1992-8#1)(2007-12#4)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
at two distinct times##2##4##(2008-3#1)(2008-4#1)
at two distinct##5##3##(1990-5#2)(1994-12#1)(2008-3#1)(2008-4#1)
at two field locations##2##4##(2008-10#1)(2008-11#1)
at two field##3##3##(2008-10#2)(2008-11#1)
at two frequencies##3##3##(2008-3#2)(2010-7#1)
at two large##2##3##(2008-1#1)(2008-9#1)
at two levels##5##3##(1994-12#1)(1996-12#1)(2008-10#2)(2009-8#1)
at two locations in eastern##2##5##(2008-10#2)
at two locations in##4##4##(2007-5#1)(2008-10#3)
at two locations##7##3##(2007-5#1)(2008-10#6)
at two orthogonal##2##3##(2008-2#1)(2008-3#1)
at two points##2##3##(2007-1#1)(2007-12#1)
at two sampling times##2##4##(2008-10#2)
at two sites##3##3##(1991-8#1)(2008-10#2)
at two spatial scales##2##4##(2008-10#1)(2010-8#1)
at two time points##2##4##(2010-1#2)
at two wavelengths##9##3##(2008-10#2)(2008-2#2)(2008-3#4)(2008-9#1)
at two##121##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#3)(1997-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-12#7)(2007-5#1)(2008-1#2)(2008-10#29)(2008-11#4)(2008-2#9)(2008-3#13)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
at two-week intervals##2##3##(1994-7#1)(2008-5#1)
at typical##3##2##(2008-10#2)(2008-2#1)
at tyrosine residues##3##3##(1990-12#1)(1994-11#1)(2011-2#1)
at tyrosine##4##2##(1990-12#1)(1992-3#1)(1994-11#1)(2011-2#1)
at ultratrace##2##2##(2008-10#2)
at up to##4##3##(2007-11#2)(2007-12#1)(2008-11#1)
at urban##2##2##(2008-10#1)(2010-8#1)
at values of##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
at values##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
at variable##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
at variance with##4##3##(1990-3#1)(1996-5#1)(2008-8#1)(2009-6#1)
at various ages##2##3##(1996-1#1)(2008-5#1)
at various concentrations of##3##4##(1995-8#1)(1997-8#1)(2008-10#1)
at various concentrations##7##3##(1993-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#3)
at various degrees of##2##4##(2008-3#1)(2008-7#1)
at various degrees##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
at various distances##3##3##(1997-2#1)(2008-10#1)(2009-2#1)
at various levels##4##3##(2008-2#1)(2009-4#2)(2011-2#1)
at various locations##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
at various pH values##2##4##(1991-8#1)(2008-10#1)
at various pH##3##3##(1991-8#1)(2008-10#2)
at various pHs##2##3##(1992-12#1)(2008-10#1)
at various phi values##2##4##(1996-12#2)
at various stages of##11##4##(1994-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
at various stages##15##3##(1994-11#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
at various temperatures and##2##4##(1992-6#1)(2008-10#1)
at various temperatures in##2##4##(2008-10#1)(2011-2#1)
at various temperatures##14##3##(1990-2#1)(1990-9#1)(1992-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#2)
at various time intervals after##3##5##(2008-10#2)(2008-5#1)
at various time intervals over##2##5##(2008-11#1)(2008-5#1)
at various time intervals##7##4##(2008-10#2)(2008-11#1)(2008-5#3)(2010-2#1)
at various time points##2##4##(2008-1#1)(2013-7#1)
at various time##9##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2010-2#1)(2013-7#1)
at various times after##3##4##(2008-10#2)(2012-1#1)
at various times during##2##4##(1992-9#1)(2008-2#1)
at various times throughout the##2##5##(1992-1#1)(2008-5#1)
at various times##13##3##(1992-1#1)(1992-9#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-8#1)(2012-1#1)
at various wavelengths##2##3##(2008-10#1)(2008-3#1)
at various##134##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-2#2)(1997-4#1)(1997-8#2)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#39)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
at varying levels##2##3##(2008-11#1)(2009-4#1)
at varying##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-8#1)
at vegetative##2##2##(2012-2#1)(2013-8#1)
at very high levels##3##4##(1992-8#1)(2008-10#2)
at very high##12##3##(1990-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-9#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
at very low concentration##3##4##(2008-10#2)(2008-7#1)
at very low concentrations##10##4##(1990-12#1)(1991-5#1)(1992-11#1)(1994-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2013-1#1)
at very low levels of##2##5##(1993-8#1)(2008-11#1)
at very low levels##8##4##(1993-8#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-9#1)
at very low##34##3##(1990-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#2)(1997-6#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#2)(2013-1#2)
at very##51##2##(1990-12#2)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#2)(1994-9#1)(1996-1#1)(1996-12#1)(1997-6#1)(2008-10#12)(2008-11#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
at video##4##2##(2007-12#2)(2008-3#2)
at visible wavelengths##2##3##(2007-12#1)(2008-7#1)
at visible##4##2##(2007-12#2)(2008-3#1)(2008-7#1)
at ward##4##2##(2010-3#3)(2013-8#1)
at wavelength##2##2##(1997-2#1)(2008-10#1)
at wavelengths from 1##2##4##(2007-12#1)(2008-3#1)
at wavelengths from##6##3##(1996-5#1)(2007-11#1)(2007-12#3)(2008-3#1)
at wavelengths longer than##3##4##(1991-5#1)(2008-3#2)
at wavelengths near##2##3##(2007-12#1)(2008-3#1)
at wavelengths of 0##2##4##(2008-2#1)(2008-3#1)
at wavelengths of 1##2##4##(2007-11#1)(2008-2#1)
at wavelengths of##17##3##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#9)
at wavelengths##32##2##(1991-5#1)(1996-5#1)(2007-11#4)(2007-12#6)(2008-2#6)(2008-3#14)
at week 10##3##3##(2013-1#3)
at week 11##2##3##(2013-1#2)
at week 12##5##3##(2008-5#2)(2013-1#2)(2013-8#1)
at week 4##3##3##(2008-5#2)(2013-1#1)
at week##17##2##(1991-6#1)(2008-4#1)(2008-5#4)(2008-7#1)(2013-1#9)(2013-8#1)
at weekly intervals##4##3##(1994-7#1)(2008-10#2)(2008-6#1)
at weeks 4##2##3##(2008-5#2)
at weeks##4##2##(2008-11#1)(2008-5#2)(2011-2#1)
at what cost?##2##3##(1996-3#1)(2011-2#1)
at what##11##2##(1993-11#1)(1994-12#2)(1996-3#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)
at whatever##2##2##(1992-3#1)(1996-12#1)
at which a##7##3##(1992-5#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#1)
at which each##2##3##(2008-7#1)(2008-8#1)
at which no##2##3##(2008-3#1)(2008-7#1)
at which point##2##3##(2008-3#1)(2013-8#1)
at which protein function##2##4##(2009-5#1)(2011-2#1)
at which the virus was acquired##2##6##(2008-10#2)
at which the##45##3##(1991-12#1)(1991-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-2#1)(2010-8#1)(2013-1#1)
at which there is##2##4##(2008-3#2)
at which they are##2##4##(1991-8#1)(2008-2#1)
at which they##5##3##(1991-8#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
at which this##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
at which time##2##3##(1992-12#1)(2013-1#1)
at which##148##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-6#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#5)(2008-2#7)(2008-3#17)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#5)(2009-10#1)(2009-5#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#3)
at wide##2##2##(2008-10#1)(2013-7#1)
at will##3##2##(1994-6#1)(1995-12#1)(2008-10#1)
at women##2##2##(2008-1#1)(2008-4#1)
at work and##2##3##(1994-11#1)(2009-10#1)
at work in##5##3##(1993-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)
at work predicted##2##3##(2011-1#2)
at work##32##2##(1991-1#1)(1993-3#1)(1994-11#2)(1995-12#1)(1995-8#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#2)(2010-4#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
at www##3##2##(2008-3#1)(2009-12#1)(2010-3#1)
at year##6##2##(2008-7#1)(2013-1#5)
at year-end 2009##4##3##(2011-2#4)
at year-end##7##2##(2011-2#7)
at young age##3##3##(2007-10#2)(2013-8#1)
at young##5##2##(1993-12#1)(2007-10#2)(2008-3#1)(2013-8#1)
at younger ages##2##3##(2007-10#1)(2008-3#1)
at younger##3##2##(2007-10#1)(2007-7#1)(2008-3#1)
at your##2##2##(1993-3#1)(1994-3#1)
at zero##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-1#1)
at zero-crossing##2##2##(2008-10#2)
at ~1##2##2##(2007-11#1)(2007-12#1)
at##21386##1##(1990-10#11)(1990-11#82)(1990-12#91)(1990-2#60)(1990-3#43)(1990-4#10)(1990-5#116)(1990-6#34)(1990-7#75)(1990-8#90)(1990-9#45)(1991-1#22)(1991-10#4)(1991-11#41)(1991-12#110)(1991-2#83)(1991-3#57)(1991-4#7)(1991-5#51)(1991-6#56)(1991-7#5)(1991-8#52)(1991-9#72)(1992-1#23)(1992-10#15)(1992-11#43)(1992-12#106)(1992-2#50)(1992-3#143)(1992-4#21)(1992-5#39)(1992-6#111)(1992-7#6)(1992-8#75)(1992-9#67)(1993-1#30)(1993-10#3)(1993-11#102)(1993-12#112)(1993-2#46)(1993-3#107)(1993-5#10)(1993-6#79)(1993-8#107)(1993-9#70)(1994-1#23)(1994-10#4)(1994-11#89)(1994-12#83)(1994-2#70)(1994-3#121)(1994-5#66)(1994-6#76)(1994-7#27)(1994-8#104)(1994-9#55)(1995-1#19)(1995-10#2)(1995-11#85)(1995-12#113)(1995-2#159)(1995-3#118)(1995-4#5)(1995-5#92)(1995-6#104)(1995-8#84)(1995-9#12)(1996-1#42)(1996-10#7)(1996-11#19)(1996-12#113)(1996-2#108)(1996-3#50)(1996-4#18)(1996-5#108)(1996-6#26)(1996-7#4)(1996-8#11)(1996-9#29)(1997-1#40)(1997-2#136)(1997-3#134)(1997-4#94)(1997-5#36)(1997-6#76)(1997-7#80)(1997-8#66)(1997-9#3)(2006-10#25)(2006-11#2)(2006-12#7)(2006-4#2)(2006-5#2)(2006-6#15)(2006-8#12)(2006-9#1)(2007-1#3)(2007-10#100)(2007-11#423)(2007-12#575)(2007-2#35)(2007-3#3)(2007-4#9)(2007-5#47)(2007-6#24)(2007-7#90)(2007-8#119)(2007-9#9)(2008-1#173)(2008-10#4975)(2008-11#748)(2008-12#350)(2008-2#633)(2008-3#1280)(2008-4#214)(2008-5#492)(2008-6#268)(2008-7#587)(2008-8#439)(2008-9#427)(2009-1#9)(2009-10#74)(2009-11#53)(2009-12#51)(2009-2#26)(2009-3#36)(2009-4#32)(2009-5#62)(2009-6#50)(2009-7#62)(2009-8#74)(2009-9#58)(2010-1#50)(2010-10#63)(2010-11#51)(2010-12#50)(2010-2#38)(2010-3#96)(2010-4#87)(2010-5#88)(2010-6#43)(2010-7#39)(2010-8#98)(2010-9#21)(2011-1#200)(2011-10#3)(2011-2#637)(2011-3#24)(2011-4#2)(2011-7#2)(2011-9#1)(2012-1#47)(2012-12#216)(2012-2#350)(2012-3#246)(2012-4#6)(2012-5#8)(2012-6#3)(2012-7#9)(2012-8#3)(2012-9#2)(2013-1#606)(2013-3#2)(2013-7#69)(2013-8#257)
at-home##2##1##(1997-2#1)(2010-4#1)
at-line##2##1##(2008-10#1)(2008-11#1)
at-risk group##3##2##(2007-6#1)(2013-1#2)
at-risk individuals##2##2##(1997-1#1)(2009-12#1)
at-risk infants##2##2##(1991-12#1)(2010-10#1)
at-risk populations##3##2##(1996-3#1)(2008-8#1)(2009-9#1)
at-risk##21##1##(1991-12#2)(1994-2#1)(1996-3#2)(1997-1#2)(1997-3#1)(1997-5#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-7#1)
at-risk&quot##4##1##(1991-12#1)(1993-3#1)(2012-3#2)
at-wavelength##3##1##(2008-3#3)
ataxia and##6##2##(2008-7#1)(2008-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
ataxia in South Africa##3##4##(1997-5#3)
ataxia in##4##2##(1997-5#3)(2013-1#1)
ataxia telangiectasia##4##2##(2008-7#4)
ataxia##33##1##(1991-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-5#4)(1997-8#2)(2008-3#1)(2008-6#2)(2008-7#9)(2008-9#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
ataxias##12##1##(2008-6#4)(2008-7#6)(2012-3#2)
ataxic and##2##2##(1996-2#1)(2012-2#1)
ataxic##4##1##(1996-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
atc6-1##2##1##(2009-10#2)
ate 5 or more servings of fruits and vegetables##2##9##(2011-1#2)
ate##5##1##(1991-6#1)(1993-3#1)(1994-12#1)(2011-1#2)
atelectasis##4##1##(1991-3#2)(1997-3#1)(2006-10#1)
atenolol and##2##2##(1995-6#1)(2008-10#1)
atenolol oxidation##3##2##(2008-10#3)
atenolol##15##1##(1992-4#1)(1992-5#1)(1992-6#2)(1995-12#1)(1995-6#2)(2008-10#8)
atherogenesis and##3##2##(1990-7#1)(1991-12#1)(1991-8#1)
atherogenesis in##2##2##(1990-12#1)(1990-2#1)
atherogenesis##21##1##(1990-12#1)(1990-2#4)(1990-7#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-5#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-5#1)(2013-1#1)
atherogenic dyslipidaemia##3##2##(2012-2#3)
atherogenic dyslipidemia##2##2##(2008-3#2)
atherogenic index##2##2##(2008-12#2)
atherogenic lipoprotein##2##2##(1992-3#1)(2013-7#1)
atherogenic##27##1##(1990-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-9#2)(2009-10#1)(2012-2#3)(2013-1#1)(2013-7#2)
atheroma##11##1##(1991-11#1)(2008-3#1)(2008-8#8)(2012-2#1)
atheromatous lesions##2##2##(1990-9#1)(1992-6#1)
atheromatous##9##1##(1990-9#2)(1992-6#1)(1997-8#1)(2008-1#1)(2009-5#2)(2010-12#1)(2012-3#1)
atherosclerosis (P less than 0##2##5##(1991-9#2)
atherosclerosis and cardiovascular disease (CVD)##2##5##(2008-1#1)(2008-6#1)
atherosclerosis and cardiovascular disease##4##4##(2008-1#1)(2008-6#3)
atherosclerosis and cardiovascular diseases##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
atherosclerosis and cardiovascular##8##3##(2008-1#2)(2008-10#1)(2008-6#3)(2008-7#1)(2012-2#1)
atherosclerosis and coronary heart disease##3##5##(2008-12#1)(2008-3#1)(2012-3#1)
atherosclerosis and osteoporosis##3##3##(2012-2#3)
atherosclerosis and postangioplasty restenosis##4##4##(2008-4#4)
atherosclerosis and the##2##3##(2008-12#1)(2012-2#1)
atherosclerosis and##49##2##(1990-2#1)(1995-12#1)(1995-8#1)(1997-8#1)(2007-10#3)(2008-1#5)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#6)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#2)
atherosclerosis by##2##2##(1996-2#1)(2008-7#1)
atherosclerosis has##3##2##(1997-8#1)(2008-12#1)(2008-7#1)
atherosclerosis in patients with##2##4##(2008-1#1)(2008-11#1)
atherosclerosis in the ascending aorta##4##5##(2007-8#4)
atherosclerosis in the##7##3##(2007-8#4)(2008-1#1)(2008-3#1)(2013-1#1)
atherosclerosis in##17##2##(2007-10#1)(2007-8#4)(2008-1#3)(2008-11#1)(2008-3#4)(2008-7#2)(2011-2#1)(2013-1#1)
atherosclerosis is a common##2##4##(2008-1#1)(2008-8#1)
atherosclerosis is a##4##3##(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)
atherosclerosis is##11##2##(1994-6#1)(1995-12#1)(1997-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-8#2)(2010-12#1)(2013-8#1)
atherosclerosis or##4##2##(1994-5#1)(2007-10#1)(2008-1#1)(2008-3#1)
atherosclerosis plaque##2##2##(2012-3#2)
atherosclerosis plaques##5##2##(2012-3#5)
atherosclerosis progression##2##2##(2008-3#1)(2012-2#1)
atherosclerosis with##2##2##(2008-1#1)(2010-8#1)
atherosclerosis##251##1##(1990-2#2)(1991-12#1)(1991-6#1)(1991-9#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-8#10)(2007-10#12)(2007-8#12)(2007-9#1)(2008-1#20)(2008-10#6)(2008-11#9)(2008-12#5)(2008-2#1)(2008-3#26)(2008-4#9)(2008-5#3)(2008-6#12)(2008-7#19)(2008-8#12)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#5)(2009-8#1)(2010-12#1)(2010-5#3)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#13)(2012-3#10)(2013-1#5)(2013-7#1)(2013-8#4)
atherosclerosis]##2##1##(2009-5#1)(2010-12#1)
atherosclerotic arteries##3##2##(2008-4#3)
atherosclerotic changes##3##2##(2008-4#1)(2011-2#2)
atherosclerotic coronary##2##2##(2007-9#1)(2008-1#1)
atherosclerotic disease and##2##3##(1991-6#1)(1996-2#1)
atherosclerotic disease##15##2##(1991-6#2)(1992-9#1)(1995-2#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-12#1)(2012-2#1)
atherosclerotic human##3##2##(1993-3#2)(1994-8#1)
atherosclerotic involvement of##2##3##(1991-5#1)(1993-3#1)
atherosclerotic lesions are##2##3##(1991-5#1)(1997-8#1)
atherosclerotic lesions in##5##3##(2008-3#1)(2008-7#3)(2011-1#1)
atherosclerotic lesions##19##2##(1991-2#1)(1991-5#1)(1992-5#1)(1993-3#1)(1996-3#1)(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#4)(2010-8#1)(2010-9#2)(2011-1#3)(2013-1#1)
atherosclerotic nephropathy##2##2##(1990-9#2)
atherosclerotic patients##3##2##(1991-9#1)(2008-7#2)
atherosclerotic plaque##13##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#4)(2011-2#2)
atherosclerotic plaques and##3##3##(1991-9#1)(1993-6#1)(2008-7#1)
atherosclerotic plaques##9##2##(1991-3#1)(1991-9#1)(1993-6#1)(1997-8#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-8#1)
atherosclerotic process##5##2##(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
atherosclerotic processes##2##2##(1995-12#1)(2008-7#1)
atherosclerotic progression##3##2##(2009-5#3)
atherosclerotic vascular disease##6##3##(2008-3#3)(2011-2#1)(2012-2#2)
atherosclerotic vascular##7##2##(2008-1#1)(2008-3#3)(2011-2#1)(2012-2#2)
atherosclerotic vessels##2##2##(2007-8#1)(2012-2#1)
atherosclerotic##113##1##(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-5#1)(1992-9#1)(1993-3#4)(1993-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-8#2)(2006-6#1)(2007-10#4)(2007-11#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#3)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#13)(2008-8#3)(2009-5#4)(2010-8#1)(2010-9#7)(2011-1#5)(2011-2#7)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
atherothrombosis##3##1##(2008-3#1)(2011-2#2)
atherothrombotic disease##2##2##(2011-1#1)(2011-2#1)
atherothrombotic##5##1##(2008-3#2)(2011-1#1)(2011-2#2)
athlete identity##2##2##(2010-7#2)
athlete is##2##2##(2010-1#1)(2012-3#1)
athlete triad##3##2##(2010-1#3)
athlete##21##1##(1993-3#2)(2008-8#3)(2009-1#1)(2010-1#4)(2010-7#2)(2011-1#1)(2011-2#6)(2012-3#2)
athlete's##2##1##(2008-8#1)(2010-1#1)
athletes aged##2##2##(2010-1#1)(2013-1#1)
athletes alike##2##2##(2008-5#1)(2008-8#1)
athletes and asthmatic individuals with EIB##2##6##(2010-1#2)
athletes and##7##2##(2010-1#2)(2010-7#1)(2012-1#1)(2012-12#2)(2013-1#1)
athletes are##2##2##(2008-5#2)
athletes as##2##2##(1993-3#1)(2008-5#1)
athletes for##2##2##(2008-5#1)(2009-9#1)
athletes from##2##2##(2009-11#1)(2012-2#1)
athletes have##3##2##(2008-5#3)
athletes may##3##2##(2010-1#1)(2012-12#1)(2013-1#1)
athletes often##3##2##(2008-5#2)(2010-1#1)
athletes participating in##2##3##(2008-5#1)(2010-1#1)
athletes who##2##2##(1995-6#1)(1996-6#1)
athletes with##5##2##(1996-6#1)(2008-5#1)(2010-1#1)(2010-12#1)(2013-1#1)
athletes##90##1##(1990-6#1)(1993-3#2)(1995-1#1)(1995-6#2)(1996-6#3)(2008-5#22)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#3)(2009-9#1)(2010-1#12)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-1#7)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#15)(2013-8#1)
athletes'##3##1##(1993-3#1)(2010-7#1)(2012-12#1)
athletic injuries##2##2##(1994-3#1)(2008-8#1)
athletic performance##3##2##(1994-2#1)(2008-5#1)(2013-1#1)
athletic##12##1##(1994-2#2)(1994-3#1)(2008-5#2)(2008-8#1)(2009-1#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#2)
athleticism##3##1##(2009-7#3)
athymic mice##8##2##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-9#1)(1997-7#1)
athymic##10##1##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-1#1)(1997-7#1)(2008-10#1)
atlantica and##2##2##(2008-10#1)(2010-2#1)
atlantica##4##1##(2008-10#3)(2010-2#1)
atlanticus##5##1##(2008-5#5)
atlanto-occipital dissociation##2##2##(2012-12#2)
atlantoaxial fusion##3##2##(2012-12#3)
atlantoaxial##7##1##(2006-10#1)(2008-12#2)(2012-12#3)(2012-3#1)
atlas is##3##2##(2008-2#2)(2013-1#1)
atlas of##2##2##(1997-2#1)(2008-2#1)
atlas##16##1##(1997-2#1)(1997-4#2)(2008-2#5)(2008-8#2)(2012-3#1)(2013-1#5)
atm of##4##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#1)
atm##10##1##(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#5)
atm)##4##1##(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#1)
atmosphere and to##2##3##(2008-10#1)(2008-3#1)
atmosphere and##17##2##(1992-2#1)(1992-3#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-2#6)(2008-3#4)
atmosphere are##6##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
atmosphere at##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
atmosphere between##2##2##(1992-7#1)(2008-3#1)
atmosphere by honeycomb##2##3##(2008-10#2)
atmosphere by##5##2##(1992-7#1)(2008-10#3)(2008-2#1)
atmosphere from the##2##3##(2008-11#1)(2008-2#1)
atmosphere from##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
atmosphere in##3##2##(2007-2#1)(2008-11#1)(2008-3#1)
atmosphere is described##2##3##(2008-10#1)(2008-2#1)
atmosphere is##8##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
atmosphere of Venus##2##3##(1992-7#1)(2008-3#1)
atmosphere of the##4##3##(2008-5#2)(2012-2#1)(2012-3#1)
atmosphere of##14##2##(1992-7#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#3)(2012-2#1)(2012-3#1)(2013-1#1)
atmosphere that is##2##3##(1991-12#1)(2007-11#1)
atmosphere that##4##2##(1991-12#1)(2007-11#1)(2008-3#2)
atmosphere where the##2##3##(2008-10#1)(2008-3#1)
atmosphere with##12##2##(2008-10#1)(2008-2#5)(2008-3#6)
atmosphere##202##1##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#3)(1995-3#3)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-11#7)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#30)(2008-11#15)(2008-12#1)(2008-2#44)(2008-3#65)(2008-4#1)(2008-5#5)(2010-11#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
atmosphere-ocean system##5##2##(2008-2#3)(2008-3#2)
atmospheres containing##2##2##(1996-12#1)(2008-2#1)
atmospheres in##2##2##(2008-10#2)
atmospheres with##2##2##(2008-2#1)(2008-3#1)
atmospheres##26##1##(1993-12#1)(1996-12#4)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#6)(2009-7#1)(2010-4#1)(2011-2#1)
atmospheric CO(2) and##2##3##(2008-2#1)(2009-8#1)
atmospheric CO(2) concentration##2##3##(2008-10#1)(2012-12#1)
atmospheric CO(2)##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)
atmospheric CO2##4##2##(2008-3#1)(2013-8#3)
atmospheric absorption##3##2##(2008-2#1)(2008-3#2)
atmospheric aerosol##14##2##(2008-10#6)(2008-2#3)(2008-3#5)
atmospheric aerosols at##3##3##(2008-2#1)(2008-3#2)
atmospheric aerosols covered by molecules##2##5##(2008-3#2)
atmospheric aerosols##12##2##(2008-10#1)(2008-2#6)(2008-3#5)
atmospheric air##3##2##(2008-3#1)(2013-8#2)
atmospheric and##8##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
atmospheric backscatter##4##2##(2008-2#2)(2008-3#2)
atmospheric boundary layer##5##3##(2008-2#1)(2008-3#4)
atmospheric carbon monoxide##2##3##(2008-3#2)
atmospheric carbon##3##2##(2008-3#2)(2013-8#1)
atmospheric chemistry and##2##3##(2008-11#2)
atmospheric chemistry##5##2##(1996-1#1)(2008-11#2)(2008-3#2)
atmospheric conditions##11##2##(2008-11#1)(2008-2#6)(2008-3#4)
atmospheric constituents##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
atmospheric correction algorithm##4##3##(2008-3#4)
atmospheric correction algorithms##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
atmospheric correction and aerosol retrieval algorithms##2##6##(2008-2#2)
atmospheric correction and##3##3##(2008-2#2)(2008-3#1)
atmospheric correction methods##2##3##(2013-8#2)
atmospheric correction results##2##3##(2013-8#2)
atmospheric correction##20##2##(2007-11#1)(2008-2#5)(2008-3#7)(2013-8#7)
atmospheric density##3##2##(2008-2#1)(2008-3#2)
atmospheric effects##2##2##(2008-3#2)
atmospheric emission##3##2##(2008-2#2)(2008-3#1)
atmospheric events##2##2##(2008-10#2)
atmospheric extinction##2##2##(2008-2#1)(2008-3#1)
atmospheric gases##3##2##(2008-3#2)(2008-8#1)
atmospheric ice crystals##2##3##(2008-3#2)
atmospheric layers##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
atmospheric measurements##5##2##(2008-2#1)(2008-3#4)
atmospheric model contains##2##3##(2008-2#1)(2008-3#1)
atmospheric model including##2##3##(2008-2#1)(2008-3#1)
atmospheric model##7##2##(2008-2#3)(2008-3#4)
atmospheric nitrogen##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
atmospheric optical parameters##3##3##(2008-2#2)(2008-3#1)
atmospheric optical phenomena##2##3##(2008-3#2)
atmospheric optical##7##2##(2008-2#3)(2008-3#4)
atmospheric optics##4##2##(2008-2#2)(2008-3#2)
atmospheric oxygen##2##2##(2008-10#2)
atmospheric parameters##6##2##(2008-2#1)(2008-3#5)
atmospheric particles##2##2##(2008-3#2)
atmospheric particulate matter##4##3##(2008-10#3)(2008-3#1)
atmospheric particulate##6##2##(2008-10#4)(2008-3#2)
atmospheric path##2##2##(2008-3#2)
atmospheric pollutants##2##2##(2008-11#1)(2008-3#1)
atmospheric pollution##5##2##(1991-3#1)(2008-2#1)(2008-3#1)(2011-2#2)
atmospheric populations of G##2##4##(2008-10#2)
atmospheric populations##3##2##(2008-10#3)
atmospheric pressure and##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
atmospheric pressure conditions##2##3##(2008-11#1)(2008-2#1)
atmospheric pressure##30##2##(1990-7#2)(1996-1#1)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#8)(2009-6#1)(2010-5#2)
atmospheric products##3##2##(2008-3#3)
atmospheric profiles from##2##3##(2008-2#1)(2008-3#1)
atmospheric profiles##3##2##(2008-2#1)(2008-3#2)
atmospheric propagation##3##2##(2008-3#3)
atmospheric radiance##3##2##(2008-2#1)(2008-3#2)
atmospheric radiative transfer##2##3##(2008-2#1)(2008-3#1)
atmospheric radiative##3##2##(2008-2#1)(2008-3#2)
atmospheric scattering##3##2##(2008-3#3)
atmospheric seeing##3##2##(2008-2#2)(2008-3#1)
atmospheric sounding##3##2##(2008-3#3)
atmospheric species##3##2##(2007-11#1)(2008-3#2)
atmospheric temperature##3##2##(2008-10#1)(2008-3#2)
atmospheric thermal structure##2##3##(2008-2#2)
atmospheric thermal##3##2##(2008-2#2)(2008-3#1)
atmospheric trace gases##3##3##(2008-10#2)(2008-2#1)
atmospheric trace##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
atmospheric transmission and##3##3##(2008-2#2)(2008-3#1)
atmospheric transmission##7##2##(2008-2#4)(2008-3#3)
atmospheric transmittance##3##2##(2008-2#1)(2008-3#2)
atmospheric turbidity and##2##3##(2008-2#1)(2008-3#1)
atmospheric turbidity##4##2##(2008-2#2)(2008-3#2)
atmospheric turbulence and reflective speckle##3##5##(2008-3#3)
atmospheric turbulence and the##2##4##(2008-3#2)
atmospheric turbulence and##6##3##(2008-2#1)(2008-3#5)
atmospheric turbulence##30##2##(1992-11#1)(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#21)
atmospheric water vapor##3##3##(2008-2#1)(2008-3#2)
atmospheric water##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
atmospheric wind##2##2##(2008-3#2)
atmospheric window##4##2##(2008-2#3)(2008-3#1)
atmospheric windows##2##2##(2007-12#1)(2008-3#1)
atmospheric##408##1##(1990-7#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1995-11#1)(1995-3#1)(1996-1#3)(1996-12#1)(1997-5#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#45)(2008-11#13)(2008-2#95)(2008-3#204)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#16)
atmospheric-dust##2##1##(2008-3#2)
atmospheric-pressure##7##1##(2008-2#3)(2008-3#2)(2012-1#2)
atmosphericlike##2##1##(2008-3#2)
atoll##3##1##(2008-1#1)(2013-8#2)
atolls##5##1##(1994-9#2)(2008-1#3)
atom adjacency matrix##2##3##(2007-11#2)
atom adjacency matrix&quot##2##3##(2007-11#2)
atom adjacency##4##2##(2007-11#4)
atom and the##2##3##(1991-5#1)(2008-10#1)
atom and##6##2##(1991-3#1)(1991-5#1)(2007-11#1)(2008-10#2)(2008-3#1)
atom at the##3##3##(1991-3#1)(1995-3#1)(2008-5#1)
atom at##4##2##(1991-3#1)(1995-3#1)(2007-11#1)(2008-5#1)
atom beam##2##2##(2007-12#2)
atom bombardment mass spectrometry##4##4##(1993-11#1)(1994-3#3)
atom bombardment mass##6##3##(1990-12#1)(1993-11#1)(1994-3#3)(2008-10#1)
atom bombardment##8##2##(1990-12#1)(1991-2#1)(1993-11#1)(1994-3#3)(1995-3#1)(2008-10#1)
atom in the##5##3##(1991-3#1)(1995-11#1)(1996-2#1)(2006-4#1)(2008-4#1)
atom in##7##2##(1991-3#1)(1995-11#1)(1996-2#1)(2006-4#1)(2007-11#1)(2008-4#1)(2008-5#1)
atom is##7##2##(1993-11#2)(1996-2#1)(1997-7#2)(2006-4#1)(2007-11#1)
atom of the##6##3##(1990-7#1)(1991-3#1)(1994-5#1)(1996-2#1)(1997-7#2)
atom of##16##2##(1990-7#1)(1991-3#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-7#2)(2008-8#4)
atom ratio and##2##3##(2008-10#2)
atom transfer radical polymerization (ATRP)##2##5##(2008-10#2)
atom transfer radical polymerization##3##4##(2008-10#2)(2008-12#1)
atom transfer to##2##3##(1996-2#1)(1997-7#1)
atom transfer##5##2##(1996-2#1)(1997-7#1)(2008-10#2)(2008-12#1)
atom trapping##2##2##(2008-10#2)
atom##133##1##(1990-11#1)(1990-12#2)(1990-7#1)(1991-2#1)(1991-3#5)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-8#1)(1993-11#4)(1993-6#1)(1993-8#1)(1994-3#3)(1994-5#2)(1995-11#1)(1995-3#5)(1996-2#14)(1996-3#1)(1996-5#3)(1997-7#6)(2006-4#3)(2007-11#16)(2007-12#6)(2008-10#23)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#4)(2010-11#1)(2010-12#2)(2010-2#2)(2012-3#1)(2013-8#2)
atom-transfer-radical polymerization##2##2##(2010-4#2)
atom-type##3##1##(2007-11#3)
atomic absorption analysis of##2##4##(2008-10#2)
atomic absorption and emission##3##4##(2008-10#3)
atomic absorption and##4##3##(2008-10#4)
atomic absorption detection##3##3##(2008-10#3)
atomic absorption determination of##4##4##(2008-10#4)
atomic absorption determination##5##3##(2008-10#5)
atomic absorption is##2##3##(2008-10#2)
atomic absorption measurements##2##3##(1995-5#1)(2008-10#1)
atomic absorption method is described for the determination of##2##9##(2008-10#2)
atomic absorption method##6##3##(2008-10#6)
atomic absorption spectrometer##20##3##(2008-10#20)
atomic absorption spectrometric determination of cadmium and lead##3##8##(2008-10#3)
atomic absorption spectrometric determination of##19##5##(2007-12#1)(2008-10#18)
atomic absorption spectrometric determination##21##4##(2007-12#1)(2008-10#20)
atomic absorption spectrometric determinations##4##4##(2008-10#4)
atomic absorption spectrometric method##4##4##(2008-10#4)
atomic absorption spectrometric procedure##2##4##(2008-10#2)
atomic absorption spectrometric##46##3##(2007-12#1)(2008-10#45)
atomic absorption spectrometry (AAS) determination was investigated##2##7##(2008-10#2)
atomic absorption spectrometry (AAS)##13##4##(2008-10#13)
atomic absorption spectrometry (CVAAS) was##2##5##(2008-10#2)
atomic absorption spectrometry (CVAAS)##7##4##(2008-10#7)
atomic absorption spectrometry (ETAAS) is##4##5##(2008-10#4)
atomic absorption spectrometry (ETAAS) method##2##5##(2008-10#2)
atomic absorption spectrometry (ETAAS) was##3##5##(2008-10#3)
atomic absorption spectrometry (ETAAS)##32##4##(2008-10#32)
atomic absorption spectrometry (GFAAS)##24##4##(2008-10#24)
atomic absorption spectrometry (TCAAS) was##2##5##(2008-10#2)
atomic absorption spectrometry after##12##4##(2008-10#11)(2013-8#1)
atomic absorption spectrometry and##6##4##(2008-10#6)
atomic absorption spectrometry as an##2##5##(2008-10#2)
atomic absorption spectrometry as##3##4##(2008-10#3)
atomic absorption spectrometry at##2##4##(2008-10#2)
atomic absorption spectrometry by##2##4##(2008-10#2)
atomic absorption spectrometry detection##2##4##(2008-10#2)
atomic absorption spectrometry determination of##2##5##(2008-10#2)
atomic absorption spectrometry determination##3##4##(2008-10#3)
atomic absorption spectrometry for##5##4##(2008-10#5)
atomic absorption spectrometry has been described##2##6##(2008-10#2)
atomic absorption spectrometry has been developed##2##6##(2008-10#2)
atomic absorption spectrometry has been##5##5##(2008-10#5)
atomic absorption spectrometry in##7##4##(2008-10#7)
atomic absorption spectrometry is described##3##5##(2008-10#3)
atomic absorption spectrometry is proposed##2##5##(2008-10#2)
atomic absorption spectrometry is##8##4##(2008-10#8)
atomic absorption spectrometry method for determination of##2##7##(2008-10#2)
atomic absorption spectrometry using a##2##5##(2008-10#2)
atomic absorption spectrometry using##14##4##(2008-10#14)
atomic absorption spectrometry utilizing##2##4##(2008-10#2)
atomic absorption spectrometry was used for the determination of##2##9##(2008-10#2)
atomic absorption spectrometry was used for##3##6##(2008-10#3)
atomic absorption spectrometry was used##4##5##(2008-10#4)
atomic absorption spectrometry was##6##4##(2008-10#6)
atomic absorption spectrometry with##14##4##(2008-10#13)(2009-6#1)
atomic absorption spectrometry##410##3##(1991-12#1)(1995-6#2)(2007-12#1)(2008-10#402)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
atomic absorption spectrometry)##2##3##(2008-10#2)
atomic absorption spectrophotometer##5##3##(2008-10#4)(2013-8#1)
atomic absorption spectrophotometric method##4##4##(1991-2#1)(2008-10#3)
atomic absorption spectrophotometric##5##3##(1991-2#1)(2008-10#4)
atomic absorption spectrophotometry (FAAS)##5##4##(2008-10#5)
atomic absorption spectrophotometry##22##3##(1997-4#1)(2008-10#21)
atomic absorption spectroscopy (AAS)##4##4##(1996-3#1)(2008-10#3)
atomic absorption spectroscopy##20##3##(1991-9#1)(1994-11#1)(1996-3#1)(2008-10#15)(2008-7#1)(2011-2#1)
atomic absorption##571##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-4#2)(2007-12#2)(2008-10#548)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#2)(2013-8#3)
atomic and background signals##2##4##(2008-10#2)
atomic and molecular##2##3##(2008-10#1)(2008-2#1)
atomic and##5##2##(2008-10#3)(2008-2#1)(2010-7#1)
atomic beam##3##2##(2008-3#3)
atomic beams##2##2##(2008-3#2)
atomic bomb survivor cancer mortality data##2##6##(2013-1#2)
atomic bomb survivor data##2##4##(2013-1#2)
atomic bomb survivor##4##3##(2013-1#4)
atomic bomb##5##2##(2013-1#5)
atomic cesium##2##2##(2007-12#1)(2008-3#1)
atomic cloud##2##2##(2008-2#2)
atomic coherence##3##2##(2007-11#3)
atomic coordinates of##2##3##(1995-2#1)(1997-2#1)
atomic emission detection##2##3##(2008-10#2)
atomic emission spectrometry using##2##4##(2008-10#2)
atomic emission spectrometry with##3##4##(2008-10#3)
atomic emission spectrometry##64##3##(1992-3#1)(2008-10#63)
atomic emission spectroscopy##5##3##(2008-10#5)
atomic emission##87##2##(1992-3#1)(2007-12#1)(2008-10#84)(2008-11#1)
atomic fluorescence spectrometer##2##3##(2008-10#2)
atomic fluorescence spectrometric detection##2##4##(2008-10#2)
atomic fluorescence spectrometric##4##3##(2008-10#4)
atomic fluorescence spectrometry (AFS) detection##2##5##(2008-10#2)
atomic fluorescence spectrometry (AFS)##4##4##(2008-10#4)
atomic fluorescence spectrometry (CVAFS)##2##4##(2008-10#2)
atomic fluorescence spectrometry (HGAFS)##2##4##(2008-10#2)
atomic fluorescence spectrometry after##2##4##(2008-10#2)
atomic fluorescence spectrometry for##2##4##(2008-10#2)
atomic fluorescence spectrometry was##2##4##(2008-10#2)
atomic fluorescence spectrometry with##2##4##(2008-10#2)
atomic fluorescence spectrometry##33##3##(2008-10#33)
atomic fluorescence##46##2##(2008-10#46)
atomic force microscope (AFM)##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
atomic force microscope##13##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-7#1)(2010-4#2)(2013-8#1)
atomic force microscopy (AFM) and##3##5##(2008-10#2)(2009-7#1)
atomic force microscopy (AFM)##18##4##(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#2)(2012-2#1)
atomic force microscopy and##3##4##(2008-10#2)(2008-2#1)
atomic force microscopy studies##2##4##(2008-3#1)(2010-2#1)
atomic force microscopy##52##3##(1993-6#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
atomic force##67##2##(1993-6#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-2#1)(2010-4#4)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
atomic gas##2##2##(2007-11#1)(2012-2#1)
atomic level study##2##3##(1993-11#2)
atomic level##4##2##(1993-11#2)(2008-7#1)(2009-9#1)
atomic number density##2##3##(2008-3#2)
atomic number##10##2##(2006-4#2)(2008-10#4)(2008-3#3)(2009-11#1)
atomic optical filter##2##3##(2007-11#2)
atomic optical##4##2##(2007-11#3)(2008-10#1)
atomic orbitals##3##2##(2007-11#2)(2010-7#1)
atomic oxygen##3##2##(2008-2#2)(2008-3#1)
atomic physics##2##2##(2007-11#1)(2007-12#1)
atomic resolution##4##2##(1990-11#1)(1994-8#1)(2008-7#1)(2009-11#1)
atomic resonance##2##2##(2007-11#1)(2008-2#1)
atomic spectrometric techniques##2##3##(2008-10#2)
atomic spectrometric##3##2##(2008-10#3)
atomic spectrometry methods##2##3##(2008-10#2)
atomic spectrometry techniques##2##3##(2008-10#2)
atomic spectrometry##10##2##(2008-10#10)
atomic spectroscopy##5##2##(2008-10#5)
atomic structure##4##2##(1997-4#1)(2007-12#1)(2008-7#1)(2011-2#1)
atomic surface roughness equations##2##4##(2008-3#2)
atomic surface roughness##5##3##(2008-3#5)
atomic system##3##2##(2007-11#2)(2007-12#1)
atomic transition##3##2##(2007-12#1)(2008-2#2)
atomic vapor##3##2##(2007-12#2)(2008-2#1)
atomic weapons##2##2##(1996-6#1)(2008-12#1)
atomic##928##1##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#3)(1992-4#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#3)(2006-4#2)(2007-11#18)(2007-12#17)(2008-10#724)(2008-11#4)(2008-12#2)(2008-2#35)(2008-3#32)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#15)(2008-8#1)(2009-11#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-2#2)(2010-4#4)(2010-7#4)(2011-1#2)(2011-2#4)(2012-2#4)(2013-1#6)(2013-8#6)
atomic-force microscope (AFM)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
atomic-force microscope##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
atomic-force microscopy##4##2##(2008-3#4)
atomic-force##8##1##(2007-12#1)(2008-2#1)(2008-3#6)
atomic-resolution##3##1##(2008-4#2)(2008-7#1)
atomic-scale##3##1##(2008-7#1)(2008-8#1)(2010-7#1)
atomisation temperatures##3##2##(2008-10#3)
atomisation##9##1##(2008-10#9)
atomiser##4##1##(2008-10#4)
atomistic##4##1##(2008-7#1)(2010-10#1)(2010-2#1)(2012-2#1)
atomistic-level##2##1##(2009-7#1)(2012-2#1)
atomization and background absorption profiles##2##5##(2008-10#2)
atomization and##4##2##(2008-10#4)
atomization atomic absorption spectrometry (ETAAS)##2##5##(2008-10#2)
atomization atomic absorption spectrometry##5##4##(2008-10#5)
atomization of##3##2##(2007-12#1)(2008-10#2)
atomization temperature##2##2##(2008-10#2)
atomization##53##1##(2007-12#1)(2008-10#50)(2008-2#1)(2011-2#1)
atomized mist##2##2##(2011-2#2)
atomized##4##1##(2008-10#2)(2011-2#2)
atomizer and##4##2##(1996-2#1)(2008-10#3)
atomizer was##3##2##(2008-10#3)
atomizer##39##1##(1996-2#2)(2008-10#37)
atoms and 0##3##3##(1994-5#2)(1995-5#1)
atoms and molecules##2##3##(2008-10#1)(2008-7#1)
atoms and##13##2##(1994-5#3)(1995-5#1)(1995-6#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
atoms are##7##2##(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
atoms from##6##2##(1991-9#1)(2007-11#2)(2007-12#1)(2008-7#1)(2011-2#1)
atoms in a##2##3##(1991-5#1)(2007-11#1)
atoms in the structure##3##4##(1996-12#2)(2008-10#1)
atoms in the##11##3##(1990-12#1)(1990-7#1)(1992-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2012-2#1)
atoms in##21##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-4#1)(1992-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2012-2#1)
atoms into##2##2##(2006-4#1)(2008-7#1)
atoms is##2##2##(1996-2#1)(2007-12#1)
atoms of the##9##3##(1993-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2007-11#2)(2008-10#3)
atoms of##16##2##(1990-2#1)(1991-9#2)(1993-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1997-7#2)(2007-11#2)(2008-10#3)(2012-2#1)
atoms on the##2##3##(2008-10#2)
atoms on##3##2##(2008-10#3)
atoms to##2##2##(1992-3#1)(2007-11#1)
atoms was identified##2##3##(2008-10#1)(2013-8#1)
atoms was##6##2##(1996-5#1)(2007-11#1)(2008-10#3)(2013-8#1)
atoms were##4##2##(2006-4#1)(2007-11#1)(2008-10#1)(2013-8#1)
atoms with##5##2##(1995-2#1)(1995-6#1)(1996-2#1)(2010-4#1)(2013-8#1)
atoms##189##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-5#2)(1991-9#3)(1992-3#1)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-5#6)(1994-8#1)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#2)(1996-12#2)(1996-2#10)(1996-5#2)(1997-2#1)(1997-7#13)(2006-4#6)(2007-11#28)(2007-12#15)(2008-10#23)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#5)(2008-8#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#8)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#4)
atoms)##2##1##(1992-4#1)(2013-1#1)
atopic asthma##2##2##(2008-11#1)(2010-5#1)
atopic bronchial asthma##2##3##(2008-7#2)
atopic dermatitis in##4##3##(2007-11#1)(2011-1#1)(2013-1#2)
atopic dermatitis##31##2##(1991-2#4)(1992-9#3)(2007-11#2)(2007-7#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#8)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)
atopic dermatitis]##2##2##(1991-2#1)(1992-9#1)
atopic diseases##4##2##(1991-2#1)(1996-8#2)(2008-10#1)
atopic disorders##4##2##(2008-10#1)(2009-5#2)(2012-12#1)
atopic patients##2##2##(1992-9#1)(2008-11#1)
atopic##58##1##(1990-3#1)(1991-2#7)(1992-9#5)(1994-9#1)(1996-8#2)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#3)(2009-5#2)(2010-5#2)(2011-1#8)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
atopy at 15 months##2##4##(2010-6#2)
atopy is##2##2##(2007-7#1)(2009-5#1)
atopy was##4##2##(2007-7#2)(2008-3#1)(2011-1#1)
atopy##31##1##(1991-2#1)(1996-6#1)(2007-6#2)(2007-7#7)(2008-1#1)(2008-10#7)(2008-3#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-6#5)(2011-1#1)(2012-3#1)(2013-8#1)
atopy-related phenotypes##2##2##(2008-3#2)
atorvastatin 10 mg/day##2##3##(2008-5#2)
atorvastatin and rosuvastatin##4##3##(2011-1#4)
atorvastatin in patients with##2##4##(2008-5#1)(2011-2#1)
atorvastatin is##2##2##(2008-5#2)
atorvastatin therapy##2##2##(2011-2#2)
atorvastatin##31##1##(2008-5#14)(2010-10#1)(2011-1#9)(2011-2#5)(2013-8#2)
atp6##2##1##(1996-10#2)
atracurium##5##1##(2009-4#1)(2010-7#4)
atranorin##4##1##(2008-5#4)
atrata##6##1##(2007-12#5)(2008-8#1)
atraumatic##8##1##(1994-8#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2010-3#1)
atrazine and simazine##5##3##(2008-10#5)
atrazine and##14##2##(2008-10#11)(2013-1#3)
atrazine at##3##2##(2008-10#2)(2013-1#1)
atrazine in water##2##3##(2008-10#2)
atrazine in##8##2##(2008-10#7)(2013-1#1)
atrazine were##4##2##(2008-10#4)
atrazine##71##1##(2008-10#61)(2013-1#10)
atresia and##2##2##(2007-8#1)(2010-11#1)
atresia is a##2##3##(2008-7#1)(2013-1#1)
atresia is##6##2##(2008-7#2)(2012-3#1)(2013-1#3)
atresia was##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
atresia##36##1##(1994-6#3)(1997-3#3)(2007-11#1)(2007-8#3)(2008-7#7)(2008-8#8)(2010-11#1)(2010-3#1)(2012-3#3)(2013-1#6)
atretic follicles##4##2##(2008-11#2)(2008-8#2)
atretic##5##1##(2008-11#3)(2008-8#2)
atria and ventricles##2##3##(2011-2#1)(2013-1#1)
atria and##4##2##(1995-11#1)(2011-2#1)(2013-1#2)
atria was##2##2##(2013-1#2)
atria##13##1##(1992-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#6)
atrial and ventricular##2##3##(1995-8#1)(2010-4#1)
atrial and##3##2##(1995-8#1)(2010-4#1)(2013-1#1)
atrial appendage##9##2##(2007-8#6)(2008-11#2)(2010-12#1)
atrial arrhythmia##3##2##(1990-9#2)(2009-4#1)
atrial arrhythmias##4##2##(2006-10#1)(2009-4#1)(2012-12#2)
atrial cells##2##2##(1996-2#2)
atrial contractility##2##2##(2007-8#1)(2008-5#1)
atrial contraction##4##2##(1994-3#1)(2008-5#3)
atrial fibrillation (AF)##6##3##(2007-8#3)(2012-12#2)(2012-3#1)
atrial fibrillation after##3##3##(1994-3#1)(2007-8#1)(2013-8#1)
atrial fibrillation and##10##3##(1994-11#1)(1995-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#2)
atrial fibrillation in##5##3##(2007-10#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
atrial fibrillation with##2##3##(2007-8#1)(2008-3#1)
atrial fibrillation##70##2##(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#2)(1997-7#1)(2007-10#3)(2007-7#1)(2007-8#18)(2008-1#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
atrial fibrillation]##2##2##(2008-10#1)(2012-3#1)
atrial fibrosis##3##2##(2012-12#2)(2013-8#1)
atrial flutter##6##2##(2007-8#2)(2010-11#2)(2012-3#2)
atrial hemangioma##2##2##(2007-8#2)
atrial lead##2##2##(2012-2#2)
atrial mass##4##2##(2007-8#4)
atrial myocardium##4##2##(2010-8#1)(2013-1#3)
atrial myxoma##6##2##(2008-11#1)(2008-7#2)(2009-6#1)(2012-12#2)
atrial myxomas##4##2##(2012-12#4)
atrial natriuretic factor (ANF)##3##4##(1990-9#1)(1994-8#1)(1996-9#1)
atrial natriuretic peptide (ANP)##3##4##(1990-12#1)(1992-3#1)(2011-2#1)
atrial natriuretic peptide##7##3##(1990-12#2)(1992-3#2)(1993-12#1)(2008-4#1)(2011-2#1)
atrial natriuretic##11##2##(1990-12#2)(1990-2#1)(1990-9#1)(1992-3#2)(1993-12#1)(1994-8#1)(1996-9#1)(2008-4#1)(2011-2#1)
atrial septal defect and##3##4##(2007-8#1)(2008-11#2)
atrial septal defect surgery##2##4##(2007-8#2)
atrial septal defect was##2##4##(2007-8#1)(2008-11#1)
atrial septal defect##22##3##(1996-6#1)(2007-8#8)(2008-11#11)(2012-3#1)(2013-1#1)
atrial septal defects##8##3##(1996-6#1)(1997-8#2)(2008-11#2)(2009-10#1)(2012-1#1)(2012-3#1)
atrial septal##32##2##(1994-11#1)(1996-6#2)(1997-8#2)(2007-8#8)(2008-11#13)(2009-10#2)(2012-1#1)(2012-3#2)(2013-1#1)
atrial tachyarrhythmias##2##2##(2010-4#2)
atrial thrombosis##4##2##(2007-8#4)
atrial thrombus##3##2##(2007-8#1)(2008-12#1)(2008-7#1)
atrial##229##1##(1990-12#4)(1990-2#1)(1990-5#1)(1990-9#3)(1992-3#2)(1992-5#1)(1993-12#1)(1994-11#3)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#2)(1996-2#3)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#4)(2007-7#1)(2007-8#58)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#18)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#1)(2009-10#2)(2009-12#2)(2009-4#3)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-4#7)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#5)(2012-1#2)(2012-12#14)(2012-2#2)(2012-3#12)(2013-1#11)(2013-7#1)(2013-8#3)
atrio-ventricular##2##1##(2008-10#1)(2008-7#1)
atrioventricular block and##2##3##(1992-4#1)(2013-8#1)
atrioventricular block##10##2##(1990-9#1)(1992-4#3)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2013-8#1)
atrioventricular conduction##2##2##(1992-6#1)(2008-10#1)
atrioventricular re-entry tachycardia using##2##4##(2008-11#2)
atrioventricular##18##1##(1990-9#1)(1992-4#3)(1992-6#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-7#2)(2009-12#1)(2013-8#1)
atrium and right##2##3##(2007-8#2)
atrium and ventricle##4##3##(2007-12#1)(2008-11#1)(2010-8#1)(2012-3#1)
atrium and##10##2##(2007-12#1)(2007-8#4)(2008-11#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
atrium is##2##2##(1992-5#1)(2008-5#1)
atrium##41##1##(1991-5#1)(1992-5#1)(1997-6#1)(2007-12#1)(2007-8#17)(2008-11#1)(2008-5#3)(2008-7#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-2#2)
atrogin-1##3##1##(2013-1#3)
atrolysin C##2##2##(1994-8#2)
atrophic gastritis##2##2##(1994-2#1)(1997-1#1)
atrophic rhinitis##2##2##(2008-5#1)(2011-1#1)
atrophic##22##1##(1991-11#1)(1994-2#1)(1995-3#1)(1997-1#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#2)(2013-8#2)
atrophied##8##1##(1991-12#1)(1995-3#1)(1997-3#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#2)
atrophy after##2##2##(2008-10#1)(2011-2#1)
atrophy and##20##2##(1992-12#1)(1993-8#1)(1996-3#1)(1997-1#2)(1997-2#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-8#1)
atrophy appeared##2##2##(2011-2#2)
atrophy as##2##2##(2008-10#1)(2010-12#1)
atrophy caused by##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
atrophy in##8##2##(1993-3#1)(1994-8#1)(2007-2#1)(2009-9#1)(2012-2#2)(2013-1#2)
atrophy of the##9##3##(1997-3#1)(1997-7#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
atrophy of##13##2##(1994-8#1)(1997-3#1)(1997-7#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
atrophy on##3##2##(2008-7#1)(2010-5#1)(2012-12#1)
atrophy was##5##2##(1990-9#1)(1996-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
atrophy were##2##2##(1991-11#1)(2013-8#1)
atrophy##125##1##(1990-9#1)(1991-11#2)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-7#4)(2008-10#9)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#16)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#3)(2010-12#7)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#16)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#10)(2013-1#10)(2013-8#3)
atropine and pethidine##3##3##(2008-10#3)
atropine and##6##2##(1993-9#1)(1994-8#1)(2008-10#3)(2008-12#1)
atropine sulphate with an oxime##2##5##(2013-1#2)
atropine##31##1##(1990-5#1)(1990-9#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-3#3)(1996-12#2)(1996-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#2)(2011-2#2)(2012-12#2)(2013-1#2)
atropine-resistant##3##1##(1990-5#1)(1993-6#1)(1997-4#1)
atropine-sensitive and##2##2##(1993-6#1)(1997-4#1)
atropine-sensitive##3##1##(1993-6#1)(1997-4#2)
atroseptica##3##1##(2008-10#3)
atroviride##5##1##(2008-10#5)
atrum (1 x 10(6) conidia per ml)##2##7##(2008-10#2)
atrum 385##6##2##(2008-10#6)
atrum conidia on##2##3##(2008-10#2)
atrum in##2##2##(2008-10#2)
atrum strains##4##2##(2008-10#4)
atrum##39##1##(2008-10#38)(2013-8#1)
attach to the##6##3##(1991-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#2)
attach to##10##2##(1991-3#1)(2008-10#2)(2008-11#3)(2009-3#1)(2011-1#2)(2011-2#1)
attach##19##1##(1991-3#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-11#6)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#2)(2011-2#1)
attached and spread on##2##4##(1993-9#1)(1994-6#1)
attached and##5##2##(1990-12#1)(1993-9#1)(1994-6#1)(2008-10#1)(2010-3#1)
attached at one port of##2##5##(2008-10#2)
attached at one##3##3##(2008-10#2)(2008-7#1)
attached at##4##2##(1994-5#1)(2008-10#2)(2008-7#1)
attached by##3##2##(1994-8#1)(2008-11#1)(2008-3#1)
attached cells##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
attached covalently##2##2##(2008-10#2)
attached directly##2##2##(2008-4#1)(2008-7#1)
attached on the surface of##2##5##(2008-10#1)(2010-5#1)
attached on the##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
attached on##4##2##(2008-10#1)(2008-2#1)(2010-5#2)
attached through##2##2##(2008-10#1)(2008-5#1)
attached to a##19##3##(1990-12#1)(1991-2#1)(1993-11#1)(1994-9#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-5#3)(2010-8#1)
attached to each##2##3##(1997-2#1)(2008-12#1)
attached to the back##2##4##(2013-1#2)
attached to the bottom##2##4##(2008-11#1)(2008-4#1)
attached to the cuticle##4##4##(2007-12#2)(2008-8#2)
attached to the enzyme##2##4##(2008-10#2)
attached to the fiber##2##4##(2008-11#1)(2008-3#1)
attached to the flow cells##2##5##(2008-10#2)
attached to the skin##2##4##(2008-10#1)(2008-5#1)
attached to the solid##2##4##(2008-11#1)(2008-4#1)
attached to the surface##2##4##(2008-2#1)(2008-3#1)
attached to the##70##3##(1990-12#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#18)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
attached to yeast##3##3##(2008-10#3)
attached to##138##2##(1990-12#3)(1990-5#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1992-6#2)(1993-11#2)(1993-8#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(2007-12#6)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2010-5#4)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
attached##208##1##(1990-11#1)(1990-12#4)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1992-3#1)(1992-6#2)(1993-11#2)(1993-8#2)(1993-9#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(2007-12#8)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#51)(2008-11#19)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#1)(2009-7#1)(2010-3#1)(2010-5#6)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#1)
attaching and effacing##2##3##(2008-9#1)(2011-1#1)
attaching to##4##2##(2008-11#2)(2009-4#1)(2013-1#1)
attaching##16##1##(1994-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-4#1)(2011-1#1)(2013-1#1)
attachment and body satisfaction##3##4##(2007-12#3)
attachment and growth##2##3##(1994-5#1)(2008-11#1)
attachment and proliferation##3##3##(2008-5#2)(2012-5#1)
attachment and##23##2##(1990-8#1)(1991-5#1)(1994-5#1)(1994-6#1)(1995-6#1)(2007-12#7)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2009-12#2)(2010-8#2)(2012-5#1)
attachment apparatus##3##2##(2012-12#1)(2012-3#2)
attachment in##2##2##(2007-2#1)(2011-2#1)
attachment insecurity##5##2##(2010-8#1)(2012-1#4)
attachment is associated with##2##4##(2012-1#2)
attachment is##4##2##(2008-11#1)(2008-7#1)(2012-1#2)
attachment level##3##2##(2008-12#2)(2013-1#1)
attachment method##2##2##(2008-10#1)(2012-5#1)
attachment methods##2##2##(2010-12#1)(2012-5#1)
attachment of a##2##3##(2008-10#1)(2008-4#1)
attachment of the##13##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1994-12#1)(1994-9#1)(1997-2#1)(2008-10#3)(2008-8#1)(2009-4#1)(2013-1#1)
attachment of##51##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-2#1)(2007-11#2)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
attachment on##3##2##(1995-6#1)(2010-3#1)(2012-2#1)
attachment organ##2##2##(2008-5#2)
attachment protein##3##2##(2009-7#1)(2009-8#1)(2012-5#1)
attachment proteins##4##2##(2008-10#3)(2012-5#1)
attachment rate##5##2##(2008-10#2)(2008-11#3)
attachment results##2##2##(2007-12#2)
attachment security##2##2##(2010-8#2)
attachment site##6##2##(1995-6#2)(1996-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
attachment sites##3##2##(1992-10#1)(1995-6#2)
attachment style##4##2##(2008-7#1)(2012-2#3)
attachment styles##2##2##(2008-12#2)
attachment through##2##2##(2008-10#2)
attachment to EC##2##3##(1990-2#2)
attachment to and##2##3##(1996-3#1)(2008-5#1)
attachment to the##6##3##(1991-12#1)(1995-11#1)(2008-11#1)(2008-4#1)(2009-3#1)(2013-8#1)
attachment to##29##2##(1990-2#2)(1990-5#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#2)(2009-3#1)(2011-2#2)(2012-4#1)(2012-5#1)(2013-8#2)
attachment was##3##2##(2008-10#1)(2008-8#1)(2012-1#1)
attachment##245##1##(1990-12#2)(1990-2#3)(1990-5#1)(1990-8#3)(1991-12#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-3#3)(1992-9#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#8)(1996-12#1)(1996-3#3)(1997-2#1)(2007-11#2)(2007-12#13)(2007-2#2)(2008-1#1)(2008-10#45)(2008-11#20)(2008-12#6)(2008-2#1)(2008-4#6)(2008-5#8)(2008-7#13)(2008-8#6)(2009-10#1)(2009-12#4)(2009-3#1)(2009-4#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#8)(2010-9#2)(2011-2#4)(2012-1#8)(2012-12#3)(2012-2#9)(2012-3#2)(2012-4#1)(2012-5#7)(2013-1#8)(2013-8#2)
attachments to##2##2##(2008-10#1)(2009-10#1)
attachments##9##1##(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#2)(2011-2#1)(2013-1#1)
attack (TIA) or##3##3##(1991-11#1)(2008-8#2)
attack (TIA)##4##2##(1991-11#1)(2008-8#2)(2011-2#1)
attack a##2##2##(2007-2#1)(2008-5#1)
attack and##11##2##(1991-3#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
attack at the##2##3##(1994-5#1)(1994-6#1)
attack at##4##2##(1990-7#1)(1994-5#1)(1994-6#1)(2008-9#1)
attack by##8##2##(1992-6#1)(1994-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2013-8#1)
attack can##2##2##(2007-12#1)(2008-10#1)
attack from##2##2##(2008-8#1)(2010-1#1)
attack in the##2##3##(1990-9#1)(2011-2#1)
attack in##6##2##(1990-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
attack is##3##2##(2008-8#1)(2013-7#2)
attack of the##6##3##(1993-6#1)(1996-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-10#1)
attack of##14##2##(1991-9#1)(1993-6#2)(1996-2#1)(1996-5#1)(2008-11#1)(2008-7#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-10#1)(2011-2#1)
attack on the##2##3##(1994-5#1)(2009-10#1)
attack on##8##2##(1991-3#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)
attack or minor##2##3##(2008-8#2)
attack or##4##2##(2007-12#1)(2008-8#3)
attack rate is##2##3##(2008-8#2)
attack rate##4##2##(2007-10#1)(2008-8#2)(2009-8#1)
attack rates and##2##3##(1990-6#1)(2007-10#1)
attack rates in the##2##4##(2007-10#2)
attack rates in##5##3##(2007-10#5)
attack rates##10##2##(1990-6#1)(1997-3#2)(2007-10#7)
attack than##2##2##(2008-9#1)(2013-1#1)
attack the##3##2##(2007-7#1)(2008-3#1)(2010-1#1)
attack to##2##2##(2008-9#1)(2013-1#1)
attack using##2##2##(2007-12#1)(2008-10#1)
attack were##3##2##(2007-10#1)(2007-12#1)(2008-10#1)
attack when##2##2##(2008-10#1)(2008-9#1)
attack##172##1##(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-3#5)(1991-9#1)(1992-6#2)(1993-2#1)(1993-6#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1995-2#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#2)(2007-10#12)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#32)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#12)(2008-9#8)(2009-10#2)(2009-5#1)(2009-8#2)(2010-1#2)(2010-12#4)(2010-2#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-10#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
attacked by##9##2##(1990-6#1)(1994-2#1)(2008-10#3)(2008-5#1)(2008-8#2)(2010-2#1)
attacked##18##1##(1990-6#1)(1992-6#1)(1994-2#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#2)(2010-2#1)(2010-3#1)(2012-3#1)
attacking##9##1##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)(2013-8#1)
attacks and##4##2##(1991-3#1)(2008-11#1)(2008-4#1)(2011-1#1)
attacks by##2##2##(2008-3#1)(2011-2#1)
attacks in##2##2##(2008-11#1)(2008-2#1)
attacks of abdominal pain##2##4##(1997-5#1)(2009-7#1)
attacks of##13##2##(1990-11#2)(1990-2#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-8#3)(2009-7#2)(2010-8#1)(2011-2#1)
attacks on the##2##3##(2007-2#1)(2011-2#1)
attacks on##4##2##(2007-2#1)(2008-8#1)(2009-7#1)(2011-2#1)
attacks or##2##2##(2008-9#1)(2012-3#1)
attacks treated##3##2##(1990-2#1)(1994-11#2)
attacks##74##1##(1990-11#2)(1990-2#2)(1990-3#1)(1991-11#1)(1991-3#1)(1994-11#4)(1994-6#2)(1995-12#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#2)(2009-7#6)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#5)(2012-3#1)(2013-7#2)(2013-8#1)
attain a##7##2##(1992-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-8#1)
attain larger##2##2##(2008-8#1)(2013-7#1)
attain the##10##2##(1992-9#1)(2008-10#5)(2008-3#1)(2009-6#1)(2010-9#1)(2012-12#1)
attain values##2##2##(2007-12#1)(2008-11#1)
attain##42##1##(1990-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-7#1)
attainable in the##2##3##(2008-10#1)(2008-2#1)
attainable in##7##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)
attainable via##2##2##(2009-12#1)(2012-2#1)
attainable with##2##2##(2008-3#1)(2008-7#1)
attainable##22##1##(1994-3#1)(2007-11#3)(2008-10#7)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2009-12#1)(2012-12#1)(2012-2#1)
attained a partial remission lasting##2##5##(1992-10#2)
attained a##9##2##(1992-10#2)(1994-12#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
attained after##2##2##(1990-2#1)(2008-10#1)
attained and##2##2##(2007-12#1)(2013-1#1)
attained at##2##2##(1992-3#1)(2008-6#1)
attained by adding##2##3##(1992-3#1)(2008-10#1)
attained by the##2##3##(1991-6#1)(2008-7#1)
attained by##11##2##(1991-6#1)(1992-3#1)(2008-10#5)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
attained for##5##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
attained in the bioreactor##2##4##(2008-11#2)
attained in the##9##3##(1990-2#1)(1993-6#1)(1995-6#3)(2008-10#1)(2008-11#3)
attained in##15##2##(1990-2#1)(1990-5#1)(1991-3#1)(1992-12#1)(1993-6#1)(1995-6#3)(2008-10#3)(2008-11#3)(2011-2#1)
attained its maximum value##2##4##(2008-10#2)
attained the highest##2##3##(1995-3#1)(2008-10#1)
attained the relatively##2##3##(2008-9#2)
attained the##7##2##(1995-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-9#2)
attained through the use of##2##5##(2008-10#2)
attained through the##3##3##(2008-10#2)(2010-8#1)
attained through##4##2##(1994-2#1)(2008-10#2)(2010-8#1)
attained using##5##2##(2008-10#4)(2008-11#1)
attained were##2##2##(1992-2#1)(2008-10#1)
attained when##2##2##(2008-10#1)(2008-6#1)
attained with the##2##3##(2008-3#1)(2009-3#1)
attained with##7##2##(1993-6#1)(1994-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
attained within##4##2##(2008-10#3)(2011-1#1)
attained##129##1##(1990-2#3)(1990-5#1)(1991-3#1)(1991-6#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#3)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#1)(1996-2#1)(2007-11#2)(2007-12#4)(2007-4#2)(2008-10#44)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
attaining the##4##2##(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#1)
attaining##19##1##(1990-6#1)(1992-3#1)(1994-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
attainment in##2##2##(2008-3#1)(2009-7#1)
attainment of AUC/MIC##4##3##(2011-2#4)
attainment of##22##2##(1992-3#1)(1992-8#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-5#2)(2013-8#3)
attainment##41##1##(1992-3#1)(1992-8#1)(1994-3#2)(1995-12#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#4)(2009-10#1)(2009-11#1)(2009-7#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-5#2)(2013-8#4)
attains##6##1##(1994-5#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
attempt a##2##2##(1990-10#1)(2008-6#1)
attempt and##3##2##(1992-1#1)(2008-7#1)(2009-7#1)
attempt at an##2##3##(1996-2#1)(2008-12#1)
attempt at##13##2##(1995-5#1)(1996-2#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
attempt has been made to determine##2##6##(2007-2#1)(2012-2#1)
attempt has been made to##7##5##(2007-2#1)(2008-10#2)(2010-8#1)(2012-2#1)(2013-1#2)
attempt has been##8##3##(2007-2#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
attempt in##8##2##(1996-5#1)(2007-7#1)(2008-1#1)(2010-2#1)(2010-3#1)(2010-7#2)(2013-1#1)
attempt is made to##6##4##(1990-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
attempt is##7##2##(1990-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-6#1)(2013-1#1)
attempt of insertion##2##3##(2010-7#2)
attempt of##6##2##(2007-8#1)(2008-7#1)(2009-3#1)(2010-7#2)(2013-8#1)
attempt the##2##2##(2008-10#1)(2008-3#1)
attempt to answer the following##2##5##(1997-3#1)(2012-12#1)
attempt to answer##4##3##(1990-8#1)(1992-2#1)(1997-3#1)(2012-12#1)
attempt to apply##2##3##(2008-10#1)(2008-11#1)
attempt to clarify the##3##4##(1993-11#1)(1994-2#1)(2008-7#1)
attempt to clarify##6##3##(1993-11#1)(1994-2#1)(1995-1#1)(2008-12#1)(2008-7#1)(2008-9#1)
attempt to compensate##2##3##(1997-7#1)(2011-2#1)
attempt to describe##2##3##(2008-1#1)(2008-11#1)
attempt to determine the##2##4##(1993-1#1)(2008-2#1)
attempt to determine whether##2##4##(2010-4#1)(2012-2#1)
attempt to determine##5##3##(1991-12#1)(1993-1#1)(2008-2#1)(2010-4#1)(2012-2#1)
attempt to develop a##3##4##(2008-10#1)(2009-11#1)(2011-2#1)
attempt to develop##7##3##(1992-11#1)(2008-10#3)(2008-11#1)(2009-11#1)(2011-2#1)
attempt to enhance##3##3##(2008-10#2)(2011-1#1)
attempt to explain##2##3##(1994-3#1)(1995-11#1)
attempt to extract##2##3##(2011-1#1)(2012-3#1)
attempt to generate##2##3##(2008-11#1)(2008-3#1)
attempt to highlight##2##3##(2012-2#1)(2013-1#1)
attempt to identify the##2##4##(1990-7#1)(1992-3#1)
attempt to identify##8##3##(1990-7#1)(1992-3#1)(2008-7#1)(2008-8#2)(2010-3#1)(2012-3#1)(2013-8#1)
attempt to improve##3##3##(2008-3#1)(2011-2#1)(2012-1#1)
attempt to induce##2##3##(1995-8#1)(2008-7#1)
attempt to link##2##3##(2007-12#1)(2008-8#1)
attempt to make a##3##4##(1997-8#1)(2008-11#1)(2011-2#1)
attempt to minimize the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
attempt to optimize##2##3##(2008-11#1)(2009-3#1)
attempt to predict##2##3##(2008-7#1)(2012-1#1)
attempt to protect##2##3##(1996-5#1)(2010-4#1)
attempt to provide##2##3##(2008-1#1)(2008-7#1)
attempt to reduce the##2##4##(1995-12#1)(1997-6#1)
attempt to reduce##4##3##(1995-12#1)(1997-6#1)(2010-3#1)(2012-2#1)
attempt to reproduce the##2##4##(2008-10#2)
attempt to review##3##3##(1990-12#1)(1993-12#1)(2012-2#1)
attempt to show that##2##4##(1992-3#1)(1994-2#1)
attempt to understand the##3##4##(1990-5#1)(2008-3#1)(2012-2#1)
attempt to understand##7##3##(1990-5#1)(2008-3#1)(2008-9#2)(2010-6#1)(2012-2#1)(2013-8#1)
attempt to use##2##3##(2008-3#1)(2013-1#1)
attempt to validate the##2##4##(1991-5#1)(1995-3#1)
attempt to##185##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#5)(2008-10#20)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#5)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-3#4)(2010-4#3)(2010-6#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#6)
attempt was made to find##2##5##(2008-5#1)(2012-2#1)
attempt was made to##10##4##(1990-6#1)(1995-4#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
attempt was##13##2##(1990-6#1)(1993-2#1)(1995-4#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
attempt with##2##2##(2009-3#2)
attempt##265##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#4)(1992-11#2)(1992-2#1)(1992-3#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#30)(2008-11#8)(2008-12#5)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#5)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#5)(2010-4#5)(2010-6#2)(2010-7#6)(2010-8#2)(2011-1#7)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#8)
attempted by##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
attempted here##2##2##(1994-11#1)(1997-3#1)
attempted in##6##2##(1990-2#1)(1991-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)
attempted suicide##4##2##(1992-1#1)(2007-8#1)(2008-11#1)(2011-2#1)
attempted through##2##2##(2008-11#1)(2008-7#1)
attempted to characterize the##2##4##(1990-5#1)(2008-10#1)
attempted to clarify the##2##4##(2008-11#1)(2013-8#1)
attempted to detect##2##3##(1994-6#1)(2008-10#1)
attempted to determine the##3##4##(1993-2#1)(2008-9#1)(2013-1#1)
attempted to determine##4##3##(1990-5#1)(1993-2#1)(2008-9#1)(2013-1#1)
attempted to develop a##2##4##(2008-10#1)(2010-1#1)
attempted to develop##3##3##(2008-10#1)(2010-1#1)(2010-8#1)
attempted to elucidate the##3##4##(1990-7#1)(2008-10#1)(2008-6#1)
attempted to identify and##2##4##(1995-2#1)(2012-12#1)
attempted to identify the##2##4##(2008-11#1)(2010-8#1)
attempted to identify##9##3##(1992-3#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#2)(2012-3#1)
attempted to improve##2##3##(1997-4#1)(2012-12#1)
attempted to obtain##2##3##(2008-11#1)(2008-6#1)
attempted to provide##2##3##(2008-1#1)(2012-12#1)
attempted to##71##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-3#4)(2008-5#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-6#2)(2010-1#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
attempted without success##2##3##(2008-11#1)(2008-4#1)
attempted##134##1##(1990-2#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#13)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#9)(2008-9#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#1)
attempting to address##2##3##(1991-12#1)(2008-12#1)
attempting to control##2##3##(1994-2#1)(2012-3#1)
attempting to develop##4##3##(1995-3#1)(2008-12#1)(2008-5#1)(2011-2#1)
attempting to provide##2##3##(1991-3#1)(2010-10#1)
attempting to##36##2##(1991-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-3#4)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#3)(2008-7#4)(2008-9#1)(2009-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
attempting##42##1##(1991-12#1)(1991-3#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#4)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#3)(2008-7#4)(2008-9#2)(2009-1#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
attempts and##6##2##(1992-12#1)(2008-1#1)(2010-6#1)(2013-1#3)
attempts are##2##2##(1992-12#1)(2008-10#1)
attempts at##13##2##(1990-6#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-3#1)(2011-2#1)
attempts by the##2##3##(1991-1#1)(2013-8#1)
attempts for##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)
attempts have been made to##4##5##(1997-2#1)(2008-9#1)(2013-1#2)
attempts have been##6##3##(1997-2#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#2)
attempts have##7##2##(1991-1#1)(1997-2#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#2)
attempts of##5##2##(2008-11#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)
attempts that##2##2##(2008-11#1)(2013-1#1)
attempts to achieve##2##3##(1996-5#1)(2012-1#1)
attempts to assess##2##3##(1994-6#1)(2008-11#1)
attempts to define the##2##4##(1993-3#1)(2008-9#1)
attempts to determine##2##3##(2008-2#1)(2008-4#1)
attempts to develop##4##3##(2007-10#2)(2009-8#1)(2012-2#1)
attempts to discuss##2##3##(2007-7#1)(2008-1#1)
attempts to engage##2##3##(1997-3#1)(2008-12#1)
attempts to establish##2##3##(1992-1#1)(1992-3#1)
attempts to explain the##2##4##(1997-7#1)(2007-11#1)
attempts to find##4##3##(1995-6#1)(2008-10#1)(2008-3#2)
attempts to gain##2##3##(2008-5#1)(2008-8#1)
attempts to highlight the##2##4##(2007-10#1)(2008-4#1)
attempts to identify##2##3##(2008-10#1)(2008-9#1)
attempts to improve##2##3##(2008-3#1)(2012-12#1)
attempts to incorporate##3##3##(1992-1#1)(2011-1#2)
attempts to increase##2##3##(1993-12#1)(2008-11#1)
attempts to induce##2##3##(2008-10#2)
attempts to integrate##2##3##(2008-12#2)
attempts to isolate##2##3##(2008-10#1)(2008-5#1)
attempts to manipulate##2##3##(2007-10#1)(2008-11#1)
attempts to provide a##2##4##(1994-9#1)(2010-10#1)
attempts to provide##6##3##(1994-12#1)(1994-9#1)(1996-8#1)(2008-11#2)(2010-10#1)
attempts to reduce##2##3##(2008-6#1)(2013-1#1)
attempts to resolve##3##3##(1993-12#1)(2008-3#1)(2010-5#1)
attempts to synthesize##3##3##(2008-9#1)(2009-8#1)(2012-3#1)
attempts to use##2##3##(2008-10#1)(2008-9#1)
attempts to##122##2##(1990-3#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-1#3)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
attempts were##5##2##(2008-10#2)(2013-1#3)
attempts with##2##2##(2008-1#1)(2008-10#1)
attempts##197##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#4)(1992-12#3)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#19)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#18)(2013-8#2)
attend the##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
attend to their##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
attend to##8##2##(1997-8#1)(2008-11#1)(2009-11#2)(2009-8#1)(2012-2#2)(2013-1#1)
attend##33##1##(1990-6#1)(1992-2#1)(1992-5#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-8#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)
attendance and##4##2##(2008-5#1)(2008-7#1)(2009-8#2)
attendance at##7##2##(1991-12#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#2)(2012-12#1)
attendance of##2##2##(2011-2#2)
attendance rate was##2##3##(1991-6#1)(1992-2#1)
attendance to prenatal care##2##4##(2009-7#2)
attendance to##3##2##(1996-9#1)(2009-7#2)
attendance was##3##2##(1991-6#1)(2008-12#1)(2009-8#1)
attendance##54##1##(1991-12#2)(1991-6#4)(1992-2#2)(1994-3#1)(1994-6#3)(1995-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-7#3)(2009-8#6)(2010-12#2)(2010-2#1)(2011-1#5)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
attendances##2##1##(1990-12#1)(1992-3#1)
attendant complications##2##2##(2011-2#2)
attendant##10##1##(1996-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#3)(2012-3#2)
attendants##8##1##(1994-3#2)(2010-12#1)(2010-5#1)(2011-1#3)(2013-1#1)
attended a##6##2##(1995-1#1)(1997-4#1)(2007-10#1)(2008-4#1)(2008-8#1)(2010-10#1)
attended an##3##2##(1993-1#1)(2008-9#1)(2013-1#1)
attended and##2##2##(2008-11#1)(2008-5#1)
attended by##12##2##(1995-12#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-5#3)(2010-11#1)(2010-3#1)(2010-5#1)
attended for##2##2##(1991-6#1)(2008-6#1)
attended the##11##2##(1992-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(2007-10#2)(2007-5#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
attended this conference##2##3##(2008-5#1)(2009-5#1)
attended this##4##2##(2008-5#3)(2009-5#1)
attended to##7##2##(1991-6#1)(1994-3#1)(2008-1#1)(2008-11#2)(2013-1#2)
attended##66##1##(1990-2#2)(1991-6#3)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-1#3)(1995-12#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-10#3)(2007-5#1)(2008-1#1)(2008-11#6)(2008-4#3)(2008-5#9)(2008-6#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#1)
attendees were##2##2##(1995-12#1)(2008-5#1)
attendees##16##1##(1990-4#1)(1991-12#2)(1991-3#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-6#1)(2010-5#1)(2012-3#1)(2013-1#1)
attenders##4##1##(1991-6#2)(1992-2#1)(2007-7#1)
attending Obstetrics and Gynaecology clinics##2##5##(2008-12#2)
attending a##19##2##(1991-8#4)(1993-2#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-9#1)(2013-1#1)
attending an outpatient##2##3##(2007-2#1)(2008-3#1)
attending an##4##2##(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)
attending medical##2##2##(1995-10#1)(2011-1#1)
attending physicians##4##2##(1992-12#1)(2008-3#1)(2010-8#1)(2013-1#1)
attending school in Cartagena##2##4##(2011-2#2)
attending school##3##2##(2011-2#2)(2012-12#1)
attending the University##2##3##(2008-11#1)(2011-2#1)
attending the##16##2##(1993-2#2)(1995-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#1)
attending their first pregnancy and adolescents with more than one##2##10##(2012-12#2)
attending to the##2##3##(2008-9#1)(2013-1#1)
attending to##8##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2013-1#2)
attending##107##1##(1990-2#1)(1991-8#4)(1992-1#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#4)(1993-6#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-2#3)(2007-7#7)(2007-8#3)(2008-10#2)(2008-11#3)(2008-12#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-3#1)(2013-1#7)(2013-8#1)
attention and sensorimotor##3##3##(1993-12#2)(1995-5#1)
attention and##23##2##(1992-1#1)(1992-3#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-5#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-1#1)
attention as a##7##3##(1996-6#1)(1997-4#1)(2007-10#1)(2008-8#2)(2010-1#1)(2012-2#1)
attention as##15##2##(1993-1#1)(1996-6#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
attention because of the##2##4##(2008-12#1)(2008-3#1)
attention because of##5##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
attention because##7##2##(1992-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
attention being focused on##2##4##(2011-1#1)(2011-2#1)
attention being paid to##2##4##(1995-1#1)(2008-7#1)
attention being##4##2##(1995-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
attention biases##2##2##(2008-11#2)
attention by##4##2##(2008-11#1)(2009-8#1)(2012-12#1)(2013-8#1)
attention compared##2##2##(2011-2#1)(2012-12#1)
attention condition##4##2##(1996-5#1)(2008-8#3)
attention deficit hyperactivity disorder (ADHD)##4##5##(2008-6#1)(2009-9#1)(2013-1#2)
attention deficit hyperactivity disorder##12##4##(2008-11#2)(2008-6#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
attention deficit hyperactivity##13##3##(2008-11#3)(2008-6#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
attention deficit##18##2##(1993-12#1)(1995-1#1)(1996-6#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
attention deficit/hyperactivity disorder##5##3##(1997-8#4)(2011-2#1)
attention deficit/hyperactivity##6##2##(1997-8#4)(2008-4#1)(2011-2#1)
attention devoted to##2##3##(1996-2#1)(2008-2#1)
attention due to its##4##4##(2008-10#1)(2008-11#2)(2009-12#1)
attention due to##7##3##(2008-10#3)(2008-11#2)(2009-12#1)(2010-5#1)
attention for the##2##3##(1997-5#1)(2012-12#1)
attention for##9##2##(1997-5#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#2)(2011-2#1)(2012-12#2)
attention from the##3##3##(2008-9#1)(2009-5#1)(2011-2#1)
attention from##7##2##(1995-5#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
attention given to the##2##4##(2008-3#1)(2008-8#1)
attention given to##4##3##(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
attention had been##2##3##(1996-1#1)(1997-6#1)
attention has been devoted to the##2##6##(1991-2#1)(2008-11#1)
attention has been devoted to##3##5##(1991-2#1)(2008-11#2)
attention has been directed to##2##5##(1993-12#1)(2008-11#1)
attention has been focused on##3##5##(1992-2#1)(2008-10#1)(2008-7#1)
attention has been focussed on##2##5##(2010-9#1)(2013-8#1)
attention has been given to the##7##6##(1993-12#1)(1993-2#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-6#1)(2009-5#1)
attention has been given to##12##5##(1992-1#1)(1993-12#1)(1993-2#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)
attention has been paid to the role of##2##8##(2009-4#1)(2011-1#1)
attention has been paid to the##12##6##(1990-2#1)(1991-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
attention has been paid to##18##5##(1990-2#1)(1991-3#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
attention has been paid##19##4##(1990-2#1)(1991-3#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)
attention has been##42##3##(1990-2#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-12#2)(1993-2#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)(2013-8#1)
attention has focused on##3##4##(1991-12#1)(1993-1#1)(2007-7#1)
attention has focused##4##3##(1991-12#1)(1993-1#1)(2007-7#1)(2012-2#1)
attention has turned to##2##4##(2008-11#1)(2009-12#1)
attention has##50##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1996-6#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2013-2#1)(2013-8#1)
attention have been##2##3##(2008-11#1)(2012-1#1)
attention in health##2##3##(1995-12#1)(2013-1#1)
attention in molecular biology##2##4##(1997-2#1)(1997-4#1)
attention in recent years##4##4##(2008-1#1)(2010-3#1)(2010-9#1)(2013-1#1)
attention in terms of##2##4##(1993-5#1)(2008-10#1)
attention in the literature##3##4##(2008-11#1)(2008-3#1)(2010-3#1)
attention in the##13##3##(1992-12#1)(1995-12#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
attention in##42##2##(1991-6#1)(1992-12#1)(1993-5#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-3#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
attention is directed##3##3##(2008-11#1)(2008-6#1)(2011-2#1)
attention is drawn##2##3##(1990-9#1)(2008-10#1)
attention is given to the##8##5##(1991-6#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-10#1)
attention is given to##14##4##(1990-12#1)(1991-6#1)(1992-3#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-9#1)(2010-10#1)
attention is paid to the##7##5##(1990-6#1)(1991-5#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
attention is paid to##12##4##(1990-6#1)(1991-5#1)(1992-3#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#1)(2011-3#1)
attention is##42##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-5#1)(1995-5#2)(1996-12#1)(1997-4#2)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2010-10#1)(2010-9#1)(2011-2#1)(2011-3#1)
attention must be paid to##7##5##(1992-3#1)(1993-6#1)(1995-5#1)(2008-7#2)(2010-11#1)(2013-1#1)
attention must be##10##3##(1992-3#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-7#2)(2010-11#1)(2010-5#1)(2013-1#1)
attention needs to be given to##2##6##(1992-12#1)(2008-6#1)
attention needs to be paid to the##2##7##(1997-1#1)(2012-12#1)
attention needs to be##5##4##(1992-12#1)(1997-1#1)(2008-6#1)(2008-7#1)(2012-12#1)
attention of an##3##3##(2007-4#1)(2008-6#1)(2008-9#1)
attention of the##4##3##(1991-3#1)(1991-6#1)(2008-10#2)
attention of##14##2##(1991-3#1)(1991-6#1)(1994-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2013-1#1)
attention on a##2##3##(2006-10#1)(2008-6#1)
attention on new##2##3##(1995-12#1)(2012-12#1)
attention on the##9##3##(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
attention on##27##2##(1992-12#1)(1992-2#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-12#1)(1996-1#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-7#1)
attention only##3##2##(2008-10#1)(2009-7#1)(2010-7#1)
attention paid to the##3##4##(2007-11#1)(2008-11#1)(2008-2#1)
attention should be focused on##2##5##(1991-5#1)(2011-2#1)
attention should be paid to the##2##6##(2008-9#1)(2012-2#1)
attention should be paid to##7##5##(1990-2#1)(1991-11#1)(1995-3#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
attention should be##10##3##(1990-2#1)(1991-11#1)(1991-5#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#2)(2012-2#1)
attention should##13##2##(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-2#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#3)(2012-2#1)
attention task performance##2##3##(1991-1#2)
attention task##3##2##(1991-1#2)(2010-7#1)
attention that##2##2##(1995-1#1)(2007-10#1)
attention to a##4##3##(2008-11#1)(2010-5#1)(2012-3#1)(2013-8#1)
attention to an##3##3##(2007-11#1)(2008-8#1)(2011-2#1)
attention to both##2##3##(1993-1#1)(1996-8#1)
attention to detail##2##3##(1996-3#1)(2010-3#1)
attention to male##2##3##(2008-9#1)(2012-3#1)
attention to physical##2##3##(2010-12#1)(2011-2#1)
attention to self##2##3##(2012-12#2)
attention to social##2##3##(2008-8#1)(2010-12#1)
attention to specific##2##3##(2008-11#1)(2009-7#1)
attention to the diagnosis and treatment of##2##7##(2012-2#1)(2013-1#1)
attention to the limited##2##4##(2008-5#1)(2008-6#1)
attention to the need for##2##5##(2008-12#1)(2009-8#1)
attention to the need##3##4##(2008-12#1)(2009-8#1)(2010-4#1)
attention to the needs##2##4##(1994-1#1)(2008-8#1)
attention to the##54##3##(1990-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#3)(1997-8#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
attention to these##4##3##(1991-11#1)(1995-1#1)(2010-5#1)(2011-1#1)
attention to this rare##2##4##(2007-8#1)(2012-12#1)
attention to this##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
attention to what##2##3##(2010-1#1)(2012-3#1)
attention to##161##2##(1990-11#1)(1990-9#2)(1991-1#1)(1991-11#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-8#6)(2008-1#4)(2008-10#9)(2008-11#8)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-7#3)(2009-8#2)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
attention towards##3##2##(1995-12#1)(2008-11#1)(2012-2#1)
attention was paid to the##5##5##(1994-3#2)(2008-10#1)(2008-12#1)(2009-5#1)
attention was paid to##10##4##(1992-6#1)(1994-3#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-1#1)
attention was##15##2##(1992-6#1)(1994-3#2)(1995-12#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-1#1)(2013-7#1)
attention with##5##2##(2008-10#1)(2008-4#1)(2008-9#2)(2012-3#1)
attention##687##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-9#3)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#4)(1991-6#6)(1992-1#3)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#2)(1993-1#4)(1993-11#1)(1993-12#10)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#6)(1994-3#5)(1994-9#1)(1995-1#6)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#12)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#3)(1996-5#1)(1996-6#6)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#3)(1997-8#7)(2006-10#1)(2007-10#2)(2007-11#10)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#6)(2007-8#11)(2008-1#9)(2008-10#46)(2008-11#53)(2008-12#11)(2008-2#7)(2008-3#14)(2008-4#13)(2008-5#8)(2008-6#18)(2008-7#20)(2008-8#23)(2008-9#27)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#6)(2009-8#7)(2009-9#8)(2010-1#9)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#7)(2010-4#4)(2010-5#10)(2010-7#6)(2010-8#2)(2010-9#3)(2011-1#12)(2011-2#28)(2011-3#4)(2012-1#2)(2012-12#19)(2012-2#14)(2012-3#10)(2013-1#24)(2013-2#1)(2013-7#4)(2013-8#10)
attention-deficit##2##1##(2008-11#1)(2008-8#1)
attention-deficit/hyperactivity disorder (ADHD) was##2##4##(2008-2#2)
attention-deficit/hyperactivity disorder (ADHD)##5##3##(2008-2#4)(2011-2#1)
attention-deficit/hyperactivity disorder##14##2##(2008-2#10)(2009-10#1)(2010-9#1)(2011-2#2)
attention/calculation and##2##2##(2008-7#2)
attentional bias##4##2##(2008-2#1)(2009-9#1)(2010-7#1)(2013-8#1)
attentional biases##5##2##(2010-7#5)
attentional control##4##2##(2008-11#1)(2010-6#1)(2012-3#2)
attentional load##2##2##(2013-8#2)
attentional processes##2##2##(1996-2#1)(2008-4#1)
attentional resources##3##2##(2008-6#2)(2009-4#1)
attentional style##2##2##(2008-4#2)
attentional task##2##2##(1996-5#2)
attentional##42##1##(1995-5#2)(1996-2#1)(1996-5#2)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#4)(2008-4#4)(2008-6#2)(2009-2#1)(2009-4#4)(2009-9#1)(2010-6#1)(2010-7#6)(2012-3#2)(2013-8#3)
attentions##2##1##(2010-7#1)(2013-8#1)
attentive##2##1##(2010-7#1)(2012-2#1)
attenuata##4##1##(1993-12#2)(2008-5#1)(2010-3#1)
attenuate the##19##2##(1990-2#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
attenuate##37##1##(1990-2#1)(1990-5#1)(1992-8#1)(1993-12#3)(1993-8#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
attenuated as##2##2##(1991-2#1)(2008-2#1)
attenuated both##2##2##(2008-11#1)(2008-8#1)
attenuated by a##4##3##(1994-2#2)(1994-9#1)(2009-9#1)
attenuated by##24##2##(1990-2#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-5#2)(1997-1#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
attenuated following the addition of HGF##2##6##(2008-11#2)
attenuated following##3##2##(2008-11#2)(2011-2#1)
attenuated in the presence of a##2##6##(1996-5#2)
attenuated in the presence of##3##5##(1996-5#2)(2008-11#1)
attenuated in##10##2##(1990-12#1)(1991-8#1)(1994-11#1)(1996-2#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-7#2)
attenuated light##2##2##(2007-12#1)(2008-1#1)
attenuated live vaccine##2##3##(1997-6#1)(2013-8#1)
attenuated live##3##2##(1997-6#2)(2013-8#1)
attenuated poliovirus##2##2##(1995-5#2)
attenuated the amphetamine-induced inhibition of gastric emptying##2##7##(2013-1#2)
attenuated the##16##2##(1990-12#1)(1993-5#1)(1994-11#1)(1995-12#4)(1995-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
attenuated total reflectance (ATR)##2##4##(2007-12#1)(2008-10#1)
attenuated total reflectance Fourier transform infrared##3##6##(2008-10#3)
attenuated total reflectance infrared##2##4##(2008-10#2)
attenuated total reflectance##9##3##(2007-11#1)(2007-12#1)(2008-10#7)
attenuated total reflectance-Fourier transform infrared spectroscopy##2##6##(2008-10#2)
attenuated total reflection (ATR)##3##4##(1990-2#1)(2008-10#2)
attenuated total reflection Fourier transform infrared##2##6##(2007-12#1)(2008-10#1)
attenuated total reflection infrared spectroscopy##2##5##(2007-12#1)(2008-10#1)
attenuated total reflection spectroscopy##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
attenuated total reflection##14##3##(1990-2#1)(2007-12#3)(2008-10#7)(2008-3#2)(2008-5#1)
attenuated total##29##2##(1990-2#1)(2007-11#1)(2007-12#4)(2008-10#18)(2008-3#3)(2008-5#2)
attenuated virus##2##2##(1995-5#1)(2011-2#1)
attenuated with##3##2##(1994-11#1)(2008-11#1)(2010-12#1)
attenuated##167##1##(1990-12#3)(1990-2#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#4)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#5)(1995-5#8)(1995-8#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#2)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#23)(2008-11#9)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#5)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
attenuated-total-reflection##2##1##(2008-2#1)(2008-3#1)
attenuates the development##2##3##(2008-7#1)(2013-1#1)
attenuates the response to##2##4##(1993-12#2)
attenuates the##11##2##(1993-12#2)(1995-12#2)(1995-5#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
attenuates##35##1##(1991-1#1)(1991-2#1)(1991-9#1)(1993-12#3)(1993-8#1)(1995-12#2)(1995-5#1)(1996-2#2)(1996-5#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-10#3)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
attenuating oxidative stress##2##3##(2008-7#1)(2011-2#1)
attenuating##10##1##(1994-5#1)(1994-6#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-3#1)
attenuation and##5##2##(2007-10#1)(2008-3#3)(2012-2#1)
attenuation at##4##2##(2008-3#2)(2011-2#1)(2012-3#1)
attenuation by##5##2##(2008-11#1)(2008-3#1)(2008-7#3)
attenuation coefficient and##2##3##(2008-3#2)
attenuation coefficient for##3##3##(2008-2#1)(2008-3#2)
attenuation coefficient of##2##3##(2008-2#1)(2008-3#1)
attenuation coefficient##20##2##(2007-12#1)(2008-2#6)(2008-3#13)
attenuation coefficients and##2##3##(2008-2#2)
attenuation coefficients##8##2##(2008-2#7)(2012-1#1)
attenuation correction##2##2##(2012-12#2)
attenuation in##5##2##(1993-3#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-3#1)
attenuation is##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
attenuation of a##2##3##(2008-2#2)
attenuation of low-coherence optical fields##2##5##(2008-3#2)
attenuation of the##7##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-12#1)
attenuation of##28##2##(1992-2#1)(1992-3#1)(1992-9#1)(1993-9#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
attenuation over##2##2##(2008-7#1)(2013-1#1)
attenuation properties of##2##3##(2007-11#1)(2008-3#1)
attenuation properties##4##2##(2007-11#2)(2008-3#2)
attenuation spectrum##4##2##(2008-3#4)
attenuation values##2##2##(2008-7#1)(2012-1#1)
attenuation was##2##2##(1990-7#1)(2007-11#1)
attenuation##133##1##(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-10#2)(2007-11#8)(2007-12#6)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#21)(2008-3#42)(2008-4#1)(2008-7#11)(2008-9#5)(2009-12#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)
attenuator##6##1##(1993-9#1)(2007-11#3)(2008-3#2)
attest to##4##2##(1997-4#1)(2008-11#1)(2008-8#1)(2012-1#1)
attest##5##1##(1997-4#1)(2008-11#1)(2008-8#1)(2012-1#1)(2013-8#1)
attested##2##1##(2008-10#1)(2008-7#1)
attests to##3##2##(2007-11#1)(2008-12#1)(2008-9#1)
attine##4##1##(2008-8#4)
attitude and behaviour##2##3##(2007-12#2)
attitude and general##2##3##(1990-2#1)(2008-10#1)
attitude and practice of##3##4##(2011-2#1)(2013-1#2)
attitude and practice questionnaire for assessing plagiarism##2##7##(2013-1#2)
attitude and practice##9##3##(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#5)
attitude and##19##2##(1990-2#1)(1994-2#2)(1994-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)
attitude by##2##2##(2008-10#1)(2013-8#1)
attitude change##2##2##(1990-11#1)(2008-5#1)
attitude in##4##2##(1991-11#1)(1994-5#1)(2008-1#1)(2010-12#1)
attitude items##2##2##(2009-11#1)(2012-12#1)
attitude objects##3##2##(2009-11#3)
attitude of a##2##3##(2009-10#1)(2011-3#1)
attitude of the##7##3##(1992-12#1)(1993-12#1)(2007-7#1)(2008-1#1)(2009-10#1)(2010-8#2)
attitude of##18##2##(1990-2#2)(1990-6#1)(1992-12#1)(1993-12#1)(2007-7#1)(2008-1#1)(2008-12#2)(2009-10#2)(2010-8#2)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)
attitude that##2##2##(2008-10#1)(2008-5#1)
attitude to and mode of second delivery##2##7##(2011-2#2)
attitude to the##2##3##(1992-3#1)(2007-8#1)
attitude to##9##2##(1990-6#1)(1992-10#1)(1992-3#1)(1996-8#1)(2007-11#1)(2007-8#1)(2011-2#2)(2012-12#1)
attitude toward##7##2##(1996-1#1)(1996-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
attitude towards the##6##3##(1992-5#1)(1994-6#1)(1996-9#1)(1997-3#1)(2008-5#1)(2013-1#1)
attitude towards their abuser##2##4##(2010-3#2)
attitude towards their##3##3##(1993-12#1)(2010-3#2)
attitude towards##18##2##(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-5#1)(2010-3#2)(2012-2#1)(2013-1#2)
attitude##118##1##(1990-11#1)(1990-2#6)(1990-3#1)(1990-6#2)(1991-11#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#5)(2008-9#1)(2009-10#2)(2009-11#4)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-8#3)(2011-1#6)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#13)(2013-7#2)(2013-8#1)
attitudes about obesity##2##3##(2010-10#2)
attitudes about##8##2##(1993-3#1)(2007-12#1)(2008-11#1)(2009-5#1)(2009-9#1)(2010-10#2)(2013-1#1)
attitudes among##4##2##(2008-9#1)(2009-11#1)(2012-2#1)(2013-7#1)
attitudes and behavior##3##3##(2009-7#1)(2013-1#2)
attitudes and behaviors##7##3##(1995-2#1)(2008-12#1)(2009-4#1)(2010-5#1)(2011-1#3)
attitudes and beliefs about##3##4##(2007-12#1)(2009-11#1)(2009-5#1)
attitudes and beliefs##9##3##(1994-12#1)(1995-1#1)(1996-1#1)(2007-12#2)(2009-11#1)(2009-5#1)(2009-9#1)(2013-8#1)
attitudes and expectations##2##3##(1993-1#1)(1993-6#1)
attitudes and experiences of##2##4##(1996-6#1)(1997-3#1)
attitudes and experiences##3##3##(1996-6#1)(1997-3#1)(1997-7#1)
attitudes and practices of##2##4##(1990-8#1)(2008-1#1)
attitudes and practices##7##3##(1990-8#1)(1995-1#1)(2008-1#1)(2008-11#2)(2010-11#1)(2011-2#1)
attitudes and values##2##3##(1996-12#1)(2008-11#1)
attitudes and##58##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
attitudes are##4##2##(1992-2#1)(1994-2#1)(2008-7#1)(2009-9#1)
attitudes concerning##2##2##(1997-5#1)(2011-2#1)
attitudes did##2##2##(2009-9#2)
attitudes for##2##2##(2010-3#1)(2012-3#1)
attitudes in##7##2##(2007-7#3)(2008-11#1)(2008-12#1)(2009-10#1)(2010-2#1)
attitudes of mental##2##3##(2008-11#1)(2013-7#1)
attitudes of nurses##2##3##(1995-3#1)(2010-3#1)
attitudes of the##4##3##(1994-1#1)(1995-5#1)(1996-6#1)(2007-7#1)
attitudes of these##2##3##(2008-1#1)(2013-7#1)
attitudes of##39##2##(1991-2#2)(1993-12#1)(1993-2#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-7#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-7#3)
attitudes regarding##5##2##(1991-5#2)(2010-5#1)(2010-6#1)(2011-2#1)
attitudes related to##2##3##(2007-7#1)(2010-10#1)
attitudes that needed##2##3##(2010-3#2)
attitudes that##8##2##(1994-3#1)(1996-2#1)(2008-9#1)(2010-3#2)(2011-2#1)(2012-3#2)
attitudes to##10##2##(1993-3#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
attitudes toward and##2##3##(2010-12#1)(2013-1#1)
attitudes toward dating conflict##4##4##(2009-7#4)
attitudes toward fatness##6##3##(2007-12#6)
attitudes toward homosexuals##3##3##(1993-1#3)
attitudes toward life and death##3##5##(1992-1#3)
attitudes toward mental health treatment##3##5##(2011-1#3)
attitudes toward the##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
attitudes toward their##3##3##(1994-3#1)(1996-2#1)(2007-12#1)
attitudes toward##56##2##(1991-5#1)(1992-1#3)(1993-1#3)(1994-3#2)(1995-1#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#2)(2007-10#1)(2007-12#8)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#2)(2011-1#5)(2011-2#2)(2012-12#1)(2013-1#4)
attitudes towards Internet use##2##4##(2013-1#2)
attitudes towards cochlear implants##2##4##(2008-9#2)
attitudes towards mental illness##4##4##(2011-2#4)
attitudes towards older people##3##4##(2012-3#3)
attitudes towards smoking##2##3##(1990-6#1)(1995-6#1)
attitudes towards##29##2##(1990-6#1)(1995-6#2)(1996-6#1)(1997-5#1)(1997-6#1)(2007-3#1)(2008-11#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-3#3)(2013-1#4)
attitudes were##5##2##(1991-2#2)(1997-6#1)(2007-12#1)(2008-7#1)
attitudes##313##1##(1990-11#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#5)(1991-5#3)(1992-1#5)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#5)(1995-1#4)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#2)(2007-10#1)(2007-12#16)(2007-2#2)(2007-3#1)(2007-7#9)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#19)(2008-12#8)(2008-3#1)(2008-5#2)(2008-7#9)(2008-9#6)(2009-10#4)(2009-11#4)(2009-4#1)(2009-5#5)(2009-7#7)(2009-8#1)(2009-9#10)(2010-10#9)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#7)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#10)(2011-2#22)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#18)(2013-7#5)(2013-8#3)
attitudinal##7##1##(1993-1#1)(1994-12#1)(1995-1#1)(1996-2#1)(2007-12#1)(2007-7#1)(2010-11#1)
attophilus##2##1##(2008-6#2)
attorney##11##1##(1992-1#1)(1992-2#2)(1994-1#1)(1995-12#1)(1996-5#3)(1997-1#1)(1997-5#2)
attorneys##7##1##(1991-2#1)(1991-3#1)(1995-12#1)(1997-5#1)(2008-11#3)
attract more##2##2##(1990-4#1)(2008-9#1)
attract the##5##2##(1994-1#2)(2007-12#1)(2008-4#1)(2013-1#1)
attract##24##1##(1990-2#1)(1990-4#1)(1993-1#1)(1994-1#3)(1995-3#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-9#1)(2013-1#3)
attractant##2##1##(2008-10#1)(2011-2#1)
attracted a##4##2##(2008-11#1)(2008-4#1)(2010-9#1)(2012-3#1)
attracted by##5##2##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
attracted the##2##2##(2012-2#1)(2013-1#1)
attracted to the##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
attracted to##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-8#1)
attracted##34##1##(1991-2#1)(1994-9#1)(1996-2#1)(1996-6#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
attracting the##3##2##(1990-11#1)(2009-8#1)(2010-9#1)
attracting##17##1##(1990-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#2)(2010-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
attraction and repulsion##2##3##(2008-9#1)(2012-2#1)
attraction and##4##2##(1992-12#1)(2008-9#2)(2012-2#1)
attraction between the##2##3##(2007-5#1)(2008-10#1)
attraction between##3##2##(2007-5#1)(2008-10#2)
attraction of##4##2##(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)
attraction on##2##2##(2008-8#1)(2009-7#1)
attraction to##3##2##(1992-6#2)(2013-8#1)
attraction##26##1##(1992-12#1)(1992-6#2)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#2)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#3)
attractions##2##1##(2008-10#1)(2008-3#1)
attractive alternative for##2##3##(2008-11#1)(2008-8#1)
attractive alternative##12##2##(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-8#1)(2012-2#1)
attractive approach to##5##3##(2007-5#1)(2008-11#1)(2008-7#1)(2009-9#1)(2013-1#1)
attractive approach##7##2##(1997-3#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2013-1#1)
attractive as a##2##3##(2008-11#1)(2011-2#1)
attractive as##12##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-7#1)(2011-2#4)(2012-12#1)
attractive because##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
attractive concept##2##2##(1992-12#1)(2010-10#1)
attractive drug##2##2##(2008-7#1)(2012-2#1)
attractive features of##2##3##(2008-2#1)(2008-3#1)
attractive for use##2##3##(2008-10#1)(2008-7#1)
attractive for##16##2##(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-5#2)(2010-7#1)(2012-12#1)
attractive from##2##2##(2009-7#1)(2010-12#1)
attractive in##3##2##(2008-1#1)(2008-2#1)(2009-7#1)
attractive male characters##2##3##(2008-8#2)
attractive male traits##2##3##(2008-8#2)
attractive male##6##2##(2008-8#6)
attractive potential##2##2##(2009-11#1)(2012-12#1)
attractive properties##3##2##(2008-10#2)(2008-6#1)
attractive prospect##3##2##(1994-12#1)(2012-2#1)(2013-8#1)
attractive sink##3##2##(2008-8#3)
attractive source##2##2##(1994-5#1)(2007-12#1)
attractive target for##7##3##(1995-2#1)(2008-11#2)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
attractive targets for##2##3##(2008-4#1)(2011-2#1)
attractive than the buffer##3##4##(2008-10#3)
attractive than the##4##3##(2008-10#3)(2008-5#1)
attractive than##6##2##(2008-10#5)(2008-5#1)
attractive to the##2##3##(1990-8#1)(2013-8#1)
attractive to##12##2##(1990-8#2)(1994-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
attractive tool for##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
attractive traits##5##2##(2008-8#5)
attractive##196##1##(1990-8#3)(1992-12#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#2)(2008-10#35)(2008-11#11)(2008-2#10)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#21)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#12)(2012-12#4)(2012-2#9)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#3)
attractiveness are##3##2##(2007-12#2)(2008-5#1)
attractiveness of##7##2##(1995-12#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)
attractiveness ratings##2##2##(2007-12#1)(2012-12#1)
attractiveness##30##1##(1994-3#1)(1995-12#1)(2007-12#8)(2008-10#7)(2008-5#6)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
attractor##5##1##(2007-12#3)(2008-8#1)(2012-2#1)
attractors that##2##2##(2007-11#1)(2008-11#1)
attractors##3##1##(2007-11#1)(2008-11#1)(2008-8#1)
attracts##3##1##(2008-2#1)(2008-3#1)(2008-5#1)
attributable mainly to##2##3##(1992-8#1)(2007-12#1)
attributable risk##2##2##(1995-9#1)(2011-1#1)
attributable to a##3##3##(1991-9#1)(2008-10#1)(2008-5#1)
attributable to an##2##3##(1990-12#1)(1991-12#1)
attributable to differences in##2##4##(1995-12#1)(2008-10#1)
attributable to differences##4##3##(1995-12#1)(2008-10#3)
attributable to individual##2##3##(2008-4#1)(2008-7#1)
attributable to its##2##3##(1993-12#1)(2011-1#1)
attributable to the##21##3##(1991-8#1)(1992-11#1)(1992-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-10#1)(2010-7#1)
attributable to##94##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-8#1)
attributable##107##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-2#2)(2012-6#1)(2013-1#1)(2013-8#1)
attribute in##2##2##(2012-5#1)(2013-7#1)
attribute of##3##2##(1991-9#1)(2009-3#1)(2012-2#1)
attribute the##5##2##(1990-8#1)(1992-9#1)(2008-9#1)(2010-2#1)(2012-7#1)
attribute this to the##2##4##(2008-11#1)(2009-12#1)
attribute this to##3##3##(2008-11#1)(2008-2#1)(2009-12#1)
attribute to##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
attribute##26##1##(1990-8#1)(1991-9#1)(1992-9#1)(1996-6#1)(1997-3#3)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-7#1)
attributed mainly to##2##3##(1997-7#1)(2008-3#1)
attributed the##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
attributed this##2##2##(1991-12#1)(2008-4#1)
attributed to Hashimoto's##2##3##(2011-2#2)
attributed to a number of##2##5##(2008-7#2)
attributed to a reduction##2##4##(2008-10#1)(2008-5#1)
attributed to a##26##3##(1990-5#1)(1992-11#1)(1992-3#1)(1993-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#2)(2011-2#2)(2013-1#1)
attributed to an interaction##2##4##(1994-5#1)(1996-5#1)
attributed to an##6##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-4#1)(2012-2#1)
attributed to both##2##3##(1990-5#1)(2013-1#1)
attributed to differences in##3##4##(2008-10#3)
attributed to differences##4##3##(2008-10#4)
attributed to direct##2##3##(1994-8#1)(2011-2#1)
attributed to high##2##3##(2008-10#1)(2008-4#1)
attributed to increased##2##3##(1991-2#1)(1996-8#1)
attributed to its ability to##2##5##(1994-3#1)(2008-10#1)
attributed to its##5##3##(1994-3#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
attributed to the electrostatic##2##4##(1990-12#1)(2008-10#1)
attributed to the formation of##2##5##(1994-3#1)(2008-10#1)
attributed to the higher##2##4##(2008-10#1)(2008-8#1)
attributed to the increase in##2##5##(2008-10#1)(2008-11#1)
attributed to the presence of##2##5##(2008-10#1)(2009-9#1)
attributed to the use of##2##5##(1994-12#1)(2012-2#1)
attributed to the##100##3##(1990-12#2)(1990-5#2)(1991-12#2)(1992-10#1)(1992-3#1)(1992-6#2)(1993-12#1)(1994-12#1)(1994-3#2)(1995-3#1)(1995-5#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#2)(2007-11#5)(2007-12#3)(2008-10#33)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#3)(2009-6#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#1)
attributed to their##6##3##(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#1)(2009-3#1)
attributed to two##2##3##(2008-10#2)
attributed to##289##2##(1990-12#2)(1990-5#4)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#5)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(2006-10#1)(2007-11#7)(2007-12#9)(2007-7#3)(2008-10#67)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#12)(2008-9#11)(2009-10#1)(2009-11#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#5)(2011-2#9)(2012-12#2)(2012-2#7)(2012-3#3)(2012-9#1)(2013-1#3)(2013-8#2)
attributed##312##1##(1990-12#2)(1990-5#4)(1990-8#3)(1991-12#4)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#5)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1996-1#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-7#2)(2006-10#1)(2007-11#7)(2007-12#9)(2007-7#3)(2008-10#72)(2008-11#7)(2008-12#7)(2008-2#3)(2008-3#12)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#13)(2008-9#11)(2009-10#1)(2009-11#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#3)(2011-1#5)(2011-2#10)(2012-12#2)(2012-2#8)(2012-3#3)(2012-9#1)(2013-1#3)(2013-8#2)
attributes and##4##2##(1996-12#1)(2008-11#1)(2008-4#1)(2010-4#1)
attributes associated with##3##3##(2007-4#1)(2008-10#1)(2008-9#1)
attributes for##4##2##(1995-9#1)(2008-5#2)(2012-2#1)
attributes in##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
attributes of a##2##3##(1993-1#1)(2010-8#1)
attributes of microbial communities##2##4##(2008-10#2)
attributes of the##6##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
attributes of##18##2##(1993-1#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)
attributes such as##2##3##(2012-12#1)(2012-2#1)
attributes that##3##2##(1995-12#1)(2013-1#2)
attributes to##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
attributes were##2##2##(2008-5#1)(2010-4#1)
attributes which##2##2##(1993-2#1)(2008-12#1)
attributes##106##1##(1991-5#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-3#5)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-2#2)(1997-3#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#13)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#5)(2010-8#5)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
attributing to##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
attributing##5##1##(1990-3#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
attribution algorithms##2##2##(2008-8#2)
attribution of##6##2##(1991-12#2)(2008-10#2)(2010-8#1)(2011-2#1)
attribution##15##1##(1991-12#2)(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2010-2#4)(2010-8#1)(2011-2#1)
attributions of##2##2##(2010-2#2)
attributions##5##1##(2008-4#1)(2010-2#4)
attrition and##3##2##(1993-2#1)(2008-8#1)(2013-8#1)
attrition rate##2##2##(1994-3#1)(2012-3#1)
attrition##18##1##(1993-1#1)(1993-2#1)(1994-3#6)(1996-3#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-4#1)(2012-3#1)(2013-8#1)
atwhich##2##1##(2008-11#1)(2008-2#1)
atypia##3##1##(2009-12#1)(2011-2#1)(2012-3#1)
atypical and##2##2##(2006-10#1)(2008-3#1)
atypical antipsychotic agents##4##3##(1992-12#2)(2008-4#1)(2008-8#1)
atypical antipsychotic medications##2##3##(2008-6#1)(2009-6#1)
atypical antipsychotic##12##2##(1992-12#2)(1995-3#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)
atypical antipsychotics##5##2##(2008-8#3)(2009-12#1)(2012-3#1)
atypical carcinoid##3##2##(2008-4#1)(2008-8#1)(2009-11#1)
atypical cells##3##2##(2008-11#2)(2012-1#1)
atypical clinical symptoms##2##3##(2008-7#1)(2010-12#1)
atypical clinical##3##2##(1990-5#1)(2008-7#1)(2010-12#1)
atypical features##2##2##(2008-11#1)(2008-12#1)
atypical forms##3##2##(1991-3#1)(2008-11#1)(2008-5#1)
atypical infections##2##2##(2007-11#2)
atypical melanocytes##2##2##(2010-6#2)
atypical mycobacteria##2##2##(2008-11#1)(2010-4#1)
atypical organisms##4##2##(2007-11#4)
atypical patterns of##2##3##(2012-2#2)
atypical pneumonia##4##2##(2007-7#1)(2010-6#3)
atypical presentation and##2##3##(2008-12#1)(2010-10#1)
atypical presentation of##3##3##(2007-10#1)(2007-7#1)(2012-12#1)
atypical presentation##6##2##(2007-10#1)(2007-7#1)(2008-12#1)(2009-8#1)(2010-10#1)(2012-12#1)
atypical protein kinase C by##2##5##(2008-3#2)
atypical protein kinase C##4##4##(2008-3#4)
atypical radiological features##2##3##(2010-5#2)
atypical symptoms##2##2##(2008-10#2)
atypical teratoid/rhabdoid tumor of the##2##5##(2011-2#2)
atypical thymic carcinoid##2##3##(2011-2#2)
atypical##159##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-11#2)(1996-3#1)(2006-10#1)(2007-10#3)(2007-11#8)(2007-12#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#9)(2008-12#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#9)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#7)(2011-1#2)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#1)
atypically##4##1##(2008-10#2)(2008-7#1)(2012-3#1)
atypicals##2##1##(2008-6#2)
au CHU de Yaoundé##2##4##(2011-2#2)
au cours de la grossesse##3##5##(2011-2#1)(2013-1#2)
au cours de##4##3##(2011-2#2)(2013-1#2)
au service d'hématologie et d'oncologie pédiatrique à l'hôpital 20 Août du CHU IBN ROCHD de Casablanca##2##16##(2013-1#2)
au traitement##2##2##(2011-2#2)
au##23##1##(2008-11#2)(2008-5#1)(2009-4#1)(2011-2#8)(2012-3#1)(2013-1#10)
auburn##3##1##(2008-5#3)
auction##2##1##(1994-7#1)(2008-9#1)
audible pop##2##2##(2008-12#2)
audible##5##1##(2008-12#5)
audience and##2##2##(2008-7#1)(2013-1#1)
audience of##2##2##(2008-11#1)(2008-5#1)
audience with##2##2##(2008-7#2)
audience##22##1##(1991-3#1)(1993-1#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2009-6#3)(2010-10#1)(2010-11#1)(2010-2#1)(2013-1#3)
audiences##6##1##(1992-12#1)(1994-3#1)(2008-12#2)(2008-5#1)(2013-1#1)
audio computer-assisted self-interview##2##3##(2013-1#2)
audio frequencies##2##2##(2008-3#1)(2012-2#1)
audio##12##1##(1994-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#3)
audio-recorded##3##1##(2008-9#1)(2012-12#2)
audio-video##2##1##(1993-2#1)(2011-2#1)
audio-visual information##2##2##(2011-1#2)
audio-visual##7##1##(2007-9#1)(2011-1#4)(2012-2#2)
audiograms##2##1##(2008-6#2)
audiologic rehabilitation##2##2##(2007-8#2)
audiological##9##1##(1990-12#3)(1995-6#1)(2008-9#3)(2011-2#2)
audiologists##2##1##(2008-9#2)
audiology##2##1##(1990-12#1)(2012-2#1)
audiometric##2##1##(2008-4#1)(2008-8#1)
audiometry##2##1##(2008-9#2)
audiotaped##2##1##(2008-11#1)(2008-12#1)
audiotapes##2##1##(1994-6#1)(2011-2#1)
audiovisual##3##1##(1995-3#1)(2008-10#1)(2013-8#1)
audit and##7##2##(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
audit can##2##2##(2007-9#1)(2012-2#1)
audit criteria##2##2##(2007-11#2)
audit in##2##2##(1994-12#1)(1996-11#1)
audit inspections##2##2##(2010-4#2)
audit is##2##2##(2007-11#1)(2010-8#1)
audit of the##2##3##(1995-11#1)(2010-12#1)
audit of##11##2##(1992-5#1)(1993-1#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#2)(2010-12#2)(2013-1#1)
audit on##2##2##(1993-1#1)(2007-11#1)
audit should be##3##3##(1991-9#1)(1996-11#2)
audit tool##4##2##(2008-11#3)(2010-12#1)
audit was used to##2##4##(1994-3#1)(2012-12#1)
audit was##3##2##(1994-3#1)(2007-11#1)(2012-12#1)
audit##87##1##(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-5#1)(1993-1#6)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-11#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#1)(1997-8#1)(2007-10#2)(2007-11#9)(2007-12#2)(2007-9#5)(2008-10#2)(2008-11#6)(2008-7#2)(2009-11#1)(2010-12#3)(2010-4#2)(2010-8#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
audited##6##1##(1992-1#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
auditing the##2##2##(1994-2#1)(1996-7#1)
auditing##12##1##(1991-3#1)(1992-1#2)(1994-12#1)(1994-2#1)(1996-1#2)(1996-2#1)(1996-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
audition##4##1##(2008-9#3)(2009-12#1)
auditive##3##1##(1991-6#1)(2011-2#2)
auditor##4##1##(1993-1#3)(1995-6#1)
auditors##3##1##(1996-2#2)(2013-7#1)
auditory and visual##3##3##(2008-8#2)(2012-2#1)
auditory and##7##2##(1995-5#1)(2008-8#2)(2008-9#1)(2012-2#2)(2013-8#1)
auditory attention##5##2##(2008-9#3)(2010-5#2)
auditory brainstem response##6##3##(2008-4#2)(2008-9#4)
auditory canal##11##2##(2006-12#2)(2008-7#4)(2008-9#3)(2011-2#1)(2013-7#1)
auditory cortex and##2##3##(2013-8#2)
auditory cortex of##3##3##(1993-9#1)(1996-2#1)(2010-7#1)
auditory cortex##22##2##(1993-9#3)(1996-2#3)(1996-5#1)(2008-11#4)(2010-12#1)(2010-7#4)(2012-2#3)(2013-8#3)
auditory cue than that##2##4##(2008-1#2)
auditory cue##3##2##(2008-1#3)
auditory cues##3##2##(1995-11#1)(2008-1#1)(2010-9#1)
auditory disorders##3##2##(2008-9#2)(2013-8#1)
auditory evoked potentials##2##3##(2008-12#1)(2008-9#1)
auditory evoked##3##2##(2008-12#1)(2008-9#1)(2011-1#1)
auditory experience##4##2##(2007-10#2)(2008-9#1)(2010-10#1)
auditory feedback##2##2##(2008-2#2)
auditory grouping##2##2##(2009-9#2)
auditory hallucinations##4##2##(2008-2#3)(2012-1#1)
auditory information##3##2##(2008-1#1)(2012-2#1)(2013-1#1)
auditory localization##2##2##(2007-12#1)(2010-5#1)
auditory meatus##2##2##(1994-2#1)(2008-9#1)
auditory modality##3##2##(2008-6#1)(2008-8#2)
auditory nerve potential##2##3##(2008-8#2)
auditory nerve##9##2##(2008-8#5)(2008-9#4)
auditory neuropathy##2##2##(2008-9#2)
auditory performance in##2##3##(2008-9#2)
auditory performance##4##2##(2008-9#3)(2012-2#1)
auditory rehabilitation##5##2##(2008-9#5)
auditory sensation##2##2##(2008-9#2)
auditory sensitivity in mice##2##4##(2008-4#2)
auditory sensory memory##2##3##(1995-12#1)(2008-9#1)
auditory steady-state##2##2##(2008-9#2)
auditory stimulation##5##2##(1991-12#3)(1995-12#1)(2008-2#1)
auditory stimuli##2##2##(2008-11#1)(2009-2#1)
auditory system##9##2##(1995-12#1)(1996-6#1)(2007-7#1)(2008-4#2)(2008-9#2)(2013-1#1)(2013-8#1)
auditory training##2##2##(2008-9#2)
auditory##188##1##(1991-1#1)(1991-12#3)(1993-5#1)(1993-9#3)(1994-2#1)(1995-11#1)(1995-12#3)(1995-5#2)(1996-2#5)(1996-5#7)(1996-6#2)(2006-12#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#8)(2008-11#7)(2008-12#1)(2008-2#9)(2008-4#8)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#55)(2009-2#2)(2009-9#3)(2010-10#1)(2010-12#1)(2010-5#5)(2010-7#4)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#5)(2013-7#1)(2013-8#10)
audits and##2##2##(1992-3#1)(2012-2#1)
audits are##2##2##(1992-2#1)(1994-3#1)
audits of##2##2##(1992-2#1)(2012-2#1)
audits with##2##2##(2010-3#1)(2011-1#1)
audits##31##1##(1992-2#3)(1992-3#2)(1994-12#2)(1994-3#3)(1995-12#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-11#3)(2009-3#1)(2010-3#1)(2011-1#1)(2012-2#7)(2012-3#3)(2013-1#1)
augite##3##1##(2008-10#3)
augment the effect of##2##4##(1993-6#1)(2008-8#1)
augment the effectiveness of##2##4##(2008-11#1)(2008-6#1)
augment the##18##2##(1993-6#1)(1994-8#1)(1995-1#1)(1996-9#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2012-12#2)(2012-3#1)
augment##33##1##(1990-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
augmentation and##2##2##(1995-12#1)(2007-12#1)
augmentation by##2##2##(2010-6#1)(2010-8#1)
augmentation in##2##2##(2010-8#1)(2012-3#1)
augmentation index##3##2##(2007-10#3)
augmentation of the##6##3##(1990-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(2007-12#1)(2008-11#1)
augmentation of##23##2##(1990-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-12#2)(1995-3#1)(2007-12#2)(2008-10#2)(2008-11#7)(2008-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
augmentation techniques##3##2##(2008-12#1)(2008-7#2)
augmentation to##2##2##(1997-3#1)(2007-11#1)
augmentation was##3##2##(2008-11#2)(2012-3#1)
augmentation with##2##2##(2010-8#1)(2013-1#1)
augmentation##59##1##(1990-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-12#4)(1995-3#1)(1997-3#1)(2007-10#3)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#11)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#2)(2010-8#8)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
augmentative##2##1##(2007-12#1)(2008-10#1)
augmented by##13##2##(1991-12#2)(1992-9#1)(1993-11#1)(1993-3#2)(1996-5#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)
augmented in##5##2##(1992-6#1)(1992-8#1)(1993-6#1)(2008-7#1)(2009-6#1)
augmented response##2##2##(1992-9#1)(2013-1#1)
augmented the uptake##2##3##(1993-9#1)(2008-11#1)
augmented the##6##2##(1993-9#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-11#1)(2013-1#1)
augmented up to##2##3##(2008-11#1)(2011-2#1)
augmented with a##2##3##(1993-1#1)(2008-3#1)
augmented with##7##2##(1993-1#1)(2008-11#1)(2008-3#2)(2012-3#3)
augmented##73##1##(1990-2#2)(1990-5#1)(1991-12#2)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
augmenter of liver regeneration##2##4##(2008-8#2)
augmenting the##4##2##(1996-12#1)(1997-2#1)(2008-10#1)(2010-11#1)
augmenting##12##1##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-11#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
augments the##4##2##(1991-9#1)(1995-6#1)(2011-1#1)(2013-1#1)
augments##11##1##(1991-9#1)(1993-12#1)(1993-9#1)(1995-6#1)(1995-8#1)(2008-11#1)(2009-11#1)(2010-7#1)(2011-1#1)(2013-1#2)
aura and ischemic stroke##2##4##(2008-9#2)
aura and##3##2##(2008-9#3)
aura##10##1##(2008-9#8)(2010-4#1)(2011-2#1)
aural##2##1##(2009-7#1)(2012-3#1)
aurantiacus##2##1##(1996-2#2)
aurantium##4##1##(2008-10#2)(2008-5#2)
aurata##5##1##(2008-7#2)(2009-5#3)
auratum subsp##2##2##(2013-7#2)
auratum##3##1##(2013-7#3)
auratus##17##1##(1994-11#1)(2008-1#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#7)(2013-7#2)
auratus)##5##1##(1995-3#1)(2008-5#1)(2008-6#2)(2008-9#1)
aureofaciens NRRL##2##2##(2008-10#2)
aureofaciens##5##1##(2008-10#5)
aureole##6##1##(2008-2#1)(2008-3#5)
aureus (MRSA)##13##2##(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-3#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
aureus V8##3##2##(1990-5#2)(1992-8#1)
aureus and##18##2##(1990-6#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#3)
aureus bacteremia##2##2##(2007-12#2)
aureus cell wall##2##3##(1990-7#1)(1996-12#1)
aureus cells##3##2##(2009-6#1)(2012-2#2)
aureus from##2##2##(1996-12#1)(2012-3#1)
aureus in a##6##3##(2007-12#2)(2008-10#2)(2008-11#1)(2010-8#1)
aureus in##20##2##(1997-4#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#2)
aureus infection##3##2##(2007-12#1)(2011-2#2)
aureus infections##4##2##(2007-7#1)(2008-10#1)(2010-8#1)(2012-2#1)
aureus intramammary infections##3##3##(2012-3#3)
aureus is##7##2##(1995-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-8#1)
aureus isolates were##2##3##(2010-8#2)
aureus isolates##5##2##(2010-8#3)(2012-3#1)(2013-8#1)
aureus protein A##4##3##(1990-8#1)(1994-3#2)(1996-6#1)
aureus skin abscesses##2##3##(2012-2#2)
aureus skin##4##2##(2007-12#1)(2008-12#1)(2012-2#2)
aureus strains##2##2##(2007-12#1)(2010-8#1)
aureus was##4##2##(1996-12#2)(1997-4#1)(2010-5#1)
aureus were##3##2##(1997-3#1)(2011-2#2)
aureus with##2##2##(2008-9#1)(2010-5#1)
aureus##205##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#1)(1991-3#1)(1991-9#3)(1992-6#4)(1992-8#1)(1993-2#1)(1994-3#2)(1995-5#1)(1995-8#3)(1996-12#7)(1996-6#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-8#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#18)(2007-7#10)(2008-10#10)(2008-11#8)(2008-12#10)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#4)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-8#10)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#13)(2012-3#9)(2013-1#4)(2013-8#5)
auricle##2##1##(2007-12#1)(2012-3#1)
auricles##6##1##(2008-5#3)(2011-1#2)(2012-3#1)
auricular acupuncture (AA)##2##3##(2008-10#1)(2008-11#1)
auricular acupuncture##7##2##(2008-10#1)(2008-11#2)(2010-6#4)
auricular##11##1##(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-6#4)
auscultating tape-recorded lung sounds##2##4##(1993-12#2)
auspices##9##1##(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#2)(2008-10#1)(2008-11#1)(2013-7#1)
australia##2##1##(2008-10#1)(2012-2#1)
autapomorphies##3##1##(2008-1#2)(2008-7#1)
auteurs##2##1##(2012-12#1)(2013-1#1)
authentic 5' and 3' ends##2##5##(1994-8#2)
authentic 5'##3##2##(1994-8#2)(2008-11#1)
authentic human##2##2##(1990-2#1)(2008-10#1)
authentic samples##2##2##(1995-3#1)(2008-10#1)
authentic standards##2##2##(1993-11#1)(2008-10#1)
authentic##44##1##(1990-12#2)(1990-2#6)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2009-2#1)(2011-2#2)(2012-3#1)
authenticated by##2##2##(2008-10#1)(2010-5#1)
authenticated##3##1##(1992-9#1)(2008-10#1)(2010-5#1)
authentication and##3##2##(2008-11#2)(2011-2#1)
authentication##10##1##(2008-10#4)(2008-11#3)(2010-4#2)(2011-2#1)
authenticity of tea##2##3##(2008-10#2)
authenticity of the cDNA##3##4##(1990-12#1)(1991-12#1)(1991-5#1)
authenticity of the##5##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1996-6#1)
authenticity of##12##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1996-6#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-11#1)
authenticity##14##1##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1996-6#1)(2008-10#6)(2008-11#1)(2009-9#1)(2010-11#1)
author addresses the##4##3##(1994-3#1)(1996-12#1)(2008-10#1)(2010-3#1)
author addresses##5##2##(1992-3#1)(1994-3#1)(1996-12#1)(2008-10#1)(2010-3#1)
author analyzes the##2##3##(1990-11#1)(1995-5#1)
author analyzes##4##2##(1990-11#1)(1991-3#1)(1993-12#1)(1995-5#1)
author and##5##2##(1991-11#1)(1992-3#1)(1996-12#1)(2008-12#1)(2008-2#1)
author argues that##4##3##(1991-2#1)(1993-2#1)(1994-1#1)(2008-11#1)
author argues##5##2##(1991-2#1)(1993-2#1)(1994-1#1)(2008-11#1)(2011-2#1)
author believes##4##2##(1992-2#1)(1993-3#1)(1996-1#1)(2008-9#1)
author concludes that##2##3##(1993-12#1)(1997-2#1)
author concludes##5##2##(1992-1#1)(1993-12#1)(1997-2#1)(2010-11#1)(2011-2#1)
author describes how##3##3##(1991-12#1)(1992-1#1)(1992-2#1)
author describes the##15##3##(1991-1#2)(1991-2#1)(1991-3#2)(1993-3#1)(1994-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
author describes##30##2##(1991-1#4)(1991-12#1)(1991-2#2)(1991-3#2)(1992-1#2)(1992-12#1)(1992-2#2)(1993-2#1)(1993-3#1)(1994-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2011-3#2)(2012-12#1)
author developed##2##2##(1991-12#1)(1992-3#1)
author discusses how a##2##4##(1992-1#1)(1993-12#1)
author discusses how##7##3##(1991-3#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-12#1)(2010-3#1)
author discusses the problem of##2##5##(1993-2#1)(1996-2#1)
author discusses the##23##3##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#2)(1994-2#2)(1994-6#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)
author discusses##40##2##(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#3)(1993-12#3)(1993-2#4)(1994-12#1)(1994-2#2)(1994-6#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-3#2)
author examines the##7##3##(1991-12#1)(1992-1#2)(1994-3#1)(1995-2#1)(2007-2#2)
author examines##15##2##(1991-12#1)(1992-1#2)(1992-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-2#3)(2010-3#1)(2012-2#1)
author explores##4##2##(1994-2#1)(1995-2#1)(1996-2#1)(2009-6#1)
author has##5##2##(1992-1#1)(2008-8#2)(2009-9#1)(2011-3#1)
author makes##3##2##(1990-12#1)(1993-2#1)(2011-2#1)
author of this##3##3##(1991-1#1)(1992-3#1)(1993-3#1)
author of##7##2##(1991-1#1)(1992-3#1)(1992-6#1)(1993-3#2)(2008-12#1)(2010-10#1)
author offers a##3##3##(1992-12#1)(1992-3#1)(2010-10#1)
author offers##7##2##(1991-12#1)(1992-12#3)(1992-3#1)(1993-1#1)(2010-10#1)
author points to the##2##4##(1997-6#1)(2008-12#1)
author points##3##2##(1996-6#1)(1997-6#1)(2008-12#1)
author presents a##9##3##(1991-3#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-5#1)(2008-9#1)
author presents the##3##3##(1991-2#1)(2007-8#1)(2008-12#1)
author presents##21##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-12#2)(2008-5#1)(2008-9#1)(2012-12#1)
author proposes a##2##3##(1993-2#1)(2008-1#1)
author proposes that##2##3##(1991-1#1)(2011-2#1)
author proposes##4##2##(1991-1#1)(1993-2#1)(2008-1#1)(2011-2#1)
author provides a##4##3##(1993-12#1)(1993-2#1)(1995-2#1)(2008-9#1)
author provides##7##2##(1993-12#1)(1993-2#1)(1995-2#1)(1997-2#1)(2007-2#1)(2008-9#2)
author relates how the##2##4##(1992-2#1)(1994-2#1)
author respectfully##2##2##(2009-9#2)
author responds##2##2##(2007-5#1)(2008-11#1)
author reviews##4##2##(1991-3#1)(2007-11#1)(2007-2#1)(2008-1#1)
author suggests that the##3##4##(1996-12#1)(1997-3#1)(2007-11#1)
author suggests that##6##3##(1991-11#1)(1992-3#1)(1993-2#1)(1996-12#1)(1997-3#1)(2007-11#1)
author suggests##10##2##(1991-11#1)(1991-12#1)(1992-3#1)(1993-2#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-11#1)(2009-5#1)
author summarizes the##3##3##(2009-12#1)(2010-5#1)(2010-8#1)
author summarizes##5##2##(1991-2#1)(1993-6#1)(2009-12#1)(2010-5#1)(2010-8#1)
author to##2##2##(2009-9#1)(2010-3#1)
author was##2##2##(1993-3#1)(2009-9#1)
author##344##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-1#11)(1991-11#4)(1991-12#8)(1991-2#6)(1991-3#11)(1991-6#2)(1991-8#1)(1992-1#13)(1992-12#7)(1992-2#11)(1992-3#11)(1992-6#1)(1993-1#2)(1993-12#8)(1993-2#15)(1993-3#5)(1993-6#5)(1994-1#4)(1994-12#4)(1994-2#6)(1994-3#3)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#10)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#3)(1996-12#8)(1996-2#7)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#2)(2007-10#1)(2007-11#6)(2007-2#10)(2007-5#1)(2007-8#16)(2008-1#7)(2008-10#1)(2008-11#8)(2008-12#8)(2008-2#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#11)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-9#5)(2010-10#2)(2010-11#1)(2010-3#7)(2010-5#1)(2010-8#3)(2011-2#12)(2011-3#3)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)
author's own experience##4##3##(1994-3#1)(2007-8#2)(2008-12#1)
author's own##5##2##(1994-3#1)(2007-8#2)(2008-10#1)(2008-12#1)
author's professional##2##2##(1993-12#1)(2008-1#1)
author's##38##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1996-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
authorial##2##1##(2007-8#2)
authorised##2##1##(1997-6#1)(2011-2#1)
authoritative##4##1##(1991-6#1)(1993-12#1)(1996-1#1)(2008-12#1)
authorities and by the##2##4##(1990-12#1)(2008-11#1)
authorities and the##2##3##(1993-11#1)(1994-3#1)
authorities and##13##2##(1990-12#1)(1993-11#1)(1994-3#1)(1995-3#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
authorities are##2##2##(1994-3#1)(1997-6#1)
authorities have##6##2##(1992-1#1)(1995-6#1)(1997-3#1)(2008-10#3)
authorities in the##3##3##(1997-2#1)(2008-10#2)
authorities in##8##2##(1990-6#1)(1992-11#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#1)
authorities of the##3##3##(1990-6#1)(2008-10#1)(2012-12#1)
authorities of##4##2##(1990-6#1)(2008-10#1)(2009-10#1)(2012-12#1)
authorities or##4##2##(1997-3#2)(2008-7#1)(2010-5#1)
authorities should##4##2##(1991-8#1)(1992-11#1)(1994-2#1)(2007-2#1)
authorities to##6##2##(1990-3#1)(1991-6#1)(2008-7#1)(2011-2#3)
authorities##95##1##(1990-12#1)(1990-3#2)(1990-6#2)(1991-6#3)(1991-8#1)(1992-1#1)(1992-11#5)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-3#1)(1995-6#3)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(2007-2#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-7#2)(2010-3#2)(2010-5#2)(2011-2#13)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
authorities'##4##1##(1995-11#1)(2010-3#1)(2012-12#2)
authority and resources##2##3##(1995-12#1)(2012-3#1)
authority and##8##2##(1991-3#1)(1995-12#1)(1995-2#1)(2007-7#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-3#1)
authority to##6##2##(1991-1#1)(1991-12#1)(1994-12#2)(1997-6#1)(2010-9#1)
authority##49##1##(1991-1#1)(1991-12#5)(1991-3#1)(1992-1#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-11#3)(2008-12#4)(2008-9#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)
authorization bill##4##2##(1995-6#3)(1996-5#1)
authorization of##2##2##(1997-6#1)(2012-2#1)
authorization##12##1##(1990-3#1)(1992-3#1)(1995-6#3)(1996-5#2)(1997-6#2)(2008-5#1)(2009-10#1)(2012-2#1)
authorize##3##1##(1996-1#2)(1997-5#1)
authorized by the##2##3##(1991-12#1)(1995-2#1)
authorized##28##1##(1991-12#1)(1992-3#1)(1994-3#2)(1995-2#2)(1996-2#1)(1996-9#1)(2008-2#2)(2010-1#2)(2011-1#2)(2011-2#3)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
authors advocate##3##2##(1995-5#1)(1996-8#1)(2007-12#1)
authors also make##2##3##(1994-3#1)(2012-3#1)
authors also##12##2##(1990-11#1)(1992-12#2)(1994-3#1)(1994-7#1)(2008-11#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
authors analyze the##2##3##(1995-12#1)(1996-3#1)
authors analyze##5##2##(1991-6#1)(1992-2#1)(1995-12#1)(1995-5#1)(1996-3#1)
authors analyzed##3##2##(1990-6#1)(2010-5#1)(2012-3#1)
authors and readers##3##3##(2010-12#3)
authors and##11##2##(1995-2#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-7#1)(2010-12#3)(2011-2#1)(2013-8#1)
authors anticipate##2##2##(1995-11#1)(1996-12#1)
authors are##11##2##(1996-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#3)
authors argue that##9##3##(1991-12#1)(1993-3#1)(1993-6#1)(1997-3#2)(2007-8#1)(2008-11#2)(2008-12#1)
authors as##3##2##(1991-9#1)(2008-7#1)(2010-7#1)
authors attempt to##2##3##(1995-1#1)(2008-5#1)
authors believe that the##3##4##(2008-5#1)(2008-7#1)(2008-9#1)
authors believe that##9##3##(1993-9#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
authors believe##15##2##(1990-6#1)(1991-4#1)(1993-9#1)(1994-1#1)(1994-6#1)(2007-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
authors call##3##2##(1991-4#1)(1997-3#1)(2008-6#1)
authors come to##2##3##(1990-2#1)(2013-8#1)
authors conclude that the##2##4##(1994-3#1)(2008-11#1)
authors conclude that there##2##4##(1994-2#1)(2008-10#1)
authors conclude that##12##3##(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-1#1)(2008-10#2)(2008-11#1)
authors conclude##16##2##(1990-6#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
authors consider##3##2##(1995-2#1)(2008-5#1)(2013-8#1)
authors considered##2##2##(1991-2#1)(2008-10#1)
authors deal with the##2##4##(1993-2#1)(2008-10#1)
authors deal##3##2##(1990-11#1)(1993-2#1)(2008-10#1)
authors decided##2##2##(1991-6#1)(2007-11#1)
authors demonstrate that##2##3##(2010-10#2)
authors describe a new##2##4##(2008-1#1)(2009-4#1)
authors describe a##24##3##(1991-2#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-5#1)(1995-2#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-7#1)
authors describe the##24##3##(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
authors describe##67##2##(1990-10#1)(1990-8#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-8#2)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-4#2)(2009-9#1)(2010-1#1)(2010-3#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
authors developed a##4##3##(1992-3#1)(1994-3#1)(1996-3#1)(2011-1#1)
authors developed##8##2##(1992-3#1)(1993-12#1)(1994-3#2)(1995-6#1)(1996-3#1)(2011-1#1)(2012-1#1)
authors discuss how##2##3##(1997-6#1)(2008-7#1)
authors discuss the##15##3##(1991-12#1)(1991-4#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-3#1)
authors discuss##31##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#3)(2011-2#2)(2011-7#1)(2012-3#1)
authors emphasize the##4##3##(1990-10#1)(1991-8#1)(2007-11#1)(2011-2#1)
authors estimated the##2##3##(2010-10#1)(2013-1#1)
authors evaluated##4##2##(1991-12#1)(1991-2#1)(1991-6#1)(2011-2#1)
authors examine the##10##3##(1990-6#1)(1991-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-2#1)(2008-2#1)(2010-8#1)
authors examine##14##2##(1990-6#1)(1991-12#2)(1991-2#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-2#1)(2010-8#1)
authors examined the role of##2##5##(1997-3#1)(2012-3#1)
authors examined the##3##3##(1992-12#1)(1997-3#1)(2012-3#1)
authors examined##9##2##(1990-10#1)(1992-12#1)(1993-12#2)(1997-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-3#1)
authors explain the basic##2##4##(2011-7#1)(2012-3#1)
authors explain##3##2##(1990-3#1)(2011-7#1)(2012-3#1)
authors explore##7##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(2010-10#1)
authors find that##2##3##(1993-12#1)(1994-3#1)
authors for##4##2##(2007-12#1)(2007-2#1)(2008-10#1)(2009-3#1)
authors found that##6##3##(1992-5#1)(1995-3#1)(1996-1#3)(2011-2#1)
authors found##10##2##(1992-5#1)(1994-12#1)(1995-3#1)(1996-1#3)(2007-11#1)(2008-1#1)(2011-2#1)(2013-8#1)
authors give a brief##2##4##(1990-8#1)(1995-2#1)
authors give a##3##3##(1990-8#1)(1992-2#1)(1995-2#1)
authors give##5##2##(1990-8#1)(1992-2#1)(1995-2#1)(2007-8#1)(2008-4#1)
authors have also##2##3##(1990-8#1)(2008-2#1)
authors have argued##2##3##(1995-2#1)(1995-5#1)
authors have developed a##3##4##(1993-2#1)(2007-11#1)(2008-9#1)
authors have developed##5##3##(1993-2#1)(2007-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
authors have discussed##2##3##(2007-11#1)(2010-3#1)
authors have identified##2##3##(1993-3#1)(2012-3#1)
authors have shown that##2##4##(1992-6#1)(1997-8#1)
authors have suggested##3##3##(1990-11#1)(1991-12#1)(2013-1#1)
authors have##39##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1995-2#1)(1995-5#1)(1995-9#1)(1997-8#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
authors highlight##2##2##(1996-11#1)(2010-10#1)
authors hypothesize that##5##3##(1993-9#1)(1995-12#1)(2008-11#2)(2010-1#1)
authors identified##3##2##(1995-12#1)(2007-11#1)(2010-10#1)
authors identify##3##2##(1992-12#1)(1996-2#1)(2008-2#1)
authors in the##2##3##(1992-12#1)(2011-2#1)
authors in##7##2##(1992-12#1)(1994-2#1)(2008-5#1)(2009-7#2)(2011-2#1)(2013-7#1)
authors of the##3##3##(2009-10#1)(2012-3#2)
authors of this##8##3##(1993-3#1)(1996-12#1)(1997-4#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
authors of##14##2##(1993-3#1)(1994-3#1)(1996-12#2)(1997-4#1)(2008-3#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-3#3)(2013-1#2)
authors offer##2##2##(1994-2#1)(2007-8#1)
authors performed##4##2##(1993-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
authors present a##17##3##(1991-6#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
authors present the##14##3##(1991-12#1)(1993-2#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-3#1)
authors present their##2##3##(1990-5#1)(1995-5#1)
authors present##47##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#2)(1995-5#1)(1997-1#1)(2007-10#1)(2007-11#4)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#4)(2009-3#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#2)
authors propose a##6##3##(1996-1#1)(1996-3#1)(2007-11#1)(2010-6#1)(2013-1#2)
authors propose##12##2##(1993-12#1)(1995-11#1)(1996-1#1)(1996-3#1)(2007-11#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#2)
authors provide a##2##3##(1997-1#1)(2008-9#1)
authors provide##7##2##(1992-2#1)(1997-1#1)(2006-7#1)(2008-11#1)(2008-9#3)
authors recommend##11##2##(1991-2#1)(1993-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-9#3)(2011-2#1)(2012-3#1)
authors reflect##2##2##(1995-2#1)(2011-2#1)
authors report on the##2##4##(1992-10#1)(1996-2#1)
authors report on##12##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-9#1)(1996-2#2)(1996-3#1)(2006-12#2)
authors report the results of##3##5##(1990-9#1)(1993-12#1)(1997-6#1)
authors report the##15##3##(1990-9#1)(1991-11#2)(1993-12#1)(1993-9#1)(1994-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)
authors report two cases of##2##5##(1992-5#1)(2013-7#1)
authors report##86##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-5#4)(1992-8#1)(1993-12#1)(1993-5#3)(1993-9#6)(1994-2#1)(1994-3#1)(1994-6#1)(1996-2#2)(1996-3#2)(1997-3#1)(1997-6#1)(2006-12#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#6)(2009-10#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#3)
authors respond##3##2##(2008-11#2)(2013-1#1)
authors review the##17##3##(1990-2#1)(1992-10#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-7#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#2)
authors review##25##2##(1990-2#1)(1991-2#1)(1992-10#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-8#1)(2011-2#3)
authors reviewed##5##2##(1991-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
authors suggest a##2##3##(1990-9#1)(2013-1#1)
authors suggest that the##4##4##(1994-1#1)(1996-1#1)(2007-8#1)(2011-2#1)
authors suggest that##11##3##(1994-1#1)(1996-1#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#3)
authors suggest##17##2##(1990-9#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#3)(2013-1#1)
authors to##13##2##(1991-2#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1997-3#1)(2007-8#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#3)
authors underline the##2##3##(1990-6#1)(1997-6#1)
authors underline##3##2##(1990-6#1)(1996-3#1)(1997-6#1)
authors use##5##2##(1994-3#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-10#1)
authors using##5##2##(1996-4#1)(2008-10#1)(2008-7#2)(2009-9#1)
authors were##2##2##(2008-10#1)(2010-8#1)
authors##836##1##(1990-10#5)(1990-11#5)(1990-12#2)(1990-2#6)(1990-3#7)(1990-5#2)(1990-6#6)(1990-8#4)(1990-9#6)(1991-1#1)(1991-11#9)(1991-12#14)(1991-2#10)(1991-3#5)(1991-4#5)(1991-5#1)(1991-6#10)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#3)(1992-12#10)(1992-2#9)(1992-3#5)(1992-5#11)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#5)(1993-11#3)(1993-12#19)(1993-2#10)(1993-3#11)(1993-5#8)(1993-6#12)(1993-9#12)(1994-1#5)(1994-11#1)(1994-12#6)(1994-2#13)(1994-3#15)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#7)(1995-11#3)(1995-12#5)(1995-2#11)(1995-3#9)(1995-5#4)(1995-6#2)(1995-9#1)(1996-1#5)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#13)(1996-4#1)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#11)(1997-4#1)(1997-6#4)(1997-8#1)(2006-10#1)(2006-12#3)(2006-7#3)(2007-10#2)(2007-11#22)(2007-12#4)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#24)(2008-1#10)(2008-10#25)(2008-11#29)(2008-12#7)(2008-2#9)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#11)(2008-7#23)(2008-8#7)(2008-9#27)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-7#3)(2009-9#3)(2010-1#4)(2010-10#15)(2010-11#2)(2010-12#11)(2010-2#2)(2010-3#8)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#17)(2011-2#44)(2011-3#2)(2011-7#4)(2012-1#5)(2012-12#10)(2012-2#4)(2012-3#18)(2013-1#16)(2013-7#2)(2013-8#11)
authors' experience##6##2##(1990-10#1)(2008-12#1)(2009-11#1)(2010-11#1)(2011-3#1)(2012-12#1)
authors' own experience##3##3##(2007-11#1)(2011-3#1)(2013-1#1)
authors' own##8##2##(1992-3#2)(2007-11#3)(2007-8#1)(2011-3#1)(2013-1#1)
authors'##67##1##(1990-10#1)(1990-11#1)(1990-9#1)(1992-1#1)(1992-3#2)(1993-12#2)(1993-3#2)(1993-9#2)(1994-3#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-11#8)(2007-12#9)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-3#2)(2012-12#1)(2012-3#2)(2013-1#1)
autism and##4##2##(2007-8#1)(2008-11#1)(2012-2#1)(2012-3#1)
autism are##3##2##(1995-5#1)(2008-11#1)(2012-3#1)
autism in##4##2##(2008-11#1)(2012-12#2)(2012-2#1)
autism is##5##2##(1997-8#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
autism spectrum disorder##3##3##(2012-12#1)(2013-1#2)
autism spectrum disorders##10##3##(2008-11#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-2#3)
autism spectrum##14##2##(2008-11#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
autism##71##1##(1991-2#3)(1995-1#1)(1995-5#2)(1997-8#5)(2007-12#1)(2007-8#9)(2008-1#1)(2008-11#9)(2008-3#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#3)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#9)(2013-1#5)(2013-8#1)
autistic children and##2##3##(1995-5#1)(1997-8#1)
autistic children##4##2##(1995-5#2)(1997-8#2)
autistic disorder##2##2##(2008-3#1)(2012-2#1)
autistic disorders##2##2##(1997-8#1)(2012-2#1)
autistic features##3##2##(2008-11#2)(2012-1#1)
autistic symptoms##2##2##(2008-11#2)
autistic##25##1##(1995-5#2)(1997-8#4)(2007-8#1)(2008-11#8)(2008-3#3)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
auto##7##1##(1996-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-12#2)
auto- and##2##2##(1992-6#1)(2008-9#1)
auto-##3##1##(1992-6#1)(2008-10#1)(2008-9#1)
auto-antibodies##4##1##(2008-1#1)(2008-7#2)(2011-2#1)
auto-antibody##2##1##(2011-2#2)
auto-immune##2##1##(1990-6#1)(2013-8#1)
auto-oxidation##4##1##(2008-10#1)(2008-5#3)
auto-oxidized##2##1##(1990-8#2)
autoactivation##2##1##(1991-9#1)(1994-5#1)
autoantibodies against##5##2##(1991-4#2)(1995-3#1)(1996-11#1)(2010-4#1)
autoantibodies and##6##2##(1990-5#1)(1993-2#1)(2008-10#3)(2010-5#1)
autoantibodies in##8##2##(1992-8#1)(1995-3#2)(1997-5#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
autoantibodies to##4##2##(2008-4#1)(2010-4#1)(2012-3#1)(2013-7#1)
autoantibodies were##4##2##(1990-11#1)(1991-8#1)(1995-2#1)(2013-1#1)
autoantibodies##61##1##(1990-11#2)(1990-5#1)(1991-12#1)(1991-4#3)(1991-8#1)(1992-12#3)(1992-8#3)(1993-2#1)(1994-12#2)(1995-2#1)(1995-3#3)(1996-11#5)(1996-12#1)(1996-5#1)(1997-5#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#6)(2012-3#6)(2013-1#2)(2013-7#5)
autoantibody and##3##2##(2013-1#2)(2013-7#1)
autoantibody levels##2##2##(2007-5#1)(2008-4#1)
autoantibody to##2##2##(1991-12#1)(2013-1#1)
autoantibody##14##1##(1991-12#1)(1992-9#1)(1994-12#1)(1996-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#2)(2010-12#1)(2013-1#3)(2013-7#1)
autoantigen##5##1##(1992-8#2)(1995-12#1)(1995-2#2)
autoantigenic##2##1##(1993-2#1)(1994-8#1)
autoantigens##6##1##(1995-2#1)(1995-3#3)(1997-8#1)(2006-10#1)
autoassociative neural networks##2##3##(2008-10#2)
autoassociative##3##1##(2008-10#2)(2008-11#1)
autobiographical memory impairment##3##3##(2009-2#3)
autobiographical memory##18##2##(2008-11#1)(2008-2#7)(2008-4#1)(2009-2#8)(2010-8#1)
autobiographical##19##1##(2008-11#1)(2008-2#8)(2008-4#1)(2009-2#8)(2010-8#1)
autocatalytic activation##2##2##(1992-6#1)(2008-1#1)
autocatalytic##15##1##(1991-2#1)(1992-6#2)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#2)(2008-1#1)(2008-10#5)
autocatalytically##3##1##(1991-5#1)(1993-6#1)(1995-6#1)
autochthonous citizens##2##2##(1992-5#2)
autochthonous inputs##2##2##(1992-3#1)(2008-9#1)
autochthonous sources##2##2##(2008-9#1)(2013-1#1)
autochthonous##10##1##(1992-3#1)(1992-5#2)(2008-10#2)(2008-4#1)(2008-9#2)(2010-4#1)(2013-1#1)
autoclaved or##3##2##(2008-10#2)(2008-11#1)
autoclaved pistachio shoots##2##3##(2008-10#2)
autoclaved rockwool##3##2##(2008-10#3)
autoclaved soil##2##2##(2008-10#1)(2008-12#1)
autoclaved##18##1##(2008-10#15)(2008-11#1)(2008-12#1)(2013-1#1)
autoclaving of##2##2##(2007-7#2)
autoclaving##7##1##(1995-11#1)(1995-3#1)(2007-7#2)(2008-11#2)(2008-5#1)
autocollimation##2##1##(2008-2#1)(2008-3#1)
autocorrelation analysis##4##2##(2008-10#4)
autocorrelation and the##2##3##(2008-2#1)(2008-3#1)
autocorrelation and##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
autocorrelation function for##4##3##(2008-3#3)(2008-8#1)
autocorrelation function is##2##3##(2008-2#2)
autocorrelation function of the##5##4##(2007-11#1)(2008-3#4)
autocorrelation function of##8##3##(2007-11#1)(2008-2#2)(2008-3#4)(2010-8#1)
autocorrelation function##23##2##(2007-11#2)(2008-10#1)(2008-2#6)(2008-3#12)(2008-8#1)(2010-8#1)
autocorrelation functions##9##2##(1992-9#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-8#1)
autocorrelation in##4##2##(2007-12#1)(2008-10#1)(2008-8#2)
autocorrelation measurements##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
autocorrelation of the##4##3##(2007-12#3)(2008-3#1)
autocorrelation of##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#2)
autocorrelation properties##2##2##(2007-12#1)(2008-3#1)
autocorrelation traces##2##2##(2007-11#2)
autocorrelation##91##1##(1992-9#1)(2007-11#9)(2007-12#10)(2008-10#17)(2008-11#1)(2008-2#17)(2008-3#22)(2008-7#1)(2008-8#8)(2009-11#1)(2010-8#1)(2013-1#2)(2013-7#1)
autocorrelator with##2##2##(2007-11#1)(2007-12#1)
autocorrelator##8##1##(2007-11#4)(2007-12#2)(2008-2#2)
autocovariance##2##1##(2008-3#2)
autocratic##2##1##(1993-2#1)(2013-7#1)
autocrine and paracrine##9##3##(1992-9#1)(1995-8#1)(2006-10#1)(2008-4#4)(2013-1#1)(2013-7#1)
autocrine and/or paracrine##3##3##(1992-9#1)(1993-3#1)(2008-4#1)
autocrine function##2##2##(1993-3#1)(1994-2#1)
autocrine growth factor in##3##4##(1990-7#1)(1993-9#2)
autocrine growth factor##4##3##(1990-7#1)(1993-9#2)(2008-4#1)
autocrine growth of##2##3##(2008-11#2)
autocrine growth##8##2##(1990-7#1)(1993-9#2)(2008-11#3)(2008-4#1)(2008-6#1)
autocrine loop##5##2##(1990-5#1)(2008-11#1)(2008-4#1)(2010-11#2)
autocrine or##2##2##(1990-5#1)(2008-4#1)
autocrine##48##1##(1990-2#1)(1990-5#2)(1990-7#1)(1992-9#3)(1993-3#3)(1993-9#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#1)(2006-10#1)(2008-11#6)(2008-4#11)(2008-5#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
autocrine/paracrine##4##1##(1993-3#2)(2008-9#1)(2010-11#1)
autoencoder##2##1##(2010-8#2)
autoencoders##4##1##(2010-8#4)
autoepitopes##4##1##(1995-2#4)
autofluorescence from##3##2##(2008-3#2)(2009-12#1)
autofluorescence imaging##2##2##(2009-4#1)(2011-7#1)
autofluorescence in##3##2##(1996-12#1)(2008-3#1)(2009-12#1)
autofluorescence spectroscopy##3##2##(2008-2#2)(2008-3#1)
autofluorescence##23##1##(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#8)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2011-1#2)(2011-2#2)(2011-7#1)
autofluorescent proteins##2##2##(2008-1#1)(2008-9#1)
autofocus##4##1##(2007-12#1)(2008-2#3)
autogenic bone grafts##3##3##(2007-11#2)(2007-8#1)
autogenic##6##1##(1991-2#1)(2007-11#2)(2007-8#1)(2012-12#1)(2012-3#1)
autogenous bone##3##2##(2008-8#1)(2010-3#1)(2010-5#1)
autogenous##11##1##(1996-2#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-3#2)(2012-3#2)
autograft and##4##2##(2009-3#2)(2011-1#1)(2012-3#1)
autograft for##2##2##(2008-7#1)(2013-8#1)
autograft of##2##2##(2006-6#1)(2008-11#1)
autograft patch##3##2##(2007-8#3)
autograft root##3##2##(2007-8#3)
autograft was##2##2##(2010-3#2)
autograft##37##1##(2006-6#3)(2007-8#10)(2008-11#1)(2008-7#4)(2009-3#5)(2010-11#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
autograft)##2##1##(2010-5#1)(2013-1#1)
autografts##8##1##(2006-6#4)(2009-3#3)(2010-3#1)
autoimmune Addison's disease##4##3##(1992-8#2)(2006-10#1)(2012-3#1)
autoimmune MRL-lpr mice##3##3##(1993-3#3)
autoimmune and##5##2##(1991-2#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-3#1)
autoimmune chronic active hepatitis##2##4##(1990-3#1)(1993-5#1)
autoimmune conditions##2##2##(2007-7#1)(2012-3#1)
autoimmune demyelinating##2##2##(2011-2#1)(2012-3#1)
autoimmune destruction of##2##3##(2009-3#1)(2010-11#1)
autoimmune diabetes##8##2##(2007-5#2)(2008-10#3)(2008-3#2)(2009-5#1)
autoimmune disease and##6##3##(1995-2#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
autoimmune disease characterized by##2##4##(1990-5#1)(2010-5#1)
autoimmune disease in##5##3##(1993-3#1)(1996-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
autoimmune disease that##2##3##(2008-4#1)(2010-12#1)
autoimmune disease which##3##3##(2008-5#1)(2012-2#2)
autoimmune disease##47##2##(1990-5#1)(1990-6#1)(1992-3#1)(1993-3#2)(1994-8#2)(1995-12#1)(1995-2#2)(1996-11#3)(1997-8#1)(2007-10#2)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#3)(2009-8#1)(2010-12#2)(2010-5#2)(2011-2#2)(2012-2#2)(2013-8#2)
autoimmune diseases and##3##3##(1993-2#1)(2008-10#1)(2013-8#1)
autoimmune diseases##45##2##(1991-11#1)(1991-5#2)(1992-5#1)(1993-2#1)(1994-8#1)(1997-5#1)(2007-5#4)(2007-7#2)(2008-10#6)(2008-4#2)(2008-7#1)(2010-12#1)(2010-5#3)(2011-2#4)(2012-1#4)(2012-3#4)(2013-1#4)(2013-8#3)
autoimmune diseases)##2##2##(1995-5#1)(2011-2#1)
autoimmune disorder##7##2##(1991-4#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
autoimmune disorders such as##2##4##(2011-2#1)(2013-1#1)
autoimmune disorders##10##2##(1990-5#1)(2006-10#1)(2007-11#1)(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#2)(2013-1#1)
autoimmune encephalomyelitis (EAE)##4##3##(1995-12#1)(2010-12#1)(2012-2#2)
autoimmune encephalomyelitis##8##2##(1995-12#2)(2010-12#2)(2012-2#3)(2013-7#1)
autoimmune etiology##3##2##(2008-4#1)(2012-3#1)(2013-1#1)
autoimmune hemolytic anemia##3##3##(1992-9#1)(1994-3#1)(2010-5#1)
autoimmune hepatitis and##2##3##(1990-9#1)(2011-1#1)
autoimmune hepatitis is##2##3##(1996-11#1)(1996-3#1)
autoimmune hepatitis was##2##3##(2012-2#2)
autoimmune hepatitis##18##2##(1990-9#1)(1996-11#4)(1996-3#2)(2006-10#5)(2008-10#1)(2011-1#3)(2012-2#2)
autoimmune liver disease##3##3##(1992-12#2)(1996-3#1)
autoimmune liver##4##2##(1992-12#2)(1996-3#1)(1997-8#1)
autoimmune mechanisms##2##2##(1997-8#1)(2012-3#1)
autoimmune neurologic diseases##2##3##(2012-3#2)
autoimmune phenomena##2##2##(2007-11#1)(2009-8#1)
autoimmune polyglandular disease type I (APECED)##2##6##(1997-2#2)
autoimmune polyglandular##4##2##(1997-2#2)(2012-3#1)(2013-1#1)
autoimmune reactions towards endocrine pancreas and##2##6##(1994-12#2)
autoimmune reactions##3##2##(1994-12#2)(2008-10#1)
autoimmune response##2##2##(1995-12#1)(2011-2#1)
autoimmune rheumatic diseases##2##3##(1991-5#1)(2006-10#1)
autoimmune syndrome##4##2##(1997-8#2)(2007-7#1)(2012-2#1)
autoimmune thyroiditis##3##2##(1991-8#2)(2007-7#1)
autoimmune##246##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#5)(1993-5#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1996-11#9)(1996-2#1)(1996-3#4)(1997-2#2)(1997-5#1)(1997-8#5)(2006-10#10)(2007-10#2)(2007-11#3)(2007-5#6)(2007-7#7)(2008-1#2)(2008-10#26)(2008-11#1)(2008-3#2)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#7)(2010-6#1)(2011-1#5)(2011-2#15)(2012-1#4)(2012-12#1)(2012-2#13)(2012-3#16)(2013-1#12)(2013-7#3)(2013-8#7)
autoimmune-prone MRL(+/+)##2##2##(2008-10#2)
autoimmune-prone##4##1##(2008-10#4)
autoimmunity and##5##2##(2007-5#1)(2008-10#1)(2008-7#2)(2010-5#1)
autoimmunity in##7##2##(2008-10#4)(2008-7#2)(2008-9#1)
autoimmunity to##3##2##(2008-4#1)(2008-7#2)
autoimmunity was##3##2##(2008-10#3)
autoimmunity##56##1##(1991-8#1)(1992-8#1)(1993-3#2)(1995-5#1)(1997-8#1)(2006-10#1)(2007-5#7)(2008-10#18)(2008-12#1)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#1)(2010-5#6)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
autoinducer##2##1##(1995-2#1)(2009-6#1)
autoinducer-2##2##1##(2008-9#2)
autologous CTL##2##2##(2008-11#2)
autologous and allogeneic##2##3##(2010-5#2)
autologous and allograft limbal##3##4##(2010-10#3)
autologous and##6##2##(2010-10#3)(2010-5#2)(2012-2#1)
autologous blood donation##5##3##(1996-9#4)(2009-3#1)
autologous blood##10##2##(1990-2#1)(1992-9#1)(1996-9#6)(2008-8#1)(2009-3#1)
autologous bone marrow recovery after allogeneic##2##6##(2011-2#2)
autologous bone marrow recovery##3##4##(2011-2#3)
autologous bone marrow transplantation##6##4##(1994-5#2)(1994-8#1)(1995-8#1)(1995-9#1)(1997-3#1)
autologous bone marrow##15##3##(1994-5#2)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1997-3#1)(2006-10#1)(2008-11#1)(2011-2#3)(2012-1#3)
autologous bone##18##2##(1994-5#2)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-7#1)(2011-2#3)(2011-7#1)(2012-1#3)
autologous cells##3##2##(2008-4#1)(2008-8#1)(2012-12#1)
autologous cultured osteoblasts mixed with fibrin##2##6##(2008-11#2)
autologous cultured##3##2##(2008-11#3)
autologous fat##2##2##(2011-2#1)(2012-2#1)
autologous or allogeneic##4##3##(1993-9#2)(1995-2#1)(2009-9#1)
autologous platelet rich plasma (PRP)##2##5##(2007-9#2)
autologous plateletpheresis##3##2##(2007-9#3)
autologous reconstruction##2##2##(2013-1#2)
autologous stem cell transplantation##2##4##(2012-12#2)
autologous stem cell##4##3##(1997-3#1)(2012-12#2)(2012-4#1)
autologous stem##5##2##(1997-3#1)(2012-12#3)(2012-4#1)
autologous transplantation of visceral fat to##2##6##(2012-2#2)
autologous transplantation of##3##3##(2012-10#1)(2012-2#2)
autologous transplantation##4##2##(2012-10#1)(2012-12#1)(2012-2#2)
autologous tumor cells##4##3##(1993-9#3)(1994-5#1)
autologous tumor##5##2##(1993-9#3)(1994-5#1)(1996-10#1)
autologous whole blood donation##2##4##(2007-9#2)
autologous whole blood##4##3##(2007-10#1)(2007-9#3)
autologous##118##1##(1990-12#1)(1990-2#1)(1992-9#1)(1993-9#6)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-9#10)(1997-3#2)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-9#9)(2008-1#1)(2008-10#1)(2008-11#10)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#3)(2009-9#1)(2010-10#3)(2010-5#2)(2011-2#7)(2011-7#1)(2012-1#4)(2012-10#1)(2012-12#9)(2012-2#6)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#4)
autolysin##5##1##(1997-6#4)(2012-2#1)
autolysis##3##1##(1992-12#1)(1992-9#1)(1994-2#1)
autolysosome formation##2##2##(1990-5#2)
autolysosomes##3##1##(1990-5#3)
autolytic##3##1##(1994-5#2)(2008-8#1)
automasking algorithm##3##2##(2012-2#3)
automate the##2##2##(2008-10#2)
automate##8##1##(2008-10#5)(2008-3#1)(2010-10#1)(2011-2#1)
automated DNA##4##2##(1994-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
automated HPLC method##2##3##(1995-2#1)(2008-10#1)
automated HPLC##3##2##(1992-9#1)(1995-2#1)(2008-10#1)
automated algorithm##2##2##(2008-3#1)(2009-11#1)
automated analysis of##2##3##(1991-5#1)(2008-10#1)
automated analysis##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
automated and##15##2##(1990-12#1)(1991-2#1)(1993-9#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
automated apparatus##2##2##(1995-12#1)(2008-10#1)
automated assay##4##2##(1993-12#1)(1995-12#1)(2008-10#2)
automated batch##2##2##(2008-10#2)
automated blood##2##2##(2008-10#1)(2011-1#1)
automated by##3##2##(2008-10#2)(2010-8#1)
automated cell culture platform##2##4##(2008-11#2)
automated cell##5##2##(1996-12#1)(2008-11#4)
automated chemical##2##2##(1997-4#1)(2008-4#1)
automated coagulation analysers##3##3##(2008-10#3)
automated combinatorial##2##2##(2008-5#1)(2009-8#1)
automated continuous flow##2##3##(2008-10#2)
automated continuous##3##2##(2008-10#3)
automated data##2##2##(2010-5#1)(2013-1#1)
automated database##3##2##(2008-11#2)(2008-4#1)
automated determination of##3##3##(2008-10#2)(2012-1#1)
automated device##3##2##(2010-7#3)
automated differential static##2##3##(2008-10#2)
automated discectomy##3##2##(1996-3#3)
automated dissolution##4##2##(2008-10#4)
automated enzymatic##2##2##(1993-9#1)(1997-2#1)
automated equipment##2##2##(1990-2#1)(2008-10#1)
automated external##2##2##(2008-3#1)(2011-2#1)
automated extraction##2##2##(2008-10#2)
automated flow cytometry##2##3##(2008-11#2)
automated flow injection system for##2##5##(2008-10#2)
automated flow injection system##4##4##(2008-10#4)
automated flow injection##7##3##(2008-10#7)
automated flow##10##2##(2008-10#8)(2008-11#2)
automated flow-injection##2##2##(2008-10#2)
automated haematology analyser##2##3##(2008-10#2)
automated high-throughput##3##2##(2008-11#1)(2008-9#1)(2009-7#1)
automated image analysis##2##3##(2008-9#1)(2012-2#1)
automated immunoassay for##2##3##(2008-10#2)
automated immunoassay##3##2##(2008-10#3)
automated in-situ monitoring of total dissolved iron and total dissolved manganese in underground water##2##14##(2008-10#2)
automated instrument##2##2##(2008-10#1)(2008-3#1)
automated liquid handling system##2##4##(2008-10#2)
automated liquid##3##2##(2008-10#2)(2013-1#1)
automated method for segmentation of epithelial##2##6##(2010-8#2)
automated method for##3##3##(2008-10#1)(2010-8#2)
automated method to##2##3##(2008-10#1)(2012-1#1)
automated method##9##2##(2008-10#6)(2010-8#2)(2012-1#1)
automated methodology##2##2##(2008-10#2)
automated methods##2##2##(2008-10#1)(2012-12#1)
automated microscopy##2##2##(1996-12#2)
automated nucleic acid##2##3##(2008-10#1)(2008-4#1)
automated on-line##2##2##(2008-10#2)
automated operation##3##2##(2008-10#2)(2008-7#1)
automated procedures##3##2##(2008-10#2)(2008-4#1)
automated process##4##2##(2008-10#2)(2010-1#1)(2010-5#1)
automated sample handling in##2##4##(2008-10#1)(2008-9#1)
automated sample handling##5##3##(1997-6#1)(2008-10#3)(2008-9#1)
automated sample preparation##4##3##(1991-5#2)(2008-10#2)
automated sample##12##2##(1991-5#2)(1997-6#1)(2008-10#8)(2008-9#1)
automated sampling##2##2##(2008-10#1)(2011-2#1)
automated screening##3##2##(1997-4#1)(2008-10#2)
automated sensor system##2##3##(2008-10#1)(2008-3#1)
automated sequential injection##2##3##(2008-10#2)
automated solid-phase##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
automated solutions that##2##3##(2008-10#1)(2011-2#1)
automated synthesis instrumentation##2##3##(1997-3#1)(1997-4#1)
automated synthesis##4##2##(1997-3#1)(1997-4#1)(2008-4#2)
automated system for liquid-liquid extraction##2##5##(2008-10#2)
automated system for the##3##4##(2008-10#3)
automated system for##8##3##(2008-10#6)(2008-3#1)(2010-12#1)
automated system to perform##2##4##(2008-10#2)
automated system to##3##3##(2008-10#2)(2008-3#1)
automated system##20##2##(1991-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#1)(2010-12#2)
automated systems##5##2##(2008-10#3)(2008-2#1)(2010-8#1)
automated target-based##2##2##(1997-4#2)
automated test methods##3##3##(2008-10#3)
automated test##6##2##(2008-10#6)
automated ultrasonic##2##2##(2008-10#1)(2010-8#1)
automated using##2##2##(2008-10#2)
automated##373##1##(1990-12#2)(1990-2#3)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-2#3)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-12#6)(1996-3#4)(1997-2#5)(1997-3#2)(1997-4#8)(1997-6#4)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#175)(2008-11#15)(2008-2#9)(2008-3#13)(2008-4#16)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#8)(2011-1#5)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#3)
automatic alignment procedure is##2##4##(2008-2#2)
automatic analyser##4##2##(2008-10#4)
automatic analysis of##2##3##(2008-10#1)(2009-10#1)
automatic and##8##2##(2008-10#7)(2008-3#1)
automatic assay##2##2##(1991-5#1)(2008-10#1)
automatic associations##2##2##(2010-8#2)
automatic determination of##5##3##(2008-10#3)(2008-3#2)
automatic determination##6##2##(2008-10#4)(2008-3#2)
automatic filtration##2##2##(2008-10#2)
automatic flow##3##2##(2008-10#3)
automatic measurement of##2##3##(2008-11#1)(2008-4#1)
automatic membrane inlet mass spectrometric##2##5##(2008-10#2)
automatic method for the determination of##3##6##(2008-10#3)
automatic method for the##4##4##(2008-10#4)
automatic method for##6##3##(2008-10#4)(2008-3#2)
automatic method##9##2##(2008-10#6)(2008-2#1)(2008-3#2)
automatic methods for##2##3##(2008-10#1)(2009-9#1)
automatic methods##4##2##(2008-10#3)(2009-9#1)
automatic monitoring##2##2##(2008-10#1)(2008-11#1)
automatic potentiometric##2##2##(2008-10#2)
automatic procedure##2##2##(2008-10#2)
automatic processing##3##2##(2008-2#1)(2008-8#2)
automatic segmentation of##2##3##(2010-4#1)(2010-8#1)
automatic segmentation##3##2##(2010-4#2)(2010-8#1)
automatic self-associations##2##2##(2010-8#2)
automatic system based on##2##4##(2008-10#2)
automatic system##3##2##(2008-10#2)(2011-2#1)
automatic target recognition (ATR) system##2##5##(2008-2#1)(2008-3#1)
automatic target recognition##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
automatic titration##2##2##(2008-10#2)
automatic##164##1##(1990-12#1)(1990-8#4)(1991-12#1)(1991-5#2)(1991-8#1)(1992-8#1)(1997-2#1)(2006-4#1)(2007-12#2)(2007-8#3)(2008-10#71)(2008-11#3)(2008-2#11)(2008-3#15)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#3)(2009-12#1)(2009-9#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#10)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
automatically analyzed by##2##3##(1994-6#1)(2008-10#1)
automatically analyzed##3##2##(1994-6#1)(2008-10#1)(2008-2#1)
automatically and##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
automatically be##3##2##(1996-2#1)(2008-2#1)(2009-12#1)
automatically determined##2##2##(2008-3#1)(2010-8#1)
automatically extracted##2##2##(2008-3#1)(2010-5#1)
automatically generates##2##2##(1996-2#1)(2008-11#1)
automatically performs##2##2##(2008-10#1)(2008-3#1)
automatically##82##1##(1991-5#1)(1993-12#1)(1994-6#2)(1995-12#2)(1996-2#2)(2007-11#2)(2007-12#2)(2008-10#20)(2008-11#5)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
automating the##6##2##(1993-2#1)(2008-10#3)(2008-2#1)(2012-12#1)
automating##9##1##(1993-2#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-5#1)(2012-12#1)
automation and##11##2##(1992-11#1)(2008-10#9)(2008-3#1)
automation as one##2##3##(2008-10#2)
automation as##5##2##(2008-10#5)
automation can##2##2##(2008-10#2)
automation development of pharmaceutical##2##4##(2008-10#2)
automation development##3##2##(2008-10#3)
automation group##2##2##(2008-10#2)
automation is##3##2##(2008-10#3)
automation of the##7##3##(1991-1#1)(2008-10#6)
automation of##18##2##(1991-1#1)(1991-5#1)(1996-12#1)(2008-10#13)(2010-8#1)(2011-2#1)
automation options##2##2##(2008-10#2)
automation support must##2##3##(2008-10#2)
automation system##2##2##(2007-12#2)
automation##110##1##(1991-1#1)(1991-5#1)(1992-11#2)(1994-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#92)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
automatized##2##1##(1993-9#1)(1997-6#1)
automaton##2##1##(2008-1#1)(2009-7#1)
automobile catalysts##2##2##(2008-10#1)(2008-11#1)
automobile emission##2##2##(2008-11#2)
automobile##13##1##(1996-10#1)(1997-6#1)(2008-10#4)(2008-11#6)(2012-2#1)
automotive catalysts are##2##3##(2008-11#2)
automotive catalysts##3##2##(2008-11#3)
automotive industry##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
automotive##16##1##(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#2)
autonomic and##3##2##(2008-4#1)(2008-7#1)(2009-2#1)
autonomic control of##2##3##(2011-2#1)(2012-3#1)
autonomic dysfunction##9##2##(1994-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
autonomic function tests##2##3##(2008-6#2)
autonomic function##5##2##(2007-10#3)(2008-6#2)
autonomic ganglia##2##2##(1995-12#1)(1996-6#1)
autonomic nerve differentiation##3##3##(2009-7#3)
autonomic nervous system activity##2##4##(2008-3#2)
autonomic nervous system in##2##4##(1997-2#1)(2012-2#1)
autonomic nervous system##16##3##(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
autonomic nervous##20##2##(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-11#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
autonomic neuropathy##9##2##(1990-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#3)
autonomic nuclei##2##2##(2007-10#2)
autonomic plexuses##2##2##(2013-8#2)
autonomic responses##2##2##(1991-1#1)(2008-5#1)
autonomic symptoms##2##2##(1990-9#1)(2008-7#1)
autonomic system (AS)##2##3##(2008-12#2)
autonomic system##4##2##(2008-12#4)
autonomic tone##2##2##(2007-10#2)
autonomic##88##1##(1990-9#3)(1991-1#1)(1991-8#1)(1994-3#1)(1995-12#3)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#10)(2007-12#1)(2008-1#3)(2008-10#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#8)(2012-3#3)(2013-1#2)(2013-8#6)
autonomous and controlled motivation##2##4##(2013-1#2)
autonomous and##3##2##(2012-12#1)(2013-1#2)
autonomous diabetes therapy##2##3##(2009-11#2)
autonomous operation##3##2##(2008-10#2)(2010-7#1)
autonomous region##2##2##(2011-2#1)(2013-8#1)
autonomous regions and##2##3##(2008-7#1)(2008-8#1)
autonomous##43##1##(1990-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#1)
autonomously for##2##2##(2008-10#1)(2010-12#1)
autonomously replicating##4##2##(1995-2#2)(1997-8#1)(2008-8#1)
autonomously##14##1##(1990-6#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-2#2)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-12#1)(2012-12#1)
autonomy and belongingness##2##3##(2009-7#2)
autonomy and##15##2##(1990-6#1)(1992-1#1)(1993-6#2)(1994-3#1)(1996-9#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#2)(2010-11#1)(2013-8#1)
autonomy may##2##2##(1991-2#1)(2008-12#1)
autonomy of##3##2##(2010-8#1)(2012-1#1)(2013-1#1)
autonomy##60##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-3#2)(1993-6#3)(1993-9#3)(1994-1#2)(1994-2#2)(1994-3#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
autooxidation of##2##2##(1992-12#1)(1996-4#1)
autooxidation##4##1##(1992-12#1)(1992-5#2)(1996-4#1)
autophagic process##2##2##(2011-2#1)(2013-1#1)
autophagic vacuoles##3##2##(2008-11#2)(2008-7#1)
autophagic##12##1##(1990-5#1)(2008-11#2)(2008-7#4)(2011-2#2)(2013-1#3)
autophagy and##4##2##(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
autophagy has##3##2##(2008-7#1)(2012-1#2)
autophagy in##4##2##(2008-11#2)(2008-7#1)(2012-1#1)
autophagy is##2##2##(2008-7#1)(2012-3#1)
autophagy##32##1##(2008-11#4)(2008-7#9)(2012-1#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)
autophagy-dedicated##2##1##(2013-1#2)
autophosphorylated EGF-R##2##2##(1995-6#2)
autophosphorylated##6##1##(1992-6#1)(1992-9#1)(1995-6#2)(1995-8#2)
autophosphorylation and##5##2##(1990-11#1)(1991-12#2)(1995-2#1)(1995-8#1)
autophosphorylation at##2##2##(1994-6#1)(1995-2#1)
autophosphorylation in##3##2##(1993-8#1)(1994-11#1)(1994-6#1)
autophosphorylation of the insulin receptor##2##5##(1990-11#1)(1991-12#1)
autophosphorylation of the##4##3##(1990-11#1)(1991-12#1)(1993-8#1)(1995-6#1)
autophosphorylation of##7##2##(1990-11#1)(1991-11#1)(1991-12#1)(1993-8#1)(1995-2#2)(1995-6#1)
autophosphorylation sites##6##2##(1995-2#4)(1995-6#1)(1996-2#1)
autophosphorylation##38##1##(1990-11#2)(1990-12#1)(1991-11#1)(1991-12#4)(1992-10#1)(1992-12#1)(1993-11#1)(1993-6#2)(1993-8#4)(1994-11#1)(1994-6#3)(1995-2#10)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)
autopolyploids##2##1##(2007-12#1)(2008-5#1)
autoprocessing##4##1##(1991-12#1)(1995-3#3)
autopsies performed##2##2##(2008-11#1)(2010-6#1)
autopsies##7##1##(1993-2#1)(1993-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-6#1)(2012-2#1)
autopsy case##3##2##(1995-11#1)(2011-2#2)
autopsy cases##3##2##(1995-3#1)(1996-5#1)(2007-8#1)
autopsy findings##2##2##(1995-11#1)(1996-11#1)
autopsy from##2##2##(1994-7#1)(1996-9#1)
autopsy in##2##2##(2008-5#1)(2008-9#1)
autopsy reports##2##2##(2006-8#1)(2012-12#1)
autopsy revealed##3##2##(2008-7#1)(2009-4#1)(2012-12#1)
autopsy study##2##2##(2008-7#2)
autopsy was performed##2##3##(1997-8#1)(2013-1#1)
autopsy were##2##2##(1992-11#1)(1995-12#1)
autopsy##63##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-9#1)(1994-7#3)(1995-11#5)(1995-12#2)(1995-3#3)(1996-11#5)(1996-5#1)(1996-9#1)(1997-8#2)(2006-8#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#4)(2009-8#1)(2011-2#4)(2012-12#6)(2013-1#3)(2013-7#1)
autoradiographic method##2##2##(1991-10#1)(1995-12#1)
autoradiographic study##2##2##(1993-12#1)(2008-7#1)
autoradiographic##13##1##(1990-12#1)(1990-7#1)(1991-10#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-5#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)
autoradiography and##3##2##(1994-2#1)(1995-12#1)(1996-5#1)
autoradiography of##2##2##(1994-2#1)(1994-3#1)
autoradiography showed##2##2##(1991-12#1)(2008-5#1)
autoradiography using##3##2##(1992-5#1)(1993-12#1)(1993-9#1)
autoradiography was##2##2##(1991-9#1)(1994-5#1)
autoradiography were##2##2##(1993-12#2)
autoradiography##35##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#4)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#3)(1996-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#1)
autoreactive T cells##5##3##(1996-11#1)(2007-5#3)(2011-2#1)
autoreactive T##7##2##(1996-11#1)(2007-5#4)(2010-5#1)(2011-2#1)
autoreactive##8##1##(1996-11#1)(2007-5#4)(2010-5#1)(2011-2#2)
autoreactivity to##2##2##(1995-12#2)
autoreactivity##4##1##(1995-12#3)(2006-10#1)
autoreceptor##3##1##(1993-3#1)(1994-8#2)
autoreceptors in##2##2##(1991-2#1)(1994-8#1)
autoreceptors##7##1##(1991-2#1)(1992-11#1)(1992-3#1)(1994-8#1)(1995-12#1)(2008-7#1)(2008-8#1)
autoregression##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
autoregressive model##2##2##(2008-3#1)(2009-9#1)
autoregressive##12##1##(1996-7#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2013-1#1)
autoregulated##3##1##(1990-11#1)(1993-6#1)(1993-9#1)
autoregulation is##3##2##(1996-6#1)(2009-1#2)
autoregulation of##3##2##(1993-9#1)(1994-12#1)(2007-10#1)
autoregulation##10##1##(1993-9#1)(1994-12#1)(1996-6#2)(2007-10#1)(2008-7#1)(2009-1#3)(2010-9#1)
autoregulatory response##2##2##(2012-3#2)
autoregulatory##10##1##(1997-7#1)(2008-2#1)(2008-6#1)(2008-7#4)(2009-1#1)(2012-3#2)
autosampler cup##4##2##(2008-10#4)
autosampler cups##3##2##(2008-10#3)
autosampler##17##1##(2008-10#16)(2013-1#1)
autosomal SNP genotypes##2##3##(2012-1#2)
autosomal SNPs##2##2##(2008-12#1)(2012-1#1)
autosomal STR##3##2##(2008-12#3)
autosomal disorder##3##2##(1992-5#1)(2008-1#1)(2008-7#1)
autosomal dominant DI##2##3##(1997-8#2)
autosomal dominant and##2##3##(2008-11#1)(2008-7#1)
autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy##3##8##(2007-10#1)(2008-8#1)(2010-12#1)
autosomal dominant cone-rod dystrophy CORD7##2##5##(2008-8#2)
autosomal dominant disease with##2##4##(2008-12#1)(2013-1#1)
autosomal dominant disease##3##3##(2008-12#1)(2013-1#2)
autosomal dominant disorder##11##3##(1997-3#1)(2007-10#1)(2007-4#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
autosomal dominant inheritance##2##3##(2008-7#2)
autosomal dominant neurohypophyseal##2##3##(1997-8#2)
autosomal dominant polycystic kidney disease##6##5##(1997-1#2)(2008-1#1)(2010-6#1)(2013-1#2)
autosomal dominant polycystic kidney##7##4##(1997-1#2)(2008-1#1)(2010-6#1)(2013-1#3)
autosomal dominant##61##2##(1992-6#1)(1993-12#1)(1996-2#1)(1997-1#2)(1997-3#5)(1997-5#1)(1997-6#1)(1997-8#4)(2007-10#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#6)(2008-8#5)(2010-12#1)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#8)(2013-8#1)
autosomal dominantly inherited##2##3##(1996-2#1)(2008-1#1)
autosomal genes##3##2##(1996-5#2)(2008-7#1)
autosomal recessive disease##3##3##(1995-6#1)(1997-1#1)(2011-1#1)
autosomal recessive disorder characterized by##2##5##(2011-1#2)
autosomal recessive disorder##7##3##(1991-8#1)(1991-9#1)(2008-7#1)(2010-3#1)(2011-1#2)(2012-12#1)
autosomal recessive hereditary##2##3##(1997-8#1)(2011-2#1)
autosomal recessive inheritance##2##3##(2007-7#1)(2008-7#1)
autosomal recessive pattern of inheritance##2##5##(2007-8#1)(2012-3#1)
autosomal recessive pattern##3##3##(2007-8#2)(2012-3#1)
autosomal recessive trait##2##3##(1994-9#1)(2007-7#1)
autosomal recessive##42##2##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#5)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)
autosomal##137##1##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#3)(1997-3#5)(1997-5#3)(1997-6#1)(1997-8#5)(2007-10#4)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#4)(2008-1#7)(2008-11#2)(2008-12#9)(2008-2#1)(2008-4#7)(2008-6#2)(2008-7#15)(2008-8#6)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#8)(2013-8#1)
autosomal-dominant##3##1##(1997-5#2)(2009-3#1)
autosomes and##2##2##(2007-11#1)(2008-12#1)
autosomes##11##1##(1993-12#2)(2007-11#1)(2007-12#1)(2008-12#2)(2008-5#2)(2008-7#1)(2010-3#1)(2010-5#1)
autosomic recessive##2##2##(2008-9#2)
autostereoscopic three-dimensional##2##2##(2007-12#1)(2008-3#1)
autotetraploid species##2##2##(1993-3#2)
autotetraploids##2##1##(2008-5#2)
autotoxicus&quot##2##1##(2008-7#2)
autotransfusion##5##1##(1990-2#1)(1992-3#2)(1993-9#2)
autotransplantation of##2##2##(1997-8#1)(2013-1#1)
autotransplantation##10##1##(1997-3#1)(1997-8#1)(2008-8#3)(2013-1#3)(2013-7#1)(2013-8#1)
autotrasplantation##2##1##(2013-1#2)
autotriploid##6##1##(2009-12#6)
autotrophic##2##1##(2011-2#2)
autoxidation of##4##2##(1993-8#1)(1995-2#2)(2008-10#1)
autoxidation##11##1##(1993-8#1)(1994-11#1)(1995-2#3)(2008-10#5)(2008-5#1)
autumn and winter##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
autumn and##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)
autumn of##6##2##(1991-11#1)(1995-3#1)(2008-2#2)(2010-8#1)(2013-1#1)
autumn temperatures##2##2##(2012-7#2)
autumn was##2##2##(2008-10#1)(2010-8#1)
autumn##46##1##(1991-11#1)(1992-6#2)(1994-12#1)(1995-3#1)(1996-12#2)(2008-10#12)(2008-11#1)(2008-2#3)(2008-5#3)(2008-6#1)(2010-8#8)(2011-2#5)(2011-9#1)(2012-7#2)(2013-1#1)(2013-7#2)
autumn)##2##1##(2008-10#1)(2008-8#1)
autumnal##8##1##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#3)(2010-8#1)
autumnata##2##1##(2008-11#2)
aux##9##1##(2008-11#3)(2008-5#1)(2009-10#1)(2013-1#4)
auxiliary beta##2##2##(2008-8#2)
auxiliary cells##2##2##(2008-7#2)
auxiliary component##2##2##(2007-11#2)
auxiliary educational retreat##2##3##(1991-3#2)
auxiliary electrode and##2##3##(2008-10#2)
auxiliary electrode##4##2##(2008-10#4)
auxiliary friendship##3##2##(2010-2#3)
auxiliary personnel##2##2##(1997-8#1)(2008-10#1)
auxiliary procedures##2##2##(2007-7#1)(2008-10#1)
auxiliary telescope##3##2##(2008-3#3)
auxiliary value##2##2##(1991-8#2)
auxiliary##52##1##(1991-1#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#2)(1993-1#1)(1993-6#1)(1995-1#1)(1995-3#3)(1997-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-3#7)(2008-7#3)(2008-8#3)(2010-2#3)(2011-1#1)
auxin and cytokinin##6##3##(2008-12#1)(2008-7#2)(2009-8#3)
auxin flow##3##2##(2009-10#1)(2009-6#1)(2012-1#1)
auxin in the##2##3##(2008-8#1)(2009-8#1)
auxin response##6##2##(2008-9#1)(2011-1#4)(2012-1#1)
auxin responsive##2##2##(2008-9#1)(2009-8#1)
auxin signaling##3##2##(2009-8#2)(2011-1#1)
auxin transport is##2##3##(2009-8#2)
auxin transport##4##2##(2009-8#3)(2012-1#1)
auxin##57##1##(2008-10#5)(2008-12#2)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#5)(2009-6#3)(2009-8#15)(2011-1#10)(2012-1#3)
auxin-induced##3##1##(2008-9#1)(2011-1#2)
auxins combinations##2##2##(2008-12#2)
auxins##8##1##(2008-10#2)(2008-12#2)(2009-8#4)
auxological parameters##2##2##(2011-1#1)(2011-2#1)
auxological##3##1##(2011-1#1)(2011-2#1)(2013-1#1)
auxotroph##9##1##(1990-5#1)(1994-8#2)(2008-10#3)(2008-11#2)(2008-8#1)
auxotrophic mutants##2##2##(2008-10#2)
auxotrophic##8##1##(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-8#1)
auxotrophs##3##1##(1995-6#2)(2008-11#1)
avail##2##1##(1995-3#1)(2008-7#1)
availability and the##4##3##(2008-10#3)(2013-7#1)
availability and use of##5##4##(1991-12#1)(1992-12#1)(1994-12#1)(2008-4#1)(2008-9#1)
availability and use##6##3##(1991-12#2)(1992-12#1)(1994-12#1)(2008-4#1)(2008-9#1)
availability and##29##2##(1991-12#2)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-1#3)(2009-6#1)(2009-8#1)(2010-8#1)(2011-10#1)(2011-2#1)(2013-1#1)(2013-7#2)
availability as##2##2##(2008-10#2)
availability for##5##2##(2008-5#1)(2008-7#1)(2008-8#3)
availability from##2##2##(2008-10#1)(2012-3#1)
availability in a##2##3##(2008-5#1)(2008-9#1)
availability in the##6##3##(1995-12#1)(2008-10#1)(2008-12#1)(2013-7#2)(2013-8#1)
availability in##15##2##(1995-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-7#2)(2013-8#2)
availability is##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
availability of a##11##3##(1994-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
availability of accurate##2##3##(1997-2#1)(2008-11#1)
availability of complete genome##2##4##(2008-4#1)(2008-9#1)
availability of complete##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
availability of food##2##3##(2008-5#1)(2013-1#1)
availability of free##3##3##(2008-10#2)(2008-5#1)
availability of home exercise equipment and##2##6##(2011-2#2)
availability of information on##2##4##(2012-2#2)
availability of information##4##3##(1992-3#1)(2008-10#1)(2012-2#2)
availability of inoculum##2##3##(2008-10#2)
availability of local##2##3##(2012-12#1)(2013-1#1)
availability of material resources##2##4##(2010-11#1)(2011-1#1)
availability of material##3##3##(2010-11#2)(2011-1#1)
availability of metals##2##3##(2008-10#2)
availability of more##3##3##(1992-2#1)(2010-8#1)(2011-2#1)
availability of multiple##2##3##(2008-4#1)(2013-1#1)
availability of new##3##3##(2008-3#2)(2008-9#1)
availability of nursing home substitutes##2##5##(2008-11#2)
availability of radiocaesium in##2##4##(1992-3#2)
availability of radiocaesium##3##3##(1992-3#3)
availability of resources##2##3##(2011-1#1)(2012-2#1)
availability of services##2##3##(1996-2#1)(2010-8#1)
availability of the##20##3##(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
availability of these##4##3##(1993-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
availability of##232##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-6#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#5)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#34)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#10)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#8)
availability on the##2##3##(1992-3#1)(2008-10#1)
availability to##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
availability was##2##2##(2010-8#1)(2012-2#1)
availability were##3##2##(1995-12#1)(1996-5#1)(2008-10#1)
availability##383##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#3)(1991-3#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#7)(1992-6#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-12#5)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#64)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#14)(2008-6#3)(2008-7#15)(2008-8#19)(2008-9#18)(2009-1#4)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#4)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#17)(2012-3#6)(2012-5#1)(2012-8#1)(2013-1#13)(2013-7#7)(2013-8#11)
available DNA##2##2##(1991-2#1)(2008-5#1)
available HMM##2##2##(2008-7#2)
available about the##5##3##(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2013-7#1)
available about##8##2##(1992-10#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-3#1)(2013-7#1)
available agents##3##2##(2008-5#2)(2010-3#1)
available alternatives##3##2##(1991-2#1)(2008-10#1)(2012-2#1)
available and easy##2##3##(2007-8#1)(2008-6#1)
available and provide##2##3##(2008-11#1)(2013-8#1)
available and the##5##3##(1993-3#1)(2007-11#1)(2008-9#2)(2012-2#1)
available and##39##2##(1993-3#1)(1994-12#1)(1994-9#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-1#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
available are##3##2##(1992-2#1)(2009-10#1)(2011-3#1)
available as a##4##3##(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
available as##19##2##(1992-3#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-6#1)(2013-1#2)
available at present##2##3##(2007-12#1)(2007-2#1)
available at that time##2##4##(1994-3#1)(2013-8#1)
available at the time##2##4##(1995-12#1)(2013-8#1)
available at the##9##3##(1992-9#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-8#1)(2013-1#1)(2013-8#1)
available at##21##2##(1992-9#1)(1994-3#3)(1995-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-8#1)(2012-5#1)(2013-1#1)(2013-8#2)
available before##2##2##(2008-10#1)(2008-12#1)
available binding##2##2##(2008-11#1)(2010-11#1)
available biological##2##2##(2008-10#1)(2011-2#1)
available but##3##2##(1992-2#1)(1996-2#1)(2008-12#1)
available by##5##2##(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-2#1)
available can##3##2##(1992-12#1)(2011-2#1)(2012-3#1)
available carbohydrates##2##2##(2010-8#1)(2012-2#1)
available chlorine##4##2##(1991-5#1)(2008-10#3)
available clinical##4##2##(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
available computer##2##2##(1996-12#1)(2010-8#1)
available concerning##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
available data and##2##3##(2008-4#1)(2010-8#1)
available data are not##2##4##(1991-12#1)(1997-3#1)
available data are##5##3##(1991-12#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
available data for##3##3##(2008-3#1)(2008-8#1)(2009-8#1)
available data from##2##3##(2008-10#1)(2011-2#1)
available data in##2##3##(1991-12#1)(2008-7#1)
available data on diet and##2##5##(1990-8#1)(1991-12#1)
available data on the##3##4##(1993-2#1)(2010-8#1)(2013-7#1)
available data on##10##3##(1990-8#1)(1991-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(2009-4#1)(2010-8#2)(2012-12#1)(2013-7#1)
available data regarding the##3##4##(2009-10#1)(2013-1#2)
available data suggest##2##3##(2007-12#1)(2013-1#1)
available data to##5##3##(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)
available databases##4##2##(2008-10#1)(2008-4#1)(2009-10#1)(2009-3#1)
available describing##2##2##(2012-12#1)(2013-7#1)
available energy##2##2##(2008-3#1)(2013-1#1)
available evidence in##2##3##(2008-11#1)(2008-12#1)
available evidence indicates that##3##4##(2008-9#1)(2010-11#1)(2011-2#1)
available evidence on##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
available evidence##23##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
available experimental data##2##3##(1996-2#1)(2013-1#1)
available experimental##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
available expertise and##2##3##(2009-8#2)
available expertise##4##2##(1992-3#1)(2009-8#2)(2010-11#1)
available for a##4##3##(1991-12#1)(1995-11#1)(2008-2#1)(2008-7#1)
available for analysis of##2##4##(1997-4#1)(2008-10#1)
available for analysis##10##3##(1991-8#1)(1997-4#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-3#1)
available for assessing##2##3##(1994-12#1)(2013-1#1)
available for children##2##3##(2011-2#1)(2012-2#1)
available for clinical use in##2##5##(1991-9#1)(2008-6#1)
available for clinical use##4##4##(1991-9#1)(2008-6#2)(2011-2#1)
available for clinical##5##3##(1991-9#1)(1995-5#1)(2008-6#2)(2011-2#1)
available for further##4##3##(1995-8#1)(2008-9#1)(2010-1#1)(2011-1#1)
available for genetic##2##3##(2008-9#1)(2013-1#1)
available for its##3##3##(2007-7#1)(2010-7#1)(2011-2#1)
available for many##2##3##(2008-9#1)(2010-3#1)
available for only##3##3##(2007-12#1)(2007-7#1)(2008-12#1)
available for over##2##3##(1994-2#1)(2012-3#1)
available for research purposes##2##4##(1993-1#1)(2013-1#1)
available for routine##2##3##(2008-1#1)(2008-9#1)
available for the analysis##2##4##(1995-5#1)(2008-10#1)
available for the assessment of##2##5##(2007-8#1)(2009-1#1)
available for the detection of##2##5##(2008-11#1)(2013-7#1)
available for the first dose##2##5##(2012-12#2)
available for the study of##2##5##(2008-11#1)(2008-7#1)
available for the treatment of##6##5##(1993-6#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-5#1)(2012-2#1)
available for the##37##3##(1990-12#1)(1993-6#1)(1995-5#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
available for these##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
available for this##4##3##(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
available for##203##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#12)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#6)(2008-9#9)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#6)(2012-2#7)(2012-3#3)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#2)
available freely##2##2##(2008-8#1)(2010-5#1)
available from a##4##3##(1994-11#1)(1995-3#1)(2008-4#1)(2008-8#1)
available from experimental##2##3##(2008-10#1)(2012-12#1)
available from the literature##2##4##(1993-8#1)(2008-11#1)
available from the##20##3##(1992-2#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#2)(2013-8#10)
available from##44##2##(1990-3#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-3#1)(1996-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#10)
available genetic##2##2##(2008-2#1)(2008-4#1)
available habitat##2##2##(2008-9#1)(2013-7#1)
available has##2##2##(2008-10#1)(2008-7#1)
available herbal##3##2##(2008-5#2)(2012-3#1)
available imaging##3##2##(2008-2#1)(2009-10#1)(2012-2#1)
available in Canada##2##3##(2008-11#1)(2008-6#1)
available in New##2##3##(2008-3#1)(2008-8#1)
available in a##8##3##(1991-1#1)(1993-1#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
available in all##4##3##(1990-6#1)(1997-5#1)(2008-12#1)(2012-2#1)
available in both##2##3##(2008-2#1)(2013-1#1)
available in many##2##3##(2008-4#1)(2012-12#1)
available in modern##2##3##(1997-8#1)(2011-2#1)
available in most##3##3##(2008-11#1)(2008-9#1)(2010-3#1)
available in several formats##2##4##(2007-11#1)(2008-4#1)
available in the Indian market##2##5##(2007-7#1)(2008-5#1)
available in the literature##6##4##(1997-7#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)
available in the near future##2##5##(1994-11#1)(2013-1#1)
available in the##36##3##(1990-11#1)(1991-3#1)(1993-12#1)(1994-11#2)(1994-12#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#4)
available in this##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
available in##110##2##(1990-11#2)(1990-3#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-12#2)(1996-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#3)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-7#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
available information on the##5##4##(1993-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
available information on##7##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
available information##19##2##(1991-9#1)(1992-9#1)(1993-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
available instruments##6##2##(1992-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#2)
available iron##2##2##(1996-12#1)(2008-10#1)
available is the##2##3##(1990-6#1)(1992-12#1)
available is##7##2##(1990-6#1)(1992-12#1)(1993-11#1)(1994-9#1)(2008-10#2)(2012-2#1)
available laser##2##2##(2008-10#1)(2008-2#1)
available literature on the##3##4##(2008-11#2)(2008-4#1)
available literature on##7##3##(2007-10#1)(2007-11#1)(2008-11#3)(2008-4#1)(2011-2#1)
available literature##23##2##(1992-2#1)(1996-12#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
available materials##3##2##(2007-12#1)(2008-10#2)
available measurements##2##2##(2008-3#1)(2011-2#1)
available medical##2##2##(1996-1#1)(2011-2#1)
available methods for##3##3##(2008-10#1)(2009-1#1)(2011-2#1)
available methods##9##2##(1991-8#1)(1992-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-1#1)(2010-11#1)(2011-2#1)(2011-3#1)
available on a##2##3##(1994-3#1)(1997-5#1)
available on the market##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
available on the prevalence of##2##5##(2008-1#1)(2013-8#1)
available on the##31##3##(1994-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#2)
available on this##2##3##(2008-11#1)(2008-5#1)
available on##52##2##(1990-6#1)(1991-6#1)(1993-1#1)(1993-2#1)(1994-12#2)(1994-3#1)(1995-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#2)
available online (www##2##3##(2010-12#2)
available online##4##2##(2009-2#1)(2010-12#2)(2012-3#1)
available only##5##2##(1991-12#1)(1992-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
available optical##2##2##(2008-3#2)
available or##6##2##(1992-12#1)(1993-1#1)(1994-3#1)(2007-7#1)(2008-4#1)(2008-8#1)
available outside of##2##3##(1996-1#1)(2007-11#1)
available over the##2##3##(2008-8#1)(2009-5#1)
available oxygen and##2##3##(1993-6#1)(1996-12#1)
available prior##2##2##(1992-3#1)(2008-7#1)
available reagents##8##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)
available regarding the##5##3##(1991-11#1)(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
available resources##11##2##(1993-1#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)
available scientific##2##2##(2008-11#1)(2011-1#1)
available sequence##2##2##(2008-1#1)(2008-10#1)
available since##2##2##(1991-12#1)(2009-8#1)
available so far##4##3##(1990-9#1)(2012-12#2)(2012-2#1)
available software##4##2##(1992-9#1)(2008-7#1)(2009-11#1)(2010-2#1)
available source of##2##3##(2008-5#1)(2009-4#1)
available space##2##2##(1992-2#1)(2013-7#1)
available standards##2##2##(2008-10#1)(2013-1#1)
available systems##4##2##(1990-5#1)(1996-2#1)(2008-8#1)(2008-9#1)
available technologies##2##2##(2008-9#1)(2011-2#1)
available technology##5##2##(1997-2#1)(2006-8#1)(2007-12#1)(2008-11#1)(2012-12#1)
available tests for##2##3##(1993-3#1)(2012-2#1)
available tests##5##2##(1991-11#1)(1993-3#1)(1996-3#1)(2012-2#1)(2013-8#1)
available that##2##2##(2008-4#1)(2008-9#1)
available the##2##2##(1996-12#1)(2007-8#1)
available through the##6##3##(1996-3#1)(1997-6#1)(1997-8#1)(2008-2#2)(2009-6#1)
available through##10##2##(1992-3#1)(1993-12#1)(1994-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-2#2)(2008-7#1)(2009-6#1)
available time##2##2##(1990-11#1)(1996-12#1)
available to all##4##3##(2007-4#1)(2008-11#2)(2008-7#1)
available to allow##2##3##(1993-2#1)(2008-10#1)
available to answer questions##2##4##(1991-3#1)(2008-5#1)
available to any##2##3##(2008-9#1)(2010-5#1)
available to date##4##3##(1994-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
available to determine the##2##4##(2008-10#1)(2008-5#1)
available to facilitate##2##3##(2008-11#1)(2012-3#1)
available to families as soon as##2##6##(1991-12#2)
available to health care##2##4##(1993-12#1)(1996-2#1)
available to measure##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
available to most##2##3##(2008-2#1)(2008-4#1)
available to patients with##2##4##(2010-4#1)(2010-9#1)
available to physicians##2##3##(1993-3#1)(2008-11#1)
available to quantify##2##3##(2008-10#1)(2013-1#1)
available to support##2##3##(2007-12#1)(2013-7#1)
available to the plant##2##4##(1992-3#1)(2008-8#1)
available to the##19##3##(1992-3#1)(1992-5#1)(1993-6#1)(1994-2#1)(1996-1#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)
available to them##3##3##(2007-6#1)(2007-7#1)(2009-5#1)
available to those##2##3##(1995-12#1)(2008-7#1)
available to treat##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
available to##144##2##(1991-1#1)(1991-12#2)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#7)(2008-11#11)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#7)(2008-8#5)(2008-9#3)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-10#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#10)(2012-3#5)(2013-1#5)(2013-7#3)
available today##5##2##(1994-1#1)(1997-2#1)(2008-11#1)(2008-5#1)(2010-12#1)
available tools##2##2##(2008-7#1)(2008-9#1)
available treatment options##2##3##(2008-1#1)(2010-8#1)
available treatment##4##2##(2008-1#1)(2010-3#1)(2010-5#1)(2010-8#1)
available treatments and the##2##4##(2008-7#1)(2012-3#1)
available treatments##9##2##(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
available under##2##2##(2008-10#1)(2011-10#1)
available until##2##2##(1997-8#1)(2010-10#1)
available via##4##2##(2008-11#1)(2008-4#1)(2008-7#2)
available water##2##2##(1991-2#1)(2008-2#1)
available were##3##2##(1994-1#1)(1997-3#1)(2008-4#1)
available when the##2##3##(1992-3#1)(2008-7#1)
available when##7##2##(1992-3#1)(1995-3#1)(2007-7#1)(2008-7#3)(2011-2#1)
available with a##2##3##(2008-6#1)(2011-2#1)
available with the##2##3##(2008-10#1)(2008-6#1)
available with##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-12#1)(2011-2#1)
available within##3##2##(1996-11#1)(2008-9#2)
available##1786##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#2)(1990-6#8)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#3)(1991-11#3)(1991-12#19)(1991-2#4)(1991-3#9)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#9)(1992-3#16)(1992-4#2)(1992-5#2)(1992-6#8)(1992-8#2)(1992-9#6)(1993-1#6)(1993-11#6)(1993-12#10)(1993-2#6)(1993-3#7)(1993-6#3)(1993-8#3)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#10)(1994-2#8)(1994-3#9)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#3)(1995-12#6)(1995-2#7)(1995-3#5)(1995-5#7)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#13)(1996-11#3)(1996-12#10)(1996-2#10)(1996-3#8)(1996-5#2)(1996-7#1)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#11)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#7)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#6)(2007-11#26)(2007-12#23)(2007-2#8)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#17)(2007-8#11)(2007-9#3)(2008-1#22)(2008-10#230)(2008-11#81)(2008-12#28)(2008-2#44)(2008-3#68)(2008-4#62)(2008-5#59)(2008-6#19)(2008-7#89)(2008-8#43)(2008-9#65)(2009-1#4)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#6)(2009-5#9)(2009-6#5)(2009-7#5)(2009-8#11)(2009-9#4)(2010-1#5)(2010-10#7)(2010-11#15)(2010-12#9)(2010-2#5)(2010-3#14)(2010-4#7)(2010-5#14)(2010-6#5)(2010-7#4)(2010-8#23)(2010-9#6)(2011-1#23)(2011-10#4)(2011-2#82)(2011-3#8)(2012-1#8)(2012-12#38)(2012-2#48)(2012-3#26)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#54)(2013-7#12)(2013-8#25)
available)##3##1##(2008-4#1)(2008-7#1)(2010-7#1)
avait##3##1##(2011-2#3)
avaiting##2##1##(1994-9#1)(2011-3#1)
avalanche photodiode for##2##3##(2007-11#2)
avalanche photodiode##6##2##(2007-11#3)(2008-3#3)
avalanche photodiodes for##2##3##(2008-2#1)(2008-3#1)
avalanche photodiodes##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
avalanche##16##1##(1993-3#1)(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#7)(2011-2#1)
avascular necrosis in##2##3##(2006-10#1)(2007-11#1)
avascular necrosis of the##3##4##(2007-11#1)(2007-8#1)(2008-5#1)
avascular necrosis##15##2##(2006-10#4)(2007-11#5)(2007-8#4)(2008-12#1)(2008-5#1)
avascular##23##1##(2006-10#4)(2006-12#1)(2007-11#5)(2007-8#4)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#3)(2013-1#2)
avec des##2##2##(2008-5#1)(2011-2#1)
avec##12##1##(2008-5#2)(2011-2#1)(2013-1#9)
avellanae and##2##2##(2008-10#2)
avenaceum##5##1##(2008-10#5)
avenae and M##2##3##(2008-10#2)
avenae and U##2##3##(2008-10#2)
avenae and##7##2##(2008-10#7)
avenae females##2##2##(2008-10#2)
avenae subsp##17##2##(2008-10#17)
avenae##42##1##(2008-10#42)
avenue for##6##2##(1992-3#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-4#1)
avenue to##4##2##(1991-1#1)(2007-11#1)(2008-7#1)(2011-2#1)
avenue##12##1##(1991-1#1)(1992-3#1)(1995-12#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)
avenues for drug discovery##2##4##(2010-11#2)
avenues for the##2##3##(2008-10#1)(2008-7#1)
avenues for##16##2##(1990-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-11#2)(2010-4#1)
avenues in##4##2##(1992-1#1)(1996-12#2)(2009-8#1)
avenues of##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-6#1)
avenues##31##1##(1990-12#1)(1992-1#1)(1994-12#1)(1996-11#1)(1996-12#2)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-4#1)(2012-2#2)
average 0##5##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
average 14##2##2##(1991-2#1)(2013-1#1)
average 18##2##2##(2007-8#1)(2008-8#1)
average 2##2##2##(1994-3#1)(2008-10#1)
average 3##2##2##(1992-1#1)(1992-3#1)
average 4##3##2##(2008-5#2)(2008-6#1)
average 401(k)##2##2##(2011-2#2)
average BE##3##2##(2012-3#3)
average G by##2##3##(2013-1#2)
average G##3##2##(2013-1#3)
average Medicare##2##2##(1992-12#1)(1994-1#1)
average PbB##2##2##(1997-4#2)
average accuracy of##4##3##(2008-3#1)(2008-4#1)(2010-8#2)
average accuracy##5##2##(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#2)
average adjusted##2##2##(1993-3#1)(1996-3#1)
average age 34##2##3##(2007-8#2)
average age at diagnosis was 10 years##2##7##(2008-6#1)(2011-2#1)
average age at##8##3##(1991-8#2)(1997-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
average age for##2##3##(1997-3#1)(2013-1#1)
average age of 69##2##4##(2007-11#1)(2008-9#1)
average age of the##3##4##(2007-7#1)(2008-7#1)(2011-1#1)
average age of##23##3##(1990-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#5)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
average age was##12##3##(2007-11#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#2)(2011-7#1)(2013-1#2)
average age##59##2##(1990-12#1)(1991-12#1)(1991-8#2)(1992-5#1)(1994-12#1)(1994-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#6)(2009-10#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#9)
average albedo##2##2##(2008-3#2)
average amount of##3##3##(1995-11#1)(1995-3#2)
average and the##2##3##(2008-10#1)(2008-12#1)
average and##14##2##(1990-9#1)(1996-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
average angular##2##2##(1996-7#1)(2012-2#1)
average annual growth rate##3##4##(2010-12#1)(2011-2#2)
average annual rate of##4##4##(1993-1#1)(1993-3#2)(1996-1#1)
average annual##15##2##(1993-1#1)(1993-3#2)(1994-9#1)(1996-1#1)(1996-8#1)(2008-10#2)(2010-12#1)(2011-2#5)(2013-1#1)
average area##2##2##(1992-3#1)(2010-9#1)
average arterial##2##2##(1997-8#1)(2008-3#1)
average background##2##2##(2008-10#1)(2013-1#1)
average between##3##2##(2008-10#2)(2008-5#1)
average biofilm density and##2##4##(2008-7#2)
average birth weight##2##3##(2012-3#1)(2013-1#1)
average cell size##2##3##(1995-9#1)(2008-7#1)
average cell##8##2##(1995-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#1)
average clutch size##2##3##(1991-5#1)(2008-9#1)
average coefficient of variation##2##4##(2008-10#1)(2012-2#1)
average concentrations##4##2##(2008-10#3)(2008-5#1)
average correlation##3##2##(2008-10#1)(2008-3#2)
average cosine of the##2##4##(2008-3#2)
average cosine of##4##3##(2008-3#4)
average cosine##7##2##(2008-3#7)
average cost of##4##3##(1993-1#1)(1994-5#1)(1995-12#1)(2010-5#1)
average cost##8##2##(1992-12#2)(1993-1#1)(1994-5#1)(1995-1#1)(1995-12#1)(2010-5#1)(2012-12#1)
average costs of##3##3##(1997-1#1)(2008-10#2)
average costs##7##2##(1991-12#1)(1992-12#1)(1993-12#1)(1996-3#1)(1997-1#1)(2008-10#2)
average cubic nonlinearity##2##3##(2007-12#2)
average daily doses##14##3##(2008-8#3)(2008-9#11)
average daily gain##2##3##(2008-12#1)(2010-2#1)
average daily##19##2##(1992-12#1)(1994-9#1)(2008-12#1)(2008-8#3)(2008-9#12)(2010-2#1)
average daytime##2##2##(2008-10#2)
average degree##5##2##(1990-5#1)(2008-10#1)(2008-2#1)(2011-2#2)
average density of##4##3##(1994-9#1)(1997-6#1)(1997-8#1)(2013-8#1)
average density##6##2##(1994-9#1)(1997-6#1)(1997-8#1)(2008-5#1)(2010-7#1)(2013-8#1)
average detection probability##2##3##(2008-10#2)
average detection##4##2##(2008-10#4)
average diameter##5##2##(2008-10#1)(2008-11#2)(2010-6#1)(2011-2#1)
average dispersion##4##2##(2007-11#2)(2007-12#2)
average dose of##2##3##(1990-12#1)(1997-8#1)
average dose##3##2##(1990-12#1)(1997-8#1)(2008-7#1)
average duration of symptoms##2##4##(2008-1#1)(2013-1#1)
average duration of the##3##4##(1994-11#1)(2011-2#1)(2013-8#1)
average duration of##12##3##(1990-2#1)(1991-12#3)(1994-11#1)(2008-1#1)(2009-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
average duration##13##2##(1990-2#1)(1991-12#3)(1994-11#1)(2008-1#1)(2008-3#1)(2009-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
average effective scatterer##2##3##(2008-3#2)
average eigenvector##3##2##(2008-2#3)
average ellipticity##2##2##(2008-2#2)
average error of##4##3##(2007-12#2)(2008-10#1)(2013-8#1)
average error##7##2##(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2013-8#1)
average excess##2##2##(2008-11#2)
average fitness##2##2##(2008-9#1)(2013-1#1)
average flow velocity of##3##4##(2011-2#3)
average flow velocity##5##3##(2007-10#1)(2011-2#4)
average flow##7##2##(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#4)
average follow-up of 3##2##4##(1992-6#1)(2012-2#1)
average follow-up of##12##3##(1990-12#1)(1992-3#1)(1992-6#1)(2006-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#2)
average follow-up period##3##3##(2007-11#2)(2008-7#1)
average follow-up was##6##3##(1996-9#1)(2008-9#2)(2009-10#1)(2009-3#2)
average follow-up##23##2##(1990-12#1)(1992-3#1)(1992-6#1)(1996-9#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#3)(2011-2#2)(2012-2#2)
average for##7##2##(1992-6#1)(1995-11#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
average fracture gap was##2##4##(2009-3#2)
average genetic distance of##2##4##(2008-10#1)(2011-2#1)
average genetic distance##3##3##(2008-10#2)(2011-2#1)
average genetic similarity##2##3##(2008-10#2)
average genetic##8##2##(2008-10#6)(2008-9#1)(2011-2#1)
average grain diameter##3##3##(2009-7#3)
average growth##2##2##(1991-12#1)(2008-7#1)
average heterozygosity##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
average humidity##5##2##(2011-1#5)
average improvement in##3##3##(2008-9#3)
average in##5##2##(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-6#1)
average infarction risk score##2##4##(1994-11#2)
average insert size##4##3##(1996-10#1)(1997-2#1)(1997-6#1)(2008-8#1)
average insert##6##2##(1996-10#2)(1997-2#2)(1997-6#1)(2008-8#1)
average intensity##4##2##(2007-11#2)(2009-5#1)(2013-8#1)
average intermarker interval##2##3##(1997-5#2)
average is##2##2##(2008-3#1)(2008-8#1)
average laser power##2##3##(2007-11#1)(2008-3#1)
average latency##2##2##(1997-6#1)(2008-4#1)
average length of stay##6##4##(1992-1#1)(1992-12#1)(1992-2#1)(1997-1#1)(2008-11#1)(2010-8#1)
average length of##10##3##(1992-1#1)(1992-12#1)(1992-2#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-8#1)
average length##13##2##(1992-1#1)(1992-12#1)(1992-2#2)(1993-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2013-1#1)
average lengths of##2##3##(1997-1#1)(2008-1#1)
average level of##2##3##(2008-7#1)(2008-8#1)
average levels of##6##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-12#1)
average life expectancy##3##3##(1991-6#1)(1993-9#1)(2007-8#1)
average life span##2##3##(1994-6#1)(1995-6#1)
average life##6##2##(1991-6#1)(1993-9#1)(1994-6#1)(1995-6#1)(2007-8#1)(2008-10#1)
average linear##2##2##(2007-11#1)(2008-8#1)
average molecular mass##3##3##(1990-5#1)(2008-5#2)
average molecular weight of##5##4##(1995-11#2)(2008-10#2)(2008-5#1)
average molecular##9##2##(1990-5#1)(1995-11#2)(2008-10#2)(2008-2#1)(2008-5#3)
average mortality##5##2##(1995-12#1)(2008-7#1)(2008-9#2)(2011-2#1)
average national##2##2##(1990-9#1)(1991-2#1)
average noise##2##2##(2007-11#1)(2008-2#1)
average number of##26##3##(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#2)
average number##30##2##(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
average of 1##4##3##(1991-5#1)(2008-10#1)(2011-1#1)(2012-2#1)
average of 10##5##3##(2007-10#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-2#1)
average of 26##3##3##(2007-12#1)(2008-1#1)(2009-10#1)
average of 3##3##3##(1990-7#1)(1996-9#1)(2007-2#1)
average of 4##7##3##(1990-7#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
average of 42##2##3##(2007-11#1)(2008-12#1)
average of 59##2##3##(1996-12#1)(2008-9#1)
average of 8##5##3##(1990-7#1)(1994-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
average of 9##2##3##(2008-9#1)(2009-3#1)
average of ten##2##3##(1991-3#1)(2008-3#1)
average of the##7##3##(2008-11#1)(2008-2#2)(2008-3#3)(2012-2#1)
average of these##2##3##(1996-6#1)(1997-3#1)
average of##123##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#4)(1991-3#1)(1991-5#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-12#4)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#9)(2009-10#1)(2009-3#3)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#3)(2013-7#2)(2013-8#1)
average on##3##2##(2008-10#2)(2012-12#1)
average or##2##2##(2008-9#1)(2009-9#1)
average outcome##2##2##(1996-6#1)(2008-10#1)
average output power has been generated from a##2##8##(2007-11#2)
average output power in##3##4##(2007-11#1)(2007-12#2)
average output power is##2##4##(2008-3#2)
average output power of##9##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)
average output power was##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
average output power##27##3##(2007-11#8)(2007-12#7)(2008-2#4)(2008-3#8)
average output powers##4##3##(2007-11#2)(2007-12#2)
average output##31##2##(2007-11#10)(2007-12#9)(2008-2#4)(2008-3#8)
average over##5##2##(1990-8#1)(2007-11#1)(2008-2#2)(2008-3#1)
average pairwise divergence##2##3##(2007-10#2)
average pairwise##3##2##(2007-10#2)(2013-8#1)
average particle size##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)
average particle##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)
average path-length parameters##3##3##(2008-2#3)
average path-length##4##2##(2008-2#4)
average patient##5##2##(1995-3#1)(2007-12#1)(2008-6#1)(2009-3#2)
average patient-related service time for##2##5##(1995-3#2)
average patients##2##2##(2006-8#1)(2008-1#1)
average per capita##7##3##(1991-3#1)(1993-3#3)(1996-3#1)(1997-1#2)
average per diem##2##3##(1991-12#1)(1994-2#1)
average per##9##2##(1991-12#1)(1991-3#1)(1993-3#3)(1994-2#1)(1996-3#1)(1997-1#2)
average percentages of##3##3##(2008-10#2)(2008-12#1)
average period of##3##3##(2007-7#1)(2007-8#1)(2008-4#1)
average pore##3##2##(1990-8#1)(2008-10#1)(2012-2#1)
average power and##3##3##(2007-11#3)
average power at##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
average power from a mode-locked##2##5##(2007-11#2)
average power in##2##3##(2007-11#1)(2008-2#1)
average power of##16##3##(2007-11#5)(2007-12#8)(2008-2#1)(2008-3#2)
average power##47##2##(1992-12#1)(2007-11#19)(2007-12#14)(2008-2#4)(2008-3#7)(2010-8#1)(2012-2#1)
average powers of up to##2##5##(2007-11#1)(2007-12#1)
average powers of##6##3##(2007-11#4)(2007-12#2)
average powers##8##2##(2007-11#6)(2007-12#2)
average prediction error##2##3##(2008-10#1)(2008-11#1)
average prediction##3##2##(2008-10#2)(2008-11#1)
average probability of##2##3##(2008-12#1)(2011-3#1)
average pump power of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
average pump power##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
average pump##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
average radius of tissue##2##4##(2008-2#2)
average range of##2##3##(2007-8#1)(2012-2#1)
average rate of##5##3##(1996-4#1)(2008-10#1)(2008-11#2)(2010-8#1)
average rate##6##2##(1995-2#1)(1996-4#1)(2008-10#1)(2008-11#2)(2010-8#1)
average rates##3##2##(1992-12#1)(2008-1#1)(2010-12#1)
average ratio of##3##3##(2008-1#3)
average ratio##4##2##(2008-1#4)
average read-length##2##2##(2011-2#2)
average recoveries from##3##3##(2008-10#3)
average recoveries of 11 carbamate pesticides##2##6##(2011-1#2)
average recoveries of OFL##2##4##(2008-10#2)
average recoveries of##10##3##(2008-10#5)(2008-5#1)(2011-1#4)
average recoveries##19##2##(2008-10#13)(2008-5#1)(2011-1#5)
average recovery for these samples was##3##6##(2008-10#3)
average recovery for##6##3##(2008-10#4)(2008-5#2)
average recovery of 100##2##4##(2008-10#2)
average recovery of##13##3##(2008-10#12)(2011-1#1)
average recovery##27##2##(2008-10#22)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
average reduction of##4##3##(2011-2#1)(2012-12#1)(2013-1#2)
average relative dose intensity##3##4##(2008-7#3)
average relative standard deviation of##2##5##(2008-10#2)
average relative standard deviation##5##4##(2008-10#5)
average relative standard##6##3##(2008-10#6)
average relative##14##2##(2008-10#10)(2008-7#3)(2013-8#1)
average roughness of##2##3##(2007-12#1)(2012-2#1)
average roughness##4##2##(2007-12#1)(2008-3#1)(2012-2#2)
average salary##4##2##(1995-3#4)
average scattering##2##2##(2008-3#2)
average score was##2##3##(1990-2#2)
average score##3##2##(1990-2#2)(2007-11#1)
average signal##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
average similarity##4##2##(2008-10#4)
average size of the##4##4##(1996-1#1)(1996-10#1)(1996-2#1)(2008-3#1)
average size of##11##3##(1994-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-3#2)(2008-5#1)(2011-1#1)(2013-7#1)
average size##13##2##(1994-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#2)(2008-3#3)(2008-5#1)(2011-1#1)(2013-7#1)
average specific growth rate##3##4##(2008-11#3)
average specific hMab productivity##2##4##(2008-11#2)
average specific##7##2##(2008-11#5)(2008-6#2)
average surface roughness##2##3##(2012-2#2)
average surface##4##2##(2008-10#1)(2008-3#1)(2012-2#2)
average survival of##3##3##(1990-2#1)(1994-6#1)(2007-10#1)
average survival##6##2##(1990-2#1)(1994-6#2)(1997-4#1)(2007-10#1)(2013-1#1)
average system optical transfer function##2##5##(2008-2#2)
average temperature during the##2##4##(2008-10#2)
average temperature during##3##3##(2008-10#3)
average temperature##9##2##(2008-10#5)(2008-8#2)(2008-9#2)
average tenure##2##2##(2010-6#2)
average the##2##2##(2011-2#1)(2013-1#1)
average thickness##2##2##(1995-3#1)(2008-2#1)
average three##2##2##(1990-6#1)(1994-2#1)
average threshold##2##2##(1992-6#2)
average time##10##2##(1996-9#1)(2008-3#2)(2008-8#2)(2010-6#3)(2012-12#1)(2013-8#1)
average to##5##2##(1993-12#1)(2008-10#1)(2013-1#3)
average torque##3##2##(2008-12#3)
average total##4##2##(1996-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
average value of##6##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
average value##13##2##(1990-8#1)(1993-3#1)(2007-11#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
average values of the##3##4##(2013-8#3)
average values of##5##3##(2008-10#1)(2008-7#1)(2013-8#3)
average values##11##2##(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)(2013-8#3)
average volume of##3##3##(1994-1#2)(1994-2#1)
average was##6##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#2)
average weight gain##2##3##(2013-1#2)
average weight##10##2##(1990-8#1)(1991-12#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#3)
average weighted##2##2##(2007-12#1)(2008-2#1)
average wind##2##2##(2008-10#2)
average with##3##2##(1995-5#1)(2008-8#1)(2011-2#1)
average working##2##2##(1992-5#1)(2011-2#1)
average yield was##2##3##(2008-11#1)(2008-6#1)
average##1483##1##(1990-11#1)(1990-12#5)(1990-2#6)(1990-3#1)(1990-5#3)(1990-6#5)(1990-7#5)(1990-8#6)(1990-9#4)(1991-1#3)(1991-12#9)(1991-2#3)(1991-3#2)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-12#15)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#12)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#10)(1993-9#2)(1994-1#7)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#7)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#15)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#12)(1996-2#8)(1996-3#12)(1996-4#4)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#6)(1997-2#9)(1997-3#2)(1997-4#8)(1997-5#4)(1997-6#7)(1997-7#2)(1997-8#6)(2006-12#1)(2006-8#1)(2007-10#6)(2007-11#69)(2007-12#57)(2007-2#5)(2007-7#4)(2007-8#25)(2007-9#1)(2008-1#18)(2008-10#217)(2008-11#41)(2008-12#20)(2008-2#63)(2008-3#93)(2008-4#8)(2008-5#39)(2008-6#15)(2008-7#42)(2008-8#41)(2008-9#63)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#11)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#2)(2009-9#7)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#10)(2010-7#1)(2010-8#13)(2010-9#1)(2011-1#21)(2011-2#71)(2011-3#3)(2011-7#1)(2012-1#2)(2012-12#21)(2012-2#28)(2012-3#11)(2013-1#52)(2013-3#1)(2013-7#4)(2013-8#20)
average) and##3##2##(1996-2#1)(1997-2#1)(2008-10#1)
average)##15##1##(1992-5#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-2#3)(1997-8#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#3)(2012-2#1)
average-power##5##1##(2007-11#3)(2007-12#1)(2008-3#1)
averaged 1##6##2##(1994-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
averaged 13##2##2##(2007-5#1)(2009-10#1)
averaged 17##2##2##(2008-9#1)(2009-10#1)
averaged 20##2##2##(1997-4#1)(2008-9#1)
averaged 27##3##2##(1992-8#1)(1994-11#1)(2008-5#1)
averaged 3##2##2##(2008-5#1)(2008-6#1)
averaged 5##2##2##(2008-10#2)
averaged 50%##2##2##(2008-4#1)(2009-4#1)
averaged across##2##2##(2008-12#1)(2011-2#1)
averaged and##3##2##(1996-4#1)(2008-12#1)(2008-2#1)
averaged between##2##2##(1994-3#1)(2010-8#1)
averaged over a##2##3##(2008-2#1)(2008-3#1)
averaged over##6##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
averaged##105##1##(1991-12#2)(1991-2#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-4#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#2)(2009-4#2)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
averages of the##2##3##(2012-12#1)(2012-3#1)
averages of##10##2##(2008-10#2)(2008-3#4)(2012-12#2)(2012-3#1)(2013-8#1)
averages##27##1##(1995-2#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-8#1)
averaging are##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
averaging in##2##2##(2007-12#1)(2008-2#1)
averaging of the##3##3##(2008-3#1)(2008-9#2)
averaging of##4##2##(2008-3#2)(2008-9#2)
averaging techniques##2##2##(2008-5#1)(2009-10#1)
averaging the##8##2##(1992-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-4#1)
averaging time of 10##2##4##(2008-2#1)(2008-3#1)
averaging time of##4##3##(2008-2#1)(2008-3#3)
averaging time##6##2##(2008-2#2)(2008-3#4)
averaging##69##1##(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1994-11#1)(1996-5#2)(2007-12#4)(2008-10#6)(2008-2#13)(2008-3#18)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
aversion for##2##2##(1993-12#1)(2008-5#1)
aversion learning##2##2##(1993-12#1)(2008-4#1)
aversion to##3##2##(1991-1#1)(2008-5#1)(2009-5#1)
aversion treatment of alcohol dependence##2##5##(1991-12#2)
aversion##25##1##(1991-1#1)(1991-12#6)(1993-12#2)(1994-5#1)(1994-8#2)(1995-12#1)(2008-4#1)(2008-5#9)(2008-8#1)(2009-5#1)
aversive behaviour##2##2##(1993-12#2)
aversive conditioning##2##2##(2008-4#1)(2008-7#1)
aversive event##3##2##(2008-11#3)
aversive thresholds##2##2##(1993-12#2)
aversive##23##1##(1993-12#4)(1993-6#2)(1995-12#1)(1996-2#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-8#1)(2012-2#1)
avert##8##1##(1990-12#1)(1997-4#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
averted##6##1##(1997-6#1)(2008-11#2)(2009-8#1)(2009-9#2)
avian and##2##2##(1997-6#1)(2008-5#1)
avian cells##4##2##(1990-5#1)(2008-3#3)
avian chlamydial MOMP gene recombinant adenovirus##3##6##(2011-2#3)
avian genomes##3##2##(1991-6#1)(1993-6#1)(2010-3#1)
avian influenza (AI)##3##3##(2007-12#1)(2007-6#1)(2011-2#1)
avian influenza A##2##3##(2008-9#1)(2009-5#1)
avian influenza virus##5##3##(1997-6#1)(2010-4#1)(2011-3#2)(2013-1#1)
avian influenza viruses##2##3##(2013-8#2)
avian influenza##20##2##(1997-6#2)(2007-12#1)(2007-2#1)(2007-6#3)(2008-9#1)(2009-5#1)(2010-4#2)(2011-2#2)(2011-3#2)(2013-1#1)(2013-8#4)
avian leukosis##2##2##(2007-6#1)(2012-3#1)
avian pox##2##2##(1997-3#1)(1997-6#1)
avian reovirus##5##2##(1997-6#4)(2007-6#1)
avian species##9##2##(1994-5#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2013-1#1)
avian vocal system##3##3##(2009-2#3)
avian##110##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#2)(1991-8#1)(1993-2#1)(1993-6#4)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#14)(2007-12#2)(2007-2#1)(2007-6#9)(2008-10#3)(2008-3#5)(2008-5#10)(2008-8#6)(2008-9#4)(2009-2#5)(2009-3#1)(2009-5#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#5)
avian-like H1N1##2##2##(2011-2#2)
avian-like##3##1##(2011-2#3)
aviaries##2##1##(1997-3#1)(2008-8#1)
aviation jet fuel##2##3##(2008-10#2)
aviation##11##1##(1997-5#1)(2008-10#2)(2008-11#1)(2009-10#4)(2012-3#3)
avid##2##1##(2008-4#1)(2012-12#1)
avidin and##3##2##(2008-10#2)(2008-12#1)
avidin biotin##2##2##(1990-12#1)(2011-2#1)
avidin layer##2##2##(2008-10#2)
avidin to##2##2##(1993-6#1)(2008-10#1)
avidin##21##1##(1990-12#1)(1992-6#1)(1993-6#5)(2008-10#7)(2008-12#5)(2008-4#1)(2011-2#1)
avidin- and##2##2##(1993-6#1)(2008-10#1)
avidin-biotin binding##2##2##(2008-10#2)
avidin-biotin##6##1##(1995-5#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-4#1)
avidity##14##1##(1990-3#1)(1991-11#1)(1991-5#1)(1992-5#1)(1994-8#1)(1995-5#3)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
avidly##4##1##(1994-12#1)(1995-8#1)(2008-5#1)(2012-12#1)
avifauna##3##1##(2008-8#1)(2008-9#2)
avirulence (Avr) genes##3##3##(2008-10#3)
avirulence (Avr)##4##2##(2008-10#4)
avirulence and##2##2##(2008-10#2)
avirulence gene in##3##3##(2008-10#3)
avirulence gene of##2##3##(2008-10#2)
avirulence gene was##2##3##(2008-10#2)
avirulence gene##17##2##(2008-10#17)
avirulence genes in##4##3##(2008-10#4)
avirulence genes##13##2##(2008-10#13)
avirulence genotype##3##2##(2008-10#3)
avirulence in the##3##3##(2008-10#3)
avirulence in##5##2##(2008-10#5)
avirulence locus##3##2##(2008-10#3)
avirulence on##3##2##(2008-10#3)
avirulence##65##1##(2008-10#65)
avirulent and virulent cultures segregated in a##2##7##(2008-10#2)
avirulent and virulent##4##3##(2008-10#3)(2010-12#1)
avirulent and##5##2##(2008-10#3)(2008-9#1)(2010-12#1)
avirulent isolates of P##2##4##(2008-10#2)
avirulent isolates of##3##3##(2008-10#3)
avirulent isolates##4##2##(2008-10#4)
avirulent on##7##2##(2008-10#7)
avirulent strains##3##2##(2008-10#3)
avirulent to Xa21##2##3##(2008-10#2)
avirulent to##11##2##(2008-10#11)
avirulent##46##1##(1995-2#1)(1995-5#1)(2008-10#41)(2008-9#2)(2010-12#1)
avium complex##5##2##(2007-12#1)(2008-11#2)(2008-5#1)(2008-8#1)
avium serovar 26##2##3##(1992-12#2)
avium serovar##3##2##(1992-12#3)
avium##13##1##(1992-12#4)(2007-12#3)(2008-11#2)(2008-5#2)(2008-8#1)(2010-4#1)
avocado (Persea americana) crude extract##2##5##(2008-10#2)
avocado fruit##6##2##(2008-10#6)
avocado fruits##2##2##(2008-10#2)
avocado tissue (Persea americana)##2##4##(2008-10#2)
avocado##19##1##(2007-11#1)(2008-10#17)(2011-2#1)
avocados##6##1##(2011-2#6)
avoid an##2##2##(2008-12#1)(2010-12#1)
avoid antitrust##2##2##(1992-3#1)(1993-1#1)
avoid complications##4##2##(1991-6#1)(2008-3#1)(2011-2#1)(2012-12#1)
avoid contamination##2##2##(2008-10#1)(2008-12#1)
avoid duplication##2##2##(2007-12#1)(2012-12#1)
avoid further##3##2##(2008-8#1)(2009-3#1)(2011-2#1)
avoid high##2##2##(2008-1#1)(2009-8#1)
avoid it##3##2##(1996-12#1)(1997-3#1)(2012-12#1)
avoid misdiagnosis##3##2##(1991-8#1)(2008-6#1)(2011-2#1)
avoid most##2##2##(1993-2#1)(2008-3#1)
avoid or##6##2##(1991-12#1)(1991-6#1)(1995-12#1)(2008-10#2)(2012-3#1)
avoid perioperative##2##2##(2007-8#1)(2013-8#1)
avoid possible interferences##2##3##(2008-10#2)
avoid possible##4##2##(1991-12#1)(2008-10#3)
avoid problems##2##2##(1992-1#1)(2008-7#1)
avoid progression##2##2##(2008-1#1)(2009-6#1)
avoid the need for##2##4##(2007-11#1)(2012-2#1)
avoid the potential##3##3##(1993-3#1)(1994-3#1)(2009-12#1)
avoid the problem##2##3##(1992-1#1)(2008-7#1)
avoid the problems##2##3##(2008-3#1)(2012-2#1)
avoid the risk of##4##4##(1993-8#1)(1994-11#1)(1994-9#1)(2008-5#1)
avoid the side##2##3##(1993-1#1)(2008-10#1)
avoid the use of##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
avoid the##57##2##(1991-8#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
avoid these problems##2##3##(1992-12#1)(2013-7#1)
avoid these##4##2##(1992-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
avoid this##2##2##(2007-8#1)(2011-2#1)
avoid unnecessary surgery##3##3##(2012-12#1)(2012-2#2)
avoid unnecessary##8##2##(1992-9#1)(1993-6#1)(2009-6#2)(2010-8#1)(2012-12#1)(2012-2#2)
avoid using##2##2##(2008-12#1)(2008-3#1)
avoid##321##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#5)(1997-3#3)(1997-5#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#9)(2008-1#3)(2008-10#47)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#17)(2008-4#9)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#10)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#4)(2009-8#6)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#4)(2011-1#1)(2011-2#21)(2011-3#1)(2012-12#6)(2012-2#12)(2012-3#3)(2013-1#8)(2013-7#6)(2013-8#7)
avoidability##2##1##(2008-11#1)(2011-1#1)
avoidable##8##1##(1994-12#1)(2008-11#3)(2008-2#1)(2009-3#1)(2011-1#1)(2013-1#1)
avoidance and treatment##2##3##(2007-12#1)(2008-8#1)
avoidance and##10##2##(1993-12#2)(1997-2#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#2)(2012-2#1)
avoidance behavior##3##2##(1992-6#1)(2008-6#1)(2013-1#1)
avoidance in##3##2##(2008-3#2)(2008-9#1)
avoidance of a##2##3##(1993-11#1)(1996-9#1)
avoidance of iatrogenic complications##2##4##(1993-10#1)(2007-9#1)
avoidance of the##2##3##(1992-8#1)(2010-5#1)
avoidance of##35##2##(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
avoidance or##2##2##(2008-11#1)(2009-2#1)
avoidance responding##3##2##(1991-1#1)(1992-12#1)(2008-6#1)
avoidance response in##2##3##(1991-12#1)(1993-12#1)
avoidance response##5##2##(1991-12#1)(1993-12#1)(2008-6#2)(2008-8#1)
avoidance responses##2##2##(1993-3#1)(2008-6#1)
avoidance task##5##2##(1991-2#2)(1993-12#1)(1994-3#1)(2008-6#1)
avoidance test##4##2##(1995-5#1)(2012-2#1)(2013-1#2)
avoidance training##3##2##(1997-2#2)(2008-6#1)
avoidance##110##1##(1991-1#1)(1991-12#1)(1991-2#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-3#3)(1993-5#2)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-12#4)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-11#4)(2008-3#6)(2008-4#4)(2008-6#13)(2008-8#2)(2008-9#9)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
avoidance) and##2##2##(2007-12#1)(2008-9#1)
avoidance)##3##1##(2007-12#1)(2008-8#1)(2008-9#1)
avoidant beliefs##2##2##(2008-12#2)
avoidant coping##2##2##(2009-5#1)(2009-7#1)
avoidant personality disorder##2##3##(2010-2#2)
avoidant##8##1##(2008-11#1)(2008-12#2)(2009-5#1)(2009-7#2)(2010-2#2)
avoided by the##4##3##(2008-10#3)(2008-7#1)
avoided by using##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
avoided by##19##2##(1992-3#1)(1996-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#3)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
avoided##106##1##(1990-11#1)(1990-5#1)(1991-3#1)(1992-3#3)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#3)(1995-2#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#1)
avoiding a##3##2##(2008-10#2)(2011-2#1)
avoiding excessive##2##2##(2008-10#1)(2012-2#1)
avoiding or reducing##2##3##(1992-3#1)(1996-9#1)
avoiding the need for##2##4##(1991-11#1)(2013-8#1)
avoiding the use of##2##4##(1990-12#1)(2008-10#1)
avoiding the##21##2##(1990-12#1)(1991-11#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-8#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
avoiding this##2##2##(2008-6#1)(2010-9#1)
avoiding##108##1##(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-6#1)(1996-9#2)(2007-12#2)(2007-7#1)(2007-8#5)(2008-10#15)(2008-11#5)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#5)
avoids most##2##2##(2007-11#1)(2008-9#1)
avoids some of the##2##4##(1997-7#1)(2008-4#1)
avoids some##3##2##(1995-2#1)(1997-7#1)(2008-4#1)
avoids the need for##3##4##(2007-11#1)(2008-3#1)(2009-5#1)
avoids the need to##2##4##(2008-10#1)(2008-2#1)
avoids the need##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
avoids the use of##3##4##(2008-10#2)(2008-2#1)
avoids the##22##2##(1990-3#2)(1991-2#1)(1991-3#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-3#1)
avoids time-consuming##2##2##(2008-10#1)(2008-9#1)
avoids##53##1##(1990-3#2)(1991-2#1)(1991-3#1)(1993-3#1)(1994-11#1)(1995-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
avoir##2##1##(2008-5#1)(2013-1#1)
avons##3##1##(2011-2#1)(2013-1#2)
avr1 and Avr1 basidiospores##2##4##(2008-10#2)
avr1##3##1##(2008-10#3)
avrBs1##4##1##(2008-10#4)
avrBs2 gene##2##2##(2008-10#2)
avrBs2##3##1##(2008-10#3)
avrI-2##3##1##(2008-10#3)
avulsed##5##1##(2008-12#1)(2008-9#2)(2010-3#1)(2013-1#1)
avulsion injuries##2##2##(2008-9#1)(2013-1#1)
avulsion of##2##2##(2007-10#1)(2012-12#1)
avulsion##17##1##(1991-8#1)(2007-10#3)(2008-12#4)(2008-9#5)(2011-2#1)(2012-12#1)(2013-1#2)
await##8##1##(1993-3#1)(1994-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
awaited##7##1##(1992-12#1)(1994-12#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-5#1)
awaiting approval##2##2##(1996-5#1)(2008-5#1)
awaiting heart transplantation##2##3##(2011-2#2)
awaiting##7##1##(1996-5#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-5#1)(2011-2#2)
awaits further##2##2##(1993-1#1)(2009-10#1)
awaits##5##1##(1993-1#1)(2008-10#2)(2008-11#1)(2009-10#1)
awake and##2##2##(2007-12#1)(2012-2#1)
awake rats##3##2##(1990-7#1)(1995-12#2)
awake##16##1##(1990-7#2)(1994-2#1)(1995-12#2)(1997-2#1)(1997-7#1)(2007-10#2)(2007-12#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#2)
awaken##2##1##(1997-6#1)(2008-11#1)
awakened##2##1##(1995-12#2)
awakening after##2##2##(2008-12#1)(2012-3#1)
awakening##7##1##(1992-8#1)(1997-2#1)(2008-11#1)(2008-12#1)(2009-12#1)(2012-3#1)(2013-1#1)
award winners##2##2##(1993-1#1)(1994-3#1)
award##21##1##(1991-1#1)(1992-3#1)(1993-1#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-6#3)(1996-2#3)(1997-5#2)(2008-11#1)(2008-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
awarded by the##2##3##(1997-2#1)(2011-2#1)
awarded by##3##2##(1997-2#1)(2011-2#1)(2013-1#1)
awarded for##2##2##(1997-5#1)(2010-12#1)
awarded the##3##2##(1996-3#1)(2008-7#1)(2010-7#1)
awarded to##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
awarded##19##1##(1991-3#1)(1993-8#1)(1995-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#2)(2008-10#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
awarding punitive damages##2##3##(1992-2#2)
awarding##4##1##(1992-2#2)(1992-3#1)(2007-11#1)
awards##10##1##(1992-2#1)(1992-3#3)(1993-3#1)(1994-9#1)(1995-3#1)(1997-5#1)(2008-12#1)(2011-2#1)
aware about the##2##3##(2006-10#1)(2012-2#1)
aware of any##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
aware of how##2##3##(1995-1#1)(2010-9#1)
aware of its##2##3##(2008-10#1)(2010-1#1)
aware of such##2##3##(2008-6#1)(2008-8#1)
aware of the adverse##2##4##(2008-8#1)(2012-12#1)
aware of the hazards of##2##5##(1991-5#1)(2010-3#1)
aware of the potential for##2##5##(1996-12#1)(2008-7#1)
aware of the potential##3##4##(1996-12#1)(2008-7#1)(2008-9#1)
aware of the weight of the object to be lifted##2##10##(2012-12#2)
aware of the##50##3##(1990-6#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)
aware of their##3##3##(2007-4#1)(2010-6#1)(2013-1#1)
aware of these##3##3##(1991-12#1)(2010-1#1)(2012-2#1)
aware of this##8##3##(1997-4#1)(2007-10#1)(2007-7#1)(2008-12#2)(2008-5#1)(2011-1#1)(2012-3#1)
aware of##104##2##(1990-6#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#1)(2010-3#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
aware that the##4##3##(2008-7#1)(2008-8#1)(2009-6#1)(2013-8#1)
aware that there##2##3##(2012-12#1)(2012-2#1)
aware that they##3##3##(1991-3#1)(2008-1#1)(2012-2#1)
aware that##17##2##(1991-3#2)(1993-12#1)(1995-6#1)(1996-8#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-8#1)
aware##135##1##(1990-6#3)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-8#2)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#4)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#1)(2010-3#2)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#8)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#3)
awareness about##3##2##(2008-1#1)(2009-10#1)(2013-1#1)
awareness among clinicians##2##3##(2011-2#2)
awareness among health professionals and##2##5##(2010-9#1)(2012-3#1)
awareness among health professionals##3##4##(2008-11#1)(2010-9#1)(2012-3#1)
awareness among##12##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
awareness and concern##2##3##(1992-1#1)(2008-11#1)
awareness and control##2##3##(2011-1#2)
awareness and interest##2##3##(2007-5#1)(2012-2#1)
awareness and knowledge of##3##4##(2008-8#1)(2012-12#1)(2012-2#1)
awareness and the##2##3##(2007-7#1)(2008-1#1)
awareness and##45##2##(1992-1#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#5)(2008-7#2)(2008-8#2)(2009-4#2)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#5)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
awareness campaign##2##2##(1997-1#1)(2011-2#1)
awareness in the##2##3##(2009-9#1)(2012-3#1)
awareness in##6##2##(1997-6#1)(2008-11#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
awareness intervention followed by semantic##2##5##(2011-1#2)
awareness intervention##3##2##(2011-1#3)
awareness is##2##2##(2010-3#1)(2011-2#1)
awareness of TC##2##3##(2009-5#2)
awareness of and confidence in adopting##2##6##(2010-8#2)
awareness of and##4##3##(2009-8#1)(2010-8#2)(2013-1#1)
awareness of health##3##3##(1995-3#1)(2007-11#1)(2009-4#1)
awareness of the disorder##2##4##(2008-1#1)(2008-7#1)
awareness of the importance of##2##5##(2007-12#1)(2011-2#1)
awareness of the need for##2##5##(2011-2#1)(2013-1#1)
awareness of the need to##2##5##(1995-1#1)(2011-2#1)
awareness of the need##4##4##(1995-1#1)(2011-2#2)(2013-1#1)
awareness of the potential##3##4##(1995-9#1)(2008-7#1)(2012-3#1)
awareness of the risk##2##4##(1992-12#1)(2011-2#1)
awareness of the##39##3##(1991-3#1)(1991-6#1)(1992-12#2)(1992-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#6)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
awareness of these##2##3##(2008-5#1)(2011-1#1)
awareness of this condition##2##4##(1995-8#1)(2009-11#1)
awareness of this##4##3##(1993-2#1)(1995-8#1)(2008-1#1)(2009-11#1)
awareness of##102##2##(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#2)(1994-1#2)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#8)(2009-11#1)(2009-4#1)(2009-5#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
awareness on##8##2##(1995-6#1)(1995-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-1#2)
awareness programs should be conducted##2##5##(2009-12#1)(2011-1#1)
awareness that##3##2##(2007-10#1)(2008-8#1)(2011-2#1)
awareness was##2##2##(2008-5#1)(2013-1#1)
awareness##269##1##(1990-12#1)(1991-1#1)(1991-3#3)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-1#6)(1994-3#3)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#5)(1996-3#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-5#1)(1997-6#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#4)(2007-5#1)(2007-7#3)(2008-1#7)(2008-10#6)(2008-11#15)(2008-12#15)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#13)(2008-8#5)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#3)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#23)(2011-2#18)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#20)(2013-7#1)(2013-8#8)
away and##2##2##(2009-3#1)(2013-1#1)
away at##2##2##(2008-10#1)(2008-3#1)
away by##2##2##(2008-6#1)(2009-12#1)
away from an##2##3##(2008-3#1)(2011-2#1)
away from home##3##3##(1994-2#1)(2008-9#1)(2011-2#1)
away from hospital##2##3##(1991-3#1)(1993-12#1)
away from its##2##3##(2010-7#1)(2013-1#1)
away from the inoculation##2##4##(2008-10#2)
away from the##47##3##(1992-12#1)(1992-4#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
away from their##2##3##(2007-7#1)(2009-6#1)
away from traditional##2##3##(2008-11#1)(2010-8#1)
away from##104##2##(1991-1#1)(1991-3#3)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#7)(2009-10#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#6)
away##147##1##(1991-1#1)(1991-3#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#8)
awe##2##1##(1996-3#1)(2013-8#1)
awkward##2##1##(2008-12#1)(2009-10#1)
awn##3##1##(2008-10#3)
awns emerging##2##2##(2008-10#2)
awns##3##1##(2008-10#3)
axei##2##1##(1996-12#2)
axenic culture##2##2##(2008-10#2)
axenic##7##1##(2008-10#7)
axenically##2##1##(2008-10#2)
axes are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
axes in the##4##3##(1997-7#1)(2008-2#1)(2008-3#1)(2013-8#1)
axes in##5##2##(1997-7#1)(2008-2#2)(2008-3#1)(2013-8#1)
axes of a##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
axes of the##6##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
axes of##16##2##(1991-8#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-6#1)(2013-8#2)
axes##53##1##(1991-12#1)(1991-8#1)(1993-8#1)(1997-6#1)(1997-7#2)(2007-11#3)(2007-12#5)(2008-10#6)(2008-2#8)(2008-3#13)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-6#1)(2013-8#3)
axes)##3##1##(1995-11#1)(2007-12#1)(2008-8#1)
axial CT##3##2##(1996-6#1)(2007-11#1)(2011-2#1)
axial and lateral##2##3##(2007-11#1)(2008-2#1)
axial and the##2##3##(1997-7#1)(2007-11#1)
axial and##13##2##(1996-2#1)(1996-9#1)(1997-7#2)(2007-11#2)(2008-2#3)(2008-3#3)(2013-1#1)
axial compression##2##2##(2008-9#1)(2013-1#1)
axial dispersion##2##2##(2008-10#1)(2009-6#1)
axial eye growth##3##3##(2010-1#3)
axial eye##4##2##(2008-2#1)(2010-1#3)
axial flow pump##2##3##(2008-8#2)
axial images##3##2##(2010-12#1)(2012-1#1)(2012-2#1)
axial intensity distribution curve##2##4##(2007-12#1)(2008-3#1)
axial intensity distribution##3##3##(2007-12#1)(2008-3#2)
axial ligand##3##2##(1996-2#2)(1997-7#1)
axial or##2##2##(2008-2#1)(2008-3#1)
axial patterning##3##2##(1994-9#1)(2008-10#2)
axial position##5##2##(1995-11#1)(1997-7#1)(2008-3#3)
axial positioning##2##2##(2008-3#2)
axial proptosis##2##2##(2008-7#1)(2010-11#1)
axial resolution of##2##3##(2007-11#2)
axial resolution##8##2##(2007-11#5)(2007-12#1)(2008-2#1)(2008-3#1)
axial response##2##2##(2007-12#1)(2008-2#1)
axial rotation##6##2##(1994-3#1)(2007-11#1)(2007-8#2)(2012-2#2)
axial skeleton and##2##3##(1991-11#1)(2012-12#1)
axial skeleton##6##2##(1991-11#1)(1995-11#1)(2009-10#1)(2011-2#2)(2012-12#1)
axial strain##5##2##(2007-12#4)(2008-7#1)
axial stress##4##2##(2007-11#1)(2008-2#1)(2008-7#1)(2009-7#1)
axial structures##2##2##(1993-12#1)(2008-6#1)
axial symmetry of the##2##4##(1993-11#1)(2008-3#1)
axial symmetry##4##2##(1993-11#1)(2007-11#1)(2008-3#2)
axial tomography##2##2##(2011-2#1)(2013-1#1)
axial velocity##2##2##(2008-3#2)
axial##172##1##(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#5)(1996-6#1)(1996-9#1)(1997-7#6)(2007-11#17)(2007-12#12)(2007-8#3)(2008-10#6)(2008-2#17)(2008-3#31)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#3)(2010-1#3)(2010-11#1)(2010-12#3)(2010-3#2)(2011-1#2)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
axial-intensity##2##1##(2008-3#2)
axially symmetric##3##2##(2007-11#1)(2008-3#2)
axially##7##1##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)
axicon##11##1##(2007-11#3)(2008-2#1)(2008-3#4)(2009-6#3)
axicons##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
axilla secretions##4##2##(2008-5#4)
axilla##36##1##(1992-12#1)(1994-12#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-5#26)(2008-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
axillae##2##1##(2008-5#1)(2011-1#1)
axillar##2##1##(2007-8#2)
axillary aerobic coryneform isolates##2##4##(2008-5#2)
axillary area##2##2##(2008-5#1)(2013-1#1)
axillary artery##4##2##(2007-8#1)(2008-7#3)
axillary bacteria##4##2##(2008-5#4)
axillary bacterial##2##2##(2008-5#2)
axillary buds##3##2##(2008-8#2)(2013-1#1)
axillary dissection is##2##3##(1994-12#1)(2008-10#1)
axillary dissection##8##2##(1993-8#1)(1994-12#2)(2008-10#4)(2013-1#1)
axillary lymph node##4##3##(1994-7#2)(2010-6#1)(2013-1#1)
axillary lymph nodes were##2##4##(1994-7#1)(2010-6#1)
axillary lymph nodes##6##3##(1993-2#1)(1994-12#1)(1994-7#1)(2008-10#1)(2010-6#1)(2013-1#1)
axillary lymph##11##2##(1993-2#1)(1994-12#1)(1994-7#3)(1995-4#1)(2008-10#1)(2010-6#2)(2013-1#2)
axillary malodor##2##2##(2008-5#2)
axillary malodour##5##2##(2008-5#5)
axillary microflora##5##2##(2008-5#5)
axillary nerve##5##2##(2008-8#1)(2008-9#2)(2013-1#2)
axillary node status##2##3##(2008-10#2)
axillary node##5##2##(2008-10#4)(2008-6#1)
axillary nodes##4##2##(1994-7#1)(1997-7#1)(2008-10#2)
axillary odour##2##2##(2008-5#2)
axillary shoots and##2##3##(2009-8#2)
axillary skin##18##2##(2008-5#18)
axillary stratum corneum##3##3##(2008-5#3)
axillary##124##1##(1990-8#1)(1991-8#1)(1993-2#1)(1993-8#1)(1994-12#3)(1994-7#5)(1995-4#3)(1995-9#1)(1997-7#2)(2007-8#3)(2008-1#1)(2008-10#11)(2008-4#1)(2008-5#58)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-8#3)(2010-5#2)(2010-6#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#10)
axillo-axillary bypass##2##2##(1993-3#2)
axis (approximately##2##2##(2008-10#2)
axis activation##2##2##(2013-1#2)
axis and the##9##3##(2007-12#1)(2008-3#5)(2008-4#1)(2010-8#1)(2012-2#1)
axis and##27##2##(1990-3#1)(1992-4#1)(1994-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
axis can be##3##3##(1994-5#1)(2008-3#2)
axis can##4##2##(1990-3#1)(1994-5#1)(2008-3#2)
axis during the##2##3##(2008-3#2)
axis during##4##2##(1997-6#1)(2008-3#2)(2008-4#1)
axis formation##3##2##(2008-6#3)
axis in the##7##3##(1991-12#2)(1991-5#1)(1995-12#1)(2007-11#1)(2008-3#1)(2010-4#1)
axis in##19##2##(1991-12#2)(1991-5#1)(1994-5#1)(1994-9#1)(1995-12#2)(2007-11#2)(2007-7#2)(2008-3#4)(2008-5#1)(2010-12#1)(2010-4#1)(2010-5#1)
axis is##7##2##(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2013-1#1)
axis of a##2##3##(2007-11#1)(2007-12#1)
axis of each##3##3##(2008-2#1)(2009-5#1)(2012-2#1)
axis of rotation of##2##4##(2009-8#1)(2012-2#1)
axis of rotation##4##3##(2007-12#1)(2009-8#1)(2012-2#2)
axis of symmetry##5##3##(1996-5#1)(2008-10#2)(2008-3#1)(2008-6#1)
axis of the laser beam##2##5##(2007-11#1)(2008-3#1)
axis of the##29##3##(1990-6#1)(1991-12#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#2)(2013-1#1)(2013-8#1)
axis of##60##2##(1990-12#2)(1990-6#1)(1991-12#2)(1996-5#1)(1997-7#1)(2007-11#3)(2007-12#6)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
axis parallel to the##2##4##(2008-2#1)(2008-3#1)
axis perpendicular to the##3##4##(2008-10#1)(2008-3#2)
axis regulates##2##2##(2010-8#1)(2012-12#1)
axis that is##2##3##(2008-3#2)
axis that##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
axis the##2##2##(2008-3#2)
axis view) (p &lt##3##4##(2008-10#3)
axis view) (p##4##3##(2008-10#4)
axis was##4##2##(1991-3#1)(1993-6#1)(1994-2#1)(2008-10#1)
axis were investigated##2##3##(1996-12#1)(2008-10#1)
axis were##5##2##(1996-12#1)(2007-10#1)(2008-10#1)(2013-1#2)
axis while##2##2##(1995-8#1)(2008-3#1)
axis with the##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
axis with##10##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#5)(2008-4#1)(2013-8#1)
axis##328##1##(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#4)(1991-3#1)(1991-5#3)(1992-4#1)(1993-5#1)(1993-6#1)(1994-2#4)(1994-5#4)(1994-6#1)(1994-9#2)(1995-12#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#3)(2007-10#1)(2007-11#20)(2007-12#20)(2007-7#4)(2007-8#4)(2008-10#20)(2008-11#8)(2008-12#3)(2008-2#26)(2008-3#76)(2008-4#10)(2008-5#5)(2008-6#9)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#7)
axis)##4##1##(1995-12#1)(2008-1#1)(2008-3#1)(2012-2#1)
axisymmetric##8##1##(2008-3#6)(2008-7#1)(2009-6#1)
axo-dendritic##2##1##(1997-2#1)(2009-5#1)
axoaxonic synapses##3##2##(1997-3#3)
axodendritic##3##1##(1993-9#1)(1995-12#1)(1996-2#1)
axolotl##5##1##(1994-11#1)(1997-9#4)
axolotls##4##1##(1997-9#4)
axon and##2##2##(2008-5#1)(2009-7#1)
axon collaterals##2##2##(1997-3#2)
axon guidance##3##2##(2008-7#3)
axon outgrowth##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
axon reflex##4##2##(2009-12#4)
axon terminals in the##5##4##(1995-6#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-5#1)
axon terminals in##7##3##(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-5#1)
axon terminals of##3##3##(1995-12#1)(1997-2#2)
axon terminals##20##2##(1993-12#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-2#2)(1997-2#6)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#2)
axon undulation##2##2##(2009-7#2)
axon volume##2##2##(2009-7#2)
axon##55##1##(1993-12#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-2#6)(1997-3#2)(2007-12#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2009-12#5)(2009-3#1)(2009-7#5)(2012-12#1)(2012-2#3)
axon-target cell##2##2##(2008-7#2)
axonal damage##2##2##(2008-7#2)
axonal degeneration##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
axonal growth##2##2##(1995-11#1)(2013-1#1)
axonal injury##4##2##(1990-5#1)(2008-7#3)
axonal integrity##3##2##(1996-5#1)(2009-6#1)(2013-1#1)
axonal neuropathy##2##2##(2008-6#1)(2008-7#1)
axonal processes##2##2##(2007-12#1)(2008-11#1)
axonal projection##2##2##(1993-12#1)(2007-12#1)
axonal regeneration##4##2##(1996-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
axonal segment##7##2##(2008-6#7)
axonal tracts##2##2##(2008-4#1)(2008-7#1)
axonal transport##6##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-7#2)(2013-1#1)
axonal##81##1##(1990-5#1)(1993-12#1)(1995-11#1)(1995-12#2)(1995-2#3)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#5)(2008-1#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#8)(2008-7#22)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2011-7#2)(2012-2#4)(2012-3#4)(2013-1#4)
axonemal##3##1##(1991-2#1)(1992-5#1)(2008-7#1)
axoneme flanked by two##3##4##(2007-12#3)
axoneme##14##1##(1991-2#2)(2007-12#6)(2008-4#1)(2008-7#5)
axonemes##3##1##(1991-2#2)(2008-6#1)
axonopodis pathovars##2##2##(2008-10#2)
axonopodis pv##52##2##(2008-10#52)
axonopodis pvs##5##2##(2008-10#5)
axonopodis##63##1##(2008-10#63)
axons and Schwann cells##2##4##(2008-7#2)
axons and synaptic terminals##2##4##(1996-2#1)(1997-3#1)
axons and##14##2##(1995-2#1)(1995-5#1)(1996-2#2)(1997-3#2)(2007-12#1)(2008-12#1)(2008-7#5)(2013-1#1)
axons are##3##2##(1994-8#1)(2007-12#1)(2009-7#1)
axons can##2##2##(2008-7#1)(2011-2#1)
axons exhibited##2##2##(1997-3#1)(2008-11#1)
axons form synapses with neurons##2##5##(2011-2#2)
axons form##4##2##(2008-5#2)(2011-2#2)
axons from the##2##3##(2007-12#1)(2008-11#1)
axons from##3##2##(1993-3#1)(2007-12#1)(2008-11#1)
axons in the##2##3##(2008-11#1)(2009-8#1)
axons in##4##2##(1995-12#1)(2008-11#1)(2009-8#1)(2013-1#1)
axons of the##4##3##(1992-8#1)(1993-9#2)(1996-5#1)
axons of##9##2##(1990-5#1)(1992-8#1)(1993-9#2)(1995-12#1)(1996-5#1)(2008-7#1)(2012-2#2)
axons project to##2##3##(2007-12#2)
axons project##3##2##(2007-12#3)
axons that##2##2##(1997-3#1)(2008-5#1)
axons to##3##2##(1995-2#1)(2007-12#2)
axons were##3##2##(1996-5#1)(2008-7#2)
axons which form##2##3##(1996-5#2)
axons which##3##2##(1996-5#3)
axons##102##1##(1990-5#1)(1992-12#2)(1992-8#1)(1993-12#2)(1993-3#2)(1993-9#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#2)(1996-2#5)(1996-5#9)(1997-3#8)(2007-12#11)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-5#5)(2008-7#19)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#7)(2012-2#2)(2013-1#4)
axotomized##3##1##(1996-12#2)(1997-3#1)
axotomy##3##1##(1990-5#2)(1997-3#1)
ayahuasca use##3##2##(2008-7#2)(2013-8#1)
ayahuasca##12##1##(2008-7#5)(2013-8#7)
azacitidine##3##1##(2008-5#1)(2009-6#1)(2013-8#1)
azacrown##3##1##(2008-10#3)
azacrown-1 and##2##2##(2008-10#2)
azadiene 27##2##2##(1996-5#2)
azadirachtin##2##1##(2008-8#2)
azafenidin##2##1##(2008-10#2)
azalides##2##1##(2007-11#1)(2008-10#1)
azapirone##2##1##(1995-12#2)
azathioprine and prednisolone##2##3##(2008-1#1)(2008-4#1)
azathioprine and prednisone in##2##4##(2008-1#2)
azathioprine and##5##2##(1990-11#1)(2008-1#3)(2008-4#1)
azathioprine##21##1##(1990-11#1)(1991-8#1)(1992-5#1)(1996-8#1)(2007-7#2)(2008-1#3)(2008-10#4)(2008-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2012-3#3)
azathioprine)##2##1##(1991-11#1)(2008-3#1)
azathioprine/6-mercaptopurine and##2##2##(2010-12#2)
azathioprine/6-mercaptopurine##5##1##(2010-12#5)
azatyrosine##4##1##(1991-12#4)
azide and##6##2##(1993-11#2)(1995-11#1)(2008-11#1)(2008-12#1)(2012-2#1)
azide##35##1##(1990-11#1)(1991-8#1)(1993-11#7)(1993-8#1)(1994-5#3)(1995-11#2)(1995-8#1)(1996-5#1)(1997-4#2)(1997-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-9#1)(2012-2#2)(2012-3#1)
azides##2##1##(2012-2#2)
azido group##2##2##(2012-2#2)
azido##5##1##(1992-8#1)(1993-8#1)(1997-7#1)(2012-2#2)
azimuth angle##5##2##(2008-3#5)
azimuth angles##3##2##(2008-3#3)
azimuth of##2##2##(2008-2#1)(2008-3#1)
azimuth##14##1##(2008-2#1)(2008-3#13)
azimuthal and##2##2##(2008-1#1)(2008-3#1)
azimuthal angles of##2##3##(2008-2#2)
azimuthal modes in distorted spheres##2##5##(2008-2#2)
azimuthal modes in##3##3##(2008-2#3)
azimuthal modes##4##2##(2008-2#4)
azimuthal scattering##2##2##(2008-2#1)(2008-3#1)
azimuthal##19##1##(2007-11#3)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#5)
azimuthally polarized##3##2##(2007-11#2)(2007-12#1)
azimuthally##8##1##(1991-8#1)(2007-11#4)(2007-12#1)(2008-3#2)
azimuths##3##1##(2008-3#3)
aziridine##4##1##(1991-5#2)(1995-6#1)(1997-2#1)
aziridinylbenzoquinones##2##1##(1993-11#2)
azithromycin##10##1##(2007-12#3)(2007-7#1)(2008-10#4)(2010-12#1)(2013-1#1)
azo compound##5##2##(1995-6#4)(2008-10#1)
azo compounds as##2##3##(2008-10#2)
azo compounds were##2##3##(1995-6#1)(2008-10#1)
azo compounds##4##2##(1995-6#1)(2008-10#3)
azo dye##12##2##(1992-9#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-5#1)(2011-1#2)
azo dyes##11##2##(2007-11#1)(2007-12#1)(2008-10#8)(2011-1#1)
azo spacer##2##2##(2008-10#2)
azo##46##1##(1990-6#1)(1992-9#1)(1995-6#5)(2007-11#1)(2007-12#5)(2008-10#26)(2008-2#1)(2008-5#1)(2011-1#3)(2012-2#2)
azo-compound##3##1##(2008-10#3)
azo-dye##3##1##(2007-11#1)(2008-10#1)(2008-3#1)
azo-histidine##2##1##(2008-10#2)
azobenzene arsonic acid compound##3##4##(2008-10#3)
azobenzene moieties##2##2##(1995-6#1)(2008-10#1)
azobenzene##21##1##(1995-6#3)(2007-11#3)(2007-12#1)(2008-10#9)(2008-3#4)(2008-7#1)
azodyes and their complexes with##2##5##(2008-10#2)
azodyes##4##1##(2008-10#4)
azole antifungal##2##2##(2008-3#1)(2008-5#1)
azole##5##1##(2008-10#1)(2008-3#1)(2008-5#3)
azole-resistant##3##1##(2008-10#1)(2008-5#1)(2013-8#1)
azoles##4##1##(2008-5#4)
azomethine-H##4##1##(2008-10#4)
azoospermia factor##2##2##(1993-12#2)
azoospermia##7##1##(1993-12#2)(1993-9#1)(1997-8#2)(2008-10#1)(2011-2#1)
azoospermic##2##1##(1997-8#1)(2008-12#1)
azoreductase##3##1##(2012-2#3)
azoreductases##3##1##(2012-2#3)
azotemia##6##1##(1992-8#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
azoxymethane (AOM)##3##2##(1992-3#1)(1992-9#1)(1993-11#1)
azoxymethane##9##1##(1992-3#1)(1992-9#3)(1993-11#1)(2009-9#1)(2011-1#2)(2011-2#1)
azoxymethane-induced##4##1##(1992-3#2)(1992-9#1)(1995-9#1)
azoxystrobin and##3##2##(2008-10#3)
azoxystrobin##7##1##(2008-10#6)(2011-2#1)
azteca##2##1##(2008-5#2)
azure-dye##2##1##(2008-10#2)
azurol S (CAS)##2##3##(2008-10#2)
azurol S##3##2##(2008-10#3)
azygos vein##11##2##(2008-11#2)(2011-2#4)(2012-12#3)(2012-3#2)
azygos##16##1##(1996-3#1)(2007-8#2)(2008-11#2)(2011-2#4)(2012-12#3)(2012-3#4)
azygous vein##4##2##(2007-8#2)(2008-11#1)(2009-5#1)
b = 0##4##3##(1997-1#2)(2009-11#2)
b = 10##5##3##(1996-2#4)(1997-7#1)
b = 11##5##3##(1996-2#3)(1997-7#1)(2007-11#1)
b = 12##5##3##(1996-2#3)(1997-7#2)
b = 13##3##3##(1996-2#3)
b = 14##2##3##(1996-2#1)(1997-7#1)
b = 16##3##3##(1996-2#1)(1997-7#1)(2013-8#1)
b = 17##2##3##(1996-2#2)
b = 18##6##3##(1996-2#4)(1996-5#1)(1997-7#1)
b = 20##2##3##(1996-2#1)(1997-1#1)
b = 24##2##3##(1992-12#1)(1996-2#1)
b = 5##2##3##(1997-7#2)
b = 8##2##3##(1997-7#2)
b = 9##2##3##(1997-7#1)(2007-11#1)
b =##61##2##(1992-11#1)(1992-12#1)(1992-9#1)(1996-2#29)(1996-5#1)(1997-1#5)(1997-7#17)(2007-11#2)(2009-11#3)(2013-8#1)
b =7##2##2##(1997-7#1)(2007-11#1)
b and##9##2##(1994-5#3)(1995-5#1)(2008-11#1)(2008-12#3)(2008-6#1)
b are##2##2##(1993-12#1)(2008-3#1)
b conjugate##4##2##(1995-5#2)(2007-11#1)(2008-10#1)
b gene##14##2##(1991-12#1)(1995-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2010-4#3)(2010-8#2)
b in##2##2##(1996-5#1)(2008-10#1)
b locus##2##2##(2008-10#2)
b mating##2##2##(2008-10#2)
b types##3##2##(2008-10#3)
b was##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
b##207##1##(1990-12#3)(1990-7#2)(1991-12#3)(1991-3#2)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#6)(1993-8#1)(1994-2#1)(1994-5#6)(1995-11#3)(1995-2#4)(1995-3#2)(1995-5#9)(1996-2#29)(1996-5#3)(1997-1#8)(1997-2#2)(1997-3#1)(1997-7#19)(2007-11#6)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#2)(2008-12#4)(2008-3#7)(2008-5#7)(2008-6#2)(2008-7#2)(2009-11#3)(2009-12#3)(2009-5#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
b( *)##6##2##(2010-4#6)
b(1)(psi)##4##1##(1996-2#4)
b(3)##3##1##(2012-12#3)
b(5)##11##1##(2008-7#6)(2011-2#5)
b(7)##3##1##(2008-10#3)
b(b)##11##1##(2008-2#2)(2008-3#9)
b(r)##2##1##(2008-3#2)
b) is##2##2##(2008-10#2)
b) the##8##2##(1991-2#1)(1991-6#1)(1992-10#1)(1993-1#1)(1993-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
b) their##2##2##(1990-6#1)(2008-5#1)
b)##45##1##(1990-11#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#2)(2011-2#3)(2012-2#3)(2013-7#2)(2013-8#1)
b-RhB##2##1##(2008-10#2)
b-lactamase##3##1##(2007-8#3)
b-wave##2##1##(2009-12#2)
b5 genes##2##2##(1992-6#2)
b5##11##1##(1992-6#9)(1994-6#2)
bFGF + FeSO(4)##2##3##(2008-11#2)
bFGF and its receptor##3##4##(1995-12#3)
bFGF and its##4##3##(1994-11#1)(1995-12#3)
bFGF and##8##2##(1994-11#2)(1995-12#3)(2008-11#3)
bFGF could be##2##3##(1990-5#1)(1995-12#1)
bFGF could##3##2##(1990-5#2)(1995-12#1)
bFGF gene expression##2##3##(1992-3#1)(1995-12#1)
bFGF gene transfected MSCs##2##4##(2008-5#2)
bFGF gene##6##2##(1992-3#1)(1995-12#1)(2008-5#4)
bFGF in the##4##3##(1990-5#1)(1992-3#1)(1995-12#1)(1997-6#1)
bFGF in##9##2##(1990-5#1)(1992-3#1)(1992-9#1)(1995-12#3)(1997-6#1)(2010-8#1)(2013-8#1)
bFGF is##2##2##(1995-12#2)
bFGF mRNA##7##2##(1992-3#3)(1994-11#1)(1995-12#3)
bFGF to##2##2##(1995-12#1)(2008-5#1)
bFGF was##2##2##(1992-3#1)(1995-12#1)
bFGF##75##1##(1990-12#1)(1990-5#5)(1991-12#4)(1991-2#1)(1992-3#7)(1992-9#2)(1994-11#5)(1995-12#25)(1997-6#2)(2008-11#14)(2008-5#5)(2008-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
bFGFs##4##1##(1990-12#4)
bHLH transcription factor##2##3##(2008-9#1)(2010-11#1)
bHLH transcription##3##2##(2007-12#1)(2008-9#1)(2010-11#1)
bHLH##4##1##(2007-12#1)(2008-9#1)(2009-8#1)(2010-11#1)
bNAs##2##1##(2008-4#2)
bR##5##1##(1993-11#5)
bZIP genes##2##2##(2008-10#1)(2013-8#1)
bZIP protein##2##2##(2008-9#2)
bZIP transcription##2##2##(2008-10#1)(2008-9#1)
bZIP##9##1##(2008-10#4)(2008-9#3)(2013-8#2)
bZIP60 mRNA##3##2##(2012-2#3)
bZIP60##5##1##(2012-2#5)
bZip##3##1##(2010-2#3)
babassu coconut##2##2##(2008-6#2)
babassu##6##1##(2008-10#1)(2008-6#5)
babies (&lt##2##2##(1994-3#1)(2009-9#1)
babies and young children##2##4##(1996-2#1)(1997-8#1)
babies and##6##2##(1990-8#1)(1995-12#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-11#1)
babies are##2##2##(1990-2#1)(2010-5#1)
babies born with##3##3##(1997-1#1)(2008-1#1)(2008-11#1)
babies born##7##2##(1990-2#1)(1991-3#1)(1997-1#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-2#1)
babies in rooms##2##3##(1990-2#2)
babies in##5##2##(1990-2#2)(1991-8#1)(1994-3#1)(1995-2#1)
babies were##2##2##(2009-11#2)
babies who##2##2##(1994-6#1)(2012-3#1)
babies with##7##2##(1990-12#2)(1994-6#2)(1996-6#1)(1997-1#1)(2008-11#1)
babies##64##1##(1990-11#1)(1990-12#3)(1990-2#8)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-5#1)(1994-1#1)(1994-3#3)(1994-6#3)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-11#4)(2008-7#1)(2009-11#2)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#4)(2012-12#2)(2012-2#1)(2012-3#1)
babies'##3##1##(1991-2#1)(1992-4#1)(2013-1#1)
baboon and human##3##3##(1993-6#3)
baboon and##5##2##(1993-6#3)(2008-9#2)
baboon glycoprotein##2##2##(1994-12#2)
baboon##18##1##(1991-12#1)(1993-6#5)(1994-12#5)(1996-12#1)(2008-9#5)(2009-3#1)
baboons##6##1##(1991-1#2)(1991-12#1)(1996-12#1)(2008-4#1)(2009-3#1)
baby and##3##2##(2007-10#1)(2008-2#1)(2012-3#1)
baby at##2##2##(2008-11#1)(2011-2#1)
baby boom generation##3##3##(2008-10#2)(2009-5#1)
baby boom##5##2##(2008-10#3)(2008-12#1)(2009-5#1)
baby food##3##2##(1996-11#2)(2008-7#1)
baby for##2##2##(1990-2#1)(1996-6#1)
baby hamster kidney##6##3##(1994-9#2)(1995-12#1)(2008-4#1)(2008-5#1)(2011-3#1)
baby was##3##2##(1992-10#1)(1994-3#1)(1995-4#1)
baby who##2##2##(1997-3#1)(2008-11#1)
baby with##4##2##(1996-2#1)(2008-11#2)(2009-12#1)
baby##66##1##(1990-2#1)(1990-8#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-3#1)(1994-3#2)(1994-7#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-6#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-4#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
baby's##6##1##(1990-2#1)(1994-2#2)(2008-11#1)(2008-2#2)
baccalaureate health administration##2##3##(1991-1#1)(1996-2#1)
baccalaureate nursing program##2##3##(2008-11#2)
baccalaureate nursing students##4##3##(2008-11#3)(2008-12#1)
baccalaureate nursing##9##2##(2008-11#6)(2008-12#2)(2012-3#1)
baccalaureate program##2##2##(1994-2#1)(1995-2#1)
baccalaureate programs in##2##3##(1994-2#1)(2008-11#1)
baccalaureate programs##3##2##(1994-2#1)(1995-2#1)(2008-11#1)
baccalaureate students##2##2##(1996-2#1)(2008-12#1)
baccalaureate##26##1##(1991-1#3)(1994-12#1)(1994-2#2)(1995-2#5)(1996-2#2)(2008-11#8)(2008-12#4)(2012-3#1)
baccatum##3##1##(2008-10#3)
baccifera##2##1##(2008-5#2)
bacillary load##2##2##(2007-7#1)(2011-2#1)
bacillary##3##1##(2007-7#1)(2011-2#1)(2013-1#1)
bacille Calmette-Guérin##2##2##(1991-11#1)(1997-2#1)
bacilli and##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
bacilli in the##2##3##(1995-2#1)(2007-7#1)
bacilli in##6##2##(1995-2#1)(1996-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)
bacilli##26##1##(1991-11#1)(1995-2#1)(1996-8#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#5)(2012-2#3)(2013-1#1)
bacilliform##2##1##(2008-10#2)
bacillus Calmette-Guérin##2##2##(2008-1#1)(2010-5#1)
bacillus and##2##2##(2007-12#1)(2008-10#1)
bacillus##11##1##(2007-12#1)(2008-1#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#3)
bacitracin##3##1##(1991-8#1)(1994-6#1)(2013-1#1)
back again##2##2##(2007-7#1)(2008-10#1)
back and leg pain##5##4##(2007-11#1)(2012-3#3)(2013-1#1)
back and##17##2##(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#5)(2008-5#1)(2011-2#1)(2012-3#4)(2013-1#1)
back by##2##2##(2008-10#1)(2008-5#1)
back extraction of zinc##2##4##(2008-10#2)
back extraction of##4##3##(2008-10#4)
back extraction##5##2##(2008-10#5)
back focal##2##2##(2008-3#2)
back from a##3##3##(2008-3#2)(2013-8#1)
back from##5##2##(2007-12#1)(2008-3#2)(2012-2#1)(2013-8#1)
back in##4##2##(2008-11#1)(2008-2#1)(2012-3#1)(2013-1#1)
back injuries##2##2##(1996-1#1)(1997-7#1)
back into a##2##3##(2007-12#1)(2008-3#1)
back into the laser##3##4##(2008-2#3)
back into the##14##3##(1994-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#4)(2009-7#1)(2012-1#1)
back into##25##2##(1991-2#1)(1992-5#1)(1994-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#5)(2008-6#1)(2008-8#1)(2009-7#1)(2010-10#1)(2012-1#1)
back muscle##2##2##(2008-5#1)(2012-12#1)
back of the##7##3##(1990-6#1)(1991-6#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
back of##13##2##(1990-6#1)(1991-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
back on##3##2##(1995-2#1)(2008-3#1)(2009-9#1)
back over##2##2##(2008-10#2)
back pain and##17##3##(1997-2#1)(2007-11#1)(2007-8#1)(2008-12#3)(2008-6#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
back pain associated with##3##4##(1991-8#1)(2010-12#2)
back pain in##7##3##(2007-8#1)(2009-3#1)(2009-4#3)(2010-10#1)(2012-3#1)
back pain is##4##3##(1993-6#1)(2007-11#1)(2008-12#1)(2009-6#1)
back pain syndrome##3##3##(2007-11#2)(2008-4#1)
back pain with##3##3##(1992-12#1)(2012-2#1)(2013-1#1)
back pain##125##2##(1990-6#2)(1991-8#1)(1992-12#2)(1993-6#4)(1993-7#1)(1993-9#1)(1994-2#2)(1995-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#15)(2007-8#8)(2008-10#3)(2008-11#1)(2008-12#15)(2008-4#1)(2008-6#2)(2009-1#2)(2009-11#1)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#5)(2010-10#1)(2010-12#5)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#2)(2013-1#8)(2013-8#1)
back pain]##4##2##(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)
back part of##2##3##(2008-7#2)
back plate##4##2##(2007-12#4)
back pressure##2##2##(2008-10#2)
back propagation neural##2##3##(2008-10#1)(2010-8#1)
back propagation of##3##3##(1997-7#1)(2008-10#1)(2009-8#1)
back propagation##8##2##(1997-7#1)(2008-10#2)(2009-8#1)(2010-8#4)
back the##5##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
back to a##3##3##(1994-9#1)(2008-5#1)(2008-6#1)
back to his##2##3##(2008-1#1)(2010-1#1)
back to normal##2##3##(2008-1#1)(2008-10#1)
back to the##38##3##(1990-3#1)(1992-4#1)(1992-8#2)(1993-3#1)(1994-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
back to their##3##3##(2007-12#1)(2011-1#1)(2011-2#1)
back to work##2##3##(1995-5#1)(2008-9#1)
back to##88##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-9#2)(1995-5#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-8#1)
back toward##2##2##(1990-7#1)(2008-2#1)
back with##2##2##(1997-4#1)(2008-5#1)
back##428##1##(1990-3#1)(1990-6#3)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-2#2)(1993-3#1)(1993-6#5)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-9#3)(1995-2#2)(1995-3#3)(1995-5#2)(1996-1#1)(1996-11#3)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#6)(1997-6#2)(1997-7#6)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#18)(2007-12#12)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#41)(2008-11#13)(2008-12#29)(2008-2#10)(2008-3#24)(2008-4#3)(2008-5#14)(2008-6#7)(2008-7#7)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#6)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#6)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#7)(2010-9#4)(2011-1#2)(2011-2#15)(2012-1#3)(2012-12#11)(2012-2#12)(2012-3#10)(2013-1#14)(2013-7#1)(2013-8#4)
back-cross hybrids##2##2##(2010-3#2)
back-cross##3##1##(2008-10#1)(2010-3#2)
back-extracted##3##1##(2008-10#3)
back-extraction##4##1##(2008-10#3)(2008-6#1)
back-flushed##3##1##(1990-8#1)(2008-10#2)
back-illuminated##3##1##(2007-12#1)(2008-10#1)(2008-3#1)
back-pressure##2##1##(2008-10#2)
back-projection##3##1##(1994-9#2)(2011-2#1)
back-propagation learning algorithm was##2##4##(2008-10#2)
back-propagation learning##5##2##(2008-10#5)
back-propagation##10##1##(2008-10#10)
back-scattered##2##1##(2008-10#2)
back-titration##3##1##(2008-10#3)
back-up##6##1##(2007-12#1)(2008-11#2)(2008-9#2)(2011-2#1)
backache and##2##2##(1993-10#1)(1995-3#1)
backache##4##1##(1993-10#3)(1995-3#1)
backbone amide##2##2##(1995-2#1)(2008-4#1)
backbone and side chain assignments##2##5##(2009-7#2)
backbone and side chain resonance assignments##2##6##(2009-7#2)
backbone and side chain##5##4##(2009-7#5)
backbone and side##6##3##(2009-7#6)
backbone and side-chain 1H##2##4##(1995-5#1)(2009-7#1)
backbone and side-chain##4##3##(1992-3#1)(1995-5#1)(2009-7#2)
backbone and##14##2##(1991-5#1)(1992-3#1)(1995-5#1)(2008-4#2)(2008-9#1)(2009-7#8)
backbone assignment of##2##3##(2009-7#2)
backbone atoms##4##2##(1994-5#2)(1995-5#1)(2008-8#1)
backbone cleavage##2##2##(1993-11#1)(2008-4#1)
backbone conformation##2##2##(2008-5#1)(2009-2#1)
backbone for##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
backbone geometry##3##2##(1991-5#1)(1992-8#2)
backbone of##7##2##(1993-12#1)(1995-8#1)(2008-7#1)(2008-9#2)(2010-3#1)(2013-1#1)
backbone resonance assignments of the 34 kDa##2##7##(2009-7#2)
backbone resonance assignments##3##3##(2009-7#3)
backbone resonance##4##2##(2009-7#4)
backbone scission##2##2##(1993-11#1)(2008-4#1)
backbone that##2##2##(2008-4#1)(2008-7#1)
backbone##89##1##(1990-8#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-8#3)(1993-11#5)(1993-12#1)(1993-8#1)(1994-5#4)(1994-8#1)(1995-2#3)(1995-5#2)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#3)(2009-2#1)(2009-7#16)(2010-3#2)(2010-4#2)(2010-5#1)(2012-2#2)(2013-1#1)
backbones of##2##2##(1995-3#1)(2006-12#1)
backbones##10##1##(1994-9#1)(1995-3#2)(2006-12#2)(2008-10#2)(2008-4#1)(2009-2#1)(2009-9#1)
backcalculation##2##1##(1992-9#2)
backcross populations derived from##2##4##(2008-10#1)(2008-4#1)
backcross populations##7##2##(2008-10#5)(2008-4#1)(2008-9#1)
backcross to##3##2##(2008-10#3)
backcross##30##1##(1995-2#1)(1996-12#2)(2008-10#21)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2013-8#1)
backcrossed to##2##2##(2008-10#2)
backcrossed##3##1##(2008-10#2)(2008-9#1)
backcrosses to the susceptible##2##4##(2008-10#2)
backcrosses to the##3##3##(2008-10#3)
backcrosses##7##1##(2008-10#6)(2008-8#1)
backcrossing to##3##2##(1991-12#1)(2008-10#2)
backcrossing##6##1##(1991-12#2)(2008-10#3)(2008-5#1)
backfat##3##1##(2010-4#2)(2012-2#1)
backflush mode##2##2##(2008-10#1)(2008-11#1)
background about##2##2##(2008-10#1)(2008-3#1)
background absorbance##5##2##(1994-9#1)(1996-5#1)(2008-10#3)
background absorption##6##2##(2008-10#6)
background adaptation##3##2##(1993-5#3)
background and a##2##3##(2008-10#1)(2011-2#1)
background and signal##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
background and##26##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
background are##2##2##(2007-11#1)(2008-9#1)
background conditions##2##2##(2008-3#2)
background correction and##3##3##(2008-10#3)
background correction##13##2##(2008-10#13)
background corrector##3##2##(2008-10#3)
background current##5##2##(2008-10#5)
background electrolyte at##2##3##(2008-10#2)
background electrolyte##8##2##(2008-10#8)
background electrolytes (BGE)##2##3##(2008-10#2)
background electrolytes##3##2##(1996-5#1)(2008-10#2)
background environmental##2##2##(2008-10#1)(2008-9#1)
background factors##3##2##(1993-1#1)(1994-7#1)(2012-1#1)
background fluorescence##5##2##(2008-10#1)(2008-3#2)(2008-9#1)(2010-3#1)
background flux##3##2##(2008-3#2)(2009-11#1)
background for the##8##3##(2008-2#1)(2008-9#3)(2009-5#1)(2011-2#2)(2012-12#1)
background for##13##2##(1994-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-5#1)(2011-2#2)(2012-12#1)
background in a##2##3##(2008-10#1)(2008-3#1)
background in##12##2##(1993-2#2)(1994-12#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2013-1#3)
background incidence of##2##3##(1991-12#1)(1994-12#1)
background information on##4##3##(1991-12#1)(1994-2#1)(1996-12#1)(2008-9#1)
background information that##2##3##(2008-7#2)
background information##8##2##(1991-12#1)(1994-2#1)(1996-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
background interference##2##2##(1995-2#1)(2008-10#1)
background is##7##2##(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)
background level of##3##3##(1991-12#1)(2008-10#2)
background level##4##2##(1991-12#1)(2008-10#2)(2008-3#1)
background levels of##2##3##(2008-10#2)
background levels##6##2##(1990-12#1)(1995-12#1)(2008-10#3)(2008-7#1)
background literature##2##2##(2007-12#1)(2008-7#1)
background lumiphore##2##2##(2008-2#2)
background move##2##2##(2008-9#2)
background mutant frequency##2##3##(2008-4#2)
background noise and##2##3##(2008-3#1)(2009-12#1)
background noise##16##2##(1994-2#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-9#1)(2009-12#1)(2012-2#1)
background of the##11##3##(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-1#1)(2012-3#1)
background of##49##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(2007-10#2)(2007-11#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
background on the##2##3##(2007-11#1)(2009-11#1)
background on##7##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)
background optical properties##2##3##(2008-2#2)
background or##2##2##(2008-2#1)(2008-9#1)
background radiation areas and nuclear workers##2##6##(2008-7#2)
background radiation levels##2##3##(1993-12#1)(2008-7#1)
background radiation##10##2##(1993-12#1)(2007-12#1)(2008-3#1)(2008-7#7)
background salt##2##2##(2008-10#2)
background signal##8##2##(2007-11#1)(2008-10#5)(2008-3#1)(2012-12#1)
background signals are##2##3##(2008-3#2)
background signals caused by##2##4##(2008-10#2)
background signals from a##3##4##(2008-3#3)
background signals from##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
background signals in##2##3##(2008-3#2)
background signals##28##2##(2007-12#1)(2008-10#7)(2008-3#19)(2010-7#1)
background spectrum##2##2##(2008-10#1)(2008-2#1)
background stratospheric aerosol##2##3##(2008-2#1)(2008-3#1)
background tissue##2##2##(2007-12#1)(2009-6#1)
background to the##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
background to##7##2##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-3#1)
background variables##4##2##(1994-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
background were##3##2##(1993-8#1)(2008-2#1)(2008-3#1)
background##503##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#5)(1993-6#1)(1993-8#1)(1994-12#7)(1994-2#4)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1997-1#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#2)(2007-10#3)(2007-11#12)(2007-12#14)(2007-2#1)(2007-5#3)(2008-1#7)(2008-10#122)(2008-11#11)(2008-12#1)(2008-2#32)(2008-3#63)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#20)(2008-8#5)(2008-9#24)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#6)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#16)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#12)(2013-8#7)
background)##3##1##(1995-8#1)(1996-11#1)(2008-10#1)
backgrounds and##6##2##(2008-10#1)(2008-11#3)(2008-12#1)(2012-12#1)
backgrounds in##5##2##(1995-1#1)(2008-10#3)(2008-11#1)
backgrounds of##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
backgrounds##54##1##(1993-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#4)(2008-9#4)(2009-5#1)(2009-8#5)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
backing substrate##2##2##(2008-10#1)(2009-5#1)
backing##11##1##(2008-10#1)(2008-3#2)(2008-5#5)(2009-5#2)(2009-7#1)
backlight system##2##2##(2008-3#2)
backlight##3##1##(2008-3#3)
backlighting##2##1##(2008-2#1)(2008-3#1)
backplane##5##1##(2008-2#5)
backpressure##2##1##(2008-10#2)
backprojection##6##1##(2008-3#2)(2011-1#2)(2012-1#2)
backpropagation algorithm##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
backpropagation and##3##2##(2008-10#1)(2008-3#2)
backpropagation models##2##2##(2008-10#2)
backpropagation##13##1##(1993-12#1)(2008-10#5)(2008-2#2)(2008-3#4)(2010-8#1)
backreflected##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
backreflecting prism##2##2##(2008-3#2)
backreflection##5##1##(2008-2#1)(2008-3#4)
backs##5##1##(1993-12#1)(1997-5#1)(2008-7#1)(2010-8#2)
backscatter and##9##2##(2008-2#3)(2008-3#6)
backscatter data##4##2##(2008-3#4)
backscatter from the##2##3##(2008-3#1)(2011-2#1)
backscatter from##5##2##(2008-2#1)(2008-3#3)(2011-2#1)
backscatter heterodyne lidar##3##3##(2008-2#2)(2008-3#1)
backscatter in##3##2##(2008-3#3)
backscatter lidar data##4##3##(2008-3#4)
backscatter lidar measurements##3##3##(2008-2#1)(2008-3#2)
backscatter lidar##11##2##(2008-2#3)(2008-3#8)
backscatter measurements##5##2##(2008-2#1)(2008-3#4)
backscatter ratio##5##2##(2008-3#5)
backscatter signal##2##2##(2008-2#1)(2008-3#1)
backscatter##93##1##(2008-2#32)(2008-3#60)(2011-2#1)
backscatter-absorption gas-imaging##2##2##(2008-2#2)
backscatter-absorption##4##1##(2007-12#2)(2008-2#2)
backscattered field##2##2##(2008-3#2)
backscattered image##3##2##(2008-3#3)
backscattered intensity##4##2##(2008-3#4)
backscattered laser##4##2##(2008-3#4)
backscattered light and##2##3##(2008-3#2)
backscattered light from##2##3##(2008-2#2)
backscattered light in an optical fiber##2##6##(2008-3#2)
backscattered light in##3##3##(2008-3#3)
backscattered light is##2##3##(2008-2#2)
backscattered light##24##2##(2007-11#1)(2008-2#8)(2008-3#15)
backscattered signal##4##2##(2007-12#2)(2008-3#2)
backscattered##61##1##(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#16)(2008-3#36)(2009-4#1)
backscattering Mueller matrix##2##3##(2008-3#2)
backscattering amplification##2##2##(2008-3#2)
backscattering and the##2##3##(2008-3#2)
backscattering and##3##2##(2008-3#3)
backscattering at grazing angles##2##4##(2007-11#2)
backscattering by##3##2##(2008-3#3)
backscattering coefficient##13##2##(2008-2#4)(2008-3#9)
backscattering coefficients of##3##3##(2008-2#1)(2008-3#2)
backscattering coefficients##8##2##(2008-2#5)(2008-3#3)
backscattering from highly absorbant##2##4##(2008-2#2)
backscattering from organic laser gain media##2##6##(2008-3#2)
backscattering from##10##2##(2007-12#2)(2008-2#3)(2008-3#5)
backscattering is##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
backscattering of light##2##3##(2008-2#2)
backscattering of the##2##3##(2007-12#2)
backscattering of##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
backscattering peak##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
backscattering properties##2##2##(2008-2#2)
backscattering ratio##3##2##(2008-2#2)(2008-3#1)
backscattering##111##1##(2007-11#9)(2007-12#10)(2008-2#29)(2008-3#63)
backside wear##3##2##(2008-8#3)
backside##5##1##(2008-3#1)(2008-7#1)(2008-8#3)
backswitch-poled lithium niobate##2##3##(2007-12#2)
backup##11##1##(1993-9#1)(1994-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-3#4)(2008-9#1)
backward Raman##2##2##(2007-11#1)(2008-3#1)
backward anisotropic scattering##3##3##(2008-3#3)
backward average path-length parameters##2##4##(2008-2#2)
backward directions##2##2##(2008-2#1)(2008-3#1)
backward inversion algorithm##3##3##(2008-3#3)
backward light scattering (BLS) signals##2##5##(2008-10#2)
backward light scattering##3##3##(2008-10#3)
backward second-harmonic generation##2##3##(2007-12#2)
backward second-harmonic##4##2##(2007-12#4)
backward stepwise linear regression##2##4##(2010-5#2)
backward third-harmonic generation##2##3##(2007-12#2)
backward##50##1##(1991-3#1)(1992-2#1)(1994-3#1)(1994-9#1)(2007-11#2)(2007-12#8)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#8)(2008-3#10)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-2#2)
backward-pumped Raman gain##2##3##(2007-11#1)(2007-12#1)
backward-pumped Raman##3##2##(2007-11#2)(2007-12#1)
backwards##4##1##(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
baclofen enantiomers##2##2##(2008-10#2)
baclofen in##2##2##(2008-10#1)(2011-2#1)
baclofen were##2##2##(1993-12#1)(2011-2#1)
baclofen##25##1##(1990-5#4)(1992-3#1)(1993-12#6)(1993-5#1)(1995-2#1)(1995-5#1)(2008-10#5)(2011-2#6)
bacoside A##3##2##(2012-2#3)
bacoside##4##1##(2012-2#4)
bacteraemia and meningitis##2##3##(1995-3#2)
bacteraemia and##3##2##(1991-3#1)(1995-3#2)
bacteraemia in##2##2##(2007-7#2)
bacteraemia##11##1##(1991-3#2)(1995-3#3)(2007-7#3)(2008-5#1)(2013-8#2)
bacteremia and##2##2##(1991-3#1)(2007-12#1)
bacteremia was##3##2##(1990-2#1)(2007-7#1)(2013-1#1)
bacteremia##27##1##(1990-2#1)(1990-3#1)(1991-3#1)(1992-11#1)(2006-10#1)(2007-12#6)(2007-7#5)(2008-7#2)(2009-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#4)
bacteria (P##2##2##(1995-2#1)(2011-2#1)
bacteria -##2##2##(2008-10#1)(2011-1#1)
bacteria among##2##2##(2008-11#1)(2010-3#1)
bacteria and EPS I were##2##5##(2008-10#2)
bacteria and fungi are##2##4##(2006-6#1)(2011-1#1)
bacteria and fungi##8##3##(2006-6#1)(2008-11#1)(2008-5#2)(2011-1#3)(2013-8#1)
bacteria and its##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
bacteria and of##2##3##(2008-10#2)
bacteria and other##2##3##(2008-10#2)
bacteria and parasites##2##3##(1994-9#1)(2008-9#1)
bacteria and protozoa##2##3##(2008-9#2)
bacteria and the##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-2#1)
bacteria and yeast##4##3##(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
bacteria and##66##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(2006-6#2)(2007-11#1)(2008-10#16)(2008-11#5)(2008-3#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#6)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
bacteria are##13##2##(1990-8#1)(1991-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-1#2)(2012-3#1)
bacteria as well as##3##4##(1994-5#1)(2008-10#1)(2009-4#1)
bacteria as well##4##3##(1994-5#1)(2008-10#2)(2009-4#1)
bacteria as##8##2##(1994-5#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-5#1)(2010-8#2)
bacteria associated with##4##3##(1997-4#1)(2008-10#3)
bacteria at the##2##3##(2009-8#1)(2011-2#1)
bacteria at##6##2##(1997-4#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-2#1)
bacteria but it##2##3##(2007-7#1)(2008-11#1)
bacteria but##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
bacteria by##7##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
bacteria can be##2##3##(2008-7#1)(2011-2#1)
bacteria can##10##2##(1990-6#1)(1991-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)
bacteria capable of##2##3##(2012-2#2)
bacteria contains##2##2##(2008-8#1)(2010-7#1)
bacteria could be##2##3##(2008-10#2)
bacteria could##4##2##(2007-7#1)(2008-10#3)
bacteria counts##2##2##(1997-4#1)(2008-1#1)
bacteria during##4##2##(2008-10#3)(2013-1#1)
bacteria for##8##2##(1990-8#1)(2008-10#2)(2008-5#3)(2011-1#1)(2012-2#1)
bacteria from a##2##3##(2011-1#1)(2012-2#1)
bacteria from the##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#2)
bacteria from##13##2##(2008-10#2)(2008-5#3)(2008-7#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-8#1)
bacteria has##4##2##(1997-4#1)(2009-5#1)(2011-1#1)(2011-2#1)
bacteria have been##2##3##(2008-5#1)(2008-6#1)
bacteria have##6##2##(1995-3#1)(2008-10#1)(2008-5#1)(2008-6#2)(2013-1#1)
bacteria in the##13##3##(1996-3#1)(1996-9#1)(2008-10#5)(2008-4#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
bacteria in their##2##3##(1996-12#1)(2008-10#1)
bacteria in##45##2##(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#3)(2006-6#1)(2007-7#2)(2008-10#16)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#4)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)
bacteria increased##2##2##(2008-8#1)(2011-2#1)
bacteria into##2##2##(2008-10#2)
bacteria is presented##2##3##(1993-8#1)(2008-9#1)
bacteria is##8##2##(1991-2#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
bacteria isolated from##11##3##(1991-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#3)(2013-8#2)
bacteria isolated##13##2##(1991-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#3)(2013-8#2)
bacteria killed by##2##3##(2008-5#2)
bacteria living##2##2##(2008-5#2)
bacteria may##5##2##(1994-8#1)(2008-10#2)(2008-4#1)(2012-2#1)
bacteria might##2##2##(2008-11#1)(2008-5#1)
bacteria of the##2##3##(2008-7#1)(2011-2#1)
bacteria of##11##2##(1997-4#3)(2007-11#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-3#1)
bacteria on pear##2##3##(2008-10#2)
bacteria on the basis of##2##5##(2008-7#1)(2008-9#1)
bacteria on the##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
bacteria on##15##2##(2007-7#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2013-1#1)
bacteria or the##2##3##(2008-1#1)(2008-10#1)
bacteria or##10##2##(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
bacteria play an##2##3##(2008-9#1)(2011-2#1)
bacteria produce##2##2##(2008-10#1)(2008-6#1)
bacteria resident##2##2##(2008-10#1)(2008-5#1)
bacteria responsible##2##2##(2010-12#2)
bacteria showed##3##2##(1990-7#1)(1991-3#1)(2007-7#1)
bacteria such as##3##3##(1994-2#1)(2008-5#1)(2013-8#1)
bacteria suspended in##2##3##(2007-7#1)(2008-5#1)
bacteria synthesize##2##2##(1994-8#1)(2010-10#1)
bacteria tested##2##2##(1995-8#1)(2012-2#1)
bacteria that are##2##3##(2008-10#1)(2011-1#1)
bacteria that can##2##3##(2008-9#1)(2011-1#1)
bacteria that cause##3##3##(1991-11#1)(2008-8#1)(2010-4#1)
bacteria that##15##2##(1991-11#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#1)
bacteria through##2##2##(2008-10#2)
bacteria to the##3##3##(2006-6#1)(2008-7#1)(2008-8#1)
bacteria to##16##2##(1994-12#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#2)
bacteria under##3##2##(1994-6#1)(2008-7#1)(2008-8#1)
bacteria was##11##2##(1996-12#1)(2008-10#5)(2008-5#3)(2008-6#1)(2008-7#1)
bacteria were applied##3##3##(2008-10#3)
bacteria were detected##4##3##(2008-10#2)(2008-5#1)(2009-5#1)
bacteria were found##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
bacteria were higher##2##3##(2009-4#1)(2013-7#1)
bacteria were isolated from##4##4##(2008-10#2)(2012-2#2)
bacteria were isolated##5##3##(2007-7#1)(2008-10#2)(2012-2#2)
bacteria were not##4##3##(2008-10#3)(2008-11#1)
bacteria were##38##2##(1992-11#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-4#1)(2007-7#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#3)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#2)(2013-7#1)
bacteria when##2##2##(2008-12#1)(2011-1#1)
bacteria which##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2013-7#1)
bacteria with##11##2##(1995-2#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
bacteria within the##4##3##(1996-6#1)(1997-6#1)(2012-2#1)(2013-8#1)
bacteria within##5##2##(1996-6#1)(1997-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
bacteria without##2##2##(1994-6#1)(1996-2#1)
bacteria##794##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1993-12#3)(1993-2#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-12#10)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-4#17)(1997-6#2)(1997-8#3)(2006-5#1)(2006-6#7)(2007-11#6)(2007-12#9)(2007-7#16)(2008-1#4)(2008-10#192)(2008-11#31)(2008-12#9)(2008-2#5)(2008-3#3)(2008-4#8)(2008-5#62)(2008-6#12)(2008-7#25)(2008-8#19)(2008-9#37)(2009-3#1)(2009-4#5)(2009-5#12)(2009-6#6)(2009-8#6)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#34)(2011-2#35)(2012-1#4)(2012-12#3)(2012-2#36)(2012-3#12)(2012-8#1)(2013-1#19)(2013-7#6)(2013-8#21)
bacteria's##2##1##(1995-2#1)(2008-10#1)
bacteria)##7##1##(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#3)(2013-1#1)
bacterial 16S rRNA##2##3##(2010-6#1)(2012-2#1)
bacterial DNA sequences##2##3##(2010-7#2)
bacterial DNA##8##2##(1994-12#1)(1994-8#1)(1995-6#1)(2008-10#1)(2009-6#1)(2010-2#1)(2010-7#2)
bacterial DnaJ##2##2##(1993-11#2)
bacterial adherence to leaves##2##4##(2008-10#2)
bacterial adherence##5##2##(1992-2#1)(1997-3#1)(2008-10#2)(2013-8#1)
bacterial adhesion##2##2##(2008-1#1)(2010-4#1)
bacterial and fungal infections##2##4##(2007-8#1)(2013-1#1)
bacterial and fungal##7##3##(2007-8#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
bacterial and viral pathogens##2##4##(2008-10#1)(2010-12#1)
bacterial and viral##4##3##(1991-2#1)(2008-10#1)(2008-5#1)(2010-12#1)
bacterial and##21##2##(1990-2#1)(1991-2#1)(1991-3#1)(1994-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
bacterial antagonists##3##2##(2008-10#3)
bacterial antigens##2##2##(1990-6#1)(1993-2#1)
bacterial artificial chromosome (BAC) library##4##5##(2008-10#1)(2008-8#2)(2010-10#1)
bacterial artificial chromosome (BAC)##8##4##(1997-8#1)(2007-6#1)(2008-10#1)(2008-8#3)(2009-10#1)(2010-10#1)
bacterial artificial chromosome##9##3##(1997-8#1)(2007-6#1)(2008-10#1)(2008-8#4)(2009-10#1)(2010-10#1)
bacterial artificial chromosomes (BACs)##2##4##(2008-4#2)
bacterial artificial chromosomes##3##3##(2008-10#1)(2008-4#2)
bacterial artificial##13##2##(1997-8#1)(2007-6#1)(2008-10#3)(2008-4#2)(2008-8#4)(2009-10#1)(2010-10#1)
bacterial binding##2##2##(1990-12#2)
bacterial biofilms##3##2##(2008-7#1)(2012-1#1)(2012-2#1)
bacterial bioreporters##3##2##(2011-2#3)
bacterial blight and blast##2##4##(2009-10#2)
bacterial blight caused##2##3##(2008-10#2)
bacterial blight disease##2##3##(2008-10#1)(2008-8#1)
bacterial blight of anthurium##2##4##(2008-10#2)
bacterial blight of##8##3##(2008-10#8)
bacterial blight pathogen##2##3##(2008-10#2)
bacterial blight resistance##6##3##(2008-10#4)(2008-8#2)
bacterial blight##32##2##(2008-10#26)(2008-8#3)(2008-9#1)(2009-10#2)
bacterial bodies##2##2##(2009-6#2)
bacterial burden##2##2##(2012-12#1)(2012-2#1)
bacterial canker development in##2##4##(2008-10#2)
bacterial canker is##2##3##(2008-10#2)
bacterial canker of tomato##2##4##(2008-10#2)
bacterial canker##15##2##(2008-10#15)
bacterial capsular polysaccharide##4##3##(2012-3#4)
bacterial capsular##5##2##(1995-6#1)(2012-3#4)
bacterial cell##7##2##(1991-9#1)(2008-1#1)(2008-10#4)(2008-9#1)
bacterial cells and##3##3##(1994-11#1)(2008-10#1)(2008-3#1)
bacterial cells by##2##3##(2008-10#2)
bacterial cells in##2##3##(2008-10#1)(2008-9#1)
bacterial cells to positively charged##2##5##(2008-10#2)
bacterial cells to##5##3##(2008-10#5)
bacterial cells with##2##3##(2008-10#2)
bacterial cells##33##2##(1993-8#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-10#18)(2008-3#1)(2008-7#3)(2008-9#2)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
bacterial chloramphenicol acetyltransferase##4##3##(1990-11#1)(1990-12#1)(1993-3#1)(1993-8#1)
bacterial colonization##10##2##(1991-3#2)(1996-2#1)(2007-12#1)(2008-10#4)(2008-5#1)(2013-8#1)
bacterial communities##4##2##(2008-10#2)(2009-6#1)(2010-10#1)
bacterial community composition##2##3##(2010-6#2)
bacterial community##7##2##(2008-10#3)(2010-6#3)(2011-2#1)
bacterial components##4##2##(1996-12#2)(2008-11#1)(2011-2#1)
bacterial concentrations (P&lt##2##3##(2009-4#2)
bacterial concentrations in##2##3##(2009-4#2)
bacterial concentrations##10##2##(2009-4#10)
bacterial conjunctivitis##2##2##(1994-2#2)
bacterial contamination of##3##3##(2008-10#1)(2008-9#1)(2012-1#1)
bacterial contamination##11##2##(1991-12#2)(1991-3#1)(1997-4#1)(2008-10#2)(2008-9#1)(2009-6#2)(2012-1#1)(2013-8#1)
bacterial conversion of daidzein##2##4##(2010-1#2)
bacterial count was##2##3##(2008-5#2)
bacterial count##8##2##(1992-2#3)(2008-5#5)
bacterial counts##5##2##(1997-2#2)(2008-10#2)(2012-2#1)
bacterial culture##5##2##(1992-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
bacterial cultures##7##2##(1992-8#1)(2007-7#1)(2008-10#2)(2008-9#2)(2013-1#1)
bacterial disease of##2##3##(2008-10#2)
bacterial disease##4##2##(2008-10#3)(2013-8#1)
bacterial diseases##2##2##(1992-2#1)(1997-7#1)
bacterial diversity and distribution##2##4##(2013-7#2)
bacterial diversity##6##2##(2011-2#1)(2012-3#1)(2013-7#4)
bacterial endocarditis##5##2##(1991-3#1)(2007-11#1)(2007-7#2)(2007-8#1)
bacterial endotoxin##4##2##(1990-12#1)(1991-3#1)(1996-12#1)(2008-4#1)
bacterial enrichment##2##2##(2008-9#1)(2012-2#1)
bacterial enzyme##2##2##(1995-2#1)(2008-5#1)
bacterial expression vector##2##3##(2008-10#2)
bacterial expression##7##2##(1992-12#2)(1995-5#1)(2008-10#2)(2008-4#1)(2011-2#1)
bacterial fatty acid##2##3##(2008-10#2)
bacterial fatty##3##2##(2008-10#3)
bacterial fermentation of dietary fibre##2##5##(1993-9#2)
bacterial flora is##2##3##(2009-5#2)
bacterial flora##8##2##(2007-6#1)(2008-5#3)(2009-5#3)(2010-1#1)
bacterial fruit blotch##2##3##(2008-10#2)
bacterial gene expression##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
bacterial genera##2##2##(2008-10#1)(2012-2#1)
bacterial genetics##4##2##(2007-12#1)(2007-6#1)(2008-2#2)
bacterial genome##3##2##(1992-6#1)(2011-2#2)
bacterial genomic DNA##2##3##(2008-2#1)(2010-2#1)
bacterial genomic##3##2##(2008-2#1)(2008-7#1)(2010-2#1)
bacterial groups and soil fertility##2##5##(2013-7#2)
bacterial groups##4##2##(2008-10#1)(2009-5#1)(2013-7#2)
bacterial growth and##3##3##(1994-6#1)(2008-6#1)(2013-8#1)
bacterial growth by##3##3##(2007-10#1)(2008-5#2)
bacterial growth in##3##3##(2008-5#2)(2008-8#1)
bacterial growth inhibition##3##3##(2008-5#2)(2011-2#1)
bacterial growth is##2##3##(1991-9#1)(2012-3#1)
bacterial growth##28##2##(1991-9#1)(1994-6#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#9)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
bacterial hyphae##2##2##(2011-1#2)
bacterial infection in##4##3##(2008-10#2)(2010-12#1)(2012-3#1)
bacterial infection##19##2##(1990-12#2)(1990-8#1)(1992-2#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)
bacterial infections are##2##3##(2008-12#1)(2012-1#1)
bacterial infections in##6##3##(2008-12#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
bacterial infections with##2##3##(1992-5#1)(2008-1#1)
bacterial infections##30##2##(1990-9#1)(1991-2#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-11#1)(1996-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#4)(2008-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
bacterial isolates were##3##3##(2008-6#1)(2010-4#1)(2013-7#1)
bacterial isolates##15##2##(1991-3#1)(1994-3#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#3)(2010-4#1)(2013-7#1)(2013-8#1)
bacterial kidney disease in salmonids##2##5##(2009-6#2)
bacterial killing##2##2##(1991-8#1)(2008-7#1)
bacterial leaf blight##2##3##(2008-10#2)
bacterial leaf spot of radish caused by Xanthomonas campestris pv##2##10##(2008-10#2)
bacterial leaf spot of radish##3##5##(2008-10#3)
bacterial leaf spot##4##3##(2008-10#4)
bacterial leaf##7##2##(2008-10#7)
bacterial levels##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
bacterial life##4##2##(2008-8#4)
bacterial lipopolysaccharide (LPS)##3##3##(1993-3#1)(1993-8#1)(2010-8#1)
bacterial lipopolysaccharide##9##2##(1991-2#2)(1993-3#1)(1993-8#1)(1995-12#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-1#1)
bacterial lipopolysaccharides##2##2##(1994-8#1)(2008-11#1)
bacterial load##3##2##(2008-12#1)(2009-8#1)(2012-3#1)
bacterial luciferase##4##2##(1990-5#1)(2008-10#1)(2008-11#2)
bacterial lung##2##2##(2008-10#1)(2008-5#1)
bacterial lysate##2##2##(1992-11#1)(1995-12#1)
bacterial membranes##2##2##(1997-6#1)(2010-5#1)
bacterial meningitis and##2##3##(2008-9#1)(2010-12#1)
bacterial meningitis in##4##3##(1992-11#1)(2007-5#1)(2008-11#1)(2009-3#1)
bacterial meningitis##23##2##(1992-11#2)(1994-9#1)(1995-11#1)(1996-3#2)(2007-5#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#3)(2010-12#2)(2011-2#2)
bacterial movement to##2##3##(2008-10#1)(2013-8#1)
bacterial movement##4##2##(2008-10#2)(2013-8#2)
bacterial multiplication in##2##3##(2008-10#2)
bacterial multiplication##5##2##(2008-10#5)
bacterial numbers##3##2##(1996-12#1)(2008-5#2)
bacterial or viral##2##3##(2007-8#1)(2013-1#1)
bacterial or##4##2##(2007-7#1)(2007-8#1)(2012-2#1)(2013-1#1)
bacterial organisms##2##2##(2010-4#2)
bacterial origin##4##2##(1992-3#1)(1997-2#1)(2008-5#2)
bacterial overgrowth##4##2##(2010-6#2)(2011-2#2)
bacterial particles##2##2##(2008-2#1)(2009-4#1)
bacterial pathogen##4##2##(1993-2#1)(2008-10#3)
bacterial pathogenesis##3##2##(2008-9#1)(2013-1#2)
bacterial pathogens for##2##3##(2008-7#1)(2008-9#1)
bacterial pathogens is##2##3##(2008-10#1)(2012-2#1)
bacterial pathogens##19##2##(2007-7#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#2)
bacterial peptidoglycan##3##2##(1995-2#2)(2009-8#1)
bacterial peritonitis (SBP)##2##3##(2009-8#1)(2013-1#1)
bacterial peritonitis and##3##3##(2009-8#1)(2011-2#2)
bacterial peritonitis in##2##3##(1995-3#1)(2013-1#1)
bacterial peritonitis##10##2##(1995-3#1)(2009-8#4)(2011-2#2)(2012-3#1)(2013-1#2)
bacterial phosphatidylinositol-specific phospholipase C##2##4##(1992-3#1)(1993-8#1)
bacterial photosynthetic reaction##2##3##(1992-6#2)
bacterial photosynthetic##4##2##(1992-6#2)(2008-10#1)(2010-2#1)
bacterial polysaccharides##3##2##(1992-12#1)(1994-9#2)
bacterial population size##2##3##(2008-10#2)
bacterial population##11##2##(2007-7#3)(2008-10#8)
bacterial populations in the##3##4##(2008-10#3)
bacterial populations in##5##3##(2008-10#5)
bacterial populations of##2##3##(2008-10#2)
bacterial populations on##3##3##(2008-10#3)
bacterial populations##22##2##(2008-10#20)(2011-1#1)(2013-1#1)
bacterial porins##3##2##(2008-10#1)(2013-1#2)
bacterial presence in the##2##4##(2010-4#1)(2012-2#1)
bacterial proliferation##2##2##(1991-8#2)
bacterial prostatitis and##2##3##(2008-10#2)
bacterial prostatitis##6##2##(2008-10#6)
bacterial protein##6##2##(1992-12#1)(1993-6#1)(1995-2#1)(2008-4#1)(2008-7#1)(2010-10#1)
bacterial proteins##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
bacterial resistance to##3##3##(1991-2#1)(1991-3#1)(1997-3#1)
bacterial resistance##10##2##(1991-2#1)(1991-3#1)(1997-3#2)(2008-10#2)(2008-7#1)(2009-5#1)(2013-1#2)
bacterial sensor performance##2##3##(2011-1#2)
bacterial sensor##6##2##(1994-12#1)(2008-10#2)(2009-8#1)(2011-1#2)
bacterial sensors##2##2##(2011-1#2)
bacterial signal##2##2##(1990-11#1)(1997-7#1)
bacterial species and##2##3##(2008-8#1)(2008-9#1)
bacterial species on##2##3##(2008-10#2)
bacterial species##21##2##(1994-12#1)(1994-8#1)(1995-2#2)(1995-3#1)(2008-10#5)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2012-2#1)
bacterial speck disease##2##3##(2008-10#2)
bacterial speck on plants##2##4##(2008-10#2)
bacterial speck##9##2##(2008-10#9)
bacterial spores##2##2##(2011-1#1)(2011-2#1)
bacterial spot of tomato##3##4##(2008-10#3)
bacterial spot of##4##3##(2008-10#4)
bacterial spot##15##2##(2008-10#15)
bacterial spread##2##2##(2008-10#2)
bacterial strain of interest##2##4##(2008-9#2)
bacterial strain##6##2##(2008-10#2)(2008-5#1)(2008-9#2)(2011-2#1)
bacterial strains isolated from##3##4##(2008-10#3)
bacterial strains isolated##4##3##(1990-2#1)(2008-10#3)
bacterial strains tested##2##3##(2008-10#1)(2011-2#1)
bacterial strains that##2##3##(2010-2#1)(2011-2#1)
bacterial strains to##2##3##(2008-10#2)
bacterial strains were##4##3##(1994-3#1)(2008-10#2)(2008-5#1)
bacterial strains##28##2##(1990-2#1)(1994-3#1)(2006-6#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
bacterial symbionts##2##2##(2007-12#1)(2008-7#1)
bacterial systems##2##2##(2008-10#1)(2008-11#1)
bacterial taxa##2##2##(2008-10#1)(2011-2#1)
bacterial therapy##2##2##(1991-3#2)
bacterial toxins##6##2##(1994-2#1)(1995-2#1)(1995-8#1)(2008-7#1)(2011-2#2)
bacterial traits##2##2##(2008-10#2)
bacterial two-hybrid system##2##3##(2008-9#2)
bacterial type##2##2##(1997-8#1)(2011-2#1)
bacterial vaginitis##2##2##(2011-1#2)
bacterial vaginosis##9##2##(2007-12#2)(2007-7#2)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#2)
bacterial virulence factors##2##3##(1996-12#2)
bacterial virulence##6##2##(1996-12#2)(2009-8#1)(2011-2#1)(2013-1#2)
bacterial volatiles##3##2##(2009-8#3)
bacterial wilt##6##2##(2008-10#6)
bacterial##988##1##(1990-11#8)(1990-12#8)(1990-2#4)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#3)(1991-2#5)(1991-3#12)(1991-8#3)(1991-9#3)(1992-11#5)(1992-12#5)(1992-2#7)(1992-3#7)(1992-5#3)(1992-6#3)(1992-8#4)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#4)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#4)(1995-11#2)(1995-12#2)(1995-2#9)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#4)(1996-1#1)(1996-12#9)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#4)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#11)(2007-5#5)(2007-6#3)(2007-7#19)(2007-8#4)(2008-1#6)(2008-10#288)(2008-11#14)(2008-12#12)(2008-2#6)(2008-3#2)(2008-4#10)(2008-5#46)(2008-6#7)(2008-7#35)(2008-8#22)(2008-9#38)(2009-10#3)(2009-2#2)(2009-3#3)(2009-4#11)(2009-5#7)(2009-6#11)(2009-7#2)(2009-8#15)(2009-9#2)(2010-1#3)(2010-10#6)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#7)(2010-7#3)(2010-8#3)(2011-1#23)(2011-2#38)(2012-1#7)(2012-12#4)(2012-2#22)(2012-3#16)(2013-1#23)(2013-7#9)(2013-8#16)
bacterially expressed##9##2##(1990-11#1)(1992-8#1)(1994-11#2)(1994-5#1)(1994-8#2)(2008-10#1)(2010-4#1)
bacterially produced salicylic##2##3##(2008-10#2)
bacterially produced##5##2##(1993-6#1)(1994-12#1)(2008-10#2)(2008-4#1)
bacterially##14##1##(1990-11#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(2008-10#3)(2008-4#1)(2010-4#1)
bactericidal action##2##2##(1997-3#1)(2008-5#1)
bactericidal activity of##2##3##(1991-2#1)(2008-5#1)
bactericidal activity##5##2##(1991-2#1)(1995-5#1)(2008-12#1)(2008-5#1)(2013-8#1)
bactericidal effect##3##2##(2008-5#2)(2012-2#1)
bactericidal##21##1##(1991-2#1)(1991-8#1)(1992-8#1)(1995-5#2)(1997-3#1)(2008-12#1)(2008-5#7)(2010-4#1)(2012-2#3)(2013-1#1)(2013-8#2)
bactericide##2##1##(2008-10#2)
bactericides##6##1##(2008-10#5)(2008-5#1)
bacteriocin##6##1##(2008-10#2)(2010-10#1)(2010-2#3)
bacteriocins##2##1##(2008-7#1)(2010-10#1)
bacteriologic and##2##2##(2008-5#1)(2011-2#1)
bacteriologic response##2##2##(1996-3#1)(2011-2#1)
bacteriologic##6##1##(1996-3#1)(2008-5#1)(2011-2#4)
bacteriological investigation##3##2##(2010-4#1)(2011-2#1)(2012-3#1)
bacteriological methods##4##2##(2007-7#1)(2008-12#2)(2008-9#1)
bacteriological##25##1##(1990-9#2)(1991-11#1)(1993-2#1)(1995-9#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#5)(2008-2#1)(2008-9#3)(2010-4#1)(2010-6#2)(2011-2#2)(2012-2#1)(2012-3#2)
bacteriology##4##1##(1990-8#2)(2010-12#1)(2011-2#1)
bacterioopsin##2##1##(1990-11#2)
bacteriophage 434 repressor##2##3##(2008-8#2)
bacteriophage DNAs##2##2##(1994-8#2)
bacteriophage LL-H##2##2##(1994-12#2)
bacteriophage MS2##2##2##(2008-11#1)(2008-2#1)
bacteriophage Pf1 coat protein##2##4##(1991-5#2)
bacteriophage Pf1##3##2##(1991-5#3)
bacteriophage T3##2##2##(1996-2#2)
bacteriophage T4 late##2##3##(1995-6#2)
bacteriophage T4##6##2##(1990-5#1)(1995-2#1)(1995-6#2)(1997-7#2)
bacteriophage T7 early##2##3##(1992-12#2)
bacteriophage T7##4##2##(1991-5#1)(1992-12#3)
bacteriophage lambda##3##2##(1993-9#1)(1995-2#2)
bacteriophage plaques##2##2##(1991-1#1)(1994-8#1)
bacteriophage##57##1##(1990-11#1)(1990-5#1)(1991-1#1)(1991-5#7)(1991-9#1)(1992-12#3)(1993-11#1)(1993-9#2)(1994-12#2)(1994-8#4)(1995-2#3)(1995-6#2)(1996-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#8)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#2)(2013-1#3)
bacteriophages##9##1##(1990-11#1)(1993-9#1)(1994-12#1)(1997-4#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
bacteriopheophytin##3##1##(2008-8#1)(2008-9#2)
bacteriopheophytins in the reaction centers##2##5##(2008-9#2)
bacteriophora##2##1##(2011-2#2)
bacteriorhodopsin (BR)##4##2##(1990-5#1)(2007-11#1)(2007-12#2)
bacteriorhodopsin (bR)##2##2##(1993-11#1)(2008-2#1)
bacteriorhodopsin and##2##2##(1997-6#1)(2007-11#1)
bacteriorhodopsin films##5##2##(2007-12#1)(2008-2#4)
bacteriorhodopsin##30##1##(1990-11#2)(1990-5#2)(1991-12#2)(1993-11#2)(1994-5#1)(1995-5#2)(1997-6#1)(2007-11#5)(2007-12#7)(2008-2#6)
bacteriostatic##2##1##(2010-7#1)(2012-2#1)
bacterium (Bacillus##3##2##(2008-10#2)(2008-6#1)
bacterium Cellulomonas fimi##3##3##(1992-11#2)(1995-5#1)
bacterium Pseudomonas##4##2##(2008-10#3)(2008-8#1)
bacterium Ralstonia solanacearum##3##3##(2008-10#3)
bacterium Serratia marcescens##2##3##(2008-10#1)(2009-6#1)
bacterium Serratia##3##2##(2008-10#2)(2009-6#1)
bacterium Xanthomonas##2##2##(1993-9#1)(2008-10#1)
bacterium Xylella fastidiosa##2##3##(2008-10#2)
bacterium and##5##2##(1997-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
bacterium causing##2##2##(2007-7#1)(2008-10#1)
bacterium has##2##2##(2008-10#1)(2008-8#1)
bacterium is##2##2##(1996-11#1)(2013-1#1)
bacterium that causes##2##3##(2008-10#2)
bacterium that has##2##3##(2008-10#1)(2011-2#1)
bacterium that##9##2##(2008-10#4)(2008-7#1)(2008-9#1)(2011-2#3)
bacterium was isolated from##2##4##(2008-8#1)(2011-2#1)
bacterium was reisolated from##2##4##(2008-10#2)
bacterium was##8##2##(2008-10#5)(2008-8#1)(2011-2#2)
bacterium which##2##2##(2008-10#1)(2011-2#1)
bacterium with##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
bacterium##152##1##(1990-11#3)(1990-12#2)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-6#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#3)(1995-5#2)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-6#1)(2007-7#3)(2008-1#1)(2008-10#55)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#6)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#2)(2011-1#5)(2011-2#16)(2012-2#3)(2013-1#6)
bacterium-like organisms##2##2##(2008-10#2)
bacteriurea##2##1##(2012-3#2)
bacteriuria among##2##2##(2010-8#2)
bacteriuria##8##1##(2007-12#2)(2008-12#1)(2010-8#3)(2011-2#1)(2012-3#1)
bacterized##2##1##(2008-10#2)
baculoviral##2##1##(2008-2#2)
baculovirus expressing##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
baculovirus expression system##13##3##(1991-2#1)(1992-10#1)(1992-8#2)(1993-6#2)(1995-6#1)(1997-4#3)(2008-11#1)(2008-2#2)
baculovirus expression vector system##5##4##(1997-4#2)(2008-11#2)(2008-7#1)
baculovirus expression vector##8##3##(1993-6#1)(1994-9#1)(1997-4#3)(2008-11#2)(2008-7#1)
baculovirus expression##23##2##(1991-2#1)(1992-10#1)(1992-8#2)(1993-6#3)(1994-9#1)(1995-6#1)(1997-4#7)(2008-11#4)(2008-2#2)(2008-7#1)
baculovirus infected##2##2##(1993-8#1)(2008-11#1)
baculovirus infection##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
baculovirus multigene##2##2##(1997-4#2)
baculovirus of##2##2##(2008-8#2)
baculovirus produced receptor##2##3##(1991-2#2)
baculovirus surface-display##2##2##(2013-8#2)
baculovirus system##7##2##(1992-10#1)(1992-3#1)(1994-8#2)(1997-4#1)(2008-11#1)(2008-2#1)
baculovirus very late##3##3##(1997-3#1)(1997-4#2)
baculovirus##87##1##(1991-2#3)(1992-10#2)(1992-3#2)(1992-8#2)(1993-6#4)(1993-8#2)(1994-10#1)(1994-8#4)(1994-9#1)(1995-6#1)(1997-3#3)(1997-4#15)(2007-2#1)(2008-10#2)(2008-11#17)(2008-2#10)(2008-4#2)(2008-7#7)(2008-8#4)(2012-2#1)(2013-8#3)
baculovirus-infected insect cells##5##3##(1991-2#1)(1993-6#1)(1994-8#1)(1997-4#1)(2008-11#1)
baculovirus-infected##7##1##(1991-2#1)(1993-6#1)(1994-8#1)(1995-2#2)(1997-4#1)(2008-11#1)
baculovirus-insect cell system##5##3##(1992-3#1)(1997-4#1)(2008-11#2)(2008-7#1)
baculoviruses##15##1##(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#2)(1997-4#1)(1997-8#2)(2008-2#4)(2008-7#1)(2008-8#2)
bad breath##2##2##(1997-4#2)
bad care##3##2##(2010-10#3)
bad faith##3##2##(1993-12#2)(1997-5#1)
bad for##2##2##(2010-9#2)
bad news##4##2##(1996-4#1)(2007-12#1)(2008-8#1)(2012-3#1)
bad obstetric history##3##3##(2007-7#3)
bad prognosis##3##2##(2007-11#1)(2011-3#1)(2013-1#1)
bad response to##2##3##(1993-11#1)(2007-11#1)
bad##72##1##(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1994-2#1)(1994-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-3#4)(1997-4#2)(1997-5#1)(2007-11#12)(2007-12#1)(2007-7#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-6#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#2)
badge of##2##2##(2008-8#2)
badge##4##1##(2008-10#1)(2008-8#3)
badius##2##1##(1994-9#1)(2011-2#1)
badly##7##1##(1993-12#1)(1994-2#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
badnavirus##3##1##(2008-10#3)
baetica##3##1##(2008-10#3)
baffle leak##3##2##(2010-5#3)
baffle##9##1##(1995-3#4)(2008-3#1)(2010-5#3)(2010-6#1)
baffle)##2##1##(1995-3#2)
baffles##5##1##(2008-3#1)(2008-6#3)(2009-10#1)
bafilomycin##3##1##(1994-6#2)(1995-3#1)
bag for##2##2##(2007-12#1)(2008-10#1)
bag##21##1##(1991-12#1)(1991-3#2)(1992-11#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#2)(2012-1#1)(2013-1#1)
bag-1##8##1##(2008-11#8)
bags and##4##2##(2008-10#1)(2011-2#1)(2012-1#2)
bags is##2##2##(2007-7#1)(2008-10#1)
bags with##3##2##(2008-10#1)(2008-5#1)(2012-1#1)
bags##33##1##(1993-3#1)(1995-5#1)(1997-6#2)(2007-7#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-1#10)(2012-12#1)(2012-2#2)(2013-1#1)
bags)##3##1##(2008-11#2)(2012-1#1)
bahrain##3##1##(2007-7#1)(2008-1#1)(2008-4#1)
baicalein##5##1##(2008-10#2)(2008-11#1)(2008-3#2)
baicalein-sensitive##2##1##(2008-3#2)
baicalin and quercetin in Scutellariae Radix and its##2##8##(2008-10#2)
bait region##4##2##(2008-11#4)
bait##20##1##(1993-2#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#3)(2013-1#1)(2013-7#1)
bait-lamina test##3##2##(2008-11#3)
baited with##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
baited##10##1##(1992-8#3)(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#2)
baiting##5##1##(2008-10#5)
baits for##3##2##(1992-5#1)(2008-10#2)
baits were##2##2##(2008-10#2)
baits##10##1##(1992-5#1)(2008-10#4)(2008-2#2)(2008-6#1)(2011-2#2)
baked##2##1##(2008-10#1)(2008-9#1)
baker's yeast strains##3##3##(2010-7#3)
baker's yeast##14##2##(1995-3#1)(1997-4#1)(2008-10#2)(2008-5#2)(2010-7#6)(2011-1#2)
baker's##17##1##(1990-3#1)(1995-3#1)(1997-4#1)(2007-10#2)(2008-10#2)(2008-5#2)(2010-7#6)(2011-1#2)
bakers##2##1##(1990-3#1)(1990-5#1)
bakery applications##2##2##(2010-7#2)
bakery waste##2##2##(2008-10#2)
bakery##7##1##(1990-3#2)(2008-10#2)(2010-7#2)(2011-2#1)
baking##11##1##(1990-3#2)(2008-10#5)(2008-2#1)(2008-3#1)(2010-7#2)
balance and##21##2##(1991-11#1)(1991-6#1)(1993-12#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2013-1#2)
balance are##2##2##(2008-10#1)(2010-12#1)
balance at the end of##2##5##(2007-8#1)(2008-1#1)
balance between cell proliferation and##2##5##(2008-11#2)
balance between cell##4##3##(2008-11#2)(2008-9#1)(2012-2#1)
balance between proliferation##2##3##(2007-10#1)(2012-1#1)
balance between the##3##3##(1993-12#1)(2008-9#1)(2010-4#1)
balance between##55##2##(1990-5#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1994-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
balance can be##4##3##(1992-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
balance during##5##2##(2008-1#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
balance equations##5##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
balance function##3##2##(1996-7#3)
balance has##2##2##(2008-11#2)
balance in computer posturography##2##4##(2010-12#2)
balance in the##10##3##(1990-6#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
balance in##23##2##(1990-6#1)(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-3#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
balance is maintained##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
balance is##7##2##(1991-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-7#1)
balance model of in vivo neutrophil formation following bone marrow rescue therapy##2##12##(2008-11#2)
balance of protein##2##3##(2008-5#2)
balance of the##7##3##(1994-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-3#2)
balance of##35##2##(1991-12#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
balance or##2##2##(1994-12#1)(2008-7#1)
balance that##3##2##(2009-12#1)(2009-7#1)(2012-12#1)
balance the distribution of the##2##5##(2011-1#2)
balance the##12##2##(1995-6#1)(1996-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#2)(2012-3#1)(2013-1#1)
balance to##2##2##(2008-11#1)(2013-1#1)
balance was##5##2##(2008-12#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
balance when##2##2##(1990-11#1)(2012-12#1)
balance##304##1##(1990-11#1)(1990-5#1)(1990-6#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-7#6)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#2)(2007-10#2)(2007-12#5)(2007-5#1)(2007-8#2)(2008-1#8)(2008-10#14)(2008-11#20)(2008-12#8)(2008-2#4)(2008-3#12)(2008-4#7)(2008-5#17)(2008-6#4)(2008-7#12)(2008-8#7)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#3)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#7)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#5)(2012-6#1)(2012-7#1)(2013-1#16)(2013-7#1)(2013-8#10)
balanced activity##2##2##(1995-12#1)(2008-5#1)
balanced against the##3##3##(1997-3#1)(1997-8#1)(2008-3#1)
balanced against##4##2##(1997-3#1)(1997-8#1)(2008-3#1)(2008-7#1)
balanced and##2##2##(2008-2#1)(2012-3#1)
balanced by a##2##3##(1991-9#1)(2011-2#1)
balanced by##9##2##(1990-5#1)(1991-9#1)(2007-11#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
balanced detection##2##2##(2007-11#1)(2007-12#1)
balanced distribution of survival##2##4##(2007-8#2)
balanced distribution##3##2##(1991-9#1)(2007-8#2)
balanced funds##3##2##(2011-2#3)
balanced homodyne detector##2##3##(2007-12#2)
balanced in##2##2##(1994-7#1)(2008-10#1)
balanced perspective##2##2##(1993-12#1)(2008-8#1)
balanced scorecard##3##2##(1995-12#2)(2008-11#1)
balanced scorecards##3##2##(2008-11#3)
balanced spherical aberration##2##3##(2008-2#2)
balanced supplementation##2##2##(2008-11#2)
balanced translocations##2##2##(2010-1#1)(2013-8#1)
balanced##95##1##(1990-5#1)(1991-12#1)(1991-9#3)(1993-12#1)(1994-1#1)(1994-7#1)(1995-12#6)(1995-9#2)(1996-3#1)(1996-9#2)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#4)(2007-8#3)(2008-10#9)(2008-11#11)(2008-2#3)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#8)(2012-3#2)(2013-1#3)(2013-8#1)
balances can##2##2##(2008-11#1)(2011-2#1)
balances of##4##2##(2008-3#1)(2008-7#1)(2011-2#2)
balances the need for##2##4##(2009-10#1)(2010-11#1)
balances the##3##2##(2008-8#1)(2009-10#1)(2010-11#1)
balances##26##1##(1991-3#1)(2006-10#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#5)(2013-1#1)
balancing of the##2##3##(2006-10#1)(2007-11#1)
balancing of##3##2##(2006-10#1)(2007-11#1)(2008-1#1)
balancing selection in##2##3##(2013-1#2)
balancing selection##3##2##(2013-1#3)
balancing the##8##2##(1994-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-5#1)(2012-1#1)(2013-1#1)
balancing##40##1##(1992-2#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#10)
balanitis xerotica obliterans##2##3##(2009-5#2)
balanitis##3##1##(2009-5#2)(2012-2#1)
ball after##2##2##(2008-6#2)
ball and##2##2##(2008-6#1)(2011-2#1)
ball bearing##3##2##(2008-3#3)
ball lens Raman probe design for##2##6##(2011-1#2)
ball lens Raman probe design##3##5##(2011-1#3)
ball lens for##2##3##(2011-1#2)
ball lens##7##2##(2011-1#7)
ball milling##3##2##(2010-4#1)(2013-1#2)
ball##54##1##(1996-1#1)(1997-7#4)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#3)(2008-4#1)(2008-6#11)(2008-7#2)(2008-9#1)(2009-7#3)(2010-4#1)(2010-8#1)(2011-1#8)(2011-2#7)(2013-1#3)
ballistic light##2##2##(2007-11#1)(2008-3#1)
ballistic movements##2##2##(2008-7#2)
ballistic##14##1##(2007-11#3)(2008-2#1)(2008-3#4)(2008-7#6)
balloon and##3##2##(2006-12#1)(2008-10#1)(2008-7#1)
balloon angioplasty and stent##2##4##(1994-11#1)(2008-11#1)
balloon angioplasty and stenting##2##4##(2008-1#1)(2012-3#1)
balloon angioplasty and##5##3##(1994-11#2)(2008-1#1)(2008-11#1)(2012-3#1)
balloon angioplasty##10##2##(1991-3#1)(1994-11#2)(1996-8#1)(1997-8#1)(2008-1#1)(2008-11#1)(2009-12#1)(2012-3#2)
balloon aortic valvuolpasty and##2##4##(2011-2#2)
balloon aortic valvuolpasty##3##3##(2011-2#3)
balloon aortic##4##2##(2011-2#4)
balloon catheter##10##2##(1993-12#1)(1995-10#1)(1996-6#1)(1997-3#3)(1997-6#2)(2013-8#2)
balloon catheters##3##2##(1991-3#1)(1994-11#1)(2008-1#1)
balloon counterpulsation##2##2##(2008-3#1)(2011-2#1)
balloon dilatation##10##2##(1991-3#3)(1995-3#1)(2008-10#1)(2010-12#1)(2013-1#4)
balloon dilation and##2##3##(2010-12#1)(2011-1#1)
balloon dilation##8##2##(2007-7#1)(2010-12#5)(2011-1#1)(2013-8#1)
balloon expandable stents##2##3##(2008-7#2)
balloon expandable##3##2##(1992-4#1)(2008-7#2)
balloon flights##4##2##(2008-11#1)(2008-3#3)
balloon for##2##2##(2008-4#1)(2008-5#1)
balloon in the##3##3##(1996-6#1)(2013-1#2)
balloon in##4##2##(1996-6#1)(1997-3#1)(2013-1#2)
balloon occlusion##2##2##(2008-11#1)(2008-7#1)
balloon or##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
balloon platform##2##2##(2008-11#1)(2008-3#1)
balloon pump##5##2##(2007-9#1)(2010-5#1)(2010-8#1)(2013-1#2)
balloon pumping##3##2##(2007-8#1)(2010-8#2)
balloon valvuloplasty##2##2##(1994-3#1)(2008-11#1)
balloon##125##1##(1991-3#5)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1994-11#3)(1994-3#1)(1995-10#1)(1995-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#5)(1997-6#6)(1997-8#2)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#4)(2008-5#3)(2008-7#11)(2009-12#1)(2009-5#1)(2010-12#7)(2010-5#3)(2010-8#5)(2011-1#1)(2011-2#9)(2012-3#2)(2013-1#8)(2013-7#4)(2013-8#4)
balloon-borne##2##1##(2008-3#2)
balloon-occluded retrograde transvenous obliteration##3##4##(2009-9#1)(2013-1#2)
balloonborne##5##1##(2007-11#1)(2008-3#4)
ballooning##7##1##(2008-10#1)(2008-11#3)(2009-6#1)(2010-5#1)(2011-2#1)
balloons were##2##2##(2008-5#2)
balloons##5##1##(2006-12#1)(2008-5#3)(2011-2#1)
balls were##2##2##(2011-2#2)
balls##6##1##(1997-4#1)(2008-2#2)(2011-1#1)(2011-2#2)
baltica's##2##1##(2011-1#2)
bamboo##4##1##(2008-10#3)(2008-8#1)
ban in##2##2##(1996-1#2)
ban on abortions##2##3##(1995-6#1)(1996-5#1)
ban on the##2##3##(1995-6#1)(1996-5#1)
ban on##10##2##(1992-3#1)(1993-3#1)(1995-6#3)(1996-1#1)(1996-5#3)(2011-3#1)
ban the##3##2##(1991-5#1)(1996-8#1)(2010-9#1)
ban##24##1##(1991-3#1)(1991-5#1)(1992-3#2)(1993-3#1)(1995-6#7)(1996-1#3)(1996-5#3)(1996-8#2)(2009-7#1)(2010-9#1)(2011-3#1)(2012-1#1)
banana is##2##2##(2008-10#2)
banana roots##2##2##(2008-10#2)
banana##24##1##(2008-10#24)
banana-growing regions##2##2##(2008-10#2)
bananas and##2##2##(2008-10#2)
bananas##3##1##(2008-10#3)
bancrofti##2##1##(2007-7#1)(2008-10#1)
band (MW##2##2##(1992-12#1)(2008-11#1)
band (R branch)##2##3##(2008-2#2)
band 11q23##2##2##(1995-6#1)(2011-3#1)
band 3 and##3##3##(1993-11#2)(1994-12#1)
band 3##13##2##(1993-11#6)(1994-12#1)(2008-3#1)(2013-7#2)(2013-8#3)
band 7##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
band 8##2##2##(2008-2#1)(2008-3#1)
band and a##2##3##(2008-11#1)(2008-3#1)
band and the##4##3##(1993-8#1)(2008-2#2)(2008-3#1)
band and##11##2##(1993-8#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#3)(2009-8#1)
band appearing##2##2##(2007-11#1)(2008-10#1)
band as##3##2##(2008-2#1)(2008-5#1)(2009-5#1)
band at##19##2##(1990-11#1)(1992-8#1)(1993-11#1)(1995-11#1)(2008-10#5)(2008-2#3)(2008-3#4)(2013-8#3)
band by##2##2##(1997-4#1)(2007-11#1)
band can be##2##3##(2008-2#1)(2008-3#1)
band centered at##3##3##(1993-11#2)(2008-10#1)
band consistent with##2##3##(1994-11#1)(1997-7#1)
band corresponding to##4##3##(1991-5#1)(1992-3#1)(1993-11#1)(2008-10#1)
band depth analysis and##4##4##(2013-8#4)
band depth##8##2##(2013-8#8)
band detection limits##2##3##(2008-3#2)
band edge##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
band frequencies##2##2##(2008-10#2)
band from##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
band gap of##2##3##(2008-10#1)(2013-8#1)
band gap##14##2##(1990-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
band imaging (NBI)##2##3##(2011-2#1)(2012-2#1)
band imaging##4##2##(2011-2#2)(2012-2#2)
band in SDS-PAGE##2##3##(1990-11#1)(2008-4#1)
band in polyacrylamide gel electrophoresis##2##5##(1996-5#1)(2013-1#1)
band in rat##2##3##(1992-6#1)(2008-9#1)
band in the gel##2##4##(2011-2#2)
band in the##11##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#2)
band in##26##2##(1990-11#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-8#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#1)
band intensity and band area measurements##3##6##(2008-10#3)
band intensity and##4##3##(2008-10#3)(2012-3#1)
band intensity##6##2##(2008-10#5)(2012-3#1)
band is##8##2##(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)
band ligation##9##2##(2013-1#9)
band locations##2##2##(2008-3#1)(2010-3#1)
band near##4##2##(2008-2#2)(2008-3#2)
band of 3##2##3##(1994-11#1)(2008-3#1)
band of CO(2)##3##3##(2007-11#1)(2007-12#2)
band of Mr##2##3##(1990-5#1)(1991-5#1)
band of NO##2##3##(2008-2#2)
band of about##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
band of approximately##4##3##(1991-12#1)(1993-3#1)(1994-2#1)(2008-10#1)
band of interest##2##3##(2008-3#1)(2008-4#1)
band of methane##2##3##(2007-12#1)(2008-3#1)
band of some##2##3##(2008-10#1)(2008-3#1)
band of the##7##3##(1992-3#1)(2007-12#2)(2008-10#1)(2008-3#3)
band of##68##2##(1990-5#1)(1991-10#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-12#1)(1997-3#1)(2007-11#3)(2007-12#5)(2008-10#11)(2008-2#4)(2008-3#14)(2008-4#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#3)
band on##5##2##(1993-3#1)(1997-2#1)(2007-11#2)(2008-10#1)
band patterns was##2##3##(2008-12#2)
band patterns##6##2##(2008-12#5)(2008-5#1)
band positions##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
band representing the##2##3##(2009-11#2)
band shape##3##2##(1997-7#1)(2008-2#1)(2008-3#1)
band shifts##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
band showed##2##2##(2008-10#2)
band signature##2##2##(2008-3#2)
band structure##2##2##(2007-11#1)(2008-7#1)
band that##3##2##(1991-4#1)(1995-11#1)(2008-3#1)
band to##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
band was detected in##2##4##(1994-6#1)(1995-6#1)
band was detected##3##3##(1992-12#1)(1994-6#1)(1995-6#1)
band was not detected##2##4##(2008-10#1)(2008-5#1)
band was observed in##3##4##(1992-11#1)(1995-11#1)(2008-10#1)
band was##16##2##(1990-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-6#1)(1995-11#2)(1995-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-3#1)
band width of the##2##4##(2008-11#1)(2012-2#1)
band with a##3##3##(1990-11#1)(1996-12#1)(2007-11#1)
band with an##3##3##(1992-8#1)(1995-5#1)(2009-9#1)
band with molecular##2##3##(1992-8#1)(2008-12#1)
band with##13##2##(1990-11#1)(1990-12#1)(1992-8#2)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-3#1)
band##473##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#5)(1991-1#1)(1991-10#2)(1991-12#4)(1991-4#3)(1991-5#5)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#3)(1992-3#7)(1992-6#2)(1992-8#3)(1993-1#1)(1993-11#12)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#5)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#3)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#6)(1997-8#1)(2007-11#21)(2007-12#19)(2007-8#2)(2008-10#79)(2008-11#7)(2008-12#7)(2008-2#37)(2008-3#73)(2008-4#4)(2008-5#5)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#4)(2009-11#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#4)(2010-5#1)(2011-2#4)(2011-3#2)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#14)(2013-7#4)(2013-8#26)
band) and##2##2##(2008-2#1)(2013-8#1)
band)##9##1##(1991-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#3)
band-edge##3##1##(2007-11#1)(2008-3#2)
band-gap##2##1##(2007-11#1)(2008-2#1)
band-shift##2##1##(1990-11#1)(1996-3#1)
band-stop##2##1##(2008-2#2)
band-transport model##2##2##(2007-11#1)(2008-3#1)
bandage##9##1##(1991-2#2)(1992-6#1)(2008-10#3)(2010-3#1)(2011-1#1)(2011-2#1)
bandages##2##1##(1991-2#1)(1992-2#1)
banded##3##1##(1997-3#1)(1997-7#1)(2011-2#1)
bandgap and##2##2##(2007-12#1)(2008-7#1)
bandgap structures##8##2##(2007-12#3)(2008-2#1)(2008-3#3)(2008-7#1)
bandgap##43##1##(2007-11#15)(2007-12#16)(2008-2#2)(2008-3#7)(2008-7#2)(2012-3#1)
banding and##2##2##(1997-3#1)(2008-11#1)
banding for##2##2##(2007-8#1)(2008-10#1)
banding in##2##2##(2008-10#1)(2012-12#1)
banding is##2##2##(2007-8#1)(2008-2#1)
banding pattern##9##2##(2008-10#6)(2008-12#2)(2008-5#1)
banding patterns resulting from##2##4##(2008-10#2)
banding patterns##13##2##(2008-10#13)
banding##46##1##(1991-2#1)(1992-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-8#5)(2008-10#23)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2012-1#1)(2012-12#4)(2012-3#1)
bandpass and##3##2##(2008-2#2)(2008-3#1)
bandpass filter to##2##3##(2008-2#1)(2008-3#1)
bandpass filter with a##2##4##(2007-11#1)(2008-3#1)
bandpass filter##12##2##(2007-11#3)(2008-2#4)(2008-3#5)
bandpass filtering##2##2##(2007-11#1)(2008-3#1)
bandpass filters##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)
bandpass of the##2##3##(2008-10#1)(2008-2#1)
bandpass of##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
bandpass##37##1##(2007-11#5)(2007-12#2)(2008-10#2)(2008-2#9)(2008-3#19)
bandpasses##2##1##(2008-3#2)
bands and##8##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)
bands appear##2##2##(1994-9#2)
bands are##7##2##(1996-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-11#1)(2013-7#1)
bands assigned to the transition moments Q(X)##2##7##(2008-9#2)
bands assigned to the##3##4##(1996-2#1)(2008-9#2)
bands assigned to##4##3##(1996-2#1)(2008-8#1)(2008-9#2)
bands associated with##2##3##(2007-12#1)(2008-5#1)
bands at the##3##3##(1995-12#1)(2008-12#1)(2008-3#1)
bands at##18##2##(1990-11#1)(1994-6#1)(1995-12#1)(1996-2#2)(1996-4#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2013-8#1)
bands between##4##2##(2008-11#1)(2008-2#1)(2008-8#2)
bands by##2##2##(2008-3#2)
bands corresponding to##4##3##(2008-10#3)(2010-12#1)
bands could##2##2##(2008-11#1)(2008-5#1)
bands for##4##2##(1997-4#1)(2008-10#2)(2008-3#1)
bands from##3##2##(2008-10#2)(2008-9#1)
bands in the spectral##2##4##(2008-10#1)(2008-2#1)
bands in the##10##3##(1996-5#1)(2007-10#1)(2008-10#6)(2008-2#1)(2011-2#1)
bands in##23##2##(1992-11#1)(1992-9#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)(2011-2#1)(2013-1#1)
bands is##2##2##(2008-10#2)
bands located##3##2##(1994-6#1)(2008-10#1)(2008-3#1)
bands obtained##4##2##(1990-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
bands of Mr##2##3##(1991-9#2)
bands of the##11##3##(1994-9#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-3#3)(2013-1#1)
bands of these##2##3##(2008-10#2)
bands of##47##2##(1991-10#1)(1991-12#2)(1991-8#2)(1991-9#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
bands on##4##2##(1992-8#1)(1995-5#1)(2008-10#1)(2009-5#1)
bands or spots##2##3##(2010-11#2)
bands revealed##2##2##(2008-10#1)(2008-7#1)
bands that are##3##3##(2007-12#2)(2008-3#1)
bands that were##5##3##(1991-12#1)(2008-10#3)(2008-3#1)
bands that##12##2##(1991-12#1)(1995-11#1)(2007-12#2)(2008-10#5)(2008-3#3)
bands was##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
bands were detected in##2##4##(2008-10#1)(2008-8#1)
bands were observed##2##3##(2007-12#1)(2008-10#1)
bands were present in##2##4##(2008-10#2)
bands were##17##2##(1992-8#1)(1993-1#1)(1993-8#1)(1995-5#1)(1996-9#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-8#1)(2009-8#1)(2013-8#1)
bands which##2##2##(2008-5#1)(2012-3#1)
bands with molecular masses of##2##5##(2008-10#2)
bands with##8##2##(1990-5#1)(1991-8#1)(1993-8#1)(2007-11#1)(2008-10#3)(2012-3#1)
bands##312##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#4)(1991-5#1)(1991-8#3)(1991-9#3)(1992-11#2)(1992-4#1)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-6#3)(1994-9#5)(1995-11#1)(1995-12#4)(1995-5#5)(1996-12#1)(1996-2#4)(1996-4#2)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#10)(2008-10#86)(2008-11#7)(2008-12#6)(2008-2#12)(2008-3#41)(2008-4#4)(2008-5#13)(2008-7#5)(2008-8#9)(2008-9#11)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
bands)##3##1##(2008-2#1)(2008-3#1)(2008-5#1)
bandwidth (&lt##2##2##(2008-2#1)(2008-3#1)
bandwidth and##12##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#3)(2010-4#1)
bandwidth are##2##2##(2008-2#1)(2008-3#1)
bandwidth at##2##2##(2007-11#1)(2008-3#1)
bandwidth between##2##2##(2008-3#2)
bandwidth beyond##3##2##(2007-11#3)
bandwidth by a##2##3##(2008-2#1)(2008-3#1)
bandwidth by##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
bandwidth for##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
bandwidth in a##2##3##(2007-11#1)(2007-12#1)
bandwidth in##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
bandwidth is##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
bandwidth may be##2##3##(1994-8#1)(2008-3#1)
bandwidth of &lt##2##3##(2008-3#2)
bandwidth of 1##2##3##(2007-11#2)
bandwidth of a##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
bandwidth of an##2##3##(2007-11#1)(2008-2#1)
bandwidth of the##23##3##(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#10)
bandwidth of##58##2##(2007-11#15)(2007-12#11)(2007-9#1)(2008-10#1)(2008-2#9)(2008-3#19)(2009-5#2)
bandwidth on the##2##3##(2008-3#2)
bandwidth on##3##2##(2008-3#2)(2008-7#1)
bandwidth per##2##2##(2007-12#1)(2008-3#1)
bandwidth requirements##2##2##(2007-12#1)(2008-3#1)
bandwidth standard for##2##3##(2008-3#2)
bandwidth standard##4##2##(2008-3#4)
bandwidth that##2##2##(2007-11#1)(2008-2#1)
bandwidth to##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
bandwidth within##2##2##(2007-12#1)(2008-3#1)
bandwidth##216##1##(1994-8#2)(1997-8#1)(2007-11#46)(2007-12#32)(2007-9#1)(2008-10#5)(2008-2#35)(2008-3#85)(2008-7#3)(2009-10#1)(2009-5#2)(2010-4#1)(2012-3#1)(2013-8#1)
bandwidth) and##2##2##(2008-3#2)
bandwidth) is##2##2##(2008-3#2)
bandwidth)##10##1##(2007-11#2)(2007-12#2)(2008-3#6)
bandwidth-limited##3##1##(2007-11#1)(2007-12#2)
bandwidths are##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
bandwidths for##2##2##(2007-11#2)
bandwidths in##2##2##(2007-12#1)(2008-7#1)
bandwidths of##9##2##(1991-2#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
bandwidths##31##1##(1991-2#2)(2007-11#7)(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#11)(2008-7#1)
bank in##2##2##(1990-11#1)(2008-8#1)
bank of##8##2##(1994-12#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-12#1)(2011-1#1)(2013-7#2)
bank voles##2##2##(2012-3#2)
bank was##3##2##(1990-11#1)(1991-7#1)(2011-2#1)
bank##42##1##(1990-11#2)(1991-7#4)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-6#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#4)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-3#3)(2013-7#2)
bankers##2##1##(1992-12#1)(1993-1#1)
banking##6##1##(1994-9#1)(1995-6#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
bankruptcy filings##4##2##(2008-11#4)
bankruptcy protection##2##2##(1990-4#1)(2008-11#1)
bankruptcy##10##1##(1990-4#1)(1993-8#1)(2008-11#8)
banks and##3##2##(2008-4#1)(2011-2#2)
banks##25##1##(1991-9#1)(1992-5#2)(1995-2#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-3#2)(2007-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#3)(2012-3#1)
banksiana##2##1##(2008-10#2)
banned the use of##2##4##(1991-12#1)(1994-6#1)
banned##9##1##(1991-12#1)(1991-6#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
bans##5##1##(1990-2#1)(1993-5#1)(1993-8#1)(1995-6#1)(2007-6#1)
bantiana##3##1##(2007-12#3)
baptism##2##1##(2008-12#2)
bar and##2##2##(2008-10#1)(2008-8#1)
bar to##2##2##(1990-10#1)(2009-7#1)
bar was##2##2##(2008-8#1)(2012-2#1)
bar##57##1##(1990-10#1)(1990-11#1)(1990-7#1)(1993-5#3)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#2)(2009-1#1)(2009-6#1)(2009-7#2)(2010-3#3)(2010-8#3)(2011-1#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
bar)##2##1##(2008-10#2)
barba##2##1##(2008-10#2)
barbadense##2##1##(2008-10#2)
barbed##3##1##(2008-1#1)(2008-12#1)(2012-2#1)
barber-surgeons##2##1##(1996-3#2)
barbiturate##3##1##(2007-8#1)(2008-6#2)
barbiturates##6##1##(1991-1#1)(2008-10#1)(2008-6#4)
barbituric acid##7##2##(2007-11#1)(2008-10#5)(2008-11#1)
barbituric##8##1##(2007-11#1)(2008-10#6)(2008-11#1)
barcode clusters##3##2##(2008-9#3)
barcode sequences##2##2##(2008-9#2)
barcode##11##1##(2008-7#1)(2008-9#8)(2011-2#1)(2012-2#1)
barcodes##5##1##(2008-7#1)(2012-2#4)
barcoding of##2##2##(2008-9#1)(2011-2#1)
barcoding##8##1##(2008-9#5)(2011-2#1)(2012-2#2)
bare FNs or Cs##2##4##(2009-11#2)
bare GC electrode##2##3##(2008-10#2)
bare GCE##2##2##(2008-10#2)
bare SOWG and##2##3##(2008-10#2)
bare SOWG##3##2##(2008-10#3)
bare and##2##2##(2008-3#1)(2013-1#1)
bare boron-doped diamond electrode##2##4##(2008-10#2)
bare fiber##2##2##(2007-11#1)(2008-10#1)
bare glassy carbon electrode##2##4##(2008-10#2)
bare hands##3##2##(1997-4#2)(2008-4#1)
bare metal stents was##2##4##(2008-11#1)(2008-12#1)
bare metal stents##7##3##(2008-11#3)(2008-12#2)(2009-12#1)(2010-5#1)
bare metal##8##2##(2008-11#3)(2008-12#2)(2009-12#1)(2010-5#2)
bare silica##2##2##(2008-10#2)
bare soil##4##2##(2008-10#4)
bare##73##1##(1997-2#2)(1997-4#2)(1997-7#1)(2007-11#2)(2007-12#2)(2007-5#2)(2008-10#31)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#5)(2009-12#1)(2010-5#2)(2012-2#1)(2013-1#1)
bare-metal stents##2##2##(2009-12#1)(2009-5#1)
bare-metal##3##1##(2009-12#1)(2009-5#2)
barely detectable##7##2##(1991-12#1)(1992-3#1)(1993-12#1)(2008-10#2)(2008-9#1)(2009-9#1)
barely visible##2##2##(1991-12#1)(2008-10#1)
barely##19##1##(1991-12#2)(1992-3#3)(1993-12#1)(1994-12#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#2)(2009-9#1)(2013-7#1)
bargaining##3##1##(1991-12#1)(1992-2#1)(2011-2#1)
bariatric surgery program in##2##4##(2013-1#2)
bariatric surgery##16##2##(1993-3#3)(1993-5#3)(2010-8#2)(2012-12#2)(2013-1#5)(2013-8#1)
bariatric##23##1##(1993-3#4)(1993-5#4)(2010-8#2)(2012-12#4)(2013-1#8)(2013-8#1)
barium and potassium in a mixture##2##6##(2008-10#2)
barium and potassium##4##3##(2008-10#4)
barium and##6##2##(2008-10#5)(2010-8#1)
barium enema##8##2##(1993-9#3)(1997-5#1)(1997-8#1)(2007-12#1)(2011-2#1)(2013-1#1)
barium hydroxide##3##2##(2008-10#3)
barium ions##2##2##(2008-10#2)
barium sulfate##2##2##(2008-10#1)(2008-8#1)
barium titanate##3##2##(1990-4#1)(2008-2#2)
barium##52##1##(1990-4#1)(1993-9#3)(1994-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#19)(2008-12#1)(2008-2#3)(2008-3#7)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#2)(2012-2#2)(2013-1#2)
bark and##2##2##(2008-5#1)(2010-3#1)
bark beetle##6##2##(2008-10#6)
bark beetles##7##2##(2008-10#4)(2008-8#1)(2011-2#2)
bark canker##2##2##(2008-10#2)
bark of##11##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
bark or##2##2##(2008-10#1)(2008-11#1)
bark samples##5##2##(2008-10#4)(2012-1#1)
bark tissue##2##2##(2008-10#2)
bark tissues##2##2##(2008-10#2)
bark##56##1##(2008-10#37)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)
barley (Hordeum vulgare L##6##4##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
barley (Hordeum vulgare)##2##3##(2008-10#1)(2008-8#1)
barley (Hordeum##9##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)
barley aleurone##3##2##(2008-8#3)
barley alpha-amylase andA##2##3##(2008-8#2)
barley alpha-amylase##3##2##(2008-8#3)
barley and cereal yellow dwarf viruses##2##6##(2008-10#1)(2008-9#1)
barley and##13##2##(1991-12#1)(2008-10#9)(2008-12#1)(2008-9#2)
barley breeding##2##2##(2008-10#2)
barley chromosome##6##2##(2008-10#6)
barley chromosomes##2##2##(2008-10#2)
barley cultivar##4##2##(2008-10#4)
barley cultivars and##2##3##(2008-10#2)
barley cultivars using##2##3##(2008-10#1)(2008-5#1)
barley cultivars with different##2##4##(2008-10#2)
barley cultivars with##3##3##(2008-10#3)
barley cultivars##13##2##(2008-10#11)(2008-5#1)(2008-9#1)
barley cv##6##2##(2008-10#6)
barley fields located##2##3##(2008-10#2)
barley fields##3##2##(2008-10#3)
barley genotype##2##2##(2008-10#2)
barley genotypes##5##2##(2008-10#5)
barley germ plasm##2##3##(2008-10#2)
barley germplasm##2##2##(2008-10#2)
barley in the##5##3##(2008-10#5)
barley in##10##2##(2008-10#10)
barley is##5##2##(2008-10#3)(2008-9#1)(2009-10#1)
barley leaf##2##2##(2008-10#2)
barley leaves##5##2##(1992-8#1)(2008-10#4)
barley or##2##2##(2008-10#2)
barley powdery mildew##2##3##(2008-10#2)
barley scald##2##2##(2008-10#2)
barley seed##2##2##(1995-6#2)
barley seedlings##2##2##(2008-10#2)
barley stripe rust##3##3##(2008-10#3)
barley stripe##4##2##(1997-3#1)(2008-10#3)
barley that##2##2##(2008-10#1)(2008-8#1)
barley was##3##2##(2008-10#2)(2008-12#1)
barley yellow dwarf virus (BYDV)##5##5##(2008-10#3)(2008-8#2)
barley yellow dwarf virus##7##4##(2008-10#5)(2008-8#2)
barley yellow dwarf##11##3##(2008-10#9)(2008-8#2)
barley##240##1##(1991-12#2)(1991-5#1)(1992-8#3)(1992-9#1)(1994-6#3)(1995-6#5)(1995-8#1)(1997-3#1)(1997-6#2)(2008-10#174)(2008-11#2)(2008-12#8)(2008-5#14)(2008-6#1)(2008-8#11)(2008-9#7)(2009-10#3)(2010-2#1)
barn##5##1##(1990-5#2)(1993-3#1)(2008-9#2)
barnacle Megabalanus rosa##5##3##(1990-5#4)(1993-6#1)
barnacle##6##1##(1990-5#4)(1993-6#2)
barnacles##3##1##(2008-9#1)(2013-7#2)
barnase was##2##2##(2008-8#2)
barnase##4##1##(1991-6#1)(2008-8#3)
barndoor##3##1##(2009-4#3)
barns##3##1##(2010-4#3)
baroceptor sensitivity and##3##3##(2008-7#3)
baroceptor sensitivity##5##2##(2008-7#5)
baroreceptor inhibition of neurosecretory##2##4##(1990-5#2)
baroreceptor inhibition of##3##3##(1990-5#3)
baroreceptor##7##1##(1990-5#5)(1997-2#1)(2010-6#1)
baroreceptors##2##1##(2008-1#2)
baroreflex function##2##2##(2008-1#2)
baroreflex gain##4##2##(2009-9#2)(2010-5#2)
baroreflex##12##1##(1991-10#1)(2007-10#1)(2008-1#2)(2008-7#1)(2009-9#3)(2010-5#3)(2011-2#1)
barotrauma##3##1##(1990-6#1)(2007-2#2)
barrage zones##5##2##(2008-10#5)
barrage##7##1##(1992-12#1)(2008-10#6)
barrel cortex##4##2##(1997-3#1)(2008-1#2)(2009-5#1)
barrel##11##1##(1991-3#1)(1991-5#1)(1997-3#2)(2008-1#4)(2008-10#1)(2009-5#1)(2013-1#1)
barren##2##1##(2008-3#1)(2008-9#1)
barrier (BBB)##6##2##(1990-5#1)(1996-5#1)(2007-11#1)(2008-7#2)(2012-2#1)
barrier against##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
barrier and the##3##3##(2007-12#1)(2012-2#1)(2013-1#1)
barrier and##16##2##(1993-12#1)(1994-6#1)(1997-2#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
barrier between embryonic and trophectodermal cell fates##2##7##(2012-12#2)
barrier between the##3##3##(2008-5#1)(2009-12#1)(2012-12#1)
barrier between##5##2##(2008-5#1)(2009-12#1)(2012-12#3)
barrier cells in##2##3##(1991-5#1)(2008-7#1)
barrier cells##5##2##(1991-5#1)(2008-7#4)
barrier discharge##4##2##(2012-1#1)(2013-8#3)
barrier for##12##2##(1995-2#1)(1996-2#2)(2007-7#1)(2008-10#3)(2008-5#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#1)
barrier function and##3##3##(2008-5#2)(2012-2#1)
barrier function in male skin##2##5##(2008-5#2)
barrier function in##8##3##(2008-5#7)(2008-7#1)
barrier function is##2##3##(2008-5#2)
barrier function of the##4##4##(2008-5#3)(2009-10#1)
barrier function of##6##3##(1992-3#1)(2008-5#4)(2009-10#1)
barrier function##47##2##(1992-3#1)(2008-5#37)(2008-7#3)(2009-10#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-2#1)
barrier in the##4##3##(1994-5#1)(1995-12#1)(2007-7#1)(2008-7#1)
barrier in##10##2##(1990-5#1)(1994-5#1)(1995-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-7#1)
barrier integrity##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
barrier into##3##2##(2009-8#2)(2012-2#1)
barrier is##2##2##(1995-2#1)(2008-10#1)
barrier may##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
barrier of the##2##3##(1992-3#1)(2007-12#1)
barrier of##7##2##(1992-3#1)(1994-11#1)(1994-5#1)(1996-2#2)(2007-12#1)(2008-1#1)
barrier products##4##2##(2013-8#4)
barrier properties##5##2##(2008-5#3)(2010-7#1)(2011-2#1)
barrier regulation##2##2##(2008-7#2)
barrier socialization##2##2##(2009-7#2)
barrier structure##2##2##(2008-5#2)
barrier that##2##2##(1997-1#1)(2011-2#1)
barrier to gene flow##2##4##(2008-10#2)
barrier to the development of##2##5##(1994-1#1)(2011-3#1)
barrier to the##11##3##(1994-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#1)(2011-3#1)(2012-2#1)
barrier to##42##2##(1994-1#1)(1994-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
barrier was##5##2##(1994-6#1)(1995-12#1)(2008-10#1)(2009-8#1)(2010-11#1)
barrier zone##2##2##(2008-10#2)
barrier##312##1##(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#4)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-3#1)(1994-5#3)(1994-6#3)(1995-12#4)(1995-2#4)(1996-2#5)(1996-3#1)(1996-5#1)(1997-1#7)(1997-2#4)(2007-11#3)(2007-12#7)(2007-5#1)(2007-7#3)(2008-1#3)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#69)(2008-7#19)(2008-8#6)(2008-9#1)(2009-10#6)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#12)(2011-3#1)(2012-1#7)(2012-12#6)(2012-2#13)(2012-3#1)(2013-1#6)(2013-8#8)
barrier&quot##2##1##(2011-2#2)
barriers and facilitators to CRC screening##3##6##(2013-1#3)
barriers and facilitators to##4##4##(2013-1#4)
barriers and facilitators##5##3##(2013-1#5)
barriers and methods for##2##4##(1997-3#1)(2009-5#1)
barriers and the##2##3##(1991-3#1)(2013-8#1)
barriers and##23##2##(1990-2#1)(1991-3#1)(1995-12#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
barriers are##5##2##(1990-11#1)(1991-12#1)(1996-3#1)(2007-11#1)(2012-3#1)
barriers at sites of##2##4##(2008-10#2)
barriers at##3##2##(2008-10#2)(2009-4#1)
barriers between##6##2##(1997-6#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-3#1)
barriers for##4##2##(1991-9#1)(1992-8#1)(1996-3#1)(2010-5#1)
barriers have##2##2##(1995-12#1)(2010-11#1)
barriers in the##4##3##(1996-2#1)(2008-8#1)(2009-11#1)(2010-1#1)
barriers in##12##2##(1996-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#2)
barriers may##2##2##(2008-1#1)(2008-10#1)
barriers of the##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
barriers of##11##2##(1990-3#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-5#1)(2013-8#1)
barriers perceived##3##2##(1994-1#1)(2012-2#1)(2013-1#1)
barriers preventing optimal##2##3##(1996-2#1)(2010-7#1)
barriers separating##2##2##(1990-3#1)(2008-10#1)
barriers that can##2##3##(2008-11#1)(2010-11#1)
barriers that##12##2##(1994-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)
barriers they encountered##2##3##(2010-4#1)(2011-1#1)
barriers they##3##2##(2010-4#1)(2011-1#1)(2011-2#1)
barriers to care##4##3##(1995-12#2)(1995-3#1)(2008-4#1)
barriers to health care##4##4##(1997-2#3)(2008-4#1)
barriers to implementation of##2##4##(1996-2#1)(2013-1#1)
barriers to implementation##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
barriers to implementing##2##3##(1994-1#2)
barriers to pain management##2##4##(2009-12#1)(2010-11#1)
barriers to reporting##2##3##(2010-11#1)(2011-2#1)
barriers to successful breast-feeding##2##4##(1994-2#2)
barriers to the##7##3##(1994-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)
barriers to training##2##3##(1996-3#1)(2011-2#1)
barriers to use##3##3##(1997-1#2)(2008-11#1)
barriers to##93##2##(1991-1#1)(1993-12#2)(1994-1#3)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-5#1)(2007-7#2)(2008-1#4)(2008-10#4)(2008-11#8)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2011-9#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)
barriers were identified in##2##4##(2008-10#2)
barriers were##6##2##(1994-8#1)(2008-1#1)(2008-10#2)(2010-6#1)(2012-3#1)
barriers##266##1##(1990-11#4)(1990-2#1)(1990-3#3)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-12#2)(1994-1#9)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#8)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-1#7)(2008-10#23)(2008-11#19)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#4)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#12)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#9)(2011-2#15)(2011-3#1)(2011-9#1)(2012-12#3)(2012-2#9)(2012-3#12)(2013-1#19)(2013-7#3)(2013-8#2)
bars and##2##2##(2008-12#1)(2011-2#1)
bars are##2##2##(2008-11#1)(2012-2#1)
bars at##2##2##(2007-11#1)(2008-3#1)
bars to##3##2##(1992-1#1)(2007-11#1)(2011-1#1)
bars were##2##2##(2008-5#1)(2008-8#1)
bars##31##1##(1990-3#1)(1992-1#1)(1992-2#1)(2007-11#3)(2007-12#1)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
basal ACTH##2##2##(1995-12#2)
basal Ca2+ concentration##2##3##(1996-2#2)
basal ES at the##3##4##(2012-2#3)
basal ES##9##2##(2009-10#2)(2012-2#7)
basal IRS1##2##2##(2013-1#2)
basal NF-κB activity##2##3##(2012-3#2)
basal PGI2 release##3##3##(1995-11#3)
basal TSH##2##2##(1995-5#1)(2008-4#1)
basal acid secretion##2##3##(1997-1#2)
basal acid##3##2##(1997-1#3)
basal activity of##3##3##(1994-11#1)(1995-6#1)(2009-11#1)
basal activity##5##2##(1992-7#1)(1993-11#1)(1994-11#1)(1995-6#1)(2009-11#1)
basal and##21##2##(1990-8#1)(1991-12#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#3)(1997-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-2#3)(2012-3#1)
basal body##4##2##(1991-11#1)(2008-7#3)
basal bone##3##2##(2007-12#1)(2011-2#2)
basal cell and squamous cell carcinomas##2##6##(2010-8#1)(2012-3#1)
basal cell carcinoma (BCC)##3##4##(1997-3#2)(2007-5#1)
basal cell carcinoma and squamous cell carcinoma##2##7##(2010-8#2)
basal cell carcinoma and##3##4##(2010-8#2)(2013-8#1)
basal cell carcinoma syndrome##5##4##(1997-3#4)(2007-4#1)
basal cell carcinoma##18##3##(1997-3#6)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2010-8#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
basal cell carcinomas##6##3##(1994-6#1)(1997-3#1)(2007-4#1)(2007-7#1)(2010-8#1)(2012-3#1)
basal cell##33##2##(1990-9#1)(1994-6#1)(1997-3#7)(2007-12#4)(2007-4#3)(2007-5#1)(2007-7#2)(2008-9#1)(2010-8#4)(2012-1#1)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
basal cerebral##2##2##(1996-3#2)
basal condition##2##2##(2008-5#1)(2012-3#1)
basal conditions or##2##3##(1994-2#1)(1995-5#1)
basal conditions##15##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-9#1)(1994-2#1)(1995-5#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-8#2)(2013-1#2)(2013-7#1)
basal cryptitis##2##2##(2011-2#2)
basal dendrites##3##2##(1995-8#1)(2007-8#2)
basal diet##7##2##(1992-9#3)(1997-3#1)(2008-10#1)(2009-12#1)(2013-1#1)
basal distance##2##2##(2010-4#2)
basal ectoplasmic specialization (basal ES)##2##5##(2009-10#1)(2012-2#1)
basal expression##5##2##(1991-9#2)(1993-12#1)(1993-6#1)(2008-6#1)
basal forebrain cholinergic neurons##4##4##(1991-12#2)(1996-5#2)
basal forebrain cholinergic##6##3##(1991-12#2)(1996-5#4)
basal forebrain##16##2##(1991-12#2)(1992-10#2)(1993-12#1)(1994-3#1)(1996-5#5)(1997-3#1)(2008-7#2)(2009-3#2)
basal fourth and fifth metatarsal arthritis##2##6##(2010-11#2)
basal function##2##2##(2012-3#2)
basal ganglia hematoma##2##3##(2013-1#2)
basal ganglia play a##2##4##(1993-9#1)(2009-10#1)
basal ganglia to##2##3##(1996-12#2)
basal ganglia##43##2##(1991-12#1)(1992-6#1)(1993-9#3)(1994-3#1)(1995-3#2)(1995-5#1)(1996-12#3)(1996-5#2)(1997-3#2)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#10)(2009-10#1)(2009-11#2)(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
basal ganglial##2##2##(2008-11#2)
basal gene##2##2##(2011-1#1)(2012-2#1)
basal glucose##2##2##(1990-8#1)(1994-12#1)
basal insulin##2##2##(2008-1#1)(2012-4#1)
basal junctions##2##2##(2007-12#1)(2009-10#1)
basal keratinocyte##2##2##(1991-12#1)(2008-5#1)
basal keratinocytes##3##2##(2008-12#1)(2008-5#1)(2013-1#1)
basal lamina##11##2##(1992-9#1)(2007-12#2)(2008-10#2)(2008-12#3)(2008-5#1)(2008-7#1)(2009-10#1)
basal laminae and##2##3##(2007-12#2)
basal layer of##3##3##(1996-2#1)(2010-6#1)(2013-1#1)
basal layer##5##2##(1996-2#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
basal leaves##2##2##(2008-10#2)
basal level of##8##3##(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-1#1)(2008-11#1)
basal level within##2##3##(1993-11#1)(1997-7#1)
basal level##13##2##(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-6#1)
basal level)##2##2##(1991-12#2)
basal levels by##2##3##(1995-2#1)(1996-12#1)
basal levels of##9##3##(1991-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
basal levels##16##2##(1990-7#1)(1991-12#1)(1991-9#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
basal media with##2##3##(2008-11#1)(2008-12#1)
basal media##7##2##(2008-11#5)(2008-12#1)(2013-1#1)
basal medium was##3##3##(2008-11#3)
basal medium##14##2##(1994-3#2)(2008-10#3)(2008-11#6)(2008-6#3)
basal metabolic rate (BMR)##3##4##(2008-8#1)(2008-9#1)(2013-1#1)
basal metabolic rate##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
basal or##5##2##(1990-12#1)(1990-3#1)(1994-11#1)(1995-2#1)(2008-6#1)
basal pinnae##2##2##(2008-5#2)
basal plane##2##2##(2008-10#1)(2008-2#1)
basal plasma##3##2##(1990-5#2)(2008-7#1)
basal promoter activity##2##3##(1996-5#1)(1997-7#1)
basal promoter##4##2##(1991-6#1)(1996-5#1)(1997-7#2)
basal region of##2##3##(1995-12#1)(2008-7#1)
basal region##5##2##(1995-12#1)(2008-7#4)
basal respiration##2##2##(2008-5#2)
basal secretion of##2##3##(1995-5#1)(1997-1#1)
basal secretion##5##2##(1995-11#1)(1995-5#1)(1997-1#2)(2008-7#1)
basal serum##2##2##(1995-3#2)
basal set of##2##3##(2008-7#2)
basal species##2##2##(2008-9#2)
basal to##4##2##(2008-8#2)(2009-10#1)(2010-3#1)
basal tone or##2##3##(1997-4#2)
basal tone##4##2##(1995-12#1)(1997-4#2)(2007-10#1)
basal transcription##5##2##(1993-6#1)(1993-9#1)(1995-2#1)(1995-6#2)
basal transcriptional##3##2##(1996-5#1)(2010-11#2)
basal tyrosine##2##2##(1992-7#1)(1992-9#1)
basal values##5##2##(1990-7#1)(1991-6#1)(1993-6#1)(1996-5#1)(2008-5#1)
basal##486##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#4)(1991-9#6)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#7)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#6)(1994-6#5)(1994-9#1)(1995-11#6)(1995-12#12)(1995-2#5)(1995-3#4)(1995-5#8)(1995-6#5)(1995-8#2)(1996-12#7)(1996-2#6)(1996-3#2)(1996-5#12)(1996-6#1)(1996-9#1)(1997-1#9)(1997-2#3)(1997-3#11)(1997-4#2)(1997-7#5)(2007-10#2)(2007-12#15)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#21)(2008-11#23)(2008-12#6)(2008-2#3)(2008-4#4)(2008-5#22)(2008-6#7)(2008-7#31)(2008-8#10)(2008-9#8)(2009-10#11)(2009-11#4)(2009-12#2)(2009-3#2)(2009-6#3)(2010-11#5)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#16)(2012-1#5)(2012-12#1)(2012-2#12)(2012-3#13)(2012-4#1)(2013-1#19)(2013-7#3)(2013-8#7)
basal)##2##1##(1993-3#1)(1995-3#1)
basal-to-apical direction##3##2##(2008-9#2)(2011-2#1)
basalis and##2##2##(1992-10#1)(1994-9#1)
basalis##20##1##(1990-5#3)(1991-12#1)(1991-9#2)(1992-10#2)(1993-12#3)(1993-3#2)(1994-8#1)(1994-9#3)(1995-12#1)(2008-8#1)(2008-9#1)
basally##3##1##(1996-12#1)(2008-7#2)
base + moisturizer##2##3##(2008-5#2)
base alterations##2##2##(1996-6#2)
base and the##3##3##(2006-12#1)(2008-10#1)(2008-12#1)
base and##23##2##(1990-12#1)(1997-1#1)(2006-12#2)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#3)(2011-2#3)(2012-2#1)(2013-1#1)
base are##5##2##(2006-12#1)(2007-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
base at the##2##3##(1995-5#1)(2008-8#1)
base at##3##2##(1995-5#1)(2008-8#1)(2008-9#1)
base calling##2##2##(1995-8#1)(2008-4#1)
base changes##2##2##(1991-7#1)(2008-12#1)
base composition##5##2##(1993-2#1)(1994-9#1)(2008-5#1)(2008-7#1)(2010-3#1)
base defects##2##2##(2006-12#1)(2011-2#1)
base electrode##2##2##(2008-10#2)
base excess##4##2##(1994-3#1)(1994-7#3)
base excision repair##3##3##(1997-6#1)(2008-1#1)(2008-11#1)
base extension##2##2##(2008-12#1)(2011-2#1)
base for the##2##3##(2006-9#1)(2011-2#1)
base for##17##2##(1990-6#1)(1990-8#1)(1993-12#1)(1995-3#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
base from##4##2##(1992-3#1)(2006-12#1)(2012-2#1)(2012-3#1)
base height##3##2##(2008-2#2)(2008-3#1)
base hydrolysis##2##2##(2012-12#2)
base in the##3##3##(1992-8#1)(1993-9#1)(2010-5#1)
base in##14##2##(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#3)(2011-2#2)
base is##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
base lesions##5##2##(2006-12#2)(2007-12#1)(2011-2#1)(2013-1#1)
base ligand##2##2##(2008-10#2)
base ligands##2##2##(2008-10#2)
base line##6##2##(1993-11#1)(2008-10#4)(2008-5#1)
base material##3##2##(2008-10#1)(2012-2#2)
base metals##3##2##(2008-10#3)
base method##3##2##(2008-1#1)(2008-10#2)
base mismatch##2##2##(2008-10#1)(2008-7#1)
base model##4##2##(1995-2#1)(2011-2#3)
base of knowledge##2##3##(2008-1#1)(2013-1#1)
base of the Andes mountains in Venezuela##2##7##(2008-5#2)
base of the##29##3##(1991-2#1)(1991-3#1)(1992-11#1)(1994-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
base of##64##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-9#1)(1994-1#2)(1994-11#1)(1994-3#1)(1994-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)
base on##6##2##(1997-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
base pair (bp)##3##3##(1991-1#1)(1993-3#1)(1995-6#1)
base pair insertion in the##2##5##(1990-5#1)(1994-9#1)
base pair sequence corresponding to the##2##6##(1996-12#2)
base pair sequence##3##3##(1996-12#2)(1996-6#1)
base pair##30##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-12#1)(1992-3#3)(1993-3#1)(1993-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-6#1)(1997-7#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-7#1)
base paired##2##2##(1993-11#1)(1993-12#1)
base pairing and##2##3##(2008-4#2)
base pairing with##3##3##(1993-11#1)(2011-2#2)
base pairing##14##2##(1991-5#3)(1992-8#1)(1993-11#1)(1997-6#1)(2008-4#3)(2008-7#2)(2009-5#1)(2011-2#2)
base pairs (bp) and##3##4##(1992-8#1)(2008-11#1)(2008-7#1)
base pairs (bp)##9##3##(1990-12#1)(1992-12#1)(1992-8#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
base pairs and##4##3##(1993-11#1)(2008-10#2)(2008-9#1)
base pairs could##2##3##(1995-2#1)(2009-6#1)
base pairs in length##2##4##(1991-5#1)(1997-9#1)
base pairs in##4##3##(1991-5#1)(1995-12#1)(1997-9#1)(2010-7#1)
base pairs of the##2##4##(1991-11#1)(1997-7#1)
base pairs of##5##3##(1991-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)
base pairs per##2##3##(1995-2#1)(2008-10#1)
base pairs upstream##2##3##(1991-11#1)(1995-6#1)
base pairs with a##2##4##(1991-9#1)(1997-9#1)
base pairs with##4##3##(1991-12#1)(1991-9#1)(1997-9#1)(2008-4#1)
base pairs##65##2##(1990-12#1)(1990-5#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-9#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#6)(2008-7#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
base pairs)##6##2##(1991-9#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
base resins##2##2##(2008-10#1)(2008-12#1)
base sequence and##2##3##(1991-9#1)(1995-5#1)
base sequence of the##2##4##(1992-3#2)
base sequence##6##2##(1991-9#1)(1992-3#2)(1993-11#1)(1993-6#1)(1995-5#1)
base solution##3##2##(2008-10#3)
base stacking##5##2##(1991-5#4)(1993-11#1)
base substitution from##2##3##(2008-1#1)(2008-10#1)
base substitution in the##2##4##(1993-3#1)(2008-10#1)
base substitution##6##2##(1991-2#2)(1993-3#1)(2008-1#1)(2008-10#2)
base substitutions##5##2##(1990-8#1)(1995-6#1)(2008-4#2)(2008-9#1)
base surgery##11##2##(2007-12#2)(2011-2#8)(2012-3#1)
base their##4##2##(1993-6#1)(2008-12#1)(2009-3#2)
base time##8##2##(2008-8#8)
base to##14##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-10#1)
base was##9##2##(1991-2#1)(1992-3#1)(1994-3#1)(2006-12#1)(2007-11#1)(2008-5#1)(2011-2#3)
base which is##2##3##(1996-2#1)(2008-10#1)
base which##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
base with##8##2##(1994-8#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)
base##636##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#7)(1991-3#1)(1991-5#9)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#11)(1992-4#2)(1992-6#6)(1992-8#8)(1992-9#2)(1993-1#3)(1993-11#10)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#2)(1994-2#3)(1994-3#7)(1994-5#5)(1994-6#2)(1994-7#3)(1994-8#5)(1994-9#3)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#5)(1995-6#9)(1995-8#1)(1996-12#2)(1996-2#4)(1996-5#1)(1996-6#5)(1997-1#3)(1997-2#5)(1997-3#3)(1997-6#3)(1997-7#4)(1997-9#2)(2006-12#13)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#15)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#10)(2008-10#108)(2008-11#13)(2008-12#10)(2008-2#5)(2008-3#6)(2008-4#22)(2008-5#28)(2008-6#4)(2008-7#22)(2008-8#15)(2008-9#9)(2009-1#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#7)(2010-7#2)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#50)(2012-1#1)(2012-12#9)(2012-2#8)(2012-3#4)(2013-1#19)(2013-7#1)
base) as##2##2##(2008-10#2)
base)##7##1##(1995-12#1)(2008-10#5)(2008-7#1)
base-base stacking##2##2##(1993-11#1)(2008-8#1)
base-catalyzed##4##1##(1993-8#1)(1996-5#1)(2008-10#2)
base-deactivated C8 column##2##3##(1995-3#2)
base-line##2##1##(2008-10#2)
base-pair##5##1##(1992-3#1)(1993-9#1)(1994-11#1)(2008-10#1)(2009-10#1)
base-paired##2##1##(1993-12#1)(2008-7#1)
base-pairing##2##1##(1993-11#2)
base-pairs##3##1##(2008-7#2)(2011-1#1)
base-triple##2##1##(1993-1#2)
baseband##2##1##(2007-11#1)(2008-3#1)
based DNA##2##2##(1990-12#1)(2008-10#1)
based SPR##2##2##(2008-10#2)
based and##5##2##(1993-1#1)(1993-12#1)(1997-3#1)(2008-1#1)(2010-3#1)
based approach for##2##3##(1994-11#1)(2013-8#1)
based approach##3##2##(1994-11#1)(2009-3#1)(2013-8#1)
based around##2##2##(2008-2#1)(2008-5#1)
based assay##4##2##(1995-2#1)(1997-7#1)(2008-11#1)(2008-7#1)
based assays##2##2##(2008-5#1)(2008-9#1)
based at##2##2##(2008-1#1)(2011-2#1)
based biosensor for##3##3##(2008-10#3)
based biosensor##5##2##(2008-10#5)
based biosensors##2##2##(2008-10#2)
based both on electrostatic##2##4##(2008-10#2)
based cancer##2##2##(2010-11#1)(2011-3#1)
based chemical##2##2##(2008-10#1)(2010-5#1)
based clinical##2##2##(2008-12#2)
based compounds##2##2##(2010-11#1)(2012-2#1)
based confidence intervals##2##3##(1996-3#1)(2010-2#1)
based confidence##3##2##(1996-3#1)(2009-12#1)(2010-2#1)
based detection of##2##3##(2008-10#1)(2009-5#1)
based detection##5##2##(2008-10#3)(2009-5#1)(2012-12#1)
based dietary##2##2##(2012-2#2)
based diets supplemented with##2##4##(2008-12#1)(2010-2#1)
based discrimination##2##2##(2007-10#1)(2008-8#1)
based either on##2##3##(2008-10#1)(2008-9#1)
based electrode##2##2##(2008-10#2)
based electrodes##5##2##(2008-10#5)
based enzyme##2##2##(2008-10#2)
based guidelines##2##2##(1991-3#1)(2009-7#1)
based has##2##2##(2008-12#1)(2008-3#1)
based high##2##2##(2010-5#1)(2012-3#1)
based in a##2##3##(2008-8#1)(2013-1#1)
based in local##2##3##(1991-1#1)(1996-1#1)
based in part on##3##4##(1993-3#1)(2008-5#1)(2008-8#1)
based in part##4##3##(1992-3#1)(1993-3#1)(2008-5#1)(2008-8#1)
based in the##11##3##(2008-10#7)(2008-3#1)(2009-7#2)(2009-8#1)
based in##37##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1996-1#1)(1996-5#2)(1996-6#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#2)(2009-5#1)(2009-7#3)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
based inner contacts##2##3##(2008-10#2)
based instruments##2##2##(2008-10#1)(2008-9#1)
based interventions##2##2##(2008-4#1)(2012-2#1)
based ion-selective electrodes##3##3##(2008-10#3)
based is##2##2##(1997-3#1)(2008-11#1)
based largely on##3##3##(1993-2#1)(2008-1#1)(2008-7#1)
based learning##12##2##(2008-11#9)(2008-12#3)
based mainly on##7##3##(1991-9#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
based medicine##5##2##(1996-2#1)(2007-7#1)(2008-7#1)(2010-9#1)(2011-2#1)
based membrane##3##2##(2008-10#3)
based membranes of##4##3##(2008-10#4)
based membranes##6##2##(2008-10#6)
based mental disorders##2##3##(2010-4#2)
based method to##2##3##(2008-1#1)(2008-10#1)
based method##8##2##(1996-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-7#2)
based methods are##2##3##(1996-3#1)(2008-9#1)
based methods for##2##3##(1994-12#1)(2008-8#1)
based methods##9##2##(1994-12#1)(1996-3#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#2)
based minerals##2##2##(2008-10#2)
based modeling of##2##3##(1997-6#1)(2013-8#1)
based models##3##2##(2007-11#1)(2008-10#1)(2009-3#1)
based mostly on##2##3##(2008-4#1)(2008-6#1)
based on (1)##2##3##(1994-12#1)(2009-5#1)
based on (i)##2##3##(1993-6#1)(2008-10#1)
based on 1##6##3##(2007-12#1)(2008-10#4)(2008-11#1)
based on 16S##3##3##(2008-10#2)(2011-1#1)
based on 2##3##3##(2008-10#3)
based on 3##5##3##(1995-12#1)(2008-10#2)(2008-11#1)(2010-3#1)
based on 5##4##3##(2007-8#1)(2008-10#3)
based on 6##2##3##(1990-12#1)(2007-11#1)
based on 7##2##3##(2008-10#1)(2012-1#1)
based on AFLP data and##2##5##(2008-10#2)
based on AFLP##3##3##(2008-10#3)
based on AFLP-finger##2##3##(2008-2#2)
based on COM##2##3##(2012-3#2)
based on DNA fingerprinting with##2##5##(2008-10#2)
based on DNA##7##3##(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-5#1)
based on Fourier analysis and##2##5##(2008-3#2)
based on Fourier analysis##3##4##(2008-3#3)
based on Fourier##5##3##(2007-12#1)(2008-3#4)
based on Fourier-transform##2##3##(2007-11#1)(2007-12#1)
based on GDx VCC##2##4##(2010-8#2)
based on IFN-gamma's##2##3##(2008-4#2)
based on ITS##2##3##(2008-10#2)
based on Markov##2##3##(2008-6#1)(2008-8#1)
based on Monte Carlo##2##4##(2008-10#1)(2008-2#1)
based on Mueller matrices##2##4##(2007-11#1)(2008-3#1)
based on Mueller##3##3##(2007-11#1)(2008-3#2)
based on N##9##3##(1992-3#1)(2007-11#1)(2008-10#7)
based on N-methylformamide##2##3##(2008-10#2)
based on PCR##2##3##(1990-12#1)(2008-10#1)
based on RAPD analysis##2##4##(2008-10#2)
based on RAPD##4##3##(2008-10#4)
based on RFLP and##2##4##(2008-5#2)
based on RNA##2##3##(2008-9#1)(2013-1#1)
based on ZnO/chitosan composite##2##4##(2008-10#2)
based on [2##2##3##(2008-10#2)
based on a Fourier-transform##2##4##(2008-2#1)(2008-3#1)
based on a case##2##4##(1994-11#1)(1996-2#1)
based on a clinical##3##4##(1997-3#1)(2008-3#1)(2009-9#1)
based on a combination of the##4##6##(2008-10#2)(2008-3#1)(2012-1#1)
based on a combination of##15##5##(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#1)(2013-1#1)
based on a comparison of##2##5##(1994-3#1)(2012-2#1)
based on a comparison##3##4##(1994-3#1)(2008-3#1)(2012-2#1)
based on a competitive##2##4##(2008-10#2)
based on a continuum##2##4##(1992-1#1)(2008-4#1)
based on a conventional##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
based on a convolution##2##4##(2007-11#1)(2008-2#1)
based on a cylindrical##2##4##(2007-11#1)(2007-12#1)
based on a different##2##4##(1993-2#1)(2008-3#1)
based on a fluorescence##2##4##(2008-10#1)(2008-2#1)
based on a generalized##2##4##(1997-7#1)(2007-12#1)
based on a genetic##2##4##(2008-3#2)
based on a historical##2##4##(2009-6#1)(2012-3#1)
based on a large##4##4##(2007-12#1)(2008-10#1)(2008-6#1)(2009-10#1)
based on a laser##2##4##(2008-10#1)(2008-2#1)
based on a least-squares##2##4##(2008-2#1)(2008-3#1)
based on a likelihood ratio test##2##6##(2008-10#1)(2008-3#1)
based on a likelihood ratio##3##5##(2008-10#1)(2008-12#1)(2008-3#1)
based on a microelectromechanical mirror##2##5##(2007-12#2)
based on a model that##3##5##(2007-6#1)(2008-3#1)(2013-1#1)
based on a model##5##4##(2007-12#1)(2007-6#1)(2008-3#1)(2012-1#1)(2013-1#1)
based on a modified##7##4##(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
based on a molecular##2##4##(2008-10#2)
based on a new##3##4##(1991-3#1)(2008-6#1)(2010-8#1)
based on a nonlinear##2##4##(2008-3#2)
based on a novel##4##4##(1995-3#1)(2008-10#3)
based on a patient's##2##4##(1994-12#1)(2008-10#1)
based on a photochemical reaction##2##5##(2008-10#2)
based on a photorefractive##2##4##(2008-3#2)
based on a piezoelectric##2##4##(2008-10#2)
based on a previously##2##4##(1994-12#1)(2008-3#1)
based on a reaction##2##4##(1991-5#1)(2008-4#1)
based on a recently synthesized##3##5##(2008-10#3)
based on a review of##4##5##(1996-2#1)(1997-2#1)(2006-7#1)(2011-2#1)
based on a sample of##3##5##(1994-6#1)(2010-11#1)(2010-5#1)
based on a sandwich##2##4##(2008-10#2)
based on a self-organizing neural network##2##6##(2008-3#2)
based on a semiconductor tapered amplifier##2##6##(2007-12#1)(2008-2#1)
based on a semiconductor##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
based on a set of##4##5##(2008-10#2)(2008-3#1)(2009-11#1)
based on a signal-to-noise ratio of##3##6##(2008-10#3)
based on a signal-to-noise ratio##4##5##(2008-10#4)
based on a simple classification##2##5##(2008-7#2)
based on a simple##9##4##(2007-11#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)
based on a single##13##4##(1994-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-2#1)
based on a special##2##4##(2008-10#1)(2008-3#1)
based on a specific##3##4##(2007-12#1)(2008-10#2)
based on a spherical##2##4##(2008-3#2)
based on a statistical analysis of the##2##7##(2008-10#1)(2008-3#1)
based on a statistical##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
based on a strong##2##4##(2008-10#1)(2008-3#1)
based on a study of##2##5##(2008-9#1)(2009-5#1)
based on a survey##2##4##(1996-1#1)(2008-9#1)
based on a system of##2##5##(2008-3#1)(2013-8#1)
based on a thorough##3##4##(2008-3#1)(2010-5#1)(2012-2#1)
based on a two-dimensional##4##4##(2007-11#3)(2008-2#1)
based on a variety of##2##5##(1994-2#1)(2008-2#1)
based on a very##2##4##(2008-10#1)(2008-5#1)
based on a visual substitution process##2##6##(1991-2#2)
based on a##497##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-7#1)(2007-10#2)(2007-11#35)(2007-12#37)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#128)(2008-11#4)(2008-12#2)(2008-2#33)(2008-3#96)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#11)(2012-1#2)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#4)
based on absorption##4##3##(2008-10#3)(2008-2#1)
based on active##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
based on actual##3##3##(2008-11#1)(2008-3#2)
based on adsorption##2##3##(2008-10#2)
based on adsorptive accumulation of##2##5##(2008-10#2)
based on adsorptive stripping technique##2##5##(2008-10#2)
based on adsorptive stripping##3##4##(2008-10#3)
based on adsorptive##5##3##(2008-10#5)
based on age##2##3##(2008-11#1)(2008-5#1)
based on all##2##3##(2008-10#1)(2011-2#1)
based on amplification##2##3##(2008-7#1)(2012-2#1)
based on amplified fragment length polymorphism##2##6##(2008-10#2)
based on an analogy##2##4##(2008-2#1)(2008-3#1)
based on an analysis of the##2##6##(1990-11#1)(1990-6#1)
based on an analysis of##4##5##(1990-11#1)(1990-6#1)(1993-12#1)(2008-10#1)
based on an array of##6##5##(2008-10#4)(2008-2#1)(2008-3#1)
based on an empirical##2##4##(2008-3#1)(2010-5#1)
based on an enrichment factor of##2##6##(2008-10#2)
based on an external-cavity##2##4##(2007-12#2)
based on an in##2##4##(2008-10#1)(2009-8#1)
based on an indirect##2##4##(2008-10#2)
based on an initial##2##4##(2008-11#1)(2008-5#1)
based on an iterative##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
based on an optical reflective device##2##6##(2008-10#2)
based on an##87##3##(1990-11#1)(1990-6#1)(1992-2#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-11#6)(2007-12#3)(2008-10#26)(2008-11#4)(2008-2#9)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-5#2)(2010-7#1)(2012-2#2)(2013-1#1)
based on analyses of##2##4##(2008-10#2)
based on analysis of spiked samples and solutions including matrix components##2##11##(2008-10#2)
based on analysis of##8##4##(2007-8#1)(2008-10#5)(2008-8#1)(2009-5#1)
based on analyzing##2##3##(2008-8#1)(2011-2#1)
based on anatomical knowledge##2##4##(1990-8#1)(2008-6#1)
based on aperiodically poled##2##4##(2007-11#2)
based on arrays of##3##4##(2008-10#2)(2008-2#1)
based on arrays##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
based on asymmetric##2##3##(2007-12#1)(2008-10#1)
based on atomic##2##3##(1995-2#1)(2010-4#1)
based on autocorrelation##2##3##(2008-10#1)(2008-3#1)
based on available##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2011-3#1)
based on average##3##3##(2008-10#2)(2013-8#1)
based on balanced##2##3##(2007-11#1)(2008-2#1)
based on beam##3##3##(2007-11#1)(2008-3#2)
based on bis(acetylacetone)propylenediimine##2##3##(2008-10#2)
based on blood##2##3##(2008-10#1)(2010-4#1)
based on both the##2##4##(2008-10#1)(2008-9#1)
based on both##11##3##(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-3#1)(2012-1#1)(2013-1#1)
based on calculations##2##3##(2007-11#1)(2008-10#1)
based on capillary electrophoresis with##2##5##(2008-10#2)
based on capillary##5##3##(2008-10#4)(2008-5#1)
based on carbon paste impregnated with##2##6##(2008-10#2)
based on carbon##7##3##(2008-10#6)(2008-7#1)
based on careful##2##3##(1994-12#1)(2012-3#1)
based on changes in the##2##5##(1997-6#1)(2007-11#1)
based on changes##3##3##(1997-6#1)(2007-11#1)(2008-10#1)
based on chemical##5##3##(1994-5#1)(2008-10#3)(2008-7#1)
based on chemically modified ring-disc electrode and its application for simultaneous measurements of nitric oxide##2##15##(2008-10#2)
based on chemically modified##5##4##(2008-10#5)
based on chi(2)##2##3##(2008-10#2)
based on classical##2##3##(1996-4#1)(2012-3#1)
based on clinical and##2##4##(2011-2#1)(2012-2#1)
based on clinical##15##3##(1992-12#1)(1993-3#1)(1994-5#1)(1996-1#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
based on collinear##2##3##(2007-11#1)(2008-10#1)
based on colorimetric detection##2##4##(2008-10#2)
based on common##4##3##(2008-12#1)(2011-2#2)(2013-8#1)
based on comparisons##2##3##(1991-9#1)(1996-12#1)
based on complementary##2##3##(2008-10#2)
based on complementation between##2##4##(2008-4#2)
based on complexation##2##3##(2008-10#2)
based on computed tomography (CT)##2##5##(2009-3#1)(2012-2#1)
based on computed tomography##3##4##(2008-3#1)(2009-3#1)(2012-2#1)
based on computer##2##3##(2008-2#1)(2012-3#1)
based on computer-generated hologram##2##4##(2008-3#2)
based on computer-generated##3##3##(2007-11#1)(2008-3#2)
based on conditional##2##3##(2008-5#1)(2012-2#1)
based on constrained##2##3##(2008-10#1)(2012-1#1)
based on contemporary##2##3##(1990-8#1)(2008-12#1)
based on continuous##9##3##(2008-10#7)(2008-7#1)(2013-1#1)
based on controlled adsorptive##2##4##(2008-10#2)
based on controlled##4##3##(2007-12#1)(2008-10#3)
based on coupled##4##3##(1992-11#1)(2007-12#2)(2008-8#1)
based on coupling##2##3##(2008-10#2)
based on current##4##3##(2007-11#1)(2009-8#1)(2010-12#1)(2010-3#1)
based on currently available##2##4##(2008-10#1)(2008-7#1)
based on cyclic##2##3##(2008-10#1)(2008-4#1)
based on data collected from##2##5##(2008-10#1)(2013-1#1)
based on data collected##3##4##(1994-6#1)(2008-10#1)(2013-1#1)
based on data from a##2##5##(2008-12#1)(2011-1#1)
based on data from the##2##5##(2008-3#1)(2011-2#1)
based on data from##11##4##(1996-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)
based on data obtained##2##4##(2008-11#1)(2012-3#1)
based on data##23##3##(1990-12#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
based on detecting##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
based on detection of the##2##5##(2008-10#1)(2011-2#1)
based on detection of##5##4##(1997-6#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
based on diagnostic##3##3##(2007-2#1)(2008-10#1)(2013-7#1)
based on difference##2##3##(2008-10#1)(2009-8#1)
based on differences in##4##4##(2008-10#2)(2008-3#1)(2009-2#1)
based on differences##5##3##(2008-10#3)(2008-3#1)(2009-2#1)
based on different##5##3##(1997-6#1)(2008-10#4)
based on diffractive##3##3##(2008-2#2)(2008-3#1)
based on diffusion of##2##4##(2007-11#1)(2008-10#1)
based on diffusion##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
based on digital##2##3##(2008-3#1)(2010-8#1)
based on dihedral##2##3##(2007-11#1)(2012-2#1)
based on direct determination of##2##5##(2008-10#2)
based on direct##7##3##(2007-10#1)(2008-10#5)(2008-8#1)
based on disease##3##3##(2008-10#3)
based on double-random phase encoding##2##5##(2008-2#1)(2008-3#1)
based on dynamic##2##3##(2008-3#1)(2011-3#1)
based on each##2##3##(2008-3#1)(2011-2#1)
based on effective##2##3##(2007-11#1)(2008-3#1)
based on efficient##2##3##(2007-12#2)
based on either a##2##4##(2008-10#1)(2012-3#1)
based on either##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
based on electrical##2##3##(2008-10#1)(2008-2#1)
based on electrochemical reduction##2##4##(2008-10#2)
based on electrochemical##3##3##(2008-10#3)
based on electrodeposition of nanometer-sized##2##5##(2008-10#2)
based on electron##2##3##(2008-10#1)(2010-4#1)
based on electropolymerized##4##3##(2008-10#4)
based on electrostatic interaction of natural polymers##2##7##(2008-10#2)
based on empirical##3##3##(2008-5#1)(2010-9#1)(2013-1#1)
based on entropy##2##3##(2007-12#1)(2008-7#1)
based on environmental##2##3##(2008-4#1)(2008-8#1)
based on enzymatic##2##3##(2008-10#1)(2008-6#1)
based on enzyme inhibition analysis##2##5##(2008-10#2)
based on enzyme##3##3##(2008-10#3)
based on ethylene##2##3##(1994-6#1)(2008-10#1)
based on evaluation of##3##4##(1992-12#1)(2008-10#1)(2013-8#1)
based on evidence from the published literature and panelists' own##2##10##(2010-12#2)
based on evidence from##3##4##(2010-12#2)(2011-2#1)
based on evidence##7##3##(2008-11#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-3#1)
based on exact##2##3##(1995-2#1)(2008-2#1)
based on excited-state##2##3##(2007-11#1)(2008-2#1)
based on experience##3##3##(2008-10#1)(2011-3#2)
based on experiences##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
based on experimental##4##3##(1994-12#1)(2008-7#2)(2009-5#1)
based on expert##2##3##(2010-6#1)(2011-10#1)
based on expression of##2##4##(1992-12#1)(2011-2#1)
based on extensive##4##3##(1991-9#1)(2008-10#1)(2008-6#1)(2013-1#1)
based on external##3##3##(2007-12#1)(2008-10#2)
based on extraction##2##3##(2008-10#2)
based on fatty acid##2##4##(2008-10#2)
based on feedback##2##3##(2008-12#1)(2008-6#1)
based on ferroelectric##2##3##(2008-3#2)
based on finite element##2##4##(2008-7#2)
based on finite##3##3##(2008-3#1)(2008-7#2)
based on fitting the##3##4##(2008-2#2)(2008-3#1)
based on fitting##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
based on five##2##3##(1997-1#1)(2008-10#1)
based on fixed##2##3##(2008-11#1)(2013-8#1)
based on flow##3##3##(2008-10#2)(2011-2#1)
based on fluorescence detection##2##4##(1990-8#1)(2008-10#1)
based on fluorescence quenching of##2##5##(2008-10#2)
based on fluorescence quenching##3##4##(2008-10#3)
based on fluorescence##10##3##(1990-8#1)(2008-1#1)(2008-10#7)(2008-3#1)
based on four##2##3##(1990-8#1)(2007-11#1)
based on four-wave mixing in microstructure fiber##2##7##(2007-11#2)
based on four-wave mixing in##3##5##(2007-11#3)
based on fourier##3##3##(2008-2#1)(2008-3#2)
based on fringe pattern matching##3##5##(2008-2#3)
based on fringe##5##3##(2008-2#3)(2008-3#2)
based on gel##2##3##(1993-8#1)(2008-8#1)
based on general##2##3##(2008-10#1)(2008-6#1)
based on genes##3##3##(2012-3#3)
based on genetic analysis of##2##5##(2008-10#2)
based on genetic evidence##2##4##(1997-6#1)(2011-2#1)
based on genetic##13##3##(1997-6#1)(2007-8#1)(2008-10#7)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
based on geometrical optics##2##4##(2008-3#2)
based on glyoxal bis(2-hydroxyanil)##2##4##(2008-10#2)
based on gold##2##3##(2008-10#2)
based on graphite paste (graphite powder and paraffin oil) has been constructed##2##12##(2008-10#2)
based on growth##2##3##(2008-10#1)(2008-9#1)
based on hierarchical##2##3##(2007-12#1)(2010-11#1)
based on high##2##3##(2008-10#2)
based on high-performance liquid chromatography##2##5##(1990-8#1)(2008-10#1)
based on high-resolution##2##3##(2008-3#1)(2012-2#1)
based on higher##2##3##(1992-2#1)(2013-8#1)
based on highly birefringent fibers##4##5##(2008-2#2)(2008-3#2)
based on highly##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
based on his##4##3##(1995-6#1)(1997-3#1)(2008-11#1)(2012-2#1)
based on histological examination##2##4##(2007-8#1)(2011-3#1)
based on histological##5##3##(2007-12#1)(2007-8#1)(2010-3#1)(2011-2#1)(2011-3#1)
based on histopathological##2##3##(2008-6#1)(2013-1#1)
based on historical##3##3##(1996-1#1)(2007-8#1)(2010-6#1)
based on history and##2##4##(2008-12#1)(2013-1#1)
based on host##3##3##(2008-10#3)
based on how##2##3##(1995-3#1)(2013-1#1)
based on hyphal##2##3##(2008-10#2)
based on immobilised##2##3##(2008-10#2)
based on immobilization of##2##4##(2008-10#2)
based on immobilized##7##3##(2008-10#7)
based on immunocytochemical detection##2##4##(2008-9#2)
based on in situ##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
based on in vitro##4##4##(2008-10#1)(2010-11#1)(2012-2#2)
based on in##8##3##(2008-10#3)(2008-2#1)(2008-9#1)(2010-11#1)(2012-2#2)
based on in-line##2##3##(2008-10#1)(2008-2#1)
based on incidence##3##3##(2008-10#3)
based on inclusion##2##3##(2008-10#1)(2012-12#1)
based on independent component analysis##2##5##(2008-10#1)(2009-11#1)
based on independent##3##3##(2008-10#1)(2009-11#2)
based on indirect##2##3##(2008-10#1)(2008-9#1)
based on individual##4##3##(1993-3#1)(1993-5#1)(2007-10#1)(2008-6#1)
based on information from##3##4##(1993-12#1)(1996-3#1)(2011-2#1)
based on information##6##3##(1993-12#1)(1995-12#1)(1996-3#1)(2008-12#1)(2010-8#1)(2011-2#1)
based on infrared##2##3##(2008-11#1)(2013-1#1)
based on integral photography##2##4##(2008-3#2)
based on integral##3##3##(2007-11#1)(2008-3#2)
based on integrated absorbance##2##4##(2008-10#2)
based on integrated##3##3##(2008-10#2)(2008-2#1)
based on interaction with##2##4##(2008-10#2)
based on interference##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
based on international##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
based on intracavity frequency doubling##2##5##(2007-11#2)
based on ion##3##3##(2008-10#3)
based on ion-pair complex##2##4##(2008-10#2)
based on its catalysis##2##4##(2008-10#2)
based on its catalytic effect on the oxidation of carminic acid by hydrogen peroxide##2##14##(2008-10#2)
based on its catalytic effect on the oxidation of carminic acid by##3##12##(2008-10#3)
based on its catalytic effect on the oxidation of##6##9##(2008-10#6)
based on its catalytic effect on the oxidation##7##8##(2008-10#7)
based on its catalytic effect on the##9##7##(2008-10#9)
based on its catalytic effect on##10##6##(2008-10#10)
based on its catalytic##12##4##(2008-10#12)
based on its complex##2##4##(2008-10#2)
based on its electrochemical##2##4##(2008-10#2)
based on its enhancing effect on the oxidation of Mn(II)##2##10##(2008-10#2)
based on its enhancing effect on the##3##7##(2008-10#3)
based on its inhibition##2##4##(2008-10#2)
based on its inhibitory effect on the##2##7##(2008-10#2)
based on its inhibitory effect on##3##6##(2008-10#3)
based on its interaction with##3##5##(2008-10#3)
based on its reaction with##4##5##(2008-10#4)
based on its##58##3##(1993-9#1)(1995-8#1)(2008-1#1)(2008-10#47)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-1#1)(2011-3#1)
based on knowledge##5##3##(1990-6#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
based on laser##5##3##(2007-12#1)(2008-10#2)(2009-5#1)(2011-2#1)
based on lead##2##3##(2008-10#2)
based on lesion type##2##4##(2008-10#2)
based on lesion##3##3##(2008-10#3)
based on levels of##2##4##(1994-2#1)(1995-6#1)
based on light##3##3##(2008-10#2)(2008-3#1)
based on limited##2##3##(2008-10#1)(2010-5#1)
based on line##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
based on linear##4##3##(2008-10#3)(2008-6#1)
based on linkage##2##3##(1994-2#1)(2008-10#1)
based on liquid chromatography##2##4##(2009-8#1)(2010-5#1)
based on liquid chromatography-tandem mass spectrometry (LC-MS/MS)##2##7##(2008-10#1)(2013-1#1)
based on liquid##7##3##(2007-12#1)(2008-10#2)(2009-8#1)(2010-5#2)(2013-1#1)
based on literature##2##3##(1990-6#1)(2008-8#1)
based on local##4##3##(1994-11#1)(1994-3#1)(1994-6#1)(2008-8#1)
based on low##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
based on low-coherence##2##3##(2007-11#1)(2007-12#1)
based on macrocyclic##3##3##(2008-10#3)
based on magnetic resonance imaging##2##5##(2012-3#1)(2013-1#1)
based on magnetic##4##3##(2008-12#1)(2008-2#1)(2012-3#1)(2013-1#1)
based on maltodextrins##3##3##(2008-10#3)
based on manganese##2##3##(2008-10#2)
based on mass spectrometry##2##4##(2008-10#1)(2010-5#1)
based on mass##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
based on material##2##3##(2007-11#1)(2013-8#1)
based on maximum likelihood##4##4##(2008-10#2)(2008-12#1)(2013-8#1)
based on measurement of##6##4##(1991-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)
based on measurement##7##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)
based on measurements of the##3##5##(1991-11#1)(2008-2#1)(2008-3#1)
based on measurements of##10##4##(1991-11#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)
based on measurements##13##3##(1991-11#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#6)
based on measuring the##3##4##(2007-12#1)(2008-10#1)(2011-3#1)
based on measuring##4##3##(2007-12#1)(2008-10#1)(2011-3#1)(2012-3#1)
based on mechanical##3##3##(2007-10#1)(2008-3#1)(2008-5#1)
based on medical##3##3##(1991-2#1)(1993-2#1)(1997-3#1)
based on meeting##2##3##(1994-3#1)(1997-2#1)
based on microscopic##2##3##(2008-10#1)(2008-3#1)
based on microwave digestion##2##4##(2008-10#2)
based on microwave##3##3##(2008-10#3)
based on miniaturized solid-state##2##4##(2008-10#2)
based on mitochondrial##6##3##(2008-10#2)(2010-3#1)(2011-2#1)(2013-8#2)
based on mixed##2##3##(2008-10#2)
based on mode##2##3##(2008-3#1)(2011-1#1)
based on molecular##6##3##(1995-3#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)
based on monitoring##2##3##(2007-6#1)(2008-10#1)
based on monthly##2##3##(2008-3#1)(2010-8#1)
based on morphology and##2##4##(2008-10#1)(2009-2#1)
based on morphology##6##3##(1996-6#1)(2008-10#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-3#1)
based on morphometric##2##3##(2007-11#1)(2008-7#1)
based on multicommutation##6##3##(2008-10#6)
based on multiple##3##3##(1996-3#1)(2008-3#1)(2012-3#1)
based on multiwavelength##2##3##(2008-2#1)(2008-3#1)
based on nanotubes##2##3##(2008-7#1)(2010-2#1)
based on national##2##3##(1994-12#1)(2012-2#1)
based on neural##3##3##(2008-3#1)(2008-9#1)(2010-8#1)
based on new##5##3##(1997-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
based on nickel##2##3##(2008-10#2)
based on nine##4##3##(2008-10#2)(2009-7#1)(2013-7#1)
based on nitrogen balance studies##2##5##(2013-8#2)
based on nonlinear##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
based on novel##2##3##(2008-10#1)(2010-11#1)
based on nuclear##2##3##(2008-10#1)(2008-9#1)
based on nucleic acid hybridization##2##5##(2008-10#2)
based on nucleotide##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
based on number theory##2##4##(2008-3#2)
based on numerical##2##3##(2007-12#1)(2008-3#1)
based on observation of the##2##5##(2007-11#1)(2008-11#1)
based on observations of##3##4##(1996-4#1)(2007-7#1)(2008-2#1)
based on observations##5##3##(1996-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)
based on observed##3##3##(1990-8#1)(2008-10#2)
based on only one##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
based on optical parametric##3##4##(2007-11#2)(2007-12#1)
based on optical##11##3##(2007-11#6)(2007-12#1)(2008-11#1)(2008-3#2)(2009-7#1)
based on orange##2##3##(2008-8#1)(2012-12#1)
based on our recent##2##4##(2008-7#1)(2009-8#1)
based on our##14##3##(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-8#1)(2013-8#1)
based on paraffin/graphite modified with sweet potato##2##7##(2008-10#2)
based on parametric##3##3##(2007-12#3)
based on partial##4##3##(1993-8#1)(2008-10#2)(2011-2#1)
based on patient##2##3##(1994-3#1)(2011-2#1)
based on peak##2##3##(2008-10#2)
based on percutaneous##2##3##(2006-10#1)(2009-11#1)
based on periodically poled KTiOPO(4)##2##5##(2007-11#1)(2007-12#1)
based on periodically poled KTiOPO4##2##5##(2008-3#2)
based on periodically poled lithium niobate##13##6##(2007-11#5)(2007-12#6)(2008-3#2)
based on periodically poled##19##4##(2007-11#6)(2007-12#9)(2008-3#4)
based on phase##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
based on phase-stepping imaging polarimetry##2##5##(2008-3#2)
based on photonic crystal##3##4##(2007-11#2)(2007-12#1)
based on physiological##2##3##(2008-10#1)(2008-7#1)
based on pi-coordinating##2##3##(2008-10#2)
based on plant##2##3##(2008-10#2)
based on polarization##2##3##(2007-11#2)
based on polyaniline##2##3##(2008-10#2)
based on population dynamics##2##4##(2008-10#1)(2013-7#1)
based on population##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
based on populations##2##3##(1990-8#1)(1994-3#1)
based on porous##2##3##(2008-10#2)
based on pre- and post-dialysis##2##5##(2008-1#2)
based on preoperative##2##3##(2012-2#1)(2013-1#1)
based on presumed##3##3##(2007-10#1)(2008-10#1)(2010-6#1)
based on previous##4##3##(2008-3#1)(2008-7#1)(2011-2#2)
based on previously##2##3##(2008-10#1)(2008-3#1)
based on principal component analysis (PCA)##2##6##(2008-10#1)(2011-2#1)
based on proteins##2##3##(1993-3#1)(2010-5#1)
based on psychological##2##3##(1995-6#1)(2009-7#1)
based on published data##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
based on published##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
based on qualitative##2##3##(2008-10#2)
based on quantitative##3##3##(2007-12#1)(2008-10#1)(2011-3#1)
based on radial artery perforators##2##5##(2008-9#2)
based on radiographic##2##3##(2007-11#1)(2008-5#1)
based on radiological##4##3##(2007-8#1)(2008-8#1)(2010-11#1)(2011-2#1)
based on rainbow refractometry##2##4##(2008-2#2)
based on random##3##3##(2008-10#2)(2008-3#1)
based on randomized##2##3##(2007-10#1)(2008-12#1)
based on ray tracing##2##4##(2008-2#1)(2008-3#1)
based on reaction##3##3##(2008-10#2)(2008-4#1)
based on real##2##3##(2011-2#1)(2013-1#1)
based on real-time##2##3##(2008-10#1)(2011-1#1)
based on recent clinical##3##4##(2008-9#2)(2011-1#1)
based on recent##8##3##(1996-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-1#1)
based on recovery studies##2##4##(2008-10#2)
based on redox reaction##2##4##(2008-10#2)
based on redox##4##3##(2008-10#4)
based on reflectance##3##3##(2008-10#2)(2008-3#1)
based on refractive-index differences##2##4##(2007-12#2)
based on relative##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
based on replicate analysis##2##4##(2008-10#2)
based on restriction##2##3##(1997-6#1)(2008-5#1)
based on results of##5##4##(2008-10#1)(2008-2#1)(2010-10#1)(2012-2#2)
based on results##8##3##(2008-10#3)(2008-2#1)(2010-10#2)(2012-2#2)
based on retrospective##2##3##(2008-7#1)(2011-1#1)
based on reviews of##2##4##(1994-6#1)(2010-5#1)
based on risk##2##3##(1997-1#1)(2012-1#1)
based on routine laboratory##2##4##(2010-8#1)(2011-2#1)
based on routine##3##3##(2008-4#1)(2010-8#1)(2011-2#1)
based on salicylate hydroxylase##2##4##(2008-10#2)
based on second-harmonic generation of##2##5##(2007-12#2)
based on second-harmonic generation##4##4##(2007-12#3)(2008-2#1)
based on second-order##2##3##(2008-2#2)
based on selection##2##3##(2008-2#1)(2012-2#1)
based on selective##4##3##(2008-10#4)
based on self-assembled monolayer##3##4##(2008-10#3)
based on self-assembled##4##3##(2008-10#4)
based on semiconductor##2##3##(2008-3#2)
based on separation of the##2##5##(2008-10#2)
based on separation of##3##4##(2008-10#3)
based on separation##4##3##(2008-10#4)
based on sequence analyses##2##4##(2008-10#2)
based on sequence##10##3##(1995-6#1)(1997-8#1)(2008-10#6)(2011-2#1)(2013-1#1)
based on sequences of the internal transcribed spacer##2##8##(2008-10#2)
based on sequences of the##4##5##(2008-10#3)(2011-2#1)
based on sequential injection analysis##2##5##(2008-10#2)
based on sequential##4##3##(2008-10#3)(2010-2#1)
based on serum##2##3##(2008-6#1)(2009-9#1)
based on several##6##3##(1990-5#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#1)
based on severity of##3##4##(1996-7#1)(2009-5#1)(2011-1#1)
based on severity##7##3##(1996-7#1)(2008-10#2)(2009-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
based on sex##2##3##(1991-12#1)(2008-8#1)
based on short##4##3##(2008-2#2)(2008-4#2)
based on signal##3##3##(1992-11#1)(2008-10#2)
based on silica##2##3##(2008-12#1)(2008-7#1)
based on simple aqueous standards##2##5##(2008-10#2)
based on simple##7##3##(2008-10#2)(2008-2#1)(2008-6#1)(2010-10#1)(2011-1#1)(2012-12#1)
based on simultaneous resolution of the overlapping bands in the whole set of absorption##2##14##(2008-10#2)
based on simultaneous##4##3##(1997-7#1)(2007-12#1)(2008-10#2)
based on single##2##3##(2008-10#1)(2008-11#1)
based on singular value decomposition##3##5##(2008-10#3)
based on size##2##3##(2008-10#1)(2012-12#1)
based on small numbers##2##4##(1993-12#1)(1994-6#1)
based on small##4##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-11#1)
based on soft##2##3##(2008-10#2)
based on soil temperature##2##4##(2008-10#2)
based on soil##3##3##(2008-10#3)
based on solid phase extraction##3##5##(2008-10#3)
based on solid phase##4##4##(2008-10#4)
based on solid##7##3##(1997-2#1)(2007-11#1)(2008-10#5)
based on solid-phase extraction##4##4##(2008-10#4)
based on solid-phase##7##3##(2008-10#7)
based on some##6##3##(1993-11#1)(2007-11#1)(2008-10#3)(2008-8#1)
based on sound##3##3##(2008-12#1)(2009-11#1)(2010-12#1)
based on spatial##2##3##(2008-2#2)
based on specific##2##3##(1993-1#1)(2013-8#1)
based on spectral##2##3##(2008-5#1)(2013-8#1)
based on spectrophotometric detection##2##4##(2008-10#2)
based on spectrophotometric measurement##2##4##(2008-10#2)
based on spectrophotometric##4##3##(2008-10#4)
based on standard##6##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)
based on statistical##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
based on stochastic##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
based on stomach##2##3##(1996-12#2)
based on stopped-flow##2##3##(2008-10#2)
based on studies##3##3##(2008-10#2)(2008-7#1)
based on studying the##2##4##(2008-10#1)(2011-2#1)
based on such##6##3##(1996-4#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-12#1)
based on supercritical##2##3##(2008-10#1)(2010-10#1)
based on surface plasmon resonance (SPR)##2##6##(2008-10#2)
based on surface plasmon resonance##5##5##(2008-10#5)
based on surface##9##3##(2007-11#1)(2008-10#7)(2008-3#1)
based on surface-plasmon resonance (SPR)##2##5##(2008-3#2)
based on surface-plasmon resonance##4##4##(2008-3#4)
based on surgical##2##3##(2008-8#1)(2010-7#1)
based on symptom severity##2##4##(2008-10#2)
based on symptoms##2##3##(2008-10#2)
based on synchronization of chaos in##2##6##(2007-11#2)
based on systematic##3##3##(2010-10#1)(2011-2#1)(2012-3#1)
based on temperature##3##3##(2008-10#3)
based on temporal##3##3##(1993-1#1)(2007-11#1)(2008-3#1)
based on tetrathia-12-crown-4##2##3##(2008-10#2)
based on that##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
based on the &quot##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
based on the Bragg##2##4##(2007-12#1)(2008-7#1)
based on the CL##5##4##(2008-10#5)
based on the DNA##2##4##(2008-10#1)(2008-12#1)
based on the Monte Carlo method##2##6##(1992-6#1)(2008-3#1)
based on the Monte Carlo##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
based on the N-terminal amino acid sequence of the##2##9##(2008-6#1)(2009-2#1)
based on the N-terminal amino acid##3##6##(1993-9#1)(2008-6#1)(2009-2#1)
based on the N-terminal##4##4##(1993-9#1)(1994-12#1)(2008-6#1)(2009-2#1)
based on the Talbot effect##2##5##(2007-11#1)(2008-3#1)
based on the Talbot##3##4##(2007-11#1)(2008-3#2)
based on the ability of a##3##6##(1991-12#1)(1995-2#1)(1995-5#1)
based on the ability of the##2##6##(2008-10#1)(2008-11#1)
based on the ability of##10##5##(1991-12#1)(1995-2#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#4)
based on the ability##12##4##(1991-12#1)(1995-2#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-6#1)(2012-1#1)
based on the above##4##4##(2008-10#2)(2008-2#1)(2012-2#1)
based on the acquisition of##2##5##(2008-10#1)(2008-8#1)
based on the adsorption of##4##5##(2008-10#4)
based on the adsorption##6##4##(2008-10#6)
based on the amino acid sequence##2##6##(1992-3#1)(1994-6#1)
based on the amino acid sequences of##2##7##(2007-6#1)(2008-10#1)
based on the amino acid##4##5##(1992-3#1)(1994-6#1)(2007-6#1)(2008-10#1)
based on the analysis of the##2##6##(2008-3#1)(2013-8#1)
based on the analysis of##8##5##(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-10#1)(2013-8#1)
based on the analytic hierarchy process##2##6##(2008-10#1)(2011-2#1)
based on the application of##6##5##(1993-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
based on the assumption of##2##5##(2008-10#2)
based on the assumption that the##4##6##(1992-6#1)(2008-2#1)(2008-3#1)(2008-9#1)
based on the assumption that##9##5##(1992-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
based on the assumption##11##4##(1992-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
based on the assumptions##2##4##(2008-2#1)(2013-7#1)
based on the availability of##2##5##(1994-12#1)(2009-8#1)
based on the available##4##4##(2007-4#1)(2008-11#1)(2008-4#1)(2012-2#1)
based on the average##3##4##(2008-10#1)(2008-2#2)
based on the best##2##4##(1996-2#1)(2008-9#1)
based on the binding of##2##5##(1990-12#1)(2008-3#1)
based on the bioluminescence inhibition of Vibrio fischeri##2##8##(2008-10#2)
based on the calculation of##2##5##(2008-10#2)
based on the calculation##3##4##(2008-10#3)
based on the catalytic effect of##16##6##(2008-10#16)
based on the catalytic##17##4##(2008-10#17)
based on the cathodic adsorptive stripping of##2##7##(2008-10#2)
based on the change in##2##5##(2008-10#1)(2008-3#1)
based on the changes in##3##5##(2008-10#2)(2008-6#1)
based on the characteristics of the##2##6##(2008-5#1)(2011-2#1)
based on the chemical##5##4##(2008-10#4)(2008-6#1)
based on the chemiluminescence (CL)##2##5##(2008-10#1)(2010-4#1)
based on the chemiluminescence reaction of##3##6##(2008-10#3)
based on the chemiluminescence##9##4##(2008-10#8)(2010-4#1)
based on the chromogenic reaction##2##5##(2008-10#2)
based on the clinical and##2##5##(2007-12#2)
based on the clinical##4##4##(2007-12#2)(2008-11#1)(2010-6#1)
based on the color##3##4##(2008-10#3)
based on the combination of##7##5##(2008-10#3)(2008-3#1)(2009-8#1)(2013-8#2)
based on the combined##4##4##(2008-10#3)(2008-2#1)
based on the common##2##4##(1996-3#1)(2012-3#1)
based on the comparison##2##4##(1996-3#1)(2008-10#1)
based on the competitive##4##4##(2008-10#4)
based on the complex formation##2##5##(2008-10#2)
based on the complex##4##4##(2008-10#3)(2008-3#1)
based on the complexation##5##4##(2008-10#5)
based on the concept of##12##5##(1997-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2011-2#1)(2012-12#1)(2013-1#1)
based on the concept##14##4##(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
based on the concepts of##2##5##(1996-1#1)(2008-3#1)
based on the contrast##2##4##(2007-12#1)(2008-3#1)
based on the conventional##2##4##(2007-12#1)(2008-2#1)
based on the coupling of a##2##6##(2008-10#2)
based on the coupling of##5##5##(2008-10#5)
based on the coupling##6##4##(2008-10#6)
based on the current##5##4##(2007-2#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)
based on the data##2##4##(1995-3#1)(2008-10#1)
based on the derivatization##3##4##(2008-10#3)
based on the detailed##2##4##(2007-5#1)(2008-3#1)
based on the detection of the##2##6##(1991-5#1)(2008-10#1)
based on the detection of##8##5##(1991-5#1)(2007-2#1)(2008-10#6)
based on the determination of##3##5##(1995-12#1)(2008-10#2)
based on the development of##4##5##(2008-10#3)(2008-5#1)
based on the difference between the##4##6##(2008-10#2)(2008-2#1)(2008-5#1)
based on the difference##7##4##(2008-10#5)(2008-2#1)(2008-5#1)
based on the different##3##4##(2008-10#2)(2008-5#1)
based on the differential##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)
based on the direct##7##4##(2008-10#6)(2008-3#1)
based on the dispersion of##2##5##(2008-10#1)(2008-2#1)
based on the dynamic##3##4##(2008-10#2)(2008-3#1)
based on the effective##3##4##(2008-10#2)(2008-3#1)
based on the electrostatic##2##4##(2008-10#1)(2012-6#1)
based on the employment of a##2##6##(2008-10#2)
based on the employment of##4##5##(2008-10#4)
based on the enhancement of##4##5##(2008-10#4)
based on the enzymatic##2##4##(2008-10#2)
based on the enzyme##2##4##(1995-2#1)(2008-10#1)
based on the evaluation of##3##5##(2008-10#3)
based on the evolution of CS(2)##2##6##(2008-10#2)
based on the experiences##2##4##(1995-5#1)(1997-1#1)
based on the experimental##3##4##(2008-10#2)(2008-3#1)
based on the fact that the##5##6##(1992-9#1)(2008-10#3)(2008-3#1)
based on the fact that##14##5##(1990-11#1)(1992-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-4#1)
based on the factors##2##4##(1992-2#1)(2013-1#1)
based on the fast##2##4##(2008-10#2)
based on the finding of##2##5##(1996-11#1)(2008-1#1)
based on the finding that the##2##6##(1995-6#1)(2008-10#1)
based on the finding that##3##5##(1995-6#1)(2008-10#1)(2009-10#1)
based on the finding##5##4##(1995-6#1)(1996-11#1)(2008-1#1)(2008-10#1)(2009-10#1)
based on the findings of a##2##6##(1996-3#1)(2007-2#1)
based on the findings of##3##5##(1996-3#1)(2007-2#1)(2010-3#1)
based on the findings##4##4##(1996-3#1)(2007-2#1)(2008-12#1)(2010-3#1)
based on the first##4##4##(1997-3#1)(2007-12#1)(2008-2#1)(2008-5#1)
based on the fluorescence enhancement of##2##6##(2008-10#2)
based on the fluorescence of##2##5##(2008-10#1)(2008-9#1)
based on the fluorescence quenching of a##2##7##(2008-10#2)
based on the fluorescence quenching of##5##6##(2008-10#5)
based on the fluorescence##15##4##(2008-10#13)(2008-2#1)(2008-9#1)
based on the following##7##4##(1990-9#1)(1991-6#1)(1996-12#1)(2008-10#3)(2013-1#1)
based on the formation of a 1##2##7##(2008-10#2)
based on the formation of a##11##6##(2008-10#11)
based on the formation of an##2##6##(2008-10#2)
based on the formation of the##4##6##(2008-10#4)
based on the formation of##32##5##(2008-10#31)(2010-5#1)
based on the formation##33##4##(2008-10#32)(2010-5#1)
based on the fractional##3##4##(2007-11#1)(2008-2#2)
based on the generalized##3##4##(1992-2#1)(2007-12#1)(2008-3#1)
based on the genetic##2##4##(2008-10#1)(2012-3#1)
based on the geometric##2##4##(2007-11#1)(2008-8#1)
based on the glucose##2##4##(2008-10#1)(2012-12#1)
based on the hypothesis that##3##5##(2008-11#1)(2009-8#1)(2010-8#1)
based on the idea of##2##5##(2007-12#1)(2008-3#1)
based on the idea##3##4##(2007-12#1)(2008-3#1)(2009-5#1)
based on the immobilization##2##4##(2008-10#2)
based on the in vitro##3##5##(2008-10#1)(2010-3#2)
based on the incorporation of##2##5##(2007-11#1)(2008-10#1)
based on the individual##2##4##(1996-5#1)(2008-9#1)
based on the induction of##2##5##(1991-6#1)(2008-4#1)
based on the information##2##4##(2006-10#1)(2009-5#1)
based on the inhibition of##2##5##(2008-10#1)(2008-3#1)
based on the inhibition##5##4##(2008-10#4)(2008-3#1)
based on the inhibitory effect of##2##6##(2008-10#2)
based on the inhibitory effect##3##5##(1990-12#1)(2008-10#2)
based on the integration of##3##5##(2008-10#3)
based on the integration##4##4##(2008-10#3)(2008-3#1)
based on the intensity##2##4##(2008-2#1)(2008-3#1)
based on the interaction between##2##5##(2008-1#1)(2008-10#1)
based on the interaction of##6##5##(2008-10#5)(2008-3#1)
based on the interaction##9##4##(2008-1#1)(2008-10#7)(2008-3#1)
based on the interference of##2##5##(2007-12#1)(2008-2#1)
based on the internal##2##4##(2008-10#1)(2008-2#1)
based on the interpretation of##2##5##(1994-11#1)(2009-6#1)
based on the ion-pair complex##2##5##(2008-10#2)
based on the ion-pair##3##4##(2008-10#3)
based on the knowledge of the##2##6##(2008-10#1)(2008-5#1)
based on the known##2##4##(1996-12#1)(2013-1#1)
based on the lack of##2##5##(1993-12#1)(2009-8#1)
based on the level of##2##5##(2008-10#2)
based on the light##2##4##(1990-8#1)(2008-2#1)
based on the linear##3##4##(1995-9#1)(2007-11#1)(2008-10#1)
based on the linear-no-threshold##2##4##(2008-12#1)(2012-2#1)
based on the literature and the##2##6##(2007-11#1)(2008-5#1)
based on the literature and##3##5##(2007-11#2)(2008-5#1)
based on the magnitude of##2##5##(1994-5#1)(2008-3#1)
based on the maximum likelihood##2##5##(2008-6#2)
based on the maximum##3##4##(2008-6#2)(2012-3#1)
based on the mean##4##4##(2008-10#3)(2008-2#1)
based on the measured##5##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-7#1)
based on the measurement of the##6##6##(2008-10#5)(2008-3#1)
based on the measurement of##13##5##(1997-4#1)(2008-10#8)(2008-3#2)(2008-9#2)
based on the method of##2##5##(2008-10#1)(2008-5#1)
based on the method##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
based on the minimization of##2##5##(2008-2#1)(2008-3#1)
based on the model of##2##5##(2008-10#1)(2008-7#1)
based on the model##3##4##(1996-12#1)(2008-10#1)(2008-7#1)
based on the modification of##3##5##(2008-10#2)(2009-12#1)
based on the modified##2##4##(2008-3#2)
based on the modulation of##2##5##(2007-11#1)(2009-8#1)
based on the more##2##4##(1997-4#1)(2008-10#1)
based on the nonlinear##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
based on the nucleotide##2##4##(2007-6#1)(2008-10#1)
based on the number of##2##5##(2008-10#2)
based on the observation of##2##5##(2007-11#1)(2007-8#1)
based on the observation that##2##5##(2008-4#1)(2008-6#1)
based on the observation##4##4##(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)
based on the observed##2##4##(1994-5#1)(1995-12#1)
based on the obtained##2##4##(2008-10#1)(2013-8#1)
based on the optical##4##4##(2008-3#4)
based on the oxidation of the##2##6##(2008-10#2)
based on the oxidation of##15##5##(2008-10#15)
based on the oxidation##18##4##(2008-10#18)
based on the patient##2##4##(1993-2#1)(2010-8#1)
based on the photoelastic effect##2##5##(2008-3#2)
based on the photorefractive##2##4##(2007-12#1)(2008-2#1)
based on the polymerase chain reaction (PCR)##2##7##(2008-10#2)
based on the premise that##3##5##(2008-11#1)(2008-9#1)(2013-1#1)
based on the presence of##10##5##(1990-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
based on the presence or absence of an##2##8##(2008-10#1)(2008-12#1)
based on the presence or absence of##5##7##(2008-10#3)(2008-12#1)(2010-7#1)
based on the presence##16##4##(1990-5#1)(1990-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-8#1)(2010-7#1)
based on the principle of##6##5##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-12#1)
based on the principle##7##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-12#1)
based on the principles of##2##5##(1996-12#1)(2008-10#1)
based on the product##2##4##(1991-5#1)(1997-3#1)
based on the proportion of##2##5##(2008-10#2)
based on the proposed##5##4##(1993-8#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-1#1)
based on the quantitative##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
based on the rapid reaction of##2##6##(2008-10#2)
based on the rapid##4##4##(2008-10#4)
based on the ratio of##2##5##(1996-4#1)(2008-10#1)
based on the reaction among##2##5##(2008-10#2)
based on the reaction between##13##5##(2008-10#13)
based on the reaction of these##3##6##(2008-10#3)
based on the reaction of##24##5##(2008-10#24)
based on the reaction with##2##5##(2008-10#2)
based on the reaction##42##4##(2008-10#42)
based on the recently developed##2##5##(2007-12#1)(2013-8#1)
based on the recently##4##4##(2007-12#1)(2008-5#1)(2009-10#1)(2013-8#1)
based on the reduction of the##3##6##(2008-10#3)
based on the reduction of##7##5##(2008-10#7)
based on the relationship##2##4##(2008-10#1)(2008-3#1)
based on the relative##2##4##(1992-9#1)(2008-12#1)
based on the requirements##2##4##(2008-11#1)(2008-3#1)
based on the research##2##4##(1992-2#1)(2008-3#1)
based on the results obtained##3##5##(2008-10#2)(2010-5#1)
based on the results of a##2##6##(2008-1#1)(2009-10#1)
based on the results of this investigation##3##7##(2008-10#3)
based on the results of this##5##6##(1995-1#1)(2008-10#3)(2011-2#1)
based on the results of##11##5##(1995-1#2)(2008-1#1)(2008-10#4)(2008-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
based on the results##14##4##(1995-1#2)(2008-1#1)(2008-10#6)(2008-3#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
based on the reversible##2##4##(2008-10#2)
based on the review of##2##5##(2008-4#1)(2013-1#1)
based on the same##10##4##(1992-10#1)(2008-10#8)(2011-2#1)
based on the scalar##2##4##(2007-11#1)(2008-3#1)
based on the selective##2##4##(1990-12#1)(1991-9#1)
based on the sensitizing effect of##2##6##(2008-10#2)
based on the separation of##2##5##(2008-10#2)
based on the separation##4##4##(2008-10#4)
based on the sequence data of the##2##7##(2008-10#2)
based on the sequence of the##3##6##(2008-10#1)(2008-4#2)
based on the sequence of##6##5##(1992-9#1)(2008-10#2)(2008-4#2)(2010-4#1)
based on the sequence##9##4##(1992-9#1)(2008-10#5)(2008-4#2)(2010-4#1)
based on the sequential injection##2##5##(2008-10#2)
based on the sequential##4##4##(2008-10#3)(2008-12#1)
based on the signal-to-noise ratio of 3##2##7##(2008-10#2)
based on the signal-to-noise ratio of##3##6##(2008-10#2)(2008-3#1)
based on the simultaneous##6##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)
based on the size##2##4##(2007-12#1)(2013-8#1)
based on the standard##2##4##(2007-12#1)(2008-3#1)
based on the study of##4##5##(2008-10#2)(2008-7#1)(2010-8#1)
based on the surface##2##4##(1995-12#1)(2008-10#1)
based on the technique described##2##5##(1996-12#1)(2008-2#1)
based on the theory of##5##5##(2007-12#1)(2008-10#1)(2008-7#1)(2013-8#2)
based on the theory##6##4##(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#2)
based on the time##2##4##(1997-8#1)(2008-3#1)
based on the treatment of##2##5##(1992-6#1)(2008-10#1)
based on the two##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
based on the type of##2##5##(2008-4#1)(2008-7#1)
based on the typical##2##4##(2008-6#1)(2012-3#1)
based on the unique##3##4##(1991-12#1)(2007-11#1)(2010-1#1)
based on the use of a##4##6##(2008-10#3)(2008-11#1)
based on the use of an##3##6##(2008-2#1)(2011-1#1)(2013-1#1)
based on the use of the peroxyoxalate##2##7##(2008-10#2)
based on the use of the##9##6##(1995-5#1)(2008-10#6)(2008-2#1)(2010-5#1)
based on the use of##55##5##(1990-12#2)(1995-5#2)(2007-11#1)(2008-10#30)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
based on the variable##2##4##(2007-11#2)
based on the viability##2##4##(2008-10#1)(2008-5#1)
based on the view##2##4##(2008-11#2)
based on the##1463##3##(1990-11#1)(1990-12#9)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#6)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#10)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#3)(1997-1#2)(1997-2#2)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#41)(2007-12#38)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#3)(2008-1#7)(2008-10#653)(2008-11#29)(2008-12#12)(2008-2#62)(2008-3#145)(2008-4#23)(2008-5#21)(2008-6#17)(2008-7#20)(2008-8#17)(2008-9#16)(2009-10#8)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#12)(2011-1#10)(2011-2#19)(2011-3#2)(2012-1#3)(2012-12#8)(2012-2#18)(2012-3#11)(2012-6#1)(2013-1#23)(2013-7#3)(2013-8#16)
based on their Zn##2##4##(2008-10#2)
based on their ability to##2##5##(2010-12#1)(2013-1#1)
based on their condensation reactions with##2##6##(2008-10#2)
based on their different##2##4##(2008-10#1)(2009-5#1)
based on their near-infrared##2##4##(2007-12#1)(2008-10#1)
based on their reaction with##2##5##(2008-10#2)
based on their reaction##3##4##(1994-6#1)(2008-10#2)
based on their##63##3##(1994-3#1)(1994-6#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#25)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
based on them##2##3##(2008-10#1)(2010-9#1)
based on therapeutic##2##3##(2007-8#1)(2013-1#1)
based on thermodynamic##2##3##(2008-10#1)(2013-1#1)
based on these results##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
based on these##17##3##(1992-9#1)(1993-3#1)(1994-12#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#4)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
based on thin-film##2##3##(2007-11#1)(2008-2#1)
based on this principle##2##4##(2008-2#1)(2008-3#1)
based on this##19##3##(1991-7#1)(1992-12#1)(1994-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)
based on those##3##3##(1995-6#1)(2008-1#1)(2008-11#1)
based on three##7##3##(1996-11#1)(2008-10#4)(2008-11#1)(2008-3#1)
based on time-resolved##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
based on traditional##3##3##(1993-9#1)(2008-10#2)
based on transgenic##2##3##(2010-9#1)(2011-2#1)
based on transverse##3##3##(2007-12#2)(2008-3#1)
based on two parameters##2##4##(1995-12#1)(2010-8#1)
based on two##17##3##(1990-8#1)(1991-6#1)(1995-12#1)(1996-9#1)(1997-6#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-8#1)
based on two-dimensional##4##3##(1991-8#1)(2008-2#1)(2008-3#1)(2011-1#1)
based on two-photon fluorescence##2##4##(2007-11#2)
based on two-photon##5##3##(1992-8#1)(2007-11#2)(2007-12#2)
based on tyrosinase-modified##2##3##(2008-10#2)
based on urease immobilized##2##4##(2008-10#2)
based on urease##3##3##(2008-10#3)
based on use of##2##4##(2008-3#1)(2008-6#1)
based on using##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
based on various##3##3##(1997-2#1)(2008-10#1)(2008-6#1)
based on virulence##2##3##(2008-10#2)
based on visual assessment of##2##5##(2008-10#1)(2008-11#1)
based on visual##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
based on wavelength-division multiplexing##2##4##(2008-3#2)
based on wheat##2##3##(2008-10#2)
based on which the##2##4##(2008-10#2)
based on which##3##3##(2008-10#2)(2013-8#1)
based on##4779##2##(1990-10#1)(1990-11#5)(1990-12#14)(1990-2#1)(1990-5#7)(1990-6#8)(1990-7#1)(1990-8#15)(1990-9#6)(1991-1#4)(1991-11#2)(1991-12#10)(1991-2#7)(1991-3#4)(1991-4#2)(1991-5#6)(1991-6#9)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#6)(1992-2#12)(1992-3#4)(1992-4#5)(1992-5#3)(1992-6#9)(1992-8#4)(1992-9#9)(1993-1#2)(1993-11#6)(1993-12#12)(1993-2#8)(1993-3#11)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#5)(1994-1#1)(1994-11#5)(1994-12#17)(1994-2#10)(1994-3#9)(1994-5#5)(1994-6#10)(1994-8#3)(1994-9#9)(1995-1#4)(1995-12#9)(1995-2#16)(1995-3#11)(1995-4#1)(1995-5#10)(1995-6#14)(1995-8#2)(1995-9#7)(1996-1#9)(1996-11#3)(1996-12#27)(1996-2#10)(1996-3#10)(1996-4#5)(1996-5#2)(1996-6#7)(1996-7#2)(1996-9#3)(1997-1#7)(1997-2#10)(1997-3#25)(1997-4#6)(1997-5#5)(1997-6#12)(1997-7#7)(1997-8#6)(2006-10#4)(2006-12#1)(2006-7#1)(2007-10#15)(2007-11#183)(2007-12#178)(2007-2#6)(2007-4#3)(2007-5#3)(2007-6#6)(2007-7#6)(2007-8#20)(2008-1#33)(2008-10#1759)(2008-11#95)(2008-12#49)(2008-2#220)(2008-3#456)(2008-4#55)(2008-5#82)(2008-6#45)(2008-7#94)(2008-8#76)(2008-9#66)(2009-10#14)(2009-11#14)(2009-12#7)(2009-2#5)(2009-3#8)(2009-4#2)(2009-5#20)(2009-6#9)(2009-7#13)(2009-8#23)(2009-9#13)(2010-1#6)(2010-10#19)(2010-11#12)(2010-12#12)(2010-2#5)(2010-3#15)(2010-4#15)(2010-5#27)(2010-6#10)(2010-7#10)(2010-8#33)(2010-9#6)(2011-1#38)(2011-10#1)(2011-2#112)(2011-3#16)(2011-9#1)(2012-1#18)(2012-12#31)(2012-2#63)(2012-3#55)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#96)(2013-7#6)(2013-8#61)
based only on the##3##4##(1991-3#1)(2007-6#1)(2008-10#1)
based only on##12##3##(1991-3#2)(1994-8#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
based optical##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
based organizations with##2##3##(2008-7#2)
based polymeric##3##2##(2008-10#2)(2012-2#1)
based practice##9##2##(2008-11#7)(2008-12#1)(2010-7#1)
based primarily on the##2##4##(1995-12#1)(2008-9#1)
based primarily on##10##3##(1991-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1995-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)
based primarily##11##2##(1991-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-6#1)(1995-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)
based real-time##2##2##(2008-10#1)(2012-3#1)
based research##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
based screening##3##2##(2008-10#1)(2008-11#2)
based sensor##5##2##(2008-10#4)(2008-7#1)
based sensors##2##2##(2008-10#2)
based service##3##2##(1990-3#1)(1993-12#2)
based solely on the##2##4##(1996-2#1)(2008-8#1)
based solely on##11##3##(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-9#1)
based specifically on##2##3##(1993-3#1)(2008-6#1)
based studies##5##2##(2008-1#1)(2008-10#1)(2013-1#3)
based study of##2##3##(1997-5#1)(2007-7#1)
based study was##3##3##(2012-3#1)(2013-1#2)
based study##8##2##(1996-11#1)(1997-5#1)(2007-7#1)(2008-12#1)(2012-3#2)(2013-1#2)
based system for##2##3##(2008-10#1)(2008-11#1)
based system##9##2##(2008-10#3)(2008-11#1)(2009-10#4)(2010-12#1)
based teaching##2##2##(2008-12#1)(2008-7#1)
based techniques##2##2##(2008-7#1)(2010-4#1)
based test##2##2##(2007-7#1)(2012-3#1)
based their##3##2##(1994-3#1)(1997-2#1)(2009-9#1)
based tools##2##2##(2008-12#1)(2008-5#1)
based upon a##4##3##(2008-10#2)(2008-9#1)(2011-1#1)
based upon an##2##3##(1991-11#1)(2009-12#1)
based upon binding of##2##4##(2008-1#1)(2008-11#1)
based upon clinical##3##3##(2007-11#1)(2007-2#1)(2008-12#1)
based upon findings##2##3##(1991-11#1)(1992-4#1)
based upon its enhancing effect on the CL reaction of luminol with hydrogen peroxide##2##14##(2008-10#2)
based upon its##4##3##(1992-6#1)(2008-10#3)
based upon the use of##2##5##(2008-7#1)(2011-1#1)
based upon the##38##3##(1990-12#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
based upon their##7##3##(1991-7#1)(1992-8#1)(1996-2#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-5#1)
based upon this##2##3##(1992-6#1)(2011-2#1)
based upon##112##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#3)(2008-12#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#5)(2009-12#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
based vector##2##2##(1990-12#1)(1997-4#1)
based##5452##1##(1990-10#1)(1990-11#6)(1990-12#18)(1990-2#1)(1990-3#1)(1990-5#7)(1990-6#10)(1990-7#1)(1990-8#19)(1990-9#6)(1991-1#7)(1991-11#4)(1991-12#11)(1991-2#11)(1991-3#13)(1991-4#2)(1991-5#7)(1991-6#9)(1991-7#3)(1991-8#5)(1991-9#5)(1992-1#2)(1992-10#3)(1992-11#6)(1992-12#9)(1992-2#14)(1992-3#7)(1992-4#7)(1992-5#3)(1992-6#12)(1992-8#5)(1992-9#9)(1993-1#3)(1993-11#6)(1993-12#20)(1993-2#10)(1993-3#14)(1993-5#2)(1993-6#4)(1993-8#3)(1993-9#5)(1994-1#2)(1994-11#7)(1994-12#20)(1994-2#11)(1994-3#12)(1994-5#6)(1994-6#10)(1994-8#4)(1994-9#9)(1995-1#4)(1995-11#1)(1995-12#10)(1995-2#18)(1995-3#13)(1995-4#1)(1995-5#11)(1995-6#16)(1995-8#2)(1995-9#9)(1996-1#11)(1996-11#4)(1996-12#28)(1996-2#13)(1996-3#15)(1996-4#5)(1996-5#5)(1996-6#8)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#9)(1997-2#11)(1997-3#29)(1997-4#8)(1997-5#7)(1997-6#16)(1997-7#11)(1997-8#8)(2006-10#4)(2006-12#1)(2006-7#1)(2007-10#17)(2007-11#193)(2007-12#184)(2007-2#7)(2007-4#3)(2007-5#5)(2007-6#8)(2007-7#12)(2007-8#23)(2007-9#1)(2008-1#43)(2008-10#1911)(2008-11#138)(2008-12#78)(2008-2#226)(2008-3#468)(2008-4#64)(2008-5#95)(2008-6#52)(2008-7#116)(2008-8#91)(2008-9#84)(2009-1#1)(2009-10#18)(2009-11#17)(2009-12#9)(2009-2#5)(2009-3#11)(2009-4#4)(2009-5#26)(2009-6#9)(2009-7#18)(2009-8#25)(2009-9#16)(2010-1#7)(2010-10#21)(2010-11#18)(2010-12#15)(2010-2#11)(2010-3#20)(2010-4#18)(2010-5#32)(2010-6#10)(2010-7#14)(2010-8#38)(2010-9#8)(2011-1#50)(2011-10#1)(2011-2#131)(2011-3#18)(2011-9#1)(2012-1#21)(2012-12#41)(2012-2#77)(2012-3#67)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#116)(2013-7#7)(2013-8#72)
baseline Hb##2##2##(2008-7#2)
baseline aerobic fitness level##2##4##(2013-8#2)
baseline and after##6##3##(2006-12#1)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#1)
baseline and follow-up##2##3##(2007-10#1)(2008-3#1)
baseline and the##2##3##(2008-10#1)(2008-7#1)
baseline and##45##2##(1991-1#1)(1992-9#1)(1993-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(2006-12#1)(2007-10#3)(2007-8#1)(2008-10#5)(2008-3#5)(2008-5#2)(2008-7#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#6)(2013-8#2)
baseline at##6##2##(1990-7#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
baseline before##2##2##(2007-8#1)(2012-3#1)
baseline by##4##2##(1991-5#1)(2008-3#1)(2011-2#2)
baseline characteristics##2##2##(2008-6#1)(2011-1#1)
baseline conditions##2##2##(2008-4#1)(2013-8#1)
baseline correction##3##2##(2008-10#2)(2008-2#1)
baseline data for##2##3##(2008-10#1)(2013-1#1)
baseline data of##2##3##(2008-3#1)(2009-9#1)
baseline data on the##4##4##(1992-2#1)(2007-10#1)(2007-7#1)(2008-1#1)
baseline data on##5##3##(1992-2#1)(2007-10#1)(2007-7#1)(2008-1#2)
baseline data##19##2##(1991-12#1)(1992-2#1)(1993-1#1)(1995-6#1)(1997-4#2)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2009-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
baseline depressive symptoms##2##3##(2008-8#1)(2009-7#1)
baseline differences##2##2##(2008-11#1)(2008-12#1)
baseline disability##2##2##(2012-12#2)
baseline drift##7##2##(2008-10#7)
baseline effects##2##2##(2008-10#1)(2009-12#1)
baseline established between##5##3##(2008-10#5)
baseline factors##3##2##(2008-7#1)(2008-9#1)(2009-8#1)
baseline for##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
baseline from##3##2##(2008-10#2)(2008-12#1)
baseline heart rate##2##3##(1990-9#1)(2013-1#1)
baseline hemoglobin A1c##2##3##(2012-5#2)
baseline in all##2##3##(2010-7#1)(2011-2#1)
baseline in the##2##3##(2008-7#1)(2013-1#1)
baseline in##11##2##(1995-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
baseline information on##2##3##(2009-4#1)(2013-1#1)
baseline information##4##2##(2008-1#1)(2008-11#1)(2009-4#1)(2013-1#1)
baseline knowledge##2##2##(2009-4#1)(2012-3#1)
baseline level##4##2##(1995-12#1)(1995-5#1)(2007-10#1)(2008-10#1)
baseline levels of##3##3##(2008-11#1)(2009-7#2)
baseline levels##10##2##(1990-10#1)(1991-12#1)(1994-6#1)(1996-7#1)(1997-4#1)(2008-11#1)(2009-7#2)(2012-2#1)(2013-1#1)
baseline measures of##2##3##(2010-10#1)(2012-1#1)
baseline measures##4##2##(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)
baseline microflora##2##2##(2008-5#2)
baseline of##9##2##(1992-10#1)(1992-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#3)(2013-1#1)
baseline patient and injury characteristics##2##5##(2008-9#2)
baseline performance was##2##3##(2008-9#1)(2012-3#1)
baseline performance##4##2##(1993-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
baseline peritoneal##3##2##(2011-2#3)
baseline recordings##2##2##(1995-12#1)(1996-6#1)
baseline resolution of##3##3##(2008-10#2)(2008-4#1)
baseline resolution##6##2##(2008-10#5)(2008-4#1)
baseline results##2##2##(2008-11#1)(2010-3#1)
baseline risk of##2##3##(2008-11#2)
baseline risk##4##2##(2008-11#3)(2008-7#1)
baseline score##2##2##(2008-6#1)(2008-7#1)
baseline separation of a##2##4##(2008-10#2)
baseline separation of##6##3##(2008-10#5)(2011-1#1)
baseline separation with##3##3##(2008-10#3)
baseline separation##11##2##(2008-10#10)(2011-1#1)
baseline separations of##2##3##(2008-10#1)(2011-1#1)
baseline service use##2##3##(2012-3#2)
baseline startle##3##2##(2008-11#3)
baseline studies##2##2##(2008-7#1)(2011-2#1)
baseline testing##5##2##(1992-11#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-3#1)
baseline than##3##2##(2013-1#1)(2013-8#2)
baseline to##8##2##(2008-1#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
baseline value##2##2##(1990-11#1)(2007-12#1)
baseline values in##2##3##(2007-10#1)(2013-1#1)
baseline values##8##2##(1992-11#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-7#1)(2013-1#2)(2013-8#1)
baseline was significantly##2##3##(2011-2#1)(2013-1#1)
baseline was##7##2##(1995-11#1)(2008-10#1)(2011-2#2)(2013-1#3)
baseline weight##2##2##(2008-3#1)(2009-12#1)
baseline with##2##2##(2007-11#1)(2011-2#1)
baseline##462##1##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-5#2)(1991-9#2)(1992-10#1)(1992-11#4)(1992-2#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-12#4)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#5)(1995-12#5)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#5)(1997-8#3)(2006-12#1)(2007-10#10)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#11)(2008-10#76)(2008-11#15)(2008-12#7)(2008-2#3)(2008-3#21)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#26)(2008-8#3)(2008-9#9)(2009-12#4)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#34)(2012-1#5)(2012-12#8)(2012-2#8)(2012-3#16)(2012-4#1)(2012-5#2)(2013-1#44)(2013-7#1)(2013-8#14)
baseline&quot##2##1##(1990-3#1)(2009-12#1)
baseline) in the##2##3##(2008-10#1)(2013-1#1)
baseline) in##3##2##(1993-1#1)(2008-10#1)(2013-1#1)
baseline)##8##1##(1991-9#1)(1993-1#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
baselines by##2##2##(2008-2#2)
baselines##5##1##(1992-1#1)(2008-2#2)(2009-12#1)(2013-8#1)
basement membrane and##5##3##(1992-12#1)(1992-9#2)(2009-10#1)(2013-8#1)
basement membrane components##4##3##(1990-12#1)(1993-2#1)(2008-11#1)(2008-4#1)
basement membrane in##2##3##(2008-1#1)(2008-11#1)
basement membrane is##2##3##(2008-11#1)(2009-10#1)
basement membrane##47##2##(1990-12#1)(1992-12#3)(1992-3#1)(1992-9#4)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-6#1)(1997-4#1)(2007-7#2)(2008-1#2)(2008-11#7)(2008-4#2)(2008-7#3)(2009-10#5)(2010-9#1)(2011-2#3)(2012-2#2)(2013-8#2)
basement membranes##6##2##(1992-11#1)(1992-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2012-3#1)
basement##55##1##(1990-12#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-9#5)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-6#1)(1997-4#2)(2007-12#1)(2007-7#2)(2008-1#2)(2008-11#8)(2008-4#2)(2008-7#3)(2009-10#6)(2010-9#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#2)
basement-membrane permeability##2##2##(1992-9#2)
bases and of##3##3##(1996-2#2)(2008-10#1)
bases and sugars##3##3##(2008-10#1)(2009-7#2)
bases and the##3##3##(1990-6#1)(1991-9#1)(2008-10#1)
bases and##20##2##(1990-6#1)(1991-9#1)(1996-12#1)(1996-2#2)(2007-11#1)(2008-10#7)(2009-7#2)(2010-4#1)(2011-1#2)(2013-7#2)
bases are##3##2##(1993-11#1)(1993-12#1)(1994-12#1)
bases for the##3##3##(2008-4#2)(2008-7#1)
bases for##14##2##(1991-12#1)(1993-10#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
bases from the##2##3##(1997-2#2)
bases from##4##2##(1994-2#1)(1997-2#2)(2008-10#1)
bases in the##3##3##(1993-11#1)(1994-5#1)(2012-2#1)
bases in##12##2##(1990-5#2)(1992-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(1996-6#1)(2008-4#2)(2009-12#2)(2012-2#1)
bases is##2##2##(1994-12#1)(2013-1#1)
bases of the##5##3##(1990-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)
bases of##30##2##(1990-11#1)(1991-5#1)(1993-12#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
bases on the##2##3##(2008-10#1)(2008-5#1)
bases on##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
bases that##2##2##(2008-10#2)
bases to##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
bases upstream from##2##3##(1992-10#1)(1995-6#1)
bases upstream##3##2##(1990-12#1)(1992-10#1)(1995-6#1)
bases were used##2##3##(1993-3#1)(2008-10#1)
bases were##7##2##(1993-3#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-3#1)
bases which##2##2##(2007-12#1)(2009-12#1)
bases with a##2##3##(1991-9#1)(1994-8#1)
bases with the##3##3##(1996-2#2)(2008-11#1)
bases with##6##2##(1991-9#1)(1994-8#1)(1995-2#1)(1996-2#2)(2008-11#1)
bases##186##1##(1990-11#1)(1990-12#2)(1990-5#4)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#5)(1996-5#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#43)(2008-11#3)(2008-2#6)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-12#3)(2009-2#1)(2009-7#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#2)
bases)##5##1##(1992-10#1)(1996-12#1)(1997-6#1)(2008-8#1)(2008-9#1)
bases]##2##1##(1990-3#1)(1994-5#1)
basic (bFGF) fibroblast growth##2##4##(1991-12#1)(2008-7#1)
basic CPR##2##2##(2013-1#2)
basic FGF##4##2##(1991-2#4)
basic age##2##2##(2011-2#1)(2013-8#1)
basic amino acid at##2##4##(1991-9#1)(2008-4#1)
basic amino acid residues##2##4##(1995-6#1)(1995-8#1)
basic amino acid##5##3##(1991-9#1)(1993-5#1)(1995-6#1)(1995-8#1)(2008-4#1)
basic amino acid-rich region##2##4##(1992-8#2)
basic amino acids##3##3##(1991-9#2)(1994-8#1)
basic amino##10##2##(1991-9#3)(1992-8#2)(1993-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-4#1)
basic amphipathic##3##2##(1990-2#3)
basic and alternate protocols##3##4##(2008-2#1)(2008-4#2)
basic and applied research##2##4##(2008-10#1)(2008-11#1)
basic and clinical science##2##4##(2008-5#1)(2008-7#1)
basic and clinical##10##3##(1994-12#1)(1997-8#1)(2008-5#2)(2008-7#1)(2008-9#3)(2012-12#1)(2013-8#1)
basic and##23##2##(1990-11#1)(1994-12#2)(1994-6#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#4)(2010-8#1)(2012-12#1)(2013-8#1)
basic anion exchange resin##2##4##(2008-10#2)
basic anion##3##2##(2008-10#3)
basic approaches##2##2##(2008-4#2)
basic aspects of the##2##4##(1996-2#1)(2007-12#1)
basic aspects of##6##3##(1996-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)
basic aspects##7##2##(1996-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)
basic assumptions##4##2##(2007-12#1)(2008-6#1)(2008-7#1)(2010-9#1)
basic beta-1##2##2##(1997-6#1)(2008-10#1)
basic beta-crystallins##2##2##(1991-6#2)
basic biological##5##2##(1992-3#1)(2008-10#2)(2011-2#1)(2012-2#1)
basic building block##2##3##(2008-2#1)(2008-3#1)
basic calponin gene and the gene product were##2##8##(2008-6#2)
basic calponin##6##2##(2008-6#6)
basic cardiopulmonary##2##2##(2013-1#2)
basic categories##2##2##(2009-9#1)(2012-2#1)
basic cell##3##2##(1994-9#1)(2008-2#1)(2008-3#1)
basic cellular processes##2##3##(1991-9#1)(2012-2#1)
basic cellular##3##2##(1991-9#1)(2008-3#1)(2012-2#1)
basic change##2##2##(1993-2#1)(1994-2#1)
basic changes##2##2##(1993-2#1)(2008-10#1)
basic characteristics of##2##3##(1991-1#1)(2008-8#1)
basic characteristics##3##2##(1991-1#1)(2008-11#1)(2008-8#1)
basic component##2##2##(2008-10#1)(2011-2#1)
basic components of##2##3##(1996-12#1)(2013-1#1)
basic components##5##2##(1996-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2013-1#1)
basic compounds##3##2##(2008-10#3)
basic concept##2##2##(2010-8#1)(2012-3#1)
basic concepts and##3##3##(1993-12#1)(2007-11#1)(2008-11#1)
basic concepts of##5##3##(1993-3#1)(1994-3#1)(2008-12#1)(2008-9#1)(2011-2#1)
basic concepts##13##2##(1990-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
basic conditions and##2##3##(1990-5#1)(2008-10#1)
basic conditions##5##2##(1990-5#1)(2008-10#2)(2008-4#1)(2012-2#1)
basic data##2##2##(2008-7#2)
basic descriptive##3##2##(1991-12#1)(1993-12#1)(2010-9#1)
basic drugs##3##2##(1990-8#1)(1995-6#1)(1997-2#1)
basic ecological##2##2##(2007-7#1)(2008-10#1)
basic factors##2##2##(2007-10#1)(2011-2#1)
basic fetoprotein##2##2##(1991-8#2)
basic fibroblast growth factor (bFGF) and##3##6##(1991-12#1)(1995-12#1)(2008-11#1)
basic fibroblast growth factor (bFGF)##6##5##(1991-12#1)(1992-3#1)(1995-12#2)(1997-6#1)(2008-11#1)
basic fibroblast growth factor and##2##5##(1997-6#1)(2008-7#1)
basic fibroblast growth factor in##4##5##(1990-5#1)(1992-3#1)(1995-12#1)(2013-1#1)
basic fibroblast growth factor##29##4##(1990-5#1)(1991-12#1)(1991-2#4)(1992-3#2)(1992-9#1)(1994-6#3)(1995-11#2)(1995-12#4)(1996-12#1)(1997-6#2)(2008-11#5)(2008-5#1)(2008-7#1)(2013-1#1)
basic fibroblast growth##31##3##(1990-12#2)(1990-5#1)(1991-12#1)(1991-2#4)(1992-3#2)(1992-9#1)(1994-6#3)(1995-11#2)(1995-12#4)(1996-12#1)(1997-6#2)(2008-11#5)(2008-5#1)(2008-7#1)(2013-1#1)
basic findings##2##2##(1994-1#1)(2011-1#1)
basic health area]##2##3##(1993-10#1)(1996-9#1)
basic health care##4##3##(1992-2#1)(1994-12#1)(1997-5#1)(2010-4#1)
basic health insurance##2##3##(2008-7#2)
basic health##11##2##(1992-2#1)(1993-10#1)(1994-12#1)(1996-1#1)(1996-9#1)(1997-5#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-12#1)
basic helix-loop-helix transcription factor##2##4##(1994-8#1)(2010-11#1)
basic helix-loop-helix transcription factors##2##4##(1996-2#1)(2011-2#1)
basic helix-loop-helix transcription##4##3##(1994-8#1)(1996-2#1)(2010-11#1)(2011-2#1)
basic helix-loop-helix##5##2##(1994-8#2)(1996-2#1)(2010-11#1)(2011-2#1)
basic human##3##2##(1993-12#1)(2010-12#1)(2011-2#1)
basic idea##6##2##(1997-2#1)(2008-10#1)(2008-3#3)(2012-3#1)
basic information about##4##3##(1990-3#1)(1997-7#1)(2008-1#1)(2010-5#1)
basic information regarding##2##3##(2008-10#1)(2010-5#1)
basic information##13##2##(1990-12#1)(1990-3#1)(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2010-5#2)
basic issues##2##2##(2009-11#1)(2012-3#1)
basic knowledge of their##2##4##(1990-3#1)(2010-7#1)
basic knowledge of##4##3##(1990-3#1)(1994-11#1)(2008-10#1)(2010-7#1)
basic knowledge##8##2##(1990-3#1)(1994-11#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
basic laparoscopic skills##4##3##(2010-3#3)(2012-3#1)
basic life support##2##3##(2008-11#2)
basic life##3##2##(2008-11#2)(2008-8#1)
basic mechanisms of##7##3##(2006-10#1)(2006-12#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-1#1)
basic mechanisms##13##2##(1994-11#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-7#1)
basic media##4##2##(2008-10#4)
basic medium##7##2##(2008-10#7)
basic metabolism##2##2##(2008-7#1)(2010-10#1)
basic methodology##3##2##(2008-10#1)(2008-4#2)
basic methods of##4##3##(1996-12#1)(1996-3#1)(2008-1#1)(2008-2#1)
basic methods##7##2##(1996-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
basic molecular research##2##3##(1997-3#2)
basic molecular##6##2##(1997-3#2)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
basic motor##2##2##(1997-2#1)(2007-11#1)
basic need##2##2##(1996-3#1)(2008-5#1)
basic needs##4##2##(1992-3#2)(2007-8#1)(2012-12#1)
basic nursing##4##2##(2010-3#2)(2012-3#1)(2013-8#1)
basic operating principles of##2##4##(2008-10#1)(2008-3#1)
basic optical##2##2##(2008-2#1)(2008-3#1)
basic pH and##2##3##(2008-10#2)
basic pH##7##2##(2008-10#6)(2010-4#1)
basic parameters##2##2##(2007-12#1)(2008-3#1)
basic peptides##2##2##(1990-2#2)
basic performance of the##2##4##(2007-12#1)(2008-10#1)
basic performance of##3##3##(2007-12#1)(2008-10#2)
basic performance##5##2##(2007-12#1)(2008-10#4)
basic phenotyping##2##2##(2008-4#1)(2008-9#1)
basic phospholipase A2 from##2##4##(2008-8#2)
basic polypeptide##2##2##(1990-5#1)(1994-2#1)
basic principle in##2##3##(1992-1#1)(1997-6#1)
basic principle##7##2##(1992-1#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2009-2#1)
basic principles and##3##3##(1995-6#1)(2011-1#1)(2012-1#1)
basic principles of the##4##4##(1994-5#1)(2008-9#2)(2011-7#1)
basic principles of##16##3##(1992-2#1)(1994-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-9#3)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-7#1)
basic principles##22##2##(1992-2#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-9#3)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2013-1#1)
basic problem is##2##3##(2008-3#1)(2012-2#1)
basic problems of##2##3##(1990-8#1)(2010-1#1)
basic problems##5##2##(1990-8#1)(2007-12#1)(2008-3#1)(2010-1#1)(2012-3#1)
basic procedure for##4##3##(1995-8#1)(2008-2#1)(2008-4#2)
basic procedure##5##2##(1990-12#1)(1995-8#1)(2008-2#1)(2008-4#2)
basic procedures##4##2##(2008-2#1)(2008-4#2)(2008-7#1)
basic properties of##4##3##(1992-3#1)(1997-8#1)(2008-2#1)(2010-9#1)
basic properties##6##2##(1992-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
basic protein (MBP)##3##3##(1995-12#1)(1996-5#1)(2008-8#1)
basic protein HPI1##2##3##(1990-7#2)
basic protein and##2##3##(2007-11#1)(2012-3#1)
basic protein promoter##3##3##(1996-12#1)(1997-4#2)
basic protein##18##2##(1990-10#1)(1990-7#2)(1992-12#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#3)(2007-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
basic proteins##5##2##(1990-7#1)(1993-6#1)(2008-10#2)(2008-9#1)
basic protocol describes how to##2##5##(2008-4#2)
basic protocol describes the##5##4##(2008-1#1)(2008-4#3)(2008-9#1)
basic protocol describes##12##3##(2008-1#1)(2008-4#10)(2008-9#1)
basic protocol details##2##3##(2008-4#2)
basic protocol for##5##3##(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)
basic protocol is##6##3##(2008-1#1)(2008-4#5)
basic protocol##39##2##(2008-1#3)(2008-2#1)(2008-4#32)(2008-9#3)
basic protocols are##2##3##(2008-4#2)
basic protocols for##4##3##(2008-4#2)(2008-9#2)
basic protocols##13##2##(2008-4#9)(2008-9#4)
basic questions##2##2##(2012-2#1)(2012-3#1)
basic region##5##2##(1993-2#1)(1995-8#2)(2008-10#1)(2009-8#1)
basic reproductive number##8##3##(2008-10#6)(2008-8#1)(2013-8#1)
basic requirement##2##2##(2007-11#1)(2008-11#1)
basic research and##2##3##(2008-11#1)(2008-5#1)
basic research in##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
basic research on biological agents##2##5##(1992-12#2)
basic research on##5##3##(1992-12#2)(1997-8#1)(2008-10#1)(2008-6#1)
basic research to##2##3##(1991-9#1)(1997-4#1)
basic research##28##2##(1991-12#2)(1991-9#1)(1992-12#2)(1995-3#1)(1997-4#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
basic residue##3##2##(1995-6#1)(1996-7#1)(2009-8#1)
basic residues in the##2##4##(1995-6#2)
basic residues##8##2##(1993-11#1)(1994-6#2)(1995-3#1)(1995-6#3)(2008-7#1)
basic science research and##2##4##(2007-12#1)(2008-4#1)
basic science research##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2012-1#1)
basic science##11##2##(1994-3#1)(1994-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-3#1)(2012-1#1)(2012-3#1)
basic sciences##2##2##(1994-12#1)(1997-7#1)
basic scientific##3##2##(2008-7#1)(2011-2#1)(2011-7#1)
basic scientists##3##2##(1992-1#1)(2007-12#1)(2008-9#1)
basic sequence##2##2##(2007-12#1)(2008-7#1)
basic setup##2##2##(2008-2#1)(2010-12#1)
basic solution##3##2##(2008-10#3)
basic solutions##4##2##(1997-4#1)(2008-10#3)
basic stages##2##2##(2008-10#1)(2008-4#1)
basic steps##2##2##(2008-4#1)(2008-9#1)
basic structural features##2##3##(1992-12#1)(2013-1#1)
basic structural##4##2##(1992-12#2)(2009-8#1)(2013-1#1)
basic structure of the##2##4##(1994-12#1)(2008-10#1)
basic structure##4##2##(1994-12#2)(2008-10#1)(2010-8#1)
basic study##2##2##(2008-8#1)(2009-9#1)
basic surgical##2##2##(2007-11#1)(2009-5#1)
basic tail##2##2##(1995-3#2)
basic taste qualities##2##3##(2013-1#2)
basic tenet of##2##3##(1993-12#1)(2010-10#1)
basic treatment##3##2##(1993-2#1)(2007-11#1)(2007-8#1)
basic types of##2##3##(1997-2#1)(2008-2#1)
basic understanding of##5##3##(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
basic understanding##6##2##(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
basic vocal##2##2##(2008-9#2)
basic##871##1##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#3)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#4)(1991-1#1)(1991-12#11)(1991-2#9)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#5)(1992-1#4)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#7)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#8)(1993-2#6)(1993-3#3)(1993-5#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#4)(1994-12#9)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#7)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#5)(1995-12#6)(1995-3#5)(1995-5#1)(1995-6#10)(1995-8#4)(1996-1#2)(1996-12#9)(1996-2#6)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#5)(1997-4#6)(1997-5#1)(1997-6#7)(1997-7#5)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#10)(2007-12#23)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#7)(2008-1#14)(2008-10#95)(2008-11#27)(2008-12#10)(2008-2#29)(2008-3#29)(2008-4#76)(2008-5#18)(2008-6#11)(2008-7#25)(2008-8#17)(2008-9#42)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#11)(2011-2#21)(2011-7#2)(2012-1#5)(2012-12#9)(2012-2#11)(2012-3#13)(2013-1#23)(2013-7#1)(2013-8#5)
basically consists of##2##3##(2007-7#1)(2010-12#1)
basically in##2##2##(2008-10#2)
basically the##3##2##(2007-12#1)(2010-10#1)(2011-1#1)
basically##32##1##(1990-11#1)(1990-2#1)(1991-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
basicity and##3##2##(1990-8#1)(2008-10#2)
basicity of the##3##3##(1997-7#1)(2008-10#2)
basicity of##4##2##(1997-7#1)(2008-10#3)
basicity##10##1##(1990-8#1)(1997-7#1)(2008-10#8)
basicola alone##2##2##(2008-10#2)
basicola and##3##2##(2008-10#3)
basicola to##4##2##(2008-10#4)
basicola utilized##2##2##(2008-10#2)
basicola was##2##2##(2008-10#2)
basicola##31##1##(2008-10#31)
basiconica##6##1##(2007-12#6)
basics of##11##2##(1995-3#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
basics##16##1##(1991-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
basidiocarps##3##1##(1997-2#1)(2008-10#1)(2008-11#1)
basidiomata##4##1##(2013-7#4)
basidiomycete fungus##2##2##(1993-12#1)(2010-7#1)
basidiomycete##11##1##(1991-11#1)(1993-12#1)(1994-11#1)(2008-10#3)(2008-6#2)(2010-7#1)(2013-1#2)
basidiomycetes##8##1##(2008-10#3)(2008-6#1)(2011-1#1)(2013-1#3)
basidiospore##6##1##(2008-10#6)
basidiospores were observed to cause infection on##2##7##(2008-10#2)
basidiospores##10##1##(2008-10#10)
basil (Ocimum##2##2##(2008-10#1)(2012-12#1)
basil and##3##2##(2008-10#2)(2008-5#1)
basil oil##9##2##(2008-5#9)
basil oils were##2##3##(2008-5#2)
basil oils##5##2##(2008-5#5)
basil##23##1##(2008-10#6)(2008-5#16)(2012-12#1)
basil)##3##1##(2008-5#3)
basilar artery occlusion treated with local thrombolysis##2##7##(2007-10#2)
basilar artery occlusion##7##3##(2007-10#5)(2008-8#2)
basilar artery thrombosis##2##3##(2012-12#2)
basilar artery##25##2##(1996-6#1)(1997-6#3)(2007-10#6)(2008-4#2)(2008-7#2)(2008-8#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#2)
basilar skull fracture##2##3##(2008-11#1)(2008-12#1)
basilar tip aneurysm##6##3##(1997-6#3)(2008-7#2)(2012-12#1)
basilar tip##7##2##(1997-6#3)(2008-7#3)(2012-12#1)
basilar trunk aneurysms##2##3##(2008-7#2)
basilar##43##1##(1996-6#1)(1997-3#1)(1997-6#6)(2007-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#9)(2008-8#3)(2008-9#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
basilar-membrane##2##1##(2008-1#1)(2009-5#1)
basilensis HMF14##5##2##(2011-1#5)
basilic vein transposition##3##3##(2007-7#2)(2008-1#1)
basilic##4##1##(2007-7#2)(2008-1#1)(2013-8#1)
basilici##4##1##(2008-10#4)
basilicum##4##1##(2008-5#1)(2010-5#2)(2012-12#1)
basin and its##2##3##(2008-11#1)(2008-12#1)
basin and##4##2##(2008-11#1)(2008-12#1)(2009-12#1)(2010-8#1)
basin of##7##2##(1990-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)
basin##35##1##(1990-8#2)(1993-6#1)(1996-4#1)(1996-6#1)(1997-5#5)(2007-5#1)(2008-10#7)(2008-11#5)(2008-12#4)(2008-5#2)(2009-12#1)(2009-5#1)(2010-8#3)(2013-7#1)
basing on##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
basing##5##1##(2008-10#2)(2008-12#1)(2009-10#1)(2011-2#1)
basins##8##1##(1996-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#2)(2013-7#1)
basis a##4##2##(1992-5#1)(1994-2#1)(2008-10#1)(2011-2#1)
basis alone##2##2##(2008-10#1)(2008-3#1)
basis and the##2##3##(2008-3#1)(2008-4#1)
basis and##16##2##(1990-8#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
basis are##2##2##(1993-12#1)(1995-12#1)
basis as##3##2##(2008-6#1)(2008-9#1)(2012-3#1)
basis for a new##3##4##(2008-10#1)(2008-2#1)(2009-6#1)
basis for a##15##3##(1990-2#1)(1991-6#1)(1995-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
basis for designing##2##3##(2008-11#1)(2012-2#1)
basis for determining##2##3##(1991-12#1)(1996-4#1)
basis for developing a##2##4##(2007-12#1)(2008-8#1)
basis for developing##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
basis for discussion##4##3##(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)
basis for further##4##3##(2007-11#1)(2008-4#1)(2009-7#1)(2010-7#1)
basis for future research##2##4##(2008-10#1)(2008-5#1)
basis for future##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
basis for one##2##3##(1992-3#1)(2008-12#1)
basis for our##2##3##(2008-3#1)(2013-1#1)
basis for selection of an##2##5##(1992-3#1)(2008-2#1)
basis for such##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
basis for targeted##2##3##(2008-11#1)(2010-4#1)
basis for the characterization of##2##5##(2009-7#1)(2010-6#1)
basis for the development of##6##5##(1994-2#1)(1996-1#1)(2008-11#1)(2009-5#1)(2010-12#1)(2012-1#1)
basis for the##59##3##(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1993-11#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-5#1)(2009-7#2)(2010-12#3)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
basis for their##4##3##(1991-2#1)(2008-10#1)(2008-12#1)(2010-3#1)
basis for these##4##3##(1994-8#1)(1995-2#1)(1997-7#1)(2007-10#1)
basis for this##15##3##(1992-9#1)(1994-11#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-1#1)
basis for treatment##2##3##(1997-4#1)(2008-9#1)
basis for two##2##3##(1990-8#1)(2008-4#1)
basis for understanding the##2##4##(2008-8#1)(2010-12#1)
basis for understanding##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)
basis for##272##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2007-10#2)(2007-11#1)(2007-12#7)(2007-7#1)(2008-1#1)(2008-10#22)(2008-11#12)(2008-12#4)(2008-2#11)(2008-3#11)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#17)(2008-8#11)(2008-9#10)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-12#6)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#6)(2013-7#2)(2013-8#8)
basis from the##2##3##(2008-11#1)(2008-4#1)
basis from##4##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
basis function##10##2##(2008-10#7)(2008-2#1)(2008-6#1)(2010-1#1)
basis functions##3##2##(2008-11#1)(2008-6#2)
basis in a##2##3##(1995-3#1)(2008-7#1)
basis in the##5##3##(1993-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
basis in##13##2##(1992-1#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)
basis is##4##2##(1994-11#1)(2008-1#1)(2008-6#1)(2010-3#1)
basis of a case##2##4##(1993-6#1)(1994-11#1)
basis of a##47##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#2)
basis of changes in##2##4##(2008-7#1)(2008-8#1)
basis of complex##2##3##(1992-3#1)(2008-10#1)
basis of differences##4##3##(2008-10#2)(2010-1#1)(2013-1#1)
basis of experimental##5##3##(1995-11#2)(2008-10#1)(2008-2#2)
basis of familial##2##3##(2007-7#1)(2008-4#1)
basis of functional##2##3##(2008-9#1)(2013-8#1)
basis of heat##2##3##(1990-10#1)(2008-7#1)
basis of inherited##3##3##(2008-4#1)(2008-5#1)(2009-5#1)
basis of its##9##3##(1992-12#1)(1992-9#1)(1993-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)
basis of learning and memory##3##5##(2007-12#1)(2007-8#1)(2009-8#1)
basis of our##10##3##(1991-2#1)(1992-12#1)(1995-12#1)(1996-11#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
basis of sequence##3##3##(1990-12#1)(1995-8#1)(1996-6#1)
basis of the##155##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#5)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#3)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(2007-11#7)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#36)(2008-11#5)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#5)
basis of these differences##2##4##(1993-12#1)(2008-10#1)
basis of these studies##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
basis of these##36##3##(1991-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2012-1#3)(2013-1#1)
basis of this##30##3##(1990-6#1)(1991-2#1)(1993-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
basis of##727##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#4)(1990-5#8)(1990-6#7)(1990-7#4)(1990-8#7)(1990-9#6)(1991-1#1)(1991-12#2)(1991-2#6)(1991-3#7)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#4)(1992-5#6)(1992-6#4)(1992-7#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#5)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#2)(2006-10#3)(2007-10#1)(2007-11#13)(2007-12#10)(2007-4#1)(2007-7#4)(2007-8#13)(2008-1#10)(2008-10#123)(2008-11#23)(2008-12#3)(2008-2#27)(2008-3#49)(2008-4#15)(2008-5#18)(2008-6#7)(2008-7#19)(2008-8#24)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#4)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#15)(2011-3#3)(2012-1#5)(2012-12#4)(2012-2#7)(2012-3#10)(2013-1#21)(2013-7#1)(2013-8#6)
basis on##3##2##(1997-2#1)(2008-12#1)(2009-2#1)
basis set that##2##3##(2007-12#1)(2008-2#1)
basis set##7##2##(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#2)(2013-8#1)
basis that##4##2##(1997-1#1)(1997-8#1)(2008-1#1)(2008-5#1)
basis the##2##2##(2008-7#1)(2012-1#1)
basis to##11##2##(1991-12#1)(1993-12#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)
basis underlying##4##2##(2008-11#1)(2009-12#1)(2012-2#1)(2012-3#1)
basis with a##2##3##(2008-10#1)(2013-1#1)
basis with##3##2##(2008-10#1)(2010-2#1)(2013-1#1)
basis##1269##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#7)(1990-5#9)(1990-6#7)(1990-7#4)(1990-8#10)(1990-9#7)(1991-1#2)(1991-11#2)(1991-12#7)(1991-2#8)(1991-3#7)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#5)(1992-1#4)(1992-10#2)(1992-11#6)(1992-12#8)(1992-2#3)(1992-3#11)(1992-4#1)(1992-5#7)(1992-6#6)(1992-7#1)(1992-9#6)(1993-1#1)(1993-11#6)(1993-12#15)(1993-2#3)(1993-3#3)(1993-6#4)(1993-8#6)(1993-9#8)(1994-1#1)(1994-11#8)(1994-12#4)(1994-2#5)(1994-3#6)(1994-5#8)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#14)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#7)(1995-6#6)(1995-8#7)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#9)(1996-2#15)(1996-3#7)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#11)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#4)(1997-9#2)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#19)(2007-12#20)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#13)(2008-1#16)(2008-10#173)(2008-11#48)(2008-12#12)(2008-2#50)(2008-3#70)(2008-4#29)(2008-5#25)(2008-6#17)(2008-7#48)(2008-8#43)(2008-9#36)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#5)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#10)(2010-4#5)(2010-5#5)(2010-6#5)(2010-7#4)(2010-8#5)(2011-1#12)(2011-2#28)(2011-3#4)(2011-9#1)(2012-1#8)(2012-12#8)(2012-2#16)(2012-3#22)(2013-1#33)(2013-7#3)(2013-8#17)
basis)##4##1##(2008-10#3)(2008-4#1)
basiscopic##2##1##(2008-5#2)
basitarsi of##2##2##(2007-12#2)
basitarsus##6##1##(2007-12#6)
basket##9##1##(1992-1#2)(1993-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
basolateral amygdala##11##2##(1990-5#1)(1993-12#2)(1993-6#4)(1995-12#2)(1997-7#1)(2008-7#1)
basolateral and##2##2##(2007-12#1)(2008-11#1)
basolateral membrane of the##2##4##(1990-2#1)(1992-5#1)
basolateral membrane of##3##3##(1990-2#1)(1992-5#1)(1994-3#1)
basolateral membrane##8##2##(1990-2#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-6#1)(2008-11#2)(2008-8#1)
basolateral membranes from dog kidney##2##5##(1993-3#2)
basolateral membranes with##2##3##(1993-3#2)
basolateral membranes##10##2##(1990-11#1)(1990-5#1)(1993-3#6)(1993-6#1)(2012-2#1)
basolateral surface##2##2##(2008-1#2)
basolateral##48##1##(1990-11#1)(1990-2#1)(1990-5#3)(1991-12#2)(1991-5#1)(1992-5#1)(1993-12#2)(1993-3#7)(1993-6#5)(1994-12#1)(1994-3#1)(1994-6#3)(1995-12#2)(1997-7#1)(2007-12#1)(2008-1#2)(2008-11#7)(2008-7#2)(2008-8#3)(2012-12#1)(2012-2#1)
basonuclin gene##4##2##(2008-9#4)
basonuclin##9##1##(2008-9#9)
basophil activation test##2##3##(2012-3#2)
basophil counts##5##2##(2008-12#1)(2011-1#4)
basophil##9##1##(2008-12#1)(2008-4#1)(2011-1#5)(2012-3#2)
basophilic and eosinophilic differentiation in##2##5##(2008-11#2)
basophilic cells##5##2##(2008-11#1)(2008-7#4)
basophilic##17##1##(1990-5#2)(1990-8#2)(1993-3#2)(2007-12#1)(2008-11#4)(2008-3#1)(2008-7#5)
basophils and##2##2##(2008-11#1)(2008-4#1)
basophils are##2##2##(2008-4#2)
basophils##11##1##(2008-11#5)(2008-4#5)(2008-6#1)
basses##2##1##(2008-10#1)(2009-10#1)
bassiana##4##1##(2008-6#4)
basteri##4##1##(2007-12#4)
bat immunology##2##2##(2013-1#2)
bat##15##1##(2007-12#2)(2008-12#1)(2008-5#5)(2009-8#2)(2011-2#2)(2013-1#3)
batangensis##2##1##(2008-10#2)
batatas (L##4##2##(2008-10#3)(2011-2#1)
batch and FI##2##3##(2008-10#2)
batch and column techniques##3##4##(2008-10#3)
batch and column##6##3##(2008-10#6)
batch and fed-batch culture##2##4##(2008-11#2)
batch and fed-batch cultures##4##4##(2008-11#4)
batch and fed-batch hydrolysis##2##4##(2011-2#2)
batch and fed-batch##13##3##(2008-11#8)(2008-7#2)(2011-2#3)
batch and flow injection (FI)##2##5##(2008-10#2)
batch and flow injection##3##4##(2008-10#3)
batch and flow##4##3##(2008-10#4)
batch and perfusion cultures##2##4##(2008-11#2)
batch and##40##2##(1994-5#2)(2008-10#17)(2008-11#11)(2008-12#1)(2008-6#3)(2008-7#3)(2011-2#3)
batch components##3##2##(2011-2#3)
batch cultivation of##2##3##(2008-7#2)
batch cultivation##8##2##(1996-7#1)(2008-11#2)(2008-6#2)(2008-7#3)
batch culture and##4##3##(2008-11#3)(2012-2#1)
batch culture of infected##2##4##(2008-11#2)
batch culture of##6##3##(1994-8#1)(2008-11#2)(2008-6#1)(2008-7#2)
batch culture to##2##3##(2008-11#2)
batch culture##42##2##(1994-8#3)(2008-11#31)(2008-6#1)(2008-7#6)(2012-2#1)
batch cultures of##5##3##(1996-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
batch cultures##27##2##(1994-5#1)(1995-9#1)(1996-7#1)(2008-11#18)(2008-6#2)(2008-7#2)(2008-8#1)(2012-3#1)
batch equilibrium##6##2##(1997-2#3)(2008-10#3)
batch experiments##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
batch fecundity and##2##3##(2010-8#2)
batch fecundity estimates##2##3##(2010-8#2)
batch fecundity##6##2##(2010-8#6)
batch fermentation##7##2##(2008-11#1)(2008-6#3)(2008-7#3)
batch fermentations were##2##3##(2008-6#1)(2008-7#1)
batch fermentations##8##2##(2008-11#1)(2008-6#3)(2008-7#3)(2012-3#1)
batch in##2##2##(1994-5#1)(2008-7#1)
batch injection analysis (BIA)##4##4##(2008-10#4)
batch injection analysis##8##3##(2008-10#8)
batch method and##3##3##(2008-10#3)
batch method##11##2##(2008-10#10)(2008-4#1)
batch mode of##2##3##(2008-10#2)
batch mode##10##2##(2008-10#7)(2008-11#1)(2008-7#2)
batch of##10##2##(2008-10#5)(2008-4#1)(2011-2#1)(2013-8#3)
batch operating mode##3##3##(2008-11#3)
batch or##6##2##(2008-10#1)(2008-11#5)
batch phase/medium composition##2##3##(2008-11#2)
batch procedure##5##2##(1994-5#1)(2008-10#4)
batch process##4##2##(2008-11#1)(2008-6#1)(2008-7#2)
batch reactor##2##2##(2008-6#1)(2008-7#1)
batch studies##3##2##(2008-10#3)
batch suspension##2##2##(2008-11#2)
batch system##4##2##(2008-10#4)
batch##289##1##(1994-11#1)(1994-5#7)(1994-8#3)(1995-9#1)(1996-7#2)(1997-2#4)(2008-10#92)(2008-11#86)(2008-12#1)(2008-3#2)(2008-4#4)(2008-6#19)(2008-7#34)(2008-8#1)(2009-6#1)(2010-4#2)(2010-8#7)(2011-1#1)(2011-2#12)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
batch-spawning##2##1##(2010-8#2)
batch-type##2##1##(2008-10#1)(2008-11#1)
batchculture##4##1##(2008-11#4)
batches (B1##2##2##(2008-11#2)
batches of an##2##3##(2008-11#1)(2011-2#1)
batches of the##3##3##(2010-2#2)(2011-2#1)
batches of##16##2##(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2010-2#3)(2010-3#2)(2011-2#2)(2013-7#1)
batches were##3##2##(2010-3#1)(2011-1#1)(2013-1#1)
batches with a##2##3##(2008-11#1)(2008-7#1)
batches##41##1##(1994-5#1)(2008-10#10)(2008-11#9)(2008-5#3)(2008-7#1)(2008-9#1)(2010-2#3)(2010-3#3)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
batchwise##10##1##(2008-10#9)(2008-6#1)
bath and##4##2##(2008-10#4)
bath application##2##2##(1995-12#1)(1995-2#1)
bath or##3##2##(1993-12#1)(2007-11#1)(2008-8#1)
bath the##2##2##(2007-12#1)(2008-3#1)
bath##54##1##(1992-11#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-5#3)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#24)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#2)
bathed in##2##2##(2008-6#1)(2009-8#1)
bathed##4##1##(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
bathers##2##1##(1992-11#2)
bathing beaches##2##2##(2007-5#2)
bathing in polluted water##2##4##(2008-10#2)
bathing in##4##2##(1992-2#1)(2008-10#3)
bathing is##2##2##(2007-10#1)(2008-10#1)
bathing solution##3##2##(1994-12#1)(1994-6#1)(2008-10#1)
bathing##21##1##(1992-2#1)(1992-8#1)(1994-12#1)(1994-6#2)(2007-10#2)(2007-2#1)(2007-5#3)(2008-10#5)(2008-7#4)(2011-2#1)
bathochromic shift##3##2##(1997-7#1)(2008-10#1)(2009-9#1)
bathochromic shifts##2##2##(1996-5#1)(2008-10#1)
bathochromic##7##1##(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-9#1)
bathocuproine##3##1##(1995-11#1)(2008-10#2)
bathophenanthroline-ferrous as##2##2##(2008-10#2)
baths##9##1##(1992-11#1)(1995-5#1)(2007-10#1)(2008-10#4)(2010-3#1)(2010-8#1)
bathymetric##5##1##(2008-2#1)(2008-3#3)(2010-8#1)
bathymetry##6##1##(2007-5#3)(2008-2#2)(2008-3#1)
bats are##2##2##(2009-8#1)(2013-1#1)
bats have##2##2##(2013-1#2)
bats##26##1##(1994-11#2)(2007-12#2)(2007-5#4)(2008-12#1)(2008-5#1)(2009-8#6)(2013-1#10)
battered children##2##2##(1995-5#2)
battered women##4##2##(2009-5#2)(2010-3#2)
battered##15##1##(1993-2#1)(1995-5#8)(2009-5#2)(2010-3#4)
batterers in##2##2##(2009-5#2)
batterers##5##1##(2009-5#5)
batterie##2##1##(2008-10#2)
batteries and##2##2##(1992-2#1)(2007-8#1)
batteries##14##1##(1992-2#2)(1996-12#3)(2007-8#1)(2008-10#3)(2008-7#3)(2010-9#1)(2012-3#1)
battering##7##1##(1995-5#1)(2009-5#3)(2010-3#3)
battery cell in the cricopharynx of a toddler##2##8##(2012-2#2)
battery cell was##2##3##(2012-2#2)
battery cell##5##2##(2012-2#5)
battery electrolyte##2##2##(2008-10#2)
battery in##2##2##(1996-12#1)(1996-5#1)
battery of test##2##3##(2008-2#1)(2012-2#1)
battery of tests##5##3##(1990-3#2)(2008-10#1)(2008-9#2)
battery of##14##2##(1990-12#1)(1990-3#3)(1990-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-10#2)(2012-2#1)
battery##48##1##(1990-12#1)(1990-3#3)(1990-6#1)(1992-2#2)(1992-3#1)(1992-8#1)(1995-12#1)(1995-3#1)(1996-12#3)(1996-5#3)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-10#2)(2012-2#6)(2013-1#2)
battery-powered##2##1##(2008-10#1)(2009-10#1)
battle against##5##2##(1996-6#1)(2007-12#1)(2008-3#1)(2009-5#1)(2012-2#1)
battle to##2##2##(1995-2#1)(1996-5#1)
battle##15##1##(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2012-2#1)
battlefield##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
battles##3##1##(1993-5#1)(1995-1#1)(1996-2#1)
bauplan##2##1##(2007-12#1)(2008-7#1)
bay laurel (Umbellularia californica)##2##4##(2008-10#2)
bay laurel green leaf litter##2##5##(2008-10#2)
bay laurel##9##2##(2008-10#9)
bay##14##1##(2007-5#1)(2008-10#11)(2008-5#1)(2008-6#1)
bayanus##5##1##(1996-6#5)
bayesian##4##1##(1997-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
bays##8##1##(2007-5#5)(2008-10#2)(2012-12#1)
bc-1(2)##8##1##(2008-10#8)
bc1 complex##3##2##(1990-5#3)
bc1##4##1##(1990-5#4)
bcNOS##2##1##(2010-12#2)
bcd##3##1##(1994-12#3)
bcl-2 alpha and bcl-2 beta mRNA##2##6##(1993-3#2)
bcl-2 alpha##3##2##(1993-3#3)
bcl-2 and bag-1##7##3##(2008-11#7)
bcl-2 and##9##2##(2008-10#1)(2008-11#7)(2008-7#1)
bcl-2 beta mRNA##3##3##(1993-3#3)
bcl-2 expression##4##2##(2008-11#2)(2008-7#2)
bcl-2 gene##4##2##(1993-3#2)(1994-10#1)(1994-3#1)
bcl-2 had a significantly##2##4##(2008-10#2)
bcl-2 in##3##2##(2008-11#3)
bcl-2 mRNAs##2##2##(1993-3#2)
bcl-2 protein##4##2##(1994-10#3)(1994-3#1)
bcl-2 transfected cells grown in##2##5##(2008-11#2)
bcl-2 transfected cells##5##3##(2008-11#5)
bcl-2 transfected##7##2##(2008-11#7)
bcl-2 was##2##2##(1994-10#1)(2008-11#1)
bcl-2##73##1##(1993-3#10)(1993-9#2)(1994-10#11)(1994-3#3)(2007-12#1)(2008-10#6)(2008-11#33)(2008-7#6)(2012-1#1)
bcl-2/CD95##3##1##(2012-1#3)
bcl-2/Ki-67##2##1##(2012-1#2)
bcl-2/scid mice##2##2##(1994-3#2)
bcr-abl##2##1##(2012-12#2)
be &gt##9##2##(1995-6#1)(1996-2#1)(2007-7#2)(2008-10#4)(2008-8#1)
be &lt##9##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#2)
be &quot##10##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(2008-11#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
be (0##2##2##(2008-10#1)(2008-11#1)
be 0##72##2##(1990-6#1)(1990-7#1)(1990-8#1)(1994-6#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-10#48)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
be 1##54##2##(1990-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#2)(2013-1#2)
be 100%##6##2##(1994-12#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-9#1)
be 2##40##2##(1992-3#2)(1994-9#1)(1995-2#1)(1996-5#1)(2008-10#28)(2008-2#4)(2008-3#1)(2008-5#1)(2011-1#1)
be 20##3##2##(1995-5#1)(2008-3#1)(2009-9#1)
be 370##2##2##(2007-12#1)(2010-8#1)
be 7##9##2##(1991-5#1)(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#4)
be 97##2##2##(1992-5#1)(2008-3#1)
be a basic##2##3##(1994-11#1)(2008-11#1)
be a better##6##3##(1995-3#1)(1996-1#1)(2007-7#1)(2008-10#2)(2012-12#1)
be a biomarker##2##3##(2010-1#1)(2010-12#1)
be a by-product##2##3##(2008-10#1)(2009-8#1)
be a candidate##4##3##(1990-3#1)(2008-8#1)(2008-9#1)(2009-9#1)
be a case##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
be a causal factor##2##4##(1995-12#1)(2013-7#1)
be a causal##3##3##(1995-12#1)(2013-7#2)
be a cause of##8##4##(1990-3#1)(1991-4#1)(1994-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
be a cell##2##3##(1993-8#1)(2008-10#1)
be a cellular##3##3##(1990-11#1)(1997-4#1)(2008-4#1)
be a central##8##3##(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
be a challenge for##2##4##(2012-3#2)
be a challenge to##4##4##(1992-1#1)(2008-10#1)(2008-2#1)(2008-6#1)
be a challenge##9##3##(1992-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)(2011-1#1)(2012-3#2)
be a challenging task##2##4##(2008-10#2)
be a challenging##4##3##(2008-10#3)(2009-3#1)
be a circulating##3##3##(1991-11#1)(1992-6#1)(1997-7#1)
be a close##3##3##(1995-2#1)(2010-10#1)(2012-12#1)
be a cofactor in##2##4##(1996-2#1)(2013-1#1)
be a common cause of##2##5##(1997-3#1)(2010-1#1)
be a common##15##3##(1990-5#1)(1991-10#1)(1991-9#1)(1994-11#2)(1994-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-1#2)
be a complex##3##3##(1992-2#1)(1995-12#1)(2008-7#1)
be a concern##2##3##(2008-6#1)(2012-3#1)
be a consequence of##7##4##(1992-6#1)(1994-5#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
be a consequence##8##3##(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
be a continuous##2##3##(1992-9#1)(2008-7#1)
be a convenient##2##3##(2008-10#1)(2012-2#1)
be a correlation between##2##4##(2008-9#1)(2009-9#1)
be a critical factor##2##4##(1994-2#1)(1994-6#1)
be a critical parameter##2##4##(1991-2#1)(2010-7#1)
be a critical##5##3##(1991-2#1)(1994-2#1)(1994-6#1)(1995-8#1)(2010-7#1)
be a crucial##4##3##(1991-12#1)(1997-4#1)(2008-5#1)(2010-12#1)
be a determinant of##2##4##(1997-3#1)(2008-4#1)
be a determinant##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
be a diagnostic##4##3##(2008-10#1)(2008-9#2)(2010-8#1)
be a difficult##2##3##(1990-6#1)(1993-12#1)
be a direct##4##3##(1993-9#1)(1994-8#1)(1995-2#1)(2008-11#1)
be a distinct##2##3##(2008-10#1)(2013-8#1)
be a factor in##2##4##(1996-4#1)(2007-2#1)
be a factor##6##3##(1991-3#1)(1991-8#1)(1996-4#1)(2007-2#1)(2008-10#1)(2011-2#1)
be a fast and reliable##2##5##(2009-12#1)(2010-8#1)
be a fast and##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-8#1)(2012-1#1)
be a fast##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-8#1)(2012-1#1)
be a feasible##2##3##(2008-10#1)(2012-12#1)
be a first-order##2##3##(1994-3#1)(2007-8#1)
be a focus##2##3##(2008-4#1)(2008-9#1)
be a form of##3##4##(2008-8#1)(2012-12#1)(2012-3#1)
be a function of the##5##5##(1991-5#1)(1997-5#1)(2008-2#1)(2008-7#1)(2011-1#1)
be a function of##9##4##(1991-12#1)(1991-5#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-1#1)
be a general##6##3##(2008-10#2)(2008-7#1)(2008-8#2)(2011-1#1)
be a good alternative to##2##5##(1995-6#1)(2008-10#1)
be a good alternative##3##4##(1995-6#1)(2008-10#1)(2009-8#1)
be a good candidate##2##4##(2008-10#1)(2008-11#1)
be a good compromise between##2##5##(2008-3#1)(2011-2#1)
be a good tool for##2##5##(1992-11#1)(2009-8#1)
be a good tool##3##4##(1992-11#1)(2008-7#1)(2009-8#1)
be a good##28##3##(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
be a great##2##3##(2008-12#1)(2010-6#1)
be a greater##3##3##(1994-2#1)(2008-10#1)(2012-3#1)
be a helpful##4##3##(2008-11#1)(2012-3#1)(2013-1#2)
be a high##7##3##(1992-12#1)(1993-9#1)(1994-5#1)(2008-11#2)(2008-8#1)(2009-3#1)
be a highly##4##3##(1991-5#1)(2008-10#2)(2008-3#1)
be a key##12##3##(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-8#2)(2013-8#1)
be a large##3##3##(1997-6#1)(2007-8#1)(2008-9#1)
be a lengthy##2##3##(1992-12#1)(1992-2#1)
be a major cause of##4##5##(1991-12#1)(1995-3#1)(2008-7#1)(2012-12#1)
be a major component of##3##5##(1997-8#1)(2008-10#1)(2008-5#1)
be a major determinant##2##4##(1994-11#1)(2008-3#1)
be a major problem##2##4##(2007-11#1)(2010-10#1)
be a major##28##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1994-11#2)(1995-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
be a marker for##2##4##(2008-8#1)(2010-3#1)
be a marker of##4##4##(2011-2#1)(2012-3#1)(2013-1#2)
be a marker##6##3##(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
be a mechanical##2##3##(2009-5#1)(2009-6#1)
be a mechanism for##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
be a mechanism##5##3##(2008-10#2)(2008-11#1)(2009-2#1)(2010-1#1)
be a member of##3##4##(1991-2#1)(1992-3#1)(1993-2#1)
be a method##2##3##(1994-12#1)(1996-5#1)
be a model##2##3##(2008-11#2)
be a more sensitive##2##4##(2008-10#2)
be a more specific##2##4##(2008-10#2)
be a more##16##3##(1993-12#1)(1994-11#1)(1994-5#1)(2008-10#8)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
be a much##2##3##(1997-1#1)(2010-8#1)
be a natural##2##3##(2008-11#2)
be a necessary##2##3##(1992-11#1)(1993-8#1)
be a need for further##2##5##(1995-1#1)(2010-10#1)
be a need##3##3##(1995-1#2)(2010-10#1)
be a new##4##3##(2008-10#1)(2008-3#2)(2008-8#1)
be a nightmare##2##3##(1992-3#1)(1996-3#1)
be a novel and##2##4##(2008-3#1)(2013-1#1)
be a novel##15##3##(1990-7#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#7)(2008-9#1)(2011-2#2)(2013-1#1)
be a parameter##2##3##(2008-3#2)
be a part of the##6##5##(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
be a part of##9##4##(1994-2#1)(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
be a partial##2##3##(1995-6#1)(2011-2#1)
be a possible##6##3##(1992-11#1)(1993-3#1)(1995-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
be a potent##12##3##(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-8#1)
be a potential target for##2##5##(1993-8#1)(2012-3#1)
be a potential therapeutic##2##4##(2008-1#1)(2010-12#1)
be a potential##10##3##(1991-2#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2010-12#1)(2012-3#1)(2013-1#1)
be a powerful tool for##6##5##(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
be a powerful tool in##5##5##(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2013-8#1)
be a powerful tool##14##4##(1993-2#1)(1995-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
be a powerful##27##3##(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-12#3)(2008-10#1)(2008-11#5)(2008-3#3)(2008-4#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
be a practical##5##3##(1996-8#1)(1997-2#1)(2007-11#1)(2008-3#1)(2008-7#1)
be a prerequisite for##2##4##(1997-1#1)(2008-9#1)
be a prerequisite##3##3##(1991-2#1)(1997-1#1)(2008-9#1)
be a primary##6##3##(1992-4#1)(1995-1#1)(2008-10#1)(2009-5#1)(2010-3#1)(2013-1#1)
be a prime##2##3##(2007-2#1)(2008-9#1)
be a priority##3##3##(2007-6#1)(2008-11#1)(2010-5#1)
be a problem##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
be a promising chemopreventive agent##2##5##(1992-9#1)(2011-2#1)
be a promising tool to##3##5##(1997-4#1)(2008-10#2)
be a promising##23##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-9#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-7#1)(2013-8#1)
be a property of##2##4##(1992-5#1)(2009-10#1)
be a protective factor##2##4##(2011-1#2)
be a protective##3##3##(1994-6#1)(2011-1#2)
be a rapid and##2##4##(2008-10#1)(2010-4#1)
be a rapid##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
be a rare##3##3##(1996-3#1)(2007-7#1)(2008-2#1)
be a reasonable approach##2##4##(2006-10#1)(2008-10#1)
be a reasonable##5##3##(1993-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
be a recombinant##2##3##(2008-10#2)
be a reflection of##4##4##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
be a reliable and##2##4##(2008-11#1)(2008-2#1)
be a reliable##8##3##(1994-2#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2012-2#1)
be a result of##8##4##(1990-6#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2012-12#1)
be a result##9##3##(1990-6#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-2#1)(2012-12#1)
be a revolutionary##2##3##(2009-6#1)(2010-7#1)
be a risk factor for##5##5##(1997-1#1)(2007-10#1)(2011-1#1)(2012-3#1)(2013-7#1)
be a risk factor in##3##5##(1991-4#1)(1992-3#1)(2007-11#1)
be a risk factor##8##4##(1991-4#1)(1992-3#1)(1997-1#1)(2007-10#1)(2007-11#1)(2011-1#1)(2012-3#1)(2013-7#1)
be a safe and effective##2##5##(2011-2#2)
be a safe and##6##4##(1990-11#1)(1996-9#1)(2007-10#1)(2011-2#2)(2012-2#1)
be a safe##10##3##(1990-11#1)(1992-2#1)(1996-9#1)(2006-10#1)(2007-10#1)(2010-7#1)(2011-2#3)(2012-2#1)
be a secondary##2##3##(1994-5#1)(2008-10#1)
be a selective##2##3##(1996-5#1)(2008-10#1)
be a sensitive##7##3##(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
be a serious##4##3##(2008-12#1)(2008-9#1)(2009-9#1)(2010-5#1)
be a sign of##2##4##(1995-8#1)(2008-10#1)
be a sign##3##3##(1995-8#1)(2008-10#1)(2010-6#1)
be a significant##17##3##(1991-3#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#2)(2010-5#1)(2011-2#2)(2012-2#1)
be a simple and##4##4##(1991-3#1)(1993-5#1)(1995-2#1)(2012-2#1)
be a simple##11##3##(1991-3#1)(1993-5#1)(1995-2#1)(1996-12#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)(2012-7#1)
be a single##5##3##(1990-11#1)(1995-8#1)(2007-7#1)(2011-2#1)(2013-7#1)
be a slow##3##3##(1992-3#1)(1997-2#1)(2008-1#1)
be a source of##9##4##(1990-12#1)(1990-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-1#1)
be a source##10##3##(1990-12#1)(1990-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-1#1)
be a standard##2##3##(1994-1#1)(2013-1#1)
be a strategic##2##3##(1996-2#1)(2008-7#1)
be a strong predictor of##2##5##(2012-2#1)(2013-1#1)
be a strong##5##3##(2007-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
be a substrate for##2##4##(2008-7#1)(2013-1#1)
be a successful##2##3##(2008-12#1)(2013-1#1)
be a suitable##11##3##(1996-1#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2012-1#1)(2012-2#1)
be a target for##4##4##(1992-6#1)(2008-6#1)(2011-2#1)(2013-1#1)
be a target##5##3##(1992-6#1)(2008-6#1)(2009-6#1)(2011-2#1)(2013-1#1)
be a tool##2##3##(1995-12#1)(2008-10#1)
be a trigger##2##3##(1994-5#1)(2012-12#1)
be a true##2##3##(1996-8#1)(2008-1#1)
be a unique##2##3##(1993-2#1)(1997-6#1)
be a useful adjunct to##3##5##(1993-2#1)(2010-11#1)(2012-3#1)
be a useful and##2##4##(1994-11#1)(2008-12#1)
be a useful marker for##2##5##(2008-4#1)(2011-2#1)
be a useful means##2##4##(2008-10#1)(2012-2#1)
be a useful method of##2##5##(1994-5#1)(2007-9#1)
be a useful method##3##4##(1994-5#1)(2007-9#1)(2010-6#1)
be a useful molecular marker##2##5##(1992-5#1)(2008-9#1)
be a useful test##2##4##(1991-3#1)(2008-2#1)
be a useful tool for the##3##6##(1990-2#1)(1992-12#1)(1993-9#1)
be a useful tool for##7##5##(1990-2#1)(1992-12#1)(1993-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
be a useful tool in the##6##6##(1994-3#1)(1996-9#1)(2008-10#2)(2008-2#1)(2010-4#1)
be a useful tool in##13##5##(1991-11#1)(1992-1#1)(1994-3#1)(1996-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)
be a useful tool##22##4##(1990-2#1)(1991-11#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-11#1)(1996-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
be a useful##68##3##(1990-2#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-5#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
be a valid##4##3##(1995-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
be a valuable tool##8##4##(1993-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-5#1)
be a valuable##18##3##(1992-1#1)(1993-2#1)(1994-6#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
be a very promising method##2##5##(1990-9#1)(2010-7#1)
be a very promising##3##4##(1990-9#1)(2007-11#1)(2010-7#1)
be a very##19##3##(1990-11#1)(1990-9#2)(1991-5#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#2)
be a viable alternative to##3##5##(2008-10#2)(2009-2#1)
be a viable alternative##4##4##(2008-10#2)(2009-2#1)(2011-2#1)
be a viable strategy for##2##5##(1994-6#1)(2008-8#1)
be a viable##11##3##(1994-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-2#1)(2011-2#2)(2013-1#1)
be a vital part of##2##5##(1993-2#1)(2011-2#1)
be a vital##3##3##(1993-2#1)(2008-9#1)(2011-2#1)
be a way##2##3##(2008-11#1)(2011-2#1)
be a##1092##2##(1990-11#9)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#3)(1990-7#6)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#8)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#6)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#4)(1992-11#7)(1992-12#10)(1992-2#5)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#7)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#9)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#5)(1994-1#4)(1994-11#12)(1994-12#7)(1994-2#11)(1994-3#6)(1994-5#6)(1994-6#7)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#4)(1995-12#8)(1995-2#9)(1995-3#10)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1996-1#3)(1996-12#6)(1996-2#5)(1996-3#7)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#6)(2006-10#6)(2006-12#2)(2007-10#5)(2007-11#8)(2007-12#15)(2007-2#7)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#4)(2007-9#2)(2008-1#10)(2008-10#142)(2008-11#49)(2008-12#12)(2008-2#16)(2008-3#42)(2008-4#12)(2008-5#20)(2008-6#9)(2008-7#35)(2008-8#30)(2008-9#29)(2009-10#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#7)(2009-7#5)(2009-8#9)(2009-9#5)(2010-1#4)(2010-10#6)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#8)(2010-7#7)(2010-8#11)(2011-1#13)(2011-2#41)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#15)(2012-2#28)(2012-3#18)(2012-7#1)(2013-1#36)(2013-7#5)(2013-8#14)
be abandoned##3##2##(1991-1#2)(1992-3#1)
be able to achieve##3##4##(2007-4#1)(2008-9#1)(2011-2#1)
be able to detect##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
be able to distinguish##2##4##(2008-2#1)(2008-8#1)
be able to offer##2##4##(1992-3#1)(1996-9#1)
be able to operate##2##4##(2008-2#1)(2008-3#1)
be able to plan##2##4##(1990-6#1)(2012-3#1)
be able to predict##3##4##(2008-11#1)(2008-7#1)(2009-11#1)
be able to provide##5##4##(1992-9#1)(1995-3#1)(2008-10#2)(2013-8#1)
be able to recognize the##2##5##(2011-3#1)(2012-3#1)
be able to recognize##3##4##(2011-2#1)(2011-3#1)(2012-3#1)
be able to stimulate##2##4##(2008-5#1)(2013-1#1)
be able to##120##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#6)
be able##122##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#12)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#6)
be abnormal in##3##3##(1991-12#1)(2008-12#1)(2009-11#1)
be abnormal##4##2##(1991-12#1)(2008-1#1)(2008-12#1)(2009-11#1)
be abolished by##3##3##(1990-8#1)(1994-3#1)(2008-8#1)
be abolished##5##2##(1990-8#1)(1994-3#1)(1996-5#1)(2008-10#1)(2008-8#1)
be above##3##2##(1996-12#1)(1996-3#1)(2008-10#1)
be absent##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
be absorbed in the##2##4##(2008-10#2)
be absorbed into the##2##4##(1995-9#1)(2008-5#1)
be absorbed##7##2##(1992-12#1)(1995-11#1)(1995-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
be accelerated##4##2##(1994-3#1)(2007-8#1)(2008-11#1)(2010-5#1)
be acceptable for##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
be acceptable##10##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
be accepted or##2##3##(1991-12#1)(2008-11#1)
be accepted##9##2##(1991-12#1)(1992-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#3)(2012-2#1)
be accessed from##2##3##(1991-12#1)(2008-10#1)
be accessed##12##2##(1991-12#1)(1994-3#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-2#1)(2010-12#1)
be accessible##4##2##(1994-2#1)(1995-2#1)(2008-11#1)(2012-3#1)
be accommodated##5##2##(1997-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-8#1)
be accompanied by a##3##4##(1992-8#1)(1997-7#1)(2008-12#1)
be accompanied by##10##3##(1992-8#1)(1993-11#1)(1993-2#1)(1994-9#1)(1996-8#1)(1997-7#2)(2008-12#1)(2008-8#1)(2009-7#1)
be accomplished by##12##3##(1994-5#1)(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#2)(2011-2#1)
be accomplished using##2##3##(2008-10#1)(2008-11#1)
be accomplished##35##2##(1993-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2011-2#2)
be accounted for by the##4##5##(1992-11#1)(1995-6#1)(2008-2#1)(2012-1#1)
be accounted for by##16##4##(1990-10#1)(1990-11#1)(1992-11#1)(1992-6#2)(1995-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#2)
be accounted for in terms of##2##6##(1990-8#1)(1995-5#1)
be accounted for in##5##4##(1990-8#2)(1995-5#1)(2008-5#1)(2009-5#1)
be accounted for##23##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#2)(1992-11#1)(1992-6#2)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-1#2)
be accumulated and##2##3##(2008-10#1)(2012-2#1)
be accumulated##4##2##(1990-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
be accurate and##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
be accurate to##2##3##(1993-3#1)(2008-3#1)
be accurate##17##2##(1993-3#1)(1995-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2010-11#1)(2010-8#1)(2012-12#2)(2012-2#1)
be accurately defined##2##3##(2008-2#1)(2009-1#1)
be accurately determined##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
be accurately##23##2##(1990-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-4#2)(2008-9#1)(2009-1#1)(2010-4#1)
be achievable##4##2##(1996-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
be achieved at##6##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
be achieved by a##2##4##(2008-3#1)(2013-8#1)
be achieved by means of##2##5##(2007-11#1)(2008-3#1)
be achieved by reducing the##2##5##(2013-1#1)(2013-8#1)
be achieved by the##2##4##(2008-10#1)(2008-5#1)
be achieved by this##2##4##(1990-2#1)(2008-2#1)
be achieved by##62##3##(1990-2#1)(1990-9#1)(1993-9#1)(1994-11#1)(1995-11#1)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#13)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
be achieved either##2##3##(2008-1#1)(2008-7#1)
be achieved even##3##3##(2008-10#2)(2013-8#1)
be achieved for##4##3##(1995-6#1)(2008-10#2)(2008-3#1)
be achieved in the##3##4##(1992-9#1)(1997-6#1)(2008-10#1)
be achieved in##16##3##(1990-8#1)(1991-12#1)(1992-9#1)(1993-1#1)(1994-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-7#1)
be achieved only##3##3##(1992-2#1)(2007-11#1)(2008-7#1)
be achieved simultaneously##2##3##(2008-2#1)(2008-3#1)
be achieved through the use of##2##6##(2008-3#1)(2010-3#1)
be achieved through##12##3##(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-7#1)
be achieved using a variety of##2##6##(1992-9#1)(2008-12#1)
be achieved using the##2##4##(2008-11#1)(2009-12#1)
be achieved using##11##3##(1992-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-8#1)
be achieved with a##8##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
be achieved with differential##2##4##(2008-3#1)(2008-7#1)
be achieved with the##5##4##(1995-3#1)(2008-10#2)(2008-3#1)(2009-5#1)
be achieved with##28##3##(1995-3#1)(1996-6#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2009-5#2)(2009-7#1)(2009-9#1)(2011-2#1)
be achieved without##7##3##(1994-8#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-5#2)
be achieved##222##2##(1990-2#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#40)(2008-11#9)(2008-12#4)(2008-2#15)(2008-3#23)(2008-4#4)(2008-5#4)(2008-7#10)(2008-8#6)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#5)
be acknowledged and##3##3##(1994-12#1)(2012-2#1)(2012-3#1)
be acknowledged##5##2##(1994-11#1)(1994-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
be acquired and##2##3##(1996-3#1)(2008-10#1)
be acquired by##3##3##(2008-10#2)(2011-1#1)
be acquired##18##2##(1996-3#1)(2007-12#3)(2008-10#7)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#2)(2011-7#1)(2012-3#1)
be acting as##4##3##(1990-11#2)(2012-2#2)
be acting##5##2##(1990-11#2)(1993-6#1)(2012-2#2)
be activated by the##3##4##(1995-12#1)(1995-6#1)(2008-11#1)
be activated by##17##3##(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-6#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2013-8#1)
be activated in##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
be activated##27##2##(1993-12#2)(1993-8#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#1)(2010-7#1)(2011-1#1)(2013-8#1)
be active in##3##3##(1992-8#1)(1995-3#1)(2010-2#1)
be active##14##2##(1992-10#1)(1992-8#1)(1994-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2011-1#2)
be actively##2##2##(2008-1#1)(2008-8#1)
be adapted for the##2##4##(1990-12#1)(2008-4#1)
be adapted for use in other##2##6##(2008-2#1)(2012-12#1)
be adapted for use##3##4##(2008-2#1)(2008-4#1)(2012-12#1)
be adapted for##8##3##(1990-12#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-4#3)(2012-12#1)
be adapted to the##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
be adapted to##29##3##(1990-5#1)(1991-5#1)(1994-12#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-7#1)(2008-9#3)(2009-8#1)(2012-12#1)
be adapted##43##2##(1990-12#1)(1990-5#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#6)(2008-7#3)(2008-9#3)(2009-8#1)(2012-12#2)
be added and##2##3##(2008-10#1)(2008-9#1)
be added in##2##3##(1995-2#1)(2012-12#1)
be added to the list of##4##6##(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
be added to the wrapped##2##5##(2008-2#2)
be added to the##16##4##(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-2#1)
be added to##19##3##(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
be added##32##2##(1990-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
be additive##2##2##(1995-12#1)(2008-10#1)
be addressed as##3##3##(1994-7#1)(2007-12#1)(2008-7#1)
be addressed before##3##3##(2008-10#1)(2010-10#1)(2011-2#1)
be addressed by the##3##4##(1992-3#1)(1993-2#1)(2010-6#1)
be addressed by##7##3##(1991-3#1)(1992-3#1)(1993-2#1)(2007-7#1)(2009-5#1)(2010-6#1)(2012-12#1)
be addressed for##6##3##(2007-12#1)(2012-2#1)(2013-8#4)
be addressed in future##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
be addressed in##17##3##(1992-9#1)(1994-1#1)(1994-12#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
be addressed include##2##3##(1993-11#1)(1995-2#1)
be addressed to##8##3##(2007-12#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
be addressed when##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
be addressed##99##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#4)(1994-12#2)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-5#1)(2007-12#4)(2007-5#1)(2007-7#3)(2008-1#4)(2008-10#3)(2008-11#3)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#15)
be adequate for##4##3##(1991-12#1)(2008-10#3)
be adequate in##2##3##(1991-12#1)(2012-3#1)
be adequate to##2##3##(2008-10#1)(2008-5#1)
be adequate##12##2##(1991-12#2)(1992-3#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
be adequately treated##3##3##(1996-11#1)(2008-2#1)(2008-6#1)
be adequately##14##2##(1996-11#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-6#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
be adjusted to##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2012-12#1)
be adjusted##22##2##(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-7#3)(2010-4#1)(2010-5#1)(2012-12#2)(2012-3#1)
be administered safely##2##3##(1992-3#1)(2010-12#1)
be administered to children##2##4##(1994-9#1)(2007-12#1)
be administered to##8##3##(1994-2#1)(1994-9#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-8#1)
be administered##25##2##(1990-11#1)(1990-6#1)(1992-3#1)(1992-8#2)(1994-2#1)(1994-9#1)(1996-3#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-3#2)(2008-5#3)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-1#1)(2013-8#2)
be admitted for##2##3##(1992-6#1)(2006-5#1)
be admitted##5##2##(1992-6#1)(1995-5#1)(1996-3#1)(2006-5#1)(2007-12#1)
be adopted as##2##3##(2008-3#1)(2011-1#1)
be adopted by##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
be adopted for##3##3##(1996-8#1)(2008-10#2)
be adopted in##2##3##(2008-10#1)(2008-12#1)
be adopted to##3##3##(2008-10#1)(2008-6#1)(2010-10#1)
be adopted##23##2##(1990-2#1)(1990-6#1)(1994-1#1)(1996-12#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
be advanced##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
be advantageous for##2##3##(2008-12#1)(2008-3#1)
be advantageous in##3##3##(1997-7#1)(2008-8#1)(2013-1#1)
be advantageous to##2##3##(2008-10#1)(2009-6#1)
be advantageous##14##2##(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2013-1#1)
be advisable to##2##3##(2007-7#1)(2013-1#1)
be advisable##4##2##(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
be advised about##2##3##(1994-3#1)(2008-3#1)
be advised to##4##3##(1996-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
be advised##8##2##(1994-3#1)(1996-11#1)(2007-2#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
be advocated as##2##3##(1997-5#1)(2012-1#1)
be advocated##5##2##(1992-3#1)(1997-5#1)(2008-4#1)(2010-10#1)(2012-1#1)
be affected by a##4##4##(1990-2#1)(1994-11#1)(1997-8#1)(2013-1#1)
be affected by other##2##4##(1990-2#1)(2013-8#1)
be affected by the##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
be affected by##30##3##(1990-2#2)(1992-11#1)(1993-6#1)(1994-11#1)(1994-3#2)(1996-3#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-10#1)(2010-8#1)(2013-1#3)(2013-8#2)
be affected in##5##3##(1992-3#1)(1997-1#1)(2008-12#1)(2009-12#1)(2012-3#1)
be affected##42##2##(1990-2#2)(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1996-3#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-8#1)(2012-3#2)(2013-1#3)(2013-8#2)
be afforded##2##2##(1995-12#1)(2008-3#1)
be aggravated by##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
be aggressive##3##2##(1996-3#1)(2007-8#1)(2012-3#1)
be aided by##3##3##(1992-9#1)(2007-12#1)(2008-7#1)
be aimed at##4##3##(1993-11#1)(1996-3#1)(2008-2#1)(2011-2#1)
be aimed##6##2##(1991-2#1)(1993-11#1)(1996-3#1)(2008-2#1)(2008-5#1)(2011-2#1)
be alert to##2##3##(2008-8#1)(2010-12#1)
be alert##4##2##(2008-12#1)(2008-8#1)(2009-9#1)(2010-12#1)
be aligned for##4##3##(2008-3#1)(2008-4#2)(2008-9#1)
be aligned##6##2##(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
be alleviated##3##2##(2008-3#3)
be allocated to##2##3##(2008-8#1)(2009-5#1)
be allowed to##5##3##(1991-2#1)(1997-5#1)(2007-7#1)(2008-12#1)(2012-3#1)
be allowed##7##2##(1991-2#1)(1997-5#1)(2007-7#1)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
be almost##5##2##(1991-2#1)(1991-8#1)(2007-11#1)(2008-11#1)(2011-2#1)
be already##2##2##(2008-1#1)(2008-10#1)
be also used to##2##4##(2008-10#1)(2012-12#1)
be also used##5##3##(2008-10#3)(2010-8#1)(2012-12#1)
be also##29##2##(1990-12#1)(1990-3#1)(1991-3#1)(1996-2#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
be altered by the##2##4##(1990-2#1)(2008-4#1)
be altered by##9##3##(1990-2#1)(1990-7#1)(1991-2#1)(1993-12#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-4#1)(2008-6#1)
be altered##21##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1993-12#1)(1994-9#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#1)(2009-11#1)(2012-1#1)(2012-2#1)
be always##3##2##(1994-9#1)(2008-5#1)(2009-4#1)
be ameliorated by##3##3##(2008-1#1)(2008-8#1)(2011-1#1)
be ameliorated##6##2##(1993-11#1)(1996-3#1)(2008-1#1)(2008-8#1)(2011-1#1)(2011-2#1)
be amenable to##4##3##(1997-7#1)(2007-7#1)(2008-10#1)(2008-6#1)
be among the##6##3##(1994-9#1)(2006-6#1)(2008-11#1)(2008-5#2)(2008-7#1)
be amplified by##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
be amplified##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-1#1)
be an absolute##2##3##(1992-1#1)(1994-8#1)
be an active##2##3##(1992-2#1)(2008-9#1)
be an adaptation to##2##4##(2011-2#1)(2013-1#1)
be an additional##9##3##(1992-12#1)(1993-6#1)(1994-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
be an advantage##2##3##(2007-12#1)(2008-7#1)
be an advantageous alternative##2##4##(2008-10#2)
be an aid in##2##4##(1991-9#1)(2012-12#1)
be an alternative method##2##4##(2008-10#1)(2008-3#1)
be an alternative to##2##4##(1997-8#1)(2008-2#1)
be an alternative##14##3##(1994-11#1)(1997-7#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
be an antagonist##2##3##(1995-3#1)(1997-2#1)
be an appropriate##8##3##(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#2)
be an attractive alternative to##2##5##(2008-1#1)(2008-10#1)
be an attractive alternative##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
be an attractive##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)
be an early##3##3##(1991-1#1)(2011-2#1)(2012-12#1)
be an effective and##3##4##(2007-10#1)(2008-10#2)
be an effective approach to##3##5##(2008-10#1)(2008-9#1)(2010-12#1)
be an effective intervention for##2##5##(2008-10#1)(2008-12#1)
be an effective means of##4##5##(1993-11#1)(1994-11#1)(2008-5#1)(2012-2#1)
be an effective means to##2##5##(1995-1#1)(2008-6#1)
be an effective means##7##4##(1993-11#1)(1994-11#1)(1995-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
be an effective method for##2##5##(1991-2#1)(2011-2#1)
be an effective method of##3##5##(1991-7#1)(1997-4#1)(2008-10#1)
be an effective method##6##4##(1991-2#1)(1991-7#1)(1997-4#1)(2008-10#2)(2011-2#1)
be an effective therapy##2##4##(1991-4#1)(2006-10#1)
be an effective treatment for##3##5##(2008-7#1)(2012-3#2)
be an effective treatment##7##4##(1992-8#1)(1997-6#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)
be an effective##56##3##(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)
be an efficient technique for the##2##6##(2008-10#1)(2011-2#1)
be an efficient##12##3##(1991-12#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
be an enzyme##2##3##(1990-2#1)(1992-8#1)
be an essential##8##3##(1991-6#1)(1992-1#1)(1993-12#1)(1994-11#1)(1996-1#1)(1996-2#1)(2007-11#1)(2013-8#1)
be an even##2##3##(2008-5#1)(2011-2#1)
be an excellent##6##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
be an ideal candidate for a##2##6##(1991-9#1)(2012-2#1)
be an ideal##4##3##(1991-9#1)(1995-5#1)(2011-1#1)(2012-2#1)
be an important component of##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
be an important determinant of the##2##6##(1990-2#1)(2008-10#1)
be an important determinant of##6##5##(1990-12#1)(1990-2#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
be an important factor for##3##5##(2008-5#1)(2008-6#1)(2013-7#1)
be an important factor in the##2##6##(1993-9#1)(1996-7#1)
be an important factor in##7##5##(1993-9#1)(1996-12#1)(1996-7#1)(2007-6#1)(2010-6#1)(2011-2#1)(2012-12#1)
be an important factor##13##4##(1993-9#1)(1996-12#1)(1996-7#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
be an important mechanism of##3##5##(2008-10#2)(2011-2#1)
be an important mechanism##7##4##(1993-2#1)(2008-10#4)(2008-8#1)(2011-2#1)
be an important part of##3##5##(1993-3#1)(2013-1#2)
be an important step##2##4##(1997-2#1)(2008-11#1)
be an important target for##2##5##(1995-2#1)(2013-8#1)
be an important tool in##2##5##(2009-7#1)(2013-8#1)
be an important##68##3##(1990-12#1)(1990-2#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
be an impractical##2##3##(1994-5#1)(2008-8#1)
be an increase in##3##4##(1992-2#1)(2008-5#1)(2011-2#1)
be an independent##3##3##(1995-4#1)(2007-10#1)(2008-7#1)
be an index of##2##4##(1993-11#1)(2008-11#1)
be an indicator##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
be an innovative##2##3##(1992-12#1)(2010-3#1)
be an interesting##4##3##(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
be an intrinsic##2##3##(1995-12#1)(2008-4#1)
be an invaluable tool##3##4##(1996-1#1)(2008-10#1)(2008-9#1)
be an option##2##3##(1997-6#1)(2012-12#1)
be an order of magnitude##2##5##(1995-2#1)(2007-11#1)
be an unusual##2##3##(1994-8#1)(1996-2#1)
be an##360##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#7)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#7)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#50)(2008-11#13)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#11)(2008-6#4)(2008-7#11)(2008-8#11)(2008-9#13)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#23)(2012-12#7)(2012-2#10)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#6)
be analogous to##3##3##(1991-8#1)(1995-8#1)(2012-2#1)
be analysed and##2##3##(2007-12#1)(2010-8#1)
be analysed by##2##3##(2008-10#2)
be analysed in##3##3##(1991-5#1)(2008-11#1)(2008-7#1)
be analysed##20##2##(1990-8#1)(1991-5#2)(1991-8#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)
be analyzed by##11##3##(1993-12#1)(1996-1#1)(1997-4#1)(2008-10#2)(2008-3#2)(2008-4#3)(2012-2#1)
be analyzed in a##3##4##(1991-5#1)(1994-8#1)(2008-9#1)
be analyzed in terms of##2##5##(2007-11#1)(2008-11#1)
be analyzed in the##3##4##(2008-10#2)(2008-4#1)
be analyzed in##12##3##(1991-5#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
be analyzed to##2##3##(1994-2#1)(2013-8#1)
be analyzed using PCR##2##4##(1993-12#1)(2008-2#1)
be analyzed using##5##3##(1991-11#1)(1993-12#1)(2007-8#1)(2008-2#1)(2008-8#1)
be analyzed with##3##3##(2008-10#2)(2008-9#1)
be analyzed##54##2##(1990-3#1)(1991-11#1)(1991-5#1)(1993-12#2)(1994-2#1)(1994-8#1)(1996-1#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
be and##2##2##(1996-1#1)(2008-9#1)
be another##5##2##(1991-2#1)(2008-11#1)(2008-5#1)(2009-3#2)
be answered before##2##3##(1995-8#1)(1997-1#1)
be answered by##3##3##(1991-7#1)(1995-1#1)(2012-2#1)
be answered in the##2##4##(2008-5#1)(2013-1#1)
be answered##13##2##(1991-7#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
be anticipated##11##2##(1990-12#1)(1993-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
be apparent##3##2##(1994-1#1)(2007-5#1)(2008-1#1)
be applicable as##2##3##(1994-3#1)(2012-3#1)
be applicable for##10##3##(1991-2#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
be applicable in the##2##4##(2008-10#1)(2010-10#1)
be applicable in##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2010-10#1)(2011-2#1)
be applicable to a##4##4##(2008-10#4)
be applicable to other##3##4##(2008-10#1)(2008-5#1)(2010-2#1)
be applicable to the determination of##2##6##(2008-10#2)
be applicable to the##10##4##(1990-5#1)(1994-12#1)(2006-6#1)(2008-10#4)(2008-5#1)(2009-3#1)(2010-12#1)
be applicable to##31##3##(1990-5#1)(1991-5#1)(1992-12#1)(1994-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-6#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-12#2)(2010-2#1)
be applicable##51##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
be applied also to##2##4##(1995-5#1)(2008-10#1)
be applied also##3##3##(1995-5#1)(2008-10#2)
be applied as a##2##4##(2008-10#1)(2009-3#1)
be applied as an##2##4##(2008-10#1)(2008-6#1)
be applied as##4##3##(2008-10#2)(2008-6#1)(2009-3#1)
be applied by##6##3##(1992-4#1)(2008-10#3)(2010-8#1)(2013-8#1)
be applied directly##2##3##(2008-10#1)(2011-2#1)
be applied for the##5##4##(2007-11#1)(2008-10#3)(2008-3#1)
be applied for##19##3##(1994-8#1)(1995-6#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2012-1#1)(2013-1#1)
be applied in order to##2##5##(2008-5#1)(2012-2#1)
be applied in other##2##4##(2011-2#1)(2013-8#1)
be applied in research##2##4##(2008-2#1)(2010-8#1)
be applied in the##6##4##(1996-11#1)(2008-10#2)(2008-6#1)(2010-8#1)(2012-2#1)
be applied in##32##3##(1990-11#1)(1996-11#1)(1997-2#2)(1997-6#1)(2007-6#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
be applied on a##2##4##(2008-4#1)(2011-2#1)
be applied satisfactorily for##3##4##(2008-10#3)
be applied successfully to##7##4##(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)
be applied to a##7##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-9#1)
be applied to all##2##4##(1991-5#1)(2008-4#1)
be applied to any##7##4##(1995-2#1)(2007-12#1)(2008-2#3)(2008-4#1)(2008-9#1)
be applied to determine##5##4##(1994-9#1)(2008-10#3)(2011-1#1)
be applied to health care##2##5##(1993-3#1)(1995-1#1)
be applied to other types of##3##6##(2008-2#1)(2008-3#1)(2008-9#1)
be applied to other##13##4##(1991-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-11#2)(2011-2#1)
be applied to public health##2##5##(2008-7#1)(2012-2#1)
be applied to routine##2##4##(1995-2#1)(2008-10#1)
be applied to the determination of##6##6##(2008-10#6)
be applied to the determination##8##5##(2008-10#8)
be applied to the##31##4##(1994-9#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2010-8#1)
be applied to##132##3##(1990-5#1)(1991-1#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-6#2)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-4#1)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#8)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#6)(2009-11#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)
be applied with##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
be applied##260##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-8#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#70)(2008-11#8)(2008-12#2)(2008-2#14)(2008-3#23)(2008-4#10)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#10)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#4)
be appointed##2##2##(1993-3#1)(1994-12#1)
be appreciated##6##2##(1993-11#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
be approached through##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
be approached##11##2##(1991-12#1)(1991-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
be appropriate for##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-6#1)(2010-12#2)(2013-1#1)
be appropriate##19##2##(1991-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#3)(2013-1#2)
be appropriately##2##2##(1995-2#1)(2008-7#1)
be approved##3##2##(1992-3#1)(2008-5#1)(2008-8#1)
be approximate##2##2##(1992-6#1)(2008-9#1)
be approximated by##2##3##(2008-10#1)(2008-3#1)
be approximated##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
be approximately 15##3##3##(1995-6#1)(1996-6#1)(2008-10#1)
be approximately##26##2##(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#5)(2008-5#1)(2010-4#1)(2011-2#1)
be arbitrarily##2##2##(2008-3#1)(2009-5#1)
be arbitrary##2##2##(1991-3#1)(2008-6#1)
be archived##2##2##(2008-10#1)(2008-5#1)
be argued that##3##3##(1994-12#1)(2008-11#1)(2009-10#1)
be argued##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
be arranged##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
be as effective as##8##4##(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
be as effective##9##3##(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
be as follows##3##3##(1997-2#1)(2008-3#1)(2008-4#1)
be as great##2##3##(1991-8#1)(2008-10#1)
be as high as##8##4##(1995-2#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-12#1)(2013-8#1)
be as important as##4##4##(2008-10#1)(2008-11#2)(2012-1#1)
be as important##5##3##(1995-6#1)(2008-10#1)(2008-11#2)(2012-1#1)
be as large as##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
be as low as##4##4##(2008-2#2)(2008-3#1)(2010-2#1)
be as##62##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-1#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
be ascertained##5##2##(1991-2#1)(1995-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
be ascribed to a##3##4##(1994-5#1)(2007-12#1)(2011-1#1)
be ascribed to the##8##4##(1991-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-9#1)
be ascribed to##17##3##(1991-2#1)(1994-3#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2009-9#1)(2011-1#1)
be ascribed##21##2##(1991-2#1)(1994-3#1)(1994-5#1)(1995-9#1)(1997-6#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#2)(2009-6#1)(2009-9#1)(2011-1#1)
be asked##5##2##(2008-11#2)(2008-4#1)(2010-10#1)(2011-2#1)
be assayed##2##2##(2008-2#1)(2008-4#1)
be assembled##5##2##(1990-2#1)(1995-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
be asserted##2##2##(1990-3#1)(2013-1#1)
be assessed accurately##2##3##(2008-10#1)(2008-2#1)
be assessed and##2##3##(1994-2#1)(2008-3#1)
be assessed by the##2##4##(1997-4#1)(2008-5#1)
be assessed by##8##3##(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#1)(2012-2#1)
be assessed for stable disease##2##5##(2008-6#2)
be assessed for##5##3##(1993-1#1)(2008-10#1)(2008-6#2)(2010-8#1)
be assessed in##2##3##(1990-12#1)(2011-1#1)
be assessed##42##2##(1990-12#1)(1990-9#1)(1991-11#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
be assigned to a##2##4##(1994-2#1)(2008-10#1)
be assigned to##8##3##(1992-6#1)(1994-2#1)(1995-12#1)(2008-10#3)(2008-7#1)(2008-9#1)
be assigned##12##2##(1992-6#1)(1994-2#1)(1995-12#1)(2008-10#7)(2008-7#1)(2008-9#1)
be assimilated##3##2##(2008-3#1)(2010-4#2)
be assisted by##4##3##(1994-11#1)(1994-2#1)(2011-1#2)
be assisted##5##2##(1993-9#1)(1994-11#1)(1994-2#1)(2011-1#2)
be associated to a##2##4##(2008-11#1)(2011-2#1)
be associated to##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
be associated with a variety of##4##6##(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
be associated with a##18##4##(1992-3#1)(1994-12#1)(1994-2#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
be associated with adverse##2##4##(2008-9#1)(2013-1#1)
be associated with an abnormal##2##5##(1990-5#1)(1994-11#1)
be associated with an increased risk of##2##7##(1992-11#1)(1992-2#1)
be associated with an increased risk##4##6##(1992-11#1)(1992-2#1)(2010-12#1)(2013-1#1)
be associated with an##7##4##(1990-5#1)(1992-11#1)(1992-2#1)(1994-11#1)(1995-3#1)(2010-12#1)(2013-1#1)
be associated with both##3##4##(2008-5#1)(2009-12#1)(2013-1#1)
be associated with changes in##3##5##(1990-2#1)(2008-12#1)(2012-2#1)
be associated with facial##2##4##(2008-9#1)(2010-4#1)
be associated with increased##3##4##(2008-7#1)(2012-12#1)(2013-1#1)
be associated with other##3##4##(1992-12#1)(2012-3#1)(2013-8#1)
be associated with renal##2##4##(2007-7#1)(2008-1#1)
be associated with severe##2##4##(2011-2#1)(2012-2#1)
be associated with the susceptibility to tuberculosis##2##7##(2011-1#2)
be associated with the##27##4##(1990-7#1)(1992-12#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-7#3)(2008-9#1)(2009-8#1)(2009-9#2)(2010-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
be associated with their##2##4##(1993-12#1)(2007-12#1)
be associated with these##2##4##(2007-8#1)(2010-10#1)
be associated with##182##3##(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#5)(2009-12#2)(2009-4#2)(2009-5#1)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#5)
be associated##193##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#5)
be assumed by##2##3##(1995-12#1)(1997-8#1)
be assumed that##3##3##(1991-1#1)(2008-7#1)(2009-1#1)
be assumed to be##4##4##(1994-5#1)(2007-12#1)(2009-12#1)(2010-3#1)
be assumed to##8##3##(1992-12#1)(1994-5#1)(2007-12#1)(2008-10#2)(2009-12#1)(2010-10#1)(2010-3#1)
be assumed##19##2##(1990-2#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-5#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-3#1)
be assured##2##2##(1993-1#1)(2012-2#1)
be asymptomatic##8##2##(1991-4#1)(2008-1#2)(2008-12#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
be asymptotically##2##2##(2010-2#1)(2012-1#1)
be at a##5##3##(1995-2#1)(1996-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
be at greater risk##2##4##(1996-11#1)(2012-12#1)
be at greater##3##3##(1993-1#1)(1996-11#1)(2012-12#1)
be at higher##2##3##(1992-2#1)(2008-4#1)
be at increased risk of##2##5##(2007-2#1)(2008-7#1)
be at increased risk##4##4##(2007-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
be at least partially responsible##2##5##(2010-3#1)(2012-2#1)
be at least partly##2##4##(1997-7#1)(2008-10#1)
be at least##10##3##(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-2#1)(2010-3#1)(2012-2#1)
be at risk for##3##4##(1996-12#1)(2009-2#1)(2011-2#1)
be at risk##10##3##(1990-5#2)(1991-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-12#1)
be at the##6##3##(1991-5#1)(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
be at##54##2##(1990-5#4)(1991-5#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
be attacked by##2##3##(2008-8#1)(2010-2#1)
be attacked##3##2##(2008-5#1)(2008-8#1)(2010-2#1)
be attainable##3##2##(1994-3#1)(2007-11#1)(2012-12#1)
be attained using##4##3##(2008-10#4)
be attained##15##2##(1990-5#1)(1992-3#1)(1993-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)
be attempted##4##2##(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
be attended to##2##3##(1994-3#1)(2013-1#1)
be attenuated by##3##3##(1995-5#1)(2009-7#1)(2011-2#1)
be attenuated##4##2##(1991-9#1)(1995-5#1)(2009-7#1)(2011-2#1)
be attracted to the##2##4##(2008-10#1)(2008-8#1)
be attractive##5##2##(2008-10#2)(2008-7#1)(2009-7#1)(2013-1#1)
be attributable to##13##3##(1991-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
be attributable##15##2##(1991-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
be attributed only to##2##4##(1990-8#1)(1991-12#1)
be attributed to a##7##4##(1992-3#1)(1995-2#1)(2007-12#1)(2011-1#2)(2011-2#2)
be attributed to its##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
be attributed to the difference in the##2##7##(1995-3#1)(2008-9#1)
be attributed to the difference in##3##6##(1995-3#1)(2008-9#1)(2012-2#1)
be attributed to the##33##4##(1990-12#1)(1992-10#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#3)(2011-2#1)(2012-2#1)(2013-1#1)
be attributed to##80##3##(1990-12#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#4)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#1)
be attributed##86##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#2)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#4)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#1)
be atypical##2##2##(2007-8#1)(2008-3#1)
be augmented##3##2##(1994-5#1)(1997-1#1)(2008-11#1)
be automated##4##2##(2008-10#3)(2008-11#1)
be automatically##5##2##(2008-10#2)(2008-3#1)(2008-8#1)(2010-12#1)
be available for##2##3##(2008-10#1)(2009-1#1)
be available in the##5##4##(1990-11#1)(1994-11#1)(2008-12#3)
be available to##5##3##(1991-12#1)(2007-4#1)(2008-10#1)(2012-2#1)(2012-3#1)
be available##29##2##(1990-11#1)(1991-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-12#2)(2007-4#1)(2008-10#5)(2008-12#4)(2008-8#2)(2009-1#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
be averaged##2##2##(1996-4#1)(2008-8#1)
be avoided and##3##3##(2008-1#2)(2008-10#1)
be avoided as##2##3##(1993-12#1)(2009-4#1)
be avoided because##2##3##(2008-7#1)(2008-9#1)
be avoided by##10##3##(1992-3#1)(1996-11#1)(2007-11#1)(2008-7#3)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
be avoided if##3##3##(1994-3#1)(1995-2#1)(2009-11#1)
be avoided in##6##3##(1994-3#2)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
be avoided##62##2##(1990-5#1)(1991-3#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#3)(1995-2#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
be aware of in##2##4##(1991-2#1)(2008-7#1)
be aware of the potential##2##5##(1996-12#1)(2008-9#1)
be aware of the##23##4##(1991-8#1)(1992-11#1)(1994-3#2)(1995-12#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)
be aware of this possible##2##5##(2008-12#1)(2012-3#1)
be aware of this##6##4##(1997-4#1)(2007-10#1)(2007-7#1)(2008-12#2)(2012-3#1)
be aware of##45##3##(1991-2#1)(1991-8#1)(1992-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
be aware that it##2##4##(1991-3#1)(2012-12#1)
be aware that they##2##4##(1991-3#1)(2012-2#1)
be aware that##10##3##(1991-3#2)(1993-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#2)
be aware##59##2##(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#1)(1997-4#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
be balanced##3##2##(1997-3#1)(2008-3#1)(2008-8#1)
be based on a##11##4##(1991-2#2)(1992-1#1)(1995-1#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
be based on an##3##4##(1990-6#1)(1992-2#1)(2008-7#1)
be based on the##12##4##(1991-5#1)(1991-6#1)(1996-4#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-12#1)
be based on##48##3##(1990-6#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
be based upon the##2##4##(1993-2#1)(2008-6#1)
be based upon##3##3##(1993-2#1)(2008-4#1)(2008-6#1)
be based##53##2##(1990-6#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
be because of the##2##4##(2008-10#1)(2008-5#1)
be because of##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
be because##10##2##(1990-11#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
be behind this##2##3##(1990-8#1)(2007-12#1)
be benchmarked##3##2##(1995-12#1)(2007-4#1)(2013-8#1)
be beneficial for improving##2##4##(2008-10#1)(2008-12#1)
be beneficial for other##2##4##(2008-3#1)(2012-12#1)
be beneficial for the##4##4##(2008-10#1)(2008-5#1)(2009-6#1)(2012-12#1)
be beneficial for##15##3##(1992-7#1)(1994-11#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
be beneficial in acute##2##4##(2007-10#2)
be beneficial in the treatment of##3##6##(1990-10#1)(2009-10#1)(2011-2#1)
be beneficial in the##6##4##(1990-10#1)(2007-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
be beneficial in##20##3##(1990-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-10#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)
be beneficial to patients##2##4##(2010-5#1)(2011-2#1)
be beneficial to##9##3##(1994-3#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
be beneficial##61##2##(1990-10#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#3)
be beneficially##2##2##(1995-5#1)(2008-3#1)
be best achieved##2##3##(2008-10#1)(2009-5#1)
be best suited for##2##4##(2007-8#1)(2008-10#1)
be best suited##4##3##(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)
be best##13##2##(1994-2#1)(1995-1#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2009-5#1)(2012-2#2)
be better able to##5##4##(1992-12#1)(1993-11#1)(1997-3#1)(2008-11#2)
be better incorporated##2##3##(2008-11#1)(2008-12#1)
be better suited for##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
be better suited##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
be better than##12##3##(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2012-1#1)
be better understood##6##3##(1992-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
be better##55##2##(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#2)(1993-11#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
be between##19##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#1)(2011-2#2)
be biased##7##2##(1992-6#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)
be biologically##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
be blocked by##8##3##(1991-9#1)(1994-10#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-7#2)(2008-12#1)
be blocked##10##2##(1991-9#1)(1993-9#1)(1994-10#1)(1994-12#1)(1996-5#2)(1997-2#1)(1997-7#2)(2008-12#1)
be bone##2##2##(1997-8#1)(2010-3#1)
be boosted##2##2##(2008-3#1)(2013-1#1)
be borne in mind##3##4##(1994-6#1)(2008-1#1)(2008-12#1)
be borne##4##2##(1994-6#1)(1994-9#1)(2008-1#1)(2008-12#1)
be both##13##2##(1990-2#1)(1991-11#1)(1992-5#1)(2008-10#5)(2008-3#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-2#1)
be bound to##4##3##(2007-11#1)(2008-10#2)(2012-3#1)
be bound##7##2##(1990-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-3#1)
be broadly applicable##2##3##(2008-9#1)(2009-10#1)
be broadly##8##2##(1997-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#1)(2013-1#1)
be broken down into##2##4##(1995-3#1)(2011-2#1)
be broken into##2##3##(2008-10#1)(2008-9#1)
be broken##5##2##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
be brought to##2##3##(1995-1#1)(2008-10#1)
be brought together##2##3##(1996-1#1)(2008-11#1)
be brought##8##2##(1994-6#1)(1995-1#1)(1996-1#1)(1996-5#1)(2008-10#2)(2008-11#1)(2013-7#1)
be built##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
be calculated as the##2##4##(2008-10#1)(2008-3#1)
be calculated as##3##3##(2008-10#2)(2008-3#1)
be calculated by use of##3##5##(2008-2#1)(2008-3#2)
be calculated by##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
be calculated for##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
be calculated from the##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
be calculated from##7##3##(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)
be calculated with##2##3##(2007-8#1)(2008-2#1)
be calculated##39##2##(1991-5#1)(1991-8#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-3#1)
be called &quot##2##3##(1994-9#2)
be called upon to##2##4##(1995-3#1)(1996-3#1)
be called##9##2##(1990-11#1)(1993-12#1)(1994-9#2)(1995-3#1)(1996-3#1)(2007-11#1)(2008-8#1)(2009-7#1)
be candidates for##3##3##(1990-4#1)(2008-10#1)(2013-1#1)
be candidates##4##2##(1990-4#1)(1993-11#1)(2008-10#1)(2013-1#1)
be capable of##26##3##(1991-1#1)(1992-3#1)(1994-2#1)(1995-5#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#2)
be capable##27##2##(1991-1#1)(1992-3#1)(1994-2#1)(1995-5#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)
be captured##6##2##(1994-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2010-12#1)(2012-2#1)
be careful##3##2##(1992-3#1)(1995-2#1)(2008-5#1)
be carefully considered##7##3##(1991-3#1)(1995-11#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-7#1)(2008-9#1)
be carefully controlled##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
be carefully evaluated with##2##4##(2011-2#1)(2013-1#1)
be carefully evaluated##4##3##(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
be carefully monitored##5##3##(1991-8#1)(2007-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
be carefully##37##2##(1990-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#5)(2008-9#3)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
be carried by##2##3##(2008-10#1)(2008-3#1)
be carried out by the##3##5##(2007-10#1)(2008-10#2)
be carried out by##5##4##(2007-10#1)(2008-10#4)
be carried out for##2##4##(1994-3#1)(2008-10#1)
be carried out in an##2##5##(2008-2#2)
be carried out in order to##3##6##(1994-6#1)(2007-11#1)(2008-10#1)
be carried out in the##3##5##(1996-5#1)(2008-10#1)(2008-7#1)
be carried out in##14##4##(1994-2#1)(1994-6#1)(1996-5#2)(1997-4#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-7#1)(2013-7#1)
be carried out on a##2##5##(1992-5#1)(2009-12#1)
be carried out on##8##4##(1992-5#1)(1993-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-11#1)(2013-8#1)
be carried out with##3##4##(2008-10#1)(2009-9#1)(2011-1#1)
be carried out##50##3##(1991-5#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1996-5#2)(1997-4#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
be carried##54##2##(1991-5#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1996-5#2)(1997-4#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
be cast in the##2##4##(1994-12#1)(2008-2#1)
be cast##3##2##(1990-8#1)(1994-12#1)(2008-2#1)
be casual##2##2##(2011-2#1)(2012-3#1)
be catalyzed by##4##3##(1993-12#1)(1994-12#1)(1994-5#1)(1995-6#1)
be catalyzed##5##2##(1993-12#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#1)
be categorized##5##2##(2008-7#1)(2010-5#1)(2012-2#2)(2013-1#1)
be causally involved in##2##4##(1992-9#2)
be causally##4##2##(1992-9#2)(1994-6#1)(2009-12#1)
be causative##2##2##(1990-6#1)(1994-5#1)
be caused by a##11##4##(1992-1#1)(1994-11#1)(1994-12#2)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-6#2)
be caused by changes##2##4##(2008-11#1)(2008-9#1)
be caused by many##2##4##(2007-11#1)(2008-7#1)
be caused by mutations in##2##5##(2008-4#1)(2011-1#1)
be caused by the##5##4##(1994-12#1)(2007-11#1)(2008-10#2)(2010-3#1)
be caused by##51##3##(1990-11#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-9#2)(1995-3#1)(1995-5#1)(1997-6#1)(2007-11#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#2)
be caused##56##2##(1990-11#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-9#2)(1995-3#1)(1995-5#1)(1997-6#1)(2007-11#4)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#2)
be cautious in##2##3##(2008-7#2)
be cautious##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-2#1)
be cells##2##2##(2013-1#1)(2013-8#1)
be central to##2##3##(1990-5#1)(2008-9#1)
be central##3##2##(1990-5#1)(1997-1#1)(2008-9#1)
be certain that##2##3##(1991-12#1)(2008-9#1)
be certified##2##2##(1991-12#1)(2008-2#1)
be challenged##2##2##(1994-2#1)(2008-11#1)
be challenging##12##2##(1995-3#1)(2007-7#1)(2008-10#1)(2009-12#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
be changed by##2##3##(1996-1#1)(2008-3#1)
be changed in##2##3##(2008-7#1)(2009-12#1)
be changed to##3##3##(1991-12#1)(1991-6#1)(2008-3#1)
be changed##17##2##(1991-12#1)(1991-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2012-3#1)
be characterized as a##4##4##(1993-3#1)(1995-3#1)(2009-10#1)(2010-11#1)
be characterized as##12##3##(1993-3#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-8#1)
be characterized by a##5##4##(1990-4#1)(1996-3#1)(2008-11#1)(2008-6#1)(2012-2#1)
be characterized by an##2##4##(2012-1#1)(2013-8#1)
be characterized by##20##3##(1990-3#1)(1990-4#1)(1991-3#1)(1992-12#2)(1992-8#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
be characterized##40##2##(1990-3#1)(1990-4#1)(1991-3#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#5)
be checked##3##2##(1990-8#1)(1995-8#1)(2008-10#1)
be chemically##4##2##(1994-5#1)(2008-10#2)(2008-12#1)
be chosen according to the##3##5##(1992-3#1)(1997-3#1)(2008-2#1)
be chosen to##2##3##(1995-5#1)(1996-8#1)
be chosen##11##2##(1990-11#1)(1992-3#1)(1993-9#1)(1995-5#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-2#2)(2012-3#1)(2013-8#1)
be clarified and##2##3##(2009-6#1)(2011-2#1)
be clarified by##2##3##(2008-1#1)(2008-11#1)
be clarified##7##2##(2008-1#2)(2008-11#1)(2009-6#1)(2011-2#2)(2013-8#1)
be classified according to##3##4##(2008-1#1)(2008-10#1)(2009-10#1)
be classified as##22##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
be classified in##4##3##(1995-3#1)(2008-10#1)(2008-4#1)(2011-10#1)
be classified into two##3##4##(1997-2#1)(2008-10#1)(2012-2#1)
be classified into##15##3##(1992-7#1)(1992-9#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
be classified##53##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-3#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
be cleaned##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
be clearly identified##2##3##(2008-10#1)(2008-5#1)
be clearly##16##2##(1991-2#1)(1996-4#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-11#1)(2011-2#2)(2012-2#1)
be cleaved by##2##3##(1991-3#1)(2008-5#1)
be cleaved within##2##3##(2008-4#1)(2009-6#1)
be cleaved##5##2##(1991-3#1)(1993-12#1)(2008-4#1)(2008-5#1)(2009-6#1)
be clinical##2##2##(1994-12#1)(2010-9#1)
be clinically relevant##5##3##(1991-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-11#1)
be clinically significant##3##3##(1994-12#1)(2007-8#1)(2011-2#1)
be clinically useful##2##3##(1992-3#1)(2006-10#1)
be clinically##16##2##(1990-10#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-5#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-2#1)
be cloned##4##2##(1997-2#1)(2008-4#3)
be close to##12##3##(1990-11#1)(1992-5#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-6#1)(2012-12#1)
be closed##4##2##(2008-11#2)(2011-2#2)
be closely linked##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
be closely related to the##2##5##(2008-10#1)(2008-8#1)
be closely related to##6##4##(1994-5#1)(2008-10#1)(2008-4#2)(2008-8#2)
be closely related##8##3##(1992-9#1)(1994-5#1)(2008-10#1)(2008-4#2)(2008-8#2)(2012-3#1)
be closely##19##2##(1992-9#1)(1994-5#1)(1995-6#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#3)(2009-5#1)(2012-3#1)
be coated with##3##3##(1994-6#1)(1997-2#1)(2008-10#1)
be coated##5##2##(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)
be collected and##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)
be collected in##2##3##(2007-12#1)(2008-3#1)
be collected##13##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)
be combined in a coherent fashion##2##6##(2008-3#2)
be combined in a##3##4##(2008-3#2)(2008-6#1)
be combined in##5##3##(2008-3#2)(2008-6#1)(2008-9#1)(2009-3#1)
be combined to##6##3##(1990-12#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)
be combined with ACE inhibitors##2##5##(1996-6#1)(2008-5#1)
be combined with a##3##4##(1995-12#1)(2008-3#1)(2011-2#1)
be combined with other##4##4##(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
be combined with the##2##4##(2008-11#1)(2008-2#1)
be combined with##25##3##(1993-11#1)(1995-12#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
be combined##41##2##(1990-12#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
be comfortable with the##2##4##(2007-2#1)(2008-8#1)
be comfortable##4##2##(2007-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
be common among##2##3##(2008-10#1)(2012-3#1)
be common to##4##3##(1991-7#1)(1994-2#1)(2008-1#1)(2008-7#1)
be common##12##2##(1991-7#1)(1994-2#1)(1996-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-4#1)(2012-3#1)
be compared to the##3##4##(2007-4#1)(2008-7#1)(2010-6#1)
be compared to those##2##4##(2008-10#1)(2009-2#1)
be compared to##10##3##(1990-10#1)(1995-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-2#1)(2010-6#1)(2013-1#1)
be compared with the##3##4##(1992-2#1)(2008-10#1)(2008-2#1)
be compared with those obtained##2##5##(1993-9#1)(2008-10#1)
be compared with those##3##4##(1990-3#1)(1993-9#1)(2008-10#1)
be compared with##11##3##(1990-3#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(2007-11#1)(2008-10#3)(2008-2#1)
be compared without##2##3##(1990-9#1)(2008-5#1)
be compared##34##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-2#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
be compatible with the##5##4##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
be compatible with##7##3##(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-8#1)
be compatible##8##2##(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2010-8#1)
be compensated by##9##3##(1995-5#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
be compensated for by a##2##5##(1990-2#1)(2008-2#1)
be compensated for by##5##4##(1990-2#1)(2007-12#1)(2008-10#1)(2008-2#2)
be compensated for##9##3##(1990-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
be compensated##23##2##(1990-2#1)(1991-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2009-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
be competed##3##2##(1995-6#2)(1997-4#1)
be competent##5##2##(1992-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)
be competitive with##2##3##(2008-10#1)(2008-3#1)
be competitive##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
be complementary to##4##3##(1992-11#1)(1994-9#1)(2007-12#1)(2008-10#1)
be complementary##5##2##(1992-11#1)(1994-9#1)(1995-5#1)(2007-12#1)(2008-10#1)
be complemented by##3##3##(1995-8#1)(2011-2#1)(2012-12#1)
be complete or partial##2##4##(1991-6#1)(2010-5#1)
be complete##4##2##(1991-6#1)(2008-11#1)(2010-5#1)(2010-8#1)
be completed by##2##3##(2008-10#1)(2008-8#1)
be completed in 2##2##4##(2007-8#1)(2008-10#1)
be completed in only##2##4##(2008-10#1)(2008-3#1)
be completed in##15##3##(1990-8#1)(1994-12#1)(1995-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#1)(2011-1#1)
be completed with##2##3##(2007-10#1)(2013-8#1)
be completed within a##2##4##(2008-5#1)(2010-12#1)
be completed within##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
be completed##29##2##(1990-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
be completely blocked by the##2##5##(1997-6#1)(2008-8#1)
be completely blocked by##3##4##(1997-6#1)(2008-8#2)
be completely effective##2##3##(2007-2#1)(2008-10#1)
be completely separated##2##3##(2008-10#2)
be completely##20##2##(1990-7#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-6#1)(2006-12#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)
be complex and##2##3##(2012-2#1)(2012-3#1)
be complex##6##2##(1990-11#1)(1992-5#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
be complexed##2##2##(2008-10#1)(2009-5#1)
be complicated by##7##3##(1997-3#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-8#1)
be complicated##9##2##(1992-11#1)(1997-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-8#1)
be composed of##6##3##(1994-6#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-2#1)
be composed##7##2##(1994-6#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-2#1)
be compounded##2##2##(2008-7#1)(2010-12#1)
be comprehensive and##2##3##(2008-7#1)(2012-12#1)
be compromised##10##2##(1995-5#1)(1996-1#1)(1996-7#1)(2008-10#1)(2008-2#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-2#1)
be computed from##2##3##(2007-11#1)(2008-4#1)
be computed##9##2##(2007-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)
be concentrated in the##2##4##(1991-12#1)(2008-10#1)
be concentrated##9##2##(1991-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2009-8#1)
be concerned about the##2##4##(1992-3#1)(1994-3#1)
be concerned about##3##3##(1991-1#1)(1992-3#1)(1994-3#1)
be concerned with##2##3##(1992-1#1)(1994-1#1)
be concerned##5##2##(1991-1#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-3#1)
be concluded that the##8##4##(1990-11#1)(1992-5#1)(2008-10#4)(2008-5#1)(2010-5#1)
be concluded that##39##3##(1990-11#1)(1990-12#1)(1992-12#1)(1992-5#1)(1994-7#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-6#2)(2007-2#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-3#1)(2012-2#5)(2012-9#1)(2013-1#1)(2013-8#1)
be concluded##42##2##(1990-11#1)(1990-12#1)(1990-6#1)(1992-12#1)(1992-5#1)(1994-12#1)(1994-7#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-6#2)(2007-2#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-3#1)(2012-2#5)(2012-9#1)(2013-1#2)(2013-8#1)
be conditioned by##3##3##(2008-10#3)
be conducted in the##3##4##(2007-7#1)(2008-5#1)(2009-6#1)
be conducted in##10##3##(1991-9#1)(1993-3#1)(1997-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
be conducted on##4##3##(2008-1#1)(2008-9#1)(2011-2#2)
be conducted to##5##3##(2009-12#1)(2010-11#1)(2010-8#2)(2013-8#1)
be conducted using##4##3##(1992-3#1)(2008-10#2)(2008-5#1)
be conducted##32##2##(1991-3#1)(1991-9#1)(1992-3#1)(1993-3#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-9#1)(2009-12#1)(2009-6#2)(2010-11#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-8#1)
be conferred##2##2##(1992-12#1)(1995-2#1)
be confident##4##2##(1996-1#1)(2008-2#1)(2009-7#1)(2013-8#1)
be confirmed by a##2##4##(1992-10#1)(2008-10#1)
be confirmed by##16##3##(1990-12#1)(1990-6#1)(1992-10#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-6#1)(2009-12#1)(2012-12#1)
be confirmed in##5##3##(1993-12#1)(1995-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
be confirmed##36##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-10#1)(1993-12#1)(1995-11#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
be confounded by##2##3##(1994-9#1)(2008-10#1)
be confronted##3##2##(2008-12#1)(2008-4#1)(2011-3#1)
be confused with other##2##4##(1992-4#1)(2008-4#1)
be confused with##12##3##(1990-5#1)(1992-11#1)(1992-4#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
be connected to##6##3##(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
be connected with##2##3##(2008-10#1)(2008-11#1)
be connected##12##2##(1995-3#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
be conservative##3##2##(2008-8#1)(2010-12#1)(2012-3#1)
be conserved##5##2##(1990-8#1)(1995-5#1)(2008-10#1)(2012-1#1)(2012-3#1)
be considerable##5##2##(1993-9#1)(2007-11#1)(2008-8#1)(2010-5#1)(2013-1#1)
be considerably##6##2##(1994-3#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-7#1)
be considered a new##2##4##(1995-12#1)(2008-10#1)
be considered a primary##2##4##(2007-7#1)(2008-2#1)
be considered a risk factor for##2##6##(1997-3#1)(2008-11#1)
be considered a valid##2##4##(1991-6#1)(2010-12#1)
be considered a##37##3##(1991-12#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#2)(1997-3#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-12#2)(2013-1#2)
be considered an adequate##2##4##(1990-6#1)(1991-12#1)
be considered an##14##3##(1990-6#1)(1991-12#1)(1993-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
be considered and##3##3##(1992-2#1)(1997-1#1)(2008-10#1)
be considered as a possible cause##2##6##(2008-10#1)(2008-12#1)
be considered as a possible##3##5##(2008-10#1)(2008-12#1)(2012-12#1)
be considered as a promising##2##5##(2012-2#1)(2013-1#1)
be considered as a##47##4##(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
be considered as an##10##4##(1994-3#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2011-2#2)(2013-1#1)
be considered as new##2##4##(2008-7#1)(2012-3#1)
be considered as the##4##4##(2008-10#1)(2008-11#1)(2012-2#2)
be considered as useful##3##4##(2008-10#1)(2008-11#1)(2010-3#1)
be considered as##98##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1997-2#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#5)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)
be considered at##4##3##(2008-11#1)(2009-7#1)(2009-8#1)(2012-6#1)
be considered before##2##3##(1995-5#1)(2010-8#1)
be considered by##5##3##(1993-11#1)(1994-1#1)(1995-3#1)(2007-12#1)(2011-2#1)
be considered during##3##3##(1997-4#1)(2007-10#1)(2012-12#1)
be considered for the treatment of##2##6##(1991-9#1)(2008-12#1)
be considered for the##6##4##(1991-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)
be considered for##28##3##(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1995-3#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-8#2)
be considered if the##2##4##(1996-6#1)(2011-2#1)
be considered if##7##3##(1992-5#1)(1996-6#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)
be considered in a##2##4##(2008-11#1)(2012-3#1)
be considered in addition to##2##5##(2008-11#1)(2013-1#1)
be considered in any##6##4##(1993-11#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
be considered in clinical##2##4##(2008-6#1)(2012-3#1)
be considered in designing##2##4##(1997-4#1)(2008-2#1)
be considered in future##3##4##(1992-9#1)(2008-1#1)(2009-2#1)
be considered in selected patients##2##5##(2007-8#1)(2011-2#1)
be considered in the design##3##5##(2008-4#1)(2013-1#1)(2013-8#1)
be considered in the differential diagnosis of any##2##8##(2006-10#1)(2012-3#1)
be considered in the differential diagnosis of##14##7##(1996-11#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)
be considered in the differential diagnosis##17##6##(1996-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
be considered in the future##2##5##(2009-6#1)(2013-1#1)
be considered in the##34##4##(1993-11#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-3#3)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#4)(2013-1#2)(2013-8#2)
be considered in##94##3##(1990-3#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-11#2)(1994-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-3#3)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#5)(2013-8#3)
be considered more##2##3##(1990-6#1)(2008-11#1)
be considered of##2##3##(2010-5#1)(2010-6#1)
be considered on the##2##4##(2008-10#1)(2008-5#1)
be considered only##2##3##(1990-6#1)(1990-9#1)
be considered suitable for##2##4##(1992-2#1)(2013-8#1)
be considered that the##2##4##(1994-9#1)(1995-12#1)
be considered that##3##3##(1994-9#1)(1995-12#1)(2008-5#1)
be considered the##5##3##(2007-12#1)(2008-5#1)(2008-8#2)(2012-2#1)
be considered to be a##6##5##(1995-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
be considered to be##11##4##(1992-11#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2012-3#1)
be considered to##20##3##(1992-11#1)(1993-6#1)(1994-9#1)(1995-11#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2012-3#1)
be considered when choosing a##2##5##(2008-8#1)(2009-8#1)
be considered when choosing##3##4##(2008-8#1)(2009-8#1)(2011-1#1)
be considered when determining##3##4##(1993-2#1)(2008-11#1)(2009-4#1)
be considered when developing##2##4##(2008-10#1)(2008-11#1)
be considered when evaluating##2##4##(1993-2#1)(2008-4#1)
be considered when interpreting##2##4##(2008-10#1)(2011-1#1)
be considered when planning##2##4##(2008-8#1)(2013-8#1)
be considered when##36##3##(1992-4#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-5#1)(1995-1#2)(1996-3#1)(1997-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#4)(2008-7#2)(2008-8#2)(2009-1#1)(2009-4#2)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
be considered within##2##3##(1990-6#1)(2008-12#1)
be considered##504##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-6#6)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#6)(1995-1#3)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-8#3)(2006-10#6)(2006-12#1)(2007-10#4)(2007-11#7)(2007-12#9)(2007-2#4)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#11)(2008-10#58)(2008-11#20)(2008-12#10)(2008-2#3)(2008-3#10)(2008-4#14)(2008-5#13)(2008-6#4)(2008-7#20)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#8)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#7)(2011-1#13)(2011-2#48)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#6)(2012-3#15)(2012-6#1)(2013-1#13)(2013-7#2)(2013-8#11)
be consistent with the##7##4##(1992-3#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
be consistent with##22##3##(1991-8#1)(1992-3#2)(1996-4#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#5)(2013-8#1)
be consistent##26##2##(1991-8#1)(1992-3#2)(1995-9#1)(1996-4#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#5)(2009-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
be consistently##3##2##(2008-10#2)(2012-3#1)
be constant##4##2##(1991-5#1)(1992-6#1)(2008-10#2)
be constrained by the##2##4##(1995-1#1)(2012-12#1)
be constrained by##3##3##(1993-2#1)(1995-1#1)(2012-12#1)
be constrained##4##2##(1993-2#1)(1995-1#1)(2008-3#1)(2012-12#1)
be constructed##21##2##(1990-11#1)(1991-5#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2011-2#1)
be construed##2##2##(1993-1#1)(2007-2#1)
be consumed##2##2##(2009-7#1)(2013-7#1)
be contained##3##2##(1991-6#1)(2008-7#2)
be contaminated by##2##3##(2008-10#1)(2009-11#1)
be contaminated##8##2##(1994-3#1)(1995-11#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-5#1)(2011-2#1)
be continued for more than 1##3##6##(2009-12#3)
be continued for more than##4##5##(2009-12#4)
be continued for##8##3##(1990-9#1)(1992-11#1)(1994-9#1)(2008-4#1)(2009-12#4)
be continued##14##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-11#1)(1994-9#1)(2008-4#1)(2008-8#1)(2009-12#4)(2010-1#1)(2012-3#1)(2013-8#1)
be continuously used##2##3##(2008-10#2)
be continuously##9##2##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)
be contraindicated##2##2##(2008-7#1)(2011-1#1)
be contributing##2##2##(2008-8#1)(2010-4#1)
be contributory##2##2##(2007-12#1)(2008-1#1)
be controlled by##31##3##(1993-6#1)(1994-3#1)(1995-12#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2011-2#2)
be controlled or##3##3##(1992-3#1)(1993-3#1)(2007-10#1)
be controlled with##5##3##(1997-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
be controlled##67##2##(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-3#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-11#5)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#7)(2008-9#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)
be convenient##3##2##(2007-7#1)(2008-11#1)(2008-4#1)
be converted into##6##3##(1996-5#1)(2007-11#1)(2008-3#1)(2009-9#1)(2010-5#1)(2011-3#1)
be converted to the##2##4##(1996-2#1)(2008-10#1)
be converted to##8##3##(1990-5#1)(1995-5#1)(1996-2#2)(2008-10#3)(2008-4#1)
be converted##16##2##(1990-5#1)(1995-5#1)(1996-2#2)(1996-5#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-4#1)(2009-9#1)(2010-5#1)(2011-3#1)
be conveyed##2##2##(1993-12#1)(2008-2#1)
be coordinated##3##2##(1994-12#1)(1994-2#1)(1997-3#1)
be correct##5##2##(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)
be corrected by##4##3##(1996-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
be corrected for##3##3##(1996-12#1)(2007-11#1)(2008-10#1)
be corrected to##2##3##(2007-11#1)(2008-3#1)
be corrected##15##2##(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#6)(2009-7#1)(2010-8#1)(2012-1#1)
be correctly##2##2##(1995-6#1)(2008-10#1)
be correlated by##2##3##(2007-11#1)(2008-3#1)
be correlated to the##2##4##(2008-10#1)(2008-11#1)
be correlated to##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
be correlated with a##3##4##(1991-6#1)(1996-12#1)(2007-12#1)
be correlated with changes in the##2##6##(1993-5#1)(2008-10#1)
be correlated with the##8##4##(1991-12#1)(1991-6#1)(1992-6#2)(1995-11#1)(2007-12#1)(2008-10#2)
be correlated with their##2##4##(2008-10#1)(2008-9#1)
be correlated with##22##3##(1991-12#1)(1991-6#2)(1992-6#2)(1993-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-12#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-3#1)
be correlated##30##2##(1991-12#1)(1991-6#2)(1992-6#2)(1993-3#1)(1993-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-3#1)
be cost effective##2##3##(2008-10#1)(2012-2#1)
be cost-effective##3##2##(1997-7#1)(2008-3#1)(2012-12#1)
be costly##2##2##(1992-11#1)(2009-5#1)
be counted##2##2##(1995-3#1)(2008-11#1)
be coupled into the##2##4##(2008-3#2)
be coupled to##8##3##(1992-3#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#1)
be coupled##16##2##(1992-3#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)
be covalently bound##3##3##(1990-2#1)(1993-6#1)(2008-10#1)
be covalently##7##2##(1990-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1997-6#1)(2008-10#1)(2008-5#1)
be covered by##4##3##(1990-2#1)(1991-11#1)(1994-3#2)
be covered in##2##3##(2007-2#1)(2008-4#1)
be covered with##2##3##(2007-12#1)(2011-2#1)
be covered##11##2##(1990-2#1)(1991-1#1)(1991-11#1)(1994-3#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
be created by##2##3##(2008-4#1)(2011-2#1)
be created##13##2##(1991-1#1)(1996-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
be critical for##9##3##(1995-5#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-2#1)(2012-7#1)
be critical to the##2##4##(2008-10#1)(2013-8#1)
be critical to##4##3##(2008-10#1)(2012-2#2)(2013-8#1)
be critical##17##2##(1990-12#1)(1992-6#1)(1995-5#1)(1995-6#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)(2010-2#1)(2012-2#2)(2012-7#1)(2013-8#1)
be critically important##2##3##(2008-10#1)(2013-1#1)
be critically##7##2##(1994-6#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2013-1#1)
be crucial for##6##3##(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2012-3#1)
be crucial to the##2##4##(1997-3#1)(2008-10#1)
be crucial to##7##3##(1997-3#1)(2008-10#2)(2008-12#1)(2010-11#1)(2010-5#1)(2012-12#1)
be crucial##17##2##(1997-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#1)
be cultured in##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
be cultured##8##2##(1990-6#1)(1994-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
be curative##5##2##(1997-2#1)(2010-10#1)(2010-3#1)(2010-6#1)(2012-12#1)
be cured by##4##3##(1994-9#1)(1995-6#1)(1996-11#1)(1997-6#1)
be cured with##3##3##(1990-12#1)(1991-9#1)(2010-3#1)
be cured##13##2##(1990-12#1)(1991-9#1)(1992-9#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)
be customized##2##2##(1996-2#1)(2008-4#1)
be cut##2##2##(2007-11#1)(2008-11#1)
be cytotoxic##2##2##(1991-12#1)(2013-1#1)
be damaged##3##2##(2007-11#1)(2008-8#1)(2012-2#1)
be dangerous to life##2##4##(2011-2#2)
be dangerous to##3##3##(2011-2#2)(2013-1#1)
be dangerous##6##2##(1995-11#1)(1996-3#1)(2008-10#1)(2011-2#2)(2013-1#1)
be dealt with##3##3##(1991-3#1)(1996-2#1)(2008-3#1)
be debated openly##2##3##(1995-5#1)(1996-11#1)
be debated##4##2##(1995-5#1)(1996-11#1)(2008-11#1)(2008-8#1)
be decomposed into a##2##4##(2008-2#1)(2008-3#1)
be decomposed##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
be decreased by##6##3##(1992-11#2)(1994-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
be decreased in##3##3##(1993-3#2)(2013-1#1)
be decreased##20##2##(1990-2#1)(1992-11#2)(1993-3#2)(1994-6#1)(1995-3#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2010-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
be decreasing in##2##3##(2008-8#1)(2010-12#1)
be deduced that the##2##4##(2008-10#2)
be deduced##10##2##(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)
be deficient in##2##3##(1995-12#1)(2008-10#1)
be deficient##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-4#1)
be defined and##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
be defined as an##2##4##(1993-6#1)(1996-3#1)
be defined as the##5##4##(1997-3#1)(2008-1#1)(2008-7#2)(2008-8#1)
be defined as##13##3##(1993-6#2)(1994-9#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-4#2)(2008-7#2)(2008-8#2)(2012-12#1)
be defined by##3##3##(1993-11#1)(2008-8#1)(2010-6#1)
be defined for##2##3##(1995-12#1)(2008-10#1)
be defined##40##2##(1991-12#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-9#1)(1995-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
be degraded by##2##3##(2008-2#1)(2008-5#1)
be degraded##11##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-5#1)(2011-2#1)
be delayed for##3##3##(1990-12#1)(1994-3#1)(2013-8#1)
be delayed##9##2##(1990-12#1)(1992-2#1)(1994-3#1)(2007-6#1)(2008-1#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-8#1)
be deleterious##2##2##(2008-10#1)(2011-2#1)
be delineated##3##2##(1996-2#1)(2008-4#1)(2013-8#1)
be delivered in a##2##4##(1995-5#1)(2011-1#1)
be delivered to patients##2##4##(2010-7#1)(2013-8#1)
be delivered to##5##3##(1993-9#1)(2008-3#1)(2008-5#1)(2010-7#1)(2013-8#1)
be delivered##16##2##(1993-9#1)(1995-5#1)(1997-1#2)(2008-11#3)(2008-3#1)(2008-5#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
be demodulated##2##2##(2008-2#2)
be demonstrated by##4##3##(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#1)
be demonstrated in the##2##4##(1992-11#1)(2007-10#1)
be demonstrated in##6##3##(1990-11#1)(1992-11#1)(1994-11#1)(1995-12#1)(1997-6#1)(2007-10#1)
be demonstrated on##2##3##(1995-2#1)(2008-2#1)
be demonstrated that##2##3##(1991-12#1)(2008-5#1)
be demonstrated to##3##3##(1992-12#1)(1995-2#1)(2012-2#1)
be demonstrated using##2##3##(2008-10#1)(2008-5#1)
be demonstrated##45##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
be denied##3##2##(1997-5#1)(2010-8#1)(2011-2#1)
be dependent on the##11##4##(1991-3#1)(1991-5#1)(1994-10#1)(1995-1#1)(1995-6#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-2#1)
be dependent on##24##3##(1990-5#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2010-5#1)(2011-2#2)
be dependent upon##10##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
be dependent##36##2##(1990-5#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#3)
be depleted##4##2##(1991-3#1)(1992-11#1)(2008-5#1)(2008-7#1)
be deployed##2##2##(1995-6#1)(2009-3#1)
be deposited##6##2##(1996-9#2)(2008-10#1)(2008-11#1)(2009-11#1)(2010-4#1)
be depressed##3##2##(1996-5#1)(2007-11#1)(2008-10#1)
be derived by##2##3##(2008-2#1)(2013-1#1)
be derived for##4##3##(2008-10#3)(2008-8#1)
be derived from a##5##4##(1994-3#1)(1996-2#1)(1997-6#1)(2008-11#1)(2009-6#1)
be derived from the##9##4##(1990-5#1)(1991-12#1)(1992-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
be derived from##36##3##(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#4)(2011-2#1)(2012-2#2)(2012-3#1)
be derived##58##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#4)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
be described as a##7##4##(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#1)
be described as the##3##4##(2008-7#1)(2008-9#1)(2013-1#1)
be described as##14##3##(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
be described by a simple##2##5##(2008-5#1)(2008-7#1)
be described by a##11##4##(1991-5#1)(1995-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)
be described by the##5##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
be described by##21##3##(1991-5#2)(1995-5#1)(2007-12#3)(2008-10#5)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#2)(2013-1#1)
be described in##5##3##(1995-3#1)(2008-3#2)(2008-5#1)(2011-1#1)
be described##62##2##(1991-5#3)(1995-3#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#5)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
be designated##7##2##(1992-12#1)(2008-10#5)(2010-3#1)
be designed and##4##3##(2007-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
be designed for##4##3##(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
be designed or##2##3##(2008-11#1)(2012-3#1)
be designed to##9##3##(1994-3#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2012-3#1)
be designed##25##2##(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
be desirable to##5##3##(2007-4#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
be desirable##10##2##(1993-1#1)(1993-11#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
be desired##4##2##(1992-3#1)(2007-10#1)(2008-10#2)
be desorbed in##2##3##(2008-10#1)(2008-7#1)
be desorbed with##4##3##(2008-10#4)
be desorbed##7##2##(2008-10#5)(2008-4#1)(2008-7#1)
be detectable##3##2##(1996-4#1)(2008-1#1)(2008-11#1)
be detected after##3##3##(1995-11#1)(1996-12#1)(2008-10#1)
be detected among##2##3##(2008-10#2)
be detected and##12##3##(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
be detected as##5##3##(1993-8#1)(1995-12#1)(2008-10#2)(2008-6#1)
be detected at a##2##4##(1995-8#1)(2008-10#1)
be detected at##7##3##(1995-8#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-6#1)
be detected by UV##2##4##(2008-10#2)
be detected by a##2##4##(2007-11#1)(2010-12#1)
be detected by the##5##4##(1993-8#1)(2008-1#1)(2008-10#2)(2008-2#1)
be detected by##36##3##(1990-6#1)(1990-9#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-8#2)(1994-7#1)(1994-9#1)(1996-12#2)(1996-5#1)(1997-2#1)(2007-11#2)(2008-1#2)(2008-10#6)(2008-2#2)(2008-4#5)(2008-9#3)(2009-6#1)(2010-12#1)(2013-1#1)
be detected directly##2##3##(1993-9#1)(2008-12#1)
be detected for##2##3##(1995-2#1)(2008-10#1)
be detected in the##21##4##(1990-11#1)(1990-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2012-3#1)
be detected in various##2##4##(1991-9#1)(1993-8#1)
be detected in##67##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-5#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
be detected on##6##3##(1991-12#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-7#2)
be detected using##7##3##(1995-6#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
be detected when##2##3##(1991-3#1)(1997-4#1)
be detected with the##2##4##(1991-3#1)(2008-10#1)
be detected with##10##3##(1991-3#1)(1994-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)
be detected within##2##3##(1995-2#1)(1997-3#1)
be detected##226##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#5)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-6#4)(1995-8#1)(1996-12#6)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#57)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#8)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#5)
be determined accurately##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
be determined and##4##3##(1990-8#1)(1995-11#1)(2008-10#1)(2008-8#1)
be determined at##2##3##(2008-10#1)(2008-2#1)
be determined by a##2##4##(2007-11#1)(2008-1#1)
be determined by measuring##2##4##(2008-10#1)(2008-7#1)
be determined by the##9##4##(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2010-4#1)
be determined by this##3##4##(2008-10#3)
be determined by##40##3##(1990-8#1)(1992-3#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-4#1)(2012-12#2)
be determined directly##5##3##(1995-2#1)(2008-10#3)(2008-11#1)
be determined during##2##3##(1995-6#1)(2008-10#1)
be determined for##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
be determined from the##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
be determined from##10##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2011-2#1)(2012-1#1)
be determined in a single##2##5##(1990-8#1)(2008-10#1)
be determined in a##3##4##(1990-8#1)(2008-10#2)
be determined in an##2##4##(2008-10#1)(2010-3#1)
be determined in the concentration##2##5##(2008-10#2)
be determined in the presence of##4##6##(2008-10#4)
be determined in the##18##4##(2008-10#17)(2008-3#1)
be determined in##43##3##(1990-8#1)(1992-5#1)(2008-10#33)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-3#1)(2012-2#1)
be determined independently##2##3##(2008-10#1)(2008-3#1)
be determined indirectly##3##3##(2008-10#3)
be determined over##3##3##(2008-10#2)(2008-7#1)
be determined simultaneously with the concentration ratios of##3##8##(2008-10#3)
be determined simultaneously with##4##4##(2008-10#4)
be determined simultaneously##9##3##(2008-10#9)
be determined to##3##3##(2008-10#1)(2008-3#2)
be determined using##5##3##(2008-10#4)(2008-4#1)
be determined whether the##2##4##(2008-11#1)(2008-5#1)
be determined whether##6##3##(2006-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)
be determined with a##5##4##(2008-10#4)(2008-3#1)
be determined with high accuracy##2##5##(2007-12#1)(2008-10#1)
be determined with the##2##4##(2008-10#1)(2008-3#1)
be determined with##16##3##(1992-7#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#2)
be determined without##2##3##(2008-10#2)
be determined##261##2##(1990-12#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#5)(2007-12#5)(2008-1#4)(2008-10#118)(2008-11#6)(2008-2#9)(2008-3#35)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)
be detrimental to##5##3##(1992-2#1)(2008-11#1)(2008-12#2)(2008-8#1)
be detrimental##8##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-1#1)
be devastating##4##2##(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
be developed and applied##2##4##(2008-10#1)(2008-3#1)
be developed and implemented##2##4##(1996-12#1)(2010-3#1)
be developed and##6##3##(1995-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
be developed as a##3##4##(2008-10#1)(2008-8#1)(2011-3#1)
be developed as##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
be developed based on##2##4##(1993-3#1)(2008-11#1)
be developed by##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
be developed for automated##2##4##(2008-10#1)(2008-2#1)
be developed for##5##3##(2007-2#1)(2008-10#3)(2008-2#1)
be developed in order to##2##5##(1993-11#1)(2008-11#1)
be developed in##4##3##(1993-11#1)(1994-7#1)(2008-11#1)(2008-5#1)
be developed into a##2##4##(1997-4#1)(2008-11#1)
be developed that##2##3##(2008-2#1)(2008-3#1)
be developed to overcome##2##4##(2013-1#1)(2013-7#1)
be developed to##9##3##(1992-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
be developed with##2##3##(2007-11#1)(2008-3#1)
be developed within the##2##4##(1991-12#1)(2008-11#1)
be developed##80##2##(1991-12#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(2007-11#1)(2007-2#1)(2008-10#12)(2008-11#9)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#2)(2010-3#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
be developmentally##2##2##(1990-11#1)(2008-10#1)
be devoted to##2##3##(1996-11#1)(2008-1#1)
be diagnosed in##2##3##(1990-3#1)(1991-3#1)
be diagnosed##14##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-3#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-4#1)(2009-1#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
be diagnostically##2##2##(1992-5#1)(2010-8#1)
be differences in##2##3##(2008-8#1)(2012-12#1)
be different between##2##3##(1997-2#1)(2009-12#1)
be different for different##2##4##(2008-10#1)(2012-2#1)
be different from that##3##4##(1993-6#1)(1996-5#1)(2008-11#1)
be different from the##2##4##(1990-8#1)(2008-10#1)
be different from those##2##4##(1996-2#1)(2007-7#1)
be different from##12##3##(1990-8#1)(1993-6#1)(1996-2#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2010-10#1)(2010-4#1)
be different in##3##3##(1993-11#1)(2008-10#1)(2008-12#1)
be different than##2##3##(1996-12#1)(2008-10#1)
be different##31##2##(1990-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2010-10#1)(2010-4#1)(2012-2#2)
be differentially##7##2##(1991-2#1)(1995-2#2)(2008-10#2)(2009-9#1)(2011-1#1)
be differentiated by##5##3##(1991-11#1)(2008-10#3)(2012-3#1)
be differentiated from other causes of##2##6##(2008-12#1)(2011-1#1)
be differentiated from other##3##4##(2008-12#1)(2010-6#1)(2011-1#1)
be differentiated from##5##3##(2008-12#1)(2010-6#1)(2011-1#2)(2011-2#1)
be differentiated into##5##3##(1997-6#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
be differentiated on##2##3##(1990-7#1)(2011-2#1)
be differentiated##26##2##(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1996-11#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)
be difficult and##3##3##(2008-12#1)(2010-11#1)(2013-7#1)
be difficult for##3##3##(1994-12#1)(2008-9#1)(2009-6#1)
be difficult in a##2##4##(1997-6#1)(2007-8#1)
be difficult or##2##3##(1997-3#1)(1997-8#1)
be difficult to achieve##2##4##(1992-3#1)(2013-1#1)
be difficult to obtain##4##4##(1991-2#1)(1992-9#1)(2006-12#1)(2008-10#1)
be difficult to##18##3##(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#3)
be difficult with##2##3##(2007-8#1)(2008-6#1)
be difficult##54##2##(1990-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#3)(2013-7#1)
be diluted##2##2##(2008-10#2)
be directed at##6##3##(1992-2#1)(1997-8#1)(2007-7#1)(2008-2#1)(2009-5#1)(2013-8#1)
be directed to##4##3##(1992-3#1)(1995-3#1)(2008-1#1)(2008-3#1)
be directed toward the##2##4##(1992-3#1)(1993-2#1)
be directed toward##3##3##(1992-3#1)(1993-2#1)(1996-1#1)
be directed towards##4##3##(1992-9#1)(1995-8#1)(2008-1#1)(2011-2#1)
be directed##20##2##(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#2)(2013-8#1)
be directly extracted from##2##4##(2008-3#1)(2013-1#1)
be directly involved in the##2##5##(1993-8#1)(1995-12#1)
be directly involved in##3##4##(1993-8#1)(1995-12#1)(2008-3#1)
be directly linked to##2##4##(2008-6#1)(2012-3#1)
be directly##41##2##(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-1#2)(2008-10#10)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
be discerned##4##2##(1997-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
be discharged##4##2##(1995-6#1)(2007-11#1)(2008-3#1)(2008-5#1)
be disclosed##5##2##(1991-3#1)(2008-10#1)(2008-8#1)(2009-4#2)
be discontinued##2##2##(1990-2#1)(1992-1#1)
be discounted##5##2##(1990-6#1)(1996-12#1)(2008-8#1)(2013-1#2)
be discovered and##2##3##(2008-10#1)(2011-2#1)
be discovered##11##2##(1991-12#1)(1991-5#1)(1995-12#1)(1996-11#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#2)
be discriminated from##3##3##(2008-3#1)(2008-7#2)
be discriminated##10##2##(1992-11#1)(2008-10#5)(2008-3#2)(2008-7#2)
be discussed and##2##3##(2010-11#1)(2012-2#1)
be discussed with##3##3##(1997-5#1)(2009-3#1)(2013-1#1)
be discussed##77##2##(1990-3#1)(1992-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#4)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
be dispersed##2##2##(2008-10#2)
be displayed##5##2##(1990-8#1)(2008-3#2)(2009-10#1)(2010-9#1)
be disregarded##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
be disrupted##6##2##(1993-6#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)
be disseminated by##2##3##(2008-10#1)(2013-8#1)
be disseminated##4##2##(1993-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
be dissociated from##3##3##(1993-8#1)(1995-6#1)(2013-8#1)
be dissociated##6##2##(1993-6#1)(1993-8#1)(1995-6#1)(2008-8#2)(2013-8#1)
be dissolved##7##2##(2008-10#5)(2009-12#1)(2013-1#1)
be distinct from those##3##4##(2006-6#1)(2008-7#1)(2012-2#1)
be distinct from##6##3##(1992-3#1)(1994-12#1)(2006-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
be distinct##11##2##(1992-3#1)(1994-12#1)(1996-2#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)
be distinguished by their##4##4##(2007-8#1)(2008-11#1)(2011-2#2)
be distinguished by##10##3##(1993-12#1)(1993-8#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2011-2#2)
be distinguished from a##2##4##(1993-2#1)(2012-2#1)
be distinguished from each other##4##5##(2008-10#1)(2008-4#1)(2009-12#1)(2009-5#1)
be distinguished from other##3##4##(2008-10#2)(2009-3#1)
be distinguished from the##4##4##(2008-2#1)(2008-3#1)(2012-3#1)(2013-7#1)
be distinguished from##25##3##(1992-2#1)(1993-2#1)(1994-9#1)(1997-6#1)(2007-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#2)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
be distinguished into##2##3##(2010-12#1)(2013-1#1)
be distinguished on the##2##4##(1993-8#1)(2008-10#1)
be distinguished on##3##3##(1993-11#1)(1993-8#1)(2008-10#1)
be distinguished##64##2##(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-9#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
be distorted##2##2##(1990-12#1)(2008-1#1)
be distributed##4##2##(1990-5#1)(1993-11#1)(2007-12#1)(2008-10#1)
be divided in##3##3##(1996-12#1)(2008-10#1)(2012-9#1)
be divided into at least##2##5##(1995-11#1)(2008-10#1)
be divided into four##3##4##(1997-8#1)(2008-10#1)(2009-8#1)
be divided into the##4##4##(1990-5#1)(1993-2#1)(2008-10#2)
be divided into three stages##2##5##(2008-10#1)(2008-4#1)
be divided into three##7##4##(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
be divided into two groups##2##5##(1991-6#1)(2008-10#1)
be divided into two##12##4##(1991-6#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)
be divided into##39##3##(1990-5#1)(1991-6#1)(1992-11#1)(1993-2#1)(1995-11#1)(1995-12#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
be divided##44##2##(1990-5#1)(1991-6#1)(1992-11#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-9#1)(2013-1#1)
be documented##4##2##(1991-3#1)(1996-11#1)(2008-10#1)(2008-7#1)
be doing##2##2##(1992-1#1)(1995-2#1)
be dominated by##5##3##(1990-6#1)(1992-9#1)(2008-3#1)(2008-9#1)(2011-2#1)
be done about##2##3##(1995-11#1)(2008-11#1)
be done and##2##3##(2008-7#1)(2012-2#1)
be done at##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2010-7#1)
be done by##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
be done in both##4##4##(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#1)
be done in the##4##4##(1991-4#1)(2008-10#2)(2011-1#1)
be done in##14##3##(1991-4#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-1#2)
be done on##3##3##(1991-11#1)(1996-3#1)(2008-10#1)
be done through the##2##4##(2008-10#1)(2012-12#1)
be done to ensure##2##4##(1991-1#1)(1992-11#1)
be done to##15##3##(1991-1#1)(1992-11#2)(1995-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
be done without##3##3##(2007-8#1)(2008-10#1)(2010-10#1)
be done?##2##2##(2012-12#2)
be dose dependent##3##3##(1992-5#1)(2008-5#1)(2012-12#1)
be dose##4##2##(1992-5#1)(2008-5#1)(2012-12#1)(2013-1#1)
be downloaded and run##2##4##(2008-4#1)(2008-9#1)
be downloaded##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
be dramatically##4##2##(1992-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
be drawn from##10##3##(1991-12#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-12#1)(2013-8#1)
be drawn##24##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-11#2)(1995-5#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#1)(2010-12#1)(2013-8#1)
be driven by the##2##4##(1993-9#1)(2010-1#1)
be driven by##5##3##(1993-9#1)(1997-3#1)(2008-8#1)(2008-9#1)(2010-1#1)
be driven##6##2##(1993-9#1)(1997-3#1)(2008-8#2)(2008-9#1)(2010-1#1)
be due entirely to##2##4##(1993-12#1)(1993-8#1)
be due in##5##3##(1993-11#1)(1995-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
be due mainly to the##2##5##(1992-8#1)(1992-9#1)
be due to a higher##2##5##(1993-8#1)(2009-7#1)
be due to a##16##4##(1991-12#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-11#1)(2011-2#2)
be due to an##4##4##(1991-12#1)(1996-2#1)(2008-10#1)(2008-7#1)
be due to differences in##2##5##(2007-12#1)(2008-10#1)
be due to genetic##2##4##(2007-2#1)(2008-10#1)
be due to inadequate##3##4##(1993-9#1)(2008-10#1)(2012-3#1)
be due to its ability to##2##6##(1991-12#1)(1993-3#1)
be due to its##7##4##(1990-12#1)(1991-12#1)(1992-8#1)(1993-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
be due to other##2##4##(1993-6#1)(2013-1#1)
be due to the fact that##4##6##(1991-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
be due to the##42##4##(1990-12#1)(1990-2#1)(1991-2#3)(1991-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-3#1)(2012-3#1)(2013-1#1)
be due to their##4##4##(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
be due to##159##3##(1990-12#2)(1990-2#2)(1990-6#2)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#4)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
be due##179##2##(1990-12#2)(1990-2#3)(1990-6#2)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#5)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
be durable##3##2##(2008-10#2)(2012-12#1)
be dynamically##4##2##(1994-8#1)(1996-2#1)(2007-11#1)(2008-2#1)
be early##2##2##(2008-11#1)(2010-6#1)
be easily achieved##6##3##(2008-1#1)(2008-10#4)(2008-9#1)
be easily adapted to##6##4##(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
be easily adapted##7##3##(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
be easily added##2##3##(2008-3#1)(2012-3#1)
be easily and##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
be easily applied##3##3##(2008-10#1)(2010-11#1)(2010-4#1)
be easily detected##5##3##(1990-2#1)(1991-5#1)(2006-6#1)(2008-10#1)(2008-3#1)
be easily determined##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
be easily distinguished from##2##4##(2008-10#2)
be easily identified##2##3##(2008-2#1)(2008-6#1)
be easily missed##3##3##(2008-7#1)(2009-4#1)(2013-8#1)
be easily modified##2##3##(2008-4#1)(2008-5#1)
be easily obtained##3##3##(2007-12#1)(2009-3#1)(2011-2#1)
be easily performed##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
be easily regenerated and##2##4##(2008-10#2)
be easily regenerated##3##3##(2008-10#3)
be easily reproduced##2##3##(2008-10#1)(2008-3#1)
be easily separated##3##3##(2008-10#3)
be easily##113##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1994-11#2)(1994-3#2)(1995-8#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#40)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
be easy##2##2##(1995-12#1)(1995-2#1)
be ecologically##2##2##(2008-11#1)(2008-8#1)
be economical##2##2##(2008-10#1)(2008-6#1)
be educated##2##2##(2010-1#1)(2012-12#1)
be effective against##4##3##(1992-12#1)(1994-6#1)(1997-6#1)(2008-10#1)
be effective for the treatment of##2##6##(2011-1#1)(2013-1#1)
be effective for the##7##4##(1997-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-6#1)(2013-1#1)
be effective for##18##3##(1994-6#1)(1997-2#1)(1997-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-6#1)(2013-1#2)
be effective if##2##3##(2008-8#1)(2010-1#1)
be effective in controlling##2##4##(2008-1#1)(2013-1#1)
be effective in obtaining##2##4##(1992-9#1)(2006-6#1)
be effective in preventing##4##4##(1992-3#1)(1995-3#1)(2007-7#1)(2010-7#1)
be effective in reducing##4##4##(1990-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
be effective in the treatment of##2##6##(2010-5#1)(2011-2#1)
be effective in the##4##4##(2008-12#1)(2010-5#1)(2011-2#2)
be effective in treating##2##4##(2008-11#1)(2013-1#1)
be effective in treatment of RE##2##6##(2008-8#2)
be effective in##52##3##(1990-3#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-3#1)(1997-1#1)(1997-6#1)(2006-6#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#3)(2009-4#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-3#1)(2013-1#5)
be effective to##2##3##(2008-11#1)(2012-2#1)
be effective##127##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#5)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#3)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#8)(2013-8#1)
be effectively determined##2##3##(1993-12#1)(2008-11#1)
be effectively used in##2##4##(2007-10#1)(2008-10#1)
be effectively used##4##3##(1994-3#1)(2007-10#1)(2007-7#1)(2008-10#1)
be effectively##25##2##(1992-9#1)(1993-12#1)(1994-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-8#1)
be efficient##12##2##(1995-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
be efficiently used for##3##4##(2008-11#1)(2008-12#1)(2008-4#1)
be efficiently used##4##3##(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)
be efficiently##22##2##(2007-11#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2012-2#1)
be efforts##2##2##(1995-3#1)(2007-10#1)
be either a##6##3##(1996-3#1)(2008-2#4)(2008-3#1)
be either##28##2##(1990-8#1)(1992-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-9#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
be elaborated##2##2##(2008-10#2)
be elevated in##4##3##(1993-12#1)(1993-8#1)(2008-5#1)(2010-11#1)
be elevated##7##2##(1992-8#1)(1993-12#1)(1993-8#1)(2008-5#1)(2010-11#1)(2010-9#1)(2013-8#1)
be elicited by##4##3##(1992-8#1)(2008-11#2)(2013-8#1)
be elicited##5##2##(1990-12#1)(1992-8#1)(2008-11#2)(2013-8#1)
be eliminated by addition of##2##5##(2008-10#1)(2008-8#1)
be eliminated by using##2##4##(2008-10#2)
be eliminated by##13##3##(1990-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)
be eliminated from##2##3##(1992-1#1)(1997-4#1)
be eliminated##33##2##(1990-8#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2012-1#1)(2013-8#1)
be elucidated##21##2##(1993-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#3)
be eluted by##2##3##(2008-10#2)
be eluted from##3##3##(1990-12#1)(2008-10#2)
be eluted##10##2##(1990-12#1)(1991-12#1)(2008-10#8)
be embodied##2##2##(1995-3#1)(2012-2#1)
be embolized##3##2##(2006-12#1)(2008-7#2)
be emphasised##2##2##(2007-7#1)(2008-11#1)
be emphasized##10##2##(1992-12#1)(1992-6#1)(1993-12#1)(1996-12#1)(1996-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2011-3#1)
be employed as a##4##4##(2007-12#1)(2008-10#3)
be employed as##7##3##(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)
be employed for the##3##4##(2008-10#2)(2009-7#1)
be employed for##10##3##(1992-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2012-3#1)
be employed in the##3##4##(1990-12#1)(2008-10#1)(2008-12#1)
be employed in##9##3##(1990-12#1)(1991-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
be employed to generate##2##4##(1996-12#1)(2008-4#1)
be employed to##21##3##(1990-7#1)(1996-12#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#1)(2013-1#1)
be employed##69##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
be emulated##2##2##(2008-6#1)(2013-8#1)
be encapsulated##2##2##(1995-2#1)(2013-1#1)
be encoded by##3##3##(1991-6#1)(2013-8#2)
be encoded##5##2##(1991-6#1)(2007-12#1)(2012-2#1)(2013-8#2)
be encountered by##2##3##(2008-11#1)(2012-2#1)
be encountered in##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
be encountered##13##2##(1990-8#1)(1993-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#2)(2012-2#3)
be encouraged by##2##3##(1991-8#1)(2008-10#1)
be encouraged to provide##2##4##(1995-3#1)(2008-10#1)
be encouraged to##9##3##(1993-1#1)(1993-2#1)(1994-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-3#1)(2013-1#1)
be encouraged##17##2##(1991-8#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
be endangered##2##2##(1996-8#1)(2008-10#1)
be enforced in##2##3##(1994-2#1)(2010-4#1)
be enforced##3##2##(1994-2#1)(2010-4#1)(2011-2#1)
be engaged in##3##3##(1993-11#1)(1995-12#1)(2008-12#1)
be engaged##4##2##(1993-11#1)(1995-12#1)(2008-12#2)
be engineered to##5##3##(2007-12#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
be engineered##7##2##(2007-12#2)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
be enhanced by the addition of##3##6##(2007-11#1)(2008-10#2)
be enhanced by the##5##4##(2007-11#1)(2008-10#3)(2009-11#1)
be enhanced by##22##3##(1990-2#1)(1993-2#1)(1994-6#1)(1996-2#1)(2007-11#3)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-7#1)
be enhanced to##2##3##(2008-11#1)(2008-4#1)
be enhanced with##3##3##(2007-11#1)(2008-8#2)
be enhanced##43##2##(1990-2#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-2#1)(1997-4#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
be enriched##7##2##(1994-11#1)(1994-12#1)(2008-10#2)(2008-4#1)(2009-9#1)(2012-12#1)
be enrolled##3##2##(1994-2#1)(2008-11#1)(2008-5#1)
be ensured by##2##3##(2008-10#1)(2012-2#1)
be entirely##6##2##(1994-12#1)(2007-10#1)(2008-10#3)(2008-8#1)
be entitled to##4##3##(1991-3#1)(1993-12#1)(1994-3#1)(1995-2#1)
be envisaged##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
be equal to the##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
be equal to##8##3##(1991-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2009-12#1)(2010-12#1)
be equally important##2##3##(1993-11#1)(1993-2#1)
be equally##12##2##(1993-11#1)(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-2#1)
be equivalent to a##2##4##(2008-10#1)(2012-3#1)
be equivalent to##7##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-3#1)
be equivalent##10##2##(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2012-3#1)
be eradicated##6##2##(1992-5#1)(1993-12#2)(1994-9#1)(2007-12#1)(2008-11#1)
be especially useful for##2##4##(1994-2#1)(2008-10#1)
be especially useful in##3##4##(1991-12#1)(2007-11#1)(2007-9#1)
be especially useful##5##3##(1991-12#1)(1994-2#1)(2007-11#1)(2007-9#1)(2008-10#1)
be especially##25##2##(1991-12#1)(1992-2#1)(1994-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
be essential for the##6##4##(1990-5#1)(1993-12#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-5#1)
be essential for##34##3##(1990-5#2)(1992-12#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#5)(2012-2#2)
be essential in##2##3##(2010-3#1)(2010-7#1)
be essential to##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
be essential when##2##3##(2010-9#1)(2012-2#1)
be essential##45##2##(1990-5#2)(1992-12#1)(1992-3#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#4)
be essentially##6##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
be established between the##3##4##(2007-7#1)(2008-10#2)
be established between##6##3##(2007-7#1)(2008-10#3)(2008-3#1)(2008-9#1)
be established by##4##3##(1990-11#1)(2007-10#1)(2008-10#1)(2011-2#1)
be established for##3##3##(1992-9#1)(2007-12#1)(2008-11#1)
be established if##2##3##(1994-12#1)(2008-7#1)
be established in##7##3##(1991-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)
be established to##2##3##(1994-12#1)(2008-10#1)
be established which##2##3##(1992-3#1)(2008-10#1)
be established with##3##3##(2007-7#1)(2008-3#1)(2012-2#1)
be established##71##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)
be estimated as##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
be estimated by##7##3##(2008-10#3)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)
be estimated from the##3##4##(1996-3#1)(2008-3#1)(2008-8#1)
be estimated from##6##3##(1996-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
be estimated very##2##3##(1992-9#1)(2008-10#1)
be estimated with a##2##4##(2008-10#1)(2008-2#1)
be estimated with##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
be estimated##36##2##(1990-9#1)(1992-2#1)(1992-6#2)(1992-9#1)(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
be evaluated against the##2##4##(1995-8#1)(2008-1#1)
be evaluated and##2##3##(2008-10#2)
be evaluated as##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
be evaluated at the##2##4##(1990-3#1)(2008-5#1)
be evaluated at##3##3##(1990-3#1)(1996-3#1)(2008-5#1)
be evaluated before##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
be evaluated by##8##3##(1994-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
be evaluated carefully##3##3##(2006-5#1)(2009-2#1)(2012-3#1)
be evaluated for##6##3##(1992-8#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
be evaluated in a##3##4##(1992-3#1)(1996-3#1)(2008-2#1)
be evaluated in terms of##2##5##(2008-4#1)(2013-7#1)
be evaluated in##15##3##(1991-8#1)(1992-2#1)(1992-3#1)(1996-3#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2010-10#1)(2010-11#1)(2013-7#1)
be evaluated objectively using##2##4##(2008-5#2)
be evaluated on##2##3##(2008-7#1)(2011-2#1)
be evaluated to##5##3##(2008-10#1)(2008-3#1)(2008-9#2)(2013-7#1)
be evaluated when##2##3##(2008-3#1)(2012-3#1)
be evaluated##101##2##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
be evidence##2##2##(1997-1#1)(1997-8#1)
be evidenced##2##2##(2008-10#1)(2012-3#1)
be evident##4##2##(2008-8#1)(2011-1#1)(2011-2#2)
be evoked##3##2##(1990-7#2)(2013-1#1)
be evolutionarily stable##3##3##(2008-8#2)(2008-9#1)
be evolutionarily##4##2##(2008-8#2)(2008-9#1)(2012-3#1)
be evolved##2##2##(2008-11#1)(2011-1#1)
be examined by##2##3##(1993-11#1)(2008-1#1)
be examined in##5##3##(1990-12#1)(1995-3#1)(1997-6#1)(2008-11#1)(2013-1#1)
be examined##20##2##(1990-12#2)(1991-1#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2013-1#3)
be exceeded##3##2##(2007-12#1)(2008-10#2)
be excessive##2##2##(2008-8#1)(2009-4#1)
be excited by##2##3##(2007-11#1)(2008-2#1)
be excited##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
be excluded from##3##3##(1993-3#1)(1997-4#1)(2010-3#1)
be excluded in##2##3##(1997-5#1)(2008-1#1)
be excluded##26##2##(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#3)(2007-4#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-3#1)(2011-8#1)
be excreted##3##2##(1992-4#1)(2008-5#1)(2010-2#1)
be exempt##2##2##(1992-3#1)(1994-12#1)
be exercised##3##2##(1991-6#1)(1993-6#1)(2008-11#1)
be expanded to##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
be expanded##12##2##(1991-9#1)(1993-1#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
be expected because##2##3##(2008-10#1)(2008-9#1)
be expected for a##2##4##(1996-6#1)(2007-12#1)
be expected for the##2##4##(1992-11#1)(2008-5#1)
be expected for##8##3##(1992-11#1)(1996-6#1)(1997-6#1)(2007-12#2)(2008-3#1)(2008-5#1)(2011-2#1)
be expected from##3##3##(1994-3#1)(2008-6#1)(2008-7#1)
be expected in the near future##2##6##(1991-3#1)(2007-12#1)
be expected in the##3##4##(1991-3#1)(1996-2#1)(2007-12#1)
be expected in##11##3##(1991-3#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
be expected only if##2##4##(2008-2#1)(2008-3#1)
be expected that the##2##4##(2008-10#1)(2010-8#1)
be expected that##4##3##(1990-2#1)(1994-3#1)(2008-10#1)(2010-8#1)
be expected to be##4##4##(1995-3#1)(1995-6#1)(2008-5#1)(2012-3#1)
be expected to have##3##4##(1994-6#1)(1995-5#1)(2008-3#1)
be expected to increase##2##4##(1996-11#1)(2008-11#1)
be expected to provide##2##4##(1991-3#1)(2008-3#1)
be expected to respond##2##4##(2008-8#1)(2009-2#1)
be expected to##39##3##(1991-3#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-2#1)(2010-5#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
be expected when##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2012-7#1)
be expected##101##2##(1990-2#1)(1990-8#2)(1991-12#1)(1991-3#3)(1992-11#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#2)
be expensive##3##2##(1990-3#1)(1994-1#1)(2008-11#1)
be explained adequately by##2##4##(1994-8#1)(2008-9#1)
be explained as##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
be explained by a##11##4##(1990-11#1)(1993-1#1)(1993-8#1)(1996-5#1)(2008-1#1)(2008-10#5)(2008-8#1)
be explained by an##3##4##(1994-5#1)(2008-5#1)(2008-9#1)
be explained by assuming##4##4##(2008-10#1)(2008-11#1)(2008-3#2)
be explained by differences##3##4##(2008-8#1)(2009-7#1)(2011-2#1)
be explained by its##3##4##(1995-11#1)(2008-10#1)(2008-2#1)
be explained by selection##2##4##(1993-11#1)(1997-7#1)
be explained by the##28##4##(1990-5#1)(1992-12#1)(1994-6#1)(1994-8#2)(1995-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#4)(2009-2#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
be explained by##99##3##(1990-11#1)(1990-5#2)(1992-12#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1997-5#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#8)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
be explained in terms of a##2##6##(1993-8#1)(2013-7#1)
be explained in terms of##12##5##(1990-8#1)(1991-3#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-7#1)
be explained in that##2##4##(1992-6#1)(2008-5#1)
be explained in##16##3##(1990-8#2)(1991-3#1)(1992-6#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)
be explained on##2##3##(1990-5#1)(1996-2#1)
be explained with##2##3##(1996-3#1)(2008-10#1)
be explained within the##2##4##(2007-11#1)(2008-8#1)
be explained##146##2##(1990-11#1)(1990-5#3)(1990-8#2)(1991-3#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-1#3)(2008-10#26)(2008-11#4)(2008-2#2)(2008-3#10)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
be exploited as##2##3##(2008-10#1)(2013-1#1)
be exploited for##6##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2012-2#1)
be exploited in##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)
be exploited to##10##3##(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-7#1)
be exploited##27##2##(1992-8#1)(1993-2#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
be explored in##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
be explored##27##2##(1991-1#1)(1991-3#1)(1994-2#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
be exponential##2##2##(2008-3#1)(2010-2#1)
be exposed to##3##3##(2008-10#1)(2010-9#1)(2011-2#1)
be exposed##7##2##(2008-10#2)(2008-11#2)(2010-9#1)(2011-2#1)(2013-1#1)
be expressed as##13##3##(1992-6#1)(1994-9#1)(1997-4#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2009-6#1)
be expressed by a##2##4##(1992-11#1)(2008-10#1)
be expressed by##5##3##(1990-11#1)(1992-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
be expressed in the##7##4##(1991-2#1)(1993-6#2)(2008-11#1)(2008-8#2)(2010-5#1)
be expressed in##23##3##(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-6#2)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-8#3)(2010-5#2)(2011-1#2)(2012-3#2)
be expressed##61##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#2)(1994-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-10#8)(2008-11#7)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-1#2)(2012-12#1)(2012-3#2)
be extended by##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
be extended for##4##3##(1990-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
be extended from##3##3##(2008-10#2)(2008-3#1)
be extended to a##3##4##(2007-11#1)(2008-7#2)
be extended to include##2##4##(2008-9#1)(2009-2#1)
be extended to more##2##4##(2007-12#1)(2008-3#1)
be extended to other##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
be extended to the##5##4##(2008-10#2)(2008-3#2)(2008-7#1)
be extended to##33##3##(1991-8#1)(1994-11#1)(1997-6#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
be extended##55##2##(1990-8#1)(1991-8#1)(1994-11#1)(1994-6#1)(1996-3#1)(1997-6#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#11)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
be extensive##2##2##(2008-10#2)
be extensively##4##2##(1993-2#1)(2008-10#1)(2008-8#1)(2009-11#1)
be extracted as##3##3##(2007-2#1)(2008-10#2)
be extracted by##4##3##(1994-8#1)(2008-10#2)(2008-3#1)
be extracted from the##5##4##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
be extracted from##9##3##(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-11#1)(2013-8#1)
be extracted into##2##3##(2008-10#2)
be extracted##25##2##(1994-8#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#5)(2010-11#1)(2013-8#1)
be extrapolated to the##3##4##(2008-3#1)(2008-5#1)(2008-9#1)
be extrapolated to##4##3##(2008-3#1)(2008-5#2)(2008-9#1)
be extrapolated##6##2##(2006-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)
be extremely difficult##3##3##(1995-6#1)(1996-1#1)(2008-10#1)
be extremely sensitive to##2##4##(1996-2#1)(1997-6#1)
be extremely sensitive##3##3##(1996-2#1)(1997-6#1)(2008-10#1)
be extremely useful for##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
be extremely useful in##2##4##(1991-9#1)(2008-12#1)
be extremely useful##5##3##(1991-9#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
be extremely##20##2##(1991-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#1)
be fabricated as##2##3##(2008-10#1)(2008-3#1)
be fabricated##9##2##(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-4#1)(2012-1#1)
be faced##4##2##(1991-2#1)(1997-2#1)(2008-1#1)(2012-2#1)
be facilitated by a##2##4##(2008-2#1)(2008-9#1)
be facilitated by the##3##4##(1993-6#1)(1995-1#1)(1995-12#1)
be facilitated by##12##3##(1990-11#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
be facilitated through##2##3##(2008-10#1)(2008-11#1)
be facilitated##21##2##(1990-11#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
be fairly##2##2##(2008-3#1)(2008-9#1)
be familiar with the##5##4##(1992-2#1)(1996-3#1)(2007-8#1)(2008-2#1)(2012-2#1)
be familiar with##10##3##(1992-2#1)(1994-5#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)
be familiar##11##2##(1992-2#1)(1994-5#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
be far more##5##3##(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
be far##9##2##(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
be fatal##5##2##(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
be favorable##2##2##(1997-8#1)(2008-10#1)
be favored by##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
be favored##5##2##(2008-8#1)(2008-9#3)(2013-1#1)
be feasible and##4##3##(1996-12#1)(2008-11#1)(2010-7#1)(2011-2#1)
be feasible for##2##3##(1992-2#1)(2008-12#1)
be feasible##14##2##(1992-2#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
be feasibly##2##2##(2011-2#1)(2013-1#1)
be filled with a##2##4##(2008-5#1)(2008-9#1)
be filled with##4##3##(1993-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
be filled##6##2##(1993-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)
be filtered##2##2##(2008-10#2)
be finished##2##2##(2008-3#1)(2010-5#1)
be firmly##2##2##(2008-3#1)(2012-2#1)
be fitted to##3##3##(2008-3#1)(2008-9#1)(2012-3#1)
be fitted with##3##3##(1991-12#1)(1997-2#1)(1997-7#1)
be fitted##7##2##(1991-12#1)(1997-2#1)(1997-7#1)(2008-3#1)(2008-9#2)(2012-3#1)
be fixed##2##2##(2008-8#1)(2013-1#1)
be flawed##2##2##(1995-6#1)(2010-2#1)
be flexible##2##2##(1997-3#1)(2008-8#1)
be focused on##9##3##(1991-5#1)(1992-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2011-2#2)(2012-3#1)
be focused##13##2##(1991-5#1)(1992-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-3#1)
be folded##2##2##(2008-10#1)(2008-4#1)
be followed by a##2##4##(1994-2#1)(2008-10#1)
be followed by all##2##4##(2008-9#1)(2012-2#1)
be followed by##11##3##(1994-2#1)(1996-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
be followed closely##2##3##(2007-12#1)(2011-1#1)
be followed in##2##3##(2012-1#1)(2012-2#1)
be followed up##7##3##(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
be followed##35##2##(1992-6#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
be for##2##2##(2008-10#1)(2013-1#1)
be forced to##4##3##(1994-2#1)(1996-5#3)
be forced##5##2##(1994-2#1)(1996-5#3)(2012-3#1)
be foreseen##2##2##(2008-5#2)
be forgotten in##2##3##(2013-1#1)(2013-8#1)
be forgotten##3##2##(1992-5#1)(2013-1#1)(2013-8#1)
be formed by a##3##4##(1997-5#1)(2007-11#1)(2008-3#1)
be formed by##8##3##(1990-7#1)(1995-3#1)(1997-5#1)(2007-11#2)(2008-3#1)(2008-4#1)(2008-7#1)
be formed in the##3##4##(1997-4#1)(2007-12#1)(2008-11#1)
be formed in##7##3##(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
be formed with##4##3##(1994-5#1)(2008-2#1)(2008-7#2)
be formed##37##2##(1990-7#1)(1991-9#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2012-1#1)
be formulated##7##2##(1991-1#1)(1992-3#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-4#1)
be forthcoming##2##2##(1994-2#1)(1997-5#1)
be found at##7##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-3#1)(2011-2#1)
be found by##3##3##(1997-8#1)(2008-10#2)
be found during the##2##4##(1996-1#1)(2008-3#1)
be found during##3##3##(1990-5#1)(1996-1#1)(2008-3#1)
be found for##2##3##(2007-10#1)(2008-6#1)
be found in all##2##4##(1995-8#1)(1997-8#1)
be found in an##2##4##(2008-2#1)(2010-1#1)
be found in medium containing##2##5##(2008-8#2)
be found in the##13##4##(1990-12#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-11#1)
be found in##47##3##(1990-12#2)(1993-2#1)(1994-11#1)(1995-8#2)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#3)
be found on##2##3##(1995-11#1)(2013-7#1)
be found through##2##3##(1993-12#1)(1994-2#1)
be found to##3##3##(2008-10#2)(2013-1#1)
be found without##2##3##(1991-11#1)(2008-4#1)
be found##111##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#3)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#6)(2013-1#1)(2013-7#2)
be founded##2##2##(1995-8#1)(2011-4#1)
be fragmented##2##2##(1995-3#1)(2012-3#1)
be free from##4##3##(1992-1#1)(2008-10#2)(2010-11#1)
be free of##3##3##(1993-12#1)(1994-3#1)(2012-2#1)
be free##9##2##(1992-1#1)(1993-12#2)(1993-8#1)(1994-3#1)(2008-10#2)(2010-11#1)(2012-2#1)
be frequent##2##2##(2008-10#1)(2013-1#1)
be from##4##2##(2008-11#2)(2009-7#1)(2011-2#1)
be fulfilled##3##2##(1995-6#1)(2008-10#1)(2013-7#1)
be fully determined##2##3##(2007-11#1)(2008-8#1)
be fully established##2##3##(2008-11#1)(2008-12#1)
be fully explained by##2##4##(1997-3#1)(2010-8#1)
be fully explained##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
be fully##34##2##(1991-12#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
be functional##6##2##(1992-3#1)(1995-9#1)(2008-11#1)(2009-10#2)(2012-2#1)
be functionally important##2##3##(2008-10#1)(2010-1#1)
be functionally redundant##2##3##(1996-2#1)(2008-11#1)
be functionally related to##2##4##(2008-10#1)(2008-8#1)
be functionally related##3##3##(1992-11#1)(2008-10#1)(2008-8#1)
be functionally##16##2##(1990-11#1)(1992-11#1)(1993-3#1)(1995-2#2)(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)
be further divided into##3##4##(2008-10#2)(2008-4#1)
be further improved by##2##4##(2008-10#1)(2008-11#1)
be further increased##2##3##(2008-11#1)(2012-2#1)
be further investigated##6##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
be further##40##2##(1990-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(2007-11#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
be gained by##5##3##(2007-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2012-3#1)
be gained from the##2##4##(1994-3#1)(2010-5#1)
be gained from##4##3##(1994-3#1)(2010-10#1)(2010-5#1)(2011-10#1)
be gained##16##2##(1994-2#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
be general##5##2##(1990-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
be generalized to##4##3##(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)
be generalized##5##2##(2008-10#2)(2008-11#1)(2009-11#1)(2009-5#1)
be generally##10##2##(1993-3#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#3)(2011-2#2)
be generated by##12##3##(1990-5#1)(1992-9#1)(1993-9#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-5#2)(2008-8#1)(2012-3#1)
be generated during##2##3##(1991-5#1)(1995-8#1)
be generated for##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
be generated from##2##3##(2008-11#1)(2008-4#1)
be generated in the##2##4##(2008-10#1)(2008-7#1)
be generated in##6##3##(1991-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
be generated to##2##3##(1996-2#1)(2010-5#1)
be generated using##3##3##(2008-2#1)(2008-4#1)(2009-11#1)
be generated##46##2##(1990-5#1)(1991-5#2)(1992-9#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-7#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
be genetically##11##2##(1991-12#1)(1994-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
be given a##5##3##(1994-9#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-8#1)
be given at##2##3##(1994-9#1)(1995-5#1)
be given by##2##3##(1997-8#1)(2007-2#1)
be given in##3##3##(2007-11#1)(2008-4#1)(2012-2#1)
be given on##2##3##(1991-5#1)(1997-2#1)
be given the##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
be given to the##4##4##(1990-11#1)(1992-12#1)(2011-1#1)(2012-2#1)
be given to##21##3##(1990-11#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-12#2)(1994-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2012-2#1)
be given##70##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-9#4)(1995-5#1)(1996-11#3)(1996-12#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
be good##16##2##(1990-6#1)(1992-11#1)(1992-12#1)(1994-1#1)(1996-3#1)(1997-8#1)(2007-2#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
be granted##2##2##(1996-8#1)(2012-3#1)
be greater for##5##3##(1993-6#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
be greater in##7##3##(1996-12#1)(1996-7#1)(1997-4#1)(2008-3#1)(2008-5#1)(2010-3#1)(2013-1#1)
be greater than the##4##4##(2007-11#1)(2008-2#1)(2009-11#1)(2012-12#1)
be greater than##10##3##(1990-12#2)(2007-11#2)(2008-10#2)(2008-2#1)(2009-11#1)(2012-12#1)(2013-1#1)
be greater##27##2##(1990-12#2)(1992-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#1)(2010-3#1)(2012-12#1)(2013-1#3)
be greatest##2##2##(1996-5#1)(2008-9#1)
be greatly enhanced by##11##4##(1997-4#1)(2008-10#8)(2008-9#1)(2013-1#1)
be greatly enhanced##13##3##(1997-4#1)(2008-10#10)(2008-9#1)(2013-1#1)
be greatly##22##2##(1997-4#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
be grounded in##3##3##(1995-1#1)(2008-1#1)(2010-12#1)
be grouped in##2##3##(1993-11#1)(2008-10#1)
be grouped into##4##3##(1991-2#1)(2008-10#2)(2010-8#1)
be grouped##10##2##(1991-2#1)(1993-11#1)(2008-10#6)(2010-8#1)(2012-2#1)
be grown in##3##3##(2008-1#1)(2008-10#2)
be grown##6##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-11#1)
be guaranteed##4##2##(1996-8#1)(2007-7#1)(2008-2#1)(2010-5#1)
be guided by the##2##4##(1992-4#1)(2007-4#1)
be guided by##8##3##(1992-4#1)(1993-3#1)(2007-10#1)(2007-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
be guided in a##2##4##(2007-12#1)(2008-10#1)
be guided##14##2##(1992-4#1)(1993-3#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
be had##2##2##(1995-1#1)(1996-8#1)
be halted##2##2##(2008-2#1)(2012-12#1)
be hampered by##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
be handled##3##2##(2008-1#1)(2008-9#1)(2011-2#1)
be harmful##3##2##(1994-11#1)(1997-5#1)(2012-3#1)
be harmless##2##2##(2007-10#1)(2007-12#1)
be harnessed to increase##2##4##(2008-7#1)(2011-1#1)
be harnessed to##3##3##(1995-12#1)(2008-7#1)(2011-1#1)
be harnessed##5##2##(1995-12#1)(1995-9#1)(2008-7#1)(2009-6#1)(2011-1#1)
be harvested##3##2##(2007-8#1)(2008-8#1)(2012-2#1)
be having##2##2##(2010-5#1)(2011-1#1)
be hazardous to##2##3##(1992-5#1)(2008-11#1)
be hazardous##3##2##(1992-5#1)(2007-8#1)(2008-11#1)
be healthy##3##2##(1992-3#1)(2008-10#1)(2013-7#1)
be heard##3##2##(1997-4#1)(2012-12#1)(2012-2#1)
be heated##2##2##(1990-12#1)(1991-7#1)
be held in##2##3##(1994-6#1)(2011-4#1)
be held to##3##3##(1995-12#1)(2008-2#2)
be held##9##2##(1991-5#1)(1994-6#1)(1995-12#1)(1996-1#1)(2008-1#1)(2008-2#2)(2011-4#1)(2012-3#1)
be helped by##4##3##(1990-6#1)(1993-2#1)(2008-1#2)
be helped##5##2##(1990-6#1)(1993-2#1)(2008-1#2)(2008-9#1)
be helpful for##16##3##(1996-12#2)(1997-7#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#2)(2013-8#1)
be helpful in improving the##3##5##(2007-7#1)(2008-5#2)
be helpful in improving##6##4##(2007-7#1)(2008-5#4)(2013-7#1)
be helpful in the diagnosis of##2##6##(1991-12#1)(2009-3#1)
be helpful in the diagnosis##5##5##(1991-12#1)(1994-9#1)(1997-8#1)(2009-3#1)(2009-4#1)
be helpful in the identification of##2##6##(1997-2#1)(2008-5#1)
be helpful in the##12##4##(1991-12#1)(1991-4#1)(1992-12#1)(1994-9#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)
be helpful in##29##3##(1991-12#1)(1991-4#1)(1992-12#1)(1994-9#1)(1997-2#1)(1997-8#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-7#1)
be helpful to##13##3##(1996-6#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
be helpful##65##2##(1991-12#1)(1991-4#1)(1992-12#1)(1994-9#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#2)
be heterogeneous##2##2##(1996-6#1)(2010-4#1)
be high##13##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-7#1)(2009-9#1)(2011-1#1)
be higher in patients with##3##5##(1993-12#1)(1996-9#1)(2007-10#1)
be higher in##14##3##(1990-7#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-3#1)(1996-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
be higher than##11##3##(1993-8#2)(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)(2013-1#1)
be higher##34##2##(1990-7#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-9#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-1#2)
be highlighted as##2##3##(2008-10#1)(2008-8#1)
be highlighted##12##2##(1992-3#1)(1994-12#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
be highly conserved##3##3##(1990-11#1)(1992-11#1)(2007-12#1)
be highly dependent on##2##4##(2008-10#1)(2013-1#1)
be highly dependent##3##3##(2008-10#2)(2013-1#1)
be highly effective in##3##4##(1993-10#1)(2007-11#1)(2008-5#1)
be highly effective##4##3##(1993-10#1)(1993-12#1)(2007-11#1)(2008-5#1)
be highly expressed##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
be highly sensitive to##2##4##(2008-7#1)(2009-9#1)
be highly sensitive##4##3##(1992-12#1)(2008-10#1)(2008-7#1)(2009-9#1)
be highly specific for##3##4##(1990-2#1)(1993-11#1)(1996-2#1)
be highly useful##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
be highly variable##2##3##(1992-5#1)(2008-8#1)
be highly##71##2##(1990-11#1)(1990-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
be homogeneous##5##2##(1990-5#1)(1992-8#1)(1994-5#1)(1994-6#1)(2008-3#1)
be homologous to##3##3##(1995-2#1)(2008-8#1)(2009-6#1)
be homologous##5##2##(1991-12#1)(1995-2#1)(1996-12#1)(2008-8#1)(2009-6#1)
be host specific##2##3##(2008-10#2)
be host##3##2##(2008-10#3)
be how##2##2##(1991-2#1)(2008-11#1)
be hypothesized##3##2##(1990-2#1)(2007-12#1)(2012-1#1)
be ideally##2##2##(2008-10#1)(2008-11#1)
be identical in##2##3##(1997-6#1)(2008-9#1)
be identical to the##4##4##(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)
be identical to##9##3##(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#2)
be identical##18##2##(1990-8#1)(1991-8#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)
be identified and##9##3##(1992-2#1)(1994-6#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
be identified as a##4##4##(2008-7#1)(2010-4#1)(2013-8#2)
be identified as##13##3##(1993-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#2)
be identified before##2##3##(2007-12#1)(2008-1#1)
be identified by##8##3##(1993-6#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)
be identified in a##2##4##(2008-10#2)
be identified in##8##3##(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
be identified that##2##3##(2008-11#1)(2008-3#1)
be identified through##2##3##(2007-11#1)(2008-9#1)
be identified to##3##3##(2007-12#1)(2008-5#1)(2010-11#1)
be identified using##5##3##(1995-2#1)(2008-10#2)(2008-9#2)
be identified with##6##3##(1991-11#1)(1997-3#2)(1997-6#1)(2009-8#1)(2012-2#1)
be identified##119##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#9)(2008-9#3)(2009-12#1)(2009-6#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#2)
be idiopathic##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
be ignored##13##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#2)
be illustrated##6##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
be imaged with##4##3##(2008-1#1)(2008-3#2)(2008-5#1)
be imaged##13##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-12#2)(2008-3#5)(2008-5#1)(2009-12#1)
be immersed in a##2##4##(2007-11#1)(2008-3#1)
be immersed in##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
be immobilized##2##2##(2008-10#1)(2008-11#1)
be immortalized##2##2##(1997-7#1)(2008-4#1)
be impacted by##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
be impaired compared##2##3##(1990-11#1)(2008-3#1)
be impaired in##4##3##(2008-10#1)(2008-7#1)(2012-1#1)(2012-3#1)
be impaired##10##2##(1990-11#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-11#1)(2012-1#1)(2012-3#1)
be implanted##2##2##(2008-11#1)(2008-8#1)
be implemented as a##2##4##(2008-3#1)(2011-1#1)
be implemented as##3##3##(2008-3#1)(2011-1#1)(2012-1#1)
be implemented at##4##3##(1991-12#1)(1996-1#1)(2007-12#1)(2013-1#1)
be implemented by##4##3##(2007-12#1)(2008-11#1)(2008-3#1)(2009-3#1)
be implemented for##3##3##(1995-5#1)(2007-11#1)(2008-2#1)
be implemented in a##4##4##(1996-1#1)(2007-11#1)(2008-4#1)(2010-8#1)
be implemented in##14##3##(1991-2#1)(1996-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
be implemented on##4##3##(1993-9#1)(2008-10#1)(2008-3#1)(2012-12#1)
be implemented to##6##3##(1992-3#1)(1993-1#1)(2008-10#1)(2008-2#1)(2013-1#2)
be implemented with##4##3##(2007-8#1)(2008-3#2)(2013-1#1)
be implemented##72##2##(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#6)(2008-3#11)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)
be implicated in the##7##4##(1993-3#1)(1993-9#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#1)
be implicated in##12##3##(1991-3#1)(1993-3#1)(1993-9#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
be implicated##14##2##(1991-3#1)(1992-12#1)(1993-3#1)(1993-9#1)(1997-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
be important factors in##2##4##(2008-11#1)(2011-1#1)
be important factors##5##3##(2008-10#2)(2008-11#2)(2011-1#1)
be important for all##2##4##(1996-2#1)(2009-8#1)
be important for the##9##4##(1994-8#1)(1995-12#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)
be important for##35##3##(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-5#1)(2009-6#1)(2009-8#1)(2011-10#1)(2011-2#2)(2012-2#1)(2013-7#1)
be important in the##24##4##(1990-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
be important in understanding##4##4##(1991-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
be important in##56##3##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#3)(2013-8#1)
be important targets in##2##4##(2006-10#1)(2013-1#1)
be important to the##4##4##(1994-8#1)(2007-2#1)(2010-5#1)(2012-3#1)
be important to##13##3##(1994-8#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-7#1)
be important when##2##3##(2008-7#1)(2010-8#1)
be important##146##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#4)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#1)(2009-12#1)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
be imposed##2##2##(1991-2#1)(2008-10#1)
be impossible##2##2##(1990-12#1)(2008-11#1)
be imprinted##2##2##(2008-11#1)(2011-2#1)
be improved and##2##3##(2008-10#1)(2008-11#1)
be improved by increasing##2##4##(1996-3#1)(2008-10#1)
be improved by using##2##4##(2008-10#1)(2010-7#1)
be improved by##32##3##(1992-2#1)(1993-1#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#1)
be improved from##2##3##(2007-11#1)(2008-10#1)
be improved if the##2##4##(2007-12#1)(2013-8#1)
be improved if##3##3##(1996-11#1)(2007-12#1)(2013-8#1)
be improved in the##3##4##(2008-12#1)(2009-3#1)(2013-1#1)
be improved significantly##3##3##(2008-3#1)(2009-3#1)(2010-8#1)
be improved through##2##3##(2009-5#1)(2012-2#1)
be improved upon##3##3##(1990-5#1)(2008-10#1)(2010-12#1)
be improved when##2##3##(2007-11#1)(2008-3#1)
be improved with##2##3##(2008-10#1)(2008-7#1)
be improved##85##2##(1990-5#1)(1990-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
be in a##11##3##(1994-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-3#1)(2011-2#1)
be in close##2##3##(2008-2#1)(2012-12#1)
be in linkage##2##3##(2008-12#1)(2008-7#1)
be in part##4##3##(1994-6#1)(2007-10#1)(2009-12#1)(2011-1#1)
be in place to##2##4##(2008-11#1)(2008-12#1)
be in place##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
be in the form of##3##5##(2008-10#1)(2008-2#1)(2011-2#1)
be in the range of##8##5##(2008-10#7)(2008-3#1)
be in the range##10##4##(2008-10#9)(2008-3#1)
be in the##31##3##(1990-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-4#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
be in this##2##3##(2008-10#1)(2008-9#1)
be in##117##2##(1990-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
be inactivated by##2##3##(2008-5#1)(2008-9#1)
be inactive##5##2##(1996-5#3)(2008-10#1)(2011-3#1)
be inadequate##8##2##(1993-3#1)(1995-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#2)
be included as##2##3##(2008-10#1)(2010-11#1)
be included in a##2##4##(2007-7#1)(2008-11#1)
be included in the differential diagnosis of##6##7##(1990-11#1)(1997-7#1)(2007-12#1)(2008-12#1)(2013-1#1)(2013-8#1)
be included in the differential diagnosis##9##6##(1990-11#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-12#1)(2009-3#1)(2010-11#1)(2013-1#1)(2013-8#1)
be included in the model##2##5##(2008-2#1)(2008-8#1)
be included in the##29##4##(1990-11#1)(1992-8#1)(1994-3#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
be included in##40##3##(1990-11#1)(1992-8#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
be included under##2##3##(2008-11#1)(2013-7#1)
be included##56##2##(1990-11#1)(1992-8#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#4)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
be inclusive##2##2##(2008-12#1)(2010-8#1)
be incompatible with##2##3##(2007-11#1)(2008-5#1)
be incompatible##3##2##(2007-11#1)(2008-5#1)(2008-9#1)
be incomplete##5##2##(1993-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
be inconclusive##2##2##(2008-5#1)(2008-7#1)
be inconsistent##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
be incorporated as##2##3##(1991-12#1)(1996-12#1)
be incorporated in the##3##4##(2008-12#1)(2009-7#1)(2012-12#1)
be incorporated in##10##3##(1994-8#1)(1995-1#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2012-12#1)
be incorporated into a##4##4##(1995-2#1)(2007-12#1)(2008-10#2)
be incorporated into routine clinical practice##2##6##(2007-11#1)(2011-2#1)
be incorporated into the optical system##2##6##(2008-3#2)
be incorporated into the##12##4##(1992-12#1)(1993-1#1)(1994-3#1)(2007-4#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)
be incorporated into##35##3##(1992-12#1)(1993-1#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-3#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
be incorporated##53##2##(1991-12#1)(1992-12#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-3#3)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
be incorrectly##2##2##(2008-10#1)(2009-1#1)
be increased by a factor of##3##6##(2008-10#1)(2008-3#1)(2008-7#1)
be increased by a##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
be increased by the addition of##2##6##(2008-10#1)(2008-3#1)
be increased by the##3##4##(1995-11#1)(2008-10#1)(2008-3#1)
be increased by##18##3##(1991-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-3#6)(2008-4#1)(2008-7#2)
be increased in##10##3##(1990-2#1)(1992-8#1)(1993-3#1)(1994-8#1)(2008-1#1)(2008-10#3)(2012-12#1)(2013-8#1)
be increased significantly##5##3##(2007-12#1)(2008-10#2)(2008-3#2)
be increased to##6##3##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
be increased##62##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
be increasing##5##2##(1994-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
be increasingly##3##2##(1996-2#1)(2008-10#1)(2009-8#1)
be incurred##2##2##(1996-11#1)(2007-11#1)
be independent of##18##3##(1990-2#1)(1991-11#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-2#1)
be independent##24##2##(1990-12#1)(1990-2#1)(1991-11#1)(1994-7#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#1)
be independently##8##2##(1991-9#1)(1992-9#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2012-3#2)
be indicated in the##2##4##(2010-12#1)(2013-1#1)
be indicated in##4##3##(2010-12#1)(2010-6#1)(2013-1#2)
be indicated##11##2##(1991-11#1)(1996-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2013-1#3)(2013-8#1)
be indicative of the##2##4##(1991-2#1)(2008-8#1)
be indicative of##5##3##(1991-2#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
be indicative##6##2##(1991-2#1)(2008-10#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
be indirect##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
be indistinguishable from##3##3##(1990-12#1)(2008-9#1)(2012-2#1)
be individualized and##2##3##(2008-9#1)(2009-10#1)
be individualized to##2##3##(2011-2#2)
be individualized##6##2##(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)
be individually tailored and##2##4##(2008-10#1)(2011-2#1)
be individually##6##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#2)
be induced by a##6##4##(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
be induced by##25##3##(1990-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)
be induced in the##2##4##(2008-4#1)(2009-8#1)
be induced in##8##3##(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
be induced into##2##3##(1991-9#1)(2009-12#1)
be induced to##9##3##(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(2008-10#2)(2008-11#2)(2008-2#1)
be induced##59##2##(1990-12#1)(1990-7#2)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#2)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#3)(2013-8#1)
be infected by##4##3##(1990-3#1)(2008-10#3)
be infected in##2##3##(1997-4#1)(2012-3#1)
be infected with HIV##3##4##(1993-6#1)(1996-9#1)(1997-5#1)
be infected with##4##3##(1993-6#1)(1996-9#1)(1997-5#1)(2008-10#1)
be infected##14##2##(1990-3#1)(1993-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(2008-10#6)(2008-9#1)(2011-2#1)(2012-3#1)
be inferred from the##3##4##(2008-3#2)(2008-5#1)
be inferred from##8##3##(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#2)(2012-2#1)
be inferred that the##2##4##(2008-3#1)(2010-6#1)
be inferred that##4##3##(1995-6#1)(2008-3#1)(2008-8#1)(2010-6#1)
be inferred##20##2##(1995-6#1)(2008-11#3)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
be influenced by the##15##4##(1990-9#1)(1994-5#1)(1996-12#3)(1997-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)
be influenced by##44##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-5#2)(1995-5#1)(1996-12#3)(1996-3#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)
be influenced##50##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-5#2)(1995-5#1)(1996-12#3)(1996-3#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
be informative for##3##3##(1997-5#1)(2008-12#1)(2013-8#1)
be informative##9##2##(1993-8#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#1)(2013-8#1)
be informed by##2##3##(2008-11#1)(2008-6#1)
be informed of the##2##4##(1996-1#1)(2008-8#1)
be informed##8##2##(1992-2#1)(1996-1#1)(1996-6#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
be inhibited by a##2##4##(1995-2#1)(1996-2#1)
be inhibited by the##3##4##(1991-1#1)(1996-12#1)(2008-8#1)
be inhibited by##23##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-1#1)(1992-9#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#3)(2010-3#1)(2013-8#1)
be inhibited##30##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-1#1)(1991-5#1)(1992-9#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#4)(2010-3#1)(2013-8#1)
be inhibitory##3##2##(2008-11#3)
be initiated at##2##3##(2008-11#1)(2010-12#1)
be initiated by##6##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-3#1)
be initiated immediately##3##3##(1994-9#1)(2008-10#2)
be initiated in##2##3##(1994-2#1)(2011-2#1)
be initiated to##4##3##(1992-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
be initiated##24##2##(1992-12#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
be injected into##2##3##(2008-4#1)(2012-2#1)
be injected##7##2##(1994-9#1)(2008-10#2)(2008-4#1)(2010-11#1)(2011-1#1)(2012-2#1)
be input##2##2##(2008-3#1)(2008-4#1)
be inserted in##2##3##(2009-4#1)(2011-1#1)
be inserted into the##3##4##(1994-8#1)(2008-10#1)(2013-1#1)
be inserted into##4##3##(1994-8#1)(2007-12#1)(2008-10#1)(2013-1#1)
be inserted##12##2##(1993-10#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
be insignificant##2##2##(2008-10#1)(2009-3#1)
be inspected##2##2##(2008-4#1)(2009-2#1)
be installed##2##2##(2008-11#1)(2010-8#1)
be instilled via##2##3##(2008-10#2)
be instituted##3##2##(1995-3#1)(1996-11#1)(2013-8#1)
be instrumental in##5##3##(1996-3#1)(2008-10#1)(2008-11#2)(2009-11#1)
be instrumental##7##2##(1993-11#1)(1996-3#1)(2008-10#1)(2008-11#2)(2009-11#1)(2012-2#1)
be insufficient for##2##3##(2008-12#1)(2008-9#1)
be insufficient##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)
be integral##4##2##(1992-8#1)(1995-8#1)(2010-8#1)(2012-3#1)
be integrated in the##2##4##(2008-6#1)(2008-8#1)
be integrated in##4##3##(1993-12#1)(2008-12#1)(2008-6#1)(2008-8#1)
be integrated into a##2##4##(1994-12#1)(1996-1#1)
be integrated into the##4##4##(1992-5#1)(1995-2#1)(2008-2#1)(2008-3#1)
be integrated into##10##3##(1992-5#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-12#1)(2013-1#1)
be integrated to##3##3##(1995-12#1)(2008-2#1)(2009-12#1)
be integrated with##10##3##(1994-1#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)
be integrated##35##2##(1992-5#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
be interested in##2##3##(2008-11#1)(2010-10#1)
be interesting for##2##3##(1990-10#1)(1993-8#1)
be interesting##4##2##(1990-10#1)(1993-8#1)(1994-5#1)(2008-10#1)
be internalized by##2##3##(1994-8#1)(2010-8#1)
be internalized##3##2##(1994-8#1)(1997-7#1)(2010-8#1)
be interpreted according to##2##4##(2008-5#2)
be interpreted as a##4##4##(1993-8#1)(2008-1#1)(2008-10#2)
be interpreted as##13##3##(1991-2#1)(1993-8#1)(1994-12#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-3#1)(2012-1#1)
be interpreted cautiously##3##3##(1995-5#1)(2008-8#1)(2010-5#1)
be interpreted in terms of a##3##6##(1993-11#1)(1994-5#1)(1996-5#1)
be interpreted in terms of the##2##6##(1993-11#1)(2008-10#1)
be interpreted in terms of##7##5##(1991-9#1)(1993-11#2)(1994-5#1)(1996-5#1)(2008-10#2)
be interpreted in##9##3##(1991-6#1)(1991-9#1)(1993-11#2)(1994-5#1)(1996-5#1)(2008-10#2)(2008-8#1)
be interpreted to##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
be interpreted with##5##3##(1994-12#1)(1997-1#1)(2007-11#1)(2008-5#1)(2011-1#1)
be interpreted##42##2##(1991-2#1)(1991-6#1)(1991-9#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-3#1)(1995-5#1)(1996-5#2)(1997-1#2)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)
be interrelated##2##2##(2008-3#1)(2009-8#1)
be interrupted##3##2##(1991-8#1)(2007-7#1)(2013-8#1)
be intrinsically##2##2##(2010-2#1)(2012-2#1)
be introduced into the##2##4##(1996-1#1)(2008-10#1)
be introduced on##2##3##(1990-3#1)(2013-1#1)
be introduced##22##2##(1990-3#1)(1992-1#1)(1993-12#1)(1996-1#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#2)(2010-11#1)(2010-3#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
be invalid##3##2##(1995-2#1)(2013-1#2)
be invaluable##3##2##(1995-1#1)(2008-1#1)(2008-7#1)
be investigated by##4##3##(1992-5#1)(1996-12#1)(2008-10#1)(2012-2#1)
be investigated further##2##3##(2009-12#1)(2010-12#1)
be investigated in##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
be investigated with##2##3##(2008-11#1)(2011-1#1)
be invoked##2##2##(1994-8#1)(2008-10#1)
be involved as##3##3##(1993-5#1)(2008-10#1)(2008-3#1)
be involved at##2##3##(1990-5#1)(1994-11#1)
be involved in both##2##4##(1994-2#1)(2008-10#1)
be involved in cell##2##4##(1992-3#1)(2010-11#1)
be involved in determining the##4##5##(1990-12#1)(1990-8#1)(1997-7#1)(2008-10#1)
be involved in iron##2##4##(1990-5#1)(2010-12#1)
be involved in its##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
be involved in regulation of##2##5##(1991-7#1)(1993-9#1)
be involved in signal transduction##3##5##(1995-5#1)(1995-6#1)(2008-11#1)
be involved in the control of##3##6##(1993-9#1)(2009-7#1)(2009-8#1)
be involved in the development##3##5##(1992-3#1)(2008-6#1)(2010-12#1)
be involved in the etiology##2##5##(1991-9#1)(2008-7#1)
be involved in the expression of##2##6##(2008-5#1)(2013-8#1)
be involved in the formation of##2##6##(1990-12#1)(2013-1#1)
be involved in the induction of##2##6##(2008-10#1)(2008-7#1)
be involved in the pathogenesis of##5##6##(1994-11#1)(1995-5#1)(2008-1#1)(2010-10#1)(2013-8#1)
be involved in the pathophysiology##2##5##(1993-3#1)(2008-7#1)
be involved in the process of##6##6##(1995-5#1)(1996-12#1)(2008-1#2)(2008-10#1)(2011-1#1)
be involved in the regulation of##4##6##(1995-12#1)(2008-8#1)(2009-8#1)(2010-12#1)
be involved in the response to##2##6##(1995-5#1)(2008-10#1)
be involved in the response##3##5##(1992-3#1)(1995-5#1)(2008-10#1)
be involved in the##100##4##(1990-11#1)(1990-12#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#5)(1992-6#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#2)
be involved in this##2##4##(1994-6#1)(1995-8#1)
be involved in##218##3##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#8)(1992-6#1)(1992-8#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#6)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-5#4)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#1)(1997-9#1)(2007-10#1)(2007-8#1)(2008-1#4)(2008-10#25)(2008-11#10)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#12)(2008-8#10)(2008-9#6)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#3)
be involved with##5##3##(1996-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-7#1)
be involved##253##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#8)(1992-6#1)(1992-8#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-5#5)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(1997-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#31)(2008-11#11)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#13)(2008-8#13)(2008-9#6)(2009-10#3)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
be irreversible##3##2##(1990-2#1)(1992-9#1)(1995-9#1)
be irreversibly##3##2##(1991-4#2)(2009-12#1)
be isolated from##10##3##(1990-8#1)(1994-2#1)(1996-6#1)(2008-4#1)(2008-6#1)(2008-9#3)(2009-11#1)(2010-6#1)
be isolated on the basis of##2##6##(1996-5#1)(2008-9#1)
be isolated##27##2##(1990-8#1)(1992-9#1)(1994-2#1)(1994-8#1)(1996-5#1)(1996-6#2)(1997-3#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
be it in##2##3##(1991-6#2)
be it##4##2##(1991-12#1)(1991-6#2)(2012-3#1)
be joined##5##2##(2008-4#3)(2008-9#1)(2012-2#1)
be judged##2##2##(2008-9#1)(2012-2#1)
be just the##2##3##(1992-11#1)(1992-12#1)
be just##4##2##(1992-11#1)(1992-12#1)(2008-11#1)(2010-12#1)
be justified and##3##3##(1992-6#1)(2008-6#1)(2011-2#1)
be justified in##3##3##(1991-8#2)(2011-1#1)
be justified##10##2##(1990-6#1)(1991-8#2)(1992-6#1)(1995-6#1)(1997-4#2)(2008-6#1)(2011-1#1)(2011-2#1)
be kept at##2##3##(2008-3#1)(2008-7#1)
be kept in mind when##2##5##(2008-7#2)
be kept in mind##11##4##(2008-7#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
be kept##22##2##(1996-6#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#3)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
be key to##2##3##(1992-8#1)(2010-10#1)
be key##6##2##(1992-8#1)(1996-2#1)(2008-1#1)(2008-12#1)(2010-10#1)(2012-3#1)
be killed##2##2##(1992-6#1)(2008-7#1)
be known for##2##3##(2008-7#1)(2008-9#1)
be known##9##2##(1996-3#1)(1997-8#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#1)
be labeled by##3##3##(1990-2#1)(2008-9#1)(2009-10#1)
be labeled with##3##3##(1991-3#1)(2007-11#1)(2008-4#1)
be labeled##8##2##(1990-2#1)(1991-3#1)(1991-9#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)
be lacking##5##2##(1993-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
be laid down##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
be large##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
be largely##11##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2010-10#1)(2011-2#2)(2013-1#1)
be larger than the##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
be larger than##9##3##(1992-9#1)(1994-7#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)
be larger##14##2##(1992-9#1)(1994-7#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2010-11#1)(2012-12#1)
be launched in 2000##2##4##(2008-5#2)
be launched in##5##3##(2008-3#1)(2008-5#4)
be launched##7##2##(2008-3#2)(2008-5#4)(2008-7#1)
be leading##2##2##(2008-11#1)(2008-12#1)
be learned about##4##3##(2008-7#2)(2008-8#1)(2009-5#1)
be learned by##4##3##(1993-12#1)(1995-2#1)(2008-12#2)
be learned##15##2##(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-12#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-5#1)
be learnt##2##2##(2008-12#1)(2008-7#1)
be led by##2##3##(1996-1#1)(2008-10#1)
be left##2##2##(2008-9#1)(2011-2#1)
be less active##2##3##(1995-8#1)(2009-6#1)
be less efficient than individuals without##2##6##(2012-12#2)
be less efficient##3##3##(2008-10#1)(2012-12#2)
be less important##4##3##(1990-5#1)(2008-10#1)(2008-7#1)(2008-9#1)
be less likely to##5##4##(1993-1#1)(2007-12#1)(2008-9#2)(2011-2#1)
be less responsive##2##3##(2008-9#1)(2010-3#1)
be less than 10##2##4##(2008-10#1)(2008-2#1)
be less than one##3##4##(1992-9#1)(2007-10#1)(2008-10#1)
be less than##26##3##(1990-11#1)(1992-9#1)(1995-12#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-9#1)(2012-3#1)
be less##69##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#1)
be life-threatening##3##2##(2011-2#2)(2012-2#1)
be limited and##2##3##(1995-12#1)(2008-11#1)
be limited by##7##3##(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2012-2#1)
be limited to##10##3##(1991-6#1)(1991-9#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)
be limited##32##2##(1991-6#1)(1991-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
be linked to a##2##4##(1994-2#1)(2008-5#1)
be linked to the##8##4##(1991-12#1)(1995-12#1)(1996-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-2#1)
be linked to##29##3##(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
be linked with##2##3##(1993-9#1)(2009-2#1)
be linked##31##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
be lipid##2##2##(1992-9#1)(2008-11#1)
be little##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
be loaded##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
be localized in##3##3##(1995-6#1)(1997-2#1)(2007-12#1)
be localized to the##4##4##(1990-11#1)(1995-2#1)(1997-1#1)(2012-2#1)
be localized##10##2##(1990-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-5#2)(2009-10#1)(2012-2#1)
be located at##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)
be located in the##6##4##(1990-2#1)(1990-5#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-8#1)
be located in##9##3##(1990-2#1)(1990-5#1)(1994-12#1)(2008-2#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)
be located on the##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
be located on##8##3##(1996-5#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
be located within the##2##4##(2007-8#1)(2012-3#1)
be located within##3##3##(1990-11#1)(2007-8#1)(2012-3#1)
be located##38##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-8#1)(1996-5#3)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
be longer than##2##3##(2010-12#1)(2010-2#1)
be longer##3##2##(2010-12#1)(2010-2#1)(2013-8#1)
be looked##3##2##(1996-2#1)(2006-10#1)(2008-7#1)
be lost in the##2##4##(2008-10#1)(2008-11#1)
be lost##7##2##(1993-12#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
be low##9##2##(1991-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
be lower in##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
be lower than that of##2##5##(2008-4#1)(2008-6#1)
be lower than##7##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
be lower##17##2##(1992-6#1)(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#3)(2013-8#1)
be lowered##5##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-8#1)
be made and##3##3##(1990-6#1)(1992-9#1)(2012-2#1)
be made as##3##3##(2008-1#1)(2008-2#1)(2010-8#1)
be made at the##3##4##(1990-3#1)(2008-10#1)(2008-3#1)
be made at##4##3##(1990-3#1)(2008-10#1)(2008-3#2)
be made available to##3##4##(2007-4#1)(2008-7#1)(2012-3#1)
be made available##6##3##(2007-4#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
be made between##8##3##(1990-7#1)(1993-2#1)(1994-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-1#1)
be made by##6##3##(1992-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
be made if##2##3##(2008-10#1)(2011-1#1)
be made in order to##2##5##(2008-10#1)(2012-1#1)
be made in##15##3##(1992-1#1)(1992-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
be made more##3##3##(1994-1#1)(1994-9#1)(2012-2#1)
be made on##4##3##(1993-11#1)(2008-8#1)(2008-9#1)(2009-10#1)
be made possible by##2##4##(2008-2#1)(2013-1#1)
be made to##13##3##(1994-5#1)(1996-3#1)(2007-11#2)(2008-3#1)(2008-4#2)(2008-9#3)(2009-5#1)(2010-8#1)(2013-1#1)
be made when##2##3##(1992-9#1)(2008-4#1)
be made with##7##3##(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-8#1)
be made##139##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-1#2)(1994-2#3)(1994-5#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-5#1)(1997-8#2)(2007-11#3)(2007-12#3)(2007-4#2)(2007-5#1)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#12)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)
be mainly mediated by##2##4##(1995-12#1)(2008-4#1)
be mainly related to the##3##5##(2008-11#2)(2008-5#1)
be mainly##13##2##(1990-12#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2012-2#2)
be maintained as##5##3##(2008-4#2)(2008-6#1)(2008-9#1)(2011-2#1)
be maintained at##3##3##(2008-2#1)(2008-6#2)
be maintained by##2##3##(2008-10#1)(2008-7#1)
be maintained during##3##3##(2013-1#3)
be maintained for##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
be maintained in the absence of##2##6##(2008-9#1)(2013-1#1)
be maintained in the##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
be maintained in##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-8#1)
be maintained within##2##3##(1996-12#1)(2008-2#1)
be maintained without##2##3##(2008-9#1)(2009-10#1)
be maintained##45##2##(1991-6#1)(1993-9#1)(1995-11#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2011-2#2)(2013-1#4)(2013-8#1)
be making##2##2##(2007-2#1)(2008-2#1)
be malignant##6##2##(1997-2#1)(2007-8#1)(2008-6#1)(2012-3#1)(2013-1#2)
be managed conservatively##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
be managed with##3##3##(2008-9#1)(2010-8#1)(2013-8#1)
be managed##23##2##(1992-2#1)(1992-3#1)(1994-2#2)(1995-2#1)(1996-11#1)(1997-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
be manipulated by##4##3##(2008-10#2)(2009-11#1)(2010-8#1)
be manipulated to##3##3##(2008-10#1)(2009-11#1)(2009-12#1)
be manipulated##11##2##(1994-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-11#2)(2009-12#1)(2010-8#1)
be many##2##2##(2008-8#1)(2012-3#1)
be mapped##3##2##(1990-5#1)(1996-8#1)(2008-10#1)
be marginally##2##2##(1997-2#1)(2008-7#1)
be marked##5##2##(1994-5#1)(2008-11#2)(2008-4#1)(2008-9#1)
be markedly##3##2##(1993-12#1)(1995-12#1)(2008-6#1)
be marketed##3##2##(1995-12#1)(1996-9#1)(2008-5#1)
be masked by##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
be masked##4##2##(1990-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
be matched##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)
be maximized##2##2##(1992-8#1)(2008-9#1)
be measured and##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
be measured at any##3##4##(2008-2#1)(2008-6#1)(2008-9#1)
be measured at##7##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)
be measured by##8##3##(2008-10#2)(2008-2#1)(2008-8#1)(2009-11#1)(2010-6#1)(2012-2#1)(2013-8#1)
be measured directly##6##3##(1995-12#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
be measured from the##2##4##(2007-12#1)(2008-3#1)
be measured in a##2##4##(2008-10#1)(2008-9#1)
be measured in the##3##4##(2008-10#2)(2008-4#1)
be measured in##14##3##(1990-8#1)(1991-9#1)(1994-3#1)(2006-4#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
be measured independently at the same time##2##7##(2008-3#2)
be measured only##2##3##(2007-12#1)(2010-4#1)
be measured to##3##3##(2008-2#1)(2008-3#2)
be measured using##3##3##(1994-3#1)(2008-8#2)
be measured with a##6##4##(2007-11#1)(2008-10#4)(2008-3#1)
be measured with an##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
be measured with##15##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#5)(2008-4#1)
be measured##111##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#2)(1993-8#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-5#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#12)(2008-3#25)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-11#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
be mechanically##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
be mediated by a##4##4##(1992-8#1)(2008-11#1)(2009-1#1)(2012-3#1)
be mediated by the##9##4##(1992-3#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)
be mediated by##42##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-3#2)(1992-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
be mediated through the##2##4##(1995-12#1)(2008-4#1)
be mediated through##10##3##(1991-1#1)(1992-6#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(2008-4#1)(2009-8#1)(2012-12#1)
be mediated via##3##3##(1990-5#1)(1995-8#1)(2008-8#1)
be mediated##59##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-5#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
be medically##3##2##(2008-7#1)(2010-10#1)(2010-12#1)
be merely##3##2##(1994-12#1)(1997-8#1)(2008-2#1)
be merged##3##2##(2007-7#1)(2008-10#1)(2008-2#1)
be met by##4##3##(2008-11#2)(2008-2#1)(2008-5#1)
be met if##2##3##(1994-3#1)(1995-2#1)
be met##25##2##(1991-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-2#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-3#1)(2012-3#1)(2013-8#1)
be metabolized##5##2##(1990-2#1)(1992-10#1)(2008-6#1)(2012-3#2)
be mindful of the##2##4##(2008-11#1)(2011-2#1)
be mindful of##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
be minimal##3##2##(1996-6#1)(2008-3#1)(2012-12#1)
be minimised##2##2##(1996-1#1)(2008-7#1)
be minimized by the##2##4##(1992-3#1)(2008-10#1)
be minimized by##9##3##(1992-3#1)(2008-10#3)(2008-3#3)(2011-2#1)(2012-2#1)
be minimized in##2##3##(1993-12#1)(2011-2#1)
be minimized##26##2##(1992-3#1)(1993-12#1)(1995-5#1)(1995-9#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#7)(2008-4#1)(2011-2#2)(2012-12#1)(2012-2#3)
be misdiagnosed as##2##3##(1991-9#1)(2007-10#1)
be misdiagnosed##3##2##(1991-9#1)(2007-10#1)(2008-4#1)
be misleading##9##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-8#1)(2012-2#1)
be missed##6##2##(2007-2#1)(2007-7#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
be missing##2##2##(1997-3#1)(2008-8#1)
be mistaken for##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
be mistaken##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
be mitigated##2##2##(1992-2#1)(2008-7#1)
be mixed with##2##3##(2010-8#1)(2012-2#1)
be mixed##3##2##(2008-2#1)(2010-8#1)(2012-2#1)
be mobilized##2##2##(1993-6#1)(2008-9#1)
be modeled by##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
be modeled##7##2##(2008-10#3)(2008-3#2)(2008-4#1)(2010-4#1)
be modelled##2##2##(1997-7#1)(2008-7#1)
be modified by##12##3##(1993-12#1)(1995-11#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
be modified if the##2##4##(2008-3#1)(2013-1#1)
be modified in##2##3##(1991-2#1)(2008-5#1)
be modified to##6##3##(1990-7#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
be modified##34##2##(1990-7#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-7#1)(1997-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-1#2)
be modulated by##17##3##(1991-12#1)(1992-12#2)(1992-8#2)(1993-3#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-8#2)
be modulated##23##2##(1991-12#1)(1992-12#2)(1992-8#2)(1993-3#2)(1996-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#3)(2013-8#2)
be monitored and##3##3##(2008-2#1)(2013-1#2)
be monitored by the##3##4##(2008-10#1)(2008-11#1)(2010-4#1)
be monitored by##11##3##(1994-5#1)(2008-10#5)(2008-11#1)(2008-4#3)(2010-4#1)
be monitored in situ##2##4##(1997-1#1)(2007-12#1)
be monitored in##7##3##(1997-1#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
be monitored simultaneously##2##3##(2008-10#1)(2008-7#1)
be monitored with##4##3##(1997-6#1)(2008-10#2)(2012-2#1)
be monitored##44##2##(1991-12#1)(1991-5#1)(1994-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
be more abundant##2##3##(2008-10#1)(2010-5#1)
be more accurate than##2##4##(2008-1#1)(2008-10#1)
be more accurate##6##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
be more aggressive##2##3##(1990-2#1)(2008-10#1)
be more appropriate##4##3##(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#1)
be more clearly##3##3##(1991-9#1)(2008-11#1)(2008-5#1)
be more clinically useful##2##4##(2008-11#1)(2013-1#1)
be more clinically##4##3##(2008-11#1)(2008-6#1)(2009-11#1)(2013-1#1)
be more common in##4##4##(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
be more common##5##3##(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
be more complex than##3##4##(2008-8#1)(2008-9#1)(2010-12#1)
be more complex##5##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)
be more complicated than##2##4##(2008-10#1)(2008-3#1)
be more complicated##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
be more concerned with##2##4##(1994-12#1)(1997-1#1)
be more cost-effective than##2##4##(1991-2#1)(2008-2#1)
be more difficult##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
be more effective in##6##4##(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)
be more effective than the##2##5##(2008-3#1)(2008-7#1)
be more effective than##5##4##(2008-3#2)(2008-7#2)(2010-1#1)
be more effective##23##3##(1992-5#1)(1997-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2010-1#1)(2010-2#1)(2010-4#2)(2012-2#2)(2013-8#1)
be more effectively##2##3##(1997-7#1)(2010-8#1)
be more efficacious##2##3##(2008-3#1)(2008-8#1)
be more efficient than##6##4##(2008-1#1)(2008-11#1)(2008-3#2)(2009-12#1)(2011-1#1)
be more efficient##13##3##(1992-8#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)
be more frequent##4##3##(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)
be more important in##5##4##(2008-8#1)(2011-2#1)(2013-1#3)
be more important than##3##4##(1990-7#1)(2009-3#1)(2013-8#1)
be more important##11##3##(1990-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
be more likely to##4##4##(1991-12#1)(1993-12#1)(2008-8#1)(2009-7#1)
be more likely##6##3##(1990-3#1)(1991-12#1)(1993-12#1)(1995-1#1)(2008-8#1)(2009-7#1)
be more precisely##2##3##(2008-1#1)(2008-2#1)
be more promising than##2##4##(2008-10#1)(2008-4#1)
be more promising##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
be more reliable##2##3##(1996-3#1)(2011-2#1)
be more sensitive than##4##4##(1990-12#1)(2008-10#1)(2008-8#1)(2012-1#1)
be more sensitive to##6##4##(1992-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#1)
be more sensitive##16##3##(1990-12#2)(1992-6#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
be more stable##5##3##(1992-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)
be more strongly##2##3##(2008-4#1)(2009-7#1)
be more successful##2##3##(1996-3#1)(2013-1#1)
be more suitable for##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
be more suitable to##2##4##(2008-12#1)(2012-3#1)
be more suitable##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
be more susceptible to##5##4##(1992-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
be more than a##2##4##(2008-10#1)(2010-10#1)
be more than##10##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2012-2#2)(2013-1#1)
be more useful than##2##4##(1994-8#1)(2009-6#1)
be more useful##5##3##(1991-4#1)(1994-8#1)(1997-3#1)(2008-10#1)(2009-6#1)
be more virulent than##2##4##(2008-5#1)(2013-1#1)
be more widely##2##3##(1990-9#1)(2008-11#1)
be more widespread than##3##4##(1996-3#1)(2008-10#1)(2008-8#1)
be more##288##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#4)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#3)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-3#6)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#31)(2008-11#12)(2008-12#4)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#12)(2008-8#18)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#4)(2012-12#4)(2012-2#9)(2012-3#1)(2012-7#1)(2013-1#12)(2013-8#4)
be most useful##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
be most##23##2##(1991-1#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2012-2#1)(2013-8#1)
be mostly##4##2##(1995-2#1)(2008-10#1)(2011-1#1)(2012-3#1)
be mounted##2##2##(2008-2#1)(2008-8#1)
be moved##2##2##(1991-1#1)(2007-12#1)
be much higher than##3##4##(2007-7#1)(2008-7#1)(2009-7#1)
be much lower than##2##4##(2008-10#1)(2008-6#1)
be much lower##6##3##(1992-2#1)(1995-3#1)(2008-10#2)(2008-6#1)(2013-1#1)
be much more##6##3##(1991-11#1)(1991-9#1)(1993-2#1)(2008-11#1)(2008-2#1)(2010-3#1)
be much##25##2##(1991-11#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-3#1)(1995-3#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
be multifactorial##4##2##(2007-11#2)(2008-1#1)(2011-2#1)
be mutagenic##2##2##(1992-5#1)(2010-6#1)
be named##6##2##(1995-6#2)(2007-12#1)(2008-10#2)(2011-1#1)
be near##2##2##(1993-1#1)(2007-12#1)
be nearly as##2##3##(1990-4#1)(1997-4#1)
be nearly##11##2##(1990-4#1)(1991-12#1)(1995-11#1)(1996-8#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
be necessary before##3##3##(1995-12#1)(2007-12#1)(2009-8#1)
be necessary for##18##3##(1990-8#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-8#1)
be necessary in##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
be necessary to achieve a##2##5##(2008-11#1)(2013-7#1)
be necessary to##34##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-8#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
be necessary##70##2##(1990-3#1)(1990-8#2)(1991-12#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
be needed for##2##3##(2008-11#1)(2009-7#1)
be needed in##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
be needed to##16##3##(1991-12#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2011-1#1)
be needed##36##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
be negatively regulated by##2##4##(1991-5#1)(1993-6#1)
be negatively##4##2##(1991-5#1)(1993-6#1)(2008-5#1)(2011-2#1)
be neglected for##3##3##(2008-2#1)(2008-3#2)
be neglected##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2012-3#1)
be negligible##11##2##(1990-5#1)(1993-2#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-3#2)
be negotiated##2##2##(1992-12#1)(2008-11#1)
be neither##3##2##(1992-11#1)(1995-12#1)(2008-8#1)
be new##18##2##(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#12)(2008-7#1)
be no##20##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-8#1)(1996-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
be normal in##2##3##(2007-11#1)(2008-11#1)
be normal##7##2##(1990-8#1)(1991-6#1)(1992-9#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
be not##7##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-8#1)
be notably##2##2##(1992-3#1)(2008-10#1)
be noted that the##5##4##(1993-11#1)(2008-10#2)(2008-11#1)(2010-6#1)
be noted that##10##3##(1991-9#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
be noted##13##2##(1991-9#1)(1993-11#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-5#3)(2010-6#1)(2011-2#1)(2012-3#1)
be nurtured##2##2##(1994-12#1)(2008-12#1)
be obscured##2##2##(2008-10#1)(2008-4#1)
be observed across##2##3##(2008-9#1)(2012-3#1)
be observed and##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
be observed as##2##3##(2008-10#2)
be observed between the##2##4##(1993-1#1)(2007-12#1)
be observed between##4##3##(1993-1#1)(2006-12#1)(2007-12#1)(2008-8#1)
be observed by##2##3##(2008-10#1)(2008-11#1)
be observed for##3##3##(2008-10#2)(2008-8#1)
be observed from the##2##4##(2007-12#1)(2008-10#1)
be observed from##7##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)
be observed in a##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
be observed in the##5##4##(1991-12#1)(1996-12#1)(2008-10#2)(2013-7#1)
be observed in##24##3##(1991-12#1)(1991-2#1)(1993-2#1)(1994-6#2)(1996-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-7#1)
be observed on##2##3##(2008-2#1)(2013-1#1)
be observed only##2##3##(2008-2#1)(2008-9#1)
be observed under##2##3##(1992-9#1)(2007-11#1)
be observed with##3##3##(1990-12#1)(1997-8#1)(2007-12#1)
be observed##99##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#2)(1994-11#1)(1994-6#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
be obtained about the##2##4##(1992-5#1)(1994-5#1)
be obtained about##3##3##(1992-5#1)(1994-5#1)(2008-1#1)
be obtained after##2##3##(2008-5#1)(2008-8#1)
be obtained at the##2##4##(2008-3#1)(2012-2#1)
be obtained at##4##3##(2008-3#1)(2008-7#1)(2009-11#1)(2012-2#1)
be obtained by isolating##2##4##(1994-1#1)(2008-4#1)
be obtained by the##5##4##(1991-12#1)(2008-10#2)(2008-3#2)
be obtained by use of##2##5##(2007-12#1)(2008-3#1)
be obtained by##44##3##(1991-12#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-1#1)
be obtained directly##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
be obtained for the##2##4##(1994-12#1)(2008-3#1)
be obtained for##7##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
be obtained from the##6##4##(2007-11#1)(2008-10#2)(2008-3#2)(2012-2#1)
be obtained from##22##3##(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
be obtained in##13##3##(1990-8#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
be obtained on##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
be obtained only##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
be obtained over a##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
be obtained per##2##3##(1997-4#1)(2008-10#1)
be obtained through a##4##4##(1994-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
be obtained through##9##3##(1992-4#1)(1994-12#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-3#1)(2011-2#2)
be obtained using a##2##4##(2008-10#1)(2008-5#1)
be obtained using##7##3##(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
be obtained when the##2##4##(2008-10#2)
be obtained when##4##3##(2008-10#2)(2008-12#1)(2008-4#1)
be obtained with a##5##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
be obtained with the##3##4##(2008-2#2)(2008-3#1)
be obtained with##24##3##(1992-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#1)(2009-5#1)(2012-2#1)(2012-7#1)(2013-8#1)
be obtained within##2##3##(2008-10#1)(2008-4#1)
be obtained without##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
be obtained##246##2##(1990-8#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#5)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#2)(2007-11#8)(2007-12#16)(2007-8#1)(2008-1#4)(2008-10#50)(2008-11#6)(2008-12#3)(2008-2#23)(2008-3#36)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#7)(2009-11#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#4)
be obviated##2##2##(2007-10#1)(2008-8#1)
be of a##4##3##(1990-10#1)(1993-6#1)(1993-9#1)(2008-10#1)
be of benefit to##2##4##(1992-3#1)(2007-2#1)
be of benefit##4##3##(1992-3#1)(1997-5#1)(2007-2#1)(2008-3#1)
be of diagnostic value##2##4##(1991-12#1)(2008-5#1)
be of fundamental##2##3##(1990-2#1)(2011-2#1)
be of general##4##3##(1994-3#1)(2008-9#1)(2010-11#1)(2011-1#1)
be of great help to##2##5##(2010-7#2)
be of great help##4##4##(1990-6#1)(1997-2#1)(2010-7#2)
be of great interest in##2##5##(2008-10#1)(2009-5#1)
be of great interest##4##4##(2008-10#2)(2008-9#1)(2009-5#1)
be of great value in##3##5##(1991-6#1)(2009-8#1)(2013-8#1)
be of great value##4##4##(1991-6#1)(1992-8#1)(2009-8#1)(2013-8#1)
be of great##17##3##(1990-6#1)(1991-6#1)(1992-8#1)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#2)(2011-1#1)(2013-8#1)
be of greater value##2##4##(2008-2#1)(2010-4#1)
be of greater##4##3##(1994-2#1)(2008-10#1)(2008-2#1)(2010-4#1)
be of importance for the##3##5##(1991-9#1)(1992-12#1)(1994-11#1)
be of importance for##5##4##(1991-9#1)(1992-12#1)(1994-11#1)(2008-3#1)(2008-5#1)
be of importance in the##2##5##(1990-11#1)(1990-12#1)
be of importance in##7##4##(1990-11#1)(1990-12#1)(1994-12#1)(1995-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
be of importance##15##3##(1990-11#1)(1990-12#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-8#1)(2006-6#1)(2008-3#2)(2008-5#2)(2009-6#1)(2011-2#2)
be of interest to other##2##5##(2010-11#1)(2011-1#1)
be of interest to##6##4##(1993-5#1)(1995-12#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-1#1)
be of interest##9##3##(1993-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
be of limited##4##3##(1995-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
be of little##3##3##(1991-2#1)(2008-10#1)(2008-3#1)
be of much##2##3##(1990-9#1)(2013-1#1)
be of particular importance in##2##5##(1994-9#1)(2007-2#1)
be of particular importance##3##4##(1994-9#1)(2007-2#1)(2008-9#1)
be of particular##7##3##(1993-12#2)(1994-9#1)(2007-2#1)(2008-9#1)(2012-3#1)(2013-8#1)
be of potential##6##3##(1993-12#1)(2008-10#1)(2008-5#3)(2010-4#1)
be of relevance in##2##4##(1990-8#1)(2007-2#1)
be of relevance##3##3##(1990-8#1)(2007-2#1)(2012-2#1)
be of significant##5##3##(1996-9#1)(2007-11#1)(2008-10#2)(2008-3#1)
be of the##8##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(2008-1#1)(2008-10#2)(2008-2#1)
be of therapeutic value##2##4##(1991-9#1)(1993-2#1)
be of therapeutic##4##3##(1991-9#1)(1993-2#1)(1995-3#1)(2008-10#1)
be of use for##2##4##(2008-11#1)(2008-2#1)
be of use in the##2##5##(2008-2#1)(2008-3#1)
be of use in##5##4##(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
be of use##7##3##(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)
be of value in the##3##5##(1990-12#1)(2008-5#1)(2008-9#1)
be of value in##8##4##(1990-12#1)(1992-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#3)
be of value to##4##4##(1997-3#1)(2008-11#1)(2010-8#1)(2012-3#1)
be of value##16##3##(1990-12#1)(1992-1#1)(1993-2#1)(1997-3#1)(2007-11#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-9#3)(2010-8#1)(2012-3#1)
be of##174##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#3)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#9)(2009-5#1)(2009-6#2)(2009-8#3)(2010-11#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#3)
be offered by##3##3##(1994-2#1)(1995-12#1)(2013-1#1)
be offered in##2##3##(2011-2#1)(2013-1#1)
be offered to##4##3##(1992-3#1)(1993-3#1)(1994-3#1)(2007-2#1)
be offered##22##2##(1990-11#1)(1992-3#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-3#1)(2007-12#1)(2007-2#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-2#3)(2013-1#2)
be offset by##3##3##(2008-8#2)(2013-1#1)
be offset##4##2##(1994-9#1)(2008-8#2)(2013-1#1)
be older than##2##3##(2008-10#1)(2009-2#1)
be older##5##2##(1992-3#1)(1994-12#1)(1995-3#1)(2008-10#1)(2009-2#1)
be omitted##5##2##(1990-8#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
be on the##10##3##(1991-12#1)(1992-2#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)
be on##22##2##(1991-12#1)(1992-2#1)(1993-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
be one mechanism##3##3##(1993-11#1)(1993-6#1)(2008-10#1)
be one of the best##2##5##(1993-8#1)(1995-12#1)
be one of the causes of##2##6##(1994-6#1)(2010-12#1)
be one of the factors responsible for##3##7##(1995-12#1)(2008-12#1)(2013-8#1)
be one of the factors##8##5##(1994-6#1)(1995-12#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
be one of the most important##3##6##(1990-12#1)(2008-11#1)(2008-7#1)
be one of the most##11##5##(1990-12#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
be one of the reasons for##2##6##(2008-10#1)(2008-8#1)
be one of the##42##4##(1990-12#1)(1991-12#1)(1993-8#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#2)(1995-5#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
be one of##46##3##(1990-12#1)(1991-12#1)(1993-8#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1997-3#2)(1997-8#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
be one reason##2##3##(2008-11#1)(2008-9#1)
be one way##2##3##(2007-5#1)(2010-10#1)
be one##60##2##(1990-12#1)(1991-12#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1997-3#2)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
be ongoing##2##2##(1992-3#1)(2008-3#1)
be only##16##2##(1990-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
be open to##4##3##(1992-11#1)(1997-1#1)(2007-8#1)(2008-1#1)
be operated##9##2##(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)
be operative##2##2##(2008-10#1)(2012-3#1)
be opportunistic##2##2##(2008-10#1)(2013-7#1)
be optimal for##3##3##(1994-2#1)(2008-7#1)(2008-8#1)
be optimal##6##2##(1992-2#1)(1994-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
be optimally##2##2##(2008-11#1)(2012-2#1)
be optimised##2##2##(1995-3#1)(2012-2#1)
be optimistic##2##2##(1992-12#1)(1996-3#1)
be optimized and##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
be optimized for##2##3##(2008-11#1)(2008-4#1)
be optimized##18##2##(1994-12#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
be or not to be##2##5##(2012-3#1)(2013-1#1)
be or##4##2##(1993-8#1)(2008-7#1)(2012-3#1)(2013-1#1)
be organized##6##2##(1991-2#1)(1995-3#1)(2008-1#1)(2008-11#2)(2008-7#1)
be otherwise##2##2##(2008-11#1)(2008-4#1)
be our##3##2##(1994-1#1)(2008-12#1)(2012-12#1)
be outlined##6##2##(1997-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2012-2#1)
be over 1##2##3##(2008-10#1)(2008-3#1)
be over##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)
be overcome before##4##3##(1994-2#1)(1997-6#1)(2008-2#1)(2012-3#1)
be overcome by##14##3##(1990-6#1)(1992-3#1)(1994-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2013-1#1)(2013-8#1)
be overcome##32##2##(1990-6#1)(1992-3#1)(1994-2#1)(1994-8#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
be overemphasized##4##2##(1990-11#1)(2007-7#1)(2008-3#1)(2010-8#1)
be overestimated##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
be overlooked in##2##3##(2011-2#1)(2013-8#1)
be overlooked##5##2##(1997-3#1)(2008-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
be owing to##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
be paid to the##7##4##(1992-3#1)(1993-12#1)(1997-1#1)(2008-1#1)(2008-9#1)(2012-12#1)(2012-2#1)
be paid to##21##3##(1990-2#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
be paid##25##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
be painful##2##2##(1997-4#1)(2007-12#1)
be part of a complex##2##5##(1997-5#1)(2008-11#1)
be part of a##9##4##(1992-3#1)(1994-8#1)(1994-9#1)(1997-3#2)(1997-5#1)(2007-12#1)(2008-11#2)
be part of an##4##4##(1992-2#1)(1992-4#1)(2008-10#1)(2008-11#1)
be part of the##9##4##(1994-9#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)
be part of##27##3##(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#1)(1994-9#2)(1996-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2012-2#1)
be part##28##2##(1990-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#1)(1994-9#2)(1996-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2012-2#1)
be partially due to the##2##5##(1993-12#1)(2008-10#1)
be partially due to##3##4##(1993-12#1)(1994-11#1)(2008-10#1)
be partially explained by the##2##5##(2008-10#1)(2013-1#1)
be partially explained by##5##4##(1993-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
be partially##22##2##(1990-2#1)(1990-7#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2013-1#1)
be particularly effective in##3##4##(2007-8#1)(2010-10#1)(2013-1#1)
be particularly effective##4##3##(2007-8#1)(2008-10#1)(2010-10#1)(2013-1#1)
be particularly useful for##5##4##(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
be particularly useful in##3##4##(1992-8#1)(2008-5#1)(2011-2#1)
be particularly useful to##4##4##(1993-3#1)(2008-2#1)(2011-2#1)(2012-12#1)
be particularly useful##15##3##(1992-11#1)(1992-8#1)(1993-3#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)
be particularly valuable to##2##4##(2008-10#1)(2008-9#1)
be particularly##41##2##(1990-2#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
be partly due to##2##4##(1991-11#1)(2011-1#1)
be partly##13##2##(1990-7#1)(1991-11#1)(1991-9#1)(1992-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2011-1#1)(2013-8#1)
be passed by##2##3##(1990-9#1)(2008-8#1)
be passed to##2##3##(1993-8#1)(2008-1#1)
be passed##4##2##(1990-9#1)(1993-8#1)(2008-1#1)(2008-8#1)
be patterned by##2##3##(2007-12#1)(2008-10#1)
be perceived##4##2##(2008-8#1)(2009-12#1)(2009-8#1)(2012-3#1)
be performed after##2##3##(2008-10#2)
be performed as##4##3##(1990-6#1)(2008-7#1)(2010-5#1)(2013-1#1)
be performed at a##2##4##(1993-11#1)(2008-3#1)
be performed at the##2##4##(1996-3#1)(2010-5#1)
be performed at##5##3##(1993-11#1)(1996-3#1)(2008-3#1)(2008-7#1)(2010-5#1)
be performed by the##5##4##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
be performed by##11##3##(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2010-7#1)(2012-3#1)
be performed for##4##3##(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)
be performed in a##4##4##(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
be performed in order to##4##5##(1990-2#1)(1996-6#1)(2013-1#2)
be performed in the##6##4##(1990-12#1)(2007-11#1)(2007-8#1)(2008-10#3)
be performed in##42##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-8#3)(2008-10#11)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
be performed on all##2##4##(2008-10#1)(2008-9#1)
be performed on the##6##4##(1991-3#1)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
be performed on##13##3##(1991-3#1)(1995-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#2)(2011-2#1)
be performed only##5##3##(1991-6#1)(1994-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
be performed prior to##2##4##(2007-8#1)(2008-10#1)
be performed safely##5##3##(1991-3#2)(2008-3#1)(2008-7#1)(2010-8#1)
be performed simultaneously##2##3##(1992-6#1)(2011-1#1)
be performed to evaluate##2##4##(2008-5#1)(2011-2#1)
be performed to##12##3##(1991-9#1)(1994-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
be performed under##5##3##(1996-1#1)(1996-12#1)(2007-4#1)(2008-3#1)(2012-3#1)
be performed using a##3##4##(2008-1#1)(2008-4#1)(2009-10#1)
be performed using##10##3##(2008-1#1)(2008-10#3)(2008-4#3)(2009-10#1)(2010-8#1)(2011-2#1)
be performed with the##3##4##(1990-12#1)(2008-10#2)
be performed with##12##3##(1990-12#1)(1990-2#1)(1992-3#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)
be performed without##2##3##(1991-3#1)(2008-10#1)
be performed##195##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#5)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-6#2)(1997-2#2)(2007-10#1)(2007-11#7)(2007-12#1)(2007-4#1)(2007-8#7)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#18)(2008-4#16)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
be persistent##2##2##(1996-7#1)(2008-9#1)
be perspective##2##2##(2008-10#1)(2008-6#1)
be phase##3##2##(2007-12#1)(2008-2#2)
be phased out##2##3##(1996-2#1)(2008-10#1)
be phased##4##2##(1992-1#1)(1996-2#1)(2008-10#1)(2008-3#1)
be phosphorylated in vivo##2##4##(1991-2#1)(1993-11#1)
be phosphorylated in##5##3##(1991-2#1)(1993-11#2)(1993-3#1)(1995-6#1)
be phosphorylated##8##2##(1991-2#1)(1993-11#2)(1993-3#1)(1994-6#1)(1995-6#1)(1997-2#1)(2011-2#1)
be physiologically##5##2##(1994-11#1)(2008-8#2)(2010-11#1)(2012-2#1)
be placed in an##2##4##(2008-11#2)
be placed in##5##3##(1996-1#1)(2008-10#2)(2008-11#2)
be placed on the##6##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
be placed on##12##3##(1993-12#1)(1995-9#1)(1996-3#1)(1997-3#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2013-1#1)
be placed##26##2##(1993-11#1)(1993-12#1)(1994-1#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-6#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
be planned##4##2##(1991-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
be plastic##2##2##(2008-10#1)(2008-8#1)
be played##3##2##(1993-12#1)(1993-2#1)(2007-6#1)
be pointed out that##2##4##(1995-4#1)(2007-8#1)
be pointed out##3##3##(1991-8#1)(1995-4#1)(2007-8#1)
be poor##2##2##(1991-5#1)(1992-9#1)
be posed##2##2##(1995-1#1)(2011-2#1)
be positioned in##2##3##(2011-2#2)
be positioned##4##2##(2007-7#1)(2008-8#1)(2011-2#2)
be positive##15##2##(1995-12#1)(1997-7#1)(2006-12#1)(2007-7#3)(2008-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
be positively correlated with##3##4##(1991-12#1)(2008-6#1)(2008-8#1)
be positively related to##2##4##(2008-9#1)(2009-7#1)
be positively##10##2##(1991-12#1)(1993-6#1)(1995-11#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)
be possible by##6##3##(1996-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)(2013-8#1)
be possible for##4##3##(1992-9#1)(1995-3#1)(2007-4#1)(2008-3#1)
be possible if##2##3##(2007-2#1)(2008-9#1)
be possible in##3##3##(1994-6#1)(2008-2#1)(2012-12#1)
be possible to evaluate##2##4##(2008-2#1)(2010-12#1)
be possible to use##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
be possible to##30##3##(1993-12#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-2#1)
be possible with##3##3##(1993-6#1)(2008-3#1)(2009-8#1)
be possible##62##2##(1991-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
be postulated##3##2##(1990-10#1)(2008-10#1)(2008-5#1)
be potent inhibitors of##2##4##(1990-2#1)(2008-5#1)
be potent##7##2##(1990-2#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
be potential sources of##2##4##(2008-10#1)(2008-5#1)
be potential##7##2##(1992-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)
be potentially reversed##2##3##(2008-11#1)(2013-1#1)
be potentially used##2##3##(2009-11#1)(2013-1#1)
be potentially useful for##3##4##(1995-11#1)(2007-12#1)(2009-7#1)
be potentially useful in##2##4##(1990-8#1)(2013-7#1)
be potentially useful##5##3##(1990-8#1)(1995-11#1)(2007-12#1)(2009-7#1)(2013-7#1)
be potentially##15##2##(1990-8#1)(1994-3#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
be practical##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
be preceded by##3##3##(1992-4#1)(1996-4#1)(2008-11#1)
be precipitated##3##2##(1990-11#1)(2008-4#1)(2013-8#1)
be precise##2##2##(2007-4#1)(2008-2#1)
be precisely##4##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
be preconcentrated##2##2##(2008-10#2)
be predicted based on##2##4##(2008-10#1)(2013-1#1)
be predicted by the##2##4##(1996-1#1)(2009-9#1)
be predicted by##10##3##(1996-1#1)(1997-6#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-3#1)
be predicted from the##6##4##(1992-7#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)
be predicted from##10##3##(1992-7#1)(1993-6#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-5#1)
be predicted using##2##3##(2008-10#2)
be predicted##40##2##(1990-12#1)(1992-7#1)(1993-6#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
be predominantly##2##2##(1990-11#1)(2009-7#1)
be preferable in##2##3##(1994-2#1)(2010-5#1)
be preferable to##5##3##(1993-3#1)(1994-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
be preferable##14##2##(1993-3#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#1)
be preferably##2##2##(2008-10#1)(2013-1#1)
be preferentially##3##2##(1993-12#1)(2008-4#1)(2009-8#1)
be preferred##8##2##(1992-11#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)
be premature##2##2##(1994-2#1)(2013-8#1)
be premedicated##2##2##(1990-3#2)
be prepared and##2##3##(2008-10#1)(2008-3#1)
be prepared by##5##3##(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-7#1)
be prepared for##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
be prepared from the##2##4##(1994-5#1)(2009-9#1)
be prepared in##7##3##(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-5#1)
be prepared to##6##3##(1991-1#1)(1991-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-12#1)
be prepared with##3##3##(2008-10#1)(2009-12#1)(2013-8#1)
be prepared##39##2##(1991-1#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2013-8#1)
be prescribed##8##2##(1993-6#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)
be present and##2##3##(2008-4#1)(2008-8#1)
be present at##5##3##(1996-5#1)(1996-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
be present in a##4##4##(1991-6#1)(2008-10#3)
be present in other##2##4##(2008-9#1)(2010-5#1)
be present in patients##2##4##(1996-5#1)(2008-8#1)
be present in the##9##4##(1991-6#1)(1994-12#1)(1995-6#1)(2008-10#4)(2008-7#1)(2010-11#1)
be present in##46##3##(1990-7#1)(1991-6#2)(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-1#2)(2008-10#15)(2008-12#3)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)
be present on##4##3##(1993-9#1)(1995-2#1)(1997-2#1)(2008-4#1)
be present##81##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#21)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
be presented as##2##3##(1996-2#1)(2011-2#1)
be presented for##3##3##(1993-3#1)(2010-3#1)(2011-2#1)
be presented in a##2##4##(1993-3#1)(2008-3#1)
be presented in##5##3##(1993-3#1)(1993-6#1)(2008-3#1)(2010-8#1)(2011-1#1)
be presented that##2##3##(2008-3#1)(2010-11#1)
be presented##33##2##(1991-5#1)(1993-3#2)(1993-6#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
be preserved by##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
be preserved for##2##3##(2007-7#1)(2008-10#1)
be preserved##8##2##(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
be prevented by a##3##4##(1991-3#1)(2007-7#1)(2007-8#1)
be prevented by##25##3##(1990-3#2)(1990-8#1)(1991-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#4)(2013-8#1)
be prevented or##2##3##(2008-12#1)(2008-5#1)
be prevented##44##2##(1990-3#2)(1990-8#1)(1991-3#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2013-1#5)(2013-8#1)
be prevented?]##2##2##(1992-9#1)(1995-2#1)
be primary##5##2##(1996-5#1)(2008-10#2)(2008-5#2)
be probed##2##2##(2008-3#1)(2008-9#1)
be processed with##2##3##(2008-10#2)
be processed##11##2##(1990-5#1)(1995-2#1)(2008-10#5)(2008-3#1)(2009-11#1)(2010-8#1)(2012-2#1)
be produced at##5##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-6#2)
be produced by the##3##4##(1994-9#1)(1995-11#1)(2008-3#1)
be produced by##13##3##(1994-9#1)(1995-11#1)(1995-6#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
be produced from##6##3##(1991-2#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
be produced in##5##3##(1990-11#1)(1993-11#1)(1994-8#1)(2008-11#1)(2008-8#1)
be produced with##2##3##(2008-3#1)(2008-6#1)
be produced##42##2##(1990-11#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#8)(2008-4#2)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)
be proficient in##3##3##(2008-3#1)(2008-7#1)(2009-5#1)
be proficient##4##2##(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
be prognostic##2##2##(2008-6#2)
be prolonged##2##2##(1997-3#1)(2013-1#1)
be promising for##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
be promising##9##2##(1996-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
be promoted by##2##3##(1993-12#1)(2008-8#1)
be promoted##8##2##(1993-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
be promptly##4##2##(1993-12#1)(2008-11#1)(2012-12#1)(2012-2#1)
be propagated##4##2##(1995-6#1)(2008-8#3)
be proper##2##2##(1997-5#1)(2011-2#1)
be properly controlled##2##3##(2008-10#2)
be properly evaluated##2##3##(2008-10#1)(2012-12#1)
be properly##12##2##(1993-8#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2012-12#1)(2013-1#1)
be proportional to##9##3##(1990-3#1)(1992-9#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
be proposed##12##2##(1990-7#1)(1990-9#1)(1994-2#1)(1994-5#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2009-8#1)(2012-12#1)
be protected by##3##3##(1995-5#1)(2008-10#1)(2010-1#1)
be protected from##2##3##(1993-6#1)(2008-11#1)
be protected##9##2##(1993-6#1)(1995-5#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-1#1)
be protective for##2##3##(2008-12#1)(2013-1#1)
be protective##6##2##(1993-9#1)(2008-12#1)(2008-8#1)(2009-7#1)(2013-1#2)
be proved##3##2##(1990-11#1)(1994-5#1)(2010-8#1)
be provided by the##2##4##(1994-1#1)(1997-9#1)
be provided by##10##3##(1990-6#1)(1992-10#1)(1992-6#1)(1994-1#1)(1996-3#1)(1997-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
be provided for##2##3##(1996-12#1)(2007-11#1)
be provided in##3##3##(2007-2#1)(2009-8#1)(2011-2#1)
be provided to##3##3##(1990-11#1)(2012-3#1)(2013-8#1)
be provided with##3##3##(1992-3#1)(2008-10#1)(2010-8#1)
be provided##38##2##(1990-11#1)(1990-6#1)(1992-10#1)(1992-3#1)(1992-6#1)(1994-1#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-9#1)(2007-11#2)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
be psychiatric##2##2##(2008-9#2)
be published in the fall issue##2##6##(1994-2#1)(1995-2#1)
be published in the##6##4##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)
be published in##8##3##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-5#1)(2008-4#1)
be published##13##2##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-5#1)(2008-4#1)(2010-12#3)(2011-2#2)
be purchased##5##2##(1992-5#1)(1994-2#1)(2008-11#1)(2008-2#1)(2010-3#1)
be purified##7##2##(1994-5#2)(1994-8#1)(1996-12#1)(2008-4#1)(2008-9#1)(2013-8#1)
be pursued##4##2##(2006-10#1)(2008-6#1)(2010-4#1)(2013-1#1)
be put in place##3##4##(1991-3#1)(1997-2#1)(2012-12#1)
be put in##4##3##(1991-3#1)(1997-2#1)(2008-2#1)(2012-12#1)
be put on##2##3##(2007-7#1)(2012-12#1)
be put##10##2##(1991-3#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-12#2)
be qualitatively##2##2##(2008-10#1)(2013-1#1)
be quality##2##2##(1992-9#1)(1994-3#1)
be quantified in##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
be quantified with##5##3##(2008-10#4)(2008-5#1)
be quantified##26##2##(2007-11#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
be quantitated##4##2##(1990-12#1)(1991-9#1)(2008-4#2)
be quantitative##3##2##(2008-10#3)
be quantitatively adsorbed on##5##4##(2008-10#5)
be quantitatively adsorbed##6##3##(2008-10#6)
be quantitatively##19##2##(2008-10#15)(2008-3#2)(2008-7#1)(2010-8#1)
be quenched##2##2##(2008-10#1)(2008-3#1)
be questioned##2##2##(1991-6#1)(2011-2#1)
be quickly##2##2##(2008-11#1)(2008-2#1)
be quite different##2##3##(2010-10#1)(2010-11#1)
be quite useful in##2##4##(1990-5#1)(2012-1#1)
be quite##23##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2010-10#1)(2010-11#1)(2012-1#1)
be raised in##3##3##(2008-9#2)(2009-11#1)
be raised##11##2##(1992-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#3)(2009-11#1)(2012-2#1)
be randomized##2##2##(2008-10#1)(2008-5#1)
be ranked##2##2##(1993-12#1)(2008-10#1)
be rapidly##9##2##(1992-9#1)(1994-10#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
be rare in##3##3##(2007-11#1)(2009-4#1)(2010-8#1)
be rare##4##2##(2007-11#1)(2008-4#1)(2009-4#1)(2010-8#1)
be rate-limiting##3##2##(1997-3#1)(2007-11#1)(2008-8#1)
be rather high##2##3##(2008-10#1)(2008-3#1)
be rather##6##2##(1990-7#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-8#1)
be rationalized##5##2##(1991-8#1)(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#1)
be rationally##2##2##(1995-2#1)(2008-5#1)
be reached and##2##3##(1993-2#1)(2008-11#1)
be reached by##3##3##(2008-1#1)(2008-3#1)(2013-8#1)
be reached##16##2##(1992-3#1)(1993-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
be reacted with##2##3##(2008-10#1)(2008-2#1)
be read##4##2##(2008-12#1)(2008-3#2)(2009-4#1)
be readily achieved by##2##4##(2007-11#1)(2008-10#1)
be readily achieved##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
be readily adaptable##2##3##(2008-10#1)(2008-3#1)
be readily detected##3##3##(2007-7#1)(2008-10#2)
be readily employed for##2##4##(2008-1#1)(2008-7#1)
be readily implemented##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
be readily##61##2##(1990-8#1)(1991-10#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#3)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-3#6)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)
be realised from##2##3##(2008-12#1)(2011-2#1)
be realised##6##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
be realistic##2##2##(1991-12#1)(2007-11#1)
be realized when##2##3##(2008-2#1)(2008-8#1)
be realized##26##2##(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#7)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
be rearranged##2##2##(2007-8#1)(2008-10#1)
be reasonably##3##2##(1994-2#1)(1994-5#1)(2008-10#1)
be recalled##2##2##(1993-12#2)
be receiving##2##2##(1991-12#1)(1996-12#1)
be recognised by##2##3##(2007-12#1)(2009-7#1)
be recognised##3##2##(2007-12#1)(2008-11#1)(2009-7#1)
be recognized and##4##3##(1995-6#1)(2008-1#1)(2009-8#1)(2010-3#1)
be recognized as a##3##4##(1995-6#1)(2012-12#1)(2013-8#1)
be recognized as##6##3##(1995-6#1)(1996-1#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
be recognized by##3##3##(1996-12#1)(2008-11#1)(2008-9#1)
be recognized to##2##3##(2010-8#1)(2011-2#1)
be recognized##24##2##(1995-11#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
be recommended as a##3##4##(1991-3#1)(2010-5#1)(2012-1#1)
be recommended as##5##3##(1991-3#1)(2007-7#1)(2010-5#1)(2011-2#1)(2012-1#1)
be recommended for patients with##2##5##(2007-8#1)(2013-1#1)
be recommended for patients##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
be recommended for routine use##2##5##(1991-6#1)(2008-10#1)
be recommended for routine##3##4##(1991-6#1)(2008-10#2)
be recommended for the##3##4##(1990-8#1)(2008-11#1)(2013-1#1)
be recommended for##14##3##(1990-8#1)(1991-6#1)(1993-2#2)(1997-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
be recommended to##2##3##(2007-2#1)(2013-1#1)
be recommended##37##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-2#2)(1994-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
be reconciled by##2##3##(1995-3#1)(2008-9#1)
be reconciled##4##2##(1995-3#1)(1995-5#1)(2008-11#1)(2008-9#1)
be reconsidered##2##2##(2007-12#1)(2011-2#1)
be reconstituted##3##2##(1997-4#1)(2008-1#1)(2008-10#1)
be reconstructed from##2##3##(2008-2#1)(2008-7#1)
be reconstructed##8##2##(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2012-1#1)
be recorded by##2##3##(2008-10#1)(2008-5#1)
be recorded in##2##3##(2008-4#1)(2010-7#1)
be recorded reliably##2##3##(1996-6#2)
be recorded when##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
be recorded##19##2##(1995-12#1)(1996-6#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
be recovered from the##3##4##(2008-10#2)(2008-2#1)
be recovered from##10##3##(1992-7#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
be recovered##23##2##(1992-7#1)(1997-2#1)(2007-11#2)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2012-12#1)
be recruited to##3##3##(1995-2#1)(1996-2#1)(2012-2#1)
be recruited##7##2##(1995-2#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2012-2#1)
be rectified##2##2##(1997-7#1)(2008-7#1)
be redesigned to##2##3##(1994-12#1)(1995-1#1)
be reduced and##2##3##(2008-11#1)(2008-3#1)
be reduced by at least##2##5##(1991-9#1)(2008-10#1)
be reduced by increasing the##2##5##(1997-8#1)(2009-5#1)
be reduced by the##3##4##(1990-12#1)(1992-2#1)(2011-2#1)
be reduced by##26##3##(1990-12#1)(1991-9#1)(1992-2#1)(1993-8#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2009-5#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
be reduced in a##2##4##(2007-12#1)(2008-10#1)
be reduced in##8##3##(1990-11#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
be reduced significantly##6##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#2)
be reduced to about##2##4##(1996-6#1)(2010-8#1)
be reduced to##12##3##(1995-5#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-8#1)
be reduced##89##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
be reduced?##2##2##(1995-9#1)(1997-8#1)
be referred to a##4##4##(1997-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
be referred to as##3##4##(2008-10#2)(2008-7#1)
be referred to##10##3##(1990-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)(2013-8#1)
be referred##14##2##(1990-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#2)(2011-2#2)(2013-8#3)
be refined##4##2##(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)
be reflected in a##2##4##(1993-6#1)(2011-2#1)
be reflected in the##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
be reflected in##7##3##(1993-6#1)(1995-11#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-8#1)
be reflected##11##2##(1991-9#1)(1993-6#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
be regarded as a##15##4##(1991-3#1)(1992-8#1)(1994-2#1)(1994-7#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-2#1)(2011-2#1)(2012-2#1)
be regarded as an##4##4##(1994-3#1)(1995-11#1)(1997-4#1)(2009-5#1)
be regarded as random##2##4##(2008-10#2)
be regarded as the##5##4##(1996-3#1)(2007-11#1)(2008-3#1)(2010-3#1)(2010-6#1)
be regarded as##45##3##(1991-3#1)(1991-4#2)(1992-2#1)(1992-8#2)(1993-5#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)
be regarded##48##2##(1990-2#1)(1991-3#1)(1991-4#2)(1992-2#1)(1992-8#2)(1993-5#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)
be regenerated by##12##3##(2008-10#11)(2008-5#1)
be regenerated##16##2##(1992-9#1)(2008-10#14)(2008-5#1)
be registered##5##2##(1991-11#1)(2008-11#2)(2008-3#1)(2008-6#1)
be regularly##3##2##(2008-3#1)(2013-1#2)
be regulated at the##3##4##(1991-12#1)(1992-3#1)(1992-8#1)
be regulated at##4##3##(1991-12#1)(1992-3#1)(1992-8#1)(2008-11#1)
be regulated by a##3##4##(1990-5#1)(1997-1#1)(2009-8#1)
be regulated by direct##2##4##(1992-3#1)(2008-8#1)
be regulated by the##3##4##(1995-2#1)(1997-2#1)(2008-10#1)
be regulated by##27##3##(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-2#1)(1995-8#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#4)(2009-6#1)(2009-8#3)(2010-3#1)(2011-10#1)(2012-2#1)
be regulated in##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
be regulated through##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
be regulated##45##2##(1990-5#1)(1991-12#2)(1991-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-2#1)(1995-8#2)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#3)(2010-3#2)(2011-10#1)(2011-2#1)(2012-2#1)
be reimbursed##3##2##(1991-1#1)(1996-1#2)
be reinforced##3##2##(1994-8#1)(2009-2#1)(2009-7#1)
be related in##2##3##(1990-8#1)(2008-10#1)
be related less to##2##4##(2008-7#1)(2012-2#1)
be related to a##7##4##(1990-5#1)(1992-12#1)(1992-6#1)(1994-8#1)(1997-7#1)(2008-11#1)(2010-12#1)
be related to an##3##4##(1990-12#1)(1990-8#1)(2008-6#1)
be related to both##2##4##(1997-4#1)(1997-5#1)
be related to cell##2##4##(2008-10#1)(2008-9#1)
be related to changes in##2##5##(1994-3#1)(2008-6#1)
be related to differences in##3##5##(2008-10#1)(2008-5#1)(2009-7#1)
be related to each other##3##5##(2008-2#1)(2009-7#1)(2013-8#1)
be related to environmental conditions##2##5##(2008-7#1)(2011-2#1)
be related to fundamental differences##2##5##(2008-5#1)(2008-9#1)
be related to its##5##4##(1995-12#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-7#1)
be related to serum resistance##2##5##(1991-8#2)
be related to the clinical##2##5##(1990-5#1)(1991-6#1)
be related to the emergence##2##5##(2006-10#1)(2009-12#1)
be related to the particular##2##5##(2008-7#1)(2010-6#1)
be related to the##62##4##(1990-12#1)(1990-3#1)(1990-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-3#2)(2013-8#1)
be related to their##4##4##(1995-2#1)(1995-3#1)(2008-10#2)
be related to these##2##4##(2008-9#1)(2011-2#1)
be related to##167##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#3)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#11)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-7#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
be related with the##2##4##(1993-11#1)(2008-10#1)
be related with##8##3##(1990-6#1)(1993-11#1)(1994-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
be related##187##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#2)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#3)(2006-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#7)(2008-7#12)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-7#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
be relative##2##2##(2008-10#1)(2008-8#1)
be relatively##19##2##(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
be released by##3##3##(1990-11#1)(1992-12#1)(2008-5#1)
be released from the##2##4##(1992-3#1)(2008-6#1)
be released from##4##3##(1992-3#1)(2008-4#2)(2008-6#1)
be released in##3##3##(1991-2#1)(2007-10#1)(2009-10#1)
be released to the##2##4##(1992-3#1)(2008-10#1)
be released##22##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1994-9#1)(1996-1#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)
be relevant for the##4##4##(1996-5#1)(2008-7#1)(2012-2#2)
be relevant for##6##3##(1996-5#2)(2008-7#2)(2012-2#2)
be relevant in##2##3##(1994-8#1)(2008-10#1)
be relevant to the##4##4##(1990-7#1)(1994-2#1)(1996-2#1)(1996-5#1)
be relevant to##11##3##(1990-5#1)(1990-7#1)(1994-2#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-2#2)
be relevant##26##2##(1990-5#1)(1990-7#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#4)
be reliable##11##2##(1992-3#2)(1996-3#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
be reliably employed##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
be reliably used in##2##4##(1992-3#1)(2008-10#1)
be reliably used##4##3##(1992-3#1)(1997-3#1)(2008-10#2)
be reliably##16##2##(1992-3#1)(1996-12#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
be relied##2##2##(2008-10#1)(2012-2#1)
be reluctant to##2##3##(1996-12#1)(2012-12#1)
be remembered##4##2##(1994-9#1)(2008-4#1)(2010-1#1)(2011-2#1)
be remotely##2##2##(2008-8#1)(2012-12#1)
be removed by use of a##2##6##(2007-12#1)(2008-3#1)
be removed by##15##3##(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#2)
be removed from the##4##4##(1993-11#1)(2008-10#2)(2008-5#1)
be removed from##10##3##(1993-11#1)(1994-3#1)(2008-10#4)(2008-2#1)(2008-5#2)(2009-9#1)
be removed in##4##3##(1996-2#1)(2008-3#1)(2008-6#1)(2013-8#1)
be removed##53##2##(1990-11#1)(1990-8#2)(1991-12#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-4#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#7)(2013-1#1)(2013-8#1)
be rendered##5##2##(1992-6#1)(1994-3#1)(1997-4#1)(2008-6#1)(2008-8#1)
be repaired with##2##3##(2007-8#1)(2008-4#1)
be repaired##4##2##(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)
be repeated##6##2##(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#2)(2008-7#1)
be repeatedly##3##2##(2008-10#2)(2008-9#1)
be replaced by a##4##4##(1990-12#1)(1995-2#1)(2008-11#2)
be replaced by##13##3##(1990-10#1)(1990-12#1)(1993-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2011-2#1)
be replaced with a##2##4##(1991-3#1)(2009-5#1)
be replaced with##5##3##(1991-3#1)(1993-2#1)(1994-12#1)(2009-5#1)(2010-7#1)
be replaced##25##2##(1990-10#1)(1990-12#1)(1991-3#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)
be replicated in##3##3##(1994-3#1)(1996-1#1)(2008-7#1)
be replicated##6##2##(1994-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2008-7#1)(2008-9#1)
be reported and##2##3##(1993-3#1)(1994-9#1)
be reported in##5##3##(1992-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
be reported to##2##3##(1997-8#1)(2008-11#1)
be reported##18##2##(1990-5#1)(1992-6#1)(1993-3#1)(1994-9#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
be representative of the##2##4##(1994-6#1)(2008-10#1)
be representative of##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
be represented by a##2##4##(2008-11#1)(2008-2#1)
be represented by the##2##4##(2008-10#1)(2008-2#1)
be represented by##8##3##(1990-8#2)(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#3)
be represented##15##2##(1990-8#2)(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)
be reproduced by##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
be reproduced in##5##3##(1992-11#1)(1997-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
be reproduced with##4##3##(1992-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
be reproduced##12##2##(1992-11#1)(1992-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
be reproducible##2##2##(2008-10#1)(2008-5#1)
be requested##2##2##(1991-3#1)(1993-8#1)
be required for a##2##4##(1991-11#1)(2012-2#1)
be required for##24##3##(1991-11#1)(1991-7#1)(1992-12#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-8#1)(2008-10#6)(2008-3#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#2)
be required in##5##3##(1993-6#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
be required to achieve a##2##5##(1996-1#1)(2008-8#1)
be required to establish##2##4##(1994-2#1)(2008-10#1)
be required to suppress##2##4##(2008-10#1)(2008-9#1)
be required to##24##3##(1990-8#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-1#2)(1996-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
be required##78##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#2)(1996-2#3)(1996-4#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)
be rescued by##4##3##(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
be rescued##6##2##(1990-2#1)(1994-3#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
be reserved for##9##3##(1990-6#1)(1992-9#1)(1993-11#1)(1997-3#1)(2007-7#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
be reserved##10##2##(1990-6#1)(1992-9#1)(1993-11#1)(1997-3#1)(2007-7#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
be resistant to the##2##4##(2008-7#1)(2013-1#1)
be resistant to##10##3##(1992-9#2)(1993-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
be resistant##12##2##(1992-9#2)(1993-9#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
be resolved by##7##3##(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
be resolved from##2##3##(1994-9#1)(2008-10#1)
be resolved in##3##3##(1992-3#1)(2008-8#1)(2012-2#1)
be resolved with##2##3##(2008-10#1)(2011-2#1)
be resolved##32##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-6#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
be responsible for some of##2##5##(1996-12#1)(2012-2#1)
be responsible for some##3##4##(1996-12#1)(2007-12#1)(2012-2#1)
be responsible for such##2##4##(1990-12#1)(2008-10#1)
be responsible for the different##2##5##(2008-8#1)(2013-1#1)
be responsible for the high##3##5##(1996-12#1)(2007-10#1)(2012-1#1)
be responsible for the increased##3##5##(1990-5#1)(1990-8#1)(2008-7#1)
be responsible for the limiting##2##5##(2008-3#2)
be responsible for the##45##4##(1990-2#1)(1990-5#2)(1990-8#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
be responsible for their##3##4##(1995-5#1)(2008-10#1)(2008-4#1)
be responsible for these##2##4##(2009-5#1)(2010-6#1)
be responsible for##100##3##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#3)(2007-4#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
be responsible##103##2##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#2)(1991-12#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#3)(2007-4#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
be restored by##7##3##(1990-11#1)(1990-5#1)(1992-8#1)(1996-3#1)(2008-4#2)(2008-8#1)
be restored in##2##3##(1997-7#1)(2009-8#1)
be restored to##3##3##(1990-5#1)(1993-11#1)(2008-9#1)
be restored with##2##3##(2011-2#1)(2013-1#1)
be restored##20##2##(1990-11#1)(1990-5#2)(1992-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
be restricted to the##3##4##(1991-6#1)(2008-7#1)(2012-2#1)
be restricted to##8##3##(1991-6#1)(1995-2#1)(1996-5#1)(2008-7#2)(2010-3#1)(2010-8#1)(2012-2#1)
be restricted##12##2##(1991-6#1)(1995-2#1)(1996-5#1)(2008-7#2)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
be resulting##2##2##(2008-10#1)(2013-8#1)
be retained as##3##3##(2008-10#3)
be retained in##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
be retained on##3##3##(2008-10#3)
be retained##12##2##(1992-2#1)(1997-2#1)(2008-10#7)(2008-7#1)(2010-3#1)(2011-2#1)
be retrieved by##2##3##(2007-11#1)(2008-7#1)
be retrieved from##3##3##(1991-4#1)(2008-2#1)(2008-3#1)
be retrieved##18##2##(1991-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-7#1)(2011-3#1)
be reused for##2##3##(2008-10#2)
be reused##7##2##(2008-10#7)
be revealed by##3##3##(2007-12#1)(2008-1#1)(2008-9#1)
be revealed##5##2##(2007-12#2)(2008-1#1)(2008-4#1)(2008-9#1)
be reversed by the##2##4##(1996-9#1)(2008-8#1)
be reversed by##8##3##(1994-8#2)(1996-9#1)(2008-7#1)(2008-8#2)(2013-7#1)(2013-8#1)
be reversed##15##2##(1990-6#1)(1991-3#1)(1993-8#1)(1994-8#2)(1996-9#2)(2008-1#1)(2008-7#1)(2008-8#2)(2013-7#2)(2013-8#2)
be reversible##6##2##(1995-12#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
be reviewed in##2##3##(2008-4#1)(2008-7#1)
be reviewed regularly##2##3##(2008-11#1)(2008-6#1)
be reviewed##24##2##(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
be revised to##2##3##(1996-5#1)(2008-1#1)
be revised##4##2##(1994-2#1)(1996-3#1)(1996-5#1)(2008-1#1)
be revisited##3##2##(2007-2#1)(2009-10#1)(2013-1#1)
be right##2##2##(1993-1#1)(2008-11#1)
be robust##5##2##(2008-10#1)(2008-11#1)(2010-3#1)(2010-9#1)(2012-3#1)
be rotated##4##2##(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
be roughly##2##2##(2008-10#1)(2008-11#1)
be routed##2##2##(1995-2#1)(2007-7#1)
be routinely screened for##2##4##(2007-7#1)(2013-1#1)
be routinely##11##2##(1994-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
be ruled out in##3##4##(2007-11#1)(2011-2#2)
be ruled out##11##3##(1993-12#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#2)(2012-2#1)
be ruled##12##2##(1993-12#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#3)(2012-2#1)
be run##2##2##(2008-10#2)
be safe and effective in##2##5##(2008-11#1)(2011-1#1)
be safe and effective##4##4##(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
be safe and##13##3##(1991-12#1)(1992-8#1)(1995-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2013-1#1)
be safe##22##2##(1991-12#1)(1992-8#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#3)
be safely used##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
be safely##16##2##(1993-12#1)(1995-1#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#3)
be safer##2##2##(2008-7#1)(2011-2#1)
be said##7##2##(1990-2#1)(1992-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
be sampled##7##2##(2008-10#4)(2008-3#2)(2011-2#1)
be satisfactory for##2##3##(2008-10#2)
be satisfactory##5##2##(2007-11#1)(2008-10#4)
be satisfied##2##2##(2008-2#1)(2013-1#1)
be saved##3##2##(2008-4#1)(2008-6#1)(2008-7#1)
be scanned##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
be scored##2##2##(1992-9#1)(2008-5#1)
be screened for##4##3##(1990-2#1)(1992-10#1)(2008-10#1)(2008-11#1)
be screened regularly##2##3##(1990-12#1)(2011-2#1)
be screened##11##2##(1990-12#1)(1990-2#1)(1992-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-5#1)(2010-4#1)(2011-2#1)
be scrutinized##2##2##(1991-12#1)(1993-12#1)
be secondary to##8##3##(1991-9#1)(1994-6#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-12#1)
be secreted##3##2##(2008-11#2)(2009-3#1)
be secured##2##2##(1994-2#1)(2013-1#1)
be seen as a##4##4##(1996-9#1)(2008-11#1)(2011-2#1)(2012-1#1)
be seen as##11##3##(1996-9#2)(1997-5#1)(1997-7#1)(2008-11#2)(2008-12#2)(2008-7#1)(2011-2#1)(2012-1#1)
be seen by##2##3##(1996-3#1)(2013-1#1)
be seen in the##5##4##(1992-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
be seen in##17##3##(1990-11#1)(1992-12#1)(1994-5#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
be seen more##2##3##(2008-7#1)(2012-12#1)
be seen on the##2##4##(1991-6#1)(1991-9#1)
be seen that the##2##4##(2008-2#1)(2008-3#1)
be seen that##5##3##(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
be seen to be##2##4##(2008-11#1)(2010-8#1)
be seen with##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
be seen##71##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-3#1)(1996-4#1)(1996-9#3)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
be segmented##3##2##(2008-3#1)(2009-10#1)(2012-1#1)
be selected for##4##3##(1995-5#1)(1996-3#1)(2008-10#2)
be selected in##2##3##(2008-10#1)(2009-8#1)
be selected to##3##3##(2008-10#1)(2008-8#1)(2012-9#1)
be selected##21##2##(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-9#1)
be selective##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-7#1)
be selectively##9##2##(1990-9#1)(1994-6#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
be sensed##2##2##(2008-10#1)(2008-3#1)
be sensitive to changes in##2##5##(1994-2#1)(2009-12#1)
be sensitive to the##7##4##(1995-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
be sensitive to##24##3##(1990-12#1)(1990-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
be sensitive##28##2##(1990-12#1)(1990-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#2)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
be sent to the##2##4##(1994-3#1)(2008-1#1)
be sent to##5##3##(1994-3#1)(1997-2#1)(2008-1#1)(2009-12#1)(2011-3#1)
be separated by##7##3##(1991-5#1)(1993-12#1)(1996-2#1)(2008-10#3)(2008-11#1)
be separated easily##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
be separated from the##3##4##(1995-5#1)(2008-10#1)(2010-8#1)
be separated from##15##3##(1990-2#1)(1990-5#1)(1995-5#1)(2008-10#9)(2008-2#1)(2008-7#1)(2010-8#1)
be separated into two##4##4##(2008-10#3)(2009-11#1)
be separated into##9##3##(1992-11#1)(2008-10#5)(2008-4#1)(2009-11#1)(2010-10#1)
be separated on##2##3##(1990-8#1)(2008-2#1)
be separated using##2##3##(2008-10#2)
be separated##63##2##(1990-2#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-8#2)(2012-2#1)(2013-8#1)
be sequenced to##2##3##(2008-10#1)(2008-7#1)
be sequenced using##2##3##(2008-2#1)(2011-2#1)
be sequenced##7##2##(1995-6#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
be serious##4##2##(2007-2#1)(2008-12#1)(2010-1#1)(2012-12#1)
be seriously considered as##3##4##(1991-2#1)(1994-6#1)(2008-5#1)
be seriously considered##5##3##(1991-2#1)(1994-6#1)(2008-11#1)(2008-5#1)(2010-1#1)
be seriously##8##2##(1991-2#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-1#1)
be served##3##2##(1991-11#1)(1997-2#1)(2008-10#1)
be set up##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
be set##10##2##(1991-9#1)(1992-12#1)(1996-12#1)(1996-2#1)(2008-2#2)(2008-3#1)(2009-10#1)(2011-2#1)(2013-8#1)
be several##3##2##(1990-5#1)(1994-2#1)(1997-1#1)
be severe##6##2##(1993-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2011-1#1)
be severely##5##2##(2007-8#1)(2008-3#2)(2008-8#1)(2012-12#1)
be shaped##3##2##(2008-3#1)(2008-9#1)(2009-8#1)
be shared by both##2##4##(1990-12#1)(2011-2#1)
be shared by##3##3##(1990-12#1)(2008-8#1)(2011-2#1)
be shared##6##2##(1990-12#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
be shifted##5##2##(1991-3#1)(2008-12#1)(2008-3#3)
be shortened##4##2##(1993-9#1)(2008-10#2)(2010-8#1)
be shown in##3##3##(1990-10#1)(1993-2#1)(2011-2#1)
be shown that the##3##4##(1995-12#1)(1997-1#1)(2013-8#1)
be shown that##8##3##(1990-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
be shown to be##4##4##(1991-5#1)(1992-9#1)(1993-12#1)(2008-10#1)
be shown to##8##3##(1991-1#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-9#1)
be shown##30##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-12#2)(1996-12#1)(1997-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
be sick##2##2##(1996-8#1)(1997-6#1)
be significant for##3##3##(1992-5#1)(2008-3#1)(2013-1#1)
be significant in##4##3##(1990-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
be significant##26##2##(1990-12#1)(1992-5#1)(1993-3#1)(1993-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#3)
be significantly (P&lt##2##3##(2008-10#1)(2008-12#1)
be significantly affected by##3##4##(2007-12#1)(2008-10#1)(2010-4#1)
be significantly increased##4##3##(1996-12#1)(1997-3#1)(2008-11#1)(2013-1#1)
be significantly influenced by the##2##5##(2011-2#2)
be significantly influenced by##3##4##(2011-2#2)(2012-2#1)
be significantly reduced by##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
be significantly reduced##7##3##(1992-11#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
be significantly suppressed##2##3##(2007-11#1)(2008-3#1)
be significantly##78##2##(1990-8#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(2007-11#2)(2007-12#8)(2007-6#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
be similar in##5##3##(1991-5#1)(1993-3#1)(1995-5#1)(2008-10#1)(2011-2#1)
be similar to that of##2##5##(2008-5#1)(2011-10#1)
be similar to that##5##4##(1990-2#1)(2007-2#1)(2008-5#1)(2009-11#1)(2011-10#1)
be similar to##17##3##(1990-2#1)(1991-9#1)(1993-11#1)(1993-9#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-10#1)(2011-2#2)(2012-2#1)
be similar##33##2##(1990-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-5#2)(2007-2#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
be similarly##4##2##(1990-11#1)(1991-3#1)(2007-12#1)(2012-3#1)
be simple to##2##3##(1996-2#1)(2010-5#1)
be simple##8##2##(1994-6#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#2)(2010-5#2)
be simplified##3##2##(1994-2#1)(1997-3#1)(2008-3#1)
be simultaneously##13##2##(1994-5#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-10#1)(2010-2#1)(2011-1#1)
be situated##2##2##(2007-11#1)(2009-6#1)
be slightly higher than the##2##5##(1996-8#1)(2008-2#1)
be slightly higher than##4##4##(1993-2#1)(1995-3#1)(1996-8#1)(2008-2#1)
be slightly##11##2##(1990-12#1)(1993-12#1)(1993-2#1)(1995-3#1)(1995-5#2)(1996-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
be slowly##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
be small##5##2##(2008-2#1)(2008-3#2)(2008-6#1)(2013-1#1)
be smaller than##6##3##(2008-3#4)(2008-9#1)(2010-8#1)
be smaller##8##2##(2008-3#5)(2008-9#1)(2010-8#1)(2012-2#1)
be so##4##2##(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#1)
be solely##2##2##(1991-2#1)(1993-3#1)
be solubilized##3##2##(1990-11#1)(1990-12#1)(1994-11#1)
be soluble##3##2##(1992-6#1)(2008-10#1)(2008-4#1)
be solved by##5##3##(1995-9#1)(2006-8#1)(2008-2#1)(2008-3#2)
be solved if##2##3##(2008-3#1)(2008-6#1)
be solved in the##2##4##(2008-10#1)(2008-3#1)
be solved in##3##3##(1996-3#1)(2008-10#1)(2008-3#1)
be solved##28##2##(1990-2#2)(1992-9#1)(1994-12#1)(1995-9#1)(1996-3#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)
be some of the##2##4##(2008-1#1)(2013-1#1)
be some##7##2##(1991-9#1)(1992-8#1)(1997-1#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
be sorted##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
be sought##4##2##(1995-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
be spatially##2##2##(2007-12#1)(2008-9#1)
be speciated##2##2##(2008-10#2)
be specific to##4##3##(1991-12#1)(1993-6#1)(2007-12#1)(2009-10#1)
be specific##12##2##(1990-7#1)(1991-12#1)(1992-3#1)(1993-6#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-6#1)
be specifically##14##2##(1990-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
be specified##8##2##(1997-4#1)(2007-7#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
be spectrally##2##2##(2007-12#1)(2008-2#1)
be spent##2##2##(2008-7#1)(2008-9#1)
be split##4##2##(2007-11#1)(2007-12#2)(2010-8#1)
be stabilised##2##2##(1995-3#1)(2007-11#1)
be stabilized##6##2##(1990-8#1)(2007-8#2)(2008-3#1)(2010-12#1)(2013-8#1)
be stable at##2##3##(2008-10#1)(2008-8#1)
be stable in##4##3##(1992-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
be stable##20##2##(1990-5#1)(1990-7#1)(1992-6#1)(1996-2#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
be stably##3##2##(1993-9#1)(1994-12#1)(2008-5#1)
be stacked##3##2##(2008-10#2)(2008-3#1)
be stained##2##2##(2008-2#1)(2008-9#1)
be started within 24##2##4##(2011-2#2)
be started##8##2##(2008-10#1)(2011-2#4)(2012-2#1)(2013-1#2)
be statistically##15##2##(1990-2#2)(1993-12#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-5#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
be still##5##2##(2008-2#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)
be stimulated by##8##3##(1990-3#1)(1990-5#2)(1991-9#1)(1993-12#1)(1995-6#1)(2009-3#1)(2012-2#1)
be stimulated to##3##3##(1991-6#1)(2008-4#2)
be stimulated##12##2##(1990-3#1)(1990-5#2)(1991-11#1)(1991-6#1)(1991-9#1)(1993-12#1)(1995-6#1)(2008-4#2)(2009-3#1)(2012-2#1)
be stopped##7##2##(1992-1#1)(1996-6#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
be stored at 4 degrees C for##2##7##(1990-12#1)(1991-11#1)
be stored at##3##3##(1990-12#1)(1991-11#1)(2008-10#1)
be stored in##7##3##(1990-11#1)(1994-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
be stored##13##2##(1990-11#1)(1990-12#2)(1991-11#1)(1994-8#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-3#2)(2012-3#1)
be straightforward##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
be strengthened##6##2##(1995-3#1)(2007-5#1)(2009-11#1)(2009-5#1)(2012-3#1)(2013-1#1)
be stressed##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
be strictly##3##2##(1997-2#1)(2008-5#1)(2010-5#1)
be stripped##2##2##(2008-10#1)(2008-4#1)
be strong##6##2##(1992-2#1)(1992-8#1)(1994-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
be stronger##5##2##(1997-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
be strongly affected by##2##4##(2008-10#2)
be strongly##23##2##(1991-12#2)(1996-2#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2011-2#2)(2013-1#1)
be structurally distinct from##2##4##(1990-8#1)(1995-2#1)
be structurally##3##2##(1990-8#1)(1994-5#1)(1995-2#1)
be structured to##4##3##(1994-3#2)(2008-11#1)(2008-8#1)
be structured##8##2##(1994-3#2)(1996-2#1)(2008-11#1)(2008-8#2)(2009-2#1)(2013-7#1)
be studied and##2##3##(2008-10#2)
be studied as##3##3##(1992-6#1)(2010-4#1)(2013-1#1)
be studied by##5##3##(1993-8#1)(2008-1#2)(2008-10#1)(2008-4#1)
be studied in the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
be studied in##7##3##(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)
be studied using##3##3##(1994-9#1)(2008-1#1)(2008-4#1)
be studied##37##2##(1991-1#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-9#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
be subdivided into##4##3##(1995-11#1)(1997-6#1)(2008-12#1)(2008-9#1)
be subdivided##5##2##(1995-11#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)
be subject to##7##3##(1992-11#1)(1997-3#1)(2007-4#1)(2008-10#3)(2012-3#1)
be subject##8##2##(1992-11#1)(1997-3#1)(2007-4#1)(2008-10#3)(2008-5#1)(2012-3#1)
be subjected to a##3##4##(1995-5#1)(2008-10#1)(2008-6#1)
be subjected to##11##3##(1992-1#2)(1995-5#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)
be subjected##12##2##(1992-1#2)(1993-3#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)
be submitted to##5##3##(1992-6#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
be submitted##6##2##(1992-6#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
be subsequently##2##2##(2008-10#1)(2012-2#1)
be substantial##3##2##(1992-2#1)(2008-10#1)(2008-8#1)
be substantially improved##3##3##(1992-3#1)(1993-12#1)(2008-2#1)
be substantially##7##2##(1992-3#1)(1993-12#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
be substituted for##4##3##(1990-12#1)(2007-12#1)(2011-2#2)
be substituted##6##2##(1990-12#1)(1991-9#1)(2007-12#1)(2009-6#1)(2011-2#2)
be successful in##10##3##(1991-2#1)(1992-6#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#2)
be successful##32##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#2)(2010-5#1)
be successfully applied to the##4##5##(2008-10#4)
be successfully applied to##6##4##(2007-12#1)(2008-10#4)(2008-3#1)
be successfully applied##11##3##(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2010-6#1)
be successfully performed##2##3##(2008-10#1)(2008-12#1)
be successfully treated##5##3##(1997-3#1)(1997-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
be successfully used for the##2##5##(2008-10#1)(2011-1#1)
be successfully used for##4##4##(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
be successfully used in##2##4##(1994-5#1)(2008-10#1)
be successfully used to determine##4##5##(2008-10#1)(2010-3#1)(2010-5#1)(2012-2#1)
be successfully used to##5##4##(2008-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
be successfully used##13##3##(1994-5#1)(2007-2#1)(2008-10#3)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
be successfully##46##2##(1990-8#1)(1993-3#1)(1994-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
be such a##2##3##(2008-12#1)(2008-8#1)
be such##4##2##(1996-2#2)(2008-12#1)(2008-8#1)
be sufficient for the##3##4##(1992-8#1)(1993-11#1)(2007-11#1)
be sufficient for##10##3##(1992-8#1)(1993-11#1)(1995-2#1)(1995-4#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-3#1)(2009-12#1)(2012-2#1)
be sufficient to explain the##2##5##(1997-5#1)(2007-12#1)
be sufficient to reach##2##4##(2006-12#1)(2011-2#1)
be sufficient to##16##3##(1993-11#1)(1994-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
be sufficient##29##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-5#1)(1995-2#1)(1995-4#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#2)
be sufficiently##6##2##(2007-12#1)(2008-2#1)(2009-3#1)(2009-7#1)(2010-3#1)(2012-2#1)
be suggested that##4##3##(1993-5#1)(1994-11#1)(2008-12#1)(2010-4#1)
be suggested##8##2##(1990-3#1)(1990-5#1)(1993-5#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-4#1)
be suitable for the routine##3##5##(1993-12#1)(2008-10#2)
be suitable for the##16##4##(1990-12#1)(1993-11#1)(1993-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-8#1)(2009-7#1)(2011-1#1)
be suitable for##27##3##(1990-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
be suitable##36##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-1#1)
be summarized##9##2##(1990-9#1)(1992-11#1)(1993-2#1)(1995-9#2)(1997-1#1)(2008-10#1)(2008-7#1)(2013-7#1)
be summed##2##2##(2008-3#2)
be superimposed by##2##3##(1993-12#1)(2013-1#1)
be superimposed on##2##3##(2008-11#1)(2008-2#1)
be superimposed##5##2##(1993-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2013-1#1)
be superior to the##9##4##(1992-1#1)(1992-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
be superior to##15##3##(1992-1#1)(1992-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
be superior##21##2##(1992-1#1)(1992-8#1)(1995-3#2)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
be superresolved by##2##3##(2008-2#1)(2008-3#1)
be superresolved##3##2##(2008-2#1)(2008-3#2)
be supplemented by##3##3##(1997-4#1)(2007-7#1)(2010-12#1)
be supplemented with##3##3##(1992-12#1)(1995-5#1)(2008-10#1)
be supplemented##8##2##(1992-12#1)(1995-5#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)
be supplied with##2##3##(1990-11#1)(1992-9#1)
be supplied##5##2##(1990-11#1)(1991-9#1)(1992-9#1)(2008-11#1)(2008-2#1)
be supported by##11##3##(1991-11#1)(1992-3#2)(1993-12#1)(1993-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
be supported##15##2##(1991-11#1)(1992-3#2)(1993-12#1)(1993-3#1)(2007-8#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
be supportive##2##2##(1994-2#1)(2010-6#1)
be suppressed by a##2##4##(1993-8#1)(1995-11#1)
be suppressed by the##2##4##(2008-10#1)(2008-11#1)
be suppressed by##8##3##(1993-8#1)(1994-3#1)(1995-11#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-9#1)
be suppressed##11##2##(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
be sure##5##2##(1993-1#1)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#1)
be surmounted##2##2##(2010-11#1)(2012-3#1)
be susceptible to##6##3##(1993-2#1)(2008-10#3)(2011-1#1)(2011-2#1)
be susceptible##7##2##(1993-2#1)(2008-10#4)(2011-1#1)(2011-2#1)
be suspect##2##2##(1993-3#1)(2007-12#1)
be suspected in##5##3##(1990-2#1)(2006-10#1)(2009-10#1)(2010-10#1)(2013-1#1)
be suspected##13##2##(1990-2#1)(1990-3#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
be sustained##5##2##(1990-11#1)(2008-10#1)(2008-9#1)(2013-1#2)
be switched##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-12#2)
be synthesized by##5##3##(1990-2#1)(1990-7#1)(1994-11#1)(1997-1#1)(2008-4#1)
be synthesized in##4##3##(1991-6#1)(1993-3#1)(1994-11#1)(1994-6#1)
be synthesized##17##2##(1990-2#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-12#1)
be systematically##3##2##(1991-11#1)(2008-3#1)(2008-9#1)
be systemically##2##2##(1993-11#1)(2007-11#1)
be tailored to##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2009-7#1)
be tailored##10##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2013-8#1)
be taken account##2##3##(2008-10#1)(2011-2#1)
be taken as##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
be taken during##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
be taken for##3##3##(1994-12#1)(1995-3#1)(2011-2#1)
be taken in the##2##4##(1997-3#1)(2008-7#1)
be taken in##4##3##(1997-3#1)(2008-7#2)(2009-12#1)
be taken into account by##4##5##(1993-12#1)(2008-10#2)(2013-1#1)
be taken into account for##2##5##(1995-2#1)(2008-5#1)
be taken into account in the##4##6##(1994-12#1)(1995-3#1)(2008-10#2)
be taken into account in##12##5##(1992-3#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
be taken into account when##5##5##(2008-10#1)(2008-2#1)(2008-9#1)(2013-7#1)(2013-8#1)
be taken into account##41##4##(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
be taken into consideration in##4##5##(1991-11#1)(2008-2#1)(2008-7#1)(2013-8#1)
be taken into consideration##18##4##(1990-6#1)(1991-11#1)(1992-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
be taken into##62##3##(1990-6#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#2)
be taken seriously by##2##4##(1996-12#1)(2008-4#1)
be taken seriously##4##3##(1996-12#1)(1996-6#1)(2008-10#1)(2008-4#1)
be taken to be##2##4##(1997-2#1)(2010-4#1)
be taken to ensure the##2##5##(1994-3#1)(2008-9#1)
be taken to ensure##3##4##(1994-3#1)(2008-4#1)(2008-9#1)
be taken to improve##2##4##(1996-2#1)(2010-8#1)
be taken to prevent##2##4##(2008-10#2)
be taken to protect##2##4##(1992-3#1)(2011-2#1)
be taken to##21##3##(1990-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
be taken under##2##3##(2007-11#1)(2008-12#1)
be taken when using##2##4##(1995-1#1)(2013-8#1)
be taken when##3##3##(1995-1#1)(2008-9#1)(2013-8#1)
be taken with##3##3##(2007-11#1)(2012-12#1)(2012-3#1)
be taken##137##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-3#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#4)
be taking##2##2##(1994-1#1)(2010-5#1)
be targeted by##4##3##(2008-10#1)(2009-4#1)(2009-8#1)(2011-2#1)
be targeted for##5##3##(1996-11#2)(2010-12#1)(2010-4#1)(2010-5#1)
be targeted##16##2##(1993-11#1)(1996-11#2)(1997-5#1)(1997-7#1)(2007-7#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
be targets##2##2##(2010-11#1)(2012-1#1)
be taught##3##2##(1992-6#1)(1994-12#1)(2011-2#1)
be temperature##2##2##(1994-8#1)(2007-12#1)
be temporarily##2##2##(1996-4#1)(2007-8#1)
be tempted to##2##3##(1994-2#1)(1995-3#1)
be terminated##4##2##(1996-1#1)(2007-8#1)(2008-2#1)(2008-8#1)
be tested as##4##3##(2007-5#1)(2008-10#2)(2008-5#1)
be tested by##3##3##(1997-2#1)(2008-9#1)(2010-12#1)
be tested for##4##3##(1995-12#1)(1996-5#1)(2007-7#1)(2008-4#1)
be tested in the field##2##5##(1996-12#1)(2008-10#1)
be tested in##10##3##(1990-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
be tested on##2##3##(2008-10#1)(2008-9#1)
be tested##38##2##(1990-11#1)(1990-3#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#1)(2013-8#2)
be that of##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
be that the##6##3##(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
be that##23##2##(1990-9#1)(1993-3#1)(1994-6#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
be the &quot##3##3##(1995-6#1)(2009-7#1)(2012-2#1)
be the basis for the##3##5##(1996-1#1)(2008-2#1)(2012-3#1)
be the basis for##4##4##(1996-1#2)(2008-2#1)(2012-3#1)
be the basis of its##2##5##(2008-10#1)(2008-6#1)
be the basis of##6##4##(1992-12#1)(1996-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
be the basis##10##3##(1992-12#1)(1996-1#2)(1996-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2012-3#1)
be the best way to##2##5##(1996-1#1)(1997-3#1)
be the best##32##3##(1990-3#1)(1990-9#1)(1993-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#2)(2010-7#1)(2011-2#1)(2012-2#1)
be the case in##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
be the case##9##3##(1990-11#1)(1990-6#1)(1992-3#1)(1993-6#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#1)
be the cause for##2##4##(2008-10#1)(2008-7#1)
be the cause of##14##4##(1990-11#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-2#1)
be the cause##18##3##(1990-11#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-3#1)(2011-2#1)
be the choice##2##3##(2008-10#2)
be the consequence of##9##4##(1990-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
be the consequence##10##3##(1990-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)
be the controlling##2##3##(2008-10#1)(2009-5#1)
be the crucial##2##3##(2009-11#1)(2012-1#1)
be the first case##3##4##(2008-12#1)(2009-3#1)(2013-1#1)
be the first example of##3##5##(1992-12#1)(2007-11#1)(2008-6#1)
be the first imaging##2##4##(1993-6#1)(2010-6#1)
be the first step##2##4##(1994-8#1)(2010-11#1)
be the first time that##3##5##(1996-1#1)(2007-11#1)(2011-1#1)
be the first time##20##4##(1996-1#1)(2007-11#12)(2007-12#5)(2008-3#1)(2011-1#1)
be the first to##3##4##(1990-2#1)(2007-12#1)(2010-3#1)
be the first##75##3##(1990-2#1)(1992-12#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(2007-11#19)(2007-12#21)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-2#2)(2013-1#1)
be the focus of this review##2##6##(2008-10#1)(2008-2#1)
be the focus of##5##4##(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
be the goal of##4##4##(1992-3#1)(1994-2#1)(2013-1#2)
be the gold standard##2##4##(2007-12#1)(2008-4#1)
be the important##2##3##(2008-9#1)(2011-3#1)
be the initial##4##3##(1990-9#1)(1991-2#1)(2010-6#1)(2011-2#1)
be the key to the##2##5##(1997-1#1)(2011-9#1)
be the key to##4##4##(1994-3#1)(1997-1#1)(2011-9#1)(2012-1#1)
be the key##8##3##(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-9#1)(2012-1#1)
be the main cause of##3##5##(2008-11#1)(2008-5#1)(2008-8#1)
be the main cause##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
be the main factor##2##4##(2013-7#2)
be the main reason for##2##5##(2009-11#1)(2009-12#1)
be the main##26##3##(1991-6#1)(1996-12#1)(1996-8#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#2)
be the major##16##3##(1991-12#1)(1994-1#1)(1994-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#1)
be the mechanism for##2##4##(2008-3#1)(2013-8#1)
be the mechanism##4##3##(1993-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
be the most important##8##4##(1991-3#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-6#1)(2008-8#1)(2009-7#1)(2013-1#1)
be the most promising##3##4##(2008-10#2)(2013-1#1)
be the most useful##4##4##(1991-6#1)(1992-1#1)(2008-9#1)(2009-12#1)
be the most##66##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#2)
be the only##13##3##(1992-3#1)(1992-5#1)(1994-9#1)(1996-11#1)(1997-3#1)(2007-7#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
be the optimal##4##3##(1995-2#1)(2007-8#1)(2008-7#1)(2012-3#1)
be the optimum##2##3##(2008-10#1)(2008-8#1)
be the origin##2##3##(2009-2#1)(2011-1#1)
be the predominant##2##3##(2008-1#1)(2008-9#1)
be the preferred##3##3##(1996-5#1)(2007-8#1)(2008-5#1)
be the presenting sign of##2##5##(2008-1#1)(2011-2#1)
be the presenting##3##3##(1995-11#1)(2008-1#1)(2011-2#1)
be the prevention of##2##4##(2007-7#1)(2008-11#1)
be the primary##10##3##(1996-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
be the reason for##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
be the reason##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
be the result of a##5##5##(2008-10#1)(2008-7#1)(2008-9#2)(2013-1#1)
be the result of the##4##5##(1991-12#1)(1993-11#1)(2008-10#1)(2008-3#1)
be the result of##28##4##(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
be the result##29##3##(1991-12#1)(1991-3#2)(1992-12#1)(1993-11#1)(1993-12#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
be the right##2##3##(2008-10#1)(2011-1#1)
be the same as##8##4##(1990-7#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
be the same##13##3##(1990-7#1)(1994-1#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)
be the sites##2##3##(1996-4#1)(2012-12#1)
be the source of##3##4##(1992-12#1)(2008-12#1)(2008-9#1)
be the subject of##2##4##(1993-11#1)(2008-4#1)
be the treatment of choice##2##5##(1992-9#1)(2010-10#1)
be the treatment##3##3##(1992-9#1)(2008-12#1)(2010-10#1)
be the underlying##2##3##(1994-3#1)(2008-7#1)
be the##572##2##(1990-11#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#2)(1991-12#6)(1991-2#1)(1991-3#4)(1991-6#5)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#8)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#2)(2006-10#1)(2007-10#4)(2007-11#26)(2007-12#30)(2007-7#8)(2007-8#6)(2007-9#1)(2008-1#9)(2008-10#70)(2008-11#12)(2008-12#8)(2008-2#12)(2008-3#18)(2008-4#10)(2008-5#7)(2008-6#10)(2008-7#23)(2008-8#19)(2008-9#20)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#4)(2010-10#4)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#2)(2010-6#4)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#13)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#4)(2012-2#14)(2012-3#6)(2012-9#1)(2013-1#12)(2013-7#5)(2013-8#5)
be their##3##2##(1991-2#1)(1991-3#1)(1993-9#1)
be then##4##2##(2008-10#1)(2010-11#1)(2010-8#1)(2012-2#1)
be theoretically##2##2##(2008-10#1)(2009-9#1)
be they##2##2##(2008-10#2)
be thin##2##2##(1991-2#1)(2007-12#1)
be those##5##2##(1993-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-4#1)
be thought of as##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
be thought##4##2##(1997-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
be through##3##2##(2008-3#1)(2008-5#2)
be tightly##3##2##(1993-8#1)(1997-3#1)(2009-8#1)
be time consuming##2##3##(2007-12#1)(2011-2#1)
be time##7##2##(1992-6#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-2#1)
be titrated##2##2##(2008-10#2)
be to establish##2##3##(1992-3#1)(1995-6#1)
be to increase##2##3##(1996-12#1)(2008-10#1)
be to prevent##2##3##(2008-10#1)(2011-2#1)
be to see##2##3##(1994-9#1)(1995-1#1)
be to##47##2##(1990-11#1)(1990-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-9#2)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#2)
be tolerated at##3##3##(1990-11#1)(2008-10#1)(2008-12#1)
be tolerated in##3##3##(1992-3#1)(2008-10#2)
be tolerated##16##2##(1990-11#1)(1992-3#1)(1994-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#1)
be too##11##2##(1990-2#1)(1995-5#1)(1995-6#1)(2007-2#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2012-2#1)
be totally##2##2##(2008-7#1)(2009-7#1)
be toxic to##4##3##(1992-12#1)(1994-5#1)(1996-12#1)(2008-11#1)
be toxic##8##2##(1991-9#1)(1992-12#1)(1994-5#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)
be traced back to##4##4##(2008-10#3)(2008-5#1)
be traced to##7##3##(1993-6#2)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#2)
be traced##14##2##(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-5#1)(2009-6#1)
be tracked##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
be trained in##4##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
be trained to##3##3##(1992-3#1)(2008-2#1)(2011-2#1)
be trained##11##2##(1992-3#1)(1994-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
be transcribed##5##2##(1994-12#1)(2008-11#2)(2008-8#1)(2008-9#1)
be transferred into##4##3##(1994-5#1)(2007-5#1)(2008-8#2)
be transferred to the##2##4##(2008-10#1)(2008-11#1)
be transferred to##5##3##(1995-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
be transferred##14##2##(1993-12#1)(1994-5#1)(1995-5#1)(1997-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-6#1)(2013-1#1)(2013-8#1)
be transformed##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
be translated into##5##3##(1991-12#1)(2008-6#1)(2008-8#1)(2010-6#1)(2012-12#1)
be translated##11##2##(1991-12#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#3)
be translocated##2##2##(1990-12#1)(2011-2#1)
be transmitted by##2##3##(2008-10#1)(2011-2#1)
be transmitted from##4##3##(1990-9#1)(2008-10#2)(2008-3#1)
be transmitted through##3##3##(1996-5#2)(2008-10#1)
be transmitted to##2##3##(1994-5#1)(2007-11#1)
be transmitted##22##2##(1990-9#1)(1993-1#1)(1994-5#1)(1995-9#1)(1996-5#2)(1996-8#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
be transparent##3##2##(2008-3#1)(2009-12#1)(2011-2#1)
be transported over long distances in##2##6##(2008-10#1)(2008-11#1)
be transported to##3##3##(1996-9#1)(2008-10#2)
be transported##10##2##(1996-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)
be trapped##3##2##(1991-9#1)(2008-10#1)(2009-12#1)
be treated as a##5##4##(1993-11#1)(2007-10#1)(2008-2#1)(2008-3#2)
be treated as##9##3##(1990-9#2)(1993-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
be treated by##7##3##(1997-4#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-7#1)(2013-8#1)
be treated in a##3##4##(2009-5#1)(2010-3#1)(2013-8#1)
be treated in##8##3##(1991-3#1)(1993-3#1)(1993-6#1)(2007-8#2)(2009-5#1)(2010-3#1)(2013-8#1)
be treated simultaneously##2##3##(2008-10#2)
be treated successfully##2##3##(1995-2#1)(2008-9#1)
be treated surgically##4##3##(1990-12#2)(1991-6#1)(2012-3#1)
be treated using##2##3##(1996-3#1)(2008-10#1)
be treated with a##3##4##(1991-3#1)(2009-4#1)(2011-2#1)
be treated with##31##3##(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-5#1)(1996-11#2)(1996-9#1)(1997-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#3)(2009-4#1)(2011-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
be treated##89##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#4)(1991-3#2)(1991-6#2)(1991-9#2)(1992-2#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-11#3)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-7#3)(2007-8#4)(2008-10#8)(2008-2#3)(2008-3#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#6)(2011-3#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
be treated]##2##2##(1993-8#1)(1997-5#1)
be tried as a##2##4##(2007-7#1)(2008-5#1)
be tried##3##2##(1993-3#1)(2007-7#1)(2008-5#1)
be triggered by##5##3##(1996-12#1)(1997-6#1)(2008-11#1)(2009-4#1)(2012-3#1)
be triggered##6##2##(1996-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-3#1)
be tuned by the##3##4##(2007-11#1)(2008-6#1)(2012-2#1)
be tuned by##6##3##(2007-11#3)(2007-12#1)(2008-6#1)(2012-2#1)
be tuned from##4##3##(2007-11#1)(2007-12#2)(2008-7#1)
be tuned over##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
be tuned to##2##3##(2008-2#1)(2011-1#1)
be tuned##23##2##(2007-11#8)(2007-12#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
be turned on##2##3##(1994-12#1)(2008-7#1)
be turned##4##2##(1992-12#1)(1994-12#1)(2008-7#1)(2008-8#1)
be typical##3##2##(1991-12#1)(1995-8#1)(2008-5#1)
be unable to##10##3##(1992-12#2)(1992-2#1)(1995-5#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
be unable##11##2##(1992-12#2)(1992-2#1)(1995-5#1)(1996-9#2)(1997-7#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
be unacceptable##2##2##(1996-8#1)(2008-7#1)
be unambiguously##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
be under the##3##3##(1992-10#1)(2008-5#1)(2010-6#1)
be under##9##2##(1990-11#2)(1992-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#1)
be underestimated##4##2##(2007-12#1)(2008-11#1)(2012-1#1)(2013-1#1)
be understood and##2##3##(2008-1#1)(2013-8#1)
be understood as##5##3##(2007-12#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
be understood from the##2##4##(1990-7#1)(2008-8#1)
be understood in##3##3##(2007-8#1)(2013-7#1)(2013-8#1)
be understood##27##2##(1990-5#1)(1990-7#1)(1991-1#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
be undertaken at##3##3##(1993-12#1)(1996-6#1)(2008-5#1)
be undertaken by##2##3##(2008-8#1)(2009-11#1)
be undertaken to##2##3##(1993-6#1)(2010-11#1)
be undertaken##17##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-6#2)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2012-3#1)
be underused in patients receiving conventional care##2##7##(2008-3#2)
be underused in##3##3##(2008-12#1)(2008-3#2)
be unique to##4##3##(1991-2#1)(1992-12#1)(2009-8#1)(2012-2#1)
be unique##12##2##(1991-2#1)(1992-12#2)(1992-5#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
be uniquely##6##2##(1991-12#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-6#1)
be universal##4##2##(1990-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
be universally##2##2##(2008-12#1)(2008-5#1)
be unrelated to the##3##4##(1995-12#2)(1997-6#1)
be unrelated to##7##3##(1992-3#1)(1995-12#2)(1996-10#1)(1996-12#1)(1997-6#1)(2007-11#1)
be unstable##4##2##(1995-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
be unsuccessful##2##2##(1997-1#1)(2008-12#1)
be unsuitable for##2##3##(1996-5#1)(2008-10#1)
be unusually##2##2##(1991-7#1)(2008-8#1)
be up to##3##3##(1994-12#1)(2007-12#1)(2012-12#1)
be updated##3##2##(1991-9#1)(2008-5#1)(2012-3#1)
be used across the##2##4##(2008-7#1)(2011-1#1)
be used and##6##3##(1990-5#1)(2007-12#1)(2008-11#1)(2008-3#2)(2012-1#1)
be used as a basis for##2##6##(2008-2#1)(2008-8#1)
be used as a basis##3##5##(2008-2#1)(2008-8#1)(2008-9#1)
be used as a model##2##5##(1990-7#1)(2011-1#1)
be used as a new##8##5##(2008-10#3)(2008-2#1)(2008-5#3)(2008-9#1)
be used as a prognostic##2##5##(2008-7#1)(2011-2#1)
be used as a rapid and##2##6##(2008-10#2)
be used as a reference##3##5##(2008-10#1)(2008-12#1)(2008-2#1)
be used as a source of##2##6##(2008-10#2)
be used as a surrogate index of##2##7##(2008-1#1)(2008-6#1)
be used as a surrogate##4##5##(2008-1#1)(2008-6#1)(2009-3#1)(2010-8#1)
be used as a tool##3##5##(2008-8#1)(2010-6#2)
be used as a vaccine##2##5##(1997-6#1)(2008-12#1)
be used as a##121##4##(1990-7#1)(1991-12#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#23)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
be used as adjuvants##2##4##(1990-11#1)(2008-5#1)
be used as an additional##2##5##(2011-2#1)(2013-1#1)
be used as an alternative to##2##6##(1992-5#1)(2008-10#1)
be used as an alternative##5##5##(1992-5#1)(2008-10#4)
be used as an effective##2##5##(2008-10#1)(2008-11#1)
be used as an indicator##2##5##(2008-10#1)(2008-3#1)
be used as an##34##4##(1990-5#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-9#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
be used as efficient##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
be used as indicators of##3##5##(1992-3#1)(2008-8#1)(2010-4#1)
be used as internal##2##4##(2008-10#1)(2008-8#1)
be used as molecular##2##4##(2010-4#1)(2012-2#1)
be used as part of a##2##6##(2008-3#1)(2010-5#1)
be used as part of##3##5##(2008-10#1)(2008-3#1)(2010-5#1)
be used as reference##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
be used as the basis##5##5##(1992-6#1)(1994-3#1)(2007-12#1)(2008-2#2)
be used as the##18##4##(1992-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2011-2#1)(2013-8#1)
be used as##267##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-9#2)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#58)(2008-11#12)(2008-12#3)(2008-2#16)(2008-3#12)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#12)(2008-9#5)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#11)(2013-8#6)
be used by health##2##4##(2008-11#1)(2008-8#1)
be used by##21##3##(1991-1#1)(1991-2#1)(1992-3#1)(1995-6#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
be used clinically##2##3##(2008-5#1)(2010-7#1)
be used directly##5##3##(1995-6#1)(2008-10#2)(2008-4#1)(2011-1#1)
be used during##3##3##(2007-8#1)(2008-10#1)(2009-10#1)
be used efficiently for the##2##5##(1992-11#1)(2007-12#1)
be used efficiently##4##3##(1992-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
be used for a##8##4##(1991-7#1)(2007-12#1)(2008-10#2)(2008-3#3)(2012-2#1)
be used for accurate##2##4##(2008-2#2)
be used for any##4##4##(1994-6#1)(1997-5#1)(2008-3#1)(2008-4#1)
be used for assessing the##2##5##(2008-10#1)(2008-7#1)
be used for at least 3 months without any divergence in##2##11##(2008-10#2)
be used for at least 3 months without any##6##9##(2008-10#6)
be used for at least##14##5##(2008-10#14)
be used for both##8##4##(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
be used for detection##3##4##(2008-10#2)(2011-1#1)
be used for determination of##3##5##(2008-10#3)
be used for determining##3##4##(2008-10#2)(2008-2#1)
be used for diagnosis##2##4##(1992-6#1)(2011-2#1)
be used for evaluation##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
be used for every##2##4##(2007-10#1)(2007-12#1)
be used for many##2##4##(2007-12#1)(2008-7#1)
be used for measuring##3##4##(1992-1#1)(2008-10#1)(2008-3#1)
be used for more than##9##5##(2008-10#9)
be used for prediction##2##4##(2008-10#1)(2012-2#1)
be used for quantitative##3##4##(2008-10#3)
be used for rapid##6##4##(2008-10#3)(2008-4#1)(2008-5#2)
be used for sensitive##2##4##(2008-10#1)(2009-3#1)
be used for studying##2##4##(2008-10#2)
be used for the design of##3##6##(2007-12#1)(2009-3#1)(2011-2#1)
be used for the determination of trace##2##7##(2008-10#2)
be used for the determination of##14##6##(1993-9#1)(2008-10#13)
be used for the development of##3##6##(2008-10#1)(2008-3#1)(2008-9#1)
be used for the evaluation of##2##6##(1990-11#1)(2008-10#1)
be used for the production of##4##6##(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#1)
be used for the##67##4##(1990-11#1)(1990-2#1)(1991-3#1)(1993-1#1)(1993-9#1)(2007-12#1)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
be used for treatment##2##4##(2008-6#1)(2010-6#1)
be used for##308##3##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#9)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#106)(2008-11#9)(2008-12#4)(2008-2#18)(2008-3#29)(2008-4#17)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#11)(2009-10#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#4)
be used if there##3##4##(2008-1#1)(2012-2#2)
be used if##5##3##(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#2)
be used in a##21##4##(2008-10#11)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
be used in all##2##4##(2008-10#1)(2008-4#1)
be used in an##4##4##(2007-10#1)(2008-10#2)(2008-3#1)
be used in association with##2##5##(2008-10#1)(2013-8#1)
be used in combination with##6##5##(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-7#1)
be used in conjunction with##7##5##(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)
be used in developing##3##4##(1997-7#1)(2008-10#1)(2009-5#1)
be used in every##3##4##(1990-3#1)(2007-10#1)(2007-12#1)
be used in future##2##4##(2008-10#1)(2012-2#1)
be used in order to##5##5##(1991-6#1)(1995-1#1)(2008-10#2)(2008-6#1)
be used in pH range of##2##6##(2008-10#2)
be used in patients with##2##5##(1993-2#1)(1996-11#1)
be used in primary##2##4##(1996-9#1)(2012-12#1)
be used in studies of##2##5##(2007-10#1)(2008-4#1)
be used in the diagnosis of##2##6##(2007-7#1)(2011-2#1)
be used in the field of##2##6##(2008-10#1)(2012-12#1)
be used in the future##3##5##(2008-10#1)(2008-3#1)(2012-6#1)
be used in the pH range from##4##7##(2008-10#4)
be used in the pH range##6##6##(2008-10#6)
be used in the treatment of##3##6##(1992-6#1)(2008-11#1)(2012-2#1)
be used in the##51##4##(1990-11#1)(1990-12#1)(1990-2#1)(1992-6#2)(1994-12#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
be used in##199##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#45)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#15)(2008-4#7)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#4)(2012-2#4)(2012-3#3)(2012-6#1)(2013-1#8)(2013-7#2)(2013-8#2)
be used instead of##6##4##(1995-12#1)(2007-11#1)(2008-3#1)(2008-4#2)(2008-7#1)
be used instead##8##3##(1995-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)
be used more##2##3##(2008-7#1)(2009-6#1)
be used not only##4##4##(1991-5#1)(2008-2#1)(2008-4#1)(2011-2#1)
be used on a##3##4##(1997-3#1)(2008-2#1)(2008-3#1)
be used on##6##3##(1997-3#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
be used or##2##3##(2008-10#1)(2010-5#1)
be used outside the##2##4##(2012-12#1)(2012-3#1)
be used prior to##3##4##(2007-8#1)(2008-10#1)(2010-8#1)
be used reliably##2##3##(2008-10#2)
be used routinely in##2##4##(1995-3#1)(2008-9#1)
be used routinely##3##3##(1995-3#1)(2008-10#1)(2008-9#1)
be used to achieve##4##4##(1995-3#1)(2008-10#1)(2008-11#1)(2009-3#1)
be used to address##2##4##(1995-8#1)(2008-8#1)
be used to amplify##3##4##(2008-10#1)(2008-4#1)(2009-4#1)
be used to assess the##5##5##(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)(2009-9#1)
be used to assess##10##4##(2008-1#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2013-1#1)
be used to better##2##4##(2009-7#1)(2013-1#1)
be used to calculate the##5##5##(2008-10#3)(2008-3#2)
be used to calculate##7##4##(2008-10#3)(2008-2#1)(2008-3#3)
be used to characterize##9##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)
be used to compare the##3##5##(1993-12#1)(2008-10#1)(2008-8#1)
be used to compare##4##4##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
be used to confirm##2##4##(2008-5#1)(2012-2#1)
be used to construct##7##4##(1992-6#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-4#1)
be used to control##3##4##(2008-2#1)(2011-1#1)(2012-2#1)
be used to correct##2##4##(2008-3#2)
be used to define##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
be used to deliver##2##4##(2008-5#1)(2008-7#1)
be used to describe the##4##5##(2008-3#2)(2008-9#1)(2010-12#1)
be used to describe##6##4##(1991-2#1)(2008-3#2)(2008-9#2)(2010-12#1)
be used to detect and##2##5##(2008-10#2)
be used to detect the##4##5##(1996-5#1)(2008-2#1)(2009-4#1)(2013-8#1)
be used to detect##30##4##(1990-3#1)(1996-5#1)(2008-10#10)(2008-2#2)(2008-4#7)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#2)
be used to determine the concentration of##3##7##(2008-10#1)(2008-4#1)(2008-9#1)
be used to determine the precise##2##6##(2008-4#1)(2012-2#1)
be used to determine the##20##5##(1990-12#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-9#1)(2012-2#1)
be used to determine total##2##5##(1994-2#1)(2008-10#1)
be used to determine##44##4##(1990-12#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-4#1)(2008-1#2)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
be used to develop##5##4##(1997-7#1)(2007-11#1)(2008-11#1)(2010-7#1)(2012-2#1)
be used to discriminate between##3##5##(1994-12#1)(2008-10#1)(2008-7#1)
be used to discriminate##6##4##(1994-12#1)(2008-10#1)(2008-7#4)
be used to distinguish among##2##5##(1993-6#1)(2008-8#1)
be used to distinguish between##2##5##(2006-4#1)(2008-1#1)
be used to distinguish##7##4##(1993-6#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-8#1)(2013-8#1)
be used to eliminate the##2##5##(2007-11#1)(2008-3#1)
be used to eliminate##3##4##(1991-9#1)(2007-11#1)(2008-3#1)
be used to enhance the##3##5##(2008-2#1)(2008-3#1)(2012-2#1)
be used to enhance##5##4##(2008-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
be used to establish##3##4##(2008-10#1)(2008-11#2)
be used to estimate the##7##5##(1994-11#1)(1996-3#1)(2008-10#5)
be used to estimate##14##4##(1994-11#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-2#4)(2008-3#1)(2013-1#1)
be used to evaluate the##6##5##(1991-1#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#2)
be used to evaluate##10##4##(1991-1#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-9#2)(2012-12#1)(2012-2#1)
be used to explain the##3##5##(2007-12#1)(2008-10#1)(2008-4#1)
be used to explain##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
be used to form##3##4##(2008-2#1)(2008-3#1)(2009-9#1)
be used to further##2##4##(2008-10#1)(2010-5#1)
be used to gain##2##4##(1995-11#1)(2007-8#1)
be used to generate##9##4##(1990-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2011-3#1)(2012-2#1)
be used to identify specific##2##5##(2008-4#1)(2010-11#1)
be used to identify##18##4##(1993-3#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
be used to improve the quality##3##6##(1994-2#1)(1994-3#1)(2008-3#1)
be used to improve the##11##5##(1994-2#1)(1994-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-6#1)(2010-12#1)
be used to improve##22##4##(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#2)(1997-3#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)
be used to infer##3##4##(1997-2#1)(2011-1#1)(2013-8#1)
be used to investigate the##4##5##(1994-12#1)(1996-12#1)(2011-1#1)(2012-3#1)
be used to investigate##7##4##(1990-5#1)(1990-7#1)(1994-12#1)(1996-12#1)(2008-7#1)(2011-1#1)(2012-3#1)
be used to measure the##8##5##(2008-1#1)(2008-2#1)(2008-3#4)(2008-4#2)
be used to measure##21##4##(1996-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#7)(2008-4#6)(2008-7#1)(2013-1#1)
be used to model##6##4##(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)
be used to modify##2##4##(2013-8#2)
be used to monitor the hydrolysis##2##6##(2008-10#2)
be used to monitor the##6##5##(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
be used to monitor##10##4##(1995-11#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
be used to obtain##7##4##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
be used to optimize##2##4##(2008-3#1)(2008-5#1)
be used to perform##2##4##(2007-12#1)(2008-2#1)
be used to predict the##6##5##(1997-4#1)(1997-9#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-8#1)
be used to predict##11##4##(1997-4#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2010-2#1)(2012-3#1)(2013-8#1)
be used to prevent##2##4##(2008-11#1)(2009-8#1)
be used to produce##12##4##(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-12#1)(2009-5#1)(2010-3#1)
be used to provide##5##4##(2008-10#1)(2008-3#1)(2008-4#2)(2013-1#1)
be used to quantify##5##4##(2008-1#1)(2008-10#2)(2008-4#1)(2010-5#1)
be used to quantitate##5##4##(1990-12#1)(2008-4#3)(2009-10#1)
be used to reduce the##4##5##(1991-12#1)(1997-6#1)(2008-2#2)
be used to reduce##8##4##(1991-12#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-2#3)
be used to refine##2##4##(2008-10#1)(2008-8#1)
be used to reliably##4##4##(2008-10#1)(2008-8#1)(2009-4#1)(2010-3#1)
be used to remove##2##4##(2008-10#1)(2008-6#1)
be used to screen##2##4##(1994-8#1)(2008-7#1)
be used to search##3##4##(1993-8#1)(2008-2#1)(2013-1#1)
be used to separate##3##4##(2007-12#1)(2008-10#1)(2009-12#1)
be used to set##2##4##(1992-2#1)(2012-2#1)
be used to study both the##2##6##(1993-6#1)(2009-4#1)
be used to study the##10##5##(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2013-8#1)
be used to study##18##4##(1993-12#1)(1993-6#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-4#1)(2010-9#1)(2013-8#1)
be used to support##2##4##(1994-6#1)(2008-10#1)
be used to tailor##2##4##(2009-12#1)(2013-1#1)
be used to target##2##4##(2011-2#1)(2012-3#1)
be used to test the##2##5##(2008-5#1)(2010-8#1)
be used to test##9##4##(1992-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-3#1)
be used to treat##5##4##(1992-1#1)(1997-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
be used to understand##2##4##(2008-7#1)(2010-7#1)
be used to##626##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-6#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#1)(2006-10#2)(2006-4#2)(2007-10#4)(2007-11#8)(2007-12#17)(2007-4#1)(2007-8#3)(2008-1#18)(2008-10#105)(2008-11#25)(2008-12#7)(2008-2#48)(2008-3#62)(2008-4#50)(2008-5#9)(2008-6#3)(2008-7#20)(2008-8#14)(2008-9#18)(2009-10#3)(2009-11#3)(2009-12#4)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#5)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#9)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#14)(2012-3#7)(2013-1#12)(2013-8#11)
be used when##9##3##(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-3#1)
be used with a##4##4##(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)
be used with most cell types##2##6##(2008-1#1)(2008-2#1)
be used with other##2##4##(2008-11#1)(2008-3#1)
be used with the##3##4##(1997-2#1)(2007-11#1)(2008-2#1)
be used with##39##3##(1991-3#1)(1991-5#1)(1992-3#2)(1994-8#1)(1996-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-7#1)(2008-9#2)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#3)
be used without##2##3##(2008-10#1)(2008-7#1)
be used##1672##2##(1990-11#5)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#6)(1992-5#2)(1992-6#7)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#6)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#5)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#3)(1996-11#3)(1996-12#11)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#5)(1996-6#3)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#8)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#3)(1997-9#1)(2006-10#3)(2006-4#3)(2007-10#11)(2007-11#21)(2007-12#41)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#11)(2008-1#30)(2008-10#366)(2008-11#58)(2008-12#19)(2008-2#109)(2008-3#138)(2008-4#91)(2008-5#33)(2008-6#14)(2008-7#53)(2008-8#38)(2008-9#45)(2009-10#6)(2009-11#8)(2009-12#6)(2009-2#3)(2009-3#10)(2009-4#4)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#7)(2010-1#2)(2010-10#3)(2010-11#6)(2010-12#10)(2010-2#3)(2010-3#8)(2010-4#5)(2010-5#10)(2010-6#10)(2010-7#6)(2010-8#12)(2010-9#1)(2011-1#23)(2011-2#40)(2011-3#3)(2012-1#4)(2012-12#15)(2012-2#32)(2012-3#15)(2012-6#1)(2013-1#42)(2013-7#2)(2013-8#28)
be useful and##4##3##(1997-5#1)(2008-8#1)(2010-8#1)(2012-1#1)
be useful as a##13##4##(1993-1#1)(1994-2#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-3#1)
be useful as##23##3##(1992-6#1)(1993-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-5#1)(2010-3#1)(2011-2#2)(2013-1#1)
be useful for a##2##4##(1994-5#1)(1997-2#1)
be useful for applications##2##4##(2007-11#1)(2008-7#1)
be useful for both##2##4##(2008-1#1)(2008-9#1)
be useful for characterizing the##2##5##(1992-1#1)(2008-11#1)
be useful for estimating##3##4##(1994-3#1)(2008-10#1)(2009-9#1)
be useful for in vitro##2##5##(1996-12#1)(2008-5#1)
be useful for in vivo##2##5##(1997-4#1)(2008-4#1)
be useful for in##4##4##(1996-12#1)(1997-4#1)(2008-4#1)(2008-5#1)
be useful for many##2##4##(2007-11#1)(2008-11#1)
be useful for monitoring##2##4##(2008-10#1)(2010-8#1)
be useful for planning##2##4##(2008-8#1)(2013-7#1)
be useful for screening##2##4##(2008-10#2)
be useful for some##2##4##(1996-4#1)(2008-10#1)
be useful for studying the##3##5##(1992-12#1)(1995-2#1)(2008-11#1)
be useful for studying##6##4##(1992-12#1)(1995-2#2)(1997-6#1)(2007-12#1)(2008-11#1)
be useful for testing##2##4##(1994-6#1)(2008-11#1)
be useful for the analysis of##2##6##(2008-10#1)(2008-2#1)
be useful for the evaluation of##2##6##(2008-5#1)(2013-1#1)
be useful for the measurement##2##5##(2008-10#1)(2008-7#1)
be useful for the treatment of##2##6##(2008-3#1)(2011-1#1)
be useful for the##22##4##(1990-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
be useful for##128##3##(1990-8#3)(1991-2#2)(1992-1#1)(1992-12#1)(1992-8#1)(1994-3#3)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#3)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#35)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
be useful in a##2##4##(2008-3#1)(2008-5#1)
be useful in assessing the##2##5##(2008-2#1)(2010-10#1)
be useful in assisting##2##4##(2008-12#1)(2010-5#1)
be useful in detection of##2##5##(1994-7#1)(2013-1#1)
be useful in determining##3##4##(1997-6#1)(2008-10#1)(2010-4#1)
be useful in developing##7##4##(1994-11#1)(2008-10#3)(2011-2#1)(2011-3#1)(2013-8#1)
be useful in diagnosing##2##4##(2007-10#1)(2008-5#1)
be useful in further##2##4##(1993-8#1)(2012-3#1)
be useful in identifying##2##4##(1992-5#1)(2011-1#1)
be useful in patients with##2##5##(1990-10#1)(1991-8#1)
be useful in predicting##4##4##(1992-3#1)(1996-6#1)(2009-5#1)(2013-1#1)
be useful in screening for##2##5##(1996-3#1)(2008-10#1)
be useful in screening##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
be useful in some##2##4##(1997-8#1)(2008-1#1)
be useful in studying the##3##5##(1993-6#1)(1996-12#1)(2008-4#1)
be useful in studying##4##4##(1993-6#1)(1996-12#1)(2006-10#1)(2008-4#1)
be useful in the development of##2##6##(1994-6#1)(2008-10#1)
be useful in the diagnosis##2##5##(1996-11#1)(2011-2#1)
be useful in the management of##2##6##(1997-8#1)(2009-11#1)
be useful in the prediction of##3##6##(1995-8#1)(1996-7#1)(2008-9#1)
be useful in the treatment of##3##6##(2008-10#1)(2008-5#1)(2009-5#1)
be useful in the##28##4##(1991-5#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-8#1)(2006-11#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-8#1)
be useful in understanding##3##4##(1996-12#1)(2008-10#1)(2012-2#1)
be useful in##130##3##(1990-10#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#3)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-4#3)(2010-5#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#3)
be useful to identify##4##4##(2008-11#1)(2008-4#2)(2011-2#1)
be useful to policy makers##2##5##(1994-1#2)
be useful to provide##2##4##(2008-12#1)(2009-5#1)
be useful to##42##3##(1992-2#2)(1993-12#1)(1994-1#2)(1994-11#1)(1997-3#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-7#1)(2013-8#2)
be useful tools##2##3##(1994-6#1)(2012-2#1)
be useful##363##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#4)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#4)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#5)(1994-7#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#3)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#75)(2008-11#17)(2008-12#7)(2008-2#10)(2008-3#13)(2008-4#10)(2008-5#12)(2008-7#11)(2008-8#9)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#9)(2012-3#4)(2012-8#1)(2013-1#9)(2013-7#3)(2013-8#7)
be usefully employed##2##3##(1990-2#1)(1990-8#1)
be utilised as##2##3##(2007-8#1)(2008-11#1)
be utilized as a##3##4##(2008-10#2)(2008-4#1)
be utilized as##7##3##(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-11#1)(2009-12#1)
be utilized for the##4##4##(2008-10#3)(2008-5#1)
be utilized for##12##3##(1990-12#1)(1992-2#1)(1994-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-6#1)
be utilized in##7##3##(1992-9#1)(1994-9#1)(2008-10#2)(2010-5#1)(2012-1#1)(2013-8#1)
be utilized to##12##3##(1990-12#1)(1992-2#1)(1994-5#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-3#1)(2013-1#2)
be utilized##48##2##(1990-12#2)(1992-2#2)(1992-9#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-5#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#2)
be vaccinated##7##2##(1990-11#1)(1996-11#1)(2007-2#2)(2008-4#1)(2009-12#1)(2009-5#1)
be valid for##3##3##(1993-6#1)(1997-8#1)(2008-3#1)
be valid##7##2##(1993-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-2#1)
be validated in##2##3##(2008-6#1)(2013-1#1)
be validated##6##2##(1991-3#1)(2008-11#1)(2008-6#1)(2011-2#1)(2011-7#1)(2013-1#1)
be valuable for##5##3##(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
be valuable in the##3##4##(1997-8#1)(2008-2#1)(2011-7#1)
be valuable in##7##3##(1990-11#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-2#1)(2011-2#1)(2011-7#1)
be valuable to others##2##4##(2010-2#1)(2013-1#1)
be valuable to##5##3##(1994-2#1)(2008-6#1)(2008-9#1)(2010-2#1)(2013-1#1)
be valuable tools##2##3##(1991-2#1)(2008-8#1)
be valuable##22##2##(1990-11#1)(1991-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
be value in##2##3##(2007-2#1)(2008-11#1)
be variable##3##2##(1993-12#1)(1995-5#1)(2013-8#1)
be varied from##2##3##(2007-12#1)(2008-10#1)
be varied in##2##3##(2007-11#1)(2008-3#1)
be varied##13##2##(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)
be vectored##2##2##(2008-10#2)
be very difficult##2##3##(1996-4#1)(2012-12#1)
be very effective##10##3##(1991-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#2)
be very helpful in##5##4##(2008-1#1)(2008-12#1)(2009-5#1)(2010-8#1)(2010-9#1)
be very helpful##6##3##(2008-1#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)
be very high##2##3##(2008-11#1)(2012-3#1)
be very important for the##3##5##(2008-1#1)(2008-5#1)(2010-7#1)
be very important for##5##4##(1990-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-7#1)
be very important##9##3##(1990-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)
be very low##2##3##(2007-12#1)(2008-8#1)
be very sensitive to##4##4##(1990-5#1)(1990-7#1)(2008-7#1)(2013-8#1)
be very sensitive##6##3##(1990-5#1)(1990-7#1)(2008-10#1)(2008-7#2)(2013-8#1)
be very similar to##2##4##(1992-12#1)(1995-5#1)
be very similar##5##3##(1992-12#1)(1993-9#1)(1995-5#1)(2008-1#1)(2008-10#1)
be very useful for##6##4##(1997-2#1)(1997-8#1)(2008-10#3)(2010-1#1)
be very useful in the##3##5##(1997-6#1)(1997-8#1)(2008-8#1)
be very useful in##6##4##(1993-11#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-2#1)
be very useful##16##3##(1993-11#1)(1994-2#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#1)(2013-1#1)
be very well##2##3##(1992-11#1)(2011-2#1)
be very##104##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#4)(2008-10#24)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
be via##2##2##(2008-10#1)(2008-11#1)
be viable##5##2##(1992-1#1)(1994-1#1)(1996-8#1)(1997-1#1)(2012-12#1)
be viewed as a##8##4##(1994-12#1)(1995-2#1)(1995-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
be viewed as an##3##4##(1992-12#1)(1997-3#1)(2008-7#1)
be viewed as##23##3##(1991-3#2)(1992-12#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
be viewed in##2##3##(1996-1#1)(1997-8#1)
be viewed with##2##3##(1991-2#1)(1993-11#1)
be viewed##35##2##(1991-2#1)(1991-3#2)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
be violated##3##2##(2008-2#1)(2012-3#1)(2013-1#1)
be visualized by##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
be visualized in##5##3##(1990-7#1)(1997-4#1)(2008-10#1)(2009-11#1)(2012-2#1)
be visualized##16##2##(1990-7#1)(1993-12#1)(1994-11#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#2)
be vital##4##2##(1993-3#1)(2008-11#1)(2008-8#1)(2013-1#1)
be vulnerable##2##2##(2009-5#1)(2011-2#1)
be warranted##7##2##(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
be weighed against##5##3##(1994-6#1)(2007-11#1)(2008-11#1)(2010-12#1)(2013-1#1)
be weighed##10##2##(1991-11#1)(1994-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
be welfare-improving##2##2##(2010-5#2)
be well advised to##2##4##(2011-2#1)(2012-12#1)
be well controlled##2##3##(1997-8#1)(2009-2#1)
be well defined##2##3##(2008-3#1)(2010-6#1)
be well fitted by##2##4##(2008-3#2)
be well informed about the##2##5##(2008-9#1)(2009-9#1)
be well informed of the##2##5##(2008-6#1)(2011-2#1)
be well informed##4##3##(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)
be well predicted using a linear combination of the##2##9##(2008-10#2)
be well separated within##4##4##(2008-10#4)
be well separated##6##3##(1996-5#1)(2008-10#5)
be well##39##2##(1993-1#1)(1994-1#1)(1994-2#1)(1996-2#2)(1996-5#1)(1997-8#1)(2007-12#2)(2007-7#2)(2008-10#10)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
be widely applied##2##3##(2008-11#1)(2013-8#1)
be widely used##3##3##(1995-3#1)(1997-3#1)(2008-10#1)
be widely##7##2##(1995-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
be wider than the##2##4##(2008-3#1)(2008-8#1)
be wider##3##2##(1994-9#1)(2008-3#1)(2008-8#1)
be willing to participate in##2##5##(1994-2#1)(2012-3#1)
be willing to##7##3##(1991-2#1)(1994-2#1)(1997-1#1)(2007-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
be withdrawn##3##2##(1992-5#1)(1993-3#1)(2008-4#1)
be within##8##2##(1992-5#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)(2013-7#1)
be worth##4##2##(1991-6#1)(1994-3#1)(1997-1#1)(2013-7#1)
be worthwhile##4##2##(1996-8#1)(2007-6#1)(2007-7#1)(2008-12#1)
be written in##4##3##(2008-11#1)(2008-3#3)
be written##16##2##(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2009-4#1)(2010-8#1)(2013-1#1)
be your##2##2##(1994-1#1)(2007-9#1)
be##24157##1##(1990-10#12)(1990-11#95)(1990-12#105)(1990-2#82)(1990-3#45)(1990-4#5)(1990-5#91)(1990-6#58)(1990-7#51)(1990-8#84)(1990-9#40)(1991-1#32)(1991-10#2)(1991-11#42)(1991-12#134)(1991-2#94)(1991-3#87)(1991-4#17)(1991-5#73)(1991-6#58)(1991-7#15)(1991-8#44)(1991-9#77)(1992-1#42)(1992-10#13)(1992-11#75)(1992-12#141)(1992-2#80)(1992-3#156)(1992-4#16)(1992-5#52)(1992-6#93)(1992-7#5)(1992-8#61)(1992-9#83)(1993-1#47)(1993-10#2)(1993-11#95)(1993-12#166)(1993-2#77)(1993-3#104)(1993-5#12)(1993-6#77)(1993-8#75)(1993-9#60)(1994-1#41)(1994-10#5)(1994-11#89)(1994-12#131)(1994-2#131)(1994-3#148)(1994-5#90)(1994-6#83)(1994-7#13)(1994-8#96)(1994-9#98)(1995-1#51)(1995-11#86)(1995-12#139)(1995-2#141)(1995-3#113)(1995-4#7)(1995-5#93)(1995-6#99)(1995-8#60)(1995-9#20)(1996-1#76)(1996-10#3)(1996-11#61)(1996-12#143)(1996-2#121)(1996-3#117)(1996-4#30)(1996-5#74)(1996-6#49)(1996-7#12)(1996-8#39)(1996-9#43)(1997-1#94)(1997-2#118)(1997-3#131)(1997-4#118)(1997-5#65)(1997-6#99)(1997-7#88)(1997-8#106)(1997-9#4)(2006-10#55)(2006-11#1)(2006-12#13)(2006-4#7)(2006-5#3)(2006-6#9)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#103)(2007-11#420)(2007-12#496)(2007-2#66)(2007-4#26)(2007-5#20)(2007-6#23)(2007-7#147)(2007-8#144)(2007-9#17)(2008-1#321)(2008-10#3940)(2008-11#978)(2008-12#321)(2008-2#703)(2008-3#1323)(2008-4#553)(2008-5#579)(2008-6#239)(2008-7#840)(2008-8#673)(2008-9#556)(2009-1#16)(2009-10#90)(2009-11#83)(2009-12#105)(2009-2#53)(2009-3#75)(2009-4#59)(2009-5#119)(2009-6#74)(2009-7#96)(2009-8#120)(2009-9#77)(2010-1#40)(2010-10#94)(2010-11#112)(2010-12#129)(2010-2#35)(2010-3#117)(2010-4#96)(2010-5#110)(2010-6#78)(2010-7#58)(2010-8#176)(2010-9#17)(2011-1#282)(2011-10#7)(2011-2#829)(2011-3#39)(2011-4#2)(2011-7#9)(2011-8#1)(2011-9#1)(2012-1#87)(2012-12#252)(2012-2#488)(2012-3#310)(2012-4#2)(2012-5#2)(2012-6#5)(2012-7#7)(2012-8#2)(2012-9#5)(2013-1#589)(2013-7#77)(2013-8#351)
be)##2##1##(1991-3#1)(1996-11#1)
be?##8##1##(1994-3#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)
beach erosion##2##2##(2007-5#2)
beach##15##1##(2007-5#6)(2008-2#1)(2010-8#1)(2013-7#6)(2013-8#1)
beaches##8##1##(2007-5#2)(2008-1#1)(2008-5#5)
beachieved##2##1##(2008-11#2)
beacon and##2##2##(2008-3#2)
beacon measurements##2##2##(2008-2#2)
beacon##18##1##(2007-11#1)(2008-10#4)(2008-2#6)(2008-3#7)
beacons for##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
beacons##16##1##(2007-11#4)(2008-10#8)(2008-3#2)(2008-9#2)
bead and##2##2##(2008-10#1)(2008-11#1)
bead in##2##2##(2008-10#2)
bead injection (BI)##2##3##(2008-10#2)
bead injection##14##2##(2008-10#14)
bead##64##1##(1990-12#1)(2008-10#32)(2008-11#4)(2008-4#3)(2008-6#7)(2008-7#7)(2008-9#4)(2009-6#1)(2010-12#1)(2010-5#1)(2012-2#3)
bead-based##4##1##(2008-1#1)(2008-10#1)(2008-9#1)(2010-5#1)
beads after##3##2##(2008-10#2)(2008-7#1)
beads and the##2##3##(1992-8#1)(2008-10#1)
beads and##13##2##(1992-8#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
beads are automatically discarded from the flow cell##2##8##(2008-10#2)
beads are##9##2##(1990-12#1)(2007-12#1)(2008-10#6)(2012-2#1)
beads as##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
beads attached##2##2##(2008-3#1)(2008-7#1)
beads by##5##2##(2008-10#2)(2008-11#1)(2008-6#2)
beads can be##2##3##(2008-10#2)
beads could be##2##3##(2008-10#2)
beads employed in##2##3##(2008-10#1)(2008-7#1)
beads for##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
beads in a##4##3##(2008-10#3)(2008-11#1)
beads in the##5##3##(2008-10#3)(2008-11#1)(2008-6#1)
beads in##11##2##(2007-11#1)(2008-10#7)(2008-11#2)(2008-6#1)
beads is##4##2##(2008-11#1)(2008-4#2)(2008-7#1)
beads of##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
beads on##4##2##(1997-2#1)(2007-12#1)(2008-10#1)(2012-3#1)
beads that##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
beads to a##2##3##(2008-9#2)
beads to which##2##3##(1994-2#1)(2008-10#1)
beads to##8##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#3)
beads under the##2##3##(2008-10#1)(2008-11#1)
beads under##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
beads was##4##2##(2008-10#1)(2008-6#1)(2008-7#2)
beads were prepared##2##3##(2008-10#1)(2008-11#1)
beads were##17##2##(2007-12#2)(2008-10#9)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)
beads with a##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
beads with##8##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-1#1)
beads##231##1##(1990-12#2)(1990-2#1)(1992-8#1)(1994-2#1)(1995-6#4)(1995-8#2)(1996-12#2)(1997-2#3)(2006-6#1)(2007-11#2)(2007-12#9)(2008-10#90)(2008-11#27)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#4)(2008-6#15)(2008-7#24)(2008-8#2)(2008-9#5)(2009-5#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#6)(2012-3#1)(2013-1#2)
beads) to##2##2##(1994-3#1)(2008-10#1)
beads)##5##1##(1994-3#2)(2008-10#3)
beagle dogs##2##2##(2011-2#1)(2012-3#1)
beagle##3##1##(1993-3#1)(2011-2#1)(2012-3#1)
beak and feather disease##3##4##(1992-2#1)(2008-5#2)
beaked##2##1##(2007-8#1)(2012-2#1)
beaker containing##2##2##(2008-10#2)
beaker##3##1##(2008-10#3)
beaks##3##1##(2009-7#1)(2011-2#2)
beam (from##2##2##(2008-3#2)
beam 1##2##2##(2007-12#2)
beam 2##2##2##(2007-12#2)
beam CT##3##2##(2007-12#1)(2008-2#1)(2009-3#1)
beam TL experiment##2##3##(2008-3#2)
beam TL##4##2##(2008-3#4)
beam absorption##2##2##(2008-3#2)
beam after the##2##3##(2007-12#1)(2008-3#1)
beam alignment##3##2##(2008-2#1)(2008-3#2)
beam and a##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
beam and the##4##3##(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
beam and to##2##3##(2008-2#1)(2008-3#1)
beam and two##2##3##(2008-2#1)(2008-3#1)
beam and##33##2##(1997-2#1)(2007-11#1)(2007-12#6)(2008-2#9)(2008-3#16)
beam are compared##2##3##(2008-3#2)
beam are derived##2##3##(2008-2#1)(2008-3#1)
beam are determined##3##3##(2007-11#2)(2007-12#1)
beam are##12##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#4)
beam as a##2##3##(2007-12#1)(2008-2#1)
beam as##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
beam at a##3##3##(2008-2#1)(2008-3#2)
beam at the crystal##2##4##(2007-11#1)(2008-3#1)
beam at the##4##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)
beam at##16##2##(1997-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#9)(2008-9#1)
beam attenuation coefficient##5##3##(2008-2#2)(2008-3#3)
beam attenuation spectrum and##2##4##(2008-3#2)
beam attenuation##7##2##(2008-2#2)(2008-3#5)
beam by a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
beam by##13##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#6)
beam can be used##3##4##(2008-2#1)(2008-3#2)
beam can be##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
beam can##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
beam capacity##3##2##(2008-3#3)
beam center##2##2##(2008-2#1)(2008-3#1)
beam characteristics##2##2##(2008-3#2)
beam close to the##2##4##(2007-12#1)(2008-3#1)
beam coagulator##6##2##(1993-12#2)(1994-3#2)(2010-8#2)
beam collimation and##2##3##(2007-11#1)(2008-3#1)
beam collimation##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
beam combiner##2##2##(2007-11#1)(2008-3#1)
beam combining of##3##3##(2007-12#3)
beam combining##8##2##(2007-12#5)(2008-3#3)
beam computed tomography##6##3##(2008-3#3)(2009-12#1)(2013-1#2)
beam configuration##4##2##(2007-11#1)(2008-3#3)
beam coupling##4##2##(2007-12#2)(2008-2#2)
beam deflection##7##2##(2008-2#3)(2008-3#4)
beam deflector##3##2##(2007-12#1)(2008-3#2)
beam delivery system##2##3##(2008-2#1)(2008-3#1)
beam delivery##6##2##(2008-2#2)(2008-3#4)
beam diameter##6##2##(2008-2#2)(2008-3#3)(2010-9#1)
beam diffracted by##2##3##(2008-2#1)(2008-3#1)
beam divergence and the##2##4##(2007-12#1)(2008-3#1)
beam divergence and##4##3##(2007-12#2)(2008-3#2)
beam divergence in##2##3##(2007-12#1)(2008-3#1)
beam divergence is##2##3##(2008-2#1)(2008-3#1)
beam divergence##17##2##(1995-2#1)(2007-12#3)(2008-2#2)(2008-3#11)
beam dwell##2##2##(2007-11#1)(2008-3#1)
beam ellipticity##2##2##(2008-3#2)
beam energy##4##2##(2007-11#1)(2008-10#1)(2008-2#2)
beam enhanced##2##2##(2007-11#1)(2008-8#1)
beam excitation##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
beam expansion##2##2##(2008-2#1)(2008-3#1)
beam exposure##2##2##(2008-3#1)(2009-9#1)
beam fanning##5##2##(2008-3#5)
beam focus##2##2##(2007-12#1)(2008-3#1)
beam focused##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
beam focusing##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
beam for the first##2##4##(2007-12#1)(2008-2#1)
beam for##4##2##(2007-12#1)(2008-2#2)(2011-1#1)
beam former##3##2##(2008-3#3)
beam forming##2##2##(2008-3#2)
beam from a##12##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#5)(2012-2#1)
beam from an##2##3##(2007-11#1)(2007-12#1)
beam from the##6##3##(2007-12#3)(2007-9#1)(2008-10#1)(2008-3#1)
beam from##23##2##(2007-11#3)(2007-12#7)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#7)(2012-2#1)
beam generated by a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
beam generated##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
beam generation##3##2##(2008-3#3)
beam geometries##4##2##(2007-12#1)(2008-3#3)
beam geometry##2##2##(2008-3#2)
beam had a##3##3##(2008-2#2)(2008-3#1)
beam had##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
beam hardening artifacts in CT##2##5##(2012-1#2)
beam hardening##3##2##(2012-1#3)
beam has a##3##3##(2008-2#2)(2008-3#1)
beam has been##2##3##(2008-3#2)
beam has##7##2##(2007-11#1)(2008-2#3)(2008-3#3)
beam illuminating##2##2##(2008-2#1)(2008-3#1)
beam in a##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-11#1)
beam in scattering media##2##4##(2008-3#2)
beam in the##10##3##(2007-11#2)(2008-2#2)(2008-3#6)
beam in##29##2##(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#16)(2009-10#1)(2009-11#1)
beam incident##2##2##(2008-2#1)(2008-3#1)
beam induced##3##2##(2007-11#1)(2009-11#2)
beam inside the##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
beam inside##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
beam intensities in the##2##4##(2008-3#2)
beam intensities##3##2##(2008-3#3)
beam intensity profile##3##3##(2008-2#2)(2008-3#1)
beam intensity ratio of 1##2##5##(2008-3#2)
beam intensity ratio##3##3##(2007-12#1)(2008-3#2)
beam intensity##13##2##(2007-12#2)(2008-2#4)(2008-3#7)
beam interference##3##2##(2007-12#1)(2008-2#2)
beam into a##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
beam into##10##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#5)
beam irradiation##11##2##(1991-2#1)(1991-6#1)(1992-12#1)(1994-11#2)(1994-3#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-7#1)(2011-2#1)
beam is a##3##3##(2007-12#1)(2008-3#2)
beam is caused##2##3##(2008-3#2)
beam is focused##3##3##(2008-2#2)(2008-3#1)
beam is incident upon the##2##5##(2008-3#2)
beam is incident##4##3##(2007-11#1)(2008-3#3)
beam is not##2##3##(2008-3#2)
beam is reflected##2##3##(2008-2#2)
beam is split##2##3##(2007-12#1)(2008-3#1)
beam is used to##2##4##(2008-2#1)(2008-3#1)
beam is used##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
beam is##66##2##(2007-11#8)(2007-12#9)(2008-2#15)(2008-3#34)
beam misalignment##3##2##(2008-3#3)
beam model##5##2##(2009-11#5)
beam modifiers##2##2##(1994-8#1)(2007-4#1)
beam near the##4##3##(2008-3#4)
beam near##5##2##(2007-12#1)(2008-3#4)
beam of M(2) approximately##2##4##(2008-3#2)
beam of a##5##3##(2007-11#1)(2008-10#1)(2008-2#3)
beam of light##2##3##(2008-3#2)
beam of the##2##3##(2008-2#1)(2012-2#1)
beam of##23##2##(1992-8#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#6)(2009-11#1)(2012-2#1)
beam on the##7##3##(2008-10#1)(2008-2#1)(2008-3#4)(2008-9#1)
beam on##12##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#6)(2008-9#1)
beam onto the##2##3##(2008-2#1)(2008-3#1)
beam passes through a##2##4##(2007-11#2)
beam passes through##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
beam passes##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
beam path##2##2##(2008-3#2)
beam pattern##2##2##(2007-12#1)(2008-2#1)
beam polarization##2##2##(2008-2#1)(2008-3#1)
beam position and current##2##4##(2008-3#2)
beam position##4##2##(2007-12#1)(2008-3#3)
beam power levels or##2##4##(2008-3#2)
beam power##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
beam powers##2##2##(2007-11#1)(2008-2#1)
beam produced##2##2##(2007-11#1)(2008-3#1)
beam profile in the##2##4##(2008-2#2)
beam profile is##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
beam profile##24##2##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#8)(2008-3#9)
beam profiles in a three-dimensional##2##5##(2008-3#2)
beam profiles in##3##3##(2008-3#3)
beam profiles##8##2##(2008-2#2)(2008-3#6)
beam propagates##2##2##(2008-3#2)
beam propagating in a##2##4##(2008-3#2)
beam propagating##4##2##(2007-12#1)(2008-3#3)
beam propagation in##3##3##(2007-12#1)(2008-3#2)
beam propagation method##10##3##(2007-11#3)(2008-2#1)(2008-3#6)
beam propagation through##2##3##(2008-3#2)
beam propagation##25##2##(2007-11#6)(2007-12#4)(2008-2#2)(2008-3#13)
beam provides##2##2##(2007-11#1)(2008-4#1)
beam quality and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
beam quality is##4##3##(2007-11#3)(2008-2#1)
beam quality of the##4##4##(2007-12#1)(2008-3#3)
beam quality of##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
beam quality##37##2##(2007-11#6)(2007-12#5)(2008-2#10)(2008-3#16)
beam radiation##5##2##(2008-3#1)(2008-6#2)(2008-7#2)
beam ratio##3##2##(2008-3#3)
beam relative to the##2##4##(2007-12#1)(2008-2#1)
beam shape##3##2##(2008-2#1)(2008-3#2)
beam shaping in##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
beam shaping of##3##3##(2007-11#2)(2008-3#1)
beam shaping##20##2##(2007-11#8)(2007-12#1)(2008-2#7)(2008-3#3)(2008-9#1)
beam size##5##2##(2008-2#2)(2008-3#3)
beam smoothing and##2##3##(2007-11#2)
beam smoothing##4##2##(2007-11#3)(2008-2#1)
beam splitter (PBS)##3##3##(2008-2#2)(2008-3#1)
beam splitter and##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
beam splitter for##3##3##(2007-12#1)(2008-2#2)
beam splitter in##2##3##(2007-12#1)(2008-2#1)
beam splitter is##3##3##(2008-3#3)
beam splitter with##2##3##(2007-11#1)(2008-3#1)
beam splitter##44##2##(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#14)(2008-3#21)
beam splitters in##3##3##(2007-12#1)(2008-3#2)
beam splitters##10##2##(2007-12#2)(2008-2#3)(2008-3#5)
beam splitting and beam combining##3##5##(2008-3#3)
beam splitting and##5##3##(2008-3#5)
beam spot size##3##3##(2007-12#1)(2008-3#2)
beam spot##6##2##(2007-12#1)(2008-3#5)
beam spreading and##2##3##(2008-3#2)
beam spreading##4##2##(2008-2#1)(2008-3#3)
beam steering##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
beam that is circulating in##2##5##(2008-3#2)
beam that is##5##3##(2007-12#2)(2008-3#3)
beam that passes through the##2##5##(2007-11#1)(2008-3#1)
beam that##17##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#9)(2009-11#1)
beam therapy##2##2##(1993-11#1)(2007-10#1)
beam through an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
beam through##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
beam to a##6##3##(2007-12#1)(2008-3#5)
beam to the##2##3##(2008-3#2)
beam to##16##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#10)(2008-6#1)(2011-1#1)
beam transmitted##2##2##(2008-2#1)(2008-3#1)
beam uniformity##2##2##(1995-9#1)(2008-3#1)
beam used##2##2##(1994-3#1)(2008-2#1)
beam using a##2##3##(2008-3#1)(2009-12#1)
beam waist and##2##3##(2007-11#2)
beam waist##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
beam was designed##2##3##(2008-3#2)
beam was found##2##3##(2008-2#1)(2008-3#1)
beam was##27##2##(2007-11#4)(2007-12#5)(2008-11#1)(2008-2#4)(2008-3#11)(2011-1#2)
beam while##2##2##(2007-11#1)(2008-3#1)
beam width and##3##3##(2008-3#3)
beam width##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
beam with a beam waist of approximately 2w(0) =##2##9##(2008-3#2)
beam with a beam##3##4##(2007-12#1)(2008-3#2)
beam with a##19##3##(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#8)(2010-9#1)
beam with an average##2##4##(2009-5#1)(2010-4#1)
beam with an##7##3##(2007-12#4)(2009-5#1)(2009-6#1)(2010-4#1)
beam with its##2##3##(2007-12#1)(2008-2#1)
beam with the##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
beam with##38##2##(2007-11#4)(2007-12#11)(2008-2#8)(2008-3#11)(2009-5#1)(2009-6#1)(2010-4#1)(2010-9#1)
beam within##2##2##(2007-12#1)(2008-2#1)
beam##1287##1##(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-3#4)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#4)(1997-2#2)(1997-8#2)(2007-10#2)(2007-11#134)(2007-12#183)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#5)(2008-2#258)(2008-3#554)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#17)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#7)(2009-9#1)(2010-4#2)(2010-8#2)(2010-9#3)(2011-1#9)(2011-2#3)(2012-1#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)
beam's##8##1##(1993-9#1)(2007-11#2)(2007-12#1)(2008-3#4)
beam)##6##1##(2008-2#1)(2008-3#5)
beam-assisted evaporation##2##2##(2008-3#2)
beam-fanning effect##2##2##(2008-3#2)
beam-fanning##6##1##(2008-3#6)
beam-forming##2##1##(2008-3#2)
beam-propagation method in##2##3##(2008-3#2)
beam-propagation method##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
beam-propagation model##2##2##(2008-2#1)(2008-3#1)
beam-propagation##15##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#9)
beam-quality degradation##2##2##(2008-3#2)
beam-quality factor M(2)##2##3##(2007-11#1)(2008-2#1)
beam-quality metrics##2##2##(2007-11#2)
beam-quality##9##1##(2007-11#3)(2008-2#1)(2008-3#5)
beam-shape coefficients (BSC's) that describe the##2##6##(2008-2#1)(2008-3#1)
beam-shape coefficients##5##2##(2008-2#2)(2008-3#3)
beam-shaping##11##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
beam-splitter emission is##2##3##(2008-3#2)
beam-splitter emission##3##2##(2008-3#3)
beam-splitter grating##3##2##(2008-3#3)
beam-splitter##14##1##(2007-12#2)(2008-3#12)
beam-splitting cube##3##2##(2008-3#3)
beam-steering##2##1##(2008-2#1)(2008-3#1)
beam/hollow cathode-optical emission spectroscopy##2##4##(2010-11#2)
beamlets##2##1##(2007-11#1)(2007-12#1)
beamline 9-2##2##2##(2008-11#2)
beamline development##2##2##(2008-11#2)
beamline##10##1##(2006-4#1)(2008-11#6)(2008-3#2)(2008-4#1)
beamlines##3##1##(2008-11#1)(2008-3#2)
beams and suggest##2##3##(2007-11#1)(2008-3#1)
beams and##19##2##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#9)(2012-1#1)
beams are##19##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#12)
beams as##4##2##(2007-11#1)(2008-3#2)(2012-1#1)
beams at##3##2##(2008-2#2)(2008-3#1)
beams by use of##6##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
beams by##12##2##(2007-11#4)(2007-12#3)(2008-2#4)(2008-3#1)
beams can be##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
beams can##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
beams containing screw##2##3##(2007-11#1)(2007-12#1)
beams containing##3##2##(2007-11#1)(2007-12#1)(2010-4#1)
beams delivered by##2##3##(2006-4#1)(2008-2#1)
beams focused##2##2##(2007-12#1)(2008-3#1)
beams for##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
beams from a##2##3##(2008-3#2)
beams from an##2##3##(2008-3#2)
beams from stage to stage##2##5##(2008-2#2)
beams from the##3##3##(2008-1#1)(2008-2#2)
beams from##12##2##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#5)(2012-1#1)
beams generated by##3##3##(2007-11#1)(2008-3#2)
beams has##2##2##(2007-12#1)(2012-1#1)
beams have##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
beams in a##4##3##(2007-12#1)(2008-3#3)
beams in the##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
beams in##28##2##(2007-11#5)(2007-12#11)(2008-2#2)(2008-3#10)
beams is derived##2##3##(2007-11#2)
beams is discussed##2##3##(2007-11#1)(2008-3#1)
beams is presented##2##3##(2007-11#1)(2008-3#1)
beams is##23##2##(2007-11#7)(2008-2#3)(2008-3#13)
beams of light##2##3##(2007-11#1)(2007-12#1)
beams of##10##2##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#3)
beams on##2##2##(2007-12#1)(2008-2#1)
beams overlap##2##2##(2007-12#1)(2008-3#1)
beams propagating in##3##3##(2008-3#3)
beams that##9##2##(2007-12#1)(2008-3#8)
beams through##2##2##(2008-3#2)
beams to##2##2##(2007-12#1)(2008-2#1)
beams were##4##2##(2007-12#1)(2008-2#1)(2011-1#1)(2012-1#1)
beams will##2##2##(2008-3#2)
beams with a##9##3##(2007-11#2)(2007-12#4)(2008-3#2)(2009-6#1)
beams with different##3##3##(2008-2#2)(2008-3#1)
beams with flat-topped profiles##2##4##(2007-11#2)
beams with various##2##3##(2007-12#2)
beams with##23##2##(2007-11#4)(2007-12#9)(2008-2#3)(2008-3#6)(2009-6#1)
beams without##2##2##(2007-11#1)(2009-11#1)
beams##365##1##(1993-9#2)(2006-4#1)(2007-10#2)(2007-11#66)(2007-12#69)(2008-1#1)(2008-10#1)(2008-2#66)(2008-3#139)(2008-6#1)(2009-11#3)(2009-6#2)(2009-7#1)(2010-4#1)(2011-1#1)(2012-1#7)(2012-12#1)(2012-2#1)
beamsplitter##2##1##(2007-9#1)(2008-2#1)
bean (Phaseolus vulgaris L##3##4##(2008-12#2)(2011-2#1)
bean (Phaseolus vulgaris)##14##3##(2008-10#14)
bean (Phaseolus##18##2##(2008-10#15)(2008-12#2)(2011-2#1)
bean and alfalfa##2##3##(2008-10#2)
bean and pea##2##3##(2008-10#2)
bean and soybean##2##3##(2008-10#2)
bean and the##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
bean and##14##2##(2007-12#1)(2008-10#10)(2008-8#1)(2008-9#1)(2013-8#1)
bean anthracnose##3##2##(2008-10#3)
bean breeding line##2##3##(2008-10#2)
bean cultivars##5##2##(2008-10#4)(2008-12#1)
bean fields in##2##3##(2008-10#2)
bean gene pools##2##3##(2008-10#2)
bean gene##3##2##(2008-10#3)
bean genotypes##3##2##(2008-10#2)(2013-8#1)
bean isolate##2##2##(2008-10#2)
bean leaf##3##2##(2008-10#3)
bean lines##2##2##(2008-10#2)
bean plants and##2##3##(2008-10#2)
bean plants##13##2##(2008-10#13)
bean pod mottle virus##2##4##(1992-8#2)
bean population##4##2##(2008-8#4)
bean production##2##2##(2008-10#2)
bean samples##8##2##(2008-10#8)
bean seedlings##6##2##(1994-8#1)(2008-10#3)(2008-9#2)
bean seeds inoculated with##2##4##(2008-10#2)
bean stem##2##2##(2008-10#2)
bean using##2##2##(1995-11#1)(2008-9#1)
bean yellow mosaic##2##3##(2008-10#2)
bean##220##1##(1990-3#2)(1991-11#3)(1992-8#2)(1993-6#2)(1994-11#1)(1994-8#1)(1995-11#2)(1995-12#2)(2007-12#1)(2008-10#163)(2008-11#1)(2008-12#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#10)(2008-9#5)(2009-8#3)(2010-11#3)(2011-10#1)(2011-2#2)(2013-8#5)
bean)##3##1##(1995-2#1)(2008-10#1)(2011-2#1)
bean-growing##2##1##(2008-10#2)
beans (Phaseolus##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
beans and##3##2##(2008-10#3)
beans from##3##2##(2008-10#3)
beans in the artificial mouth##2##5##(2008-10#2)
beans in the##3##3##(2008-10#3)
beans in##5##2##(2008-10#5)
beans##49##1##(1994-2#1)(2008-10#34)(2008-3#5)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#3)
bear a##7##2##(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)
bear on##6##2##(1992-1#1)(1994-2#1)(1994-3#1)(2010-1#1)(2010-9#2)
bear the##4##2##(1996-5#1)(2008-11#1)(2008-2#1)(2011-2#1)
bear##45##1##(1991-12#1)(1992-1#1)(1993-11#1)(1993-8#1)(1994-2#2)(1994-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
beard##2##1##(2008-1#1)(2008-10#1)
beard-like##2##1##(2009-4#2)
bearers##2##1##(2007-7#1)(2007-8#1)
bearing a single##2##3##(2009-12#1)(2011-2#1)
bearing a##9##2##(1992-11#1)(1992-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
bearing an##4##2##(1991-7#1)(1994-9#1)(2008-9#1)(2010-8#1)
bearing deletions##2##2##(1992-3#1)(1994-11#1)
bearing either##2##2##(1990-8#1)(1993-8#1)
bearing human##2##2##(1995-2#1)(2012-3#1)
bearing in mind the##2##4##(2007-6#1)(2010-11#1)
bearing in##4##2##(2007-6#1)(2010-11#1)(2012-12#2)
bearing mice##2##2##(1992-3#1)(1993-9#1)
bearing on the##2##3##(1997-4#1)(2007-8#1)
bearing on whether they feel involved or not##2##8##(2011-2#2)
bearing on##8##2##(1996-3#1)(1997-4#1)(2007-8#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
bearing surface##3##2##(2008-3#1)(2008-8#2)
bearing the terminal sugar##2##4##(1992-12#2)
bearing the##19##2##(1991-9#1)(1992-12#2)(1992-8#2)(1993-3#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
bearing was##2##2##(2008-6#1)(2011-2#1)
bearing##151##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#7)(1992-5#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#10)
bearing)##2##1##(2008-3#1)(2008-8#1)
bears a##2##2##(2010-11#1)(2012-12#1)
bears an##4##2##(1990-11#1)(2008-11#1)(2009-10#1)(2013-1#1)
bears some##2##2##(2008-8#1)(2008-9#1)
bears##23##1##(1990-11#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-6#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
beast##3##1##(2009-10#3)
beat and##2##2##(2008-3#1)(2010-8#1)
beat frequencies##5##2##(2007-11#2)(2008-3#3)
beat frequency##10##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#5)
beat length and##2##3##(2007-12#2)
beat length of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
beat length##7##2##(2007-11#3)(2007-12#3)(2008-3#1)
beat measurements##2##2##(2007-11#1)(2007-12#1)
beat noise##4##2##(2007-12#1)(2008-3#3)
beat note##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
beat notes##2##2##(2007-11#1)(2007-12#1)
beat signal##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
beat wave##2##2##(2007-11#2)
beat with##2##2##(2007-11#1)(2007-12#1)
beat##60##1##(1991-5#1)(1994-11#1)(1996-6#1)(2007-11#16)(2007-12#13)(2007-6#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#18)(2009-10#1)(2010-8#1)(2012-3#1)(2013-7#1)
beaten by##2##2##(2010-3#1)(2013-8#1)
beating cardiac myocytes##2##3##(1994-11#1)(2008-3#1)
beating cardiac##3##2##(1994-11#1)(1996-2#1)(2008-3#1)
beating cells##2##2##(2008-11#1)(2010-3#1)
beating heart CAB surgery patients##2##5##(2010-8#2)
beating heart##12##2##(2007-8#7)(2009-12#1)(2009-5#1)(2010-8#2)(2012-3#1)
beating of the##2##3##(1996-3#1)(2008-3#1)
beating of##4##2##(1996-3#1)(2008-2#2)(2008-3#1)
beating##40##1##(1994-11#2)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-8#7)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-8#2)(2012-3#2)(2013-7#1)
beating-heart##2##1##(2012-1#2)
beats and##2##2##(1996-6#1)(2013-8#1)
beats min-1##2##2##(1995-12#2)
beats per min##2##3##(1991-10#1)(1991-6#1)
beats##9##1##(1991-10#1)(1991-6#1)(1995-12#2)(1996-3#1)(1996-6#2)(2010-8#1)(2013-8#1)
beats/min and##2##2##(2007-12#1)(2008-6#1)
beats/min##8##1##(1991-6#1)(2007-12#1)(2008-6#2)(2008-7#2)(2009-8#1)(2013-1#1)
beats/min)##2##1##(2008-6#2)
beautiful##5##1##(1990-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
beauty and##3##2##(2008-10#1)(2008-5#2)
beauty in##2##2##(2007-12#1)(2010-8#1)
beauty##14##1##(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#6)(2008-9#2)(2010-8#1)(2012-12#1)
beberine##2##1##(2008-10#2)
became Chair of Surgery at##2##5##(2012-3#2)
became a major##3##3##(1997-6#1)(2008-10#1)(2010-11#1)
became a##18##2##(1995-5#1)(1996-1#1)(1996-3#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-8#2)(2010-11#1)(2012-2#1)(2012-3#1)
became acutely ill##2##3##(1992-4#1)(1997-6#1)
became adapted to##2##3##(2008-11#1)(2008-8#1)
became an important##2##3##(2008-8#1)(2010-11#1)
became an##7##2##(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-1#1)
became apparent that##4##3##(1994-2#1)(1996-3#1)(2008-11#1)(2008-2#1)
became apparent##10##2##(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-3#1)(1997-6#1)(2008-11#2)(2008-2#1)
became asymptotic##2##2##(2008-10#2)
became at##2##2##(1991-6#1)(2008-3#1)
became available##4##2##(1992-9#1)(2008-11#1)(2008-3#1)(2011-2#1)
became aware of##2##3##(1997-3#1)(2008-12#1)
became clear##7##2##(1990-11#1)(1991-1#1)(2008-10#3)(2008-11#1)(2011-2#1)
became diseased##4##2##(2008-10#4)
became dominant in##2##3##(2008-10#2)
became dominant##3##2##(2008-10#2)(2008-7#1)
became effective##2##2##(1993-3#1)(1994-2#1)
became elevated##2##2##(1990-6#1)(2013-7#1)
became established##2##2##(2008-10#2)
became evident after##2##3##(1991-6#1)(1995-2#1)
became evident that##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
became evident##9##2##(1991-6#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)
became fully##2##2##(1994-11#1)(1994-2#1)
became ill##2##2##(2007-2#2)
became independent##2##2##(2008-10#1)(2013-1#1)
became infected as##2##3##(1991-3#1)(1997-5#1)
became infected during##3##3##(2008-10#2)(2008-5#1)
became infected in the##2##4##(1996-5#1)(2008-10#1)
became infected in##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
became infected with##6##3##(2006-10#1)(2008-10#5)
became infected##20##2##(1991-12#1)(1991-3#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-10#14)(2008-5#1)
became involved in##2##3##(2007-2#1)(2008-4#1)
became involved##3##2##(1991-8#1)(2007-2#1)(2008-4#1)
became less##5##2##(1990-6#1)(1991-9#1)(2008-10#3)
became longer##2##2##(1997-4#1)(2008-7#1)
became manifest##2##2##(1993-2#1)(1997-4#1)
became more complex##2##3##(1994-2#1)(2008-10#1)
became more pronounced##2##3##(1992-11#1)(2008-5#1)
became more significant with##2##4##(2008-10#1)(2013-1#1)
became more similar##2##3##(2011-2#2)
became more##23##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#2)(2011-2#3)(2013-1#1)
became much##2##2##(2008-8#1)(2011-3#1)
became necessary##2##2##(2007-12#1)(2008-10#1)
became necrotic and##3##3##(2008-10#3)
became necrotic##4##2##(2008-10#4)
became normal##3##2##(1995-3#1)(2008-3#1)(2013-1#1)
became obvious that##2##3##(2008-5#2)
became obvious##3##2##(2008-11#1)(2008-5#2)
became of##2##2##(2008-10#2)
became one of the##2##4##(2008-12#1)(2013-1#1)
became one of##3##3##(1993-3#1)(2008-12#1)(2013-1#1)
became popular##2##2##(2008-11#1)(2008-3#1)
became possible##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
became pregnant and##3##3##(1996-8#1)(2013-1#2)
became pregnant##5##2##(1990-2#1)(1996-8#1)(2011-1#1)(2013-1#2)
became progressively##3##2##(2008-6#1)(2009-8#1)(2012-2#1)
became prominent##2##2##(1997-7#1)(2008-7#1)
became resistant to##2##3##(1993-8#1)(2008-8#1)
became sensitive to amiloride##2##4##(1991-5#2)
became sensitive to##3##3##(1991-5#2)(1994-11#1)
became significantly##2##2##(2007-1#1)(2013-1#1)
became stronger##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
became susceptible##3##2##(1990-11#1)(2008-10#2)
became the dominant##2##3##(1996-3#1)(2013-8#1)
became the##18##2##(1992-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-2#1)(2013-8#2)
became undetectable##4##2##(1997-6#1)(2008-1#1)(2008-8#1)(2010-12#1)
became visible in the##2##4##(1990-7#1)(2008-7#1)
became visible##3##2##(1990-7#1)(2007-11#1)(2008-7#1)
became widely##2##2##(1995-5#1)(2008-9#1)
became##359##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-5#4)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#78)(2008-11#16)(2008-12#6)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#13)(2008-8#15)(2008-9#4)(2009-10#1)(2009-7#4)(2009-8#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
because (1) the##2##3##(1991-7#1)(2008-3#1)
because 75% of##2##3##(2008-5#1)(2011-1#1)
because a##10##2##(1991-12#1)(1992-12#1)(2008-10#5)(2008-2#1)(2008-8#1)(2009-6#1)
because all##10##2##(1994-11#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
because at##3##2##(1992-3#1)(1996-2#1)(2008-7#1)
because both##7##2##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
because cells##2##2##(2008-10#1)(2008-7#1)
because changes in##2##3##(1993-1#1)(2008-8#1)
because contact##2##2##(2008-1#1)(2013-1#1)
because contrasts##2##2##(1997-4#1)(2008-10#1)
because data##2##2##(2008-10#2)
because diagnosis is##2##3##(1990-3#1)(2008-5#1)
because different##4##2##(1994-5#1)(2008-3#1)(2008-4#1)(2008-9#1)
because each##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
because early##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
because environmental##2##2##(2008-11#1)(2008-9#1)
because equilibrium##2##2##(1991-2#1)(1993-6#1)
because females##2##2##(2008-8#1)(2008-9#1)
because fermentation##2##2##(2008-10#1)(2008-6#1)
because few##2##2##(2008-6#1)(2008-9#1)
because he had##2##3##(1997-5#1)(2013-1#1)
because he was##3##3##(1995-6#2)(1997-5#1)
because he##9##2##(1993-3#1)(1995-12#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-5#2)(2013-1#1)
because in addition to##2##4##(2008-10#1)(2008-2#1)
because in##9##2##(1994-3#1)(2006-10#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-9#1)
because infection##3##2##(2008-10#3)
because it allows##5##3##(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
because it also##2##3##(1997-1#1)(2006-6#1)
because it can be##2##4##(1991-9#1)(2008-4#1)
because it can##11##3##(1991-9#1)(1996-6#1)(1997-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-1#1)(2009-5#1)(2013-8#2)
because it cannot be##2##4##(2008-2#1)(2008-4#1)
because it could be##2##4##(2008-10#2)
because it does not##9##4##(1992-6#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-4#1)
because it has been##4##4##(1990-8#1)(1997-2#1)(2011-2#1)(2012-2#1)
because it has##11##3##(1990-8#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
because it involves##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
because it is a##4##4##(1992-6#1)(2008-10#1)(2010-2#1)(2011-2#1)
because it is able to##2##5##(2008-1#1)(2011-2#1)
because it is considered##2##4##(1994-8#1)(2011-2#1)
because it is difficult to##2##5##(2008-3#1)(2012-12#1)
because it is important to##2##5##(2008-4#1)(2013-1#1)
because it is more##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
because it is not##2##4##(1993-9#1)(1997-8#1)
because it is##41##3##(1991-3#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#7)(2012-12#1)(2013-1#3)(2013-7#1)
because it may##7##3##(1993-11#1)(1994-3#1)(1994-9#1)(2008-11#2)(2008-2#1)(2008-7#1)
because it permits##2##3##(1993-12#1)(2007-12#1)
because it preserves##2##3##(1994-6#1)(2008-2#1)
because it prevents##2##3##(2008-10#1)(2008-7#1)
because it provides a##2##4##(2008-10#1)(2009-3#1)
because it provides##5##3##(2008-10#3)(2008-5#1)(2009-3#1)
because it requires fewer steps##2##5##(2008-1#1)(2008-2#1)
because it requires##6##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)
because it showed##2##3##(2008-10#1)(2011-2#1)
because it shows##2##3##(2008-10#1)(2011-2#1)
because it uses##2##3##(2008-3#1)(2008-6#1)
because it was not##2##4##(2008-5#1)(2008-7#1)
because it was##14##3##(1992-11#1)(1995-6#1)(1997-6#2)(2006-10#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)
because it##184##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#4)(2008-10#38)(2008-11#4)(2008-2#10)(2008-3#13)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#5)(2009-1#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#14)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
because its##12##2##(1992-1#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-2#1)(2009-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
because many##5##2##(2008-11#3)(2008-12#1)(2008-4#1)
because minimal##2##2##(2008-1#1)(2012-12#1)
because more##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
because morphological##2##2##(2008-10#1)(2013-1#1)
because most studies##2##3##(2008-11#1)(2011-2#1)
because most##10##2##(1993-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
because much##3##2##(1995-5#1)(2008-10#1)(2013-1#1)
because multiple##2##2##(1994-12#1)(2008-10#1)
because natural##2##2##(2007-7#1)(2011-2#1)
because neither##5##2##(1990-11#1)(1992-9#1)(1995-11#1)(2007-11#1)(2013-8#1)
because no##11##2##(2008-10#7)(2008-6#1)(2011-3#1)(2012-3#1)(2013-8#1)
because of AIDS##2##3##(1990-3#1)(2010-3#1)
because of a lack of##4##5##(2008-1#1)(2008-11#1)(2009-6#1)(2012-1#1)
because of a##28##3##(1993-12#1)(1993-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
because of absenteeism and##2##4##(1995-6#1)(1997-5#1)
because of adverse events##2##4##(2008-3#1)(2012-12#1)
because of adverse##4##3##(1992-11#1)(2008-1#1)(2008-3#1)(2012-12#1)
because of age##2##3##(2007-10#1)(2008-7#1)
because of an apparent##2##4##(1992-6#1)(2008-1#1)
because of an increase in##2##5##(1996-9#1)(2011-1#1)
because of an##15##3##(1992-6#1)(1994-12#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
because of better##2##3##(2009-6#1)(2013-7#1)
because of constraints on##2##4##(1994-3#1)(2008-8#1)
because of differences in##5##4##(1991-11#1)(1996-3#1)(2008-1#1)(2008-7#1)(2010-5#1)
because of difficulty in##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
because of difficulty##6##3##(1992-3#1)(1993-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
because of early##2##3##(2008-7#1)(2011-2#1)
because of enhanced##2##3##(1993-1#1)(2008-4#1)
because of high##4##3##(2007-7#1)(2008-1#1)(2008-7#1)(2012-3#1)
because of his##2##3##(1995-12#1)(2008-11#1)
because of hydrogen bonding##2##4##(2008-10#1)(2010-4#1)
because of inadequate##2##3##(1993-3#1)(2013-1#1)
because of increased##2##3##(2008-6#1)(2011-2#1)
because of interference##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
because of its high##8##4##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
because of its higher##2##4##(2008-10#1)(2008-5#1)
because of its low##2##4##(2008-2#1)(2009-10#1)
because of its potential##2##4##(2007-6#1)(2010-10#1)
because of its widespread##2##4##(2008-9#2)
because of its##79##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
because of lack of##3##4##(1995-11#1)(1997-6#1)(2009-12#1)
because of less##2##3##(2011-2#1)(2012-12#1)
because of limited resources##2##4##(1990-2#1)(2007-4#1)
because of limited##3##3##(1990-2#1)(2007-4#1)(2011-2#1)
because of low##5##3##(1995-2#1)(1996-1#1)(1997-1#1)(2008-10#1)(2011-1#1)
because of lower##3##3##(2011-1#1)(2012-12#2)
because of more##2##3##(2007-10#1)(2011-2#1)
because of necrosis of##2##4##(2008-6#2)
because of poor##7##3##(1993-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)
because of potential##3##3##(2008-11#1)(2008-9#1)(2010-3#1)
because of precipitation##2##3##(2008-10#2)
because of previous##2##3##(1990-12#1)(2011-2#1)
because of serious side effects##2##5##(2008-10#1)(2011-2#1)
because of severe##6##3##(1990-12#1)(1994-6#1)(2008-12#1)(2008-2#1)(2011-2#2)
because of side effects##3##4##(1991-6#1)(2011-2#1)(2013-1#1)
because of slow##3##3##(1991-3#1)(1997-3#1)(2012-2#1)
because of small##2##3##(2008-10#1)(2009-10#1)
because of the ability of the##2##6##(2008-3#1)(2008-5#1)
because of the ability##3##4##(1994-9#1)(2008-3#1)(2008-5#1)
because of the absence of##3##5##(2008-2#1)(2008-3#1)(2010-12#1)
because of the close proximity of##2##6##(2008-3#1)(2013-1#1)
because of the complex##2##4##(2009-10#1)(2011-2#1)
because of the complexity of the##3##6##(1995-5#1)(2008-10#1)(2010-12#1)
because of the death of 3 patients##2##7##(2007-11#2)
because of the development of##3##5##(1994-2#1)(2007-2#1)(2012-1#1)
because of the difficulty in##3##5##(2008-11#1)(2008-3#1)(2010-3#1)
because of the difficulty##6##4##(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-3#1)
because of the double##2##4##(1995-8#1)(2009-10#1)
because of the effect of##2##5##(2007-11#1)(2008-3#1)
because of the effects of##2##5##(1997-5#1)(2008-3#1)
because of the extremely##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
because of the finite size of the##2##7##(2008-2#1)(2008-3#1)
because of the genetic##2##4##(2008-10#1)(2010-7#1)
because of the high frequency of##2##6##(2006-10#1)(2008-7#1)
because of the high##11##4##(1993-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-1#1)
because of the higher##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
because of the importance##2##4##(2008-11#1)(2011-2#1)
because of the increasing##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
because of the lack of a##3##6##(1997-6#1)(2008-10#1)(2008-11#1)
because of the lack of##9##5##(1995-6#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
because of the large##3##4##(2008-1#1)(2008-3#2)
because of the limited##5##4##(1995-2#1)(1996-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
because of the low##6##4##(1996-9#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
because of the need##2##4##(2007-12#1)(2007-8#1)
because of the onset of##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
because of the positive##2##4##(1992-2#1)(2007-8#1)
because of the possibility to##2##5##(2007-8#1)(2013-1#1)
because of the possibility##3##4##(1996-3#1)(2007-8#1)(2013-1#1)
because of the potential##4##4##(1994-6#1)(1996-12#1)(2008-3#1)(2008-9#1)
because of the presence of##7##5##(1991-11#1)(1992-2#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-4#1)
because of the reduced##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
because of the reduction##2##4##(1996-6#1)(2008-2#1)
because of the relatively##4##4##(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)
because of the risk of##4##5##(1993-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
because of the risk##5##4##(1992-3#1)(1993-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
because of the small##7##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
because of the use of##3##5##(2007-12#1)(2008-10#1)(2008-11#1)
because of the various##2##4##(2008-3#1)(2009-7#1)
because of the very##3##4##(1992-6#1)(2009-4#1)(2013-1#1)
because of the wide##2##4##(2008-3#1)(2008-7#1)
because of the##273##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-9#1)(1992-2#3)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#7)(2007-12#9)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#15)(2008-12#5)(2008-2#12)(2008-3#30)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#7)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#11)(2011-7#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#3)
because of their ability to##2##5##(2007-12#1)(2011-2#1)
because of their high affinity for##2##6##(2008-10#1)(2008-7#1)
because of their high##8##4##(1995-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)
because of their immature##2##4##(2006-5#1)(2013-8#1)
because of their potential##3##4##(1995-3#1)(2008-10#1)(2010-4#1)
because of their##60##3##(1992-12#2)(1992-5#1)(1993-12#1)(1994-2#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-1#1)(2006-5#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#4)(2013-8#2)
because of this##4##3##(1993-1#1)(1996-2#1)(2008-11#1)(2008-2#1)
because of variation in##2##4##(2008-2#1)(2009-10#1)
because of various##2##3##(2008-5#1)(2008-9#1)
because of##802##2##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#3)(1991-3#1)(1991-6#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#3)(1992-9#3)(1993-1#4)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#5)(1995-8#2)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#4)(1996-5#3)(1996-6#4)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#5)(2006-10#2)(2006-12#1)(2006-5#2)(2007-10#8)(2007-11#13)(2007-12#19)(2007-2#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#12)(2008-1#12)(2008-10#70)(2008-11#33)(2008-12#10)(2008-2#35)(2008-3#54)(2008-4#8)(2008-5#25)(2008-6#13)(2008-7#29)(2008-8#18)(2008-9#22)(2009-1#3)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#7)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#62)(2011-7#2)(2012-1#4)(2012-12#14)(2012-2#13)(2012-3#13)(2013-1#29)(2013-7#5)(2013-8#9)
because one##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
because only a##3##3##(1993-9#1)(1996-12#1)(2008-8#1)
because only##6##2##(1993-9#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
because past##2##2##(2008-9#2)
because preoperative##2##2##(1996-9#1)(2013-1#1)
because research##2##2##(1995-6#1)(2012-12#1)
because responding##2##2##(2008-5#2)
because response##2##2##(2007-10#1)(2009-4#1)
because similar##2##2##(1997-1#1)(2008-10#1)
because small##2##2##(1990-12#1)(2012-3#1)
because some of##2##3##(2007-11#1)(2009-6#1)
because some##8##2##(1992-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)
because such##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
because symptoms##2##2##(2008-10#1)(2008-3#1)
because that##2##2##(1994-1#1)(2008-5#1)
because the PDLC becomes transparent or##2##6##(2008-2#1)(2008-3#1)
because the alternative##2##3##(1997-6#1)(2008-4#1)
because the data##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
because the first##2##3##(1990-3#1)(2008-10#1)
because the individual##2##3##(2007-12#1)(2008-4#1)
because the latter##4##3##(1993-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
because the liver##2##3##(2008-1#1)(2010-7#1)
because the metal##2##3##(2010-6#2)
because the model##2##3##(2008-10#1)(2008-3#1)
because the natural##2##3##(2009-4#1)(2010-4#1)
because the optical##2##3##(2007-12#1)(2008-2#1)
because the parameters##2##3##(1992-9#1)(1997-2#1)
because the patient##3##3##(1993-12#1)(1995-3#1)(2013-1#1)
because the patients##2##3##(2007-10#1)(2008-5#1)
because the presence of##2##4##(2008-10#1)(2008-3#1)
because the prevention of##2##4##(2008-10#1)(2010-12#1)
because the spatial pattern of CTV incidence at the within-group scale##2##11##(2008-10#2)
because the tumor##2##3##(1992-2#1)(1995-4#1)
because the##235##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#1)(1995-3#4)(1995-4#1)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#2)(2007-10#2)(2007-11#3)(2007-12#8)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#36)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#18)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#9)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#1)(2013-8#2)
because their##11##2##(1993-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)(2013-8#1)
because there are no##2##4##(1992-3#1)(2008-7#1)
because there are only##2##4##(2007-12#1)(2011-2#1)
because there are some##2##4##(1991-1#1)(2007-12#1)
because there are##8##3##(1991-1#1)(1991-11#1)(1992-3#1)(2007-12#2)(2008-7#1)(2008-8#1)(2011-2#1)
because there is a##3##4##(2008-10#1)(2011-2#2)
because there is no known##2##5##(1995-6#1)(2013-1#1)
because there is no##8##4##(1992-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-11#1)(2013-1#1)
because there is##15##3##(1991-12#1)(1992-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#2)(2013-1#1)
because there were##2##3##(2008-12#1)(2008-7#1)
because there##27##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#3)(2013-1#1)
because these##14##2##(1990-6#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2012-3#1)(2013-7#1)
because they are##24##3##(1990-3#1)(1991-2#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#2)
because they can be##2##4##(2008-10#1)(2008-3#1)
because they can##5##3##(1997-3#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-3#1)
because they contain##2##3##(2008-3#1)(2008-9#1)
because they do not##6##4##(1993-12#1)(1994-7#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
because they fail to##2##4##(2008-10#1)(2008-7#1)
because they had##3##3##(1991-12#1)(2007-10#1)(2008-11#1)
because they have the potential to##2##6##(2009-3#1)(2010-5#1)
because they have##6##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-5#1)
because they may harbor dangerous pathogens such as human immunodeficiency virus (HIV)##2##12##(2008-4#1)(2008-9#1)
because they may##4##3##(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)
because they provide##2##3##(2008-9#1)(2011-2#1)
because they reduce##2##3##(2008-7#1)(2008-8#1)
because they represent##2##3##(2008-10#1)(2010-7#1)
because they require##2##3##(2011-1#1)(2012-12#1)
because they target##2##3##(2009-8#1)(2012-3#1)
because they were##9##3##(1996-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
because they##116##2##(1990-3#1)(1991-12#1)(1991-2#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#3)
because this##14##2##(1992-12#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
because very few##2##3##(1994-11#1)(2011-2#1)
because we had##2##3##(2008-10#1)(2008-5#1)
because we##9##2##(2008-10#3)(2008-3#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-7#1)(2012-2#1)
because working wavelength determination was more precise and spectral overlap was less##2##12##(2008-10#2)
because##1886##1##(1990-11#6)(1990-12#6)(1990-2#4)(1990-3#7)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-11#5)(1991-12#10)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-9#6)(1992-1#2)(1992-11#7)(1992-12#7)(1992-2#6)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#6)(1992-9#7)(1993-1#6)(1993-11#8)(1993-12#12)(1993-2#2)(1993-3#7)(1993-5#3)(1993-6#6)(1993-8#1)(1993-9#9)(1994-1#4)(1994-11#7)(1994-12#4)(1994-2#7)(1994-3#13)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#5)(1994-9#3)(1995-11#8)(1995-12#10)(1995-2#8)(1995-3#9)(1995-4#1)(1995-5#5)(1995-6#13)(1995-8#3)(1996-1#5)(1996-11#4)(1996-12#9)(1996-2#7)(1996-3#7)(1996-4#2)(1996-5#12)(1996-6#7)(1996-9#4)(1997-1#9)(1997-2#5)(1997-3#15)(1997-4#8)(1997-5#8)(1997-6#9)(1997-7#7)(1997-8#8)(2006-10#6)(2006-12#1)(2006-5#2)(2006-6#2)(2007-10#14)(2007-11#21)(2007-12#40)(2007-2#5)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#7)(2007-8#15)(2008-1#26)(2008-10#272)(2008-11#70)(2008-12#20)(2008-2#70)(2008-3#114)(2008-4#39)(2008-5#55)(2008-6#26)(2008-7#74)(2008-8#67)(2008-9#61)(2009-1#5)(2009-10#13)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#8)(2009-5#9)(2009-6#5)(2009-7#1)(2009-8#9)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#11)(2010-2#4)(2010-3#5)(2010-4#11)(2010-5#9)(2010-6#6)(2010-7#12)(2010-8#9)(2010-9#3)(2011-1#21)(2011-2#102)(2011-3#1)(2011-7#2)(2012-1#8)(2012-12#29)(2012-2#31)(2012-3#30)(2012-6#1)(2013-1#55)(2013-7#8)(2013-8#20)
beclomethasone dipropionate##6##2##(1990-9#2)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#1)
beclomethasone##9##1##(1990-9#4)(1996-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)
become &quot##3##2##(1996-1#1)(2008-11#2)
become a crucial##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
become a major##11##3##(1991-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-7#1)(2011-2#1)
become a mandate for##2##4##(1996-3#1)(2008-12#1)
become a national##2##3##(1993-12#1)(2011-2#1)
become a new##4##3##(2008-1#1)(2011-2#2)(2012-12#1)
become a part of the##2##5##(1995-12#1)(1995-6#1)
become a part of##4##4##(1994-1#1)(1995-12#1)(1995-6#1)(2008-10#1)
become a powerful tool for##2##5##(2008-10#1)(2008-8#1)
become a powerful tool in the##2##6##(1994-9#1)(2008-10#1)
become a powerful tool in##3##5##(1994-9#1)(2008-10#1)(2008-9#1)
become a powerful tool##5##4##(1994-9#1)(2008-10#2)(2008-8#1)(2008-9#1)
become a powerful##9##3##(1994-9#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
become a priority##2##3##(2008-9#1)(2013-1#1)
become a reality##4##3##(1991-3#1)(2008-10#1)(2008-9#1)(2013-8#1)
become a reliable##2##3##(2007-12#1)(2008-10#1)
become a routine##2##3##(2008-7#1)(2008-9#1)
become a serious##3##3##(1991-6#1)(1996-3#1)(2011-2#1)
become a standard##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2012-3#1)
become a useful##3##3##(1997-8#1)(2008-7#1)(2012-2#1)
become a widely##2##3##(2008-11#1)(2012-2#1)
become a##123##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#2)(1996-12#2)(1996-3#4)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#3)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-9#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
become accessible##2##2##(1993-11#1)(2008-3#1)
become active##6##2##(1995-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
become adults##2##2##(1995-2#1)(2006-10#1)
become an accepted##2##3##(1997-4#1)(2010-11#1)
become an essential##6##3##(1992-1#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-1#1)
become an important tool for##4##5##(1997-4#1)(2010-12#1)(2011-7#1)(2012-3#1)
become an important tool##6##4##(1997-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-7#1)(2012-3#1)
become an important##22##3##(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-3#1)
become an increasingly##4##3##(1991-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
become an##50##2##(1991-1#1)(1992-1#1)(1992-5#1)(1992-8#1)(1994-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#2)(2011-7#1)(2012-2#2)(2012-3#3)
become apparent that##7##3##(1995-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
become apparent##12##2##(1995-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)
become available for##2##3##(1993-11#1)(2008-6#1)
become available in##2##3##(2011-2#1)(2013-1#1)
become available to##3##3##(2008-11#1)(2008-3#1)(2010-7#1)
become available##23##2##(1992-1#1)(1992-3#1)(1993-11#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
become capable##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
become chronic##2##2##(2008-4#1)(2008-7#1)
become circular##2##2##(2008-3#1)(2012-3#1)
become clear that##5##3##(2008-1#1)(2008-10#1)(2009-3#2)(2010-12#1)
become clinical##2##2##(1997-1#1)(2008-12#1)
become confluent##2##2##(1991-5#1)(1992-3#1)
become critical##3##2##(1996-3#1)(2008-5#1)(2008-7#1)
become depressed##2##2##(1993-3#2)
become disordered##2##2##(1995-3#1)(2008-10#1)
become effective##3##2##(1993-5#1)(2008-11#1)(2011-2#1)
become essential##2##2##(2011-1#1)(2013-1#1)
become established in##4##3##(1997-6#1)(2008-10#2)(2011-2#1)
become established##9##2##(1997-6#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)
become even more##5##3##(1992-12#1)(1994-11#1)(1995-5#1)(1997-1#1)(2009-3#1)
become even##6##2##(1992-12#1)(1994-11#1)(1995-5#1)(1997-1#1)(2009-3#1)(2009-6#1)
become evident##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
become exposed##2##2##(1995-12#1)(2007-12#1)
become familiar and comfortable with##2##5##(2007-12#1)(2011-2#1)
become familiar with##3##3##(1991-1#1)(2008-11#1)(2010-8#1)
become familiar##6##2##(1991-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)
become feasible with##2##3##(2008-10#1)(2008-11#1)
become feasible##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
become fragmented in the micropylar end##2##6##(2008-11#1)(2008-9#1)
become heavily##2##2##(1996-12#1)(2009-7#1)
become important for##4##3##(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
become important tools in##2##4##(2007-8#1)(2008-10#1)
become important##9##2##(1992-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-5#1)
become incorporated##3##2##(1993-6#1)(2007-12#1)(2010-8#1)
become increasingly common in##2##4##(2008-7#1)(2011-1#1)
become increasingly common##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
become increasingly important in the##4##5##(1994-2#1)(2008-4#1)(2010-12#1)(2010-9#1)
become increasingly important to##3##4##(1994-3#1)(1995-1#1)(2007-5#1)
become increasingly important##11##3##(1994-2#1)(1994-3#1)(1995-1#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2010-9#1)
become increasingly more##2##3##(2008-7#1)(2008-9#1)
become increasingly recognized##2##3##(2008-10#1)(2008-4#1)
become increasingly##41##2##(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
become indicators of##2##3##(2013-1#2)
become infected and##2##3##(2008-10#1)(2012-2#1)
become infected##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
become institutionalised##2##2##(2011-2#2)
become involved in the##2##4##(1994-2#1)(1996-1#1)
become involved in##4##3##(1994-2#1)(1996-1#1)(1996-3#1)(2008-11#1)
become involved##6##2##(1994-1#1)(1994-2#1)(1996-1#1)(1996-3#1)(2007-6#1)(2008-11#1)
become just##2##2##(2008-10#1)(2008-11#1)
become known##2##2##(1992-12#1)(2009-5#1)
become less##10##2##(1990-11#1)(1990-5#1)(1990-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)
become linked##2##2##(2008-11#1)(2008-7#1)
become locally##2##2##(2008-6#1)(2008-9#1)
become loose##2##2##(2007-11#1)(2007-8#1)
become malignant##2##2##(2008-7#1)(2012-12#1)
become manifest##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
become members of##2##3##(1997-5#1)(2008-11#1)
become more actively involved##2##4##(2008-11#1)(2011-2#1)
become more and more important##2##5##(2007-8#1)(2008-3#1)
become more and more##5##4##(2007-8#1)(2008-3#1)(2009-11#1)(2009-12#1)(2011-2#1)
become more aware of##3##4##(2008-10#1)(2010-6#1)(2010-9#1)
become more important##2##3##(2008-10#1)(2013-8#1)
become more involved##2##3##(2007-2#1)(2008-10#1)
become more of##2##3##(2008-11#1)(2008-9#1)
become more prevalent##2##3##(2008-10#1)(2012-12#1)
become more##64##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
become necessary##3##2##(1995-12#1)(1997-3#1)(2012-12#1)
become of##4##2##(1992-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
become one of the main##2##5##(2011-1#1)(2011-2#1)
become one of the##10##4##(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
become one##11##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#2)
become organized into##2##3##(2008-11#1)(2008-9#1)
become part of##8##3##(1992-1#1)(1994-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-9#1)
become particularly##2##2##(2008-7#1)(2012-2#1)
become permeable to##2##3##(1990-11#2)
become popular##4##2##(1993-1#2)(2008-10#1)(2012-2#1)
become possible to##5##3##(1990-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)
become possible##7##2##(1990-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
become pregnant##3##2##(1990-2#1)(2008-3#1)(2012-12#1)
become prevalent in##2##3##(1991-2#1)(2008-10#1)
become refractory to##3##3##(1995-8#1)(2008-5#2)
become relatively##2##2##(2008-1#1)(2009-8#1)
become resistant to tamoxifen##2##4##(1993-1#2)
become resistant to##6##3##(1993-1#2)(1995-3#1)(2008-10#3)
become resistant##7##2##(1993-1#2)(1995-3#1)(2008-10#4)
become routine in##2##3##(2008-9#1)(2010-5#1)
become routine##4##2##(1993-11#1)(2008-12#1)(2008-9#1)(2010-5#1)
become saturated##2##2##(1991-12#1)(2008-10#1)
become serious##3##2##(1993-3#1)(2008-7#1)(2011-2#1)
become significant##3##2##(2007-11#1)(2008-10#1)(2011-3#1)
become significantly##2##2##(1996-9#1)(2008-7#1)
become standard##4##2##(1997-8#1)(2008-7#1)(2010-12#1)(2012-12#1)
become symptomatic##3##2##(2008-10#2)(2010-12#1)
become targets for##2##3##(1994-11#1)(2008-6#1)
become the basis##2##3##(1997-4#1)(2009-4#1)
become the focus of##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
become the main##3##3##(1992-9#1)(2008-7#1)(2012-2#1)
become the most##8##3##(1994-9#1)(2008-10#3)(2008-12#1)(2010-2#1)(2011-2#2)
become the predominant##2##3##(1995-6#1)(2008-1#1)
become the standard for##2##4##(1996-12#1)(2008-11#1)
become the standard##7##3##(1994-12#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-2#2)
become the treatment of choice##2##5##(1994-12#1)(2011-2#1)
become the##68##2##(1991-5#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-12#3)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1997-4#1)(2006-10#1)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#5)(2008-6#1)(2008-7#3)(2008-9#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#1)
become thin and##2##3##(2007-11#1)(2008-5#1)
become very##3##2##(2008-10#2)(2010-1#1)
become widely used##4##3##(1996-1#1)(1997-4#1)(2008-11#1)(2013-1#1)
become widely##7##2##(1996-1#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
become worse##2##2##(1997-6#1)(2007-4#1)
become##841##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#3)(1992-12#7)(1992-2#1)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#7)(1994-2#8)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-12#6)(1995-2#5)(1995-3#7)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#9)(1996-5#1)(1996-9#2)(1997-1#7)(1997-2#3)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#4)(2006-10#6)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#21)(2007-2#8)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#23)(2008-10#95)(2008-11#49)(2008-12#11)(2008-2#12)(2008-3#20)(2008-4#27)(2008-5#15)(2008-6#5)(2008-7#41)(2008-8#13)(2008-9#29)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#4)(2009-4#2)(2009-5#9)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#5)(2011-1#9)(2011-2#43)(2011-3#6)(2011-7#1)(2012-1#4)(2012-12#14)(2012-2#22)(2012-3#12)(2012-5#1)(2013-1#20)(2013-7#4)(2013-8#14)
becomes a more##2##3##(1994-12#1)(2008-11#1)
becomes a natural##2##3##(2007-11#1)(2008-11#1)
becomes a##22##2##(1991-11#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
becomes active##2##2##(2008-10#2)
becomes almost##2##2##(2008-10#1)(2012-2#1)
becomes an##5##2##(1992-2#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
becomes apparent##2##2##(2008-5#1)(2010-3#1)
becomes available##3##2##(1991-3#1)(1993-12#1)(2008-7#1)
becomes comparable##2##2##(2008-3#2)
becomes equal to##2##3##(2008-3#2)
becomes especially important##2##3##(1992-5#1)(1993-10#1)
becomes even more important##2##4##(2007-11#1)(2011-2#1)
becomes even more##4##3##(1996-2#1)(2007-11#1)(2008-7#1)(2011-2#1)
becomes evident##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
becomes important##3##2##(2008-10#1)(2008-3#2)
becomes impossible##2##2##(1990-12#1)(2008-1#1)
becomes increasingly important##2##3##(2008-11#1)(2008-3#1)
becomes increasingly##8##2##(1994-1#1)(1995-2#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)
becomes large##2##2##(2008-2#1)(2008-3#1)
becomes larger as##2##3##(2007-11#1)(2008-11#1)
becomes larger##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
becomes less##4##2##(1991-9#1)(1992-11#1)(2007-12#1)(2008-10#1)
becomes linear##2##2##(1992-6#1)(1996-6#1)
becomes manifest##2##2##(1990-2#1)(2013-1#1)
becomes more and more##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
becomes more##21##2##(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(1994-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)
becomes much##2##2##(1995-6#1)(2008-10#1)
becomes necessary to##2##3##(2007-7#2)
becomes necessary##3##2##(2007-7#2)(2011-2#1)
becomes nonlinear##2##2##(2008-2#1)(2008-3#1)
becomes possible##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
becomes progressively more##3##3##(1990-3#1)(1994-2#1)(2010-7#1)
becomes progressively##6##2##(1990-3#1)(1990-7#1)(1994-2#1)(2008-10#1)(2008-12#1)(2010-7#1)
becomes questionable##2##2##(1991-3#1)(2008-2#1)
becomes sharper##2##2##(1996-8#1)(1997-7#1)
becomes significant##4##2##(2008-3#4)
becomes the first##2##3##(1996-2#1)(2010-8#1)
becomes the##14##2##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-2#1)(2007-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)
becomes transparent or opalescent##2##4##(2008-3#2)
becomes transparent or##3##3##(2008-2#1)(2008-3#2)
becomes very##2##2##(1991-11#1)(2008-10#1)
becomes weaker with##2##3##(2008-7#1)(2012-2#1)
becomes##259##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#3)(1996-4#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-7#3)(2008-1#6)(2008-10#30)(2008-11#11)(2008-12#3)(2008-2#13)(2008-3#30)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#7)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
becoming a major##2##3##(2008-10#1)(2009-6#1)
becoming a smoker (AOR = 1##2##6##(2013-1#2)
becoming a##28##2##(1991-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2012-3#1)(2013-1#4)
becoming an important##6##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)
becoming an increasingly##6##3##(1994-2#1)(2006-6#1)(2008-8#1)(2010-10#1)(2013-1#2)
becoming an##17##2##(1994-2#1)(1996-1#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#2)
becoming apparent##3##2##(1990-5#1)(2008-3#1)(2010-5#1)
becoming available##6##2##(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)
becoming aware of the##2##4##(1991-2#1)(2008-6#1)
becoming aware of##3##3##(1991-2#1)(1995-1#1)(2008-6#1)
becoming clear that##3##3##(2008-7#2)(2009-4#1)
becoming ever more##2##3##(1993-11#1)(1995-3#1)
becoming extinct##2##2##(2008-8#2)
becoming important##2##2##(1996-2#1)(2008-2#1)
becoming increasingly important##7##3##(1993-11#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
becoming increasingly popular##2##3##(1994-9#1)(2011-2#1)
becoming increasingly prevalent##2##3##(2008-3#1)(2013-8#1)
becoming increasingly##21##2##(1992-3#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
becoming infected with##2##3##(1995-6#1)(2008-9#1)
becoming infected##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
becoming more and more##3##4##(2008-10#1)(2010-7#1)(2013-8#1)
becoming more attractive##2##3##(2007-12#1)(2008-7#1)
becoming more common##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
becoming more popular##3##3##(1992-2#1)(1995-2#1)(2008-8#1)
becoming more##22##2##(1991-3#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-1#1)(1995-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-8#2)
becoming the most##2##3##(2008-4#2)
becoming the##11##2##(1990-2#1)(2007-12#1)(2008-10#3)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
becoming widespread##2##2##(2008-10#1)(2008-7#1)
becoming##189##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#15)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#5)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#5)
bed and##4##2##(1995-11#1)(2007-11#1)(2007-5#1)(2008-9#1)
bed bioreactor using##2##3##(2008-11#2)
bed bioreactor##8##2##(2008-11#8)
bed boost##2##2##(2011-2#2)
bed by##2##2##(2008-10#1)(2008-11#1)
bed for##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
bed is##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-4#1)
bed mobility##2##2##(2012-1#1)(2012-3#1)
bed nets##2##2##(1997-4#1)(2011-2#1)
bed nucleus of the stria terminalis##2##6##(1993-12#1)(1994-2#1)
bed of a##2##3##(2008-10#1)(2008-9#1)
bed of##8##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
bed reactor##4##2##(2008-11#1)(2008-6#1)(2008-7#2)
bed rest##3##2##(2008-3#1)(2008-7#2)
bed size##2##2##(1993-12#1)(1996-1#1)
bed to##2##2##(2007-11#1)(2007-8#1)
bed use##3##2##(1995-2#2)(2012-2#1)
bed was##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
bed were##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
bed##130##1##(1990-12#1)(1990-6#1)(1991-2#4)(1991-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#28)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#14)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)
bed)##3##1##(1990-6#1)(2008-11#1)(2010-12#1)
bedding and##2##2##(1990-2#1)(2008-12#1)
bedding in the##2##3##(1991-11#1)(2011-1#1)
bedding##8##1##(1990-2#3)(1991-11#2)(2008-10#1)(2008-12#1)(2011-1#1)
bedrest##2##1##(1993-6#2)
bedrooms##2##1##(1995-6#1)(2011-2#1)
beds and##6##2##(1994-12#1)(1997-6#1)(2010-8#1)(2013-8#3)
beds are##3##2##(1991-1#1)(1997-6#1)(2011-2#1)
beds in##2##2##(1996-3#1)(2008-11#1)
beds is##2##2##(1997-5#1)(2010-9#1)
beds of##2##2##(2008-1#1)(2008-12#1)
beds were##2##2##(1993-2#1)(2011-2#1)
beds where stem gall had##2##5##(2008-10#2)
beds##72##1##(1990-6#1)(1990-9#1)(1991-1#3)(1991-3#1)(1991-6#4)(1991-8#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#3)(2011-2#3)(2013-7#1)(2013-8#7)
beds)##3##1##(2008-4#3)
bedside nurse##3##2##(2008-1#2)(2011-1#1)
bedside to##2##2##(2007-7#2)
bedside##29##1##(1993-3#1)(1995-11#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-8#1)(2007-3#1)(2007-5#1)(2007-7#3)(2008-1#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#3)(2009-6#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
bedtime##8##1##(2007-6#1)(2007-7#1)(2008-5#1)(2010-6#1)(2012-12#4)
bee and##2##2##(2008-6#1)(2013-1#1)
bee colonies##3##2##(2008-5#1)(2008-6#1)(2011-2#1)
bee products##3##2##(2008-10#3)
bee sting acupuncture##4##3##(2012-3#4)
bee venom##4##2##(1996-5#1)(2008-10#2)(2012-3#1)
bee##35##1##(1996-5#1)(2007-12#1)(2008-10#8)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#4)(2012-3#5)(2013-1#3)
beef and##4##2##(1990-5#1)(2007-12#1)(2008-10#1)(2013-1#1)
beef cattle##10##2##(1991-3#2)(2010-4#4)(2012-1#1)(2012-3#3)
beef heart mitochondrial##2##3##(1990-7#1)(2008-11#1)
beef herds##2##2##(2012-3#2)
beef liver##3##2##(1992-11#1)(2008-10#2)
beef patties##9##2##(2010-4#9)
beef##75##1##(1990-5#3)(1990-7#1)(1991-3#2)(1992-11#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-9#1)(2010-4#29)(2012-1#1)(2012-3#6)(2013-1#5)
beef-based raw diet##3##3##(2009-4#3)
beef-in-sauce products##3##2##(2011-2#3)
beehives were##2##2##(2008-10#2)
beekeepers##4##1##(2008-10#4)
been 30##2##2##(2008-3#1)(2013-8#1)
been a concern##2##3##(2008-12#1)(2011-1#1)
been a major##13##3##(1990-6#1)(1992-11#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#1)
been a problem##3##3##(1993-3#1)(1995-9#1)(2008-9#1)
been a source of##3##4##(2008-10#1)(2008-12#2)
been a well known##2##4##(1994-5#1)(1997-5#1)
been a##169##2##(1990-11#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-5#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2011-4#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#8)
been able to identify##3##4##(1991-12#1)(1997-4#1)(1997-7#1)
been able to show that##2##5##(2008-12#1)(2008-4#1)
been able to##29##3##(1991-12#1)(1992-12#1)(1992-9#1)(1994-9#1)(1996-11#1)(1996-8#2)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2009-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
been absorbed##2##2##(2008-10#1)(2008-6#1)
been abundant##2##2##(2012-3#2)
been accepted that##2##3##(2008-10#1)(2008-7#1)
been accepted##6##2##(1990-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
been accompanied by a##3##4##(1994-1#1)(2008-10#1)(2012-3#1)
been accompanied by an##2##4##(2008-10#1)(2008-11#1)
been accompanied by##10##3##(1994-1#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2010-3#1)(2012-3#1)
been accomplished by##9##3##(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2009-7#1)(2012-3#1)
been accomplished with##2##3##(1992-2#1)(2008-4#1)
been accomplished##18##2##(1991-6#1)(1992-2#1)(1994-12#1)(1994-5#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-4#1)(2009-7#1)(2012-3#1)
been accumulated##4##2##(1994-5#1)(2007-8#1)(2008-1#1)(2012-12#1)
been accurately##2##2##(2008-10#2)
been achieved and##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
been achieved at##2##3##(1995-12#1)(2010-4#1)
been achieved by use of a##2##6##(2007-11#1)(2007-12#1)
been achieved by use of##4##5##(2007-11#1)(2007-12#3)
been achieved by##10##3##(1992-9#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
been achieved for##5##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)
been achieved in the##6##4##(1997-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
been achieved in##13##3##(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
been achieved using##5##3##(2008-10#3)(2008-11#1)(2010-4#1)
been achieved with a##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
been achieved with##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)
been achieved##95##2##(1991-2#1)(1992-9#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#7)(2007-12#10)(2007-7#1)(2007-8#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-4#1)(2012-12#3)(2012-3#1)
been acknowledged##3##2##(2008-11#2)(2011-2#1)
been acquired in##2##3##(2008-10#1)(2008-3#1)
been acquired##9##2##(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2011-1#1)
been acting##2##2##(2008-3#1)(2012-3#1)
been active in sports##3##4##(2007-11#2)(2007-8#1)
been active in##4##3##(2007-11#2)(2007-8#1)(2008-12#1)
been adapted in##3##3##(1995-12#1)(2008-10#1)(2009-6#1)
been adapted to##5##3##(2008-11#1)(2008-12#1)(2008-2#1)(2010-7#1)(2012-12#1)
been adapted##8##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2010-7#1)(2012-12#1)
been added as##2##3##(1994-12#1)(2008-11#1)
been added to the##3##4##(1993-12#1)(2008-10#1)(2008-3#1)
been added to##8##3##(1993-12#1)(2008-10#4)(2008-3#1)(2010-4#1)(2013-7#1)
been added##12##2##(1993-12#1)(1994-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-7#1)
been addressed by##6##3##(2007-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)
been addressed in the##2##4##(2008-2#1)(2008-9#1)
been addressed in##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
been addressed##14##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
been adequate##3##2##(1995-6#1)(2007-12#1)(2008-11#1)
been adequately##9##2##(1991-8#1)(1992-6#1)(1997-8#1)(2008-11#1)(2008-2#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
been administered to##2##3##(1995-5#1)(2010-8#1)
been administered##7##2##(1990-9#1)(1995-5#1)(1996-1#1)(2008-12#1)(2010-8#2)(2011-3#1)
been admitted to the##2##4##(2008-1#1)(2012-3#1)
been admitted##4##2##(1990-12#1)(2008-1#1)(2012-12#1)(2012-3#1)
been adopted to##2##3##(2007-11#1)(2012-1#1)
been adopted##7##2##(1994-9#1)(2007-11#1)(2008-2#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-3#1)
been advanced##3##2##(1990-3#1)(2008-8#1)(2011-1#1)
been advised##3##2##(1991-6#1)(2008-10#1)(2010-11#1)
been advocated to##2##3##(1991-3#1)(1991-6#1)
been advocated##9##2##(1991-3#1)(1991-6#1)(1996-3#2)(2008-11#2)(2009-6#1)(2010-2#1)(2013-1#1)
been affected##2##2##(1994-3#1)(2009-10#1)
been afforded##2##2##(2008-7#1)(2009-6#1)
been aimed at improving##2##4##(2008-3#1)(2012-12#1)
been aimed at##3##3##(1996-8#1)(2008-3#1)(2012-12#1)
been aimed##5##2##(1996-8#1)(2007-8#1)(2008-3#1)(2012-12#1)(2013-1#1)
been almost##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
been also##23##2##(1990-12#1)(1994-12#1)(1997-7#1)(2007-11#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-8#1)(2010-7#1)(2013-1#1)
been always a##2##3##(2008-10#1)(2008-11#1)
been always##4##2##(1990-6#1)(1990-9#1)(2008-10#1)(2008-11#1)
been amply##3##2##(1994-11#1)(1997-2#1)(2007-8#1)
been an emerging##2##3##(2012-3#1)(2013-8#1)
been an important##7##3##(2007-5#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
been an increased##4##3##(1996-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
been an##43##2##(1990-3#1)(1992-1#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2006-5#1)(2007-5#2)(2008-1#2)(2008-10#2)(2008-11#7)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
been analysed and##2##3##(2008-7#1)(2012-12#1)
been analysed by##4##3##(1990-8#1)(1991-5#1)(2008-10#2)
been analysed in##3##3##(1991-5#1)(2007-11#1)(2008-10#1)
been analysed using the##2##4##(2008-10#2)
been analysed using##3##3##(2008-10#2)(2008-7#1)
been analysed##22##2##(1990-6#1)(1990-8#1)(1991-5#2)(2007-11#1)(2008-10#10)(2008-3#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)
been analyzed at##2##3##(2007-12#1)(2008-10#1)
been analyzed by##7##3##(1992-2#1)(1992-9#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-8#1)
been analyzed in terms of##2##5##(1991-5#1)(1994-12#1)
been analyzed in##10##3##(1991-5#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-5#1)(2011-1#2)
been analyzed to##2##3##(1997-7#1)(2008-11#1)
been analyzed with##2##3##(2008-2#1)(2008-5#1)
been analyzed##46##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#2)(2011-1#3)(2012-3#2)(2013-1#1)(2013-7#1)
been and##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
been any##3##2##(1990-7#1)(1992-12#1)(2008-6#1)
been applied as##2##3##(2008-10#1)(2008-7#1)
been applied for the determination of##5##6##(2008-10#5)
been applied for the##8##4##(2008-10#8)
been applied for##19##3##(2007-12#1)(2008-10#15)(2008-2#1)(2008-3#1)(2012-3#1)
been applied in the##4##4##(2008-10#4)
been applied in##16##3##(2008-10#12)(2008-11#1)(2008-8#1)(2010-12#1)(2013-8#1)
been applied to a##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
been applied to determine##10##4##(1996-12#1)(2008-10#9)
been applied to different##2##4##(2008-10#1)(2010-9#1)
been applied to investigate the##2##5##(2008-10#1)(2008-2#1)
been applied to monitor##3##4##(2008-2#1)(2008-7#1)(2008-8#1)
been applied to the analysis of##10##6##(2008-10#10)
been applied to the determination of trace##12##7##(2008-10#12)
been applied to the determination of##53##6##(2008-10#53)
been applied to the direct determination of##3##7##(2008-10#3)
been applied to the separation##2##5##(1996-5#1)(2008-10#1)
been applied to the study of##2##6##(2008-3#1)(2011-1#1)
been applied to the##98##4##(1991-2#1)(1991-5#1)(1992-3#1)(1994-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#83)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#3)
been applied to##178##3##(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-8#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#4)(2007-12#2)(2007-5#1)(2008-10#128)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)
been applied##252##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-8#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-11#4)(2007-12#3)(2007-5#1)(2008-10#180)(2008-11#2)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-8#1)
been appreciated##6##2##(2008-8#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
been approached##3##2##(1992-9#1)(2008-10#1)(2012-12#1)
been approved by the##3##4##(2008-4#1)(2011-2#2)
been approved by##4##3##(2008-1#1)(2008-4#1)(2011-2#2)
been approved for use in##2##5##(2007-11#1)(2013-1#1)
been approved for##5##3##(1993-11#1)(2007-11#2)(2008-7#1)(2013-1#1)
been approved##16##2##(1993-11#1)(1996-1#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
been argued that##3##3##(2008-9#1)(2009-11#1)(2012-2#1)
been argued##5##2##(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)
been as##2##2##(2008-10#1)(2008-9#1)
been ascribed to##4##3##(1997-7#1)(2007-12#1)(2008-3#1)(2012-2#1)
been assayed by##3##3##(1991-5#1)(1992-8#1)(2010-5#1)
been assayed##5##2##(1991-5#1)(1992-8#1)(2008-10#2)(2010-5#1)
been assembled##6##2##(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
been assessed by##4##3##(1994-3#1)(2008-11#1)(2013-1#2)
been assessed for##2##3##(2008-10#1)(2012-2#1)
been assessed in the##2##4##(2008-10#1)(2009-11#1)
been assessed in##7##3##(1994-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-5#1)
been assessed with##3##3##(2008-10#3)
been assessed##29##2##(1994-12#1)(1994-3#1)(1995-3#1)(2007-11#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
been assigned for##2##3##(1993-8#1)(2008-11#1)
been assigned to the##6##4##(1996-6#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
been assigned to##11##3##(1990-7#1)(1991-5#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2012-2#1)
been assigned##17##2##(1990-7#1)(1991-5#1)(1993-8#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
been associated to##3##3##(2009-6#1)(2009-8#1)(2013-1#1)
been associated with a##14##4##(1991-9#1)(1992-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
been associated with an increased##3##5##(2007-10#1)(2012-12#1)(2012-5#1)
been associated with an##6##4##(1994-5#1)(2007-10#1)(2008-5#1)(2012-12#1)(2012-5#1)(2013-1#1)
been associated with higher##3##4##(1994-3#1)(2007-12#1)(2008-11#1)
been associated with increased risk of##2##6##(2008-2#1)(2012-2#1)
been associated with increased##4##4##(2008-2#2)(2008-8#1)(2012-2#1)
been associated with poor##3##4##(1990-6#1)(2009-11#1)(2009-5#1)
been associated with significant##2##4##(1990-6#1)(2008-4#1)
been associated with the##11##4##(1993-12#1)(1995-5#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-5#1)(2012-12#2)(2013-8#1)
been associated with##101##3##(1990-6#2)(1991-2#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-7#1)(1997-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#3)(2009-9#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#6)
been associated##107##2##(1990-6#2)(1991-2#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-7#1)(1997-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#6)
been assumed that##4##3##(1990-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
been assumed to be##2##4##(1993-3#1)(2008-10#1)
been assumed to##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
been assumed##12##2##(1990-7#1)(1993-3#1)(2008-10#4)(2008-11#1)(2008-2#4)(2013-1#1)
been at the##2##3##(1993-5#1)(2012-7#1)
been at##4##2##(1991-3#1)(1993-5#1)(2008-11#1)(2012-7#1)
been attached to the##2##4##(1991-5#1)(1994-6#1)
been attached to##3##3##(1991-5#1)(1994-6#1)(2008-4#1)
been attained##5##2##(1995-6#2)(1996-2#1)(2008-11#1)(2008-3#1)
been attempted to##2##3##(2010-7#1)(2012-2#1)
been attempted##12##2##(1990-2#1)(1993-2#1)(1994-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-7#1)(2013-1#1)
been attracting##3##2##(1995-2#1)(2009-8#1)(2010-7#1)
been attributed to a##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
been attributed to the##4##4##(2008-10#3)(2008-8#1)
been attributed to their##2##4##(1994-5#1)(2009-3#1)
been attributed to##25##3##(1991-2#1)(1991-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-5#2)(2007-7#1)(2008-10#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
been attributed##28##2##(1991-2#1)(1991-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-7#1)(2007-7#1)(2008-10#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
been available for##6##3##(1994-2#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
been available in##2##3##(1996-3#1)(2012-3#1)
been available##16##2##(1991-12#1)(1994-2#1)(1995-11#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#1)(2012-3#1)
been based on##5##3##(1994-6#1)(1996-1#1)(1997-6#1)(2007-10#1)(2008-8#1)
been based##7##2##(1994-6#1)(1996-1#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-8#1)
been because##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
been believed that##2##3##(2008-5#1)(2010-11#1)
been believed##3##2##(1991-3#1)(2008-5#1)(2010-11#1)
been below##2##2##(1997-4#1)(2008-10#1)
been both##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
been briefly##3##2##(2008-10#3)
been broadly##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
been built and##4##3##(2008-3#2)(2008-8#1)(2009-8#1)
been built##13##2##(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#2)(2009-8#1)(2012-12#1)
been calculated and##3##3##(2008-10#2)(2008-3#1)
been calculated by##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
been calculated for##2##3##(1997-2#1)(2008-10#1)
been calculated to be##2##4##(2007-10#1)(2008-10#1)
been calculated##25##2##(1992-9#1)(1993-2#1)(1994-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-7#1)(2013-1#3)
been called##7##2##(1990-5#1)(1994-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
been carried out at the##2##5##(1997-6#1)(2008-10#1)
been carried out at##5##4##(1994-11#1)(1997-6#1)(2008-10#2)(2008-3#1)
been carried out by using##2##5##(2008-10#1)(2013-1#1)
been carried out by##16##4##(1990-3#1)(2007-11#2)(2008-10#11)(2012-3#1)(2013-1#1)
been carried out for the##2##5##(2008-10#1)(2010-12#1)
been carried out for##5##4##(1997-7#1)(2008-10#2)(2008-3#1)(2010-12#1)
been carried out in order to##3##6##(1994-5#1)(2008-10#1)(2013-1#1)
been carried out in the##3##5##(2008-10#2)(2011-2#1)
been carried out in##16##4##(1990-2#1)(1992-8#1)(1994-5#1)(1997-5#1)(2008-10#7)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
been carried out on the##6##5##(1993-9#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
been carried out on##13##4##(1993-9#1)(2007-6#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2011-2#1)(2012-1#1)
been carried out to determine##2##5##(2008-5#1)(2008-7#1)
been carried out to##8##4##(1992-10#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
been carried out using a##2##5##(2008-10#2)
been carried out using##8##4##(2008-10#4)(2009-3#1)(2010-7#1)(2010-8#2)
been carried out with the##2##5##(1990-7#1)(2013-7#1)
been carried out with##6##4##(1990-7#1)(2008-10#2)(2008-3#2)(2013-7#1)
been carried out within the##2##5##(1990-3#1)(2008-3#1)
been carried out within##3##4##(1990-3#1)(2008-3#1)(2010-7#1)
been carried out##113##3##(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-6#1)(2008-10#43)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#2)
been carried##117##2##(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-6#1)(2008-10#43)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-3#4)(2013-1#4)(2013-7#2)
been categorized as##2##3##(2008-5#1)(2013-1#1)
been categorized##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
been certified##4##2##(1991-6#1)(1995-5#1)(2008-10#1)(2013-1#1)
been challenged##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2013-8#1)
been changed to##3##3##(1992-1#1)(1995-5#2)
been changed##5##2##(1990-10#1)(1992-1#1)(1995-5#2)(2008-11#1)
been characterised as##2##3##(2011-2#1)(2012-5#1)
been characterised by##2##3##(2008-10#2)
been characterised##6##2##(1996-2#1)(2008-10#3)(2011-2#1)(2012-5#1)
been characterized as a##4##4##(1991-12#1)(1992-11#1)(1995-2#1)(2013-1#1)
been characterized as##9##3##(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1995-2#1)(2009-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
been characterized by means of##2##5##(2008-2#1)(2008-3#1)
been characterized by##19##3##(1993-1#1)(1994-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
been characterized in##7##3##(1990-11#2)(1991-7#1)(1993-2#1)(2008-10#1)(2009-8#1)(2012-2#1)
been characterized on the basis of##2##6##(2008-10#1)(2010-3#1)
been characterized using##5##3##(2008-10#3)(2008-8#1)(2011-1#1)
been characterized##71##2##(1990-11#2)(1991-12#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#16)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#4)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
been checked in##2##3##(2008-1#1)(2008-10#1)
been checked##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
been chemically##3##2##(1995-2#1)(1995-5#1)(2008-10#1)
been chosen as##3##3##(1991-5#1)(2008-10#2)
been chosen##8##2##(1991-5#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-8#1)
been cited as##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#2)
been cited##7##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#3)
been claimed##4##2##(1991-4#1)(1992-10#1)(1996-2#1)(1997-4#1)
been clarified##5##2##(1993-3#1)(2007-11#1)(2008-1#1)(2012-2#1)(2013-1#1)
been classified as##5##3##(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)
been classified into##2##3##(2008-6#1)(2012-3#1)
been classified##9##2##(1990-11#1)(1996-12#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#3)
been clearly demonstrated##2##3##(2008-10#1)(2011-2#1)
been clearly established##2##3##(2008-10#1)(2011-2#1)
been clearly##17##2##(1990-11#1)(1990-8#1)(1991-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#5)(2012-2#1)
been clinically##5##2##(2007-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2011-3#1)
been cloned and characterised##2##4##(1993-3#1)(2008-7#1)
been cloned and characterized##2##4##(1991-2#1)(2011-1#1)
been cloned and expressed in##3##5##(1993-12#1)(1993-3#1)(1997-6#1)
been cloned and sequenced##8##4##(1990-5#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
been cloned and##20##3##(1990-5#2)(1991-2#1)(1992-10#1)(1993-12#2)(1993-3#2)(1995-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
been cloned from a##3##4##(1993-12#1)(1994-11#1)(1996-2#1)
been cloned from##8##3##(1993-12#1)(1994-11#1)(1995-8#1)(1996-2#1)(2008-8#1)(2008-9#3)
been cloned##47##2##(1990-5#2)(1991-2#1)(1992-10#1)(1993-12#4)(1993-3#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#3)(1995-8#2)(1996-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#6)(2010-12#1)(2011-1#1)
been closely##2##2##(1996-1#1)(1996-2#1)
been coated with a##2##4##(2008-10#1)(2008-3#1)
been coated with##4##3##(1990-12#1)(1995-12#1)(2008-10#1)(2008-3#1)
been collected by##2##3##(1991-7#1)(2013-8#1)
been collected from##2##3##(2008-9#1)(2013-1#1)
been collected on##2##3##(2008-11#1)(2008-8#1)
been collected##21##2##(1991-7#1)(1992-8#1)(1994-8#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
been combined with the##2##4##(2008-10#1)(2008-8#1)
been combined with##6##3##(2008-10#3)(2008-8#1)(2009-11#1)(2010-12#1)
been combined##8##2##(2008-10#4)(2008-8#1)(2009-11#1)(2010-12#1)(2012-12#1)
been commercialized##2##2##(1992-11#1)(2012-3#1)
been common##2##2##(2008-8#1)(2008-9#1)
been commonly used##2##3##(2007-5#1)(2008-7#1)
been commonly##3##2##(2007-5#1)(2008-7#1)(2012-12#1)
been compared by##2##3##(1990-7#1)(1992-3#1)
been compared to##11##3##(1991-5#1)(1993-9#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#3)(2008-12#1)
been compared with that of##6##5##(1996-2#1)(2007-11#1)(2008-10#4)
been compared with that##7##4##(1990-2#1)(1996-2#1)(2007-11#1)(2008-10#4)
been compared with the##2##4##(1990-9#1)(2008-10#1)
been compared with those of##2##5##(1994-9#1)(2008-10#1)
been compared with those##3##4##(1994-9#1)(2008-10#2)
been compared with##18##3##(1990-2#1)(1990-9#1)(1994-9#1)(1996-2#1)(2007-11#1)(2008-10#11)(2008-3#1)(2010-8#1)
been compared##45##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-3#3)(2010-8#1)
been compiled##4##2##(2008-10#2)(2008-11#1)(2008-2#1)
been completed in##3##3##(2007-5#1)(2008-10#1)(2012-2#1)
been completed with##2##3##(2007-8#1)(2008-10#1)
been completed##23##2##(1991-2#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
been completely sequenced##4##3##(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)
been completely##11##2##(1995-6#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-5#1)(2010-6#1)(2012-3#1)(2013-1#2)
been conclusively##5##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
been conducted in##9##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#3)
been conducted on the##4##4##(2008-2#2)(2011-2#1)(2012-12#1)
been conducted on##9##3##(2007-6#1)(2008-10#2)(2008-2#2)(2011-2#2)(2012-12#1)(2012-2#1)
been conducted to##9##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
been conducted##55##2##(1992-10#1)(1996-2#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#4)(2013-1#5)
been configured##2##2##(2008-10#1)(2008-3#1)
been confirmed as##2##3##(1997-3#1)(2008-10#1)
been confirmed by experimental data##2##5##(2007-11#1)(2008-6#1)
been confirmed by##9##3##(1990-9#1)(1994-12#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-4#1)
been confirmed in##6##3##(1992-6#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-9#1)
been confirmed to##2##3##(2008-10#1)(2013-1#1)
been confirmed##37##2##(1990-9#1)(1992-6#1)(1992-8#1)(1994-12#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#3)
been conjugated with##2##3##(1994-9#1)(2008-9#1)
been conjugated##3##2##(1994-9#1)(2008-7#1)(2008-9#1)
been conserved##4##2##(1997-9#1)(2008-4#1)(2009-6#1)(2012-2#1)
been considerable##7##2##(1991-9#1)(1992-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2013-1#1)
been considered a##8##3##(2008-10#3)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
been considered an##3##3##(1993-3#1)(2008-3#1)(2008-8#1)
been considered as a##2##4##(2008-12#1)(2012-3#1)
been considered as an##2##4##(1997-6#1)(2010-6#1)
been considered as##11##3##(1992-10#1)(1992-12#1)(1997-6#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
been considered by##2##3##(2008-7#1)(2012-2#1)
been considered in##3##3##(2008-10#2)(2013-1#1)
been considered to be the##2##5##(1996-8#1)(2007-10#1)
been considered to be##8##4##(1996-8#1)(2007-10#2)(2007-12#1)(2008-11#1)(2010-3#1)(2010-8#1)(2011-2#1)
been considered to##11##3##(1996-8#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)
been considered##58##2##(1992-10#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#4)(2008-8#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
been consistent##4##2##(1994-12#1)(2008-11#1)(2008-4#1)(2012-1#1)
been consistently##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
been constructed and##5##3##(2007-9#1)(2008-3#2)(2008-9#2)
been constructed by##3##3##(1990-11#1)(1996-3#1)(2009-10#1)
been constructed for##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
been constructed to##4##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)
been constructed##35##2##(1990-11#1)(1990-5#1)(1991-6#1)(1993-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
been controlled by operating##2##4##(2008-7#2)
been controlled by##4##3##(2008-10#2)(2008-7#2)
been controlled##9##2##(1997-6#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-7#2)(2013-1#1)
been controversial##3##2##(1990-5#1)(2008-7#1)(2010-6#1)
been corrected##2##2##(2008-3#1)(2008-9#1)
been correlated with the##3##4##(1997-6#1)(2008-10#1)(2012-2#1)
been correlated with##11##3##(1991-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
been correlated##12##2##(1991-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
been coupled##4##2##(1992-9#1)(2008-10#2)(2010-7#1)
been covered##2##2##(1992-10#1)(1997-2#1)
been created that##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
been created to##2##3##(2008-7#2)
been created##17##2##(1991-6#1)(1993-11#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#4)(2009-8#1)(2010-6#2)(2012-12#2)(2012-2#1)(2013-1#1)
been critically assessed##2##3##(2007-12#1)(2008-10#1)
been critically##5##2##(2007-12#1)(2008-10#3)(2011-3#1)
been criticized for##2##3##(1994-12#1)(1996-2#1)
been criticized##8##2##(1991-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2013-1#2)
been crucial##3##2##(2008-11#2)(2008-4#1)
been cultured##3##2##(1991-9#1)(2008-11#2)
been cured##2##2##(2007-11#1)(2007-8#1)
been debated##4##2##(1991-9#1)(1996-3#1)(2008-7#1)(2008-8#1)
been decided##4##2##(1993-1#1)(1994-3#1)(1996-12#1)(2011-3#1)
been declared##2##2##(1991-3#1)(2013-8#1)
been decomposed into lateral##2##4##(2008-11#2)
been decreasing##3##2##(1990-3#1)(1991-3#1)(1992-2#1)
been dedicated to##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
been deduced from the##2##4##(1992-10#1)(2008-5#1)
been deduced##7##2##(1990-12#1)(1992-10#1)(1995-8#1)(2008-10#3)(2008-5#1)
been defined as a##2##4##(1995-12#1)(2008-10#1)
been defined as##7##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
been defined by##4##3##(1996-2#1)(2008-5#1)(2010-8#2)
been defined in##3##3##(2009-12#1)(2012-2#1)(2012-3#1)
been defined##28##2##(1991-11#1)(1992-12#1)(1992-9#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
been definitively##2##2##(1997-3#1)(2009-10#1)
been deleted##5##2##(1990-12#1)(1990-5#1)(1995-2#3)
been delivered##4##2##(1991-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
been demonstrated as##3##3##(1990-8#1)(2008-10#1)(2009-9#1)
been demonstrated by##17##3##(1991-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
been demonstrated for the##5##4##(2008-10#2)(2008-2#2)(2008-3#1)
been demonstrated for##14##3##(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-7#1)
been demonstrated in numerous##2##4##(1992-5#1)(2008-3#1)
been demonstrated in the##4##4##(1991-12#1)(2008-4#2)(2011-1#1)
been demonstrated in##38##3##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#2)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1995-12#2)(1997-3#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
been demonstrated on##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)
been demonstrated previously##2##3##(2008-10#1)(2011-2#1)
been demonstrated that##26##3##(1991-1#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-7#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2011-2#1)(2013-1#1)
been demonstrated to be a##5##5##(1992-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
been demonstrated to be effective##2##5##(2010-5#1)(2012-2#1)
been demonstrated to be##20##4##(1991-6#1)(1992-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
been demonstrated to have##4##4##(2007-8#1)(2009-3#1)(2010-6#1)(2013-7#1)
been demonstrated to##37##3##(1990-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-5#2)(1995-3#2)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
been demonstrated using##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
been demonstrated##228##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-5#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#3)(1994-7#1)(1994-8#1)(1995-12#3)(1995-3#2)(1995-6#2)(1996-12#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-7#1)(2007-8#4)(2008-10#29)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#19)(2008-4#5)(2008-5#8)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#6)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)
been depleted of##2##3##(1997-7#1)(2008-4#1)
been deployed##4##2##(1997-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
been deposited in the##2##4##(1995-3#1)(2008-11#1)
been deposited##7##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#2)
been derived from the##4##4##(1994-11#1)(1997-2#1)(1997-4#1)(2009-7#1)
been derived from##12##3##(1992-12#1)(1993-2#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)(2012-4#1)
been derived##24##2##(1992-12#1)(1993-2#1)(1994-11#1)(1994-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-3#1)(2012-4#1)
been described and used for##2##5##(2008-10#1)(2011-2#1)
been described and##9##3##(2008-10#3)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
been described as a##4##4##(1992-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
been described as an##3##4##(2008-3#1)(2009-8#1)(2013-8#1)
been described as##21##3##(1990-11#1)(1990-5#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
been described by##7##3##(1994-2#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
been described earlier##3##3##(2007-7#1)(2008-11#1)(2008-7#1)
been described for a##2##4##(2007-10#1)(2008-10#1)
been described for the##16##4##(1990-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(2008-10#11)(2008-11#1)
been described for##30##3##(1990-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2013-1#3)
been described in other##5##4##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
been described in patients with##3##5##(1994-5#1)(2008-1#1)(2008-4#1)
been described in patients##4##4##(1994-5#1)(1997-5#1)(2008-1#1)(2008-4#1)
been described in relation to##2##5##(1993-9#1)(2007-7#1)
been described in the literature##8##5##(2007-5#1)(2008-10#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
been described in the##10##4##(2006-10#1)(2007-5#1)(2008-10#1)(2009-3#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
been described in##54##3##(1990-5#1)(1990-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-5#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
been described on##3##3##(1992-10#1)(1995-8#1)(2008-10#1)
been described previously##6##3##(1992-12#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-12#1)
been described so far##3##4##(1991-6#1)(2008-5#1)(2013-1#1)
been described that##4##3##(1994-5#1)(2008-12#1)(2010-6#1)(2013-1#1)
been described to be##2##4##(1993-6#1)(2010-5#1)
been described to##6##3##(1990-8#1)(1993-6#1)(2007-8#1)(2008-11#1)(2010-5#1)(2010-8#1)
been described with##3##3##(1992-5#1)(1997-3#1)(2011-2#1)
been described##237##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#3)(2007-10#3)(2007-12#3)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#51)(2008-11#11)(2008-12#4)(2008-3#6)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#2)
been designed and fabricated##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
been designed and synthesized##2##4##(2008-10#2)
been designed and##15##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)(2012-3#1)
been designed for the##2##4##(1992-3#1)(1995-3#1)
been designed for##6##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-3#2)(2008-7#1)
been designed so##2##3##(2008-5#1)(2010-8#1)
been designed to##13##3##(1992-2#1)(1993-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#2)
been designed##50##2##(1990-7#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
been detected and##2##3##(1990-11#1)(2008-2#1)
been detected at##3##3##(1997-2#1)(2008-7#1)(2010-5#1)
been detected in many##3##4##(2008-10#2)(2013-1#1)
been detected in the##4##4##(1995-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
been detected in##27##3##(1990-12#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
been detected with##2##3##(1997-7#1)(2008-3#1)
been detected##60##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#3)
been determined and##8##3##(1991-5#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#2)(2009-9#1)(2010-10#1)
been determined as a function of the##2##7##(1991-11#1)(1994-12#1)
been determined as##3##3##(1991-11#1)(1994-12#1)(2008-5#1)
been determined at 2##3##4##(1993-8#1)(1994-12#1)(1995-3#1)
been determined at##13##3##(1993-8#1)(1994-12#1)(1995-3#1)(2008-10#8)(2008-3#2)
been determined based on##2##4##(2008-10#1)(2009-7#1)
been determined by X-ray crystallography##3##5##(1992-8#1)(1997-7#1)(2008-10#1)
been determined by X-ray##4##4##(1992-8#1)(1996-2#1)(1997-7#1)(2008-10#1)
been determined by means of##3##5##(2008-10#2)(2008-3#1)
been determined by the##4##4##(1990-11#1)(1997-4#1)(2008-10#1)(2008-5#1)
been determined by##35##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-5#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
been determined for the##4##4##(1990-5#1)(1993-3#1)(2008-3#2)
been determined for##7##3##(1990-5#1)(1993-3#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-3#2)
been determined from##2##3##(2008-10#1)(2008-3#1)
been determined in the##3##4##(2008-10#2)(2008-3#1)
been determined in##18##3##(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-10#9)(2008-3#1)
been determined simultaneously with##2##4##(2008-10#2)
been determined simultaneously##3##3##(2008-10#3)
been determined to be##2##4##(2008-2#1)(2008-9#1)
been determined to##4##3##(1994-8#1)(2007-8#1)(2008-2#1)(2008-9#1)
been determined under##2##3##(1992-11#1)(2008-5#1)
been determined using##9##3##(1990-8#1)(1991-8#1)(1992-7#1)(1994-5#2)(1995-3#1)(2008-10#3)
been determined##174##2##(1990-11#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#5)(1994-5#4)(1994-8#2)(1994-9#1)(1995-3#3)(1995-5#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#65)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#11)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
been developed and applied to the##2##6##(1994-12#1)(2008-2#1)
been developed and applied##5##4##(1994-12#1)(2008-10#3)(2008-2#1)
been developed and clinically##2##4##(2010-12#1)(2010-8#1)
been developed and implemented##2##4##(2008-3#1)(2013-1#1)
been developed and tested##4##4##(1996-1#1)(2008-10#2)(2009-11#1)
been developed and used##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2010-8#1)
been developed and validated for the##5##6##(2008-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
been developed and validated for##6##5##(2008-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)
been developed and validated##9##4##(2008-10#3)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)
been developed and##49##3##(1991-2#1)(1992-1#1)(1993-11#1)(1994-12#1)(1994-3#1)(1996-1#2)(2007-12#2)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2013-1#1)
been developed as##6##3##(2008-10#2)(2008-3#2)(2008-5#1)(2012-12#1)
been developed based##9##3##(1992-3#1)(2007-11#2)(2008-10#5)(2008-4#1)
been developed by the##5##4##(1994-12#1)(1994-7#1)(1995-12#1)(2008-10#1)(2013-1#1)
been developed by##18##3##(1993-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(2007-11#1)(2008-10#11)(2013-1#1)
been developed during the last##2##5##(2008-10#1)(2008-8#1)
been developed for a##4##4##(1996-5#1)(2008-3#1)(2008-9#1)(2012-3#1)
been developed for analysis of##3##5##(2008-10#1)(2008-3#1)(2012-12#1)
been developed for analyzing##2##4##(2009-7#1)(2010-12#1)
been developed for determination of##7##5##(2008-10#6)(2008-2#1)
been developed for measuring##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
been developed for quantitative determination of##2##6##(2008-10#2)
been developed for quantitative##4##4##(2008-10#2)(2010-5#2)
been developed for the detection of##2##6##(2008-10#2)
been developed for the detection##3##5##(2008-10#3)
been developed for the determination of##43##6##(1991-5#1)(1996-5#1)(2008-10#39)(2008-3#1)(2011-1#1)
been developed for the determination##44##5##(1991-5#1)(1996-5#1)(2008-10#40)(2008-3#1)(2011-1#1)
been developed for the extraction of##2##6##(2008-10#2)
been developed for the simultaneous determination of##10##7##(1990-8#1)(2008-10#9)
been developed for the simultaneous##14##5##(1990-8#1)(2008-10#11)(2008-5#1)(2010-3#1)
been developed for the treatment of##3##6##(1992-8#1)(2008-10#1)(2010-6#1)
been developed for the##127##4##(1990-8#1)(1991-5#1)(1992-8#1)(1994-2#2)(1996-12#1)(1996-5#2)(2008-10#99)(2008-11#4)(2008-3#5)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-12#1)(2013-1#1)
been developed for use##3##4##(2008-2#1)(2008-9#1)(2011-1#1)
been developed for##218##3##(1990-6#1)(1990-8#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#2)(1995-11#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#3)(2007-12#3)(2008-10#141)(2008-11#5)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#2)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#1)
been developed from##4##3##(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#1)
been developed in the##2##4##(2008-10#1)(2008-3#1)
been developed in this##6##4##(2007-12#1)(2008-10#5)
been developed in##18##3##(1997-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-7#1)(2011-2#1)
been developed over the##3##4##(1996-12#1)(2008-4#1)(2012-2#1)
been developed over##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
been developed specifically for##2##4##(2008-3#1)(2008-4#1)
been developed that is##2##4##(1997-3#1)(2012-2#1)
been developed that##18##3##(1994-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#2)
been developed to allow##3##4##(1992-3#1)(2008-1#1)(2008-10#1)
been developed to assess##2##4##(2008-10#2)
been developed to be##2##4##(2008-11#1)(2008-12#1)
been developed to detect##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
been developed to increase the##2##5##(2007-8#1)(2008-10#1)
been developed to measure the##2##5##(1996-12#1)(2008-2#1)
been developed to measure##3##4##(1996-12#1)(2008-2#1)(2008-3#1)
been developed to overcome##3##4##(1994-6#1)(2008-1#1)(2008-3#1)
been developed to predict the##3##5##(1991-12#1)(2008-10#1)(2008-6#1)
been developed to provide a##3##5##(1996-2#1)(2008-10#1)(2008-3#1)
been developed to provide##4##4##(1996-2#1)(2008-10#1)(2008-3#2)
been developed to quantify##2##4##(2008-10#2)
been developed to simulate##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
been developed to tackle##2##4##(2011-2#1)(2013-1#1)
been developed to##96##3##(1990-7#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#3)
been developed using##14##3##(1996-2#1)(2007-8#2)(2008-10#11)
been developed which##8##3##(1993-3#1)(1995-2#1)(2008-10#4)(2009-10#1)(2009-12#1)
been developed with a##3##4##(2008-10#1)(2008-11#1)(2009-7#1)
been developed with##12##3##(1990-2#1)(1994-12#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-11#1)(2011-2#1)
been developed##733##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-3#1)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-11#8)(2007-12#14)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#371)(2008-11#18)(2008-12#3)(2008-2#24)(2008-3#56)(2008-4#11)(2008-5#10)(2008-6#7)(2008-7#11)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#4)(2009-5#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#4)(2011-1#7)(2011-2#15)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#1)
been devised##9##2##(1991-5#1)(1992-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-3#1)(2010-8#1)(2012-3#1)
been devoted to the##3##4##(1991-2#1)(2008-11#1)(2010-8#1)
been devoted to##9##3##(1991-2#1)(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)(2010-8#1)
been diagnosed as##3##3##(1991-9#1)(1995-3#1)(1996-11#1)
been diagnosed with the##3##4##(2009-10#1)(2013-1#2)
been diagnosed with##8##3##(2006-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#2)
been diagnosed##19##2##(1990-3#1)(1991-9#1)(1994-12#1)(1995-3#1)(1996-11#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
been difficult to determine##2##4##(2008-10#1)(2013-1#1)
been difficult to##11##3##(1992-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
been difficult##17##2##(1992-1#1)(1993-11#1)(1993-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-7#1)(2013-1#1)(2013-8#1)
been directed at##2##3##(2008-5#1)(2009-12#1)
been directed toward##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
been directed##11##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#2)
been directly measured##2##3##(1997-2#1)(2008-3#1)
been directly##4##2##(1994-3#1)(1997-2#1)(2008-11#1)(2008-3#1)
been disappointing##4##2##(1994-12#1)(2008-2#1)(2010-7#1)(2010-8#1)
been discovered in the##3##4##(1991-7#1)(2008-7#1)(2009-3#1)
been discovered in##10##3##(1990-11#2)(1991-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-7#1)(2012-1#1)
been discovered that##2##3##(2007-11#1)(2008-10#1)
been discovered to##2##3##(2008-5#1)(2013-7#1)
been discovered##20##2##(1990-11#2)(1990-7#1)(1991-7#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-7#1)(2012-1#1)(2013-7#1)
been discussed in detail##2##4##(2008-10#1)(2008-3#1)
been discussed in terms of the##2##6##(2008-10#1)(2008-11#1)
been discussed in the literature##3##5##(2008-3#1)(2008-7#1)(2011-2#1)
been discussed in the##6##4##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
been discussed in##12##3##(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-2#1)(2011-3#1)
been discussed##43##2##(1990-2#1)(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
been disrupted##2##2##(1994-12#1)(2010-5#1)
been disseminated##3##2##(2008-10#2)(2012-3#1)
been distributed##3##2##(1990-2#2)(1997-3#1)
been divided into##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
been documented for##3##3##(1996-5#1)(2008-6#1)(2010-11#1)
been documented in##7##3##(1997-1#1)(2007-12#1)(2008-12#1)(2008-8#1)(2012-2#3)
been documented to##3##3##(2008-10#1)(2013-7#1)(2013-8#1)
been documented##30##2##(1994-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
been done and##4##3##(2008-12#1)(2008-7#1)(2009-12#1)(2012-2#1)
been done by##2##3##(2008-10#2)
been done in##8##3##(1991-3#1)(1997-7#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#3)
been done on##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
been done with##6##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-8#1)
been done##36##2##(1990-12#1)(1991-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
been due to the##3##4##(2008-10#1)(2009-5#1)(2011-2#1)
been due to##4##3##(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)
been effective##2##2##(2010-5#1)(2013-8#1)
been elaborated##6##2##(1992-11#1)(2006-10#1)(2008-10#3)(2010-3#1)
been eliminated with##2##3##(2008-10#1)(2008-2#1)
been eliminated##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)
been elucidated as##2##3##(1997-4#1)(2008-1#1)
been elucidated##21##2##(1990-11#1)(1991-6#1)(1993-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
been elusive##2##2##(1994-6#1)(2007-12#1)
been embedded in##3##3##(2008-10#2)(2008-6#1)
been employed as##3##3##(2007-11#1)(2008-10#2)
been employed for the##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
been employed for##10##3##(1990-12#1)(1992-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
been employed in the##4##4##(1991-12#1)(1997-3#1)(2008-4#1)(2013-1#1)
been employed in##10##3##(1991-12#1)(1993-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
been employed to obtain##2##4##(1996-12#1)(2008-9#1)
been employed to##15##3##(1991-3#1)(1991-9#1)(1993-8#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-9#1)(2010-8#1)(2012-3#1)
been employed##47##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
been encapsulated##2##2##(1993-8#1)(1996-5#1)
been encountered in##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
been encountered##4##2##(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
been endorsed by the##2##4##(1992-2#1)(2013-1#1)
been endorsed by##3##3##(1992-2#1)(2008-1#1)(2013-1#1)
been endorsed##5##2##(1992-2#1)(1997-7#1)(2008-1#1)(2013-1#1)(2013-8#1)
been engaged##2##2##(2008-9#1)(2010-4#1)
been engineered##6##2##(1997-3#1)(2007-12#1)(2008-4#1)(2009-2#1)(2010-5#1)(2013-8#1)
been enhanced##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
been enough##2##2##(1997-1#1)(2008-10#1)
been enrolled##2##2##(2008-11#1)(2010-3#1)
been established and the##2##4##(2011-3#1)(2012-2#1)
been established and##10##3##(1993-8#1)(2008-10#2)(2010-12#3)(2010-3#1)(2010-6#1)(2011-3#1)(2012-2#1)
been established as##6##3##(1993-9#1)(1994-8#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
been established by##5##3##(1996-2#1)(2008-10#2)(2008-11#1)(2011-3#1)
been established for the##5##4##(1990-11#1)(1990-5#1)(1996-12#1)(2007-12#1)(2008-10#1)
been established for##9##3##(1990-11#1)(1990-5#1)(1993-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-3#1)
been established in##7##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2012-3#1)
been established on the basis of##2##6##(2007-11#1)(2012-2#1)
been established that##15##3##(1990-5#1)(1990-8#1)(1993-6#1)(1996-5#1)(1996-6#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#3)
been established to help##2##4##(2009-11#2)
been established to##6##3##(1997-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#2)
been established with##2##3##(1991-2#1)(2008-8#1)
been established##112##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-4#2)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#6)(2011-3#3)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#1)
been estimated##21##2##(1991-2#1)(1992-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-11#1)(2011-2#2)
been evaluated and the##2##4##(2008-10#1)(2008-2#1)
been evaluated and##6##3##(2008-10#5)(2008-2#1)
been evaluated as##3##3##(2008-10#1)(2009-5#1)(2012-3#1)
been evaluated by##11##3##(1994-3#1)(2007-11#1)(2008-10#6)(2008-12#1)(2009-7#1)(2013-1#1)
been evaluated for##15##3##(1994-2#1)(1994-6#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)
been evaluated in a##4##4##(2008-11#1)(2008-5#1)(2010-1#1)(2012-12#1)
been evaluated in human##2##4##(1997-4#1)(2008-11#1)
been evaluated in terms of##2##5##(2008-10#2)
been evaluated in##20##3##(1990-12#1)(1993-2#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2009-1#1)(2009-7#1)(2010-1#1)(2012-12#3)(2013-1#1)
been evaluated on##2##3##(2008-10#1)(2009-7#1)
been evaluated using##5##3##(1990-11#1)(1990-12#1)(2008-10#2)(2008-9#1)
been evaluated##99##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-3#2)(1996-8#1)(1997-4#1)(2007-11#2)(2008-10#44)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
been evidenced in the##3##4##(1994-3#1)(1996-1#1)(2012-5#1)
been evidenced in##4##3##(1994-3#1)(1996-1#1)(2012-3#1)(2012-5#1)
been evidenced##5##2##(1994-3#1)(1996-1#1)(2008-7#1)(2012-3#1)(2012-5#1)
been evident in##2##3##(2012-3#1)(2013-1#1)
been examined and##5##3##(2008-10#4)(2008-5#1)
been examined as a##3##4##(1997-7#1)(2008-10#2)
been examined as##4##3##(1997-7#1)(2008-10#3)
been examined by##6##3##(1990-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
been examined for##5##3##(1990-2#1)(1993-11#1)(1997-7#1)(2008-3#1)(2008-5#1)
been examined in detail##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
been examined in the##2##4##(1995-5#1)(2008-10#1)
been examined in##11##3##(1990-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-5#2)(2008-10#2)(2008-8#1)(2010-1#1)
been examined using a##2##4##(1993-11#1)(1997-6#1)
been examined using##4##3##(1993-11#1)(1997-6#1)(2008-10#1)(2010-12#1)
been examined with##2##3##(2008-10#1)(2009-8#1)
been examined##70##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#3)(1993-2#2)(1993-3#1)(1994-12#1)(1995-11#1)(1995-3#2)(1995-5#3)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(2007-12#1)(2008-10#22)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
been excluded##3##2##(1993-9#1)(1995-3#1)(2011-1#1)
been expanded##4##2##(1990-6#1)(1991-11#1)(1995-2#1)(2010-6#1)
been experienced##2##2##(1993-11#1)(1996-9#1)
been experimentally studied##2##3##(1992-5#1)(2007-12#1)
been experimentally##9##2##(1992-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2009-5#1)
been explained by##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
been explained##10##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
been exploited for##5##3##(1995-5#1)(2008-10#2)(2009-12#1)(2009-3#1)
been exploited to##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
been exploited##14##2##(1990-8#1)(1995-5#1)(1996-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-1#1)
been explored for##4##3##(2008-10#3)(2009-12#1)
been explored in detail##2##4##(2008-3#1)(2012-2#1)
been explored in##4##3##(2007-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
been explored##21##2##(1990-8#1)(1992-9#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#2)
been exposed to##11##3##(1990-8#1)(1991-4#1)(1993-6#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
been exposed##15##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1993-6#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
been expressed for##2##3##(2008-10#1)(2012-2#1)
been expressed in Escherichia coli##3##5##(1991-3#1)(1995-2#1)(1995-6#1)
been expressed in##9##3##(1990-12#1)(1991-3#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-3#1)(2008-8#1)
been expressed##14##2##(1990-12#1)(1991-3#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
been extended for##3##3##(2008-10#1)(2008-3#2)
been extended to##11##3##(1992-3#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2012-2#1)
been extended##17##2##(1992-3#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
been extensive##3##2##(1994-1#1)(1994-9#1)(2008-10#1)
been extensively explored##2##3##(2008-10#1)(2012-2#1)
been extensively investigated##7##3##(1997-7#1)(2007-12#1)(2008-1#1)(2009-11#2)(2010-12#1)(2013-8#1)
been extensively studied##15##3##(1991-2#1)(1996-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
been extensively used for##2##4##(2008-8#1)(2012-2#1)
been extensively used in##2##4##(1992-11#1)(2008-10#1)
been extensively used##7##3##(1992-11#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-2#1)
been extensively##37##2##(1991-2#1)(1992-11#1)(1994-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
been extracted##5##2##(1993-9#1)(2008-10#3)(2008-3#1)
been extremely##5##2##(1994-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#1)
been fabricated and##2##3##(2007-12#1)(2008-2#1)
been fabricated by##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
been fabricated for##2##3##(2007-12#1)(2008-3#1)
been fabricated##19##2##(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#7)(2008-7#2)
been fed##3##2##(1990-11#1)(1997-5#1)(2011-2#1)
been firmly established##3##3##(1995-8#1)(2008-11#1)(2009-10#1)
been fitted##2##2##(2008-3#1)(2011-3#1)
been focused on the##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
been focused on##11##3##(1992-2#1)(1993-1#1)(1994-2#1)(1996-1#1)(2006-10#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-8#1)
been focused##16##2##(1992-2#1)(1993-1#1)(1994-2#1)(1996-1#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#2)(2013-8#1)
been followed up##5##3##(1995-4#1)(1997-8#1)(2008-10#1)(2008-6#1)(2009-3#1)
been followed##9##2##(1995-4#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)
been for##2##2##(2008-10#1)(2008-9#1)
been formally tested##2##3##(2008-10#1)(2010-4#1)
been formally##6##2##(2006-10#1)(2008-10#2)(2010-4#1)(2012-1#1)(2012-12#1)
been formed and##2##3##(2008-3#1)(2012-2#1)
been formed##5##2##(1996-1#1)(2008-10#2)(2008-3#1)(2012-2#1)
been formulated in##2##3##(2008-3#1)(2012-1#1)
been formulated##6##2##(1992-1#1)(2007-7#1)(2008-3#1)(2008-5#2)(2012-1#1)
been found at##2##3##(1992-5#1)(2008-6#1)
been found between the##2##4##(1990-6#1)(2008-2#1)
been found between##4##3##(1990-6#1)(2008-2#1)(2008-3#1)(2008-7#1)
been found by##6##3##(1996-4#1)(2008-10#2)(2008-3#2)(2012-3#1)
been found in a##4##4##(1993-9#1)(1994-8#1)(1996-2#1)(2007-11#1)
been found in association with##2##5##(2008-7#1)(2013-1#1)
been found in other##3##4##(1991-5#1)(2008-5#1)(2008-6#1)
been found in some##2##4##(1997-7#1)(2007-12#1)
been found in the##9##4##(1990-5#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)
been found in##48##3##(1990-5#2)(1991-5#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2009-5#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
been found previously##2##3##(1994-8#1)(2008-10#1)
been found that the##9##4##(1990-8#1)(2007-12#1)(2008-10#5)(2008-5#1)(2013-8#1)
been found that##22##3##(1990-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-3#2)(2008-5#3)(2008-9#1)(2009-11#1)(2010-4#1)(2013-8#1)
been found to be associated##2##5##(1994-11#1)(2012-2#1)
been found to be effective##2##5##(2008-11#1)(2009-5#1)
been found to be equally##2##5##(2007-7#1)(2010-7#1)
been found to be in the##2##6##(2008-10#2)
been found to be more##2##5##(1992-5#1)(2008-5#1)
been found to be##60##4##(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
been found to cause##2##4##(2009-12#1)(2012-3#1)
been found to exhibit##3##4##(2008-10#2)(2009-5#1)
been found to follow the##2##5##(1994-12#1)(1997-2#1)
been found to follow##3##4##(1994-12#1)(1997-2#1)(2007-12#1)
been found to influence##2##4##(1992-10#1)(2009-9#1)
been found to reduce##2##4##(1990-7#1)(2008-2#1)
been found to show##2##4##(1996-4#1)(2008-3#1)
been found to##104##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
been found useful##2##3##(2008-2#2)
been found##233##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-5#2)(1992-8#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#3)(2006-10#1)(2007-11#6)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#53)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#13)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#7)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#2)
been founded##2##2##(2007-8#1)(2008-6#1)
been frequently##7##2##(1994-12#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-7#1)
been fully characterized##4##3##(1997-7#1)(2007-11#1)(2008-2#1)(2012-3#1)
been fully elucidated##6##3##(1990-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
been fully evaluated##2##3##(1994-2#1)(2008-1#1)
been fully##34##2##(1990-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
been functionally##2##2##(1992-9#1)(1994-12#1)
been further developed##2##3##(2008-2#1)(2011-1#1)
been further##11##2##(1990-3#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#3)
been gained##5##2##(2008-10#3)(2009-5#1)(2013-1#1)
been gaining##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
been gathered from##2##3##(2008-8#1)(2009-4#1)
been gathered##4##2##(2008-2#1)(2008-8#1)(2009-12#1)(2009-4#1)
been generally##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
been generated at##2##3##(2007-12#2)
been generated by the##2##4##(1993-6#1)(2009-10#1)
been generated by##7##3##(1993-6#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
been generated from a##4##4##(2007-11#3)(2007-12#1)
been generated from##5##3##(2007-11#3)(2007-12#1)(2008-12#1)
been generated in##3##3##(1994-11#1)(2008-3#1)(2013-7#1)
been generated##29##2##(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-9#1)(1996-5#1)(2007-11#5)(2007-12#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2009-10#1)(2010-10#1)(2012-2#1)(2013-7#1)
been genetically modified to##2##4##(2007-12#1)(2008-10#1)
been genetically modified##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
been genetically##9##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-5#1)
been given and##2##3##(2008-10#1)(2011-1#1)
been given to##16##3##(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)
been given##27##2##(1990-7#1)(1991-9#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)
been good##2##2##(1992-11#1)(2008-11#1)
been gradually##3##2##(1997-2#1)(2010-8#1)(2011-2#1)
been granted##3##2##(1995-5#2)(1996-2#1)
been greatly enhanced by##2##4##(2008-1#1)(2010-3#1)
been greatly enhanced##3##3##(1997-6#1)(2008-1#1)(2010-3#1)
been greatly facilitated##2##3##(2008-4#1)(2013-1#1)
been greatly##9##2##(1994-11#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
been grown by##2##3##(1995-3#1)(2013-1#1)
been grown##7##2##(1992-11#1)(1992-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
been hampered by the lack of##3##6##(2008-10#1)(2008-4#1)(2008-5#1)
been hampered by the##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
been hampered by##8##3##(1994-6#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#1)
been hampered##9##2##(1994-6#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#1)
been hard to##2##3##(1995-5#1)(1997-4#1)
been held responsible##2##3##(1995-6#1)(2008-7#1)
been held##4##2##(1990-2#1)(1995-6#1)(2008-4#1)(2008-7#1)
been helpful in##2##3##(1995-6#1)(2008-11#1)
been higher##3##2##(1990-11#1)(1994-3#1)(2010-4#1)
been highlighted in##3##3##(2013-1#3)
been highlighted##6##2##(1992-12#1)(2008-11#1)(2013-1#4)
been highly conserved in##2##4##(1995-2#1)(1997-9#1)
been highly conserved##4##3##(1992-12#1)(1993-6#1)(1995-2#1)(1997-9#1)
been highly##5##2##(1992-12#1)(1993-6#1)(1995-2#1)(1997-9#1)(2007-9#1)
been hindered by the##3##4##(1997-7#1)(2008-11#1)(2010-5#1)
been hindered by##5##3##(1996-9#1)(1997-7#1)(2008-11#1)(2008-6#1)(2010-5#1)
been hindered##7##2##(1996-3#1)(1996-9#1)(1997-7#1)(2008-11#2)(2008-6#1)(2010-5#1)
been hitherto##2##2##(1995-6#1)(2008-5#1)
been hypothesized to##10##3##(1993-12#1)(1997-2#1)(2008-10#3)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
been hypothesized##18##2##(1993-12#1)(1994-11#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-8#3)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)
been identified among##2##3##(2008-10#1)(2012-2#1)
been identified and characterized##5##4##(1995-12#1)(1996-12#1)(2008-5#1)(2008-7#2)
been identified and##19##3##(1990-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#5)(2010-11#1)
been identified as a key##4##5##(1994-12#1)(2008-4#1)(2009-11#1)(2012-12#1)
been identified as a potentially important##2##6##(1993-8#1)(2008-2#1)
been identified as a##34##4##(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#10)
been identified as an##7##4##(1991-3#1)(1991-9#1)(1994-12#1)(1997-4#1)(2008-2#1)(2010-5#1)(2012-2#1)
been identified as important##3##4##(1996-3#1)(2008-7#1)(2012-2#1)
been identified as key##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
been identified as the##8##4##(1992-8#1)(1994-12#2)(1996-2#1)(1997-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
been identified as##74##3##(1991-3#1)(1991-9#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#2)(2010-5#2)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#11)
been identified at##2##3##(2008-7#1)(2008-9#1)
been identified by the##3##4##(1996-2#1)(1996-9#1)(1997-8#1)
been identified by##18##3##(1992-5#1)(1992-6#1)(1993-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-6#1)(2012-5#1)(2013-1#1)
been identified for##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
been identified from##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2010-7#1)
been identified in a##6##4##(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
been identified in the##8##4##(1990-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)
been identified in##39##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-6#1)(1997-4#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-5#2)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)
been identified on##4##3##(1993-11#1)(1997-3#1)(2008-4#1)(2009-3#1)
been identified that##9##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-6#1)
been identified to##8##3##(1991-12#1)(1992-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)
been identified using##2##3##(1993-12#1)(2008-10#1)
been identified with##2##3##(1992-3#1)(2008-7#1)
been identified##276##2##(1990-11#2)(1990-12#2)(1990-6#1)(1990-8#2)(1991-1#2)(1991-12#5)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#4)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#14)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#8)(2008-5#5)(2008-6#5)(2008-7#21)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#4)(2010-7#2)(2011-1#4)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#11)
been ignored##3##2##(1996-12#1)(2010-7#1)(2012-2#1)
been illustrated##2##2##(1990-5#1)(1994-12#1)
been imaged##2##2##(2008-5#1)(2010-1#1)
been immobilized##4##2##(2008-10#4)
been implanted in##2##3##(2008-9#1)(2010-8#1)
been implanted##6##2##(2008-7#2)(2008-9#1)(2010-8#2)(2012-12#1)
been implemented and##4##3##(2007-12#1)(2008-2#1)(2009-8#1)(2010-4#1)
been implemented for##2##3##(2008-3#1)(2008-7#1)
been implemented in the##4##4##(1994-1#1)(2008-2#1)(2008-3#1)(2010-5#1)
been implemented in##11##3##(1994-1#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
been implemented to##2##3##(2008-11#1)(2008-3#1)
been implemented##33##2##(1993-3#1)(1994-1#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#7)(2008-7#3)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
been implicated as a cause of##2##6##(2011-2#2)
been implicated as a##9##4##(1991-8#1)(1994-8#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
been implicated as##13##3##(1991-8#1)(1994-8#2)(1995-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
been implicated in a number of##3##6##(2009-5#1)(2009-6#1)(2012-12#1)
been implicated in a variety of##5##6##(1990-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-4#1)
been implicated in a##10##4##(1990-11#1)(1992-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-4#1)(2009-5#1)(2009-6#1)(2012-12#1)
been implicated in growth of##2##5##(2011-2#2)
been implicated in several##5##4##(2006-10#1)(2008-8#1)(2009-12#1)(2012-2#2)
been implicated in the development##2##5##(2008-1#1)(2012-3#1)
been implicated in the etiology of##2##6##(2008-9#1)(2011-2#1)
been implicated in the pathogenesis of##10##6##(1992-12#1)(1993-12#1)(1996-12#1)(1996-7#2)(2008-1#1)(2008-7#1)(2012-2#1)(2013-8#2)
been implicated in the regulation of##3##6##(1992-9#1)(2008-9#1)(2012-2#1)
been implicated in the##44##4##(1991-11#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-7#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
been implicated in various##3##4##(2008-4#1)(2012-2#1)(2013-7#1)
been implicated in##104##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#2)(2006-10#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
been implicated##123##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-2#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#2)(2006-10#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
been important in##2##3##(1996-6#1)(2013-8#1)
been important##4##2##(1992-8#1)(1996-6#1)(2007-12#1)(2013-8#1)
been imposed##3##2##(2007-6#1)(2008-10#1)(2008-3#1)
been improved##20##2##(1992-6#1)(1997-3#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-8#1)(2012-2#1)
been in a##2##3##(2008-1#1)(2009-8#1)
been in the##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
been in##27##2##(1991-2#1)(1992-1#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-3#1)(2012-3#1)
been included in the##5##4##(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
been included in this##2##4##(2008-10#1)(2012-12#1)
been included in##9##3##(1991-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
been included##17##2##(1991-8#1)(1993-11#1)(1995-12#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
been inconclusive##3##2##(2006-5#1)(2009-5#1)(2011-1#1)
been inconsistent##6##2##(1996-11#1)(2008-10#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-8#1)
been incorporated into##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
been incorporated##8##2##(1992-11#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
been increased by##2##3##(2008-11#1)(2010-12#1)
been increased##12##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
been increasing in##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
been increasing##20##2##(1991-2#1)(1991-3#1)(1993-12#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#4)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
been increasingly used for##2##4##(2011-2#1)(2012-2#1)
been increasingly used##4##3##(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
been increasingly##14##2##(1992-1#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
been incriminated in the##2##4##(2011-2#1)(2012-2#1)
been incriminated in##4##3##(2007-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
been incriminated##5##2##(2007-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
been indicated##2##2##(1997-6#1)(2012-2#1)
been induced by##2##3##(1994-8#1)(2008-11#1)
been induced##6##2##(1993-6#1)(1994-8#1)(1995-12#1)(2008-11#2)(2008-8#1)
been infected with HIV##2##4##(1996-11#1)(1997-6#1)
been infected with##3##3##(1996-11#1)(1997-4#1)(1997-6#1)
been infected##8##2##(1990-2#1)(1993-8#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-4#1)(1997-6#1)(2008-1#1)
been initially##3##2##(1996-12#1)(2008-6#1)(2008-7#1)
been initiated in the##2##4##(1992-11#1)(2008-5#1)
been initiated##13##2##(1992-11#1)(1996-1#1)(1997-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
been injected##4##2##(1995-12#1)(2007-11#1)(2013-8#2)
been instituted##2##2##(1991-12#1)(1996-5#1)
been instrumental in##6##3##(1995-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
been integrated in##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
been integrated into##5##3##(1996-12#1)(2008-11#1)(2008-3#1)(2011-1#2)
been integrated##12##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
been intensively##6##2##(2007-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
been interpreted##6##2##(2006-12#1)(2008-10#2)(2009-6#2)(2012-3#1)
been introduced as a##4##4##(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
been introduced as##7##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
been introduced at##2##3##(1990-8#1)(2008-10#1)
been introduced for the##2##4##(2008-10#1)(2008-11#1)
been introduced for##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
been introduced in##3##3##(1997-8#1)(2008-1#1)(2008-11#1)
been introduced into the##2##4##(1990-8#1)(2008-4#1)
been introduced into##8##3##(1990-12#1)(1990-8#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
been introduced to##11##3##(1997-8#1)(2008-10#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-7#1)
been introduced##51##2##(1990-12#1)(1990-8#2)(1992-9#1)(1994-2#1)(1997-5#1)(1997-6#2)(1997-8#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
been invented##2##2##(2008-10#1)(2008-6#1)
been investigated and found##2##4##(2008-10#2)
been investigated and the##2##4##(2008-10#2)
been investigated and##15##3##(1990-11#1)(1995-11#1)(2008-10#8)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
been investigated as a function of##3##6##(1995-5#1)(1997-7#1)(2008-10#1)
been investigated as a##5##4##(1995-5#1)(1997-7#1)(2008-10#1)(2009-5#1)(2010-1#1)
been investigated as##15##3##(1993-11#1)(1995-5#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2012-2#1)
been investigated at##4##3##(1990-5#1)(2008-10#3)
been investigated by a##2##4##(2008-8#1)(2008-9#1)
been investigated by means of##6##5##(1990-12#1)(2008-10#3)(2008-5#1)(2011-2#1)
been investigated by measuring the##3##5##(1994-3#1)(2008-10#2)
been investigated by using##3##4##(1991-9#1)(2008-10#2)
been investigated by##36##3##(1990-12#1)(1990-5#1)(1991-9#1)(1993-8#1)(1994-3#3)(1994-5#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)
been investigated for a##2##4##(2008-5#1)(2010-12#1)
been investigated for the##5##4##(2008-10#3)(2008-2#1)(2008-7#1)
been investigated for their##2##4##(2008-7#1)(2011-1#1)
been investigated for##15##3##(1997-7#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#2)
been investigated in animal##2##4##(2008-1#1)(2008-3#1)
been investigated in detail##8##4##(1994-5#1)(2008-10#7)
been investigated in the present work##2##6##(2008-11#1)(2009-10#1)
been investigated in the##8##4##(1991-6#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)
been investigated in this##2##4##(2008-12#1)(2011-2#1)
been investigated in##43##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-4#1)
been investigated on##3##3##(1997-4#1)(1997-7#1)(2013-1#1)
been investigated over the##3##4##(2008-10#2)(2008-3#1)
been investigated over##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
been investigated previously##2##3##(2008-10#2)
been investigated so far##3##4##(1995-11#1)(2007-10#1)(2008-6#1)
been investigated through##4##3##(2008-10#1)(2009-6#1)(2011-2#1)(2013-8#1)
been investigated using the##2##4##(1997-4#1)(2008-10#1)
been investigated using##9##3##(1990-5#1)(1993-6#1)(1996-2#1)(1997-4#1)(2008-10#4)(2009-8#1)
been investigated with the##2##4##(1996-5#1)(2008-10#1)
been investigated with##6##3##(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)
been investigated##292##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-12#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-4#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#4)(1995-2#1)(1995-5#2)(1996-2#3)(1996-5#1)(1997-2#1)(1997-4#3)(1997-7#6)(2007-10#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#127)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#16)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#1)
been involved in the##7##4##(1990-5#1)(1996-6#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#2)
been involved in##9##3##(1990-5#1)(1995-12#1)(1996-6#1)(2008-10#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#2)
been involved##11##2##(1990-5#1)(1995-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#2)
been irradiated##2##2##(1997-3#1)(1997-4#1)
been isolated and characterized##8##4##(1991-5#2)(1991-6#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-6#1)(2008-11#1)
been isolated and sequenced##3##4##(1991-6#1)(1992-4#1)(1993-2#1)
been isolated and##16##3##(1990-12#1)(1991-5#2)(1991-6#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
been isolated by##3##3##(1993-2#1)(2008-11#1)(2010-5#1)
been isolated from a lambda##3##5##(1991-12#1)(1991-6#1)(1993-2#1)
been isolated from a##8##4##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-10#1)(1993-2#1)(1995-3#1)(2011-2#1)
been isolated from human##3##4##(1990-7#1)(2011-2#1)(2012-12#1)
been isolated from the##7##4##(1990-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(2008-11#2)
been isolated from##43##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#2)(1996-10#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2009-2#1)(2011-1#1)(2011-2#4)(2012-12#1)
been isolated##76##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-6#1)(1995-2#2)(1995-3#1)(1995-6#3)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#2)(2007-11#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-5#2)(2008-8#2)(2009-2#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#1)
been issued##2##2##(2008-9#1)(2010-7#1)
been kept##4##2##(1996-12#1)(2007-5#2)(2008-10#1)
been known for a long time##2##6##(2007-12#1)(2008-4#1)
been known for##11##3##(1991-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
been known that##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
been known to##11##3##(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)
been known##35##2##(1991-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)
been lacking##2##2##(1992-11#1)(2010-11#1)
been largely ignored##4##3##(1997-8#1)(2008-7#1)(2008-8#1)(2009-9#1)
been largely overlooked##3##3##(2008-3#1)(2008-8#1)(2010-3#1)
been largely##19##2##(1990-9#1)(1992-11#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2013-7#1)
been launched##2##2##(2008-5#1)(2013-1#1)
been learned##12##2##(1993-11#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-3#1)
been learnt##2##2##(1992-11#1)(2008-12#1)
been left##3##2##(1995-3#1)(2008-7#1)(2011-2#1)
been limited by its##2##4##(2011-2#1)(2012-3#1)
been limited by##11##3##(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
been limited to the##2##4##(2008-7#1)(2011-7#1)
been limited to##15##3##(1994-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#3)(2011-1#1)(2011-7#1)(2013-1#1)
been limited##41##2##(1992-2#1)(1994-6#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been linked to the##2##4##(2008-4#1)(2008-7#1)
been linked to##21##3##(1994-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
been linked with##11##3##(1990-8#1)(2007-12#1)(2008-5#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
been linked##33##2##(1990-8#1)(1994-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
been little studied##2##3##(1997-1#1)(2008-7#1)
been little##15##2##(1991-4#1)(1992-1#1)(1992-12#1)(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-3#1)(2012-1#2)(2012-2#1)
been localized to the##2##4##(1995-11#1)(1995-2#1)
been localized to##5##3##(1995-11#1)(1995-2#1)(2007-7#2)(2008-4#1)
been localized##6##2##(1990-8#1)(1995-11#1)(1995-2#1)(2007-7#2)(2008-4#1)
been located on##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
been located##5##2##(1993-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
been lost##6##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#2)(2013-1#1)
been lower##2##2##(2008-2#1)(2010-12#1)
been made and##3##3##(1997-4#1)(2008-10#2)
been made between##2##3##(1995-11#1)(2009-12#1)
been made by##10##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-4#1)(2010-8#1)(2011-1#1)
been made for##3##3##(1996-3#1)(2008-10#2)
been made in identifying the##2##5##(2008-11#2)
been made in the development##2##5##(2008-7#1)(2008-8#1)
been made in the past##2##5##(2007-12#1)(2010-7#1)
been made in the treatment##2##5##(2007-6#1)(2013-1#1)
been made in the understanding of the##2##7##(2008-11#1)(2008-3#1)
been made in the understanding of##4##6##(2008-11#2)(2008-3#1)(2008-7#1)
been made in the##19##4##(1990-9#1)(1991-12#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-11#3)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
been made in this##2##4##(2008-11#1)(2011-2#1)
been made in understanding the##3##5##(2008-11#1)(2008-5#1)(2011-1#1)
been made in understanding##4##4##(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
been made in##46##3##(1990-9#1)(1991-12#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#10)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
been made on the basis of the##2##7##(1992-12#1)(2008-10#1)
been made on##5##3##(1992-12#1)(2007-8#1)(2008-10#2)(2008-11#1)
been made to determine the##2##5##(2007-2#1)(2008-10#1)
been made to determine##3##4##(2007-2#1)(2008-10#1)(2012-2#1)
been made to develop##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
been made to##29##3##(1991-1#1)(1991-2#1)(1995-2#2)(1997-2#1)(2007-11#2)(2007-2#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
been made toward##6##3##(1990-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-9#1)
been made towards##2##3##(2008-8#1)(2012-2#1)
been made with##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)
been made##159##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#14)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
been mainly##5##2##(1990-2#1)(2008-10#2)(2010-5#1)(2013-1#1)
been maintained##8##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2012-3#1)(2013-1#1)
been managed##4##2##(1996-3#1)(1997-2#1)(2008-11#1)(2008-9#1)
been manufactured##2##2##(2007-12#2)
been many##4##2##(2007-11#1)(2008-3#1)(2009-2#1)(2009-5#1)
been mapped to the##2##4##(1991-6#1)(2008-8#1)
been mapped to##4##3##(1991-6#1)(1994-12#1)(2008-8#1)(2012-3#1)
been mapped##15##2##(1990-12#1)(1990-7#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#3)(2012-3#1)
been markedly##3##2##(1991-3#1)(1992-1#1)(2009-5#1)
been marketed##3##2##(2007-2#1)(2008-5#1)(2010-8#1)
been mathematically##2##2##(2008-11#1)(2008-3#1)
been measured and##2##3##(2007-12#1)(2008-2#1)
been measured as a function of##2##6##(1997-7#1)(2007-12#1)
been measured at##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
been measured by##4##3##(1996-2#2)(2008-10#1)(2008-2#1)
been measured directly##2##3##(2008-11#1)(2008-2#1)
been measured for the##2##4##(2007-12#1)(2008-2#1)
been measured for##4##3##(1997-8#1)(2007-12#1)(2008-2#1)(2008-8#1)
been measured from##3##3##(1997-2#1)(2007-12#1)(2008-2#1)
been measured in the range##2##5##(2008-10#2)
been measured in the##7##4##(2008-10#2)(2008-3#3)(2008-7#1)(2010-11#1)
been measured in##17##3##(1994-2#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2010-11#2)(2010-4#1)(2013-1#1)
been measured through##2##3##(2008-6#1)(2011-2#1)
been measured using##2##3##(1995-2#1)(2010-6#1)
been measured with a##3##4##(2007-12#1)(2008-3#2)
been measured with##5##3##(2007-12#1)(2008-10#1)(2008-3#3)
been measured##77##2##(1990-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#12)(2008-10#11)(2008-11#2)(2008-2#10)(2008-3#17)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
been mentioned##2##2##(2008-11#1)(2012-12#1)
been met##3##2##(1995-2#1)(1996-1#1)(2008-8#1)
been mixed##2##2##(1991-12#1)(2008-10#1)
been modeled##2##2##(2008-3#1)(2013-7#1)
been models##2##2##(2008-9#1)(2013-1#1)
been modified##18##2##(1992-3#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2010-8#1)(2011-3#1)
been monitored##7##2##(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)
been more effectively##2##3##(2006-10#1)(2008-11#1)
been more than##3##3##(1990-6#1)(1994-12#1)(2010-10#1)
been more##16##2##(1990-11#1)(1990-6#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#1)
been most##5##2##(1995-2#1)(2008-1#1)(2008-10#2)(2008-8#1)
been moved to##3##3##(1997-4#1)(2008-10#1)(2009-4#1)
been much##11##2##(1990-9#1)(1992-4#1)(2008-1#1)(2008-3#1)(2008-7#3)(2008-9#2)(2012-12#2)
been mutated##3##2##(1994-12#1)(2008-11#1)(2009-12#1)
been named##6##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
been neglected in##2##3##(1996-12#1)(2008-8#1)
been neglected##5##2##(1995-9#1)(1996-12#1)(2008-12#1)(2008-8#2)
been no reported cases##2##4##(2007-12#1)(2011-2#1)
been no significant##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
been no systematic##2##3##(2012-2#1)(2013-1#1)
been no##45##2##(1990-11#1)(1990-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
been noted in the##2##4##(2008-10#1)(2009-11#1)
been noted in##8##3##(1991-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2010-8#1)
been noted##21##2##(1991-2#2)(1991-4#1)(1992-1#1)(1992-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
been noticed##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-7#1)
been notified to the##3##4##(1992-11#2)(2008-11#1)
been notified##5##2##(1992-11#3)(1996-5#1)(2008-11#1)
been observed and found##2##4##(2008-2#1)(2008-8#1)
been observed and##6##3##(1991-5#1)(1993-2#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-8#1)
been observed by##4##3##(1995-6#1)(1997-2#1)(2008-4#1)(2009-1#1)
been observed during the##2##4##(2007-11#1)(2012-2#1)
been observed during##3##3##(1992-3#1)(2007-11#1)(2012-2#1)
been observed for the##2##4##(1992-8#1)(2008-10#1)
been observed for##10##3##(1992-8#1)(2007-11#2)(2008-10#3)(2008-3#3)(2008-5#1)
been observed from##2##3##(2007-11#1)(2007-12#1)
been observed in a##6##4##(1996-2#1)(2007-12#2)(2008-2#1)(2008-6#1)(2008-7#1)
been observed in patients with##2##5##(2008-7#1)(2011-1#1)
been observed in patients##4##4##(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
been observed in several##2##4##(2008-10#1)(2010-3#1)
been observed in the##6##4##(1997-4#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)
been observed in##50##3##(1990-2#1)(1991-3#1)(1992-2#1)(1992-6#3)(1993-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
been observed on the##2##4##(2007-8#1)(2008-5#1)
been observed over##2##3##(1990-8#1)(2008-10#1)
been observed that##10##3##(1991-2#1)(2008-10#6)(2008-11#1)(2010-1#1)(2012-3#1)
been observed to be##5##4##(1993-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
been observed to##10##3##(1993-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2012-12#1)
been observed with this##2##4##(2008-10#1)(2008-3#1)
been observed with##6##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-10#1)
been observed##167##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#11)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#33)(2008-11#6)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
been obtained and##4##3##(1997-7#1)(2008-10#3)
been obtained at##4##3##(1991-5#1)(1997-7#1)(2008-2#1)(2008-3#1)
been obtained by use of##2##5##(2007-11#1)(2008-3#1)
been obtained by##16##3##(1990-9#1)(1991-2#1)(1991-6#1)(1995-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2010-4#1)
been obtained for the##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2009-7#1)
been obtained for##12##3##(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#1)(2009-7#1)
been obtained from a##3##4##(1994-11#1)(2008-1#1)(2008-7#1)
been obtained from##10##3##(1991-5#1)(1994-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
been obtained in##5##3##(1994-6#1)(1995-11#1)(2008-2#1)(2009-3#1)(2012-1#1)
been obtained that##2##3##(2008-2#1)(2008-3#1)
been obtained##109##2##(1990-5#2)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-3#2)(1997-5#2)(1997-7#3)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#17)(2008-3#10)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#2)(2010-4#2)(2010-8#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
been of##8##2##(1992-11#1)(1992-6#1)(1994-12#1)(1994-6#1)(1997-8#1)(2008-4#1)(2008-5#1)(2011-2#1)
been offered##5##2##(1994-12#1)(1994-9#1)(2008-10#2)(2008-11#1)
been on the##6##3##(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
been on##16##2##(1993-2#1)(1994-2#1)(1996-2#2)(1996-6#1)(1997-1#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#2)
been only##14##2##(1991-3#1)(1992-10#1)(1992-2#2)(1994-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
been operated on##3##3##(1997-6#1)(2008-10#1)(2012-12#1)
been operated##4##2##(1990-3#1)(1997-6#1)(2008-10#1)(2012-12#1)
been optically##2##2##(2007-12#1)(2008-3#1)
been optimised for##2##3##(2008-10#2)
been optimised to##3##3##(2008-10#3)
been optimised##11##2##(2008-10#11)
been optimized and the##4##4##(2008-10#4)
been optimized and##5##3##(2008-10#4)(2009-8#1)
been optimized for##2##3##(2008-10#1)(2009-8#1)
been optimized in##2##3##(2006-12#1)(2008-10#1)
been optimized on##2##3##(2008-10#2)
been optimized##31##2##(1991-5#1)(1997-4#2)(2006-12#1)(2008-10#22)(2008-4#1)(2009-6#1)(2009-8#2)(2009-9#1)
been or are being##2##4##(1991-12#1)(2008-5#1)
been or are##3##3##(1991-12#1)(2008-11#1)(2008-5#1)
been or##4##2##(1991-12#1)(1997-6#1)(2008-11#1)(2008-5#1)
been organized in##2##3##(2008-10#1)(2008-11#1)
been organized##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
been outlined##3##2##(2007-2#1)(2008-10#1)(2010-1#1)
been overcome##3##2##(2008-10#2)(2008-4#1)
been overexpressed##2##2##(1994-12#1)(2008-4#1)
been overlooked##6##2##(1991-6#1)(1996-12#1)(2008-12#1)(2008-7#2)(2009-6#1)
been paid a##2##3##(1990-9#1)(2009-11#1)
been paid to##21##3##(1990-2#1)(1991-3#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)(2013-8#1)
been paid##24##2##(1990-2#1)(1990-9#1)(1991-3#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)(2013-8#1)
been partially##3##2##(1991-11#1)(2008-10#1)(2009-9#1)
been particularly##6##2##(1990-3#1)(1995-2#1)(1995-9#1)(2008-10#1)(2008-8#1)(2012-12#1)
been partly##3##2##(1993-9#1)(2008-7#1)(2012-3#1)
been perceived##2##2##(2009-7#1)(2010-12#1)
been performed by##11##3##(2007-8#1)(2008-10#9)(2008-9#1)
been performed for a##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
been performed for##7##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
been performed in order to##2##5##(1996-2#1)(2008-11#1)
been performed in the##2##4##(2007-8#1)(2008-2#1)
been performed in##19##3##(1990-12#1)(1990-9#1)(1993-6#1)(1994-2#1)(1996-2#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2010-8#1)(2012-3#1)
been performed on a##2##4##(2008-3#1)(2009-9#1)
been performed on##9##3##(1994-6#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-9#1)
been performed to##9##3##(1994-6#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)
been performed using##4##3##(1997-4#1)(2008-6#1)(2008-7#2)
been performed with the##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
been performed with##7##3##(1990-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
been performed##120##2##(1990-12#2)(1990-8#1)(1990-9#1)(1992-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#5)(2008-2#8)(2008-3#12)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#2)(2009-11#2)(2009-9#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)
been placed on the##4##4##(1993-2#1)(1996-3#1)(2008-12#1)(2011-1#1)
been placed on##6##3##(1993-2#1)(1996-3#1)(2008-12#1)(2011-1#1)(2013-8#2)
been placed##11##2##(1993-2#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#2)
been poorly understood and##2##4##(2008-5#1)(2008-7#1)
been poorly understood##3##3##(2008-5#2)(2008-7#1)
been poorly##8##2##(1990-3#1)(2007-7#1)(2008-5#2)(2008-7#1)(2013-7#3)
been possible to##14##3##(1993-8#1)(1994-6#1)(1996-8#1)(1997-8#1)(2006-12#2)(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-1#1)
been possible using##2##3##(2008-10#1)(2011-1#1)
been possible##20##2##(1993-8#1)(1994-6#1)(1996-8#1)(1997-8#1)(2006-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-2#1)
been postulated as##2##3##(1990-3#1)(2008-1#1)
been postulated in##3##3##(1992-11#1)(1996-2#1)(2008-9#1)
been postulated to be##2##4##(2008-7#1)(2012-2#1)
been postulated to##5##3##(1990-5#1)(1995-2#1)(1995-5#1)(2008-7#1)(2012-2#1)
been postulated##21##2##(1990-3#1)(1990-5#2)(1991-2#1)(1992-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
been predicted to##2##3##(2008-5#1)(2008-7#1)
been predicted##6##2##(1991-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)
been predominantly##2##2##(2009-9#1)(2012-12#1)
been prepared and##14##3##(1992-3#1)(2008-10#12)(2008-4#1)
been prepared by##12##3##(1992-6#1)(1994-9#1)(1996-2#1)(2008-10#6)(2008-5#1)(2008-8#1)(2013-1#1)
been prepared for##2##3##(1992-2#1)(2008-1#1)
been prepared in##4##3##(1992-2#1)(1992-3#1)(1997-7#1)(2007-11#1)
been prepared on##2##3##(1992-9#1)(2008-10#1)
been prepared using##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
been prepared##50##2##(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#26)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2012-3#1)(2013-1#1)
been preparing##2##2##(1992-12#1)(2008-6#1)
been present for##2##3##(1990-3#1)(2008-11#1)
been present in the##2##4##(1991-12#1)(2008-10#1)
been present##7##2##(1990-3#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)
been presented for##3##3##(1993-3#1)(2008-12#1)(2009-11#1)
been presented##31##2##(1991-12#1)(1991-3#2)(1993-3#1)(2007-11#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-1#1)(2013-1#1)
been prevented##2##2##(2008-11#1)(2008-5#1)
been previously considered##2##3##(1992-6#1)(2008-8#1)
been previously described##7##3##(2008-10#2)(2008-7#2)(2008-8#1)(2010-1#1)(2010-6#1)
been previously developed##2##3##(2009-11#1)(2012-12#1)
been previously evaluated##2##3##(1990-10#1)(2008-11#1)
been previously implicated in##2##4##(2009-8#1)(2010-12#1)
been previously reported for##2##4##(1996-12#1)(2008-10#1)
been previously reported in the literature##4##6##(2007-8#1)(2009-7#1)(2010-3#1)(2011-2#1)
been previously reported in the##6##5##(2007-8#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#2)
been previously reported in##9##4##(2007-8#1)(2008-5#1)(2009-1#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#2)
been previously reported##26##3##(1991-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-9#2)(2010-3#2)(2010-6#1)(2011-2#2)(2012-3#2)(2013-8#1)
been previously shown to##3##4##(1990-12#1)(2008-10#1)(2012-12#1)
been previously shown##5##3##(1990-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-12#1)
been previously##86##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-6#3)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#2)(2011-2#3)(2012-12#3)(2012-3#5)(2013-1#1)(2013-8#2)
been primarily##3##2##(1996-3#1)(2008-3#1)(2010-8#1)
been problematic##4##2##(2008-10#1)(2009-3#1)(2010-10#1)(2013-1#1)
been processed by##4##3##(2007-11#1)(2008-10#2)(2010-8#1)
been processed##7##2##(1997-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2010-8#1)
been produced in##3##3##(1995-12#1)(1996-12#1)(2008-11#1)
been produced##17##2##(1995-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
been proposed and developed##2##4##(2009-4#1)(2012-3#1)
been proposed and##10##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-3#1)
been proposed as a potential##2##5##(1997-2#1)(2008-2#1)
been proposed as a##15##4##(1990-5#1)(1993-11#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-7#1)(2012-12#1)(2013-1#1)
been proposed as an##5##4##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
been proposed as the##2##4##(1991-2#1)(2008-5#1)
been proposed as##30##3##(1990-5#1)(1991-2#1)(1993-11#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#3)
been proposed based on the##3##5##(2008-10#2)(2013-1#1)
been proposed based on##4##4##(1990-8#1)(2008-10#2)(2013-1#1)
been proposed by##2##3##(1991-12#1)(2008-10#1)
been proposed for the##8##4##(1990-5#1)(1991-5#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-7#1)
been proposed for##28##3##(1990-5#1)(1991-5#1)(1993-1#1)(1993-11#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
been proposed in a##2##4##(1994-6#1)(2008-3#1)
been proposed in the literature##4##5##(2008-3#1)(2008-7#2)(2009-9#1)
been proposed in the##6##4##(1996-11#1)(2008-3#1)(2008-7#2)(2009-9#1)(2011-1#1)
been proposed in##12##3##(1994-3#1)(1994-6#1)(1996-11#1)(1997-8#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-9#1)(2011-1#1)
been proposed that the##9##4##(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2011-1#1)
been proposed that##22##3##(1990-12#1)(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-8#1)
been proposed to be##8##4##(1990-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-2#1)(2008-6#1)(2008-9#1)(2010-3#1)
been proposed to explain the##3##5##(2008-7#1)(2009-12#1)(2012-3#1)
been proposed to explain this##2##5##(2008-10#1)(2008-9#1)
been proposed to explain##5##4##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#1)
been proposed to##35##3##(1990-11#1)(1990-12#1)(1990-8#1)(1992-3#2)(1993-12#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
been proposed##214##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#2)(1992-3#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#3)(1995-5#1)(1996-11#2)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#5)(2007-8#2)(2008-1#4)(2008-10#37)(2008-11#10)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#6)(2011-2#6)(2011-7#2)(2012-12#3)(2012-2#7)(2012-3#6)(2012-8#1)(2013-1#5)(2013-8#3)
been proved to be##8##4##(2008-10#4)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
been proved to##11##3##(1990-2#1)(1994-6#1)(2008-10#4)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
been proved##24##2##(1990-2#1)(1992-5#1)(1994-6#1)(1996-3#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been proven to be an##2##5##(2008-10#2)
been proven to be##7##4##(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-5#1)
been proven to##9##3##(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-1#1)
been proven##19##2##(1990-7#1)(1993-2#1)(1993-3#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-5#2)(2013-1#1)
been provided to##3##3##(1997-1#1)(2008-2#1)(2009-6#1)
been provided##7##2##(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
been published about##2##3##(2006-10#1)(2008-10#1)
been published for##2##3##(2008-11#1)(2013-1#1)
been published from##3##3##(1993-6#1)(2008-1#1)(2008-4#1)
been published in##13##3##(1997-8#2)(2008-11#6)(2008-5#2)(2008-7#1)(2013-1#2)
been published on##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
been published##59##2##(1990-11#2)(1991-12#1)(1991-2#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-6#1)(1997-8#2)(2006-10#3)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#6)
been purified and##2##3##(1990-5#1)(2007-11#1)
been purified from human##2##4##(1992-8#1)(1993-3#1)
been purified from##9##3##(1991-2#1)(1992-8#3)(1993-11#1)(1993-3#1)(1994-5#1)(1995-2#1)(2008-8#1)
been purified to homogeneity by##2##5##(1991-12#1)(1992-6#1)
been purified to homogeneity##7##4##(1990-11#2)(1990-7#1)(1991-12#1)(1992-6#1)(1993-12#1)(2008-8#1)
been purified to##11##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1997-4#1)(2008-8#1)
been purified##23##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-8#2)
been put##5##2##(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)
been quantified##4##2##(2008-10#3)(2011-2#1)
been quantitatively##3##2##(2008-10#2)(2008-4#1)
been questioned because of the##2##5##(1994-9#1)(2008-10#1)
been questioned because##4##3##(1994-9#1)(2008-10#2)(2008-3#1)
been questioned due to the##2##5##(1992-6#1)(2010-12#1)
been questioned##12##2##(1990-8#1)(1992-12#1)(1992-6#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
been rapid##2##2##(1994-9#1)(2007-7#1)
been rarely described##3##3##(2008-7#2)(2012-3#1)
been rarely##8##2##(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2012-3#1)
been reached as to##2##4##(1995-2#1)(2013-8#1)
been reached##10##2##(1990-6#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
been realised##3##2##(2007-8#1)(2008-1#2)
been realized##10##2##(1997-6#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-4#1)(2010-5#1)
been receiving increasing attention##4##4##(1993-1#1)(2007-10#1)(2013-8#2)
been receiving##6##2##(1993-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2013-8#2)
been recently described##2##3##(1994-9#1)(2010-10#1)
been recently developed##5##3##(2008-11#1)(2008-5#1)(2009-5#1)(2010-11#1)(2011-3#1)
been recently introduced##2##3##(2008-2#1)(2008-5#1)
been recently proposed##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
been recently##45##2##(1990-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#5)(2008-7#1)(2009-3#1)(2009-5#3)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
been recognised##6##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
been recognized as a major##2##5##(1997-1#1)(2013-8#1)
been recognized as a##8##4##(1997-1#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been recognized as an##3##4##(1997-2#1)(2007-7#1)(2008-8#1)
been recognized as the##3##4##(1994-2#1)(2008-3#2)
been recognized as##20##3##(1994-2#1)(1995-8#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-8#2)(2009-8#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
been recognized in##6##3##(2006-10#1)(2007-7#1)(2009-12#1)(2009-8#1)(2013-1#1)(2013-7#1)
been recognized that the##2##4##(2008-5#1)(2008-7#1)
been recognized that##4##3##(2008-5#1)(2008-7#2)(2010-1#1)
been recognized to##2##3##(2008-10#1)(2010-12#1)
been recognized##44##2##(1990-9#1)(1993-3#1)(1994-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
been recommended as##2##3##(1991-6#1)(2008-9#1)
been recommended by##3##3##(1993-10#1)(2008-1#1)(2008-8#1)
been recommended for##5##3##(1992-8#2)(2008-8#1)(2011-2#1)(2012-2#1)
been recommended##19##2##(1991-6#1)(1992-8#2)(1993-10#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
been recorded in##5##3##(2007-12#1)(2008-12#1)(2011-2#2)(2013-8#1)
been recorded with##2##3##(2008-3#1)(2010-8#1)
been recorded##22##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-4#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-8#2)(2009-10#1)(2010-8#2)(2011-2#2)(2013-8#1)
been recovered from##4##3##(1996-8#1)(2008-10#1)(2008-8#1)(2009-3#1)
been recovered##6##2##(1996-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)
been reduced##5##2##(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
been referred to as##3##4##(1994-5#1)(1996-1#1)(2011-2#1)
been referred to##4##3##(1994-2#1)(1994-5#1)(1996-1#1)(2011-2#1)
been referred##8##2##(1990-12#1)(1990-3#1)(1994-2#1)(1994-5#1)(1996-1#1)(2008-9#1)(2011-2#1)(2012-12#1)
been refined to##4##3##(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#1)
been refined##6##2##(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2011-2#1)
been regarded as a##3##4##(1990-9#1)(1995-2#1)(2010-11#1)
been regarded as an##2##4##(1996-2#1)(2008-11#1)
been regarded as the##2##4##(2010-5#1)(2012-3#1)
been regarded as##10##3##(1990-9#1)(1993-3#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-3#1)
been registered##5##2##(1990-6#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)
been reinvestigated##3##2##(1994-11#1)(2008-2#1)(2009-2#1)
been related to the##3##4##(1993-9#1)(2008-9#1)(2011-1#1)
been related to##9##3##(1993-1#1)(1993-9#1)(1994-6#1)(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#2)
been related##10##2##(1991-6#1)(1993-1#1)(1993-9#1)(1994-6#1)(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#2)
been relatively little##2##3##(2008-5#1)(2008-8#1)
been relatively##8##2##(1992-8#1)(1993-12#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-1#1)
been released in the##2##4##(2009-12#1)(2011-2#1)
been released in##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
been released##6##2##(1992-6#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#2)
been remarkable##3##2##(2008-11#1)(2010-8#1)(2011-1#1)
been remarkably##3##2##(2008-8#1)(2010-6#1)(2011-2#1)
been removed##5##2##(1992-9#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-4#1)
been repeatedly described##2##3##(2008-12#1)(2008-7#1)
been repeatedly##8##2##(1992-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
been replaced by the##2##4##(1990-5#1)(2007-8#1)
been replaced by##9##3##(1990-5#1)(1991-2#1)(1991-7#1)(1995-8#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-3#1)(2010-5#1)
been replaced with Ala##2##4##(1990-7#1)(1992-3#1)
been replaced with##3##3##(1990-7#1)(1992-3#1)(2013-8#1)
been replaced##12##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-3#1)(2010-5#1)(2013-8#1)
been reported along##2##3##(2008-5#1)(2011-2#1)
been reported among##4##3##(1991-12#1)(2007-2#1)(2008-4#1)(2009-5#1)
been reported and##3##3##(2007-11#1)(2008-6#1)(2010-7#1)
been reported as a##4##4##(1990-8#1)(2008-7#1)(2012-1#1)(2013-1#1)
been reported as##14##3##(1990-8#1)(1992-5#1)(1996-11#3)(1996-5#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
been reported before in the literature##2##6##(1997-8#1)(2011-2#1)
been reported before in the##3##5##(1997-8#1)(2008-11#1)(2011-2#1)
been reported before##4##3##(1993-12#1)(1997-8#1)(2008-11#1)(2011-2#1)
been reported during##2##3##(2008-7#1)(2009-12#1)
been reported earlier##2##3##(1992-9#2)
been reported elsewhere##2##3##(1994-3#1)(2008-10#1)
been reported for the##4##4##(2008-10#2)(2008-9#1)(2009-11#1)
been reported for##13##3##(1990-8#1)(1993-8#1)(1995-6#1)(2008-10#5)(2008-9#1)(2009-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
been reported from birds##2##4##(2008-5#2)
been reported from##6##3##(1995-8#1)(2007-7#1)(2008-10#1)(2008-5#2)(2009-10#1)
been reported in English literature##2##5##(2012-12#1)(2012-2#1)
been reported in Korea##2##4##(2010-6#2)
been reported in a few##2##5##(2012-12#1)(2012-2#1)
been reported in a##6##4##(2007-10#1)(2009-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
been reported in literature##2##4##(2010-12#1)(2012-2#1)
been reported in other##3##4##(1991-12#1)(1997-7#1)(1997-9#1)
been reported in patients with##7##5##(1994-12#1)(1995-11#1)(2007-10#1)(2008-7#1)(2009-4#1)(2010-1#1)(2012-12#1)
been reported in rodents##2##4##(1992-2#1)(2012-12#1)
been reported in several##4##4##(1991-12#1)(1994-11#1)(2007-10#1)(2011-2#1)
been reported in some##3##4##(2008-1#1)(2011-1#1)(2013-7#1)
been reported in the literature##19##5##(1990-12#1)(1990-8#1)(1996-11#1)(1996-6#1)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#2)(2013-1#3)(2013-7#1)
been reported in the medical literature##4##6##(1990-8#1)(2010-6#2)(2013-1#1)
been reported in the##42##4##(1990-12#1)(1990-8#2)(1991-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#5)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
been reported in##133##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#5)(1992-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-10#2)(2006-12#1)(2007-10#4)(2007-12#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#7)(2010-7#1)(2011-1#8)(2011-2#3)(2012-12#5)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#9)(2013-7#2)(2013-8#2)
been reported on##6##3##(1990-11#1)(2008-10#4)(2013-1#1)
been reported previously in##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
been reported previously##15##3##(1990-7#1)(1993-8#1)(1995-6#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-3#1)(2009-11#1)(2011-1#1)(2013-8#1)
been reported recently##2##3##(2008-11#1)(2013-1#1)
been reported since##4##3##(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)
been reported so far##8##4##(1992-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
been reported to be associated with##2##6##(1994-5#1)(2012-1#1)
been reported to be important in the##2##7##(1992-8#1)(2008-7#1)
been reported to be increased in##2##6##(2008-10#1)(2012-12#1)
been reported to be increased##3##5##(1994-12#1)(2008-10#1)(2012-12#1)
been reported to be involved in##2##6##(2008-7#1)(2011-2#1)
been reported to be##29##4##(1991-1#1)(1992-8#1)(1993-8#2)(1994-12#2)(1994-5#1)(1994-6#2)(1995-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)
been reported to cause##3##4##(2008-10#3)
been reported to date##7##4##(2008-1#3)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
been reported to exhibit##3##4##(1995-2#1)(2008-11#1)(2008-5#1)
been reported to have a##4##5##(2007-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
been reported to have##9##4##(1994-12#1)(2007-10#1)(2008-11#3)(2008-6#1)(2010-11#1)(2012-3#1)(2013-8#1)
been reported to improve##2##4##(2008-12#1)(2008-5#1)
been reported to increase##4##4##(2008-10#2)(2008-4#1)(2011-2#1)
been reported to occur in the##2##6##(1995-10#1)(2013-1#1)
been reported to occur in##6##5##(1995-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
been reported to occur##8##4##(1995-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
been reported to play a##3##5##(1992-6#1)(1993-6#1)(2013-8#1)
been reported to possess##3##4##(1992-3#1)(2008-10#1)(2013-1#1)
been reported to##101##3##(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-7#1)(1997-1#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#14)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
been reported with##11##3##(2008-10#3)(2008-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
been reported worldwide##4##3##(1995-3#1)(2007-7#1)(2009-8#1)(2013-1#1)
been reported##497##2##(1990-11#2)(1990-12#2)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#4)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#2)(1991-3#1)(1991-8#4)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#6)(1993-9#2)(1994-11#2)(1994-12#6)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-11#4)(1996-12#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#5)(1997-9#1)(2006-10#4)(2006-12#1)(2007-10#9)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#9)(2007-8#6)(2008-1#6)(2008-10#66)(2008-11#12)(2008-12#9)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#21)(2008-8#6)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#4)(2009-4#3)(2009-5#4)(2009-8#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#12)(2010-7#2)(2010-8#2)(2011-1#13)(2011-2#32)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#14)(2012-3#7)(2012-8#1)(2013-1#28)(2013-7#3)(2013-8#13)
been represented##2##2##(2011-3#1)(2013-1#1)
been required to##2##3##(2008-10#2)
been researched##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
been resolved##11##2##(1990-10#1)(1991-5#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-3#1)(2012-2#1)
been restricted to##5##3##(1997-8#1)(2008-4#1)(2008-7#2)(2011-2#1)
been restricted##9##2##(1997-8#1)(2008-11#2)(2008-4#1)(2008-7#3)(2011-2#1)(2012-3#1)
been restructured##2##2##(1994-12#1)(1995-12#1)
been revealed in##3##3##(1991-9#1)(2010-2#2)
been revealed##12##2##(1991-9#2)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-2#2)
been reviewed##6##2##(1990-12#1)(1997-3#1)(2008-7#1)(2009-10#1)(2010-1#1)(2012-2#1)
been revised and##2##3##(2008-11#1)(2010-8#1)
been revised##4##2##(2008-11#2)(2010-8#1)(2012-1#1)
been routinely##2##2##(2008-10#1)(2008-9#1)
been run##3##2##(1990-3#1)(2008-3#1)(2008-7#1)
been running for##2##3##(2008-7#1)(2012-3#1)
been running##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
been satisfactorily##19##2##(2008-10#17)(2008-3#1)(2008-7#1)
been scaled up##2##3##(2008-11#1)(2008-7#1)
been scaled##4##2##(2008-11#2)(2008-3#1)(2008-7#1)
been seen in##6##3##(1994-2#1)(1995-2#1)(1995-8#1)(2009-2#1)(2012-3#1)(2013-1#1)
been seen##14##2##(1994-2#1)(1995-2#1)(1995-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
been selected for the##3##4##(2008-10#3)
been selected for##8##3##(1992-12#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-8#2)
been selected##13##2##(1992-12#1)(1996-9#1)(1997-7#1)(2008-10#6)(2008-7#1)(2008-8#2)(2010-8#1)
been separated by##3##3##(2008-10#3)
been separated into##2##3##(1994-12#1)(2008-10#1)
been separated##15##2##(1994-12#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)
been sequenced##8##2##(1990-12#1)(1994-2#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-7#2)
been shown by##6##3##(1993-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
been shown capable of##2##4##(1993-11#1)(2008-10#1)
been shown in the##3##4##(1991-8#1)(1995-5#1)(2008-10#1)
been shown in##11##3##(1991-8#1)(1992-12#1)(1994-11#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-5#1)(2010-8#1)
been shown not to##3##4##(1990-12#1)(1990-2#1)(2008-1#1)
been shown not##4##3##(1990-12#1)(1990-2#1)(2008-1#1)(2012-12#1)
been shown previously to##6##4##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1995-2#1)
been shown previously##7##3##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1995-2#1)(2008-2#1)
been shown that a##2##4##(1995-9#1)(2008-7#1)
been shown that in##2##4##(1994-8#1)(2008-10#1)
been shown that the##14##4##(1990-11#1)(1993-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
been shown that these##3##4##(1990-11#1)(2008-11#1)(2011-2#1)
been shown that##50##3##(1990-11#2)(1991-9#1)(1992-11#1)(1993-11#1)(1994-11#2)(1994-2#2)(1994-8#2)(1995-3#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
been shown to activate the##3##5##(1992-4#1)(2008-11#1)(2009-6#1)
been shown to activate##7##4##(1992-4#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
been shown to alter the natural##2##6##(2008-7#1)(2010-12#1)
been shown to alter##3##4##(2008-4#1)(2008-7#1)(2010-12#1)
been shown to be a potent##2##6##(1993-12#1)(2008-8#1)
been shown to be a##22##5##(1990-11#2)(1990-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
been shown to be associated with##8##6##(2008-4#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)
been shown to be capable of##5##6##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
been shown to be effective in##4##6##(2008-11#1)(2011-2#1)(2012-12#2)
been shown to be effective##8##5##(2008-11#3)(2009-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
been shown to be efficacious##2##5##(2008-10#1)(2012-2#1)
been shown to be important##4##5##(1995-6#1)(2007-2#1)(2011-2#1)(2012-3#1)
been shown to be involved in the##3##7##(2007-8#1)(2008-10#1)(2010-10#1)
been shown to be involved in##6##6##(1992-11#1)(1994-5#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-8#1)
been shown to be moderately effective in##2##7##(2012-12#2)
been shown to be more##4##5##(2008-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
been shown to be necessary for##3##6##(1994-6#1)(2008-7#1)(2008-9#1)
been shown to be of##4##5##(1993-2#1)(1994-3#1)(2008-10#1)(2008-9#1)
been shown to be present##2##5##(1991-5#1)(1995-2#1)
been shown to be regulated by##2##6##(1991-2#1)(2008-8#1)
been shown to be regulated directly by##2##7##(2008-8#1)(2010-3#1)
been shown to be regulated##5##5##(1991-2#1)(2008-8#2)(2010-3#1)(2011-2#1)
been shown to be related to the##2##7##(2008-10#1)(2008-5#1)
been shown to be related to##3##6##(2008-10#1)(2008-3#1)(2008-5#1)
been shown to be the main cause of##2##8##(2008-11#1)(2008-5#1)
been shown to be the##3##5##(1991-6#1)(2008-11#1)(2008-5#1)
been shown to be very##3##5##(1997-6#1)(1997-8#1)(2009-7#1)
been shown to be##161##4##(1990-11#3)(1990-2#3)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-8#1)(2008-10#15)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#1)
been shown to belong to##2##5##(2008-10#1)(2008-5#1)
been shown to bind##5##4##(1994-5#1)(1994-8#1)(1995-6#1)(2008-5#1)(2011-1#1)
been shown to cause##9##4##(1993-12#1)(1993-6#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
been shown to contain##3##4##(1990-5#1)(1995-6#1)(2008-3#1)
been shown to contribute to##3##5##(2008-9#1)(2009-12#1)(2012-12#1)
been shown to correlate with##3##5##(1996-12#1)(2009-11#1)(2009-12#1)
been shown to correlate##4##4##(1993-9#1)(1996-12#1)(2009-11#1)(2009-12#1)
been shown to decrease##7##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
been shown to enhance##2##4##(2008-11#1)(2012-12#1)
been shown to exert##3##4##(2008-5#1)(2008-7#1)(2010-9#1)
been shown to exhibit##3##4##(1990-5#1)(2008-7#2)
been shown to exist in##3##5##(1993-8#1)(1995-11#1)(2008-9#1)
been shown to function as a##2##6##(2008-10#1)(2010-10#1)
been shown to function##4##4##(2008-10#1)(2008-5#1)(2010-10#1)(2012-1#1)
been shown to have a##7##5##(1993-3#1)(1994-3#1)(1994-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
been shown to have beneficial effects##3##6##(2008-3#1)(2009-3#1)(2010-5#1)
been shown to have##28##4##(1990-11#1)(1990-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#2)(2012-12#1)(2013-1#2)
been shown to improve the##4##5##(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
been shown to improve##11##4##(1994-9#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
been shown to increase the risk##2##6##(2008-1#1)(2010-8#1)
been shown to increase the##4##5##(1996-2#1)(2008-1#2)(2010-8#1)
been shown to increase##10##4##(1990-8#1)(1995-5#1)(1996-2#1)(1997-1#1)(2008-1#2)(2008-5#2)(2010-8#1)(2010-9#1)
been shown to induce##10##4##(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-2#1)(2008-11#1)(2013-1#1)
been shown to influence the##2##5##(2008-7#1)(2009-10#1)
been shown to influence##4##4##(1991-6#1)(1997-1#1)(2008-7#1)(2009-10#1)
been shown to inhibit pepsinogen secretion##2##6##(1995-8#2)
been shown to inhibit##7##4##(1992-11#1)(1992-5#1)(1994-6#1)(1995-8#2)(2010-11#1)(2013-1#1)
been shown to interact with##5##5##(1993-8#2)(1994-5#1)(1995-2#1)(2013-1#1)
been shown to interact##6##4##(1993-8#2)(1994-5#1)(1995-2#1)(2008-4#1)(2013-1#1)
been shown to involve the##2##5##(1990-7#1)(1997-8#1)
been shown to markedly##3##4##(2008-12#1)(2008-3#1)(2013-8#1)
been shown to modulate the##2##5##(2008-10#1)(2008-11#1)
been shown to modulate##6##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
been shown to occur in##2##5##(2008-11#1)(2008-7#1)
been shown to occur##3##4##(2008-11#1)(2008-7#1)(2009-2#1)
been shown to offer##3##4##(2008-7#2)(2009-3#1)
been shown to play an important role in##2##8##(2008-7#1)(2008-9#1)
been shown to play important roles in##3##7##(2008-11#1)(2008-7#1)(2009-10#1)
been shown to play##9##4##(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#2)
been shown to possess##2##4##(1992-3#1)(2009-12#1)
been shown to promote##4##4##(1995-6#1)(1995-8#1)(2008-10#1)(2013-1#1)
been shown to provide a##3##5##(1994-12#1)(2008-10#1)(2008-3#1)
been shown to provide##9##4##(1994-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#2)(2010-12#1)
been shown to reduce##11##4##(1993-3#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
been shown to regulate the##3##5##(2008-9#1)(2010-8#1)(2011-2#1)
been shown to regulate##7##4##(1995-12#1)(2008-11#1)(2008-9#3)(2010-8#1)(2011-2#1)
been shown to significantly##2##4##(2008-11#1)(2008-7#1)
been shown to stimulate##5##4##(1990-12#1)(1997-1#1)(2008-3#2)(2012-2#1)
been shown to suppress the##2##5##(2008-7#1)(2010-7#1)
been shown to suppress##4##4##(1995-3#1)(2008-10#1)(2008-7#1)(2010-7#1)
been shown to##439##3##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#3)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#6)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#7)(1995-8#3)(1996-12#7)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-8#2)(2008-1#3)(2008-10#34)(2008-11#22)(2008-12#1)(2008-2#4)(2008-3#17)(2008-4#10)(2008-5#21)(2008-6#3)(2008-7#20)(2008-8#11)(2008-9#11)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#7)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#13)(2012-1#3)(2012-12#12)(2012-2#10)(2012-3#3)(2013-1#14)(2013-8#4)
been shown##539##2##(1990-11#7)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#3)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#4)(1994-11#7)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#6)(1994-8#5)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#5)(1995-6#7)(1995-8#3)(1995-9#1)(1996-12#7)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#6)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#48)(2008-11#26)(2008-12#1)(2008-2#5)(2008-3#21)(2008-4#12)(2008-5#23)(2008-6#3)(2008-7#23)(2008-8#11)(2008-9#12)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#9)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#7)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#6)(2011-2#17)(2012-1#3)(2012-12#13)(2012-2#13)(2012-3#5)(2013-1#18)(2013-8#6)
been significant##8##2##(1990-11#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
been significantly reduced##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
been significantly##8##2##(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#2)
been simulated##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
been simultaneously##4##2##(2007-11#1)(2008-10#3)
been slow to##2##3##(1997-2#1)(2013-1#1)
been slow##7##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2013-1#2)
been slower##2##2##(1990-11#1)(1995-2#1)
been so##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)
been solved by##3##3##(1992-4#1)(1992-8#1)(1996-2#1)
been solved##7##2##(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#1)(1995-2#1)(1996-2#1)(1997-7#1)
been somewhat##2##2##(2008-5#1)(2008-9#1)
been spatially##2##2##(2008-5#1)(2013-1#1)
been specifically designed for##2##4##(2008-3#1)(2008-4#1)
been specifically designed to##2##4##(1996-1#1)(2008-4#1)
been specifically designed##4##3##(1996-1#1)(2008-3#1)(2008-4#2)
been specifically developed##2##3##(2008-3#1)(2008-4#1)
been specifically##8##2##(1996-1#1)(2008-3#3)(2008-4#3)(2010-5#1)
been speculated that##4##3##(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)
been speculated to be the##2##5##(2008-5#1)(2012-2#1)
been speculated##6##2##(2008-10#1)(2008-5#2)(2009-6#1)(2011-2#1)(2012-2#1)
been stabilized##6##2##(1991-2#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-4#1)
been stable##4##2##(1990-2#1)(1997-6#1)(2008-6#1)(2009-3#1)
been stably##3##2##(1992-9#1)(1994-2#1)(2008-9#1)
been started##4##2##(1990-11#1)(1990-6#1)(2006-10#1)(2012-12#1)
been statistically##2##2##(2008-10#1)(2010-8#1)
been stimulated##2##2##(1997-5#1)(2012-1#1)
been strongly##2##2##(2011-1#1)(2012-2#1)
been studied and##13##3##(1990-11#1)(1992-6#1)(2008-10#9)(2008-2#1)(2008-3#1)
been studied as a function of pH##2##7##(1990-5#1)(2008-10#1)
been studied as a function of##4##6##(1990-5#1)(2008-10#2)(2008-3#1)
been studied as a##6##4##(1990-5#1)(2008-10#3)(2008-3#1)(2008-4#1)
been studied at 25 degrees C##2##6##(1997-7#1)(2008-10#1)
been studied at##11##3##(1990-8#1)(1995-5#1)(1997-7#1)(2008-10#7)(2011-10#1)
been studied by spectrophotometry##2##4##(2008-10#2)
been studied by the##4##4##(1990-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
been studied by using##2##4##(2008-10#1)(2008-8#1)
been studied by##41##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#2)(2010-3#1)(2012-3#1)
been studied experimentally##2##3##(2008-3#1)(2008-9#1)
been studied extensively##12##3##(1995-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#2)
been studied for decades##3##4##(2008-10#3)
been studied for the##2##4##(2008-10#2)
been studied for##11##3##(2008-1#1)(2008-10#9)(2008-8#1)
been studied in a##5##4##(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-1#1)
been studied in aqueous solution##2##5##(1996-2#1)(2008-10#1)
been studied in detail to optimize the conditions for determination in##2##11##(2008-10#2)
been studied in detail to optimize the conditions for determination##3##10##(2008-10#3)
been studied in detail to optimize the conditions for##6##9##(2008-10#6)
been studied in detail to optimize the conditions##7##8##(2008-10#7)
been studied in detail##14##4##(2008-10#12)(2008-5#1)(2010-3#1)
been studied in the##4##4##(1992-12#1)(1997-3#1)(2008-10#2)
been studied in##51##3##(1990-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-3#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-7#1)
been studied on##3##3##(2008-10#3)
been studied over##2##3##(2008-3#1)(2008-6#1)
been studied previously##2##3##(1990-5#1)(2012-7#1)
been studied so far##2##4##(1997-6#1)(2008-7#1)
been studied spectrophotometrically##2##3##(2008-10#2)
been studied to##6##3##(1995-11#1)(2008-10#3)(2010-3#1)(2010-7#1)
been studied using##17##3##(1992-8#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#8)(2008-8#1)(2009-5#1)(2009-7#1)
been studied very##2##3##(2008-10#1)(2012-2#1)
been studied with the##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
been studied with##10##3##(1993-6#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-3#2)(2011-2#1)(2013-1#1)
been studied##329##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#5)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#3)(2008-1#3)(2008-10#151)(2008-11#5)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-3#5)(2010-5#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#6)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#3)(2013-7#1)
been subject to##5##3##(1992-1#1)(2008-11#1)(2012-1#1)(2012-2#2)
been subjected to a##3##4##(1990-2#1)(2008-11#1)(2010-7#1)
been subjected to##14##3##(1990-2#1)(1996-1#1)(2008-10#1)(2008-11#4)(2009-7#1)(2010-4#1)(2010-7#1)(2012-12#2)(2012-3#2)
been submitted to the##2##4##(2008-1#1)(2013-1#1)
been submitted to##6##3##(1997-2#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
been submitted##8##2##(1997-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
been substituted with a##2##4##(1992-6#1)(2008-10#1)
been substituted##4##2##(1992-6#1)(1996-9#1)(2008-10#2)
been successful in reducing##2##4##(2008-11#1)(2012-1#1)
been successful in##15##3##(1992-2#1)(1994-12#2)(1996-3#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
been successful##20##2##(1992-2#1)(1994-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#1)(2010-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
been successfully applied for##15##4##(2008-10#14)(2009-6#1)
been successfully applied to analyze the##2##6##(2008-10#2)
been successfully applied to the analysis of##2##7##(2008-10#2)
been successfully applied to the determination of trace##3##8##(2008-10#3)
been successfully applied to the determination of##24##7##(2008-10#24)
been successfully applied to the##33##5##(1991-12#1)(2008-10#32)
been successfully applied to##53##4##(1991-12#1)(2008-10#50)(2009-9#1)(2012-12#1)
been successfully applied##70##3##(1991-12#1)(2008-10#65)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)
been successfully expressed in##2##4##(2008-11#1)(2008-7#1)
been successfully incorporated into##2##4##(1996-1#1)(2012-2#1)
been successfully performed##3##3##(2008-7#1)(2009-4#1)(2013-1#1)
been successfully tested for##2##4##(2008-10#2)
been successfully tested##5##3##(2008-10#3)(2009-2#1)(2011-2#1)
been successfully used for##7##4##(2007-11#1)(2008-10#4)(2008-2#1)(2010-8#1)
been successfully used to treat##2##5##(2008-7#1)(2012-12#1)
been successfully used to##12##4##(1994-3#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
been successfully used##27##3##(1994-2#1)(1994-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
been successfully utilized##3##3##(1997-8#1)(2008-10#2)
been successfully##142##2##(1991-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#90)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
been suffering##3##2##(2008-11#1)(2010-6#1)(2013-8#1)
been sufficiently##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
been suggested as a##5##4##(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
been suggested as possible##3##4##(1990-11#1)(2008-4#1)(2010-6#1)
been suggested as##18##3##(1990-11#1)(1994-12#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
been suggested by##3##3##(2008-8#2)(2013-1#1)
been suggested for##7##3##(1993-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
been suggested in##4##3##(1991-11#1)(2008-12#1)(2008-2#1)(2012-2#1)
been suggested that##52##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
been suggested to be involved in##2##6##(1995-6#1)(2009-9#1)
been suggested to be##13##4##(1991-2#1)(1994-8#2)(1995-3#1)(1995-6#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)
been suggested to play an important role in##3##8##(1993-12#1)(2008-10#1)(2008-3#1)
been suggested to play##5##4##(1993-12#1)(1994-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
been suggested to##33##3##(1991-2#1)(1993-12#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
been suggested##143##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#3)(1991-9#1)(1992-12#1)(1992-8#3)(1993-12#2)(1993-6#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#3)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#5)(2013-1#10)(2013-7#1)(2013-8#1)
been superseded by##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
been supplemented##2##2##(2008-11#2)
been supported##2##2##(1994-3#1)(2008-9#1)
been suppressed##2##2##(2007-11#1)(2009-10#1)
been surgically##2##2##(1991-2#1)(2007-11#1)
been suspected##6##2##(1991-1#1)(1992-11#1)(2008-10#1)(2010-1#1)(2010-4#1)(2011-1#1)
been sustained##3##2##(2008-3#1)(2012-12#1)(2013-8#1)
been synthesised for the##2##4##(2008-10#2)
been synthesised##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
been synthesized and characterized by##5##5##(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#1)
been synthesized and characterized##9##4##(1995-3#1)(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#3)(2008-5#1)
been synthesized and##21##3##(1995-11#1)(1995-3#3)(1996-2#2)(1997-7#2)(2007-11#2)(2008-10#7)(2008-5#1)(2009-2#1)(2010-6#1)(2013-1#1)
been synthesized by##4##3##(2008-10#3)(2011-1#1)
been synthesized for the##2##4##(1996-5#1)(2008-6#1)
been synthesized for##3##3##(1995-2#1)(1996-5#1)(2008-6#1)
been synthesized in##9##3##(1990-8#1)(1995-6#1)(2008-10#2)(2009-10#1)(2009-2#1)(2009-7#1)(2012-2#1)(2012-3#1)
been synthesized##62##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-2#2)(1996-5#3)(1997-7#2)(2007-11#3)(2008-10#20)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-2#2)(2009-7#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
been systematically investigated##3##3##(2008-10#2)(2010-11#1)
been systematically##8##2##(1991-2#1)(2007-11#1)(2008-10#3)(2010-11#1)(2010-12#1)(2012-12#1)
been taken into account##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
been taken to##5##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)
been taken##19##2##(1990-8#2)(1992-6#1)(1993-8#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#2)(2012-3#1)
been taking##3##2##(1991-3#1)(1993-3#1)(2008-6#1)
been targeted##2##2##(2008-7#1)(2013-8#1)
been termed##6##2##(1993-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-6#1)
been tested against##2##3##(2007-11#1)(2009-12#1)
been tested as##5##3##(1992-3#1)(2007-11#1)(2008-10#2)(2009-2#1)
been tested for the##3##4##(2008-10#2)(2008-12#1)
been tested for##15##3##(1996-2#1)(1996-3#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-6#1)(2009-12#1)(2013-1#1)
been tested in##8##3##(1993-3#1)(1994-6#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)
been tested on##10##3##(2007-12#1)(2008-10#4)(2008-3#2)(2010-8#2)(2012-1#1)
been tested using##4##3##(1990-5#1)(1992-9#1)(2006-4#1)(2007-12#1)
been tested with##3##3##(1997-6#1)(2007-10#1)(2008-10#1)
been tested##71##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#27)(2008-12#1)(2008-2#1)(2008-3#6)(2008-6#4)(2008-7#1)(2008-8#2)(2009-12#2)(2009-2#1)(2010-8#2)(2012-1#2)(2013-1#1)(2013-8#1)
been that##4##2##(1997-1#1)(2006-10#1)(2008-8#2)
been the case##2##3##(1995-6#1)(2008-11#1)
been the focus of intense##2##5##(2008-6#1)(2010-9#1)
been the focus of##4##4##(2008-11#1)(2008-6#1)(2009-11#1)(2010-9#1)
been the main##2##3##(2008-10#1)(2013-7#1)
been the mainstay of##2##4##(1996-2#1)(2007-10#1)
been the major##2##3##(2007-12#1)(2007-2#1)
been the most important##3##4##(2007-12#1)(2008-5#1)(2010-11#1)
been the most prevalent##2##4##(1994-12#1)(2008-10#1)
been the most##9##3##(1994-12#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-11#1)
been the subject of extensive##2##5##(2008-11#1)(2008-8#1)
been the subject of many##2##5##(2007-6#1)(2008-7#1)
been the subject of##12##4##(2007-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
been the##95##2##(1991-12#3)(1991-3#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-2#2)(2006-4#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)
been theoretically##4##2##(1990-12#1)(2008-2#2)(2008-3#1)
been theorized to##2##3##(2010-10#1)(2013-1#1)
been thoroughly studied##2##3##(2008-2#1)(2012-2#1)
been thoroughly##8##2##(2008-10#2)(2008-2#1)(2009-7#1)(2010-3#1)(2012-2#2)(2013-8#1)
been thought to be##5##4##(1990-5#1)(1996-12#1)(2008-6#1)(2010-12#1)(2012-2#1)
been thought to##7##3##(1990-5#1)(1992-11#1)(1996-12#2)(2008-6#1)(2010-12#1)(2012-2#1)
been thought##9##2##(1990-5#1)(1992-11#1)(1994-8#1)(1996-12#2)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
been through##4##2##(1996-11#1)(2009-2#1)(2010-3#1)(2011-2#1)
been thrust##2##2##(1994-1#1)(2007-7#1)
been to describe##2##3##(2007-12#1)(2008-10#1)
been to the##2##3##(1995-12#1)(2011-1#1)
been to##21##2##(1991-3#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
been told that##2##3##(2010-4#1)(2010-9#1)
been told##4##2##(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#1)
been traditionally##5##2##(2007-12#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
been trained##7##2##(1990-11#1)(1995-1#1)(1996-5#1)(2008-10#3)(2010-11#1)
been transferred to##2##3##(1995-6#1)(2008-9#1)
been transferred##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
been transformed##6##2##(1996-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
been translated into several languages##2##5##(1993-11#1)(2010-5#1)
been translated into##4##3##(1993-11#1)(1994-7#1)(2009-4#1)(2010-5#1)
been translated##5##2##(1993-11#1)(1994-7#1)(2008-10#1)(2009-4#1)(2010-5#1)
been transmitted##4##2##(1990-3#1)(1990-9#1)(1995-9#1)(2007-12#1)
been treated by##6##3##(1990-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
been treated with high doses of##2##6##(1994-3#1)(2006-10#1)
been treated with##26##3##(1991-9#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
been treated##53##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)
been tried to##2##3##(2010-7#1)(2010-8#1)
been tried##6##2##(1990-5#1)(2008-10#2)(2008-5#1)(2010-7#1)(2010-8#1)
been trying to##2##3##(2008-6#1)(2013-1#1)
been unable to##7##3##(1995-3#1)(1996-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
been unclear##5##2##(1993-11#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
been under development##2##3##(2010-10#1)(2013-1#1)
been under##6##2##(2008-10#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#2)
been underestimated##3##2##(2008-8#1)(2009-7#1)(2012-2#1)
been undergoing##3##2##(1992-12#1)(1996-12#1)(2012-3#1)
been undertaken to##8##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-1#1)
been undertaken##16##2##(1993-11#1)(1994-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
been underutilized##2##2##(2008-12#1)(2012-3#1)
been unequivocally##2##2##(1997-8#1)(2008-7#1)
been uniformly##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
been unsuccessful##3##2##(1992-9#1)(1995-8#1)(2008-10#1)
been updated##3##2##(1993-3#1)(2008-10#1)(2013-7#1)
been used and##2##3##(2008-3#1)(2009-5#1)
been used as a##17##4##(1992-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
been used as an##8##4##(2008-10#5)(2008-7#1)(2010-4#1)(2012-12#1)
been used as substrates##2##4##(1992-8#1)(2008-10#1)
been used as the##4##4##(1992-4#1)(2008-10#2)(2008-11#1)
been used as##56##3##(1992-11#1)(1992-4#1)(1992-8#1)(1994-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-11#2)(2008-10#25)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
been used by##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
been used effectively in##2##4##(2009-10#1)(2011-2#1)
been used extensively in the##2##5##(2008-10#1)(2008-3#1)
been used extensively in##5##4##(1995-12#1)(2007-9#1)(2008-10#2)(2008-3#1)
been used extensively##8##3##(1995-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
been used for a##4##4##(2008-1#1)(2008-10#2)(2008-5#1)
been used for many years as##3##6##(2007-11#1)(2007-8#1)(2009-8#1)
been used for many years##4##5##(2007-11#1)(2007-8#1)(2008-5#1)(2009-8#1)
been used for the detection of##2##6##(2008-10#1)(2012-3#1)
been used for the determination of the##2##7##(2008-10#2)
been used for the determination of##12##6##(2008-10#12)
been used for the determination##13##5##(2008-10#13)
been used for the##35##4##(1993-9#1)(2007-7#1)(2008-10#25)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
been used for this purpose##3##5##(1995-5#1)(2008-1#1)(2008-10#1)
been used for this##5##4##(1995-5#1)(2008-1#1)(2008-10#2)(2008-3#1)
been used for##108##3##(1990-11#1)(1990-5#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#47)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been used in a##5##4##(2007-12#1)(2008-2#3)(2008-6#1)
been used in an##2##4##(2008-3#1)(2011-1#1)
been used in combination with##3##5##(1996-12#1)(2008-10#1)(2013-1#1)
been used in the treatment of##3##6##(1994-5#1)(1996-3#1)(2006-12#1)
been used in the##17##4##(1994-5#1)(1995-11#1)(1996-3#1)(2006-12#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-9#1)(2010-12#1)(2010-8#2)(2012-12#1)(2012-2#1)
been used in##66##3##(1991-1#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
been used previously##2##3##(1992-8#1)(2008-10#1)
been used successfully for the##3##5##(1997-2#1)(2008-10#1)(2008-7#1)
been used successfully for##6##4##(1997-2#1)(2008-10#3)(2008-2#1)(2008-7#1)
been used successfully in##6##4##(2008-10#2)(2008-4#1)(2009-10#1)(2009-4#1)(2010-11#1)
been used successfully to##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
been used successfully##19##3##(1992-12#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-8#1)
been used to assay##2##4##(1997-4#1)(2008-10#1)
been used to characterize the##3##5##(1993-11#1)(1993-8#1)(2008-3#1)
been used to characterize##5##4##(1992-12#1)(1993-11#1)(1993-8#1)(1994-11#1)(2008-3#1)
been used to control##2##4##(2008-10#2)
been used to detect##7##4##(2008-10#3)(2008-2#1)(2008-9#2)(2010-5#1)
been used to determine the##8##5##(1990-9#1)(1991-2#1)(1992-6#1)(1994-5#1)(1995-5#1)(2008-10#2)(2008-7#1)
been used to determine##18##4##(1990-9#1)(1991-2#1)(1992-6#1)(1994-5#1)(1995-5#1)(2007-11#1)(2008-10#11)(2008-7#1)
been used to develop##4##4##(1994-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
been used to evaluate the##2##5##(2008-10#2)
been used to express##2##4##(1993-6#1)(2008-4#1)
been used to fabricate##2##4##(2008-10#1)(2008-3#1)
been used to find the##2##5##(2007-12#1)(2008-10#1)
been used to generate##4##4##(1994-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
been used to identify##9##4##(1992-3#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-1#1)(2012-3#1)
been used to improve##2##4##(2008-10#1)(2009-12#1)
been used to investigate the##6##5##(1990-8#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
been used to investigate##7##4##(1990-8#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-3#2)(2008-4#1)
been used to measure the##2##5##(1994-9#1)(2008-3#1)
been used to measure##6##4##(1994-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)
been used to monitor the##4##5##(1992-3#1)(1994-5#1)(2008-10#1)(2008-11#1)
been used to monitor##5##4##(1992-3#1)(1994-5#1)(2008-10#2)(2008-11#1)
been used to obtain##3##4##(2008-3#1)(2009-11#1)(2009-8#1)
been used to optimize the##3##5##(1997-2#1)(2008-10#2)
been used to probe the##4##5##(1995-6#1)(2008-10#3)
been used to reduce##3##4##(1996-11#1)(2008-1#1)(2008-2#1)
been used to resolve##2##4##(1990-8#1)(2007-7#1)
been used to screen##2##4##(2008-2#1)(2008-8#1)
been used to study the##13##5##(1990-11#1)(1991-8#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#2)
been used to study##21##4##(1990-11#1)(1991-12#1)(1991-8#1)(1994-5#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
been used to treat##4##4##(1993-11#1)(1993-2#1)(1996-11#1)(2008-8#1)
been used to##202##3##(1990-11#3)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#6)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#8)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#61)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#10)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
been used widely##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
been used with success for##2##5##(1992-11#1)(2007-11#1)
been used with##6##3##(1992-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)
been used##539##2##(1990-11#4)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#8)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#17)(2007-12#6)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#170)(2008-11#15)(2008-12#3)(2008-2#12)(2008-3#28)(2008-4#18)(2008-5#20)(2008-6#10)(2008-7#21)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#11)(2011-1#4)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#4)(2013-8#2)
been useful in##3##3##(1991-3#1)(2008-2#2)
been useful##6##2##(1991-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#1)
been using the##2##3##(1994-1#1)(2008-5#1)
been using##5##2##(1993-3#1)(1994-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
been utilized as an##5##4##(1991-9#1)(2008-10#3)(2012-7#1)
been utilized as##8##3##(1991-9#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-7#1)
been utilized for##6##3##(1990-12#1)(2007-11#1)(2008-10#3)(2009-10#1)
been utilized in##2##3##(2008-10#1)(2008-12#1)
been utilized to study##2##4##(2008-3#2)
been utilized to##11##3##(1990-5#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-12#1)
been utilized##30##2##(1990-12#2)(1990-5#1)(1991-9#1)(1995-3#1)(1996-5#1)(1997-1#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-7#1)
been vaccinated##5##2##(1990-11#1)(1995-9#1)(2007-2#1)(2009-5#2)
been validated against##2##3##(2008-7#1)(2010-9#1)
been validated by##6##3##(2008-10#6)
been validated in##4##3##(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
been validated##28##2##(1990-2#1)(1994-3#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2013-1#4)
been verified by##7##3##(2007-11#1)(2008-10#5)(2008-2#1)
been verified experimentally##4##3##(1997-1#1)(1997-6#1)(2008-2#1)(2008-3#1)
been verified in##2##3##(1994-2#1)(2008-2#1)
been verified##20##2##(1992-12#1)(1994-2#1)(1997-1#1)(1997-6#1)(2007-11#2)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#1)
been very limited##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
been very little##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
been very successful##3##3##(1995-9#1)(2008-10#1)(2008-4#1)
been very##20##2##(1990-5#1)(1991-9#1)(1994-6#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#2)
been viewed as##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
been violated##2##2##(1995-12#1)(2011-2#1)
been visualized by##3##3##(1995-12#1)(2008-11#1)(2008-9#1)
been visualized##4##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-9#1)
been weakened##2##2##(2006-10#1)(2008-1#1)
been well characterized in##2##4##(1995-11#1)(2009-4#1)
been well characterized##5##3##(1991-12#1)(1995-11#1)(2006-10#1)(2009-4#1)(2009-7#1)
been well defined##3##3##(1992-3#1)(2008-10#1)(2011-1#1)
been well described##4##3##(2007-7#1)(2008-11#1)(2008-9#1)(2011-2#1)
been well documented in##3##4##(1997-8#1)(2007-8#1)(2008-12#1)
been well documented##11##3##(1994-12#1)(1995-1#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
been well established that##2##4##(1992-9#1)(2008-9#1)
been well established##12##3##(1992-9#1)(1994-10#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
been well recognized##2##3##(1996-11#1)(2010-2#1)
been well studied##5##3##(1991-12#1)(1997-3#1)(2008-1#2)(2012-2#1)
been well##58##2##(1991-12#2)(1992-3#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
been well-documented##3##2##(1997-1#1)(2009-4#1)(2010-3#1)
been widely accepted##2##3##(1991-6#1)(2013-1#1)
been widely adopted for##2##4##(2008-10#1)(2008-3#1)
been widely adopted##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
been widely applied##2##3##(2010-12#1)(2013-8#1)
been widely discussed##4##3##(1994-2#1)(2008-11#1)(2009-6#1)(2009-9#1)
been widely implemented in##2##4##(1992-1#1)(2008-7#1)
been widely investigated##3##3##(1990-7#1)(2008-7#1)(2012-2#1)
been widely recognized##2##3##(2009-8#1)(2010-12#1)
been widely reported in##3##4##(2007-12#1)(2008-9#1)(2009-3#1)
been widely reported##4##3##(2007-12#1)(2008-9#1)(2009-3#1)(2012-12#1)
been widely studied##4##3##(2008-2#1)(2008-9#1)(2010-4#1)(2011-1#1)
been widely used as##6##4##(1992-11#1)(2008-10#2)(2008-5#1)(2010-11#1)(2012-2#1)
been widely used for the##6##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-8#1)
been widely used for##10##4##(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2013-8#1)
been widely used in##10##4##(1990-11#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-3#2)(2013-1#2)
been widely used to study##2##5##(2009-9#1)(2012-3#1)
been widely used to##4##4##(1990-8#1)(2009-9#1)(2012-3#2)
been widely used##31##3##(1990-11#1)(1990-8#1)(1992-11#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-9#1)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
been widely##73##2##(1990-11#1)(1990-7#2)(1990-8#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
been withdrawn##15##2##(2007-2#1)(2008-10#1)(2008-11#9)(2008-7#1)(2012-3#1)(2013-1#2)
been without##2##2##(1990-8#1)(2008-1#1)
been worked out for##2##4##(1991-11#1)(1992-9#1)
been worked out##3##3##(1991-11#1)(1992-9#1)(2008-2#1)
been written about##10##3##(1991-3#1)(1992-1#1)(1994-8#1)(1995-3#1)(2007-9#1)(2008-11#2)(2010-10#1)(2012-2#2)
been written##17##2##(1991-3#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2010-10#1)(2010-2#1)(2012-2#2)
been##12190##1##(1990-10#5)(1990-11#60)(1990-12#42)(1990-2#33)(1990-3#25)(1990-5#62)(1990-6#32)(1990-7#24)(1990-8#50)(1990-9#23)(1991-1#12)(1991-10#3)(1991-11#14)(1991-12#62)(1991-2#42)(1991-3#42)(1991-4#7)(1991-5#32)(1991-6#33)(1991-7#6)(1991-8#14)(1991-9#33)(1992-1#21)(1992-10#17)(1992-11#36)(1992-12#45)(1992-2#34)(1992-3#48)(1992-4#10)(1992-5#20)(1992-6#42)(1992-7#1)(1992-8#46)(1992-9#40)(1993-1#15)(1993-10#2)(1993-11#40)(1993-12#49)(1993-2#31)(1993-3#45)(1993-5#1)(1993-6#36)(1993-8#35)(1993-9#27)(1994-1#12)(1994-10#2)(1994-11#33)(1994-12#88)(1994-2#49)(1994-3#47)(1994-5#58)(1994-6#48)(1994-7#6)(1994-8#49)(1994-9#37)(1995-1#9)(1995-10#1)(1995-11#29)(1995-12#51)(1995-2#73)(1995-3#44)(1995-4#1)(1995-5#49)(1995-6#65)(1995-8#28)(1995-9#10)(1996-1#31)(1996-10#4)(1996-11#26)(1996-12#55)(1996-2#64)(1996-3#45)(1996-4#6)(1996-5#42)(1996-6#21)(1996-7#6)(1996-8#14)(1996-9#10)(1997-1#38)(1997-2#57)(1997-3#44)(1997-4#60)(1997-5#24)(1997-6#46)(1997-7#65)(1997-8#45)(1997-9#4)(2006-10#42)(2006-12#12)(2006-4#7)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#46)(2007-11#220)(2007-12#213)(2007-2#21)(2007-4#2)(2007-5#16)(2007-6#9)(2007-7#50)(2007-8#81)(2007-9#7)(2008-1#134)(2008-10#2778)(2008-11#497)(2008-12#118)(2008-2#271)(2008-3#552)(2008-4#203)(2008-5#319)(2008-6#133)(2008-7#461)(2008-8#248)(2008-9#225)(2009-1#8)(2009-10#47)(2009-11#38)(2009-12#46)(2009-2#20)(2009-3#33)(2009-4#23)(2009-5#75)(2009-6#41)(2009-7#40)(2009-8#68)(2009-9#32)(2010-1#36)(2010-10#44)(2010-11#46)(2010-12#77)(2010-2#22)(2010-3#59)(2010-4#47)(2010-5#66)(2010-6#56)(2010-7#42)(2010-8#101)(2010-9#14)(2011-1#143)(2011-10#1)(2011-2#346)(2011-3#30)(2011-4#2)(2011-7#5)(2012-1#44)(2012-12#146)(2012-2#248)(2012-3#178)(2012-4#3)(2012-5#5)(2012-6#1)(2012-7#7)(2012-8#4)(2013-1#314)(2013-2#1)(2013-7#43)(2013-8#121)
beer and wine##2##3##(1997-1#1)(2008-10#1)
beer and##3##2##(1997-1#1)(2008-10#2)
beer aroma##2##2##(2008-10#2)
beer fermentation##5##2##(2008-10#3)(2008-7#2)
beer samples##6##2##(2008-10#6)
beer were##2##2##(2008-10#2)
beer##42##1##(1991-5#1)(1997-1#1)(2008-10#31)(2008-6#1)(2008-7#2)(2009-7#1)(2011-1#1)(2012-2#4)
beers by##3##2##(2008-10#3)
beers##13##1##(2008-10#13)
bees as##2##2##(2008-5#1)(2008-7#1)
bees were##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
bees##26##1##(1992-3#1)(2007-12#2)(2008-10#3)(2008-5#6)(2008-6#8)(2008-7#3)(2008-9#1)(2013-1#2)
beet cyst nematode##5##3##(2008-10#2)(2008-12#3)
beet cyst##6##2##(2008-10#2)(2008-12#4)
beet seedlings##4##2##(2008-10#4)
beet yellow stunt virus##2##4##(2008-10#2)
beet##67##1##(1994-8#1)(2008-10#46)(2008-12#15)(2008-5#3)(2012-3#2)
beetle Philonthus##2##2##(2007-12#2)
beetle populations##4##2##(2008-10#2)(2011-2#2)
beetle species##2##2##(2008-10#1)(2013-1#1)
beetle##39##1##(1992-8#1)(2007-12#5)(2008-10#13)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2011-2#5)(2013-1#1)
beetles (Coleoptera##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
beetles and##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
beetles at##2##2##(2008-10#1)(2008-9#1)
beetles infested with P##3##4##(2008-10#3)
beetles may##2##2##(2008-10#1)(2008-12#1)
beetles were##3##2##(2008-10#2)(2008-5#1)
beetles##47##1##(2007-12#4)(2008-10#18)(2008-12#1)(2008-5#7)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2011-2#6)(2013-7#2)
beets and##3##2##(2008-10#3)
beets##12##1##(2008-10#12)
before (15 -##2##3##(2011-2#2)
before 1960##2##2##(2008-10#1)(2010-1#1)
before CPB##2##2##(2007-8#2)
before PD start##2##3##(2011-2#2)
before SL##2##2##(1991-4#2)
before September 1994##2##3##(1994-8#1)(2008-2#1)
before a##18##2##(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2009-8#1)(2010-12#1)(2013-1#1)
before acclimatization in July and after acclimatization in September##2##9##(2009-12#2)
before acclimatization##3##2##(2009-12#3)
before acute food##2##3##(2011-1#2)
before adding##2##2##(1994-6#1)(2008-10#1)
before administration##2##2##(2010-5#1)(2011-2#1)
before admission to the hospital##2##5##(1997-7#1)(2011-1#1)
before admission##5##2##(1992-4#1)(1996-3#1)(1997-7#1)(2011-1#1)(2013-8#1)
before age##5##2##(1993-1#1)(1997-4#1)(2007-8#2)(2012-12#1)
before all the##2##3##(1992-12#1)(1997-4#1)
before an##10##2##(1994-2#1)(1995-12#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
before analysis##7##2##(1990-12#1)(1991-5#1)(2008-10#5)
before and 2##2##3##(2008-10#2)
before and 3 months after##2##5##(2008-10#2)
before and after 3##2##4##(1994-6#1)(2008-10#1)
before and after N-glycanase treatment##2##5##(1990-11#1)(1991-12#1)
before and after a##11##4##(1990-2#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
before and after an##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
before and after contact with##2##5##(2008-10#1)(2012-12#1)
before and after each##2##4##(1996-12#1)(2013-8#1)
before and after exposure##2##4##(2008-10#1)(2013-1#1)
before and after implementation of the##2##6##(1995-12#1)(2006-10#1)
before and after intervention##2##4##(2011-2#1)(2012-3#1)
before and after laser##2##4##(2007-12#2)
before and after off road driving]##2##6##(1990-6#2)
before and after one##2##4##(1991-11#1)(2011-1#1)
before and after phenelzine treatment##3##5##(1996-7#3)
before and after surgery##3##4##(1990-8#1)(2007-8#1)(2012-2#1)
before and after surgical##3##4##(2007-8#3)
before and after the addition of##3##6##(2008-10#2)(2008-4#1)
before and after the application of##3##6##(2008-5#1)(2013-1#2)
before and after the intervention##4##5##(2008-12#4)
before and after the treatment##2##5##(2010-12#1)(2013-1#1)
before and after the##44##4##(1991-5#1)(1991-6#1)(1992-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#2)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-12#6)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#5)(2013-8#2)
before and after therapy##4##4##(1990-3#1)(2007-8#1)(2008-10#1)(2012-1#1)
before and after treatment##9##4##(1991-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#2)(2011-1#2)(2013-1#1)
before and after##193##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#4)(1997-2#2)(1997-3#1)(1997-4#2)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#3)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#4)
before and at the end of the##2##7##(2008-5#1)(2008-7#1)
before and at the end of##3##6##(2008-10#1)(2008-5#1)(2008-7#1)
before and at##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
before and during the procedure##2##5##(1992-12#1)(2008-5#1)
before and during the##4##4##(1992-11#1)(1992-12#1)(2008-10#1)(2008-5#1)
before and during##11##3##(1990-5#1)(1992-11#1)(1992-12#2)(1993-1#1)(1994-3#1)(1996-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
before and following##2##3##(1990-5#1)(2007-10#1)
before and immediately after##2##4##(2007-7#1)(2009-6#1)
before and##233##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-6#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#13)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#9)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#6)(2009-12#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#15)(2013-7#1)(2013-8#5)
before and/or##2##2##(2008-1#1)(2012-2#1)
before any##7##2##(1995-6#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
before aspiration into the##2##4##(2008-10#2)
before attempting##2##2##(1997-6#1)(2008-10#1)
before becoming##3##2##(1991-11#1)(1995-2#1)(2008-9#1)
before been##3##2##(2008-2#1)(2008-7#1)(2012-1#1)
before beginning##3##2##(1994-1#1)(1996-3#1)(2013-1#1)
before being##13##2##(1990-12#1)(1990-5#1)(1991-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#2)(2010-8#1)(2013-8#1)
before birth##3##2##(1991-11#1)(1993-3#1)(2008-7#1)
before canopy development##2##3##(2008-10#2)
before canopy##3##2##(2008-10#3)
before chemotherapy##2##2##(2008-7#1)(2011-2#1)
before commencement of##2##3##(2008-7#1)(2012-12#1)
before committing##2##2##(1991-3#1)(2008-7#1)
before conception##3##2##(1990-9#2)(1994-3#1)
before conducting##2##2##(1996-5#1)(2013-1#1)
before current##2##2##(1995-5#1)(2012-3#1)
before death##7##2##(1990-9#1)(1991-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(2009-6#1)(2011-1#1)
before decomposition##2##2##(2008-10#2)
before definitive##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
before delivery##2##2##(1995-8#1)(2008-2#1)
before determining##2##2##(2008-5#1)(2008-7#1)
before developing##2##2##(2008-1#1)(2008-10#1)
before development##2##2##(1991-9#1)(2007-11#1)
before discharge from the##2##4##(2008-11#1)(2009-3#1)
before discharge##3##2##(2008-11#1)(2009-3#1)(2010-7#1)
before dying##2##2##(1990-10#2)
before each##5##2##(1993-6#1)(1997-7#1)(2008-5#1)(2008-6#1)(2008-8#1)
before eclosion##2##2##(2007-12#2)
before embarking on##3##3##(1991-2#1)(1997-1#1)(2009-11#1)
before entering##3##2##(2008-10#2)(2012-2#1)
before examination##2##2##(1993-1#1)(1997-1#1)
before exposure of##2##3##(2007-12#1)(2011-2#1)
before exposure##3##2##(1990-11#1)(2007-12#1)(2011-2#1)
before fertilization##2##2##(2008-11#1)(2009-12#1)
before final##2##2##(2008-10#1)(2008-11#1)
before for##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
before formation of a##2##4##(2008-10#2)
before freezing##2##2##(2008-10#2)
before further##2##2##(2008-10#1)(2008-3#1)
before giving##2##2##(2010-1#1)(2012-2#1)
before grazing on##2##3##(2012-2#2)
before grazing##4##2##(2012-2#4)
before harvest##4##2##(2008-10#4)
before hatching##2##2##(2008-11#1)(2008-8#1)
before he##2##2##(1994-12#1)(1996-5#1)
before heat##2##2##(1995-2#1)(2007-12#1)
before hospitalization##2##2##(1993-1#1)(1995-5#1)
before hysteroscopic##2##2##(1996-2#2)
before implementing##3##2##(1994-2#2)(2009-6#1)
before in the##4##3##(1997-8#1)(2007-12#1)(2008-11#1)(2011-2#1)
before in##6##2##(1994-5#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
before induction of##3##3##(1991-9#1)(2007-8#1)(2010-7#1)
before induction##5##2##(1991-9#1)(1995-12#1)(2007-8#1)(2010-7#2)
before infection##2##2##(2008-10#2)
before initiating##2##2##(2010-12#1)(2011-2#1)
before initiation of the##2##4##(2008-10#1)(2008-3#1)
before initiation of##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
before injecting the##2##3##(2007-8#1)(2008-10#1)
before injection##2##2##(2011-3#1)(2012-3#1)
before inoculation reduced##2##3##(2008-10#2)
before inoculation with##7##3##(2008-10#7)
before inoculation##12##2##(2008-10#12)
before intervention##2##2##(2008-7#1)(2013-1#1)
before irradiation##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)
before ischemia##2##2##(1991-5#1)(2008-12#1)
before it is##4##3##(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
before it##9##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
before its##3##2##(1991-11#1)(2008-10#2)
before mating##2##2##(2008-8#1)(2008-9#1)
before measurement##2##2##(2008-10#1)(2008-5#1)
before mixing##2##2##(2009-7#1)(2011-2#1)
before obtaining##2##2##(1990-12#1)(1997-1#1)
before onset of the disease##2##5##(1991-12#1)(1993-9#1)
before onset of the##3##4##(1991-12#1)(1993-9#1)(1996-11#1)
before operation##2##2##(2007-11#1)(2008-12#1)
before or after the##4##4##(1993-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
before or after##19##3##(1991-2#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
before or during##2##3##(2010-4#1)(2011-2#1)
before or##26##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
before organ transplantation##2##3##(1997-5#2)
before ovulation##4##2##(1994-7#3)(2008-12#1)
before parturition##3##2##(2010-2#3)
before patients##2##2##(1995-1#1)(2012-3#1)
before performing##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
before planting##2##2##(2008-10#2)
before pregnancy##3##2##(1997-8#1)(2009-1#1)(2009-3#1)
before proceeding##2##2##(1992-2#1)(2008-10#1)
before puberty##2##2##(1991-2#1)(2008-4#1)
before public##2##2##(1994-2#1)(1996-2#1)
before reaching the##2##3##(2008-4#1)(2008-7#1)
before reaching##5##2##(1993-6#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
before registration##2##2##(2008-11#2)
before rehabilitation##2##2##(2007-10#1)(2007-8#1)
before returning to##2##3##(2008-5#1)(2009-11#1)
before separation##3##2##(1990-7#1)(2009-2#1)(2012-1#1)
before she##2##2##(1995-12#1)(2010-3#1)
before spawning##2##2##(2010-8#2)
before stage##2##2##(2007-8#2)
before start of##2##3##(1994-12#1)(2008-1#1)
before start##3##2##(1994-12#1)(2008-1#1)(2008-8#1)
before such##2##2##(2008-10#1)(2010-10#1)
before surgery and##7##3##(1995-2#1)(2007-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
before surgery to##3##3##(2007-11#1)(2008-8#2)
before surgery with##2##3##(2007-8#1)(2013-8#1)
before surgery##38##2##(1990-6#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-3#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
before testing##2##2##(2008-11#1)(2010-8#1)
before that##3##2##(1990-10#1)(1997-1#1)(2009-10#1)
before the advent of the##2##5##(1996-11#1)(2008-4#1)
before the advent of##3##4##(1996-11#1)(2008-4#1)(2009-10#1)
before the age of 5 years##2##6##(1997-3#1)(2007-8#1)
before the age of##11##4##(1990-12#1)(1992-1#1)(1996-11#1)(1997-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
before the appearance of clinical##2##5##(1992-5#1)(2008-9#1)
before the appearance of##3##4##(1992-5#1)(2008-1#1)(2008-9#1)
before the beginning of the##2##5##(1990-2#1)(2008-5#1)
before the birth##2##3##(2007-11#1)(2008-9#1)
before the colonoscopy##3##3##(2011-2#3)
before the commencement of##2##4##(2007-5#1)(2008-6#1)
before the completion of##3##4##(1992-6#1)(2012-2#2)
before the development of##3##4##(2008-1#1)(2009-11#1)(2012-1#1)
before the disease##3##3##(2008-10#2)(2012-3#1)
before the end of the##3##5##(1996-11#1)(2008-9#2)
before the end of##5##4##(1996-11#1)(2007-11#1)(2008-6#1)(2008-9#2)
before the experiments##2##3##(1992-8#1)(2010-2#1)
before the first##6##3##(1995-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2010-5#1)(2013-1#1)
before the interview##2##3##(1990-12#2)
before the introduction of##3##4##(2007-8#1)(2008-7#1)(2009-12#1)
before the last larval##2##4##(1992-6#1)(2007-12#1)
before the measurement##2##3##(2008-10#1)(2008-5#1)
before the mortality event##2##4##(2008-5#2)
before the mortality##3##3##(2008-5#3)
before the onset of##17##4##(1990-12#1)(1990-3#1)(1990-8#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
before the operation##4##3##(1990-3#1)(1994-3#1)(2007-8#1)(2008-10#1)
before the past 12 months##2##5##(2009-5#2)
before the patient##2##3##(1994-9#1)(2008-7#1)
before the procedure##2##3##(2008-12#1)(2012-12#1)
before the pulse##2##3##(2007-12#1)(2008-7#1)
before the second operation##3##4##(2008-7#3)
before the split of##2##4##(2008-1#1)(2009-10#1)
before the start of a##2##5##(1996-6#1)(2008-10#1)
before the start of the##3##5##(2008-12#1)(2008-8#1)(2012-2#1)
before the start of##8##4##(1991-6#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
before the study##6##3##(1996-5#1)(1997-5#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)
before the test##2##3##(2008-1#1)(2009-10#1)
before the##254##2##(1990-12#6)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#4)(1992-8#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#2)(1995-12#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#6)(2008-10#27)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#12)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#1)
before their##13##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)
before therapy##3##2##(2007-10#2)(2008-4#1)
before these##3##2##(1992-3#1)(2008-2#1)(2008-5#1)
before they are##5##3##(1992-12#1)(1994-3#1)(1995-5#1)(2007-7#1)(2008-4#1)
before they began##2##3##(2008-10#1)(2010-3#1)
before they can##3##3##(1994-12#1)(2008-7#1)(2012-12#1)
before they were##2##3##(1994-3#1)(2008-10#1)
before they##19##2##(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-5#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
before this##8##2##(1990-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(2008-10#2)(2010-10#1)(2011-2#1)
before to##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
before transplantation##6##2##(1997-5#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-2#1)
before treatment and after##3##4##(2008-7#1)(2013-8#2)
before treatment and##8##3##(1991-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2013-8#2)
before treatment is initiated##2##4##(1994-6#1)(2010-3#1)
before treatment is##3##3##(1993-9#1)(1994-6#1)(2010-3#1)
before treatment with infliximab##4##4##(2013-8#4)
before treatment with##6##3##(2008-10#1)(2012-3#1)(2013-8#4)
before treatment##25##2##(1991-8#1)(1991-9#1)(1993-9#1)(1994-6#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-3#2)(2013-8#6)
before undertaking##2##2##(2007-11#1)(2008-10#1)
before use##2##2##(2011-2#2)
before using them##2##3##(1997-4#1)(2011-2#1)
before using##5##2##(1997-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
before virus##2##2##(1997-6#1)(2008-10#1)
before visible##3##2##(2008-10#2)(2008-11#1)
before we can##2##3##(1995-6#1)(2008-1#1)
before we##5##2##(1995-11#1)(1995-6#1)(1997-1#1)(2008-1#1)(2010-9#1)
before widespread##2##2##(1993-3#1)(2011-2#1)
before you##2##2##(1994-2#1)(1994-3#1)
before##1495##1##(1990-10#3)(1990-11#3)(1990-12#13)(1990-2#4)(1990-3#6)(1990-5#6)(1990-6#8)(1990-7#2)(1990-8#3)(1990-9#5)(1991-11#7)(1991-12#6)(1991-2#10)(1991-3#9)(1991-4#3)(1991-5#7)(1991-6#8)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#9)(1992-2#6)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#7)(1992-8#3)(1993-1#5)(1993-10#1)(1993-11#4)(1993-12#8)(1993-2#2)(1993-3#10)(1993-5#2)(1993-6#8)(1993-8#1)(1993-9#7)(1994-1#3)(1994-11#3)(1994-12#8)(1994-2#9)(1994-3#13)(1994-5#9)(1994-6#5)(1994-7#4)(1994-8#6)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#14)(1995-2#4)(1995-3#8)(1995-5#10)(1995-6#7)(1995-8#3)(1996-1#3)(1996-11#6)(1996-12#5)(1996-2#11)(1996-3#6)(1996-4#4)(1996-5#9)(1996-6#5)(1996-7#6)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#6)(1997-3#7)(1997-4#13)(1997-5#5)(1997-6#7)(1997-7#4)(1997-8#5)(2006-10#5)(2006-12#3)(2006-6#2)(2007-10#9)(2007-11#27)(2007-12#32)(2007-2#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#40)(2007-9#1)(2008-1#24)(2008-10#211)(2008-11#36)(2008-12#23)(2008-2#22)(2008-3#33)(2008-4#15)(2008-5#48)(2008-6#11)(2008-7#50)(2008-8#30)(2008-9#29)(2009-1#2)(2009-10#11)(2009-11#5)(2009-12#10)(2009-2#1)(2009-3#8)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#14)(2010-2#8)(2010-3#4)(2010-4#6)(2010-5#3)(2010-6#5)(2010-7#8)(2010-8#13)(2010-9#1)(2011-1#10)(2011-2#72)(2011-3#6)(2012-1#9)(2012-12#23)(2012-2#34)(2012-3#23)(2012-5#1)(2012-6#1)(2013-1#51)(2013-7#8)(2013-8#25)
before&quot##2##1##(1993-12#1)(1996-1#1)
before-after study##2##2##(2008-12#2)
beforehand##3##1##(2007-11#1)(2008-10#1)(2008-7#1)
began a breeding regimen of six consecutive##3##7##(1997-4#3)
began a##6##2##(1996-2#1)(1997-4#3)(2008-5#2)
began and##2##2##(1990-10#1)(1992-2#1)
began as a##2##3##(2008-1#1)(2011-9#1)
began at##3##2##(1991-11#1)(2008-10#1)(2010-8#1)
began first##2##2##(2008-6#1)(2008-8#1)
began in the early##3##4##(1992-10#1)(2008-3#1)(2009-7#1)
began in the##7##3##(1992-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-7#1)(2013-1#1)
began in##17##2##(1992-10#1)(1994-8#1)(1995-12#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
began its##2##2##(1992-10#1)(1997-2#1)
began the##2##2##(2010-3#1)(2012-2#1)
began to appear##2##3##(2008-2#1)(2011-2#1)
began to be expressed in the lumen of the gut tube on day 16##2##14##(1993-6#2)
began to be##4##3##(1992-6#1)(1993-6#2)(2008-5#1)
began to develop##2##3##(2007-12#1)(2008-10#1)
began to form##2##3##(2008-10#1)(2008-11#1)
began to take##2##3##(2011-2#1)(2013-8#1)
began to##34##2##(1990-11#1)(1990-4#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-6#1)(1995-3#1)(1995-6#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
began with a##3##3##(2008-5#1)(2010-8#1)(2011-2#1)
began with the##5##3##(1997-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-3#1)
began with##12##2##(1997-8#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
began##115##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-10#2)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
begin a##2##2##(2008-3#1)(2008-7#1)
begin at the##2##3##(1995-6#1)(2012-3#1)
begin at##3##2##(1995-6#1)(2007-12#1)(2012-3#1)
begin by##4##2##(2008-11#1)(2008-6#1)(2010-4#1)(2013-8#1)
begin in##4##2##(1996-3#1)(2008-5#2)(2008-7#1)
begin now##2##2##(1993-2#1)(1995-12#1)
begin the##2##2##(1993-12#1)(2012-2#1)
begin their##2##2##(2007-2#1)(2008-10#1)
begin this##2##2##(1995-1#1)(2008-6#1)
begin to address the##2##4##(1992-1#1)(1993-12#1)
begin to address##3##3##(1992-1#1)(1993-12#1)(1994-2#1)
begin to explore##2##3##(1994-6#1)(1997-1#1)
begin to understand the##2##4##(2008-8#1)(2009-12#1)
begin to##33##2##(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#2)(1994-6#1)(1995-5#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-1#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
begin with the##2##3##(2008-2#1)(2010-8#1)
begin with##10##2##(1995-3#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
begin##92##1##(1990-3#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-1#2)(1994-2#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-7#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
beginner##4##1##(2007-11#1)(2008-11#1)(2010-8#1)(2012-3#1)
beginners##2##1##(2011-1#1)(2012-3#1)
beginning a##4##2##(1996-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
beginning and##8##2##(1990-9#2)(2007-2#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
beginning at##14##2##(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-9#1)
beginning before the##2##3##(1992-2#1)(2008-7#1)
beginning in January 1992##2##4##(1992-1#1)(1992-12#1)
beginning in##10##2##(1992-1#1)(1992-12#1)(1992-2#1)(1996-3#1)(1996-4#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
beginning nursing##2##2##(2008-11#1)(2008-12#1)
beginning of the 20th century##4##5##(2009-7#3)(2010-10#1)
beginning of the exercises##2##4##(2007-11#2)
beginning of the study##3##4##(1991-8#1)(2008-9#1)(2011-1#1)
beginning of the##58##3##(1990-12#1)(1990-2#1)(1991-7#1)(1991-8#1)(1992-2#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-5#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#4)(2010-10#1)(2010-2#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
beginning of this##2##3##(1997-4#1)(2007-8#1)
beginning of##115##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-2#2)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)
beginning on day##2##3##(1994-8#2)
beginning on the##2##3##(1990-3#1)(2012-2#1)
beginning on##4##2##(1990-3#1)(1994-8#2)(2012-2#1)
beginning the##3##2##(1997-4#1)(2008-5#1)(2010-11#1)
beginning to be understood##3##4##(1997-7#1)(2007-12#1)(2009-8#1)
beginning to be##7##3##(1997-7#1)(2007-12#2)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
beginning to demand##2##3##(1997-1#1)(2008-11#1)
beginning to emerge##5##3##(1995-9#1)(2007-12#2)(2011-2#2)
beginning to establish##2##3##(2008-7#1)(2008-8#1)
beginning to implement##2##3##(1993-2#1)(1994-2#1)
beginning to see##2##3##(1992-1#1)(2010-4#1)
beginning to understand##2##3##(2007-4#1)(2011-2#1)
beginning to##42##2##(1991-3#1)(1992-1#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-9#1)(1997-1#1)(1997-7#1)(2007-12#4)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#5)
beginning with ischaemia onset up to##2##6##(1993-9#2)
beginning with the development of a concept and needs assessment and ending with the influence a women's health center has on health care for others##2##25##(1994-3#2)
beginning with the##9##3##(1994-3#2)(1995-12#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-1#1)(2013-8#1)
beginning with##16##2##(1992-1#1)(1993-9#2)(1994-3#2)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#2)(2012-12#1)(2013-1#1)(2013-8#1)
beginning##273##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#3)(1991-12#4)(1991-3#1)(1991-7#1)(1991-8#2)(1992-1#4)(1992-12#1)(1992-2#5)(1992-3#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#38)(2008-11#15)(2008-12#7)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#6)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#1)
beginnings##6##1##(1996-3#1)(2008-10#4)(2008-9#1)
begins after##2##2##(1995-3#1)(2008-10#1)
begins at##9##2##(1994-3#1)(1995-6#2)(1996-11#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-6#1)
begins by identifying##2##3##(2008-11#2)
begins by##8##2##(1994-3#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-9#1)
begins in the##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
begins in##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
begins to##14##2##(1993-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2013-1#1)
begins with a discussion of##3##5##(2008-4#1)(2009-4#1)(2012-2#1)
begins with a##7##3##(1993-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2012-2#1)
begins with an##2##3##(1992-1#1)(2008-4#1)
begins with the##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2010-3#1)
begins with##24##2##(1992-1#1)(1992-3#1)(1993-3#1)(1995-1#1)(1995-12#2)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-9#2)(2009-4#1)(2009-9#1)(2010-3#1)(2012-12#2)(2012-2#1)
begins##83##1##(1990-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-5#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-3#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-5#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
begomovirus species##9##2##(2008-10#9)
begomovirus##25##1##(2008-10#25)
begomoviruses and##3##2##(2008-10#3)
begomoviruses from##3##2##(2008-10#3)
begomoviruses in##3##2##(2008-10#3)
begomoviruses may##2##2##(2008-10#2)
begomoviruses with##2##2##(2008-10#2)
begomoviruses##35##1##(2008-10#35)
begun the##2##2##(1993-6#1)(2011-2#1)
begun to be##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
begun to develop##2##3##(1994-1#1)(2006-6#1)
begun to provide##2##3##(2008-10#1)(2011-2#1)
begun to reveal the##2##4##(2008-10#1)(2008-9#1)
begun to reveal##3##3##(1993-5#1)(2008-10#1)(2008-9#1)
begun to yield##2##3##(2007-10#1)(2010-1#1)
begun to##41##2##(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#2)
begun##58##1##(1991-12#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
behalf of##14##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-1#2)(1995-6#3)(1997-5#1)(2010-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
behalf##19##1##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#2)(1995-12#1)(1995-6#3)(1997-5#1)(2009-5#2)(2010-10#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
behave as##11##2##(1990-11#1)(1992-8#1)(1993-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)
behave differently in##2##3##(1992-5#1)(2008-10#1)
behave differently##3##2##(1992-5#1)(2007-12#1)(2008-10#1)
behave in##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
behave like the##2##3##(1994-6#1)(2008-10#1)
behave like##7##2##(1991-2#1)(1991-8#1)(1992-12#1)(1994-6#1)(1997-6#1)(2008-10#2)
behave##32##1##(1990-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#3)
behaved as a competitive inhibitor##2##5##(1991-12#1)(1993-8#1)
behaved as##3##2##(1991-12#1)(1993-8#1)(1994-3#1)
behaved differently##3##2##(2008-10#3)
behaved in a similar##3##4##(1990-12#1)(2008-11#1)(2008-9#1)
behaved in a##4##3##(1990-12#1)(2008-11#2)(2008-9#1)
behaved in##5##2##(1990-12#1)(1995-2#1)(2008-11#2)(2008-9#1)
behaved like##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
behaved more##2##2##(2008-12#1)(2008-7#1)
behaved similarly##2##2##(1990-11#1)(2008-10#1)
behaved##22##1##(1990-11#1)(1990-12#1)(1991-12#2)(1992-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
behaves as a reversed-phase packing##2##5##(2008-10#2)
behaves as a##15##3##(1992-8#1)(1993-6#1)(1997-4#1)(2007-11#3)(2008-10#5)(2008-2#1)(2008-7#1)(2010-8#1)(2012-2#1)
behaves as an##3##3##(1991-9#1)(1997-2#1)(2008-2#1)
behaves as##18##2##(1991-9#1)(1992-8#1)(1993-6#1)(1997-2#1)(1997-4#1)(2007-11#3)(2008-10#5)(2008-2#2)(2008-7#1)(2010-8#1)(2012-2#1)
behaves in##2##2##(1995-12#1)(2008-5#1)
behaves like a viscoelastic##2##4##(2012-2#2)
behaves like a##5##3##(1991-11#1)(2008-10#1)(2008-3#1)(2012-2#2)
behaves like##7##2##(1991-11#1)(1991-7#1)(1994-5#1)(2008-10#1)(2008-3#1)(2012-2#2)
behaves well##2##2##(2008-2#1)(2013-7#1)
behaves##38##1##(1991-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-11#4)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-7#1)
behaving animal##2##2##(1991-2#1)(2007-12#1)
behaving animals##3##2##(1991-2#1)(2007-8#1)(2008-4#1)
behaving as##2##2##(2008-3#1)(2010-3#1)
behaving##15##1##(1991-2#2)(1993-12#1)(1993-6#1)(1996-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-3#1)
behavior across##2##2##(2009-10#1)(2009-8#1)
behavior affects##2##2##(2008-3#1)(2008-8#1)
behavior after##3##2##(1991-2#1)(1997-8#1)(2008-9#1)
behavior among##8##2##(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)
behavior and a##2##3##(2009-7#1)(2013-1#1)
behavior and children's early emotion regulation skills##2##7##(2011-2#2)
behavior and determination of##3##4##(2008-10#3)
behavior and disease##2##3##(1995-6#1)(2008-7#1)
behavior and health##4##3##(2009-5#2)(2013-1#2)
behavior and morphology##2##3##(2007-12#1)(2008-8#1)
behavior and of##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
behavior and perceived##2##3##(2007-8#1)(2009-7#1)
behavior and the##17##3##(1991-2#1)(1992-2#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2013-1#3)
behavior and was##2##3##(1995-3#1)(2008-5#1)
behavior and were##2##3##(2008-4#1)(2012-2#1)
behavior and##128##2##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#5)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#15)(2013-7#1)(2013-8#3)
behavior are discussed##2##3##(1994-6#1)(2008-10#1)
behavior are##12##2##(1990-8#1)(1994-6#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2013-1#1)
behavior as a function of the##2##6##(2007-12#1)(2008-3#1)
behavior as a function of##4##5##(2007-12#1)(2008-3#2)(2013-1#1)
behavior as a##8##3##(1993-12#1)(1993-8#1)(2007-12#1)(2008-3#2)(2008-6#1)(2013-1#1)(2013-8#1)
behavior as##11##2##(1993-12#1)(1993-8#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-9#1)(2013-1#1)(2013-8#1)
behavior at all##2##3##(1991-2#1)(2008-10#1)
behavior at the##3##3##(2009-5#1)(2010-9#1)(2013-1#1)
behavior at##17##2##(1991-2#1)(1993-8#2)(1995-8#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-9#1)(2012-3#1)(2013-1#1)
behavior between the##2##3##(2008-10#1)(2010-10#1)
behavior between##8##2##(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#2)(2010-10#1)
behavior by##6##2##(1990-12#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)
behavior can be##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
behavior can##6##2##(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)
behavior change##12##2##(1993-12#2)(1994-12#1)(1997-6#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
behavior concordant with##2##3##(2008-12#2)
behavior depends on##2##3##(2008-11#1)(2008-2#1)
behavior disorders##5##2##(2008-11#1)(2011-1#2)(2013-8#2)
behavior does not##2##3##(1991-6#1)(2009-10#1)
behavior during the##3##3##(1991-2#1)(1995-2#1)(2008-4#1)
behavior during##9##2##(1991-2#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-2#1)
behavior following##2##2##(1991-2#1)(2008-11#1)
behavior for##13##2##(1992-2#1)(1994-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-7#2)(2010-2#1)
behavior from a##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
behavior from##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-12#1)
behavior genetics##2##2##(2008-8#2)
behavior has been##5##3##(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
behavior has not##2##3##(2007-8#1)(2009-9#1)
behavior has##7##2##(2007-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
behavior have been##2##3##(2008-6#1)(2010-8#1)
behavior in 6-hydroxydopamine-treated mice##3##4##(1995-12#3)
behavior in Drosophila##2##3##(2008-8#1)(2008-9#1)
behavior in a##10##3##(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-7#1)(2013-1#2)
behavior in both situation##2##4##(1990-12#2)
behavior in both##3##3##(1990-12#2)(1993-5#1)
behavior in children##3##3##(2008-11#2)(2013-1#1)
behavior in continuous##3##3##(2008-11#1)(2008-7#2)
behavior in different##2##3##(2012-1#1)(2013-8#1)
behavior in mouse##2##3##(2008-10#1)(2010-3#1)
behavior in rats##2##3##(1992-6#1)(2012-1#1)
behavior in response to##3##4##(2008-11#2)(2013-8#1)
behavior in the presence of##2##5##(2008-5#1)(2008-8#1)
behavior in the##22##3##(1990-10#1)(1990-6#1)(1991-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2013-1#1)
behavior in vivo##2##3##(1994-9#1)(2008-1#1)
behavior in##123##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-9#1)(1995-12#4)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#8)(2009-11#1)(2009-4#1)(2009-5#3)(2009-8#3)(2009-9#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
behavior induced by##3##3##(1991-1#1)(2007-11#1)(2008-4#1)
behavior is a##2##3##(2008-8#1)(2011-1#1)
behavior is associated with##4##4##(1990-12#1)(2007-12#1)(2009-5#1)(2013-1#1)
behavior is influenced by##2##4##(2008-10#1)(2008-8#1)
behavior is investigated##2##3##(2008-5#1)(2009-7#1)
behavior is more##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
behavior is not##2##3##(2009-7#1)(2011-2#1)
behavior is observed for the##2##5##(1993-11#1)(2008-3#1)
behavior is observed in the##2##5##(2008-1#1)(2009-11#1)
behavior is observed##4##3##(1993-11#1)(2008-1#1)(2008-3#1)(2009-11#1)
behavior is the##2##3##(1990-12#1)(2009-8#1)
behavior is to##2##3##(2008-8#1)(2012-2#1)
behavior is##58##2##(1990-12#2)(1992-12#1)(1993-11#1)(1994-5#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#7)(2008-9#3)(2009-11#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
behavior linked to##2##3##(2009-12#1)(2009-7#1)
behavior management##2##2##(1995-2#2)
behavior may##5##2##(2008-11#1)(2009-9#2)(2011-1#1)(2012-3#1)
behavior observed##6##2##(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)
behavior occurs##2##2##(2008-3#1)(2012-12#1)
behavior of a tunnel diode##2##5##(2008-3#2)
behavior of a##19##3##(1991-4#1)(1992-6#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
behavior of adult##2##3##(1994-8#1)(2012-12#1)
behavior of an##5##3##(2008-10#2)(2008-3#2)(2008-8#1)
behavior of blazed-binary gratings##2##4##(2007-12#2)
behavior of carbon##2##3##(2007-11#1)(2010-2#1)
behavior of cells##3##3##(2008-11#1)(2009-12#1)(2009-7#1)
behavior of different##2##3##(2008-10#2)
behavior of divalent first row transition##2##6##(2008-10#2)
behavior of divalent##3##3##(2008-10#3)
behavior of epinephrine at##2##4##(2008-10#2)
behavior of ethylene##2##3##(2008-11#2)
behavior of hemin##2##3##(2008-10#2)
behavior of individual##3##3##(1994-9#1)(2008-3#1)(2008-9#1)
behavior of infrared##2##3##(2008-3#2)
behavior of patients with##2##4##(1996-2#1)(1996-5#1)
behavior of photon##3##3##(2007-12#1)(2008-3#2)
behavior of pigeons##2##3##(2011-2#2)
behavior of rats##4##3##(1993-3#1)(1995-12#1)(1996-2#1)(1997-6#1)
behavior of sadomasochism##2##3##(2011-1#2)
behavior of solitary##2##3##(2008-6#1)(2008-9#1)
behavior of some##9##3##(1991-4#1)(2008-10#6)(2008-3#1)(2012-3#1)
behavior of such##2##3##(2007-12#1)(2013-8#1)
behavior of the animal##2##4##(2008-5#2)
behavior of the cell##2##4##(2008-1#1)(2008-9#1)
behavior of the chemically modified electrode##2##6##(2008-10#2)
behavior of the complex##2##4##(2008-10#1)(2008-8#1)
behavior of the model is##2##5##(2008-10#1)(2008-8#1)
behavior of the modified electrode##2##5##(2008-10#2)
behavior of the networks##2##4##(2008-11#2)
behavior of the system##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2009-11#1)
behavior of the systems##2##4##(2008-2#1)(2008-5#1)
behavior of the tumor##2##4##(2007-12#1)(2013-1#1)
behavior of the##110##3##(1990-11#1)(1990-8#5)(1991-2#1)(1991-9#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#32)(2008-11#2)(2008-2#9)(2008-3#17)(2008-5#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#3)
behavior of these two##2##4##(1990-7#1)(2010-10#1)
behavior of these##11##3##(1990-7#1)(1991-6#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-10#1)(2011-2#2)
behavior of uranium##2##3##(2008-10#2)
behavior of various##2##3##(1990-7#1)(1994-8#1)
behavior of##421##2##(1990-11#2)(1990-12#1)(1990-6#2)(1990-7#3)(1990-8#6)(1991-2#2)(1991-4#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#6)(1997-6#1)(1997-8#2)(2007-10#2)(2007-11#9)(2007-12#20)(2007-5#1)(2008-1#2)(2008-10#137)(2008-11#11)(2008-12#2)(2008-2#15)(2008-3#45)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#4)(2008-8#18)(2008-9#11)(2009-10#3)(2009-11#3)(2009-12#2)(2009-5#2)(2009-7#5)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#8)(2013-8#2)
behavior on the##3##3##(2008-12#1)(2010-10#1)(2011-2#1)
behavior on##11##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)
behavior one##2##2##(1991-2#1)(2012-12#1)
behavior or##4##2##(1991-2#1)(2008-2#1)(2008-9#1)(2013-1#1)
behavior over##2##2##(1993-8#1)(2008-5#1)
behavior problems##10##2##(1995-2#1)(2008-12#1)(2009-11#2)(2009-9#1)(2010-11#4)(2013-7#1)
behavior revealed##2##2##(2008-10#1)(2008-8#1)
behavior score was##2##3##(1990-12#2)
behavior score##3##2##(1990-12#2)(2012-3#1)
behavior such as##2##3##(2008-1#1)(2012-2#1)
behavior than##5##2##(1990-2#1)(2008-12#1)(2009-7#1)(2009-8#1)(2010-7#1)
behavior that can be##2##4##(2008-4#1)(2010-6#1)
behavior that is##3##3##(1997-2#1)(2007-11#1)(2008-11#1)
behavior that resulted##2##3##(1993-2#1)(2008-2#1)
behavior that##14##2##(1993-12#1)(1993-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-3#1)(2010-6#1)(2013-7#1)
behavior therapy##6##2##(2012-2#2)(2013-1#4)
behavior to##9##2##(1992-2#1)(1992-6#1)(1993-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
behavior toward##2##2##(1993-3#1)(1995-5#1)
behavior under##2##2##(2008-3#2)
behavior using##4##2##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
behavior was also##2##3##(2008-10#1)(2008-3#1)
behavior was found##2##3##(2008-8#1)(2010-4#1)
behavior was observed in##2##4##(2008-11#1)(2008-9#1)
behavior was observed##5##3##(1993-1#1)(1994-5#1)(2008-11#1)(2008-9#1)(2012-1#1)
behavior was used to##3##4##(1990-8#1)(2008-10#1)(2012-3#1)
behavior was##32##2##(1990-8#1)(1991-2#1)(1993-1#1)(1993-3#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#3)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
behavior were studied##3##3##(1990-2#1)(2008-10#2)
behavior were##8##2##(1990-2#1)(2008-10#3)(2008-12#1)(2010-10#1)(2011-1#1)(2013-1#1)
behavior when##4##2##(1990-7#1)(1997-5#1)(2008-12#1)(2008-7#1)
behavior which##4##2##(1990-8#1)(1991-8#1)(2008-11#1)(2009-2#1)
behavior with a##2##3##(1997-7#1)(2008-10#1)
behavior with the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
behavior with##22##2##(1995-1#1)(1996-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
behavior within a##2##3##(2008-6#1)(2009-9#1)
behavior within the##2##3##(1993-12#1)(2008-3#1)
behavior within##5##2##(1993-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)
behavior would##2##2##(2008-11#1)(2008-9#1)
behavior##1541##1##(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#5)(1990-8#14)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#19)(1991-3#1)(1991-4#3)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#2)(1992-6#6)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#17)(1993-2#2)(1993-3#12)(1993-5#4)(1993-6#4)(1993-8#8)(1994-11#1)(1994-12#3)(1994-2#9)(1994-3#3)(1994-5#4)(1994-6#8)(1994-8#6)(1994-9#5)(1995-1#4)(1995-11#1)(1995-12#13)(1995-2#13)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#9)(1996-3#2)(1996-4#3)(1996-5#9)(1996-7#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#3)(2006-12#1)(2007-10#4)(2007-11#26)(2007-12#49)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#8)(2008-1#11)(2008-10#230)(2008-11#81)(2008-12#40)(2008-2#28)(2008-3#82)(2008-4#33)(2008-5#34)(2008-6#28)(2008-7#29)(2008-8#80)(2008-9#50)(2009-10#11)(2009-11#14)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#16)(2009-6#5)(2009-7#35)(2009-8#19)(2009-9#18)(2010-10#10)(2010-11#6)(2010-12#2)(2010-2#5)(2010-3#6)(2010-4#13)(2010-5#6)(2010-6#5)(2010-7#10)(2010-8#5)(2010-9#7)(2011-1#22)(2011-2#37)(2011-3#1)(2012-1#6)(2012-12#23)(2012-2#27)(2012-3#17)(2012-5#2)(2013-1#74)(2013-7#7)(2013-8#18)
behavior)##4##1##(1990-3#1)(2008-11#1)(2008-4#1)(2008-5#1)
behavior?##5##1##(1995-3#1)(2007-8#1)(2008-6#1)(2010-9#1)(2012-12#1)
behavior]##2##1##(1990-3#1)(1995-6#1)
behavioral actions##2##2##(1991-1#1)(1995-5#1)
behavioral activation therapy##2##3##(2009-11#2)
behavioral activation##6##2##(1993-12#1)(1996-12#1)(2009-11#3)(2011-2#1)
behavioral alterations##2##2##(2008-10#1)(2013-8#1)
behavioral analyses##2##2##(1995-12#1)(2008-8#1)
behavioral and cognitive##2##3##(2007-8#2)
behavioral and emotional problems##2##4##(2009-7#1)(2013-1#1)
behavioral and morphological##2##3##(2008-8#2)
behavioral and neurochemical##4##3##(1997-2#1)(2008-4#2)(2011-2#1)
behavioral and physiological responses##2##4##(2008-9#2)
behavioral and physiological##3##3##(2008-10#1)(2008-9#2)
behavioral and##32##2##(1991-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-11#3)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
behavioral assays##4##2##(2008-3#2)(2008-4#2)
behavioral assumptions##2##2##(2008-8#2)
behavioral avoidance##2##2##(2012-2#2)
behavioral change##9##2##(1991-3#2)(1993-2#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
behavioral changes in##3##3##(1996-2#1)(2012-2#1)(2013-1#1)
behavioral changes##11##2##(1996-2#3)(1997-2#1)(2008-6#1)(2009-12#1)(2010-9#1)(2012-2#2)(2013-1#2)
behavioral characteristics of##2##3##(1996-3#1)(2011-1#1)
behavioral concerns##3##2##(1994-1#1)(2007-8#2)
behavioral conditions##2##2##(1994-2#1)(2008-5#1)
behavioral consequences##2##2##(1991-2#1)(1997-7#1)
behavioral control##2##2##(2008-5#1)(2013-1#1)
behavioral data were collected##2##4##(2009-4#1)(2013-1#1)
behavioral data##3##2##(2008-9#1)(2009-4#1)(2013-1#1)
behavioral decision##2##2##(2008-9#2)
behavioral deficits were##2##3##(1992-11#1)(1997-6#1)
behavioral deficits##7##2##(1991-2#2)(1992-11#1)(1993-12#1)(1997-2#2)(1997-6#1)
behavioral depression##3##2##(1992-12#2)(1996-7#1)
behavioral differences##2##2##(1993-5#1)(1994-2#1)
behavioral disinhibition##2##2##(2009-2#1)(2012-12#1)
behavioral disorders##6##2##(1990-11#1)(1991-6#1)(2008-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
behavioral disturbance##2##2##(2008-6#2)
behavioral disturbances##5##2##(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
behavioral dyscontrol##2##2##(1994-2#1)(2009-9#1)
behavioral ecologists##2##2##(2008-8#2)
behavioral ecology##3##2##(2008-8#2)(2008-9#1)
behavioral effects of cocaine##3##4##(1991-1#1)(1991-12#1)(2008-10#1)
behavioral effects of##4##3##(1991-1#1)(1991-12#1)(1991-2#1)(2008-10#1)
behavioral effects##9##2##(1991-1#2)(1991-12#1)(1991-2#2)(1993-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
behavioral emergencies##2##2##(2010-9#2)
behavioral enrichment##4##2##(2009-4#1)(2009-8#3)
behavioral findings##2##2##(2007-8#1)(2013-8#1)
behavioral functions##2##2##(2007-8#1)(2009-8#1)
behavioral genetic##2##2##(2008-8#1)(2012-3#1)
behavioral health care companies##3##4##(1995-1#3)
behavioral health care##6##3##(1995-1#5)(1996-2#1)
behavioral health##11##2##(1991-3#1)(1995-1#6)(1996-12#1)(1996-2#1)(2008-6#1)(2010-9#1)
behavioral impairments##2##2##(1991-2#1)(1992-11#1)
behavioral improvement##3##2##(1996-2#1)(2013-8#2)
behavioral impulsivity##3##2##(2010-6#1)(2011-2#1)(2013-7#1)
behavioral indices##2##2##(2007-10#2)
behavioral inhibition##3##2##(2008-4#1)(2009-9#2)
behavioral intentions##3##2##(2008-12#1)(2008-4#1)(2011-1#1)
behavioral interventions for##2##3##(2007-10#1)(2011-2#1)
behavioral interventions##6##2##(1995-1#1)(2007-10#1)(2008-2#1)(2011-2#1)(2013-1#2)
behavioral isolation##4##2##(2008-9#4)
behavioral measures##2##2##(1993-3#1)(2010-6#1)
behavioral mechanisms##2##2##(1993-12#1)(2011-2#1)
behavioral model##5##2##(1991-1#1)(1992-12#2)(2008-4#1)(2011-2#1)
behavioral momentum theory##2##3##(2010-10#2)
behavioral momentum##4##2##(2010-10#4)
behavioral monitoring##2##2##(2008-4#1)(2009-4#1)
behavioral observations##2##2##(2007-8#1)(2009-10#1)
behavioral or physiological##2##3##(2008-8#2)
behavioral outcomes##3##2##(2009-8#1)(2012-12#1)(2013-8#1)
behavioral paradigms##3##2##(1992-12#1)(1993-3#1)(2008-4#1)
behavioral patterns##5##2##(2008-1#1)(2008-4#1)(2008-8#1)(2009-9#1)(2013-1#1)
behavioral phenotypes##2##2##(2008-8#2)
behavioral phenotyping of##2##3##(2008-4#1)(2008-8#1)
behavioral plasticity and##2##3##(2008-8#1)(2013-7#1)
behavioral problems were##2##3##(1991-2#1)(2007-2#1)
behavioral problems##8##2##(1991-2#1)(1996-1#1)(2007-12#1)(2007-2#1)(2008-8#1)(2008-9#2)(2009-7#1)
behavioral profiles##2##2##(2008-4#1)(2009-10#1)
behavioral reactions##2##2##(2009-8#1)(2011-2#1)
behavioral repertoires##2##2##(2008-8#1)(2009-10#1)
behavioral research##2##2##(2008-6#2)
behavioral response##3##2##(1994-8#1)(1995-12#1)(2009-8#1)
behavioral responses to##2##3##(2009-6#1)(2012-2#1)
behavioral responses##11##2##(1993-12#2)(1995-12#1)(1995-8#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-1#2)(2012-2#1)
behavioral risk factors##3##3##(2008-3#2)(2013-8#1)
behavioral rule##3##2##(2008-9#3)
behavioral rules##2##2##(2008-8#1)(2008-9#1)
behavioral sensitization##2##2##(1993-3#1)(1995-3#1)
behavioral signs##2##2##(1997-8#1)(2009-12#1)
behavioral state##7##2##(1991-12#1)(1991-5#1)(1993-12#1)(2009-8#4)
behavioral studies##2##2##(2008-11#1)(2008-7#1)
behavioral study##2##2##(1992-11#1)(2013-1#1)
behavioral supersensitivity##3##2##(1993-12#3)
behavioral support##2##2##(2008-9#1)(2013-1#1)
behavioral symptoms##3##2##(1994-2#1)(1995-12#1)(2011-10#1)
behavioral task##3##2##(2008-4#1)(2011-2#1)(2013-8#1)
behavioral tasks on the##2##4##(1997-2#2)
behavioral tasks##7##2##(1993-5#1)(1997-2#4)(2008-5#1)(2013-8#1)
behavioral test##3##2##(1991-12#1)(2008-4#1)(2008-8#1)
behavioral tests##4##2##(1996-2#2)(2008-10#1)(2009-8#1)
behavioral therapy for##2##3##(2012-2#1)(2013-7#1)
behavioral therapy##8##2##(2008-8#2)(2012-2#5)(2013-7#1)
behavioral training##2##2##(1994-3#1)(2013-8#1)
behavioral trait##3##2##(2008-8#1)(2008-9#2)
behavioral traits are##2##3##(2008-1#1)(2008-9#1)
behavioral traits##3##2##(2008-1#1)(2008-9#2)
behavioral variables##3##2##(1993-12#1)(2008-7#1)(2009-8#1)
behavioral weight loss##2##3##(2008-3#1)(2008-4#1)
behavioral##450##1##(1990-11#2)(1991-1#5)(1991-12#3)(1991-2#8)(1991-3#3)(1991-5#1)(1991-6#3)(1992-11#3)(1992-12#5)(1992-6#1)(1993-12#12)(1993-2#1)(1993-3#5)(1993-5#4)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#6)(1994-3#3)(1994-8#1)(1995-1#7)(1995-12#7)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#9)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#4)(1997-1#2)(1997-2#11)(1997-6#4)(1997-7#1)(1997-8#1)(2007-10#4)(2007-12#4)(2007-2#1)(2007-8#9)(2008-1#5)(2008-10#9)(2008-11#15)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#28)(2008-5#6)(2008-6#11)(2008-7#5)(2008-8#36)(2008-9#24)(2009-10#4)(2009-11#7)(2009-12#3)(2009-2#3)(2009-4#3)(2009-6#1)(2009-7#3)(2009-8#15)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-9#4)(2011-1#2)(2011-10#1)(2011-2#11)(2012-12#6)(2012-2#16)(2012-3#6)(2013-1#19)(2013-7#5)(2013-8#17)
behaviorally##5##1##(1993-1#1)(2009-8#2)(2011-1#1)(2013-8#1)
behaviors (e##2##2##(2010-9#1)(2013-1#1)
behaviors across all##2##3##(2010-7#1)(2013-1#1)
behaviors among African##2##3##(2008-4#1)(2010-4#1)
behaviors among a##2##3##(1991-1#1)(2009-7#1)
behaviors among adolescents##4##3##(1994-2#1)(1996-1#1)(2008-11#1)(2013-1#1)
behaviors among##14##2##(1991-1#1)(1994-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
behaviors and social##2##3##(1995-3#1)(2008-11#1)
behaviors and the##4##3##(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
behaviors and##42##2##(1991-1#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2009-5#2)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
behaviors are described##2##3##(1995-2#1)(2007-12#1)
behaviors are##14##2##(1992-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2013-8#4)
behaviors as##2##2##(1994-2#1)(2011-1#1)
behaviors associated with HIV##2##4##(1991-1#1)(2009-5#1)
behaviors associated with the##2##4##(2009-7#1)(2011-2#1)
behaviors associated with##6##3##(1991-1#1)(1993-12#1)(1993-6#1)(2009-5#1)(2009-7#1)(2011-2#1)
behaviors at##2##2##(2008-12#1)(2011-2#1)
behaviors by##4##2##(2008-12#1)(2008-9#2)(2009-12#1)
behaviors can##3##2##(1990-3#1)(2007-12#1)(2012-12#1)
behaviors during the##2##3##(2008-11#2)
behaviors exhibited##2##2##(1993-12#1)(2008-10#1)
behaviors for eating disorder##2##4##(2013-8#2)
behaviors for the##2##3##(1991-12#1)(2009-11#1)
behaviors for##9##2##(1991-12#1)(1992-1#1)(2007-8#1)(2008-11#1)(2009-11#2)(2013-1#1)(2013-8#2)
behaviors has##2##2##(2007-12#1)(2012-12#1)
behaviors in a##5##3##(2008-12#1)(2009-5#2)(2010-5#1)(2011-1#1)
behaviors in rats##2##3##(2008-4#2)
behaviors in the use of hospital care##2##7##(1994-2#2)
behaviors in the##6##3##(1994-2#2)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
behaviors in their##2##3##(2009-11#1)(2010-8#1)
behaviors in this##2##3##(2008-10#1)(2009-5#1)
behaviors in##50##2##(1990-12#1)(1993-12#1)(1993-6#1)(1994-2#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#5)(2013-8#1)
behaviors is a##2##3##(2008-4#1)(2008-7#1)
behaviors is##6##2##(1997-4#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)
behaviors observed for##2##3##(2008-10#1)(2009-12#1)
behaviors of adolescents##2##3##(1996-1#1)(2010-9#1)
behaviors of the##6##3##(1993-1#1)(2008-5#2)(2009-8#1)(2012-2#1)(2013-1#1)
behaviors of these##4##3##(2008-10#3)(2008-11#1)
behaviors of##46##2##(1992-11#1)(1993-1#1)(1995-8#1)(1996-1#2)(1997-6#1)(2007-2#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
behaviors or##2##2##(2008-4#1)(2009-7#1)
behaviors regarding##2##2##(2009-4#1)(2012-12#1)
behaviors such as##3##3##(1996-1#2)(2008-8#1)
behaviors that are##3##3##(1996-7#1)(2008-4#1)(2009-6#1)
behaviors that##22##2##(1993-1#1)(1994-2#1)(1995-12#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-4#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-2#2)(2011-2#1)
behaviors to##3##2##(1997-3#1)(2007-2#1)(2011-1#1)
behaviors under##2##2##(2008-10#1)(2008-11#1)
behaviors was##2##2##(2008-10#1)(2012-12#1)
behaviors were examined##2##3##(2008-9#1)(2009-10#1)
behaviors were##15##2##(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-10#1)(2012-2#1)
behaviors while##3##2##(1994-2#1)(2013-1#1)(2013-8#1)
behaviors with a##2##3##(1995-12#1)(2008-6#1)
behaviors with##3##2##(1995-12#1)(2008-6#1)(2009-11#1)
behaviors##477##1##(1990-12#1)(1990-3#1)(1991-1#5)(1991-12#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#1)(1993-1#3)(1993-12#8)(1993-3#3)(1993-6#4)(1994-2#15)(1995-1#1)(1995-12#7)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#5)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#10)(2007-2#3)(2007-8#5)(2008-1#2)(2008-10#29)(2008-11#26)(2008-12#15)(2008-2#6)(2008-3#10)(2008-4#25)(2008-5#8)(2008-6#9)(2008-7#4)(2008-8#6)(2008-9#9)(2009-10#2)(2009-11#11)(2009-12#2)(2009-3#1)(2009-4#6)(2009-5#17)(2009-6#3)(2009-7#9)(2009-8#6)(2009-9#8)(2010-10#1)(2010-11#4)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#13)(2010-7#5)(2010-8#6)(2010-9#6)(2011-1#8)(2011-10#1)(2011-2#12)(2012-1#2)(2012-12#15)(2012-2#15)(2012-3#5)(2013-1#38)(2013-8#27)
behaviour amongst##2##2##(2008-10#2)
behaviour and increases##3##3##(2008-4#2)(2008-7#1)
behaviour and the##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
behaviour and##37##2##(1991-2#2)(1993-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
behaviour are##2##2##(1990-3#1)(2008-11#1)
behaviour at##2##2##(1994-3#1)(2008-10#1)
behaviour by##9##2##(1993-6#3)(1996-12#1)(2008-11#2)(2009-6#1)(2009-7#1)(2011-1#1)
behaviour change##3##2##(1994-2#1)(2010-2#1)(2011-1#1)
behaviour changes##2##2##(2008-10#1)(2009-4#1)
behaviour during the##2##3##(2008-10#1)(2008-7#1)
behaviour for##5##2##(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
behaviour has been##2##3##(2008-5#1)(2012-2#1)
behaviour in general##2##3##(2007-12#1)(2013-8#1)
behaviour in reversed-phase##2##3##(1996-5#2)
behaviour in the##4##3##(1992-3#1)(2008-5#1)(2010-12#1)(2011-1#1)
behaviour in##33##2##(1991-12#1)(1992-3#1)(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
behaviour is not##2##3##(2007-2#1)(2012-3#1)
behaviour is##14##2##(1990-9#1)(1991-5#1)(1993-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
behaviour may be##2##3##(2008-11#1)(2008-3#1)
behaviour modification##3##2##(1991-8#3)
behaviour of 3##2##3##(2008-10#2)
behaviour of a##7##3##(1993-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2012-2#1)
behaviour of both##2##3##(2008-10#1)(2008-11#1)
behaviour of copper(II) and silver(I) with##2##6##(2008-10#2)
behaviour of gold##2##3##(2008-10#2)
behaviour of human##2##3##(1992-2#1)(2008-5#1)
behaviour of maleic hydrazide##2##4##(2008-10#2)
behaviour of some##4##3##(2008-10#4)
behaviour of the cornea##2##4##(2008-7#2)
behaviour of the herbicide##2##4##(2008-10#2)
behaviour of the isolated##2##4##(1990-12#1)(2008-10#1)
behaviour of the markers##2##4##(2008-10#2)
behaviour of the##38##3##(1990-11#2)(1990-12#1)(1992-3#1)(1994-3#1)(1995-2#1)(2007-10#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#3)(2009-11#1)(2009-7#2)(2013-1#1)(2013-8#1)
behaviour of these##5##3##(1993-6#1)(2008-10#2)(2008-7#1)(2009-7#1)
behaviour of##155##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#3)(1991-5#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#70)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#8)(2008-9#1)(2009-11#1)(2009-7#8)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#2)(2013-8#1)
behaviour on##7##2##(1992-3#1)(2007-2#2)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
behaviour or##2##2##(1990-2#1)(2008-12#1)
behaviour patterns##2##2##(1992-9#1)(2012-2#1)
behaviour problems##2##2##(2008-9#1)(2013-1#1)
behaviour research##3##2##(1995-6#2)(2008-4#1)
behaviour surveys##2##2##(1993-9#1)(2011-2#1)
behaviour that##4##2##(1992-8#1)(1996-12#1)(2008-10#1)(2009-10#1)
behaviour therapy##3##2##(1990-6#1)(1993-12#1)(2011-1#1)
behaviour to a##2##3##(2008-11#1)(2008-8#1)
behaviour to##3##2##(1991-5#1)(2008-11#1)(2008-8#1)
behaviour was also##2##3##(1993-12#1)(2008-5#1)
behaviour was observed##2##3##(2007-7#1)(2008-10#1)
behaviour was##12##2##(1990-11#1)(1993-12#1)(1996-2#1)(2007-7#1)(2008-10#3)(2008-5#2)(2010-8#1)(2011-1#2)
behaviour when##2##2##(1994-6#1)(2010-5#1)
behaviour with##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
behaviour##490##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#6)(1991-12#1)(1991-2#4)(1991-5#4)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#11)(1993-2#5)(1993-3#1)(1993-6#6)(1993-9#2)(1994-12#1)(1994-2#4)(1994-3#9)(1994-6#2)(1994-8#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#1)(1996-1#3)(1996-11#5)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#8)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#108)(2008-11#31)(2008-12#6)(2008-3#2)(2008-4#12)(2008-5#25)(2008-6#3)(2008-7#26)(2008-8#3)(2008-9#7)(2009-10#5)(2009-11#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#15)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#8)(2011-1#13)(2011-2#16)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#2)(2012-7#1)(2013-1#10)(2013-8#4)
behavioural and neural responses to gaze shifts were modulated by the social context##2##13##(2008-11#2)
behavioural and neurochemical##3##3##(1992-7#2)(1993-6#1)
behavioural and##13##2##(1992-7#2)(1993-6#1)(1995-12#1)(1996-5#1)(2008-11#5)(2008-12#1)(2008-9#1)(2010-8#1)
behavioural changes and##2##3##(2007-7#2)
behavioural changes##9##2##(1990-3#2)(1991-2#2)(2007-7#3)(2008-9#1)(2011-1#1)
behavioural control##2##2##(1996-5#1)(2008-11#1)
behavioural deficits in##2##3##(1994-8#1)(1997-2#1)
behavioural deficits##6##2##(1991-2#1)(1993-12#1)(1994-8#3)(1997-2#1)
behavioural disorders##4##2##(1994-3#1)(2006-10#1)(2008-9#2)
behavioural disturbances in##3##3##(2008-5#1)(2011-1#2)
behavioural experiments##2##2##(2007-12#1)(2012-2#1)
behavioural outcomes##2##2##(1993-2#1)(2008-9#1)
behavioural problems##3##2##(1992-2#1)(2008-11#1)(2012-1#1)
behavioural response##2##2##(1992-7#1)(1995-12#1)
behavioural responses##2##2##(1996-2#2)
behavioural risk##2##2##(2010-6#1)(2013-8#1)
behavioural sciences##2##2##(2008-11#1)(2012-2#1)
behavioural studies##2##2##(1991-2#1)(1992-10#1)
behavioural symptoms##2##2##(1995-12#1)(2008-9#1)
behavioural therapy##2##2##(2007-7#2)
behavioural traits##2##2##(2008-10#2)
behavioural types##2##2##(2010-8#1)(2011-1#1)
behavioural variant frontotemporal dementia##2##4##(2013-1#2)
behavioural##137##1##(1990-11#1)(1990-3#2)(1991-2#5)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#3)(1994-8#5)(1995-12#7)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#3)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#5)(2007-7#7)(2008-1#3)(2008-10#7)(2008-11#11)(2008-12#2)(2008-5#1)(2008-7#4)(2008-9#17)(2009-10#1)(2009-9#2)(2010-10#1)(2010-6#6)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#2)(2012-2#7)(2013-1#2)(2013-8#2)
behaviourally##6##1##(1992-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-5#1)(2012-2#1)
behaviours among##2##2##(2010-6#1)(2013-8#1)
behaviours and attitudes##3##3##(2008-11#2)(2010-3#1)
behaviours and##9##2##(1992-1#1)(1997-8#1)(2008-11#2)(2008-4#1)(2010-3#1)(2011-2#2)(2012-12#1)
behaviours during##2##2##(2011-2#1)(2012-2#1)
behaviours in##5##2##(2008-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
behaviours of##8##2##(1992-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-12#1)
behaviours that##2##2##(2008-5#1)(2012-2#1)
behaviours were##2##2##(2008-10#1)(2008-9#1)
behaviours##62##1##(1992-1#1)(1992-3#2)(1993-2#1)(1995-1#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-9#4)(2010-10#2)(2010-3#2)(2010-6#3)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
behind a promoter##2##3##(1996-6#1)(2008-2#1)
behind a##9##2##(1991-9#1)(1996-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2011-2#1)
behind an##3##2##(2008-3#2)(2009-8#1)
behind in##2##2##(1995-5#1)(2008-11#1)
behind such##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
behind the development of##2##4##(2008-10#1)(2010-1#1)
behind the various##2##3##(2011-2#1)(2013-1#1)
behind the##47##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
behind their##5##2##(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
behind these##4##2##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
behind this##8##2##(1990-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#2)
behind with##2##2##(1992-5#1)(2008-6#1)
behind##144##1##(1990-8#1)(1991-1#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-3#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#5)(2007-2#1)(2008-1#4)(2008-10#12)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
being &quot##6##2##(2008-12#5)(2013-7#1)
being 0##5##2##(2008-10#4)(2011-1#1)
being 1##4##2##(1996-2#1)(2008-10#1)(2008-7#2)
being 10##2##2##(2008-12#1)(2012-12#1)
being 2-3 times##2##3##(1993-12#2)
being 20##2##2##(1990-2#1)(2008-11#1)
being 3##3##2##(1997-7#1)(2008-10#1)(2010-8#1)
being 4##2##2##(2008-10#2)
being 8##2##2##(2007-5#1)(2007-7#1)
being a highly##2##3##(2008-3#1)(2008-7#1)
being a rare##2##3##(1997-7#1)(2011-1#1)
being a simple##2##3##(1996-2#1)(2008-3#1)
being a specific##2##3##(1996-3#1)(2008-5#1)
being a successful designer##2##4##(2012-3#2)
being a successful##3##3##(2012-3#3)
being a useful tool##2##4##(2008-10#1)(2008-5#1)
being a##71##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-4#1)(1997-7#2)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
being able to##16##3##(1991-3#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)
being about##3##2##(1991-5#1)(1995-2#1)(2008-10#1)
being accepted##2##2##(2007-11#1)(2008-4#1)
being accumulated##2##2##(2008-10#1)(2008-9#1)
being achieved##5##2##(1990-7#1)(1992-2#1)(1994-1#1)(2008-3#1)(2013-8#1)
being activated##2##2##(1996-12#1)(2008-7#1)
being actively##2##2##(1991-9#1)(2009-5#1)
being added to##2##3##(2008-10#1)(2008-7#1)
being added##4##2##(2008-10#2)(2008-7#1)(2012-1#1)
being addressed##5##2##(1991-12#1)(1997-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
being administered##3##2##(1991-8#1)(1996-5#1)(2010-11#1)
being admitted to an##2##4##(2012-12#2)
being admitted##3##2##(1996-3#1)(2012-12#2)
being adopted##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
being affected##2##2##(2008-4#1)(2010-5#1)
being almost##3##2##(1997-3#1)(2009-3#1)(2012-2#1)
being also##2##2##(1995-12#1)(2008-10#1)
being altered##2##2##(1996-3#1)(2009-9#1)
being among##2##2##(2008-7#1)(2013-8#1)
being an##14##2##(1991-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
being analyzed##5##2##(2008-10#2)(2008-11#2)(2010-10#1)
being applied in##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
being applied to##6##3##(1997-1#1)(2006-10#1)(2008-10#1)(2009-12#1)(2010-4#1)(2010-5#1)
being applied##12##2##(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
being as##3##2##(2008-1#1)(2012-2#1)(2012-3#1)
being asked to##2##3##(1995-12#1)(2007-10#1)
being asked##3##2##(1995-12#1)(1996-2#1)(2007-10#1)
being assessed##5##2##(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)
being assisted by##2##3##(2011-1#1)(2013-8#1)
being assisted##3##2##(2009-6#1)(2011-1#1)(2013-8#1)
being associated with the##2##4##(1995-8#1)(2013-8#1)
being associated with##7##3##(1995-8#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)(2013-8#1)
being at##3##2##(1996-12#1)(2008-10#1)(2010-10#1)
being based on the##2##4##(2008-10#1)(2008-6#1)
being based on##5##3##(1995-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-6#1)
being based##6##2##(1995-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
being better##2##2##(2008-12#1)(2010-1#1)
being between##2##2##(2008-10#2)
being called##2##2##(1997-3#1)(2008-12#1)
being cared for in##2##4##(2008-11#1)(2011-2#1)
being carried##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
being challenged##4##2##(1994-2#1)(1997-2#1)(2011-1#1)(2013-1#1)
being close to##3##3##(2008-10#3)
being close##4##2##(2008-10#3)(2011-1#1)
being closely associated with##2##4##(2010-5#1)(2010-8#1)
being closely##4##2##(1991-12#1)(2010-11#1)(2010-5#1)(2010-8#1)
being collected##4##2##(1994-2#1)(2008-10#1)(2008-8#1)(2009-12#1)
being compared##4##2##(1992-2#1)(1996-2#1)(2008-10#2)
being complete##2##2##(2008-1#1)(2008-10#1)
being completely##3##2##(2007-7#1)(2008-11#1)(2008-5#1)
being concerned with##2##3##(2010-1#1)(2012-12#1)
being conducted by the##2##4##(1995-6#1)(2008-5#1)
being conducted by##3##3##(1994-12#1)(1995-6#1)(2008-5#1)
being conducted in##2##3##(2008-4#1)(2009-6#1)
being conducted##8##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-8#1)
being confined to##2##3##(1993-8#1)(2007-7#1)
being confronted with##2##3##(1990-11#1)(2010-7#1)
being considered as a##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
being considered as##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
being considered for##4##3##(1995-2#1)(1997-1#1)(2008-1#1)(2008-3#1)
being considered##14##2##(1990-9#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
being consistent with the##2##4##(1994-8#1)(2010-5#1)
being consistent with##4##3##(1992-11#1)(1994-8#1)(2008-3#1)(2010-5#1)
being constructed##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
being contaminated##2##2##(1997-5#1)(2007-6#1)
being controlled##2##2##(1990-12#1)(2010-1#1)
being crowded##2##2##(1991-12#1)(2009-6#1)
being defined##2##2##(2009-12#1)(2012-3#1)
being demanded##2##2##(1996-12#1)(2008-10#1)
being dependent on the##2##4##(1993-5#1)(2008-10#1)
being dependent on##3##3##(1993-5#1)(2008-10#1)(2010-10#1)
being depressed and##2##3##(1996-6#1)(2010-2#1)
being derived from##2##3##(1993-1#1)(2008-10#1)
being described##2##2##(2007-7#1)(2013-1#1)
being designed to##3##3##(2008-6#1)(2008-8#2)
being designed##6##2##(1991-12#1)(1992-1#1)(2008-4#1)(2008-6#1)(2008-8#2)
being destroyed by the##2##4##(2008-10#1)(2011-2#1)
being detected##5##2##(1991-6#1)(1992-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
being determined##4##2##(1994-3#1)(1994-8#1)(1996-12#1)(2008-7#1)
being developed and##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
being developed as##2##3##(2008-7#1)(2010-4#1)
being developed at the##2##4##(2008-3#2)
being developed by the##2##4##(1996-12#1)(2008-6#1)
being developed for##7##3##(2006-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-5#1)
being developed in##2##3##(1996-1#1)(2008-1#1)
being developed to##6##3##(1997-1#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-12#1)(2012-2#1)
being developed##41##2##(1992-3#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-5#2)(2006-10#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-2#1)
being diagnosed with diabetes##2##4##(2011-1#1)(2013-8#1)
being diagnosed with##4##3##(1995-2#1)(2008-12#1)(2011-1#1)(2013-8#1)
being diagnosed##5##2##(1995-2#1)(2008-12#1)(2010-6#1)(2011-1#1)(2013-8#1)
being dialyzed through##2##3##(2007-7#2)
being dialyzed##3##2##(2007-7#3)
being directed##2##2##(2010-5#1)(2010-8#1)
being directly##2##2##(1995-8#1)(2008-10#1)
being discharged##3##2##(1995-3#1)(2008-11#1)(2009-3#1)
being discontinued##2##2##(2007-8#1)(2008-10#1)
being discovered##2##2##(2008-12#1)(2008-4#1)
being discussed##6##2##(1996-3#1)(1997-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2013-1#1)
being done to##2##3##(1992-8#1)(2008-11#1)
being done##5##2##(1992-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
being driven by the##2##4##(1996-12#1)(1997-4#1)
being driven by##3##3##(1996-12#1)(1997-4#1)(2008-8#1)
being driven##4##2##(1996-12#1)(1997-4#1)(2008-8#1)(2009-3#1)
being due to##6##3##(1995-3#1)(2007-11#1)(2007-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
being effective##2##2##(1992-4#1)(1997-8#1)
being either##2##2##(1995-11#1)(2010-10#1)
being elicited##2##2##(2008-10#1)(2013-8#1)
being eliminated##3##2##(1991-6#1)(1997-3#1)(2013-1#1)
being employed in##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
being employed##8##2##(1991-3#1)(1997-6#1)(2008-10#2)(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
being equal##2##2##(2008-10#2)
being essential##2##2##(1991-9#1)(2011-2#1)
being evaluated as##2##3##(2008-5#1)(2008-7#1)
being evaluated for the##2##4##(1997-1#1)(2008-5#1)
being evaluated for##4##3##(1997-1#1)(2008-2#1)(2008-5#1)(2013-8#1)
being evaluated in##4##3##(2007-10#1)(2008-5#2)(2013-1#1)
being evaluated##16##2##(1997-1#1)(2007-10#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
being examined##4##2##(2007-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
being exploited##4##2##(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)
being explored for##2##3##(2008-7#1)(2009-12#1)
being explored##9##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-4#1)(2010-7#1)(2013-8#1)
being exposed to##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
being expressed as##2##3##(1994-3#1)(2009-6#1)
being expressed at##2##3##(1994-6#1)(1997-4#1)
being expressed##7##2##(1994-2#1)(1994-3#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-7#1)(2009-6#1)
being extended to##3##3##(2007-8#1)(2008-7#1)(2013-8#1)
being extractable with chloroform##2##4##(2008-10#2)
being female##2##2##(2008-7#1)(2011-1#1)
being filled by##2##3##(2007-12#1)(2008-5#1)
being filled##3##2##(1992-8#1)(2007-12#1)(2008-5#1)
being focused on##3##3##(2007-12#1)(2011-1#1)(2011-2#1)
being followed up##2##3##(2008-5#1)(2012-2#1)
being followed##4##2##(1991-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
being followed-up##2##2##(2008-1#1)(2013-1#1)
being formed in##2##3##(2007-11#1)(2008-10#1)
being formed##6##2##(1994-8#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
being found in##2##3##(1992-8#1)(2008-10#1)
being found on the##2##4##(2007-11#1)(2008-1#1)
being found to##2##3##(1994-12#1)(2008-11#1)
being found with the##2##4##(1990-9#1)(2008-10#1)
being found##12##2##(1990-9#1)(1992-8#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
being fully utilized##3##3##(2008-2#1)(2008-4#1)(2009-4#1)
being fully##4##2##(1991-12#1)(2008-2#1)(2008-4#1)(2009-4#1)
being generated##4##2##(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)
being given by##4##3##(1991-3#1)(1993-12#1)(2007-11#1)(2008-2#1)
being given to##7##3##(1990-6#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(2009-6#2)
being given##13##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(2007-11#1)(2008-2#1)(2009-6#3)(2012-3#1)
being greater than 0##2##4##(2008-10#1)(2012-12#1)
being greater than the##2##4##(1994-3#1)(2009-4#1)
being greater than##4##3##(1994-3#1)(2008-10#1)(2009-4#1)(2012-12#1)
being guided by##2##3##(1994-12#1)(2007-12#1)
being held##2##2##(1994-8#1)(2013-8#1)
being higher in##2##3##(2008-10#1)(2008-7#1)
being higher##6##2##(1992-8#1)(1995-1#1)(2008-10#2)(2008-3#1)(2008-7#1)
being highest in##3##3##(1991-4#1)(2008-10#1)(2008-9#1)
being highest##4##2##(1991-4#1)(1992-8#1)(2008-10#1)(2008-9#1)
being highly sensitive##2##3##(2008-10#1)(2008-3#1)
being highly##9##2##(1990-6#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)
being identified and##2##3##(1990-3#1)(2008-9#1)
being identified##8##2##(1990-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
being implemented in##2##3##(1994-3#1)(2008-11#1)
being implemented##6##2##(1994-3#1)(1997-3#1)(2008-11#2)(2008-12#1)(2013-1#1)
being in a##6##3##(1995-12#1)(1996-7#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-11#1)
being in delirium##2##3##(2010-10#2)
being in receipt of a DG##2##6##(2012-12#2)
being in the##10##3##(1992-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1996-6#1)(2008-10#1)(2009-8#1)(2010-10#1)(2013-1#1)
being in##27##2##(1991-8#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-12#2)(1996-6#1)(1996-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2009-4#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#1)(2012-12#2)(2013-1#2)
being included##2##2##(1996-2#1)(2009-5#1)
being incorporated##2##2##(2008-2#1)(2010-12#1)
being increased##2##2##(1991-12#1)(1995-12#1)
being increasingly adopted##2##3##(2010-2#1)(2011-2#1)
being increasingly recognized as##3##4##(2007-7#1)(2008-9#1)(2009-3#1)
being increasingly recognized##4##3##(2007-7#1)(2008-9#1)(2009-3#1)(2009-9#1)
being increasingly##14##2##(1993-11#1)(2006-10#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#2)
being induced##2##2##(2008-10#1)(2008-8#1)
being infected by##2##3##(2008-8#1)(2010-8#1)
being infected##5##2##(2007-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)
being initially##2##2##(1994-8#1)(2011-1#1)
being injected##2##2##(2008-7#1)(2011-2#1)
being installed##2##2##(2008-3#1)(2013-1#1)
being intermediate##3##2##(1990-7#1)(1991-8#1)(2010-2#1)
being introduced##3##2##(1992-3#1)(2008-11#1)(2008-3#1)
being investigated as a##2##4##(2007-11#1)(2008-10#1)
being investigated as##3##3##(2007-11#1)(2008-10#2)
being investigated for##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
being investigated##15##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)
being involved in##6##3##(1993-3#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
being involved##7##2##(1993-3#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
being isolated##2##2##(1990-7#1)(2012-3#1)
being largely##2##2##(2008-1#1)(2008-10#1)
being lead##2##2##(1997-4#1)(2008-10#1)
being left##2##2##(2008-5#1)(2011-2#1)
being less than##4##3##(1997-7#1)(2008-2#1)(2010-11#1)(2012-2#1)
being less##8##2##(1997-7#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
being limited by the##2##4##(1992-6#1)(2007-12#1)
being limited by##3##3##(1992-6#2)(2007-12#1)
being limited to##2##3##(1990-5#1)(2008-1#1)
being limited##5##2##(1990-5#1)(1992-6#2)(2007-12#1)(2008-1#1)
being made in##3##3##(2006-10#1)(2008-1#1)(2012-12#1)
being made to##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
being made##12##2##(1992-12#1)(1993-2#1)(1995-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-12#1)
being maintained at##2##3##(2007-12#1)(2008-10#1)
being maintained##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
being male##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
being malignant##2##2##(1996-1#1)(2012-2#1)
being managed##2##2##(1995-2#1)(2010-1#1)
being measured and##2##3##(2008-3#1)(2008-9#1)
being measured##7##2##(1993-1#1)(1995-3#1)(2008-3#3)(2008-7#1)(2008-9#1)
being mediated by##2##3##(1994-11#1)(2008-6#1)
being mediated##4##2##(1994-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
being met in##2##3##(2008-8#1)(2010-10#1)
being met##7##2##(1992-8#1)(1995-12#1)(1996-1#1)(2008-8#1)(2010-10#1)(2013-1#2)
being mixed##2##2##(2007-10#1)(2007-12#1)
being monitored by##2##3##(2007-6#1)(2008-10#1)
being monitored##3##2##(2007-6#1)(2008-10#1)(2008-7#1)
being more similar##2##3##(2008-10#1)(2010-3#1)
being more strongly##2##3##(2009-9#1)(2010-5#1)
being more##27##2##(1990-12#1)(1992-8#1)(1994-11#1)(1996-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#2)
being most##3##2##(2008-2#1)(2011-2#1)(2012-12#1)
being negatively##2##2##(2007-5#1)(2008-9#1)
being normal##2##2##(1995-11#1)(2010-11#1)
being not##3##2##(1991-12#1)(2008-5#1)(2008-7#1)
being noted##2##2##(2008-10#1)(2009-2#1)
being observed##5##2##(1996-2#1)(2008-3#1)(2008-7#2)(2010-5#1)
being obtained##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
being of##6##2##(1991-6#1)(1996-1#1)(1997-7#1)(2008-11#1)(2008-5#1)(2010-8#1)
being often##2##2##(2010-10#1)(2013-1#1)
being on the##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
being on##9##2##(1995-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#2)(2013-1#1)(2013-8#1)
being one of the most##2##5##(2012-12#1)(2012-3#1)
being one of the##4##4##(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#1)
being one of##5##3##(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
being one##7##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
being only##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
being overcome##2##2##(1997-8#1)(2008-12#1)
being overweight##4##2##(2007-12#1)(2007-2#1)(2010-7#1)(2013-1#1)
being oxidized##3##2##(2008-10#3)
being paid to##3##3##(1995-1#1)(1996-12#1)(2008-7#1)
being part of a##2##4##(2009-6#1)(2011-1#1)
being part of##3##3##(2009-6#1)(2011-1#1)(2012-3#1)
being particularly##2##2##(2012-2#1)(2013-7#1)
being performed by##2##3##(1997-2#1)(2013-8#1)
being performed##7##2##(1991-1#1)(1997-2#1)(2008-9#1)(2010-1#1)(2010-5#1)(2013-1#1)(2013-8#1)
being placed##2##2##(2007-12#1)(2008-11#1)
being planned##4##2##(2008-1#1)(2008-12#1)(2009-6#1)(2010-7#1)
being possible to##2##3##(2008-10#1)(2008-8#1)
being possible##3##2##(2008-10#2)(2008-8#1)
being prescribed##4##2##(1994-11#1)(2008-11#2)(2010-4#1)
being present at##2##3##(2008-10#2)
being present in##4##3##(1991-9#1)(1993-9#1)(2007-8#1)(2013-1#1)
being present##7##2##(1991-12#1)(1991-9#1)(1993-9#1)(2007-8#1)(2008-10#2)(2013-1#1)
being presented##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
being preserved##2##2##(1991-2#1)(2012-3#1)
being processed##3##2##(1990-8#1)(1991-9#1)(2007-11#1)
being produced##8##2##(1993-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)
being promoted##2##2##(1996-12#1)(2011-1#1)
being proposed##2##2##(1991-5#1)(1997-3#1)
being provided##6##2##(2008-7#1)(2011-2#2)(2013-7#3)
being questioned##2##2##(1995-1#1)(1997-3#1)
being realized##2##2##(1992-1#1)(1993-2#1)
being recognized##2##2##(2007-9#1)(2009-9#1)
being recorded##2##2##(2008-5#1)(2010-8#1)
being reduced##2##2##(1995-12#1)(2008-10#1)
being rejected##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
being related to##2##3##(2010-4#1)(2011-2#1)
being relatively##3##2##(1993-3#1)(2007-12#1)(2008-10#1)
being released##2##2##(2007-12#1)(2010-3#1)
being reported in##3##3##(2007-7#2)(2008-5#1)
being reported##19##2##(1996-9#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
being required for##2##3##(1997-2#1)(2008-8#1)
being responsible for##3##3##(1996-9#1)(2008-1#1)(2011-2#1)
being restricted to the##2##4##(2008-2#1)(2012-2#1)
being run##2##2##(2008-11#1)(2012-12#1)
being sampled##2##2##(2010-8#1)(2012-3#1)
being searched##2##2##(2008-4#1)(2012-12#1)
being secreted##2##2##(1990-11#1)(2008-10#1)
being selected##3##2##(2008-10#2)(2008-5#1)
being separated##3##2##(1991-12#1)(2008-10#1)(2008-4#1)
being served##2##2##(1992-2#1)(1997-2#1)
being sexually##2##2##(1997-6#1)(2009-5#1)
being shared##2##2##(2007-5#1)(2009-6#1)
being shown##2##2##(2008-10#1)(2008-7#1)
being significant##2##2##(1990-2#1)(1991-11#1)
being significantly less##2##3##(1992-9#1)(1994-6#1)
being significantly more##2##3##(1997-7#1)(2008-10#1)
being significantly##6##2##(1992-9#1)(1994-3#1)(1994-6#1)(1997-7#1)(2008-10#1)(2008-9#1)
being similar to##2##3##(2011-2#1)(2012-3#1)
being single##4##2##(2011-2#3)(2013-8#1)
being slightly higher##2##3##(1995-5#1)(2012-2#1)
being slightly##4##2##(1995-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
being smaller##2##2##(2010-2#1)(2011-2#1)
being sought##4##2##(1994-6#1)(1995-1#1)(2013-1#2)
being spent on##2##3##(1992-2#1)(2008-11#1)
being statistically significant##2##3##(1990-12#1)(2008-11#1)
being studied and##5##3##(1994-2#1)(1994-5#1)(2008-3#1)(2008-7#2)
being studied in##3##3##(1992-10#1)(2008-5#1)(2011-3#1)
being studied##14##2##(1992-10#1)(1994-2#1)(1994-5#1)(1997-4#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-7#1)(2011-2#1)(2011-3#1)
being successful##2##2##(2010-8#2)
being susceptible##2##2##(2008-10#1)(2008-11#1)
being taken for##2##3##(1990-12#1)(2008-6#1)
being taken##7##2##(1990-12#1)(1990-9#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-2#1)
being tested for##2##3##(2008-5#1)(2012-2#1)
being tested in##3##3##(1996-5#1)(2008-1#1)(2008-5#1)
being tested##11##2##(1996-5#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#2)(2012-2#1)(2012-3#1)
being that the##3##3##(1995-5#1)(2010-6#1)(2013-8#1)
being that##5##2##(1995-5#1)(2008-3#2)(2010-6#1)(2013-8#1)
being the basis of##2##4##(1991-9#1)(1992-9#1)
being the case##3##3##(1992-12#1)(1995-1#1)(2008-10#1)
being the largest##2##3##(1992-1#1)(2008-10#1)
being the least##2##3##(1993-2#1)(2011-1#1)
being the most common##8##4##(1990-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#2)
being the most effective##4##4##(1995-3#1)(1995-5#1)(2013-1#2)
being the most frequent##3##4##(2008-6#1)(2011-1#1)(2013-8#1)
being the most potent##3##4##(1992-9#1)(1995-11#1)(2010-6#1)
being the most prevalent##2##4##(2008-10#1)(2008-5#1)
being the most##31##3##(1990-6#1)(1991-3#1)(1992-9#1)(1995-11#2)(1995-3#1)(1995-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
being the subject of##2##4##(2008-10#1)(2012-3#1)
being the##105##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#2)(2008-3#5)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#1)
being their##2##2##(2008-12#1)(2008-7#1)
being those##2##2##(2008-9#1)(2010-12#1)
being threatened##2##2##(1990-12#1)(2011-2#1)
being through##2##2##(2008-9#1)(2010-8#1)
being to##6##2##(1990-5#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
being too##2##2##(2011-2#1)(2012-3#1)
being transformed into##2##3##(1996-3#1)(2008-6#1)
being translated##3##2##(1995-12#1)(2008-2#1)(2008-3#1)
being transmitted##2##2##(2008-3#1)(2013-8#1)
being treated by##2##3##(1990-2#1)(2008-4#1)
being treated for##2##3##(2008-9#1)(2009-10#1)
being treated in##2##3##(2006-10#1)(2008-9#1)
being treated with a##3##4##(1993-2#1)(2007-5#1)(2013-1#1)
being treated with##14##3##(1991-11#1)(1993-2#2)(1997-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-1#1)(2013-1#1)
being treated##22##2##(1990-2#1)(1991-11#1)(1993-2#2)(1996-6#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-10#1)(2011-1#1)(2013-1#1)
being undertaken in##2##3##(1994-12#1)(2013-8#1)
being undertaken##7##2##(1993-2#1)(1994-12#1)(1995-5#1)(2008-11#1)(2010-11#1)(2013-1#1)(2013-8#1)
being up-regulated##2##2##(2008-7#1)(2010-4#1)
being used as a##3##4##(1994-6#1)(2008-11#1)(2008-7#1)
being used as an##2##4##(1997-1#1)(2008-11#1)
being used as##13##3##(1990-9#1)(1994-6#1)(1995-6#1)(1997-1#1)(2008-11#3)(2008-7#2)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)
being used at##2##3##(1996-2#1)(2008-7#1)
being used by##3##3##(1994-2#1)(2008-2#1)(2012-12#1)
being used for the##4##4##(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)
being used for##11##3##(2007-11#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
being used in the##4##4##(1990-12#1)(2008-11#2)(2011-2#1)
being used in##16##3##(1990-12#1)(1991-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
being used increasingly##2##3##(2008-10#1)(2008-4#1)
being used to explore the##2##5##(2010-10#1)(2013-8#1)
being used to explore##3##4##(2008-7#1)(2010-10#1)(2013-8#1)
being used to generate##2##4##(2008-11#1)(2008-6#1)
being used to identify##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
being used to measure##2##4##(2008-2#1)(2008-3#1)
being used to study##2##4##(2008-11#1)(2008-7#1)
being used to##25##3##(1990-11#1)(1994-5#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-8#1)
being used when##2##3##(2007-12#1)(2008-1#1)
being used##91##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-2#2)(1997-1#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
being useful in##2##3##(1993-1#1)(2008-10#1)
being utilized in##2##3##(2008-3#1)(2008-9#1)
being utilized##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
being very important##2##3##(1994-2#1)(2011-2#1)
being very##7##2##(1992-2#1)(1992-3#1)(1994-2#1)(1995-6#1)(2007-7#1)(2008-12#1)(2011-2#1)
being well##5##2##(1992-3#1)(2008-3#1)(2008-8#1)(2013-7#1)(2013-8#1)
being widely used in##2##4##(2008-10#1)(2012-2#1)
being widely##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
being within##3##2##(2008-10#3)
being##1872##1##(1990-11#5)(1990-12#7)(1990-2#4)(1990-3#2)(1990-5#6)(1990-6#6)(1990-7#4)(1990-8#5)(1990-9#5)(1991-1#2)(1991-11#4)(1991-12#18)(1991-2#4)(1991-3#6)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#6)(1991-9#6)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#7)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#9)(1992-9#8)(1993-1#6)(1993-11#3)(1993-12#4)(1993-2#7)(1993-3#4)(1993-5#2)(1993-6#2)(1993-8#8)(1993-9#1)(1994-1#2)(1994-11#5)(1994-12#9)(1994-2#11)(1994-3#7)(1994-5#3)(1994-6#9)(1994-8#6)(1994-9#4)(1995-1#11)(1995-11#6)(1995-12#18)(1995-2#8)(1995-3#7)(1995-5#8)(1995-6#6)(1995-8#4)(1996-1#6)(1996-11#1)(1996-12#15)(1996-2#13)(1996-3#11)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#8)(1997-2#9)(1997-3#13)(1997-4#8)(1997-5#9)(1997-6#5)(1997-7#12)(1997-8#5)(2006-10#6)(2006-7#1)(2007-1#1)(2007-10#6)(2007-11#16)(2007-12#28)(2007-2#2)(2007-5#6)(2007-6#3)(2007-7#29)(2007-8#10)(2007-9#2)(2008-1#31)(2008-10#248)(2008-11#94)(2008-12#38)(2008-2#29)(2008-3#53)(2008-4#32)(2008-5#54)(2008-6#19)(2008-7#88)(2008-8#40)(2008-9#43)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#7)(2009-2#1)(2009-3#8)(2009-4#6)(2009-5#5)(2009-6#14)(2009-7#4)(2009-8#6)(2009-9#7)(2010-1#10)(2010-10#18)(2010-11#13)(2010-12#10)(2010-2#8)(2010-3#10)(2010-4#10)(2010-5#14)(2010-6#7)(2010-7#11)(2010-8#23)(2010-9#1)(2011-1#30)(2011-2#83)(2011-3#4)(2012-1#7)(2012-12#38)(2012-2#42)(2012-3#31)(2013-1#62)(2013-7#16)(2013-8#36)
being)##2##1##(1996-3#1)(2009-8#1)
beings##14##1##(1991-6#1)(1992-9#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2010-1#1)(2012-2#2)(2013-1#1)
belches##2##1##(2013-8#2)
belief in the 10##2##4##(2008-12#2)
belief in the free choice model of homosexuality##3##8##(2008-12#3)
belief in the##7##3##(1990-12#1)(1994-2#1)(2008-12#5)
belief in##10##2##(1990-12#1)(1994-2#1)(1996-12#1)(2008-12#5)(2010-2#1)(2012-3#1)
belief that the##5##3##(1994-2#1)(1996-2#1)(2008-12#2)(2009-6#1)
belief that##26##2##(1990-12#1)(1990-5#1)(1991-6#2)(1992-2#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
belief##57##1##(1990-12#2)(1990-5#1)(1991-6#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#2)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-2#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
beliefs about the##7##3##(2007-2#1)(2009-10#2)(2011-2#1)(2013-8#3)
beliefs about##18##2##(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-8#3)
beliefs among##2##2##(2010-5#1)(2013-1#1)
beliefs and attitudes##3##3##(2008-7#1)(2009-9#1)(2012-12#1)
beliefs and practices##4##3##(2008-9#2)(2009-9#1)(2013-1#1)
beliefs and the##2##3##(2010-1#1)(2011-2#1)
beliefs and values##2##3##(2008-11#1)(2008-12#1)
beliefs and##22##2##(2007-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#2)(2010-1#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#2)
beliefs for##2##2##(2009-7#1)(2010-4#1)
beliefs in##2##2##(2008-12#1)(2010-8#1)
beliefs may##2##2##(2008-12#1)(2009-10#1)
beliefs of##5##2##(1995-1#1)(1996-1#1)(2009-4#1)(2011-1#2)
beliefs on##2##2##(2009-6#1)(2012-12#1)
beliefs regarding##5##2##(1992-12#1)(1995-1#1)(1996-5#1)(2013-7#1)(2013-8#1)
beliefs that##2##2##(2008-4#1)(2009-10#1)
beliefs were related to the##2##5##(2007-12#1)(2010-5#1)
beliefs were##4##2##(2007-12#1)(2008-12#1)(2010-5#1)(2011-2#1)
beliefs##109##1##(1992-12#1)(1994-12#2)(1994-2#1)(1995-1#3)(1996-1#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2008-11#4)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#4)(2008-9#3)(2009-10#7)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-1#4)(2010-10#1)(2010-4#3)(2010-5#7)(2010-8#7)(2011-1#6)(2011-2#5)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
believe in##8##2##(1996-1#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-1#1)
believe is a##12##3##(2008-3#11)(2012-3#1)
believe is the##8##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
believe is##23##2##(1995-1#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#14)(2008-9#1)(2012-3#2)
believe it is##4##3##(1993-12#1)(1997-2#1)(2008-7#1)(2009-5#1)
believe it##9##2##(1991-4#1)(1993-12#1)(1994-2#1)(1997-2#2)(2008-10#1)(2008-7#1)(2009-5#1)(2009-6#1)
believe our##2##2##(2010-12#1)(2012-2#1)
believe that it is##2##4##(1991-12#1)(2012-3#1)
believe that it##4##3##(1991-12#1)(2008-1#1)(2008-11#1)(2012-3#1)
believe that our##5##3##(1992-1#1)(1995-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
believe that the mass##2##4##(2007-8#1)(2008-9#1)
believe that the use of##2##5##(1996-2#1)(2009-1#1)
believe that the##33##3##(1992-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
believe that they##4##3##(2008-1#1)(2008-7#1)(2008-9#1)(2013-7#1)
believe that this is a##2##5##(2009-1#1)(2011-2#1)
believe that this is##5##4##(2007-11#1)(2007-12#1)(2009-1#1)(2010-3#1)(2011-2#1)
believe that this##10##3##(1992-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#1)(2009-1#1)(2010-3#1)(2011-2#2)
believe that we have##2##4##(2010-11#1)(2013-1#1)
believe that we##3##3##(1994-3#1)(2010-11#1)(2013-1#1)
believe that##123##2##(1990-10#2)(1990-3#2)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-11#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#7)(2009-1#2)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
believe the use of##2##4##(2008-3#1)(2008-6#1)
believe the##13##2##(1990-2#2)(1990-6#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-6#2)(2009-3#1)(2011-1#1)(2012-2#1)
believe there##2##2##(2008-1#1)(2012-2#1)
believe this##8##2##(1994-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
believe to be an##2##4##(2008-4#1)(2008-9#1)
believe to be##22##3##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#11)(2008-4#1)(2008-9#1)
believe##237##1##(1990-10#2)(1990-2#2)(1990-3#2)(1990-6#1)(1991-1#1)(1991-12#3)(1991-4#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-4#1)(1997-2#4)(1997-6#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#14)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#33)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#17)(2008-8#3)(2008-9#10)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#5)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#1)
believed in the##2##3##(2009-11#1)(2009-4#1)
believed in##3##2##(2007-7#1)(2009-11#1)(2009-4#1)
believed that family planning##2##4##(1992-4#2)
believed that i##2##3##(2008-1#2)
believed that many##2##3##(2010-7#1)(2011-1#1)
believed that such##2##3##(2008-3#1)(2008-4#1)
believed that the##10##3##(1990-8#1)(1994-8#1)(1996-2#1)(2008-4#2)(2008-5#1)(2012-1#1)(2012-12#2)(2012-3#1)
believed that there##2##3##(1995-1#1)(1996-1#1)
believed that these##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
believed that they##2##3##(1994-2#1)(2011-2#1)
believed that this##5##3##(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#2)
believed that##58##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-4#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#3)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
believed the##2##2##(1995-1#1)(2008-7#1)
believed to affect##2##3##(2008-8#1)(2010-12#1)
believed to arise##3##3##(1994-5#1)(2007-10#1)(2008-11#1)
believed to be a##16##4##(1991-9#1)(1993-2#1)(1994-11#1)(1994-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#4)(2008-9#1)(2011-2#2)(2012-2#1)
believed to be caused by##2##5##(2007-11#1)(2008-10#1)
believed to be due##2##4##(1993-1#1)(1997-7#1)
believed to be involved in the##5##6##(2008-11#1)(2008-7#1)(2010-3#1)(2013-8#2)
believed to be new##11##4##(2008-3#11)
believed to be novel##7##4##(2008-3#7)
believed to be related to##2##5##(1994-3#1)(2008-10#1)
believed to be responsible for##2##5##(1997-8#1)(2007-12#1)
believed to be the first##35##5##(2007-11#18)(2007-12#15)(2008-2#1)(2008-3#1)
believed to be the##41##4##(1992-4#1)(1992-9#1)(1997-2#1)(2007-11#19)(2007-12#17)(2008-2#1)(2008-3#1)
believed to be##110##3##(1990-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#22)(2007-12#18)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#23)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#3)
believed to cause##2##3##(2008-10#1)(2008-4#1)
believed to contain##2##3##(1991-6#1)(1996-12#1)
believed to contribute to the##3##5##(2008-3#1)(2008-5#1)(2012-3#1)
believed to contribute to##4##4##(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
believed to exert##2##3##(1994-8#1)(2009-5#1)
believed to have an##2##4##(2007-11#1)(2008-4#1)
believed to initiate##2##3##(1995-3#1)(2008-6#1)
believed to mediate##2##3##(1990-8#1)(2008-5#1)
believed to play a##2##4##(1991-9#1)(2013-1#1)
believed to play##6##3##(1991-9#1)(1995-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
believed to underlie##2##3##(1994-5#1)(1996-2#1)
believed to##174##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-4#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#2)(2007-11#23)(2007-12#18)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#24)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
believed##249##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-3#3)(1991-6#1)(1991-9#2)(1992-10#1)(1992-4#5)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#3)(1995-1#3)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#2)(2007-11#23)(2007-12#19)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#27)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-11#2)(2009-4#4)(2009-5#3)(2009-7#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#4)
believer##2##1##(1996-12#1)(2011-2#1)
believes that the##2##3##(1993-12#1)(2012-3#1)
believes that##7##2##(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(2008-4#1)(2012-3#1)
believes##17##1##(1990-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
believing##4##1##(1991-2#1)(1995-12#1)(2008-11#1)(2009-7#1)
bell pepper##10##2##(2008-10#10)
bell##13##1##(2008-10#11)(2008-6#1)(2011-2#1)
bell-shaped curve##2##2##(1990-7#1)(2008-5#1)
bell-shaped dose-response curve##2##3##(2008-11#2)
bell-shaped##7##1##(1990-7#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)
bellicosus##2##1##(2008-9#2)
bells##2##1##(1991-3#1)(2010-2#1)
belly##7##1##(1996-12#2)(2008-7#3)(2009-10#2)
belong to a group of##2##5##(1995-5#1)(2011-2#1)
belong to a new class of##2##6##(1992-9#1)(1997-2#1)
belong to a new##3##4##(1992-9#1)(1993-2#1)(1997-2#1)
belong to a single##2##4##(2008-10#2)
belong to a##15##3##(1992-9#1)(1993-2#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
belong to different##3##3##(2007-12#2)(2008-10#1)
belong to four##2##3##(2008-10#1)(2008-5#1)
belong to one##2##3##(2008-3#1)(2008-4#1)
belong to the class of##2##5##(1995-12#1)(2008-11#1)
belong to the class##3##4##(1995-12#1)(2008-11#1)(2008-2#1)
belong to the family##3##4##(1995-6#1)(2008-5#1)(2013-7#1)
belong to the genus##2##4##(2008-10#1)(2012-2#1)
belong to the orthorhombic##2##4##(1992-12#1)(2013-8#1)
belong to the same species##2##5##(2008-10#1)(2013-7#1)
belong to the same##6##4##(1991-5#2)(2008-10#1)(2008-8#1)(2011-1#1)(2013-7#1)
belong to the##51##3##(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
belong to this##2##3##(1992-9#1)(2008-2#1)
belong to two##4##3##(1994-9#1)(2008-10#2)(2008-11#1)
belong to##112##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#27)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
belong##119##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#2)(2007-12#2)(2007-8#1)(2008-10#29)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#4)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-7#1)(2011-1#3)(2011-2#6)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
belonged to a single##4##4##(2007-6#1)(2008-10#3)
belonged to a##9##3##(2007-6#1)(2007-7#1)(2008-10#5)(2008-4#1)(2011-2#1)
belonged to different##3##3##(1992-11#1)(2008-10#1)(2011-2#1)
belonged to either##2##3##(2008-10#1)(2008-12#1)
belonged to genotype##2##3##(2008-10#1)(2013-8#1)
belonged to group##2##3##(2008-10#2)
belonged to subgenogroup B5##2##4##(2008-12#2)
belonged to the same cluster as##2##6##(2008-10#1)(2008-12#1)
belonged to the same##6##4##(1992-11#1)(2008-10#4)(2008-12#1)
belonged to the##22##3##(1992-11#1)(1995-3#1)(1996-11#1)(2008-10#11)(2008-12#2)(2008-5#3)(2010-11#1)(2011-1#1)(2013-8#1)
belonged to three##2##3##(2008-10#1)(2013-7#1)
belonged to##77##2##(1990-12#1)(1992-11#2)(1993-2#1)(1994-5#1)(1995-3#1)(1996-11#1)(2007-6#1)(2007-7#4)(2008-10#38)(2008-12#6)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
belonged##80##1##(1990-12#1)(1992-11#2)(1993-2#1)(1994-5#1)(1995-3#1)(1996-11#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#39)(2008-12#6)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
belonging to a##6##3##(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2011-2#1)
belonging to different##2##3##(2008-10#2)
belonging to eight##2##3##(2008-10#1)(2013-7#1)
belonging to family##3##3##(2008-10#2)(2010-10#1)
belonging to four##3##3##(2007-5#1)(2008-10#1)(2008-7#1)
belonging to other##3##3##(1997-6#1)(2008-10#2)
belonging to six##2##3##(2008-10#1)(2013-7#1)
belonging to subgroup##2##3##(2008-10#2)
belonging to the Bacillus##2##4##(2011-2#2)
belonging to the C##2##4##(2008-10#2)
belonging to the CSF-1 transduction pathway##2##6##(1997-7#2)
belonging to the S##2##4##(2008-10#2)
belonging to the families##2##4##(2008-10#1)(2013-8#1)
belonging to the family of##2##5##(1995-6#1)(2012-2#1)
belonging to the family##8##4##(1995-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-2#2)
belonging to the genera##5##4##(2008-10#2)(2008-7#1)(2013-7#1)(2013-8#1)
belonging to the genus##6##4##(1991-12#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-3#1)
belonging to the same##4##4##(1997-6#1)(2008-1#1)(2008-3#1)(2008-5#1)
belonging to the three##2##4##(2008-10#1)(2010-8#1)
belonging to the##85##3##(1990-12#1)(1990-5#1)(1991-12#3)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-2#1)(1995-6#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
belonging to three##4##3##(2008-10#3)(2010-10#1)
belonging to two##5##3##(1997-9#1)(2008-10#3)(2008-12#1)
belonging to##167##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-9#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#1)(1997-9#2)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#63)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#3)(2013-8#3)
belonging##174##1##(1990-12#1)(1990-5#1)(1991-12#3)(1991-9#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#1)(1997-9#2)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#63)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#2)(2009-5#1)(2009-7#5)(2009-8#1)(2010-10#3)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#3)(2013-8#3)
belongingness (i##2##2##(2009-7#2)
belongingness##6##1##(2009-7#6)
belongings##3##1##(1992-12#1)(2008-10#1)(2008-2#1)
belongs to a family of##2##5##(2009-10#1)(2010-10#1)
belongs to a##9##3##(1993-6#1)(1995-6#1)(1996-2#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
belongs to family##3##3##(2008-12#1)(2008-8#1)(2013-8#1)
belongs to the class of##3##5##(2008-3#1)(2008-5#1)(2009-12#1)
belongs to the family of##3##5##(1991-12#1)(1993-6#1)(2009-7#1)
belongs to the family##8##4##(1991-12#1)(1993-6#1)(2009-7#1)(2011-2#5)
belongs to the order##2##4##(2008-9#1)(2011-2#1)
belongs to the##47##3##(1991-12#1)(1992-8#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-6#1)(1996-12#1)(1997-2#2)(1997-7#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
belongs to##72##2##(1991-12#1)(1992-8#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2008-10#10)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
belongs##79##1##(1991-12#1)(1991-6#1)(1992-8#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-7#1)(2008-10#11)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
below 0##20##2##(1991-8#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-5#2)(2009-7#1)(2012-1#1)(2013-1#1)
below 1##11##2##(1990-12#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
below 1%##2##2##(2007-7#1)(2012-12#1)
below 10##9##2##(1991-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-3#1)
below 10%##8##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
below 1000 m##3##3##(1996-12#3)
below 1000##4##2##(1996-12#3)(2007-11#1)
below 11##2##2##(2008-3#1)(2011-1#1)
below 15##2##2##(1995-11#2)
below 15%##2##2##(2008-10#2)
below 190 eV##3##3##(2007-11#3)
below 2##8##2##(1995-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2012-12#1)
below 2% for##2##3##(2008-10#2)
below 2%##5##2##(2008-10#5)
below 20##2##2##(1991-6#1)(2008-2#1)
below 200 nm##2##3##(2007-11#1)(2008-3#1)
below 200##4##2##(1990-2#1)(2007-11#1)(2008-3#1)(2008-7#1)
below 3##3##2##(2008-10#2)(2008-7#1)
below 3%##2##2##(1997-4#1)(2008-10#1)
below 30##4##2##(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
below 300##4##2##(1990-9#1)(1992-12#1)(2008-10#1)(2008-3#1)
below 32 degrees##2##3##(1995-11#1)(2008-3#1)
below 37 degrees##2##3##(2008-10#1)(2008-11#1)
below 4##9##2##(1993-12#1)(1993-8#1)(2008-10#5)(2009-5#1)(2011-1#1)
below 40 degrees C##2##4##(2008-10#1)(2008-8#1)
below 40##3##2##(1995-3#1)(2008-10#1)(2008-8#1)
below 400##4##2##(2008-3#1)(2008-5#2)(2012-2#1)
below 5##13##2##(1992-11#2)(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#5)
below 5%##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
below 50##2##2##(2007-12#1)(2008-10#1)
below 6 degrees C##2##4##(2008-10#2)
below 6##4##2##(1992-11#1)(1996-3#1)(2008-10#2)
below 60##2##2##(1996-2#1)(2007-12#1)
below 7##2##2##(2008-10#2)
below 70##2##2##(1993-11#1)(2008-1#1)
below 8##3##2##(2008-10#2)(2011-1#1)
below 8%##2##2##(2008-10#2)
below 90##2##2##(2008-3#1)(2008-7#1)
below a certain##2##3##(1995-8#1)(2008-7#1)
below a critical##2##3##(2008-8#2)
below a threshold##2##3##(1996-8#1)(2008-8#1)
below a##9##2##(1995-8#1)(1996-8#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#3)(2012-1#1)
below about 3##2##3##(1996-4#1)(2008-10#1)
below age##3##2##(1990-6#1)(1990-9#1)(1994-6#1)
below an##3##2##(2008-10#1)(2008-2#2)
below and above the critical##2##5##(2008-10#1)(2008-7#1)
below and above the isoelectric points##2##6##(2008-10#2)
below and above the##7##4##(1994-2#1)(1994-3#1)(1995-3#1)(2008-10#3)(2008-7#1)
below and above##10##3##(1994-2#1)(1994-3#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2013-1#1)
below and##11##2##(1994-2#1)(1994-3#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2013-1#1)
below approximately##3##2##(2008-3#3)
below both##2##2##(2007-8#1)(2008-8#1)
below detection##2##2##(2008-10#2)
below it##2##2##(2008-2#1)(2008-3#1)
below its##4##2##(2007-12#1)(2008-6#1)(2009-5#1)(2010-4#1)
below normal##2##2##(2008-10#1)(2011-1#1)
below or above##2##3##(1996-5#1)(2008-10#1)
below or##4##2##(1991-2#1)(1996-5#1)(2008-10#2)
below room temperature##2##3##(2007-11#1)(2010-12#1)
below that in the##2##4##(2008-10#1)(2008-2#1)
below that of the##4##4##(1994-12#1)(1997-5#1)(2008-10#1)(2012-2#1)
below that of##5##3##(1994-12#1)(1997-5#1)(2007-2#1)(2008-10#1)(2012-2#1)
below that##15##2##(1993-6#1)(1993-9#1)(1994-12#1)(1997-5#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2012-2#1)
below the &quot##3##3##(1991-11#3)
below the age of##6##4##(1995-6#1)(1997-8#2)(2008-1#1)(2008-8#1)(2010-3#1)
below the aircraft##2##3##(2008-3#2)
below the average##4##3##(1995-11#1)(1995-12#1)(1996-2#1)(2013-1#1)
below the cloud tops##2##4##(1991-5#1)(1992-7#1)
below the cloud##3##3##(1991-5#1)(1992-7#1)(2008-3#1)
below the concentrations##2##3##(2008-10#2)
below the control mean -##2##5##(1996-7#2)
below the critical depth of 2##2##6##(2008-10#2)
below the critical##5##3##(2007-12#1)(2008-10#3)(2008-4#1)
below the detection limit##5##4##(2008-10#4)(2008-7#1)
below the fundamental##2##3##(2008-2#2)
below the instrumental##2##3##(2008-3#2)
below the level of detection##3##5##(2008-10#2)(2008-5#1)
below the level of##5##4##(2008-10#2)(2008-5#2)(2009-12#1)
below the level##7##3##(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)
below the limit of detection##2##5##(2012-2#1)(2012-8#1)
below the limits##2##3##(2008-2#1)(2008-3#1)
below the lower##2##3##(1993-8#1)(2008-10#1)
below the maximum##2##3##(2008-10#1)(2013-8#1)
below the minimum##2##3##(2008-10#1)(2013-1#1)
below the range##2##3##(1992-6#1)(1997-7#1)
below the shot-noise level##2##4##(2007-12#2)
below the shot-noise##3##3##(2007-11#1)(2007-12#2)
below the spontaneous level##3##4##(2008-7#3)
below the spontaneous##5##3##(2008-7#5)
below the threshold for##2##4##(2008-10#2)
below the threshold of##2##4##(2008-10#1)(2008-7#1)
below the threshold##9##3##(2008-10#8)(2008-7#1)
below the##168##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1991-11#3)(1991-5#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-4#1)(1997-7#2)(1997-8#2)(2007-11#6)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#4)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#1)
below their##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
below this threshold##2##3##(2008-10#2)
below this##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
below those of##2##3##(1993-9#1)(2008-10#1)
below those##5##2##(1993-9#1)(1994-6#1)(2008-10#2)(2008-7#1)
below threshold##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2009-11#1)
below values##2##2##(1991-3#1)(2012-3#1)
below which the##3##3##(1992-5#1)(1997-4#1)(2008-9#1)
below which##11##2##(1990-3#1)(1992-5#1)(1992-9#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-12#1)
below##528##1##(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#5)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#3)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#2)(1997-7#2)(1997-8#2)(2007-11#17)(2007-12#25)(2007-2#1)(2007-7#1)(2007-8#9)(2008-1#9)(2008-10#145)(2008-11#8)(2008-12#4)(2008-2#21)(2008-3#41)(2008-4#2)(2008-5#20)(2008-6#2)(2008-7#17)(2008-8#16)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#11)(2012-3#2)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#3)
below)##4##1##(1997-3#1)(2011-1#1)(2011-2#2)
belt was##3##2##(2013-1#3)
belt##15##1##(1993-3#1)(1997-6#3)(2008-2#1)(2008-7#3)(2009-9#1)(2011-1#1)(2013-1#4)(2013-8#1)
belts##2##1##(1993-3#1)(2010-1#1)
benA##3##1##(1997-2#3)
benazepril plus##2##2##(2012-3#2)
benazepril##3##1##(2012-3#3)
bench and##3##2##(2007-7#1)(2008-5#1)(2010-6#1)
bench press and##3##3##(2008-5#3)
bench press##6##2##(2008-5#5)(2009-1#1)
bench scale##2##2##(1994-5#1)(2009-2#1)
bench to##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
bench top##4##2##(1995-12#2)(2009-10#2)
bench##30##1##(1994-5#1)(1995-12#2)(1995-3#1)(1996-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#1)(2010-6#1)(2012-12#1)
bench-scale##2##1##(2008-11#1)(2011-2#1)
bench-top##4##1##(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
benches##2##1##(2008-10#1)(2008-3#1)
benchmark for risk##2##3##(2008-10#1)(2008-8#1)
benchmark for##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
benchmark of US$50##2##3##(2009-8#2)
benchmark of##4##2##(2008-8#1)(2009-8#2)(2010-4#1)
benchmark products##2##2##(2008-5#2)
benchmark results##3##2##(2008-3#1)(2012-12#2)
benchmark##35##1##(1991-2#1)(1995-1#2)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#3)(2008-8#2)(2009-5#2)(2009-8#2)(2010-4#1)(2010-9#1)(2012-12#4)(2012-2#2)(2013-1#2)
benchmarked against##2##2##(2007-2#1)(2008-5#1)
benchmarked##6##1##(1995-12#1)(2007-2#1)(2007-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
benchmarking and##5##2##(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#1)
benchmarking can be##2##3##(1995-12#1)(1996-3#1)
benchmarking can##5##2##(1995-1#1)(1995-12#2)(1996-3#2)
benchmarking is##2##2##(1995-3#1)(1996-3#1)
benchmarking often##2##2##(1995-12#1)(1997-1#1)
benchmarking partner##2##2##(1995-12#2)
benchmarking partners##2##2##(1995-3#1)(1997-1#1)
benchmarking project##4##2##(1997-1#1)(2008-11#3)
benchmarking##45##1##(1994-1#1)(1994-12#4)(1994-3#1)(1995-1#2)(1995-12#8)(1995-3#6)(1996-1#1)(1996-12#1)(1996-3#7)(1997-1#10)(2008-11#4)
benchmarks for##3##2##(1993-3#1)(2012-2#2)
benchmarks##15##1##(1993-3#1)(1994-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-2#2)
benchtop##3##1##(2007-11#1)(2008-10#1)(2008-9#1)
bend occurs##2##2##(1993-8#2)
bend sites##3##2##(1996-2#3)
bend##23##1##(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#3)(1995-5#1)(1995-8#2)(1996-2#4)(2007-11#2)(2007-12#1)(2008-3#5)(2011-2#1)(2012-2#1)
bending and##7##2##(2008-5#4)(2010-4#1)(2011-1#1)(2012-2#1)
bending by##2##2##(1995-8#1)(2008-3#1)
bending efficiency##2##2##(2007-11#2)
bending in the##2##3##(2008-8#1)(2010-4#1)
bending in##6##2##(1992-6#1)(1993-8#1)(2008-8#2)(2010-4#1)(2013-1#1)
bending loss##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
bending losses##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
bending moments##2##2##(2008-3#1)(2012-2#1)
bending occurs##2##2##(1992-6#1)(2009-4#1)
bending of a##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
bending of the##3##3##(1991-7#1)(1992-6#1)(2008-9#1)
bending of##8##2##(1991-7#1)(1992-6#1)(1996-12#1)(2007-12#2)(2008-3#2)(2008-9#1)
bending properties##2##2##(2008-5#1)(2009-7#1)
bending radius##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
bending stiffness##3##2##(2008-5#3)
bending strains##3##2##(2008-3#3)
bending##92##1##(1991-7#1)(1992-6#4)(1993-8#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#7)(2007-11#5)(2007-12#5)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#20)(2008-5#8)(2008-7#4)(2008-8#7)(2008-9#1)(2009-4#1)(2009-7#3)(2010-4#4)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#4)
bends and##3##2##(2007-7#1)(2008-2#1)(2009-11#1)
bends##12##1##(1992-2#1)(1992-6#1)(1993-8#1)(2007-11#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#3)
beneath a##3##2##(2007-12#1)(2008-10#2)
beneath appressoria of conidia that had failed to produce secondary hyphae##2##11##(2008-10#2)
beneath appressoria##3##2##(2008-10#3)
beneath the cuticle##2##3##(2008-10#2)
beneath the patellar tendon##2##4##(2008-9#2)
beneath the sea surface##2##4##(2008-2#1)(2008-3#1)
beneath the surface of##2##4##(1995-3#1)(2007-12#1)
beneath the surface##3##3##(1995-3#1)(2007-12#2)
beneath the##30##2##(1991-12#1)(1992-9#1)(1994-12#1)(1995-3#1)(1995-6#2)(2007-11#2)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
beneath##49##1##(1991-12#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#3)(1997-7#1)(2007-11#2)(2007-12#6)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#3)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
benefical##2##1##(2008-7#1)(2011-1#1)
beneficence and##3##2##(1991-2#1)(2007-2#1)(2009-6#1)
beneficence##9##1##(1991-2#1)(1992-3#1)(1995-9#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-11#1)
beneficial action of##2##3##(1995-5#1)(2008-7#1)
beneficial and##9##2##(1994-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-1#1)(2013-8#1)
beneficial bacteria in the##2##4##(1996-9#1)(2012-2#1)
beneficial bacteria##3##2##(1996-9#1)(2012-2#2)
beneficial changes in##3##3##(1991-2#1)(2013-1#2)
beneficial effect in##2##3##(1997-6#1)(2010-2#1)
beneficial effect is##3##3##(1995-2#1)(1995-3#1)(1996-6#1)
beneficial effect of the##2##4##(1996-1#1)(2013-1#1)
beneficial effect of##15##3##(1990-2#1)(1992-12#1)(1994-11#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-5#1)(2008-10#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
beneficial effect on##13##3##(1991-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
beneficial effect##36##2##(1990-2#2)(1991-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
beneficial effects are##2##3##(2008-7#1)(2008-8#1)
beneficial effects by##2##3##(2013-7#1)(2013-8#1)
beneficial effects in##6##3##(1997-6#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-6#1)(2010-5#1)
beneficial effects of the##2##4##(2008-1#1)(2008-10#1)
beneficial effects of##27##3##(1991-9#1)(1992-7#1)(1996-2#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-7#6)(2009-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)
beneficial effects on##9##3##(1990-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)
beneficial effects##62##2##(1990-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1996-2#2)(1996-6#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#10)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-7#2)(2013-8#1)
beneficial for improving##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
beneficial for patients with##2##4##(2008-7#1)(2011-2#1)
beneficial for patients##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
beneficial for the##9##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
beneficial for##36##2##(1991-3#1)(1992-7#1)(1993-3#1)(1994-11#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
beneficial functions##2##2##(2008-5#1)(2013-8#1)
beneficial health effects##2##3##(2008-10#1)(2009-11#1)
beneficial health##3##2##(2008-10#1)(2009-11#1)(2009-5#1)
beneficial impact##3##2##(1991-12#1)(2008-11#1)(2009-8#1)
beneficial in acute stroke##2##4##(2007-10#2)
beneficial in acute##3##3##(2007-10#3)
beneficial in many##2##3##(2008-10#1)(2008-3#1)
beneficial in patients with##2##4##(2008-5#1)(2012-2#1)
beneficial in the treatment of##4##5##(1990-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
beneficial in the##9##3##(1990-10#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
beneficial in##35##2##(1990-10#1)(1990-2#1)(2007-10#4)(2007-11#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
beneficial influence of##2##3##(1991-6#1)(1993-12#1)
beneficial influence##3##2##(1991-6#1)(1993-12#1)(2008-5#1)
beneficial not only##2##3##(1995-9#1)(2009-3#1)
beneficial or##4##2##(2008-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
beneficial properties##2##2##(2008-10#2)
beneficial role in##2##3##(2011-2#1)(2013-1#1)
beneficial role##6##2##(2008-1#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
beneficial to health##2##3##(2008-11#1)(2008-7#1)
beneficial to human health##2##4##(2008-7#1)(2010-1#1)
beneficial to patients with##2##4##(2008-9#1)(2011-2#1)
beneficial to patients##3##3##(2008-9#1)(2010-5#1)(2011-2#1)
beneficial to the##4##3##(1996-11#1)(1996-6#1)(2011-2#1)(2013-1#1)
beneficial to##28##2##(1994-3#1)(1996-11#1)(1996-6#1)(2007-7#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
beneficial traits##2##2##(2013-1#1)(2013-8#1)
beneficial##328##1##(1990-10#1)(1990-2#3)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#2)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(2006-10#2)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#10)(2008-12#7)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#15)(2008-6#2)(2008-7#25)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#5)(2010-10#4)(2010-12#1)(2010-2#5)(2010-3#1)(2010-5#3)(2010-8#1)(2011-1#6)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#13)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#11)
beneficially##5##1##(1993-5#1)(1995-5#1)(2008-3#1)(2008-7#1)(2013-8#1)
beneficiaries admitted##2##2##(1994-12#1)(1995-12#1)
beneficiaries and##3##2##(1994-2#1)(1996-1#1)(1997-3#1)
beneficiaries are##5##2##(1991-3#1)(1995-12#3)(1996-2#1)
beneficiaries during##2##2##(1991-2#1)(1992-12#1)
beneficiaries for##3##2##(1992-12#1)(1994-3#1)(1995-12#1)
beneficiaries have higher##2##3##(1992-2#1)(1995-2#1)
beneficiaries have##5##2##(1991-2#1)(1992-2#1)(1995-2#1)(1996-3#2)
beneficiaries in##7##2##(1991-3#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-3#1)(2008-7#2)
beneficiaries of##2##2##(1995-1#1)(2008-8#1)
beneficiaries to##3##2##(1995-2#1)(1996-3#1)(1997-2#1)
beneficiaries under##2##2##(1991-3#1)(1995-12#1)
beneficiaries with information##2##3##(1997-3#2)
beneficiaries with##3##2##(1997-2#1)(1997-3#2)
beneficiaries##109##1##(1991-1#1)(1991-2#5)(1991-3#6)(1992-1#1)(1992-12#5)(1992-2#3)(1993-1#3)(1993-12#5)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#4)(1995-1#1)(1995-12#14)(1995-2#7)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#9)(1997-1#1)(1997-2#5)(1997-3#12)(1997-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2013-1#1)
beneficiaries'##3##1##(1994-1#1)(1994-12#1)(1997-2#1)
beneficiary population##2##2##(1991-1#1)(1991-3#1)
beneficiary##12##1##(1991-1#1)(1991-2#2)(1991-3#3)(1992-2#1)(1993-12#1)(1993-3#1)(1997-1#1)(1997-3#2)
benefit a##2##2##(1997-1#1)(2008-8#1)
benefit amount for a##2##4##(1992-12#2)
benefit and risk##2##3##(2007-8#1)(2011-2#1)
benefit and##19##2##(1992-3#1)(1994-2#1)(1994-6#1)(1995-3#2)(1997-1#1)(2007-8#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-6#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
benefit as the##2##3##(1994-3#1)(1995-2#1)
benefit as##6##2##(1994-3#1)(1995-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-10#1)
benefit at##3##2##(1994-2#1)(2007-11#1)(2008-8#1)
benefit available##2##2##(1995-1#1)(2008-10#1)
benefit both##4##2##(1990-9#1)(2007-2#1)(2010-10#1)(2013-8#1)
benefit by##4##2##(2008-8#2)(2012-2#2)
benefit compared with##2##3##(1996-9#1)(2008-7#1)
benefit derived from##2##3##(1991-9#1)(2008-10#1)
benefit for weight-loss outpatient services##3##5##(2010-8#3)
benefit for##17##2##(1993-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#3)(2012-1#1)(2013-1#1)(2013-8#1)
benefit from a##10##3##(1991-2#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-2#1)(1997-3#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-7#1)
benefit from adjuvant##2##3##(1993-1#1)(2011-2#1)
benefit from an##3##3##(1993-3#1)(2012-1#1)(2012-3#1)
benefit from cochlear##2##3##(2008-9#1)(2012-2#1)
benefit from early##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
benefit from high##2##3##(2008-9#1)(2013-1#1)
benefit from interventions##2##3##(1995-2#1)(2007-12#1)
benefit from more##3##3##(2010-11#1)(2010-12#1)(2012-2#1)
benefit from such##5##3##(1990-6#1)(1996-6#1)(1996-9#1)(1997-6#1)(2013-8#1)
benefit from the experiences of##2##5##(1990-6#1)(1991-2#1)
benefit from the use of##3##5##(1992-2#1)(2008-3#1)(2011-2#1)
benefit from the##22##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-2#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-3#1)
benefit from their##3##3##(1995-1#1)(2008-11#1)(2009-6#1)
benefit from therapy##2##3##(2012-2#1)(2013-8#1)
benefit from these##2##3##(1991-2#1)(2012-1#1)
benefit from this approach##2##4##(2008-10#1)(2013-8#1)
benefit from this technique##2##4##(2008-12#1)(2010-7#1)
benefit from this##10##3##(1992-12#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
benefit from treatment with##3##4##(1996-9#1)(2009-4#1)(2010-5#1)
benefit from treatment##4##3##(1996-9#1)(2009-4#1)(2010-5#1)(2011-2#1)
benefit from understanding##2##3##(2009-9#1)(2010-10#1)
benefit from using##2##3##(2007-12#1)(2008-9#1)
benefit from##140##2##(1990-3#2)(1990-6#2)(1991-12#2)(1991-2#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-3#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#4)(1997-8#1)(2006-4#1)(2007-10#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#6)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#3)(2012-7#2)(2013-1#2)(2013-7#1)(2013-8#4)
benefit has##3##2##(1994-12#1)(1996-11#1)(2008-9#1)
benefit in a##3##3##(2010-10#1)(2010-12#1)(2013-1#1)
benefit in patients##3##3##(2006-10#1)(2008-5#1)(2010-12#1)
benefit in terms of##2##4##(2010-3#1)(2013-1#1)
benefit in the##3##3##(2007-9#1)(2012-3#1)(2013-7#1)
benefit in##24##2##(1992-1#1)(1994-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#3)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
benefit is the##2##3##(1994-3#1)(2008-12#1)
benefit is##10##2##(1993-11#1)(1994-3#2)(1995-2#1)(1996-1#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#1)
benefit may be##3##3##(1991-8#1)(1993-11#1)(2007-9#1)
benefit may##6##2##(1991-3#1)(1991-8#2)(1993-11#1)(1994-2#1)(2007-9#1)
benefit more from##2##3##(2008-12#1)(2012-12#1)
benefit mosquitoes##2##2##(2008-12#2)
benefit most from##4##3##(2008-1#1)(2008-7#1)(2010-4#1)(2012-2#1)
benefit most##5##2##(2008-1#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
benefit of a##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
benefit of adjuvant##3##3##(1990-10#2)(1992-11#1)
benefit of an##2##3##(2007-12#1)(2008-10#1)
benefit of chemotherapy##2##3##(2008-6#1)(2010-3#1)
benefit of early##3##3##(1996-11#1)(2008-3#1)(2008-9#1)
benefit of the##12##3##(1992-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-11#2)(2010-8#1)(2013-1#2)
benefit of these##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
benefit of this##5##3##(2007-8#1)(2008-6#1)(2009-11#1)(2010-5#1)(2011-1#1)
benefit of##108##2##(1990-10#2)(1992-11#1)(1992-2#2)(1994-2#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
benefit on the##2##3##(2011-2#1)(2013-1#1)
benefit only##2##2##(2008-6#1)(2008-8#1)
benefit or harm##2##3##(2011-2#1)(2012-2#1)
benefit or##5##2##(1997-3#1)(2006-10#1)(2011-2#1)(2012-2#2)
benefit over##3##2##(2008-1#1)(2008-10#1)(2009-10#1)
benefit package##3##2##(1992-1#1)(1992-3#1)(1995-12#1)
benefit patients with##2##3##(2008-12#1)(2013-8#1)
benefit patients##6##2##(1994-12#1)(1997-6#1)(2008-12#1)(2008-5#1)(2009-8#1)(2013-8#1)
benefit period##2##2##(1992-12#2)
benefit plan##3##2##(1994-2#1)(1994-3#1)(1996-1#1)
benefit plans##3##2##(1991-1#1)(1992-3#1)(1994-3#1)
benefit programs##2##2##(1991-2#1)(1994-1#1)
benefit than##3##2##(1997-1#1)(2008-5#1)(2008-6#1)
benefit that##4##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
benefit the patient and##2##4##(1992-3#1)(1995-2#1)
benefit the##10##2##(1992-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#2)
benefit to the##2##3##(1996-12#1)(2007-2#1)
benefit to them##2##3##(1992-3#1)(2008-11#1)
benefit to##22##2##(1991-1#1)(1992-3#3)(1993-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#1)
benefit under##2##2##(1992-1#1)(1995-1#1)
benefit was##4##2##(1995-1#1)(2007-10#1)(2013-1#2)
benefit while##2##2##(2008-4#1)(2008-7#1)
benefit will##2##2##(1993-1#1)(2012-3#1)
benefit with this##2##3##(2007-11#1)(2007-12#1)
benefit with##3##2##(2007-11#1)(2007-12#1)(2010-12#1)
benefit##588##1##(1990-10#3)(1990-3#2)(1990-6#3)(1990-9#1)(1991-1#3)(1991-12#2)(1991-2#5)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#7)(1992-2#3)(1992-3#8)(1993-1#6)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#10)(1994-3#8)(1994-6#3)(1994-9#1)(1995-1#7)(1995-11#2)(1995-12#3)(1995-2#13)(1995-3#4)(1995-5#3)(1995-6#2)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1996-9#4)(1997-1#10)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#2)(2006-10#3)(2006-4#1)(2007-10#7)(2007-11#6)(2007-12#12)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#36)(2008-11#19)(2008-12#11)(2008-2#7)(2008-3#17)(2008-4#5)(2008-5#13)(2008-6#10)(2008-7#14)(2008-8#27)(2008-9#18)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#5)(2009-5#3)(2009-6#4)(2009-8#3)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#27)(2011-3#2)(2012-1#5)(2012-12#7)(2012-2#14)(2012-3#10)(2012-7#2)(2013-1#20)(2013-7#4)(2013-8#9)
benefit)##2##1##(1992-3#1)(1995-5#1)
benefit?##3##1##(2008-10#1)(2011-2#2)
benefit?]##2##1##(1997-6#1)(2008-4#1)
benefited from its##2##3##(2011-2#1)(2013-7#1)
benefited from other##2##3##(1997-3#1)(2008-7#1)
benefited from the use of##2##5##(2008-10#1)(2008-5#1)
benefited from the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
benefited from##18##2##(1991-6#1)(1994-9#1)(1995-4#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
benefited more##2##2##(1996-2#1)(2008-5#1)
benefited most from##2##3##(1991-5#1)(2010-12#1)
benefited the##2##2##(2008-10#2)
benefited##29##1##(1990-5#1)(1991-5#1)(1991-6#1)(1992-5#1)(1994-9#1)(1995-4#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#2)(2010-1#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
benefiting from##5##2##(1996-1#1)(1996-12#1)(2007-8#1)(2008-9#1)(2009-10#1)
benefiting##9##1##(1996-1#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
benefits and barriers##2##3##(1997-3#1)(2008-11#1)
benefits and costs##8##3##(1993-1#1)(1995-3#1)(2008-8#4)(2009-4#1)(2011-1#1)
benefits and disadvantages of##2##4##(1992-3#1)(1996-3#1)
benefits and drawbacks##3##3##(2009-11#1)(2013-1#2)
benefits and limitations of##7##4##(1996-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)
benefits and limitations##10##3##(1996-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-8#1)(2013-1#1)
benefits and risks of these##2##5##(2011-2#1)(2013-1#1)
benefits and risks of##8##4##(1993-1#1)(2008-10#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
benefits and risks##13##3##(1992-3#2)(1993-1#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
benefits and##66##2##(1990-2#1)(1990-4#1)(1991-3#1)(1992-1#2)(1992-3#3)(1993-1#3)(1993-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#5)(2009-11#1)(2009-12#2)(2009-4#2)(2010-1#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#1)
benefits are discussed##2##3##(1995-1#1)(2008-10#1)
benefits are similar##2##3##(1994-12#1)(2009-6#1)
benefits are##15##2##(1992-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-1#1)(2009-6#1)(2012-1#1)
benefits as##2##2##(1996-2#1)(2011-1#1)
benefits associated with##5##3##(1994-1#2)(2008-8#1)(2011-2#1)(2013-1#1)
benefits at##2##2##(1996-12#1)(1996-2#1)
benefits because of##2##3##(1994-6#1)(2008-10#1)
benefits because##3##2##(1994-6#1)(1997-1#1)(2008-10#1)
benefits can be##4##3##(1990-4#1)(1997-7#1)(2008-5#1)(2011-2#1)
benefits can##6##2##(1990-4#1)(1991-3#1)(1997-1#1)(1997-7#1)(2008-5#1)(2011-2#1)
benefits compared with##3##3##(2008-6#1)(2011-2#2)
benefits experienced##2##2##(1995-1#2)
benefits for both##3##3##(2008-11#1)(2009-10#1)(2013-1#1)
benefits for individuals##2##3##(1993-3#1)(2012-12#1)
benefits for patients##2##3##(2008-11#1)(2008-6#1)
benefits for the##5##3##(1995-12#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-3#1)
benefits for##36##2##(1992-12#1)(1992-2#2)(1993-3#1)(1995-1#1)(1995-12#1)(1997-5#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
benefits from a##3##3##(1997-2#1)(2009-8#1)(2010-8#1)
benefits from both##2##3##(2008-10#1)(2008-9#1)
benefits from its##2##3##(1991-3#1)(1997-7#1)
benefits from their##2##3##(2008-10#1)(2012-12#1)
benefits from this##2##3##(1992-12#1)(2009-6#1)
benefits from##26##2##(1991-3#1)(1992-12#1)(1992-8#1)(1993-2#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
benefits have##2##2##(2010-12#1)(2012-2#1)
benefits in reducing##2##3##(2009-4#1)(2011-1#1)
benefits in terms of##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
benefits in the##5##3##(1995-12#1)(1995-8#1)(1996-2#1)(2008-12#1)(2008-6#1)
benefits in this##2##3##(2008-7#1)(2009-11#1)
benefits in##29##2##(1991-8#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
benefits include##2##2##(2008-7#1)(2011-2#1)
benefits is##2##2##(1994-3#1)(2008-5#1)
benefits obtained##2##2##(2008-1#1)(2009-12#1)
benefits of a##10##3##(1991-2#1)(1993-1#1)(1994-1#1)(1994-2#1)(1996-12#1)(1996-3#1)(2008-12#2)(2008-3#1)(2013-8#1)
benefits of health care##2##4##(1995-12#1)(2008-4#1)
benefits of mental##2##3##(1996-12#1)(2011-2#1)
benefits of our##2##3##(2012-1#1)(2012-3#1)
benefits of performing##2##3##(1993-10#1)(2013-1#1)
benefits of preventing##2##3##(2007-11#1)(2013-1#1)
benefits of probiotics##2##3##(2008-10#1)(2013-7#1)
benefits of research##2##3##(2009-4#1)(2012-2#1)
benefits of the##18##3##(1992-12#1)(1992-2#2)(1993-12#1)(1994-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
benefits of these##5##3##(1990-3#1)(1990-9#1)(1996-3#1)(2008-10#1)(2011-2#1)
benefits of this##11##3##(1992-2#1)(2007-12#2)(2007-9#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
benefits of using the##2##4##(1995-1#1)(2007-11#1)
benefits of using##8##3##(1995-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#1)
benefits of##197##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#2)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
benefits on##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
benefits or##4##2##(1995-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
benefits outweigh the##2##3##(2008-8#1)(2010-6#1)
benefits outweigh##3##2##(2008-8#1)(2010-5#1)(2010-6#1)
benefits over##3##2##(2008-5#2)(2009-11#1)
benefits package##3##2##(1994-12#1)(1994-8#1)(1995-3#1)
benefits provided by##2##3##(2008-10#1)(2008-8#1)
benefits should##2##2##(1997-3#1)(2013-1#1)
benefits such as##2##3##(1994-9#1)(2012-12#1)
benefits than##2##2##(2008-9#1)(2009-8#1)
benefits that are##2##3##(1992-12#1)(2008-11#1)
benefits that can be##2##4##(1994-12#1)(2009-3#1)
benefits that can##3##3##(1994-12#1)(1995-1#1)(2009-3#1)
benefits that may##2##3##(2008-11#1)(2012-1#1)
benefits that##13##2##(1992-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2012-1#1)(2013-1#1)
benefits the##3##2##(2008-11#2)(2008-8#1)
benefits to be##3##3##(1994-2#2)(1994-3#1)
benefits to patients##3##3##(1992-12#1)(2008-7#1)(2011-2#1)
benefits to the##6##3##(1992-2#1)(1997-3#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-1#1)
benefits to##31##2##(1992-12#1)(1992-2#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#1)
benefits under a##2##3##(1995-1#1)(1997-5#1)
benefits were found##2##3##(2010-10#1)(2013-1#1)
benefits were##4##2##(1991-5#1)(2007-12#1)(2010-10#1)(2013-1#1)
benefits will##2##2##(1993-1#1)(2009-5#1)
benefits with regard to##2##4##(2009-11#2)
benefits with##4##2##(2008-5#1)(2009-11#2)(2010-5#1)
benefits without##2##2##(1997-5#1)(2011-2#1)
benefits##654##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#7)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#3)(1992-12#5)(1992-2#8)(1992-3#6)(1992-8#1)(1993-1#8)(1993-10#1)(1993-12#4)(1993-2#3)(1993-3#4)(1994-1#6)(1994-11#1)(1994-12#3)(1994-2#10)(1994-3#7)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#12)(1995-12#12)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#7)(1996-3#7)(1996-5#2)(1996-8#1)(1997-1#6)(1997-2#3)(1997-3#7)(1997-5#8)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#1)(2007-10#4)(2007-11#10)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#38)(2008-11#30)(2008-12#14)(2008-2#2)(2008-3#21)(2008-4#3)(2008-5#17)(2008-6#10)(2008-7#26)(2008-8#26)(2008-9#21)(2009-1#1)(2009-10#3)(2009-11#11)(2009-12#6)(2009-3#1)(2009-4#8)(2009-5#6)(2009-6#8)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#20)(2011-2#22)(2012-1#5)(2012-12#7)(2012-2#14)(2012-3#9)(2013-1#27)(2013-7#2)(2013-8#9)
benefits?##2##1##(1993-12#1)(1997-1#1)
benefitted##5##1##(1990-8#1)(1992-8#1)(1995-1#1)(2009-9#1)(2012-2#1)
benet##2##1##(2009-6#2)
benfluron##2##1##(1996-5#2)
bengal##2##1##(1994-12#1)(2008-10#1)
benign and malignant conditions of##2##5##(1991-3#1)(1993-11#1)
benign and malignant lesions##2##4##(2007-5#1)(2008-7#1)
benign and malignant neoplastic##2##4##(2008-6#1)(2012-2#1)
benign and malignant renal##2##4##(2012-2#2)
benign and malignant tumors##4##4##(1990-11#1)(2007-12#1)(2008-1#1)(2010-3#1)
benign and malignant##28##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-9#1)(1993-11#2)(1995-3#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#1)
benign and of##2##3##(2010-3#1)(2013-1#1)
benign and##35##2##(1990-11#1)(1990-12#1)(1991-3#1)(1992-9#2)(1993-11#2)(1995-3#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#5)(2013-1#2)(2013-8#1)
benign bone##3##2##(2006-10#1)(2010-5#1)(2012-12#1)
benign breast disease##5##3##(1993-1#1)(1994-5#3)(1994-9#1)
benign breast##8##2##(1993-1#2)(1994-5#3)(1994-9#1)(2007-5#1)(2008-12#1)
benign cervical tumors##3##3##(1991-2#3)
benign condition with##2##3##(2008-7#1)(2012-3#1)
benign condition##7##2##(2007-5#1)(2008-7#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
benign conditions##3##2##(2008-11#1)(2010-11#1)(2012-2#1)
benign course##3##2##(2008-7#1)(2011-2#2)
benign cystic##2##2##(1994-9#1)(2011-1#1)
benign disease of##2##3##(1990-6#1)(2008-6#1)
benign disease##9##2##(1990-10#1)(1990-6#1)(1992-2#1)(1993-12#1)(1994-7#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)
benign diseases of the##2##4##(1990-5#1)(1990-6#1)
benign diseases##3##2##(1990-5#1)(1990-6#2)
benign epithelial##2##2##(2007-12#1)(2011-2#1)
benign esophageal disease##2##3##(2012-1#1)(2013-1#1)
benign esophageal diseases##3##3##(2013-1#3)
benign esophageal##6##2##(2012-1#1)(2013-1#5)
benign familial neonatal seizures (BFNS)##2##5##(2008-8#2)
benign gastric ulcer##2##3##(1990-3#2)
benign gastric##4##2##(1990-3#3)(1992-9#1)
benign group##2##2##(2011-2#2)
benign in##4##2##(1992-5#1)(2008-11#1)(2008-3#1)(2011-1#1)
benign intraductal papilloma##2##3##(1991-2#2)
benign lesion##7##2##(1990-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2012-3#1)
benign lesions##7##2##(1990-12#1)(1991-12#2)(1994-12#1)(1997-7#1)(2010-12#1)(2011-2#1)
benign lipomatous##2##2##(2008-6#1)(2009-1#1)
benign liver##5##2##(1993-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
benign mature##2##2##(2007-8#1)(2009-7#1)
benign melanocytic nevi##2##3##(2011-2#2)
benign melanocytic##3##2##(2008-7#1)(2011-2#2)
benign mesenchymal##4##2##(1997-3#1)(2007-12#1)(2010-6#1)(2013-7#1)
benign metastatic##2##2##(2012-3#2)
benign nature##4##2##(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
benign neoplasm of##2##3##(1990-5#1)(2013-1#1)
benign neoplasm##5##2##(1990-5#1)(1992-5#1)(1993-9#1)(2007-8#1)(2013-1#1)
benign neoplasms##3##2##(1991-2#1)(2009-3#1)(2012-2#1)
benign or malignant##4##3##(1992-9#1)(1993-6#1)(2008-4#1)(2009-12#1)
benign or##6##2##(1990-12#1)(1992-9#1)(1993-6#1)(2008-4#1)(2009-12#1)(2011-2#1)
benign pain##5##2##(1997-1#2)(2008-4#3)
benign pathology##2##2##(1990-6#1)(2012-12#1)
benign pilomatrixoma##2##2##(1994-8#2)
benign post-tracheostomy stenosis##2##3##(2013-1#2)
benign post-tracheostomy##3##2##(2013-1#3)
benign prostatic hyperplasia and##2##4##(2008-11#1)(2008-5#1)
benign prostatic hyperplasia##11##3##(1990-9#2)(1993-2#1)(1994-11#1)(1994-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)
benign prostatic hypertrophy##3##3##(1990-11#1)(1990-3#2)
benign prostatic##14##2##(1990-11#1)(1990-3#2)(1990-9#2)(1993-2#1)(1994-11#1)(1994-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)
benign renal##2##2##(1992-2#1)(2013-8#1)
benign soft tissue##4##3##(2008-6#2)(2010-6#1)(2012-2#1)
benign solitary intraosseous schwannoma of the tibia##2##7##(2009-3#2)
benign stenosis##3##2##(2008-4#2)(2013-1#1)
benign thyroid##4##2##(1990-6#1)(1992-8#1)(2008-12#2)
benign to##2##2##(1993-10#1)(2008-12#1)
benign tumor with a##2##4##(2008-10#1)(2010-3#1)
benign tumor with##4##3##(2007-5#1)(2008-10#1)(2010-3#1)(2012-3#1)
benign tumor##12##2##(1994-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#3)(2009-5#1)(2010-3#1)(2012-3#1)
benign tumors of the##3##4##(1995-11#1)(2010-3#1)(2013-8#1)
benign tumors##11##2##(1995-11#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-8#2)
benign tumour of the lung##2##5##(2008-7#2)
benign tumour of the##3##4##(2008-10#1)(2008-7#2)
benign tumour##8##2##(1993-3#1)(1994-3#1)(2007-8#2)(2008-10#1)(2008-7#2)(2013-1#1)
benign tumours##4##2##(1991-11#1)(1996-8#1)(2007-8#1)(2012-2#1)
benign uterine leiomyoma##2##3##(2012-3#2)
benign##358##1##(1990-10#2)(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#6)(1990-5#3)(1990-6#8)(1990-8#1)(1990-9#4)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#1)(1991-4#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#3)(1992-5#3)(1992-8#1)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-7#1)(1994-8#2)(1994-9#4)(1995-11#2)(1995-3#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-5#6)(2007-8#12)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#11)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#3)(2008-6#7)(2008-7#12)(2008-8#4)(2008-9#2)(2009-1#2)(2009-12#3)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#5)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#9)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#18)(2012-3#16)(2013-1#29)(2013-7#3)(2013-8#11)
benign&quot##2##1##(1993-6#1)(1997-2#1)
benignancy##2##1##(2008-5#1)(2011-2#1)
benignity of##2##2##(1991-6#1)(1992-5#1)
benignity##4##1##(1991-6#1)(1992-5#1)(1993-5#1)(2012-12#1)
benomyl is not##2##3##(1990-5#1)(2008-10#1)
benomyl##15##1##(1990-5#2)(1997-2#2)(2008-10#10)(2011-2#1)
benomyl-resistant and##2##2##(1997-2#1)(2008-10#1)
benomyl-resistant strain 91T-1##2##3##(1997-2#2)
benomyl-resistant##8##1##(1997-2#4)(2008-10#4)
benorilate##3##1##(2008-10#3)
benserazide##6##1##(1990-8#2)(2008-10#4)
bensulfuron-methyl##2##1##(2008-10#2)
bent DNA##4##2##(1996-3#1)(1997-6#1)(2008-7#1)(2008-8#1)
bent by##2##2##(2008-3#1)(2009-11#1)
bent fibers##2##2##(2008-3#2)
bent sapphire fibers##2##3##(2008-3#2)
bent single-mode optical fibers##2##4##(2008-3#2)
bent step-index##2##2##(2008-3#2)
bent##44##1##(1992-9#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#17)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2011-2#1)
bentazon##3##1##(2008-10#3)
bentgrass##14##1##(2008-10#14)
benthamiana and N##2##3##(2008-10#2)
benthamiana and##4##2##(2008-10#4)
benthamiana leaves##4##2##(2008-10#4)
benthamiana plants##8##2##(1995-2#1)(2008-10#5)(2008-9#1)(2011-2#1)
benthamiana##41##1##(1995-2#2)(2008-10#35)(2008-9#3)(2011-2#1)
benthic community condition##5##3##(2012-1#5)
benthic community##9##2##(2011-2#2)(2012-1#6)(2012-2#1)
benthic macrofauna##3##2##(2012-1#3)
benthic organisms##3##2##(2008-5#3)
benthic species##3##2##(2007-5#3)
benthic##33##1##(2007-5#6)(2008-10#1)(2008-5#10)(2008-9#2)(2011-2#2)(2012-1#10)(2012-2#1)(2013-1#1)
benthos##5##1##(2008-5#2)(2011-2#1)(2012-1#1)(2013-7#1)
benthos-based##3##1##(2012-1#3)
bentonite##5##1##(2008-10#5)
bentonites##2##1##(2008-10#2)
benz[a]anthracene##2##1##(1995-11#1)(2008-10#1)
benzaldehyde##6##1##(2008-10#4)(2008-5#1)(2010-12#1)
benzalkonium chloride##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
benzamide##4##1##(1990-11#2)(2008-10#2)
benzamides##7##1##(1990-5#2)(2008-10#3)(2008-7#2)
benzamidine##2##1##(1995-5#1)(2008-11#1)
benzathine##4##1##(1997-5#2)(2008-10#2)
benzene and##16##2##(2008-10#12)(2008-2#3)(2008-3#1)
benzene concentration##3##2##(2008-3#3)
benzene derivatives##2##2##(2008-10#2)
benzene in##6##2##(1993-11#1)(2008-10#5)
benzene molecules##3##2##(1993-11#3)
benzene ring##3##2##(2008-10#2)(2010-11#1)
benzene sulfonate##4##2##(2008-10#4)
benzene sulfonic acid##3##3##(2008-10#3)
benzene vapours##2##2##(2008-10#2)
benzene was##3##2##(2008-10#3)
benzene##104##1##(1990-8#1)(1993-11#4)(1994-3#1)(1996-2#2)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#75)(2008-11#4)(2008-2#4)(2008-3#5)(2010-11#1)(2010-2#1)(2010-6#1)
benzeneethanol##2##1##(2008-10#2)
benzenes##3##1##(2008-10#3)
benzenesulfinate##2##1##(1996-5#2)
benzenoid##3##1##(2007-11#2)(2010-2#1)
benzilate is negative##2##3##(1995-11#2)
benzilate##5##1##(1990-5#1)(1995-11#3)(1995-6#1)
benzils##2##1##(2007-11#2)
benzimidazole and##2##2##(2008-10#2)
benzimidazole anthelmintics##2##2##(2008-10#2)
benzimidazole##12##1##(1990-2#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#1)(2012-2#1)
benzimidazole-resistant##2##1##(1991-8#2)
benzimidazole-susceptible##2##1##(1991-8#2)
benzimidazolylazo group##2##2##(2008-10#2)
benzindenoazepine##2##1##(2008-11#2)
benziodarone##4##1##(1990-11#4)
benzo (a) anthracene##2##3##(2008-10#2)
benzo 15 crown 5##2##4##(2008-10#2)
benzo##5##1##(2008-10#5)
benzo(a)pyrene in##2##2##(2008-10#2)
benzo(a)pyrene was##2##2##(2008-10#1)(2008-4#1)
benzo(a)pyrene##16##1##(1993-8#2)(2008-10#9)(2008-11#1)(2008-4#2)(2010-1#1)(2010-5#1)
benzo(b##2##1##(2008-10#2)
benzo(g##2##1##(2008-10#2)
benzo(k)fluoranthene##2##1##(2008-10#2)
benzo-15-crown-5##2##1##(2008-10#2)
benzo-18-crown-6##5##1##(2008-10#5)
benzoN(4) nickel(II) macrocyclic complexes##2##4##(2008-10#2)
benzo[1##2##1##(1996-5#1)(2008-10#1)
benzo[12]crown-4##3##1##(2008-10#3)
benzo[15]crown-5##3##1##(2008-10#3)
benzo[3n]crown-n##2##1##(2008-10#2)
benzo[a]pyrene (BaP)##2##2##(2008-10#1)(2011-1#1)
benzo[a]pyrene 7##4##2##(1992-2#4)
benzo[a]pyrene hydroxylase activity and CO reducible##3##6##(1994-6#3)
benzo[a]pyrene in##4##2##(2008-10#4)
benzo[a]pyrene##30##1##(1992-2#4)(1992-8#1)(1994-5#1)(1994-6#3)(1994-8#2)(1995-5#2)(1997-4#1)(2008-10#14)(2011-1#2)
benzo[b]fluoranthene##3##1##(1990-7#2)(2008-10#1)
benzo[g##2##1##(2008-10#2)
benzoate and##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2010-4#1)
benzoate##15##1##(2008-10#3)(2008-6#1)(2008-8#3)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#2)
benzocyclobutene##3##1##(2007-11#1)(2008-3#2)
benzodiazepine Ro 16-6028 during ontogenesis in##2##6##(1991-12#2)
benzodiazepine binding sites##3##3##(1992-3#1)(1995-11#1)(1995-12#1)
benzodiazepine binding##5##2##(1992-3#1)(1995-11#3)(1995-12#1)
benzodiazepine pharmacology##2##2##(1995-11#2)
benzodiazepine receptor ligands##4##3##(1992-3#1)(1995-11#1)(1995-12#2)
benzodiazepine receptor radioligand binding by##2##5##(1995-11#1)(1995-12#1)
benzodiazepine receptor##15##2##(1992-3#2)(1994-2#2)(1995-11#4)(1995-12#3)(1996-2#1)(2008-8#1)(2012-2#2)
benzodiazepine receptors in##2##3##(1993-12#1)(2008-6#1)
benzodiazepine receptors##10##2##(1993-12#2)(1995-12#2)(1995-5#1)(1996-2#4)(2008-6#1)
benzodiazepine site ligands##2##3##(1995-11#2)
benzodiazepine site##3##2##(1995-11#3)
benzodiazepine##54##1##(1991-12#2)(1992-3#4)(1992-7#1)(1993-12#2)(1994-2#3)(1995-11#16)(1995-12#6)(1995-5#1)(1996-12#1)(1996-2#5)(1996-9#3)(2008-10#2)(2008-6#2)(2008-8#1)(2009-9#3)(2012-2#2)
benzodiazepines (BZD)##2##2##(1991-12#2)
benzodiazepines and##5##2##(1991-1#1)(1995-11#1)(1996-9#1)(2008-6#1)(2010-1#1)
benzodiazepines in##4##2##(2008-10#1)(2009-9#2)(2012-2#1)
benzodiazepines##27##1##(1991-1#2)(1991-12#3)(1991-3#1)(1993-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-9#2)(1997-2#1)(2008-10#3)(2008-6#2)(2009-9#2)(2010-1#1)(2010-4#2)(2011-10#1)(2011-2#1)(2012-2#1)
benzoic acid was##2##3##(2008-10#2)
benzoic acid##12##2##(2008-10#12)
benzoic##15##1##(1990-8#1)(2008-10#14)
benzophenone and##2##2##(2008-10#2)
benzophenone derivatives##2##2##(2008-5#2)
benzophenone in##2##2##(2008-10#1)(2008-5#1)
benzophenone phenylhydrazone##2##2##(2008-10#2)
benzophenone##17##1##(2008-10#12)(2008-5#4)(2010-4#1)
benzophenone-3 and##2##2##(2008-5#2)
benzophenone-3##13##1##(2008-3#6)(2008-5#7)
benzoquinone ansamycins##2##2##(1994-8#2)
benzoquinone##6##1##(1994-8#3)(2008-10#3)
benzothiadiazole (BTH)##3##2##(2008-10#3)
benzothiadiazole##4##1##(2008-10#4)
benzothiaxolyldiazoaminoazobenzene##2##1##(2008-10#2)
benzothiazole##6##1##(2008-10#2)(2010-2#3)(2010-7#1)
benzotriazole##3##1##(2007-12#1)(2013-1#2)
benzoxazinone derivative##2##2##(2007-11#2)
benzoxazinone derivatives##2##2##(2007-11#1)(2012-2#1)
benzoxazinone##5##1##(2007-11#3)(2011-1#1)(2012-2#1)
benzoxazinones##3##1##(2008-12#2)(2008-5#1)
benzoyl carbonyl##2##2##(1991-3#2)
benzoyl chloride##2##2##(2007-11#1)(2008-10#1)
benzoyl groups##2##2##(1990-9#1)(1996-5#1)
benzoyl peroxide cleanser and 4% benzoyl peroxide##2##7##(2010-8#2)
benzoyl peroxide foaming cloth cleanser##2##5##(2010-8#2)
benzoyl peroxide foaming cloth##4##4##(2010-8#4)
benzoyl peroxide##17##2##(2008-10#6)(2008-5#1)(2010-8#10)
benzoyl peroxide-containing foaming cloth##2##4##(2010-8#2)
benzoyl peroxide-containing##3##2##(2010-8#3)
benzoyl##30##1##(1990-9#1)(1991-3#2)(1996-5#1)(2007-11#3)(2008-10#9)(2008-5#1)(2010-8#13)
benzoylacetonate in chloroform##3##3##(2008-10#3)
benzoylacetone##2##1##(2008-11#1)(2008-3#1)
benzoylurea (BU) insecticides##2##3##(2008-10#2)
benzoylurea##4##1##(2008-10#4)
benzyl alcohol and##3##3##(2008-10#3)
benzyl alcohol##7##2##(2008-10#7)
benzyl butyl phthalate (BBP)##2##4##(2008-10#1)(2008-5#1)
benzyl##22##1##(1991-9#2)(1992-5#1)(1992-8#1)(2007-11#2)(2008-10#11)(2008-5#1)(2009-11#1)(2010-2#1)(2012-12#1)(2013-1#1)
benzyl3##3##1##(1994-8#3)
benzylic##7##1##(1995-3#3)(2007-11#1)(2012-12#1)(2013-1#2)
benzylisoquinoline##2##1##(2008-10#2)
benzyloxyresorufin##4##1##(1994-8#4)
benzylpenicillin##6##1##(1990-11#1)(1992-12#2)(1995-3#1)(2011-1#2)
bep4##2##1##(1997-6#2)
berbamine##6##1##(1995-11#6)
berberine hydrochloride##2##2##(2012-3#1)(2013-1#1)
berberine in##2##2##(2008-10#2)
berberine##14##1##(2008-10#9)(2012-3#4)(2013-1#1)
bereaved parents##4##2##(2007-4#1)(2008-11#3)
bereaved##7##1##(1991-2#1)(2007-4#1)(2008-11#4)(2008-12#1)
bereavement programs in##2##3##(2007-11#2)
bereavement programs##5##2##(2007-11#5)
bereavement##17##1##(1991-11#1)(1991-2#1)(1993-3#1)(2007-11#6)(2008-12#4)(2009-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
bereft of##2##2##(1997-1#1)(2013-1#1)
berghei##10##1##(1992-6#2)(1993-8#1)(1995-5#1)(2009-4#1)(2010-2#3)(2012-2#2)
bermudagrass genotypes##4##2##(2008-10#4)
bermudagrass##7##1##(2008-10#7)
berries aged##3##2##(2008-10#3)
berries and##2##2##(2008-10#2)
berries bored by Hypothenemus hampei (Ferrari)##2##6##(2008-6#2)
berries bored by##3##3##(2008-6#3)
berries of##5##2##(2008-10#5)
berries than on##2##3##(2008-10#2)
berries than##3##2##(2008-10#3)
berries was##4##2##(2008-10#3)(2008-6#1)
berries were##5##2##(2008-10#5)
berries##76##1##(2008-10#68)(2008-6#7)(2012-12#1)
berry and rachis susceptibility##2##4##(2008-10#2)
berry development##2##2##(2008-10#2)
berry weights##2##2##(2008-10#2)
berry##27##1##(2008-10#27)
beryllium and##2##2##(1990-5#1)(2008-10#1)
beryllium concentrations##2##2##(2008-10#2)
beryllium oxide##2##2##(2008-10#2)
beryllium##40##1##(1990-5#3)(2007-11#3)(2008-10#33)(2012-1#1)
beryllium- and##2##2##(2008-3#2)
beside the##4##2##(1992-5#1)(1994-11#1)(2008-3#1)(2011-3#1)
beside##11##1##(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-3#1)(2012-12#1)
besides its##2##2##(2011-2#1)(2013-1#1)
besides the##17##2##(1990-5#1)(1991-12#1)(1991-5#1)(2008-1#1)(2008-10#4)(2008-8#1)(2009-12#1)(2009-8#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
besides##58##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-9#1)(1995-12#1)(1997-1#1)(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
best accuracy##3##2##(2008-10#2)(2011-2#1)
best achieved by##2##3##(2008-10#1)(2010-7#1)
best achieved##5##2##(2007-12#1)(2008-10#1)(2009-5#1)(2010-3#1)(2010-7#1)
best after##2##2##(2008-11#1)(2012-2#1)
best agreement##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
best aided##2##2##(2012-2#2)
best alternative##4##2##(2007-7#1)(2008-10#2)(2008-4#1)
best among##2##2##(2008-1#1)(2008-10#1)
best analytical conditions##2##3##(2008-10#2)
best analytical##7##2##(2008-10#7)
best and##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
best approach for##3##3##(1996-1#1)(2008-10#2)
best approach##9##2##(1991-12#1)(1992-2#1)(1995-12#1)(1996-1#1)(2008-10#4)(2009-12#1)
best arterial and##2##3##(2013-1#2)
best at##3##2##(1992-8#1)(2008-6#1)(2008-7#1)
best basis wavelet functions##2##4##(2010-8#2)
best basis##4##2##(2008-10#1)(2010-8#2)(2012-3#1)
best be##4##2##(1995-9#1)(2008-6#1)(2008-9#1)(2011-2#1)
best by a##3##3##(1992-9#1)(1997-7#1)(2010-2#1)
best candidate for##2##3##(1993-9#1)(2006-6#1)
best candidate##3##2##(1993-9#1)(2006-6#1)(2008-10#1)
best choice for the##2##4##(2008-3#2)
best choice for##7##3##(2008-10#4)(2008-3#2)(2012-3#1)
best choice##11##2##(2008-10#5)(2008-3#5)(2012-3#1)
best clinical##4##2##(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
best combination##7##2##(1991-5#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)
best conditions for##10##3##(1992-9#1)(1996-12#1)(2008-10#7)(2011-2#1)
best conditions were##2##3##(2008-10#2)
best conditions##16##2##(1992-9#1)(1996-12#1)(2008-10#11)(2008-11#1)(2011-2#1)(2013-1#1)
best corrected visual acuity (BCVA)##2##5##(2011-2#2)
best corrected visual acuity##3##4##(2010-10#1)(2011-2#2)
best correlation##2##2##(1993-2#1)(2012-2#1)
best decision##2##2##(1993-12#1)(2008-10#1)
best described as a##4##4##(1991-5#1)(1996-2#1)(2008-10#2)
best described as##5##3##(1991-5#1)(1996-2#1)(2008-1#1)(2008-10#2)
best described by a##2##4##(1993-11#1)(1996-2#1)
best described by##6##3##(1993-11#1)(1996-2#1)(2008-10#2)(2008-9#1)(2013-1#1)
best described the##4##3##(2008-10#4)
best described##17##2##(1991-5#1)(1993-11#1)(1996-2#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-9#1)(2011-2#1)(2013-1#1)
best detection limit##2##3##(2008-10#2)
best detection##3##2##(2008-10#3)
best diagnostic##4##2##(1990-9#1)(1991-2#1)(1992-12#1)(2013-8#1)
best done##2##2##(1993-12#1)(1994-3#1)
best effects##2##2##(2007-11#1)(2008-10#1)
best efforts##2##2##(2008-8#1)(2010-5#1)
best estimate##2##2##(2008-2#1)(2013-1#1)
best evidence##27##2##(2007-8#24)(2008-7#2)(2009-8#1)
best explained by##4##3##(1997-6#1)(2008-10#1)(2008-4#2)
best explained##6##2##(1993-8#1)(1997-6#1)(2008-10#1)(2008-4#2)(2009-6#1)
best extraction##4##2##(2008-10#4)
best fit for##3##3##(2008-10#2)(2011-2#1)
best fit into##2##3##(1994-12#1)(2008-10#1)
best fit of##3##3##(2008-10#2)(2008-3#1)
best fit to##2##3##(1996-12#1)(2008-3#1)
best fit##20##2##(1991-12#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-2#1)(2008-3#3)(2011-2#2)(2012-2#1)
best fits##4##2##(1991-1#1)(1996-1#2)(2013-1#1)
best focus##3##2##(2008-3#3)
best for a##2##3##(2008-7#1)(2013-1#1)
best for the##3##3##(1991-3#1)(2008-10#2)
best for##17##2##(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-9#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
best formulation##6##2##(2009-10#1)(2010-3#1)(2012-2#4)
best from##2##2##(2008-10#1)(2008-7#1)
best growth##2##2##(2008-10#1)(2008-5#1)
best hope##2##2##(1995-2#1)(2010-9#1)
best in##7##2##(1994-1#1)(1994-6#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
best interest##5##2##(1992-12#1)(1997-1#1)(2008-10#1)(2009-6#1)(2012-2#1)
best interests##8##2##(1990-6#2)(1991-2#1)(1992-3#1)(1995-2#1)(1997-8#1)(2010-9#2)
best known as an##2##4##(1995-2#1)(2008-11#1)
best known as##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
best known for##2##3##(1995-12#1)(2008-12#1)
best known of the##2##4##(2007-11#1)(2008-8#1)
best known##16##2##(1991-4#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#1)(2013-1#1)
best life histories##2##3##(2008-8#2)
best linear combination##2##3##(2012-1#2)
best linear##4##2##(2008-10#1)(2012-1#3)
best management of##3##3##(2007-12#1)(2012-3#1)(2013-1#1)
best management##6##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
best media##2##2##(2008-12#2)
best medium for##2##3##(2008-10#2)
best method of##5##3##(1996-8#1)(2007-8#1)(2008-3#1)(2008-6#1)(2013-1#1)
best method##8##2##(1990-12#1)(1994-5#1)(1996-8#1)(2007-8#1)(2008-3#1)(2008-6#2)(2013-1#1)
best model##9##2##(1996-12#1)(2008-10#3)(2008-3#1)(2010-4#2)(2010-8#1)(2011-2#1)
best models##3##2##(2008-10#3)
best of a bad##2##4##(2008-8#1)(2008-9#1)
best of both##2##3##(1993-2#1)(2012-2#1)
best of times##2##3##(1991-6#1)(2008-11#1)
best of##60##2##(1991-6#1)(1991-9#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-11#4)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
best on##3##2##(2007-7#1)(2008-5#1)(2011-2#1)
best operative##3##2##(2007-12#1)(2010-8#1)(2011-2#1)
best option##7##2##(1996-3#1)(2007-7#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
best outcome##4##2##(1995-5#1)(2007-8#2)(2011-1#1)
best outcomes##2##2##(2007-11#1)(2013-1#1)
best overall##5##2##(2008-10#2)(2008-3#1)(2010-4#1)(2012-2#1)
best performance was achieved##2##4##(2008-10#2)
best performance was exhibited by the membrane having##2##8##(2008-10#2)
best performance was obtained##2##4##(2008-10#2)
best performance was##9##3##(2008-10#8)(2008-12#1)
best performance##17##2##(1995-3#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)
best performing##2##2##(2008-7#1)(2010-4#1)
best practice guidelines##2##3##(2008-3#2)
best practice is##2##3##(2007-11#1)(2008-12#1)
best practice##19##2##(1995-12#2)(1995-3#1)(1996-12#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-10#5)(2010-4#1)(2012-12#1)(2013-8#1)
best practice&quot##3##2##(1991-12#1)(2008-10#2)
best practices for##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
best practices##15##2##(1991-12#1)(1994-12#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#3)(2012-2#3)(2013-1#1)
best prediction of##2##3##(1992-12#1)(1996-12#1)
best prediction##4##2##(1992-12#1)(1996-12#1)(2008-10#2)
best predictors##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)
best prognostic##2##2##(1990-3#1)(1991-6#1)
best relationship##2##2##(2008-10#1)(2008-6#1)
best reported##2##2##(2008-6#1)(2008-7#1)
best response characteristics##2##3##(2008-10#2)
best response##5##2##(1991-3#1)(1991-8#1)(2008-10#2)(2008-12#1)
best result for##2##3##(2008-10#2)
best result was obtained with the##2##6##(2007-10#1)(2008-10#1)
best result##10##2##(2007-10#1)(2007-11#2)(2008-10#7)
best results are obtained with the##2##6##(2008-10#1)(2008-3#1)
best results are obtained##4##4##(1990-6#1)(2008-10#2)(2008-3#1)
best results are##5##3##(1990-6#1)(1994-11#1)(2008-10#2)(2008-3#1)
best results for the##3##4##(1996-2#1)(2008-10#1)(2008-5#1)
best results for##4##3##(1996-2#1)(2008-10#2)(2008-5#1)
best results in##4##3##(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
best results were obtained using the##2##6##(2008-10#1)(2013-1#1)
best results were obtained using##6##5##(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#1)
best results were obtained##15##4##(2008-10#8)(2008-5#3)(2008-7#2)(2012-1#1)(2013-1#1)
best results were##19##3##(2007-11#1)(2007-8#1)(2008-10#8)(2008-5#3)(2008-6#1)(2008-7#2)(2010-4#1)(2012-1#1)(2013-1#1)
best results##50##2##(1990-10#1)(1990-11#1)(1990-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-8#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
best retention##2##2##(2008-10#1)(2008-11#1)
best scientific##2##2##(2008-12#1)(2008-4#1)
best sensitivity##3##2##(2007-2#1)(2008-10#2)
best separation##4##2##(2008-10#4)
best serve##3##2##(1997-2#1)(2008-12#1)(2008-8#1)
best served##2##2##(1991-2#1)(1997-3#1)
best signal##3##2##(2008-10#1)(2008-3#2)
best strategy##4##2##(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
best studied##4##2##(2008-1#1)(2008-12#1)(2008-3#1)(2011-2#1)
best suited for##7##3##(1990-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)
best suited to##4##3##(1993-12#1)(1993-9#1)(2006-10#1)(2008-10#1)
best suited##12##2##(1990-11#1)(1993-12#1)(1993-9#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2011-2#1)
best support##2##2##(2008-11#1)(2013-1#1)
best supported##2##2##(2007-12#1)(2010-8#1)
best surgical##4##2##(2007-8#1)(2008-11#1)(2008-12#1)(2010-8#1)
best system##4##2##(1991-2#1)(1996-2#1)(2008-10#1)(2012-2#1)
best teacher##2##2##(1994-1#1)(2009-12#1)
best time for##2##3##(1994-7#1)(2009-5#1)
best to##18##2##(1992-11#1)(1994-11#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
best treatment##12##2##(1991-9#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#4)(2010-3#1)(2012-3#1)(2013-1#1)
best understood as##2##3##(1995-2#1)(2012-2#1)
best understood##6##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-4#2)(2012-2#1)
best use##2##2##(1992-2#1)(2013-1#1)
best visualized##2##2##(2008-10#1)(2008-9#1)
best way to##12##3##(1993-12#1)(1994-3#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-9#2)(2011-2#1)
best way##15##2##(1990-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-9#2)(2010-12#1)(2011-2#1)
best when##3##2##(1993-12#1)(2007-8#1)(2008-10#1)
best with##5##2##(1993-12#1)(1997-7#1)(2008-11#1)(2008-7#1)(2011-1#1)
best##1099##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#2)(1990-5#3)(1990-6#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#4)(1991-3#8)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#11)(1993-2#3)(1993-3#3)(1993-8#5)(1993-9#3)(1994-1#4)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#2)(1995-1#3)(1995-11#2)(1995-12#8)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#7)(1995-8#1)(1995-9#2)(1996-1#5)(1996-12#8)(1996-2#8)(1996-3#8)(1996-5#3)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#8)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#3)(2006-10#2)(2006-6#3)(2007-10#3)(2007-11#22)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#36)(2008-1#9)(2008-10#253)(2008-11#31)(2008-12#26)(2008-2#20)(2008-3#51)(2008-4#21)(2008-5#23)(2008-6#19)(2008-7#27)(2008-8#17)(2008-9#21)(2009-1#3)(2009-10#4)(2009-11#3)(2009-12#4)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#8)(2009-8#7)(2009-9#1)(2010-10#7)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#6)(2010-4#6)(2010-5#5)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#11)(2011-2#46)(2011-3#2)(2012-1#6)(2012-12#10)(2012-2#31)(2012-3#15)(2013-1#41)(2013-7#2)(2013-8#14)
best&quot##2##1##(1992-12#1)(2008-8#1)
best-fit##3##1##(2008-3#1)(2008-4#1)(2012-2#1)
best-performing##3##1##(2007-11#1)(2008-12#1)(2011-1#1)
best-selling##2##1##(2008-11#1)(2011-2#1)
best-studied##3##1##(2007-7#1)(2008-10#1)(2008-7#1)
bestatin and##2##2##(1994-8#1)(1997-4#1)
bestatin##11##1##(1992-5#4)(1994-2#2)(1994-8#1)(1995-6#1)(1996-2#2)(1997-4#1)
bestow##2##1##(1995-2#1)(2008-3#1)
besylate##7##1##(2008-10#6)(2013-8#1)
beta (IL-1 beta)##4##3##(1994-11#1)(1995-12#2)(1996-12#1)
beta -barium borate##3##3##(2007-11#1)(2007-12#2)
beta -galactosidase or phytase##2##4##(2008-11#2)
beta 1 and beta 2 adrenergic##2##6##(1993-12#2)
beta 1 and##5##3##(1993-12#2)(1993-8#1)(1994-8#1)(1995-2#1)
beta 1 chain##2##3##(1992-2#2)
beta 1##50##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-2#5)(1992-10#6)(1992-12#1)(1992-2#4)(1992-3#1)(1992-8#2)(1993-11#3)(1993-12#2)(1993-8#12)(1993-9#1)(1994-8#1)(1995-2#2)(1995-6#2)(2011-2#1)
beta 1- and beta 2-subunit mRNAs##2##6##(1996-12#2)
beta 1-3##2##2##(1996-12#2)
beta 1-9##2##2##(1995-12#2)
beta 1-receptor##2##2##(1992-3#2)
beta 146His does not##2##4##(1990-8#2)
beta 1g##2##2##(1993-8#2)
beta 2 adrenergic receptor##2##4##(1993-12#1)(2010-6#1)
beta 2 adrenergic##3##3##(1993-12#2)(2010-6#1)
beta 2 and##4##3##(1995-11#3)(2010-8#1)
beta 2 gamma##5##3##(1995-11#5)
beta 2 integrin##2##3##(2008-11#2)
beta 2##33##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-8#1)(1995-11#15)(2008-11#6)(2010-6#2)(2010-8#1)
beta 2-adrenergic##2##2##(1992-3#2)
beta 2-agonists are##2##3##(1997-1#2)
beta 2-agonists##3##2##(1994-6#1)(1997-1#2)
beta 2-microglobulin (beta##4##3##(1994-5#1)(1994-6#1)(1996-12#1)(1997-3#1)
beta 2-microglobulin and##2##3##(1991-2#1)(1995-2#1)
beta 2-microglobulin##11##2##(1990-11#1)(1991-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-2#1)(1996-12#1)(1997-3#1)
beta 2AR##4##2##(1992-3#4)
beta 2His residues##2##3##(1990-8#2)
beta 2His##3##2##(1990-8#3)
beta 2M##3##2##(1994-6#3)
beta 3 subunit##3##3##(1997-4#3)
beta 3##21##2##(1990-8#1)(1995-11#7)(1995-6#1)(1997-4#12)
beta 3-adrenoceptor##8##2##(1995-11#8)
beta 4##11##2##(1990-8#1)(1991-10#2)(1992-4#2)(1993-3#1)(1995-11#4)(2010-8#1)
beta 40##6##2##(1995-12#3)(1996-5#3)
beta 42##8##2##(1995-12#3)(1996-5#5)
beta = 102##2##3##(1996-2#2)
beta = 105##2##3##(1996-2#1)(1997-7#1)
beta = 107##2##3##(1996-2#2)
beta = 108##2##3##(1996-2#2)
beta = 109##2##3##(1996-2#1)(1997-7#1)
beta = 112##3##3##(1996-2#1)(1997-7#2)
beta = 113##2##3##(1996-2#2)
beta = 90##3##3##(1997-7#2)(2008-8#1)
beta = 92##4##3##(1996-2#3)(2007-11#1)
beta = 93##2##3##(1997-7#2)
beta = 94##2##3##(1996-2#1)(1996-5#1)
beta = 97##7##3##(1992-9#1)(1996-2#3)(1997-7#3)
beta =##46##2##(1992-11#1)(1992-9#1)(1996-2#24)(1996-5#1)(1997-7#16)(2007-11#2)(2008-8#1)
beta A##5##2##(1991-5#2)(1993-11#3)
beta A(25-35)NH2##2##2##(1994-11#2)
beta A(31-35)NH2##2##2##(1994-11#2)
beta A2 and beta A4##2##5##(1991-6#2)
beta A2##3##2##(1991-6#3)
beta A27S mutant##2##3##(1990-7#2)
beta A27S##3##2##(1990-7#3)
beta A27V##2##2##(1990-7#2)
beta A4##10##2##(1991-6#4)(1992-8#2)(1992-9#4)
beta AP plaques##2##3##(1991-10#2)
beta AP##3##2##(1991-10#3)
beta AP1-40##3##2##(1995-12#3)
beta APP expression##2##3##(1991-10#2)
beta APP in the##2##4##(1991-10#1)(1992-9#1)
beta APP in##3##3##(1991-10#1)(1992-12#1)(1992-9#1)
beta APP may##2##3##(1991-10#1)(1992-8#1)
beta APP sequences##2##3##(1992-8#2)
beta APP##18##2##(1991-10#7)(1991-11#1)(1992-12#5)(1992-8#3)(1992-9#2)
beta ARK##2##2##(1992-3#2)
beta CD##3##2##(1995-11#1)(1996-5#2)
beta E-1-26##2##2##(1991-5#2)
beta E-1-27##7##2##(1991-5#7)
beta E-1-31##7##2##(1991-5#7)
beta Gal activity##2##3##(1990-5#1)(1997-4#1)
beta Gal##7##2##(1990-5#2)(1993-9#2)(1997-4#3)
beta H globin gene##2##4##(1991-5#2)
beta II##3##2##(1994-5#1)(1996-5#1)(2008-10#1)
beta NKA##2##2##(1990-11#2)
beta P##3##2##(1991-9#3)
beta S##6##2##(1992-11#1)(1992-8#1)(1993-8#1)(1995-11#3)
beta Tub##6##2##(1993-6#6)
beta actin cDNA##2##3##(2010-5#2)
beta actin gene##2##3##(2010-5#2)
beta actin##5##2##(2010-5#5)
beta activity##2##2##(1993-3#1)(1995-2#1)
beta adrenergic receptor##3##3##(1993-12#2)(1994-9#1)
beta adrenergic receptors##5##3##(1993-12#4)(1994-9#1)
beta adrenergic##11##2##(1993-12#7)(1994-9#3)(1997-1#1)
beta agonist##10##2##(2008-2#1)(2012-1#9)
beta amyloid##5##2##(1992-6#2)(1994-8#3)
beta analogues##2##2##(1990-2#2)
beta and IL-6##3##3##(1995-12#2)(1996-2#1)
beta and epsilon and beta and delta##2##7##(2008-8#2)
beta and gamma##9##3##(1990-7#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-11#1)(2008-11#1)(2008-7#1)(2008-8#1)
beta and gamma)##2##3##(1993-3#1)(1994-6#1)
beta and the##2##3##(1991-12#1)(1992-3#1)
beta and##43##2##(1990-12#2)(1990-2#2)(1990-7#2)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-3#3)(1993-6#2)(1994-11#3)(1994-6#1)(1995-11#1)(1995-12#5)(1995-5#1)(1996-2#2)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#5)
beta at##3##2##(1992-3#1)(1994-11#1)(1995-2#1)
beta barium borate##2##3##(2008-2#1)(2008-3#1)
beta blockers##8##2##(1990-2#1)(2008-11#2)(2008-7#1)(2009-6#2)(2010-5#2)
beta cDNA##2##2##(1990-11#1)(1995-6#1)
beta cell##9##2##(1990-11#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-11#2)(2013-7#1)
beta cells are##2##3##(2008-1#1)(2009-8#1)
beta cells in##2##3##(2008-10#1)(2008-11#1)
beta cells##20##2##(1991-7#1)(1993-8#1)(1994-12#1)(1994-8#2)(1996-11#1)(1997-4#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-11#3)
beta chain##7##2##(1990-12#2)(1992-3#1)(1993-8#1)(1997-5#2)(2008-4#1)
beta chains##5##2##(1990-7#2)(1994-6#1)(1994-8#1)(1997-4#1)
beta delta##6##2##(1993-11#6)
beta deposits##3##2##(1994-11#1)(1996-5#2)
beta frequency##2##2##(1996-7#1)(2008-11#1)
beta from##3##2##(1994-11#1)(1995-2#1)(2008-11#1)
beta function for##2##3##(2008-10#2)
beta function##4##2##(2008-10#4)
beta gal##3##2##(1991-5#3)
beta gamma subunits of##4##4##(1992-9#1)(1993-3#2)(1995-8#1)
beta gamma##10##2##(1992-9#1)(1993-3#4)(1993-6#1)(1993-9#2)(1995-8#2)
beta gene have##2##3##(1993-12#1)(1993-8#1)
beta gene##4##2##(1993-12#1)(1993-8#2)(1995-8#1)
beta globin##2##2##(1991-5#1)(2012-12#1)
beta hCG##5##2##(1993-6#1)(1994-3#1)(1997-4#3)
beta in##10##2##(1990-12#1)(1992-3#1)(1994-6#2)(1994-8#2)(1995-6#2)(2008-4#2)
beta increased the##2##3##(1990-2#1)(1996-12#1)
beta induced##2##2##(1994-9#1)(1995-6#1)
beta inhibitor##2##2##(1992-9#2)
beta interferon##4##2##(1991-6#3)(2010-12#1)
beta is##13##2##(1990-12#1)(1992-3#3)(1993-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
beta mRNA levels##6##3##(1993-3#1)(1996-12#1)(1997-2#4)
beta mRNA##19##2##(1993-3#3)(1996-12#3)(1997-2#13)
beta method##2##2##(2012-3#2)
beta mutant##3##2##(1993-8#2)(1995-2#1)
beta or##4##2##(1990-5#1)(1991-12#2)(2008-3#1)
beta peptides##3##2##(1993-11#1)(1996-2#1)(1996-5#1)
beta polypeptide##3##2##(1994-5#3)
beta polypeptides##3##2##(1993-6#1)(1994-5#2)
beta precursor##5##2##(1995-2#4)(1996-5#1)
beta production##5##2##(1996-12#1)(1996-5#1)(2007-2#3)
beta protein in##2##3##(1995-12#1)(2007-5#1)
beta protein##12##2##(1992-12#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#2)(1995-12#3)(2007-5#1)(2008-4#1)
beta receptor##6##2##(1994-6#2)(1995-12#1)(1995-2#1)(1997-6#1)(1997-7#1)
beta receptors##2##2##(1995-12#1)(1995-5#1)
beta sheet##2##2##(1992-8#1)(1995-6#1)
beta subunit and##2##3##(1995-8#1)(1997-2#1)
beta subunit gene##2##3##(1995-6#1)(1996-2#1)
beta subunit of##6##3##(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#2)
beta subunit##40##2##(1990-7#2)(1991-2#3)(1992-3#1)(1992-6#1)(1992-9#4)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#6)(1995-6#4)(1995-8#3)(1996-2#1)(1997-2#1)(2008-8#3)
beta subunits##20##2##(1990-7#2)(1990-8#1)(1991-10#2)(1991-7#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-8#1)(2008-8#3)
beta system##4##2##(1996-12#4)
beta thalassemia##2##2##(1994-12#1)(2011-2#1)
beta to##3##2##(1990-7#1)(1994-8#1)(1995-2#1)
beta tricalcium phosphate##2##3##(2008-5#1)(2012-3#1)
beta values##4##2##(2008-10#3)(2008-3#1)
beta was##7##2##(1990-10#1)(1990-8#1)(1991-12#2)(1994-3#1)(1994-8#1)(1995-12#1)
beta were##3##2##(1994-11#2)(1994-3#1)
beta with##2##2##(1995-2#1)(1995-6#1)
beta##1066##1##(1990-10#4)(1990-11#16)(1990-12#15)(1990-2#10)(1990-3#1)(1990-5#6)(1990-7#18)(1990-8#22)(1991-10#16)(1991-11#1)(1991-12#14)(1991-2#10)(1991-5#29)(1991-6#15)(1991-7#2)(1991-9#3)(1992-10#6)(1992-11#6)(1992-12#13)(1992-2#4)(1992-3#34)(1992-4#5)(1992-6#6)(1992-8#18)(1992-9#24)(1993-11#27)(1993-12#21)(1993-2#2)(1993-3#19)(1993-6#17)(1993-8#37)(1993-9#6)(1994-11#44)(1994-12#10)(1994-2#2)(1994-3#3)(1994-5#10)(1994-6#19)(1994-8#28)(1994-9#9)(1995-11#44)(1995-12#38)(1995-2#30)(1995-5#3)(1995-6#20)(1995-8#15)(1996-11#1)(1996-12#26)(1996-2#37)(1996-5#28)(1996-7#1)(1997-1#4)(1997-2#16)(1997-3#3)(1997-4#23)(1997-5#4)(1997-6#1)(1997-7#17)(2007-11#6)(2007-12#3)(2007-2#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#10)(2008-10#31)(2008-11#21)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#15)(2008-8#17)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-5#7)(2010-6#2)(2010-8#2)(2011-2#6)(2012-1#9)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#6)
beta'##3##1##(1990-7#1)(1991-12#2)
beta(1##2##1##(1990-5#1)(2008-10#1)
beta(1)##4##1##(2008-10#3)(2008-11#1)
beta(1)gamma(2) subunits##2##2##(2008-9#2)
beta(155)-PCB chromophores##2##2##(2008-8#2)
beta(2##2##1##(2008-3#2)
beta(2)##4##1##(2008-10#2)(2008-11#1)(2009-10#1)
beta(2)-tomatine and tomatidine##2##3##(2008-10#2)
beta(2a) subunit##2##2##(2008-8#2)
beta(2a)##9##1##(2008-8#9)
beta(3)##2##1##(2008-8#2)
beta(9##2##1##(2008-3#2)
beta(I)##2##1##(2008-10#2)
beta(lambda) was##2##2##(2008-3#2)
beta(nuc) for##2##2##(2009-8#2)
beta(nuc)##3##1##(2009-8#3)
beta) and##5##2##(1990-5#1)(1991-12#1)(1993-3#1)(1995-12#2)
beta) in the##2##3##(1992-9#1)(1994-8#1)
beta) in##3##2##(1992-9#1)(1994-8#1)(1995-2#1)
beta) is a##2##3##(1992-8#1)(1996-2#1)
beta) is##3##2##(1992-8#1)(1994-8#1)(1996-2#1)
beta)##34##1##(1990-5#9)(1991-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-12#4)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
beta- and gamma-CD##3##3##(1996-5#2)(2008-10#1)
beta- and gamma-cyclodextrins##3##3##(2008-10#3)
beta- and gamma-peptides##5##3##(2006-12#5)
beta- and kappa-caseins##2##3##(2008-10#1)(2008-12#1)
beta- and##24##2##(1990-8#2)(1993-8#1)(1995-6#2)(1996-5#2)(2006-12#7)(2008-10#8)(2008-12#1)(2010-5#1)
beta-##42##1##(1990-11#1)(1990-12#1)(1990-8#2)(1992-3#6)(1993-8#1)(1994-5#2)(1995-6#2)(1996-2#4)(1996-5#2)(2006-12#7)(2008-10#12)(2008-12#1)(2010-5#1)
beta-(1-40)##2##1##(1994-8#2)
beta-(1-42)##3##1##(1994-8#3)
beta-1##72##1##(1991-12#2)(1991-5#3)(1992-11#2)(1992-7#4)(1994-8#1)(1995-5#1)(1997-6#6)(2008-10#49)(2008-9#3)(2009-8#1)
beta-1b##2##1##(1996-8#2)
beta-2 microglobulin##2##2##(1995-1#1)(2008-7#1)
beta-2##4##1##(1995-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
beta-2-microglobulin##2##1##(1994-8#1)(1997-8#1)
beta-AP(1-40)##5##1##(2008-8#5)
beta-APP release##2##2##(1993-8#2)
beta-APP##5##1##(1993-8#5)
beta-Amyloid##2##1##(1991-11#1)(1992-2#1)
beta-BaB(2)O(4) (BBO)##2##2##(2007-12#1)(2008-2#1)
beta-BaB(2)O(4)##6##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
beta-CCE##4##1##(1995-11#1)(1996-2#3)
beta-CD and##6##2##(1994-3#1)(2008-10#3)(2008-11#2)
beta-CD as##2##2##(2008-10#2)
beta-CD at##3##2##(1994-3#1)(2008-10#2)
beta-CD concentration##2##2##(2008-10#2)
beta-CD has##2##2##(2008-10#1)(2008-6#1)
beta-CD in##3##2##(1994-3#2)(2008-11#1)
beta-CD was##3##2##(2008-10#2)(2008-11#1)
beta-CD with##2##2##(2008-10#1)(2008-11#1)
beta-CD##57##1##(1994-3#6)(1996-5#1)(2008-10#35)(2008-11#6)(2008-6#7)(2011-1#2)
beta-CDP##2##1##(2008-10#2)
beta-CDs##2##1##(1996-5#1)(2008-10#1)
beta-CF2-TAD##2##1##(1995-3#2)
beta-CGRP gene##4##2##(1992-6#4)
beta-CGRP##14##1##(1992-6#14)
beta-Carotene##4##1##(2007-1#1)(2009-6#1)(2009-8#2)
beta-Correction##2##1##(2008-10#2)
beta-Cyclodextrin##2##1##(2008-10#2)
beta-D-GalpA-(1--&gt##3##1##(1992-12#3)
beta-D-galactopyranosyl##2##1##(2009-8#2)
beta-D-galactosidase##3##1##(1992-12#1)(1995-11#1)(2008-10#1)
beta-D-glucopyranose hydrochloride##4##2##(1995-11#4)
beta-D-glucosidase##2##1##(1992-12#1)(1995-11#1)
beta-D-glucuronidase (GUS) activity##2##3##(2008-10#2)
beta-D-glucuronide##5##1##(1996-12#4)(2008-10#1)
beta-Galactosidase##3##1##(1990-5#1)(2008-11#1)(2009-8#1)
beta-HCG##3##1##(2008-6#3)
beta-Keggin##2##1##(1996-2#2)
beta-Man##2##1##(1990-5#1)(1994-5#1)
beta-Mono-##2##1##(1996-5#2)
beta-MyHC gene##3##2##(1995-2#3)
beta-PDH##2##1##(1994-11#2)
beta-TCP material##2##2##(2008-5#2)
beta-TCP##4##1##(2008-5#4)
beta-TG and PF(4) plasma levels##2##5##(2008-7#2)
beta-TG##3##1##(2008-7#2)(2010-3#1)
beta-actin mRNA was##3##3##(1995-12#1)(2008-7#1)(2008-8#1)
beta-actin mRNA##6##2##(1995-12#2)(1996-12#1)(1996-2#1)(2008-7#1)(2008-8#1)
beta-actin promoter##4##2##(1993-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
beta-actin were##2##2##(1996-12#1)(1996-2#1)
beta-actin##22##1##(1993-12#1)(1995-12#5)(1995-2#1)(1996-12#2)(1996-2#3)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#2)
beta-adducin##3##1##(1994-11#3)
beta-adrenergic agonist##2##2##(1991-12#1)(2008-9#1)
beta-adrenergic antagonist##2##2##(1995-3#1)(2008-2#1)
beta-adrenergic antagonists among selected patients##2##5##(2008-3#2)
beta-adrenergic receptor characteristics in##2##4##(1997-6#2)
beta-adrenergic receptor characteristics##3##3##(1997-6#3)
beta-adrenergic receptor mechanism##2##3##(1995-3#1)(2010-7#1)
beta-adrenergic receptor##12##2##(1992-12#2)(1992-3#1)(1995-3#3)(1997-6#5)(2010-7#1)
beta-adrenergic receptors##2##2##(1994-6#1)(1997-6#1)
beta-adrenergic stimulation##2##2##(1991-12#1)(1994-2#1)
beta-adrenergic##33##1##(1991-12#4)(1992-12#3)(1992-3#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-3#4)(1997-6#6)(2008-2#2)(2008-3#3)(2008-9#3)(2010-4#2)(2010-7#1)
beta-adrenoceptor antagonist##2##2##(1992-5#1)(1995-12#1)
beta-adrenoceptor##7##1##(1992-5#1)(1995-11#1)(1995-12#4)(1997-2#1)
beta-adrenoceptors in area CA1##2##4##(2008-9#2)
beta-adrenoceptors in##5##2##(1995-12#3)(2008-9#2)
beta-adrenoceptors##13##1##(1994-5#1)(1995-11#1)(1995-12#7)(1997-2#1)(1997-7#1)(2008-9#2)
beta-agonists##7##1##(2008-11#1)(2009-6#1)(2010-5#1)(2011-1#4)
beta-alanine##3##1##(1995-5#2)(2008-10#1)
beta-alpha-beta##2##1##(1990-7#2)
beta-amino acid##2##2##(1994-2#1)(2008-5#1)
beta-amino##5##1##(1994-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-3#1)
beta-amylase in##2##2##(2008-9#2)
beta-amylase is##2##2##(2008-9#2)
beta-amylase##8##1##(1992-11#1)(2008-9#7)
beta-amyloid in the brain##2##4##(1992-12#1)(1994-5#1)
beta-amyloid is##2##2##(1992-12#2)
beta-amyloid peptide (beta##2##3##(1991-10#1)(1995-12#1)
beta-amyloid peptide##5##2##(1991-10#1)(1992-12#1)(1995-12#2)(1996-2#1)
beta-amyloid precursor protein (beta APP)##2##5##(1991-10#1)(1992-8#1)
beta-amyloid precursor protein##13##3##(1991-10#2)(1991-11#2)(1992-12#3)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#1)
beta-amyloid precursor proteins##2##3##(1992-12#1)(1994-5#1)
beta-amyloid precursor##15##2##(1991-10#2)(1991-11#2)(1992-12#4)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#2)
beta-amyloid protein##8##2##(1992-6#2)(1992-8#2)(2008-7#2)(2008-8#2)
beta-amyloid##43##1##(1991-10#3)(1991-11#2)(1992-12#11)(1992-6#3)(1992-8#4)(1993-8#2)(1994-5#3)(1995-12#2)(1995-5#3)(1996-2#1)(1996-5#2)(2008-7#2)(2008-8#2)(2010-2#3)
beta-anomeric##3##1##(1995-11#2)(2008-5#1)
beta-barium borate crystal##2##3##(2007-12#2)
beta-barium borate nonlinear##2##3##(2008-2#2)
beta-barium borate##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
beta-barrel##5##1##(1991-5#1)(1993-8#1)(1995-5#1)(1997-4#1)(2008-7#1)
beta-binomial distribution is##2##3##(2008-10#1)(2010-3#1)
beta-binomial distribution##19##2##(2008-10#17)(2010-3#2)
beta-binomial##30##1##(2008-10#27)(2010-3#3)
beta-blockade##3##1##(1993-2#1)(1995-2#1)(2010-4#1)
beta-blocker therapy##2##2##(2008-3#1)(2008-7#1)
beta-blocker use##2##2##(2007-10#1)(2008-3#1)
beta-blocker with##2##2##(1995-2#1)(2008-10#1)
beta-blocker##14##1##(1992-6#1)(1995-2#1)(1997-8#2)(2007-10#1)(2008-10#3)(2008-3#5)(2008-7#1)
beta-blockers are##3##2##(2008-3#2)(2008-4#1)
beta-blockers##32##1##(1991-11#1)(1992-5#1)(1992-6#1)(1993-2#2)(1994-12#1)(1995-2#2)(1995-6#8)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2010-4#2)(2011-2#2)
beta-blocking##3##1##(1992-3#1)(2008-7#2)
beta-carboline##4##1##(1992-3#1)(2008-10#3)
beta-carboxamide##2##1##(1995-3#2)
beta-carotene 15##2##2##(2009-6#2)
beta-carotene and##4##2##(1990-11#1)(1992-9#2)(2009-8#1)
beta-carotene in##2##2##(2008-7#1)(2009-6#1)
beta-carotene##17##1##(1990-11#1)(1992-9#4)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#5)(2009-8#1)(2013-8#2)
beta-caryophyllene##3##1##(2009-8#3)
beta-casein gene##4##2##(2008-8#4)
beta-casein##9##1##(1991-12#1)(1996-2#1)(2008-10#1)(2008-8#5)(2010-5#1)
beta-catenin##15##1##(1994-11#2)(2007-12#5)(2008-11#1)(2008-7#1)(2009-8#5)(2010-8#1)
beta-cell cAMP##2##2##(1990-8#1)(1995-8#1)
beta-cell dysfunction##2##2##(2008-1#1)(2009-3#1)
beta-cell function and insulin sensitivity##4##5##(1994-12#4)
beta-cell function and##7##3##(1994-12#4)(2008-4#1)(2008-7#1)(2009-8#1)
beta-cell function##13##2##(1991-7#1)(1994-12#5)(2008-1#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2013-8#1)
beta-cell secretory##4##2##(1991-7#1)(1992-6#1)(1994-12#1)(2008-3#1)
beta-cell##33##1##(1990-8#1)(1991-7#3)(1992-6#1)(1993-5#1)(1994-12#7)(1995-8#1)(2008-1#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#5)(2009-8#1)(2010-11#1)(2013-8#1)
beta-cells and##2##2##(2008-1#1)(2010-12#1)
beta-cells from##2##2##(2008-1#1)(2008-11#1)
beta-cells in##4##2##(2008-12#1)(2009-3#3)
beta-cells##32##1##(1990-8#3)(1991-12#1)(1994-11#3)(1996-2#4)(1996-5#6)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#4)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#2)
beta-chain of##4##2##(1995-3#2)(1995-6#1)(1997-4#1)
beta-chain##13##1##(1991-6#2)(1992-5#2)(1993-3#1)(1993-8#1)(1994-11#2)(1995-3#2)(1995-6#2)(1997-4#1)
beta-chains##5##1##(1990-8#1)(1991-6#1)(1992-8#1)(1997-4#2)
beta-core##5##1##(1996-12#5)
beta-correction spectrophotometry using##2##3##(2008-10#2)
beta-correction spectrophotometry##7##2##(2008-10#7)
beta-correction##9##1##(2008-10#9)
beta-crystallin##3##1##(1991-6#3)
beta-crystallins##3##1##(1991-6#3)
beta-cyclodextrin (CD)##3##2##(2008-10#2)(2008-6#1)
beta-cyclodextrin (beta-CD) and##4##3##(2008-10#4)
beta-cyclodextrin (beta-CD) has been##3##4##(2008-10#3)
beta-cyclodextrin (beta-CD) is##2##3##(1994-3#1)(2008-10#1)
beta-cyclodextrin (beta-CD)##18##2##(1994-3#1)(1996-5#1)(2008-10#15)(2011-1#1)
beta-cyclodextrin and##5##2##(1994-3#1)(2008-10#3)(2008-11#1)
beta-cyclodextrin as a chiral##2##4##(2008-10#2)
beta-cyclodextrin as##3##2##(2008-10#3)
beta-cyclodextrin bonded##2##2##(2008-10#2)
beta-cyclodextrin concentration##2##2##(2008-10#2)
beta-cyclodextrin polymer##2##2##(1996-5#1)(2008-10#1)
beta-cyclodextrin were##2##2##(2008-10#2)
beta-cyclodextrin##56##1##(1994-3#2)(1996-5#4)(2007-11#2)(2008-10#44)(2008-11#1)(2008-6#1)(2011-1#2)
beta-cyclodextrins##4##1##(2008-10#3)(2008-7#1)
beta-defensin expression##3##2##(2008-5#2)(2011-3#1)
beta-defensin##5##1##(2008-5#4)(2011-3#1)
beta-dicarbonyl##3##1##(2007-11#3)
beta-diketonates##5##1##(2008-10#5)
beta-diol and##2##2##(1990-8#1)(1992-3#1)
beta-diol##9##1##(1990-11#7)(1990-8#1)(1992-3#1)
beta-elimination##5##1##(1995-2#1)(1996-5#1)(2008-8#1)(2009-8#2)
beta-endorphin and##3##2##(1990-5#1)(1994-9#1)(2008-11#1)
beta-endorphin from the##2##3##(1993-5#1)(1994-9#1)
beta-endorphin from##3##2##(1993-5#2)(1994-9#1)
beta-endorphin in##4##2##(1990-12#2)(1990-5#1)(1993-5#1)
beta-endorphin release##3##2##(1990-12#3)
beta-endorphin secretion##2##2##(1990-12#1)(1994-9#1)
beta-endorphin##36##1##(1990-12#7)(1990-5#2)(1991-5#2)(1991-6#2)(1992-3#5)(1993-5#4)(1994-2#2)(1994-9#5)(1995-12#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-7#1)
beta-erythrofuranose##2##1##(1990-9#2)
beta-estradiol (0##2##2##(1991-12#1)(1995-11#1)
beta-estradiol##24##1##(1990-11#1)(1990-2#1)(1991-12#1)(1993-9#6)(1995-11#4)(1995-12#2)(1995-6#1)(1996-12#2)(1996-5#4)(2008-11#2)
beta-gal expression levels##2##3##(2008-7#2)
beta-gal expression##3##2##(2008-7#3)
beta-gal##5##1##(1997-8#1)(2008-7#4)
beta-galactosidase (beta Gal)##3##3##(1990-5#1)(1993-9#1)(1997-4#1)
beta-galactosidase (beta##4##2##(1990-5#1)(1991-5#1)(1993-9#1)(1997-4#1)
beta-galactosidase (lacZ)##2##2##(1990-5#1)(1995-8#1)
beta-galactosidase activities##2##2##(1994-11#1)(2008-8#1)
beta-galactosidase activity##10##2##(1990-2#1)(1991-5#1)(1994-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
beta-galactosidase and carboxypeptidase##4##3##(1993-8#4)
beta-galactosidase and##7##2##(1993-8#5)(1994-12#1)(1995-2#1)
beta-galactosidase from##6##2##(1992-12#2)(1994-6#2)(1995-2#1)(2012-3#1)
beta-galactosidase gene##6##2##(1994-5#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
beta-galactosidase in##3##2##(1992-12#1)(1993-12#1)(1997-8#1)
beta-galactosidase is##3##2##(1990-2#1)(1995-2#1)(2008-8#1)
beta-galactosidase production##2##2##(2008-11#2)
beta-galactosidase to##3##2##(1990-5#1)(2009-8#2)
beta-galactosidase was##2##2##(1990-5#1)(2008-8#1)
beta-galactosidase yield##3##2##(2008-11#3)
beta-galactosidase##92##1##(1990-11#1)(1990-2#4)(1990-5#9)(1991-5#5)(1992-12#5)(1993-12#2)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-12#2)(1995-2#6)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#7)(2008-10#4)(2008-11#11)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-3#1)
beta-galactosidase)##3##1##(1990-5#1)(1994-12#1)(1997-4#1)
beta-galactosidase-binding interface##3##2##(1995-2#3)
beta-galactosidase-binding##4##1##(1995-2#4)
beta-galactosidase-catalyzed cleavage of 4-nitrophenyl-2-deoxy-beta-D-galactopyranoside##2##4##(2009-8#2)
beta-globin gene (IVS-2-654 C--&gt##2##4##(2008-8#2)
beta-globin gene##12##2##(1990-8#1)(1991-9#1)(1992-12#1)(1993-3#2)(1996-2#1)(2008-11#1)(2008-8#3)(2012-12#2)
beta-globin mRNA##3##2##(2008-11#1)(2008-8#2)
beta-globin##21##1##(1990-8#2)(1991-9#1)(1992-12#1)(1993-3#2)(1993-6#1)(1994-8#1)(1996-2#2)(2008-11#4)(2008-8#5)(2012-12#2)
beta-glucan##3##1##(1991-5#1)(1994-6#2)
beta-glucosidase activity##4##2##(2008-10#2)(2008-6#2)
beta-glucosidase production##2##2##(2008-6#2)
beta-glucosidase##21##1##(1990-5#2)(1995-6#4)(1997-4#3)(2008-10#4)(2008-11#1)(2008-6#6)(2008-8#1)
beta-glucosidases##3##1##(1991-5#3)
beta-glucosides##2##1##(1990-5#1)(1995-11#1)
beta-glucuronidase (GUS) reporter gene and##2##5##(2008-10#2)
beta-glucuronidase (GUS)##5##2##(2008-10#4)(2008-9#1)
beta-glucuronidase activity##5##2##(1996-12#2)(2008-10#3)
beta-glucuronidase##22##1##(1990-6#1)(1990-7#1)(1991-12#1)(1993-8#1)(1996-12#3)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)
beta-glycan##2##1##(1995-12#2)
beta-hairpin##2##1##(1992-8#1)(1995-5#1)
beta-human chorionic##2##2##(2007-10#1)(2008-6#1)
beta-hydroxy acids##2##2##(2008-5#2)
beta-hydroxy##4##1##(1995-3#1)(2007-11#1)(2008-5#2)
beta-hydroxybutyrate##2##1##(2008-10#2)
beta-hydroxylase##6##1##(1991-5#3)(1995-12#2)(1997-3#1)
beta-hydroxysteroid dehydrogenase##6##2##(1990-11#2)(1995-11#1)(1996-5#2)(2008-1#1)
beta-hydroxysteroid##9##1##(1990-11#2)(1990-12#2)(1994-6#1)(1995-11#1)(1996-5#2)(2008-1#1)
beta-keratins##3##1##(2011-2#3)
beta-ketoacyl-ACP synthases I and II##2##5##(1995-6#2)
beta-ketoacyl-ACP synthases##3##2##(1995-6#3)
beta-lactam antibiotic##5##2##(1994-12#1)(1994-8#1)(2008-10#2)(2009-12#1)
beta-lactam antibiotics and dipeptides##2##4##(1990-11#2)
beta-lactam antibiotics with##2##3##(1990-11#1)(1995-3#1)
beta-lactam antibiotics##16##2##(1990-11#8)(1992-12#1)(1994-12#1)(1994-8#3)(1995-3#1)(2010-6#1)(2011-2#1)
beta-lactam##32##1##(1990-11#8)(1992-12#2)(1993-8#1)(1994-12#2)(1994-8#4)(1995-3#1)(1996-3#2)(2007-11#5)(2008-10#2)(2008-7#1)(2009-12#1)(2010-6#2)(2011-2#1)
beta-lactamase active site##2##3##(1992-6#2)
beta-lactamase gene##2##2##(1994-3#1)(1997-4#1)
beta-lactamase inhibitors##2##2##(1997-3#1)(2008-11#1)
beta-lactamase of Enterobacter cloacae P99##2##5##(1992-6#2)
beta-lactamase##16##1##(1990-11#1)(1992-3#1)(1992-6#4)(1994-11#1)(1994-3#1)(1997-3#2)(1997-4#2)(2008-11#1)(2010-2#2)(2010-6#1)
beta-lactamines##2##1##(1997-3#2)
beta-lactams and##2##2##(2008-12#1)(2008-8#1)
beta-lactams are the##2##3##(1996-3#1)(2010-6#1)
beta-lactams##16##1##(1993-8#3)(1996-3#2)(2007-11#4)(2007-2#1)(2008-12#3)(2008-7#1)(2008-8#1)(2010-6#1)
beta-lactoglobulin as##2##2##(1997-2#1)(2008-11#1)
beta-lactoglobulin##15##1##(1995-5#6)(1997-2#3)(2008-10#2)(2008-11#2)(2008-7#2)
beta-like##4##1##(1992-9#1)(2008-8#3)
beta-mercaptoethanol and##4##2##(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
beta-mercaptoethanol##12##1##(1991-2#1)(1992-8#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
beta-methyl##5##1##(1992-3#4)(2008-5#1)
beta-methylene ATP##3##2##(1990-5#1)(1995-12#2)
beta-methylene##4##1##(1990-5#1)(1995-12#2)(1996-5#1)
beta-methylene-ATP = UTP##2##3##(1995-8#2)
beta-methylene-ATP##3##1##(1995-8#3)
beta-methylphenylalanine##2##1##(1995-6#2)
beta-migrating##2##1##(1995-2#1)(1995-6#1)
beta-myosin heavy chain gene##2##4##(1992-11#1)(1995-2#1)
beta-myosin heavy chain##4##3##(1992-11#2)(1995-2#2)
beta-myrcene##2##1##(2008-10#2)
beta-nicotinamide adenine dinucleotide##3##3##(1994-11#1)(2008-10#2)
beta-oxidation of fatty acids##2##4##(1995-6#1)(2012-2#1)
beta-oxidation of##3##2##(1990-5#1)(1995-6#1)(2012-2#1)
beta-oxidation##13##1##(1990-5#2)(1992-11#1)(1994-6#4)(1995-6#1)(1996-12#1)(1996-5#1)(2008-6#2)(2012-2#1)
beta-peptide##6##1##(1996-2#1)(2006-12#2)(2008-5#3)
beta-peptides##8##1##(2006-12#7)(2008-4#1)
beta-phenyltropane##2##1##(1991-12#2)
beta-pinene##4##1##(2008-10#2)(2008-11#1)(2008-12#1)
beta-pleated sheet##3##2##(1997-9#2)(2008-10#1)
beta-pleated##4##1##(1997-9#3)(2008-10#1)
beta-protein precursor##7##2##(1991-2#2)(1991-6#1)(1992-12#2)(1994-9#2)
beta-protein##13##1##(1991-11#1)(1991-2#2)(1991-6#1)(1992-12#6)(1994-9#3)
beta-secretase##4##1##(2008-11#4)
beta-sheet and##4##2##(1991-11#1)(1994-12#1)(1996-2#1)(2008-8#1)
beta-sheet conformation##3##2##(1992-6#1)(1994-11#1)(2009-7#1)
beta-sheet poly(L-lysine)##2##2##(1992-6#2)
beta-sheet structure##6##2##(1992-11#1)(1994-11#1)(1995-5#2)(2008-10#1)(2008-5#1)
beta-sheet when##2##2##(1992-6#2)
beta-sheet##38##1##(1990-11#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#7)(1993-11#1)(1994-11#2)(1994-12#1)(1995-2#3)(1995-5#4)(1995-8#1)(1996-2#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#2)(2009-9#1)
beta-sitosterol##6##1##(1990-2#1)(2007-1#1)(2008-10#1)(2008-12#3)
beta-strand##6##1##(1995-2#1)(1995-5#1)(1997-4#1)(2008-8#2)(2008-9#1)
beta-strands##4##1##(1993-11#2)(1993-8#1)(2008-10#1)
beta-structural##3##1##(1990-2#2)(1993-11#1)
beta-structure and##2##2##(1990-2#1)(2008-7#1)
beta-structure##8##1##(1990-2#3)(1991-9#1)(1992-5#1)(1993-11#1)(2008-7#1)(2008-9#1)
beta-subunit gene##2##2##(1995-2#2)
beta-subunit of human##2##3##(1993-11#1)(1997-4#1)
beta-subunit of the##2##3##(1993-11#1)(2007-7#1)
beta-subunit of##14##2##(1990-11#1)(1990-2#1)(1993-11#4)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-12#2)(1997-4#1)(2007-7#1)
beta-subunit##28##1##(1990-11#1)(1990-2#1)(1990-8#1)(1992-9#1)(1993-11#7)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-2#2)(1996-12#3)(1996-2#3)(1997-4#1)(2007-7#1)
beta-subunits of##5##2##(1990-2#2)(1991-3#1)(1994-5#1)(2008-8#1)
beta-subunits##11##1##(1990-2#2)(1990-4#2)(1991-3#2)(1993-11#1)(1994-5#1)(1995-6#1)(2008-8#1)(2009-7#1)
beta-thalassaemia##5##1##(1995-5#1)(1996-8#1)(2007-11#2)(2008-8#1)
beta-thalassemia##6##1##(1993-3#4)(2011-2#1)(2012-2#1)
beta-threo-2-pentulofuranose (0##2##2##(1990-9#2)
beta-threofuranose##2##1##(1990-9#2)
beta-tricalcium phosphate##2##2##(2008-5#2)
beta-tubulin and##2##2##(2008-10#1)(2010-3#1)
beta-tubulin gene##9##2##(1990-5#1)(2008-10#6)(2008-9#2)
beta-tubulin genes##2##2##(2008-10#2)
beta-tubulin##27##1##(1990-5#2)(1992-9#1)(1995-5#4)(2008-10#15)(2008-9#3)(2010-2#1)(2010-3#1)
beta-tubulin-encoding gene##3##2##(1990-5#1)(1997-2#2)
beta-tubulin-encoding genes##2##2##(1993-6#1)(1997-2#1)
beta-tubulin-encoding##5##1##(1990-5#1)(1993-6#1)(1997-2#3)
beta-turn conformation##2##2##(1993-11#1)(1994-11#1)
beta-turn##15##1##(1991-10#2)(1991-5#1)(1991-6#2)(1992-5#4)(1993-11#1)(1994-11#2)(1994-8#1)(1995-12#1)(2008-9#1)
beta-type complex##3##2##(2008-10#3)
beta-type##7##1##(1994-8#3)(2008-10#4)
beta-unsaturated ketones 3a-3j in good to excellent isolated yields with complete E-stereoselectivity##2##12##(2010-7#2)
beta-unsaturated##4##1##(2008-10#1)(2010-7#3)
beta/A4 peptide##3##2##(1992-6#3)
beta/A4##8##1##(1992-12#2)(1992-6#4)(1992-9#2)
beta1 and##2##2##(2008-11#2)
beta1##10##1##(1997-5#2)(2008-10#3)(2008-11#3)(2008-8#2)
beta1-42##2##1##(2008-5#2)
beta2##3##1##(2007-8#1)(2008-11#1)(2011-2#1)
beta2-M level in##2##3##(2007-7#2)
beta2-M level##3##2##(2007-7#3)
beta2-M##8##1##(2007-10#1)(2007-7#7)
beta2-agonists##2##1##(2010-2#1)(2011-2#1)
beta2-microglobulin (beta2m)##2##2##(1997-9#1)(2008-4#1)
beta2-microglobulin##9##1##(1997-9#2)(2007-10#1)(2007-12#1)(2007-7#3)(2008-4#1)(2011-2#1)
beta2M level##2##2##(2008-1#2)
beta2M##5##1##(2008-1#5)
beta2m##13##1##(1997-9#12)(2008-4#1)
beta2m)##4##1##(1997-9#4)
beta3 integrin##5##2##(2006-6#1)(2009-9#4)
beta3 subunit##2##2##(2006-6#2)
beta3##11##1##(2006-6#4)(2008-10#1)(2008-11#2)(2009-9#4)
beta=-0##2##1##(2008-10#2)
betaAP##5##1##(2008-7#5)
betaAR##2##1##(2010-4#2)
betaGal activities##2##2##(1997-7#2)
betaTC3 cells##3##2##(1997-1#2)(2008-11#1)
betablockers and##2##2##(2008-10#1)(2012-3#1)
betablockers##5##1##(2008-10#4)(2012-3#1)
betagamma##5##1##(1997-1#2)(2008-2#2)(2008-8#1)
betagamma-crystallin##3##1##(2009-7#3)
betahistine in##2##2##(2008-2#2)
betahistine versus placebo##2##3##(2008-2#2)
betahistine##5##1##(2008-2#5)
betaine (CAPB)##3##2##(2008-10#1)(2008-5#2)
betaine and##3##2##(1991-12#1)(2008-11#1)(2008-8#1)
betaine samples##2##2##(2008-10#2)
betaine##18##1##(1991-12#6)(2008-10#6)(2008-11#1)(2008-5#4)(2008-8#1)
betalactamase##2##1##(2010-2#2)
betamethasone plus##2##2##(1992-2#2)
betamethasone valerate 1%##2##3##(2007-11#2)
betamethasone##6##1##(1991-1#1)(1992-2#2)(2007-11#2)(2008-10#1)
betaxolol##2##1##(2008-10#1)(2008-5#1)
betel nut chewing##3##3##(2008-1#3)
betel nut##6##2##(2008-1#6)
betel##8##1##(2008-1#8)
bethylid##3##1##(2008-9#3)
beticola##3##1##(2008-10#3)
better HEI score##2##3##(2011-2#2)
better able to##10##3##(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-11#2)(2008-3#1)
better able##11##2##(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-11#2)(2008-3#1)(2008-5#1)
better acceptance##3##2##(1993-11#1)(1997-8#1)(2011-2#1)
better access to##4##3##(1991-6#1)(1995-12#1)(2006-10#1)(2010-1#1)
better accessibility##4##2##(2008-10#3)(2013-7#1)
better accuracy##4##2##(2008-10#3)(2008-3#1)
better adapted to##2##3##(2010-1#1)(2012-6#1)
better adherence to##2##3##(1995-2#1)(2008-11#1)
better adherence##5##2##(1995-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-9#1)
better after##2##2##(1990-12#1)(1991-6#1)
better agreement##3##2##(2008-2#2)(2008-3#1)
better analytical##2##2##(2008-10#1)(2008-7#1)
better and##9##2##(1992-9#1)(1995-12#1)(2008-10#1)(2011-2#4)(2012-2#1)(2012-3#1)
better approach##4##2##(1991-2#1)(1995-2#1)(1996-1#1)(2013-8#1)
better assessment of##2##3##(2007-11#1)(2007-8#1)
better assessment##3##2##(2007-11#1)(2007-8#1)(2009-11#1)
better at the##4##3##(2007-5#1)(2007-7#1)(2008-4#1)(2013-7#1)
better at##10##2##(2007-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2011-1#1)(2012-2#2)(2013-7#1)
better awareness of##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
better brain##2##2##(2012-3#1)(2013-1#1)
better but##2##2##(2007-12#1)(2008-6#1)
better care of##2##3##(2008-1#1)(2010-8#1)
better care##4##2##(1995-8#1)(2008-1#1)(2008-5#1)(2010-8#1)
better characterization of the##4##4##(2008-10#1)(2009-10#1)(2010-10#1)(2012-3#1)
better characterization of##5##3##(2008-10#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-3#1)
better characterized##2##2##(2008-10#1)(2008-6#1)
better choice##2##2##(2006-12#1)(2010-3#1)
better clinical conditions##2##3##(1990-2#1)(1997-7#1)
better clinical##8##2##(1990-2#1)(1990-6#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-9#1)(2013-1#1)
better compared##3##2##(1990-9#1)(1994-5#1)(2008-10#1)
better compliance##3##2##(1990-2#1)(2007-12#1)(2008-1#1)
better comprehension of##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
better control of the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
better control of##11##3##(1992-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2010-5#1)(2012-12#1)(2013-8#2)
better control##13##2##(1992-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
better correlation##2##2##(2008-2#1)(2008-9#1)
better data##3##2##(1994-1#2)(2011-2#1)
better define##7##2##(1990-6#1)(2008-10#3)(2011-2#1)(2013-1#2)
better defined##4##2##(1991-12#1)(2008-10#2)(2008-4#1)
better definition of the##3##4##(1991-8#1)(1997-3#1)(2008-10#1)
better definition of##4##3##(1991-8#1)(1996-3#1)(1997-3#1)(2008-10#1)
better definition##5##2##(1991-8#1)(1996-3#1)(1997-3#1)(2007-4#1)(2008-10#1)
better detection limits##2##3##(2008-10#2)
better detection of##2##3##(2008-10#2)
better detection##5##2##(2008-10#4)(2010-12#1)
better determination of##2##3##(2008-2#1)(2012-1#1)
better determine##2##2##(2008-4#1)(2012-3#1)
better developed##2##2##(2007-12#1)(2008-5#1)
better diagnosis##2##2##(1997-7#1)(2013-8#1)
better diagnostic##3##2##(2008-3#1)(2011-2#2)
better discrimination##3##2##(1995-3#1)(2008-3#2)
better disease##3##2##(2008-10#1)(2009-4#1)(2010-8#1)
better drugs##2##2##(2008-4#1)(2008-7#1)
better during##2##2##(1991-8#1)(2008-11#1)
better educated##2##2##(2008-10#1)(2012-12#1)
better efficacy##3##2##(1994-6#1)(2011-2#1)(2012-12#1)
better efficiency##4##2##(1996-9#1)(2008-10#1)(2008-3#2)
better equipped##3##2##(1993-2#1)(2007-10#1)(2009-3#1)
better estimates of##2##3##(1997-7#1)(2008-3#1)
better explained by##4##3##(2010-6#1)(2013-1#3)
better facilities##2##2##(2008-11#1)(2012-2#1)
better fit than##2##3##(2008-10#1)(2009-8#1)
better fit to##2##3##(1995-12#1)(2008-9#1)
better fit##9##2##(1995-12#1)(2008-10#5)(2008-9#1)(2009-8#1)(2013-1#1)
better for the##5##3##(1994-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
better for##17##2##(1992-2#1)(1994-2#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
better functional outcome##2##3##(2008-6#1)(2011-2#1)
better functional##3##2##(2008-6#1)(2011-1#1)(2011-2#1)
better future in##2##3##(1997-5#1)(2008-10#1)
better future##3##2##(1991-2#1)(1997-5#1)(2008-10#1)
better guidelines##2##2##(1993-2#1)(2009-8#1)
better habitats##3##2##(2008-8#3)
better health and##3##3##(1997-2#1)(2008-1#1)(2008-7#1)
better health care##3##3##(1991-6#1)(1994-1#1)(2008-7#1)
better health##15##2##(1991-6#1)(1994-1#1)(1994-3#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-2#3)(2012-12#1)
better host##2##2##(2008-11#1)(2009-9#1)
better identification##3##2##(1997-1#1)(2008-9#1)(2010-10#1)
better identify##3##2##(2007-11#1)(2010-1#1)(2010-9#1)
better if##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
better image##2##2##(2008-3#2)
better images##2##2##(2008-2#1)(2011-2#1)
better in the##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
better in this##3##3##(1991-2#1)(1995-3#1)(2008-11#1)
better in those who##2##4##(2013-1#2)
better in##22##2##(1991-2#1)(1993-11#1)(1994-7#1)(1995-3#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#4)
better information on##2##3##(2008-10#1)(2008-3#1)
better information##5##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
better initial##2##2##(2007-11#1)(2008-10#1)
better integration of##2##3##(2010-10#1)(2012-3#1)
better integration##3##2##(2010-10#1)(2012-3#1)(2013-7#1)
better interventions##3##2##(2010-10#1)(2012-2#1)(2012-3#1)
better knowledge of the##4##4##(1990-12#1)(1992-12#1)(2008-10#1)(2008-4#1)
better knowledge of##6##3##(1990-12#1)(1992-12#1)(1996-6#1)(2008-10#2)(2008-4#1)
better knowledge##8##2##(1990-12#1)(1992-12#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-4#1)
better known as##2##3##(2010-1#1)(2012-2#1)
better known##3##2##(2010-1#1)(2012-2#1)(2012-3#1)
better lateral##2##2##(2007-11#1)(2008-2#1)
better linearity##2##2##(2008-10#2)
better long-term patency than the saphenous##2##6##(2007-8#2)
better long-term patency##3##3##(1997-3#1)(2007-8#2)
better long-term results##2##3##(1993-11#1)(2011-2#1)
better long-term##10##2##(1993-11#1)(1997-3#1)(2007-11#2)(2007-8#2)(2008-10#1)(2011-2#3)
better manage##3##2##(1994-2#1)(2007-4#1)(2008-8#1)
better management of##3##3##(1997-1#1)(2008-10#1)(2009-11#1)
better management##4##2##(1992-1#1)(1997-1#1)(2008-10#1)(2009-11#1)
better medical##2##2##(2008-11#1)(2009-6#1)
better models##2##2##(2008-10#1)(2009-6#1)
better nutrition##2##2##(1991-2#1)(2007-12#1)
better nutritional status##2##3##(2007-12#1)(2013-7#1)
better nutritional##3##2##(1995-2#1)(2007-12#1)(2013-7#1)
better off##2##2##(1995-3#1)(2012-2#1)
better on##2##2##(2008-2#1)(2010-7#1)
better optical##2##2##(2007-12#1)(2008-3#1)
better or worse?##2##3##(1996-12#1)(2013-8#1)
better or##3##2##(1996-12#1)(2007-12#1)(2013-8#1)
better organization##2##2##(2007-8#1)(2012-2#1)
better outcome in##5##3##(1995-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-10#1)
better outcome##12##2##(1992-9#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-8#2)
better outcomes from##3##3##(2008-7#3)
better outcomes##14##2##(1995-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#5)(2011-1#1)(2011-2#3)
better overall physical##2##3##(2009-11#1)(2013-1#1)
better overall##6##2##(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
better pain##2##2##(2007-8#1)(2012-2#1)
better patient##4##2##(2007-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
better performance in##7##3##(1993-9#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
better performance of##2##3##(2008-10#1)(2008-11#1)
better performance on##3##3##(2008-6#1)(2012-3#1)(2013-1#1)
better performance than the##2##4##(2008-10#1)(2008-3#1)
better performance than##9##3##(2008-10#5)(2008-3#3)(2013-8#1)
better performance##28##2##(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
better planning##2##2##(2008-11#1)(2013-1#1)
better position to##4##3##(1992-3#1)(1996-2#1)(2008-11#1)(2008-3#1)
better positioned##2##2##(1997-3#1)(2013-1#1)
better postoperative##2##2##(1990-3#1)(2009-10#1)
better precision##3##2##(2008-10#3)
better predict##2##2##(2008-11#1)(2010-8#1)
better prediction ability##2##3##(2008-10#2)
better prediction##4##2##(2007-8#1)(2008-10#3)
better prepared to##4##3##(1993-2#1)(1994-1#1)(1997-1#1)(2013-7#1)
better preserved in##2##3##(2011-2#2)
better prevention of##2##3##(1991-2#1)(2008-2#1)
better prevention##3##2##(1991-2#1)(2008-2#1)(2012-2#1)
better prognosis than##2##3##(2012-2#1)(2013-1#1)
better prognosis when##2##3##(1993-1#1)(2008-6#1)
better prognosis with##2##3##(2013-1#1)(2013-8#1)
better prognosis##18##2##(1991-2#1)(1992-9#1)(1993-1#1)(1994-6#1)(2008-12#1)(2008-6#2)(2008-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
better protect##2##2##(2008-10#1)(2009-4#1)
better protection of the##2##4##(1996-1#1)(2007-8#1)
better protection of##3##3##(1996-1#1)(2007-8#1)(2008-10#1)
better protection##4##2##(1996-1#1)(2007-8#1)(2008-10#1)(2013-8#1)
better quality of life##5##4##(1990-10#1)(1991-2#1)(2008-7#1)(2011-2#2)
better quality of##7##3##(1990-10#1)(1990-6#1)(1991-2#1)(1991-6#1)(2008-7#1)(2011-2#2)
better quality##15##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-6#1)(1994-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#2)(2009-7#1)(2010-2#1)(2011-2#2)(2012-2#1)
better reflect##3##2##(2008-10#2)(2013-8#1)
better resolution and##3##3##(2008-10#3)
better resolved##2##2##(1996-5#1)(2008-10#1)
better response##5##2##(1990-9#1)(1991-2#1)(2007-7#1)(2008-10#1)(2009-8#1)
better result##2##2##(1995-5#1)(2013-8#1)
better results and##2##3##(2008-10#1)(2010-8#1)
better results in##4##3##(2007-11#1)(2009-3#1)(2011-2#1)(2013-1#1)
better results than regimen A in##2##6##(1997-7#2)
better results than regimen A##3##5##(1997-7#3)
better results than the##4##4##(2008-2#1)(2008-6#1)(2011-2#2)
better results than##19##3##(1991-6#1)(1997-7#3)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#2)(2011-2#2)(2012-2#1)
better results when##2##3##(1994-3#1)(2008-5#1)
better results##35##2##(1991-6#1)(1992-9#1)(1994-3#1)(1997-7#3)(2007-11#5)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#1)(2010-8#3)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
better safety##2##2##(1990-3#1)(2012-12#1)
better screening##3##2##(1991-6#1)(2009-1#1)(2012-12#1)
better selection of patients##2##4##(2007-10#1)(2008-10#1)
better selectivity##5##2##(2007-12#1)(2008-10#4)
better sensitivity##4##2##(2008-10#4)
better separation##4##2##(1995-6#1)(1996-5#1)(2008-10#2)
better short-term##2##2##(2008-6#1)(2013-8#1)
better stability##3##2##(2008-5#2)(2013-7#1)
better substrates for##2##3##(2008-7#1)(2012-2#1)
better suited for##5##3##(2008-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
better suited to##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2010-9#1)
better suited##9##2##(1991-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-9#1)(2011-2#1)
better survival in##2##3##(2010-8#1)(2013-1#1)
better survival##9##2##(1990-6#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-7#1)(2010-8#1)(2013-1#1)
better sustained##2##2##(2008-10#1)(2008-12#1)
better techniques##2##2##(2011-1#1)(2012-2#1)
better than 0##18##3##(1991-2#1)(1992-7#1)(2008-10#10)(2008-2#2)(2008-3#4)
better than 1##8##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)
better than 1%##6##3##(2008-10#3)(2008-3#3)
better than 10%##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
better than 2##3##3##(1992-11#1)(2007-12#1)(2008-10#1)
better than 2%##2##3##(2008-10#2)
better than 20##3##3##(2007-11#1)(2008-3#2)
better than 200##2##3##(2008-2#1)(2008-3#1)
better than 3%##4##3##(1996-5#1)(2008-10#3)
better than 4%##2##3##(2008-10#2)
better than 5%##3##3##(2008-2#1)(2008-3#2)
better than 7%##3##3##(2008-10#2)(2008-2#1)
better than 90%##2##3##(2007-11#2)
better than a##4##3##(2008-10#1)(2008-2#1)(2009-7#1)(2010-5#1)
better than approximately##2##3##(2008-2#1)(2008-3#1)
better than by##2##3##(2008-10#1)(2008-3#1)
better than chance##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
better than conventional##3##3##(2007-12#1)(2012-1#1)(2012-2#1)
better than for##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
better than in##2##3##(2007-11#1)(2011-2#1)
better than other##2##3##(2008-10#1)(2013-8#1)
better than that obtained##3##4##(2008-10#2)(2008-3#1)
better than that of the##3##5##(2008-3#2)(2009-7#1)
better than that of##13##4##(2007-11#2)(2008-1#2)(2008-10#3)(2008-3#3)(2008-8#1)(2009-7#1)(2012-1#1)
better than that##18##3##(2007-11#2)(2008-1#2)(2008-10#6)(2008-3#5)(2008-8#1)(2009-7#1)(2012-1#1)
better than the conventional##2##4##(2008-10#1)(2010-8#1)
better than the figure-of-8##2##4##(2009-3#2)
better than the other##2##4##(2012-2#1)(2013-1#1)
better than the results obtained by##2##6##(2008-10#1)(2008-2#1)
better than the results obtained##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
better than the traditional##2##4##(2010-8#1)(2013-1#1)
better than the##38##3##(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-3#2)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
better than those obtained by other##2##6##(2008-10#1)(2008-7#1)
better than those obtained by##5##5##(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
better than those obtained##8##4##(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-3#1)
better than those of the##2##5##(2007-11#1)(2008-10#1)
better than those of##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
better than those that##2##4##(2008-12#1)(2008-2#1)
better than those##20##3##(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-3#1)(2010-4#1)(2012-3#1)
better than with a##2##4##(2007-12#1)(2008-6#1)
better than with##3##3##(2007-12#1)(2007-8#1)(2008-6#1)
better than##249##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-7#1)(1993-1#1)(1993-3#3)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#4)(1995-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#15)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#66)(2008-11#1)(2008-12#3)(2008-2#21)(2008-3#45)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#3)
better the##8##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-12#1)
better therapeutic##2##2##(2008-5#1)(2010-2#1)
better to##7##2##(1997-2#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
better tolerated##6##2##(1991-9#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
better tool##2##2##(2008-1#1)(2008-10#1)
better tracking##2##2##(2008-3#2)
better trained##2##2##(1997-2#1)(2007-8#1)
better treatment and##3##3##(2007-11#1)(2008-11#1)(2010-8#1)
better treatment##6##2##(1994-3#1)(2007-11#1)(2007-5#1)(2008-11#1)(2010-8#1)(2013-1#1)
better understand and##4##3##(2007-12#1)(2008-12#1)(2010-10#1)(2012-3#1)
better understand how##7##3##(1995-5#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-9#1)(2013-1#2)
better understand if##2##3##(2012-2#1)(2013-7#1)
better understand processes##2##3##(2008-7#1)(2012-2#1)
better understand the biological##2##4##(1993-8#1)(2010-12#1)
better understand the development and perpetuation of most spinal pain and related disorders##2##13##(2008-12#2)
better understand the molecular##2##4##(2008-10#1)(2012-2#1)
better understand the physiological##2##4##(1994-6#1)(1997-2#1)
better understand the role of##3##5##(2008-11#2)(2008-7#1)
better understand the##51##3##(1990-8#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-6#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
better understand this##3##3##(2008-10#1)(2008-7#1)(2009-10#1)
better understand##82##2##(1990-8#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-9#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#2)(2009-5#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#1)
better understanding and##3##3##(1997-8#1)(2008-3#1)(2008-4#1)
better understanding of how##4##4##(2008-11#1)(2008-7#1)(2010-3#1)(2010-9#1)
better understanding of its##2##4##(2008-10#1)(2013-1#1)
better understanding of the biological##2##5##(2009-11#1)(2012-2#1)
better understanding of the dynamics of##3##6##(1997-3#1)(2008-10#1)(2010-3#1)
better understanding of the mechanisms##5##5##(2008-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
better understanding of the pathogenesis of##3##6##(1990-9#1)(2007-10#1)(2007-5#1)
better understanding of the role of##3##6##(1995-12#1)(2009-12#1)(2012-3#1)
better understanding of the##56##4##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
better understanding of##93##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
better understanding the##4##3##(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
better understanding##101##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#3)
better understood##8##2##(1992-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
better use of##6##3##(2007-11#1)(2008-1#2)(2010-9#1)(2011-1#1)(2013-8#1)
better use##7##2##(2007-11#1)(2008-1#2)(2010-9#1)(2011-1#1)(2013-8#2)
better used by##2##3##(1992-1#1)(2008-5#1)
better utility##2##2##(1992-1#1)(2008-7#1)
better utilize##2##2##(1992-1#1)(2013-1#1)
better visualization of##2##3##(2007-11#2)
better visualization##3##2##(2007-11#2)(2010-5#1)
better way of doing##2##4##(1995-2#1)(1996-3#1)
better way of##4##3##(1995-2#1)(1996-3#1)(2008-5#1)(2010-8#1)
better way##9##2##(1994-2#1)(1995-2#1)(1996-1#1)(1996-3#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)
better ways of##2##3##(1991-1#1)(1994-3#1)
better ways to##2##3##(1992-3#1)(1996-1#1)
better ways##5##2##(1991-1#1)(1992-3#1)(1994-3#1)(1996-1#1)(1996-3#1)
better when compared##2##3##(2008-10#1)(2008-5#1)
better when##6##2##(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#2)(2012-4#1)
better with the##6##3##(1995-2#1)(2007-11#1)(2007-7#1)(2008-3#1)(2009-8#1)(2011-2#1)
better with##14##2##(1991-3#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-3#1)
better##1562##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-6#4)(1990-8#2)(1990-9#5)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#11)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#8)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#4)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#6)(1993-8#3)(1993-9#1)(1994-1#7)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#8)(1995-3#5)(1995-5#7)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#8)(1996-4#4)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#7)(1997-3#12)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#6)(1997-9#1)(2006-10#3)(2006-12#1)(2007-10#9)(2007-11#43)(2007-12#36)(2007-2#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#11)(2007-8#16)(2007-9#3)(2008-1#20)(2008-10#260)(2008-11#55)(2008-12#19)(2008-2#52)(2008-3#95)(2008-4#17)(2008-5#37)(2008-6#23)(2008-7#51)(2008-8#24)(2008-9#29)(2009-1#2)(2009-10#8)(2009-11#11)(2009-12#6)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#7)(2009-6#4)(2009-7#6)(2009-8#9)(2009-9#4)(2010-1#7)(2010-10#8)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#10)(2010-4#4)(2010-5#7)(2010-6#4)(2010-7#7)(2010-8#22)(2010-9#9)(2011-1#22)(2011-2#81)(2011-3#3)(2011-7#1)(2012-1#10)(2012-12#20)(2012-2#37)(2012-3#39)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#54)(2013-7#15)(2013-8#38)
better&quot##4##1##(2008-12#4)
better?##6##1##(1992-12#1)(1992-2#1)(1994-3#2)(2007-12#1)(2009-5#1)
better?]##2##1##(1996-9#1)(2013-1#1)
bettered##2##1##(2008-3#2)
between &quot##10##2##(1993-12#2)(1993-6#1)(1994-2#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-8#1)(2010-6#1)(2012-2#1)
between (i)##2##2##(2008-10#1)(2008-3#1)
between -0##5##2##(2008-10#4)(2012-12#1)
between -698##2##2##(1997-6#2)
between 0 and 0##2##4##(2008-3#1)(2008-6#1)
between 0 and 14 years##2##5##(2013-1#1)(2013-7#1)
between 0 and 5##2##4##(2008-10#2)
between 0 and##19##3##(1990-10#1)(1994-3#1)(1996-1#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)
between 0##177##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-3#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#105)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#4)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)
between 1 January##3##3##(1990-2#1)(2011-2#1)(2012-12#1)
between 1 and 1##2##4##(1992-9#1)(2009-10#1)
between 1 and 15##2##4##(2007-8#1)(2008-10#1)
between 1 and 2##2##4##(2007-10#1)(2008-1#1)
between 1 and 4##4##4##(1993-6#1)(1993-9#1)(2008-10#1)(2011-2#1)
between 1 and 5##2##4##(1990-9#1)(2008-10#1)
between 1 and 6##2##4##(2008-3#1)(2012-2#1)
between 1 and 7##3##4##(2007-10#1)(2008-10#1)(2012-1#1)
between 1 and##36##3##(1990-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1997-2#1)(1997-4#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#2)(2009-10#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
between 1##93##2##(1990-2#1)(1990-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-8#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#45)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
between 1-[G'(1)]-1-[G'(4)]##2##2##(1996-5#2)
between 10 and 20##2##4##(2008-10#1)(2012-12#1)
between 10 and 40##2##4##(2008-10#2)
between 10 and 80##2##4##(2008-4#1)(2013-1#1)
between 10 and##23##3##(1992-12#1)(1993-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#1)
between 10##31##2##(1992-12#1)(1993-12#1)(1994-11#1)(1995-11#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#2)(2013-1#1)
between 10% and##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
between 10(-6) and##2##3##(2008-10#2)
between 10(-9) and##2##3##(2008-10#2)
between 100 °C and 140 °C##2##6##(2011-2#2)
between 100##6##2##(1994-8#1)(2007-7#1)(2008-10#2)(2011-2#2)
between 1000 and##3##3##(2007-11#1)(2008-10#2)
between 101##2##2##(2008-10#1)(2008-5#1)
between 11##4##2##(1997-4#1)(2008-10#1)(2013-8#2)
between 12 and 36##2##4##(2008-10#1)(2008-2#1)
between 12 and##9##3##(1992-11#1)(1997-3#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-7#1)
between 12 to 24##2##4##(2007-10#1)(2008-10#1)
between 12 to##3##3##(2007-10#1)(2008-10#2)
between 12##14##2##(1992-11#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)
between 1200 and##2##3##(1994-6#1)(1995-5#1)
between 13##2##2##(2008-5#1)(2013-1#1)
between 14 and##2##3##(2008-10#1)(2009-5#1)
between 14##4##2##(1996-5#1)(2008-10#2)(2009-5#1)
between 15 and##13##3##(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
between 15##15##2##(1995-12#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
between 16 and##7##3##(1997-6#1)(2008-10#4)(2009-10#1)(2012-3#1)
between 16##9##2##(1997-6#1)(2008-1#1)(2008-10#5)(2009-10#1)(2012-3#1)
between 18 and##3##3##(2007-11#1)(2008-10#2)
between 18##6##2##(2007-11#1)(2008-10#2)(2008-5#1)(2012-12#2)
between 1850 and##2##3##(2009-10#1)(2011-2#1)
between 1880 and##3##3##(2008-11#1)(2009-7#2)
between 19 and##2##3##(2008-10#1)(2011-2#1)
between 19##3##2##(2008-10#2)(2011-2#1)
between 1950 and 1985##2##4##(1990-8#2)
between 1950##3##2##(1990-8#2)(1996-1#1)
between 1963 and##2##3##(1992-9#1)(2008-10#1)
between 1970 and##2##3##(2008-7#1)(2012-12#1)
between 1976 and##2##3##(2008-7#1)(2013-1#1)
between 1978 and##4##3##(1990-3#1)(1992-2#1)(1997-5#1)(2007-11#1)
between 1979 and 2006##2##4##(2009-5#1)(2013-8#1)
between 1979 and##4##3##(2008-4#1)(2009-5#1)(2012-12#1)(2013-8#1)
between 1980 and 1990##3##4##(1992-2#1)(1993-12#1)(1997-5#1)
between 1980 and##13##3##(1992-2#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-8#2)(2009-7#1)(2010-3#1)(2010-7#1)(2012-2#1)
between 1981 and##4##3##(1991-2#1)(1992-12#1)(2008-10#1)(2012-3#1)
between 1981/1982 and 1991/1992##2##4##(2009-10#2)
between 1982 and 1987##2##4##(1990-11#1)(2008-11#1)
between 1982 and##4##3##(1990-11#1)(1997-6#1)(2008-11#1)(2013-1#1)
between 1983##2##2##(1992-1#1)(2008-6#1)
between 1984 and##5##3##(1991-6#1)(1992-12#2)(1995-12#1)(1996-3#1)
between 1985 and 1989##2##4##(1990-9#1)(1991-8#1)
between 1985 and##7##3##(1990-9#1)(1991-8#1)(1997-6#1)(1997-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
between 1986 and 1988##2##4##(1992-2#1)(1993-1#1)
between 1986 and 1990##2##4##(1992-8#1)(1993-9#1)
between 1986 and##7##3##(1992-2#1)(1992-8#1)(1993-1#1)(1993-9#2)(1994-6#1)(2013-1#1)
between 1987 and 1991##2##4##(1992-6#1)(1993-9#1)
between 1987 and##8##3##(1991-12#1)(1992-2#1)(1992-6#1)(1993-9#1)(1996-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
between 1988 and 2000##2##4##(1991-1#2)
between 1988 and##7##3##(1991-1#2)(1994-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
between 1989 and##3##3##(1992-4#1)(2008-10#1)(2009-7#1)
between 1990 and 2000##2##4##(2007-8#1)(2008-9#1)
between 1990 and##9##3##(1996-11#1)(2007-8#1)(2008-10#1)(2008-9#2)(2012-1#1)(2012-3#1)(2013-1#2)
between 1991 and##5##3##(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
between 1992 and##4##3##(1995-12#1)(2006-12#1)(2012-3#1)(2013-1#1)
between 1993 and##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
between 1994 and 2005##2##4##(2008-1#1)(2009-9#1)
between 1994 and##7##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)
between 1995 and 1998##2##4##(2008-10#1)(2008-5#1)
between 1995 and 2001##2##4##(2007-8#1)(2009-3#1)
between 1995 and##9##3##(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
between 1996 and##3##3##(2008-10#1)(2011-2#1)(2012-6#1)
between 1997 and 2002##2##4##(2007-11#1)(2007-5#1)
between 1997 and 2007##2##4##(2011-2#1)(2012-12#1)
between 1997 and##6##3##(2007-11#1)(2007-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
between 1998 and 2002##2##4##(2008-10#2)
between 1998 and 2004##2##4##(2008-11#1)(2012-12#1)
between 1998 and 2006##2##4##(2008-12#1)(2008-9#1)
between 1998 and 2008##2##4##(2011-2#2)
between 1998 and##10##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#2)(2012-12#2)
between 1999 and 2002##3##4##(2007-11#1)(2007-7#1)(2008-10#1)
between 1999 and##5##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
between 1st##2##2##(1997-3#1)(2010-5#1)
between 1x10(-6) and##2##3##(2008-10#2)
between 2 and 10##2##4##(2008-10#2)
between 2 and 3##3##4##(2007-10#2)(2009-4#1)
between 2 and 5##2##4##(2008-3#1)(2009-11#1)
between 2 and 6##2##4##(1997-3#1)(2013-1#1)
between 2 and 8##2##4##(1995-6#1)(2007-12#1)
between 2 and##22##3##(1995-6#1)(1997-3#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-11#1)(2009-4#1)(2011-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
between 2 days and##2##4##(1996-5#1)(2007-12#1)
between 2##49##2##(1991-5#1)(1994-11#1)(1994-5#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#3)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-1#1)(2011-10#1)(2011-2#1)(2013-1#1)(2013-7#2)
between 20 and 30##3##4##(1994-3#1)(2008-2#1)(2011-2#1)
between 20 and##14##3##(1990-5#1)(1992-12#1)(1994-3#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
between 20##17##2##(1990-5#1)(1992-12#1)(1994-3#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
between 20% and##2##3##(1995-3#1)(2009-5#1)
between 20-25 km altitude##2##4##(2012-2#2)
between 20-30##3##2##(1992-5#1)(2012-12#1)(2013-8#1)
between 200 and##3##3##(2008-10#2)(2008-2#1)
between 200##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-2#1)
between 2000 and 2004 in##2##5##(2008-11#1)(2011-2#1)
between 2000 and 2004##5##4##(2008-11#3)(2009-10#1)(2011-2#1)
between 2000 and 2010##7##4##(2013-1#1)(2013-8#6)
between 2000 and##20##3##(2008-10#2)(2008-11#5)(2009-10#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#7)
between 2001 and 2003##3##4##(2008-10#1)(2008-12#1)(2010-3#1)
between 2001 and##7##3##(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
between 2002 and 2003##2##4##(2008-5#1)(2011-2#1)
between 2002 and 2005##2##4##(2008-10#1)(2010-3#1)
between 2002 and 2008##2##4##(2009-6#1)(2012-3#1)
between 2002 and##7##3##(2008-10#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
between 2004 and 2008##2##4##(2012-3#1)(2013-8#1)
between 2004 and##4##3##(2008-12#1)(2012-3#2)(2013-8#1)
between 2005 and 2006##2##4##(2008-12#1)(2012-3#1)
between 2005 and 2008##3##4##(2010-11#1)(2011-3#1)(2012-12#1)
between 2005 and 2011##3##4##(2012-12#2)(2013-1#1)
between 2005 and##10##3##(2008-12#1)(2010-11#1)(2010-8#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
between 2006 and 2008##2##4##(2010-4#1)(2013-1#1)
between 2006 and 2010##5##4##(2012-12#2)(2013-1#2)(2013-8#1)
between 2006 and##9##3##(2010-4#2)(2010-7#1)(2012-12#2)(2013-1#3)(2013-8#1)
between 2007 and##2##3##(2012-12#1)(2012-3#1)
between 2008 and 2009##2##4##(2013-1#2)
between 2008 and##3##3##(2013-1#3)
between 21##4##2##(2007-11#1)(2012-12#2)(2012-3#1)
between 210##2##2##(1994-9#1)(1997-2#1)
between 22 and##2##3##(1993-3#1)(2008-10#1)
between 22##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
between 24 and##3##3##(2007-11#1)(2008-6#1)(2008-7#1)
between 25 and 50%##3##4##(2008-7#3)
between 25 and##11##3##(1992-10#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#3)(2012-3#1)(2013-1#1)
between 25##15##2##(1992-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2012-3#1)(2013-1#3)
between 26 and##2##3##(1996-11#1)(2010-3#1)
between 27 and##2##3##(2010-3#1)(2011-2#1)
between 28 and##2##3##(2008-12#1)(2008-7#1)
between 29 and##2##3##(1993-5#1)(1996-9#1)
between 2D##2##2##(2008-2#1)(2008-4#1)
between 2x10(-6) and##2##3##(2008-10#2)
between 3 and 6##4##4##(1994-9#1)(2007-10#1)(2008-11#1)(2008-7#1)
between 3 and 7##2##4##(2008-5#1)(2008-7#1)
between 3 and##13##3##(1994-9#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-4#1)
between 3##30##2##(1993-3#1)(1994-9#1)(1996-5#1)(1997-9#1)(2006-10#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#2)(2010-4#1)(2011-1#1)
between 30 and 40##2##4##(2008-10#1)(2008-5#1)
between 30 and 49 years of age##2##7##(2007-2#1)(2011-2#1)
between 30 and 49##3##4##(2007-2#1)(2010-8#1)(2011-2#1)
between 30 and 70%##2##4##(2008-10#1)(2008-5#1)
between 30 and##14##3##(1991-11#1)(1995-11#1)(1996-2#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-8#1)(2011-2#1)
between 30 to##2##3##(2008-10#1)(2012-12#1)
between 30##17##2##(1991-11#1)(1995-11#1)(1996-2#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-12#1)
between 30% and 60%##2##4##(1994-2#1)(2009-10#1)
between 300 and##3##3##(2008-10#2)(2008-2#1)
between 300##4##2##(2008-10#2)(2008-11#1)(2008-2#1)
between 32 and##3##3##(1996-11#1)(2008-10#1)(2009-5#1)
between 33 and##2##3##(1996-2#1)(2008-10#1)
between 35 and##4##3##(1990-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
between 36##2##2##(1990-3#1)(2008-10#1)
between 38 and##2##3##(2008-10#2)
between 4 and 10##3##4##(1990-7#1)(2008-10#1)(2008-9#1)
between 4 and 20##2##4##(2008-10#2)
between 4 and 28 months##2##5##(1990-3#1)(2008-6#1)
between 4 and 8##2##4##(1996-12#1)(2008-10#1)
between 4 and 9 months of age in B10##2##9##(1990-3#2)
between 4 and##23##3##(1990-3#3)(1990-7#1)(1993-9#1)(1996-12#1)(1996-3#1)(2007-9#1)(2008-10#11)(2008-6#1)(2008-9#2)(2013-1#1)
between 4##35##2##(1990-3#3)(1990-7#1)(1993-9#1)(1996-12#2)(1996-3#1)(1997-5#1)(2007-9#1)(2008-10#12)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2011-1#1)(2012-3#2)(2013-1#3)
between 40 and 75 years##2##5##(1990-9#2)
between 40 and##10##3##(1990-5#1)(1990-9#2)(1992-7#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-3#1)(2012-12#1)
between 400 and 700 nm##2##5##(2008-2#1)(2008-3#1)
between 400 and##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
between 4000 and##2##3##(2008-10#1)(2008-11#1)
between 41 and##2##3##(2008-11#1)(2010-8#1)
between 42 degrees C and##2##5##(1991-5#1)(1994-12#1)
between 42##3##2##(1991-5#2)(1994-12#1)
between 420 and##2##3##(2008-10#1)(2008-2#1)
between 45 and 65 years##2##5##(1993-9#1)(2008-5#1)
between 45 and##4##3##(1990-5#1)(1991-3#1)(1993-9#1)(2008-5#1)
between 45##5##2##(1990-5#1)(1991-3#1)(1993-9#1)(2008-10#1)(2008-5#1)
between 5 and 10##2##4##(2008-10#1)(2008-11#1)
between 5 and 100 mg l(-1)##2##6##(2008-10#2)
between 5 and 20##4##4##(1995-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
between 5 and##21##3##(1995-3#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2011-1#1)(2011-2#1)
between 5##35##2##(1990-12#1)(1994-11#1)(1995-3#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
between 5% and##2##3##(2008-3#1)(2008-8#1)
between 5-HT##2##2##(2008-7#1)(2012-12#1)
between 50 and##11##3##(1993-2#1)(1995-2#1)(2008-10#5)(2008-3#1)(2010-3#1)(2010-8#1)(2012-12#1)
between 50##13##2##(1990-12#1)(1993-2#1)(1995-2#1)(2008-10#5)(2008-3#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
between 50% and##2##3##(1990-8#1)(2013-1#1)
between 51##2##2##(2008-10#1)(2013-7#1)
between 53 and##2##3##(1993-9#1)(2008-7#1)
between 6 and 10##2##4##(1997-6#1)(2007-10#1)
between 6 and 14##2##4##(2008-10#1)(2013-1#1)
between 6 and 8##3##4##(1990-2#1)(1997-3#1)(2008-10#1)
between 6 and##12##3##(1990-2#1)(1992-9#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-9#1)(2009-5#2)(2013-1#1)
between 6 months##2##3##(2007-11#1)(2008-5#1)
between 6##17##2##(1990-2#1)(1992-9#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-5#2)(2011-1#1)(2013-1#1)
between 60 and##4##3##(1996-6#1)(2008-10#1)(2008-6#1)(2011-2#1)
between 60##5##2##(1996-6#1)(2008-10#1)(2008-6#1)(2011-2#2)
between 65 and##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
between 68##2##2##(1990-12#1)(1994-9#1)
between 7 and##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2010-6#1)
between 7##13##2##(1992-3#1)(1993-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2010-6#1)(2012-12#1)
between 70 and##3##3##(2008-10#3)
between 70##4##2##(2008-10#3)(2009-3#1)
between 75##2##2##(2008-10#1)(2008-8#1)
between 79 and##2##3##(2008-10#2)
between 79##3##2##(2008-10#3)
between 8 and 12 years of age##2##7##(1991-2#1)(2009-10#1)
between 8 and 12##3##4##(1991-2#1)(2008-10#1)(2009-10#1)
between 8 and##8##3##(1991-2#1)(1991-5#1)(1993-12#1)(1995-8#1)(2008-10#2)(2009-10#1)(2011-2#1)
between 8##13##2##(1991-2#1)(1991-5#1)(1993-12#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
between 80 and 90##2##4##(2010-5#1)(2011-1#1)
between 80 and##9##3##(1991-6#1)(1992-11#1)(2008-10#4)(2010-5#1)(2011-1#1)(2013-1#1)
between 800 and##2##3##(2008-10#2)
between 82 and##2##3##(2008-10#1)(2008-2#1)
between 85##3##2##(2007-11#1)(2008-10#2)
between 86##4##2##(2008-10#4)
between 9 and##5##3##(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
between 9##11##2##(1996-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
between 90 and##2##3##(2008-10#1)(2008-7#1)
between 90##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
between 91 and##2##3##(2008-10#2)
between 91##3##2##(2008-10#3)
between 92 and##5##3##(2008-10#5)
between 92##9##2##(2008-10#8)(2008-5#1)
between 93 and##3##3##(2008-10#3)
between 93##4##2##(2008-10#4)
between 94 and##2##3##(2008-10#2)
between 94##3##2##(2008-10#3)
between 95 and 100%##2##4##(2008-10#1)(2012-12#1)
between 95 and##5##3##(2008-10#4)(2012-12#1)
between 95##11##2##(2008-10#9)(2011-1#1)(2012-12#1)
between 96 and##4##3##(2008-10#4)
between 96##7##2##(2008-10#7)
between 97 and##4##3##(2008-10#4)
between 97##10##2##(2008-10#10)
between 98 and##2##3##(2008-10#2)
between 98##8##2##(2008-10#8)
between 99##3##2##(1995-2#1)(2008-10#2)
between A and B##2##4##(1990-12#1)(2008-6#1)
between A and##5##3##(1990-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)
between A##8##2##(1990-12#1)(1996-2#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-1#1)
between A/Zhejiang/18/98 and##3##3##(2011-1#3)
between A59 and RI##2##4##(1997-3#2)
between AA##2##2##(2006-10#1)(2008-10#1)
between AD patients and##2##4##(2008-7#1)(2012-2#1)
between ADT and##2##3##(2008-2#2)
between ARMD and##2##3##(2011-2#2)
between ASY and##2##3##(2008-9#2)
between Acridine Orange and Safranine T##3##6##(2008-10#3)
between Afro-Andean and Andean isolates from Africa##2##7##(2008-10#2)
between Afro-Andean##3##2##(2008-10#3)
between American##3##2##(1993-3#2)(2008-9#1)
between April##7##2##(1993-2#1)(1993-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2010-10#1)(2012-3#1)
between Arg##2##2##(1992-6#1)(1995-5#1)
between August##4##2##(1992-1#1)(2006-10#1)(2008-10#1)(2012-3#1)
between B##5##2##(1990-12#1)(1995-5#1)(2008-10#2)(2008-9#1)
between BALB/c and##2##3##(1996-12#1)(2008-12#1)
between BALB/cJ (mean##3##3##(2008-5#3)
between BM##2##2##(1991-8#1)(2010-9#1)
between BMD##2##2##(2011-2#2)
between BMI and##5##3##(2007-12#1)(2007-8#1)(2008-3#1)(2009-7#1)(2011-2#1)
between C##7##2##(1992-6#1)(1993-9#1)(2007-10#1)(2008-10#3)(2008-8#1)
between CA[n]##2##2##(2008-10#2)
between CCP and TAMRA##2##4##(2009-8#2)
between CEVd and##2##3##(2008-10#2)
between CMV and##2##3##(2008-10#1)(2010-12#1)
between CMV##3##2##(2007-7#1)(2008-10#1)(2010-12#1)
between CT##2##2##(1997-7#1)(2010-8#1)
between Canadian##2##2##(2008-10#1)(2008-11#1)
between Caucasians and##2##3##(2008-1#2)
between Chinese##3##2##(1995-6#1)(2008-8#1)(2011-1#1)
between D##4##2##(1992-6#1)(2008-10#2)(2008-5#1)
between DATA1 and DATA2##2##4##(2012-2#2)
between DNA and##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
between DNA##11##2##(1993-3#1)(1994-12#1)(1995-4#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-1#2)(2013-8#1)
between DNAs##2##2##(1994-8#1)(2009-6#1)
between DON and##4##3##(2008-10#4)
between December##6##2##(1997-3#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#2)
between Drosophila##2##2##(2008-7#1)(2008-9#1)
between E##4##2##(1995-6#1)(1996-12#1)(2008-9#2)
between EAS and ENA and between EAS and WNA##2##9##(2008-8#2)
between EAS and ENA##4##4##(2008-8#4)
between EAS and WNA##3##4##(2008-8#3)
between EAS and##7##3##(2008-8#7)
between EAS##8##2##(2008-8#8)
between EH and##2##3##(2008-9#2)
between ENA and WNA##2##4##(2008-8#2)
between EV71##3##2##(2013-8#3)
between Eastern##2##2##(2008-8#1)(2009-10#1)
between Eu(3+)##2##2##(2007-12#1)(2008-10#1)
between F##5##2##(2007-6#1)(2008-10#4)
between Fe(II) and##2##3##(2008-10#2)
between February and September##2##4##(1997-3#1)(2008-3#1)
between February and##3##3##(1996-6#1)(1997-3#1)(2008-3#1)
between February##6##2##(1994-12#1)(1996-6#1)(1997-3#1)(2008-3#1)(2011-2#2)
between G##2##2##(2008-7#1)(2008-9#1)
between GM2##2##2##(1996-5#2)
between GPs##2##2##(2008-3#2)
between GT##2##2##(2008-5#1)(2009-10#1)
between German and English##2##4##(2007-10#1)(2008-2#1)
between Group##2##2##(1993-2#2)
between Groups##2##2##(2010-12#1)(2010-7#1)
between Grx5 and##2##3##(2008-7#2)
between H##8##2##(2008-1#1)(2008-10#1)(2008-5#2)(2013-1#3)(2013-7#1)
between HBV##4##2##(2008-8#1)(2011-1#2)(2013-8#1)
between HIV and##2##3##(2007-7#1)(2008-6#1)
between HIV##6##2##(1993-11#1)(2007-7#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-8#1)
between HMG proteins and the##2##5##(2008-8#2)
between HMO##3##2##(1991-3#1)(1997-2#1)(2008-11#1)
between HPLC and##2##3##(2008-10#1)(2011-1#1)
between HPLC##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
between Hispanic and##2##3##(2008-9#1)(2012-12#1)
between I and##2##3##(2008-10#1)(2010-4#1)
between I##6##2##(2007-2#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#2)
between IA and OA##2##4##(2010-8#2)
between ICP-MS and##2##3##(2008-10#2)
between IGF-I##3##2##(2010-8#2)(2011-1#1)
between IP3- and Ca(2+)-sensitive##2##4##(1996-5#2)
between IR##3##2##(2007-12#1)(2012-5#1)(2013-8#1)
between JF and P##2##4##(2008-5#2)
between January 1##6##3##(2009-6#1)(2011-2#5)
between January 1985 and##2##4##(1992-10#1)(1995-5#1)
between January 1990 and##2##4##(1994-12#1)(2007-8#1)
between January 1991 and##2##4##(2008-7#1)(2013-8#1)
between January 1993 and##2##4##(1996-2#1)(2008-9#1)
between January 2000 and December##2##5##(2007-8#1)(2008-8#1)
between January 2000 and##3##4##(2007-10#1)(2007-8#1)(2008-8#1)
between January 2001 and##3##4##(2007-7#1)(2008-1#1)(2012-2#1)
between January 2002 and December##2##5##(2010-11#1)(2013-1#1)
between January 2002 and##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
between January and December##2##4##(2008-11#1)(2008-6#1)
between January and##5##3##(1994-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
between January##40##2##(1991-2#1)(1992-10#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
between Japanese Black and##2##4##(2013-1#2)
between Japanese##4##2##(2008-12#1)(2012-1#1)(2013-1#2)
between July and##2##3##(2008-5#2)
between July##7##2##(1991-1#1)(1993-12#1)(2007-10#1)(2007-7#1)(2008-5#2)(2008-6#1)
between June and##2##3##(1994-9#1)(2008-10#1)
between June##6##2##(1994-9#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
between L##3##2##(2008-10#3)
between L-arginine and the##2##4##(1991-9#2)
between Lysholm##2##2##(2013-1#2)
between M##2##2##(2008-10#1)(2012-3#1)
between MALT and PLA##2##4##(2008-5#2)
between MMRPE##2##2##(2013-1#2)
between MRI and##2##3##(2007-4#1)(2012-12#1)
between MS##2##2##(1995-12#1)(2012-3#1)
between March 1995 and##2##4##(2008-7#1)(2010-3#1)
between March##4##2##(2007-5#1)(2008-5#1)(2008-7#1)(2010-3#1)
between May and July##2##4##(2007-7#1)(2008-12#1)
between May and##3##3##(1996-11#1)(2007-7#1)(2008-12#1)
between May##6##2##(1996-11#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2013-7#1)
between N##2##2##(2008-10#2)
between N-terminal pro-B-type natriuretic peptide##3##5##(2011-2#2)(2012-2#1)
between N-terminal##4##2##(2008-8#1)(2011-2#2)(2012-2#1)
between November 2002 and##2##4##(2009-3#1)(2012-3#1)
between November 2007 and##2##4##(2011-2#1)(2013-7#1)
between November##9##2##(2007-10#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
between ON and OFF states##2##5##(2008-7#2)
between OPG##2##2##(2013-8#2)
between October 1##2##3##(2007-10#2)
between October##3##2##(2007-10#2)(2007-8#1)
between P##11##2##(2008-10#9)(2008-6#1)(2008-7#1)
between PKC##2##2##(1994-2#1)(2008-8#1)
between PM##2##2##(2008-6#1)(2008-7#1)
between PM10 and##2##3##(2011-2#2)
between PM10##3##2##(2011-2#3)
between PTH and##2##3##(2011-1#2)
between Pb##2##2##(2008-10#2)
between Pipizini and##2##3##(2008-8#2)
between Plecoptera and##3##3##(2007-12#3)
between R##4##2##(2008-10#3)(2008-8#1)
between RFLP##2##2##(2008-10#1)(2008-9#1)
between RNA##2##2##(1992-8#1)(2012-3#1)
between Rpc1 and the##2##4##(2008-10#2)
between S##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
between SNPs##2##2##(2008-10#1)(2010-12#1)
between SPL and##2##3##(2011-1#2)
between Savannah and Genghis##2##4##(2008-10#2)
between September 2007 and##2##4##(2011-2#1)(2012-2#1)
between September and##2##3##(2008-10#2)
between September##7##2##(2008-10#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
between South##2##2##(2008-10#1)(2011-2#1)
between T and##2##3##(1991-8#1)(2008-4#1)
between T##5##2##(1991-8#1)(2007-12#1)(2008-10#2)(2008-4#1)
between T-SR values and##2##4##(1994-7#2)
between T2 and T3##2##4##(1990-6#1)(1991-8#1)
between TB and##2##3##(2008-10#1)(2009-4#1)
between TB##3##2##(2008-10#1)(2009-4#1)(2010-5#1)
between TE and TM##2##4##(2007-11#1)(2008-3#1)
between TJ and anchoring junction##2##5##(2009-10#2)
between TNT and##2##3##(2008-10#2)
between TPA and CA15##2##4##(1990-8#2)
between TPA and##3##3##(1990-8#3)
between Th##3##2##(2008-10#1)(2008-5#2)
between Trichoderma spp##2##3##(2008-10#2)
between US-1 and##3##3##(2008-10#3)
between V##3##2##(2008-10#3)
between Verticillium##2##2##(2008-10#2)
between WM##2##2##(2010-7#1)(2012-2#1)
between a Triticum isolate##2##4##(2008-10#2)
between a disposable electrochemical DNA biosensor and a Vibrio fischeri-based luminescent sensor for the detection of toxicants in water samples##2##20##(2008-10#2)
between a few##2##3##(2008-3#1)(2012-1#1)
between a group##2##3##(1991-3#1)(2010-2#1)
between a health maintenance organization##2##5##(1992-2#1)(1994-12#1)
between a health##3##3##(1992-2#1)(1994-12#1)(1996-3#1)
between a high##3##3##(1990-8#1)(1990-9#1)(1994-6#1)
between a new and a familiar##2##6##(1992-10#2)
between a new##3##3##(1992-10#2)(2008-12#1)
between a porous##2##3##(2008-5#1)(2010-2#1)
between a single##2##3##(2008-10#1)(2008-11#1)
between a wide range of##2##5##(2008-10#2)
between a##141##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-6#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#1)(2008-10#28)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
between abnormal##2##2##(1995-2#1)(2009-10#1)
between absolute##2##2##(2007-10#1)(2008-12#1)
between absorbance and analyte concentration##2##5##(2008-10#2)
between absorbance##4##2##(2008-10#4)
between abundance##2##2##(2008-8#1)(2012-6#1)
between academic institutions##2##3##(2009-12#1)(2010-3#1)
between academic##5##2##(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-3#1)
between academics and##2##3##(1993-12#1)(1995-12#1)
between accuracy##2##2##(1993-12#1)(2008-3#1)
between acid##2##2##(1992-3#1)(2010-12#1)
between actin and##2##3##(1990-2#1)(1994-8#1)
between activated##2##2##(1990-2#1)(1991-2#1)
between active and inactive##2##4##(1994-12#1)(2008-10#1)
between active and passive##2##4##(1995-8#1)(2008-2#1)
between active and##4##3##(1994-12#1)(1995-8#1)(2008-10#1)(2008-2#1)
between active##5##2##(1994-12#1)(1995-8#1)(2008-10#2)(2008-2#1)
between activity##3##2##(1995-12#1)(2007-8#1)(2008-5#1)
between acute##5##2##(1993-6#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
between adjacent cells##2##3##(1994-6#1)(1996-8#1)
between adjacent domains##2##3##(1992-4#1)(2007-12#1)
between adjacent images##2##3##(2008-3#2)
between adjacent laminar flows in##2##5##(2008-10#2)
between adjacent laminar flows##3##4##(2008-10#3)
between adjacent pixels##2##3##(2013-8#2)
between adjacent pulses##3##3##(2007-11#1)(2007-12#2)
between adjacent##27##2##(1992-4#1)(1994-5#1)(1994-6#1)(1996-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2009-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
between admission##2##2##(1990-2#1)(2012-2#1)
between adolescent##2##2##(2007-12#1)(2009-8#1)
between adolescents##2##2##(2011-1#1)(2013-1#1)
between adult and##2##3##(1997-2#1)(2008-8#1)
between adult##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
between adults##2##2##(1994-3#1)(2010-3#1)
between age and##6##3##(1991-12#1)(1996-5#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
between age groups##4##3##(1991-12#1)(1996-6#1)(2008-7#1)(2012-3#1)
between age##17##2##(1991-12#2)(1996-5#1)(1996-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2011-2#3)(2012-12#1)(2012-3#1)
between ages##3##2##(1991-5#1)(1992-1#1)(1995-10#1)
between aging##2##2##(1993-12#1)(1994-5#1)
between albuminuria##3##2##(1992-9#2)(2008-7#1)
between alcohol##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
between alcoholics and##2##3##(1993-2#1)(1997-5#1)
between alfalfa##2##2##(2008-10#1)(2011-2#1)
between all groups##2##3##(1992-9#1)(2013-1#1)
between all the##2##3##(2008-10#1)(2012-3#1)
between all##20##2##(1992-9#1)(1993-2#1)(1994-12#1)(1995-2#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
between alleles##3##2##(1997-5#1)(2008-10#1)(2008-8#1)
between alpha-cyclodextrin##2##2##(2008-10#2)
between alpha-helix##3##2##(1992-6#1)(1995-2#1)(1995-5#1)
between alterations##2##2##(2008-10#1)(2013-8#1)
between alternate##2##2##(2007-12#1)(2008-3#1)
between ambient##2##2##(2008-11#2)
between amino acids##3##3##(1991-12#1)(1993-3#1)(1995-11#1)
between an aqueous##3##3##(2008-10#3)
between an##45##2##(1990-8#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-12#1)(1997-2#1)(2007-11#6)(2007-12#2)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-8#2)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
between analogous##2##2##(1995-5#1)(2008-5#1)
between analyses##2##2##(2008-10#2)
between analytical##3##2##(2008-10#3)
between and among##2##3##(1997-1#1)(2009-11#1)
between and within##5##3##(1993-12#1)(2007-7#1)(2008-10#2)(2008-9#1)
between and##12##2##(1993-12#1)(1993-2#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-11#1)(2010-11#1)
between anger intensity and the##2##5##(2010-11#2)
between anger##3##2##(2010-11#3)
between animal##4##2##(2007-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
between animals##5##2##(1995-5#1)(1996-5#1)(2008-8#1)(2009-6#1)(2012-2#1)
between antibodies##2##2##(1991-3#1)(1995-2#1)
between antibody##4##2##(1997-6#1)(2008-1#1)(2008-11#1)(2009-11#1)
between anticipating and lag synchronization##2##5##(2007-11#2)
between antigenically##3##2##(2008-10#1)(2011-2#2)
between antihypertensive##2##2##(1992-8#1)(2008-3#1)
between antineoplastic##2##2##(1994-7#1)(2007-11#1)
between anxiety##3##2##(2009-6#1)(2009-7#1)(2013-8#1)
between any two isolates##2##4##(2008-10#1)(2008-5#1)
between any two##7##3##(1990-11#1)(1990-7#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
between any##9##2##(1990-11#1)(1990-7#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-3#1)
between apo(a) and LDL##2##4##(1995-6#2)
between appearance and##2##3##(2008-11#1)(2008-9#1)
between appearance##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
between approximately##2##2##(2008-10#2)
between aqueous and##4##3##(1990-5#1)(2008-10#3)
between aqueous##5##2##(1990-5#1)(2008-10#4)
between arc##2##2##(2008-10#1)(2013-8#1)
between areas##2##2##(2010-6#1)(2011-2#1)
between aromatic##2##2##(2008-10#2)
between assessment##2##2##(2008-10#1)(2009-9#1)
between astrocytes and##3##3##(2008-4#1)(2009-3#1)(2013-7#1)
between astrocytes##6##2##(2008-4#2)(2008-7#2)(2009-3#1)(2013-7#1)
between atherosclerosis and osteoporosis##2##4##(2012-2#2)
between attachment avoidance and##2##4##(2010-8#2)
between attachment##4##2##(2010-8#3)(2012-1#1)
between autotriploid and diploid##2##4##(2009-12#2)
between auxiliary friendship and health status##2##6##(2010-2#2)
between average##2##2##(2008-2#1)(2008-8#1)
between avidin and##2##3##(2008-10#1)(2008-12#1)
between bacteria and##2##3##(1991-3#1)(2006-6#1)
between bacterial##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
between bare##2##2##(2007-5#1)(2008-3#1)
between baseline##5##2##(1995-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
between basic and clinical##2##4##(1994-12#1)(2008-5#1)
between basic##5##2##(1990-2#1)(1992-12#1)(1994-12#1)(2008-5#1)(2008-9#1)
between batches##2##2##(2008-11#1)(2008-5#1)
between bedside##2##2##(1996-1#1)(2009-11#1)
between before##2##2##(2010-6#1)(2013-1#1)
between behavioral##2##2##(2008-8#2)
between being##2##2##(2009-7#1)(2011-2#1)
between benign and malignant endometrial##2##5##(1995-3#2)
between benign and malignant##3##4##(1995-3#2)(2012-2#1)
between benign and##5##3##(1995-3#2)(2010-3#1)(2012-2#1)(2013-8#1)
between benzene and water##2##4##(2008-10#2)
between biliverdin and bovine serum albumin##2##6##(2008-10#2)
between biological##6##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
between biologists##2##2##(2008-7#2)
between biology and##2##3##(2008-10#1)(2013-1#1)
between biotin and##2##3##(2008-10#1)(2008-9#1)
between bipolar##2##2##(1996-7#1)(1997-5#1)
between birth and##2##3##(1994-7#1)(1996-5#1)
between blacks and##2##3##(2010-2#1)(2011-2#1)
between blood and##2##3##(2008-10#1)(2009-12#1)
between blood pressure##2##3##(2012-2#1)(2013-8#1)
between blood##6##2##(2008-10#1)(2009-12#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
between body mass index##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
between body##14##2##(1992-3#1)(1997-8#1)(2007-12#2)(2008-10#1)(2009-5#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
between bone##5##2##(1993-11#1)(2007-8#1)(2009-7#1)(2010-8#1)(2013-1#1)
between both approaches##2##3##(2008-10#1)(2011-2#1)
between both factors##2##3##(2008-10#1)(2013-8#1)
between both groups was##2##4##(2008-10#1)(2008-5#1)
between both groups##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
between both methods were##2##4##(2008-10#2)
between both methods##4##3##(2008-10#3)(2010-12#1)
between both occasions##2##3##(2008-10#2)
between both the##2##3##(1990-5#1)(2009-8#1)
between both##45##2##(1990-5#2)(1991-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#1)
between bound BTX and##2##4##(2008-8#2)
between boys and##2##3##(2010-3#1)(2013-8#1)
between boys##3##2##(2009-5#1)(2010-3#1)(2013-8#1)
between bp##3##2##(1990-5#1)(1991-6#1)(1996-5#1)
between brain##7##2##(1995-5#1)(1996-5#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
between breast cancer and##2##4##(2008-5#1)(2013-1#1)
between breastfeeding duration##2##3##(2008-10#1)(2010-6#1)
between breastfeeding##5##2##(2008-10#2)(2010-6#3)
between breeds##4##2##(1995-2#2)(1996-12#1)(2010-4#1)
between bud##2##2##(2008-10#2)
between bulk##2##2##(2007-12#1)(2008-3#1)
between bystander##2##2##(2008-7#2)
between calculated and experimental##2##4##(2008-2#1)(2008-3#1)
between calculated and##4##3##(1997-2#1)(2008-2#1)(2008-3#2)
between calculated##5##2##(1997-2#1)(2008-2#1)(2008-3#3)
between cancer patients and##3##4##(1996-3#1)(2013-1#2)
between cancer##8##2##(1991-3#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
between cankers on small branches##2##5##(2008-10#2)
between carboxylic##2##2##(2008-10#1)(2010-4#1)
between cardiovascular##4##2##(2006-10#1)(2010-5#1)(2013-8#2)
between caregiver and professional perceptions of##2##6##(1996-1#2)
between caregivers##4##2##(2008-7#1)(2010-2#1)(2013-1#2)
between caries##2##2##(2010-3#1)(2012-2#1)
between case and control groups##2##5##(2007-2#2)
between cases with and without##2##5##(2012-2#1)(2013-1#1)
between cases##3##2##(1990-8#1)(2012-2#1)(2013-1#1)
between catalytic##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
between causal##2##2##(1991-9#1)(2012-12#1)
between cell cycle##2##3##(2008-11#1)(2008-7#1)
between cell types##2##3##(1991-9#1)(2013-1#1)
between cell##17##2##(1991-9#1)(1993-3#1)(2007-12#1)(2008-11#6)(2008-7#2)(2008-9#3)(2009-5#1)(2012-2#1)(2013-1#1)
between cells and their extracellular substrates##2##6##(2011-1#2)
between cells and their extracellular##3##5##(2011-1#3)
between cells and their##4##4##(2010-10#1)(2011-1#3)
between cells and##7##3##(1994-6#1)(2008-1#1)(2010-10#1)(2011-1#3)(2013-1#1)
between cells##16##2##(1994-6#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-1#3)(2013-1#1)
between cellular compartments##2##3##(2008-1#1)(2008-7#1)
between cellular##3##2##(1995-2#1)(2008-1#1)(2008-7#1)
between central and##2##3##(2008-3#1)(2009-8#1)
between cerebral##4##2##(1995-11#1)(1996-6#1)(2008-7#2)
between certain##2##2##(1993-2#1)(2008-9#1)
between chains decreased##2##3##(2008-8#1)(2008-9#1)
between changes in##8##3##(1991-12#1)(1992-6#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-8#3)
between chaotic##2##2##(2007-11#1)(2008-11#1)
between chemical and##2##3##(2008-10#2)
between chemical##6##2##(1995-11#1)(1997-2#1)(2008-10#3)(2013-7#1)
between child and parent##3##4##(1995-12#1)(2008-3#2)
between child##6##2##(1995-12#1)(1995-2#1)(2008-12#1)(2008-3#2)(2009-5#1)
between childhood oral diseases and obesity##2##6##(2010-3#2)
between childhood##5##2##(2008-11#2)(2009-7#1)(2010-3#2)
between children with##2##3##(2011-1#1)(2011-2#1)
between children##8##2##(1992-4#1)(1994-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
between children's##3##2##(1995-2#1)(2008-12#1)(2012-2#1)
between cholesterol and##2##3##(2008-10#1)(2013-1#1)
between cholesterol##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
between chronic##8##2##(1993-11#1)(1996-6#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
between circulating##2##2##(2008-10#1)(2013-7#1)
between citrus viroids##2##3##(2008-10#2)
between citrus##3##2##(2008-10#2)(2011-2#1)
between classical and##2##3##(2008-3#1)(2008-9#1)
between classical##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
between clinical and##5##3##(2007-9#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
between clinical practice##2##3##(1993-3#1)(2012-3#1)
between clinical##18##2##(1991-6#2)(1993-3#2)(1995-6#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
between clinicians and##3##3##(2007-11#1)(2009-9#1)(2011-1#1)
between clinicians##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2009-9#1)(2011-1#1)
between closely related##2##3##(2008-4#1)(2008-9#1)
between closely similar DNA sequences##3##5##(2008-4#1)(2008-9#2)
between closely##7##2##(2008-3#1)(2008-4#2)(2008-9#3)(2012-3#1)
between coding##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
between cognitive##2##2##(2008-9#1)(2013-8#1)
between colloidal##2##2##(2008-10#2)
between colorectal carcinoma and##2##4##(1992-8#1)(1993-12#1)
between colorectal##3##2##(1992-8#1)(1993-12#1)(2013-1#1)
between common##6##2##(2008-8#1)(2008-9#2)(2010-12#1)(2012-3#2)
between communities##2##2##(2013-7#2)
between competition and dispersal##2##4##(2008-8#2)
between competition and##3##3##(2008-8#2)(2009-1#1)
between competitive##4##2##(2008-8#3)(2009-7#1)
between complementary##2##2##(2008-10#1)(2008-7#1)
between complex##2##2##(1994-12#1)(2008-10#1)
between complicity and resistance to##2##5##(2009-5#2)
between concentrations##2##2##(2008-10#1)(2013-7#1)
between concurrent##2##2##(2011-2#2)
between conditions##4##2##(1991-5#1)(1994-9#1)(2009-11#1)(2013-8#1)
between consecutive##5##2##(1997-8#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#1)
between consumer##2##2##(2008-11#1)(2008-8#1)
between consumption and##2##3##(2008-4#1)(2008-5#1)
between consumption##3##2##(2008-4#1)(2008-5#1)(2012-1#1)
between contaminated##2##2##(2007-12#1)(2008-10#1)
between continents##4##2##(2008-10#4)
between control and##11##3##(1990-12#1)(1991-5#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
between control##14##2##(1990-12#1)(1991-5#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)
between conventional straight wire and self-ligating brackets##2##7##(2009-7#2)
between conventional##4##2##(2007-12#1)(2008-10#1)(2009-7#2)
between coping style and##2##4##(2010-5#2)
between coping##4##2##(1995-1#1)(2010-5#3)
between copper(II) and##2##3##(2008-10#2)
between corresponding##2##2##(1992-4#1)(2008-10#1)
between cortical##3##2##(2008-10#1)(2009-9#1)(2013-1#1)
between cost and##2##3##(1992-12#1)(1995-2#1)
between cost##3##2##(1992-12#1)(1995-2#1)(2008-10#1)
between countries##9##2##(1991-11#1)(1991-4#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
between crossed polarizers##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
between crown##2##2##(2008-10#2)
between crystal and##2##3##(1992-8#1)(2011-2#1)
between crystal##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
between cultivars##3##2##(2008-10#2)(2011-10#1)
between current and##2##3##(2007-12#1)(2008-10#1)
between current##5##2##(2007-12#2)(2008-10#1)(2009-5#1)(2010-8#1)
between cutaneous and##2##3##(1991-4#1)(2008-6#1)
between cvs##2##2##(2008-10#2)
between cytochrome P450##2##3##(1994-6#1)(2008-7#1)
between cytochrome##5##2##(1994-5#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#1)
between cytoplasmic##3##2##(2006-10#1)(2006-6#1)(2008-9#1)
between data##3##2##(2007-11#1)(2008-3#1)(2010-10#1)
between days reliability##3##3##(2010-12#3)
between days##10##2##(2008-10#6)(2008-5#1)(2010-12#3)
between decision makers##2##3##(1997-1#2)
between degree of##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
between delta##3##2##(1992-6#1)(2008-8#1)(2011-1#1)
between demographic##2##2##(1996-2#1)(2012-2#1)
between dental caries and##2##4##(2011-1#2)
between dental caries##3##3##(2010-3#1)(2011-1#2)
between dental##5##2##(2009-2#1)(2010-3#1)(2011-1#2)(2012-12#1)
between depression and##2##3##(2008-11#1)(2010-2#1)
between depth##2##2##(2008-3#2)
between determined and##2##3##(2008-10#2)
between developmental##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
between diabetes##2##2##(2009-12#1)(2012-3#1)
between diabetic and control##2##4##(1994-11#1)(2008-10#1)
between diabetic and##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
between diagnosis and##2##3##(2011-1#1)(2012-12#1)
between diagnosis##3##2##(2008-6#1)(2011-1#1)(2012-12#1)
between diagnostic groups##2##3##(2010-5#2)
between diagnostic##4##2##(1990-12#1)(2009-11#1)(2010-5#2)
between diapause eggs and non-diapause eggs##2##6##(2008-5#2)
between diet##2##2##(1990-8#1)(2011-1#1)
between dietary##5##2##(1994-2#2)(2007-12#1)(2011-1#1)(2012-2#1)
between different cell##2##3##(1994-12#1)(2008-4#1)
between different chromosomal##2##3##(2007-11#1)(2010-3#1)
between different hospitals and different counties##2##6##(1991-11#2)
between different phases##2##3##(1990-5#1)(2008-5#1)
between different treatment##2##3##(1995-5#1)(2009-8#1)
between different types of##5##4##(1993-8#1)(2008-10#1)(2012-1#1)(2013-1#2)
between different##75##2##(1990-5#1)(1990-8#1)(1991-11#2)(1992-3#1)(1993-8#2)(1994-12#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
between diffraction##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
between digital##2##2##(2008-2#1)(2009-3#1)
between diminished##2##2##(1991-12#1)(2010-8#1)
between direct and indirect##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
between disease activity and##3##4##(2012-1#3)
between disease incidence and##2##4##(2008-10#2)
between disease incidence##3##3##(2008-10#3)
between disease severity and##5##4##(2008-10#5)
between disease##17##2##(1995-9#1)(2008-10#13)(2012-1#3)
between dispersion and##2##3##(2007-12#1)(2008-3#1)
between distinct##3##2##(2007-5#1)(2008-11#2)
between domestic##2##2##(1996-12#1)(2011-2#1)
between donor and receptor##2##4##(2008-10#1)(2011-2#1)
between donor and##3##3##(2008-10#1)(2011-2#2)
between dopamine-##2##2##(1995-11#2)
between dose and##3##3##(1993-12#1)(2008-11#1)(2008-7#1)
between doses##2##2##(1994-9#1)(1997-7#1)
between double##3##2##(2008-10#2)(2011-2#1)
between drinkers and non-drinkers##2##4##(2008-1#1)(2008-10#1)
between drug##12##2##(1990-2#1)(1992-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#2)(2010-5#1)
between drugs##2##2##(1994-11#1)(1997-6#1)
between dural arteries and##2##4##(2008-7#2)
between duration##2##2##(1997-8#1)(2008-6#1)
between dynamic##2##2##(2008-11#1)(2013-8#1)
between each of##2##3##(2008-11#1)(2008-9#1)
between each##13##2##(1991-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-9#1)(2009-6#1)(2009-8#1)(2013-8#1)
between ear##2##2##(2008-10#2)
between early and late##4##4##(2007-8#1)(2008-10#2)(2008-11#1)
between early##12##2##(1990-3#1)(1991-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
between eastern and western populations##3##5##(2008-10#3)
between eastern and western##4##4##(2008-10#3)(2009-10#1)
between eastern and##5##3##(2008-10#4)(2009-10#1)
between eating##3##2##(2011-1#2)(2012-2#1)
between education and##2##3##(2008-11#2)
between efficiency##2##2##(1995-12#1)(2012-3#1)
between egg size and##2##4##(1991-5#1)(2010-8#1)
between either##6##2##(1991-8#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#2)
between electrical and mechanical asynchrony##3##5##(2008-10#3)
between electrodes##5##2##(1992-12#2)(2007-9#1)(2008-10#1)(2010-2#1)
between elevated##9##2##(1990-2#1)(1996-5#1)(1997-7#2)(2007-10#1)(2007-7#1)(2008-7#1)(2009-6#1)(2011-2#1)
between embryonic##3##2##(2008-9#1)(2012-12#2)
between endothelial cells##2##3##(2008-4#1)(2012-2#1)
between environmental##6##2##(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
between estimated and actual severity##3##5##(2008-10#3)
between estimated##4##2##(1997-4#1)(2008-10#3)
between ethnic groups on the##2##5##(2008-1#2)
between ethnicity##2##2##(2006-10#1)(2010-1#1)
between every##3##2##(1997-6#1)(2010-10#2)
between evidence and##3##3##(1993-12#2)(2008-3#1)
between executive function and##5##4##(2009-10#5)
between existing##2##2##(1992-12#1)(1995-1#1)
between exons##2##2##(1993-11#2)
between expected##3##2##(1994-12#1)(2008-10#1)(2012-1#1)
between experimental and##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)
between experimental results##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
between experimental##13##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2010-3#1)
between experiments and##2##3##(2007-12#1)(2008-3#1)
between experiments##7##2##(1997-3#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#2)
between experts##2##2##(1993-12#1)(2010-5#1)
between exposure to##2##3##(2008-12#1)(2012-2#1)
between exposure##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
between exposures##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
between expression levels and telomere length##2##6##(2012-3#2)
between expression of##9##3##(1992-2#1)(1993-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-10#1)(2013-8#1)
between expression##12##2##(1992-2#1)(1993-1#1)(2008-10#1)(2008-11#3)(2008-8#2)(2009-10#1)(2012-3#2)(2013-8#1)
between external##5##2##(1996-3#1)(2008-4#1)(2011-2#2)(2012-12#1)
between extraction##2##2##(2008-10#1)(2012-1#1)
between extracurricular activities##3##3##(2009-7#3)
between familiar and unfamiliar##3##4##(2010-2#3)
between familiar##4##2##(2010-2#4)
between familiarity and##2##3##(1993-1#1)(2012-1#1)
between family##11##2##(1996-9#1)(1997-2#1)(2008-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#3)(2013-8#2)
between father's##2##2##(1990-12#1)(2012-12#1)
between fatty acid##3##3##(1991-12#1)(1994-3#1)(2008-7#1)
between fearful temperament and protective##2##5##(2012-12#2)
between fibers and##2##3##(2008-3#2)
between fibronectin##2##2##(2008-7#2)
between field##3##2##(2008-10#2)(2011-2#1)
between fields##3##2##(2008-10#3)
between first and second##2##4##(2007-1#1)(2011-2#1)
between first##6##2##(1991-8#1)(1992-5#1)(1992-9#1)(2007-1#1)(2009-4#1)(2011-2#1)
between fish##2##2##(1995-11#1)(2008-10#1)
between five##4##2##(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
between fluorescence##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
between food##4##2##(2008-1#1)(2008-5#1)(2009-8#1)(2012-12#1)
between forensic##2##2##(2008-12#2)
between formats##2##2##(2010-10#2)
between fortuitous and biologically##2##4##(1996-3#2)
between four##4##2##(2008-10#1)(2008-9#2)(2010-8#1)
between frames##2##2##(2008-2#1)(2008-3#1)
between free##3##2##(1991-12#1)(2008-10#1)(2010-11#1)
between fresh##2##2##(2008-1#1)(2008-11#1)
between functional##6##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-8#1)(2013-7#1)
between fungal##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
between fungicide##2##2##(2008-10#2)
between gallbladder##2##2##(2010-12#1)(2013-8#1)
between gender and##4##3##(2009-10#1)(2012-12#3)
between genders##2##2##(2009-2#1)(2009-7#1)
between gene##3##2##(1991-9#1)(2008-10#1)(2010-6#1)
between general practitioners##2##3##(1997-4#1)(2008-3#1)
between general##4##2##(1997-4#1)(2007-12#1)(2008-3#1)(2012-3#1)
between genes##4##2##(2011-3#1)(2012-3#2)(2013-7#1)
between genetic and environmental factors##3##5##(2008-3#1)(2008-6#1)(2009-6#1)
between genetic and environmental##4##4##(2008-3#1)(2008-6#1)(2009-6#1)(2010-12#1)
between genetic and geographic distance##3##5##(2008-10#3)
between genetic and geographic##4##4##(2008-10#4)
between genetic and##13##3##(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
between genetic##24##2##(1994-2#1)(1996-8#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#2)(2013-1#2)
between genetically##4##2##(1994-9#1)(1995-12#1)(1995-2#1)(2008-8#1)
between genetics and##2##3##(2008-7#1)(2011-2#1)
between genital papillomavirus infection and risk of cervical intraepithelial neoplasia##2##10##(1994-2#2)
between genomic##4##2##(1993-8#1)(2008-11#1)(2008-4#1)(2010-3#1)
between genotype and phenotype##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
between genotype and##5##3##(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
between genotype##6##2##(1996-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
between genotypes and##2##3##(2008-11#1)(2009-10#1)
between genotypes##6##2##(2008-10#4)(2008-11#1)(2009-10#1)
between germ##2##2##(2008-5#1)(2009-3#1)
between germination##2##2##(2008-10#1)(2011-2#1)
between gingival blood flow##2##4##(2011-2#2)
between glia and neurons##2##4##(2008-2#1)(2008-5#1)
between global##3##2##(2008-10#1)(2008-9#1)(2009-2#1)
between good##2##2##(2008-10#1)(2010-3#1)
between grade and##2##3##(2008-6#1)(2011-1#1)
between grade##3##2##(2008-6#1)(2011-1#2)
between green and##2##3##(2008-10#1)(2008-3#1)
between group members##2##3##(2008-9#2)
between group size and##4##4##(1994-3#2)(2008-8#2)
between group##11##2##(1994-3#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-1#1)(2012-2#1)
between groups (p##2##3##(2011-2#1)(2013-1#1)
between groups and##2##3##(2009-7#1)(2011-2#1)
between groups in##8##3##(1996-1#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
between groups of##3##3##(1994-9#1)(1997-9#1)(2013-7#1)
between groups were##5##3##(1991-3#1)(1994-3#1)(2008-12#1)(2011-2#1)(2013-1#1)
between groups with and without##2##5##(2008-7#1)(2013-8#1)
between groups with##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
between groups##53##2##(1991-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-1#1)(1997-9#1)(2007-8#5)(2008-10#6)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#1)
between growing##2##2##(1996-8#1)(2008-10#1)
between growth and circumnutations##2##4##(2009-6#2)
between growth and##5##3##(2008-8#2)(2009-6#2)(2010-7#1)
between growth of##3##3##(2007-12#1)(2008-10#2)
between growth rate and##2##4##(2008-12#1)(2009-6#1)
between growth##15##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#3)(2009-6#3)(2010-7#1)(2012-6#1)
between hIL-6 and hIL-6R##2##4##(2008-8#2)
between hIL-6 and##3##3##(2008-8#3)
between hIL-6##4##2##(2008-8#4)
between hair##2##2##(1993-9#1)(2008-5#1)
between health care##5##3##(1993-1#2)(1993-2#1)(1994-1#1)(1996-1#1)
between health professionals and##4##4##(1991-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
between health professionals##6##3##(1991-6#1)(1995-5#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
between health##20##2##(1991-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-5#1)(1996-1#1)(1996-11#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
between healthy and##5##3##(1997-2#1)(2008-10#2)(2009-8#1)(2012-3#1)
between healthy##10##2##(1992-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
between heat##2##2##(2008-4#1)(2011-1#1)
between heavy metal##2##3##(2008-10#1)(2013-8#1)
between heavy##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
between helices##4##2##(1993-8#1)(1995-2#2)(1995-5#1)
between hemostasis impairment##2##3##(2011-1#2)
between heparinized##2##2##(2011-2#2)
between hepatitis B##2##3##(1993-2#1)(2007-7#1)
between heterozygosity and##2##3##(2008-8#2)
between high and low##2##4##(2012-2#1)(2013-1#1)
between high risk human papillomavirus##2##5##(2011-1#2)
between high##12##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#1)
between higher education##3##3##(2008-11#2)(2008-12#1)
between higher##7##2##(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
between highly##2##2##(1995-2#1)(2008-4#1)
between histopathology##2##2##(2007-10#1)(2012-2#1)
between home and##2##3##(1997-5#1)(2009-10#1)
between home##8##2##(1991-3#1)(1992-2#1)(1997-5#1)(2008-8#3)(2009-10#1)(2010-7#1)
between hospital##6##2##(1995-12#1)(1996-3#3)(2008-11#1)(2013-1#1)
between hospitals and##6##3##(1991-1#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-2#1)(1996-1#1)
between hospitals##10##2##(1991-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(2008-7#2)
between host and parasite##4##4##(2008-8#2)(2010-8#1)(2012-3#1)
between host and##7##3##(1994-11#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-8#1)(2012-3#1)
between host genetic diversity and##2##5##(2009-2#2)
between host species##2##3##(2008-10#1)(2012-3#1)
between host##19##2##(1994-11#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#3)(2009-2#2)(2010-8#1)(2012-3#2)
between hosts##3##2##(2008-10#3)
between household##2##2##(2011-2#1)(2013-8#1)
between human and rat##2##4##(1991-12#1)(1996-12#1)
between human and##7##3##(1991-12#1)(1992-3#1)(1996-12#1)(2008-11#1)(2008-4#1)(2010-5#1)(2012-3#1)
between human##18##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-2#1)(1996-12#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-5#2)(2012-12#1)(2012-3#1)(2013-1#1)
between humans and##3##3##(2008-11#1)(2011-2#2)
between hydrogen peroxide and##4##4##(1991-9#1)(2008-10#2)(2009-4#1)
between hydrogen peroxide##5##3##(1991-9#1)(2008-10#3)(2009-4#1)
between hydrogen##7##2##(1991-9#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-9#1)
between hydrogenotrophic sulphate-reducers##2##3##(2008-7#2)
between hypertensive##2##2##(2007-10#1)(2011-2#1)
between iTFA##2##2##(2012-2#2)
between illness##3##2##(1994-6#1)(2008-11#1)(2011-1#1)
between image##3##2##(2008-3#1)(2008-6#1)(2012-1#1)
between implants and##2##3##(2012-2#2)
between implants##3##2##(2012-2#3)
between in situ##2##3##(2008-3#1)(2009-12#1)
between in vitro and in vivo##4##6##(1991-2#1)(1992-6#1)(2008-5#2)
between in vitro##10##3##(1991-2#1)(1992-6#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#3)(2011-1#1)
between in##15##2##(1990-5#1)(1991-2#1)(1992-6#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-12#1)(2011-1#1)
between in-phase and opposed-phase##2##4##(1997-8#2)
between inbred##2##2##(1994-5#1)(2009-10#1)
between incidence and severity##2##4##(2008-10#2)
between incidence of##2##3##(2008-10#2)
between incidence##6##2##(2008-10#6)
between income and##3##3##(1993-3#1)(2008-8#2)
between income inequality and mortality at##2##6##(2008-8#2)
between income inequality and mortality##4##5##(2008-8#4)
between income##8##2##(1993-3#1)(2008-8#6)(2010-7#1)
between increased##6##2##(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#2)
between increasing##4##2##(2008-10#1)(2008-5#1)(2010-1#1)(2012-3#1)
between individual##9##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
between individuals and groups##3##4##(1993-12#1)(2008-10#1)(2009-12#1)
between individuals and##5##3##(1993-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)
between individuals in##2##3##(2008-10#1)(2013-7#1)
between individuals with##2##3##(2010-8#1)(2012-2#1)
between individuals##20##2##(1993-12#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
between infected##2##2##(2012-2#1)(2013-8#1)
between infection##2##2##(1994-11#1)(2011-2#1)
between initial and##2##3##(1992-6#1)(2013-1#1)
between initial##6##2##(1991-2#1)(1992-6#1)(2007-1#1)(2008-11#1)(2008-6#1)(2013-1#1)
between injection##2##2##(1997-4#1)(2008-10#1)
between inoculation##2##2##(2008-10#2)
between inorganic##2##2##(2008-10#2)
between inpatient##2##2##(1996-3#1)(2011-1#1)
between inpatients and outpatients##2##4##(2011-2#2)
between insect##2##2##(2007-12#1)(2008-8#1)
between insulin resistance and##2##4##(1997-7#1)(2008-1#1)
between intact and##2##3##(1990-11#1)(2008-8#1)
between intact##3##2##(1990-11#1)(1990-12#1)(2008-8#1)
between intake##2##2##(2008-2#1)(2011-1#1)
between intensity##2##2##(2008-10#1)(2008-7#1)
between internal and external##2##4##(1992-12#1)(2007-12#1)
between internal##3##2##(1992-12#2)(2007-12#1)
between intracellular##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
between invasive##2##2##(2008-8#1)(2008-9#1)
between ion##2##2##(2008-10#1)(2009-8#1)
between iron(III) and##2##3##(2008-10#2)
between iron(III)##3##2##(2008-10#3)
between isolates and##2##3##(2008-10#1)(2011-1#1)
between isolates from the##2##4##(2008-10#2)
between isolates of P##2##4##(2008-10#2)
between isolates of##8##3##(2008-10#8)
between isolates within##2##3##(2008-10#2)
between isolates##22##2##(2008-10#20)(2010-10#1)(2011-1#1)
between it and the##3##4##(2008-3#2)(2013-8#1)
between its##6##2##(1990-7#1)(1995-8#1)(2008-11#1)(2010-8#1)(2011-1#1)(2012-3#1)
between job stress##2##3##(2010-10#2)
between job##4##2##(1996-2#1)(2010-10#3)
between knowledge##2##2##(1997-6#1)(2013-1#1)
between known concentrations and concentrations derived from##2##7##(2008-10#2)
between known##3##2##(2008-10#2)(2008-9#1)
between laboratories##8##2##(1990-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)
between laboratory##3##2##(1992-3#1)(2006-6#1)(2008-10#1)
between lactic acid##2##3##(2008-10#1)(2013-1#1)
between lambda(1)##2##2##(2008-10#2)
between large##4##2##(1995-8#1)(1996-4#1)(2008-10#1)(2010-2#1)
between latency and##2##3##(2008-6#2)
between leaf##3##2##(2008-10#2)(2008-9#1)
between learning##2##2##(2008-11#2)
between left##4##2##(1994-3#1)(2008-11#1)(2012-2#1)(2013-7#1)
between lemma and palea##2##4##(2008-10#2)
between lemma##3##2##(2008-10#3)
between lesion##2##2##(2007-10#1)(2008-2#1)
between levels in##2##3##(1991-11#1)(1995-8#1)
between levels of##5##3##(1994-3#1)(1996-12#1)(2007-11#1)(2008-8#1)(2012-2#1)
between levels##9##2##(1991-11#1)(1994-3#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-11#2)(2008-8#1)(2012-2#1)
between light##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2010-3#1)
between limb##2##2##(2008-6#1)(2010-3#1)
between lineages 1 and 2##2##5##(2010-8#2)
between lineages##3##2##(2008-10#1)(2010-8#2)
between lines##2##2##(2008-8#1)(2012-3#1)
between linked and unlinked markers##2##5##(2008-8#2)
between lipid and protein oxidation##2##5##(2010-4#2)
between lipid and##3##3##(1992-6#1)(2010-4#2)
between lipid##6##2##(1992-6#1)(1994-5#1)(1996-2#1)(2008-10#1)(2010-4#2)
between live##2##2##(2007-6#1)(2009-6#1)
between liver##2##2##(1995-12#2)
between local and##2##3##(2008-8#2)
between local##14##2##(1994-2#1)(1994-8#1)(1995-9#1)(1996-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-4#1)(2010-12#1)
between localized##2##2##(2008-3#1)(2011-2#1)
between locally##2##2##(2008-7#1)(2013-1#1)
between locations and##2##3##(2008-8#1)(2013-1#1)
between locations##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
between loci##2##2##(2008-10#1)(2009-2#1)
between log S##2##3##(2008-8#2)
between log##4##2##(2008-10#2)(2008-8#2)
between long##3##2##(2008-10#2)(2008-8#1)
between longitudinal modes##2##3##(2007-12#1)(2008-3#1)
between longitudinal##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
between low##5##2##(1996-8#1)(2008-3#1)(2012-2#2)(2013-8#1)
between lysine##2##2##(1995-12#1)(2008-10#1)
between mRNA##2##2##(1992-6#1)(2010-4#1)
between maize and##2##3##(1990-8#1)(2012-3#1)
between maize##3##2##(1990-8#1)(2008-10#1)(2012-3#1)
between male and female components of the mate recognition system##2##10##(2008-9#2)
between male and female##11##4##(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-7#1)
between male##13##2##(1995-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
between males and females##9##4##(1990-3#1)(1991-2#1)(1994-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#2)(2013-7#1)
between males##11##2##(1990-3#1)(1991-2#1)(1994-6#1)(1995-8#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#2)(2013-7#1)
between malignancy and##2##3##(1991-3#1)(1993-8#1)
between malignant##3##2##(1991-12#1)(1993-9#1)(1995-2#1)
between mammography##2##2##(2011-2#1)(2013-1#1)
between managers and employees##2##4##(1994-12#2)
between markers##3##2##(1997-5#1)(2008-12#1)(2013-1#1)
between mass##2##2##(2008-12#1)(2008-7#1)
between maternal acculturation and##2##4##(2009-7#2)
between maternal##9##2##(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#2)(2011-2#1)(2012-2#1)
between maximum##3##2##(2008-5#1)(2008-8#1)(2010-8#1)
between mean values##2##3##(2008-11#1)(2008-7#1)
between mean##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)
between measured and calculated##3##4##(2008-2#1)(2008-3#2)
between measured and simulated##2##4##(2008-2#1)(2008-3#1)
between measured and##9##3##(2008-10#1)(2008-2#3)(2008-3#4)(2009-5#1)
between measured##13##2##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-5#1)
between measurements##5##2##(1996-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
between measures of##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
between mechanical##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
between medical care##3##3##(1995-12#1)(2008-11#2)
between medical staffs and##2##4##(1991-2#2)
between medical##9##2##(1991-2#2)(1995-1#1)(1995-12#1)(1996-6#1)(2008-11#2)(2008-4#1)(2008-7#1)
between medicine and##2##3##(2010-10#1)(2013-8#1)
between melody recognition##2##3##(2008-9#2)
between members of##2##3##(1996-7#1)(2008-10#1)
between membrane##3##2##(1992-3#1)(1992-8#1)(2009-6#1)
between membranes##2##2##(1992-5#1)(1992-6#1)
between men and women##12##4##(1991-11#1)(1991-6#1)(1993-2#2)(1996-8#1)(1997-6#1)(2007-7#2)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
between men and##14##3##(1991-11#1)(1991-6#1)(1993-2#2)(1996-8#1)(1997-6#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
between men##15##2##(1991-11#1)(1991-6#1)(1991-9#1)(1993-2#2)(1996-8#1)(1997-6#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
between mental##4##2##(1993-3#1)(2008-12#1)(2010-12#1)(2010-7#1)
between mercury##2##2##(1995-2#1)(2008-10#1)
between metabolic rate and##2##4##(1997-6#2)
between metabolic##5##2##(1997-6#2)(2008-1#1)(2008-3#1)(2008-7#1)
between metastatic##2##2##(1992-9#1)(2013-7#1)
between methods##4##2##(2008-10#3)(2008-6#1)
between miRNA##2##2##(2011-2#1)(2012-12#1)
between migraine with aura and##2##5##(2008-9#2)
between migraine with##3##3##(2008-9#3)
between migraine##5##2##(2008-9#5)
between mitochondria and ATPases##4##4##(2008-7#4)
between mitochondrial##2##2##(1994-11#1)(2013-1#1)
between mixed and##2##3##(1990-12#1)(2008-10#1)
between mixed##3##2##(1990-12#1)(2008-10#2)
between mixing##2##2##(2008-11#1)(2008-2#1)
between model and##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
between model##6##2##(2008-11#3)(2008-3#1)(2008-7#2)
between modeled and##2##3##(2008-3#2)
between models##3##2##(2008-10#2)(2011-1#1)
between molecular markers and##2##4##(2008-10#2)
between molecular##7##2##(2008-10#5)(2008-3#1)(2008-5#1)
between molecules in##2##3##(1992-9#1)(2008-1#1)
between molecules##8##2##(1992-9#1)(1994-2#1)(2008-1#2)(2008-2#2)(2008-4#1)(2010-7#1)
between monolayer##2##2##(1991-3#1)(1992-6#1)
between morphological##2##2##(2008-11#1)(2008-8#1)
between most##2##2##(2008-10#1)(2011-2#1)
between motor disability and cognitive##2##5##(2008-7#2)
between motor##3##2##(2008-7#2)(2009-8#1)
between mouse and human##2##4##(1992-8#1)(1997-8#1)
between mouse and##3##3##(1992-8#1)(1995-2#1)(1997-8#1)
between multiple##6##2##(1995-2#2)(2007-12#1)(2008-5#1)(2010-1#1)(2011-2#1)
between muscarinic M2 receptors and beta-adrenoceptors##3##6##(1995-12#3)
between muscarinic##4##2##(1995-12#4)
between muscles##4##2##(1990-7#1)(2010-4#1)(2010-9#1)(2012-7#1)
between mutant and##2##3##(1995-2#1)(2008-10#1)
between native and##2##3##(1995-3#1)(2008-6#1)
between native##4##2##(1995-2#1)(1995-3#1)(1997-7#1)(2008-6#1)
between natural and##3##3##(2008-3#1)(2008-9#1)(2011-1#1)
between natural##6##2##(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#1)
between naturally occurring##2##3##(2008-4#1)(2008-9#1)
between negative##3##2##(2008-9#1)(2009-11#1)(2010-10#1)
between neighboring##8##2##(1996-12#1)(2007-12#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-5#1)
between neural networks##2##3##(2008-11#2)
between neural##3##2##(2008-11#3)
between neuronal##2##2##(2008-7#1)(2009-5#1)
between neurons and astrocytes##2##4##(2008-7#1)(2009-3#1)
between neurons and glial cells##3##5##(2008-5#1)(2008-7#2)
between neurons and##6##3##(2008-5#1)(2008-7#3)(2009-3#1)(2009-8#1)
between neurotransmitter##2##2##(1995-11#1)(1996-12#1)
between new##3##2##(1991-11#1)(1997-3#1)(2012-2#1)
between nine##2##2##(2008-10#1)(2013-1#1)
between nitrogen and##2##3##(2008-10#2)
between normal and neoplastic cells##2##5##(1992-8#1)(1993-9#1)
between normal and neoplastic##4##4##(1992-8#2)(1993-9#1)(1994-2#1)
between normal and##9##3##(1990-12#1)(1990-9#1)(1992-8#2)(1993-9#1)(1994-2#1)(1997-6#1)(2011-1#1)(2013-1#1)
between normal subjects and##2##4##(2008-2#1)(2008-7#1)
between normal##21##2##(1990-12#1)(1990-9#1)(1992-8#2)(1993-1#1)(1993-9#2)(1994-2#1)(1996-11#1)(1997-6#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
between nt##2##2##(1991-6#1)(1994-9#1)
between nucleoporins and##2##3##(2011-2#2)
between nucleotide##2##2##(1990-11#1)(1994-9#1)
between nucleotides##3##2##(1991-2#1)(1993-2#1)(2012-2#1)
between number of##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
between number##5##2##(1990-12#1)(2008-10#1)(2011-2#2)(2013-1#1)
between nurses and##5##3##(1993-2#1)(2007-10#1)(2008-1#1)(2011-1#1)(2013-8#1)
between nurses##6##2##(1993-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-8#1)
between nursing##4##2##(1994-3#1)(1996-12#1)(2008-1#1)(2010-3#1)
between nutrition and##3##3##(1991-6#1)(2008-12#2)
between nutritional##2##2##(2008-11#1)(2013-1#1)
between obese and nonobese patients##2##5##(2011-2#1)(2013-1#1)
between obese and##3##3##(1996-12#1)(2011-2#1)(2013-1#1)
between obesity and##3##3##(2009-2#1)(2009-7#1)(2013-8#1)
between obesity##6##2##(2008-1#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-3#1)(2013-8#1)
between objective##3##2##(2007-12#1)(2008-5#1)(2009-10#1)
between observed and simulated##2##4##(1990-9#1)(2008-10#1)
between observed and##7##3##(1990-9#1)(2008-10#6)
between observed##10##2##(1990-9#1)(1995-11#1)(2008-10#6)(2008-3#1)(2012-4#1)
between odour##2##2##(2008-10#1)(2008-5#1)
between old and young##2##4##(2009-10#1)(2009-8#1)
between older##2##2##(1993-2#1)(2007-12#1)
between oligosaccharides##2##2##(1994-5#1)(2009-2#1)
between on and off##2##4##(2008-12#1)(2008-3#1)
between one and##2##3##(2007-8#1)(2008-4#1)
between one##11##2##(1990-8#1)(1994-5#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-7#1)
between onset of##2##3##(1995-12#1)(2008-7#1)
between onset##3##2##(1995-12#1)(2008-7#1)(2009-7#1)
between oocytes##2##2##(1990-7#1)(1995-11#1)
between optical##4##2##(2008-2#2)(2008-3#1)(2009-5#1)
between optoelectronic##2##2##(2008-2#1)(2008-3#1)
between or within##2##3##(2007-11#1)(2011-1#1)
between or##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
between oral##8##2##(1990-6#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
between organelles##2##2##(2009-5#1)(2011-2#1)
between organic##3##2##(1991-9#1)(2008-10#2)
between organisms##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
between orthogonally polarized##2##3##(2008-3#2)
between orthogonally##3##2##(2007-12#1)(2008-3#2)
between orthopaedic##2##2##(2007-11#1)(2009-3#1)
between other##2##2##(2008-8#1)(2009-6#1)
between our##7##2##(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#2)(2012-3#1)
between oxalate##2##2##(2008-10#1)(2012-2#1)
between oxidative stress##3##3##(1996-9#1)(2008-3#1)(2008-7#1)
between oxidative##4##2##(1996-9#1)(2008-3#1)(2008-7#1)(2009-5#1)
between p53 and##3##3##(2010-10#2)(2011-2#1)
between p53##8##2##(1994-7#1)(1997-7#1)(2007-8#1)(2008-5#1)(2010-10#2)(2011-2#1)(2013-8#1)
between pGluHA and age##2##4##(2008-7#2)
between pH 2##4##3##(1997-2#1)(2008-10#3)
between pH 4 and##2##4##(2008-10#1)(2008-8#1)
between pH 6##3##3##(1991-9#1)(2008-10#2)
between pH 7 and##2##4##(1991-8#1)(1994-5#1)
between pH 7##3##3##(1991-8#1)(1994-5#1)(2008-6#1)
between pH 9##2##3##(1994-11#1)(2013-1#1)
between pH##19##2##(1990-8#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-5#1)(1997-2#1)(2008-10#9)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
between pK(a)##3##2##(2008-10#3)
between paediatric and##3##3##(2008-11#1)(2008-9#2)
between paired##2##2##(2008-7#2)
between pairs of##6##3##(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
between parasite##2##2##(2008-10#1)(2008-8#1)
between parasites##2##2##(2008-9#1)(2012-12#1)
between parent##2##2##(1990-12#1)(1994-3#1)
between parental##5##2##(2008-10#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)
between parenting##2##2##(1995-2#1)(2009-5#1)
between parents and##8##3##(1990-12#2)(1995-1#1)(1997-7#1)(2008-11#1)(2012-12#2)(2013-1#1)
between parents##9##2##(1990-12#2)(1995-1#1)(1997-7#1)(2008-11#1)(2009-2#1)(2012-12#2)(2013-1#1)
between partially##3##2##(1995-2#1)(2008-10#2)
between particle##3##2##(2007-12#1)(2008-2#1)(2009-6#1)
between parts of##2##3##(1996-1#1)(2010-3#1)
between paternal##3##2##(2008-8#1)(2011-1#2)
between pathogen##3##2##(2008-10#3)
between pathotypes##2##2##(2008-10#2)
between patient##6##2##(1995-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2011-1#1)
between patients and controls##4##4##(1997-5#2)(2013-1#1)(2013-8#1)
between patients and dietitians/dietetic interns##2##5##(1995-2#2)
between patients and their##2##4##(1996-3#1)(2008-3#1)
between patients and##15##3##(1995-2#2)(1995-5#1)(1996-3#1)(1996-7#1)(1997-5#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#3)(2013-8#1)
between patients in different##2##4##(2011-2#2)
between patients in##3##3##(2008-8#1)(2011-2#2)
between patients treated with##2##4##(1990-6#1)(2008-5#1)
between patients treated##3##3##(1990-6#1)(1990-8#1)(2008-5#1)
between patients who received##2##4##(1990-11#1)(2007-7#1)
between patients who##4##3##(1990-11#1)(2007-7#1)(2011-1#1)(2013-1#1)
between patients with or without##2##5##(1993-12#1)(1997-5#1)
between patients with##15##3##(1991-12#1)(1993-12#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
between patients##45##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#3)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#8)(2013-8#2)
between peak height and the concentration of##3##7##(2008-10#3)
between peak height and##6##4##(2008-10#6)
between peak height##7##3##(2008-10#7)
between peak##11##2##(2008-10#11)
between people##4##2##(1990-9#1)(2008-1#1)(2010-12#1)(2011-2#1)
between people's##2##2##(2010-2#2)
between perceived##4##2##(1993-12#1)(2009-7#1)(2011-2#1)(2012-2#1)
between perceptions of family connectedness and body satisfaction##2##8##(2010-10#2)
between perceptions of##3##3##(1995-3#1)(2010-10#2)
between performance##2##2##(2008-8#2)
between peri-implantitis and##2##3##(2013-1#2)
between peripheral##2##2##(1991-3#1)(1996-1#1)
between personal##3##2##(1992-3#1)(1995-1#1)(2008-11#1)
between persons##2##2##(1994-12#1)(2008-10#1)
between phases of the micellar system##2##6##(1990-5#2)
between phases##4##2##(1990-5#2)(2008-5#1)(2009-11#1)
between phenotype and##2##3##(2011-2#1)(2012-3#1)
between phospholipase activity and##2##4##(2008-5#2)
between phycoerythrin and##2##3##(1996-12#1)(2008-8#1)
between physical and mental health and the##2##7##(2011-2#2)
between physical and##3##3##(2010-2#1)(2011-2#2)
between physical##10##2##(2008-10#1)(2008-3#1)(2008-9#1)(2010-2#3)(2011-2#2)(2012-2#1)(2013-1#1)
between physician and patient##3##4##(1993-11#2)(1995-2#1)
between physician and##4##3##(1993-11#2)(1995-2#1)(2008-3#1)
between physicians and##5##3##(1992-12#1)(1997-6#1)(2008-11#1)(2011-2#1)(2013-8#1)
between physicians##8##2##(1991-6#1)(1992-12#1)(1995-12#1)(1997-6#1)(2008-11#1)(2009-2#1)(2011-2#1)(2013-8#1)
between physiological and##2##3##(2009-8#1)(2012-2#1)
between plant##4##2##(1994-11#1)(2008-10#1)(2008-8#1)(2013-7#1)
between plants and animals##3##4##(2008-9#1)(2009-6#2)
between plants and herbivores##2##4##(2008-8#2)
between plants and##9##3##(2008-10#1)(2008-8#3)(2008-9#1)(2009-6#2)(2009-8#1)(2011-10#1)
between plants by##2##3##(2008-10#1)(2008-9#1)
between plants##14##2##(1997-4#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-6#2)(2009-8#1)(2011-10#1)(2013-7#1)
between plasma and CSF##2##4##(1994-8#1)(1995-11#1)
between plasma and##4##3##(1992-12#1)(1994-8#2)(1995-11#1)
between plasma gonadotropin levels and the OSC amplitude in##2##9##(2008-6#2)
between plasma##17##2##(1990-11#1)(1992-12#1)(1992-9#2)(1994-7#1)(1994-8#2)(1995-11#1)(2008-5#1)(2008-6#3)(2008-7#2)(2010-3#1)(2012-12#1)(2013-1#1)
between platelet##4##2##(1991-12#1)(1992-12#1)(1997-7#1)(2008-7#1)
between polar growth and cell cycle##2##6##(2009-8#2)
between polarizers##3##2##(2008-3#3)
between polymorphism##2##2##(1997-8#1)(2011-1#1)
between polymorphisms in##3##3##(1997-5#1)(2008-10#2)
between polymorphisms of##2##3##(2011-1#2)
between polymorphisms##5##2##(1997-5#1)(2008-10#2)(2011-1#2)
between population##2##2##(2008-10#2)
between populations can be##2##4##(2008-10#1)(2013-1#1)
between populations from different##2##4##(2008-10#2)
between populations from##3##3##(2008-10#2)(2008-5#1)
between populations in##2##3##(2008-10#1)(2008-9#1)
between populations of the##3##4##(2008-10#3)
between populations of##5##3##(1992-12#1)(2008-10#3)(2010-2#1)
between populations was##2##3##(2008-10#1)(2012-3#1)
between populations##32##2##(1992-12#1)(1994-3#1)(2007-1#2)(2008-10#12)(2008-5#2)(2008-8#2)(2008-9#3)(2010-2#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)
between porcine##2##2##(1991-8#1)(1995-6#1)
between positions##3##2##(1995-6#1)(1997-9#2)
between positive and negative##3##4##(1993-9#1)(2008-10#1)(2009-8#1)
between positive##6##2##(1990-3#1)(1993-9#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-8#1)
between postoperative##2##2##(2007-11#1)(2008-7#1)
between potential##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
between ppoFEV1##2##2##(2007-8#2)
between practice and##2##3##(1993-2#1)(2010-10#1)
between prasinoviruses##2##2##(2013-1#2)
between pre- and##3##3##(2008-7#1)(2012-12#2)
between pre-eclampsia##3##2##(2011-2#3)
between precipitation and##2##3##(2008-10#1)(2008-8#1)
between predicted and experimental##2##4##(2008-10#2)
between predicted and##4##3##(2008-10#3)(2008-3#1)
between predicted postoperative forced expiratory volumes in##2##7##(2007-8#2)
between predicted##8##2##(1991-12#1)(2007-8#2)(2008-10#4)(2008-3#1)
between prenatal care and birth outcome##2##6##(1995-2#2)
between prenatal care and birth##3##5##(1992-2#1)(1995-2#2)
between prenatal famine and##2##4##(2011-1#2)
between prenatal##8##2##(1992-2#1)(1995-2#2)(2008-11#1)(2008-2#1)(2011-1#2)(2013-1#1)
between previously##2##2##(2007-11#1)(2008-10#1)
between primary and secondary##3##4##(1995-2#1)(1996-11#1)(2008-10#1)
between primary and##4##3##(1995-2#1)(1996-11#1)(2008-10#1)(2009-9#1)
between primary care##3##3##(1993-10#1)(1993-9#1)(2011-1#1)
between primary##11##2##(1990-2#1)(1993-10#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-1#1)
between production of##2##3##(1992-9#1)(2008-8#1)
between professional##3##2##(1990-2#1)(1996-3#1)(2008-9#1)
between proliferation and##3##3##(1997-6#1)(2012-1#1)(2012-3#1)
between proliferation##4##2##(1997-6#1)(2007-10#1)(2012-1#1)(2012-3#1)
between prolonged##2##2##(1994-6#2)
between prostate cancer##2##3##(2009-5#2)
between prostate##3##2##(2007-10#1)(2009-5#2)
between protein kinase C##3##4##(1993-6#1)(2008-11#2)
between protein##15##2##(1990-12#1)(1993-6#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
between proteins and Ponceau 4R##2##5##(2008-10#2)
between proteins and##8##3##(1997-2#1)(2008-10#3)(2008-2#2)(2008-4#1)(2009-2#1)
between proteins of the##2##4##(2011-2#1)(2013-1#1)
between proteins of##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
between proteins##18##2##(1994-8#1)(1997-2#1)(2008-10#3)(2008-2#3)(2008-4#6)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
between providing##2##2##(2009-5#1)(2010-10#1)
between proximal##2##2##(1990-9#1)(2008-11#1)
between psychiatric disorders and##2##4##(2011-1#2)
between psychiatric##4##2##(2011-1#2)(2011-2#1)(2012-12#1)
between psychological##3##2##(2008-2#1)(2010-4#1)(2012-2#1)
between public##5##2##(1993-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(2011-1#1)
between pulse##2##2##(2007-12#1)(2008-3#1)
between pulses in##3##3##(2007-11#3)
between pulses##4##2##(2007-11#3)(2011-1#1)
between pump and probe pulses##2##5##(2007-11#1)(2007-12#1)
between purchasers and providers##4##4##(1994-1#2)(1994-12#1)(1997-1#1)
between quality assurance##2##3##(1991-1#2)
between quality##3##2##(1991-1#2)(2012-1#1)
between queens and##2##3##(2008-5#1)(2008-8#1)
between queens##3##2##(2008-5#1)(2008-8#2)
between race and##3##3##(2008-11#1)(2010-3#1)(2012-2#1)
between race##5##2##(2008-10#2)(2008-11#1)(2010-3#1)(2012-2#1)
between racial##3##2##(2008-11#1)(2009-7#2)
between radiation##5##2##(1996-2#1)(2007-11#1)(2008-3#1)(2008-7#2)
between radiology##2##2##(1991-12#1)(2007-4#1)
between rat and human##2##4##(2012-2#2)
between rat##5##2##(1991-9#1)(1994-9#1)(2008-3#1)(2012-2#2)
between reaction##2##2##(2008-10#1)(2010-10#1)
between reactive oxygen metabolites and##2##5##(2012-12#1)(2012-3#1)
between reactive oxygen##4##3##(2008-1#1)(2008-7#1)(2012-12#1)(2012-3#1)
between receptor and donor##2##4##(2011-2#2)
between receptor and##3##3##(2008-4#1)(2011-2#2)
between recombinant##2##2##(2008-8#2)
between redox##2##2##(2008-10#2)
between reduced##3##2##(1996-7#1)(2008-8#2)
between reduction##3##2##(1994-10#1)(2008-10#1)(2008-7#1)
between reference##2##2##(2008-10#1)(2008-2#1)
between regional##3##2##(2008-9#1)(2009-10#2)
between regions##11##2##(1990-8#1)(2007-5#1)(2008-10#6)(2008-6#1)(2011-1#1)(2013-8#1)
between regulatory focus##2##3##(2009-5#2)
between regulatory##3##2##(2009-5#2)(2009-8#1)
between related##2##2##(2008-10#2)
between relative##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
between relatives##8##2##(1997-7#1)(2008-9#2)(2009-10#3)(2012-3#2)
between religion and##6##3##(2009-11#4)(2009-6#2)
between religious##2##2##(2009-7#1)(2009-8#1)
between reported##2##2##(1994-6#1)(2013-1#1)
between reproductive##2##2##(2008-8#1)(2008-9#1)
between research and practice##8##4##(2008-1#1)(2010-10#5)(2013-1#2)
between research and##11##3##(1992-12#1)(2008-1#1)(2008-10#1)(2010-10#5)(2010-4#1)(2013-1#2)
between research##12##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#5)(2010-4#1)(2013-1#2)
between researchers and##4##3##(1997-1#1)(1997-3#1)(2010-10#1)(2010-4#1)
between researchers##5##2##(1997-1#1)(1997-3#1)(2010-10#2)(2010-4#1)
between resident and##2##3##(2008-8#1)(2010-8#1)
between resident##4##2##(1990-2#1)(2008-10#1)(2008-8#1)(2010-8#1)
between residues##10##2##(1990-12#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-4#2)(1995-5#1)(2008-11#1)(2008-8#1)
between resistance to##3##3##(2008-10#2)(2008-8#1)
between resistant and sensitive##2##4##(2008-10#2)
between resistant and susceptible##4##4##(2008-10#4)
between resistant and##6##3##(2008-10#6)
between resistant##8##2##(2008-10#8)
between resolution and##2##3##(2011-1#1)(2012-2#1)
between response##2##2##(2008-10#1)(2010-1#1)
between results obtained by the proposed method and##2##8##(2008-10#2)
between results obtained by the##4##5##(2008-10#4)
between results obtained by##5##4##(2008-10#5)
between results obtained##7##3##(2008-10#6)(2008-5#1)
between results of##2##3##(2008-10#2)
between results##15##2##(2007-10#1)(2008-10#12)(2008-3#1)(2008-5#1)
between reversibility in##2##3##(2007-2#2)
between rice and Arabidopsis##2##4##(2009-10#2)
between rice and##3##3##(2008-8#1)(2009-10#2)
between risk##3##2##(1991-12#1)(2011-1#1)(2013-1#1)
between rural##2##2##(2010-4#1)(2013-1#1)
between s and p polarization##2##5##(2007-12#1)(2008-3#1)
between salicylic acid##2##3##(2008-10#1)(2009-8#1)
between salt##2##2##(2008-9#1)(2009-10#1)
between sample##5##2##(2007-11#1)(2008-10#2)(2011-2#1)(2012-3#1)
between samples and##2##3##(2008-10#1)(2008-7#1)
between samples##6##2##(2008-10#5)(2008-7#1)
between sampling sites##2##3##(2008-7#1)(2011-2#1)
between sampling##6##2##(2007-11#1)(2008-10#3)(2008-7#1)(2011-2#1)
between satellites and floaters##2##4##(2008-8#2)
between satellites##3##2##(2008-2#1)(2008-8#2)
between scattering and##2##3##(2008-3#2)
between schizophrenia and##3##3##(1997-5#1)(2008-3#1)(2013-1#1)
between school burnout and depressive symptoms##2##6##(2009-9#2)
between school##4##2##(2009-7#2)(2009-9#2)
between schools##2##2##(2009-2#1)(2009-7#1)
between science and##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
between screen-based sedentary behavior and##2##5##(2013-1#2)
between screen-based##3##2##(2013-1#3)
between seasons##2##2##(2008-10#2)
between second and third##2##4##(2008-10#1)(2008-2#1)
between secondary##2##2##(2008-4#1)(2008-8#1)
between secretion##2##2##(2008-7#1)(2013-8#1)
between seed##2##2##(2008-10#1)(2008-12#1)
between segments##2##2##(2008-12#1)(2012-3#1)
between selected##3##2##(1997-6#1)(2008-10#1)(2012-1#1)
between selection##2##2##(1995-2#1)(2008-10#1)
between selenium##2##2##(2008-10#1)(2009-10#1)
between self-reported##2##2##(1992-12#1)(2013-1#1)
between semen##4##2##(2007-10#1)(2008-7#1)(2010-2#1)(2011-1#1)
between sensitive##4##2##(2007-7#1)(2008-10#3)
between sensitivity and##2##3##(2008-10#1)(2011-2#1)
between sensor and##2##3##(2007-12#1)(2008-3#1)
between sensory##2##2##(2011-2#1)(2013-1#1)
between sequence##4##2##(1993-6#1)(1997-3#1)(2008-9#1)(2011-2#1)
between sequences##3##2##(1996-6#1)(2008-6#2)
between serotonergic##2##2##(2008-5#1)(2008-7#1)
between serum 25-hydroxyvitamin D##2##4##(2011-2#2)
between serum##16##2##(1991-12#1)(1991-5#2)(2006-6#1)(2008-7#2)(2011-1#5)(2011-2#3)(2013-1#1)(2013-7#1)
between service##3##2##(1995-1#1)(1996-12#1)(2008-12#1)
between sets##2##2##(2008-7#1)(2009-1#1)
between several##9##2##(1990-5#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)
between sex and##2##3##(1991-6#1)(2008-5#1)
between sex##5##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-3#1)
between sexes and##2##3##(2008-8#1)(2011-2#1)
between sexes##7##2##(2008-12#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
between sexting##4##2##(2013-1#4)
between sexual and clonal##2##4##(2008-9#1)(2009-2#1)
between sexual##8##2##(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#2)(2012-3#1)
between shift##2##2##(2008-8#1)(2011-2#1)
between short-term##3##2##(1992-11#1)(1993-12#1)(1996-4#1)
between shyness and social phobia##2##5##(2008-4#2)
between siblings##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
between sides##2##2##(2010-9#1)(2013-1#1)
between signal##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2009-8#1)
between signals##5##2##(1995-11#1)(2007-9#1)(2008-3#1)(2008-8#2)
between similar##2##2##(1996-4#1)(2008-8#1)
between simple##4##2##(1990-10#1)(1993-12#1)(1994-9#1)(2010-1#1)
between simulated##4##2##(2008-2#1)(2008-3#3)
between single##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)
between sites##5##2##(2008-10#3)(2008-8#2)
between six##2##2##(1994-3#1)(2007-7#1)
between size at maturity and asymptotic size##4##7##(2008-9#4)
between size##6##2##(1994-11#1)(2008-3#1)(2008-9#4)
between skin and the nervous system##3##6##(2008-5#3)
between skin and##4##3##(2008-5#4)
between skin##5##2##(2008-3#1)(2008-5#4)
between sleep and mood##2##4##(1996-7#2)
between sleep and##3##3##(1996-7#2)(2013-1#1)
between sleep##7##2##(1996-7#3)(2011-2#1)(2013-1#3)
between small##5##2##(1992-3#2)(1994-5#1)(2008-3#1)(2010-8#1)
between smokers and non-smokers##2##4##(2008-12#1)(2008-7#1)
between smokers and nonsmokers##2##4##(2008-10#1)(2009-5#1)
between smokers and##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)
between smoking##3##2##(1996-3#1)(2013-1#2)
between social complexity and transitive inference##2##6##(2009-8#2)
between social support and##3##4##(1992-3#1)(2009-7#1)(2013-8#1)
between social##12##2##(1992-12#1)(1992-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
between socioeconomic status and##2##4##(2011-1#2)
between socioeconomic##4##2##(2008-12#1)(2011-1#3)
between sodium intake and##2##4##(2011-1#2)
between soil and##2##3##(2008-10#2)
between soil##4##2##(2008-10#4)
between solar##2##2##(2008-3#1)(2010-1#1)
between solute and##2##3##(2008-10#2)
between solution##2##2##(1997-2#1)(2008-10#1)
between some of the##2##4##(1990-5#1)(2008-10#1)
between some##7##2##(1990-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#2)
between source and detector##2##4##(2008-3#2)
between source and##3##3##(2008-3#3)
between southern and northern##2##4##(2008-8#2)
between spatial and temporal##2##4##(2007-12#1)(2008-2#1)
between spatial resolution and##2##4##(2008-6#1)(2008-7#1)
between spatial##8##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
between spatially##5##2##(1992-4#1)(1996-2#1)(2008-9#1)(2010-3#1)(2012-2#1)
between species and##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
between species is##2##3##(2008-8#1)(2009-6#1)
between species or##2##3##(2008-8#2)
between species richness##2##3##(2008-8#2)
between species were##2##3##(2008-10#1)(2013-7#1)
between species##37##2##(1990-12#1)(1991-8#1)(1996-5#1)(2008-10#7)(2008-4#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-2#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-3#5)(2012-5#1)(2013-7#1)
between specific##5##2##(2008-10#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#1)
between speed and##2##3##(2008-8#1)(2008-9#1)
between sperm##2##2##(2008-8#2)
between spinal##2##2##(2007-11#2)
between spontaneous##3##2##(2008-11#1)(2013-8#2)
between spores##2##2##(2008-10#1)(2011-2#1)
between staff##2##2##(1994-2#1)(1996-3#1)
between state##2##2##(1993-3#1)(1994-12#1)
between states##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
between steps##2##2##(2008-10#1)(2009-12#1)
between sterile and fertile##2##4##(2008-8#2)
between steroid##2##2##(1991-12#1)(1994-9#1)
between stimuli##2##2##(2009-10#1)(2011-2#1)
between strains from##3##3##(2008-10#3)
between strains of different##2##4##(2008-10#2)
between strains of##4##3##(2008-10#4)
between strains##9##2##(2008-10#8)(2008-5#1)
between stress and##4##3##(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)
between stress##6##2##(1992-3#1)(2008-7#2)(2009-7#1)(2009-8#1)(2009-9#1)
between structural##4##2##(1992-4#1)(1997-4#1)(2008-11#1)(2011-1#1)
between structure and##6##3##(1992-6#1)(2008-10#1)(2009-5#2)(2010-4#1)(2012-2#1)
between structure##7##2##(1992-6#1)(2008-10#2)(2009-5#2)(2010-4#1)(2012-2#1)
between structures and##2##3##(1995-3#1)(2008-3#1)
between structures##4##2##(1995-3#1)(2008-3#2)(2008-9#1)
between student##2##2##(2007-10#1)(2008-11#1)
between students and##2##3##(2007-12#1)(2009-7#1)
between students'##2##2##(2008-12#1)(2009-7#1)
between studied##2##2##(2008-10#1)(2012-3#1)
between studies##5##2##(1994-2#1)(2007-10#1)(2008-3#1)(2012-12#2)
between subgroups##2##2##(1992-9#1)(2007-10#1)
between subjective##3##2##(2007-12#1)(2008-5#1)(2010-7#1)
between subjects with##5##3##(1995-8#1)(2008-7#2)(2012-2#2)
between subjects##7##2##(1990-2#1)(1995-8#1)(2008-2#1)(2008-7#2)(2012-2#2)
between subpopulations##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
between subsequent##2##2##(2007-12#1)(2008-9#1)
between substance##3##2##(2008-11#1)(2008-5#1)(2008-6#1)
between substrate##2##2##(1993-8#1)(1994-5#1)
between subunits##3##2##(1992-8#1)(2011-1#1)(2013-7#1)
between such##2##2##(2007-12#1)(2008-7#1)
between support##2##2##(1992-3#1)(2008-12#1)
between surface##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
between surgeons##2##2##(2008-10#1)(2010-8#1)
between surgical##2##2##(1991-3#1)(2007-12#1)
between survival and##2##3##(2008-10#1)(2008-8#1)
between survival of##2##3##(2008-10#1)(2012-3#1)
between survival##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
between surviving and##2##3##(1994-12#1)(2009-6#1)
between susceptible and resistant cultivars##2##5##(2008-10#2)
between susceptible and resistant##3##4##(2008-10#3)
between susceptible and##4##3##(1996-12#1)(2008-10#3)
between susceptible##5##2##(1996-12#1)(2008-10#4)
between symptom onset and##2##4##(1994-3#1)(2011-2#1)
between symptom##6##2##(1994-3#1)(2007-11#1)(2007-2#1)(2008-7#2)(2011-2#1)
between symptoms##3##2##(2008-6#1)(2008-7#1)(2010-2#1)
between synaptic##2##2##(2008-11#1)(2008-2#1)
between target and##2##3##(2008-2#2)
between target##3##2##(2008-2#2)(2013-1#1)
between technical##4##2##(1992-1#1)(1993-1#1)(2008-1#1)(2010-10#1)
between technological##2##2##(1992-5#1)(1994-2#1)
between temperate##2##2##(2008-10#1)(2012-3#1)
between temperature and##2##3##(2008-10#1)(2011-2#1)
between temperature##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
between ten##2##2##(2008-4#1)(2008-9#1)
between terminal##2##2##(1994-3#1)(2011-1#1)
between that of the##2##4##(1990-8#1)(2009-12#1)
between that of##4##3##(1990-8#2)(1991-8#1)(2009-12#1)
between that##5##2##(1990-8#2)(1991-8#1)(1997-2#1)(2009-12#1)
between the 1##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
between the 2 groups##7##4##(1991-11#2)(2007-7#1)(2009-10#1)(2009-3#1)(2012-3#1)(2013-1#1)
between the 2##13##3##(1991-11#2)(2007-10#2)(2007-6#1)(2007-7#1)(2008-4#2)(2009-10#1)(2009-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
between the 3rd and##2##4##(1995-8#1)(2012-2#1)
between the 5S and 18S genes##2##6##(2008-10#2)
between the A and##2##4##(1997-7#1)(2008-10#1)
between the AIDS##2##3##(1997-3#1)(2008-5#1)
between the Ab production efficiency and the##2##7##(2008-11#2)
between the B37 CAG repeat##2##5##(1997-5#2)
between the Bragg##2##3##(2007-12#1)(2008-3#1)
between the CA##2##3##(1995-11#1)(1995-3#1)
between the CER3 and PA-d(31)##3##5##(2008-10#3)
between the CL intensity##2##4##(2008-10#1)(2010-4#1)
between the Chinese##2##3##(2008-10#1)(2008-8#1)
between the DNA##2##3##(2008-10#1)(2008-9#1)
between the G##3##3##(1993-11#2)(1993-9#1)
between the GM and conventional varieties##2##6##(2011-2#2)
between the IVB and the IVB/IVT groups (p = 0##2##10##(2011-2#2)
between the Indiana##2##3##(2008-10#2)
between the LTRAs and##2##4##(2008-3#2)
between the LV and RV##2##5##(2008-10#2)
between the MPUT and parameters of grip force control##2##9##(2013-1#2)
between the N-terminal##3##3##(1992-11#1)(1994-5#1)(2008-10#1)
between the North##2##3##(2008-6#1)(2009-9#1)
between the P-R interval and##3##5##(1994-5#2)(1994-6#1)
between the PFC##3##3##(2013-8#3)
between the RFLP##2##3##(2008-5#1)(2008-9#1)
between the Rsa I genotype and the##2##7##(2008-8#2)
between the T##3##3##(1990-8#1)(2008-10#2)
between the TSK mutation and##2##5##(1997-8#2)
between the UP layers##2##4##(1997-7#2)
between the US-1 and US-8##2##5##(2008-10#2)
between the X##2##3##(2008-10#1)(2008-8#1)
between the a##2##3##(2008-10#1)(2008-3#1)
between the aa sequences of##2##5##(1990-11#1)(1993-12#1)
between the ability of##2##4##(1996-3#1)(2008-10#1)
between the ability to##2##4##(2009-2#1)(2011-2#1)
between the ability##4##3##(1996-3#1)(2008-10#1)(2009-2#1)(2011-2#1)
between the above##2##3##(1995-4#1)(2008-1#1)
between the absorbance##3##3##(2008-10#3)
between the active##3##3##(1990-3#1)(1992-6#1)(2008-10#1)
between the adolescent##2##3##(2008-9#1)(2010-3#1)
between the age of##4##4##(1991-11#1)(1991-3#1)(2006-10#1)(2008-9#1)
between the age##7##3##(1991-11#1)(1991-3#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
between the ages of##12##4##(1990-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(2007-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
between the alpha##2##3##(1991-5#1)(1992-9#1)
between the alpha- and beta-conformations of fac-Re(CO)(3)(dpknph)Cl##3##7##(2008-10#3)
between the alpha- and##5##4##(1991-6#1)(1995-3#1)(2008-10#3)
between the amount of##4##4##(1994-3#1)(2008-10#3)
between the analyte and the##2##5##(2008-10#1)(2010-7#1)
between the analyte and##4##4##(2008-10#3)(2010-7#1)
between the analyte##6##3##(2008-10#5)(2010-7#1)
between the antagonist and##2##4##(2008-10#2)
between the aortic root and the##2##6##(2007-8#2)
between the aortic##3##3##(2007-8#2)(2008-10#1)
between the apparent##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
between the areas##2##3##(1993-11#1)(2008-6#1)
between the aspartate receptor##2##4##(1992-8#2)
between the assessment before treatment with infliximab and##2##8##(2013-8#2)
between the assessment before treatment##3##5##(2013-8#3)
between the auditory cortices##2##4##(1996-5#2)
between the average##4##3##(2008-10#2)(2008-12#1)(2009-11#1)
between the beta##2##3##(1991-5#1)(1994-9#1)
between the binding##3##3##(1990-12#1)(1996-2#1)(1996-5#1)
between the biological##2##3##(1995-2#1)(2008-9#1)
between the biotin##2##3##(1990-2#1)(2008-10#1)
between the body##2##3##(2008-12#1)(2008-5#1)
between the bone##2##3##(1991-11#1)(2011-2#1)
between the brain and##2##4##(2008-2#1)(2008-5#1)
between the camera and the##2##5##(2008-2#1)(2008-3#1)
between the catalytic##5##3##(1990-7#1)(1995-11#1)(1997-2#1)(2008-10#2)
between the cationic##2##3##(2008-10#1)(2009-8#1)
between the cell##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
between the cells and##2##4##(2008-11#1)(2008-7#1)
between the cells of the##2##5##(2008-10#1)(2008-11#1)
between the cells##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
between the central##2##3##(1992-11#1)(1993-11#1)
between the certified##3##3##(2008-10#3)
between the change in##2##4##(1995-8#1)(2008-10#1)
between the channel##2##3##(2007-12#1)(2008-10#1)
between the characteristic##2##3##(2010-10#1)(2013-8#1)
between the child's##4##3##(1993-2#2)(2008-11#1)(2008-12#1)
between the circadian clock and##2##5##(2009-8#2)
between the clinical##7##3##(1993-6#1)(1994-6#1)(1995-5#1)(1997-3#1)(2008-1#1)(2012-12#2)
between the clusters##3##3##(2008-10#1)(2008-6#1)(2009-2#1)
between the community and the##2##5##(1994-1#1)(1996-2#1)
between the complex##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
between the concentration of##8##4##(2008-10#7)(2008-8#1)
between the concentrations##2##3##(1992-11#1)(2008-10#1)
between the control and the##2##5##(2007-12#1)(2011-3#1)
between the control and##4##4##(1990-3#1)(2007-12#1)(2008-2#1)(2011-3#1)
between the control##6##3##(1990-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-3#1)
between the core##4##3##(1994-8#2)(2008-11#1)(2008-3#1)
between the corrected##2##3##(1994-6#1)(2008-2#1)
between the corresponding##2##3##(2008-10#1)(2012-1#1)
between the cytoplasm and the nucleus##2##6##(2011-2#2)
between the daily##2##3##(2008-11#1)(2012-2#1)
between the data##2##3##(2008-10#1)(2008-6#1)
between the degree of##11##4##(1990-2#1)(1992-11#1)(1996-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
between the developing##2##3##(2008-10#1)(2009-10#1)
between the development of##2##4##(2010-1#1)(2013-1#1)
between the diagnosis##2##3##(2011-2#1)(2012-12#1)
between the different categories##3##4##(1990-9#1)(2012-12#2)
between the different##19##3##(1990-9#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
between the diffraction efficiency and the##2##6##(2008-3#2)
between the disease-nonspecific##2##3##(2008-7#2)
between the distance##2##3##(2013-1#2)
between the distribution of##5##4##(1992-2#1)(1994-2#1)(2008-10#2)(2011-1#1)
between the donor##2##3##(2009-10#1)(2009-11#1)
between the drug and##2##4##(1994-5#1)(2008-10#1)
between the drug##4##3##(1994-5#1)(2008-10#3)
between the drugs and##2##4##(1996-5#1)(2008-10#1)
between the duct##2##3##(2007-12#2)
between the duration of##3##4##(2007-7#1)(2008-10#1)(2008-8#1)
between the duration##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
between the dysthymic group and major depression group##2##8##(2011-2#2)
between the education##2##3##(2008-11#2)
between the effect of a##2##5##(1993-11#1)(2008-5#1)
between the effect of##6##4##(1993-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)
between the effects of##5##4##(1993-6#1)(1995-5#1)(2007-11#1)(2008-11#1)(2012-3#1)
between the effects##6##3##(1992-3#1)(1993-6#1)(1995-5#1)(2007-11#1)(2008-11#1)(2012-3#1)
between the electric field##2##4##(2008-3#2)
between the electric##3##3##(2008-10#1)(2008-3#2)
between the electrical##2##3##(2008-3#1)(2010-8#1)
between the electrode and##2##4##(2008-10#1)(2008-12#1)
between the electrode##3##3##(2008-10#2)(2008-12#1)
between the electrodes##3##3##(2007-11#1)(2008-3#2)
between the employees##2##3##(2011-2#2)
between the end of##2##4##(2007-8#1)(2012-9#1)
between the endoplasmic reticulum and the Golgi apparatus##2##8##(1990-7#1)(2008-11#1)
between the environment##2##3##(1995-11#1)(2007-12#1)
between the enzymatic##2##3##(1990-12#1)(2008-10#1)
between the enzyme and##2##4##(1995-2#1)(2008-10#1)
between the estimates of##2##4##(2012-2#1)(2012-7#1)
between the estimation and production trials##2##6##(2013-8#2)
between the estimation and production##3##5##(2013-8#3)
between the expected##2##3##(2008-10#2)
between the experimental and theoretical##2##5##(2008-3#2)
between the experimental and##4##4##(2008-2#1)(2008-3#2)(2011-2#1)
between the experimental##9##3##(1995-3#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
between the expression of##7##4##(1990-12#1)(1997-6#1)(2010-3#1)(2011-3#2)(2013-8#2)
between the extinction##2##3##(2008-2#1)(2008-3#1)
between the extracellular##2##3##(1993-2#1)(2008-10#1)
between the extreme##2##3##(2008-3#1)(2008-8#1)
between the extremes##2##3##(2008-10#1)(2011-1#1)
between the features##2##3##(2010-4#1)(2010-8#1)
between the fields##2##3##(2007-10#2)
between the fifth and##2##4##(2007-12#1)(2008-10#1)
between the films##2##3##(2008-10#2)
between the first and second##4##5##(1995-5#1)(1995-8#1)(2008-10#1)(2011-2#1)
between the first and##5##4##(1995-5#1)(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
between the first##7##3##(1995-5#1)(1995-8#1)(2008-10#3)(2008-3#1)(2011-2#1)
between the fluorescence intensity and##2##5##(2008-10#2)
between the fluorescence intensity##3##4##(2008-10#2)(2008-3#1)
between the fluorescence##6##3##(2007-11#1)(2008-10#4)(2008-3#1)
between the focal##2##3##(1997-4#1)(2008-3#1)
between the following##2##3##(2008-7#1)(2010-3#1)
between the four##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
between the fourth and##2##4##(2007-12#1)(2012-3#1)
between the fraction of##2##4##(2008-10#2)
between the frequency of social support##2##6##(2009-7#2)
between the frequency of##5##4##(2008-12#1)(2009-7#2)(2013-1#2)
between the frequency##7##3##(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#2)(2013-1#2)
between the functional##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
between the fundamental##2##3##(2007-12#1)(2010-2#1)
between the fungal##3##3##(2008-10#2)(2011-10#1)
between the gene##2##3##(2007-12#1)(2008-8#1)
between the genera##2##3##(2008-6#1)(2008-7#1)
between the genes##3##3##(1995-6#1)(1997-6#1)(2008-9#1)
between the genetic variation and##2##5##(2010-1#1)(2013-8#1)
between the genetic##4##3##(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
between the grazing intensity and amount of##2##7##(2008-12#2)
between the group of patients##2##5##(1992-12#1)(2011-2#1)
between the group of##3##4##(1992-12#1)(2010-6#1)(2011-2#1)
between the group##4##3##(1992-12#1)(2009-10#1)(2010-6#1)(2011-2#1)
between the groups (all##2##4##(1997-7#1)(2011-2#1)
between the groups as##2##4##(1995-8#1)(2012-3#1)
between the groups with##2##4##(1995-4#1)(2009-12#1)
between the groups##30##3##(1990-3#1)(1990-5#1)(1991-2#1)(1995-1#1)(1995-4#1)(1995-8#1)(1997-7#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-8#1)
between the hair##3##3##(2008-5#3)
between the health service##2##4##(1997-8#1)(2008-12#1)
between the health##4##3##(1992-2#1)(1997-8#1)(2008-1#1)(2008-12#1)
between the heat##2##3##(2008-10#1)(2011-1#1)
between the high and##2##4##(2008-10#1)(2008-9#1)
between the high plasma digoxin level and serum##2##8##(1994-6#2)
between the high##5##3##(1994-6#2)(2008-10#2)(2008-9#1)
between the hippocampus and##2##4##(1993-6#1)(1994-3#1)
between the home##2##3##(1992-2#1)(1995-3#1)
between the hospital and##2##4##(1993-1#1)(1995-2#1)
between the hospital##3##3##(1993-1#1)(1995-2#1)(2008-11#1)
between the hospitals##4##3##(1991-2#1)(1991-9#1)(1997-2#1)(2006-8#1)
between the host and the##2##5##(2008-10#1)(2008-5#1)
between the host and##3##4##(2008-10#2)(2008-5#1)
between the host##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
between the human##2##3##(1991-12#1)(2008-4#1)
between the hydroxyl groups of##2##5##(2008-10#1)(2008-5#1)
between the image##2##3##(2008-3#1)(2008-6#1)
between the immobilized##2##3##(2008-10#2)
between the in vitro and in vivo##2##7##(2008-5#1)(2009-12#1)
between the in vitro and in##3##6##(2008-5#1)(2009-12#2)
between the in vitro##5##4##(1997-7#1)(2008-5#2)(2009-12#2)
between the incidence##2##3##(2008-10#2)
between the incident##2##3##(2008-2#1)(2008-3#1)
between the increase in##3##4##(1994-5#1)(1996-12#1)(2008-10#1)
between the increasing##2##3##(1990-6#2)
between the index##4##3##(1992-2#1)(1996-2#1)(2008-11#1)(2008-3#1)
between the initial##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
between the input and the reference##2##6##(2008-2#1)(2008-3#1)
between the input and##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
between the input##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
between the intensity of the##2##5##(1990-7#1)(2008-10#1)
between the intensity##4##3##(1990-7#1)(2008-10#2)(2008-3#1)
between the intracellular##2##3##(1996-5#1)(2008-11#1)
between the iol and hut operons##2##6##(1995-12#2)
between the ion##2##3##(1994-6#1)(2008-10#1)
between the iron##2##3##(1994-5#1)(1995-11#1)
between the known##2##3##(1995-3#1)(2008-4#1)
between the laser##4##3##(2007-12#3)(2008-3#1)
between the latter##3##3##(1996-7#1)(2008-9#1)(2009-7#1)
between the layers of the##2##5##(2008-3#1)(2012-12#1)
between the layers##4##3##(2008-3#3)(2012-12#1)
between the left and right##4##5##(2007-7#1)(2008-7#1)(2011-2#2)
between the left and##5##4##(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#2)
between the left##7##3##(2007-7#1)(2008-1#1)(2008-7#1)(2010-3#2)(2011-2#2)
between the length of##3##4##(1991-2#1)(1994-11#1)(2007-8#1)
between the level of##10##4##(1990-10#1)(1990-11#1)(1992-10#1)(1992-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
between the levels of##3##4##(1991-1#1)(1994-12#1)(2008-10#1)
between the levels##4##3##(1991-1#1)(1994-12#1)(2008-10#1)(2009-9#1)
between the ligand##2##3##(1992-3#1)(2008-10#1)
between the light##2##3##(2008-10#1)(2008-3#1)
between the lipid##2##3##(2009-12#1)(2009-5#1)
between the local##2##3##(1995-6#1)(2008-3#1)
between the logarithm of##2##4##(2008-10#2)
between the long##2##3##(2008-5#1)(2013-1#1)
between the major##2##3##(2008-10#2)
between the male and female##3##5##(2008-11#1)(2008-12#1)(2008-8#1)
between the male and##4##4##(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
between the marker##2##3##(2007-11#1)(2008-10#1)
between the markers##4##3##(1995-6#1)(2008-11#1)(2009-2#2)
between the mass##2##3##(2011-1#1)(2012-12#1)
between the masticatory##2##3##(2010-9#1)(2012-12#1)
between the maximum##3##3##(1990-7#1)(2008-2#2)
between the mean and##2##4##(1993-9#1)(2008-3#1)
between the mean##7##3##(1991-4#1)(1993-9#1)(2008-10#1)(2008-3#3)(2008-7#1)
between the measured and the##2##5##(2007-11#1)(2008-3#1)
between the measured and##5##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
between the measured##19##3##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#4)(2008-7#1)(2008-9#1)(2011-1#2)(2012-1#1)
between the measures of##2##4##(2008-10#1)(2013-1#1)
between the measures##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
between the mechanical##2##3##(2007-10#1)(2011-2#1)
between the medial##2##3##(2007-12#1)(2009-4#1)
between the medical care##2##4##(1995-12#1)(2013-8#1)
between the medical##5##3##(1995-12#1)(2008-12#1)(2008-7#1)(2013-8#2)
between the membrane and##2##4##(2008-3#1)(2009-9#1)
between the metabolic syndrome##2##4##(2008-1#1)(2011-1#1)
between the metabolic##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
between the metabolome and##2##4##(2009-8#1)(2012-5#1)
between the metal##4##3##(1997-7#1)(2008-10#3)
between the methods of##2##4##(1992-5#1)(2010-8#1)
between the methods##6##3##(1992-5#1)(1997-3#1)(2008-10#3)(2010-8#1)
between the model and the##2##5##(2008-3#1)(2010-4#1)
between the model and##5##4##(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)
between the model##11##3##(1990-12#2)(1994-5#1)(2008-3#2)(2008-7#3)(2010-10#1)(2010-4#1)(2011-2#1)
between the modules##2##3##(1992-12#1)(2012-3#1)
between the mouse##2##3##(1991-6#1)(1994-12#1)
between the muscle##2##3##(1995-12#1)(2010-12#1)
between the natural##2##3##(2008-10#1)(2008-11#1)
between the new##3##3##(2008-10#2)(2011-2#1)
between the normal and the##2##5##(1995-12#1)(2009-8#1)
between the normal and##4##4##(1994-2#1)(1995-12#1)(2008-5#1)(2009-8#1)
between the normal##5##3##(1994-2#1)(1995-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
between the nuclear##2##3##(2008-10#1)(2008-8#1)
between the nucleus and the##2##5##(2008-1#1)(2012-2#1)
between the nucleus and##3##4##(2008-1#1)(2012-12#1)(2012-2#1)
between the number of pops and##2##6##(2008-12#2)
between the number of##14##4##(1990-2#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
between the number##15##3##(1990-2#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
between the numbers of##2##4##(2008-10#1)(2012-3#1)
between the numerical##2##3##(2008-2#1)(2008-3#1)
between the nursing##2##3##(2008-11#2)
between the object and the##2##5##(2008-2#2)
between the object and##3##4##(2008-2#2)(2008-5#1)
between the observed and##3##4##(2008-10#1)(2008-8#1)(2009-9#1)
between the observed##4##3##(2008-10#2)(2008-8#1)(2009-9#1)
between the obtained results and##2##5##(2008-10#2)
between the obtained##3##3##(2008-10#2)(2008-2#1)
between the occurrence of##3##4##(1990-8#1)(1997-6#1)(2010-3#1)
between the olfactory bulb and the piriform cortex##2##8##(2013-1#2)
between the onset of symptoms and diagnosis##2##7##(2012-12#2)
between the onset of symptoms and##4##6##(2012-12#4)
between the onset of##5##4##(2008-7#1)(2012-12#4)
between the optical##5##3##(1994-5#1)(2008-2#2)(2008-3#2)
between the optimal##2##3##(2008-2#1)(2008-3#1)
between the organic##2##3##(2008-10#1)(2010-4#1)
between the original##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
between the other##2##3##(2008-10#1)(2012-2#1)
between the outcome##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
between the output##2##3##(2008-3#2)
between the overall##3##3##(2008-10#1)(2009-2#1)(2010-8#1)
between the parents and##2##4##(1990-12#1)(2008-4#1)
between the parents##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
between the partners##2##3##(2008-7#1)(2010-10#1)
between the pathogen and##2##4##(2008-10#1)(2013-1#1)
between the patient and##5##4##(2007-10#1)(2008-6#1)(2010-5#1)(2010-6#1)(2011-1#1)
between the patient##6##3##(2007-10#1)(2008-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
between the peak area of##2##5##(2008-10#2)
between the peak area##4##4##(2008-10#3)(2011-1#1)
between the peak intensity of the C?N stretching band and the concentration of##2##13##(2008-2#2)
between the peak##11##3##(2008-10#7)(2008-2#3)(2011-1#1)
between the perceived##2##3##(2008-9#1)(2009-7#1)
between the percentage##2##3##(1994-2#1)(2008-10#1)
between the performance of##4##4##(1993-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
between the phylogenetic##2##3##(2011-2#1)(2012-3#1)
between the plasma membrane and##2##5##(1997-6#1)(2009-9#1)
between the plasma##4##3##(1992-11#1)(1997-6#1)(2008-9#1)(2009-9#1)
between the points##2##3##(2013-1#2)
between the polarization-state##2##3##(2007-11#1)(2008-3#1)
between the polymer##2##3##(2009-11#1)(2010-12#1)
between the populations##6##3##(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
between the positions##2##3##(1991-8#1)(2008-6#1)
between the potential change (peak height) and the##2##8##(2008-10#2)
between the potential##3##3##(2008-10#3)
between the predicted and the##2##5##(2008-10#1)(2013-1#1)
between the predicted and##3##4##(2008-10#2)(2013-1#1)
between the predicted##6##3##(1991-5#1)(1991-9#1)(2008-10#3)(2013-1#1)
between the prefrontal cortex and##2##5##(2008-7#1)(2013-8#1)
between the presence of WICE and##2##6##(1994-7#2)
between the presence of##7##4##(1991-8#1)(1994-7#2)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
between the previously##2##3##(1993-12#1)(1993-8#1)
between the primary##3##3##(2008-10#1)(2010-10#1)(2011-2#1)
between the principal##3##3##(2007-12#1)(2012-12#1)(2013-8#1)
between the probe and the##2##5##(2008-3#1)(2008-7#1)
between the probe and##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
between the production of##3##4##(1995-2#1)(2008-11#1)(2013-8#1)
between the proportion of##3##4##(2008-11#1)(2009-5#1)(2010-6#1)
between the proposed method and the##2##6##(2008-10#2)
between the proposed method and##3##5##(2008-10#3)
between the proposed##8##3##(2008-10#8)
between the protein and the##3##5##(1992-6#1)(1994-3#1)(1997-2#1)
between the protein##5##3##(1992-6#1)(1993-11#1)(1994-3#1)(1997-2#1)(2009-6#1)
between the proximal##2##3##(1997-8#1)(2008-6#1)
between the pulse##2##3##(2007-11#1)(2008-3#1)
between the pump and the##2##5##(2007-12#1)(2008-2#1)
between the pump##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
between the quality##2##3##(2008-11#1)(2008-3#1)
between the quantities##2##3##(1990-8#1)(2008-10#1)
between the rat and##3##4##(1991-9#1)(1996-12#1)(2008-11#1)
between the rate of##5##4##(1992-8#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)
between the rates of##2##4##(1991-5#1)(2008-10#1)
between the ratio of##3##4##(2008-10#3)
between the rats treated with##2##5##(2011-1#2)
between the receptor##3##3##(2008-3#1)(2008-7#2)
between the recordings##2##3##(2008-3#2)
between the redox##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
between the reference and the##3##5##(2008-2#1)(2008-3#2)
between the reference and##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
between the reference##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
between the relative abundance of##2##5##(2008-10#1)(2008-5#1)
between the relative##8##3##(1994-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)
between the researcher and the##2##5##(1992-2#1)(2012-2#1)
between the resistance and##2##4##(2008-10#2)
between the resistance##4##3##(2008-10#3)(2008-12#1)
between the resistant##9##3##(2008-10#8)(2011-2#1)
between the responses of the##2##5##(1994-12#1)(2008-7#1)
between the responses##5##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
between the results obtained by the proposed method and##2##9##(2008-10#2)
between the results obtained by the proposed##3##7##(2008-10#3)
between the results obtained by the##5##6##(2008-10#5)
between the results obtained by##6##5##(2008-10#6)
between the results obtained in##2##5##(2008-10#2)
between the results obtained with the##2##6##(2008-10#1)(2008-3#1)
between the results obtained with##3##5##(1993-8#1)(2008-10#1)(2008-3#1)
between the results obtained##13##4##(1993-8#1)(2008-10#10)(2008-3#2)
between the results of the two##2##6##(2008-10#1)(2008-4#1)
between the results of these##2##5##(1995-5#1)(2011-2#1)
between the results of##5##4##(1995-5#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
between the results##24##3##(1993-8#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#14)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#1)
between the risk##3##3##(1991-6#1)(2009-7#1)(2013-8#1)
between the sample and##2##4##(2007-12#1)(2008-10#1)
between the sample##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
between the sampling points##2##4##(2008-3#2)
between the second##2##3##(1997-3#1)(2009-7#1)
between the secondary##2##3##(2008-4#1)(2008-7#1)
between the sensitivity##2##3##(2007-12#1)(2008-10#1)
between the sensor##2##3##(2008-10#2)
between the separation##3##3##(2008-10#3)
between the serum##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
between the services##2##3##(2012-3#2)
between the severity of##4##4##(1991-9#1)(1993-8#1)(2008-11#1)(2011-2#1)
between the sexes##16##3##(1995-2#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#4)(2012-3#1)(2013-7#1)(2013-8#1)
between the shape of##2##4##(1991-2#1)(2008-8#1)
between the signal and the##7##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
between the signal and##8##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
between the signal sequence and##2##5##(1991-6#1)(2008-11#1)
between the signal##11##3##(1991-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
between the site of##2##4##(1991-6#2)
between the six##2##3##(2008-1#1)(2011-2#1)
between the sixth and seventh##2##5##(1995-8#1)(2007-12#1)
between the size of##4##4##(1993-11#1)(1996-1#1)(1996-12#1)(1997-9#1)
between the skin##2##3##(1991-8#1)(2012-3#1)
between the solute and the##2##5##(1990-8#1)(2008-7#1)
between the spatial and##2##4##(2008-3#1)(2013-8#1)
between the spatial##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
between the species##6##3##(2008-10#2)(2008-8#3)(2012-3#1)
between the specific##3##3##(1994-5#1)(1995-5#1)(2008-7#1)
between the spectral##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
between the stability of the##2##5##(2008-10#2)
between the standard##2##3##(2008-10#1)(2009-2#1)
between the stimuli##2##3##(2008-9#1)(2009-8#1)
between the strains##3##3##(2008-10#3)
between the stretching##2##3##(2008-2#1)(2008-3#1)
between the structural##3##3##(1997-6#1)(2008-10#1)(2010-2#1)
between the structure of the##3##5##(1993-8#1)(2008-10#2)
between the structure of##4##4##(1993-8#1)(2008-10#2)(2008-4#1)
between the structure##6##3##(1993-8#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)
between the studies##2##3##(2008-12#1)(2009-6#1)
between the surface##2##3##(2008-3#1)(2013-8#1)
between the test and##2##4##(2008-3#1)(2011-2#1)
between the tests##2##3##(2007-7#1)(2008-12#1)
between the theoretical and experimental results##2##6##(2007-11#1)(2008-10#1)
between the theoretical and the##2##5##(2008-3#1)(2009-12#1)
between the theoretical and##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2009-12#1)
between the three groups##8##4##(1996-12#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-10#3)(2012-2#1)
between the three major##2##4##(2008-12#1)(2013-1#1)
between the three syndromic groups##2##5##(2009-10#2)
between the three##25##3##(1990-6#1)(1992-10#1)(1992-4#1)(1996-12#2)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#5)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
between the time##5##3##(1991-12#1)(1993-3#1)(2008-11#2)(2011-2#1)
between the total##4##3##(1991-5#1)(1995-12#1)(2008-10#1)(2008-3#1)
between the transition##2##3##(2008-10#1)(2008-2#1)
between the transmitted##3##3##(2008-3#3)
between the treatment##2##3##(1993-11#1)(2008-10#1)
between the treatments##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
between the trp repressor and##2##5##(1992-6#2)
between the tube##2##3##(2008-7#1)(2011-1#1)
between the tubes##2##3##(2008-7#1)(2012-2#1)
between the two cell lines##4##5##(2008-11#1)(2008-9#2)(2012-12#1)
between the two cell##5##4##(1993-3#1)(2008-11#1)(2008-9#2)(2012-12#1)
between the two conditions##2##4##(2009-11#1)(2010-6#1)
between the two cyanine subunits##2##5##(2008-10#2)
between the two diseases##2##4##(1994-8#1)(2008-10#1)
between the two electrodes##4##4##(2007-12#1)(2008-10#3)
between the two extremes##2##4##(2008-10#1)(2008-9#1)
between the two fungi likely##2##5##(2008-10#2)
between the two genes##2##4##(1991-7#1)(1995-8#1)
between the two grating planes on the moiré fringes in##2##10##(2008-3#2)
between the two grating planes##4##5##(2008-3#4)
between the two groups at##2##5##(2011-2#1)(2013-1#1)
between the two groups for##2##5##(2008-12#1)(2012-12#1)
between the two groups in the##3##6##(1990-2#1)(1995-4#1)(2007-11#1)
between the two groups in##4##5##(1990-2#1)(1990-6#1)(1995-4#1)(2007-11#1)
between the two groups of##6##5##(1995-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
between the two groups was##2##5##(2008-7#1)(2011-1#1)
between the two groups##60##4##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-7#1)(1995-12#2)(1995-4#1)(1996-2#2)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
between the two groups'##2##4##(1996-1#1)(2007-2#1)
between the two hexasaccharide variants was the presence##2##8##(1990-7#2)
between the two host-adapted populations##2##5##(2008-10#2)
between the two images##2##4##(2008-3#1)(2008-6#1)
between the two major##3##4##(1995-8#1)(2008-10#1)(2009-6#1)
between the two methods for##2##5##(2008-3#2)
between the two methods of analysis##2##6##(2008-10#2)
between the two methods were##2##5##(2008-10#2)
between the two methods##15##4##(1992-12#1)(2008-10#10)(2008-2#1)(2008-3#2)(2013-1#1)
between the two monolayers##2##4##(1990-11#1)(2007-12#1)
between the two phases##2##4##(1991-6#1)(1994-12#1)
between the two populations##3##4##(1992-10#1)(2008-10#2)
between the two proteins##6##4##(1991-9#2)(1993-8#1)(2008-2#1)(2009-10#1)(2012-2#1)
between the two receptor##2##4##(1993-6#1)(2008-11#1)
between the two samples##3##4##(2008-10#1)(2008-2#1)(2010-1#1)
between the two sides##2##4##(2008-10#1)(2008-8#1)
between the two species in##3##5##(1991-6#1)(2008-8#2)
between the two species##12##4##(1991-6#2)(1994-11#2)(1996-5#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#2)
between the two strains##3##4##(2007-6#1)(2008-10#2)
between the two subunits##3##4##(1990-8#1)(1992-6#1)(2010-5#1)
between the two techniques##2##4##(1995-5#1)(2008-8#1)
between the two treatment groups##4##5##(1992-6#1)(1995-4#1)(1997-7#1)(2008-6#1)
between the two treatment##5##4##(1992-6#1)(1992-9#1)(1995-4#1)(1997-7#1)(2008-6#1)
between the two types of##4##5##(1993-1#1)(1993-8#1)(2011-2#1)(2013-8#1)
between the two waveguides##2##4##(2007-11#1)(2008-3#1)
between the two##351##3##(1990-11#1)(1990-2#1)(1990-6#2)(1990-7#4)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-12#3)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#3)(1993-12#3)(1993-3#3)(1993-6#3)(1993-8#4)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#3)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#4)(1997-6#3)(1997-7#2)(2007-10#1)(2007-11#13)(2007-12#10)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#65)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#25)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#6)(2011-1#4)(2011-2#8)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#11)(2013-8#3)
between the upper and lower##2##5##(2008-10#1)(2012-12#1)
between the upper and##3##4##(2008-10#2)(2012-12#1)
between the use of##6##4##(1996-3#2)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
between the values of##3##4##(1992-8#1)(2008-2#1)(2011-1#1)
between the values##4##3##(1992-8#1)(2008-2#1)(2008-3#1)(2011-1#1)
between the variables##3##3##(2008-10#3)
between the various histological types of lung cancer##2##8##(1996-9#2)
between the various##16##3##(1994-9#1)(1995-5#1)(1996-2#1)(1996-9#2)(1997-3#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-1#1)(2009-11#1)(2010-6#1)(2013-1#1)
between the width of the##2##5##(2008-5#1)(2013-8#1)
between the wild##2##3##(2008-8#1)(2010-4#1)
between the wild-type and mutant##2##5##(1992-8#1)(2008-10#1)
between the wild-type and##3##4##(1992-8#1)(2008-10#1)(2008-8#1)
between the years##8##3##(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2013-1#1)
between the young##2##3##(1994-5#1)(2008-9#1)
between the youngest##2##3##(2008-7#1)(2009-2#1)
between the##2808##2##(1990-10#1)(1990-11#6)(1990-12#8)(1990-2#11)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#7)(1990-7#17)(1990-8#12)(1990-9#5)(1991-1#2)(1991-11#7)(1991-12#6)(1991-2#12)(1991-3#5)(1991-4#1)(1991-5#11)(1991-6#16)(1991-7#1)(1991-8#6)(1991-9#11)(1992-1#1)(1992-10#4)(1992-11#7)(1992-12#10)(1992-2#11)(1992-3#10)(1992-4#2)(1992-5#4)(1992-6#12)(1992-8#5)(1992-9#9)(1993-1#6)(1993-11#14)(1993-12#19)(1993-2#8)(1993-3#9)(1993-5#1)(1993-6#10)(1993-8#12)(1993-9#3)(1994-1#4)(1994-11#5)(1994-12#13)(1994-2#6)(1994-3#10)(1994-5#22)(1994-6#12)(1994-7#5)(1994-8#13)(1994-9#3)(1995-1#3)(1995-11#4)(1995-12#16)(1995-2#13)(1995-3#15)(1995-4#4)(1995-5#14)(1995-6#8)(1995-8#14)(1995-9#1)(1996-1#7)(1996-11#2)(1996-12#17)(1996-2#20)(1996-3#5)(1996-5#9)(1996-6#4)(1996-7#3)(1996-9#3)(1997-1#2)(1997-2#18)(1997-3#17)(1997-4#9)(1997-5#5)(1997-6#15)(1997-7#18)(1997-8#9)(1997-9#2)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#20)(2007-11#58)(2007-12#75)(2007-2#1)(2007-5#2)(2007-6#4)(2007-7#8)(2007-8#16)(2007-9#3)(2008-1#22)(2008-10#565)(2008-11#78)(2008-12#41)(2008-2#82)(2008-3#212)(2008-4#28)(2008-5#76)(2008-6#36)(2008-7#76)(2008-8#68)(2008-9#62)(2009-1#1)(2009-10#13)(2009-11#9)(2009-12#11)(2009-2#11)(2009-3#7)(2009-4#2)(2009-5#8)(2009-6#5)(2009-7#15)(2009-8#13)(2009-9#10)(2010-1#4)(2010-10#10)(2010-11#4)(2010-12#6)(2010-2#10)(2010-3#14)(2010-4#18)(2010-5#9)(2010-6#8)(2010-7#6)(2010-8#21)(2010-9#2)(2011-1#36)(2011-10#1)(2011-2#91)(2011-3#4)(2011-4#1)(2012-1#9)(2012-12#38)(2012-2#40)(2012-3#34)(2012-5#2)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#62)(2013-7#9)(2013-8#59)
between their##24##2##(1993-1#1)(1993-6#1)(1996-3#1)(1997-6#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#2)(2013-1#3)(2013-8#1)
between them and the##2##4##(2008-12#1)(2012-2#1)
between them and##4##3##(1991-12#1)(1996-12#1)(2008-12#1)(2012-2#1)
between them by##2##3##(2008-3#2)
between them was##2##3##(1994-11#1)(2008-8#1)
between them were##2##3##(2008-5#1)(2013-8#1)
between them##52##2##(1990-11#1)(1991-12#1)(1991-3#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#6)(2009-11#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
between theoretical and experimental##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
between theory and experiment is##3##5##(1992-5#1)(2007-12#1)(2008-2#1)
between theory and experiment##8##4##(1992-5#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)
between theory and practice##2##4##(1997-3#1)(2008-11#1)
between theory and##11##3##(1992-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)
between theory##13##2##(1992-5#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)
between thermodynamic##2##2##(1995-5#1)(2008-5#1)
between these different##3##3##(1992-4#1)(2011-2#1)(2012-2#1)
between these entities##2##3##(2008-3#1)(2012-12#1)
between these factors and##2##4##(2011-1#1)(2013-8#1)
between these factors##5##3##(1990-3#1)(1991-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
between these fungi##2##3##(2008-10#2)
between these groups##5##3##(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
between these isolates##2##3##(2008-10#2)
between these measurements##2##3##(2007-11#1)(2008-3#1)
between these parameters##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
between these possibilities##2##3##(1994-5#1)(2009-8#1)
between these proteins##3##3##(1994-5#1)(2009-10#1)(2013-8#1)
between these regions##2##3##(1995-5#1)(2008-4#1)
between these species##4##3##(2008-10#2)(2008-7#1)(2010-3#1)
between these states##2##3##(1991-8#1)(2008-8#1)
between these three##2##3##(2012-3#1)(2013-1#1)
between these traits was##2##4##(2008-10#1)(2008-8#1)
between these traits##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
between these two diseases##3##4##(2012-12#1)(2012-3#2)
between these two forms##2##4##(2008-7#1)(2009-7#1)
between these two functions##2##4##(1993-12#1)(2008-10#1)
between these two groups##5##4##(1990-2#1)(1992-11#1)(2008-1#2)(2008-8#1)
between these two methods##4##4##(2008-10#3)(2008-2#1)
between these two parameters##2##4##(1994-5#1)(2008-10#1)
between these two species##3##4##(1996-12#1)(2008-10#1)(2011-2#1)
between these two viroids in##2##5##(2008-10#2)
between these two##67##3##(1990-2#1)(1991-8#1)(1992-11#1)(1993-12#1)(1994-5#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)
between these variables##2##3##(2008-10#1)(2009-8#1)
between these##174##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#4)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#32)(2008-11#6)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#6)(2008-7#9)(2008-8#3)(2008-9#5)(2009-10#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#13)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#4)
between this method and##2##4##(2007-11#1)(2008-10#1)
between this polymorphism and##2##4##(2008-12#1)(2008-6#1)
between this##28##2##(1991-11#1)(1991-2#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#3)(2013-7#1)
between those of##3##3##(1990-11#1)(1994-5#1)(2008-5#1)
between those who frequently##2##4##(2009-5#2)
between those who##6##3##(1992-2#1)(1993-3#1)(2008-11#1)(2009-10#1)(2009-5#2)
between those with##2##3##(2007-10#1)(2007-2#1)
between those##25##2##(1990-11#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#2)(2012-12#2)(2013-1#1)
between three and##2##3##(1990-8#1)(2008-9#1)
between three different##2##3##(2008-10#1)(2008-5#1)
between three##9##2##(1990-8#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
between tight##2##2##(2009-10#2)
between time##2##2##(1992-9#1)(2012-2#1)
between today's##2##2##(1993-3#2)
between tolerance##2##2##(2007-5#1)(2008-10#1)
between total##9##2##(1991-12#2)(1992-12#1)(2008-10#3)(2008-3#1)(2009-4#1)(2012-3#1)
between training and##2##3##(1993-2#1)(2009-3#1)
between training##3##2##(1993-2#1)(1996-3#1)(2009-3#1)
between traits##6##2##(1997-4#1)(2008-8#1)(2010-4#1)(2012-3#3)
between transcription##2##2##(1994-8#1)(2008-7#1)
between transdermal and oral granisetron##3##5##(2010-12#3)
between transgenic and##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
between transgenic##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
between treated and##4##3##(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
between treatment and##2##3##(1993-9#1)(2012-3#1)
between treatment groups##6##3##(2008-7#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
between treatment##13##2##(1993-9#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#2)(2012-2#2)(2012-3#2)
between treatments were##2##3##(2008-10#2)
between treatments##14##2##(1993-1#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-7#2)
between trees and##2##3##(2008-10#1)(2008-3#1)
between trials##4##2##(2008-10#1)(2010-11#2)(2013-8#1)
between trophic##2##2##(2008-6#1)(2008-8#1)
between true and##2##3##(2008-10#2)
between true##3##2##(2008-10#2)(2008-11#1)
between tumor##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
between tumors##2##2##(1993-11#1)(2013-8#1)
between tumour##4##2##(1997-4#1)(2007-10#1)(2008-1#1)(2008-7#1)
between twins##2##2##(1997-7#1)(2008-12#1)
between two Drosophila species##2##4##(2008-9#2)
between two adjacent##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
between two alternative##2##3##(2008-10#1)(2009-5#1)
between two and##2##3##(1992-9#1)(2008-2#1)
between two closely##2##3##(2007-11#1)(2009-8#1)
between two consecutive##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
between two different##4##3##(2008-3#1)(2008-4#2)(2012-2#1)
between two glass##2##3##(1996-12#1)(2008-3#1)
between two groups of##2##4##(2008-2#1)(2008-5#1)
between two groups##7##3##(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
between two identical##3##3##(1992-3#1)(2008-3#2)
between two individuals##2##3##(1995-6#1)(2012-3#1)
between two isolates of##2##4##(2008-10#2)
between two laser##2##3##(2008-2#1)(2013-7#1)
between two major##2##3##(2008-10#1)(2008-8#1)
between two of##2##3##(2008-5#1)(2009-9#1)
between two or more##3##4##(1992-5#1)(2008-10#1)(2012-2#1)
between two samples##2##3##(2008-10#1)(2008-4#1)
between two separate##2##3##(1991-5#1)(2007-11#1)
between two sibling##2##3##(1996-6#1)(2008-9#1)
between two##186##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#2)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-11#13)(2007-12#6)(2008-10#27)(2008-11#8)(2008-12#3)(2008-2#13)(2008-3#20)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#5)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
between two-dimensional##2##2##(2007-12#1)(2008-2#1)
between type##6##2##(1992-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2010-3#1)(2012-12#1)
between types of##4##3##(1992-12#1)(1992-3#1)(1995-2#1)(1996-2#1)
between types##6##2##(1992-12#1)(1992-3#2)(1994-12#1)(1995-2#1)(1996-2#1)
between typical##2##2##(2008-10#1)(2009-4#1)
between tyrosine##3##2##(1994-6#1)(1996-12#1)(1996-2#1)
between university##2##2##(1993-6#1)(1995-1#1)
between unrelated individuals##2##3##(2008-8#1)(2012-3#1)
between up and down##2##4##(2008-11#2)
between urban and rural##3##4##(1996-3#1)(2013-1#2)
between urea##2##2##(1995-3#1)(2009-8#1)
between using 1##2##3##(1993-3#2)
between using##5##2##(1993-3#2)(2008-9#1)(2009-8#1)(2011-2#1)
between uterine##3##2##(1993-12#2)(2008-9#1)
between vaccine responders##2##3##(2012-12#2)
between vaccine##3##2##(1995-2#1)(2012-12#2)
between values##2##2##(2008-10#1)(2008-8#1)
between van't Hoff and calorimetric##3##5##(1997-2#3)
between variables##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
between variation in##2##3##(2008-10#1)(2008-7#1)
between various types of##2##4##(1990-5#1)(2010-10#1)
between various##14##2##(1990-5#1)(1990-6#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)
between vascular##2##2##(2006-6#1)(2008-12#1)
between vestibulo-ocular reflex and optokinetic afternystagmus in normal subjects and in patients with##2##13##(2008-4#2)
between viable##2##2##(2008-10#1)(2008-9#1)
between villous height and the##2##5##(2013-1#2)
between viral and cellular##2##4##(2008-10#1)(2009-2#1)
between viral and##3##3##(2008-10#1)(2009-2#1)(2011-3#1)
between viral##4##2##(1997-1#1)(2008-10#1)(2009-2#1)(2011-3#1)
between virulence and vertical transmission##4##5##(2008-9#4)
between virulence and##6##3##(2008-10#2)(2008-9#4)
between virulence##7##2##(2008-10#3)(2008-9#4)
between virus##2##2##(1997-6#1)(2009-2#1)
between viruses##3##2##(2008-10#2)(2013-1#1)
between visual##5##2##(1996-2#1)(2008-10#1)(2008-5#2)(2008-8#1)
between warm and##2##3##(1991-8#1)(2012-12#1)
between water and##3##3##(1990-7#1)(2008-10#1)(2010-8#1)
between water##4##2##(1990-7#1)(2008-10#2)(2010-8#1)
between wavelength##2##2##(2007-11#1)(2008-2#1)
between weakly and strongly absorbing aerosols##2##6##(2008-2#1)(2008-3#1)
between wear##2##2##(2008-8#1)(2008-9#1)
between weather##2##2##(2008-10#2)
between weight-related beliefs and consumption of##2##6##(2011-2#2)
between weight-related##3##2##(2007-12#1)(2011-2#2)
between what##5##2##(1991-1#1)(1991-3#1)(1996-3#1)(2010-10#1)(2010-12#1)
between wheat##4##2##(1993-11#1)(2008-10#1)(2008-9#1)(2009-12#1)
between whole##2##2##(2008-10#1)(2010-1#1)
between wild##2##2##(2008-10#1)(2008-12#1)
between wild-type##2##2##(2008-7#1)(2008-9#1)
between women and men##2##4##(2008-5#1)(2009-11#1)
between women##3##2##(1996-12#1)(2008-5#1)(2009-11#1)
between women's##2##2##(2008-5#1)(2010-11#1)
between work##2##2##(1991-6#1)(2010-4#1)
between working conditions and##2##4##(1992-5#2)
between working##3##2##(1992-5#2)(2013-7#1)
between years##13##2##(2008-10#11)(2008-12#1)(2012-3#1)
between young##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
between younger and older##2##4##(2008-5#1)(2013-8#1)
between yttrium and##3##3##(2008-10#3)
between##11477##1##(1990-10#4)(1990-11#24)(1990-12#41)(1990-2#32)(1990-3#21)(1990-4#3)(1990-5#34)(1990-6#18)(1990-7#34)(1990-8#49)(1990-9#15)(1991-1#14)(1991-10#1)(1991-11#26)(1991-12#45)(1991-2#36)(1991-3#29)(1991-4#3)(1991-5#35)(1991-6#37)(1991-7#1)(1991-8#30)(1991-9#25)(1992-1#12)(1992-10#11)(1992-11#17)(1992-12#43)(1992-2#27)(1992-3#45)(1992-4#16)(1992-5#14)(1992-6#43)(1992-7#3)(1992-8#23)(1992-9#37)(1993-1#23)(1993-10#2)(1993-11#39)(1993-12#59)(1993-2#41)(1993-3#36)(1993-5#5)(1993-6#29)(1993-8#37)(1993-9#31)(1994-1#15)(1994-10#1)(1994-11#26)(1994-12#47)(1994-2#52)(1994-3#39)(1994-5#63)(1994-6#40)(1994-7#14)(1994-8#44)(1994-9#34)(1995-1#17)(1995-10#1)(1995-11#35)(1995-12#62)(1995-2#73)(1995-3#42)(1995-4#6)(1995-5#50)(1995-6#29)(1995-8#36)(1995-9#8)(1996-1#21)(1996-10#2)(1996-11#14)(1996-12#62)(1996-2#54)(1996-3#39)(1996-4#7)(1996-5#38)(1996-6#19)(1996-7#16)(1996-8#5)(1996-9#9)(1997-1#21)(1997-2#55)(1997-3#49)(1997-4#32)(1997-5#28)(1997-6#52)(1997-7#48)(1997-8#24)(1997-9#6)(2006-10#10)(2006-12#4)(2006-4#3)(2006-6#8)(2006-8#1)(2007-1#6)(2007-10#72)(2007-11#182)(2007-12#213)(2007-2#23)(2007-4#2)(2007-5#15)(2007-6#12)(2007-7#39)(2007-8#62)(2007-9#9)(2008-1#99)(2008-10#2362)(2008-11#330)(2008-12#190)(2008-2#235)(2008-3#520)(2008-4#139)(2008-5#310)(2008-6#116)(2008-7#355)(2008-8#391)(2008-9#312)(2009-1#6)(2009-10#81)(2009-11#43)(2009-12#39)(2009-2#38)(2009-3#26)(2009-4#22)(2009-5#63)(2009-6#41)(2009-7#79)(2009-8#82)(2009-9#38)(2010-1#31)(2010-10#60)(2010-11#26)(2010-12#52)(2010-2#47)(2010-3#60)(2010-4#50)(2010-5#41)(2010-6#27)(2010-7#27)(2010-8#81)(2010-9#17)(2011-1#175)(2011-10#7)(2011-2#424)(2011-3#13)(2011-4#1)(2011-8#1)(2012-1#49)(2012-12#163)(2012-2#203)(2012-3#185)(2012-4#5)(2012-5#8)(2012-6#6)(2012-7#4)(2012-8#1)(2012-9#4)(2013-1#367)(2013-7#73)(2013-8#206)
between-class scatter##3##2##(2008-6#3)
between-class##4##1##(2008-3#1)(2008-6#3)
between-day##7##1##(1991-2#1)(1992-11#1)(2008-10#5)
between-days##2##1##(2008-10#2)
between-group difference in##2##3##(2008-12#1)(2011-2#1)
between-group differences##2##2##(1995-12#1)(2013-1#1)
between-group##6##1##(1995-12#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
between-study##3##1##(2008-10#2)(2013-1#1)
between-subjects##3##1##(1992-6#1)(2008-9#1)(2012-2#1)
betweenthe##2##1##(2008-11#1)(2008-2#1)
bevacizumab and##4##2##(2008-7#3)(2011-3#1)
bevacizumab injection##3##2##(2011-1#1)(2011-2#2)
bevacizumab was##2##2##(2010-10#1)(2013-8#1)
bevacizumab##16##1##(2008-7#4)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2013-1#2)(2013-8#2)
beveling##3##1##(2008-3#3)
beverage industry##2##2##(1995-2#1)(2008-12#1)
beverage samples##2##2##(2008-10#2)
beverage##18##1##(1995-2#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)
beverages (SSB)##2##2##(2011-2#1)(2012-2#1)
beverages and##7##2##(1990-6#1)(1997-1#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
beverages are##2##2##(1997-1#1)(2009-5#1)
beverages by##5##2##(2008-10#5)
beverages is##2##2##(2008-8#1)(2012-2#1)
beverages such as##3##3##(2008-10#2)(2012-12#1)
beverages using##3##2##(2008-10#3)
beverages were##2##2##(2008-10#1)(2010-9#1)
beverages with##4##2##(2008-10#2)(2012-2#2)
beverages##72##1##(1990-6#2)(1991-9#1)(1993-9#1)(1997-1#3)(2008-10#32)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#3)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#9)(2013-1#2)
beware of##2##2##(1992-3#1)(2008-1#1)
beware##4##1##(1992-3#1)(1996-11#1)(1997-6#1)(2008-1#1)
beyond 2##2##2##(2008-11#1)(2008-8#1)
beyond 5##2##2##(1991-11#1)(2012-12#1)
beyond a##8##2##(1994-8#1)(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
beyond any reported##2##3##(1993-12#1)(1993-6#1)
beyond her##2##2##(1993-12#1)(1995-6#1)
beyond it##2##2##(2007-11#1)(2008-11#1)
beyond our##3##2##(2008-10#1)(2008-7#2)
beyond survival##2##2##(2008-7#1)(2010-5#1)
beyond that##4##2##(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
beyond the age##2##3##(2012-12#1)(2013-7#1)
beyond the capacity##2##3##(1995-3#2)
beyond the diffraction limit##4##4##(2007-11#1)(2008-3#2)(2009-5#1)
beyond the financial##2##3##(1994-12#1)(2010-2#1)
beyond the first##2##3##(2008-7#1)(2009-9#1)
beyond the optical##2##3##(2007-11#1)(2008-3#1)
beyond the scope of this##3##5##(2008-5#1)(2008-7#1)(2013-7#1)
beyond the scope of##6##4##(1996-12#1)(1997-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
beyond the site of##3##4##(1992-3#3)
beyond the traditional##2##3##(2010-12#1)(2010-8#1)
beyond the year 2000##2##4##(1997-3#2)
beyond the##119##2##(1990-7#1)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#3)(1993-12#3)(1994-12#2)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#3)
beyond their##8##2##(1995-1#1)(1997-4#1)(2007-10#1)(2008-3#1)(2011-1#2)(2012-3#1)(2013-1#1)
beyond this##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
beyond those##3##2##(1994-5#1)(2008-9#2)
beyond what is##3##3##(1994-1#1)(2008-11#1)(2008-3#1)
beyond which the##3##3##(1996-8#1)(2008-2#1)(2008-3#1)
beyond which##4##2##(1996-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
beyond##288##1##(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#6)(1993-12#6)(1993-2#2)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-12#4)(1995-2#6)(1995-3#2)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(2007-10#2)(2007-11#8)(2007-12#8)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#21)(2008-11#13)(2008-12#4)(2008-2#9)(2008-3#13)(2008-5#8)(2008-6#3)(2008-7#15)(2008-8#5)(2008-9#7)(2009-10#2)(2009-12#1)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#12)(2012-3#3)(2013-1#8)(2013-7#4)(2013-8#3)
bezafibrate##3##1##(1991-2#2)(1996-3#1)
bg/bg##3##1##(1991-8#3)
bg/bg-nu/+ mice##3##2##(2008-5#3)
bg/bg-nu/nu mice##3##2##(2008-5#3)
bg/bg-nu/nu##4##1##(2008-5#4)
bg/bg-nu/nuand##2##1##(2008-5#2)
bg/bg-nu/numice##2##1##(2008-5#2)
bgq60 structural gene##2##3##(1995-6#2)
bi- and triantennary complex-type##2##4##(1994-5#2)
bi- and triantennary##3##3##(1994-5#2)(2008-8#1)
bi- and##7##2##(1993-11#1)(1994-5#2)(2008-10#3)(2008-8#1)
bi- or##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
bi-##12##1##(1993-11#2)(1994-5#2)(2008-10#5)(2008-8#1)(2011-1#1)(2013-1#1)
bi-annual##2##1##(2007-5#1)(2011-4#1)
bi-dimensional##2##1##(2008-11#1)(2008-8#1)
bi-directional cavopulmonary shunt##2##3##(2007-8#2)
bi-directional sex-changing##2##2##(2010-8#2)
bi-directional##10##1##(1993-8#1)(2007-8#2)(2008-10#2)(2009-3#2)(2010-8#2)(2011-2#1)
bi-enzymatic##2##1##(2008-10#2)
bi-phasic##3##1##(1994-8#1)(2008-11#1)(2013-8#1)
bi-rooted primary canines##3##3##(2010-3#3)
bi-specific antibody##2##2##(1993-9#2)
biamperometric end-point detection##2##3##(2008-10#2)
biamperometric##5##1##(2008-10#5)
biaryl##3##1##(2007-11#1)(2009-12#2)
bias across##2##2##(2008-11#1)(2009-5#1)
bias and standard deviation##2##4##(2008-10#1)(2008-2#1)
bias and that##2##3##(2008-8#1)(2009-11#1)
bias and the##3##3##(1995-12#1)(2008-3#2)
bias and variance##2##3##(1992-9#1)(2008-10#1)
bias and##29##2##(1992-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)
bias are##2##2##(2007-12#1)(2008-10#1)
bias can##2##2##(1995-12#1)(2013-1#1)
bias caused by environmental covariances##2##5##(2008-8#2)
bias caused by the##2##4##(1994-11#1)(2008-10#1)
bias caused by##4##3##(1994-11#1)(2008-10#1)(2008-8#2)
bias correction##2##2##(2008-10#1)(2008-3#1)
bias current##5##2##(2007-12#2)(2008-3#3)
bias during##2##2##(1993-3#1)(2008-10#1)
bias error##4##2##(2008-10#4)
bias for##6##2##(1995-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-1#1)
bias in anxiety##2##3##(2008-2#2)
bias in phenotypic estimates of selection##2##6##(2008-8#2)
bias in phenotypic estimates of##3##5##(2008-8#3)
bias in the##15##3##(1992-2#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2013-1#2)
bias in##34##2##(1992-2#2)(1994-2#1)(1995-2#2)(1995-8#1)(1996-3#2)(1997-1#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-4#1)(2008-8#5)(2010-7#2)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
bias inherent to##2##3##(1996-11#1)(2008-6#1)
bias is##12##2##(1990-3#1)(1992-6#1)(1995-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
bias method##2##2##(2008-2#2)
bias of##5##2##(2007-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-2#1)
bias suit##2##2##(1995-12#1)(1997-5#1)
bias than##3##2##(1992-6#1)(1993-12#1)(2008-11#1)
bias that##4##2##(1995-5#1)(1997-3#1)(2008-9#1)(2013-1#1)
bias the##3##2##(1994-2#1)(1997-2#1)(2008-8#1)
bias to##4##2##(1996-2#1)(1997-1#1)(2008-3#1)(2012-3#1)
bias toward##2##2##(2008-8#1)(2010-12#1)
bias towards##3##2##(1995-12#1)(2008-11#1)(2011-1#1)
bias voltage##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
bias was##6##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-9#1)
bias were##2##2##(2008-10#1)(2010-7#1)
bias##264##1##(1990-3#3)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-2#3)(1992-6#3)(1992-9#2)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#5)(1994-3#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-5#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-5#3)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#11)(2008-12#4)(2008-2#13)(2008-3#24)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#18)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#5)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#5)
bias&quot##2##1##(1996-1#1)(2008-8#1)
bias)##2##1##(2009-11#1)(2010-3#1)
biased about their health)##2##4##(2008-4#2)
biased and##2##2##(1993-12#1)(1995-12#1)
biased by##5##2##(1992-6#1)(1995-2#1)(2008-2#1)(2008-8#1)(2010-3#1)
biased estimates of the##2##4##(1994-11#1)(2012-1#1)
biased estimates of##3##3##(1994-11#1)(2008-8#1)(2012-1#1)
biased estimates##6##2##(1993-2#1)(1994-11#2)(2008-2#1)(2008-8#1)(2012-1#1)
biased in favour of##3##4##(1991-2#1)(2008-7#1)(2010-3#1)
biased in##4##2##(1990-3#1)(1991-2#1)(2008-7#1)(2010-3#1)
biased photorefractive##2##2##(2007-12#2)
biased random walk##2##3##(2008-9#1)(2013-8#1)
biased sex ratios##2##3##(2008-9#2)
biased to##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
biased toward##3##2##(1994-2#1)(1997-5#1)(2008-8#1)
biased towards##2##2##(2008-7#1)(2011-2#1)
biased##67##1##(1990-3#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#4)(2009-2#1)(2009-9#2)(2010-3#3)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-8#1)
biases and##6##2##(1994-2#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)
biases are##3##2##(2008-8#1)(2010-4#1)(2010-7#1)
biases associated with body image concerns##2##6##(2007-12#2)
biases in the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
biases in##14##2##(1992-6#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
biases may##2##2##(2007-12#1)(2008-1#1)
biases of##2##2##(1994-8#1)(2008-3#1)
biases that##2##2##(2009-5#1)(2012-12#1)
biases the##3##2##(1991-2#1)(2008-11#1)(2008-8#1)
biases##66##1##(1991-2#1)(1992-6#2)(1994-2#1)(1994-8#1)(1997-3#4)(1997-5#2)(2007-11#2)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-2#2)(2009-5#1)(2010-4#2)(2010-7#5)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
biasing techniques##2##2##(2008-2#2)
biasing##6##1##(2008-2#2)(2008-3#1)(2008-8#3)
biaxial crystals##3##2##(2006-4#1)(2008-3#2)
biaxial layers##2##2##(2008-3#2)
biaxial thin layer##2##3##(2008-3#2)
biaxial thin##3##2##(2008-3#3)
biaxial##16##1##(2006-4#2)(2007-11#3)(2008-3#11)
biaxially##2##1##(2007-12#2)
bibliographic database##3##2##(1991-12#1)(1992-12#1)(1997-1#1)
bibliographic instruction##3##2##(1995-3#3)
bibliographic research##2##2##(2009-10#1)(2012-3#1)
bibliographic review]##2##2##(1996-9#1)(2012-3#1)
bibliographic##20##1##(1991-12#1)(1992-1#1)(1992-12#1)(1994-12#1)(1995-3#4)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-10#2)(2010-2#1)(2010-8#1)(2012-3#4)
bibliographies of key articles were searched##2##6##(2012-12#2)
bibliographies of key articles##5##4##(2012-12#5)
bibliography##15##1##(1992-1#1)(1992-12#1)(1993-2#2)(2008-10#2)(2008-9#5)(2009-6#1)(2011-2#1)(2013-1#2)
bibliometric##2##1##(1996-11#1)(2010-12#1)
bicalutamide##2##1##(2007-12#2)
bicarbonate and##8##2##(1990-11#1)(1990-8#1)(2008-10#3)(2010-3#3)
bicarbonate buffer##4##2##(2008-10#1)(2008-11#3)
bicarbonate was##2##2##(1990-11#1)(2008-4#1)
bicarbonate##31##1##(1990-11#4)(1990-8#1)(1991-1#1)(1994-3#1)(1995-2#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-4#3)(2008-6#1)(2010-3#4)(2011-1#2)(2011-2#1)(2013-8#1)
bicellular##2##1##(2007-12#1)(2008-10#1)
biceps brachii##3##2##(2007-12#1)(2008-12#1)(2009-1#1)
biceps femoris##2##2##(1995-12#1)(2010-4#1)
biceps##10##1##(1990-8#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-1#1)(2010-4#1)(2010-8#1)
bichromatic##4##1##(2007-12#4)
bicinchoninic acid (BCA)##2##3##(2008-10#1)(2008-9#1)
bicine ligands##2##2##(2008-10#2)
bicistronic expression vectors##2##3##(2008-11#2)
bicistronic expression##3##2##(2008-11#3)
bicistronic##4##1##(2008-11#4)
bicoid##2##1##(1994-12#2)
bicolor damselfish##2##2##(2007-5#2)
bicolor##14##1##(1993-3#1)(1994-5#1)(2007-5#2)(2008-10#4)(2008-3#1)(2009-10#1)(2011-1#4)
bicompartmental TKA##2##2##(2013-1#2)
bicompartmental##4##1##(2008-5#1)(2013-1#3)
bicomponent diffraction system##2##3##(2008-3#2)
bicomponent##5##1##(2008-2#2)(2008-3#3)
biconcave##3##1##(2007-11#2)(2008-3#1)
bicornuate uterus##3##2##(2013-1#3)
bicubic##2##1##(2008-6#2)
bicuculline (0##3##2##(1992-3#1)(1996-5#1)(1997-2#1)
bicuculline but not##2##3##(2008-8#2)
bicuculline##22##1##(1992-3#2)(1993-12#4)(1993-3#1)(1995-5#2)(1996-5#3)(1997-2#4)(2008-7#2)(2008-8#3)(2008-9#1)
bicuspid aortic valve##3##3##(2008-12#1)(2012-1#1)(2012-3#1)
bicuspid##4##1##(2008-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
bicycle exercise test##2##3##(1992-4#2)
bicycle##12##1##(1990-8#1)(1992-4#2)(1992-6#1)(1996-1#1)(2007-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
bicyclic##12##1##(1991-8#2)(1996-5#1)(2007-11#4)(2008-4#1)(2008-8#1)(2010-2#2)(2010-7#1)
bicyclo[3##5##1##(1996-5#3)(2007-11#2)
bid##10##1##(1991-1#2)(1991-3#1)(1993-2#1)(1994-3#1)(1997-5#1)(2007-7#1)(2012-3#3)
bidding##3##1##(1992-11#1)(2008-10#1)(2008-9#1)
bidentate ligand##2##2##(1997-7#1)(2008-10#1)
bidentate##6##1##(1996-2#2)(1997-7#1)(2008-10#2)(2012-2#1)
bideposition##3##1##(2008-3#3)
bidimensional##2##1##(2008-3#1)(2008-8#1)
bidirectional communication between##2##3##(2008-12#1)(2009-3#1)
bidirectional communication##4##2##(2008-12#1)(2009-3#2)(2009-5#1)
bidirectional deletions##2##2##(1994-12#2)
bidirectional effects##2##2##(2008-2#1)(2010-10#1)
bidirectional reflectance distribution function (BRDF)##6##5##(2008-2#1)(2008-3#5)
bidirectional reflectance distribution function##11##4##(2008-2#3)(2008-3#8)
bidirectional reflectance##16##2##(2008-2#6)(2008-3#10)
bidirectional reflection##2##2##(2008-3#2)
bidirectional##57##1##(1994-12#4)(1995-11#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#10)(2008-3#17)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-8#3)(2011-2#1)(2012-3#1)
bien##3##1##(2008-5#2)(2013-1#1)
biennial breast cancer screening##2##4##(2012-12#2)
biennial##6##1##(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#3)
bienzyme biosensor##2##2##(2008-10#2)
bienzyme electrode##2##2##(2008-10#2)
bienzyme##6##1##(2008-10#5)(2010-5#1)
bienzymic##2##1##(2008-10#2)
biexciton##2##1##(1990-12#1)(2007-12#1)
biexponential##4##1##(1991-5#1)(1993-11#1)(1996-2#1)(2008-5#1)
bifid##5##1##(1997-3#2)(2008-10#2)(2012-3#1)
bifida##6##1##(1990-9#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
bifidobacteria##9##1##(2008-11#1)(2008-12#3)(2008-5#1)(2009-5#3)(2011-2#1)
bifidobacterial##2##1##(2009-5#1)(2011-2#1)
biflavonoids##5##1##(2008-11#5)
biflexa##6##1##(2007-7#1)(2008-9#5)
bifrontal##2##1##(2006-12#1)(2011-2#1)
bifunctional chelators have been##2##4##(2012-3#2)
bifunctional chelators##3##2##(2012-3#3)
bifunctional enzyme##2##2##(1994-11#2)
bifunctional inhibitor##2##2##(1992-8#1)(2008-10#1)
bifunctional##22##1##(1990-8#2)(1992-8#3)(1994-11#2)(1994-8#1)(1997-2#3)(2008-10#4)(2008-4#1)(2009-5#1)(2011-1#1)(2012-3#4)
bifurcated fiber optic sensor and##2##5##(2008-10#2)
bifurcated optical fiber##3##3##(2008-10#2)(2008-7#1)
bifurcated##12##1##(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
bifurcation by##2##2##(1994-2#1)(2011-2#1)
bifurcation lesions##2##2##(2008-11#2)
bifurcation mechanism##2##2##(2007-11#1)(2009-8#1)
bifurcation of##2##2##(1994-5#1)(2008-3#1)
bifurcation##39##1##(1990-8#1)(1991-5#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#3)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
bifurcations##8##1##(1993-5#1)(2007-11#2)(2007-7#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#1)
bifurcations)##2##1##(2008-9#2)
big EDN3##2##2##(1994-12#2)
big ET##3##2##(1990-2#3)
big PTTH##2##2##(1995-11#2)
big business##2##2##(1992-5#1)(1996-1#1)
big endothelin-1##3##2##(1990-12#2)(2006-7#1)
big##70##1##(1990-12#4)(1990-2#5)(1990-6#1)(1991-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-3#2)(1995-6#2)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#2)(2006-7#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#2)(2009-8#2)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
big-vein disease##2##2##(2008-10#2)
big-vein symptoms##2##2##(2008-10#2)
big-vein##8##1##(2008-10#8)
bigger than the##2##3##(2008-10#1)(2008-3#1)
bigger than##5##2##(2007-9#1)(2008-10#2)(2008-3#2)
bigger##29##1##(1991-12#1)(1994-3#2)(1995-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
biggest challenge##2##2##(2010-7#1)(2013-8#1)
biggest challenges##2##2##(1991-1#1)(2012-2#1)
biggest impact on the##2##4##(2008-1#1)(2012-12#1)
biggest impact##3##2##(2008-1#1)(2010-7#1)(2012-12#1)
biggest##24##1##(1990-2#1)(1991-1#1)(1991-2#2)(1995-12#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
bighead carp##3##2##(2008-12#1)(2010-5#2)
biglycan##4##1##(2008-9#1)(2012-1#3)
bij##4##1##(1996-11#1)(2012-12#3)
bike##2##1##(1996-2#1)(2011-2#1)
bilateral 6-hydroxydopamine lesions##2##3##(1997-6#2)
bilateral IMA##2##2##(2007-8#2)
bilateral ITA##2##2##(2007-8#2)
bilateral THA##2##2##(2009-3#2)
bilateral TKA##4##2##(2009-3#3)(2013-1#1)
bilateral VLO##2##2##(1994-3#2)
bilateral adrenal masses##2##3##(2013-1#2)
bilateral adrenal##3##2##(2013-1#3)
bilateral and##3##2##(1992-5#2)(2007-12#1)
bilateral anterior##4##2##(2008-1#1)(2008-11#2)(2011-2#1)
bilateral basal ganglia##4##3##(2009-11#2)(2013-1#2)
bilateral breast cancers##2##3##(1994-12#1)(1995-4#1)
bilateral breast##9##2##(1992-2#1)(1994-12#2)(1994-8#1)(1995-4#1)(2007-5#1)(2008-10#2)(2009-9#1)
bilateral calf (tibial) deep venous thrombosis##2##6##(2007-2#2)
bilateral calf (tibial)##3##3##(2007-2#3)
bilateral calf##5##2##(2007-2#5)
bilateral carotid##3##2##(1995-12#1)(1997-2#1)(2011-3#1)
bilateral cataract##2##2##(2007-7#1)(2012-2#1)
bilateral cleft lip and palate##3##5##(2013-1#3)
bilateral cleft##4##2##(2011-2#1)(2013-1#3)
bilateral cochlear implant recipients##2##4##(2008-9#1)(2012-2#1)
bilateral cochlear implant##3##3##(2008-9#2)(2012-2#1)
bilateral cochlear implantation##4##3##(2008-9#3)(2012-2#1)
bilateral cochlear implants##3##3##(2012-2#3)
bilateral cochlear##12##2##(2008-9#7)(2012-2#5)
bilateral common carotid##3##3##(2007-10#2)(2008-7#1)
bilateral destruction of the##2##4##(1990-5#1)(1994-3#1)
bilateral destruction of##4##3##(1990-5#2)(1993-3#1)(1994-3#1)
bilateral diffuse##2##2##(2013-1#2)
bilateral disease##4##2##(1993-1#1)(2010-3#1)(2012-2#2)
bilateral ethmoid osteomas##2##3##(2011-2#2)
bilateral frontal##2##2##(1991-5#1)(1996-5#1)
bilateral fusion##5##2##(2008-8#5)
bilateral hernias##2##2##(1992-5#1)(1996-9#1)
bilateral hip##2##2##(2009-3#1)(2013-1#1)
bilateral ibotenic acid##2##3##(1990-5#1)(1994-3#1)
bilateral implantation##4##2##(2008-9#1)(2012-2#3)
bilateral increase in##2##3##(1990-9#2)
bilateral increase##3##2##(1990-9#2)(1994-8#1)
bilateral increases in##2##3##(2012-2#1)(2013-8#1)
bilateral increases##3##2##(1996-12#1)(2012-2#1)(2013-8#1)
bilateral injections of##2##3##(1993-12#1)(1996-5#1)
bilateral internal##3##2##(2007-8#2)(2008-7#1)
bilateral intrarenal##2##2##(2008-1#2)
bilateral involvement##2##2##(2011-2#1)(2013-1#1)
bilateral knee##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
bilateral lesions of the##5##4##(1990-5#1)(1993-3#1)(1993-6#1)(1994-3#2)
bilateral lesions of##7##3##(1990-5#1)(1993-3#1)(1993-6#1)(1994-3#2)(2008-7#2)
bilateral loculated pyopneumothorax##2##3##(2010-5#2)
bilateral lung##2##2##(2007-10#1)(2013-1#1)
bilateral microinjection of##2##3##(1990-5#1)(2007-10#1)
bilateral nasal##3##2##(2011-1#3)
bilateral oophorectomy##2##2##(2013-1#2)
bilateral or##2##2##(1991-11#1)(2008-12#1)
bilateral prolonged##2##2##(2012-3#2)
bilateral ptosis following right putaminal hemorrhage##2##6##(2007-10#2)
bilateral ptosis##4##2##(2007-10#4)
bilateral pulmonary artery banding##2##4##(2007-8#2)
bilateral pulmonary nodules##2##3##(2008-10#1)(2013-7#1)
bilateral pulmonary##8##2##(2007-10#1)(2007-8#3)(2008-10#2)(2010-11#1)(2013-7#1)
bilateral renal##4##2##(2008-1#2)(2008-10#2)
bilateral shoulder pain##2##3##(2008-12#1)(2009-3#1)
bilateral shoulder##3##2##(2007-8#1)(2008-12#1)(2009-3#1)
bilateral simultaneous cochlear implantation in a##2##6##(2008-9#2)
bilateral simultaneous cochlear implantation in##3##5##(2008-9#2)(2012-2#1)
bilateral simultaneous cochlear##4##3##(2008-9#2)(2012-2#2)
bilateral simultaneous##5##2##(2008-7#1)(2008-9#2)(2012-2#2)
bilateral spontaneous##2##2##(2008-10#1)(2008-7#1)
bilateral swelling of##2##3##(2008-5#1)(2011-2#1)
bilateral symmetry##2##2##(2010-4#1)(2010-6#1)
bilateral testicular masses##2##3##(2008-10#2)
bilateral thermography##2##2##(1994-5#2)
bilateral total knee arthroplasty##2##4##(2008-8#1)(2009-3#1)
bilateral total##4##2##(2008-8#1)(2009-3#3)
bilateral upper##2##2##(1997-3#1)(2011-1#1)
bilateral ureteral##2##2##(2007-7#1)(2010-11#1)
bilateral vestibular##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
bilateral visual cortex##2##3##(2008-7#1)(2013-8#1)
bilateral visual##3##2##(2008-7#1)(2011-1#1)(2013-8#1)
bilateral##415##1##(1990-3#1)(1990-5#6)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-5#4)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#3)(1993-6#2)(1994-12#5)(1994-3#10)(1994-5#2)(1994-7#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-12#1)(1996-2#4)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#5)(1997-8#1)(2006-12#1)(2007-10#16)(2007-11#2)(2007-12#2)(2007-2#6)(2007-5#2)(2007-7#5)(2007-8#20)(2008-1#7)(2008-10#34)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#23)(2008-8#12)(2008-9#18)(2009-11#2)(2009-12#1)(2009-3#14)(2009-4#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#15)(2011-2#21)(2011-3#2)(2012-1#1)(2012-12#9)(2012-2#26)(2012-3#7)(2013-1#36)(2013-7#1)(2013-8#12)
bilaterally in the##4##3##(1993-12#2)(1996-12#1)(2012-2#1)
bilaterally in##9##2##(1990-6#1)(1993-12#2)(1994-8#1)(1996-12#2)(1996-5#1)(2008-10#1)(2012-2#1)
bilaterally lesioned animals##2##3##(1990-5#1)(2008-7#1)
bilaterally paired##2##2##(2007-12#1)(2008-5#1)
bilaterally symmetrical##3##2##(1997-8#1)(2007-12#2)
bilaterally were##2##2##(1996-2#1)(2012-12#1)
bilaterally##49##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-2#1)(1992-10#1)(1992-3#1)(1993-12#3)(1994-2#1)(1994-3#2)(1994-8#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#4)(2008-9#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)
bilaterian##5##1##(2007-12#1)(2010-4#2)(2011-2#1)(2012-2#1)
bilaterians##2##1##(2009-6#1)(2010-4#1)
bilayer and a##2##3##(1991-5#1)(2008-10#1)
bilayer and##7##2##(1990-11#1)(1990-12#1)(1991-5#1)(1993-11#1)(1994-12#1)(2008-10#2)
bilayer are##3##2##(1990-7#1)(2008-4#1)(2008-9#1)
bilayer by##2##2##(1993-8#1)(2008-4#1)
bilayer in##3##2##(1992-5#1)(1992-9#1)(1993-11#1)
bilayer is##5##2##(1992-5#5)
bilayer lipid membranes##4##3##(1997-7#2)(2008-10#1)(2009-12#1)
bilayer lipid##5##2##(1994-2#1)(1997-7#2)(2008-10#1)(2009-12#1)
bilayer membrane##3##2##(1995-2#1)(2008-8#1)(2009-5#1)
bilayer modified gold##2##3##(2008-10#2)
bilayer properties##2##2##(1991-9#1)(2008-4#1)
bilayer stability##3##2##(1994-12#1)(1994-3#2)
bilayer structure of##3##3##(1990-7#1)(1997-6#1)(2008-8#1)
bilayer structure##5##2##(1990-7#1)(1991-5#1)(1997-6#1)(2008-7#1)(2008-8#1)
bilayer system##2##2##(1991-9#1)(1993-3#1)
bilayer thickness##2##2##(1993-11#1)(1993-8#1)
bilayer to hexagonal##2##3##(1990-2#1)(1994-12#1)
bilayer to##3##2##(1990-2#1)(1993-11#1)(1994-12#1)
bilayer##110##1##(1990-11#6)(1990-12#1)(1990-2#5)(1990-5#1)(1990-7#4)(1991-5#5)(1991-9#2)(1992-3#2)(1992-5#8)(1992-6#3)(1992-9#4)(1993-11#8)(1993-3#1)(1993-8#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#2)(1995-11#3)(1995-2#2)(1997-6#1)(1997-7#2)(2008-10#13)(2008-11#2)(2008-4#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#3)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)
bilayers and##3##2##(1993-3#1)(1994-12#1)(2008-10#1)
bilayers at##4##2##(1990-7#1)(1992-3#1)(1992-6#1)(2008-10#1)
bilayers containing cholesterol##2##3##(1992-6#2)
bilayers containing##4##2##(1990-2#1)(1992-6#3)
bilayers could accommodate##2##3##(1993-8#2)
bilayers for##2##2##(2008-10#1)(2008-4#1)
bilayers in##2##2##(1992-3#1)(2008-5#1)
bilayers of##3##2##(1990-7#1)(2008-5#1)(2008-9#1)
bilayers the##3##2##(1992-5#1)(2008-10#1)(2008-7#1)
bilayers was##3##2##(1990-2#1)(1993-11#1)(2008-10#1)
bilayers with##3##2##(1992-3#1)(1995-11#1)(2008-10#1)
bilayers##92##1##(1990-11#2)(1990-2#13)(1990-5#1)(1990-7#2)(1992-3#4)(1992-5#11)(1992-6#7)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#2)(1994-12#1)(1994-5#2)(1995-11#1)(2008-10#23)(2008-11#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2010-5#2)
bile acid excretion##2##3##(2008-10#1)(2008-5#1)
bile acid transport##2##3##(1991-9#2)
bile acid transporter##2##3##(1994-12#1)(2008-5#1)
bile acid##19##2##(1991-6#1)(1991-9#3)(1992-3#3)(1994-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2013-1#1)
bile acids in serum##3##4##(1993-2#3)
bile acids in##9##3##(1991-5#1)(1992-9#1)(1993-2#3)(1994-8#1)(1995-9#1)(2008-4#2)
bile acids were##4##3##(1993-2#4)
bile acids##31##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-5#1)(1992-3#4)(1992-9#4)(1993-2#7)(1994-12#1)(1994-8#1)(1995-9#1)(2008-11#1)(2008-4#3)(2008-8#1)(2013-1#3)
bile and##5##2##(1996-5#1)(2008-10#2)(2008-9#1)(2013-1#1)
bile canalicular contractions##2##3##(1993-3#2)
bile canalicular##4##2##(1993-3#2)(2008-11#2)
bile duct stones can be##2##5##(1991-3#1)(1997-8#1)
bile duct stones##5##3##(1991-3#2)(1997-8#2)(2010-12#1)
bile duct##28##2##(1990-5#2)(1990-6#1)(1990-9#4)(1991-3#4)(1991-8#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-11#1)(1996-11#1)(1997-8#2)(2008-2#1)(2009-9#2)(2010-12#4)(2013-1#2)
bile ducts##6##2##(1993-9#1)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#2)
bile ductular epithelial cells##3##4##(1990-12#3)
bile flow and##2##3##(2008-5#1)(2012-2#1)
bile flow in##3##3##(1993-3#1)(2008-5#1)(2012-2#1)
bile flow##12##2##(1990-5#1)(1993-3#3)(1996-12#1)(2008-11#1)(2008-5#3)(2012-2#3)
bile in##3##2##(1990-8#1)(2008-5#1)(2012-2#1)
bile salt##2##2##(1990-8#1)(2008-11#1)
bile salts##3##2##(1990-8#3)
bile samples##2##2##(2008-5#1)(2012-2#1)
bile secretion##2##2##(2006-10#1)(2012-2#1)
bile##155##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#4)(1990-6#1)(1990-8#7)(1990-9#4)(1991-12#2)(1991-3#7)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-3#9)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#10)(1993-3#8)(1993-9#2)(1994-12#3)(1994-8#1)(1995-11#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-8#2)(2006-10#1)(2008-10#7)(2008-11#12)(2008-2#3)(2008-4#4)(2008-5#10)(2008-8#5)(2008-9#1)(2009-8#1)(2009-9#2)(2010-12#4)(2011-2#1)(2012-2#9)(2013-1#11)
bile-pancreatic juice diversion were##2##4##(2008-7#2)
bile-pancreatic juice diversion##3##3##(2008-7#3)
bileaflet##2##1##(2007-8#1)(2010-8#1)
bilevel positive airway pressure##5##4##(2007-8#5)
bilharzial urinary bladder##2##3##(1990-12#2)
bilharzial##3##1##(1990-12#3)
biliary anatomical variants##2##3##(2012-2#2)
biliary and##2##2##(1993-9#1)(2012-2#1)
biliary atresia##6##2##(1994-6#3)(2013-1#3)
biliary bypass##3##2##(2011-2#3)
biliary cases##3##2##(2011-2#3)
biliary cirrhosis and##3##3##(1990-3#1)(2013-1#2)
biliary cirrhosis##15##2##(1990-3#1)(1990-9#1)(1991-5#1)(1992-12#3)(1992-6#1)(1992-9#2)(1993-5#1)(1994-2#1)(2006-10#2)(2013-1#2)
biliary cystadenoma##3##2##(2010-12#1)(2011-2#2)
biliary diseases##3##2##(1991-3#1)(2010-12#2)
biliary drainage##3##2##(1990-2#1)(1992-3#1)(2011-2#1)
biliary excretion of##2##3##(1994-12#1)(2008-9#1)
biliary flow##3##2##(1991-3#1)(2012-2#1)(2013-1#1)
biliary lithiasis##5##2##(1990-3#3)(1991-5#2)
biliary obstruction##5##2##(2012-2#2)(2013-1#3)
biliary pancreatitis##3##2##(2007-8#2)(2012-12#1)
biliary secretion##2##2##(2008-8#1)(2012-2#1)
biliary stenting##2##2##(2008-12#1)(2013-1#1)
biliary strictures##2##2##(2013-1#2)
biliary system##4##2##(1993-5#1)(2010-12#3)
biliary tract##20##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1992-3#1)(1992-9#6)(2006-10#1)(2008-11#1)(2008-4#4)(2009-8#1)(2013-1#1)
biliary tree##4##2##(1993-9#1)(2008-11#1)(2012-12#1)(2013-1#1)
biliary##128##1##(1990-2#1)(1990-3#4)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-3#7)(1991-5#4)(1991-6#2)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#10)(1993-5#2)(1993-9#4)(1994-12#1)(1994-2#1)(1994-6#3)(2006-10#4)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-12#9)(2010-2#1)(2011-2#11)(2012-12#2)(2012-2#7)(2013-1#19)
biliary-digestive bypass with##2##3##(1993-3#2)
biligonigerus##3##1##(2008-7#3)
bilinear##11##1##(1992-6#1)(2008-10#5)(2008-2#1)(2008-6#2)(2010-5#1)(2012-2#1)
bilingual and##2##2##(1993-9#1)(2010-5#1)
bilingual##13##1##(1993-9#2)(1997-5#1)(2007-10#1)(2008-11#2)(2008-12#2)(2010-5#1)(2010-8#1)(2011-2#3)
bilingualism##4##1##(2008-11#4)
bilinguals##2##1##(2013-8#2)
biliopancreatic diversion##3##2##(1993-3#1)(1993-5#1)(2012-3#1)
bilirubin and##2##2##(2008-10#2)
bilirubin as##2##2##(1992-8#1)(2013-1#1)
bilirubin between small unilamellar##2##4##(1992-3#2)
bilirubin between##3##2##(1992-3#3)
bilirubin in##3##2##(1992-4#1)(2008-10#1)(2012-3#1)
bilirubin measurement##2##2##(2008-11#1)(2011-2#1)
bilirubin of##3##2##(2008-5#1)(2012-3#2)
bilirubin was##2##2##(1992-3#1)(1993-12#1)
bilirubin were##4##2##(1990-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
bilirubin##65##1##(1990-6#1)(1990-8#1)(1991-11#1)(1992-3#11)(1992-4#4)(1992-8#3)(1993-1#1)(1993-12#4)(1994-9#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-5#6)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#6)
bilirubinometry##2##1##(2008-11#1)(2011-2#1)
bilirubins##5##1##(1990-8#1)(2008-10#4)
biliteracies##2##1##(2008-11#2)
biliverdin IX alpha##2##3##(1990-8#1)(1994-5#1)
biliverdin and##3##2##(2008-10#3)
biliverdin##12##1##(1990-8#3)(1992-3#2)(1994-5#1)(2008-10#6)
biliverdins with##2##2##(1992-3#2)
biliverdins##9##1##(1990-8#6)(1992-3#3)
bill files##2##2##(1991-1#1)(1993-3#1)
bill for##2##2##(1991-3#1)(1995-9#1)
bill in##2##2##(1992-1#1)(1996-5#1)
bill on##2##2##(1992-1#1)(1997-5#1)
bill that##4##2##(1995-6#1)(1996-5#3)
bill to##5##2##(1994-3#1)(1995-6#2)(1997-5#1)(2008-8#1)
bill will##2##2##(1992-1#1)(1996-5#1)
bill##49##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-3#1)(1992-1#3)(1992-3#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#12)(1995-9#1)(1996-2#1)(1996-5#9)(1997-2#2)(1997-5#3)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-3#1)
billboards##2##1##(1997-6#2)
billed##2##1##(1991-1#1)(1996-1#1)
billing for##2##2##(1991-3#1)(1996-2#1)
billing records##5##2##(1996-2#2)(2008-9#1)(2011-2#2)
billing##19##1##(1991-3#2)(1994-1#1)(1995-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-3#2)(2013-7#1)
billion Yen [216018]##2##3##(2008-5#2)
billion a##2##2##(1992-3#1)(2012-12#1)
billion dollars##2##2##(2008-10#1)(2008-3#1)
billion in##14##2##(1991-1#1)(1992-12#1)(1992-3#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2013-7#1)(2013-8#1)
billion people##4##2##(1995-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
billion to##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2012-12#1)
billion years##2##2##(2008-2#1)(2008-4#1)
billion##72##1##(1990-2#1)(1991-1#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1993-8#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#3)(1995-5#1)(1995-6#3)(1996-3#1)(1996-5#4)(1997-3#1)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
billion)##3##1##(1992-6#1)(1996-1#2)
billion/100##2##1##(2007-12#2)
billions of dollars##2##3##(2008-7#1)(2011-2#1)
billions of##4##2##(2008-7#1)(2011-2#1)(2013-8#2)
billions##6##1##(1994-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#2)
bills were##2##2##(2008-11#2)
bills##11##1##(1990-4#1)(1992-2#1)(1994-2#1)(1994-8#2)(1997-3#1)(2008-11#3)(2013-1#2)
bilobed##2##1##(2008-5#1)(2008-8#1)
bilogistic##2##1##(1997-3#2)
bimaculatus##10##1##(2008-5#4)(2008-6#2)(2008-7#4)
bimanual rhythmic##2##2##(1994-3#2)
bimanual##6##1##(1994-3#4)(2007-12#1)(2011-2#1)
bimaxillary##2##1##(2009-7#1)(2010-3#1)
bimodal distribution of##3##3##(1994-6#1)(2008-10#1)(2009-7#1)
bimodal distribution##10##2##(1994-6#1)(2008-10#3)(2008-3#2)(2009-7#4)
bimodal##35##1##(1991-2#1)(1992-1#1)(1992-10#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-3#1)(2012-1#1)(2013-8#1)
bimodality##2##1##(2008-10#1)(2008-9#1)
bimolecular complex with##2##3##(1992-2#2)
bimolecular fluorescence complementation (BiFC)##2##4##(2008-4#1)(2012-2#1)
bimolecular##12##1##(1992-2#2)(1992-8#1)(1993-3#1)(1995-6#1)(2008-4#2)(2008-8#3)(2012-2#2)
bimorph##3##1##(2007-11#1)(2008-3#2)
bin width##2##2##(2012-1#2)
bin##7##1##(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#3)(2012-3#1)
binarized##4##1##(2007-12#1)(2008-3#3)
binary Markovian##2##2##(2008-2#2)
binary amplitude##3##2##(2008-2#2)(2008-3#1)
binary and ternary complexes##3##4##(2008-10#3)
binary and ternary mixtures##5##4##(2008-10#5)
binary and ternary##11##3##(1994-3#1)(2008-10#10)
binary and##14##2##(1994-3#1)(1995-12#1)(2008-10#11)(2008-3#1)
binary arrays with perfect##2##4##(2008-2#1)(2008-3#1)
binary arrays with##4##3##(2008-2#3)(2008-3#1)
binary arrays##6##2##(2008-2#5)(2008-3#1)
binary complex of##4##3##(1995-2#1)(1995-5#3)
binary complex##7##2##(1994-5#1)(1995-2#1)(1995-5#3)(2008-10#2)
binary complexes with##2##3##(1995-2#1)(2008-10#1)
binary complexes##6##2##(1995-2#1)(2008-10#4)(2008-5#1)
binary composite##2##2##(2008-3#2)
binary data##9##2##(1995-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)
binary diffraction grating##2##3##(2008-3#2)
binary diffraction gratings##2##3##(2008-3#2)
binary diffraction##4##2##(2008-3#4)
binary diffractive optical element##2##4##(2008-3#2)
binary diffractive##3##2##(2007-12#1)(2008-3#2)
binary encoded##2##2##(2008-2#1)(2008-3#1)
binary epidemic##2##2##(2008-10#2)
binary epidemics##3##2##(2008-10#3)
binary extraction system##2##3##(2008-10#2)
binary form of Taylor's power law##4##6##(2008-10#4)
binary form of##6##3##(2008-10#6)
binary gratings##2##2##(2008-2#1)(2008-3#1)
binary image##3##2##(2008-3#3)
binary key code##3##3##(2008-3#3)
binary logic operations##2##3##(2008-3#2)
binary logic##3##2##(2008-3#3)
binary logistic regression model##3##4##(2011-2#3)
binary logistic regression##6##3##(1995-2#1)(2011-2#3)(2013-1#2)
binary mask##2##2##(2008-2#1)(2008-3#1)
binary mixture of##4##3##(2008-10#3)(2008-7#1)
binary mixture##7##2##(2008-10#5)(2008-3#1)(2008-7#1)
binary mixtures can##2##3##(2008-10#1)(2008-2#1)
binary mixtures containing##2##3##(2008-10#2)
binary mixtures of these compounds##2##5##(2008-10#2)
binary mixtures of##12##3##(2008-10#10)(2008-7#2)
binary mixtures using##3##3##(2008-10#3)
binary mixtures with##4##3##(2008-10#3)(2008-3#1)
binary mixtures##35##2##(2008-10#30)(2008-2#1)(2008-3#1)(2008-7#3)
binary mobile phase##2##3##(2008-10#2)
binary optical elements##2##3##(2007-12#1)(2008-2#1)
binary optical##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
binary phase##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
binary phase-only filter##2##3##(2007-12#1)(2008-3#1)
binary phase-only filters##5##3##(2007-12#1)(2008-2#4)
binary phase-only##8##2##(2007-12#2)(2008-2#5)(2008-3#1)
binary power law analysis##2##4##(2008-10#2)
binary power law##7##3##(2008-10#7)
binary power##8##2##(2008-10#8)
binary sequence##2##2##(2007-12#1)(2008-2#1)
binary signal##2##2##(2007-12#1)(2008-2#1)
binary system##4##2##(1992-1#1)(2008-10#2)(2010-12#1)
binary vector##2##2##(2008-10#1)(2011-1#1)
binary vectors##2##2##(2008-10#2)
binary zone##2##2##(2008-3#2)
binary##271##1##(1990-11#1)(1990-7#1)(1992-1#1)(1992-9#1)(1993-9#3)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#5)(1995-5#3)(2006-4#1)(2007-11#5)(2007-12#16)(2008-10#104)(2008-11#2)(2008-2#31)(2008-3#63)(2008-5#2)(2008-7#9)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
binary-phase##10##1##(2007-12#4)(2008-2#3)(2008-3#3)
binary-valued##2##1##(2008-3#2)
bind DNA in the##2##4##(1994-6#1)(1995-8#1)
bind DNA##5##2##(1991-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(2009-8#1)
bind actin##2##2##(1990-5#1)(2011-2#1)
bind an##2##2##(2010-10#1)(2012-12#1)
bind and##11##2##(1991-12#2)(1991-5#1)(1991-9#1)(1993-11#1)(1993-6#1)(1995-6#1)(2008-4#2)(2010-8#1)(2011-2#1)
bind as##2##2##(1995-8#1)(1996-2#1)
bind at the##2##3##(1990-9#1)(1994-6#1)
bind at##5##2##(1990-9#1)(1994-6#1)(1995-3#1)(2010-5#1)(2012-3#1)
bind both##2##2##(1990-5#1)(1995-2#1)
bind directly to##3##3##(1993-11#1)(1993-6#1)(2008-8#1)
bind efficiently##2##2##(1995-8#1)(2008-4#1)
bind heparin##2##2##(1994-6#2)
bind in##6##2##(1992-5#1)(1992-8#1)(1994-8#1)(1995-3#2)(1997-2#1)
bind metal ions##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
bind metal##4##2##(2008-10#2)(2010-11#1)(2011-2#1)
bind only##4##2##(1991-9#1)(1992-11#1)(1997-3#2)
bind selectively##2##2##(2008-4#1)(2009-12#1)
bind specifically to the##2##4##(1992-8#1)(1995-11#1)
bind specifically to##7##3##(1991-12#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-9#1)
bind the sequence##3##3##(1993-6#2)(1994-6#1)
bind the##20##2##(1992-8#1)(1993-6#3)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#2)(1997-2#2)(2008-10#3)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
bind to CCAAT##2##3##(1995-2#1)(2008-9#1)
bind to DNA##4##3##(1994-8#1)(1995-5#1)(2008-8#1)(2009-8#1)
bind to a protein##2##4##(2008-1#1)(2008-10#1)
bind to a##6##3##(1994-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)
bind to and##5##3##(1991-9#2)(1994-5#1)(1995-8#1)(2008-4#1)
bind to each##2##3##(2008-1#1)(2009-11#1)
bind to one##2##3##(1990-9#1)(1993-6#1)
bind to specific##2##3##(1997-7#1)(2008-4#1)
bind to the HIV-1##2##4##(2008-4#1)(2013-1#1)
bind to the TATA##2##4##(1993-8#1)(1997-2#1)
bind to the conserved##2##4##(1992-6#1)(2012-12#1)
bind to the enzyme##2##4##(1994-5#1)(1995-6#1)
bind to the same region##3##5##(1990-12#1)(1993-8#2)
bind to the same##7##4##(1990-12#2)(1993-8#2)(1994-12#1)(1995-5#1)(2008-8#1)
bind to the##43##3##(1990-12#2)(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#3)(1993-3#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#2)(1995-6#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#2)
bind to##125##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#6)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#3)(2007-11#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#7)(2009-11#1)(2009-7#2)(2009-8#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
bind with high affinity to##2##5##(1996-12#1)(2008-4#1)
bind with high affinity##3##4##(1996-12#1)(2006-6#1)(2008-4#1)
bind with##12##2##(1990-5#1)(1995-2#1)(1996-12#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2013-7#1)
bind##308##1##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#3)(1990-5#6)(1990-8#3)(1990-9#2)(1991-12#6)(1991-5#3)(1991-9#4)(1992-11#4)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#9)(1992-9#2)(1993-11#3)(1993-3#2)(1993-6#8)(1993-8#5)(1993-9#1)(1994-11#4)(1994-12#6)(1994-2#4)(1994-5#7)(1994-6#7)(1994-8#8)(1994-9#2)(1995-11#6)(1995-12#2)(1995-2#13)(1995-3#4)(1995-5#6)(1995-6#8)(1995-8#7)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#4)(1997-3#4)(1997-6#2)(1997-7#4)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#14)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#15)(2008-9#11)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#2)
binder of##2##2##(2008-10#2)
binder viscosity##2##2##(2008-10#2)
binder##16##1##(1993-8#1)(2008-1#1)(2008-10#12)(2010-5#1)(2012-2#1)
binders##13##1##(1991-12#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2012-12#4)(2013-1#1)
binding (IC50##2##2##(1994-8#1)(1995-2#1)
binding (i##3##2##(1990-8#1)(1997-2#2)
binding GP##2##2##(1993-6#2)
binding a##2##2##(1990-12#1)(2008-9#1)
binding ability of##3##3##(2008-10#3)
binding ability##8##2##(1990-11#1)(1990-6#1)(1992-8#1)(2008-10#5)
binding activities##7##2##(1990-12#1)(1990-8#1)(1993-6#1)(1993-8#1)(1997-4#2)(2008-9#1)
binding activity and##2##3##(1995-8#1)(1997-7#1)
binding activity in the##2##4##(1994-9#1)(1997-4#1)
binding activity in##3##3##(1993-3#1)(1994-9#1)(1997-4#1)
binding activity is##2##3##(1995-6#1)(2011-1#1)
binding activity of the##3##4##(1992-12#1)(1992-9#1)(1994-6#1)
binding activity of##7##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-6#1)(1997-3#1)(2008-9#1)
binding activity to##2##3##(1992-9#1)(2008-8#1)
binding activity##34##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-9#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-3#2)(1997-4#2)(1997-7#2)(2008-1#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#1)
binding affinities for##2##3##(1994-5#1)(1995-3#1)
binding affinities of these##2##4##(1990-11#1)(1993-11#1)
binding affinities of##5##3##(1990-11#1)(1993-11#1)(1993-6#1)(2008-11#1)(2009-12#1)
binding affinities##13##2##(1990-11#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-3#2)(1996-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)
binding affinity and##2##3##(2008-9#1)(2011-2#1)
binding affinity between##3##3##(2008-10#1)(2009-3#1)(2012-2#1)
binding affinity for Ca(2+)##2##4##(2009-7#2)
binding affinity for##13##3##(1990-5#1)(1993-11#1)(1993-6#1)(1993-8#2)(1995-2#1)(1995-6#1)(2008-10#3)(2008-3#1)(2009-7#2)
binding affinity in the##2##4##(1993-3#1)(1995-3#1)
binding affinity in##4##3##(1993-3#1)(1995-3#1)(1995-8#1)(2008-10#1)
binding affinity of the##7##4##(1990-5#2)(1992-6#1)(1995-2#3)(1997-6#1)
binding affinity of##12##3##(1990-5#2)(1991-5#1)(1992-6#1)(1995-11#1)(1995-2#3)(1995-5#1)(1997-6#1)(2008-4#1)(2008-8#1)
binding affinity to##8##3##(1990-2#1)(1991-12#1)(1991-2#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#1)(2009-5#1)
binding affinity was##2##3##(1995-3#1)(2008-8#1)
binding affinity##78##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-6#1)(1995-11#3)(1995-2#8)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2008-10#8)(2008-3#2)(2008-4#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
binding agent##2##2##(1992-3#1)(2010-5#1)
binding also##2##2##(2007-12#1)(2010-5#1)
binding amino acids##3##3##(2011-2#3)
binding and activation##2##3##(1994-6#1)(1995-2#1)
binding and catalysis##3##3##(1993-11#1)(1993-8#1)(1995-5#1)
binding and dissociation##2##3##(2008-5#1)(2008-7#1)
binding and elution##2##3##(1991-12#1)(2008-10#1)
binding and enzymatic##2##3##(1990-12#2)
binding and internalization##3##3##(1991-2#1)(1995-11#1)(1995-6#1)
binding and metabolism##2##3##(1992-2#1)(1995-11#1)
binding and phagocytosis##2##3##(1995-2#1)(2008-4#1)
binding and receptor##2##3##(1990-12#1)(2008-4#1)
binding and release##3##3##(2008-7#2)(2011-2#1)
binding and state##2##3##(1994-5#2)
binding and stimulation of##2##4##(1993-11#1)(1993-3#1)
binding and that the##2##4##(1991-9#1)(1994-6#1)
binding and the##6##3##(1996-2#1)(1997-2#1)(2008-10#3)(2008-7#1)
binding and uptake##2##3##(1992-3#1)(1994-5#1)
binding and##108##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#5)(1994-5#4)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#3)(1995-5#3)(1995-6#4)(1995-8#3)(1996-12#3)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-8#1)(2008-10#11)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#3)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
binding approximately##2##2##(1997-1#2)
binding aptamers##2##2##(2009-12#2)
binding are##3##2##(1990-2#1)(1993-2#1)(1993-8#1)
binding assay and##3##3##(1992-3#1)(1995-8#1)(2008-9#1)
binding assay demonstrated that##2##4##(2008-9#1)(2010-6#1)
binding assay for##6##3##(1990-7#2)(1992-11#2)(1992-6#2)
binding assay##29##2##(1990-11#1)(1990-12#4)(1990-7#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-9#3)(2010-12#3)(2010-6#1)
binding assays showed##2##3##(1996-12#1)(1997-6#1)
binding assays using##2##3##(1993-3#1)(1997-4#1)
binding assays with##2##3##(2008-10#1)(2008-11#1)
binding assays##30##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)
binding at a##2##3##(1992-12#1)(1994-9#1)
binding at low concentrations##2##4##(1995-3#2)
binding at the same##2##4##(1990-5#1)(1994-8#1)
binding at the##5##3##(1990-11#1)(1990-5#1)(1992-3#1)(1994-8#1)(2007-11#1)
binding at##16##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-3#3)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#3)(1995-6#1)(2007-11#1)(2010-11#1)
binding between the##3##3##(1996-7#1)(2008-10#1)(2008-3#1)
binding between##7##2##(1996-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2011-2#1)
binding but##2##2##(1993-8#1)(1995-2#1)
binding by 43%##2##3##(1994-12#1)(1995-12#1)
binding by the##3##3##(1992-6#2)(2009-7#1)
binding by##27##2##(1990-5#4)(1990-6#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)
binding can be##4##3##(1993-8#1)(1995-6#1)(1996-12#1)(2008-10#1)
binding can##6##2##(1993-8#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
binding capacities##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
binding capacity and##5##3##(1995-2#1)(1997-6#2)(2008-10#1)(2013-1#1)
binding capacity of the##2##4##(1990-12#1)(2008-10#1)
binding capacity of##14##3##(1990-11#1)(1990-12#2)(1990-5#3)(1991-5#1)(1992-4#1)(1993-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
binding capacity to##2##3##(2009-5#1)(2012-2#1)
binding capacity##29##2##(1990-11#1)(1990-12#2)(1990-5#4)(1991-5#2)(1992-4#1)(1993-3#1)(1993-6#1)(1995-2#1)(1997-6#2)(2007-11#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-2#1)(2013-1#3)(2013-8#1)
binding cavity##5##2##(1992-6#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
binding characteristics of##10##3##(1990-12#1)(1990-2#1)(1991-9#1)(1993-1#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)
binding characteristics to##2##3##(1993-8#1)(1997-4#1)
binding characteristics##20##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#2)(2009-9#1)
binding component##5##2##(1990-11#3)(1994-8#1)(1995-2#1)
binding conditions##3##2##(1997-2#2)(2013-1#1)
binding conformation of##2##3##(1991-1#1)(2012-2#1)
binding conformations##2##2##(1992-11#1)(2012-3#1)
binding constant (K)##2##3##(2008-10#2)
binding constant for the##3##4##(1995-2#1)(2008-10#2)
binding constant for##5##3##(1992-3#1)(1994-8#1)(1995-2#1)(2008-10#2)
binding constant of the##4##4##(1993-8#1)(2008-10#3)
binding constant of##7##3##(1993-8#2)(1997-7#1)(2008-10#4)
binding constant to##5##3##(1995-2#3)(2008-10#1)(2008-12#1)
binding constant##28##2##(1990-8#1)(1992-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-2#4)(1997-2#1)(1997-7#1)(2008-10#14)(2008-12#1)(2008-5#1)
binding constants and##3##3##(1990-8#1)(2008-10#2)
binding constants for##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
binding constants of##5##3##(1992-10#1)(1992-4#1)(1993-1#1)(1997-7#1)(2008-10#1)
binding constants##22##2##(1990-8#5)(1992-10#1)(1992-4#1)(1992-8#1)(1993-1#1)(1994-5#1)(1995-2#3)(1997-2#1)(1997-7#1)(2008-10#6)(2008-5#1)
binding could serve as##2##4##(1993-8#1)(2013-7#1)
binding could##3##2##(1991-12#1)(1993-8#1)(2013-7#1)
binding curves##4##2##(1990-8#1)(1993-8#1)(1997-2#1)(2008-10#1)
binding data##11##2##(1990-12#1)(1990-7#1)(1991-5#1)(1993-1#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#2)
binding decreased##2##2##(1993-8#1)(1996-2#1)
binding directly to##2##3##(1992-8#1)(2008-11#1)
binding domain between##2##3##(2008-8#2)
binding domain of the human##2##5##(1997-2#1)(2006-6#1)
binding domain of the##4##4##(1991-2#1)(1992-12#1)(1997-2#1)(2006-6#1)
binding domain of##12##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1995-5#1)(1995-6#1)(1997-2#2)(2006-6#1)(2008-9#1)(2012-12#1)
binding domain##33##2##(1990-11#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-1#1)(1992-12#2)(1995-5#2)(1995-6#4)(1996-5#1)(1997-2#2)(2006-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-12#2)
binding domains of##3##3##(1990-7#1)(1994-8#1)(1996-2#1)
binding domains on the##2##4##(1993-3#2)
binding domains##10##2##(1990-11#1)(1990-7#1)(1991-12#1)(1993-3#2)(1994-8#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-8#1)
binding during##2##2##(1993-1#1)(2008-7#1)
binding energies##7##2##(1996-2#2)(2008-3#1)(2008-9#1)(2010-7#3)
binding energy##8##2##(1992-5#1)(1993-11#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
binding enthalpy##2##2##(1992-10#2)
binding events##3##2##(2008-4#1)(2009-2#1)(2010-12#1)
binding experiments are##2##3##(1993-11#1)(2008-4#1)
binding experiments##8##2##(1990-7#1)(1991-8#1)(1993-11#3)(2008-4#1)(2008-8#1)(2008-9#1)
binding factor##4##2##(1995-2#1)(2008-11#2)(2011-2#1)
binding factors##4##2##(1991-5#1)(1993-8#2)(2008-9#1)
binding fold##3##2##(2008-11#2)(2008-8#1)
binding following##3##2##(1994-11#1)(1995-5#1)(2008-11#1)
binding for##6##2##(1993-6#1)(1994-8#1)(1995-5#1)(2008-10#1)(2009-2#2)
binding force##2##2##(1990-2#1)(2008-5#1)
binding fragments##2##2##(1994-11#1)(1995-5#1)
binding free energy##2##3##(1995-2#1)(2008-4#1)
binding globulin##7##2##(1990-11#1)(1990-2#2)(1991-3#3)(2011-2#1)
binding in a concentration-dependent manner##2##5##(1990-7#1)(1995-5#1)
binding in a dose-dependent manner##2##5##(1994-3#1)(1994-8#1)
binding in a##8##3##(1990-7#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(2008-4#1)
binding in human##2##3##(1992-3#1)(1993-9#1)
binding in rat brain##2##4##(1995-11#1)(1996-2#1)
binding in rat##5##3##(1991-5#1)(1992-3#1)(1995-11#1)(1996-2#1)(1997-1#1)
binding in the molecular layer##2##5##(1993-9#1)(1996-5#1)
binding in the presence of##2##5##(1990-2#1)(1995-12#1)
binding in the##11##3##(1990-2#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-7#1)(2010-11#1)(2013-8#1)
binding in vitro##2##3##(1995-6#1)(2009-4#1)
binding in young animals was##2##5##(1996-5#2)
binding in##64##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-3#3)(1993-12#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-5#3)(1995-6#2)(1996-12#2)(1996-2#1)(1996-5#6)(1996-7#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
binding induces a##2##3##(1994-5#1)(1994-6#1)
binding inhibiting##2##2##(1995-12#2)
binding inhibitors##2##2##(1990-5#1)(1993-12#1)
binding interaction##3##2##(1990-5#1)(2008-10#1)(2008-12#1)
binding interactions##5##2##(2008-10#1)(2008-9#3)(2010-11#1)
binding interface##2##2##(2008-8#1)(2013-1#1)
binding is##25##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)
binding isotherms##4##2##(1993-8#1)(1997-2#3)
binding kinetics##4##2##(2006-6#1)(2008-10#1)(2009-10#1)(2013-8#1)
binding ligands##3##2##(1992-11#1)(1992-9#1)(2008-10#1)
binding may##4##2##(1990-12#1)(1993-6#1)(1995-11#1)(1995-3#1)
binding mechanism##3##2##(2008-10#2)(2013-1#1)
binding media##10##2##(1992-12#1)(2008-10#9)
binding method##2##2##(1993-8#1)(2008-12#1)
binding mode and##2##3##(1991-12#1)(2013-1#1)
binding mode##13##2##(1990-7#1)(1991-12#1)(1992-3#3)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2009-7#1)(2013-1#2)
binding model for##2##3##(1994-5#1)(2008-10#1)
binding model##9##2##(1994-5#4)(1997-2#1)(1997-7#1)(2007-6#1)(2008-10#1)(2010-5#1)
binding modes of##2##3##(1990-7#1)(1995-11#1)
binding modes##11##2##(1990-7#2)(1994-5#1)(1995-11#1)(1997-2#2)(1997-7#1)(2008-4#1)(2008-9#1)(2013-7#2)
binding motif and##2##3##(2008-1#1)(2013-1#1)
binding motif of the##2##4##(1990-11#1)(2008-10#1)
binding motif##9##2##(1990-11#1)(1991-12#1)(1994-6#1)(1997-4#1)(2008-1#2)(2008-10#1)(2009-12#1)(2013-1#1)
binding motifs for##2##3##(1997-4#1)(2012-2#1)
binding motifs##4##2##(1997-4#1)(2008-4#1)(2008-8#1)(2012-2#1)
binding number and##2##3##(2008-10#2)
binding number##5##2##(2008-10#5)
binding observed##2##2##(2008-10#1)(2008-6#1)
binding occurs at##2##3##(1993-8#1)(1994-5#1)
binding occurs##5##2##(1990-7#1)(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#1)
binding of 125I-EGF##2##3##(1993-3#2)
binding of 2##4##3##(1990-8#1)(1992-5#1)(1995-2#1)(1995-6#1)
binding of 3##3##3##(1991-2#1)(1993-8#2)
binding of ATP##5##3##(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1995-2#1)
binding of CETP to lipoproteins##2##5##(1995-5#2)
binding of CaM kinase II##2##5##(1993-6#2)
binding of E##2##3##(2008-10#2)
binding of ESA to the cell surface##2##7##(2008-11#2)
binding of N-methyl-11C-clozapine in##2##4##(1996-5#2)
binding of NBMPR##2##3##(1994-8#2)
binding of NE##3##3##(2008-3#3)
binding of TNT##2##3##(1995-6#2)
binding of [125I]IL-8##3##3##(1993-6#3)
binding of a##9##3##(1991-11#1)(1994-11#1)(1995-2#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
binding of adenine nucleotides##2##4##(1991-8#1)(1992-6#1)
binding of agonists to the A1 adenosine receptor##2##8##(1993-3#1)(1994-5#1)
binding of agonists to the##3##5##(1993-3#1)(1994-5#2)
binding of alpha-actinin to actin is##2##6##(1993-8#2)
binding of an##4##3##(1991-3#1)(2008-11#1)(2008-4#1)(2012-12#1)
binding of biomolecules##2##3##(2010-2#1)(2010-7#1)
binding of both##4##3##(1990-12#1)(1992-2#1)(1995-5#1)(2008-7#1)
binding of calcium##2##3##(1990-7#1)(1993-6#1)
binding of carbon##2##3##(1991-12#1)(1995-3#1)
binding of charged ligands to##2##5##(1997-2#2)
binding of coumestrol##2##3##(1995-11#2)
binding of d- and##2##4##(2008-10#2)
binding of different##2##3##(2008-1#1)(2008-4#1)
binding of drugs##2##3##(2008-10#1)(2008-8#1)
binding of estrogen receptor##2##4##(1995-2#2)
binding of exogenously added IF-[57Co]Cbl##2##5##(1990-11#2)
binding of fibrinogen to##3##4##(1995-2#2)(2006-6#1)
binding of human##2##3##(1995-6#1)(1996-12#1)
binding of metal##2##3##(1994-11#1)(2008-10#1)
binding of mouse##2##3##(1993-8#1)(1997-6#1)
binding of myosin##2##3##(1994-5#1)(1995-2#1)
binding of nanocarriers##2##3##(2008-12#2)
binding of substrate##2##3##(1991-12#1)(1995-2#1)
binding of the cationic probe##2##5##(1992-6#2)
binding of the dye##2##4##(1994-12#1)(2008-1#1)
binding of the substrate##2##4##(1990-5#1)(1993-8#1)
binding of the##62##3##(1990-11#1)(1990-12#3)(1990-5#3)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#4)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-12#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#2)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#2)
binding of these##5##3##(1990-5#1)(1992-12#1)(1994-12#1)(1994-5#1)(1995-2#1)
binding of three##2##3##(1990-12#1)(1993-6#1)
binding of two##2##3##(1990-11#1)(1994-5#1)
binding of zinc to an aminoacyl-tRNA synthetase##2##7##(1994-6#2)
binding of zinc##4##3##(1994-6#2)(2010-10#2)
binding of##392##2##(1990-11#10)(1990-12#10)(1990-2#2)(1990-5#12)(1990-6#1)(1990-7#5)(1990-8#5)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#10)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#1)(1993-1#5)(1993-11#3)(1993-12#2)(1993-3#6)(1993-6#11)(1993-8#9)(1993-9#3)(1994-11#7)(1994-12#3)(1994-3#3)(1994-5#16)(1994-6#5)(1994-8#8)(1994-9#1)(1995-11#15)(1995-12#2)(1995-2#20)(1995-3#4)(1995-5#8)(1995-6#9)(1996-12#5)(1996-2#4)(1996-5#5)(1996-8#1)(1997-2#7)(1997-4#3)(1997-6#2)(1997-7#2)(1997-9#1)(2006-6#2)(2007-11#2)(2008-1#3)(2008-10#32)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#4)(2009-2#3)(2009-5#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#4)
binding on the##2##3##(1994-5#1)(2008-10#1)
binding on##9##2##(1994-5#1)(1995-5#1)(2008-10#4)(2008-8#1)(2011-2#2)
binding or the##2##3##(1991-12#1)(1993-3#1)
binding or##6##2##(1991-12#1)(1992-9#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-8#1)
binding parameters of##3##3##(1994-2#1)(1995-2#1)(2008-10#1)
binding parameters##11##2##(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#8)
binding partner##2##2##(2008-4#1)(2012-2#1)
binding partners to##2##3##(2008-9#1)(2013-1#1)
binding partners##6##2##(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
binding pattern##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
binding patterns##4##2##(1997-6#3)(2008-8#1)
binding peptides##2##2##(1994-12#1)(2008-10#1)
binding phase##3##2##(2008-10#2)(2009-7#1)
binding pocket of##4##3##(1991-12#1)(1991-8#1)(1995-5#1)(2013-7#1)
binding pocket##10##2##(1991-12#1)(1991-8#1)(1992-4#1)(1994-5#2)(1995-5#1)(2007-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
binding pockets##2##2##(2007-6#2)
binding process##8##2##(1991-12#1)(1997-2#2)(1997-6#1)(2008-10#3)(2008-12#1)
binding properties and##4##3##(1991-8#1)(1993-8#1)(1995-8#1)(2008-10#1)
binding properties in##2##3##(1995-11#1)(2009-10#1)
binding properties of a##2##4##(1991-3#1)(2011-1#1)
binding properties of the##4##4##(1991-3#1)(1992-3#1)(1995-5#1)(2008-9#1)
binding properties of##9##3##(1991-3#2)(1992-3#1)(1995-5#2)(1996-3#1)(2008-10#1)(2008-9#1)(2011-1#1)
binding properties##21##2##(1990-8#1)(1991-3#2)(1991-8#1)(1992-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)
binding protein (MBP)##2##3##(1992-11#1)(1995-12#1)
binding protein and##6##3##(1990-6#1)(1991-2#1)(1992-6#1)(1992-9#1)(1997-4#1)(2011-2#1)
binding protein for dipeptides and beta-lactam antibiotics##4##7##(1990-11#4)
binding protein for##7##3##(1990-11#5)(1991-9#1)(1994-12#1)
binding protein from##6##3##(1990-12#1)(1992-3#1)(1993-11#1)(1995-5#1)(1997-4#1)(2009-7#1)
binding protein gene##3##3##(1995-5#1)(2008-8#2)
binding protein in the##2##4##(1990-12#1)(1990-8#1)
binding protein in##7##3##(1990-12#3)(1990-8#1)(1991-2#1)(1997-4#1)(2008-10#1)
binding protein is##2##3##(1994-2#1)(1995-2#1)
binding protein of##2##3##(1990-12#1)(1995-12#1)
binding protein was##2##3##(1992-12#1)(1994-12#1)
binding protein##110##2##(1990-11#6)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#3)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-3#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-2#4)(1994-8#3)(1995-12#2)(1995-2#3)(1995-5#7)(1995-8#3)(1996-12#2)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
binding protein)##2##2##(1994-2#1)(2008-9#1)
binding protein-1##2##2##(2011-2#1)(2012-2#1)
binding protein-4##2##2##(2011-1#1)(2013-1#1)
binding proteins (IGFBPs)##3##3##(1993-3#1)(2008-4#1)(2008-5#1)
binding proteins and##3##3##(1993-9#1)(2011-2#1)(2012-2#1)
binding proteins in##9##3##(1991-2#1)(1991-5#1)(1993-6#1)(1996-5#1)(2008-8#5)
binding proteins that##2##3##(1991-2#1)(1993-6#1)
binding proteins##51##2##(1991-2#2)(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#6)(2008-9#2)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#3)
binding rate of##2##3##(2008-10#1)(2013-8#1)
binding ratio##2##2##(2008-10#2)
binding reaction##4##2##(1992-9#1)(2008-10#2)(2008-12#1)
binding reactions##4##2##(1991-12#1)(2008-10#2)(2012-2#1)
binding region as##2##3##(2008-10#1)(2008-6#1)
binding region of GIP##3##4##(1997-4#3)
binding region of the##2##4##(1991-12#1)(2008-8#1)
binding region of##7##3##(1991-12#1)(1993-11#1)(1995-5#1)(1997-4#3)(2008-8#1)
binding region##10##2##(1991-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(1997-4#3)(2008-10#1)(2008-6#1)(2008-8#1)
binding requirements##2##2##(1993-6#1)(1995-3#1)
binding requires##2##2##(2008-10#1)(2008-4#1)
binding sensitivity##2##2##(1993-12#2)
binding sequence##5##2##(1990-7#1)(1991-11#1)(1992-12#1)(2008-10#1)(2010-6#1)
binding sequences##3##2##(1995-6#2)(2008-8#1)
binding site and the##3##4##(1991-12#1)(1994-5#1)(2008-9#1)
binding site and##9##3##(1990-5#1)(1991-12#1)(1993-3#1)(1994-5#2)(1995-5#1)(1997-5#1)(2008-9#1)(2012-3#1)
binding site by DHEA##3##4##(2008-10#3)
binding site for the liganded Ah receptor##2##7##(1992-8#2)
binding site for the##11##4##(1990-5#2)(1990-7#1)(1991-5#1)(1992-8#2)(1993-12#1)(1993-3#1)(1995-5#1)(1995-6#1)(2009-8#1)
binding site for##25##3##(1990-5#2)(1990-7#1)(1991-5#3)(1992-8#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-8#1)(2010-10#1)(2012-2#1)
binding site in the##5##4##(1990-5#2)(1992-3#1)(1996-2#1)(2008-10#1)
binding site in##9##3##(1990-5#2)(1990-8#1)(1992-3#1)(1992-6#1)(1996-12#1)(1996-2#1)(2008-10#2)
binding site is located##2##4##(1991-12#1)(1995-2#1)
binding site is##6##3##(1990-8#1)(1991-12#1)(1995-2#2)(1995-6#1)(2008-5#1)
binding site of a##2##4##(1990-11#1)(1993-2#1)
binding site of the##5##4##(1994-11#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-5#1)
binding site of##18##3##(1990-11#2)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-2#1)
binding site on microtubules##2##4##(1994-5#1)(2008-8#1)
binding site on the##2##4##(1990-7#1)(2009-8#1)
binding site on##8##3##(1990-7#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-2#2)(2008-8#1)(2009-8#1)
binding site preference##2##3##(1990-7#1)(1995-5#1)
binding site size##2##3##(1992-11#1)(2008-4#1)
binding site was##3##3##(1991-7#1)(1992-6#1)(2008-9#1)
binding site which may##2##4##(1993-11#1)(1994-3#1)
binding site which##3##3##(1991-5#1)(1993-11#1)(1994-3#1)
binding site with##3##3##(1990-2#1)(1993-11#1)(1994-5#1)
binding site##168##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#9)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#5)(1991-7#1)(1992-11#2)(1992-12#3)(1992-3#4)(1992-6#5)(1992-8#5)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#3)(1994-11#2)(1994-3#2)(1994-5#8)(1994-6#1)(1994-8#2)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#7)(1995-6#2)(1995-8#5)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-2#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
binding site(s)##8##2##(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1997-7#1)(2006-6#1)(2008-1#1)(2012-2#1)
binding sites (C(L))##2##3##(2008-10#2)
binding sites and##5##3##(1990-12#3)(2008-11#1)(2013-1#1)
binding sites are##6##3##(1991-5#1)(1993-8#1)(1995-8#1)(2008-11#1)(2008-4#2)
binding sites associated with the##2##5##(1991-1#1)(1992-3#1)
binding sites for IgE##2##4##(2008-10#2)
binding sites for [3H]-staurosporine##3##4##(1990-8#3)
binding sites for nuclear##2##4##(1992-12#1)(2011-2#1)
binding sites for several##2##4##(1994-11#1)(2008-11#1)
binding sites for the##3##4##(1993-3#1)(1993-8#1)(1995-8#1)
binding sites for##46##3##(1990-12#2)(1990-5#2)(1990-8#5)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-6#1)(2011-2#1)
binding sites in rat brain##3##5##(1990-7#1)(1993-11#1)(1993-5#1)
binding sites in rat##4##4##(1990-7#2)(1993-11#1)(1993-5#1)
binding sites in the##15##4##(1990-2#2)(1991-1#1)(1992-6#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#2)
binding sites in##28##3##(1990-2#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-5#2)(1992-6#1)(1993-11#1)(1993-5#1)(1994-3#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#2)(2012-2#1)(2012-3#1)
binding sites is##4##3##(1993-8#1)(1994-12#1)(1995-8#1)(2012-3#1)
binding sites labelled by##2##4##(1994-2#1)(1995-12#1)
binding sites of the##3##4##(1990-12#1)(1997-2#1)(2008-10#1)
binding sites of##11##3##(1990-12#2)(1992-8#1)(1993-3#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-10#4)
binding sites on the##2##4##(1990-12#1)(1993-8#1)
binding sites on##8##3##(1990-12#2)(1990-5#2)(1993-8#1)(1995-5#1)(2008-9#1)(2010-5#1)
binding sites per##2##3##(1993-6#1)(2008-11#1)
binding sites that##2##3##(2008-11#1)(2008-8#1)
binding sites to##2##3##(1995-2#1)(2008-10#1)
binding sites was detected##3##4##(1990-5#1)(1994-11#2)
binding sites was##9##3##(1990-5#3)(1994-11#3)(1995-12#1)(1995-8#1)(1996-5#1)
binding sites were detected in the##2##6##(1994-2#1)(2008-3#1)
binding sites were##5##3##(1994-2#2)(1994-5#1)(2008-3#1)(2008-7#1)
binding sites with a Kd of 1##2##7##(1990-2#1)(1995-8#1)
binding sites with a Kd of##4##6##(1990-2#1)(1993-12#1)(1993-8#1)(1995-8#1)
binding sites with a##5##4##(1990-2#1)(1990-8#1)(1993-12#1)(1993-8#1)(1995-8#1)
binding sites with##12##3##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-8#2)(2012-2#1)
binding sites within##4##3##(2008-11#2)(2012-3#1)(2013-1#1)
binding sites##232##2##(1990-11#2)(1990-12#12)(1990-2#4)(1990-5#11)(1990-7#5)(1990-8#7)(1991-1#2)(1991-2#3)(1991-5#6)(1991-6#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#8)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#1)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#8)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#19)(2008-11#14)(2008-3#3)(2008-4#5)(2008-7#7)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-2#4)(2012-3#3)(2013-1#3)
binding sites/cell##2##2##(1993-12#1)(1994-8#1)
binding species##2##2##(1992-4#1)(2008-10#1)
binding specificity as##2##3##(1991-9#1)(2009-9#1)
binding specificity for##2##3##(1993-6#1)(2008-8#1)
binding specificity of the##3##4##(1993-5#1)(1994-2#1)(1995-5#1)
binding specificity of##4##3##(1993-5#1)(1994-2#1)(1995-5#2)
binding specificity##14##2##(1991-9#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-2#2)(1995-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
binding states##2##2##(2008-11#1)(2008-12#1)
binding step##2##2##(1994-2#1)(1997-2#1)
binding strength##4##2##(1990-2#1)(1990-5#1)(2008-9#1)(2009-7#1)
binding studies of the##2##4##(1992-12#1)(1992-3#1)
binding studies of##3##3##(1992-12#1)(1992-3#1)(1994-6#1)
binding studies on##2##3##(1995-2#1)(1995-3#1)
binding studies to##2##3##(1990-7#1)(2008-9#1)
binding studies were##2##3##(1994-9#1)(1995-12#1)
binding studies with##4##3##(1991-7#1)(1993-3#1)(1995-11#1)(2008-10#1)
binding studies##23##2##(1990-7#2)(1991-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
binding study##2##2##(1991-6#1)(2008-10#1)
binding target##3##2##(1995-2#1)(2009-12#1)(2010-12#1)
binding technique##2##2##(1991-6#1)(1994-9#1)
binding than##2##2##(2008-9#1)(2013-1#1)
binding that##3##2##(1995-2#1)(1996-12#1)(1996-5#1)
binding the##6##2##(1993-8#2)(2008-10#2)(2008-8#1)(2009-8#1)
binding to DNA and##2##4##(1992-12#1)(1996-2#1)
binding to DNA##10##3##(1992-12#2)(1992-2#1)(1992-7#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-8#1)(2008-9#1)
binding to Kupffer cells##2##4##(1992-11#2)
binding to VLDL##2##3##(1993-6#2)
binding to a##13##3##(1990-2#1)(1990-7#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-4#1)(2008-7#1)(2010-8#1)
binding to actin##2##3##(1997-7#1)(2011-2#1)
binding to an##3##3##(1991-2#1)(1992-11#1)(2011-1#1)
binding to angiotensin##3##3##(1992-9#1)(1995-12#2)
binding to both##4##3##(1993-12#1)(1995-2#1)(1997-6#1)(2008-9#1)
binding to bovine##2##3##(1990-8#1)(2008-3#1)
binding to class II MHC##3##5##(1993-3#3)
binding to class##4##3##(1993-3#3)(2008-4#1)
binding to cytochrome oxidase##2##4##(1990-3#2)
binding to cytochrome##4##3##(1990-3#2)(1994-5#1)(1995-2#1)
binding to deep cortical layers of##2##6##(1993-12#2)
binding to either##4##3##(1994-5#2)(1995-5#1)(2012-12#1)
binding to heme##2##3##(1993-8#1)(2007-11#1)
binding to human serum albumin##2##5##(2008-10#2)
binding to human##7##3##(1990-8#1)(1992-10#1)(1993-9#1)(1994-12#1)(2006-6#1)(2008-10#2)
binding to immobilized Interleukin-1alpha##2##4##(2008-10#2)
binding to immobilized##3##3##(2008-10#3)
binding to intact##2##3##(1990-12#1)(1997-1#1)
binding to its receptor##3##4##(1995-2#1)(1995-6#1)(2009-2#1)
binding to its##5##3##(1993-3#1)(1995-2#1)(1995-6#1)(2009-2#1)(2009-8#1)
binding to membrane##2##3##(1996-5#2)
binding to p75R##2##3##(1994-2#2)
binding to partially oxidized##2##4##(1990-8#2)
binding to partially##3##3##(1990-8#2)(1993-9#1)
binding to platelets##2##3##(1993-3#1)(2008-3#1)
binding to pure receptor##2##4##(1990-5#2)
binding to specific receptors##2##4##(2008-8#1)(2010-10#1)
binding to specific##5##3##(1990-2#1)(1993-8#1)(2008-4#1)(2008-8#1)(2010-10#1)
binding to the 3' UTR of##2##6##(1996-12#1)(2010-11#1)
binding to the 3'##3##4##(1996-12#1)(2009-5#1)(2010-11#1)
binding to the ER##2##4##(2008-11#2)
binding to the alpha 1 beta 1 dimer##2##8##(1993-8#2)
binding to the alpha##3##4##(1990-7#1)(1993-8#2)
binding to the protein##2##4##(1995-3#1)(2008-10#1)
binding to the receptor##3##4##(1993-3#1)(1995-2#1)(1995-6#1)
binding to the specific##2##4##(2008-4#1)(2009-8#1)
binding to the##88##3##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-3#1)(1991-5#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
binding to these##3##3##(1990-12#1)(1993-8#1)(2009-12#1)
binding to vascular muscle##2##4##(1991-6#2)
binding to yeast phosphoglycerate kinase##2##5##(1990-5#2)
binding to##318##2##(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#8)(1990-7#3)(1990-8#10)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#5)(1992-10#2)(1992-11#8)(1992-12#6)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#9)(1993-5#1)(1993-6#8)(1993-8#11)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#7)(1994-6#4)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#12)(1995-3#3)(1995-5#3)(1995-6#11)(1995-8#3)(1996-12#3)(1996-2#5)(1996-5#2)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#5)(1997-7#7)(1997-8#2)(2006-6#1)(2007-11#2)(2007-6#3)(2008-1#2)(2008-10#18)(2008-11#8)(2008-3#2)(2008-4#12)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#8)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
binding transcription##2##2##(2008-9#1)(2012-12#1)
binding type##2##2##(1990-12#1)(2008-11#1)
binding using##5##2##(1990-11#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-4#1)
binding was inhibited by##4##4##(1992-9#1)(1993-3#1)(1993-9#1)(2010-5#1)
binding was inhibited##6##3##(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(2010-5#1)
binding was not##2##3##(1996-12#1)(2008-3#1)
binding was observed with##2##4##(1994-2#1)(2008-10#1)
binding was observed##7##3##(1993-11#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-5#1)(2008-10#2)
binding was reduced##4##3##(1992-9#1)(1993-6#1)(1995-5#1)(1996-5#1)
binding was##54##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#4)(1991-5#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#5)(1993-8#2)(1993-9#3)(1994-2#2)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#6)(1996-5#4)(1997-4#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-5#1)
binding were obtained##2##3##(1995-11#1)(2008-3#1)
binding were##12##2##(1990-5#1)(1993-8#1)(1995-11#3)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
binding with a##4##3##(1993-6#1)(1994-8#1)(2008-10#2)
binding with both##2##3##(1994-3#1)(1997-2#1)
binding with high affinity to##2##5##(1990-5#1)(1993-6#1)
binding with high affinity##3##4##(1990-5#1)(1992-9#1)(1993-6#1)
binding with specific##2##3##(2007-11#1)(2008-10#1)
binding with the##6##3##(1993-6#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
binding with##27##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-9#1)(1993-6#3)(1994-3#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-5#1)(2010-11#2)(2012-2#1)
binding##2833##1##(1990-10#3)(1990-11#53)(1990-12#57)(1990-2#28)(1990-3#6)(1990-4#2)(1990-5#64)(1990-6#6)(1990-7#38)(1990-8#54)(1991-1#7)(1991-10#3)(1991-11#5)(1991-12#36)(1991-2#31)(1991-3#9)(1991-5#32)(1991-6#9)(1991-7#3)(1991-8#14)(1991-9#24)(1992-1#2)(1992-10#7)(1992-11#22)(1992-12#35)(1992-2#5)(1992-3#44)(1992-4#7)(1992-5#5)(1992-6#35)(1992-7#1)(1992-8#21)(1992-9#24)(1993-1#16)(1993-11#30)(1993-12#24)(1993-2#5)(1993-3#44)(1993-5#5)(1993-6#59)(1993-8#68)(1993-9#15)(1994-11#38)(1994-12#19)(1994-2#26)(1994-3#13)(1994-5#63)(1994-6#29)(1994-8#41)(1994-9#10)(1995-11#56)(1995-12#40)(1995-2#96)(1995-3#34)(1995-5#69)(1995-6#57)(1995-8#33)(1996-12#30)(1996-2#38)(1996-3#3)(1996-5#33)(1996-7#3)(1996-8#2)(1997-1#8)(1997-2#57)(1997-3#10)(1997-4#29)(1997-5#1)(1997-6#21)(1997-7#25)(1997-8#7)(1997-9#2)(2006-6#7)(2007-11#15)(2007-12#4)(2007-6#8)(2008-1#14)(2008-10#275)(2008-11#66)(2008-12#15)(2008-2#6)(2008-3#26)(2008-4#64)(2008-5#18)(2008-6#6)(2008-7#37)(2008-8#65)(2008-9#65)(2009-10#4)(2009-11#1)(2009-12#8)(2009-2#9)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#17)(2009-8#9)(2009-9#7)(2010-1#2)(2010-10#7)(2010-11#13)(2010-12#10)(2010-2#3)(2010-4#2)(2010-5#10)(2010-6#6)(2010-7#6)(2010-8#1)(2011-1#13)(2011-2#31)(2011-3#2)(2012-1#3)(2012-12#12)(2012-2#40)(2012-3#10)(2013-1#33)(2013-7#6)(2013-8#14)
binding)##3##1##(1994-12#1)(1994-2#1)(1996-3#1)
binding-site##3##1##(1994-8#2)(1995-2#1)
binding-sites##3##1##(1994-11#2)(2010-5#1)
bindings##6##1##(1992-3#2)(1992-6#1)(1995-12#1)(2008-10#1)(2008-3#1)
binds a##4##2##(1991-11#1)(1995-5#1)(1995-8#2)
binds and internalizes##2##3##(1994-5#1)(1995-6#1)
binds and is##2##3##(1992-10#1)(1992-3#1)
binds and##8##2##(1992-10#1)(1992-3#1)(1994-11#1)(1994-5#2)(1995-2#2)(1995-6#1)
binds at least##2##3##(1993-8#1)(2012-2#1)
binds at##4##2##(1990-5#1)(1993-8#2)(2012-2#1)
binds both##4##2##(1993-6#1)(1993-8#1)(1995-3#1)(2007-12#1)
binds differently to##2##3##(1992-3#1)(1995-2#1)
binds directly to##3##3##(1995-6#1)(2011-2#1)(2012-2#1)
binds in##2##2##(1997-2#1)(2011-2#1)
binds more##2##2##(1990-7#1)(2008-9#1)
binds multiple##2##2##(1996-12#1)(2011-2#1)
binds not only##2##3##(1995-11#1)(2008-5#1)
binds preferentially to the##2##4##(1993-9#1)(1994-5#1)
binds preferentially to##3##3##(1993-9#1)(1994-5#1)(1997-2#1)
binds specifically to the##3##4##(1995-2#1)(2008-9#1)(2011-1#1)
binds specifically to##6##3##(1990-11#1)(1990-12#1)(1995-2#1)(2008-9#1)(2011-1#1)(2012-2#1)
binds specifically##8##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-8#1)(1995-2#1)(2008-9#1)(2011-1#1)(2012-2#1)
binds the##10##2##(1993-8#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)
binds tightly to the##2##4##(1992-3#1)(1994-12#1)
binds tightly to##3##3##(1992-3#2)(1994-12#1)
binds tightly##4##2##(1992-3#2)(1994-11#1)(1994-12#1)
binds to DNA##2##3##(1991-2#1)(1995-3#1)
binds to a specific##3##4##(1990-5#1)(1997-7#1)(2008-2#1)
binds to a##10##3##(1990-5#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-2#2)(1996-12#1)(1997-7#2)(2008-2#1)
binds to an##4##3##(1994-8#2)(1995-6#1)(1996-12#1)
binds to and activates the##2##5##(2008-4#1)(2011-2#1)
binds to and activates##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
binds to and##6##3##(1992-3#1)(1994-5#1)(1997-4#1)(2007-11#1)(2008-4#1)(2011-2#1)
binds to both##3##3##(1992-6#1)(1993-3#1)(1995-2#1)
binds to certain##2##3##(1990-5#1)(1991-5#1)
binds to its##2##3##(1997-4#1)(2008-9#1)
binds to regulatory##2##3##(1995-6#1)(2008-11#1)
binds to specific##2##3##(1995-8#1)(1997-7#1)
binds to the same##2##4##(1991-10#1)(1995-2#1)
binds to the##20##3##(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#2)(1997-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
binds to their##2##3##(1994-3#1)(2009-8#1)
binds to two##3##3##(1993-3#1)(1994-11#1)(2008-9#1)
binds to##113##2##(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-3#5)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#5)(1995-11#3)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#1)
binds very##2##2##(1990-8#1)(1994-11#1)
binds with high affinity (IC50 =##2##6##(1993-11#1)(2010-12#1)
binds with high affinity to##3##5##(1992-3#1)(1995-3#1)(2007-11#1)
binds with high affinity##6##4##(1992-3#1)(1993-11#1)(1995-3#1)(1997-2#1)(2007-11#1)(2010-12#1)
binds with##10##2##(1992-3#1)(1993-11#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2010-12#1)
binds within the##2##3##(2008-8#1)(2010-11#1)
binds##245##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#4)(1990-7#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#3)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#8)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#3)(1993-3#5)(1993-6#3)(1993-8#9)(1993-9#1)(1994-11#9)(1994-12#7)(1994-2#3)(1994-3#1)(1994-5#6)(1994-6#3)(1994-8#8)(1994-9#1)(1995-11#5)(1995-2#14)(1995-3#3)(1995-5#5)(1995-6#8)(1995-8#5)(1996-12#6)(1996-2#2)(1996-3#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#3)(2006-6#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#8)(2009-10#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-2#6)(2013-1#1)
binge drinking##5##2##(2008-10#1)(2009-5#3)(2011-2#1)
binge eating##15##2##(2007-7#8)(2008-4#6)(2008-6#1)
binge##26##1##(2007-7#10)(2008-10#2)(2008-4#8)(2008-6#1)(2009-5#3)(2011-2#2)
bingeing##5##1##(2007-7#1)(2008-4#4)
binning##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
binocular fusion##3##2##(2008-9#3)
binocular##12##1##(1990-8#1)(1994-8#1)(2008-4#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-12#3)(2013-8#1)
binomial distribution for##3##3##(2008-10#2)(2008-6#1)
binomial distribution##18##2##(2008-10#12)(2008-3#1)(2008-6#2)(2010-3#1)(2010-5#1)(2013-1#1)
binomial function##2##2##(2008-10#2)
binomial index of dispersion (D) and##2##6##(2008-10#2)
binomial##35##1##(1994-9#1)(1995-6#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-6#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
binormal##7##1##(1997-3#7)
bins##6##1##(2008-10#1)(2008-3#2)(2008-5#2)(2012-1#1)
binuclear##10##1##(1995-2#1)(1997-7#4)(2008-10#4)(2013-1#1)
binucleate Rhizoctonia (BNR)##2##3##(2008-10#2)
binucleate Rhizoctonia spp##6##3##(2008-10#6)
binucleate Rhizoctonia##12##2##(2008-10#10)(2008-12#2)
binucleate##16##1##(2007-12#1)(2008-10#12)(2008-12#3)
bio##4##1##(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)
bio- and##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
bio-analytical##2##1##(2008-10#2)
bio-assays##2##1##(2008-10#1)(2008-11#1)
bio-control##6##1##(2008-10#6)
bio-economic##2##1##(2008-10#2)
bio-imaging and##2##2##(2008-10#2)
bio-inspired##2##1##(2009-8#2)
bio-machined##2##1##(2008-8#2)
bio-medical##2##1##(2008-1#1)(2011-2#1)
bio-mimetic##2##1##(2008-10#2)
bio-molecules##4##1##(2008-10#2)(2009-12#1)(2011-2#1)
bio-optical model##2##2##(2008-2#1)(2008-3#1)
bio-optical properties##2##2##(2008-2#2)
bio-optical##8##1##(2008-2#3)(2008-3#5)
bioabsorbable##5##1##(2009-5#1)(2011-2#3)(2012-3#1)
bioaccumulation in##2##2##(2008-7#1)(2012-12#1)
bioaccumulation of HCHs and DDTs##2##5##(2008-7#2)
bioaccumulation of heavy metals##2##4##(2008-12#1)(2008-5#1)
bioaccumulation of##7##2##(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#2)
bioaccumulation potential##2##2##(2008-11#2)
bioaccumulation##20##1##(1991-12#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-5#3)(2008-7#3)(2012-12#1)(2013-1#2)
bioaccumulative##5##1##(2008-11#4)(2008-5#1)
bioactivated##2##1##(1991-8#1)(2008-11#1)
bioactivation##5##1##(1991-8#1)(1995-6#3)(2008-11#1)
bioactive amines in##3##3##(2008-10#3)
bioactive component##2##2##(2008-10#1)(2011-1#1)
bioactive components##2##2##(2008-12#1)(2012-1#1)
bioactive compounds##8##2##(2008-10#5)(2008-11#1)(2011-1#1)(2011-2#1)
bioactive glass##8##2##(2007-12#1)(2008-5#3)(2009-7#4)
bioactive lipids##2##2##(1992-8#2)
bioactive metabolites##3##2##(2009-5#1)(2011-1#1)(2013-8#1)
bioactive molecules that##2##3##(2008-10#1)(2012-3#1)
bioactive molecules##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
bioactive peptide##2##2##(2008-4#1)(2011-2#1)
bioactive peptides##5##2##(1991-5#1)(1994-8#1)(1995-3#1)(2011-2#1)(2012-1#1)
bioactive proteins##2##2##(1997-4#1)(2008-11#1)
bioactive species##2##2##(2008-4#1)(2009-12#1)
bioactive##81##1##(1991-5#1)(1992-12#1)(1992-8#2)(1994-8#2)(1995-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-4#4)(2008-5#10)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#7)(2010-12#1)(2011-1#6)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#2)
bioactives##2##1##(2008-5#2)
bioactivities of##3##2##(2008-10#1)(2011-3#1)(2013-1#1)
bioactivities##4##1##(2008-10#2)(2011-3#1)(2013-1#1)
bioactivity against human##2##3##(1994-11#1)(2009-2#1)
bioactivity against##3##2##(1994-11#1)(2008-11#1)(2009-2#1)
bioactivity and##3##2##(2008-11#1)(2008-8#1)(2009-2#1)
bioactivity data##2##2##(2013-1#2)
bioactivity in##2##2##(2008-11#1)(2008-4#1)
bioactivity is##3##2##(2008-4#2)(2008-5#1)
bioactivity of the##2##3##(2008-10#2)
bioactivity of##8##2##(2007-11#1)(2008-10#3)(2008-4#1)(2009-7#1)(2011-3#1)(2012-2#1)
bioactivity##38##1##(1992-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-4#4)(2008-5#5)(2008-8#3)(2009-2#2)(2009-7#2)(2010-4#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#2)
bioadhesion##4##1##(2008-5#2)(2010-5#2)
bioanalysis##12##1##(2008-10#5)(2010-11#7)
bioanalytical applications##3##2##(2008-10#2)(2010-11#1)
bioanalytical assays##4##2##(2008-10#3)(2010-11#1)
bioanalytical columns prepared with##2##4##(2008-10#2)
bioanalytical method##4##2##(2010-11#4)
bioanalytical methods in##2##3##(2010-11#2)
bioanalytical methods##7##2##(2008-10#2)(2010-11#5)
bioanalytical##34##1##(2008-10#14)(2008-4#1)(2010-11#16)(2010-4#1)(2010-7#1)(2011-2#1)
bioartificial islet##2##2##(2010-10#2)
bioartificial liver support systems##2##4##(2008-11#2)
bioartificial liver support##3##3##(2008-11#2)(2010-12#1)
bioartificial liver##7##2##(2008-11#3)(2010-12#1)(2011-2#1)(2012-2#2)
bioartificial##10##1##(2008-11#4)(2010-10#2)(2010-12#1)(2011-2#1)(2012-2#2)
bioassay and##7##2##(1993-12#1)(2008-10#5)(2009-12#1)
bioassay for screening##2##3##(2008-10#2)
bioassay for the##4##3##(1991-6#1)(1997-4#1)(2008-10#2)
bioassay for##12##2##(1990-12#1)(1991-6#1)(1997-4#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)
bioassay is##2##2##(2008-10#1)(2008-4#1)
bioassay method##4##2##(2008-10#2)(2008-4#1)(2011-3#1)
bioassay of##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
bioassay on##2##2##(2008-10#1)(2008-8#1)
bioassay showed##2##2##(2008-10#1)(2008-5#1)
bioassay to measure##2##3##(2008-10#2)
bioassay was##4##2##(2008-10#2)(2008-12#2)
bioassay with##2##2##(2013-7#1)(2013-8#1)
bioassay##88##1##(1990-12#1)(1991-12#1)(1991-6#2)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-4#3)(2008-10#44)(2008-11#4)(2008-12#4)(2008-4#6)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#2)(2011-2#1)(2011-3#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
bioassay-guided fractionation of##2##3##(1992-8#1)(2008-11#1)
bioassays and##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
bioassays are used##2##3##(2008-10#1)(2008-8#1)
bioassays are##3##2##(2008-10#2)(2008-8#1)
bioassays for##3##2##(1990-12#1)(1994-9#1)(2008-10#1)
bioassays in##2##2##(1993-12#1)(2008-10#1)
bioassays of##2##2##(2008-3#1)(2011-2#1)
bioassays were##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
bioassays with##4##2##(2008-10#1)(2008-9#1)(2011-2#2)
bioassays##49##1##(1990-12#1)(1990-8#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-9#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2013-7#1)(2013-8#1)
bioavailability and##5##2##(2008-10#1)(2008-11#2)(2008-5#2)
bioavailability by##3##2##(2008-8#1)(2011-2#1)(2011-3#1)
bioavailability compared with##2##3##(2007-11#1)(2012-12#1)
bioavailability in humans##2##3##(1992-9#1)(2011-2#1)
bioavailability in the##2##3##(2010-12#1)(2010-2#1)
bioavailability in##5##2##(1992-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
bioavailability is##4##2##(2008-10#1)(2009-12#1)(2012-2#2)
bioavailability of drugs##2##3##(2008-11#1)(2012-2#1)
bioavailability of the##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
bioavailability of##24##2##(2008-10#6)(2008-11#3)(2009-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#5)(2013-1#1)
bioavailability that##3##2##(1991-11#1)(2008-10#1)(2012-2#1)
bioavailability was##4##2##(1991-2#1)(2008-10#1)(2011-2#1)(2011-3#1)
bioavailability##81##1##(1991-11#1)(1991-2#1)(1992-8#1)(1992-9#3)(1997-1#1)(2007-11#1)(2008-10#14)(2008-11#6)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#8)(2011-3#4)(2012-12#1)(2012-2#16)(2012-3#1)(2013-1#1)(2013-8#1)
bioavailabilty##2##1##(2011-2#1)(2012-2#1)
bioavailable orally##2##2##(1994-6#1)(2008-3#1)
bioavailable##6##1##(1990-11#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
biobanks##8##1##(2008-7#7)(2012-2#1)
biocatalysis in##2##2##(2008-7#1)(2011-1#1)
biocatalysis##9##1##(1997-7#1)(2008-6#1)(2008-7#1)(2011-1#4)(2012-2#2)
biocatalyst consumption in##2##3##(1991-5#2)
biocatalyst consumption##3##2##(1991-5#3)
biocatalyst for##3##2##(2008-6#1)(2011-1#2)
biocatalyst recycling##2##2##(2011-1#2)
biocatalyst##22##1##(1991-5#3)(1997-7#1)(2008-10#2)(2008-6#2)(2008-7#5)(2011-1#6)(2011-2#2)(2013-1#1)
biocatalysts for the##2##3##(2007-11#1)(2011-1#1)
biocatalysts in##2##2##(1995-3#1)(2013-1#1)
biocatalysts##14##1##(1995-3#2)(2007-11#4)(2008-10#1)(2011-1#4)(2013-1#3)
biocatalytic##7##1##(2008-10#4)(2010-4#2)(2011-2#1)
biochanin A##3##2##(2010-3#3)
biochemical activities##2##2##(1994-8#1)(2008-7#1)
biochemical activity##3##2##(1991-9#1)(1997-7#1)(2008-5#1)
biochemical analyses##2##2##(1994-12#1)(2008-10#1)
biochemical analysis##14##2##(1992-11#1)(1992-6#1)(2007-12#1)(2008-10#4)(2009-12#1)(2009-6#1)(2010-4#1)(2012-2#1)(2013-8#3)
biochemical and behavioral##2##3##(1993-12#1)(1995-12#1)
biochemical and cell biological##2##4##(2008-4#1)(2012-2#1)
biochemical and genetic##2##3##(1994-9#1)(2008-2#1)
biochemical and histological##2##3##(2009-8#1)(2012-3#1)
biochemical and morphological##2##3##(2008-3#1)(2011-1#1)
biochemical and##46##2##(1990-9#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-2#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
biochemical assays##4##2##(2008-10#3)(2012-2#1)
biochemical basis for##2##3##(1992-10#1)(2009-8#1)
biochemical basis of##4##3##(1990-5#1)(1990-8#1)(1996-2#1)(2008-10#1)
biochemical basis##6##2##(1990-5#1)(1990-8#1)(1992-10#1)(1996-2#1)(2008-10#1)(2009-8#1)
biochemical changes in##2##3##(1991-9#1)(1997-2#1)
biochemical changes of##3##3##(1991-12#1)(2008-7#2)
biochemical changes were##2##3##(1995-12#1)(2008-12#1)
biochemical changes##14##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-2#2)
biochemical characteristics of##4##3##(1992-8#1)(1997-6#1)(2008-4#1)(2008-7#1)
biochemical characteristics##7##2##(1990-10#1)(1992-8#1)(1997-6#1)(2008-4#1)(2008-7#2)(2013-8#1)
biochemical characterization of the##3##4##(1991-2#1)(1992-3#1)(1995-6#1)
biochemical characterization of##6##3##(1991-2#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-5#1)(1995-6#1)
biochemical characterization##7##2##(1991-2#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-5#1)(1995-6#1)(2008-10#1)
biochemical composition##3##2##(2010-11#2)(2010-2#1)
biochemical data##9##2##(1993-12#1)(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-1#1)(2013-8#1)
biochemical differences##3##2##(1990-6#1)(1994-2#1)(2008-10#1)
biochemical dysfunction##2##2##(2008-1#2)
biochemical effects of the##2##4##(1992-3#1)(1993-8#1)
biochemical effects of##5##3##(1992-3#1)(1993-8#1)(2008-5#1)(2010-1#2)
biochemical effects##7##2##(1992-3#1)(1993-8#1)(2008-5#1)(2008-7#2)(2010-1#2)
biochemical events##2##2##(1995-12#1)(2008-11#1)
biochemical evidence of##4##3##(1990-12#1)(1991-8#1)(2007-5#1)(2008-1#1)
biochemical evidence##6##2##(1990-12#1)(1991-8#1)(1993-3#1)(1994-11#1)(2007-5#1)(2008-1#1)
biochemical features##5##2##(1993-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-11#1)
biochemical findings##4##2##(1997-3#1)(2007-7#1)(2008-12#1)(2008-5#1)
biochemical fractionation##2##2##(1994-10#1)(2008-1#1)
biochemical function of##2##3##(2008-4#1)(2011-2#1)
biochemical function##4##2##(2008-4#1)(2008-9#1)(2011-2#2)
biochemical functions##2##2##(1990-11#1)(2008-11#1)
biochemical genetics##2##2##(2008-4#1)(2013-1#1)
biochemical identification##2##2##(2008-11#1)(2010-12#1)
biochemical indicators##2##2##(1994-5#1)(2008-10#1)
biochemical investigations##2##2##(2008-9#1)(2013-1#1)
biochemical levels##2##2##(2008-9#1)(2011-2#1)
biochemical marker for##5##3##(1990-8#2)(2007-12#1)(2008-10#2)
biochemical marker##6##2##(1990-8#2)(1996-12#1)(2007-12#1)(2008-10#2)
biochemical markers in##2##3##(2009-3#1)(2013-1#1)
biochemical markers of bone##3##4##(2007-11#1)(2008-7#2)
biochemical markers of##9##3##(1990-2#1)(1993-8#2)(1994-2#1)(1994-5#1)(2007-11#1)(2008-11#1)(2008-7#2)
biochemical markers##16##2##(1990-2#1)(1990-3#1)(1993-8#2)(1994-2#1)(1994-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
biochemical measurements of##2##3##(2008-7#1)(2008-8#1)
biochemical measurements##4##2##(2008-11#1)(2008-7#2)(2008-8#1)
biochemical mechanism##4##2##(1991-5#1)(2008-10#1)(2010-7#2)
biochemical mechanisms involved##2##3##(1990-8#1)(2008-11#1)
biochemical mechanisms of##2##3##(1991-5#1)(1997-6#1)
biochemical mechanisms##9##2##(1990-8#1)(1991-5#1)(1992-9#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
biochemical methods##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-7#1)
biochemical modulator##2##2##(1992-8#1)(1993-12#1)
biochemical nature of##3##3##(1997-2#1)(2008-11#1)(2008-6#1)
biochemical networks##6##2##(2008-11#1)(2008-7#2)(2010-10#3)
biochemical nutritional parameters and fluid overload problems in##2##8##(2007-7#2)
biochemical oscillations##2##2##(1990-8#2)
biochemical oxygen demand##3##3##(2008-10#3)
biochemical parameters and##3##3##(2007-7#1)(2008-3#1)(2012-3#1)
biochemical parameters in##6##3##(2008-12#1)(2008-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
biochemical parameters including##2##3##(1994-5#1)(2012-2#1)
biochemical parameters##25##2##(1993-11#1)(1994-5#1)(1994-7#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-1#2)(2011-10#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)
biochemical pathways##8##2##(1997-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)
biochemical processes involved in##2##4##(2008-11#1)(2008-7#1)
biochemical processes##10##2##(2008-10#1)(2008-11#1)(2008-7#2)(2009-8#3)(2012-5#1)(2013-8#2)
biochemical properties as##2##3##(1995-11#1)(2008-10#1)
biochemical properties##8##2##(1990-2#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2009-3#1)(2012-2#1)
biochemical reactions in##2##3##(2008-11#1)(2008-5#1)
biochemical reactions##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-2#2)
biochemical research##3##2##(2011-1#1)(2011-3#1)(2012-3#1)
biochemical responses in##2##3##(1994-6#1)(2008-7#1)
biochemical responses##9##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-10#1)(2012-5#1)(2012-6#2)
biochemical results##2##2##(1997-8#1)(2011-2#1)
biochemical screening##2##2##(1996-12#1)(2008-10#1)
biochemical studies have##3##3##(1996-12#1)(1997-4#1)(2008-5#1)
biochemical studies##14##2##(1991-8#1)(1992-11#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-10#1)
biochemical study##3##2##(1991-12#1)(2008-10#1)(2010-3#1)
biochemical systems##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
biochemical tests of liver function##2##5##(1992-12#2)
biochemical tests##12##2##(1992-12#2)(1992-5#1)(1995-3#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-6#1)(2012-2#1)
biochemical variables##3##2##(1994-6#1)(2008-4#1)(2013-1#1)
biochemical##474##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#8)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#6)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#4)(1996-2#3)(1996-5#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#5)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#6)(2007-8#2)(2008-1#6)(2008-10#54)(2008-11#20)(2008-12#9)(2008-2#4)(2008-3#5)(2008-4#18)(2008-5#17)(2008-6#3)(2008-7#31)(2008-8#4)(2008-9#6)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#6)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#6)(2010-6#1)(2010-7#4)(2011-1#12)(2011-10#5)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#18)(2012-3#10)(2012-5#2)(2012-6#3)(2013-1#10)(2013-7#1)(2013-8#9)
biochemically and serologically##2##3##(1996-12#1)(2008-5#1)
biochemically and##7##2##(1996-12#1)(1997-6#1)(2007-8#1)(2008-5#2)(2008-9#1)(2012-2#1)
biochemically##23##1##(1992-12#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
biochemicals##3##1##(2009-9#1)(2011-2#1)(2013-8#1)
biochemist##3##1##(1994-12#1)(1997-6#1)(2012-1#1)
biochemistry and molecular biology of##2##5##(1997-1#1)(2009-5#1)
biochemistry and##10##2##(1991-5#1)(1992-11#1)(1995-5#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
biochemistry has##2##2##(1994-12#1)(2011-2#1)
biochemistry in##3##2##(1994-12#3)
biochemistry is##2##2##(1994-12#1)(2008-4#1)
biochemistry of##6##2##(1992-3#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
biochemistry tests##2##2##(1997-8#1)(2013-8#1)
biochemistry training##2##2##(1994-12#2)
biochemistry values##2##2##(1991-11#1)(2008-5#1)
biochemistry##69##1##(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#27)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
biochemists##10##1##(1994-12#8)(2008-10#1)(2008-4#1)
biochip##2##1##(2009-12#2)
biochips##5##1##(2008-7#1)(2009-12#3)(2010-11#1)
biocidal agents##2##2##(2008-9#1)(2010-7#1)
biocidal products##2##2##(2008-3#2)
biocidal##6##1##(2008-10#2)(2008-3#2)(2008-9#1)(2010-7#1)
biocide##8##1##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#3)(2013-7#1)
biocides and##2##2##(2008-10#2)
biocides in the healthcare environment##2##5##(2008-3#2)
biocides in the##3##3##(2008-3#3)
biocides##10##1##(2008-10#2)(2008-11#3)(2008-3#5)
biocompatibility and##5##2##(1990-5#1)(2008-10#1)(2008-5#1)(2013-1#2)
biocompatibility##33##1##(1990-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#5)(2009-11#5)(2009-7#2)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#2)
biocompatible and##3##2##(2008-10#1)(2008-5#1)(2009-11#1)
biocompatible dialysis##2##2##(2008-10#1)(2011-2#1)
biocompatible materials##2##2##(2008-7#1)(2010-10#1)
biocompatible polymers##4##2##(2008-10#3)(2010-10#1)
biocompatible##26##1##(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2009-11#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-2#4)(2012-2#2)(2013-1#1)
biocomposites##2##1##(2008-10#2)
bioconjugatable##2##1##(2009-12#2)
bioconjugation##2##1##(2008-10#2)
biocontrol ability of##2##3##(2008-10#2)
biocontrol activity against##5##3##(2008-10#5)
biocontrol activity of##6##3##(2008-10#6)
biocontrol activity##19##2##(2008-10#19)
biocontrol agent Trichoderma##3##3##(2008-10#3)
biocontrol agent of##7##3##(2008-10#7)
biocontrol agent that##2##3##(2008-10#2)
biocontrol agent was##3##3##(2008-10#3)
biocontrol agent##29##2##(2008-10#28)(2008-12#1)
biocontrol agents against##4##3##(2008-10#4)
biocontrol agents for##3##3##(2008-10#3)
biocontrol agents of soilborne pathogens##2##5##(2008-10#2)
biocontrol agents of##4##3##(2008-10#4)
biocontrol agents were##3##3##(2008-10#3)
biocontrol agents##34##2##(2008-10#34)
biocontrol capacities##2##2##(2008-10#2)
biocontrol characteristics##2##2##(2008-10#2)
biocontrol efficacy of##2##3##(2008-10#2)
biocontrol efficacy was##2##3##(2008-10#2)
biocontrol efficacy##11##2##(2008-10#11)
biocontrol fungus##5##2##(2008-10#5)
biocontrol isolates##7##2##(2008-10#7)
biocontrol mechanisms##3##2##(2008-10#3)
biocontrol of##9##2##(2008-10#6)(2008-5#1)(2012-2#2)
biocontrol potential##4##2##(2008-10#4)
biocontrol pseudomonads##3##2##(2008-10#3)
biocontrol strains of##2##3##(2008-10#1)(2008-5#1)
biocontrol strains##6##2##(2008-10#5)(2008-5#1)
biocontrol strategies##2##2##(2008-10#2)
biocontrol treatments##3##2##(2008-10#3)
biocontrol yeasts##5##2##(2008-10#5)
biocontrol##174##1##(2008-10#168)(2008-12#1)(2008-5#2)(2012-2#2)(2013-8#1)
bioconversion of##6##2##(1997-2#1)(2008-12#1)(2008-6#2)(2011-1#1)(2012-2#1)
bioconversion##21##1##(1991-9#2)(1997-2#1)(2008-10#1)(2008-12#2)(2008-6#10)(2008-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
bioconversions##2##1##(2008-7#2)
biocorrosion behaviors of##2##3##(2012-2#2)
biocorrosion behaviors##3##2##(2012-2#3)
biocorrosion resistance##2##2##(2010-4#1)(2012-2#1)
biocorrosion##7##1##(2010-4#2)(2012-12#1)(2012-2#4)
biodegradability and##3##2##(1992-5#1)(2008-5#1)(2012-8#1)
biodegradability##9##1##(1992-5#1)(2007-11#6)(2008-5#1)(2012-8#1)
biodegradable implant##3##2##(2012-2#3)
biodegradable materials##3##2##(2007-11#2)(2007-12#1)
biodegradable plastics##3##2##(2008-6#3)
biodegradable polymer matrix##2##3##(2008-7#1)(2009-12#1)
biodegradable polymer##7##2##(2008-7#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-5#1)
biodegradable##35##1##(1993-1#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#2)(2008-12#2)(2008-5#4)(2008-6#5)(2008-7#2)(2009-11#1)(2009-12#2)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#1)(2012-2#3)(2012-7#1)(2013-1#1)
biodegradation by bacteria##2##3##(2011-1#2)
biodegradation of##9##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-3#2)(2011-1#1)
biodegradation##31##1##(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#4)(2009-3#4)(2009-9#2)(2010-10#1)(2010-7#1)(2011-1#12)
biodetection##2##1##(2008-10#1)(2008-7#1)
biodiesel blends (0-100%##2##3##(2008-10#2)
biodiesel blends##4##2##(2008-10#4)
biodiesel production##9##2##(2009-3#5)(2013-1#4)
biodiesel##24##1##(2008-10#4)(2008-6#2)(2009-3#11)(2013-1#7)
biodisponibility##2##1##(2008-5#2)
biodistribution and##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
biodistribution##9##1##(1995-2#2)(2007-10#3)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
biodiversity and the##2##3##(2009-8#1)(2011-2#1)
biodiversity and##3##2##(2009-8#1)(2011-2#1)(2013-7#1)
biodiversity conservation and management##2##4##(2012-3#1)(2013-7#1)
biodiversity in this##2##3##(2008-5#1)(2011-1#1)
biodiversity in##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
biodiversity of these##2##3##(2008-10#1)(2008-8#1)
biodiversity of##6##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#3)
biodiversity within##2##2##(2012-2#1)(2013-7#1)
biodiversity##31##1##(1994-11#1)(2008-10#3)(2008-5#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-7#9)
biodiversity)##2##1##(2008-8#1)(2010-2#1)
bioelectric##4##1##(1997-7#1)(2008-7#3)
bioelectrical impedance##6##2##(1990-5#1)(2007-12#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
bioelectrical##7##1##(1990-5#1)(1992-3#1)(2007-12#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
bioelectrode was tested##2##3##(2008-10#2)
bioelectrode##5##1##(2008-10#5)
bioenergetics##6##1##(1991-5#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-8#1)
bioengineered##4##1##(2009-11#2)(2011-2#1)(2012-2#1)
bioengineering##8##1##(2008-11#3)(2008-3#1)(2008-9#1)(2009-12#2)(2010-10#1)
bioengineers##2##1##(2008-11#1)(2009-3#1)
bioequivalence of##2##2##(1996-2#1)(2012-12#1)
bioequivalence studies##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
bioequivalence##9##1##(1992-9#1)(1996-2#1)(2008-10#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#2)
bioethical decisions##2##2##(1995-3#1)(2008-1#1)
bioethical issues##2##2##(2008-7#1)(2012-2#1)
bioethical##12##1##(1994-12#4)(1995-3#1)(2008-1#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-8#1)
bioethics committees##2##2##(1990-2#1)(1991-2#1)
bioethics##9##1##(1990-2#1)(1991-2#1)(1994-1#1)(1996-11#1)(1996-2#1)(1997-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
biofeedback##7##1##(1995-12#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#3)
biofeedback-controlled##2##1##(2008-1#2)
biofilm and adjunctive use of##2##5##(2012-2#1)(2012-3#1)
biofilm communities##3##2##(2008-9#3)
biofilm community##2##2##(2009-4#2)
biofilm decay in##3##3##(2009-6#3)
biofilm density and substrate consumption rates##2##6##(2008-7#2)
biofilm density and##3##3##(2008-7#3)
biofilm density##4##2##(2008-7#4)
biofilm development##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
biofilm for##2##2##(2008-7#1)(2013-1#1)
biofilm formation and##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
biofilm formation by##2##3##(2008-7#1)(2013-1#1)
biofilm formation on##2##3##(2011-2#1)(2013-1#1)
biofilm formation was##2##3##(2008-10#1)(2008-7#1)
biofilm formation##36##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-6#2)(2010-4#1)(2011-1#9)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
biofilm formed##2##2##(2007-7#1)(2008-10#1)
biofilm on the##2##3##(2008-10#1)(2008-7#1)
biofilm reactor##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
biofilm samples##2##2##(2008-10#1)(2008-9#1)
biofilm to##3##2##(2008-7#2)(2009-6#1)
biofilm viability##3##2##(2013-1#3)
biofilm was##4##2##(2008-7#4)
biofilm##109##1##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#32)(2008-8#3)(2008-9#18)(2009-4#2)(2009-6#7)(2010-4#1)(2011-1#9)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#13)(2013-8#6)
biofilm-forming##2##1##(2013-1#1)(2013-8#1)
biofilms and##4##2##(2008-7#2)(2009-4#1)(2013-8#1)
biofilms can##2##2##(2008-8#2)
biofilms in the##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
biofilms in##9##2##(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2011-2#2)(2012-1#1)
biofilms was##2##2##(2008-7#1)(2008-8#1)
biofilms##48##1##(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#10)(2009-4#3)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
biofilter##3##1##(2008-7#3)
biofluids##5##1##(2008-10#2)(2009-11#1)(2010-11#2)
biofortification##5##1##(2011-2#1)(2013-8#4)
biofouling of##2##2##(2008-2#1)(2010-8#1)
biofouling##5##1##(2008-10#3)(2008-2#1)(2010-8#1)
biofuel##5##1##(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
biofuels mandate##2##2##(2012-12#2)
biofuels##6##1##(2009-6#1)(2011-1#1)(2012-12#2)(2013-1#2)
biofunctionality##3##1##(2008-11#3)
biogas production##2##2##(2013-1#2)
biogas##3##1##(2013-1#3)
biogenesis and##5##2##(2011-2#1)(2012-3#3)(2013-1#1)
biogenesis in##2##2##(2012-3#2)
biogenesis is##2##2##(2011-2#1)(2012-2#1)
biogenesis of##5##2##(1990-5#1)(1994-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
biogenesis##35##1##(1990-5#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-8#1)(2008-1#2)(2008-11#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-2#5)(2012-2#4)(2012-3#8)(2013-1#1)(2013-8#1)
biogenetic##3##1##(2008-1#1)(2008-8#1)(2009-5#1)
biogenic amine receptors##2##3##(2008-7#2)
biogenic amine##5##2##(1991-5#1)(1997-1#1)(2008-10#1)(2008-7#2)
biogenic amines and##2##3##(2008-7#1)(2013-7#1)
biogenic amines##15##2##(1991-5#2)(2008-10#8)(2008-4#1)(2008-7#3)(2013-7#1)
biogenic detritus##2##2##(2008-11#2)
biogenic##35##1##(1991-5#7)(1992-3#2)(1997-1#1)(2008-10#12)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#5)(2010-11#1)(2013-7#1)
biogeochemical cycles##2##2##(2008-10#1)(2011-2#1)
biogeochemical cycling##3##2##(2008-10#3)
biogeochemical##8##1##(2008-10#5)(2011-2#1)(2012-3#1)(2013-8#1)
biogeographic transition##2##2##(2013-7#2)
biogeographic##7##1##(2008-5#2)(2008-6#2)(2008-8#1)(2013-7#2)
biogeographical studies of##2##3##(2007-5#1)(2008-9#1)
biogeographical##3##1##(2007-5#1)(2008-9#2)
biogeography of the##2##3##(2008-6#1)(2012-2#1)
biogeography of##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
biogeography##8##1##(2008-6#1)(2008-8#3)(2008-9#2)(2012-2#2)
biogerontology##4##1##(2008-3#1)(2009-5#3)
biographies##4##1##(1993-3#1)(2007-2#1)(2008-11#2)
biohazards##4##1##(2008-4#2)(2008-9#2)
bioherbicide for the control of##2##5##(2008-10#2)
bioimaging applications##2##2##(2009-7#1)(2010-4#1)
bioimaging##7##1##(2009-7#2)(2010-11#1)(2010-4#2)(2011-1#2)
bioimpedance and##2##2##(2008-5#2)
bioimpedance##3##1##(2008-5#3)
bioinformatic analysis##2##2##(2008-9#1)(2009-5#1)
bioinformatic resources##2##2##(2008-7#2)
bioinformatic##8##1##(2008-10#1)(2008-7#4)(2008-9#1)(2009-5#1)(2013-8#1)
bioinformatics and##6##2##(2007-12#2)(2008-12#1)(2008-7#2)(2009-9#1)
bioinformatics approach##3##2##(2008-6#1)(2008-7#1)(2011-3#1)
bioinformatics challenges##2##2##(2008-7#1)(2010-12#1)
bioinformatics resources##2##2##(2008-7#1)(2010-11#1)
bioinformatics software##2##2##(2008-4#1)(2013-8#1)
bioinformatics to##2##2##(2008-11#1)(2009-4#1)
bioinformatics tools##3##2##(2008-7#3)
bioinformatics##49##1##(1997-4#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#7)(2008-6#1)(2008-7#24)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2011-3#1)(2013-8#2)
bioinorganic chemistry##2##2##(2010-11#2)
bioinsecticide##2##1##(2008-11#1)(2008-6#1)
bioisosteres##2##1##(1992-10#1)(2008-10#1)
biolistic bombardment##2##2##(2008-10#1)(2008-5#1)
biolistic inoculation##4##2##(2008-10#4)
biolistic transformation##2##2##(2008-10#1)(2008-5#1)
biolistic##11##1##(2008-10#7)(2008-5#3)(2010-2#1)
bioload##3##1##(2012-2#3)
biologic activity of##3##3##(1991-3#1)(1995-3#1)(1995-5#1)
biologic activity##6##2##(1991-3#2)(1995-3#1)(1995-5#1)(2010-12#1)(2013-1#1)
biologic aggressiveness of the##2##4##(1991-2#1)(1994-6#1)
biologic and##2##2##(2007-7#1)(2007-8#1)
biologic basis for##2##3##(2007-7#1)(2013-1#1)
biologic basis##4##2##(1993-12#1)(2007-7#1)(2008-1#1)(2013-1#1)
biologic behavior of##2##3##(1992-10#1)(2007-12#1)
biologic behavior##5##2##(1990-2#1)(1991-6#1)(1992-10#1)(2007-12#1)(2008-11#1)
biologic characteristics##2##2##(1991-6#1)(2013-1#1)
biologic fluids##3##2##(2008-4#3)
biologic functions of##2##3##(2013-1#1)(2013-7#1)
biologic functions##4##2##(2008-5#1)(2013-1#2)(2013-7#1)
biologic meshes##3##2##(2011-2#3)
biologic properties##4##2##(1991-6#1)(1997-3#1)(2013-1#2)
biologic prostheses##2##2##(2011-2#2)
biologic therapies##5##2##(2008-6#2)(2009-6#1)(2010-5#1)(2011-2#1)
biologic tissue##3##2##(2008-3#3)
biologic tissues##2##2##(1991-3#1)(2008-3#1)
biologic##86##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#4)(1991-6#3)(1991-9#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-9#2)(2009-6#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-7#1)
biological actions##6##2##(1993-2#1)(2008-7#1)(2009-3#1)(2012-2#3)
biological activities and##3##3##(2008-8#1)(2011-1#1)(2011-3#1)
biological activities are##2##3##(1991-12#1)(2011-2#1)
biological activities of the##4##4##(2010-4#1)(2010-5#1)(2013-8#2)
biological activities of##10##3##(2007-11#1)(2008-5#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
biological activities were evaluated##2##4##(2008-5#1)(2013-1#1)
biological activities were##4##3##(1992-8#1)(2008-5#1)(2008-9#1)(2013-1#1)
biological activities##37##2##(1990-4#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-11#1)(1995-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
biological activity and##9##3##(1990-9#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
biological activity at##2##3##(2008-4#1)(2008-7#1)
biological activity in##4##3##(1992-5#1)(1993-8#2)(2013-1#1)
biological activity of the##9##4##(1990-12#1)(1990-8#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-8#1)(2009-3#1)(2009-6#1)
biological activity of this##3##4##(1992-6#1)(1992-8#1)(2011-3#1)
biological activity of##41##3##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-6#2)(1992-8#2)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-6#1)(2010-4#1)(2011-3#1)(2012-2#1)
biological activity than##2##3##(1991-8#1)(2008-5#1)
biological activity was##3##3##(1990-12#1)(1991-2#1)(1995-12#1)
biological activity##121##2##(1990-12#7)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-8#4)(1992-5#2)(1992-6#2)(1992-8#4)(1993-1#1)(1993-5#1)(1993-8#5)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#5)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#12)(2008-9#3)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
biological agent##2##2##(2008-5#1)(2010-3#1)
biological agents for##2##3##(1992-12#1)(2010-10#1)
biological agents##12##2##(1992-12#3)(1995-3#1)(2007-11#1)(2008-5#2)(2008-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
biological analysis of##2##3##(2010-12#2)
biological and biochemical##3##3##(2008-10#3)
biological and chemical monitoring##2##4##(2008-10#2)
biological and chemical##5##3##(2008-10#4)(2008-6#1)
biological and clinical##5##3##(1991-3#1)(2008-11#1)(2008-9#1)(2010-11#1)(2012-2#1)
biological and computational sciences##2##4##(2008-10#1)(2008-7#1)
biological and environmental samples##5##4##(2008-10#5)
biological and environmental##7##3##(2008-10#7)
biological and genetic markers##2##4##(2013-1#1)(2013-8#1)
biological and genetic##6##3##(2007-2#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
biological and medical##3##3##(1991-6#1)(2007-11#1)(2008-12#1)
biological and molecular characteristics##2##4##(2008-10#2)
biological and molecular events##2##4##(2008-9#1)(2010-5#1)
biological and molecular##7##3##(2008-10#5)(2008-9#1)(2010-5#1)
biological and nonbiological##2##3##(2008-3#1)(2010-3#1)
biological and pathological processes##2##4##(2010-12#1)(2012-12#1)
biological and pharmacological activities##2##4##(2008-10#1)(2011-1#1)
biological and psychosocial##3##3##(1995-5#1)(2008-1#1)(2008-4#1)
biological and social##3##3##(1991-6#2)(2008-2#1)
biological and soil samples##2##4##(2008-10#2)
biological and##85##2##(1990-2#1)(1991-3#1)(1991-6#3)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
biological applications##5##2##(2008-11#2)(2009-12#1)(2012-12#1)(2013-1#1)
biological approaches##3##2##(2008-9#1)(2009-6#1)(2010-7#1)
biological aspects of##2##3##(2008-5#1)(2012-12#1)
biological aspects##5##2##(1993-6#1)(2008-5#1)(2012-12#2)(2012-3#1)
biological assay (MTT-assay)##2##3##(2008-11#2)
biological assay##7##2##(1990-12#2)(1994-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
biological assays##3##2##(2008-10#3)
biological attack##2##2##(2010-7#2)
biological availability##2##2##(2008-10#2)
biological barriers##2##2##(2010-6#2)
biological basis for##2##3##(1994-8#1)(2007-12#1)
biological basis of##4##3##(1993-9#1)(2008-10#1)(2008-4#1)(2013-1#1)
biological basis##6##2##(1993-9#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
biological behavior and##2##3##(1990-8#1)(2010-3#1)
biological behavior in##3##3##(1992-9#1)(2009-5#1)(2010-3#1)
biological behavior of##6##3##(1990-6#1)(2007-10#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
biological behavior##14##2##(1990-6#1)(1990-8#1)(1992-9#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
biological behaviour and##2##3##(2008-6#1)(2009-4#1)
biological behaviour of##3##3##(1993-6#1)(2008-7#2)
biological behaviour##5##2##(1993-6#1)(2008-6#1)(2008-7#2)(2009-4#1)
biological bone resorption##2##3##(1995-3#2)
biological cell##3##2##(2008-2#1)(2008-3#2)
biological cells##10##2##(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#3)(2009-9#1)
biological certified reference materials##3##4##(2008-10#3)
biological certified##4##2##(2008-10#4)
biological changes##2##2##(1994-5#1)(2010-9#1)
biological characteristics and##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
biological characteristics of##10##3##(1992-8#1)(2007-10#1)(2007-8#2)(2008-4#2)(2008-6#2)(2012-2#1)(2013-8#1)
biological characteristics##19##2##(1990-9#1)(1992-8#1)(1992-9#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2012-2#1)(2013-8#2)
biological clock mechanisms##2##3##(1994-5#2)
biological clock##3##2##(1994-5#3)
biological components of##2##3##(2008-10#1)(2008-3#1)
biological components##4##2##(2008-10#1)(2008-3#1)(2009-7#1)(2010-8#1)
biological compounds##2##2##(2008-11#1)(2008-9#1)
biological conditions##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
biological consequences##6##2##(1997-7#1)(2008-10#1)(2008-4#2)(2008-7#2)
biological containment methods##3##3##(2011-2#3)
biological containment##5##2##(2011-2#5)
biological control activity##3##3##(2008-10#3)
biological control agent of##2##4##(2008-10#2)
biological control agent##14##3##(2008-10#12)(2008-5#1)(2010-10#1)
biological control agents (BCAs)##2##4##(2008-10#2)
biological control agents##13##3##(2008-10#12)(2008-8#1)
biological control and##3##3##(2008-10#2)(2008-6#1)
biological control by##4##3##(2008-10#4)
biological control in##5##3##(1991-2#1)(2008-10#3)(2011-2#1)
biological control is##2##3##(2008-10#1)(2008-8#1)
biological control of Fusarium wilt of tomato##2##7##(2008-10#2)
biological control of LLS disease##2##5##(2008-10#2)
biological control of fire blight##5##5##(2008-10#5)
biological control of leaf spot##2##5##(2008-10#2)
biological control of plant pathogens##2##5##(2008-10#2)
biological control of plant##3##4##(2008-10#3)
biological control of postharvest diseases##4##5##(2008-10#4)
biological control of soilborne##2##4##(2008-10#2)
biological control of the##2##4##(2008-10#2)
biological control of##42##3##(2008-10#41)(2008-8#1)
biological control or##2##3##(2008-10#2)
biological control##125##2##(1991-2#1)(1997-7#1)(2008-10#111)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#4)(2010-10#1)(2011-2#3)
biological controls of##2##3##(2008-10#1)(2011-2#1)
biological criteria##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
biological data##10##2##(1992-5#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
biological defense research##4##3##(1992-12#4)
biological details##2##2##(2008-7#1)(2012-2#1)
biological determinism##2##2##(1991-6#1)(2012-2#1)
biological difference##2##2##(2009-10#1)(2010-3#1)
biological differences in##2##3##(2008-5#1)(2010-11#1)
biological differences##5##2##(2008-10#3)(2008-5#1)(2010-11#1)
biological dosimeter for##2##3##(1991-5#2)
biological dosimetry##3##2##(2008-10#1)(2008-7#2)
biological effect of##5##3##(1991-12#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-8#1)
biological effect##9##2##(1990-12#1)(1991-12#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)
biological effectiveness##3##2##(1994-3#1)(2008-11#1)(2008-6#1)
biological effects and the##2##4##(2008-11#1)(2009-10#1)
biological effects and##4##3##(1992-11#1)(1995-2#1)(2008-11#1)(2009-10#1)
biological effects in##2##3##(2008-4#1)(2012-3#1)
biological effects of##13##3##(1995-8#1)(1997-2#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
biological effects##32##2##(1992-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
biological efficacy##2##2##(1992-9#2)
biological entities##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
biological events in the##2##4##(1992-6#1)(1994-9#1)
biological events##6##2##(1991-12#1)(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2009-5#1)
biological evidence to##2##3##(2011-2#1)(2013-1#1)
biological evidence##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
biological evolution##3##2##(2010-3#3)
biological experiments##2##2##(1995-12#1)(2010-10#1)
biological factors##7##2##(1992-11#1)(2007-8#3)(2008-8#2)(2010-11#1)
biological features##3##2##(2008-1#1)(2011-2#1)(2013-8#1)
biological fluid##7##2##(2008-10#5)(2008-12#1)(2008-4#1)
biological fluids and##2##3##(2008-10#2)
biological fluids were##2##3##(1995-11#1)(2008-10#1)
biological fluids##59##2##(1990-12#3)(1990-8#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#2)(1995-11#1)(1996-12#2)(1996-2#1)(1997-7#1)(2008-10#32)(2008-11#1)(2008-4#3)(2008-7#1)(2010-11#2)(2010-4#2)(2011-1#1)(2013-8#1)
biological function in the##2##4##(1995-12#1)(2007-12#1)
biological function of the##2##4##(1994-11#1)(2008-7#1)
biological function of##9##3##(1991-2#1)(1994-11#3)(2008-11#2)(2008-7#1)(2011-1#1)(2012-3#1)
biological function##22##2##(1991-2#1)(1994-11#4)(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-2#3)(2012-3#1)
biological functions of##8##3##(1990-11#1)(1991-5#1)(1992-12#1)(1993-11#1)(1995-6#1)(2008-9#1)(2009-11#1)(2011-2#1)
biological functions##21##2##(1990-11#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-6#2)(1995-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
biological hazards##2##2##(1992-12#1)(2012-3#1)
biological imaging##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2008-9#1)
biological importance##7##2##(1991-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-3#1)
biological in nature##2##3##(2008-10#1)(2008-4#1)
biological information##9##2##(2008-10#2)(2008-7#3)(2008-9#1)(2011-2#2)(2011-3#1)
biological insight into##2##3##(2008-11#1)(2008-4#1)
biological insight##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
biological interaction##2##2##(2009-6#2)
biological interactions##3##2##(2008-10#1)(2008-4#1)(2010-11#1)
biological interest##2##2##(2008-7#1)(2011-1#1)
biological investigations##2##2##(2006-12#1)(2008-10#1)
biological knowledge##2##2##(2010-11#1)(2012-3#1)
biological macromolecules##8##2##(1990-8#2)(1997-6#3)(2008-10#2)(2008-11#1)
biological markers in##3##3##(1991-11#2)(2007-10#1)
biological markers##12##2##(1991-11#3)(1993-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-8#3)(2011-2#2)
biological mashed tomato##2##3##(2008-10#2)
biological material for##2##3##(2007-11#1)(2008-1#1)
biological material in##2##3##(2008-10#1)(2009-12#1)
biological material##12##2##(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-7#1)
biological materials and##5##3##(2007-12#1)(2008-10#4)
biological materials by high-performance##2##4##(1990-8#1)(1991-7#1)
biological materials by##7##3##(1990-8#1)(1991-7#1)(2008-10#5)
biological materials in##2##3##(2008-10#1)(2009-12#1)
biological materials such as##2##4##(2008-4#1)(2012-2#1)
biological materials##33##2##(1990-8#1)(1991-7#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-4#3)(2008-9#2)(2009-12#1)(2009-7#1)(2012-2#2)
biological matrices by##3##3##(2008-10#3)
biological matrices##14##2##(2008-10#8)(2010-11#4)(2012-12#2)
biological meaning##2##2##(2008-7#1)(2008-8#1)
biological mechanism for triggering of ABA accumulation under water stress##2##10##(2008-8#2)
biological mechanism##3##2##(2008-7#1)(2008-8#2)
biological mechanisms##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
biological media##7##2##(1991-5#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-1#2)
biological membranes and##3##3##(1992-3#1)(1994-2#1)(1994-5#1)
biological membranes##12##2##(1992-3#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)
biological methods##2##2##(2007-8#1)(2008-5#1)
biological models##3##2##(2007-12#1)(2008-9#1)(2011-1#1)
biological molecules##9##2##(2008-10#5)(2008-4#1)(2009-5#1)(2009-6#1)(2010-12#1)
biological monitoring of##2##3##(2008-10#2)
biological monitoring##4##2##(2008-10#3)(2008-6#1)
biological motion##4##2##(2008-11#4)
biological network##2##2##(2010-10#1)(2010-12#1)
biological networks and##2##3##(2008-11#1)(2010-12#1)
biological networks##3##2##(2008-11#1)(2010-10#1)(2010-12#1)
biological neural##3##2##(2008-11#3)
biological objects##2##2##(2008-3#2)
biological or##3##2##(1992-12#1)(1993-3#1)(2008-11#1)
biological organisms##2##2##(2008-8#1)(2010-11#1)
biological oxidation##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
biological oxygen demand##2##3##(2008-10#2)
biological parameters##8##2##(1993-6#1)(1996-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
biological parents##2##2##(2011-1#1)(2012-12#1)
biological parts##2##2##(2008-11#1)(2012-2#1)
biological pathways in##2##3##(2008-4#2)
biological pathways##7##2##(2008-11#1)(2008-4#3)(2009-12#1)(2010-10#1)(2010-5#1)
biological performance##3##2##(2009-11#1)(2009-7#1)(2013-1#1)
biological phenomena##8##2##(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-4#2)(2012-3#1)
biological phenomenon##2##2##(2008-9#1)(2011-3#1)
biological problems##5##2##(1994-9#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)
biological process and##2##3##(2008-7#1)(2013-8#1)
biological process of##2##3##(2009-10#1)(2011-2#1)
biological process##8##2##(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-8#1)
biological processes and##4##3##(2010-10#1)(2011-2#2)(2012-2#1)
biological processes including##2##3##(1995-11#1)(2009-11#1)
biological processes occurring##2##3##(2008-11#1)(2008-7#1)
biological processes of##2##3##(2008-3#1)(2013-1#1)
biological processes that##3##3##(2008-10#1)(2009-10#1)(2010-10#1)
biological processes##50##2##(1990-12#1)(1991-5#1)(1995-11#1)(1996-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#2)
biological products##5##2##(2008-10#1)(2008-11#2)(2012-2#2)
biological profile##4##2##(1997-8#1)(2008-10#1)(2008-5#1)(2011-3#1)
biological profiles##4##2##(2011-3#4)
biological properties and##2##3##(1992-6#1)(1997-6#1)
biological properties of the##2##4##(2008-11#1)(2010-3#1)
biological properties of##8##3##(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#2)(2010-3#1)(2012-12#1)
biological properties##26##2##(1991-9#1)(1992-6#1)(1993-8#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-5#3)(2008-9#2)(2009-7#2)(2010-3#2)(2012-12#1)(2012-3#1)
biological property of##2##3##(1995-2#1)(2008-10#1)
biological questions##3##2##(2008-7#1)(2010-2#1)(2013-8#1)
biological rationale and##2##3##(1990-11#1)(2008-10#1)
biological rationale##4##2##(1990-11#1)(2008-10#1)(2008-8#1)(2010-10#1)
biological reaction##2##2##(2008-5#1)(2013-1#1)
biological reference material##2##3##(2008-10#2)
biological reference materials##4##3##(2008-10#4)
biological reference##6##2##(2008-10#6)
biological relevance of these##2##4##(1995-2#1)(1997-1#1)
biological relevance of##5##3##(1995-2#1)(1997-1#2)(2008-7#1)(2009-8#1)
biological relevance##8##2##(1990-5#1)(1995-2#1)(1997-1#2)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#1)
biological research in the##2##4##(2008-1#1)(2008-11#1)
biological research##6##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
biological response##7##2##(1990-11#1)(1997-4#1)(2008-5#4)(2009-11#1)
biological responses in##2##3##(1996-2#1)(2008-4#1)
biological responses##9##2##(1992-12#1)(1995-9#1)(1996-2#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)
biological role of##5##3##(1991-2#1)(1993-6#1)(2008-4#1)(2008-5#1)(2013-7#1)
biological role##7##2##(1991-2#1)(1993-6#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-7#1)
biological roles##4##2##(1990-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
biological sample is##2##3##(2008-10#1)(2009-12#1)
biological sample##15##2##(1993-12#1)(2007-11#2)(2008-10#5)(2008-3#1)(2008-7#2)(2009-12#1)(2010-5#1)(2011-1#2)
biological samples (human blood and urine)##2##6##(2008-10#2)
biological samples and##5##3##(2008-1#1)(2008-10#3)(2008-7#1)
biological samples are##2##3##(2008-3#1)(2010-11#1)
biological samples by##10##3##(1993-9#1)(2008-10#9)
biological samples from##2##3##(1994-8#1)(2008-4#1)
biological samples in##3##3##(1993-2#1)(2008-2#2)
biological samples is##4##3##(1993-9#1)(2008-10#3)
biological samples such as##4##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
biological samples to##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
biological samples using##5##3##(2008-10#3)(2008-4#1)(2009-12#1)
biological samples was##3##3##(2008-10#2)(2011-1#1)
biological samples were##2##3##(2008-10#1)(2008-3#1)
biological samples with satisfactory results##2##5##(2008-10#2)
biological samples with##6##3##(2007-12#1)(2008-10#4)(2008-4#1)
biological samples##131##2##(1991-5#1)(1993-2#1)(1993-9#2)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#86)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#8)(2008-7#2)(2008-8#1)(2009-12#5)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)
biological science##2##2##(2008-12#1)(2008-7#1)
biological sciences##4##2##(1991-5#1)(1994-12#1)(2008-2#1)(2008-7#1)
biological sequence##2##2##(2008-4#1)(2009-3#1)
biological sequences##2##2##(2008-4#1)(2008-7#1)
biological signals##3##2##(2008-11#2)(2008-5#1)
biological significance of the##3##4##(1996-3#1)(2007-12#1)(2010-12#1)
biological significance of##12##3##(1990-12#1)(1990-9#1)(1994-11#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
biological significance##18##2##(1990-12#1)(1990-9#1)(1991-12#1)(1994-11#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
biological solutions##2##2##(2008-10#1)(2010-5#1)
biological species##9##2##(2008-10#3)(2008-6#1)(2008-8#1)(2010-10#2)(2010-2#1)(2010-6#1)
biological specimens##8##2##(1994-8#1)(2008-12#1)(2008-3#2)(2008-9#2)(2010-4#1)(2010-5#1)
biological stability##3##2##(2007-11#1)(2008-7#1)(2013-1#1)
biological structures##3##2##(1992-5#1)(2008-2#1)(2010-9#1)
biological studies of##2##3##(1991-1#1)(1995-3#1)
biological studies##7##2##(1991-1#1)(1991-11#1)(1995-3#1)(2007-10#1)(2007-6#1)(2008-4#1)(2012-1#1)
biological substrate##3##2##(1992-1#1)(2008-10#1)(2008-4#1)
biological suppression##2##2##(2008-10#2)
biological system##6##2##(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)
biological systems and##2##3##(2008-10#1)(2008-4#1)
biological systems are##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)
biological systems in##5##3##(2008-7#2)(2008-9#1)(2010-7#1)(2013-8#1)
biological systems##52##2##(1990-3#1)(1991-5#2)(1992-3#2)(1994-9#1)(1997-2#1)(1997-6#1)(2006-12#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#3)(2013-1#2)(2013-8#1)
biological techniques##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
biological tests##6##2##(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
biological therapies##4##2##(2009-12#2)(2010-12#1)(2013-1#1)
biological therapy##4##2##(2007-11#1)(2013-1#1)(2013-8#2)
biological threats##2##2##(1992-12#1)(2008-8#1)
biological time##3##2##(2008-8#1)(2010-11#1)(2010-7#1)
biological tissue by use of##2##5##(2007-12#2)
biological tissue##26##2##(2007-11#2)(2007-12#10)(2008-2#1)(2008-3#8)(2008-4#1)(2009-10#1)(2009-8#1)(2011-1#2)
biological tissues and##4##3##(2008-2#2)(2008-3#1)(2008-9#1)
biological tissues can be##3##4##(2008-3#2)(2013-8#1)
biological tissues was##2##3##(2008-2#1)(2008-3#1)
biological tissues with##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
biological tissues##35##2##(1995-6#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#5)(2008-3#14)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
biological traits##2##2##(2011-1#1)(2013-7#1)
biological treatment##4##2##(1992-5#1)(2008-6#2)(2012-3#1)
biological treatments##2##2##(2010-7#1)(2012-3#1)
biological variability##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
biological variation is##2##3##(2008-6#1)(2008-7#1)
biological warfare##5##2##(1990-2#1)(1992-12#3)(2008-11#1)
biological weapons##8##2##(1990-2#3)(1992-12#4)(2010-7#1)
biological##1776##1##(1990-11#4)(1990-12#15)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#8)(1990-9#6)(1991-1#1)(1991-11#4)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#13)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-11#4)(1992-12#24)(1992-3#5)(1992-5#5)(1992-6#7)(1992-8#8)(1992-9#10)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#8)(1993-9#5)(1994-11#8)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#9)(1994-6#5)(1994-8#6)(1994-9#5)(1995-11#4)(1995-12#7)(1995-2#8)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#5)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#2)(2006-12#6)(2007-10#6)(2007-11#30)(2007-12#22)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#10)(2008-1#10)(2008-10#462)(2008-11#68)(2008-12#9)(2008-2#21)(2008-3#53)(2008-4#67)(2008-5#48)(2008-6#16)(2008-7#76)(2008-8#65)(2008-9#51)(2009-10#6)(2009-11#10)(2009-12#19)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#13)(2009-6#8)(2009-7#10)(2009-8#7)(2009-9#4)(2010-10#15)(2010-11#19)(2010-12#17)(2010-2#7)(2010-3#18)(2010-4#15)(2010-5#7)(2010-6#6)(2010-7#12)(2010-8#8)(2010-9#5)(2011-1#24)(2011-2#41)(2011-3#12)(2012-1#4)(2012-12#15)(2012-2#40)(2012-3#22)(2013-1#33)(2013-7#7)(2013-8#21)
biologically active and##2##3##(1993-6#1)(2008-4#1)
biologically active compounds##3##3##(2007-11#1)(2008-4#1)(2010-2#1)
biologically active in##2##3##(1992-12#1)(2008-10#1)
biologically active peptide##2##3##(1993-3#1)(1993-6#1)
biologically active peptides from##2##4##(1995-3#1)(2012-1#1)
biologically active peptides##7##3##(1993-6#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-1#1)
biologically active protein##2##3##(1993-6#1)(2008-8#1)
biologically active##59##2##(1990-12#5)(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#2)(1993-3#3)(1993-6#7)(1994-11#3)(1994-5#3)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-11#3)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-5#2)(2011-1#2)(2012-1#1)
biologically aggressive##2##2##(2012-3#2)
biologically and clinically##2##3##(1996-3#1)(2011-2#1)
biologically and##9##2##(1996-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)
biologically and/or##2##2##(2008-8#1)(2013-1#1)
biologically based##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
biologically characterized##2##2##(2008-10#1)(2013-1#1)
biologically derived##3##2##(2008-10#3)
biologically different##3##2##(2008-10#2)(2010-3#1)
biologically important##11##2##(1991-9#1)(1993-9#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
biologically inactive##7##2##(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-12#1)(2008-4#1)(2010-6#1)
biologically inspired##2##2##(2012-2#1)(2013-8#1)
biologically interesting##2##2##(2007-11#1)(2008-2#1)
biologically meaningful##3##2##(2008-10#2)(2008-8#1)
biologically or clinically##2##3##(2011-2#2)
biologically plausible##7##2##(1993-12#1)(1993-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#1)
biologically realistic##2##2##(2009-8#1)(2013-1#1)
biologically reasonable##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
biologically relevant##9##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
biologically significant##3##2##(1994-8#1)(2008-9#1)(2009-9#1)
biologically stable##2##2##(1994-8#1)(2008-3#1)
biologically##173##1##(1990-12#5)(1990-3#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#7)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#4)(1995-2#2)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-4#3)(2007-11#5)(2007-12#1)(2008-10#29)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#5)(2008-7#5)(2008-8#9)(2008-9#4)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#4)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
biologicals##8##1##(2007-11#1)(2008-11#3)(2008-2#1)(2008-8#1)(2010-11#1)(2012-3#1)
biologics##6##1##(2008-10#2)(2008-11#1)(2008-6#1)(2010-10#1)(2011-2#1)
biologies##2##1##(1993-11#1)(2012-12#1)
biologist controversies##2##2##(2013-8#2)
biologist##10##1##(1994-3#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-9#2)(2013-8#2)
biologists and##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
biologists of##2##2##(2008-10#1)(2008-9#1)
biologists to##4##2##(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
biologists who##2##2##(2008-8#1)(2012-12#1)
biologists##40##1##(1991-5#1)(1993-3#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#6)(2008-8#4)(2008-9#5)(2009-3#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-5#1)(2012-12#4)(2013-8#1)
biology and clinical importance##2##4##(2008-6#2)
biology and clinical##3##3##(2008-10#1)(2008-6#2)
biology and development##3##3##(2008-10#3)
biology and ecology##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
biology and its##2##3##(2007-12#1)(2010-12#1)
biology and medicine##3##3##(2008-3#1)(2008-5#1)(2010-7#1)
biology and pathology##2##3##(2008-11#1)(2008-7#1)
biology and the##11##3##(1993-1#1)(1996-11#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)
biology and treatment##2##3##(2008-6#1)(2010-4#1)
biology and##89##2##(1992-8#2)(1993-1#1)(1993-11#1)(1994-3#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#3)(2006-10#3)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
biology approaches##2##2##(2012-2#1)(2013-8#1)
biology are##2##2##(2009-2#1)(2009-7#1)
biology as##2##2##(2010-5#1)(2012-2#1)
biology during##2##2##(2008-7#1)(2013-8#1)
biology for##5##2##(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)
biology has been##2##3##(2008-9#1)(2012-3#1)
biology has##7##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#2)
biology have been##2##3##(1994-5#1)(2008-8#1)
biology have##8##2##(1994-5#1)(2006-10#1)(2007-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-5#1)(2012-3#1)
biology in general##2##3##(2009-5#1)(2010-12#1)
biology in the##3##3##(2008-4#1)(2008-8#1)(2010-7#1)
biology in##17##2##(1997-3#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#2)
biology into##2##2##(2009-9#1)(2010-3#1)
biology is a##2##3##(2008-11#2)
biology is to understand##2##4##(2008-2#1)(2008-7#1)
biology is##9##2##(1994-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-12#1)(2012-2#1)
biology of many##2##3##(2008-10#1)(2008-8#1)
biology of the##19##3##(1991-6#1)(1994-8#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
biology of this##5##3##(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
biology of##75##2##(1991-12#1)(1991-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#6)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#3)(2010-4#1)(2011-2#3)(2012-3#3)(2012-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
biology rather than##2##3##(1990-11#1)(2008-8#1)
biology research##3##2##(2008-2#1)(2011-2#1)(2012-2#1)
biology since##2##2##(2009-5#1)(2009-6#1)
biology techniques##5##2##(1997-6#1)(1997-7#1)(2007-7#1)(2010-12#1)(2012-2#1)
biology that##2##2##(2008-12#1)(2012-3#1)
biology to##10##2##(1995-9#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-3#2)(2009-6#1)(2011-2#1)(2012-2#1)
biology##472##1##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-2#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#9)(2006-10#5)(2007-10#1)(2007-11#2)(2007-12#5)(2007-5#2)(2007-7#3)(2008-1#6)(2008-10#35)(2008-11#25)(2008-12#7)(2008-2#8)(2008-3#3)(2008-4#20)(2008-5#23)(2008-6#7)(2008-7#26)(2008-8#23)(2008-9#22)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#4)(2009-3#12)(2009-4#1)(2009-5#13)(2009-6#7)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#6)(2010-4#4)(2010-5#5)(2010-7#4)(2010-8#3)(2010-9#6)(2011-1#4)(2011-2#19)(2012-1#2)(2012-12#7)(2012-2#23)(2012-3#23)(2012-5#1)(2013-1#8)(2013-7#3)(2013-8#11)
biology-based##2##1##(2010-2#1)(2011-1#1)
biology?##2##1##(2008-1#1)(2009-12#1)
bioluminescence inhibition of##4##3##(2008-10#4)
bioluminescence inhibition tests##2##3##(2008-10#2)
bioluminescence inhibition##7##2##(2008-10#7)
bioluminescence resonance energy transfer (BRET)##2##5##(2008-4#1)(2011-3#1)
bioluminescence tomography##2##2##(2011-1#2)
bioluminescence##22##1##(1995-2#1)(2007-12#1)(2008-10#12)(2008-4#1)(2008-5#2)(2011-1#3)(2011-3#1)(2012-2#1)
bioluminescent bacterial sensor##2##3##(2008-10#1)(2011-1#1)
bioluminescent##12##1##(1990-7#3)(1990-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
biomachining processes##2##2##(2008-8#2)
biomachining##5##1##(2008-8#5)
biomagnetic##2##1##(2008-10#1)(2008-7#1)
biomarker and##2##2##(2008-10#1)(2010-1#1)
biomarker assays##2##2##(2010-11#2)
biomarker candidates##2##2##(2008-7#1)(2010-5#1)
biomarker compounds##2##2##(2008-11#2)
biomarker development##2##2##(2010-11#1)(2010-5#1)
biomarker discovery and##2##3##(2008-10#1)(2008-4#1)
biomarker discovery##11##2##(2008-10#1)(2008-4#1)(2010-12#1)(2010-5#4)(2010-7#3)(2013-8#1)
biomarker for assessing the##2##4##(2010-5#2)
biomarker for##15##2##(1992-9#1)(2008-10#4)(2010-1#1)(2010-5#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
biomarker identification##2##2##(2008-4#1)(2010-5#1)
biomarker in##6##2##(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
biomarker of##11##2##(1994-5#1)(1995-3#1)(2008-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
biomarker studies##9##2##(1991-12#1)(2008-8#2)(2010-5#4)(2012-2#2)
biomarker to##2##2##(2009-6#1)(2010-1#1)
biomarker##100##1##(1990-5#1)(1991-12#1)(1992-9#1)(1994-5#1)(1995-3#1)(2008-10#10)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#3)(2010-5#21)(2010-6#2)(2010-7#3)(2010-9#2)(2011-2#5)(2012-1#1)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#4)
biomarker-discovery platforms##2##2##(2010-7#2)
biomarkers and to##2##3##(2008-12#1)(2010-5#1)
biomarkers and##10##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-5#2)(2011-2#1)(2012-12#3)(2012-2#1)
biomarkers are##6##2##(2008-10#1)(2010-5#3)(2011-3#1)(2012-1#1)
biomarkers can be##2##3##(2010-5#1)(2012-1#1)
biomarkers can##3##2##(2008-10#1)(2010-5#1)(2012-1#1)
biomarkers for the##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
biomarkers for##18##2##(2007-10#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#2)
biomarkers have##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
biomarkers in the diagnosis of##2##5##(2010-5#1)(2011-2#1)
biomarkers in the##4##3##(2010-5#2)(2011-2#1)(2013-1#1)
biomarkers in##20##2##(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2010-12#2)(2010-5#3)(2011-2#4)(2012-2#1)(2013-1#3)
biomarkers is a##2##3##(2010-5#1)(2010-9#1)
biomarkers of exposure##2##3##(2008-10#1)(2010-5#1)
biomarkers of##13##2##(1995-3#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#1)
biomarkers or##2##2##(2009-4#1)(2012-2#1)
biomarkers that reveal##2##3##(2008-7#1)(2012-3#1)
biomarkers that##9##2##(2007-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)
biomarkers were##2##2##(2012-1#2)
biomarkers##145##1##(1995-3#1)(1997-4#1)(2007-10#2)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#8)(2008-8#11)(2009-4#1)(2010-1#1)(2010-11#7)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#18)(2010-7#2)(2010-9#3)(2011-1#1)(2011-2#13)(2011-3#1)(2012-1#10)(2012-12#3)(2012-2#13)(2012-3#5)(2013-1#11)(2013-8#2)
biomass accumulation in##2##3##(2008-10#1)(2012-8#1)
biomass accumulation##4##2##(2008-10#2)(2008-6#1)(2012-8#1)
biomass allocation##2##2##(2008-8#2)
biomass and chlorophyll##2##3##(2008-12#2)
biomass and productivity of Thalassia testudinum##2##6##(2008-5#2)
biomass and productivity##3##3##(2007-5#1)(2008-5#2)
biomass and##20##2##(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
biomass are##2##2##(2008-10#1)(2009-8#1)
biomass carbon and nitrogen##2##4##(2008-10#2)
biomass concentration reached##2##3##(2008-5#1)(2008-7#1)
biomass concentration##5##2##(2008-5#2)(2008-7#3)
biomass density##2##2##(2008-5#1)(2008-7#1)
biomass dynamics##2##2##(2008-7#2)
biomass estimation##4##2##(2013-8#4)
biomass for the##2##3##(2013-1#1)(2013-8#1)
biomass in##4##2##(2008-10#1)(2008-7#1)(2008-9#2)
biomass into##2##2##(2008-6#1)(2013-1#1)
biomass is##7##2##(2008-10#1)(2008-6#1)(2008-7#2)(2012-3#1)(2013-8#2)
biomass measurement##2##2##(2008-10#1)(2008-3#1)
biomass of a##3##3##(2008-10#2)(2008-7#1)
biomass of the##3##3##(2008-5#2)(2013-1#1)
biomass of##17##2##(2008-10#7)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
biomass partitioning##2##2##(2008-8#2)
biomass production and##4##3##(2008-10#3)(2013-1#1)
biomass production##8##2##(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
biomass to ethanol##2##3##(2008-6#2)
biomass to##4##2##(2008-10#1)(2008-6#3)
biomass using##3##2##(2008-6#2)(2013-1#1)
biomass was##11##2##(2007-5#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#3)
biomass were##4##2##(2008-10#3)(2008-5#1)
biomass##231##1##(1997-5#1)(2007-10#2)(2007-5#4)(2008-10#61)(2008-11#11)(2008-12#7)(2008-3#3)(2008-5#22)(2008-6#20)(2008-7#28)(2008-8#16)(2008-9#9)(2009-8#4)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-2#3)(2012-3#3)(2012-8#1)(2013-1#18)(2013-7#2)(2013-8#8)
biomass-to-ethanol##3##1##(2008-6#3)
biomasses##4##1##(2008-12#2)(2008-6#2)
biomaterial##8##1##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#3)
biomaterials and##2##2##(2007-12#1)(2009-11#1)
biomaterials have been investigated##2##4##(2011-3#1)(2012-2#1)
biomaterials have been##3##3##(2009-12#1)(2011-3#1)(2012-2#1)
biomaterials have##4##2##(2008-10#1)(2009-12#1)(2011-3#1)(2012-2#1)
biomaterials##33##1##(1991-3#1)(2007-12#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-12#2)(2009-7#2)(2009-8#1)(2010-10#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#1)
biome##4##1##(2008-6#1)(2008-8#1)(2013-7#2)
biomechanical aspects of##2##3##(2007-8#1)(2009-7#1)
biomechanical behaviour##2##2##(2008-7#2)
biomechanical effects of zoledronic##2##4##(2013-1#2)
biomechanical effects of##3##3##(2008-9#1)(2013-1#2)
biomechanical effects##4##2##(2008-8#1)(2008-9#1)(2013-1#2)
biomechanical factors##2##2##(1990-6#1)(2009-7#1)
biomechanical model##2##2##(2008-12#1)(2009-3#1)
biomechanical principles##2##2##(2008-8#2)
biomechanical properties of##7##3##(2007-11#1)(2008-9#4)(2009-3#1)(2009-8#1)
biomechanical properties##13##2##(2007-11#1)(2008-5#3)(2008-9#6)(2009-3#1)(2009-8#1)(2010-9#1)
biomechanical studies##2##2##(2008-5#1)(2009-7#1)
biomechanical study on cadaver lumbar spine##2##6##(2012-2#2)
biomechanical study##5##2##(2008-9#1)(2009-3#1)(2012-2#2)(2013-1#1)
biomechanical system identification problems with##2##5##(2007-9#2)
biomechanical system##3##2##(2007-12#1)(2007-9#2)
biomechanical testing##2##2##(2007-11#1)(2008-9#1)
biomechanical##66##1##(1990-6#1)(1993-9#1)(1994-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#12)(2009-1#1)(2009-3#3)(2009-4#1)(2009-7#6)(2009-8#1)(2010-9#2)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#1)
biomechanically##3##1##(2012-3#1)(2013-1#2)
biomechanics and##5##2##(1992-9#1)(2007-11#2)(2010-3#2)
biomechanics of the##2##3##(2008-8#1)(2013-1#1)
biomechanics of##5##2##(2008-12#1)(2008-8#1)(2013-1#3)
biomechanics##20##1##(1992-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#5)
biomedical and##7##2##(1991-12#1)(1993-3#1)(2008-7#1)(2009-12#1)(2010-4#1)(2013-1#2)
biomedical applications of##3##3##(2008-11#1)(2011-1#1)(2012-8#1)
biomedical applications##20##2##(1994-11#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-5#6)(2009-12#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-8#1)
biomedical devices##4##2##(2008-8#3)(2009-7#1)
biomedical field##4##2##(2009-12#1)(2010-8#1)(2011-1#2)
biomedical imaging##6##2##(2007-11#1)(2008-3#2)(2009-5#1)(2010-1#1)(2013-1#1)
biomedical journals##2##2##(1991-6#1)(2008-11#1)
biomedical knowledge##4##2##(2008-10#1)(2008-7#2)(2009-4#1)
biomedical model##2##2##(2008-4#1)(2008-9#1)
biomedical research makes##2##3##(2008-7#1)(2009-5#1)
biomedical research##24##2##(1993-3#2)(1996-3#1)(1997-2#2)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
biomedical signal##2##2##(2010-8#2)
biomedical waste##2##2##(2007-7#2)
biomedical##114##1##(1990-8#2)(1991-12#1)(1991-6#1)(1993-3#3)(1994-11#1)(1994-3#2)(1994-9#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#5)(2008-11#3)(2008-3#5)(2008-4#2)(2008-5#8)(2008-7#10)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#5)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#6)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)(2012-8#1)(2013-1#6)
biomedically##2##1##(2008-11#2)
biomedicine##5##1##(1995-11#1)(2008-7#1)(2010-2#1)(2010-6#1)(2013-8#1)
biomembranes##3##1##(1990-2#1)(2008-11#1)(2008-7#1)
biomes##3##1##(2008-9#1)(2010-3#2)
biometallization processes##2##2##(2010-5#2)
biometric##3##1##(2008-10#1)(2008-6#1)(2008-8#1)
biometrological##3##1##(2008-5#3)
biomicroscopy##3##1##(2009-5#1)(2010-9#1)(2011-1#1)
biomimetic membranes##2##2##(1995-2#1)(2008-10#1)
biomimetic##21##1##(1995-2#2)(1995-3#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-5#1)
biomimetics##2##1##(2008-7#2)
biomolecular interactions##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#2)
biomolecular systems##3##2##(2007-11#1)(2013-1#2)
biomolecular##21##1##(1997-6#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-2#1)(2010-10#1)(2010-7#1)(2012-8#1)(2013-1#2)
biomolecule##15##1##(2007-10#2)(2007-11#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#4)(2009-12#1)(2010-7#1)
biomolecules and bioparticles##2##3##(2010-7#2)
biomolecules and##7##2##(1997-6#1)(2008-5#2)(2010-7#3)(2011-1#1)
biomolecules for##2##2##(2008-10#1)(2008-5#1)
biomolecules in solution##2##3##(1997-6#1)(2008-7#1)
biomolecules in##5##2##(1997-6#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-2#1)
biomolecules inside##2##2##(2008-10#1)(2008-9#1)
biomolecules on##2##2##(2008-5#1)(2010-2#1)
biomolecules that##2##2##(2011-2#1)(2012-2#1)
biomolecules##49##1##(1992-6#1)(1996-12#1)(1997-4#1)(1997-6#4)(2007-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#5)(2008-9#3)(2009-11#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#4)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
biomonitoring of lead (Pb)##2##4##(2008-10#2)
biomonitoring of##5##2##(1997-4#1)(2008-10#3)(2008-12#1)
biomonitoring##8##1##(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#2)
bionanocapsules##3##1##(2013-1#3)
bioneutralizing antibodies##2##2##(1997-4#2)
bioorganic chemistry##2##2##(2006-12#1)(2007-11#1)
bioorganic##5##1##(2006-12#1)(2007-11#1)(2009-9#3)
biopanning##2##1##(1994-12#1)(2012-2#1)
bioparticle##5##1##(2008-6#2)(2008-7#3)
bioparticles##3##1##(2010-7#3)
biopeptide##4##1##(2008-5#4)
biopesticides##2##1##(2008-11#1)(2008-7#1)
biopharmaceutical process##3##2##(2008-11#2)(2010-11#1)
biopharmaceutical product##3##2##(2008-11#1)(2012-2#2)
biopharmaceutical##14##1##(2008-11#7)(2010-11#1)(2012-2#5)(2012-3#1)
biopharmaceuticals and##2##2##(2008-10#1)(2011-2#1)
biopharmaceuticals are##2##2##(2008-11#2)
biopharmaceuticals##16##1##(1994-3#1)(2008-10#3)(2008-11#6)(2008-8#2)(2011-2#3)(2012-2#1)
biophysical and biochemical##2##3##(2012-2#2)
biophysical and##5##2##(2008-5#1)(2008-8#1)(2012-2#3)
biophysical characteristics##2##2##(2008-10#1)(2010-7#1)
biophysical parameters##4##2##(2008-5#3)(2012-3#1)
biophysical properties and##2##3##(2008-2#1)(2008-9#1)
biophysical properties of##3##3##(1997-1#1)(1997-6#1)(2008-9#1)
biophysical properties##10##2##(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-12#1)(2013-1#1)
biophysical skin##2##2##(2008-5#2)
biophysical##53##1##(1992-6#1)(1994-5#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-6#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#11)(2008-8#6)(2008-9#3)(2009-12#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
biophysics and##2##2##(2008-7#1)(2009-9#1)
biophysics##5##1##(2008-5#1)(2008-7#1)(2009-9#2)(2012-3#1)
bioplastics##5##1##(2008-6#4)(2011-2#1)
biopolymer##16##1##(2006-12#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#2)
biopolymers##13##1##(1995-2#3)(1995-3#1)(1996-5#2)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-5#1)
biopreparation treatments##3##2##(2008-10#3)
biopreparation##4##1##(2008-10#4)
biopreparation-treated##2##1##(2008-10#2)
biopreparations##3##1##(2008-10#3)
biopriming##4##1##(2008-10#4)
bioprocess QbD framework##2##3##(2012-2#2)
bioprocess QbD##3##2##(2012-2#3)
bioprocess environment##2##2##(2008-11#2)
bioprocess##22##1##(1997-7#1)(2008-10#2)(2008-11#5)(2008-6#4)(2008-8#1)(2012-2#5)(2013-1#4)
bioprocesses##6##1##(2008-10#1)(2008-11#1)(2008-6#1)(2010-10#1)(2013-1#2)
bioprocessing##8##1##(1997-2#3)(2008-11#2)(2009-5#1)(2012-3#1)(2013-1#1)
bioprostheses##2##1##(1991-2#1)(2010-8#1)
bioprosthesis##9##1##(2007-7#3)(2007-8#6)
bioprosthetic graft##2##2##(2007-7#1)(2011-2#1)
bioprosthetic valve##2##2##(1994-6#1)(2007-8#1)
bioprosthetic##7##1##(1994-6#1)(2007-7#1)(2007-8#1)(2010-8#1)(2011-2#2)(2012-2#1)
biopsied and##2##2##(1991-2#1)(2008-10#1)
biopsied##9##1##(1991-2#2)(1994-12#1)(2008-10#3)(2008-8#1)(2010-6#1)(2012-3#1)
biopsies and##7##2##(1990-11#1)(1990-9#1)(1991-11#1)(2008-5#3)(2008-6#1)
biopsies are##2##2##(1993-9#1)(2012-2#1)
biopsies at##2##2##(2008-1#2)
biopsies by##2##2##(2008-1#1)(2011-2#1)
biopsies for the##2##3##(1991-2#1)(2013-1#1)
biopsies for##3##2##(1991-2#1)(2010-12#1)(2013-1#1)
biopsies from the##3##3##(1993-1#1)(1996-8#1)(2007-12#1)
biopsies from##9##2##(1993-1#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
biopsies in the period##2##4##(2008-1#2)
biopsies may##2##2##(2008-2#1)(2010-12#1)
biopsies obtained##4##2##(2008-1#2)(2008-3#1)(2008-5#1)
biopsies of the##2##3##(1991-3#1)(2007-7#1)
biopsies of##8##2##(1991-3#1)(1994-5#2)(2007-7#1)(2007-8#1)(2008-5#2)(2011-2#1)
biopsies or##2##2##(2008-1#1)(2008-9#1)
biopsies performed##4##2##(1990-12#1)(1992-10#1)(2007-7#1)(2008-1#1)
biopsies revealed that##2##3##(1996-12#1)(2008-6#1)
biopsies revealed##3##2##(1996-12#1)(2008-10#1)(2008-6#1)
biopsies revealing##2##2##(1992-3#1)(2010-12#1)
biopsies showing##2##2##(1993-2#1)(2008-7#1)
biopsies to##2##2##(2008-4#1)(2013-8#1)
biopsies was##2##2##(1990-2#1)(2013-7#1)
biopsies were obtained##2##3##(1994-3#1)(2008-1#1)
biopsies were performed##4##3##(1990-3#1)(2008-1#1)(2008-11#1)(2008-4#1)
biopsies were taken from the cervix##2##6##(1996-12#2)
biopsies were taken from the##3##5##(1996-12#2)(1996-6#1)
biopsies were taken from##5##4##(1996-12#2)(1996-6#1)(2008-5#2)
biopsies were taken##9##3##(1992-10#1)(1996-12#2)(1996-6#1)(2008-10#1)(2008-5#2)(2010-12#1)(2012-12#1)
biopsies were##22##2##(1990-3#1)(1991-11#1)(1992-10#1)(1994-1#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2010-12#2)(2012-12#1)
biopsies##151##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-11#5)(1991-2#1)(1991-3#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#3)(1993-1#1)(1993-2#4)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#2)(2007-11#1)(2007-12#2)(2007-7#5)(2007-8#1)(2008-1#21)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#2)(2008-9#3)(2009-4#2)(2009-8#3)(2010-11#1)(2010-12#5)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#5)
biopsy (16##2##2##(1991-11#1)(2013-1#1)
biopsy Gleason score##2##3##(2010-11#1)(2011-2#1)
biopsy and radical prostatectomy##2##4##(2007-10#1)(2010-11#1)
biopsy and##18##2##(1990-2#1)(1991-6#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
biopsy are##2##2##(2008-1#1)(2008-6#1)
biopsy as a##2##3##(1991-12#1)(2013-7#1)
biopsy as##3##2##(1991-12#1)(2007-7#1)(2013-7#1)
biopsy can be##2##3##(2008-2#1)(2008-9#1)
biopsy can##5##2##(2008-1#1)(2008-2#1)(2008-9#1)(2012-3#1)(2013-1#1)
biopsy confirmed the diagnosis of##2##5##(2007-7#1)(2013-1#1)
biopsy confirmed the##3##3##(2007-7#1)(2013-1#2)
biopsy confirmed##4##2##(2007-7#1)(2012-2#1)(2013-1#2)
biopsy could##2##2##(1991-8#1)(2008-12#1)
biopsy demonstrated a##2##3##(1990-2#2)
biopsy demonstrated##3##2##(1990-2#2)(2008-5#1)
biopsy failed to##3##3##(2008-1#2)(2008-6#1)
biopsy findings##4##2##(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
biopsy followed by##2##3##(2008-1#1)(2013-7#1)
biopsy for breast##2##3##(1997-8#1)(2012-2#1)
biopsy for clinical##2##3##(1994-9#1)(2010-12#1)
biopsy for histology and##2##4##(1996-6#1)(2008-1#1)
biopsy for##15##2##(1992-10#1)(1994-9#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
biopsy from the##3##3##(1991-6#1)(1997-3#1)(2007-7#1)
biopsy from##5##2##(1991-6#1)(1997-3#1)(1997-8#1)(2007-7#1)(2013-8#1)
biopsy has the potential to##2##5##(2008-10#2)
biopsy has##3##2##(2008-10#3)
biopsy in patients with##2##4##(2008-10#1)(2009-8#1)
biopsy in the diagnosis of##2##5##(1991-2#1)(2008-11#1)
biopsy in the diagnosis##3##4##(1991-2#1)(2008-11#1)(2011-1#1)
biopsy in the##9##3##(1991-2#1)(1994-2#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
biopsy in##26##2##(1990-11#1)(1991-2#1)(1994-2#1)(1996-11#1)(1997-6#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
biopsy is a##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
biopsy is required##2##3##(2008-1#1)(2012-2#1)
biopsy is##10##2##(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#3)
biopsy may##2##2##(2012-3#2)
biopsy needle##2##2##(2007-12#2)
biopsy of the##18##3##(1990-11#2)(1990-3#1)(1991-11#1)(1994-2#1)(1994-9#1)(2007-10#1)(2008-1#2)(2008-6#1)(2010-11#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
biopsy of##29##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-11#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-6#2)(2010-11#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
biopsy or##6##2##(1990-10#1)(1991-3#1)(1996-9#1)(2011-2#3)
biopsy proved##2##2##(1990-2#1)(2008-1#1)
biopsy proven##2##2##(2008-1#1)(2013-1#1)
biopsy results##2##2##(1996-11#1)(2008-1#1)
biopsy revealed a##2##3##(2008-7#1)(2010-11#1)
biopsy revealed##9##2##(1991-3#1)(1992-5#1)(1994-7#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
biopsy samples##7##2##(1996-12#2)(1996-6#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
biopsy showed a##5##3##(2011-2#1)(2013-1#1)(2013-8#3)
biopsy showed##16##2##(1992-5#1)(1997-3#1)(2006-10#2)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-1#1)(2011-2#2)(2013-1#1)(2013-8#3)
biopsy specimen revealed##2##3##(2010-6#1)(2013-8#1)
biopsy specimen showed##3##3##(2007-7#1)(2007-9#1)(2009-8#1)
biopsy specimen was##2##3##(2008-7#1)(2010-11#1)
biopsy specimen##12##2##(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-6#1)(2013-8#1)
biopsy specimens from##4##3##(1990-9#1)(1992-2#1)(1993-12#1)(2008-12#1)
biopsy specimens revealed##5##3##(1991-11#1)(2008-1#2)(2010-10#1)(2011-2#1)
biopsy specimens##21##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#1)(1996-8#1)(1997-8#1)(2008-1#3)(2008-12#4)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#2)
biopsy technique##2##2##(2007-12#1)(2012-3#1)
biopsy to confirm##2##3##(2008-1#1)(2013-8#1)
biopsy to##3##2##(1997-3#1)(2008-1#1)(2013-8#1)
biopsy using##3##2##(2007-7#1)(2012-12#1)(2013-8#1)
biopsy was consistent with##3##4##(2006-10#1)(2008-1#1)(2010-8#1)
biopsy was obtained##2##3##(2008-1#1)(2010-12#1)
biopsy was performed in##6##4##(2007-7#1)(2007-8#1)(2009-10#2)(2011-2#2)
biopsy was performed on##2##4##(2007-7#1)(2011-2#1)
biopsy was performed##11##3##(1994-7#1)(2007-7#2)(2007-8#1)(2008-6#1)(2009-10#2)(2009-8#1)(2011-2#3)
biopsy was taken##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
biopsy was##27##2##(1990-12#1)(1994-7#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
biopsy with##3##2##(2007-8#1)(2011-1#1)(2012-2#1)
biopsy would##2##2##(1994-12#1)(2012-2#1)
biopsy yielded##2##2##(1994-7#1)(1996-11#1)
biopsy##417##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#5)(1990-6#2)(1990-9#2)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#4)(1991-6#4)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-8#2)(1993-12#1)(1993-5#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-7#3)(1994-9#2)(1995-11#2)(1995-5#2)(1996-11#5)(1996-12#4)(1996-2#2)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#6)(2006-10#6)(2007-10#3)(2007-11#3)(2007-12#10)(2007-5#1)(2007-7#11)(2007-8#10)(2007-9#1)(2008-1#34)(2008-10#13)(2008-11#5)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#8)(2008-7#10)(2008-8#1)(2008-9#2)(2009-1#2)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#9)(2010-12#9)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#8)(2011-2#37)(2011-7#1)(2012-1#4)(2012-12#3)(2012-2#29)(2012-3#16)(2013-1#24)(2013-7#5)(2013-8#12)
biopsy)##3##1##(2008-4#1)(2008-7#1)(2010-12#1)
biopsy-proven pulmonary##2##2##(2008-6#2)
biopsy-proven##5##1##(1995-4#1)(1997-3#1)(2008-6#2)(2008-8#1)
biopsy]##4##1##(1991-6#1)(1995-11#1)(1997-2#1)(2012-2#1)
biopsychosocial and##2##2##(2011-2#2)
biopsychosocial model##5##2##(1991-6#1)(2008-10#1)(2008-4#1)(2009-9#1)(2013-8#1)
biopsychosocial##11##1##(1991-6#1)(1995-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-9#1)(2011-2#2)(2013-8#1)
bioreactor at##2##2##(2008-11#1)(2008-6#1)
bioreactor by##3##2##(2008-11#2)(2008-6#1)
bioreactor configuration and##2##3##(2008-11#1)(2008-7#1)
bioreactor cultivation##2##2##(2008-11#1)(2011-2#1)
bioreactor culture##3##2##(2008-11#2)(2008-7#1)
bioreactor cultures##2##2##(2008-11#2)
bioreactor for continuous ultra-slow uniaxial distraction of a##2##8##(2011-2#2)
bioreactor for##8##2##(1992-11#1)(2008-11#3)(2008-7#1)(2011-2#2)(2013-1#1)
bioreactor performance##2##2##(2008-6#1)(2011-2#1)
bioreactor scale##3##2##(2008-11#2)(2008-7#1)
bioreactor system for##2##3##(1995-3#1)(2008-11#1)
bioreactor system##6##2##(1995-3#1)(2008-11#5)
bioreactor systems##2##2##(2008-11#2)
bioreactor to##3##2##(2008-11#3)
bioreactor under##3##2##(2008-11#2)(2011-2#1)
bioreactor using magnetic resonance##2##4##(2008-11#1)(2008-7#1)
bioreactor using##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
bioreactor was compared##2##3##(2008-11#1)(2008-7#1)
bioreactor was##6##2##(2008-11#4)(2008-6#1)(2008-7#1)
bioreactor were##2##2##(2008-11#2)
bioreactor with a##3##3##(2008-11#3)
bioreactor with##9##2##(2008-11#9)
bioreactor##156##1##(1992-11#1)(1994-3#2)(1994-5#2)(1995-3#1)(2008-10#4)(2008-11#104)(2008-3#3)(2008-6#7)(2008-7#15)(2009-7#3)(2010-5#1)(2011-2#6)(2012-2#2)(2013-1#5)
bioreactor-based 3D##2##2##(2010-10#2)
bioreactors and##2##2##(2008-10#1)(2008-11#1)
bioreactors in##3##2##(2008-11#2)(2010-10#1)
bioreactors##39##1##(1994-3#1)(2008-10#3)(2008-11#24)(2008-6#1)(2008-7#6)(2010-10#1)(2010-11#1)(2011-2#2)
biorecognition element##2##2##(2008-10#1)(2009-5#1)
biorecognition elements##2##2##(2008-10#1)(2010-11#1)
biorecognition groups to solids##2##4##(2008-10#2)
biorecognition##7##1##(2008-10#5)(2009-5#1)(2010-11#1)
bioremediation of##5##2##(2008-5#2)(2008-7#1)(2012-2#2)
bioremediation##18##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#5)(2008-7#1)(2009-4#1)(2011-1#3)(2011-2#1)(2012-2#2)
bioreporter##3##1##(2008-10#1)(2011-2#2)
bioreporters##6##1##(2011-1#1)(2011-2#5)
bioresorbable##2##1##(2008-11#1)(2008-5#1)
biorheological##3##1##(2008-9#3)
biorthogonal wavelet##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
biorthogonal##6##1##(2007-11#1)(2008-10#1)(2008-6#2)(2010-4#2)
biosafety levels (as established by the U##2##7##(2008-4#1)(2008-9#1)
biosafety##10##1##(1991-5#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#4)(2011-2#1)
biosecurity measures##2##2##(2007-6#1)(2011-2#1)
biosecurity##3##1##(2007-6#1)(2011-2#2)
biosensing applications##2##2##(2008-10#1)(2009-5#1)
biosensing devices##2##2##(2008-10#1)(2009-12#1)
biosensing of##3##2##(1992-11#1)(2008-10#1)(2010-5#1)
biosensing system##3##2##(2008-10#2)(2010-5#1)
biosensing##20##1##(1992-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-5#2)(2010-7#1)(2013-1#1)
biosensor agreed well with##2##4##(2008-10#2)
biosensor and##9##2##(2008-10#7)(2008-9#2)
biosensor applications##3##2##(2008-10#2)(2010-5#1)
biosensor are##3##2##(2008-10#3)
biosensor array##3##2##(2008-10#1)(2008-9#1)(2009-11#1)
biosensor based on a ruthenium complex mediator of low redox potential##2##11##(2008-10#2)
biosensor based on the##4##4##(2008-10#4)
biosensor based on urate oxidase-peroxidase coupled enzyme system for##2##9##(2008-10#2)
biosensor based on##38##3##(2008-10#38)
biosensor can be used to##2##5##(2008-10#2)
biosensor can be used##3##4##(2008-10#3)
biosensor can##5##2##(2008-10#5)
biosensor could##3##2##(2008-10#3)
biosensor design##3##2##(2008-10#2)(2011-1#1)
biosensor device is##2##3##(2008-10#2)
biosensor devices##2##2##(2008-10#2)
biosensor displayed##2##2##(2008-10#2)
biosensor exhibited##4##2##(2008-10#3)(2010-5#1)
biosensor for detecting##2##3##(2008-10#2)
biosensor for detection of##3##4##(2008-10#3)
biosensor for detection##4##3##(2008-10#4)
biosensor for determination of##4##4##(2008-10#4)
biosensor for isocitrate##2##3##(2008-10#2)
biosensor for phenol##2##3##(2008-10#2)
biosensor for phenols##2##3##(2008-10#2)
biosensor for the detection of DNA strand cleaving agents##2##9##(2008-10#2)
biosensor for the detection of##8##5##(2008-10#8)
biosensor for the detection##9##4##(2008-10#9)
biosensor for the determination of##3##5##(2008-10#3)
biosensor for the##25##3##(1995-3#1)(2008-10#23)(2010-5#1)
biosensor for##69##2##(1995-3#1)(2008-10#66)(2008-11#1)(2010-5#1)
biosensor has been##6##3##(2008-10#6)
biosensor has##9##2##(2008-10#9)
biosensor in##4##2##(2008-10#4)
biosensor is a##2##3##(2008-10#2)
biosensor is based on an##2##5##(2008-10#2)
biosensor is based on##3##4##(2008-10#3)
biosensor is described##2##3##(2008-10#2)
biosensor is##21##2##(2008-10#21)
biosensor method##4##2##(1995-12#1)(2008-10#3)
biosensor on a##2##3##(2008-10#2)
biosensor performance##3##2##(1994-8#1)(2008-10#2)
biosensor prepared by##2##3##(2008-10#2)
biosensor responded##2##2##(2008-10#2)
biosensor responds##2##2##(2008-10#2)
biosensor response for##2##3##(2008-10#2)
biosensor response##7##2##(2008-10#7)
biosensor showed a##3##3##(2008-10#3)
biosensor showed##5##2##(2008-10#5)
biosensor shows a##2##3##(2008-10#2)
biosensor surface##3##2##(2008-10#3)
biosensor system##2##2##(1992-11#1)(2008-10#1)
biosensor technology##4##2##(1995-12#1)(2008-10#2)(2009-3#1)
biosensor to##4##2##(2008-10#3)(2013-8#1)
biosensor using an##2##3##(2008-10#2)
biosensor using##3##2##(2008-10#3)
biosensor was applied##2##3##(2008-10#2)
biosensor was constructed##2##3##(2008-10#2)
biosensor was developed for the##2##5##(2008-10#2)
biosensor was developed for##3##4##(2008-10#3)
biosensor was developed##5##3##(1995-3#1)(2008-10#4)
biosensor was fabricated by##2##4##(2008-10#2)
biosensor was investigated##2##3##(2008-10#2)
biosensor was used##3##3##(2008-10#3)
biosensor was##33##2##(1995-3#1)(2008-10#30)(2010-5#2)
biosensor with##4##2##(2008-10#3)(2008-7#1)
biosensor##398##1##(1991-5#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#2)(1997-2#3)(2008-10#363)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#1)(2010-11#1)(2010-5#5)(2011-1#1)(2013-8#1)
biosensors and##3##2##(2008-10#3)
biosensors are##4##2##(2008-10#2)(2009-11#1)(2009-3#1)
biosensors based on the##5##4##(2008-10#5)
biosensors based on urease##2##4##(2008-10#2)
biosensors based on##19##3##(2008-10#18)(2008-7#1)
biosensors by##2##2##(2008-10#1)(2008-9#1)
biosensors for monitoring##2##3##(2008-10#2)
biosensors for the##2##3##(2008-10#2)
biosensors for##6##2##(2008-10#6)
biosensors have##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
biosensors in a##2##3##(2008-10#1)(2008-9#1)
biosensors in##5##2##(2008-10#3)(2008-9#1)(2010-7#1)
biosensors is the##2##3##(2009-11#1)(2009-3#1)
biosensors is##6##2##(2008-10#4)(2009-11#1)(2009-3#1)
biosensors obtained##2##2##(2008-10#2)
biosensors to monitor##2##3##(2008-10#1)(2008-11#1)
biosensors to##6##2##(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
biosensors were proposed##2##3##(2008-10#2)
biosensors were##14##2##(2008-10#14)
biosensors with##2##2##(2008-10#1)(2010-7#1)
biosensors##149##1##(1995-3#2)(2007-12#1)(2008-10#121)(2008-11#1)(2008-3#2)(2008-7#3)(2008-9#2)(2009-11#7)(2009-3#2)(2009-8#1)(2010-5#1)(2010-7#3)(2010-8#1)(2013-8#2)
bioseparation##2##1##(2008-11#1)(2009-8#1)
biosimilars##3##1##(2011-3#1)(2012-2#2)
biosocial##2##1##(1991-6#1)(2008-11#1)
biosolid extract##4##2##(2011-2#4)
biosolids##9##1##(2007-12#1)(2008-10#1)(2008-6#7)
biosorbent##5##1##(2008-10#3)(2008-12#2)
biosorption of##3##2##(2008-10#2)(2008-12#1)
biosorption##10##1##(2008-10#5)(2008-12#1)(2008-6#1)(2011-2#2)(2013-8#1)
biospecific##2##1##(2008-3#1)(2008-6#1)
biosphere##2##1##(1997-5#1)(2008-11#1)
biostatistical recommendations##2##2##(2008-12#2)
biostatistical##4##1##(2008-12#4)
biosurfactant##4##1##(2008-6#4)
biosurveillance##4##1##(2010-8#3)(2011-9#1)
biosynthesis and##13##2##(1990-5#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-1#1)(2012-2#1)
biosynthesis are##2##2##(1993-2#1)(1994-5#1)
biosynthesis by##3##2##(1995-3#1)(1995-6#1)(2008-10#1)
biosynthesis gene cluster##2##3##(2008-10#1)(2008-9#1)
biosynthesis gene##3##2##(2008-10#2)(2008-9#1)
biosynthesis genes##6##2##(2008-10#6)
biosynthesis in Escherichia coli##2##4##(1992-12#1)(1995-6#1)
biosynthesis in##23##2##(1990-4#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-5#3)(1995-6#1)(1997-2#2)(2008-11#3)(2008-7#2)(2009-8#1)(2011-10#1)(2012-2#2)
biosynthesis inhibitor##2##2##(2008-10#2)
biosynthesis inhibitors##3##2##(2008-10#3)
biosynthesis is##9##2##(1990-11#1)(1990-12#1)(1993-9#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
biosynthesis may##2##2##(1994-11#1)(1997-2#1)
biosynthesis of a spore pigment##2##5##(2008-8#2)
biosynthesis of a##4##3##(1990-5#1)(1993-11#1)(2008-8#2)
biosynthesis of the##12##3##(1990-2#1)(1990-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(2008-10#4)(2008-7#1)(2011-2#1)
biosynthesis of these##3##3##(1990-3#1)(1994-11#1)(2011-1#1)
biosynthesis of##58##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-5#1)(1992-12#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#3)(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#3)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
biosynthesis pathway##2##2##(1995-8#1)(2008-9#1)
biosynthesis pathways##2##2##(2008-10#1)(2008-7#1)
biosynthesis to##2##2##(1992-11#1)(2008-7#1)
biosynthesis was##4##2##(1990-11#1)(1994-11#1)(2008-5#1)(2010-10#1)
biosynthesis##232##1##(1990-11#4)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#3)(1991-4#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-5#7)(1994-8#6)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#36)(2008-11#6)(2008-12#1)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#14)(2009-10#7)(2009-6#5)(2009-7#1)(2009-8#3)(2010-10#1)(2010-2#1)(2011-1#5)(2011-10#1)(2011-2#6)(2012-1#1)(2012-2#13)(2012-3#2)(2013-8#2)
biosynthetic activity##2##2##(1993-1#1)(2008-7#1)
biosynthetic and##3##2##(1994-3#1)(2009-5#1)(2012-2#1)
biosynthetic enzyme##2##2##(1992-3#1)(2012-2#1)
biosynthetic enzymes in##2##3##(2008-7#1)(2013-1#1)
biosynthetic enzymes##3##2##(1992-4#1)(2008-7#1)(2013-1#1)
biosynthetic gene cluster##2##3##(1990-5#1)(2012-2#1)
biosynthetic genes##9##2##(1992-4#2)(1993-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2012-2#1)
biosynthetic pathway for##2##3##(1997-6#1)(2012-2#1)
biosynthetic pathway in##2##3##(1995-2#1)(2011-2#1)
biosynthetic pathway of##2##3##(1992-12#1)(2008-1#1)
biosynthetic pathway##16##2##(1990-7#1)(1992-12#1)(1994-12#1)(1994-8#2)(1995-2#3)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)
biosynthetic pathways or##2##3##(2008-11#1)(2008-5#1)
biosynthetic pathways##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
biosynthetic precursor##2##2##(1993-3#1)(2008-7#1)
biosynthetic precursors##2##2##(1994-11#1)(2008-11#1)
biosynthetic##66##1##(1990-12#1)(1990-5#1)(1990-7#1)(1992-12#2)(1992-3#1)(1992-4#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-8#5)(1995-12#1)(1995-2#3)(1996-8#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#8)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)
biosynthetically##4##1##(1990-5#1)(2008-1#2)(2008-4#1)
biota##7##1##(1996-4#1)(2008-10#3)(2012-1#1)(2012-2#1)(2013-1#1)
biotech##7##1##(1996-2#1)(2008-11#3)(2010-5#1)(2011-1#1)(2011-2#1)
biotech-derived##2##1##(2008-8#2)
biotechnological applications##10##2##(2008-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#1)(2013-1#1)
biotechnological approaches##2##2##(2008-11#1)(2011-1#1)
biotechnological potential##3##2##(1994-11#1)(2008-7#2)
biotechnological process##2##2##(2008-11#1)(2008-6#1)
biotechnological##31##1##(1994-11#1)(2008-10#4)(2008-11#6)(2008-5#1)(2008-6#3)(2008-7#4)(2009-10#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#6)(2011-2#1)(2013-1#1)
biotechnologically##2##1##(2008-11#1)(2011-1#1)
biotechnology and pharmaceutical##2##3##(2008-5#1)(2009-3#1)
biotechnology and##8##2##(1995-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)
biotechnology are##2##2##(1997-6#1)(2008-11#1)
biotechnology in##2##2##(2008-11#2)
biotechnology inventions##2##2##(2011-1#2)
biotechnology##59##1##(1990-2#1)(1990-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-4#2)(1997-6#5)(2008-10#5)(2008-11#14)(2008-4#1)(2008-5#2)(2008-7#8)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-2#1)(2013-1#1)
biotests##2##1##(2008-11#2)
biotherapeutic effects##2##2##(2008-5#2)
biotherapeutic##7##1##(2008-10#3)(2008-11#1)(2008-5#2)(2010-11#1)
biotherapeutics##7##1##(2008-10#5)(2010-11#1)(2011-2#1)
biotherapy##3##1##(2010-3#1)(2013-1#2)
biotic and abiotic factors##2##4##(2008-10#1)(2008-6#1)
biotic and abiotic stresses##3##4##(2008-8#1)(2010-10#2)
biotic and abiotic##6##3##(2008-10#2)(2008-6#1)(2008-8#1)(2010-10#2)
biotic and##7##2##(2008-10#3)(2008-6#1)(2008-8#1)(2010-10#2)
biotic or abiotic##2##3##(2008-10#1)(2008-8#1)
biotic##27##1##(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2011-2#1)
biotin and##7##2##(1990-2#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#2)
biotin conjugated to##2##3##(1990-12#1)(2008-10#1)
biotin is##3##2##(2008-10#2)(2008-4#1)
biotin transport process##2##3##(1992-6#2)
biotin transport##13##2##(1992-6#13)
biotin was##5##2##(1990-12#1)(1992-6#1)(1993-8#1)(2008-10#1)(2008-12#1)
biotin##61##1##(1990-12#3)(1990-2#1)(1992-6#17)(1993-11#1)(1993-6#1)(1993-8#2)(1995-11#1)(1995-2#6)(2008-10#17)(2008-12#2)(2008-4#5)(2008-7#1)(2008-9#3)(2011-2#1)
biotin-avidin##2##1##(2008-10#2)
biotin-labeled##3##1##(1992-8#1)(2008-10#2)
biotinidase##7##1##(1990-8#7)
biotinylated BSM-BSA##2##2##(2008-10#2)
biotinylated DNA##4##2##(1995-8#1)(2008-10#2)(2008-4#1)
biotinylated derivative##2##2##(1992-6#1)(1995-6#1)
biotinylated dextran##2##2##(1996-5#1)(2008-4#1)
biotinylated human##2##2##(1993-6#1)(2010-2#1)
biotinylated protein##4##2##(1990-12#2)(1992-6#1)(2008-11#1)
biotinylated##59##1##(1990-12#2)(1990-2#1)(1992-11#1)(1992-6#2)(1993-5#1)(1993-6#4)(1994-5#1)(1994-6#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#3)(1997-3#1)(2008-1#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2012-3#1)
biotinylation and##2##2##(1993-6#1)(1997-2#1)
biotinylation of the##3##3##(1997-2#2)(2008-4#1)
biotinylation of##8##2##(1997-2#2)(2008-1#2)(2008-4#3)(2008-9#1)
biotinylation##18##1##(1993-6#1)(1997-2#5)(2006-6#1)(2008-1#2)(2008-4#6)(2008-7#1)(2008-9#1)(2010-12#1)
biotissues##2##1##(1994-3#2)
biotope##3##1##(1991-8#1)(2008-5#1)(2013-7#1)
biotopes##5##1##(2008-5#1)(2011-2#2)(2013-1#2)
biotransformation and##2##2##(2008-10#1)(2008-7#1)
biotransformation in##2##2##(1996-12#1)(2008-7#1)
biotransformation of odourless##2##3##(2008-5#2)
biotransformation of##15##2##(1990-6#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2011-1#1)(2011-3#1)
biotransformation reactions##2##2##(2009-12#1)(2011-2#1)
biotransformation##37##1##(1990-6#2)(1991-2#1)(1994-11#2)(1994-6#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-5#4)(2008-6#2)(2008-7#5)(2009-12#1)(2011-1#1)(2011-2#1)(2011-3#1)
biotransformations##3##1##(1991-12#1)(2008-5#1)(2008-7#1)
biotransformed##3##1##(1993-8#1)(1995-3#1)(2008-5#1)
biotreatment##2##1##(2008-6#2)
biotrophic fungi##2##2##(2008-10#1)(2010-3#1)
biotrophic##17##1##(2008-10#12)(2009-6#1)(2010-3#3)(2012-2#1)
biotype B)##2##2##(2008-10#2)
biotype of B##2##3##(2011-2#2)
biotype of Bemisia tabaci##2##4##(2008-10#1)(2011-2#1)
biotype of the##2##3##(2008-10#1)(2009-8#1)
biotype of##8##2##(2008-10#4)(2009-8#1)(2011-2#3)
biotype##30##1##(1992-5#1)(2007-7#2)(2008-10#16)(2009-8#1)(2011-2#8)(2013-1#2)
biotypes maintained##2##2##(2008-10#2)
biotypes of##4##2##(2008-10#4)
biotypes##17##1##(2008-10#14)(2008-5#1)(2010-3#1)(2011-2#1)
biovar 1##2##2##(2008-10#2)
biovar 2##4##2##(2008-10#4)
biovar N2 strains from Japan##2##5##(2008-10#2)
biovar N2 strains##3##3##(2008-10#3)
biovar##16##1##(1991-9#2)(2008-10#11)(2008-7#1)(2011-1#1)(2011-2#1)
biovars##2##1##(1991-9#1)(2008-10#1)
biovolume##5##1##(2008-11#5)
bipartite DNA##2##2##(1992-6#1)(2008-10#1)
bipartite begomovirus##3##2##(2008-10#3)
bipartite closterovirus##3##2##(2008-10#3)
bipartite##28##1##(1992-3#2)(1992-6#2)(1993-2#1)(1997-6#1)(2008-10#20)(2009-8#1)(2013-1#1)
bipedal##2##1##(1991-6#1)(2010-12#1)
biphasic and##3##2##(1997-2#1)(2007-8#1)(2008-10#1)
biphasic changes##2##2##(1992-3#1)(1993-3#1)
biphasic diacylglycerol##2##2##(1991-5#1)(1992-9#1)
biphasic dose-response relationships##3##3##(2008-7#3)
biphasic dose-response##4##2##(2008-7#4)
biphasic effect##4##2##(1994-3#1)(2008-7#2)(2012-4#1)
biphasic effects##3##2##(1992-12#1)(1992-9#1)(1997-2#1)
biphasic increase##3##2##(1990-2#1)(1994-2#1)(1996-12#1)
biphasic manner##2##2##(1990-11#1)(1992-7#1)
biphasic pattern##3##2##(1993-11#1)(2008-1#1)(2008-5#1)
biphasic response##2##2##(1992-9#1)(1995-3#1)
biphasic system##2##2##(1990-5#1)(2013-1#1)
biphasic tumors##2##2##(2009-5#1)(2011-2#1)
biphasic variation##2##2##(1991-2#1)(1991-9#1)
biphasic##71##1##(1990-11#1)(1990-2#4)(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#10)(2009-5#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-4#1)(2013-1#1)(2013-8#1)
biphasically##2##1##(1991-9#1)(2008-8#1)
biphenyl##7##1##(1991-2#2)(2008-10#3)(2011-2#1)(2012-1#1)
biphenyls and##2##2##(1993-12#1)(2008-11#1)
biphenyls in##4##2##(1993-12#1)(2008-10#3)
biphenyls##29##1##(1993-12#4)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#16)(2008-11#3)(2008-7#2)
biphotonic##2##1##(2007-12#2)
bipolar (BP)##2##2##(1997-5#2)
bipolar I disorder##3##3##(1997-5#2)(2011-1#1)
bipolar I##7##2##(1997-5#4)(2011-1#3)
bipolar affective disorder##6##3##(1995-11#1)(1996-7#2)(1997-5#3)
bipolar affective##8##2##(1995-11#1)(1996-7#2)(1997-5#4)(2013-7#1)
bipolar and##2##2##(1994-2#1)(2007-12#1)
bipolar coagulation##4##2##(1995-3#3)(2006-12#1)
bipolar device##2##2##(2007-8#2)
bipolar disorder (BP)##2##3##(1997-5#2)
bipolar disorder (BPD)##3##3##(2008-4#1)(2009-8#2)
bipolar disorder and in##2##4##(2008-3#1)(2008-6#1)
bipolar disorder and##5##3##(1993-8#1)(2008-3#1)(2008-6#1)(2010-6#1)(2013-8#1)
bipolar disorder are##2##3##(2008-7#1)(2010-7#1)
bipolar disorder in children and adolescents##2##6##(2008-8#2)
bipolar disorder in##5##3##(1997-5#2)(2008-8#2)(2012-3#1)
bipolar disorder##49##2##(1993-8#1)(1996-7#3)(1997-5#7)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#5)(2009-11#4)(2009-3#1)(2009-6#2)(2009-8#2)(2010-6#1)(2010-7#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#4)
bipolar disorders##2##2##(2008-6#1)(2011-1#1)
bipolar electrosurgical##2##2##(1992-12#2)
bipolar illness##2##2##(1997-5#2)
bipolar interconnection##2##2##(2008-3#2)
bipolar patients and normal subjects##2##5##(1996-7#2)
bipolar patients##10##2##(1995-11#4)(1996-7#5)(2013-8#1)
bipolar prosthesis implantation##2##3##(2007-8#2)
bipolar prosthesis##4##2##(2007-8#4)
bipolar sensory##2##2##(2007-12#2)
bipolar type (SA/BP)##2##3##(1997-5#2)
bipolar##146##1##(1991-2#1)(1992-12#4)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#5)(1995-3#3)(1996-7#12)(1997-5#27)(2006-12#1)(2007-11#2)(2007-12#4)(2007-8#8)(2008-1#1)(2008-10#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#5)(2009-10#1)(2009-11#5)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#4)(2010-8#2)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#7)
bipolarity##4##1##(2009-10#4)
bipy can be##2##3##(2008-10#2)
bipy##4##1##(2008-10#4)
bipy)##2##1##(2008-10#2)
bipyramidal##3##1##(1997-7#1)(2008-10#1)(2008-5#1)
bipyridilium herbicides##2##2##(2008-10#2)
bipyridine##2##1##(1997-7#1)(2008-10#1)
bipyridinium##3##1##(2010-12#3)
bipyridyl groups##2##2##(2008-10#2)
bipyridyl##6##1##(2008-10#6)
biquintic##2##1##(2008-6#2)
biracial/ethnic youth and young adults##2##5##(2013-8#2)
biracial/ethnic##4##1##(2013-8#4)
biradical##2##1##(1993-6#1)(1996-5#1)
biradicals##2##1##(1996-5#2)
birch (Betula##2##2##(2008-11#1)(2012-5#1)
birch bark##6##2##(2008-10#3)(2012-1#3)
birch leaf##2##2##(2008-11#2)
birch##15##1##(2008-10#3)(2008-11#4)(2012-1#3)(2012-12#1)(2012-3#1)(2012-5#3)
bird and##2##2##(2008-3#1)(2008-8#1)
bird distribution in##2##3##(2008-5#1)(2013-8#1)
bird dropping strains##2##3##(2008-5#2)
bird droppings##2##2##(2008-5#2)
bird nests##4##2##(2008-6#3)(2008-8#1)
bird species##6##2##(2008-5#4)(2008-9#1)(2012-3#1)
bird##40##1##(1995-10#1)(1996-8#2)(1997-3#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#9)(2008-6#3)(2008-8#7)(2008-9#2)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
birds after##2##2##(1997-3#1)(1997-6#1)
birds and mammals##6##3##(1994-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)
birds and the##2##3##(2008-5#1)(2008-8#1)
birds and##19##2##(1994-5#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2010-3#3)(2011-2#2)(2013-1#1)
birds are##3##2##(1997-4#1)(2008-11#1)(2008-8#1)
birds as##2##2##(1997-4#1)(2008-9#1)
birds because##2##2##(1995-3#1)(2008-8#1)
birds did not##2##3##(1997-6#1)(2008-8#1)
birds from##2##2##(1997-3#2)
birds have##3##2##(1994-3#2)(2009-5#1)
birds having##2##2##(1997-6#1)(2008-5#1)
birds in both years##2##4##(2007-6#2)
birds in the Central##2##4##(2011-2#2)
birds in##12##2##(1997-4#1)(2007-6#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#3)
birds of##5##2##(1992-2#1)(2008-8#1)(2010-4#2)(2011-2#1)
birds per##2##2##(1997-3#1)(2010-2#1)
birds showed##3##2##(1997-2#1)(1997-3#1)(2008-8#1)
birds that##2##2##(2008-5#1)(2008-8#1)
birds was##3##2##(1997-6#1)(2007-6#1)(2008-9#1)
birds were##8##2##(1995-12#1)(1997-3#2)(1997-6#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)
birds with##3##2##(2008-8#2)(2011-2#1)
birds##185##1##(1991-11#2)(1991-6#2)(1992-2#2)(1994-11#2)(1994-3#4)(1994-5#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-8#2)(1997-2#2)(1997-3#17)(1997-4#6)(1997-6#15)(1997-8#1)(2007-12#1)(2007-2#1)(2007-6#6)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#18)(2008-7#1)(2008-8#30)(2008-9#26)(2009-2#2)(2009-5#2)(2009-8#1)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#1)(2011-2#9)(2012-1#1)(2012-3#3)(2013-1#5)(2013-7#1)
birefringence and its##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
birefringence and temperature##3##3##(2008-3#3)
birefringence and##13##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#5)(2010-4#2)
birefringence as##2##2##(2007-12#1)(2008-10#1)
birefringence at##3##2##(1990-7#1)(2008-3#2)
birefringence by use of the##2##5##(2008-2#1)(2008-3#1)
birefringence by use of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
birefringence compensation##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
birefringence dispersion##2##2##(2007-11#2)
birefringence from##2##2##(2008-2#1)(2008-3#1)
birefringence imaging in##2##3##(2008-3#2)
birefringence in GRIN rod lenses##2##5##(2008-3#2)
birefringence in Nd##2##3##(2007-11#2)
birefringence in a##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
birefringence in solid-state lasers##2##4##(2007-12#2)
birefringence in the##4##3##(2007-11#2)(2008-3#2)
birefringence in##21##2##(2007-11#8)(2007-12#5)(2008-2#1)(2008-3#7)
birefringence induced##2##2##(2007-12#1)(2008-2#1)
birefringence measurements##3##2##(2007-11#2)(2008-3#1)
birefringence modulation##2##2##(2008-3#2)
birefringence of a##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
birefringence of single-mode##3##3##(2008-3#3)
birefringence of the##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
birefringence of##28##2##(2007-11#4)(2007-12#2)(2008-2#5)(2008-3#16)(2009-11#1)
birefringence on the##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
birefringence on##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
birefringence that is##2##3##(2008-3#2)
birefringence that##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2009-10#1)
birefringence vector distribution in##3##4##(2008-3#3)
birefringence vector distribution##6##3##(2008-3#6)
birefringence vector distributions##3##3##(2008-3#3)
birefringence vector##11##2##(2007-12#1)(2008-3#10)
birefringence##191##1##(1990-7#5)(2007-11#35)(2007-12#25)(2008-10#1)(2008-2#30)(2008-3#90)(2009-10#1)(2009-11#1)(2010-4#2)(2011-1#1)
birefringence-customized##2##1##(2008-2#2)
birefringences at different##2##3##(2008-2#2)
birefringent blur filter##5##3##(2008-3#5)
birefringent fiber##4##2##(2007-11#3)(2007-12#1)
birefringent fibers##11##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)
birefringent filter##3##2##(2007-12#1)(2008-3#2)
birefringent material##3##2##(2008-3#3)
birefringent materials##2##2##(2008-3#2)
birefringent media##4##2##(2008-3#3)(2012-2#1)
birefringent optical##2##2##(2007-11#1)(2007-12#1)
birefringent##66##1##(2007-11#9)(2007-12#11)(2007-7#1)(2008-2#7)(2008-3#37)(2012-2#1)
birth and the##2##3##(2009-10#1)(2012-3#1)
birth and##23##2##(1990-9#2)(1992-5#1)(1992-8#1)(1994-7#1)(1995-8#1)(1996-5#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-5#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
birth as##4##2##(1990-2#1)(1992-6#1)(2009-11#1)(2010-12#1)
birth at##4##2##(1993-8#1)(1996-11#1)(2013-1#2)
birth attendants in##2##3##(2011-1#2)
birth attendants##6##2##(1994-3#1)(2010-12#1)(2011-1#3)(2013-1#1)
birth certificates##2##2##(2012-12#2)
birth cohort in##2##3##(2010-6#1)(2011-2#1)
birth cohort of##2##3##(2011-2#1)(2012-12#1)
birth cohort##9##2##(1990-6#1)(2008-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
birth cohorts (65##2##3##(2008-7#2)
birth cohorts##3##2##(2008-7#3)
birth control pill##2##3##(1997-6#2)
birth control##10##2##(1994-3#2)(1994-8#1)(1994-9#1)(1996-8#2)(1997-6#2)(1997-8#1)(2008-7#1)
birth date##2##2##(1990-9#1)(1992-6#1)
birth defect##3##2##(2009-6#2)(2012-1#1)
birth defects and##3##3##(2008-7#1)(2010-1#2)
birth defects identified##2##3##(2012-12#2)
birth defects in##2##3##(2008-11#1)(2012-12#1)
birth defects surveillance##3##3##(2012-12#3)
birth defects##18##2##(2008-11#2)(2008-7#3)(2008-8#1)(2010-1#2)(2012-12#9)(2012-3#1)
birth during##3##2##(2010-11#1)(2011-1#2)
birth for##2##2##(2010-8#1)(2013-8#1)
birth has##3##2##(2007-2#2)(2009-5#1)
birth in the##2##3##(2009-10#1)(2012-3#1)
birth in##8##2##(1995-8#1)(2007-2#1)(2008-12#1)(2009-10#3)(2012-3#1)(2013-8#1)
birth incidence##3##2##(2008-11#3)
birth is##2##2##(1990-6#1)(2007-10#1)
birth of an##2##3##(2008-10#1)(2009-10#1)
birth of the##2##3##(1996-9#1)(2012-12#1)
birth of##12##2##(1991-6#1)(1993-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2012-12#2)(2012-2#1)
birth outcomes##10##2##(1993-3#2)(1997-7#5)(2007-12#1)(2007-2#1)(2013-1#1)
birth rate##7##2##(1993-3#1)(1994-9#2)(1996-11#1)(1997-8#1)(2008-11#1)(2008-9#1)
birth rates##3##2##(1994-2#1)(2008-8#1)(2012-3#1)
birth spacing##3##2##(1992-4#3)
birth the##4##2##(1990-5#1)(1991-11#1)(2007-11#1)(2008-4#1)
birth to##16##2##(1990-9#1)(1994-7#1)(1996-12#1)(1996-5#2)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
birth weight (P &lt##2##4##(2010-2#1)(2011-2#1)
birth weight and##6##3##(1995-12#1)(2007-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
birth weight in##4##3##(1991-12#1)(2008-11#2)(2013-1#1)
birth weight newborns##2##3##(1991-12#1)(2013-1#1)
birth weight of##5##3##(1995-9#1)(2010-2#1)(2012-12#1)(2012-3#2)
birth weight was##2##3##(1992-2#1)(2007-12#1)
birth weight##64##2##(1991-11#1)(1991-12#6)(1991-6#1)(1992-2#2)(1993-12#1)(1993-3#2)(1994-3#1)(1995-12#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-6#1)(2007-12#2)(2008-10#1)(2008-11#7)(2008-12#4)(2008-4#1)(2010-2#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#1)
birth weights##8##2##(1990-8#1)(1991-12#1)(1994-6#2)(1997-7#2)(2008-11#2)
birth were##3##2##(1991-6#1)(1995-6#1)(2009-11#1)
birth##432##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#6)(1990-7#2)(1990-8#3)(1990-9#6)(1991-11#3)(1991-12#8)(1991-2#1)(1991-6#4)(1992-10#1)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#3)(1993-3#7)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#8)(1994-6#2)(1994-7#4)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#6)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#8)(1996-6#2)(1996-8#3)(1996-9#1)(1997-2#6)(1997-5#1)(1997-6#8)(1997-7#9)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#23)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#22)(2008-12#11)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#4)(2009-10#8)(2009-11#8)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#14)(2011-2#14)(2012-1#2)(2012-12#22)(2012-2#15)(2012-3#15)(2013-1#27)(2013-8#4)
birth)##7##1##(1992-2#1)(1993-6#1)(1994-8#1)(1995-12#2)(1997-2#1)(2007-11#1)
birth?##4##1##(2006-9#1)(2008-7#1)(2013-1#2)
birthday##10##1##(1990-8#1)(1992-5#1)(1995-3#1)(1997-6#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)
birthing##4##1##(1994-1#1)(1996-12#1)(2009-6#1)(2013-1#1)
birthmarks##2##1##(2007-12#1)(2009-4#1)
birthplace of##2##2##(1994-6#1)(2008-11#1)
births and deaths##4##3##(2008-11#1)(2008-9#1)(2012-12#2)
births and##7##2##(1994-3#1)(1995-6#2)(2008-11#1)(2008-9#1)(2012-12#2)
births has##2##2##(1990-6#1)(1991-3#1)
births in the##2##3##(1992-4#1)(2012-12#1)
births in##3##2##(1992-4#1)(1995-2#1)(2012-12#1)
births was##2##2##(1995-6#1)(2013-1#1)
births were##2##2##(1995-6#1)(2008-11#1)
births##61##1##(1990-12#1)(1990-6#4)(1990-9#1)(1991-11#2)(1991-3#5)(1992-4#1)(1994-3#3)(1995-12#2)(1995-2#1)(1995-6#7)(1997-2#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#5)(2012-1#1)(2012-12#7)(2013-1#8)
birthweight and##2##2##(1992-11#2)
birthweight##15##1##(1992-11#3)(1992-2#2)(1993-3#2)(1997-2#1)(2007-11#1)(2007-2#2)(2008-1#1)(2010-10#2)(2010-5#1)
bis##2##1##(1992-6#1)(2008-10#1)
bis(2##8##1##(1990-8#1)(2008-10#7)
bis(2-ethylhexyl) sebacate (DOS)##2##3##(2008-10#2)
bis(2-ethylhexyl)##3##1##(2008-10#2)(2010-5#1)
bis(2-ethylhexyl)sebacate (DOS) as##2##3##(2008-10#2)
bis(2-ethylhexyl)sebacate (DOS)##3##2##(2008-10#3)
bis(2-nitrophenyl)disulfide##2##1##(2008-10#2)
bis(heptamethine cyanine)##2##2##(2008-10#2)
bis(sulfosuccinimidyl)##2##1##(1992-2#2)
bis(tetrabutylammonium)##3##1##(1996-2#3)
bis(trimethylsilyl)trifluoroacetamide##2##1##(2008-10#2)
bis- and trisphosphates##2##3##(1997-1#2)
bis- and##3##2##(1997-1#2)(2008-10#1)
bis-##4##1##(1990-7#1)(1997-1#2)(2008-10#1)
bis-benzimidazoles##2##1##(2007-11#2)
bis-cyanines##2##1##(2008-10#2)
bis[4-(1##2##1##(2008-10#2)
bis[4-N-(1-aza-4##2##1##(2008-10#2)
bisbenzofuran-2-yl-methanone##2##1##(2007-11#2)
bisbenzospiropyran##3##1##(2009-7#3)
biscuit##2##1##(2008-1#1)(2008-10#1)
biscuits##2##1##(2008-10#1)(2012-1#1)
bisected##2##1##(1993-11#1)(1994-5#1)
bisection task##2##2##(1995-12#1)(2009-10#1)
bisection##6##1##(1995-12#1)(2008-2#1)(2009-10#4)
bisector##2##1##(2008-2#1)(2008-3#1)
bisexual men##9##2##(1991-11#1)(1992-2#1)(2008-12#2)(2013-7#5)
bisexual##30##1##(1991-11#1)(1992-2#1)(2008-12#17)(2009-5#2)(2009-7#1)(2010-3#1)(2010-8#2)(2013-7#5)
bismuth and selenium in##2##4##(2008-10#2)
bismuth and selenium##3##3##(2008-10#3)
bismuth and##5##2##(1993-9#1)(2008-10#4)
bismuth by##2##2##(2008-10#2)
bismuth cysteine##2##2##(2010-11#2)
bismuth determination in##2##3##(2008-10#2)
bismuth determination##3##2##(2008-10#3)
bismuth film electrode (BiFE)##2##4##(2008-10#2)
bismuth film electrode##5##3##(2008-10#5)
bismuth film electrodes##3##3##(2008-10#3)
bismuth film##12##2##(2008-10#12)
bismuth glutathione##2##2##(2010-11#2)
bismuth subcitrate##3##2##(2008-10#1)(2010-11#2)
bismuth was##3##2##(2008-10#3)
bismuth were##4##2##(2008-10#4)
bismuth##90##1##(1993-9#1)(2007-11#2)(2007-12#2)(2008-10#67)(2008-2#1)(2008-3#2)(2009-11#1)(2010-11#9)(2013-1#3)(2013-8#2)
bismuth(III) complexes##2##2##(2007-11#1)(2008-10#1)
bismuth(III) was##2##2##(2008-10#2)
bismuth(III)##16##1##(2007-11#1)(2008-10#15)
bismuth-film electrode##3##2##(2008-10#3)
bismuth-film##4##1##(2008-10#4)
bismuthine##2##1##(2008-10#2)
bisoprolol##2##1##(2008-10#2)
bisoxabenzonorbornadienes##2##1##(2008-8#2)
bispecific antibodies##2##2##(2009-2#1)(2013-8#1)
bispecific antibody##6##2##(1994-3#6)
bispecific##11##1##(1994-2#2)(1994-3#7)(2009-2#1)(2013-8#1)
bispectral index##3##2##(2010-8#1)(2012-12#2)
bisphenol A (BPA)##4##3##(2008-10#3)(2009-8#1)
bisphenol A and malachite green##2##5##(2010-5#2)
bisphenol A and##3##3##(2008-10#1)(2010-5#2)
bisphenol A##16##2##(2008-10#8)(2009-8#2)(2010-12#1)(2010-5#3)(2012-2#1)(2013-1#1)
bisphenol S derivative compounds##3##4##(2013-1#3)
bisphenol S##9##2##(2013-1#9)
bisphenol##29##1##(2008-10#11)(2008-4#1)(2009-8#2)(2010-12#1)(2010-5#3)(2012-2#1)(2013-1#10)
bisphosphate##5##1##(1993-8#1)(1994-9#1)(2008-8#2)(2009-10#1)
bisphosphonate drugs##2##2##(2012-1#2)
bisphosphonate therapy##14##2##(2007-11#6)(2008-11#2)(2008-7#4)(2012-12#1)(2012-3#1)
bisphosphonate##30##1##(1993-11#1)(1995-3#1)(2007-11#9)(2008-11#5)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2010-3#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
bisphosphonate-related osteonecrosis of the##2##4##(2012-12#2)
bisphosphonates administration##2##2##(2007-11#2)
bisphosphonates and##2##2##(2008-8#1)(2011-1#1)
bisphosphonates can##2##2##(2008-7#1)(2012-12#1)
bisphosphonates have##4##2##(2008-8#2)(2010-4#2)
bisphosphonates in##4##2##(1993-11#2)(2007-11#1)(2010-4#1)
bisphosphonates or##2##2##(2007-11#1)(2008-8#1)
bisphosphonates that##2##2##(1993-11#1)(2008-7#1)
bisphosphonates was##3##2##(2007-11#2)(2010-1#1)
bisphosphonates##45##1##(1993-11#3)(1996-11#1)(2007-11#11)(2008-11#3)(2008-5#1)(2008-7#6)(2008-8#5)(2009-12#1)(2010-1#1)(2010-3#5)(2010-4#4)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
bisporus##7##1##(1997-1#2)(2008-10#4)(2011-1#1)
bisquinolines##7##1##(1992-6#7)
bissettii##3##1##(2010-6#3)
bistability of##2##2##(2007-11#1)(2008-3#1)
bistability##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
bistable states##3##2##(2007-12#2)(2008-7#1)
bistable##9##1##(2007-12#5)(2008-3#2)(2008-7#1)(2010-12#1)
bistatic and monostatic##2##3##(2008-3#2)
bistatic##7##1##(2008-3#7)
bisubstrate##2##1##(1990-8#1)(1995-5#1)
bisulfite##3##1##(1992-12#1)(1994-9#1)(1997-4#1)
bisulphate was##2##2##(2008-10#2)
bisulphate##5##1##(2008-10#5)
bit error rate##6##3##(2007-12#1)(2008-3#5)
bit error##8##2##(2007-12#1)(2008-3#7)
bit errors##2##2##(2007-11#1)(2008-3#1)
bit of##4##2##(1990-9#1)(2007-12#1)(2008-10#1)(2011-1#1)
bit rate##2##2##(2007-11#1)(2008-2#1)
bit##41##1##(1990-9#1)(1996-2#1)(1996-5#2)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#14)(2009-6#1)(2011-1#3)(2012-3#3)(2013-8#2)
bit-error rate (BER)##2##3##(2007-11#1)(2008-2#1)
bit-error rate is##3##3##(2008-2#1)(2008-3#2)
bit-error rate of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
bit-error rate##19##2##(2007-11#4)(2007-12#3)(2008-2#8)(2008-3#4)
bit-error##21##1##(2007-11#4)(2007-12#4)(2008-2#9)(2008-3#4)
bit-error-rate##3##1##(2007-12#1)(2008-3#2)
bit-oriented##3##1##(2008-3#3)
bit-parallel##3##1##(2008-3#3)
bit-to-bit##2##1##(2007-12#1)(2008-3#1)
bite in##2##2##(2009-7#1)(2010-9#1)
bite of##4##2##(1991-2#1)(2008-7#1)(2010-1#2)
bite##30##1##(1991-2#1)(1996-11#4)(1996-2#1)(1996-5#1)(2007-12#3)(2007-2#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-1#3)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
bites and##2##2##(2007-2#1)(2008-1#1)
bites are##2##2##(2011-1#2)
bites in##3##2##(2011-1#2)(2013-8#1)
bites occurred##2##2##(1996-11#2)
bites##29##1##(1991-6#1)(1996-11#4)(1996-3#1)(2006-5#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-4#3)(2008-8#1)(2011-1#6)(2011-2#1)(2013-8#6)
bithorax complex##2##2##(2012-3#2)
biting preferences##2##2##(2010-1#2)
biting##10##1##(1996-5#3)(2008-5#1)(2008-7#1)(2010-1#3)(2012-12#2)
bits and##2##2##(2008-3#1)(2008-4#1)
bits of##2##2##(2008-2#1)(2008-3#1)
bits##16##1##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
bitten##3##1##(1996-11#1)(2010-1#1)(2012-12#1)
bitter almond##4##2##(2013-8#4)
bitter rot##5##2##(2008-10#5)
bitter taste##3##2##(2008-9#1)(2010-5#2)
bitter##21##1##(2008-10#8)(2008-5#1)(2008-9#1)(2010-5#3)(2013-1#1)(2013-8#7)
bitterling##7##1##(2008-5#2)(2010-8#5)
bitterness##3##1##(1996-8#1)(2011-2#2)
bitumen-in-water emulsion##2##2##(2008-10#2)
biuret assay##2##2##(2008-10#2)
biuret##10##1##(1990-8#2)(2008-10#6)(2008-9#1)(2009-8#1)
bivalent ligands##2##2##(2013-1#2)
bivalent metal ions##2##3##(2008-10#2)
bivalent##14##1##(1990-7#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2013-1#3)
bivalents##9##1##(2008-5#6)(2008-9#2)(2009-12#1)
bivalirudin##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
bivalve##8##1##(1997-4#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-8#1)(2012-1#1)(2013-7#1)
bivalves##4##1##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
bivalvia##2##1##(2008-12#2)
bivariate analyses##2##2##(1995-1#1)(2009-4#1)
bivariate analysis##9##2##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#4)
bivariate and multivariate##2##3##(2009-4#1)(2012-3#1)
bivariate and##3##2##(1994-11#1)(2009-4#1)(2012-3#1)
bivariate correlation##2##2##(2008-10#2)
bivariate regression##2##2##(2010-5#1)(2011-2#1)
bivariate response##3##2##(1997-7#3)
bivariate##36##1##(1994-11#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#3)(1997-7#3)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-9#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)
biventricular##5##1##(2007-8#2)(2008-10#1)(2008-12#1)(2011-2#1)
biweekly##4##1##(2008-10#2)(2008-6#1)(2013-1#1)
bizarre and##2##2##(1996-11#1)(2009-10#1)
bizarre##12##1##(1992-3#1)(1992-4#1)(1993-9#1)(1995-12#1)(1996-11#1)(1997-5#1)(2008-1#1)(2009-10#2)(2010-3#1)(2011-1#1)(2011-2#1)
bizelesin##4##1##(1993-11#4)
bjoerkna##2##1##(2012-2#2)
blLAP with##2##2##(1992-5#2)
blLAP##5##1##(1992-5#5)
black African##2##2##(1991-11#1)(2008-1#1)
black Americans##2##2##(1996-12#1)(2011-2#1)
black T##2##2##(2008-10#2)
black and Hispanic##3##3##(1994-9#1)(2011-2#2)
black and non-black##2##3##(2009-5#2)
black and pu-erh teas##2##4##(2008-10#2)
black and red stripes##2##4##(2011-2#2)
black and red##3##3##(2011-2#3)
black and white##5##3##(1993-3#1)(1995-12#1)(2011-2#3)
black and##18##2##(1993-3#1)(1994-9#1)(1995-12#1)(2008-10#2)(2009-5#2)(2011-2#10)(2012-3#1)
black bean aphid##2##3##(2009-8#2)
black beneficiaries were##2##3##(1995-2#2)
black beneficiaries##3##2##(1995-2#3)
black box##4##2##(1995-12#1)(2008-11#1)(2009-10#2)
black box&quot##3##2##(1991-1#1)(2008-3#1)(2012-3#1)
black carbon##9##2##(2008-3#9)
black coated microdisk electrodes##2##4##(2008-10#2)
black currant##5##2##(1994-2#3)(2008-10#2)
black fathers##4##2##(2010-3#4)
black female##4##2##(1992-9#1)(1994-12#1)(2010-10#1)(2012-12#1)
black hole##2##2##(2012-2#1)(2013-1#1)
black in##3##2##(1995-6#1)(2008-10#2)
black leading edges stimulated an ETR##2##6##(2011-2#2)
black macule##3##2##(2010-6#3)
black male employment##2##3##(2009-9#2)
black male##4##2##(2009-9#4)
black on pink##2##3##(2008-10#2)
black patients with##2##3##(1995-12#2)
black patients##5##2##(1993-9#1)(1995-12#3)(2006-10#1)
black porgy##4##2##(2008-7#4)
black race##2##2##(2011-2#1)(2012-2#1)
black root##2##2##(2008-10#2)
black rot in##2##3##(2008-10#2)
black rot is##2##3##(2008-10#2)
black rot of##2##3##(2008-10#2)
black rot symptoms##2##3##(2008-10#2)
black rot##19##2##(2008-10#19)
black salsify##2##2##(2008-10#2)
black sand##3##2##(2008-3#3)
black scurf##2##2##(2008-10#1)(2008-12#1)
black seed##5##2##(2008-12#4)(2011-2#1)
black shale samples##2##3##(2008-10#2)
black shank##2##2##(2008-10#2)
black spot##3##2##(2008-10#3)
black spruce##2##2##(2008-10#2)
black tea on the##2##4##(2009-8#2)
black tea##12##2##(2008-10#2)(2008-11#3)(2009-8#7)
black tooth stains##4##3##(2013-1#4)
black women##6##2##(2013-1#6)
black##242##1##(1990-6#2)(1991-1#2)(1991-11#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-9#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-6#3)(1996-12#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#72)(2008-11#6)(2008-12#6)(2008-3#26)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#9)(2009-9#5)(2010-10#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#1)(2011-2#19)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#1)
black-box##3##1##(2008-11#3)
black-pigmented##2##1##(2008-3#1)(2013-1#1)
black-rotted fruit##2##2##(2008-10#2)
black-spot development and fruit softening##2##5##(2008-10#2)
black-spot symptoms##2##2##(2008-10#2)
black-spot##4##1##(2008-10#4)
black-white discrimination##3##2##(1993-5#2)(1996-5#1)
blackberry (Rubus##2##2##(2008-10#2)
blackberry##4##1##(2008-10#4)
blackbody##10##1##(2008-2#5)(2008-3#5)
blackcurrant##4##1##(2012-4#4)
blackish##2##1##(2008-1#1)(2008-5#1)
blackleg disease##3##2##(2008-10#2)(2011-10#1)
blackleg of##2##2##(2008-10#2)
blackleg##6##1##(2008-10#5)(2011-10#1)
blacklight##2##1##(2008-10#2)
blacks and whites##3##3##(1993-3#1)(2007-10#1)(2010-2#1)
blacks and##5##2##(1993-3#1)(2007-10#1)(2010-2#1)(2010-3#1)(2011-2#1)
blacks##16##1##(1992-8#1)(1993-3#1)(1995-11#3)(1995-12#1)(2007-10#1)(2009-9#3)(2010-2#1)(2010-3#2)(2011-2#3)
bladder and kidney##2##3##(1991-8#2)
bladder and periurethral skeletal muscle##2##5##(1997-7#2)
bladder and prostate##2##3##(2011-1#1)(2011-2#1)
bladder and urethra##3##3##(1997-7#3)
bladder and##27##2##(1991-8#3)(1993-3#1)(1995-12#2)(1996-12#1)(1997-7#5)(2007-9#1)(2008-10#4)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#6)
bladder are##2##2##(2008-10#2)
bladder associated with##3##3##(2008-7#2)(2009-2#1)
bladder augmentation##2##2##(2008-10#2)
bladder cancer and##3##3##(1991-8#1)(1995-12#2)
bladder cancer cells##4##3##(1990-12#2)(2013-8#2)
bladder cancer patients##3##3##(2008-4#1)(2013-8#2)
bladder cancer##51##2##(1990-12#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-9#3)(1995-12#2)(1995-8#1)(1997-4#1)(2007-10#5)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-7#2)(2009-4#3)(2009-9#1)(2011-2#4)(2013-1#1)(2013-8#10)
bladder capacity and##2##3##(1990-5#1)(2008-3#1)
bladder capacity##5##2##(1990-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2013-8#1)
bladder carcinogenesis##3##2##(1992-3#1)(2007-10#1)(2012-1#1)
bladder carcinoma cell##2##3##(2008-4#2)
bladder carcinoma##9##2##(1990-12#1)(1990-6#1)(1993-9#2)(2007-10#1)(2007-7#2)(2008-4#2)
bladder cases##3##2##(2008-10#3)
bladder contractions##7##2##(1992-3#3)(1995-12#2)(2008-7#2)
bladder control##3##2##(2007-2#1)(2008-10#1)(2012-2#1)
bladder dermoid##2##2##(2009-7#2)
bladder diverticulum in##3##3##(2008-10#1)(2011-2#2)
bladder diverticulum##4##2##(2008-10#1)(2011-2#3)
bladder drainage##2##2##(1995-2#1)(2011-2#1)
bladder duplication with exstrophy of one moiety##3##7##(2008-10#3)
bladder dysfunction##2##2##(2008-10#1)(2008-12#1)
bladder endometriosis##2##2##(2010-12#2)
bladder epithelium##3##2##(1991-9#1)(1992-3#2)
bladder exstrophy##16##2##(2008-10#15)(2011-2#1)
bladder function##4##2##(1992-12#1)(1992-3#1)(2007-7#1)(2008-3#1)
bladder in a##3##3##(2008-10#2)(2010-11#1)
bladder in children##3##3##(2008-10#3)
bladder in##13##2##(1997-2#1)(2007-10#2)(2008-10#5)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#2)
bladder injury##2##2##(1995-1#1)(1996-2#1)
bladder is a##5##3##(1992-12#1)(2008-10#1)(2009-7#1)(2010-12#1)(2013-1#1)
bladder is##6##2##(1992-12#1)(2008-10#1)(2009-7#2)(2010-12#1)(2013-1#1)
bladder neck contractures##2##3##(2013-8#2)
bladder neck##6##2##(2008-10#3)(2013-8#3)
bladder necrosis##2##2##(2008-10#1)(2011-2#1)
bladder of the##2##3##(1992-12#1)(2008-10#1)
bladder of##6##2##(1992-12#1)(2007-7#2)(2008-10#2)(2012-2#1)
bladder or##5##2##(1990-5#1)(1996-12#1)(2009-5#1)(2010-3#1)(2011-2#1)
bladder outflow obstruction##4##3##(1991-11#1)(2008-10#3)
bladder outlet obstruction##3##3##(2008-10#2)(2011-2#1)
bladder outlet##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
bladder overactivity##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
bladder preservation##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
bladder smooth muscle##5##3##(1994-8#4)(2008-10#1)
bladder sonography##3##2##(2012-12#3)
bladder stones##2##2##(1994-5#1)(2008-10#1)
bladder tissue##5##2##(1994-2#2)(2007-12#1)(2009-2#1)(2012-2#1)
bladder tissues##3##2##(1994-2#3)
bladder tumor##2##2##(2007-10#1)(2008-10#1)
bladder tumors##7##2##(1992-1#1)(1994-2#3)(2007-10#2)(2008-1#1)
bladder tumour##3##2##(2008-10#1)(2012-12#2)
bladder tumours are##2##3##(1991-6#1)(2008-10#1)
bladder tumours can be##2##4##(1991-9#2)
bladder tumours##13##2##(1991-6#8)(1991-9#2)(2008-10#1)(2011-2#1)(2012-12#1)
bladder voiding##2##2##(1990-5#2)
bladder volumes##3##2##(1992-11#2)(2008-7#1)
bladder wall to discharge its##2##5##(2009-7#2)
bladder wall##7##2##(1992-12#3)(1993-11#1)(2009-7#3)
bladder was##7##2##(1992-3#1)(1993-2#1)(1997-7#3)(2008-10#1)(2012-12#1)
bladder were##3##2##(1992-11#1)(1992-12#1)(1993-9#1)
bladder with##2##2##(2008-10#1)(2008-7#1)
bladder without cutaneous hemangiomatosis##2##4##(2008-10#2)
bladder##408##1##(1990-12#3)(1990-5#7)(1990-6#1)(1990-8#3)(1991-11#4)(1991-5#1)(1991-6#11)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#6)(1992-12#10)(1992-3#11)(1992-5#1)(1992-6#2)(1993-11#2)(1993-2#6)(1993-3#1)(1993-8#1)(1993-9#8)(1994-2#9)(1994-3#2)(1994-5#1)(1994-8#5)(1995-1#1)(1995-12#6)(1995-2#1)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#1)(1997-2#2)(1997-4#5)(1997-7#9)(1997-8#1)(2007-10#13)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#6)(2007-9#3)(2008-1#2)(2008-10#95)(2008-11#3)(2008-12#6)(2008-3#3)(2008-4#9)(2008-5#1)(2008-7#12)(2008-8#1)(2009-11#3)(2009-2#4)(2009-4#4)(2009-5#5)(2009-7#8)(2009-9#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#30)(2012-1#4)(2012-12#11)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#17)
bladder)##2##1##(1991-11#1)(2013-8#1)
bladders##4##1##(1991-11#1)(2008-1#1)(2008-10#2)
blade bevel angle##2##3##(2008-12#2)
blade impeller##2##2##(2008-6#2)
blade##20##1##(2008-10#3)(2008-12#5)(2008-5#3)(2008-6#2)(2009-12#3)(2012-1#2)(2013-1#2)
blade's impeller##2##2##(2008-6#2)
blade's##3##1##(2008-5#1)(2008-6#2)
blade)##2##1##(1990-7#2)
blades and##2##2##(1992-1#1)(2008-5#1)
blades##9##1##(1992-1#3)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
blame##5##1##(1994-1#1)(1994-12#1)(1996-3#1)(1997-8#1)(2007-12#1)
blamed##4##1##(1990-3#1)(1991-6#1)(1996-5#1)(2008-10#1)
blaming##2##1##(1993-3#1)(2008-9#1)
blank and##3##2##(2008-10#2)(2012-3#1)
blank determination##2##2##(2008-10#1)(2008-5#1)
blank levels##3##2##(2008-10#3)
blank measurements##3##2##(2008-10#3)
blank of the##2##3##(2008-10#2)
blank of##4##2##(2008-10#4)
blank samples##2##2##(2008-10#2)
blank signal##8##2##(2008-10#8)
blank solution##4##2##(2008-10#4)
blank values##4##2##(2008-10#4)
blank was##6##2##(2008-10#6)
blank##86##1##(1990-5#1)(1992-3#1)(1992-9#2)(2007-12#1)(2008-10#74)(2008-12#1)(2008-5#1)(2008-9#2)(2010-5#1)(2012-12#1)(2012-3#1)
blank)##8##1##(2008-10#8)
blanket##3##1##(1992-3#2)(2010-8#1)
blanks are##2##2##(2008-10#2)
blanks of##3##2##(2008-10#3)
blanks##12##1##(1995-6#1)(2008-10#11)
blast and##3##2##(2008-10#3)
blast caused by Magnaporthe grisea##2##5##(2008-10#1)(2009-10#1)
blast caused by Magnaporthe##3##4##(2008-10#1)(2009-10#1)(2012-2#1)
blast caused by##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
blast cells##5##2##(1995-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#1)
blast control##2##2##(2008-10#2)
blast epidemic##2##2##(2008-10#2)
blast formation of##2##3##(1995-12#2)
blast fungus isolate##2##3##(2008-10#2)
blast fungus##8##2##(2008-10#8)
blast in##5##2##(2008-10#4)(2012-2#1)
blast infection##2##2##(2008-10#2)
blast on##2##2##(2008-10#2)
blast pathogen##3##2##(2008-10#3)
blast proliferation##3##2##(2006-6#3)
blast resistance gene##2##3##(2008-10#2)
blast resistance genes##3##3##(2008-10#3)
blast resistance##11##2##(2008-10#10)(2009-10#1)
blast severity was##2##3##(2008-10#2)
blast severity##4##2##(2008-10#4)
blast than##2##2##(2008-10#2)
blast##107##1##(1995-12#3)(1997-4#1)(2006-6#6)(2007-12#1)(2008-10#79)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2009-10#3)(2011-2#2)(2012-2#4)(2013-8#1)
blasticidin##2##1##(1995-11#1)(2008-10#1)
blastocyst biopsy##2##2##(2012-3#2)
blastocyst development##3##2##(2008-9#3)
blastocyst stage in##2##3##(2008-11#1)(2008-5#1)
blastocyst stage##6##2##(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#2)(2013-1#1)
blastocyst##29##1##(1992-2#1)(1993-6#2)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-9#11)(2012-3#4)(2013-1#1)
blastocysts derived in the serum-supplemented medium##2##6##(2008-11#2)
blastocysts derived in##3##3##(2008-11#3)
blastocysts in##2##2##(1996-8#1)(2013-8#1)
blastocysts##26##1##(1995-2#1)(1996-8#5)(1997-4#1)(1997-8#1)(2008-11#9)(2008-5#1)(2008-9#5)(2012-3#1)(2013-1#1)(2013-8#1)
blastoderm##3##1##(1993-9#1)(1994-8#1)(2007-12#1)
blastogenesis##3##1##(1997-6#2)(2008-10#1)
blastoma##2##1##(2008-10#2)
blastomeres from##2##2##(2008-4#2)
blastomeres##6##1##(1993-6#1)(2008-4#3)(2008-6#1)(2012-12#1)
blastomycosis##2##1##(2007-12#1)(2013-8#1)
blastospores were##3##2##(2008-10#3)
blastospores##5##1##(2008-10#4)(2012-3#1)
blasts in bone marrow aspirate##2##5##(2007-4#2)
blasts in##3##2##(2006-6#1)(2007-4#2)
blasts were##3##2##(2006-6#2)(2009-12#1)
blasts##16##1##(1991-2#1)(1995-2#2)(2006-6#5)(2007-4#2)(2008-10#3)(2008-4#1)(2009-12#1)(2011-2#1)
blastula##3##1##(1997-7#1)(2008-8#1)(2010-8#1)
blaze angle##4##2##(2008-2#3)(2008-3#1)
blazed diffraction##3##2##(2007-11#1)(2008-3#2)
blazed grating##6##2##(2008-3#6)
blazed gratings and##2##3##(2008-3#2)
blazed gratings##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
blazed##24##1##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#15)
blazed-grating##2##1##(2008-3#2)
bleach##4##1##(2008-10#4)
bleached hair##2##2##(2008-5#2)
bleached##6##1##(2008-10#1)(2008-3#2)(2008-5#2)(2009-8#1)
bleaching and##3##2##(2007-12#1)(2008-5#1)(2009-8#1)
bleaching event##2##2##(2008-9#1)(2012-2#1)
bleaching events##3##2##(2008-9#3)
bleaching has been##2##3##(2008-3#1)(2008-5#1)
bleaching in##2##2##(1996-2#1)(2007-12#1)
bleaching of the##2##3##(2007-12#1)(2008-5#1)
bleaching of##6##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
bleaching was##2##2##(2008-3#1)(2008-5#1)
bleaching##47##1##(1996-2#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#5)(2008-9#6)(2009-2#1)(2009-8#2)(2010-3#1)(2012-2#4)
blebbing and##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
blebbing##8##1##(1990-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-3#1)
blebs##3##1##(1990-7#1)(1995-12#1)(2008-7#1)
bled and##2##2##(2008-10#1)(2008-7#1)
bled##4##1##(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)
bleed and##2##2##(2008-10#1)(2011-2#1)
bleed##11##1##(1995-11#1)(1996-6#1)(2007-10#1)(2008-10#2)(2008-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
bleeding after##3##2##(1990-3#1)(2013-1#2)
bleeding and the##2##3##(2007-10#1)(2007-8#1)
bleeding and##25##2##(1990-9#2)(1993-9#1)(1995-6#1)(2006-10#1)(2007-10#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
bleeding are##3##2##(2007-12#1)(2010-12#1)(2010-8#1)
bleeding as##3##2##(2012-2#1)(2013-1#2)
bleeding by##2##2##(1994-9#1)(2012-2#1)
bleeding complications##7##2##(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#3)
bleeding diathesis##2##2##(2008-7#2)
bleeding disorder caused by##2##4##(1990-5#1)(2008-12#1)
bleeding disorders##5##2##(1997-7#2)(2008-11#1)(2008-7#1)(2011-2#1)
bleeding diverticulum##2##2##(1991-5#1)(2008-3#1)
bleeding due to angiodysplasia##2##4##(2007-8#1)(2012-2#1)
bleeding due to##3##3##(2007-8#1)(2012-12#1)(2012-2#1)
bleeding during##2##2##(2007-8#1)(2011-1#1)
bleeding esophageal varices##3##3##(2013-1#3)
bleeding esophageal##4##2##(2013-1#4)
bleeding from duodenal##2##3##(2007-8#1)(2011-2#1)
bleeding from the nidus##3##4##(2008-7#1)(2008-9#2)
bleeding from the##6##3##(2007-5#1)(2008-1#1)(2008-7#2)(2008-9#2)
bleeding from##18##2##(1991-5#1)(1991-6#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#3)
bleeding gastroduodenal ulcers##2##3##(2012-2#2)
bleeding had higher##2##3##(2011-1#2)
bleeding had##3##2##(2011-1#3)
bleeding in patients##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
bleeding in the##6##3##(1996-11#1)(2007-8#2)(2008-1#1)(2008-7#1)(2012-3#1)
bleeding in##27##2##(1992-11#1)(1995-11#1)(1995-9#1)(1996-11#2)(2006-10#1)(2007-8#5)(2008-1#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
bleeding index##4##2##(2008-12#2)(2011-2#2)
bleeding is common##3##3##(1994-9#1)(2008-7#1)(2011-2#1)
bleeding is##12##2##(1994-9#2)(2006-10#2)(2008-7#1)(2010-3#1)(2010-4#2)(2011-2#3)(2012-2#1)
bleeding made##2##2##(1992-12#1)(1996-11#1)
bleeding need##2##2##(1995-11#1)(2009-8#1)
bleeding occurred##2##2##(1992-6#1)(2012-2#1)
bleeding of##3##2##(1997-8#1)(2008-4#1)(2011-2#1)
bleeding or##7##2##(1993-8#1)(2007-8#3)(2008-7#1)(2009-12#1)(2009-8#1)
bleeding patterns in##2##3##(2011-2#2)
bleeding prevention##3##2##(2007-8#1)(2011-2#2)
bleeding profile##2##2##(2009-3#2)
bleeding rate##4##2##(1994-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
bleeding requiring##2##2##(1991-1#1)(1995-12#1)
bleeding risk##5##2##(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)
bleeding that##2##2##(1997-7#1)(2012-2#1)
bleeding time##3##2##(1990-12#1)(2007-10#1)(2008-9#1)
bleeding ulcer##2##2##(2008-10#1)(2012-2#1)
bleeding was the##2##3##(1991-12#1)(1997-8#1)
bleeding was##6##2##(1991-12#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
bleeding were##6##2##(1990-11#1)(1993-8#2)(1995-3#1)(2007-8#1)(2013-8#1)
bleeding who##3##2##(2009-6#1)(2011-2#1)(2013-1#1)
bleeding with##4##2##(1992-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
bleeding##334##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#3)(1991-6#4)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#4)(1992-6#5)(1993-12#1)(1993-8#3)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#5)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#4)(1996-8#1)(1997-3#1)(1997-7#3)(1997-8#3)(2006-10#6)(2006-12#2)(2007-10#9)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#27)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#19)(2008-8#9)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#5)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#7)(2011-2#47)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#16)(2012-3#9)(2013-1#25)(2013-7#1)(2013-8#6)
bleeding)##2##1##(2007-8#1)(2013-1#1)
bleedings##6##1##(1992-5#2)(1995-11#1)(2008-10#1)(2011-2#2)
bleeds##7##1##(1995-11#1)(1996-6#2)(2009-3#3)(2010-8#1)
blend of##5##2##(1993-1#1)(1993-12#1)(2008-10#1)(2009-8#2)
blend##26##1##(1993-1#1)(1993-12#2)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-7#1)(2009-7#2)(2009-8#4)(2010-11#1)(2010-4#3)(2013-8#1)
blended in##3##2##(2007-11#1)(2008-5#1)(2012-3#1)
blended with##3##2##(2008-12#1)(2008-5#1)(2009-7#1)
blended##13##1##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#5)(2009-7#1)(2012-3#1)(2013-1#1)
blending in##2##2##(2008-10#2)
blending the reagent##2##3##(2008-10#2)
blending the##3##2##(2008-10#2)(2008-5#1)
blending##16##1##(2008-1#1)(2008-10#9)(2008-5#2)(2008-6#1)(2009-7#2)(2010-5#1)
blending)##2##1##(2008-1#1)(2008-10#1)
blends by##2##2##(2008-10#1)(2008-2#1)
blends of##2##2##(2008-2#1)(2008-9#1)
blends##23##1##(2008-10#9)(2008-2#2)(2008-5#4)(2008-9#1)(2009-7#4)(2010-11#1)(2010-4#1)(2011-2#1)
bleomycin##5##1##(1990-12#1)(1992-11#1)(1993-3#1)(1995-10#1)(2009-11#1)
blessings##3##1##(2008-12#3)
blight (caused by##4##3##(2008-10#4)
blight and leaf##3##3##(2008-10#3)
blight and the##2##3##(2008-10#2)
blight and##19##2##(1992-8#1)(2008-10#15)(2008-9#1)(2009-10#2)
blight are##2##2##(2008-10#2)
blight caused by Xanthomonas##2##4##(2008-10#1)(2009-10#1)
blight caused by##5##3##(2008-10#3)(2009-10#1)(2009-6#1)
blight caused##6##2##(2008-10#4)(2009-10#1)(2009-6#1)
blight developed##3##2##(2008-10#3)
blight development in##2##3##(2008-10#2)
blight development##5##2##(2008-10#5)
blight disease of##2##3##(2008-10#2)
blight disease##8##2##(2008-10#7)(2008-8#1)
blight diseases##2##2##(2008-10#2)
blight epidemics in##2##3##(2008-10#2)
blight epidemics were##2##3##(2008-10#2)
blight epidemics##12##2##(2008-10#12)
blight forecasters##2##2##(2008-10#2)
blight fungus##5##2##(2008-10#4)(2008-9#1)
blight has##3##2##(2008-10#3)
blight in four of##2##4##(2008-10#2)
blight in##24##2##(2008-10#24)
blight infection##3##2##(2008-10#3)
blight is##5##2##(2008-10#5)
blight lesions##2##2##(2008-10#2)
blight management##2##2##(2008-10#2)
blight of barley##2##3##(2008-10#2)
blight of cassava##2##3##(2008-10#2)
blight of onion##4##3##(2008-10#4)
blight of pistachio##7##3##(2008-10#7)
blight of rice##3##3##(2008-10#3)
blight of##45##2##(2008-10#45)
blight on##4##2##(2008-10#4)
blight pathogen##11##2##(2008-10#10)(2008-8#1)
blight pathogens##2##2##(2008-10#2)
blight resistance gene##2##3##(2008-10#1)(2008-8#1)
blight resistance in##4##3##(2008-10#4)
blight resistance##13##2##(2008-10#10)(2008-8#3)
blight risk##2##2##(2008-10#2)
blight severity##9##2##(2008-10#9)
blight symptoms##3##2##(2008-10#3)
blight than##3##2##(2008-10#3)
blight was##11##2##(2008-10#11)
blight were##4##2##(2008-10#4)
blight would##2##2##(2008-10#2)
blight##350##1##(1992-8#1)(2008-10#335)(2008-8#6)(2008-9#3)(2009-10#3)(2009-6#1)(2011-10#1)
blight)##3##1##(2008-10#3)
blight-infected plants##2##2##(2008-10#2)
blight-resistant rice##2##2##(2008-10#2)
blighted blossoms##2##2##(2008-10#2)
blighted##8##1##(2008-10#8)
blind and##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
blind assessment##2##2##(1991-1#1)(2009-11#1)
blind chicks##4##2##(1990-11#4)
blind deconvolution method##3##3##(2008-3#3)
blind deconvolution##8##2##(2008-3#8)
blind elderly##3##2##(2008-7#3)
blind loop##3##2##(1991-9#3)
blind randomized clinical trial##2##4##(2011-2#1)(2012-3#1)
blind randomized##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
blind study was##2##3##(1990-3#1)(1994-11#1)
blind study##6##2##(1990-3#2)(1994-11#1)(1997-2#1)(2008-7#1)(2010-7#1)
blind trial and##2##3##(1995-11#1)(1997-1#1)
blind trial##6##2##(1990-5#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-5#1)
blind##85##1##(1990-11#5)(1990-3#2)(1990-5#3)(1991-1#1)(1991-5#1)(1991-9#3)(1992-11#1)(1993-1#1)(1994-11#2)(1994-8#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
blind&quot##2##1##(2008-10#1)(2008-11#1)
blinded fashion##2##2##(2007-10#1)(2008-5#1)
blinded to the##4##3##(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#1)
blinded to treatment##3##3##(1997-3#1)(2007-11#1)(2008-8#1)
blinded to##8##2##(1997-3#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2010-7#1)(2011-2#1)
blinded##27##1##(1992-2#1)(1994-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
blinding diseases##2##2##(2008-7#1)(2011-7#1)
blinding##9##1##(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#2)(2010-8#1)(2011-2#1)(2011-7#1)
blindly##2##1##(1996-5#1)(2007-12#1)
blindness among##2##2##(2010-2#1)(2012-12#1)
blindness in developed countries##2##4##(2008-1#1)(2011-2#1)
blindness in##7##2##(2008-1#1)(2008-5#1)(2010-10#1)(2011-1#2)(2011-2#2)
blindness##37##1##(1991-8#3)(1996-11#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#6)(2011-2#5)(2011-9#1)(2012-12#1)
blink##4##1##(1992-8#1)(2008-11#1)(2009-4#2)
blister rust epidemic##2##3##(2008-10#2)
blister rust fungus##2##3##(2008-10#2)
blister rust##23##2##(2008-10#23)
blister##31##1##(1990-2#1)(2006-10#2)(2008-10#25)(2008-11#1)(2008-2#1)(2011-2#1)
blistering and##2##2##(2008-10#1)(2012-3#1)
blistering##5##1##(1991-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
blisters##3##1##(1991-11#1)(1997-5#1)(2006-10#1)
bloating##6##1##(2008-10#4)(2008-6#1)(2013-1#1)
bloc mastoidectomy##2##2##(2008-7#2)
bloc resection##2##2##(2011-2#1)(2012-2#1)
bloc##11##1##(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#4)(2011-2#1)(2012-2#1)
block a##2##2##(2008-2#1)(2009-7#1)
block and facilitation##3##3##(2008-8#3)
block and##15##2##(1992-4#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#3)(2010-8#2)(2012-2#1)(2013-8#1)
block are sampled##2##3##(2008-10#2)
block are##3##2##(1992-5#1)(2008-10#2)
block as##2##2##(2007-11#1)(2008-7#1)
block by##3##2##(2008-8#2)(2010-7#1)
block calcium##2##2##(1992-12#1)(1993-6#1)
block caused by##2##3##(1995-11#1)(1996-3#1)
block copolymer##10##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2010-2#1)(2013-1#3)
block copolymers##6##2##(2008-10#1)(2008-7#1)(2009-9#2)(2010-2#2)
block design with##5##3##(2008-10#2)(2008-12#3)
block design##10##2##(2008-10#6)(2008-12#3)(2010-8#1)
block developed in 1##2##4##(2012-3#2)
block developed##3##2##(2008-8#1)(2012-3#2)
block for##7##2##(2007-11#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-12#2)(2012-2#1)
block grants##4##2##(1991-1#1)(1996-3#1)(1997-2#1)(1997-3#1)
block group##3##2##(2008-8#2)(2009-7#1)
block groups##2##2##(2008-8#2)
block in the##4##3##(1993-9#1)(1995-11#1)(1995-6#1)(2009-9#1)
block in##10##2##(1993-9#1)(1995-11#1)(1995-6#1)(2008-10#2)(2009-9#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)
block induced by##2##3##(1995-11#1)(2012-2#1)
block is##3##2##(2008-7#1)(2008-8#1)(2010-8#1)
block matching##2##2##(2012-2#2)
block objects##2##2##(2008-3#2)
block of hNa(v)1##2##3##(2008-8#2)
block of the##5##3##(1990-3#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-9#1)
block of##23##2##(1990-3#1)(1992-6#1)(1993-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-7#1)(2012-3#1)
block on##3##2##(2009-4#1)(2012-1#1)(2012-3#1)
block phase measures##2##3##(2011-2#2)
block phase##3##2##(1994-2#1)(2011-2#2)
block proliferation##2##2##(2011-1#1)(2012-3#1)
block radiography##4##2##(1997-8#4)
block the activity of the##2##5##(1996-2#1)(2009-4#1)
block the effects##2##3##(1994-11#1)(1995-12#1)
block the expression of##3##4##(1991-12#1)(1997-6#1)(2008-8#1)
block the growth##2##3##(1995-6#1)(1996-2#1)
block the induction of##2##4##(2008-8#1)(2012-2#1)
block the##39##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-11#2)(1994-8#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#4)(1996-2#3)(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2011-3#2)(2012-2#1)(2012-3#1)
block transmission of malaria##2##4##(1991-5#2)
block using##2##2##(2008-10#1)(2008-11#1)
block was##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
block with##5##2##(1996-5#1)(2008-10#1)(2008-7#1)(2012-12#2)
block##342##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-5#4)(1992-12#2)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#5)(1995-11#6)(1995-12#5)(1995-3#1)(1995-6#9)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#5)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#4)(1997-8#4)(2007-10#2)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#40)(2008-11#9)(2008-12#8)(2008-2#5)(2008-3#13)(2008-4#2)(2008-6#2)(2008-7#19)(2008-8#29)(2008-9#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#6)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#5)(2010-8#7)(2011-1#1)(2011-2#9)(2011-3#2)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#10)(2013-1#8)(2013-8#1)
block)##3##1##(1997-1#1)(2008-10#2)
blockade and##5##2##(1993-2#1)(1993-9#1)(1995-2#1)(2012-12#1)(2012-2#1)
blockade by##4##2##(1991-2#1)(1994-11#1)(2007-10#1)(2008-2#1)
blockade in##4##2##(1992-12#1)(2008-7#1)(2010-5#1)(2012-2#1)
blockade of dopamine##2##3##(1995-2#1)(1995-3#1)
blockade of hepatic##3##3##(2008-3#3)
blockade of nitric oxide##2##4##(1996-5#1)(2013-1#1)
blockade of the##6##3##(1996-2#1)(2006-6#1)(2008-8#2)(2012-2#1)(2013-1#1)
blockade of##35##2##(1990-5#2)(1991-2#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-5#2)(1997-7#1)(2006-6#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#3)
blockade on the##2##3##(1992-11#1)(1993-1#1)
blockade on##4##2##(1992-11#1)(1993-1#1)(1995-12#1)(2012-12#1)
blockade was##2##2##(1994-9#1)(2010-4#1)
blockade with##3##2##(1993-1#1)(1993-6#1)(2012-12#1)
blockade##94##1##(1990-5#2)(1991-2#2)(1991-7#1)(1992-11#1)(1992-12#2)(1993-1#3)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-9#2)(1995-12#4)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-7#3)(2006-6#1)(2007-10#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#3)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#7)
blockades##2##1##(2007-9#1)(2008-8#1)
blockage of the##4##3##(1992-8#1)(1995-12#1)(1997-2#1)(2011-2#1)
blockage of##10##2##(1990-12#1)(1992-8#1)(1994-8#2)(1995-12#1)(1997-2#1)(2011-2#2)(2011-3#1)(2013-1#1)
blockage##17##1##(1990-12#1)(1990-6#1)(1992-8#1)(1994-8#4)(1995-12#1)(1997-2#1)(2008-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
blocked at##2##2##(1995-6#1)(2008-1#1)
blocked both the##2##3##(1991-5#1)(1993-11#1)
blocked by 3##2##3##(2008-8#2)
blocked by DuP 714 with an IC50 value of##2##9##(1991-9#2)
blocked by a##6##3##(1992-9#1)(1994-9#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-7#1)
blocked by inhibitors of##2##4##(1994-8#1)(1994-9#1)
blocked by pretreatment with##3##4##(1993-6#1)(1997-6#1)(2012-2#1)
blocked by pretreatment##4##3##(1993-6#1)(1995-2#1)(1997-6#1)(2012-2#1)
blocked by specific##2##3##(1997-7#1)(2008-11#1)
blocked by strychnine##2##3##(1995-2#2)
blocked by the 5-HT1D##2##4##(1995-12#2)
blocked by the known##2##4##(2008-11#2)
blocked by the protein##2##4##(1995-6#1)(2010-7#1)
blocked by the##22##3##(1990-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-6#1)(1996-2#2)(1997-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2010-7#1)(2013-1#1)
blocked by##127##2##(1990-12#1)(1990-5#3)(1990-7#1)(1991-1#2)(1991-12#2)(1991-9#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#2)(1993-6#5)(1994-10#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#4)(1995-11#1)(1995-12#10)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#5)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2010-4#2)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
blocked each##2##2##(1994-2#1)(1995-5#1)
blocked in##9##2##(1990-11#1)(1990-5#1)(1993-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
blocked phenolic OH groups##2##4##(2008-10#2)
blocked the effect of##2##4##(1991-1#1)(1997-1#1)
blocked the increase in##3##4##(1990-7#1)(1992-12#1)(1994-8#1)
blocked the platelet aggregation##2##4##(1992-8#2)
blocked the##34##2##(1990-12#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-8#1)(1995-12#2)(1996-12#2)(1997-1#1)(1997-2#2)(2007-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
blocked vocalization##2##2##(2012-12#2)
blocked when##2##2##(1995-3#1)(2008-9#1)
blocked with##6##2##(1990-11#1)(1991-5#1)(1993-12#1)(1996-5#1)(2008-11#1)(2008-8#1)
blocked##257##1##(1990-11#4)(1990-12#3)(1990-3#1)(1990-5#7)(1990-7#3)(1991-1#3)(1991-12#3)(1991-5#4)(1991-9#3)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#7)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#10)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#9)(1994-9#4)(1995-11#1)(1995-12#14)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#6)(1995-8#2)(1996-12#8)(1996-2#4)(1996-5#4)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#4)(1997-7#7)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#13)(2008-9#4)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
blocker in##2##2##(2008-4#1)(2012-3#1)
blocker nifedipine##2##2##(1995-12#1)(1997-1#1)
blocker of##7##2##(1990-12#1)(1991-9#1)(1997-2#1)(1997-7#1)(2008-5#1)(2009-2#1)(2013-1#1)
blocker verapamil##2##2##(1991-12#1)(1991-8#1)
blocker##57##1##(1990-12#2)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-8#3)(1992-9#1)(1993-12#1)(1994-2#4)(1994-9#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#3)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#1)(2010-12#1)(2012-3#2)(2013-1#2)
blocker)##3##1##(1992-3#1)(2008-10#1)(2008-11#1)
blockers and##10##2##(1995-11#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2013-1#1)
blockers are##2##2##(1996-6#1)(2008-7#1)
blockers as##2##2##(1990-3#1)(2008-11#1)
blockers for##2##2##(1990-2#1)(1996-2#1)
blockers have been##2##3##(1995-2#1)(2012-3#1)
blockers in the treatment of##2##5##(2008-1#1)(2011-1#1)
blockers in##5##2##(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
blockers of the##2##3##(1990-7#1)(1992-3#1)
blockers of##4##2##(1990-7#1)(1992-3#1)(2008-8#1)(2009-3#1)
blockers on##3##2##(1990-7#1)(2009-6#1)(2013-8#1)
blockers such as verapamil and##2##5##(1993-3#1)(1994-8#1)
blockers such as##3##3##(1993-3#1)(1994-8#2)
blockers were##5##2##(1992-8#1)(1996-5#1)(2010-5#2)(2011-2#1)
blockers##94##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#1)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#5)(2008-1#2)(2008-10#4)(2008-11#9)(2008-3#2)(2008-7#8)(2008-8#7)(2009-3#1)(2009-6#4)(2010-5#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
blocking action##2##2##(1995-12#1)(1996-2#1)
blocking agent##4##2##(1996-12#1)(2008-4#1)(2008-9#1)(2011-1#1)
blocking agents##8##2##(1992-2#1)(1993-1#2)(1997-7#1)(2008-10#1)(2008-8#1)(2010-11#1)(2013-1#1)
blocking and##3##2##(1992-3#1)(2007-12#1)(2007-8#1)
blocking antibody##2##2##(1991-5#1)(2008-6#1)
blocking both##2##2##(2010-3#1)(2011-2#1)
blocking in##3##2##(1996-3#1)(2008-8#1)(2012-3#1)
blocking its##2##2##(1990-7#1)(2008-8#1)
blocking of the##2##3##(1993-2#1)(1993-3#1)
blocking of##10##2##(1990-12#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-12#1)
blocking reagents##2##2##(1990-12#1)(2008-10#1)
blocking the action##2##3##(1995-12#1)(2008-8#1)
blocking the interaction##2##3##(1995-2#1)(2008-5#1)
blocking the##18##2##(1993-6#1)(1995-12#1)(1995-2#2)(1997-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-3#1)(2013-1#1)
blocking this##2##2##(1994-2#1)(1995-2#1)
blocking##110##1##(1990-12#4)(1990-2#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#3)(1995-2#6)(1996-12#2)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
blocks and##10##2##(1991-9#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2012-1#1)
blocks are##3##2##(1995-6#1)(2008-4#1)(2008-6#1)
blocks binding##2##2##(1991-12#1)(1995-11#1)
blocks for##14##2##(1996-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
blocks from##2##2##(1997-8#1)(2008-5#1)
blocks in##6##2##(2008-10#2)(2008-4#1)(2008-8#2)(2012-3#1)
blocks is##2##2##(1992-1#1)(2008-3#1)
blocks of heterochromatin##2##3##(2008-12#2)
blocks of##20##2##(1992-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
blocks or##3##2##(2008-10#1)(2008-12#1)(2010-7#1)
blocks surrounding the##2##3##(2007-11#1)(2008-12#1)
blocks the mitogenic##2##3##(1990-12#1)(1994-12#1)
blocks the##15##2##(1990-12#2)(1990-8#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#2)(1996-2#1)(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
blocks to##2##2##(1997-6#1)(2012-3#1)
blocks were##3##2##(2007-8#1)(2008-3#1)(2013-1#1)
blocks with a##2##3##(2007-11#1)(2008-2#1)
blocks with##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
blocks##167##1##(1990-12#3)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#3)(1996-3#6)(1996-5#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-5#2)(2007-8#2)(2008-10#10)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#10)(2008-4#11)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#6)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
blocks)##5##1##(2007-10#1)(2007-11#2)(2010-11#1)(2013-1#1)
blood -##2##2##(2008-4#1)(2008-5#1)
blood LPA##2##2##(2011-2#2)
blood after##5##2##(1990-8#1)(1993-8#1)(2008-10#2)(2008-7#1)
blood agar##4##2##(1996-11#2)(2012-12#1)(2012-2#1)
blood alcohol concentration##3##3##(2011-2#2)(2013-1#1)
blood analysis##4##2##(2008-3#2)(2008-5#1)(2008-9#1)
blood and blood products##4##4##(2007-9#3)(2008-12#1)
blood and blood##5##3##(1993-11#1)(2007-9#3)(2008-12#1)
blood and body fluids##3##4##(1991-1#1)(2007-7#2)
blood and body##4##3##(1991-1#2)(2007-7#2)
blood and bone marrow##3##4##(1995-11#1)(2008-4#1)(2009-2#1)
blood and brain##7##3##(1997-7#2)(2008-10#4)(2009-12#1)
blood and in##3##3##(1992-5#1)(2008-2#1)(2008-7#1)
blood and lymphatic##3##3##(2008-9#1)(2010-7#1)(2011-2#1)
blood and meat quality parameters in growing and finishing pigs##2##10##(2010-2#2)
blood and plasma##4##3##(1996-5#1)(2008-10#1)(2008-2#2)
blood and saliva##2##3##(2008-10#1)(2013-1#1)
blood and that##2##3##(1991-3#1)(1994-3#1)
blood and the##2##3##(2008-10#1)(2010-8#1)
blood and tissue##3##3##(1992-3#1)(2008-5#1)(2012-3#1)
blood and urine##7##3##(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)(2012-3#1)
blood and##98##2##(1990-5#1)(1991-1#2)(1991-3#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-7#2)(2006-6#2)(2007-10#1)(2007-7#3)(2007-9#3)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#2)(2009-2#1)(2009-9#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
blood anticoagulated with##3##3##(2008-10#3)
blood antioxidant system##2##3##(2013-1#2)
blood are##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
blood as well as##2##4##(2008-7#1)(2008-9#1)
blood at trace##2##3##(2008-10#2)
blood at##4##2##(1990-8#1)(2008-10#2)(2008-11#1)
blood bags##3##2##(2007-7#2)(2008-10#1)
blood bank##6##2##(1991-7#4)(1992-12#1)(1995-6#1)
blood banking##3##2##(1994-9#1)(1995-6#1)(2011-2#1)
blood banks##5##2##(1995-6#3)(1996-1#1)(2011-2#1)
blood biochemical##2##2##(2012-12#1)(2013-1#1)
blood borne##2##2##(2009-5#1)(2012-12#1)
blood brain barrier##2##3##(2007-11#1)(2013-1#1)
blood by the##2##3##(1995-2#1)(2008-11#1)
blood by##15##2##(1990-12#1)(1995-2#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
blood can be##3##3##(2007-9#1)(2008-10#1)(2008-4#1)
blood can##5##2##(1996-1#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
blood cardioplegia##6##2##(1991-3#3)(1996-9#3)
blood cell and platelet counts##2##5##(2008-10#2)
blood cell count##9##3##(1991-6#2)(2007-12#1)(2008-10#1)(2008-7#2)(2011-2#2)(2013-1#1)
blood cell parameters##2##3##(1996-12#1)(2008-5#1)
blood cell##61##2##(1990-8#2)(1991-6#2)(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-8#1)(1996-12#2)(1996-7#2)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#5)
blood cells (WBC)##2##3##(1992-5#1)(2008-4#1)
blood cells and##8##3##(1991-8#1)(1993-9#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
blood cells as well as##2##5##(1990-12#1)(1994-8#1)
blood cells from##6##3##(1993-12#1)(1994-2#1)(1995-2#2)(1996-12#1)(2008-3#1)
blood cells in##5##3##(1996-9#1)(2008-10#1)(2008-9#2)(2012-2#1)
blood cells of##5##3##(1993-12#1)(1994-12#1)(1997-6#1)(2008-8#1)(2012-2#1)
blood cells or##2##3##(1991-11#1)(2008-7#1)
blood cells was##3##3##(1990-2#1)(1995-2#1)(2008-11#1)
blood cells with##3##3##(1990-12#1)(2008-11#1)(2008-9#1)
blood cells##141##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-11#3)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-2#5)(1995-3#1)(1995-5#1)(1996-12#3)(1996-7#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-10#18)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#11)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#8)(2009-11#5)(2009-2#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#1)
blood cells)##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
blood chemistry parameters##2##3##(2013-1#2)
blood chemistry##3##2##(2008-5#1)(2013-1#2)
blood cholesterol##3##2##(2008-1#2)(2008-7#1)
blood circuit##2##2##(2008-3#1)(2011-1#1)
blood circulation##9##2##(1993-11#1)(1993-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2010-3#1)(2013-8#2)
blood clots##4##2##(2008-10#1)(2010-5#1)(2013-1#1)(2013-7#1)
blood clotting##3##2##(1992-6#1)(2008-8#1)(2011-2#1)
blood coagulation and##2##3##(1991-6#1)(1992-12#1)
blood coagulation factor IX##2##4##(2008-7#1)(2008-8#1)
blood coagulation factor##4##3##(1992-12#1)(1993-11#1)(2008-7#1)(2008-8#1)
blood coagulation##22##2##(1990-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1993-11#2)(1993-3#1)(1995-2#1)(1995-6#1)(1997-4#2)(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
blood collected##2##2##(2008-12#1)(2008-5#1)
blood collection##4##2##(1994-9#1)(2008-10#1)(2010-6#2)
blood compatibility of rutile-type titanium oxide##2##6##(2008-8#2)
blood compatibility of##3##3##(2008-8#3)
blood component##3##2##(1990-11#1)(1995-2#1)(2008-12#1)
blood components and##3##3##(2008-4#2)(2010-7#1)
blood components##8##2##(1991-3#2)(2008-4#2)(2008-9#1)(2010-7#1)(2011-3#1)(2013-8#1)
blood concentration of##2##3##(2008-7#1)(2011-2#1)
blood concentration##4##2##(1991-3#1)(2008-7#1)(2011-2#2)
blood conservation in##3##3##(2007-9#2)(2010-7#1)
blood conservation##4##2##(1990-2#1)(2007-9#2)(2010-7#1)
blood containing##3##2##(2007-7#2)(2008-11#1)
blood cortisol##2##2##(2011-2#1)(2012-3#1)
blood could be##2##3##(2011-2#2)
blood count##9##2##(1990-9#1)(2007-8#1)(2008-10#3)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
blood counts##8##2##(1990-10#1)(2007-11#1)(2008-10#4)(2011-1#1)(2013-8#1)
blood culture system##2##3##(1990-9#1)(2011-1#1)
blood culture##20##2##(1990-11#1)(1990-9#1)(2008-5#1)(2010-12#4)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#8)
blood culture-positive##3##2##(2010-6#3)
blood cultures and##2##3##(2011-2#1)(2012-3#1)
blood cultures from##2##3##(2011-2#1)(2013-8#1)
blood cultures were##4##3##(2007-12#1)(2008-7#1)(2011-2#2)
blood cultures##22##2##(1997-7#1)(2007-12#2)(2007-8#1)(2008-7#1)(2010-12#4)(2010-6#5)(2011-1#1)(2011-2#5)(2012-3#1)(2013-8#1)
blood dendritic cells##2##3##(2008-4#1)(2008-9#1)
blood derived##2##2##(1997-8#1)(2008-5#1)
blood donation##12##2##(1992-2#1)(1994-3#1)(1996-1#1)(1996-9#4)(2007-9#3)(2008-12#1)(2009-3#1)
blood donations##2##2##(1991-7#1)(1994-9#1)
blood donor##6##2##(1993-12#1)(1994-12#2)(1994-3#1)(2008-10#1)(2009-3#1)
blood donors and##3##3##(1990-6#1)(1996-12#1)(2009-3#1)
blood donors from different regions##2##5##(1991-11#2)
blood donors from##3##3##(1991-11#2)(2012-12#1)
blood donors in##5##3##(1992-6#1)(1996-3#1)(2009-4#1)(2013-1#1)(2013-7#1)
blood donors were##2##3##(2008-11#1)(2011-2#1)
blood donors with##3##3##(1993-12#1)(2008-12#1)(2008-7#1)
blood donors##36##2##(1990-6#3)(1991-11#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-7#1)
blood drawn from##2##3##(1997-4#1)(2007-11#1)
blood draws##2##2##(2012-2#2)
blood drive donations##2##3##(2008-12#2)
blood drive##3##2##(2008-12#3)
blood drives##3##2##(2008-10#2)(2008-12#1)
blood during##3##2##(1990-6#1)(2007-11#1)(2010-7#1)
blood elements##2##2##(2008-4#1)(2010-12#1)
blood ethanol concentrations##2##3##(2008-11#2)
blood ethanol levels##2##3##(2008-11#2)
blood ethanol##4##2##(2008-11#4)
blood film##4##2##(1994-11#1)(1995-3#1)(2007-7#2)
blood films##3##2##(2006-6#1)(2007-7#2)
blood flow (CBF) in##2##4##(2008-12#1)(2008-7#1)
blood flow (CBF)##12##3##(1996-5#1)(1996-7#1)(2007-8#1)(2008-12#1)(2008-7#7)(2011-1#1)
blood flow and oxygen metabolism##3##5##(2006-7#1)(2007-10#2)
blood flow and tissue##2##4##(2008-10#1)(2009-11#1)
blood flow and##21##3##(1990-5#1)(1994-2#1)(1995-12#1)(1997-4#1)(2006-7#1)(2007-10#3)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
blood flow as##2##3##(2007-10#1)(2008-5#1)
blood flow at##4##3##(2008-3#1)(2008-7#1)(2011-2#2)
blood flow by##2##3##(2008-7#1)(2013-8#1)
blood flow can be##2##4##(2007-11#1)(2007-12#1)
blood flow changes in##2##4##(1995-2#1)(2007-10#1)
blood flow changes##6##3##(1990-7#1)(1995-2#1)(1996-6#1)(2007-10#1)(2007-7#1)(2011-1#1)
blood flow conditions##3##3##(1997-1#1)(2006-6#2)
blood flow during##3##3##(1995-12#1)(2007-8#1)(2008-7#1)
blood flow for##2##3##(2008-7#1)(2013-1#1)
blood flow from the##3##4##(1996-9#1)(2007-8#1)(2010-12#1)
blood flow in the##5##4##(1992-1#1)(1996-12#1)(2007-8#2)(2012-3#1)
blood flow in##22##3##(1992-1#1)(1992-6#2)(1994-9#1)(1995-5#3)(1996-12#1)(1996-5#3)(1996-6#1)(2007-10#3)(2007-12#2)(2007-8#2)(2008-4#1)(2012-2#1)(2012-3#1)
blood flow increase##3##3##(1996-2#1)(2008-2#2)
blood flow is##3##3##(2007-10#1)(2011-1#1)(2012-12#1)
blood flow measurements and##2##4##(2011-2#2)
blood flow measurements##5##3##(1995-8#1)(1996-6#1)(2011-1#1)(2011-2#2)
blood flow of##10##3##(2007-10#1)(2008-10#5)(2008-12#1)(2008-4#2)(2012-1#1)
blood flow responses during##2##4##(1995-2#1)(2011-1#1)
blood flow through the reproductive organs##2##6##(2008-12#2)
blood flow through the##6##4##(1997-1#1)(2008-12#4)(2009-11#1)
blood flow through##7##3##(1997-1#1)(2008-12#4)(2008-7#1)(2009-11#1)
blood flow to the##2##4##(2008-12#1)(2008-8#1)
blood flow to##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
blood flow velocity of the##2##5##(1996-3#1)(2008-3#1)
blood flow velocity were##2##4##(2013-1#2)
blood flow velocity##10##3##(1996-2#1)(1996-3#2)(2007-11#3)(2007-12#1)(2008-3#1)(2013-1#2)
blood flow was##6##3##(1995-5#1)(1996-2#1)(1996-5#1)(2008-5#1)(2008-7#1)(2011-1#1)
blood flow were measured##2##4##(2008-12#1)(2013-3#1)
blood flow were##3##3##(1990-7#1)(2008-12#1)(2013-3#1)
blood flow##227##2##(1990-3#2)(1990-5#2)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#5)(1992-8#1)(1994-2#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#7)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#9)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#5)(1997-4#1)(2006-6#2)(2006-7#1)(2007-10#16)(2007-11#8)(2007-12#7)(2007-7#3)(2007-8#8)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#20)(2008-8#4)(2008-9#2)(2009-11#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#10)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-3#1)(2013-8#5)
blood for##8##2##(1990-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)
blood from 3##2##3##(1996-2#1)(2008-10#1)
blood from a##2##3##(1990-12#1)(2012-12#1)
blood from the##2##3##(2008-4#1)(2013-1#1)
blood from##13##2##(1990-12#1)(1996-2#1)(2007-10#1)(2008-10#5)(2008-4#2)(2012-12#1)(2012-2#1)(2013-1#1)
blood gas analysis##3##3##(1997-3#1)(2010-10#1)(2011-2#1)
blood gas levels##2##3##(1997-3#1)(1997-7#1)
blood gas##11##2##(1990-8#1)(1994-7#1)(1997-3#3)(1997-7#1)(2008-10#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
blood gases##7##2##(1993-2#1)(1995-8#1)(1996-5#1)(2008-7#1)(2009-1#1)(2012-3#1)(2013-1#1)
blood glucose (BG)##2##3##(2009-11#1)(2009-9#1)
blood glucose and plasma##2##4##(2008-7#1)(2010-5#1)
blood glucose and##5##3##(1993-12#1)(2008-1#2)(2008-7#1)(2010-5#1)
blood glucose concentration##3##3##(1993-1#1)(2007-11#2)
blood glucose concentrations##3##3##(1990-5#1)(1993-1#1)(2013-8#1)
blood glucose control##3##3##(1990-8#1)(1991-2#1)(1993-12#1)
blood glucose level (BGL)##2##4##(2007-10#1)(2012-2#1)
blood glucose level in##2##4##(2009-11#1)(2011-1#1)
blood glucose level was##2##4##(2008-1#1)(2010-4#1)
blood glucose level##19##3##(1991-2#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-11#1)(2010-4#6)(2011-1#1)(2011-3#1)(2012-2#3)
blood glucose levels and##4##4##(2009-3#1)(2010-11#1)(2010-2#1)(2012-3#1)
blood glucose levels in##2##4##(2008-3#1)(2010-11#1)
blood glucose levels##19##3##(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2009-3#1)(2010-11#5)(2010-2#1)(2010-4#1)(2012-3#1)(2012-5#1)
blood glucose monitoring##3##3##(2007-10#1)(2010-2#2)
blood glucose of##2##3##(2010-2#1)(2012-2#1)
blood glucose##98##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1994-12#2)(1994-8#1)(1997-2#1)(2007-10#2)(2007-11#2)(2008-1#6)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#5)(2008-7#3)(2008-8#2)(2009-11#5)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#6)(2010-4#8)(2010-5#1)(2011-1#2)(2011-3#2)(2012-2#5)(2012-3#1)(2012-5#2)(2013-8#1)
blood group A##3##3##(1990-7#3)
blood group and##5##3##(1990-6#1)(1995-6#1)(2007-9#2)(2013-1#1)
blood group antibody##2##3##(1992-12#1)(2012-2#1)
blood group antigen##2##3##(1992-12#1)(1995-2#1)
blood group antigens in##2##4##(1993-12#1)(2012-2#1)
blood group antigens##8##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-8#2)(1995-6#1)(2012-2#1)
blood group system##7##3##(1992-12#2)(1994-12#1)(2012-2#2)(2013-1#2)
blood group##39##2##(1990-12#1)(1990-6#1)(1990-7#3)(1992-12#6)(1992-9#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(2007-7#1)(2007-9#2)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#6)(2012-3#1)(2013-1#3)
blood grouping and##3##3##(1992-12#1)(1992-6#1)(1994-6#1)
blood grouping reagents##2##3##(1993-12#2)
blood grouping##5##2##(1992-12#1)(1992-6#1)(1993-12#2)(1994-6#1)
blood groups##4##2##(1993-12#2)(2008-10#1)(2013-8#1)
blood in feces##2##3##(1990-8#1)(1991-3#1)
blood in the##10##3##(1990-2#1)(1993-3#1)(1996-5#1)(2008-1#1)(2009-1#1)(2010-11#1)(2010-8#2)(2011-2#1)(2013-8#1)
blood in##29##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-3#2)(1993-3#1)(1993-6#1)(1995-6#1)(1996-5#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
blood injection model##2##3##(2007-10#2)
blood into##2##2##(1990-12#1)(1994-9#1)
blood is a##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
blood is##20##2##(1991-11#1)(1991-2#1)(1992-4#1)(1992-5#1)(1994-3#1)(1995-11#1)(1996-9#2)(1997-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#2)(2010-5#1)
blood lactate concentration##2##3##(2013-8#2)
blood lactate##5##2##(2008-10#1)(2009-1#1)(2013-1#1)(2013-8#2)
blood lead##5##2##(1995-11#1)(1995-3#1)(1997-4#2)(2008-10#1)
blood leukocytes##6##2##(1992-6#1)(1996-2#2)(2008-10#1)(2009-6#1)(2013-1#1)
blood level of##2##3##(2007-7#1)(2012-1#1)
blood level##5##2##(1991-11#2)(2007-7#1)(2008-1#1)(2012-1#1)
blood levels above##2##3##(1994-8#1)(2008-1#1)
blood levels of CoQ10##2##4##(1991-5#1)(1993-3#1)
blood levels of##10##3##(1990-5#1)(1991-5#1)(1993-1#1)(1993-3#1)(2007-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
blood levels##18##2##(1990-5#2)(1991-1#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-8#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
blood lipid##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
blood lipids##8##2##(1994-11#1)(1997-5#1)(2008-1#1)(2008-5#1)(2011-2#3)(2013-8#1)
blood loss and##8##3##(1992-2#1)(1994-12#1)(1994-9#1)(1996-2#1)(2006-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
blood loss as##2##3##(1994-3#1)(2008-4#1)
blood loss due to##2##4##(1991-6#1)(2008-10#1)
blood loss during##5##3##(1993-1#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)
blood loss using##2##3##(1994-3#1)(2012-3#1)
blood loss was##6##3##(1992-2#1)(1996-9#1)(2007-8#1)(2008-10#2)(2011-2#1)
blood loss##67##2##(1991-6#2)(1992-2#2)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-9#2)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#2)(1997-8#1)(2006-12#3)(2007-8#5)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-3#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
blood lymphocyte##4##2##(1992-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
blood lymphocytes (PBL) from##2##4##(2008-9#1)(2013-1#1)
blood lymphocytes (PBL)##5##3##(1991-9#1)(1995-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
blood lymphocytes to##2##3##(1997-6#1)(2008-4#1)
blood lymphocytes##41##2##(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#3)(1993-8#2)(1994-3#1)(1994-6#1)(1995-12#3)(1997-3#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-11#8)(2008-4#2)(2008-9#7)(2010-12#2)(2013-1#1)
blood may##2##2##(2009-11#1)(2010-5#1)
blood metabolites##2##2##(2008-12#2)
blood monitoring##2##2##(2007-8#1)(2009-4#1)
blood monocytes of renal cancer patients##2##6##(1993-9#2)
blood monocytes##8##2##(1990-7#1)(1993-9#3)(2008-4#2)(2008-9#2)
blood mononuclear cells of##3##4##(1993-3#1)(2008-11#1)(2011-1#1)
blood mononuclear cells##35##3##(1990-2#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-6#2)(1995-2#1)(1995-3#4)(1997-2#1)(2008-10#3)(2008-11#6)(2008-4#6)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2011-3#1)
blood mononuclear##39##2##(1990-2#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-6#2)(1995-2#1)(1995-3#5)(1997-2#2)(1997-4#1)(2008-10#3)(2008-11#6)(2008-4#6)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#2)(2011-3#1)
blood neutrophil##3##2##(2008-7#1)(2013-1#2)
blood of a##3##3##(1994-7#1)(1996-9#1)(2008-7#1)
blood of the##3##3##(1993-12#1)(2007-7#1)(2011-1#1)
blood of##33##2##(1990-12#1)(1993-12#1)(1994-7#1)(1996-12#3)(1996-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2011-1#4)(2011-2#1)(2012-2#3)(2013-1#1)
blood on##2##2##(2008-2#1)(2011-2#1)
blood or blood products##3##4##(1992-6#1)(2011-3#1)(2013-1#1)
blood or bone marrow##3##4##(2008-4#1)(2008-9#1)(2012-12#1)
blood or in##3##3##(1990-2#1)(2008-8#1)(2012-2#1)
blood or urine##3##3##(1990-2#1)(1993-12#2)
blood or##21##2##(1990-2#2)(1990-8#1)(1992-6#1)(1993-12#2)(1994-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
blood oxygen saturation##2##3##(2009-11#1)(2010-8#1)
blood oxygen##3##2##(2009-11#1)(2010-8#1)(2013-8#1)
blood oxygenation##5##2##(2007-10#1)(2008-11#2)(2008-3#2)
blood pH##2##2##(2011-2#2)
blood parameters##5##2##(2008-12#2)(2010-2#1)(2011-1#1)(2013-1#1)
blood patch##3##2##(1993-10#3)
blood patching following inadvertent dural puncture##2##6##(1993-10#2)
blood patching##3##2##(1993-10#3)
blood perfusion in##2##3##(2010-11#1)(2012-12#1)
blood perfusion##6##2##(1993-12#1)(2009-11#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
blood picture##4##2##(2008-12#4)
blood plasma and erythrocyte##2##4##(2008-10#2)
blood plasma and##4##3##(2008-10#3)(2008-9#1)
blood plasma samples##4##3##(2008-10#4)
blood plasma##28##2##(1991-9#1)(1992-5#1)(1994-6#1)(1995-12#1)(1997-7#1)(2007-8#1)(2008-10#19)(2008-9#1)(2011-2#1)(2013-1#1)
blood platelets##5##2##(1992-12#1)(1992-6#1)(2006-6#1)(2008-1#1)(2008-4#1)
blood preassure##2##2##(2007-11#2)
blood pressure &gt##2##3##(2008-7#2)
blood pressure (BP) and heart rate (HR)##3##7##(1990-5#1)(2008-11#2)
blood pressure (BP) and##4##4##(1990-5#1)(2008-11#2)(2013-8#1)
blood pressure (BP) is##3##4##(1991-3#1)(2008-8#1)(2011-1#1)
blood pressure (BP) levels##2##4##(2010-4#2)
blood pressure (BP) measurements##2##4##(1992-6#1)(2009-11#1)
blood pressure (BP)##17##3##(1990-5#1)(1991-3#1)(1992-6#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
blood pressure among##2##3##(2008-1#1)(2013-8#1)
blood pressure and heart rate##4##5##(1990-8#1)(1991-2#1)(1995-12#2)
blood pressure and heart##5##4##(1990-8#1)(1991-2#1)(1995-12#2)(1997-8#1)
blood pressure and the##4##4##(1990-5#1)(1997-8#1)(2007-7#1)(2012-3#1)
blood pressure and##43##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
blood pressure at rest and during##2##6##(2008-3#2)
blood pressure at##7##3##(2008-1#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-3#2)
blood pressure between##2##3##(2008-1#1)(2008-3#1)
blood pressure by##3##3##(1993-2#1)(1995-12#1)(2009-5#1)
blood pressure changes##3##3##(1995-12#2)(2008-8#1)
blood pressure control##14##3##(1992-8#1)(1996-2#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2013-1#1)(2013-8#2)
blood pressure decrease##3##3##(1997-7#1)(2008-7#2)
blood pressure decreased from##2##4##(1990-11#1)(1991-6#1)
blood pressure during##4##3##(1994-3#1)(2008-10#1)(2008-7#1)(2012-1#1)
blood pressure elevation##5##3##(1992-8#1)(2008-5#1)(2009-5#3)
blood pressure for##3##3##(1997-2#1)(2008-3#1)(2008-5#1)
blood pressure goals##2##3##(2008-8#1)(2012-12#1)
blood pressure guided##2##3##(2008-1#2)
blood pressure in a##4##4##(1992-8#1)(1995-12#1)(2007-10#1)(2008-7#1)
blood pressure in men##2##4##(1991-6#1)(2008-3#1)
blood pressure in the##5##4##(1997-5#3)(2008-1#1)(2013-1#1)
blood pressure in##27##3##(1990-8#1)(1991-6#1)(1992-5#1)(1992-8#2)(1994-3#1)(1995-12#1)(1997-5#3)(1997-8#2)(2007-10#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
blood pressure index##4##3##(1993-12#4)
blood pressure is##7##3##(1993-11#1)(1993-2#1)(1997-2#1)(1997-5#1)(2008-5#2)(2008-8#1)
blood pressure levels and##2##4##(2011-2#1)(2012-2#1)
blood pressure levels##4##3##(2008-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
blood pressure maintenance##2##3##(1997-7#2)
blood pressure may##2##3##(1992-8#1)(1997-5#1)
blood pressure measurement and##2##4##(1996-6#1)(2013-8#1)
blood pressure measurement in##2##4##(1994-3#1)(2008-10#1)
blood pressure measurement##8##3##(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-8#1)(2013-8#1)
blood pressure measurements##3##3##(1990-11#1)(2008-1#1)(2012-1#1)
blood pressure monitoring in##5##4##(1994-9#1)(2008-1#1)(2009-11#1)(2010-1#2)
blood pressure monitoring##16##3##(1990-11#2)(1992-8#1)(1994-9#1)(1997-8#1)(2007-10#1)(2008-1#3)(2009-11#3)(2010-1#3)(2012-3#1)
blood pressure of##7##3##(1995-12#1)(2007-10#1)(2008-1#4)(2008-3#1)
blood pressure on day 1##2##5##(2007-10#2)
blood pressure or##2##3##(1993-1#1)(2008-3#1)
blood pressure readings##3##3##(2008-5#3)
blood pressure reduction##2##3##(1992-8#1)(2013-8#1)
blood pressure reductions##2##3##(1992-8#1)(2008-3#1)
blood pressure regulation##2##3##(1997-2#1)(2008-6#1)
blood pressure response##4##3##(2008-1#2)(2008-7#2)
blood pressure should be##3##4##(1993-2#1)(1996-6#2)
blood pressure should##5##3##(1990-3#1)(1992-6#1)(1993-2#1)(1996-6#2)
blood pressure stability##2##3##(2011-2#2)
blood pressure stabilization##2##3##(2008-1#2)
blood pressure to##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
blood pressure values##4##3##(2008-5#1)(2008-7#2)(2013-8#1)
blood pressure was##9##3##(1990-5#1)(1993-10#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
blood pressure were the##2##4##(2007-10#1)(2012-3#1)
blood pressure were##8##3##(1992-8#1)(2007-10#2)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
blood pressure with##6##3##(1994-3#1)(1997-3#1)(2007-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
blood pressure without##2##3##(2007-10#2)
blood pressure##469##2##(1990-11#6)(1990-2#3)(1990-3#4)(1990-5#3)(1990-7#1)(1990-8#4)(1991-10#4)(1991-2#2)(1991-3#2)(1991-6#8)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#5)(1992-8#12)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#7)(1994-11#3)(1994-12#1)(1994-3#6)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#12)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-6#4)(1997-2#5)(1997-3#4)(1997-5#6)(1997-6#1)(1997-7#8)(1997-8#7)(2007-10#18)(2007-11#1)(2007-12#3)(2007-7#5)(2007-8#2)(2008-1#42)(2008-10#10)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#19)(2008-4#1)(2008-5#17)(2008-6#1)(2008-7#39)(2008-8#14)(2008-9#1)(2009-1#2)(2009-11#6)(2009-5#6)(2009-7#2)(2009-9#1)(2010-1#4)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#15)(2012-1#7)(2012-12#9)(2012-2#8)(2012-3#19)(2013-1#12)(2013-8#18)
blood pressure-related##2##2##(2010-4#1)(2012-12#1)
blood pressure]##4##2##(1990-8#1)(1991-9#1)(2010-12#2)
blood pressures were##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
blood pressures##8##2##(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-8#1)
blood products##16##2##(1992-6#1)(1996-6#1)(2007-9#3)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-3#2)(2013-1#1)
blood retinal barrier##2##3##(2011-2#2)
blood revealed##3##2##(1992-11#1)(2010-3#1)(2013-1#1)
blood sample was##2##3##(1994-12#1)(2013-1#1)
blood sample were##2##3##(2008-10#1)(2011-1#1)
blood sample##13##2##(1991-6#1)(1994-12#1)(2006-10#1)(2008-10#3)(2008-4#2)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
blood samples and##4##3##(1995-11#1)(2008-5#2)(2010-5#1)
blood samples are##2##3##(2008-9#1)(2009-11#1)
blood samples by##4##3##(1992-3#1)(2008-10#2)(2008-5#1)
blood samples collected from##2##4##(2009-12#1)(2012-3#1)
blood samples containing##2##3##(1992-3#1)(2008-10#1)
blood samples for##3##3##(1994-11#1)(2008-7#1)(2008-9#1)
blood samples from##13##3##(1990-7#1)(1992-6#1)(1994-6#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-9#2)(2009-3#1)(2010-1#1)(2011-2#2)
blood samples of##4##3##(1990-8#1)(2011-2#1)(2013-1#2)
blood samples taken from##2##4##(1990-8#1)(2008-10#1)
blood samples taken##3##3##(1990-8#1)(1995-9#1)(2008-10#1)
blood samples were analyzed for##2##5##(2008-5#1)(2011-1#1)
blood samples were collected at##2##5##(1991-6#1)(2008-3#1)
blood samples were collected from the##2##6##(2008-12#1)(2008-9#1)
blood samples were collected from##5##5##(2008-12#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-2#1)
blood samples were collected##11##4##(1990-12#1)(1991-6#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
blood samples were drawn from the##2##6##(2008-1#1)(2008-10#1)
blood samples were drawn##5##4##(1991-6#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-3#1)
blood samples were extracted##2##4##(2008-10#1)(2011-2#1)
blood samples were taken before##3##5##(1990-3#1)(2013-1#1)(2013-8#1)
blood samples were taken from##4##5##(1997-3#1)(2008-12#1)(2010-4#1)(2011-2#1)
blood samples were taken##9##4##(1990-3#1)(1997-3#1)(2008-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
blood samples were##32##3##(1990-12#1)(1990-3#1)(1991-6#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
blood samples##99##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#4)(1991-12#1)(1991-6#2)(1992-3#2)(1992-6#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#5)(2009-11#3)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-3#3)(2013-1#6)(2013-8#1)
blood sampling##9##2##(1990-9#2)(1996-3#3)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
blood serum and on##2##4##(2008-5#2)
blood serum and urine of patients with cancer of the stomach##2##11##(2008-7#2)
blood serum and urine##3##4##(2008-7#3)
blood serum and whole blood##3##5##(2008-10#3)
blood serum and##9##3##(2008-10#3)(2008-5#2)(2008-7#4)
blood serum of patients##3##4##(2008-7#1)(2013-1#2)
blood serum of##5##3##(2008-5#1)(2008-7#1)(2013-1#3)
blood serum samples##7##3##(2008-10#7)
blood serum using##2##3##(2008-10#2)
blood serum##41##2##(1995-11#1)(2008-10#22)(2008-3#1)(2008-5#3)(2008-7#5)(2011-1#2)(2013-1#7)
blood showed##2##2##(2007-7#1)(2011-2#1)
blood smear##3##2##(1990-3#1)(1995-3#1)(2012-3#1)
blood smears##3##2##(2010-5#1)(2012-12#1)(2012-2#1)
blood spatters##2##2##(1995-11#2)
blood specimen##3##2##(2008-11#1)(2010-6#2)
blood specimens from##3##3##(1996-12#2)(1997-3#1)
blood specimens##6##2##(1993-12#1)(1996-12#2)(1997-3#1)(2008-10#2)
blood spots##7##2##(1991-2#2)(1991-8#1)(1992-12#1)(1993-9#1)(2010-11#2)
blood stains in##2##3##(1990-7#2)
blood stains##5##2##(1990-7#3)(2008-12#2)
blood stasis##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
blood stem##7##2##(1997-3#1)(2006-10#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)
blood stimulation##2##2##(2008-4#2)
blood sugar levels##3##3##(1993-11#1)(2008-1#1)(2008-3#1)
blood sugar##13##2##(1993-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-10#1)(2011-2#1)
blood supply and##2##3##(2007-11#1)(2007-5#1)
blood supply by##2##3##(1995-6#1)(2008-7#1)
blood supply for##2##3##(1996-9#1)(2008-5#1)
blood supply to the##7##4##(1996-2#1)(1997-8#1)(2007-8#1)(2009-3#1)(2011-2#2)(2012-1#1)
blood supply to##8##3##(1996-2#1)(1997-8#1)(2007-8#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-12#1)
blood supply was##2##3##(2006-12#2)
blood supply##33##2##(1995-12#1)(1995-6#2)(1996-2#2)(1996-9#3)(1997-8#1)(2006-12#3)(2007-11#1)(2007-5#2)(2007-8#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)
blood testing##7##2##(1992-6#1)(1994-11#1)(1994-2#2)(2007-8#1)(2009-12#1)(2010-8#1)
blood tests for##2##3##(1996-8#1)(2007-7#1)
blood tests in##2##3##(1993-3#1)(2008-10#1)
blood tests##6##2##(1993-3#1)(1993-8#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-2#1)
blood that##3##2##(1993-12#1)(1997-5#1)(2008-7#1)
blood through the##2##3##(1990-11#1)(2009-6#1)
blood through##3##2##(1990-11#1)(2006-10#1)(2009-6#1)
blood to the##3##3##(1992-9#1)(1993-3#1)(2007-7#1)
blood to##11##2##(1990-11#1)(1990-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
blood transfusion and##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
blood transfusion in##6##3##(1995-12#1)(1996-9#1)(1997-5#1)(2008-1#1)(2013-1#2)
blood transfusion or##2##3##(2009-5#1)(2011-2#1)
blood transfusion##34##2##(1991-8#1)(1995-12#2)(1996-3#1)(1996-9#2)(1997-5#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
blood transfusions and##3##3##(1990-5#1)(2008-1#2)
blood transfusions or pregnancy##2##4##(1991-3#2)
blood transfusions##21##2##(1990-5#1)(1991-3#2)(1992-12#1)(1992-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
blood transplantation##4##2##(2008-11#1)(2012-2#1)(2013-1#2)
blood units##8##2##(1991-8#2)(2007-7#4)(2010-11#2)
blood urea concentration##2##3##(2008-4#2)
blood urea nitrogen (BUN)##2##4##(1994-5#2)
blood urea nitrogen and##2##4##(2008-10#1)(2008-4#1)
blood urea nitrogen##7##3##(1994-5#2)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
blood urea##10##2##(1994-5#2)(1995-3#1)(2008-10#1)(2008-4#3)(2008-5#1)(2011-2#1)(2012-2#1)
blood using##9##2##(1992-3#1)(1996-12#1)(2008-10#5)(2008-11#2)
blood velocity in##2##3##(2007-8#1)(2011-1#1)
blood velocity##7##2##(1996-6#1)(2007-10#3)(2007-8#1)(2011-1#1)(2013-8#1)
blood vessel and small intestine##2##5##(1994-11#2)
blood vessel endothelium##2##3##(2009-10#1)(2010-11#1)
blood vessel##20##2##(1991-12#1)(1994-11#2)(1995-3#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-3#5)(2008-4#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-1#3)(2013-8#1)
blood vessels and nerves##2##4##(1996-3#1)(2011-1#1)
blood vessels and##13##3##(1991-6#1)(1994-9#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-3#1)
blood vessels from##3##3##(1995-12#1)(2010-9#1)(2013-8#1)
blood vessels in the##2##4##(2009-12#1)(2012-1#1)
blood vessels in##4##3##(1991-8#1)(2008-1#1)(2009-12#1)(2012-1#1)
blood vessels of##5##3##(1992-12#1)(2008-11#3)(2013-1#1)
blood vessels were##3##3##(2011-2#3)
blood vessels##73##2##(1991-6#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-5#1)(1994-9#5)(1995-12#2)(1996-3#1)(1997-6#1)(2007-10#2)(2007-12#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
blood viscosity##3##2##(2008-7#1)(2009-11#2)
blood volume and##3##3##(2008-5#1)(2008-7#1)(2010-7#1)
blood volume flow##4##3##(2006-10#4)
blood volume##15##2##(1997-3#1)(2006-10#4)(2007-10#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)
blood was collected##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
blood was transfused##3##3##(1994-12#1)(1996-3#1)(2007-9#1)
blood was##25##2##(1990-2#2)(1991-12#1)(1991-2#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-6#1)(1996-3#2)(2007-9#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#4)(2013-8#1)
blood were found##2##3##(2008-10#1)(2010-3#1)
blood were##11##2##(1993-8#1)(1997-5#1)(2008-10#4)(2008-5#2)(2010-3#1)(2011-2#2)
blood which##4##2##(1990-12#1)(1991-7#1)(1993-3#1)(2013-8#1)
blood with##8##2##(1991-8#1)(1997-4#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
blood withdrawn##2##2##(1996-9#2)
blood without##3##2##(1991-2#1)(1994-2#1)(2008-4#1)
blood##2895##1##(1990-10#1)(1990-11#13)(1990-12#16)(1990-2#20)(1990-3#9)(1990-5#14)(1990-6#6)(1990-7#15)(1990-8#28)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#12)(1991-12#11)(1991-2#20)(1991-3#16)(1991-4#3)(1991-5#4)(1991-6#19)(1991-7#7)(1991-8#9)(1991-9#6)(1992-1#2)(1992-11#5)(1992-12#20)(1992-2#8)(1992-3#18)(1992-4#1)(1992-5#7)(1992-6#24)(1992-8#14)(1992-9#9)(1993-1#9)(1993-10#10)(1993-11#9)(1993-12#31)(1993-2#16)(1993-3#13)(1993-6#5)(1993-8#15)(1993-9#8)(1994-1#1)(1994-11#13)(1994-12#24)(1994-2#12)(1994-3#22)(1994-5#6)(1994-6#13)(1994-7#6)(1994-8#7)(1994-9#20)(1995-1#2)(1995-11#12)(1995-12#26)(1995-2#18)(1995-3#13)(1995-5#9)(1995-6#15)(1995-8#5)(1995-9#1)(1996-1#7)(1996-11#7)(1996-12#25)(1996-2#14)(1996-3#16)(1996-5#16)(1996-6#10)(1996-7#4)(1996-8#1)(1996-9#33)(1997-1#10)(1997-2#10)(1997-3#13)(1997-4#10)(1997-5#13)(1997-6#10)(1997-7#14)(1997-8#12)(2006-10#9)(2006-12#6)(2006-6#11)(2006-7#2)(2007-10#55)(2007-11#27)(2007-12#15)(2007-2#3)(2007-5#2)(2007-7#49)(2007-8#29)(2007-9#18)(2008-1#81)(2008-10#279)(2008-11#78)(2008-12#55)(2008-2#20)(2008-3#66)(2008-4#79)(2008-5#67)(2008-6#6)(2008-7#124)(2008-8#50)(2008-9#78)(2009-1#6)(2009-10#5)(2009-11#28)(2009-12#7)(2009-2#3)(2009-3#8)(2009-4#2)(2009-5#11)(2009-6#4)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#7)(2010-10#5)(2010-11#21)(2010-12#17)(2010-2#11)(2010-3#8)(2010-4#22)(2010-5#14)(2010-6#19)(2010-7#14)(2010-8#14)(2010-9#3)(2011-1#63)(2011-2#143)(2011-3#9)(2012-1#14)(2012-12#29)(2012-2#49)(2012-3#49)(2012-5#2)(2013-1#112)(2013-3#1)(2013-7#3)(2013-8#57)
blood&quot##2##1##(2013-1#2)
blood)##3##1##(2008-10#2)(2013-8#1)
blood-##2##1##(1993-2#1)(2009-8#1)
blood-CSF barrier dysfunction##2##3##(1993-8#2)
blood-borne pathogens##2##2##(1992-12#1)(2007-3#1)
blood-borne##6##1##(1990-7#1)(1992-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
blood-brain barrier (BBB)##5##3##(1990-5#1)(1996-5#1)(2008-7#2)(2012-2#1)
blood-brain barrier and##7##3##(1993-12#1)(1997-2#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
blood-brain barrier##34##2##(1990-5#2)(1990-7#1)(1992-3#2)(1993-12#1)(1994-5#1)(1995-12#3)(1995-2#2)(1996-5#1)(1997-2#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
blood-brain##36##1##(1990-5#2)(1990-7#1)(1992-3#2)(1993-12#1)(1994-5#1)(1995-12#3)(1995-2#2)(1996-5#1)(1997-2#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
blood-cerebrospinal fluid##2##2##(2008-7#1)(2013-7#1)
blood-clotting products##4##2##(1996-5#3)(1997-5#1)
blood-derived##2##1##(2008-4#1)(2008-9#1)
blood-filled##2##1##(2010-6#1)(2011-1#1)
blood-flow##6##1##(1991-11#2)(2008-1#1)(2008-3#1)(2012-1#2)
blood-injection-injury##2##1##(2012-2#2)
blood-pressure##2##1##(1990-9#1)(1994-3#1)
blood-stage parasites##2##2##(2012-2#2)
blood-stained##2##1##(1990-11#1)(1995-12#1)
blood-sucking##2##1##(2011-2#2)
blood-testis barrier (BTB)##3##3##(2009-10#1)(2012-2#2)
blood-testis barrier##5##2##(2009-10#2)(2012-2#3)
blood-tissue barriers##4##2##(1990-11#3)(2012-2#1)
blood-vessels##2##1##(1991-11#1)(1991-3#1)
blood]##3##1##(1996-11#1)(2010-12#1)(2013-8#1)
bloodborne pathogens standard##3##3##(1993-2#1)(1994-3#2)
bloodborne pathogens##5##2##(1993-2#1)(1994-3#3)(2007-4#1)
bloodborne viral##2##2##(2007-2#2)
bloodborne viruses##3##2##(2007-12#1)(2007-2#2)
bloodborne##10##1##(1993-2#1)(1994-3#3)(2007-12#1)(2007-2#4)(2007-4#1)
bloodless surgery##2##2##(1992-3#1)(2010-8#1)
bloodless##3##1##(1992-3#1)(2010-8#1)(2012-3#1)
bloodstains##4##1##(2008-10#1)(2010-5#3)
bloodstream infection##2##2##(2008-10#1)(2010-12#1)
bloodstream infections##4##2##(2007-7#2)(2008-10#1)(2010-6#1)
bloodstream##13##1##(2007-7#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
bloody diarrhea##2##2##(2008-7#1)(2011-2#1)
bloody diarrhoea##2##2##(2008-12#1)(2009-10#1)
bloody##8##1##(1990-11#2)(1992-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
bloom and fruit developmental stages##3##5##(2008-10#3)
bloom and fruit##5##3##(2008-10#5)
bloom and##9##2##(2008-10#8)(2008-8#1)
bloom developed##2##2##(2008-10#2)
bloom in##2##2##(2008-10#2)
bloom of##2##2##(1993-11#1)(2008-10#1)
bloom stage##3##2##(2008-10#3)
bloom stages##6##2##(2008-10#6)
bloom to suppress##2##3##(2008-10#2)
bloom to##3##2##(2008-10#3)
bloom##59##1##(1993-11#1)(2008-10#53)(2008-8#4)(2009-8#1)
blooming effect##2##2##(2008-2#2)
blooming##7##1##(1997-4#1)(2008-2#3)(2008-3#2)(2011-2#1)
blooms##10##1##(1992-8#1)(1994-3#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-8#1)(2010-5#1)
blossom blight of prunes##2##4##(2008-10#2)
blossom blight##8##2##(2008-10#8)
blossom protection##2##2##(2008-10#2)
blossom were##2##2##(2008-10#2)
blossom##20##1##(2008-10#20)
blossomed##2##1##(2006-10#1)(2008-7#1)
blossoms and##3##2##(2008-10#3)
blossoms from##2##2##(2008-10#2)
blossoms in the orchard##2##4##(2008-10#2)
blossoms in the##3##3##(2008-10#3)
blossoms in##5##2##(2008-10#5)
blossoms inoculated with##2##3##(2008-10#2)
blossoms of##3##2##(2008-10#3)
blossoms prior to##2##3##(2008-10#2)
blossoms sampled##2##2##(2008-10#2)
blossoms were inoculated with##2##4##(2008-10#2)
blossoms were##4##2##(2008-10#4)
blossoms##51##1##(2008-10#51)
blot analyses confirmed##2##3##(2006-12#1)(2008-10#1)
blot analyses indicated that##4##4##(1992-3#1)(1993-12#2)(1997-8#1)
blot analyses of##4##3##(1993-3#1)(1995-8#1)(2008-10#2)
blot analyses revealed that##2##4##(2008-10#2)
blot analyses revealed##3##3##(2006-12#1)(2008-10#2)
blot analyses showed##2##3##(1994-12#1)(2008-10#1)
blot analyses##28##2##(1990-5#1)(1991-10#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#2)(2008-10#7)(2008-6#1)(2012-12#1)
blot analysis and in##2##4##(2008-11#1)(2008-6#1)
blot analysis and the##2##4##(2008-8#1)(2010-12#1)
blot analysis and##7##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)
blot analysis confirmed##3##3##(1997-7#1)(2008-10#2)
blot analysis demonstrated that##3##4##(1994-12#1)(2008-5#1)(2008-8#1)
blot analysis demonstrated##6##3##(1994-12#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-8#2)
blot analysis in##2##3##(1992-2#1)(1993-3#1)
blot analysis indicate that##2##4##(1991-9#1)(1993-12#1)
blot analysis indicated that the two##2##6##(1990-2#2)
blot analysis indicated that the##3##5##(1990-2#2)(1993-3#1)
blot analysis indicated##6##3##(1990-2#2)(1993-3#2)(2007-12#1)(2008-9#1)
blot analysis indicates that the##2##5##(1994-12#1)(1997-7#1)
blot analysis indicates that##3##4##(1993-6#1)(1994-12#1)(1997-7#1)
blot analysis of rat##3##4##(1990-12#2)(1994-6#1)
blot analysis of the##7##4##(1990-2#1)(1992-11#1)(1993-9#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#1)
blot analysis of##25##3##(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#4)(2011-2#1)
blot analysis revealed that the gene##2##6##(1995-6#1)(1997-6#1)
blot analysis revealed that the##7##5##(1990-7#1)(1992-9#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-6#1)
blot analysis revealed that##18##4##(1990-7#1)(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-2#1)
blot analysis revealed##23##3##(1990-7#1)(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#2)(2009-3#1)(2012-2#1)
blot analysis reveals##2##3##(1990-8#1)(2008-11#1)
blot analysis showed that the##6##5##(1990-5#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-8#1)
blot analysis showed that##15##4##(1990-5#1)(1991-11#1)(1991-2#1)(1994-12#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-4#2)(1997-8#1)(2008-11#2)(2008-6#1)(2008-8#1)
blot analysis showed##24##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-8#1)(1994-11#2)(1994-12#1)(1995-6#2)(1996-12#2)(1996-6#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
blot analysis using polyclonal##2##4##(1990-8#1)(1993-6#1)
blot analysis using##11##3##(1990-8#1)(1992-11#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-10#1)(2008-10#1)(2008-9#1)
blot analysis was##2##3##(1996-12#1)(1997-8#1)
blot analysis with the##2##4##(1991-9#1)(1995-6#1)
blot analysis with##7##3##(1990-5#1)(1991-9#1)(1993-11#1)(1995-6#1)(1996-6#1)(2008-11#1)(2008-8#1)
blot analysis##182##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-8#1)(1991-9#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#6)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#6)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#6)(1995-8#1)(1996-10#1)(1996-12#7)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#7)(1997-8#8)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#10)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#11)(2008-9#4)(2009-12#1)(2009-3#1)(2010-12#2)(2011-2#3)(2012-2#1)(2013-1#1)
blot and ELISA##2##3##(1997-4#1)(2008-9#1)
blot and immunoprecipitation##2##3##(1993-3#1)(2008-11#1)
blot and##20##2##(1990-2#1)(1990-7#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-5#1)(2013-8#1)
blot assay to##3##3##(1996-11#1)(2008-2#1)(2008-4#1)
blot assay##9##2##(1995-2#1)(1996-11#3)(2008-2#1)(2008-4#1)(2008-9#3)
blot assays##2##2##(2008-10#2)
blot data##3##2##(2008-7#3)
blot experiments##3##2##(1992-11#1)(1994-12#1)(1995-6#1)
blot hybridization analysis of##2##4##(2008-10#2)
blot hybridization analysis##6##3##(1996-6#1)(2008-10#5)
blot hybridization and##3##3##(1990-11#1)(1993-3#1)(2008-10#1)
blot hybridization of##2##3##(1994-9#1)(2008-4#1)
blot hybridization with a##2##4##(1997-2#1)(2008-10#1)
blot hybridization with##5##3##(1990-7#1)(1997-2#1)(2008-10#3)
blot hybridization##30##2##(1990-11#1)(1990-7#1)(1991-8#1)(1992-3#2)(1993-3#1)(1994-1#2)(1994-9#1)(1996-6#1)(1997-2#1)(2008-10#15)(2008-4#2)(2008-5#1)(2008-9#1)
blot hybridizations showed that##2##4##(2008-10#2)
blot hybridizations to detect##2##4##(2008-10#2)
blot hybridizations##6##2##(1997-3#1)(2008-10#5)
blot immunoassays##2##2##(2008-10#2)
blot in##2##2##(1993-12#1)(2008-5#1)
blot indicated##3##2##(1996-12#1)(2008-4#1)(2008-9#1)
blot or##2##2##(1995-6#1)(2012-2#1)
blot results indicated that##2##4##(1997-4#1)(2008-8#1)
blot results##3##2##(1997-4#1)(2008-7#1)(2008-8#1)
blot technique##2##2##(1990-7#1)(2007-10#1)
blot transfer membranes##3##3##(2008-2#3)
blot transfer##4##2##(2008-2#4)
blot with##2##2##(1995-6#1)(1997-1#1)
blot##367##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#3)(1990-7#5)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-8#3)(1991-9#3)(1992-11#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-8#7)(1992-9#2)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#9)(1993-6#6)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#10)(1995-8#5)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#1)(1996-6#3)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#6)(1997-6#3)(1997-7#9)(1997-8#9)(1997-9#1)(2006-12#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#57)(2008-11#13)(2008-12#2)(2008-2#6)(2008-4#8)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#22)(2008-9#19)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
blotch (STB)##4##2##(2008-10#4)
blotch and##2##2##(2008-10#2)
blotch disease##5##2##(2008-10#5)
blotch in##5##2##(2008-10#5)
blotch of##5##2##(2008-10#5)
blotch on##2##2##(2008-10#2)
blotch pathogen##4##2##(2008-10#4)
blotch resistance in##2##3##(2008-10#2)
blotch resistance##6##2##(2008-10#6)
blotch##59##1##(2008-10#59)
blots and##4##2##(1995-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
blots can be##3##3##(2008-4#3)
blots indicate that##2##3##(1995-8#1)(1996-12#1)
blots of chronic sera##2##4##(1992-8#2)
blots of##9##2##(1990-12#1)(1991-6#1)(1992-3#2)(1992-8#2)(1994-9#1)(2008-10#2)
blots showed##4##2##(1991-8#1)(1992-3#1)(1992-8#1)(2008-10#1)
blots to##4##2##(1991-6#1)(1993-8#1)(1995-6#1)(2008-10#1)
blots using##2##2##(1993-12#1)(2009-9#1)
blots were##2##2##(2008-10#1)(2008-7#1)
blots with the##2##3##(1993-12#1)(1995-12#1)
blots with##7##2##(1990-12#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-7#1)
blots##64##1##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-8#1)(1992-3#3)(1992-8#6)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#3)(1995-6#3)(1995-8#2)(1996-12#1)(2008-10#11)(2008-4#7)(2008-5#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-9#1)(2012-12#1)
blotted##2##1##(2008-10#2)
blotting analysis##10##2##(1991-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)
blotting and hybridization##4##3##(2008-4#4)
blotting and##10##2##(1990-5#1)(1992-10#1)(1994-9#1)(1995-12#1)(2008-4#4)(2008-6#1)(2012-12#1)
blotting demonstrated that##2##3##(1995-8#1)(2008-9#1)
blotting experiments##2##2##(1995-12#1)(1995-5#1)
blotting in##2##2##(1996-5#1)(2008-1#1)
blotting indicated that the##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
blotting of##6##2##(1992-9#1)(1994-11#2)(2008-10#1)(2008-11#1)(2008-9#1)
blotting revealed##4##2##(1992-9#1)(1993-8#1)(1994-12#1)(1996-10#1)
blotting using##5##2##(1992-12#1)(1993-11#1)(1996-12#1)(1997-1#1)(2008-11#1)
blotting was employed##2##3##(1990-12#1)(2008-11#1)
blotting with##10##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-11#1)(1997-1#1)(2008-8#2)(2008-9#1)(2010-12#1)
blotting##117##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-5#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-11#1)(1993-8#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#11)(2010-12#3)(2010-6#1)(2011-1#2)(2011-3#3)(2012-12#1)(2012-3#2)(2013-1#2)
blotting) is used to identify specific antigens recognized by polyclonal or monoclonal antibodies##2##13##(2008-4#2)
blotting)##5##1##(2008-2#1)(2008-4#4)
blow##4##1##(1991-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
blowfly##2##1##(1997-7#1)(2008-11#1)
blowing the nose##2##3##(2008-11#2)
blowing##4##1##(1992-3#1)(2008-11#2)(2008-7#1)
blown##5##1##(1992-6#1)(1993-6#1)(2008-5#1)(2008-7#2)
blowout fracture##3##2##(2008-8#1)(2011-1#2)
blows##2##1##(2010-3#1)(2012-2#1)
blubber of ringed seal##2##4##(2008-10#2)
blubber of ringed##3##3##(2008-10#3)
blubber of##4##2##(2008-10#4)
blubber##6##1##(2008-10#6)
blue (MB) and##2##3##(2008-10#2)
blue (MB)##14##2##(2008-10#14)
blue (MTB) as##2##3##(2008-10#2)
blue (VB)##2##2##(2008-10#2)
blue LED##3##2##(2008-10#3)
blue and UV##2##3##(2008-2#2)
blue and gray##2##3##(2008-10#2)
blue and the##2##3##(2008-10#1)(2008-7#1)
blue and##24##2##(1992-11#1)(1992-12#1)(1997-3#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)
blue at##2##2##(2008-10#2)
blue beam##2##2##(2007-12#2)
blue color##7##2##(1997-4#1)(2008-10#5)(2010-2#1)
blue colour##2##2##(1997-4#1)(2008-10#1)
blue complex is monitored##2##4##(2008-10#2)
blue complex is##4##3##(2008-10#4)
blue complex##17##2##(2008-10#17)
blue copper protein##2##3##(1993-11#2)
blue copper proteins##2##3##(1993-11#2)
blue copper##4##2##(1993-11#4)
blue derivative##2##2##(2008-10#2)
blue diode lasers##2##3##(2008-3#2)
blue dye exclusion test##2##4##(1992-9#1)(2008-11#1)
blue dye exclusion##4##3##(1992-9#1)(2008-11#3)
blue dye##15##2##(1990-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#3)
blue electrophosphorescence##2##2##(2010-4#2)
blue fluorescence##2##2##(2008-10#1)(2008-3#1)
blue form of##2##3##(1994-5#1)(2008-10#1)
blue from##2##2##(2008-10#2)
blue in the presence of##2##5##(2008-10#2)
blue in the##4##3##(2008-10#3)(2008-7#1)
blue in##7##2##(2008-10#5)(2008-2#1)(2008-7#1)
blue indicator##2##2##(2008-1#1)(2008-10#1)
blue into##2##2##(2008-10#2)
blue is##5##2##(2008-10#4)(2008-2#1)
blue light activated redox reactions##2##5##(1994-11#2)
blue light emitting diode##2##4##(2008-12#1)(2008-7#1)
blue light even##2##3##(2007-11#1)(2011-2#1)
blue light for##2##3##(2007-11#1)(2007-12#1)
blue light in##2##3##(1992-8#1)(2007-12#1)
blue light##23##2##(1991-9#1)(1992-8#2)(1994-11#3)(2007-11#4)(2007-12#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
blue method##8##2##(2008-10#8)
blue mold on##2##3##(2008-10#2)
blue mold##13##2##(2008-10#13)
blue or green##2##3##(2008-2#1)(2008-3#1)
blue radiation##4##2##(2007-12#4)
blue reaction##4##2##(2008-10#2)(2013-8#2)
blue second-harmonic generation##2##3##(2007-12#2)
blue sensitized##2##2##(2008-10#2)
blue shift of the##4##4##(1991-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
blue shift##7##2##(1991-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-8#1)
blue spectral region##3##3##(2007-11#1)(2008-3#2)
blue spectral##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
blue stain##2##2##(1991-1#1)(2008-10#1)
blue staining##6##2##(2008-11#1)(2008-2#1)(2008-4#2)(2012-3#1)(2013-8#1)
blue tit Parus caeruleus##2##4##(1994-3#1)(2008-9#1)
blue tit##4##2##(1994-3#1)(2008-8#2)(2008-9#1)
blue tits##5##2##(1994-3#3)(2008-8#2)
blue to##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
blue was##2##2##(2008-10#2)
blue were##2##2##(2008-10#2)
blue wing##2##2##(1991-11#1)(2007-12#1)
blue with##2##2##(2008-10#2)
blue##399##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#2)(1993-8#2)(1994-11#5)(1994-12#1)(1994-3#4)(1994-5#2)(1995-12#1)(1995-8#1)(1996-6#1)(1997-3#2)(1997-4#3)(2007-11#14)(2007-12#26)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#187)(2008-11#17)(2008-12#1)(2008-2#15)(2008-3#20)(2008-4#11)(2008-5#4)(2008-7#4)(2008-8#7)(2008-9#4)(2009-6#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#6)
blue)##6##1##(1997-2#1)(2006-6#1)(2008-10#3)(2008-2#1)
blue-coloured##2##1##(1990-12#1)(2008-10#1)
blue-green alga Spirulina platensis##2##4##(2008-10#1)(2008-8#1)
blue-green algae##2##2##(2008-10#1)(2008-8#1)
blue-green##13##1##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-8#2)(2013-1#1)
blue-light##3##1##(1992-8#1)(2007-12#1)(2008-3#1)
blue-pumped##2##1##(2007-12#2)
blue-stain fungi##2##2##(2008-10#2)
blue-stained##2##1##(1993-9#1)(2008-10#1)
blueberries##2##1##(2008-10#2)
blueberry clones##3##2##(2008-10#3)
blueberry in##2##2##(2008-10#2)
blueberry##14##1##(2008-10#14)
bluegill Lepomis macrochirus larvae##2##4##(2010-8#2)
bluegill##3##1##(2008-10#1)(2010-8#2)
bluegills##3##1##(2008-6#3)
bluehead wrasse##2##2##(2007-5#1)(2008-8#1)
blueprint for public##2##3##(1995-12#1)(1997-3#1)
blueprint for##11##2##(1994-12#2)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#2)
blueprint of the##2##3##(1993-2#1)(2011-2#1)
blueprint##15##1##(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#3)(2008-4#1)(2011-2#1)
blues##2##1##(1991-8#1)(2008-4#1)
bluetongue virus (BTV)##2##3##(1997-4#1)(2010-4#1)
bluetongue virus##5##2##(1991-3#2)(1997-4#1)(2010-4#2)
bluetongue##8##1##(1991-3#2)(1997-4#1)(2008-8#2)(2010-4#2)(2011-2#1)
bluish##3##1##(1991-6#1)(2008-10#1)(2008-5#1)
blumei iridescent scales##2##3##(2008-2#2)
blunt abdominal trauma##5##3##(1990-2#2)(2008-10#2)(2010-1#1)
blunt abdominal##7##2##(1990-2#4)(2008-10#2)(2010-1#1)
blunt chest trauma##4##3##(2007-8#3)(2012-2#1)
blunt head injury##2##3##(2008-7#2)
blunt head##5##2##(2008-7#2)(2011-2#3)
blunt thoracic trauma are##2##4##(2012-2#2)
blunt thoracic trauma##3##3##(2012-2#2)(2013-1#1)
blunt trauma##8##2##(1990-9#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
blunt##45##1##(1990-2#4)(1990-9#4)(1991-6#1)(1997-7#1)(2007-12#1)(2007-8#4)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#6)(2013-1#2)
blunt-ended nuclei##2##2##(1994-6#1)(2010-6#1)
blunted in##2##2##(1995-8#1)(2008-8#1)
blunted##10##1##(1995-8#1)(1997-7#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2013-7#1)
blunting##2##1##(1997-4#1)(2009-6#1)
blunts##2##1##(1993-12#1)(2008-12#1)
blur and additive##2##3##(2008-2#1)(2008-3#1)
blur function is##2##3##(2008-3#2)
blur function##4##2##(2008-3#4)
blur##29##1##(2008-2#7)(2008-3#20)(2008-6#2)
blurred image##2##2##(2008-3#2)
blurred images##4##2##(2007-12#1)(2008-3#1)(2008-6#2)
blurred vision in##2##3##(2011-1#1)(2013-1#1)
blurred vision##6##2##(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
blurred##19##1##(1996-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
blurring of##2##2##(1994-12#1)(2008-2#1)
blurring the##2##2##(1991-3#1)(2008-3#1)
blurring##10##1##(1991-3#1)(1994-12#1)(2007-12#1)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-1#1)
blurs##4##1##(2008-3#4)
blushing in##2##2##(2010-4#2)
blushing##7##1##(2010-4#7)
blushing-fearful individuals##2##2##(2010-4#2)
blushing-fearful participants##2##2##(2010-4#2)
blushing-fearful##4##1##(2010-4#4)
bmi-1 gene##2##2##(1991-5#2)
bmi-1##9##1##(1991-5#9)
boar spermatozoa##2##2##(2013-1#2)
boar##4##1##(2010-4#1)(2013-1#3)
board and senior##2##3##(1993-12#1)(1994-2#1)
board and##5##2##(1993-12#1)(1994-1#1)(1994-2#1)(2010-11#1)(2010-5#1)
board certified##2##2##(1992-3#1)(1996-2#1)
board for##2##2##(1992-1#1)(1992-11#1)
board in##4##2##(1992-8#1)(1995-12#1)(2007-2#1)(2010-4#1)
board members##6##2##(1992-12#1)(1995-2#1)(2008-11#1)(2010-12#3)
board of directors##6##3##(1992-2#1)(1993-1#2)(1995-6#1)(1996-3#1)(2007-9#1)
board of##9##2##(1992-2#1)(1993-1#2)(1995-6#1)(1996-3#1)(2007-9#1)(2008-8#1)(2012-3#1)(2013-1#1)
board or##2##2##(1993-1#1)(2008-3#1)
board##112##1##(1991-1#5)(1991-12#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-8#2)(1993-1#6)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#5)(1994-3#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-3#1)(1997-6#1)(2007-2#7)(2007-9#3)(2008-10#3)(2008-11#3)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
boardroom##2##1##(1992-2#1)(1994-2#1)
boards and management##2##3##(1994-12#1)(2008-11#1)
boards and##6##2##(1994-12#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-2#1)(2012-2#1)
boards are##2##2##(1991-1#1)(1994-12#1)
boards in##2##2##(1993-1#1)(2012-1#1)
boards is##2##2##(2008-2#1)(2012-2#1)
boards of directors##2##3##(1994-12#1)(1996-1#1)
boards of the##2##3##(1994-1#1)(2008-2#1)
boards of##5##2##(1994-1#1)(1994-12#1)(1996-1#1)(2007-8#1)(2008-2#1)
boards should##2##2##(1991-12#1)(2008-11#1)
boards to##4##2##(2008-11#1)(2008-2#1)(2008-5#2)
boards##64##1##(1991-1#8)(1991-12#3)(1992-1#3)(1992-12#1)(1992-3#3)(1993-1#3)(1994-1#2)(1994-12#6)(1994-2#2)(1995-1#2)(1995-3#3)(1996-1#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#8)(2008-4#4)(2008-5#2)(2012-1#1)(2012-2#5)
boat and##2##2##(2007-5#1)(2008-10#1)
boat##5##1##(1994-9#1)(2007-2#1)(2007-5#1)(2008-10#1)(2009-7#1)
bobcats and Indochinese tigers##2##4##(2009-4#2)
bobcats##6##1##(2009-4#6)
bobsled track##2##2##(2012-12#2)
boceprevir##2##1##(2012-12#2)
bodes well for##2##3##(1995-9#1)(2011-2#1)
bodies (FBs) in##2##3##(1991-12#1)(2007-8#1)
bodies (e##2##2##(2010-6#1)(2011-2#1)
bodies and in##2##3##(1995-5#1)(1996-12#1)
bodies and two##3##3##(2007-12#2)(2008-7#1)
bodies and##32##2##(1992-12#1)(1993-12#1)(1995-5#1)(1996-12#2)(1997-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#10)(2009-10#1)(2009-5#1)(2010-5#1)(2012-2#1)
bodies are##10##2##(1991-2#1)(2007-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
bodies as##2##2##(2008-10#1)(2008-9#1)
bodies at##2##2##(1990-3#1)(2007-12#1)
bodies by##2##2##(1991-11#1)(2008-5#1)
bodies can be##2##3##(2008-4#1)(2009-6#1)
bodies can##3##2##(2008-11#1)(2008-4#1)(2009-6#1)
bodies from##4##2##(1995-11#1)(2008-10#2)(2009-8#1)
bodies have##3##2##(1997-3#1)(2008-2#1)(2008-8#1)
bodies in the oleosin knockdown##2##5##(2009-10#2)
bodies in the##16##3##(1993-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-7#1)(2008-9#1)(2009-10#2)(2010-5#1)(2011-2#1)
bodies in various##2##3##(2007-12#1)(2008-7#1)
bodies in##33##2##(1991-7#1)(1993-12#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2010-5#1)(2011-2#2)
bodies is##3##2##(2007-5#1)(2008-5#1)(2010-2#1)
bodies occur##2##2##(2007-12#1)(2008-7#1)
bodies of the##5##3##(1991-5#1)(1996-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
bodies of##17##2##(1990-12#1)(1990-5#1)(1991-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
bodies or##3##2##(2008-8#1)(2008-9#1)(2012-1#1)
bodies that##5##2##(1997-6#1)(2008-9#1)(2009-10#1)(2011-1#2)
bodies to the##2##3##(1996-2#1)(2008-10#1)
bodies to##4##2##(1996-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
bodies under##2##2##(2007-8#1)(2010-12#1)
bodies was##3##2##(1995-8#1)(2007-7#1)(2008-11#1)
bodies were present##2##3##(2008-6#1)(2008-7#1)
bodies were##13##2##(1991-10#1)(1992-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)
bodies with##5##2##(1995-3#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-12#1)
bodies without##2##2##(2008-5#1)(2011-2#1)
bodies##304##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-4#2)(1993-12#3)(1993-3#1)(1993-9#1)(1994-2#2)(1994-7#1)(1995-11#3)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#5)(1996-2#1)(1996-5#3)(1997-2#1)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#22)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#32)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#33)(2008-8#6)(2008-9#13)(2009-10#11)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#5)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#8)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#6)
bodies)##3##1##(2007-8#1)(2008-7#1)(2008-8#1)
bodily pain##3##2##(2007-11#2)(2009-11#1)
bodily##9##1##(1996-3#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-5#1)(2009-10#1)(2009-11#1)(2012-12#1)
body COM acceleration##2##3##(2013-1#2)
body after##3##2##(1995-5#1)(2008-8#1)(2008-9#1)
body against##3##2##(1994-6#1)(2007-8#1)(2008-11#1)
body and is##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
body and plays##2##3##(2008-6#1)(2012-3#1)
body and tail##4##3##(2007-5#1)(2010-1#1)(2010-12#1)(2011-1#1)
body and the##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
body and##58##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
body are##7##2##(1995-1#1)(2007-7#1)(2008-10#3)(2009-7#1)(2012-1#1)
body area##3##2##(2007-7#1)(2008-9#1)(2010-8#1)
body as##4##2##(2008-2#1)(2009-3#1)(2012-3#1)(2013-1#1)
body awareness##3##2##(2008-7#1)(2009-1#2)
body axis##4##2##(1995-8#1)(1997-4#1)(2007-12#2)
body balance##6##2##(2008-12#5)(2010-9#1)
body burden of##4##3##(2008-12#1)(2008-7#2)(2009-12#1)
body burden##7##2##(1992-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-12#1)
body by##2##2##(2007-12#1)(2007-8#1)
body can##2##2##(2008-3#1)(2009-11#1)
body cavities##3##2##(2010-9#1)(2012-1#1)(2013-8#1)
body cavity##5##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-8#1)(2008-9#1)
body change strategies##3##3##(2007-12#3)
body composition and hormonal##2##4##(2008-5#1)(2011-2#1)
body composition and inflammation in##2##5##(2011-2#2)
body composition and##11##3##(2008-5#6)(2011-2#3)(2012-2#1)(2012-3#1)
body composition assessment##2##3##(2008-5#1)(2009-11#1)
body composition in##6##3##(1990-5#1)(2008-5#1)(2008-7#2)(2012-12#1)(2012-2#1)
body composition##47##2##(1990-5#2)(1993-12#1)(1996-11#1)(1997-8#1)(2007-12#2)(2008-11#3)(2008-4#1)(2008-5#17)(2008-7#5)(2009-11#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
body condition##6##2##(1996-8#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
body core temperature##4##3##(2008-4#1)(2008-5#3)
body density##2##2##(2008-10#1)(2009-11#1)
body details##2##2##(2008-7#2)
body dissatisfaction and##5##3##(2007-12#2)(2012-2#2)(2013-8#1)
body dissatisfaction during pregnancy##2##4##(2007-12#2)
body dissatisfaction predicted##2##3##(2007-12#2)
body dissatisfaction##25##2##(2007-12#21)(2012-2#2)(2013-8#2)
body dose##3##2##(1997-1#1)(2008-7#2)
body dysmorphic disorder##2##3##(2008-1#1)(2008-6#1)
body esteem##3##2##(2007-12#3)
body examination##2##2##(2007-11#2)
body extracts##2##2##(2008-10#2)
body fat %##4##3##(2008-1#4)
body fat (-0##2##3##(2008-5#2)
body fat and muscle##2##4##(2008-7#2)
body fat and##5##3##(2008-11#1)(2008-4#1)(2008-7#2)(2010-8#1)
body fat distribution and##3##4##(1990-9#1)(2010-6#2)
body fat distribution##6##3##(1990-9#1)(2008-3#1)(2010-6#4)
body fat in##2##3##(2008-3#1)(2008-5#1)
body fat##40##2##(1990-9#2)(1997-7#1)(2007-12#2)(2008-1#4)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-7#3)(2009-7#1)(2010-4#1)(2010-6#4)(2010-8#1)(2012-2#4)(2013-8#1)
body fat) were matched according to##2##6##(2008-5#2)
body fatness##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
body fluid##4##2##(2008-4#1)(2011-2#2)(2012-2#1)
body fluids and##3##3##(2008-10#2)(2011-2#1)
body fluids##21##2##(1990-12#1)(1991-1#1)(1991-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(1997-7#1)(2007-7#2)(2008-10#7)(2008-5#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#1)
body for##2##2##(2008-11#1)(2008-9#1)
body formation##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
body fracture##3##2##(2010-5#3)
body function and##2##3##(2008-11#1)(2009-5#1)
body granuloma##2##2##(2012-12#2)
body hair##2##2##(2008-1#1)(2012-3#1)
body has##2##2##(2008-5#1)(2012-2#1)
body height and##2##3##(2007-8#1)(2008-5#1)
body height##4##2##(2007-8#2)(2008-5#1)(2012-2#1)
body homeostasis##3##2##(2009-6#1)(2012-2#2)
body image and sexual health among adolescent boys##2##8##(2009-5#2)
body image and##11##3##(2007-12#9)(2009-5#2)
body image assessment##2##3##(2007-12#2)
body image change and##2##4##(2007-12#2)
body image change##3##3##(2007-12#3)
body image concerns##6##3##(2007-12#6)
body image construct##2##3##(2007-12#2)
body image dissatisfaction and##3##4##(2007-12#2)(2012-2#1)
body image dissatisfaction##13##3##(2007-12#11)(2012-2#2)
body image disturbances##2##3##(2007-12#2)
body image improvements were correlated##2##5##(2007-12#2)
body image improvements were##3##4##(2007-12#3)
body image improvements##4##3##(2007-12#4)
body image were##2##3##(2007-12#2)
body image##82##2##(2007-12#75)(2009-5#3)(2010-11#2)(2012-2#2)
body imaging##2##2##(2010-3#1)(2012-12#1)
body in the##6##3##(2007-9#1)(2008-11#1)(2008-12#2)(2011-2#1)(2013-8#1)
body in##16##2##(1991-2#1)(1996-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-8#2)
body into the##3##3##(2009-8#2)(2011-2#1)
body irradiation with##2##3##(1992-9#1)(1995-9#1)
body irradiation##9##2##(1992-9#1)(1993-9#2)(1995-9#1)(1996-6#1)(2007-11#1)(2007-4#2)(2008-1#1)
body is##9##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2013-8#1)
body kinematics of##2##3##(2011-2#2)
body kinematics##3##2##(2008-6#1)(2011-2#2)
body language##2##2##(2011-2#2)
body length of##3##3##(2008-6#1)(2013-1#2)
body length##7##2##(2008-6#2)(2008-8#1)(2013-1#3)(2013-7#1)
body load##2##2##(1992-11#1)(2007-12#1)
body locations##3##2##(2007-6#1)(2009-9#1)(2013-1#1)
body lotion##3##2##(2008-10#3)
body mass by##2##3##(1997-4#1)(2007-8#1)
body mass estimate##2##3##(2011-2#2)
body mass has##2##3##(2008-8#1)(2012-12#1)
body mass in##3##3##(2008-5#1)(2008-9#1)(2010-2#1)
body mass index &gt##2##4##(2011-2#1)(2013-8#1)
body mass index (BMI) and##5##5##(2007-12#3)(2008-3#1)(2013-1#1)
body mass index (BMI) of##3##5##(2008-12#1)(2008-3#1)(2012-12#1)
body mass index (BMI) was##2##5##(2008-1#1)(2008-9#1)
body mass index (BMI) were##2##5##(2008-7#1)(2010-1#1)
body mass index (BMI)##37##4##(1991-11#1)(1994-12#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-9#1)(2010-1#1)(2010-4#2)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
body mass index (r = 0##2##6##(2008-8#1)(2010-4#1)
body mass index and serum cholesterol##2##6##(2008-7#2)
body mass index and##9##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2011-2#2)
body mass index as##2##4##(1993-12#1)(2011-1#1)
body mass index is##3##4##(2007-8#1)(2011-1#1)(2011-2#1)
body mass index of##2##4##(2008-11#1)(2008-7#1)
body mass index on##2##4##(2009-2#1)(2011-1#1)
body mass index or##2##4##(2009-6#1)(2011-2#1)
body mass index##118##3##(1990-3#1)(1991-11#2)(1991-12#2)(1993-12#1)(1994-12#4)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#4)(2009-2#2)(2009-6#2)(2009-9#2)(2010-1#1)(2010-4#4)(2010-6#2)(2010-7#1)(2011-1#10)(2011-2#14)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#13)(2013-8#3)
body mass indices##2##3##(2009-3#1)(2012-2#1)
body mass##161##2##(1990-3#1)(1991-11#2)(1991-12#2)(1993-12#1)(1994-12#4)(1995-2#2)(1995-3#1)(1997-4#1)(1997-8#1)(2007-12#6)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-3#4)(2008-5#7)(2008-6#1)(2008-7#18)(2008-8#5)(2008-9#8)(2009-2#2)(2009-3#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#4)(2010-6#2)(2010-7#1)(2011-1#10)(2011-2#16)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#15)(2013-8#6)
body mass)##3##2##(2008-3#1)(2010-8#1)(2012-2#1)
body measurements##3##2##(1996-8#2)(2007-12#1)
body metabolism##2##2##(2008-5#1)(2013-8#1)
body modification practices##2##3##(2007-12#2)
body occlusion in##2##3##(2008-7#2)
body odours##2##2##(2008-5#2)
body of data##5##3##(1993-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)
body of evidence has accumulated##2##5##(1992-3#1)(2008-7#1)
body of evidence indicates that##2##5##(1994-9#1)(2009-3#1)
body of evidence indicates##3##4##(1990-9#1)(1994-9#1)(2009-3#1)
body of evidence suggests that##2##5##(2007-12#1)(2013-8#1)
body of evidence that##3##4##(1997-7#1)(2008-3#1)(2009-2#1)
body of evidence##20##3##(1990-9#1)(1992-3#1)(1994-3#1)(1994-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
body of knowledge##3##3##(1995-12#1)(2008-12#1)(2011-1#1)
body of literature on##2##4##(2008-8#1)(2012-3#1)
body of literature##10##3##(1991-12#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-8#1)(2012-3#1)
body of research##9##3##(1993-1#1)(2007-6#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
body of the##16##3##(1990-12#1)(1992-5#1)(1996-10#1)(2007-5#1)(2008-10#3)(2008-5#2)(2008-7#3)(2009-7#1)(2010-5#2)(2010-6#1)
body of##94##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-10#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-2#1)(2010-5#6)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
body on##3##2##(1996-12#1)(2007-8#1)(2013-1#1)
body or##6##2##(1995-5#1)(1995-6#1)(1996-2#1)(2007-11#2)(2011-2#1)
body organs and##2##3##(1994-5#1)(2008-10#1)
body organs##8##2##(1994-5#1)(2008-10#1)(2008-12#2)(2008-7#3)(2011-2#1)
body paragangliomas##2##2##(1996-8#2)
body parts##5##2##(1991-3#1)(1992-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
body perceptions and behavior##3##4##(2010-7#3)
body plans##2##2##(2009-6#1)(2010-4#1)
body position##4##2##(1990-9#1)(2008-5#2)(2009-4#1)
body posture after##2##3##(1991-2#2)
body posture##9##2##(1991-2#5)(2007-11#1)(2009-8#3)
body proportions##2##2##(2013-1#1)(2013-7#1)
body representation##2##2##(1995-8#1)(2009-2#1)
body righting##2##2##(1992-12#2)
body rotations in##2##3##(1995-5#1)(2008-3#1)
body rotations##3##2##(1995-5#2)(2008-3#1)
body satisfaction may co-occur among##2##5##(2012-2#2)
body satisfaction were##2##3##(2009-5#1)(2010-10#1)
body satisfaction##16##2##(2007-12#5)(2008-9#2)(2009-5#1)(2010-10#5)(2012-2#2)(2013-8#1)
body shape and size##2##4##(2007-12#1)(2007-7#1)
body shape and##4##3##(2007-12#3)(2007-7#1)
body shape##16##2##(2007-12#5)(2007-7#9)(2010-8#1)(2013-7#1)
body signals##4##2##(2008-11#4)
body site##4##2##(2008-5#2)(2009-4#2)
body sites##2##2##(2008-5#2)
body size and shape in##2##5##(2013-7#2)
body size and##15##3##(2007-12#4)(2008-8#5)(2008-9#1)(2010-3#1)(2010-8#2)(2013-7#2)
body size at##3##3##(2008-8#2)(2008-9#1)
body size in##2##3##(1995-2#1)(2008-8#1)
body size is##3##3##(2008-8#2)(2013-7#1)
body size may##2##3##(2007-12#1)(2011-1#1)
body size of##2##3##(2008-8#1)(2008-9#1)
body size##64##2##(1991-12#1)(1995-2#2)(2007-12#13)(2008-5#1)(2008-8#15)(2008-9#9)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#3)(2012-3#3)(2013-1#3)(2013-7#5)
body size)##2##2##(2008-8#1)(2010-8#1)
body sizes##5##2##(2007-12#4)(2009-10#1)
body stalk##2##2##(1997-3#2)
body strength##2##2##(2010-1#2)
body structure##2##2##(1997-7#1)(2007-12#1)
body surface area##8##3##(1990-6#1)(2008-8#2)(2009-4#1)(2010-5#1)(2011-2#2)(2012-1#1)
body surface##16##2##(1990-6#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-1#1)
body surveillance##2##2##(2007-12#2)
body sway##3##2##(1994-1#1)(1995-5#1)(2012-3#1)
body systems##2##2##(2008-10#1)(2009-10#1)
body temperature and##7##3##(1992-2#1)(1995-3#2)(2007-2#1)(2008-5#1)(2013-1#2)
body temperature in##2##3##(2007-10#1)(2008-8#1)
body temperature variations##2##3##(2013-7#2)
body temperature##29##2##(1991-11#1)(1992-2#2)(1995-3#2)(2007-10#4)(2007-2#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-11#1)(2010-5#2)(2013-1#2)(2013-7#4)
body temperatures##3##2##(1992-3#1)(2008-3#1)(2008-8#1)
body tissues##3##2##(1996-3#2)(2011-2#1)
body to##5##2##(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
body volume##3##2##(2007-12#3)
body wall##3##2##(1997-3#1)(1997-7#1)(2007-12#1)
body was##6##2##(1995-5#1)(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#2)
body water##6##2##(1997-8#2)(2008-7#2)(2009-11#1)(2012-3#1)
body weight (BW)##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
body weight and body composition##2##5##(2012-1#1)(2012-2#1)
body weight and body##5##4##(2007-12#1)(2008-9#2)(2012-1#1)(2012-2#1)
body weight and feed##2##4##(1997-3#1)(2008-12#1)
body weight and##28##3##(1992-10#2)(1995-3#1)(1997-3#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)
body weight changes##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
body weight daily##2##3##(1992-11#1)(2012-3#1)
body weight for##3##3##(2008-12#1)(2008-7#1)(2008-9#1)
body weight gain and##2##4##(1996-12#1)(2008-5#1)
body weight gain of##4##4##(2008-9#4)
body weight gain##13##3##(1996-12#1)(2008-12#2)(2008-5#2)(2008-9#4)(2010-4#3)(2013-1#1)
body weight gains of##2##4##(2008-9#1)(2011-2#1)
body weight gains##5##3##(2008-5#3)(2008-9#1)(2011-2#1)
body weight in acetone 5 days per week for##10##9##(2008-9#10)
body weight in acetone##11##4##(2008-9#11)
body weight in ethanol##5##4##(2008-9#5)
body weight in two##2##4##(2008-10#1)(2008-12#1)
body weight in##25##3##(1993-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#19)
body weight loss##2##3##(2008-10#1)(2013-8#1)
body weight of##9##3##(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
body weight or##5##3##(1994-12#1)(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#1)
body weight significantly reduced the##3##5##(2008-4#2)(2013-7#1)
body weight to males and##4##5##(2008-8#1)(2008-9#3)
body weight to##5##3##(2008-8#1)(2008-9#3)(2010-4#1)
body weight##188##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#3)(1996-12#3)(1996-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#5)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#9)(2008-3#5)(2008-4#5)(2008-5#13)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#31)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-11#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#2)(2012-1#3)(2012-2#6)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#6)
body weight) was##3##3##(1997-6#1)(2008-10#1)(2012-2#1)
body weight)##10##2##(1995-2#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
body weight/day##3##2##(1991-12#1)(1995-3#1)(2008-10#1)
body weight/day)##2##2##(1991-5#1)(1993-11#1)
body weights at##2##3##(1991-12#1)(2012-2#1)
body weights in##2##3##(2008-12#1)(2008-9#1)
body weights of 50##2##4##(2008-8#1)(2008-9#1)
body weights of dosed groups were similar to those of the vehicle##5##12##(2008-9#5)
body weights of dosed groups##7##5##(2008-9#7)
body weights of dosed##10##4##(2008-9#10)
body weights of males##4##4##(2008-9#4)
body weights of the##2##4##(2008-9#2)
body weights of##37##3##(2008-5#1)(2008-8#3)(2008-9#33)
body weights were similar to those of vehicle controls##2##9##(2008-9#2)
body weights were similar to those of##3##7##(2008-9#3)
body weights##56##2##(1991-12#1)(1997-6#1)(2008-10#2)(2008-12#3)(2008-5#1)(2008-8#4)(2008-9#42)(2009-5#1)(2012-2#1)
body were##4##2##(1992-3#1)(2008-5#2)(2008-7#1)
body which##5##2##(2007-12#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)
body with##6##2##(1996-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-8#1)
body without##3##2##(1990-9#1)(1994-5#1)(2013-1#1)
body wt##15##2##(1992-2#1)(1992-5#4)(1993-11#1)(1995-3#2)(1996-5#1)(2008-10#2)(2012-3#1)(2013-1#3)
body##1656##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#6)(1991-1#2)(1991-11#4)(1991-12#6)(1991-2#7)(1991-3#2)(1991-5#2)(1991-6#5)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#6)(1992-3#10)(1992-4#1)(1992-5#6)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-12#8)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#9)(1995-2#6)(1995-3#12)(1995-5#7)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#2)(1996-8#9)(1997-1#3)(1997-2#4)(1997-3#8)(1997-4#4)(1997-6#4)(1997-7#6)(1997-8#7)(2007-10#4)(2007-11#19)(2007-12#198)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#26)(2007-8#26)(2007-9#1)(2008-1#18)(2008-10#86)(2008-11#40)(2008-12#38)(2008-2#8)(2008-3#30)(2008-4#18)(2008-5#106)(2008-6#15)(2008-7#90)(2008-8#50)(2008-9#111)(2009-1#2)(2009-10#10)(2009-11#16)(2009-12#4)(2009-2#4)(2009-3#8)(2009-4#9)(2009-5#13)(2009-6#6)(2009-7#6)(2009-8#7)(2009-9#4)(2010-1#6)(2010-10#10)(2010-11#4)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#17)(2010-5#17)(2010-6#12)(2010-7#5)(2010-8#18)(2010-9#4)(2011-1#24)(2011-2#66)(2011-3#5)(2012-1#11)(2012-12#16)(2012-2#49)(2012-3#24)(2013-1#74)(2013-7#20)(2013-8#41)
body's##14##1##(1992-11#1)(1997-6#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-1#1)
body)##2##1##(2010-7#1)(2011-1#1)
body-like##2##1##(2008-10#1)(2012-1#1)
body-outline##2##1##(1992-3#2)
body-size##2##1##(2007-12#1)(2008-8#1)
body-weight category##2##2##(2009-2#2)
body-weight##6##1##(1991-5#1)(2007-7#2)(2009-2#2)(2009-6#1)
bodyweight##5##1##(1995-8#1)(1996-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
bog water)##2##2##(2008-10#2)
bog##3##1##(2008-10#2)(2008-8#1)
bogs##2##1##(2008-8#2)
bohemine##6##1##(2008-11#6)
boiled##5##1##(1994-11#1)(2008-10#4)
boiler water##2##2##(2008-10#2)
boiling point and##2##3##(2007-11#1)(2008-10#1)
boiling point of##2##3##(2007-11#1)(2011-2#1)
boiling point##8##2##(2007-11#4)(2008-10#3)(2011-2#1)
boiling points of##5##3##(2007-11#4)(2008-10#1)
boiling points##9##2##(2007-11#6)(2008-10#3)
boiling##33##1##(1995-3#1)(1996-12#1)(2007-11#12)(2008-10#15)(2008-12#1)(2008-7#1)(2011-2#2)
bold##5##1##(2008-9#3)(2010-6#1)(2011-2#1)
boldine##2##1##(1996-5#1)(2007-1#1)
boldly##3##1##(1995-3#1)(2008-8#1)(2012-3#1)
boldness##2##1##(2008-8#2)
bole##3##1##(2008-10#3)
boll##7##1##(2008-10#2)(2011-2#5)
bolls##11##1##(2008-10#5)(2011-2#6)
bolometer array##4##2##(2008-3#4)
bolometer##8##1##(2008-2#1)(2008-3#7)
bolometers##9##1##(2008-3#9)
bolstered by##3##2##(2008-1#1)(2008-7#1)(2010-8#1)
bolt##2##1##(2007-7#1)(2007-8#1)
bolus dispersion##6##2##(1997-2#6)
bolus dose of##3##3##(1993-1#1)(2007-7#1)(2007-9#1)
bolus dose##5##2##(1993-1#1)(2007-7#1)(2007-9#1)(2008-11#1)(2011-2#1)
bolus doses##2##2##(2007-12#1)(2007-7#1)
bolus injection of Talipexole##2##4##(2007-10#2)
bolus injection of##4##3##(1992-5#1)(1996-9#1)(2007-10#2)
bolus injection##9##2##(1992-5#1)(1996-9#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-6#3)
bolus insulin##2##2##(2008-1#2)
bolus is injected##2##3##(1997-1#1)(2008-10#1)
bolus is##3##2##(1997-1#1)(2008-10#1)(2008-7#1)
bolus of##4##2##(1996-11#1)(2007-9#1)(2008-10#1)(2008-7#1)
bolus##53##1##(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-1#2)(1997-2#6)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-6#4)(2008-7#4)(2008-8#1)(2009-7#1)(2011-2#3)(2012-1#1)(2013-8#4)
boluses##2##1##(2007-7#1)(2013-8#1)
bomb and##4##2##(1995-12#1)(2008-10#3)
bomb explosion##2##2##(2007-8#2)
bomb##15##1##(1991-5#1)(1995-12#1)(1996-12#1)(2007-8#2)(2008-10#5)(2013-1#5)
bombacina##2##1##(2008-10#2)
bombarded with##2##2##(2008-5#1)(2008-7#1)
bombarded##6##1##(2008-10#1)(2008-5#4)(2008-7#1)
bombardment (FAB)##2##2##(1995-3#1)(2008-4#1)
bombardment mass spectrometry##5##3##(1993-11#1)(1994-3#3)(1995-11#1)
bombardment mass##7##2##(1990-12#1)(1993-11#1)(1994-3#3)(1995-11#1)(2008-10#1)
bombardment of##2##2##(2008-10#1)(2008-5#1)
bombardment##27##1##(1990-12#1)(1991-2#1)(1993-11#1)(1994-3#3)(1995-11#1)(1995-3#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-4#1)
bombesin and##2##2##(1991-12#1)(2008-7#1)
bombesin##12##1##(1991-12#5)(1992-8#1)(1994-3#4)(2008-7#1)(2010-6#1)
bombolitin III##4##2##(1994-5#4)
bombs and##2##2##(2008-10#2)
bombs##6##1##(2008-10#4)(2008-12#1)(2013-1#1)
bombykol##2##1##(2007-12#1)(2008-10#1)
bombyxin genes have##2##3##(2008-6#2)
bombyxin genes##3##2##(2008-6#3)
bombyxin##6##1##(2008-6#6)
bona fide##3##2##(1995-2#1)(2008-4#1)(2008-9#1)
bona##4##1##(1995-2#1)(2008-4#1)(2008-9#1)(2010-8#1)
bond and##9##2##(1990-8#1)(1995-11#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
bond angle##2##2##(1992-9#1)(2008-8#1)
bond angles##6##2##(1992-4#1)(1997-4#1)(2008-8#2)(2008-9#2)
bond are##2##2##(1994-3#1)(2007-11#1)
bond assignments##2##2##(1993-8#2)
bond at##3##2##(1992-12#1)(1995-6#1)(2008-9#1)
bond between the##3##3##(1992-3#1)(1993-1#1)(1994-5#1)
bond between##12##2##(1990-7#1)(1992-3#3)(1993-1#2)(1994-5#1)(1995-2#2)(1995-5#1)(2008-10#1)(2008-5#1)
bond cleavage of##3##3##(2008-4#1)(2010-2#1)(2010-4#1)
bond cleavage##7##2##(1990-2#1)(1993-11#1)(1996-5#2)(2008-4#1)(2010-2#1)(2010-4#1)
bond distances##4##2##(1993-8#1)(1996-2#2)(2008-10#1)
bond formation in##3##3##(1993-9#1)(2008-1#1)(2009-9#1)
bond formation##11##2##(1990-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(2008-1#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-2#1)
bond forming##3##2##(2008-10#2)(2010-7#1)
bond hydrolysis##2##2##(1991-8#1)(2011-1#1)
bond in the##8##3##(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(2007-11#1)(2007-7#1)
bond in##13##2##(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-5#2)(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)
bond induced by##2##3##(1996-5#1)(2008-10#1)
bond is##3##2##(1995-2#1)(1997-7#1)(2007-11#1)
bond length and##2##3##(2008-8#1)(2008-9#1)
bond length of##2##3##(2008-9#1)(2011-2#1)
bond length##5##2##(1996-2#1)(2008-8#1)(2008-9#2)(2011-2#1)
bond lengths and 1##3##4##(1992-4#1)(1997-4#1)(2008-8#1)
bond lengths and##6##3##(1992-4#2)(1997-4#1)(2008-8#2)(2008-9#1)
bond of the##2##3##(2008-10#1)(2008-5#1)
bond of##7##2##(1990-12#1)(1990-2#1)(1990-5#1)(2008-10#2)(2008-5#1)(2012-12#1)
bond strength and##3##3##(2008-12#1)(2013-1#2)
bond strength for##2##3##(2008-12#1)(2009-8#1)
bond strength of##13##3##(2008-12#3)(2009-8#2)(2010-12#1)(2013-1#7)
bond strength when##2##3##(2013-1#2)
bond strength##28##2##(2008-12#8)(2009-8#3)(2010-12#1)(2013-1#15)(2013-7#1)
bond strengths##4##2##(2008-12#1)(2009-8#1)(2013-1#2)
bond to the##3##3##(1992-6#1)(1993-11#1)(2008-3#1)
bond to##6##2##(1991-2#1)(1992-6#1)(1993-11#1)(1995-3#1)(1997-7#1)(2008-3#1)
bond was##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
bond with the##2##3##(1995-8#1)(1996-5#1)
bond with##8##2##(1990-8#1)(1991-5#1)(1992-3#1)(1992-9#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-12#1)
bond##275##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-7#3)(1990-8#6)(1991-11#1)(1991-2#2)(1991-5#4)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#5)(1992-12#2)(1992-3#7)(1992-4#6)(1992-6#8)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#7)(1993-3#1)(1993-6#1)(1993-8#7)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#4)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#2)(1996-2#8)(1996-5#7)(1997-2#1)(1997-4#3)(1997-7#7)(2007-11#9)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#12)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#8)(2008-9#12)(2009-11#2)(2009-8#6)(2009-9#3)(2010-12#4)(2010-2#1)(2010-4#5)(2010-5#1)(2010-7#7)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#20)(2013-7#1)
bond-breaking##2##1##(1992-6#1)(2008-5#1)
bonded diethylenetriamine##2##2##(2008-10#2)
bonded glucose##3##2##(2008-10#3)
bonded onto##3##2##(2008-2#1)(2009-8#2)
bonded phase##4##2##(1992-6#1)(2008-10#3)
bonded silica gel##2##3##(2008-10#2)
bonded silica stationary phase##3##4##(2008-10#3)
bonded silica stationary phases##2##4##(2008-10#2)
bonded silica stationary##5##3##(2008-10#5)
bonded silica##12##2##(1990-8#1)(2008-10#11)
bonded to a##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
bonded to the surface##2##4##(2008-3#1)(2010-4#1)
bonded to the##8##3##(1994-5#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
bonded to##19##2##(1994-5#1)(1995-2#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
bonded with##5##2##(2008-10#2)(2009-7#2)(2013-1#1)
bonded##72##1##(1990-8#2)(1991-3#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#4)(1995-5#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#32)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#2)(2009-8#3)(2010-4#1)(2013-1#2)
bonding and##10##2##(1991-8#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-12#1)
bonding between the##3##3##(2008-3#1)(2008-7#1)(2009-11#1)
bonding between##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)
bonding in the##4##3##(1991-1#1)(1991-8#1)(2008-10#1)(2008-4#1)
bonding in##6##2##(1991-1#1)(1991-8#1)(1995-5#1)(2008-10#1)(2008-4#1)(2012-1#1)
bonding interactions##5##2##(1993-8#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-7#1)
bonding is##2##2##(1991-9#1)(1995-5#1)
bonding of the##2##3##(2008-10#1)(2010-4#1)
bonding of##5##2##(2008-10#4)(2010-4#1)
bonding pads are##2##3##(2008-3#2)
bonding process##2##2##(2008-11#1)(2008-3#1)
bonding protocol##2##2##(2008-7#1)(2013-1#1)
bonding through an##2##3##(2008-10#2)
bonding to##3##2##(1990-8#1)(2008-3#1)(2009-9#1)
bonding within##2##2##(1991-8#1)(2010-12#1)
bonding##105##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-5#2)(1991-8#4)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#9)(2007-11#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#4)(2009-10#4)(2009-11#3)(2009-12#1)(2009-7#1)(2009-9#3)(2010-12#4)(2010-4#4)(2010-7#1)(2012-1#2)(2012-2#1)(2013-1#7)(2013-7#1)
bonds and the##3##3##(1990-5#2)(2007-11#1)
bonds and##7##2##(1990-5#2)(1991-3#1)(1992-10#1)(1996-5#1)(2007-11#2)
bonds are##8##2##(1990-5#1)(1992-12#1)(1993-9#1)(1994-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2013-1#1)
bonds as##3##2##(1992-3#1)(1992-8#1)(2011-1#1)
bonds between##6##2##(1992-6#1)(1995-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-1#1)
bonds can##2##2##(2008-10#1)(2008-11#1)
bonds for##2##2##(1993-11#1)(2008-12#1)
bonds in the##2##3##(1995-5#1)(2006-12#1)
bonds in##12##2##(1990-7#1)(1992-3#1)(1995-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-12#1)(2010-5#1)
bonds of the##2##3##(1991-5#1)(1992-10#1)
bonds of##9##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-10#1)(1993-11#1)(1996-1#1)(1996-5#1)(2007-11#1)(2013-1#1)
bonds on the carboxyl side of##2##6##(1994-5#2)
bonds on##3##2##(1994-5#2)(2008-10#1)
bonds to##3##2##(1990-5#1)(1994-5#1)(1996-2#1)
bonds were##5##2##(1990-5#2)(1994-9#1)(2008-10#1)(2009-7#1)
bonds which could##2##3##(1990-5#1)(1992-5#1)
bonds with the##3##3##(1992-8#1)(2008-10#2)
bonds with##6##2##(1991-8#1)(1992-8#1)(2008-10#2)(2008-7#1)(2012-2#1)
bonds##152##1##(1990-12#1)(1990-5#8)(1990-7#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#4)(1993-11#3)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#6)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#4)(1996-1#1)(1996-2#3)(1996-5#2)(1997-7#2)(2006-12#1)(2007-11#5)(2007-12#1)(2008-1#4)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#3)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#3)(2012-1#2)(2012-2#2)(2013-1#3)
bone ALP levels were##2##4##(1991-5#2)
bone ALP##8##2##(1991-5#8)
bone GLA-protein##4##2##(1990-2#4)
bone abnormalities##2##2##(2010-3#1)(2013-1#1)
bone age##2##2##(2011-2#2)
bone alkaline phosphatase##2##3##(1992-6#1)(2009-5#1)
bone allograft##3##2##(1992-12#1)(1997-8#1)(2012-12#1)
bone allografts##4##2##(1992-12#2)(1996-3#2)
bone and are##2##3##(2007-11#1)(2010-3#1)
bone and cartilage##3##3##(1990-11#2)(2013-7#1)
bone and joint##3##3##(2010-3#1)(2013-8#2)
bone and liver alkaline phosphatase##2##5##(1991-5#2)
bone and soft tissue tumors##2##5##(2011-2#2)
bone and soft tissue##8##4##(2008-6#4)(2008-8#1)(2009-4#1)(2011-2#2)
bone and soft tissues##2##4##(2008-6#1)(2010-6#1)
bone and soft##10##3##(2008-6#5)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#2)
bone and the##2##3##(2008-10#1)(2012-1#1)
bone and##50##2##(1990-11#2)(1991-5#2)(1994-12#1)(1996-6#1)(2007-11#7)(2008-10#2)(2008-6#9)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#3)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#5)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#4)
bone architecture and bone mineral properties##2##6##(2011-2#2)
bone architecture##4##2##(2009-7#1)(2011-2#3)
bone are##4##2##(1995-6#1)(2006-12#1)(2009-7#1)(2011-2#1)
bone around##2##2##(2008-11#1)(2008-5#1)
bone at##2##2##(1993-11#1)(1995-11#1)
bone atrophy##2##2##(2011-7#1)(2013-1#1)
bone becomes##2##2##(2008-11#1)(2012-12#1)
bone biopsies##3##2##(1991-11#2)(2008-4#1)
bone biopsy##4##2##(1991-11#2)(1997-6#1)(2006-10#1)
bone by##5##2##(1997-1#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
bone calcium content##2##3##(2011-1#2)
bone calcium##4##2##(1990-9#1)(2011-1#3)
bone can##2##2##(2009-4#1)(2010-6#1)
bone cell##3##2##(1990-11#1)(2008-7#1)(2009-7#1)
bone cells in##2##3##(1994-6#1)(2008-11#1)
bone cells##12##2##(1993-11#1)(1994-11#1)(1994-6#2)(1997-1#1)(2007-11#1)(2008-11#3)(2008-7#1)(2010-9#1)(2011-1#1)
bone cement in the treatment of##2##6##(2007-11#1)(2007-8#1)
bone cement##7##2##(2007-11#5)(2007-8#2)
bone changes and##2##3##(2008-9#1)(2011-2#1)
bone changes##4##2##(2008-10#1)(2008-9#2)(2011-2#1)
bone cholesteatoma##5##2##(2011-2#5)
bone cuts##2##2##(2009-4#2)
bone cyst##8##2##(2006-10#1)(2012-12#5)(2013-1#2)
bone cysts##4##2##(2012-12#1)(2013-1#3)
bone defect##7##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)
bone defects was##2##3##(2008-11#2)
bone defects##7##2##(2007-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-6#1)
bone deformities##2##2##(2008-4#1)(2009-4#1)
bone deformity in##2##3##(1997-3#2)
bone deformity##6##2##(1990-6#1)(1997-3#5)
bone demineralization and##2##3##(2007-8#1)(2013-1#1)
bone densitometry##4##2##(1997-6#2)(2008-8#1)(2011-2#1)
bone density and##5##3##(1991-11#1)(2007-8#2)(2008-8#1)(2012-2#1)
bone density by##2##3##(1991-11#1)(2008-8#1)
bone density in##2##3##(2007-7#1)(2012-2#1)
bone density measurement##2##3##(1994-12#1)(2007-8#1)
bone density##27##2##(1991-11#3)(1993-7#1)(1994-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#6)(2009-12#1)(2012-2#2)(2013-1#2)
bone destruction and##3##3##(2010-6#2)(2012-3#1)
bone destruction that##2##3##(2007-11#1)(2008-7#1)
bone destruction##13##2##(1992-3#1)(2006-12#1)(2007-11#3)(2008-12#1)(2008-7#2)(2010-6#2)(2012-12#1)(2012-3#2)
bone development##3##2##(1991-5#2)(2013-1#1)
bone disease resulting##2##3##(2008-11#1)(2013-1#1)
bone disease##19##2##(1997-6#2)(2007-11#2)(2008-11#1)(2008-4#2)(2008-7#3)(2010-4#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
bone diseases##2##2##(1991-5#1)(2008-5#1)
bone erosion##3##2##(2011-2#3)
bone explants##5##2##(2009-7#3)(2010-9#2)
bone flap##4##2##(2006-12#1)(2008-7#3)
bone for##2##2##(2010-3#1)(2011-2#1)
bone formation in##5##3##(1994-12#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
bone formation is##2##3##(2008-8#1)(2013-1#1)
bone formation was##2##3##(1991-5#1)(2008-5#1)
bone formation##35##2##(1990-11#1)(1991-5#1)(1993-11#4)(1994-12#1)(1994-2#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
bone fracture##6##2##(1991-2#1)(2007-11#2)(2007-8#1)(2008-8#1)(2009-7#1)
bone fractures in##3##3##(1991-6#1)(1993-11#1)(2007-11#1)
bone fractures##12##2##(1991-6#1)(1993-11#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#2)(2013-1#1)
bone fragility##2##2##(1993-11#1)(2011-1#1)
bone fragments##6##2##(1995-6#1)(2007-8#1)(2013-1#4)
bone from##6##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(2008-4#1)(2008-7#1)
bone geometry##2##2##(2008-12#1)(2009-4#1)
bone graft donor site##3##4##(2008-6#3)
bone graft in##3##3##(2008-8#2)(2010-5#1)
bone graft incorporation##2##3##(2008-11#2)
bone graft substitutes##5##3##(2008-8#4)(2010-6#1)
bone graft to##3##3##(2008-6#1)(2008-8#1)(2010-6#1)
bone graft##38##2##(1995-12#2)(2007-11#4)(2007-12#2)(2008-11#3)(2008-12#1)(2008-6#5)(2008-8#8)(2009-10#1)(2009-3#1)(2009-7#1)(2010-5#2)(2010-6#2)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
bone grafting##20##2##(1996-3#1)(2007-11#1)(2007-12#3)(2008-6#1)(2008-8#5)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-3#2)
bone grafts was##2##3##(2007-11#1)(2009-4#1)
bone grafts were##2##3##(2007-11#1)(2009-4#1)
bone grafts##15##2##(1992-4#1)(2007-11#7)(2007-8#1)(2009-4#4)(2010-6#2)
bone growth##3##2##(1996-11#1)(2008-11#1)(2013-1#1)
bone health##6##2##(2008-12#1)(2008-5#1)(2010-10#2)(2012-2#1)(2013-8#1)
bone height##4##2##(2012-12#1)(2013-1#3)
bone in 1##2##3##(2006-10#2)
bone in a##5##3##(1990-6#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#1)
bone in the##11##3##(1990-11#1)(1990-12#2)(2007-12#1)(2007-8#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
bone in##33##2##(1990-11#1)(1990-12#2)(1990-6#1)(1994-12#1)(1996-3#1)(1997-7#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
bone ingrowth and##3##3##(2008-11#3)
bone ingrowth##4##2##(2008-11#3)(2009-7#1)
bone involvement##9##2##(1991-11#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-6#1)
bone is a rare##2##4##(2008-7#1)(2009-10#1)
bone is more##3##3##(1996-3#1)(2011-2#2)
bone is presented##3##3##(2008-7#1)(2008-9#1)(2009-7#1)
bone is##20##2##(1991-11#1)(1996-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#4)(2011-2#4)
bone lesions##7##2##(2007-11#1)(2008-6#3)(2008-7#1)(2011-2#1)(2012-3#1)
bone level##3##2##(2008-11#1)(2013-1#2)
bone loss and##5##3##(1993-11#1)(2007-7#1)(2010-10#2)(2012-12#1)
bone loss in##2##3##(2008-7#1)(2010-10#1)
bone loss is##2##3##(2009-10#1)(2010-5#1)
bone loss treatment##2##3##(2011-1#2)
bone loss##47##2##(1991-11#1)(1993-11#8)(1994-9#1)(1996-3#1)(2007-7#1)(2008-11#2)(2008-12#8)(2008-7#2)(2008-8#2)(2009-10#1)(2010-10#3)(2010-5#3)(2010-6#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
bone lymphoma##4##2##(2007-5#4)
bone malignancy##2##2##(2010-3#1)(2013-8#1)
bone marrow (BM)##4##3##(2007-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
bone marrow analysis##2##3##(2008-10#2)
bone marrow and spleen##2##4##(1991-6#1)(2010-8#1)
bone marrow and##11##3##(1991-6#1)(1992-2#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-7#1)(2010-8#1)(2012-3#1)
bone marrow aspirate##8##3##(2007-4#2)(2008-11#3)(2008-12#1)(2008-7#2)
bone marrow aspirates and##2##4##(1996-2#1)(2008-11#1)
bone marrow aspirates##9##3##(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-3#1)(2012-12#1)
bone marrow aspiration and##2##4##(1994-12#1)(2011-2#1)
bone marrow aspiration##3##3##(1994-12#1)(1995-2#1)(2011-2#1)
bone marrow biopsies##2##3##(1994-10#1)(2009-8#1)
bone marrow biopsy showed##2##4##(2009-1#1)(2013-8#1)
bone marrow biopsy##3##3##(1991-6#1)(2009-1#1)(2013-8#1)
bone marrow by##2##3##(2008-4#1)(2008-5#1)
bone marrow cell##3##3##(1991-6#1)(1993-8#1)(2008-10#1)
bone marrow cells and##3##4##(1993-8#1)(1997-8#1)(2013-1#1)
bone marrow cells from##2##4##(1990-3#1)(2012-2#1)
bone marrow cells in##3##4##(2008-11#1)(2010-11#1)(2012-1#1)
bone marrow cells of##3##4##(1997-8#1)(2010-1#2)
bone marrow cells was##2##4##(1990-6#1)(2008-7#1)
bone marrow cells##35##3##(1990-3#2)(1990-5#1)(1990-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-3#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-1#2)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)
bone marrow cultures##2##3##(2008-8#1)(2013-1#1)
bone marrow derived cells##2##4##(2008-9#2)
bone marrow derived mesenchymal stem##2##5##(2008-11#1)(2008-9#1)
bone marrow derived##7##3##(1994-6#1)(2008-10#1)(2008-11#1)(2008-9#4)
bone marrow failure##2##3##(2008-11#1)(2011-1#1)
bone marrow fibrosis##4##3##(2009-8#4)
bone marrow from##2##3##(1993-9#1)(2010-11#1)
bone marrow hematopoietic stem##2##4##(1993-8#1)(2010-11#1)
bone marrow in##4##3##(1995-11#1)(2010-6#1)(2011-2#2)
bone marrow involvement##2##3##(2006-10#1)(2012-12#1)
bone marrow is##2##3##(2010-8#1)(2011-2#1)
bone marrow mesenchymal stem cells in##2##6##(2012-1#1)(2012-12#1)
bone marrow mesenchymal stem cells on##2##6##(2008-11#1)(2012-3#1)
bone marrow mesenchymal stem cells##12##5##(2008-11#4)(2009-12#2)(2010-12#1)(2012-1#2)(2012-12#2)(2012-3#1)
bone marrow mesenchymal##13##3##(2008-11#4)(2009-12#2)(2010-12#1)(2012-1#3)(2012-12#2)(2012-3#1)
bone marrow microenvironment##3##3##(2010-8#1)(2011-1#1)(2011-2#1)
bone marrow mononuclear cells in##2##5##(2010-6#1)(2012-1#1)
bone marrow mononuclear cells##6##4##(2008-10#1)(2010-6#4)(2012-1#1)
bone marrow mononuclear##7##3##(2008-10#1)(2010-6#5)(2012-1#1)
bone marrow necrosis##2##3##(2008-12#2)
bone marrow oedema##2##3##(2011-2#2)
bone marrow of##5##3##(1994-5#1)(2008-4#2)(2008-9#1)(2010-6#1)
bone marrow or stem cell##2##5##(2011-2#2)
bone marrow or##4##3##(2008-11#1)(2009-10#1)(2011-2#2)
bone marrow recovery##4##3##(1991-6#1)(2011-2#3)
bone marrow smears##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
bone marrow specimens##3##3##(2007-10#1)(2008-4#1)(2009-8#1)
bone marrow stem##3##3##(2010-11#1)(2010-8#1)(2012-2#1)
bone marrow stromal cell line##4##5##(2008-10#1)(2008-11#3)
bone marrow stromal cell##5##4##(2008-10#1)(2008-11#3)(2011-1#1)
bone marrow stromal cells##2##4##(2008-11#1)(2009-4#1)
bone marrow stromal##7##3##(2008-10#1)(2008-11#4)(2009-4#1)(2011-1#1)
bone marrow suppression##4##3##(1991-2#1)(2006-10#1)(2008-11#1)(2011-2#1)
bone marrow toxicity was##2##4##(1991-2#1)(2008-5#1)
bone marrow toxicity##3##3##(1991-2#1)(2008-11#1)(2008-5#1)
bone marrow transplant##4##3##(1995-1#1)(2007-12#1)(2008-11#1)(2013-8#1)
bone marrow transplantation (BMT)##2##4##(2007-4#1)(2008-1#1)
bone marrow transplantation or##2##4##(1993-2#1)(2008-11#1)
bone marrow transplantation was##2##4##(1997-3#1)(2010-6#1)
bone marrow transplantation##26##3##(1991-2#1)(1993-2#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(1997-3#2)(1997-5#1)(1997-7#3)(2007-4#2)(2008-1#1)(2008-11#4)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
bone marrow transplantation]##3##3##(1991-5#1)(1993-3#1)(2008-1#1)
bone marrow transplants##2##3##(1991-2#1)(2008-5#1)
bone marrow-derived endothelial progenitor cells##2##5##(2009-11#1)(2012-3#1)
bone marrow-derived stromal cells##2##4##(2008-8#2)
bone marrow-derived stromal##3##3##(2008-11#1)(2008-8#2)
bone marrow-derived##11##2##(1992-10#1)(1997-8#1)(2008-11#2)(2008-8#2)(2009-11#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#1)
bone marrows##2##2##(2008-10#1)(2008-5#1)
bone mass and##8##3##(1993-11#4)(2008-8#2)(2010-10#1)(2010-3#1)
bone mass in##2##3##(1991-11#1)(2010-3#1)
bone mass is##3##3##(1993-11#1)(2007-7#1)(2009-3#1)
bone mass measurements##3##3##(1993-11#2)(2008-4#1)
bone mass##39##2##(1991-11#3)(1993-11#19)(1997-8#2)(2007-7#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-3#1)(2010-10#2)(2010-3#2)(2011-1#2)(2011-2#2)(2013-1#1)
bone matrix##10##2##(1991-11#1)(1991-12#1)(1991-5#2)(1993-11#2)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#1)
bone may##2##2##(2008-12#1)(2011-2#1)
bone mechanical##2##2##(2007-8#1)(2010-10#1)
bone metabolism##15##2##(1991-11#1)(1992-6#1)(1993-11#1)(1997-7#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
bone metastases and##4##3##(1996-9#1)(2007-11#3)
bone metastases are##5##3##(2007-11#4)(2011-2#1)
bone metastases from breast cancer##3##5##(2007-11#1)(2008-7#2)
bone metastases from##9##3##(2007-11#3)(2008-10#1)(2008-7#4)(2013-7#1)
bone metastases in##4##3##(2007-11#3)(2008-7#1)
bone metastases of##2##3##(1991-2#1)(2007-11#1)
bone metastases to the hip##2##5##(2007-11#2)
bone metastases to the proximal epiphysis of the femur##2##9##(2007-11#2)
bone metastases to the##6##4##(2007-11#6)
bone metastases to##8##3##(2007-11#8)
bone metastases treated##3##3##(2007-11#2)(2008-7#1)
bone metastases treatment##2##3##(2007-11#2)
bone metastases were##2##3##(2007-11#1)(2007-7#1)
bone metastases##99##2##(1990-2#1)(1991-2#1)(1991-8#3)(1993-11#1)(1994-7#2)(1996-9#1)(2007-10#1)(2007-11#60)(2007-7#1)(2008-1#2)(2008-10#5)(2008-7#11)(2010-3#2)(2011-2#7)(2013-7#1)
bone metastasis and##3##3##(1994-12#2)(2010-3#1)
bone metastasis##14##2##(1990-2#1)(1994-12#6)(1997-3#1)(1997-7#1)(2008-6#1)(2010-10#2)(2010-3#1)(2011-2#1)
bone metastatses##4##2##(2007-11#4)
bone mineral content (BMC)##2##4##(1991-11#1)(2011-2#1)
bone mineral content was##2##4##(1990-11#1)(1994-7#1)
bone mineral content##7##3##(1990-11#2)(1991-11#1)(1993-11#1)(1994-7#1)(2008-7#1)(2011-2#1)
bone mineral density (BMD) and##2##5##(2010-1#1)(2011-2#1)
bone mineral density (BMD) in##2##5##(2011-2#2)
bone mineral density (BMD) was measured##2##6##(2007-11#1)(2008-12#1)
bone mineral density (BMD) was##3##5##(2007-11#1)(2008-12#1)(2008-8#1)
bone mineral density (BMD)##15##4##(1991-11#1)(1993-11#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#5)(2012-2#2)
bone mineral density and##5##4##(1995-11#1)(2007-11#1)(2008-11#1)(2008-8#2)
bone mineral density in Vietnamese women##2##6##(2010-3#2)
bone mineral density in##9##4##(2007-11#1)(2007-7#1)(2008-5#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)
bone mineral density##42##3##(1991-11#2)(1993-11#1)(1995-11#1)(1995-9#1)(1996-8#2)(1997-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2010-1#2)(2010-10#1)(2010-3#3)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#1)
bone mineral mass##3##3##(2008-4#3)
bone mineral##60##2##(1990-11#2)(1991-11#3)(1993-11#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-6#2)(1995-9#1)(1996-8#2)(1997-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#2)(2010-10#1)(2010-3#3)(2011-1#1)(2011-2#12)(2012-12#2)(2012-2#4)(2012-3#1)
bone mineralization##2##2##(1997-7#1)(2009-7#1)
bone morphogenetic protein##3##3##(1994-6#1)(2008-8#1)(2012-1#1)
bone morphogenetic protein-2##3##3##(2011-2#2)(2013-8#1)
bone morphogenetic proteins (BMPs)##2##4##(2008-8#1)(2012-12#1)
bone morphogenetic proteins##4##3##(1991-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
bone morphogenetic##12##2##(1991-5#1)(1994-6#1)(1996-11#1)(2008-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2013-8#1)
bone morphogenic##2##2##(2008-8#1)(2012-3#1)
bone necroses##4##2##(2007-11#4)
bone of the##4##3##(1990-12#1)(2007-12#2)(2011-2#1)
bone of##8##2##(1990-12#1)(1991-11#1)(1995-9#1)(2007-12#2)(2008-7#1)(2011-2#2)
bone or##3##2##(2008-6#1)(2013-1#2)
bone osteomyelitis##3##2##(2010-6#3)
bone pain##12##2##(1990-6#1)(1991-11#1)(1997-7#1)(2007-11#3)(2008-10#1)(2008-7#5)
bone pains##2##2##(1991-5#1)(2008-4#1)
bone present##2##2##(1991-11#1)(2007-12#1)
bone preservation##2##2##(1996-3#1)(2007-12#1)
bone protection##2##2##(2007-11#1)(2008-11#1)
bone quality and##2##3##(2007-8#1)(2013-1#1)
bone quality##8##2##(1991-11#1)(1995-9#1)(2007-8#1)(2008-12#1)(2010-10#1)(2011-2#1)(2011-7#1)(2013-1#1)
bone regeneration in distraction osteogenesis##2##5##(2007-8#2)
bone regeneration using##2##3##(2007-12#1)(2010-6#1)
bone regeneration##9##2##(2007-12#3)(2007-8#2)(2008-5#2)(2010-6#1)(2012-12#1)
bone remodeling##9##2##(1991-11#1)(1993-11#1)(2007-11#1)(2007-8#4)(2008-8#1)(2010-9#1)
bone remodelling##10##2##(1990-5#1)(2008-7#4)(2009-4#1)(2013-1#4)
bone resection for##2##3##(1996-3#1)(2011-2#1)
bone resection with subsequent##2##4##(2007-11#2)
bone resection##8##2##(1996-3#1)(2007-11#4)(2011-2#3)
bone resorbing factors##3##3##(1993-12#3)
bone resorbing##4##2##(1993-12#3)(1993-8#1)
bone resorption and##10##3##(1992-3#1)(1993-11#3)(1997-7#1)(2007-11#2)(2007-8#1)(2008-11#1)(2013-1#1)
bone resorption by##4##3##(1992-3#1)(2008-11#2)(2010-10#1)
bone resorption in##4##3##(1992-3#1)(1993-6#2)(1995-3#1)
bone resorption induced by##2##4##(1993-6#2)
bone resorption was##3##3##(1992-3#1)(1995-3#2)
bone resorption##51##2##(1991-11#1)(1992-3#5)(1993-11#5)(1993-6#9)(1994-6#1)(1995-2#1)(1995-3#6)(1997-7#2)(2007-11#2)(2007-8#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#1)(2011-7#1)(2013-1#5)
bone resorptive##2##2##(2011-2#2)
bone samples were##2##3##(1995-6#2)
bone samples##7##2##(1995-6#2)(2008-10#1)(2009-4#3)(2011-2#1)
bone sarcoma##3##2##(2006-10#1)(2008-6#1)(2010-3#1)
bone sarcomas##7##2##(2008-6#4)(2011-1#3)
bone scan is##2##3##(2007-11#1)(2010-3#1)
bone scan##11##2##(1991-11#1)(2006-10#1)(2007-11#4)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
bone scans##3##2##(2006-10#1)(2007-11#1)(2008-7#1)
bone scintigraphic##3##2##(2011-2#3)
bone scintigraphy in##3##3##(2007-11#2)(2008-7#1)
bone scintigraphy##9##2##(2007-11#3)(2008-1#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
bone sclerosis##3##2##(1991-11#1)(2011-2#2)
bone status##2##2##(2008-1#1)(2008-8#1)
bone stock##4##2##(2007-11#3)(2011-2#1)
bone strength##4##2##(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#1)
bone structure##2##2##(2008-7#1)(2009-8#1)
bone structures##3##2##(2007-11#3)
bone substitutes##2##2##(2009-7#2)
bone surface##2##2##(1995-6#1)(2010-9#1)
bone that##2##2##(2007-12#1)(2008-8#1)
bone tissue engineering##8##3##(2008-5#1)(2009-7#6)(2012-6#1)
bone tissue in rheumatoid arthritis##2##5##(2007-11#2)
bone tissue in##3##3##(2007-11#2)(2010-6#1)
bone tissue is##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
bone tissue##33##2##(1995-6#5)(1996-3#1)(2007-11#4)(2007-8#5)(2008-12#1)(2008-5#3)(2009-3#1)(2009-4#1)(2009-7#7)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-6#1)
bone to##3##2##(1991-6#1)(2008-7#1)(2012-12#1)
bone toxicity in##2##3##(2012-1#2)
bone toxicity##3##2##(2012-1#3)
bone transport##2##2##(2007-12#1)(2007-8#1)
bone tumor##2##2##(2008-5#1)(2011-2#1)
bone tumors in##3##3##(2007-11#2)(2008-2#1)
bone tumors of adulthood##2##4##(2008-2#2)
bone tumors of##3##3##(2008-2#2)(2011-1#1)
bone tumors##23##2##(2007-10#1)(2007-11#5)(2007-8#1)(2008-2#4)(2008-6#4)(2009-3#1)(2011-1#3)(2011-2#3)(2012-12#1)
bone tumour##5##2##(2008-6#4)(2010-5#1)
bone tumours and##2##3##(2008-1#1)(2008-6#1)
bone tumours in##2##3##(2007-8#1)(2008-6#1)
bone tumours##10##2##(2007-8#1)(2008-1#1)(2008-6#6)(2010-3#1)(2012-12#1)
bone tunnel##5##2##(2013-1#5)
bone turnover in##3##3##(1997-6#1)(2008-11#1)(2008-7#1)
bone turnover markers##2##3##(2010-10#1)(2011-2#1)
bone turnover##14##2##(1990-2#1)(1993-11#3)(1997-6#1)(2008-11#1)(2008-7#3)(2009-3#1)(2010-10#1)(2011-2#2)(2012-3#1)
bone union and##2##3##(2007-8#2)
bone union in##2##3##(2007-8#2)
bone union was achieved##2##4##(2007-11#1)(2007-8#1)
bone union##15##2##(2007-11#3)(2007-8#10)(2008-11#1)(2010-12#1)
bone using##2##2##(2008-5#1)(2012-3#1)
bone via the##2##3##(1991-6#1)(2011-2#1)
bone volume##5##2##(1993-11#2)(2011-2#1)(2012-12#2)
bone was##6##2##(1990-11#1)(1995-6#1)(1995-9#1)(1997-7#1)(2011-2#1)(2012-2#1)
bone were##5##2##(2007-11#1)(2007-8#2)(2009-7#2)
bone width##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
bone with##6##2##(2006-12#1)(2008-7#2)(2011-2#1)(2013-1#2)
bone##1805##1##(1990-11#11)(1990-12#4)(1990-2#7)(1990-3#2)(1990-5#2)(1990-6#5)(1990-9#1)(1991-11#36)(1991-12#2)(1991-2#6)(1991-4#1)(1991-5#23)(1991-6#9)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#8)(1992-4#1)(1992-6#3)(1992-8#3)(1993-11#57)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#9)(1993-7#1)(1993-8#7)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#13)(1994-2#3)(1994-5#9)(1994-6#5)(1994-7#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#7)(1995-5#1)(1995-6#24)(1995-8#2)(1995-9#6)(1996-11#3)(1996-2#1)(1996-3#19)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-3#8)(1997-5#1)(1997-6#12)(1997-7#17)(1997-8#9)(2006-10#15)(2006-12#5)(2007-10#4)(2007-11#177)(2007-12#24)(2007-2#1)(2007-4#4)(2007-5#5)(2007-7#12)(2007-8#53)(2008-1#13)(2008-10#42)(2008-11#78)(2008-12#28)(2008-2#5)(2008-3#3)(2008-4#30)(2008-5#31)(2008-6#55)(2008-7#85)(2008-8#59)(2008-9#31)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#15)(2009-4#24)(2009-5#2)(2009-6#1)(2009-7#53)(2009-8#11)(2010-1#7)(2010-10#19)(2010-11#10)(2010-12#3)(2010-2#2)(2010-3#27)(2010-4#6)(2010-5#8)(2010-6#34)(2010-7#1)(2010-8#11)(2010-9#10)(2011-1#25)(2011-2#153)(2011-7#4)(2012-1#18)(2012-12#48)(2012-2#21)(2012-3#22)(2012-6#2)(2012-8#1)(2013-1#87)(2013-7#3)(2013-8#14)
bone)##4##1##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)
bone-anchored hearing##3##2##(2008-9#2)(2011-2#1)
bone-forming##2##1##(1993-11#1)(2010-3#1)
bone-marrow##4##1##(1990-11#1)(1993-9#1)(1997-5#1)(2008-11#1)
bone-marrow-derived##5##1##(1994-6#1)(2010-6#3)(2011-1#1)
bone-resorbing activity##5##2##(2008-11#5)
bone-resorbing osteoclasts##3##2##(2008-11#2)(2008-8#1)
bone-resorbing##9##1##(2008-11#8)(2008-8#1)
bone-specific alcaline phosphatase##2##3##(2008-7#2)
bone-specific##3##1##(1993-3#1)(2008-7#2)
bones and##11##2##(1997-3#1)(2007-11#5)(2007-8#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
bones are##2##2##(1991-11#1)(2008-10#1)
bones as##2##2##(2008-9#1)(2009-4#1)
bones buried##2##2##(2008-10#2)
bones in##7##2##(1990-9#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-1#1)
bones is##3##2##(2007-11#1)(2008-8#1)(2009-4#1)
bones may##2##2##(2007-11#1)(2009-9#1)
bones of the foot##2##4##(2009-10#2)
bones of the##11##3##(1995-9#1)(1997-3#1)(2007-11#2)(2008-6#1)(2009-10#2)(2009-3#1)(2010-3#2)(2010-6#1)
bones of##15##2##(1995-9#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-6#1)(2009-10#2)(2009-3#1)(2010-3#2)(2010-6#1)(2012-1#1)
bones or##3##2##(2008-11#1)(2008-6#1)(2009-4#1)
bones was##2##2##(1996-12#1)(2011-2#1)
bones were##6##2##(2007-11#1)(2008-12#1)(2008-9#1)(2012-1#2)(2012-2#1)
bones with##4##2##(2007-11#2)(2007-2#1)(2008-9#1)
bones##126##1##(1990-9#1)(1991-11#1)(1991-6#1)(1993-6#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-12#1)(1997-3#4)(2007-10#1)(2007-11#25)(2007-2#1)(2007-8#4)(2008-10#11)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#2)(2009-10#3)(2009-2#1)(2009-3#3)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#3)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#6)(2012-1#7)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
bones]##2##1##(1991-11#1)(1997-7#1)
bont tick##2##2##(1996-12#1)(2010-1#1)
bonus##3##1##(1990-2#1)(1996-3#1)(2007-11#1)
bonuses##3##1##(1993-3#1)(2008-1#1)(2008-4#1)
bony and##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
bony defect##2##2##(2007-12#1)(2013-8#1)
bony fusion##3##2##(2008-8#1)(2012-3#2)
bony groove##2##2##(2008-7#2)
bony metastases##3##2##(2008-6#1)(2008-7#1)(2012-2#1)
bony structures##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
bony##55##1##(1996-6#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#2)(2009-3#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
book The##2##2##(2008-7#1)(2013-1#1)
book published##2##2##(1993-12#1)(2010-12#1)
book reviews##2##2##(2008-4#2)
book##32##1##(1990-4#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-3#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#4)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
booklet on the##2##3##(1990-3#1)(1996-8#1)
booklet##5##1##(1990-3#1)(1996-8#1)(2007-12#1)(2008-3#1)(2009-12#1)
booklets##2##1##(1990-6#1)(1996-2#1)
books and##7##2##(2007-12#1)(2007-2#1)(2007-5#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-8#1)
books in##2##2##(2008-10#2)
books##29##1##(1990-4#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-8#1)
boom and##2##2##(2008-10#1)(2008-11#1)
boom of##2##2##(2008-11#1)(2012-2#1)
boom##10##1##(2008-10#4)(2008-11#3)(2008-12#1)(2009-5#1)(2012-2#1)
boon##2##1##(2008-1#1)(2010-5#1)
boost in##3##2##(1994-3#1)(2008-8#1)(2012-2#1)
boost the immune response##2##4##(2008-2#1)(2008-5#1)
boost the##4##2##(2007-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
boost##24##1##(1994-3#4)(1994-5#1)(1995-11#1)(1995-9#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
boosted by##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
boosted pumping##3##2##(2008-3#3)
boosted##10##1##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2011-2#1)(2013-1#1)
booster sessions##2##2##(2013-1#2)
booster##10##1##(1990-8#1)(2008-4#1)(2008-9#1)(2010-10#1)(2013-1#6)
boosters##3##1##(2007-1#2)(2009-4#1)
boosting with rMEG990 resulted in##2##5##(2013-1#2)
boosting##7##1##(2008-11#2)(2009-4#1)(2010-7#1)(2013-1#3)
boosts##5##1##(1994-8#1)(1995-12#1)(2007-10#3)
boot##3##1##(2008-10#3)
booting##5##1##(2008-10#3)(2008-12#2)
bootstrap analysis of##2##3##(2008-10#2)
bootstrap analysis##8##2##(1995-3#1)(2008-10#4)(2008-4#2)(2010-1#1)
bootstrap procedure##2##2##(2008-10#2)
bootstrap support for##2##3##(2008-10#2)
bootstrap support##5##2##(2008-10#4)(2008-9#1)
bootstrap values##7##2##(2008-10#2)(2008-5#3)(2008-6#1)(2008-9#1)
bootstrap##33##1##(1992-9#1)(1995-3#1)(2008-10#20)(2008-4#2)(2008-5#3)(2008-6#2)(2008-9#2)(2010-1#1)(2010-4#1)
bootstrapping##3##1##(2008-10#1)(2008-4#1)(2010-8#1)
borate and##4##2##(1990-3#1)(1990-8#1)(2008-10#2)
borate buffer (pH 8##3##4##(1997-2#1)(2008-10#2)
borate buffer (pH 9##6##4##(1994-9#1)(2008-10#5)
borate buffer (pH##10##3##(1994-9#1)(1997-2#1)(2008-10#8)
borate buffer at pH 10##2##5##(1996-12#1)(2008-10#1)
borate buffer with the##2##4##(2008-10#2)
borate buffer with##3##3##(1994-9#1)(2008-10#2)
borate buffer##22##2##(1994-9#2)(1996-12#1)(1996-5#2)(1997-2#1)(2008-10#15)(2011-1#1)
borate complex##2##2##(2008-10#2)
borate crystal##4##2##(2007-11#1)(2007-12#3)
borate produced##2##2##(2007-12#1)(2008-10#1)
borate##73##1##(1990-3#3)(1990-8#1)(1994-9#2)(1996-12#1)(1996-5#3)(1997-2#1)(2007-11#2)(2007-12#9)(2008-10#43)(2008-2#5)(2008-3#1)(2010-11#1)(2011-1#1)
borax buffer##2##2##(1994-9#1)(2008-10#1)
borax##4##1##(1994-9#1)(2008-10#3)
border and##4##2##(2006-10#1)(2007-12#2)(2011-1#1)
border cell production##2##3##(2008-10#2)
border cell##5##2##(2008-10#5)
border cells with##2##3##(2008-10#2)
border cells##12##2##(2008-10#12)
border crossing for##3##3##(1994-3#1)(1995-12#1)(1997-3#1)
border crossing##5##2##(1994-3#3)(1995-12#1)(1997-3#1)
border membrane##14##2##(1990-11#9)(1991-12#1)(1991-9#2)(2007-7#1)(2008-9#1)
border membranes##6##2##(1990-11#2)(1992-3#3)(1993-6#1)
border of the T-DNA##2##4##(1990-11#1)(2008-10#1)
border of the##8##3##(1990-11#1)(1990-12#1)(1994-3#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-9#1)
border of##18##2##(1990-11#1)(1990-12#1)(1994-3#1)(1996-10#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-9#2)(2010-3#1)(2012-12#1)(2012-2#4)(2013-1#1)
border sequences##2##2##(1995-8#1)(2008-10#1)
border to##2##2##(2008-7#2)
border zone##2##2##(2010-8#1)(2012-2#1)
border##102##1##(1990-11#15)(1990-12#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#2)(1993-5#1)(1993-6#1)(1994-3#4)(1994-6#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-3#3)(1997-4#1)(2006-10#3)(2007-10#1)(2007-12#9)(2007-7#1)(2008-10#22)(2008-3#1)(2008-7#4)(2008-9#4)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#2)
border-crossing##4##1##(1995-12#2)(1997-3#1)(2011-2#1)
bordering Myanmar##2##2##(2011-1#2)
bordering the##6##2##(1990-8#1)(1995-2#1)(2007-12#1)(2008-10#2)(2011-2#1)
bordering##11##1##(1990-8#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2009-9#1)(2011-1#2)(2011-2#1)
borderline and##3##2##(1990-2#2)(2008-7#1)
borderline between##2##2##(2007-7#1)(2008-9#1)
borderline cognitive##2##2##(1992-8#1)(2008-11#1)
borderline lesions##2##2##(2008-6#1)(2009-8#1)
borderline personality disorder has##2##4##(2009-10#2)
borderline personality disorder##8##3##(1994-2#1)(2008-11#1)(2008-4#1)(2009-10#3)(2009-9#1)(2013-1#1)
borderline personality##12##2##(1992-1#1)(1994-2#1)(1996-3#1)(2008-11#1)(2008-4#1)(2009-10#4)(2009-9#2)(2013-1#1)
borderline tuberculoid leprosy##2##3##(2007-7#2)
borderline##57##1##(1990-2#6)(1990-9#1)(1991-6#1)(1992-1#3)(1992-6#1)(1992-8#1)(1993-12#1)(1994-2#2)(1994-9#1)(1995-4#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#4)(2009-5#1)(2009-8#2)(2009-9#2)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
borders of##6##2##(1990-7#1)(1991-12#1)(2008-1#1)(2008-10#3)
borders over##2##2##(2007-7#1)(2008-11#1)
borders##25##1##(1990-12#1)(1990-7#1)(1991-12#1)(1993-11#1)(1995-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#2)(2011-2#2)(2013-1#1)
bore no##3##2##(2008-10#1)(2011-2#2)
bore##14##1##(1997-3#1)(1997-4#1)(2006-6#1)(2008-10#4)(2008-2#2)(2008-8#1)(2008-9#1)(2011-2#3)
boreal##3##1##(2008-8#1)(2008-9#2)
bored berries##2##2##(2008-6#2)
bored##6##1##(2007-2#1)(2008-6#5)
boredom##3##1##(2008-1#3)
borer##14##1##(1995-6#2)(2007-12#2)(2008-10#5)(2008-7#2)(2011-2#2)(2013-1#1)
borers##2##1##(2008-10#2)
boric acid as a modifier##2##5##(2008-10#2)
boric acid as a##3##4##(2008-10#3)
boric acid concentration##3##3##(2008-10#3)
boric acid##18##2##(1990-8#2)(2008-10#15)(2008-5#1)
boric##20##1##(1990-8#2)(2008-10#17)(2008-5#1)
born after##2##2##(1991-3#1)(1996-9#1)
born and##3##2##(1995-12#1)(2008-2#1)(2009-4#1)
born at the##9##3##(1990-2#1)(1991-11#1)(1992-2#1)(1995-2#1)(2008-12#1)(2012-2#4)
born at##16##2##(1990-2#1)(1991-11#1)(1991-12#1)(1992-2#1)(1995-2#1)(2007-2#1)(2008-11#3)(2008-12#1)(2009-5#1)(2011-1#1)(2012-2#4)
born between##3##2##(1992-1#1)(2007-11#1)(2011-2#1)
born during##4##2##(1990-2#1)(1991-11#1)(1996-5#1)(2011-2#1)
born from##3##2##(1994-11#1)(2012-3#2)
born in a##2##3##(1997-5#1)(2012-2#1)
born in other prefectures##2##4##(1994-6#2)
born in that prefecture compared with##2##6##(1994-6#2)
born in the Kagoshima prefecture##2##5##(1994-6#2)
born in the##10##3##(1992-2#1)(1992-8#1)(1994-6#2)(1996-11#1)(1996-5#1)(2008-11#1)(2008-12#1)(2011-2#2)
born in##31##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-6#6)(1996-11#1)(1996-5#2)(1997-5#1)(1997-6#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
born into a##3##3##(1994-8#2)(2008-8#1)
born into##4##2##(1994-8#2)(2008-11#1)(2008-8#1)
born prematurely and##2##3##(1994-1#1)(2013-8#1)
born prematurely##6##2##(1994-1#1)(1994-3#1)(1996-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
born to parents irradiated##2##4##(2011-1#2)
born to##8##2##(1992-5#1)(1994-11#1)(1994-9#1)(2008-10#1)(2008-12#1)(2011-1#2)(2012-12#1)
born with##10##2##(1990-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)
born##131##1##(1990-12#1)(1990-2#11)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-2#2)(1992-5#1)(1992-8#1)(1993-12#3)(1994-1#1)(1994-11#2)(1994-3#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-11#3)(1996-5#3)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#8)(2008-12#6)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#6)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#2)
borne at##4##2##(1997-4#3)(2010-10#1)
borne by##2##2##(1994-9#1)(1996-3#1)
borne litters in##5##3##(1997-4#5)
borne litters##7##2##(1997-4#7)
borne out by##2##3##(2008-6#1)(2011-2#1)
borne out##4##2##(2008-6#1)(2008-8#2)(2011-2#1)
borne##29##1##(1994-6#1)(1994-9#1)(1996-3#1)(1997-4#11)(2007-7#1)(2008-1#1)(2008-12#3)(2008-6#1)(2008-8#2)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)
borohydride and##3##2##(1991-12#1)(2008-10#2)
borohydride reduction of##2##3##(2008-10#1)(2010-6#1)
borohydride reduction##4##2##(2008-10#3)(2010-6#1)
borohydride##20##1##(1990-7#1)(1991-12#1)(1995-11#1)(2008-10#15)(2010-6#1)(2013-8#1)
boron at##2##2##(2008-10#2)
boron atom##3##2##(1993-11#2)(1996-2#1)
boron complex##2##2##(2008-10#2)
boron compound may##2##3##(1995-2#2)
boron compound##3##2##(1994-3#1)(1995-2#2)
boron concentration##2##2##(1990-3#2)
boron concentrations##3##2##(1990-3#1)(1995-2#2)
boron doped diamond##4##3##(2008-10#4)
boron in soil##4##3##(2008-10#4)
boron in##17##2##(1993-11#1)(2008-10#16)
boron neutron capture therapy##7##4##(1994-3#6)(1995-2#1)
boron neutron capture##8##3##(1994-3#7)(1995-2#1)
boron##90##1##(1990-3#10)(1993-11#3)(1994-3#9)(1995-2#13)(1996-2#2)(2007-11#1)(2008-10#45)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2012-2#2)
boron(III)##2##1##(2008-10#2)
boron-carbide##2##1##(2008-2#2)
boron-doped diamond (BDD) electrode##2##4##(2008-10#2)
boron-doped diamond (BDD)##4##3##(2008-10#4)
boron-doped diamond electrode is##2##4##(2008-10#2)
boron-doped diamond electrode##6##3##(2008-10#6)
boron-doped diamond microelectrode##2##3##(2008-10#2)
boron-doped diamond thin film electrode##5##5##(2008-10#5)
boron-doped diamond thin film##7##4##(2008-10#7)
boron-doped diamond##21##2##(2008-10#21)
boron-doped##22##1##(2007-12#1)(2008-10#21)
boron-histidine##3##1##(1993-11#3)
boron-modified bioactive glass particles implanted in rat tibia bone marrow##2##10##(2008-5#2)
boron-modified##3##1##(2008-5#3)
boron-serine##2##1##(1993-11#2)
boronate##2##1##(1990-8#1)(2007-11#1)
boronic acid##10##2##(1993-11#2)(2008-10#8)
borosilicate glass##2##2##(2008-3#2)
borosilicate##4##1##(2008-10#1)(2008-3#2)(2009-7#1)
borreliacidal antibodies##3##2##(2008-9#3)
borrow##2##1##(1994-2#2)
borrowed from##2##2##(1993-3#1)(1996-2#1)
borrowed##3##1##(1993-3#1)(1996-2#1)(2008-12#1)
borrowing##3##1##(1991-9#1)(1992-2#1)(1994-2#1)
bortezomib may##2##2##(2011-2#2)
bortezomib on##3##2##(2011-2#2)(2012-2#1)
bortezomib##13##1##(2008-7#1)(2009-4#1)(2010-4#2)(2010-8#1)(2011-2#7)(2012-2#1)
borylation of a Boc protected aminobromoquinoline compound##2##7##(2007-11#2)
borylation##3##1##(2007-11#3)
bosentan##7##1##(2009-10#3)(2010-10#4)
boson peak##2##2##(1995-3#2)
bosutinib##3##1##(2010-11#3)
botanical cannabis##2##2##(2013-8#2)
botanical origin of##3##3##(2008-10#3)
botanical origin##6##2##(2008-10#6)
botanical origins##3##2##(2008-10#3)
botanical products##2##2##(2008-5#1)(2013-7#1)
botanical##23##1##(1993-11#1)(2008-10#13)(2008-12#2)(2008-5#1)(2013-7#1)(2013-8#5)
botanicals and##2##2##(2008-10#1)(2008-5#1)
botanicals##7##1##(2008-10#1)(2008-5#5)(2009-6#1)
botanists##3##1##(2008-10#2)(2010-2#1)
botany##2##1##(2008-7#1)(2009-6#1)
both 1##5##2##(1993-11#1)(1997-7#1)(2008-10#2)(2008-12#1)
both 2004 and##2##3##(2008-10#1)(2013-1#1)
both 4##2##2##(1990-9#1)(2008-4#1)
both 5' and 3'##3##4##(1990-7#2)(2008-8#1)
both 5-lipoxygenase (5-LO) and##2##4##(1991-8#2)
both A##2##2##(1990-7#1)(2008-6#1)
both A1 and A2##2##4##(1992-9#1)(2008-10#1)
both ALDH3c and ALDH3m##2##4##(1992-8#2)
both AM and non-AM plants##2##5##(2008-12#2)
both ATP and GTP##2##4##(1992-8#2)
both ATP and##4##3##(1992-8#2)(2008-4#1)(2010-3#1)
both ATP##5##2##(1992-8#2)(1994-5#1)(2008-4#1)(2010-3#1)
both African##2##2##(2008-8#1)(2010-5#1)
both As(III) and As(V)##2##4##(2008-10#2)
both Australian and##2##3##(2007-11#1)(2012-12#1)
both B##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
both CO concentrations##3##3##(1990-5#3)
both CT and MRI##4##4##(2010-9#1)(2012-2#3)
both CT and##5##3##(2008-7#1)(2010-9#1)(2012-2#3)
both Cr(VI)##2##2##(2008-10#2)
both CymMV and ORSV in##2##5##(2008-10#2)
both D##3##2##(2008-10#2)(2011-2#1)
both DA and##2##3##(1993-12#1)(2008-7#1)
both DNA and##2##3##(2008-12#1)(2009-10#1)
both DNA##4##2##(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
both DNA-A and DNA-B##2##4##(2008-10#2)
both EGF##2##2##(1991-12#1)(2008-6#1)
both English and Spanish##3##4##(2008-12#1)(2008-2#1)(2012-12#1)
both Fe and Zn##2##4##(1995-3#2)
both Fe(II) and Fe(III)##2##4##(2008-10#1)(2010-4#1)
both GAMNP and DOX##2##4##(2009-11#2)
both GH##2##2##(2010-5#1)(2010-8#1)
both Gram positive and Gram negative##2##6##(2010-10#1)(2012-3#1)
both Gram##3##2##(2010-10#1)(2012-3#2)
both HA##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
both HGF and EGF##2##4##(1991-12#2)
both HIV-1##2##2##(2011-2#1)(2011-3#1)
both IL-2##2##2##(1991-12#1)(1992-5#1)
both IORT and WBI##2##4##(2011-2#2)
both LDL##3##2##(1991-2#1)(1994-3#1)(1995-12#1)
both LTA and WTA##2##4##(1995-6#2)
both M##2##2##(2008-10#1)(2012-2#1)
both MAT##2##2##(1992-6#1)(2008-10#1)
both MAbs##2##2##(1990-12#1)(1994-3#1)
both N- and##3##3##(1996-5#1)(2008-1#1)(2011-2#1)
both NA and DA in##2##5##(2008-7#2)
both NA and DA##3##4##(2008-7#3)
both NMDA##2##2##(1995-5#1)(2009-12#1)
both NO donors##2##3##(1995-5#2)
both NO##3##2##(1995-5#2)(2013-8#1)
both Na and##3##3##(2008-2#1)(2008-5#1)(2008-9#1)
both Na+ and K+##2##4##(1992-6#2)
both NiCoTs and##2##3##(2013-1#2)
both P##9##2##(1994-2#2)(2007-7#1)(2008-10#5)(2008-7#1)
both P2 and##2##3##(1995-8#1)(2008-4#1)
both PLS-1 and##2##3##(2008-10#2)
both PMA and##2##3##(1995-8#1)(1997-1#1)
both PPII and triple helix##2##5##(2013-1#2)
both PS1 and PS2 bind##2##5##(1995-8#2)
both PS1 and PS2##3##4##(1995-8#3)
both Phytophthora spp##2##3##(2008-10#2)
both R##2##2##(2008-12#2)
both RNA and##3##3##(1992-3#1)(2008-4#1)(2008-7#1)
both RNA##5##2##(1992-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
both Raman##2##2##(2007-12#1)(2008-3#1)
both S##5##2##(1994-12#1)(2008-10#3)(2012-3#1)
both SDS and##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
both SLO and OCT as a##2##6##(2011-1#2)
both STATs 1 and 3##2##5##(2012-3#2)
both States##3##2##(1991-1#2)(1994-3#1)
both TIEG2 and MAO B##2##5##(2009-12#2)
both UV and##2##3##(2008-10#2)
both UV##3##2##(2008-10#3)
both V##3##2##(1991-9#1)(2008-10#2)
both X##2##2##(2007-12#1)(2008-7#1)
both a and alpha##2##4##(1990-11#1)(1995-9#1)
both a good##2##3##(2008-10#1)(2013-1#1)
both a##80##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#2)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-10#11)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#3)(2009-8#1)(2010-11#1)(2010-4#3)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
both abstract##2##2##(1992-1#1)(2008-5#1)
both accuracy and precision##2##4##(2008-10#1)(2008-3#1)
both accuracy and##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
both accurate and##2##3##(2008-10#1)(2009-1#1)
both acid and alkaline##2##4##(2008-10#1)(2008-11#1)
both acid and##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
both acidic and##2##3##(2008-10#1)(2012-6#1)
both acidic##3##2##(2008-10#2)(2012-6#1)
both acquisition and retention##2##4##(2012-2#2)
both acquisition and##4##3##(2006-4#1)(2012-1#1)(2012-2#2)
both activated##2##2##(1993-8#1)(1995-2#1)
both active and##2##3##(1996-6#1)(2008-10#1)
both active##7##2##(1993-1#1)(1996-6#1)(2008-10#3)(2008-12#1)(2013-8#1)
both activities##4##2##(1991-9#1)(1995-2#2)(2008-5#1)
both acute and chronic##5##4##(2008-11#1)(2008-8#1)(2010-6#1)(2012-12#1)(2013-1#1)
both acute and long-term##2##4##(2012-2#1)(2012-3#1)
both acute and##9##3##(1991-1#1)(2008-11#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
both adenoma and##2##3##(1990-11#1)(2010-12#1)
both adherent and##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
both adhesion formation and##2##4##(1992-1#1)(1992-3#1)
both adults and children##3##4##(1996-2#1)(2008-6#1)(2012-12#1)
both adults and##4##3##(1996-2#1)(1997-3#1)(2008-6#1)(2012-12#1)
both advantages and disadvantages##2##4##(2008-4#1)(2010-8#1)
both affect##2##2##(2008-3#1)(2009-8#1)
both affected by##2##3##(2008-10#1)(2010-10#1)
both affected##3##2##(2007-1#1)(2008-10#1)(2010-10#1)
both after##4##2##(1990-9#1)(1992-5#1)(1996-12#1)(2008-7#1)
both age and##2##3##(1991-6#1)(2008-10#1)
both age groups##3##3##(1992-9#2)(1994-6#1)
both age##6##2##(1991-6#1)(1992-9#2)(1994-6#1)(2008-10#1)(2008-7#1)
both agents##5##2##(1991-12#1)(1991-2#1)(1991-8#1)(2008-10#1)(2010-3#1)
both ages##3##2##(1990-3#1)(2013-7#2)
both alpha- and##2##3##(1992-3#1)(1992-6#1)
both alternatives##2##2##(1991-1#1)(1991-12#1)
both amelioration##2##2##(2007-11#1)(2013-8#1)
both ammonium##2##2##(2008-10#2)
both among##3##2##(1996-1#1)(2010-10#1)(2013-8#1)
both amplitude and phase##4##4##(2007-11#2)(2008-3#2)
both an analytical##2##3##(2008-2#1)(2008-3#1)
both an##20##2##(1991-5#1)(1991-9#1)(1993-12#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
both analyses##2##2##(2008-10#1)(2012-12#1)
both analytes are##2##3##(2008-10#2)
both analytes was##2##3##(2008-10#2)
both analytes##24##2##(2008-10#22)(2013-1#2)
both analytical and##3##3##(1991-5#1)(2008-10#2)
both analytical##4##2##(1991-5#1)(2008-10#3)
both analytically and by##2##4##(2007-11#1)(2008-8#1)
both analytically and##3##3##(2007-11#2)(2008-8#1)
both anatomical and physiological##2##4##(1997-6#1)(2012-3#1)
both anatomical and##3##3##(1997-6#1)(2012-12#1)(2012-3#1)
both anatomical##5##2##(1991-6#1)(1997-6#1)(2007-8#1)(2012-12#1)(2012-3#1)
both anchorage-dependent and anchorage-independent##3##4##(1994-3#1)(1997-1#2)
both and##4##2##(2008-10#2)(2009-9#1)(2012-2#1)
both angiogenesis and##2##3##(2008-1#1)(2010-11#1)
both angles##2##2##(2007-11#1)(2008-3#1)
both animal and human##3##4##(2008-5#1)(2008-7#1)(2009-7#1)
both animal and##5##3##(1991-12#1)(1992-3#1)(2008-5#1)(2008-7#1)(2009-7#1)
both animal##10##2##(1991-12#1)(1992-3#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#1)
both anions##4##2##(2008-10#3)(2012-7#1)
both anterior##3##2##(2007-11#1)(2008-7#2)
both antibiotics##2##2##(2008-11#1)(2012-12#1)
both antibodies##4##2##(1991-2#1)(1995-6#2)(2008-8#1)
both antibody##3##2##(2007-2#1)(2008-7#1)(2011-1#1)
both antigens##4##2##(1990-12#2)(1994-3#1)(2008-10#1)
both antioxidants and##2##3##(2008-10#1)(2013-1#1)
both antioxidants##4##2##(2008-10#3)(2013-1#1)
both antisera##2##2##(1990-5#1)(2008-5#1)
both approaches##10##2##(1995-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#2)
both appropriate##2##2##(2008-11#1)(2008-6#1)
both approximately##2##2##(1993-6#1)(2008-10#1)
both aqueous and##6##3##(1994-6#1)(2008-10#4)(2008-6#1)
both aqueous##7##2##(1994-6#1)(2008-10#4)(2008-6#2)
both are known to##2##4##(1993-12#1)(2013-1#1)
both are##18##2##(1991-2#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-10#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#1)
both areas of##3##3##(1992-3#1)(1995-6#1)(2008-4#1)
both areas##9##2##(1991-5#1)(1992-10#1)(1992-3#1)(1995-6#1)(1996-5#1)(1997-2#2)(2008-4#1)(2010-8#1)
both arrest##2##2##(1997-3#1)(2010-7#1)
both arterial##2##2##(1990-3#1)(2007-8#1)
both as a bulk drug and in formulations was developed and validated##2##12##(2008-10#2)
both as a##11##3##(1991-6#1)(1992-12#1)(2007-12#1)(2008-10#6)(2008-3#1)(2011-2#1)
both as an##2##3##(1992-5#1)(2008-10#1)
both as##27##2##(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-11#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)
both asexual and sexual reproduction##2##5##(2008-10#2)
both asexual and sexual##3##4##(2008-10#3)
both aspects##2##2##(2008-11#1)(2008-3#1)
both assays##9##2##(1990-12#1)(1991-12#1)(1993-12#2)(2008-1#1)(2008-10#2)(2010-5#1)(2012-2#1)
both at 10##2##3##(1990-7#1)(2013-1#1)
both at a##2##3##(2008-6#1)(2010-2#1)
both at the light and electron##2##6##(2008-7#2)
both at the light and##3##5##(2008-7#3)
both at the##21##3##(1991-9#2)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#3)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
both at##49##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
both atmospheric and##2##3##(2008-10#1)(2008-3#1)
both atmospheric##3##2##(2008-10#1)(2008-3#2)
both automated##2##2##(2008-10#1)(2008-4#1)
both average##2##2##(2008-10#1)(2009-9#1)
both axes##2##2##(2008-10#1)(2008-2#1)
both axial##2##2##(2008-2#1)(2011-7#1)
both bare##2##2##(2008-10#2)
both basal##2##2##(1991-12#1)(2010-8#1)
both basic and##3##3##(2008-2#1)(2008-9#2)
both basic##4##2##(1992-3#1)(2008-2#1)(2008-9#2)
both batch and column##4##4##(2008-10#4)
both batch and##7##3##(2008-10#5)(2008-11#1)(2008-7#1)
both bays##3##2##(2007-5#3)
both be##6##2##(1993-1#1)(1995-5#1)(2008-11#2)(2008-5#1)(2012-2#1)
both before and after##7##4##(1994-1#1)(1996-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
both before##9##2##(1994-1#1)(1996-7#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
both being##4##2##(1990-6#1)(1994-2#1)(2013-1#2)
both below##2##2##(1994-3#1)(2007-11#1)
both beneficial and##4##3##(2008-10#1)(2008-4#1)(2010-1#1)(2013-8#1)
both benign and malignant##2##4##(1991-3#1)(2007-5#1)
both benign and##3##3##(1991-3#1)(2007-5#1)(2012-2#1)
both biochemical and##5##3##(1994-9#1)(2008-10#1)(2008-6#1)(2011-10#1)(2011-2#1)
both biochemical##6##2##(1994-9#1)(2008-10#2)(2008-6#1)(2011-10#1)(2011-2#1)
both biocontrol agents##3##3##(2008-10#3)
both biocontrol##4##2##(2008-10#4)
both biological##2##2##(1990-9#1)(2008-7#1)
both bistable states##2##3##(2007-12#2)
both black and##2##3##(2009-5#1)(2011-2#1)
both block##2##2##(2008-8#1)(2011-2#1)
both blood and##2##3##(2011-2#1)(2012-3#1)
both blood##4##2##(1994-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
both body size and##2##4##(2007-12#1)(2008-8#1)
both body##3##2##(2007-12#1)(2008-8#1)(2010-10#1)
both bovine serum albumin (BSA) and##2##6##(2008-10#2)
both boys and girls##4##4##(1994-2#1)(2010-1#1)(2011-1#1)(2012-2#1)
both brain##2##2##(1994-2#1)(2008-7#1)
both breasts##3##2##(2007-5#1)(2007-8#1)(2008-10#1)
both bulk##2##2##(2008-3#1)(2012-2#1)
both by a##2##3##(2008-12#1)(2008-4#1)
both by direct##2##3##(2008-2#1)(2009-4#1)
both by the##5##3##(1996-6#1)(2008-10#2)(2008-5#1)(2012-12#1)
both by##29##2##(1990-12#1)(1991-5#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-6#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)
both cDNAs##2##2##(1991-5#1)(1993-12#1)
both cancer##2##2##(2009-12#1)(2009-9#1)
both carbonate/hydrogencarbonate and hydroxide selective##2##5##(2008-10#2)
both cardiac and##2##3##(1995-2#1)(2008-11#1)
both cardiovascular and cerebrovascular##2##4##(2008-7#1)(2011-1#1)
both cardiovascular and##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
both cases the##10##3##(1993-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
both cases were##2##3##(2009-3#1)(2012-2#1)
both cases##72##2##(1990-5#1)(1990-7#1)(1991-2#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#4)(2008-10#19)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
both cationic and##2##3##(2008-10#1)(2008-4#1)
both cationic##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
both cell growth and##2##4##(1995-8#1)(2008-11#1)
both cell growth##3##3##(1995-8#1)(2008-11#1)(2008-7#1)
both cell lines##14##3##(1991-5#1)(1994-11#1)(1994-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-4#2)(2010-1#1)(2011-2#1)(2012-12#2)
both cell surface##2##3##(1995-2#1)(1997-1#1)
both cell types was##2##4##(1990-2#1)(2008-5#1)
both cell types##12##3##(1990-11#2)(1990-2#1)(1995-8#1)(1996-12#2)(1997-4#1)(2008-11#2)(2008-5#2)(2008-7#1)
both cell##36##2##(1990-11#2)(1990-2#1)(1991-5#2)(1991-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-12#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#2)
both cells##8##2##(1992-11#1)(1993-8#2)(1994-12#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
both cellular and##2##3##(2008-11#1)(2008-9#1)
both cellular##3##2##(1994-8#1)(2008-11#1)(2008-9#1)
both central##2##2##(1997-3#1)(2008-8#1)
both cerebral hemispheres##4##3##(1996-2#1)(2008-7#1)(2011-2#2)
both cerebral##5##2##(1990-12#1)(1996-2#1)(2008-7#1)(2011-2#2)
both changes in##2##3##(1994-9#1)(2008-11#1)
both changes##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
both channels##2##2##(2007-12#1)(2008-10#1)
both chemical and##2##3##(1997-5#1)(2008-10#1)
both children and adults##6##4##(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)
both cholinergic##2##2##(1994-9#1)(2008-7#1)
both chronic##2##2##(2006-10#1)(2008-7#1)
both cities##2##2##(1992-5#2)
both classes of##6##3##(1993-9#1)(2008-11#2)(2008-7#3)
both classical##2##2##(2008-5#1)(2011-2#1)
both clinical and##6##3##(1990-5#1)(1992-1#1)(1993-12#1)(2008-11#1)(2009-10#1)(2013-8#1)
both clinical##10##2##(1990-5#1)(1992-1#1)(1993-12#1)(1995-5#1)(1997-1#1)(2008-11#2)(2008-5#1)(2009-10#1)(2013-8#1)
both clinically and##4##3##(2008-11#1)(2009-10#1)(2010-12#1)(2013-1#1)
both clones##2##2##(1990-8#1)(2008-11#1)
both coding and non-coding##2##4##(2007-12#1)(2011-2#1)
both cognitive and##3##3##(2008-1#1)(2009-8#1)(2012-12#1)
both collagen##2##2##(2008-11#1)(2008-5#1)
both columns##3##2##(1990-8#1)(2008-10#2)
both combinatorial chemistry and##2##4##(2008-10#2)
both common and##2##3##(2012-2#1)(2012-5#1)
both common##6##2##(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)
both community and academic##2##4##(2012-2#2)
both community and##4##3##(1995-1#1)(1995-2#1)(2012-2#2)
both community##5##2##(1995-1#1)(1995-2#1)(2008-11#1)(2012-2#2)
both competent##2##2##(1995-3#1)(2011-2#1)
both complexes##3##2##(1995-3#1)(1996-2#2)
both components of##2##3##(1990-2#1)(2008-11#1)
both components##6##2##(1990-12#1)(1990-2#1)(2008-10#1)(2008-11#2)(2008-2#1)
both compounds in##2##3##(2008-10#2)
both compounds##15##2##(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-5#1)(2008-10#10)
both conditions are##2##3##(2008-11#1)(2011-1#1)
both conditions the##2##3##(1994-2#1)(1994-6#1)
both conditions##18##2##(1994-2#2)(1994-6#1)(1996-5#1)(1997-4#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#2)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
both conducting and##2##3##(2008-10#1)(2008-7#1)
both conducting##3##2##(2008-10#1)(2008-7#2)
both confirmed the##2##3##(1993-9#1)(2008-8#1)
both conservative and##2##3##(2007-8#1)(2012-2#1)
both constituents##2##2##(2007-12#1)(2008-10#1)
both constitutive and##3##3##(1996-5#1)(2008-11#1)(2008-8#1)
both constructs##2##2##(1994-11#1)(2008-12#1)
both containing##2##2##(2008-10#1)(2008-7#1)
both contributed to##2##3##(1996-1#1)(2008-11#1)
both control and##7##3##(1995-12#1)(1997-4#1)(2007-7#1)(2008-11#4)
both conventional and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
both conventional##8##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#2)(2011-2#1)
both copies##3##2##(2007-11#2)(2008-7#1)
both coronary heart disease and##3##5##(1993-12#2)(2008-1#1)
both coronary##6##2##(1991-8#1)(1993-12#2)(2008-1#1)(2009-7#1)(2009-9#1)
both cost##2##2##(1994-12#1)(2008-10#1)
both countries##7##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#2)(2013-1#2)
both crop##2##2##(2008-9#1)(2011-2#1)
both crops##7##2##(2008-10#5)(2008-12#2)
both crystalline and##2##3##(2008-10#1)(2008-4#1)
both cultivars were##2##3##(2008-10#2)
both cultivars##16##2##(2008-10#16)
both culture##2##2##(2008-12#1)(2008-7#1)
both current and future##2##4##(1994-2#1)(2013-1#1)
both current##5##2##(1994-2#1)(1997-1#1)(2009-4#1)(2010-8#1)(2013-1#1)
both cw and##2##3##(2008-2#2)
both cyclic voltammetry##2##3##(2008-10#2)
both cytoplasmic and##2##3##(1992-10#1)(2008-9#1)
both cytosolic and particulate fractions##2##5##(1996-5#2)
both cytosolic and particulate##3##4##(1996-5#2)(1997-4#1)
both cytosolic and##5##3##(1993-8#1)(1995-11#1)(1996-5#2)(1997-4#1)
both cytosolic##6##2##(1990-7#1)(1993-8#1)(1995-11#1)(1996-5#2)(1997-4#1)
both delta##3##2##(1991-9#1)(1992-5#1)(1996-2#1)
both design##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
both devices##5##2##(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)
both diagnosis and treatment##3##4##(1992-6#1)(2008-10#1)(2008-12#1)
both diagnosis and##5##3##(1992-6#1)(2008-10#1)(2008-12#2)(2008-9#1)
both diagnostic and prognostic##2##4##(2008-4#1)(2010-3#1)
both diagnostic and##4##3##(1993-1#1)(2008-4#1)(2008-9#1)(2010-3#1)
both diagnostic##6##2##(1993-1#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)
both diapause##2##2##(2008-5#1)(2013-1#1)
both dietary and##2##3##(1997-6#1)(2012-2#1)
both direct and indirect effects##2##5##(2008-7#1)(2011-1#1)
both direct and indirect##11##4##(1990-5#1)(1991-12#1)(1992-3#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)
both direct##18##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-2#2)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)
both directions##9##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2011-2#1)
both directly and indirectly##2##4##(2008-12#1)(2008-3#1)
both directly##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
both disciplines##2##2##(1993-3#1)(2012-2#1)
both disease##4##2##(1994-9#1)(2008-10#1)(2008-7#1)(2009-5#1)
both diseases##12##2##(2008-10#4)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
both disorders##3##2##(2008-3#1)(2009-6#1)(2012-2#1)
both doctors and patients##2##4##(2008-8#1)(2013-1#1)
both domestic and##2##3##(2009-8#1)(2010-8#1)
both domestic##3##2##(1996-12#1)(2009-8#1)(2010-8#1)
both dominant##2##2##(1995-6#1)(2008-8#1)
both donor and##2##3##(2007-12#1)(2011-2#1)
both donor##3##2##(2007-12#1)(2008-4#1)(2011-2#1)
both dopamine##3##2##(1995-11#1)(1995-12#1)(1996-5#1)
both dose##3##2##(1996-12#1)(2008-6#1)(2010-5#1)
both doses##4##2##(1991-3#1)(1994-12#1)(1994-2#1)(2006-10#1)
both drug##2##2##(1997-4#1)(2009-10#1)
both drugs did not##2##4##(2008-5#1)(2013-1#1)
both drugs were##3##3##(1990-3#1)(1993-6#1)(2008-5#1)
both drugs##22##2##(1990-3#1)(1990-7#1)(1990-9#2)(1993-6#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#6)(2008-5#5)(2011-10#1)(2013-1#1)
both during##9##2##(1993-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-1#1)(2009-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
both ear##2##2##(2008-10#2)
both early and late##2##4##(2007-8#1)(2008-5#1)
both early##3##2##(2007-8#1)(2008-5#2)
both ecological and##2##3##(2008-8#2)
both effective##3##2##(1991-11#1)(2007-11#1)(2008-10#1)
both efficacy and##2##3##(2008-10#1)(2012-3#1)
both egg##3##2##(2008-8#1)(2010-8#2)
both electrodes##2##2##(2008-10#2)
both elements##4##2##(1990-5#1)(2008-10#2)(2013-1#1)
both elevated##2##2##(1990-2#1)(2011-2#1)
both enantiomeric forms##2##3##(1994-9#2)
both enantiomers of##3##3##(1992-11#1)(2011-1#1)(2012-3#1)
both enantiomers##6##2##(1992-11#1)(1994-8#1)(2008-10#2)(2011-1#1)(2012-3#1)
both endogenously##2##2##(2008-4#1)(2008-5#1)
both ends of the##2##4##(2008-1#1)(2009-2#1)
both ends of##4##3##(1994-12#1)(2008-1#1)(2008-8#1)(2009-2#1)
both ends##9##2##(1993-3#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
both enhanced##2##2##(1990-5#1)(2008-6#1)
both entities are##2##3##(1991-8#1)(2008-7#1)
both entities##3##2##(1991-8#1)(2008-5#1)(2008-7#1)
both environmental and##3##3##(2008-10#2)(2011-2#1)
both environmental##5##2##(2008-10#2)(2008-8#2)(2011-2#1)
both environments##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
both enzymatic and##2##3##(1990-12#1)(2011-2#1)
both enzymatic##4##2##(1990-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
both enzyme##5##2##(1990-7#1)(1997-6#1)(2008-10#1)(2008-7#2)
both enzymes were##2##3##(2008-11#1)(2008-7#1)
both enzymes##11##2##(1990-11#1)(1990-12#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
both epithelial and myoepithelial##2##4##(1990-12#1)(2013-8#1)
both epithelial and##4##3##(1990-12#1)(2008-10#1)(2009-5#1)(2013-8#1)
both epithelial##5##2##(1990-12#1)(2008-10#1)(2009-5#1)(2013-1#1)(2013-8#1)
both eukaryotic##2##2##(1997-4#1)(2009-7#1)
both euthyroid and thyroidectomized rats##2##5##(1991-9#1)(1995-12#1)
both evoked and spontaneous##2##4##(1997-7#1)(2008-4#1)
both excitation##2##2##(2008-2#1)(2008-3#1)
both excitatory and inhibitory##2##4##(1996-12#1)(2007-12#1)
both exogenous##4##2##(1991-2#1)(1993-6#1)(2008-5#1)(2011-1#1)
both experimental and##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
both experimental##7##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#2)(2011-2#1)(2012-2#1)
both experimentally and theoretically##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
both experimentally and##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
both experimentally##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#1)
both experiments##12##2##(1992-10#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)
both external and##2##3##(1996-2#1)(2008-4#1)
both external##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
both extraction##3##2##(2008-10#3)
both eyes of##2##3##(1992-6#1)(1995-9#1)
both eyes##12##2##(1992-6#1)(1995-9#1)(2008-5#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
both factors##10##2##(1990-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
both families##3##2##(1991-12#2)(2012-12#1)
both fast and##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
both fast##5##2##(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)
both fatigue protocols##2##3##(2013-8#2)
both female and male##5##4##(1990-3#1)(1992-8#1)(1994-2#1)(2007-12#1)(2010-8#1)
both field and greenhouse##2##4##(2008-10#2)
both field and##3##3##(2008-10#3)
both field locations##2##3##(2008-10#2)
both field##7##2##(2007-12#1)(2008-10#6)
both first and second##2##4##(2008-10#1)(2010-11#1)
both first##3##2##(2008-10#1)(2010-11#1)(2011-2#1)
both fish species##2##3##(2008-10#2)
both flow##2##2##(2008-10#1)(2008-9#1)
both fluorescence microscopy and##2##4##(1991-5#1)(2011-2#1)
both fluorescence##3##2##(1991-5#1)(2008-3#1)(2011-2#1)
both food##2##2##(1993-8#1)(2012-2#1)
both for the##14##3##(1991-1#1)(1994-12#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#1)
both for##51##2##(1991-1#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
both forms of PAM##2##4##(1994-11#2)
both forms of the##2##4##(1991-5#1)(2009-9#1)
both forms of##10##3##(1991-5#1)(1992-8#1)(1993-8#1)(1994-11#2)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
both forms##13##2##(1991-5#1)(1992-8#1)(1993-8#1)(1994-11#2)(1995-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#1)
both formulations##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2010-5#1)
both fractions##9##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-12#1)(1996-2#1)(1996-5#1)(2008-10#3)
both free and##6##3##(1990-12#1)(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#2)
both from a##2##3##(2008-11#1)(2008-7#1)
both from the point of view of##3##7##(1990-3#1)(2008-10#1)(2008-7#1)
both from the##13##3##(1990-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-2#1)
both from##27##2##(1990-3#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)
both functions##2##2##(1994-8#1)(1995-5#1)
both fungi were##3##3##(2008-10#3)
both fungi##12##2##(2008-10#10)(2008-5#1)(2008-6#1)
both fungicides##6##2##(2008-10#6)
both gas##2##2##(1995-2#1)(2008-10#1)
both gender##2##2##(2010-5#1)(2012-2#1)
both genders and##2##3##(2006-6#1)(2011-2#1)
both genders##9##2##(1994-2#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
both gene expression and##3##4##(1990-5#1)(2008-9#1)(2010-10#1)
both gene##6##2##(1990-5#1)(2008-10#3)(2008-9#1)(2010-10#1)
both general and##2##3##(1991-2#1)(2008-11#1)
both general##5##2##(1991-2#1)(1991-3#1)(2007-12#1)(2008-11#1)(2012-2#1)
both generations##2##2##(2008-10#1)(2009-12#1)
both generic and##2##3##(2009-3#1)(2009-9#1)
both genes and##2##3##(2008-10#2)
both genes##12##2##(1991-5#1)(1991-6#1)(1993-2#1)(1997-5#1)(2008-1#1)(2008-10#5)(2010-3#1)(2012-2#1)
both genetic and environmental factors##2##5##(2011-2#1)(2012-2#1)
both genetic and environmental##5##4##(2007-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
both genetic and##10##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-2#1)
both genetic##13##2##(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-10#2)(2011-2#1)(2012-2#1)
both genetically##2##2##(2008-7#1)(2012-3#1)
both genomic##5##2##(1990-12#1)(1992-12#1)(2008-10#2)(2010-3#1)
both genotypes were##2##3##(2008-10#2)
both genotypes##7##2##(2008-10#5)(2010-4#1)(2013-1#1)
both glass and##2##3##(2008-10#1)(2008-7#1)
both global##2##2##(1996-5#1)(2013-7#1)
both glucose and##3##3##(1994-12#1)(2012-3#1)(2013-1#1)
both glycosylation##3##2##(1992-3#2)(1992-6#1)
both goals##2##2##(2008-7#1)(2009-7#1)
both government and##2##3##(2008-11#2)
both greatly##2##2##(2008-11#1)(2008-9#1)
both ground-based##2##2##(2008-3#2)
both groups combined##2##3##(1994-2#1)(2008-12#1)
both groups did not##2##4##(2007-11#1)(2013-1#1)
both groups of fish##2##4##(2008-11#1)(2008-7#1)
both groups of patients##2##4##(1993-12#1)(2011-2#1)
both groups of##19##3##(1990-8#1)(1991-12#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
both groups was##5##3##(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2013-7#1)
both groups were##10##3##(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
both groups##152##2##(1990-2#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#4)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-3#2)(2008-5#6)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#5)
both growth stages##2##3##(2008-10#2)
both growth##4##2##(2008-10#3)(2013-1#1)
both had##5##2##(1992-3#1)(1994-2#1)(2007-12#1)(2008-10#1)(2012-1#1)
both hard##2##2##(2007-12#2)
both have been##2##3##(2008-4#1)(2010-7#1)
both have##11##2##(1992-3#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-7#1)(2012-2#2)
both health care##2##3##(1992-12#1)(1993-1#1)
both health##3##2##(1992-12#1)(1993-1#1)(2010-12#1)
both healthy and##2##3##(2008-10#1)(2012-12#1)
both healthy##4##2##(2008-10#1)(2008-11#1)(2010-6#1)(2012-12#1)
both heat-treated##2##2##(2008-10#2)
both hemispheres##4##2##(1996-12#1)(1996-5#1)(1997-8#1)(2008-1#1)
both hepatic and##2##3##(1993-9#1)(2008-8#1)
both hepatitis##2##2##(2007-12#2)
both hereditary##2##2##(1994-6#1)(1994-8#1)
both heterodimers##2##2##(1996-2#2)
both high and low##2##4##(2008-10#1)(2008-2#1)
both high##14##2##(1993-6#1)(1994-3#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#3)(2010-2#1)(2011-2#1)(2012-2#1)
both highly##3##2##(1994-2#1)(2011-2#1)(2012-3#1)
both his##2##2##(1991-1#1)(2009-3#1)
both homogeneous and##2##3##(2008-10#1)(2008-3#1)
both homotropic and heterotropic effects##2##5##(1990-8#2)
both host and##2##3##(1995-5#1)(2008-8#1)
both host species##2##3##(2008-10#2)
both host##7##2##(1995-5#1)(2008-10#3)(2008-8#3)
both hosts##5##2##(2008-10#5)
both human and mouse##2##4##(2008-4#1)(2008-9#1)
both human and rat##3##4##(1992-10#1)(1994-3#1)(2012-12#1)
both human and##14##3##(1992-10#1)(1994-3#1)(1995-5#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#2)(2012-12#2)(2012-3#1)
both human##21##2##(1990-2#1)(1991-2#1)(1992-10#1)(1992-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#2)(2011-2#1)(2012-12#2)(2012-3#1)
both humans and##5##3##(1994-2#1)(1997-9#1)(2008-11#1)(2008-7#1)(2013-8#1)
both humoral and##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
both humoral##4##2##(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#1)
both hydrophilic and hydrophobic##3##4##(2009-9#1)(2010-10#2)
both hypotheses##2##2##(2008-11#1)(2008-8#1)
both imaging##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
both immediate##2##2##(1992-8#1)(2012-2#1)
both immediately##2##2##(2007-8#1)(2013-1#1)
both immobilized##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
both implants at##2##3##(2012-2#2)
both implants##5##2##(2012-2#5)
both improved##4##2##(1992-11#1)(1996-3#1)(1997-2#1)(2011-1#1)
both in a##4##3##(1992-12#1)(1992-6#1)(1996-1#1)(2007-12#1)
both in cell##2##3##(1994-11#1)(2008-11#1)
both in children and##2##4##(2008-7#1)(2011-2#1)
both in clinical practice and in##2##6##(1995-11#1)(2006-10#1)
both in crude##2##3##(1992-3#1)(1996-12#1)
both in laboratory##2##3##(2008-3#1)(2010-5#1)
both in major##2##3##(1997-5#1)(2008-7#1)
both in micellar##2##3##(1996-5#1)(2008-10#1)
both in normal and##4##4##(1995-12#1)(2007-11#1)(2008-9#1)(2010-8#1)
both in normal##6##3##(1990-5#1)(1993-3#1)(1995-12#1)(2007-11#1)(2008-9#1)(2010-8#1)
both in patients and in##2##5##(1997-2#1)(2013-1#1)
both in terms of their##2##5##(2008-10#1)(2008-11#1)
both in terms of##11##4##(1993-12#1)(1996-12#1)(1996-9#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2010-5#1)
both in the United States and##2##6##(2009-11#1)(2013-1#1)
both in the absence and in the presence of##2##9##(1991-2#1)(1994-6#1)
both in the clinical##2##4##(1996-9#1)(2008-11#1)
both in the early##2##4##(1992-5#1)(2008-7#1)
both in the laboratory and in##4##6##(2008-10#1)(2008-3#2)(2008-5#1)
both in the laboratory and##5##5##(2008-10#2)(2008-3#2)(2008-5#1)
both in the patient##2##4##(1993-12#1)(2007-8#1)
both in the presence and absence of##5##7##(1994-2#1)(1994-3#1)(1995-6#1)(2008-11#1)(2008-8#1)
both in the presence and##6##5##(1994-2#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
both in the presence of##3##5##(1992-12#1)(2008-10#1)(2008-11#1)
both in the presence##9##4##(1992-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-8#1)
both in the##75##3##(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-5#2)(1993-11#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1995-6#2)(1996-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
both in their##2##3##(1991-3#1)(2008-1#1)
both in vitro and in vivo##22##6##(1990-7#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
both in vitro and in##24##5##(1990-7#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-5#5)(2008-7#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
both in vitro and##25##4##(1990-7#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-5#5)(2008-7#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)
both in vitro##29##3##(1990-7#1)(1991-11#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-5#6)(2008-7#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)
both in vivo and in vitro##14##6##(1990-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#2)(2009-6#1)(2011-2#1)(2012-2#1)
both in vivo##16##3##(1990-9#1)(1991-12#1)(1991-4#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#2)(2009-6#1)(2011-2#1)(2012-2#1)
both in##267##2##(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#1)(1995-11#4)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#42)(2008-11#20)(2008-12#2)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#6)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#1)
both incorporation of labelled substrate into thyroid slices##2##8##(1994-11#1)(1994-6#1)
both increase##2##2##(1994-5#1)(2008-10#1)
both increased##3##2##(1995-12#1)(2008-2#1)(2011-1#1)
both increases##3##2##(2008-7#1)(2008-9#1)(2012-3#1)
both individual##4##2##(1991-1#1)(2011-1#2)(2013-1#1)
both indoor and outdoor##2##4##(1997-4#1)(2010-5#1)
both indoors and outdoors##3##4##(2008-10#1)(2012-12#2)
both induced##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
both inducing##2##2##(1990-7#1)(2008-10#1)
both industrialized##2##2##(2007-7#1)(2009-6#1)
both inflammatory and##2##3##(2008-1#1)(2008-3#1)
both inflammatory##4##2##(1991-8#1)(2006-10#1)(2008-1#1)(2008-3#1)
both inhibited##3##2##(1990-2#1)(1994-8#1)(1996-2#1)
both initial and##2##3##(2008-8#1)(2008-9#1)
both initial##3##2##(1990-12#1)(2008-8#1)(2008-9#1)
both injuries##2##2##(1991-6#1)(2012-3#1)
both inoculated and uninoculated##2##4##(2008-10#2)
both inoculated and##3##3##(2008-10#3)
both inoculum##2##2##(2008-10#2)
both inorganic##2##2##(2008-10#2)
both inpatient and outpatient##3##4##(1995-2#1)(1996-3#1)(2013-1#1)
both inpatient and##4##3##(1995-2#1)(1996-3#1)(1997-1#1)(2013-1#1)
both insects##5##2##(2006-12#1)(2007-12#3)(2008-8#1)
both inside and outside the##2##5##(2008-2#1)(2011-2#1)
both instant and lasting relief of##2##6##(2011-2#2)
both instruments##6##2##(2008-3#6)
both insulin and##3##3##(1994-11#1)(2008-7#1)(2010-6#1)
both insulin##5##2##(1994-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-6#1)
both intact##4##2##(1990-11#1)(1992-11#1)(1994-11#2)
both intensity and##3##3##(1990-8#1)(1994-8#1)(2007-12#1)
both inter- and##2##3##(1996-12#1)(2008-8#1)
both internal and external##7##4##(1991-5#1)(1992-12#1)(1996-2#1)(2007-8#2)(2008-11#1)(2008-3#1)
both internal##11##2##(1991-5#1)(1992-12#1)(1996-2#2)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
both internalizing and externalizing##2##4##(1995-2#1)(2008-12#1)
both interventions##4##2##(1995-12#1)(2008-12#1)(2009-8#1)(2011-1#1)
both intra- and extracellular##2##4##(1994-8#1)(2008-7#1)
both intra- and##5##3##(1994-5#1)(1994-8#1)(2008-7#2)(2009-6#1)
both intrinsic and extrinsic##3##4##(2008-7#1)(2010-1#1)(2013-1#1)
both intrinsic##4##2##(2008-7#1)(2009-10#1)(2010-1#1)(2013-1#1)
both ionic##2##2##(2008-10#2)
both ionotropic and metabotropic##3##4##(2008-7#3)
both ions##3##2##(2008-10#3)
both irradiation and##2##3##(1995-2#1)(2008-5#1)
both is a##3##3##(2008-5#1)(2012-12#2)
both is##5##2##(2008-3#1)(2008-5#1)(2012-12#2)(2012-3#1)
both isolates##4##2##(2008-10#3)(2008-5#1)
both isotropic and anisotropic scattering media##2##6##(2008-3#2)
both isotropic and anisotropic##3##4##(2008-2#1)(2008-3#2)
both its##14##2##(1992-12#1)(1994-5#2)(1996-6#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)
both jaws##2##2##(2008-12#1)(2010-3#1)
both juvenile and layer turkeys##2##5##(2013-1#2)
both juvenile and##3##3##(2012-2#1)(2013-1#2)
both knee##2##2##(1994-8#1)(2008-7#1)
both laser##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
both lateral##3##2##(2008-2#2)(2012-12#1)
both layers##2##2##(2007-12#1)(2008-3#1)
both leaf and##2##3##(2008-10#2)
both leaf##3##2##(2008-10#3)
both leaves and##2##3##(2008-10#2)
both legs##4##2##(1995-3#1)(2008-12#2)(2011-2#1)
both life##2##2##(2008-10#1)(2011-2#1)
both ligands##4##2##(1993-3#1)(1995-5#1)(1996-5#1)(2008-10#1)
both light and##2##3##(2008-10#2)
both light##6##2##(1993-9#1)(2008-10#3)(2008-2#1)(2008-3#1)
both linear and##2##3##(2007-11#1)(2008-3#1)
both linear##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
both liquid and solid##2##4##(2008-3#1)(2008-7#1)
both liquid and##3##3##(1995-3#1)(2008-3#1)(2008-7#1)
both live and fixed cells##2##5##(2008-9#2)
both liver and##3##3##(1990-11#1)(1990-5#1)(2012-2#1)
both liver##4##2##(1990-11#1)(1990-5#2)(2012-2#1)
both livestock##2##2##(2008-9#1)(2011-1#1)
both living##2##2##(2007-11#1)(2010-7#1)
both loading##3##2##(2008-10#1)(2009-3#2)
both lobes##4##2##(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
both local and global##3##4##(1996-5#1)(2008-11#1)(2008-3#1)
both local and regional processes##2##5##(2008-9#1)(2009-2#1)
both local and regional##3##4##(2008-9#1)(2009-2#2)
both local and systemic##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
both local and##12##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2010-9#1)(2011-2#1)
both local##18##2##(1994-2#2)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#2)(2010-9#1)(2011-2#1)(2013-1#1)
both located on##2##3##(1993-12#1)(2008-10#1)
both located##4##2##(1992-8#1)(1993-12#1)(2008-10#2)
both locations##8##2##(2008-1#1)(2008-10#5)(2010-8#1)(2013-8#1)
both loci##2##2##(1991-6#1)(2011-2#1)
both long and short##2##4##(2007-12#1)(2008-2#1)
both low and high##2##4##(2008-10#1)(2009-8#1)
both low and##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
both low##6##2##(1995-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-8#1)
both lower and##2##3##(1996-2#1)(2008-3#1)
both lower limbs##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
both lower##7##2##(1993-8#1)(1996-2#1)(2007-2#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
both lungs on##2##3##(2008-1#1)(2010-12#1)
both lungs##7##2##(2007-8#1)(2008-1#2)(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#1)
both mGlu and cannabinoid receptors##2##5##(2008-7#2)
both magnitude and##2##3##(1990-8#1)(2012-2#1)
both major psychoses##2##3##(1997-5#2)
both malaria##2##2##(2009-10#1)(2010-1#1)
both male and female rats is##2##6##(1993-5#1)(2010-1#1)
both male and female##10##4##(1992-11#2)(1993-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
both males and females and##2##5##(2008-4#1)(2013-7#1)
both males and females##10##4##(1995-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
both mass##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
both material##2##2##(2007-11#1)(2008-12#1)
both materials##4##2##(2008-10#1)(2008-2#1)(2008-5#2)
both mating types in##2##4##(2008-10#2)
both mating types were##2##4##(2008-10#2)
both mating types##6##3##(2008-10#6)
both may##4##2##(1997-9#1)(2008-10#1)(2009-1#1)(2010-8#1)
both measurements##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
both mechanical and biological valve prostheses##2##6##(2010-8#2)
both mechanical and##5##3##(2009-8#1)(2010-8#2)(2011-2#1)(2012-2#1)
both mechanical##6##2##(2008-10#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-2#1)
both media##3##2##(2008-10#1)(2008-11#1)(2012-4#1)
both medical and##4##3##(1994-12#2)(1996-6#1)(2013-1#1)
both medical##5##2##(1994-12#2)(1996-6#1)(2009-7#1)(2013-1#1)
both members of the##2##4##(1993-12#1)(2008-10#1)
both membrane and##2##3##(1991-5#1)(1996-5#1)
both membrane##3##2##(1991-5#1)(1996-5#1)(2008-10#1)
both memory and attention##2##4##(2008-7#1)(2012-1#1)
both men and women##18##4##(1994-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#4)(2013-1#3)
both men and##20##3##(1990-12#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#4)(2013-1#3)
both mental##2##2##(1992-2#1)(2007-8#1)
both mesodermal##2##2##(2008-12#1)(2012-12#1)
both metal ions##2##3##(2008-10#2)
both metals in##5##3##(2008-10#5)
both metals##14##2##(1995-3#1)(2008-10#13)
both methanol##3##2##(2008-10#1)(2008-2#1)(2010-12#1)
both methodologies##4##2##(2008-10#4)
both methods allows##2##3##(2008-10#1)(2008-4#1)
both methods are in good agreement##2##6##(2008-10#2)
both methods are##6##3##(2008-10#5)(2008-3#1)
both methods of##3##3##(2008-11#1)(2010-12#1)(2012-3#1)
both methods to##4##3##(2008-10#3)(2008-3#1)
both methods were compared##3##4##(1996-5#1)(2008-10#1)(2012-3#1)
both methods were##7##3##(1990-12#1)(1996-5#1)(2008-10#4)(2012-3#1)
both methods##67##2##(1990-12#2)(1990-8#1)(1992-3#1)(1992-5#1)(1993-8#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)
both mitogenic##2##2##(1991-3#1)(1995-2#1)
both models are##2##3##(1996-4#1)(2008-7#1)
both models##12##2##(1992-3#1)(1996-4#1)(1997-7#1)(2007-10#1)(2008-10#6)(2008-7#1)(2012-12#1)
both modes of##2##3##(2008-3#1)(2012-3#1)
both modes##9##2##(1994-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-3#1)
both molecular##2##2##(2010-3#1)(2010-5#1)
both molecules##3##2##(1990-2#1)(1992-3#1)(1995-2#1)
both monomeric##2##2##(1990-2#1)(2008-7#1)
both monomers##2##2##(1991-2#1)(2011-1#1)
both monovalent##2##2##(1993-6#1)(2011-2#1)
both more##5##2##(1992-12#1)(2008-10#1)(2008-6#1)(2010-11#1)(2013-8#1)
both morphologically##2##2##(1990-12#1)(2011-2#1)
both morphology and##2##3##(2007-12#1)(2008-5#1)
both mother and child##2##4##(1995-1#1)(2012-12#1)
both mother and##4##3##(1995-1#1)(2007-2#1)(2008-1#1)(2012-12#1)
both mouse and human##2##4##(1993-3#1)(2008-4#1)
both mouse and##3##3##(1991-5#1)(1993-3#1)(2008-4#1)
both mouse##8##2##(1991-5#1)(1993-3#1)(1993-6#1)(1994-11#1)(2008-4#1)(2008-5#2)(2012-2#1)
both murine and human##4##4##(1995-11#1)(2008-4#2)(2008-9#1)
both muscarinic##2##2##(1995-11#1)(1995-12#1)
both muscle##3##2##(1991-12#1)(1997-3#1)(2008-5#1)
both mutant##3##2##(1990-11#1)(1995-5#1)(1995-8#1)
both native and##2##3##(2008-10#1)(2008-8#1)
both native##5##2##(1992-12#1)(2008-10#2)(2008-8#1)(2012-12#1)
both natural and synthetic##2##4##(2008-11#1)(2012-2#1)
both natural and##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
both natural##6##2##(1996-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)
both necessary and sufficient##5##4##(1991-2#2)(1995-2#1)(2009-10#1)(2012-3#1)
both negative and positive##2##4##(2008-10#1)(2008-9#1)
both negatively##2##2##(2008-9#1)(2011-2#1)
both neuronal and glial##2##4##(1994-2#1)(2008-7#1)
both neuronal##3##2##(1994-2#1)(1995-5#1)(2008-7#1)
both neuropeptides##3##2##(1995-11#1)(2007-2#2)
both neutral and##3##3##(1990-7#1)(1992-10#1)(2010-7#1)
both nitric and hydrochloric acid##2##5##(2008-10#2)
both nm23-HI and nm23-H2##2##4##(1993-9#2)
both no##2##2##(2008-11#2)
both normal and##13##3##(1990-12#1)(1992-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
both normal##20##2##(1990-12#1)(1992-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-1#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
both novice and experienced##2##4##(2008-12#1)(2008-4#1)
both nucleoside##2##2##(1990-8#1)(2008-4#1)
both nucleotide##2##2##(1994-9#1)(2011-1#1)
both number##2##2##(2007-8#1)(2011-1#1)
both numerical##2##2##(2008-3#2)
both nursing and medical##2##4##(1992-12#1)(2007-11#1)
both objective and##2##3##(2008-7#1)(2011-2#1)
both objective##3##2##(2008-7#1)(2010-6#1)(2011-2#1)
both of the parametric and nonparametric component##2##7##(2009-10#2)
both of the##22##3##(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#3)(1997-3#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-10#2)(2010-5#1)(2012-1#1)
both of them##7##3##(1991-6#1)(1994-1#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-1#1)
both of these two##2##4##(1991-12#1)(2007-5#1)
both of these##33##3##(1990-8#1)(1991-12#2)(1991-3#1)(1992-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#1)
both of which are described##2##5##(2008-4#1)(2008-9#1)
both of which are##14##4##(1991-2#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)
both of which can##3##4##(1993-9#1)(2008-3#1)(2008-9#1)
both of which have a##2##5##(1992-6#1)(2008-10#1)
both of which have been##2##5##(1996-6#1)(2008-8#1)
both of which have##4##4##(1992-6#1)(1996-6#1)(2008-10#1)(2008-8#1)
both of which were##6##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
both of which##51##3##(1991-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-7#1)
both of whom##2##3##(1994-2#1)(2007-7#1)
both of##134##2##(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#4)(1994-2#2)(1994-6#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#6)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
both oils##4##2##(2008-10#2)(2008-11#1)(2009-3#1)
both on the##10##3##(1991-6#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-3#2)(2012-2#1)(2013-1#1)
both on##27##2##(1991-6#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
both open##2##2##(2008-10#1)(2008-2#1)
both operational and##2##3##(1994-12#1)(2008-10#1)
both opportunities##2##2##(2008-12#1)(2008-7#1)
both optical##5##2##(2008-3#4)(2011-1#1)
both optimal##2##2##(2007-11#1)(2009-2#1)
both or neither##2##3##(2008-10#1)(2008-2#1)
both oral##2##2##(1992-3#1)(2008-5#1)
both orchards##2##2##(2008-10#1)(2008-6#1)
both orders##2##2##(2008-3#2)
both organic and inorganic##3##4##(2008-10#3)
both organic and##4##3##(2008-10#4)
both organisms##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)
both orientations##2##2##(1997-2#1)(2008-8#1)
both our##2##2##(2008-6#1)(2008-7#1)
both outcome measures##2##3##(2007-11#1)(2008-7#1)
both output##2##2##(1991-12#1)(2008-2#1)
both overall##2##2##(1997-3#1)(2011-2#1)
both overlapping and##2##3##(2007-10#1)(2008-10#1)
both oxidation##2##2##(2008-10#1)(2013-1#1)
both p &lt##5##3##(2008-3#1)(2008-9#4)
both pH##4##2##(1991-5#1)(1994-8#1)(1997-2#1)(2008-10#1)
both parameters were##2##3##(1994-6#1)(1995-8#1)
both parameters##9##2##(1994-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)
both parametric##2##2##(1997-7#1)(2012-1#1)
both parent##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
both parental##5##2##(2008-10#2)(2008-11#1)(2008-8#2)
both parenting and##3##3##(2010-1#3)
both parents and children##2##4##(1995-1#1)(2009-11#1)
both parents and##5##3##(1995-1#1)(2008-10#1)(2008-12#1)(2009-11#1)(2011-2#1)
both parents were##2##3##(1997-5#1)(2010-4#1)
both parents##13##2##(1995-1#1)(1995-12#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
both particle##2##2##(2008-10#2)
both parties##5##2##(1992-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)
both partners##2##2##(2008-10#1)(2011-1#1)
both parts##2##2##(2008-2#1)(2008-3#1)
both passive and active##2##4##(2009-11#1)(2012-3#1)
both pathogen##3##2##(2008-10#3)
both pathogens##15##2##(2008-10#15)
both pathotypes##2##2##(2008-10#2)
both pathways##2##2##(1990-12#1)(1991-9#1)
both patient and##5##3##(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
both patient##11##2##(1991-9#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
both patients and health##2##4##(1992-4#1)(2013-8#1)
both patients and nurses##2##4##(2009-12#1)(2010-3#1)
both patients and##12##3##(1992-4#1)(1995-12#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
both patients had##4##3##(2006-10#2)(2012-12#1)(2013-1#1)
both patients was##2##3##(1991-3#1)(2013-1#1)
both patients with##2##3##(2008-7#2)
both patients##38##2##(1990-10#1)(1991-3#2)(1992-2#1)(1992-4#2)(1995-12#1)(1997-6#1)(2006-10#2)(2007-11#1)(2008-7#7)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
both people and##2##3##(2008-10#1)(2008-11#1)
both peptides##6##2##(1990-5#3)(1991-5#1)(1992-6#1)(1994-5#1)
both perceived##3##2##(2009-5#1)(2009-7#1)(2011-2#1)
both performance and##2##3##(2011-2#1)(2013-8#1)
both pharmacological and non-pharmacological##2##4##(1993-2#1)(2009-7#1)
both pharmacological and##5##3##(1993-2#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-12#1)
both phases##2##2##(2007-12#1)(2008-10#1)
both phenomena##2##2##(2008-11#1)(2013-1#1)
both physical and mental##2##4##(2010-6#1)(2012-3#1)
both physical and##6##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#1)
both physical##7##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
both physicians and##2##3##(1992-8#1)(1996-3#1)
both physiological and##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
both plant AChEs##2##3##(2009-8#2)
both plant and##2##3##(2008-10#1)(2008-7#1)
both plant##5##2##(2008-10#2)(2008-7#1)(2009-8#2)
both plants##3##2##(2008-10#3)
both plasma and##3##3##(1991-9#2)(2009-11#1)
both plasma##4##2##(1991-9#2)(2008-4#1)(2009-11#1)
both plasmids##3##2##(1991-7#1)(1993-8#1)(1994-11#1)
both platelet##2##2##(2006-6#1)(2008-7#1)
both players' previous##2##3##(2008-8#2)
both point mutations##2##3##(1991-7#1)(2008-7#1)
both polar##2##2##(1992-6#1)(2008-10#1)
both polarization and anisotropy##2##4##(2008-10#2)
both polarization states##3##3##(2007-11#1)(2008-3#2)
both polarization##7##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
both polarizations##2##2##(2007-11#1)(2008-3#1)
both polyclonal antibodies##2##3##(1992-6#1)(1995-12#1)
both polymers##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2010-5#1)
both populations is##2##3##(1991-2#1)(2008-9#1)
both populations of##3##3##(1993-3#1)(2013-1#1)(2013-8#1)
both populations##23##2##(1990-8#4)(1991-2#1)(1993-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#2)(2013-8#2)
both positive and negative##12##4##(1992-3#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#1)
both positive and##13##3##(1992-3#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#1)
both positive##17##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)
both positively##3##2##(1990-5#1)(2007-11#1)(2008-10#1)
both posterior##2##2##(1994-9#1)(1997-6#1)
both potato and tomato##4##4##(2008-10#4)
both potato and##5##3##(2008-10#5)
both pp 44 and pp 42##2##6##(1993-8#2)
both practical and##4##3##(1992-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
both practice and##2##3##(1991-1#1)(2008-11#1)
both pre- and postsynaptic##2##4##(1990-12#1)(2009-8#1)
both pre- and##5##3##(1990-12#1)(1992-3#1)(1997-4#1)(2008-12#1)(2009-8#1)
both pregnant and##2##3##(1994-8#1)(1995-6#1)
both preparations##3##2##(1990-12#1)(2008-1#1)(2008-10#1)
both prevent##2##2##(2011-2#1)(2012-2#1)
both primary and secondary##3##4##(1994-8#1)(2009-9#1)(2010-5#1)
both primary and##5##3##(1994-2#1)(1994-8#1)(2008-11#1)(2009-9#1)(2010-5#1)
both primary##7##2##(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-5#1)
both prior handling and##2##4##(1992-7#2)
both prior##3##2##(1992-7#2)(1996-2#1)
both private and public##2##4##(1991-12#1)(1997-4#1)
both pro- and##2##3##(2006-10#1)(2012-2#1)
both procedures##13##2##(2007-10#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-9#1)(2011-2#2)
both processes##10##2##(1993-3#1)(1993-8#1)(1996-2#1)(2007-11#1)(2008-10#4)(2009-7#1)(2009-8#1)
both produced##2##2##(1993-11#1)(2008-6#1)
both products##6##2##(1990-7#1)(1991-3#1)(1993-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
both prokaryotic and eukaryotic##2##4##(1997-4#1)(1997-7#1)
both promoter activation and gene amplification##2##6##(2008-11#2)
both promoters were##2##3##(1992-6#2)
both proposed##2##2##(1994-5#1)(2008-10#1)
both protein and mRNA##2##4##(1993-3#1)(2013-1#1)
both protein and##5##3##(1993-12#1)(1993-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
both protein kinase C##2##4##(1993-3#1)(1994-11#1)
both protein##11##2##(1991-5#1)(1993-12#1)(1993-3#2)(1994-11#1)(1995-11#1)(1995-6#1)(2008-4#2)(2012-2#1)(2013-1#1)
both proteins were##3##3##(1997-2#1)(2009-10#1)(2009-3#1)
both proteins##14##2##(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#1)
both protocols yield similar results for transformation with linear plasmid or genomic DNA##2##13##(2008-1#1)(2008-2#1)
both provinces##4##2##(1994-2#1)(2008-10#3)
both proximal and##2##3##(2008-5#1)(2009-5#1)
both psychiatrists and##2##3##(2008-6#1)(2009-9#1)
both psychiatrists##3##2##(2008-2#1)(2008-6#1)(2009-9#1)
both public and private##3##4##(1997-3#1)(2008-7#1)(2012-1#1)
both pulse##2##2##(2007-12#1)(2008-2#1)
both purified##2##2##(1994-8#1)(2008-10#1)
both qualitative and quantitative##7##4##(1996-4#1)(2008-10#3)(2008-12#1)(2010-10#2)
both quality and##4##3##(1994-1#1)(1995-1#1)(2008-11#1)(2008-5#1)
both quality##5##2##(1994-1#1)(1995-1#1)(1996-6#1)(2008-11#1)(2008-5#1)
both quantitative and qualitative##11##4##(1992-2#1)(1993-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
both quantitative##12##2##(1992-2#1)(1993-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
both quaternary##2##2##(1990-8#1)(1992-11#1)
both races##4##2##(2008-10#4)
both random and##2##3##(2008-2#1)(2012-2#1)
both rapid##2##2##(2008-1#1)(2008-4#1)
both rapidly##3##2##(1995-6#2)(2008-10#1)
both rat and human##2##4##(1993-12#1)(1997-4#1)
both rat and mouse embryos##2##5##(1995-3#2)
both rat and##5##3##(1993-12#1)(1995-3#2)(1997-1#1)(1997-4#1)
both rat##7##2##(1990-12#1)(1990-5#1)(1993-12#1)(1995-3#2)(1997-1#1)(1997-4#1)
both rats and##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
both rats##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
both reactions##2##2##(1992-8#1)(2008-10#1)
both recent and##2##3##(2008-10#1)(2010-4#1)
both receptor##2##2##(1994-11#1)(2008-4#1)
both receptors##5##2##(1990-11#1)(1993-3#1)(2008-11#1)(2008-4#1)(2011-2#1)
both recombinant##3##2##(1991-11#1)(1993-8#1)(1995-6#1)
both recording##2##2##(1990-7#1)(2007-12#1)
both reduce the##2##3##(2006-10#1)(2008-11#1)
both reduced##5##2##(1992-9#1)(1996-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
both reducing##2##2##(2008-5#1)(2012-2#1)
both reference materials##2##3##(2008-10#2)
both reference##3##2##(2008-10#3)
both reflective##2##2##(2008-3#2)
both regions##2##2##(1996-12#1)(1996-2#1)
both renal##3##2##(1994-5#1)(1994-8#1)(1995-12#1)
both renin##2##2##(1993-6#1)(1996-5#1)
both repair and##2##3##(1997-2#1)(2008-7#1)
both reported##2##2##(1997-2#1)(2012-12#1)
both research and clinical##2##4##(2008-10#1)(2011-7#1)
both research and##3##3##(2008-10#1)(2008-11#1)(2011-7#1)
both resistance##3##2##(2008-10#3)
both resistant and susceptible##2##4##(2008-10#1)(2011-10#1)
both respiratory##2##2##(2008-10#1)(2010-7#1)
both responses##2##2##(1993-6#1)(1997-2#1)
both resting##3##2##(1993-12#1)(1994-3#1)(2008-7#1)
both ridges lasing##2##3##(2007-11#2)
both right##2##2##(2007-12#1)(2010-6#1)
both root##4##2##(2007-11#1)(2008-10#3)
both roots and##2##3##(2008-10#2)
both roots##3##2##(2008-10#2)(2008-5#1)
both routes##2##2##(1996-12#1)(2008-9#1)
both rural and urban##4##4##(1996-3#1)(2009-7#1)(2011-2#1)(2012-2#1)
both safe and effective##3##4##(1992-2#1)(2006-12#1)(2011-2#1)
both safe and##5##3##(1992-2#1)(1994-2#1)(2006-12#1)(2011-2#1)(2012-3#1)
both sample introduction##2##3##(2008-10#2)
both sample##5##2##(2008-10#5)
both samples and##3##3##(2008-10#2)(2008-2#1)
both samples##10##2##(1996-7#1)(2008-10#4)(2008-2#2)(2009-11#1)(2010-1#1)(2011-1#1)
both sampling periods##2##3##(2008-10#2)
both sampling##4##2##(2008-10#4)
both scattering##2##2##(2008-3#2)
both schizophrenia and##2##3##(1997-5#1)(2011-1#1)
both scientific and##3##3##(1995-9#1)(1996-6#1)(2008-10#1)
both scientific##7##2##(1991-5#1)(1995-9#1)(1996-6#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
both seasons##3##2##(2008-10#2)(2008-5#1)
both seed##3##2##(2008-10#1)(2008-12#1)(2009-6#1)
both seedling and##2##3##(2008-10#2)
both selectively##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
both sensitive##2##2##(1990-2#1)(2008-10#1)
both sensor##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
both sensors##3##2##(2008-10#3)
both sensory##3##2##(1992-6#1)(2008-1#1)(2011-2#1)
both separately and##2##3##(1996-1#1)(2008-10#1)
both sequence##2##2##(1995-2#1)(1997-9#1)
both series##2##2##(1997-4#1)(2008-10#1)
both serum##3##2##(1990-3#1)(1995-2#1)(2008-8#1)
both sets of##4##3##(1992-12#1)(2008-10#1)(2010-4#2)
both sets##5##2##(1992-12#1)(2008-10#2)(2010-4#2)
both sex##3##2##(2008-11#1)(2008-7#1)(2010-4#1)
both sexes and##3##3##(1991-6#1)(2012-12#1)(2012-3#1)
both sexes are##2##3##(2009-5#1)(2010-3#1)
both sexes at##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
both sexes between##3##3##(2006-10#1)(2008-7#1)(2011-1#1)
both sexes in the##2##4##(1991-6#1)(2013-1#1)
both sexes in##7##3##(1991-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
both sexes of##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)
both sexes that##2##3##(1990-10#1)(2008-5#1)
both sexes were##4##3##(1990-2#1)(2008-8#1)(2011-2#1)(2013-7#1)
both sexes##80##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1991-12#1)(1991-6#4)(1992-12#1)(1992-6#1)(1993-8#2)(1994-2#1)(1995-2#1)(1995-8#2)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#6)(2008-7#8)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#3)
both sexual and asexual reproduction##4##5##(2008-10#4)
both sexual and##5##3##(2008-10#4)(2008-9#1)
both sexual##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2009-5#1)
both short-term and long-term##4##4##(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
both short-term##5##2##(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
both show##2##2##(2008-3#1)(2013-1#1)
both showed##2##2##(1993-9#1)(1996-2#1)
both sides of the membrane##2##5##(1990-11#1)(1993-3#1)
both sides of the root##2##5##(2008-10#2)
both sides of the##23##4##(1990-11#1)(1990-2#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#4)(2012-12#1)(2013-7#1)
both sides of##24##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#4)(2012-12#1)(2013-7#1)
both sides##43##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-1#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
both significant and insignificant##2##4##(2008-10#2)
both significant##4##2##(2006-10#1)(2008-10#2)(2010-10#1)
both simple and##2##3##(2008-11#1)(2009-2#1)
both simple##3##2##(2008-11#1)(2008-3#1)(2009-2#1)
both simulated and real##4##4##(2008-10#2)(2008-3#1)(2008-7#1)
both simulated and##5##3##(2008-10#2)(2008-3#2)(2008-7#1)
both single and##2##3##(2008-6#1)(2011-1#1)
both single##4##2##(1992-8#1)(2008-11#1)(2008-6#1)(2011-1#1)
both single-##2##2##(2008-2#1)(2008-7#1)
both single-mode and multimode##2##4##(2007-11#1)(2008-3#1)
both sites and##2##3##(2008-10#2)
both sites##12##2##(1990-5#1)(1991-3#1)(1992-3#1)(1993-3#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
both size and##3##3##(1993-9#1)(2008-10#1)(2008-4#1)
both size##4##2##(1993-9#1)(1995-11#1)(2008-10#1)(2008-4#1)
both skin and##2##3##(2008-5#1)(2008-9#1)
both skin##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
both sleep and##2##3##(1991-9#1)(2012-2#1)
both small and##3##3##(1996-2#1)(2008-11#1)(2010-11#1)
both small##7##2##(1992-5#1)(1996-2#1)(1996-4#1)(2008-11#2)(2010-11#1)(2012-12#1)
both soapnut and jatropha##2##4##(2009-3#2)
both social##3##2##(2007-12#1)(2008-11#1)(2010-4#1)
both soil##2##2##(2008-10#1)(2012-6#1)
both soils##2##2##(2008-10#2)
both solid##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
both soluble and##2##3##(1995-2#1)(2008-4#1)
both soluble##3##2##(1995-2#1)(2006-6#1)(2008-4#1)
both sources##4##2##(1994-5#2)(2008-10#1)(2009-7#1)
both space and##2##3##(2008-10#1)(2013-1#1)
both space##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
both spatial and temporal##2##4##(2008-3#2)
both spatial and##4##3##(1993-12#1)(2008-2#1)(2008-3#2)
both spatially##2##2##(2008-8#1)(2009-3#1)
both species are##2##3##(2008-9#1)(2013-7#1)
both species in##6##3##(1994-3#1)(2008-10#2)(2008-8#1)(2012-8#1)(2013-7#1)
both species to##2##3##(1990-2#1)(2008-10#1)
both species were##5##3##(1991-8#1)(1993-8#1)(2008-10#2)(2010-8#1)
both species##66##2##(1990-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-5#4)(2008-7#4)(2008-8#8)(2008-9#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#3)(2012-1#1)(2012-8#1)(2013-7#3)
both specific##2##2##(2008-10#1)(2011-2#1)
both spectral##3##2##(2008-2#1)(2008-3#2)
both spontaneous and##2##3##(2006-6#1)(2008-7#1)
both spontaneous##4##2##(1991-9#1)(2006-6#1)(2008-7#1)(2008-8#1)
both spore##3##2##(2008-10#3)
both spring and##3##3##(2008-10#2)(2010-8#1)
both stable##3##2##(2008-1#1)(2008-2#1)(2012-4#1)
both stages##2##2##(2008-11#1)(2012-2#1)
both states##4##2##(1993-11#1)(2008-5#2)(2013-8#1)
both static and dynamic##11##4##(1990-7#1)(2007-8#1)(2008-10#7)(2008-3#2)
both static and##12##3##(1990-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)
both steps##2##2##(2008-10#1)(2010-8#1)
both stimuli##2##2##(1993-3#1)(2008-10#1)
both strains grew##2##3##(2008-10#2)
both strains were##2##3##(1993-11#1)(2008-10#1)
both strains##28##2##(1991-8#1)(1993-11#1)(1993-12#2)(1994-3#2)(1994-5#1)(1996-12#2)(2007-10#1)(2007-6#1)(2008-10#11)(2008-11#2)(2011-1#2)(2011-2#1)(2013-1#1)
both strands of##3##3##(1994-12#1)(1994-8#1)(1996-6#1)
both strands##6##2##(1992-3#1)(1994-12#1)(1994-8#1)(1996-6#1)(2008-2#2)
both stronger##2##2##(1992-7#1)(2007-12#1)
both structural and##2##3##(2007-12#1)(2008-3#1)
both structures##2##2##(1994-2#1)(2006-4#1)
both students and##3##3##(1996-1#1)(2008-11#1)(2008-12#1)
both studied##5##2##(2008-10#2)(2008-12#1)(2010-1#1)(2013-8#1)
both studies##29##2##(1992-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#20)(2009-9#1)(2010-1#2)(2012-12#1)
both subgroups##2##2##(2008-10#1)(2008-7#1)
both subjects##2##2##(1994-2#1)(1996-1#1)
both subpopulations##2##2##(1993-8#1)(1996-5#1)
both substances##4##2##(2008-10#3)(2009-7#1)
both substrates##10##2##(1990-11#1)(1991-9#1)(1994-5#1)(1994-6#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
both subunits and##2##3##(1992-3#1)(1994-5#1)
both subunits##5##2##(1992-3#1)(1994-5#1)(1996-2#2)(2008-7#1)
both sufficient##2##2##(2007-11#1)(2008-9#1)
both surface and##2##3##(2008-10#1)(2008-3#1)
both surgery and##3##3##(1992-2#1)(2012-1#1)(2012-12#1)
both surgical##2##2##(2007-11#1)(2011-3#1)
both surveys##2##2##(2009-9#2)
both susceptible and resistant##2##4##(2008-10#2)
both susceptible and##4##3##(2008-10#4)
both suspension and##4##3##(2008-11#4)
both symmetric##2##2##(1993-8#1)(2008-8#1)
both symptomatic and##2##3##(2008-10#1)(2008-3#1)
both symptomatic##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
both syndromes##2##2##(2008-11#1)(2009-12#1)
both synthetic and##5##3##(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
both synthetic##8##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
both systems and##2##3##(1990-8#1)(2008-10#1)
both systems##25##2##(1990-8#1)(1992-12#1)(1993-2#1)(1993-8#4)(1994-8#1)(2006-10#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#1)(2009-12#2)
both systolic##2##2##(1994-11#1)(2007-10#1)
both tandem##2##2##(2008-7#1)(2009-5#1)
both tasks##2##2##(1994-8#1)(2010-5#1)
both technical and##2##3##(2009-11#1)(2013-1#1)
both technical##3##2##(2009-11#1)(2011-2#1)(2013-1#1)
both techniques was##2##3##(2007-10#1)(2011-2#1)
both techniques##25##2##(1991-12#1)(1992-11#1)(1993-12#1)(1996-1#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
both technologies##2##2##(2010-8#2)
both temperature and##5##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-3#1)
both temperatures##3##2##(2008-12#1)(2010-8#1)(2012-12#1)
both temporal and spatial##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
both temporal and##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
both test##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
both tested##6##2##(1995-5#1)(2008-10#3)(2008-12#1)(2008-5#1)
both testicles##2##2##(2008-10#1)(2012-12#1)
both tests##7##2##(1992-3#1)(1994-8#1)(1997-6#1)(2007-2#1)(2008-10#2)(2011-1#1)
both the 5' and##2##4##(2008-10#2)
both the SNC and##2##4##(1996-12#2)
both the Stokes##2##3##(2007-11#1)(2008-3#1)
both the T and##2##4##(1990-8#1)(1995-6#1)
both the X and##2##4##(1994-1#1)(2008-2#1)
both the ability to##2##4##(2008-11#1)(2008-8#1)
both the absence##5##3##(1991-5#1)(1993-9#1)(1995-5#1)(2008-10#2)
both the activation##2##3##(1993-8#1)(1994-8#1)
both the acute and##2##4##(1995-12#1)(1997-1#1)
both the acute##3##3##(1995-12#1)(1997-1#1)(2007-10#1)
both the alpha- and##3##4##(1990-8#1)(1992-3#1)(2008-5#1)
both the amino##2##3##(2008-10#2)
both the amount of##4##4##(2008-10#2)(2008-5#1)(2009-8#1)
both the amplitude and the phase##2##6##(2007-12#1)(2008-3#1)
both the amplitude and the##4##5##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
both the average##2##3##(2007-12#1)(2008-10#1)
both the batch and##3##4##(2008-10#2)(2008-7#1)
both the benefits##2##3##(1995-1#1)(2008-8#1)
both the biological##2##3##(2010-3#1)(2010-6#1)
both the cases##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
both the cell##4##3##(1991-9#1)(1995-9#1)(2008-8#1)(2009-3#1)
both the cellular##2##3##(1993-8#1)(2010-1#1)
both the clinical##2##3##(1994-12#1)(2009-8#1)
both the coding##2##3##(1992-9#1)(2008-1#1)
both the complex##2##3##(2008-2#2)
both the control and the##3##5##(2008-10#1)(2012-3#1)(2013-8#1)
both the control and##4##4##(2007-7#1)(2008-10#1)(2012-3#1)(2013-8#1)
both the control group and##2##5##(2007-6#1)(2009-5#1)
both the control##6##3##(2007-6#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-3#1)(2013-8#1)
both the core##2##3##(1994-8#1)(1995-12#1)
both the cytoplasmic and##2##4##(1992-10#1)(2008-9#1)
both the cytosolic and##3##4##(1993-12#2)(1996-5#1)
both the demographic##2##3##(2008-8#1)(2008-9#1)
both the developed##2##3##(1997-7#1)(2008-10#1)
both the development##2##3##(2008-7#1)(2011-2#1)
both the diagnosis and##2##4##(2010-5#1)(2011-2#1)
both the epidermis and##2##4##(1996-12#1)(2008-5#1)
both the evolution of##2##4##(2008-8#1)(2010-6#1)
both the expression##2##3##(1995-12#1)(2008-8#1)
both the extracellular##3##3##(1993-3#1)(1994-9#1)(2010-4#1)
both the extraction##2##3##(2008-10#2)
both the fast##2##3##(1995-2#1)(2008-3#1)
both the formation of##3##4##(1995-6#1)(1997-2#1)(1997-8#1)
both the formation##4##3##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)
both the frequency and the##2##5##(2007-11#1)(2008-7#1)
both the frequency##3##3##(1995-3#1)(2007-11#1)(2008-7#1)
both the fundamental and the##2##5##(2007-11#1)(2008-3#1)
both the fundamental##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
both the gene##2##3##(2008-2#1)(2010-5#1)
both the global and##2##4##(2008-10#1)(2009-8#1)
both the global##3##3##(2008-10#2)(2009-8#1)
both the groups##2##3##(2011-2#1)(2012-2#1)
both the high##3##3##(2008-1#1)(2008-10#1)(2010-1#1)
both the host##2##3##(2008-8#1)(2011-2#1)
both the human and##4##4##(1993-6#1)(2008-4#1)(2011-2#1)(2012-3#1)
both the human##6##3##(1991-12#1)(1993-6#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-3#1)
both the incidence of##2##4##(1991-5#1)(2008-4#1)
both the increase##2##3##(1992-3#1)(2009-12#1)
both the individual and##2##4##(2008-5#1)(2008-9#1)
both the individual##3##3##(2008-5#1)(2008-9#1)(2011-1#1)
both the initial##4##3##(1993-11#1)(2007-10#1)(2008-6#1)(2008-8#1)
both the initiation and##2##4##(1992-5#1)(2008-11#1)
both the inner and outer##2##5##(1991-10#1)(2013-8#1)
both the input and the output##2##6##(2007-12#1)(2008-3#1)
both the input and the##3##5##(2007-12#1)(2008-3#2)
both the input##4##3##(2007-12#1)(2008-3#3)
both the intensity and the##2##5##(2007-12#2)
both the intensity##3##3##(2007-12#2)(2008-10#1)
both the left##2##3##(2010-7#1)(2011-2#1)
both the level of##2##4##(2008-10#1)(2009-8#1)
both the level##3##3##(1996-2#1)(2008-10#1)(2009-8#1)
both the linear##2##3##(2007-11#1)(2008-3#1)
both the local##2##3##(1995-5#1)(2008-10#1)
both the magnitude##2##3##(2008-3#1)(2009-5#1)
both the male##2##3##(1990-5#1)(2013-1#1)
both the mean##2##3##(2008-3#1)(2010-10#1)
both the medial##2##3##(1994-3#1)(2008-11#1)
both the model##2##3##(1994-2#1)(2008-7#1)
both the mother and##2##4##(2008-10#1)(2011-1#1)
both the native and##2##4##(1995-5#1)(2011-2#1)
both the native##3##3##(1995-2#1)(1995-5#1)(2011-2#1)
both the nature of##2##4##(2012-12#1)(2012-2#1)
both the nature##3##3##(2010-4#1)(2012-12#1)(2012-2#1)
both the normal and##2##4##(1993-12#1)(2007-11#1)
both the normal##3##3##(1993-12#1)(2007-11#1)(2008-10#1)
both the nuclear##2##3##(1994-8#1)(2012-2#1)
both the number of##11##4##(1990-12#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-9#2)(2009-8#1)(2011-1#1)
both the number##12##3##(1990-12#1)(1990-5#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-9#2)(2009-8#1)(2011-1#1)
both the ophthalmologist and the##2##5##(2013-1#1)(2013-7#1)
both the patient and the##5##5##(1991-12#1)(1994-2#1)(2007-6#1)(2009-9#1)(2012-12#1)
both the patient and##6##4##(1991-11#1)(1991-12#1)(1994-2#1)(2007-6#1)(2009-9#1)(2012-12#1)
both the patients##3##3##(1990-9#1)(2007-7#1)(2008-11#1)
both the physical and##2##4##(2008-3#1)(2008-4#1)
both the physical##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
both the pig##2##3##(2008-7#1)(2011-2#1)
both the plasma membrane and the##2##6##(2008-11#1)(2009-8#1)
both the plasma##3##3##(1992-6#1)(2008-11#1)(2009-8#1)
both the positive##2##3##(2008-11#1)(2010-5#1)
both the primary##2##3##(1993-3#1)(2011-2#1)
both the private##2##3##(1995-12#1)(1997-3#1)
both the procedures##2##3##(2008-10#2)
both the proliferation##2##3##(1991-12#1)(2008-11#1)
both the protein and##2##4##(1993-11#1)(2010-1#1)
both the protein##4##3##(1990-7#1)(1993-11#1)(2008-4#1)(2010-1#1)
both the public and##3##4##(1992-12#1)(1995-1#1)(2011-2#1)
both the rate of##3##4##(1995-11#1)(2008-10#1)(2008-8#1)
both the real and the imaginary parts of the refractive index##2##11##(2007-11#1)(2007-12#1)
both the real and the imaginary parts of the##3##9##(2007-11#1)(2007-12#1)(2008-3#1)
both the real and##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
both the reduction and oxidation##2##5##(2008-10#2)
both the reduction of##3##4##(2007-12#1)(2009-8#1)(2012-12#1)
both the reduction##5##3##(2007-12#1)(2008-10#2)(2009-8#1)(2012-12#1)
both the regular##2##3##(1994-12#1)(2008-3#1)
both the relative and absolute##2##5##(2008-8#2)
both the relative##3##3##(1995-5#1)(2008-8#2)
both the right and##2##4##(2008-10#1)(2008-7#1)
both the root##2##3##(2008-10#1)(2012-1#1)
both the same##2##3##(1995-12#1)(2008-10#1)
both the sample and##2##4##(2008-10#1)(2008-7#1)
both the sensitivity and##2##4##(2008-10#2)
both the separation##2##3##(2008-10#2)
both the serum##2##3##(1995-3#2)
both the short##2##3##(2008-7#1)(2008-8#1)
both the signal##2##3##(2008-11#1)(2008-3#1)
both the size and##2##4##(2008-2#1)(2011-2#1)
both the size of the##2##5##(2008-10#1)(2008-5#1)
both the size##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
both the spatial##4##3##(2007-11#1)(2008-3#2)(2010-7#1)
both the species##2##3##(2008-10#1)(2010-7#1)
both the state and##2##4##(1994-3#1)(1996-1#1)
both the stress##2##3##(2008-7#1)(2011-2#1)
both the temperature##2##3##(2008-3#2)
both the time##4##3##(1990-11#1)(2008-10#3)
both the timing##2##3##(2007-12#1)(2013-8#1)
both the total##5##3##(1995-12#1)(2008-5#3)(2012-12#1)
both the transmitted and the##2##5##(2008-2#1)(2008-3#1)
both the transmitted##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
both the tumor##2##3##(1994-2#1)(2011-2#1)
both the type of##2##4##(2007-6#1)(2008-4#1)
both the use of##3##4##(2008-10#1)(2009-10#1)(2009-12#1)
both the wavelength and the##2##5##(2007-11#1)(2008-3#1)
both the wild-type##2##3##(2008-10#2)
both the##896##2##(1990-11#5)(1990-12#2)(1990-2#2)(1990-5#5)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-5#5)(1991-6#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#9)(1992-5#1)(1992-6#3)(1992-9#6)(1993-11#8)(1993-12#11)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#4)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#6)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#9)(1995-2#5)(1995-3#7)(1995-5#9)(1995-6#9)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#6)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2006-12#1)(2007-10#3)(2007-11#20)(2007-12#14)(2007-6#3)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#158)(2008-11#32)(2008-12#9)(2008-2#27)(2008-3#59)(2008-4#18)(2008-5#23)(2008-6#7)(2008-7#33)(2008-8#27)(2008-9#22)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#10)(2009-9#4)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#7)(2010-5#9)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#34)(2012-1#4)(2012-12#9)(2012-2#14)(2012-3#13)(2012-6#1)(2013-1#15)(2013-7#5)(2013-8#7)
both thein vitro##2##3##(2008-8#2)
both their##16##2##(1990-2#1)(1991-3#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-1#1)(2013-1#2)
both theoretical##2##2##(1994-12#1)(1996-3#1)
both theoretically and experimentally that the##2##6##(2007-12#1)(2008-3#1)
both theoretically and experimentally that##6##5##(2007-12#1)(2008-2#1)(2008-3#4)
both theoretically and experimentally##17##4##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#10)
both theoretically and##18##3##(1990-7#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#10)
both theory and##2##3##(2008-12#1)(2010-11#1)
both therapeutic##2##2##(2008-7#1)(2011-1#1)
both these##16##2##(1991-12#1)(1995-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#4)(2009-6#1)(2011-2#1)
both thin##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
both through the##2##3##(1997-1#1)(2013-8#1)
both through##5##2##(1997-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#1)
both thyrocytes and C cells##2##5##(2012-3#2)
both thyroid##2##2##(1990-3#1)(2008-4#1)
both time and##4##3##(2007-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
both time points##5##3##(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#2)
both time##10##2##(1992-6#1)(2007-12#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
both time-consuming and##2##3##(2008-10#1)(2008-11#1)
both tissue##2##2##(1991-9#1)(2008-10#1)
both tissues##8##2##(1990-5#1)(1991-8#1)(1992-9#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-6#1)
both to inhibit##2##3##(1994-6#1)(2007-8#1)
both to the##8##3##(1990-2#1)(1995-2#1)(1997-2#1)(2008-10#1)(2009-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
both to##39##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-6#1)(1995-2#2)(1997-2#2)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
both tomato and potato##2##4##(2008-10#2)
both tomato and##3##3##(2008-10#3)
both total##3##2##(1993-12#2)(2008-10#1)
both toxins##2##2##(2008-10#1)(2011-1#1)
both traditional##4##2##(1992-1#1)(1994-6#1)(1996-2#1)(2006-10#1)
both traits##3##2##(2008-10#3)
both transabdominal##3##2##(1996-1#2)(2011-2#1)
both transcription##2##2##(2008-11#2)
both transcriptional and posttranscriptional##2##4##(2008-11#1)(2012-12#1)
both transcriptional and##3##3##(1995-6#1)(2008-11#1)(2012-12#1)
both transcripts##2##2##(1994-9#1)(1997-7#1)
both transient##3##2##(1995-12#1)(2008-1#1)(2008-2#1)
both translational and##2##3##(1995-11#1)(2008-3#1)
both transmembrane domains##2##3##(2008-4#2)
both treated##2##2##(1990-2#1)(2010-4#1)
both treatment and##2##3##(2012-2#1)(2012-3#1)
both treatment##6##2##(1993-12#1)(2007-8#1)(2008-6#1)(2010-12#1)(2012-2#1)(2012-3#1)
both treatments and##2##3##(2009-5#1)(2010-1#1)
both treatments##10##2##(1991-3#1)(2008-10#2)(2008-5#1)(2008-9#3)(2009-5#1)(2010-1#1)(2011-2#1)
both tributaries##2##2##(2010-8#2)
both tumor##4##2##(2007-8#1)(2011-2#3)
both tumors##2##2##(2010-11#1)(2013-1#1)
both tumours##2##2##(1990-11#1)(2013-7#1)
both twins##2##2##(1995-6#1)(2010-1#1)
both two##2##2##(2008-10#1)(2008-12#1)
both two-photon##2##2##(2008-8#2)
both type 1 and type 2 diabetes##4##7##(2008-1#1)(2008-8#1)(2013-1#2)
both type 1##5##3##(2008-1#1)(2008-8#1)(2009-11#1)(2013-1#2)
both type##8##2##(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-11#1)(2013-1#2)
both types of measurements##2##4##(2008-10#2)
both types of receptors##2##4##(1993-6#1)(1997-1#1)
both types of##52##3##(1991-1#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-12#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
both types##55##2##(1991-1#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-12#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
both tyrosine phosphorylation and respiratory-burst activity##2##6##(1994-6#2)
both tyrosine##4##2##(1993-8#1)(1994-6#2)(1996-2#1)
both tyrosine-kinase-dependent and -independent pathways##2##5##(1994-6#2)
both under##2##2##(2008-10#1)(2013-1#1)
both undergraduate and postgraduate##3##4##(2007-10#1)(2008-11#1)(2012-1#1)
both undergraduate and##4##3##(2007-10#1)(2008-11#1)(2008-12#1)(2012-1#1)
both univariate and##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
both university##2##2##(1990-10#1)(2013-1#1)
both upper##2##2##(2012-2#1)(2013-8#1)
both urban and##3##3##(1993-12#1)(2008-11#1)(2009-4#1)
both urban##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2009-4#1)
both vaccines##2##2##(1995-5#2)
both variables##2##2##(2008-10#2)
both vascular and##2##3##(2007-11#1)(2012-2#1)
both vascular##3##2##(2007-11#1)(2011-2#1)(2012-2#1)
both vasopressin and##2##3##(1992-5#1)(1995-12#1)
both versions##2##2##(2008-10#1)(2008-8#1)
both vertical and horizontal##2##4##(2008-10#1)(2008-11#1)
both vertical and##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
both very##2##2##(2008-10#1)(2008-3#1)
both viral##2##2##(2008-11#1)(2008-9#1)
both virulence and resistance##2##4##(2008-10#1)(2013-1#1)
both virulence and##4##3##(2008-10#3)(2013-1#1)
both virulence##6##2##(2008-10#5)(2013-1#1)
both viruses in the##2##4##(2008-10#2)
both viruses in##4##3##(2008-10#4)
both viruses was##2##3##(2008-10#1)(2008-9#1)
both viruses were##2##3##(2008-10#2)
both viruses##26##2##(1995-12#3)(2008-10#22)(2008-9#1)
both visible and invisible##2##4##(2008-1#2)
both visual##4##2##(2007-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
both was##3##2##(2008-10#2)(2008-9#1)
both water and##3##3##(1992-9#1)(2008-3#1)(2012-12#1)
both water##5##2##(1992-9#1)(2007-2#1)(2008-12#1)(2008-3#1)(2012-12#1)
both wavelengths##3##2##(1995-6#1)(2007-12#1)(2008-2#1)
both well-established##2##2##(1993-6#1)(2008-10#1)
both were##12##2##(1991-11#1)(1992-6#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2012-2#1)(2012-3#1)
both when##6##2##(2008-10#3)(2008-11#2)(2011-1#1)
both wild-type and##3##3##(1994-6#1)(1994-8#1)(2011-3#1)
both with a##2##3##(2006-10#1)(2013-1#1)
both with and without##9##4##(1995-2#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)
both with native##2##3##(1995-11#1)(2008-10#1)
both with the##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
both with##31##2##(1991-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-5#2)(2006-10#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-5#1)(2013-1#2)
both within and among##2##4##(2008-8#1)(2008-9#1)
both within and between patches##2##5##(2008-8#2)
both within and between the##2##5##(2008-7#1)(2010-7#1)
both within and between##9##4##(1990-12#1)(1993-1#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-7#1)(2012-3#2)
both within and outside the##2##5##(1991-2#1)(2013-1#1)
both within and outside##3##4##(1991-2#1)(2008-10#1)(2013-1#1)
both within and##17##3##(1990-12#1)(1991-2#1)(1993-1#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#3)(2013-1#1)
both within the##3##3##(1994-1#1)(2008-10#1)(2008-7#1)
both within##26##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-1#1)(1994-1#1)(1997-4#1)(2008-10#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)(2012-3#4)(2013-1#1)
both women and men##2##4##(1991-8#1)(1996-3#1)
both women and##3##3##(1991-6#1)(1991-8#1)(1996-3#1)
both women##4##2##(1991-6#1)(1991-8#1)(1996-3#1)(2008-3#1)
both workers and##3##3##(1992-2#1)(2007-12#2)
both worlds##4##2##(2009-11#3)(2012-2#1)
both years##38##2##(1996-12#1)(2007-5#1)(2007-6#2)(2008-10#22)(2008-11#4)(2008-4#2)(2008-6#1)(2011-2#5)
both young and old rats##3##5##(1994-6#1)(1994-8#1)(2008-7#1)
both young and old##4##4##(1994-6#2)(1994-8#1)(2008-7#1)
both young and##6##3##(1994-6#2)(1994-8#1)(1997-6#1)(2008-7#1)(2008-9#1)
both young##8##2##(1994-6#2)(1994-8#1)(1997-6#2)(2008-5#1)(2008-7#1)(2008-9#1)
both##8020##1##(1990-10#4)(1990-11#28)(1990-12#43)(1990-2#30)(1990-3#14)(1990-5#41)(1990-6#5)(1990-7#26)(1990-8#40)(1990-9#9)(1991-1#15)(1991-10#2)(1991-11#12)(1991-12#45)(1991-2#33)(1991-3#23)(1991-4#3)(1991-5#38)(1991-6#23)(1991-7#2)(1991-8#17)(1991-9#31)(1992-1#13)(1992-10#7)(1992-11#23)(1992-12#43)(1992-2#24)(1992-3#55)(1992-4#7)(1992-5#16)(1992-6#36)(1992-7#4)(1992-8#30)(1992-9#28)(1993-1#12)(1993-10#1)(1993-11#32)(1993-12#84)(1993-2#13)(1993-3#30)(1993-5#4)(1993-6#38)(1993-8#47)(1993-9#21)(1994-1#12)(1994-10#2)(1994-11#30)(1994-12#49)(1994-2#59)(1994-3#37)(1994-5#33)(1994-6#40)(1994-7#4)(1994-8#50)(1994-9#27)(1995-1#13)(1995-11#41)(1995-12#57)(1995-2#62)(1995-3#32)(1995-5#53)(1995-6#53)(1995-8#26)(1995-9#8)(1996-1#21)(1996-10#2)(1996-11#4)(1996-12#49)(1996-2#49)(1996-3#19)(1996-4#5)(1996-5#44)(1996-6#15)(1996-7#6)(1996-8#5)(1996-9#8)(1997-1#24)(1997-2#51)(1997-3#26)(1997-4#40)(1997-5#14)(1997-6#31)(1997-7#32)(1997-8#16)(1997-9#4)(2006-10#24)(2006-12#5)(2006-4#2)(2006-6#9)(2006-8#1)(2007-1#1)(2007-10#30)(2007-11#100)(2007-12#148)(2007-2#13)(2007-4#3)(2007-5#12)(2007-6#10)(2007-7#22)(2007-8#60)(2007-9#4)(2008-1#66)(2008-10#1599)(2008-11#301)(2008-12#123)(2008-2#167)(2008-3#365)(2008-4#121)(2008-5#214)(2008-6#59)(2008-7#284)(2008-8#179)(2008-9#187)(2009-1#7)(2009-10#39)(2009-11#33)(2009-12#27)(2009-2#17)(2009-3#24)(2009-4#11)(2009-5#25)(2009-6#25)(2009-7#31)(2009-8#47)(2009-9#27)(2010-1#34)(2010-10#30)(2010-11#21)(2010-12#23)(2010-2#11)(2010-3#28)(2010-4#40)(2010-5#42)(2010-6#27)(2010-7#19)(2010-8#48)(2010-9#8)(2011-1#98)(2011-10#5)(2011-2#249)(2011-3#5)(2011-7#3)(2012-1#30)(2012-12#97)(2012-2#143)(2012-3#92)(2012-4#3)(2012-5#2)(2012-6#3)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#200)(2013-7#39)(2013-8#88)
both)##11##1##(1990-12#1)(1991-4#1)(1991-7#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-2#1)
bother##2##1##(2009-5#1)(2011-2#1)
bothersome##3##1##(1997-4#1)(2008-10#1)(2008-7#1)
bothin vitro andin vivo##2##4##(2008-8#2)
bothin##3##1##(2008-8#3)
botrocetin##4##1##(1993-3#3)(1994-11#1)
botryoid##4##1##(2007-10#1)(2007-7#3)
bottle gourd##2##2##(2013-8#2)
bottle##15##1##(1991-5#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-8#2)
bottled##6##1##(2008-10#5)(2008-8#1)
bottleneck for##2##2##(2011-1#1)(2011-2#1)
bottleneck in##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
bottleneck of##3##2##(2008-3#1)(2008-7#1)(2010-7#1)
bottleneck##20##1##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)
bottlenecks in##5##2##(1995-2#2)(2007-8#1)(2008-11#1)(2013-1#1)
bottlenecks##17##1##(1991-5#1)(1995-2#3)(1997-4#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
bottles were##2##2##(2008-10#2)
bottles##23##1##(1992-1#1)(1992-12#1)(1997-2#1)(2007-4#1)(2008-10#5)(2008-11#7)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-7#1)
bottom albedo##2##2##(2008-2#1)(2008-3#1)
bottom and##2##2##(2008-5#1)(2009-11#1)
bottom antireflective coating##2##3##(2008-3#2)
bottom depths##6##2##(2008-2#2)(2008-3#4)
bottom line##11##2##(1994-1#3)(1995-1#1)(1995-2#1)(1997-6#1)(2007-9#1)(2008-9#3)(2011-2#1)
bottom of the vial##3##4##(2008-3#3)
bottom of the##19##3##(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2009-12#2)(2009-9#1)(2012-4#1)
bottom of##23##2##(1992-4#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-9#1)(2011-2#1)(2012-4#1)
bottom phase##3##2##(2008-10#3)
bottom up##2##2##(2008-7#1)(2013-1#1)
bottom##105##1##(1990-8#1)(1992-4#1)(1992-8#2)(1994-1#3)(1995-1#2)(1995-2#1)(1995-8#2)(1997-6#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#16)(2008-3#19)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#6)(2009-11#3)(2009-12#2)(2009-9#1)(2011-2#7)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#2)(2013-8#1)
bottom-up approach for the##2##4##(2008-7#1)(2012-2#1)
bottom-up approach##6##2##(1995-3#1)(2008-7#2)(2011-2#1)(2012-2#2)
bottom-up##15##1##(1995-3#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#2)
bottoms##4##1##(2008-5#4)
botulinum and non-proteolytic C##2##4##(2011-2#2)
botulinum during##2##2##(2011-2#2)
botulinum exoenzyme C3##2##3##(1992-3#1)(1996-5#1)
botulinum neurotoxin##7##2##(1990-5#2)(1994-11#3)(2011-2#2)
botulinum toxin injections##2##3##(2008-8#1)(2011-1#1)
botulinum toxin type A injection into the detrusor##2##8##(2008-10#2)
botulinum toxin type A##6##4##(2008-10#3)(2008-2#1)(2008-8#1)(2010-8#1)
botulinum toxin##17##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-8#3)(2009-3#1)(2009-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
botulinum type##5##2##(1992-3#2)(1993-2#1)(2007-12#2)
botulinum##55##1##(1990-5#3)(1992-3#5)(1993-2#1)(1994-11#3)(1996-5#1)(1997-4#2)(2007-11#1)(2007-12#7)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#15)(2012-2#1)(2012-3#2)
botulism in Ontario##3##3##(2007-12#3)
botulism in##5##2##(1991-3#1)(2007-12#4)
botulism##8##1##(1991-3#1)(2007-12#4)(2011-1#1)(2011-2#2)
bought##2##1##(1993-3#1)(2008-1#1)
bound Ca2+##3##2##(1992-6#1)(1994-2#1)(1995-6#1)
bound GDP##3##2##(1991-12#1)(1994-11#2)
bound and unbound##2##3##(1994-8#1)(2008-11#1)
bound and##4##2##(1991-5#1)(1994-6#1)(1994-8#1)(2008-11#1)
bound antigen##3##2##(1990-12#2)(2008-4#1)
bound at the##2##3##(2008-10#2)
bound at##9##2##(1990-8#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-7#1)(2010-6#1)
bound by the##2##3##(1992-10#1)(1995-2#1)
bound by##10##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-2#2)(2008-9#1)(2010-11#1)
bound core modes##2##3##(2008-3#2)
bound form##2##2##(2007-11#1)(2008-11#1)
bound from free##2##3##(1995-11#1)(1995-5#1)
bound in a##3##3##(1991-9#1)(2008-10#1)(2008-2#1)
bound in the##4##3##(1990-2#1)(1993-11#1)(1995-8#1)(2008-10#1)
bound in##11##2##(1990-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-8#1)(2008-10#3)(2008-2#1)(2009-8#1)
bound inhibitor##3##2##(1992-5#1)(1993-11#2)
bound is##3##2##(1990-6#1)(2007-12#1)(2008-10#1)
bound labelled##2##2##(1995-11#1)(2008-10#1)
bound ligand##3##2##(1992-6#1)(1994-8#1)(2008-10#1)
bound mainly to##2##3##(2008-10#1)(2008-8#1)
bound metal ion##2##3##(1992-3#1)(2010-10#1)
bound metal##4##2##(1992-3#1)(2008-10#2)(2010-10#1)
bound on the##2##3##(2008-6#1)(2010-4#1)
bound on##5##2##(1994-2#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-4#1)
bound one##2##2##(1995-6#1)(2008-10#1)
bound only##3##2##(1990-7#1)(1991-12#1)(1994-8#1)
bound onto the##2##3##(2008-10#1)(2009-11#1)
bound onto##3##2##(2008-10#2)(2009-11#1)
bound per mole of##2##4##(1992-6#1)(1994-5#1)
bound per##5##2##(1991-8#1)(1991-9#2)(1992-6#1)(1994-5#1)
bound preferentially to the##2##4##(1992-3#1)(1996-2#1)
bound preferentially##3##2##(1990-12#1)(1992-3#1)(1996-2#1)
bound proteins##4##2##(1990-5#2)(1993-6#1)(2008-2#1)
bound residues##2##2##(2008-11#2)
bound saturably to##2##3##(1993-6#1)(1993-9#1)
bound sialic acid##2##3##(1990-5#1)(1994-11#1)
bound so##2##2##(1995-2#1)(2009-3#1)
bound solitons are##2##3##(2007-11#2)
bound solitons##3##2##(2007-11#3)
bound specifically##3##2##(1996-5#1)(2008-11#1)(2008-9#1)
bound states and##2##3##(2007-11#1)(2007-12#1)
bound states of##2##3##(1994-3#1)(2007-12#1)
bound states##5##2##(1994-3#1)(2007-11#1)(2007-12#3)
bound than dimers in which the hydrogen bond##2##8##(2010-7#2)
bound the##7##2##(1992-3#1)(1994-6#1)(1994-8#2)(1995-9#1)(2008-10#1)(2008-2#1)
bound to DNA##3##3##(1990-5#1)(1996-2#1)(2008-10#1)
bound to HIV-1 reverse transcriptase##2##5##(1993-3#2)
bound to MTSC4##2##3##(2008-8#2)
bound to Sepharose##2##3##(2008-4#2)
bound to a binding protein in##2##6##(1990-12#2)
bound to a component in##2##5##(1993-3#2)
bound to a##17##3##(1990-12#2)(1990-8#1)(1993-3#3)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2009-8#1)
bound to actin##3##3##(1991-5#1)(1994-5#2)
bound to aminopropyl-glass bead##2##4##(2008-10#2)
bound to both##2##3##(1995-12#1)(2008-10#1)
bound to different##2##3##(1992-3#1)(2008-5#1)
bound to low molecular weight##2##5##(1990-2#1)(2008-10#1)
bound to metallothionein-like proteins##2##4##(2010-5#2)
bound to one##2##3##(1993-1#1)(2008-10#1)
bound to organic matter##3##4##(2008-10#3)
bound to proteins##3##3##(2008-10#3)
bound to rat##2##3##(1990-11#1)(1991-5#1)
bound to silica##2##3##(2008-10#2)
bound to the P##2##4##(1990-2#1)(1993-11#1)
bound to the RRE##2##4##(1993-8#2)
bound to the negative##2##4##(2008-11#2)
bound to the same##2##4##(1994-5#1)(1995-2#1)
bound to the surface of##4##5##(1995-2#1)(2008-10#1)(2008-4#2)
bound to the surface##5##4##(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#2)
bound to the##66##3##(1990-12#3)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-5#2)(1995-2#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2008-10#11)(2008-11#6)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-2#2)
bound to transferrin##2##3##(2008-10#2)
bound to##208##2##(1990-11#2)(1990-12#7)(1990-2#3)(1990-5#5)(1990-7#2)(1990-8#4)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#8)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#5)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#7)(1993-6#5)(1993-8#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#6)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#43)(2008-11#11)(2008-4#10)(2008-5#4)(2008-7#1)(2008-8#7)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#5)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
bound together##2##2##(2009-9#1)(2012-2#1)
bound via##2##2##(2008-10#1)(2008-7#1)
bound water##4##2##(1991-11#1)(2008-10#1)(2008-5#2)
bound with high affinity##2##4##(1990-12#1)(1995-12#1)
bound with##7##2##(1990-12#1)(1994-8#1)(1995-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
bound zinc##2##2##(1994-5#2)
bound##521##1##(1990-10#2)(1990-11#5)(1990-12#18)(1990-2#5)(1990-5#11)(1990-6#1)(1990-7#4)(1990-8#6)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#16)(1991-8#4)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#6)(1992-3#9)(1992-5#2)(1992-6#11)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#10)(1993-12#1)(1993-2#1)(1993-3#8)(1993-6#10)(1993-8#5)(1993-9#1)(1994-11#9)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#14)(1994-6#3)(1994-8#11)(1995-11#5)(1995-12#3)(1995-2#11)(1995-3#1)(1995-5#6)(1995-6#8)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#4)(1996-5#4)(1997-2#7)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#11)(2007-12#9)(2007-2#1)(2008-1#2)(2008-10#84)(2008-11#19)(2008-2#5)(2008-3#3)(2008-4#14)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#13)(2008-9#8)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#6)(2010-6#3)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
bound&quot##2##1##(1991-11#1)(1991-8#1)
bound-abrasive##2##1##(2008-2#2)
boundaries and##15##2##(1993-12#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-3#2)
boundaries are##3##2##(1997-5#2)(2008-6#1)
boundaries between the##2##3##(2008-11#1)(2008-5#1)
boundaries between##5##2##(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2012-12#1)
boundaries for##2##2##(1995-2#1)(2008-8#1)
boundaries in the##2##3##(1997-5#1)(2010-6#1)
boundaries in##4##2##(1997-5#1)(2008-3#1)(2010-3#1)(2010-6#1)
boundaries of the##6##3##(1992-3#1)(1993-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-9#1)
boundaries of##9##2##(1992-3#1)(1993-12#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-7#1)(2008-9#1)
boundaries that##2##2##(2010-8#1)(2012-3#1)
boundaries to##2##2##(2008-10#1)(2008-3#1)
boundaries were##2##2##(2008-10#1)(2008-7#1)
boundaries with##2##2##(1995-8#1)(2008-2#1)
boundaries##98##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#2)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#4)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2010-3#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#1)
boundary and##5##2##(1996-4#1)(2008-11#1)(2008-3#2)(2008-8#1)
boundary between the##5##3##(2008-2#2)(2008-3#1)(2009-9#1)(2013-1#1)
boundary between##14##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
boundary cells##2##2##(2012-12#2)
boundary condition and##3##3##(2008-3#3)
boundary condition##15##2##(2007-11#1)(2008-2#2)(2008-3#11)(2008-7#1)
boundary conditions and##2##3##(2007-12#1)(2008-7#1)
boundary conditions for a metal film##2##6##(2008-2#2)
boundary conditions for##3##3##(2008-2#2)(2010-3#1)
boundary conditions in##2##3##(2008-3#2)
boundary conditions of the##2##4##(2008-3#1)(2013-8#1)
boundary conditions##24##2##(1996-4#1)(2007-12#2)(2008-2#5)(2008-3#8)(2008-6#1)(2008-7#3)(2010-3#1)(2012-12#1)(2013-8#2)
boundary extinction##2##2##(2008-2#1)(2008-3#1)
boundary in##4##2##(1991-9#1)(2008-8#2)(2010-8#1)
boundary integral##2##2##(2009-10#2)
boundary is##2##2##(2008-2#1)(2008-4#1)
boundary issues##2##2##(1997-2#1)(2008-12#1)
boundary layer can be##2##4##(2008-3#2)
boundary layer with##2##3##(2008-2#2)
boundary layer##30##2##(1997-5#1)(2008-10#1)(2008-11#3)(2008-2#8)(2008-3#16)(2008-5#1)
boundary layers##2##2##(2008-3#2)
boundary markers##2##2##(2012-12#2)
boundary of the##8##3##(1996-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2012-2#1)
boundary of##11##2##(1996-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
boundary value##5##2##(2008-2#1)(2008-3#4)
boundary##194##1##(1990-5#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#4)(1996-12#1)(1996-4#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#3)(2008-2#30)(2008-3#61)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#7)(2009-10#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#6)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
boundary-element method##4##2##(2008-11#1)(2008-3#3)
boundary-element##5##1##(2008-11#1)(2008-3#4)
boundary-layer inversion##2##2##(2008-2#2)
boundary-layer##6##1##(2008-2#4)(2008-3#2)
boundary-value problem for##2##3##(2008-3#2)
bounded by a##2##3##(2007-12#1)(2011-2#1)
bounded by the##2##3##(1997-4#1)(2011-2#1)
bounded by##8##2##(1997-4#1)(2007-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)
bounded with##2##2##(2008-3#2)
bounded##13##1##(1997-4#1)(2007-11#1)(2007-12#2)(2008-3#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)
bounding##2##1##(1995-9#1)(2008-3#1)
bounds for##2##2##(1995-9#1)(2008-7#1)
bounds of##2##2##(2008-10#1)(2008-3#1)
bounds on the##4##3##(2008-3#2)(2009-5#1)(2012-3#1)
bounds##18##1##(1992-9#1)(1995-9#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#6)(2008-6#2)(2008-7#1)(2009-5#1)(2012-3#1)
bout of##5##2##(2008-5#2)(2012-3#1)(2013-1#1)(2013-8#1)
bout##14##1##(2008-10#2)(2008-5#4)(2008-8#3)(2012-3#1)(2013-1#1)(2013-8#3)
bouton##3##1##(1997-3#2)(2012-2#1)
boutons at##2##2##(1997-3#1)(1997-7#1)
boutons immunoreactive for##2##3##(1997-2#2)
boutons were##3##2##(1997-2#1)(1997-3#1)(2008-7#1)
boutons##19##1##(1997-2#8)(1997-3#4)(1997-7#4)(2008-7#1)(2008-8#1)(2012-2#1)
bouts of abdominal pain##2##4##(1991-2#1)(1997-7#1)
bouts of##6##2##(1991-2#1)(1997-7#1)(2007-12#1)(2008-7#1)(2009-9#1)(2012-3#1)
bouts##14##1##(1991-2#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-9#3)(2010-1#1)(2012-3#1)
bovine EFIA#1##3##2##(1993-2#3)
bovine TIMP##2##2##(1990-8#2)
bovine abortion##2##2##(2012-3#2)
bovine adrenal chromaffin cells##4##4##(1992-6#1)(1994-5#2)(1995-11#1)
bovine adrenal medullary cells##2##4##(1994-8#2)
bovine adrenal medullary##3##3##(1994-8#3)
bovine adrenal##16##2##(1990-2#1)(1991-12#1)(1992-6#1)(1993-3#4)(1993-8#2)(1994-5#2)(1994-8#3)(1995-11#1)(2009-9#1)
bovine albumin serum##2##3##(2008-10#2)
bovine albumin##4##2##(1993-6#1)(2008-10#2)(2008-11#1)
bovine and human cathepsin B##2##5##(1994-12#2)
bovine and human##3##3##(1994-12#2)(1994-8#1)
bovine and mouse##2##3##(1992-11#1)(1994-9#1)
bovine and##9##2##(1992-10#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(2008-7#1)
bovine aortic endothelial cells##11##4##(1990-12#3)(1990-2#2)(1991-5#2)(1991-9#1)(1992-11#1)(1993-8#1)(2008-11#1)
bovine aortic endothelial##12##3##(1990-12#3)(1990-2#2)(1991-5#2)(1991-9#1)(1992-11#1)(1993-8#1)(1995-11#1)(2008-11#1)
bovine aortic##14##2##(1990-12#3)(1990-2#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-11#1)(2008-11#1)
bovine beta-casein##2##2##(2008-8#2)
bovine beta-crystallin##2##2##(1991-6#2)
bovine beta-lactoglobulin##3##2##(1995-5#2)(2008-11#1)
bovine beta-trypsin##3##2##(1990-8#3)
bovine blastocysts##3##2##(2008-11#3)
bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme##2##9##(1997-2#2)
bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase##4##8##(1997-2#4)
bovine brain cytosol##3##3##(1991-2#1)(1992-11#1)(1994-9#1)
bovine brain lipid extract##2##4##(1991-5#2)
bovine brain membranes##3##3##(1990-8#2)(1992-11#1)
bovine brain##27##2##(1990-8#3)(1991-2#1)(1991-5#3)(1992-11#5)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#2)(1996-12#1)(1997-2#6)(2013-7#1)
bovine cDNA##2##2##(1990-7#1)(1991-6#1)
bovine cardiac troponin##2##3##(1991-12#2)
bovine cardiac##3##2##(1991-12#3)
bovine cerebellum##2##2##(1995-12#1)(2008-8#1)
bovine cerebral cortex##2##3##(1991-5#1)(2008-9#1)
bovine chromaffin cells##3##3##(1990-11#1)(1995-11#2)
bovine collagen##3##2##(2008-11#2)(2010-8#1)
bovine corneal endothelial##2##3##(2008-11#2)
bovine corneal##3##2##(2008-11#2)(2008-2#1)
bovine cortical##2##2##(1991-8#1)(1992-3#1)
bovine embryos##4##2##(1991-2#4)
bovine erythrocytes##2##2##(1994-8#1)(2008-10#1)
bovine experiments##2##2##(2007-8#2)
bovine granulosa cells##4##3##(1992-11#4)
bovine heart submitochondrial particles##3##4##(1992-6#2)(1994-11#1)
bovine heart##8##2##(1990-5#1)(1992-12#1)(1992-6#2)(1994-11#1)(1995-2#3)
bovine hemoglobin##8##2##(1990-8#1)(1995-3#4)(1997-6#2)(2008-10#1)
bovine hepatocytes##2##2##(2008-11#2)
bovine herpesvirus##3##2##(2008-5#1)(2011-2#2)
bovine lactoferrin##7##2##(1996-12#7)
bovine leukemia virus-transformed##2##3##(1995-8#1)(2008-11#1)
bovine liver and kidney tissues##2##5##(2008-10#2)
bovine liver and##5##3##(1992-10#1)(2008-10#4)
bovine liver##14##2##(1990-7#2)(1992-10#1)(1992-12#1)(1992-3#2)(1993-8#1)(2008-10#7)
bovine mastitis##3##2##(1991-8#2)(1993-2#1)
bovine milk##11##2##(1992-12#1)(2008-10#5)(2012-2#4)(2012-3#1)
bovine neutrophil cytosol##2##3##(1992-6#1)(1994-11#1)
bovine neutrophil##5##2##(1992-6#3)(1993-8#1)(1994-11#1)
bovine oxytocin gene##2##3##(1991-2#1)(1992-11#1)
bovine oxytocin##3##2##(1991-2#2)(1992-11#1)
bovine pancreatic preprocarboxypeptidase A##2##4##(1991-2#2)
bovine pancreatic trypsin inhibitor (BPTI)##2##5##(1991-11#1)(1997-2#1)
bovine pancreatic##4##2##(1991-11#1)(1991-2#2)(1997-2#1)
bovine pericardium##3##2##(2007-8#1)(2010-8#1)(2013-1#1)
bovine psi EFIA#1 gene##2##4##(1993-2#2)
bovine psi EFIA#1##3##3##(1993-2#3)
bovine pulmonary endothelial##2##3##(1994-5#2)
bovine retinal on-bipolar cell##2##4##(1993-8#2)
bovine retinal rod outer segments##2##5##(1995-5#1)(1997-1#1)
bovine retinal##5##2##(1993-3#1)(1993-8#2)(1995-5#1)(1997-1#1)
bovine seminal RNase##3##3##(1990-5#3)
bovine seminal plasma##3##3##(1990-5#1)(1994-3#2)
bovine seminal##6##2##(1990-5#4)(1994-3#2)
bovine sera##2##2##(1992-9#1)(1996-12#1)
bovine serum (FBS)##8##3##(1995-3#1)(2007-11#1)(2008-11#6)
bovine serum albumin (BSA) and##5##5##(2008-10#4)(2008-7#1)
bovine serum albumin (BSA) as a##2##6##(2008-10#1)(2009-9#1)
bovine serum albumin (BSA) as##3##5##(1995-12#1)(2008-10#1)(2009-9#1)
bovine serum albumin (BSA) in an antigen conjugate##2##8##(2008-11#2)
bovine serum albumin (BSA) in##3##5##(2008-10#1)(2008-11#2)
bovine serum albumin (BSA) was##4##5##(1995-12#1)(2008-10#3)
bovine serum albumin (BSA)##33##4##(1990-12#1)(1995-12#2)(1995-6#1)(2008-10#23)(2008-11#3)(2008-3#1)(2008-7#1)(2009-9#1)
bovine serum albumin and##9##4##(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)
bovine serum albumin by##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
bovine serum albumin in##2##4##(1995-12#1)(2008-11#1)
bovine serum albumin##73##3##(1990-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-8#2)(1994-6#1)(1995-12#6)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#35)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#4)(2008-9#1)(2009-9#1)(2013-1#1)
bovine serum albumin)##4##3##(2008-10#2)(2008-3#2)
bovine serum amine oxidase##2##4##(1991-9#2)
bovine serum amine##3##3##(1991-9#3)
bovine serum and##3##3##(1992-11#1)(2008-11#1)(2010-3#1)
bovine serum for##2##3##(2008-11#1)(2012-6#1)
bovine serum samples##2##3##(2008-10#2)
bovine serum was##2##3##(1992-11#1)(1992-9#1)
bovine serum##110##2##(1990-12#1)(1990-6#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-8#2)(1994-11#1)(1994-6#1)(1995-12#7)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#42)(2008-11#16)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#4)(2008-9#1)(2009-9#1)(2010-3#1)(2012-6#1)(2013-1#1)
bovine spleen##2##2##(1992-3#2)
bovine spongiform encephalopathy (BSE)##4##4##(1997-3#1)(2010-4#1)(2011-2#2)
bovine spongiform encephalopathy##11##3##(1990-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-11#1)(2010-4#2)(2011-2#4)
bovine submaxillary mucin##3##3##(1994-9#3)
bovine tissue factor##3##3##(1991-12#3)
bovine tissue##4##2##(1990-8#1)(1991-12#3)
bovine trypsin and##2##3##(1991-9#1)(1996-12#1)
bovine trypsin##6##2##(1990-12#3)(1990-7#1)(1991-9#1)(1996-12#1)
bovine urine##2##2##(2008-10#2)
bovine viral diarrhoea virus infection##2##5##(1993-2#1)(1997-5#1)
bovine viral diarrhoea virus##3##4##(1993-2#1)(1997-5#2)
bovine viral##4##2##(1993-2#1)(1997-5#2)(2008-11#1)
bovine##515##1##(1990-11#3)(1990-12#11)(1990-2#3)(1990-5#8)(1990-6#1)(1990-7#7)(1990-8#14)(1990-9#1)(1991-11#1)(1991-12#9)(1991-2#16)(1991-3#1)(1991-5#7)(1991-6#5)(1991-8#9)(1991-9#8)(1992-10#6)(1992-11#16)(1992-12#3)(1992-3#8)(1992-5#1)(1992-6#9)(1992-8#4)(1992-9#9)(1993-11#7)(1993-12#1)(1993-2#12)(1993-3#7)(1993-6#6)(1993-8#13)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#7)(1994-6#3)(1994-8#12)(1994-9#6)(1995-11#6)(1995-12#13)(1995-2#4)(1995-3#5)(1995-5#8)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#14)(1996-3#2)(1996-6#1)(1997-1#4)(1997-2#8)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#1)(2007-11#1)(2007-8#5)(2008-10#63)(2008-11#39)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#6)(2009-12#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#6)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#1)
bovis BCG in##2##3##(2013-1#2)
bovis BCG##4##2##(1996-11#1)(1997-4#1)(2013-1#2)
bovis and##3##2##(2010-4#1)(2011-2#1)(2012-3#1)
bovis was##2##2##(1997-6#1)(2012-3#1)
bovis##27##1##(1996-11#2)(1996-12#1)(1997-4#1)(1997-6#3)(1997-8#1)(2008-7#1)(2010-2#2)(2010-4#1)(2011-2#4)(2012-3#5)(2013-1#5)(2013-8#1)
bow##4##1##(2008-2#3)(2008-3#1)
bow-tie fiber##2##2##(2007-11#2)
bow-tie##4##1##(2007-11#3)(2008-2#1)
bowel anastomoses##2##2##(2013-1#2)
bowel and##5##2##(1990-2#1)(1991-12#1)(1993-9#1)(1996-3#1)(1996-6#1)
bowel as##2##2##(1992-5#1)(2008-7#1)
bowel can##2##2##(1990-11#1)(1993-9#1)
bowel cancer##4##2##(1991-6#3)(2012-3#1)
bowel disease (IBD)##8##3##(2008-11#1)(2009-12#1)(2010-12#3)(2011-1#1)(2011-2#1)(2013-8#1)
bowel disease diagnosis##2##3##(2010-12#2)
bowel disease##49##2##(1991-8#1)(1992-6#2)(1994-2#3)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#2)(2009-8#1)(2010-12#18)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
bowel diseases##15##2##(1996-2#3)(2008-10#2)(2010-12#8)(2012-2#2)
bowel gas##3##2##(2008-10#3)
bowel habits##2##2##(1990-11#1)(2013-1#1)
bowel in##5##2##(1990-8#1)(1991-6#1)(1993-9#1)(2011-2#2)
bowel metastases##2##2##(1993-8#1)(1995-12#1)
bowel metastasis from##2##3##(1993-8#2)
bowel obstruction##15##2##(1993-9#1)(1997-8#1)(2008-12#2)(2009-8#5)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
bowel perforation##2##2##(1995-10#1)(2008-7#1)
bowel preparation and##2##3##(2008-1#2)
bowel preparation for##2##3##(2011-2#2)
bowel preparation##6##2##(2008-1#2)(2011-2#3)(2013-1#1)
bowel resection##6##2##(1992-5#2)(2008-10#1)(2010-12#3)
bowel rest##2##2##(2008-12#1)(2010-8#1)
bowel syndrome (IBS)##3##3##(1997-6#1)(2010-6#1)(2013-1#1)
bowel syndrome##17##2##(1991-12#3)(1993-5#1)(1994-3#1)(1995-10#1)(1997-6#2)(2007-10#1)(2008-10#1)(2010-12#1)(2010-6#2)(2012-12#1)(2013-1#3)
bowel syndrome]##2##2##(2008-10#1)(2013-1#1)
bowel wall##6##2##(1992-5#1)(2008-7#1)(2009-12#2)(2012-2#2)
bowel##237##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#5)(1991-3#1)(1991-6#6)(1991-8#1)(1992-12#1)(1992-5#7)(1992-6#2)(1992-8#1)(1992-9#1)(1993-5#1)(1993-8#4)(1993-9#9)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#3)(1995-12#2)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#2)(1997-6#2)(1997-8#2)(2007-10#2)(2007-5#2)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#4)(2008-4#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-1#1)(2009-12#4)(2009-4#1)(2009-5#2)(2009-8#6)(2010-12#42)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#15)(2012-3#6)(2013-1#18)(2013-7#1)(2013-8#6)
bowels##5##1##(1996-6#3)(2009-10#1)(2012-3#1)
bowtie filtered fluence##2##3##(2012-1#2)
box and##6##2##(1993-12#1)(1993-8#1)(1994-12#1)(1997-2#1)(2010-11#1)(2010-5#1)
box binding##3##2##(1993-8#2)(2012-3#1)
box sequence##2##2##(1997-6#1)(2008-8#1)
box trainer##3##2##(2010-3#2)(2012-3#1)
box##91##1##(1990-11#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-12#3)(1993-6#5)(1993-8#5)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-2#7)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#4)(2006-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#5)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#1)(2009-8#1)(2010-11#2)(2010-3#2)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
box&quot##5##1##(1991-1#1)(1993-9#1)(1995-2#1)(2008-3#1)(2012-3#1)
box-containing##2##1##(1993-8#1)(2011-2#1)
boxA##2##1##(1995-3#2)
boxB##2##1##(1995-3#2)
boxer##3##1##(1995-2#2)(2008-7#1)
boxers##4##1##(2010-1#4)
boxes and a##2##3##(1993-6#1)(1997-7#1)
boxes and##8##2##(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)(2008-5#1)
boxes but##2##2##(1993-2#1)(1993-3#1)
boxes for##2##2##(1995-3#1)(2008-10#1)
boxes##35##1##(1991-6#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-3#1)(1995-3#3)(1995-6#1)(1996-10#1)(1997-2#3)(1997-7#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)
boxing##9##1##(1992-2#1)(2008-1#1)(2008-7#3)(2010-1#4)
boy affected by##2##3##(2008-10#1)(2011-1#1)
boy affected##3##2##(2008-10#1)(2011-1#2)
boy aged##2##2##(1997-3#2)
boy and a##3##3##(2007-7#1)(2008-7#1)(2010-5#1)
boy and##5##2##(1996-5#1)(2007-7#1)(2008-7#1)(2010-5#1)(2012-2#1)
boy presented with haematuria and##2##5##(2008-10#2)
boy presented with##7##3##(2008-10#4)(2008-11#1)(2009-7#1)(2010-9#1)
boy presented##8##2##(2008-10#4)(2008-11#1)(2009-7#1)(2010-9#1)(2012-12#1)
boy presenting with##2##3##(2008-11#1)(2012-2#1)
boy presenting##3##2##(2008-11#1)(2009-9#1)(2012-2#1)
boy who had##3##3##(2007-8#1)(2008-10#1)(2012-12#1)
boy who presented with a##2##5##(1996-6#1)(2007-8#1)
boy who presented with##7##4##(1996-6#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
boy who presented##8##3##(1996-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
boy who sustained##2##3##(2013-1#2)
boy who##19##2##(1996-6#1)(2007-5#2)(2007-8#2)(2008-10#3)(2008-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)
boy with a##5##3##(1995-11#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
boy with the##3##3##(1994-3#1)(2008-10#1)(2012-3#1)
boy with##29##2##(1991-11#1)(1991-8#1)(1994-3#2)(1995-11#1)(1996-2#1)(1997-3#2)(1997-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
boy##116##1##(1990-6#1)(1991-11#2)(1991-8#1)(1992-11#1)(1993-6#1)(1994-3#2)(1995-11#1)(1995-5#3)(1996-11#1)(1996-2#1)(1996-5#4)(1996-6#2)(1996-9#1)(1997-3#5)(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#4)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#6)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#2)
boyhood##2##1##(2012-2#2)
boys aged##2##2##(1990-9#1)(2007-8#1)
boys and 2##2##3##(1993-8#1)(2011-1#1)
boys and girls##19##3##(1990-2#1)(1991-9#1)(1994-2#1)(1996-6#1)(2007-12#4)(2008-10#1)(2008-11#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
boys and men##3##3##(2009-10#1)(2013-8#2)
boys and##51##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#1)(1991-9#5)(1993-8#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-6#2)(1996-9#1)(1997-3#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2009-10#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#6)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
boys by##2##2##(2007-12#2)
boys in##3##2##(2008-9#1)(2009-8#1)(2011-2#1)
boys recovered##2##2##(2013-8#2)
boys were not##2##3##(2007-12#1)(2008-12#1)
boys were##5##2##(2007-12#1)(2008-12#1)(2009-7#1)(2010-7#1)(2013-8#1)
boys who were satisfied with their bodies##2##7##(2009-5#2)
boys who were##3##3##(2009-5#3)
boys who##4##2##(1997-3#1)(2009-5#3)
boys with autism spectrum disorder##2##5##(2013-1#2)
boys with##13##2##(2007-8#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-1#3)(2011-2#2)(2013-1#2)(2013-7#1)
boys##157##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-6#1)(1990-9#2)(1991-12#1)(1991-6#1)(1991-9#5)(1992-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-5#1)(1996-11#2)(1996-6#4)(1996-9#1)(1997-3#2)(2007-11#2)(2007-12#11)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#6)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#8)(2009-7#7)(2009-8#4)(2010-1#2)(2010-10#3)(2010-3#1)(2010-4#3)(2010-7#3)(2010-8#1)(2011-1#11)(2011-2#12)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#9)
boys' body image##3##3##(2007-12#3)
boys'##8##1##(2007-12#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)
boys) with a median age of##2##6##(2011-1#2)
boys) with a##3##3##(2008-1#1)(2011-1#2)
boys)##15##1##(1996-9#1)(2008-1#1)(2008-11#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-4#1)(2011-1#4)(2013-1#1)(2013-8#1)
bp (X##4##2##(2008-10#4)
bp 3'-untranslated region##2##3##(1990-11#1)(2010-5#1)
bp 5'-untranslated region and a##2##5##(1990-11#1)(2010-5#1)
bp 5'-untranslated region##3##3##(1990-11#1)(1991-7#1)(2010-5#1)
bp DNA fragment##3##3##(1995-6#1)(1997-3#1)(2008-12#1)
bp DNA##6##2##(1995-6#1)(1997-3#3)(2008-12#1)(2008-8#1)
bp and##15##2##(1993-6#1)(1993-8#1)(1994-8#2)(1995-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#5)(2013-1#1)
bp as##2##2##(1993-6#1)(1997-7#1)
bp cDNA##5##2##(1993-8#3)(2008-8#2)
bp deletion as##2##3##(1990-7#1)(1995-12#1)
bp deletion resulting in a##2##5##(1993-6#2)
bp deletion##8##2##(1990-7#2)(1993-6#2)(1995-12#3)(2008-9#1)
bp downstream from##2##3##(1993-12#1)(1994-12#1)
bp downstream##5##2##(1993-12#2)(1994-12#1)(1995-2#1)(1996-6#1)
bp encoding##4##2##(1991-12#1)(2008-4#1)(2011-2#2)
bp for D##3##3##(2008-10#3)
bp for X##4##3##(2008-10#4)
bp for##9##2##(1994-11#1)(2008-10#8)
bp fragment from the##2##4##(1995-9#1)(1997-3#1)
bp fragment from##3##3##(1995-9#1)(1996-3#1)(1997-3#1)
bp fragment of the##2##4##(1995-6#1)(2010-8#1)
bp fragment of##5##3##(1993-8#1)(1995-6#1)(1997-3#1)(2008-5#1)(2010-8#1)
bp fragment##11##2##(1993-8#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-3#3)(1997-6#1)(2008-5#1)(2008-8#1)(2010-8#1)
bp from##2##2##(1996-3#1)(1996-6#1)
bp genome with its 3##2##5##(2011-2#2)
bp genome with its##3##4##(2011-2#3)
bp genome##4##2##(2011-2#4)
bp in length and contains an open reading frame##2##9##(1993-2#1)(1994-12#1)
bp in length and contains an##3##6##(1993-2#1)(1994-12#1)(2008-8#1)
bp in length and##4##4##(1993-2#1)(1994-12#1)(2008-7#1)(2008-8#1)
bp in length with##2##4##(2008-7#1)(2008-9#1)
bp in length##11##3##(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#1)
bp in size##2##3##(2008-10#1)(2010-5#1)
bp in the##2##3##(1992-9#1)(1997-7#1)
bp in##18##2##(1992-9#1)(1993-2#1)(1994-12#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-7#2)(2008-8#5)(2008-9#1)(2010-5#2)
bp insert##3##2##(1990-8#1)(1992-8#1)(1995-2#1)
bp inverted##2##2##(1995-8#1)(1996-6#1)
bp is##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-9#1)
bp long and##6##3##(1993-2#1)(1996-10#2)(1997-2#1)(1997-7#1)(2008-10#1)
bp long clone##2##3##(1997-7#2)
bp long genome with its 1##5##6##(2011-2#5)
bp long genome with its 2##11##6##(2011-2#11)
bp long genome with its 3##7##6##(2011-2#7)
bp long genome with its 4##3##6##(2011-2#3)
bp long genome with its##29##5##(2011-2#29)
bp long genome##32##3##(2011-2#32)
bp long single replicon genome with its 3##2##8##(2011-2#2)
bp long single replicon genome with its##5##7##(2011-2#5)
bp long##51##2##(1990-12#1)(1993-2#1)(1995-12#1)(1996-10#2)(1997-2#1)(1997-4#1)(1997-7#4)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#37)
bp of 5'##3##3##(1990-12#1)(1995-2#1)(2008-9#1)
bp of the 5'-UTR##2##4##(1996-5#2)
bp of the##11##3##(1991-2#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-5#4)(1997-8#1)(2008-6#1)(2009-5#1)
bp of##24##2##(1990-12#1)(1990-7#1)(1991-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#1)(1996-12#1)(1996-5#4)(1997-4#2)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)
bp on average)##2##3##(1997-2#2)
bp on##3##2##(1996-2#1)(1997-2#2)
bp segment##3##2##(1993-8#1)(2006-8#2)
bp sequence##2##2##(1991-5#1)(2008-9#1)
bp substitution##2##2##(1990-5#1)(1991-5#1)
bp target sequence##3##3##(2008-10#1)(2008-12#2)
bp target##5##2##(1995-8#1)(2008-10#1)(2008-12#2)(2012-3#1)
bp that encodes##2##3##(1990-12#1)(2008-7#1)
bp that##4##2##(1990-11#1)(1990-12#1)(1994-12#1)(2008-7#1)
bp to##5##2##(1994-6#1)(1997-7#2)(2008-10#1)(2008-8#1)
bp upstream from the translation initiation codon##2##7##(1993-3#1)(1997-6#1)
bp upstream from the##6##4##(1991-6#2)(1993-12#1)(1993-3#1)(1994-12#1)(1997-6#1)
bp upstream from##7##3##(1991-6#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1997-6#1)
bp upstream of the##3##4##(1997-7#2)(2008-9#1)
bp upstream of##4##3##(1997-7#2)(2008-8#1)(2008-9#1)
bp upstream##14##2##(1991-6#2)(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1997-2#1)(1997-6#1)(1997-7#3)(2008-8#1)(2008-9#1)
bp was##2##2##(1993-6#1)(1994-6#1)
bp within##2##2##(1994-8#1)(2008-9#1)
bp##364##1##(1990-11#5)(1990-12#7)(1990-5#2)(1990-7#7)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#3)(1991-7#1)(1992-12#2)(1992-3#3)(1992-8#2)(1992-9#1)(1993-12#5)(1993-2#5)(1993-3#1)(1993-6#6)(1993-8#14)(1994-11#3)(1994-12#9)(1994-2#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-12#6)(1995-2#4)(1995-6#4)(1995-8#10)(1995-9#3)(1996-10#2)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#7)(1996-6#8)(1997-2#8)(1997-3#6)(1997-4#3)(1997-6#9)(1997-7#12)(1997-8#8)(2006-8#2)(2008-10#39)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#23)(2008-9#17)(2009-5#2)(2009-6#1)(2010-5#4)(2010-8#1)(2011-2#56)(2012-3#3)(2013-1#2)
bp) and the##2##3##(1994-12#2)
bp) and##8##2##(1994-12#2)(1997-6#1)(1997-7#1)(2008-10#2)(2009-6#1)(2011-2#1)
bp) containing##2##2##(1991-5#1)(1995-12#1)
bp) contains##2##2##(1995-12#1)(2008-5#1)
bp) for##2##2##(2008-6#1)(2011-2#1)
bp) in the##2##3##(1997-6#1)(2008-8#1)
bp) is##2##2##(1995-8#2)
bp) of the##2##3##(1990-11#1)(2008-5#1)
bp) of##5##2##(1990-11#1)(1995-8#1)(2008-5#1)(2009-6#1)(2010-8#1)
bp) was##4##2##(1991-1#1)(1991-9#1)(1992-8#1)(1993-3#1)
bp)##45##1##(1990-11#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#5)(1995-12#2)(1995-8#3)(1997-6#2)(1997-7#1)(2008-10#8)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-8#1)(2011-2#3)(2012-3#1)
bpV(pic) and vanadate##4##3##(1997-1#4)
bpV(pic)##7##1##(1997-1#7)
bpm##3##1##(2008-3#2)(2012-3#1)
bppz##4##1##(1997-7#4)
bps##2##1##(2007-11#1)(2008-11#1)
bqsS##2##1##(2009-6#2)
br /&gt##315##2##(2007-11#315)
brace##2##1##(2011-2#2)
braces##4##1##(2007-11#1)(2007-8#3)
brachial and##2##2##(2008-7#1)(2009-1#1)
brachial arteries##2##2##(2008-1#1)(2008-7#1)
brachial artery flow-mediated vasodilatation##5##4##(2008-11#5)
brachial artery##9##2##(2007-8#1)(2008-11#5)(2008-7#2)(2012-12#1)
brachial plexus block##3##3##(2009-4#1)(2012-2#2)
brachial plexus in##3##3##(2008-9#2)(2013-1#1)
brachial plexus injuries##9##3##(2008-8#2)(2008-9#7)
brachial plexus injury##4##3##(2008-9#2)(2011-2#1)(2013-1#1)
brachial plexus palsy##6##3##(2008-11#1)(2008-8#1)(2008-9#3)(2010-9#1)
brachial plexus##42##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#19)(2009-3#6)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#4)
brachial##62##1##(1991-11#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#6)(2008-7#6)(2008-8#5)(2008-9#20)(2009-1#3)(2009-3#6)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)
brachiation and##2##2##(2012-12#2)
brachiation##10##1##(2012-12#10)
brachii##7##1##(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-3#2)
brachio-cephalic##2##1##(2007-7#1)(2011-2#1)
brachiocephalic vein##2##2##(2008-1#1)(2012-3#1)
brachiocephalic##5##1##(1997-6#1)(1997-8#1)(2008-1#1)(2012-3#2)
brachydactyly##3##1##(1997-3#1)(2010-6#1)(2011-1#1)
brachytherapy for##3##2##(1991-8#1)(1994-2#1)(1995-8#1)
brachytherapy in the treatment of##2##5##(1994-8#1)(1995-9#1)
brachytherapy in the##3##3##(1993-9#1)(1994-8#1)(1995-9#1)
brachytherapy in##6##2##(1993-9#1)(1994-8#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-6#1)
brachytherapy##25##1##(1990-10#1)(1991-8#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#2)(1995-9#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-6#5)(2009-11#2)(2009-2#1)(2013-7#1)
brachyuran##3##1##(2007-12#2)(2013-7#1)
bracing##4##1##(2007-11#3)(2008-7#1)
bracket##7##1##(1993-6#1)(1995-2#1)(2009-7#2)(2010-3#2)(2013-7#1)
brackets##13##1##(1996-5#1)(2008-10#2)(2009-7#7)(2013-1#3)
bracovirus##3##1##(2010-4#3)
bracteata##2##1##(2008-10#1)(2008-11#1)
bracts##2##1##(2008-10#1)(2009-8#1)
bradycardia and##2##2##(1992-5#1)(2008-4#1)
bradycardia or##2##2##(1992-5#1)(2011-2#1)
bradycardia with##3##2##(2007-5#2)(2008-7#1)
bradycardia##26##1##(1990-5#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-5#4)(1995-3#1)(1997-6#1)(2007-5#2)(2008-12#1)(2008-4#1)(2008-7#6)(2010-4#1)(2010-8#1)(2011-2#4)
bradycardic##6##1##(1991-12#3)(1997-2#3)
bradykinesia##8##1##(2008-7#7)(2012-12#1)
bradykinin (1##2##2##(1992-3#1)(1997-1#1)
bradykinin and its analogues##3##4##(1996-7#3)
bradykinin and##4##2##(1990-7#1)(1996-7#3)
bradykinin in##2##2##(1997-2#2)
bradykinin is##3##2##(1995-12#2)(1996-7#1)
bradykinin were##2##2##(1997-2#1)(2007-8#1)
bradykinin##43##1##(1990-7#4)(1991-12#7)(1991-5#1)(1992-3#5)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#4)(1996-7#9)(1997-1#2)(1997-2#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
bradykinin- and ATP-induced increases in [Ca2+]i##2##6##(1995-11#2)
bradykinin- and ATP-induced##3##3##(1995-11#3)
bradykinin- and##5##2##(1992-3#2)(1995-11#3)
bradykinin-induced##4##1##(1991-12#1)(1993-12#1)(1995-12#2)
bradykinin-stimulated##2##1##(1995-11#2)
bragg grating sensors##4##3##(2008-2#2)(2008-3#2)
bragg grating##7##2##(2008-2#4)(2008-3#3)
bragg gratings##5##2##(2008-2#2)(2008-3#3)
bragg reflection##2##2##(2008-3#2)
bragg##16##1##(2008-2#6)(2008-3#10)
brain AVMs##2##2##(1997-3#2)
brain CSF##3##2##(1993-1#3)
brain CT##2##2##(1990-12#1)(1995-11#1)
brain LDH##3##2##(2013-1#3)
brain NBs##2##2##(2007-12#2)
brain PD##4##2##(2009-4#4)
brain PI with##2##3##(1996-2#2)
brain PI##3##2##(1996-2#3)
brain RNA##3##2##(1990-12#1)(1990-7#2)
brain abnormalities##3##2##(1996-5#1)(2008-6#1)(2012-2#1)
brain abscess##4##2##(2009-2#1)(2010-11#2)(2013-8#1)
brain abscesses in##3##3##(2007-12#2)(2007-7#1)
brain abscesses##6##2##(1995-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-7#1)
brain acetylcholine levels##2##3##(1992-8#2)
brain activation during##4##3##(1994-3#1)(1996-2#1)(2009-6#1)(2012-12#1)
brain activation##8##2##(1994-3#1)(1995-11#1)(1996-2#1)(2009-6#3)(2012-1#1)(2012-12#1)
brain activations during##2##3##(2012-12#2)
brain activations##5##2##(2008-10#1)(2012-12#4)
brain activity during##2##3##(2008-4#1)(2008-6#1)
brain activity##12##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-5#1)(2009-8#1)(2013-8#3)
brain after##5##2##(1990-7#1)(1993-12#1)(1994-12#1)(1996-2#1)(2008-10#1)
brain aging##5##2##(1990-3#1)(1994-5#1)(1994-6#1)(1996-5#1)(2009-8#1)
brain and behaviour research##2##4##(1995-6#2)
brain and body##2##3##(1995-1#1)(2008-9#1)
brain and bone##2##3##(1996-3#1)(2008-3#1)
brain and gut tissue of##2##5##(1994-11#2)
brain and gut##3##3##(1991-8#1)(1994-11#2)
brain and has##2##3##(1993-11#1)(2009-11#1)
brain and heart##3##3##(2008-10#2)(2010-8#1)
brain and in the##2##4##(1995-3#1)(2012-12#1)
brain and in##6##3##(1991-11#1)(1993-11#1)(1995-3#2)(1995-8#1)(2012-12#1)
brain and intestine##4##3##(1991-5#2)(1991-8#1)(2011-2#1)
brain and liver##2##3##(1990-7#1)(2008-12#1)
brain and lung##2##3##(1990-7#1)(2012-12#1)
brain and peripheral##2##3##(1991-2#1)(1997-6#1)
brain and spinal cord were##2##5##(1993-12#1)(1995-3#1)
brain and spinal cord##13##4##(1993-11#1)(1993-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-5#2)(2008-7#2)(2010-12#2)(2010-8#1)(2013-1#1)
brain and the##4##3##(1993-5#1)(2008-1#1)(2008-2#1)(2010-8#1)
brain and to##2##3##(1994-6#1)(1997-2#1)
brain and##115##2##(1990-11#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-5#2)(1994-11#3)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
brain are reported##2##3##(2008-3#1)(2008-6#1)
brain are##14##2##(1992-12#1)(1994-2#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2013-1#1)
brain area is necessary##2##4##(2007-8#1)(2008-11#1)
brain area##9##2##(1995-12#1)(1995-2#1)(1995-5#1)(2007-8#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
brain areas of##4##3##(2008-11#1)(2011-1#2)(2011-2#1)
brain areas##23##2##(1991-2#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
brain arteriovenous malformations (AVM)##2##4##(1996-6#1)(2012-2#1)
brain arteriovenous malformations##4##3##(1996-6#1)(2008-2#1)(2008-9#1)(2012-2#1)
brain as a##2##3##(1990-7#1)(2009-6#1)
brain as an##2##3##(1996-12#1)(2008-4#1)
brain as revealed by##2##4##(1990-5#1)(1995-6#1)
brain as##10##2##(1990-5#1)(1990-7#1)(1994-5#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-6#1)
brain ascorbate##2##2##(1990-9#2)
brain atrophy##2##2##(2007-7#2)
brain barrier##3##2##(2007-11#1)(2008-4#1)(2013-1#1)
brain but not in##2##4##(1995-3#1)(2013-1#1)
brain but not##3##3##(1990-11#1)(1995-3#1)(2013-1#1)
brain but##6##2##(1990-11#1)(1992-6#1)(1995-2#1)(1995-3#1)(2008-7#1)(2013-1#1)
brain by in situ hybridization histochemistry##2##6##(1996-12#2)
brain by in situ hybridization##3##5##(1992-12#1)(1996-12#2)
brain by in##4##3##(1992-12#1)(1996-12#2)(1997-1#1)
brain by the##2##3##(1990-11#1)(2009-12#1)
brain by##17##2##(1990-11#1)(1992-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#3)(1997-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2010-5#1)
brain cAMP##2##2##(2008-8#2)
brain cDNA library was screened##2##5##(1992-6#1)(2008-9#1)
brain cDNA library##9##3##(1992-3#1)(1992-6#1)(1993-8#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-8#1)(2008-9#1)
brain cDNA##14##2##(1991-2#1)(1992-3#1)(1992-6#1)(1993-8#3)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-8#1)(2008-9#1)
brain cannabinoid##2##2##(1991-4#2)
brain cell death##3##3##(2007-10#1)(2012-2#2)
brain cell##6##2##(2007-10#1)(2008-6#1)(2009-12#1)(2012-2#3)
brain cells##11##2##(1992-11#1)(1994-2#2)(1996-11#1)(2008-11#1)(2008-4#1)(2008-8#5)
brain changes in##2##3##(1997-8#1)(2009-7#1)
brain changes##5##2##(1994-6#1)(1997-8#1)(2008-11#1)(2008-6#1)(2009-7#1)
brain circuitry##2##2##(2013-8#2)
brain computed##2##2##(2008-8#1)(2012-3#1)
brain conditions##3##2##(2008-4#2)(2008-7#1)
brain connectivity##3##2##(1995-5#2)(2012-2#1)
brain contains##3##2##(1992-12#1)(1993-12#1)(2008-4#1)
brain cortex##2##2##(2007-10#1)(2012-1#1)
brain damage and##5##3##(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-4#1)
brain damage in##4##3##(1990-12#1)(1996-5#1)(2007-10#1)(2011-2#1)
brain damage is##2##3##(2008-4#1)(2009-12#1)
brain damage##33##2##(1990-12#1)(1991-12#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(2007-10#3)(2007-11#1)(2008-11#2)(2008-4#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
brain dead##3##2##(1996-2#1)(2007-11#1)(2008-7#1)
brain death as a##2##4##(1991-9#1)(2007-11#1)
brain death##11##2##(1991-9#1)(1995-6#1)(1996-2#1)(2007-11#6)(2008-8#1)(2011-2#1)
brain derived##2##2##(1993-3#1)(2013-1#1)
brain development and##7##3##(1993-12#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#3)
brain development in##4##3##(2007-12#4)
brain development is##2##3##(2007-12#2)
brain development##29##2##(1993-12#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-5#3)(2007-12#7)(2008-1#3)(2008-11#2)(2008-4#1)(2011-2#2)(2012-12#1)(2012-2#5)
brain differentiation##2##2##(1994-6#1)(2008-11#1)
brain disease##3##2##(1990-8#1)(1995-3#1)(2012-2#1)
brain diseases##2##2##(2008-10#1)(2008-7#1)
brain disorders in##2##3##(1997-8#1)(2011-1#1)
brain disorders##5##2##(1997-8#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
brain dopamine##2##2##(1993-1#1)(1997-2#1)
brain during the##2##3##(1995-2#1)(1997-2#1)
brain during##4##2##(1990-7#1)(1995-2#1)(1997-2#1)(2013-1#1)
brain dynamics##3##2##(2008-11#1)(2009-9#2)
brain dysfunction and##2##3##(2008-7#1)(2013-1#1)
brain dysfunction in##3##3##(1993-12#1)(2008-2#1)(2008-4#1)
brain dysfunction##7##2##(1991-12#1)(1993-12#1)(1995-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
brain edema##2##2##(2008-8#1)(2013-1#1)
brain electric##2##2##(1992-8#1)(2008-11#1)
brain endothelial cells##2##3##(2008-5#1)(2013-1#1)
brain endothelial##3##2##(2008-5#1)(2009-2#1)(2013-1#1)
brain enzyme##2##2##(1990-5#1)(1991-5#1)
brain expansion##2##2##(2012-3#2)
brain extracts of##2##3##(1992-8#1)(1994-12#1)
brain extracts##5##2##(1990-7#1)(1990-8#1)(1992-8#1)(1994-12#1)(1996-12#1)
brain finger protein gene (ZNF179)##2##5##(1997-3#2)
brain following##4##2##(1995-12#3)(1996-12#1)
brain for##4##2##(1993-11#1)(2008-1#2)(2012-1#1)
brain free magnesium concentration##3##4##(2008-7#3)
brain free magnesium##5##3##(2008-7#5)
brain from##4##2##(1994-11#1)(1995-12#1)(2007-10#1)(2007-12#1)
brain function and##3##3##(1996-6#1)(2008-7#1)(2008-8#1)
brain function performance##2##3##(2008-5#2)
brain function##23##2##(1991-1#1)(1992-12#1)(1993-8#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2013-1#1)(2013-8#2)
brain functioning##3##2##(2008-1#1)(2009-7#1)(2013-1#1)
brain functions##4##2##(1992-12#1)(2007-8#1)(2008-8#1)(2013-8#1)
brain had##3##2##(1991-6#1)(1994-6#1)(2008-7#1)
brain has been##6##3##(1992-6#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
brain has##10##2##(1992-6#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)
brain have been##2##3##(2008-7#1)(2011-2#1)
brain health##4##2##(2012-2#1)(2013-1#3)
brain heart infusion agar##2##4##(2008-10#1)(2008-12#1)
brain heart infusion##3##3##(1993-12#1)(2008-10#1)(2008-12#1)
brain hexokinase##3##2##(1991-5#3)
brain homogenate##5##2##(1991-1#1)(1994-6#1)(1996-2#1)(1997-2#1)(2013-7#1)
brain homogenates##3##2##(1991-12#1)(1994-11#1)(1996-2#1)
brain images##3##2##(2011-2#3)
brain imaging studies##4##3##(1995-2#1)(2008-6#1)(2009-8#2)
brain imaging techniques##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
brain imaging##18##2##(1995-2#1)(2007-8#1)(2008-11#4)(2008-6#1)(2008-8#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
brain in mice##2##3##(2013-1#2)
brain in the##2##3##(1995-8#1)(1997-4#1)
brain in vivo##4##3##(1993-12#1)(1993-3#1)(1995-11#1)(2010-2#1)
brain in##24##2##(1990-11#1)(1990-7#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#4)(2008-4#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-2#1)(2013-1#4)
brain increased##2##2##(1994-6#1)(2008-8#1)
brain infarct##3##2##(2011-2#2)(2013-1#1)
brain infarction##2##2##(1995-5#1)(2008-2#1)
brain infarcts##2##2##(1991-11#1)(2007-10#1)
brain information processing##2##3##(2008-11#2)
brain information##3##2##(2008-11#2)(2008-7#1)
brain injured individual##2##3##(1994-12#2)
brain injured##3##2##(1994-12#2)(1996-1#1)
brain injuries##4##2##(1994-12#1)(1996-1#1)(2012-2#1)(2013-1#1)
brain injury (TBI)##9##3##(1993-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
brain injury and##3##3##(2007-10#1)(2008-8#1)(2013-1#1)
brain injury in##5##3##(1993-12#1)(1996-6#1)(2007-9#1)(2008-7#1)(2012-2#1)
brain injury is##2##3##(1990-12#1)(1995-12#1)
brain injury was##2##3##(2008-7#1)(2013-1#1)
brain injury##83##2##(1990-12#3)(1991-11#2)(1991-12#4)(1992-3#1)(1993-12#4)(1993-6#1)(1994-11#1)(1994-12#2)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(2007-10#2)(2007-11#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#1)(2010-1#2)(2010-5#2)(2010-9#2)(2011-2#2)(2011-7#2)(2012-1#2)(2012-2#5)(2013-1#3)(2013-8#4)
brain insulin##2##2##(2009-11#2)
brain is##25##2##(1991-5#1)(1993-8#3)(1994-5#2)(1995-11#1)(1995-12#1)(1996-5#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)
brain ischaemia##2##2##(1996-6#1)(2013-8#1)
brain ischemia##7##2##(1994-2#1)(1997-2#2)(2007-10#2)(2007-8#1)(2008-3#1)
brain ischemia/reperfusion##3##2##(2010-1#1)(2013-1#2)
brain lead##3##2##(1992-12#3)
brain lesions##12##2##(1991-2#2)(1993-5#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-5#2)(2008-7#2)(2011-2#1)
brain levels##2##2##(1997-7#1)(2008-5#1)
brain linked##2##2##(2009-8#1)(2012-2#1)
brain lipid##3##2##(1991-5#2)(1996-2#1)
brain magnetic resonance imaging (MRI)##2##5##(2011-2#1)(2012-2#1)
brain magnetic resonance imaging##3##4##(2011-2#2)(2012-2#1)
brain maturation and##2##3##(1992-12#1)(2008-11#1)
brain maturation##3##2##(1992-12#1)(1993-3#1)(2008-11#1)
brain may##3##2##(1997-8#1)(2009-7#1)(2011-1#1)
brain mechanisms##4##2##(2007-8#1)(2009-10#1)(2009-5#1)(2013-8#1)
brain membranes##8##2##(1990-8#2)(1991-1#1)(1992-11#1)(1993-6#4)
brain metabolic##2##2##(1994-2#2)
brain metabolism in##2##3##(1991-10#1)(1994-2#1)
brain metabolism##3##2##(1991-10#1)(1994-2#2)
brain metastases##8##2##(1991-2#1)(1992-12#1)(1995-9#2)(2008-4#1)(2010-3#1)(2010-8#1)(2010-9#1)
brain metastasis##3##2##(1990-12#1)(1991-2#1)(2011-3#1)
brain microsomal##2##2##(1992-9#1)(1994-8#1)
brain mitochondria##3##2##(1990-3#2)(1996-5#1)
brain model##2##2##(2009-5#1)(2010-11#1)
brain must##3##2##(1990-5#1)(2009-8#2)
brain natriuretic peptide##7##3##(1990-3#1)(1991-2#1)(1991-5#1)(1994-8#1)(1996-8#1)(2010-4#1)(2011-2#1)
brain networks##7##2##(2008-11#1)(2008-8#1)(2009-8#4)(2013-8#1)
brain neuroprotective##2##2##(2008-4#2)
brain neurosecretory cells##2##3##(1995-11#2)
brain nuclei##3##2##(1994-2#2)(2008-4#1)
brain of female##2##3##(1993-6#1)(2013-1#1)
brain of patients##2##3##(1992-12#1)(2013-8#1)
brain of rats##3##3##(1990-5#1)(1993-3#1)(2012-1#1)
brain of the##13##3##(1993-5#2)(1994-2#1)(1996-12#2)(1997-3#1)(2007-12#4)(2008-6#2)(2013-1#1)
brain of##44##2##(1990-5#1)(1990-7#2)(1992-12#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-12#6)(2008-4#1)(2008-6#4)(2008-7#5)(2009-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
brain on##2##2##(1993-12#1)(1996-12#1)
brain or##3##2##(1995-12#1)(1997-3#1)(2010-6#1)
brain parenchyma##9##2##(1992-12#1)(1993-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
brain perfusion##6##2##(1996-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-3#1)
brain plasticity##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
brain postsynaptic##2##2##(1996-12#2)
brain potentials##2##2##(1991-1#1)(2008-11#1)
brain proteins##2##2##(1995-3#1)(1996-12#1)
brain ratio (VBR) and prefrontal sulcal prominence (PSP)##2##8##(1996-7#2)
brain ratio##3##2##(1996-7#2)(2009-4#1)
brain region##10##2##(1992-8#1)(1996-12#2)(2008-4#2)(2008-7#2)(2010-5#1)(2012-2#1)(2013-1#1)
brain regions and spinal cord of the##2##7##(1991-1#1)(1997-2#1)
brain regions and spinal cord of##4##6##(1991-1#1)(1997-2#3)
brain regions and spinal cord##5##5##(1991-1#1)(1997-2#4)
brain regions and##8##3##(1991-1#1)(1991-2#1)(1997-2#5)(2008-12#1)
brain regions are##4##3##(1997-2#1)(2008-11#1)(2010-5#1)(2010-6#1)
brain regions associated with attention##2##5##(2008-10#2)
brain regions associated with##4##4##(2008-10#2)(2008-11#1)(2012-12#1)
brain regions but##2##3##(1993-8#1)(1995-2#1)
brain regions during adulthood##2##4##(1995-12#1)(1996-5#1)
brain regions implicated in the##2##5##(2008-4#1)(2009-2#1)
brain regions in##3##3##(1994-6#1)(1997-2#1)(2008-11#1)
brain regions involved in##2##4##(2008-4#1)(2009-2#1)
brain regions of rats##2##4##(1994-6#1)(1996-2#1)
brain regions of the##3##4##(1993-8#1)(1994-2#1)(1996-5#1)
brain regions of##11##3##(1991-10#1)(1992-1#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)
brain regions such as##2##4##(1994-6#1)(2009-10#1)
brain regions that##3##3##(1994-8#1)(1996-12#1)(2008-4#1)
brain regions were##2##3##(1990-5#1)(1995-2#1)
brain regions##80##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#1)(1992-1#2)(1993-8#2)(1994-2#3)(1994-5#2)(1994-6#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#7)(1996-2#1)(1996-5#2)(1997-2#8)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#5)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-9#1)(2010-5#2)(2010-6#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
brain renin-angiotensin system##2##3##(1993-12#2)
brain repair##3##2##(1997-2#1)(2008-11#1)(2008-7#1)
brain research##4##2##(1990-6#1)(1995-6#1)(2010-9#2)
brain retraction##3##2##(2006-12#1)(2008-7#2)
brain reward##5##2##(2007-8#2)(2008-7#1)(2011-2#1)(2013-8#1)
brain samples by##2##3##(2008-10#2)
brain samples##5##2##(1992-8#1)(2008-10#3)(2010-11#1)
brain sections##4##2##(1996-2#2)(1996-5#1)(2008-7#1)
brain serotonin##3##2##(1992-11#1)(1997-6#1)(2013-1#1)
brain shift##4##2##(1995-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
brain signals##2##2##(2008-11#1)(2010-8#1)
brain size##9##2##(1996-7#1)(2012-3#8)
brain slice preparation##3##3##(1996-2#1)(2008-4#2)
brain slice##6##2##(1996-2#1)(2008-4#3)(2008-7#2)
brain slices##16##2##(1990-7#2)(1993-5#1)(1993-6#1)(1996-5#1)(1997-2#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#2)
brain sonography##2##2##(2011-2#2)
brain specific##4##2##(1993-12#1)(1993-8#2)(1996-12#1)
brain stem and##3##3##(2008-7#3)
brain stem catecholaminergic##2##3##(1994-2#2)
brain stem structures##2##3##(2011-1#2)
brain stem##29##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#2)(1995-12#4)(1995-3#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-7#7)(2009-3#1)(2011-1#2)(2011-2#1)(2012-3#1)
brain stimulation (DBS)##6##3##(2008-1#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-3#1)
brain stimulation in##2##3##(2009-9#1)(2010-12#1)
brain stimulation reward##3##3##(1992-12#1)(1993-6#1)(1994-3#1)
brain stimulation##22##2##(1992-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(2008-1#4)(2008-11#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
brain structure and function##3##4##(2009-7#2)(2012-2#1)
brain structure and##5##3##(1993-9#1)(2009-7#3)(2012-2#1)
brain structure##9##2##(1993-9#1)(2007-12#1)(2008-7#1)(2009-7#3)(2012-2#1)(2012-3#1)(2013-8#1)
brain structures##6##2##(1996-12#2)(1997-7#1)(2007-8#1)(2008-6#2)
brain succinic semialdehyde reductase##2##4##(1997-2#2)
brain surface##2##2##(1995-5#1)(2008-1#1)
brain surgery##2##2##(1993-6#1)(1994-3#1)
brain synaptosomal##2##2##(1992-3#2)
brain syndrome##2##2##(2008-7#2)
brain systems##5##2##(1995-5#1)(2008-2#1)(2008-4#1)(2011-1#1)(2013-8#1)
brain targeted delivery of methadone##2##5##(2010-5#2)
brain temperature##6##2##(1991-9#2)(2007-12#1)(2008-1#3)
brain that##6##2##(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-4#1)(2009-5#1)
brain tissue in##2##3##(1995-12#1)(2008-6#1)
brain tissue was diagnosed at 12 wks##2##7##(2012-3#2)
brain tissue was##5##3##(1995-12#1)(2008-7#1)(2012-3#2)(2013-1#1)
brain tissue##48##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1993-9#2)(1994-11#3)(1995-12#3)(1996-12#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-7#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
brain tissues##13##2##(1990-5#1)(1994-11#1)(1995-6#1)(1997-2#4)(2008-10#2)(2008-7#2)(2011-1#1)(2011-2#1)
brain to##11##2##(1991-1#1)(1995-12#1)(1996-5#3)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)
brain trauma##2##2##(1997-8#1)(2008-7#1)
brain tubulin##2##2##(1993-8#1)(1994-5#1)
brain tumor cells##2##3##(1990-6#1)(2013-1#1)
brain tumor##16##2##(1990-6#1)(1992-9#1)(1995-12#1)(1995-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
brain tumors and##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
brain tumors in##2##3##(1995-2#1)(2013-8#1)
brain tumors with##2##3##(1993-6#1)(2008-12#1)
brain tumors##26##2##(1992-9#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#2)(2008-11#1)(2008-12#3)(2008-5#4)(2008-7#5)(2011-2#5)(2013-8#2)
brain tumour##4##2##(1990-6#2)(1991-6#1)(2008-7#1)
brain tumours and##2##3##(2009-4#1)(2012-2#1)
brain tumours##12##2##(1995-12#1)(2007-10#1)(2008-7#2)(2009-4#4)(2011-3#1)(2012-2#1)(2013-1#2)
brain using##6##2##(1993-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
brain ventricles##2##2##(2008-5#1)(2010-7#1)
brain volume##2##2##(2009-10#1)(2013-8#1)
brain was studied##2##3##(1993-12#1)(1996-5#1)
brain was##11##2##(1992-10#1)(1992-11#1)(1993-12#2)(1994-12#1)(1994-6#1)(1996-5#1)(1997-2#1)(2010-1#1)(2011-2#1)(2012-3#1)
brain were##12##2##(1990-11#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-11#1)(1996-12#2)(1996-2#2)(1997-7#1)(2008-10#1)(2008-8#1)
brain where##2##2##(2008-6#1)(2008-7#1)
brain with##2##2##(2008-11#1)(2008-4#1)
brain##2027##1##(1990-10#1)(1990-11#10)(1990-12#14)(1990-2#1)(1990-3#13)(1990-5#14)(1990-6#7)(1990-7#25)(1990-8#6)(1990-9#2)(1991-1#14)(1991-10#3)(1991-11#4)(1991-12#14)(1991-2#15)(1991-4#2)(1991-5#19)(1991-6#5)(1991-7#2)(1991-8#5)(1991-9#9)(1992-1#2)(1992-10#4)(1992-11#12)(1992-12#22)(1992-3#9)(1992-6#9)(1992-7#1)(1992-8#9)(1992-9#6)(1993-1#5)(1993-11#11)(1993-12#32)(1993-2#1)(1993-3#14)(1993-5#11)(1993-6#17)(1993-8#19)(1993-9#7)(1994-11#12)(1994-12#15)(1994-2#25)(1994-3#11)(1994-5#21)(1994-6#23)(1994-8#18)(1994-9#3)(1995-1#1)(1995-11#15)(1995-12#41)(1995-2#15)(1995-3#18)(1995-5#12)(1995-6#12)(1995-8#7)(1995-9#3)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#56)(1996-2#36)(1996-3#5)(1996-5#47)(1996-6#7)(1996-7#5)(1996-8#3)(1997-1#5)(1997-2#51)(1997-3#13)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#10)(1997-8#10)(1997-9#1)(2006-10#1)(2006-12#1)(2007-10#20)(2007-11#16)(2007-12#56)(2007-5#1)(2007-7#3)(2007-8#24)(2007-9#1)(2008-1#30)(2008-10#49)(2008-11#78)(2008-12#10)(2008-2#21)(2008-3#6)(2008-4#61)(2008-5#33)(2008-6#29)(2008-7#149)(2008-8#35)(2008-9#17)(2009-10#13)(2009-11#8)(2009-12#15)(2009-2#6)(2009-3#5)(2009-4#9)(2009-5#19)(2009-6#7)(2009-7#16)(2009-8#30)(2009-9#13)(2010-1#10)(2010-11#7)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#16)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#9)(2011-1#21)(2011-2#46)(2011-3#3)(2011-7#2)(2012-1#14)(2012-12#18)(2012-2#44)(2012-3#34)(2013-1#61)(2013-7#4)(2013-8#35)
brain's##8##1##(1994-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-8#2)(2012-12#1)
brain)##3##1##(2008-5#1)(2010-11#1)(2013-7#1)
brain-computer##2##1##(2008-11#1)(2012-12#1)
brain-damaged##5##1##(1991-2#1)(1993-3#1)(1995-12#1)(2008-4#2)
brain-death criterion##2##2##(1991-9#2)
brain-derived neurotrophic factor (BDNF) in##2##5##(2012-2#1)(2013-1#1)
brain-derived neurotrophic factor (BDNF) was##2##5##(1996-12#1)(1997-2#1)
brain-derived neurotrophic factor (BDNF)##11##4##(1994-8#1)(1995-5#1)(1996-12#1)(1997-2#2)(2008-5#1)(2008-7#2)(2009-3#1)(2012-2#1)(2013-1#1)
brain-derived neurotrophic factor mRNA##2##4##(1997-2#1)(1997-6#1)
brain-derived neurotrophic factor##17##3##(1994-8#2)(1995-5#1)(1996-12#1)(1997-2#4)(1997-6#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
brain-derived##20##1##(1990-7#1)(1994-8#2)(1995-5#1)(1996-12#1)(1997-2#5)(1997-6#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
brain-imaging##2##1##(1997-8#1)(2007-10#1)
brain-injured patients##2##2##(2008-2#1)(2009-8#1)
brain-injured##4##1##(1995-3#1)(2008-2#1)(2009-8#2)
brain-machine interface##2##2##(2009-5#2)
brain-machine##3##1##(2008-11#1)(2009-5#2)
brain-sparing flow vs##2##3##(2011-2#2)
brain-sparing flow##6##2##(2011-2#6)
brain-sparing##7##1##(2011-2#7)
brain-specific##7##1##(1992-11#2)(1993-12#1)(1994-12#1)(1995-6#2)(2012-3#1)
brain]##3##1##(1990-9#1)(1992-8#1)(1995-6#1)
brains and##4##2##(1997-3#1)(2008-1#1)(2008-6#2)
brains are##2##2##(2008-4#1)(2010-11#1)
brains as##3##2##(1993-9#1)(1995-12#1)(2008-11#1)
brains from##2##2##(1994-8#1)(2008-7#1)
brains of insects and vertebrates##2##5##(2007-12#2)
brains of##27##2##(1991-5#1)(1992-12#1)(1992-8#2)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-5#3)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#5)(2008-11#2)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)
brains were##2##2##(1993-12#1)(2008-7#1)
brains with##4##2##(1992-12#1)(1994-11#1)(1995-12#1)(1996-12#1)
brains##88##1##(1990-5#2)(1991-5#2)(1991-7#2)(1992-12#3)(1992-6#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#4)(1995-12#6)(1996-12#4)(1996-2#2)(1996-5#5)(1997-2#2)(1997-3#2)(1997-8#1)(2007-10#3)(2007-12#5)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#2)(2009-10#1)(2009-12#4)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
brainstem and##3##2##(1991-9#1)(2008-4#2)
brainstem auditory##2##2##(2008-12#1)(2008-9#1)
brainstem regions##2##2##(1991-5#1)(1996-12#1)
brainstem response##8##2##(2008-4#2)(2008-9#5)(2013-1#1)
brainstem structures##3##2##(1991-10#1)(1993-12#2)
brainstem were##3##2##(1990-9#1)(1993-12#1)(2011-2#1)
brainstem##43##1##(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-3#1)(1993-12#3)(1994-2#2)(1994-3#1)(1996-12#1)(1996-5#4)(1997-2#1)(1997-3#1)(2007-10#3)(2008-12#1)(2008-4#5)(2008-7#1)(2008-9#6)(2011-2#3)(2012-3#2)(2013-1#1)
bramble finch##2##2##(2008-8#2)
bran and##4##2##(1993-11#1)(1997-2#1)(2008-10#1)(2010-2#1)
bran##15##1##(1992-8#2)(1993-11#3)(1997-2#1)(1997-8#1)(2008-10#5)(2010-2#2)(2013-8#1)
branch and##3##2##(1996-5#1)(2008-5#1)(2012-2#1)
branch cuts##5##2##(2008-2#1)(2008-3#4)
branch lengths##2##2##(2008-10#1)(2008-7#1)
branch migration of Holliday junctions##2##5##(1995-3#2)
branch of the bacteria##2##4##(1997-4#2)
branch of the ulnar nerve##3##5##(1992-6#1)(2008-9#2)
branch of the##20##3##(1991-9#1)(1992-6#1)(1993-12#3)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-8#2)(2008-3#1)(2008-9#3)(2011-1#1)(2012-3#2)
branch of##30##2##(1991-9#1)(1992-6#1)(1993-12#3)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-8#3)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
branch point is##2##3##(2007-12#2)
branch point##4##2##(2007-12#2)(2008-4#2)
branch points in the##2##4##(2007-12#1)(2008-3#1)
branch points##4##2##(1992-12#1)(2007-12#2)(2008-3#1)
branch retinal vein occlusion##2##4##(2011-1#1)(2013-1#1)
branch retinal##3##2##(2010-3#1)(2011-1#1)(2013-1#1)
branch surfaces##2##2##(2008-10#2)
branch to the##2##3##(2008-7#1)(2008-9#1)
branch##118##1##(1991-3#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#3)(1994-1#1)(1995-3#2)(1995-8#2)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#7)(2007-8#3)(2008-10#16)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#7)(2009-9#2)(2010-10#1)(2010-3#1)(2010-8#4)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
branch'##2##1##(2011-1#2)
branch-cut method##4##2##(2008-3#4)
branch-cut##7##1##(2008-2#1)(2008-3#6)
branched actin filament##2##3##(2008-1#1)(2009-9#1)
branched chain##2##2##(1991-5#1)(1996-5#1)
branched distal##2##2##(2007-12#2)
branched phosphatidylcholines##2##2##(1997-2#2)
branched polysaccharides##2##2##(1992-12#2)
branched##39##1##(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#2)(1993-12#2)(1995-11#1)(1996-2#1)(1996-5#1)(1997-2#3)(2007-12#6)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-9#1)(2010-10#1)(2013-7#3)
branched-chain amino acid##2##3##(1994-5#2)
branched-chain amino acids##3##3##(1993-12#1)(1994-5#1)(1995-11#1)
branched-chain amino##5##2##(1993-12#1)(1994-5#3)(1995-11#1)
branched-chain fatty acid##2##3##(2008-6#1)(2009-4#1)
branched-chain fatty acids##2##3##(2008-6#2)
branched-chain fatty##4##2##(2008-6#3)(2009-4#1)
branched-chain##10##1##(1990-12#1)(1993-12#1)(1994-5#3)(1995-11#1)(2008-6#3)(2009-4#1)
branches and##10##2##(1993-3#1)(1997-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
branches in##2##2##(1997-3#1)(2009-10#1)
branches of medicine##2##3##(1994-12#1)(2008-1#1)
branches of the##13##3##(1990-12#1)(1993-12#1)(1994-9#2)(1996-5#1)(1997-3#3)(1997-5#1)(2008-11#1)(2009-3#1)(2012-3#2)
branches of##31##2##(1990-12#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-9#3)(1996-5#1)(1997-3#4)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
branches per plant##2##3##(2008-12#1)(2008-5#1)
branches that##2##2##(2008-10#2)
branches was##2##2##(2008-10#2)
branches with##2##2##(2008-10#1)(2011-2#1)
branches##99##1##(1990-12#1)(1990-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#5)(1997-5#1)(1997-8#9)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
branchial HSP70##2##2##(2010-5#2)
branchial nerves/ganglia##2##2##(1996-5#2)
branchial##16##1##(1996-5#3)(2008-11#1)(2008-7#8)(2010-5#4)
branching at the##2##3##(1997-1#1)(2008-6#1)
branching at##3##2##(1997-1#1)(2008-10#1)(2008-6#1)
branching events##2##2##(2008-11#1)(2010-6#1)
branching hierarchy##2##2##(1990-8#1)(2008-10#1)
branching in the##2##3##(1993-11#1)(2008-7#1)
branching in##3##2##(1993-11#2)(2008-7#1)
branching of germ tubes##2##4##(2008-10#2)
branching of the##4##3##(1993-11#1)(2008-7#3)
branching of##12##2##(1993-11#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-7#4)(2010-10#1)(2012-2#1)
branching pattern of##2##3##(1997-3#1)(2013-1#1)
branching patterns of##2##3##(2010-8#1)(2012-2#1)
branching patterns##7##2##(1997-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)
branching points##4##2##(1997-3#1)(2008-10#2)(2012-12#1)
branching ratios##2##2##(2008-2#2)
branching sites are##2##3##(2012-12#2)
branching sites##4##2##(2012-12#4)
branching##63##1##(1990-8#1)(1991-1#1)(1992-6#1)(1993-11#3)(1995-3#2)(1997-1#1)(1997-3#3)(2007-12#2)(2007-5#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2009-8#2)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#2)
branchiosaurids have##2##2##(2010-6#2)
branchiosaurids##8##1##(2010-6#8)
brand of##4##2##(1992-8#1)(1995-2#1)(2008-10#1)(2008-4#1)
brand##15##1##(1992-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#5)(2012-2#1)(2013-1#2)
brandies and##2##2##(2008-10#2)
brandies##7##1##(2008-10#7)
branding##2##1##(2007-10#2)
brands and##2##2##(2008-10#1)(2013-8#1)
brands of beer##2##3##(2008-10#2)
brands of##11##2##(1992-2#1)(2007-11#1)(2008-10#6)(2008-5#2)(2013-1#1)
brands were##2##2##(2008-10#1)(2013-1#1)
brands##16##1##(1992-2#1)(2007-11#1)(2008-10#8)(2008-5#2)(2013-1#3)(2013-8#1)
brantii##3##1##(2008-12#3)
brasiliensis##9##1##(2008-10#2)(2008-4#2)(2008-5#4)(2013-8#1)
brass and##2##2##(2008-10#2)
brass samples and##2##3##(2008-10#2)
brass##9##1##(2008-10#9)
brassboard##2##1##(2008-3#2)
brassica##3##1##(2009-8#1)(2010-10#2)
brassicae in##3##2##(2008-10#3)
brassicae##20##1##(2008-10#19)(2010-10#1)
brassicas and##3##2##(2008-10#2)(2010-10#1)
brassinosteroid (BR)##2##2##(2008-9#1)(2009-8#1)
brassinosteroid##4##1##(2008-9#2)(2009-8#2)
braunii##2##1##(2008-6#2)
brave new world of##3##4##(1991-3#1)(1997-2#1)(2008-11#1)
braziliensis##2##1##(2012-12#1)(2013-1#1)
brazzein##4##1##(2008-9#4)
brd1##4##1##(1995-8#4)
breach of##3##2##(1997-5#2)(2012-3#1)
breach##8##1##(1996-12#1)(1997-5#2)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
breached##4##1##(1995-2#1)(1995-6#1)(1997-5#1)(2010-1#1)
breaches may##2##2##(2012-12#2)
breaches of##2##2##(1993-12#1)(2007-4#1)
breaches##7##1##(1993-12#1)(2007-12#2)(2007-4#2)(2012-12#2)
breaching##3##1##(1996-5#1)(1997-5#1)(2013-7#1)
bread and##2##2##(1990-8#1)(2010-1#1)
bread wheat (Triticum##2##3##(2008-10#1)(2008-12#1)
bread wheat cultivars and##2##4##(2008-10#2)
bread wheat cultivars##5##3##(2008-10#5)
bread wheat##18##2##(1991-12#1)(2008-10#15)(2008-12#1)(2008-5#1)
bread##28##1##(1990-8#1)(1991-12#1)(1991-6#2)(2008-10#18)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#2)(2012-12#1)
breadth and##5##2##(1995-2#1)(1995-6#1)(2008-5#1)(2008-7#1)(2012-12#1)
breadth of species##2##3##(2008-8#1)(2012-3#1)
breadth of the##3##3##(2008-1#1)(2008-10#1)(2013-7#1)
breadth of##12##2##(1993-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
breadth##31##1##(1993-12#1)(1995-2#1)(1995-6#5)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-7#2)
break (DSB) repair##2##3##(2011-1#1)(2013-1#1)
break and##3##2##(2008-10#3)
break down##6##2##(1990-11#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
break in the##2##3##(2007-11#1)(2008-2#1)
break in##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
break of##3##2##(2007-7#1)(2008-8#1)(2012-2#1)
break repair##7##2##(1995-6#1)(1996-2#1)(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)
break the law##2##3##(1992-12#1)(1993-6#1)
break the##11##2##(1991-3#1)(1992-12#1)(1993-6#1)(2007-5#1)(2008-10#3)(2008-3#1)(2009-11#1)(2010-9#1)(2011-1#1)
break through volume##2##3##(2008-10#2)
break through##3##2##(1997-3#1)(2008-10#2)
break##68##1##(1990-11#1)(1990-3#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#2)(2009-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#2)(2012-3#1)(2012-4#4)(2012-8#1)(2013-1#3)(2013-7#1)
break-even analysis##2##2##(1992-12#1)(2010-9#1)
break-even##3##1##(1992-12#2)(2010-9#1)
break-up##2##1##(1997-6#1)(2009-8#1)
breakage in##4##2##(1992-1#1)(1997-3#1)(2008-10#1)(2012-3#1)
breakage is##3##2##(2008-5#1)(2012-3#2)
breakage of##6##2##(1993-5#1)(1995-5#1)(1997-6#1)(2008-5#1)(2008-8#1)(2009-8#1)
breakage##40##1##(1991-12#1)(1992-1#1)(1993-10#1)(1993-5#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-4#3)(1997-6#2)(2007-7#1)(2008-10#3)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#7)(2013-1#1)
breakdown and its role in the acrosome reaction##2##8##(2008-8#2)
breakdown and##8##2##(1991-12#1)(2008-10#2)(2008-7#1)(2008-8#3)(2008-9#1)
breakdown in the##2##3##(1990-9#1)(2008-7#1)
breakdown in##11##2##(1990-9#1)(1994-11#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
breakdown is##2##2##(2008-2#1)(2008-8#1)
breakdown model##2##2##(2007-12#1)(2008-3#1)
breakdown models##2##2##(2008-3#2)
breakdown of a##2##3##(2008-4#1)(2008-7#1)
breakdown of cell##2##3##(2008-10#1)(2008-8#1)
breakdown of the blood-brain barrier##2##5##(1995-12#2)
breakdown of the##4##3##(1995-12#2)(1995-3#1)(2009-8#1)
breakdown of##29##2##(1990-11#1)(1992-12#1)(1993-6#2)(1993-8#1)(1995-12#2)(1995-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)
breakdown products of##5##3##(1994-2#1)(1994-8#1)(2008-11#2)(2010-5#1)
breakdown products##12##2##(1994-2#1)(1994-8#1)(2008-10#4)(2008-11#5)(2010-5#1)
breakdown pulses##4##2##(1991-5#4)
breakdown region##2##2##(2008-3#2)
breakdown spectrometry (LIBS)##3##3##(2008-10#2)(2008-2#1)
breakdown spectrometry##6##2##(2008-10#4)(2008-2#2)
breakdown spectroscopy (LIBS)##2##3##(2008-10#1)(2013-8#1)
breakdown spectroscopy##9##2##(2007-12#2)(2008-10#2)(2008-2#3)(2013-8#2)
breakdown threshold of##2##3##(2008-3#2)
breakdown threshold##3##2##(2008-1#1)(2008-3#2)
breakdown voltage##2##2##(1991-5#1)(2007-11#1)
breakdown##139##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#7)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-4#2)(1996-9#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#15)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#7)(2008-9#4)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
breakdowns in##2##2##(1994-3#1)(2007-11#1)
breakfast consumption##4##2##(2012-1#2)(2013-1#2)
breakfast has##3##2##(2012-1#3)
breakfast##13##1##(1991-6#1)(2007-7#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-1#5)(2013-1#2)(2013-8#1)
breaking activity##4##2##(1996-2#4)
breaking and##2##2##(1995-2#1)(2012-2#1)
breaking by##2##2##(1996-2#2)
breaking load##3##2##(2008-9#3)
breaking of##4##2##(1996-2#1)(2008-12#1)(2008-3#1)(2010-12#1)
breaking the##6##2##(1996-2#1)(2006-4#1)(2009-11#1)(2009-4#1)(2011-3#1)(2012-2#1)
breaking up##2##2##(2007-11#1)(2008-10#1)
breaking##43##1##(1990-8#1)(1991-6#1)(1994-5#1)(1995-2#3)(1996-1#2)(1996-2#8)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-11#1)(2009-4#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#2)
breakpoint (50 +/- 1##2##4##(2008-7#2)
breakpoint regions##3##2##(2008-6#1)(2011-3#1)(2013-1#1)
breakpoint##17##1##(1996-12#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#3)
breakpoints of a polymorphic inversion##2##5##(2013-1#2)
breakpoints of##3##2##(2013-1#3)
breakpoints##14##1##(1994-11#1)(1997-3#1)(1997-5#3)(2008-5#3)(2011-2#1)(2013-1#5)
breaks (DSBs)##5##2##(1995-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
breaks and##8##2##(1991-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
breaks by##2##2##(1991-12#1)(1997-4#1)
breaks can##2##2##(2008-7#1)(2008-9#1)
breaks down##10##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
breaks in##8##2##(1993-3#2)(1993-9#1)(1997-4#1)(1997-7#1)(2008-3#1)(2008-4#1)(2009-5#1)
breaks with##2##2##(2008-10#1)(2008-9#1)
breaks##92##1##(1991-12#2)(1991-9#1)(1992-3#2)(1993-12#1)(1993-3#6)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-8#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-4#6)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#12)(2009-10#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-3#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#1)(2012-4#2)(2013-1#4)(2013-8#1)
breaks)##2##1##(1995-2#1)(2008-9#1)
breakthrough capacities##2##2##(2008-10#2)
breakthrough capacity##4##2##(2008-10#4)
breakthrough in the##2##3##(1997-6#1)(2008-7#1)
breakthrough in##8##2##(1997-6#1)(2008-11#1)(2008-7#2)(2009-11#1)(2012-2#1)(2013-1#2)
breakthrough isolates##2##2##(1997-4#2)
breakthrough volume and##3##3##(2008-10#3)
breakthrough volume##6##2##(2008-10#6)
breakthrough##35##1##(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-4#2)(1997-6#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-7#3)(2009-11#1)(2010-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
breakthroughs in the##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
breakthroughs in##6##2##(1993-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
breakthroughs##11##1##(1993-12#1)(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-12#1)(2013-8#1)
breakup##7##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
bream##13##1##(2008-10#1)(2008-7#3)(2009-5#3)(2010-5#4)(2010-8#2)
breast -##3##2##(2007-11#2)(2012-3#1)
breast MRI##2##2##(2009-11#2)
breast adenocarcinoma##4##2##(1993-9#1)(2012-2#1)(2013-8#2)
breast and MXT##2##3##(1993-1#2)
breast and cervical cancer screening##3##5##(1990-8#1)(1997-1#1)(1997-2#1)
breast and cervical cancer##4##4##(1990-8#2)(1997-1#1)(1997-2#1)
breast and colorectal##2##3##(1995-6#1)(2013-1#1)
breast and endometrial cancer cells##3##5##(2011-2#3)
breast and endometrial cancer##5##4##(2008-10#2)(2011-2#3)
breast and ovarian cancer xenografts##2##5##(1997-7#2)
breast and ovarian cancer##4##4##(1997-7#4)
breast and prostate cancer##5##4##(2007-11#2)(2008-7#1)(2011-2#2)
breast and prostate##9##3##(2007-11#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
breast and uterine cervix cancer in##2##6##(1990-6#2)
breast and##44##2##(1990-12#1)(1990-6#2)(1990-8#2)(1991-12#1)(1993-1#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-1#1)(1997-2#2)(1997-7#4)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
breast are##5##2##(1991-8#1)(1993-12#1)(1994-6#1)(2007-11#1)(2008-7#1)
breast as##2##2##(1991-2#1)(1994-7#1)
breast cancer (n =##4##4##(1993-1#3)(1994-10#1)
breast cancer 5##2##3##(2007-11#1)(2011-2#1)
breast cancer MCF-7 cells##3##4##(1993-9#2)(2008-11#1)
breast cancer MCF-7##4##3##(1993-9#2)(2008-11#1)(2011-2#1)
breast cancer and a##2##4##(1993-11#1)(2008-10#1)
breast cancer and colorectal cancer##2##5##(2013-1#2)
breast cancer and multiple##2##4##(2007-11#2)
breast cancer and primary biliary##3##5##(1992-12#3)
breast cancer and their##4##4##(1994-3#1)(1995-4#1)(1996-3#1)(2013-1#1)
breast cancer and to##2##4##(1990-11#1)(2012-3#1)
breast cancer and##52##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#2)(1991-6#1)(1991-8#3)(1992-10#2)(1992-12#3)(1992-2#1)(1993-1#3)(1993-11#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-4#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#5)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
breast cancer are##7##3##(1992-2#1)(1996-11#2)(2007-5#1)(2008-7#1)(2010-9#1)(2012-3#1)
breast cancer associated with##3##4##(1994-2#1)(2008-10#2)
breast cancer at##3##3##(1991-12#1)(1992-2#1)(2008-10#1)
breast cancer between##2##3##(1992-10#1)(1997-7#1)
breast cancer but##2##3##(1994-9#1)(2008-10#1)
breast cancer by##4##3##(1994-2#1)(1994-6#1)(1995-4#1)(2010-6#1)
breast cancer cases##4##3##(1994-7#1)(1997-3#1)(2008-5#1)(2012-3#1)
breast cancer cell growth##3##4##(2008-11#2)(2012-3#1)
breast cancer cell line##7##4##(1990-11#1)(1993-3#1)(2008-11#2)(2011-1#1)(2012-3#1)(2013-1#1)
breast cancer cell lines##12##4##(1992-4#1)(1993-1#1)(1994-12#1)(1997-7#1)(2008-11#3)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
breast cancer cell proliferation##2##4##(1992-9#1)(2012-2#1)
breast cancer cell##27##3##(1990-11#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1997-7#1)(2008-11#7)(2008-2#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
breast cancer cells in vitro##2##5##(1994-8#1)(1997-7#1)
breast cancer cells in##7##4##(1994-12#2)(1994-8#1)(1997-7#1)(2008-11#1)(2012-2#2)
breast cancer cells##45##3##(1990-12#1)(1990-5#2)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-2#2)(1997-7#2)(2007-11#1)(2008-11#6)(2008-4#1)(2009-2#1)(2009-4#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#1)
breast cancer death##3##3##(1991-12#2)(1997-1#1)
breast cancer detection##2##3##(1992-2#1)(2008-2#1)
breast cancer development##2##3##(1994-12#1)(2012-2#1)
breast cancer diagnosed##2##3##(2007-10#1)(2012-3#1)
breast cancer diagnosis##2##3##(1993-1#1)(2008-3#1)
breast cancer families##3##3##(1994-9#1)(1997-7#1)(2008-10#1)
breast cancer has##6##3##(1990-12#1)(1997-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
breast cancer have been##2##4##(1994-2#1)(1996-11#1)
breast cancer have##3##3##(1994-2#1)(1996-11#1)(2008-4#1)
breast cancer in Sweden##2##4##(1992-8#1)(1993-1#1)
breast cancer in a##4##4##(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
breast cancer in males##2##4##(1997-7#2)
breast cancer in post-menopausal##2##4##(2008-10#1)(2013-8#1)
breast cancer in the##2##4##(1990-8#1)(2007-5#1)
breast cancer in women##2##4##(1993-1#1)(2010-1#1)
breast cancer in##33##3##(1990-8#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-1#2)(1993-11#1)(1994-12#1)(1994-6#1)(1995-4#1)(1997-7#3)(2007-11#1)(2007-2#1)(2007-5#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-1#1)(2010-8#4)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
breast cancer incidence and##2##4##(1991-4#1)(1992-2#1)
breast cancer incidence##4##3##(1991-4#2)(1992-2#1)(2013-1#1)
breast cancer is a##3##4##(1990-6#1)(1991-12#1)(2009-9#1)
breast cancer is##10##3##(1990-6#1)(1991-12#1)(1993-8#1)(1994-12#2)(1995-8#1)(2007-5#1)(2008-4#1)(2009-9#1)(2012-3#1)
breast cancer may##2##3##(1990-2#1)(1991-8#1)
breast cancer mortality##4##3##(1997-1#1)(1997-7#1)(2008-4#1)(2012-12#1)
breast cancer patient##3##3##(1993-11#1)(2007-5#1)(2008-9#1)
breast cancer patients after surgery was prospectively assessed using a newly developed Japanese QOL questionnaire##2##15##(1994-12#1)(1995-4#1)
breast cancer patients after surgery##4##5##(1994-12#3)(1995-4#1)
breast cancer patients and their families##2##6##(1994-3#1)(1995-2#1)
breast cancer patients and##4##4##(1992-2#1)(1994-3#1)(1995-2#1)(2007-5#1)
breast cancer patients in the##2##5##(1993-1#1)(2013-1#1)
breast cancer patients in##5##4##(1993-1#1)(1994-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
breast cancer patients treated with##4##5##(2009-4#3)(2009-5#1)
breast cancer patients who##3##4##(1993-1#1)(2008-10#1)(2012-3#1)
breast cancer patients with##4##4##(1992-12#1)(1993-11#1)(2007-11#1)(2011-2#1)
breast cancer patients##55##3##(1990-12#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-2#2)(1993-1#4)(1993-11#4)(1993-12#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#2)(1995-2#1)(1995-4#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-10#3)(2008-4#3)(2008-7#1)(2009-2#1)(2009-4#3)(2009-5#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
breast cancer patients]##3##3##(1991-3#1)(2007-10#1)(2013-8#1)
breast cancer prevention##2##3##(1995-9#1)(2008-4#1)
breast cancer progression##2##3##(2011-2#1)(2012-2#1)
breast cancer resistance##2##3##(2012-3#1)(2013-1#1)
breast cancer risk is##2##4##(1990-6#1)(1994-2#1)
breast cancer risk##11##3##(1990-6#2)(1994-2#4)(1995-9#2)(2008-4#1)(2012-2#1)(2012-3#1)
breast cancer screening clinic for underserved women##2##7##(2011-2#2)
breast cancer screening for##2##4##(1995-4#1)(2012-12#1)
breast cancer screening##22##3##(1992-2#1)(1994-3#1)(1995-12#1)(1995-4#2)(1996-2#2)(1997-1#3)(1997-3#1)(2008-4#1)(2010-8#1)(2011-2#2)(2012-12#4)(2013-1#3)
breast cancer seems to be##2##5##(1990-8#1)(2013-1#1)
breast cancer subsequent to##2##4##(1991-2#1)(1992-8#1)
breast cancer survivors##8##3##(2008-4#4)(2008-7#2)(2012-12#1)(2012-3#1)
breast cancer susceptibility gene##2##4##(1994-9#1)(1995-12#1)
breast cancer susceptibility##4##3##(1994-9#2)(1995-12#1)(1997-7#1)
breast cancer to##2##3##(1991-8#1)(2008-1#1)
breast cancer treated by##2##4##(1991-8#1)(2011-2#1)
breast cancer treated with##4##4##(1992-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
breast cancer treated##7##3##(1991-8#2)(1992-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
breast cancer treatment##8##3##(2008-4#4)(2010-8#1)(2011-2#2)(2013-1#1)
breast cancer tumor##2##3##(2013-1#2)
breast cancer using##2##3##(1995-4#1)(2008-4#1)
breast cancer was studied##2##4##(1990-12#1)(1993-1#1)
breast cancer was##10##3##(1990-12#2)(1991-2#1)(1992-12#1)(1993-1#1)(1995-4#2)(2007-5#1)(2012-3#1)(2013-1#1)
breast cancer were treated with##2##5##(1991-6#1)(1997-7#1)
breast cancer were##12##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1994-12#1)(1995-4#2)(1996-3#1)(1997-7#2)(2012-12#1)(2013-1#1)
breast cancer which is##2##4##(2007-10#1)(2012-3#1)
breast cancer which##5##3##(1990-11#1)(1991-8#1)(2007-10#1)(2012-3#1)(2013-7#1)
breast cancer who had been##2##5##(1991-8#1)(1995-4#1)
breast cancer who had##3##4##(1991-8#1)(1992-10#1)(1995-4#1)
breast cancer who##11##3##(1991-8#1)(1992-10#2)(1995-4#1)(1997-7#1)(2011-2#1)(2012-3#1)(2013-1#4)
breast cancer with an##3##4##(1990-6#1)(1991-8#2)
breast cancer with##8##3##(1990-6#1)(1991-8#2)(1992-10#1)(1993-1#1)(1994-2#1)(1997-3#1)(2013-1#1)
breast cancer without##2##3##(1993-11#1)(1994-12#1)
breast cancer xenografts##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
breast cancer##784##2##(1990-10#1)(1990-11#4)(1990-12#17)(1990-2#4)(1990-5#2)(1990-6#7)(1990-8#8)(1991-12#18)(1991-2#3)(1991-3#2)(1991-4#6)(1991-6#7)(1991-8#15)(1992-10#13)(1992-12#7)(1992-2#17)(1992-4#2)(1992-5#3)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#27)(1993-11#34)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#21)(1994-2#13)(1994-3#7)(1994-6#3)(1994-7#13)(1994-8#10)(1994-9#5)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-4#19)(1995-8#5)(1995-9#9)(1996-10#1)(1996-11#5)(1996-2#2)(1996-3#6)(1996-6#1)(1997-1#7)(1997-3#8)(1997-7#23)(1997-8#6)(2007-10#9)(2007-11#17)(2007-2#3)(2007-4#1)(2007-5#15)(2008-1#3)(2008-10#19)(2008-11#14)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#33)(2008-5#6)(2008-7#23)(2008-9#1)(2009-1#1)(2009-2#3)(2009-4#11)(2009-5#8)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-6#6)(2010-7#8)(2010-8#12)(2010-9#3)(2011-1#14)(2011-2#29)(2012-1#1)(2012-12#9)(2012-2#12)(2012-3#30)(2013-1#46)(2013-7#4)(2013-8#14)
breast cancer?##2##2##(2008-4#1)(2011-2#1)
breast cancer]##10##2##(1992-2#1)(1993-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2011-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
breast cancers with##3##3##(1993-11#1)(1995-4#1)(2008-10#1)
breast cancers##37##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#2)(1992-8#1)(1993-1#2)(1993-11#5)(1994-12#2)(1994-2#1)(1995-12#1)(1995-4#3)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
breast carcinogenesis##4##2##(1990-6#2)(1993-11#1)(2008-2#1)
breast carcinoma and##3##3##(1993-2#1)(1994-6#1)(2008-4#1)
breast carcinoma in a##2##4##(1992-8#1)(1994-12#1)
breast carcinoma in##3##3##(1992-8#1)(1994-12#1)(1995-8#1)
breast carcinoma were##2##3##(1992-10#1)(1993-12#1)
breast carcinoma##46##2##(1990-12#2)(1991-2#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-12#7)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-8#1)(1997-5#1)(1997-8#2)(2007-10#4)(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
breast carcinoma]##2##2##(1993-6#1)(1997-7#1)
breast carcinomas in##2##3##(1994-12#1)(1996-10#1)
breast carcinomas##11##2##(1993-9#1)(1994-12#1)(1994-8#1)(1996-10#1)(1997-7#3)(2007-10#2)(2008-11#1)(2013-8#1)
breast cell##3##2##(1992-12#1)(1994-11#1)(2008-11#1)
breast conservation therapy##5##3##(1995-4#1)(2007-11#4)
breast conservation##8##2##(1994-12#1)(1995-4#1)(2007-11#4)(2010-7#1)(2013-1#1)
breast conserving surgery##2##3##(1997-7#1)(2011-2#1)
breast conserving therapy##2##3##(2011-2#2)
breast conserving treatment (BCT)##2##4##(1994-12#1)(1995-4#1)
breast conserving##6##2##(1994-12#1)(1995-4#1)(1997-7#1)(2011-2#3)
breast cyst fluid##3##3##(1994-7#1)(2008-12#2)
breast cyst fluids##4##3##(1993-1#2)(2008-4#2)
breast cyst##9##2##(1993-1#2)(1994-7#1)(2008-12#4)(2008-4#2)
breast cysts##5##2##(2008-12#2)(2008-4#3)
breast disease##7##2##(1993-1#1)(1994-5#3)(1994-9#1)(2008-12#1)(2008-4#1)
breast diseases##3##2##(1993-1#1)(2008-12#1)(2012-2#1)
breast edema##2##2##(1993-8#2)
breast epithelia##2##2##(1991-12#1)(2013-8#1)
breast epithelial and stromal cells from Li-Fraumeni syndrome##2##8##(2011-2#2)
breast epithelial and stromal cells##3##5##(2011-2#3)
breast epithelial cells##2##3##(1990-12#1)(1994-5#1)
breast epithelial##9##2##(1990-12#1)(1993-1#4)(1994-5#1)(2011-2#3)
breast epithelium##2##2##(1991-12#2)
breast fat##2##2##(2007-10#2)
breast feeding##13##2##(1990-2#6)(1991-6#1)(1995-8#1)(1995-9#2)(1997-4#1)(2008-1#1)(2012-2#1)
breast feeding]##2##2##(1995-8#1)(1996-9#1)
breast health##5##2##(1996-2#2)(2007-10#3)
breast imaging##4##2##(1990-8#1)(1997-3#1)(2007-11#1)(2008-3#1)
breast implants is##2##3##(2012-2#2)
breast implants##3##2##(2012-2#3)
breast in a##2##3##(1992-2#1)(1995-9#1)
breast in##7##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-9#1)(2007-8#1)
breast involvement##2##2##(1992-2#2)
breast irradiation##10##2##(1990-12#1)(1994-12#1)(1994-8#1)(1995-8#1)(2009-2#1)(2011-2#1)(2013-1#3)(2013-8#1)
breast is##5##2##(1992-2#1)(1995-4#1)(2007-5#1)(2008-1#1)(2012-3#1)
breast lesion##4##2##(1993-1#1)(1993-12#1)(2007-5#1)(2012-2#1)
breast lesions##5##2##(1990-2#1)(2010-8#1)(2012-2#3)
breast lump##3##2##(1990-10#1)(1991-12#1)(1994-7#1)
breast lumps##4##2##(1990-10#2)(1991-12#1)(2008-7#1)
breast lymphoma##4##2##(2012-2#3)(2013-8#1)
breast malignancies##2##2##(2007-5#1)(2012-2#1)
breast masses##3##2##(1990-10#1)(2007-5#1)(2008-4#1)
breast microcysts##3##2##(1990-11#3)
breast milk and##2##3##(2008-10#2)
breast milk##17##2##(1991-6#1)(1993-6#1)(2008-10#5)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#5)(2013-1#2)
breast mound##2##2##(2013-1#2)
breast nodularity##4##2##(1994-5#4)
breast or##3##2##(2008-7#2)(2009-4#1)
breast processes##2##2##(2007-5#1)(2013-1#1)
breast radiotherapy##2##2##(2009-2#2)
breast reconstruction##13##2##(1990-9#3)(1992-5#2)(1993-11#1)(1994-12#1)(2013-1#6)
breast screening##5##2##(1993-2#1)(1996-11#1)(1996-6#1)(2012-12#2)
breast self-examination##3##2##(1990-8#1)(2007-10#2)
breast skin##2##2##(2007-10#1)(2008-10#1)
breast stromal fibroblasts and##2##4##(2013-1#2)
breast stromal fibroblasts##3##3##(2013-1#3)
breast surgery##2##2##(1992-9#2)
breast tissue in##2##3##(2008-2#1)(2008-3#1)
breast tissue was##2##3##(1995-4#1)(2008-3#1)
breast tissue##20##2##(1990-12#1)(1990-2#1)(1991-12#2)(1993-1#1)(1993-11#1)(1995-4#1)(2007-11#3)(2008-11#1)(2008-2#3)(2008-3#5)(2009-11#1)
breast tissues##3##2##(1990-12#1)(2008-3#1)(2011-2#1)
breast tumor cell line##2##4##(1995-10#1)(1995-6#1)
breast tumor cell##3##3##(1995-10#1)(1995-6#2)
breast tumor cells##3##3##(1992-12#2)(1993-11#1)
breast tumor recurrence##2##3##(1994-8#1)(2013-1#1)
breast tumor##13##2##(1990-7#1)(1992-12#2)(1993-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#2)(2008-10#2)(2011-1#1)(2013-1#1)
breast tumors in##2##3##(1992-9#1)(1993-9#1)
breast tumors is##2##3##(1997-7#1)(2008-3#1)
breast tumors##8##2##(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(1997-7#1)(2008-10#1)(2008-3#1)
breast tumour##2##2##(2011-3#2)
breast tumours##2##2##(1990-11#1)(1993-5#1)
breast using##2##2##(1994-12#1)(1995-4#1)
breast was##4##2##(1990-12#1)(1991-2#1)(2007-7#1)(2008-10#1)
breast were##2##2##(1990-12#1)(1992-5#1)
breast##1384##1##(1990-10#7)(1990-11#11)(1990-12#33)(1990-2#15)(1990-3#1)(1990-5#2)(1990-6#12)(1990-7#1)(1990-8#17)(1990-9#4)(1991-12#29)(1991-2#11)(1991-3#2)(1991-4#8)(1991-6#9)(1991-8#17)(1992-10#14)(1992-11#1)(1992-12#10)(1992-2#28)(1992-3#1)(1992-4#2)(1992-5#8)(1992-6#3)(1992-7#2)(1992-8#10)(1992-9#8)(1993-1#43)(1993-11#50)(1993-12#9)(1993-2#7)(1993-3#3)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#9)(1993-9#13)(1994-10#1)(1994-11#3)(1994-12#43)(1994-2#18)(1994-3#8)(1994-5#12)(1994-6#8)(1994-7#25)(1994-8#16)(1994-9#6)(1995-10#2)(1995-11#4)(1995-12#10)(1995-2#4)(1995-4#34)(1995-6#3)(1995-8#10)(1995-9#13)(1996-1#1)(1996-10#2)(1996-11#6)(1996-2#4)(1996-3#7)(1996-6#2)(1996-9#2)(1997-1#8)(1997-2#3)(1997-3#12)(1997-4#1)(1997-5#1)(1997-7#35)(1997-8#12)(2007-10#25)(2007-11#37)(2007-2#4)(2007-4#2)(2007-5#25)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#39)(2008-11#19)(2008-12#14)(2008-2#7)(2008-3#18)(2008-4#47)(2008-5#12)(2008-6#1)(2008-7#33)(2008-8#2)(2008-9#2)(2009-1#3)(2009-11#3)(2009-12#2)(2009-2#7)(2009-4#12)(2009-5#8)(2009-7#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#6)(2010-5#1)(2010-6#9)(2010-7#10)(2010-8#15)(2010-9#3)(2011-1#17)(2011-2#49)(2011-3#4)(2012-1#3)(2012-12#19)(2012-2#36)(2012-3#37)(2013-1#76)(2013-7#4)(2013-8#27)
breast-cancer##2##1##(2008-10#1)(2013-1#1)
breast-conserving surgery and definitive##2##4##(1994-8#1)(1995-8#1)
breast-conserving surgery and radiation therapy##2##5##(1994-8#1)(1995-9#1)
breast-conserving surgery and##4##3##(1994-8#2)(1995-8#1)(1995-9#1)
breast-conserving surgery##7##2##(1991-2#1)(1994-8#2)(1995-8#1)(1995-9#1)(1996-11#1)(2011-2#1)
breast-conserving##11##1##(1991-2#1)(1994-12#1)(1994-8#3)(1995-8#1)(1995-9#1)(1996-11#1)(2007-5#1)(2011-2#2)
breast-fed their##2##2##(1991-11#2)
breast-fed##5##1##(1991-11#4)(2011-2#1)
breast-feeding education##2##2##(1994-2#2)
breast-feeding practices##2##2##(1994-2#2)
breast-feeding##15##1##(1991-11#2)(1994-2#7)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#2)
breast-ovarian cancer##2##2##(1994-6#2)
breast-specific##2##1##(1990-8#1)(2013-1#1)
breast]##2##1##(1992-4#1)(1992-9#1)
breastfed children##2##2##(1991-8#1)(2010-6#1)
breastfed for##2##2##(1991-8#1)(2010-5#1)
breastfed##10##1##(1991-8#3)(2007-10#1)(2007-2#3)(2010-5#1)(2010-6#2)
breastfeeding and##2##2##(1993-6#1)(1997-4#1)
breastfeeding duration and##2##3##(2008-10#1)(2010-6#1)
breastfeeding duration##3##2##(2008-10#2)(2010-6#1)
breastfeeding in##6##2##(1993-6#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)
breastfeeding mothers##2##2##(2007-2#1)(2012-2#1)
breastfeeding to##4##2##(1991-8#2)(2013-1#2)
breastfeeding was associated with a##2##5##(1991-8#1)(2007-2#1)
breastfeeding was##4##2##(1990-12#1)(1991-8#1)(2007-2#2)
breastfeeding##59##1##(1990-12#1)(1991-8#4)(1993-6#3)(1997-4#1)(2007-10#1)(2007-2#8)(2008-10#6)(2008-11#2)(2009-4#2)(2010-12#4)(2010-5#7)(2010-6#7)(2011-1#1)(2011-2#1)(2012-2#8)(2013-1#2)(2013-7#1)
breasts were##3##2##(1995-4#1)(2007-3#2)
breasts##17##1##(1990-10#1)(1990-12#1)(1992-9#1)(1994-12#1)(1995-4#1)(2007-10#1)(2007-3#6)(2007-5#1)(2007-8#2)(2008-10#1)(2012-2#1)
breath and##3##2##(2007-8#1)(2008-10#1)(2010-5#1)
breath holding##6##2##(2013-8#6)
breath holds##2##2##(1996-2#2)
breath hydrogen excretion##4##3##(1996-6#4)
breath hydrogen##5##2##(1996-6#4)(2011-2#1)
breath test##2##2##(1990-2#1)(2010-6#1)
breath##48##1##(1990-2#1)(1995-6#1)(1996-2#3)(1996-6#4)(1997-4#3)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-10#3)(2010-11#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#7)
breath-hold##9##1##(1997-8#3)(2009-11#4)(2010-6#1)(2013-8#1)
breath-holding##5##1##(2008-10#4)(2009-11#1)
breathable##2##1##(1996-12#1)(1997-1#1)
breathe##5##1##(1993-3#1)(2009-6#2)(2010-8#1)(2011-2#1)
breathed##4##1##(1991-12#1)(1993-1#1)(1995-12#1)(2008-7#1)
breathers##2##1##(2007-12#2)
breathing and##4##2##(1995-3#1)(2007-6#1)(2010-3#1)(2012-2#1)
breathing cassette##4##2##(1991-3#4)
breathing control##2##2##(2008-2#1)(2009-11#1)
breathing disorders##4##2##(2007-12#4)
breathing exercise##2##2##(1991-10#1)(2012-2#1)
breathing exercises##2##2##(1991-12#1)(2012-2#1)
breathing in the##2##3##(1990-7#1)(2009-10#1)
breathing in##3##2##(1990-7#1)(2009-10#1)(2013-1#1)
breathing is##2##2##(2008-10#1)(2012-2#1)
breathing pattern and##3##3##(1992-3#2)(2013-7#1)
breathing pattern of##2##3##(1996-2#2)
breathing pattern##9##2##(1992-3#3)(1994-12#1)(1996-2#2)(1996-3#1)(2008-10#1)(2013-7#1)
breathing patterns##2##2##(1991-12#1)(1994-12#1)
breathing problems##2##2##(2010-3#1)(2011-2#1)
breathing tests##2##2##(2013-1#2)
breathing##86##1##(1990-7#3)(1991-10#1)(1991-12#3)(1991-3#5)(1991-6#1)(1992-2#1)(1992-3#3)(1994-12#4)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#4)(2007-12#7)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-7#2)(2009-10#1)(2009-11#1)(2010-3#2)(2010-5#2)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#4)(2013-7#3)
breathlessness##3##1##(2007-6#1)(2010-10#1)(2010-5#1)
breaths per##2##2##(2007-8#1)(2012-2#1)
breaths##6##1##(1996-2#1)(2007-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
breaths)##2##1##(1992-3#2)
bred in##2##2##(2012-1#1)(2012-3#1)
bred to##2##2##(1996-6#1)(2008-10#1)
bred##14##1##(1996-6#1)(2007-5#1)(2008-10#4)(2008-8#3)(2008-9#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-7#1)
breech presentation##2##2##(2011-1#1)(2011-2#1)
breed and##3##2##(2008-12#2)(2008-5#1)
breed assignment test##2##3##(2013-1#2)
breed dogs##2##2##(2008-12#1)(2008-8#1)
breed in##2##2##(2008-12#1)(2008-8#1)
breed of##2##2##(1994-1#1)(2008-12#1)
breed##36##1##(1994-1#1)(2008-10#1)(2008-12#15)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#1)(2010-4#4)(2013-1#4)(2013-8#1)
breed-related##2##1##(1996-12#2)
breed-specific legislation##2##2##(2013-8#2)
breeder flocks##2##2##(1997-3#1)(2008-5#1)
breeder##8##1##(1995-9#2)(1997-3#1)(2008-5#2)(2008-8#1)(2008-9#2)
breeders and##2##2##(2008-8#1)(2011-2#1)
breeders for##2##2##(2008-10#2)
breeders##15##1##(2008-10#5)(2008-5#2)(2008-8#3)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#1)
breeding and##8##2##(1992-11#1)(1992-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)
breeding are##2##2##(2008-10#1)(2013-8#1)
breeding colony##2##2##(1995-6#2)
breeding experience on female##2##4##(2008-8#2)
breeding for FHB resistance##2##4##(2008-10#2)
breeding for SSLB resistance##2##4##(2008-10#2)
breeding for resistance to##3##4##(2008-10#3)
breeding for resistance##5##3##(2008-10#5)
breeding for##13##2##(2008-10#13)
breeding habitat##2##2##(2008-8#1)(2008-9#1)
breeding in##6##2##(2008-5#1)(2008-8#3)(2008-9#1)(2010-10#1)
breeding is##3##2##(2008-8#2)(2013-7#1)
breeding line##7##2##(2008-10#7)
breeding lines##7##2##(2008-10#7)
breeding of##7##2##(1995-2#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-4#1)(2013-7#1)
breeding pond##2##2##(2008-6#1)(2012-3#1)
breeding population##2##2##(2008-9#2)
breeding program##3##2##(2008-10#3)
breeding programs and##2##3##(2008-10#1)(2008-5#1)
breeding programs in##4##3##(2008-10#3)(2008-7#1)
breeding programs##21##2##(2008-10#17)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)
breeding schemes##3##2##(2008-10#3)
breeding season in##2##3##(2008-8#1)(2008-9#1)
breeding season reproductive##2##3##(2010-8#2)
breeding season##20##2##(2008-5#3)(2008-6#3)(2008-8#8)(2008-9#2)(2010-8#3)(2013-7#1)
breeding sites##4##2##(1992-6#2)(2008-5#1)(2008-8#1)
breeding strategies##3##2##(2008-10#2)(2012-4#1)
breeding strategy##2##2##(2008-10#1)(2008-9#1)
breeding system##3##2##(2008-5#1)(2008-9#2)
breeding to##3##2##(2008-10#1)(2008-8#2)
breeding values##3##2##(2008-8#2)(2012-1#1)
breeding##212##1##(1992-11#1)(1992-5#1)(1992-6#2)(1995-2#1)(1995-6#3)(1996-6#1)(1997-3#1)(1997-4#3)(2007-10#1)(2007-8#1)(2008-10#75)(2008-12#1)(2008-5#11)(2008-6#6)(2008-7#3)(2008-8#48)(2008-9#19)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-8#4)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-3#2)(2012-4#2)(2013-7#8)(2013-8#2)
breeds and##2##2##(2008-5#1)(2013-1#1)
breeds in##2##2##(1996-12#1)(2011-1#1)
breeds of livestock##2##3##(1997-7#1)(2011-2#1)
breeds of##3##2##(1996-12#1)(1997-7#1)(2011-2#1)
breeds the##2##2##(1995-2#2)
breeds##34##1##(1995-2#3)(1996-11#1)(1996-12#5)(1997-7#1)(2008-12#1)(2008-5#1)(2008-8#3)(2010-4#2)(2011-1#4)(2011-2#2)(2012-1#8)(2013-1#3)
brefeldin A##10##2##(1990-7#3)(1997-7#5)(2009-8#1)(2010-3#1)
brefeldin##11##1##(1990-7#3)(1997-7#5)(2008-11#1)(2009-8#1)(2010-3#1)
brengen##2##1##(2012-12#2)
bretylium##2##1##(1990-5#1)(1992-11#1)
breve UCC2003##7##2##(2011-1#3)(2011-2#4)
breve##8##1##(2008-11#1)(2011-1#3)(2011-2#4)
brevifolium##2##1##(2008-10#2)
brevipes##2##1##(2008-10#2)
brevirostris##3##1##(2010-8#3)
brevis##8##1##(2008-11#1)(2008-12#1)(2008-6#1)(2010-5#2)(2011-2#1)(2012-2#2)
brewer##3##1##(2008-2#2)(2011-2#1)
brewer's yeast##3##2##(2011-2#3)
brewery residues##2##2##(2008-6#2)
brewery##6##1##(2008-6#6)
brewing##6##1##(1991-5#1)(2008-10#3)(2013-1#2)
brick industry##2##2##(2008-10#1)(2011-2#1)
brick##5##1##(2008-10#2)(2008-7#1)(2010-4#1)(2011-2#1)
bricks and##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
bricks##4##1##(2008-10#2)(2010-4#1)(2013-8#1)
bridge MTs##2##2##(2009-10#2)
bridge between the two##3##4##(1994-12#1)(1997-3#1)(2012-3#1)
bridge between the##5##3##(1994-12#1)(1997-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
bridge between##14##2##(1990-12#2)(1993-2#1)(1994-12#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2012-2#1)(2012-3#1)
bridge for##2##2##(1996-2#1)(2008-2#1)
bridge formation##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
bridge graft##2##2##(2007-7#2)
bridge in the##2##3##(1990-12#1)(1990-8#1)
bridge in##4##2##(1990-12#1)(1990-8#1)(2007-12#1)(2008-10#1)
bridge is##2##2##(2008-10#1)(2010-4#1)
bridge it##3##2##(2010-3#1)(2013-1#2)
bridge of##2##2##(1992-6#1)(2013-1#1)
bridge that##2##2##(2008-12#1)(2013-1#1)
bridge the gap between##6##4##(1990-2#1)(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
bridge the gap##7##3##(1990-2#1)(1991-1#1)(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
bridge the##14##2##(1990-2#1)(1991-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)
bridge to community##2##3##(1994-1#1)(1996-3#1)
bridge to liver transplantation##2##4##(2008-11#1)(2013-1#1)
bridge to recovery##2##3##(2010-6#1)(2011-2#1)
bridge to the##2##3##(2008-4#1)(2013-1#1)
bridge to transplantation##3##3##(2010-6#1)(2011-2#2)
bridge to##18##2##(1990-12#1)(1994-1#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#2)(2011-2#6)(2013-1#4)
bridge with##2##2##(1996-2#1)(2011-2#1)
bridge##119##1##(1990-12#5)(1990-2#1)(1990-8#1)(1991-1#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#3)(1994-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#5)(1996-3#1)(1996-5#2)(1997-3#2)(1997-7#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
bridged by##4##2##(1995-8#1)(1997-7#2)(2007-12#1)
bridged##11##1##(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#2)
bridges in the##4##3##(1992-12#1)(1992-9#1)(1997-4#1)(2008-10#1)
bridges in##5##2##(1992-12#1)(1992-9#1)(1996-2#1)(1997-4#1)(2008-10#1)
bridges##25##1##(1990-5#1)(1992-12#2)(1992-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2011-2#1)
bridging between##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
bridging ligand##4##2##(1997-7#4)
bridging the gap between##3##4##(1996-3#1)(2008-3#1)(2008-4#1)
bridging the gap##4##3##(1993-3#1)(1996-3#1)(2008-3#1)(2008-4#1)
bridging the##10##2##(1993-3#1)(1993-8#1)(1995-12#1)(1996-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-4#2)
bridging units##2##2##(1997-7#1)(2009-9#1)
bridging##47##1##(1993-3#1)(1993-8#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-7#10)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#4)(2009-10#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#2)(2011-2#3)(2012-2#3)
brief account##3##2##(1990-8#1)(1996-9#1)(2007-2#1)
brief and##2##2##(1995-12#1)(2008-11#1)
brief background on##3##3##(2007-5#1)(2008-4#1)(2009-11#1)
brief background##4##2##(1996-12#1)(2007-5#1)(2008-4#1)(2009-11#1)
brief comment on##2##3##(2007-5#1)(2008-5#1)
brief comment##3##2##(2007-5#1)(2008-5#1)(2010-7#1)
brief description of the##12##4##(1991-11#1)(1992-2#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
brief description of##16##3##(1991-11#1)(1992-2#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
brief discussion of the##6##4##(1990-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-4#1)
brief discussion of##10##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-4#1)(2009-9#1)(2012-12#1)(2013-1#1)
brief discussion##13##2##(1990-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-3#1)(2009-4#1)(2009-9#1)(2012-12#1)(2013-1#1)
brief exposure to##5##3##(1992-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-4#1)
brief history of##8##3##(1991-9#1)(1993-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#2)
brief history##10##2##(1991-9#1)(1993-12#1)(1995-5#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#2)
brief in##2##2##(1991-12#1)(1996-12#1)
brief intervention##9##2##(2008-11#7)(2013-1#2)
brief interventions##7##2##(2007-12#1)(2008-11#6)
brief introduction##11##2##(2008-10#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
brief literature##2##2##(2009-3#1)(2012-3#1)
brief motivational##2##2##(2008-11#1)(2008-8#1)
brief or##2##2##(1995-1#1)(2008-5#1)
brief overview about##2##3##(2006-10#1)(2008-5#1)
brief overview of some##2##4##(2008-4#1)(2008-5#1)
brief overview of the##13##4##(1992-12#1)(1994-12#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
brief overview of##23##3##(1992-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
brief overview##32##2##(1992-1#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-9#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
brief pain##2##2##(1992-2#1)(2007-7#1)
brief period##3##2##(1990-11#1)(1996-3#1)(2008-10#1)
brief presentation of the##2##4##(2008-10#1)(2012-12#1)
brief pulse ECT##2##3##(2012-12#2)
brief pulse##3##2##(2012-12#3)
brief report##5##2##(1994-1#1)(1996-12#1)(2007-7#1)(2008-4#1)(2010-11#1)
brief review of the literature##7##5##(1990-3#1)(2008-8#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
brief review of the##15##4##(1990-12#1)(1990-3#1)(1993-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#3)(2010-1#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
brief review of##21##3##(1990-12#1)(1990-3#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#3)(2010-1#1)(2010-8#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
brief review##32##2##(1990-12#1)(1990-3#1)(1992-2#1)(1993-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#3)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
brief sketch##2##2##(2010-10#1)(2013-1#1)
brief summary of the##4##4##(1996-8#1)(1997-3#1)(2009-8#1)(2012-2#1)
brief summary of##5##3##(1996-8#1)(1997-3#1)(2008-10#1)(2009-8#1)(2012-2#1)
brief synopsis of##2##3##(2008-11#1)(2008-8#1)
brief##275##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#4)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#4)(2008-10#20)(2008-11#28)(2008-12#2)(2008-2#5)(2008-4#19)(2008-5#14)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#8)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#2)(2011-2#3)(2012-12#10)(2012-2#6)(2012-3#6)(2013-1#13)(2013-8#2)
briefer##2##1##(1991-9#1)(2012-1#1)
briefing##3##1##(1995-6#1)(2008-11#1)(2008-9#1)
briefly considered##2##2##(2008-10#2)
briefly describe the##4##3##(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
briefly describe##6##2##(2008-10#1)(2008-7#3)(2011-1#1)(2012-2#1)
briefly described##15##2##(1991-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)
briefly discuss the##5##3##(1993-1#1)(1994-12#1)(2008-3#1)(2010-5#1)(2011-1#1)
briefly discuss##11##2##(1993-1#1)(1994-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
briefly discussed##19##2##(1990-9#1)(1992-10#1)(1992-6#1)(1993-8#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2009-3#1)(2009-9#1)
briefly discusses the##3##3##(1990-2#1)(1997-2#1)(2008-12#1)
briefly discusses##5##2##(1990-2#1)(1997-2#1)(2007-12#1)(2008-12#1)(2013-8#1)
briefly illustrate##2##2##(2008-11#1)(2008-7#1)
briefly mentioned##2##2##(1990-8#1)(2008-10#1)
briefly outlines the##2##3##(2008-3#1)(2008-5#1)
briefly outlines##4##2##(1995-8#1)(2008-3#1)(2008-5#1)(2009-11#1)
briefly presented##4##2##(1995-8#1)(1996-3#1)(2008-3#1)(2013-1#1)
briefly review the##3##3##(2008-5#1)(2008-7#1)(2013-2#1)
briefly review##6##2##(1996-9#1)(2008-5#1)(2008-7#2)(2010-3#1)(2013-2#1)
briefly reviewed##8##2##(1991-12#1)(1996-11#1)(1996-7#1)(1997-8#1)(2008-11#1)(2008-2#1)(2010-8#1)(2013-8#1)
briefly reviews the##5##3##(1995-6#1)(1997-2#1)(2008-9#1)(2009-12#1)(2013-1#1)
briefly reviews##6##2##(1995-6#1)(1997-2#1)(2008-12#1)(2008-9#1)(2009-12#1)(2013-1#1)
briefly summarize##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
briefly the history of the##2##5##(1997-1#1)(2007-10#1)
briefly the##5##2##(1997-1#1)(2007-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
briefly##168##1##(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-8#1)(2006-12#1)(2007-10#2)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#17)(2008-11#11)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-2#1)(2013-8#4)
bright and dark##4##3##(1991-5#2)(2007-12#2)
bright and long-lasting phosphorescence##3##4##(2008-3#3)
bright and##9##2##(1991-5#3)(2007-12#2)(2008-10#1)(2008-3#3)
bright field##2##2##(2008-3#2)
bright future##4##2##(1992-11#1)(2006-10#1)(2008-12#1)(2011-7#1)
bright light##8##2##(1997-6#3)(2008-2#1)(2008-3#1)(2013-1#3)
bright photovoltaic spatial##2##3##(2007-12#2)
bright red##2##2##(2008-11#1)(2013-1#1)
bright signal##3##2##(1997-8#2)(2008-8#1)
bright spot##4##2##(2008-3#3)(2010-12#1)
bright##75##1##(1990-2#1)(1991-5#4)(1992-11#1)(1994-12#1)(1995-2#1)(1997-6#3)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#13)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-8#2)(2011-7#1)(2013-1#6)
bright-field##3##1##(2008-2#1)(2008-9#1)(2011-2#1)
brighter and##2##2##(2008-10#1)(2008-5#1)
brighter##3##1##(2008-10#1)(2008-3#1)(2008-5#1)
brightest##3##1##(2007-12#1)(2008-10#1)(2008-4#1)
brightfield##4##1##(2008-4#2)(2008-9#2)
brightly illuminated##2##2##(2008-8#2)
brightly##4##1##(1992-11#1)(2008-1#1)(2008-8#2)
brightness of the##2##3##(2008-3#1)(2011-2#1)
brightness of##4##2##(2007-12#1)(2008-3#2)(2011-2#1)
brightness on##2##2##(2007-10#1)(2008-2#1)
brightness##26##1##(1995-2#1)(1995-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#6)(2009-2#2)(2011-2#1)(2013-8#4)
brightnesses##2##1##(1995-6#1)(2010-4#1)
brilliant blue##6##2##(2008-1#1)(2008-10#2)(2008-4#1)(2009-8#2)
brilliant##11##1##(1995-3#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-8#2)(2010-8#1)
brimonidine##3##1##(1995-12#3)
brine shrimp nauplius##3##3##(2010-2#3)
brine shrimp##10##2##(1994-8#1)(2007-12#2)(2008-9#2)(2010-2#5)
brine##13##1##(1994-8#1)(2007-12#2)(2008-10#2)(2008-9#2)(2010-2#5)(2010-4#1)
bring a##5##2##(1992-1#1)(1996-3#1)(2008-10#1)(2010-8#1)(2011-1#1)
bring about a##3##3##(1990-2#1)(1994-8#1)(2012-1#1)
bring about change##2##3##(1992-3#1)(2008-11#1)
bring about##23##2##(1990-11#1)(1990-2#1)(1991-8#1)(1992-3#1)(1994-8#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-5#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
bring forth##2##2##(2008-3#1)(2012-3#1)
bring further##3##2##(1990-12#1)(1991-6#1)(2013-8#1)
bring in##3##2##(1992-12#1)(1996-3#1)(2008-10#1)
bring it##2##2##(1992-1#1)(2008-5#1)
bring new##2##2##(2008-3#1)(2010-2#1)
bring specificity##2##2##(2008-11#1)(2011-2#1)
bring the##14##2##(1990-8#2)(1992-1#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
bring this##3##2##(2007-7#1)(2008-4#1)(2008-9#1)
bring to##5##2##(1995-3#1)(2007-8#1)(2008-12#2)(2009-5#1)
bring together##7##2##(1993-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#2)
bring##110##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#3)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1997-3#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#9)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-5#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#3)
bringing about##2##2##(2007-11#1)(2009-7#1)
bringing together the##2##3##(1996-4#1)(2007-11#1)
bringing together##6##2##(1995-5#1)(1996-4#1)(2007-11#1)(2008-4#1)(2010-12#1)(2010-7#1)
bringing##29##1##(1991-3#1)(1993-1#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#2)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
brings about a##3##3##(1990-5#2)(2008-10#1)
brings about##7##2##(1990-5#2)(1990-6#1)(1994-6#1)(1996-6#1)(2007-6#1)(2008-10#1)
brings into##2##2##(1995-3#1)(2009-4#1)
brings out##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
brings the##7##2##(1992-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-2#1)(2013-1#1)
brings to the##2##3##(1995-2#1)(2008-2#1)
brings to##6##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#2)
brings together the##2##3##(2008-9#1)(2012-3#1)
brings together##4##2##(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
brings##43##1##(1990-5#2)(1990-6#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#4)(2009-4#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
brisk##3##1##(1991-12#1)(2010-12#1)(2013-8#1)
bristle pattern##3##2##(2009-5#3)
bristle##4##1##(2008-10#1)(2009-5#3)
bristol##2##1##(2008-11#1)(2013-1#1)
british columbia##3##2##(2009-3#2)(2013-1#1)
british##4##1##(2007-2#1)(2009-3#2)(2013-1#1)
brittle stars##2##2##(2013-8#2)
brittle##14##1##(1991-12#2)(1996-4#2)(2009-7#2)(2010-10#1)(2012-2#3)(2013-8#4)
brix##2##1##(2008-10#2)
brlA##2##1##(2010-2#2)
broad VMT##2##2##(2013-1#2)
broad absorption##2##2##(2008-10#1)(2008-2#1)
broad acceptance##3##2##(1994-3#1)(1995-12#1)(2009-5#1)
broad and tunable control over##2##5##(2008-12#2)
broad and##8##2##(1995-5#1)(2008-10#2)(2008-12#2)(2011-1#1)(2012-3#2)
broad applicability##2##2##(2008-10#1)(2008-4#1)
broad applications in##2##3##(2008-9#1)(2012-2#1)
broad applications##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-2#1)
broad array of##6##3##(2008-5#1)(2008-6#1)(2009-5#2)(2012-2#1)(2013-7#1)
broad as well##2##3##(2008-2#1)(2008-3#1)
broad bandwidth##2##2##(2007-11#1)(2007-12#1)
broad base of##2##3##(2008-1#1)(2008-10#1)
broad bean plants##4##3##(2008-10#4)
broad bean stain##2##3##(1995-12#2)
broad bean##10##2##(1995-12#2)(2008-10#7)(2008-8#1)
broad categories##2##2##(1990-5#1)(1997-1#1)
broad clinical##2##2##(1995-1#1)(2008-7#1)
broad coverage##2##2##(2008-7#1)(2010-5#1)
broad definition##2##2##(1997-5#1)(2011-2#1)
broad dynamic range for##2##4##(2008-10#1)(2012-2#1)
broad exposure##2##2##(2006-12#2)
broad field##3##2##(1994-12#1)(2007-7#1)(2008-11#1)
broad freedom of choice and access to uniformly available##2##9##(1995-1#2)
broad groups of##2##3##(2011-2#1)(2012-12#1)
broad guidelines##2##2##(1993-12#1)(1994-12#1)
broad host range of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
broad host range##9##3##(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
broad host##10##2##(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#2)
broad nasal##2##2##(1997-3#1)(2010-8#1)
broad neck##2##2##(1997-6#2)
broad pattern##2##2##(1996-4#1)(2008-8#1)
broad range of##71##3##(1993-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#17)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#2)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
broad range##79##2##(1993-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#20)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#6)(2008-9#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
broad research##2##2##(2008-10#1)(2008-9#1)
broad resistance##2##2##(2008-10#2)
broad signal##3##2##(1995-12#2)(2007-12#1)
broad spectral##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
broad spectrum and##2##3##(1991-8#1)(2008-10#1)
broad spectrum of activity##6##4##(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
broad spectrum of antibiotics##2##4##(2010-12#1)(2011-2#1)
broad spectrum of##31##3##(1991-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
broad spectrum##43##2##(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
broad subject##2##2##(1991-12#1)(2008-11#1)
broad substrate specificity##2##3##(2009-9#1)(2011-1#1)
broad substrate##3##2##(1997-7#1)(2009-9#1)(2011-1#1)
broad temperature##5##2##(1992-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
broad view of##3##3##(1992-3#1)(2008-12#1)(2008-9#1)
broad wavelength region##2##3##(2007-12#1)(2008-3#1)
broad wavelength##3##2##(2007-12#2)(2008-3#1)
broad##384##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#6)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-4#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#2)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#12)(2007-12#16)(2007-7#2)(2008-1#3)(2008-10#71)(2008-11#19)(2008-12#9)(2008-2#10)(2008-3#24)(2008-4#3)(2008-5#16)(2008-6#2)(2008-7#13)(2008-8#15)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#14)(2012-3#7)(2013-1#6)(2013-7#3)(2013-8#1)
broad-area diode##2##2##(2008-2#2)
broad-area laser##3##2##(2008-2#1)(2008-3#2)
broad-area semiconductor lasers##2##3##(2008-2#1)(2008-3#1)
broad-area semiconductor##4##2##(2008-2#2)(2008-3#2)
broad-area##10##1##(2008-2#5)(2008-3#5)
broad-bandwidth##2##1##(2007-11#2)
broad-based##4##1##(1994-1#1)(1994-3#1)(2008-1#1)(2012-3#1)
broad-host-range##2##1##(1990-5#1)(2008-10#1)
broad-range##4##1##(1996-8#1)(2007-12#1)(2008-7#1)(2011-2#1)
broad-scale##2##1##(2008-10#1)(2008-9#1)
broad-sense heritability##2##2##(2008-10#2)
broad-sense##3##1##(2008-10#3)
broad-spectrum activity##2##2##(2008-10#1)(2008-5#1)
broad-spectrum and##2##2##(2009-10#1)(2011-2#1)
broad-spectrum antibiotic##4##2##(2008-12#1)(2010-5#1)(2010-6#1)(2012-2#1)
broad-spectrum resistance##3##2##(2008-10#3)
broad-spectrum##21##1##(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
broad-stripe##3##1##(2007-12#3)
broadband absorbers##2##2##(2008-3#2)
broadband absorption##2##2##(2008-2#1)(2008-3#1)
broadband and##3##2##(2007-11#1)(2007-12#2)
broadband characteristics##2##2##(2007-12#1)(2008-2#1)
broadband coherent anti-Stokes##2##3##(2008-2#1)(2008-3#1)
broadband emission##3##2##(2007-12#1)(2008-3#2)
broadband infrared##2##2##(2008-2#1)(2008-3#1)
broadband light is##2##3##(2007-11#1)(2008-3#1)
broadband light##8##2##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#2)
broadband operation##2##2##(2008-3#2)
broadband optical##3##2##(2007-11#1)(2008-3#2)
broadband pulses##2##2##(2007-12#1)(2008-3#1)
broadband radiation##2##2##(2007-11#1)(2008-3#1)
broadband spectral region##2##3##(2008-3#2)
broadband tuning##3##2##(2007-12#1)(2008-2#2)
broadband##117##1##(2007-11#33)(2007-12#16)(2008-10#1)(2008-2#19)(2008-3#43)(2008-7#1)(2011-1#2)(2012-2#2)
broadcast##4##1##(1994-3#1)(1996-5#1)(2008-3#1)(2008-8#1)
broadcasting##6##1##(2007-12#1)(2008-2#1)(2008-3#3)(2009-9#1)
broaden the scope of##3##4##(1990-8#1)(1996-2#1)(2010-12#1)
broaden the##13##2##(1990-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2010-12#1)(2010-3#1)(2011-2#1)
broaden their##2##2##(2008-11#1)(2008-12#1)
broaden##24##1##(1990-8#1)(1994-9#1)(1995-1#1)(1995-5#2)(1996-2#2)(1996-6#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
broadened by##7##2##(1994-5#1)(2007-8#1)(2008-2#4)(2008-3#1)
broadened the##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
broadened to include##2##3##(2007-12#1)(2008-10#1)
broadened to##3##2##(2007-12#2)(2008-10#1)
broadened##25##1##(1994-5#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)
broadening and##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2008-7#1)
broadening caused by##2##3##(1990-12#1)(2007-12#1)
broadening coefficients##2##2##(2008-2#2)
broadening in the##2##3##(2007-12#1)(2008-10#1)
broadening in##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
broadening is##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
broadening of the##12##3##(1991-12#1)(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#4)
broadening of##21##2##(1991-12#1)(1994-5#1)(2007-11#5)(2007-12#3)(2008-2#3)(2008-3#7)(2012-12#1)
broadening provides##2##2##(1994-5#1)(2007-11#1)
broadening the##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
broadening##74##1##(1990-12#1)(1991-12#2)(1992-8#1)(1994-2#1)(1994-5#3)(1995-1#1)(1995-2#2)(1997-6#1)(2007-11#14)(2007-12#9)(2008-10#3)(2008-11#1)(2008-2#18)(2008-3#15)(2008-7#1)(2012-12#1)
broadens the distribution of##2##4##(1991-12#1)(2008-6#1)
broadens the##4##2##(1991-12#1)(2007-11#1)(2008-3#1)(2008-6#1)
broadens##9##1##(1991-12#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2012-2#1)
broader and##2##2##(1994-2#1)(2011-2#1)
broader application##2##2##(2007-12#1)(2008-3#1)
broader community##3##2##(1993-1#1)(1997-2#1)(2013-1#1)
broader context of##4##3##(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)
broader context##13##2##(1993-2#1)(1996-8#4)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)
broader perspective##2##2##(1997-3#1)(2009-6#1)
broader public##4##2##(1993-1#1)(2008-1#1)(2010-12#1)(2011-2#1)
broader range of##3##3##(1992-12#1)(2008-8#1)(2009-5#1)
broader range##4##2##(1992-12#1)(2008-10#1)(2008-8#1)(2009-5#1)
broader spectrum of##7##3##(1993-2#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)
broader spectrum##8##2##(1993-2#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)(2013-8#1)
broader than##2##2##(2007-11#1)(2009-5#1)
broader tuning##2##2##(2008-3#2)
broader##106##1##(1992-10#1)(1992-12#1)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-3#2)(1996-8#4)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
broadest##5##1##(2007-11#1)(2008-10#3)(2008-8#1)
broadly and##2##2##(1995-3#1)(2012-12#1)
broadly applicable to##3##3##(2008-3#1)(2008-9#2)
broadly applicable##7##2##(2008-11#1)(2008-3#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-4#1)
broadly applied##2##2##(1993-2#1)(2008-10#1)
broadly as##2##2##(2008-11#1)(2008-9#1)
broadly defined species##2##3##(2008-10#2)
broadly defined##4##2##(2008-1#1)(2008-10#2)(2008-12#1)
broadly divided##3##2##(2007-7#1)(2010-9#1)(2013-1#1)
broadly tunable##6##2##(2007-12#3)(2008-3#3)
broadly used##2##2##(2011-1#1)(2011-2#1)
broadly##60##1##(1991-9#1)(1993-2#1)(1995-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-12#3)(2012-3#1)(2013-1#3)
broccoli head##3##2##(2008-10#3)
broccoli or grass##2##3##(2008-10#2)
broccoli residue##5##2##(2008-10#5)
broccoli residues##2##2##(2008-10#2)
broccoli roots##2##2##(2008-10#2)
broccoli treatments##2##2##(2008-10#2)
broccoli##30##1##(1991-3#1)(2008-10#28)(2008-12#1)
brochures##3##1##(1992-11#1)(1993-2#1)(2011-2#1)
broiler and##3##2##(2012-1#3)
broiler ascites##2##2##(1997-3#1)(1997-6#1)
broiler breeder##2##2##(1995-9#1)(1997-3#1)
broiler chickens##9##2##(1997-3#2)(1997-6#2)(2007-6#3)(2008-10#1)(2008-5#1)
broiler chicks were##3##3##(1997-3#1)(1997-6#1)(2010-4#1)
broiler chicks##13##2##(1991-9#1)(1997-3#1)(1997-6#1)(2008-12#7)(2010-4#3)
broiler house##2##2##(2011-2#2)
broiler houses##2##2##(2011-2#2)
broiler##45##1##(1991-9#1)(1995-9#1)(1997-3#11)(1997-6#5)(2007-6#4)(2008-10#1)(2008-12#8)(2008-5#2)(2010-4#3)(2011-2#5)(2012-1#4)
broilers##22##1##(1991-11#1)(1995-9#1)(1997-3#14)(1997-6#2)(2008-5#2)(2010-4#2)
broke down##5##2##(1994-1#1)(2008-10#2)(2008-5#1)(2009-5#1)
broke out##2##2##(1992-6#1)(1993-3#1)
broke the##2##2##(1996-3#1)(2008-10#1)
broke##12##1##(1992-6#1)(1993-3#1)(1994-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-5#1)(2009-5#1)(2013-1#1)
broken by##2##2##(2008-4#1)(2012-2#1)
broken down##3##2##(1995-3#1)(1997-3#1)(2011-2#1)
broken fringes##2##2##(2008-2#2)
broken up##2##2##(2008-4#1)(2010-5#1)
broken##39##1##(1990-10#1)(1990-9#1)(1995-3#1)(1996-11#1)(1997-3#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
bromate and##7##2##(2008-10#6)(2008-9#1)
bromate as##3##2##(2008-10#2)(2008-9#1)
bromate by##2##2##(2008-10#1)(2008-9#1)
bromate concentrations##2##2##(2008-10#2)
bromate in##9##2##(2008-10#4)(2008-9#4)(2010-5#1)
bromate ion##3##2##(2008-10#1)(2010-5#2)
bromate is##2##2##(2008-10#1)(2008-9#1)
bromate was##2##2##(2008-10#1)(2008-9#1)
bromate##56##1##(2008-10#34)(2008-9#18)(2010-5#4)
bromate)##2##1##(2008-10#2)
bromazepam##5##1##(1990-8#2)(2008-10#3)
brome streak mosaic virus##2##4##(2008-10#2)
brome##4##1##(2008-10#3)(2008-12#1)
bromelain##8##1##(1990-5#2)(1992-3#1)(2013-1#5)
bromhexine##4##1##(2008-10#3)(2009-7#1)
bromi populations##4##2##(2008-10#4)
bromi##12##1##(2008-10#12)
bromide (CPB)##4##2##(2008-10#4)
bromide (CTAB)##14##2##(2008-10#12)(2008-11#2)
bromide (CTMAB)##3##2##(2008-10#3)
bromide (EB) and##2##3##(2008-10#2)
bromide (TBAB) and##2##3##(2008-10#2)
bromide (TTAB)##2##2##(1997-2#1)(2008-10#1)
bromide adsorbent##2##2##(2008-10#2)
bromide and##16##2##(1992-11#1)(1994-12#1)(1994-5#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)
bromide as##3##2##(2008-10#3)
bromide by##3##2##(2008-10#3)
bromide for##2##2##(2008-10#1)(2010-5#1)
bromide in the##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
bromide in##13##2##(1990-12#1)(1995-3#1)(2008-10#10)(2008-9#1)
bromide intercalation##2##2##(1994-5#2)
bromide ion in a developer was##2##6##(2008-10#2)
bromide ion in a developer##6##5##(2008-10#6)
bromide ion in##8##3##(2008-10#8)
bromide ion##11##2##(2008-10#11)
bromide ion-selective electrode detector##2##4##(2008-10#2)
bromide ion-selective##3##2##(2008-10#3)
bromide ions##7##2##(2008-10#7)
bromide is##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
bromide on the##4##3##(1990-2#1)(2008-10#2)(2008-11#1)
bromide on##5##2##(1990-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
bromide or##2##2##(2008-10#2)
bromide selective##2##2##(2008-10#2)
bromide solution##2##2##(2008-10#2)
bromide staining##2##2##(1993-12#1)(2008-9#1)
bromide was##5##2##(1992-12#1)(2008-10#4)
bromide with##2##2##(2008-10#1)(2008-4#1)
bromide##230##1##(1990-12#2)(1990-2#3)(1990-5#3)(1990-7#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#6)(1994-9#2)(1995-3#2)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-8#1)(2008-10#156)(2008-11#8)(2008-2#3)(2008-4#5)(2008-7#1)(2008-9#7)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#3)
bromide)##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)
bromide-naphthalene##2##1##(2008-10#2)
bromides##9##1##(2007-11#1)(2008-10#3)(2008-5#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)
brominated##3##1##(2008-10#2)(2008-9#1)
bromination of##3##2##(2008-10#1)(2010-2#1)(2010-5#1)
bromination##9##1##(2008-10#5)(2010-2#2)(2010-5#2)
bromine treatment gives##2##3##(2008-10#2)
bromine##21##1##(1991-12#1)(1991-3#1)(1996-5#3)(2008-10#13)(2008-2#1)(2010-2#2)
bromo##2##1##(2008-10#1)(2012-2#1)
bromoacetate##4##1##(1996-5#1)(2008-10#2)(2010-8#1)
bromoalcohols##3##1##(2008-10#3)
bromoalkanes##2##1##(2008-10#2)
bromobenzene##5##1##(1992-3#5)
bromocresol green##9##2##(2008-10#9)
bromocresol orange##2##2##(2008-10#2)
bromocresol##11##1##(2008-10#11)
bromocriptine##10##1##(1991-1#2)(1993-2#1)(1993-5#3)(1994-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
bromodeoxyuridine##11##1##(1993-11#1)(1994-10#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-6#1)(2009-12#1)
bromodichloromethane in drinking water##2##4##(2008-9#2)
bromodichloromethane in##3##2##(2008-9#3)
bromodichloromethane##9##1##(2008-10#1)(2008-9#8)
bromodomains##2##1##(1995-8#2)
bromoethane##2##1##(2008-10#2)
bromoform##2##1##(2008-10#2)
bromophenols in fish##3##3##(2008-10#3)
bromophenols in##4##2##(2008-10#4)
bromophenols##7##1##(2008-10#7)
bromopropylate##3##1##(2008-10#3)
bromopyrogallol red##2##2##(2008-10#2)
bromouridine##2##1##(2008-9#2)
bromovirus##2##1##(2008-10#2)
bronchi and##2##2##(2010-8#1)(2012-3#1)
bronchi##8##1##(1995-12#1)(2007-8#1)(2008-3#1)(2010-8#3)(2012-3#1)(2013-1#1)
bronchial and##3##2##(1995-12#1)(2007-8#1)(2008-7#1)
bronchial arteries in##3##3##(1992-9#1)(2010-8#2)
bronchial arteries##5##2##(1992-9#1)(2010-8#4)
bronchial artery embolization##3##3##(1992-9#2)(2012-3#1)
bronchial artery##4##2##(1992-9#2)(1997-1#1)(2012-3#1)
bronchial asthma and##3##3##(2008-1#2)(2008-7#1)
bronchial asthma##19##2##(1991-11#1)(1991-2#2)(1992-3#1)(1996-7#3)(2008-1#3)(2008-12#1)(2008-4#1)(2008-7#3)(2010-2#2)(2010-6#1)(2011-2#1)
bronchial asthma]##3##2##(1991-11#1)(1996-7#1)(2013-8#1)
bronchial biopsy##2##2##(2008-1#1)(2013-1#1)
bronchial carcinoma##3##2##(1990-8#1)(2007-8#2)
bronchial circulation##3##2##(1992-3#1)(1997-1#2)
bronchial epithelium and##2##3##(2011-2#2)
bronchial hyperreactivity or##2##3##(1990-8#1)(2011-2#1)
bronchial hyperresponsiveness and##2##3##(2007-6#1)(2010-5#1)
bronchial hyperresponsiveness##4##2##(1992-3#2)(2007-6#1)(2010-5#1)
bronchial mucosa##2##2##(1990-9#1)(2008-6#1)
bronchial obstruction and hyperresponsiveness##2##4##(1992-2#2)
bronchial obstruction episodes##2##3##(2008-1#2)
bronchial obstruction##6##2##(1992-2#2)(2008-1#2)(2008-7#1)(2013-1#1)
bronchial secretions##2##2##(1990-9#1)(2008-5#1)
bronchial tissue##2##2##(1992-2#1)(2008-3#1)
bronchial tree##5##2##(1994-9#1)(1995-12#2)(1996-1#1)(1997-1#1)
bronchial vasculature##5##2##(1997-1#5)
bronchial washings##2##2##(1991-11#1)(2010-12#1)
bronchial##117##1##(1990-8#2)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-2#4)(1992-3#4)(1992-5#2)(1992-9#6)(1994-12#2)(1994-9#1)(1995-12#4)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-7#5)(1996-9#1)(1997-1#11)(2007-6#1)(2007-8#9)(2008-1#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-7#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#9)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
bronchiectasis in##2##2##(2007-8#1)(2008-1#1)
bronchiectasis##12##1##(1991-3#1)(1994-12#1)(1997-3#1)(2007-8#3)(2008-1#2)(2008-3#1)(2011-3#1)(2013-1#2)
bronchiolar##7##1##(1990-7#1)(1995-12#1)(2007-10#1)(2008-1#1)(2013-1#3)
bronchioles##2##1##(1995-8#1)(1997-1#1)
bronchiolitis obliterans organizing##3##3##(2008-1#1)(2012-12#2)
bronchiolitis obliterans syndrome (BOS)##2##4##(2011-3#1)(2012-2#1)
bronchiolitis obliterans syndrome##4##3##(2011-3#3)(2012-2#1)
bronchiolitis obliterans##10##2##(2008-1#2)(2011-3#3)(2012-12#2)(2012-2#1)(2013-1#2)
bronchiolitis##18##1##(1994-6#2)(2008-1#2)(2010-12#1)(2010-5#3)(2011-3#4)(2012-12#2)(2012-2#1)(2013-1#3)
bronchiolo-alveolar cell carcinoma##2##3##(2008-1#2)
bronchiseptica##2##1##(2013-8#2)
bronchitis and##6##2##(1992-9#1)(1996-8#1)(2007-12#1)(2008-7#2)(2013-1#1)
bronchitis is##3##2##(1991-4#3)
bronchitis virus##21##2##(1996-11#1)(1997-3#3)(1997-6#5)(2007-6#2)(2008-5#10)
bronchitis##60##1##(1990-2#2)(1991-11#3)(1991-4#5)(1991-9#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-8#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-6#5)(2007-12#1)(2007-6#2)(2008-4#1)(2008-5#12)(2008-7#3)(2009-5#1)(2011-1#2)(2013-1#3)(2013-8#2)
bronchoalveolar lavage (BAL)##4##3##(1996-9#1)(2007-8#1)(2008-12#1)(2011-2#1)
bronchoalveolar lavage fluid (BALF)##2##4##(1992-11#1)(1994-8#1)
bronchoalveolar lavage fluid in##3##4##(1991-12#1)(2008-7#1)(2012-2#1)
bronchoalveolar lavage fluid##14##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#4)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
bronchoalveolar lavage##26##2##(1990-2#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-3#5)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-9#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
bronchoalveolar##28##1##(1990-2#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-3#5)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-9#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
bronchoconstriction (ID50 =##2##3##(1997-7#2)
bronchoconstriction and airway microvascular leakage in##2##6##(1992-3#2)
bronchoconstriction and airway microvascular leakage##3##5##(1992-3#3)
bronchoconstriction and##6##2##(1992-3#4)(1997-7#1)(2010-1#1)
bronchoconstriction in##3##2##(1992-3#1)(1994-11#2)
bronchoconstriction##20##1##(1990-5#1)(1992-3#7)(1994-11#3)(1996-3#2)(1997-7#4)(2010-1#3)
bronchodilation and##2##2##(1992-2#1)(2008-1#1)
bronchodilation##5##1##(1992-2#1)(1994-11#1)(2008-1#1)(2010-5#1)(2011-3#1)
bronchodilator response##4##2##(1994-11#1)(1997-1#1)(2011-2#2)
bronchodilator use##2##2##(2010-1#1)(2012-2#1)
bronchodilator##20##1##(1992-2#1)(1992-3#1)(1994-11#2)(1996-12#2)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#8)(2012-2#1)
bronchodilators and##2##2##(1997-1#1)(2008-7#1)
bronchodilators##5##1##(1996-11#1)(1997-1#2)(2008-7#1)(2011-2#1)
bronchoesophageal fistula##2##2##(2012-3#2)
bronchoesophageal##3##1##(1997-1#1)(2012-3#2)
bronchogenic carcinoma##7##2##(2007-7#3)(2007-8#2)(2010-5#1)(2011-2#1)
bronchogenic cyst##5##2##(2007-8#4)(2008-5#1)
bronchogenic cysts##2##2##(2007-8#2)
bronchogenic##15##1##(2007-7#3)(2007-8#8)(2008-5#1)(2010-5#1)(2011-2#1)(2011-3#1)
bronchomalacia##2##1##(2007-8#2)
bronchopleural fistula##6##2##(1995-11#1)(2007-8#3)(2012-2#2)
bronchopleural fistulas after##2##3##(1995-11#2)
bronchopleural fistulas##4##2##(1995-11#2)(2007-8#2)
bronchopleural##11##1##(1995-11#3)(2007-8#5)(2012-2#3)
bronchopneumonia##6##1##(1991-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
bronchopulmonary aspergillosis##3##2##(1994-3#1)(2010-5#2)
bronchopulmonary dysplasia##5##2##(1990-11#1)(2010-5#2)(2012-3#1)(2013-1#1)
bronchopulmonary##12##1##(1990-11#1)(1990-9#1)(1992-3#1)(1994-3#1)(2008-11#1)(2010-5#4)(2012-3#1)(2013-1#2)
bronchoscope##3##1##(1992-3#1)(2007-8#1)(2010-8#1)
bronchoscopic interventions##2##2##(2010-8#1)(2013-1#1)
bronchoscopic##13##1##(1992-5#1)(1992-8#1)(2007-8#3)(2010-2#1)(2010-8#4)(2013-1#3)
bronchoscopy room##2##2##(2010-8#2)
bronchoscopy##23##1##(1990-3#1)(1992-5#1)(1994-12#1)(1994-2#2)(2007-8#3)(2008-6#1)(2008-7#2)(2010-10#2)(2010-2#1)(2010-8#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
bronchoscopy)##2##1##(2007-12#1)(2013-1#1)
bronchospasm with AP##2##3##(1996-12#2)
bronchospasm##11##1##(1991-9#1)(1992-5#1)(1996-12#4)(2006-10#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-7#1)
bronchus##16##1##(1990-12#1)(1990-8#1)(1995-11#1)(1997-1#1)(2007-8#4)(2008-6#1)(2010-2#1)(2010-8#3)(2011-2#1)(2013-1#2)
bronze##4##1##(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
brood adoption##2##2##(2008-9#2)
brood amalgamation##3##2##(2008-9#3)
brood cells##3##2##(2008-6#3)
brood desertion and##2##3##(2008-9#2)
brood desertion##3##2##(2008-9#3)
brood food proteins##3##3##(2008-6#3)
brood food##4##2##(2008-6#4)
brood parasitic##2##2##(2010-8#2)
brood parasitism##8##2##(2008-8#4)(2008-9#2)(2010-8#2)
brood size##3##2##(2008-8#1)(2012-12#2)
brood##47##1##(2008-12#1)(2008-6#10)(2008-8#9)(2008-9#17)(2010-8#5)(2012-12#5)
brood)##2##1##(2008-6#1)(2012-12#1)
brooding##2##1##(1991-6#1)(2008-5#1)
broods##8##1##(2008-9#8)
broom device##2##2##(2009-6#2)
broom##6##1##(2008-10#4)(2009-6#2)
brooms at##2##2##(2008-10#2)
brooms##9##1##(2008-10#9)
broth and##2##2##(2008-9#1)(2012-2#1)
broth containing##3##2##(1991-8#1)(2008-10#2)
broth culture of##2##3##(2007-6#1)(2008-10#1)
broth microdilution##4##2##(2008-12#2)(2008-5#1)(2013-1#1)
broth of the##2##3##(2008-12#1)(2009-6#1)
broth of##5##2##(2008-11#2)(2008-12#1)(2009-6#1)(2013-1#1)
broth plus 1% casamino acids##2##5##(2008-10#2)
broth##50##1##(1991-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#2)(2013-1#3)
brothels##3##1##(1990-3#1)(2010-8#1)(2011-2#1)
brother and##4##2##(1994-2#1)(1996-6#1)(2007-7#2)
brother of the##2##3##(1997-3#1)(2007-7#1)
brother was##2##2##(1994-11#1)(2008-10#1)
brother##16##1##(1990-9#1)(1993-6#1)(1994-11#1)(1994-2#2)(1996-6#1)(1997-3#2)(2007-7#3)(2008-10#2)(2008-7#1)(2011-2#2)
brothers and##2##2##(1993-6#1)(2010-1#1)
brothers with##2##2##(1996-6#1)(2012-12#1)
brothers##15##1##(1993-6#1)(1996-6#1)(2008-10#1)(2008-12#2)(2009-5#3)(2010-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
broths##4##1##(1991-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
brought about a significant##2##4##(1991-12#1)(2012-12#1)
brought about a##6##3##(1991-12#2)(1991-4#1)(2007-11#1)(2008-5#1)(2012-12#1)
brought about an##2##3##(1992-3#1)(2008-11#1)
brought about by the##7##4##(1990-2#1)(1990-8#1)(1993-9#1)(1996-5#1)(2008-2#1)(2008-7#2)
brought about by##24##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-5#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-5#2)(2010-4#1)(2011-2#1)(2012-12#1)
brought about the##2##3##(2008-10#1)(2008-9#1)
brought about##37##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-4#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-1#1)(1995-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#2)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
brought by##5##2##(1997-5#1)(2008-10#2)(2008-4#1)(2010-12#1)
brought down##2##2##(1994-6#1)(2008-9#1)
brought from##2##2##(2008-10#1)(2008-7#1)
brought in##4##2##(2008-10#3)(2008-11#1)
brought into contact with##4##4##(2008-3#1)(2008-7#1)(2009-5#2)
brought into##8##2##(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#2)(2013-8#1)
brought new##2##2##(2008-10#1)(2008-8#1)
brought on by##3##3##(1993-3#1)(1995-2#1)(1996-3#1)
brought on##4##2##(1993-3#1)(1995-2#1)(1996-3#1)(2011-1#1)
brought out in##2##3##(2008-10#2)
brought the##7##2##(1990-12#1)(1992-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)
brought to light##3##3##(1994-6#1)(2008-10#1)(2008-8#1)
brought to the hospital##2##4##(1991-11#1)(2009-3#1)
brought to the##10##3##(1991-11#1)(1991-3#1)(1992-6#1)(1995-4#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#2)(2013-8#1)
brought to##23##2##(1991-11#1)(1991-3#2)(1992-1#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-3#1)(2010-12#2)(2010-7#1)(2012-8#1)(2013-8#1)
brought together##11##2##(1994-2#1)(1996-1#1)(1997-3#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-9#1)
brought up by##2##3##(1991-6#1)(2008-9#1)
brought up to##2##3##(2011-2#1)(2013-7#1)
brought up##5##2##(1991-6#1)(2008-9#1)(2011-2#2)(2013-7#1)
brought##141##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-3#4)(1996-5#2)(1997-2#2)(1997-3#1)(1997-5#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#4)(2010-12#3)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2011-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-7#1)(2013-8#2)
brow##3##1##(2010-8#1)(2012-12#2)
brown adipose tissue and##2##4##(1990-12#1)(2008-1#1)
brown adipose tissue##8##3##(1990-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#2)(2013-1#2)
brown alga##6##2##(2008-10#2)(2008-11#2)(2008-12#2)
brown algae##3##2##(1990-7#1)(2008-11#1)(2012-2#1)
brown algal##2##2##(2009-8#2)
brown fat##2##2##(2007-8#1)(2008-4#1)
brown hare##3##2##(2013-1#3)
brown necrotic##2##2##(2008-10#2)
brown pigment production##2##3##(2008-10#2)
brown plant-hoppers##2##2##(2008-10#2)
brown rats##3##2##(2008-12#3)
brown rice##2##2##(2013-1#2)
brown rot in##5##3##(2008-10#5)
brown rot incidence##3##3##(2008-10#3)
brown rot infections in##2##4##(2008-10#2)
brown rot infections##3##3##(2008-10#3)
brown rot of##4##3##(2008-10#4)
brown rot##33##2##(2008-10#33)
brown spot lesions##4##3##(2008-10#4)
brown spot of##3##3##(2008-10#3)
brown spot##13##2##(2008-10#13)
brown stem rot of soybean##3##5##(2008-10#3)
brown stem rot resistance##2##4##(2008-10#2)
brown stem rot##17##3##(2008-10#17)
brown stem rot-resistant##2##3##(2008-10#2)
brown stem##20##2##(2008-10#20)
brown to##4##2##(2008-10#4)
brown##152##1##(1990-11#1)(1990-12#1)(1990-7#1)(1995-3#1)(1997-6#1)(2006-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#99)(2008-11#4)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#1)
brown-pigmented##2##1##(2008-10#1)(2011-2#1)
brownish##5##1##(2008-5#2)(2010-6#1)(2011-2#1)(2012-2#1)
browse##2##1##(2008-4#1)(2008-9#1)
browser##3##1##(2007-9#1)(2008-4#1)(2008-7#1)
browsing##2##1##(1997-3#1)(2008-4#1)
brucei and T##4##3##(1994-12#4)
brucei##14##1##(1993-9#2)(1994-12#4)(1995-11#1)(2009-7#4)(2010-2#1)(2011-2#2)
brucella##3##1##(1995-3#1)(1996-12#2)
brucellar##2##1##(2012-3#2)
brucellosis in##2##2##(1990-9#1)(2012-2#1)
brucellosis##10##1##(1990-9#1)(1991-3#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-2#2)(2012-2#3)
bruise##2##1##(2008-11#1)(2011-1#1)
bruises##5##1##(2008-11#1)(2008-7#1)(2010-7#2)(2013-7#1)
bruising##3##1##(2008-11#2)(2010-7#1)
brush border and##2##3##(2007-12#2)
brush border membrane vesicles##5##4##(1990-11#4)(1991-9#1)
brush border membrane##13##3##(1990-11#9)(1991-12#1)(1991-9#2)(2007-7#1)
brush border membranes of##2##4##(1992-3#1)(1993-6#1)
brush border membranes##5##3##(1990-11#2)(1992-3#2)(1993-6#1)
brush border##24##2##(1990-11#12)(1990-12#1)(1991-12#1)(1991-9#2)(1992-3#2)(1993-6#1)(2007-12#2)(2007-7#1)(2008-7#2)
brush cytology##4##2##(1996-6#1)(2008-11#1)(2008-6#1)(2011-2#1)
brush layer##2##2##(2009-5#2)
brush phase##3##2##(2008-10#3)
brush their##2##2##(1997-4#1)(2008-9#1)
brush##48##1##(1990-11#12)(1990-12#1)(1991-12#2)(1991-9#2)(1992-3#2)(1993-6#1)(1994-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#6)(2009-6#2)(2011-2#1)(2012-2#1)
brush-border membrane##6##2##(1992-6#2)(1994-6#1)(1994-8#1)(1995-11#1)(2006-12#1)
brush-border##9##1##(1991-5#1)(1992-2#1)(1992-6#2)(1994-6#1)(1994-8#1)(1995-11#1)(2006-12#1)(2013-1#1)
brush-modified##3##1##(2010-7#3)
brushed##2##1##(2008-10#1)(2008-9#1)
brushes##6##1##(2009-5#1)(2010-4#2)(2010-7#3)
brushing with##3##2##(2013-1#3)
brushing##14##1##(1997-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#5)
brut&quot##2##1##(2008-10#2)
brutal##2##1##(1996-3#1)(2011-2#1)
bruxism##2##1##(2010-6#2)
bryoniae and##3##2##(2008-10#3)
bryoniae##6##1##(2008-10#6)
bryostatin##2##1##(1992-9#2)
bryozoan##3##1##(2011-2#3)
bryozoans##4##1##(2008-9#2)(2011-2#2)
bs##2##1##(1994-6#1)(2012-12#1)
bubble and##2##2##(1995-2#1)(2007-12#1)
bubble fermenter##2##2##(2008-6#2)
bubble formation##2##2##(1994-3#1)(2008-10#1)
bubble is##3##2##(2008-11#3)
bubble packing##3##2##(2009-11#3)
bubble populations##2##2##(2008-2#2)
bubble size##2##2##(2008-2#1)(2008-3#1)
bubble surface##2##2##(1994-3#1)(2008-11#1)
bubble##50##1##(1993-5#1)(1994-12#1)(1994-3#7)(1995-2#2)(2007-12#3)(2008-10#4)(2008-11#13)(2008-2#4)(2008-3#2)(2008-6#4)(2008-7#3)(2009-11#4)(2010-3#1)(2011-2#1)
bubbles and##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
bubbles are##2##2##(2008-10#1)(2008-2#1)
bubbles in##5##2##(1994-3#1)(2008-2#1)(2008-7#1)(2009-11#1)(2012-2#1)
bubbles##31##1##(1994-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-2#6)(2008-3#1)(2008-7#1)(2009-11#5)(2012-2#2)(2013-1#1)
bubbling##2##1##(2008-10#2)
buccal cells##3##2##(2008-12#1)(2008-5#2)
buccal mucosa vulvovaginoplasty##2##3##(2008-10#2)
buccal mucosa##11##2##(1991-2#1)(1992-9#1)(1995-9#1)(2008-10#3)(2009-5#1)(2010-5#1)(2013-1#2)(2013-8#1)
buccal root##2##2##(2010-3#2)
buccal##30##1##(1991-2#1)(1992-9#1)(1995-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
buccoadhesive##2##1##(2010-5#2)
buccolingual##3##1##(2010-3#3)
bucket##3##1##(2008-10#2)(2008-3#1)
buckling of##2##2##(2008-7#1)(2008-9#1)
buckling##7##1##(1992-8#1)(2007-12#2)(2008-7#3)(2008-9#1)
bucks##3##1##(1991-2#1)(1995-3#1)(1995-9#1)
bud and##5##2##(1995-8#1)(2008-10#2)(2010-3#1)(2011-2#1)
bud at##3##2##(1990-5#1)(1992-8#1)(2008-10#1)
bud break##8##2##(2008-10#3)(2012-4#4)(2012-8#1)
bud burst##3##2##(2008-10#1)(2009-8#1)(2012-4#1)
bud development and##3##3##(2008-10#1)(2011-2#1)(2012-4#1)
bud development##7##2##(2008-10#2)(2008-8#1)(2009-8#2)(2011-2#1)(2012-4#1)
bud necrosis virus##3##3##(2008-10#3)
bud size##2##2##(2009-8#2)
bud##59##1##(1990-5#1)(1991-11#1)(1992-8#1)(1993-12#4)(1995-6#2)(1995-8#3)(1997-3#1)(2008-10#24)(2008-5#3)(2008-8#1)(2009-8#6)(2010-3#1)(2011-2#2)(2012-4#6)(2012-8#2)(2013-1#1)
budbreak##6##1##(2008-10#5)(2012-8#1)
budded cells##3##2##(1995-6#1)(1996-3#2)
budded virus##4##2##(1997-3#2)(2008-11#2)
budded##7##1##(1995-6#1)(1996-3#2)(1997-3#2)(2008-11#2)
budding and fission##2##3##(1995-6#1)(2009-8#1)
budding and##4##2##(1995-6#1)(1996-6#1)(2008-10#1)(2009-8#1)
budding of##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
budding yeast Saccharomyces cerevisiae##8##4##(1990-5#1)(1992-8#1)(1993-8#2)(1995-12#1)(1996-3#1)(1997-7#1)(2012-3#1)
budding yeast and##2##3##(1993-8#1)(1995-6#1)
budding yeast##26##2##(1990-5#1)(1992-8#1)(1993-8#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#2)(1996-6#3)(1997-7#1)(2008-11#1)(2008-2#4)(2008-8#1)(2008-9#3)(2012-3#2)
budding##53##1##(1990-5#1)(1992-8#1)(1993-8#3)(1995-12#1)(1995-2#2)(1995-6#2)(1996-3#2)(1996-6#5)(1997-1#4)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#2)
buddy##4##1##(2008-12#3)(2008-9#1)
budesonide##6##1##(1997-2#1)(2007-11#3)(2010-12#2)
budgerigars##4##1##(2012-2#4)
budget analysis##2##2##(2007-11#1)(2008-8#1)
budget and##3##2##(1990-12#1)(2008-6#1)(2012-12#1)
budget cuts##2##2##(1996-3#2)
budget deficit##2##2##(1994-3#1)(1995-6#1)
budget for##5##2##(1996-5#2)(2008-10#1)(2008-11#1)(2012-3#1)
budget in##2##2##(1993-1#1)(1993-3#1)
budget is##4##2##(1992-3#1)(1997-8#1)(2007-7#1)(2008-10#1)
budget of the peatland##2##4##(2008-8#2)
budget of the##3##3##(2008-2#1)(2008-8#2)
budget of##10##2##(1991-1#1)(1997-1#1)(2008-11#3)(2008-2#1)(2008-8#2)(2008-9#1)(2012-2#1)
budget strategies on the needs of the frail elderly##2##9##(1993-1#2)
budget was##2##2##(2008-10#1)(2008-7#1)
budget##86##1##(1990-12#1)(1990-4#1)(1991-1#4)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#3)(1993-1#3)(1993-2#1)(1993-3#4)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
budgetary##4##1##(1995-1#1)(1996-2#1)(1997-3#1)(2012-12#1)
budgeted##2##1##(1995-12#1)(1997-2#1)
budgeting and##2##2##(1994-2#1)(2012-12#1)
budgeting##23##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#2)(1993-1#3)(1993-2#2)(1993-3#1)(1994-1#2)(1994-2#5)(1996-12#1)(1996-2#1)(2008-11#1)(2008-9#1)(2012-12#1)
budgets and##3##2##(2008-5#1)(2012-12#1)(2012-3#1)
budgets for##2##2##(1994-12#1)(2008-3#1)
budgets in the##2##3##(1994-12#1)(2007-7#1)
budgets of##3##2##(1990-2#1)(2008-11#1)(2008-5#1)
budgets##36##1##(1990-2#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-3#1)(1994-1#2)(1994-12#3)(1995-1#3)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-11#6)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#2)(2012-3#1)(2013-8#1)
buds and##2##2##(1990-5#1)(2008-10#1)
buds of##5##2##(1992-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
buds to##2##2##(2012-8#1)(2013-1#1)
buds##37##1##(1990-5#1)(1992-8#1)(1993-12#1)(1995-6#1)(2008-10#15)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-8#1)(2013-1#7)
buffalo calves##2##2##(2008-5#2)
buffalo meat is more suitable for processing in##2##8##(2010-4#2)
buffalo meat##7##2##(2010-4#7)
buffalo##21##1##(1990-3#1)(2008-12#4)(2008-5#2)(2010-4#8)(2011-2#1)(2012-3#2)(2013-1#3)
buffaloes##4##1##(1991-8#1)(2008-5#1)(2010-4#1)(2013-1#1)
buffer (0##10##2##(1992-10#2)(1993-12#1)(2008-10#6)(2008-7#1)
buffer (1##2##2##(2008-10#2)
buffer (25##2##2##(2008-10#1)(2011-1#1)
buffer (5##2##2##(2008-10#2)
buffer (50mM##2##2##(2008-10#2)
buffer (pH 1##2##3##(2008-10#2)
buffer (pH 10##3##3##(1994-9#1)(2008-10#2)
buffer (pH 2##8##3##(1995-3#1)(1996-5#1)(2008-10#6)
buffer (pH 3##3##3##(2008-10#3)
buffer (pH 4##6##3##(2008-10#6)
buffer (pH 6##7##3##(2008-10#6)(2008-4#1)
buffer (pH 7##21##3##(1990-8#1)(1995-5#2)(1995-6#1)(1997-4#1)(2008-10#16)
buffer (pH 8##9##3##(1996-5#1)(1997-2#1)(2008-10#7)
buffer (pH 9##7##3##(1994-9#1)(2008-10#6)
buffer (pH##79##2##(1990-8#1)(1994-9#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#3)(1997-2#1)(1997-4#1)(2008-10#66)(2008-4#1)
buffer additive##2##2##(1996-5#1)(2008-10#1)
buffer against##2##2##(2008-8#1)(2013-1#1)
buffer and 0##3##3##(1992-10#1)(2008-10#2)
buffer and the##3##3##(2008-10#3)
buffer and water##2##3##(2008-10#1)(2008-6#1)
buffer and##28##2##(1992-10#1)(1992-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#19)(2008-11#1)(2008-6#2)(2008-9#1)
buffer as a##4##3##(2008-10#4)
buffer as##8##2##(2008-10#7)(2008-6#1)
buffer at pH 5##2##4##(2008-10#2)
buffer at pH 6##5##4##(2008-10#4)(2008-5#1)
buffer at pH 7##5##4##(2008-10#5)
buffer at pH 8##5##4##(2008-10#5)
buffer at pH##29##3##(1996-12#1)(2008-10#27)(2008-5#1)
buffer at##36##2##(1995-5#1)(1996-12#1)(2008-10#33)(2008-5#1)
buffer but##2##2##(1990-12#1)(2008-10#1)
buffer by##2##2##(2008-10#2)
buffer capacity##5##2##(2008-10#5)
buffer concentration##10##2##(2008-10#10)
buffer concentrations and##2##3##(2008-10#2)
buffer conditions##2##2##(1990-8#1)(2008-10#1)
buffer containing 0##5##3##(1990-12#1)(1995-6#1)(2008-10#3)
buffer containing##15##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-11#1)(1994-6#1)(1995-6#2)(1997-1#1)(2008-10#6)(2009-3#1)
buffer for##2##2##(1993-8#1)(2008-10#1)
buffer from##3##2##(2008-10#3)
buffer gas##3##2##(2007-12#2)(2008-3#1)
buffer in the##5##3##(2008-10#3)(2008-11#1)(2008-2#1)
buffer in##9##2##(1996-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)
buffer ionic strength##2##3##(1992-3#1)(1994-9#1)
buffer is##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-4#1)
buffer layer##3##2##(2008-3#3)
buffer media##6##2##(2008-10#6)
buffer medium (pH##2##3##(2008-10#2)
buffer medium##5##2##(2008-10#5)
buffer of pH 5##2##4##(2008-10#2)
buffer of pH 7##2##4##(2008-10#2)
buffer of pH##6##3##(1990-8#1)(2008-10#5)
buffer of##7##2##(1990-8#1)(2008-10#6)
buffer pH 4##3##3##(2008-10#3)
buffer pH 5##4##3##(2008-10#3)(2011-1#1)
buffer pH 9##3##3##(2008-10#3)
buffer pH##22##2##(1996-5#1)(2008-10#17)(2011-1#1)(2011-2#2)(2013-1#1)
buffer saline##4##2##(1992-3#1)(2008-10#3)
buffer salt##2##2##(1997-2#1)(2008-10#1)
buffer solution (pH 4##4##4##(2008-10#4)
buffer solution (pH 6##4##4##(2008-10#4)
buffer solution (pH##13##3##(2008-10#13)
buffer solution after##2##3##(2008-10#1)(2009-7#1)
buffer solution and##4##3##(2008-10#4)
buffer solution at pH##5##4##(2008-10#5)
buffer solution at##7##3##(1994-3#1)(2008-10#6)
buffer solution by##3##3##(2008-10#2)(2009-9#1)
buffer solution containing##6##3##(2008-10#6)
buffer solution of pH##2##4##(2008-10#2)
buffer solution of##3##3##(2008-10#3)
buffer solution the##2##3##(2007-12#1)(2008-10#1)
buffer solution used##3##3##(2008-10#3)
buffer solution was##4##3##(2008-10#4)
buffer solution##97##2##(1990-5#2)(1993-8#1)(1994-3#1)(2007-12#1)(2008-10#85)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2013-1#1)
buffer solution)##3##2##(2008-10#3)
buffer solutions (pH##2##3##(2008-10#2)
buffer solutions and in##2##4##(2008-10#1)(2008-8#1)
buffer solutions containing##2##3##(2008-10#1)(2008-8#1)
buffer solutions of##2##3##(1990-8#1)(2008-5#1)
buffer solutions##21##2##(1990-8#2)(2008-10#13)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)
buffer system of##2##3##(2008-4#1)(2013-1#1)
buffer system##8##2##(2008-10#4)(2008-2#1)(2008-4#1)(2013-1#2)
buffer systems##4##2##(1996-5#1)(2008-10#2)(2008-6#1)
buffer the effects of##2##4##(2010-4#1)(2012-12#1)
buffer the##3##2##(2008-2#1)(2010-4#1)(2012-12#1)
buffer to adjust##2##3##(2008-10#2)
buffer to the##2##3##(1992-10#1)(2008-10#1)
buffer to##5##2##(1992-10#1)(1994-3#1)(2008-10#3)
buffer used##2##2##(2008-10#2)
buffer was 6##2##3##(1997-2#1)(2008-10#1)
buffer was investigated##3##3##(2008-10#3)
buffer was used and the##2##5##(2008-10#2)
buffer was used and##3##4##(2008-10#2)(2008-11#1)
buffer was used##4##3##(2008-10#3)(2008-11#1)
buffer was##14##2##(1990-5#1)(1997-2#1)(2008-10#10)(2008-11#1)(2009-7#1)
buffer were studied##2##3##(2008-10#2)
buffer were##4##2##(1990-8#1)(1992-8#1)(2008-10#2)
buffer while##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
buffer with##8##2##(1994-12#1)(1994-9#1)(2008-10#5)(2008-7#1)
buffer zone##2##2##(2008-8#1)(2010-12#1)
buffer##686##1##(1990-11#3)(1990-12#6)(1990-2#1)(1990-5#4)(1990-8#10)(1991-5#2)(1992-10#4)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-5#1)(1993-8#2)(1994-12#2)(1994-3#4)(1994-6#1)(1994-9#7)(1995-12#1)(1995-3#1)(1995-5#4)(1995-6#5)(1995-8#3)(1996-12#1)(1996-5#13)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#1)(2007-12#7)(2008-10#483)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#12)(2008-5#3)(2008-6#6)(2008-7#3)(2008-8#6)(2008-9#7)(2009-10#4)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#7)
buffer)##8##1##(1990-12#1)(1992-12#1)(1997-7#1)(2008-10#3)(2010-3#1)(2012-12#1)
buffer-filled##2##1##(2008-10#1)(2008-2#1)
buffered at pH 4##2##4##(2008-10#2)
buffered at pH 5##2##4##(2008-10#2)
buffered at pH##6##3##(1996-2#1)(2008-10#5)
buffered at##7##2##(1996-2#1)(2008-10#6)
buffered medium at pH##2##4##(2008-10#2)
buffered medium##3##2##(2008-10#3)
buffered mobile##2##2##(2008-10#1)(2008-5#1)
buffered saline##9##2##(1994-11#2)(2008-10#5)(2009-11#1)(2009-9#1)
buffered solution##5##2##(1991-5#1)(2008-10#4)
buffered solutions##3##2##(1991-5#1)(2008-10#1)(2009-12#1)
buffered##51##1##(1991-5#2)(1994-11#2)(1996-2#2)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
buffering and##5##2##(2008-10#1)(2008-6#1)(2009-9#1)(2010-3#1)(2012-3#1)
buffering capacity of##2##3##(2008-10#1)(2011-2#1)
buffering capacity##4##2##(1995-2#1)(1996-8#1)(2008-10#1)(2011-2#1)
buffering of acidified samples##2##4##(2008-10#2)
buffering##20##1##(1992-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
buffers and the##2##3##(2008-10#1)(2008-9#1)
buffers and##6##2##(1993-11#1)(2008-10#3)(2008-5#1)(2008-9#1)
buffers at##2##2##(2008-10#2)
buffers of##3##2##(1993-3#1)(2008-10#2)
buffers with##2##2##(2008-10#1)(2011-2#1)
buffers##49##1##(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#28)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#3)(2013-8#1)
buffy coat##2##2##(2012-3#1)(2013-1#1)
bug feeding##3##2##(2011-2#3)
bug infestations##2##2##(2011-2#1)(2013-8#1)
bug##21##1##(2007-12#5)(2008-10#1)(2008-5#1)(2011-2#13)(2013-8#1)
bugs in##3##2##(2009-1#1)(2011-2#1)(2013-8#1)
bugs per ear##2##3##(2011-2#2)
bugs##14##1##(2007-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-2#4)(2013-8#5)
build a##25##2##(1993-12#1)(1994-2#2)(1995-12#2)(1996-3#2)(1997-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
build and##4##2##(1996-1#1)(2008-4#1)(2010-10#1)(2011-7#1)
build on the##2##3##(1996-3#1)(2008-12#1)
build on##6##2##(1996-3#1)(1997-2#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-4#1)
build the##8##2##(2008-10#3)(2008-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)
build up the##2##3##(2007-12#1)(2010-7#1)
build up##7##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2010-7#1)
build##93##1##(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#2)(1996-1#2)(1996-3#3)(1997-1#3)(1997-2#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-2#4)(2013-1#3)(2013-8#1)
build-up and##2##2##(1991-6#1)(2008-10#1)
build-up of carbonaceous residues inside the##2##6##(2008-10#2)
build-up of carbonaceous residues##3##4##(2008-10#3)
build-up of##4##2##(1992-8#1)(2008-10#3)
build-up##11##1##(1991-6#1)(1992-8#1)(1994-8#1)(2007-11#1)(2008-10#5)(2008-5#1)(2010-12#1)
building a##20##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)
building an##3##2##(1996-3#1)(1997-1#1)(2008-10#1)
building and##10##2##(1991-2#1)(1992-2#1)(1994-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
building block for##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
building block of##5##3##(1992-6#1)(1996-2#1)(2007-7#1)(2009-8#1)(2010-7#1)
building block##12##2##(1992-6#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-8#1)(2010-7#1)(2012-2#1)
building blocks and the##2##4##(2008-4#1)(2012-1#1)
building blocks for the##3##4##(2008-11#2)(2008-4#1)
building blocks for##12##3##(1996-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#2)(2011-1#1)(2012-2#1)
building blocks of##6##3##(1992-11#1)(1996-2#1)(2008-11#1)(2008-6#1)(2009-5#1)(2012-12#1)
building blocks##34##2##(1992-1#1)(1992-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#9)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
building capacity##2##2##(2012-2#2)
building consensus##2##2##(1991-3#1)(1994-2#1)
building core##2##2##(2008-3#2)
building in##6##2##(1991-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-5#1)(2010-10#1)
building maintenance workers##3##3##(1991-12#3)
building materials##4##2##(1991-12#2)(2008-10#2)
building models##2##2##(2007-11#1)(2013-8#1)
building of##4##2##(1995-1#1)(2009-7#2)(2013-1#1)
building on a##2##3##(1995-12#1)(2010-10#1)
building on the##2##3##(1992-12#1)(1993-3#1)
building on##8##2##(1992-12#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-5#1)(2010-10#1)(2012-12#1)(2013-1#1)
building process##2##2##(1996-12#1)(2012-3#1)
building relationships with##2##3##(1995-12#1)(2010-7#1)
building the##14##2##(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
building with##2##2##(2008-12#1)(2010-2#1)
building##211##1##(1991-12#11)(1991-2#3)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#5)(1997-3#4)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#12)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-7#3)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#7)(2013-8#4)
building-related##3##1##(1994-9#2)(2008-10#1)
buildings and##3##2##(1992-2#1)(2008-7#1)(2013-8#1)
buildings with asbestos-containing materials##2##4##(1991-12#2)
buildings##16##1##(1991-12#7)(1992-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#2)
builds a##4##2##(1992-1#1)(1993-5#1)(2008-1#1)(2008-5#1)
builds on##3##2##(1997-3#1)(2008-3#1)(2012-2#1)
builds upon the##2##3##(1997-1#1)(2008-4#1)
builds upon##5##2##(1997-1#1)(2008-12#1)(2008-4#2)(2009-9#1)
builds##17##1##(1992-1#1)(1993-5#1)(1994-6#1)(1997-1#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
buildup dynamics##2##2##(2007-12#1)(2008-2#1)
buildup of the##2##3##(2008-6#2)
buildup of##3##2##(1996-12#1)(2008-6#2)
buildup times##2##2##(2007-11#1)(2008-3#1)
buildup##17##1##(1992-12#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#2)(2008-8#1)(2012-12#1)
built a##15##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)
built and tested##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
built and##16##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#7)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
built around a##4##3##(2007-12#1)(2008-3#1)(2012-2#1)(2012-3#1)
built around##6##2##(1997-3#1)(2007-12#2)(2008-3#1)(2012-2#1)(2012-3#1)
built as##2##2##(2008-11#1)(2008-3#1)
built at##2##2##(2008-4#1)(2012-12#1)
built by##6##2##(1997-3#1)(2008-10#2)(2008-3#1)(2013-8#2)
built for the##3##3##(1994-12#1)(2008-11#1)(2008-5#1)
built for##9##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2011-1#1)
built from##5##2##(1994-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
built in the##4##3##(1996-3#1)(2007-11#1)(2008-5#1)(2009-7#1)
built in##7##2##(1992-2#1)(1996-3#1)(2007-11#1)(2008-5#1)(2009-7#1)(2010-4#1)(2012-3#1)
built into the##2##3##(1994-3#1)(2008-3#1)
built into##3##2##(1994-3#1)(1994-6#1)(2008-3#1)
built on##4##2##(1993-12#1)(2007-10#1)(2008-11#1)(2013-1#1)
built the##3##2##(1990-11#1)(2008-3#2)
built to##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
built up##6##2##(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
built upon##3##2##(1996-12#1)(1996-2#1)(2012-2#1)
built using##2##2##(2008-6#1)(2008-7#1)
built with a##2##3##(2007-11#1)(2008-3#1)
built with the##3##3##(2008-10#2)(2008-7#1)
built with##13##2##(2007-11#1)(2008-10#7)(2008-3#3)(2008-7#1)(2009-5#1)
built##150##1##(1990-11#1)(1990-3#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#39)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
built-in##11##1##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-4#2)(2010-8#1)(2012-2#1)
built-up##3##1##(2008-10#2)(2008-9#1)
bulb circuit##2##2##(2012-2#2)
bulb##44##1##(1990-11#1)(1990-7#3)(1992-8#2)(1993-3#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2009-12#7)(2012-2#4)(2013-1#5)
bulbar urethra##2##2##(2008-10#2)
bulbar##7##1##(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
bulbil production##2##2##(2009-5#2)
bulbil##3##1##(2009-5#3)
bulbocastanum and S##2##3##(2008-10#2)
bulbocastanum##3##1##(2008-10#3)
bulbs##7##1##(1993-3#1)(1994-2#1)(1996-5#2)(2008-10#2)(2008-7#1)
bulbus arteriosus##2##2##(2008-5#2)
bulgaricus OLL1073R-1##2##2##(2008-11#2)
bulgaricus##6##1##(1994-6#2)(1995-8#2)(2008-11#2)
bulge##5##1##(1994-8#1)(2008-2#1)(2008-5#3)
bulges##2##1##(2008-5#1)(2009-11#1)
bulging##4##1##(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)
bulgy morph tadpoles##2##3##(2012-12#2)
bulgy morph##4##2##(2012-12#4)
bulgy##6##1##(2012-12#6)
bulimia nervosa##6##2##(2007-7#4)(2008-6#1)(2011-2#1)
bulimia##12##1##(1991-1#1)(1993-12#1)(1997-7#1)(2007-7#7)(2008-6#1)(2011-2#1)
bulimic##2##1##(2007-7#2)
bulk acoustic wave (BAW) sensor##2##5##(2008-10#2)
bulk acoustic wave (BAW)##5##4##(2008-10#5)
bulk acoustic wave impedance biosensor##2##5##(2008-10#2)
bulk acoustic wave##16##3##(2008-10#16)
bulk acoustic##18##2##(2008-10#17)(2010-4#1)
bulk analysis##2##2##(1991-12#1)(2009-12#1)
bulk and surface##3##3##(1991-8#1)(2010-4#2)
bulk and##17##2##(1990-5#1)(1991-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-3#2)(2008-9#1)(2010-4#2)(2011-1#1)
bulk crystal##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
bulk culture##2##2##(2008-11#2)
bulk density and##2##3##(2008-12#2)
bulk density##10##2##(2008-12#6)(2011-1#2)(2013-7#2)
bulk drug and in##3##4##(2008-10#3)
bulk drug and its##3##4##(2008-10#3)
bulk drug and##9##3##(2008-10#7)(2010-5#1)(2011-1#1)
bulk drug##10##2##(2008-10#8)(2010-5#1)(2011-1#1)
bulk drugs##2##2##(2008-10#2)
bulk fluctuations##2##2##(2008-3#2)
bulk form##3##2##(2008-10#3)
bulk glass##4##2##(2007-12#2)(2008-3#2)
bulk glasses##2##2##(2007-12#2)
bulk insulating materials##2##3##(2013-8#2)
bulk liquid membrane##5##3##(2008-10#5)
bulk liquid##9##2##(2008-10#6)(2008-11#2)(2008-6#1)
bulk liquids##5##2##(2008-11#5)
bulk material##8##2##(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2012-2#1)
bulk materials and##2##3##(2007-12#1)(2010-5#1)
bulk materials##7##2##(2007-12#1)(2008-3#3)(2008-7#1)(2010-5#1)(2012-1#1)
bulk mating##3##2##(2008-10#3)
bulk media##4##2##(2007-11#1)(2007-12#3)
bulk milk somatic cell##2##4##(1996-3#1)(1996-8#1)
bulk milk##3##2##(1996-3#1)(1996-8#1)(2010-2#1)
bulk modified##2##2##(2008-10#2)
bulk of the##15##3##(1994-9#2)(1997-7#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#1)
bulk of##34##2##(1990-12#1)(1990-5#1)(1994-9#2)(1996-5#1)(1997-7#1)(2007-12#5)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-2#1)
bulk optical properties of##2##4##(2008-3#2)
bulk optical properties##4##3##(2008-3#4)
bulk optical##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)
bulk optode for the##2##4##(2008-10#2)
bulk optode##4##2##(2008-10#4)
bulk or surface##2##3##(2007-11#1)(2010-4#1)
bulk or##4##2##(2007-11#1)(2008-2#1)(2008-7#1)(2010-4#1)
bulk phase##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
bulk populations##2##2##(1994-6#2)
bulk quantities of##2##3##(2008-3#1)(2008-7#1)
bulk sample##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
bulk samples##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
bulk segregant analysis##2##3##(2008-10#2)
bulk semiconductor##3##2##(2007-11#1)(2007-12#2)
bulk soil##2##2##(2008-10#1)(2008-11#1)
bulk solution##12##2##(1991-8#1)(1997-2#1)(2008-10#5)(2008-6#4)(2013-8#1)
bulk to##2##2##(2008-4#1)(2010-4#1)
bulk water##3##2##(2008-5#3)
bulk##326##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-8#2)(1992-11#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-9#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#14)(2007-12#38)(2008-10#104)(2008-11#14)(2008-12#9)(2008-2#11)(2008-3#37)(2008-4#2)(2008-5#6)(2008-6#7)(2008-7#14)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#7)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#4)
bulk-loading algorithm##3##2##(2009-9#3)
bulk-loading##5##1##(2009-9#5)
bulk-modified##2##1##(2008-10#2)
bulk-optic##2##1##(2008-3#2)
bulked plant samples##3##3##(2008-10#3)
bulked segregant analysis##9##3##(1995-6#1)(2008-10#5)(2008-5#2)(2008-9#1)
bulked segregant##10##2##(1995-6#2)(2008-10#5)(2008-5#2)(2008-9#1)
bulked##15##1##(1995-6#2)(2008-10#10)(2008-5#2)(2008-9#1)
bulkiness of the##3##3##(1994-12#1)(2008-10#2)
bulkiness##4##1##(1994-12#1)(2008-10#3)
bulking agents##4##2##(2008-12#4)
bulking##5##1##(2008-12#4)(2013-1#1)
bulks##8##1##(2008-10#6)(2008-5#1)(2008-8#1)
bulky##27##1##(1991-12#1)(1991-5#2)(1992-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-11#1)(2012-3#1)
bull##2##1##(1997-6#1)(2008-10#1)
bull's-eye&quot##2##1##(2011-2#2)
bulla##4##1##(2007-8#2)(2008-1#1)(2012-12#1)
bullae##6##1##(2007-7#1)(2008-1#1)(2008-10#3)(2009-4#1)
bullata##3##1##(2008-10#3)
bulldog##2##1##(1997-5#1)(2009-8#1)
bullectomy##2##1##(1991-6#1)(2007-8#1)
bullet##2##1##(2007-10#1)(2011-2#1)
bullfighters##4##1##(2008-3#4)
bullfrog Rana catesbeiana##3##3##(1992-3#1)(1993-5#1)(1997-7#1)
bullfrog##10##1##(1990-5#2)(1992-3#1)(1993-5#1)(1996-2#1)(1997-7#5)
bullied##6##1##(2008-11#1)(2008-12#2)(2009-7#2)(2011-1#1)
bullosa##18##1##(1991-11#2)(1991-12#2)(1992-3#2)(1997-5#1)(2008-10#2)(2008-5#2)(2012-12#1)(2012-3#6)
bullous impetigo##2##2##(2008-12#2)
bullous pemphigoid##3##2##(2007-7#2)(2009-3#1)
bullous##13##1##(1995-11#1)(2006-10#2)(2007-7#2)(2008-10#1)(2008-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2013-1#1)
bulls##7##1##(2010-4#2)(2011-1#1)(2012-3#1)(2013-1#3)
bully##2##1##(2008-11#1)(2010-1#1)
bully-victims and non-involved adolescents##2##4##(2009-7#2)
bully-victims##3##1##(2009-7#3)
bullying and victimization##2##3##(2010-1#2)
bullying and##3##2##(2009-7#1)(2010-1#2)
bullying behavior##2##2##(2009-7#2)
bullying##25##1##(2008-11#7)(2008-12#4)(2009-7#10)(2010-1#3)(2010-8#1)
bumetanide##6##1##(1990-5#1)(1991-8#1)(1992-3#2)(1994-3#1)(2008-6#1)
bump##5##1##(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#2)
bumps on the##2##3##(2008-3#1)(2009-8#1)
bumps##6##1##(2008-10#2)(2008-3#3)(2009-8#1)
bunches##4##1##(2007-12#1)(2008-2#2)(2011-1#1)
bunchgrass seedlings##3##2##(2008-9#3)
bunchgrass##4##1##(2008-9#4)
bunchgrasses##4##1##(2008-9#4)
bunching##2##1##(2007-11#1)(2008-3#1)
bundle and##4##2##(1996-2#1)(2008-3#2)(2008-7#1)
bundle branch block and##2##4##(2008-12#1)(2010-8#1)
bundle branch block##9##3##(1994-1#1)(1997-3#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-8#2)(2012-12#1)
bundle branch blocks##2##3##(1995-8#1)(2008-7#1)
bundle branch##12##2##(1994-1#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-12#2)(2008-7#3)(2010-8#2)(2012-12#1)
bundle for##3##2##(2008-2#3)
bundle in##3##2##(2008-3#2)(2008-9#1)
bundle is##3##2##(1995-12#1)(2008-3#1)(2013-1#1)
bundle of##4##2##(1991-2#1)(1995-12#1)(2009-7#1)(2013-1#1)
bundle sheath##2##2##(1994-8#1)(2008-10#1)
bundle was tested##2##3##(2008-2#2)
bundle was##3##2##(2008-2#3)
bundle with##3##2##(1991-12#1)(1992-8#1)(2008-7#1)
bundle##79##1##(1991-12#1)(1991-2#3)(1992-10#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-3#3)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#4)(1995-5#2)(1995-8#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#9)(2008-4#3)(2008-7#7)(2008-9#2)(2009-3#2)(2009-7#1)(2009-9#1)(2010-8#2)(2012-12#1)(2013-1#4)(2013-7#1)
bundle-sheath cells of##2##3##(1990-5#2)
bundle-sheath cells##3##2##(1990-5#3)
bundle-sheath chloroplasts##2##2##(1990-5#2)
bundle-sheath##5##1##(1990-5#5)
bundled##5##1##(2008-10#1)(2008-3#1)(2009-7#1)(2009-9#1)(2011-2#1)
bundles and##5##2##(1992-2#1)(2008-10#3)(2012-2#1)
bundles for##3##2##(2008-3#1)(2008-7#2)
bundles in##4##2##(1995-12#1)(2008-10#3)
bundles of##9##2##(1992-2#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
bundles that##2##2##(1992-2#1)(2007-12#1)
bundles was##2##2##(2007-12#2)
bundles##64##1##(1990-7#1)(1992-2#4)(1993-3#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-12#1)(1997-3#1)(2007-12#8)(2008-10#14)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-4#1)(2011-2#3)(2012-2#5)(2013-1#4)
bundling and##2##2##(2009-11#1)(2012-2#1)
bundling of##2##2##(2008-2#1)(2009-9#1)
bundling##7##1##(2008-2#1)(2009-11#1)(2009-9#1)(2011-2#2)(2012-2#2)
bunion surgery##3##2##(2009-10#1)(2010-9#2)
bunion##4##1##(2009-10#1)(2010-9#3)
bunt fungus##2##2##(2008-10#2)
bunt of wheat##3##3##(2008-10#3)
bunt##10##1##(2008-10#10)
bunting (Emberiza##3##2##(1997-4#1)(2008-9#2)
buoyancy##12##1##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#8)(2012-2#1)
buoyant density of##2##3##(1990-5#1)(2008-10#1)
buoyant density##4##2##(1990-5#1)(1993-8#1)(2008-10#2)
buoyant smoke##4##2##(1996-12#4)
buoyant##10##1##(1990-5#1)(1993-8#1)(1996-12#4)(2008-10#2)(2008-7#1)(2012-2#1)
bupivacaine 0##2##2##(2008-7#1)(2012-12#1)
bupivacaine and##3##2##(2007-11#1)(2011-2#2)
bupivacaine in##2##2##(2007-11#1)(2008-7#1)
bupivacaine plus##3##2##(1993-1#1)(2011-2#2)
bupivacaine with##6##2##(1993-1#2)(2007-11#2)(2007-8#1)(2011-2#1)
bupivacaine##29##1##(1993-1#4)(1995-3#1)(2007-11#6)(2007-8#2)(2008-10#2)(2008-7#5)(2011-2#7)(2012-12#2)
buprenorphine##25##1##(1991-1#6)(1995-12#3)(1996-4#1)(2008-11#8)(2008-6#7)
bupropion SR##2##2##(2008-6#1)(2010-11#1)
bupropion and##2##2##(1991-1#1)(2013-8#1)
bupropion in##2##2##(2008-6#1)(2011-2#1)
bupropion##13##1##(1991-1#1)(2008-6#4)(2010-11#2)(2011-2#2)(2012-3#1)(2013-8#3)
bur##4##1##(2008-9#2)(2012-3#1)(2013-8#1)
burbot (Lota##2##2##(2008-10#1)(2008-7#1)
burbot##13##1##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#10)
burden among##4##2##(2007-12#1)(2008-1#1)(2008-12#1)(2013-8#1)
burden and##18##2##(1991-4#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2010-10#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
burden by##2##2##(2007-2#1)(2013-8#1)
burden for##6##2##(2008-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
burden from##3##2##(2009-9#1)(2012-2#2)
burden in all##2##3##(2008-7#1)(2012-2#1)
burden in patients with##2##4##(2008-7#1)(2012-2#1)
burden in the##4##3##(1996-1#1)(1996-12#1)(2008-10#1)(2013-1#1)
burden in##16##2##(1992-1#1)(1992-11#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-7#4)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
burden is the##2##3##(2008-3#1)(2010-4#1)
burden is##7##2##(1991-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
burden of cancer##2##3##(2012-12#1)(2012-3#1)
burden of cardiovascular disease##2##4##(2009-4#1)(2012-2#1)
burden of disease and##2##4##(2011-2#1)(2013-1#1)
burden of disease for##3##4##(2012-12#3)
burden of disease##14##3##(2008-3#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-12#6)(2013-1#1)(2013-8#1)
burden of hypertension##3##3##(2008-11#1)(2010-4#2)
burden of illness##2##3##(1994-9#1)(2012-12#1)
burden of pneumococcal##2##3##(2007-12#1)(2008-10#1)
burden of stroke in##6##4##(2008-8#5)(2009-7#1)
burden of stroke##10##3##(2008-8#9)(2009-7#1)
burden of the##4##3##(1990-8#2)(1996-1#1)(2011-1#1)
burden of these##2##3##(2008-12#1)(2011-2#1)
burden of##86##2##(1990-8#2)(1991-12#1)(1992-2#1)(1994-1#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#10)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#6)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-12#10)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
burden on##4##2##(1997-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
burden to##3##2##(1995-11#1)(2008-11#1)(2009-8#1)
burden was##7##2##(1990-2#1)(1992-12#1)(1992-2#1)(2008-6#1)(2010-12#1)(2013-8#2)
burden worldwide##2##2##(2008-7#1)(2013-8#1)
burden##218##1##(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#2)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#6)(2008-7#21)(2008-8#13)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#8)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#2)(2011-1#7)(2011-2#14)(2011-3#1)(2012-12#16)(2012-2#10)(2012-3#4)(2013-1#4)(2013-8#18)
burden&quot##2##1##(1995-2#1)(2008-1#1)
burden-of-illness score##3##2##(1994-9#3)
burden-of-illness##4##1##(1994-9#4)
burdened##2##1##(2008-10#1)(2012-12#1)
burdens and##5##2##(1996-12#2)(2006-10#1)(2009-6#2)
burdens of##6##2##(1996-12#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-8#1)
burdens the##2##2##(1996-12#1)(2008-7#1)
burdens##44##1##(1991-12#1)(1991-3#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#6)(1996-3#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-6#2)(2009-9#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#10)
burdensome for##2##2##(2008-12#1)(2010-10#1)
burdensome##5##1##(1995-1#1)(1995-2#1)(2008-11#1)(2008-12#1)(2010-10#1)
bureaucracies##2##1##(1995-2#2)
bureaucracy##9##1##(1993-1#1)(1993-2#1)(1994-2#2)(1994-5#1)(1995-3#1)(1997-5#1)(2008-1#1)(2013-1#1)
bureaucratic##12##1##(1991-3#1)(1993-2#2)(1995-1#2)(1995-2#1)(1996-1#1)(2008-1#2)(2008-11#1)(2008-6#1)(2009-4#1)
burette##3##1##(2008-10#3)
burgdorferi and##2##2##(2008-9#1)(2010-6#1)
burgdorferi in##8##2##(1991-11#2)(2008-9#2)(2010-6#4)
burgdorferi##40##1##(1990-2#3)(1991-11#4)(1992-11#1)(1992-3#3)(1995-5#1)(2008-9#14)(2010-6#8)(2011-2#6)
burgeoning##6##1##(1992-2#1)(1994-1#1)(2006-10#1)(2008-11#1)(2008-5#2)
burgher##2##1##(2008-10#1)(2008-11#1)
burglary##2##1##(1994-12#1)(1996-12#1)
burial of##4##2##(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#1)
burial##10##1##(1993-3#1)(1995-2#1)(1997-2#1)(2008-10#7)
burials##3##1##(2008-10#3)
buried at##3##2##(1992-4#1)(2008-10#2)
buried in soil and##2##4##(2008-10#2)
buried in the##4##3##(1990-12#1)(1990-7#1)(1994-5#1)(2008-10#1)
buried in##11##2##(1990-12#1)(1990-7#1)(1992-6#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-2#2)
buried lysine##2##2##(1997-2#2)
buried penis##2##2##(1991-8#1)(2008-10#1)
buried residues##5##2##(2008-10#5)
buried tumors##3##2##(2008-2#3)
buried waveguides formed##2##3##(2007-11#2)
buried##68##1##(1990-12#1)(1990-7#1)(1991-8#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#2)(1994-5#1)(1995-12#1)(1996-4#1)(1997-2#4)(1997-5#1)(2007-11#4)(2007-12#1)(2008-10#26)(2008-2#7)(2008-4#2)(2008-5#2)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)
burn in##3##2##(2008-5#1)(2010-7#1)(2011-1#1)
burn injury is##2##3##(2008-8#2)
burn injury##9##2##(1996-3#1)(2008-8#6)(2012-3#2)
burn patient##2##2##(2008-12#1)(2010-10#1)
burn patients##3##2##(1990-2#1)(2009-6#1)(2010-9#1)
burn wound##3##2##(1994-5#1)(2010-4#1)(2013-7#1)
burn##35##1##(1990-2#1)(1990-8#2)(1992-2#1)(1994-5#3)(1996-3#1)(2008-12#1)(2008-5#1)(2008-8#6)(2009-1#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#5)(2013-7#1)
burned out again##2##3##(2013-1#2)
burned out##3##2##(2008-11#1)(2013-1#2)
burned patients##3##2##(1991-3#1)(1997-3#2)
burned##14##1##(1991-3#1)(1994-5#1)(1997-3#2)(2007-12#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
burner head##2##2##(2008-10#2)
burner##13##1##(2008-10#2)(2008-2#4)(2008-3#7)
burnetii was##2##2##(1995-12#1)(2007-12#1)
burnetii##18##1##(1991-8#1)(1992-5#1)(1994-12#2)(1995-12#6)(1995-8#2)(2007-12#4)(2008-4#2)
burning in##7##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2011-2#2)
burning mouth##2##2##(2008-5#1)(2013-1#1)
burning of##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
burning or##2##2##(2008-11#1)(2013-1#1)
burning pain##2##2##(1991-6#1)(2008-8#1)
burning sensation in the##2##4##(2008-7#1)(2013-1#1)
burning##45##1##(1991-6#1)(1992-6#1)(1997-4#1)(2007-11#5)(2007-12#8)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#9)(2008-5#3)(2008-7#2)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#3)
burnout among##2##2##(2010-12#1)(2010-2#1)
burnout and vital exhaustion##2##4##(2008-11#2)
burnout and##19##2##(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#4)(2009-9#5)(2010-2#1)(2010-9#2)(2011-2#2)(2012-1#1)
burnout are##2##2##(2010-7#1)(2011-2#1)
burnout diagnosis##2##2##(2011-2#2)
burnout in##2##2##(1991-3#1)(2008-10#1)
burnout levels##3##2##(2009-5#2)(2010-9#1)
burnout phase##4##2##(1996-2#1)(1997-1#3)
burnout than##3##2##(1996-2#1)(2010-9#2)
burnout##101##1##(1991-3#1)(1992-1#6)(1994-3#1)(1995-1#2)(1996-2#9)(1997-1#5)(2007-4#1)(2008-10#8)(2008-11#9)(2008-9#1)(2009-5#3)(2009-9#8)(2010-12#2)(2010-2#6)(2010-7#2)(2010-9#11)(2011-2#22)(2012-1#1)(2013-1#3)
burns and shocks##2##3##(2011-2#2)
burns from##2##2##(2008-9#1)(2010-9#1)
burns##23##1##(1991-6#1)(1992-12#1)(1992-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2013-1#1)(2013-7#1)
burns]##2##1##(1991-3#1)(2012-3#1)
burnt##2##1##(2008-10#2)
burr hole##6##2##(1997-6#1)(2006-12#2)(2008-7#3)
burr##7##1##(1997-6#1)(2006-12#2)(2008-7#4)
burrowing##3##1##(1992-12#1)(1994-11#1)(2008-10#1)
burrows##5##1##(2007-2#1)(2008-5#2)(2011-2#1)(2012-3#1)
bursa and liver##2##3##(2008-5#2)
bursa and##3##2##(2008-5#3)
bursa of Fabricius and##2##4##(2008-5#1)(2008-9#1)
bursa of Fabricius##3##3##(1997-3#1)(2008-5#1)(2008-9#1)
bursa##11##1##(1997-3#1)(2007-11#1)(2008-5#8)(2008-9#1)
bursae##10##1##(2007-11#7)(2008-5#2)(2010-3#1)
bursal disease##6##2##(1997-6#2)(2008-5#4)
bursal##8##1##(1997-6#4)(2008-5#4)
bursitis##7##1##(1991-6#1)(2006-10#4)(2008-12#1)(2008-8#1)
burst and##2##2##(1991-2#1)(2008-10#1)
burst firing was##2##3##(1996-2#2)
burst firing##5##2##(1993-12#1)(1996-2#4)
burst in##6##2##(1991-2#1)(1995-6#1)(2008-10#4)
burst of##7##2##(1991-9#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
burst stimulation in##2##3##(1992-6#1)(2010-7#1)
burst swimming##2##2##(2010-8#2)
burst##70##1##(1990-2#2)(1990-8#1)(1991-2#4)(1991-5#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-6#4)(1994-8#1)(1995-6#7)(1996-2#5)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
burst)##2##1##(2008-10#1)(2008-9#1)
bursting##9##1##(1991-5#1)(1993-12#1)(1994-3#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)
bursts in the##2##3##(1994-8#1)(1997-2#1)
bursts in##3##2##(1994-8#1)(1997-2#1)(1997-7#1)
bursts of##2##2##(1994-3#1)(2013-8#1)
bursts was##2##2##(1990-9#1)(2008-2#1)
bursts##12##1##(1990-9#1)(1994-3#1)(1994-8#2)(1997-2#2)(1997-7#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#2)
burying##6##1##(1993-3#4)(1994-2#1)(2008-5#1)
bus driver##3##2##(1995-12#1)(2008-1#2)
bus##14##1##(1995-12#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-3#3)(2008-6#3)(2011-2#1)(2012-12#1)
buserelin##2##1##(1990-2#2)
buses##7##1##(1997-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#3)
bush##5##1##(1995-10#1)(2008-10#3)(2010-1#1)
bushbabies##2##1##(1995-2#2)
bushen##3##1##(2013-8#3)
business and health##2##3##(1992-1#1)(2008-1#1)
business and legal##3##3##(1994-3#1)(1995-12#1)(2008-11#1)
business and##14##2##(1991-12#1)(1991-2#1)(1992-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
business as usual&quot##2##3##(1995-1#1)(1997-1#1)
business as##4##2##(1992-1#1)(1994-2#1)(1995-1#1)(1997-1#1)
business coalition##2##2##(1994-1#1)(1996-3#1)
business community##3##2##(1993-3#1)(1994-12#1)(1995-2#1)
business executives##2##2##(1991-12#1)(1994-2#1)
business function##2##2##(1995-3#1)(1996-3#1)
business in the##2##3##(1995-3#1)(1996-2#1)
business in##4##2##(1994-3#1)(1995-3#1)(1996-2#1)(2008-5#1)
business is##2##2##(1997-3#1)(2008-10#1)
business network##2##2##(1993-3#2)
business of##4##2##(1992-3#1)(1995-2#1)(2007-4#1)(2008-4#1)
business plan##2##2##(1993-2#1)(2010-7#1)
business planning and##2##3##(2008-11#2)
business process##4##2##(1993-12#2)(1993-3#1)(1994-2#1)
business processes##2##2##(1993-3#1)(2007-9#1)
business sector##3##2##(1994-1#1)(1995-12#1)(2007-10#1)
business skills##2##2##(1996-3#1)(1997-2#1)
business##156##1##(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#7)(1991-2#3)(1991-3#2)(1992-1#4)(1992-11#2)(1992-12#2)(1992-3#4)(1992-5#1)(1993-1#4)(1993-12#5)(1993-2#4)(1993-3#8)(1994-1#4)(1994-12#4)(1994-2#7)(1994-3#4)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#9)(1996-5#1)(1997-1#4)(1997-2#3)(1997-3#5)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#10)(2008-12#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#3)(2009-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2012-3#4)(2013-1#1)(2013-8#1)
businesses and##2##2##(1994-2#1)(2008-9#1)
businesses have##2##2##(1993-1#1)(1994-2#1)
businesses in##2##2##(2008-10#1)(2008-11#1)
businesses##16##1##(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-2#2)(1995-1#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
businessperson##2##1##(2012-3#2)
buspirone and##2##2##(1991-1#1)(2007-10#1)
buspirone##4##1##(1991-1#1)(1994-2#1)(2007-10#1)(2008-6#1)
bustards##3##1##(1997-3#3)
busulphan treatment for chronic myeloid leukemia##2##6##(1993-8#2)
busulphan##4##1##(1993-8#4)
busy##9##1##(1996-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
but &lt##2##2##(2008-10#1)(2008-3#1)
but &quot##2##2##(1996-2#1)(1997-3#1)
but 1##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
but 10##2##2##(2008-10#1)(2008-7#1)
but 2##3##2##(1992-10#1)(1992-8#1)(2008-8#1)
but 7##2##2##(1991-6#1)(1995-8#1)
but C##2##2##(2008-10#1)(2012-3#1)
but I'm##2##2##(2008-1#1)(2010-12#1)
but L##2##2##(2008-11#1)(2010-8#1)
but MRI##2##2##(2008-12#1)(2012-2#1)
but Not##3##2##(2008-10#2)(2012-3#1)
but Rabphilin-3A was phosphorylated##2##4##(1994-9#2)
but a clear##2##3##(1995-11#1)(2011-1#1)
but a complete##2##3##(1997-2#1)(2009-2#1)
but a comprehensive##2##3##(1992-12#1)(1997-8#1)
but a few##6##3##(1992-6#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
but a group of##2##4##(1991-3#1)(2013-1#1)
but a lack of##2##4##(2008-11#1)(2009-9#1)
but a large##2##3##(1994-12#1)(2008-10#1)
but a lower##2##3##(1995-12#1)(2008-10#1)
but a much##3##3##(1992-10#1)(1996-2#1)(2008-9#1)
but a normal##2##3##(1995-6#1)(2011-1#1)
but a recent study##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
but a significant difference##2##4##(2008-12#1)(2009-3#1)
but a significant##5##3##(1994-6#1)(1995-12#1)(2008-12#1)(2009-3#1)(2011-2#1)
but a similar##4##3##(1994-2#1)(2006-6#1)(2008-4#1)(2011-1#1)
but a small##2##3##(1991-9#1)(2012-1#1)
but a substantial##2##3##(2008-11#1)(2009-7#1)
but a##115##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
but about##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
but above##3##2##(2007-7#1)(2008-10#1)(2008-8#1)
but absent from##2##3##(1991-12#1)(1995-6#1)
but absent in##2##3##(2008-10#2)
but absent##4##2##(1991-12#1)(1995-6#1)(2008-10#2)
but absolute##2##2##(1992-12#1)(1993-12#1)
but accuracy did not##2##4##(2013-1#2)
but accurate##2##2##(2008-10#1)(2008-3#1)
but achieved##2##2##(2008-6#1)(2012-2#1)
but activates##2##2##(1991-12#1)(2009-10#1)
but actually##2##2##(1990-12#1)(1994-2#1)
but affects##2##2##(2008-8#1)(2009-12#1)
but after a##2##3##(1992-10#1)(1992-12#1)
but after the##2##3##(2007-11#1)(2007-8#1)
but after##14##2##(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)
but aggressive##4##2##(1992-12#1)(1993-3#1)(2008-12#1)(2011-2#1)
but all other##2##3##(2009-10#1)(2011-2#1)
but all were##2##3##(2008-10#1)(2008-5#1)
but all##13##2##(1990-3#1)(1994-12#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-8#1)
but allow##2##2##(1995-6#1)(2008-10#1)
but allows##5##2##(1992-6#1)(1993-3#1)(2007-8#1)(2008-8#1)(2010-8#1)
but almost##3##2##(1997-4#1)(2010-11#1)(2012-3#1)
but also a new##2##4##(2008-2#1)(2008-9#1)
but also a##11##3##(1990-11#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2011-1#1)
but also address##2##3##(1997-1#1)(2013-1#1)
but also adverse##2##3##(1993-11#1)(1997-2#1)
but also allows##2##3##(1991-12#1)(2007-11#1)
but also an important##2##4##(2008-10#1)(2009-5#1)
but also as a##5##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
but also as##12##3##(1990-3#1)(1992-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)
but also at##4##3##(2007-12#1)(2008-3#1)(2009-1#1)(2012-3#1)
but also by the##6##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
but also by##21##3##(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
but also can##5##3##(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
but also contribute to##2##4##(2008-6#1)(2012-2#1)
but also demonstrated##2##3##(2008-9#1)(2012-3#1)
but also due to##2##4##(1995-2#1)(2011-2#1)
but also during##2##3##(2008-7#1)(2011-2#1)
but also effectively##2##3##(1994-1#1)(2008-10#1)
but also facilitate the##2##4##(2008-9#1)(2010-10#1)
but also for a##3##4##(1991-6#1)(1996-5#1)(2013-8#1)
but also for other##2##4##(2008-7#1)(2011-2#1)
but also for the##3##4##(1990-5#1)(1997-8#1)(2008-3#1)
but also for##35##3##(1990-5#1)(1991-2#1)(1991-6#1)(1993-3#1)(1995-9#1)(1996-5#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
but also found##2##3##(2010-11#1)(2011-2#1)
but also from the##4##4##(1991-5#1)(1995-5#1)(2007-12#1)(2008-3#1)
but also from##9##3##(1991-5#1)(1992-6#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#2)
but also has##4##3##(2007-8#1)(2010-11#1)(2012-12#1)(2012-3#1)
but also have##2##3##(2011-2#1)(2013-1#1)
but also human##2##3##(1990-11#1)(2011-2#1)
but also improves the##2##4##(2008-10#1)(2008-12#1)
but also in other##3##4##(1991-2#1)(1997-6#1)(2008-11#1)
but also in relation##2##4##(2008-8#1)(2009-5#1)
but also in terms of##3##5##(1997-1#1)(2007-9#1)(2008-10#1)
but also in the design of##2##6##(2008-1#1)(2008-7#1)
but also in the##13##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2010-3#1)(2011-2#1)(2012-2#1)
but also in##55##3##(1990-5#2)(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
but also included##2##3##(2008-10#1)(2008-5#1)
but also increase##2##3##(2011-2#1)(2013-1#1)
but also increased the##2##4##(2008-10#1)(2008-8#1)
but also increased##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
but also indicate that##2##4##(1993-11#1)(2008-9#1)
but also indicate##3##3##(1993-11#1)(2008-11#1)(2008-9#1)
but also into##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
but also is##2##3##(2007-11#1)(2008-10#1)
but also may##3##3##(2006-10#1)(2008-11#1)(2013-1#1)
but also more##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
but also of the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
but also of##11##3##(1991-11#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2011-1#1)
but also offers##2##3##(2008-10#1)(2008-9#1)
but also on its##3##4##(1991-2#2)(2008-5#1)
but also on the##6##4##(1991-12#1)(2008-10#1)(2008-2#2)(2010-12#1)(2012-3#1)
but also on##20##3##(1991-12#1)(1991-2#2)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)
but also one of the##2##5##(2008-2#1)(2013-7#1)
but also other##4##3##(1991-2#1)(1992-9#1)(2010-8#1)(2013-1#1)
but also present##2##3##(1997-2#1)(2008-10#1)
but also provide##4##3##(1993-3#1)(2010-3#1)(2011-2#2)
but also provides##3##3##(2008-4#1)(2008-7#1)(2013-8#1)
but also qualitative##2##3##(1994-3#1)(2008-4#1)
but also recognized##2##3##(1991-2#1)(2008-5#1)
but also reduced the##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
but also reduces##2##3##(2008-8#1)(2010-10#1)
but also relatively##2##3##(2010-6#1)(2013-7#1)
but also resulted in##2##4##(2008-8#1)(2011-1#1)
but also revealed##2##3##(1990-7#1)(2012-2#1)
but also reveals##3##3##(2007-12#1)(2009-12#1)(2012-3#1)
but also reversed##2##3##(1992-3#1)(2008-10#1)
but also that##4##3##(2008-10#1)(2008-3#1)(2011-10#1)(2012-1#1)
but also the##47##3##(1991-6#1)(1992-12#1)(1992-3#2)(1994-3#2)(1995-3#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
but also their##6##3##(1991-12#1)(1995-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
but also to a##2##4##(1997-6#1)(2008-7#1)
but also to the##10##4##(1991-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2013-1#1)
but also to##56##3##(1990-5#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1994-1#1)(1995-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#2)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#2)
but also was##2##3##(1995-1#1)(2008-10#1)
but also will##2##3##(1997-1#1)(2008-11#1)
but also with the##3##4##(2008-3#1)(2008-8#1)(2011-2#1)
but also with##13##3##(1990-7#1)(1995-1#1)(1997-3#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
but also##620##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#5)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#1)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#4)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2006-10#2)(2007-11#6)(2007-12#10)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#68)(2008-11#41)(2008-12#6)(2008-2#19)(2008-3#26)(2008-4#13)(2008-5#17)(2008-6#4)(2008-7#35)(2008-8#25)(2008-9#17)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#4)(2009-3#3)(2009-4#1)(2009-5#5)(2009-7#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#7)(2011-1#8)(2011-10#1)(2011-2#38)(2012-1#6)(2012-12#8)(2012-2#17)(2012-3#13)(2012-6#1)(2013-1#17)(2013-7#2)(2013-8#7)
but an effective##2##3##(1992-2#1)(1996-3#1)
but an##19##2##(1991-11#2)(1992-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#3)(2008-6#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#2)
but another##2##2##(1997-3#1)(2008-10#1)
but any##2##2##(1997-8#1)(2007-12#1)
but apparently##6##2##(1992-8#1)(1994-9#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-8#1)
but appears to##2##3##(2007-2#1)(2008-7#1)
but appears##3##2##(2007-2#1)(2008-7#1)(2009-8#1)
but are also##6##3##(1997-7#1)(2007-9#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)
but are consistent with##2##4##(2008-10#1)(2008-6#1)
but are highly##2##3##(1992-8#1)(1994-8#1)
but are limited##2##3##(2008-3#1)(2013-1#1)
but are more##2##3##(1992-3#1)(2008-10#1)
but are not effective##3##4##(1994-9#1)(1997-1#1)(2008-2#1)
but are not limited to##2##5##(2009-11#2)
but are not##13##3##(1991-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-2#1)(2008-12#1)(2008-2#2)(2009-11#2)(2009-6#1)
but are seldom##2##3##(1996-2#1)(2013-1#1)
but are smaller##2##3##(1993-3#1)(1995-11#1)
but are##79##2##(1990-3#1)(1991-3#2)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-12#3)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
but as a##5##3##(1992-12#1)(2008-7#2)(2011-3#1)(2013-1#1)
but as an##3##3##(1991-12#1)(2008-4#1)(2008-8#1)
but as yet##2##3##(1994-6#1)(2007-11#1)
but as##18##2##(1991-12#1)(1992-12#2)(1992-2#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
but at a lower##2##4##(1990-12#1)(2008-10#1)
but at a##12##3##(1990-12#1)(1990-7#1)(1991-8#1)(1995-2#1)(2008-10#4)(2008-6#1)(2009-10#1)(2012-2#1)(2012-3#1)
but at different##2##3##(2009-8#1)(2010-3#1)
but at high##3##3##(1990-11#1)(1992-12#1)(2007-11#1)
but at higher##2##3##(1992-9#1)(2008-10#1)
but at least some##2##4##(2013-1#2)
but at least##3##3##(2011-2#1)(2013-1#2)
but at low levels in##2##5##(1992-12#1)(2008-10#1)
but at low##3##3##(1992-12#1)(2008-10#2)
but at lower##2##3##(2008-6#1)(2011-2#1)
but at the##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
but at##50##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-8#1)(1992-12#2)(1992-9#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#11)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
but attempts to##2##3##(1996-2#1)(2008-10#1)
but bacterial##3##2##(1990-6#1)(1991-8#1)(1991-9#1)
but barely##2##2##(1994-12#1)(2008-10#1)
but became##4##2##(1990-11#1)(1992-3#1)(1997-6#1)(2008-5#1)
but because of the##2##4##(1997-8#1)(2008-12#1)
but because of##4##3##(1997-8#1)(2008-12#1)(2008-8#1)(2009-5#1)
but because they are##2##4##(2007-12#1)(2008-9#1)
but because##7##2##(1997-8#1)(2007-12#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-5#1)
but becomes##4##2##(1991-9#1)(1995-6#1)(2008-10#1)(2008-2#1)
but below the##2##3##(2008-10#2)
but below##3##2##(2007-12#1)(2008-10#2)
but benign##2##2##(1994-7#1)(2008-6#1)
but beta##3##2##(1991-5#2)(2010-5#1)
but better##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
but between##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
but blocked##3##2##(1990-12#1)(1994-2#1)(1996-5#1)
but both##12##2##(1994-12#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-6#1)(2010-8#1)(2012-2#1)
but breast##2##2##(1990-12#1)(2007-11#1)
but by a##3##3##(1991-12#1)(2007-12#1)(2012-2#1)
but by different##2##3##(1991-5#1)(2012-3#1)
but by the##2##3##(1997-3#1)(2007-8#1)
but by##21##2##(1990-3#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-12#1)(2012-2#2)(2012-3#1)
but can also be##2##4##(2008-10#1)(2008-7#1)
but can also##6##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-10#1)
but can be applied##2##4##(2008-10#1)(2008-2#1)
but can be reactivated##2##4##(1991-9#1)(2011-2#1)
but can be used##2##4##(2008-10#1)(2008-4#1)
but can be##21##3##(1991-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
but can cause##2##3##(2010-11#1)(2011-2#1)
but can only be##2##4##(1997-6#1)(2008-9#1)
but can##41##2##(1991-9#1)(1992-3#1)(1992-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
but cannot be##5##3##(1990-7#1)(1991-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
but cannot differentiate between##2##4##(2008-10#1)(2013-1#1)
but cannot##10##2##(1990-7#1)(1991-12#1)(1995-2#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
but care##2##2##(2008-1#1)(2008-9#1)
but carotenoids content##2##3##(2008-12#2)
but carries a##2##3##(2008-12#1)(2008-8#1)
but carries##3##2##(1995-11#1)(2008-12#1)(2008-8#1)
but caused##6##2##(1997-7#1)(2008-10#3)(2008-11#1)(2008-7#1)
but causes a##2##3##(1992-9#1)(1994-8#1)
but causes##5##2##(1990-8#1)(1992-9#1)(1994-8#1)(2009-10#1)(2011-3#1)
but cells##2##2##(1995-8#1)(2008-5#1)
but changes##3##2##(1990-3#1)(1994-5#1)(2010-5#1)
but clearly##6##2##(1990-7#1)(1991-1#1)(1991-9#1)(2008-11#1)(2008-5#1)(2008-6#1)
but cleavage##2##2##(2007-12#1)(2009-8#1)
but clinical##2##2##(2008-10#1)(2011-2#1)
but close##2##2##(2008-8#1)(2012-3#1)
but closely##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
but common##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
but comparison##2##2##(1994-9#1)(2010-9#1)
but compatible with##3##3##(1994-9#1)(2008-10#1)(2008-9#1)
but completely##3##2##(1993-6#1)(1996-2#1)(2007-5#1)
but concomitantly##2##2##(1994-8#1)(1997-4#1)
but considerable##2##2##(1996-3#1)(2008-5#1)
but considerably less##2##3##(1991-2#1)(2008-6#1)
but considerably##3##2##(1991-2#1)(2008-6#1)(2008-7#1)
but consistent##3##2##(2008-2#1)(2009-11#1)(2013-8#1)
but contain##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
but contains##3##2##(1993-3#1)(1994-8#1)(2008-3#1)
but continued##3##2##(2007-12#1)(2008-10#2)
but controlled##4##2##(1990-5#1)(1993-11#1)(2007-12#1)(2011-1#1)
but could also##3##3##(1992-8#1)(2010-10#1)(2010-3#1)
but could be##5##3##(2007-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
but could##17##2##(1992-10#1)(1992-8#1)(1993-11#1)(1995-1#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-2#2)
but cultures##2##2##(1996-6#1)(2008-5#1)
but current##3##2##(2008-11#1)(2008-3#1)(2010-5#1)
but daily##2##2##(2008-9#2)
but data##2##2##(2008-5#1)(2012-12#1)
but decrease##2##2##(1997-7#1)(2013-8#1)
but decreased in##3##3##(1990-12#1)(1997-2#1)(2008-11#1)
but decreased the##2##3##(2010-6#1)(2013-8#1)
but decreased to##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
but decreased with##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
but decreased##23##2##(1990-12#2)(1993-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
but decreases the##2##3##(1993-6#1)(1997-7#1)
but decreases with##2##3##(2008-8#1)(2009-7#1)
but decreases##6##2##(1992-6#1)(1993-6#1)(1997-7#1)(2008-8#1)(2009-7#1)(2011-1#1)
but decreasing##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
but definitive##3##2##(1994-2#1)(1995-8#1)(2008-8#1)
but despite their##2##3##(2008-11#1)(2010-6#1)
but despite##4##2##(1994-9#1)(2008-11#2)(2010-6#1)
but detectable##4##2##(1992-12#1)(2008-10#2)(2012-2#1)
but determined##2##2##(2008-10#1)(2010-6#1)
but did affect the##2##4##(2008-10#1)(2008-11#1)
but did enhance##2##3##(1995-11#1)(1997-1#1)
but did inhibit##2##3##(2006-6#1)(2008-10#1)
but did not act on##2##5##(2008-8#2)
but did not affect the##8##5##(1993-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
but did not affect##16##4##(1990-12#1)(1990-5#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#2)
but did not alter its##2##5##(1990-7#1)(1995-11#1)
but did not alter##3##4##(1990-7#1)(1995-11#1)(2008-8#1)
but did not amplify##2##4##(2008-10#1)(2008-11#1)
but did not change the##3##5##(1993-12#1)(1994-6#1)(2008-7#1)
but did not change##6##4##(1990-3#1)(1993-12#1)(1994-6#1)(2008-7#2)(2013-1#1)
but did not decrease the##2##5##(1995-5#1)(2008-5#1)
but did not decrease##3##4##(1995-5#1)(2008-5#1)(2008-8#1)
but did not detect##2##4##(1990-5#1)(2011-2#1)
but did not differ##3##4##(1996-7#1)(2009-9#1)(2010-1#1)
but did not for##2##4##(1993-8#1)(2008-10#1)
but did not have##2##4##(2008-10#1)(2008-12#1)
but did not increase##2##4##(1993-8#1)(2008-8#1)
but did not influence##2##4##(1993-8#1)(2013-1#1)
but did not predict##2##4##(2008-7#1)(2013-1#1)
but did not react with##2##5##(2008-10#1)(2008-11#1)
but did not show any##2##5##(1997-6#1)(2013-8#1)
but did not show##3##4##(1997-6#1)(2008-6#1)(2013-8#1)
but did not significantly##5##4##(1990-12#1)(1993-11#1)(1995-12#2)(2013-1#1)
but did not##103##3##(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-12#2)(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#5)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#5)(2013-8#1)
but did react with##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
but did reduce##2##3##(2008-10#2)
but did show##3##3##(1990-8#1)(2008-10#1)(2009-9#1)
but did##132##2##(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#3)(1993-8#5)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#2)(2006-12#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#32)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#5)(2013-8#1)
but died##4##2##(1994-12#1)(1995-11#1)(2008-7#1)(2010-10#1)
but differ in the##2##4##(2007-12#1)(2008-4#1)
but differ in##3##3##(1995-8#1)(2007-12#1)(2008-4#1)
but differed in the##2##4##(2008-10#2)
but differed in##4##3##(2008-10#3)(2008-5#1)
but differences between##2##3##(2008-10#1)(2011-1#1)
but differences in the##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
but differences in##4##3##(1991-12#1)(2008-10#2)(2008-8#1)
but differences##7##2##(1991-12#1)(2008-10#4)(2008-8#1)(2011-1#1)
but different between##2##3##(2008-10#2)
but different from##2##3##(1993-6#1)(2011-10#1)
but different##25##2##(1990-12#1)(1990-5#1)(1993-6#2)(1994-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-10#1)(2012-3#1)(2012-6#1)
but differs from it##2##4##(2007-12#1)(2008-5#1)
but differs from##3##3##(1994-5#1)(2007-12#1)(2008-5#1)
but differs in##2##3##(2007-12#1)(2008-9#1)
but differs##6##2##(1994-5#1)(2007-12#3)(2008-5#1)(2008-9#1)
but difficult##2##2##(2008-10#1)(2008-11#1)
but disappeared##2##2##(1991-8#1)(2008-10#1)
but disease##4##2##(2008-10#3)(2010-6#1)
but displayed##5##2##(1994-3#1)(1994-6#1)(1995-6#1)(2012-12#1)(2013-1#1)
but distinct from that##2##4##(2008-11#1)(2009-10#1)
but distinct from##3##3##(1995-2#1)(2008-11#1)(2009-10#1)
but distinct##9##2##(1991-3#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#2)
but distinctive##2##2##(1993-12#1)(1996-5#1)
but do not affect##2##4##(1995-2#1)(2007-12#1)
but do not increase##2##4##(1996-5#1)(2008-10#1)
but do not##18##3##(1993-6#1)(1994-3#1)(1995-2#2)(1996-12#2)(1996-5#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2011-2#1)
but do##21##2##(1993-6#1)(1994-3#1)(1995-2#2)(1996-12#2)(1996-5#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
but does increase the##2##4##(1994-5#1)(2007-8#1)
but does not affect##2##4##(1993-3#1)(1997-3#1)
but does not cause##2##4##(1991-5#1)(1994-5#1)
but does not##30##3##(1990-11#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-2#2)(1996-5#1)(1997-3#2)(2007-12#2)(2008-10#4)(2008-2#1)(2008-8#2)(2009-2#1)(2011-2#1)(2013-1#1)
but does##39##2##(1990-11#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-12#3)(1995-2#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-3#2)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
but dominated by##2##3##(2008-10#1)(2008-3#1)
but down-regulated##2##2##(2009-10#1)(2010-4#1)
but due to##3##3##(2008-10#2)(2011-2#1)
but during the##2##3##(1991-9#1)(2008-12#1)
but during##4##2##(1991-9#1)(1992-3#1)(2008-12#1)(2008-7#1)
but each##5##2##(2008-10#2)(2008-7#1)(2009-11#1)(2010-4#1)
but early##3##2##(1997-3#1)(2008-9#1)(2012-1#1)
but effective##5##2##(1997-6#1)(2008-10#1)(2008-3#3)
but either##3##2##(1995-2#1)(2008-8#1)(2010-4#1)
but enhanced##2##2##(1995-2#1)(2008-9#1)
but enhances##2##2##(2008-10#1)(2008-6#1)
but especially##5##2##(1997-5#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
but even then##2##3##(2008-7#1)(2008-8#1)
but even##14##2##(1990-3#1)(1992-8#1)(1994-3#1)(1996-11#1)(1997-7#1)(2007-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2013-8#1)
but evidence##4##2##(1994-11#1)(2008-10#1)(2010-9#1)(2011-1#1)
but exact##2##2##(2008-1#1)(2008-9#1)
but exhibit##2##2##(2008-9#1)(2012-2#1)
but exhibited##6##2##(1990-11#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-3#1)
but exhibits##3##2##(1993-8#1)(2008-8#1)(2010-11#1)
but expensive##2##2##(1991-3#1)(2008-11#1)
but experimental##2##2##(2008-8#1)(2012-2#1)
but expressed##4##2##(1993-3#1)(1994-3#1)(1995-11#1)(2008-11#1)
but extremely##3##2##(1996-6#1)(1997-4#1)(2013-1#1)
but failed to##12##3##(1990-7#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
but failed##14##2##(1990-7#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)
but fails to##4##3##(1994-6#1)(1995-6#1)(1997-3#1)(2008-8#1)
but few are##2##3##(1995-1#1)(2008-10#1)
but few have##3##3##(2008-12#1)(2008-9#1)(2011-1#1)
but few studies have##2##4##(2008-4#1)(2010-1#1)
but few studies##3##3##(2008-4#1)(2008-8#1)(2010-1#1)
but few##18##2##(1991-2#1)(1991-5#1)(1995-1#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#2)
but fewer##2##2##(2010-1#1)(2011-1#1)
but final##2##2##(2008-5#1)(2010-11#1)
but five##2##2##(1996-2#1)(2008-2#1)
but fluorescence##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
but following##2##2##(2008-6#1)(2013-1#1)
but for the##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
but for##24##2##(1994-2#1)(1994-5#1)(1995-2#1)(1997-1#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)
but formed a##2##3##(2008-10#1)(2008-12#1)
but found to##2##3##(2008-10#1)(2008-7#1)
but found##5##2##(1990-8#1)(1992-11#1)(1997-4#1)(2008-10#1)(2008-7#1)
but four##7##2##(1991-9#1)(1992-3#1)(1994-12#1)(1994-6#1)(2008-5#1)(2011-2#2)
but frequent##3##2##(2008-10#1)(2009-2#1)(2013-8#1)
but frequently##2##2##(2008-10#1)(2011-2#1)
but from the##2##3##(1997-8#1)(2013-8#1)
but from##7##2##(1992-5#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-11#1)(2013-8#1)
but functional##2##2##(2008-9#2)
but functionally##2##2##(1991-5#1)(2008-9#1)
but further work is##2##4##(1996-5#1)(2007-8#1)
but further##11##2##(1994-8#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)
but generalized##2##2##(1992-11#1)(2008-6#1)
but generally##9##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
but genetic##3##2##(1996-2#1)(2008-7#1)(2011-2#1)
but good##3##2##(1991-4#1)(1994-9#1)(2008-10#1)
but gradually##2##2##(1995-5#1)(2008-6#1)
but greater than##3##3##(1990-11#1)(2009-11#1)(2009-5#1)
but greater##4##2##(1990-11#1)(2007-12#1)(2009-11#1)(2009-5#1)
but group##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
but growth##3##2##(2008-1#1)(2008-11#1)(2011-1#1)
but had a##7##3##(1993-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
but had less##2##3##(1992-12#1)(1994-11#1)
but had little effect##2##4##(1991-5#1)(1994-8#1)
but had no effect in##2##5##(1995-12#1)(2012-3#1)
but had no effect on the##4##6##(1993-3#1)(1995-3#1)(1995-8#1)(2012-12#1)
but had no effect on##10##5##(1993-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2009-4#1)(2012-12#1)
but had no effect##13##4##(1993-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
but had no significant effect on##2##6##(1993-5#1)(2008-12#1)
but had no##21##3##(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-3#1)(2012-12#2)(2012-3#1)
but had not##2##3##(1991-11#1)(2008-6#1)
but had##52##2##(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-4#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
but has a##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
but has also been##3##4##(2010-11#1)(2010-5#1)(2012-12#1)
but has also##5##3##(2008-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
but has an##2##3##(1990-2#1)(2008-3#1)
but has been##6##3##(1991-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)
but has no effect on##5##5##(1993-3#1)(1995-3#1)(1995-5#1)(1997-7#1)(2013-8#1)
but has no##6##3##(1993-3#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2013-8#1)
but has not been##4##4##(1995-6#1)(2008-7#1)(2011-1#1)(2012-1#1)
but has not yet been##2##5##(1992-11#1)(1994-6#1)
but has not##9##3##(1992-11#1)(1994-6#1)(1995-6#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-1#1)
but has only##2##3##(1990-2#1)(1994-5#1)
but has the##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
but has##59##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#2)(1991-6#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
but have a##2##3##(2008-10#1)(2013-8#1)
but have also been##3##4##(2008-9#1)(2011-1#1)(2013-1#1)
but have also##4##3##(2008-9#1)(2009-11#1)(2011-1#1)(2013-1#1)
but have been##4##3##(1996-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
but have different##3##3##(1993-12#1)(2008-7#1)(2011-2#1)
but have not been##2##4##(1996-4#1)(2008-9#1)
but have not##5##3##(1992-11#1)(1996-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
but have##31##2##(1991-2#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1996-12#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
but having the##2##3##(2011-2#1)(2013-1#1)
but having##3##2##(1995-5#1)(2011-2#1)(2013-1#1)
but he##4##2##(2007-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
but health care##3##3##(1994-12#1)(1997-1#1)(2008-11#1)
but her##3##2##(2006-10#1)(2007-9#1)(2008-11#1)
but here##2##2##(1997-6#1)(2008-3#1)
but high levels of##2##4##(1994-8#1)(2012-12#1)
but high##7##2##(1994-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-12#1)
but higher##11##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#1)
but highly##8##2##(1992-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
but his##4##2##(1990-11#1)(1991-11#1)(2007-4#1)(2013-1#1)
but how##6##2##(1993-12#1)(1994-11#1)(2008-1#1)(2008-11#1)(2010-10#1)(2013-1#1)
but if##7##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
but important##5##2##(1993-3#1)(2007-2#1)(2008-7#1)(2009-5#1)(2009-9#1)
but in a##5##3##(1990-11#1)(1991-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
but in addition##3##3##(2008-10#2)(2009-7#1)
but in all cases##2##4##(2007-12#1)(2008-5#1)
but in all##3##3##(1993-2#1)(2007-12#1)(2008-5#1)
but in cases of##2##4##(1992-11#1)(2011-3#1)
but in certain##2##3##(1995-5#1)(2013-8#1)
but in contrast##2##3##(1990-2#1)(2008-10#1)
but in fact##2##3##(1997-3#1)(2013-1#1)
but in general##2##3##(1996-9#1)(2008-9#1)
but in most cases##2##4##(1997-3#1)(2008-10#1)
but in most##3##3##(1990-12#1)(1997-3#1)(2008-10#1)
but in only##3##3##(1996-5#1)(2008-7#1)(2008-8#1)
but in practice##2##3##(2008-3#1)(2008-9#1)
but in recent years##2##4##(2006-10#1)(2011-2#1)
but in some##3##3##(1992-3#1)(1997-6#1)(2009-12#1)
but in the absence of##2##5##(2008-4#1)(2008-8#1)
but in the case of##6##5##(1990-12#1)(1993-6#1)(2008-10#4)
but in the conventional tillage treatment##2##6##(2008-10#2)
but in the present##2##4##(1990-5#1)(2008-11#1)
but in the##37##3##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1993-6#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
but in this##3##3##(1990-5#1)(2008-5#1)(2008-7#1)
but in ways that##2##4##(2008-11#1)(2012-2#1)
but in##122##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
but inactive##2##2##(2007-7#1)(2008-9#1)
but includes##2##2##(2007-11#1)(2011-2#1)
but incomplete##2##2##(2008-7#1)(2011-1#1)
but inconsistent with##2##3##(1994-3#1)(2008-10#1)
but increased during##2##3##(2008-7#1)(2008-8#1)
but increased in##3##3##(1996-2#1)(2008-11#1)(2012-8#1)
but increased the##2##3##(1992-3#1)(1994-8#1)
but increased##23##2##(1991-12#1)(1992-3#1)(1992-6#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2012-4#1)(2012-8#1)(2013-1#1)
but increases##6##2##(1994-3#1)(1995-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
but independent##5##2##(1994-11#1)(2008-10#2)(2011-2#1)(2012-12#1)
but induced##4##2##(1991-12#1)(1994-8#1)(2008-10#1)(2008-11#1)
but induces##2##2##(1997-6#1)(2008-7#1)
but inhibited by##4##3##(1992-8#1)(1993-6#1)(1997-1#1)(2010-11#1)
but inhibited the##2##3##(1993-12#1)(2008-4#1)
but inhibited##13##2##(1991-5#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1997-1#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-11#2)
but inhibits##3##2##(1993-8#1)(1994-11#1)(1994-5#1)
but instead of##2##3##(2008-11#1)(2008-4#1)
but instead##7##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-5#1)
but interactions between##2##3##(2008-10#1)(2013-7#1)
but invariably##2##2##(2007-8#1)(2008-9#1)
but is a##6##3##(1992-9#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-7#1)
but is absent##2##3##(2008-10#1)(2013-8#1)
but is also associated with##2##5##(1991-11#1)(2011-2#1)
but is also important##2##4##(2008-8#1)(2009-6#1)
but is also##9##3##(1991-11#1)(1994-9#1)(1996-12#1)(1997-2#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#2)
but is applicable to##2##4##(1994-6#1)(2008-3#1)
but is converted##2##3##(1992-6#1)(2010-1#1)
but is expected to##2##4##(1997-6#1)(2011-2#1)
but is expensive and limited to specialized laboratories##2##8##(2013-1#2)
but is less##2##3##(2008-3#1)(2009-10#1)
but is limited by##2##4##(1997-3#1)(2008-9#1)
but is not affected by the##2##6##(1992-8#1)(1994-9#1)
but is not affected by##4##5##(1992-8#1)(1994-12#1)(1994-9#1)(2010-12#1)
but is not always##2##4##(2008-11#2)
but is not necessarily##2##4##(2008-10#1)(2012-2#1)
but is not the##2##4##(2008-10#2)
but is not##25##3##(1990-8#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
but is unable to##2##4##(1995-5#1)(2007-12#1)
but is very important to##2##5##(2006-10#1)(2008-2#1)
but is very##3##3##(1992-12#1)(2006-10#1)(2008-2#1)
but is##136##2##(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#5)(1994-2#3)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#2)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#12)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
but isolates##2##2##(2008-10#2)
but it also##6##3##(1990-11#1)(1993-2#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-10#1)
but it can also##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
but it can be##4##4##(2007-12#1)(2007-5#1)(2013-1#2)
but it can##13##3##(1995-12#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-3#2)(2008-9#1)(2012-3#1)(2013-1#4)
but it cannot##2##3##(1997-4#1)(2008-3#1)
but it could not##2##4##(2008-7#1)(2009-5#1)
but it could##3##3##(2008-7#1)(2009-5#1)(2013-7#1)
but it did not##5##4##(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
but it did##6##3##(2007-11#1)(2008-10#2)(2008-11#2)(2011-2#1)
but it does not##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)
but it does##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)
but it had##2##3##(2008-10#1)(2008-6#1)
but it has no##2##4##(1997-7#1)(2008-10#1)
but it has##9##3##(1993-8#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
but it is also##3##4##(2008-4#1)(2008-5#1)(2009-8#1)
but it is necessary##2##4##(2008-10#1)(2010-7#1)
but it is not essential for##2##6##(1996-8#1)(1997-3#1)
but it is not##7##4##(1990-5#1)(1995-12#1)(1996-8#1)(1997-3#1)(2007-11#1)(2009-10#1)(2013-1#1)
but it is only##2##4##(1994-12#1)(1994-7#1)
but it is rarely##3##4##(2006-10#1)(2008-11#1)(2009-8#1)
but it is still##2##4##(2008-7#1)(2008-8#1)
but it is unclear how##3##5##(2009-5#1)(2010-3#1)(2013-8#1)
but it is unclear##5##4##(2007-10#1)(2009-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
but it is unknown##2##4##(2008-7#1)(2013-1#1)
but it is##57##3##(1990-5#1)(1991-9#2)(1992-12#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-7#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-3#3)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
but it may also be##3##5##(2008-10#1)(2008-8#1)(2010-8#1)
but it may also##5##4##(1997-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
but it may##8##3##(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2010-8#1)(2013-1#1)
but it might##2##3##(2008-4#1)(2009-10#1)
but it remains##3##3##(2008-8#3)
but it requires##5##3##(2007-11#1)(2008-3#2)(2010-5#1)(2011-1#1)
but it seems to be##2##5##(1996-5#1)(2008-11#1)
but it should be##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
but it was not##6##4##(1991-3#1)(1995-4#1)(2008-10#2)(2008-11#2)
but it was##21##3##(1990-8#1)(1991-3#1)(1994-12#1)(1995-4#1)(2006-12#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
but it##178##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-4#1)(1996-12#2)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#4)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#3)(2009-5#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#4)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#1)
but its activity##2##3##(1993-12#1)(2008-5#1)
but its concentration##2##3##(1991-5#1)(2008-11#1)
but its expression is##2##4##(2007-12#1)(2008-11#1)
but its expression##5##3##(1993-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
but its function##2##3##(1993-3#1)(2012-2#1)
but its main##2##3##(2008-11#1)(2010-3#1)
but its presence in##2##4##(1994-12#1)(2013-7#1)
but its role in the##3##5##(1995-2#1)(2012-2#1)(2013-1#1)
but its role in##4##4##(1994-11#1)(1995-2#1)(2012-2#1)(2013-1#1)
but its role##7##3##(1994-11#1)(1995-2#1)(1997-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
but its##61##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
but knowledge of##2##3##(1994-10#1)(2008-10#1)
but lack##5##2##(1993-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)
but lacked##4##2##(1990-7#1)(1995-2#1)(1996-10#1)(2008-10#1)
but lacking a##2##3##(1997-1#1)(2010-8#1)
but lacking##6##2##(1992-6#1)(1997-1#1)(2008-12#2)(2008-5#1)(2010-8#1)
but lacks the C-terminal##2##4##(1994-5#1)(2010-5#1)
but lacks the##4##3##(1994-5#1)(1996-6#1)(2009-9#1)(2010-5#1)
but lacks##6##2##(1990-5#1)(1994-5#1)(1996-6#1)(2008-5#1)(2009-9#1)(2010-5#1)
but large##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
but largely##3##2##(1992-1#1)(1994-9#1)(2010-6#1)
but larger##2##2##(2008-9#1)(2012-3#1)
but later##6##2##(1992-9#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
but leaves##2##2##(1993-12#1)(1994-6#1)
but led to##2##3##(1997-8#1)(2008-10#1)
but less than##4##3##(1990-12#1)(1993-5#1)(1994-11#1)(2008-10#1)
but less##27##2##(1990-12#2)(1990-2#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#2)
but lethal complication of##2##4##(2012-1#1)(2012-12#1)
but lethal##3##2##(2008-7#1)(2012-1#1)(2012-12#1)
but levels##2##2##(1995-12#1)(2010-8#1)
but limited##4##2##(1992-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
but limits##2##2##(2008-10#1)(2008-12#1)
but little is known about the##7##6##(1996-3#1)(2008-5#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
but little is known about##11##5##(1996-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
but little or no##5##4##(1990-12#1)(2008-10#4)
but little##23##2##(1990-12#1)(1991-8#1)(1995-3#1)(1996-3#2)(1997-2#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
but long-lasting##2##2##(1993-12#1)(2007-8#1)
but low##11##2##(1990-8#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-8#1)
but lower##7##2##(1995-1#1)(2007-7#1)(2008-6#1)(2008-9#2)(2012-3#1)(2013-1#1)
but mainly##3##2##(1990-6#1)(1994-8#1)(2012-12#1)
but maintained##4##2##(1993-8#1)(2008-11#1)(2008-2#1)(2012-1#1)
but many of##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
but many##10##2##(2007-2#1)(2008-10#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
but marked##2##2##(1991-6#1)(2008-9#1)
but markedly##5##2##(1990-6#1)(1994-3#1)(2007-11#1)(2008-10#1)(2013-8#1)
but mass##2##2##(1996-12#1)(2008-10#1)
but may also be##3##4##(2012-2#1)(2012-3#2)
but may also##7##3##(1990-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#2)
but may be a##2##4##(2009-6#1)(2011-2#1)
but may be an##2##4##(2011-2#1)(2013-1#1)
but may be##15##3##(1992-3#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-3#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
but may help##2##3##(2008-5#1)(2011-1#1)
but may instead reflect##2##4##(1996-2#1)(2008-11#1)
but may not##2##3##(1993-9#1)(2008-8#1)
but may reflect##2##3##(1997-3#1)(2006-10#1)
but may##54##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1996-11#1)(1996-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)
but medical##2##2##(1994-12#1)(2009-6#1)
but men##2##2##(2008-12#1)(2011-1#1)
but microscopic##2##2##(2009-1#1)(2011-1#1)
but might be##3##3##(2008-11#1)(2009-4#1)(2012-1#1)
but might##6##2##(1996-2#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-1#1)
but minor##2##2##(2008-10#1)(2008-6#1)
but moderate to##2##3##(2008-4#1)(2008-5#1)
but moderate##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
but more distant##2##3##(1992-12#1)(2008-10#1)
but more importantly##3##3##(1992-4#1)(2008-1#1)(2008-7#1)
but more likely##2##3##(1992-3#1)(2008-10#1)
but more severe##3##3##(1991-9#1)(1994-5#1)(2007-8#1)
but more than##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
but more##36##2##(1990-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-5#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#2)(2010-12#1)(2010-2#1)(2013-8#1)
but morphologically##2##2##(2011-2#1)(2012-3#1)
but mortality##2##2##(1991-6#1)(2008-10#1)
but most of the##4##4##(1992-2#1)(1995-9#1)(2008-1#1)(2011-2#1)
but most of them##3##4##(2008-10#1)(2010-5#1)(2012-4#1)
but most of##7##3##(1992-2#1)(1995-9#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-4#1)
but most##21##2##(1992-2#1)(1992-3#1)(1993-3#1)(1995-9#1)(1997-1#1)(1997-9#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-4#1)
but mostly with##2##3##(2008-10#1)(2011-2#1)
but mostly##6##2##(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
but much more##2##3##(1991-9#1)(1995-5#1)
but much##7##2##(1991-9#1)(1995-5#1)(1995-6#1)(2007-10#1)(2007-7#1)(2009-7#1)(2011-2#1)
but multiple##3##2##(1992-10#1)(1997-5#1)(2013-8#1)
but must be##2##3##(2008-10#1)(2013-1#1)
but must##4##2##(2008-10#1)(2008-9#1)(2010-2#1)(2013-1#1)
but mutually##2##2##(2008-3#1)(2011-2#1)
but my##3##2##(2007-2#1)(2012-2#1)(2013-7#1)
but nearly##2##2##(1995-8#1)(2010-4#1)
but necessary##3##2##(1991-12#1)(1994-2#1)(2011-2#1)
but negative for##4##3##(1991-6#1)(1997-2#1)(2008-11#1)(2012-1#1)
but negative##8##2##(1991-6#1)(1997-2#2)(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-1#1)
but negatively##2##2##(2008-10#1)(2008-11#1)
but neglected##2##2##(1996-12#1)(2010-10#1)
but neither the##2##3##(1993-12#1)(2007-12#1)
but neither##15##2##(1993-11#1)(1993-12#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-5#2)(2009-1#1)(2011-2#1)
but never in##3##3##(2008-10#2)(2011-2#1)
but never##6##2##(1994-2#1)(1994-5#1)(2008-10#3)(2011-2#1)
but nevertheless##4##2##(1990-9#1)(1995-12#1)(2009-8#1)(2010-6#1)
but new##3##2##(1997-5#1)(2008-10#1)(2012-3#1)
but no apothecia of##2##4##(2008-10#2)
but no apparent##3##3##(1993-8#1)(2006-10#1)(2008-10#1)
but no change was##2##4##(1992-8#1)(1994-12#1)
but no change##4##3##(1992-8#1)(1994-12#1)(1995-5#1)(2008-10#1)
but no changes##3##3##(1990-7#1)(1995-3#1)(1997-8#1)
but no detectable##2##3##(2008-8#1)(2009-6#1)
but no difference##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)
but no differences were##2##4##(2008-11#1)(2010-4#1)
but no differences##3##3##(1990-8#1)(2008-11#1)(2010-4#1)
but no effect##2##3##(2008-10#1)(2012-12#1)
but no evidence of##4##4##(1991-1#1)(1996-12#1)(2009-1#1)(2010-4#1)
but no evidence##6##3##(1991-1#1)(1996-12#1)(2008-10#1)(2009-1#1)(2010-4#1)(2011-2#1)
but no general##2##3##(1991-12#1)(2008-9#1)
but no greater##2##3##(1995-2#1)(1995-3#1)
but no increase in##3##4##(1994-9#1)(2008-10#2)
but no neurological##2##3##(1995-5#1)(2012-2#1)
but no obvious difference##2##4##(1995-3#1)(2008-11#1)
but no other##2##3##(1992-9#1)(2008-7#1)
but no reduction in##2##4##(1990-6#1)(2008-1#1)
but no significant changes were##2##5##(2008-10#1)(2012-3#1)
but no significant difference in##2##5##(1993-6#1)(2007-2#1)
but no significant difference was found##2##6##(2008-7#1)(2010-12#1)
but no significant difference##4##4##(1993-6#1)(2007-2#1)(2008-7#1)(2010-12#1)
but no significant differences were found##2##6##(1993-2#1)(2011-3#1)
but no significant differences were##3##5##(1993-2#1)(2008-10#1)(2011-3#1)
but no significant differences##4##4##(1993-2#1)(2008-10#1)(2010-3#1)(2011-3#1)
but no significant##18##3##(1993-2#2)(1993-6#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#2)
but no such##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
but no synergistic##2##3##(2007-2#1)(2008-10#1)
but no##155##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-2#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#5)(1995-5#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-1#3)(2008-10#30)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#5)(2011-3#1)(2011-4#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
but non-specific##2##2##(1997-2#1)(2008-4#1)
but none are##2##3##(1993-12#1)(2010-1#1)
but none have##2##3##(2008-11#1)(2008-3#1)
but none of the analytes##2##5##(2008-10#2)
but none of the##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
but none of##6##3##(1990-12#1)(1995-12#1)(2008-10#2)(2012-2#1)(2013-8#1)
but none was##2##3##(1990-5#1)(2011-1#1)
but none##25##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-2#2)(1995-12#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
but nonidentical##2##2##(1994-5#1)(1995-5#1)
but nonsignificant##2##2##(2008-3#1)(2008-7#1)
but normal##3##2##(1991-12#1)(1991-8#1)(2010-5#1)
but not 1##2##3##(1996-9#1)(2008-10#1)
but not 10##2##3##(1993-12#1)(1995-12#1)
but not 2##2##3##(2008-10#1)(2013-1#1)
but not 6 days##2##4##(1992-11#2)
but not B##3##3##(1991-1#1)(1992-12#1)(2008-10#1)
but not DMNQ##2##3##(2009-9#2)
but not EGF##2##3##(1993-9#2)
but not Fos##2##3##(1995-11#2)
but not N##2##3##(2008-10#2)
but not a##5##3##(1995-6#1)(1996-7#1)(2008-10#2)(2008-11#1)
but not accounted for##2##4##(2008-12#2)
but not after##6##3##(1993-12#2)(1995-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
but not all##30##3##(1990-6#1)(1991-10#1)(1991-8#1)(1992-6#2)(1993-3#1)(1995-1#1)(1997-9#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#4)(2013-1#1)
but not always sufficient##2##4##(2008-10#1)(2008-11#1)
but not always##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
but not among##3##3##(1994-3#1)(2008-11#1)(2012-2#1)
but not any##2##3##(2008-10#1)(2008-11#1)
but not apoptosis##2##3##(1994-9#1)(2008-10#1)
but not as a##4##4##(2008-12#1)(2008-5#2)(2012-3#1)
but not as##5##3##(1993-8#1)(2008-12#1)(2008-5#2)(2012-3#1)
but not at 50 mg/kg##2##5##(1991-12#2)
but not at all in the##2##6##(1990-11#1)(1997-8#1)
but not at high##2##4##(2008-10#1)(2008-2#1)
but not at pH##2##4##(1991-8#1)(2008-5#1)
but not at##26##3##(1990-11#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
but not between plasma##2##4##(1994-8#1)(2008-7#1)
but not between##5##3##(1994-8#1)(2007-1#1)(2008-7#1)(2008-8#1)(2010-9#1)
but not by a##3##4##(1994-2#2)(1995-6#1)
but not by an inactive##2##5##(1992-12#1)(1994-8#1)
but not by cAMP-dependent##2##4##(1990-11#1)(1995-2#1)
but not by casein##2##4##(1992-6#1)(1993-8#1)
but not by other##2##4##(1990-2#1)(2008-10#1)
but not by phorbol esters##2##5##(1995-6#1)(1996-2#1)
but not by phorbol##3##4##(1994-11#1)(1995-6#1)(1996-2#1)
but not by the##2##4##(1996-2#1)(2008-10#1)
but not by##92##3##(1990-11#3)(1990-2#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-9#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#4)(1992-9#2)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#4)(1996-12#1)(1996-2#3)(1996-7#1)(1997-2#2)(1997-7#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2013-1#1)
but not completely##4##3##(1994-2#1)(2008-11#1)(2010-8#1)(2013-8#1)
but not control##3##3##(1994-9#1)(2008-12#1)(2011-1#1)
but not cue learning or swim speed##3##7##(1993-12#3)
but not detected##2##3##(1991-2#1)(2012-12#1)
but not during the##2##4##(1994-8#1)(2011-2#1)
but not during##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
but not enough to##4##4##(1994-1#1)(1996-5#1)(2008-10#1)(2008-11#1)
but not exclusively##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
but not faces and names##2##5##(2012-1#2)
but not for boys##2##4##(2007-12#1)(2010-10#1)
but not for the higher##2##5##(2008-5#1)(2008-7#1)
but not for the##9##4##(1992-11#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
but not for those##2##4##(1993-11#1)(2009-7#1)
but not for##50##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-8#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-10#8)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
but not from a##3##4##(1994-9#1)(2008-10#1)(2011-2#1)
but not from the##3##4##(1990-5#1)(1996-12#1)(1996-5#1)
but not from##18##3##(1990-2#1)(1990-5#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#6)(2008-7#1)(2009-9#1)(2011-2#1)
but not fully##2##3##(2009-12#1)(2011-1#1)
but not healthy##2##3##(2008-10#2)
but not hematopoietic##2##3##(2010-8#2)
but not high-threat##2##3##(2012-12#2)
but not highly##2##3##(2013-1#2)
but not in a##4##4##(1994-11#1)(1994-8#1)(2008-10#1)(2012-1#1)
but not in all##2##4##(1993-9#1)(2008-10#1)
but not in an##2##4##(1995-8#1)(1997-7#1)
but not in cerebellum##2##4##(1997-2#2)
but not in females##2##4##(1994-6#1)(2013-8#1)
but not in healthy##2##4##(2008-10#1)(2008-3#1)
but not in human##3##4##(1990-8#1)(1997-1#1)(2008-10#1)
but not in liver##4##4##(1996-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
but not in maize leaves showing##2##6##(2008-10#2)
but not in most normal##2##5##(1990-11#1)(2008-11#1)
but not in neat##2##4##(1992-6#1)(1996-2#1)
but not in normal##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
but not in old ones##2##5##(2008-7#2)
but not in other##4##4##(1993-12#1)(2008-4#1)(2008-8#1)(2010-3#1)
but not in primary##2##4##(1992-8#1)(1993-6#1)
but not in susceptible##2##4##(2008-10#2)
but not in the hippocampus##3##5##(1994-3#1)(2008-11#2)
but not in the other##3##5##(2007-12#1)(2008-5#1)(2013-8#1)
but not in the presence of##2##6##(1997-7#1)(2007-2#1)
but not in the##68##4##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#4)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-2#2)(1997-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
but not in their normal##2##5##(1991-8#1)(1995-2#1)
but not in their##3##4##(1991-8#1)(1995-2#1)(2008-8#1)
but not in##237##3##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-12#5)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#6)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#5)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#5)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#48)(2008-11#9)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#9)(2008-9#4)(2009-1#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
but not its##4##3##(1993-3#1)(1995-11#1)(1995-3#1)(2008-11#1)
but not least##4##3##(1991-3#1)(2007-11#1)(2008-11#1)(2011-1#1)
but not mRNA##2##3##(1994-2#2)
but not mitochondrial##2##3##(1993-11#1)(2008-7#1)
but not more##2##3##(2008-8#1)(2008-9#1)
but not normal##4##3##(1992-3#1)(1994-11#1)(1994-6#1)(2011-2#1)
but not nuclear##2##3##(1990-8#1)(1994-6#1)
but not of the##3##4##(1991-12#1)(1993-3#1)(2008-10#1)
but not of##23##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2010-11#1)(2012-2#1)
but not on the##5##4##(1992-6#1)(1993-1#1)(1993-6#1)(2008-10#2)
but not on##25##3##(1990-3#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2013-1#1)(2013-8#1)
but not other##3##3##(1993-3#1)(1994-8#2)
but not overall##2##3##(2008-8#1)(2011-2#1)
but not quinpirole##2##3##(1992-3#1)(2008-7#1)
but not significant##2##3##(1994-12#1)(2010-8#1)
but not significantly##6##3##(1990-7#1)(1993-3#1)(1997-7#2)(2008-3#1)(2011-2#1)
but not small##2##3##(2007-12#1)(2008-3#1)
but not sufficient##3##3##(1991-3#1)(1994-5#1)(1997-6#1)
but not that of the##3##5##(1991-7#1)(1993-9#1)(2008-10#1)
but not that of##12##4##(1991-7#1)(1993-9#2)(1994-9#1)(1995-11#1)(1997-7#3)(2007-7#1)(2008-10#2)(2008-11#1)
but not that##18##3##(1991-7#1)(1992-10#1)(1992-12#1)(1993-9#2)(1994-11#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-5#1)(1997-7#3)(2007-7#1)(2008-10#2)(2008-11#1)
but not the apparent Km##2##5##(1992-6#2)
but not the mutant##2##4##(1990-5#1)(1995-6#1)
but not the other##2##4##(1990-5#1)(2008-9#1)
but not the##78##3##(1990-11#1)(1990-5#3)(1991-2#2)(1991-8#1)(1992-10#1)(1992-3#3)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-5#2)(1997-2#3)(1997-7#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
but not their##2##3##(1994-6#1)(2008-10#1)
but not those##5##3##(1992-8#2)(1993-9#1)(1995-5#1)(2009-10#1)
but not through##2##3##(2008-8#1)(2010-8#1)
but not to a##3##4##(1991-6#1)(1997-6#1)(2007-12#1)
but not to other##3##4##(1991-12#1)(1997-3#1)(2012-12#1)
but not to the##2##4##(1995-11#1)(2009-2#1)
but not to##35##3##(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-6#2)(1992-8#1)(1993-9#1)(1995-11#2)(1995-8#1)(1996-5#1)(1997-3#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2012-12#1)(2013-8#1)
but not vice versa##4##4##(1996-5#1)(2007-12#1)(2009-7#1)(2012-2#1)
but not well##2##3##(1994-1#1)(1996-4#1)
but not when they##3##4##(1991-3#1)(1992-6#1)(2009-11#1)
but not when##8##3##(1991-3#1)(1992-6#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-5#1)
but not with HbA1c level##2##5##(2012-5#2)
but not with a##3##4##(2008-10#1)(2008-5#2)
but not with either##3##4##(1994-6#1)(1997-4#1)(2008-10#1)
but not with the##6##4##(1997-7#1)(2008-10#2)(2010-2#1)(2011-1#1)(2013-8#1)
but not with##46##3##(1990-3#1)(1990-5#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#3)(1993-6#2)(1994-2#1)(1994-6#3)(1994-8#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#3)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-4#1)(2012-5#2)(2013-8#1)
but not within##4##3##(1997-9#1)(2008-10#2)(2010-4#1)
but not yet##5##3##(1994-9#1)(1995-6#1)(2008-10#1)(2008-7#2)
but not##1198##2##(1990-10#1)(1990-11#14)(1990-12#7)(1990-2#8)(1990-3#4)(1990-5#14)(1990-6#1)(1990-7#6)(1990-8#9)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#14)(1991-2#12)(1991-3#5)(1991-5#8)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#4)(1992-1#3)(1992-10#4)(1992-11#7)(1992-12#8)(1992-3#13)(1992-4#1)(1992-5#1)(1992-6#14)(1992-8#13)(1992-9#10)(1993-1#3)(1993-11#10)(1993-12#27)(1993-3#17)(1993-5#1)(1993-6#12)(1993-8#9)(1993-9#12)(1994-1#2)(1994-10#1)(1994-11#9)(1994-12#4)(1994-2#12)(1994-3#7)(1994-5#9)(1994-6#20)(1994-8#23)(1994-9#12)(1995-1#2)(1995-11#18)(1995-12#20)(1995-2#14)(1995-3#5)(1995-5#6)(1995-6#16)(1995-8#12)(1996-12#14)(1996-2#15)(1996-3#2)(1996-4#1)(1996-5#16)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#15)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#20)(1997-8#2)(1997-9#3)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#8)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#181)(2008-11#47)(2008-12#10)(2008-2#7)(2008-3#9)(2008-4#9)(2008-5#25)(2008-6#6)(2008-7#29)(2008-8#35)(2008-9#19)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#6)(2009-2#3)(2009-4#1)(2009-5#3)(2009-6#6)(2009-7#6)(2009-8#6)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#1)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#3)(2010-8#12)(2010-9#2)(2011-1#10)(2011-10#1)(2011-2#26)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#13)(2012-3#7)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#23)(2013-7#5)(2013-8#11)
but nothing##2##2##(1992-10#1)(2007-12#1)
but now##7##2##(1996-4#1)(1997-7#1)(2007-3#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-7#1)
but occasionally##5##2##(1993-9#1)(1997-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
but occurs##2##2##(1996-2#1)(2008-7#1)
but of##8##2##(1991-12#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-7#1)
but often##13##2##(1991-11#1)(1991-3#1)(1992-3#1)(1993-9#1)(1996-7#1)(1997-4#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
but on the##2##3##(2009-12#1)(2011-2#1)
but on##6##2##(1992-12#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
but once##3##2##(1993-5#1)(2010-4#1)(2010-5#1)
but one of the nonpathogenic isolates##2##6##(2008-10#2)
but one of the##10##4##(1992-3#1)(2007-12#1)(2008-10#6)(2008-9#1)(2009-11#1)
but one of##12##3##(1990-2#1)(1992-3#1)(2007-12#1)(2008-10#6)(2008-9#1)(2009-11#1)(2011-2#1)
but one patient##4##3##(2006-10#1)(2007-8#1)(2008-11#1)(2011-2#1)
but one##48##2##(1990-12#2)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-8#1)(2013-1#1)
but only 15##2##3##(2007-7#1)(2013-1#1)
but only 2##2##3##(2008-10#1)(2008-9#1)
but only 3##2##3##(1997-7#1)(2008-10#1)
but only a few##5##4##(2007-11#1)(2008-10#1)(2008-8#1)(2010-6#1)(2012-2#1)
but only a##10##3##(1990-2#1)(2007-11#1)(2008-10#2)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
but only at##7##3##(1990-2#1)(1991-8#1)(1992-5#1)(1992-6#1)(2007-12#1)(2008-3#1)(2012-12#1)
but only by##2##3##(1990-3#1)(2008-10#1)
but only few##3##3##(2008-7#2)(2013-8#1)
but only for##6##3##(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-1#1)
but only if##2##3##(1991-1#1)(2008-11#1)
but only in the##8##4##(1991-5#1)(1994-12#1)(1997-8#1)(2008-10#3)(2011-2#1)(2013-1#1)
but only in##15##3##(1990-2#1)(1991-5#1)(1992-10#1)(1994-12#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-4#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-4#1)(2013-1#1)
but only on##2##3##(2008-10#1)(2008-8#1)
but only one of##2##4##(1992-5#1)(1995-2#1)
but only one##5##3##(1992-3#1)(1992-5#1)(1995-2#1)(2008-12#1)(2008-5#1)
but only rarely##2##3##(2008-10#2)
but only the##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
but only three##2##3##(2008-10#1)(2008-9#1)
but only two of them##2##5##(2008-10#1)(2008-5#1)
but only two##4##3##(1991-6#1)(1995-2#1)(2008-10#1)(2008-5#1)
but only when the##2##4##(1997-2#1)(2008-10#1)
but only when##4##3##(1997-2#1)(2008-10#2)(2013-1#1)
but only##155##2##(1990-12#2)(1990-2#4)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#2)(2008-10#34)(2008-11#6)(2008-12#2)(2008-3#6)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#4)(2013-8#1)
but other factors##3##3##(1997-7#1)(2008-7#1)(2012-2#1)
but other nucleoside##2##3##(1995-11#1)(2008-1#1)
but other##19##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-9#1)(1995-11#1)(1997-5#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-1#1)(2010-3#1)(2012-2#1)(2013-1#1)
but others were##2##3##(1997-6#1)(2013-1#1)
but others##3##2##(1997-6#1)(2008-5#1)(2013-1#1)
but otherwise it##2##3##(1994-12#1)(2008-7#1)
but otherwise##7##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2013-1#2)
but our understanding of the##2##5##(2007-12#1)(2012-2#1)
but our##5##2##(2007-12#2)(2008-7#1)(2009-8#1)(2012-2#1)
but over the##2##3##(2008-9#1)(2011-2#1)
but over##4##2##(1996-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
but overall##2##2##(1990-2#1)(2008-10#1)
but oxendolone##2##2##(1990-11#2)
but partial##2##2##(1992-7#1)(2008-10#1)
but partially##2##2##(1994-6#1)(2008-4#1)
but particularly in##2##3##(1995-2#1)(2008-7#1)
but particularly##3##2##(1992-2#1)(1995-2#1)(2008-7#1)
but patient##2##2##(2007-5#1)(2008-11#1)
but patients treated with##2##4##(1997-3#1)(2012-12#1)
but patients##3##2##(1990-8#1)(1997-3#1)(2012-12#1)
but perceived##2##2##(2008-9#1)(2013-8#1)
but perhaps##3##2##(1997-4#1)(2007-8#1)(2008-3#1)
but persistent##5##2##(1992-6#1)(1994-5#1)(1994-6#1)(1997-3#1)(2008-7#1)
but poor##2##2##(1996-3#1)(2011-1#1)
but poorly##3##2##(1992-6#1)(2011-2#1)(2012-3#1)
but population##2##2##(2008-10#2)
but positive##3##2##(1997-7#1)(2008-4#1)(2011-2#1)
but possess##2##2##(2007-5#1)(2008-10#1)
but possessed##2##2##(1991-5#1)(2008-10#1)
but potentially serious##2##3##(2011-2#1)(2012-3#1)
but potentially##8##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
but practically##2##2##(1995-9#1)(2008-7#1)
but presented##2##2##(2008-10#1)(2013-1#1)
but previously##3##2##(1993-12#1)(1993-9#1)(2007-11#1)
but prior to##2##3##(1994-11#1)(1994-12#1)
but probably not##2##3##(1990-12#1)(2008-10#1)
but probably##8##2##(1990-12#1)(1991-11#1)(1991-9#1)(1993-11#2)(1997-6#1)(2008-10#2)
but produces##2##2##(2008-3#2)
but production was##2##3##(2008-10#2)
but production##3##2##(2008-10#3)
but progressive##2##2##(1991-2#1)(2012-3#1)
but proper##2##2##(2008-7#1)(2010-7#1)
but proved to be##2##4##(2008-11#1)(2008-7#1)
but proved##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
but quality##2##2##(1992-9#1)(2007-11#1)
but ranged from##2##3##(2008-10#2)
but rare complication##2##3##(2007-8#1)(2009-3#1)
but rare in##2##3##(2007-12#1)(2008-5#1)
but rare##6##2##(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-3#1)
but rarely in##2##3##(2007-10#1)(2008-5#1)
but rarely##12##2##(1993-12#1)(1994-6#1)(1995-11#1)(1996-11#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
but rather a##6##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)
but rather an##2##3##(2012-2#1)(2013-8#1)
but rather are##2##3##(2008-10#1)(2012-3#1)
but rather as a##2##4##(1995-6#1)(2013-8#1)
but rather as##3##3##(1995-6#1)(2008-5#1)(2013-8#1)
but rather by##2##3##(1993-8#1)(2008-11#1)
but rather due to##2##4##(1990-5#1)(2008-9#1)
but rather exact a toll on the individual sufferer and the family system at large##2##15##(2013-1#2)
but rather from##3##3##(1990-12#1)(1992-2#1)(1996-5#1)
but rather has##2##3##(1992-11#1)(2007-12#1)
but rather on##2##3##(1992-12#1)(2012-3#1)
but rather that the##2##4##(1990-11#1)(2008-9#1)
but rather that##3##3##(1990-11#1)(2008-10#1)(2008-9#1)
but rather the##2##3##(1993-11#1)(2011-2#1)
but rather to provide##2##4##(2008-10#1)(2011-2#1)
but rather to the##2##4##(2008-10#1)(2009-10#1)
but rather to##10##3##(1992-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#2)
but rather##73##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-1#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
but reacted##2##2##(2008-10#2)
but real##2##2##(1990-6#1)(1994-5#1)
but recent##6##2##(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
but recovered##6##2##(1991-12#1)(1993-12#2)(1997-2#1)(2008-10#2)
but reduced by##2##3##(1994-6#1)(1995-12#1)
but reduced the##5##3##(1990-2#1)(1990-3#1)(1995-12#1)(2008-10#1)(2011-2#1)
but reduced##11##2##(1990-2#1)(1990-3#1)(1994-3#1)(1994-6#1)(1995-12#2)(1997-3#1)(2008-10#2)(2011-1#1)(2011-2#1)
but reductions##2##2##(1995-12#1)(2008-11#1)
but reflects##2##2##(2008-5#1)(2010-11#1)
but related##3##2##(1994-11#1)(2008-11#1)(2008-8#1)
but relatively little is known about##2##6##(2007-10#1)(2010-8#1)
but relatively##10##2##(1992-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
but release##2##2##(2010-5#1)(2013-1#1)
but reliable##2##2##(2008-10#1)(2011-2#1)
but remain##3##2##(2008-10#3)
but remained##6##2##(1994-5#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
but remains##8##2##(1990-5#1)(1993-6#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
but reproducible##3##2##(2008-10#3)
but require##5##2##(1995-5#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-5#1)
but required##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
but requires a##3##3##(2008-2#1)(2011-1#1)(2012-2#1)
but requires##10##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)
but resistance##2##2##(2008-10#1)(2008-11#1)
but resistant to##4##3##(2008-10#4)
but responded##2##2##(1993-6#1)(2007-8#1)
but resulted in##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
but results in##2##3##(1994-11#1)(2010-7#1)
but results##5##2##(1994-11#1)(1994-5#1)(2008-3#1)(2009-10#1)(2010-7#1)
but retained its##2##3##(2008-10#2)
but retained##6##2##(2008-10#3)(2008-5#1)(2010-11#1)(2013-7#1)
but retaining##2##2##(1993-8#1)(1995-2#1)
but returned to##2##3##(2007-11#1)(2013-1#1)
but returned##3##2##(1991-8#1)(2007-11#1)(2013-1#1)
but revealed##2##2##(2008-10#1)(2009-8#1)
but reversible##2##2##(1992-3#2)
but rhizosphere##2##2##(2008-10#1)(2013-8#1)
but rose##2##2##(2007-7#1)(2011-2#1)
but satisfactory##2##2##(1994-9#1)(2013-1#1)
but scientific##3##2##(2008-10#2)(2013-1#1)
but seldom##2##2##(1995-12#1)(2010-11#1)
but sensitive to##3##3##(1996-12#1)(2008-10#2)
but sensitive##4##2##(1996-12#1)(2007-12#1)(2008-10#2)
but separate##2##2##(1992-6#1)(2012-12#1)
but serious complications##2##3##(2011-2#1)(2013-1#1)
but serious##4##2##(2007-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
but serum##3##2##(2008-5#1)(2008-6#1)(2012-3#1)
but several##10##2##(1991-5#1)(1993-11#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)
but severe##3##2##(2006-10#1)(2010-12#1)(2013-8#1)
but should be carried out over time##2##7##(2011-1#1)(2011-2#1)
but should be##3##3##(1992-4#1)(2011-1#1)(2011-2#1)
but should not be##2##4##(1992-4#1)(2010-8#1)
but should##8##2##(1992-4#2)(1995-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
but show that##2##3##(2008-2#1)(2012-3#1)
but show##6##2##(2007-8#1)(2008-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
but showed a##4##3##(2008-10#3)(2008-7#1)
but showed no##2##3##(1994-11#1)(2008-9#1)
but showed##12##2##(1990-11#1)(1994-11#1)(1994-8#1)(1995-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)
but shows only##2##3##(1994-8#1)(2012-3#1)
but shows##6##2##(1994-8#1)(1996-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
but significant correlation between##2##4##(2008-10#2)
but significant decrease##2##3##(2008-10#1)(2008-11#1)
but significant increase in the##2##5##(2008-5#1)(2008-9#1)
but significant increase in##3##4##(1991-5#1)(2008-5#1)(2008-9#1)
but significant increases in##3##4##(1990-3#1)(1995-11#1)(2008-10#1)
but significant increases##4##3##(1990-3#1)(1995-11#1)(2008-10#1)(2013-8#1)
but significant##40##2##(1990-11#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#2)(1994-2#1)(1994-3#1)(1995-11#2)(1995-8#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
but significantly decreased##2##3##(2008-12#1)(2013-1#1)
but significantly enhanced##2##3##(1997-4#1)(2008-10#1)
but significantly greater##4##3##(2008-10#3)(2009-7#1)
but significantly higher##2##3##(2008-10#1)(2013-8#1)
but significantly increased##2##3##(1995-12#1)(2008-7#1)
but significantly reduced the##2##4##(1995-5#1)(2008-10#1)
but significantly reduced##4##3##(1994-3#1)(1995-2#1)(1995-5#1)(2008-10#1)
but significantly##29##2##(1990-12#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-4#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
but similar in##2##3##(1996-6#1)(2008-5#1)
but similar##6##2##(1996-6#1)(1997-3#1)(2007-8#1)(2008-12#1)(2008-5#2)
but simply##2##2##(2010-3#1)(2011-2#1)
but six##2##2##(1997-3#1)(2008-10#1)
but slightly##2##2##(1990-5#1)(2008-10#1)
but slowed##2##2##(1996-3#1)(2008-7#1)
but small##2##2##(1992-12#1)(1996-4#1)
but so far##2##3##(1994-3#1)(2008-7#1)
but so##4##2##(1994-3#1)(2008-3#1)(2008-7#2)
but some have##2##3##(2008-11#1)(2008-7#1)
but some of the##2##4##(1990-6#1)(1997-8#1)
but some of##3##3##(1990-6#1)(1992-11#1)(1997-8#1)
but some require##2##3##(2008-7#1)(2009-11#1)
but some##28##2##(1990-2#1)(1990-6#2)(1991-12#1)(1992-11#1)(1993-6#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
but sometimes##7##2##(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-1#1)
but stable##2##2##(1991-11#1)(2008-7#1)
but standard##2##2##(1992-9#1)(2008-5#1)
but statistically significant##13##3##(1992-2#1)(1996-8#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-2#1)
but steadily##2##2##(1993-6#1)(2008-10#1)
but steady##2##2##(2008-3#1)(2008-4#1)
but still##34##2##(1990-10#1)(1993-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
but strong##4##2##(1991-9#1)(1997-5#1)(2008-10#2)
but stronger##2##2##(1995-1#1)(2008-10#1)
but strongly inhibited##2##3##(1996-2#1)(1997-7#1)
but strongly##6##2##(1992-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
but studies of##2##3##(1990-12#1)(2008-9#1)
but studies##5##2##(1990-12#1)(2007-11#1)(2008-9#1)(2009-4#1)(2009-5#1)
but subsequently##2##2##(1994-8#1)(2010-7#1)
but such a##3##3##(1991-11#1)(1992-9#1)(2009-6#1)
but such##8##2##(1991-11#1)(1992-12#1)(1992-9#1)(2008-10#2)(2008-5#2)(2009-6#1)
but suffer from##2##3##(1990-11#1)(2012-2#1)
but suggest that##5##3##(1991-12#1)(1993-12#1)(1997-2#1)(2009-2#1)(2013-1#1)
but suggest##6##2##(1991-12#1)(1993-12#1)(1995-12#1)(1997-2#1)(2009-2#1)(2013-1#1)
but suggests that##2##3##(2008-10#1)(2008-11#1)
but suppressed the##2##3##(2008-10#1)(2009-12#1)
but susceptible to##2##3##(2008-10#2)
but susceptible##3##2##(2008-10#3)
but techniques##2##2##(2007-12#1)(2008-4#1)
but tended to##2##3##(1993-8#1)(2008-10#1)
but that a##6##3##(1990-11#1)(1990-8#1)(1991-8#1)(1992-9#1)(2007-12#1)(2008-1#1)
but that are##3##3##(2008-3#1)(2008-8#1)(2009-2#1)
but that at##2##3##(2008-10#1)(2008-7#1)
but that has##2##3##(2010-8#1)(2011-2#1)
but that important##2##3##(1994-11#1)(2008-11#1)
but that it can##2##4##(1996-2#1)(2008-2#1)
but that it is##4##4##(1992-6#1)(1993-9#1)(2008-3#1)(2010-5#1)
but that it##10##3##(1992-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#1)
but that of##10##3##(1990-3#1)(1990-7#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-6#1)(2012-2#1)
but that the##15##3##(1990-11#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#2)(2011-1#1)(2012-2#1)
but that there is a##3##5##(1992-12#1)(2008-9#1)(2011-2#1)
but that this##2##3##(2008-10#1)(2008-7#1)
but that##111##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#4)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#6)(2008-9#3)(2009-2#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#6)(2013-1#1)(2013-8#2)
but the Kd##2##3##(1994-11#1)(1997-2#1)
but the ability to##2##4##(1995-5#1)(2008-7#1)
but the ability##3##3##(1992-6#1)(1995-5#1)(2008-7#1)
but the accuracy##2##3##(2008-3#1)(2010-12#1)
but the active##2##3##(1995-5#1)(2008-10#1)
but the actual##2##3##(1994-6#1)(2008-8#1)
but the amounts were##2##4##(2008-10#2)
but the appearance of##2##4##(1992-2#1)(1994-5#1)
but the best##2##3##(1993-11#1)(2007-8#1)
but the binding was##2##4##(1993-6#1)(2010-5#1)
but the calculation##2##3##(2008-10#1)(2013-1#1)
but the causal##2##3##(2008-10#2)
but the cause##2##3##(2011-1#1)(2011-2#1)
but the change##2##3##(1994-12#1)(2008-5#1)
but the complexity of##2##4##(1996-3#1)(2008-10#1)
but the concentration##3##3##(1996-12#1)(2008-10#2)
but the correlation##2##3##(1992-9#1)(2008-10#1)
but the cost##2##3##(2007-12#1)(2010-9#1)
but the data##2##3##(1994-9#1)(2013-1#1)
but the decrease##2##3##(1993-12#1)(2011-1#1)
but the degree of##3##4##(1995-11#1)(1996-2#1)(2008-10#1)
but the detection limits were higher##2##6##(2008-10#2)
but the detection limits##3##4##(2008-10#3)
but the detection##4##3##(2008-10#3)(2010-12#1)
but the difference was not statistically significant##2##7##(1996-12#1)(2008-5#1)
but the difference##3##3##(1991-6#1)(1996-12#1)(2008-5#1)
but the differences between##3##4##(2008-12#1)(2008-5#1)(2008-7#1)
but the differences were not significant##3##6##(1992-2#1)(2008-5#2)
but the differences were not statistically significant##2##7##(2008-1#1)(2008-10#1)
but the differences were not##5##5##(1992-2#1)(2008-1#1)(2008-10#1)(2008-5#2)
but the differences##11##3##(1992-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#1)(2012-12#1)(2012-3#1)
but the disease##3##3##(1997-6#1)(2008-5#1)(2011-2#1)
but the distribution##2##3##(2008-10#2)
but the diversity##2##3##(2008-10#1)(2013-7#1)
but the effect is##2##4##(2008-5#1)(2011-2#1)
but the effect of##6##4##(1995-3#1)(1996-2#1)(2008-10#3)(2011-2#1)
but the effect##10##3##(1995-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
but the effects of##4##4##(1997-4#1)(2008-10#1)(2008-7#1)(2009-9#1)
but the effects##6##3##(1997-4#1)(2008-10#2)(2008-7#1)(2009-9#1)(2012-1#1)
but the entire##3##3##(1992-2#1)(1996-3#1)(1996-6#1)
but the enzyme##3##3##(1991-12#1)(1991-9#1)(1992-3#1)
but the exact##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
but the expression of##4##4##(1994-11#1)(1995-12#1)(2011-2#1)(2011-3#1)
but the expression##5##3##(1994-11#1)(1995-12#1)(2008-8#1)(2011-2#1)(2011-3#1)
but the extent of##2##4##(2008-10#1)(2011-1#1)
but the extent##3##3##(2008-10#2)(2011-1#1)
but the first##2##3##(1997-3#1)(2008-11#1)
but the foamate##2##3##(2008-6#2)
but the formation of##2##4##(1993-3#1)(2007-12#1)
but the former##4##3##(1992-6#1)(1993-9#1)(2011-2#1)(2012-3#1)
but the frequency of##3##4##(1993-9#1)(2007-10#1)(2013-1#1)
but the function of these##2##5##(2008-9#1)(2013-1#1)
but the function of##4##4##(2008-9#3)(2013-1#1)
but the future##2##3##(2007-2#1)(2012-2#1)
but the general##2##3##(1995-5#1)(2008-9#1)
but the genetic##2##3##(1996-12#1)(2012-3#1)
but the highest##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2010-4#1)
but the inhibitory##2##3##(1995-6#1)(1996-5#1)
but the interpretation of the##2##5##(1994-5#1)(2007-10#1)
but the isolates##2##3##(2008-10#2)
but the latter##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
but the least##2##3##(1992-5#1)(2011-2#1)
but the levels##5##3##(1992-2#1)(2008-10#3)(2011-2#1)
but the magnitude of the##3##5##(2008-5#1)(2008-8#2)
but the magnitude of##6##4##(1994-8#1)(1995-3#1)(2008-5#1)(2008-8#2)(2011-2#1)
but the main##2##3##(2008-11#1)(2009-10#1)
but the majority of##2##4##(1993-2#1)(2012-2#1)
but the mechanism by which these##2##6##(1994-11#1)(2008-11#1)
but the mechanism of##4##4##(1993-9#1)(1995-6#1)(2008-5#1)(2009-12#1)
but the mechanism##7##3##(1993-9#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-5#1)(2009-12#1)(2013-1#1)
but the mechanisms are##2##4##(2008-7#1)(2008-9#1)
but the mechanisms##6##3##(1996-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
but the method##2##3##(2008-10#1)(2012-3#1)
but the minimal##2##3##(1991-3#1)(1992-4#1)
but the molecular mechanism##2##4##(2008-11#1)(2008-4#1)
but the molecular##4##3##(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
but the more##2##3##(1994-5#1)(2008-3#1)
but the most##4##3##(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
but the nature of##3##4##(2008-5#1)(2009-12#1)(2011-2#1)
but the number of##4##4##(2007-10#1)(2007-12#1)(2008-8#1)(2013-1#1)
but the number##5##3##(2007-10#1)(2007-12#1)(2008-8#1)(2010-4#1)(2013-1#1)
but the opposite##2##3##(2008-10#1)(2008-7#1)
but the other##4##3##(2008-10#2)(2010-2#1)(2011-2#1)
but the overall##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
but the patient died##2##4##(1991-6#1)(2007-6#1)
but the patient had##2##4##(1994-12#1)(2013-8#1)
but the patient##12##3##(1991-4#1)(1991-6#2)(1994-12#1)(1997-4#1)(2007-6#2)(2007-8#1)(2008-6#1)(2011-2#1)(2011-3#1)(2013-8#1)
but the pattern##2##3##(2008-10#1)(2011-2#1)
but the peak##2##3##(1992-9#1)(2008-10#1)
but the power##2##3##(2008-9#1)(2009-12#1)
but the presence of##5##4##(1990-5#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)
but the principles##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
but the procedure is##3##4##(2008-9#1)(2011-2#1)(2012-2#1)
but the process of##3##4##(1993-6#1)(2008-9#1)(2011-2#1)
but the process##5##3##(1992-3#1)(1993-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
but the rate at which##2##5##(2010-12#1)(2013-8#1)
but the rate of##5##4##(1990-7#1)(1990-9#1)(1992-11#1)(1995-2#1)(2008-10#1)
but the rate##8##3##(1990-7#1)(1990-9#1)(1992-11#1)(1995-2#1)(2008-10#2)(2010-12#1)(2013-8#1)
but the real##3##3##(1993-8#1)(1994-3#1)(2011-2#1)
but the recovery of##2##4##(2008-10#2)
but the reduction##2##3##(2008-10#1)(2008-7#1)
but the relationship##2##3##(2008-1#1)(2011-1#1)
but the relative##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
but the remaining##2##3##(2008-10#1)(2013-8#1)
but the removal of##2##4##(1994-8#1)(2009-9#1)
but the response##3##3##(1995-11#1)(1995-8#1)(2008-7#1)
but the results##8##3##(1994-6#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
but the risk of##2##4##(2008-7#1)(2012-2#1)
but the risk##3##3##(2008-7#1)(2010-4#1)(2012-2#1)
but the role of##2##4##(2008-10#1)(2008-8#1)
but the same##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
but the sequences##2##3##(1992-3#1)(2008-9#1)
but the shift##2##3##(1995-5#1)(2008-2#1)
but the size##2##3##(2012-1#1)(2013-8#1)
but the skin##2##3##(2011-3#1)(2013-8#1)
but the spatial##2##3##(1996-5#1)(2008-3#1)
but the specific##3##3##(1997-3#1)(2008-11#1)(2010-2#1)
but the systemic##2##3##(2008-10#2)
but the tendency##2##3##(1997-6#1)(2007-12#1)
but the third##2##3##(2008-3#1)(2010-5#1)
but the total##2##3##(1994-2#1)(2008-10#1)
but the treatment##2##3##(1991-9#1)(2008-3#1)
but the tumor##2##3##(1993-6#1)(2011-1#1)
but the two##5##3##(1995-11#1)(2008-10#2)(2010-4#1)(2012-2#1)
but the underlying##3##3##(1993-1#1)(2007-8#1)(2012-2#1)
but the use of##7##4##(2008-10#3)(2008-5#1)(2012-12#1)(2013-1#2)
but the use##8##3##(2008-10#3)(2008-5#1)(2012-12#2)(2013-1#2)
but the##700##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#5)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#4)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#1)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#5)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#5)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2008-1#5)(2008-10#130)(2008-11#27)(2008-12#7)(2008-2#6)(2008-3#20)(2008-4#11)(2008-5#26)(2008-6#6)(2008-7#22)(2008-8#16)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#39)(2011-3#3)(2012-1#2)(2012-12#10)(2012-2#16)(2012-3#11)(2013-1#17)(2013-7#2)(2013-8#12)
but their clinical##3##3##(2008-5#1)(2012-12#2)
but their effect on##2##4##(2008-7#1)(2013-1#1)
but their functional##2##3##(2008-5#1)(2008-7#1)
but their relative##3##3##(1993-3#1)(2008-3#1)(2008-8#1)
but their use is limited by##2##6##(2008-10#1)(2013-7#1)
but their use##4##3##(1997-7#1)(2008-10#1)(2011-1#1)(2013-7#1)
but their##56##2##(1990-12#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-7#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
but then##4##2##(2008-10#2)(2009-8#1)(2010-5#1)
but there are also##2##4##(2008-8#1)(2010-6#1)
but there are few##2##4##(1993-2#1)(1994-6#1)
but there are several##2##4##(1993-3#1)(2010-6#1)
but there are##15##3##(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#2)(2011-2#1)(2013-8#1)
but there has been no##5##5##(1990-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
but there has been##8##4##(1990-6#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
but there have been few##2##5##(2008-9#1)(2012-3#1)
but there have been##5##4##(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
but there is a high##2##5##(2013-1#1)(2013-8#1)
but there is a##8##4##(1994-6#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
but there is evidence##2##4##(1992-7#1)(2012-2#1)
but there is no significant##2##5##(2008-9#1)(2009-5#1)
but there is no##10##4##(1995-9#1)(1996-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
but there is still a need for##2##7##(2008-5#1)(2013-1#1)
but there is still##7##4##(1990-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
but there is##40##3##(1990-9#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
but there may be##2##4##(1995-8#1)(2008-7#1)
but there was a significant##3##5##(1995-8#1)(2008-6#1)(2012-12#1)
but there was a##13##4##(1990-11#1)(1990-5#1)(1995-8#1)(1996-3#1)(2007-12#2)(2007-2#1)(2008-3#1)(2008-6#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-12#1)
but there was no correlation##2##5##(2011-2#2)
but there was no evidence of##2##6##(1991-1#1)(1991-6#1)
but there was no significant change in##2##7##(2011-2#1)(2013-1#1)
but there was no significant difference##2##6##(1992-9#1)(2011-2#1)
but there was no significant##8##5##(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
but there was no statistically significant difference##2##7##(1994-2#1)(2009-12#1)
but there was no##22##4##(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-9#1)(2011-2#4)(2012-1#1)(2013-1#1)
but there was significant##2##4##(2008-9#1)(2009-4#1)
but there was##45##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#2)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#2)
but there were no significant differences##2##6##(2008-12#1)(2008-5#1)
but there were no significant##4##5##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
but there were no##7##4##(1993-12#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-3#1)
but there were significant##3##4##(1996-1#1)(2008-10#1)(2008-12#1)
but there were##14##3##(1990-9#1)(1993-12#1)(1996-1#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
but there##135##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#9)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#7)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#1)(2010-6#3)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#3)
but these agents##2##3##(1996-2#1)(2010-4#1)
but these are##3##3##(1997-8#1)(2008-8#1)(2011-2#1)
but these may##2##3##(2008-10#1)(2013-1#1)
but these were not##3##4##(2008-10#3)
but these were##7##3##(1990-12#1)(2008-10#4)(2008-7#1)(2012-2#1)
but these##46##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
but they also##6##3##(1994-5#1)(1995-12#1)(2008-6#1)(2008-7#2)(2010-2#1)
but they are also##3##4##(2008-11#1)(2010-12#1)(2013-1#1)
but they are not##4##4##(1990-5#1)(1994-3#1)(1996-11#1)(2008-8#1)
but they are##24##3##(1990-5#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-9#1)(2010-12#2)(2010-5#2)(2013-1#1)(2013-8#1)
but they can be##4##4##(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)
but they can##5##3##(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)(2013-8#1)
but they cannot##2##3##(1994-12#1)(2007-11#1)
but they could##2##3##(1996-6#1)(2009-7#1)
but they did not##4##4##(1994-11#1)(1994-12#1)(2008-7#1)(2012-12#1)
but they do not##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)
but they have##4##3##(1993-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
but they may##4##3##(1994-8#1)(2007-6#1)(2008-5#1)(2013-1#1)
but they showed##2##3##(1991-3#1)(1997-6#1)
but they were absent##2##4##(2008-10#1)(2009-8#1)
but they were not##3##4##(2008-10#2)(2013-1#1)
but they were##16##3##(1995-12#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-1#2)
but they##91##2##(1990-2#1)(1990-5#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#7)(2013-8#2)
but this approach##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
but this did not##2##4##(2008-7#1)(2008-9#1)
but this difference##4##3##(1991-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
but this effect was not##2##5##(1997-7#1)(2008-12#1)
but this effect was##6##4##(1997-1#1)(1997-7#1)(2008-10#3)(2008-12#1)
but this effect##8##3##(1993-11#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)
but this is##11##3##(1993-9#1)(1995-5#1)(2006-10#1)(2008-10#1)(2010-4#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
but this may be##4##4##(1993-1#1)(1997-5#1)(2006-6#1)(2008-7#1)
but this may##5##3##(1993-1#1)(1997-5#1)(2006-6#1)(2008-11#1)(2008-7#1)
but this method is##2##4##(1997-4#1)(2011-2#1)
but this method##4##3##(1997-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
but this phenomenon may##2##4##(1992-12#1)(1992-2#1)
but this reduction##2##3##(2007-11#1)(2008-10#1)
but this was not##5##4##(1997-1#1)(2007-8#1)(2008-12#1)(2008-6#1)(2013-1#1)
but this was##6##3##(1997-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)
but this##98##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#5)
but those of##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2013-7#1)
but those##10##2##(1992-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-7#1)
but time##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
but to a lesser degree##2##5##(1994-8#1)(2008-3#1)
but to a lesser extent than##3##6##(1991-12#1)(1995-8#1)(2012-2#1)
but to a lesser extent##6##5##(1991-12#1)(1991-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(2012-2#1)
but to a lesser##8##4##(1991-12#1)(1991-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-3#1)(2012-2#1)
but to a##15##3##(1990-3#1)(1991-12#1)(1991-6#1)(1992-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2012-2#1)
but to date##3##3##(2008-7#1)(2008-8#1)(2009-2#1)
but to the##3##3##(1996-1#1)(2008-11#1)(2008-8#1)
but to##44##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-6#1)(1992-8#1)(1994-1#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#2)(2010-10#1)(2011-2#2)(2012-2#3)(2013-7#1)(2013-8#1)
but too##2##2##(2008-3#1)(2008-5#1)
but took##3##2##(1991-3#1)(2008-10#1)(2008-2#1)
but transcribed##2##2##(1994-8#1)(2012-3#1)
but transient##4##2##(1996-12#2)(1997-1#1)(2008-9#1)
but treatment with##2##3##(2008-12#1)(2011-2#1)
but two of##2##3##(2007-12#1)(2008-11#1)
but two patients##3##3##(1993-2#1)(2008-7#1)(2008-9#1)
but two were##2##3##(2011-2#1)(2012-12#1)
but two##17##2##(1993-2#2)(1994-3#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
but typical##2##2##(2008-10#1)(2011-1#1)
but ultimately##2##2##(2008-11#1)(2009-6#1)
but ultrasonography##2##2##(1994-2#1)(1996-11#1)
but uncommon##2##2##(2013-7#1)(2013-8#1)
but under##2##2##(2011-2#1)(2012-3#1)
but underlying##2##2##(2008-2#1)(2008-3#1)
but understudied issue##2##3##(2013-1#2)
but undetected##2##2##(1992-8#1)(2008-5#1)
but unfortunately##3##2##(2008-7#1)(2012-12#1)(2012-3#1)
but unknown##3##2##(2008-10#3)
but unlike##4##2##(1994-3#1)(1995-12#1)(2008-7#1)(2009-4#1)
but until recently##4##3##(2008-8#1)(2011-7#1)(2012-1#1)(2012-3#1)
but unwanted##2##2##(1992-2#1)(2009-12#1)
but up to##2##3##(2008-5#1)(2008-9#1)
but up##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
but upon##2##2##(1997-1#1)(2008-5#1)
but use##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
but used##2##2##(1995-1#1)(2011-2#1)
but useful##3##2##(2008-7#1)(2011-10#1)(2013-8#1)
but using##4##2##(1995-12#1)(2008-10#2)(2011-1#1)
but usually##3##2##(2007-12#1)(2008-7#1)(2009-5#1)
but values##2##2##(2010-8#1)(2012-2#1)
but variable##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
but varied in##2##3##(2008-10#1)(2008-8#1)
but very few##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
but very little##3##3##(1994-2#1)(2009-7#1)(2013-1#1)
but very low##2##3##(2008-10#2)
but very##14##2##(1993-8#1)(1994-2#1)(2007-11#1)(2008-10#4)(2008-5#2)(2009-7#2)(2012-2#1)(2013-1#1)(2013-7#1)
but vitamin##2##2##(1992-11#1)(2009-9#1)
but was able to##2##4##(1995-12#1)(2010-6#1)
but was absent from##2##4##(1994-11#1)(2008-10#1)
but was clearly##2##3##(1992-6#1)(2008-10#1)
but was found to be##2##5##(1992-12#1)(1995-12#1)
but was found to##3##4##(1990-2#1)(1992-12#1)(1995-12#1)
but was found##4##3##(1990-2#1)(1992-12#1)(1995-12#1)(2013-1#1)
but was greater##2##3##(2008-10#1)(2008-3#1)
but was independent of##2##4##(2008-8#2)
but was ineffective##3##3##(1992-12#1)(2008-10#2)
but was inhibited by##2##4##(1997-7#1)(2013-1#1)
but was inhibited##4##3##(1992-9#1)(1997-7#1)(2011-2#1)(2013-1#1)
but was less##2##3##(2008-1#1)(2008-11#1)
but was lower##2##3##(1990-5#1)(1992-3#1)
but was not as effective as##2##6##(2008-10#1)(2013-1#1)
but was not as##3##4##(1995-5#1)(2008-10#1)(2013-1#1)
but was not found##2##4##(1991-4#1)(2008-9#1)
but was not statistically significant##2##5##(2009-10#1)(2011-2#1)
but was not##22##3##(1991-12#2)(1991-4#1)(1995-5#1)(1997-3#2)(2007-7#1)(2008-10#7)(2008-12#1)(2008-9#2)(2009-10#1)(2011-2#2)(2013-1#2)
but was reduced by##3##4##(1993-6#1)(1996-2#1)(2008-10#1)
but was reduced##4##3##(1993-6#1)(1993-9#1)(1996-2#1)(2008-10#1)
but was resistant to##2##4##(1995-2#1)(2008-10#1)
but was restored by##2##4##(1991-5#1)(1996-4#1)
but was significantly lower##2##4##(2008-10#1)(2011-2#1)
but was similar to that##2##5##(2008-9#2)
but was unchanged##2##3##(1990-5#1)(1994-2#1)
but was weakly related to##2##5##(2008-10#2)
but was##130##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
but we found##2##3##(1990-5#1)(2008-8#1)
but we##19##2##(1990-5#1)(1993-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-7#1)
but weak##3##2##(1996-12#1)(1997-3#1)(2011-2#1)
but weaker##2##2##(1993-5#1)(2008-7#1)
but weakly##4##2##(1992-10#1)(1993-9#1)(2008-8#1)(2008-9#1)
but well##5##2##(1992-3#1)(1997-5#1)(2008-10#1)(2008-7#1)(2010-10#1)
but were ineffective against##2##4##(1994-6#1)(2008-10#1)
but were less##2##3##(2008-10#1)(2008-8#1)
but were more##3##3##(1994-11#1)(2008-10#1)(2008-12#1)
but were much##3##3##(1996-5#1)(2008-6#1)(2010-5#1)
but were not detected in##3##5##(1995-11#1)(1997-6#1)(2008-10#1)
but were not detected##4##4##(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#1)
but were not##10##3##(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#2)
but were shown to##2##4##(1995-8#1)(2008-12#1)
but were significantly##3##3##(2008-10#2)(2012-5#1)
but were smaller##2##3##(2007-10#1)(2008-10#1)
but were still##2##3##(1991-9#1)(2012-12#1)
but were very##2##3##(2008-1#1)(2008-10#1)
but were##68##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
but when the##3##3##(2008-5#1)(2009-5#1)(2010-1#1)
but when##21##2##(1993-6#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-7#1)(2010-9#1)
but where hybrids are##2##4##(2013-1#2)
but where##4##2##(1991-9#1)(2008-5#1)(2013-1#2)
but whether they##2##3##(1997-1#1)(2009-8#1)
but whether##5##2##(1997-1#1)(1997-7#1)(2009-8#1)(2011-2#1)(2013-7#1)
but which is##2##3##(2008-2#1)(2008-7#1)
but which##14##2##(1991-5#1)(1995-3#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-8#1)
but who##6##2##(1992-1#1)(1997-8#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
but whose##3##2##(2008-1#1)(2010-12#1)(2012-3#1)
but will not##2##3##(2008-10#1)(2008-11#1)
but will##10##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
but with a##17##3##(1992-11#1)(1992-3#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
but with an##2##3##(2008-3#1)(2009-7#1)
but with different##7##3##(1997-5#1)(2008-10#4)(2008-5#2)
but with higher##2##3##(2008-10#1)(2008-11#1)
but with less##2##3##(1995-8#1)(2007-11#1)
but with minimal##2##3##(2008-5#1)(2011-2#1)
but with no##3##3##(1994-3#1)(2008-1#1)(2008-7#1)
but with only##2##3##(2008-10#1)(2008-5#1)
but with respect to##2##4##(2008-5#1)(2008-6#1)
but with the##8##3##(1997-2#2)(2008-10#3)(2008-11#1)(2008-8#1)(2013-8#1)
but with##90##2##(1990-11#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(2006-6#1)(2007-11#2)(2007-8#4)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
but within##4##2##(1994-5#1)(1995-3#1)(2012-12#1)(2013-7#1)
but without a##2##3##(2008-3#1)(2009-3#1)
but without the additional##2##4##(2007-12#1)(2011-2#1)
but without the##6##3##(2007-12#1)(2008-10#2)(2011-2#2)(2012-2#1)
but without##27##2##(1991-12#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
but worthwhile##2##2##(1996-12#1)(2008-1#1)
but would##3##2##(2007-7#1)(2008-1#1)(2012-1#1)
but##8055##1##(1990-10#5)(1990-11#48)(1990-12#49)(1990-2#34)(1990-3#21)(1990-4#2)(1990-5#55)(1990-6#14)(1990-7#22)(1990-8#27)(1990-9#11)(1991-1#13)(1991-10#2)(1991-11#16)(1991-12#62)(1991-2#36)(1991-3#23)(1991-4#8)(1991-5#41)(1991-6#31)(1991-7#5)(1991-8#24)(1991-9#29)(1992-1#9)(1992-10#14)(1992-11#27)(1992-12#44)(1992-2#16)(1992-3#54)(1992-4#9)(1992-5#18)(1992-6#51)(1992-7#2)(1992-8#34)(1992-9#44)(1993-1#12)(1993-11#36)(1993-12#66)(1993-2#21)(1993-3#48)(1993-5#6)(1993-6#47)(1993-8#37)(1993-9#35)(1994-1#10)(1994-10#2)(1994-11#34)(1994-12#48)(1994-2#55)(1994-3#43)(1994-5#45)(1994-6#50)(1994-7#7)(1994-8#65)(1994-9#42)(1995-1#18)(1995-10#1)(1995-11#58)(1995-12#80)(1995-2#72)(1995-3#36)(1995-4#1)(1995-5#42)(1995-6#48)(1995-8#43)(1995-9#5)(1996-1#13)(1996-10#2)(1996-11#13)(1996-12#52)(1996-2#64)(1996-3#27)(1996-4#11)(1996-5#55)(1996-6#20)(1996-7#7)(1996-8#8)(1996-9#11)(1997-1#32)(1997-2#52)(1997-3#52)(1997-4#37)(1997-5#18)(1997-6#34)(1997-7#53)(1997-8#27)(1997-9#4)(2006-10#26)(2006-12#3)(2006-4#1)(2006-6#7)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#23)(2007-11#60)(2007-12#116)(2007-2#18)(2007-3#1)(2007-4#4)(2007-5#11)(2007-6#11)(2007-7#28)(2007-8#47)(2007-9#5)(2008-1#60)(2008-10#1238)(2008-11#302)(2008-12#114)(2008-2#85)(2008-3#198)(2008-4#107)(2008-5#230)(2008-6#80)(2008-7#311)(2008-8#236)(2008-9#211)(2009-1#6)(2009-10#47)(2009-11#29)(2009-12#37)(2009-2#21)(2009-3#17)(2009-4#21)(2009-5#34)(2009-6#29)(2009-7#36)(2009-8#48)(2009-9#30)(2010-1#18)(2010-10#25)(2010-11#27)(2010-12#39)(2010-2#21)(2010-3#37)(2010-4#31)(2010-5#38)(2010-6#30)(2010-7#21)(2010-8#49)(2010-9#10)(2011-1#92)(2011-10#5)(2011-2#315)(2011-3#11)(2011-4#1)(2011-7#2)(2012-1#37)(2012-12#94)(2012-2#161)(2012-3#112)(2012-4#4)(2012-5#3)(2012-6#4)(2012-7#3)(2012-8#4)(2013-1#229)(2013-7#32)(2013-8#102)
butane gas abuse##2##3##(2011-2#2)
butane gas##3##2##(2011-2#3)
butane##8##1##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#4)
butanol and##2##2##(1990-12#1)(2008-10#1)
butanol##12##1##(1990-11#1)(1990-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2013-1#5)
butch##3##1##(2008-12#3)
butenafine##4##1##(2007-7#4)
buthionine sulfoximine (BSO)##2##3##(2009-10#1)(2012-2#1)
buthionine sulfoximine##4##2##(1992-11#1)(1995-11#1)(2009-10#1)(2012-2#1)
buthionine##5##1##(1992-11#1)(1995-11#1)(2008-2#1)(2009-10#1)(2012-2#1)
butorphanol##4##1##(1991-1#1)(2010-7#2)(2012-3#1)
butoxide##2##1##(1994-5#1)(2007-10#1)
butt coupled##2##2##(2008-3#2)
butt coupling a Fabry-Perot laser diode to##2##7##(2008-2#2)
butt coupling##3##2##(2007-12#1)(2008-2#2)
butt##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
butt-coupled##3##1##(2008-2#1)(2008-3#2)
butter##5##1##(1990-8#2)(1991-3#1)(1992-8#1)(2008-10#1)
butterflies##6##1##(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#2)
butterfly rash##2##2##(2013-1#2)
butterfly wing##2##2##(2008-2#1)(2012-2#1)
butterfly wings##3##2##(2008-2#1)(2012-2#2)
butterfly##28##1##(1997-8#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#9)(2008-9#1)(2012-2#4)(2012-3#1)(2013-1#2)
buttock##12##1##(2008-6#2)(2009-2#1)(2010-8#4)(2012-12#4)(2013-8#1)
buttocks##5##1##(1990-3#1)(2008-5#3)(2013-8#1)
button of columnar epithelium##2##4##(1991-2#2)
button##13##1##(1991-2#4)(2008-10#1)(2008-2#4)(2010-10#1)(2011-2#1)(2013-8#2)
buttons##2##1##(2008-2#1)(2008-9#1)
buttress##2##1##(2008-5#1)(2012-12#1)
buttressing bone formation##2##3##(2013-1#2)
buttressing bone##3##2##(2013-1#3)
buttressing##7##1##(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
butyl methoxy dibenzoyl methane##2##4##(2008-5#2)
butyl methoxydibenzoylmethane##3##2##(2008-5#3)
butyl phosphonate (DBBP)##2##3##(2008-10#2)
butyl rhodamine B (b-RhB)##2##4##(2008-10#2)
butyl rhodamine B##5##3##(2008-10#5)
butyl##21##1##(1990-5#1)(2007-1#1)(2008-10#11)(2008-5#7)(2013-1#1)
butyl(3-hydroxybutyl)tin dilaurate##2##2##(1993-12#2)
butylamine##2##1##(1995-3#1)(2008-10#1)
butylammonium##2##1##(1997-7#2)
butylated hydroxyanisole and##2##3##(1992-9#1)(1996-2#1)
butylated hydroxyanisole##5##2##(1992-9#1)(1995-5#1)(1996-2#1)(2008-10#2)
butylated hydroxytoluene (BHT)##5##3##(1994-3#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-5#1)
butylated hydroxytoluene##9##2##(1992-9#1)(1994-3#1)(1994-5#2)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#2)
butylated##15##1##(1992-9#2)(1994-3#1)(1994-5#2)(1995-3#1)(1995-5#1)(1996-2#2)(2008-10#3)(2008-11#1)(2008-5#2)
butyltin##5##1##(2008-10#3)(2008-11#2)
butyltins##3##1##(2008-10#3)
butyrate and##4##2##(1990-3#1)(1992-2#1)(1997-1#1)(2008-11#1)
butyrate in##3##2##(1990-3#1)(1990-6#1)(2012-2#1)
butyrate treatment##3##2##(1993-6#1)(2008-11#2)
butyrate##50##1##(1990-3#3)(1990-6#4)(1992-2#2)(1992-3#5)(1993-6#3)(1993-9#5)(1994-11#1)(1997-1#1)(2008-11#21)(2008-5#1)(2012-2#2)(2013-1#2)
butyrate)##2##1##(2008-11#2)
butyric acid##12##2##(1990-6#1)(1994-8#1)(2008-10#1)(2008-11#4)(2008-6#2)(2012-12#1)(2012-2#2)
butyric##14##1##(1990-6#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#4)(2008-6#3)(2012-12#1)(2012-2#2)
butyricum##3##1##(1995-3#1)(2013-1#2)
butyryl##3##1##(1990-11#1)(2013-1#2)
butyrylcholinesterase (BuChE)##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
butyrylcholinesterase##14##1##(1992-12#2)(1992-8#2)(1994-6#1)(2008-10#5)(2008-7#2)(2009-8#1)(2012-2#1)
buy and##2##2##(1992-12#1)(2012-2#1)
buy##19##1##(1990-4#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-8#1)(1993-5#1)(1994-6#1)(1995-2#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(2010-4#1)(2012-2#2)
buy-in##5##1##(2007-9#1)(2012-2#1)(2013-1#3)
buyang huanwu decoction##2##3##(2013-8#2)
buyer##3##1##(1992-2#1)(1996-5#1)(2007-5#1)
buyers and##2##2##(1997-2#1)(2008-11#1)
buyers##3##1##(1996-1#1)(1997-2#1)(2008-11#1)
buying power##2##2##(1992-12#1)(1994-3#1)
buying##10##1##(1991-1#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-5#1)(2008-12#1)(2012-2#1)
buyout##2##1##(1993-5#1)(2013-7#1)
buzzword##2##1##(1995-12#1)(2008-10#1)
bv##9##1##(2008-10#2)(2008-6#2)(2008-8#1)(2011-2#4)
bvFTD patients##2##2##(2013-1#2)
bvFTD##3##1##(2013-1#3)
bw##6##1##(1991-6#1)(1993-6#1)(2008-10#3)(2010-5#1)
by &gt##15##2##(1992-11#1)(1993-3#1)(1995-2#2)(1995-5#2)(2007-12#1)(2008-10#6)(2008-3#1)(2010-8#1)
by &quot##24##2##(1991-1#1)(1992-8#1)(1993-12#1)(1993-2#6)(1993-3#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-11#1)(2012-1#1)
by 'specials'##2##2##(2011-1#2)
by (1) the##2##3##(2008-5#1)(2012-2#1)
by (1)##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
by (1)H NMR##4##3##(2008-10#3)(2012-12#1)
by (1)H and##2##3##(1996-2#1)(2007-11#1)
by (1)H##7##2##(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#3)(2012-12#1)
by (13)C NMR spectrometry##2##4##(2008-10#2)
by (13)C NMR##5##3##(1997-7#1)(2008-10#2)(2013-1#2)
by (13)C##6##2##(1997-7#1)(2008-10#2)(2009-7#1)(2013-1#2)
by (a)##2##2##(1993-11#1)(1993-6#1)
by (i)##6##2##(1990-2#1)(2008-10#3)(2008-12#1)(2008-3#1)
by -0##2##2##(2008-10#1)(2010-5#1)
by 0##26##2##(1992-10#1)(1993-1#3)(1993-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-7#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
by 1 alpha##3##3##(1991-12#1)(1994-9#2)
by 1 mM##3##3##(1990-5#1)(1992-6#1)(1995-2#1)
by 1 to##2##3##(1991-4#1)(2008-10#1)
by 1 week##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
by 1##60##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#1)(1994-9#2)(1995-2#2)(1997-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#2)
by 1%##2##2##(2008-10#1)(2008-8#1)
by 10 mM##4##3##(1990-11#1)(1992-6#1)(1993-6#1)(1995-6#1)
by 10 microM##2##3##(1995-12#2)
by 10##19##2##(1990-11#1)(1990-3#1)(1992-6#2)(1993-6#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#2)
by 10% and##2##3##(1995-3#1)(2008-3#1)
by 10%##12##2##(1991-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#2)(2013-8#1)
by 10-20%##2##2##(1994-8#1)(2008-3#1)
by 10-fold##3##2##(1992-1#1)(1994-8#1)(2008-7#1)
by 100 microM##2##3##(1990-2#1)(1990-8#1)
by 100 times##2##3##(1992-12#1)(2007-10#1)
by 100##8##2##(1990-2#1)(1990-8#1)(1992-12#1)(1994-11#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#1)
by 10mM##2##2##(1990-11#1)(2008-10#1)
by 11 months##2##3##(2008-9#1)(2009-3#1)
by 11##6##2##(1996-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)
by 11%##6##2##(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)
by 12 and##2##3##(1997-4#1)(2008-10#1)
by 12##17##2##(1991-1#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)
by 12%##5##2##(2008-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
by 120 days##2##3##(2013-1#2)
by 120 s##2##3##(1996-12#1)(2008-10#1)
by 120##5##2##(1991-5#1)(1996-12#1)(2008-10#1)(2013-1#2)
by 13##7##2##(1990-6#1)(1991-5#1)(1993-3#1)(1995-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
by 13%##2##2##(2008-10#1)(2011-2#1)
by 13C-NMR##3##2##(1995-2#1)(1997-1#2)
by 13C-n##2##2##(1990-9#2)
by 14##7##2##(1990-3#1)(1992-5#1)(1996-2#1)(1997-6#1)(2007-8#1)(2010-2#1)(2013-1#1)
by 14%##2##2##(2008-10#1)(2010-6#1)
by 15 and##2##3##(1991-10#1)(2008-10#1)
by 15##15##2##(1990-12#1)(1991-10#1)(1991-3#1)(1992-3#1)(1994-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-8#2)(2009-5#1)
by 15%##7##2##(1990-12#1)(1995-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
by 155%##2##2##(2008-11#1)(2011-2#1)
by 16 percent##2##3##(1991-1#1)(2008-11#1)
by 16##12##2##(1990-6#1)(1991-1#1)(1992-12#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-3#1)(2013-1#1)(2013-8#1)
by 16%##2##2##(1991-8#1)(2007-11#1)
by 16S rRNA##2##3##(1997-2#1)(2012-2#1)
by 17 beta-estradiol##4##3##(1993-9#1)(1995-6#1)(1996-5#2)
by 17##13##2##(1991-6#1)(1993-9#1)(1995-1#1)(1995-6#1)(1996-5#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
by 17%##3##2##(1993-3#1)(2008-7#1)(2010-11#1)
by 18 h##3##3##(1995-11#1)(1997-2#1)(2008-10#1)
by 18##9##2##(1990-6#1)(1991-6#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2012-2#1)
by 18%##4##2##(1996-2#1)(2007-11#1)(2008-11#1)(2011-2#1)
by 180##2##2##(1996-12#1)(2008-3#1)
by 19##4##2##(1993-3#1)(1993-6#1)(2008-10#1)(2008-8#1)
by 19%##2##2##(2008-12#1)(2008-2#1)
by 1995##3##2##(1990-3#1)(1993-12#1)(2008-11#1)
by 1H NMR spectroscopy##2##4##(1992-3#1)(1996-5#1)
by 1H NMR##5##3##(1992-3#1)(1993-3#1)(1994-5#1)(1996-5#1)(2011-3#1)
by 1H and##3##3##(1991-5#1)(1993-11#1)(1995-3#1)
by 1H##9##2##(1991-11#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-5#1)(2011-3#1)
by 1H-NMR##4##2##(1993-2#1)(1994-11#1)(1994-5#1)(2010-4#1)
by 2 days##4##3##(1997-3#1)(2008-10#2)(2008-11#1)
by 2 orders of magnitude##2##5##(1994-5#1)(2008-3#1)
by 2 weeks##2##3##(2007-8#1)(2009-5#1)
by 2##60##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-7#2)(2007-10#1)(2007-12#3)(2007-8#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2009-5#1)(2009-9#2)(2010-9#1)(2011-3#1)(2013-1#2)(2013-8#3)
by 2%##2##2##(1991-8#1)(2010-4#1)
by 2-3##2##2##(1993-2#1)(2008-10#1)
by 2-fold##2##2##(1992-1#1)(1993-8#1)
by 20 microM##2##3##(1993-3#2)
by 20##12##2##(1992-9#1)(1993-3#2)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-7#1)
by 20% of##2##3##(1995-2#1)(2008-8#1)
by 20%##10##2##(1990-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-6#1)
by 2000##2##2##(1993-12#1)(2008-11#1)
by 2005##3##2##(1995-12#1)(1996-2#1)(2008-1#1)
by 2010##3##2##(2007-2#1)(2008-11#1)(2010-3#1)
by 2015##2##2##(2008-11#1)(2008-12#1)
by 2030##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
by 21##4##2##(1997-7#1)(2008-10#2)(2008-5#1)
by 22##4##2##(1990-5#1)(1994-8#2)(2008-7#1)
by 22%##4##2##(1990-11#1)(2008-10#2)(2008-5#1)
by 23##3##2##(1991-9#1)(1995-1#1)(2012-1#1)
by 23%##2##2##(1993-12#1)(2008-10#1)
by 24 h##2##3##(1990-5#1)(1992-12#1)
by 24 hours##2##3##(1997-3#1)(2008-7#1)
by 24##9##2##(1990-5#1)(1992-12#1)(1995-2#1)(1997-3#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
by 25 and##3##3##(1991-5#1)(1994-8#2)
by 25##9##2##(1991-5#1)(1994-8#2)(1995-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
by 25% in##2##3##(2008-10#1)(2013-1#1)
by 25%##7##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-1#1)
by 26##4##2##(1990-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
by 26%##2##2##(1994-6#1)(2007-11#1)
by 27##3##2##(1991-6#1)(2008-3#1)(2008-9#1)
by 27%##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
by 28 to##2##3##(1994-6#1)(1995-1#1)
by 28##4##2##(1994-6#1)(1995-1#1)(1996-12#1)(2008-7#1)
by 28%##2##2##(2008-3#1)(2010-11#1)
by 29%##2##2##(2011-1#1)(2012-3#1)
by 2D##2##2##(1994-11#1)(1994-5#1)
by 3 days##5##3##(2007-8#1)(2008-10#2)(2008-11#2)
by 3 h##2##3##(1993-6#1)(2008-10#1)
by 3 months##3##3##(2008-6#1)(2008-9#2)
by 3 orders of magnitude##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
by 3##33##2##(1992-3#1)(1992-6#2)(1993-12#1)(1993-6#2)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#3)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
by 3%##3##2##(2007-11#1)(2008-5#1)(2011-2#1)
by 3' RACE##2##3##(1994-11#1)(2008-8#1)
by 3'##3##2##(1994-11#1)(1997-3#1)(2008-8#1)
by 3-fold##2##2##(1992-12#1)(1995-6#1)
by 3-methylcholanthrene##3##2##(1992-8#1)(2008-11#2)
by 30 percent##2##3##(1991-1#1)(1995-3#1)
by 30 to##2##3##(2008-10#2)
by 30##11##2##(1991-1#1)(1991-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-12#1)(2012-12#1)
by 30% in##2##3##(1994-8#1)(1997-9#1)
by 30%##8##2##(1990-8#1)(1991-11#1)(1994-8#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-3#1)
by 30-40%##4##2##(2008-1#1)(2008-6#1)(2011-2#1)(2013-8#1)
by 31 +/-##2##3##(1996-2#1)(1997-1#1)
by 31##7##2##(1991-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-3#2)
by 31%##4##2##(1997-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
by 31P NMR##2##3##(1992-12#1)(1993-11#1)
by 31P##4##2##(1992-12#1)(1993-11#2)(2008-10#1)
by 32##2##2##(1992-2#1)(2008-10#1)
by 32%##2##2##(1996-2#1)(2007-10#1)
by 32P-postlabelling##2##2##(1994-2#2)
by 33##3##2##(1990-6#1)(2007-5#1)(2008-10#1)
by 33%##2##2##(2008-10#1)(2012-12#1)
by 34##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
by 35##2##2##(1990-2#1)(2008-7#1)
by 35%##6##2##(1993-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
by 36##2##2##(1993-12#1)(2008-5#1)
by 36%##4##2##(1990-2#1)(2008-3#1)(2008-8#1)(2012-1#1)
by 37##3##2##(1993-2#1)(2008-6#1)(2008-8#1)
by 37%##2##2##(1994-8#1)(1997-7#1)
by 38%##2##2##(2008-11#1)(2008-3#1)
by 39##2##2##(1996-1#1)(2008-10#1)
by 4 weeks##4##3##(1996-12#1)(2008-10#2)(2013-1#1)
by 4##25##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#2)
by 40##4##2##(1996-5#1)(2007-7#1)(2008-4#1)(2009-9#1)
by 40% and##3##3##(2008-11#1)(2008-5#2)
by 40% at##2##3##(2008-5#1)(2008-6#1)
by 40% by##2##3##(2008-3#1)(2013-1#1)
by 40% in##2##3##(2008-1#1)(2008-7#1)
by 40%##17##2##(1990-11#1)(1995-8#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
by 41%##2##2##(1996-2#1)(2008-10#1)
by 42##2##2##(2008-10#2)
by 42%##2##2##(1997-1#1)(2011-2#1)
by 43##4##2##(1995-12#1)(1997-4#1)(2008-10#1)(2008-3#1)
by 43%##4##2##(1990-12#1)(1994-12#1)(1995-12#1)(2008-10#1)
by 44##3##2##(1994-6#1)(2008-3#1)(2012-3#1)
by 44%##5##2##(1992-6#1)(1995-12#1)(1997-1#1)(2008-10#1)(2012-12#1)
by 45##5##2##(1991-6#1)(1993-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
by 45%##2##2##(1990-12#1)(1996-9#1)
by 47##2##2##(2008-10#1)(2011-2#1)
by 47%##2##2##(1996-9#1)(2007-10#1)
by 48 h##2##3##(1996-12#1)(2008-7#1)
by 48##3##2##(1990-2#1)(1996-12#1)(2008-7#1)
by 49##2##2##(2008-10#1)(2008-9#1)
by 49%##2##2##(1996-9#1)(2008-10#1)
by 5 min##3##3##(1995-12#1)(1995-2#1)(2008-7#1)
by 5##21##2##(1991-5#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#2)(2011-2#1)
by 5%##2##2##(2008-2#1)(2008-3#1)
by 5'##5##2##(1997-7#3)(2008-9#1)(2010-5#1)
by 50##4##2##(1994-11#1)(2008-10#2)(2008-5#1)
by 50% at a##2##4##(1997-1#1)(2008-10#1)
by 50% by##3##3##(2008-11#2)(2011-1#1)
by 50% in##2##3##(1990-5#1)(1991-12#1)
by 50% of##2##3##(1992-6#1)(2009-10#1)
by 50% without##2##3##(2010-12#1)(2010-8#1)
by 50%##30##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-9#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
by 500##2##2##(2008-10#1)(2008-3#1)
by 52##3##2##(1995-12#1)(2008-10#1)(2008-12#1)
by 54##2##2##(1997-7#1)(2008-10#1)
by 54%##4##2##(1991-3#1)(1996-2#1)(2010-3#1)(2011-2#1)
by 55##4##2##(1990-7#1)(1991-5#1)(1993-2#1)(2008-10#1)
by 55%##4##2##(1997-2#1)(1997-4#1)(2008-11#1)(2008-7#1)
by 56%##2##2##(2008-10#1)(2008-5#1)
by 57##2##2##(1992-2#1)(2010-12#1)
by 6 months##5##3##(1995-6#2)(2008-9#2)(2013-1#1)
by 6 weeks##3##3##(1996-5#1)(2011-1#1)(2013-1#1)
by 6##16##2##(1992-12#1)(1992-6#1)(1993-1#1)(1995-6#2)(1996-5#1)(2008-5#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#4)
by 60##3##2##(1994-3#1)(1997-6#1)(2008-7#1)
by 60% compared##2##3##(2008-10#1)(2008-11#1)
by 60%##6##2##(1992-3#1)(1992-6#1)(2008-10#1)(2008-11#2)(2008-8#1)
by 61##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
by 62% of the##2##4##(1993-10#1)(2010-4#1)
by 64##2##2##(2008-10#1)(2011-2#1)
by 64-slice computed##2##3##(2009-7#1)(2010-5#1)
by 65%##4##2##(1993-9#1)(1995-5#1)(2008-10#1)(2008-11#1)
by 67##2##2##(1994-8#1)(1995-12#1)
by 67%##2##2##(1993-3#1)(1994-8#1)
by 68%##3##2##(1993-9#1)(2008-11#2)
by 7 days##2##3##(2008-10#2)
by 7##15##2##(1991-8#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#5)(2009-4#1)
by 7%##2##2##(1996-12#1)(2008-3#1)
by 70##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
by 70%##7##2##(1990-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(2008-5#1)(2013-8#1)
by 71##2##2##(1994-8#1)(2008-4#1)
by 72##2##2##(1994-8#1)(2008-10#1)
by 73%##3##2##(1996-11#1)(1997-2#1)(2008-10#1)
by 75##2##2##(2008-10#2)
by 75% and##3##3##(1997-2#1)(1997-3#1)(2008-10#1)
by 75%##6##2##(1993-3#1)(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-6#1)
by 8##3##2##(1991-9#1)(2008-10#2)
by 8%##4##2##(1991-5#1)(2008-2#1)(2008-3#1)(2012-2#1)
by 8-OH-DPAT##3##2##(1991-2#3)
by 80 to 90%##2##4##(1997-8#1)(2008-10#1)
by 80% of##2##3##(1991-6#1)(2008-3#1)
by 80%##6##2##(1990-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(2008-3#1)(2008-9#1)
by 84##2##2##(2008-10#2)
by 85%##3##2##(1991-1#1)(2008-10#1)(2008-5#1)
by 9##9##2##(1990-12#1)(1990-3#2)(1991-10#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2012-2#1)
by 90 degrees##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
by 90% and##3##3##(1993-11#1)(1996-12#1)(2012-1#1)
by 90%##8##2##(1991-5#1)(1993-11#1)(1993-6#1)(1995-12#1)(1996-12#2)(2008-4#1)(2012-1#1)
by 92##2##2##(1992-5#1)(1993-1#1)
by 95% at##2##3##(1997-1#1)(2008-10#1)
by 95%##6##2##(1997-1#1)(2008-10#3)(2008-2#1)(2008-8#1)
by 96##4##2##(2007-7#1)(2008-10#2)(2012-3#1)
by 97%##3##2##(1993-11#1)(2008-12#1)(2012-12#1)
by A##28##2##(1991-3#1)(1991-9#1)(1993-11#1)(1994-11#1)(2008-10#15)(2008-6#2)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
by A23187##2##2##(1990-2#1)(1993-8#1)
by A506##2##2##(2008-10#2)
by AAS and##2##3##(2008-10#2)
by AAS##8##2##(2008-10#8)
by ACPD in##2##3##(1995-12#2)
by ACPD##5##2##(1995-12#5)
by ADP##4##2##(1990-5#1)(1990-7#1)(1997-7#2)
by ADR##3##2##(1990-2#1)(2011-3#2)
by AFLP analysis##2##3##(2008-10#2)
by AFLP##7##2##(2008-10#7)
by AFM##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
by AFS##3##2##(1996-12#1)(2008-10#2)
by AG490##2##2##(2011-2#2)
by AGEs##2##2##(2011-1#2)
by AIDS##2##2##(1990-12#1)(1997-6#1)
by ANGIII##2##2##(1993-6#2)
by ANOVA and##3##3##(2008-11#1)(2009-8#1)(2013-1#1)
by ANOVA##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
by ASM##2##2##(2008-10#2)
by ATP and histamine##2##4##(1994-2#2)
by ATP and##6##3##(1990-7#1)(1992-12#1)(1994-2#2)(2008-4#1)(2009-3#1)
by ATP##18##2##(1990-11#3)(1990-7#1)(1991-12#1)(1992-12#1)(1993-6#1)(1993-8#2)(1994-2#2)(1995-2#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-3#1)
by ATRA##2##2##(2008-4#1)(2011-2#1)
by Acidovorax avenae subsp##3##4##(2008-10#3)
by Adult##2##2##(2008-10#2)
by Aedes##3##2##(2007-10#2)(2007-7#1)
by African##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
by Agrobacterium tumefaciens##4##3##(2008-10#2)(2011-2#2)
by Agrobacterium##6##2##(2008-10#2)(2008-8#2)(2011-2#2)
by Agrobacterium-mediated##2##2##(1997-2#1)(2008-9#1)
by AlCl(3)##2##2##(2008-11#1)(2013-1#1)
by Ala##4##2##(1992-6#2)(1994-5#2)
by Alcaligenes eutrophus##4##3##(2008-6#2)(2008-7#2)
by Allen##2##2##(1990-8#1)(2008-4#1)
by Alternaria##5##2##(2008-10#5)
by American##2##2##(2012-3#1)(2013-8#1)
by Aphanomyces euteiches##2##3##(2008-10#2)
by Aphis gossypii##2##3##(2008-10#2)
by Apocephalus##2##2##(2008-6#2)
by Application of##2##3##(2008-10#2)
by Applied##2##2##(1996-12#1)(2013-8#1)
by Arieli et al##2##4##(2008-2#2)
by Armillaria ostoyae##2##3##(2008-10#2)
by Armillaria spp##2##3##(2008-10#2)
by Armillaria##5##2##(2008-10#5)
by Asian##2##2##(1997-2#1)(2010-8#1)
by Aspergillus flavus and A##3##5##(2008-10#3)
by Aspergillus flavus##9##3##(2008-10#9)
by Aspergillus##13##2##(1992-9#1)(1993-2#1)(2008-10#9)(2008-7#1)(2013-1#1)
by AuTM##2##2##(1994-5#1)(1995-3#1)
by Aulacorthum solani##2##3##(2008-10#2)
by B cells##2##3##(1995-5#1)(2008-4#1)
by B##18##2##(1990-11#1)(1993-6#1)(1995-5#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-6#1)(2010-1#1)(2013-8#1)
by B-mode ultrasonography##2##3##(2007-10#1)(2008-1#1)
by B-mode##4##2##(2007-10#1)(2008-1#1)(2010-12#1)(2013-8#1)
by BABA##2##2##(2008-10#1)(2009-6#1)
by BBM vesicles##2##3##(1991-9#2)
by BBR treatment##3##3##(2012-3#3)
by BCR##3##2##(2008-10#2)(2011-2#1)
by BLAST searches##2##3##(2009-5#1)(2010-4#1)
by BLAST##4##2##(2008-4#2)(2009-5#1)(2010-4#1)
by BMI (beta = 0##2##5##(2010-4#2)
by BMI##3##2##(2010-4#2)(2013-1#1)
by BNR##2##2##(2008-10#2)
by BOX-polymerase chain reaction##2##4##(2008-10#2)
by BP##3##2##(1997-5#1)(2008-10#1)(2009-4#1)
by BQ##2##2##(2009-9#2)
by BRAF--&gt##2##2##(2008-8#2)
by BTX##2##2##(2008-8#2)
by Bacillus cereus##2##3##(1992-3#1)(1994-11#1)
by Bacillus spp##6##3##(2008-10#6)
by Bacillus subtilis##2##3##(2008-10#1)(2008-8#1)
by Bacillus##14##2##(1992-3#1)(1994-11#1)(2008-10#7)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
by Bacteroides##2##2##(2008-11#1)(2010-12#1)
by Barbara##3##2##(1994-2#1)(1995-5#1)(2008-4#1)
by Barley yellow dwarf virus##2##5##(2008-10#2)
by Bcl-2##2##2##(2008-11#1)(2008-8#1)
by Bemisia tabaci##2##3##(2008-10#2)
by BisEMA##2##2##(2013-1#2)
by Blocking##2##2##(2011-2#1)(2013-1#1)
by BmNPV##2##2##(2008-11#2)
by Botrytis cinerea and##3##4##(2008-10#3)
by Botrytis cinerea was##3##4##(2008-10#3)
by Botrytis cinerea##10##3##(2008-10#10)
by Bragg##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by Burkholderia##3##2##(2007-12#1)(2007-7#1)(2008-10#1)
by C##24##2##(1991-9#1)(1996-12#1)(2007-12#1)(2008-10#17)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
by C-banding##4##2##(2008-12#2)(2008-5#2)
by C3##3##2##(1993-6#1)(2008-10#2)
by C9-1S##2##2##(2008-10#2)
by CCD##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
by CCK##2##2##(1993-6#1)(1994-2#1)
by CCK-8S##2##2##(1996-2#2)
by CD measurements##2##3##(1992-6#1)(1995-6#1)
by CD##8##2##(1990-2#1)(1990-5#1)(1991-1#1)(1992-6#2)(1995-6#2)(2008-4#1)
by CD4##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
by CE##2##2##(2008-10#2)
by CHA0##2##2##(2008-10#2)
by CHO cells##7##3##(1992-10#1)(2008-11#6)
by CK-2##3##2##(1992-6#3)
by CMV##3##2##(2008-10#2)(2008-9#1)
by CO 2 laser##2##4##(1991-2#1)(1993-1#1)
by CO##5##2##(1991-2#1)(1991-5#1)(1993-1#1)(1995-2#1)(2008-2#1)
by CO(2) laser##2##3##(2008-10#1)(2008-3#1)
by CO(2)##5##2##(1991-5#1)(2008-10#3)(2008-3#1)
by CO2 laser##2##3##(1991-4#1)(1991-6#1)
by CS##2##2##(2011-1#1)(2012-3#1)
by CT and MRI##2##4##(2007-10#1)(2012-12#1)
by CT in##2##3##(1993-1#1)(2012-2#1)
by CT is##2##3##(2008-7#1)(2011-2#1)
by CT scan##2##3##(2007-10#1)(2013-7#1)
by CT##15##2##(1991-12#1)(1992-9#1)(1993-1#1)(1996-6#1)(2007-10#2)(2008-7#2)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
by CTAB##2##2##(2008-11#2)
by CTX##2##2##(1993-3#2)
by CVAAS##2##2##(2008-10#2)
by CYP3A4##2##2##(2008-8#1)(2010-8#1)
by CYSDV##3##2##(2008-10#3)
by CZE##4##2##(1996-5#1)(2008-10#3)
by Ca(2+) and##2##3##(2008-8#2)
by Ca(2+)##5##2##(2008-11#1)(2008-4#1)(2008-8#3)
by Ca2+ and Mg2+##2##4##(1990-5#1)(1995-11#1)
by Ca2+ channel blockers##3##4##(1990-12#1)(1995-11#2)
by Ca2+##12##2##(1990-12#1)(1990-5#2)(1990-7#1)(1994-3#1)(1994-6#1)(1995-11#3)(1995-6#3)
by CaM-kinase II##2##3##(1995-2#2)
by Canadian Physiotherapy##2##3##(1993-3#1)(1996-2#1)
by Canadian##4##2##(1991-12#1)(1993-3#1)(1996-2#1)(2008-11#1)
by Candida albicans##2##3##(2008-1#1)(2008-5#1)
by Candida##5##2##(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)
by Cb##2##2##(1995-12#2)
by Cd##3##2##(2008-10#3)
by Cell##2##2##(2008-10#1)(2010-5#1)
by Cephalosporium gramineum##2##3##(2008-10#2)
by Cercospora arachidicola##3##3##(2008-10#3)
by Cercospora##5##2##(2008-10#5)
by Cercosporidium personatum##2##3##(2008-10#2)
by Chinese##6##2##(2007-12#1)(2008-11#4)(2008-7#1)
by Chlamydia##2##2##(1990-6#1)(2012-3#1)
by Cladosporium tenuissimum##2##3##(2008-10#2)
by Cladosporium##4##2##(2008-10#3)(2012-2#1)
by Claviceps##2##2##(2008-10#2)
by Clostridium botulinum##2##3##(1993-2#1)(2007-12#1)
by Clostridium##6##2##(1993-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2009-5#1)(2013-1#1)
by Co(II)##2##2##(2008-10#2)
by Cochliobolus heterostrophus##4##3##(2008-10#4)
by Cochliobolus##7##2##(2008-10#7)
by Colletotrichum acutatum##3##3##(2008-10#3)
by Colletotrichum coccodes##2##3##(2008-10#2)
by Colletotrichum glososporioides##2##3##(1997-6#2)
by Colletotrichum graminicola##3##3##(2008-10#3)
by Colletotrichum##20##2##(1997-6#2)(2008-10#17)(2008-11#1)
by Con##2##2##(1992-8#1)(1994-11#1)
by Congress##2##2##(1991-1#1)(1992-1#1)
by Conidia##2##2##(2008-10#2)
by Crowe##2##2##(2012-12#2)
by Cu(2+)##3##2##(2008-10#2)(2009-8#1)
by Cu(II)##7##2##(1995-2#4)(2008-10#3)
by Cucumber mosaic virus (CMV)##2##5##(2008-10#2)
by Cx43 transfection##2##3##(2008-11#2)
by Cylindrocarpon destructans##2##3##(2008-10#2)
by D##7##2##(1991-6#1)(1995-2#1)(2008-10#4)(2008-11#1)
by DAX-8##2##2##(2008-10#2)
by DDQ oxidation after conversion of the azide group into the##2##11##(1997-4#2)
by DGT##2##2##(2008-10#2)
by DM##2##2##(1995-11#1)(2008-10#1)
by DNA damage##5##3##(2008-11#3)(2010-3#1)(2013-1#1)
by DNA fingerprinting##4##3##(2008-10#4)
by DNA fragmentation and##2##4##(2008-1#1)(2008-11#1)
by DNA fragmentation##4##3##(1992-9#1)(1995-2#1)(2008-1#1)(2008-11#1)
by DNA ligase##2##3##(1990-7#1)(1997-7#1)
by DNA sequencing##6##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)
by DNA##37##2##(1990-5#1)(1990-7#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
by DNase I footprinting##2##4##(1995-5#1)(2008-8#1)
by DPP##2##2##(2008-10#2)
by Dan##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
by David##3##2##(1996-11#1)(1996-3#1)(2008-5#1)
by Diane S##2##3##(2008-4#2)
by Different##2##2##(2008-10#1)(2008-11#1)
by Direct##2##2##(1996-5#1)(2008-2#1)
by DnaC##2##2##(1991-12#2)
by Doppler ultrasonography##2##3##(2010-11#1)(2013-1#1)
by Dr##26##2##(1990-8#1)(1993-9#1)(1995-6#1)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)(2008-5#7)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#1)
by DuP 714##3##3##(1991-9#3)
by DuP##4##2##(1991-5#1)(1991-9#3)
by Dutch##2##2##(1996-11#1)(1996-8#1)
by E##15##2##(1990-12#1)(1991-3#1)(1992-8#1)(1995-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2009-12#1)(2010-6#1)
by E2##2##2##(1990-11#1)(1994-9#1)
by EA##2##2##(1995-2#1)(1996-12#1)
by EC##2##2##(1994-9#1)(2012-4#1)
by EDTA##9##2##(1991-9#1)(1992-8#1)(1994-5#1)(2008-10#5)(2008-8#1)
by EFS##3##2##(1996-5#1)(1997-4#2)
by EGF##4##2##(1990-11#1)(1991-12#3)
by EGTA##2##2##(2008-10#1)(2008-8#1)
by ELISA and##9##3##(1992-6#1)(1997-6#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
by ELISA at##2##3##(2008-10#2)
by ELISA in##3##3##(1995-12#1)(2008-9#1)(2010-3#1)
by ELISA is##2##3##(2008-10#1)(2008-11#1)
by ELISA with##2##3##(1992-11#1)(1995-12#1)
by ELISA##45##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-6#1)(1993-11#1)(1995-12#3)(1997-2#1)(1997-6#5)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
by EMA##2##2##(2009-6#1)(2012-3#1)
by EMF##2##2##(2008-10#1)(2011-2#1)
by EMSA##2##2##(1995-8#1)(2008-11#1)
by EPR spectroscopy##2##3##(2008-10#2)
by EPR##5##2##(1990-2#1)(1993-8#1)(2008-10#2)(2008-5#1)
by ER##2##2##(2011-2#1)(2012-2#1)
by ERW##2##2##(2008-11#2)
by ESA##2##2##(2008-11#2)
by ESR##4##2##(1990-5#1)(1993-6#1)(2007-11#2)
by ET AAS##4##3##(2008-10#4)
by ET##5##2##(2008-10#4)(2012-3#1)
by ET-1##2##2##(1991-11#1)(1994-8#1)
by ETAAS using##2##3##(2008-10#2)
by ETAAS##12##2##(2008-10#12)
by ETV-ICP-MS##3##2##(2008-10#3)
by Enterococcus##2##2##(1997-3#1)(2011-2#1)
by Eric##2##2##(2008-4#1)(2010-11#1)
by Erwinia amylovora##4##3##(2008-10#4)
by Escherichia coli in##2##4##(2007-7#1)(2010-4#1)
by Escherichia coli##15##3##(1992-12#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#2)(2013-1#1)
by European##5##2##(2008-10#2)(2008-12#1)(2008-9#1)(2010-4#1)
by Exserohilum rostratum##2##3##(2007-7#1)(2008-10#1)
by Exserohilum##3##2##(2007-7#1)(2008-10#2)
by Extracts##2##2##(2008-10#2)
by F##16##2##(2008-10#16)
by FA##2##2##(1993-6#2)
by FAAS after##3##3##(2008-10#3)
by FAAS and##2##3##(2008-10#2)
by FAAS##22##2##(2008-10#22)
by FACS##4##2##(2008-11#3)(2012-3#1)
by FCM##2##2##(2009-6#2)
by FDA##4##2##(2011-2#2)(2011-3#1)(2012-3#1)
by FI-CV-AAS after##2##3##(2008-10#2)
by FI-CV-AAS##3##2##(2008-10#3)
by FI-HGAAS##4##2##(2008-10#4)
by FIA##2##2##(2008-10#2)
by FISH analysis##4##3##(1996-6#1)(1996-8#1)(2008-11#1)(2009-8#1)
by FISH and##2##3##(1997-2#1)(2008-5#1)
by FISH##11##2##(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-2#1)(2009-8#1)
by FK506##2##2##(1993-11#1)(1993-8#1)
by FLAASH##2##2##(2013-8#2)
by FM##2##2##(2008-10#1)(2008-2#1)
by FPGA##2##2##(2012-3#2)
by FPLC##4##2##(1990-5#1)(1993-8#1)(2008-4#1)(2008-9#1)
by FRAP##2##2##(2008-1#1)(2013-1#1)
by FRET##2##2##(2008-1#1)(2010-12#1)
by FT-IR and##2##3##(2008-10#2)
by FT-IR spectroscopy##5##3##(1994-6#1)(2008-10#4)
by FT-IR##11##2##(1994-6#1)(2008-10#10)
by FT-Raman##2##2##(2008-10#2)
by FTIR spectroscopy applying the constant ratio method##2##8##(2008-10#2)
by FTIR spectroscopy##5##3##(2008-10#4)(2008-5#1)
by FTIR##11##2##(2008-10#9)(2008-5#1)(2008-7#1)
by Fe##3##2##(2008-10#2)(2010-6#1)
by FeCl(3)##2##2##(2008-10#1)(2013-1#1)
by Ficoll-Paque##3##2##(2008-11#2)(2008-9#1)
by Fisher##2##2##(1995-6#1)(1997-5#1)
by Flame##2##2##(2008-10#2)
by Flesia and Korb##2##4##(2008-3#2)
by Fluorescence##2##2##(2008-10#1)(2008-4#1)
by Fluorescent##2##2##(2008-10#2)
by Food##2##2##(2008-11#1)(2012-2#1)
by Fourier Transform##2##3##(2008-10#2)
by Fourier transform infrared (FTIR) spectroscopy##2##6##(2008-10#1)(2008-8#1)
by Fourier transform infrared (FTIR)##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
by Fourier transform infrared reflection spectrometry##2##6##(1991-5#2)
by Fourier transform infrared spectroscopy (FTIR)##3##6##(2008-10#1)(2008-5#1)(2013-8#1)
by Fourier transform infrared spectroscopy##8##5##(2007-12#1)(2008-10#3)(2008-5#2)(2010-5#1)(2013-8#1)
by Fourier transform infrared##16##4##(1991-5#2)(2007-12#1)(2008-10#6)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2013-8#1)
by Fourier transform##19##3##(1991-5#2)(1996-5#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2013-8#1)
by Fourier##25##2##(1991-5#2)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2013-8#1)
by French##3##2##(2010-1#1)(2011-1#1)(2011-2#1)
by Fusarium graminearum##5##3##(2008-10#4)(2011-10#1)
by Fusarium moniliforme##2##3##(2008-10#2)
by Fusarium oxysporum f##13##4##(2008-10#13)
by Fusarium spp##3##3##(2008-10#3)
by Fusarium verticillioides##2##3##(2008-10#2)
by Fusarium##30##2##(2008-10#29)(2011-10#1)
by G##5##2##(2008-10#4)(2008-4#1)
by GABA##4##2##(2008-8#1)(2008-9#2)(2010-12#1)
by GC and GC/MS##3##4##(2008-11#1)(2008-12#2)
by GC and##4##3##(2008-11#1)(2008-12#2)(2012-2#1)
by GC##6##2##(2008-11#1)(2008-12#2)(2009-8#1)(2012-2#1)(2013-8#1)
by GC-ECD##2##2##(2008-10#2)
by GC-FID##3##2##(2008-10#3)
by GC-HRMS analysis##2##3##(2008-10#2)
by GC-HRMS##3##2##(2008-10#3)
by GC-MS and##2##3##(2007-11#1)(2008-11#1)
by GC-MS##20##2##(1991-5#1)(1992-5#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-5#1)(2010-11#1)(2011-3#1)(2012-3#1)
by GC-MS]##2##2##(2012-3#1)(2013-8#1)
by GC/FID##2##2##(2008-10#2)
by GC/MS and##3##3##(2008-10#2)(2008-12#1)
by GC/MS##12##2##(1995-2#1)(2008-10#8)(2008-11#2)(2008-12#1)
by GDP##4##2##(1991-5#1)(1993-8#1)(1994-11#1)(1995-5#1)
by GF-AAS##3##2##(2008-10#3)
by GFAAS##11##2##(2008-10#11)
by GFJ##2##2##(2008-8#2)
by GGT##2##2##(1995-12#2)
by GPs##4##2##(2007-2#1)(2008-3#3)
by GRP##2##2##(1992-6#2)
by GSH##2##2##(1991-9#1)(2010-5#1)
by GSTT (100 and 30 mg x L(-1))##2##8##(2011-3#2)
by GTP##3##2##(1990-7#2)(1995-5#1)
by GTP-binding##2##2##(1992-8#1)(1993-3#1)
by Gaeumannomyces graminis var##3##4##(2008-10#3)
by Gaussian##2##2##(2008-2#1)(2008-3#1)
by GeneMark as##2##3##(1995-12#2)
by GeneMark##3##2##(1995-12#3)
by Genome##2##2##(2008-10#1)(2010-5#1)
by George##3##2##(2008-5#3)
by Gibberella zeae##2##3##(2008-10#2)
by Gibson and##2##3##(1990-8#1)(2008-10#1)
by Glaxo##2##2##(1990-3#1)(1994-3#1)
by Glu##2##2##(1992-6#1)(1992-8#1)
by Gluconacetobacter sp##2##3##(2008-6#2)
by Glucose##2##2##(2011-2#1)(2012-2#1)
by GnRH##3##2##(1996-2#1)(1997-2#1)(2008-5#1)
by Golgi##2##2##(2009-10#1)(2010-1#1)
by Gram-negative##2##2##(1994-2#1)(2007-12#1)
by GroE##4##2##(1992-3#4)
by H##10##2##(1995-12#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
by H&amp##2##2##(2012-3#1)(2013-8#1)
by H(2)O(2)##4##2##(2008-10#4)
by H-7##2##2##(1990-2#1)(1991-2#1)
by H-point standard addition method (HPSAM)##2##6##(2008-10#2)
by H-point standard addition method##5##5##(2008-10#5)
by H2O2##5##2##(1991-9#1)(1995-8#1)(1997-8#3)
by HB##2##2##(2008-8#2)
by HI test##2##3##(1997-6#2)
by HIV-1 and HIV-2 proteinases##2##5##(1990-8#2)
by HIV-1 protease##2##3##(1992-11#2)
by HIV-1##8##2##(1990-8#2)(1991-2#1)(1992-11#2)(2008-11#2)(2011-3#1)
by HMG1##3##2##(1994-9#3)
by HMOs##3##2##(1993-3#1)(1995-12#1)(1996-3#1)
by HMW-BCGF##2##2##(1991-3#2)
by HPLC and##9##3##(1992-3#1)(1995-11#1)(2008-10#4)(2008-6#1)(2009-8#1)(2011-2#1)
by HPLC at##2##3##(2008-10#1)(2008-5#1)
by HPLC in the##2##4##(1994-11#1)(1997-7#1)
by HPLC using a##2##4##(1993-11#1)(2008-10#1)
by HPLC using an##2##4##(1995-3#1)(2008-10#1)
by HPLC using##8##3##(1993-11#1)(1995-3#1)(2008-10#6)
by HPLC with UV detection##2##5##(2008-10#2)
by HPLC with##6##3##(2008-10#6)
by HPLC##71##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-3#3)(1993-11#2)(1994-11#2)(1994-8#1)(1995-11#2)(1995-3#1)(1997-6#1)(1997-7#1)(2008-10#40)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-8#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
by HPLC-ICP-MS##5##2##(2008-10#5)
by HPLC-ICPMS##2##2##(2008-10#1)(2010-11#1)
by HPLC-MS##2##2##(1995-5#1)(2009-9#1)
by HPLC-UV##4##2##(2008-10#4)
by HPLC/UV##2##2##(2008-5#2)
by HPLC]##2##2##(2013-8#2)
by HPV##4##2##(1991-2#1)(2012-3#2)(2013-1#1)
by HRV analysis##2##3##(2009-11#2)
by HRV##3##2##(2009-11#2)(2013-8#1)
by HS##2##2##(1991-9#1)(2008-10#1)
by HS-SPME##2##2##(2008-10#2)
by HSF##2##2##(2008-5#2)
by HSP70##2##2##(1993-8#1)(2008-9#1)
by HT29 cells##2##3##(1992-9#2)
by HeLa##2##2##(1993-8#1)(1995-6#1)
by Helicobacter pylori##3##3##(1990-11#1)(2011-2#1)(2012-12#1)
by Herman and##2##3##(2008-2#2)
by Hg(2+) and##2##3##(2008-10#2)
by Hg(2+)##3##2##(2008-10#3)
by Hg2+##2##2##(1992-11#1)(1993-12#1)
by High-Performance Liquid Chromatography##2##4##(2008-12#1)(2009-8#1)
by Hispanic##3##2##(1995-12#2)(2012-12#1)
by HlyA##2##2##(1994-2#2)
by Howard##2##2##(1996-5#1)(2013-1#1)
by Human##2##2##(1994-11#1)(2011-1#1)
by I##4##2##(1995-2#1)(2008-3#1)(2010-6#2)
by ICI D1694##2##3##(1994-8#2)
by ICP##6##2##(2008-10#6)
by ICP-AES after##3##3##(2008-10#3)
by ICP-AES analysis##2##3##(2008-10#2)
by ICP-AES using##2##3##(2008-10#2)
by ICP-AES##22##2##(2008-10#22)
by ICP-MS and##3##3##(2008-10#3)
by ICP-MS##19##2##(2008-10#19)
by ICP-OES##5##2##(2008-10#5)
by ICPMS##2##2##(2008-10#2)
by IFN-gamma##6##2##(1994-6#1)(2008-11#4)(2013-8#1)
by IGF-I##2##2##(1991-5#1)(1993-9#1)
by IHC##3##2##(2009-8#1)(2013-8#2)
by IL-1 and IL-6##2##4##(1994-6#2)
by IL-1 and##3##3##(1994-6#2)(2008-8#1)
by IL-1##8##2##(1990-11#1)(1990-12#3)(1994-6#2)(1995-6#1)(2008-8#1)
by IL-17##2##2##(2007-11#1)(2009-12#1)
by IL-2##4##2##(1990-12#1)(2008-8#3)
by IL-6##2##2##(1990-5#1)(2008-4#1)
by IPTG##4##2##(1993-8#1)(1993-9#1)(1994-8#1)(2013-1#1)
by IR and##2##3##(2008-5#1)(2010-4#1)
by IR spectroscopy##2##3##(2008-10#2)
by IR##13##2##(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#2)(2010-4#1)
by IVC##3##2##(1990-2#3)
by IgE##2##2##(2008-11#1)(2010-5#1)
by Infrared##2##2##(2009-9#1)(2011-1#1)
by Insulin##2##2##(2008-12#1)(2008-3#1)
by Inter##2##2##(2008-10#1)(2008-7#1)
by Iranian##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
by J##7##2##(1990-11#1)(1991-6#1)(1993-2#1)(2008-10#3)(2008-3#1)
by J774##2##2##(1994-11#1)(1994-8#1)
by JHBP##2##2##(2012-2#2)
by James##2##2##(2008-12#1)(2008-8#1)
by January##2##2##(1996-1#1)(2008-10#1)
by Japanese##5##2##(1997-4#3)(2008-10#1)(2011-2#1)
by Job's method##2##3##(2008-10#2)
by Joglekar et al##2##4##(2010-11#2)
by John Wiley &amp##2##4##(2012-2#1)(2012-3#1)
by John##3##2##(2007-11#1)(2012-2#1)(2012-3#1)
by Jones##2##2##(2012-12#1)(2013-1#1)
by July##2##2##(1995-6#1)(2010-3#1)
by K##4##2##(2008-7#1)(2011-2#2)(2012-2#1)
by K+##5##2##(1990-11#2)(1990-7#1)(1991-7#1)(1997-7#1)
by KA##2##2##(1995-5#2)
by KCl##3##2##(1995-12#1)(2008-12#1)(2008-6#1)
by KMnO(4)##2##2##(2008-10#2)
by Karl Fischer titration##2##4##(2008-10#2)
by Kjeldahl##2##2##(2008-10#2)
by Kohonen artificial neural networks##2##5##(2008-10#2)
by L##8##2##(1996-12#3)(2006-10#2)(2008-10#2)(2011-2#1)
by L-Glu##2##2##(1997-2#2)
by L-NAME##2##2##(1997-7#1)(2008-11#1)
by L-carnitine##2##2##(1993-6#1)(2011-2#1)
by LA-ICP-MS##5##2##(2008-10#5)
by LC##7##2##(2008-10#6)(2010-11#1)
by LC-ESI-MS##2##2##(2008-10#2)
by LC-ICP-MS##2##2##(2008-10#2)
by LC-MS##3##2##(2008-10#2)(2011-2#1)
by LC-MS/MS##3##2##(2008-4#1)(2011-3#2)
by LDL##2##2##(1992-5#1)(1994-9#1)
by LIF##4##2##(1997-7#1)(2008-3#1)(2008-4#2)
by LPL##2##2##(1992-12#1)(1995-6#1)
by LPS##8##2##(1993-11#1)(1993-8#1)(1994-10#1)(1995-12#1)(1997-1#1)(2008-8#3)
by LY 294002##2##3##(2008-4#2)
by La(3+)##3##2##(2008-10#2)(2008-11#1)
by La3+##2##2##(1997-2#2)
by Laccase of##2##3##(2008-10#2)
by Laser##2##2##(2008-11#1)(2011-2#1)
by Latreille in##2##3##(2010-1#2)
by Le##2##2##(1997-3#2)
by Leishmania##2##2##(2008-7#1)(2012-2#1)
by Li##2##2##(2008-10#1)(2008-5#1)
by Li+##2##2##(1990-11#2)
by Lixiscope##2##2##(1997-3#2)
by Louis##2##2##(1995-12#1)(1997-3#1)
by M##20##2##(1990-12#1)(1993-3#1)(2008-10#12)(2008-9#1)(2010-10#2)(2010-7#1)(2012-3#1)(2013-7#1)
by M-CSF##2##2##(1991-5#2)
by MALDI-TOF mass spectrometry##2##4##(2008-10#2)
by MALDI-TOF##3##2##(2008-10#3)
by MAS##3##2##(1996-2#3)
by MDR cells##3##3##(1990-2#3)
by MHC class##2##3##(1995-5#1)(2012-12#1)
by MHT and HT##2##4##(2011-2#2)
by MHT##4##2##(2011-2#4)
by MLR##2##2##(2008-10#2)
by MPTP##2##2##(1990-7#2)
by MR imaging##2##3##(1997-8#1)(2008-6#1)
by MRI and##2##3##(1996-6#1)(2007-10#1)
by MRI to##2##3##(2007-8#1)(2010-9#1)
by MRI##16##2##(1994-2#1)(1995-11#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
by MS and##2##3##(2009-6#1)(2011-1#1)
by MS##6##2##(2008-10#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-2#1)
by MSC##3##2##(2011-1#3)
by MTT and##2##3##(2007-2#1)(2008-9#1)
by MTT assay##2##3##(2011-3#1)(2013-7#1)
by MTT##6##2##(2007-2#1)(2008-9#1)(2009-9#1)(2011-3#2)(2013-7#1)
by Magnaporthe grisea##5##3##(2008-10#4)(2009-10#1)
by Magnaporthe##6##2##(2008-10#4)(2009-10#1)(2012-2#1)
by Malassezia furfur##2##3##(2008-5#2)
by Malassezia##4##2##(2008-5#4)
by Mannich reaction##2##3##(2008-10#2)
by McGill##2##2##(2007-8#1)(2008-2#1)
by Means of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
by Medicaid##6##2##(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)
by Medicare and Medicaid##2##4##(1996-3#1)(1997-3#1)
by Medicare and##4##3##(1993-3#1)(1996-3#1)(1997-3#2)
by Medicare beneficiaries##3##3##(1993-12#1)(1994-1#1)(1995-3#1)
by Medicare##17##2##(1990-4#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-1#1)(1995-12#2)(1995-3#1)(1996-3#2)(1997-3#2)(2008-11#1)
by Merck##2##2##(2008-10#1)(2008-5#1)
by Mg(2+)##2##2##(1997-7#1)(2008-8#1)
by Mg2+##3##2##(1990-5#2)(1995-6#1)
by Microsphaeropsis sp##2##3##(2008-10#2)
by Mie theory##3##3##(2007-11#1)(2008-2#2)
by Mie##4##2##(2007-11#2)(2008-2#2)
by Miller##2##2##(2008-1#1)(2008-10#1)
by Mohs micrographic surgery surgeons##2##5##(2010-8#2)
by Monilinia fructicola##6##3##(2008-10#6)
by Monilinia vaccinii-corymbosi##4##3##(2008-10#4)
by Monilinia##13##2##(2008-10#13)
by Monte Carlo simulation##2##4##(2008-3#1)(2009-11#1)
by Monte Carlo simulations##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by Monte Carlo##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)
by Mos##3##2##(1994-8#2)(1995-2#1)
by Mycobacterium tuberculosis##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
by Mycobacterium##5##2##(2007-8#1)(2008-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
by Mycosphaerella fragariae##2##3##(2008-10#2)
by Mycosphaerella graminicola on##2##4##(2008-10#2)
by Mycosphaerella##8##2##(2008-10#8)
by Myzus persicae##2##3##(2008-10#2)
by N##4##2##(1991-9#2)(2008-10#1)(2008-6#1)
by N-acetyl-L-cysteine##2##2##(1994-6#1)(2008-11#1)
by N-acetylcysteine##2##2##(1991-9#1)(2009-4#1)
by N-acetylglucosamine but not by D-mannose##2##6##(1992-9#2)
by N-acetylglucosamine##3##2##(1992-9#3)
by N-bromosuccinimide##2##2##(1992-6#1)(2008-10#1)
by N-ethylmaleimide##2##2##(1995-8#2)
by N-methyl-D-aspartate##2##2##(1991-12#1)(2012-2#1)
by N-terminal amino##2##3##(1994-12#1)(2008-8#1)
by N-terminal sequencing##4##3##(1993-12#1)(1994-8#1)(1997-8#1)(2008-10#1)
by N-terminal##7##2##(1993-12#1)(1994-12#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
by NAC##4##2##(2008-11#1)(2009-9#2)(2011-2#1)
by NADPH##4##2##(1990-12#1)(1990-8#1)(1993-6#1)(1995-6#1)
by NAGO##2##2##(1995-5#2)
by NAT##2##2##(2011-2#2)
by NC-1800##2##2##(1997-7#2)
by NE##2##2##(2008-2#1)(2008-3#1)
by NGF##10##2##(1991-12#1)(1992-12#1)(1992-9#2)(1995-12#1)(1997-2#1)(1997-6#1)(2008-11#3)
by NHS##2##2##(1996-3#1)(2008-11#1)
by NIR spectroscopy##3##3##(2008-10#3)
by NIR##4##2##(2008-10#4)
by NK cells##2##3##(2008-4#1)(2008-8#1)
by NMDA##7##2##(1993-5#1)(1995-12#1)(1996-5#1)(2008-8#4)
by NMR and##3##3##(1991-5#1)(1995-3#1)(1997-1#1)
by NMR spectroscopy##5##3##(1992-4#1)(2006-12#1)(2008-10#1)(2008-4#1)(2009-7#1)
by NMR##20##2##(1991-11#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-1#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-2#2)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#2)(2012-2#1)(2013-1#1)
by NO##3##2##(1995-11#1)(1995-5#1)(2008-7#1)
by Na+##6##2##(1990-11#6)
by NaBH4##2##2##(2008-10#2)
by NaCl##6##2##(1993-9#1)(1997-2#3)(1997-8#1)(2009-8#1)
by NaOH treatment##2##3##(1997-4#2)
by National##3##2##(2008-10#2)(2010-9#1)
by Native##3##2##(2008-10#2)(2012-2#1)
by Nd##3##2##(2008-2#3)
by Nei's##2##2##(2008-10#2)
by New##2##2##(1996-12#1)(2007-12#1)
by Nonpathogenic Fusarium oxysporum##2##4##(2008-10#2)
by Nonpathogenic Fusarium##4##3##(2008-10#4)
by Nonpathogenic##5##2##(2008-10#5)
by Northern analysis##4##3##(1990-12#1)(1995-11#1)(1996-2#1)(2008-9#1)
by Northern blot analysis##9##4##(1992-3#1)(1993-2#1)(1993-3#2)(1993-9#1)(1995-11#1)(1995-6#1)(1997-1#1)(2008-5#1)
by Northern blot and##3##4##(1993-3#1)(1997-7#1)(2010-5#1)
by Northern blot hybridization##2##4##(1990-11#1)(1992-3#1)
by Northern blot##18##3##(1990-11#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-9#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-7#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)
by Northern blotting##7##3##(1990-7#1)(1991-5#1)(1994-11#1)(1996-10#1)(1996-6#2)(2008-6#1)
by Northern##32##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1995-11#2)(1995-6#2)(1996-10#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-5#1)
by Nuclear##2##2##(2008-10#2)
by O(2)##3##2##(2008-10#2)(2008-3#1)
by OA##3##2##(1994-11#2)(1997-4#1)
by OMEGA##2##2##(2008-2#2)
by Optical##2##2##(2008-5#1)(2011-1#1)
by Oshar##2##2##(2008-12#2)
by P##47##2##(1991-3#1)(2008-10#41)(2008-11#1)(2008-4#2)(2011-10#1)(2012-12#1)
by P2 Tin protein##2##4##(1997-3#2)
by P2X receptors##2##3##(2008-4#2)
by P2Y receptors##3##3##(2008-4#2)(2009-3#1)
by P2Y(1)##2##2##(2008-4#2)
by PACAP##2##2##(1995-11#2)
by PAGE##2##2##(1990-11#1)(1994-11#1)
by PAP##2##2##(2008-10#2)
by PCA##4##2##(2008-10#4)
by PCP##2##2##(1991-1#1)(2009-3#1)
by PCPA treatment##2##3##(1992-11#2)
by PCPA##4##2##(1992-11#4)
by PCR Amplification of##2##4##(2008-10#2)
by PCR amplification of the##2##5##(1997-3#1)(1997-4#1)
by PCR amplification of##3##4##(1990-11#1)(1997-3#1)(1997-4#1)
by PCR amplification using primers##2##5##(1994-12#1)(2008-8#1)
by PCR amplification##7##3##(1990-11#2)(1993-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(2008-8#1)
by PCR and restriction##2##4##(1992-8#1)(2012-12#1)
by PCR and used for##2##5##(1995-8#1)(2008-8#1)
by PCR and##20##3##(1992-12#1)(1992-8#2)(1994-8#2)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-5#2)(2008-8#4)(2008-9#1)(2012-12#1)
by PCR from the##2##4##(1995-8#1)(2011-1#1)
by PCR from##4##3##(1995-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
by PCR in the##2##4##(2008-10#1)(2008-2#1)
by PCR in##6##3##(2008-10#4)(2008-12#1)(2008-2#1)
by PCR method##2##3##(2008-8#1)(2011-1#1)
by PCR or##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
by PCR using##5##3##(1992-9#1)(1995-11#1)(1995-8#1)(2012-12#1)(2013-1#1)
by PCR was##2##3##(2008-10#1)(2008-2#1)
by PCR with##3##3##(1992-3#1)(1996-6#1)(2008-10#1)
by PCR##103##2##(1990-11#2)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-8#3)(1995-11#2)(1995-2#1)(1995-8#3)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-7#1)(2008-10#18)(2008-12#5)(2008-2#11)(2008-4#2)(2008-5#3)(2008-8#10)(2008-9#5)(2009-8#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#3)
by PCR-RFLP and##2##3##(2013-1#2)
by PCR-RFLP##5##2##(2008-10#1)(2010-4#1)(2013-1#3)
by PEG method##2##3##(2008-8#1)(2008-9#1)
by PET##2##2##(1995-2#1)(1996-2#1)
by PEUs##3##2##(2008-11#3)
by PFGE##2##2##(1992-6#1)(2008-10#1)
by PI##4##2##(1993-11#1)(1994-11#1)(2008-9#2)
by PK-C##2##2##(1991-2#1)(1993-6#1)
by PKA##2##2##(1992-3#1)(2008-11#1)
by PKC##6##2##(1993-3#1)(1995-5#1)(1996-5#1)(2008-11#1)(2008-4#2)
by PLA2##2##2##(1990-11#1)(1991-2#1)
by PLS##2##2##(2008-10#2)
by PMA and##2##3##(1993-6#1)(2008-4#1)
by PMA was##2##3##(1993-6#1)(1994-6#1)
by PMA##14##2##(1990-12#1)(1991-2#1)(1993-6#2)(1994-6#3)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2006-6#1)(2008-11#1)(2008-4#1)
by PMNs of##2##3##(2008-4#2)
by PMNs##5##2##(1991-9#1)(2008-4#4)
by PPAR gamma 2##2##4##(1994-12#2)
by PQ##3##2##(1995-8#3)
by PRPSE##2##2##(2008-2#1)(2008-3#1)
by PTH and##2##3##(1994-11#1)(1995-6#1)
by PTH##3##2##(1994-11#1)(1995-6#1)(2008-8#1)
by Pacific##3##2##(1996-3#1)(2012-12#2)
by Pantoea agglomerans##2##3##(2008-10#2)
by Parkinson's disease##2##3##(2008-7#1)(2009-10#1)
by Partial Least##2##3##(2008-10#2)
by Paul##2##2##(2008-7#1)(2010-6#1)
by Pb2+##3##2##(1995-11#3)
by Penicillium expansum##6##3##(2008-10#6)
by Penicillium##10##2##(2008-10#8)(2008-6#1)(2011-2#1)
by Peronospora##2##2##(2008-10#2)
by Peyer's patch##2##3##(2008-11#2)
by Peyer's##4##2##(1997-1#1)(2008-11#3)
by Phoma ligulicola##2##3##(2008-10#2)
by Phoma##3##2##(2008-10#3)
by Phomopsis cucurbitae##2##3##(2008-10#2)
by Phomopsis obscurans##2##3##(2008-10#2)
by Phomopsis##5##2##(2008-10#5)
by Phytophthora and Pythium##2##4##(2008-10#2)
by Phytophthora infestans##4##3##(2008-10#3)(2009-6#1)
by Phytophthora lateralis##2##3##(2008-10#2)
by Phytophthora nicotianae and P##2##5##(2008-10#2)
by Phytophthora parasitica##2##3##(2008-10#2)
by Phytophthora##18##2##(2008-10#17)(2009-6#1)
by Pi##2##2##(1990-11#2)
by Pichia##2##2##(2008-10#1)(2013-1#1)
by Pipes##2##2##(1996-2#2)
by Plasmopara viticola##4##3##(2008-10#4)
by Pleurotus ostreatus##3##3##(2008-5#2)(2011-1#1)
by Pneumocystis##2##2##(1992-2#1)(2010-12#1)
by Polymerase Chain Reaction##3##4##(1990-12#1)(2008-10#1)(2008-12#1)
by President##2##2##(1991-12#1)(1995-12#1)
by Prof##2##2##(1990-10#1)(2008-10#1)
by Professor##5##2##(2007-12#1)(2008-5#3)(2013-1#1)
by Pseudomonas aeruginosa##3##3##(1995-2#1)(2008-6#1)(2013-1#1)
by Pseudomonas fluorescens SS101##2##4##(2008-10#2)
by Pseudomonas fluorescens##9##3##(2008-10#8)(2011-1#1)
by Pseudomonas putida##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
by Pseudomonas spp##3##3##(2008-10#3)
by Pseudomonas syringae pv##8##4##(2008-10#8)
by Pseudomonas syringae##13##3##(2008-10#12)(2009-8#1)
by Pseudomonas##32##2##(1991-7#1)(1995-2#1)(2008-10#23)(2008-6#2)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
by Puccinia graminis##2##3##(2008-10#2)
by Puccinia striiformis##7##3##(2008-10#7)
by Puccinia##18##2##(2008-10#18)
by Pyrenophora tritici-repentis##2##3##(2008-10#2)
by Pyrenophora##3##2##(2008-10#3)
by Pythium aphanidermatum##5##3##(2008-10#5)
by Pythium group F##2##4##(2008-10#2)
by Pythium spp##3##3##(2008-10#3)
by Pythium ultimum##8##3##(2008-10#8)
by Pythium##19##2##(2008-10#19)
by Q##2##2##(2007-12#1)(2008-10#1)
by QCM##2##2##(2008-10#2)
by QTL##2##2##(2008-10#1)(2008-12#1)
by QUAC is##2##3##(2013-8#2)
by Quickenden et al##2##4##(2008-3#2)
by R##18##2##(1991-8#1)(2007-7#1)(2008-10#14)(2008-7#1)(2013-1#1)
by RA##6##2##(1994-11#1)(1996-5#1)(2008-11#3)(2008-8#1)
by RAM##2##2##(1993-8#1)(2008-10#1)
by RAPD##4##2##(2008-10#4)
by RFLP analysis##6##3##(2008-10#5)(2008-5#1)
by RFLP mapping##2##3##(2008-8#2)
by RFLP##9##2##(2008-10#6)(2008-5#1)(2008-8#2)
by RGS proteins and##2##4##(2008-4#1)(2009-7#1)
by RHD##2##2##(2012-2#1)(2012-3#1)
by RIA##5##2##(1991-12#2)(1991-6#1)(2008-7#1)(2008-9#1)
by RNA gel blot##2##4##(2012-3#2)
by RNA interference##5##3##(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
by RNA polymerase II##3##4##(1994-8#2)(2009-5#1)
by RNA polymerase containing sigma##2##5##(1990-12#1)(1993-12#1)
by RNA polymerase containing##3##4##(1990-12#1)(1993-12#1)(1995-6#1)
by RNA polymerase##8##3##(1990-12#1)(1993-12#1)(1994-8#2)(1995-6#2)(1997-7#1)(2009-5#1)
by RNA##20##2##(1990-12#1)(1991-12#1)(1993-12#2)(1994-8#2)(1995-6#2)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#2)
by RNAi##5##2##(2008-2#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
by RNase##2##2##(1995-2#1)(1995-6#1)
by ROS##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
by RP-HPLC and##2##3##(2008-10#1)(2012-2#1)
by RP-HPLC##9##2##(1990-8#1)(1996-5#2)(2008-10#4)(2012-2#2)
by RP-HPLC]##2##2##(2012-3#2)
by RT-PCR analysis##2##3##(1994-11#1)(2008-9#1)
by RT-PCR and##7##3##(1993-9#1)(1994-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-3#1)(2013-8#1)
by RT-PCR in##2##3##(2008-10#1)(2008-12#1)
by RT-PCR technique##2##3##(2008-8#1)(2008-9#1)
by RT-PCR using##2##3##(1993-3#1)(2008-10#1)
by RT-PCR with##3##3##(2008-11#1)(2008-9#2)
by RT-PCR##34##2##(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1997-9#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#7)(2011-1#1)(2011-3#1)(2013-1#1)(2013-8#3)
by Race##2##2##(2008-10#1)(2012-12#1)
by Ralstonia solanacearum##7##3##(2008-10#7)
by Raman spectroscopy##7##3##(1991-5#2)(1992-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
by Raman##9##2##(1991-5#2)(1992-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
by Rayleigh light scattering##2##4##(2008-10#2)
by Rayleigh scattering##2##3##(2008-3#2)
by Rayleigh##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
by Real-Time Polymerase Chain Reaction##3##5##(2008-10#3)
by Real-Time##4##2##(2008-10#3)(2008-12#1)
by Repetitive##2##2##(2008-10#1)(2008-5#1)
by Restriction##2##2##(2008-10#2)
by Rhizoctonia solani##8##3##(2008-10#8)
by Rhizoctonia##9##2##(2008-10#9)
by Rhizopus oryzae##3##3##(2008-10#2)(2008-6#1)
by Rhodococcus erythropolis##2##3##(2008-6#2)
by Rhodotorula##3##2##(2009-11#3)
by Rhynchosporium secalis##2##3##(2008-10#2)
by Rives' technique##2##3##(1992-5#2)
by Robert##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
by Roche##2##2##(2008-5#2)
by Ron##2##2##(1991-1#1)(2008-7#1)
by Rp-cAMPS##2##2##(1993-6#2)
by Russian##2##2##(2012-3#1)(2013-8#1)
by RuvAB##3##2##(1995-3#3)
by S##18##2##(1991-3#2)(1995-12#1)(2008-10#10)(2008-5#1)(2010-12#1)(2010-8#2)(2013-1#1)
by S-1(A2)##2##2##(1992-4#2)
by S1 nuclease protection analysis##2##5##(1992-3#1)(1993-3#1)
by S1 nuclease##3##3##(1992-3#1)(1993-3#1)(1994-11#1)
by S1##7##2##(1991-9#1)(1992-3#4)(1993-3#1)(1994-11#1)
by SA##2##2##(2008-10#1)(2011-10#1)
by SDA##2##2##(2008-12#2)
by SDS gel electrophoresis##2##4##(1990-5#1)(1990-7#1)
by SDS##6##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-8#1)(1995-5#1)(2008-5#1)
by SDS-PAGE and Western blot##2##5##(2008-11#1)(2011-1#1)
by SDS-PAGE and autoradiography##2##4##(1991-2#1)(1995-11#1)
by SDS-PAGE and the##3##4##(2008-4#2)(2008-5#1)
by SDS-PAGE and##12##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#1)(1995-11#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2011-1#1)
by SDS-PAGE electrophoresis##2##3##(1990-11#2)
by SDS-PAGE in the##2##4##(1995-11#2)
by SDS-PAGE##38##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-11#3)(1997-4#2)(2008-11#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
by SDS/PAGE##2##2##(1990-5#1)(1990-7#1)
by SEC##2##2##(2008-10#2)
by SEM##7##2##(1990-11#1)(2008-10#1)(2008-5#2)(2009-7#1)(2012-3#1)(2013-1#1)
by SERS##2##2##(2010-5#1)(2013-1#1)
by SHG##2##2##(2007-11#1)(2007-12#1)
by SIN-1##2##2##(1997-4#2)
by SK&amp##3##2##(1991-8#3)
by SMVEA##2##2##(2008-10#2)
by SNP##2##2##(1995-11#1)(2008-12#1)
by SPE##4##2##(1997-2#1)(2008-10#3)
by SPE(60)##2##2##(2008-10#2)
by SS-RTP##2##2##(2008-10#2)
by SWAdSV##2##2##(2008-10#2)
by Saccharomyces##3##2##(1995-6#1)(2008-10#1)(2012-3#1)
by Scanning##2##2##(1990-11#1)(2008-5#1)
by Scatchard plot##2##3##(2008-10#2)
by Scatchard##3##2##(1992-9#1)(2008-10#2)
by Sclerotinia sclerotiorum##4##3##(2008-10#4)
by Sclerotinia##6##2##(2008-10#6)
by Sclerotium rolfsii##2##3##(2008-10#2)
by Se deficiency##3##3##(1993-6#1)(2012-2#2)
by Se##4##2##(1991-12#1)(1993-6#1)(2012-2#2)
by Sephadex column##2##3##(2008-10#2)
by Sephadex##3##2##(2008-10#2)(2008-11#1)
by Sertoli cells##3##3##(2008-4#1)(2009-10#1)(2012-2#1)
by Shigella dysenteriae##2##3##(1994-9#1)(2011-1#1)
by Southern analysis##4##3##(1992-9#1)(1994-12#1)(1997-2#1)(2008-10#1)
by Southern blot analysis##5##4##(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#1)
by Southern blot hybridization##5##4##(1992-3#1)(2008-10#4)
by Southern blot##11##3##(1992-3#1)(1996-6#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-9#1)
by Southern hybridization and##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
by Southern hybridization with##2##4##(2008-10#1)(2008-8#1)
by Southern hybridization##11##3##(1993-3#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
by Southern##30##2##(1990-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-2#2)(1997-8#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#3)
by Soxhlet##3##2##(2008-10#3)
by Spectroscopic Ellipsometry##2##3##(2008-2#1)(2008-3#1)
by Src##2##2##(2011-1#2)
by Stagonospora nodorum##4##3##(2008-10#4)
by Staphylococcus aureus in##3##4##(1997-4#1)(2007-7#1)(2008-12#1)
by Staphylococcus aureus##8##3##(1994-3#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-9#1)(2012-12#1)
by Staphylococcus##9##2##(1994-3#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
by State##3##2##(1997-1#1)(1997-2#1)(1997-3#1)
by States to##2##3##(1996-1#1)(1997-2#1)
by Stemphylium vesicarium##2##3##(2008-10#2)
by Stenotrophomonas maltophilia Strain C3##2##5##(2008-10#2)
by Stenotrophomonas maltophilia##3##3##(2008-10#3)
by Steven##3##2##(2008-4#1)(2008-6#2)
by Stoppa's technique##2##3##(1992-5#2)
by Streptococcus##6##2##(1991-11#1)(1994-9#1)(1997-2#1)(2010-2#1)(2011-2#2)
by Streptomyces hygroscopicus##2##3##(2010-8#2)
by Streptomyces##7##2##(2008-10#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#2)
by Sudan##2##2##(1996-12#2)
by Sum Frequency Generation##2##4##(2008-10#2)
by Sum Frequency##3##3##(2008-10#2)(2008-2#1)
by Swiss 3T3 cells##2##4##(1994-3#2)
by Swiss##3##2##(1994-3#2)(2011-2#1)
by T cells##4##3##(1994-9#1)(2007-11#1)(2008-4#1)(2008-9#1)
by T##23##2##(1992-8#1)(1994-9#1)(1996-2#1)(2007-11#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-12#1)(2013-8#1)
by T-cell##2##2##(1990-5#1)(1997-6#1)
by T-tube extraction##2##3##(1991-3#2)
by T3##3##2##(1994-11#2)(2008-10#1)
by T4 RNA ligase##2##4##(1993-11#1)(2008-8#1)
by T4##4##2##(1991-9#2)(1993-11#1)(2008-8#1)
by TBI##2##2##(2012-2#2)
by TBTO##2##2##(2008-10#2)
by TCA and##3##3##(1997-1#1)(2008-10#2)
by TCAAS##2##2##(2008-10#2)
by TCDD##4##2##(1992-12#1)(1995-11#1)(2008-10#2)
by TCE##2##2##(2008-10#2)
by TDM##2##2##(1991-11#2)
by TEA+##2##2##(1993-3#1)(1994-11#1)
by TEM##5##2##(2008-10#2)(2008-5#1)(2009-9#1)(2013-1#1)
by TG-FTIR##2##2##(2008-10#2)
by TGA##2##2##(2008-10#1)(2009-6#1)
by TGF##2##2##(1991-12#1)(1997-4#1)
by TGF-beta 1##2##3##(1992-3#2)
by TGF-beta##3##2##(1992-3#2)(2008-6#1)
by THP-1##3##2##(2008-10#1)(2013-1#2)
by TLC and##2##3##(1990-2#1)(2008-11#1)
by TLC on##2##3##(2008-5#2)
by TLC##8##2##(1990-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#1)
by TMGMV-S##3##2##(2008-10#3)
by TNF##3##2##(1992-7#1)(1993-6#1)(2008-9#1)
by TNF-alpha##6##2##(1992-12#1)(1992-8#2)(1993-6#2)(2008-9#1)
by TP53##2##2##(2011-2#1)(2013-1#1)
by TPA was##2##3##(1990-2#1)(1997-1#1)
by TPA##13##2##(1990-12#1)(1990-2#2)(1990-8#2)(1992-9#1)(1993-9#3)(1996-12#1)(1997-1#2)(2008-9#1)
by TPKI and TPKII##2##4##(1995-12#2)
by TPKI##3##2##(1995-12#3)
by TRH (500 nM)##2##4##(1992-8#2)
by TRH##4##2##(1992-8#2)(1993-11#1)(1995-5#1)
by TRUS##3##2##(1997-8#1)(2011-2#2)
by TRX f1##2##3##(2009-10#2)
by TRXs##2##2##(2009-10#2)
by TSWV##3##2##(2008-10#3)
by TYLCV-Is##3##2##(2008-10#3)
by Talaromyces flavus##2##3##(2008-10#2)
by Taphrina deformans##2##3##(2008-10#2)
by Taq DNA polymerase##2##4##(1994-12#1)(2008-5#1)
by Tax protein##2##3##(2008-8#2)
by TbCSV-[Y35]##2##2##(2008-10#2)
by The##5##2##(1994-12#1)(1994-3#1)(1996-1#1)(2008-9#2)
by Thielaviopsis basicola##2##3##(2008-10#2)
by Tim##2##2##(2011-2#1)(2013-1#1)
by Tranzschelia discolor##3##3##(2008-10#3)
by Treatment##2##2##(2008-10#1)(2010-4#1)
by Trichoderma spp##3##3##(2008-10#3)
by Trichoderma##9##2##(2008-10#8)(2008-6#1)
by Trichophyton tonsurans##3##3##(2008-5#3)
by Trichophyton##4##2##(2008-5#4)
by Triton X-100##2##3##(1997-8#1)(2008-10#1)
by Triton##3##2##(1992-3#1)(1997-8#1)(2008-10#1)
by Turkish##2##2##(1992-5#1)(1995-12#1)
by Two##2##2##(2008-10#2)
by U##10##2##(1995-3#2)(2008-10#7)(2011-3#1)
by U-ARF##2##2##(2008-8#2)
by US##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
by UTI##2##2##(2007-7#1)(2011-2#1)
by UV absorption##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
by UV and##2##3##(1990-7#1)(2008-10#1)
by UV at##2##3##(1996-5#1)(2008-10#1)
by UV cross-linking##2##3##(1995-6#1)(2008-2#1)
by UV exposure##2##3##(1995-3#1)(2008-3#1)
by UV irradiation##4##3##(1992-11#1)(2008-10#1)(2008-12#1)(2008-5#1)
by UV light##5##3##(2007-12#2)(2008-10#2)(2008-4#1)
by UV radiation##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
by UV spectrophotometry and##2##4##(1995-2#1)(2008-10#1)
by UV spectrophotometry##3##3##(1995-2#1)(2008-10#2)
by UV spectroscopy##3##3##(1990-7#1)(2008-5#1)(2013-1#1)
by UV##41##2##(1990-7#3)(1991-8#1)(1992-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#2)(2007-11#1)(2007-12#2)(2008-10#14)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2011-2#1)(2013-1#1)
by UV-Vis spectroscopy##3##3##(2008-10#3)
by UV-Vis##5##2##(2007-11#1)(2008-10#4)
by UV-vis spectroscopy##2##3##(2008-10#2)
by UV-vis##6##2##(2008-10#6)
by UV-visible spectrophotometry##2##3##(2008-10#2)
by UV-visible##3##2##(2008-10#3)
by UVB##4##2##(2008-10#1)(2008-5#2)(2011-2#1)
by UVC irradiation##2##3##(2008-11#2)
by Uncinula necator##2##3##(2008-10#2)
by Use of a##5##4##(2008-2#2)(2008-3#3)
by Use of an##2##4##(2008-2#2)
by Use of##12##3##(2008-2#5)(2008-3#7)
by Using##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
by V##8##2##(2008-10#7)(2009-8#1)
by V108LRUH1##2##2##(2008-10#2)
by VATS in##2##3##(2008-10#1)(2010-8#1)
by VATS##5##2##(2007-8#1)(2008-10#3)(2010-8#1)
by VIP##2##2##(2008-4#2)
by VPA##2##2##(1996-5#1)(2013-1#1)
by VUV##2##2##(2010-4#2)
by Val##2##2##(2008-9#1)(2009-5#1)
by Van##2##2##(2007-11#1)(2008-10#1)
by Vargas##2##2##(2008-2#1)(2008-9#1)
by Venturia inaequalis##2##3##(2008-10#2)
by Venturia nashicola##2##3##(2008-10#2)
by Venturia##4##2##(2008-10#4)
by ViraPap##2##2##(1994-1#2)
by ViraType##2##2##(1994-1#2)
by Volatiles of##2##3##(2008-10#2)
by W##4##2##(1993-12#1)(2008-5#1)(2010-7#1)(2013-1#1)
by WB4101##2##2##(1995-12#2)
by WHO criteria##2##3##(2008-3#1)(2008-6#1)
by WHO##5##2##(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
by WT##2##2##(1995-5#1)(2011-1#1)
by Western blot analyses##2##4##(1991-10#1)(1992-8#1)
by Western blot analysis##8##4##(1990-8#1)(1992-2#1)(1992-8#1)(1993-6#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
by Western blot and##3##4##(1990-7#1)(1994-5#1)(1997-4#1)
by Western blot using##3##4##(1997-4#1)(2008-5#1)(2008-8#1)
by Western blot##24##3##(1990-7#1)(1990-8#1)(1991-10#1)(1992-2#1)(1992-8#2)(1993-6#1)(1994-5#1)(1996-12#1)(1997-4#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
by Western blotting of##2##4##(1994-11#1)(2008-11#1)
by Western blotting using a##2##5##(1992-12#1)(1997-1#1)
by Western blotting with##3##4##(1991-8#1)(1992-3#1)(1997-1#1)
by Western blotting##19##3##(1991-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-1#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-3#1)
by Western##45##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-4#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
by Whole##2##2##(2012-3#1)(2013-1#1)
by World Health Organization##2##4##(2007-2#1)(2008-3#1)
by World##3##2##(2007-2#1)(2008-1#1)(2008-3#1)
by X##5##2##(2007-12#1)(2008-10#4)
by X-ray absorption fine##2##4##(2008-10#1)(2011-2#1)
by X-ray absorption##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
by X-ray analysis of##2##4##(1995-3#1)(1996-5#1)
by X-ray analysis##3##3##(1995-3#1)(1996-5#2)
by X-ray crystal##2##3##(1992-8#1)(1996-5#1)
by X-ray crystallography and##2##4##(1993-11#1)(1996-2#1)
by X-ray crystallography##8##3##(1992-4#1)(1992-8#1)(1993-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-4#1)
by X-ray diffraction (XRD)##3##4##(2008-10#3)
by X-ray diffraction and##2##4##(1994-5#1)(2008-10#1)
by X-ray diffraction for the##2##5##(1996-2#1)(1996-5#1)
by X-ray diffraction##13##3##(1994-5#1)(1996-2#3)(1996-5#1)(2008-10#7)(2013-8#1)
by X-ray fluorescence (XRF)##2##4##(2008-10#1)(2008-5#1)
by X-ray fluorescence spectrometry##3##4##(2008-10#3)
by X-ray fluorescence##7##3##(2008-10#5)(2008-5#1)(2013-8#1)
by X-ray photoelectron##3##3##(2008-10#3)
by X-ray powder##3##3##(2011-3#1)(2012-2#1)(2013-8#1)
by X-ray##51##2##(1990-12#1)(1991-8#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#2)(1996-2#4)(1996-5#4)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#4)
by XRD##3##2##(2008-10#1)(2013-8#2)
by XRF##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
by Xanthomonas axonopodis pv##2##4##(2008-10#2)
by Xanthomonas oryzae pv##3##4##(2008-10#2)(2009-10#1)
by Xanthomonas##13##2##(2008-10#12)(2009-10#1)
by YAC##2##2##(1996-10#1)(1996-12#1)
by Z##3##2##(2008-12#1)(2008-6#2)
by ZETAAS##2##2##(2008-10#2)
by Zeeman ETAAS using##2##4##(2008-10#2)
by Zeeman-corrected electrothermal##2##3##(2008-10#2)
by Zn##2##2##(1994-10#1)(2008-10#1)
by Zymomonas mobilis##3##3##(2008-6#2)(2008-7#1)
by a &quot##5##3##(1990-8#1)(1992-12#1)(2008-10#2)(2008-11#1)
by a 1##5##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-3#1)
by a 2##3##3##(2007-12#2)(2008-3#1)
by a 3##2##3##(2008-10#1)(2009-5#1)
by a C##3##3##(2008-10#3)
by a CCD camera##2##4##(2008-3#2)
by a CCD##4##3##(2008-3#4)
by a CCK type##2##4##(1994-2#2)
by a CD##2##3##(1990-8#2)
by a DNA##3##3##(1997-3#1)(2008-11#1)(2008-4#1)
by a HPLC##2##3##(2008-10#2)
by a Ti##3##3##(2007-12#2)(2008-3#1)
by a UV##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
by a World##2##3##(2008-10#1)(2010-4#1)
by a back##2##3##(1995-2#1)(1997-7#1)
by a backward##2##3##(1994-3#1)(2008-10#1)
by a bacterial##2##3##(1996-2#1)(2008-9#1)
by a basic##2##3##(2008-12#1)(2008-4#1)
by a batch method##2##4##(2008-10#2)
by a batch##4##3##(2008-10#4)
by a binary##2##3##(1995-12#1)(2008-3#1)
by a biological##2##3##(1990-8#1)(1992-8#1)
by a bivariate##2##3##(2008-10#1)(2009-9#1)
by a brief##3##3##(1990-2#1)(1991-12#1)(2008-4#1)
by a broad band##2##4##(2008-10#2)
by a broad##3##3##(2008-10#2)(2010-8#1)
by a calcified mass##2##4##(2007-8#1)(2011-1#1)
by a camera##2##3##(2008-2#1)(2008-9#1)
by a carbon##2##3##(2008-10#2)
by a cardiac##2##3##(1996-2#1)(2008-7#1)
by a cellular##3##3##(2008-4#1)(2008-8#1)(2012-2#1)
by a central##4##3##(1991-2#1)(1995-3#1)(1995-8#1)(1996-12#1)
by a change in the##5##5##(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
by a change in##10##4##(1995-6#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-9#1)
by a change##11##3##(1995-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-9#1)
by a chemical reaction##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
by a chemical##5##3##(2007-12#1)(2008-10#3)(2008-7#1)
by a child##2##3##(2008-9#1)(2013-1#1)
by a classical##4##3##(2007-11#1)(2008-10#2)(2009-11#1)
by a clinical exam##2##4##(2008-7#1)(2010-12#1)
by a clinical pharmacist##2##4##(2008-11#2)
by a clinical##6##3##(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
by a colorimetric assay##2##4##(2008-10#1)(2008-11#1)
by a colorimetric method##3##4##(1993-9#1)(2008-10#2)
by a colorimetric##5##3##(1993-9#1)(2008-10#3)(2008-11#1)
by a combination of both##3##5##(2008-10#1)(2008-7#1)(2009-2#1)
by a combination of molecular##2##5##(2007-11#1)(2008-8#1)
by a combination of these##2##5##(1991-8#1)(2008-10#1)
by a combination of##41##4##(1990-11#1)(1990-12#1)(1991-5#2)(1991-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
by a combination##43##3##(1990-11#1)(1990-12#1)(1991-5#2)(1991-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
by a commercial##5##3##(2007-12#1)(2008-10#4)
by a common##4##3##(1990-2#1)(1994-8#1)(1995-8#1)(2009-10#1)
by a community##2##3##(1993-2#1)(2013-1#1)
by a comparison of the##2##5##(1992-6#1)(2008-3#1)
by a complete##2##3##(1993-11#1)(2008-11#1)
by a complex array of##2##5##(1992-8#1)(2008-4#1)
by a complex network##2##4##(2009-8#1)(2010-8#1)
by a complex##11##3##(1992-8#1)(1994-12#1)(2008-10#1)(2008-4#1)(2009-6#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#1)
by a computer program##3##4##(1994-6#1)(1997-2#1)(2008-10#1)
by a computer##10##3##(1994-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-3#4)
by a computer-aided##2##3##(2008-10#2)
by a computer-assisted##2##3##(1990-6#1)(1994-12#1)
by a computerized##2##3##(2008-2#1)(2011-1#1)
by a confocal microscope##2##4##(2008-10#1)(2008-2#1)
by a considerable##2##3##(1995-1#1)(2008-10#1)
by a consortium of##2##4##(2008-11#1)(2009-11#1)
by a constant##3##3##(2008-10#2)(2009-6#1)
by a continuous##7##3##(1992-5#1)(1994-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2013-1#1)
by a conventional##11##3##(1993-2#1)(2008-10#5)(2008-3#4)(2008-5#1)
by a critical##2##3##(2009-4#1)(2012-3#1)
by a cross##3##3##(2008-11#1)(2008-5#1)(2010-2#1)
by a cw##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by a daily##2##3##(1991-8#1)(2007-7#1)
by a dc##2##3##(2007-11#1)(2008-2#1)
by a decline##4##3##(1990-3#1)(1990-7#1)(1991-2#1)(1992-12#1)
by a decrease in the##9##5##(1990-11#1)(1991-5#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-7#1)
by a decrease in##20##4##(1990-11#1)(1990-2#1)(1991-2#2)(1991-5#1)(1992-8#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2013-7#1)
by a decrease of##3##4##(1992-9#1)(1993-12#1)(1994-8#1)
by a decrease##26##3##(1990-11#1)(1990-2#1)(1991-2#2)(1991-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-7#1)
by a decreased##4##3##(1992-3#1)(1993-9#1)(2008-11#1)(2011-2#1)
by a deficiency of##2##4##(2007-7#1)(2011-2#1)
by a deficiency##4##3##(1996-8#1)(2007-7#1)(2008-5#1)(2011-2#1)
by a delayed##4##3##(1990-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
by a dense##2##3##(1997-3#1)(2008-5#1)
by a detailed analysis of##2##5##(2008-3#1)(2010-1#1)
by a detection##2##3##(2008-10#1)(2008-7#1)
by a dialysis##2##3##(1993-8#1)(2008-7#1)
by a difference##2##3##(1997-2#1)(2011-2#1)
by a different##10##3##(1990-11#1)(1990-5#1)(1991-2#2)(1997-4#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)
by a diffuse##3##3##(1990-6#1)(1995-12#1)(1997-1#1)
by a diffuser##2##3##(2008-2#2)
by a digital camera##3##4##(2008-3#2)(2010-8#1)
by a digital##4##3##(2008-10#1)(2008-3#2)(2010-8#1)
by a diode array##2##4##(2008-10#1)(2008-2#1)
by a diode laser##3##4##(2007-12#3)
by a diode##5##3##(2007-12#3)(2008-10#1)(2008-2#1)
by a diode-pumped##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
by a direct##10##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(2007-12#1)
by a discrete##3##3##(2008-3#2)(2008-5#1)
by a discussion##14##3##(1994-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
by a distance##2##3##(2013-1#1)(2013-7#1)
by a distinct##3##3##(1992-3#1)(2007-12#1)(2008-4#1)
by a diverse##2##3##(2008-10#1)(2011-2#1)
by a dominant##2##3##(2008-10#1)(2008-8#1)
by a dramatic decrease in##2##5##(1990-3#1)(1992-1#1)
by a dramatic##3##3##(1990-3#1)(1992-1#1)(2013-1#1)
by a dual##4##3##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
by a dynamic##2##3##(2007-11#2)
by a factor of 1##5##5##(1992-12#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
by a factor of 10##4##5##(1992-3#1)(1994-12#1)(2008-10#1)(2008-3#1)
by a factor of 10(4)##2##5##(1995-2#1)(1996-7#1)
by a factor of 16##2##5##(2007-11#1)(2011-2#1)
by a factor of 2##10##5##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)
by a factor of 2-3##3##5##(1994-3#1)(2008-3#1)(2008-6#1)
by a factor of 3##7##5##(1997-4#1)(2008-10#3)(2008-3#2)(2009-5#1)
by a factor of 4##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
by a factor of 5##4##5##(1996-5#1)(2007-11#2)(2007-12#1)
by a factor of 6##4##5##(2008-10#3)(2008-2#1)
by a factor of 8##2##5##(2008-10#1)(2008-3#1)
by a factor of about##2##5##(2008-10#1)(2008-5#1)
by a factor of up to##2##6##(2008-10#1)(2011-2#1)
by a factor of##78##4##(1992-12#2)(1992-3#1)(1993-11#1)(1993-9#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-11#5)(2007-12#4)(2008-10#21)(2008-2#5)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)
by a factor ranging from##2##5##(1992-12#1)(2008-10#1)
by a factor##88##3##(1990-8#3)(1992-12#3)(1992-3#1)(1993-11#1)(1993-9#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-11#6)(2007-12#5)(2008-10#23)(2008-2#6)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)
by a family of##3##4##(1996-2#1)(2008-4#1)(2008-5#1)
by a family##4##3##(1993-6#1)(1996-2#1)(2008-4#1)(2008-5#1)
by a fast##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
by a femtosecond##3##3##(2007-11#2)(2008-3#1)
by a few milliwatts of##2##5##(2007-11#1)(2007-12#1)
by a few##11##3##(1990-12#1)(1991-3#1)(1992-11#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)
by a fiber Bragg grating##2##5##(2007-11#1)(2007-12#1)
by a fiber##6##3##(2007-11#1)(2007-12#3)(2008-2#2)
by a fixed##2##3##(2007-12#1)(2008-3#1)
by a flame##3##3##(2008-10#3)
by a flow cytometric##2##4##(1994-2#1)(2008-2#1)
by a flow injection##3##4##(2008-10#3)
by a flow of##3##4##(2008-1#1)(2008-10#2)
by a flow##10##3##(1994-2#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-9#1)
by a fluorescence##2##3##(2008-10#2)
by a focused laser##3##4##(2008-2#1)(2008-3#2)
by a focused##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
by a formulation##2##3##(2008-10#1)(2008-5#1)
by a fractional##2##3##(1996-2#1)(2008-3#1)
by a frequency-doubled##2##3##(2007-12#2)
by a functional##3##3##(1997-8#1)(2007-12#1)(2009-1#1)
by a further##2##3##(1995-12#1)(1997-4#1)
by a gas##2##3##(2008-10#1)(2013-1#1)
by a gel##2##3##(1992-12#1)(2008-10#1)
by a gene##7##3##(1990-5#1)(1993-8#1)(1994-8#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
by a general practitioner##3##4##(1993-2#1)(2009-3#1)(2011-1#1)
by a general##9##3##(1993-2#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
by a generalized##2##3##(2008-10#1)(2008-2#1)
by a giant##2##3##(1991-11#1)(2009-10#1)
by a given##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
by a global##3##3##(1995-6#1)(2008-7#1)(2011-2#1)
by a good##2##3##(2011-2#2)
by a gradual##2##3##(2008-10#1)(2008-3#1)
by a graphite furnace atomic absorption##3##6##(2008-10#3)
by a grating##3##3##(2007-11#1)(2008-2#1)(2008-5#1)
by a group of##6##4##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#1)
by a group##8##3##(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#2)
by a health##2##3##(1993-1#1)(2010-12#1)
by a heat##2##3##(1992-6#1)(1993-6#1)
by a high level of##2##5##(1990-12#1)(1995-8#1)
by a high risk of##2##5##(2007-8#1)(2010-3#1)
by a high##20##3##(1990-12#1)(1993-3#1)(1994-11#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-10#1)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#2)
by a higher##5##3##(1990-11#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-7#1)
by a highly##5##3##(1992-9#1)(1995-3#1)(2008-10#2)(2008-3#1)
by a holographic##4##3##(2007-11#2)(2008-3#2)
by a home-made##2##3##(2008-10#2)
by a homogeneous##2##3##(2008-3#2)
by a homography##2##3##(2008-6#2)
by a hospital##2##3##(1991-1#1)(2008-10#1)
by a host##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
by a human##2##3##(1990-12#1)(1995-6#1)
by a hypothetical##2##3##(1990-11#1)(1991-9#1)
by a jet nebulizer##2##4##(1994-12#1)(1996-3#1)
by a labeling##2##3##(1996-5#1)(2008-10#1)
by a lack of##14##4##(1994-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2013-1#1)
by a large number of##6##5##(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2013-1#1)
by a large##19##3##(1990-5#1)(1990-9#1)(1992-6#2)(1996-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2013-1#2)
by a laser diode##2##4##(2007-11#1)(2008-2#1)
by a laser##3##3##(2007-11#1)(2008-2#2)
by a layer of##3##4##(2008-10#2)(2009-7#1)
by a least-squares##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
by a left##3##3##(1990-6#1)(2008-6#1)(2012-3#1)
by a lens##2##3##(2008-3#2)
by a lesion on the##2##5##(2007-10#2)
by a lesion##4##3##(1993-12#1)(1996-3#1)(2007-10#2)
by a less##2##3##(1995-5#1)(2008-10#1)
by a light##2##3##(1991-2#1)(2008-10#1)
by a linear regression##2##4##(2008-10#1)(2013-8#1)
by a linear##8##3##(1992-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-5#1)(2013-8#1)
by a linearly##2##3##(2008-3#2)
by a liquid-crystal##3##3##(2008-2#2)(2008-3#1)
by a local##4##3##(1994-8#1)(1997-2#1)(1997-5#1)(2013-8#1)
by a locally##2##3##(1993-8#1)(2007-12#1)
by a long##4##3##(1992-3#1)(1994-12#1)(2008-7#1)(2013-1#1)
by a long-period##2##3##(1997-5#1)(2007-12#1)
by a longer##3##3##(1994-12#1)(2008-3#1)(2009-8#1)
by a loss of##2##4##(1996-12#1)(2009-4#1)
by a loss##3##3##(1996-12#1)(2008-11#1)(2009-4#1)
by a lot of##2##4##(1990-2#1)(1997-4#1)
by a low##4##3##(1993-12#1)(1997-1#1)(2008-3#1)(2009-7#1)
by a lower##4##3##(1993-8#1)(2007-12#1)(2008-10#1)(2013-8#1)
by a luciferase##2##3##(2008-11#1)(2011-2#1)
by a major##2##3##(2008-9#1)(2009-5#1)
by a mammalian##2##3##(1990-12#1)(1991-6#1)
by a mass##2##3##(1992-6#1)(2008-10#1)
by a mathematical model##2##4##(2008-2#1)(2008-7#1)
by a maximum of##4##4##(1990-5#2)(1995-12#1)(2013-1#1)
by a maximum##7##3##(1990-5#2)(1993-3#1)(1995-12#1)(2008-10#1)(2009-5#1)(2013-1#1)
by a mean of##3##4##(1991-8#1)(1996-2#1)(2008-4#1)
by a mean##6##3##(1991-8#1)(1996-2#2)(2008-11#1)(2008-4#1)(2008-7#1)
by a mechanism independent of##2##5##(1993-9#1)(2008-4#1)
by a mechanism that does not involve##3##7##(1994-8#1)(1995-3#1)(1995-8#1)
by a mechanism which##2##4##(1990-5#1)(1997-7#1)
by a mechanism##14##3##(1990-2#1)(1990-5#1)(1991-12#1)(1993-9#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-4#1)
by a medical##3##3##(1990-6#1)(1992-2#1)(2011-2#1)
by a medium##2##3##(1992-8#1)(2007-12#1)
by a membrane##2##3##(1991-8#1)(2008-10#1)
by a membrane-bound##2##3##(1992-8#1)(1995-6#1)
by a meta-analysis of##2##4##(2008-10#1)(2008-11#1)
by a method##4##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
by a microcomputer##3##3##(2008-10#3)
by a micromachined##2##3##(2007-11#2)
by a mild##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
by a mixed##2##3##(2008-10#1)(2008-6#1)
by a mixture of##6##4##(2007-11#1)(2007-8#1)(2008-10#3)(2008-9#1)
by a mode-locked##3##3##(2007-12#3)
by a model based on##2##5##(2007-11#1)(2008-2#1)
by a model##8##3##(1990-11#1)(1991-5#1)(1994-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
by a moderate##2##3##(1992-6#1)(2008-3#1)
by a modification of##2##4##(2008-1#1)(2008-11#1)
by a modification##4##3##(2008-1#1)(2008-10#2)(2008-11#1)
by a modified##8##3##(1992-8#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2011-2#1)
by a monoclonal antibody##4##4##(1992-8#1)(1994-12#1)(1995-3#2)
by a more reduced##2##4##(2008-1#2)
by a more##9##3##(1992-12#1)(1996-3#1)(1996-5#1)(2008-1#2)(2008-10#3)(2008-6#1)
by a moving##4##3##(2007-8#1)(2008-3#1)(2008-7#1)(2010-9#1)
by a much##4##3##(1990-5#1)(2007-12#1)(2008-8#1)(2013-1#1)
by a multidisciplinary team of##2##5##(1990-6#1)(2007-12#1)
by a multidisciplinary team##6##4##(1990-6#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
by a multidisciplinary##8##3##(1990-6#1)(1996-1#1)(2007-12#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
by a multimode##3##3##(2008-3#3)
by a multiwavelength##2##3##(2007-11#1)(2008-3#1)
by a mutation in the##4##5##(1995-2#1)(2008-12#1)(2012-3#1)(2013-1#1)
by a mutation in##5##4##(1995-2#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#1)
by a mutation##6##3##(1995-2#1)(2007-8#1)(2008-12#1)(2012-3#2)(2013-1#1)
by a national##2##3##(2012-1#1)(2012-12#1)
by a natural##3##3##(2008-2#1)(2008-9#1)(2012-2#1)
by a needle##2##3##(1990-2#1)(1993-9#1)
by a negative##2##3##(1993-11#1)(2007-12#1)
by a nested##2##3##(2008-10#2)
by a network of##2##4##(1990-11#1)(2012-2#1)
by a neural##2##3##(2007-12#1)(2012-1#1)
by a neutral##2##3##(2007-5#1)(2008-11#1)
by a new approach##2##4##(1996-5#1)(2008-10#1)
by a new technique##2##4##(1991-2#1)(2008-4#1)
by a new##26##3##(1990-5#1)(1991-2#2)(1992-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(2007-12#3)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
by a newly##3##3##(1991-2#1)(2008-10#1)(2008-6#1)
by a non-linear method##2##4##(2008-10#2)
by a non-linear##3##3##(2008-10#2)(2009-8#1)
by a nonlinear##3##3##(2008-10#2)(2008-3#1)
by a novel##14##3##(1990-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-4#1)
by a nuclear gene##2##4##(1995-6#1)(2008-10#1)
by a nucleotide##2##3##(1991-11#1)(2008-11#1)
by a number of##27##4##(1990-7#1)(1990-8#1)(1990-9#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2009-1#1)(2013-1#1)
by a numerical##3##3##(2007-11#1)(2008-3#2)
by a one-dimensional##2##3##(2007-11#1)(2008-11#1)
by a pair of##6##4##(1990-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
by a parallel##2##3##(1994-11#1)(2008-3#1)
by a parameter##2##3##(2008-10#1)(2008-3#1)
by a particular##6##3##(1990-4#1)(1992-3#1)(2008-10#3)(2008-4#1)
by a passive sampler##2##4##(2008-10#2)
by a passive##5##3##(1995-11#1)(2007-11#1)(2008-10#3)
by a pathway##2##3##(1994-11#1)(1995-8#1)
by a patient with##2##4##(1996-2#1)(1997-4#1)
by a pedometer)##2##3##(2013-1#2)
by a peptide##3##3##(1993-11#1)(1994-2#1)(1995-2#1)
by a perception##2##3##(2008-4#1)(2012-12#1)
by a period of##3##4##(1990-5#1)(2008-10#1)(2010-8#1)
by a pharmacist##3##3##(2008-11#1)(2010-3#2)
by a phase##7##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)
by a phase-stepping##2##3##(2008-2#1)(2008-3#1)
by a photocatalytic oxidation method using##2##6##(2008-10#2)
by a physical##2##3##(1997-7#1)(2008-3#1)
by a physician and##3##4##(2007-7#1)(2008-1#1)(2009-6#1)
by a physician##9##3##(1991-1#1)(1993-3#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#1)
by a planar##3##3##(1990-8#1)(2007-12#1)(2008-3#1)
by a plane wave##5##4##(2007-11#1)(2008-3#4)
by a plant##2##3##(2008-9#1)(2009-8#1)
by a plethora of##3##4##(2008-10#1)(2009-9#1)(2012-3#1)
by a point mutation in the##2##6##(1991-2#1)(2008-10#1)
by a point mutation##3##4##(1991-2#2)(2008-10#1)
by a polymerase chain##3##4##(2008-10#1)(2008-2#2)
by a population of##2##4##(2008-2#1)(2008-8#1)
by a porous##3##3##(2008-10#2)(2008-7#1)
by a post-receptor defect##2##4##(1994-12#2)
by a potassium##2##3##(2008-10#1)(2008-2#1)
by a powerful##2##3##(2008-9#1)(2012-2#1)
by a primary##4##3##(2007-8#1)(2008-1#1)(2009-9#1)(2011-2#1)
by a prior##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2010-5#1)
by a probe##2##3##(2007-11#1)(2008-10#1)
by a procedure##5##3##(1990-7#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
by a process called##2##4##(2008-7#1)(2012-12#1)
by a process of##2##4##(2008-8#1)(2011-2#1)
by a process##8##3##(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
by a production##3##3##(2008-11#2)(2008-4#1)
by a progressive increase in the##2##6##(1990-7#1)(2010-10#1)
by a progressive##7##3##(1990-7#1)(1991-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2013-8#1)
by a proper##2##3##(2008-10#1)(2008-2#1)
by a proportional##2##3##(2008-10#1)(2008-8#1)
by a protein kinase C##2##5##(1991-12#1)(1997-1#1)
by a protein kinase##3##4##(1991-12#1)(1993-3#1)(1997-1#1)
by a protein##5##3##(1991-12#1)(1993-3#1)(1995-6#1)(1997-1#1)(2007-12#1)
by a proton##3##3##(1990-2#1)(2007-11#1)(2010-2#1)
by a psychiatric##2##3##(1996-12#1)(2008-7#1)
by a pulse##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by a pulsed##7##3##(1992-1#1)(2008-10#1)(2008-3#5)
by a pump##2##3##(2007-11#1)(2007-12#1)
by a pure##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
by a qualitative##2##3##(2011-1#1)(2011-2#1)
by a quantitative##2##3##(1995-3#1)(2008-5#1)
by a quasi-monochromatic##4##3##(2007-12#1)(2008-3#3)
by a random##3##3##(1992-10#1)(2008-2#2)
by a range of##2##4##(2008-9#1)(2010-11#1)
by a rapid decline in##2##5##(2008-8#1)(2010-1#1)
by a rapid##7##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#2)(2013-8#1)
by a ray-tracing##2##3##(2008-2#1)(2008-3#1)
by a reactive##3##3##(1991-9#1)(2008-11#1)(2012-12#1)
by a real##2##3##(2008-2#1)(2010-12#1)
by a recent case##2##4##(2008-7#1)(2008-9#1)
by a recent##9##3##(1992-3#1)(1992-6#1)(1993-1#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)
by a recently##8##3##(1997-7#1)(2008-10#5)(2008-2#1)(2008-5#1)
by a recombinant##3##3##(2008-11#1)(2008-6#1)(2008-8#1)
by a recovery##3##3##(2008-10#2)(2013-8#1)
by a reduced##3##3##(2007-12#1)(2008-7#2)
by a reduction in##6##4##(1991-9#1)(1992-4#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
by a reduction of the##2##5##(2008-3#1)(2008-5#1)
by a reduction of##4##4##(1996-5#1)(2007-11#1)(2008-3#1)(2008-5#1)
by a reduction##11##3##(1991-9#1)(1992-4#1)(1993-3#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
by a reference##4##3##(2008-10#4)
by a region##4##3##(1992-3#1)(1994-12#1)(1996-3#1)(2007-12#1)
by a relative##2##3##(2008-10#1)(2013-8#1)
by a research##3##3##(2008-11#1)(2008-2#1)(2009-4#1)
by a resonance##3##3##(1995-5#1)(2008-10#2)
by a resonant##2##3##(1991-8#1)(1996-2#1)
by a reversal##2##3##(1993-1#1)(2010-8#1)
by a reverse##3##3##(1992-12#1)(2008-10#1)(2009-2#1)
by a reversed-phase##3##3##(2008-10#3)
by a review of the##3##5##(1991-3#1)(1991-6#1)(1991-9#1)
by a review of##4##4##(1991-3#1)(1991-6#1)(1991-9#1)(2010-6#1)
by a ring##3##3##(2007-11#2)(2012-12#1)
by a rotating##2##3##(2008-7#1)(2008-8#1)
by a scanning##2##3##(2008-3#1)(2008-7#1)
by a second##7##3##(1990-11#1)(1990-5#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-6#1)
by a segmental##2##3##(2007-12#1)(2009-10#1)
by a selective##2##3##(1990-12#1)(2008-10#1)
by a sensitive##4##3##(1990-6#1)(2008-1#1)(2008-10#2)
by a sequence of##3##4##(2007-11#1)(2009-6#1)(2013-8#1)
by a sequential##2##3##(2008-10#2)
by a series of##17##4##(1990-2#1)(1990-8#1)(1992-6#1)(1992-9#1)(1994-5#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
by a set of##10##4##(1994-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)
by a severe##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
by a sharp##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
by a shift##2##3##(1995-2#1)(2010-11#1)
by a short##3##3##(1993-3#1)(2007-12#1)(2008-10#1)
by a shortage of##3##4##(1993-2#1)(2008-12#1)(2009-3#1)
by a signal transduction##2##4##(1994-11#1)(2008-4#1)
by a signal##5##3##(1993-12#1)(1994-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
by a significant increase in##4##5##(1994-3#1)(1997-6#1)(2007-11#1)(2009-8#1)
by a significant increase##6##4##(1994-3#1)(1997-6#1)(2007-11#1)(2008-11#1)(2009-8#1)(2012-12#1)
by a significant##17##3##(1992-3#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#3)(2009-8#1)(2010-11#1)(2012-12#1)
by a similar##7##3##(1990-3#1)(1991-9#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
by a simple and##4##4##(2008-10#3)(2013-8#1)
by a simple##33##3##(1991-3#1)(1993-12#1)(1996-12#1)(1996-5#1)(2007-11#3)(2008-10#9)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
by a simulation##3##3##(1992-9#1)(2008-3#2)
by a single base##2##4##(1992-8#1)(2008-1#1)
by a single copy gene##3##5##(1992-12#1)(1994-11#1)(2008-5#1)
by a single dominant gene##7##5##(2008-10#7)
by a single dominant##12##4##(2008-10#12)
by a single dose of##2##5##(1995-11#1)(2008-5#1)
by a single dose##3##4##(1995-11#1)(2008-12#1)(2008-5#1)
by a single gene##12##4##(1990-11#1)(1990-5#1)(1995-6#1)(2008-10#8)(2010-4#1)
by a single laser##2##4##(2007-12#1)(2008-3#1)
by a single line flow-injection##2##5##(2008-10#2)
by a single step##2##4##(1993-6#1)(1995-11#1)
by a single##96##3##(1990-11#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#4)(2008-9#2)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
by a single-frequency##2##3##(2007-12#2)
by a single-mode##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
by a slight but##2##4##(1994-5#1)(2008-7#1)
by a slight increase##2##4##(2008-10#1)(2013-1#1)
by a slight##6##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
by a slow##6##3##(1990-2#1)(1991-8#1)(1994-6#1)(1997-1#1)(2008-3#2)
by a small number of##2##5##(2008-12#1)(2008-6#1)
by a small##16##3##(1990-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2012-3#1)
by a smaller##4##3##(1992-6#1)(1994-2#1)(2009-8#1)(2010-8#1)
by a smooth##2##3##(2008-3#2)
by a soft##2##3##(2008-11#1)(2008-9#1)
by a sol-gel process##2##4##(2008-10#1)(2008-5#1)
by a sol-gel##3##3##(2008-10#2)(2008-5#1)
by a solid##2##3##(2009-8#1)(2013-8#1)
by a solution##2##3##(2008-10#2)
by a spatial##2##3##(1994-8#1)(2008-2#1)
by a spatially##2##3##(2007-12#1)(2008-8#1)
by a special##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
by a specialist##2##3##(1992-5#1)(2008-8#1)
by a specific##6##3##(1991-2#1)(1992-3#1)(1994-9#1)(1995-2#1)(2007-12#1)(2010-8#1)
by a spectral##2##3##(1995-2#1)(2007-11#1)
by a spectrophotometric method##5##4##(2008-10#5)
by a spectrophotometric##6##3##(2008-10#6)
by a square##2##3##(2008-10#1)(2008-3#1)
by a square-wave voltammetric scan##2##5##(2008-10#2)
by a standard method##2##4##(2012-2#1)(2013-8#1)
by a standard##7##3##(1995-5#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
by a standardized##3##3##(1996-11#1)(2008-10#1)(2013-1#1)
by a stochastic##3##3##(2008-6#1)(2008-7#1)(2010-7#1)
by a strain of##3##4##(2008-10#1)(2008-6#2)
by a stream of##2##4##(2008-10#2)
by a strong##5##3##(1995-2#1)(2007-12#2)(2008-10#1)(2008-9#1)
by a study##2##3##(2008-10#1)(2008-5#1)
by a subcutaneous##2##3##(1995-12#1)(2012-3#1)
by a subsequent##2##3##(2008-7#2)
by a substantial##2##3##(2008-10#1)(2013-1#1)
by a sudden##3##3##(1994-12#1)(1995-3#1)(2007-12#1)
by a suitable##2##3##(2008-10#1)(2008-5#1)
by a suitably##3##3##(2008-10#2)(2008-2#1)
by a support##2##3##(2007-11#1)(2008-4#1)
by a supported##2##3##(2008-10#2)
by a surface plasmon resonance##2##5##(2008-10#1)(2008-11#1)
by a surface##5##3##(2008-10#3)(2008-11#1)(2008-2#1)
by a survey##2##3##(2007-11#1)(2007-7#1)
by a suspension of##2##4##(2008-3#1)(2008-4#1)
by a sustained##5##3##(1990-2#1)(1992-6#1)(1995-12#1)(2007-11#1)(2008-11#1)
by a synthetic peptide##3##4##(1990-2#1)(1994-6#1)(1995-2#1)
by a synthetic##5##3##(1990-2#1)(1994-6#1)(1995-2#1)(2007-11#1)(2008-2#1)
by a syringe##2##3##(2008-10#2)
by a system##3##3##(1994-3#1)(1995-6#1)(2007-12#1)
by a team##3##3##(1995-2#1)(2007-8#1)(2013-8#1)
by a theoretical##2##3##(2007-11#1)(2009-8#1)
by a thermal##2##3##(1992-8#1)(2008-10#1)
by a thin film of chlorogenic acid##2##7##(2008-10#2)
by a thin##8##3##(1997-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#2)(2009-6#1)
by a third independent##2##4##(1994-3#1)(2013-1#1)
by a third##6##3##(1991-4#1)(1994-3#1)(2008-12#2)(2008-3#1)(2013-1#1)
by a time-dependent##2##3##(1992-12#1)(2007-11#1)
by a transient##4##3##(1993-1#1)(1994-2#1)(2007-11#1)(2008-11#1)
by a trusted##2##3##(1992-1#1)(2012-12#1)
by a tumor promoting phorbol ester##2##6##(1994-11#2)
by a tumor##3##3##(1994-11#2)(1994-6#1)
by a tunable laser##2##4##(2008-3#2)
by a tunable##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
by a two-dimensional##2##3##(2008-10#1)(2008-2#1)
by a two-level##2##3##(2007-11#1)(2008-10#1)
by a two-stage##3##3##(1994-12#1)(2007-12#2)
by a two-step##2##3##(2008-10#1)(2008-2#1)
by a type##2##3##(1994-2#2)
by a typical##2##3##(2008-10#1)(2012-2#1)
by a unilateral##2##3##(1995-2#1)(1996-2#1)
by a unique##6##3##(1993-8#1)(1997-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
by a user##2##3##(2008-10#1)(2011-1#1)
by a variant##2##3##(2008-9#1)(2010-5#1)
by a variation of the##2##5##(2008-10#1)(2008-3#1)
by a variation##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
by a variety of agents##2##5##(1995-6#1)(2008-8#1)
by a variety of clinical##2##5##(2008-1#1)(2011-1#1)
by a variety of mechanisms##2##5##(2011-2#1)(2012-12#1)
by a variety of##23##4##(1994-12#1)(1995-6#2)(1996-2#2)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
by a vector##3##3##(2007-12#1)(2008-10#2)
by a very##3##3##(1995-3#1)(2008-5#1)(2013-1#1)
by a visual##2##3##(2008-10#1)(2013-1#1)
by a water##2##3##(1995-5#1)(2008-10#1)
by a weak##4##3##(1990-11#1)(1992-9#1)(1995-3#1)(2008-3#1)
by a white-light##2##3##(2007-11#1)(2008-3#1)
by a wide range of##3##5##(2008-11#1)(2008-3#1)(2008-7#1)
by a wide##5##3##(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)
by a wild-type strain of##2##5##(2008-10#2)
by a##2928##2##(1990-10#1)(1990-11#13)(1990-12#16)(1990-2#16)(1990-3#4)(1990-4#1)(1990-5#18)(1990-6#6)(1990-7#16)(1990-8#17)(1990-9#8)(1991-1#2)(1991-11#3)(1991-12#6)(1991-2#25)(1991-3#5)(1991-4#1)(1991-5#8)(1991-6#6)(1991-7#1)(1991-8#8)(1991-9#6)(1992-1#5)(1992-10#4)(1992-11#5)(1992-12#21)(1992-2#3)(1992-3#19)(1992-4#1)(1992-5#5)(1992-6#17)(1992-7#1)(1992-8#13)(1992-9#11)(1993-1#7)(1993-11#7)(1993-12#18)(1993-2#11)(1993-3#11)(1993-6#7)(1993-8#10)(1993-9#13)(1994-1#2)(1994-11#12)(1994-12#30)(1994-2#13)(1994-3#12)(1994-5#10)(1994-6#11)(1994-8#20)(1994-9#10)(1995-1#3)(1995-11#11)(1995-12#21)(1995-2#26)(1995-3#16)(1995-5#12)(1995-6#17)(1995-8#19)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#16)(1996-2#17)(1996-3#9)(1996-4#3)(1996-5#11)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#12)(1997-4#12)(1997-5#3)(1997-6#7)(1997-7#12)(1997-8#5)(1997-9#1)(2006-12#1)(2006-6#2)(2007-10#8)(2007-11#102)(2007-12#155)(2007-2#1)(2007-5#3)(2007-6#3)(2007-7#8)(2007-8#13)(2008-1#23)(2008-10#570)(2008-11#89)(2008-12#27)(2008-2#151)(2008-3#280)(2008-4#35)(2008-5#62)(2008-6#30)(2008-7#71)(2008-8#53)(2008-9#42)(2009-1#2)(2009-10#11)(2009-11#7)(2009-12#5)(2009-2#6)(2009-3#5)(2009-4#4)(2009-5#8)(2009-6#9)(2009-7#15)(2009-8#16)(2009-9#11)(2010-1#3)(2010-10#4)(2010-11#6)(2010-12#15)(2010-2#6)(2010-3#9)(2010-4#9)(2010-5#12)(2010-6#3)(2010-7#3)(2010-8#16)(2010-9#3)(2011-1#18)(2011-2#52)(2011-3#3)(2012-1#8)(2012-12#22)(2012-2#31)(2012-3#24)(2012-5#1)(2012-7#1)(2013-1#60)(2013-7#2)(2013-8#25)
by ab initio##2##3##(1991-5#1)(2010-12#1)
by abdominal pain##2##3##(1997-8#1)(2013-1#1)
by abdominal##6##2##(1997-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
by aberrant expression of##2##4##(2008-9#1)(2013-1#1)
by aberrant##4##2##(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
by abiotic stresses##2##3##(2008-10#1)(2011-2#1)
by abiotic##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
by ablating##2##2##(2008-2#1)(2011-2#1)
by abnormalities in##2##3##(2012-3#1)(2013-1#1)
by about 1##2##3##(1994-2#1)(2010-3#1)
by about 10%##2##3##(2013-1#1)(2013-8#1)
by about 20%##2##3##(1995-1#1)(2009-8#1)
by about 30%##2##3##(1993-2#1)(2008-6#1)
by about 50%##5##3##(1990-11#1)(1993-3#1)(1994-11#1)(2008-10#1)(2013-8#1)
by about two##2##3##(2007-12#1)(2008-5#1)
by about##48##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
by abscisic acid##2##3##(2008-8#1)(2009-8#1)
by absence of##3##3##(1996-12#1)(2008-10#2)
by absorbance at##2##3##(1991-12#1)(1995-2#1)
by absorbance##6##2##(1991-12#1)(1993-3#1)(1995-2#1)(2008-10#3)
by absorption##5##2##(1992-12#1)(1995-2#1)(2008-10#2)(2008-3#1)
by academic##2##2##(2008-12#1)(2010-1#1)
by accelerated solvent extraction##2##4##(2008-10#2)
by accelerated solvent##3##3##(2008-10#3)
by accelerated##4##2##(2008-10#3)(2008-5#1)
by accessory##2##2##(1993-11#1)(2008-11#1)
by accident##2##2##(1990-5#1)(2011-2#1)
by accidental##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
by accumulation of##8##3##(1993-8#1)(1994-6#1)(2007-7#1)(2008-10#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-3#1)
by accurate##3##2##(2007-12#1)(2008-3#1)(2008-4#1)
by acetic##3##2##(2008-10#2)(2011-1#1)
by acetone##2##2##(2008-10#1)(2008-4#1)
by acetonitrile##3##2##(2008-10#2)(2011-1#1)
by acetyl##2##2##(1993-11#1)(2008-10#1)
by acetylation rate##2##3##(2008-10#2)
by acetylation##3##2##(2008-10#3)
by acetylcholine##5##2##(1990-5#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-3#1)
by acetylcholinesterase##2##2##(2008-10#2)
by achieving##2##2##(2007-10#1)(2012-3#1)
by acid digestion##3##3##(2008-10#3)
by acid hydrolysis##2##3##(2008-10#1)(2008-5#1)
by acid treatment##2##3##(2008-10#2)
by acid##13##2##(1993-8#1)(2008-10#11)(2008-5#1)
by acid-base titration##2##3##(2008-10#2)
by acidic##4##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
by acidification##2##2##(2008-10#1)(2008-9#1)
by acoustic##2##2##(2007-12#1)(2008-3#1)
by acquiring a##3##3##(1993-2#1)(2008-3#1)(2008-9#1)
by acquisition of##2##3##(2008-10#1)(2011-2#1)
by acting as a##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
by acting as##5##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
by acting on the##4##4##(2007-8#1)(2008-3#1)(2008-6#1)(2009-12#1)
by acting on##7##3##(1994-8#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)
by acting##15##2##(1992-3#1)(1992-8#1)(1994-11#2)(1994-8#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-12#1)
by actinomycin D and cycloheximide##2##5##(1994-9#2)
by actinomycin D and##3##4##(1994-9#2)(2008-11#1)
by actinomycin D##5##3##(1994-8#1)(1994-9#2)(2008-11#1)(2008-4#1)
by activated##13##2##(1991-9#2)(1992-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#3)(2008-9#1)(2009-8#1)
by activating the##9##3##(1994-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-1#1)
by activating##23##2##(1991-12#1)(1993-8#1)(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
by activation of the##3##4##(1993-9#1)(1997-7#1)(2009-8#1)
by activation of##19##3##(1990-11#1)(1990-5#2)(1992-12#1)(1992-3#1)(1993-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
by activation or##2##3##(1992-3#1)(2008-11#1)
by activation##22##2##(1990-11#1)(1990-5#2)(1992-12#1)(1992-3#2)(1993-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
by active##8##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
by actively##2##2##(1995-8#1)(2007-10#1)
by activin A##2##3##(1995-8#2)
by activities##2##2##(1992-12#1)(1995-2#1)
by activity##2##2##(1993-12#1)(2008-10#1)
by actual##4##2##(1990-8#1)(1993-2#1)(2008-11#2)
by acute renal##2##3##(2008-1#1)(2013-8#1)
by acute##18##2##(1991-9#1)(1994-2#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
by adapting the##2##3##(2008-11#1)(2008-3#1)
by adapting##4##2##(2008-10#1)(2008-11#2)(2008-3#1)
by added##2##2##(1994-5#1)(2012-2#1)
by adding 0##4##3##(2008-10#2)(2008-11#2)
by adding a##10##3##(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2013-1#1)
by adding an##2##3##(2008-10#1)(2010-7#1)
by adding copper##2##3##(1997-8#1)(2008-11#1)
by adding small##2##3##(2008-10#2)
by adding sodium##3##3##(2008-10#3)
by adding standard recovery experiment##2##5##(2013-8#2)
by adding the##6##3##(2008-10#4)(2008-8#1)(2010-4#1)
by adding unlabeled##2##3##(1992-3#1)(1993-6#1)
by adding##91##2##(1990-11#2)(1990-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#40)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-3#2)(2010-4#2)(2010-7#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
by addition of EUL##2##4##(2010-2#2)
by addition of a##4##4##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
by addition of excess##2##4##(1994-11#1)(2008-10#1)
by addition of ferrous##2##4##(1992-8#1)(2008-10#1)
by addition of recombinant##2##4##(1990-5#1)(1997-7#1)
by addition of the##5##4##(1993-11#1)(2008-3#2)(2008-5#1)(2011-1#1)
by addition of##67##3##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-5#2)(1992-8#3)(1993-11#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-2#3)(2011-1#1)(2011-2#2)(2011-3#1)
by addition##68##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-5#2)(1992-8#3)(1993-11#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-2#3)(2011-1#1)(2011-2#2)(2011-3#1)
by additional##8##2##(1990-5#1)(1995-12#2)(1995-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
by additive##3##2##(2008-2#1)(2008-4#1)(2008-8#1)
by addressing##4##2##(1993-9#1)(1994-2#1)(1996-1#1)(2009-10#1)
by adenosine diphosphate##2##3##(1997-6#1)(2006-6#1)
by adenosine in##2##3##(1993-6#1)(2008-4#1)
by adenosine##15##2##(1990-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-6#1)(2006-6#1)(2008-4#4)(2008-5#1)
by adequate##2##2##(1992-2#1)(2011-2#1)
by adequately##2##2##(2008-10#1)(2008-7#1)
by adhesion##3##2##(1990-8#1)(2008-5#1)(2009-5#1)
by adipocytes##4##2##(1990-4#1)(2008-1#1)(2008-3#1)(2008-4#1)
by adipose tissue##2##3##(2007-8#1)(2008-3#1)
by adipose##3##2##(2007-8#1)(2008-3#1)(2013-8#1)
by adjacent##3##2##(1995-8#1)(2008-10#1)(2011-2#1)
by adjusting parameters##2##3##(2008-11#1)(2008-2#1)
by adjusting the##14##3##(1990-2#1)(1992-2#1)(1994-12#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2009-11#1)(2009-7#1)
by adjusting##23##2##(1990-2#1)(1992-2#1)(1994-12#1)(1995-5#1)(1995-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-2#1)
by adjustment of the##11##4##(2007-11#3)(2007-12#5)(2008-10#1)(2008-3#1)(2008-4#1)
by adjustment of##14##3##(2007-11#3)(2007-12#5)(2008-10#1)(2008-3#4)(2008-4#1)
by adjuvant##7##2##(1990-9#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-3#1)
by administering##5##2##(1995-3#1)(2009-8#1)(2012-2#2)(2013-1#1)
by administration of##13##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#1)(1995-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-7#1)
by adolescent##2##2##(2008-11#1)(2009-7#1)
by adolescents with and without a history of specific language impairment (SLI)##2##12##(2012-3#2)
by adolescents##5##2##(2008-11#1)(2009-7#1)(2010-9#1)(2012-3#2)
by adopting a##2##3##(1994-1#1)(2008-4#1)
by adopting##6##2##(1994-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
by adoption and##2##3##(2009-11#2)
by adoption of##2##3##(2008-10#1)(2008-3#1)
by adoption##6##2##(2008-10#1)(2008-3#1)(2009-11#4)
by adsorbing##3##2##(2008-10#2)(2008-9#1)
by adsorption cathodic##2##3##(2008-10#2)
by adsorption chronopotentiometry##2##3##(2008-10#2)
by adsorption of##4##3##(2008-10#4)
by adsorption##16##2##(2008-10#15)(2010-11#1)
by adsorptive cathodic stripping voltammetry##4##5##(2008-10#4)
by adsorptive square-wave anodic stripping voltammetry on##2##7##(2008-10#2)
by adsorptive square-wave##3##3##(2008-10#3)
by adsorptive stripping voltammetry##8##4##(2008-10#8)
by adsorptive voltammetry##2##3##(2008-10#2)
by adsorptive##20##2##(2008-10#20)
by adult cochlear implant##2##4##(2008-9#2)
by adult##10##2##(1991-1#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-9#5)(2010-12#1)
by adulthood##2##2##(2007-2#1)(2008-4#1)
by adults##7##2##(2008-10#2)(2008-11#1)(2008-9#2)(2009-10#1)(2012-12#1)
by advanced glycation end products##2##5##(1993-6#1)(2011-1#1)
by advanced##4##2##(1990-11#1)(1993-6#1)(2008-2#1)(2011-1#1)
by adverse##2##2##(2008-1#1)(2008-7#1)
by advocating##2##2##(2008-11#1)(2009-8#1)
by aerobic##3##2##(1990-2#1)(1995-3#1)(2013-1#1)
by aerosol##4##2##(1992-3#2)(1994-12#1)(1997-2#1)
by affecting the##6##3##(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
by affecting##11##2##(1990-7#1)(1997-6#1)(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
by afferent##2##2##(1993-12#1)(2008-11#1)
by affinity chromatography and gel filtration##2##6##(2008-10#1)(2008-8#1)
by affinity chromatography and##3##4##(1991-9#1)(2008-10#1)(2008-8#1)
by affinity chromatography on a##2##5##(1990-11#1)(1997-2#1)
by affinity chromatography on##3##4##(1990-11#1)(1993-8#1)(1997-2#1)
by affinity chromatography using##2##4##(1991-5#1)(2008-9#1)
by affinity chromatography##18##3##(1990-11#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-5#1)(1995-6#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-4#1)
by affinity labeling with##2##4##(1991-12#1)(2008-6#1)
by affinity##22##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)
by agar dilution##2##3##(2008-5#1)(2012-3#1)
by agar gel##2##3##(1997-3#1)(2008-7#1)
by agar##4##2##(1997-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
by agarose gel electrophoresis and##2##5##(1994-6#1)(2013-1#1)
by agarose gel electrophoresis was##2##5##(2008-10#1)(2013-1#1)
by agarose gel electrophoresis##10##4##(1991-9#1)(1993-8#1)(1994-6#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#2)
by agarose gel##11##3##(1991-9#1)(1992-3#1)(1993-8#1)(1994-6#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#2)
by age and sex##2##4##(2008-12#1)(2011-2#1)
by age and##6##3##(1991-6#1)(1993-6#1)(2008-12#2)(2011-2#1)(2012-3#1)
by age of##3##3##(1992-10#1)(1996-8#1)(2012-1#1)
by age or gender##2##4##(1993-2#1)(2010-11#1)
by age or##3##3##(1993-2#1)(1996-7#1)(2010-11#1)
by age##41##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#5)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-3#1)(2013-8#1)
by aged##3##2##(1991-3#1)(1996-2#1)(1996-5#1)
by agencies##2##2##(1996-12#1)(2008-8#1)
by agenesis of the##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
by agents that##2##3##(1996-2#1)(2008-4#1)
by agents##4##2##(1992-12#1)(1996-2#1)(2008-4#1)(2008-7#1)
by aggressive##5##2##(1994-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-3#1)
by aging##8##2##(1994-2#1)(1994-5#4)(1997-2#1)(2008-10#1)(2009-12#1)
by agonists##2##2##(1991-12#1)(1992-8#1)
by air bags##2##3##(1993-3#1)(1995-5#1)
by air##15##2##(1990-6#1)(1992-9#1)(1993-3#1)(1995-5#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#2)(2012-2#1)
by airborne##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
by airway epithelial and vascular endothelial cells##2##7##(1991-5#2)
by airway##3##2##(1991-5#2)(2011-2#1)
by alanine##6##2##(1992-8#1)(2008-10#4)(2010-5#1)
by alcohol##6##2##(1990-9#1)(1992-12#1)(1994-12#1)(2008-10#1)(2009-7#1)(2012-12#1)
by alfalfa##2##2##(2008-10#1)(2008-12#1)
by algae##2##2##(1994-8#1)(2011-2#1)
by aliphatic##2##2##(1995-9#1)(2007-12#1)
by alkali##5##2##(1992-6#2)(2008-10#3)
by alkaline extraction##2##3##(1991-9#1)(2008-6#1)
by alkaline phosphatase##4##3##(1993-11#1)(1993-8#1)(2008-11#1)(2008-8#1)
by alkaline##13##2##(1991-10#1)(1991-9#2)(1993-11#1)(1993-8#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-9#1)(2012-1#1)
by all four##2##3##(2008-10#2)
by all means##2##3##(1992-6#1)(1995-2#1)
by all of##3##3##(1995-2#1)(1997-3#1)(2010-7#1)
by all patients##3##3##(2007-8#1)(2008-7#2)
by all the three##2##4##(2008-10#1)(2008-11#1)
by all the##11##3##(1990-11#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
by all three##6##3##(1996-12#2)(2008-10#3)(2008-11#1)
by all##70##2##(1990-11#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#3)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-3#2)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-8#2)
by all-optical##2##2##(2007-11#2)
by allele-specific DNA amplification##2##4##(1993-3#2)
by allelic##2##2##(2008-10#1)(2012-3#1)
by alliances##3##2##(2013-1#3)
by allowing for##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
by allowing the##2##3##(2008-11#1)(2008-7#1)
by allowing##18##2##(1990-9#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-2#1)(2011-1#1)(2013-1#1)
by almost##3##2##(1992-3#1)(1994-8#1)(2008-11#1)
by alpha##3##2##(1994-6#1)(1995-12#1)(2009-12#1)
by alpha2-adrenoceptors##2##2##(1995-12#2)
by alteration of the##3##4##(1996-5#1)(2008-3#1)(2011-2#1)
by alteration of##5##3##(1995-6#1)(1996-5#1)(2008-3#1)(2011-2#1)(2012-3#1)
by alterations in##4##3##(1991-5#1)(1994-5#1)(2009-5#1)(2012-2#1)
by altered##2##2##(2008-10#2)
by altering the balance between##2##5##(2008-4#1)(2008-7#1)
by altering the##11##3##(1992-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-2#1)
by altering##17##2##(1990-12#1)(1992-4#1)(1992-6#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)
by alternate##6##2##(1994-11#1)(1994-2#2)(2007-11#1)(2007-8#1)(2008-3#1)
by alternating current##3##3##(2008-10#3)
by alternative splicing##5##3##(1991-2#1)(1992-12#1)(1993-8#1)(1993-9#1)(1995-12#1)
by alternative##8##2##(1991-2#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-8#1)
by amiloride##3##2##(1995-8#1)(1996-9#1)(2008-4#1)
by amine coupling##2##3##(2008-10#1)(2013-8#1)
by amine##3##2##(2008-10#2)(2013-8#1)
by amino acid analysis and##3##5##(1992-3#1)(1995-3#1)(1995-6#1)
by amino acid analysis##8##4##(1991-12#1)(1992-3#1)(1992-6#1)(1995-3#1)(1995-6#1)(2008-2#1)(2008-4#2)
by amino acid##15##3##(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#2)(1995-3#1)(1995-6#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#2)
by amino acids##2##3##(1991-2#1)(2008-8#1)
by amino##17##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#2)(1995-3#1)(1995-6#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)
by amino-terminal##3##2##(1992-3#1)(1996-8#1)(1997-6#1)
by ammonium sulfate fractionation##4##4##(1991-12#2)(1994-6#1)(2010-11#1)
by ammonium sulfate precipitation and##3##5##(2008-10#2)(2008-4#1)
by ammonium sulfate precipitation##5##4##(2008-10#3)(2008-4#1)(2010-2#1)
by ammonium sulfate##9##3##(1991-12#2)(1994-6#1)(2008-10#3)(2008-4#1)(2010-11#1)(2010-2#1)
by ammonium##13##2##(1990-5#1)(1991-12#2)(1994-6#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)
by amniocentesis##3##2##(1990-2#1)(1990-5#1)(1990-9#1)
by amperometry##2##2##(2008-10#2)
by amplification of the##2##4##(2008-10#1)(2013-8#1)
by amplification of##4##3##(2008-10#3)(2013-8#1)
by amplification##7##2##(2008-10#3)(2008-11#1)(2012-1#1)(2013-8#2)
by amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
by amplified fragment length polymorphism##4##5##(2008-10#4)
by amplified fragment length polymorphisms##3##5##(2008-10#3)
by amplified fragment length##7##4##(2008-10#7)
by amplified spontaneous emission##2##4##(2007-12#2)
by amplified##9##2##(2007-12#2)(2008-10#7)
by amplifying##3##2##(1994-11#1)(1997-4#1)(2011-2#1)
by amygdala lesions##2##3##(1993-6#2)
by an &quot##3##3##(1990-3#1)(2008-1#1)(2008-8#1)
by an HPLC method##2##4##(2008-10#2)
by an HPLC##3##3##(2008-10#3)
by an aberrant##2##3##(2011-2#1)(2012-3#1)
by an abnormal##4##3##(1991-3#1)(2008-11#2)(2013-8#1)
by an absence of##2##4##(1991-2#1)(1994-12#1)
by an accumulation of##2##4##(1997-7#1)(2011-2#1)
by an accumulation##4##3##(1997-7#1)(2008-10#2)(2011-2#1)
by an activation of##2##4##(1997-2#1)(2008-5#1)
by an acute##4##3##(1990-8#1)(1990-9#1)(2011-2#1)(2012-3#1)
by an additional##2##3##(1995-5#1)(2011-1#1)
by an air##2##3##(1994-12#1)(2008-3#1)
by an alkaline##2##3##(1997-4#1)(2008-10#1)
by an all-solid-state##2##3##(2007-11#2)
by an almost##2##3##(2007-12#1)(2009-6#1)
by an alternative technique##2##4##(2008-10#2)
by an alternative##6##3##(1993-9#1)(2008-10#4)(2008-9#1)
by an amorphous##2##3##(2008-10#2)
by an amount##2##3##(1995-3#1)(2008-3#1)
by an analysis of##4##4##(2008-10#2)(2008-2#1)(2008-7#1)
by an analysis##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
by an annular##2##3##(1995-5#1)(2008-10#1)
by an antibody against##2##4##(1990-5#1)(1993-11#1)
by an antibody raised against##2##5##(1992-11#1)(1993-12#1)
by an antibody##5##3##(1990-5#1)(1992-11#1)(1993-11#1)(1993-12#1)(2008-7#1)
by an apparent##2##3##(1990-5#1)(1993-2#1)
by an appropriate##5##3##(1992-10#1)(2007-11#2)(2008-10#1)(2008-4#1)
by an artificial##2##3##(2007-11#1)(2010-8#1)
by an atomic absorption##2##4##(2008-10#2)
by an atomic##3##3##(2008-10#3)
by an audit##2##3##(1993-1#2)
by an automated##4##3##(1991-2#1)(2008-10#3)
by an average of##8##4##(1991-5#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-8#1)(2013-1#1)
by an average##9##3##(1990-6#1)(1991-5#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-8#1)(2013-1#1)
by an early##3##3##(1994-5#1)(2008-10#1)(2011-3#1)
by an efficient##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
by an electrical##3##3##(2008-10#2)(2008-7#1)
by an electro-optic##2##3##(2007-11#1)(2008-2#1)
by an electrochemical##2##3##(2008-10#2)
by an electron##3##3##(2007-12#3)
by an electronic##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
by an electrostatic##2##3##(2008-10#1)(2008-2#1)
by an emphasis on##2##4##(1991-6#1)(2008-7#1)
by an endoprotease##2##3##(1991-9#1)(1995-8#1)
by an endoscopic transsphenoidal approach##3##5##(2011-2#3)
by an enhanced##2##3##(2008-10#1)(2008-11#1)
by an environmental##2##3##(1991-12#1)(2013-8#1)
by an enzyme immunoassay##2##4##(1991-5#2)
by an enzyme##3##3##(1991-5#2)(2008-11#1)
by an enzyme-linked##2##3##(1993-9#1)(2008-11#1)
by an epineural ganglion##2##4##(2008-9#2)
by an equation##2##3##(2008-10#1)(2013-8#1)
by an erbium-doped fiber amplifier##2##5##(2007-12#1)(2008-2#1)
by an evanescent field##2##4##(2007-11#1)(2007-12#1)
by an example##3##3##(2007-11#1)(2008-3#2)
by an excess of##2##4##(1993-9#1)(2008-8#1)
by an experienced##6##3##(1991-12#1)(1991-3#1)(1996-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
by an experiment##2##3##(2007-11#1)(2008-7#1)
by an experimental##3##3##(2008-3#3)
by an expert##5##3##(2007-8#1)(2010-8#2)(2011-1#1)(2012-2#1)
by an extended##3##3##(2007-8#1)(2008-1#1)(2008-7#1)
by an extensive##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
by an external##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
by an externally applied##2##4##(2007-11#2)
by an extinguished##2##3##(2008-5#2)
by an extracellular##2##3##(1991-5#1)(2008-7#1)
by an extract from##2##4##(1990-2#2)
by an i##2##3##(1994-2#1)(1995-12#1)
by an imaging##2##3##(2007-10#1)(2008-3#1)
by an imbalance between##3##4##(2008-10#1)(2009-12#1)(2013-8#1)
by an imbalance##4##3##(2007-11#1)(2008-10#1)(2009-12#1)(2013-8#1)
by an immunomagnetic isolation procedure##2##5##(2010-3#2)
by an improved procedure##2##4##(1991-8#1)(1992-6#1)
by an improved##4##3##(1991-8#1)(1992-6#1)(2008-10#1)(2011-2#1)
by an improvement##2##3##(2008-11#1)(2011-2#1)
by an in vivo##2##4##(2008-5#1)(2009-12#1)
by an in##3##3##(2008-5#2)(2009-12#1)
by an increase in the##15##5##(1992-6#1)(1992-8#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
by an increase in##43##4##(1990-7#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-8#3)
by an increase of the##2##5##(1994-3#1)(2008-5#1)
by an increase of##4##4##(1994-3#1)(2008-5#2)(2008-7#1)
by an increase##50##3##(1990-7#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-8#3)
by an increased##9##3##(1990-6#1)(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-7#1)
by an increasing##2##3##(2008-10#1)(2008-5#1)
by an independent##7##3##(1993-1#1)(1997-3#1)(2008-10#2)(2009-11#1)(2009-3#1)(2011-2#1)
by an indirect mechanism##2##4##(1992-12#1)(2008-10#1)
by an indirect##6##3##(1992-12#1)(1993-2#1)(1994-3#1)(2008-10#2)(2008-5#1)
by an individual surface protrusion##2##5##(2008-3#2)
by an individual##5##3##(1996-12#1)(2008-12#1)(2008-3#3)
by an inductively coupled##2##4##(2008-10#1)(2008-3#1)
by an infectious##2##3##(1992-2#1)(2013-8#1)
by an infinite##3##3##(2008-2#3)
by an inhibition of##2##4##(1992-3#1)(2008-10#1)
by an injection-locked##2##3##(2007-11#1)(2008-2#1)
by an intense##2##3##(1992-8#1)(2008-2#1)
by an intensified CCD##2##4##(2007-12#1)(2008-3#1)
by an intensity##3##3##(2008-2#1)(2008-3#2)
by an interaction between##2##4##(2008-4#1)(2010-1#1)
by an intracavity##3##3##(2007-11#1)(2007-12#2)
by an intracellular##3##3##(1992-11#1)(2008-10#1)(2009-8#1)
by an intramolecular##4##3##(1991-5#1)(1995-3#1)(2009-5#1)(2009-7#1)
by an intron##4##3##(1993-8#1)(1995-6#1)(1995-8#1)(1997-2#1)
by an inverse##2##3##(2008-3#2)
by an ion##2##3##(1997-4#1)(2008-3#1)
by an isocratic##3##3##(2008-10#3)
by an isoleucine to serine mutation##2##6##(2008-10#2)
by an isoleucine to##4##4##(2008-10#4)
by an iterative##2##3##(2008-11#1)(2008-4#1)
by an off-axis##2##3##(2008-3#2)
by an official##2##3##(1992-5#1)(2008-10#1)
by an on-line continuous precipitation-dissolution flow system##2##7##(2008-10#2)
by an on-line##4##3##(1992-11#1)(2008-10#3)
by an open##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
by an optical microscope##2##4##(2008-3#1)(2008-5#1)
by an optical system##2##4##(2007-12#1)(2008-3#1)
by an optical##9##3##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-5#1)
by an optically##2##3##(2007-12#1)(2008-3#1)
by an order of magnitude from##2##6##(1995-6#1)(2008-10#1)
by an order of magnitude relative to##2##7##(1994-8#1)(2008-10#1)
by an order of magnitude##11##5##(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
by an organic##2##3##(2007-12#1)(2008-10#1)
by an outward##2##3##(1990-2#1)(2009-1#1)
by an ultrafast##2##3##(2007-11#1)(2007-12#1)
by an unknown##2##3##(2010-10#1)(2012-2#1)
by an##689##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#3)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#6)(1992-8#4)(1992-9#2)(1993-1#3)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#5)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#5)(1995-5#4)(1995-6#4)(1995-8#7)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#3)(2007-11#27)(2007-12#30)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#9)(2008-10#118)(2008-11#29)(2008-12#7)(2008-2#31)(2008-3#58)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#25)(2008-8#12)(2008-9#7)(2009-1#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#5)(2011-2#20)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#5)(2012-9#1)(2013-1#14)(2013-7#2)(2013-8#13)
by analogy to##2##3##(1996-2#1)(2008-8#1)
by analogy with the##2##4##(1993-11#1)(2008-10#1)
by analogy with##4##3##(1992-6#1)(1993-11#1)(2008-10#1)(2008-3#1)
by analogy##7##2##(1992-3#1)(1992-6#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
by analyses of several##2##4##(2008-10#2)
by analyses of##3##3##(2008-10#3)
by analyses##4##2##(2008-10#4)
by analysing a##4##3##(1992-12#1)(2008-10#3)
by analysing certified reference##2##4##(2008-10#2)
by analysing several certified reference materials##2##6##(2008-10#2)
by analysing several##3##3##(2008-10#3)
by analysing spiked##2##3##(2008-10#2)
by analysing the##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
by analysing two##3##3##(2008-10#3)
by analysing##31##2##(1992-12#1)(2008-10#23)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
by analysis of certified reference materials and##2##7##(2008-10#2)
by analysis of certified reference materials##3##6##(2008-10#3)
by analysis of certified reference##4##5##(2008-10#4)
by analysis of restriction fragment length##2##6##(1996-5#1)(2008-9#1)
by analysis of the (1)H##2##5##(1997-7#1)(2012-12#1)
by analysis of the##12##4##(1992-8#1)(1993-2#1)(1993-9#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2012-12#1)
by analysis of two##2##4##(2007-11#1)(2008-10#1)
by analysis of variance##2##4##(2008-10#1)(2009-2#1)
by analysis of##49##3##(1990-3#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#21)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#3)(2009-2#1)(2012-12#1)(2013-1#1)
by analysis with##2##3##(1994-5#1)(2008-1#1)
by analysis##54##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-2#1)(2012-12#1)(2013-1#1)
by analytic##2##2##(2007-11#1)(2008-3#1)
by analytical ultracentrifugation##2##3##(1994-5#1)(1995-2#1)
by analytical##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)
by analyzing a certified reference material##3##6##(2008-10#3)
by analyzing a series of seven replicates##3##7##(2008-10#3)
by analyzing a##12##3##(2008-10#12)
by analyzing certified reference materials##2##5##(2008-10#2)
by analyzing certified reference##3##4##(2008-10#3)
by analyzing samples##2##3##(2008-10#1)(2008-5#1)
by analyzing the##13##3##(1992-9#1)(1993-12#1)(1993-9#1)(1997-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#2)
by analyzing two##3##3##(1990-8#1)(2008-10#2)
by analyzing##77##2##(1990-8#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-6#1)(2008-10#44)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
by anaphylaxis##2##2##(2012-3#1)(2013-1#1)
by anchoring##2##2##(2008-10#1)(2013-8#1)
by and large##3##3##(1991-12#1)(1994-12#1)(2012-2#1)
by and##9##2##(1991-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)
by androgen##4##2##(1991-5#1)(1993-8#1)(2008-7#1)(2013-1#1)
by angiogenesis##2##2##(1994-12#1)(2008-7#1)
by angiogenin##4##2##(1992-11#4)
by angiography##3##2##(1997-8#1)(2007-10#1)(2007-8#1)
by angiotensin II##3##3##(1995-12#2)(1997-2#1)
by angiotensin-converting enzyme inhibitors##2##4##(2008-11#1)(2010-5#1)
by angle##2##2##(2007-12#1)(2008-3#1)
by angular##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
by animal##3##2##(1991-3#1)(1995-3#1)(2008-11#1)
by anion exchange and##3##4##(1991-9#1)(1992-3#1)(2008-10#1)
by anion exchange chromatography##2##4##(2008-10#1)(2008-7#1)
by anion exchange##6##3##(1991-9#1)(1992-3#1)(1995-6#1)(2008-10#2)(2008-7#1)
by anion-exchange chromatography##6##3##(1990-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-4#1)
by anion-exchange high-performance liquid chromatography##2##5##(1991-2#1)(1994-12#1)
by anion-exchange##13##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#2)(2008-10#5)(2008-4#1)
by anions##2##2##(1990-5#1)(1994-5#1)
by anisotropic##2##2##(2008-2#1)(2008-3#1)
by ankle##2##2##(2009-1#1)(2011-2#1)
by annealed and reverse proton exchange##2##6##(2007-11#2)
by annealing at##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
by annealing##5##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
by annexin V##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
by annexin##4##2##(2008-10#1)(2008-11#2)(2012-12#1)
by anodic adsorptive stripping voltammetry##2##5##(2008-10#2)
by anodic stripping differential pulse##2##5##(2008-10#2)
by anodic stripping voltammetry with##2##5##(2008-10#2)
by anodic stripping voltammetry##6##4##(2008-10#6)
by anodic stripping##9##3##(2008-10#9)
by anodic##14##2##(2008-10#14)
by anomalous##2##2##(2006-4#1)(2012-12#1)
by another species##2##3##(2010-2#1)(2012-3#1)
by another##23##2##(1992-4#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
by antagonizing##2##2##(1996-2#1)(2008-9#1)
by anterior##2##2##(2008-7#1)(2008-8#1)
by anthropometry and bioimpedance##2##4##(2008-5#2)
by anthropometry##3##2##(2008-5#2)(2012-12#1)
by anti-CD3 and##2##3##(1995-12#1)(2008-4#1)
by anti-Fas antibody##3##3##(2008-8#3)
by anti-IgE##4##2##(1991-12#3)(2008-10#1)
by anti-inflammatory##3##2##(2010-5#1)(2013-8#2)
by antibiotic##3##2##(1990-5#1)(2008-12#1)(2010-1#1)
by antibodies to##3##3##(1991-1#1)(1995-11#1)(1996-5#1)
by antibodies##11##2##(1990-11#2)(1991-1#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(2008-4#1)(2008-9#1)(2011-2#1)
by antibody to the IGF-I receptor##2##6##(1993-9#2)
by antibody to##4##3##(1990-12#1)(1992-12#1)(1993-9#2)
by antibody##6##2##(1990-12#1)(1992-12#1)(1992-2#1)(1993-8#1)(1993-9#2)
by antigen##3##2##(1993-3#1)(1995-5#2)
by antigen-presenting cells (APCs)##2##4##(1997-4#1)(2008-11#1)
by antioxidant##3##2##(1991-9#1)(2008-1#1)(2013-1#1)
by antioxidants that##2##3##(1991-9#1)(1992-9#1)
by antioxidants##7##2##(1991-9#1)(1992-9#1)(1995-5#1)(1995-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
by antisense RNA##3##3##(1991-9#1)(1992-8#1)(2008-8#1)
by antisense##7##2##(1991-9#1)(1992-8#1)(1995-11#1)(2008-8#2)(2008-9#2)
by antisocial personality##2##3##(1994-2#2)
by ants##4##2##(2008-10#3)(2008-8#1)
by any of the##7##4##(1990-11#1)(1990-5#1)(1993-3#1)(1994-9#1)(2008-11#1)(2008-6#1)(2009-11#1)
by any other##2##3##(2008-10#1)(2008-8#1)
by any##34##2##(1990-11#1)(1990-2#1)(1990-5#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-2#2)(1996-7#1)(2006-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2011-1#1)(2013-8#2)
by apheresis##2##2##(1994-12#1)(2011-2#1)
by aphids##3##2##(2008-10#2)(2008-12#1)
by apo##2##2##(1990-12#1)(1994-3#1)
by apolipoprotein E##2##3##(1995-6#1)(1996-2#1)
by apomorphine##3##2##(1995-12#1)(2008-7#2)
by apoptosis##15##2##(1991-12#1)(1993-3#1)(1994-11#3)(1994-3#1)(1995-6#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-1#1)
by application of a##8##4##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2012-2#1)
by application of an##2##4##(2007-12#1)(2008-2#1)
by application of the##6##4##(1990-7#1)(2008-10#2)(2008-3#2)(2009-8#1)
by application of##36##3##(1990-7#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-2#5)(2008-3#8)(2008-7#1)(2009-8#1)(2012-2#1)
by application to##3##3##(2008-10#2)(2008-3#1)
by application##42##2##(1990-7#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-2#5)(2008-3#9)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
by applying a##20##3##(1995-5#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-5#1)(2010-4#1)
by applying an##6##3##(2008-10#3)(2008-11#2)(2008-5#1)
by applying artificial neural networks##2##5##(2008-10#2)
by applying it to a##4##5##(2008-10#2)(2008-3#1)(2009-11#1)
by applying it to##9##4##(1997-2#1)(2008-10#6)(2008-3#1)(2009-11#1)
by applying suitable##2##3##(2007-12#1)(2008-11#1)
by applying the method##2##4##(2008-10#2)
by applying the non-linear##2##4##(2010-8#2)
by applying the##16##3##(1997-3#1)(1997-4#1)(2008-10#5)(2008-2#1)(2008-3#2)(2009-8#1)(2010-8#3)(2013-1#1)(2013-8#1)
by applying them to##2##4##(2008-6#1)(2008-7#1)
by applying these##2##3##(2008-10#1)(2008-5#1)
by applying##102##2##(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#45)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-3#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
by approaching##2##2##(1993-12#1)(2012-1#1)
by appropriate choice of##2##4##(1995-12#1)(2008-10#1)
by appropriate##16##2##(1992-11#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
by appropriately##3##2##(2008-10#2)(2013-8#1)
by approx##2##2##(1990-11#1)(1993-6#1)
by approximately 1##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
by approximately 1000##2##3##(1991-10#1)(2008-5#1)
by approximately 15%##3##3##(2008-3#1)(2010-4#1)(2013-1#1)
by approximately 2##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
by approximately 20%##2##3##(1992-11#1)(1994-11#1)
by approximately 25##2##3##(2008-3#1)(2008-6#1)
by approximately 30%##3##3##(2007-11#1)(2008-4#1)(2008-7#1)
by approximately 50##2##3##(2008-3#1)(2008-6#1)
by approximately a##2##3##(1992-6#1)(2008-5#1)
by approximately##52##2##(1991-10#1)(1992-11#3)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-2#2)(1996-2#1)(1997-2#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2010-4#1)(2011-1#1)(2013-1#3)
by approximating the##2##3##(2008-7#1)(2013-1#1)
by aqua regia##2##3##(2008-10#2)
by aquatic HS##2##3##(2008-10#2)
by aqueous##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-3#1)
by arachidonic acid##7##3##(1990-12#1)(1993-8#1)(1994-11#1)(1995-11#3)(1997-7#1)
by aromatase##2##2##(1994-2#1)(2012-2#1)
by aromatic##2##2##(2008-10#2)
by aromatization##2##2##(1996-5#1)(2009-5#1)
by around##4##2##(1996-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
by arresting##2##2##(1990-11#1)(1991-12#1)
by arthroscopic##2##2##(2009-1#1)(2009-3#1)
by artificial inoculation##3##3##(2008-10#3)
by artificial neural networks##4##4##(2008-10#4)
by artificial##12##2##(1993-8#1)(1997-6#1)(1997-7#1)(2008-10#8)(2013-1#1)
by artificially##2##2##(1997-3#1)(2008-2#1)
by as many##2##3##(1992-3#1)(1995-1#1)
by as much as 1##4##5##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
by as much as 100-fold##2##5##(1995-5#1)(2008-9#1)
by as much as a factor of##3##7##(2007-11#1)(2008-2#1)(2008-3#1)
by as much as a##5##5##(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#2)
by as much as##31##4##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1995-11#1)(1995-3#2)(1995-5#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
by as##33##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
by ascorbate##6##2##(1992-6#2)(2008-10#1)(2009-9#2)(2011-1#1)
by ascorbic acid##4##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-5#1)
by ascorbic and uric##2##4##(2008-10#2)
by ascorbic##6##2##(1990-5#1)(1993-12#1)(2008-10#3)(2008-5#1)
by ascospores at##2##3##(2008-10#2)
by ascospores originating from##2##4##(2008-10#2)
by ascospores##9##2##(2008-10#9)
by asexual##2##2##(2008-5#1)(2008-8#1)
by ashing the##2##3##(2008-10#2)
by asking##4##2##(1992-12#1)(1993-3#1)(1995-2#1)(2013-8#1)
by assay of##2##3##(1993-12#1)(2008-10#1)
by assaying##7##2##(1991-5#1)(1992-2#1)(1995-2#1)(2008-10#2)(2008-4#1)(2010-5#1)
by assays of##2##3##(1992-9#1)(1994-12#1)
by assessing the##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2013-1#1)
by assessing##9##2##(2007-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
by assisted##2##2##(1991-11#1)(2007-8#1)
by associating with##2##3##(2008-8#1)(2012-2#1)
by associating##3##2##(2008-8#2)(2012-2#1)
by association of##2##3##(1990-2#1)(2012-2#1)
by association##3##2##(1990-2#1)(2008-11#1)(2012-2#1)
by assuming a random##2##4##(1995-9#1)(2008-3#1)
by assuming a##5##3##(1995-3#1)(1995-9#1)(2008-2#1)(2008-3#2)
by assuming that the##3##4##(1995-9#1)(2008-11#1)(2008-3#1)
by assuming that##5##3##(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
by assuming the##5##3##(2008-10#4)(2013-1#1)
by assuming##21##2##(1995-3#1)(1995-9#2)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2008-8#1)(2011-2#1)(2013-1#1)
by astrocyte##3##2##(2008-11#2)(2008-7#1)
by astrocytes##3##2##(1996-2#1)(2008-4#1)(2008-5#1)
by asymmetric##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
by at least a factor of##2##6##(1993-8#1)(2008-3#1)
by at least one of the##2##6##(2010-11#1)(2013-8#1)
by at least one##3##4##(2008-11#1)(2010-11#1)(2013-8#1)
by at least three distinct##2##5##(1992-8#1)(1994-5#1)
by at least two##4##4##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
by at least##24##3##(1991-9#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
by atherosclerosis##5##2##(2007-10#2)(2008-1#1)(2009-2#1)(2012-2#1)
by atherosclerotic##4##2##(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
by atmospheric aerosols##3##3##(2008-2#1)(2008-3#2)
by atmospheric turbulence##5##3##(2008-2#2)(2008-3#3)
by atmospheric##11##2##(2008-10#1)(2008-2#3)(2008-3#7)
by atomic absorption spectrometry (AAS)##3##5##(2008-10#3)
by atomic absorption spectrometry has been##3##6##(2008-10#3)
by atomic absorption spectrometry##24##4##(2008-10#24)
by atomic absorption spectrophotometry with flame##2##6##(2008-10#2)
by atomic absorption spectrophotometry with##3##5##(2008-10#3)
by atomic absorption spectrophotometry##6##4##(1997-4#1)(2008-10#5)
by atomic absorption spectroscopy (AAS)##2##5##(1996-3#1)(2008-10#1)
by atomic absorption spectroscopy##6##4##(1991-9#1)(1994-11#1)(1996-3#1)(2008-10#3)
by atomic absorption##40##3##(1991-9#1)(1994-11#1)(1996-3#1)(1997-4#1)(2008-10#35)(2008-5#1)
by atomic fluorescence spectrometry##2##4##(2008-10#2)
by atomic fluorescence##4##3##(2008-10#4)
by atomic force microscopy (AFM) and##2##6##(2008-10#1)(2009-7#1)
by atomic force microscopy (AFM)##3##5##(2008-10#2)(2009-7#1)
by atomic force microscopy in the imaging##2##7##(2008-5#2)
by atomic force microscopy##14##4##(1993-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2009-7#1)
by atomic force##16##3##(1993-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2009-7#2)
by atomic spectrometry##3##3##(2008-10#3)
by atomic##66##2##(1991-9#1)(1993-6#1)(1994-11#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#46)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#2)(2009-7#2)(2011-1#1)
by atomic-force microscopy##2##3##(2008-3#2)
by atrial##2##2##(1992-3#1)(2013-1#1)
by atrophy##2##2##(1995-5#1)(2012-1#1)
by attaching##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
by attachment of##3##3##(2007-11#1)(2008-10#2)
by attachment##4##2##(2007-11#1)(2008-10#2)(2008-4#1)
by attention##4##2##(2008-6#1)(2008-8#3)
by attenuated total reflectance##3##4##(2008-10#3)
by attenuated total reflection##5##4##(2007-12#1)(2008-10#3)(2008-3#1)
by attenuated total##9##3##(2007-12#1)(2008-10#7)(2008-3#1)
by attenuation of the##2##4##(1996-12#1)(2012-12#1)
by atypical##2##2##(1990-6#1)(2008-8#1)
by autoclaving##4##2##(1995-11#1)(2008-11#2)(2008-5#1)
by autoimmune##3##2##(1991-5#1)(1992-12#1)(2010-5#1)
by autologous##3##2##(1993-9#1)(2008-4#1)(2012-12#1)
by automated##10##2##(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1996-12#1)(2008-10#4)
by automatic##5##2##(1992-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
by automating##2##2##(2007-9#1)(2010-5#1)
by automobile##2##2##(2008-11#2)
by autopsy##2##2##(1991-12#1)(2008-5#1)
by autoradiographic##2##2##(1990-7#1)(1991-12#1)
by autoradiography##3##2##(1991-12#1)(1993-12#1)(1995-2#1)
by available##3##2##(1991-12#1)(2008-11#1)(2010-2#1)
by average##2##2##(2008-7#1)(2012-3#1)
by averaging the##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
by averaging##5##2##(1992-1#1)(1992-6#1)(2008-10#2)(2008-3#1)
by avian influenza##2##3##(2010-4#1)(2011-2#1)
by avian##3##2##(2007-12#1)(2010-4#1)(2011-2#1)
by avoiding##9##2##(2008-10#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-5#1)(2011-2#1)
by axial##2##2##(2008-10#1)(2008-7#1)
by axillary bacteria##2##3##(2008-5#2)
by axons##2##2##(1995-2#1)(2007-8#1)
by azathioprine after##2##3##(2007-7#1)(2009-5#1)
by bFGF##2##2##(1995-12#1)(2008-11#1)
by back##3##2##(1995-3#1)(2008-10#1)(2009-1#1)
by backcrossing to##2##3##(1991-12#1)(2008-10#1)
by backcrossing##3##2##(1991-12#2)(2008-10#1)
by baclofen##3##2##(1990-5#1)(1995-2#1)(1995-5#1)
by bacteria and##2##3##(2008-10#1)(2013-8#1)
by bacteria or##2##3##(2008-10#1)(2010-11#1)
by bacteria##15##2##(2007-11#1)(2008-10#6)(2008-12#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#2)(2013-8#1)
by bacterial lipopolysaccharide##2##3##(1991-2#2)
by bacterial##18##2##(1991-2#2)(1992-2#1)(1993-9#1)(1994-8#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
by balancing##3##2##(2007-11#1)(2008-5#1)(2009-5#1)
by balloon##3##2##(1994-3#1)(1996-6#1)(2008-7#1)
by base pairing##2##3##(1997-6#1)(2008-7#1)
by base##6##2##(1992-6#1)(1993-12#1)(1997-6#1)(2008-7#1)(2008-8#2)
by baseline##2##2##(2012-1#2)
by basic fibroblast growth factor##3##5##(1995-12#1)(1997-6#1)(2008-5#1)
by basic##7##2##(1990-12#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-5#1)(2009-8#1)
by batch and##2##3##(2008-10#1)(2008-6#1)
by batch##10##2##(1997-2#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#2)
by beam##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by beating##2##2##(2008-3#1)(2013-7#1)
by behavior##2##2##(2008-11#1)(2008-6#1)
by behavioral##3##2##(2010-10#1)(2010-5#1)(2013-8#1)
by behavioural##2##2##(1992-10#1)(1992-3#1)
by being a##3##3##(1992-11#1)(1993-1#1)(2008-9#1)
by being##12##2##(1991-12#1)(1992-11#1)(1992-8#1)(1993-1#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-9#1)(2009-6#1)(2010-8#1)
by bench top gas chromatography-mass spectrometry##2##6##(1995-12#2)
by beneficiaries##2##2##(1991-2#1)(1997-3#1)
by benzoic acid##2##3##(2008-10#2)
by berberine##2##2##(2008-10#1)(2012-3#1)
by beryllium##2##2##(1990-5#1)(2008-10#1)
by beta##2##2##(1991-5#1)(1992-3#1)
by beta-CD##2##2##(1994-3#1)(2008-10#1)
by beta-adrenergic##2##2##(1992-3#1)(1995-3#1)
by beta-correction spectrophotometry and##2##4##(2008-10#2)
by beta-correction spectrophotometry##3##3##(2008-10#3)
by betaine##2##2##(1991-12#2)
by between##6##2##(2008-10#5)(2012-12#1)
by bicuculline##5##2##(1992-3#2)(1995-5#1)(2008-8#1)(2008-9#1)
by big##2##2##(1992-5#1)(1995-11#1)
by bilateral##9##2##(1990-5#1)(1993-3#1)(1995-12#1)(1995-5#2)(2007-10#1)(2009-3#1)(2010-9#1)(2013-1#1)
by bilirubin##2##2##(1993-12#1)(2008-10#1)
by binary##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
by binding of the##2##4##(1992-4#1)(2009-7#1)
by binding of##7##3##(1992-4#1)(1993-8#2)(1994-5#1)(1995-2#1)(2009-7#2)
by binding the##2##3##(1993-8#1)(2008-8#1)
by binding to a##2##4##(2008-7#1)(2010-8#1)
by binding to the 3'##2##5##(2009-5#1)(2010-11#1)
by binding to the estrogen receptor##2##6##(2008-11#2)
by binding to the##10##4##(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-5#1)(2010-11#1)(2010-12#1)
by binding to##24##3##(1991-2#1)(1992-11#1)(1993-9#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
by binding with the##2##4##(1997-8#1)(2008-5#1)
by binding with##3##3##(1990-5#1)(1997-8#1)(2008-5#1)
by binding##44##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-4#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
by bioassay##3##2##(1992-6#1)(2008-10#1)(2008-4#1)
by biochemical and##2##3##(2008-5#1)(2008-7#1)
by biochemical##8##2##(1994-12#1)(1994-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)
by bioelectrical impedance analysis##2##4##(2011-2#1)(2012-3#1)
by bioelectrical impedance##3##3##(2007-12#1)(2011-2#1)(2012-3#1)
by biogenic##4##2##(2008-10#4)
by biolistic##4##2##(2008-10#3)(2008-5#1)
by biological and##2##3##(1994-5#1)(2008-10#1)
by biological##10##2##(1992-11#1)(1992-5#1)(1994-5#1)(1995-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2013-8#1)
by biologically##3##2##(2008-10#3)
by bioluminescence##2##2##(2008-10#1)(2008-4#1)
by biopsy##3##2##(2008-5#1)(2011-2#2)
by biotechnology##2##2##(1994-3#1)(2008-11#1)
by biotinylated##2##2##(1993-6#1)(1997-2#1)
by bipolar##2##2##(1995-3#1)(1997-5#1)
by birefringence##2##2##(2007-12#1)(2008-10#1)
by birth##5##2##(2009-11#4)(2011-2#1)
by bisphenol A##2##3##(2010-5#2)
by bisphosphonate##2##2##(2007-11#1)(2013-1#1)
by biting##2##2##(1996-5#1)(2008-7#1)
by blending##3##2##(2008-1#1)(2008-5#1)(2009-7#1)
by blind##2##2##(2008-2#1)(2013-1#1)
by blinded##3##2##(1997-8#1)(2008-8#1)(2013-1#1)
by blocking of##2##3##(1993-2#1)(2008-12#1)
by blocking the##5##3##(1995-2#1)(2007-12#1)(2008-8#1)(2010-3#1)(2013-1#1)
by blocking##18##2##(1990-7#1)(1992-3#1)(1993-2#1)(1995-2#4)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
by blood testing##2##3##(1994-2#2)
by blood##11##2##(1990-12#1)(1992-12#1)(1992-6#1)(1994-2#2)(1995-6#1)(1996-3#1)(2007-7#1)(2009-7#2)(2010-4#1)
by blue light##4##3##(1992-8#2)(1994-11#2)
by blue##5##2##(1992-8#2)(1994-11#2)(2008-8#1)
by body##5##2##(2008-11#1)(2008-3#1)(2009-4#1)(2010-7#1)(2011-2#1)
by bone cells##2##3##(1993-11#1)(2010-9#1)
by bone marrow cells##2##4##(1993-8#1)(1997-8#1)
by bone marrow examination##2##4##(2007-7#1)(2008-11#1)
by bone marrow##5##3##(1993-8#1)(1997-8#1)(2007-7#1)(2008-11#1)(2012-12#1)
by bone##11##2##(1993-11#1)(1993-12#1)(1993-8#1)(1997-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
by bootstrap##3##2##(1995-3#1)(2008-10#1)(2010-4#1)
by both a##3##3##(1990-5#1)(1995-11#1)(2010-4#1)
by both an##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
by both batch and column techniques##2##6##(2008-10#2)
by both batch and##3##4##(2008-10#3)
by both cell types##2##4##(1990-2#1)(2008-5#1)
by both direct and indirect##2##5##(1991-12#1)(1992-3#1)
by both direct##4##3##(1991-12#1)(1992-3#1)(1993-12#1)(1994-8#1)
by both groups##2##3##(1993-2#1)(2010-8#1)
by both methods are##2##4##(2008-10#2)
by both methods at##2##4##(2008-10#2)
by both methods##10##3##(1996-5#1)(2007-7#1)(2008-10#6)(2008-5#1)(2013-1#1)
by both modes##2##3##(1994-8#1)(2008-3#1)
by both parents##2##3##(1995-12#1)(2013-8#1)
by both procedures##2##3##(2008-10#2)
by both static and dynamic##5##5##(2008-10#5)
by both systems##3##3##(1993-8#3)
by both techniques##4##3##(1992-11#1)(1993-12#1)(1996-1#1)(2008-10#1)
by both tests##2##3##(1997-6#1)(2011-1#1)
by both the##19##3##(1992-12#2)(1993-11#1)(2008-10#8)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
by both transabdominal and transvaginal##2##5##(1996-1#2)
by both vitamins C and E##2##6##(1992-9#2)
by both##211##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-2#2)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#69)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#14)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
by bound##2##2##(1992-8#1)(2008-3#1)
by bovine##7##2##(1994-8#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
by boys&quot##2##2##(2007-12#2)
by bradykinin##5##2##(1990-7#1)(1992-3#1)(1995-12#1)(1997-1#2)
by brain##8##2##(1992-9#1)(1995-12#2)(1995-5#1)(2008-12#2)(2008-5#1)(2011-2#1)
by branch##2##2##(2008-2#1)(2013-8#1)
by breaking##2##2##(2008-4#1)(2011-3#1)
by breast##3##2##(1990-11#1)(1991-4#1)(1997-4#1)
by breath##2##2##(2011-2#1)(2013-8#1)
by breeding programs##2##3##(2008-10#1)(2009-8#1)
by brief exposure to##3##4##(1995-12#1)(1997-7#1)(2008-4#1)
by brief##4##2##(1995-12#1)(1997-7#1)(2008-4#1)(2008-7#1)
by bringing##3##2##(1997-2#1)(2007-11#1)(2008-5#1)
by bromate##4##2##(2008-10#4)
by bromide ions##2##3##(2008-10#2)
by bromodeoxyuridine##2##2##(1994-5#1)(2008-6#1)
by bronchoscopy##2##2##(1992-5#1)(2011-2#1)
by broth microdilution##2##3##(2008-5#1)(2013-1#1)
by bubble##4##2##(1994-3#3)(2009-11#1)
by budding##3##2##(2008-10#3)
by building##3##2##(2007-11#1)(2008-3#1)(2010-10#1)
by bulk polymerization##3##3##(2008-10#3)
by bulk##6##2##(2008-10#4)(2008-7#1)(2013-8#1)
by bulked segregant analysis##2##4##(2008-10#2)
by bumetanide and##2##3##(1990-5#1)(1992-3#1)
by bushen##2##2##(2013-8#2)
by butyrate##5##2##(1990-3#1)(2008-11#4)
by c-Jun##2##2##(1991-2#1)(2013-7#1)
by c-myc##2##2##(1992-6#1)(2008-11#1)
by cAMP in##2##3##(1994-11#2)
by cAMP##9##2##(1993-3#1)(1994-11#2)(1995-6#1)(1996-2#1)(1997-6#2)(2008-11#2)
by cAMP-dependent protein kinase##4##4##(1992-3#1)(1993-3#1)(1995-2#1)(1995-3#1)
by cAMP-dependent##5##2##(1990-11#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-3#1)
by cDNA array##3##3##(2008-9#3)
by cDNA cloning##2##3##(1990-5#1)(1994-11#1)
by cDNA##8##2##(1990-5#1)(1991-9#1)(1993-11#1)(1994-11#1)(1997-9#1)(2008-9#3)
by ca##5##2##(1993-11#1)(2008-10#4)
by cadmium##2##2##(1993-12#2)
by calcium##7##2##(1990-2#1)(1990-7#1)(1994-2#1)(1994-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
by calculating the area of##2##5##(1996-5#1)(2010-4#1)
by calculating the average##2##4##(1993-3#1)(1996-8#1)
by calculating the distances##2##4##(2010-7#2)
by calculating the##18##3##(1993-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2010-4#1)(2010-7#2)(2012-12#1)(2013-8#1)
by calculating##25##2##(1993-3#1)(1994-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#3)(2010-4#1)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
by calculation of the##4##4##(2008-3#4)
by calculation of##6##3##(2007-11#1)(2008-3#5)
by calculation##7##2##(2007-11#1)(2008-11#1)(2008-3#5)
by calibration##4##2##(2008-10#3)(2008-9#1)
by calpain##2##2##(1992-12#2)
by cancer cells##3##3##(1992-9#1)(2008-11#1)(2009-4#1)
by cancer cells)##2##3##(1993-9#1)(1994-7#1)
by cancer in##2##3##(2008-1#1)(2012-12#1)
by cancer##12##2##(1990-3#1)(1990-9#1)(1992-9#1)(1993-9#1)(1994-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-1#1)
by capillary column##2##3##(2008-10#1)(2011-1#1)
by capillary electrophoresis (CE) with##3##5##(2008-10#3)
by capillary electrophoresis (CE)##7##4##(2008-10#6)(2010-5#1)
by capillary electrophoresis and##2##4##(1996-5#1)(2008-10#1)
by capillary electrophoresis in##4##4##(1991-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
by capillary electrophoresis using##2##4##(1996-5#1)(2008-10#1)
by capillary electrophoresis with electrochemical detection##3##6##(2008-10#3)
by capillary electrophoresis with laser-induced fluorescence##2##6##(2008-10#2)
by capillary electrophoresis with##12##4##(1994-9#3)(2008-10#9)
by capillary electrophoresis##66##3##(1991-1#1)(1994-9#6)(1996-5#7)(1997-2#1)(2008-10#47)(2008-12#1)(2008-4#1)(2010-5#2)
by capillary gas chromatography##2##4##(2008-10#2)
by capillary isotachophoresis##3##3##(2008-10#3)
by capillary zone electrophoresis (CZE)##4##5##(1994-9#1)(2008-10#3)
by capillary zone electrophoresis using##2##5##(2008-10#2)
by capillary zone electrophoresis with##7##5##(2008-10#7)
by capillary zone electrophoresis##34##4##(1992-12#2)(1994-9#3)(2008-10#29)
by capillary##114##2##(1991-1#1)(1991-2#1)(1992-12#2)(1994-9#9)(1996-5#7)(1997-2#3)(2008-10#86)(2008-12#1)(2008-4#1)(2010-5#2)(2011-1#1)
by capping##2##2##(1992-2#1)(2008-10#1)
by capsaicin##6##2##(2008-11#3)(2012-3#3)
by capsule switching##2##3##(2007-12#2)
by capturing##3##2##(1992-3#1)(2008-4#1)(2012-3#1)
by carbachol was##2##3##(1994-11#1)(1996-12#1)
by carbachol##6##2##(1990-7#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-5#2)
by carbamylcholine chloride##2##3##(1995-8#2)
by carbohydrates##2##2##(2010-12#1)(2013-1#1)
by carbon monoxide (CO)##2##4##(1996-12#1)(2008-4#1)
by carbon monoxide##4##3##(1996-12#1)(2008-4#1)(2010-12#1)(2012-12#1)
by carbon paste electrode##2##4##(2008-10#2)
by carbon##12##2##(1991-9#2)(1993-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
by carboxylesterase##2##2##(2008-8#1)(2010-8#1)
by carcinogen##2##2##(1992-11#1)(2012-3#1)
by carcinoma##2##2##(1990-8#1)(1993-8#1)
by cardiac catheterization##2##3##(2007-8#1)(2011-2#1)
by cardiac##10##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
by cardiovascular##7##2##(1996-11#1)(2008-5#1)(2009-10#1)(2011-1#4)
by careful##3##2##(2007-11#1)(2008-1#1)(2009-7#1)
by carefully controlling##2##3##(2008-4#1)(2008-7#1)
by carefully##4##2##(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)
by caregivers##3##2##(1992-3#1)(1996-1#1)(2010-10#1)
by carrier-mediated##2##2##(1992-3#1)(2008-4#1)
by carrying out the##3##4##(2008-10#2)(2011-2#1)
by carrying out##9##3##(1990-11#1)(1990-7#1)(2008-10#5)(2008-3#1)(2011-2#1)
by cascade##2##2##(2007-12#2)
by cascaded##2##2##(2007-11#1)(2008-2#1)
by cascading##2##2##(2007-11#2)
by case##5##2##(1993-9#1)(1996-3#1)(2008-8#2)(2013-1#1)
by casein kinase II##3##4##(1990-11#1)(1993-8#2)
by casein kinase##4##3##(1990-11#1)(1993-8#3)
by casein##6##2##(1990-11#1)(1992-6#2)(1993-8#3)
by casting##3##2##(2008-10#3)
by catalase##2##2##(1993-6#1)(2008-10#1)
by catalysing the##2##3##(1990-7#1)(2008-7#1)
by catalysis of the##2##4##(2008-10#2)
by catalytic adsorptive##3##3##(2008-10#3)
by catalytic##7##2##(1992-8#1)(2008-10#5)(2008-11#1)
by catalyzing the formation of##2##5##(1992-10#1)(1995-12#1)
by cathepsin D##3##3##(1990-12#1)(1994-5#1)(1995-8#1)
by cathepsin##5##2##(1990-12#1)(1992-5#1)(1994-5#1)(1995-2#1)(1995-8#1)
by cathodic stripping voltammetry at##2##5##(2008-10#2)
by cathodic stripping voltammetry##5##4##(2008-10#5)
by cathodic stripping##9##3##(2008-10#9)
by cathodic##10##2##(2008-10#10)
by cation exchange chromatography##3##4##(1995-5#1)(2008-10#1)(2009-3#1)
by cation exchange##4##3##(1992-3#1)(1995-5#1)(2008-10#1)(2009-3#1)
by cationic liposomes##2##3##(1994-12#2)
by cationic peptides##2##3##(2008-4#2)
by cationic##8##2##(1994-12#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#2)
by cause##2##2##(1991-6#1)(2013-1#1)
by causing a##5##3##(1990-7#1)(1991-9#1)(1995-5#1)(2008-10#1)(2008-7#1)
by causing##11##2##(1990-7#1)(1991-9#1)(1995-5#2)(1997-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
by cdk-cyclin A##2##3##(1994-8#2)
by cell culture##2##3##(2008-11#1)(2008-5#1)
by cell fusion with##2##4##(1995-11#1)(2008-11#1)
by cell fusion##4##3##(1993-3#1)(1995-11#1)(2007-6#1)(2008-11#1)
by cell##33##2##(1991-5#1)(1993-3#2)(1994-11#1)(1995-11#2)(1995-8#1)(2007-6#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
by cell-cell##2##2##(2008-7#1)(2012-1#1)
by cells from##2##3##(2007-12#1)(2008-11#1)
by cells in##6##3##(1990-5#1)(1990-8#1)(1994-12#1)(2008-4#1)(2010-8#1)(2011-2#1)
by cells##23##2##(1990-5#1)(1990-8#1)(1992-9#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(2007-12#1)(2008-11#5)(2008-4#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
by cellular##12##2##(1993-3#2)(1994-3#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
by cellulase##3##2##(2008-10#3)
by central obesity##2##3##(2008-10#1)(2012-2#1)
by central##13##2##(1991-2#1)(1992-6#1)(1992-8#2)(1993-5#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-9#1)(2010-12#1)(2012-2#1)
by centrifugal partition chromatography##2##4##(1994-12#2)
by centrifugal##3##2##(1992-9#1)(1994-12#2)
by centrifugation and##4##3##(1992-12#1)(1994-6#1)(2008-10#1)(2008-5#1)
by centrifugation in##2##3##(1990-7#1)(1994-12#1)
by centrifugation##14##2##(1990-11#1)(1990-7#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2012-2#1)
by cerebral##4##2##(1992-6#1)(1993-5#1)(1995-5#1)(2008-7#1)
by certain##11##2##(1990-11#1)(1992-12#1)(1994-5#1)(1996-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
by cervical##3##2##(2007-10#2)(2008-12#1)
by cesarean section##5##3##(1994-9#1)(2008-9#1)(2011-2#2)(2013-1#1)
by cesium chloride##2##3##(2008-10#1)(2008-9#1)
by chain##2##2##(1995-5#1)(2012-2#1)
by challenging##2##2##(2008-10#1)(2008-9#1)
by chance##7##2##(1993-3#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
by changes in the time##2##5##(2011-2#2)
by changes in the##14##4##(1992-8#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(2007-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#2)(2013-7#1)
by changes in##36##3##(1992-8#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#2)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
by changes##41##2##(1992-8#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#2)(2010-4#1)(2011-2#3)(2013-7#1)(2013-8#1)
by changing from##2##3##(1992-11#1)(1997-8#1)
by changing the pH##2##4##(1990-5#1)(1994-9#1)
by changing the position of the##2##6##(2007-12#1)(2008-10#1)
by changing the refractive index of##2##6##(2008-3#1)(2010-2#1)
by changing the##49##3##(1990-5#2)(1990-6#1)(1992-6#1)(1994-9#2)(1996-2#2)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-2#4)(2008-3#8)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-2#1)
by changing##62##2##(1990-5#2)(1990-6#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-3#1)(1994-9#3)(1995-6#2)(1996-2#2)(1997-1#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-2#4)(2008-3#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)
by characterization of##3##3##(2007-12#1)(2008-10#2)
by characterizing the##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
by characterizing##5##2##(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
by chelating##2##2##(2008-10#2)
by chelation##2##2##(1996-5#1)(2008-10#1)
by chemical and##3##3##(1994-11#1)(1995-5#1)(2008-10#1)
by chemical cross-linking with##2##4##(1994-5#1)(2008-4#1)
by chemical methods##3##3##(2008-12#1)(2010-6#1)(2013-1#1)
by chemical modification##3##3##(1992-5#1)(1993-8#1)(2008-4#1)
by chemical reduction method##2##4##(2012-2#2)
by chemical reduction##4##3##(1995-3#1)(2008-10#1)(2012-2#2)
by chemical vapor deposition using##2##5##(2008-10#2)
by chemical##39##2##(1990-5#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#3)(2013-1#1)
by chemically cross-linking##2##3##(1993-9#1)(2008-4#1)
by chemically##4##2##(1993-6#1)(1993-9#1)(2008-4#1)(2008-5#1)
by chemicals##2##2##(2008-11#1)(2008-5#1)
by chemiluminescence##6##2##(1990-8#1)(2008-10#5)
by chemometric##4##2##(2008-10#4)
by chemotherapy##14##2##(1990-8#1)(1992-6#1)(1994-7#1)(1996-12#1)(2007-8#2)(2008-7#3)(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
by chest##3##2##(2008-1#2)(2008-7#1)
by chicken##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
by children and adults##2##4##(1995-5#1)(2008-9#1)
by children and##4##3##(1995-5#1)(2008-11#2)(2008-9#1)
by children in##2##3##(1993-12#1)(2012-2#1)
by children##12##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-11#2)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#2)
by chitin##2##2##(2008-10#2)
by chloride ions##2##3##(1997-2#1)(1997-7#1)
by chloride##4##2##(1997-2#1)(1997-7#2)(2008-10#1)
by chlorine##2##2##(1991-6#1)(2008-10#1)
by chloroperoxidase##2##2##(1994-5#2)
by chloroquine and##2##3##(1993-8#1)(1995-8#1)
by choice of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
by cholate##3##2##(1990-2#2)(1992-3#1)
by cholecystokinin##2##2##(1993-6#1)(1995-8#1)
by cholera toxin##3##3##(1991-12#2)(2008-4#1)
by cholesterol##4##2##(1990-2#1)(1991-9#1)(2008-4#1)(2011-1#1)
by chondrocytes##4##2##(1991-11#1)(1993-12#2)(2011-2#1)
by choosing##7##2##(2007-12#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
by chromaffin cell grafts##2##4##(1993-12#2)
by chromatic##2##2##(1992-11#1)(2008-3#1)
by chromatin immunoprecipitation##3##3##(2008-2#2)(2011-2#1)
by chromatin##8##2##(2008-11#1)(2008-2#2)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#1)
by chromatographic and##3##3##(1994-8#1)(1997-1#1)(2008-11#1)
by chromatographic separation##2##3##(2008-10#2)
by chromatographic techniques##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
by chromatographic##9##2##(1994-8#1)(1997-1#1)(2008-10#3)(2008-11#2)(2010-4#2)
by chromatography on a##2##4##(1993-6#1)(1995-11#1)
by chromatography on##5##3##(1991-5#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-6#1)
by chromatography##8##2##(1991-5#1)(1992-11#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-6#1)(2008-10#2)
by chromium (VI)##2##3##(1994-11#2)
by chromium(VI) in##2##3##(2008-10#2)
by chromosomal translocation##2##3##(1995-11#1)(2008-6#1)
by chromosomal##3##2##(1994-8#1)(1995-11#1)(2008-6#1)
by chromosome##6##2##(1990-2#1)(1991-4#1)(1996-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
by chronic EtOH treatment##2##4##(2008-10#2)
by chronic EtOH##3##3##(2008-10#3)
by chronic exposure to##3##4##(1991-4#2)(1997-4#1)
by chronic granulomatous##2##3##(1990-3#1)(2008-5#1)
by chronic pain patients##2##4##(1991-1#1)(2010-9#1)
by chronic pain##3##3##(1991-1#1)(1997-8#1)(2010-9#1)
by chronic##27##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-5#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2010-9#1)(2013-1#1)
by chronically mentally ill Medicaid##2##5##(1994-2#2)
by chronological age##2##3##(2010-10#1)(2012-12#1)
by cigarette smoking##2##3##(1991-12#1)(2013-8#1)
by cigarette##3##2##(1991-12#1)(1993-8#1)(2013-8#1)
by circular dichroism (CD)##3##4##(1990-5#1)(1992-6#1)(1994-11#1)
by circular dichroism and##2##4##(1993-11#2)
by circular dichroism##9##3##(1990-5#1)(1992-5#1)(1992-6#2)(1993-11#2)(1994-11#1)(1995-5#1)(2008-4#1)
by circular##14##2##(1990-5#1)(1992-5#1)(1992-6#2)(1993-11#2)(1994-11#1)(1995-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)
by circulating##2##2##(1990-6#1)(2008-7#1)
by citrus##2##2##(2008-10#1)(2013-8#1)
by clarifying the##2##3##(2008-11#1)(2013-1#1)
by class##4##2##(2007-12#1)(2009-7#1)(2013-1#2)
by classic##2##2##(1990-6#1)(2008-1#1)
by classical methods##2##3##(2008-10#2)
by classical##13##2##(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-5#2)(2008-7#1)(2010-5#1)
by clear##2##2##(1991-8#1)(2008-7#1)
by cleavage and##2##3##(1993-11#1)(2007-12#1)
by cleavage with cyanogen bromide##3##5##(1990-5#2)(1991-9#1)
by cleavage##7##2##(1990-5#2)(1991-9#1)(1993-11#1)(1997-3#1)(2007-12#1)(2008-10#1)
by cleaving through the##2##4##(2007-11#1)(2007-12#1)
by cleaving##4##2##(1992-4#1)(2007-11#1)(2007-12#1)(2011-1#1)
by clients##3##2##(1991-1#1)(1996-2#1)(2008-9#1)
by climate##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
by climatic##2##2##(2008-10#1)(2013-7#1)
by clinical and##2##3##(2008-11#1)(2009-1#1)
by clinical criteria##2##3##(2007-10#1)(2007-7#1)
by clinical examination and##2##4##(1990-10#1)(1992-5#1)
by clinical examination##4##3##(1990-10#1)(1990-6#1)(1992-5#1)(2008-6#1)
by clinical signs and##2##4##(1994-7#1)(2013-1#1)
by clinical##26##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
by clinicians and researchers##3##4##(2008-12#1)(2008-4#1)(2012-12#1)
by clinicians and##6##3##(1993-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
by clinicians to treat##2##4##(1991-1#1)(2009-3#1)
by clinicians to##3##3##(1991-1#1)(2009-3#1)(2013-1#1)
by clinicians##16##2##(1991-1#1)(1993-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
by clofibrate##4##2##(1990-12#1)(1990-2#1)(1991-4#2)
by clonal##2##2##(2008-10#1)(2013-1#1)
by cloning a##2##3##(1991-9#1)(1995-6#1)
by cloning and sequencing##2##4##(1995-6#1)(2008-10#1)
by cloning and##4##3##(1991-5#1)(1995-6#1)(2008-10#1)(2008-8#1)
by cloning##8##2##(1991-5#1)(1991-9#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
by close##2##2##(2010-11#1)(2011-1#1)
by closed reduction##2##3##(2007-8#2)
by closed##4##2##(1990-5#1)(2007-8#2)(2013-8#1)
by closely##3##2##(1997-4#1)(2008-10#1)(2008-2#1)
by closing##2##2##(2008-10#2)
by closure##2##2##(2008-4#2)
by cloud##2##2##(2008-10#1)(2008-2#1)
by cloud-point extraction##2##3##(2008-10#2)
by cluster analyses of##2##4##(2008-10#1)(2008-5#1)
by clustering##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
by co-application##2##2##(1995-11#1)(2008-4#1)
by co-culturing the##2##3##(2008-11#2)
by co-culturing##3##2##(2008-11#2)(2008-8#1)
by co-expression of##2##3##(1997-4#1)(2012-12#1)
by co-expression##3##2##(1997-4#1)(2008-4#1)(2012-12#1)
by co-incubation with##2##3##(2008-4#1)(2011-1#1)
by co-injecting##2##2##(2008-10#1)(2013-1#1)
by co-injection of##3##3##(1991-12#1)(1993-12#1)(2012-12#1)
by co-treatment with##3##3##(1991-1#1)(1997-4#1)(2008-4#1)
by coalescence##2##2##(2008-5#2)
by coating the##2##3##(2008-10#1)(2013-1#1)
by coating##7##2##(2008-10#4)(2008-7#1)(2010-5#1)(2013-1#1)
by cochlear implant##2##3##(2008-9#2)
by cochlear##3##2##(2008-9#3)
by coculture##2##2##(1990-11#1)(2008-9#1)
by coculturing##2##2##(2008-11#2)
by coenzyme Q##2##3##(1992-11#2)
by coexisting##3##2##(2008-10#2)(2012-2#1)
by coexpression of##3##3##(1993-6#1)(1995-11#1)(2011-2#1)
by coherent##7##2##(2007-11#4)(2008-3#3)
by coherently##2##2##(2007-12#1)(2008-3#1)
by coinjection##2##2##(1993-12#1)(1997-2#1)
by colchicine##4##2##(1993-6#1)(1995-5#2)(2008-11#1)
by cold vapor atomic absorption spectrometry##4##6##(2008-10#4)
by cold vapour atomic absorption spectrometry (CVAAS)##2##7##(2008-10#2)
by cold vapour atomic absorption spectrometry##4##6##(2008-10#4)
by cold vapour atomic absorption##5##5##(2008-10#5)
by cold vapour atomic##7##4##(2008-10#7)
by cold##14##2##(1995-11#1)(2008-10#12)(2009-8#1)
by collaboration##2##2##(1997-4#1)(2008-7#1)
by collagen##5##2##(1990-12#1)(1997-7#1)(2007-11#1)(2008-5#2)
by collecting data##2##3##(2008-11#1)(2008-5#1)
by collecting##15##2##(1996-10#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2012-2#1)
by collision##3##2##(2008-10#2)(2009-11#1)
by colloid##2##2##(1991-11#1)(2008-10#1)
by colon##2##2##(1991-12#1)(2010-1#1)
by colonoscopy##2##2##(1993-9#1)(2008-1#1)
by colony hybridization and##2##4##(1996-10#1)(1996-12#1)
by colony##4##2##(1996-10#2)(1996-11#1)(1996-12#1)
by column chromatography and##2##4##(2008-12#1)(2012-2#1)
by column chromatography##6##3##(2008-10#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#1)
by column method##4##3##(2008-10#4)
by column##17##2##(1990-11#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#1)
by combination of flow injection##2##5##(2008-10#2)
by combination of two##2##4##(2008-3#1)(2010-5#1)
by combination of##12##3##(2007-11#1)(2008-10#7)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
by combination##13##2##(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
by combinatorial##2##2##(2008-4#1)(2011-2#1)
by combined treatment##2##3##(2007-11#1)(2008-7#1)
by combined##14##2##(1990-3#1)(1993-8#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#3)
by combining a##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
by combining an##2##3##(2007-12#1)(2008-6#1)
by combining experimental##2##3##(2008-7#1)(2008-8#1)
by combining internal##2##3##(2008-7#1)(2012-3#1)
by combining liquid chromatography and##2##5##(2008-10#2)
by combining the##12##3##(1992-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2012-2#3)(2013-8#1)
by combining##54##2##(1990-5#1)(1992-6#1)(1993-2#1)(1995-5#1)(1996-1#1)(1997-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
by combustion##2##2##(2008-10#2)
by commercial##8##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)
by commercially available##2##3##(2008-7#1)(2009-11#1)
by commercially##3##2##(2008-10#1)(2008-7#1)(2009-11#1)
by committees##2##2##(1994-12#1)(1996-1#1)
by common solvent##2##3##(2012-2#2)
by common##11##2##(1990-9#1)(1993-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#3)
by commonly used##2##3##(2008-10#1)(2008-8#1)
by community pharmacists##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
by community##7##2##(1996-12#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-10#1)(2011-1#1)(2013-1#1)
by community-acquired##2##2##(2007-12#1)(2013-8#1)
by comparative sequence analysis##2##4##(2008-5#1)(2008-7#1)
by comparative##13##2##(1994-6#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)
by comparing data##2##3##(2008-10#1)(2008-3#1)
by comparing experimental##2##3##(2008-2#1)(2008-7#1)
by comparing it to##2##4##(2010-4#1)(2012-2#1)
by comparing it##3##3##(2008-3#1)(2010-4#1)(2012-2#1)
by comparing its##2##3##(2007-8#1)(2008-3#1)
by comparing patients##2##3##(1997-3#1)(2008-8#1)
by comparing results with##2##4##(1994-1#1)(2008-10#1)
by comparing results##4##3##(1994-1#1)(2008-10#2)(2008-5#1)
by comparing selected##2##3##(2008-10#1)(2008-4#1)
by comparing the concentrations##2##4##(2008-10#2)
by comparing the experimental##2##4##(1996-5#1)(2008-10#1)
by comparing the likelihood##2##4##(1996-4#2)
by comparing the luminescence##2##4##(1996-12#1)(2008-2#1)
by comparing the number##2##4##(1991-6#1)(1996-4#1)
by comparing the response##2##4##(2008-10#1)(2008-3#1)
by comparing the results obtained##3##5##(2008-10#3)
by comparing the results with##4##5##(1993-2#1)(2008-10#3)
by comparing the results##7##4##(1993-2#1)(2008-10#6)
by comparing the##53##3##(1991-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1994-5#1)(1996-12#1)(1996-4#3)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#22)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2012-1#1)(2013-1#1)
by comparing their##3##3##(1990-5#1)(2008-10#1)(2013-1#1)
by comparing them with##3##4##(2007-11#1)(2008-10#1)(2011-3#1)
by comparing with##3##3##(2008-10#2)(2008-5#1)
by comparing##110##2##(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#2)(2007-11#1)(2007-8#1)(2008-10#37)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
by comparison of the results##2##5##(2008-10#2)
by comparison of the##11##4##(1991-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-2#1)(2010-12#1)
by comparison of theoretical and##2##5##(2008-3#2)
by comparison of##20##3##(1991-5#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#7)(2009-2#1)(2010-12#1)
by comparison to##4##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
by comparison with a##5##4##(2008-1#1)(2008-10#3)(2008-3#1)
by comparison with an##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
by comparison with the results##2##5##(2008-2#1)(2008-8#1)
by comparison with the##7##4##(1997-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)
by comparison with##32##3##(1992-6#1)(1994-5#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#14)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2013-1#1)
by comparison##60##2##(1991-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#4)(2008-1#1)(2008-10#21)(2008-12#1)(2008-2#7)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2013-1#1)
by comparisons##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
by competent##2##2##(2008-12#1)(2011-2#1)
by competing##5##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-8#1)(2011-2#1)
by competition ELISA##2##3##(2008-10#1)(2008-7#1)
by competition##10##2##(1995-2#2)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
by competitive inhibition##2##3##(2008-11#1)(2008-5#1)
by competitive polymerase chain reaction##2##5##(1995-12#1)(2008-10#1)
by competitive##9##2##(1990-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
by complementary##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
by complementation of a##2##4##(1993-9#1)(1994-8#1)
by complementation of an##2##4##(1990-5#1)(1994-8#1)
by complementation of##6##3##(1990-5#1)(1993-9#1)(1994-8#2)(1997-4#2)
by complementation##12##2##(1990-5#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-2#1)(1997-4#2)(2008-10#2)(2008-9#1)
by complete##9##2##(1992-8#1)(1993-11#1)(1996-5#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-3#1)
by complex formation with##2##4##(1997-7#1)(2008-10#1)
by complex##14##2##(1991-3#1)(1992-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-11#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
by complexation with##6##3##(1995-2#1)(2008-10#5)
by complexation##7##2##(1995-2#1)(2008-10#6)
by complexing with##3##3##(1991-12#1)(2008-10#2)
by complexing##4##2##(1991-12#1)(2008-10#3)
by components of the##3##4##(2008-7#1)(2009-8#1)(2010-2#1)
by composite##2##2##(2008-10#1)(2011-2#1)
by compound 48/80##3##3##(1992-3#2)(2008-10#1)
by compound##5##2##(1992-3#2)(2008-10#1)(2008-11#1)(2008-2#1)
by compounds##2##2##(1991-5#1)(2008-10#1)
by comprehensive two-dimensional##2##3##(2008-10#2)
by comprehensive##4##2##(2008-10#2)(2009-10#1)(2012-2#1)
by compression of the##2##4##(2007-11#1)(2008-3#1)
by compression of##3##3##(2007-11#1)(2008-3#1)(2010-7#1)
by compression##5##2##(1994-3#1)(2007-11#2)(2008-3#1)(2010-7#1)
by compressive##3##2##(1994-11#1)(2007-11#1)(2012-1#1)
by computational##3##2##(2008-11#2)(2008-7#1)
by computed tomography (CT) of the thorax##2##7##(2008-8#1)(2011-1#1)
by computed tomography (CT)##5##4##(2007-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-8#1)
by computed tomography##12##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#2)(2013-8#2)
by computed##13##2##(1996-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#2)(2013-8#2)
by computer analysis##4##3##(2007-10#4)
by computer simulation##3##3##(2007-11#1)(2008-3#2)
by computer simulations##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
by computer tomography##2##3##(2007-8#2)
by computer##29##2##(1991-2#1)(1992-12#1)(1996-11#1)(2006-12#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-2#6)(2008-3#7)(2010-3#1)
by computerised##2##2##(2010-5#1)(2011-2#1)
by computerized tomography##2##3##(1991-11#1)(2008-12#1)
by computing the mean##2##4##(1992-9#1)(2008-10#1)
by computing the##5##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-7#1)
by computing##8##2##(1992-9#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-7#1)
by concentrated##3##2##(2008-10#3)
by concentrating##3##2##(1993-12#1)(2008-10#1)(2008-6#1)
by concentration##6##2##(1995-3#1)(2008-10#1)(2008-2#2)(2010-5#1)(2011-1#1)
by concerns##3##2##(1992-1#1)(1992-2#1)(2009-11#1)
by concomitant##4##2##(1997-2#1)(2006-10#1)(2009-2#1)(2012-2#1)
by concurrent##3##2##(1990-5#1)(1995-1#1)(2008-10#1)
by condensation of a##2##4##(1990-7#1)(1997-3#1)
by condensation of##3##3##(1990-7#1)(1997-3#1)(2008-3#1)
by condensation##4##2##(1990-7#1)(1997-3#1)(2008-3#1)(2013-1#1)
by condensing##2##2##(2008-10#1)(2008-4#1)
by conditioned media##2##3##(1992-3#1)(2012-4#1)
by conditioned##6##2##(1992-3#1)(1993-6#2)(1996-5#1)(2008-11#1)(2012-4#1)
by conducting a##2##3##(2008-10#1)(2008-8#1)
by conducting##11##2##(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-2#1)(2011-1#1)
by conductivity##2##2##(2008-10#2)
by confirmatory##2##2##(2008-12#2)
by confocal laser scanning microscopy##2##5##(2008-11#2)
by confocal laser##4##3##(1995-5#1)(2007-12#1)(2008-11#2)
by confocal microscopy##7##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
by confocal##14##2##(1995-5#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-3#2)(2008-7#1)(2013-1#2)
by congenital##2##2##(2007-12#1)(2011-1#1)
by conidia##5##2##(2008-10#5)
by coniine for##2##3##(1996-12#2)
by conjugate##2##2##(1995-8#1)(2008-10#1)
by conjugation##3##2##(1991-5#1)(2008-10#2)
by connecting##2##2##(2008-10#1)(2008-3#1)
by consecutive phases of primary and secondary infection##2##8##(2008-10#2)
by consecutive##3##2##(2008-10#3)
by consensus##7##2##(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#3)
by conserving##2##2##(2008-11#1)(2012-2#1)
by consideration of##2##3##(1994-2#1)(2012-2#1)
by considering several##2##3##(1991-9#1)(1995-2#1)
by considering the##12##3##(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
by considering##28##2##(1991-9#1)(1995-2#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
by constant##2##2##(1995-11#1)(2008-10#1)
by constant-wavelength synchronous spectrofluorimetry in##2##5##(2008-10#2)
by constitutional##2##2##(2007-11#2)
by constitutive##4##2##(2008-5#1)(2008-7#1)(2009-2#2)
by constructing a##3##3##(1997-7#1)(2007-11#1)(2010-7#1)
by constructing an##2##3##(2007-12#1)(2008-10#1)
by constructing nuclear and mitochondrial gene genealogies##2##7##(2008-10#2)
by constructing##9##2##(1993-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-7#1)
by construction##2##2##(1996-8#1)(2008-12#1)
by consumers in##2##3##(2007-12#1)(2008-5#1)
by consumers##4##2##(2007-12#1)(2008-12#1)(2008-5#2)
by consuming##2##2##(2008-12#1)(2011-1#1)
by consumption of##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
by contact sensitizers##2##3##(2008-10#2)
by contact with the##2##4##(1995-2#1)(2008-10#1)
by contact with##5##3##(1995-2#1)(1995-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
by contact##11##2##(1992-6#1)(1995-2#2)(1995-9#1)(2008-10#3)(2008-11#1)(2011-2#2)(2013-8#1)
by contaminated##2##2##(1996-5#1)(1997-4#1)
by contamination of##2##3##(1996-12#1)(2008-5#1)
by contamination##4##2##(1996-12#1)(2008-11#1)(2008-5#1)(2010-5#1)
by content##2##2##(1995-3#1)(2008-3#1)
by continual##3##2##(1993-12#1)(2007-11#1)(2008-10#1)
by continuous exposure to##3##4##(2008-11#1)(2008-12#1)(2011-2#1)
by continuous flow##2##3##(2008-10#2)
by continuous hydride generation and##2##5##(2008-10#2)
by continuous hydride generation##3##4##(2008-10#3)
by continuous##24##2##(1990-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-2#2)
by contrast##10##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#3)
by contributing##2##2##(1994-11#1)(2009-6#1)
by control of##2##3##(2007-10#1)(2007-11#1)
by control##7##2##(1993-12#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-9#2)(2010-2#1)
by controlled proteolysis##2##3##(1995-6#1)(2008-7#1)
by controlled##9##2##(1991-7#1)(1995-6#1)(1996-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)
by controlling the levels of##2##5##(1992-12#2)
by controlling the##12##3##(1992-12#2)(1994-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2009-11#2)(2009-8#1)
by controlling##20##2##(1992-12#2)(1994-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#3)(2009-8#1)(2010-2#1)(2010-9#1)(2012-2#1)
by convenience##3##2##(2011-2#1)(2013-1#2)
by conventional angiography##2##3##(2008-11#1)(2008-12#1)
by conventional bacteriological methods##2##4##(2007-7#1)(2008-9#1)
by conventional electron microscopy##2##4##(2008-5#1)(2008-8#1)
by conventional means##2##3##(2008-3#1)(2010-12#1)
by conventional method##2##3##(2007-7#1)(2008-11#1)
by conventional methods##3##3##(1994-8#1)(2008-11#1)(2012-12#1)
by conventional microscopy##2##3##(2008-3#2)
by conventional nebulisation##2##3##(2008-10#2)
by conventional techniques##2##3##(2008-10#1)(2012-3#1)
by conventional##60##2##(1990-10#1)(1990-11#1)(1991-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#2)(1995-5#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
by conversion of the##3##4##(1995-3#1)(1996-12#1)(2007-12#1)
by conversion of##7##3##(1990-11#1)(1995-3#1)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#2)
by conversion##9##2##(1990-11#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#3)
by converting it##2##3##(2008-10#1)(2008-6#1)
by converting##5##2##(2008-10#2)(2008-6#1)(2010-8#1)(2012-2#1)
by convolution of the##2##4##(2008-10#1)(2008-3#1)
by cooling##3##2##(1993-6#1)(2007-12#2)
by coordinating##2##2##(1996-3#1)(2008-10#1)
by cop##2##2##(2009-2#2)
by copolymerization of styrene and poly(ethylene oxide) macromonomer##2##8##(2008-10#2)
by copolymerization of##3##3##(2007-12#1)(2008-10#2)
by copper##5##2##(2008-10#5)
by copper(II)##2##2##(2008-10#2)
by coprecipitation with##2##3##(2008-10#2)
by coprecipitation##5##2##(2008-10#4)(2008-4#1)
by coronary angiography##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
by coronary##4##2##(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
by correlating the##2##3##(2008-10#2)
by correlating##3##2##(1997-6#1)(2008-10#2)
by correlation and##2##3##(2008-10#1)(2011-2#1)
by correlation##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
by cortical##4##2##(1995-12#1)(2008-7#3)
by cortisol##2##2##(1996-12#1)(2008-1#1)
by cosinor##2##2##(2008-11#2)
by cotransfection of##3##3##(1993-2#1)(1994-8#1)(2008-2#1)
by coulometric##2##2##(1991-8#1)(2008-10#1)
by counting the number of##2##5##(1990-3#1)(2008-3#1)
by counting the##4##3##(1990-3#1)(1997-6#1)(1997-8#1)(2008-3#1)
by counting##13##2##(1990-3#1)(1993-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)
by country##4##2##(1990-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
by coupled##2##2##(2007-12#1)(2008-10#1)
by coupling CHA with##2##4##(2008-10#2)
by coupling a##4##3##(2008-10#3)(2008-8#1)
by coupling an##2##3##(1994-5#1)(2008-3#1)
by coupling it through##2##4##(2008-10#2)
by coupling it##4##3##(2008-10#4)
by coupling of two##3##4##(2007-11#1)(2010-2#1)(2012-2#1)
by coupling of##7##3##(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-2#1)(2012-2#1)
by coupling the##8##3##(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)
by coupling with##6##3##(1993-11#1)(2008-10#4)(2008-3#1)
by coupling##42##2##(1990-8#1)(1993-11#1)(1994-5#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2012-2#1)
by covalent approach##2##3##(2008-10#2)
by covalent attachment##2##3##(1995-6#1)(2008-10#1)
by covalent binding##2##3##(1995-5#1)(2008-10#1)
by covalent##13##2##(1990-2#1)(1990-8#2)(1995-5#1)(1995-6#1)(2008-10#7)(2008-4#1)
by covalently##2##2##(2008-10#1)(2013-1#1)
by creating a##8##3##(1993-12#1)(1995-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)
by creating##12##2##(1993-12#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-8#1)
by creatinine##2##2##(1992-11#1)(1995-3#1)
by creation of a##2##4##(2007-12#1)(2008-3#1)
by crop rotation and##2##4##(2008-12#2)
by crop rotation##4##3##(2008-10#2)(2008-12#2)
by crop##5##2##(2008-10#2)(2008-12#3)
by cross pathogenicity##2##3##(2008-10#2)
by cross##5##2##(1990-5#1)(2008-10#3)(2008-3#1)
by cross-linking with glutaraldehyde##4##4##(2008-10#4)
by cross-linking with##5##3##(1990-2#1)(2008-10#4)
by cross-linking##8##2##(1990-2#1)(1995-5#1)(2008-10#4)(2008-5#1)(2009-10#1)
by cross-phase modulation##2##3##(2007-11#2)
by cross-validation##3##2##(2008-10#2)(2010-4#1)
by crossed##2##2##(1991-8#1)(2008-3#1)
by crossing resistant##2##3##(2008-10#2)
by crossing##9##2##(1994-3#1)(1995-8#1)(2007-12#1)(2008-10#6)
by crosslinking with##2##3##(1994-2#1)(2008-10#1)
by crosslinking##5##2##(1993-8#1)(1994-2#1)(1995-2#1)(2008-10#2)
by crowded glands with##2##4##(2011-2#2)
by crowding##2##2##(2009-8#1)(2012-2#1)
by crude##2##2##(2008-12#1)(2010-12#1)
by crystal##4##2##(2007-12#2)(2008-10#2)
by cultivar##2##2##(2008-10#2)
by cultural##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
by culture in##2##3##(2008-5#2)
by culture isolation##2##3##(2008-5#2)
by culture on##2##3##(2008-11#1)(2009-11#1)
by culture##17##2##(1995-11#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#5)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
by cultured##6##2##(1990-2#1)(1991-5#2)(1995-11#1)(2007-11#1)(2008-1#1)
by culturing a##2##3##(2008-11#2)
by culturing with##2##3##(1993-6#1)(2008-9#1)
by culturing##12##2##(1990-11#1)(1993-6#1)(2008-10#3)(2008-11#5)(2008-6#1)(2008-9#1)
by curative##2##2##(1991-2#1)(1997-6#1)
by curcumin##3##2##(2008-10#1)(2011-2#2)
by current##8##2##(1990-2#1)(1994-1#1)(1997-3#1)(2008-7#1)(2008-8#2)(2011-1#1)(2013-8#1)
by cutting##5##2##(1993-12#1)(2008-5#1)(2008-9#2)(2010-3#1)
by cyanide##6##2##(1991-9#1)(1992-12#2)(1993-11#1)(1994-6#1)(2009-2#1)
by cyclic AMP-dependent protein kinase##3##5##(1991-2#1)(1994-9#2)
by cyclic and##4##3##(2008-10#4)
by cyclic strain##2##3##(1993-3#1)(1994-11#1)
by cyclic voltammetry (CV) and##2##5##(2008-10#2)
by cyclic voltammetry (CV)##8##4##(2008-10#8)
by cyclic voltammetry and amperometric##2##5##(2013-1#2)
by cyclic voltammetry and##7##4##(2008-10#5)(2013-1#2)
by cyclic voltammetry##32##3##(2008-10#30)(2013-1#2)
by cyclic##47##2##(1991-2#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-9#2)(2007-11#1)(2008-10#37)(2008-4#1)(2013-1#2)
by cyclization of##2##3##(2007-11#1)(2009-5#1)
by cyclization##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2009-5#1)
by cycloheximide treatment##2##3##(1993-12#1)(1995-6#1)
by cycloheximide##7##2##(1991-12#1)(1992-8#2)(1993-12#1)(1993-8#1)(1995-6#1)(2008-11#1)
by cyclophosphamide##3##2##(1994-5#2)(2008-10#1)
by cyclosporin A##2##3##(1994-8#1)(1997-4#1)
by cyclosporin##4##2##(1990-3#1)(1994-8#1)(1997-4#1)(1997-6#1)
by cyclosporine A##2##3##(1992-12#1)(1994-8#1)
by cysteine##9##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-12#1)(1995-2#2)(2008-10#2)(2008-8#1)
by cystic##5##2##(1992-12#1)(1992-9#1)(2008-1#1)(2010-11#1)(2012-12#1)
by cytochemical##4##2##(1993-11#1)(2007-12#1)(2008-10#2)
by cytochrome P450##3##3##(1991-2#2)(2008-8#1)
by cytochrome P450cam##2##3##(1992-11#2)
by cytochrome##8##2##(1991-2#2)(1991-8#1)(1992-11#2)(1994-8#1)(2008-3#1)(2008-8#1)
by cytogenetic##2##2##(2008-5#1)(2012-3#1)
by cytokines and##2##3##(1992-2#1)(2012-2#1)
by cytokines##5##2##(1992-2#1)(1994-3#1)(1997-1#1)(2008-5#1)(2012-2#1)
by cytometry##3##2##(2008-11#1)(2008-9#2)
by cytopathic effect##2##3##(1994-6#1)(2007-6#1)
by cytoplasmic##4##2##(1990-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
by cytosolic##3##2##(1991-8#1)(1993-8#1)(2013-1#1)
by cytotoxic##5##2##(1992-2#1)(1993-1#1)(1997-6#1)(2007-10#1)(2008-7#1)
by daily##3##2##(2008-10#2)(2013-8#1)
by damage to##3##3##(2007-8#1)(2009-11#1)(2012-1#1)
by damage##5##2##(2007-8#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-8#1)
by data from##2##3##(1996-11#1)(2008-11#1)
by data##8##2##(1996-11#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)
by day and##2##3##(1995-12#1)(2011-2#1)
by day##12##2##(1990-12#1)(1993-12#1)(1995-12#1)(2006-6#1)(2007-12#1)(2008-11#2)(2008-6#1)(2010-4#1)(2011-2#1)(2011-9#1)(2012-3#1)
by decomposition of##3##3##(1993-11#1)(2008-10#2)
by decomposition##4##2##(1993-11#1)(2008-10#3)
by deconvolution##2##2##(2007-12#1)(2008-10#1)
by decrease in the##2##4##(1994-6#1)(2008-10#1)
by decrease in##4##3##(1994-6#1)(2008-10#1)(2011-1#1)(2013-7#1)
by decreased##5##2##(1993-2#1)(1995-2#1)(2008-4#1)(2010-3#1)(2012-2#1)
by decreases in##3##3##(1991-3#1)(1997-1#1)(1997-7#1)
by decreasing its##2##3##(1990-5#1)(2008-10#1)
by decreasing the##8##3##(1990-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-2#1)
by decreasing##20##2##(1990-5#2)(1992-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
by dedicated##2##2##(1993-12#1)(2008-8#1)
by defects in##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
by deficiency of the##2##4##(1991-9#1)(1996-2#1)
by deficient##2##2##(1990-6#1)(1997-3#1)
by defining a##2##3##(1993-12#1)(2008-10#1)
by defining the##3##3##(1991-12#1)(2010-10#1)(2012-2#1)
by defining##8##2##(1991-12#1)(1993-12#1)(1994-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)(2012-2#1)
by degenerate##2##2##(2007-12#1)(2008-9#1)
by degeneration##2##2##(2008-4#1)(2009-10#1)
by degenerative disc disease##2##4##(2011-2#1)(2012-12#1)
by degradation##2##2##(1991-6#1)(2008-4#1)
by delay##2##2##(1992-5#1)(1997-2#1)
by delayed##6##2##(2007-11#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
by delaying the##3##3##(1996-12#1)(2008-10#1)(2010-12#1)
by delaying##6##2##(1996-12#1)(2008-10#3)(2008-7#1)(2010-12#1)
by deleting##2##2##(1992-12#1)(2008-10#1)
by deletion and##2##3##(1994-6#1)(2008-9#1)
by deletion of##3##3##(1992-8#1)(1994-8#1)(1995-6#1)
by deletion##6##2##(1992-8#1)(1994-6#1)(1994-8#1)(1995-6#2)(2008-9#1)
by deletions##2##2##(1997-2#1)(2009-8#1)
by delivering##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)
by dementia##2##2##(2008-5#1)(2008-7#1)
by demonstrating that##4##3##(2009-12#1)(2009-4#1)(2009-7#1)(2013-8#1)
by demonstrating the##4##3##(1995-4#1)(1996-2#1)(2007-7#1)(2011-1#1)
by demonstrating##13##2##(1990-8#1)(1991-11#1)(1993-12#1)(1995-4#1)(1996-2#1)(2007-7#1)(2008-2#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-8#1)
by denaturation and##2##3##(1997-4#1)(1997-7#1)
by denaturation##4##2##(1993-11#1)(1997-4#1)(1997-7#1)(2013-1#1)
by denaturing gradient gel electrophoresis (DGGE)##2##6##(2008-10#1)(2010-6#1)
by denaturing gradient gel electrophoresis##3##5##(2008-10#2)(2010-6#1)
by denaturing##4##2##(2008-10#3)(2010-6#1)
by dendritic##2##2##(2008-4#2)
by densitometric##2##2##(2007-11#1)(2008-10#1)
by densitometry##5##2##(1990-6#1)(1996-9#1)(2007-10#1)(2008-4#2)
by density gradient centrifugation##4##4##(1994-8#1)(1995-12#1)(2008-9#1)(2011-2#1)
by density gradient##5##3##(1993-12#1)(1994-8#1)(1995-12#1)(2008-9#1)(2011-2#1)
by density##6##2##(1993-12#1)(1994-8#2)(1995-12#1)(2008-9#1)(2011-2#1)
by dental##5##2##(2008-4#2)(2011-2#1)(2012-3#2)
by dentists##3##2##(1993-12#1)(2008-12#1)(2012-1#1)
by denying##2##2##(1993-12#1)(1996-5#1)
by depolarization##2##2##(1992-11#1)(1993-11#1)
by depolarizing##4##2##(1990-7#1)(1993-11#1)(1993-3#1)(2008-8#1)
by depositing##3##2##(2008-5#1)(2008-8#1)(2009-11#1)
by deposition of##3##3##(2007-12#1)(2008-10#2)
by deposition##5##2##(2007-12#1)(2008-10#4)
by deprivation of##2##3##(2008-11#1)(2008-7#1)
by derivative spectrophotometric##3##3##(2008-10#3)
by derivative spectrophotometry##4##3##(2008-10#4)
by derivative##10##2##(2008-10#10)
by derivatization with##3##3##(1994-9#1)(2008-11#2)
by derivatization##4##2##(1990-8#1)(1994-9#1)(2008-11#2)
by dermal application for 26 or 39 weeks##2##8##(2008-9#2)
by dermal application for 26##3##5##(2008-9#3)
by dermal application##5##3##(2008-9#5)
by dermal##6##2##(2007-9#1)(2008-9#5)
by descent##2##2##(1997-5#1)(2012-3#1)
by describing the##2##3##(2010-4#1)(2012-3#1)
by describing##6##2##(1992-2#1)(2008-6#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)
by desferrioxamine##3##2##(1990-12#1)(1991-3#1)(2008-11#1)
by design##3##2##(2006-12#1)(2008-2#1)(2011-2#1)
by designing##2##2##(2007-10#1)(2010-12#1)
by destabilizing##2##2##(1990-5#1)(2008-8#1)
by destroying the##2##3##(1990-2#1)(2010-4#1)
by detailed##5##2##(1996-12#1)(2007-12#1)(2007-7#1)(2009-3#1)(2011-2#1)
by detecting the##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2009-12#1)
by detecting##17##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2009-12#1)(2009-6#1)(2010-8#1)(2013-1#1)
by detection of human myoglobin using a double-sandwich ELISA##2##9##(1995-2#2)
by detection of the##2##4##(2007-11#1)(2008-3#1)
by detection of##14##3##(1993-9#1)(1995-2#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-9#1)
by detergent##2##2##(2008-4#2)
by determination of the##5##4##(1994-11#1)(2007-11#1)(2008-10#2)(2008-12#1)
by determination of##13##3##(1991-5#1)(1994-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
by determination##14##2##(1991-5#1)(1994-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
by determining Cr(VI)##2##3##(2008-10#2)
by determining the total##2##4##(2008-10#2)
by determining the##29##3##(1990-12#2)(1992-4#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-5#2)(2007-11#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#2)(2011-2#1)(2013-1#1)
by determining their##2##3##(2008-8#1)(2009-2#1)
by determining whether##2##3##(2008-8#1)(2009-8#1)
by determining##50##2##(1990-12#2)(1992-4#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#23)(2008-11#3)(2008-3#3)(2008-5#2)(2008-8#3)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
by deuterium NMR##2##3##(1990-12#1)(1990-7#1)
by developing a##7##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-2#1)
by developing an##2##3##(2008-3#1)(2009-12#1)
by developing##14##2##(1990-2#1)(1994-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-8#1)(2009-12#1)(2011-2#1)(2013-8#1)
by development of a##2##4##(2010-1#1)(2013-1#1)
by development of##5##3##(1992-12#1)(2007-7#1)(2010-1#1)(2013-1#2)
by deviant##2##2##(1994-12#1)(2009-2#1)
by deviations##2##2##(2008-10#1)(2008-8#1)
by dew##3##2##(2008-10#3)
by dexamethasone and##2##3##(1991-12#1)(1995-8#1)
by dexamethasone##12##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-1#2)(2008-11#1)
by diabetes mellitus##4##3##(2007-7#2)(2008-1#1)(2011-3#1)
by diabetes##6##2##(2007-7#2)(2008-1#1)(2008-4#1)(2011-3#1)(2013-1#1)
by diabetic patients##2##3##(1995-9#1)(2011-1#1)
by diabetic##7##2##(1990-5#1)(1995-9#1)(2008-5#1)(2011-1#3)(2012-12#1)
by diagnosis##2##2##(1996-7#1)(1997-1#1)
by diagnosis-related##2##2##(1991-3#1)(1992-2#1)
by diagnostic##4##2##(2008-1#1)(2008-10#3)
by dialysis and##3##3##(1993-12#1)(2007-7#1)(2008-4#1)
by dialysis##8##2##(1993-12#1)(1994-11#1)(1994-12#1)(2007-7#1)(2007-8#1)(2008-4#3)
by dibutyryl cAMP##2##3##(1991-9#1)(1996-2#1)
by dichloromethane##2##2##(2008-10#2)
by dielectric##8##2##(2007-11#2)(2008-2#1)(2008-3#4)(2013-1#1)
by diene##2##2##(1991-5#1)(1994-5#1)
by diepoxybutane##2##2##(1997-3#1)(2008-4#1)
by diet and##2##3##(1990-8#1)(1994-5#1)
by diet##6##2##(1990-8#1)(1991-2#2)(1994-5#1)(1996-7#1)(2008-5#1)
by dietary treatment##2##3##(2010-2#1)(2012-2#1)
by dietary##16##2##(1990-8#1)(1992-11#1)(1993-12#1)(1995-9#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-2#1)(2012-2#1)
by difference in##2##3##(2007-12#1)(2008-10#1)
by difference spectroscopy##2##3##(1991-3#1)(1992-11#1)
by difference##13##2##(1990-7#1)(1991-3#1)(1992-11#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-2#1)
by difference-frequency mixing##2##3##(2007-12#1)(2008-2#1)
by difference-frequency##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
by differences in their##2##4##(2008-8#2)
by differences in##13##3##(2007-11#1)(2008-10#3)(2008-8#4)(2009-12#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
by differences##16##2##(2007-11#1)(2008-10#4)(2008-8#5)(2009-12#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
by different age groups##2##4##(1993-12#1)(1995-2#1)
by different authors##4##3##(1994-3#1)(2008-10#2)(2013-1#1)
by different centers##2##3##(2012-3#2)
by different degrees of##2##4##(1991-7#1)(1994-11#1)
by different effectors##2##3##(1990-3#2)
by different experimental##2##3##(1997-2#1)(2008-10#1)
by different factors##2##3##(2010-11#1)(2010-8#1)
by different groups##2##3##(1994-11#1)(2008-7#1)
by different kinds of##2##4##(2008-3#1)(2008-4#1)
by different levels of##2##4##(2008-10#1)(2012-3#1)
by different mechanisms##6##3##(1991-1#1)(1991-5#1)(1997-8#1)(2012-1#1)(2012-3#2)
by different methods##3##3##(1990-7#1)(2008-11#1)(2008-2#1)
by different pathways##2##3##(1995-6#1)(2008-10#1)
by different regions of the##2##5##(1997-2#1)(2008-10#1)
by different strains##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
by different techniques##2##3##(2008-10#1)(2008-3#1)
by different##121##2##(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#25)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#2)
by differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
by differential absorption##3##3##(2008-2#1)(2008-3#2)
by differential and##2##3##(1990-11#1)(2008-1#1)
by differential centrifugation##2##3##(1993-8#1)(2008-10#1)
by differential display##2##3##(1994-6#1)(2008-8#1)
by differential pulse adsorptive stripping voltammetry##4##6##(2008-10#4)
by differential pulse anodic stripping voltammetry (DPASV)##3##7##(2008-10#3)
by differential pulse anodic stripping voltammetry##12##6##(2008-10#12)
by differential pulse cathodic stripping##2##5##(2008-10#2)
by differential pulse polarography (DPP)##4##5##(2008-10#4)
by differential pulse polarography##10##4##(2008-10#10)
by differential pulse stripping##2##4##(2008-10#2)
by differential pulse voltammetry##5##4##(2008-10#5)
by differential pulse##38##3##(2008-10#38)
by differential scanning calorimetry (DSC)##3##5##(1993-8#1)(2008-10#1)(2008-11#1)
by differential scanning calorimetry##9##4##(1993-8#3)(1994-3#1)(1997-2#2)(2008-10#1)(2008-11#1)(2011-2#1)
by differential##74##2##(1990-11#2)(1992-12#1)(1992-9#1)(1993-8#4)(1994-11#1)(1994-3#1)(1994-6#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#44)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#2)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
by differentiated##2##2##(1991-11#1)(1992-9#1)
by differentiating##2##2##(1990-4#1)(2012-2#1)
by differentiation##2##2##(2008-11#2)
by difficulty##2##2##(2008-9#1)(2009-5#1)
by diffraction##3##2##(2008-3#2)(2008-5#1)
by diffractive##2##2##(2007-11#1)(2008-3#1)
by diffuse reflectance##7##3##(2008-1#1)(2008-10#6)
by diffuse##10##2##(2008-1#1)(2008-10#6)(2008-3#2)(2012-3#1)
by diffusion of##2##3##(1991-5#1)(2007-12#1)
by diffusion optical tomography##2##4##(2008-3#2)
by diffusion through a##2##4##(1990-2#1)(2008-10#1)
by diffusion##12##2##(1990-12#1)(1990-2#1)(1991-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-9#1)(2012-2#1)
by digestion of the##4##4##(2008-10#3)(2008-2#1)
by digestion of##6##3##(1992-6#1)(1996-12#1)(2008-10#3)(2008-2#1)
by digestion with##8##3##(1990-2#1)(1990-5#1)(1992-6#1)(1993-11#1)(2008-1#2)(2008-5#1)(2013-8#1)
by digestion##14##2##(1990-2#1)(1990-5#1)(1992-6#2)(1993-11#1)(1996-12#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#1)(2013-8#1)
by digital image processing##2##4##(2008-11#1)(2008-2#1)
by digital image##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
by digital##11##2##(1991-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)
by diltiazem##2##2##(1990-7#1)(2008-7#1)
by dilute##2##2##(2008-10#2)
by diluting the##3##3##(1994-12#1)(2009-11#1)(2009-6#1)
by diluting##4##2##(1994-12#1)(2008-5#1)(2009-11#1)(2009-6#1)
by dilution##2##2##(1990-2#1)(2008-11#1)
by dimethyl sulfoxide##3##3##(1993-3#2)(2008-10#1)
by dimethyldioxirane##3##2##(1990-5#1)(2007-11#2)
by diminishing the##2##3##(1993-12#1)(2013-8#1)
by diminishing##3##2##(1993-12#1)(2008-4#1)(2013-8#1)
by diode laser##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
by diode##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
by dip coating with hardenable liquids##2##6##(2008-2#2)
by dip coating##3##3##(2007-12#1)(2008-2#2)
by dip##5##2##(1992-2#1)(2007-10#1)(2007-12#1)(2008-2#2)
by dipping##2##2##(2008-10#1)(2010-1#1)
by direct analysis of the##2##5##(2008-3#2)
by direct analysis of##3##4##(1993-3#1)(2008-3#2)
by direct analysis##4##3##(1993-3#1)(2008-10#1)(2008-3#2)
by direct and derivative##2##4##(2008-10#2)
by direct and##5##3##(2008-10#3)(2008-11#1)(2010-8#1)
by direct application of##2##4##(1996-2#1)(2010-4#1)
by direct chemiluminescence##2##3##(2008-10#2)
by direct contact##2##3##(1995-11#1)(2008-10#1)
by direct detection##2##3##(2007-11#1)(2007-12#1)
by direct electron-beam##2##3##(2008-2#1)(2008-3#1)
by direct extraction of##2##4##(2008-10#1)(2011-2#1)
by direct immunofluorescence##2##3##(2007-10#1)(2012-3#1)
by direct injection of##2##4##(1990-8#1)(1992-11#1)
by direct injection##3##3##(1990-8#1)(1992-11#1)(2008-10#1)
by direct interaction##2##3##(1993-8#2)
by direct introduction##2##3##(1991-11#1)(2008-10#1)
by direct irradiation##2##3##(1991-8#1)(2008-2#1)
by direct measurement of##2##4##(2008-10#1)(2008-4#1)
by direct measurement##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
by direct microscopy##2##3##(2007-7#1)(2008-12#1)
by direct observations in the##2##5##(2007-10#2)
by direct protein##2##3##(1991-6#1)(2008-9#1)
by direct sequencing##2##3##(1992-8#1)(1994-12#1)
by direct visualization of##2##4##(1992-9#1)(1995-2#1)
by direct##112##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
by directed##2##2##(2008-8#1)(2008-9#1)
by directing##3##2##(1995-5#1)(2009-3#1)(2011-1#1)
by directly measuring the##2##4##(1991-3#1)(2008-10#1)
by directly##11##2##(1991-3#1)(1991-7#1)(1991-9#1)(1993-12#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
by disability##2##2##(1992-3#1)(2007-11#1)
by disc diffusion method##2##4##(2010-3#1)(2012-3#1)
by disc diffusion##3##3##(2010-3#1)(2012-3#2)
by discharge##2##2##(2007-10#1)(2008-11#1)
by discriminant function analysis##2##4##(1992-11#1)(1995-6#1)
by discriminant function##3##3##(1992-11#1)(1993-5#1)(1995-6#1)
by discriminant##4##2##(1991-12#1)(1992-11#1)(1993-5#1)(1995-6#1)
by discussing the##6##3##(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-3#1)
by discussing##12##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
by disease##5##2##(1994-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
by diseases##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
by disk##2##2##(2007-10#1)(2008-5#1)
by disodium##2##2##(2008-10#1)(2008-7#1)
by dispersal##2##2##(2008-8#1)(2008-9#1)
by dispersing##2##2##(2007-12#1)(2011-2#1)
by dispersion##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
by displacement of##3##3##(1995-12#2)(2008-2#1)
by disrupting the##2##3##(2008-10#1)(2008-7#1)
by disrupting##6##2##(1990-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
by disruption of##2##3##(1994-8#1)(2008-10#1)
by dissection##3##2##(2007-12#1)(2009-2#1)(2011-1#1)
by dissolution##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
by dissolved oxygen##2##3##(2008-10#2)
by dissolved##3##2##(2008-10#3)
by dissolving##9##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2012-2#1)
by distal##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
by distance among##2##3##(2009-2#2)
by distance##20##2##(1995-6#1)(2008-10#9)(2008-8#1)(2008-9#2)(2009-2#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
by distillation in the presence of##2##6##(2008-10#2)
by distillation##5##2##(2008-10#4)(2008-4#1)
by distinct##10##2##(1990-5#1)(1992-9#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-2#1)
by distinctive##2##2##(1996-2#1)(2007-12#1)
by disulfide##2##2##(1990-5#1)(1994-8#1)
by dithiothreitol##2##2##(1991-5#1)(1993-6#1)
by divalent cations##2##3##(1990-7#1)(1993-6#1)
by diverse##7##2##(1992-5#1)(1996-6#1)(2008-10#3)(2008-4#1)(2013-1#1)
by dividing##4##2##(1993-6#1)(2008-12#1)(2008-8#1)(2008-9#1)
by docking##3##2##(1991-6#1)(1992-3#1)(2013-8#1)
by doctor##2##2##(1995-6#1)(1997-2#1)
by doctors##7##2##(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-12#1)
by dog##2##2##(2008-10#1)(2013-1#1)
by doing##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
by domain##2##2##(2007-12#1)(2010-12#1)
by domestic##2##2##(1995-3#1)(2008-7#1)
by dominance##2##2##(2008-4#2)
by dominant negative##2##3##(1995-11#2)
by dominant##3##2##(1995-11#2)(2007-11#1)
by donor##4##2##(2007-8#1)(2008-9#2)(2009-9#1)
by donors##5##2##(1995-9#1)(1997-7#1)(2008-10#1)(2008-12#1)(2012-12#1)
by dopamine##3##2##(1993-5#1)(2008-10#1)(2008-7#1)
by dopaminergic##4##2##(1995-11#1)(1995-12#1)(1996-2#1)(2013-1#1)
by doping##6##2##(2008-10#2)(2008-3#2)(2009-11#1)(2013-8#1)
by dorsal##3##2##(1996-5#1)(2008-7#1)(2010-8#1)
by dose##3##2##(2008-10#3)
by double photon absorptiometry##2##4##(1991-11#2)
by double##7##2##(1990-12#1)(1991-11#2)(1993-8#1)(1996-5#1)(2008-10#2)
by double-antibody sandwich##2##3##(2008-10#2)
by double-antibody##3##2##(2008-10#3)
by down-regulating##2##2##(2008-11#1)(2012-3#1)
by downregulating the expression of##2##5##(2009-8#1)(2012-12#1)
by downregulating##5##2##(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
by doxorubicin treatment##2##3##(2011-2#2)
by doxorubicin##6##2##(1991-6#1)(2011-2#5)
by doxycycline]##2##2##(1997-5#1)(2009-5#1)
by drainage##2##2##(1991-3#1)(2007-8#1)
by dramatic##2##2##(1991-3#1)(2008-8#1)
by drawing and discharging##2##4##(2008-10#2)
by drawing##4##2##(1995-8#1)(2008-10#2)(2011-2#1)
by drilling##2##2##(2007-12#1)(2008-2#1)
by drinking water##3##3##(2007-2#1)(2008-9#2)
by drive-netting##2##2##(2009-4#2)
by dropping##2##2##(2009-12#1)(2009-5#1)
by drought##2##2##(2008-8#1)(2012-6#1)
by drug##7##2##(1990-9#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-4#1)(2008-10#1)(2013-8#1)
by drugs##12##2##(1990-11#1)(1990-9#1)(1994-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
by dry ashing##2##3##(2008-10#2)
by dry periods##2##3##(2008-10#2)
by dry##6##2##(2007-12#1)(2008-10#4)(2008-6#1)
by drying##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
by dual energy##2##3##(2008-5#1)(2008-7#1)
by dual photon absorptiometry##2##4##(1991-11#2)
by dual##8##2##(1990-8#1)(1991-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
by dual-channel##2##2##(2007-11#1)(2010-5#1)
by dual-energy##2##2##(2008-8#1)(2011-2#1)
by dual-wavelength##2##2##(2008-10#1)(2009-12#1)
by duplication of##2##3##(1995-6#1)(2007-9#1)
by duplication##4##2##(1995-6#2)(2007-9#1)(2008-10#1)
by dye##2##2##(2008-10#1)(2008-9#1)
by dynamic light scattering##4##4##(2007-11#1)(2008-10#1)(2009-9#1)(2013-7#1)
by dynamic##9##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
by each State##2##3##(1992-3#1)(1996-1#1)
by each other##2##3##(2008-3#1)(2013-1#1)
by each sample##2##3##(2008-10#1)(2008-4#1)
by each sponsor sector##2##4##(1991-12#1)(1994-1#1)
by each##42##2##(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-9#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
by earlier##4##2##(1992-3#1)(2007-10#1)(2008-7#1)(2013-1#1)
by early diagnosis##2##3##(1992-9#1)(2013-1#1)
by early##18##2##(1990-12#1)(1990-9#1)(1992-1#1)(1992-6#1)(1992-9#2)(1994-3#1)(1994-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
by echocardiography and the##2##4##(2008-11#2)
by echocardiography and##8##3##(1991-9#1)(1996-6#1)(2007-8#1)(2008-11#2)(2011-2#1)(2012-3#2)
by echocardiography##22##2##(1991-9#1)(1995-3#1)(1996-6#2)(1997-3#1)(1997-8#2)(2007-8#4)(2008-10#1)(2008-11#5)(2010-4#1)(2011-2#2)(2012-3#2)
by ecological and##2##3##(2008-8#1)(2008-9#1)
by ecological##5##2##(2008-8#2)(2008-9#1)(2010-10#1)(2012-3#1)
by economic##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
by educating##2##2##(1990-9#1)(2010-9#1)
by education and##2##3##(1995-12#1)(1995-3#1)
by education##3##2##(1995-12#1)(1995-3#1)(2009-10#1)
by effective##2##2##(1993-1#1)(2007-11#1)
by effervescent method##3##3##(2010-3#3)
by eight##3##2##(1990-5#1)(1994-12#1)(2008-10#1)
by either C##2##3##(2008-10#2)
by either a##8##3##(1992-1#1)(1994-5#1)(1996-4#1)(2007-12#1)(2008-10#3)(2013-8#1)
by either an##3##3##(1994-5#1)(2008-7#1)(2011-1#1)
by either direct##2##3##(2008-5#1)(2009-9#1)
by either of the##2##4##(1993-11#1)(2008-10#1)
by either the##5##3##(1992-6#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-3#1)
by either##90##2##(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#2)(1995-2#4)(1995-6#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#2)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#6)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-10#1)(2012-12#1)(2012-2#1)(2013-8#2)
by elastic##2##2##(2012-2#2)
by elastin##2##2##(2008-5#1)(2008-7#1)
by elderly patients##2##3##(1993-11#1)(2007-8#1)
by elective cesarean section##3##4##(1997-8#1)(2011-2#2)
by electric##6##2##(1990-7#1)(1994-8#1)(1997-6#2)(2008-10#1)(2012-2#1)
by electrical stimulation of the##10##5##(1992-11#1)(1992-3#1)(1993-12#5)(1996-2#1)(2010-7#2)
by electrical stimulation of##12##4##(1992-11#1)(1992-3#1)(1993-12#5)(1995-12#1)(1996-2#2)(2010-7#2)
by electrical stimulation##17##3##(1992-11#1)(1992-3#1)(1993-12#5)(1995-12#2)(1996-2#2)(1997-6#1)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#1)
by electrical##29##2##(1991-5#1)(1992-11#1)(1992-3#1)(1993-12#5)(1995-12#2)(1996-2#2)(1996-5#1)(1997-6#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#3)
by electro-optic sampling##2##3##(2007-11#1)(2008-2#1)
by electro-optic##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
by electroacupuncture##4##2##(1995-12#1)(1996-12#2)(2010-7#1)
by electroantennography##2##2##(2008-10#2)
by electrochemical and##2##3##(2008-10#2)
by electrochemical deposition of##2##4##(2008-10#1)(2010-4#1)
by electrochemical deposition##4##3##(2008-10#3)(2010-4#1)
by electrochemical impedance##2##3##(2008-10#2)
by electrochemical method##3##3##(2008-10#2)(2013-1#1)
by electrochemical##16##2##(1993-12#1)(2007-12#1)(2008-10#12)(2010-4#1)(2013-1#1)
by electrochemically##2##2##(2008-10#2)
by electrodeposition of##4##3##(2008-10#3)(2010-4#1)
by electrodeposition##6##2##(2008-10#5)(2010-4#1)
by electrolysis##2##2##(2008-10#1)(2008-11#1)
by electron and##2##3##(2008-10#1)(2010-7#1)
by electron beam evaporation##3##4##(2008-10#3)
by electron beam irradiation##5##4##(1991-6#1)(1994-11#2)(2008-11#1)(2009-7#1)
by electron beam##9##3##(1991-6#1)(1994-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2009-7#1)
by electron microscopy and X-ray##2##5##(2008-10#1)(2008-5#1)
by electron microscopy and##5##4##(1994-11#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
by electron microscopy showed##2##4##(1997-3#1)(2009-8#1)
by electron microscopy##24##3##(1990-2#1)(1991-2#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2012-3#1)
by electron paramagnetic resonance spectroscopy##2##5##(1993-11#1)(1997-1#1)
by electron paramagnetic resonance##3##4##(1990-12#1)(1993-11#1)(1997-1#1)
by electron spin resonance##2##4##(2008-10#1)(2008-5#1)
by electron##45##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-11#3)(1995-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2009-7#1)(2009-8#1)(2010-7#1)(2012-3#1)
by electron-beam evaporation##2##3##(2008-3#2)
by electron-beam##4##2##(2008-2#1)(2008-3#3)
by electronic##9##2##(1990-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)(2009-1#1)
by electrophoresis and##4##3##(2008-10#2)(2008-2#1)(2013-8#1)
by electrophoresis in##3##3##(1995-6#1)(1996-5#1)(2008-9#1)
by electrophoresis##15##2##(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-8#1)
by electrophoretic mobility shift##3##4##(2008-11#2)(2008-9#1)
by electrophoretic mobility##4##3##(1995-11#1)(2008-11#2)(2008-9#1)
by electrophoretic##7##2##(1991-2#1)(1995-11#1)(2008-11#3)(2008-4#1)(2008-9#1)
by electrophysiological##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
by electropolymerization of##5##3##(2008-10#5)
by electropolymerization##6##2##(2008-10#6)
by electroporation of##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
by electroporation##14##2##(1990-5#1)(1994-2#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#3)(2009-11#1)
by electrospinning##2##2##(2012-1#2)
by electrospray ionization mass spectrometry##2##5##(1990-12#1)(1995-2#1)
by electrospray ionization##4##3##(1990-12#1)(1995-2#1)(2010-11#1)(2011-1#1)
by electrospray ionization-ion##2##3##(2008-10#2)
by electrospray mass spectrometry##2##4##(2008-10#2)
by electrospray##9##2##(1990-12#1)(1995-2#1)(1995-5#1)(2008-10#4)(2010-11#1)(2011-1#1)
by electrostatic##6##2##(1990-12#1)(2008-10#2)(2008-11#1)(2009-5#1)(2012-2#1)
by electrothermal atomic absorption spectrometry (ETAAS) was##2##7##(2008-10#2)
by electrothermal atomic absorption spectrometry (ETAAS)##14##6##(2008-10#14)
by electrothermal atomic absorption spectrometry after complexation and sorption on##2##10##(2008-10#2)
by electrothermal atomic absorption spectrometry after##5##6##(2008-10#5)
by electrothermal atomic absorption spectrometry in##2##6##(2008-10#2)
by electrothermal atomic absorption spectrometry using permanent modifiers##2##8##(2008-10#2)
by electrothermal atomic absorption spectrometry using##7##6##(2008-10#7)
by electrothermal atomic absorption spectrometry with##3##6##(2008-10#3)
by electrothermal atomic absorption spectrometry##54##5##(1995-6#1)(2008-10#53)
by electrothermal atomic absorption spectroscopy##3##5##(2008-10#3)
by electrothermal atomic absorption##59##4##(1995-6#1)(2008-10#58)
by electrothermal atomization absorption spectrometry##2##5##(2008-10#2)
by electrothermal atomization##4##3##(2008-10#4)
by electrothermal vaporization inductively coupled plasma mass spectrometry##3##8##(2008-10#3)
by electrothermal vaporization##6##3##(2008-10#6)
by electrothermal##70##2##(1995-6#1)(2008-10#69)
by elemental analyses##3##3##(2007-11#1)(2008-5#1)(2011-1#1)
by elemental analysis and##2##4##(1996-2#1)(2007-11#1)
by elemental analysis##10##3##(1996-2#2)(2007-11#1)(2008-10#7)
by elemental##14##2##(1996-2#2)(2007-11#2)(2008-10#8)(2008-5#1)(2011-1#1)
by elevated levels of##3##4##(1996-12#1)(1997-4#1)(2008-7#1)
by elevated plasma##2##3##(1994-5#1)(1994-8#1)
by elevated##9##2##(1994-5#1)(1994-8#1)(1996-12#1)(1997-4#1)(2008-7#3)(2011-2#1)(2013-8#1)
by elevating the##2##3##(1996-2#1)(2008-10#1)
by elevation of##2##3##(1992-3#1)(2007-12#1)
by eliciting##4##2##(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#1)
by eliminating the need##2##4##(2008-10#1)(2008-4#1)
by eliminating the##9##3##(1996-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)
by eliminating##12##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2011-2#1)
by elimination of##2##3##(2008-10#1)(2008-3#1)
by ellipsometry##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
by eluting the##2##3##(2008-10#2)
by eluting##4##2##(2008-10#4)
by elution with##7##3##(1994-6#1)(2008-10#6)
by elution##10##2##(1994-6#1)(2008-10#9)
by email##3##2##(1996-8#1)(2009-2#1)(2011-2#1)
by embolization##4##2##(1992-9#1)(2008-7#2)(2013-1#1)
by emerging##3##2##(2008-8#1)(2010-12#1)(2012-2#1)
by emotional##2##2##(1990-11#1)(2008-11#1)
by emphasizing##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
by empirical##2##2##(2008-3#1)(2011-2#1)
by employing a##12##3##(1990-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)(2012-2#1)
by employing an##4##3##(1995-8#1)(2008-10#2)(2009-11#1)
by employing different##2##3##(2008-5#1)(2008-8#1)
by employing the##9##3##(1992-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)
by employing two##2##3##(2008-1#1)(2008-7#1)
by employing##54##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#3)
by employment of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
by emulsion##3##2##(2008-8#1)(2010-5#1)(2011-3#1)
by encoding##2##2##(1997-3#1)(1997-5#1)
by encouraging##3##2##(1996-1#1)(2007-2#1)(2009-3#1)
by end##2##2##(2008-10#1)(2008-3#1)
by endocrine##2##2##(1993-12#1)(2008-1#1)
by endogenous components##2##3##(2008-8#1)(2010-11#1)
by endogenous processes##2##3##(2008-7#2)
by endogenous##15##2##(1992-12#1)(1992-8#2)(1994-3#1)(1996-10#1)(2008-1#1)(2008-11#3)(2008-7#3)(2008-8#2)(2010-11#1)
by endogenously##2##2##(1995-12#1)(2009-10#1)
by endoscopic##12##2##(1992-7#1)(1996-3#1)(1997-8#1)(2007-10#1)(2008-12#2)(2008-5#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
by endoscopy##3##2##(1990-9#1)(2011-2#1)(2013-8#1)
by endothelial cells and##3##4##(1995-12#2)(2012-1#1)
by endothelial cells##7##3##(1992-10#1)(1993-3#1)(1994-6#1)(1995-12#2)(2008-11#1)(2012-1#1)
by endothelial##10##2##(1991-9#1)(1992-10#1)(1993-3#1)(1994-6#1)(1995-12#2)(2008-11#1)(2008-4#2)(2012-1#1)
by endothelin-1##4##2##(1991-12#1)(1994-8#1)(1995-12#2)
by endovascular##3##2##(1997-6#1)(2013-1#1)(2013-7#1)
by energy dispersive X-ray fluorescence spectrometry##2##6##(2008-10#2)
by energy dispersive X-ray fluorescence##4##5##(2008-10#4)
by energy##10##2##(1992-4#1)(2007-12#1)(2008-10#5)(2008-5#1)(2012-2#1)(2013-1#1)
by engineers##2##2##(2007-12#1)(2008-8#1)
by enhanced##10##2##(1991-4#1)(1996-5#1)(1996-9#1)(2008-10#2)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#2)
by enhancing the##3##3##(2008-10#1)(2010-11#1)(2010-8#1)
by enhancing##9##2##(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#2)(2010-8#1)(2012-2#1)
by ensuring the##2##3##(2010-6#1)(2010-8#1)
by ensuring##5##2##(1996-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)
by entrapment##3##2##(1992-11#1)(2008-10#2)
by environment##2##2##(2008-5#1)(2013-1#1)
by environmental and##2##3##(2008-10#1)(2008-6#1)
by environmental changes##2##3##(2009-8#1)(2011-2#1)
by environmental covariances##3##3##(2008-8#3)
by environmental factors##6##3##(2008-10#2)(2009-8#1)(2012-2#1)(2013-1#2)
by environmental##24##2##(1995-11#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-6#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
by enzymatic assay##2##3##(1993-3#1)(2008-10#1)
by enzymatic digestion##2##3##(1990-5#2)
by enzymatic hydrolysis##3##3##(1990-7#1)(2008-10#1)(2008-6#1)
by enzymatic##17##2##(1990-5#2)(1990-7#1)(1990-8#1)(1993-3#2)(1993-8#1)(1994-8#1)(2008-10#4)(2008-4#2)(2008-6#1)(2008-7#1)(2013-1#1)
by enzyme immunoassay##3##3##(1993-9#1)(1995-9#1)(2008-10#1)
by enzyme linked immunosorbent assay (ELISA)##2##6##(1993-3#1)(2008-1#1)
by enzyme##14##2##(1990-5#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-9#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)
by enzyme-linked immunosorbent assay (ELISA)##2##5##(1997-6#1)(2008-10#1)
by enzyme-linked immunosorbent assay using##3##5##(2008-10#2)(2010-4#1)
by enzyme-linked immunosorbent assay##16##4##(1990-5#1)(1997-6#1)(2008-10#10)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#1)
by enzyme-linked##17##2##(1990-5#1)(1997-6#1)(2008-10#10)(2009-5#1)(2010-4#1)(2011-2#2)(2012-3#1)
by enzymes in##2##3##(2008-10#1)(2010-12#1)
by enzymes##5##2##(1990-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)
by eosin Y##2##3##(2008-10#2)
by eosin##3##2##(2008-10#2)(2009-10#1)
by epifluorescence microscopy##3##3##(2008-10#2)(2008-8#1)
by epifluorescence##4##2##(2008-1#1)(2008-10#2)(2008-8#1)
by epigenetic##2##2##(2009-4#1)(2012-12#1)
by episodes of##3##3##(1997-8#1)(2011-2#1)(2012-3#1)
by epithelial cells##2##3##(1997-5#1)(2010-3#1)
by equilibrium##5##2##(1990-7#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-4#1)
by established##2##2##(1997-2#1)(2008-5#1)
by establishing a##6##3##(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
by establishing##10##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
by esterification##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
by estimating the##4##3##(1991-2#1)(1995-12#1)(2009-9#1)(2010-8#1)
by estimating##5##2##(1991-2#1)(1995-12#1)(2008-10#1)(2009-9#1)(2010-8#1)
by estimation of##2##3##(2011-1#1)(2012-3#1)
by estradiol and##2##3##(1991-12#1)(1992-4#1)
by estradiol##4##2##(1990-5#1)(1991-12#1)(1992-4#1)(1994-3#1)
by estrogen##11##2##(1992-9#1)(1995-11#1)(2008-11#7)(2008-5#1)(2008-6#1)
by estrogens in##2##3##(1990-5#2)
by etching##2##2##(2008-3#2)
by ethanol and##2##3##(1995-5#1)(2008-6#1)
by ethanol##10##2##(1990-11#1)(1995-5#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-8#1)
by ethyl acetate##2##3##(1992-9#1)(2008-10#1)
by ethyl##3##2##(1992-9#1)(1996-2#1)(2008-10#1)
by ethylene##2##2##(2008-10#1)(2009-8#1)
by evaluating disease suppression##2##4##(2008-10#2)
by evaluating disease##3##3##(2008-10#3)
by evaluating several parameters##2##4##(2008-5#1)(2013-1#1)
by evaluating the##6##3##(1993-6#1)(2008-10#3)(2008-11#1)(2009-2#1)
by evaluating their##2##3##(2008-11#1)(2008-5#1)
by evaluating##23##2##(1990-12#1)(1991-5#1)(1993-6#1)(1994-9#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2009-2#1)(2009-4#1)(2012-3#1)(2013-1#1)
by evaluation of dental arch relationships in##2##7##(2011-2#2)
by evaluation of the##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
by evaluation of##7##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#2)
by evaporation##2##2##(1995-3#1)(2008-10#1)
by events##3##2##(1996-4#1)(1997-6#1)(2012-12#1)
by every 0##4##3##(2013-1#4)
by every##5##2##(2008-11#1)(2013-1#4)
by evolutionary##2##2##(2008-10#1)(2008-8#1)
by evolving factor analysis (EFA)##2##5##(2008-10#2)
by evolving##3##2##(2008-10#2)(2012-2#1)
by exacerbating##2##2##(1993-12#1)(2012-12#1)
by examination of##4##3##(1997-5#1)(2008-3#1)(2008-7#1)(2008-8#1)
by examining its##3##3##(1993-2#1)(1996-3#1)(2011-2#1)
by examining the effects of##2##5##(1992-6#1)(1994-3#1)
by examining the##15##3##(1992-6#1)(1993-5#1)(1994-3#1)(1996-7#1)(1997-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-8#1)(2013-1#1)
by examining their##2##3##(2010-9#1)(2011-2#1)
by examining whether##2##3##(1993-3#1)(1995-12#1)
by examining##44##2##(1990-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)
by example##2##2##(1996-3#1)(2012-2#1)
by examples from##2##3##(1992-2#1)(2008-9#1)
by examples##3##2##(1992-2#1)(2007-6#1)(2008-9#1)
by excess##3##2##(1995-3#1)(2007-12#1)(2008-4#1)
by excessive##4##2##(2007-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
by exchanging##3##2##(1995-2#1)(2008-10#2)
by excision and##2##3##(2008-4#1)(2013-1#1)
by excision##3##2##(2008-4#1)(2009-5#1)(2013-1#1)
by excitation##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
by excluding##2##2##(2008-9#1)(2012-2#1)
by exclusion##5##2##(1992-11#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-2#1)
by excreting##2##2##(2008-11#1)(2013-1#1)
by executives##3##2##(1994-3#1)(1995-1#1)(1995-12#1)
by exercise##6##2##(1990-3#1)(2008-12#1)(2008-7#1)(2013-1#2)(2013-8#1)
by exerting##2##2##(1995-12#1)(2008-4#1)
by existing##3##2##(1994-12#1)(2007-11#1)(2008-11#1)
by exogenous Mg(2+)##2##3##(2008-8#2)
by exogenous application of##2##4##(2008-5#1)(2010-3#1)
by exogenous##19##2##(1990-2#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2010-3#1)(2013-7#1)
by exon##3##2##(1991-2#1)(1993-6#1)(1997-9#1)
by expanding##2##2##(1992-3#1)(2012-2#1)
by expansion of the##2##4##(1993-1#1)(2010-8#1)
by expansion##3##2##(1993-1#1)(1994-11#1)(2010-8#1)
by experienced##8##2##(1994-2#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#2)(2013-8#1)
by experiment##9##2##(2008-10#1)(2008-2#1)(2008-3#7)
by experimental and##3##3##(1992-11#1)(2008-10#1)(2012-5#1)
by experimental data##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)
by experimental design##2##3##(2008-10#2)
by experimental results##4##3##(2008-2#1)(2008-3#3)
by experimental##22##2##(1992-11#1)(1993-6#1)(1993-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#1)(2009-5#1)(2012-5#1)
by experiments in##2##3##(2008-11#1)(2013-1#1)
by experiments##10##2##(1994-11#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#3)(2013-1#1)
by expert##3##2##(1993-12#1)(1994-3#1)(2010-6#1)
by experts##6##2##(1991-3#1)(2008-10#2)(2009-8#1)(2011-2#2)
by explaining##2##2##(1992-1#1)(2008-12#1)
by explicitly##3##2##(1995-6#1)(2008-3#1)(2008-9#1)
by exploiting a##2##3##(2008-2#2)
by exploiting the##5##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
by exploiting##10##2##(2006-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2010-3#1)
by exploring the##5##3##(1995-2#1)(2008-10#1)(2008-8#1)(2010-3#1)(2012-12#1)
by exploring##6##2##(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-12#1)
by exponential##3##2##(2008-3#1)(2008-4#1)(2008-9#1)
by exposing plants to##2##4##(2008-10#1)(2011-10#1)
by exposing the animals##2##4##(1997-4#1)(2013-1#1)
by exposing the##4##3##(1995-12#1)(1997-4#1)(2008-11#1)(2013-1#1)
by exposing##13##2##(1990-2#1)(1992-11#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2011-10#1)(2012-2#1)(2013-1#1)
by exposure of cells to##3##5##(1994-12#1)(1997-4#2)
by exposure of the cells to##2##6##(1990-5#1)(1992-3#1)
by exposure of the##3##4##(1990-5#1)(1992-3#1)(2007-12#1)
by exposure of##9##3##(1990-5#1)(1992-3#1)(1994-12#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
by exposure to 4 mol/l MgCl2##2##6##(1995-12#2)
by exposure to 4##3##4##(1995-12#2)(2008-7#1)
by exposure to UV light##2##5##(1994-6#2)
by exposure to a##2##4##(2008-3#1)(2008-6#1)
by exposure to alkaline##2##4##(1995-11#1)(1995-2#1)
by exposure to low temperature##2##5##(2008-11#2)
by exposure to##29##3##(1990-8#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)
by exposure##40##2##(1990-5#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-4#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)
by expressing##7##2##(1992-9#1)(1993-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
by expression of##3##3##(1994-11#1)(1994-12#1)(2008-8#1)
by expression studies##2##3##(2008-8#1)(2012-2#1)
by expression##9##2##(1993-3#1)(1994-11#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-3#1)(2012-2#1)
by extended##6##2##(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#2)(2012-3#1)
by extending the##2##3##(1992-9#1)(2008-11#1)
by extending##5##2##(1992-9#1)(1997-7#1)(2007-11#1)(2008-11#1)(2009-9#1)
by extension of the##2##4##(2008-3#1)(2008-5#1)
by extension##4##2##(1995-9#1)(2008-1#1)(2008-3#1)(2008-5#1)
by extensive##11##2##(1992-8#1)(1992-9#1)(1997-2#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-6#1)
by external calibration##2##3##(2008-10#2)
by external fixation##2##3##(2007-11#1)(2008-9#1)
by external##27##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1992-9#1)(1993-11#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-8#2)
by externally##2##2##(2008-8#1)(2011-2#1)
by extinction##3##2##(1992-12#1)(1993-6#1)(2008-3#1)
by extracellular matrix##3##3##(1993-8#1)(2008-11#1)(2012-3#1)
by extracellular nucleotides##4##3##(2008-4#4)
by extracellular##21##2##(1992-12#2)(1992-6#1)(1993-8#1)(2008-11#2)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
by extracting##5##2##(1996-12#1)(2008-10#3)(2008-9#1)
by extraction and##2##3##(2008-10#2)
by extraction chromatography##2##3##(2008-10#2)
by extraction in##2##3##(2008-10#1)(2009-8#1)
by extraction into##3##3##(2008-10#3)
by extraction of the##4##4##(1992-3#1)(2008-10#1)(2008-3#2)
by extraction of##6##3##(1992-3#1)(1996-12#1)(2008-10#1)(2008-3#2)(2008-4#1)
by extraction using##2##3##(2008-10#2)
by extraction with##4##3##(1996-2#1)(2008-10#3)
by extraction##26##2##(1992-3#1)(1996-12#1)(1996-2#1)(2008-10#18)(2008-3#2)(2008-4#1)(2009-8#1)(2013-1#1)
by extractive##4##2##(1994-11#1)(2008-10#2)(2011-2#1)
by extrapolation##3##2##(1992-6#1)(2008-10#2)
by extreme##3##2##(1991-2#1)(1996-12#1)(2010-4#1)
by extrinsic##2##2##(1994-3#1)(2011-2#1)
by extrusion##2##2##(1996-5#1)(2012-3#1)
by eye##3##2##(2008-11#1)(2010-8#1)(2013-7#1)
by fMLP##3##2##(1994-11#1)(1995-6#1)(1996-2#1)
by fabrication##2##2##(2008-2#1)(2008-3#1)
by face-to-face##3##2##(1996-5#1)(2007-9#1)(2011-1#1)
by facilitating the##5##3##(1992-10#1)(1993-8#1)(1996-12#1)(2008-11#1)(2008-5#1)
by facilitating##9##2##(1992-10#1)(1993-8#1)(1996-12#1)(2008-11#3)(2008-5#1)(2011-1#1)(2013-7#1)
by factor VIII##2##3##(2008-12#1)(2008-9#1)
by factor analysis and##2##4##(2008-10#1)(2012-1#1)
by factor analysis##3##3##(2008-10#2)(2012-1#1)
by factor##9##2##(1991-3#1)(1991-9#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-1#1)
by factorial design##3##3##(2008-10#3)
by factorial##4##2##(2008-10#4)
by factors of##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
by factors such as##4##4##(1990-3#1)(1995-3#1)(2008-11#1)(2012-12#1)
by factors that##2##3##(1991-8#1)(1997-2#1)
by factors##14##2##(1990-3#1)(1991-8#1)(1992-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
by failure to##2##3##(1991-3#1)(2007-7#1)
by familial##4##2##(1990-6#1)(1991-1#1)(1993-12#1)(2011-2#1)
by family physicians##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
by family##13##2##(1991-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)
by far exceeds the##2##4##(2008-2#1)(2013-1#1)
by far less##2##3##(2008-3#1)(2011-1#1)
by far the highest##2##4##(2007-12#1)(2012-2#1)
by far the most##2##4##(1994-11#1)(2010-12#1)
by far the##10##3##(1990-5#1)(1993-1#1)(1994-11#1)(1996-9#1)(2007-12#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-2#1)
by far too##2##3##(2008-11#1)(2008-8#1)
by far##20##2##(1990-5#1)(1990-6#1)(1993-1#1)(1994-11#1)(1995-5#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
by farmers##2##2##(1997-7#1)(2011-1#1)
by fast atom bombardment##2##4##(1991-2#1)(1994-3#1)
by fast##7##2##(1991-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
by fasting##3##2##(1991-7#1)(2008-3#2)
by fatty acids##6##3##(1992-8#1)(1993-11#1)(1993-9#2)(1996-3#1)(2008-10#1)
by fatty##7##2##(1992-8#1)(1993-11#1)(1993-9#2)(1996-3#1)(2008-10#2)
by favourable##2##2##(2012-2#1)(2013-8#1)
by federal##3##2##(1996-12#1)(1996-2#1)(2011-2#1)
by feedback-based flow ratiometry##2##4##(2008-10#2)
by feeding##9##2##(1990-5#1)(1992-9#1)(1993-12#1)(1996-9#1)(1997-1#1)(2008-10#3)(2010-2#1)
by female##4##2##(1995-12#1)(2008-8#1)(2009-9#1)(2011-1#1)
by females of the##2##4##(1997-4#1)(2013-1#1)
by females##11##2##(1997-4#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#4)(2012-12#1)(2012-3#1)(2013-1#1)
by femtosecond laser##2##3##(2007-11#2)
by femtosecond pulses##2##3##(2007-11#2)
by femtosecond##10##2##(2007-11#6)(2007-12#3)(2008-2#1)
by ferricyanide##2##2##(1992-11#1)(2008-10#1)
by fetal blood sampling##2##4##(1990-9#1)(1996-3#1)
by fetal##7##2##(1990-9#2)(1991-2#1)(1994-3#1)(1994-9#1)(1996-3#1)(2012-3#1)
by fever##3##2##(1994-9#1)(2009-11#1)(2013-8#1)
by feverfew extracts##2##3##(2008-10#2)
by feverfew##3##2##(2008-10#3)
by fiber##2##2##(2008-2#1)(2008-3#1)
by fibrin##3##2##(1991-9#1)(1994-5#1)(1997-4#1)
by fibroblasts##3##2##(1992-3#1)(1994-11#1)(1995-12#1)
by fibrous tissue##2##3##(1990-3#1)(1997-5#1)
by fibrous##3##2##(1990-3#1)(1997-5#1)(2010-12#1)
by field##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)
by filamentous fungi##2##3##(1997-7#1)(2008-5#1)
by filling the##2##3##(2008-10#1)(2008-2#1)
by filling##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
by filter##2##2##(1993-8#1)(2010-10#1)
by filtering the##2##3##(2007-11#1)(2008-3#1)
by filtering##5##2##(1992-3#1)(2007-11#1)(2008-10#2)(2008-3#1)
by filtration##6##2##(1990-8#1)(1992-11#1)(1992-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
by financial##2##2##(1992-3#1)(1994-3#1)
by finding the##3##3##(1992-12#1)(2008-11#1)(2012-12#1)
by finding##8##2##(1992-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#1)(2012-12#1)
by fine needle aspiration cytology##3##5##(1990-6#1)(2010-8#1)(2013-8#1)
by fine needle aspiration##5##4##(1990-6#1)(1991-6#2)(2010-8#1)(2013-8#1)
by fine##6##2##(1990-6#1)(1991-6#2)(2008-3#1)(2010-8#1)(2013-8#1)
by fire##5##2##(1996-12#1)(2009-10#4)
by firing##2##2##(2007-8#1)(2008-1#1)
by first##13##2##(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
by first-derivative##2##2##(2008-10#2)
by fitting of##2##3##(2007-12#1)(2008-3#1)
by fitting the data##4##4##(1990-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
by fitting the##13##3##(1990-8#1)(2008-10#5)(2008-2#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)
by fitting##25##2##(1990-8#1)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-8#1)
by five replicate##2##3##(2008-10#2)
by five##20##2##(1992-12#1)(1992-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-3#1)(2013-1#1)
by fixed##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
by fixing the##2##3##(1991-11#1)(2013-1#1)
by fixing##4##2##(1991-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
by flame AAS##9##3##(2008-10#9)
by flame atomic absorption spectrometry (FAAS) and##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) in##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) is##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) was##2##7##(2008-10#2)
by flame atomic absorption spectrometry (FAAS)##32##6##(2008-10#32)
by flame atomic absorption spectrometry##72##5##(2008-10#72)
by flame atomic absorption spectrophotometry (FAAS)##2##6##(2008-10#2)
by flame atomic absorption spectrophotometry after preconcentration##2##7##(2008-10#2)
by flame atomic absorption spectrophotometry##6##5##(2008-10#6)
by flame atomic absorption##81##4##(2008-10#81)
by flame atomic##84##3##(2008-10#84)
by flame##97##2##(2008-10#97)
by flat##3##2##(2007-12#2)(2010-6#1)
by flavonoids##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
by flexural acoustic waves##2##4##(2007-12#2)
by flotation##3##2##(2008-10#2)(2008-4#1)
by flow cytometric analysis##3##4##(1993-2#1)(2008-5#1)(2008-9#1)
by flow cytometric##5##3##(1993-2#1)(2008-10#1)(2008-5#1)(2008-9#2)
by flow cytometry analysis##3##4##(1997-7#2)(2007-10#1)
by flow cytometry and##2##4##(2008-11#2)
by flow cytometry for##2##4##(2008-7#1)(2008-9#1)
by flow cytometry has##2##4##(2008-9#2)
by flow cytometry in##3##4##(2008-11#1)(2008-9#2)
by flow cytometry measurements##2##4##(1995-8#1)(2008-4#1)
by flow cytometry##66##3##(1993-11#2)(1993-2#1)(1993-9#1)(1994-6#1)(1995-8#1)(1996-6#1)(1997-7#3)(2006-6#1)(2007-10#1)(2008-10#2)(2008-11#8)(2008-3#1)(2008-4#5)(2008-7#3)(2008-9#29)(2011-2#1)(2012-1#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#1)
by flow injection (FI)##2##4##(2008-10#2)
by flow injection analysis (FIA)##3##5##(2008-10#3)
by flow injection analysis in##2##5##(2008-10#2)
by flow injection analysis with on-line##2##6##(2008-10#2)
by flow injection analysis with##5##5##(2008-10#5)
by flow injection analysis##18##4##(1992-11#1)(2008-10#17)
by flow injection flame atomic absorption spectrometry##2##7##(2008-10#2)
by flow injection hydride generation atomic##2##6##(2008-10#2)
by flow injection hydride generation##4##5##(2008-10#4)
by flow injection method##2##4##(2008-10#2)
by flow injection with amperometric detection##2##6##(2008-10#2)
by flow injection##42##3##(1992-11#1)(2008-10#41)
by flow injection-hydride generation-atomic##2##4##(2008-10#2)
by flow injection-inductively coupled plasma optical emission spectrometry##2##8##(2008-10#2)
by flow reversal##2##3##(2008-10#2)
by flow##128##2##(1992-11#1)(1993-11#2)(1993-2#2)(1993-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-6#1)(1997-7#3)(2006-6#1)(2007-10#1)(2008-10#54)(2008-11#9)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-9#33)(2011-2#1)(2012-1#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#1)
by flow-injection analysis##7##3##(1995-6#1)(2008-10#6)
by flow-injection##14##2##(1995-6#1)(2008-10#13)
by flowing nitrogen##2##3##(2008-10#2)
by flowing##4##2##(2008-10#4)
by fluctuations in##2##3##(2010-10#1)(2010-8#1)
by fluctuations##3##2##(2008-3#1)(2010-10#1)(2010-8#1)
by fluid percussion##2##3##(1993-12#1)(1995-12#1)
by fluid##5##2##(1990-11#1)(1993-12#1)(1995-12#1)(2011-2#1)(2013-1#1)
by fluorescein##2##2##(1996-12#1)(2008-10#1)
by fluorescence activated cell sorting##2##5##(2008-11#1)(2009-12#1)
by fluorescence and##2##3##(2007-11#1)(2008-10#1)
by fluorescence correlation spectroscopy##2##4##(1997-6#1)(2008-3#1)
by fluorescence detection##4##3##(2008-10#4)
by fluorescence in situ hybridization (FISH)##2##6##(1997-2#1)(2008-9#1)
by fluorescence in situ hybridization##5##5##(1997-2#1)(1997-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
by fluorescence in situ##6##4##(1994-12#1)(1997-2#1)(1997-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
by fluorescence measurements##2##3##(1992-10#1)(1995-5#1)
by fluorescence microscopy##4##3##(1996-6#1)(2008-1#1)(2008-10#2)
by fluorescence quenching of##2##4##(2008-10#2)
by fluorescence quenching##4##3##(1993-8#1)(2008-10#3)
by fluorescence resonance energy transfer##2##5##(1994-3#1)(2008-4#1)
by fluorescence spectroscopy##4##3##(1990-5#1)(1995-6#1)(2008-10#2)
by fluorescence##48##2##(1990-5#1)(1990-8#1)(1992-10#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)
by fluorescent in situ hybridization##2##5##(1997-4#1)(2008-4#1)
by fluorescent microscopy##4##3##(1990-5#1)(1997-2#1)(2008-1#1)(2012-1#1)
by fluorescent staining##2##3##(2007-2#1)(2008-10#1)
by fluorescent##18##2##(1990-12#1)(1990-5#1)(1997-2#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2012-1#1)(2012-2#1)
by fluorescing hyphae of##2##4##(2008-10#2)
by fluoride##2##2##(2008-10#1)(2008-4#1)
by fluorimetry##2##2##(1994-3#1)(2008-10#1)
by fluorography##2##2##(1990-12#1)(1992-8#1)
by focal##3##2##(2008-1#1)(2008-7#1)(2010-1#1)
by focused##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
by focusing on the##2##4##(1992-2#1)(2008-8#1)
by focusing on##10##3##(1992-2#1)(1994-1#1)(1994-2#1)(1997-2#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
by focusing##16##2##(1992-2#1)(1994-1#1)(1994-2#1)(1997-2#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#2)(2012-3#1)
by focussed sonication##2##3##(2008-10#2)
by focussed##3##2##(2008-10#3)
by following the expression##2##4##(1997-6#1)(2008-11#1)
by following the##9##3##(1990-12#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
by following##11##2##(1990-12#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
by food##5##2##(1991-1#1)(1995-10#1)(2008-1#1)(2008-11#1)(2011-2#1)
by force##4##2##(1993-12#1)(2008-5#1)(2009-9#1)(2013-1#1)
by forced##2##2##(1997-3#1)(2008-10#1)
by formaldehyde##3##2##(1993-6#1)(2008-10#1)(2008-12#1)
by formation of a##2##4##(1995-6#1)(2007-11#1)
by formation of##8##3##(1990-11#1)(1995-6#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-8#1)
by forming a complex with##2##5##(1990-7#1)(1993-3#1)
by forming a complex##3##4##(1990-7#1)(1993-3#1)(2008-10#1)
by forming a##9##3##(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1995-8#1)(2008-10#3)(2011-1#1)
by forming the##2##3##(2008-10#1)(2008-7#1)
by forming##22##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
by forskolin##3##2##(1994-11#1)(1997-1#1)(1997-7#1)
by four##20##2##(1990-5#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
by four-wave mixing##2##3##(2007-11#1)(2007-12#1)
by four-wave##3##2##(2007-11#1)(2007-12#2)
by fourfold##2##2##(2008-10#1)(2008-6#1)
by fourier transform##2##3##(2008-3#1)(2011-1#1)
by fourier##4##2##(2008-3#2)(2011-1#1)(2013-7#1)
by fractional Fourier transform##3##4##(2007-12#3)
by fractionation##2##2##(1990-4#1)(2008-5#1)
by fracture##2##2##(2007-7#1)(2011-2#1)
by fragments of##2##3##(1994-12#1)(2012-12#1)
by fragments##3##2##(1994-12#1)(2008-8#1)(2012-12#1)
by frame##3##2##(1993-3#1)(2007-12#1)(2008-2#1)
by free fatty acids##2##4##(1990-7#1)(2008-1#1)
by free radicals##5##3##(1990-3#1)(1992-9#1)(1993-2#1)(1995-5#1)(1995-6#1)
by free##11##2##(1990-3#1)(1990-7#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#1)
by free-radical##2##2##(1992-9#1)(2008-3#1)
by free-space##2##2##(2008-2#2)
by freeze-fracture electron microscopy##2##4##(1990-12#1)(1992-6#1)
by freeze-fracture##3##2##(1990-12#1)(1992-6#2)
by freezing and thawing##2##4##(1994-11#1)(1995-3#1)
by freezing and##3##3##(1994-11#1)(1995-3#1)(2008-5#1)
by freezing##5##2##(1992-9#1)(1994-11#1)(1995-3#1)(2008-5#1)(2013-7#1)
by frequency doubling of a##3##5##(2007-11#1)(2007-12#2)
by frequency doubling of##7##4##(2007-11#1)(2007-12#6)
by frequency doubling##10##3##(2007-11#3)(2007-12#7)
by frequency##17##2##(1995-5#1)(2007-11#3)(2007-12#9)(2008-10#1)(2008-2#2)(2008-3#1)
by frequency-domain##3##2##(2007-12#1)(2008-3#2)
by from##2##2##(1995-8#1)(2007-6#1)
by frozen section##2##3##(1995-4#1)(2013-1#1)
by frozen##3##2##(1995-4#2)(2013-1#1)
by fructose##3##2##(1990-5#1)(2008-9#2)
by fruit##3##2##(2008-10#2)(2013-8#1)
by full##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
by full-length##2##2##(2008-8#1)(2011-2#1)
by fully##3##2##(1996-4#1)(2008-8#1)(2009-12#1)
by fumigation##2##2##(2008-10#1)(2008-11#1)
by fumonisin##2##2##(2008-10#2)
by functional complementation of a yeast cox10##2##7##(1994-8#2)
by functional complementation##3##3##(1994-8#2)(1995-12#1)
by functional##14##2##(1990-3#1)(1992-8#1)(1994-8#2)(1995-12#1)(1995-8#1)(1997-7#2)(2007-11#1)(2008-11#3)(2009-5#1)(2009-8#1)
by functionalizing##3##2##(2008-10#1)(2009-12#2)
by fungal cell##2##3##(2008-10#2)
by fungal##7##2##(1994-11#1)(2008-10#4)(2008-5#1)(2013-8#1)
by fungicide##2##2##(2008-10#2)
by further improving##2##3##(1992-3#1)(1997-3#1)
by further##15##2##(1991-11#1)(1992-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
by fusicoccin##2##2##(1995-2#2)
by fusing##7##2##(1994-12#1)(1994-2#1)(2008-11#4)(2008-4#1)
by fusion of two##2##4##(2007-12#1)(2011-2#1)
by fusion of##3##3##(2007-12#1)(2009-12#1)(2011-2#1)
by fusion##7##2##(1995-11#1)(2007-12#1)(2008-10#3)(2009-12#1)(2011-2#1)
by future##4##2##(1995-1#1)(1996-2#1)(2007-10#1)(2008-1#1)
by gain##3##2##(2008-2#1)(2009-5#2)
by gains in##2##3##(2008-8#1)(2011-1#1)
by gait##2##2##(2013-1#2)
by galactose##4##2##(1990-5#4)
by gamma##4##2##(1994-11#1)(1996-5#1)(1997-1#1)(2008-5#1)
by gamma-irradiation##2##2##(1997-4#1)(2008-10#1)
by gap##2##2##(2008-7#1)(2009-12#1)
by gas chromatography (GC) with flame##2##6##(2008-10#2)
by gas chromatography (GC)##10##4##(1993-12#1)(2008-10#8)(2008-12#1)
by gas chromatography and##5##4##(1995-2#1)(2008-10#4)
by gas chromatography coupled with mass##2##6##(2008-10#2)
by gas chromatography coupled##3##4##(2008-10#3)
by gas chromatography in##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
by gas chromatography on##2##4##(1991-12#1)(2010-4#1)
by gas chromatography using##7##4##(2008-10#6)(2009-8#1)
by gas chromatography with electron impact mass spectrometric detection in the selected ion monitoring mode (GC-MS-SIM)##2##16##(2008-10#2)
by gas chromatography with electron##3##5##(2008-10#3)
by gas chromatography with flame##2##5##(2008-10#1)(2008-5#1)
by gas chromatography with mass spectrometric detection##4##7##(2008-10#4)
by gas chromatography with mass##5##5##(1997-6#1)(2008-10#4)
by gas chromatography with##11##4##(1997-6#1)(2008-10#9)(2008-5#1)
by gas chromatography##60##3##(1991-12#1)(1993-12#1)(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#45)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#2)
by gas chromatography-mass spectrometry (GC-MS) and##2##6##(1990-5#1)(2012-1#1)
by gas chromatography-mass spectrometry (GC-MS)##10##5##(1990-5#1)(1992-5#1)(1995-2#1)(2008-10#4)(2008-5#1)(2012-1#2)
by gas chromatography-mass spectrometry of the##2##6##(1990-7#1)(1990-8#1)
by gas chromatography-mass spectrometry##23##4##(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1995-2#1)(2008-10#11)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#2)(2013-8#1)
by gas chromatography-mass##25##3##(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1995-2#1)(2008-10#13)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#2)(2013-8#1)
by gas chromatography/mass spectrometry (GC/MS)##2##5##(1995-11#1)(2008-10#1)
by gas chromatography/mass spectrometry##3##4##(1995-11#1)(2008-10#2)
by gas phase molecular absorption##2##5##(2008-10#2)
by gas phase##3##3##(1993-3#1)(2008-10#2)
by gas##107##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-6#1)(2008-10#71)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-8#1)
by gastric##2##2##(2007-8#1)(2012-3#1)
by gastrin##6##2##(1992-3#1)(1994-8#4)(1997-1#1)
by gastrointestinal##3##2##(2008-8#1)(2008-9#1)(2010-5#1)
by gavage for 26 weeks##2##5##(2008-9#2)
by gavage for 26##4##4##(2008-9#4)
by gavage for##6##3##(2008-10#1)(2008-9#5)
by gavage with##2##3##(2008-10#1)(2013-8#1)
by gavage##14##2##(1992-12#1)(2008-10#2)(2008-8#1)(2008-9#8)(2010-1#1)(2013-8#1)
by gaze##2##2##(2007-4#1)(2008-11#1)
by gel electrophoresis##4##3##(1995-6#1)(2008-11#1)(2008-4#1)(2013-1#1)
by gel filtration and##5##4##(1991-12#1)(1992-12#1)(1992-8#1)(2008-10#1)(2008-6#1)
by gel filtration chromatography and##2##5##(2008-10#2)
by gel filtration chromatography##4##4##(1991-9#1)(2008-10#3)
by gel filtration of##2##4##(1990-2#1)(1993-6#1)
by gel filtration on##2##4##(1990-2#1)(1990-5#1)
by gel filtration to##2##4##(1994-8#1)(2008-10#1)
by gel filtration##26##3##(1990-2#3)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-8#2)(1995-11#1)(1995-5#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
by gel permeation chromatography (GPC)##2##5##(2008-10#1)(2011-1#1)
by gel permeation chromatography##4##4##(1990-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
by gel##37##2##(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
by gemcitabine##3##2##(2008-6#2)(2013-1#1)
by gender and ethnicity##2##4##(2011-2#1)(2012-3#1)
by gender and living conditions##2##5##(2008-9#2)
by gender and##8##3##(2008-9#2)(2009-3#1)(2011-2#3)(2012-3#2)
by gender##22##2##(2008-3#1)(2008-9#3)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)
by gene disruption##2##3##(1997-3#1)(2008-8#1)
by gene expression##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
by gene targeting##2##3##(2008-11#1)(2008-2#1)
by gene therapy##2##3##(2008-5#1)(2013-8#1)
by gene##19##2##(1994-12#3)(1997-3#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
by general practitioners and##2##4##(1997-4#1)(2011-2#1)
by general practitioners for##2##4##(2007-2#2)
by general practitioners in##2##4##(1991-9#1)(2013-1#1)
by general practitioners##13##3##(1991-6#1)(1991-9#1)(1993-2#1)(1994-11#1)(1997-4#2)(1997-8#1)(2007-2#3)(2008-10#1)(2011-2#1)(2013-1#1)
by general##23##2##(1990-12#1)(1991-6#1)(1991-9#1)(1993-2#1)(1994-11#1)(1996-3#2)(1997-4#2)(1997-8#1)(2007-2#3)(2007-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
by generalist##2##2##(2008-10#1)(2008-8#1)
by generalized##2##2##(2008-3#2)
by generating a##2##3##(2008-10#1)(2008-2#1)
by generating##13##2##(1995-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-5#1)(2011-2#1)
by generation of##4##3##(2007-12#1)(2008-10#1)(2009-12#1)(2009-8#1)
by genes##2##2##(2008-8#1)(2010-3#1)
by genetic engineering##4##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
by genetic factors##2##3##(1990-2#1)(2008-2#1)
by genetic mapping##2##3##(1995-6#1)(2008-8#1)
by genetic##24##2##(1990-2#1)(1991-5#1)(1992-11#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
by genetically##2##2##(2008-1#1)(2008-8#1)
by genome addition##2##3##(2008-9#2)
by genome##5##2##(2008-10#1)(2008-9#2)(2010-8#1)(2011-2#1)
by genomic##7##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)
by genotyping##3##2##(2008-5#2)(2012-3#1)
by gentle##3##2##(2008-10#2)(2008-8#1)
by geographic##2##2##(1994-1#1)(2012-2#1)
by geographical information systems##2##4##(2008-10#2)
by geographical##6##2##(1993-11#1)(1994-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
by geometrical##2##2##(2008-10#1)(2008-3#1)
by germ tubes##2##3##(2008-10#2)
by germ##3##2##(2008-10#2)(2009-10#1)
by girls&quot##2##2##(2007-12#2)
by giving rise to##2##4##(2008-10#1)(2008-7#1)
by giving##8##2##(1990-2#2)(1994-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-8#1)
by glandular##2##2##(1990-12#1)(2008-2#1)
by glass electrode##2##3##(2008-10#2)
by glass##4##2##(2008-10#3)(2010-5#1)
by glia##2##2##(2008-7#2)
by glial cells##2##3##(2008-7#1)(2009-3#1)
by glibenclamide##2##2##(1992-3#2)
by global##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
by glow discharge quadrupole mass spectrometry##2##6##(2008-10#2)
by glucagon##2##2##(1990-7#1)(1996-2#1)
by glucagon-37##2##2##(1997-6#2)
by glucocorticoids in the##2##4##(1992-12#1)(1993-5#1)
by glucocorticoids##7##2##(1992-12#1)(1993-5#1)(1994-9#2)(1995-12#1)(1996-5#1)(2008-11#1)
by glucose in##2##3##(1994-8#2)
by glucose starvation##2##3##(2008-11#1)(2008-7#1)
by glucose##14##2##(1990-5#2)(1993-12#1)(1994-12#1)(1994-8#2)(1995-8#2)(2008-1#1)(2008-11#3)(2008-7#2)
by glutamate##4##2##(1997-7#1)(2008-11#1)(2008-7#2)
by glutamine##2##2##(1990-7#1)(2008-11#1)
by glutaraldehyde with##2##3##(2008-10#2)
by glutaraldehyde##5##2##(2008-10#5)
by glutathione##5##2##(1992-8#1)(1995-6#1)(1996-9#1)(2008-10#1)(2012-2#1)
by glycerol##2##2##(2008-10#1)(2008-11#1)
by glycine and##2##3##(1995-2#1)(1995-5#1)
by glycine##5##2##(1992-9#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-10#1)
by glycinebetaine##3##2##(1997-4#2)(2008-4#1)
by glycosidase digestions##2##3##(2008-8#2)
by glycosylation##2##2##(1992-5#1)(1994-3#1)
by gold##6##2##(1995-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-1#1)
by good##2##2##(2013-1#1)(2013-8#1)
by government##4##2##(2011-2#3)(2012-12#1)
by governments and##2##3##(1994-3#1)(2008-11#1)
by governments##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
by gradient elution with##3##4##(1990-8#1)(2008-10#1)(2011-1#1)
by gradient##4##2##(1990-8#1)(1997-3#1)(2008-10#1)(2011-1#1)
by gradual##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-5#1)
by gradually##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
by graft##2##2##(2009-5#1)(2011-2#1)
by grafting collagen via##3##4##(2008-5#3)
by grafting##12##2##(2008-10#8)(2008-5#4)
by graphite furnace atomic absorption spectrometry (GFAAS) using##2##8##(2008-10#2)
by graphite furnace atomic absorption spectrometry (GFAAS)##16##7##(2008-10#16)
by graphite furnace atomic absorption spectrometry after##6##7##(2008-10#6)
by graphite furnace atomic absorption spectrometry##40##6##(1991-12#1)(1995-6#1)(2008-10#38)
by graphite furnace atomic absorption spectroscopy##2##6##(2008-10#1)(2008-7#1)
by graphite furnace atomic absorption##42##5##(1991-12#1)(1995-6#1)(2008-10#39)(2008-7#1)
by graphite furnace atomic##43##4##(1991-12#1)(1995-6#1)(2008-10#40)(2008-7#1)
by graphite furnace##45##3##(1991-12#1)(1992-3#1)(1995-6#1)(2008-10#41)(2008-7#1)
by graphite##46##2##(1991-12#1)(1992-3#1)(1995-6#1)(2008-10#42)(2008-7#1)
by gratings##2##2##(2007-11#1)(2008-3#1)
by gravity through##2##3##(2007-12#2)
by gravity##3##2##(2007-12#2)(2008-3#1)
by greater##6##2##(1995-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
by gross##2##2##(1990-8#1)(1996-8#1)
by ground-based Fourier-transform infrared emission spectroscopy##2##6##(2008-2#2)
by ground-based##3##2##(2008-2#3)
by group##7##2##(1995-5#1)(1995-8#1)(2007-7#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-4#1)
by groups of##2##3##(2007-12#1)(2009-10#1)
by growers##3##2##(2008-10#2)(2011-2#1)
by growing##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
by growth factors##2##3##(1996-2#1)(2010-10#1)
by growth hormone##4##3##(1990-12#3)(1993-3#1)
by growth on##2##3##(1991-7#1)(1991-9#1)
by growth##14##2##(1990-12#3)(1991-7#1)(1991-9#1)(1993-3#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
by guanidine##2##2##(1997-2#1)(2008-5#1)
by guanine nucleotides##3##3##(1992-11#1)(1993-6#2)
by guanine##4##2##(1992-11#1)(1993-6#2)(1994-8#1)
by gut##5##2##(2007-12#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
by hair##2##2##(1990-8#1)(2008-5#1)
by half##6##2##(1995-5#2)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#1)
by haloperidol treatment##2##3##(1996-7#1)(1997-7#1)
by hampering the##2##3##(2008-4#1)(2008-7#1)
by hand and##5##3##(1997-6#1)(2008-6#1)(2008-7#1)(2010-5#2)
by hand##9##2##(1994-9#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#2)
by handling##2##2##(1992-7#1)(1994-8#1)
by harmonics##2##2##(1993-12#1)(2008-3#1)
by having a##4##3##(2008-3#1)(2008-5#1)(2012-3#1)(2013-7#1)
by having##11##2##(1994-2#2)(1994-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-7#1)
by head##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
by headspace SPME##2##3##(2008-10#1)(2012-12#1)
by headspace solid-phase microextraction##2##4##(2008-10#2)
by headspace##5##2##(2008-10#3)(2011-1#1)(2012-12#1)
by health authorities##2##3##(1990-12#1)(1991-6#1)
by health care professionals##2##4##(1996-12#1)(2010-9#1)
by health care providers##2##4##(1996-12#1)(2007-2#1)
by health care reform##2##4##(1995-12#1)(1996-3#1)
by health care##15##3##(1991-1#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#2)(2007-2#1)(2008-11#1)(2010-10#1)(2010-9#1)
by health challenges##2##3##(2008-1#2)
by health insurance##3##3##(1991-3#1)(2008-4#1)(2011-2#1)
by health policy makers##2##4##(2008-8#2)
by health professionals##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
by health visitors##2##3##(1990-12#1)(1992-11#1)
by health##39##2##(1990-12#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-3#2)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
by healthcare organizations##2##3##(2007-9#1)(2013-1#1)
by healthcare##3##2##(1995-3#1)(2007-9#1)(2013-1#1)
by healthy##6##2##(1996-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
by heart##5##2##(1990-11#1)(1990-3#1)(2007-7#1)(2008-12#1)(2008-5#1)
by heat shock is##2##4##(1994-11#1)(1995-11#1)
by heat shock##8##3##(1991-9#1)(1993-8#1)(1994-11#2)(1995-11#1)(1997-7#2)(2008-5#1)
by heat stress##2##3##(1991-9#1)(1995-5#1)
by heat treatment##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
by heat##21##2##(1991-5#1)(1991-9#2)(1992-11#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#1)(2011-2#1)
by heating in##2##3##(1990-5#1)(2007-11#1)
by heating of the##2##4##(2007-12#1)(2008-10#1)
by heating##15##2##(1990-5#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-9#1)(2010-8#1)
by heavy atom##2##3##(2008-10#2)
by heavy metal##2##3##(1995-3#1)(2013-8#1)
by heavy metals##2##3##(2008-12#1)(2013-8#1)
by heavy##9##2##(1993-12#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-8#2)
by helical##3##2##(1995-2#1)(2008-1#1)(2009-2#1)
by helper##2##2##(1990-12#1)(1994-12#1)
by heme##2##2##(2008-8#1)(2011-1#1)
by hemin##2##2##(1991-9#2)
by hemodialysis##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
by hemorrhage##2##2##(2007-10#1)(2008-7#1)
by heparin##6##2##(1990-12#1)(1991-2#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-3#1)
by hepatic##2##2##(1996-12#1)(1996-5#1)
by hepatitis##4##2##(2008-7#2)(2008-8#1)(2009-4#1)
by hepatocytes##5##2##(1990-5#1)(1992-12#1)(1994-8#2)(2013-1#1)
by her##2##2##(2008-12#1)(2009-3#1)
by herbimycin A##2##3##(1993-8#1)(1994-8#1)
by herbivores in##2##3##(2008-5#1)(2008-9#1)
by herbivores##4##2##(2008-5#2)(2008-9#1)(2012-1#1)
by herpes##2##2##(2007-2#1)(2012-3#1)
by heterodyne detection##2##3##(2007-12#1)(2008-3#1)
by heterodyne interferometry##2##3##(2008-3#2)
by heterodyne##4##2##(2007-12#1)(2008-3#3)
by heterologous##2##2##(1990-12#1)(1997-9#1)
by high K+##2##3##(1993-12#1)(1996-5#1)
by high affinity##2##3##(1993-12#1)(1993-6#1)
by high concentrations of##3##4##(1990-2#1)(1990-7#1)(2008-5#1)
by high dose##3##3##(2008-1#1)(2008-7#1)(2008-8#1)
by high frequency##2##3##(1995-12#1)(2008-11#1)
by high inoculum##2##3##(2008-10#2)
by high ionic strength##2##4##(1994-3#1)(2009-5#1)
by high levels of##2##4##(2008-8#1)(2009-8#1)
by high performance capillary electrophoresis##2##5##(2008-10#2)
by high performance liquid chromatography (HPLC) and##4##7##(2008-10#2)(2010-2#2)
by high performance liquid chromatography (HPLC) using##2##7##(2008-10#2)
by high performance liquid chromatography (HPLC) with##3##7##(2008-10#2)(2008-5#1)
by high performance liquid chromatography (HPLC)##15##6##(2008-10#10)(2008-5#2)(2010-2#2)(2013-1#1)
by high performance liquid chromatography and##3##6##(1990-7#1)(2008-10#2)
by high performance liquid chromatography with fluorescence detection##3##8##(2008-10#3)
by high performance liquid chromatography with ultraviolet detection##2##8##(2008-10#2)
by high performance liquid chromatography with ultraviolet##3##7##(2008-10#3)
by high performance liquid chromatography with##8##6##(2008-10#8)
by high performance liquid chromatography##34##5##(1990-7#1)(1990-8#1)(1993-6#1)(2008-10#25)(2008-5#3)(2010-2#2)(2013-1#1)
by high performance liquid chromatography-electrospray ionization-quadrupole ion trap mass spectrometry##2##10##(2008-8#2)
by high performance liquid chromatography-electrospray##3##5##(2008-10#1)(2008-8#2)
by high performance liquid chromatography/electrospray/mass spectrometry##2##6##(2008-10#2)
by high performance liquid##43##4##(1990-7#1)(1990-8#1)(1993-6#1)(2008-10#31)(2008-5#3)(2008-8#2)(2010-2#2)(2011-1#1)(2013-1#1)
by high performance##45##3##(1990-7#1)(1990-8#1)(1993-6#1)(2008-10#33)(2008-5#3)(2008-8#2)(2010-2#2)(2011-1#1)(2013-1#1)
by high pressure liquid chromatography (HPLC)##3##6##(1995-12#1)(2008-10#1)(2011-1#1)
by high pressure liquid chromatography##4##5##(1995-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
by high rates of##2##4##(2008-11#1)(2012-2#1)
by high resolution##4##3##(1994-6#1)(1995-8#1)(2008-4#1)(2013-1#1)
by high temperature##3##3##(1997-2#1)(2013-8#2)
by high##116##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-8#1)(1993-11#2)(1993-12#2)(1993-6#2)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#42)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#6)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
by high-contrast##2##2##(2008-9#2)
by high-density##2##2##(1991-12#1)(2011-2#1)
by high-order##2##2##(2007-11#2)
by high-performance anion-exchange chromatography with##2##5##(1991-7#1)(2008-10#1)
by high-performance capillary electrophoresis with##2##5##(1996-5#1)(1997-2#1)
by high-performance capillary##3##3##(1996-5#1)(1997-2#1)(2008-10#1)
by high-performance liquid chromatography (HPLC) and##3##6##(1992-2#1)(2008-10#1)(2009-8#1)
by high-performance liquid chromatography (HPLC) with##5##6##(1997-2#1)(2008-10#4)
by high-performance liquid chromatography (HPLC)##17##5##(1990-8#2)(1992-2#1)(1996-2#1)(1997-2#1)(2008-10#11)(2009-8#1)
by high-performance liquid chromatography and##4##5##(1990-8#1)(1992-11#1)(2008-10#2)
by high-performance liquid chromatography on##3##5##(1990-8#2)(2008-10#1)
by high-performance liquid chromatography with evaporative##2##6##(1995-3#1)(2008-10#1)
by high-performance liquid chromatography with##11##5##(1990-8#2)(1992-1#1)(1995-3#1)(1997-2#1)(2008-10#5)(2008-5#1)
by high-performance liquid chromatography##58##4##(1990-8#14)(1992-1#1)(1992-11#1)(1992-2#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-2#4)(2008-10#27)(2008-5#2)(2009-8#2)(2011-2#1)
by high-performance liquid chromatography-inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
by high-performance liquid##62##3##(1990-8#14)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-2#4)(2008-10#30)(2008-5#2)(2009-8#2)(2011-2#1)
by high-performance thin-layer chromatography##2##4##(2008-5#1)(2012-2#1)
by high-performance##72##2##(1990-8#14)(1991-5#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-5#3)(1997-2#5)(2008-10#32)(2008-4#1)(2008-5#3)(2009-8#2)(2011-2#1)(2012-2#1)
by high-pressure liquid chromatography##3##4##(1990-7#1)(2008-5#1)(2008-6#1)
by high-quality##2##2##(2008-3#2)
by high-resolution##9##2##(1990-7#1)(1994-5#1)(1995-3#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)
by high-speed counter-current chromatography##2##4##(2008-10#1)(2011-1#1)
by high-speed counter-current##3##3##(2008-10#1)(2011-1#2)
by high-speed##5##2##(2008-10#2)(2011-1#2)(2012-2#1)
by high-throughput##2##2##(2008-7#1)(2013-1#1)
by higher doses##2##3##(2008-7#1)(2011-2#1)
by higher##14##2##(1990-2#1)(1990-9#1)(1991-12#1)(1992-8#1)(1995-3#1)(2008-10#4)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
by highlighting##3##2##(1997-6#1)(2008-5#1)(2009-9#1)
by highly selective##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
by highly##14##2##(1990-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
by hippocampal##2##2##(1992-3#1)(2013-8#1)
by his own##2##3##(1995-5#1)(2011-2#1)
by his##8##2##(1992-2#1)(1995-5#1)(2007-5#1)(2008-2#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-2#1)
by histamine in##2##3##(1994-6#1)(1996-2#1)
by histamine##4##2##(1992-9#1)(1994-2#1)(1994-6#1)(1996-2#1)
by histochemical staining##3##3##(1992-1#1)(1993-12#1)(1997-3#1)
by histochemical##4##2##(1992-1#1)(1993-12#1)(1997-3#1)(2008-10#1)
by histologic##2##2##(1993-6#1)(2008-5#1)
by histological and immunohistochemical##2##4##(2011-2#1)(2013-8#1)
by histological and##4##3##(1992-9#1)(1997-5#1)(2011-2#1)(2013-8#1)
by histological##9##2##(1992-2#1)(1992-9#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
by histology##5##2##(1992-6#1)(2007-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
by histopathological examination##3##3##(2008-8#1)(2012-2#1)(2013-7#1)
by histopathological##6##2##(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
by histopathology##4##2##(1994-7#1)(1997-8#1)(2007-7#1)(2008-5#1)
by holographic lithography##2##3##(2007-11#1)(2008-3#1)
by holographic##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
by homeostatic##2##2##(2008-11#1)(2008-3#1)
by homocysteine##2##2##(1992-9#1)(2008-3#1)
by homogeneous##5##2##(2008-10#4)(2011-1#1)
by homologous recombination in embryonic stem##2##6##(1995-11#1)(1995-2#1)
by homologous recombination in##5##4##(1995-11#1)(1995-2#1)(2008-4#2)(2010-1#1)
by homologous recombination of the##2##5##(1991-6#1)(2008-9#1)
by homologous recombination of##3##4##(1991-6#1)(2008-9#2)
by homologous recombination##15##3##(1991-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#2)(2010-1#1)
by homologous##18##2##(1990-12#1)(1991-6#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#2)(2010-1#1)
by homology##3##2##(1994-5#1)(1994-8#1)(2008-9#1)
by hormonal##4##2##(1990-6#1)(1992-8#1)(2008-5#1)(2012-1#1)
by hormones and##3##3##(1993-12#1)(1996-2#1)(2012-2#1)
by hormones##4##2##(1993-12#1)(1996-2#1)(2009-5#1)(2012-2#1)
by horseradish peroxidase##3##3##(2008-10#3)
by hospital administrators##2##3##(1991-1#1)(1993-1#1)
by hospital##12##2##(1990-12#1)(1991-1#1)(1993-1#1)(1993-3#1)(1994-1#2)(1996-1#1)(1997-2#1)(1997-8#1)(2008-11#2)(2008-4#1)
by hospitals and##4##3##(1992-1#2)(2008-11#2)
by hospitals in##2##3##(1992-1#1)(1994-12#1)
by hospitals##12##2##(1991-3#2)(1992-1#3)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#2)(2008-11#2)
by host##7##2##(2008-10#4)(2008-8#2)(2010-12#1)
by hot piperidine##2##3##(1992-3#1)(1993-8#1)
by hot##6##2##(1992-3#3)(1993-8#1)(2008-2#1)(2008-5#1)
by human anti-Sm##2##3##(1993-2#2)
by human hepatic uroporphyrinogen decarboxylase##2##5##(1991-5#2)
by human hepatic##3##3##(1991-5#2)(2010-11#1)
by human immunodeficiency virus##2##4##(1990-3#1)(1992-11#1)
by human intestinal bacteria##2##4##(2008-11#2)
by human keratinocytes##3##3##(1993-5#1)(2008-11#1)(2008-5#1)
by human leukocytes and rat##2##5##(1991-5#2)
by human lymphocytes##2##3##(2008-11#1)(2008-4#1)
by human monocytes##2##3##(1994-11#1)(1995-8#1)
by human neutrophils##2##3##(1993-11#1)(1993-6#1)
by human osteoblast-like cells in response to##2##7##(1990-2#2)
by human skin fibroblasts##2##4##(2008-5#2)
by human##63##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#4)(1992-11#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-2#2)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#2)
by humans and##3##3##(1994-2#1)(2008-7#1)(2008-9#1)
by humans##14##2##(1993-11#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
by hybrid##5##2##(2008-10#1)(2008-8#1)(2012-12#2)(2013-1#1)
by hybridization analysis with##3##4##(1997-2#1)(2008-4#2)
by hybridization analysis##4##3##(1997-2#1)(2008-10#1)(2008-4#2)
by hybridization of##3##3##(1990-12#1)(1995-6#1)(2012-2#1)
by hybridization to##4##3##(1992-11#1)(1993-12#1)(2008-11#2)
by hybridization with a##3##4##(1992-6#1)(1994-11#1)(1996-6#1)
by hybridization with the##2##4##(2008-10#1)(2008-6#1)
by hybridization with##7##3##(1992-6#1)(1994-11#1)(1995-6#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-6#1)
by hybridization##21##2##(1990-12#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-6#2)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-6#1)(2010-3#1)(2012-2#1)
by hybridizing##3##2##(2008-10#2)(2008-4#1)
by hybridoma technique##2##3##(2008-8#1)(2008-9#1)
by hybridoma##5##2##(2008-11#3)(2008-8#1)(2008-9#1)
by hybrids##2##2##(2008-8#1)(2008-9#1)
by hydrazine##2##2##(1991-3#1)(2008-10#1)
by hydrazinolysis##2##2##(1991-12#1)(1993-11#1)
by hydride generation atomic absorption spectrometry (HGAAS)##2##7##(2008-10#2)
by hydride generation atomic absorption spectrometry##5##6##(2008-10#5)
by hydride generation atomic fluorescence spectrometry (HG-AFS)##2##7##(2008-10#2)
by hydride generation atomic fluorescence spectrometry##4##6##(2008-10#4)
by hydride generation atomic##9##4##(2008-10#9)
by hydride generation gas phase molecular absorption spectrometry##3##8##(2008-10#3)
by hydride generation##18##3##(2008-10#18)
by hydride generation-atomic fluorescence spectrometry##3##5##(2008-10#3)
by hydride generation-atomic##4##3##(2008-10#4)
by hydride generation-gas phase molecular absorption spectrometry##2##7##(2008-10#2)
by hydride##29##2##(2008-10#29)
by hydrochloric acid##2##3##(2008-10#2)
by hydrodynamic amperometry##2##3##(2008-10#2)
by hydrodynamic voltammetry##2##3##(2008-10#2)
by hydrodynamic##5##2##(1990-8#1)(2008-10#4)
by hydrogen bonds##2##3##(1995-3#1)(1997-7#1)
by hydrogen exchange##2##3##(1995-5#1)(2012-1#1)
by hydrogen peroxide and##4##4##(2008-10#3)(2011-2#1)
by hydrogen peroxide in##2##4##(2008-10#2)
by hydrogen peroxide##18##3##(1991-9#2)(1992-12#1)(1992-3#1)(1994-5#1)(2008-10#12)(2011-2#1)
by hydrogen##25##2##(1991-9#2)(1992-12#1)(1992-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-10#12)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)
by hydrolysis of##4##3##(1996-2#1)(1996-5#1)(2008-10#1)(2011-1#1)
by hydrolysis##6##2##(1996-2#1)(1996-5#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-12#1)
by hydrophobic interaction chromatography##3##4##(1991-5#1)(2008-10#2)
by hydrophobic interaction##4##3##(1991-5#1)(2008-10#3)
by hydrophobic##8##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-6#1)(1997-7#1)(2008-10#3)
by hydroxide##2##2##(2008-10#2)
by hydroxy##2##2##(2008-10#2)
by hydroxylamine##2##2##(1991-3#1)(2009-2#1)
by hydroxyurea##2##2##(1993-9#1)(2012-3#1)
by hyperpolarization##2##2##(1990-7#1)(1994-11#1)
by hyperspectral remote sensing##2##4##(2008-12#2)
by hypertension##4##2##(2007-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
by hyperventilation##2##2##(1991-9#1)(2012-3#1)
by hyphenated##2##2##(2008-10#1)(2010-11#1)
by hypochlorite##4##2##(2008-10#4)
by hypocrellins A and B##3##5##(2008-8#3)
by hypolipidemic##2##2##(2011-2#1)(2013-1#1)
by hypoxia and##2##3##(1994-2#1)(2010-8#1)
by hypoxia in##2##3##(1996-12#1)(2010-11#1)
by hypoxia##9##2##(1993-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(2010-11#3)(2010-8#1)(2013-1#1)
by hypoxic##2##2##(1993-6#1)(1995-3#1)
by hysteroscopic##2##2##(1991-2#1)(1994-9#1)
by i##7##2##(1993-8#1)(1995-12#1)(1997-4#2)(2008-11#1)(2008-12#1)(2008-9#1)
by ibotenic acid##2##3##(1993-6#1)(2008-10#1)
by identification of the##2##4##(1995-6#1)(2012-3#1)
by identification of##5##3##(1993-9#1)(1995-6#1)(2008-7#1)(2009-12#1)(2012-3#1)
by identification##6##2##(1993-9#1)(1995-6#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-3#1)
by identifying the##2##3##(2008-11#1)(2010-8#1)
by identifying##19##2##(1992-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
by ignoring##3##2##(2008-10#1)(2008-3#2)
by illumination of the##2##4##(2007-11#1)(2007-12#1)
by illumination of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
by illumination##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
by image analysis##6##3##(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-1#1)
by image##12##2##(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2010-2#1)(2013-1#1)
by imaging with##2##3##(2008-1#1)(2008-3#1)
by imaging##7##2##(2007-12#1)(2008-1#2)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
by immature##2##2##(1995-12#1)(2013-1#1)
by immediate##3##2##(2007-12#1)(2008-9#1)(2012-7#1)
by immersing the##5##3##(2008-10#3)(2008-4#2)
by immersing##6##2##(2008-10#3)(2008-4#2)(2009-7#1)
by immersion##2##2##(1990-5#1)(2007-11#1)
by immobilising##2##2##(2008-10#2)
by immobilization##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
by immobilized##6##2##(1991-5#1)(1992-11#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
by immobilizing glucose oxidase##2##4##(2008-10#2)
by immobilizing polyphenol oxidase##2##4##(2008-10#2)
by immobilizing##17##2##(1992-11#1)(2008-10#15)(2008-11#1)
by immune cells##2##3##(1994-11#1)(2013-1#1)
by immune##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
by immunization of rabbits with a conjugate of##2##8##(2008-10#2)
by immunization of rabbits with##3##5##(1996-2#1)(2008-10#2)
by immunization of rabbits##4##4##(1996-2#1)(2008-10#3)
by immunization of##5##3##(1995-5#1)(1996-2#1)(2008-10#3)
by immunization with a##2##4##(1994-8#1)(2008-4#1)
by immunization with##7##3##(1994-8#1)(1997-6#1)(2008-4#3)(2008-9#1)(2011-2#1)
by immunization##13##2##(1994-8#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-4#3)(2008-9#1)(2009-4#1)(2011-2#1)
by immunizing##3##2##(1991-5#1)(2008-7#1)(2008-8#1)
by immuno-PCR##2##2##(2008-8#2)
by immunoaffinity chromatography on##2##4##(1990-11#1)(1993-9#1)
by immunoaffinity chromatography##7##3##(1990-11#1)(1990-7#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-4#1)
by immunoaffinity##9##2##(1990-11#1)(1990-7#1)(1991-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
by immunoassay##3##2##(1995-2#1)(1995-8#1)(2011-2#1)
by immunoblot analysis##4##3##(1994-6#1)(1995-8#1)(2008-10#1)(2008-11#1)
by immunoblot##6##2##(1993-8#1)(1994-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
by immunoblotting and immunohistochemistry##2##4##(1991-5#1)(2009-12#1)
by immunoblotting and##8##3##(1990-11#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-5#1)(2008-11#1)(2009-12#1)
by immunoblotting to##2##3##(1991-5#1)(2007-12#1)
by immunoblotting with##2##3##(1993-12#1)(1995-11#1)
by immunoblotting##25##2##(1990-11#2)(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1995-11#2)(1995-5#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-11#1)(2009-12#1)(2012-3#1)
by immunochemical analysis##2##3##(1990-7#1)(1997-2#1)
by immunochemical##5##2##(1990-7#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)
by immunocompetent cells##2##3##(1994-5#1)(2008-5#1)
by immunocytochemical##3##2##(1993-3#1)(2008-11#1)(2008-7#1)
by immunocytochemistry and##3##3##(1992-6#1)(2008-5#1)(2010-12#1)
by immunocytochemistry##8##2##(1992-6#1)(1994-2#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#1)
by immunodeficiency##2##2##(2008-7#1)(2012-12#1)
by immunodetection of##2##3##(2008-10#1)(2008-12#1)
by immunoelectron microscopy##4##3##(1995-6#2)(1996-3#1)(2011-1#1)
by immunofixation##2##2##(1993-8#1)(2013-8#1)
by immunofluorescence staining##2##3##(1997-4#1)(2008-1#1)
by immunofluorescence##12##2##(1995-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-5#2)(2012-2#1)
by immunohistochemical and##3##3##(1990-12#1)(1991-5#1)(1997-2#1)
by immunohistochemical##8##2##(1990-12#1)(1991-5#1)(1997-2#1)(1997-3#1)(2010-7#1)(2011-2#2)(2013-1#1)
by immunohistochemistry and##3##3##(1997-2#1)(2011-2#1)(2013-8#1)
by immunohistochemistry in##2##3##(1993-9#1)(1994-10#1)
by immunohistochemistry##19##2##(1991-10#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#4)
by immunological##2##2##(2008-10#2)
by immunoperoxidase##2##2##(1991-2#1)(1995-12#1)
by immunoprecipitation of##2##3##(1992-8#1)(2008-2#1)
by immunoprecipitation with##2##3##(1992-12#2)
by immunoprecipitation##10##2##(1990-5#1)(1992-12#2)(1992-2#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-2#1)(2010-12#1)
by immunostaining for##3##3##(1997-3#1)(2008-9#1)(2012-1#1)
by immunostaining##5##2##(1997-3#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
by impaired##7##2##(1994-11#1)(1996-5#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
by impairing##2##2##(1997-8#1)(2010-8#1)
by impedance##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
by imperfect##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
by implantation of##2##3##(1994-2#1)(2007-8#1)
by implanting##2##2##(2008-12#1)(2012-3#1)
by implementing a##2##3##(2009-6#1)(2012-2#1)
by implementing the##3##3##(1994-12#1)(2008-8#1)(2012-12#1)
by implementing##10##2##(1992-3#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#3)
by implication##3##2##(1994-12#1)(2008-2#1)(2008-9#1)
by imposing##3##2##(2008-12#1)(2008-2#1)(2009-7#1)
by impregnation##2##2##(2008-10#2)
by improved##4##2##(1997-2#1)(2007-11#1)(2008-1#1)(2009-11#1)
by improvement of##2##3##(2008-1#1)(2013-1#1)
by improvement##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
by improvements in##2##3##(2008-8#1)(2012-3#1)
by improving the##6##3##(1994-1#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-5#1)
by improving##14##2##(1991-7#1)(1994-1#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
by in situ generation of##2##5##(1992-11#2)
by in situ hybridization and##2##5##(1996-12#1)(2008-11#1)
by in situ hybridization histochemistry##4##5##(1996-12#2)(1996-2#1)(1997-4#1)
by in situ hybridization##23##4##(1990-7#1)(1992-12#1)(1993-5#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-12#7)(1996-2#2)(1997-4#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2012-1#1)
by in situ measurements##2##4##(2008-3#2)
by in situ##39##3##(1990-7#1)(1992-11#2)(1992-12#1)(1993-5#1)(1994-8#1)(1995-12#2)(1995-6#2)(1996-12#7)(1996-2#2)(1997-4#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-1#1)
by in vitro and in vivo##3##6##(2008-10#1)(2008-11#1)(2011-2#1)
by in vitro binding##2##4##(1993-12#1)(2008-9#1)
by in vitro closure##2##4##(2011-1#2)
by in vitro immunization##6##4##(2008-11#6)
by in vitro site-specific recombination##2##5##(2008-4#1)(2012-2#1)
by in vitro site-specific##3##4##(2008-4#2)(2012-2#1)
by in vitro transcription##3##4##(1990-5#1)(1990-7#1)(2008-9#1)
by in vitro translation##2##4##(1991-11#1)(1995-6#1)
by in vitro##45##3##(1990-5#1)(1990-7#1)(1991-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#10)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
by in vivo microdialysis##4##4##(1995-12#2)(1997-2#1)(1997-6#1)
by in vivo##18##3##(1990-5#1)(1991-5#2)(1991-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(2008-11#2)(2008-8#1)
by in##103##2##(1990-5#2)(1990-7#2)(1991-11#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#5)(1995-2#2)(1995-6#3)(1996-12#8)(1996-2#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#13)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
by in-line##2##2##(2007-12#1)(2008-10#1)
by inactivation of##2##3##(1994-12#1)(2008-11#1)
by including a##3##3##(1996-2#1)(2008-3#1)(2010-7#1)
by including the##7##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-10#1)
by including##22##2##(1991-1#1)(1992-5#1)(1993-8#1)(1995-5#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2010-10#1)(2010-7#1)
by inclusion of an##2##4##(1996-4#1)(2008-11#1)
by inclusion of##9##3##(1991-10#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
by inclusion##10##2##(1991-10#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
by incoherent##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by incomplete##4##2##(1992-9#1)(1997-3#1)(2008-7#1)(2012-2#1)
by incorporating a##2##3##(2008-10#1)(2012-3#1)
by incorporating the##4##3##(1993-12#1)(2008-10#3)
by incorporating three##2##3##(2008-10#2)
by incorporating##22##2##(1991-12#1)(1992-9#1)(1993-12#1)(1996-9#1)(2008-10#11)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#2)(2012-3#1)
by incorporation of a##5##4##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
by incorporation of the##2##4##(2008-3#2)
by incorporation of##10##3##(1991-9#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
by incorporation##11##2##(1991-9#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#2)
by increase in##3##3##(1994-6#1)(2008-12#2)
by increase##4##2##(1994-6#1)(2008-10#1)(2008-12#2)
by increased VEGF##2##3##(2010-5#1)(2013-1#1)
by increased levels of##2##4##(2008-10#1)(2011-2#1)
by increased rates of##2##4##(1996-12#1)(2008-10#1)
by increased##49##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#2)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
by increases in the##2##4##(1991-5#1)(2008-5#1)
by increases in##7##3##(1991-5#1)(1995-12#1)(2008-10#1)(2008-5#1)(2010-4#2)(2012-12#1)
by increasing cell##2##3##(2009-8#1)(2012-1#1)
by increasing its##2##3##(2008-7#1)(2013-1#1)
by increasing level of energy##2##5##(2008-12#2)
by increasing local##3##3##(1994-6#1)(2008-10#2)
by increasing the concentration of##4##5##(1992-6#1)(1997-2#1)(2008-10#1)(2008-7#1)
by increasing the concentration##5##4##(1992-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
by increasing the number of##4##5##(2007-10#1)(2008-10#1)(2009-2#1)(2012-12#1)
by increasing the##45##3##(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2010-10#1)(2012-12#1)
by increasing their##5##3##(1991-5#1)(1992-1#1)(2008-4#1)(2012-3#1)(2013-1#1)
by increasing##104##2##(1990-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1996-1#2)(1996-3#3)(1996-6#1)(1997-2#2)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#1)
by incubating the##2##3##(1992-6#1)(2012-3#1)
by incubating##9##2##(1990-11#1)(1992-6#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-9#1)(2012-3#1)
by incubation of##5##3##(1991-1#1)(1993-11#1)(1994-2#1)(1996-5#1)(2013-1#1)
by incubation with a##3##4##(1992-3#1)(1994-5#1)(2008-2#1)
by incubation with the##2##4##(1992-5#1)(1994-3#1)
by incubation with##23##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#2)(2008-2#1)(2012-2#1)(2013-1#1)
by incubation##29##2##(1990-12#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-7#2)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#2)
by independent raters##2##3##(1995-5#1)(2009-11#1)
by independent##8##2##(1992-6#1)(1995-5#1)(1996-5#1)(2008-10#2)(2009-11#1)(2011-1#1)(2012-1#1)
by indigenous##4##2##(2008-10#3)(2008-7#1)
by indirect calorimetry##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
by indirect immunofluorescence##4##3##(1995-3#1)(2007-10#1)(2008-10#2)
by indirect##15##2##(1992-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
by individual##14##2##(1991-9#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#3)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
by individuals with##2##3##(2007-7#1)(2012-12#1)
by individuals##10##2##(1990-12#1)(1994-12#1)(1996-2#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#1)
by indomethacin##8##2##(1990-11#1)(1990-2#2)(1991-3#1)(1992-3#1)(1995-3#1)(1995-5#1)(1997-1#1)
by induced##2##2##(2007-12#1)(2008-10#1)
by inducible nitric oxide synthase (iNOS)##2##6##(2008-5#1)(2011-1#1)
by inducing a##4##3##(1995-8#1)(2007-11#1)(2008-9#1)(2013-1#1)
by inducing stress##2##3##(2008-3#1)(2012-12#1)
by inducing the##4##3##(1996-2#1)(2008-4#1)(2009-6#1)(2010-8#1)
by inducing##23##2##(1990-2#1)(1990-8#1)(1994-8#1)(1995-8#1)(1996-2#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
by induction of apoptosis##2##4##(2008-9#1)(2011-2#1)
by induction of##10##3##(1991-5#1)(1992-12#1)(1992-8#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#1)
by induction##12##2##(1991-5#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)
by inductively coupled plasma atomic emission spectrometry (ICP-AES) after##2##9##(2008-10#2)
by inductively coupled plasma atomic emission spectrometry (ICP-AES)##5##8##(2008-10#5)
by inductively coupled plasma atomic emission spectrometry after##2##8##(2008-10#2)
by inductively coupled plasma atomic emission spectrometry##22##7##(1992-3#1)(2008-10#21)
by inductively coupled plasma atomic emission spectroscopy##2##7##(2008-10#2)
by inductively coupled plasma atomic emission##25##6##(1992-3#1)(2008-10#24)
by inductively coupled plasma mass spectrometry (ICP-MS)##9##7##(2008-10#7)(2013-8#2)
by inductively coupled plasma mass spectrometry##22##6##(1993-9#1)(2008-10#19)(2013-8#2)
by inductively coupled plasma mass spectrometry]##2##6##(2013-8#2)
by inductively coupled plasma mass##24##5##(1993-9#1)(2008-10#19)(2013-8#4)
by inductively coupled plasma optical emission spectrometry (ICP-OES)##4##8##(2008-10#4)
by inductively coupled plasma optical emission spectrometry##10##7##(2008-10#10)
by inductively coupled plasma##63##4##(1992-3#2)(1993-9#1)(2008-10#56)(2013-8#4)
by inductively coupled plasma-atomic emission spectrometry (ICP-AES)##5##7##(2008-10#5)
by inductively coupled plasma-atomic emission spectrometry##13##6##(2008-10#13)
by inductively coupled plasma-atomic emission spectroscopy (ICP-AES)##2##7##(2008-10#2)
by inductively coupled plasma-atomic emission spectroscopy##3##6##(1995-2#1)(2008-10#2)
by inductively coupled plasma-atomic emission##17##5##(1995-2#1)(2008-10#16)
by inductively coupled plasma-mass spectrometry##3##5##(2008-10#3)
by inductively coupled plasma-optical emission##3##5##(2008-10#3)
by inductively coupled##89##3##(1992-3#2)(1993-9#1)(1995-2#1)(2008-10#81)(2013-8#4)
by inductively##90##2##(1992-3#2)(1993-9#1)(1995-2#1)(2008-10#82)(2013-8#4)
by industry##3##2##(2008-10#2)(2009-11#1)
by infected##7##2##(1990-6#1)(1997-1#1)(1997-6#1)(2008-10#2)(2011-2#1)(2012-3#1)
by infecting##3##2##(1991-3#1)(1996-12#1)(1997-4#1)
by infection of##4##3##(1996-6#1)(2008-2#1)(2008-9#1)(2013-8#1)
by infection with##9##3##(1990-5#1)(1996-11#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#2)
by infection##19##2##(1990-12#1)(1990-5#1)(1996-11#1)(1996-6#1)(1997-4#1)(2007-7#2)(2008-10#5)(2008-2#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#2)(2013-8#1)
by infections##3##2##(1994-5#1)(1995-5#1)(2011-2#1)
by infectious##2##2##(1990-6#1)(2011-1#1)
by inference##4##2##(1990-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
by inflammation##4##2##(2008-3#1)(2008-7#1)(2009-1#1)(2012-12#1)
by inflammatory cells##2##3##(1992-2#1)(2012-3#1)
by inflammatory cytokines##2##3##(2010-8#2)
by inflammatory##10##2##(1992-2#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-8#2)(2012-2#1)(2012-3#1)
by influencing the##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
by influencing##7##2##(1996-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)
by informing##2##2##(1996-2#1)(2008-4#1)
by infrared spectroscopy##4##3##(2007-10#1)(2008-10#3)
by infrared##10##2##(1993-1#1)(2007-10#1)(2008-10#5)(2008-3#2)(2008-5#1)
by infusion of##2##3##(1993-3#2)
by ingesting the##2##3##(2007-12#2)
by ingesting##3##2##(1991-11#1)(2007-12#2)
by ingestion of##3##3##(1997-4#1)(2008-5#1)(2009-6#1)
by ingestion##5##2##(1992-8#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-6#1)
by inhalation or##2##3##(1997-1#1)(2008-5#1)
by inhalation##7##2##(1990-12#1)(1992-3#1)(1996-2#1)(1997-1#2)(2008-5#2)
by inhaled##2##2##(1992-3#1)(1993-8#1)
by inhibiting the##10##3##(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-3#1)(2012-3#1)
by inhibiting##28##2##(1990-2#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-2#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
by inhibition of the##2##4##(1992-3#2)
by inhibition of##14##3##(1991-12#1)(1991-5#1)(1992-3#2)(1994-2#1)(1995-12#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2013-1#1)
by inhibition##18##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-3#2)(1994-2#1)(1995-12#2)(1995-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-9#1)(2013-1#1)
by inhibitors of protein##2##4##(1990-12#1)(2009-9#1)
by inhibitors of##6##3##(1990-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(2009-9#1)
by inhibitory##4##2##(1993-3#1)(1993-5#1)(1997-2#1)(2008-10#1)
by initial conditions##4##3##(2008-10#3)(2008-8#1)
by initial##11##2##(1990-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
by initially##2##2##(1993-1#1)(2008-4#1)
by injecting a##5##3##(1994-8#1)(2008-10#3)(2008-6#1)
by injecting in##2##3##(2008-10#1)(2008-5#1)
by injecting the##3##3##(1992-11#1)(1993-6#1)(2008-11#1)
by injecting##28##2##(1992-11#1)(1993-6#1)(1994-8#2)(1997-2#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#2)
by injection into##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
by injection of##19##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1993-8#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
by injection##24##2##(1990-5#1)(1991-1#1)(1991-12#2)(1991-6#1)(1993-8#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)(2013-1#1)
by injections of##3##3##(1994-8#2)(1996-2#1)
by injury##2##2##(2010-1#1)(2013-1#1)
by inoculating plants##2##3##(2008-10#2)
by inoculating##9##2##(1997-8#1)(2008-10#7)(2008-8#1)
by inoculation of##4##3##(2008-10#4)
by inoculation with the##2##4##(2008-10#2)
by inoculation with##9##3##(2008-10#9)
by inoculation##15##2##(2008-10#15)
by inoculum##2##2##(2008-10#2)
by inorganic##2##2##(1991-5#1)(2008-10#1)
by inositol##3##2##(1991-8#1)(1993-6#1)(2008-11#1)
by inpatient##3##2##(1991-11#1)(1995-11#1)(2008-4#1)
by insect##2##2##(2008-10#1)(2008-5#1)
by insects##8##2##(2007-12#1)(2008-10#3)(2008-8#2)(2009-8#1)(2010-1#1)
by inserting a##4##3##(1992-11#1)(2007-11#1)(2008-9#1)(2010-8#1)
by inserting##7##2##(1990-7#1)(1992-11#1)(1995-8#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-8#1)
by insertion of a liquid-crystal##2##5##(2007-12#1)(2008-3#1)
by insertion of a##8##4##(1990-11#1)(1993-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#2)
by insertion of##10##3##(1990-11#2)(1993-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
by insertion##11##2##(1990-11#2)(1991-6#1)(1993-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
by insoluble iron-containing minerals##2##4##(1990-12#2)
by insoluble##3##2##(1990-12#2)(2008-10#1)
by inspection of##2##3##(1992-9#1)(2008-6#1)
by installing##2##2##(2008-3#1)(2009-12#1)
by instillation##2##2##(2010-10#1)(2012-3#1)
by instrument##2##2##(1991-5#1)(2011-2#1)
by insulin and##2##3##(1994-11#1)(2008-3#1)
by insulin but##2##3##(1994-11#1)(1996-2#1)
by insulin in the##3##4##(1997-6#2)(2011-2#1)
by insulin or phorbol esters##2##5##(1995-6#2)
by insulin resistance##4##3##(1994-12#1)(2010-11#1)(2012-12#1)(2013-1#1)
by insulin sensitivity##2##3##(2008-1#1)(2011-2#1)
by insulin treatment##2##3##(1993-8#1)(1997-6#1)
by insulin##32##2##(1992-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-6#6)(1996-11#1)(1996-2#3)(1996-5#1)(1997-6#5)(2008-1#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
by insurance##4##2##(1994-1#1)(1996-2#1)(1997-1#1)(2010-8#1)
by intact##4##2##(1994-8#1)(2008-7#1)(2009-5#1)(2009-8#1)
by integral##2##2##(1991-2#1)(2008-3#1)
by integrated##5##2##(1996-5#1)(2008-10#2)(2008-3#2)
by integrating the##2##3##(1996-3#1)(2008-3#1)
by integrating##10##2##(1993-12#1)(1996-3#1)(2008-10#2)(2008-3#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)
by integration of the##4##4##(2008-2#1)(2008-3#3)
by integration of##8##3##(2008-11#1)(2008-2#3)(2008-3#3)(2011-2#1)
by integration##13##2##(2007-11#1)(2008-11#2)(2008-2#4)(2008-3#4)(2010-11#1)(2011-2#1)
by integrative##2##2##(2009-12#1)(2013-8#1)
by intense##5##2##(2008-10#1)(2008-5#2)(2009-6#1)(2010-6#1)
by intensity##3##2##(1995-11#2)(2007-12#1)
by intensive##2##2##(1996-11#2)
by interacting with##10##3##(1991-12#1)(1993-11#1)(1994-11#2)(1994-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-1#1)(2013-1#1)
by interacting##11##2##(1990-5#1)(1991-12#1)(1993-11#1)(1994-11#2)(1994-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-1#1)(2013-1#1)
by interaction between##2##3##(2007-11#1)(2008-10#1)
by interaction of##2##3##(1990-12#1)(2008-8#1)
by interaction with an##2##4##(1992-12#1)(1994-11#1)
by interaction with##7##3##(1992-12#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-9#1)
by interaction##14##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#3)
by interactions with##4##3##(1993-11#1)(2008-7#1)(2009-12#1)(2010-8#1)
by interactions##7##2##(1993-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)
by intercellular##2##2##(1995-2#1)(2008-5#1)
by interference in##2##3##(1992-11#1)(1995-6#1)
by interference of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
by interference##14##2##(1992-11#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)(2008-9#1)(2010-11#1)
by interfering with the##4##4##(1990-7#1)(1994-6#1)(2010-7#1)(2011-2#1)
by interfering with##6##3##(1990-7#1)(1994-6#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)
by interfering##8##2##(1990-7#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)
by interferometry##2##2##(2008-2#1)(2008-3#1)
by interferon-gamma##3##2##(1995-12#1)(1997-1#2)
by interferons##4##2##(1997-1#3)(2008-4#1)
by interleukin##2##2##(1994-8#1)(2008-4#1)
by interleukin-1##4##2##(1990-12#1)(1993-8#1)(1994-6#2)
by interleukin-1beta was##2##3##(1997-1#2)
by interleukin-1beta##5##2##(1997-1#5)
by interleukin-2##2##2##(1994-12#1)(2008-8#1)
by interleukin-4##4##2##(1992-5#1)(1997-1#3)
by intermolecular hydrogen##2##3##(1993-8#1)(2008-11#1)
by internal##14##2##(1990-3#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(2008-10#3)(2008-12#2)(2009-10#1)(2009-8#1)(2011-2#2)
by international##3##2##(2008-10#2)(2011-2#1)
by internucleosomal DNA##2##3##(1993-3#1)(1995-8#1)
by interpolating##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
by interpolation between##2##3##(2008-2#1)(2008-4#1)
by interpolation##3##2##(2008-2#1)(2008-4#1)(2008-8#1)
by interrupting the##2##3##(2008-7#2)
by interrupting##4##2##(1993-12#1)(2008-4#1)(2008-7#2)
by interval##2##2##(2008-10#1)(2008-12#1)
by interview##2##2##(1997-5#1)(2012-12#1)
by interviews##2##2##(1992-11#1)(2013-1#1)
by intestinal bacteria##2##3##(2008-11#1)(2010-11#1)
by intestinal##5##2##(1997-1#1)(1997-6#1)(2008-11#1)(2010-11#1)(2011-2#1)
by intimate##2##2##(2008-10#1)(2012-12#1)
by intra- and##2##3##(1992-12#1)(2008-10#1)
by intra-accumbens##2##2##(1993-6#2)
by intracavity frequency doubling of a##2##6##(2008-3#2)
by intracavity frequency doubling of##3##5##(2007-12#1)(2008-3#2)
by intracavity frequency doubling##5##4##(2007-12#3)(2008-3#2)
by intracavity##6##2##(2007-12#4)(2008-3#2)
by intracellular calcium##2##3##(1991-2#1)(2008-8#1)
by intracellular##12##2##(1991-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2013-1#2)
by intracerebral##3##2##(1994-8#1)(2008-8#1)(2009-11#1)
by intracytoplasmic##3##2##(1991-8#1)(2007-12#1)(2008-9#1)
by intraluminal##4##2##(1990-12#2)(1992-6#1)(1996-6#1)
by intramolecular##4##2##(1993-8#1)(1995-3#1)(2008-4#1)(2010-2#1)
by intramuscular injection of##4##4##(1997-4#1)(1997-8#3)
by intramuscular injection##5##3##(1991-3#1)(1997-4#1)(1997-8#3)
by intramuscular##6##2##(1991-3#1)(1997-4#1)(1997-8#3)(2012-1#1)
by intranasal##4##2##(2008-10#2)(2012-12#2)
by intraoperative##3##2##(1990-10#1)(1993-5#1)(2007-11#1)
by intraperitoneal injection of##2##4##(2008-7#1)(2011-3#1)
by intraperitoneal##9##2##(1991-6#1)(1995-12#2)(1996-2#1)(2008-7#2)(2008-9#1)(2011-3#1)(2012-2#1)
by intrastriatal##2##2##(1993-12#1)(1995-12#1)
by intratracheal##2##2##(1996-3#1)(2008-5#1)
by intravascular##2##2##(1994-5#1)(2008-6#1)
by intravenous administration##3##3##(1990-6#1)(1995-12#1)(2008-9#1)
by intravenous infusion##2##3##(1990-2#1)(1991-8#1)
by intravenous injection##2##3##(2012-1#1)(2013-1#1)
by intravenous##17##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-8#1)(1993-6#1)(1995-12#2)(2007-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-6#1)(2012-1#2)(2013-1#1)
by intravital microscopy##2##3##(1995-12#1)(2011-2#1)
by intrinsic##2##2##(1995-8#1)(2007-12#1)
by introducing a##7##3##(1992-6#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
by introducing human##2##3##(2008-11#2)
by introducing##32##2##(1991-2#1)(1991-5#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
by introduction of a##5##4##(1992-8#1)(2007-11#1)(2008-2#1)(2008-3#2)
by introduction of an##2##4##(2008-10#1)(2008-3#1)
by introduction of##9##3##(1992-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
by introduction##10##2##(1992-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
by introns and##2##3##(1993-8#1)(1994-11#1)
by invasive##2##2##(2011-2#1)(2013-1#1)
by inverse##8##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
by inversion##6##2##(1994-8#1)(2008-11#1)(2008-3#4)
by inverting the##2##3##(2007-11#1)(2009-5#1)
by inverting##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
by investigating the effect of##2##5##(2008-10#2)
by investigating the##10##3##(1997-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2009-12#1)(2013-8#1)
by investigating##16##2##(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
by investigation##2##2##(1993-12#1)(2012-3#1)
by investigators##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
by invoking##2##2##(1992-12#1)(2008-6#1)
by iodide##3##2##(1995-2#1)(2008-10#2)
by iodine##2##2##(2008-10#1)(2008-7#1)
by iodonium biphenyl##2##3##(1991-2#2)
by ion beam##2##3##(2008-3#1)(2008-8#1)
by ion chromatography (IC) with##3##5##(2008-10#3)
by ion chromatography (IC)##4##4##(2008-10#4)
by ion chromatography with##3##4##(2008-10#3)
by ion chromatography##13##3##(2008-10#13)
by ion exchange and##5##4##(1993-9#1)(2008-10#4)
by ion exchange chromatography##3##4##(1994-8#1)(2008-10#1)(2009-9#1)
by ion exchange##12##3##(1993-9#1)(1994-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2009-9#1)
by ion mobility increment##2##4##(2008-10#2)
by ion mobility##3##3##(2008-10#3)
by ion pairing##2##3##(2008-10#1)(2008-5#1)
by ion##37##2##(1990-8#1)(1993-9#1)(1994-8#1)(2007-12#1)(2008-10#25)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-9#1)
by ion-assisted##2##2##(2008-2#1)(2008-3#1)
by ion-beam##2##2##(2008-3#2)
by ion-chromatography##2##2##(2008-10#2)
by ion-exchange chromatography and##2##4##(1993-8#1)(1997-1#1)
by ion-exchange chromatography using##2##4##(2008-10#1)(2008-4#1)
by ion-exchange chromatography##6##3##(1990-8#2)(1993-8#1)(1997-1#1)(2008-10#1)(2008-4#1)
by ion-exchange##10##2##(1990-8#2)(1993-8#2)(1997-1#1)(2008-10#3)(2008-4#1)(2008-7#1)
by ion-pair reversed-phase high-performance liquid chromatography with spectrophotometric detection##2##9##(2008-10#2)
by ion-pair reversed-phase##3##3##(2008-10#3)
by ion-pair##8##2##(2008-10#8)
by ion-pairing##2##2##(2008-11#1)(2010-11#1)
by ionic##4##2##(1992-12#1)(1993-11#1)(2008-10#1)(2012-12#1)
by ionization##2##2##(1993-11#1)(2007-12#1)
by ionizing radiation##2##3##(2008-9#1)(2012-2#1)
by ionizing##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
by ionomycin##2##2##(1994-3#1)(1995-11#1)
by ionophores##2##2##(1992-8#1)(1995-2#1)
by ionotropic##3##2##(1996-5#1)(2008-4#1)(2008-7#1)
by ions##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
by iontophoretic application of##2##4##(1995-5#2)
by iridium##2##2##(1991-8#1)(2008-10#1)
by iron and##2##3##(2008-10#2)
by iron in##2##3##(1993-2#1)(2008-10#1)
by iron limitation##2##3##(1996-12#1)(2012-2#1)
by iron##10##2##(1993-2#1)(1996-12#1)(2008-10#4)(2010-5#1)(2012-2#2)(2013-8#1)
by irradiation of the##2##4##(1996-2#1)(2007-11#1)
by irradiation of##8##3##(1990-5#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
by irradiation was##3##3##(1994-11#1)(1995-6#2)
by irradiation with ArF excimer##2##5##(2008-2#1)(2008-3#1)
by irradiation with##6##3##(1990-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
by irradiation##23##2##(1990-11#1)(1990-5#1)(1994-11#1)(1995-6#5)(1996-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)
by irrelevant##2##2##(2008-9#1)(2012-3#1)
by irrigation##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
by ischemia##2##2##(2008-6#1)(2008-7#1)
by ischemic##2##2##(1990-5#1)(1996-9#1)
by isocratic##3##2##(1991-5#1)(1996-5#1)(2009-8#1)
by isoelectric focusing##5##3##(1991-8#1)(2008-10#2)(2008-4#2)
by isolate##2##2##(2008-10#2)
by isolate-specific##2##2##(2008-10#2)
by isolated mitochondria##3##3##(1990-7#2)(1991-3#1)
by isolated rat##2##3##(1990-2#1)(2011-1#1)
by isolated##12##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-3#1)(1994-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)
by isolates from##2##3##(2008-10#2)
by isolates of##3##3##(1997-6#1)(2008-10#2)
by isolates##6##2##(1997-6#1)(2008-10#5)
by isolating##5##2##(1994-1#1)(2008-10#2)(2008-4#1)(2011-2#1)
by isolation of##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
by isolation##4##2##(1991-2#1)(2008-10#2)(2011-2#1)
by isoproterenol##6##2##(1991-12#1)(1993-3#1)(1996-9#1)(2008-4#2)(2009-2#1)
by isoquinoline derivatives##2##3##(1995-5#2)
by isotope dilution inductively coupled##2##5##(2008-10#2)
by isotope dilution##6##3##(2008-10#6)
by isotope##10##2##(1991-9#1)(1993-8#1)(2008-10#7)(2008-4#1)
by isotopic##4##2##(1994-5#1)(2008-10#1)(2008-3#1)(2012-2#1)
by issues##2##2##(2008-1#1)(2012-3#1)
by it##7##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-8#1)
by iterative##3##2##(2008-11#2)(2008-3#1)
by itraconazole##2##2##(1990-9#1)(2007-12#1)
by its ability to##7##4##(1993-8#2)(1995-11#1)(1996-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
by its binding to##2##4##(1992-9#1)(2008-3#1)
by its binding##3##3##(1990-12#1)(1992-9#1)(2008-3#1)
by its catalytic##2##3##(2008-10#2)
by its direct effects on##2##5##(2008-8#1)(2011-2#1)
by its enhancement effect on the##2##6##(2008-10#2)
by its inhibition##3##3##(1992-3#1)(2008-10#2)
by its interaction with##4##4##(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)
by its lack of##4##4##(1992-5#1)(1995-12#1)(1996-7#1)(2013-1#1)
by its native##2##3##(2008-10#1)(2008-7#1)
by its overall##2##3##(2008-10#1)(2008-4#1)
by its own##2##3##(1995-2#1)(2009-10#1)
by its reaction with##2##4##(2008-10#2)
by its unusual##2##3##(1992-5#1)(2008-10#1)
by its very##2##3##(2009-10#1)(2010-12#1)
by its##132##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1996-3#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-11#2)(2007-12#2)(2008-10#28)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
by itself had no##3##4##(1991-8#1)(1996-2#2)
by itself##23##2##(1990-11#1)(1990-5#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-2#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
by jet nebulizers##4##3##(1992-3#1)(1994-12#1)(1995-3#2)
by jet##5##2##(1991-1#1)(1992-3#1)(1994-12#1)(1995-3#2)
by joining##2##2##(2008-3#1)(2008-4#1)
by journalists##3##2##(1992-6#1)(1994-3#1)(2008-9#1)
by juvenile##2##2##(2008-5#1)(2008-8#1)
by keeping the##6##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)
by keeping##8##2##(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
by key##2##2##(1994-12#1)(2010-2#1)
by kinetic##5##2##(1996-12#1)(2008-10#3)(2008-11#1)
by kinetics##2##2##(1990-8#1)(2008-10#1)
by kriging data from##2##4##(2008-10#2)
by kriging##3##2##(2008-10#3)
by l-ascorbic acid##2##3##(2008-10#2)
by labeling of##2##3##(1995-6#1)(2008-7#1)
by labeling with##2##3##(1995-6#1)(2008-3#1)
by labeling##5##2##(1995-12#1)(1995-6#2)(2008-3#1)(2008-7#1)
by laboratory##5##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
by lack of##4##3##(1994-8#1)(2007-11#1)(2007-6#1)(2013-1#1)
by lactate dehydrogenase##2##3##(1992-11#1)(1992-8#1)
by lactate##3##2##(1992-11#1)(1992-8#1)(2013-1#1)
by lactofen##2##2##(2008-10#2)
by lambda##2##2##(2008-10#1)(2008-3#1)
by laparoscopic##2##2##(1994-9#1)(2012-2#1)
by laparoscopy and##3##3##(1992-3#1)(1995-1#1)(2008-7#1)
by laparoscopy##12##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-9#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-8#1)(2007-7#1)(2008-7#1)
by laparotomy and##3##3##(1994-3#1)(1996-1#1)(2009-7#1)
by laparotomy##6##2##(1991-2#1)(1991-3#1)(1994-3#1)(1996-1#1)(2009-7#1)(2011-2#1)
by large amounts of##2##4##(2008-10#2)
by large##20##2##(1993-3#1)(1994-5#1)(1996-2#1)(1997-6#1)(2007-10#4)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
by larvae of##2##3##(2007-12#1)(2012-12#1)
by larvae##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
by larval##3##2##(2008-9#3)
by laser ablation##8##3##(1991-2#1)(2007-12#2)(2008-10#2)(2008-3#1)(2010-11#1)(2011-2#1)
by laser diffraction##2##3##(2008-3#2)
by laser interferometry##2##3##(2008-2#2)
by laser scanning confocal microscopy##2##5##(2008-11#1)(2008-7#1)
by laser scanning##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
by laser##34##2##(1990-12#1)(1990-5#1)(1991-2#3)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#7)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-7#1)
by laser-induced fluorescence##3##3##(2008-3#3)
by laser-induced incandescence##2##3##(2008-3#2)
by laser-induced##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
by late##5##2##(1993-3#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
by lateral##6##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
by latex##3##2##(1990-9#1)(2008-3#1)(2011-2#1)
by launching##3##2##(2007-11#1)(2007-12#2)
by law enforcement##2##3##(2009-2#1)(2010-5#1)
by law##6##2##(1991-4#1)(1997-3#1)(1997-8#1)(2009-10#1)(2009-2#1)(2010-5#1)
by layer-by-layer assembly##2##3##(2008-10#1)(2009-11#1)
by layer-by-layer deposition##3##3##(2008-10#2)(2010-4#1)
by layer-by-layer##7##2##(2008-10#4)(2009-11#2)(2010-4#1)
by lead##3##2##(1995-6#1)(2008-10#2)
by leaders##2##2##(1993-12#1)(2009-3#1)
by leakage of lactate dehydrogenase (LDH)##2##6##(1994-11#1)(1995-11#1)
by leakage of##3##3##(1994-11#1)(1995-11#1)(2008-7#1)
by leakage##4##2##(1994-11#1)(1995-11#1)(2008-10#1)(2008-7#1)
by learning##4##2##(1993-2#1)(1995-1#1)(1996-2#1)(1997-6#1)
by least-squares##4##2##(2008-2#2)(2008-3#2)
by leaving##2##2##(2008-11#1)(2011-2#1)
by lectins##2##2##(1994-11#1)(2013-1#1)
by lecturers##2##2##(2008-11#1)(2010-3#1)
by left##3##2##(2007-8#1)(2009-2#1)(2013-7#1)
by leg##3##2##(1995-2#1)(2007-10#1)(2013-1#1)
by length##2##2##(1996-2#1)(2008-10#1)
by leptin##4##2##(2012-3#4)
by lesion##3##2##(2008-10#2)(2008-11#1)
by lesioning##2##2##(1994-8#1)(2008-7#1)
by lesions of the##3##4##(1993-12#1)(1994-2#1)(1996-5#1)
by lesions of##4##3##(1993-12#1)(1994-2#1)(1996-5#1)(1997-1#1)
by lesions##6##2##(1992-10#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-1#1)(2009-4#1)
by less specific##2##3##(2008-10#1)(2008-7#1)
by less than 5%##2##4##(2008-10#1)(2011-2#1)
by less than##7##3##(2007-11#1)(2008-1#2)(2008-10#2)(2008-6#1)(2011-2#1)
by less##11##2##(2007-11#1)(2008-1#2)(2008-10#5)(2008-6#1)(2008-7#1)(2011-2#1)
by leucine##2##2##(1992-3#1)(1995-6#1)
by leukocytes##2##2##(1995-12#1)(2008-5#1)
by levels of##2##3##(1993-8#1)(2009-8#1)
by lidar in the##3##4##(2008-2#1)(2008-3#2)
by lidar measurements##2##3##(2007-11#1)(2008-3#1)
by lidar##8##2##(2007-11#1)(2008-2#2)(2008-3#5)
by lidoflazine and##2##3##(1994-8#2)
by ligand binding##5##3##(1991-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-4#1)
by ligand##6##2##(1990-12#1)(1991-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-4#1)
by ligands which##2##3##(1990-2#2)
by ligands##4##2##(1990-2#2)(2008-10#2)
by light and electron microscopy##4##5##(1992-9#1)(1995-2#1)(2008-10#1)(2012-1#1)
by light and##7##3##(1992-9#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)
by light microscopy##11##3##(2007-12#3)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)
by light scattering technique##3##4##(2008-10#3)
by light scattering##4##3##(1990-12#1)(2008-10#3)
by light was##2##3##(2008-10#1)(2011-1#1)
by light##39##2##(1990-12#1)(1992-9#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
by light-scattering##2##2##(2008-10#2)
by lignin peroxidase##2##3##(1993-3#1)(2008-6#1)
by lignin##4##2##(1993-3#2)(2008-6#1)(2012-2#1)
by likelihood##2##2##(2011-2#2)
by limitations in the##2##4##(2008-2#1)(2008-3#1)
by limited proteolysis##2##3##(1995-11#1)(2008-9#1)
by limited##8##2##(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-9#1)
by limiting the##3##3##(1992-11#1)(2008-8#1)(2008-9#1)
by limiting##11##2##(1992-11#1)(1994-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-9#1)(2013-8#1)
by limits##2##2##(1994-2#1)(2008-9#1)
by line##3##2##(1991-9#1)(2008-7#1)(2012-12#1)
by linear discriminant analysis##2##4##(2008-10#1)(2008-7#1)
by linear regression##4##3##(1995-2#1)(2008-10#3)
by linear sweep voltammetry##6##4##(2008-10#6)
by linear sweep##8##3##(2008-10#8)
by linear##27##2##(1990-8#1)(1995-2#1)(2008-10#16)(2008-2#3)(2008-3#4)(2008-7#1)(2013-8#1)
by lines##2##2##(2008-11#1)(2008-8#1)
by linkage of##2##3##(1990-7#1)(2008-8#1)
by linkage##4##2##(1990-7#1)(1993-6#1)(2008-1#1)(2008-8#1)
by linking##2##2##(1996-3#1)(2008-8#1)
by lipopolysaccharide##5##2##(1992-3#2)(1994-11#1)(1994-12#1)(1994-8#1)
by liposome##2##2##(1993-8#1)(2010-5#1)
by liquid chromatographic##3##3##(2008-10#3)
by liquid chromatography (LC)##4##4##(2008-10#4)
by liquid chromatography and##3##4##(2008-10#3)
by liquid chromatography coupled with##3##5##(2008-10#3)
by liquid chromatography with##2##4##(2008-10#2)
by liquid chromatography##23##3##(1990-2#1)(2008-10#20)(2008-5#1)(2012-1#1)
by liquid chromatography-electrospray ionization##2##4##(2008-10#1)(2011-2#1)
by liquid chromatography-electrospray##3##3##(2008-10#2)(2011-2#1)
by liquid chromatography-electrospray-mass spectrometry##2##4##(2008-10#2)
by liquid chromatography-hydride##2##3##(2008-10#2)
by liquid chromatography-mass spectrometry##3##4##(2008-10#3)
by liquid chromatography-mass##4##3##(2008-10#3)(2011-1#1)
by liquid chromatography-tandem mass spectrometry##2##5##(2008-10#2)
by liquid chromatography-tandem mass##3##4##(2008-10#2)(2011-1#1)
by liquid scintillation##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
by liquid##52##2##(1990-2#1)(1995-11#1)(1996-5#1)(2008-10#42)(2008-11#1)(2008-5#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)
by liquid-liquid extraction using##3##4##(2008-10#2)(2011-2#1)
by liquid-liquid extraction##6##3##(2008-10#5)(2011-2#1)
by liquid-phase microextraction##2##3##(2008-10#2)
by listing the##2##3##(1993-1#1)(2008-2#1)
by listing##3##2##(1993-1#1)(2008-2#1)(2008-7#1)
by lithium##2##2##(2008-7#1)(2009-11#1)
by little##2##2##(2011-2#1)(2012-2#1)
by live##3##2##(1997-8#1)(2008-4#1)(2009-10#1)
by liver and##3##3##(1993-12#1)(1994-11#1)(2008-12#1)
by liver biopsy##3##3##(2010-8#1)(2011-1#1)(2013-1#1)
by liver microsomes##3##3##(1991-12#2)(1995-6#1)
by liver##14##2##(1991-12#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-6#2)(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
by living##3##2##(2008-9#1)(2010-10#1)(2010-5#1)
by loading the##2##3##(2008-10#1)(2011-2#1)
by loading##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
by local administration of##2##4##(1996-11#1)(2011-2#1)
by local biotypes##2##3##(2008-10#2)
by local councils##2##3##(1997-8#2)
by local environmental constraints##2##4##(2010-6#2)
by local environmental##3##3##(2008-10#1)(2010-6#2)
by local injection##2##3##(1992-10#1)(2008-11#1)
by local##27##2##(1992-10#1)(1992-9#2)(1995-12#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-6#2)(2011-2#2)(2011-9#1)(2013-1#1)
by localization##2##2##(1996-2#1)(2008-5#1)
by localized##3##2##(1991-2#1)(2008-10#1)(2012-2#1)
by locally##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
by locating##3##2##(1993-9#1)(1995-1#1)(2008-10#1)
by location##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
by locking lasers##2##3##(2007-12#1)(2008-3#1)
by locking##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
by log##2##2##(2011-2#1)(2013-1#1)
by log-rank##2##2##(1995-2#1)(2008-6#1)
by logistic regression##2##3##(2012-12#1)(2012-2#1)
by long##5##2##(1992-8#1)(1996-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
by long-term##8##2##(1992-12#1)(1992-2#1)(1993-3#1)(1996-7#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
by longicomin##2##2##(2008-8#2)
by longitudinal##2##2##(2007-11#1)(2008-9#1)
by looking##3##2##(2008-8#1)(2009-7#1)(2012-2#1)
by loss of##10##3##(1994-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
by loss##12##2##(1994-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
by losses##2##2##(2008-1#1)(2009-5#1)
by low concentrations of##7##4##(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#1)(1997-2#1)(2008-5#1)
by low concentrations##8##3##(1990-7#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#1)(1997-2#1)(2008-5#1)
by low dose##2##3##(2008-6#1)(2008-7#1)
by low doses##2##3##(2008-7#2)
by low pH##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
by low temperature##2##3##(2008-11#1)(2008-7#1)
by low temperatures##2##3##(2008-10#2)
by low##50##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-1#1)
by low-coherence interferometry##2##3##(2008-3#2)
by low-coherence##3##2##(2008-3#3)
by low-dose##4##2##(2008-3#1)(2008-7#3)
by low-frequency##3##2##(2008-2#1)(2008-3#2)
by low-level##2##2##(1993-8#2)
by lower doses of##2##4##(1993-12#1)(2008-7#1)
by lower doses##3##3##(1990-9#1)(1993-12#1)(2008-7#1)
by lower##13##2##(1990-9#1)(1992-12#2)(1993-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
by lowering the##6##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)
by lowering##11##2##(1990-7#1)(1992-2#1)(1994-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
by lubricin addition##2##3##(2010-10#2)
by luminescence##2##2##(2008-10#2)
by lung##2##2##(1990-6#1)(2012-2#1)
by lupus##2##2##(2008-1#1)(2013-1#1)
by lysates##2##2##(1994-8#1)(2008-10#1)
by lysine##2##2##(1995-2#1)(1995-6#1)
by lysis##3##2##(1994-2#1)(2006-10#1)(2008-10#1)
by lysosomal##2##2##(2010-8#2)
by lysosomes##2##2##(1992-12#2)
by m-Nis##2##2##(2011-3#2)
by mAb##2##2##(1990-5#1)(1996-12#1)
by mRNA##3##2##(1994-8#1)(1996-9#1)(2008-9#1)
by maceration##3##2##(2008-5#1)(2013-1#2)
by macrophages in##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
by macrophages##15##2##(1990-12#1)(1991-5#4)(1993-3#2)(1995-3#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2013-7#1)
by macroscopic##2##2##(1991-12#1)(2012-2#1)
by magnesium##2##2##(1991-1#1)(2008-7#1)
by magnetic resonance imaging (MRI)##3##5##(2008-9#1)(2010-9#2)
by magnetic resonance imaging##9##4##(1997-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#2)(2011-2#1)(2012-12#1)
by magnetic resonance##11##3##(1994-5#1)(1997-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#2)(2011-2#1)(2012-12#1)
by magnetic##13##2##(1992-3#1)(1994-5#1)(1997-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)
by mail##2##2##(2008-8#1)(2012-3#1)
by maintaining the##2##3##(2008-10#1)(2013-8#1)
by maintaining##12##2##(1996-3#1)(2007-2#1)(2008-10#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
by maintenance##2##2##(1991-11#1)(2010-3#1)
by major##4##2##(1990-11#1)(1997-8#1)(2008-10#1)(2012-2#1)
by making a##2##3##(1992-4#1)(2008-10#1)
by making it##2##3##(2008-10#1)(2008-2#1)
by making the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
by making their##2##3##(1995-12#1)(1996-2#1)
by making use of a##2##5##(2008-10#1)(2008-9#1)
by making use of the##2##5##(2008-10#2)
by making use of##7##4##(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)
by making##30##2##(1990-8#1)(1991-6#1)(1992-4#1)(1994-9#1)(1995-12#1)(1996-2#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#3)(2012-12#1)
by malaria##4##2##(2012-12#4)
by male##3##2##(1991-1#1)(2008-8#1)(2009-5#1)
by males and females##2##4##(2008-5#1)(2008-9#1)
by males and##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
by males##6##2##(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)
by malignant##3##2##(1991-5#1)(1991-9#1)(1992-3#1)
by malondialdehyde formation##2##3##(1990-12#1)(2008-10#1)
by mammalian cells##3##3##(1994-11#1)(1995-11#1)(1997-7#1)
by mammalian##4##2##(1991-3#1)(1994-11#1)(1995-11#1)(1997-7#1)
by mammography##5##2##(1994-3#1)(1994-7#1)(1995-4#1)(1997-5#2)
by managed care plans##2##4##(1994-3#1)(1996-12#1)
by managed care##5##3##(1993-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)
by managed##6##2##(1993-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-3#1)
by management##5##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
by managers##2##2##(1993-2#2)
by manganese##3##2##(2008-10#1)(2008-7#2)
by manipulating the##5##3##(1997-2#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
by manipulating##15##2##(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#1)(2011-2#1)(2013-1#2)
by manipulation of the##3##4##(1996-5#1)(2007-12#1)(2008-3#1)
by manipulation of##4##3##(1996-12#1)(1996-5#1)(2007-12#1)(2008-3#1)
by manual and##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
by manual palpation##3##3##(2007-5#1)(2008-8#1)(2010-9#1)
by manual stimulation##2##3##(2009-4#2)
by manual##19##2##(1992-8#1)(1994-12#1)(1994-6#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#2)(2010-9#1)(2013-1#1)
by manufacturers##6##2##(1993-11#1)(1994-2#1)(1997-4#1)(2008-10#1)(2010-6#1)(2012-2#1)
by many cells##2##3##(2008-1#1)(2008-9#1)
by many different##2##3##(2007-11#1)(2010-3#1)
by many factors##2##3##(2008-5#1)(2011-1#1)
by many in##2##3##(2007-2#1)(2008-11#1)
by many of##2##3##(2007-12#1)(2008-11#1)
by many orders of magnitude##2##5##(2008-3#1)(2008-4#1)
by many researchers##2##3##(1996-8#1)(2008-7#1)
by many##43##2##(1992-2#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
by mapping##5##2##(1995-3#1)(2008-10#2)(2008-7#1)(2011-1#1)
by marine##5##2##(1994-8#1)(1997-4#1)(2008-12#2)(2013-1#1)
by markedly##3##2##(1996-2#1)(2008-1#1)(2010-1#1)
by marker##2##2##(1991-12#1)(2008-10#1)
by masking the##2##3##(1995-8#1)(2007-11#1)
by mass spectrometric##3##3##(1993-8#1)(2013-1#2)
by mass spectrometry and##2##4##(2008-2#1)(2008-5#1)
by mass spectrometry##20##3##(1990-8#2)(1991-2#1)(1992-8#1)(1993-8#1)(2006-12#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
by mass spectroscopy##2##3##(2008-10#1)(2008-7#1)
by mass transfer##2##3##(1994-12#1)(2008-10#1)
by mass transport on##2##4##(1997-2#2)
by mass transport##3##3##(1997-2#2)(2008-3#1)
by mass##35##2##(1990-8#2)(1991-2#1)(1992-8#1)(1993-8#3)(1994-12#1)(1997-2#2)(2006-12#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
by matching of the##2##4##(1995-6#1)(2007-11#1)
by matching##7##2##(1991-12#1)(1991-4#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)
by maternal##11##2##(1990-9#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
by mathematical##2##2##(2007-12#1)(2008-10#1)
by mating pheromone##2##3##(1991-5#1)(1994-12#1)
by mating with##3##3##(2008-8#3)
by mating##10##2##(1991-5#1)(1994-12#2)(1995-6#1)(2008-10#2)(2008-12#1)(2008-8#3)
by matrix effects##2##3##(1997-2#1)(2008-10#1)
by matrix##8##2##(1993-3#1)(1997-2#1)(2008-10#5)(2008-2#1)
by matrix-assisted laser desorption/ionization time-of-flight##2##5##(2008-10#1)(2008-11#1)
by matrix-assisted laser desorption/ionization##5##4##(2008-10#1)(2008-11#4)
by matrix-assisted##6##2##(2008-10#1)(2008-11#5)
by maximal##3##2##(1994-11#1)(2009-1#1)(2013-1#1)
by maximizing##2##2##(2007-12#1)(2010-3#1)
by maximum likelihood##2##3##(1994-9#1)(2012-3#1)
by maximum##3##2##(1994-9#1)(1995-2#1)(2012-3#1)
by mean##6##2##(1990-12#1)(1990-2#1)(1992-7#1)(2008-10#2)(2008-7#1)
by means of EDTA exchange##2##5##(2008-10#2)
by means of Fourier##2##4##(2007-11#1)(2008-10#1)
by means of Hamou resectoscope##2##5##(1994-9#2)
by means of IR##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
by means of X-ray diffraction##2##5##(2008-11#1)(2009-8#1)
by means of a hybrid##2##5##(2008-10#1)(2008-3#1)
by means of a laser##2##5##(1993-2#1)(2008-3#1)
by means of a model##2##5##(1994-6#1)(2008-10#1)
by means of a new##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
by means of a polarization-sensitive optical time-domain##2##7##(2007-11#1)(2007-12#1)
by means of a portable##2##5##(1997-4#1)(2008-10#1)
by means of a procedure##2##5##(2008-10#2)
by means of a quantitative##2##5##(2008-10#1)(2011-2#1)
by means of a questionnaire##2##5##(1994-6#1)(2008-9#1)
by means of a simple##2##5##(2008-10#1)(2008-3#1)
by means of a##119##4##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-3#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-10#39)(2008-11#3)(2008-2#7)(2008-3#20)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
by means of air##2##4##(2008-10#1)(2008-11#1)
by means of an algorithm##3##5##(2008-3#2)(2008-4#1)
by means of an extended Kalman filter (EKF)##2##8##(2008-2#1)(2008-3#1)
by means of an intracavity##2##5##(2008-3#2)
by means of an##26##4##(1990-6#1)(1991-8#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#10)(2008-4#1)(2009-10#1)(2009-3#1)(2010-6#1)(2012-12#1)(2013-1#1)
by means of aqueous standards##2##5##(2008-10#2)
by means of artificial neural networks##3##6##(2008-10#3)
by means of automated##2##4##(2008-10#1)(2013-1#1)
by means of chemical##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
by means of computer simulations##2##5##(2008-3#2)
by means of coordinated##2##4##(1994-8#1)(2009-6#1)
by means of different##3##4##(2008-10#2)(2013-1#1)
by means of differential##2##4##(2008-3#1)(2008-9#1)
by means of digital holography##2##5##(2007-11#1)(2008-3#1)
by means of electrochemical##2##4##(2008-10#2)
by means of electron microscopy and##2##6##(2008-5#1)(2008-9#1)
by means of electron microscopy##3##5##(2008-10#1)(2008-5#1)(2008-9#1)
by means of flow##2##4##(2008-10#1)(2008-9#1)
by means of fluorescence##4##4##(1994-5#1)(2008-10#3)
by means of high resolution##2##5##(1993-9#1)(2008-11#1)
by means of high##3##4##(1993-9#1)(2008-10#1)(2008-11#1)
by means of high-performance##4##4##(1996-12#2)(2008-10#1)(2010-12#1)
by means of histology and##2##5##(2010-10#1)(2011-2#1)
by means of increasing the##2##5##(2007-11#1)(2008-2#1)
by means of its##2##4##(1993-6#1)(2008-3#1)
by means of linear regression##2##5##(2008-10#1)(2012-3#1)
by means of linear##3##4##(2008-10#2)(2012-3#1)
by means of monitoring the change in##2##7##(2008-2#1)(2008-3#1)
by means of multivariate##2##4##(2008-1#1)(2008-10#1)
by means of optical parametric##2##5##(2008-2#1)(2008-3#1)
by means of optical##4##4##(2008-2#2)(2008-3#1)(2009-7#1)
by means of positive displacement with air through a time-based injector##2##11##(2008-10#2)
by means of programmable##2##4##(2007-7#1)(2010-12#1)
by means of quantitative##2##4##(1991-12#1)(2012-3#1)
by means of questionnaires to##2##5##(1992-5#1)(1997-4#1)
by means of scanning electron##2##5##(2007-12#1)(2008-6#1)
by means of scanning##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
by means of shifting the##2##5##(2008-3#2)
by means of surface-enhanced##2##4##(2013-8#2)
by means of synchronous##2##4##(1993-8#1)(2008-3#1)
by means of the Langmuir##2##5##(1994-5#1)(2008-10#1)
by means of the fast##2##5##(1994-12#1)(2008-3#1)
by means of the standard additions method##2##7##(2008-10#2)
by means of the##74##4##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-6#1)(1994-12#1)(1994-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#24)(2008-11#2)(2008-2#5)(2008-3#13)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
by means of their##2##4##(2008-10#1)(2008-3#1)
by means of this##5##4##(1993-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
by means of time-resolved##2##4##(2008-10#2)
by means of transmission##2##4##(2008-5#2)
by means of two##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2013-8#1)
by means of varying the##3##5##(2008-3#3)
by means of which##2##4##(2008-3#1)(2011-3#1)
by means of##596##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#31)(2007-12#25)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#168)(2008-11#17)(2008-12#4)(2008-2#33)(2008-3#98)(2008-4#1)(2008-5#20)(2008-6#3)(2008-7#10)(2008-8#8)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#8)
by means##599##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#31)(2007-12#25)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#168)(2008-11#19)(2008-12#4)(2008-2#33)(2008-3#98)(2008-4#1)(2008-5#20)(2008-6#3)(2008-7#10)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#8)
by measurement of a##2##4##(2007-11#1)(2008-3#1)
by measurement of the fluorescence##2##5##(2008-2#1)(2008-3#1)
by measurement of the##29##4##(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#13)(2008-4#1)(2010-4#1)
by measurement of##47##3##(1991-8#2)(1994-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#5)(2008-10#4)(2008-2#2)(2008-3#18)(2008-4#1)(2008-5#1)(2010-4#1)
by measurement##50##2##(1991-8#2)(1994-2#2)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#5)(2008-10#4)(2008-2#2)(2008-3#20)(2008-4#1)(2008-5#1)(2010-4#1)
by measurements of the##2##4##(2008-10#1)(2008-2#1)
by measurements of##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
by measurements on##2##3##(2008-2#1)(2008-3#1)
by measurements##8##2##(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)
by measuring fluorescence##2##3##(1990-7#1)(2008-10#1)
by measuring optical##2##3##(2008-10#1)(2008-3#1)
by measuring the absorbance##2##4##(2008-10#2)
by measuring the amount of##2##5##(2008-10#1)(2008-5#1)
by measuring the change in absorbance##2##6##(2008-10#2)
by measuring the change in##3##5##(2008-10#2)(2010-2#1)
by measuring the change##4##4##(2008-10#3)(2010-2#1)
by measuring the conversion of##2##5##(1995-2#1)(2008-10#1)
by measuring the decrease in the absorbance of##3##8##(2008-10#3)
by measuring the decrease in##7##5##(2008-10#7)
by measuring the decrease of fluorescence##2##6##(2008-10#2)
by measuring the decrease of##3##5##(2008-10#2)(2011-2#1)
by measuring the decrease##10##4##(2008-10#9)(2011-2#1)
by measuring the distance##2##4##(2008-10#2)
by measuring the fluorescence##2##4##(1994-2#1)(2008-4#1)
by measuring the formation of##2##5##(2008-10#1)(2012-2#1)
by measuring the frequency##2##4##(2007-12#1)(2013-7#1)
by measuring the intensity of##2##5##(2008-10#2)
by measuring the peak current##2##5##(2008-10#2)
by measuring the ratio of##2##5##(1991-5#1)(2008-3#1)
by measuring the ratio##4##4##(1991-5#2)(2008-10#1)(2008-3#1)
by measuring the release of##6##5##(1990-12#1)(1990-5#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
by measuring the stimulation of##2##5##(1991-12#1)(1994-11#1)
by measuring the##118##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#49)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2010-2#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
by measuring their##2##3##(1997-2#1)(2008-3#1)
by measuring##193##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#70)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#14)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
by mechanical inoculation of##3##4##(2008-10#3)
by mechanical inoculation##5##3##(2008-10#5)
by mechanical strain##2##3##(1995-2#2)
by mechanical##23##2##(1991-5#1)(1992-2#1)(1992-6#1)(1993-9#1)(1995-2#2)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)
by mechanisms that##2##3##(1992-5#1)(1994-9#1)
by mechanisms##4##2##(1991-5#1)(1992-5#1)(1994-9#1)(2009-6#1)
by media&quot##2##2##(1996-11#2)
by medial##2##2##(1992-8#1)(1994-2#1)
by mediastinoscopy##2##2##(2007-8#1)(2008-1#1)
by mediating##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
by medical and##2##3##(1994-12#1)(2008-7#1)
by medical librarians##2##3##(1991-2#2)
by medical practitioners##2##3##(2008-10#2)
by medical students##5##3##(2008-11#1)(2008-3#1)(2009-6#2)(2012-3#1)
by medical##27##2##(1991-2#2)(1991-3#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-1#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
by medication##2##2##(1996-6#1)(2008-10#1)
by medium##6##2##(2008-10#2)(2008-11#3)(2008-8#1)
by melatonin##4##2##(1990-5#1)(1993-6#1)(2008-10#1)(2011-2#1)
by melittin##2##2##(1993-11#1)(2009-12#1)
by members of the##9##4##(1994-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-11#1)(2010-3#1)(2013-8#1)
by members of##11##3##(1994-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
by membrane##10##2##(1992-8#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)
by membrane-associated##2##2##(1990-8#1)(1995-6#1)
by membranes##2##2##(1993-6#1)(2008-4#1)
by men##3##2##(1993-9#1)(2008-11#1)(2008-12#1)
by mental health professionals##2##4##(1994-1#1)(2008-11#1)
by mental health##3##3##(1994-1#1)(1995-1#1)(2008-11#1)
by mental##4##2##(1994-1#1)(1995-1#1)(2008-11#1)(2008-5#1)
by mere##2##2##(2008-1#1)(2010-5#1)
by merging##6##2##(2007-5#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-8#1)
by mesulergine##2##2##(1994-2#2)
by metabolic##4##2##(2008-5#1)(2008-7#1)(2011-1#1)(2013-7#1)
by metabotropic##2##2##(1996-5#1)(2008-7#1)
by metal##2##2##(2008-10#1)(2008-7#1)
by metallic##2##2##(2007-11#1)(2007-12#1)
by metallorganic chemical-vapor deposition##2##4##(2008-3#2)
by metastatic##5##2##(1991-6#1)(1992-5#1)(1993-12#1)(2007-11#1)(2008-6#1)
by metered-dose inhaler##2##3##(2008-8#2)
by metformin##2##2##(1994-8#2)
by methamphetamine##5##2##(1995-3#5)
by methanol##2##2##(1995-3#1)(2012-2#1)
by methionine##2##2##(2008-5#1)(2010-5#1)
by methods such##2##3##(2008-10#1)(2008-7#1)
by methods##6##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
by methyl viologen##2##3##(1991-5#1)(2008-10#1)
by methyl##6##2##(1990-7#1)(1991-5#1)(1994-5#1)(2008-10#3)
by methylation analysis##2##3##(1993-11#1)(2008-9#1)
by methylation of##3##3##(1994-12#1)(1994-8#1)(1997-2#1)
by methylation##6##2##(1993-11#1)(1994-12#1)(1994-8#2)(1997-2#1)(2008-9#1)
by methylene##2##2##(1991-9#1)(2008-10#1)
by miRNA##2##2##(2012-12#1)(2012-2#1)
by miRNAs##2##2##(2008-10#1)(2008-11#1)
by micellar electrokinetic capillary chromatography##7##5##(1994-9#3)(2008-10#4)
by micellar electrokinetic chromatography (MEKC)##4##5##(1990-8#1)(2008-10#3)
by micellar electrokinetic chromatography with N-dodecanoyl-L-serine##2##6##(1994-9#2)
by micellar electrokinetic chromatography with##5##5##(1990-8#2)(1994-9#2)(2008-10#1)
by micellar electrokinetic chromatography##10##4##(1990-8#4)(1994-9#2)(2008-10#4)
by micellar electrokinetic##17##3##(1990-8#4)(1994-9#5)(2008-10#8)
by micellar##18##2##(1990-8#4)(1994-9#5)(2008-10#9)
by micro##2##2##(2008-3#1)(2010-8#1)
by microarray analysis##4##3##(2007-11#1)(2008-10#2)(2010-3#1)
by microarray##5##2##(2007-11#1)(2008-10#2)(2010-3#1)(2013-8#1)
by microbes##2##2##(2008-11#1)(2010-3#1)
by microbial##8##2##(1990-6#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
by microbiological##2##2##(2008-6#1)(2012-2#1)
by micrococcal nuclease##2##3##(1997-3#1)(2008-8#1)
by microdialysis in##2##3##(1992-3#1)(1997-2#1)
by microdialysis##8##2##(1992-3#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-7#1)
by microelectrode##2##2##(2008-10#1)(2013-1#1)
by microemulsion##2##2##(1996-5#1)(2008-10#1)
by microinjecting##2##2##(1994-8#1)(2008-2#1)
by microinjection of##2##3##(1992-5#1)(2010-5#1)
by microinjection##6##2##(1992-5#1)(1997-7#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)
by micromolar concentrations of##2##4##(1992-12#1)(1994-6#1)
by microorganism##2##2##(1994-3#1)(2012-2#1)
by microorganisms in##2##3##(2008-10#1)(2012-3#1)
by microorganisms##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
by microprojectile bombardment##2##3##(2008-9#2)
by microsatellite DNA markers##2##4##(2008-5#1)(2008-9#1)
by microsatellite##5##2##(2008-10#1)(2008-5#2)(2008-9#1)(2009-5#1)
by microscopic examination##3##3##(1996-12#1)(2008-10#1)(2012-12#1)
by microscopic##10##2##(1996-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-12#1)
by microscopy and##2##3##(2008-5#1)(2008-7#1)
by microscopy##5##2##(1991-11#1)(2008-11#2)(2008-5#1)(2008-7#1)
by microsomal##2##2##(1993-11#1)(1994-8#1)
by microsomes##2##2##(1990-12#1)(1996-12#1)
by microsurgery##2##2##(1992-3#2)
by microsurgical##2##2##(1996-9#1)(2008-7#1)
by microtubule##2##2##(1997-6#1)(2008-7#1)
by microwave digestion##3##3##(2008-10#1)(2013-8#2)
by microwave induced plasma atomic emission spectrometry##2##7##(2008-10#2)
by microwave irradiation##2##3##(2008-10#2)
by microwave plasma torch atomic emission spectrometry##2##7##(2008-10#2)
by microwave plasma##3##3##(2008-10#3)
by microwave##12##2##(2008-10#9)(2008-5#1)(2013-8#2)
by microwave-assisted digestion##2##3##(2008-10#2)
by microwave-assisted##3##2##(2008-10#3)
by microwaves##3##2##(2008-10#1)(2011-2#2)
by midbrain##2##2##(1993-12#2)
by midwives##2##2##(1996-12#1)(2013-1#1)
by migration##2##2##(2012-3#1)(2013-7#1)
by mild acid##2##3##(1991-12#1)(2008-10#1)
by mild##11##2##(1991-12#1)(1993-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)
by milk consumption##2##3##(2009-2#2)
by mimicking##3##2##(1993-8#1)(2007-7#1)(2008-10#1)
by minimal##3##2##(1990-7#1)(2007-8#1)(2008-10#1)
by minimising##2##2##(1996-11#1)(2008-10#1)
by minimizing the##4##3##(2007-12#1)(2008-2#1)(2008-6#1)(2012-1#1)
by minimizing##6##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)(2012-1#1)
by minocycline##2##2##(2008-7#2)
by minor##3##2##(2008-10#1)(2010-10#1)(2012-2#1)
by mitochondria##4##2##(1994-5#2)(2009-8#1)(2011-2#1)
by mitogen-activated protein kinases##2##4##(1996-2#2)
by mitogen-activated protein##3##3##(1996-2#2)(2008-10#1)
by mixed##5##2##(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#2)
by mixing a##2##3##(2007-11#1)(2008-10#1)
by mixing in##2##3##(2008-10#2)
by mixing the##5##3##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
by mixing with##3##3##(2008-10#2)(2011-1#1)
by mixing##25##2##(1990-8#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#1)(2009-6#1)(2011-1#1)(2012-1#1)
by mobile##5##2##(2008-10#1)(2008-12#3)(2009-3#1)
by model##5##2##(1992-6#1)(2008-10#3)(2008-3#1)
by modeling of the##2##4##(2007-11#1)(2008-3#1)
by modeling of##3##3##(2007-11#1)(2008-3#2)
by modeling the##2##3##(2008-11#1)(2008-9#1)
by modeling##6##2##(1993-9#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-9#1)
by modelling the##2##3##(1997-8#1)(2008-10#1)
by modelling##3##2##(1993-9#1)(1997-8#1)(2008-10#1)
by moderate or##2##3##(1990-12#1)(2008-7#1)
by moderate##3##2##(1990-12#1)(2008-1#1)(2008-7#1)
by modern##5##2##(2008-7#3)(2010-5#2)
by modification of the##4##4##(1996-7#1)(2007-11#1)(2008-10#2)
by modification of##6##3##(1994-5#1)(1996-7#1)(2007-11#1)(2008-10#3)
by modification##7##2##(1994-5#1)(1996-7#1)(2007-11#1)(2008-10#3)(2013-1#1)
by modified##9##2##(1990-11#1)(1993-8#1)(1995-12#1)(2008-10#4)(2008-2#1)(2013-8#1)
by modifying the##7##3##(1993-12#1)(1995-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
by modifying##12##2##(1993-11#1)(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2011-2#1)
by modulating its##2##3##(2009-8#1)(2012-2#1)
by modulating the expression of##4##5##(1992-8#1)(2008-11#1)(2008-9#1)(2009-10#1)
by modulating the expression##5##4##(1992-8#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-10#1)
by modulating the##14##3##(1990-12#1)(1992-8#1)(1994-6#1)(1997-3#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#2)(2013-8#1)
by modulating##25##2##(1990-12#1)(1992-8#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#2)
by modulation of the##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
by modulation of##7##3##(1994-3#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-12#1)
by modulation##9##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-12#1)
by modulator##2##2##(1993-8#2)
by mole fraction) and##2##4##(2008-2#1)(2008-3#1)
by molecular beam epitaxy##4##4##(1995-3#1)(2007-12#1)(2009-11#2)
by molecular cloning##2##3##(1993-2#1)(1995-11#1)
by molecular dynamics##4##3##(1993-11#1)(1994-8#1)(2008-10#1)(2008-4#1)
by molecular markers##2##3##(2008-10#1)(2008-8#1)
by molecular mechanics##2##3##(2008-10#1)(2008-8#1)
by molecular modeling##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
by molecular modelling##2##3##(1995-11#2)
by molecular oxygen##2##3##(1997-7#1)(2008-5#1)
by molecular replacement using the##2##5##(1992-4#1)(1993-8#1)
by molecular replacement##9##3##(1992-4#1)(1993-8#2)(2008-4#2)(2008-8#3)(2008-9#1)
by molecular##45##2##(1990-11#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-8#1)(1995-11#3)(1995-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#6)(2008-9#2)(2009-11#2)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
by moment analysis of correlation peaks##2##6##(2008-2#2)
by monitoring an##2##3##(1994-9#1)(2008-10#1)
by monitoring the change in##2##5##(1995-6#1)(2008-11#1)
by monitoring the##17##3##(1991-8#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)
by monitoring##34##2##(1990-12#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1994-9#2)(1995-5#2)(1995-6#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
by monoclonal antibodies##5##3##(1990-12#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-5#1)
by monoclonal antibody##4##3##(1995-2#1)(2006-6#1)(2008-10#1)(2008-8#1)
by monoclonal##11##2##(1990-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(2006-6#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
by monocytes##4##2##(1992-2#1)(1995-8#2)(2010-5#1)
by monolithic##2##2##(2008-10#1)(2008-3#1)
by more intensive##2##3##(1994-3#1)(2007-10#1)
by more than 1 order of magnitude##2##7##(2008-3#2)
by more than 20-fold##2##4##(1993-6#1)(2008-10#1)
by more than 25%##2##4##(2008-10#1)(2011-1#1)
by more than 50%##6##4##(1993-11#1)(1994-2#1)(1995-5#1)(2008-7#1)(2010-3#1)(2012-12#1)
by more than 90%##2##4##(1992-12#1)(2008-10#1)
by more than a factor of##3##6##(1990-8#1)(1997-2#1)(2008-10#1)
by more than an order of magnitude##2##7##(2007-11#2)
by more than one##5##4##(2007-12#1)(2008-10#2)(2008-12#1)(2010-2#1)
by more than##44##3##(1990-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
by more##54##2##(1990-8#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-2#2)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
by morning##2##2##(2008-10#1)(2012-2#1)
by morphine##4##2##(1991-1#1)(1993-12#1)(1994-2#1)(1995-11#1)
by morphological changes##2##3##(1994-6#1)(2008-9#1)
by morphological##6##2##(1991-6#1)(1994-6#1)(2008-10#2)(2008-9#2)
by morphology##3##2##(2008-10#2)(2011-2#1)
by mosquitoes##3##2##(2007-2#1)(2008-10#1)(2011-2#1)
by most isolates##2##3##(2008-10#2)
by most of the##4##4##(1990-12#1)(1993-8#1)(2007-7#1)(2013-1#1)
by most##21##2##(1990-12#1)(1990-9#1)(1992-12#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-9#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
by mothers and fathers##2##4##(1994-12#1)(2009-7#1)
by mothers##7##2##(1994-12#1)(1995-1#1)(2008-2#1)(2009-7#2)(2009-8#2)
by motion##4##2##(2008-3#1)(2008-8#1)(2012-3#2)
by motivating##2##2##(1996-3#1)(2008-11#1)
by motor##2##2##(1996-5#1)(2010-7#1)
by mounting##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
by mouse brain slices##2##4##(1990-7#2)
by mouse##5##2##(1990-7#2)(1995-2#1)(1997-4#1)(2008-8#1)
by mouth##5##2##(1990-11#1)(1991-4#1)(1991-9#1)(1997-1#1)(2012-2#1)
by movement of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
by movement##5##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
by moving in##2##3##(2008-10#1)(2009-12#1)
by moving the##3##3##(1991-1#1)(2008-3#2)
by moving##9##2##(1991-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)
by mtDNA##2##2##(2008-12#1)(2010-8#1)
by mu##5##2##(2008-10#4)(2008-8#1)
by much##2##2##(2007-11#1)(2011-2#1)
by mucosal routes##2##3##(1997-3#2)
by mucosal##4##2##(1997-3#2)(2008-5#2)
by multidetector-row computed tomography##2##4##(2012-2#2)
by multidimensional analysis##2##3##(2008-10#1)(2008-9#1)
by multidimensional##3##2##(1996-7#1)(2008-10#1)(2008-9#1)
by multidisciplinary teams##2##3##(2011-1#1)(2011-2#1)
by multidisciplinary##3##2##(2011-1#1)(2011-2#1)(2012-3#1)
by multifocal##2##2##(2011-2#1)(2012-1#1)
by multiphoton##3##2##(2007-11#2)(2008-9#1)
by multiple genes##2##3##(2008-6#1)(2012-3#1)
by multiple linear regression##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
by multiple reaction monitoring##2##4##(2011-2#1)(2013-1#1)
by multiple regression##2##3##(1994-12#1)(2013-8#1)
by multiple##64##2##(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
by multiplex PCR##2##3##(2008-12#1)(2011-2#1)
by multiplex RT-PCR##2##3##(2008-10#1)(2013-8#1)
by multiplex##6##2##(2008-10#3)(2008-12#1)(2011-2#1)(2013-8#1)
by multiplexing the##2##3##(2008-1#1)(2008-2#1)
by multiplying##6##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)
by multiresistant##3##2##(2010-4#1)(2013-8#2)
by multivalent##2##2##(1995-5#1)(2009-2#1)
by multivariate analysis##3##3##(1991-8#1)(1993-9#1)(1994-7#1)
by multivariate calibration##3##3##(2008-10#2)(2008-2#1)
by multivariate regression##2##3##(1990-3#1)(2008-10#1)
by multivariate spectrophotometric calibration##2##4##(2008-10#2)
by multivariate##15##2##(1990-3#1)(1991-8#1)(1993-5#1)(1993-9#1)(1994-7#1)(1997-7#1)(2008-10#7)(2008-2#1)(2011-2#1)
by murine##4##2##(1991-9#1)(1992-8#1)(1994-5#1)(2008-9#1)
by muscarinic##4##2##(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#1)
by muscular##2##2##(1990-3#1)(2008-7#1)
by mutagenesis##2##2##(1995-2#1)(2008-2#1)
by mutant##3##2##(2008-12#1)(2008-4#1)(2008-8#1)
by mutating##2##2##(1993-8#1)(2008-10#1)
by mutation in##2##3##(2008-9#1)(2011-1#1)
by mutation##7##2##(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)
by mutations in the gene##3##5##(1990-5#1)(1997-3#1)(2011-1#1)
by mutations in the##8##4##(1990-5#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-1#2)(2011-1#1)(2013-8#1)
by mutations in these##2##4##(2008-4#2)
by mutations in##18##3##(1990-5#1)(1996-2#1)(1997-1#1)(1997-3#2)(2007-7#2)(2008-1#2)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
by mutations##23##2##(1990-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-3#2)(2007-7#3)(2008-1#2)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
by my##2##2##(2012-12#2)
by mycelial##2##2##(2008-10#2)
by mycobacteria##2##2##(2008-8#1)(2013-1#1)
by myo-inositol##2##2##(1992-12#2)
by myocardial infarction##2##3##(1993-1#1)(2011-2#1)
by myocardial##3##2##(1993-1#1)(2011-2#1)(2013-8#1)
by myristic acid co-chemisorption##2##4##(2008-10#2)
by naloxone##5##2##(1991-1#1)(1992-3#1)(1994-8#1)(1995-12#1)(1996-2#1)
by nanoindentation##2##2##(2009-7#1)(2010-4#1)
by nanosecond##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
by narrow##2##2##(2007-12#2)
by narrowing##2##2##(2007-11#1)(2008-12#1)
by native##7##2##(1993-6#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2013-8#1)
by natural and##2##3##(2008-5#1)(2008-8#1)
by natural disasters is##2##4##(2013-1#2)
by natural or##2##3##(1997-3#1)(2011-1#1)
by natural selection##5##3##(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#2)
by natural##20##2##(1991-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#3)
by naturally occurring##6##3##(1994-11#1)(1995-2#1)(1995-9#2)(2007-6#1)(2008-10#1)
by nature and##2##3##(2008-10#1)(2010-7#1)
by nature##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
by near infrared##2##3##(2008-10#2)
by near##4##2##(1995-12#1)(2008-10#2)(2011-1#1)
by near-field##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by near-infrared (NIR)##2##3##(2007-12#1)(2008-10#1)
by near-infrared spectroscopy and##2##4##(2007-12#1)(2008-10#1)
by near-infrared spectroscopy##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
by near-infrared##10##2##(2007-12#2)(2008-10#4)(2008-3#3)(2008-5#1)
by nearby##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
by nearly##8##2##(1990-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)
by nebulization##2##2##(1995-3#2)
by neck##2##2##(1997-3#1)(2008-12#1)
by necrotizing##2##2##(2008-1#1)(2008-10#1)
by needle##2##2##(2008-10#1)(2008-7#1)
by negative selection##2##3##(2008-4#2)
by negative##5##2##(2008-10#1)(2008-11#1)(2008-4#2)(2012-2#1)
by negatively regulating##2##3##(1995-2#1)(2010-11#1)
by neither##2##2##(2008-9#1)(2011-1#1)
by nematode##2##2##(2008-10#2)
by neonatal##5##2##(1992-5#1)(1993-3#1)(2008-1#1)(2008-11#1)(2008-4#1)
by neoplastic##3##2##(1990-3#1)(1992-8#1)(2012-12#1)
by nerve growth factor (NGF)##2##5##(1992-9#1)(1996-12#1)
by nerve growth factor##6##4##(1992-9#2)(1993-12#1)(1994-8#1)(1996-12#1)(2008-11#1)
by nerve##9##2##(1992-9#2)(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
by nested PCR##3##3##(2008-10#2)(2011-1#1)
by nested##5##2##(2008-10#3)(2008-12#1)(2011-1#1)
by network##4##2##(2007-11#1)(2012-2#1)(2012-3#2)
by networks of##2##3##(1990-5#1)(2010-1#1)
by neural network##2##3##(2008-10#1)(2008-3#1)
by neural##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
by neurodegeneration##3##2##(1995-5#2)(2008-7#1)
by neuronal loss##2##3##(2008-7#2)
by neuronal##7##2##(1994-8#1)(2007-10#1)(2008-5#2)(2008-7#3)
by neurons in the##2##4##(1991-5#1)(1994-2#1)
by neurons##4##2##(1991-5#1)(1994-2#1)(2008-4#1)(2008-7#1)
by neuropeptide Y##2##3##(1993-5#1)(1995-12#1)
by neuropeptide##4##2##(1993-5#1)(1994-8#1)(1995-11#1)(1995-12#1)
by neuropsychological##2##2##(2008-2#1)(2011-1#1)
by neurotransmitters##2##2##(2008-11#1)(2013-8#1)
by neutral endopeptidase##3##3##(1991-2#2)(1992-6#1)
by neutral##6##2##(1991-2#2)(1992-6#1)(1995-6#1)(2008-6#1)(2008-8#1)
by neutralization##2##2##(2008-5#1)(2011-1#1)
by neutralizing antibodies##2##3##(1993-3#1)(1995-2#1)
by neutralizing##4##2##(1993-3#1)(1995-2#1)(2008-5#1)(2012-12#1)
by neutron##2##2##(1995-8#1)(2008-10#1)
by neutrophil##3##2##(1990-5#1)(1991-5#1)(1997-1#1)
by new##6##2##(1994-3#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)
by nickel##2##2##(2008-10#1)(2010-2#1)
by nicotine##6##2##(1995-6#1)(1996-2#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
by nine##5##2##(1990-12#1)(1995-2#1)(2008-10#2)(2008-11#1)
by nisoldipine##2##2##(1993-3#2)
by nitrate##3##2##(2008-10#2)(2011-2#1)
by nitric acid##2##3##(2008-10#2)
by nitric oxide##5##3##(1992-3#1)(1995-5#1)(2008-12#1)(2008-4#1)(2009-10#1)
by nitric##7##2##(1992-3#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-10#1)
by nitrite##4##2##(1992-12#1)(1993-11#1)(2008-10#2)
by nitrogen##3##2##(1994-12#1)(1997-7#1)(2008-10#1)
by no means##8##3##(1990-12#1)(1994-1#1)(1995-1#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)
by no##11##2##(1990-12#1)(1994-1#1)(1995-1#1)(1996-5#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-12#1)(2009-3#1)
by noise##6##2##(2007-11#2)(2008-10#1)(2008-3#2)(2008-9#1)
by non##2##2##(2008-10#2)
by non-Medicare payers##2##3##(1994-12#2)
by non-Medicare##3##2##(1993-3#1)(1994-12#2)
by non-invasive methods##2##3##(1990-9#1)(1993-12#1)
by non-invasive##3##2##(1990-9#1)(1993-12#1)(2008-5#1)
by non-linear regression##5##3##(2008-10#5)
by non-linear##7##2##(2008-10#7)
by non-suppressed##2##2##(2008-10#2)
by nonaqueous##2##2##(2008-10#2)
by noncollinear##2##2##(2007-12#2)
by noncontact##2##2##(2008-3#1)(2009-10#1)
by noncovalent##2##2##(2008-10#1)(2008-4#1)
by nonlinear propagation##2##3##(2007-12#2)
by nonlinear regression analysis##3##4##(1993-3#1)(2008-10#2)
by nonlinear##11##2##(1993-3#1)(1995-2#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-7#1)(2011-1#1)
by nonprofit organizations##2##3##(1993-2#1)(1995-2#1)
by nonprofit##4##2##(1992-3#2)(1993-2#1)(1995-2#1)
by nonspecific##2##2##(1990-12#1)(1992-6#1)
by nonspherical particles with##2##4##(2008-3#2)
by nonspherical##3##2##(2008-3#3)
by noradrenaline##4##2##(1995-12#1)(1997-4#3)
by norepinephrine##5##2##(1990-5#1)(1993-6#1)(1996-5#1)(2008-4#2)
by normal human fibroblasts##3##4##(2008-5#3)
by normal human##4##3##(1992-2#1)(2008-5#3)
by normal##14##2##(1992-2#1)(1992-9#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-5#3)(2009-12#1)(2012-7#1)(2013-7#2)
by normal-phase##2##2##(2008-10#2)
by normalization of##3##3##(2008-1#1)(2008-3#2)
by normalization##4##2##(2008-1#1)(2008-3#3)
by northern blot##3##3##(2008-10#2)(2008-4#1)
by northern##4##2##(2008-10#2)(2008-4#2)
by not only##4##3##(1992-8#1)(1995-8#1)(1996-3#1)(2012-1#1)
by not##7##2##(1990-12#1)(1992-8#1)(1995-8#1)(1996-3#1)(2010-12#1)(2012-1#1)(2012-2#1)
by noting##3##2##(2010-11#1)(2010-2#1)(2012-2#1)
by novel##5##2##(1990-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
by np-BNR##2##2##(2008-10#2)
by nuclear magnetic resonance (NMR)##2##5##(1995-5#1)(2008-10#1)
by nuclear magnetic resonance spectroscopy##3##5##(1994-5#1)(1995-5#1)(2008-10#1)
by nuclear magnetic resonance##9##4##(1991-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(2008-10#3)
by nuclear transfer##2##3##(2008-11#1)(2008-9#1)
by nuclear##15##2##(1991-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2010-3#1)
by nuclease protection##3##3##(1995-2#1)(2008-2#1)(2008-4#1)
by nuclease##5##2##(1990-7#2)(1995-2#1)(2008-2#1)(2008-4#1)
by nucleotide sequence analysis of##2##5##(2008-10#2)
by nucleotide sequencing##2##3##(1990-12#1)(1992-8#1)
by nucleotide##7##2##(1990-12#1)(1992-8#1)(1994-12#1)(2008-10#2)(2008-4#1)(2010-2#1)
by null ellipsometry##3##3##(2008-3#3)
by null##4##2##(2008-3#3)(2009-8#1)
by number##2##2##(1996-5#1)(2008-10#1)
by numerical integration##2##3##(1991-5#1)(2007-11#1)
by numerical simulation##2##3##(2008-10#1)(2008-3#1)
by numerical simulations that##2##4##(2007-11#1)(2007-12#1)
by numerical simulations##10##3##(2007-11#3)(2007-12#4)(2008-3#2)(2013-8#1)
by numerical##23##2##(1991-5#1)(1994-12#1)(2007-11#6)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2013-8#1)
by numerous##12##2##(1990-11#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(2008-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
by nurse##6##2##(1990-12#1)(2008-11#3)(2008-12#1)(2012-3#1)
by nurses to##2##3##(2008-1#1)(2010-10#1)
by nurses##16##2##(1996-2#1)(1997-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-9#2)(2010-10#2)(2012-2#1)(2013-1#4)
by nursing students##4##3##(2008-11#4)
by nursing##10##2##(1991-2#2)(1996-7#1)(2008-11#4)(2010-10#1)(2013-1#2)
by nutrient##4##2##(2008-5#1)(2008-7#3)
by nutrients##2##2##(2008-8#1)(2009-5#1)
by nutritional##4##2##(1991-12#1)(1995-3#1)(2007-7#1)(2012-1#1)
by oblique##2##2##(2008-10#1)(2008-2#1)
by observation of the##2##4##(2008-3#2)
by observation of##6##3##(1992-6#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
by observation##8##2##(1990-12#1)(1992-6#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
by observations##3##2##(1996-4#1)(1996-6#1)(2008-6#1)
by observing a##2##3##(2008-3#1)(2008-7#1)
by observing the##5##3##(1991-12#1)(2008-3#2)(2008-5#1)(2012-1#1)
by observing##11##2##(1991-12#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-1#1)
by obtaining##5##2##(2008-10#3)(2008-8#1)(2009-11#1)
by occlusion of a##2##4##(2008-2#1)(2008-7#1)
by occlusion of##3##3##(2007-10#1)(2008-2#1)(2008-7#1)
by occlusion##5##2##(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)
by occupational##4##2##(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)
by offering an##3##3##(2009-6#1)(2013-1#2)
by offering##5##2##(2008-11#1)(2008-4#1)(2009-6#1)(2013-1#2)
by office-based##2##2##(2008-11#1)(2011-2#1)
by okadaic acid##4##3##(1992-12#1)(1994-11#1)(1995-11#1)(1995-8#1)
by older##4##2##(1993-12#1)(1993-6#1)(2012-12#1)(2012-2#1)
by oleic acid in##2##4##(1990-5#1)(1990-7#1)
by oleic acid##4##3##(1990-5#1)(1990-7#1)(1993-9#2)
by oligonucleotide##3##2##(1992-12#1)(1996-7#1)(1997-1#1)
by oligonucleotide-directed mutagenesis##2##3##(1990-10#1)(1992-3#1)
by omega##2##2##(1992-8#1)(2008-9#1)
by omega-conotoxin##2##2##(1992-7#1)(1996-5#1)
by omitting the##2##3##(1995-2#1)(2008-10#1)
by on-line column##2##3##(2008-10#2)
by on-line elution##3##3##(2008-10#3)
by on-line reaction with##2##4##(2008-10#2)
by on-line##27##2##(2008-10#26)(2008-2#1)
by once##2##2##(2007-11#1)(2008-8#1)
by oncogene transfection##2##3##(2008-11#2)
by oncogene##4##2##(1994-9#1)(2008-11#3)
by oncogenes##3##2##(2008-11#2)(2008-6#1)
by one (5%)##2##3##(1996-9#2)
by one of the most##2##5##(2008-9#2)
by one of the##5##4##(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#2)
by one of these##2##4##(2007-11#1)(2012-2#1)
by one of two##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
by one of##15##3##(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-8#1)(2012-2#1)
by one or more of the following##2##7##(1991-9#1)(2008-10#1)
by one or more##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
by one or two##2##4##(2008-10#1)(2008-8#1)
by one or##7##3##(1991-9#1)(1995-8#1)(2008-10#2)(2008-8#1)(2008-9#2)
by one pathologist##2##3##(1992-8#2)
by one position downstream##2##4##(1997-7#2)
by one species##3##3##(2008-5#1)(2008-8#2)
by one surgeon##2##3##(2008-7#1)(2008-9#1)
by one##73##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-9#2)(1997-3#1)(1997-7#2)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#7)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
by one's##2##2##(2008-11#1)(2008-3#1)
by one- or two-dimensional##2##4##(1993-8#1)(2008-10#1)
by one-##3##2##(1993-8#1)(1995-11#1)(2008-10#1)
by one-dimensional##2##2##(2008-2#1)(2008-6#1)
by one-step##4##2##(1996-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
by ongoing##2##2##(2008-6#1)(2009-8#1)
by only 10%##2##3##(1993-9#1)(2008-3#1)
by only a few##2##4##(2008-10#1)(2010-3#1)
by only a single##2##4##(1991-9#1)(2008-8#1)
by only a##5##3##(1991-9#1)(2008-10#1)(2008-8#1)(2010-3#1)(2012-1#1)
by only one##3##3##(1991-12#1)(2008-5#1)(2009-5#1)
by only two##2##3##(2008-10#1)(2008-2#1)
by only##31##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-7#2)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-7#1)
by opaque##2##2##(1990-3#1)(2008-3#1)
by open reduction and internal fixation##3##6##(2008-8#1)(2012-2#2)
by open reduction##4##3##(2008-8#1)(2009-4#1)(2012-2#2)
by open##13##2##(1997-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
by opening##2##2##(2007-11#1)(2013-1#1)
by operating##6##2##(1995-6#1)(2007-12#1)(2008-7#3)(2011-2#1)
by operation of##2##3##(2007-12#1)(2008-2#1)
by operation##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
by optical absorption##2##3##(1995-2#1)(2008-10#1)
by optical and##2##3##(1994-12#1)(2008-10#1)
by optical coherence tomography##2##4##(2007-11#1)(2008-2#1)
by optical emission##2##3##(2008-10#2)
by optical means##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
by optical microscopy and##3##4##(2008-10#1)(2008-3#1)(2009-7#1)
by optical microscopy##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
by optical rectification of##2##4##(2007-11#2)
by optical rectification##3##3##(2007-11#3)
by optical##44##2##(1994-11#1)(1994-12#1)(1995-2#1)(2007-11#8)(2007-12#11)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#4)(2009-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
by optimal##3##2##(2007-11#2)(2012-3#1)
by optimization of the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
by optimization of##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
by optimization##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)
by optimizing the##3##3##(1997-2#1)(2007-12#1)(2008-10#1)
by optimizing##5##2##(1997-2#1)(2007-12#1)(2008-10#2)(2013-8#1)
by optoelectronic##2##2##(2007-11#1)(2008-3#1)
by oral administration of##3##4##(2008-10#2)(2008-11#1)
by oral gavage##3##3##(2008-10#2)(2011-2#1)
by oral route##4##3##(2008-5#3)(2012-2#1)
by oral##16##2##(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
by orchiectomy##2##2##(2008-10#2)
by order##2##2##(1992-2#1)(2008-6#1)
by ordering##2##2##(1996-12#2)
by orders of##2##3##(2008-3#1)(2008-7#1)
by ordinary##5##2##(2008-10#3)(2008-3#2)
by organic##5##2##(1995-11#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
by organisms in##2##3##(2010-11#1)(2011-2#1)
by organizations that##3##3##(1994-2#1)(2011-2#1)(2013-8#1)
by orthogonal##3##2##(2008-10#3)
by osteoblasts##3##2##(1997-1#2)(2010-10#1)
by other approaches##2##3##(2008-3#1)(2008-7#1)
by other authors using the##2##5##(1996-4#1)(2008-7#1)
by other authors using##3##4##(1996-4#1)(2008-7#2)
by other authors##9##3##(1991-2#1)(1996-4#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)
by other demographic characteristics##2##4##(1993-2#1)(2008-12#1)
by other environmental##2##3##(1997-2#1)(2008-5#1)
by other factors##4##3##(1990-3#1)(1992-8#1)(1995-12#1)(2008-11#1)
by other investigators##3##3##(1994-2#1)(2008-10#1)(2008-8#1)
by other methods##10##3##(1990-3#1)(1991-2#1)(2008-10#3)(2008-2#1)(2008-4#2)(2011-1#1)(2013-8#1)
by other private##2##3##(1992-3#1)(1997-1#1)
by other researchers##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
by other techniques##2##3##(2007-12#1)(2008-3#1)
by other##108##2##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#2)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#3)
by others as##2##3##(2008-10#1)(2008-5#1)
by others in##3##3##(1994-11#1)(1995-12#1)(2008-10#1)
by others to##2##3##(1997-3#1)(2009-4#1)
by others##24##2##(1990-10#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
by ouabain##5##2##(1990-11#1)(1992-3#1)(1994-12#2)(1994-3#1)
by our group##7##3##(2008-10#3)(2008-2#1)(2008-9#1)(2009-11#1)(2010-12#1)
by our laboratory##2##3##(2008-10#1)(2009-8#1)
by our method##2##3##(2008-2#1)(2008-3#1)
by our observation that##2##4##(1990-7#1)(2011-2#1)
by our study##2##3##(1990-5#1)(2013-1#1)
by our##46##2##(1990-5#1)(1990-7#1)(1992-6#2)(1993-5#1)(1993-9#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
by ourselves##2##2##(1990-9#1)(1994-9#1)
by outlining##2##2##(1994-3#1)(2008-11#1)
by over##13##2##(1990-5#1)(1992-3#1)(1993-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)
by over-expression of##2##3##(1994-9#1)(2008-11#1)
by overall##2##2##(1996-7#1)(2008-1#1)
by overexpressing the##2##3##(1997-3#1)(2012-3#1)
by overexpressing##3##2##(1997-3#1)(1997-7#1)(2012-3#1)
by overexpression of##9##3##(1990-11#1)(1993-11#1)(1994-10#1)(1995-2#1)(1996-5#1)(1997-7#1)(2008-11#2)(2008-7#1)
by overgrowth##2##2##(2008-11#2)
by overlapping##3##2##(1991-2#1)(1993-9#1)(2010-10#1)
by overturning##2##2##(2007-5#1)(2009-8#1)
by oxidants##2##2##(1990-7#1)(1991-9#1)
by oxidation of##9##3##(2008-10#8)(2008-5#1)
by oxidation to##2##3##(1994-2#1)(1994-8#1)
by oxidation with##5##3##(1995-2#1)(2008-10#4)
by oxidation##19##2##(1991-7#1)(1994-2#1)(1994-8#1)(1995-2#1)(2008-10#12)(2008-5#1)(2008-8#1)(2013-7#1)
by oxidative stress##5##3##(1992-3#1)(1994-2#1)(1995-5#1)(2008-4#1)(2008-7#1)
by oxidative##8##2##(1992-3#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
by oxidizing##4##2##(2008-10#2)(2008-7#1)(2012-8#1)
by oxygen free radicals##2##4##(1991-9#1)(1995-12#1)
by oxygen##10##2##(1990-12#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)
by oxygen-covered##2##2##(2010-12#2)
by ozonation##2##2##(1992-5#1)(2013-1#1)
by ozonolysis##2##2##(1992-12#1)(1996-5#1)
by p53##2##2##(1994-9#1)(2008-5#1)
by pH titration##2##3##(2008-10#2)
by pH##8##2##(1994-8#1)(2008-10#6)(2008-5#1)
by pI##2##2##(2008-4#1)(2010-4#1)
by packaging##2##2##(1992-8#1)(2012-2#1)
by packing##3##2##(2008-10#3)
by paediatric residents##2##3##(2008-11#2)
by pain and##2##3##(2008-11#1)(2008-7#1)
by pain##6##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
by pairing##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
by palmitic acid##2##3##(2008-5#1)(2011-1#1)
by pancreatic##2##2##(1991-3#1)(1995-5#1)
by paper electrophoresis##2##3##(1993-11#1)(2008-10#1)
by paper##3##2##(1993-11#1)(1994-9#1)(2008-10#1)
by parallel##5##2##(1991-6#1)(2008-10#4)
by parameter##2##2##(2008-10#2)
by parametric##2##2##(2007-11#1)(2008-2#1)
by parasites##3##2##(2009-2#1)(2010-8#1)(2011-2#1)
by parasitic##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
by parathyroid hormone##2##3##(1993-6#1)(1995-6#1)
by parathyroid##3##2##(1993-6#1)(1995-6#1)(2009-7#1)
by parent and teacher improved to##2##6##(2012-2#2)
by parental##3##2##(1991-9#1)(1993-1#1)(2008-9#1)
by parents of children##2##4##(1992-2#1)(2008-11#1)
by parents##15##2##(1992-2#2)(1993-3#1)(1995-1#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
by partial least squares (PLS)##2##5##(2008-10#2)
by partial least squares regression##2##5##(2008-10#2)
by partial least squares##7##4##(2008-10#7)
by partial least-squares##3##3##(2008-10#3)
by partial sequencing##2##3##(1997-3#1)(2011-1#1)
by partial##20##2##(1991-8#1)(1997-3#1)(2007-10#1)(2008-10#12)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
by partially##4##2##(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
by participant##2##2##(2009-11#1)(2012-2#1)
by participants for impact##2##4##(2008-4#2)
by participants in##2##3##(2009-6#1)(2010-8#1)
by participants##13##2##(1994-3#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#2)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
by participating in##2##3##(1992-1#1)(2008-10#1)
by participating##4##2##(1992-1#1)(2008-10#1)(2008-4#1)(2008-9#1)
by particle bombardment and##2##4##(2008-10#2)
by particle bombardment##5##3##(2008-10#4)(2008-5#1)
by particle size##2##3##(2008-10#1)(2008-5#1)
by particle##10##2##(1997-2#1)(2007-12#1)(2008-10#5)(2008-5#2)(2010-11#1)
by particles##2##2##(2008-2#1)(2008-3#1)
by partitioning##2##2##(1993-8#1)(2008-10#1)
by partly##2##2##(1996-5#1)(2012-2#1)
by passage of##2##3##(1992-8#1)(2008-10#1)
by passage through##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
by passage##5##2##(1992-8#1)(1995-12#1)(2008-10#2)(2008-3#1)
by passing them##2##3##(2008-10#2)
by passing##13##2##(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)
by passive##5##2##(1995-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-12#1)
by pathogen##2##2##(2008-10#2)
by pathogenic##3##2##(2008-10#2)(2013-1#1)
by pathogenicity assays##2##3##(2008-10#2)
by pathogenicity tests and##2##4##(2008-10#2)
by pathogenicity tests##4##3##(2008-10#4)
by pathogenicity##11##2##(2008-10#11)
by pathogens##5##2##(2008-10#2)(2009-6#1)(2011-10#1)(2013-1#1)
by pathological examination##4##3##(2007-8#1)(2008-10#1)(2012-12#1)(2013-7#1)
by pathological##5##2##(2006-12#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-7#1)
by pathologists##2##2##(2008-3#1)(2011-2#1)
by patient##6##2##(1990-12#1)(1994-11#1)(1997-5#1)(2007-8#1)(2011-2#2)
by patients and by physicians##2##5##(2012-1#2)
by patients and their##2##4##(1990-10#1)(2012-3#1)
by patients and##11##3##(1990-10#1)(1991-6#1)(1995-12#1)(1996-1#1)(1996-8#1)(2008-11#1)(2010-6#1)(2012-1#2)(2012-3#2)
by patients in##4##3##(1992-12#1)(2008-6#1)(2010-10#2)
by patients with##8##3##(1991-12#1)(1996-1#1)(2008-10#3)(2008-4#1)(2010-5#1)(2012-3#1)
by patients##44##2##(1990-10#1)(1991-12#2)(1991-6#1)(1992-12#1)(1993-5#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-3#4)(2013-1#1)(2013-8#1)
by patients'##2##2##(2010-2#1)(2013-1#1)
by pattern recognition of##2##4##(2008-3#2)
by patterns of##2##3##(1994-9#1)(2008-8#1)
by paying##4##2##(1995-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
by peer##3##2##(1991-3#1)(2008-11#1)(2013-1#1)
by people of##2##3##(1993-12#1)(2012-3#1)
by people##7##2##(1993-12#1)(2008-10#3)(2012-2#1)(2012-3#2)
by pepstatin A##2##3##(1991-9#1)(1995-8#1)
by peptide##4##2##(1990-8#1)(1993-3#1)(1993-8#1)(2008-7#1)
by peptides##3##2##(1990-11#1)(1994-8#1)(2008-5#1)
by perceived##3##2##(2011-2#2)(2013-1#1)
by percent##2##2##(2008-10#1)(2013-1#1)
by percutaneous##3##2##(1991-8#1)(1993-8#1)(2007-7#1)
by performing a##4##3##(1991-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
by performing the##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
by performing##31##2##(1991-3#1)(1991-4#1)(1994-1#1)(2007-11#1)(2007-12#4)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
by perfusing##2##2##(1997-2#1)(2008-10#1)
by perfusion of##3##3##(1995-6#2)(2013-8#1)
by perfusion##4##2##(1995-6#2)(2008-2#1)(2013-8#1)
by perinatal administration of##2##4##(1993-5#2)
by periodate##4##2##(2008-10#4)
by periodic##3##2##(2007-11#1)(2008-10#2)
by periodically##2##2##(2007-12#1)(2008-2#1)
by periods at##2##3##(2008-10#2)
by peripheral##7##2##(1992-3#1)(1993-12#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-3#1)(2012-3#1)
by peritoneal##3##2##(2007-7#1)(2011-2#1)(2012-3#1)
by permanent section##2##3##(1995-4#2)
by permanent##5##2##(1995-4#2)(1997-2#2)(2007-10#1)
by permanganate##2##2##(2008-10#2)
by peroxodisulfate##2##2##(2008-10#2)
by peroxynitrite##3##2##(2008-10#2)(2008-5#1)
by persistent##2##2##(2010-5#1)(2012-1#1)
by personal##3##2##(1993-9#1)(2008-12#1)(2013-1#1)
by persons with##2##3##(2008-10#1)(2008-6#1)
by persons##4##2##(1995-1#1)(2008-10#1)(2008-6#1)(2010-10#1)
by perturbation of##3##3##(1995-12#1)(2008-3#1)(2008-8#1)
by pertussis toxin##3##3##(1990-8#1)(1994-9#1)(1997-1#1)
by pertussis##4##2##(1990-8#1)(1992-9#1)(1994-9#1)(1997-1#1)
by pervaporation##2##2##(2008-10#2)
by phage assay##2##3##(2007-7#2)
by phage display##2##3##(2008-10#1)(2010-12#1)
by phage##4##2##(2007-7#2)(2008-10#1)(2010-12#1)
by phagocytes##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
by pharmaceutical##2##2##(2008-10#1)(2008-2#1)
by pharmacies##3##2##(1990-2#1)(1995-1#1)(2008-8#1)
by pharmacologic##2##2##(1991-12#1)(1994-3#1)
by pharmacological##7##2##(1994-10#1)(1995-11#1)(2007-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#1)
by phase contrast##3##3##(1992-12#1)(2012-3#1)(2013-7#1)
by phase modulation##2##3##(2007-11#1)(2008-3#1)
by phase##15##2##(1990-5#1)(1991-2#1)(1992-12#1)(2007-11#4)(2008-3#5)(2011-2#1)(2012-3#1)(2013-7#1)
by phenol##2##2##(2008-10#1)(2008-2#1)
by phenolic compounds##4##3##(1991-5#1)(2008-10#3)
by phenolic##6##2##(1991-5#1)(2008-10#5)
by phenols##2##2##(2008-10#2)
by phenotypic##2##2##(2008-10#1)(2012-3#1)
by phenoxodiol##2##2##(2009-9#2)
by phenylephrine##4##2##(1991-6#2)(1994-3#2)
by phorbol 12-myristate 13-acetate (PMA)##2##5##(1994-11#1)(2008-11#1)
by phorbol 12-myristate 13-acetate##3##4##(1992-12#1)(1994-11#1)(2008-11#1)
by phorbol ester in##2##4##(1994-6#1)(1997-1#1)
by phorbol ester##7##3##(1991-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-6#1)(1997-1#1)(2008-11#1)
by phorbol esters##5##3##(1990-12#2)(1993-8#1)(1995-6#1)(1996-2#1)
by phorbol myristate acetate (PMA)##2##5##(1997-4#1)(2006-6#1)
by phorbol myristate acetate##4##4##(1993-11#1)(1994-6#1)(1997-4#1)(2006-6#1)
by phorbol##19##2##(1990-12#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-8#2)(1994-11#2)(1994-6#2)(1995-6#2)(1996-2#1)(1997-1#1)(1997-4#1)(2006-6#1)(2008-11#2)
by phorids##3##2##(2008-6#3)
by phosphate##4##2##(1991-5#1)(1992-8#1)(2008-10#1)(2010-12#1)
by phosphatidylinositol##3##2##(1993-8#1)(2008-8#1)(2011-2#1)
by phosphoinositide##2##2##(1993-11#1)(1997-4#1)
by phosphoinositides##2##2##(1993-8#1)(1994-12#1)
by phospholipase A2##2##3##(1990-11#1)(1994-3#1)
by phospholipase C##3##3##(1993-6#2)(2008-11#1)
by phospholipase##6##2##(1990-11#1)(1993-6#2)(1994-3#1)(2008-11#2)
by phospholipases##2##2##(1991-5#1)(1994-11#1)
by phospholipids##3##2##(1992-12#1)(1994-3#1)(2008-5#1)
by phosphonic acid-imbedded polyurethane foam##2##5##(2008-10#2)
by phosphorylation of the##3##4##(1992-9#1)(1995-3#1)(1997-2#1)
by phosphorylation##15##2##(1990-8#3)(1992-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#3)(1997-7#1)(2008-11#1)
by phosphorylation-dephosphorylation##2##2##(1992-11#1)(1995-6#1)
by photoaffinity labeling with##2##4##(1993-11#1)(1995-11#1)
by photoaffinity##3##2##(1993-11#1)(1993-8#1)(1995-11#1)
by photobleaching techniques##2##3##(2008-1#1)(2011-2#1)
by photobleaching##4##2##(2008-1#3)(2011-2#1)
by photochemical##3##2##(1992-6#1)(2008-2#1)(2008-5#1)
by photochemically##2##2##(2008-10#1)(2008-11#1)
by photodynamic therapy##4##3##(1992-9#1)(1996-8#1)(2008-8#1)(2012-2#1)
by photodynamic##5##2##(1992-9#1)(1996-8#1)(2008-8#1)(2012-2#2)
by photogenerated##2##2##(2008-10#1)(2009-11#1)
by photolithography##2##2##(2007-11#1)(2008-11#1)
by photolysis##5##2##(1996-5#1)(2008-10#2)(2008-4#1)(2008-5#1)
by photometric##2##2##(1991-9#1)(2008-10#1)
by photometry##3##2##(2008-10#2)(2008-5#1)
by photomultiplier##2##2##(2008-2#1)(2008-3#1)
by photons##3##2##(2007-12#3)
by photopolymerization##2##2##(2007-11#1)(2007-12#1)
by photorefractive##3##2##(2007-12#3)
by phylogenetic analyses of the##2##5##(2008-10#1)(2008-8#1)
by phylogenetic analyses##3##3##(2007-6#1)(2008-10#1)(2008-8#1)
by phylogenetic##5##2##(2007-6#1)(2008-10#1)(2008-8#1)(2009-2#1)(2013-8#1)
by physical adsorption##2##3##(2008-10#2)
by physical agents##2##3##(1990-6#2)
by physical and##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
by physical examination##2##3##(1995-4#1)(2008-1#1)
by physical exercise##2##3##(2010-6#1)(2013-8#1)
by physical therapists##3##3##(1991-3#1)(1992-3#1)(2008-12#1)
by physical##19##2##(1990-2#1)(1990-6#2)(1991-3#1)(1992-3#1)(1995-4#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-7#1)(2013-8#1)
by physician##3##2##(2008-3#1)(2009-11#1)(2012-1#1)
by physicians and##2##3##(1991-2#1)(1996-3#1)
by physicians##20##2##(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-12#1)(2010-5#1)(2012-1#4)(2012-3#1)(2013-1#1)
by phytic acid##3##3##(2008-10#3)
by phytoplasmas##2##2##(2008-10#2)
by picrotoxin##3##2##(1995-12#1)(1995-5#1)(2008-9#1)
by piecewise##2##2##(2007-11#1)(2008-10#1)
by placing the##4##3##(1992-5#1)(1994-12#1)(2008-3#1)(2011-1#1)
by placing##12##2##(1992-5#1)(1994-12#1)(1995-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2011-1#1)
by plant extracts##2##3##(2008-11#1)(2008-5#1)
by plant##11##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-7#1)
by plants##8##2##(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#2)
by plaque##3##2##(1992-8#1)(2008-10#1)(2008-9#1)
by plasma##6##2##(1995-5#1)(2007-12#1)(2008-10#2)(2012-2#2)
by plasma-enhanced##2##2##(2007-11#1)(2008-3#1)
by plasmid##2##2##(2008-8#1)(2011-1#1)
by plastic##3##2##(1993-9#1)(2007-12#1)(2012-12#1)
by plasticized##2##2##(2008-10#2)
by plate counts##2##3##(2008-10#2)
by platelet##3##2##(1991-3#1)(1991-8#1)(1992-6#1)
by platelets in##2##3##(1995-11#1)(1997-7#1)
by platelets##3##2##(1995-11#1)(1997-7#1)(2009-3#1)
by plating##3##2##(2008-10#2)(2011-1#1)
by plotting the##4##3##(2008-10#4)
by plotting##6##2##(2008-10#5)(2008-3#1)
by plugging##2##2##(1990-10#1)(2008-10#1)
by point mutations##2##3##(1991-12#1)(2008-7#1)
by point##5##2##(1991-12#1)(1992-8#1)(2008-11#1)(2008-7#1)(2010-12#1)
by poisoning##2##2##(1997-3#1)(2012-12#1)
by polarization##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
by polarized##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
by polarography##6##2##(2008-10#6)
by poliomyelitis##2##2##(2009-3#2)
by polishing##5##2##(2008-10#5)
by pollen##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
by pollination##2##2##(2008-10#1)(2009-10#1)
by polyacrylamide gel electrophoresis##7##4##(1990-7#1)(1992-12#1)(1992-3#1)(2008-4#2)(2008-5#1)(2008-7#1)
by polyacrylamide##8##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(2008-4#2)(2008-5#1)(2008-7#1)
by polyamines##2##2##(1992-11#1)(2008-8#1)
by polyclonal antibodies##2##3##(1992-8#1)(1995-6#1)
by polyclonal##9##2##(1990-9#1)(1991-2#1)(1992-8#1)(1995-6#2)(2008-4#4)
by polycyclic##2##2##(1995-11#1)(2008-10#1)
by polyethylene##2##2##(2009-3#1)(2011-3#1)
by polymerase chain reaction (PCR) and##3##6##(2008-10#1)(2010-6#1)(2011-2#1)
by polymerase chain reaction (PCR) screening##3##6##(1996-10#1)(1996-12#1)(1997-2#1)
by polymerase chain reaction (PCR) using##3##6##(1996-12#1)(1996-8#1)(2008-7#1)
by polymerase chain reaction (PCR)##20##5##(1991-9#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)
by polymerase chain reaction amplification of##2##6##(2008-10#2)
by polymerase chain reaction amplification##4##5##(2008-10#4)
by polymerase chain reaction and##4##5##(1991-9#1)(2008-10#1)(2008-5#1)(2008-6#1)
by polymerase chain reaction from##4##5##(2008-10#3)(2008-4#1)
by polymerase chain reaction in##2##5##(1996-3#1)(2008-10#1)
by polymerase chain reaction of##2##5##(1993-8#1)(2008-10#1)
by polymerase chain reaction using##3##5##(2008-10#2)(2012-12#1)
by polymerase chain reaction##61##4##(1990-12#2)(1990-5#1)(1990-7#1)(1991-9#2)(1992-6#1)(1993-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#30)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-6#2)(2011-2#2)(2012-12#2)
by polymerase chain##64##3##(1990-12#2)(1990-5#1)(1990-7#1)(1991-9#2)(1992-2#1)(1992-6#1)(1993-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#31)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-6#2)(2011-2#2)(2012-12#2)
by polyurethane##2##2##(2008-10#2)
by pooling##3##2##(1994-11#1)(1994-9#1)(2008-10#1)
by poor##6##2##(1990-10#1)(1991-9#1)(2007-9#1)(2008-10#1)(2008-2#1)(2012-12#1)
by population##6##2##(1995-9#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
by populations of##3##3##(2008-10#2)(2013-1#1)
by porcine##3##2##(1991-8#1)(1992-3#1)(1992-8#1)
by portal##2##2##(1991-11#2)
by positioning a##2##3##(1994-12#1)(2013-1#1)
by positioning##5##2##(1994-12#1)(2007-11#1)(2008-10#1)(2013-1#2)
by positive##9##2##(1992-8#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
by positron emission tomography (PET)##3##5##(1990-8#1)(1996-2#1)(1996-5#1)
by positron emission tomography##4##4##(1990-8#1)(1996-2#1)(1996-5#2)
by possibly##2##2##(2008-10#1)(2013-1#1)
by post##5##2##(2008-12#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
by post-column##2##2##(1990-8#1)(2008-10#1)
by post-transcriptional##2##2##(1990-11#1)(2008-10#1)
by postnatal##3##2##(1994-2#1)(1996-5#1)(2008-4#1)
by posttraining##2##2##(1994-8#1)(2008-5#1)
by postulating##2##2##(1992-6#1)(1994-5#1)
by potassium hexacyanoferrate(III)##2##3##(2008-10#2)
by potassium periodate in##2##4##(2008-10#2)
by potassium periodate##5##3##(2008-10#5)
by potassium##12##2##(1990-5#1)(2008-10#10)(2008-3#1)
by potato##3##2##(2008-10#3)
by potential##5##2##(1992-12#1)(1996-12#1)(2008-10#2)(2011-1#1)
by potentiometric and##2##3##(2008-10#2)
by potentiometric titration##5##3##(2008-10#5)
by potentiometric titrations##2##3##(2008-10#2)
by potentiometric##16##2##(2008-10#16)
by potentiometry and##5##3##(2008-10#5)
by potentiometry##9##2##(2008-10#9)
by potocytosis##2##2##(1994-6#1)(1995-6#1)
by powder metallurgy##2##3##(2009-7#2)
by practical examples##2##3##(1996-5#1)(2012-12#1)
by practical##3##2##(1996-5#1)(2008-11#1)(2012-12#1)
by practising##2##2##(1996-6#1)(2008-12#1)
by practitioners and##2##3##(1996-3#1)(2007-12#1)
by practitioners##5##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)
by prazosin##2##2##(1990-12#1)(1990-5#1)
by pre-column##2##2##(2008-10#1)(2011-1#1)
by pre-treatment with genistein or daidzein##2##6##(2008-10#2)
by pre-treatment with##3##3##(1991-9#1)(2008-10#2)
by pre-treatment##4##2##(1991-9#1)(2008-10#2)(2008-4#1)
by precipitating##2##2##(2008-10#2)
by precipitation with##3##3##(1994-6#1)(2008-10#1)(2008-8#1)
by precipitation##9##2##(1994-6#1)(2008-10#5)(2008-6#1)(2008-8#1)(2013-1#1)
by precise##2##2##(2008-11#1)(2008-6#1)
by precolumn##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
by preconcentration##4##2##(2008-10#4)
by predators and##2##3##(1997-7#1)(2008-8#1)
by predators as##2##3##(2012-3#2)
by predators##6##2##(1997-7#1)(2008-8#2)(2012-3#3)
by preferential##2##2##(1997-2#1)(2008-10#1)
by pregnant women##5##3##(1995-8#1)(2008-7#1)(2009-4#1)(2013-1#2)
by preincubating##2##2##(1994-6#1)(2008-8#1)
by preincubation of cells with##2##5##(1991-12#1)(1994-6#1)
by preincubation of##4##3##(1991-12#1)(1994-6#1)(1995-11#1)(1997-1#1)
by preincubation with##3##3##(1991-9#1)(1993-9#1)(1995-11#1)
by preincubation##7##2##(1991-12#1)(1991-9#1)(1993-9#1)(1994-6#1)(1995-11#2)(1997-1#1)
by premature##4##2##(1994-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
by prenatal##2##2##(1990-2#1)(1996-5#1)
by preparative##6##2##(1990-12#1)(1994-12#1)(1995-6#1)(2006-12#1)(2008-10#1)(2008-5#1)
by preparing##2##2##(1995-3#1)(2008-11#1)
by prescription##2##2##(1995-1#1)(2008-2#1)
by presenting a##2##3##(1996-1#1)(2008-3#1)
by presenting the##4##3##(1997-3#1)(2008-6#1)(2009-6#1)(2011-2#1)
by presenting##12##2##(1992-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
by pressure and##2##3##(1995-2#1)(2010-8#1)
by pressure##5##2##(1990-6#1)(1995-2#1)(1996-12#1)(2008-10#1)(2010-8#1)
by pressurized##2##2##(2008-10#2)
by pretreating the##2##3##(1995-12#1)(1996-5#1)
by pretreatment of the cells with##2##6##(1997-1#2)
by pretreatment of the##3##4##(1995-2#1)(1997-1#2)
by pretreatment of##8##3##(1992-8#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
by pretreatment with the extracts##2##5##(2013-1#2)
by pretreatment with the##4##4##(1990-5#1)(1993-12#1)(2013-1#2)
by pretreatment with##10##3##(1990-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1997-6#1)(1997-7#1)(2012-2#1)(2013-1#2)
by pretreatment##20##2##(1990-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1997-1#2)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
by preventing the##3##3##(1990-7#1)(1995-12#1)(2008-5#1)
by preventing##14##2##(1990-5#1)(1990-7#2)(1991-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#1)(2012-3#1)
by prevention of##3##3##(1990-12#1)(2008-10#1)(2012-12#1)
by previous##9##2##(1995-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#3)
by previously##3##2##(2008-10#3)
by primary care physicians##2##4##(1996-11#1)(2009-9#1)
by primary care##4##3##(1995-2#1)(1996-11#2)(2009-9#1)
by primary##11##2##(1990-9#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-11#2)(2008-10#1)(2009-9#1)
by primer extension analysis of##2##5##(1993-2#1)(1993-8#1)
by primer extension analysis##3##4##(1990-11#1)(1993-2#1)(1993-8#1)
by primer extension##9##3##(1990-11#2)(1990-12#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)
by primer##10##2##(1990-11#2)(1990-12#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(2008-10#1)
by principal component analysis (PCA) and##5##6##(2008-10#5)
by principal component analysis (PCA)##8##5##(2008-10#7)(2013-1#1)
by principal component analysis##12##4##(2008-10#9)(2011-2#1)(2013-1#2)
by principal component##13##3##(2008-10#10)(2011-2#1)(2013-1#2)
by prior exposure to##2##4##(1994-9#1)(1997-1#1)
by prior i##2##3##(1996-2#1)(1997-4#1)
by prior##15##2##(1992-12#1)(1992-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-4#1)(2011-2#1)
by private insurers##2##3##(1993-1#1)(1994-1#1)
by private##10##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(1997-4#1)(2008-10#1)(2009-8#1)(2011-2#1)
by pro-choice##2##2##(1995-6#1)(1996-5#1)
by probabilistic##2##2##(2008-7#1)(2010-8#1)
by probing##6##2##(1990-5#1)(1991-9#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
by problems##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
by procedure##2##2##(2008-10#2)
by process##2##2##(1996-5#1)(2008-7#1)
by processing of##2##3##(2007-11#1)(2008-3#1)
by processing##8##2##(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
by producing a##4##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
by producing##12##2##(1994-2#1)(1994-6#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
by production of##2##3##(1990-8#1)(2008-4#1)
by products##3##2##(2008-10#2)(2008-5#1)
by prof##2##2##(2007-8#2)
by professional##4##2##(1990-2#1)(1996-1#1)(2010-8#1)(2011-2#1)
by professionals##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
by profile##2##2##(2011-1#2)
by progesterone in normal##2##4##(1990-5#2)
by progesterone##4##2##(1990-5#2)(1991-12#1)(2008-8#1)
by programmed##3##2##(1995-12#1)(2007-8#1)(2008-10#1)
by progressive##12##2##(1992-12#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-7#1)
by projection##2##2##(2008-2#2)
by prolonged treatment##2##3##(1990-12#1)(1991-12#1)
by prolonged##8##2##(1990-12#1)(1991-12#1)(1997-1#1)(2008-1#1)(2008-7#1)(2011-1#2)(2013-1#1)
by prolonging the##2##3##(2008-11#1)(2008-4#1)
by prolonging##3##2##(2008-11#1)(2008-4#1)(2011-3#1)
by promoter##3##2##(1995-6#1)(2008-9#1)(2011-1#1)
by promoting a##3##3##(1992-9#1)(1994-8#1)(2008-8#1)
by promoting the##4##3##(1994-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
by promoting##12##2##(1992-9#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
by prompt##2##2##(2010-11#1)(2010-8#1)
by propagation##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
by proper##4##2##(1995-12#1)(2007-12#2)(2008-10#1)
by properly##2##2##(2011-1#1)(2012-3#1)
by prophylactic##2##2##(1993-3#1)(1996-11#1)
by proportional##2##2##(2008-10#1)(2012-12#1)
by proposing##3##2##(1996-3#1)(1997-1#1)(2008-10#1)
by prostaglandin E1 infusion##3##4##(2007-8#3)
by prostaglandin##4##2##(1994-5#1)(2007-8#3)
by prostatic##2##2##(1990-3#1)(1993-8#1)
by protease##4##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
by proteases##2##2##(1994-2#1)(2008-10#1)
by protecting##4##2##(1994-2#1)(1995-2#1)(2008-5#2)
by protein G##2##3##(1990-12#2)
by protein engineering##3##3##(1992-11#1)(1997-6#2)
by protein kinase A##5##4##(1991-2#2)(1994-6#1)(2008-10#1)(2008-8#1)
by protein kinase C (PKC)##2##5##(1994-11#1)(2008-4#1)
by protein kinase C activation##2##5##(1995-8#1)(2013-1#1)
by protein kinase C and##3##5##(1995-5#1)(1995-6#1)(1997-2#1)
by protein kinase C##19##4##(1990-11#3)(1992-11#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1997-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
by protein kinase##26##3##(1990-11#3)(1991-2#2)(1992-11#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
by protein kinases C and##2##5##(1995-6#1)(2011-2#1)
by protein kinases##3##3##(1990-8#1)(1995-6#1)(2011-2#1)
by protein sequencing##2##3##(1993-9#1)(1995-6#1)
by protein##47##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#2)(1991-5#1)(1992-11#3)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#3)(1995-8#3)(1997-2#1)(1997-6#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#3)
by proteins##5##2##(1994-2#1)(2008-10#3)(2013-1#1)
by proteolysis##5##2##(1990-7#1)(2008-4#2)(2008-5#1)(2009-8#1)
by proteolytic cleavage of the##2##5##(1994-11#1)(1994-12#1)
by proteolytic cleavage##3##3##(1994-11#1)(1994-12#2)
by proteolytic processing##2##3##(1992-12#1)(1995-8#1)
by proteolytic##7##2##(1992-12#1)(1993-11#1)(1994-11#1)(1994-12#2)(1995-8#1)(2008-11#1)
by proton magnetic resonance spectroscopy##2##5##(1992-3#1)(2008-7#1)
by proton##3##2##(1992-3#1)(1996-3#1)(2008-7#1)
by provider##2##2##(2008-7#1)(2013-7#1)
by providers##5##2##(1993-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-6#1)
by providing a##11##3##(1994-1#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2013-7#1)
by providing timely##2##3##(1996-1#1)(2008-7#1)
by providing##38##2##(1991-9#1)(1993-3#1)(1994-1#2)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
by provincial##3##2##(2007-12#1)(2008-8#1)(2009-5#1)
by proximity##3##2##(2008-9#3)
by proxy##5##2##(1992-12#1)(1995-5#2)(1996-2#1)(2010-12#1)
by psychiatrists and##2##3##(1996-11#1)(2012-3#1)
by psychiatrists##3##2##(1996-11#1)(2012-3#1)(2013-8#1)
by psychological##2##2##(2007-7#1)(2008-6#1)
by public health##2##3##(1996-2#1)(1996-3#1)
by public##5##2##(1991-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2012-12#1)
by pulmonary##5##2##(2008-1#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
by pulse radiolysis##2##3##(2008-9#2)
by pulse##3##2##(1995-2#1)(2008-9#2)
by pulsed field gel electrophoresis##2##5##(2008-10#1)(2012-3#1)
by pulsed laser##5##3##(2007-11#4)(2008-2#1)
by pulsed##11##2##(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-3#1)
by pulsed-field gel electrophoresis##8##4##(1993-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-1#1)(2008-10#2)
by pulsed-field##11##2##(1993-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-3#2)
by pumping with the##2##4##(2008-2#2)
by pumping with##3##3##(2007-12#1)(2008-2#2)
by pumping##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2010-6#1)
by puncturing the##2##3##(1996-3#1)(2008-11#1)
by pure##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
by purified protein kinase C##2##5##(1990-11#1)(1991-2#1)
by purified##8##2##(1990-11#1)(1991-2#1)(1992-12#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-11#1)
by purinergic agents##2##3##(1995-8#2)
by putting##3##2##(1992-2#1)(1995-3#1)(2008-9#1)
by pyramiding##2##2##(2008-10#2)
by pyridoxal##2##2##(1995-6#1)(1997-7#1)
by pyridoxine##3##2##(1995-6#1)(2011-1#2)
by pyrophosphate gel electrophoresis##2##4##(1996-9#2)
by q-PCR##2##2##(2008-10#2)
by qualitative##6##2##(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
by qualitatively##2##2##(2008-11#1)(2010-1#1)
by quantification of##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
by quantification theory I and stepwise regression analysis##2##8##(1995-6#2)
by quantification##5##2##(1995-6#2)(2008-10#1)(2008-12#1)(2008-5#1)
by quantifying the##7##3##(2008-10#5)(2008-3#1)(2011-2#1)
by quantifying##8##2##(2007-10#1)(2008-10#5)(2008-3#1)(2011-2#1)
by quantitating the##3##3##(1994-5#1)(1995-2#1)(2006-6#1)
by quantitative PCR##3##3##(1993-6#1)(1995-2#1)(2008-2#1)
by quantitative autoradiography##3##3##(1992-5#1)(1995-12#1)(1996-5#1)
by quantitative in situ hybridization##2##5##(1993-5#1)(1996-12#1)
by quantitative polymerase chain reaction##2##5##(2008-10#1)(2013-8#1)
by quantitative real-time PCR##4##4##(2009-2#1)(2010-11#1)(2012-3#2)
by quantitative real-time##5##3##(2009-2#1)(2010-11#1)(2012-12#1)(2012-3#2)
by quantitative trait##2##3##(2008-10#1)(2008-9#1)
by quantitative##35##2##(1992-5#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
by quantum interference in##3##4##(2007-11#3)
by quantum##5##2##(2007-11#3)(2007-12#1)(2010-12#1)
by quartz crystal microbalance##3##4##(2008-10#3)
by quartz##4##2##(2008-10#3)(2008-3#1)
by quasi-elastic light scattering##3##4##(2008-10#2)(2008-3#1)
by questionnaire##4##2##(2008-6#1)(2011-2#2)(2012-3#1)
by questionnaires##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
by quinine##3##2##(2008-10#3)
by quinones##2##2##(1992-3#1)(1993-8#1)
by rabbit##2##2##(1996-2#1)(1996-5#1)
by race in the##2##4##(1995-2#2)
by race##12##2##(1995-2#3)(2008-10#3)(2008-12#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)
by race/ethnicity##2##2##(2013-1#2)
by races 1##2##3##(2008-10#2)
by races##4##2##(2008-10#4)
by radial##4##2##(1990-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
by radiation and##2##3##(1993-2#1)(2013-1#1)
by radiation therapy for##2##4##(2011-1#1)(2013-8#1)
by radiation therapy##5##3##(2006-12#1)(2008-1#1)(2008-7#1)(2011-1#1)(2013-8#1)
by radiation##12##2##(1990-10#1)(1993-2#1)(1993-6#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
by radical##10##2##(1990-6#1)(1994-6#2)(1995-11#1)(1995-8#1)(1996-5#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
by radioimmunoassay (RIA)##3##3##(1990-11#1)(2008-4#1)(2008-7#1)
by radioimmunoassay in##2##3##(1990-5#1)(1992-3#1)
by radioimmunoassay##14##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-3#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
by radiological##3##2##(1990-6#1)(2007-7#1)(2008-7#1)
by radiology##2##2##(2012-12#1)(2013-8#1)
by radiotherapy and##3##3##(1991-8#1)(2007-11#1)(2008-8#1)
by radiotherapy##13##2##(1990-12#1)(1990-6#2)(1991-8#1)(1991-9#1)(1993-8#1)(1996-9#2)(2007-11#2)(2008-8#2)(2010-11#1)
by rain##2##2##(2008-10#2)
by rainbow sizing##2##3##(2008-2#2)
by raising the##7##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-1#1)
by raising##11##2##(1991-8#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
by random amplified polymorphic DNA (RAPD) analysis##3##7##(2008-10#3)
by random amplified polymorphic DNA (RAPD)##4##6##(2008-10#4)
by random amplified polymorphic DNA##8##5##(2008-10#7)(2012-3#1)
by random amplified##9##3##(2008-10#8)(2012-3#1)
by random##17##2##(1990-11#1)(1996-6#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
by randomized##2##2##(2008-7#1)(2011-2#1)
by randomly##5##2##(1990-5#1)(2008-10#2)(2008-3#2)
by rapid##14##2##(1990-2#1)(1992-8#1)(1993-3#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
by rapidly##2##2##(1995-2#1)(1997-8#1)
by rare##3##2##(1995-4#1)(2013-1#1)(2013-8#1)
by rat hepatic microsomes##3##4##(2011-1#3)
by rat liver##2##3##(1994-8#1)(1995-8#1)
by rat##16##2##(1990-8#2)(1991-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#2)(1995-8#1)(2008-10#2)(2008-11#1)(2011-1#3)(2013-1#1)
by rates of##2##3##(2008-7#1)(2008-9#1)
by rats##6##2##(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#2)
by raw##2##2##(2007-2#1)(2013-1#1)
by ray tracing##2##3##(2008-2#2)
by ray##3##2##(2008-10#1)(2008-2#2)
by reacting with##3##3##(2008-10#2)(2008-5#1)
by reacting##12##2##(1994-2#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-4#1)
by reaction of the##2##4##(1992-2#1)(1996-2#1)
by reaction of##11##3##(1992-2#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-5#1)
by reaction with##19##3##(1993-8#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#11)(2008-12#1)(2008-4#1)(2009-9#1)
by reaction##33##2##(1992-2#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-10#14)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2013-1#1)
by reactive ion-assisted##3##3##(2008-3#3)
by reactive oxygen species (ROS)##5##5##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
by reactive oxygen species##6##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
by reactive##15##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
by reagent##2##2##(1996-12#1)(2008-10#1)
by real time PCR##2##4##(2011-2#2)
by real time##4##3##(2007-8#1)(2008-10#1)(2011-2#2)
by real##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#2)
by real-time PCR##4##3##(2008-10#2)(2012-1#1)(2012-3#1)
by real-time RT-PCR##3##3##(2010-4#1)(2012-2#1)(2013-1#1)
by real-time polymerase chain reaction##2##5##(2008-10#1)(2010-6#1)
by real-time polymerase chain##3##4##(2008-10#1)(2008-5#1)(2010-6#1)
by real-time reverse transcription-polymerase chain reaction##2##6##(2008-10#1)(2013-1#1)
by real-time##15##2##(2008-10#5)(2008-5#2)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
by realistic##2##2##(2008-11#1)(2008-3#1)
by reasonableness##2##2##(1992-2#1)(1995-9#1)
by receiving##2##2##(1993-2#1)(2010-4#1)
by recent##11##2##(1994-3#1)(1994-6#1)(1995-1#1)(1996-6#1)(1997-5#1)(2008-1#1)(2008-4#3)(2009-5#1)(2013-8#1)
by receptor##6##2##(1991-12#1)(1994-3#1)(1995-2#2)(1997-4#1)(2008-11#1)
by receptor-mediated endocytosis##2##3##(1995-2#1)(2008-10#1)
by receptor-mediated##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
by recognition##2##2##(2008-11#1)(2008-3#1)
by recognizing##3##2##(2008-8#1)(2009-10#1)(2011-1#1)
by recombinant DNA techniques##2##4##(1990-8#1)(1994-2#1)
by recombinant adeno-associated viral##2##4##(2008-9#2)
by recombinant human##4##3##(1990-12#1)(2008-1#1)(2013-1#1)(2013-8#1)
by recombinant##19##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1994-2#1)(1995-5#1)(1997-8#3)(2007-11#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-9#3)(2013-1#1)(2013-8#1)
by recombination among##3##3##(2008-10#3)
by recombination of##2##3##(1996-2#1)(2008-7#1)
by recombination##7##2##(1994-8#1)(1996-2#1)(2007-6#1)(2008-10#3)(2008-7#1)
by reconstitution of##2##3##(1994-12#1)(1994-5#1)
by reconstruction##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
by reconstructive##3##2##(1990-9#1)(1992-5#1)(2009-3#1)
by recording emission fluorescence spectra between##2##6##(2008-10#2)
by recording of the##2##4##(2007-11#1)(2008-10#1)
by recording of##4##3##(2007-11#3)(2008-10#1)
by recording the spectra##2##4##(2008-5#2)
by recording the##8##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2010-4#1)(2012-2#1)
by recording##20##2##(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-12#1)(2010-4#1)(2010-7#2)(2012-2#1)
by recoveries of##2##3##(2008-10#2)
by recovery measurements##3##3##(2008-10#3)
by recovery studies##4##3##(2010-5#4)
by recovery test##2##3##(2008-10#2)
by recovery##9##2##(2008-10#5)(2010-5#4)
by recruiting##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
by recurrent##10##2##(1990-10#1)(1996-5#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
by red blood cells##3##4##(2008-2#2)(2008-3#1)
by red light##2##3##(1990-5#1)(2008-4#1)
by red##7##2##(1990-5#1)(2007-5#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#1)
by reduced##14##2##(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-12#1)
by reducing the##22##3##(1990-2#1)(1991-12#1)(1991-3#1)(1994-1#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
by reducing total##2##3##(1991-6#1)(2008-8#1)
by reducing##53##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-3#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-9#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#5)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
by reduction at -1##2##4##(2008-10#2)
by reduction in##2##3##(1995-8#1)(2013-7#1)
by reduction of the##9##4##(1990-2#1)(1992-9#1)(2008-10#2)(2008-2#3)(2008-3#2)
by reduction of##15##3##(1990-2#1)(1992-9#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-5#1)
by reduction with##6##3##(1993-11#1)(1996-5#4)(2007-11#1)
by reduction##29##2##(1990-2#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-8#1)(1996-5#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#2)(2008-5#1)(2012-2#1)(2013-7#1)
by reductions in##2##3##(1995-12#1)(2008-5#1)
by reference methods##2##3##(2008-10#2)
by reference to the##2##4##(1990-9#1)(2008-3#1)
by reference to##7##3##(1990-9#1)(1994-2#1)(2008-10#1)(2008-3#2)(2012-2#2)
by reference##9##2##(1990-9#1)(1994-2#1)(2008-10#3)(2008-3#2)(2012-2#2)
by referring to templates##2##4##(2008-6#2)
by referring##3##2##(1996-1#1)(2008-6#2)
by refinement##2##2##(2008-3#2)
by reflecting##5##2##(2008-3#2)(2010-11#1)(2010-12#1)(2011-2#1)
by reflection##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
by reflections##2##2##(2007-12#1)(2008-2#1)
by reflex##2##2##(2008-1#2)
by regarding##2##2##(1995-1#1)(2013-8#1)
by region##4##2##(1992-2#1)(2008-10#2)(2012-2#1)
by regions of higher intensity##2##5##(2007-12#2)
by regions##3##2##(2007-12#2)(2008-10#1)
by regioselective##2##2##(2008-4#1)(2008-8#1)
by regressing##2##2##(2008-3#1)(2011-2#1)
by regression analysis##3##3##(2008-10#3)
by regression##5##2##(2008-10#4)(2011-1#1)
by regular##7##2##(1991-8#1)(1995-8#1)(2008-10#3)(2012-1#1)(2013-1#1)
by regulated##3##2##(1996-3#1)(2008-8#1)(2010-11#1)
by regulating the##6##3##(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#1)(2013-1#1)
by regulating##15##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-11#1)(2009-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
by regulation of##2##3##(2009-5#1)(2013-8#1)
by regulations##2##2##(1994-2#1)(2012-2#1)
by regulators##2##2##(2007-5#1)(2012-2#1)
by regulatory agencies##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
by regulatory##6##2##(1994-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-6#1)
by related##2##2##(1992-7#1)(2009-10#1)
by relating##2##2##(1990-11#1)(2008-10#1)
by relative standard deviation##2##4##(2008-10#2)
by relative standard##3##3##(2008-10#3)
by relative##11##2##(1993-2#1)(2008-10#5)(2008-11#1)(2008-3#2)(2011-1#1)(2011-2#1)
by relatively##7##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)
by relaxing##2##2##(2008-8#1)(2008-9#1)
by release of##5##3##(1990-5#1)(1993-12#1)(1994-2#1)(1995-8#1)(1997-4#1)
by releasing ATP##2##3##(2008-5#1)(2008-7#1)
by releasing the##2##3##(2008-11#1)(2011-2#1)
by releasing##6##2##(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)
by religious##5##2##(1996-9#1)(2008-12#1)(2009-6#1)(2009-7#1)(2012-12#1)
by remote##7##2##(1990-10#1)(1995-3#1)(1996-5#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
by removal of residual##2##4##(2008-10#1)(2008-12#1)
by removal of the##5##4##(1990-11#1)(1996-5#1)(2008-11#1)(2008-4#1)(2010-10#1)
by removal of##15##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-10#2)(2012-3#2)
by removal##16##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-10#2)(2012-3#2)
by removing a##2##3##(2008-10#1)(2012-2#1)
by removing the##5##3##(1991-2#1)(1997-4#1)(2008-8#1)(2009-8#1)(2010-2#1)
by removing##15##2##(1991-2#1)(1993-3#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
by renal dysfunction##3##3##(1997-4#2)(2013-1#1)
by renal##10##2##(1991-11#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-7#1)(2008-6#1)(2013-1#2)
by rep-PCR##3##2##(2008-10#3)
by repeat##2##2##(1993-9#1)(2008-7#1)
by repeated##18##2##(1992-3#2)(1994-9#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-7#1)(2010-8#1)(2011-2#1)
by repeatedly##2##2##(2008-10#1)(2009-9#1)
by repeating the##3##3##(2008-4#2)(2012-3#1)
by repeating##7##2##(2008-10#1)(2008-2#2)(2008-4#2)(2011-2#1)(2012-3#1)
by reperfusion##6##2##(1993-3#1)(1995-12#1)(2008-12#1)(2010-1#1)(2010-3#1)(2010-6#1)
by repetition of##2##3##(2007-11#1)(2008-2#1)
by repetitive##6##2##(1990-9#1)(2008-10#5)
by replacement of the##2##4##(1993-1#1)(2007-12#1)
by replacement of##8##3##(1990-12#1)(1991-5#1)(1992-3#2)(1993-1#1)(1995-12#1)(2007-12#1)(2008-3#1)
by replacing the##5##3##(1997-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-10#1)
by replacing##13##2##(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)
by replication##2##2##(2008-10#1)(2008-3#1)
by repressing##2##2##(2011-2#1)(2013-1#1)
by reproductive##2##2##(1993-11#1)(2008-9#1)
by requiring##2##2##(1992-1#1)(2009-10#1)
by research##6##2##(1997-8#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-7#1)(2013-1#1)
by researchers at##3##3##(1997-2#1)(2007-12#1)(2008-10#1)
by researchers in##2##3##(2008-4#1)(2010-5#1)
by researchers##12##2##(1992-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-8#1)
by residual##3##2##(2007-12#1)(2008-2#2)
by residues##2##2##(1994-5#1)(2008-5#1)
by resistance is##2##3##(2008-10#1)(2008-8#1)
by resistance##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
by resistant##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
by resolution of##2##3##(2008-3#1)(2013-1#1)
by resonance Raman##2##3##(1990-8#1)(1995-5#1)
by resonance##4##2##(1990-8#1)(1995-5#1)(2008-10#2)
by respiratory##4##2##(1992-2#1)(1996-3#1)(2011-2#1)(2012-3#1)
by responding##2##2##(1990-11#1)(2011-1#1)
by response surface##3##3##(2008-10#2)(2012-3#1)
by response##4##2##(1990-12#1)(2008-10#2)(2012-3#1)
by resting##2##2##(1995-3#1)(2008-4#1)
by restoring##5##2##(1993-12#1)(1993-3#1)(1995-3#1)(2008-2#1)(2010-12#1)
by restricted##2##2##(2008-9#1)(2012-12#1)
by restricting##3##2##(1993-12#1)(2008-10#1)(2008-6#1)
by restriction analysis of##3##4##(1996-3#1)(1996-6#1)(2008-10#1)
by restriction analysis##5##3##(1992-3#1)(1993-6#1)(1996-3#1)(1996-6#1)(2008-10#1)
by restriction endonuclease analysis##2##4##(1997-6#2)
by restriction endonuclease##3##3##(1997-6#2)(2008-8#1)
by restriction enzyme analysis##4##4##(1992-8#1)(1997-4#1)(2008-10#2)
by restriction enzyme digestion##2##4##(2008-10#2)
by restriction enzyme##7##3##(1992-8#1)(1997-4#1)(2008-10#5)
by restriction enzyme-mediated integration (REMI)##2##5##(2008-10#2)
by restriction fragment length polymorphism (RFLP) analysis##2##7##(2008-10#2)
by restriction fragment length polymorphism (RFLP)##4##6##(2008-10#4)
by restriction fragment length polymorphism analysis of the internal transcribed spacer##2##11##(2008-10#2)
by restriction fragment length polymorphism analysis of##3##7##(2008-10#3)
by restriction fragment length polymorphism analysis##5##6##(2008-10#5)
by restriction fragment length polymorphism##14##5##(1996-10#1)(2008-10#12)(2008-9#1)
by restriction fragment length polymorphisms##2##5##(2008-10#1)(2011-1#1)
by restriction fragment length##16##4##(1996-10#1)(2008-10#13)(2008-9#1)(2011-1#1)
by restriction mapping##2##3##(1992-8#1)(1992-9#1)
by restriction##37##2##(1992-3#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-2#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#21)(2008-8#1)(2008-9#1)(2011-1#1)
by results from##2##3##(1990-12#1)(2008-10#1)
by results##5##2##(1990-12#1)(1991-11#1)(1992-3#1)(2008-10#1)(2008-7#1)
by retardation##2##2##(2007-12#1)(2008-10#1)
by retention##2##2##(2006-10#1)(2008-5#1)
by reticulocytes##3##2##(1995-11#1)(1996-2#2)
by retinal##2##2##(2010-1#1)(2011-1#1)
by retinoic acid##8##3##(1992-8#1)(1993-3#3)(1994-10#1)(1994-11#1)(2008-11#2)
by retinoic##9##2##(1992-8#2)(1993-3#3)(1994-10#1)(1994-11#1)(2008-11#2)
by retinoids##3##2##(1992-2#1)(1994-6#1)(2008-4#1)
by retrograde##4##2##(1993-12#1)(2007-12#1)(2007-7#1)(2008-9#1)
by retrospective##2##2##(1994-3#1)(1995-5#1)
by retroviral##2##2##(2008-11#1)(2008-9#1)
by returning##3##2##(2007-2#1)(2008-1#1)(2010-8#1)
by reversal of the##2##4##(1992-12#1)(2008-3#1)
by reverse flow##2##3##(2008-10#2)
by reverse phase##4##3##(1990-12#1)(1991-8#1)(1997-4#1)(2008-10#1)
by reverse transcriptase polymerase chain reaction (RT-PCR)##2##7##(1996-12#1)(2008-7#1)
by reverse transcriptase polymerase chain reaction and##2##7##(1997-3#1)(2011-2#1)
by reverse transcriptase polymerase chain reaction##5##6##(1996-12#1)(1997-1#1)(1997-3#1)(2008-7#1)(2011-2#1)
by reverse transcriptase##6##3##(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-7#1)(2011-2#1)
by reverse transcriptase-polymerase chain reaction (RT-PCR)##2##6##(1997-6#1)(2008-8#1)
by reverse transcriptase-polymerase chain reaction##3##5##(1994-11#1)(1997-6#1)(2008-8#1)
by reverse transcription PCR##2##4##(2008-2#1)(2008-6#1)
by reverse transcription and polymerase chain reaction##2##7##(1995-12#1)(2011-2#1)
by reverse transcription and##3##4##(1993-8#1)(1995-12#1)(2011-2#1)
by reverse transcription##8##3##(1992-6#1)(1993-8#1)(1995-12#1)(1995-8#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#1)
by reverse transcription-PCR##2##3##(1995-8#1)(1996-12#1)
by reverse transcription-polymerase chain reaction (RT-PCR)##7##6##(1992-8#1)(1994-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-1#1)
by reverse transcription-polymerase chain reaction using##3##6##(1997-7#1)(2008-10#1)(2008-7#1)
by reverse transcription-polymerase chain reaction##13##5##(1992-8#1)(1993-11#1)(1994-6#1)(1995-12#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-1#1)
by reverse##41##2##(1990-12#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-8#2)(1996-12#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#2)
by reverse-flow injection##2##3##(2008-10#2)
by reverse-phase HPLC##3##3##(1994-5#1)(1995-5#1)(2008-10#1)
by reverse-phase chromatography##2##3##(2008-10#1)(2008-6#1)
by reverse-phase##8##2##(1993-11#1)(1994-5#1)(1995-5#1)(2008-10#4)(2008-6#1)
by reverse-transcription polymerase chain reaction (RT-PCR)##2##6##(2008-10#2)
by reverse-transcription polymerase chain reaction##3##5##(2008-10#3)
by reverse-transcription##4##2##(2008-10#3)(2008-4#1)
by reversed phase##4##3##(1993-9#1)(1995-2#1)(2008-10#2)
by reversed##6##2##(1990-7#1)(1993-9#1)(1995-2#1)(2008-10#3)
by reversed-phase HPLC and##2##4##(1996-5#1)(2008-10#1)
by reversed-phase HPLC##6##3##(1990-5#1)(1996-12#1)(1996-5#1)(2008-10#3)
by reversed-phase high performance liquid chromatography##4##6##(2008-10#3)(2008-11#1)
by reversed-phase high-performance liquid chromatography (RP-HPLC)##4##6##(1990-8#1)(2008-10#3)
by reversed-phase high-performance liquid chromatography and##2##6##(1992-6#1)(1993-9#1)
by reversed-phase high-performance liquid chromatography using##2##6##(1991-5#1)(2008-10#1)
by reversed-phase high-performance liquid chromatography with##3##6##(1990-8#1)(1991-5#2)
by reversed-phase high-performance liquid chromatography##18##5##(1990-8#4)(1991-12#1)(1991-5#4)(1992-6#1)(1993-9#1)(1995-6#1)(2008-10#6)
by reversed-phase liquid chromatography##3##4##(2008-10#2)(2008-5#1)
by reversed-phase##33##2##(1990-5#1)(1990-8#5)(1991-12#1)(1991-5#4)(1992-6#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#15)(2008-11#1)(2008-5#1)
by reversible##7##2##(1993-6#1)(2008-2#1)(2008-4#3)(2009-10#1)(2009-9#1)
by reversing the flow##2##4##(2008-10#2)
by reviewing the##4##3##(1996-12#1)(2008-6#1)(2010-7#1)(2012-12#1)
by reviewing##9##2##(1996-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-12#2)
by rf##2##2##(2007-12#1)(2008-3#1)
by rhodamine 6G##2##3##(2008-10#2)
by rhodamine##3##2##(2008-10#3)
by ribonuclease protection##2##3##(2008-10#2)
by ribosomal##2##2##(2008-8#1)(2012-12#1)
by right##2##2##(2008-11#1)(2011-2#1)
by rigorous##7##2##(1990-9#1)(1991-3#1)(1995-5#1)(2007-12#1)(2008-3#3)
by rising##2##2##(1992-5#1)(1995-1#1)
by risk##4##2##(1996-3#1)(1997-4#1)(2012-1#1)(2013-8#1)
by road##4##2##(2009-10#1)(2009-7#1)(2013-1#2)
by rolling##2##2##(1993-8#1)(2008-3#1)
by root##2##2##(2008-10#1)(2013-8#1)
by rotating the##2##3##(2008-3#2)
by rotating##5##2##(2008-3#3)(2008-7#1)(2009-7#1)
by rotation of the beam splitter grating about the axis##2##10##(2008-3#2)
by rotation of the##12##4##(1992-12#1)(2007-12#3)(2008-3#8)
by rotation of##13##3##(1992-12#1)(2007-12#3)(2008-2#1)(2008-3#8)
by rotenone##3##2##(1990-11#1)(1990-5#1)(2008-7#1)
by roughly##2##2##(2008-3#2)
by routine##6##2##(1990-6#1)(1991-7#1)(1992-12#1)(2008-3#1)(2012-2#1)(2012-3#1)
by running##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
by rupture##4##2##(1991-6#1)(2007-8#1)(2011-2#2)
by s##3##2##(1992-6#1)(1994-3#1)(2007-11#1)
by saline water##2##3##(2008-10#2)
by saline##4##2##(1992-8#1)(1997-2#1)(2008-10#2)
by salt stress##6##3##(1997-7#1)(1997-8#1)(2008-9#1)(2009-8#3)
by salt##8##2##(1997-2#1)(1997-7#1)(1997-8#1)(2008-12#1)(2008-9#1)(2009-8#3)
by samarium iodide##2##3##(2008-10#2)
by sample##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#1)
by sample-to-sample differences in DNA extraction##2##6##(2008-10#2)
by sampling dates##2##3##(2008-10#1)(2008-7#1)
by sampling of##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
by sampling the##3##3##(2008-10#2)(2008-7#1)
by sampling##23##2##(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
by saralasin##2##2##(1990-12#1)(1997-2#1)
by sarcoplasmic reticulum##2##3##(1994-11#1)(2008-8#1)
by scaling##2##2##(2008-5#1)(2012-2#1)
by scanning and transmission electron microscopy##3##6##(2007-12#3)
by scanning and transmission electron##4##5##(2007-12#4)
by scanning electron microscopy (SEM) and##3##6##(2008-7#1)(2009-7#1)(2012-2#1)
by scanning electron microscopy (SEM)##7##5##(2008-10#3)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
by scanning electron microscopy and##2##5##(2007-12#1)(2008-10#1)
by scanning electron microscopy to##2##5##(2008-12#1)(2009-7#1)
by scanning electron microscopy##21##4##(1992-2#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#2)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
by scanning electron##22##3##(1992-2#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#2)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
by scanning the potential##3##4##(2008-10#3)
by scanning the##5##3##(2008-10#3)(2008-3#1)(2008-4#1)
by scanning##41##2##(1992-2#1)(2007-12#5)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
by scattering##2##2##(2008-2#1)(2008-3#1)
by scavenging##4##2##(1991-9#1)(2008-10#1)(2010-5#1)(2011-2#1)
by scenario##2##2##(2008-12#1)(2013-1#1)
by schistosomes##3##2##(2009-5#3)
by school##3##2##(1993-6#1)(2010-1#1)(2012-2#1)
by scientific##2##2##(1993-6#1)(1997-3#1)
by scientists##3##2##(1992-12#1)(1996-9#1)(2008-9#1)
by scintigraphy##4##2##(2007-11#2)(2007-8#1)(2008-7#1)
by scintillation counting##2##3##(2008-11#1)(2008-8#1)
by scoring##2##2##(2008-10#1)(2012-1#1)
by screen-printing##2##2##(2008-10#2)
by screening a##8##3##(1991-2#1)(1991-6#1)(1994-8#1)(1996-10#1)(1997-4#1)(2008-8#2)(2008-9#1)
by screening with the##2##4##(1993-2#1)(1997-8#1)
by screening with##4##3##(1992-8#1)(1993-2#2)(1997-8#1)
by screening##25##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-8#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-4#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2012-3#1)
by search##3##2##(2008-8#2)(2010-8#1)
by searching for the##2##4##(2008-3#1)(2011-2#1)
by searching for##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
by searching##4##2##(2007-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
by second##3##2##(1991-6#1)(2008-10#1)(2008-12#1)
by second-derivative##3##2##(1993-8#1)(2008-10#2)
by second-harmonic generation frequency-resolved optical gating##2##6##(2007-11#1)(2007-12#1)
by second-harmonic##6##2##(2007-11#2)(2007-12#4)
by second-order##3##2##(1996-2#1)(2007-11#1)(2007-12#1)
by secondary##12##2##(1990-6#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2011-1#1)(2011-2#1)
by secreted##2##2##(2008-7#1)(2009-8#1)
by secretion of##3##3##(1990-4#1)(2008-7#1)(2009-12#1)
by secretion##4##2##(1990-4#1)(2007-12#1)(2008-7#1)(2009-12#1)
by sedimentation equilibrium##2##3##(1995-6#1)(2008-10#1)
by sedimentation##3##2##(1993-8#1)(1995-6#1)(2008-10#1)
by seed and##3##3##(2008-10#2)(2008-12#1)
by seed##7##2##(2006-11#1)(2008-10#5)(2008-12#1)
by seeding##4##2##(2007-11#1)(2008-5#2)(2012-12#1)
by segmented flow injection-hydride generation atomic absorption spectrometry (SFI-HGAAS)##2##9##(2008-10#2)
by segmented##4##2##(2008-10#2)(2008-2#1)(2009-7#1)
by seizures##2##2##(1995-5#1)(2013-7#1)
by selected ion monitoring (SIM) method##2##6##(2008-10#2)
by selected ion monitoring (SIM)##3##5##(2008-10#3)
by selected ion monitoring##4##4##(2008-10#4)
by selected##8##2##(1996-12#1)(1997-3#1)(2008-10#5)(2008-12#1)
by selecting a##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2012-3#1)
by selecting the##2##3##(2008-10#1)(2013-8#1)
by selecting##14##2##(1991-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
by selection at##2##3##(1997-7#1)(2010-3#1)
by selection of a##2##4##(2008-3#1)(2011-2#1)
by selection of the##3##4##(2007-12#1)(2008-3#2)
by selection of##7##3##(1993-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2011-2#1)
by selection##18##2##(1993-11#1)(1995-2#1)(1996-6#1)(1997-7#2)(2007-12#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2013-8#2)
by selective and sequential elution with 0##2##7##(2008-10#2)
by selective##22##2##(1990-5#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2011-2#1)
by selectively##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
by selenium##2##2##(1993-6#1)(2009-10#1)
by self-administered##2##2##(1993-2#1)(2013-1#1)
by self-assembly##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
by self-efficacy##2##2##(1993-12#1)(2010-2#1)
by self-phase modulation##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
by semantic##3##2##(1996-2#1)(2011-1#2)
by semi-quantitative RT-PCR##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
by semi-quantitative##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
by semi-structured interviews##2##3##(2007-10#1)(2008-9#1)
by senior management##2##3##(1992-12#1)(1992-2#1)
by senior##4##2##(1990-3#1)(1992-12#1)(1992-2#2)
by sensing##2##2##(2009-8#1)(2012-2#1)
by sensitization with##2##3##(2008-11#1)(2008-3#1)
by sensor##2##2##(2007-12#1)(2008-10#1)
by sensory##4##2##(1992-6#1)(1993-1#1)(2007-12#1)(2009-8#1)
by separate##4##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#1)
by separating##4##2##(1993-12#1)(2008-10#2)(2011-2#1)
by separation of##2##3##(2008-10#2)
by separation##4##2##(1990-8#1)(2008-10#3)
by sequence analysis of##4##4##(1993-12#1)(1993-2#1)(2008-10#2)
by sequence analysis##9##3##(1993-12#2)(1993-2#2)(2008-10#4)(2009-6#1)
by sequence homology##2##3##(1991-12#1)(2008-8#1)
by sequence##13##2##(1991-12#1)(1993-12#2)(1993-2#2)(2008-10#6)(2008-8#1)(2009-6#1)
by sequencing of##2##3##(1993-12#1)(2008-10#1)
by sequencing the##4##3##(1990-8#1)(1992-9#1)(2008-10#2)
by sequencing##13##2##(1990-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
by sequential extraction##2##3##(2008-10#2)
by sequential injection analysis and##2##5##(2008-10#2)
by sequential injection analysis##11##4##(2008-10#11)
by sequential injection chromatography##2##4##(2008-10#2)
by sequential injection##16##3##(2008-10#16)
by sequential metal vapor elution analysis (SMVEA)##2##7##(2008-10#2)
by sequential metal vapor elution analysis##3##6##(2008-10#3)
by sequential##31##2##(1990-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(2008-10#26)(2012-2#1)
by sera from##3##3##(1990-5#1)(2008-11#1)(2009-6#1)
by serial##8##2##(1990-3#1)(1993-11#1)(1994-8#1)(2008-10#2)(2008-2#2)(2008-9#1)
by serine proteases##3##3##(2008-1#2)(2008-5#1)
by serine##8##2##(1991-2#1)(1993-3#1)(1997-8#1)(2006-6#1)(2008-1#2)(2008-5#1)(2011-1#1)
by serological##6##2##(2007-12#1)(2008-10#3)(2008-4#1)(2011-2#1)
by serology##2##2##(2007-7#1)(2011-2#1)
by serotonin##2##2##(1993-12#1)(1996-7#1)
by serum is##2##3##(1990-8#1)(1994-9#1)
by serum starvation##2##3##(1992-3#1)(1993-9#1)
by serum##11##2##(1990-2#1)(1990-8#1)(1992-3#1)(1993-2#1)(1993-9#2)(1994-9#3)(1995-6#1)(2008-11#1)
by serving as##2##3##(2008-10#2)
by setting the##2##3##(2008-11#1)(2008-7#1)
by seven##6##2##(1997-4#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-10#1)(2013-8#1)
by several authors##4##3##(1993-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
by several different##5##3##(1992-3#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-5#1)
by several factors##5##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
by several groups##5##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2009-3#1)
by several mechanisms##4##3##(1990-11#1)(2008-5#1)(2008-6#1)(2009-3#1)
by several members of##2##4##(1994-8#1)(2008-10#1)
by several methods##2##3##(2008-4#1)(2013-8#1)
by several months##2##3##(2006-10#1)(2010-6#1)
by several orders of magnitude##7##5##(1994-5#1)(2007-11#2)(2008-10#1)(2008-3#2)(2012-2#1)
by several published##2##3##(2010-9#1)(2011-2#1)
by several species of##3##4##(2008-10#2)(2010-2#1)
by several strains of##3##4##(2008-10#3)
by several types of##3##4##(1996-3#1)(1997-3#1)(2008-4#1)
by several##98##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#4)(2008-10#19)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2009-3#2)(2009-8#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
by severe##14##2##(1990-9#1)(1997-3#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
by severity of##2##3##(1996-7#1)(2009-10#1)
by sewage##2##2##(2007-2#1)(2007-5#1)
by sex and age##2##4##(1995-12#1)(2011-2#1)
by sex and##5##3##(1995-12#1)(2008-7#2)(2011-2#1)(2013-8#1)
by sex hormones##2##3##(1994-3#1)(2010-6#1)
by sex##21##2##(1990-11#1)(1991-2#1)(1991-6#4)(1992-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#3)(2013-8#1)
by sexual selection##2##3##(2008-9#1)(2013-1#1)
by sexual##3##2##(2008-9#1)(2011-1#1)(2013-1#1)
by sexually##2##2##(2008-1#1)(2008-9#1)
by shaking with an##2##4##(2008-10#2)
by shaking##3##2##(2008-10#3)
by sharing##3##2##(1997-3#1)(2008-8#1)(2009-8#1)
by sharp##2##2##(2008-10#1)(2008-12#1)
by shifting of the##2##4##(2007-11#1)(2008-3#1)
by shifting of##3##3##(2007-11#1)(2008-3#2)
by shifting the##8##3##(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#1)
by shifting##14##2##(1995-6#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-8#2)(2011-2#1)
by short DNA##2##3##(2008-11#1)(2008-3#1)
by short##17##2##(1994-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
by shortening##3##2##(1997-4#1)(2007-12#1)(2008-10#1)
by showing how##2##3##(2008-3#1)(2009-5#1)
by showing that the##2##4##(2007-12#1)(2008-10#1)
by showing##8##2##(1991-5#1)(1992-6#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)
by siRNA##6##2##(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
by side##11##2##(1991-11#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2013-8#1)
by sigma##2##2##(1990-12#1)(1993-9#1)
by signal##2##2##(1991-11#1)(2008-9#1)
by significant increases in##2##4##(1996-12#1)(2008-10#1)
by significant##13##2##(1995-6#1)(1996-12#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-8#2)(2010-1#1)(2011-2#1)
by significantly increasing##2##3##(2012-2#2)
by significantly##5##2##(1991-3#1)(2008-6#1)(2010-2#1)(2012-2#2)
by silane##2##2##(2008-5#1)(2009-7#1)
by silencing##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
by silica gel##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
by silver staining##3##3##(1992-8#1)(1995-12#1)(2010-3#1)
by silver##9##2##(1992-8#1)(1995-12#1)(1997-3#1)(2008-10#5)(2010-3#1)
by similar##4##2##(1996-12#1)(2008-10#2)(2008-5#1)
by simple mechanical polishing##2##4##(2008-10#2)
by simple##32##2##(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
by simply polishing##5##3##(2008-10#5)
by simply##17##2##(1990-11#1)(1993-3#1)(2006-6#1)(2008-10#10)(2008-2#1)(2008-6#1)(2009-12#1)(2012-2#1)
by simulated sunlight##2##3##(2008-11#2)
by simulated##7##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2013-8#1)
by simulating the##2##3##(1993-3#1)(2008-3#1)
by simulating##4##2##(1993-3#1)(2007-12#1)(2008-3#1)(2008-5#1)
by simulation##10##2##(1997-2#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2012-1#1)(2013-1#1)
by simulations and experiments##3##4##(2008-3#3)
by simulations##5##2##(1996-4#1)(2007-12#1)(2008-3#3)
by simultaneous atomic absorption spectrometry##2##5##(2008-10#2)
by simultaneous detection of##2##4##(2008-10#1)(2011-1#1)
by simultaneous fermentation and cyclization##2##5##(2008-6#2)
by simultaneous measurement of##2##4##(2008-2#1)(2008-4#1)
by simultaneous##29##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-6#1)(1994-6#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
by simultaneously##4##2##(1994-3#1)(2008-11#2)(2008-4#1)
by single crystal X-ray##2##4##(2007-11#2)
by single seed descent from##2##5##(2008-10#2)
by single##33##2##(1995-6#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#18)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
by single-crystal X-ray diffraction##4##4##(1996-2#1)(1997-7#2)(2010-5#1)
by single-crystal##7##2##(1996-2#1)(1997-7#3)(2006-4#1)(2008-3#1)(2010-5#1)
by single-locus analysis##2##3##(2008-4#2)
by single-pass frequency doubling of the##2##6##(2007-11#2)
by single-pass frequency doubling of##3##5##(2007-11#2)(2007-12#1)
by single-pass##4##2##(2007-11#2)(2007-12#2)
by single-scan##2##2##(2008-3#1)(2012-8#1)
by single-strand conformation polymorphism##3##4##(1992-8#1)(2008-10#2)
by single-strand##4##2##(1992-8#1)(1994-5#1)(2008-10#2)
by single-stranded DNA##2##3##(1995-2#1)(2012-3#1)
by single-sweep oscillopolarography##3##3##(2008-10#3)
by sinusoidal##2##2##(2008-3#2)
by site##3##2##(1990-2#1)(1992-9#1)(1995-2#1)
by site-directed mutagenesis and expressed the##2##6##(1992-3#1)(1993-3#1)
by site-directed mutagenesis and##3##4##(1992-3#2)(1993-3#1)
by site-directed mutagenesis of##3##4##(1990-5#1)(1991-9#1)(1992-3#1)
by site-directed mutagenesis to##3##4##(1992-1#1)(1993-11#1)(2008-10#1)
by site-directed mutagenesis##35##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#4)(1992-6#2)(1992-8#2)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#2)(1995-2#4)(1995-5#4)(2008-10#1)(2008-8#1)(2008-9#3)
by site-directed##36##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#5)(1992-6#2)(1992-8#2)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#2)(1995-2#4)(1995-5#4)(2008-10#1)(2008-8#1)(2008-9#3)
by site-specific mutagenesis##2##3##(1992-3#1)(2008-8#1)
by six##8##2##(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-11#1)
by size exclusion chromatography##5##4##(1995-6#1)(2008-10#3)(2011-2#1)
by size exclusion##6##3##(1995-6#1)(2008-10#4)(2011-2#1)
by size##7##2##(1995-6#1)(2008-10#4)(2011-2#2)
by size-exclusion and##2##3##(1993-11#1)(2008-10#1)
by size-exclusion chromatography##6##3##(1993-11#1)(1993-6#1)(1996-5#2)(1997-2#1)(2008-9#1)
by size-exclusion##8##2##(1993-11#2)(1993-6#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-9#1)
by skin prick##2##3##(1997-6#1)(2012-3#1)
by skin##10##2##(1990-3#1)(1991-12#1)(1994-6#1)(1997-6#1)(2008-9#3)(2012-3#1)(2013-1#1)(2013-8#1)
by slab##2##2##(1995-6#1)(2008-10#1)
by slightly##3##2##(2007-11#1)(2008-10#2)
by slow##5##2##(1992-8#1)(2008-2#1)(2008-3#1)(2010-7#1)(2013-1#1)
by slowing down##2##3##(2011-2#2)
by slowing##4##2##(1991-12#1)(2008-7#1)(2011-2#2)
by slurry sampling##4##3##(2008-10#4)
by slurry##7##2##(2008-10#7)
by small molecules##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
by small##25##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
by smooth muscle cells##2##4##(1993-3#1)(1995-2#1)
by smooth##4##2##(1993-3#1)(1995-2#1)(2007-12#1)(2008-5#1)
by soaking##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
by social##7##2##(1992-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#2)
by society##2##2##(1993-12#1)(1993-6#1)
by sodium and##2##3##(1990-5#1)(2008-10#1)
by sodium channel##2##3##(2008-12#1)(2011-2#1)
by sodium deoxycholate##2##3##(1993-8#1)(2008-10#1)
by sodium dodecyl sulfate polyacrylamide gel electrophoresis##3##7##(1990-10#1)(2008-10#1)(2012-2#1)
by sodium dodecyl sulfate##6##4##(1990-10#1)(1990-7#1)(2008-10#2)(2008-11#1)(2012-2#1)
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##6##6##(1990-10#1)(2008-10#4)(2008-11#1)
by sodium dodecyl##13##3##(1990-10#2)(1990-7#1)(1997-4#1)(2008-10#6)(2008-11#2)(2012-2#1)
by sodium hydroxide##2##3##(2008-10#1)(2013-1#1)
by sodium sulfide##2##3##(2008-10#2)
by sodium##32##2##(1990-10#2)(1990-5#1)(1990-7#1)(1991-5#1)(1993-8#1)(1997-4#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
by soft##4##2##(1991-2#1)(2007-8#1)(2008-12#1)(2008-3#1)
by soil##10##2##(2008-10#7)(2010-5#1)(2013-7#1)(2013-8#1)
by sol-gel method##5##3##(2008-10#5)
by sol-gel technique##3##3##(2008-10#3)
by sol-gel##10##2##(2008-10#10)
by solar##3##2##(1992-7#1)(2008-5#2)
by solid phase extraction (SPE) using##2##6##(2008-10#2)
by solid phase extraction (SPE)##3##5##(2008-10#3)
by solid phase extraction and##2##5##(2008-10#2)
by solid phase extraction##7##4##(2008-10#7)
by solid phase microextraction##3##4##(2008-10#3)
by solid phase spectrophotometry##2##4##(2008-10#2)
by solid phase##18##3##(1990-2#1)(2008-10#15)(2008-4#1)(2011-2#1)
by solid sampling Zeeman atomic absorption spectrometry##2##7##(2008-10#2)
by solid sampling##4##3##(2008-10#4)
by solid state (13)C NMR spectroscopy##2##6##(2008-10#2)
by solid state bioprocessing##2##4##(1997-2#2)
by solid state##5##3##(1997-2#2)(2008-10#3)
by solid##32##2##(1990-2#1)(1997-2#2)(2008-10#27)(2008-4#1)(2011-2#1)
by solid-matrix##2##2##(2008-10#2)
by solid-phase extraction and gas chromatography-mass##2##6##(2008-10#2)
by solid-phase extraction and##5##4##(1992-11#1)(1997-2#1)(2008-10#3)
by solid-phase extraction with##3##4##(2008-10#3)
by solid-phase extraction##15##3##(1992-11#1)(1997-2#3)(2008-10#10)(2008-5#1)
by solid-phase microextraction (SPME)##4##4##(2008-10#4)
by solid-phase microextraction coupled##3##4##(2008-10#3)
by solid-phase microextraction##10##3##(2008-10#9)(2012-12#1)
by solid-phase synthesis and##2##4##(1993-11#1)(2008-4#1)
by solid-phase synthesis##3##3##(1993-11#1)(2008-4#2)
by solid-phase##33##2##(1990-12#1)(1992-11#1)(1992-3#1)(1993-11#1)(1997-2#3)(2008-10#21)(2008-4#2)(2008-5#1)(2008-9#1)(2012-12#1)
by solid-state##2##2##(2010-12#1)(2011-2#1)
by solubilization of##2##3##(2008-1#1)(2013-1#1)
by soluble factors##2##3##(2008-9#1)(2013-1#1)
by soluble##3##2##(1997-7#1)(2008-9#1)(2013-1#1)
by solution calorimetry##3##3##(2008-10#3)
by solution of the##2##4##(2007-12#1)(2008-2#1)
by solution##8##2##(1993-8#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-2#1)
by solvent extraction##5##3##(2008-10#4)(2008-5#1)
by solvent sublation##2##3##(2008-10#2)
by solvent##11##2##(1995-2#1)(2008-10#7)(2008-2#1)(2008-5#1)(2011-1#1)
by solving a##4##3##(2008-2#1)(2008-7#1)(2010-7#1)(2010-8#1)
by solving the##2##3##(2008-2#1)(2010-10#1)
by solving##8##2##(2008-10#2)(2008-2#2)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)
by somatic##2##2##(2008-10#1)(2008-5#1)
by some as##2##3##(1995-3#1)(2008-11#1)
by some authors##3##3##(1993-6#1)(2008-7#1)(2013-1#1)
by some form of##2##4##(2008-11#1)(2010-11#1)
by some of the##3##4##(1995-12#1)(1997-7#2)
by some of##6##3##(1990-10#1)(1995-12#1)(1995-5#1)(1997-7#2)(2008-10#1)
by some patients##2##3##(1996-2#1)(2009-4#1)
by some proteases##2##3##(1995-3#2)
by some##52##2##(1990-10#1)(1990-12#1)(1993-10#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2006-4#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
by sonication##5##2##(1990-11#1)(1993-12#1)(2008-10#3)
by soot in##2##3##(2008-3#2)
by sorption on a conical minicolumn packed with activated carbon (AC) at pH 5##2##14##(2008-10#2)
by sorption on a##4##4##(2008-10#4)
by sorption on##6##3##(2008-10#6)
by source##3##2##(1992-3#1)(2008-12#1)(2013-8#1)
by sources##3##2##(2007-12#2)(2008-3#1)
by sows fed the##2##4##(2010-2#2)
by space##2##2##(2008-12#1)(2008-9#1)
by spaceborne##4##2##(2008-2#1)(2008-3#3)
by spatial analysis##2##3##(2008-10#1)(2008-8#1)
by spatial##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)
by spatially##2##2##(2007-11#1)(2012-2#1)
by spatiotemporal##2##2##(2007-11#1)(2008-8#1)
by special##2##2##(2007-7#1)(2008-9#1)
by specialist##4##2##(1997-8#1)(2008-3#1)(2009-6#1)(2009-8#1)
by specialists in##2##3##(1993-6#1)(1995-11#1)
by specialists##6##2##(1993-6#1)(1995-11#1)(1996-9#1)(2008-9#1)(2009-6#1)(2011-1#1)
by specialized##2##2##(2008-7#1)(2013-1#1)
by specialty##2##2##(1993-12#1)(2009-9#1)
by species of##3##3##(2007-12#1)(2008-10#2)
by species##5##2##(2007-12#1)(2008-10#3)(2008-9#1)
by species-specific primers##3##3##(2008-10#3)
by specific and##2##3##(1991-5#1)(1996-12#1)
by specific antibodies##2##3##(1990-12#1)(1992-11#1)
by specific##41##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-5#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-8#2)(2011-2#4)(2013-1#1)(2013-8#2)
by specifying##2##2##(1992-9#1)(2012-1#1)
by spectral analysis##2##3##(1991-10#1)(1997-6#1)
by spectral phase##2##3##(2007-12#2)
by spectral##11##2##(1991-10#1)(1997-6#1)(2007-12#5)(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
by spectrofluorimetry using##2##3##(2008-10#2)
by spectrofluorimetry##10##2##(1990-8#1)(2008-10#8)(2008-11#1)
by spectrometry##2##2##(2008-11#1)(2008-8#1)
by spectrophotometric and##2##3##(2008-10#2)
by spectrophotometric##7##2##(2008-10#5)(2009-8#1)(2013-8#1)
by spectrophotometry and##3##3##(2008-10#3)
by spectrophotometry##29##2##(2006-10#1)(2008-10#25)(2008-3#1)(2008-5#1)(2008-7#1)
by spectroscopic and##2##3##(1996-2#1)(2008-3#1)
by spectroscopic ellipsometry##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
by spectroscopic methods##2##3##(2007-1#1)(2008-10#1)
by spectroscopic techniques##2##3##(2007-11#1)(2008-11#1)
by spectroscopic##15##2##(1992-3#1)(1996-2#1)(2007-1#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2010-6#1)
by speech##2##2##(1990-12#1)(2009-11#1)
by spending##2##2##(2008-11#1)(2009-8#1)
by spermidine##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
by spermine in the old##2##5##(1990-3#2)
by spermine in##3##3##(1990-3#3)
by spermine##7##2##(1990-3#5)(1991-5#2)
by spheres##2##2##(2008-2#2)
by spiking the##2##3##(2008-10#1)(2008-7#1)
by spiking##8##2##(2008-10#7)(2008-7#1)
by spin##2##2##(2008-10#2)
by spinal##4##2##(1993-3#1)(2007-11#2)(2008-7#1)
by splenic##2##2##(1991-12#1)(2011-2#1)
by splitting##2##2##(2008-10#1)(2008-2#1)
by sponges##3##2##(2011-2#2)(2012-2#1)
by spontaneous##13##2##(1990-2#1)(1994-8#1)(1994-9#1)(2007-12#4)(2007-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#1)
by spot##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
by spray##4##2##(2008-10#3)(2008-11#1)
by spring##2##2##(2008-12#2)
by sputtering##2##2##(2008-10#1)(2009-5#1)
by squamometry as they were in a##2##7##(2008-5#2)
by square wave adsorptive stripping voltammetry##5##6##(2008-10#5)
by square wave anodic stripping voltammetry##2##6##(2008-10#2)
by square wave cathodic stripping voltammetry##2##6##(2008-10#2)
by square wave voltammetry##2##4##(2008-10#2)
by square wave##12##3##(2008-10#12)
by square-wave and##2##3##(2008-10#2)
by square-wave anodic stripping voltammetry (SWASV)##2##6##(2008-10#2)
by square-wave anodic stripping voltammetry##3##5##(2008-10#3)
by square-wave anodic##4##3##(2008-10#4)
by square-wave##8##2##(2008-10#8)
by stabilization of##2##3##(1994-9#1)(2009-11#1)
by stabilization##3##2##(1994-9#1)(2009-11#1)(2012-2#1)
by stabilizing##2##2##(2008-8#1)(2012-2#1)
by stable##3##2##(1997-1#1)(2008-11#1)(2009-7#1)
by stacking##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
by staff and##2##3##(1993-1#1)(1996-12#1)
by staff##6##2##(1992-11#1)(1992-3#1)(1993-1#1)(1996-12#1)(1997-3#1)(2010-4#1)
by stage##4##2##(1990-12#1)(2007-8#1)(2008-1#1)(2012-2#1)
by staining with a##3##4##(1990-12#1)(2008-11#1)(2008-5#1)
by staining with##9##3##(1990-12#1)(1990-7#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)
by staining##13##2##(1990-12#1)(1990-7#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#2)
by stakeholder##2##2##(1994-3#1)(2012-2#1)
by stakeholders##2##2##(2008-7#1)(2013-1#1)
by standard addition method##3##4##(2008-10#3)
by standard addition##5##3##(2008-10#5)
by standard additions##2##3##(2008-10#2)
by standard laboratory techniques##2##4##(2007-7#2)
by standard techniques##2##3##(2007-7#1)(2008-10#1)
by standard##31##2##(1991-12#1)(1991-2#1)(1992-5#1)(1993-2#1)(1994-5#1)(1996-2#1)(2007-12#1)(2007-7#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
by stannous chloride##2##3##(2008-10#2)
by starting##2##2##(2008-7#1)(2012-3#1)
by state##7##2##(1995-1#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-3#1)(2008-11#1)
by static##3##2##(1994-5#1)(2008-10#1)(2008-3#1)
by statistical analysis of##2##4##(2008-10#1)(2013-1#1)
by statistical methods##2##3##(2008-10#1)(2008-3#1)
by statistical##9##2##(1992-7#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
by staurosporine##3##2##(1991-2#1)(1992-9#2)
by steady##3##2##(2008-10#2)(2008-7#1)
by steady-state fluorescence##2##3##(1991-5#1)(1992-6#1)
by steady-state##3##2##(1990-8#1)(1991-5#1)(1992-6#1)
by steering##2##2##(2007-12#1)(2008-3#1)
by step##5##2##(1991-3#1)(1997-1#1)(1997-5#1)(2008-11#1)(2008-8#1)
by stepwise elution##2##3##(1995-11#1)(2008-10#1)
by stepwise##5##2##(1995-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
by stereoscopic##2##2##(2008-3#1)(2008-9#1)
by stereoselective##2##2##(1996-5#1)(2008-4#1)
by sterile##3##2##(2008-12#2)(2008-9#1)
by steroid hormones##2##3##(1994-9#1)(2009-4#1)
by steroids##2##2##(1990-11#1)(1992-5#1)
by still##3##2##(1995-8#1)(2008-4#1)(2010-11#1)
by stimulated Brillouin scattering##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
by stimulated Raman##2##3##(2008-2#1)(2008-3#1)
by stimulated##12##2##(1991-9#1)(1993-11#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)(2012-2#1)
by stimulating the##5##3##(1990-9#1)(1996-11#1)(1997-2#1)(2008-1#1)(2011-2#1)
by stimulating##14##2##(1990-9#1)(1992-8#1)(1993-8#1)(1995-8#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
by stimulation of the##2##4##(1993-12#1)(1997-2#1)
by stimulation of##7##3##(1990-8#1)(1993-12#2)(1996-5#1)(1997-2#2)(1997-4#1)
by stimulation##13##2##(1990-8#2)(1993-12#2)(1996-11#1)(1996-5#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)
by stimulus##2##2##(1993-12#1)(1996-2#1)
by stink bug##2##3##(2011-2#2)
by stirring##2##2##(2008-10#1)(2008-5#1)
by stochastic effects##2##3##(2008-8#1)(2012-2#1)
by stochastic##5##2##(2008-10#1)(2008-8#2)(2010-7#1)(2012-2#1)
by stochasticity##2##2##(2008-8#2)
by stopped-flow##2##2##(1995-2#1)(2008-10#1)
by stopping and##2##3##(1997-4#1)(2008-1#1)
by stopping##4##2##(1997-4#1)(2008-1#1)(2008-10#1)(2013-1#1)
by storage##2##2##(1992-3#2)
by strain 89B61##2##3##(2008-10#2)
by strain 90-166##2##3##(2008-10#2)
by strain##17##2##(2008-10#13)(2008-3#1)(2009-1#1)(2009-8#1)(2013-1#1)
by strains of##5##3##(2008-10#2)(2011-2#2)(2013-8#1)
by strains##8##2##(2008-10#4)(2011-2#2)(2013-8#2)
by streamlining##2##2##(1993-1#1)(1997-2#1)
by streptomycin##2##2##(2008-10#1)(2008-8#1)
by streptozotocin##6##2##(2008-12#1)(2010-11#1)(2011-2#1)(2012-3#3)
by stress##8##2##(1995-12#1)(1997-6#2)(2008-10#1)(2008-7#1)(2010-4#2)(2011-2#1)
by stretching##4##2##(1995-8#1)(2007-10#1)(2008-2#1)(2008-3#1)
by stripping voltammetry with a##2##5##(2008-10#2)
by stripping voltammetry##6##3##(2008-10#6)
by stripping##8##2##(2008-10#8)
by stromal cells##4##3##(1993-9#2)(2008-11#1)(2008-8#1)
by strong##9##2##(1990-5#1)(1991-8#1)(1995-6#1)(2007-12#1)(2008-2#3)(2008-9#1)(2010-10#1)
by strongly##2##2##(1992-6#1)(2008-3#1)
by structural changes in the##2##5##(1993-6#1)(2008-10#1)
by structural defects##2##3##(1997-6#1)(2008-2#1)
by structural##9##2##(1993-6#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-4#1)
by structured##2##2##(2007-11#1)(2008-2#1)
by students and##3##3##(1997-2#1)(2008-11#2)
by students in the##2##4##(2008-12#1)(2012-12#1)
by students in##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
by students##13##2##(1992-3#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-12#3)(2009-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
by studies of##3##3##(1995-5#1)(2008-6#1)(2008-8#1)
by studies##10##2##(1994-8#1)(1995-5#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-8#2)(2011-2#2)
by studying the effect of##2##5##(1995-11#1)(2008-10#1)
by studying the##16##3##(1992-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2011-2#1)
by studying##30##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
by subcutaneous administration of##2##4##(1995-2#1)(2012-2#1)
by subcutaneous injection of##2##4##(2008-6#1)(2013-7#1)
by subcutaneous injection##4##3##(2008-11#1)(2008-6#1)(2013-1#1)(2013-7#1)
by subcutaneous##12##2##(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-10#2)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
by subjecting the##3##3##(2009-11#1)(2010-5#1)(2010-8#1)
by subjecting##4##2##(1995-12#1)(2009-11#1)(2010-5#1)(2010-8#1)
by subjective##4##2##(2007-12#1)(2008-5#1)(2012-1#1)(2013-1#1)
by subjects##3##2##(2007-6#2)(2008-11#1)
by subsequent##11##2##(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1997-4#1)(2008-10#3)(2009-11#1)(2010-12#1)
by subsets of##2##3##(1993-12#1)(2009-8#1)
by substance P##5##3##(1991-12#1)(1995-11#1)(1995-12#1)(1997-4#1)(2008-4#1)
by substance##9##2##(1991-12#1)(1992-1#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-4#1)(2009-5#1)
by substantial##2##2##(2009-12#1)(2013-8#1)
by substituting a##2##3##(1991-2#1)(2008-5#1)
by substituting the##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
by substituting##10##2##(1990-2#1)(1991-2#1)(1992-3#1)(1994-8#2)(1997-4#1)(2008-10#2)(2008-5#1)(2012-3#1)
by substitution##3##2##(1992-12#1)(1994-11#1)(2008-7#1)
by substrate##4##2##(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
by substrates##3##2##(1990-12#1)(1992-8#1)(1994-8#1)
by subtle differences##2##3##(2008-6#1)(2009-11#1)
by subtle##3##2##(2008-5#1)(2008-6#1)(2009-11#1)
by subtracting the concentration of##2##5##(1995-12#1)(2008-10#1)
by subtracting the##4##3##(1995-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
by subtracting##6##2##(1995-12#1)(2008-10#2)(2008-2#1)(2008-8#2)
by subtraction of a##2##4##(2008-3#2)
by subtraction of##3##3##(2008-3#3)
by subtraction##6##2##(1990-4#1)(2007-12#1)(2008-3#4)
by subtractive##3##2##(1995-11#1)(1995-12#1)(2010-12#1)
by successful##4##2##(1995-6#1)(1996-5#1)(1997-2#1)(2009-9#1)
by successive##8##2##(1990-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-1#1)
by such a##2##3##(1995-12#1)(2008-3#1)
by such factors as##3##4##(1990-2#1)(1995-2#1)(2013-1#1)
by such##21##2##(1990-2#1)(1991-9#1)(1992-2#3)(1995-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
by sucrose density gradient centrifugation##2##5##(1994-8#1)(1997-3#1)
by sucrose density gradient##3##4##(1993-11#1)(1994-8#1)(1997-3#1)
by sucrose##5##2##(1990-11#1)(1990-5#1)(1993-11#1)(1994-8#1)(1997-3#1)
by sudden##5##2##(1991-5#1)(1993-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
by sugars##3##2##(1990-8#1)(2008-10#2)
by suggesting that##4##3##(1994-12#1)(2008-12#1)(2008-7#1)(2009-12#1)
by suggesting##6##2##(1991-3#1)(1994-12#2)(2008-12#1)(2008-7#1)(2009-12#1)
by suitable##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
by suitably##2##2##(2007-11#1)(2008-10#1)
by sulfamethoxazole##2##2##(2008-10#2)
by sulfate##2##2##(1992-3#1)(2008-3#1)
by sulfur trioxide anion radicals##2##5##(1994-11#2)
by sulfur##3##2##(1994-11#2)(2008-10#1)
by sum-frequency generation##2##3##(2007-12#1)(2008-3#1)
by sum-frequency##3##2##(2007-12#2)(2008-3#1)
by summing##4##2##(1995-11#1)(2008-10#2)(2008-8#1)
by sun exposure##2##3##(2008-5#2)
by sun glint##2##3##(2008-3#2)
by sun##5##2##(2008-3#2)(2008-5#2)(2011-2#1)
by sunscreen##2##2##(2008-5#2)
by sunscreens##3##2##(2008-5#3)
by supercritical##5##2##(2008-10#4)(2013-1#1)
by superficial temporal##2##3##(2008-12#1)(2012-3#1)
by superficial##4##2##(1992-8#1)(2008-12#1)(2012-12#1)(2012-3#1)
by superimposing##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by superoxide dismutase##5##3##(1993-11#1)(1993-8#1)(1996-2#1)(2008-5#1)(2012-2#1)
by superoxide##6##2##(1993-11#1)(1993-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
by superposition of##2##3##(2008-2#2)
by supersonic jet/multiphoton ionization/mass spectrometry##2##5##(2008-10#2)
by supplementation##2##2##(1991-12#1)(2008-12#1)
by supplementing##3##2##(1993-2#1)(2008-2#1)(2010-2#1)
by supplying##2##2##(1997-2#1)(2009-5#1)
by suppressing the##2##3##(2008-10#1)(2008-5#1)
by suppressing##10##2##(1994-2#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
by suppression of##5##3##(1990-5#1)(1994-10#1)(1995-2#1)(2008-10#1)(2013-1#1)
by suppression##6##2##(1990-5#1)(1994-10#1)(1995-2#1)(2008-10#1)(2010-4#1)(2013-1#1)
by surface attachment of##2##4##(2008-10#1)(2008-11#1)
by surface plasmon resonance##5##4##(2008-10#4)(2008-4#1)
by surface plasmon##6##3##(2008-10#4)(2008-4#1)(2011-2#1)
by surface plasmons##2##3##(2007-12#1)(2008-11#1)
by surface##25##2##(1990-6#1)(1994-12#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-4#1)(2011-2#1)
by surface-enhanced Raman spectroscopy##2##4##(2008-10#2)
by surface-enhanced Raman##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
by surface-enhanced##5##2##(2008-10#3)(2012-2#1)(2013-8#1)
by surfactant-mediated##3##2##(2008-10#3)
by surgeons##3##2##(1991-4#1)(1996-9#1)(2007-8#1)
by surgery##10##2##(1991-12#1)(1992-5#1)(1992-6#1)(1997-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2013-8#1)
by surgical treatment##2##3##(2007-11#1)(2008-8#1)
by surgical##16##2##(1990-5#1)(1993-1#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#2)
by survey##2##2##(1992-3#1)(2008-10#1)
by surveying##3##2##(1994-2#1)(2011-2#1)(2012-2#1)
by suspending a##2##3##(2008-10#2)
by sustained##4##2##(1995-2#1)(1995-8#1)(2008-11#1)(2010-3#1)
by suture##3##2##(2007-11#2)(2012-1#1)
by swelling##2##2##(2008-1#1)(2008-8#1)
by swimming in##2##3##(2007-10#1)(2008-5#1)
by swimming##4##2##(1995-6#1)(1997-4#1)(2007-10#1)(2008-5#1)
by switching the##3##3##(2007-8#1)(2008-10#2)
by switching##7##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
by sympathetic##3##2##(1992-8#1)(1994-9#1)(1996-5#1)
by symptoms of##3##3##(2008-2#1)(2013-1#1)(2013-8#1)
by symptoms##7##2##(1990-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
by synaptic##2##2##(1994-8#1)(2013-8#1)
by synchronous fluorescence##3##3##(2008-10#3)
by synchronous##6##2##(1993-8#1)(2008-10#5)
by synthesis of##2##3##(2008-10#1)(2008-9#1)
by synthesis##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
by synthesizing##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
by synthetic peptides##3##3##(1994-3#1)(1994-6#2)
by synthetic##8##2##(1990-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-5#1)(2008-11#1)(2008-9#1)
by system##2##2##(2008-11#1)(2008-2#1)
by systematic##6##2##(1995-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)
by systemic lupus##2##3##(1991-5#1)(2012-3#1)
by systemic vasculitis##2##3##(2008-1#1)(2012-3#1)
by systemic##11##2##(1991-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2011-3#1)(2012-3#2)
by t##4##2##(2008-11#2)(2008-8#1)(2009-8#1)
by t-test##2##2##(2008-10#1)(2008-12#1)
by tailoring the##2##3##(2007-11#1)(2008-10#1)
by taking a##3##3##(1990-10#1)(1991-2#1)(2008-10#1)
by taking advantage of the##2##5##(1995-3#1)(2008-4#1)
by taking advantage of##6##4##(1991-9#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-4#1)
by taking into account the##5##5##(1993-12#1)(2007-12#1)(2008-3#3)
by taking into account##9##4##(1993-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-3#3)
by taking the##4##3##(1992-6#1)(1997-3#1)(2007-12#1)(2008-8#1)
by taking##31##2##(1990-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)
by tamoxifen##2##2##(2008-11#1)(2008-4#1)
by tandem mass spectrometry##5##4##(1990-7#2)(2008-4#1)(2010-2#1)(2012-1#1)
by tandem##6##2##(1990-7#2)(2008-4#1)(2008-9#1)(2010-2#1)(2012-1#1)
by tapping##3##2##(2008-10#1)(2009-5#1)(2012-2#1)
by target cells##3##3##(1996-2#1)(2008-11#1)(2009-2#1)
by target##8##2##(1993-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)
by targeted##2##2##(2008-10#2)
by targeting the##3##3##(2013-1#3)
by targeting##13##2##(1994-8#1)(1995-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
by taste##2##2##(1996-5#2)
by taurocholate##2##2##(1992-3#1)(1994-12#1)
by tax-exempt entities##2##3##(1996-3#2)
by teachers##5##2##(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
by techniques##2##2##(2008-10#1)(2008-4#1)
by telephone##13##2##(1993-2#1)(1995-1#1)(1996-5#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
by telomere##2##2##(1990-5#1)(2008-5#1)
by temperature and##2##3##(2008-10#1)(2010-3#1)
by temperature tuning##2##3##(2007-11#1)(2008-2#1)
by temperature##17##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-3#1)(2010-8#1)(2012-6#1)(2013-8#1)
by temporal##3##2##(1996-7#1)(2007-12#1)(2008-8#1)
by temporarily##3##2##(2008-8#1)(2009-11#1)(2010-7#1)
by ten##3##2##(2008-10#2)(2010-8#1)
by terahertz##2##2##(2008-3#1)(2010-5#1)
by terminal##3##2##(1992-12#1)(1997-7#1)(2008-9#1)
by termites##2##2##(2013-8#2)
by testing individual##2##3##(2008-10#2)
by testing the##5##3##(2008-10#2)(2008-5#1)(2010-8#1)(2013-8#1)
by testing##20##2##(1992-5#1)(1994-3#1)(1995-12#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#2)
by testosterone##5##2##(1994-2#1)(1995-12#3)(2012-3#1)
by tests of##2##3##(1993-5#1)(2008-3#1)
by tests##4##2##(1990-9#1)(1993-5#1)(2008-3#2)
by tetrachlorohydroquinone##3##2##(2009-3#3)
by tetracycline##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
by tetraethylammonium##2##2##(1990-5#1)(1994-12#1)
by tetrodotoxin##2##2##(1992-3#1)(2007-10#1)
by thapsigargin##2##2##(1991-8#1)(1994-11#1)
by that of##4##3##(1994-8#1)(1997-4#1)(2008-5#1)(2008-8#1)
by that##13##2##(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2013-8#1)
by the &quot##4##3##(1990-5#1)(1996-11#1)(2008-5#1)(2008-8#1)
by the 1##3##3##(2008-10#2)(2008-3#1)
by the 2D##2##3##(1992-3#1)(2008-10#1)
by the ATP##2##3##(1993-6#1)(2013-1#1)
by the American Academy of Pediatrics##2##6##(2010-8#1)(2013-1#1)
by the American College of##3##5##(1994-12#1)(2008-3#1)(2010-9#1)
by the American Heart Association and##2##6##(1996-6#1)(2010-9#1)
by the American Medical Association##2##5##(1993-3#1)(1996-12#1)
by the American##15##3##(1990-6#1)(1991-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2010-9#2)(2012-3#1)(2013-1#2)
by the Association of##2##4##(1995-12#1)(2008-10#1)
by the Association##4##3##(1990-6#1)(1995-12#1)(2008-10#1)(2012-12#1)
by the Australian##2##3##(1991-2#1)(2008-2#1)
by the Authors on##2##4##(1990-10#1)(1990-3#1)
by the Authors##4##3##(1990-10#1)(1990-3#1)(1991-3#1)(1991-5#1)
by the B biotype##2##4##(2008-10#2)
by the B##3##3##(2008-10#3)
by the Brazilian##4##3##(1991-12#1)(2008-10#1)(2011-2#2)
by the British##5##3##(1990-9#1)(2008-10#3)(2008-11#1)
by the Brn-3a##2##3##(1995-6#2)
by the C-terminal##3##3##(1993-11#1)(1995-5#1)(2013-8#1)
by the CCD##3##3##(2007-12#2)(2008-3#1)
by the Ca2+##2##3##(1994-11#1)(1994-3#1)
by the Canadian College of Health Service Executives and 3M##2##10##(1996-2#1)(1997-2#1)
by the Canadian Infectious##2##4##(2007-12#2)
by the Canadian##7##3##(1993-9#1)(1996-2#1)(1997-2#1)(2007-12#2)(2009-3#1)(2012-12#1)
by the Center for##2##4##(1993-3#1)(1997-5#1)
by the Centers for Disease Control##2##6##(1996-5#1)(2007-7#1)
by the Central##2##3##(2008-10#1)(2008-3#1)
by the Centre for##2##4##(1990-3#1)(2008-11#1)
by the Chinese##2##3##(2008-10#1)(2008-7#1)
by the Combination of##2##4##(2008-10#2)
by the D##2##3##(2008-10#2)
by the DNA##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
by the DPPH##2##3##(2008-11#1)(2008-5#1)
by the Danish##2##3##(1990-12#1)(1997-3#1)
by the Department of##8##4##(1990-2#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
by the Dialysis Outcomes Quality Initiative##2##6##(2007-12#2)
by the Dutch##3##3##(1994-12#1)(1996-8#1)(2008-2#1)
by the E##2##3##(1995-2#1)(1995-8#1)
by the ELISA method##2##4##(2008-10#2)
by the ELISA##3##3##(2008-10#3)
by the Earth's atmosphere##2##4##(2008-3#2)
by the Epstein-Barr virus##2##4##(1995-2#1)(2007-12#1)
by the Escherichia coli##3##4##(1995-12#1)(1995-3#1)(1995-8#1)
by the European Commission##3##4##(2008-10#3)
by the European Society of Radiology##4##6##(2012-2#4)
by the European Society of##5##5##(2012-2#4)(2013-1#1)
by the European Union##2##4##(2007-5#1)(2008-10#1)
by the European##21##3##(2007-5#1)(2008-10#8)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#4)(2012-3#1)(2013-1#1)
by the FDA##5##3##(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
by the Family Health##2##4##(2008-9#1)(2011-2#1)
by the Family##4##3##(2008-9#1)(2011-2#2)(2013-8#1)
by the Federal##3##3##(1995-3#1)(2007-9#1)(2008-10#1)
by the Food and Drug Administration##4##6##(1994-1#1)(2008-4#1)(2008-8#1)(2009-9#1)
by the Food##5##3##(1994-1#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-4#1)
by the Foundation for##2##4##(1994-3#1)(2008-10#1)
by the G##2##3##(1995-8#1)(2008-6#1)
by the German##3##3##(2007-5#1)(2008-1#1)(2012-2#1)
by the HIV virus##2##4##(2012-2#2)
by the HIV##3##3##(2010-5#1)(2012-2#2)
by the HPLC method##4##4##(1990-8#2)(2008-10#1)(2009-8#1)
by the HPLC##6##3##(1990-8#3)(2008-10#2)(2009-8#1)
by the Health Care Financing Administration (HCFA)##3##7##(1994-12#1)(1995-12#1)(1997-3#1)
by the Health##4##3##(1994-1#1)(1994-12#1)(1995-12#1)(1997-3#1)
by the HiPco##2##3##(2008-10#2)
by the Hospital##2##3##(1994-3#1)(2008-10#1)
by the House##2##3##(1995-12#1)(1997-2#1)
by the IR##2##3##(2007-11#1)(2008-7#1)
by the IRS##2##3##(1995-2#1)(2008-12#1)
by the IUCN##2##3##(2013-1#1)(2013-7#1)
by the Information##2##3##(1991-3#1)(1996-3#1)
by the Institut##3##3##(2008-10#2)(2010-1#1)
by the Institute of Medicine##3##5##(1996-5#1)(1997-2#1)(2010-4#1)
by the Institute of##4##4##(1995-2#1)(1996-5#1)(1997-2#1)(2010-4#1)
by the Institute##5##3##(1995-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2010-4#1)
by the Internal Revenue##2##4##(1992-12#1)(1996-3#1)
by the International Society##3##4##(2008-5#1)(2008-8#1)(2011-9#1)
by the International##12##3##(1995-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
by the JCAHO##2##3##(1993-2#2)
by the Japanese##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
by the Joint Council of Governmental Public Health Agencies##2##9##(1996-3#2)
by the Joint##3##3##(1996-3#2)(2009-9#1)
by the Kirby-Bauer##2##3##(2008-7#1)(2013-8#1)
by the LFN##2##3##(2008-7#2)
by the Langmuir-Blodgett##3##3##(2007-11#1)(2008-11#2)
by the MM3##2##3##(1995-11#1)(1996-5#1)
by the Mann-Whitney test##2##4##(2010-5#1)(2013-1#1)
by the Medical##2##3##(1993-6#1)(2008-1#1)
by the Ministry of Health and##2##6##(2008-5#1)(2013-1#1)
by the Ministry of Health##7##5##(1994-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)
by the Ministry of##10##4##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2012-3#1)(2013-1#2)
by the Minnesota##2##3##(2010-1#1)(2012-12#1)
by the Monte Carlo method##3##5##(2008-2#2)(2008-3#1)
by the Monte Carlo##4##4##(2008-2#2)(2008-3#2)
by the N-terminal##2##3##(1997-6#1)(2009-8#1)
by the NCI##2##3##(2009-4#1)(2012-3#1)
by the Nafion/MV modified##2##4##(2008-10#2)
by the National Cancer Institute##3##5##(2008-9#2)(2010-2#1)
by the National Health Service (NHS)##2##6##(2008-11#1)(2012-1#1)
by the National Health Service##3##5##(2008-11#2)(2012-1#1)
by the National Institute for##2##5##(2008-10#1)(2008-7#1)
by the National Institute of##2##5##(1991-3#1)(2008-9#1)
by the National Institute##6##4##(1991-3#1)(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)
by the National Institutes of Health##11##6##(1996-9#1)(2013-8#10)
by the National Library of Medicine##2##6##(1992-1#1)(1996-3#1)
by the National Malaria Control Program##2##6##(2011-2#2)
by the National##42##3##(1991-3#1)(1992-1#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#11)
by the New York##2##4##(1991-12#1)(1994-12#1)
by the New##3##3##(1991-12#1)(1994-12#1)(2012-12#1)
by the Norwegian##4##3##(1990-6#1)(1996-6#1)(1996-8#1)(2008-10#1)
by the Occupational Safety and Health##2##6##(1993-12#1)(1994-3#1)
by the Ontario Ministry of##2##5##(1991-2#1)(1995-3#1)
by the Ontario##4##3##(1991-2#1)(1993-3#1)(1994-3#1)(1995-3#1)
by the P2X(7)R##2##3##(2008-4#2)
by the PCR##5##3##(1994-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
by the Pan American Health Organization##2##6##(1994-9#1)(2013-1#1)
by the Pharmacy and Therapeutics Committee##2##6##(2012-3#2)
by the Physiotherapy Section##2##4##(1992-3#2)
by the Polish##2##3##(2011-2#1)(2012-1#1)
by the Professional##2##3##(1991-3#1)(1996-2#1)
by the Public Health##2##4##(1997-2#1)(2012-12#1)
by the Public##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
by the Quality##2##3##(1993-12#1)(1994-3#1)
by the RNA##2##3##(1995-6#1)(2008-10#1)
by the Royal##2##3##(1994-12#1)(2008-5#1)
by the S##2##3##(2008-10#2)
by the SGC##2##3##(1995-2#1)(2008-3#1)
by the Scientific##2##3##(2008-10#1)(2008-12#1)
by the Social##2##3##(2007-10#1)(2008-11#1)
by the South##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
by the State##2##3##(1995-6#1)(2011-2#1)
by the Sun##3##3##(2007-12#1)(2008-2#2)
by the SyFS##2##3##(2008-10#2)
by the T cell##2##4##(1993-11#1)(2007-12#1)
by the TRLFS)##2##3##(2008-10#2)
by the Tukey's##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
by the U##8##3##(1994-2#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)
by the UK##2##3##(1996-12#1)(2008-12#1)
by the US Environmental Protection Agency (EPA)##2##7##(2008-10#2)
by the US FDA##2##4##(2010-5#1)(2011-2#1)
by the US Food and Drug Administration (FDA) for##2##9##(2008-9#2)
by the US Food and Drug Administration##4##7##(2008-9#2)(2010-4#1)(2012-12#1)
by the US##16##3##(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
by the US-8##2##3##(2008-10#2)
by the United Nations##2##4##(2008-9#1)(2010-12#1)
by the United States Environmental Protection Agency##3##7##(2008-9#3)
by the United States##7##4##(1994-3#1)(2008-10#2)(2008-9#3)(2012-3#1)
by the United##9##3##(1994-3#1)(2008-10#2)(2008-9#4)(2010-12#1)(2012-3#1)
by the University of##3##4##(1993-6#1)(2008-1#1)(2008-11#1)
by the University##6##3##(1993-6#1)(2008-1#1)(2008-10#3)(2008-11#1)
by the WHO for##2##4##(2011-2#1)(2013-7#1)
by the WHO##9##3##(1992-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)
by the World Health Organisation (WHO)##2##6##(2008-10#1)(2012-2#1)
by the World Health Organisation##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
by the World Health Organization (WHO) as##2##7##(2009-6#1)(2013-1#1)
by the World Health Organization (WHO)##7##6##(2008-1#1)(2008-3#2)(2009-6#1)(2010-5#1)(2013-1#2)
by the World Health Organization##15##5##(1991-9#1)(1992-1#1)(1994-9#1)(1996-9#1)(2008-1#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#2)
by the World Health##18##4##(1991-9#1)(1992-1#1)(1994-9#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
by the World Organisation for Animal Health##3##7##(2011-2#3)
by the World##21##3##(1991-9#1)(1992-1#1)(1994-9#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#3)
by the Yeast##2##3##(1997-3#1)(2008-10#1)
by the ability of the##3##5##(1995-6#1)(2008-11#1)(2011-2#1)
by the ability of##5##4##(1990-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
by the ability to##5##4##(1995-1#1)(2007-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
by the ability##10##3##(1990-8#1)(1995-1#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
by the above##5##3##(1994-1#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-5#1)
by the absence of the##2##5##(2007-12#1)(2008-11#1)
by the absence of##13##4##(1993-3#1)(1993-9#1)(1994-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)
by the absence##15##3##(1991-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)
by the absorption##3##3##(2008-10#1)(2008-11#2)
by the academic##2##3##(1990-2#1)(1996-1#1)
by the accumulation of##2##4##(2007-8#1)(2008-9#1)
by the acquisition of##3##4##(1992-6#1)(2009-6#1)(2012-3#1)
by the acquisition##4##3##(1992-6#1)(2008-10#1)(2009-6#1)(2012-3#1)
by the action of the##2##5##(1990-11#1)(2007-11#1)
by the action of##9##4##(1990-11#1)(1991-9#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
by the actions of##2##4##(2008-5#1)(2009-3#1)
by the activation of##5##4##(1993-6#1)(1995-12#1)(1997-7#1)(2010-2#1)(2010-6#1)
by the active##5##3##(1992-3#2)(2007-11#1)(2008-8#1)(2013-7#1)
by the activities of##2##4##(2011-2#2)
by the activity of the##3##5##(1993-12#1)(1994-8#1)(2008-11#1)
by the activity of##6##4##(1993-12#1)(1994-8#2)(2008-11#1)(2008-4#1)(2009-10#1)
by the adaptive##2##3##(2008-3#2)
by the addition of ATP##2##5##(1992-12#1)(2008-8#1)
by the addition of EDTA##4##5##(2008-10#3)(2008-4#1)
by the addition of a nitrogen flow and##2##8##(2008-10#2)
by the addition of a single##2##6##(1990-7#1)(2009-12#1)
by the addition of a##11##5##(1990-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2013-1#1)
by the addition of actinomycin D##2##6##(1992-8#1)(1997-2#1)
by the addition of nitrite and##2##6##(2008-10#2)
by the addition of proteins##2##5##(2008-10#2)
by the addition of superoxide dismutase (SOD)##2##7##(1992-9#1)(1997-4#1)
by the addition of superoxide dismutase##3##6##(1992-9#1)(1994-6#1)(1997-4#1)
by the addition of the##3##5##(1995-2#1)(2008-11#2)
by the addition of##104##4##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-2#2)(1996-12#2)(1997-1#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#12)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-12#1)(2009-7#2)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
by the addition##106##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-2#2)(1996-12#2)(1997-1#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#13)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-12#1)(2009-7#2)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
by the additive##2##3##(1996-12#1)(2008-6#1)
by the adjacent##3##3##(1996-5#2)(1997-3#1)
by the administration of##12##4##(1990-11#1)(1990-7#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
by the adsorption##2##3##(2008-10#2)
by the advent of##2##4##(1996-6#1)(2008-5#1)
by the agarose gel electrophoresis##2##5##(1990-11#1)(2008-10#1)
by the age of##5##4##(1990-9#1)(1993-11#1)(1995-12#1)(1997-3#1)(2008-5#1)
by the age##8##3##(1990-9#1)(1993-11#1)(1995-12#1)(1997-3#1)(2008-4#1)(2008-5#2)(2013-8#1)
by the agonist##3##3##(1992-9#1)(2012-2#2)
by the aid of##5##4##(1990-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-8#1)
by the alcohols##2##3##(1990-11#2)
by the alkaline elution test##2##5##(1993-12#2)
by the altered##2##3##(1996-3#1)(2010-10#1)
by the ambient##3##3##(2008-10#1)(2008-6#1)(2010-7#1)
by the amount of##7##4##(1996-12#1)(2008-1#1)(2008-10#4)(2010-12#1)
by the analyses of##2##4##(2008-10#2)
by the analysis of a##3##5##(1994-3#1)(2008-10#2)
by the analysis of certified reference materials and##2##8##(2008-10#2)
by the analysis of certified reference materials##3##7##(2008-10#3)
by the analysis of the standard reference material##2##8##(2008-10#2)
by the analysis of the standard reference##3##7##(2008-10#3)
by the analysis of the##11##5##(1990-5#1)(1993-12#1)(1994-12#1)(2008-10#5)(2010-12#1)(2010-3#1)(2012-3#1)
by the analysis of##27##4##(1990-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#20)(2010-12#1)(2010-3#1)(2012-3#1)
by the analysis##31##3##(1990-5#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#20)(2008-2#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#1)
by the analyte##4##3##(2008-10#4)
by the analytical##3##3##(1996-12#1)(2008-9#1)(2011-2#1)
by the anesthesiologist##2##3##(2007-11#1)(2009-4#1)
by the animal##2##3##(2008-4#1)(2008-7#1)
by the anion-exchange##2##3##(2008-10#2)
by the antagonists##2##3##(1994-6#1)(2008-10#1)
by the antibody##3##3##(1993-9#1)(1994-9#1)(2008-11#1)
by the aphid##3##3##(2008-10#3)
by the appearance of a##2##5##(2008-10#1)(2008-3#1)
by the appearance of##6##4##(1994-10#1)(2008-10#3)(2008-3#2)
by the application of a##4##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
by the application of the##5##5##(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
by the application of##18##4##(1994-9#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-1#1)(2012-3#1)
by the application##19##3##(1994-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-1#1)(2012-3#1)
by the applied##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
by the appropriate##3##3##(1994-3#1)(2008-2#1)(2008-4#1)
by the area under the##3##5##(2008-3#1)(2012-12#1)(2013-1#1)
by the area##6##3##(1990-8#1)(2008-3#3)(2012-12#1)(2013-1#1)
by the aromatic##2##3##(2008-10#1)(2011-1#1)
by the arotinoid##2##3##(1993-9#2)
by the artificial##2##3##(1995-2#1)(2013-7#1)
by the artisanal fishery##2##4##(2013-7#2)
by the artisanal##3##3##(2013-7#3)
by the assay##3##3##(1990-2#1)(1992-6#1)(2008-10#1)
by the assembly of##2##4##(2008-8#1)(2009-7#1)
by the assembly##3##3##(1994-12#1)(2008-8#1)(2009-7#1)
by the assessment of the##2##5##(2008-3#1)(2008-5#1)
by the assessment of##3##4##(2008-3#1)(2008-5#1)(2009-7#1)
by the assistant##2##3##(1992-1#1)(1993-6#1)
by the association of two##2##5##(1995-2#1)(2008-10#1)
by the association of##4##4##(1995-2#1)(2008-10#2)(2009-7#1)
by the association##6##3##(1995-2#1)(2008-10#3)(2009-4#1)(2009-7#1)
by the assumption of##3##4##(1997-2#1)(2008-12#1)(2008-3#1)
by the assumption that##2##4##(1996-4#1)(2007-12#1)
by the assumption##5##3##(1996-4#1)(1997-2#1)(2007-12#1)(2008-12#1)(2008-3#1)
by the attending##2##3##(2007-8#1)(2011-1#1)
by the author and##2##4##(1991-11#1)(2008-2#1)
by the author##7##3##(1991-11#2)(1992-2#1)(1993-6#1)(1997-6#1)(2008-2#1)(2009-9#1)
by the authors for##2##4##(2007-12#1)(2007-2#1)
by the authors in##2##4##(1994-2#1)(2013-7#1)
by the authors to##2##4##(1993-12#1)(1995-1#1)
by the authors##23##3##(1992-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#2)(1996-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-7#1)
by the autosampler##2##3##(2008-10#2)
by the availability of##7##4##(1997-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#2)
by the availability##9##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-1#2)(2013-7#1)
by the available##3##3##(1996-3#1)(2007-11#1)(2008-7#1)
by the average number of##2##5##(2009-9#1)(2010-12#1)
by the average##5##3##(2008-3#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)
by the axon reflex was 1##2##6##(2009-12#2)
by the axon reflex was##3##5##(2009-12#3)
by the bacteria##5##3##(1990-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
by the bacterial##2##3##(1994-12#1)(1994-5#1)
by the bacterium Erwinia##2##4##(2008-10#2)
by the bacterium##5##3##(2008-10#4)(2008-6#1)
by the baculovirus-insect cell system##2##5##(2008-11#2)
by the basic##2##3##(2008-10#1)(2009-11#1)
by the basidiomycete##2##3##(2008-10#1)(2008-6#1)
by the beam##2##3##(2008-3#1)(2012-1#1)
by the behaviour of##2##4##(1992-3#1)(1993-11#1)
by the beta##2##3##(1992-9#1)(1994-12#1)
by the beta-binomial##3##3##(2008-10#3)
by the binding of##14##4##(1990-7#2)(1991-8#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
by the binding##16##3##(1990-7#2)(1991-8#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-2#1)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-12#1)
by the biocatalytic##2##3##(2008-10#2)
by the biocontrol agent##3##4##(2008-10#3)
by the biocontrol agents##2##4##(2008-10#2)
by the biocontrol##6##3##(2008-10#6)
by the biosensor##3##3##(2008-10#3)
by the birds##2##3##(2008-5#1)(2013-1#1)
by the bite of##2##4##(2008-7#1)(2010-1#1)
by the brain##3##3##(1995-12#1)(2008-11#2)
by the breakdown##2##3##(1991-5#1)(2008-11#1)
by the bulk##2##3##(2008-10#1)(2008-3#1)
by the cDNA##2##3##(1990-12#1)(2008-5#1)
by the calcium##2##3##(1994-6#1)(2008-11#1)
by the calculation of##2##4##(2008-2#1)(2013-8#1)
by the capacity of##2##4##(1993-12#1)(2012-12#1)
by the cardiac##2##3##(1990-12#1)(2010-8#1)
by the carrier##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
by the case##2##3##(2010-3#1)(2012-12#1)
by the catalytic##2##3##(1995-2#1)(2008-12#1)
by the cavity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by the cell##6##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)
by the cells##14##3##(1990-5#1)(1994-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-7#2)(2008-8#1)
by the cellular##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
by the central nervous system##2##5##(1995-12#1)(2008-9#1)
by the central##7##3##(1992-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)
by the change in the##2##5##(1990-2#1)(2008-10#1)
by the change in##5##4##(1990-2#1)(1995-11#1)(1997-2#1)(2008-10#2)
by the change##7##3##(1990-2#1)(1992-1#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-3#1)
by the changes in##2##4##(1990-2#1)(2008-2#1)
by the changing##4##3##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)
by the characteristic##2##3##(2008-10#1)(2008-7#1)
by the characteristics of the##2##5##(2008-10#1)(2009-6#1)
by the charge##3##3##(1991-5#1)(2008-10#2)
by the chelating##4##3##(2008-10#4)
by the chemical##4##3##(1997-5#1)(2008-10#2)(2008-2#1)
by the choice of##4##4##(2008-6#1)(2008-7#2)(2009-11#1)
by the cholinergic##2##3##(1993-3#1)(1993-9#1)
by the chromatographic methods##2##4##(2008-10#1)(2010-4#1)
by the chromatographic##3##3##(2008-10#2)(2010-4#1)
by the chromosome##2##3##(2008-1#1)(2011-2#1)
by the classical##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
by the clinic##2##3##(1996-1#1)(1996-3#1)
by the clinical##6##3##(1991-12#1)(2006-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
by the clinician##2##3##(2012-2#1)(2012-3#1)
by the clinicians##2##3##(1994-12#1)(2007-9#1)
by the cloned##2##3##(1991-9#1)(1997-6#1)
by the colony##2##3##(1996-11#1)(2008-10#1)
by the column method##2##4##(2008-10#2)
by the combination of##10##4##(1993-6#1)(1995-12#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-8#1)(2012-3#1)(2013-7#1)
by the combination##11##3##(1993-6#1)(1995-12#1)(1995-6#1)(1997-4#1)(2008-10#3)(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
by the combined administration of##2##5##(1992-3#1)(1997-4#1)
by the combined modulation condition##2##5##(2008-1#2)
by the combined##9##3##(1992-3#1)(1997-4#1)(2008-1#2)(2008-10#3)(2010-4#1)(2011-2#1)
by the comet assay##3##4##(1997-4#1)(2010-5#2)
by the common##2##3##(2008-10#1)(2008-3#1)
by the comparison of##2##4##(2008-10#1)(2008-2#1)
by the comparison##3##3##(2008-10#1)(2008-2#2)
by the complementary##2##3##(2008-1#1)(2008-10#1)
by the complex##2##3##(2007-11#1)(2008-10#1)
by the composition##2##3##(2008-10#1)(2010-4#1)
by the compound##2##3##(2011-1#1)(2013-1#1)
by the computer##3##3##(1995-12#1)(2008-10#1)(2012-2#1)
by the concentration of##3##4##(1990-6#1)(1991-12#1)(2008-10#1)
by the concentration##5##3##(1990-6#1)(1991-12#1)(1994-8#1)(2008-10#1)(2012-2#1)
by the concurrent##2##3##(1993-5#1)(1997-5#1)
by the condensation of##2##4##(2011-1#2)
by the consumer##3##3##(2008-11#1)(2008-5#2)
by the content of##2##4##(2008-2#1)(2013-8#1)
by the control##10##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#3)
by the controlled##2##3##(2010-12#1)(2011-2#1)
by the conventional##12##3##(1993-12#1)(1994-9#1)(1995-6#1)(2008-10#4)(2008-3#5)
by the coronary##2##3##(2008-10#2)
by the correlation##2##3##(1992-3#1)(2010-12#1)
by the corresponding##3##3##(2008-10#2)(2008-2#1)
by the country##2##3##(1992-5#1)(2013-1#1)
by the cuff of the##2##5##(2008-2#2)
by the cuff##3##3##(1991-12#1)(2008-2#2)
by the cumulative##2##3##(2010-2#1)(2012-3#1)
by the current##5##3##(1992-8#1)(1994-8#1)(2007-12#1)(2008-3#1)(2008-9#1)
by the cyclic##2##3##(1990-11#1)(1996-5#1)
by the cytochrome##2##3##(1992-8#1)(2012-12#1)
by the damage##2##3##(2008-10#1)(2008-3#1)
by the data##3##3##(2010-12#1)(2010-8#2)
by the decision bits##2##4##(2008-3#2)
by the decrease in##2##4##(2008-10#1)(2008-3#1)
by the decrease##3##3##(2008-10#2)(2008-3#1)
by the deep##2##3##(2008-12#1)(2011-2#1)
by the deficiency of##2##4##(2008-7#1)(2012-3#1)
by the degree of##8##4##(1990-3#1)(1991-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-1#1)
by the deletion of##4##4##(1992-8#1)(1993-6#1)(1994-5#1)(2008-10#1)
by the demonstration of##6##4##(1992-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(2007-7#1)
by the density##2##3##(2008-10#1)(2008-8#1)
by the dependence##2##3##(2008-10#2)
by the deposition of##2##4##(2007-12#1)(2008-10#1)
by the described##2##3##(2008-10#2)
by the description of##2##4##(2008-9#1)(2012-3#1)
by the design##2##3##(2007-11#1)(2011-2#1)
by the detection of##5##4##(1991-3#1)(2007-8#1)(2008-2#1)(2008-3#2)
by the detection##6##3##(1991-3#1)(2007-8#1)(2008-2#2)(2008-3#2)
by the detector##6##3##(2008-10#5)(2008-3#1)
by the determination of molybdenum##2##5##(2008-10#2)
by the determination of nitrite##2##5##(2008-10#1)(2008-11#1)
by the determination of the##3##5##(1990-3#1)(2008-10#2)
by the determination of##19##4##(1990-3#1)(1991-3#1)(1993-8#1)(2008-10#15)(2008-11#1)
by the developed##5##3##(2008-10#4)(2010-5#1)
by the development of a##4##5##(2008-10#2)(2008-12#1)(2008-5#1)
by the development of##13##4##(1992-9#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#2)(2010-6#1)(2011-3#1)(2012-3#1)(2013-8#1)
by the development##15##3##(1992-9#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#2)(2010-6#1)(2011-3#1)(2012-3#1)(2013-8#1)
by the diameter of##2##4##(2008-10#1)(2013-1#1)
by the dietary##2##3##(1991-12#2)
by the difference between the##2##5##(1994-9#1)(2008-9#1)
by the difference between##4##4##(1994-9#1)(2008-10#1)(2008-2#1)(2008-9#1)
by the difference in the##2##5##(2007-11#1)(2007-12#1)
by the difference in##5##4##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#1)
by the difference##11##3##(1992-9#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2010-4#1)
by the different##12##3##(1990-5#1)(1995-5#1)(2008-10#7)(2008-12#1)(2010-9#1)(2013-8#1)
by the differential pulse voltammetry (DPV)##2##6##(2008-10#2)
by the differential##5##3##(1991-9#1)(2008-10#3)(2008-2#1)
by the difficulty##3##3##(1995-2#1)(1997-7#1)(2008-3#1)
by the diffraction##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by the digestion##2##3##(1993-8#1)(2008-10#1)
by the dimension##2##3##(1996-3#1)(2008-10#1)
by the dipole##2##3##(2008-10#1)(2008-3#1)
by the direct##9##3##(1990-8#1)(1992-12#1)(2008-10#4)(2008-11#1)(2011-1#1)(2012-12#1)
by the discovery of##2##4##(2008-10#1)(2010-5#1)
by the discovery that##2##4##(1997-3#1)(2012-12#1)
by the discovery##4##3##(1997-3#1)(2008-10#1)(2010-5#1)(2012-12#1)
by the disease##9##3##(1990-3#1)(1990-6#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-5#1)
by the disruption of the##2##5##(1991-12#1)(1994-11#1)
by the dissolution of##2##4##(2008-10#1)(2008-3#1)
by the distance from the##2##5##(2008-2#1)(2013-7#1)
by the distance##3##3##(2008-2#1)(2008-8#1)(2013-7#1)
by the distribution of##2##4##(1991-5#1)(2011-2#1)
by the distribution##3##3##(1991-5#1)(2008-10#1)(2011-2#1)
by the divergence of the##2##5##(2008-3#2)
by the division of##2##4##(2008-2#1)(2012-2#1)
by the doctors##2##3##(1994-7#1)(2009-10#1)
by the dose-response##2##3##(2008-10#2)
by the double##2##3##(1995-6#1)(2008-10#1)
by the drop##2##3##(2008-10#2)
by the drug##2##3##(1993-12#1)(2008-8#1)
by the drying##2##3##(2008-6#1)(2008-7#1)
by the dual-process##2##3##(2013-1#2)
by the duration of the##3##5##(2008-10#1)(2011-2#2)
by the early##3##3##(1990-11#1)(2008-10#1)(2012-12#1)
by the economic##2##3##(1995-5#1)(2012-3#1)
by the effect of the##2##5##(2008-10#2)
by the effect of##4##4##(2008-10#3)(2013-1#1)
by the effector##2##3##(2008-10#1)(2008-3#1)
by the effects of##4##4##(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)
by the elderly##6##3##(1993-3#2)(1994-1#1)(1995-12#1)(1995-3#1)(2008-6#1)
by the electric##2##3##(2008-1#1)(2012-2#1)
by the electro-optic##2##3##(2008-2#1)(2008-3#1)
by the electrochemical##4##3##(1991-8#1)(2008-10#3)
by the electron spin resonance##2##5##(2008-10#2)
by the electronic##4##3##(2008-10#1)(2008-3#1)(2010-8#1)(2012-2#1)
by the electropolymerization of##2##4##(2008-10#2)
by the electrostatic##2##3##(1994-5#1)(2007-11#1)
by the elevated##2##3##(2011-2#1)(2013-1#1)
by the emergence of##2##4##(2007-5#1)(2008-8#1)
by the emergency##2##3##(1994-3#1)(1995-11#1)
by the emerging##2##3##(2008-10#1)(2010-1#1)
by the emission of##2##4##(1990-5#1)(2008-10#1)
by the encoding##2##3##(2008-3#2)
by the end of the century##3##6##(1994-5#1)(1994-9#1)(1997-6#1)
by the end of the second##3##6##(1997-2#1)(2008-10#2)
by the end of the study##3##6##(2008-10#1)(2008-9#1)(2010-3#1)
by the end of the##20##5##(1991-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-7#1)(2013-8#1)
by the end of##27##4##(1990-12#1)(1991-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
by the end##29##3##(1990-12#1)(1991-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
by the endogenous##2##3##(1990-12#1)(1997-4#1)
by the endophyte##2##3##(2008-10#2)
by the endoscopic##2##3##(1990-3#1)(2008-5#1)
by the endothelium##2##3##(1994-9#1)(2008-3#1)
by the environment##2##3##(1992-2#1)(2008-10#1)
by the enzymatic##3##3##(2008-10#2)(2008-7#1)
by the enzyme##12##3##(1990-5#1)(1990-8#1)(1991-5#2)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-5#1)
by the epidemic##2##3##(2007-7#1)(2008-4#1)
by the equation##2##3##(1996-5#1)(2011-3#1)
by the evaluation##2##3##(2012-2#1)(2013-1#1)
by the evolution of##2##4##(2008-4#1)(2010-7#1)
by the evolutionary##2##3##(2008-8#2)
by the example of##2##4##(1990-5#1)(2011-2#1)
by the example##3##3##(1990-5#1)(1992-6#1)(2011-2#1)
by the excitation of##2##4##(2008-10#1)(2008-11#1)
by the excitation##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
by the existence of a##2##5##(1995-2#1)(2008-6#1)
by the existence of##4##4##(1995-2#1)(2008-6#1)(2008-9#1)(2009-7#1)
by the exogenous##2##3##(1990-5#1)(2008-10#1)
by the experimental##2##3##(2008-2#1)(2008-3#1)
by the experimenter##2##3##(2007-6#2)
by the expert##2##3##(2007-12#1)(2008-5#1)
by the exponential##2##3##(2007-12#1)(2008-10#1)
by the expression of the##4##5##(1995-8#1)(1996-2#1)(2007-12#1)(2008-11#1)
by the expression of##7##4##(1991-5#1)(1993-6#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-11#1)(2010-6#1)
by the expression##8##3##(1991-5#1)(1993-6#1)(1995-8#1)(1996-2#1)(2007-12#2)(2008-11#1)(2010-6#1)
by the extended##2##3##(1992-5#1)(2007-11#1)
by the external##2##3##(2008-10#1)(2011-2#1)
by the extinction##2##3##(2008-2#1)(2008-3#1)
by the extraction##2##3##(2008-10#1)(2010-12#1)
by the fabrication##2##3##(2007-12#1)(2008-10#1)
by the fact that the##6##5##(1991-3#1)(1992-1#1)(2007-11#1)(2008-10#1)(2008-11#2)
by the fact that there are##2##6##(2008-11#1)(2008-4#1)
by the fact that##21##4##(1990-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)
by the failure of##2##4##(1995-12#1)(1995-5#1)
by the family##5##3##(1990-3#1)(1996-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
by the features##2##3##(1990-11#1)(2008-5#1)
by the female##2##3##(2007-12#1)(2009-12#1)
by the femur##2##3##(2013-1#2)
by the fermentation##2##3##(1995-5#1)(2011-1#1)
by the ferric##2##3##(1997-7#1)(2008-11#1)
by the fiber##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
by the fifth harmonic of a##3##6##(2007-11#2)(2008-2#1)
by the film##2##3##(2008-3#2)
by the finding that##6##4##(1994-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
by the findings of##2##4##(2008-11#1)(2008-9#1)
by the findings##3##3##(1997-3#1)(2008-11#1)(2008-9#1)
by the first##14##3##(1991-6#1)(1991-9#1)(1993-6#1)(1994-11#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2013-1#2)
by the fixed##2##3##(2008-10#2)
by the flame##2##3##(2008-10#1)(2008-2#1)
by the flight##2##3##(2007-12#1)(2008-10#1)
by the flow injection##2##4##(2008-10#2)
by the flow##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
by the fluid##3##3##(2008-7#2)(2011-2#1)
by the fluorescence quenching method##2##5##(2008-10#2)
by the fluorescence##4##3##(1993-8#1)(1997-2#1)(2008-10#2)
by the focal##2##3##(2008-10#1)(2008-3#1)
by the following##12##3##(1990-5#1)(1992-3#1)(1992-6#1)(1994-12#1)(1996-2#1)(1996-6#1)(2008-11#2)(2008-5#2)(2008-9#1)(2013-8#1)
by the forced##2##3##(2008-11#1)(2013-1#1)
by the formation of a##2##5##(2008-10#2)
by the formation of##21##4##(1992-12#1)(1993-3#1)(1994-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2010-6#1)(2013-1#2)
by the formation##22##3##(1992-12#1)(1993-3#1)(1994-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#2)
by the former##3##3##(1994-12#1)(2008-10#1)(2010-6#1)
by the four methods##2##4##(2008-10#1)(2013-8#1)
by the four##6##3##(1994-7#1)(1995-3#1)(2008-10#3)(2013-8#1)
by the fourth##2##3##(2007-10#1)(2008-2#1)
by the frequency of##2##4##(1994-6#1)(2010-10#1)
by the frequency##4##3##(1993-9#1)(1994-6#1)(2008-3#1)(2010-10#1)
by the function of the##3##5##(2008-10#1)(2012-12#1)(2013-1#1)
by the functional state of the feeding apparatus##2##8##(2010-8#2)
by the functional##4##3##(2007-12#1)(2008-10#1)(2010-8#2)
by the fundamental##2##3##(2007-11#1)(2007-12#1)
by the fungal##2##3##(2008-10#2)
by the fungi##2##3##(2008-10#1)(2008-6#1)
by the fungus but##2##4##(2008-10#1)(2008-11#1)
by the fungus##23##3##(1992-3#1)(1995-3#1)(2008-10#19)(2008-11#1)(2010-3#1)
by the fusion##2##3##(2008-11#1)(2008-8#1)
by the gas##4##3##(1992-9#1)(2008-10#1)(2008-3#2)
by the gel test##4##4##(2011-1#4)
by the gel##6##3##(2008-10#1)(2011-1#5)
by the gene##4##3##(1993-2#1)(1995-6#1)(1997-3#1)(2008-10#1)
by the general practitioner##2##4##(1990-11#1)(2008-11#1)
by the general##7##3##(1990-11#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2013-1#1)
by the generalized phase-contrast##2##4##(2007-11#1)(2008-3#1)
by the generalized##3##3##(2007-11#1)(2008-3#2)
by the generation##3##3##(2007-11#1)(2008-9#1)(2012-12#1)
by the genetic##4##3##(1993-3#1)(2007-7#1)(2008-7#1)(2012-2#1)
by the geometry##2##3##(2007-12#1)(2008-7#1)
by the global##2##3##(1995-8#1)(2008-2#1)
by the good fit of the##2##6##(2008-10#2)
by the good##4##3##(2008-10#4)
by the government##6##3##(1993-1#1)(1995-3#2)(1997-8#1)(2008-11#1)(2008-7#1)
by the grating##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
by the gravimetric method##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
by the greater##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
by the green##2##3##(1994-11#1)(2008-8#1)
by the greenhouse whitefly##2##4##(2008-10#2)
by the group of##2##4##(2008-5#1)(2008-7#1)
by the group##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
by the growth##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
by the head##4##3##(2008-10#4)
by the health##4##3##(1995-6#1)(1997-2#1)(2008-10#1)(2011-1#1)
by the healthcare##2##3##(2009-6#2)
by the heat##3##3##(1996-2#1)(2008-10#2)
by the hepatitis##2##3##(2007-12#1)(2008-8#1)
by the high##11##3##(1993-9#1)(1994-9#2)(1995-6#1)(2008-11#1)(2008-2#2)(2009-5#1)(2010-5#1)(2012-1#1)(2013-8#1)
by the higher##4##3##(1993-8#1)(1997-4#1)(2008-11#1)(2013-1#1)
by the highly##2##3##(1993-12#1)(2008-10#1)
by the hollow##2##3##(2007-11#1)(2008-11#1)
by the hormone##2##3##(1996-5#1)(2008-7#1)
by the hospital and##2##4##(1995-1#1)(1996-2#1)
by the hospital##8##3##(1991-6#1)(1992-5#1)(1994-1#2)(1995-1#2)(1996-2#1)(2008-10#1)
by the host##9##3##(1990-2#1)(1995-2#1)(2008-10#5)(2008-4#1)(2011-2#1)
by the human body##2##4##(2008-10#1)(2009-5#1)
by the human immunodeficiency virus (HIV)##3##6##(1990-9#1)(1996-11#1)(2008-5#1)
by the human immunodeficiency virus##4##5##(1990-9#2)(1996-11#1)(2008-5#1)
by the human##14##3##(1990-6#1)(1990-9#2)(1993-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-1#1)
by the hybrid##3##3##(1993-9#1)(2008-3#1)(2012-3#1)
by the hydrogen peroxide##2##4##(2008-10#1)(2011-2#1)
by the hydrogen##3##3##(2008-10#2)(2011-2#1)
by the hydrolysis of##4##4##(1992-9#1)(1995-5#1)(2008-10#1)(2008-6#1)
by the hydrothermal##2##3##(2008-10#1)(2013-8#1)
by the i##2##3##(1995-11#1)(1996-2#1)
by the identification of##5##4##(1997-4#1)(1997-8#1)(2007-7#1)(2009-10#1)(2012-3#1)
by the identification##6##3##(1991-2#1)(1997-4#1)(1997-8#1)(2007-7#1)(2009-10#1)(2012-3#1)
by the immobilization of##3##4##(2008-10#3)
by the immobilization##4##3##(2008-10#4)
by the immune system##5##4##(1997-4#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
by the immune##7##3##(1991-9#1)(1997-4#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
by the immunohistochemical method##2##4##(1990-5#1)(2008-5#1)
by the impact##2##3##(2008-10#1)(2008-2#1)
by the in situ##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
by the in##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
by the incident##2##3##(2008-10#2)
by the incorporation of##4##4##(1992-6#1)(1995-12#1)(2008-10#2)
by the increase in the##2##5##(2006-10#1)(2008-10#1)
by the increase in##6##4##(1990-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
by the increase of##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
by the increase##9##3##(1990-12#2)(2006-10#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-2#1)
by the increased levels of##2##5##(1995-6#1)(2012-6#1)
by the increased number of##2##5##(2008-10#1)(2008-3#1)
by the increased##9##3##(1995-6#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)(2012-6#1)
by the increasing##3##3##(1992-3#1)(1996-12#1)(2008-8#1)
by the independent##2##3##(1990-8#1)(2012-3#1)
by the indirect##2##3##(1994-6#1)(2008-11#1)
by the individual##4##3##(1990-8#1)(2008-11#1)(2010-4#1)(2010-6#1)
by the induction of##6##4##(2008-10#1)(2009-12#2)(2010-11#1)(2012-2#1)(2013-1#1)
by the induction##8##3##(2008-10#2)(2008-11#1)(2009-12#2)(2010-11#1)(2012-2#1)(2013-1#1)
by the infection##2##3##(2008-10#1)(2011-2#1)
by the inflammatory##2##3##(2009-3#1)(2010-8#1)
by the information##2##3##(2009-5#1)(2011-2#1)
by the inherent##3##3##(2008-11#1)(2008-3#1)(2010-6#1)
by the inhibition of the##4##5##(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)
by the inhibition of##8##4##(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
by the inhibition##10##3##(1992-3#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
by the inhibitor of##2##4##(2008-8#1)(2013-8#1)
by the inhibitors##2##3##(1995-2#1)(2009-11#1)
by the initial rate##3##4##(1990-12#1)(2008-10#2)
by the initial##8##3##(1990-12#1)(1996-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-6#1)
by the injection of##5##4##(1990-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
by the injection##6##3##(1990-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#2)
by the inner filter effect##2##5##(2008-10#2)
by the inner##4##3##(2008-10#2)(2010-11#2)
by the inoculum##2##3##(2008-10#2)
by the insect##2##3##(1994-8#1)(2007-12#1)
by the insertion of a##2##5##(1994-12#1)(2012-2#1)
by the insertion of##5##4##(1991-7#1)(1994-12#1)(2008-10#2)(2012-2#1)
by the institution in##2##4##(1991-3#1)(2012-2#1)
by the institution##3##3##(1991-3#1)(2008-9#1)(2012-2#1)
by the instrument##3##3##(2008-3#2)(2008-9#1)
by the integration of##2##4##(1993-6#1)(1997-1#1)
by the intensity##2##3##(2008-10#1)(2008-3#1)
by the interaction between##5##4##(1990-12#1)(1991-2#1)(2008-10#2)(2008-8#1)
by the interaction of##5##4##(1995-5#1)(2008-4#2)(2008-8#1)(2013-8#1)
by the interaction with##2##4##(1996-5#1)(2008-4#1)
by the interaction##13##3##(1990-12#1)(1991-2#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-4#3)(2008-8#2)(2012-2#1)(2013-8#1)
by the interference of two##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
by the interference of##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
by the interference##7##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#4)
by the internal standard method##2##5##(1993-3#1)(2008-10#1)
by the internal standard##3##4##(1993-3#1)(2008-10#2)
by the internal##5##3##(1993-3#1)(1993-9#1)(2008-10#2)(2008-2#1)
by the interplay between##3##4##(2007-11#1)(2008-12#1)(2009-8#1)
by the intersection of##2##4##(2007-11#1)(2008-3#1)
by the intervention##2##3##(2008-12#2)
by the intestinal##2##3##(1991-12#1)(2010-1#1)
by the intracellular pathogen##2##4##(1995-2#1)(2009-8#1)
by the intracluster correlation##2##4##(1992-9#1)(2008-10#1)
by the introduction of a##4##5##(2008-10#3)(2008-6#1)
by the introduction of the##2##5##(2008-3#1)(2011-2#1)
by the introduction of##11##4##(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
by the invading##2##3##(2008-10#2)
by the inverse##2##3##(2008-10#2)
by the investigators##2##3##(2008-6#1)(2011-2#1)
by the involved##2##3##(1994-7#1)(2013-8#1)
by the ion##2##3##(1990-11#1)(2008-10#1)
by the iron##3##3##(1990-11#1)(1990-12#1)(1992-3#1)
by the irradiation of##2##4##(2008-10#1)(2012-2#1)
by the irradiation##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
by the isolates##3##3##(2008-10#2)(2008-12#1)
by the kappa##2##3##(1992-8#1)(1996-12#1)
by the kidney##2##3##(1997-1#1)(2011-2#1)
by the kinase inhibitor##2##4##(1992-12#1)(1993-3#1)
by the kinetic##2##3##(2008-10#1)(2008-4#1)
by the laboratory##2##3##(2011-2#1)(2013-1#1)
by the lack of a##5##5##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
by the lack of##17##4##(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
by the large##7##3##(1992-3#1)(1992-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
by the largest##2##3##(2008-10#1)(2013-7#1)
by the larval##2##3##(2008-10#1)(2012-12#1)
by the laser beam##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
by the laser pulse##2##4##(2007-11#1)(2007-12#1)
by the laser##8##3##(1995-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
by the lateral##2##3##(2008-5#1)(2013-1#1)
by the latter##6##3##(1991-8#1)(2007-11#1)(2008-10#3)(2008-5#1)
by the length of##2##4##(2011-2#1)(2013-7#1)
by the lesion##4##3##(1990-12#1)(1993-12#1)(1995-8#1)(1997-6#1)
by the less##2##3##(1990-2#1)(2008-8#1)
by the level of##6##4##(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-3#1)
by the librarian##2##3##(1991-3#1)(1992-12#1)
by the lidar receiver##2##4##(2008-2#2)
by the lidar##4##3##(2008-2#2)(2008-3#2)
by the ligand##3##3##(1991-5#1)(1997-4#1)(2007-11#1)
by the light-scattering##2##3##(2008-10#1)(2008-3#1)
by the limited##2##3##(2008-10#1)(2008-9#1)
by the linear regression##2##4##(2008-10#1)(2013-8#1)
by the linear##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
by the liver##8##3##(1990-11#1)(1991-7#1)(1992-12#1)(1993-9#1)(1996-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
by the local##6##3##(1992-6#1)(1997-4#1)(2007-2#1)(2008-5#1)(2008-9#1)(2013-8#1)
by the localized##2##3##(1996-2#1)(2008-3#1)
by the logistic##3##3##(2008-10#2)(2008-7#1)
by the long##2##3##(2008-10#1)(2008-8#1)
by the loss of a##2##5##(1991-9#1)(2008-4#1)
by the loss of##6##4##(1991-9#1)(1992-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
by the low##10##3##(1995-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
by the lower##3##3##(2008-1#1)(2009-1#1)(2012-2#1)
by the magnetic field##3##4##(2008-8#2)(2008-9#1)
by the magnetic##4##3##(2007-8#1)(2008-8#2)(2008-9#1)
by the main##5##3##(1990-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
by the maintenance##2##3##(2008-11#2)
by the major##6##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-3#1)(2013-1#1)
by the majority of##2##4##(2008-11#1)(2008-12#1)
by the male##2##3##(2008-6#2)
by the mammalian##2##3##(2008-8#1)(2009-8#1)
by the manual##2##3##(1990-5#1)(2008-10#1)
by the manufacturer##6##3##(2008-10#4)(2008-3#1)(2008-5#1)
by the manufacturers##3##3##(1997-3#1)(2008-10#2)
by the marked increase in the##2##6##(1994-12#1)(2008-3#1)
by the mass spectrometer##2##4##(2008-10#2)
by the mass##5##3##(1996-11#1)(2008-10#2)(2008-11#1)(2010-8#1)
by the matrix effect##2##4##(2008-10#1)(2010-11#1)
by the matrix##6##3##(1994-11#1)(2008-10#4)(2010-11#1)
by the maximum##3##3##(1994-2#1)(1997-8#1)(2008-3#1)
by the mean##2##3##(2007-12#1)(2011-1#1)
by the means of##2##4##(2011-2#2)
by the measurement of the##2##5##(2006-6#1)(2008-10#1)
by the measurement of##8##4##(1990-12#1)(1990-5#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-3#1)
by the measurement##9##3##(1990-12#1)(1990-5#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-3#2)
by the media##4##3##(1991-9#1)(1996-11#1)(2010-2#2)
by the medical##4##3##(1991-3#1)(1993-6#1)(1993-8#1)(2007-12#1)
by the members of##2##4##(1997-8#1)(2009-8#1)
by the membrane##7##3##(1990-2#1)(2008-10#5)(2010-5#1)
by the metal##2##3##(1994-5#1)(2008-10#1)
by the method of##16##4##(1990-11#1)(1991-6#1)(1992-6#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
by the method##27##3##(1990-11#1)(1991-6#1)(1992-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
by the methods##2##3##(2008-10#2)
by the microwave##2##3##(2007-12#1)(2008-3#1)
by the middle##2##3##(1995-6#1)(2008-10#1)
by the mixed##3##3##(2008-10#1)(2008-6#2)
by the mixture##2##3##(2008-10#1)(2011-1#1)
by the model of##2##4##(2008-3#1)(2008-5#1)
by the model##13##3##(1992-9#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-1#1)
by the models##3##3##(1995-3#1)(2008-9#1)(2009-7#1)
by the modification of##3##4##(2008-10#2)(2010-5#1)
by the modified Brdicka procedure##2##5##(2008-10#2)
by the modified##6##3##(2008-10#4)(2012-3#1)(2013-8#1)
by the molecular##5##3##(1994-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
by the molybdenum blue##2##4##(2008-10#2)
by the monitoring of##3##4##(2008-10#2)(2008-3#1)
by the more##2##3##(1992-11#1)(2012-2#1)
by the most common##2##4##(2008-4#1)(2013-7#1)
by the most##8##3##(1992-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-7#1)
by the mother##2##3##(2008-8#1)(2013-1#1)
by the movement of the##2##5##(1995-12#1)(2007-12#1)
by the mu##2##3##(1997-7#1)(2008-11#1)
by the much##2##3##(2008-10#1)(2009-8#1)
by the multiple##5##3##(1997-4#2)(2008-10#1)(2008-3#1)(2008-9#1)
by the multivariate##2##3##(2008-10#1)(2012-2#1)
by the mutant##2##3##(2008-10#2)
by the mutual##3##3##(1995-3#1)(1996-3#1)(2008-1#1)
by the national##4##3##(1994-12#1)(1994-6#1)(1995-12#1)(2011-2#1)
by the native##2##3##(1993-8#1)(1997-4#1)
by the natural##4##3##(1990-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
by the nature of the##5##5##(1993-5#1)(1994-8#1)(1996-12#1)(1996-4#1)(2008-10#1)
by the nature of##7##4##(1993-5#1)(1994-8#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2010-3#1)
by the nature##9##3##(1992-8#1)(1993-5#1)(1994-8#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)
by the necrotrophic##2##3##(2008-10#2)
by the need for##5##4##(1997-4#1)(2008-10#1)(2008-2#1)(2010-2#2)
by the need to##2##4##(2008-3#1)(2013-1#1)
by the need##7##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#2)(2013-1#1)
by the negative##4##3##(1990-5#1)(1991-3#1)(2008-10#1)(2008-11#1)
by the nematode##2##3##(2007-2#1)(2008-10#1)
by the neonatal##2##3##(2008-11#2)
by the nervous system##3##4##(2008-7#1)(2009-3#2)
by the new Occupational##2##4##(1993-2#1)(1995-2#1)
by the new method##2##4##(2008-10#1)(2008-3#1)
by the new##13##3##(1992-2#1)(1993-2#1)(1994-11#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
by the newly established##2##4##(2008-11#1)(2012-12#1)
by the nitrogen##2##3##(1993-6#1)(2008-2#1)
by the noise##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
by the non-linear##2##3##(2008-10#2)
by the nonlinear##6##3##(2007-11#1)(2007-12#3)(2008-3#1)(2008-7#1)
by the nonpathogenic##2##3##(2008-10#2)
by the novel##2##3##(1995-5#1)(2011-3#1)
by the nucleotide##2##3##(2008-10#1)(2008-11#1)
by the number of##20##4##(1991-2#1)(1993-12#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-7#5)(2013-8#2)
by the number##22##3##(1991-2#1)(1993-12#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-7#5)(2013-8#2)
by the numerical simulation of the##2##6##(2008-2#2)
by the numerical simulation of##3##5##(2008-2#2)(2009-8#1)
by the numerical##4##3##(2008-2#3)(2009-8#1)
by the nurse##4##3##(2010-3#1)(2010-7#2)(2011-2#1)
by the nursing##3##3##(1990-10#1)(2008-9#1)(2012-3#1)
by the nutritionists##2##3##(1991-2#2)
by the obligate##2##3##(2008-10#2)
by the observation of a##3##5##(1991-5#2)(1997-2#1)
by the observation of##5##4##(1991-5#2)(1992-9#1)(1997-2#1)(2013-1#1)
by the observation that the##2##5##(1995-2#1)(2009-9#1)
by the observation that##7##4##(1991-9#1)(1992-2#1)(1992-3#1)(1994-11#1)(1995-2#1)(2008-3#1)(2009-9#1)
by the observation##13##3##(1991-5#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-2#1)(1997-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2013-1#1)
by the observer##2##3##(2008-3#1)(2011-2#1)
by the occurrence of##3##4##(2008-10#2)(2008-7#1)
by the occurrence##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2012-12#1)
by the official##4##3##(2008-10#3)(2008-11#1)
by the on-line##3##3##(2008-10#3)
by the ongoing##2##3##(1997-6#1)(2013-1#1)
by the onset of##2##4##(1994-11#1)(2010-8#1)
by the open##2##3##(2007-7#1)(2008-10#1)
by the optical mapping##2##4##(2013-1#2)
by the optical##7##3##(2008-2#1)(2008-3#2)(2009-5#1)(2013-1#3)
by the order of##2##4##(2008-10#1)(2008-8#1)
by the organization of##2##4##(2008-10#1)(2010-6#1)
by the organization##3##3##(1994-1#1)(2008-10#1)(2010-6#1)
by the original##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
by the other##8##3##(1992-8#1)(1994-8#1)(2007-11#2)(2008-1#1)(2008-10#3)
by the overwhelming##2##3##(2011-2#1)(2013-1#1)
by the oxidation of the##2##5##(1994-8#1)(2008-10#1)
by the oxidation of##6##4##(1994-8#1)(2008-10#5)
by the oxidation##7##3##(1994-8#1)(2008-10#6)
by the oxidative##4##3##(1990-5#1)(2008-10#3)
by the pH##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
by the panel of##2##4##(1992-9#1)(2012-12#1)
by the parameters##2##3##(2010-8#1)(2011-1#1)
by the parasitoid##2##3##(1992-6#1)(2007-12#1)
by the parents##5##3##(1996-2#1)(2006-10#1)(2008-10#1)(2010-4#1)(2011-1#1)
by the participants##2##3##(2008-10#1)(2011-2#1)
by the passage of##2##4##(1995-3#1)(2008-9#1)
by the pathogen##14##3##(2008-10#14)
by the pathogens##3##3##(2008-10#2)(2011-2#1)
by the pathologist##3##3##(1991-2#1)(1992-2#1)(2012-2#1)
by the patient##12##3##(1990-11#1)(1991-6#1)(1993-11#1)(1994-12#1)(1996-2#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
by the patient's##2##3##(1993-11#1)(2012-12#1)
by the patients themselves##2##4##(1993-2#1)(2007-12#1)
by the patients with##2##4##(2008-10#1)(2008-12#1)
by the patients##9##3##(1992-8#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2009-10#2)(2010-3#1)
by the paucity of##2##4##(1991-8#1)(2008-10#1)
by the peak area##3##4##(1990-8#1)(2008-10#2)
by the peak##5##3##(1990-8#1)(2008-10#3)(2008-2#1)
by the peptide##2##3##(1990-12#1)(1992-9#1)
by the percentage of##3##4##(1993-3#1)(2008-10#1)(2011-1#1)
by the percentage##4##3##(1993-3#1)(2008-10#1)(2010-8#1)(2011-1#1)
by the performance of the##2##5##(2008-10#2)
by the peripheral##2##3##(1991-7#1)(1996-2#1)
by the perturbation of##2##4##(2008-10#1)(2008-7#1)
by the perturbation##3##3##(2008-10#2)(2008-7#1)
by the phage##2##3##(1994-12#1)(2008-11#1)
by the pharmaceutical industry##3##4##(1996-2#1)(1997-5#1)(2012-1#1)
by the pharmacological##2##3##(2008-8#1)(2012-2#1)
by the phase##10##3##(1997-1#1)(2007-11#1)(2008-2#4)(2008-3#4)
by the phorbol ester##3##4##(1992-9#2)(1997-1#1)
by the phosphoramidite##3##3##(2008-4#3)
by the physician and##3##4##(1992-4#1)(1996-6#1)(2010-7#1)
by the physician at the##2##5##(1996-9#1)(2008-1#1)
by the physician##10##3##(1991-11#1)(1992-4#1)(1993-8#1)(1996-6#1)(1996-9#1)(2008-1#1)(2008-11#1)(2010-3#1)(2010-7#2)
by the physicians##2##3##(2008-1#1)(2009-5#1)
by the pineal hormone##2##4##(1995-9#1)(2008-5#1)
by the plant##2##3##(2008-10#1)(2008-11#1)
by the plant-pathogenic fungus##2##4##(2008-10#2)
by the plasma##2##3##(1995-2#1)(2008-1#1)
by the polarization##2##3##(1990-2#1)(2008-3#1)
by the polyhedrin promoter##2##4##(2008-11#2)
by the polymerase chain reaction (PCR)##4##6##(1995-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
by the polymerase chain reaction and##2##6##(1994-12#1)(2007-10#1)
by the polymerase chain reaction##19##5##(1990-11#1)(1991-6#2)(1992-10#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)
by the polymerase##21##3##(1990-11#1)(1991-6#2)(1992-10#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)(2011-1#1)
by the polyurethane##2##3##(2008-10#2)
by the population##4##3##(1991-12#1)(1994-2#1)(2007-10#1)(2013-8#1)
by the position of the##2##5##(2008-5#1)(2011-2#1)
by the positive##5##3##(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
by the possibility##2##3##(1994-9#1)(2008-8#1)
by the potent##2##3##(1994-8#1)(2012-2#1)
by the power law##2##4##(2008-10#1)(2010-5#1)
by the power##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
by the practicing##2##3##(2012-12#1)(2013-1#1)
by the practitioner##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
by the preparation##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
by the presence of a##8##5##(1992-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
by the presence of both##2##5##(2008-10#1)(2009-10#1)
by the presence of large amounts of##2##7##(2008-10#2)
by the presence of other##4##5##(2008-10#4)
by the presence of the##8##5##(1990-5#1)(1993-3#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#2)
by the presence of two##3##5##(1994-8#1)(2008-4#1)(2008-5#1)
by the presence of##108##4##(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-3#3)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#4)(2010-8#1)(2011-2#2)(2012-12#3)(2013-8#2)
by the presence or absence of##5##6##(1995-11#1)(2008-10#3)(2008-4#1)
by the presence##119##3##(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#4)(1995-3#4)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#4)(2010-8#1)(2011-2#3)(2012-12#3)(2013-8#2)
by the present method##9##4##(1995-3#1)(2008-10#8)
by the present##17##3##(1995-3#1)(1996-2#1)(2008-10#13)(2008-3#1)(2011-1#1)
by the presented##2##3##(2007-12#1)(2008-10#1)
by the previous##2##3##(2008-12#1)(2011-2#1)
by the primary health##2##4##(1991-6#2)
by the primary structure of the##2##6##(1994-2#1)(2008-2#1)
by the primary##9##3##(1991-6#2)(1993-6#1)(1994-2#1)(1995-4#1)(2007-10#1)(2007-12#1)(2008-2#1)(2013-1#1)
by the prior##2##3##(1994-11#1)(1995-2#1)
by the probe##3##3##(1990-9#1)(2008-3#2)
by the product of##2##4##(1997-3#1)(2008-5#1)
by the production of##7##4##(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
by the program##3##3##(1993-3#1)(1996-2#1)(1997-5#1)
by the progressive##3##3##(2008-4#1)(2008-9#1)(2009-10#1)
by the properties##2##3##(1995-5#1)(2008-4#1)
by the proportion of##2##4##(2008-8#1)(2008-9#1)
by the proportion##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
by the proposed method and by##2##6##(2008-10#2)
by the proposed method and the##2##6##(2008-10#2)
by the proposed method and##7##5##(2008-10#7)
by the proposed method are##2##5##(2008-10#2)
by the proposed method in##2##5##(2008-10#2)
by the proposed method were compared##2##6##(2008-10#2)
by the proposed method were##4##5##(2008-10#4)
by the proposed method##29##4##(2008-10#27)(2008-3#1)(2012-3#1)
by the proposed procedure##3##4##(2008-10#2)(2008-6#1)
by the proposed##56##3##(1990-8#1)(1997-1#1)(2008-10#49)(2008-3#2)(2008-6#1)(2009-10#1)(2012-3#1)
by the protein kinase C (PKC)##2##6##(1993-6#1)(2013-1#1)
by the protein kinase C##3##5##(1993-6#1)(1995-6#1)(2013-1#1)
by the protein kinase##4##4##(1993-6#1)(1995-12#1)(1995-6#1)(2013-1#1)
by the protein phosphatase##2##4##(1993-8#1)(1994-11#1)
by the protein##12##3##(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-7#1)(2010-7#1)(2013-1#1)
by the proteinases##2##3##(1990-5#1)(1993-11#1)
by the provincial government##2##4##(1992-2#1)(1995-2#1)
by the public##2##3##(1995-3#1)(2008-7#1)
by the pulse width##2##4##(2008-3#2)
by the quality of##4##4##(1996-1#1)(2010-5#1)(2013-1#2)
by the quality##5##3##(1996-1#1)(2008-3#1)(2010-5#1)(2013-1#2)
by the quantitative##3##3##(2008-1#1)(2008-10#2)
by the radial##2##3##(1995-5#1)(2007-10#1)
by the radiation pressure of a##2##6##(2007-12#2)
by the radiation##4##3##(2007-12#2)(2009-11#1)(2013-7#1)
by the radical##2##3##(2008-10#1)(2008-11#1)
by the radiologist##2##3##(1991-3#1)(2012-2#1)
by the radiology##2##3##(1993-2#1)(1994-12#1)
by the rainbow method##2##4##(2008-3#2)
by the random##4##3##(1992-10#1)(2008-10#2)(2008-8#1)
by the range of##3##4##(1990-11#1)(2007-12#1)(2008-11#1)
by the rapid##11##3##(1992-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
by the rate of##6##4##(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#2)
by the rate##8##3##(1997-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)
by the ratio of the##3##5##(1994-12#1)(2008-4#1)(2008-5#1)
by the ratio of##6##4##(1994-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)
by the ratio##7##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)
by the reaction between##4##4##(2008-10#4)
by the reaction of##8##4##(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#3)(2011-1#2)
by the reaction##16##3##(1993-8#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#9)(2011-1#2)
by the reagents##2##3##(1994-11#1)(2008-10#1)
by the recent##5##3##(2007-12#1)(2008-11#1)(2008-8#2)(2013-8#1)
by the recently##3##3##(1991-2#1)(1994-12#1)(2008-8#1)
by the receptor##3##3##(1992-10#1)(1993-11#1)(1994-12#1)
by the recognition of##2##4##(1995-2#1)(2007-8#1)
by the recombinant vaccinia virus##2##5##(2008-8#2)
by the recombinant##5##3##(1992-8#1)(2008-10#1)(2008-8#3)
by the reconstructive surgeon##2##4##(2011-2#1)(2012-2#1)
by the recovery of##2##4##(2008-10#2)
by the recovery##3##3##(2008-10#3)
by the red##2##3##(2011-2#1)(2012-2#1)
by the redox##3##3##(1992-8#1)(2008-10#1)(2008-7#1)
by the reduced##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
by the reducing##2##3##(1994-11#1)(1995-11#1)
by the reduction in##2##4##(1990-11#1)(2008-9#1)
by the reduction of the##2##5##(2008-10#1)(2008-11#1)
by the reduction of##7##4##(2008-10#6)(2008-11#1)
by the reduction##9##3##(1990-11#1)(2008-10#6)(2008-11#1)(2008-9#1)
by the reference method##2##4##(2008-10#2)
by the reference##8##3##(2008-10#8)
by the regression##2##3##(2008-10#1)(2008-9#1)
by the regulatory protein##2##4##(1990-7#2)
by the regulatory##3##3##(1990-7#2)(1997-2#1)
by the relation##2##3##(1997-2#1)(2008-3#1)
by the relative##8##3##(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)
by the relatively low##2##4##(2008-6#1)(2009-1#1)
by the relatively##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-1#1)
by the release of##8##4##(1990-5#1)(1994-11#1)(1995-3#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
by the release##9##3##(1990-5#1)(1994-11#1)(1995-3#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2013-8#1)
by the relevant##2##3##(2008-11#1)(2012-3#1)
by the removal of##4##4##(1992-11#1)(1992-3#1)(1995-11#1)(2009-9#1)
by the reorientation of##2##4##(2008-10#2)
by the repeating##2##3##(1992-9#1)(2011-2#1)
by the replacement of##2##4##(1994-3#1)(2008-12#1)
by the replacement##3##3##(1993-11#1)(1994-3#1)(2008-12#1)
by the replication##2##3##(1990-7#1)(1994-11#1)
by the repressor##2##3##(1992-6#1)(1994-3#1)
by the research team##2##4##(2010-11#1)(2010-3#1)
by the research##3##3##(2010-11#1)(2010-3#1)(2010-4#1)
by the researcher##2##3##(1990-12#1)(2011-1#1)
by the resin phase##2##4##(2008-10#2)
by the resin##5##3##(2008-10#5)
by the resistant##2##3##(2008-10#1)(2008-11#1)
by the resonant##2##3##(2007-11#1)(2008-3#1)
by the respective##3##3##(1991-2#1)(1993-6#1)(2008-10#1)
by the result that##2##4##(1997-8#1)(2011-2#1)
by the results of the##3##5##(1992-5#1)(2008-4#1)(2008-8#1)
by the results of this##2##5##(2008-10#1)(2008-6#1)
by the results of##13##4##(1992-5#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)
by the retrospective##2##3##(2012-3#2)
by the reverse transcription polymerase chain reaction##2##7##(1997-7#1)(2008-5#1)
by the reverse##4##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-5#1)
by the review of##2##4##(2008-11#1)(2008-8#1)
by the review##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
by the right transradial approach##2##5##(2008-11#2)
by the risk of recurrence##2##5##(1993-9#1)(1996-11#1)
by the risk##3##3##(1993-9#1)(1996-11#1)(2012-2#1)
by the rotation##3##3##(1997-7#1)(2008-3#2)
by the same examiner##2##4##(2008-12#1)(2013-1#1)
by the same investigator##2##4##(2011-1#1)(2013-1#1)
by the same mechanism as##2##5##(1993-12#1)(2008-10#1)
by the same mechanism##4##4##(1993-12#1)(1995-12#1)(2008-10#1)(2011-2#1)
by the same stimulus##2##4##(1995-5#1)(1997-1#1)
by the same surgeon##4##4##(2007-8#2)(2008-8#1)(2008-9#1)
by the same surgeons##2##4##(1995-1#1)(2012-1#1)
by the same##77##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#5)
by the sample##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2013-8#1)
by the scaling##2##3##(2008-5#1)(2008-8#1)
by the scarcity of##3##4##(2011-2#1)(2011-3#1)(2012-12#1)
by the scattered##2##3##(2008-3#2)
by the scattering##3##3##(2008-2#1)(2008-3#2)
by the screening##2##3##(1997-4#1)(2008-10#1)
by the second##12##3##(1991-6#1)(1991-9#1)(2007-10#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)
by the second-order##2##3##(2008-3#1)(2011-1#1)
by the segregation of##2##4##(2008-10#2)
by the selected##2##3##(2007-11#1)(2008-6#1)
by the selection##3##3##(1997-9#1)(2008-10#1)(2008-11#1)
by the selective##4##3##(1991-8#1)(1995-12#1)(1995-5#1)(1996-2#1)
by the senior author##4##4##(1993-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
by the senior##5##3##(1993-12#2)(2008-9#1)(2012-3#1)(2013-1#1)
by the sensor##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
by the separation##2##3##(2008-10#1)(2008-3#1)
by the sequence##2##3##(1997-3#1)(2008-9#1)
by the sequences##2##3##(1993-3#1)(1993-8#1)
by the sequential##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
by the serological##2##3##(1995-12#1)(1997-8#1)
by the set of##2##4##(2008-1#1)(2008-3#1)
by the shape of the##3##5##(2008-2#2)(2012-3#1)
by the shape##5##3##(2008-2#2)(2008-5#1)(2012-3#2)
by the sharp##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
by the shortage of##2##4##(2006-10#1)(2010-11#1)
by the significant##2##3##(2008-10#1)(2008-4#1)
by the significantly##3##3##(1990-8#1)(2013-1#1)(2013-8#1)
by the simple##2##3##(2008-10#1)(2008-3#1)
by the simplest##2##3##(2008-11#1)(2008-8#1)
by the simplex method##2##4##(2008-10#2)
by the simulation##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
by the simultaneous##7##3##(1992-6#1)(1996-5#1)(2007-12#2)(2008-10#1)(2009-2#1)(2009-3#1)
by the single cell gel##2##5##(1996-2#1)(2013-1#1)
by the single##7##3##(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2011-2#1)(2013-1#1)
by the size of the##6##5##(1996-6#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#1)
by the size##9##3##(1995-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#1)
by the skin##5##3##(2008-5#5)
by the slope##4##3##(2008-10#3)(2008-3#1)
by the small##9##3##(1990-8#1)(1994-6#2)(1994-9#1)(2008-10#3)(2009-5#1)(2013-8#1)
by the so-called##5##3##(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
by the social##4##3##(1995-5#1)(2008-11#2)(2009-6#1)
by the soft##2##3##(2008-10#1)(2012-2#1)
by the software##2##3##(2008-9#1)(2012-3#1)
by the soilborne fungus##2##4##(2008-10#2)
by the soilborne##6##3##(2008-10#6)
by the sol-gel##2##3##(2008-10#2)
by the solution##2##3##(1992-6#1)(2008-3#1)
by the solvent extraction method##2##5##(2008-10#2)
by the solvent##7##3##(1996-5#1)(2008-10#3)(2008-7#1)(2011-1#1)(2013-1#1)
by the somatostatin##2##3##(1995-2#1)(2012-3#1)
by the source##6##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
by the spatial##2##3##(2009-5#1)(2009-9#1)
by the special##2##3##(2008-3#2)
by the specialist##2##3##(1995-3#1)(2008-9#1)
by the specialized##2##3##(1994-9#1)(2013-1#1)
by the species##2##3##(2008-10#2)
by the specific##7##3##(1990-12#1)(1995-8#1)(2007-12#1)(2008-10#3)(2011-2#1)
by the spectral##4##3##(2007-12#1)(2008-10#1)(2011-3#1)(2012-2#1)
by the spectrometer autosampler##2##4##(2008-10#2)
by the spectrophotometric method##5##4##(2008-10#3)(2013-8#2)
by the spectrophotometric##7##3##(1995-2#1)(2008-10#4)(2013-8#2)
by the speed of##2##4##(2007-11#1)(2008-3#1)
by the square##2##3##(2008-2#1)(2008-3#1)
by the stable##2##3##(2008-7#1)(2013-8#1)
by the standard addition method##7##5##(2008-10#7)
by the standard addition##8##4##(2008-10#8)
by the standard additions method##2##5##(2008-10#2)
by the standard deviation##2##4##(2008-11#1)(2008-2#1)
by the standard##20##3##(1990-11#1)(1992-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
by the state##3##3##(1995-2#1)(1996-2#1)(2013-1#1)
by the stimulation##4##3##(1990-12#1)(1992-12#1)(2008-4#1)(2009-8#1)
by the stochastic parallel##2##4##(2007-11#1)(2008-3#1)
by the stochastic##4##3##(2007-11#1)(2008-3#2)(2008-7#1)
by the strength of the##2##5##(1994-11#1)(2007-11#1)
by the strength##3##3##(1994-11#1)(2007-11#1)(2013-8#1)
by the stripping##2##3##(2008-10#2)
by the structural characterization##2##4##(2008-10#1)(2008-4#1)
by the structural##4##3##(1993-9#1)(2008-10#1)(2008-4#1)(2012-2#1)
by the structure of the##4##5##(1990-8#1)(1993-2#1)(2010-2#2)
by the structure##5##3##(1990-8#1)(1993-2#1)(2008-10#1)(2010-2#2)
by the students##5##3##(2008-11#2)(2010-10#1)(2010-3#1)(2013-1#1)
by the studied##2##3##(2008-10#1)(2008-7#1)
by the study of##3##4##(2008-10#3)
by the study##6##3##(1990-2#1)(1992-12#1)(2008-10#3)(2010-11#1)
by the subject##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
by the substitution of##3##4##(1990-12#1)(1993-11#1)(1993-12#1)
by the substitution##4##3##(1990-12#1)(1993-11#1)(1993-12#1)(2008-11#1)
by the successful##2##3##(2008-10#1)(2008-3#1)
by the superimposition##2##3##(1995-6#1)(2008-2#1)
by the surface##7##3##(1991-2#1)(1994-6#1)(2007-11#1)(2008-10#3)(2008-3#1)
by the surfactant##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
by the surgeon##3##3##(2007-11#1)(2012-3#2)
by the surrounding##2##3##(1993-3#1)(2008-7#1)
by the sustained##2##3##(1994-6#1)(1997-8#1)
by the synergistic##2##3##(2008-10#1)(2008-4#1)
by the synthesis of##3##4##(2008-10#2)(2008-4#1)
by the synthetic##2##3##(1991-9#1)(2008-10#1)
by the system##6##3##(1994-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
by the target##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-3#1)
by the team##2##3##(1997-2#1)(2011-1#1)
by the technique of##4##4##(2008-2#2)(2008-3#1)(2008-8#1)
by the technique##6##3##(2008-2#2)(2008-3#2)(2008-8#1)(2012-2#1)
by the temperature##3##3##(1991-8#1)(1997-6#1)(2008-3#1)
by the term##3##3##(1993-8#2)(2007-10#1)
by the test##2##3##(1997-3#1)(2008-5#1)
by the theoretical##2##3##(2007-11#1)(2008-3#1)
by the thickness of the##2##5##(2007-11#1)(2008-10#1)
by the thickness##3##3##(2007-11#1)(2008-10#2)
by the third##4##3##(1995-8#1)(1996-1#1)(2007-12#1)(2008-3#1)
by the three##7##3##(1992-11#1)(1995-11#1)(1996-2#1)(2008-10#4)
by the time of##2##4##(1997-2#1)(2007-12#1)
by the time they##2##4##(1991-9#1)(2009-10#1)
by the time##10##3##(1991-9#1)(1994-3#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
by the top##2##3##(1993-12#1)(2008-3#1)
by the topical##2##3##(1991-8#1)(1994-2#1)
by the total##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
by the traditional technique##2##4##(2011-2#2)
by the traditional##6##3##(1994-3#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#2)
by the transcription factor##2##4##(1995-6#1)(2010-7#1)
by the transfected##2##3##(1995-5#1)(2008-11#1)
by the transformant##2##3##(2011-1#2)
by the transforming##2##3##(2008-10#2)
by the transient##2##3##(1990-7#1)(2008-10#1)
by the transplant##2##3##(2011-2#1)(2011-3#1)
by the transverse##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
by the treated##2##3##(1994-12#1)(2006-10#1)
by the treatment of##3##4##(2008-10#1)(2008-11#2)
by the treatment with##2##4##(1993-3#1)(1996-12#1)
by the treatment##7##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#2)(2009-10#1)(2012-2#1)
by the triad of##2##4##(2008-8#1)(2011-1#1)
by the tube test##4##4##(2011-1#4)
by the tumor stage##2##4##(2008-6#2)
by the tumor##8##3##(1992-9#1)(2006-12#1)(2008-6#3)(2009-3#1)(2009-7#1)(2010-9#1)
by the tumour##4##3##(2008-6#1)(2008-7#2)(2009-4#1)
by the tungsten##2##3##(2007-12#1)(2008-10#1)
by the two instruments##2##4##(2008-3#2)
by the two methods##9##4##(1992-6#1)(1996-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
by the two##40##3##(1992-6#1)(1994-2#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#6)(2008-6#1)(2008-8#2)(2008-9#3)(2010-10#1)(2012-12#1)(2012-5#1)
by the type of##6##4##(1995-11#1)(2008-10#3)(2008-5#1)(2010-6#1)
by the type##7##3##(1995-11#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-6#1)
by the tyrosine kinase inhibitor##2##5##(1993-9#1)(1994-8#1)
by the ultrasonic##3##3##(1993-2#1)(1997-6#1)(2013-8#1)
by the underlying##6##3##(2007-12#1)(2008-1#2)(2008-11#3)
by the univariate method##2##4##(2008-10#2)
by the univariate##3##3##(2008-10#3)
by the upper##2##3##(1991-5#1)(1993-9#1)
by the usage##2##3##(1996-2#1)(2012-3#1)
by the use of a##14##5##(1992-6#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-7#1)(2009-6#1)
by the use of attenuated total##2##6##(2008-10#2)
by the use of different##2##5##(1990-2#1)(2010-12#1)
by the use of rapid##2##5##(1995-6#1)(2008-10#1)
by the use of the##4##5##(1990-12#1)(2008-10#2)(2008-3#1)
by the use of##81##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1991-12#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-3#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#27)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
by the use##84##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1991-12#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-3#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#29)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
by the user##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#1)
by the usual##2##3##(2007-8#1)(2008-10#1)
by the value##2##3##(2008-3#1)(2012-2#1)
by the various##7##3##(1995-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
by the vascular##3##3##(1991-4#1)(2008-10#1)(2012-3#1)
by the vector##4##3##(2008-10#4)
by the ventral##2##3##(2007-12#1)(2008-5#1)
by the vessel##2##3##(2008-3#1)(2012-3#1)
by the viral##2##3##(1992-12#1)(2008-10#1)
by the virus and##2##4##(2011-1#1)(2012-2#1)
by the virus##4##3##(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)
by the volume##2##3##(2008-10#1)(2008-3#1)
by the water##3##3##(2008-2#1)(2008-3#2)
by the way##2##3##(2008-10#1)(2011-2#1)
by the whitefly##3##3##(2008-10#3)
by the whole limb##2##4##(2010-3#2)
by the whole##3##3##(2008-10#1)(2010-3#2)
by the widespread##2##3##(1995-5#1)(2008-10#1)
by the width of the##2##5##(2008-10#1)(2008-2#1)
by the wild##2##3##(1997-2#1)(2008-10#1)
by the wild-type##5##3##(1990-5#1)(1991-12#2)(2008-10#2)
by the woman##2##3##(1991-6#1)(1995-1#1)
by the word##2##3##(2008-5#1)(2009-11#1)
by the work##2##3##(1994-2#1)(2008-9#1)
by the year 2000##11##4##(1990-2#1)(1993-3#1)(1994-9#2)(1997-2#2)(1997-6#4)(2008-11#1)
by the year 2010##2##4##(2007-2#1)(2011-1#1)
by the year##15##3##(1990-2#1)(1993-3#1)(1994-9#3)(1997-2#2)(1997-6#4)(2007-2#1)(2008-11#1)(2009-10#1)(2011-1#1)
by the yeast##5##3##(1992-6#1)(1994-9#1)(1995-5#1)(2008-6#2)
by the##6401##2##(1990-10#4)(1990-11#38)(1990-12#28)(1990-2#29)(1990-3#11)(1990-5#40)(1990-6#8)(1990-7#20)(1990-8#29)(1990-9#12)(1991-1#6)(1991-10#2)(1991-11#5)(1991-12#34)(1991-2#26)(1991-3#21)(1991-4#2)(1991-5#23)(1991-6#16)(1991-7#6)(1991-8#19)(1991-9#27)(1992-1#11)(1992-10#4)(1992-11#11)(1992-12#30)(1992-2#19)(1992-3#42)(1992-4#6)(1992-5#11)(1992-6#34)(1992-7#1)(1992-8#18)(1992-9#24)(1993-1#5)(1993-11#25)(1993-12#33)(1993-2#22)(1993-3#34)(1993-5#3)(1993-6#29)(1993-8#34)(1993-9#29)(1994-1#11)(1994-10#1)(1994-11#31)(1994-12#53)(1994-2#23)(1994-3#39)(1994-5#25)(1994-6#23)(1994-7#6)(1994-8#35)(1994-9#26)(1995-1#14)(1995-11#24)(1995-12#54)(1995-2#50)(1995-3#30)(1995-4#1)(1995-5#28)(1995-6#43)(1995-8#19)(1995-9#3)(1996-1#14)(1996-11#9)(1996-12#37)(1996-2#41)(1996-3#16)(1996-4#4)(1996-5#31)(1996-6#16)(1996-7#4)(1996-8#6)(1996-9#8)(1997-1#20)(1997-2#45)(1997-3#28)(1997-4#32)(1997-5#9)(1997-6#22)(1997-7#24)(1997-8#18)(1997-9#1)(2006-10#10)(2006-12#3)(2006-4#3)(2006-6#1)(2007-10#30)(2007-11#104)(2007-12#138)(2007-2#9)(2007-4#1)(2007-5#6)(2007-6#6)(2007-7#13)(2007-8#33)(2007-9#2)(2008-1#54)(2008-10#1468)(2008-11#222)(2008-12#56)(2008-2#189)(2008-3#392)(2008-4#85)(2008-5#175)(2008-6#73)(2008-7#153)(2008-8#134)(2008-9#122)(2009-1#4)(2009-10#29)(2009-11#17)(2009-12#12)(2009-2#8)(2009-3#19)(2009-4#9)(2009-5#17)(2009-6#15)(2009-7#18)(2009-8#38)(2009-9#19)(2010-1#11)(2010-10#8)(2010-11#16)(2010-12#19)(2010-2#16)(2010-3#27)(2010-4#25)(2010-5#27)(2010-6#16)(2010-7#14)(2010-8#37)(2010-9#9)(2011-1#79)(2011-10#1)(2011-2#162)(2011-3#12)(2011-7#1)(2011-9#1)(2012-1#23)(2012-12#57)(2012-2#84)(2012-3#67)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#138)(2013-7#29)(2013-8#77)
by theanine##2##2##(2008-11#2)
by their ability to##5##4##(1994-6#1)(1994-8#1)(1997-6#1)(2008-7#1)(2008-9#1)
by their direct##2##3##(1992-8#1)(1994-2#1)
by their enzymatic##2##3##(2008-11#2)
by their failure to##2##4##(1994-9#1)(1995-5#1)
by their high##4##3##(2008-10#1)(2008-2#1)(2008-6#1)(2010-2#1)
by their interaction##2##3##(1990-5#1)(2008-10#1)
by their large##3##3##(1993-6#1)(2008-10#1)(2008-4#1)
by their molecular##2##3##(1996-5#1)(2008-8#1)
by their own##2##3##(1993-3#1)(2011-2#1)
by their parents##2##3##(2007-7#1)(2008-5#1)
by their responses to##2##4##(1994-9#2)
by their specific##2##3##(2008-10#1)(2008-4#1)
by their##168##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#4)(2013-8#3)
by them##9##2##(1990-9#1)(1993-3#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
by themselves##8##2##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)
by theoretical##6##2##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
by theory and##4##3##(2007-12#1)(2008-10#1)(2013-1#2)
by theory##7##2##(2007-12#2)(2008-10#1)(2008-9#1)(2013-1#3)
by therapeutic##6##2##(1991-9#1)(2008-7#2)(2009-5#1)(2012-3#1)(2013-1#1)
by thermal initiation polymerization##2##4##(2008-10#2)
by thermal initiation##4##3##(2008-10#4)
by thermal ionization mass spectrometry##2##5##(1992-3#1)(2008-10#1)
by thermal lensing##4##3##(2008-10#4)
by thermal tides##2##3##(1992-7#2)
by thermal##27##2##(1992-3#1)(1992-7#2)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#3)
by thermally##2##2##(2008-10#2)
by thermogravimetric##2##2##(2008-10#2)
by thermolysin##5##2##(1993-8#1)(1994-5#4)
by these agents##7##3##(1990-2#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2013-1#2)
by these bacteria##2##3##(2008-10#2)
by these cells##10##3##(1991-5#1)(1992-2#1)(1992-9#2)(1993-5#1)(1995-11#1)(2008-11#3)(2008-9#1)
by these factors##2##3##(2008-11#1)(2008-8#1)
by these genes##2##3##(2008-10#1)(2009-8#1)
by these groups##2##3##(1995-12#1)(2011-1#1)
by these inhibitors##2##3##(1992-6#1)(1992-8#1)
by these methods##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
by these patients##2##3##(2007-11#1)(2012-3#1)
by these peptides##2##3##(1990-5#1)(1994-12#1)
by these procedures##2##3##(2008-10#1)(2008-9#1)
by these proteins##2##3##(1992-5#1)(1993-9#1)
by these receptors##3##3##(1995-12#1)(1997-5#1)(2008-10#1)
by these strains##2##3##(2008-10#1)(2008-8#1)
by these systems##2##3##(1994-3#1)(1996-1#1)
by these three##3##3##(1992-1#1)(2008-10#1)(2010-12#1)
by these two##14##3##(1990-5#1)(1994-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-3#1)
by these viruses##2##3##(2008-11#1)(2013-1#1)
by these##161##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-3#2)(1991-5#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-7#1)(2007-11#3)(2007-4#1)(2007-5#1)(2008-10#26)(2008-11#11)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
by theta##2##2##(2008-10#1)(2010-7#1)
by thiamin##3##2##(1995-6#3)
by thin layer chromatography and##2##5##(2008-10#1)(2008-11#1)
by thin layer chromatography##7##4##(2008-10#3)(2008-11#1)(2009-7#1)(2009-8#1)(2010-5#1)
by thin layer##8##3##(1992-9#1)(2008-10#3)(2008-11#1)(2009-7#1)(2009-8#1)(2010-5#1)
by thin##9##2##(1992-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-5#1)
by thin-layer chromatography (TLC)##2##4##(1992-11#1)(2008-4#1)
by thin-layer chromatography##4##3##(1992-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
by thiol##2##2##(1992-3#1)(1994-8#1)
by thiols##3##2##(1991-3#1)(1991-9#1)(2008-10#1)
by thiourea##2##2##(2008-10#1)(2011-2#1)
by third derivative spectrophotometry##2##4##(2008-10#2)
by third##4##2##(1995-2#1)(2008-10#2)(2011-2#1)
by thirteen##2##2##(1997-8#1)(2011-2#1)
by this age group##2##4##(1992-11#1)(1995-2#1)
by this analysis##2##3##(1992-2#1)(1995-3#1)
by this approach##3##3##(2007-11#1)(2008-3#1)(2009-10#1)
by this bacterium##2##3##(2008-10#2)
by this enzyme##3##3##(1990-11#1)(1994-8#1)(1997-7#1)
by this fungus##3##3##(2008-10#2)(2011-1#1)
by this in##2##3##(1995-2#1)(2008-11#1)
by this kinase##2##3##(1992-11#1)(1994-6#1)
by this method are##4##4##(1992-4#1)(2008-10#3)
by this method correlated##2##4##(1990-2#1)(1995-12#1)
by this method were in good agreement with##3##8##(2008-10#3)
by this method were in##4##5##(2008-10#3)(2008-5#1)
by this method were##9##4##(1990-8#1)(2008-10#7)(2008-5#1)
by this method##47##3##(1990-2#1)(1990-8#2)(1991-5#1)(1992-4#2)(1994-11#1)(1995-12#1)(1997-1#1)(2007-12#2)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-12#1)
by this model##3##3##(1996-4#1)(2008-3#1)(2012-12#1)
by this new method##2##4##(2008-10#1)(2009-9#1)
by this new##4##3##(1996-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
by this newly developed method##2##5##(2008-10#2)
by this organism##3##3##(1990-6#1)(2007-6#1)(2012-3#1)
by this pathogen##4##3##(2008-10#2)(2009-8#2)
by this plant##2##3##(2009-12#1)(2009-8#1)
by this population##2##3##(2008-10#1)(2012-12#1)
by this procedure##7##3##(1995-10#1)(2008-10#5)(2008-6#1)
by this process##2##3##(2007-12#2)
by this program##2##3##(2009-3#1)(2011-2#1)
by this proposed##2##3##(2008-10#2)
by this protein##2##3##(1995-6#1)(2013-1#1)
by this reagent##2##3##(2008-4#2)
by this route##3##3##(1993-11#1)(1995-12#1)(2011-2#1)
by this sensor##2##3##(2008-10#2)
by this species##2##3##(2011-2#1)(2013-8#1)
by this strategy##2##3##(1993-12#1)(2013-1#1)
by this study##5##3##(1990-6#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-11#1)
by this system##6##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
by this technique is##2##4##(2007-11#1)(2008-10#1)
by this technique##11##3##(1990-11#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2011-3#1)
by this type of##2##4##(1990-8#1)(2008-3#1)
by this##231##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#7)(2007-6#1)(2007-8#1)(2008-10#66)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
by thoracic##2##2##(2007-11#1)(2010-8#1)
by thoracoscopic##4##2##(1997-4#1)(2007-8#1)(2008-1#1)(2011-2#1)
by those genes##2##3##(2008-10#2)
by those in##2##3##(2008-10#1)(2013-8#1)
by those of##2##3##(2008-10#1)(2008-3#1)
by those preferring##2##3##(2009-9#2)
by those that##2##3##(1996-5#1)(2013-1#1)
by those who##3##3##(1990-6#1)(1994-1#1)(2009-4#1)
by those with##4##3##(1992-3#2)(1996-3#1)(2008-1#1)
by those##30##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1994-1#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
by three different##5##3##(1992-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
by three dimensional##2##3##(2012-3#1)(2013-8#1)
by three experienced##2##3##(2011-2#1)(2012-1#1)
by three independent##2##3##(2009-8#1)(2012-1#1)
by three parameters##2##3##(2008-2#1)(2008-9#1)
by three species of##2##4##(2008-12#1)(2013-1#1)
by three##66##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
by three-dimensional##2##2##(2010-8#1)(2011-2#1)
by three-way##2##2##(2008-10#2)
by threonine##2##2##(1994-11#1)(1997-8#1)
by thrombin##9##2##(1990-8#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-11#1)(2008-10#1)
by thymic##2##2##(2008-8#1)(2012-12#1)
by thyroid hormone##3##3##(1993-3#2)(1994-11#1)
by ticks##2##2##(2007-2#1)(2008-8#1)
by time and##3##3##(1996-4#1)(2007-5#1)(2008-10#1)
by time##12##2##(1992-11#1)(1996-4#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-2#1)(2013-1#2)
by time-domain##2##2##(2007-12#1)(2013-1#1)
by time-resolved##9##2##(1990-8#1)(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
by time-varying magnetic fields##2##4##(1992-3#2)
by timed##2##2##(1993-9#1)(2010-3#1)
by tinea##2##2##(2008-5#2)
by tissue plasminogen activator##2##4##(1997-2#2)
by tissue##8##2##(1991-9#1)(1997-2#2)(2008-10#2)(2008-3#1)(2009-9#1)(2010-4#1)
by tissues##2##2##(2008-7#1)(2011-2#1)
by titration calorimetry##3##3##(1992-10#1)(1997-2#1)(2008-10#1)
by titration##4##2##(1992-10#1)(1997-2#1)(2008-10#2)
by to##2##2##(2008-11#1)(2009-5#1)
by tobacco##3##2##(1992-6#2)(2013-1#1)
by toluidine blue O##2##4##(2008-10#2)
by topical application##3##3##(1996-5#1)(2008-12#1)(2008-6#1)
by topical##4##2##(1996-5#1)(2008-12#1)(2008-6#2)
by topically##3##2##(1994-6#1)(2008-12#1)(2008-5#1)
by total##14##2##(1992-11#1)(1995-3#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#2)(2013-7#1)
by traditional methods##2##3##(2008-10#1)(2008-9#1)
by traditional##24##2##(1991-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-8#1)(2011-1#1)(2013-8#2)
by trained interviewers##2##3##(2010-2#1)(2011-2#1)
by trained personnel##3##3##(2008-4#1)(2012-2#2)
by trained##9##2##(1993-6#1)(2007-12#1)(2008-4#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#2)
by training##2##2##(1991-2#1)(2008-3#1)
by trains##2##2##(2007-12#1)(2008-2#1)
by transcranial##2##2##(2007-8#1)(2010-5#1)
by transcription##5##2##(1993-11#1)(1993-9#1)(1995-2#1)(2008-7#1)(2008-9#1)
by transcriptional##2##2##(2012-12#1)(2012-2#1)
by transcriptionally##2##2##(2008-11#1)(2013-1#1)
by transduction of##2##3##(1994-5#1)(2008-11#1)
by transesophageal echocardiography (TEE)##2##4##(2008-7#1)(2011-2#1)
by transesophageal echocardiography##4##3##(2007-8#1)(2008-7#2)(2011-2#1)
by transfecting##6##2##(2008-11#4)(2008-8#1)(2008-9#1)
by transfection of##2##3##(2008-11#1)(2008-6#1)
by transfection##6##2##(1992-9#1)(1995-2#1)(2008-11#3)(2008-6#1)
by transfer of the 2-deoxygalactosyl group from beta-galactosidase to##2##9##(2009-8#2)
by transfer of the##4##4##(2008-1#1)(2008-9#1)(2009-8#2)
by transfer of##8##3##(1991-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#2)(2012-2#1)
by transferring##5##2##(1997-4#1)(2008-10#2)(2008-9#2)
by transformation of the##3##4##(1993-8#1)(1994-9#1)(2008-3#1)
by transformation with##3##3##(2008-10#3)
by transformation##6##2##(1993-8#1)(1994-9#1)(2008-10#3)(2008-3#1)
by transforming growth##3##3##(1990-8#2)(1993-6#1)
by transforming##7##2##(1990-8#2)(1992-11#1)(1993-6#1)(2007-11#1)(2008-10#2)
by transient absorption##2##3##(2008-10#1)(2011-1#1)
by transient transfection##3##3##(1992-9#1)(1997-7#1)(2008-11#1)
by transient##11##2##(1990-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
by translation##4##2##(2008-2#1)(2008-6#1)(2008-9#2)
by transmission electron microscopy and##4##5##(2008-10#3)(2009-11#1)
by transmission electron microscopy to##2##5##(2008-10#1)(2008-7#1)
by transmission electron microscopy##17##4##(1992-11#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#2)(2009-9#1)
by transmission scattering##2##3##(2008-3#2)
by transmission##24##2##(1992-11#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#2)(2009-9#1)(2010-8#1)(2011-2#1)
by transplantation##2##2##(1993-12#1)(1997-4#1)
by trapping##2##2##(1990-12#1)(2007-12#1)
by traumatic##2##2##(2008-5#1)(2012-3#1)
by treating##7##2##(1993-6#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-5#2)(2011-2#1)
by treatment in##2##3##(1996-5#1)(2013-1#1)
by treatment of the hydroxide residue with##2##7##(2008-10#2)
by treatment of the##4##4##(1990-9#1)(2008-10#3)
by treatment of##9##3##(1990-9#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-2#1)(2008-10#4)
by treatment with 2%##2##4##(2008-10#1)(2008-11#1)
by treatment with a##2##4##(2008-10#1)(2010-5#1)
by treatment with an##2##4##(2008-4#1)(2011-2#1)
by treatment with either##3##4##(1992-5#1)(1994-2#1)(2008-1#1)
by treatment with the##3##4##(1991-12#1)(1991-2#1)(2012-2#1)
by treatment with##53##3##(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
by treatment##68##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
by trehalose##2##2##(1997-2#2)
by triangle##2##2##(2008-10#1)(2008-6#1)
by triggering##2##2##(1992-6#1)(2009-6#1)
by triple##2##2##(1996-12#1)(2009-7#1)
by triple-antibody sandwich##2##3##(2008-10#2)
by trophic##3##2##(1991-12#1)(2008-7#2)
by trypan blue##3##3##(2008-10#1)(2008-11#2)
by trypsin digestion##4##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)
by trypsin##14##2##(1990-2#1)(1990-5#4)(1991-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-5#3)(1997-2#1)(2008-9#1)
by tryptic digestion of##2##4##(1993-6#1)(1994-8#1)
by tryptic digestion##3##3##(1991-12#1)(1993-6#1)(1994-8#1)
by tryptic##5##2##(1990-12#1)(1991-12#1)(1993-6#1)(1994-8#1)(1995-2#1)
by tryptophan and its analogue##2##5##(2008-11#2)
by tryptophan##3##2##(1995-2#1)(2008-11#2)
by tumor cells##5##3##(1990-12#1)(1990-6#1)(2008-5#2)(2008-9#1)
by tumor necrosis##2##3##(1992-12#1)(2008-9#1)
by tumor##15##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-12#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
by tumors##3##2##(2008-10#2)(2013-1#1)
by tumour##4##2##(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
by tungsten coil electrothermal atomic absorption spectrometry##5##7##(2008-10#5)
by tungsten##6##2##(2008-10#6)
by tunicamycin##3##2##(1991-9#1)(1994-11#1)(2013-1#1)
by tuning of the pump##2##5##(2007-11#2)
by tuning of the##4##4##(2007-11#2)(2007-12#2)
by tuning the wavelength of the##2##6##(2007-11#1)(2007-12#1)
by tuning the##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2010-12#1)
by tuning##8##2##(2007-11#3)(2007-12#3)(2008-3#1)(2010-12#1)
by turbidity##3##2##(1990-2#1)(2011-2#2)
by turbulence##3##2##(2008-3#3)
by two amino##2##3##(1992-9#1)(1993-11#1)
by two case studies##3##4##(1995-2#1)(2008-10#2)
by two codominant##2##3##(1990-8#1)(2008-5#1)
by two competing##2##3##(2008-10#1)(2008-8#1)
by two complementary test systems##2##5##(2008-12#1)(2012-3#1)
by two complementary##4##3##(1992-6#1)(2008-12#1)(2008-3#1)(2012-3#1)
by two different methods##2##4##(2008-12#1)(2008-5#1)
by two different models##2##4##(2007-10#1)(2008-10#1)
by two different##14##3##(1991-3#1)(1992-10#1)(1994-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
by two distinct##2##3##(1996-2#1)(2008-11#1)
by two genes##2##3##(1997-7#1)(2008-10#1)
by two groups##2##3##(2008-5#2)
by two independent reviewers##3##4##(1997-8#1)(2012-12#2)
by two independent##6##3##(1994-11#1)(1997-8#1)(2009-8#1)(2011-2#1)(2012-12#2)
by two major##4##3##(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)
by two methods##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
by two models##2##3##(1995-8#1)(2007-11#1)
by two or more##2##4##(2008-10#2)
by two other##2##3##(2008-3#1)(2008-5#1)
by two types of##4##4##(1990-12#1)(2007-10#1)(2008-11#1)(2008-2#1)
by two##204##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#6)(1997-8#1)(2007-10#2)(2007-11#11)(2007-12#11)(2008-10#28)(2008-11#9)(2008-12#4)(2008-2#6)(2008-3#20)(2008-4#4)(2008-5#9)(2008-6#2)(2008-8#5)(2008-9#7)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#4)
by two-color##2##2##(2008-3#1)(2008-4#1)
by two-dimensional NMR techniques##2##4##(1990-9#1)(2008-8#1)
by two-dimensional electrophoresis##2##3##(1996-8#1)(2008-4#1)
by two-dimensional gel electrophoresis##4##4##(1993-11#1)(1995-12#1)(2008-10#1)(2010-12#1)
by two-dimensional##16##2##(1990-11#1)(1990-9#2)(1993-11#3)(1993-9#1)(1995-12#2)(1995-3#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)
by two-photon absorption##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
by two-photon##8##2##(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#1)(2010-1#1)
by two-photon-initiated polymerization##2##3##(2007-11#2)
by two-stage##3##2##(1994-12#1)(2008-6#1)(2009-5#1)
by two-wave mixing with a##2##5##(2007-12#1)(2008-3#1)
by two-wave mixing##4##3##(2007-12#1)(2008-3#3)
by two-wave##5##2##(2007-12#1)(2008-3#4)
by type 2 diabetes mellitus##2##5##(2008-7#1)(2010-8#1)
by type I##8##3##(1990-5#1)(1996-2#2)(2007-12#2)(2008-2#1)(2010-8#1)(2013-1#1)
by type II##3##3##(1990-5#1)(1996-2#2)
by type of service and##2##5##(1992-3#1)(1997-1#1)
by type of##8##3##(1992-3#1)(1994-12#1)(1996-3#1)(1997-1#1)(2008-11#1)(2009-3#1)(2012-2#1)(2013-1#1)
by type##25##2##(1990-5#3)(1992-3#1)(1994-12#1)(1994-2#1)(1996-2#4)(1996-3#1)(1997-1#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-8#2)(2012-2#1)(2013-1#3)(2013-8#1)
by typical##4##2##(1991-4#1)(2008-10#1)(2008-12#1)(2009-8#1)
by tyrosinase##2##2##(2008-10#1)(2008-5#1)
by tyrosine##4##2##(1991-9#1)(1993-9#1)(1995-2#1)(1996-5#1)
by ultra performance liquid chromatography##3##5##(2011-1#2)(2012-3#1)
by ultra performance liquid##5##4##(2011-1#3)(2012-3#2)
by ultracentrifugation##2##2##(1990-8#1)(1991-2#1)
by ultrafast##2##2##(2007-11#1)(2008-2#1)
by ultrafiltration##10##2##(1992-3#2)(1993-12#2)(1996-5#1)(2008-10#4)(2012-2#1)
by ultrashort##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
by ultrasonic and##2##3##(1993-2#1)(2008-5#1)
by ultrasonic nebulization##2##3##(2008-10#2)
by ultrasonic##10##2##(1990-2#1)(1993-2#2)(1994-9#1)(2008-10#5)(2008-5#1)
by ultrasonography or##2##3##(2007-8#1)(2011-2#1)
by ultrasonography##8##2##(1992-9#1)(1995-6#1)(1997-8#1)(2007-8#2)(2008-12#1)(2011-1#1)(2011-2#1)
by ultrasound examination##2##3##(1996-11#1)(2013-1#1)
by ultrasound guided##2##3##(1993-3#1)(2009-7#1)
by ultrasound in##3##3##(1993-8#1)(1997-3#1)(2012-3#1)
by ultrasound or##2##3##(2008-8#1)(2012-3#1)
by ultrasound##28##2##(1990-10#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-3#3)(2013-1#3)(2013-8#1)
by ultrasound-assisted extraction##2##3##(2008-10#1)(2013-1#1)
by ultrasound-assisted##3##2##(2008-10#2)(2013-1#1)
by ultrastructural##2##2##(1994-8#1)(2008-5#1)
by ultraviolet irradiation##2##3##(1995-11#1)(2008-3#1)
by ultraviolet light##2##3##(2007-12#1)(2008-5#1)
by ultraviolet radiation##2##3##(1994-8#1)(2007-12#1)
by ultraviolet##13##2##(1992-3#1)(1994-8#1)(1995-11#1)(1997-4#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#3)
by ultraviolet-visible##3##2##(2007-12#1)(2008-10#2)
by understanding the##2##3##(2008-6#1)(2008-9#1)
by understanding##3##2##(1996-12#1)(2008-6#1)(2008-9#1)
by unfolding##2##2##(2008-10#1)(2008-9#1)
by uniaxial##2##2##(2008-3#1)(2010-4#1)
by uniform##2##2##(2008-10#1)(2013-8#1)
by unilateral##6##2##(1995-12#3)(2008-12#1)(2008-5#1)(2013-8#1)
by unique##4##2##(1993-6#1)(2008-10#2)(2008-8#1)
by univariate analysis and##2##4##(2012-12#1)(2012-2#1)
by univariate analysis##3##3##(1994-7#1)(2012-12#1)(2012-2#1)
by univariate method##3##3##(2008-10#3)
by univariate##6##2##(1994-7#1)(2008-10#3)(2012-12#1)(2012-2#1)
by universities##2##2##(1993-3#1)(1997-3#1)
by unknown##2##2##(2008-1#1)(2008-10#1)
by unlabeled##3##2##(1992-3#1)(1993-1#1)(1994-6#1)
by unpaired##2##2##(2007-10#1)(2012-3#1)
by unsaturated fatty acids##3##4##(1993-3#1)(1996-3#1)(2008-5#1)
by unweighted##3##2##(2008-10#3)
by up to 10%##2##4##(2008-3#2)
by up to 15##2##4##(1997-1#1)(2008-7#1)
by up to 30%##2##4##(1996-12#1)(2008-3#1)
by up to a factor of##2##6##(1995-12#1)(2008-7#1)
by up to a##3##4##(1995-12#1)(2008-11#1)(2008-7#1)
by up to##24##3##(1992-3#1)(1993-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-3#6)(2008-4#1)(2008-7#2)(2011-2#1)
by up##25##2##(1992-3#1)(1993-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#4)(2008-3#6)(2008-4#2)(2008-7#2)(2011-2#1)
by upper##2##2##(1994-12#1)(2010-12#1)
by upregulating##2##2##(2008-4#1)(2010-3#1)
by upregulation of##3##3##(2009-12#1)(2010-5#1)(2013-1#1)
by uranyl##3##2##(2008-10#1)(2008-8#2)
by urea##3##2##(1990-8#1)(1993-11#1)(1994-5#1)
by urinary##4##2##(1993-12#1)(1994-3#1)(2007-7#2)
by urine##2##2##(1992-8#1)(2011-2#1)
by us##17##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)
by use of 193-nm##2##4##(2007-11#1)(2008-3#1)
by use of Fresnel##2##4##(2007-11#1)(2008-3#1)
by use of Mie##2##4##(2008-3#2)
by use of a CCD##2##5##(2008-2#1)(2008-3#1)
by use of a CO(2) laser##2##6##(2008-2#1)(2008-3#1)
by use of a CO(2)##3##5##(2008-2#2)(2008-3#1)
by use of a Cr2+##2##5##(2008-3#2)
by use of a Fourier##3##5##(2008-2#1)(2008-3#2)
by use of a Monte Carlo##2##6##(2008-2#1)(2008-3#1)
by use of a Ti##2##5##(2007-11#1)(2008-3#1)
by use of a broadband##2##5##(2007-11#2)
by use of a compact##3##5##(2007-11#1)(2008-3#2)
by use of a continuous-wave##2##5##(2007-12#1)(2008-3#1)
by use of a discrete##2##5##(2008-3#2)
by use of a dual-wavelength##2##5##(2007-11#1)(2008-3#1)
by use of a fiber##2##5##(2007-12#1)(2008-2#1)
by use of a focused##2##5##(2007-12#1)(2008-2#1)
by use of a frequency-domain##2##5##(2008-3#2)
by use of a holographic optical element##3##7##(2007-12#1)(2008-2#1)(2008-3#1)
by use of a large##2##5##(2007-12#1)(2008-2#1)
by use of a linear##2##5##(2008-2#1)(2008-3#1)
by use of a liquid-crystal cell##2##6##(2007-11#2)
by use of a liquid-crystal##3##5##(2007-11#2)(2008-3#1)
by use of a model##2##5##(2007-12#1)(2008-3#1)
by use of a modified##5##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
by use of a new##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
by use of a nonreciprocal phase shift##3##7##(2008-3#3)
by use of a nonreciprocal##4##5##(2008-3#4)
by use of a novel##5##5##(2007-11#1)(2007-12#3)(2008-3#1)
by use of a number of##2##6##(1991-12#1)(2008-2#1)
by use of a periodically poled KTP waveguide crystal##2##9##(2007-12#2)
by use of a periodically poled##3##6##(2007-12#3)
by use of a programmable##2##5##(2007-11#1)(2008-3#1)
by use of a pulsed##2##5##(2008-2#1)(2008-3#1)
by use of a rigorous##2##5##(2007-11#1)(2008-3#1)
by use of a scanning##3##5##(2007-11#1)(2008-3#2)
by use of a series of##2##6##(1997-7#1)(2008-3#1)
by use of a simple##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
by use of a simplified##2##5##(2007-12#1)(2008-3#1)
by use of a single##8##5##(2007-11#2)(2007-12#2)(2008-3#4)
by use of a small##2##5##(2008-3#2)
by use of a specially##2##5##(2007-11#1)(2007-12#1)
by use of a standard##3##5##(2008-2#1)(2008-3#2)
by use of a static##2##5##(2007-12#1)(2008-3#1)
by use of a two-dimensional##3##5##(2007-12#1)(2008-3#2)
by use of a two-step##2##5##(2007-12#1)(2008-3#1)
by use of a##313##4##(1990-12#1)(1991-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-11#52)(2007-12#69)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#48)(2008-3#129)(2008-4#1)(2008-9#2)(2009-1#1)
by use of adaptive##3##4##(2008-2#2)(2008-3#1)
by use of an adaptive##3##5##(2007-11#1)(2008-3#2)
by use of an adequate##2##5##(2008-3#2)
by use of an array of##2##6##(2008-3#2)
by use of an extended##2##5##(2007-11#1)(2007-12#1)
by use of an external-cavity##3##5##(2007-11#1)(2008-3#2)
by use of an intracavity semiconductor##2##6##(2007-11#1)(2007-12#1)
by use of an intracavity##5##5##(2007-11#1)(2007-12#3)(2008-3#1)
by use of an optical##3##5##(2007-11#2)(2008-3#1)
by use of an optically addressed##2##6##(2007-11#1)(2007-12#1)
by use of an##56##4##(2007-11#13)(2007-12#11)(2008-2#11)(2008-3#20)(2008-9#1)
by use of angular multiplexing##3##5##(2007-12#1)(2008-3#2)
by use of anisotropic self-diffraction##2##5##(2008-3#2)
by use of binary##2##4##(2008-2#1)(2008-3#1)
by use of binary-phase holograms##2##5##(2007-12#2)
by use of both##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
by use of concurrent##2##4##(2008-2#1)(2008-3#1)
by use of conventional##2##4##(2008-2#1)(2008-3#1)
by use of different##8##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
by use of digital holography##4##5##(2007-12#1)(2008-3#3)
by use of digital##5##4##(2007-12#1)(2008-3#4)
by use of either##3##4##(2008-2#3)
by use of electro-optic##2##4##(2007-12#2)
by use of fluorescent##2##4##(2007-11#2)
by use of focused-ion-beam milling##2##5##(2008-3#2)
by use of four-wave mixing##2##5##(2007-12#1)(2008-3#1)
by use of interferometric##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
by use of iterated-function system##2##5##(2008-2#2)
by use of its##3##4##(1991-2#1)(2008-3#2)
by use of laser##2##4##(2008-3#2)
by use of laser-induced##2##4##(2007-11#1)(2007-12#1)
by use of linear##2##4##(2008-3#2)
by use of low-coherence interferometry##2##5##(2007-11#1)(2008-3#1)
by use of low-coherence##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
by use of machine vision##2##5##(2007-11#2)
by use of modal##2##4##(2007-12#1)(2008-3#1)
by use of molecular##2##4##(2008-8#2)
by use of moving gratings at##2##6##(2008-3#2)
by use of moving gratings##4##5##(2008-2#1)(2008-3#3)
by use of multimode##2##4##(2008-3#2)
by use of multiple##4##4##(2008-3#4)
by use of numerical##2##4##(2008-2#1)(2008-3#1)
by use of one##3##4##(2008-2#1)(2008-3#2)
by use of only##2##4##(2008-3#2)
by use of optical coherence tomography##2##6##(2007-12#1)(2008-3#1)
by use of optical##8##4##(2007-11#2)(2007-12#2)(2008-3#4)
by use of our##3##4##(1995-12#1)(2008-3#2)
by use of partial##2##4##(2008-3#2)
by use of phase##3##4##(2008-3#3)
by use of phase-shifting##2##4##(2007-11#1)(2008-3#1)
by use of photon##2##4##(2007-12#1)(2008-3#1)
by use of photorefractive##2##4##(2007-12#1)(2008-3#1)
by use of polarization-sensitive optical coherence tomography##2##7##(2007-11#1)(2008-3#1)
by use of polarization-sensitive##3##4##(2007-11#2)(2008-3#1)
by use of radiative transfer calculations##2##6##(2008-2#1)(2008-3#1)
by use of short##2##4##(2007-12#1)(2008-2#1)
by use of simple##2##4##(2008-2#1)(2008-3#1)
by use of spatial##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
by use of spectral##2##4##(2007-12#1)(2008-3#1)
by use of spectrally resolved##2##5##(2007-12#1)(2008-2#1)
by use of standard##2##4##(2008-3#1)(2013-1#1)
by use of steady-state##2##4##(2007-12#2)
by use of stellar scintillation patterns##2##6##(2008-3#2)
by use of synthetic##3##4##(2007-12#1)(2008-2#1)(2010-7#1)
by use of the Fresnel diffraction##2##6##(2008-2#1)(2008-3#1)
by use of the LYES##2##5##(2013-1#2)
by use of the conventional##2##5##(2008-3#2)
by use of the developed##2##5##(2008-3#2)
by use of the finite-difference time-domain method##2##7##(2007-11#2)
by use of the finite-difference time-domain##3##6##(2007-11#3)
by use of the measured##3##5##(2008-3#3)
by use of the optical##2##5##(2008-3#2)
by use of the pulsed-laser deposition technique##2##7##(2007-12#2)
by use of the quadratic##2##5##(2007-12#1)(2008-2#1)
by use of the split-step reconstruction technique##2##7##(2008-3#2)
by use of the technique##2##5##(2007-12#1)(2008-3#1)
by use of the two##2##5##(2007-12#1)(2008-3#1)
by use of the##130##4##(1991-9#1)(2007-11#14)(2007-12#14)(2008-1#1)(2008-10#1)(2008-2#23)(2008-3#71)(2008-6#1)(2009-7#1)(2010-6#1)(2013-1#2)
by use of thermally##2##4##(2008-2#1)(2008-3#1)
by use of this system##2##5##(2008-3#2)
by use of this technique##2##5##(2007-12#1)(2008-3#1)
by use of this##14##4##(1990-12#1)(1991-2#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)
by use of time-resolved##3##4##(2007-12#1)(2008-3#2)
by use of tunable##2##4##(2008-2#1)(2008-3#1)
by use of two different##2##5##(2007-11#1)(2008-3#1)
by use of two random phase##2##6##(2008-3#2)
by use of two wavelengths##2##5##(2008-3#2)
by use of two##17##4##(2007-11#5)(2007-12#1)(2008-2#2)(2008-3#8)(2013-1#1)
by use of two-photon absorption in a##2##7##(2007-11#2)
by use of two-photon excitation##2##5##(2007-11#2)
by use of two-photon##4##4##(2007-11#4)
by use of##974##3##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-11#149)(2007-12#173)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#163)(2008-3#416)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#8)
by use##976##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-11#149)(2007-12#173)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#164)(2008-3#417)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#8)
by users##2##2##(2011-1#1)(2011-2#1)
by using 0##3##3##(2008-10#3)
by using 1##3##3##(2008-10#3)
by using 18##2##3##(2008-10#2)
by using 5##4##3##(2008-10#4)
by using DNA##2##3##(2008-9#1)(2013-1#1)
by using GFP##2##3##(2008-9#2)
by using GUS##2##3##(2008-10#1)(2008-9#1)
by using HPLC##2##3##(2008-10#2)
by using Monte Carlo##2##4##(2008-2#1)(2008-3#1)
by using N##3##3##(2008-10#3)
by using NIR##2##3##(2008-10#2)
by using NaCl##2##3##(2008-10#2)
by using PBMC and whole blood culture assays##2##8##(2011-2#2)
by using UV##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
by using a column containing Amberlite XAD-16 resin and##2##9##(2008-10#2)
by using a combination of##6##5##(1992-3#1)(2008-10#3)(2008-8#1)(2013-1#1)
by using a common spectrofluorometer##2##5##(2008-10#2)
by using a common##3##4##(2008-10#2)(2008-11#1)
by using a conjugate##2##4##(2008-11#1)(2008-3#1)
by using a conventional##2##4##(2008-10#2)
by using a fibrin-glue coated collagen patch##2##7##(2007-8#2)
by using a flow##3##4##(2008-10#2)(2011-2#1)
by using a high##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
by using a model##2##4##(2008-10#1)(2008-3#1)
by using a modified##2##4##(2008-10#1)(2008-2#1)
by using a new##3##4##(2008-10#2)(2013-1#1)
by using a newly##2##4##(1994-11#1)(2008-10#1)
by using a simple##3##4##(2008-10#2)(2008-2#1)
by using a solid##2##4##(2008-10#1)(2013-8#1)
by using a special##2##4##(2007-11#1)(2008-11#1)
by using a specific##2##4##(1990-5#1)(1995-8#1)
by using a standard##4##4##(2008-10#3)(2008-2#1)
by using a system##2##4##(2008-2#1)(2008-5#1)
by using a validated##2##4##(2010-7#1)(2012-12#1)
by using a##198##3##(1990-5#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1997-2#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#76)(2008-11#10)(2008-2#23)(2008-3#19)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-3#1)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
by using amplified##2##3##(1990-12#1)(2008-10#1)
by using an HPLC##2##4##(2008-10#2)
by using an acid##2##4##(2008-10#2)
by using an active##2##4##(2008-2#1)(2012-1#1)
by using an##39##3##(1995-2#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-2#6)(2008-3#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2012-1#1)(2012-2#1)(2013-1#1)
by using angular multiplexing##2##4##(2008-3#2)
by using artificial neural##2##4##(2008-10#1)(2010-8#1)
by using both the##2##4##(2007-12#1)(2008-6#1)
by using both##8##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)
by using capillary##3##3##(2008-10#3)
by using commercial##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
by using conventional##2##3##(2008-10#1)(2008-11#1)
by using crystal##2##3##(2008-10#1)(2008-2#1)
by using cyclic##3##3##(2008-10#2)(2009-9#1)
by using data from##2##4##(1992-6#1)(2011-2#1)
by using data##3##3##(1992-6#1)(2008-12#1)(2011-2#1)
by using different##8##3##(2008-10#4)(2008-12#1)(2008-7#1)(2010-5#1)(2011-1#1)
by using differential##3##3##(2008-10#2)(2010-12#1)
by using either the##2##4##(1992-3#1)(2008-2#1)
by using flow injection analysis##3##5##(2008-10#3)
by using fluorescence##2##3##(1994-5#1)(2008-10#1)
by using four##3##3##(1991-9#1)(2007-12#1)(2008-3#1)
by using gel##2##3##(2008-8#2)
by using gelatin##2##3##(2008-10#2)
by using gene##2##3##(2008-8#2)
by using high##2##3##(2008-10#1)(2012-12#1)
by using higher##2##3##(1994-12#1)(2008-11#1)
by using in##2##3##(1992-7#1)(2008-3#1)
by using individual##2##3##(2010-7#1)(2013-1#1)
by using inductively coupled##2##4##(2008-10#2)
by using ion##2##3##(2007-11#1)(2008-10#1)
by using it as##2##4##(2008-10#1)(2008-12#1)
by using methylene blue##2##4##(2008-10#2)
by using multivariate calibration##2##4##(2008-10#2)
by using multivariate##3##3##(2008-10#2)(2008-3#1)
by using new##2##3##(1990-3#1)(1995-9#1)
by using of##2##3##(2008-10#2)
by using one##2##3##(1995-12#1)(2008-3#1)
by using optical and##2##4##(2008-5#1)(2009-7#1)
by using optical##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2013-1#1)
by using partial least squares##3##5##(2008-10#3)
by using partial##4##3##(2008-10#4)
by using patch##2##3##(1994-8#1)(2012-1#1)
by using polymerase chain reaction and restriction fragment length##2##9##(2008-12#1)(2013-1#1)
by using polymerase chain##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
by using principal component##2##4##(2008-10#1)(2008-11#1)
by using principal##3##3##(2008-10#2)(2008-11#1)
by using reference materials##2##4##(2008-10#2)
by using reference##3##3##(2008-10#2)(2008-2#1)
by using short##2##3##(2008-3#1)(2008-9#1)
by using silica gel loaded with##2##6##(2008-10#2)
by using silica gel##3##4##(2008-10#2)(2008-11#1)
by using simple##2##3##(2008-3#1)(2012-1#1)
by using sodium##2##3##(2008-10#2)
by using specific##2##3##(2008-8#1)(2011-3#1)
by using spectral##2##3##(2007-12#1)(2008-2#1)
by using square wave voltammetry##2##5##(2008-10#2)
by using square wave##3##4##(2008-10#3)
by using standard##6##3##(1991-3#1)(2008-10#2)(2008-11#1)(2008-12#2)
by using such##2##3##(2008-7#1)(2013-8#1)
by using synchrotron radiation##2##4##(2008-2#2)
by using synthetic##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
by using the API-ZYM##2##4##(2008-5#2)
by using the DNPH-method##2##4##(2010-4#2)
by using the area under the##2##6##(2008-10#2)
by using the first##2##4##(2008-10#1)(2009-9#1)
by using the method of##4##5##(2007-11#1)(2008-10#1)(2010-12#1)(2013-1#1)
by using the modified##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
by using the proposed##3##4##(2008-10#3)
by using the same##3##4##(2007-9#1)(2008-3#1)(2008-4#1)
by using the two##2##4##(2008-11#1)(2012-7#1)
by using the##156##3##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-2#2)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#61)(2008-11#6)(2008-2#8)(2008-3#21)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#9)
by using these##7##3##(1992-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)
by using this##9##3##(1993-11#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)
by using three##2##3##(2008-10#2)
by using two##8##3##(1992-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)
by using various##5##3##(2008-10#1)(2008-5#1)(2009-11#1)(2012-3#1)(2013-8#1)
by using yeast two-hybrid##2##4##(2008-9#2)
by using##957##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#2)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#5)(1994-9#1)(1995-12#4)(1995-2#8)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#2)(2006-4#1)(2006-6#1)(2007-10#4)(2007-11#15)(2007-12#15)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#391)(2008-11#37)(2008-12#11)(2008-2#56)(2008-3#74)(2008-4#9)(2008-5#14)(2008-6#7)(2008-7#16)(2008-8#33)(2008-9#16)(2009-1#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#9)(2011-1#7)(2011-2#18)(2011-3#4)(2012-1#6)(2012-12#3)(2012-2#6)(2012-3#6)(2012-7#2)(2013-1#17)(2013-8#24)
by utilising the##2##3##(2008-10#1)(2008-2#1)
by utilising##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
by utilizing a flow-through type##2##5##(2008-10#2)
by utilizing a##6##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
by utilizing the##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
by utilizing##23##2##(1991-3#1)(1991-7#1)(1992-11#1)(1993-9#1)(1995-5#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-9#1)
by vaccination with##2##3##(1995-2#1)(2008-8#1)
by vaccination##4##2##(1991-6#1)(1995-2#1)(1995-9#1)(2008-8#1)
by vacuum##4##2##(1992-8#1)(2008-10#2)(2008-3#1)
by vaginal##2##2##(1995-8#1)(1996-12#1)
by validated##2##2##(1991-2#1)(2010-7#1)
by valine##2##2##(1995-8#2)
by valinomycin##3##2##(1990-2#1)(1992-12#2)
by vanadate##5##2##(1990-5#2)(1994-12#2)(1994-6#1)
by vapor##2##2##(2007-12#1)(2008-10#1)
by variable temperature##2##3##(1996-2#1)(2009-11#1)
by variable##5##2##(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-11#1)
by variance##2##2##(2008-10#1)(2013-1#1)
by variation in##2##3##(1993-11#1)(2010-3#1)
by variation of##2##3##(2008-3#2)
by variation##5##2##(1993-11#1)(2008-3#2)(2009-7#1)(2010-3#1)
by variations in the##2##4##(1996-3#1)(2008-10#1)
by variations in##5##3##(1996-3#1)(2007-11#1)(2008-10#3)
by various elements##2##3##(2008-3#1)(2011-2#1)
by various factors##5##3##(2007-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
by various investigators##3##3##(1995-2#1)(1996-12#1)(2008-4#1)
by various methods of##2##4##(1995-11#1)(2008-8#1)
by various methods##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
by various peptide##2##3##(1994-8#1)(1995-6#1)
by various signaling pathways##2##4##(2008-8#1)(2009-5#1)
by various techniques and##2##4##(2008-10#2)
by various techniques##5##3##(1990-7#1)(2008-10#2)(2009-5#1)(2012-2#1)
by various##79##2##(1990-2#2)(1990-7#3)(1991-12#2)(1991-5#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-12#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#2)
by varying the amount of##2##5##(2008-10#2)
by varying the magnitude of the applied current##2##8##(2008-10#2)
by varying the##31##3##(1994-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-6#1)
by varying##44##2##(1990-5#1)(1991-11#1)(1994-12#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-6#2)(2012-3#1)
by vascular endothelial cells##2##4##(1990-2#1)(1995-11#1)
by vascular endothelial##3##3##(1990-2#1)(1995-11#1)(2008-10#1)
by vascular##8##2##(1990-2#1)(1995-11#1)(1995-2#1)(2006-10#1)(2008-10#2)(2009-8#1)(2010-3#1)
by vasculitis##2##2##(1990-8#1)(1996-3#1)
by vasoactive##3##2##(1995-5#1)(1997-1#1)(2011-2#1)
by vector##3##2##(2008-10#2)(2008-3#1)
by vectors##4##2##(2008-10#4)
by velocity sedimentation##2##3##(1990-12#1)(1993-8#1)
by velocity##3##2##(1990-12#1)(1993-5#1)(1993-8#1)
by venipuncture##2##2##(2010-11#1)(2011-2#1)
by venous##2##2##(2007-8#1)(2013-1#1)
by ventral##2##2##(1993-6#1)(1996-2#1)
by ventricular##2##2##(2008-10#1)(2012-2#1)
by verbascoside##2##2##(2008-8#2)
by vertical##2##2##(2007-11#1)(2012-3#1)
by very low##2##3##(1994-11#1)(1994-8#1)
by very##5##2##(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
by vesicular##3##2##(1992-12#1)(1994-6#1)(2008-7#1)
by vessel##2##2##(1992-9#1)(2010-9#1)
by viable##4##2##(2008-11#2)(2009-12#1)(2010-4#1)
by vibration of##2##3##(2007-12#1)(2008-3#1)
by vibration##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
by video##3##2##(1993-3#1)(1994-8#1)(2008-3#1)
by video-assisted thoracoscopic##2##3##(2007-8#1)(2013-7#1)
by video-assisted##3##2##(2007-8#1)(2008-1#1)(2013-7#1)
by videothoracoscopic surgery##2##3##(2007-8#2)
by viewing the##2##3##(2008-3#1)(2008-8#1)
by viewing##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
by vincristine##2##2##(1994-12#1)(1995-9#1)
by violence for##2##3##(2008-9#2)
by violence##4##2##(1995-8#1)(2008-9#3)
by viral infection##2##3##(1990-6#1)(1992-12#1)
by viral infections##2##3##(2006-10#1)(2012-3#1)
by viral##9##2##(1990-6#1)(1992-12#1)(1995-2#1)(1997-6#1)(2006-10#1)(2008-11#3)(2012-3#1)
by virtue of its ability to##2##6##(1996-2#1)(2007-11#1)
by virtue of its##4##4##(1993-11#1)(1996-2#1)(2007-11#1)(2008-10#1)
by virtue of the##2##4##(1995-2#1)(2009-3#1)
by virtue of their##3##4##(1993-2#1)(2008-9#1)(2009-12#1)
by virtue of##13##3##(1991-9#1)(1993-11#2)(1993-2#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)
by virulence##2##2##(2008-10#2)
by virus##7##2##(1997-6#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
by viruses##3##2##(2010-1#1)(2011-2#2)
by visible light irradiation##2##4##(2009-3#2)
by visible light##3##3##(2009-3#2)(2011-1#1)
by visible##4##2##(2008-10#1)(2009-3#2)(2011-1#1)
by visual##14##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1996-11#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
by visualization of##2##3##(2008-10#1)(2008-4#1)
by visualization##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
by visually estimating the##2##4##(2008-10#2)
by visually##3##2##(1990-8#1)(2008-10#2)
by vitamin D##2##3##(1992-1#1)(2008-1#1)
by vitamin E##3##3##(1992-9#1)(1994-5#1)(1995-6#1)
by vitamin K##2##3##(1996-6#1)(1997-7#1)
by vitamin K3##2##3##(1991-12#2)
by vitamin##11##2##(1991-12#2)(1992-1#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)
by volatile##3##2##(1990-2#1)(2008-10#1)(2009-8#1)
by voltammetric##3##2##(2008-10#3)
by voltammetry##2##2##(2008-10#2)
by volume times##2##3##(2007-12#1)(2008-3#1)
by volume##14##2##(1994-9#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-7#2)
by volumetric Karl Fischer (KF) titration##2##6##(2008-10#2)
by volumetric Karl Fischer##3##4##(2008-10#3)
by volunteer##2##2##(1995-11#1)(1996-2#1)
by volunteers##3##2##(1994-3#2)(2008-5#1)
by von##2##2##(2008-6#2)
by warfarin##2##2##(2008-10#1)(2009-11#1)
by washing the##2##3##(2008-10#2)
by washing with##4##3##(2008-10#3)(2008-4#1)
by washing##7##2##(1992-3#1)(2008-10#5)(2008-4#1)
by water and##3##3##(1995-3#1)(2008-10#1)(2012-12#1)
by water molecules##2##3##(2008-10#1)(2008-2#1)
by water##20##2##(1995-3#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-6#1)(2012-12#1)
by water-soluble##2##2##(1994-3#1)(2008-11#1)
by wavelength modulation##2##3##(2008-3#2)
by wavelength##4##2##(2008-10#1)(2008-3#3)
by wavelength-modulation##2##2##(2007-12#1)(2008-2#1)
by way of the##5##4##(1993-3#1)(2008-11#1)(2008-12#2)(2008-7#1)
by way of##30##3##(1990-6#1)(1992-9#1)(1993-3#2)(1995-2#1)(1996-9#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-8#4)(2011-2#1)(2013-1#1)
by weather variables##2##3##(2008-10#1)(2012-3#1)
by week##4##2##(1991-3#1)(1992-8#1)(2008-7#1)(2011-2#1)
by weekly##2##2##(2008-10#1)(2008-5#1)
by weighing the##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
by weighing##6##2##(1994-3#1)(2008-10#3)(2008-12#1)(2008-5#1)
by weight of##2##3##(1993-6#1)(2008-5#1)
by weight status##2##3##(2011-2#2)
by weight##12##2##(1991-12#1)(1993-3#2)(1993-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#2)
by well##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
by western blot analysis##2##4##(1993-6#1)(2008-10#1)
by western blot##4##3##(1993-6#1)(2008-10#3)
by western blotting##6##3##(1994-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
by western##14##2##(1991-12#1)(1993-6#1)(1994-11#1)(2008-10#6)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#1)
by wet mount##2##3##(2007-7#1)(2013-8#1)
by wet##5##2##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
by what##2##2##(1997-3#1)(2008-3#1)
by wheat germ agglutinin##2##4##(1992-6#1)(1993-6#1)
by wheat##5##2##(1992-6#1)(1993-6#1)(2008-10#2)(2013-8#1)
by whether the##2##3##(2008-9#1)(2011-2#1)
by whether##3##2##(1994-2#1)(2008-9#1)(2011-2#1)
by which ATP##2##3##(1995-2#1)(1997-7#1)
by which a##8##3##(1994-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-10#1)(2010-5#1)(2010-7#1)
by which disgust##3##3##(2010-7#3)
by which health care##2##4##(1994-3#1)(1997-3#1)
by which health##3##3##(1994-3#1)(1997-2#1)(1997-3#1)
by which inflammation##2##3##(1992-2#1)(2008-3#1)
by which it##3##3##(1995-9#1)(2008-10#1)(2011-1#1)
by which oncogenic##2##3##(1994-8#1)(2008-8#1)
by which the signal##2##4##(2007-11#1)(2008-3#1)
by which the##44##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(2007-11#2)(2007-2#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2010-5#2)(2011-1#1)(2013-1#2)(2013-8#1)
by which these##8##3##(1994-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
by which they##5##3##(1990-12#1)(1995-2#1)(2008-10#1)(2011-2#2)
by which this occurs##5##4##(1992-9#1)(2008-11#2)(2008-7#1)(2013-1#1)
by which this##15##3##(1990-7#1)(1992-3#1)(1992-9#1)(1994-8#1)(1996-1#1)(2007-8#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2013-1#1)
by which time##4##3##(1992-6#1)(1996-2#1)(2008-10#1)(2008-7#1)
by which to##3##3##(1994-3#1)(2008-2#1)(2013-8#1)
by which we##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
by which##250##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#3)(2007-12#8)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#14)(2008-2#5)(2008-3#9)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#10)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#4)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#9)(2013-8#4)
by white##2##2##(2008-12#1)(2009-9#1)
by whiteflies##4##2##(2008-10#4)
by whole##3##2##(1990-12#1)(2008-4#1)(2009-2#1)
by whole-cell##4##2##(1995-12#1)(2008-10#1)(2008-8#1)(2009-12#1)
by wide##5##2##(1995-4#1)(2008-3#1)(2008-6#1)(2008-7#2)
by widespread##2##2##(2008-10#1)(2009-11#1)
by wild type##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
by wild##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
by wild-type strains##2##3##(2008-10#2)
by wild-type##6##2##(1993-11#1)(2008-10#5)
by wind and##2##3##(2008-11#1)(2008-8#1)
by wind over##2##3##(2008-8#1)(2010-1#1)
by wind##9##2##(2008-10#3)(2008-11#2)(2008-8#3)(2010-1#1)
by wine##2##2##(2008-10#1)(2009-7#1)
by winter##2##2##(1997-6#1)(2008-10#1)
by with##2##2##(2008-10#1)(2012-2#1)
by withdrawal##2##2##(2008-10#1)(2008-4#1)
by women and men##2##4##(1994-2#1)(2013-1#1)
by women with##2##3##(1996-11#1)(2007-12#1)
by women##12##2##(1991-6#2)(1993-9#1)(1994-2#2)(1994-5#1)(1995-2#1)(1996-11#1)(2007-12#1)(2013-1#2)(2013-8#1)
by woody plants##2##3##(2008-9#2)
by woody##3##2##(2008-10#1)(2008-9#2)
by work##2##2##(1995-8#1)(2010-10#1)
by working in a##2##4##(1997-5#1)(2010-7#1)
by working in##3##3##(1997-5#1)(2008-10#1)(2010-7#1)
by working##7##2##(1994-2#1)(1995-1#1)(1997-5#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
by wortmannin##3##2##(1994-11#1)(1995-8#1)(2008-11#1)
by wounding##4##2##(1997-2#2)(2008-10#2)
by writing##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by x-ray crystallographic methods##2##4##(1991-12#1)(1994-8#1)
by x-ray crystallography##2##3##(1994-8#1)(2009-10#1)
by x-ray##7##2##(1991-12#1)(1994-8#2)(2007-12#1)(2008-8#1)(2009-10#1)(2011-1#1)
by xenobiotics##2##2##(1994-8#1)(2008-11#1)
by xi = gamma + 3##2##6##(2008-3#2)
by xuefu zhuyu decoction##2##4##(2013-8#2)
by year##3##2##(1996-1#1)(2008-10#1)(2012-3#1)
by yeast addition##2##3##(2008-12#2)
by yeast cells##4##3##(1990-2#1)(1990-5#1)(2008-10#2)
by yeast two-hybrid system##4##4##(2008-8#1)(2008-9#3)
by yeast##15##2##(1990-2#2)(1990-5#1)(1992-3#1)(1993-8#1)(2008-10#3)(2008-12#3)(2008-8#1)(2008-9#3)
by young##3##2##(2007-11#1)(2008-5#1)(2013-8#1)
by younger##2##2##(1990-6#1)(2008-5#1)
by youth##3##2##(1996-12#1)(2008-12#1)(2012-2#1)
by ytterbium codoping##2##3##(2007-12#2)
by zinc##5##2##(1992-9#2)(1994-10#1)(1994-6#1)(2008-5#1)
by zone##2##2##(1996-12#1)(2008-3#1)
by zymography##3##2##(1997-3#1)(2010-3#1)(2013-8#1)
by##46346##1##(1990-10#34)(1990-11#227)(1990-12#245)(1990-2#191)(1990-3#81)(1990-4#10)(1990-5#277)(1990-6#88)(1990-7#161)(1990-8#229)(1990-9#81)(1991-1#54)(1991-10#11)(1991-11#64)(1991-12#217)(1991-2#182)(1991-3#127)(1991-4#21)(1991-5#224)(1991-6#98)(1991-7#28)(1991-8#101)(1991-9#179)(1992-1#48)(1992-10#31)(1992-11#142)(1992-12#233)(1992-2#116)(1992-3#325)(1992-4#35)(1992-5#80)(1992-6#239)(1992-7#18)(1992-8#214)(1992-9#184)(1993-1#59)(1993-10#3)(1993-11#210)(1993-12#270)(1993-2#132)(1993-3#274)(1993-5#33)(1993-6#207)(1993-8#227)(1993-9#162)(1994-1#58)(1994-10#14)(1994-11#247)(1994-12#264)(1994-2#186)(1994-3#200)(1994-5#181)(1994-6#162)(1994-7#23)(1994-8#338)(1994-9#171)(1995-1#60)(1995-10#2)(1995-11#215)(1995-12#410)(1995-2#369)(1995-3#219)(1995-4#14)(1995-5#227)(1995-6#297)(1995-8#202)(1995-9#39)(1996-1#78)(1996-10#13)(1996-11#58)(1996-12#248)(1996-2#312)(1996-3#122)(1996-4#31)(1996-5#248)(1996-6#68)(1996-7#36)(1996-8#38)(1996-9#61)(1997-1#152)(1997-2#299)(1997-3#201)(1997-4#216)(1997-5#53)(1997-6#174)(1997-7#210)(1997-8#141)(1997-9#11)(2006-10#30)(2006-11#1)(2006-12#21)(2006-4#8)(2006-6#22)(2006-8#2)(2007-1#2)(2007-10#179)(2007-11#959)(2007-12#1214)(2007-2#46)(2007-3#3)(2007-4#9)(2007-5#43)(2007-6#33)(2007-7#153)(2007-8#224)(2007-9#26)(2008-1#353)(2008-10#10645)(2008-11#1650)(2008-12#494)(2008-2#1312)(2008-3#2598)(2008-4#792)(2008-5#1146)(2008-6#456)(2008-7#1089)(2008-8#1092)(2008-9#913)(2009-1#26)(2009-10#145)(2009-11#133)(2009-12#113)(2009-2#68)(2009-3#96)(2009-4#68)(2009-5#148)(2009-6#110)(2009-7#157)(2009-8#238)(2009-9#115)(2010-1#83)(2010-10#91)(2010-11#130)(2010-12#169)(2010-2#103)(2010-3#122)(2010-4#179)(2010-5#173)(2010-6#87)(2010-7#86)(2010-8#228)(2010-9#39)(2011-1#456)(2011-10#11)(2011-2#1143)(2011-3#83)(2011-7#2)(2011-9#4)(2012-1#143)(2012-12#408)(2012-2#645)(2012-3#498)(2012-4#8)(2012-5#6)(2012-6#6)(2012-7#10)(2012-8#3)(2012-9#1)(2013-1#981)(2013-3#1)(2013-7#118)(2013-8#557)
by-pass grafts##3##2##(2011-2#3)
by-pass##7##1##(1995-11#1)(1997-3#1)(2008-10#1)(2011-2#4)
by-product of##12##2##(1991-9#1)(1992-3#1)(1994-12#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
by-product##22##1##(1991-9#1)(1992-3#1)(1994-12#1)(1994-3#2)(1996-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
by-products in drinking water##3##4##(2008-10#3)
by-products in##4##2##(2008-10#4)
by-products of##2##2##(1995-3#1)(2008-11#1)
by-products##27##1##(1990-11#1)(1990-9#1)(1995-3#1)(2008-10#13)(2008-11#2)(2008-5#2)(2008-9#4)(2010-4#1)(2011-2#2)
bylaws##5##1##(1991-2#3)(1991-3#1)(2008-11#1)
bypass (CPB) procedures##2##3##(2007-8#1)(2008-10#1)
bypass (CPB)##13##2##(1995-12#1)(2007-8#6)(2007-9#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-8#1)
bypass and##7##2##(1992-6#1)(2006-10#1)(2007-8#2)(2008-1#1)(2013-1#2)
bypass by##2##2##(1994-8#1)(2007-8#1)
bypass for##7##2##(2007-8#3)(2008-7#2)(2011-2#1)(2013-1#1)
bypass graft surgery##10##3##(1993-12#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2012-12#1)(2013-8#1)
bypass graft##19##2##(1992-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2007-11#2)(2007-7#1)(2007-8#4)(2008-11#2)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
bypass grafting on the arrested##2##5##(2007-8#2)
bypass grafting on##3##3##(2007-8#3)
bypass grafting##60##2##(1991-9#1)(1993-12#1)(2006-8#1)(2007-8#40)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-12#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#3)
bypass grafts##4##2##(2007-8#1)(2011-2#3)
bypass in the treatment of##2##5##(1990-9#1)(2013-1#1)
bypass in##9##2##(1990-9#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
bypass is a technically##2##4##(1993-3#1)(2007-8#1)
bypass is a##3##3##(1993-3#2)(2007-8#1)
bypass is##6##2##(1993-3#2)(2007-8#1)(2008-7#2)(2013-1#1)
bypass operations##5##2##(1990-2#1)(1991-8#1)(1993-3#1)(1994-11#1)(2008-10#1)
bypass patients with##2##3##(1995-12#1)(2010-8#1)
bypass patients##5##2##(1995-12#3)(2007-8#1)(2010-8#1)
bypass procedures in##2##3##(1997-6#2)
bypass surgeries##2##2##(2012-2#2)
bypass surgery and##3##3##(1995-3#1)(2009-10#1)(2012-2#1)
bypass surgery is##2##3##(2008-11#1)(2011-3#1)
bypass surgery##39##2##(1990-2#1)(1990-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#3)(2006-10#1)(2006-6#1)(2007-8#6)(2008-10#1)(2008-11#3)(2008-12#4)(2008-3#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#5)(2012-5#1)(2013-7#1)
bypass surgical##2##2##(1990-6#1)(1996-9#1)
bypass the##4##2##(1997-4#1)(2007-12#1)(2008-9#1)(2012-3#1)
bypass to##4##2##(2007-8#3)(2008-12#1)
bypass trapped-flow analysis system##2##4##(2008-10#2)
bypass was##2##2##(2011-3#1)(2012-3#1)
bypass with##7##2##(1993-3#2)(2007-8#2)(2008-7#1)(2011-2#1)(2013-1#1)
bypass##296##1##(1990-2#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#7)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-9#6)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#9)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#106)(2007-9#8)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-5#2)(2010-8#12)(2011-2#12)(2011-3#6)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#12)(2012-5#3)(2013-1#12)(2013-7#1)(2013-8#3)
bypass-exchange switch##2##2##(2008-2#1)(2008-3#1)
bypassed by##2##2##(1992-8#1)(2008-11#1)
bypassed##4##1##(1992-8#1)(2007-8#1)(2008-11#1)(2012-2#1)
bypasses the##4##2##(1994-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
bypasses were performed##2##3##(2013-1#1)(2013-8#1)
bypasses##10##1##(1990-11#1)(1991-3#1)(1994-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-3#2)(2013-1#1)(2013-8#1)
bypassing the##3##2##(2008-11#1)(2008-5#1)(2009-2#1)
bypassing##7##1##(1992-12#1)(1994-5#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)
bypivacain##4##1##(2012-3#4)
byproduct of##2##2##(2008-3#1)(2008-6#1)
byproduct##7##1##(2008-11#1)(2008-3#1)(2008-6#4)(2008-7#1)
byproducts##4##1##(2008-11#1)(2008-6#2)(2009-12#1)
byssochlamic acid and##2##3##(2010-3#2)
byssoidea##6##1##(2008-10#6)
bystander and adaptive responses in cell and tissue models##2##9##(2008-7#2)
bystander and adaptive responses##3##4##(2008-7#3)
bystander cells##2##2##(2008-7#2)
bystander effect##5##2##(2008-7#4)(2013-8#1)
bystander effects may##2##3##(2008-7#2)
bystander effects##10##2##(2008-7#10)
bystander responses##3##2##(2008-7#3)
bystander##33##1##(1997-1#1)(2008-7#30)(2013-1#1)(2013-8#1)
bystanders##3##1##(1994-12#1)(1996-5#1)(2013-1#1)
byusing##2##1##(2008-11#1)(2008-2#1)
bzip##3##1##(1992-3#3)
bénéficié##2##1##(2011-2#1)(2013-1#1)
c = 10##2##3##(1997-7#1)(2007-11#1)
c = 12##4##3##(1996-2#3)(2007-11#1)
c = 13##5##3##(1996-2#4)(1997-7#1)
c = 14##4##3##(1996-2#1)(1997-7#3)
c = 15##2##3##(1996-2#1)(1997-7#1)
c = 16##2##3##(1996-2#2)
c = 17##3##3##(1997-7#3)
c = 18##5##3##(1996-2#3)(1997-7#1)(2008-8#1)
c = 19##2##3##(1996-2#2)
c = 20##3##3##(1996-2#3)
c = 21##3##3##(1996-2#2)(1997-7#1)
c = 24##2##3##(1996-2#2)
c = 8##3##3##(1996-5#1)(1997-7#1)(2007-11#1)
c = 9##2##3##(1996-2#2)
c =##59##2##(1992-11#1)(1992-12#1)(1992-9#1)(1996-2#31)(1996-5#1)(1997-7#16)(2007-11#3)(2008-11#1)(2008-8#3)(2013-8#1)
c and##9##2##(1994-8#1)(1995-2#3)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
c axes##2##2##(2007-11#1)(2008-2#1)
c axis##7##2##(1990-4#1)(1996-2#1)(1997-7#1)(2008-3#4)
c from##2##2##(1994-6#1)(1995-2#1)
c has been##2##3##(1994-5#1)(1995-2#1)
c in the##2##3##(1995-5#1)(2012-2#1)
c in##6##2##(1993-3#1)(1995-5#2)(1997-7#1)(2007-10#1)(2012-2#1)
c is##4##2##(1990-5#1)(1995-2#1)(2008-10#1)(2009-9#1)
c levels##3##2##(1995-5#2)(2008-1#1)
c molecule with##2##3##(2008-10#2)
c on##3##2##(1995-5#2)(2008-8#1)
c oxidase I##2##3##(2008-6#1)(2013-7#1)
c oxidase subunit I and##2##5##(2010-4#2)
c oxidase subunit I##3##4##(2010-4#3)
c oxidase subunit##6##3##(1991-6#1)(2008-10#2)(2010-4#3)
c oxidase##23##2##(1990-12#1)(1991-6#4)(1992-12#2)(1995-2#4)(1997-7#4)(2008-10#3)(2008-6#1)(2010-4#3)(2013-7#1)
c reductase activity in##2##4##(1990-11#1)(1996-3#1)
c reductase activity##5##3##(1990-11#4)(1996-3#1)
c reductase##9##2##(1990-11#6)(1995-2#1)(1996-3#1)(1997-3#1)
c release and##2##3##(2010-6#1)(2011-2#1)
c release##4##2##(2010-3#2)(2010-6#1)(2011-2#1)
c to##4##2##(1994-8#1)(1995-2#1)(1997-2#1)(2008-11#1)
c was##8##2##(1993-3#3)(1995-2#1)(2008-11#4)
c##347##1##(1990-11#6)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#5)(1990-8#2)(1991-1#2)(1991-2#1)(1991-5#2)(1991-6#4)(1992-11#1)(1992-12#3)(1992-3#12)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#9)(1993-3#5)(1993-6#2)(1994-11#5)(1994-2#5)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#4)(1995-12#13)(1995-2#20)(1995-5#11)(1996-12#2)(1996-2#48)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#5)(1997-3#1)(1997-4#12)(1997-6#1)(1997-7#24)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#12)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#4)(2008-7#2)(2008-8#7)(2009-9#3)(2010-1#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#14)(2011-2#6)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
c(6A)##4##1##(2009-10#4)
c(L##6##1##(2008-10#6)
c(L)=0##4##1##(2008-10#4)
c(i)(r)##3##1##(2012-2#3)
c) in##2##2##(2008-11#1)(2011-2#1)
c) the##4##2##(1991-6#1)(1992-10#1)(2008-7#1)(2013-8#1)
c) was##2##2##(2008-10#1)(2011-2#1)
c)##28##1##(1990-6#1)(1991-6#2)(1992-10#1)(1993-12#1)(1993-9#1)(1995-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#2)(2013-8#1)
c-Abl##9##1##(1994-10#1)(1995-8#5)(2012-12#3)
c-Abl/Arg activation##2##2##(2012-12#2)
c-Abl/Arg inhibitors##2##2##(2012-12#2)
c-Abl/Arg##7##1##(2012-12#7)
c-DIV for##2##2##(2008-10#2)
c-DIV##6##1##(2008-10#6)
c-FLIP expression##2##2##(2012-2#2)
c-FLIP is##2##2##(2012-2#2)
c-FLIP##11##1##(2009-9#1)(2011-2#1)(2012-2#9)
c-FLIP(L) and c-FLIP(S)##2##3##(2012-2#2)
c-FLIP(L)##3##1##(2012-2#3)
c-Fos##9##1##(1992-12#2)(1994-8#2)(1996-12#1)(2008-7#1)(2013-1#3)
c-Ha-ras##5##1##(1990-12#2)(1992-8#1)(2008-11#2)
c-Jun N-terminal kinase (JNK)##3##4##(2008-4#1)(2011-2#1)(2013-7#1)
c-Jun N-terminal kinase##4##3##(2008-4#1)(2010-12#1)(2011-2#1)(2013-7#1)
c-Jun N-terminal kinases##2##3##(1995-2#1)(2012-12#1)
c-Jun N-terminal##6##2##(1995-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
c-Jun and c-Fos##2##3##(1992-12#2)
c-Jun and##5##2##(1992-12#2)(1995-2#1)(2010-3#2)
c-Jun expression and c-Jun/AP-1##2##4##(1995-12#2)
c-Jun expression##3##2##(1995-12#2)(1996-12#1)
c-Jun in##3##2##(1995-2#2)(1996-12#1)
c-Jun##34##1##(1991-2#1)(1992-12#2)(1995-12#3)(1995-2#12)(1996-12#4)(2008-4#1)(2008-7#1)(2010-12#2)(2010-3#5)(2011-2#1)(2012-12#1)(2013-7#1)
c-Jun/AP-1 activity##2##2##(1995-12#2)
c-Jun/AP-1##3##1##(1995-12#3)
c-KIT or##2##2##(2013-1#2)
c-KIT##4##1##(2013-1#4)
c-Ki-ras gene##4##2##(1992-8#3)(1992-9#1)
c-Ki-ras##5##1##(1992-8#4)(1992-9#1)
c-Kit is##2##2##(2010-4#2)
c-Kit positive##2##2##(2009-12#2)
c-Kit##11##1##(2008-6#1)(2009-12#3)(2010-4#4)(2010-8#2)(2013-1#1)
c-MYC and##2##2##(1993-8#1)(2012-2#1)
c-MYC protein expression##2##3##(1993-11#2)
c-MYC##5##1##(1993-11#2)(1993-8#1)(2012-2#2)
c-Met receptor in##2##3##(2011-2#2)
c-Met receptor##5##2##(2011-2#5)
c-Met##6##1##(2011-2#6)
c-Mil##3##1##(1995-2#3)
c-Mil/Raf##4##1##(1995-2#4)
c-Mos##2##1##(1994-8#1)(1995-2#1)
c-Mpl##4##1##(2008-8#4)
c-Myb##2##1##(2010-2#2)
c-Myc and##2##2##(2008-9#1)(2011-2#1)
c-Myc directly##2##2##(2013-1#2)
c-Myc induced##2##2##(1994-9#1)(1996-12#1)
c-Myc is a##2##3##(2008-11#1)(2013-1#1)
c-Myc protein##3##2##(1990-5#2)(1996-12#1)
c-Myc was##2##2##(1994-9#1)(1996-12#1)
c-Myc##30##1##(1990-5#2)(1994-9#2)(1996-12#4)(1997-8#2)(2008-11#4)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#12)
c-Raf-1 and##2##2##(1995-2#1)(1995-5#1)
c-Raf-1##5##1##(1995-2#3)(1995-5#2)
c-Rel##4##1##(1993-9#3)(1995-6#1)
c-Rmil##6##1##(1993-6#6)
c-abl##2##1##(1995-8#2)
c-axis##2##1##(2008-10#2)
c-erbA alpha gene##4##3##(1993-3#4)
c-erbA alpha##5##2##(1993-3#5)
c-erbA proteins##2##2##(1991-2#2)
c-erbA##9##1##(1990-8#1)(1991-2#3)(1993-3#5)
c-erbB-2 expression##7##2##(1994-7#6)(1995-4#1)
c-erbB-2 gene product associates with catenins##2##6##(1994-11#2)
c-erbB-2 gene product##4##3##(1994-11#4)
c-erbB-2 protein was##2##3##(1993-1#2)
c-erbB-2 protein##6##2##(1993-1#5)(1994-12#1)
c-erbB-2##24##1##(1993-1#5)(1994-11#4)(1994-12#1)(1994-5#1)(1994-7#9)(1995-4#3)(1997-8#1)
c-fms##2##1##(1997-7#1)(2010-6#1)
c-fos and c-jun##2##3##(1991-5#1)(1996-12#1)
c-fos and junB in striatum and nucleus accumbens##2##8##(1994-8#2)
c-fos and junB in##3##4##(1994-8#3)
c-fos and junB##8##3##(1994-8#8)
c-fos and##15##2##(1991-5#1)(1992-9#1)(1994-11#1)(1994-8#8)(1996-12#2)(2008-9#2)
c-fos expression and##2##3##(1994-11#1)(1996-12#1)
c-fos expression in##3##3##(1993-12#1)(1994-11#1)(1997-2#1)
c-fos expression##9##2##(1991-12#1)(1993-12#1)(1994-11#3)(1996-12#1)(1997-2#1)(1997-3#2)
c-fos gene##6##2##(1991-12#3)(1992-9#1)(1994-11#2)
c-fos in the##2##3##(1997-2#1)(1997-3#1)
c-fos in##3##2##(1996-5#1)(1997-2#1)(1997-3#1)
c-fos mRNA##5##2##(1993-1#1)(1994-8#1)(1996-12#3)
c-fos protein##3##2##(1990-5#1)(1991-12#1)(1993-12#1)
c-fos##64##1##(1990-12#3)(1990-5#3)(1991-12#5)(1991-5#1)(1992-12#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-6#1)(1994-11#9)(1994-6#1)(1994-8#10)(1995-12#2)(1996-12#10)(1996-5#1)(1997-2#3)(1997-3#3)(2007-5#1)(2008-11#1)(2008-9#2)
c-jun AS cells##2##3##(2008-11#2)
c-jun AS##4##2##(2008-11#4)
c-jun AS-SEAP cells##2##3##(2008-11#2)
c-jun AS-SEAP##3##2##(2008-11#3)
c-jun and c-myc##2##3##(1990-12#2)
c-jun and##4##2##(1990-12#2)(1991-12#1)(1994-8#1)
c-jun expression##3##2##(1991-12#1)(1991-2#1)(2008-11#1)
c-jun gene##3##2##(1995-8#1)(2008-11#2)
c-jun mRNA was##3##3##(1991-2#1)(1991-9#1)(1995-8#1)
c-jun oncogene##2##2##(1995-8#2)
c-jun were##2##2##(1991-12#1)(1996-12#1)
c-jun##39##1##(1990-12#3)(1991-12#4)(1991-2#3)(1991-5#1)(1991-9#2)(1992-12#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-8#6)(1996-12#3)(2008-11#11)(2008-7#1)
c-kit and PDGFR##3##3##(2009-7#1)(2011-2#2)
c-kit##16##1##(1993-3#8)(2008-11#1)(2008-9#1)(2009-7#1)(2010-11#2)(2010-12#1)(2011-2#2)
c-met##5##1##(1995-8#5)
c-myb##10##1##(1990-6#3)(1994-10#7)
c-myc allele on the##3##4##(1993-2#3)
c-myc amplification##3##2##(1991-4#2)(1992-9#1)
c-myc and##7##2##(1990-12#1)(1992-8#1)(1992-9#1)(2007-5#1)(2008-8#2)(2008-9#1)
c-myc expression was##2##3##(1991-9#1)(2008-11#1)
c-myc expression##6##2##(1990-12#1)(1991-9#1)(1993-11#2)(1997-7#1)(2008-11#1)
c-myc gene was##3##3##(1993-2#1)(1993-3#1)(2008-8#1)
c-myc gene##24##2##(1991-4#1)(1992-8#6)(1992-9#3)(1993-2#2)(1993-3#6)(2008-11#3)(2008-8#3)
c-myc levels and##4##3##(1992-2#3)(2008-5#1)
c-myc levels##6##2##(1992-2#5)(2008-5#1)
c-myc mRNA##7##2##(1990-12#3)(1991-9#2)(1993-11#1)(1997-7#1)
c-myc protein##3##2##(1992-2#2)(1993-3#1)
c-myc proto-oncogene##2##2##(1990-12#1)(1991-9#1)
c-myc were##2##2##(1993-2#1)(2008-5#1)
c-myc##95##1##(1990-12#6)(1991-4#6)(1991-9#4)(1992-2#9)(1992-3#1)(1992-6#1)(1992-8#10)(1992-9#6)(1993-1#1)(1993-11#3)(1993-2#11)(1993-3#7)(1993-6#2)(1993-8#1)(1994-9#1)(1995-9#1)(1997-7#3)(2007-5#1)(2008-11#12)(2008-5#3)(2008-8#5)(2008-9#1)
c-reactive protein##2##2##(2011-2#2)
c-sis/PDGF-B##2##1##(2008-9#2)
c-src##3##1##(1990-12#2)(2008-8#1)
c-type cytochromes##3##2##(1994-5#1)(1994-8#2)
c-type##5##1##(1994-11#2)(1994-5#1)(1994-8#2)
c/ml##3##1##(2008-11#3)
c/o##2##1##(1997-2#1)(2008-4#1)
c1/c1 genotype##4##2##(2008-8#4)
c3 and##2##2##(1994-5#2)
c3##7##1##(1994-5#7)
cAA-AM1##3##1##(1997-7#3)
cADPR and##2##2##(1995-3#1)(2010-11#1)
cADPR was##5##2##(1994-11#1)(1995-3#4)
cADPR##16##1##(1994-11#2)(1995-3#9)(2010-11#5)
cAMP accumulation in##2##3##(1993-9#1)(1995-8#1)
cAMP accumulation##8##2##(1993-3#1)(1993-9#2)(1995-6#1)(1995-8#1)(1997-2#1)(2008-4#2)
cAMP analog##2##2##(1995-11#1)(2010-11#1)
cAMP and Ca(2+) signaling pathways##2##5##(2008-11#2)
cAMP and##11##2##(1991-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(2008-11#2)(2009-10#1)
cAMP antagonist##2##2##(1995-11#1)(1997-6#1)
cAMP are##2##2##(1994-8#2)
cAMP as##2##2##(1995-11#1)(1995-8#1)
cAMP complex concentrations##2##3##(1997-6#2)
cAMP complex##4##2##(1997-6#4)
cAMP content in##2##3##(1995-12#1)(1995-8#1)
cAMP content of##2##3##(1996-5#1)(2008-8#1)
cAMP content##5##2##(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-8#1)
cAMP elevation##2##2##(1994-6#2)
cAMP formation in##4##3##(1991-12#1)(1995-12#1)(1995-6#1)(1997-2#1)
cAMP formation was##3##3##(1993-9#1)(1994-9#2)
cAMP formation##14##2##(1991-12#1)(1992-4#1)(1993-9#1)(1994-9#4)(1995-11#1)(1995-12#2)(1995-6#3)(1997-2#1)
cAMP generation in##2##3##(1991-3#1)(1995-8#1)
cAMP generation##3##2##(1990-12#1)(1991-3#1)(1995-8#1)
cAMP in##8##2##(1991-9#1)(1993-3#2)(1994-11#2)(1994-8#1)(1997-2#1)(2010-1#1)
cAMP level and##2##3##(1994-8#1)(1995-8#1)
cAMP level##7##2##(1994-11#1)(1994-8#1)(1995-8#1)(2008-8#4)
cAMP levels are##2##3##(1995-8#1)(1996-5#1)
cAMP levels in##4##3##(1991-12#1)(1993-3#1)(1995-8#1)(2008-10#1)
cAMP levels##14##2##(1990-8#1)(1991-12#1)(1993-3#3)(1995-8#4)(1996-2#2)(1996-5#1)(2008-10#2)
cAMP may##3##2##(1994-11#1)(1994-8#1)(1994-9#1)
cAMP on mouse islet##2##4##(2010-11#2)
cAMP on##5##2##(1994-11#1)(1995-6#1)(1996-5#1)(2010-11#2)
cAMP or##4##2##(1991-2#1)(1995-5#1)(1997-2#1)(2008-11#1)
cAMP pathway with##2##3##(2008-1#1)(2008-11#1)
cAMP pathway##9##2##(1994-12#1)(1996-5#1)(2008-1#1)(2008-11#6)
cAMP production by##3##3##(1991-3#1)(1997-2#1)(1997-4#1)
cAMP production in##2##3##(1993-11#1)(1993-3#1)
cAMP production##9##2##(1991-12#1)(1991-3#1)(1993-11#1)(1993-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(2008-4#1)
cAMP regulatory##2##2##(1991-9#1)(1994-8#1)
cAMP response element-binding##2##3##(2008-7#1)(2012-3#1)
cAMP response to##2##3##(1992-12#1)(1995-8#1)
cAMP response##5##2##(1992-12#1)(1994-8#1)(1995-8#1)(2008-7#1)(2012-3#1)
cAMP signaling##4##2##(1994-8#1)(2008-11#2)(2009-2#1)
cAMP was##3##2##(1991-3#1)(1993-3#1)(1997-2#1)
cAMP were##2##2##(1991-12#1)(1992-6#1)
cAMP##196##1##(1990-12#1)(1990-5#1)(1990-8#4)(1991-12#5)(1991-2#9)(1991-3#5)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-3#15)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#1)(1994-6#4)(1994-8#12)(1994-9#5)(1995-11#8)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#9)(1995-8#14)(1996-12#1)(1996-2#6)(1996-5#8)(1997-1#1)(1997-2#13)(1997-3#2)(1997-4#1)(1997-6#7)(2008-1#1)(2008-10#3)(2008-11#12)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#7)(2009-10#1)(2009-2#2)(2010-1#1)(2010-11#3)(2012-3#1)
cAMP-dependent kinase##2##2##(1990-11#1)(1995-11#1)
cAMP-dependent pathway##2##2##(2008-7#2)
cAMP-dependent phosphorylation of##2##3##(1994-8#2)
cAMP-dependent phosphorylation##4##2##(1994-8#2)(1995-3#2)
cAMP-dependent protein kinase (PKA)##6##4##(1992-3#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(2008-8#1)
cAMP-dependent protein kinase A (PKA)##2##5##(1994-8#1)(2008-10#1)
cAMP-dependent protein kinase phosphorylation##2##4##(2008-12#2)
cAMP-dependent protein kinase##26##3##(1990-2#1)(1990-8#1)(1992-3#2)(1993-11#1)(1993-3#5)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#5)(1995-3#1)(1995-5#1)(2008-10#1)(2008-12#2)(2008-8#1)
cAMP-dependent signaling##2##2##(1994-11#1)(1997-2#1)
cAMP-dependent##38##1##(1990-11#1)(1990-2#1)(1990-8#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#5)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#5)(1995-3#3)(1995-5#1)(1997-2#2)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#1)
cAMP-induced##6##1##(1990-12#2)(1991-2#2)(1996-2#2)
cAMP-mediated##4##1##(1992-6#1)(1994-8#1)(2008-4#1)(2012-2#1)
cAMP-regulated##3##1##(1991-10#1)(1994-8#1)(2010-11#1)
cAMP-response##2##1##(1994-11#1)(1996-2#1)
cAMP-specific phosphodiesterase##3##2##(1994-6#1)(1994-8#1)(2008-5#1)
cAMP-specific##4##1##(1993-6#1)(1994-6#1)(1994-8#1)(2008-5#1)
cAMP/PKA##2##1##(2009-8#1)(2013-7#1)
cCDC25 and cSOS1##2##3##(1994-8#2)
cCDC25##3##1##(1994-8#3)
cCDC25-CAAX##2##1##(1994-8#2)
cDNA also##2##2##(1990-8#1)(1992-8#1)
cDNA and amino acid sequence##2##5##(1990-12#1)(1994-6#1)
cDNA and amino acid##3##4##(1990-12#1)(1991-12#1)(1994-6#1)
cDNA and deduced amino acid##2##5##(1992-10#1)(2008-11#1)
cDNA and genomic DNA sequences##2##5##(1991-9#1)(1996-8#1)
cDNA and genomic DNA##3##4##(1991-9#1)(1996-8#1)(2008-9#1)
cDNA and genomic clones##5##4##(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#1)(2010-5#1)
cDNA and genomic sequences##2##4##(1991-9#1)(1994-8#1)
cDNA and genomic##11##3##(1991-9#3)(1993-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-9#1)(2010-5#1)
cDNA and its##6##3##(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(2008-6#1)
cDNA and the##4##3##(1990-8#2)(1995-6#1)(1997-4#1)
cDNA and##40##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-9#3)(1992-10#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-8#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)
cDNA array analysis##2##3##(2008-5#1)(2008-9#1)
cDNA array##7##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#4)
cDNA arrays##7##2##(2008-7#5)(2008-9#2)
cDNA as a probe##8##4##(1992-11#1)(1993-6#2)(1994-11#1)(1994-8#1)(1995-6#1)(1997-4#2)
cDNA as a##11##3##(1992-11#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-4#2)(2008-9#1)
cDNA as probe##3##3##(1995-6#1)(1996-12#1)(2008-8#1)
cDNA as##15##2##(1992-11#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-12#1)(1997-4#2)(2008-8#1)(2008-9#2)
cDNA at##2##2##(1997-4#2)
cDNA by RT-PCR##2##3##(1993-9#1)(2008-9#1)
cDNA by##8##2##(1990-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1997-2#2)(2008-9#1)(2010-5#1)
cDNA clone AWI 31##2##4##(1997-2#2)
cDNA clone UDPGTh2##2##3##(2008-11#2)
cDNA clone as a##2##4##(1997-2#1)(2008-10#1)
cDNA clone encoding a##4##4##(1993-9#1)(1994-8#1)(1996-12#1)(1997-1#1)
cDNA clone encoding human##2##4##(1990-11#1)(1994-11#1)
cDNA clone encoding the##3##4##(1993-2#1)(1994-12#1)(1995-6#1)
cDNA clone encoding##15##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-9#1)
cDNA clone for a##2##4##(1991-5#1)(2008-5#1)
cDNA clone for##5##3##(1990-12#1)(1991-5#1)(1992-10#1)(1993-6#1)(2008-5#1)
cDNA clone from a##2##4##(1990-7#1)(1993-3#1)
cDNA clone from##3##3##(1990-7#1)(1993-3#1)(1995-8#1)
cDNA clone is##2##3##(1991-9#1)(2008-8#1)
cDNA clone of##5##3##(1994-12#1)(1997-3#1)(2008-10#2)(2008-8#1)
cDNA clone was##3##3##(1995-8#1)(1997-2#1)(2008-10#1)
cDNA clone which is##2##4##(1994-11#1)(2008-8#1)
cDNA clone##71##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#5)(1994-12#2)(1994-6#1)(1994-8#3)(1995-6#2)(1995-8#4)(1996-12#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2008-10#5)(2008-11#4)(2008-5#2)(2008-8#5)
cDNA clones and##3##3##(1993-2#1)(2008-9#1)(2010-4#1)
cDNA clones coding for##2##4##(1993-6#1)(1997-2#1)
cDNA clones coding##3##3##(1993-6#1)(1997-2#1)(2008-8#1)
cDNA clones encoding human##2##4##(1990-8#1)(1992-8#1)
cDNA clones encoding##7##3##(1990-8#1)(1991-6#1)(1992-8#1)(1993-3#1)(1997-2#1)(2008-2#1)(2008-5#1)
cDNA clones for##3##3##(1992-10#1)(1992-8#2)
cDNA clones from human##4##4##(1995-8#1)(1996-2#2)(1996-8#1)
cDNA clones from##7##3##(1990-12#1)(1991-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-8#1)
cDNA clones have##2##3##(1990-12#1)(2008-11#1)
cDNA clones isolated from##2##4##(1991-2#1)(1993-11#1)
cDNA clones of human cell line KG-1##2##7##(1995-8#1)(1996-2#1)
cDNA clones of the##2##4##(1997-6#1)(2008-10#1)
cDNA clones of##9##3##(1991-2#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-9#1)
cDNA clones revealed that##2##4##(1990-12#1)(1997-6#1)
cDNA clones that##3##3##(1990-12#1)(1994-12#1)(1996-10#1)
cDNA clones were isolated##3##4##(1990-8#1)(1992-3#1)(2008-8#1)
cDNA clones were obtained##2##4##(1996-8#1)(1997-7#1)
cDNA clones were##12##3##(1990-8#1)(1991-12#1)(1992-3#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-8#1)(2008-9#3)
cDNA clones will##2##3##(1996-8#1)(2008-11#1)
cDNA clones##94##2##(1990-12#4)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-6#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#4)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#3)(1994-12#2)(1995-2#1)(1995-8#3)(1996-10#5)(1996-12#2)(1996-2#5)(1996-8#5)(1997-2#5)(1997-6#2)(1997-7#1)(1997-8#3)(2008-10#8)(2008-11#9)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#9)(2010-4#1)
cDNA cloning and sequencing##3##4##(1990-5#1)(2008-10#2)
cDNA cloning and##5##3##(1990-5#1)(1994-11#1)(2008-10#2)(2008-9#1)
cDNA cloning of##4##3##(1992-8#1)(1993-3#1)(1994-11#1)(2008-11#1)
cDNA cloning##13##2##(1990-5#2)(1991-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
cDNA coding for the##3##4##(1995-2#1)(1995-8#1)(1996-2#1)
cDNA coding for##10##3##(1991-6#2)(1991-9#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-2#2)(1995-8#1)(1996-2#1)
cDNA coding##12##2##(1991-6#2)(1991-9#1)(1992-3#2)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#2)(1995-8#1)(1996-2#1)
cDNA consists of##3##3##(2008-7#2)(2010-5#1)
cDNA contained##3##2##(1991-5#1)(1992-9#1)(1997-7#1)
cDNA containing the##2##3##(1991-12#1)(1993-2#1)
cDNA contains##2##2##(1994-12#2)
cDNA copies##2##2##(2008-10#2)
cDNA copy##2##2##(2008-10#2)
cDNA demonstrated that##2##3##(1990-12#1)(1990-2#1)
cDNA derived from human##2##4##(2008-4#2)
cDNA derived from##4##3##(1993-3#1)(1995-2#1)(2008-4#2)
cDNA derived##5##2##(1991-9#1)(1993-3#1)(1995-2#1)(2008-4#2)
cDNA differential bands##2##3##(2008-8#2)
cDNA differential##3##2##(2008-8#3)
cDNA directed##2##2##(1994-9#1)(1995-6#1)
cDNA encoded a##3##3##(1990-12#1)(1993-8#1)(2010-5#1)
cDNA encoded##5##2##(1990-12#1)(1993-8#1)(1995-8#1)(2008-6#1)(2010-5#1)
cDNA encodes##3##2##(1991-7#1)(1994-12#1)(2008-6#1)
cDNA encoding a protein##3##4##(1990-11#1)(1994-6#1)(2008-9#1)
cDNA encoding a##14##3##(1990-11#1)(1992-8#2)(1993-8#1)(1994-12#3)(1994-6#1)(1995-11#1)(1997-1#1)(2008-8#2)(2008-9#2)
cDNA encoding bovine##3##3##(1991-12#1)(1993-2#2)
cDNA encoding human##9##3##(1990-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-11#1)(2008-8#4)
cDNA encoding phytoene##2##3##(1995-2#2)
cDNA encoding rat##3##3##(1990-5#1)(1991-2#1)(1994-6#1)
cDNA encoding the human##5##4##(1991-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(2008-5#1)
cDNA encoding the major##2##4##(1994-12#1)(2008-5#1)
cDNA encoding the##21##3##(1990-12#1)(1991-6#2)(1992-11#1)(1992-8#1)(1993-3#3)(1993-6#2)(1993-8#2)(1994-12#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-5#2)
cDNA encoding##73##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-6#2)(1992-11#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#3)(1994-11#3)(1994-12#7)(1994-6#3)(1994-8#3)(1995-11#2)(1995-2#3)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#7)(2008-9#2)
cDNA expression construct##2##3##(1992-8#1)(1992-9#1)
cDNA expression libraries##2##3##(1993-12#1)(2008-4#1)
cDNA expression library of##2##4##(1993-11#1)(2008-9#1)
cDNA expression library was##2##4##(2008-8#1)(2008-9#1)
cDNA expression library##7##3##(1991-2#1)(1993-11#1)(1994-8#1)(2008-8#2)(2008-9#2)
cDNA expression##16##2##(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-12#2)(1997-9#1)(2008-4#2)(2008-8#2)(2008-9#2)
cDNA for a##5##3##(1993-3#1)(1993-6#1)(1995-2#1)(1997-8#1)(2010-5#1)
cDNA for rat##3##3##(1990-12#1)(1990-8#1)(1996-12#1)
cDNA for the rat##2##4##(1994-11#1)(1995-2#1)
cDNA for the##8##3##(1990-12#1)(1992-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-9#1)
cDNA for this##2##3##(1990-12#1)(1991-9#1)
cDNA for##34##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-5#1)(2008-8#1)(2010-5#1)
cDNA fragment encoding##2##3##(1997-7#2)
cDNA fragment from##2##3##(1997-6#1)(2008-11#1)
cDNA fragment of##2##3##(2008-10#1)(2008-8#1)
cDNA fragment was##4##3##(1997-6#1)(2008-8#2)(2010-1#1)
cDNA fragment##20##2##(1991-5#1)(1992-8#1)(1993-3#1)(1994-6#1)(1997-6#2)(1997-7#2)(2008-10#1)(2008-11#1)(2008-8#7)(2008-9#2)(2010-1#1)
cDNA fragments and##2##3##(1996-2#2)
cDNA fragments containing##2##3##(2008-10#1)(2008-8#1)
cDNA fragments were##2##3##(2008-8#2)
cDNA fragments##11##2##(1996-2#2)(2008-10#1)(2008-5#1)(2008-8#6)(2008-9#1)
cDNA from a human lung##2##5##(1991-5#1)(1993-11#1)
cDNA from a##3##3##(1991-12#1)(1991-5#1)(1993-11#1)
cDNA from human##2##3##(1991-6#1)(1993-3#1)
cDNA from needles##2##3##(2008-7#2)
cDNA from the##2##3##(1993-2#1)(2008-8#1)
cDNA from##23##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-7#5)(2008-8#2)
cDNA has a##2##3##(1992-8#1)(2008-10#1)
cDNA has an##2##3##(1993-8#1)(2008-4#1)
cDNA has been##4##3##(1990-12#1)(1992-8#1)(1992-9#1)(1994-5#1)
cDNA has##8##2##(1990-12#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-4#1)
cDNA have##2##2##(1991-6#1)(1995-6#1)
cDNA hybridized to a##2##4##(1990-12#2)
cDNA hybridized##3##2##(1990-12#2)(1992-6#1)
cDNA in a##4##3##(1990-12#1)(1994-12#1)(1994-8#1)(1995-6#1)
cDNA in the##5##3##(1995-6#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
cDNA in##20##2##(1990-12#2)(1991-12#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-6#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#5)(2008-9#1)
cDNA insert##5##2##(1990-7#1)(1991-12#1)(1994-8#2)(2008-11#1)
cDNA into##5##2##(1990-5#1)(1992-3#1)(1993-6#1)(2008-10#1)(2008-8#1)
cDNA is a##2##3##(1993-11#1)(2008-8#1)
cDNA is##12##2##(1990-11#1)(1993-11#2)(1993-2#1)(1993-6#1)(1997-2#1)(2008-8#5)(2008-9#1)
cDNA libraries of##3##3##(1995-6#1)(1997-2#2)
cDNA libraries prepared##2##3##(2008-11#1)(2008-4#1)
cDNA libraries with a##2##4##(1990-11#1)(1997-4#1)
cDNA libraries with##3##3##(1990-11#1)(1997-4#1)(2008-2#1)
cDNA libraries##19##2##(1990-11#1)(1995-6#1)(1996-12#1)(1996-8#2)(1997-2#4)(1997-4#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2012-3#1)
cDNA library and##6##3##(1994-11#1)(1997-7#1)(2008-8#3)(2011-2#1)
cDNA library by##7##3##(1993-2#1)(1994-8#2)(2008-11#2)(2008-8#1)(2008-9#1)
cDNA library constructed from the##2##5##(1995-2#1)(1997-2#1)
cDNA library constructed from##3##4##(1990-7#1)(1995-2#1)(1997-2#1)
cDNA library construction##2##3##(1996-2#1)(2008-4#1)
cDNA library derived from##6##4##(1990-11#1)(1990-8#1)(1991-1#1)(1992-9#1)(1993-6#1)(1994-12#1)
cDNA library from##4##3##(1990-7#1)(1993-3#1)(1993-6#1)(1994-8#1)
cDNA library of##4##3##(1991-2#1)(1992-9#1)(1994-11#1)(1995-8#1)
cDNA library screening and##2##4##(1991-9#1)(1996-2#1)
cDNA library using##3##3##(1991-12#1)(1991-6#1)(1992-8#1)
cDNA library was constructed##2##4##(2008-9#1)(2010-5#1)
cDNA library was screened using##4##5##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#1)
cDNA library was screened##8##4##(1990-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
cDNA library was##13##3##(1990-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#2)(1994-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-5#1)
cDNA library which##2##3##(1992-3#1)(1996-2#1)
cDNA library with the##2##4##(1993-8#1)(2008-9#1)
cDNA library with##5##3##(1993-8#1)(1997-7#1)(2008-2#1)(2008-8#1)(2008-9#1)
cDNA library##107##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#3)(1994-11#7)(1994-12#4)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#5)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#9)(2008-9#5)(2010-5#1)(2010-6#1)(2011-2#1)
cDNA microarray##6##2##(2008-10#1)(2008-7#2)(2009-10#1)(2010-4#2)
cDNA microarrays##4##2##(2008-4#2)(2008-7#1)(2008-8#1)
cDNA nucleotide sequence##2##3##(1996-12#1)(1996-2#1)
cDNA nucleotide##5##2##(1993-2#1)(1996-12#3)(1996-2#1)
cDNA of a##3##3##(2008-8#2)(2008-9#1)
cDNA of human red-sensitive pigment##2##5##(1990-12#2)
cDNA of human##4##3##(1990-12#2)(1994-11#1)(1997-2#1)
cDNA of the##4##3##(1991-2#1)(1996-5#1)(2008-10#1)(2008-12#1)
cDNA of##26##2##(1990-12#3)(1991-2#1)(1992-3#1)(1994-11#1)(1995-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-8#5)(2008-9#2)(2010-5#2)
cDNA or##3##2##(1991-7#1)(2008-10#1)(2008-11#1)
cDNA phage display##2##3##(2008-7#2)
cDNA phage##3##2##(2008-7#3)
cDNA probe derived from##2##4##(1991-1#1)(2008-10#1)
cDNA probe to##2##3##(1992-8#1)(2008-10#1)
cDNA probe##14##2##(1990-12#1)(1990-2#2)(1991-1#1)(1991-6#1)(1992-8#2)(1993-2#1)(1993-5#1)(1997-2#1)(2008-10#4)
cDNA probes to##3##3##(1993-2#1)(2008-10#2)
cDNA probes##10##2##(1991-6#1)(1992-6#1)(1993-2#1)(1994-11#1)(2008-10#4)(2008-7#1)(2008-8#1)
cDNA produced##2##2##(1992-12#1)(1994-11#1)
cDNA selection##2##2##(1993-11#1)(1997-8#1)
cDNA sequence and regulation##2##4##(1991-5#1)(1993-6#1)
cDNA sequence and##5##3##(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-6#1)
cDNA sequence as a probe##2##5##(1990-12#1)(1993-2#1)
cDNA sequence as a##3##4##(1990-12#1)(1992-10#1)(1993-2#1)
cDNA sequence encoding the##2##4##(1992-10#1)(1993-2#1)
cDNA sequence for##3##3##(1992-10#1)(1993-6#1)(2008-10#1)
cDNA sequence in##2##3##(1991-6#1)(1997-9#1)
cDNA sequence of the##2##4##(1990-8#1)(1993-3#1)
cDNA sequence of##4##3##(1990-8#1)(1993-3#1)(1994-11#1)(2008-10#1)
cDNA sequence was##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
cDNA sequence##39##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-10#3)(1992-3#1)(1992-8#1)(1993-2#2)(1993-3#2)(1993-6#3)(1994-11#1)(1994-12#2)(1994-8#2)(1995-6#2)(1996-12#2)(1996-2#1)(1997-6#1)(1997-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)
cDNA sequences encoding##2##3##(1991-6#1)(2010-5#1)
cDNA sequences for##2##3##(1992-11#1)(2010-3#1)
cDNA sequences of##2##3##(1990-12#1)(1993-6#1)
cDNA sequences##18##2##(1990-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#2)(1996-10#2)(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)
cDNA sequencing and##2##3##(1997-4#1)(2008-10#1)
cDNA sequencing##6##2##(1991-6#1)(1992-3#1)(1994-11#1)(1997-4#1)(1997-6#1)(2008-10#1)
cDNA shares##2##2##(1995-6#1)(1997-4#1)
cDNA species##3##2##(1993-8#1)(1996-10#1)(1996-2#1)
cDNA synthesis and##2##3##(2008-8#2)
cDNA synthesis##8##2##(1994-12#2)(1997-2#2)(2008-11#1)(2008-8#2)(2008-9#1)
cDNA that##3##2##(1990-12#1)(1994-11#1)(1997-2#1)
cDNA thus##2##2##(1991-5#1)(1993-8#1)
cDNA to the##3##3##(1993-11#1)(1995-2#1)(1997-1#1)
cDNA to##6##2##(1992-8#1)(1993-11#1)(1994-10#1)(1995-2#1)(1997-1#1)(2008-5#1)
cDNA transfection##3##2##(1991-9#1)(1996-12#2)
cDNA using##2##2##(2008-4#1)(2008-9#1)
cDNA was also##2##3##(1990-2#1)(1993-8#1)
cDNA was amplified from##2##4##(1997-9#1)(2008-4#1)
cDNA was cloned and##2##4##(1995-2#1)(1996-12#1)
cDNA was cloned##7##3##(1990-12#1)(1991-12#1)(1992-3#1)(1995-2#1)(1996-12#1)(2008-9#2)
cDNA was determined##2##3##(1993-12#1)(1997-7#1)
cDNA was isolated##3##3##(1992-3#1)(1992-8#1)(1995-12#1)
cDNA was obtained##2##3##(2008-10#1)(2008-9#1)
cDNA was subcloned##2##3##(1992-8#1)(1996-12#1)
cDNA was transfected into##2##4##(1990-8#1)(2008-3#1)
cDNA was used##3##3##(1990-11#1)(1997-1#1)(2008-10#1)
cDNA was##45##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-3#2)(1992-8#3)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#2)(1997-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#5)(2009-11#1)(2010-5#1)
cDNA were##5##2##(1993-12#1)(1994-9#1)(1995-2#1)(2010-5#2)
cDNA which encodes##2##3##(1993-8#1)(1995-6#1)
cDNA which##3##2##(1991-9#1)(1993-8#1)(1995-6#1)
cDNA with an open reading frame##2##6##(2008-7#2)
cDNA with an##3##3##(1994-12#1)(2008-7#2)
cDNA with the##2##3##(1994-9#2)
cDNA with##6##2##(1994-12#1)(1994-9#2)(2008-10#1)(2008-7#2)
cDNA##1086##1##(1990-11#10)(1990-12#36)(1990-2#7)(1990-5#7)(1990-7#6)(1990-8#16)(1991-1#3)(1991-11#2)(1991-12#16)(1991-2#10)(1991-5#14)(1991-6#23)(1991-7#3)(1991-9#13)(1992-10#7)(1992-11#5)(1992-12#5)(1992-3#20)(1992-6#6)(1992-8#28)(1992-9#9)(1993-1#1)(1993-11#15)(1993-12#9)(1993-2#22)(1993-3#23)(1993-5#1)(1993-6#32)(1993-8#27)(1993-9#5)(1994-10#2)(1994-11#37)(1994-12#34)(1994-2#1)(1994-5#5)(1994-6#11)(1994-8#21)(1994-9#10)(1995-11#6)(1995-12#10)(1995-2#18)(1995-5#1)(1995-6#26)(1995-8#13)(1996-10#12)(1996-12#23)(1996-2#20)(1996-3#2)(1996-5#1)(1996-8#11)(1996-9#1)(1997-1#4)(1997-2#30)(1997-3#2)(1997-4#18)(1997-6#12)(1997-7#20)(1997-8#7)(1997-9#7)(2008-1#1)(2008-10#59)(2008-11#36)(2008-12#3)(2008-2#8)(2008-3#1)(2008-4#19)(2008-5#14)(2008-6#6)(2008-7#30)(2008-8#82)(2008-9#51)(2009-10#3)(2009-11#1)(2010-1#1)(2010-3#1)(2010-4#3)(2010-5#14)(2010-6#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
cDNA-amplified fragment length polymorphism (cDNA-AFLP)##2##5##(2008-10#1)(2009-6#1)
cDNA-derived NQO1##2##2##(1994-8#2)
cDNA-derived hypovirus RNA##2##3##(2008-10#2)
cDNA-derived##5##1##(1993-6#1)(1994-8#2)(2008-10#2)
cDNA-specific##2##1##(1993-12#1)(1995-11#1)
cDNAclones##2##1##(2008-11#2)
cDNAs amplified##2##2##(1993-12#1)(1994-12#1)
cDNAs and##3##2##(1993-12#1)(1997-7#1)(2008-11#1)
cDNAs corresponding to the##2##4##(1993-12#1)(2008-10#1)
cDNAs corresponding to##3##3##(1993-12#2)(2008-10#1)
cDNAs derived from##4##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-8#1)
cDNAs encode##2##2##(1994-11#1)(1994-12#1)
cDNAs encoding a##3##3##(1993-12#1)(1994-12#1)(2008-7#1)
cDNAs encoding cell-surface##2##3##(2008-2#2)
cDNAs encoding the alpha and beta subunits of##2##8##(1993-2#2)
cDNAs encoding the##6##3##(1992-12#2)(1993-12#1)(1993-2#2)(1994-12#1)
cDNAs encoding##21##2##(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(2008-2#3)(2008-7#2)
cDNAs for the##3##3##(1995-2#1)(2008-11#1)(2010-5#1)
cDNAs for##6##2##(1992-8#1)(1993-8#1)(1994-3#1)(1995-2#1)(2008-11#1)(2010-5#1)
cDNAs from##8##2##(1991-5#1)(1992-10#1)(1993-8#1)(1994-12#2)(1997-8#1)(2008-11#1)(2008-7#1)
cDNAs in##3##2##(1993-5#1)(1994-12#1)(2008-8#1)
cDNAs isolated##2##2##(1991-12#1)(1994-12#1)
cDNAs of the##2##3##(2008-10#1)(2008-7#1)
cDNAs of##10##2##(1994-11#2)(1994-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#2)
cDNAs representing##2##2##(1991-7#1)(2008-10#1)
cDNAs that##3##2##(1991-12#1)(1993-6#1)(2008-10#1)
cDNAs were cloned##2##3##(1994-12#1)(1996-10#1)
cDNAs were expressed##2##3##(1992-9#1)(1995-8#1)
cDNAs were isolated##2##3##(1993-8#1)(1997-8#1)
cDNAs were##15##2##(1992-8#2)(1992-9#1)(1993-2#1)(1993-8#3)(1994-12#2)(1995-8#1)(1996-10#1)(1997-2#1)(1997-8#3)
cDNAs with##2##2##(2008-11#1)(2008-8#1)
cDNAs##138##1##(1990-11#1)(1990-12#1)(1990-8#2)(1991-12#4)(1991-5#4)(1991-6#2)(1991-7#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#12)(1993-2#5)(1993-5#1)(1993-6#4)(1993-8#8)(1994-11#7)(1994-12#17)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-10#2)(1997-2#4)(1997-4#1)(1997-7#3)(1997-8#5)(2008-10#7)(2008-11#9)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#7)(2009-10#1)(2010-5#1)
cELISA##3##1##(2008-10#2)(2011-2#1)
cER transcript##2##2##(1992-9#2)
cER##4##1##(1992-9#4)
cFIX##4##1##(2008-9#4)
cGMP and##2##2##(1995-8#1)(1997-1#1)
cGMP in##3##2##(1995-2#1)(1995-8#1)(2008-5#1)
cGMP levels in##2##3##(1990-12#1)(1995-2#1)
cGMP levels##6##2##(1990-12#4)(1995-2#1)(2008-7#1)
cGMP may##2##2##(1995-8#2)
cGMP production##3##2##(1991-9#1)(1995-2#1)(2008-11#1)
cGMP##41##1##(1990-12#6)(1991-12#1)(1991-9#1)(1992-3#2)(1993-8#1)(1995-2#7)(1995-8#7)(1997-1#1)(2008-11#2)(2008-4#8)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-3#1)
cGMP-PDE gamma##2##2##(1994-12#2)
cGMP-PDE##3##1##(1994-12#3)
cGMP-binding activity in##2##3##(1995-8#2)
cGMP-binding activity##3##2##(1995-8#3)
cGMP-binding in##2##2##(1995-8#2)
cGMP-binding##9##1##(1995-8#9)
cGMP-gated##3##1##(1990-11#3)
cGy##8##1##(1991-8#1)(1992-9#1)(2008-10#1)(2008-6#1)(2008-7#3)(2009-11#1)
cGy) and##2##2##(1993-9#2)
cGy) are##2##2##(1993-9#2)
cGy)##12##1##(1993-9#12)
cI repressor##6##2##(1992-4#1)(1995-8#5)
cI##7##1##(1992-4#1)(1995-8#5)(2008-2#1)
cITP##2##1##(2008-10#2)
cLBP##3##1##(2013-1#3)
cM and##6##2##(1996-10#1)(1997-2#1)(2008-10#1)(2008-9#3)
cM away from the##2##4##(2008-10#1)(2012-3#1)
cM away##3##2##(2008-10#2)(2012-3#1)
cM from a##2##3##(2008-10#2)
cM from fzp(t)##2##3##(2008-9#2)
cM from##10##2##(1995-9#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#2)
cM in the##2##3##(2008-10#2)
cM of##4##2##(1996-10#1)(1997-5#1)(2008-10#1)(2008-5#1)
cM to##2##2##(2008-9#2)
cM##50##1##(1995-6#1)(1995-9#1)(1996-10#2)(1997-2#2)(1997-5#5)(2008-10#20)(2008-12#1)(2008-5#6)(2008-8#1)(2008-9#8)(2012-3#2)(2013-1#1)
cM) and##7##2##(2008-10#7)
cM) in##3##2##(2008-10#3)
cM) to##2##2##(2008-10#2)
cM)##25##1##(1997-5#1)(2008-10#24)
cMAP##2##1##(2008-4#2)
cMOAT##3##1##(2008-11#2)(2008-8#1)
cMRI##2##1##(2013-7#2)
cPLA(2) and##2##2##(2008-8#1)(2011-2#1)
cPLA(2)##3##1##(2008-8#2)(2011-2#1)
cPLA2 in##2##2##(1994-11#2)
cPLA2##9##1##(1993-11#4)(1993-6#1)(1994-11#4)
cPTH-(1-34) and cPTH-(1-88)##2##3##(1991-3#2)
cPTH-(1-34)##3##1##(1991-3#3)
cPTH-(1-88)##3##1##(1991-3#3)
cRNA##3##1##(1995-2#1)(1996-12#1)(2008-10#1)
cSOS1##3##1##(1994-8#3)
cSOS1-CAAX##2##1##(1994-8#2)
cTR##6##1##(1991-6#6)
cTnI and cTnT##2##3##(2011-2#2)
cTnI in##2##2##(2008-10#1)(2010-12#1)
cTnI##12##1##(2008-10#5)(2010-12#5)(2011-2#2)
cZi DBS##3##2##(2012-3#3)
cZi##5##1##(2012-3#5)
c[actin]5/2##2##1##(1993-8#2)
ca##96##1##(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#54)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#2)(2009-7#1)(2009-9#3)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-9#1)
ca(2+)##3##1##(2008-8#3)
cabbage (Brassica oleracea var##2##4##(2008-10#2)
cabbage (Brassica##4##2##(1997-2#2)(2008-10#2)
cabbage and##5##2##(2008-10#3)(2013-8#2)
cabbage butterfly##4##2##(1997-8#2)(2008-5#1)(2008-8#1)
cabbage##39##1##(1990-8#2)(1997-2#2)(1997-4#1)(1997-8#2)(2008-10#22)(2008-5#1)(2008-7#1)(2008-8#4)(2011-3#1)(2012-3#1)(2013-8#2)
cabergoline##5##1##(2008-7#4)(2011-1#1)
cabin environment##3##2##(1996-12#2)(2007-2#1)
cabin fire##2##2##(1996-12#2)
cabin fires##2##2##(1996-12#2)
cabin length##2##2##(1996-12#2)
cabin occupants##2##2##(1996-12#2)
cabin smoke control##2##3##(1996-12#2)
cabin ventilation##2##2##(1996-12#2)
cabin##32##1##(1996-12#28)(2007-2#2)(2008-1#2)
cabinet##2##1##(2008-10#1)(2008-11#1)
cable and##2##2##(2008-2#1)(2008-9#1)
cable car##2##2##(2007-2#1)(2008-11#1)
cable in##2##2##(2008-9#1)(2009-3#1)
cable##24##1##(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#9)(2009-3#5)(2010-9#2)(2012-12#2)
cables is##2##2##(2012-2#2)
cables##13##1##(1994-8#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-2#8)
cacao isolates##2##2##(2008-10#2)
cacao##13##1##(2008-10#12)(2012-3#1)
cacao)##3##1##(2008-10#2)(2008-5#1)
cache for##2##2##(2008-3#2)
cache##3##1##(1993-2#1)(2008-3#2)
cachectic##2##1##(1996-3#1)(2008-5#1)
caches##4##1##(2008-1#1)(2008-3#2)(2008-9#1)
cachexia and xyloporosis##2##3##(2008-10#2)
cachexia and##4##2##(2008-10#3)(2012-2#1)
cachexia##15##1##(1992-8#2)(2008-10#6)(2008-5#5)(2012-2#1)(2013-8#1)
caching##3##1##(2008-3#3)
cacodylate buffer##2##2##(2008-10#1)(2008-5#1)
cacti##4##1##(2008-10#3)(2008-9#1)
cactophilic Drosophila mojavensis##3##3##(2008-8#2)(2008-9#1)
cactorum and P##2##3##(2008-10#2)
cactorum##16##1##(2008-10#16)
cactus##8##1##(2008-10#6)(2008-8#1)(2008-9#1)
cadaver kidney##2##2##(1991-9#1)(2008-10#1)
cadaver lumbar spine##3##3##(2012-2#3)
cadaver of##2##2##(2007-11#1)(2013-1#1)
cadaver study##2##2##(2008-12#1)(2009-2#1)
cadaver##24##1##(1991-9#1)(1994-1#1)(1995-12#1)(1997-2#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
cadaveric dissection##2##2##(2011-2#2)
cadaveric donor##2##2##(2011-2#2)
cadaveric donors has##2##3##(2008-4#1)(2011-2#1)
cadaveric donors##5##2##(2008-10#2)(2008-4#1)(2011-2#2)
cadaveric hands##2##2##(2008-9#2)
cadaveric model##2##2##(2008-9#2)
cadaveric specimens##2##2##(2011-2#2)
cadaveric studies##2##2##(2006-12#1)(2011-2#1)
cadaveric study##6##2##(2006-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
cadaveric transplant##2##2##(2007-7#1)(2011-2#1)
cadaveric transplantation##3##2##(2006-10#1)(2007-7#1)(2008-7#1)
cadaveric wrist was##2##3##(2012-1#2)
cadaveric wrist##3##2##(2012-1#3)
cadaveric##45##1##(1991-3#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#14)(2012-1#4)(2012-2#1)(2013-1#1)
cadaveric)##2##1##(1991-11#1)(2008-8#1)
cadaverine##5##1##(1994-8#1)(2008-10#3)(2008-5#1)
cadavers from##2##2##(2009-2#1)(2012-3#1)
cadavers in##2##2##(2008-1#1)(2008-4#1)
cadavers of##2##2##(2007-11#2)
cadavers##16##1##(1995-11#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-12#3)(2008-4#1)(2008-9#1)(2009-1#1)(2009-2#2)(2009-3#1)(2011-2#1)(2012-3#1)
cadence and acceleration##2##3##(2013-1#2)
cadence##8##1##(2007-10#2)(2008-12#1)(2010-9#1)(2013-1#4)
cadherin##4##1##(1991-5#1)(1994-9#1)(2008-8#2)
cadmium (Cd)##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
cadmium (II) and##3##3##(2008-10#3)
cadmium (II)##6##2##(2008-10#6)
cadmium and copper determination in##2##5##(2008-10#2)
cadmium and copper##7##3##(1995-3#1)(2008-10#6)
cadmium and lead in##11##4##(2008-10#11)
cadmium and lead##23##3##(2008-10#22)(2008-8#1)
cadmium and mercury are##2##4##(1994-3#1)(2008-10#1)
cadmium and mercury ions##2##4##(1991-9#1)(2008-10#1)
cadmium and mercury##7##3##(1991-9#1)(1994-3#1)(2008-10#5)
cadmium and nickel in##2##4##(2008-10#2)
cadmium and nickel##6##3##(2008-10#5)(2009-12#1)
cadmium and zinc##7##3##(1994-6#1)(1997-4#3)(2008-10#3)
cadmium and##64##2##(1991-9#1)(1994-3#1)(1994-6#1)(1995-3#2)(1996-7#1)(1997-4#3)(2008-10#49)(2008-11#2)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
cadmium are##3##2##(2008-10#3)
cadmium at the##2##3##(2008-10#2)
cadmium at##4##2##(2008-10#4)
cadmium by##3##2##(2008-10#3)
cadmium chloride##5##2##(1990-5#1)(1997-7#1)(2008-11#1)(2008-7#2)
cadmium complex##2##2##(2008-10#2)
cadmium concentration##2##2##(2008-10#2)
cadmium content in##2##3##(1993-12#1)(2008-10#1)
cadmium determination in##5##3##(2008-10#5)
cadmium determination##8##2##(2008-10#8)
cadmium from##3##2##(2008-10#3)
cadmium in drug samples by##2##5##(2008-10#2)
cadmium in seawater##2##3##(2008-10#2)
cadmium in the##4##3##(1993-12#1)(2008-10#2)(2008-12#1)
cadmium in##35##2##(1993-12#1)(2008-10#33)(2008-12#1)
cadmium intake from food##4##4##(1992-12#4)
cadmium intake##5##2##(1992-12#5)
cadmium ions##5##2##(2008-10#5)
cadmium is##3##2##(2008-10#3)
cadmium reductor##4##2##(2008-10#4)
cadmium salts##2##2##(2008-10#2)
cadmium sulfide quantum dots##2##4##(2007-11#2)
cadmium sulfide##3##2##(2007-11#2)(2007-12#1)
cadmium sulfur quantum dots##2##4##(2007-12#2)
cadmium sulphide microcrystallite production##4##4##(1996-7#4)
cadmium sulphide##5##2##(1996-7#5)
cadmium using##3##2##(2008-10#3)
cadmium was##4##2##(2008-10#4)
cadmium were##4##2##(1993-12#1)(2008-10#3)
cadmium with##2##2##(2008-10#2)
cadmium##305##1##(1990-5#1)(1991-9#1)(1992-12#7)(1993-12#7)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#5)(1995-5#1)(1996-7#8)(1997-4#13)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#225)(2008-11#7)(2008-12#3)(2008-3#1)(2008-7#6)(2008-8#2)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#2)
cadmium(II) and zinc(II)##3##3##(1991-5#2)(2008-10#1)
cadmium(II) and##7##2##(1991-5#3)(2008-10#4)
cadmium(II) in aqueous##2##3##(2008-10#2)
cadmium(II) with##2##2##(2008-10#2)
cadmium(II)##34##1##(1991-5#4)(2008-10#30)
cadmium-induced lethality##2##2##(1993-12#2)
cadmium-induced renal dysfunction##2##3##(1997-4#2)
cadmium-induced##6##1##(1990-7#1)(1993-12#3)(1997-4#2)
cadmium-metallothionein##2##1##(1995-3#1)(2008-10#1)
cadre of##5##2##(1996-3#1)(2007-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
caeca##2##1##(2007-12#1)(2008-5#1)
caecal microflora##4##2##(1993-8#4)
caecal##8##1##(1993-8#5)(1997-6#1)(2008-5#2)
caecum##3##1##(1993-9#1)(2008-10#1)(2012-2#1)
caerulein##4##1##(1993-6#4)
caeruloplasmin##2##1##(1993-2#2)
caesarean section and##2##3##(1993-10#1)(2012-3#1)
caesarean section was performed##2##4##(1992-5#1)(2012-8#1)
caesarean section was##3##3##(1992-5#1)(2011-2#1)(2012-8#1)
caesarean section##26##2##(1990-12#1)(1992-5#1)(1993-10#3)(1994-3#2)(1994-7#1)(1996-11#1)(2006-10#1)(2008-7#2)(2009-7#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#2)
caesarean sections at##2##3##(1992-11#1)(1994-3#1)
caesarean sections##4##2##(1992-11#1)(1994-3#2)(2008-11#1)
caesarean##34##1##(1990-12#1)(1992-11#1)(1992-5#1)(1993-10#3)(1993-12#1)(1994-3#4)(1994-7#1)(1995-12#1)(1996-11#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#3)
caesium in##2##2##(1992-3#2)
caesium##4##1##(1992-3#4)
cafeteria diet control##2##3##(2013-1#2)
cafeteria diet##6##2##(2013-1#6)
cafeteria##10##1##(1992-1#3)(1996-2#1)(2013-1#6)
caffeic acid and##4##3##(2008-10#2)(2012-1#1)(2013-1#1)
caffeic acid##22##2##(2007-7#1)(2008-10#9)(2008-11#5)(2008-5#1)(2009-12#2)(2012-1#1)(2013-1#3)
caffeic and quinic acids##3##4##(2008-11#3)
caffeic and##4##2##(2008-11#4)
caffeic##29##1##(2007-7#1)(2008-10#12)(2008-11#9)(2008-5#1)(2009-12#2)(2012-1#1)(2013-1#3)
caffeine (CF)##2##2##(2008-10#2)
caffeine and nicotine in##3##4##(2009-7#3)
caffeine and nicotine##4##3##(2009-7#4)
caffeine and non-steroidal anti-inflammatory drugs##2##5##(2008-10#2)
caffeine and##10##2##(2008-10#4)(2008-5#1)(2009-7#5)
caffeine in##8##2##(1995-8#1)(1996-5#1)(2008-10#5)(2008-5#1)
caffeine on##6##2##(1995-11#5)(2008-5#1)
caffeine sensor##2##2##(2008-10#2)
caffeine solution was##2##3##(2008-10#2)
caffeine to##2##2##(1995-8#1)(2008-10#1)
caffeine##77##1##(1990-2#1)(1991-1#3)(1992-7#1)(1995-11#5)(1995-8#9)(1996-11#2)(1996-5#2)(2008-10#30)(2008-5#12)(2008-6#1)(2008-8#1)(2009-7#6)(2010-9#2)(2011-2#1)(2013-1#1)
caffeine-induced##2##1##(1991-2#1)(1996-5#1)
café##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
caféine##2##1##(2013-1#2)
cagA-/vacA+##2##1##(2008-12#2)
cage and##2##2##(1996-2#1)(2008-10#1)
cage compounds##2##2##(1996-5#2)
cage distortion##2##2##(2007-11#2)
cage overgrowth##2##2##(2012-2#2)
cage to##2##2##(2008-11#1)(2010-5#1)
cage##37##1##(1994-8#1)(1996-2#3)(1996-5#2)(2007-11#5)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#2)(2012-2#4)(2013-1#1)
caged cADPR was##2##3##(1995-3#2)
caged cADPR##3##2##(1995-3#3)
caged molecules##2##2##(2008-4#2)
caged with##3##2##(2008-10#3)
caged##21##1##(1991-12#1)(1994-6#1)(1995-2#1)(1995-3#3)(2008-10#4)(2008-4#5)(2008-8#1)(2009-10#1)(2009-3#2)(2010-4#2)
cages (PVC pipe##2##3##(2008-10#2)
cages were##4##2##(2008-10#4)
cages##21##1##(1992-11#1)(1992-3#1)(1993-6#1)(1996-3#1)(1996-5#3)(1997-4#1)(2008-10#10)(2008-7#1)(2010-2#1)(2010-4#1)
caja (Spondias mombin L##2##4##(2012-2#2)
cajan (L##2##2##(2008-10#1)(2010-3#1)
cajan##3##1##(2008-10#1)(2010-10#1)(2010-3#1)
cajani##2##1##(2008-10#2)
cakes##6##1##(2012-2#6)
cal mol-1##2##2##(1995-5#1)(1997-2#1)
cal/mol##2##1##(1990-11#1)(2008-11#1)
calamity##3##1##(2008-10#2)(2008-6#1)
calanolide A##3##2##(1992-8#3)
calanolide B (4)##2##3##(1992-8#2)
calanolide##6##1##(1992-8#6)
calanolides##3##1##(1992-8#3)
calbindin##5##1##(1994-2#1)(1995-5#1)(1996-5#1)(2012-3#1)(2013-8#1)
calbindin-D28k##7##1##(1993-12#6)(1994-2#1)
calcaneal fracture##6##2##(2007-11#1)(2010-3#1)(2012-2#4)
calcaneal fractures##3##2##(2007-11#1)(2007-8#1)(2012-2#1)
calcaneal intraosseous lipoma##2##3##(2010-3#2)
calcaneal intraosseous lipomas##2##3##(2010-3#2)
calcaneal intraosseous##4##2##(2010-3#4)
calcaneal##18##1##(2007-11#2)(2007-8#2)(2010-3#8)(2012-2#6)
calcaneo-valgus foot##2##2##(2010-3#2)
calcaneo-valgus##3##1##(2010-3#3)
calcaneocuboid joint##2##2##(2009-10#2)
calcaneocuboid##3##1##(2009-10#2)(2012-2#1)
calcaneum##3##1##(2010-3#2)(2012-2#1)
calcaneus##7##1##(2007-11#2)(2007-8#3)(2009-10#1)(2010-11#1)
calcar femorale##2##2##(2007-11#2)
calcar loading and##2##3##(2009-4#2)
calcar##8##1##(2007-11#5)(2008-7#1)(2009-4#2)
calcareous soil##3##2##(2012-6#2)(2012-9#1)
calcareous##10##1##(1990-11#1)(2008-12#1)(2012-6#5)(2012-9#3)
calcein##7##1##(1994-11#2)(2008-10#4)(2008-4#1)
calcemia levels##2##2##(1990-9#2)
calcific aortic stenosis##4##3##(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
calcific aortic##6##2##(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
calcific deposits##3##2##(2012-12#3)
calcific##12##1##(1992-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
calcification and##4##2##(1990-3#1)(2008-6#1)(2010-3#1)(2012-3#1)
calcification in the##2##3##(2008-7#1)(2009-11#1)
calcification in two##2##3##(2008-4#2)
calcification in##7##2##(2008-4#3)(2008-7#1)(2009-11#1)(2010-3#1)(2012-12#1)
calcification of the falx cerebri##2##5##(1997-3#2)
calcification of the##4##3##(1990-11#2)(1997-3#2)
calcification of##6##2##(1990-11#2)(1997-3#2)(2009-12#1)(2012-12#1)
calcification##43##1##(1990-11#3)(1990-3#1)(1990-6#1)(1991-3#1)(1991-9#1)(1992-6#1)(1997-3#2)(2007-11#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#2)(2009-1#2)(2009-11#3)(2009-12#1)(2009-4#1)(2010-3#2)(2010-6#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
calcification-induced changes in##2##3##(2008-3#2)
calcifications and##2##2##(2008-12#1)(2008-7#1)
calcifications in##2##2##(1997-3#1)(2012-2#1)
calcifications within the##2##3##(2011-2#2)
calcifications within##3##2##(2008-7#1)(2011-2#2)
calcifications##20##1##(1996-3#1)(1997-3#1)(1997-8#6)(2008-12#1)(2008-7#2)(2009-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#1)
calcified nodules##2##2##(2008-11#1)(2012-12#1)
calcified tissues and##2##3##(1991-5#1)(2008-11#1)
calcified tissues##9##2##(1991-2#1)(1991-5#1)(2008-11#3)(2008-3#3)(2013-8#1)
calcified##34##1##(1991-2#1)(1991-3#2)(1991-5#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-3#5)(2009-5#1)(2009-7#2)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#2)
calcifying tendinitis##2##2##(1991-4#1)(1997-6#1)
calcifying tendonitis##2##2##(2012-12#2)
calcifying##5##1##(1991-11#1)(1991-4#1)(1997-6#1)(2012-12#2)
calcination in##2##2##(2008-10#2)
calcination##4##1##(2008-10#3)(2009-11#1)
calcined at##4##2##(2008-10#3)(2009-8#1)
calcined##5##1##(2008-10#3)(2009-8#1)(2013-1#1)
calcineurin inhibitors##4##2##(2008-1#2)(2008-8#1)(2012-3#1)
calcineurin##15##1##(1991-9#3)(1995-3#3)(2007-11#1)(2008-1#2)(2008-3#1)(2008-8#1)(2008-9#2)(2011-3#1)(2012-3#1)
calcining##2##1##(2009-8#1)(2013-8#1)
calcinosis##2##1##(2008-3#1)(2008-8#1)
calciotrophic hormones##4##2##(1990-11#4)
calcipotriol##3##1##(1993-11#1)(1995-5#2)
calcite##14##1##(1990-11#1)(1997-4#1)(2008-10#9)(2008-2#2)(2013-1#1)
calcitic##3##1##(1997-4#3)
calcitonin and##3##2##(1990-2#1)(1992-6#1)(1993-11#1)
calcitonin binding sites##2##3##(1990-2#2)
calcitonin binding##3##2##(1990-2#2)(1993-11#1)
calcitonin gene##5##2##(1990-12#2)(1990-2#2)(1992-9#1)
calcitonin gene-related peptide (CGRP)##7##4##(1990-7#1)(1993-3#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-4#2)
calcitonin gene-related peptide##25##3##(1990-7#2)(1991-1#1)(1992-6#10)(1993-3#2)(1994-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-2#1)(2008-4#2)(2013-1#1)(2013-8#1)
calcitonin gene-related##27##2##(1990-7#2)(1991-1#1)(1992-6#10)(1993-3#2)(1994-8#2)(1997-1#1)(1997-3#3)(1997-4#1)(2007-2#1)(2008-4#2)(2013-1#1)(2013-8#1)
calcitonin is##2##2##(1993-11#1)(1993-6#1)
calcitonin levels##2##2##(1990-12#2)
calcitonin may prevent##2##3##(1993-11#2)
calcitonin##75##1##(1990-12#6)(1990-2#8)(1990-7#2)(1990-9#1)(1991-1#1)(1992-6#15)(1992-9#1)(1993-11#15)(1993-3#2)(1993-6#2)(1994-8#2)(1995-3#1)(1997-1#1)(1997-3#3)(1997-4#2)(2007-2#1)(2007-8#1)(2008-4#4)(2008-5#2)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
calcitonin-producing##2##1##(1993-6#2)
calcitonin/CGRP gene##2##2##(1992-6#2)
calcitonin/alpha-CGRP and beta-CGRP genes##3##4##(1992-6#3)
calcitonin/alpha-CGRP##6##1##(1992-6#6)
calcitonins were##2##2##(2008-5#2)
calcitonins##4##1##(2008-5#4)
calcitriol##8##1##(1991-3#1)(1993-3#1)(2008-1#5)(2011-1#1)
calcium (0##2##2##(1993-11#1)(1994-3#1)
calcium (Ca)##5##2##(1995-8#1)(1997-7#1)(2011-1#3)
calcium (Ca2+)##2##2##(1991-1#1)(1996-12#1)
calcium ([Ca2+]i)##2##2##(1994-11#1)(1994-9#1)
calcium 2##2##2##(2008-1#1)(2008-4#1)
calcium abolished the##2##3##(1990-12#1)(1994-6#1)
calcium across##2##2##(1990-2#1)(2008-4#1)
calcium alginate##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
calcium and 500 IU vitamin D/250 mL)##2##6##(2013-7#2)
calcium and cadmium##3##3##(2008-10#3)
calcium and filamentous actin##2##4##(1994-6#2)
calcium and magnesium in water samples##2##6##(2008-10#2)
calcium and magnesium in##7##4##(2008-10#6)(2010-12#1)
calcium and magnesium ions##3##4##(2008-10#3)
calcium and magnesium##20##3##(1991-5#1)(2008-10#17)(2008-3#1)(2010-12#1)
calcium and pH##3##3##(1990-2#2)(1993-5#1)
calcium and phosphorus##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
calcium and potassium##2##3##(1996-2#1)(2008-10#1)
calcium and the##2##3##(1993-12#1)(1994-7#1)
calcium and##67##2##(1990-2#4)(1990-5#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#2)(1994-7#1)(1995-11#1)(1996-2#1)(1997-8#2)(2008-10#27)(2008-3#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
calcium and/or##2##2##(2008-10#1)(2008-4#1)
calcium antagonists and##3##3##(1990-2#1)(1994-9#1)(2008-10#1)
calcium antagonists##18##2##(1990-2#2)(1990-6#1)(1991-5#1)(1991-8#2)(1992-2#1)(1994-9#5)(1995-12#1)(1996-5#2)(2008-10#1)(2008-7#2)
calcium are##2##2##(2008-10#1)(2009-8#1)
calcium as##3##2##(1992-9#1)(1995-11#1)(1997-7#1)
calcium ascorbate##2##2##(2008-5#2)
calcium at##4##2##(1990-7#1)(1994-11#1)(1997-7#1)(2008-4#1)
calcium atomic beam##2##3##(2008-3#2)
calcium binding protein##2##3##(2009-4#1)(2012-1#1)
calcium binding to##2##3##(2008-10#1)(2013-8#1)
calcium binding##10##2##(1990-7#2)(1995-6#1)(2008-10#4)(2009-4#1)(2012-1#1)(2013-8#1)
calcium but not##2##3##(1994-11#1)(1995-11#1)
calcium by##2##2##(1991-8#1)(2008-8#1)
calcium can##2##2##(1994-3#1)(2008-9#1)
calcium carbonate and##2##3##(2011-2#2)
calcium carbonate polymorphs##2##3##(2008-10#2)
calcium carbonate##19##2##(1990-11#1)(2008-10#9)(2008-7#1)(2011-2#7)(2012-12#1)
calcium channel activity##3##3##(1994-9#2)(2008-8#1)
calcium channel antagonists##2##3##(1994-11#1)(2008-10#1)
calcium channel blockade##2##3##(1993-6#1)(2008-2#1)
calcium channel blocker##6##3##(1992-8#2)(1996-5#1)(2008-5#1)(2008-7#2)
calcium channel blockers (CCB)##2##4##(2008-10#1)(2008-7#1)
calcium channel blockers and##2##4##(2008-11#1)(2008-7#1)
calcium channel blockers such as##2##5##(1993-3#1)(1994-8#1)
calcium channel blockers were##2##4##(1992-8#1)(2010-5#1)
calcium channel blockers##23##3##(1990-7#1)(1992-8#2)(1993-3#1)(1994-8#1)(1996-5#1)(1996-6#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-7#2)(2008-8#3)(2010-5#2)(2012-12#1)
calcium channel currents in vascular smooth muscle cells##2##8##(1992-12#2)
calcium channel currents in##3##4##(1992-12#2)(1993-12#1)
calcium channel currents was##2##4##(1993-12#2)
calcium channel currents with##2##4##(1992-12#1)(1993-12#1)
calcium channel currents##9##3##(1992-12#4)(1993-12#5)
calcium channel##62##2##(1990-12#1)(1990-7#1)(1992-12#4)(1992-8#4)(1993-11#2)(1993-12#5)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-3#2)(1996-5#2)(1996-6#2)(1997-4#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#7)(2010-5#2)(2012-12#2)(2013-1#1)
calcium channels are##2##3##(2008-8#2)
calcium channels in the##3##4##(1993-9#1)(1995-3#1)(2008-8#1)
calcium channels in##7##3##(1992-12#1)(1993-9#2)(1995-3#1)(1996-2#1)(2008-8#2)
calcium channels with##2##3##(1993-11#1)(2008-9#1)
calcium channels##31##2##(1992-12#2)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#2)(1994-6#1)(1995-3#3)(1996-2#1)(1996-5#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-8#12)(2008-9#1)(2012-3#1)
calcium chelator##3##2##(1993-12#1)(2008-10#1)(2008-8#1)
calcium chelators##3##2##(1992-6#2)(1995-2#1)
calcium chloride##6##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)
calcium concentration ([Ca2+]i)##4##3##(1990-5#1)(1992-6#2)(1992-9#1)
calcium concentration in biological##2##4##(2008-10#1)(2013-8#1)
calcium concentration in##10##3##(1992-6#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-10#4)(2013-8#1)
calcium concentration##35##2##(1990-2#2)(1990-5#1)(1991-12#3)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#3)(1994-6#2)(1995-2#2)(1995-8#3)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
calcium concentrations##10##2##(1990-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-9#1)(2008-8#2)(2009-8#1)(2011-2#1)
calcium content (TCa)##2##3##(1997-4#2)
calcium content##7##2##(1996-9#1)(1997-4#2)(2008-10#2)(2011-1#2)
calcium dependence##2##2##(1992-3#1)(1992-8#1)
calcium dependent##2##2##(2008-4#2)
calcium efflux from##2##3##(1990-2#2)
calcium efflux##4##2##(1990-2#4)
calcium entry blockers##2##3##(1990-3#1)(1993-6#1)
calcium entry##6##2##(1990-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-4#2)
calcium flux##2##2##(1991-1#1)(2008-9#1)
calcium for##4##2##(1995-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
calcium from##3##2##(1991-8#1)(1995-11#1)(2008-4#1)
calcium homeostasis in##2##3##(1995-3#1)(1997-2#1)
calcium homeostasis##8##2##(1991-9#1)(1995-3#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)
calcium hydroxide##6##2##(2008-10#2)(2013-1#4)
calcium hydroxylapatite##4##2##(2008-10#4)
calcium imaging##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
calcium in human##3##3##(1993-12#2)(2008-10#1)
calcium in the##7##3##(1991-2#1)(1993-11#1)(1994-3#1)(1995-11#1)(2008-10#1)(2010-12#1)(2012-3#1)
calcium in##21##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-11#1)(1995-5#1)(2008-1#1)(2008-10#5)(2008-8#1)(2010-12#1)(2012-3#1)
calcium independent##2##2##(1993-8#1)(1994-12#1)
calcium indicators##3##2##(1991-5#1)(2008-4#2)
calcium induced##2##2##(1993-3#1)(1994-8#1)
calcium influx and##3##3##(1993-11#2)(2010-5#1)
calcium influx in##2##3##(1993-11#1)(1994-5#1)
calcium influx##11##2##(1993-11#3)(1994-11#1)(1994-5#1)(1996-5#1)(1996-9#2)(2007-11#1)(2008-4#1)(2010-5#1)
calcium intake##2##2##(1993-11#2)
calcium ion concentration##2##3##(1995-12#1)(2009-12#1)
calcium ion##11##2##(1990-2#1)(1990-5#1)(1992-9#1)(1993-8#1)(1995-12#1)(1997-4#1)(1997-7#1)(2009-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
calcium ionophore A23187##4##3##(1993-8#1)(1994-11#1)(2008-10#1)(2008-8#1)
calcium ionophore##16##2##(1990-12#1)(1990-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
calcium ions##16##2##(1990-7#1)(1995-11#2)(1995-2#1)(1995-8#2)(1997-4#1)(1997-7#1)(2008-10#5)(2008-9#1)(2009-12#2)
calcium is##4##2##(1990-2#1)(1997-8#2)(2008-8#1)
calcium lactate##3##2##(2010-4#2)(2011-1#1)
calcium level##2##2##(1995-11#1)(2008-5#1)
calcium levels were##2##3##(1991-8#1)(2008-10#1)
calcium levels##6##2##(1991-5#1)(1991-8#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
calcium loss##2##2##(2011-1#2)
calcium medium##2##2##(1994-3#1)(2008-5#1)
calcium metabolism are##2##3##(1991-12#1)(1992-9#1)
calcium metabolism##3##2##(1991-12#1)(1992-9#1)(2008-4#1)
calcium mobilization and##3##3##(1990-5#1)(1993-11#1)(2008-4#1)
calcium mobilization##12##2##(1990-5#2)(1990-8#1)(1993-11#2)(1993-6#1)(1995-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
calcium on the##3##3##(1990-8#1)(1991-12#1)(1994-6#1)
calcium oscillations in##3##3##(1993-5#1)(1994-11#2)
calcium oscillations##4##2##(1993-5#1)(1994-11#3)
calcium overload##6##2##(1991-2#1)(2008-1#1)(2010-3#3)(2011-2#1)
calcium oxalate crystals##2##3##(1992-5#1)(1992-9#1)
calcium oxalate stone formation##2##4##(1992-9#2)
calcium oxalate stone##3##3##(1991-12#1)(1992-9#2)
calcium oxalate##15##2##(1991-12#2)(1992-5#3)(1992-9#4)(1993-3#2)(1995-8#1)(2008-10#3)
calcium phosphate discs##2##3##(2012-1#2)
calcium phosphate##11##2##(1995-11#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2012-1#4)
calcium release from intracellular stores##2##5##(1990-12#1)(1994-11#1)
calcium release from##3##3##(1990-12#1)(1991-2#1)(1994-11#1)
calcium release##7##2##(1990-12#1)(1990-8#1)(1991-2#2)(1993-8#1)(1994-11#1)(1994-8#1)
calcium removal##4##2##(2008-8#4)
calcium response evoked by##2##4##(2008-4#2)
calcium response##6##2##(1995-11#1)(2008-4#5)
calcium responses##2##2##(1994-2#1)(2008-4#1)
calcium salt##2##2##(2008-10#1)(2010-4#1)
calcium selective##2##2##(2008-10#2)
calcium sensors##2##2##(2008-10#1)(2008-4#1)
calcium should##2##2##(1990-2#1)(2008-10#1)
calcium signal##3##2##(1994-9#1)(2008-8#1)(2008-9#1)
calcium signaling##6##2##(2008-11#1)(2008-8#1)(2009-12#2)(2009-6#1)(2009-7#1)
calcium signalling##2##2##(1995-5#1)(2008-4#1)
calcium signals##4##2##(1992-12#1)(1995-2#1)(1996-12#1)(2010-11#1)
calcium silicate##2##2##(2008-10#2)
calcium sulfate##2##2##(2007-12#1)(2010-6#1)
calcium supplements##3##2##(1993-11#1)(2008-10#1)(2011-1#1)
calcium to##5##2##(1991-6#1)(1992-3#1)(1994-3#1)(1995-2#1)(2011-2#1)
calcium transients##2##2##(2008-8#2)
calcium transport##2##2##(1996-5#2)
calcium upon##2##2##(1995-11#1)(2008-9#1)
calcium uptake by##2##3##(1996-5#1)(2008-8#1)
calcium uptake in##2##3##(1997-1#1)(2013-8#1)
calcium uptake##5##2##(1996-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
calcium was##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
calcium were##4##2##(1990-7#1)(1995-8#1)(2008-10#1)(2012-2#1)
calcium with a single##2##4##(2008-10#2)
calcium with##6##2##(1993-12#1)(1997-7#1)(2008-10#4)
calcium##829##1##(1990-11#2)(1990-12#6)(1990-2#30)(1990-3#3)(1990-5#7)(1990-6#1)(1990-7#10)(1990-8#6)(1990-9#1)(1991-1#3)(1991-11#4)(1991-12#13)(1991-2#6)(1991-3#1)(1991-5#6)(1991-6#4)(1991-8#7)(1991-9#4)(1992-12#11)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#8)(1992-8#5)(1992-9#12)(1993-11#18)(1993-12#12)(1993-2#1)(1993-3#7)(1993-5#3)(1993-6#12)(1993-8#6)(1993-9#3)(1994-11#13)(1994-12#1)(1994-2#9)(1994-3#12)(1994-5#3)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#11)(1995-11#22)(1995-12#5)(1995-2#11)(1995-3#9)(1995-5#2)(1995-6#1)(1995-8#11)(1996-11#1)(1996-12#2)(1996-2#4)(1996-5#9)(1996-6#2)(1996-9#8)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#8)(1997-5#2)(1997-7#10)(1997-8#4)(2007-11#2)(2007-12#3)(2007-5#4)(2007-8#1)(2008-1#10)(2008-10#144)(2008-11#14)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#41)(2008-5#10)(2008-6#1)(2008-7#14)(2008-8#44)(2008-9#10)(2009-10#1)(2009-12#7)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#11)(2011-2#15)(2012-1#5)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#8)
calcium)##5##1##(1994-2#1)(2007-8#1)(2008-10#2)(2010-9#1)
calcium- and##4##2##(1992-9#1)(1995-11#1)(1997-4#1)(2013-7#1)
calcium-activated##3##1##(1995-11#1)(1997-2#1)(2010-11#1)
calcium-antagonists##2##1##(1993-2#1)(2006-8#1)
calcium-based binders##3##2##(2012-12#3)
calcium-based##5##1##(2008-3#1)(2012-12#4)
calcium-binding protein##4##2##(1993-12#1)(2009-7#3)
calcium-binding proteins##3##2##(1995-5#1)(1996-5#1)(1997-2#1)
calcium-binding sites on##2##3##(1991-5#2)
calcium-binding##12##1##(1991-5#2)(1993-12#2)(1994-5#2)(1995-5#1)(1996-5#1)(1997-2#1)(2009-7#3)
calcium-channel blockers##7##2##(1992-12#1)(1994-8#1)(2008-11#1)(2008-7#2)(2009-6#2)
calcium-channel##8##1##(1992-12#1)(1994-8#1)(2008-11#2)(2008-7#2)(2009-6#2)
calcium-dependent and##2##2##(1993-3#1)(1995-11#1)
calcium-dependent protease##2##2##(1994-5#1)(1995-3#1)
calcium-dependent protein kinase##2##3##(1993-11#2)
calcium-dependent##17##1##(1990-5#1)(1992-3#1)(1993-11#2)(1993-3#1)(1994-5#2)(1994-6#2)(1995-11#1)(1995-3#1)(1995-8#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)
calcium-free medium##2##2##(1990-12#1)(1992-3#1)
calcium-free##3##1##(1990-12#1)(1992-3#1)(1992-6#1)
calcium-independent##4##1##(1990-5#1)(1995-11#1)(1995-2#1)(2008-4#1)
calcium-induced amylase release##2##3##(1992-12#2)
calcium-induced##4##1##(1990-11#1)(1990-8#1)(1992-12#2)
calcium-mediated cellular##2##2##(1997-4#2)
calcium-mediated events##2##2##(1997-4#2)
calcium-mediated##8##1##(1992-3#1)(1994-11#1)(1997-4#4)(2008-8#1)(2011-2#1)
calcium-phosphate coating##2##2##(2009-7#2)
calcium-phosphate##3##1##(2009-7#2)(2012-2#1)
calcium-phosphorus product##2##2##(1991-8#1)(2010-5#1)
calcium-regulated##2##1##(2008-4#1)(2009-5#1)
calcium-release##2##1##(1990-2#2)
calcium-selective##3##1##(2008-10#3)
calcium-sensing receptor (CaSR)##2##3##(2008-11#2)
calcium-sensitive##2##1##(1994-2#1)(2008-10#1)
calcium/calmodulin-dependent kinase II##2##3##(1996-12#1)(2009-7#1)
calcium/calmodulin-dependent protein kinase II##7##4##(1995-2#2)(1996-2#3)(2008-8#2)
calcium/calmodulin-dependent protein kinase##8##3##(1990-8#1)(1995-2#2)(1996-2#3)(2008-8#2)
calcium/calmodulin-dependent signaling##2##2##(2008-10#2)
calcium/calmodulin-dependent##12##1##(1990-8#1)(1995-2#2)(1996-12#1)(1996-2#3)(2008-10#2)(2008-8#2)(2009-7#1)
calcium/phosphorus balance##2##2##(1991-11#2)
calculate the absorption##2##3##(2008-3#2)
calculate the cost##2##3##(1992-12#1)(2008-8#1)
calculate the dispersion##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
calculate the distribution##2##3##(2008-3#1)(2008-5#1)
calculate the expected##2##3##(2008-3#1)(2008-7#1)
calculate the number of##2##4##(1997-7#1)(2008-7#1)
calculate the real##2##3##(2008-3#2)
calculate the##129##2##(1990-7#1)(1992-12#1)(1993-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#2)(2007-11#5)(2007-12#9)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#16)(2008-3#31)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)
calculate their##2##2##(1995-1#1)(2008-3#1)
calculate##188##1##(1990-7#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#10)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#8)(2008-12#3)(2008-2#21)(2008-3#40)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
calculated SBLS spectra##2##3##(2008-2#2)
calculated a##6##2##(1992-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
calculated absorption##2##2##(2008-3#2)
calculated according to##4##3##(2006-8#1)(2008-3#2)(2012-2#1)
calculated after##8##2##(1997-7#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-12#1)
calculated along the##2##3##(2008-7#1)(2010-6#1)
calculated and compared with the##2##5##(2008-3#1)(2008-5#1)
calculated and compared with##6##4##(2008-10#1)(2008-3#3)(2008-5#1)(2011-1#1)
calculated and compared##10##3##(2008-1#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
calculated and discussed##2##3##(2008-10#2)
calculated and experimental##3##3##(2008-2#2)(2008-3#1)
calculated and measured##4##3##(2008-2#2)(2008-3#2)
calculated and observed##2##3##(1997-2#1)(2008-3#1)
calculated and the##7##3##(1994-8#1)(2008-10#4)(2008-3#1)(2013-8#1)
calculated and##49##2##(1994-8#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#4)(2008-3#12)(2008-5#1)(2008-6#1)(2008-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
calculated are##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
calculated as 0##2##3##(2008-10#2)
calculated as 3##2##3##(2008-10#1)(2011-2#1)
calculated as a function of##5##5##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
calculated as a##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
calculated as relative standard deviation (R##4##6##(2008-10#4)
calculated as relative standard deviation##5##5##(2008-10#5)
calculated as the difference between total##2##6##(2008-10#2)
calculated as the difference between##4##5##(2008-10#4)
calculated as the difference##5##4##(2008-10#5)
calculated as the ratio of##2##5##(1991-6#1)(2012-1#1)
calculated as the##14##3##(1991-6#1)(2008-10#6)(2008-3#2)(2008-7#1)(2009-11#1)(2012-1#1)(2012-3#1)(2013-7#1)
calculated as three times the standard deviation of the##2##9##(2008-10#2)
calculated as##46##2##(1991-6#1)(1996-12#1)(2007-11#1)(2008-10#24)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-7#2)(2013-7#1)(2013-8#1)
calculated assuming##2##2##(2008-3#1)(2013-7#1)
calculated at the##3##3##(1993-8#1)(2008-12#1)(2008-3#1)
calculated at##12##2##(1993-8#1)(2008-10#5)(2008-12#1)(2008-3#3)(2011-1#1)(2011-2#1)
calculated autocorrelation##2##2##(2008-2#1)(2008-3#1)
calculated based on the##2##4##(2007-12#1)(2008-10#1)
calculated based on##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
calculated based##5##2##(2007-12#1)(2008-10#3)(2008-7#1)
calculated before##2##2##(2007-8#1)(2011-2#1)
calculated between##3##2##(1991-10#1)(2008-10#1)(2008-12#1)
calculated by a##3##3##(1991-5#1)(2008-10#1)(2010-2#1)
calculated by comparing##2##3##(2008-10#1)(2008-7#1)
calculated by difference##2##3##(2008-10#2)
calculated by subtracting##2##3##(2008-10#2)
calculated by the Monte Carlo method##2##6##(2008-2#1)(2008-3#1)
calculated by the##12##3##(1992-12#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2011-3#1)
calculated by use of a##5##5##(2007-12#2)(2008-3#3)
calculated by use of the##7##5##(2008-2#2)(2008-3#5)
calculated by use of##14##4##(2007-12#2)(2008-2#2)(2008-3#10)
calculated by using the##4##4##(2008-10#2)(2009-1#1)(2013-1#1)
calculated by using##5##3##(2008-10#2)(2008-7#1)(2009-1#1)(2013-1#1)
calculated by##71##2##(1991-5#1)(1992-12#1)(1993-3#1)(1995-11#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#16)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#3)(2013-8#1)
calculated conditions##2##2##(2008-10#1)(2008-3#1)
calculated considering##2##2##(2008-10#1)(2008-6#1)
calculated data##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
calculated detection limit##3##3##(2008-10#3)
calculated detection limits##3##3##(2008-10#3)
calculated detection##6##2##(2008-10#6)
calculated dose##2##2##(1995-12#1)(2010-9#1)
calculated for a##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
calculated for all the##2##4##(2008-2#1)(2011-2#1)
calculated for all##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
calculated for an##2##3##(2008-2#1)(2008-3#1)
calculated for both##3##3##(2008-2#1)(2012-12#1)(2012-3#1)
calculated for different##3##3##(2008-3#3)
calculated for each##13##3##(2008-10#7)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
calculated for the four##2##4##(1997-2#1)(2008-3#1)
calculated for the##14##3##(1993-2#1)(1994-1#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
calculated for various##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
calculated for##93##2##(1991-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#10)(2008-3#17)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
calculated from 10##2##3##(2008-10#2)
calculated from a##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
calculated from data##2##3##(2008-10#1)(2010-3#1)
calculated from experimental data##2##4##(2008-10#1)(2008-2#1)
calculated from kinetic data##2##4##(2008-10#2)
calculated from measurements##2##3##(1995-5#1)(2008-3#1)
calculated from the Mie theory##2##5##(2008-3#2)
calculated from the data##3##4##(1990-8#1)(1992-6#1)(2008-10#1)
calculated from the difference between the##2##6##(2008-10#1)(2008-9#1)
calculated from the difference##4##4##(2008-10#3)(2008-9#1)
calculated from the fitting##2##4##(2008-10#2)
calculated from the measured##2##4##(2008-10#1)(2008-2#1)
calculated from the molecular##2##4##(2008-10#2)
calculated from the peak heights obtained##3##6##(2008-10#3)
calculated from the##64##3##(1990-8#2)(1992-2#1)(1992-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#28)(2008-11#2)(2008-2#4)(2008-3#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-5#1)(2012-2#1)
calculated from these##2##3##(1996-2#1)(2008-3#1)
calculated from this##2##3##(1992-8#1)(2008-2#1)
calculated from two##2##3##(2008-3#1)(2008-7#1)
calculated from##121##2##(1990-8#2)(1990-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#53)(2008-11#2)(2008-2#6)(2008-3#21)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-6#1)
calculated giving##2##2##(2008-10#2)
calculated in a##2##3##(2008-2#1)(2008-3#1)
calculated in order to##2##4##(1995-5#1)(2010-8#1)
calculated in the##3##3##(2008-10#1)(2008-2#2)
calculated in this##2##3##(1991-5#1)(2008-1#1)
calculated in##17##2##(1991-10#1)(1991-5#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-8#1)(2010-8#1)(2012-12#2)
calculated molecular weight of##5##4##(1990-12#1)(1990-7#2)(1995-6#1)(2008-8#1)
calculated molecular##9##2##(1990-12#1)(1990-7#2)(1993-3#1)(1995-6#1)(1996-6#1)(2008-4#1)(2008-8#1)(2012-2#1)
calculated number of##2##3##(1996-5#1)(2008-2#1)
calculated on a##2##3##(2008-10#1)(2008-9#1)
calculated on the basis of##6##5##(1990-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
calculated on the##7##3##(1990-5#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-5#1)
calculated on##12##2##(1990-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-5#1)
calculated over##3##2##(2008-10#1)(2009-12#1)(2013-8#1)
calculated phase##3##2##(2007-12#1)(2008-3#2)
calculated rate##2##2##(1991-3#1)(2008-2#1)
calculated ratio##2##2##(2009-1#2)
calculated results##7##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-11#1)
calculated risk##2##2##(1995-8#1)(2009-12#1)
calculated spectra##4##2##(1996-2#1)(2008-2#2)(2008-3#1)
calculated that##4##2##(1994-8#1)(1995-8#1)(2006-6#1)(2008-10#1)
calculated the##15##2##(1990-9#1)(1992-9#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2012-1#1)(2012-5#1)
calculated through##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
calculated to be 0##5##4##(1990-8#1)(2008-10#3)(2008-2#1)
calculated to be 3##2##4##(2008-10#2)
calculated to be 4##3##4##(1993-1#1)(2008-10#2)
calculated to be as##2##4##(2007-10#1)(2008-3#1)
calculated to be##32##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1993-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#16)(2008-2#2)(2008-3#3)(2009-12#1)(2011-1#1)
calculated to evaluate the##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
calculated to##46##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#19)(2008-2#3)(2008-3#6)(2008-7#1)(2009-12#1)(2011-1#2)(2012-12#1)(2012-3#1)
calculated transmission spectra##2##3##(2007-11#1)(2008-3#1)
calculated transmission##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
calculated using a##3##3##(1994-12#1)(2008-3#1)(2008-7#1)
calculated using the##22##3##(1992-12#2)(1995-3#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)
calculated using this##2##3##(1990-12#1)(1994-9#1)
calculated using##47##2##(1990-12#1)(1992-12#2)(1992-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
calculated value##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
calculated values derived##2##3##(2008-10#1)(2008-3#1)
calculated values for##2##3##(2008-3#2)
calculated values of sensitivity##2##4##(2008-10#1)(2008-3#1)
calculated values of##3##3##(2008-10#1)(2008-3#2)
calculated values##11##2##(2008-10#2)(2008-3#8)(2008-5#1)
calculated with Fourier optics##2##4##(2008-2#2)
calculated with a##3##3##(2008-3#3)
calculated with the##6##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
calculated with##23##2##(2007-8#2)(2008-10#6)(2008-2#5)(2008-3#7)(2008-6#1)(2013-1#1)(2013-8#1)
calculated##986##1##(1990-11#1)(1990-12#2)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#4)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#6)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-12#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#6)(1995-5#5)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#2)(1996-5#3)(1996-6#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#14)(2007-12#16)(2007-7#1)(2007-8#10)(2008-1#6)(2008-10#301)(2008-11#15)(2008-12#11)(2008-2#76)(2008-3#166)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#17)(2008-8#17)(2008-9#9)(2009-1#3)(2009-10#1)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#4)(2010-12#1)(2010-2#1)(2010-3#5)(2010-5#5)(2010-6#2)(2010-8#3)(2010-9#4)(2011-1#10)(2011-2#28)(2011-3#3)(2012-1#6)(2012-12#19)(2012-2#11)(2012-3#7)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#16)(2013-7#2)(2013-8#14)
calculates the##9##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
calculates##13##1##(1991-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-7#1)
calculating the average##3##3##(1993-3#1)(1996-8#1)(2008-10#1)
calculating the light##2##3##(2008-3#2)
calculating the scattering##2##3##(2008-3#2)
calculating the##55##2##(1990-12#1)(1993-3#1)(1994-1#1)(1996-12#2)(1996-5#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#10)(2008-3#18)(2008-5#2)(2009-11#1)(2010-4#1)(2010-7#2)(2012-12#1)(2013-8#3)
calculating##101##1##(1990-12#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-1#2)(1994-3#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-8#1)(2007-11#1)(2007-12#3)(2007-7#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#16)(2008-3#23)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
calculation and##4##2##(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#1)
calculation based on the##2##4##(1992-6#1)(2008-5#1)
calculation based on##4##3##(1992-6#1)(2007-11#1)(2008-5#1)(2010-10#1)
calculation by##2##2##(2008-3#2)
calculation for##6##2##(2008-2#2)(2008-3#3)(2012-1#1)
calculation in##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
calculation is##7##2##(1996-6#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
calculation method##4##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
calculation of a##8##3##(1992-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#2)
calculation of average##2##3##(2008-3#1)(2008-5#1)
calculation of light##2##3##(2008-1#1)(2008-3#1)
calculation of normal boiling points##2##5##(2007-11#2)
calculation of optical##2##3##(2008-3#2)
calculation of scalar diffraction in the Fresnel approximation##2##8##(2008-3#2)
calculation of the minimum##2##4##(1996-3#1)(2008-10#1)
calculation of the ratio of the##2##6##(2007-12#1)(2008-3#1)
calculation of the##45##3##(1993-3#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#6)(2008-3#18)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
calculation of##120##2##(1992-12#1)(1992-6#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-11#8)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#23)(2008-12#1)(2008-2#17)(2008-3#37)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2010-12#2)(2010-8#1)(2013-1#2)(2013-8#1)
calculation procedures##2##2##(2008-2#1)(2011-1#1)
calculation results##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
calculation showed that the##2##4##(2008-2#1)(2011-1#1)
calculation skills in##2##3##(2008-11#2)
calculation skills##4##2##(2008-11#3)(2008-12#1)
calculation that##3##2##(1992-9#1)(2008-3#1)(2008-7#1)
calculation time##3##2##(2008-3#3)
calculation was##3##2##(2008-3#2)(2008-8#1)
calculation were##2##2##(1995-12#1)(2011-2#1)
calculation with##3##2##(1995-9#1)(2008-2#1)(2008-3#1)
calculation yields##3##2##(2007-12#2)(2008-2#1)
calculation##241##1##(1992-12#1)(1992-6#4)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#12)(2007-12#6)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#34)(2008-11#6)(2008-12#9)(2008-2#35)(2008-3#62)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#4)(2009-3#1)(2010-10#1)(2010-12#3)(2010-3#3)(2010-8#2)(2011-1#4)(2011-2#5)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#4)
calculational##2##1##(2008-2#1)(2008-3#1)
calculations and##13##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)
calculations are based on##2##4##(2008-10#1)(2008-3#1)
calculations are performed##2##3##(2008-2#1)(2008-3#1)
calculations are presented##2##3##(2008-3#1)(2009-5#1)
calculations are used##2##3##(2008-2#2)
calculations are##17##2##(1994-3#1)(1996-5#1)(2008-10#2)(2008-2#5)(2008-3#6)(2009-5#1)(2010-12#1)
calculations at##2##2##(2008-10#1)(2008-12#1)
calculations based on##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
calculations can##2##2##(2008-11#1)(2008-3#1)
calculations confirm##2##2##(2008-6#1)(2009-5#1)
calculations for a##4##3##(2008-2#1)(2008-3#2)(2010-8#1)
calculations for the##2##3##(2008-3#2)
calculations for##17##2##(2008-2#2)(2008-3#11)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
calculations from a##2##3##(2007-11#1)(2008-3#1)
calculations have been performed to##2##5##(2008-3#1)(2012-3#1)
calculations have been##4##3##(2008-11#1)(2008-3#1)(2010-6#1)(2012-3#1)
calculations in##2##2##(2008-3#1)(2009-12#1)
calculations indicate that the##5##4##(1991-6#1)(2008-2#2)(2010-2#2)
calculations indicate that##7##3##(1991-6#1)(1995-5#1)(2008-2#2)(2008-3#1)(2010-2#2)
calculations indicate##8##2##(1991-6#1)(1995-5#1)(2008-2#2)(2008-3#1)(2010-2#2)(2013-1#1)
calculations is not##2##3##(1996-5#1)(2008-3#1)
calculations is##7##2##(1996-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)
calculations made##2##2##(2008-10#2)
calculations of free-electron densities for intracellular##2##6##(2011-1#2)
calculations of the scattering##2##4##(2008-3#2)
calculations of the##17##3##(1990-8#1)(1991-11#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-3#6)(2009-9#2)
calculations of##45##2##(1990-12#1)(1990-8#1)(1991-11#1)(1993-3#1)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#15)(2008-5#1)(2009-9#3)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#1)
calculations on the##2##3##(1994-3#1)(1996-2#1)
calculations on##6##2##(1994-3#1)(1996-2#1)(2007-11#1)(2010-2#2)(2012-12#1)
calculations performed by##2##3##(2008-3#2)
calculations predict##2##2##(2007-11#2)
calculations provide##2##2##(1992-3#1)(1996-5#1)
calculations reveal##2##2##(1996-2#1)(1996-5#1)
calculations show that the##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)
calculations show that##8##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-12#1)
calculations show##13##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-12#1)
calculations that##3##2##(2008-2#1)(2008-3#2)
calculations the##3##2##(1997-6#1)(2008-2#2)
calculations to##7##2##(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
calculations using the##2##3##(2008-2#1)(2009-9#1)
calculations using##3##2##(2008-10#1)(2008-2#1)(2009-9#1)
calculations was##2##2##(2008-10#1)(2013-1#1)
calculations were carried out##2##4##(2007-11#1)(2008-7#1)
calculations were made##2##3##(2008-10#1)(2008-3#1)
calculations were performed for##2##4##(1995-5#1)(2008-10#1)
calculations were##11##2##(1995-5#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#2)(2013-8#1)
calculations with##5##2##(1996-2#1)(2008-2#2)(2008-3#2)
calculations within the##2##3##(2007-11#1)(2008-3#1)
calculations##310##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#3)(1994-3#3)(1994-5#1)(1995-11#1)(1995-2#2)(1995-5#3)(1996-12#1)(1996-2#9)(1996-3#1)(1996-5#6)(1997-2#1)(1997-6#1)(2006-12#1)(2007-11#18)(2007-12#7)(2008-10#43)(2008-11#8)(2008-12#2)(2008-2#38)(2008-3#91)(2008-5#2)(2008-6#3)(2008-7#3)(2009-12#3)(2009-5#4)(2009-7#1)(2009-9#5)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
calculator##5##1##(2008-11#5)
calculi and##2##2##(2008-1#1)(2008-10#1)
calculi by##2##2##(2007-10#1)(2012-12#1)
calculi is##2##2##(1995-8#1)(2011-1#1)
calculi##18##1##(1991-3#2)(1994-5#1)(1995-8#3)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#3)(2011-1#4)(2012-12#1)
calculous cholecystitis##3##2##(2013-8#3)
calculus and##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
calculus for##2##2##(2008-10#1)(2008-3#1)
calculus in##3##2##(1990-12#1)(1992-6#1)(2008-7#1)
calculus##15##1##(1990-12#1)(1992-6#1)(2008-10#2)(2008-3#3)(2008-7#4)(2009-5#1)(2011-2#1)(2013-1#2)
caldesmon##9##1##(1993-11#2)(1993-8#1)(1994-5#6)
calendar instruments##4##2##(2010-1#4)
calendar period##3##2##(1991-6#1)(1993-9#2)
calendar time##3##2##(1992-9#1)(1994-9#1)(2008-8#1)
calendar year##4##2##(1991-2#1)(1995-12#1)(2012-2#1)(2013-1#1)
calendar years##3##2##(1991-2#2)(1994-6#1)
calendar##24##1##(1991-2#3)(1991-6#1)(1992-3#1)(1992-9#2)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#6)(2012-2#1)(2013-1#1)
calf is##2##2##(1994-7#1)(2007-12#1)
calf serum (FCS)##4##3##(1994-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
calf serum and##2##3##(1990-12#2)
calf serum##18##2##(1990-12#3)(1990-2#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#2)(1994-2#1)(1995-2#1)(2008-11#5)(2008-7#1)(2013-1#1)
calf spleen##2##2##(1994-8#2)
calf thymus DNA (ctDNA)##4##4##(2008-10#4)
calf thymus DNA and fish sperm DNA##2##7##(2008-10#2)
calf thymus DNA and##3##4##(2008-10#3)
calf thymus DNA by##2##4##(1995-2#1)(2008-8#1)
calf thymus DNA##24##3##(1992-2#1)(1995-2#2)(1995-6#1)(2007-11#1)(2008-10#17)(2008-4#1)(2008-8#1)
calf thymus##32##2##(1990-8#2)(1992-2#1)(1992-3#1)(1995-2#2)(1995-3#1)(1995-6#4)(2007-11#1)(2008-10#18)(2008-4#1)(2008-8#1)
calf uterine##3##2##(1990-11#2)(1995-11#1)
calf was##2##2##(1997-5#1)(2008-12#1)
calf##92##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-6#3)(1991-8#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1994-2#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#4)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#1)(2007-2#5)(2008-10#18)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#3)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
calf-thymus DNA##2##2##(1991-5#2)
calgranulin##2##1##(2010-12#2)
caliber##5##1##(1992-1#1)(1993-1#1)(2008-9#2)(2010-8#1)
calibrate the spectral bandwidth##2##4##(2008-3#2)
calibrate the##6##2##(2008-3#5)(2009-12#1)
calibrate##22##1##(1990-2#1)(2008-10#1)(2008-3#13)(2008-4#1)(2008-6#1)(2008-9#2)(2009-12#1)(2012-2#1)(2013-1#1)
calibrated against##2##2##(2007-12#1)(2008-3#1)
calibrated and##2##2##(2008-10#1)(2013-1#1)
calibrated by every 0##2##4##(2013-1#2)
calibrated by##5##2##(2007-11#1)(2008-10#2)(2013-1#2)
calibrated examiner##2##2##(2008-1#1)(2008-12#1)
calibrated for##2##2##(2008-10#1)(2008-2#1)
calibrated in the##3##3##(2008-10#3)
calibrated in##6##2##(2008-10#5)(2008-2#1)
calibrated to the##2##3##(2008-3#1)(2010-9#1)
calibrated to##4##2##(2008-3#2)(2010-9#1)(2012-1#1)
calibrated with a reference##2##4##(1993-9#1)(2008-10#1)
calibrated with a##5##3##(1993-9#1)(2008-10#1)(2008-3#3)
calibrated with##9##2##(1992-7#1)(1993-6#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)
calibrated##71##1##(1990-2#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1997-2#2)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#18)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
calibrating##5##1##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-3#1)
calibration accuracy##4##2##(2008-2#2)(2008-3#2)
calibration against aqueous standards##2##4##(2008-10#2)
calibration against aqueous##3##3##(2008-10#3)
calibration against##4##2##(2008-10#4)
calibration and prediction##2##3##(2008-10#1)(2008-2#1)
calibration and shading correction##2##4##(2008-9#2)
calibration and validation##5##3##(2008-10#5)
calibration and##32##2##(2007-11#1)(2008-10#18)(2008-11#1)(2008-2#6)(2008-3#1)(2008-9#3)(2013-1#2)
calibration applied to##2##3##(2008-10#2)
calibration approach##5##2##(2008-10#4)(2008-3#1)
calibration approaches##4##2##(2008-10#3)(2009-12#1)
calibration are assessed##2##3##(2008-10#1)(2008-3#1)
calibration are##3##2##(2008-10#2)(2008-3#1)
calibration by every 0##2##4##(2013-1#2)
calibration by##8##2##(1991-1#1)(2008-10#5)(2013-1#2)
calibration can be##3##3##(2008-10#2)(2008-3#1)
calibration coefficient##4##2##(2008-10#1)(2008-3#3)
calibration coefficients##3##2##(2008-3#3)
calibration curve and##2##3##(2008-10#2)
calibration curve by##5##3##(2008-10#4)(2008-9#1)
calibration curve for##7##3##(2008-10#6)(2008-8#1)
calibration curve in the range of##2##6##(2008-10#2)
calibration curve in the range##5##5##(2008-10#5)
calibration curve in the##6##4##(2008-10#6)
calibration curve in##7##3##(2008-10#7)
calibration curve is linear from##2##5##(2008-10#2)
calibration curve is linear in the##2##6##(2008-10#2)
calibration curve is linear over a range of##3##8##(2008-10#3)
calibration curve is linear over the concentration range 0##3##9##(2008-10#3)
calibration curve is linear over the##4##6##(2008-10#4)
calibration curve is linear over##8##5##(2008-10#8)
calibration curve is linear##14##4##(2008-10#14)
calibration curve is##20##3##(2008-10#19)(2008-8#1)
calibration curve of##6##3##(2008-10#6)
calibration curve over the range of 0##2##7##(2008-10#2)
calibration curve systems##2##3##(2008-10#2)
calibration curve was 0##3##4##(2008-10#3)
calibration curve was constructed##3##4##(2008-10#3)
calibration curve was linear in the concentration range##2##8##(2008-10#2)
calibration curve was linear in the##4##6##(2008-10#4)
calibration curve was linear over a##2##6##(2008-10#1)(2011-2#1)
calibration curve was linear over the concentration range##5##8##(2008-10#5)
calibration curve was linear over the range 0##2##8##(2008-10#2)
calibration curve was linear over the range##4##7##(2008-10#4)
calibration curve was linear over the##9##6##(2008-10#9)
calibration curve was linear over##11##5##(2008-10#10)(2011-2#1)
calibration curve was linear##20##4##(2008-10#19)(2011-2#1)
calibration curve was obtained in##2##5##(2008-10#2)
calibration curve was obtained with##2##5##(2008-10#2)
calibration curve was obtained##6##4##(2008-10#6)
calibration curve was##40##3##(2008-10#38)(2011-2#1)(2012-2#1)
calibration curve with a##2##4##(2008-10#2)
calibration curve with##4##3##(2008-10#4)
calibration curve##120##2##(1991-5#1)(2008-10#111)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
calibration curves are##4##3##(2008-10#3)(2008-3#1)
calibration curves for##5##3##(1990-8#1)(2008-10#3)(2008-3#1)
calibration curves in the##2##4##(2008-10#2)
calibration curves in##4##3##(2008-10#2)(2010-11#2)
calibration curves of the##2##4##(2008-10#1)(2012-3#1)
calibration curves of##6##3##(2008-10#3)(2008-2#1)(2012-1#1)(2012-3#1)
calibration curves showed good linearity##2##5##(2008-10#1)(2011-1#1)
calibration curves showed good##3##4##(2008-10#2)(2011-1#1)
calibration curves showed##4##3##(2008-10#3)(2011-1#1)
calibration curves were##13##3##(2008-10#13)
calibration curves##56##2##(1990-8#1)(2008-10#44)(2008-2#1)(2008-3#4)(2009-8#1)(2010-11#2)(2011-1#1)(2012-1#1)(2012-3#1)
calibration data and##2##3##(2008-2#1)(2010-3#1)
calibration data in the##2##4##(2007-12#1)(2008-10#1)
calibration data##6##2##(2007-12#2)(2008-10#1)(2008-2#2)(2010-3#1)
calibration dependencies##2##2##(2008-10#2)
calibration equation##4##2##(2008-10#2)(2008-2#2)
calibration equations##3##2##(2007-12#1)(2008-10#2)
calibration error##3##2##(2008-3#3)
calibration errors of##2##3##(2007-12#1)(2008-2#1)
calibration errors##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
calibration established##2##2##(2008-10#2)
calibration experiments##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
calibration for each##2##3##(2008-10#2)
calibration for the##10##3##(1992-11#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-9#1)
calibration for##18##2##(1992-11#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-9#2)
calibration from##3##2##(2008-3#3)
calibration function##4##2##(2008-10#4)
calibration functions##4##2##(2008-2#3)(2010-11#1)
calibration graph for the determination of##2##6##(2008-10#2)
calibration graph for##7##3##(2008-10#7)
calibration graph is linear in the range of##4##8##(2008-10#4)
calibration graph is linear in the range##5##7##(2008-10#5)
calibration graph is linear over the range##3##7##(2008-10#3)
calibration graph is linear over the##4##6##(2008-10#4)
calibration graph is linear up to##2##6##(2008-10#2)
calibration graph is linear##11##4##(2008-10#11)
calibration graph is##17##3##(2008-10#17)
calibration graph was linear from##6##5##(2008-10#6)
calibration graph was linear in the range 0##3##8##(2008-10#3)
calibration graph was linear in the range of##4##8##(2008-10#4)
calibration graph was linear in the range##10##7##(2008-10#10)
calibration graph was linear in the##13##6##(2008-10#13)
calibration graph was linear over the range of##2##8##(2008-10#2)
calibration graph was linear over the range##5##7##(2008-10#5)
calibration graph was linear over##7##5##(2008-10#7)
calibration graph was linear up to##4##6##(2008-10#4)
calibration graph was linear##31##4##(2008-10#31)
calibration graph was obtained over the##4##6##(2008-10#4)
calibration graph was obtained##15##4##(2008-10#15)
calibration graph was##48##3##(2008-10#48)
calibration graph##96##2##(2008-10#96)
calibration graphs based on##2##4##(2008-10#2)
calibration graphs for##4##3##(2008-10#4)
calibration graphs obtained##2##3##(2008-10#2)
calibration graphs of##3##3##(2008-10#3)
calibration graphs were linear in the concentration ranges of##2##9##(2008-10#2)
calibration graphs were linear in the concentration##3##7##(2008-10#3)
calibration graphs were linear in the range of##3##8##(2008-10#3)
calibration graphs were linear in the##6##6##(2008-10#6)
calibration graphs were linear over the##2##6##(2008-10#2)
calibration graphs were linear##11##4##(2008-10#11)
calibration graphs were obtained in the range##2##7##(2008-10#2)
calibration graphs were obtained over the##3##6##(2008-10#3)
calibration graphs were obtained##10##4##(2008-10#10)
calibration graphs were##28##3##(2008-10#28)
calibration graphs with##2##3##(2008-10#2)
calibration graphs##59##2##(2008-10#59)
calibration has been##2##3##(2008-10#1)(2008-6#1)
calibration in a##2##3##(1992-11#1)(2008-10#1)
calibration in the##6##3##(2008-10#6)
calibration in##14##2##(1992-11#1)(2008-10#12)(2008-3#1)
calibration is performed##2##3##(2008-10#1)(2008-3#1)
calibration is##12##2##(1997-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-6#1)(2010-3#1)
calibration line##5##2##(2007-12#1)(2008-10#4)
calibration lines##5##2##(2008-10#3)(2008-3#2)
calibration matrix was##3##3##(2008-10#3)
calibration matrix were##2##3##(2008-10#2)
calibration matrix##13##2##(2008-10#12)(2008-3#1)
calibration measurements##2##2##(2008-3#2)
calibration method based on##3##4##(2008-10#3)
calibration method is##3##3##(2008-10#3)
calibration method was##2##3##(2008-10#2)
calibration method with##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
calibration method##27##2##(2008-10#17)(2008-2#5)(2008-3#3)(2008-9#1)(2010-3#1)
calibration methodology##2##2##(2008-10#2)
calibration methods such as##2##4##(2008-10#2)
calibration methods to##3##3##(2008-10#3)
calibration methods##24##2##(2008-1#2)(2008-10#20)(2008-3#1)(2013-8#1)
calibration model for##3##3##(2008-10#3)
calibration model has##2##3##(2007-12#1)(2008-10#1)
calibration model was obtained##2##4##(2008-10#2)
calibration model##28##2##(2007-12#4)(2008-10#24)
calibration models for##2##3##(2008-10#2)
calibration models##11##2##(2007-12#1)(2008-10#10)
calibration of a dynamic surface tension detector##2##7##(2008-10#2)
calibration of a##9##3##(1997-8#1)(2008-10#5)(2008-3#3)
calibration of mixtures##2##3##(2008-10#2)
calibration of the Sea-viewing Wide##2##5##(2008-3#2)
calibration of the SeaWiFS##2##4##(2008-3#2)
calibration of the instrument##4##4##(2008-2#2)(2008-3#2)
calibration of the moderate-resolution imaging##2##5##(2008-3#2)
calibration of the##37##3##(1991-5#1)(2008-10#4)(2008-2#10)(2008-3#19)(2008-4#1)(2008-9#1)(2010-3#1)
calibration of##70##2##(1991-5#1)(1997-8#1)(2007-11#1)(2008-10#20)(2008-2#14)(2008-3#29)(2008-4#2)(2008-9#1)(2010-3#1)
calibration or##2##2##(1994-12#1)(2008-10#1)
calibration parameters##6##2##(1995-9#3)(2008-3#3)
calibration plot for##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
calibration plot is##2##3##(2008-10#2)
calibration plot of##4##3##(2008-10#4)
calibration plot##14##2##(1992-11#1)(2008-10#12)(2008-6#1)
calibration plots are##2##3##(2008-10#2)
calibration plots for##4##3##(2008-10#4)
calibration plots were##3##3##(2008-10#3)
calibration plots##17##2##(2008-10#17)
calibration precision limits##2##3##(2008-10#2)
calibration problem##2##2##(1997-8#2)
calibration problems##2##2##(2008-10#1)(2008-2#1)
calibration procedure for##2##3##(2008-10#2)
calibration procedure##14##2##(2008-10#6)(2008-2#1)(2008-3#6)(2012-1#1)
calibration procedures##4##2##(2008-10#2)(2008-3#2)
calibration protocol##2##2##(2008-3#2)
calibration range for##2##3##(2008-10#2)
calibration range of##4##3##(2008-10#4)
calibration range was##7##3##(2008-10#7)
calibration range##27##2##(2008-10#26)(2009-8#1)
calibration ranges for##2##3##(1995-3#1)(2008-10#1)
calibration ranges##5##2##(1995-3#1)(2008-10#4)
calibration rate##2##2##(2013-1#2)
calibration recovery##3##2##(2008-10#3)
calibration requirement##2##2##(2008-2#2)
calibration results##2##2##(2008-10#1)(2008-3#1)
calibration samples##4##2##(2008-10#4)
calibration set and##3##3##(2007-12#1)(2008-10#2)
calibration set was composed##3##4##(2008-10#3)
calibration set was##5##3##(2008-10#5)
calibration set##21##2##(2007-12#7)(2008-10#14)
calibration slope of##2##3##(2008-10#2)
calibration solutions##5##2##(2008-10#5)
calibration source##2##2##(2008-3#2)
calibration spectra##3##2##(2007-11#1)(2007-12#2)
calibration standard##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
calibration standards##6##2##(2008-10#6)
calibration steps##2##2##(2008-2#1)(2008-3#1)
calibration straight lines##2##3##(2008-10#2)
calibration strategy##2##2##(2008-10#2)
calibration system that##2##3##(2007-11#1)(2008-3#1)
calibration system##4##2##(2007-11#1)(2008-3#2)(2008-8#1)
calibration technique based on##2##4##(2008-10#1)(2008-3#1)
calibration technique for the##2##4##(2008-10#1)(2010-5#1)
calibration technique##14##2##(2008-10#8)(2008-2#2)(2008-3#2)(2008-6#1)(2010-5#1)
calibration techniques##4##2##(2008-10#2)(2008-3#2)
calibration that##3##2##(2008-3#2)(2008-9#1)
calibration transfer##3##2##(2007-12#2)(2008-10#1)
calibration uncertainties##2##2##(2008-3#2)
calibration uncertainty##3##2##(2008-2#2)(2010-6#1)
calibration using a##2##3##(2008-10#2)
calibration using##4##2##(2008-10#3)(2008-3#1)
calibration was accomplished##2##3##(2008-10#2)
calibration was applied to##2##4##(2008-10#2)
calibration was obtained##3##3##(2008-10#3)
calibration was##17##2##(2008-10#16)(2008-7#1)
calibration with aqueous standards##2##4##(2008-10#2)
calibration with##12##2##(2008-10#9)(2008-3#2)(2008-6#1)
calibration without##3##2##(1997-8#1)(2008-10#2)
calibration##1084##1##(1990-8#1)(1991-1#1)(1991-5#2)(1992-11#3)(1994-12#1)(1995-3#1)(1995-9#3)(1996-5#1)(1997-8#5)(2007-10#1)(2007-11#5)(2007-12#24)(2008-1#3)(2008-10#764)(2008-11#2)(2008-12#2)(2008-2#69)(2008-3#133)(2008-4#3)(2008-5#2)(2008-6#8)(2008-7#2)(2008-8#3)(2008-9#13)(2009-12#1)(2009-8#2)(2010-11#3)(2010-3#5)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#4)
calibration)##2##1##(2008-10#2)
calibrations are##2##2##(2008-10#1)(2008-3#1)
calibrations for##3##2##(2008-10#3)
calibrations in the##2##3##(2007-11#1)(2008-10#1)
calibrations of##2##2##(2008-10#2)
calibrations were##5##2##(2008-10#4)(2008-3#1)
calibrations##35##1##(2007-11#1)(2007-12#2)(2008-10#23)(2008-2#2)(2008-3#4)(2009-6#1)(2010-4#1)(2012-2#1)
calibrator##12##1##(1994-8#1)(1995-2#2)(2008-10#8)(2008-2#1)
calibre and##2##2##(1997-3#1)(2008-3#1)
calibre##4##1##(1997-3#1)(2008-3#1)(2008-7#1)(2011-2#1)
calico mosaic virus##3##3##(2008-10#3)
california##8##1##(1990-11#1)(2008-10#7)
californianus)##2##1##(1995-8#1)(2009-2#1)
californica in##2##2##(1997-6#2)
californica nuclear polyhedrosis virus##8##4##(1994-11#1)(1995-12#1)(1997-4#2)(2008-11#1)(2008-7#2)(2008-8#1)
californica##32##1##(1992-12#1)(1992-6#2)(1993-12#3)(1994-11#1)(1994-8#1)(1995-12#2)(1997-3#1)(1997-4#3)(1997-6#5)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-2#1)
californica)##4##1##(2008-10#3)(2008-7#1)
calipers##2##1##(2006-12#1)(2013-7#1)
calix##2##1##(1990-9#1)(2008-10#1)
calix(6)arene##2##1##(2008-10#2)
calix[4]arene and##3##2##(2008-10#3)
calix[4]arene dibenzocrown##2##2##(2008-10#2)
calix[4]arene##17##1##(1996-5#2)(2008-10#15)
calix[4]arene-o-vanillinsemicarbazone##2##1##(2008-10#2)
calix[4]arene/hydroxy-terminated silicone##2##2##(2008-10#2)
calix[4]arenes##3##1##(1996-5#2)(2008-10#1)
calix[4]crown ether-ester##2##2##(2008-10#2)
calix[4]crown-5-azacrown-5##2##1##(2008-10#2)
calix[4]pyrroles##2##1##(2011-1#2)
calix[4]resorcinarene##3##1##(2008-10#3)
calix[6]arene tetraester I##2##3##(2008-10#2)
calix[6]arene tetraester##3##2##(2008-10#3)
calix[6]arene##4##1##(2008-10#4)
calixarene hydroxamic acid##2##3##(2008-10#2)
calixarene##5##1##(2008-10#5)
calixarenes##3##1##(2008-10#3)
calixcrown ethers##2##2##(2008-10#2)
calixcrown##3##1##(2008-10#3)
call &quot##3##2##(1991-4#1)(2008-10#1)(2012-12#1)
call attention to the##3##4##(2008-11#1)(2008-12#1)(2008-8#1)
call backs##2##2##(2010-8#2)
call duration##5##2##(1994-8#1)(2009-9#4)
call for a##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2010-2#1)
call for more##2##3##(2008-5#1)(2012-12#1)
call for the##4##3##(1996-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
call for##29##2##(1993-2#1)(1993-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#2)(2010-2#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
call has##2##2##(2008-8#1)(2008-9#1)
call in the##2##3##(2009-5#1)(2011-2#1)
call in##4##2##(2008-8#2)(2009-5#1)(2011-2#1)
call into question##2##3##(1992-12#1)(1995-5#1)
call of##4##2##(2010-2#1)(2013-7#3)
call on##5##2##(1995-3#1)(2008-6#1)(2008-8#3)
call the##8##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-9#1)(2012-12#1)
call this##2##2##(1994-2#1)(2008-8#1)
call to action##4##3##(1992-2#1)(1996-1#1)(2009-5#1)(2011-1#1)
call to##10##2##(1991-3#1)(1992-2#1)(1993-1#1)(1996-1#1)(2007-12#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-1#1)
call type##3##2##(2009-9#2)(2010-2#1)
call types##4##2##(2009-9#3)(2010-2#1)
call##140##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#13)(2008-9#1)(2009-10#3)(2009-11#1)(2009-5#3)(2009-8#1)(2009-9#16)(2010-1#1)(2010-2#8)(2010-3#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#4)
callback program##2##2##(1994-3#2)
called &quot##33##2##(1990-3#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-9#2)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
called a##13##2##(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2011-1#2)
called an##4##2##(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
called apoptosis##2##2##(2008-7#1)(2008-8#1)
called for##10##2##(1991-11#1)(1992-11#1)(1996-2#1)(2008-11#2)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
called in##4##2##(1991-2#1)(2007-12#1)(2008-4#1)(2008-5#1)
called its##2##2##(1990-5#1)(2009-7#1)
called mitochondrial##2##2##(2008-11#2)
called on to##2##3##(1993-12#1)(2013-7#1)
called on##3##2##(1993-12#1)(1997-2#1)(2013-7#1)
called the##49##2##(1990-11#1)(1990-8#1)(1991-2#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
called to##2##2##(1997-2#1)(2008-1#1)
called upon to develop##2##4##(2008-11#1)(2008-12#1)
called upon to help##3##4##(1995-3#1)(2008-10#2)
called upon to##15##3##(1991-1#1)(1992-3#1)(1995-3#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
called##384##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-5#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#4)(1996-3#4)(1996-9#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#4)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#9)(2008-10#36)(2008-11#15)(2008-12#7)(2008-2#12)(2008-3#24)(2008-4#16)(2008-5#16)(2008-6#7)(2008-7#16)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-10#3)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#5)(2011-2#17)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#9)
callers##2##1##(1996-5#1)(1996-9#1)
calli and##3##2##(2008-12#1)(2008-9#2)
calli of##2##2##(2008-12#1)(2008-9#1)
calli was##2##2##(2008-8#2)
calli##10##1##(2008-12#2)(2008-8#3)(2008-9#5)
calligraphies and traditional Chinese paintings##2##5##(2008-10#2)
calling for##2##2##(1997-2#1)(2008-8#1)
calling to##2##2##(1996-1#1)(2013-8#1)
calling##18##1##(1994-12#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-4#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
callipeltin##2##1##(2007-12#2)
callitrichid##2##1##(2012-3#2)
callitrichines##3##1##(2011-2#3)
callosal##3##1##(1994-3#1)(1996-2#1)(2008-7#1)
callose wall##2##2##(2011-2#2)
callose##10##1##(2008-10#7)(2009-10#1)(2011-2#2)
callose-enriched wall appositions##2##3##(2008-10#2)
calls and##6##2##(1992-8#1)(1994-8#1)(2007-11#1)(2010-3#2)(2011-2#1)
calls are##3##2##(1992-11#1)(2008-11#1)(2012-2#1)
calls by##2##2##(2008-8#2)
calls for a##2##3##(1993-1#1)(1996-12#1)
calls for more##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
calls for the##6##3##(1994-1#1)(1994-3#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-8#1)
calls for##32##2##(1990-4#1)(1991-3#1)(1993-1#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
calls from##6##2##(2009-8#1)(2010-3#3)(2013-1#1)(2013-7#1)
calls had##2##2##(2008-9#2)
calls in the##2##3##(2008-8#1)(2009-9#1)
calls in##3##2##(2008-8#1)(2009-9#1)(2011-2#1)
calls into question##2##3##(2008-11#1)(2009-9#1)
calls on the##2##3##(2008-11#1)(2010-11#1)
calls on##4##2##(2008-11#1)(2010-11#1)(2012-3#2)
calls over##4##2##(2009-9#3)(2012-3#1)
calls the attention##2##3##(1997-3#1)(2007-10#1)
calls to##3##2##(1991-3#1)(2008-8#1)(2011-1#1)
calls were##3##2##(2009-9#1)(2010-3#1)(2011-2#1)
calls with##4##2##(2008-3#1)(2008-9#1)(2009-9#1)(2013-7#1)
calls##113##1##(1990-4#1)(1991-3#2)(1992-11#1)(1992-5#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-3#3)(1994-8#5)(1995-11#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-3#2)(2008-6#2)(2008-8#10)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#5)(2009-9#10)(2010-11#1)(2010-3#6)(2010-4#1)(2011-1#3)(2011-2#6)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#4)(2013-8#1)
callus and##3##2##(1996-10#1)(2008-12#2)
callus##20##1##(1996-10#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#7)(2008-8#2)
calmagite##5##1##(2008-10#5)
calming##3##1##(2008-10#1)(2008-4#2)
calmodulin (CaM)##3##2##(1994-12#1)(1994-3#1)(2008-8#1)
calmodulin and actin##2##3##(1990-12#1)(1990-5#1)
calmodulin and##8##2##(1990-12#1)(1990-5#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-11#2)(2008-8#1)
calmodulin antagonists##5##2##(1992-9#2)(1995-2#1)(2008-10#2)
calmodulin binding##2##2##(1993-6#1)(2008-8#1)
calmodulin gene##3##2##(1991-9#1)(1992-12#1)(2008-10#1)
calmodulin kinase##2##2##(1996-12#2)
calmodulin mRNA##2##2##(1992-12#2)
calmodulin was found to##2##4##(1990-12#1)(1994-12#1)
calmodulin was##3##2##(1990-12#1)(1993-6#1)(1994-12#1)
calmodulin##73##1##(1990-12#5)(1990-5#2)(1990-8#1)(1991-12#3)(1991-8#1)(1991-9#3)(1992-12#8)(1992-9#6)(1993-6#9)(1994-12#7)(1994-3#2)(1995-11#4)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#2)(1997-2#3)(2008-10#5)(2008-7#1)(2008-8#6)(2010-3#1)
calmodulin-binding fraction##2##2##(1990-11#1)(1993-9#1)
calmodulin-binding protein##3##2##(1990-11#1)(1994-5#2)
calmodulin-binding##8##1##(1990-11#3)(1990-5#1)(1993-9#1)(1994-5#2)(2008-8#1)
calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes##2##5##(1997-2#2)
calmodulin-dependent cyclic nucleotide phosphodiesterase##7##4##(1997-2#7)
calmodulin-dependent protein kinase II##2##4##(1993-6#1)(2008-10#1)
calmodulin-dependent protein kinase##5##3##(1993-6#1)(2008-10#1)(2008-8#3)
calmodulin-dependent##14##1##(1991-9#1)(1992-3#1)(1993-6#1)(1997-2#7)(2008-10#1)(2008-8#3)
calmodulin-encoding gene##2##2##(1991-9#2)
calmodulin-encoding##3##1##(1991-9#2)(1994-12#1)
calmodulin-like calcium-binding protein from##2##4##(2009-7#2)
calmodulin-like##3##1##(1992-9#1)(2009-7#2)
calnexin##4##1##(1994-11#1)(1996-9#3)
calomel##7##1##(2008-10#7)
caloric and formula intake##2##4##(1991-12#2)
caloric and##4##2##(1991-12#2)(2009-4#1)(2011-2#1)
caloric density##3##2##(1991-12#1)(1995-2#1)(2008-9#1)
caloric expenditure##2##2##(2008-5#1)(2012-2#1)
caloric intake and##2##3##(1992-12#1)(2008-10#1)
caloric intake is##2##3##(1990-8#1)(1991-5#1)
caloric intake##10##2##(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
caloric restriction##10##2##(1994-5#2)(2008-10#2)(2008-11#1)(2008-7#3)(2009-5#1)(2010-1#1)
caloric##38##1##(1990-8#2)(1991-1#1)(1991-12#4)(1991-5#3)(1992-12#1)(1994-5#3)(1995-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
calorie diet##4##2##(1990-9#1)(2008-3#2)(2011-2#1)
calorie intake##2##2##(1993-9#1)(2007-12#1)
calorie restriction (CR)##2##3##(2008-7#1)(2009-5#1)
calorie restriction##6##2##(2008-4#3)(2008-7#1)(2009-5#1)(2013-8#1)
calorie##26##1##(1990-9#1)(1993-9#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#7)(2008-4#5)(2008-5#4)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
calories and##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
calories##12##1##(1990-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#2)
calorimeter##6##1##(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
calorimetric enthalpy##5##2##(1993-8#1)(1997-2#3)(1997-7#1)
calorimetric measurements##2##2##(2008-10#2)
calorimetric method##2##2##(2008-10#2)
calorimetric profile##2##2##(1990-2#1)(1995-8#1)
calorimetric studies##3##2##(1990-8#1)(1997-2#2)
calorimetric study of##2##3##(1990-7#1)(1990-8#1)
calorimetric study##3##2##(1990-7#1)(1990-8#1)(1997-2#1)
calorimetric techniques##2##2##(2008-10#1)(2011-1#1)
calorimetric##30##1##(1990-2#1)(1990-7#3)(1990-8#3)(1993-8#1)(1995-8#1)(1997-2#8)(1997-7#1)(2008-10#8)(2008-4#1)(2008-8#1)(2011-1#2)
calorimetrically determined##2##2##(1990-8#1)(1992-5#1)
calorimetrically##3##1##(1990-8#1)(1992-5#1)(2008-10#1)
calorimetry and##7##2##(1990-2#1)(1995-11#1)(1997-7#1)(2008-10#3)(2011-1#1)
calorimetry can be##2##3##(2008-10#1)(2008-2#1)
calorimetry in##3##2##(2008-10#2)(2011-1#1)
calorimetry the##2##2##(1997-2#2)
calorimetry##58##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#3)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1997-2#6)(1997-7#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#2)(2009-3#1)(2011-1#4)(2011-2#1)
calpain 2##3##2##(2013-1#3)
calpain I##6##2##(1990-2#2)(1992-6#4)
calpain II##6##2##(1990-2#1)(1994-5#2)(1995-3#3)
calpain##39##1##(1990-2#7)(1992-12#8)(1992-6#4)(1992-9#3)(1994-5#3)(1995-11#1)(1995-3#5)(1996-8#1)(2008-11#1)(2010-11#3)(2013-1#3)
calpains##5##1##(1990-2#3)(1995-11#1)(2010-11#1)
calpastatin##6##1##(2008-11#4)(2010-11#2)
calphostin C##4##2##(1997-1#1)(2008-4#2)(2008-9#1)
calphostin##5##1##(1993-11#1)(1997-1#1)(2008-4#2)(2008-9#1)
calponin and##2##2##(2008-11#1)(2008-6#1)
calponin was##2##2##(1993-6#1)(2008-6#1)
calponin##13##1##(1993-6#5)(2008-11#1)(2008-6#7)
calprotectin##3##1##(2010-12#1)(2013-8#2)
calreticulin glycosylation##3##2##(1994-11#3)
calreticulin##9##1##(1994-11#8)(1995-3#1)
calretinin-immunoreactive##2##1##(1996-5#1)(1997-2#1)
calvaria have##2##2##(1994-2#1)(2008-11#1)
calvaria##14##1##(1990-11#4)(1993-8#2)(1994-2#1)(2008-10#1)(2008-11#6)
calvarial##5##1##(1993-6#1)(2006-12#1)(2008-11#1)(2009-11#1)(2013-8#1)
calvasculin##3##1##(1992-12#3)
calves and cows##2##3##(2013-1#2)
calves and##5##2##(2008-11#1)(2011-1#2)(2013-1#2)
calves by##2##2##(1991-3#1)(1996-11#1)
calves during the##2##3##(1994-7#1)(1996-12#1)
calves from##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
calves had##2##2##(1994-7#1)(1997-5#1)
calves in##5##2##(1994-7#2)(1996-11#1)(1996-12#2)
calves of##4##2##(2012-12#2)(2012-2#2)
calves were##9##2##(1994-7#1)(1996-12#2)(1996-3#1)(1997-5#2)(2008-9#1)(2012-12#1)(2013-1#1)
calves##73##1##(1991-3#4)(1991-8#1)(1994-7#8)(1996-11#2)(1996-12#10)(1996-3#2)(1997-5#7)(2008-11#1)(2008-5#2)(2008-9#2)(2010-2#2)(2010-5#2)(2011-1#3)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#10)
calves'##2##1##(2007-2#1)(2012-12#1)
calves)##2##1##(1996-12#2)
calving##4##1##(2010-4#2)(2012-2#2)
calvum##3##1##(2011-2#3)
calyculin A##5##2##(1992-12#3)(1994-11#1)(1997-6#1)
calyculin##6##1##(1992-12#3)(1994-10#1)(1994-11#1)(1997-6#1)
calyptras##2##1##(2008-10#2)
calyx##4##1##(2008-10#4)
camaldulensis##5##1##(2008-5#5)
cambial##3##1##(2008-10#3)
cambium##12##1##(2008-10#11)(2010-3#1)
cambogia in rats##2##3##(2012-2#2)
cambogia in##3##2##(2012-2#3)
cambogia##5##1##(2008-5#1)(2012-2#4)
came due to pain##2##4##(2013-1#2)
came for##2##2##(1992-1#1)(2011-1#1)
came from a##2##3##(1992-4#1)(2008-12#1)
came from families with##2##4##(1994-6#1)(2009-8#1)
came from the##10##3##(1990-11#1)(1993-2#1)(1993-8#1)(2008-10#5)(2008-8#1)(2010-12#1)
came from##31##2##(1990-11#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2008-10#10)(2008-12#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
came in##4##2##(2008-11#1)(2008-5#1)(2010-8#2)
came into being##2##3##(2008-10#1)(2008-9#1)
came into##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
came out##2##2##(2007-8#1)(2008-12#1)
came to Bergen##2##3##(1990-6#1)(1992-6#1)
came to our##2##3##(2008-5#1)(2013-1#1)
came to that of##3##4##(2011-2#3)
came to the##4##3##(2007-7#1)(2008-12#1)(2009-7#1)(2010-2#1)
came to##17##2##(1990-6#1)(1992-6#1)(1993-1#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
came together##2##2##(1997-2#1)(2008-7#1)
came##78##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#5)(2013-8#4)
camel##6##1##(1990-12#1)(1996-12#3)(2011-2#2)
camels and##3##2##(2011-2#3)
camels were##3##2##(1996-12#2)(2011-2#1)
camels##16##1##(1993-3#1)(1996-12#3)(2011-2#12)
camera and a##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2011-1#1)
camera and an##2##3##(2008-2#1)(2011-1#1)
camera and##13##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#2)(2008-7#1)(2011-1#2)
camera are##4##2##(2007-11#1)(2008-3#3)
camera at##4##2##(2008-2#2)(2008-3#1)(2009-6#1)
camera for##8##2##(2007-11#1)(2008-3#3)(2008-4#1)(2010-12#1)(2011-1#2)
camera in##5##2##(2008-1#1)(2008-3#1)(2008-5#2)(2010-8#1)
camera is limited##2##3##(2007-11#1)(2008-3#1)
camera is##11##2##(1994-5#1)(2007-11#1)(2008-2#3)(2008-3#5)(2008-6#1)
camera motion can##2##3##(2008-6#2)
camera motion##4##2##(2008-6#4)
camera system that##2##3##(2008-2#1)(2008-3#1)
camera system##4##2##(2008-2#1)(2008-3#3)
camera that##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
camera to##6##2##(1996-3#1)(2008-11#1)(2008-3#2)(2010-3#1)(2012-2#1)
camera was##2##2##(1992-12#1)(2008-3#1)
camera with a##4##3##(2007-11#1)(2008-3#2)(2008-6#1)
camera with##7##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-6#1)
camera##195##1##(1991-1#1)(1992-12#5)(1994-2#1)(1994-5#3)(1996-2#3)(1996-3#1)(2007-11#15)(2007-12#9)(2007-8#1)(2008-1#6)(2008-10#8)(2008-11#1)(2008-2#24)(2008-3#68)(2008-4#1)(2008-5#3)(2008-6#13)(2008-7#3)(2008-9#7)(2009-4#1)(2009-6#2)(2010-11#4)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#8)(2012-12#1)(2012-2#1)(2012-6#1)
camera-based##2##1##(2008-3#1)(2011-1#1)
cameras and##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
cameras are##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
cameras have##2##2##(2008-3#1)(2008-6#1)
cameras in##2##2##(1995-12#1)(2008-4#1)
cameras that##2##2##(2007-12#1)(2012-2#1)
cameras##36##1##(1990-12#1)(1995-12#1)(2007-11#3)(2007-12#1)(2008-2#5)(2008-3#11)(2008-4#2)(2008-6#8)(2008-9#1)(2011-1#2)(2012-2#1)
camp##7##1##(2008-12#2)(2008-7#4)(2010-9#1)
campaign against##3##2##(1992-12#1)(1997-2#1)(2011-1#1)
campaign and##5##2##(1992-2#1)(1995-3#1)(1996-3#1)(1996-8#1)(2010-4#1)
campaign for##4##2##(1990-3#1)(2008-11#1)(2008-12#1)(2012-2#1)
campaign in##2##2##(1991-8#1)(2008-3#1)
campaign is##3##2##(1995-1#1)(1996-11#1)(2007-10#1)
campaign of##2##2##(1991-9#1)(1996-5#1)
campaign on##2##2##(1992-2#1)(2008-5#1)
campaign to##10##2##(1992-2#1)(1994-5#1)(1997-6#2)(2008-1#2)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
campaign was##8##2##(1991-9#1)(1993-6#1)(1997-1#1)(2008-12#2)(2008-5#1)(2010-1#1)(2013-1#1)
campaign will##3##2##(1994-1#1)(1997-6#1)(2008-12#1)
campaign with##2##2##(1995-5#1)(1997-6#1)
campaign##99##1##(1990-3#3)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-1#8)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-8#8)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#7)(2007-10#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#5)(2008-5#4)(2008-7#1)(2008-9#4)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)
campaign's##2##1##(1995-1#1)(2012-2#1)
campaigns against##2##2##(1993-2#1)(2010-1#1)
campaigns and##5##2##(2008-12#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#1)
campaigns are presented and discussed##2##5##(2008-3#2)
campaigns are presented##3##3##(2008-10#1)(2008-3#2)
campaigns have been##2##3##(2008-3#1)(2012-12#1)
campaigns have##4##2##(2008-3#1)(2008-9#1)(2012-12#2)
campaigns in##4##2##(2010-1#3)(2011-2#1)
campaigns to reduce##2##3##(1992-6#1)(2007-12#1)
campaigns to##7##2##(1992-6#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-7#1)
campaigns with##2##2##(1990-3#1)(2008-3#1)
campaigns##51##1##(1990-3#1)(1990-4#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-6#1)(2007-10#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#1)(2008-9#3)(2009-5#1)(2009-7#2)(2010-1#5)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
campaniform sensilla##4##2##(2007-12#4)
campestris and##3##2##(2008-10#2)(2009-6#1)
campestris in Brassica Genomes##2##4##(2008-10#2)
campestris in Brassica##3##3##(2008-10#3)
campestris in##7##2##(2008-10#6)(2011-1#1)
campestris isolates##2##2##(2008-10#2)
campestris pathovars##4##2##(2008-10#4)
campestris pv##95##2##(2008-10#91)(2008-8#1)(2009-6#1)(2010-10#2)
campestris races##3##2##(2008-10#3)
campestris##132##1##(1997-2#2)(2008-10#120)(2008-8#1)(2009-6#2)(2010-10#4)(2011-1#2)(2012-2#1)
campestris)##2##1##(2008-10#1)(2011-1#1)
camphor##6##1##(1992-8#1)(2007-10#1)(2008-10#1)(2010-5#2)(2011-2#1)
campion)##2##1##(2008-8#2)
camps##7##1##(1994-9#1)(2008-7#3)(2013-1#3)
camptothecin derivatives##4##2##(1995-5#4)
camptothecin stacking##2##2##(1993-8#2)
camptothecin##13##1##(1990-7#2)(1993-8#4)(1994-8#2)(1995-3#1)(1995-5#4)
camptothecin-induced##3##1##(1993-8#3)
campus##14##1##(1991-2#1)(1991-3#1)(1996-12#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2010-9#1)(2013-1#2)
campuses##6##1##(2008-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
campylobacter jejuni##2##2##(1995-5#1)(2008-7#1)
campylobacteriosis##5##1##(2008-10#2)(2008-7#2)(2011-1#1)
campylobacters were##2##2##(1990-3#2)
campylobacters##3##1##(1990-3#3)
camsylate##2##1##(1996-12#2)
can (1)##2##2##(2008-2#1)(2012-2#1)
can a##7##2##(1992-2#1)(1993-5#1)(1994-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2012-12#1)
can accelerate the##4##3##(2008-10#2)(2008-8#1)(2010-8#1)
can accelerate##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2010-8#1)
can accept##2##2##(1995-11#1)(2011-2#1)
can access##2##2##(1996-1#1)(2008-9#1)
can accommodate a##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
can accommodate##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
can accompany##5##2##(1990-9#1)(2007-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
can account for the##5##4##(1990-8#1)(1991-11#1)(2007-12#1)(2008-11#1)(2010-4#1)
can account for##13##3##(1990-8#1)(1991-11#1)(1991-6#1)(2007-12#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)
can account##14##2##(1990-8#1)(1991-11#1)(1991-6#1)(2007-12#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)
can accumulate##6##2##(1996-6#1)(2008-10#2)(2008-11#2)(2009-8#1)
can accurately predict##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
can accurately##9##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
can achieve a##3##3##(1992-3#1)(2007-7#1)(2008-1#1)
can achieve any##2##3##(1996-1#1)(2007-11#1)
can achieve the##4##3##(2008-3#2)(2011-1#1)(2013-8#1)
can achieve##27##2##(1992-3#1)(1993-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#2)(2012-2#1)(2013-8#1)
can acquire a##2##3##(1994-8#1)(2007-12#1)
can acquire##4##2##(1994-8#1)(2007-12#1)(2008-11#1)(2009-5#1)
can act as a##11##4##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-2#1)
can act as an##2##4##(1990-12#1)(1994-2#1)
can act as both##2##4##(1994-3#1)(2008-10#1)
can act as effective##2##4##(1995-2#1)(2010-7#1)
can act as##26##3##(1990-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
can act in##2##3##(2008-8#2)
can act to##3##3##(1994-11#1)(2008-8#1)(2013-7#1)
can act##40##2##(1990-12#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
can activate the##4##3##(1994-6#1)(1997-2#1)(1997-7#1)(2012-2#1)
can activate##14##2##(1991-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-8#1)(2009-8#1)(2012-2#2)
can actually##2##2##(1991-12#1)(2011-2#1)
can adapt##3##2##(1996-2#1)(2007-11#1)(2009-9#1)
can add##5##2##(1991-3#1)(1995-12#1)(2008-9#1)(2009-7#1)(2013-1#1)
can address the##2##3##(2009-5#1)(2012-1#1)
can address##8##2##(1991-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
can adequately##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)
can adhere##3##2##(2008-1#1)(2011-2#1)(2012-1#1)
can adjust##2##2##(2008-3#1)(2008-7#1)
can adopt a##2##3##(1994-8#1)(2008-11#1)
can adopt##4##2##(1994-8#1)(2008-11#1)(2009-6#1)(2011-2#1)
can adsorb##2##2##(2008-10#2)
can adversely affect##2##3##(2008-10#1)(2012-12#1)
can adversely##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
can affect cell##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
can affect the##23##3##(1991-2#1)(1993-11#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
can affect up to##2##4##(2007-11#1)(2008-4#1)
can affect##53##2##(1991-2#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#6)(2008-11#4)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
can afford to##3##3##(1993-12#1)(1994-12#1)(1996-2#1)
can afford##5##2##(1993-12#1)(1994-12#2)(1996-2#1)(2009-8#1)
can aid in the##3##4##(1996-9#1)(1997-1#1)(2013-8#1)
can aid in##7##3##(1992-9#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-3#1)(2008-9#1)(2013-8#1)
can aid##9##2##(1992-9#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-12#1)(2013-8#1)
can all be##5##3##(1992-3#1)(2008-8#2)(2011-2#1)(2013-8#1)
can all##11##2##(1992-3#1)(1997-2#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
can alleviate the##2##3##(2008-3#1)(2012-2#1)
can alleviate##4##2##(2007-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
can allow##7##2##(1995-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)
can already be##2##3##(1992-6#1)(1996-1#1)
can already##3##2##(1992-6#1)(1996-1#1)(2013-1#1)
can also affect##2##3##(2012-2#1)(2013-8#1)
can also alter the##2##4##(2008-10#1)(2012-1#1)
can also be a##2##4##(1994-3#1)(2008-10#1)
can also be achieved##2##4##(1995-2#1)(2009-6#1)
can also be adapted to##2##5##(2008-2#1)(2008-4#1)
can also be adapted##5##4##(1990-12#1)(2008-2#2)(2008-4#2)
can also be altered by##2##5##(2008-11#1)(2008-4#1)
can also be applied to other##2##6##(1991-5#1)(2008-2#1)
can also be applied to##9##5##(1991-5#1)(1992-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2011-2#1)
can also be applied##11##4##(1991-5#1)(1992-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#3)(2011-2#1)
can also be carried out in##2##6##(1996-5#2)
can also be detected##3##4##(1990-11#1)(2008-3#1)(2008-4#1)
can also be determined##4##4##(2008-10#4)
can also be easily##2##4##(2008-10#1)(2008-4#1)
can also be employed to##2##5##(2008-3#1)(2010-7#1)
can also be employed##4##4##(2008-3#2)(2010-7#1)(2012-3#1)
can also be found in##3##5##(1997-6#1)(2009-2#1)(2009-9#1)
can also be found##4##4##(1997-6#1)(2007-12#1)(2009-2#1)(2009-9#1)
can also be generated##2##4##(1994-12#1)(2009-11#1)
can also be improved##2##4##(2008-4#1)(2011-1#1)
can also be induced##3##4##(1997-7#1)(2008-2#1)(2008-4#1)
can also be integrated##2##4##(2008-2#1)(2008-6#1)
can also be investigated using##2##5##(1991-11#1)(2008-3#1)
can also be measured##3##4##(2008-2#1)(2008-3#1)(2010-7#1)
can also be observed in##2##5##(1996-12#1)(2012-12#1)
can also be obtained##4##4##(1991-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
can also be reliably##2##4##(2006-12#1)(2012-2#1)
can also be removed##2##4##(2008-2#1)(2008-5#1)
can also be selected##2##4##(2008-4#1)(2011-1#1)
can also be successfully##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
can also be used as a##2##6##(2008-4#1)(2008-7#1)
can also be used as an##2##6##(2008-10#1)(2009-5#1)
can also be used as##8##5##(1994-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-11#1)(2009-5#1)
can also be used for##7##5##(1991-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
can also be used in##3##5##(2008-3#1)(2008-6#1)(2012-6#1)
can also be used to assess##2##6##(2008-3#1)(2008-7#1)
can also be used to determine##3##6##(1990-12#1)(2008-10#1)(2008-8#1)
can also be used to estimate##2##6##(1995-6#1)(2008-3#1)
can also be used to measure##3##6##(2008-3#2)(2008-4#1)
can also be used to##24##5##(1990-12#1)(1995-6#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#4)(2008-4#3)(2008-7#3)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
can also be used##48##4##(1990-12#1)(1991-8#1)(1994-12#1)(1995-6#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#6)(2008-4#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-8#1)
can also be useful for##2##5##(2008-11#1)(2008-2#1)
can also be utilized to##2##5##(1994-5#1)(2009-10#1)
can also be##182##3##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-6#3)(1997-7#1)(2006-12#1)(2006-4#1)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#15)(2008-3#17)(2008-4#23)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#2)
can also block##2##3##(1995-6#1)(2008-8#1)
can also cause##2##3##(2007-12#1)(2011-2#1)
can also change the##2##4##(1997-1#1)(2008-10#1)
can also demonstrate the##2##4##(2008-2#1)(2011-2#1)
can also demonstrate##3##3##(2008-2#1)(2010-12#1)(2011-2#1)
can also determine##2##3##(2008-3#2)
can also estimate##2##3##(2008-2#2)
can also explain##2##3##(2007-12#1)(2013-8#1)
can also facilitate##2##3##(1994-11#1)(2009-11#1)
can also help##3##3##(1992-12#1)(2007-2#1)(2008-2#1)
can also include a##2##4##(2008-2#1)(2013-1#1)
can also increase##2##3##(2008-3#2)
can also induce##2##3##(2008-4#1)(2011-10#1)
can also influence##2##3##(2008-8#1)(2010-6#1)
can also interact##2##3##(1996-2#1)(2008-10#1)
can also occur##3##3##(2008-11#1)(2008-5#1)(2013-7#1)
can also prevent##2##3##(2010-5#1)(2013-1#1)
can also produce##3##3##(1993-11#1)(2008-2#1)(2011-2#1)
can also provide##4##3##(2008-3#1)(2008-7#2)(2010-10#1)
can also reduce##3##3##(1996-11#1)(2008-3#1)(2012-2#1)
can also result##2##3##(2007-12#1)(2011-2#1)
can also serve##2##3##(2008-2#1)(2008-7#1)
can also stimulate##2##3##(1992-11#1)(2008-10#1)
can also##294##2##(1990-11#1)(1990-12#3)(1990-2#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-12#4)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1997-1#2)(1997-3#1)(1997-6#3)(1997-7#1)(2006-12#1)(2006-4#1)(2007-12#10)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#22)(2008-3#27)(2008-4#25)(2008-5#7)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#6)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#2)(2013-8#5)
can alter the expression of##2##5##(1994-8#1)(2010-9#1)
can alter the##10##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-5#1)(2010-1#1)(2010-9#1)
can alter##22##2##(1991-12#1)(1992-12#1)(1994-6#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#5)(2008-9#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)
can alternatively be quantitatively adsorbed on##4##6##(2008-10#4)
can alternatively be quantitatively##5##4##(2008-10#5)
can always be##2##3##(2008-8#1)(2010-10#1)
can always##4##2##(2008-7#1)(2008-8#2)(2010-10#1)
can ameliorate the##2##3##(1993-12#1)(1994-5#1)
can ameliorate##3##2##(1993-12#2)(1994-5#1)
can amplify##2##2##(2008-11#1)(2010-5#1)
can and does occur##2##4##(2008-7#1)(2009-9#1)
can and should be##3##4##(1992-9#1)(2007-10#1)(2007-8#1)
can and##8##2##(1992-9#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)
can answer##2##2##(1997-2#1)(2008-3#1)
can appear in the##3##4##(2008-10#2)(2008-2#1)
can appear in##4##3##(1994-9#1)(2008-10#2)(2008-2#1)
can appear##10##2##(1991-11#1)(1991-8#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)
can apply to##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
can apply##6##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
can arise from##4##3##(1991-2#1)(1995-8#1)(2008-11#1)(2012-2#1)
can arise in##2##3##(2008-3#1)(2011-1#1)
can arise when##3##3##(2007-5#1)(2008-11#1)(2009-9#1)
can arise##15##2##(1991-2#1)(1991-3#1)(1995-8#1)(2007-5#1)(2008-1#1)(2008-11#3)(2008-3#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#3)
can arrest##3##2##(2008-9#1)(2011-2#1)(2011-3#1)
can assemble into dimers##2##4##(1994-8#1)(2008-8#1)
can assemble##4##2##(1994-3#1)(1994-8#1)(2008-10#1)(2008-8#1)
can assess##2##2##(1995-9#1)(1996-2#1)
can assist in the##6##4##(1995-2#1)(1995-5#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)
can assist in##12##3##(1990-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-3#2)(2009-4#1)(2009-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
can assist the##5##3##(1993-12#1)(1993-2#1)(2008-12#1)(2010-10#1)(2012-12#1)
can assist##25##2##(1990-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-3#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-8#2)
can associate with##3##3##(1991-12#1)(1991-5#1)(1995-6#1)
can associate##4##2##(1991-12#1)(1991-5#1)(1995-6#1)(2012-2#1)
can assume##2##2##(1990-7#1)(1994-12#1)
can attain##4##2##(1990-8#1)(2007-12#1)(2008-3#2)
can attenuate the##2##3##(1995-5#1)(2008-10#1)
can attenuate##3##2##(1993-12#1)(1995-5#1)(2008-10#1)
can augment##2##2##(2008-6#1)(2013-8#1)
can avoid the##5##3##(1995-12#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-8#1)
can avoid##13##2##(1992-12#1)(1992-9#1)(1993-12#2)(1995-12#1)(1995-5#1)(2008-3#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
can be 1##2##3##(1992-6#1)(2008-3#1)
can be a cause of##3##5##(1990-3#1)(1991-4#1)(2013-1#1)
can be a challenge##3##4##(2007-7#1)(2009-3#1)(2012-3#1)
can be a challenging##3##4##(2008-10#2)(2009-3#1)
can be a determinant##2##4##(1997-3#1)(2008-10#1)
can be a fast##2##4##(2008-10#1)(2010-8#1)
can be a good##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
can be a helpful##2##4##(2008-11#1)(2013-1#1)
can be a major##3##4##(2007-11#1)(2012-12#1)(2013-1#1)
can be a powerful tool in##2##6##(2010-8#1)(2013-8#1)
can be a powerful tool##3##5##(1995-12#1)(2010-8#1)(2013-8#1)
can be a powerful##6##4##(1995-12#1)(1995-2#1)(1995-3#1)(2008-9#1)(2010-8#1)(2013-8#1)
can be a problem##2##4##(2007-9#1)(2008-3#1)
can be a promising##2##4##(2011-1#1)(2011-2#1)
can be a source of##2##5##(2008-3#1)(2013-1#1)
can be a useful method##2##5##(2007-9#1)(2010-6#1)
can be a useful tool##2##5##(2008-10#1)(2008-3#1)
can be a useful##10##4##(1993-2#1)(1994-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-8#1)(2009-9#1)(2010-6#1)
can be a valuable tool for##4##6##(1993-2#1)(2007-12#1)(2008-9#1)(2009-4#1)
can be a valuable##6##4##(1992-1#1)(1993-2#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-4#1)
can be a##100##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#8)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
can be accessed##7##3##(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-12#1)
can be accompanied by##3##4##(1994-9#1)(1996-8#1)(2008-8#1)
can be accomplished by##10##4##(1994-5#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-9#2)(2011-2#1)
can be accomplished in##3##4##(2007-10#1)(2008-11#1)(2008-2#1)
can be accomplished with##3##4##(1995-1#1)(2007-11#1)(2008-3#1)
can be accomplished##25##3##(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#2)(2011-2#2)
can be accounted for by the##3##6##(1992-11#1)(2008-2#1)(2012-1#1)
can be accounted for by##6##5##(1992-11#1)(1992-6#1)(1997-2#1)(1997-7#1)(2008-2#1)(2012-1#1)
can be accounted for in##2##5##(1995-5#1)(2008-5#1)
can be accounted for##9##4##(1992-11#1)(1992-6#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-2#2)(2008-5#1)(2012-1#1)
can be accurately determined with##2##5##(2008-10#1)(2008-3#1)
can be accurately determined##3##4##(2008-10#1)(2008-3#2)
can be accurately##13##3##(1990-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#2)
can be achieved at##4##4##(2007-12#2)(2008-11#1)(2008-2#1)
can be achieved by an##2##5##(1997-7#1)(2008-2#1)
can be achieved by use of a##2##7##(2007-12#1)(2008-2#1)
can be achieved by use of##7##6##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2011-2#1)
can be achieved by using##6##5##(2008-10#4)(2008-4#1)(2008-7#1)
can be achieved by##42##4##(1990-9#1)(1993-9#1)(1997-7#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#8)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#3)
can be achieved even for##2##5##(2008-10#1)(2013-8#1)
can be achieved for##2##4##(2008-10#1)(2008-3#1)
can be achieved from##2##4##(2008-10#1)(2008-12#1)
can be achieved in##4##4##(1994-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
can be achieved only##2##4##(2007-11#1)(2008-7#1)
can be achieved through##5##4##(1994-9#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-7#1)
can be achieved using##5##4##(2008-1#1)(2008-4#2)(2008-7#1)(2009-8#1)
can be achieved when the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
can be achieved when##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
can be achieved with a##6##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
can be achieved with the proposed##2##6##(2008-10#1)(2009-5#1)
can be achieved with##16##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2009-5#2)(2009-7#1)(2009-9#1)
can be achieved without##2##4##(2007-12#1)(2008-2#1)
can be achieved##121##3##(1990-9#2)(1991-3#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1997-7#2)(2007-11#7)(2007-12#11)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#16)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#4)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-7#1)(2013-8#4)
can be acquired at##2##4##(2007-12#1)(2008-10#1)
can be acquired by##2##4##(2008-10#1)(2011-1#1)
can be acquired from##2##4##(2007-12#1)(2011-7#1)
can be acquired##10##3##(2007-12#3)(2008-10#4)(2008-3#1)(2011-1#1)(2011-7#1)
can be activated by##7##4##(1994-11#1)(1995-12#1)(1996-12#1)(1997-6#2)(2008-5#1)(2008-7#1)
can be activated in##2##4##(2008-1#1)(2008-10#1)
can be activated##11##3##(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
can be adapted for##4##4##(1994-3#1)(2008-4#2)(2012-12#1)
can be adapted to evaluate##2##5##(2008-11#1)(2008-3#1)
can be adapted to##13##4##(1990-5#1)(1991-5#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)
can be adapted##19##3##(1990-5#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-9#1)(2012-12#1)
can be added to the##3##5##(2008-11#1)(2008-5#1)(2008-7#1)
can be added to##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
can be added##7##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
can be addressed##2##3##(1993-2#1)(2008-11#1)
can be adequately described by a##2##6##(2008-2#2)
can be adequately described##3##4##(1996-2#1)(2008-2#2)
can be adequately##4##3##(1996-2#1)(2008-2#2)(2012-2#1)
can be adjusted by the##2##5##(2008-3#1)(2010-5#1)
can be adjusted by##4##4##(2008-10#1)(2008-3#2)(2010-5#1)
can be adjusted##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-5#1)(2012-12#1)
can be administered to##5##4##(1994-2#1)(1994-9#1)(2010-12#1)(2010-4#1)(2013-8#1)
can be administered##6##3##(1994-2#1)(1994-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
can be adopted for the##2##5##(2008-10#2)
can be adopted##5##3##(1990-2#1)(2008-10#2)(2008-12#1)(2008-3#1)
can be adsorbed at the mercury electrode and yields a sensitive oscillopolarographic wave##2##13##(2008-10#2)
can be adsorbed at the mercury electrode and yields a sensitive##3##11##(2008-10#3)
can be adsorbed##6##3##(2008-10#5)(2010-5#1)
can be advanced##2##3##(2008-10#1)(2008-11#1)
can be affected by the##2##5##(2008-10#1)(2009-8#1)
can be affected by##7##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-8#1)
can be aggravated by##2##4##(2008-2#1)(2011-2#1)
can be alleviated##2##3##(2008-3#2)
can be also used as##2##5##(2008-10#1)(2010-8#1)
can be also used##4##4##(2008-10#2)(2010-8#1)(2012-12#1)
can be also##10##3##(2008-1#1)(2008-10#5)(2008-11#2)(2010-8#1)(2012-12#1)
can be altered by##3##4##(1990-2#1)(1991-2#1)(2008-6#1)
can be altered##6##3##(1990-2#1)(1991-2#1)(1991-6#1)(2008-3#1)(2008-6#1)(2008-9#1)
can be ameliorated by##2##4##(2008-1#1)(2008-8#1)
can be ameliorated##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
can be amplified##2##3##(2008-2#1)(2010-12#1)
can be an alternative##2##4##(2008-2#1)(2010-6#1)
can be an effective##9##4##(1991-12#1)(1995-1#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
can be an efficient##2##4##(2008-10#1)(2010-11#1)
can be an important##7##4##(1993-1#1)(1993-3#1)(1996-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
can be an##39##3##(1990-8#1)(1991-1#1)(1991-12#1)(1993-1#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)
can be analysed directly##2##4##(2008-10#2)
can be analysed in##2##4##(1991-5#1)(2008-7#1)
can be analysed##10##3##(1991-5#2)(2007-12#1)(2008-10#5)(2008-7#1)(2009-4#1)
can be analyzed by##7##4##(1993-12#1)(2008-10#1)(2008-3#2)(2008-4#2)(2012-2#1)
can be analyzed in##3##4##(2007-11#1)(2008-1#1)(2008-10#1)
can be analyzed using##2##4##(1993-12#1)(2008-8#1)
can be analyzed with##2##4##(2008-10#1)(2008-9#1)
can be analyzed##26##3##(1993-12#2)(2007-11#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2012-2#1)
can be anticipated##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
can be applicable to##2##4##(2008-10#2)
can be applied also##2##4##(1995-5#1)(2008-10#1)
can be applied by##3##4##(2008-10#2)(2013-8#1)
can be applied for any##3##5##(1994-8#1)(1995-6#1)(2008-2#1)
can be applied for the##2##5##(2008-10#2)
can be applied for##8##4##(1994-8#1)(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#1)
can be applied in many##2##5##(1997-2#1)(2008-5#1)
can be applied in##13##4##(1990-11#1)(1997-2#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#2)
can be applied safely##2##4##(1995-8#1)(2010-12#1)
can be applied successfully to##3##5##(2008-10#1)(2008-11#1)(2009-10#1)
can be applied to a variety of##3##7##(2008-9#2)(2009-9#1)
can be applied to a##4##5##(2008-2#1)(2008-9#2)(2009-9#1)
can be applied to any other##2##6##(2008-2#1)(2008-4#1)
can be applied to any##6##5##(1995-2#1)(2008-2#3)(2008-4#1)(2008-9#1)
can be applied to both##2##5##(2008-3#1)(2011-2#1)
can be applied to determine the##2##6##(1994-9#1)(2008-10#1)
can be applied to determine##4##5##(1994-9#1)(2008-10#2)(2011-1#1)
can be applied to many##2##5##(2008-10#1)(2008-11#1)
can be applied to other##4##5##(2008-3#1)(2009-11#2)(2011-2#1)
can be applied to the##15##5##(1994-9#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
can be applied to##71##4##(1993-12#1)(1994-9#2)(1995-2#1)(1996-12#1)(1997-6#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#4)(2009-11#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
can be applied with##2##4##(2008-10#1)(2008-3#1)
can be applied##124##3##(1990-11#1)(1993-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-6#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
can be approached##2##3##(1991-2#1)(2008-3#1)
can be approximated##2##3##(2008-3#1)(2013-8#1)
can be as fast as##2##5##(2008-3#2)
can be as high as##4##5##(1995-2#1)(2008-3#2)(2013-8#1)
can be as large as##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
can be as##14##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2012-2#1)(2013-8#1)
can be ascribed to the##3##5##(2008-10#1)(2008-3#1)(2009-9#1)
can be ascribed to##7##4##(1997-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)(2011-1#1)
can be ascribed##8##3##(1997-6#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)(2011-1#1)
can be assessed##10##3##(1990-12#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-6#1)
can be associated with the##2##5##(2008-7#1)(2009-9#1)
can be associated with##18##4##(1990-5#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
can be associated##19##3##(1990-5#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
can be assumed that##2##4##(2008-7#1)(2009-1#1)
can be assumed to##2##4##(2008-10#1)(2010-3#1)
can be assumed##7##3##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-3#1)
can be attained##8##3##(1992-3#1)(1993-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-3#1)
can be attributed to a##2##5##(1995-2#1)(2007-12#1)
can be attributed to the difference in##2##7##(2008-9#1)(2012-2#1)
can be attributed to the##16##5##(1992-10#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)
can be attributed to##26##4##(1992-10#1)(1992-2#1)(1995-2#1)(1996-3#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-9#1)
can be attributed##28##3##(1991-12#1)(1992-10#1)(1992-2#1)(1995-2#1)(1996-3#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-9#1)
can be automatically##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
can be avoided by using##2##5##(1992-3#1)(2008-7#1)
can be avoided by##7##4##(1992-3#1)(1996-11#1)(2007-11#1)(2008-7#2)(2009-5#1)(2010-8#1)
can be avoided##19##3##(1990-5#1)(1991-3#1)(1992-3#2)(1992-6#1)(1993-2#1)(1994-3#2)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-8#1)
can be based on##2##4##(2008-6#1)(2008-8#1)
can be based##3##3##(1995-6#1)(2008-6#1)(2008-8#1)
can be beneficial##4##3##(1994-3#1)(2008-11#1)(2008-3#1)(2011-1#1)
can be best##2##3##(2012-2#2)
can be better identified##2##4##(2008-8#1)(2010-12#1)
can be better than##2##4##(2008-2#1)(2008-3#1)
can be better understood##2##4##(2008-11#1)(2013-1#1)
can be better##10##3##(1992-1#1)(1994-3#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#2)
can be biased by##2##4##(1992-6#1)(2010-3#1)
can be biased##3##3##(1992-6#1)(2008-7#1)(2010-3#1)
can be blocked by##4##4##(1991-9#1)(1994-10#1)(1997-2#1)(2008-12#1)
can be both##4##3##(1990-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
can be bound to##2##4##(2007-11#1)(2008-10#1)
can be broadly divided into##2##5##(2010-9#1)(2013-1#1)
can be broadly##5##3##(2008-2#1)(2008-4#1)(2008-7#1)(2010-9#1)(2013-1#1)
can be broken##3##3##(1995-3#1)(2008-4#1)(2008-9#1)
can be brought##2##3##(1996-5#1)(2008-10#1)
can be by##3##3##(1992-8#1)(2008-10#1)(2008-2#1)
can be calculated by use of##2##6##(2008-2#1)(2008-3#1)
can be calculated by##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
can be calculated from##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
can be calculated##18##3##(1991-5#1)(1994-8#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#5)(2011-3#1)(2012-3#1)
can be calibrated##4##3##(2008-10#2)(2008-3#2)
can be captured in##2##4##(1994-2#1)(2008-2#1)
can be captured##3##3##(1994-2#1)(2008-2#1)(2010-12#1)
can be carried out in the##2##6##(2008-10#1)(2008-7#1)
can be carried out in##5##5##(1994-2#1)(2008-10#2)(2008-2#1)(2008-7#1)
can be carried out on##3##5##(1993-12#1)(2008-10#1)(2008-7#1)
can be carried out##14##4##(1991-5#1)(1993-12#1)(1994-2#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#2)(2012-1#1)
can be carried##16##3##(1991-5#1)(1993-12#1)(1994-2#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#2)(2009-12#1)(2012-1#1)
can be cast##2##3##(1990-8#1)(2008-2#1)
can be catalyzed by##2##4##(1993-12#1)(1995-6#1)
can be categorized as either##2##5##(2012-2#1)(2013-1#1)
can be categorized as##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
can be categorized##4##3##(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
can be caused by a##2##5##(1992-1#1)(1994-12#1)
can be caused by##6##4##(1992-1#1)(1994-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
can be caused not only by##2##6##(1993-2#1)(2008-10#1)
can be caused##8##3##(1992-1#1)(1993-2#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
can be challenging##7##3##(2007-7#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
can be changed##7##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
can be characterized as a##3##5##(1993-3#1)(2009-10#1)(2010-11#1)
can be characterized as##9##4##(1993-3#1)(2008-10#2)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-8#1)
can be characterized by##5##4##(1991-3#1)(2008-10#2)(2008-2#1)(2012-1#1)
can be characterized##14##3##(1991-3#1)(1993-3#1)(2008-10#4)(2008-2#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-8#1)
can be chosen##2##3##(2008-2#1)(2012-3#1)
can be circumvented##2##3##(2008-10#1)(2008-3#1)
can be classified according to the##2##6##(2008-10#1)(2009-10#1)
can be classified as##6##4##(1991-3#1)(1993-3#1)(1993-9#1)(2008-10#1)(2008-11#1)(2012-2#1)
can be classified in##2##4##(1995-3#1)(2008-10#1)
can be classified into three##3##5##(2007-11#1)(2013-1#1)(2013-8#1)
can be classified into##8##4##(1992-7#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
can be classified##19##3##(1991-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
can be clearly distinguished from##2##5##(1991-2#1)(2008-10#1)
can be clearly seen##2##4##(2008-3#1)(2012-2#1)
can be clearly##6##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
can be closed##2##3##(2008-11#2)
can be closely##2##3##(1994-5#1)(2008-1#1)
can be collected and##2##4##(2008-9#1)(2010-8#1)
can be collected##3##3##(2007-12#1)(2008-9#1)(2010-8#1)
can be combined in##2##4##(2008-3#1)(2008-9#1)
can be combined with other##2##5##(1993-11#1)(2008-11#1)
can be combined with##12##4##(1993-11#1)(2007-11#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)
can be combined##18##3##(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2012-1#1)
can be compared to##3##4##(2008-7#1)(2009-2#1)(2010-6#1)
can be compared with##3##4##(1992-2#1)(1993-9#1)(1994-11#1)
can be compared##12##3##(1992-2#1)(1993-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-6#1)(2013-1#1)
can be compensated by##3##4##(2008-10#1)(2009-5#1)(2013-8#1)
can be compensated for by##3##5##(2007-12#1)(2008-2#2)
can be compensated for##6##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
can be compensated##11##3##(1991-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#1)(2013-8#1)
can be competed with##2##4##(1995-6#1)(1997-4#1)
can be completed in less than##2##6##(1995-11#1)(2011-1#1)
can be completed in##7##4##(1990-8#1)(1995-11#1)(2008-1#1)(2008-10#3)(2011-1#1)
can be completed##11##3##(1990-8#1)(1994-3#1)(1995-11#1)(2008-1#1)(2008-10#5)(2011-1#1)(2013-8#1)
can be completely##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
can be complex##3##3##(1990-11#1)(2008-10#1)(2012-2#1)
can be computed##5##3##(2007-11#1)(2008-3#2)(2008-6#1)(2008-7#1)
can be concentrated##2##3##(2008-10#2)
can be concluded that##28##4##(1990-12#1)(1994-7#1)(1994-8#1)(1996-11#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-3#1)(2012-2#4)(2012-9#1)(2013-1#1)(2013-8#1)
can be concluded##30##3##(1990-12#1)(1994-12#1)(1994-7#1)(1994-8#1)(1996-11#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-3#1)(2012-2#4)(2012-9#1)(2013-1#2)(2013-8#1)
can be conducted in##2##4##(1991-9#1)(1993-3#1)
can be conducted using##2##4##(2008-10#1)(2008-5#1)
can be conducted##5##3##(1991-9#1)(1993-3#1)(2008-10#2)(2008-5#1)
can be confident that##2##4##(1996-1#1)(2008-2#1)
can be confidently##2##3##(2012-2#1)(2013-1#1)
can be confirmed by##2##4##(1990-12#1)(2012-12#1)
can be confirmed##6##3##(1990-12#1)(1991-3#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
can be conjugated##2##3##(2008-10#1)(2012-2#1)
can be considerably##5##3##(1994-3#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-7#1)
can be considered a##6##4##(1993-12#1)(1993-3#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-4#1)
can be considered an##5##4##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
can be considered as a##12##5##(1994-3#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
can be considered as an##4##5##(1997-2#1)(2008-10#2)(2008-5#1)
can be considered as##29##4##(1990-11#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
can be considered in##3##4##(1994-9#1)(2008-5#1)(2011-2#1)
can be considered to be a##2##6##(2008-10#1)(2008-5#1)
can be considered to be##5##5##(1992-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
can be considered to##6##4##(1992-11#1)(2008-10#2)(2008-3#2)(2008-5#1)
can be considered##72##3##(1990-11#1)(1990-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-9#3)(1997-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-3#3)(2008-5#7)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#7)(2012-2#1)(2012-3#2)(2013-7#1)
can be constructed by##2##4##(2008-10#1)(2009-11#1)
can be constructed from##2##4##(1991-5#1)(2007-12#1)
can be constructed with##2##4##(2008-3#2)
can be constructed##10##3##(1991-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-11#1)(2011-2#1)
can be continuously tuned##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
can be continuously##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
can be controlled by the applied##2##6##(2008-2#1)(2008-3#1)
can be controlled by the##6##5##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
can be controlled by##19##4##(1993-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#2)(2009-12#1)(2009-7#1)(2011-2#1)
can be controlled to##2##4##(2008-11#1)(2008-7#1)
can be controlled with the##2##5##(2008-11#1)(2008-3#1)
can be controlled with##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
can be controlled within the range##2##6##(2008-7#2)
can be controlled##34##3##(1992-6#1)(1993-6#1)(1994-2#1)(1997-8#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#7)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#2)
can be conveniently##3##3##(1996-2#1)(2008-3#1)(2008-4#1)
can be converted into##5##4##(1996-5#1)(2008-3#1)(2009-9#1)(2010-5#1)(2011-3#1)
can be converted to##3##4##(1990-5#1)(1996-2#1)(2008-10#1)
can be converted##9##3##(1990-5#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-3#1)(2009-9#1)(2010-5#1)(2011-3#1)
can be corrected##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
can be correlated with a##2##5##(1996-12#1)(2007-12#1)
can be correlated with##5##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
can be correlated##7##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
can be coupled to##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
can be coupled with##4##4##(2008-10#2)(2008-4#1)(2008-9#1)
can be coupled##9##3##(2008-10#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)
can be created##6##3##(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2013-1#1)
can be cultured in##2##4##(2008-11#1)(2012-2#1)
can be cultured##3##3##(2008-11#2)(2012-2#1)
can be cumbersome##2##3##(1991-3#1)(2008-12#1)
can be curative##4##3##(1997-2#1)(2010-10#1)(2010-3#1)(2010-6#1)
can be cured by##2##4##(1996-11#1)(1997-6#1)
can be cured with##2##4##(1990-12#1)(1991-9#1)
can be cured##9##3##(1990-12#1)(1991-9#1)(1992-9#1)(1996-11#1)(1997-6#1)(2010-4#1)(2010-8#1)(2011-2#2)
can be decomposed##2##3##(2008-3#1)(2013-1#1)
can be decreased##5##3##(1993-3#1)(1997-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
can be deduced from##2##4##(2007-12#1)(2008-3#1)
can be deduced##6##3##(2007-12#1)(2008-10#2)(2008-3#3)
can be defined as a##2##5##(1993-6#1)(2008-4#1)
can be defined as the##2##5##(1997-3#1)(2008-7#1)
can be defined as##9##4##(1993-6#1)(1994-9#1)(1996-3#1)(1997-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-12#1)
can be defined##16##3##(1993-11#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2012-12#1)
can be degraded##2##3##(2008-10#1)(2011-2#1)
can be delayed for##2##4##(1994-3#1)(2013-8#1)
can be delayed##3##3##(1994-3#1)(2007-6#1)(2013-8#1)
can be delivered to##2##4##(1993-9#1)(2010-7#1)
can be delivered##5##3##(1993-9#1)(1997-1#2)(2010-7#1)(2011-2#1)
can be demonstrated by##2##4##(1996-5#1)(2008-1#1)
can be demonstrated##11##3##(1990-3#1)(1992-11#1)(1992-5#1)(1994-1#1)(1996-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#2)
can be deposited##2##3##(2008-10#1)(2010-4#1)
can be derived and interpreted##2##5##(2008-2#1)(2010-7#1)
can be derived for##2##4##(2008-10#1)(2008-8#1)
can be derived from the##4##5##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
can be derived from##12##4##(1992-12#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
can be derived##25##3##(1992-12#1)(1996-1#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)
can be described as a##6##5##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
can be described as the##2##5##(2008-9#1)(2013-1#1)
can be described as##9##4##(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
can be described by a##9##5##(1991-5#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
can be described by the##4##5##(1991-5#1)(2007-12#1)(2008-2#1)(2013-1#1)
can be described by##16##4##(1991-5#2)(1995-5#1)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
can be described well by the##2##6##(2008-10#1)(2008-3#1)
can be described with##2##4##(2008-2#1)(2008-3#1)
can be described##35##3##(1991-5#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#2)
can be designated##2##3##(1992-12#1)(2010-3#1)
can be designed for##3##4##(1994-12#1)(2008-10#1)(2008-2#1)
can be designed to##3##4##(2008-11#1)(2008-3#2)
can be designed##11##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2010-2#1)(2012-2#1)
can be desorbed with 2##2##5##(2008-10#2)
can be desorbed##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
can be detected after##2##4##(1996-12#1)(2008-10#1)
can be detected and determined using##2##6##(2008-10#1)(2008-11#1)
can be detected and the##2##5##(2008-4#1)(2008-9#1)
can be detected and##7##4##(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
can be detected as##2##4##(2008-10#1)(2008-6#1)
can be detected at##3##4##(2008-10#2)(2008-3#1)
can be detected by the##3##5##(1993-8#1)(2008-1#1)(2008-10#1)
can be detected by##17##4##(1990-6#1)(1990-9#1)(1993-8#1)(1994-7#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-4#4)(2008-9#3)(2009-6#1)
can be detected early##2##4##(2011-2#1)(2012-2#1)
can be detected in a##2##5##(1994-2#1)(2010-1#1)
can be detected in the##6##5##(1993-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
can be detected in##16##4##(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-1#1)
can be detected using this##2##5##(1995-6#1)(2008-9#1)
can be detected using##5##4##(1995-6#1)(2008-1#1)(2008-9#1)(2009-7#1)(2011-1#1)
can be detected##77##3##(1990-6#1)(1990-9#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#2)(1994-7#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#2)(1997-4#1)(1997-7#1)(2007-11#2)(2008-1#5)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#6)(2008-6#1)(2008-8#1)(2008-9#6)(2009-6#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
can be determined accurately##2##4##(2008-10#1)(2008-3#1)
can be determined by the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
can be determined by##16##4##(1990-8#1)(1992-3#1)(1996-3#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#1)(2009-11#1)
can be determined directly##3##4##(2008-10#3)
can be determined easily##2##4##(2008-3#1)(2010-5#1)
can be determined from the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
can be determined from##7##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)
can be determined in the presence of##3##7##(2008-10#3)
can be determined in the range of 0##3##8##(2008-10#3)
can be determined in the range##7##6##(2008-10#7)
can be determined in the##12##5##(2008-10#11)(2008-3#1)
can be determined in##21##4##(1990-8#1)(2008-10#18)(2008-11#1)(2008-3#1)
can be determined separately##2##4##(2007-11#1)(2008-3#1)
can be determined simultaneously in##2##5##(2008-10#2)
can be determined simultaneously with the concentration ratios of##2##9##(2008-10#2)
can be determined simultaneously##6##4##(2008-10#6)
can be determined using the##2##5##(2008-10#2)
can be determined using##3##4##(2008-10#3)
can be determined with a##2##5##(2008-10#1)(2008-3#1)
can be determined with##8##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
can be determined##105##3##(1990-8#2)(1992-3#1)(1994-2#1)(1995-11#1)(1996-3#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#57)(2008-11#2)(2008-2#7)(2008-3#16)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2012-1#1)
can be detrimental to##2##4##(2008-12#1)(2008-8#1)
can be detrimental##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
can be devastating##2##3##(2010-3#1)(2010-4#1)
can be developed and##2##4##(1995-1#1)(1996-12#1)
can be developed by##2##4##(1997-4#1)(2008-10#1)
can be developed for##2##4##(2008-10#1)(2008-2#1)
can be developed in##2##4##(1993-11#1)(2008-5#1)
can be developed to##2##4##(2008-9#1)(2011-1#1)
can be developed##20##3##(1993-11#1)(1995-1#1)(1996-12#1)(1997-4#2)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-8#1)(2011-1#2)(2012-2#1)
can be diagnosed by##2##4##(1996-11#1)(2010-6#1)
can be diagnosed##4##3##(1996-11#1)(2009-1#1)(2010-6#1)(2011-1#1)
can be diagnostic##2##3##(2008-10#1)(2012-2#1)
can be differentiated by##3##4##(1991-11#1)(2008-10#1)(2012-3#1)
can be differentiated into##2##4##(2007-12#1)(2008-9#1)
can be differentiated##9##3##(1990-6#1)(1990-7#1)(1991-11#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)
can be difficult because##2##4##(2008-10#1)(2010-7#1)
can be difficult to treat##2##5##(2012-12#1)(2013-1#1)
can be difficult to##6##4##(2007-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
can be difficult##20##3##(1990-11#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
can be directed##2##3##(1992-9#1)(2008-1#1)
can be directly determined by##2##5##(1995-11#1)(2008-10#1)
can be directly determined##4##4##(1995-11#1)(2007-12#1)(2008-10#2)
can be directly used##2##4##(2008-10#2)
can be directly##14##3##(1991-9#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-4#1)(2012-3#1)
can be discriminated##3##3##(2008-10#2)(2008-3#1)
can be displayed on a##2##5##(2008-3#1)(2010-9#1)
can be displayed##3##3##(2008-3#1)(2009-10#1)(2010-9#1)
can be disrupted##2##3##(2008-4#1)(2009-10#1)
can be dissociated from##2##4##(1995-6#1)(2013-8#1)
can be dissociated##4##3##(1993-6#1)(1995-6#1)(2008-8#1)(2013-8#1)
can be dissolved in##2##4##(2008-10#1)(2013-1#1)
can be dissolved##4##3##(2008-10#3)(2013-1#1)
can be distinguished according to##2##5##(2008-12#1)(2013-8#1)
can be distinguished and##2##4##(1996-9#1)(2008-5#1)
can be distinguished as##2##4##(2008-10#1)(2008-7#1)
can be distinguished by##3##4##(1993-9#1)(2007-8#1)(2008-10#1)
can be distinguished from each other##2##6##(2008-4#1)(2009-5#1)
can be distinguished from other##2##5##(2008-10#2)
can be distinguished from the##2##5##(2008-2#1)(2013-7#1)
can be distinguished from##9##4##(1993-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-7#1)(2013-8#1)
can be distinguished##27##3##(1993-11#1)(1993-2#1)(1993-9#1)(1996-9#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#2)
can be divided in three main##2##6##(2008-10#1)(2012-9#1)
can be divided into four##2##5##(1997-8#1)(2009-8#1)
can be divided into the##3##5##(1990-5#1)(2008-10#2)
can be divided into three##6##5##(1997-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2011-2#1)
can be divided into two##5##5##(1991-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can be divided into##27##4##(1990-5#1)(1991-6#1)(1992-11#1)(1995-12#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
can be divided##30##3##(1990-5#1)(1991-6#1)(1992-11#1)(1995-12#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-9#1)(2013-1#1)
can be documented##2##3##(1991-3#1)(2008-7#1)
can be done at##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
can be done by##4##4##(2008-10#3)(2008-3#1)
can be done in the##2##5##(2008-10#1)(2011-1#1)
can be done in##6##4##(1994-8#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
can be done to##4##4##(1992-11#2)(2008-1#1)(2008-10#1)
can be done with##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
can be done without##2##4##(2008-10#1)(2010-10#1)
can be downloaded##2##3##(2008-10#1)(2008-4#1)
can be drawn from the##5##5##(1991-12#1)(1993-12#1)(2008-11#1)(2008-12#1)(2008-2#1)
can be drawn from##8##4##(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-12#1)
can be drawn on##2##4##(2007-11#1)(2008-11#1)
can be drawn##18##3##(1990-8#1)(1991-12#1)(1993-12#1)(1994-11#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#1)(2010-12#1)
can be driven by##2##4##(2008-9#1)(2010-1#1)
can be due to##6##4##(1995-6#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-3#1)
can be dynamically##2##3##(2007-11#1)(2008-2#1)
can be easier than alternate techniques##2##6##(2008-1#1)(2008-2#1)
can be easier than##3##4##(2008-1#1)(2008-2#1)(2012-2#1)
can be easily achieved##3##4##(2008-10#2)(2008-9#1)
can be easily adapted to the##2##6##(2008-10#1)(2008-12#1)
can be easily adapted to##5##5##(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#1)
can be easily adapted##6##4##(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#1)
can be easily and##2##4##(2008-10#1)(2012-3#1)
can be easily detected##2##4##(1991-5#1)(2006-6#1)
can be easily extended to##2##5##(2008-8#1)(2010-3#1)
can be easily implemented with##2##5##(2008-3#1)(2008-7#1)
can be easily implemented##4##4##(2008-3#2)(2008-7#1)(2013-7#1)
can be easily missed##2##4##(2008-7#1)(2009-4#1)
can be easily monitored##2##4##(2007-12#1)(2008-10#1)
can be easily obtained##2##4##(2007-12#1)(2009-3#1)
can be easily performed##2##4##(2008-3#1)(2011-2#1)
can be easily prepared##2##4##(1990-12#1)(2009-11#1)
can be easily reduced on the##2##6##(2008-10#2)
can be easily regenerated##2##4##(2008-10#2)
can be easily##69##3##(1990-12#1)(1991-5#1)(1993-11#1)(1994-11#1)(1994-3#2)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#3)(2013-7#1)(2013-8#2)
can be effective in##9##4##(1993-3#1)(1995-3#1)(2006-6#1)(2007-5#1)(2008-10#1)(2010-4#1)(2011-2#2)(2013-1#1)
can be effective##15##3##(1993-3#1)(1995-3#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
can be effectively used##2##4##(2007-10#1)(2007-7#1)
can be effectively##15##3##(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)(2013-8#1)
can be efficiently used for##2##5##(2008-11#1)(2008-4#1)
can be efficiently used##3##4##(2008-11#1)(2008-4#1)(2009-7#1)
can be efficiently##14##3##(2007-11#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
can be either##7##3##(2008-2#1)(2008-4#2)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
can be elicited by##2##4##(1992-8#1)(2008-11#1)
can be elicited##3##3##(1990-12#1)(1992-8#1)(2008-11#1)
can be eliminated by a##2##5##(2008-10#1)(2008-11#1)
can be eliminated by##5##4##(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
can be eliminated##13##3##(1997-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)
can be elucidated##2##3##(2008-4#1)(2011-2#1)
can be eluted from##2##4##(1990-12#1)(2008-10#1)
can be eluted##4##3##(1990-12#1)(1991-12#1)(2008-10#2)
can be employed as a##3##5##(2007-12#1)(2008-10#2)
can be employed as##5##4##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
can be employed by##2##4##(1996-1#1)(2008-3#1)
can be employed for the##2##5##(2008-10#2)
can be employed for##7##4##(1992-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)
can be employed in##2##4##(2008-10#1)(2008-12#1)
can be employed to##11##4##(1990-7#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)
can be employed##32##3##(1990-7#1)(1992-5#1)(1993-6#1)(1994-12#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#1)
can be engineered to##4##4##(2007-12#1)(2008-3#1)(2010-7#1)(2011-2#1)
can be engineered##5##3##(2007-12#2)(2008-3#1)(2010-7#1)(2011-2#1)
can be enhanced by La(3+)##2##5##(2008-10#2)
can be enhanced by the addition of##2##7##(2007-11#1)(2008-10#1)
can be enhanced by the##3##5##(2007-11#1)(2008-10#1)(2009-11#1)
can be enhanced by##10##4##(1990-2#1)(2007-11#3)(2008-10#5)(2009-11#1)
can be enhanced with##2##4##(2008-8#2)
can be enhanced##21##3##(1990-2#1)(1994-12#1)(1995-1#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-3#1)(2008-8#2)(2009-11#1)(2010-11#1)(2012-3#1)(2013-1#1)
can be enriched##2##3##(2008-4#1)(2012-12#1)
can be equally##2##3##(2008-11#1)(2011-2#1)
can be especially##3##3##(2007-9#1)(2009-11#1)(2011-2#1)
can be established between##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
can be established by##2##4##(1990-11#1)(2011-2#1)
can be established in##2##4##(2007-12#1)(2008-1#1)
can be established##12##3##(1990-11#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-9#1)(2011-2#1)
can be estimated by a##2##5##(2008-10#1)(2009-9#1)
can be estimated by##5##4##(2008-10#3)(2009-9#1)(2012-12#1)
can be estimated from the##2##5##(2008-3#1)(2008-8#1)
can be estimated from##5##4##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
can be estimated that the##2##5##(1992-2#1)(2008-2#1)
can be estimated using##2##4##(1994-2#1)(2008-8#1)
can be estimated##19##3##(1992-2#1)(1992-6#2)(1992-9#1)(1994-2#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-12#1)
can be evaluated at##2##4##(1996-3#1)(2008-5#1)
can be evaluated by##4##4##(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
can be evaluated from a##2##5##(1990-8#1)(2008-10#1)
can be evaluated in a##2##5##(1992-3#1)(2008-2#1)
can be evaluated to##2##4##(2008-3#1)(2008-9#1)
can be evaluated##22##3##(1990-12#1)(1990-8#1)(1992-3#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
can be evolutionarily stable##2##4##(2008-8#2)
can be examined in##2##4##(1997-6#1)(2008-11#1)
can be examined##3##3##(1997-6#1)(2008-11#1)(2013-1#1)
can be excised##3##3##(1992-1#1)(1994-12#1)(2008-9#1)
can be excited##2##3##(2007-11#1)(2008-10#1)
can be excreted##2##3##(1992-4#1)(2008-5#1)
can be expanded##3##3##(1994-1#1)(2007-12#1)(2008-6#1)
can be expected in##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
can be expected to be##3##5##(1995-3#1)(1995-6#1)(2008-5#1)
can be expected to##16##4##(1992-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)
can be expected when##2##4##(2008-10#1)(2012-7#1)
can be expected##33##3##(1990-2#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2012-7#1)(2013-8#1)
can be experimentally##2##3##(1995-8#1)(2007-12#1)
can be explained as a##2##5##(2008-3#1)(2008-8#1)
can be explained as##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
can be explained by a model##2##6##(1990-11#1)(2008-8#1)
can be explained by a more##3##6##(1996-5#1)(2008-1#1)(2008-10#1)
can be explained by a##7##5##(1990-11#1)(1993-8#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-8#1)
can be explained by assuming that##2##6##(2008-10#1)(2008-11#1)
can be explained by its##2##5##(1995-11#1)(2008-2#1)
can be explained by the##10##5##(1994-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-3#3)(2009-2#1)(2010-1#1)(2010-10#1)
can be explained by##40##4##(1990-11#1)(1990-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-5#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-10#1)(2012-12#1)(2013-1#1)
can be explained in terms of##4##6##(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
can be explained in##6##4##(1992-6#1)(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
can be explained through##2##4##(2008-1#1)(2008-10#1)
can be explained using##2##4##(2008-10#1)(2008-5#1)
can be explained##61##3##(1990-11#1)(1990-5#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-5#2)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
can be exploited for##4##4##(2007-11#1)(2008-3#2)(2012-2#1)
can be exploited in##3##4##(2008-10#2)(2008-11#1)
can be exploited to reduce the##2##6##(2008-10#1)(2008-3#1)
can be exploited to##7##4##(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2013-7#1)
can be exploited##15##3##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2012-2#1)(2013-7#1)
can be expressed as a##4##5##(1992-6#1)(2007-11#1)(2008-2#1)(2008-7#1)
can be expressed as##8##4##(1992-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)
can be expressed by##2##4##(2008-10#1)(2008-3#1)
can be expressed in terms of##2##6##(1990-8#1)(2008-2#1)
can be expressed in##4##4##(1990-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
can be expressed##18##3##(1990-8#1)(1992-6#1)(1994-9#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-12#1)
can be extended for##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
can be extended from##2##4##(2008-10#1)(2008-3#1)
can be extended to a##2##5##(2007-11#1)(2008-7#1)
can be extended to the##2##5##(2008-10#1)(2008-3#1)
can be extended to##18##4##(1991-8#1)(1994-11#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)
can be extended##30##3##(1990-8#1)(1991-8#1)(1994-11#1)(1996-3#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#2)(2008-7#1)(2012-2#1)
can be extracted by##3##4##(1994-8#1)(2008-10#1)(2008-3#1)
can be extracted easily##2##4##(2008-10#1)(2008-3#1)
can be extracted from the##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
can be extracted from##6##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-8#1)
can be extracted##14##3##(1994-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2010-11#1)(2013-8#1)
can be extremely useful for##2##5##(2008-2#1)(2008-3#1)
can be extremely##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
can be fabricated##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
can be facilitated by##4##4##(1992-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
can be facilitated##7##3##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)
can be fatal##3##3##(2007-2#1)(2008-10#1)(2012-12#1)
can be favored##2##3##(2008-9#1)(2013-1#1)
can be fitted##2##3##(1997-2#1)(2012-3#1)
can be focused##2##3##(2008-8#1)(2011-2#1)
can be followed by##2##4##(2008-10#1)(2008-11#1)
can be followed##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
can be formed by##6##4##(1990-7#1)(1995-3#1)(2007-11#2)(2008-4#1)(2008-7#1)
can be formed from##2##4##(2008-2#1)(2008-5#1)
can be formed in##3##4##(2007-12#1)(2008-3#1)(2008-5#1)
can be formed into##2##4##(2008-8#1)(2009-11#1)
can be formed with##2##4##(1994-5#1)(2008-7#1)
can be formed##20##3##(1990-7#1)(1991-9#1)(1994-5#1)(1995-3#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2012-1#1)
can be formulated##5##3##(2008-3#2)(2008-5#1)(2008-8#1)(2012-4#1)
can be found at##5##4##(2007-11#1)(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)
can be found in the##6##5##(2008-10#3)(2008-3#1)(2008-9#1)(2009-11#1)
can be found in##22##4##(1994-11#1)(1995-8#2)(2007-10#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2011-2#2)
can be found that##3##4##(2007-11#2)(2008-3#1)
can be found##44##3##(1991-11#1)(1994-11#1)(1994-2#1)(1995-8#2)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#4)(2013-1#1)(2013-7#1)
can be frequency##2##3##(2008-3#2)
can be fully##8##3##(1993-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-8#1)
can be functional##2##3##(1992-3#1)(2012-2#1)
can be functionally##2##3##(1995-2#1)(2011-2#1)
can be further##15##3##(1994-3#1)(1995-12#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-2#1)
can be gained by##2##4##(2007-11#1)(2008-2#1)
can be gained##6##3##(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-5#1)
can be gated##2##3##(2008-7#1)(2008-9#1)
can be generated by##6##4##(2007-11#2)(2007-12#2)(2008-5#2)
can be generated for##2##4##(2007-11#1)(2008-10#1)
can be generated in##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
can be generated using##2##4##(2008-2#1)(2008-4#1)
can be generated with a##2##5##(2007-12#1)(2008-3#1)
can be generated with##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
can be generated##27##3##(1996-7#1)(2007-11#4)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#1)(2010-5#1)
can be given##4##3##(1995-5#1)(2008-6#2)(2008-9#1)
can be greatly enhanced by addition of##2##7##(2008-10#2)
can be greatly enhanced by quinine##2##6##(2008-10#2)
can be greatly enhanced by##6##5##(2008-10#6)
can be greatly improved##3##4##(2008-10#1)(2008-3#1)(2009-11#1)
can be greatly##13##3##(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#2)(2009-11#1)(2011-2#1)
can be grouped as##2##4##(2008-10#1)(2012-2#1)
can be grouped##5##3##(1993-11#1)(2008-10#2)(2010-8#1)(2012-2#1)
can be grown##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
can be guaranteed##2##3##(2007-7#1)(2008-2#1)
can be guided##3##3##(2007-12#1)(2008-10#2)
can be hard to##2##4##(1996-1#1)(2007-9#1)
can be harnessed##2##3##(1995-9#1)(2008-7#1)
can be hazardous##2##3##(1992-5#1)(2007-8#1)
can be helped by##2##4##(1990-6#1)(1993-2#1)
can be helpful for##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
can be helpful in improving the##2##6##(2008-5#2)
can be helpful in improving##3##5##(2008-5#3)
can be helpful in the diagnosis and##2##7##(1997-8#1)(2009-4#1)
can be helpful in the diagnosis##3##6##(1994-9#1)(1997-8#1)(2009-4#1)
can be helpful in the##4##5##(1991-4#1)(1994-9#1)(1997-8#1)(2009-4#1)
can be helpful in##9##4##(1991-4#1)(1994-9#1)(1997-8#1)(2008-11#1)(2008-5#3)(2009-4#1)(2010-10#1)
can be helpful to##4##4##(2008-7#1)(2008-8#1)(2009-1#1)(2010-8#1)
can be helpful##17##3##(1991-4#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-8#1)(2012-2#2)
can be highly##6##3##(1993-12#1)(2008-3#1)(2008-8#2)(2009-9#1)(2011-2#1)
can be hypothesized that##2##4##(2007-12#1)(2012-1#1)
can be identified and##2##4##(2008-7#1)(2010-11#1)
can be identified as##3##4##(1993-3#1)(1997-4#1)(2010-4#1)
can be identified by##4##4##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
can be identified for the##2##5##(2008-10#1)(2009-12#1)
can be identified from the UV spectrum of a 1##2##10##(2008-10#2)
can be identified from the##3##5##(1995-12#1)(2008-10#2)
can be identified from##4##4##(1995-12#1)(2008-10#3)
can be identified in##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
can be identified using##2##4##(1995-2#1)(2008-10#1)
can be identified with##3##4##(1997-3#1)(2009-8#1)(2012-2#1)
can be identified##38##3##(1991-5#1)(1993-3#1)(1993-6#2)(1995-12#1)(1995-2#2)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-2#1)
can be imaged with##3##4##(2008-3#2)(2008-5#1)
can be imaged##9##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#4)(2008-5#1)(2009-12#1)
can be implemented by##3##4##(2007-12#1)(2008-3#1)(2009-3#1)
can be implemented in a##2##5##(2008-4#1)(2010-8#1)
can be implemented in##7##4##(2008-11#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
can be implemented on##2##4##(1993-9#1)(2008-10#1)
can be implemented optically##2##4##(2008-2#1)(2008-3#1)
can be implemented to##3##4##(1993-1#1)(2008-10#1)(2008-2#1)
can be implemented with##3##4##(2007-8#1)(2008-3#1)(2013-1#1)
can be implemented##35##3##(1991-12#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#3)
can be important in##2##4##(2008-10#1)(2012-2#1)
can be important##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
can be improved by use of##3##6##(2007-11#2)(2008-2#1)
can be improved by##18##4##(1992-2#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
can be improved upon##2##4##(1990-5#1)(2010-12#1)
can be improved using##2##4##(1992-12#1)(2008-11#1)
can be improved##36##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
can be in the##2##4##(2007-7#1)(2008-3#1)
can be included in the##3##5##(1994-3#1)(2008-8#1)(2010-11#1)
can be included##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
can be incorporated in##4##4##(1994-8#1)(1996-12#1)(2008-3#1)(2012-12#1)
can be incorporated into a##3##5##(1995-2#1)(2008-10#2)
can be incorporated into the##3##5##(1994-3#1)(2008-3#1)(2009-9#1)
can be incorporated into##11##4##(1994-3#1)(1995-2#1)(2008-10#3)(2008-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
can be incorporated##17##3##(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
can be increased by##10##4##(1991-9#1)(1994-12#1)(2008-10#3)(2008-3#4)(2008-4#1)
can be increased significantly##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
can be increased to##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
can be increased##22##3##(1991-9#1)(1994-12#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#8)(2008-4#1)(2009-6#1)
can be individually##2##3##(2008-3#1)(2008-7#1)
can be induced by a##4##5##(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)
can be induced by##14##4##(1993-3#1)(1994-12#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)
can be induced in##3##4##(2007-11#1)(2008-4#1)(2009-8#1)
can be induced to develop##2##5##(1993-6#1)(2008-10#1)
can be induced to differentiate into##2##6##(2008-11#2)
can be induced to##7##4##(1991-5#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#2)
can be induced##33##3##(1990-7#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)
can be infected##2##3##(1996-9#1)(2008-10#1)
can be inferred from the##2##5##(2008-3#1)(2008-5#1)
can be inferred from##5##4##(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)
can be inferred##7##3##(2008-3#3)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
can be influenced by the##2##5##(1996-12#1)(2008-9#1)
can be influenced by##12##4##(1991-12#1)(1992-2#1)(1992-6#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
can be influenced##14##3##(1990-9#1)(1991-12#1)(1992-2#1)(1992-6#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2013-1#1)
can be inhibited by##5##4##(1992-9#1)(1995-12#1)(1996-2#1)(2008-5#1)(2013-8#1)
can be inhibited##8##3##(1992-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2013-8#1)
can be initiated by##2##4##(1992-9#1)(2012-3#1)
can be injected##2##3##(1994-9#1)(2008-4#1)
can be injured by##2##4##(2008-1#1)(2011-2#1)
can be inserted into##2##4##(2007-12#1)(2013-1#1)
can be inserted##5##3##(2007-12#1)(2008-3#1)(2010-9#1)(2012-12#1)(2013-1#1)
can be integrated easily##2##4##(2008-3#1)(2011-1#1)
can be integrated into the##2##5##(2008-2#1)(2008-3#1)
can be integrated into##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
can be integrated with##6##4##(2007-12#1)(2008-10#2)(2008-7#2)(2011-2#1)
can be integrated##16##3##(1993-12#2)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#2)(2011-1#1)(2011-2#1)
can be interpreted as a##3##5##(1993-8#1)(2008-1#1)(2008-10#1)
can be interpreted as##8##4##(1991-2#1)(1993-8#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
can be interpreted in terms of a##2##7##(1993-11#1)(1996-5#1)
can be interpreted in terms of##5##6##(1991-9#1)(1993-11#1)(1996-5#1)(2008-10#2)
can be interpreted to##2##4##(1996-5#1)(2008-3#1)
can be interpreted##16##3##(1991-2#1)(1991-9#1)(1993-11#1)(1993-8#1)(1995-3#1)(1996-5#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2012-1#1)
can be interrogated##4##3##(2008-10#2)(2008-7#1)(2009-12#1)
can be introduced##4##3##(1992-1#1)(2008-4#2)(2013-7#1)
can be inverted##2##3##(2008-3#2)
can be investigated in##2##4##(2008-11#1)(2013-8#1)
can be investigated##6##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
can be involved in##2##4##(1994-8#1)(2008-1#1)
can be isolated from the##2##5##(2008-9#1)(2010-6#1)
can be isolated from##5##4##(2008-4#1)(2008-9#3)(2010-6#1)
can be isolated##11##3##(1992-9#1)(1994-8#1)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#3)(2010-6#1)
can be jeopardized by##2##4##(1994-9#1)(1995-5#1)
can be joined##2##3##(2008-4#1)(2012-2#1)
can be justified##2##3##(1997-4#1)(2011-1#1)
can be kept below##2##4##(2008-2#2)
can be kept##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
can be labeled with a fluorescent##2##6##(2007-11#1)(2008-4#1)
can be labeled##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
can be large enough to##2##5##(2008-2#1)(2008-3#1)
can be large##3##3##(2008-2#1)(2008-3#2)
can be largely##2##3##(2007-12#1)(2008-2#1)
can be larger##2##3##(2008-2#1)(2008-3#1)
can be learned about##2##4##(2008-7#2)
can be learned by##2##4##(1995-2#1)(2008-12#1)
can be learned##5##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#2)
can be limited##2##3##(2007-12#1)(2008-10#1)
can be linked to##3##4##(1995-12#1)(2008-11#1)(2009-5#1)
can be loaded into##2##4##(2008-10#1)(2008-9#1)
can be loaded##3##3##(2008-10#2)(2008-9#1)
can be localized##2##3##(1997-1#1)(2008-5#1)
can be located at##2##4##(2008-2#1)(2008-6#1)
can be located in##2##4##(2008-2#1)(2011-2#1)
can be located##7##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
can be lowered##2##3##(1991-12#1)(2008-8#1)
can be made as##2##4##(2008-1#1)(2008-2#1)
can be made by##2##4##(1992-5#1)(2008-5#1)
can be made for##3##4##(1997-5#1)(2008-11#1)(2008-7#1)
can be made from the##3##5##(2007-11#1)(2008-3#1)(2011-2#1)
can be made from##4##4##(2007-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
can be made in the##3##5##(1992-3#1)(2008-7#1)(2008-8#1)
can be made in##5##4##(1992-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
can be made to##3##4##(2007-11#2)(2008-3#1)
can be made##44##3##(1991-1#1)(1992-3#1)(1992-5#1)(1994-9#1)(1996-3#1)(1997-5#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
can be mainly##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
can be maintained in the##2##5##(2008-11#1)(2008-9#1)
can be maintained in##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can be maintained##10##3##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)
can be malignant in##2##4##(2013-1#2)
can be managed conservatively##2##4##(2008-7#1)(2013-8#1)
can be managed##9##3##(1992-2#1)(1994-2#1)(1996-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2013-8#2)
can be manipulated by##2##4##(2008-10#1)(2010-8#1)
can be manipulated to##2##4##(2008-10#1)(2009-11#1)
can be manipulated##6##3##(1994-3#1)(2008-10#2)(2008-11#1)(2009-11#1)(2010-8#1)
can be manufactured##2##3##(1996-6#1)(2008-10#1)
can be mapped##2##3##(1990-5#1)(1996-8#1)
can be measured and##2##4##(2008-11#1)(2012-12#1)
can be measured at any one time##2##7##(2008-2#1)(2008-6#1)
can be measured at##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
can be measured by##3##4##(2008-10#1)(2008-2#1)(2010-6#1)
can be measured directly##3##4##(1995-12#1)(2008-10#1)(2008-3#1)
can be measured in the##2##5##(2008-10#1)(2008-4#1)
can be measured in vitro by##2##6##(1991-9#1)(2008-1#1)
can be measured in##7##4##(1991-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
can be measured to##2##4##(2008-2#1)(2008-3#1)
can be measured using the##2##5##(1994-3#1)(2008-8#1)
can be measured with a precision of##2##7##(2007-11#1)(2008-3#1)
can be measured with a##4##5##(2007-11#1)(2008-10#2)(2008-3#1)
can be measured with an uncertainty##2##6##(2008-2#1)(2008-3#1)
can be measured with high##2##5##(1993-8#1)(2008-3#1)
can be measured with##10##4##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
can be measured##53##3##(1991-9#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#13)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
can be mechanically##2##3##(2008-7#1)(2012-12#1)
can be mediated by##2##4##(2008-10#1)(2012-3#1)
can be mediated##3##3##(1994-3#1)(2008-10#1)(2012-3#1)
can be merged##2##3##(2007-7#1)(2008-2#1)
can be met by##3##4##(2008-11#2)(2008-2#1)
can be met##4##3##(2008-10#1)(2008-11#2)(2008-2#1)
can be metabolized##3##3##(1990-2#1)(1992-10#1)(2012-3#1)
can be mimicked##2##3##(1996-5#1)(2011-1#1)
can be miniaturized and##2##4##(2008-4#2)
can be miniaturized##3##3##(2008-4#2)(2010-2#1)
can be minimized by##4##4##(2008-10#2)(2008-3#2)
can be minimized##14##3##(2007-11#2)(2008-10#3)(2008-3#5)(2008-4#1)(2011-2#1)(2012-2#2)
can be missed##2##3##(2007-7#1)(2008-5#1)
can be mistaken for a##2##5##(2008-7#1)(2012-2#1)
can be mistaken##3##3##(2007-11#1)(2008-7#1)(2012-2#1)
can be modeled by##2##4##(2008-10#1)(2008-3#1)
can be modeled##3##3##(2008-10#2)(2008-3#1)
can be modified by##5##4##(1995-11#1)(1996-7#1)(2008-3#1)(2008-5#1)(2008-7#1)
can be modified##8##3##(1993-3#1)(1995-11#1)(1996-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
can be modulated by##7##4##(1992-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
can be modulated##10##3##(1992-12#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
can be monitored by measuring the##2##6##(2008-10#2)
can be monitored by reversible staining or##2##7##(2008-4#2)
can be monitored by##7##4##(2008-10#4)(2008-4#3)
can be monitored spectrophotometrically by measuring the decrease in##2##9##(2008-10#2)
can be monitored with##2##4##(1997-6#1)(2012-2#1)
can be monitored##18##3##(1991-5#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-4#3)(2008-7#1)(2009-8#1)(2012-2#2)
can be more effective##3##4##(2008-5#2)(2013-8#1)
can be more efficient than##2##5##(2008-3#2)
can be more severe##2##4##(2008-7#1)(2008-9#1)
can be more than##2##4##(2007-12#1)(2010-10#1)
can be more##19##3##(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-10#1)(2012-1#1)(2013-8#2)
can be multiplexed##2##3##(2007-12#1)(2008-3#1)
can be nearly##2##3##(1990-4#1)(2008-3#1)
can be neglected for##2##4##(2008-3#2)
can be neglected##4##3##(2007-12#1)(2008-3#3)
can be neutralized by##2##4##(1994-8#1)(2009-8#1)
can be no##3##3##(1992-2#1)(2008-1#1)(2008-3#1)
can be observed and##2##4##(2008-5#1)(2008-8#1)
can be observed at the##2##5##(2008-5#1)(2010-4#1)
can be observed at##6##4##(1990-5#1)(1992-3#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
can be observed between##2##4##(2006-12#1)(2007-12#1)
can be observed from##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
can be observed in##6##4##(1994-6#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
can be observed with##2##4##(1990-12#1)(2007-12#1)
can be observed##40##3##(1990-12#1)(1990-5#2)(1992-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
can be obtained at##2##4##(2008-3#1)(2008-7#1)
can be obtained by a##3##5##(2008-3#3)
can be obtained by means of##2##6##(1993-3#1)(2007-12#1)
can be obtained by the##3##5##(2008-10#1)(2008-3#2)
can be obtained by using##2##5##(2008-1#1)(2008-10#1)
can be obtained by##31##4##(1993-3#1)(1994-9#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-1#1)
can be obtained directly##2##4##(2008-3#1)(2008-8#1)
can be obtained during##2##4##(2008-1#1)(2008-7#1)
can be obtained for##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
can be obtained from a##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
can be obtained from the##2##5##(2008-10#1)(2008-3#1)
can be obtained from##14##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)
can be obtained if the##2##5##(2008-10#1)(2008-3#1)
can be obtained in a##2##5##(1990-8#1)(1993-3#1)
can be obtained in##8##4##(1990-8#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
can be obtained over a##2##5##(2008-2#1)(2008-4#1)
can be obtained simultaneously##2##4##(2008-2#1)(2008-3#1)
can be obtained solely from its intensity##2##7##(2008-3#2)
can be obtained through a##2##5##(1994-12#1)(2008-12#1)
can be obtained through##5##4##(1992-4#1)(1994-12#1)(2008-12#1)(2008-2#1)(2008-9#1)
can be obtained using##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
can be obtained when##2##4##(2008-10#1)(2008-4#1)
can be obtained with a##3##5##(2007-12#2)(2008-2#1)
can be obtained with##13##4##(1992-3#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-5#1)(2012-2#1)(2013-8#1)
can be obtained without##2##4##(2008-3#1)(2008-9#1)
can be obtained##146##3##(1990-8#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-8#1)(2008-1#3)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#28)(2008-4#11)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#6)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
can be of great##5##4##(2008-10#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-8#1)
can be of value##2##4##(1993-2#1)(2008-6#1)
can be of##18##3##(1990-8#1)(1992-5#1)(1993-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-9#2)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
can be omitted##2##3##(2008-10#1)(2008-4#1)
can be one of the##2##5##(1995-1#1)(1997-3#1)
can be one##3##3##(1995-1#1)(1997-3#1)(2012-3#1)
can be only##3##3##(1992-12#1)(2008-10#1)(2012-1#1)
can be operated at##2##4##(2008-10#1)(2008-7#1)
can be operated##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
can be optimized by##3##4##(1994-12#1)(1994-9#1)(2008-5#1)
can be optimized to##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
can be optimized##10##3##(1994-12#1)(1994-9#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
can be overcome by the##3##5##(1994-8#1)(2008-2#1)(2013-8#1)
can be overcome by##9##4##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2013-1#1)(2013-8#1)
can be overcome##14##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
can be part of##2##4##(2008-11#1)(2008-7#1)
can be partially##3##3##(1992-12#1)(1992-3#1)(1992-9#1)
can be particularly useful##2##4##(2007-11#1)(2011-2#1)
can be particularly##3##3##(2007-11#1)(2010-10#1)(2011-2#1)
can be partly##3##3##(1997-4#1)(2008-10#1)(2009-12#1)
can be performed at##2##4##(2008-3#1)(2010-5#1)
can be performed by##6##4##(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)
can be performed in the##4##5##(2007-8#1)(2008-10#3)
can be performed in##16##4##(1991-3#1)(1992-12#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-9#1)(2012-3#1)
can be performed on the##2##5##(2008-11#1)(2008-3#1)
can be performed on##3##4##(2008-11#1)(2008-3#1)(2008-9#1)
can be performed safely and effectively##2##6##(2008-3#1)(2008-7#1)
can be performed safely and##3##5##(1991-3#1)(2008-3#1)(2008-7#1)
can be performed safely##4##4##(1991-3#2)(2008-3#1)(2008-7#1)
can be performed to assess##2##5##(2008-11#1)(2008-4#1)
can be performed to##4##4##(2008-11#2)(2008-3#1)(2008-4#1)
can be performed under##2##4##(1996-12#1)(2008-3#1)
can be performed using a##2##5##(2008-1#1)(2008-4#1)
can be performed using##7##4##(2008-1#1)(2008-10#2)(2008-4#3)(2010-8#1)
can be performed with a##2##5##(2008-3#1)(2008-4#1)
can be performed with##7##4##(1990-2#1)(1992-3#1)(1995-1#1)(2008-3#2)(2008-4#1)(2008-7#1)
can be performed##74##3##(1990-2#1)(1990-6#1)(1991-3#4)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1995-1#1)(1996-12#2)(1997-2#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#12)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
can be phosphorylated##3##3##(1993-3#1)(1994-6#1)(1997-2#1)
can be placed in##2##4##(2008-10#1)(2008-11#1)
can be placed on##2##4##(1993-12#1)(2008-9#1)
can be placed##8##3##(1993-11#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-12#1)
can be positioned##2##3##(2007-7#1)(2011-2#1)
can be positive##3##3##(1995-12#1)(2008-7#1)(2009-7#1)
can be possible by##2##4##(2008-11#1)(2009-10#1)
can be postulated##2##3##(2008-10#1)(2008-5#1)
can be potentially##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
can be precisely##2##3##(2007-12#1)(2008-10#1)
can be predicted by##5##4##(1996-1#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
can be predicted for##2##4##(2008-5#1)(2008-7#1)
can be predicted from the##5##5##(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)
can be predicted from##7##4##(1993-6#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-5#1)
can be predicted##18##3##(1993-6#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2012-1#2)
can be prepared by##2##4##(2008-10#1)(2008-7#1)
can be prepared in situ##2##5##(2007-12#1)(2008-11#1)
can be prepared in##6##4##(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-5#1)
can be prepared through##2##4##(2007-11#1)(2008-11#1)
can be prepared with##2##4##(2008-10#1)(2009-12#1)
can be prepared##15##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)
can be present in##5##4##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
can be present##6##3##(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
can be presented##2##3##(1993-6#1)(2011-2#1)
can be preserved by##2##4##(2008-10#1)(2008-3#1)
can be prevented by a##2##5##(1991-3#1)(2007-7#1)
can be prevented by##14##4##(1990-3#2)(1991-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
can be prevented##21##3##(1990-3#2)(1991-3#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-6#1)(1997-2#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-2#1)(2013-1#1)
can be prioritized##2##3##(1994-3#1)(2009-8#1)
can be problematic##5##3##(2008-1#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-3#1)
can be processed in##2##4##(2008-10#1)(2008-3#1)
can be processed##6##3##(2008-10#3)(2008-3#1)(2009-11#1)(2012-2#1)
can be produced at##2##4##(2008-11#1)(2008-6#1)
can be produced by the##2##5##(1994-9#1)(2008-3#1)
can be produced by##3##4##(1994-9#1)(2008-3#2)
can be produced from##4##4##(1995-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
can be produced in the##2##5##(1993-11#1)(2008-8#1)
can be produced in##4##4##(1993-11#1)(1994-8#1)(2008-11#1)(2008-8#1)
can be produced##22##3##(1993-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#8)(2008-4#2)(2008-6#1)(2008-8#1)(2012-12#1)
can be programmed##2##3##(2008-3#1)(2011-3#1)
can be promoted##3##3##(1997-7#1)(2008-9#1)(2011-1#1)
can be propagated##2##3##(2008-8#2)
can be properly##2##3##(1993-8#1)(2008-10#1)
can be proposed as a##2##5##(1990-7#1)(1994-5#1)
can be proposed as##3##4##(1990-7#1)(1994-2#1)(1994-5#1)
can be proposed##6##3##(1990-7#1)(1994-2#1)(1994-5#1)(2008-1#1)(2008-3#1)(2008-4#1)
can be provided by##2##4##(1996-3#1)(2008-9#1)
can be provided in##2##4##(2007-2#1)(2011-2#1)
can be provided##9##3##(1995-2#1)(1996-3#2)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
can be purified##2##3##(2008-4#1)(2008-9#1)
can be put##2##3##(1997-3#1)(2008-2#1)
can be quantified by##2##4##(2008-10#1)(2008-4#1)
can be quantified using##2##4##(2008-10#1)(2011-2#1)
can be quantified with##4##4##(2008-10#3)(2008-5#1)
can be quantified##15##3##(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
can be quantitated##3##3##(1991-9#1)(2008-4#2)
can be quantitatively determined##3##4##(2008-10#1)(2008-3#2)
can be quantitatively##8##3##(2008-10#4)(2008-3#2)(2008-7#1)(2010-8#1)
can be quite##6##3##(1994-3#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-10#1)
can be rapidly and easily##2##5##(2008-10#2)
can be rapidly and##3##4##(1992-9#1)(2008-10#2)
can be rapidly##6##3##(1992-9#1)(1994-10#1)(2008-10#2)(2008-4#1)(2013-8#1)
can be rationalized in terms of##2##6##(1991-8#1)(2008-10#1)
can be rationalized##4##3##(1991-8#1)(1994-5#1)(1996-2#1)(2008-10#1)
can be reached##8##3##(1993-2#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
can be read##2##3##(2008-12#1)(2008-3#1)
can be readily achieved##2##4##(2007-11#1)(2007-12#1)
can be readily adapted to##2##5##(2008-4#1)(2008-6#1)
can be readily applied to##4##5##(1992-11#1)(1996-5#1)(2008-10#2)
can be readily detected##2##4##(2007-7#1)(2008-10#1)
can be readily determined##3##4##(2008-10#1)(2008-4#1)(2009-11#1)
can be readily obtained##2##4##(1997-4#1)(2008-3#1)
can be readily performed##2##4##(1990-8#1)(2008-1#1)
can be readily removed by##2##5##(1997-4#1)(2008-4#1)
can be readily##44##3##(1990-8#1)(1991-10#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-4#3)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#1)
can be realised##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
can be realized by a##2##5##(2007-11#1)(2008-3#1)
can be realized by##6##4##(2007-11#1)(2007-12#1)(2008-3#1)(2009-10#1)(2010-5#1)(2013-8#1)
can be realized##13##3##(1994-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2009-10#1)(2010-2#1)(2010-5#1)(2013-8#1)
can be recognised##2##3##(2007-12#1)(2008-11#1)
can be recognized as a##2##5##(2012-12#1)(2013-8#1)
can be recognized##4##3##(1996-12#1)(2008-1#1)(2012-12#1)(2013-8#1)
can be recommended for clinical##2##5##(1993-2#2)
can be recommended for##8##4##(1993-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
can be recommended##12##3##(1992-9#1)(1993-2#2)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
can be reconciled##2##3##(1995-3#1)(1995-5#1)
can be reconstructed##3##3##(2008-2#1)(2008-3#2)
can be recorded##6##3##(2008-3#3)(2008-5#2)(2008-6#1)
can be recovered by##2##4##(2008-2#1)(2008-3#1)
can be recovered from the##2##5##(2008-10#1)(2008-2#1)
can be recovered from##7##4##(1992-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
can be recovered##18##3##(1992-7#1)(2007-11#2)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2012-12#1)
can be recruited##2##3##(2008-11#1)(2012-2#1)
can be reduced by##15##4##(1990-12#1)(1993-8#1)(1994-9#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-3#1)(2013-1#1)
can be reduced considerably##2##4##(2008-3#2)
can be reduced further and##2##5##(2008-2#1)(2008-3#1)
can be reduced in##3##4##(1990-11#1)(2007-12#1)(2008-3#1)
can be reduced significantly##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
can be reduced substantially##2##4##(2008-2#1)(2008-3#1)
can be reduced to a##3##5##(1995-5#1)(2008-3#1)(2008-6#1)
can be reduced to##6##4##(1995-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)
can be reduced##46##3##(1990-11#1)(1990-12#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#11)(2008-6#1)(2010-8#2)(2011-3#1)(2013-1#1)
can be refined##2##3##(2008-3#1)(2008-6#1)
can be regarded as a##5##5##(1994-2#1)(1994-7#1)(2008-10#1)(2009-2#1)(2011-2#1)
can be regarded as an##3##5##(1994-3#1)(1995-11#1)(2009-5#1)
can be regarded as proven##2##5##(1991-4#1)(2011-2#1)
can be regarded as the##2##5##(2007-11#1)(2008-3#1)
can be regarded as##20##4##(1991-4#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-2#2)
can be regarded##21##3##(1991-4#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-2#2)
can be regenerated by simply polishing##2##6##(2008-10#2)
can be regenerated by simply##3##5##(2008-10#3)
can be regenerated by##7##4##(2008-10#7)
can be regenerated##9##3##(2008-10#9)
can be regulated at##2##4##(1991-12#1)(2008-11#1)
can be regulated by##9##4##(1992-3#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-8#2)(2009-8#2)(2010-3#1)
can be regulated in##2##4##(1997-6#1)(2008-10#1)
can be regulated##15##3##(1991-12#1)(1992-3#1)(1995-11#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-3#1)
can be related to the##3##5##(1995-3#1)(2007-11#1)(2008-10#1)
can be related to##10##4##(1995-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)(2013-1#1)
can be related with##2##4##(2008-10#1)(2013-8#1)
can be related##12##3##(1995-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
can be relatively##2##3##(2008-11#1)(2008-8#1)
can be released from##2##4##(2008-4#2)
can be released##5##3##(1990-11#1)(2007-10#1)(2008-4#2)(2008-8#1)
can be reliably employed##2##4##(1996-12#1)(2008-11#1)
can be reliably used##3##4##(1992-3#1)(1997-3#1)(2008-10#1)
can be reliably##9##3##(1992-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
can be removed by##4##4##(1994-6#1)(2008-3#1)(2009-11#1)(2011-2#1)
can be removed from the##2##5##(2008-10#2)
can be removed from##3##4##(2008-10#2)(2009-9#1)
can be removed##17##3##(1993-9#1)(1994-6#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
can be rendered##2##3##(2008-6#1)(2008-8#1)
can be repaired by##2##4##(2008-8#1)(2008-9#1)
can be repaired##3##3##(2007-8#1)(2008-8#1)(2008-9#1)
can be repeated##3##3##(2006-10#1)(2007-10#1)(2008-11#1)
can be repeatedly##2##3##(2008-10#1)(2008-9#1)
can be replaced by a##3##5##(1990-12#1)(1995-2#1)(2008-11#1)
can be replaced by##4##4##(1990-12#1)(1995-2#1)(2008-11#1)(2008-3#1)
can be replaced##6##3##(1990-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
can be replicated in##2##4##(1994-3#1)(1996-1#1)
can be replicated##3##3##(1994-3#1)(1995-6#1)(1996-1#1)
can be reported##2##3##(1994-9#1)(2008-3#1)
can be represented as##2##4##(2007-12#1)(2009-5#1)
can be represented by##5##4##(1990-8#2)(2008-10#1)(2008-11#1)(2008-2#1)
can be represented##9##3##(1990-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-1#1)
can be reproduced in vitro by##2##6##(1997-7#1)(2008-11#1)
can be reproduced in vitro##4##5##(1992-11#1)(1997-7#1)(2008-11#1)(2008-5#1)
can be reproduced##6##3##(1992-11#1)(1997-7#1)(2008-11#2)(2008-5#1)(2009-8#1)
can be required##2##3##(2011-2#1)(2012-12#1)
can be rescued by##2##4##(2007-12#1)(2011-2#1)
can be resolved by##4##4##(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)
can be resolved in the##2##5##(1992-3#1)(2008-8#1)
can be resolved into##2##4##(1992-5#1)(2008-10#1)
can be resolved##13##3##(1991-3#1)(1992-3#1)(1992-5#1)(1993-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
can be restored by##6##4##(1990-11#1)(1990-5#1)(1992-8#1)(1996-3#1)(2008-4#2)
can be restored to##2##4##(1993-11#1)(2008-9#1)
can be restored##11##3##(1990-11#1)(1990-5#1)(1992-8#1)(1993-11#1)(1994-8#1)(1996-3#1)(1997-7#1)(2008-4#2)(2008-9#1)(2011-2#1)
can be retained##2##3##(2008-10#1)(2010-3#1)
can be retrieved from##2##4##(2008-2#1)(2008-3#1)
can be retrieved with##3##4##(2008-3#3)
can be retrieved##13##3##(2007-11#1)(2008-2#2)(2008-3#8)(2008-4#2)
can be revealed by##2##4##(2008-1#1)(2008-9#1)
can be reversed by##4##4##(1994-8#2)(1996-9#1)(2013-8#1)
can be reversed##6##3##(1991-3#1)(1994-8#2)(1996-9#1)(2013-7#1)(2013-8#1)
can be reverted by##2##4##(1997-1#1)(2009-9#1)
can be ruled out##2##4##(1993-12#1)(2009-11#1)
can be safely and##3##4##(2007-8#1)(2008-4#1)(2011-2#1)
can be safely performed in##2##5##(2008-8#1)(2011-2#1)
can be safely used##2##4##(2008-11#1)(2011-2#1)
can be safely##12##3##(1997-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#3)
can be said that##3##4##(1990-2#1)(2008-12#1)(2011-2#1)
can be said##5##3##(1990-2#1)(1992-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
can be saved##2##3##(2008-4#1)(2008-6#1)
can be scaled to##2##4##(2007-12#1)(2008-7#1)
can be scaled##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
can be screened##2##3##(2008-11#1)(2009-5#1)
can be searched##2##3##(1991-2#1)(2008-3#1)
can be secreted##2##3##(2008-11#1)(2009-3#1)
can be seen as##3##4##(2008-12#1)(2008-7#1)(2011-2#1)
can be seen in the##3##5##(2006-12#1)(2008-11#1)(2011-2#1)
can be seen in##8##4##(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
can be seen with the##2##5##(2008-10#1)(2008-3#1)
can be seen##27##3##(1991-5#1)(1993-9#1)(1996-4#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#2)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
can be segmented into a##2##5##(2008-3#1)(2012-1#1)
can be selected##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
can be selectively##8##3##(1990-9#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
can be sensitized##2##3##(2008-10#1)(2008-11#1)
can be separated by##5##4##(1993-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
can be separated from##6##4##(1990-2#1)(2008-10#5)
can be separated in##3##4##(1996-5#1)(2008-10#2)
can be separated into two##2##5##(2008-10#1)(2009-11#1)
can be separated with high##2##5##(2008-10#2)
can be separated with##5##4##(1990-8#1)(2008-10#3)(2013-8#1)
can be separated##33##3##(1990-2#1)(1990-8#2)(1993-12#1)(1996-2#1)(1996-5#1)(2008-10#19)(2008-11#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-8#1)(2013-8#1)
can be seriously##2##3##(1995-12#1)(2008-11#1)
can be set up##2##4##(2008-2#1)(2008-3#1)
can be set##5##3##(1991-9#1)(2008-2#2)(2008-3#1)(2011-2#1)
can be severe in##2##4##(2008-10#2)
can be severe##5##3##(1993-12#1)(2007-2#1)(2008-10#2)(2008-7#1)
can be shifted##3##3##(1991-3#1)(2008-3#2)
can be shortened##2##3##(1993-9#1)(2010-8#1)
can be shown to##2##4##(1991-5#1)(2008-9#1)
can be shown##4##3##(1991-5#1)(1991-9#1)(2008-9#1)(2009-12#1)
can be significant##3##3##(1997-1#1)(2007-11#1)(2013-1#1)
can be significantly improved by##2##5##(2008-2#1)(2008-3#1)
can be significantly reduced##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
can be significantly##12##3##(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
can be simulated by##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
can be simulated##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
can be simultaneously detected##2##4##(2008-10#1)(2008-4#1)
can be simultaneously determined##2##4##(2008-10#2)
can be simultaneously##9##3##(1994-5#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2011-1#1)
can be so severe that##2##5##(2008-4#1)(2008-7#1)
can be so##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
can be solved by use of##2##6##(2008-3#2)
can be solved by##3##4##(2008-2#1)(2008-3#2)
can be solved with##2##4##(2008-3#1)(2008-7#1)
can be solved##12##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2009-12#1)
can be sorted##2##3##(2008-11#1)(2008-9#1)
can be specifically##4##3##(1996-12#1)(1997-7#1)(2008-4#1)(2011-2#1)
can be specified##3##3##(2008-2#2)(2011-2#1)
can be spectrophotometrically monitored at##2##5##(2008-10#2)
can be split##3##3##(2007-11#1)(2007-12#1)(2010-8#1)
can be stabilized##2##3##(2007-8#1)(2010-12#1)
can be stably##2##3##(1994-12#1)(2008-5#1)
can be standardized##2##3##(2008-10#2)
can be stated##3##3##(1992-11#1)(1994-5#1)(2009-8#1)
can be stimulated by##2##4##(1990-5#1)(1993-12#1)
can be stimulated##3##3##(1990-5#1)(1993-12#1)(2008-4#1)
can be stored in##5##4##(1990-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
can be stored##7##3##(1990-11#1)(1990-12#2)(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
can be strengthened through##2##4##(1995-3#1)(2009-11#1)
can be strengthened##4##3##(1995-3#1)(2007-5#1)(2009-11#1)(2009-5#1)
can be strongly##6##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
can be structured##2##3##(2008-11#1)(2009-2#1)
can be studied as##2##4##(1992-6#1)(2010-4#1)
can be studied by##2##4##(2008-1#2)
can be studied in##4##4##(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
can be studied##17##3##(1991-9#1)(1992-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
can be subdivided into two##2##5##(1995-11#1)(2008-12#1)
can be subdivided into##3##4##(1995-11#1)(2008-12#1)(2008-9#1)
can be subject to##2##4##(2008-10#2)
can be substantially improved##2##4##(1992-3#1)(1993-12#1)
can be substantially reduced##2##4##(2008-10#1)(2008-3#1)
can be substantially##4##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-3#1)
can be substituted for the##2##5##(1990-12#1)(2007-12#1)
can be substituted##4##3##(1990-12#1)(1991-9#1)(2007-12#1)(2009-6#1)
can be successful##3##3##(1996-12#1)(2008-4#1)(2010-10#1)
can be successfully applied in##2##5##(2007-8#1)(2008-10#1)
can be successfully applied to the##3##6##(2008-10#3)
can be successfully applied to##5##5##(2007-12#1)(2008-10#3)(2008-3#1)
can be successfully applied##10##4##(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2010-6#1)
can be successfully treated##4##4##(1997-3#1)(1997-8#1)(2011-2#1)(2013-8#1)
can be successfully used for##2##5##(2008-10#1)(2011-2#1)
can be successfully used to determine the drug content of marketed##2##11##(2010-3#1)(2012-2#1)
can be successfully used to determine the drug##3##8##(2010-3#1)(2010-5#1)(2012-2#1)
can be successfully used to##4##5##(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
can be successfully used##8##4##(2008-10#2)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
can be successfully##32##3##(1990-8#1)(1993-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-10#9)(2008-3#3)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-8#1)
can be sufficient##2##3##(1993-11#1)(2008-9#1)
can be sufficiently##2##3##(2008-2#1)(2012-2#1)
can be suggested##5##3##(1990-5#1)(1994-11#1)(2008-1#1)(2008-10#1)(2010-4#1)
can be suitably##3##3##(1990-11#1)(1990-12#1)(1996-5#1)
can be summarized as follows##4##5##(1990-9#1)(1995-9#2)(2008-10#1)
can be summarized as##5##4##(1990-9#1)(1992-11#1)(1995-9#2)(2008-10#1)
can be summarized##6##3##(1990-9#1)(1992-11#1)(1995-9#2)(2008-10#1)(2008-7#1)
can be superimposed##2##3##(2007-12#1)(2013-1#1)
can be supported##3##3##(2008-11#2)(2008-3#1)
can be supposed##2##3##(1997-7#1)(2008-11#1)
can be suppressed by##4##4##(1994-3#1)(2007-11#2)(2008-11#1)
can be switched between##2##4##(2007-11#1)(2008-3#1)
can be switched##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#2)
can be synthesized through##2##4##(1992-6#1)(2009-11#1)
can be synthesized##6##3##(1992-12#1)(1992-6#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)
can be tailored to##3##4##(2008-10#1)(2008-4#1)(2009-7#1)
can be tailored##7##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)
can be taken into account by considering##2##7##(2008-10#2)
can be taken into account##3##5##(2007-11#1)(2008-10#2)
can be taken into##4##4##(2007-11#1)(2008-10#2)(2010-5#1)
can be taken to##4##4##(1990-12#1)(1994-9#1)(2008-8#1)(2008-9#1)
can be taken##14##3##(1990-12#1)(1992-8#1)(1994-9#1)(1996-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)
can be targeted by##2##4##(2009-4#1)(2011-2#1)
can be targeted##4##3##(1993-11#1)(1997-7#1)(2009-4#1)(2011-2#1)
can be tested in##2##4##(1996-4#1)(2010-12#1)
can be tested##9##3##(1990-11#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-8#1)
can be the##14##3##(1992-3#1)(1994-8#1)(1995-1#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
can be thought##2##3##(1997-7#1)(2013-1#1)
can be tolerated in considerable amounts##2##6##(2008-10#2)
can be tolerated##6##3##(1990-11#1)(2008-10#4)(2008-3#1)
can be toxic to##2##4##(1996-12#1)(2008-11#1)
can be traced to the##2##5##(1995-2#1)(2008-10#1)
can be traced to##6##4##(1993-6#2)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)
can be traced##7##3##(1993-6#2)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2009-6#1)
can be trained##3##3##(1994-3#1)(2008-2#1)(2010-8#1)
can be transferred to##3##4##(1995-5#1)(2008-10#2)
can be transferred##6##3##(1995-5#1)(2008-10#2)(2008-8#1)(2010-6#1)(2013-1#1)
can be transformed##3##3##(1994-12#1)(2008-7#1)(2013-8#1)
can be translated into##4##4##(1991-12#1)(2008-6#1)(2008-8#1)(2012-12#1)
can be translated##6##3##(1991-12#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
can be transmitted from##3##4##(1990-9#1)(2008-10#1)(2008-3#1)
can be transmitted through##2##4##(1996-5#1)(2008-10#1)
can be transmitted##12##3##(1990-9#1)(1993-1#1)(1996-5#1)(1996-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#1)
can be transplanted##2##3##(2008-11#1)(2008-8#1)
can be transported##3##3##(2008-10#2)(2008-11#1)
can be trapped##2##3##(1991-9#1)(2009-12#1)
can be treated as a##2##5##(2008-2#1)(2008-3#1)
can be treated as##4##4##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
can be treated by##3##4##(2007-7#1)(2008-7#1)(2013-8#1)
can be treated in##2##4##(2007-8#1)(2013-8#1)
can be treated with either##2##5##(2007-7#1)(2008-7#1)
can be treated with##10##4##(1990-9#1)(1991-3#1)(1991-9#1)(1992-5#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-3#1)
can be treated##29##3##(1990-12#1)(1990-9#2)(1991-3#1)(1991-9#2)(1992-2#1)(1992-5#2)(1993-3#1)(1995-2#1)(1996-11#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-7#1)(2012-3#1)(2013-8#2)
can be triggered by##2##4##(1996-12#1)(2009-4#1)
can be tuned by the##2##5##(2007-11#1)(2012-2#1)
can be tuned by##5##4##(2007-11#3)(2007-12#1)(2012-2#1)
can be tuned from##2##4##(2007-11#1)(2008-7#1)
can be tuned over##2##4##(2007-12#1)(2008-3#1)
can be tuned##14##3##(2007-11#5)(2007-12#2)(2008-11#1)(2008-3#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
can be turned##2##3##(1994-12#1)(2008-8#1)
can be understood as a##2##5##(2008-10#1)(2008-6#1)
can be understood as an##2##5##(2007-12#1)(2013-8#1)
can be understood as##4##4##(2007-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
can be understood##13##3##(1990-5#1)(1990-7#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#1)
can be undertaken##4##3##(1992-9#1)(1993-12#1)(1995-5#1)(2007-8#1)
can be used and##2##4##(2008-3#2)
can be used as a basis##2##6##(2008-2#1)(2008-9#1)
can be used as a guide##2##6##(2011-2#1)(2012-2#1)
can be used as a marker##2##6##(2009-12#1)(2009-2#1)
can be used as a measure of the##2##8##(2008-10#1)(2008-2#1)
can be used as a measure of##3##7##(2008-10#1)(2008-2#1)(2008-3#1)
can be used as a new##6##6##(2008-10#3)(2008-2#1)(2008-5#2)
can be used as a platform##2##6##(2008-7#1)(2010-5#1)
can be used as a potential##2##6##(2008-10#1)(2013-1#1)
can be used as a##64##5##(1991-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#5)
can be used as an aid##2##6##(1991-11#1)(2008-10#1)
can be used as an alternative##2##6##(1992-5#1)(2008-10#1)
can be used as an##16##5##(1990-5#1)(1991-11#1)(1992-5#1)(1993-9#1)(1994-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2011-2#1)
can be used as efficient##2##5##(2008-10#1)(2008-8#1)
can be used as first-line##2##5##(1993-2#1)(1997-3#1)
can be used as reference##2##5##(2008-10#1)(2013-1#1)
can be used as the basis for##4##7##(1992-6#1)(2007-12#1)(2008-2#2)
can be used as the##9##5##(1992-6#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2013-8#1)
can be used as##127##4##(1990-5#1)(1991-11#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#5)(2013-1#9)(2013-8#2)
can be used at##3##4##(1994-12#1)(2008-10#1)(2008-7#1)
can be used by the##3##5##(2006-10#1)(2008-12#1)(2011-2#1)
can be used by##12##4##(1991-1#1)(1991-2#1)(1992-3#1)(1995-6#1)(2006-10#1)(2008-12#2)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
can be used directly for##2##5##(1995-6#1)(2008-10#1)
can be used directly##4##4##(1995-6#1)(2008-10#2)(2008-4#1)
can be used effectively##3##4##(2008-2#1)(2013-8#2)
can be used efficiently##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
can be used either##2##4##(2008-10#1)(2008-3#1)
can be used for a##4##5##(1991-7#1)(2008-10#2)(2008-3#1)
can be used for analytical##2##5##(2008-10#1)(2008-2#1)
can be used for any##2##5##(2008-3#1)(2008-4#1)
can be used for at least 3 months without any considerable##3##11##(2008-10#3)
can be used for at least 3 months without any##5##10##(2008-10#5)
can be used for at least##12##6##(2008-10#12)
can be used for both##6##5##(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)
can be used for determination of##2##6##(2008-10#2)
can be used for determining##2##5##(2008-10#2)
can be used for efficient##2##5##(2008-2#1)(2008-3#1)
can be used for its determination##2##6##(2008-10#2)
can be used for measurements##2##5##(2008-3#2)
can be used for measuring##2##5##(2008-10#1)(2008-3#1)
can be used for more than##4##6##(2008-10#4)
can be used for purposes of##2##6##(1991-6#1)(1994-6#1)
can be used for rapid screening##2##6##(2008-10#1)(2008-4#1)
can be used for rapid##4##5##(2008-10#2)(2008-4#1)(2008-5#1)
can be used for reliable##2##5##(1993-12#1)(2008-10#1)
can be used for research and##2##6##(1996-12#1)(2007-10#1)
can be used for routine##2##5##(2008-10#1)(2008-12#1)
can be used for simultaneous##2##5##(2008-10#1)(2011-3#1)
can be used for the analysis of##3##7##(2008-10#1)(2008-2#1)(2008-4#1)
can be used for the design of##2##7##(2007-12#1)(2011-2#1)
can be used for the detection of##2##7##(2008-10#1)(2008-3#1)
can be used for the determination of##7##7##(1993-9#1)(2008-10#6)
can be used for the development of##2##7##(2008-10#1)(2008-9#1)
can be used for the production of##2##7##(2008-6#1)(2008-8#1)
can be used for the routine##2##6##(2008-10#1)(2010-4#1)
can be used for the separation##2##6##(2008-10#1)(2008-7#1)
can be used for the##38##5##(1993-9#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)
can be used for##191##4##(1991-6#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-7#1)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#69)(2008-11#4)(2008-12#3)(2008-2#10)(2008-3#22)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
can be used in a##7##5##(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)
can be used in clinical##2##5##(2010-8#1)(2011-1#1)
can be used in combination with##3##6##(2008-5#1)(2009-6#1)(2013-7#1)
can be used in conjunction with##4##6##(2008-4#2)(2008-8#2)
can be used in developing##2##5##(2008-10#1)(2009-5#1)
can be used in every##2##5##(2007-10#1)(2007-12#1)
can be used in optical##3##5##(2008-2#2)(2008-3#1)
can be used in the analysis##2##6##(1994-2#1)(2008-10#1)
can be used in the pH range##5##7##(2008-10#5)
can be used in the##21##5##(1994-2#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
can be used in this##2##5##(2007-12#1)(2012-12#1)
can be used in##78##4##(1992-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
can be used individually##2##4##(1996-1#1)(2008-8#1)
can be used instead of##3##5##(2007-11#1)(2008-3#1)(2008-4#1)
can be used instead##5##4##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
can be used not only to##2##6##(1991-5#1)(2008-4#1)
can be used not only##3##5##(1991-5#1)(2008-2#1)(2008-4#1)
can be used on##5##4##(1997-3#1)(1997-4#1)(2008-2#1)(2008-9#1)(2013-8#1)
can be used over a##6##5##(2007-11#1)(2008-10#4)(2008-3#1)
can be used prior to##2##5##(2008-10#1)(2010-8#1)
can be used repeatedly for##2##5##(2008-10#1)(2008-6#1)
can be used safely##2##4##(2007-8#1)(2012-12#1)
can be used successfully to##2##5##(2008-3#1)(2008-5#1)
can be used successfully##4##4##(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)
can be used to accurately##3##5##(1994-3#1)(2008-10#1)(2010-3#1)
can be used to achieve##3##5##(1995-3#1)(2008-10#1)(2009-3#1)
can be used to amplify##2##5##(2008-4#1)(2009-4#1)
can be used to analyze the##2##6##(1995-3#1)(2008-4#1)
can be used to analyze##5##5##(1995-3#1)(1996-2#1)(1996-5#1)(2008-4#1)(2013-8#1)
can be used to assess the##2##6##(2008-11#1)(2009-8#1)
can be used to assess##5##5##(2008-1#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#1)
can be used to calculate the##3##6##(2008-10#2)(2008-3#1)
can be used to calculate##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
can be used to characterise the##2##6##(2008-10#1)(2010-4#1)
can be used to characterize the##3##6##(2008-3#1)(2008-4#1)(2010-5#1)
can be used to characterize##8##5##(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)
can be used to compare the##2##6##(2008-10#1)(2008-8#1)
can be used to compare##3##5##(2008-10#1)(2008-8#1)(2008-9#1)
can be used to compute##4##5##(2008-2#1)(2008-4#1)(2008-8#1)(2009-9#1)
can be used to concentrate##2##5##(2008-10#1)(2008-2#1)
can be used to construct##4##5##(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
can be used to control the##2##6##(2008-2#1)(2012-2#1)
can be used to create a##2##6##(2008-2#1)(2011-2#1)
can be used to create##5##5##(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-2#1)
can be used to define the##2##6##(2007-11#1)(2008-11#1)
can be used to define##3##5##(2007-11#1)(2008-10#1)(2008-11#1)
can be used to derive an##2##6##(2007-12#1)(2009-3#1)
can be used to derive##5##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)
can be used to describe the##3##6##(2008-3#2)(2010-12#1)
can be used to describe##4##5##(2008-3#2)(2008-9#1)(2010-12#1)
can be used to detect the##2##6##(1996-5#1)(2008-2#1)
can be used to detect##18##5##(1996-5#1)(2008-10#4)(2008-2#2)(2008-4#6)(2008-7#1)(2008-9#1)(2009-11#1)(2010-6#1)(2012-3#1)
can be used to determine a##2##6##(1993-12#1)(2008-3#1)
can be used to determine the number of##2##8##(2006-10#1)(2008-10#1)
can be used to determine the relevance of##2##8##(1996-2#1)(2008-10#1)
can be used to determine the##15##6##(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)
can be used to determine whether the##2##7##(2008-2#1)(2008-3#1)
can be used to determine##26##5##(1993-12#1)(1996-2#1)(2006-10#1)(2006-4#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)
can be used to develop##3##5##(1997-7#1)(2008-11#1)(2012-2#1)
can be used to discriminate##2##5##(1994-12#1)(2008-7#1)
can be used to distinguish##4##5##(2008-1#1)(2008-10#2)(2013-8#1)
can be used to educate##2##5##(2007-4#1)(2008-12#1)
can be used to effectively##2##5##(2008-10#1)(2008-11#1)
can be used to eliminate##2##5##(1991-9#1)(2007-11#1)
can be used to enhance the##2##6##(2008-2#1)(2008-3#1)
can be used to enhance##3##5##(2008-11#1)(2008-2#1)(2008-3#1)
can be used to establish##2##5##(2008-10#1)(2008-11#1)
can be used to estimate the##6##6##(1994-11#1)(1996-3#1)(2008-10#4)
can be used to estimate##9##5##(1994-11#1)(1996-3#1)(2008-10#4)(2008-2#2)(2013-1#1)
can be used to evaluate the##5##6##(1991-1#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
can be used to evaluate##7##5##(1991-1#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-12#1)
can be used to explain##2##5##(2008-4#1)(2012-12#1)
can be used to express##2##5##(2008-3#1)(2008-7#1)
can be used to extract##3##5##(1990-12#1)(2008-10#1)(2008-3#1)
can be used to find##4##5##(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
can be used to form##2##5##(2008-2#1)(2009-9#1)
can be used to generate##8##5##(1990-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2011-3#1)(2012-2#1)
can be used to help##4##5##(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
can be used to identify the##5##6##(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)
can be used to identify##14##5##(1993-3#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-4#3)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
can be used to implement##2##5##(2008-3#2)
can be used to improve the quality of##2##8##(1994-3#1)(2008-3#1)
can be used to improve the##7##6##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-6#1)
can be used to improve##13##5##(1994-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-6#1)(2009-9#1)(2011-1#1)
can be used to inform##3##5##(1996-1#1)(2012-12#1)(2013-8#1)
can be used to investigate the##2##6##(1996-12#1)(2012-3#1)
can be used to investigate##4##5##(1990-5#1)(1990-7#1)(1996-12#1)(2012-3#1)
can be used to locate##2##5##(2007-11#1)(2008-3#1)
can be used to make a##2##6##(2012-2#1)(2013-1#1)
can be used to make##7##5##(2008-3#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
can be used to map##3##5##(1996-4#1)(2008-4#1)(2008-9#1)
can be used to measure the##7##6##(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#2)
can be used to measure##16##5##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#5)(2008-4#5)(2008-7#1)(2013-1#1)
can be used to model##4##5##(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)
can be used to monitor the##2##6##(2008-3#1)(2008-4#1)
can be used to monitor##4##5##(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
can be used to obtain##5##5##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
can be used to overcome##2##5##(1996-3#1)(2012-2#1)
can be used to predict the##4##6##(1997-9#1)(2008-10#1)(2010-2#1)(2013-8#1)
can be used to predict##7##5##(1997-9#1)(2008-10#2)(2008-3#2)(2010-2#1)(2013-8#1)
can be used to probe##2##5##(2007-11#1)(2008-1#1)
can be used to produce a##2##6##(2008-2#1)(2008-3#1)
can be used to produce##10##5##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-12#1)(2009-5#1)(2010-3#1)
can be used to provide a##2##6##(2008-3#1)(2008-4#1)
can be used to provide##4##5##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
can be used to quantify##2##5##(2008-1#1)(2010-5#1)
can be used to quantitate##3##5##(1990-12#1)(2008-4#2)
can be used to quantitatively##2##5##(2008-10#2)
can be used to rapidly##2##5##(2007-12#1)(2011-2#1)
can be used to reconstruct##2##5##(2008-3#1)(2010-6#1)
can be used to reduce the##3##6##(1997-6#1)(2008-2#2)
can be used to reduce##6##5##(1997-6#1)(2007-12#2)(2008-2#3)
can be used to search for##2##6##(2008-2#1)(2013-1#1)
can be used to solve##4##5##(2008-11#1)(2008-3#1)(2009-12#1)(2010-7#1)
can be used to study the##7##6##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)
can be used to study##13##5##(1993-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2010-9#1)
can be used to test for##2##6##(1992-11#1)(2008-10#1)
can be used to test##7##5##(1992-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
can be used to transfer##2##5##(1990-5#1)(2008-10#1)
can be used to treat##4##5##(1992-1#1)(1997-6#1)(2007-11#1)(2011-2#1)
can be used to##417##4##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-4#1)(2007-11#7)(2007-12#13)(2007-4#1)(2007-8#2)(2008-1#14)(2008-10#63)(2008-11#16)(2008-12#4)(2008-2#36)(2008-3#51)(2008-4#40)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#11)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#7)(2013-8#5)
can be used when it is##2##6##(2007-12#1)(2008-10#1)
can be used when##4##4##(2007-12#1)(2008-10#2)(2008-12#1)
can be used with any##2##5##(2008-2#1)(2013-1#1)
can be used with or without##2##6##(1992-3#1)(2007-7#1)
can be used with##20##4##(1991-3#1)(1991-5#1)(1992-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-9#1)(2011-1#2)(2013-1#2)
can be used##948##3##(1990-11#1)(1990-12#3)(1990-5#3)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#4)(1996-1#3)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-6#4)(1997-7#2)(1997-8#2)(1997-9#1)(2006-10#2)(2006-4#2)(2007-10#3)(2007-11#16)(2007-12#30)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#18)(2008-10#203)(2008-11#28)(2008-12#12)(2008-2#71)(2008-3#104)(2008-4#66)(2008-5#18)(2008-6#7)(2008-7#22)(2008-8#22)(2008-9#26)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#8)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#11)(2011-2#21)(2011-3#2)(2012-1#2)(2012-12#8)(2012-2#17)(2012-3#7)(2013-1#26)(2013-7#1)(2013-8#12)
can be useful as##2##4##(2008-10#2)
can be useful for the##3##5##(2008-10#1)(2008-7#1)(2013-8#1)
can be useful for##16##4##(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#2)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
can be useful in the##3##5##(1995-11#1)(1996-11#1)(2008-7#1)
can be useful in##15##4##(1991-2#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)
can be useful to identify##3##5##(2008-4#2)(2011-2#1)
can be useful to##7##4##(1992-2#1)(2008-10#1)(2008-4#2)(2009-5#1)(2011-2#2)
can be useful##46##3##(1991-2#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
can be utilized as##2##4##(2008-11#1)(2009-12#1)
can be utilized for##6##4##(1992-2#1)(1994-11#1)(2008-10#1)(2009-10#1)(2009-3#1)(2010-6#1)
can be utilized in##5##4##(1994-9#1)(2008-10#2)(2010-5#1)(2012-1#1)
can be utilized reliably##2##4##(2008-10#1)(2008-5#1)
can be utilized to##4##4##(1995-5#1)(2008-4#1)(2008-9#1)(2013-1#1)
can be utilized##21##3##(1992-2#1)(1994-11#1)(1994-9#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
can be varied by##3##4##(1994-9#1)(2008-3#1)(2008-5#1)
can be varied##7##3##(1994-9#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
can be very effective##2##4##(2008-10#2)
can be very helpful in##2##5##(2008-1#1)(2008-12#1)
can be very misleading##2##4##(1994-12#1)(1997-1#1)
can be very useful as##2##5##(2008-4#1)(2011-2#1)
can be very useful##4##4##(2008-4#1)(2010-1#1)(2011-2#1)(2013-1#1)
can be very##16##3##(1994-12#1)(1997-1#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
can be viewed as a##4##5##(1994-12#1)(2008-3#1)(2008-8#1)(2010-12#1)
can be viewed as##9##4##(1991-3#1)(1993-12#1)(1994-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
can be viewed##14##3##(1991-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)
can be virtually##2##3##(1991-3#1)(2011-2#1)
can be visualized in##2##4##(1997-4#1)(2008-10#1)
can be visualized##7##3##(1993-12#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)
can be well separated within##2##5##(2008-10#2)
can be well separated##4##4##(1996-5#1)(2008-10#3)
can be well##8##3##(1996-5#1)(2008-10#4)(2008-3#2)(2009-2#1)
can be written as a##3##5##(2008-10#1)(2008-2#1)(2013-1#1)
can be written as##4##4##(2008-10#2)(2008-2#1)(2013-1#1)
can be written in less than 1##2##7##(2008-3#2)
can be written in##3##4##(2008-3#3)
can be written##9##3##(2008-10#3)(2008-2#1)(2008-3#4)(2013-1#1)
can be##5896##2##(1990-10#1)(1990-11#16)(1990-12#23)(1990-2#11)(1990-3#4)(1990-4#1)(1990-5#18)(1990-6#5)(1990-7#7)(1990-8#19)(1990-9#10)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#13)(1991-2#12)(1991-3#21)(1991-4#3)(1991-5#18)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#24)(1992-1#10)(1992-10#3)(1992-11#14)(1992-12#18)(1992-2#16)(1992-3#23)(1992-4#3)(1992-5#12)(1992-6#24)(1992-7#2)(1992-8#8)(1992-9#13)(1993-1#4)(1993-11#15)(1993-12#27)(1993-2#16)(1993-3#23)(1993-5#1)(1993-6#18)(1993-8#11)(1993-9#16)(1994-1#3)(1994-10#2)(1994-11#12)(1994-12#30)(1994-2#26)(1994-3#35)(1994-5#17)(1994-6#6)(1994-7#3)(1994-8#25)(1994-9#24)(1995-1#13)(1995-11#13)(1995-12#18)(1995-2#24)(1995-3#17)(1995-5#13)(1995-6#16)(1995-8#7)(1995-9#4)(1996-1#12)(1996-11#12)(1996-12#27)(1996-2#20)(1996-3#19)(1996-4#4)(1996-5#18)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#15)(1997-2#20)(1997-3#16)(1997-4#22)(1997-5#3)(1997-6#21)(1997-7#17)(1997-8#13)(1997-9#1)(2006-10#5)(2006-12#3)(2006-4#2)(2006-6#2)(2007-10#11)(2007-11#156)(2007-12#196)(2007-2#6)(2007-4#1)(2007-5#5)(2007-6#4)(2007-7#20)(2007-8#35)(2007-9#6)(2008-1#96)(2008-10#1083)(2008-11#225)(2008-12#56)(2008-2#313)(2008-3#622)(2008-4#245)(2008-5#110)(2008-6#59)(2008-7#188)(2008-8#140)(2008-9#156)(2009-1#3)(2009-10#16)(2009-11#27)(2009-12#28)(2009-2#10)(2009-3#16)(2009-4#8)(2009-5#26)(2009-6#12)(2009-7#14)(2009-8#28)(2009-9#24)(2010-1#7)(2010-10#15)(2010-11#19)(2010-12#29)(2010-2#7)(2010-3#20)(2010-4#21)(2010-5#28)(2010-6#25)(2010-7#10)(2010-8#46)(2010-9#5)(2011-1#55)(2011-10#1)(2011-2#160)(2011-3#8)(2011-7#3)(2012-1#25)(2012-12#43)(2012-2#99)(2012-3#49)(2012-4#1)(2012-6#1)(2012-7#2)(2012-9#3)(2013-1#105)(2013-7#15)(2013-8#76)
can become a##2##3##(1994-9#1)(2008-10#1)
can become active##2##3##(1995-2#1)(2011-1#1)
can become##17##2##(1992-12#1)(1994-9#1)(1995-2#1)(2007-12#1)(2007-2#2)(2008-10#5)(2008-11#3)(2011-1#1)(2013-1#1)(2013-7#1)
can begin##2##2##(1994-1#1)(2008-7#1)
can benefit from a##2##4##(1992-3#1)(1997-3#1)
can benefit from the##3##4##(1991-2#1)(1992-2#1)(2008-9#1)
can benefit from##13##3##(1991-2#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-9#2)(2011-2#1)(2013-8#1)
can benefit##14##2##(1991-2#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
can best be##2##3##(2008-6#1)(2011-2#1)
can best##6##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
can better##6##2##(1992-1#1)(2007-11#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
can bind and##2##3##(1993-6#1)(2011-2#1)
can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC)##2##15##(2008-4#2)
can bind to and##2##4##(1991-9#1)(1994-5#1)
can bind to the##8##4##(1991-12#1)(1993-8#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#2)(2013-8#1)
can bind to##16##3##(1990-9#1)(1991-12#1)(1991-9#1)(1993-8#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-4#3)(2008-6#1)(2008-8#3)(2013-8#1)
can bind with##2##3##(2008-8#1)(2013-7#1)
can bind##34##2##(1990-12#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#5)(2009-12#1)(2011-2#3)(2013-7#1)(2013-8#1)
can block##4##2##(1994-8#1)(2008-8#1)(2008-9#1)(2012-2#1)
can boost the##2##3##(2008-5#1)(2012-3#1)
can both##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2011-10#1)(2013-1#1)
can bring about##6##3##(1990-11#1)(1996-3#1)(2008-1#1)(2008-11#1)(2012-1#1)(2012-2#1)
can bring##8##2##(1990-11#1)(1996-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2012-1#1)(2012-2#1)
can build##4##2##(1995-12#1)(2007-12#1)(2010-10#1)(2013-1#1)
can calculate##4##2##(1995-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
can capture the##3##3##(2009-5#1)(2010-10#1)(2012-12#1)
can capture##7##2##(1994-8#1)(2008-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
can carry##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
can catalyse##2##2##(1992-12#1)(1992-6#1)
can catalyze the##3##3##(1993-8#1)(2008-10#2)
can catalyze##4##2##(1993-8#1)(1994-5#1)(2008-10#2)
can categorize##2##2##(2007-12#1)(2008-8#1)
can cause a##4##3##(1990-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
can cause death##2##3##(1997-3#1)(2008-7#1)
can cause diagnostic##2##3##(2010-8#1)(2011-2#1)
can cause intrauterine##2##3##(1992-5#1)(2013-1#1)
can cause many##2##3##(1993-3#1)(2008-10#1)
can cause morbidity and##2##4##(2008-5#1)(2013-1#1)
can cause problems##2##3##(2007-12#1)(2011-2#1)
can cause serious complications##2##4##(2009-4#1)(2013-1#1)
can cause serious##4##3##(2008-11#1)(2009-4#1)(2010-7#1)(2013-1#1)
can cause severe##6##3##(1996-11#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
can cause significant morbidity##2##4##(2008-8#1)(2012-8#1)
can cause significant##4##3##(2007-10#1)(2008-8#1)(2010-9#1)(2012-8#1)
can cause such##2##3##(2009-5#1)(2011-2#1)
can cause##115##2##(1990-2#1)(1990-6#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1993-3#1)(1994-12#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-12#2)(2007-10#4)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#12)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#8)(2013-8#2)
can change the##3##3##(1994-3#1)(2008-3#1)(2012-3#1)
can change their##2##3##(1996-2#1)(2010-12#1)
can change##13##2##(1994-3#1)(1996-2#1)(1997-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-3#2)
can characterize##2##2##(2008-10#1)(2013-1#1)
can choose##2##2##(2008-3#1)(2010-8#1)
can clearly be##2##3##(2008-10#1)(2012-3#1)
can clearly##3##2##(1992-9#1)(2008-10#1)(2012-3#1)
can clinically##2##2##(2007-7#1)(2010-12#1)
can coexist##4##2##(1995-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
can collaborate##2##2##(1991-5#1)(1992-3#1)
can collect##2##2##(2008-10#1)(2009-5#1)
can colonize##2##2##(2008-10#1)(2008-5#1)
can come to##2##3##(2008-5#1)(2012-2#1)
can come##4##2##(2007-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
can compensate for##5##3##(1997-3#1)(2007-11#2)(2007-12#1)(2011-1#1)
can compensate##6##2##(1997-3#1)(2007-11#2)(2007-12#1)(2008-3#1)(2011-1#1)
can compete##2##2##(1994-9#1)(2008-6#1)
can complement the##2##3##(1994-12#1)(2010-11#1)
can complement##4##2##(1994-12#1)(2008-5#1)(2008-8#1)(2010-11#1)
can complete##4##2##(2008-10#4)
can completely##3##2##(1995-5#1)(2007-11#1)(2008-3#1)
can complex with##2##3##(1991-5#1)(1994-5#1)
can complicate the##2##3##(2012-3#1)(2013-1#1)
can complicate##3##2##(1995-3#1)(2012-3#1)(2013-1#1)
can compromise##2##2##(2009-10#1)(2010-10#1)
can conclude that the##2##4##(2008-2#1)(2013-8#1)
can conclude that##8##3##(1994-8#1)(2008-2#1)(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-8#1)
can conclude##9##2##(1994-8#1)(2008-2#1)(2008-9#1)(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-8#1)
can confer##5##2##(1993-8#1)(1997-4#1)(2008-9#1)(2011-2#1)(2013-8#1)
can confidently##2##2##(2007-8#1)(2008-11#1)
can considerably##3##2##(1997-8#1)(2008-11#1)(2008-3#1)
can constitute a##2##3##(2006-4#1)(2013-1#1)
can contain##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
can contaminate the##2##3##(2008-10#1)(2008-4#1)
can continuously##2##2##(2008-10#1)(2008-8#1)
can contract##2##2##(1995-12#1)(1996-2#1)
can contribute greatly to##2##4##(2010-6#2)
can contribute to a##2##4##(2011-2#1)(2013-1#1)
can contribute to the##17##4##(1990-6#1)(1991-3#1)(1994-12#1)(1995-1#1)(1997-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
can contribute to##36##3##(1990-6#1)(1991-3#1)(1994-12#1)(1994-5#1)(1995-1#2)(1997-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
can contribute##44##2##(1990-6#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-5#1)(1995-1#2)(1996-2#1)(1997-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
can control the##7##3##(2007-11#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-12#1)
can control##14##2##(1992-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
can conveniently be##2##3##(2008-3#2)
can conveniently##3##2##(2007-12#1)(2008-3#2)
can convert##4##2##(1991-12#1)(1993-12#1)(1993-5#1)(2013-1#1)
can cooperate with##2##3##(1994-12#1)(2009-9#1)
can cope with##2##3##(2008-3#1)(2012-12#1)
can correct##2##2##(1997-1#1)(2007-12#1)
can correctly##2##2##(1990-5#1)(2008-7#1)
can cover##2##2##(2008-3#1)(2010-9#1)
can create a##3##3##(1993-2#1)(1997-3#1)(2008-5#1)
can create an##3##3##(1994-12#1)(2010-5#1)(2010-8#1)
can create##13##2##(1993-2#1)(1994-1#1)(1994-12#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#2)
can cross##2##2##(2008-1#1)(2009-8#1)
can damage##4##2##(1991-9#1)(1992-9#1)(2008-10#1)(2008-3#1)
can deal with##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
can decrease the##4##3##(2007-10#1)(2011-3#1)(2013-1#1)(2013-8#1)
can decrease##9##2##(1995-3#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
can defend##2##2##(2008-6#1)(2009-8#1)
can define the##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
can define##5##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
can degrade##6##2##(1993-11#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#1)
can delay the evolution of##2##5##(1995-6#2)
can delay##4##2##(1990-5#1)(1995-6#2)(2008-9#1)
can deliver##8##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)
can demonstrate##3##2##(2008-7#3)
can describe the##2##3##(2008-10#1)(2008-9#1)
can describe##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
can design##4##2##(1996-2#1)(1997-3#1)(2007-11#1)(2008-3#1)
can destroy the##2##3##(1992-2#1)(1994-9#1)
can destroy##4##2##(1992-2#1)(1994-9#1)(2008-11#1)(2008-8#1)
can detect a##3##3##(1990-2#1)(2007-11#1)(2008-3#1)
can detect the##6##3##(1991-4#1)(2007-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
can detect##21##2##(1990-2#1)(1991-4#1)(1995-12#2)(1996-12#1)(2007-11#3)(2008-10#2)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)
can determine the##9##3##(1994-7#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#1)
can determine##17##2##(1994-3#1)(1994-7#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
can detrimentally affect##3##3##(2008-11#1)(2010-11#1)(2013-1#1)
can develop at any##2##4##(1993-2#1)(2011-1#1)
can develop##20##2##(1990-10#1)(1993-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
can diagnose##3##2##(1991-12#1)(2007-2#1)(2008-3#1)
can differ in##2##3##(2008-10#1)(2008-8#1)
can differ##6##2##(1997-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)
can differentiate into##5##3##(2008-7#2)(2012-12#3)
can differentiate##8##2##(2007-5#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-12#3)
can diffuse##2##2##(2008-10#1)(2008-7#1)
can diminish##2##2##(2008-10#1)(2008-7#1)
can direct##2##2##(1994-6#1)(1994-8#1)
can directly##12##2##(1991-5#1)(1992-1#1)(1994-8#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-11#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
can disclose##2##2##(2008-3#1)(2008-8#1)
can discriminate between tastants##2##4##(2008-11#2)
can discriminate between##4##3##(1990-11#1)(2008-10#1)(2008-11#2)
can discriminate##6##2##(1990-11#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#2)
can display##2##2##(1992-12#1)(2012-3#1)
can disrupt##3##2##(1997-7#1)(2011-2#1)(2013-8#1)
can distinguish the##2##3##(2008-10#1)(2008-9#1)
can distinguish##8##2##(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)
can do about it##2##4##(1996-3#1)(2008-11#1)
can do to##3##3##(2008-12#2)(2008-6#1)
can do##8##2##(1992-3#1)(1992-8#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#1)
can dramatically influence the##2##4##(1996-7#1)(1997-2#1)
can dramatically##11##2##(1992-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(2007-11#3)(2008-10#2)(2008-8#1)(2013-1#1)
can drive the##6##3##(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
can drive##8##2##(1991-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
can dynamically##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
can ease the##2##3##(1996-1#1)(2008-6#1)
can ease##3##2##(1992-3#1)(1996-1#1)(2008-6#1)
can easily and quickly label##2##5##(2008-10#2)
can easily and##3##3##(2008-10#2)(2008-6#1)
can easily be achieved##2##4##(2007-11#1)(2008-3#1)
can easily be applied to##2##5##(1994-3#1)(2008-4#1)
can easily be applied##3##4##(1994-3#1)(2008-10#1)(2008-4#1)
can easily be detected##2##4##(2007-12#1)(2008-5#1)
can easily be determined##2##4##(2007-12#1)(2008-10#1)
can easily be extended to##4##5##(2007-11#1)(2008-3#2)(2008-9#1)
can easily be regenerated by##2##5##(2008-10#1)(2008-5#1)
can easily be used##2##4##(2008-11#1)(2008-2#1)
can easily be##35##3##(1990-2#1)(1990-9#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-9#1)(2010-1#1)(2012-1#1)
can easily##51##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
can effectively communicate##2##3##(1992-2#1)(1994-2#1)
can effectively increase the##2##4##(2008-3#1)(2012-3#1)
can effectively inhibit the##3##4##(1991-9#1)(2008-11#1)(2011-2#1)
can effectively inhibit##4##3##(1991-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
can effectively reduce##3##3##(2008-10#1)(2008-3#2)
can effectively remove##2##3##(2008-10#1)(2011-1#1)
can effectively suppress##2##3##(2008-3#1)(2008-9#1)
can effectively##32##2##(1991-3#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-8#1)
can efficiently##7##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2011-3#2)(2013-1#1)
can either be##2##3##(2008-7#1)(2008-8#1)
can either enhance or##2##4##(2008-10#1)(2008-11#1)
can either##10##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-5#1)
can elicit##4##2##(2008-11#1)(2008-9#1)(2012-12#1)(2012-2#1)
can eliminate the##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)
can eliminate this problem##2##4##(1995-6#1)(2007-11#1)
can eliminate##15##2##(1994-1#1)(1995-6#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-8#1)(2010-3#1)(2011-1#1)
can emerge##4##2##(2006-12#1)(2008-7#3)
can emit##3##2##(2008-10#2)(2008-11#1)
can emulate##2##2##(1991-12#1)(2011-2#1)
can enable a##2##3##(2008-11#1)(2008-7#1)
can enable##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#2)
can encode##2##2##(2007-12#1)(2013-1#1)
can engage in##2##3##(2008-11#1)(2013-1#1)
can enhance the##17##3##(1993-3#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2011-2#1)(2011-3#1)(2013-8#1)
can enhance their##3##3##(1991-3#1)(1995-1#1)(2012-12#1)
can enhance##39##2##(1991-3#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
can ensure the##3##3##(1992-2#1)(1993-2#1)(2008-3#1)
can ensure##4##2##(1992-2#1)(1993-2#1)(2008-2#1)(2008-3#1)
can enter a##2##3##(2007-11#1)(2011-2#1)
can enter##9##2##(1994-11#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-9#3)(2011-2#1)
can equal that of an on-axis conventional##2##7##(2008-2#1)(2008-3#1)
can equally##2##2##(2008-11#1)(2010-10#1)
can establish##3##2##(1994-6#1)(1995-6#1)(2013-8#1)
can estimate##5##2##(1992-6#1)(2008-10#2)(2008-2#1)(2008-4#1)
can evaluate the##4##3##(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
can evaluate##9##2##(1993-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-9#1)(2013-1#1)
can even lead to##2##4##(2008-10#1)(2008-5#1)
can even##8##2##(1990-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-9#1)
can evolve when##2##3##(2008-8#2)
can evolve##13##2##(2008-10#1)(2008-7#1)(2008-8#9)(2010-10#1)(2013-1#1)
can exacerbate##3##2##(2008-7#1)(2009-6#1)(2009-8#1)
can exceed##4##2##(2007-11#1)(2008-3#3)
can exert##2##2##(2008-10#1)(2009-3#1)
can exhibit##8##2##(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2013-8#2)
can exist in the##2##4##(2007-11#1)(2008-3#1)
can exist in##4##3##(1992-3#1)(2007-11#1)(2008-3#1)(2008-4#1)
can exist only in##2##4##(1992-3#1)(2008-3#1)
can exist##11##2##(1992-3#2)(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)(2008-9#3)(2013-1#1)
can expand##2##2##(1995-1#1)(2008-4#1)
can expect the##2##3##(2010-3#1)(2010-6#1)
can expect to spend##2##4##(2011-2#2)
can expect to##4##3##(2007-2#1)(2008-4#1)(2011-2#2)
can expect##13##2##(1997-3#1)(2007-2#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
can experience##3##2##(1995-3#1)(2008-12#1)(2013-8#1)
can explain all##2##3##(1994-8#1)(2008-3#1)
can explain differences##2##3##(2008-8#1)(2013-1#1)
can explain the##14##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
can explain##26##2##(1991-9#1)(1994-8#1)(1995-11#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
can exploit##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
can explore##2##2##(2008-11#1)(2013-1#1)
can express##3##2##(1993-3#1)(2008-3#1)(2008-9#1)
can extend the##2##3##(1997-3#1)(2007-12#1)
can extend to##2##3##(1991-3#1)(2008-5#1)
can extend##5##2##(1991-3#1)(1997-3#1)(2007-12#1)(2008-3#1)(2008-5#1)
can extract##4##2##(1996-1#1)(2007-12#1)(2008-3#2)
can facilitate a##2##3##(2008-11#1)(2012-2#1)
can facilitate the development of##2##5##(1993-12#1)(2008-7#1)
can facilitate the learning and##2##5##(1997-2#1)(2008-11#1)
can facilitate the##14##3##(1993-12#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
can facilitate##31##2##(1992-2#1)(1993-12#1)(1994-12#2)(1995-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
can fail##4##2##(1994-3#1)(2008-10#1)(2008-3#2)
can favour##3##2##(2008-10#1)(2010-10#1)(2012-12#1)
can finally##3##2##(1997-1#1)(2008-9#1)(2010-12#1)
can find the##2##3##(2007-11#1)(2008-10#1)
can find##9##2##(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
can fit into##2##3##(2009-9#1)(2012-12#1)
can fit##3##2##(2008-3#1)(2009-9#1)(2012-12#1)
can focus##2##2##(2007-8#1)(2011-1#1)
can form a complex with##2##5##(2008-8#1)(2012-12#1)
can form a##7##3##(2008-10#3)(2008-7#1)(2008-8#2)(2012-12#1)
can form the 1##2##4##(2008-10#2)
can form the##4##3##(1994-12#1)(2008-10#2)(2012-12#1)
can form##22##2##(1990-2#1)(1994-12#1)(1997-7#1)(2008-10#7)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)
can function as a##3##4##(1995-2#1)(2008-3#1)(2008-7#1)
can function as##8##3##(1995-2#2)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
can function in the##2##4##(1994-11#1)(2008-10#1)
can function in##4##3##(1993-12#1)(1994-11#1)(2008-10#1)(2008-5#1)
can function##15##2##(1993-12#1)(1994-11#1)(1995-2#2)(1997-4#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
can fundamentally##2##2##(1995-11#1)(2009-8#1)
can further improve##2##3##(2007-12#1)(2011-2#1)
can further reduce the##2##4##(1990-8#1)(2008-4#1)
can further##11##2##(1990-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
can gain##7##2##(1996-3#1)(2008-1#1)(2008-6#1)(2008-8#3)(2010-4#1)
can generate##15##2##(1994-12#1)(1994-8#1)(2008-10#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
can germinate##2##2##(2011-2#2)
can get##10##2##(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1996-7#1)(2008-2#2)(2008-4#1)(2010-8#1)(2011-3#1)
can give a##5##3##(1990-6#1)(1993-6#1)(2008-10#2)(2008-6#1)
can give insights into the##2##5##(2010-7#1)(2012-3#1)
can give more##2##3##(2008-10#1)(2011-1#1)
can give rise to##9##4##(1991-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
can give satisfactory##2##3##(2008-10#1)(2008-3#1)
can give the##2##3##(1993-12#1)(2008-10#1)
can give useful##2##3##(1990-9#1)(2008-5#1)
can give##40##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
can go##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
can greatly alter the##2##4##(2008-9#1)(2012-3#1)
can greatly enhance the##3##4##(1994-2#1)(2006-10#1)(2008-9#1)
can greatly improve the##3##4##(2007-12#1)(2008-10#1)(2008-6#1)
can greatly##12##2##(1992-9#1)(1994-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2012-3#1)
can grow##9##2##(1990-5#1)(1991-7#1)(1993-9#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-6#1)(2009-8#1)(2013-7#1)
can guide##4##2##(2006-5#1)(2008-1#1)(2008-3#1)(2012-2#1)
can handle##6##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#2)
can hardly be##4##3##(2007-12#1)(2008-2#2)(2009-10#1)
can hardly##5##2##(1990-6#1)(2007-12#1)(2008-2#2)(2009-10#1)
can have a detrimental effect on the##2##7##(2008-5#1)(2011-2#1)
can have a direct##2##4##(2008-10#1)(2011-2#1)
can have a significant impact on the##2##7##(2008-2#1)(2008-3#1)
can have a significant impact on##3##6##(2008-2#1)(2008-3#1)(2012-2#1)
can have a significant##4##4##(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
can have a##28##3##(1992-12#1)(1994-3#1)(1996-6#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
can have an important##2##4##(2008-12#1)(2008-8#1)
can have an##7##3##(1992-1#1)(1992-2#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)
can have beneficial##2##3##(2008-7#2)
can have detrimental##2##3##(2008-1#1)(2008-11#1)
can have devastating##3##3##(2008-8#1)(2011-2#2)
can have different##2##3##(1996-2#1)(1997-2#1)
can have high##2##3##(2008-2#1)(2008-3#1)
can have important##2##3##(2008-9#1)(2009-6#1)
can have on##2##3##(2008-4#1)(2008-7#1)
can have profound effects on##2##5##(2008-8#2)
can have the##3##3##(1995-5#1)(2009-5#1)(2012-3#1)
can have##98##2##(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#7)(2012-3#1)(2013-1#4)
can help discern##2##3##(2010-7#1)(2013-1#1)
can help hospitals##2##3##(1992-3#1)(1995-2#1)
can help identify##2##3##(2011-1#1)(2011-2#1)
can help in the##2##4##(1990-2#1)(2010-8#1)
can help in##7##3##(1990-2#1)(2007-11#1)(2008-1#1)(2008-7#2)(2009-10#1)(2010-8#1)
can help reduce##3##3##(1997-1#1)(1997-2#1)(2008-8#1)
can help refine##2##3##(1997-1#1)(1997-3#1)
can help the##2##3##(1996-12#1)(2013-1#1)
can help them##2##3##(1995-1#1)(2007-2#1)
can help to achieve##2##4##(2008-10#1)(2010-8#1)
can help to define##2##4##(2008-4#1)(2013-1#1)
can help to reduce##2##4##(2008-5#1)(2013-1#1)
can help to##21##3##(1990-3#1)(1995-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#4)(2009-12#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
can help us to##2##4##(1991-6#1)(2008-2#1)
can help us##6##3##(1991-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-3#1)
can help with##4##3##(1995-3#1)(1995-9#1)(2008-12#1)(2010-8#1)
can help you##2##3##(1994-2#1)(1996-2#1)
can help##93##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#2)(1994-2#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-9#2)(1996-12#2)(1996-2#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#3)(2008-4#5)(2008-5#6)(2008-7#4)(2008-8#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#4)(2013-8#1)
can hold two CO molecules##2##5##(1990-3#2)
can hold##4##2##(1990-3#3)(2008-8#1)
can hospitals##2##2##(1991-12#1)(1995-2#1)
can hydrolyze##2##2##(2008-11#1)(2008-6#1)
can identify##13##2##(1996-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-1#1)
can impact the##3##3##(2007-2#1)(2008-8#1)(2010-10#1)
can impact##7##2##(2007-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
can impair the##4##3##(1991-12#1)(1995-12#1)(2008-10#2)
can impair##7##2##(1991-12#1)(1995-12#1)(2008-10#2)(2008-7#1)(2009-10#1)(2013-1#1)
can impede##2##2##(2008-11#1)(2010-3#1)
can implement##5##2##(1992-3#1)(2007-10#1)(2008-2#1)(2008-3#2)
can improve both##2##3##(2008-5#1)(2009-10#1)
can improve health##2##3##(1997-2#1)(2011-1#1)
can improve its##2##3##(2008-3#1)(2008-8#1)
can improve quality##2##3##(1995-3#1)(2008-7#1)
can improve symptom control##2##4##(2010-12#1)(2011-2#1)
can improve the efficiency##2##4##(2007-12#1)(2008-11#1)
can improve the quality of##4##5##(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
can improve the##28##3##(1997-2#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2011-2#1)(2013-1#1)(2013-8#1)
can improve##67##2##(1993-2#2)(1993-3#1)(1994-12#1)(1995-3#2)(1996-3#1)(1997-2#2)(2007-10#2)(2007-12#4)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
can in principle##2##3##(2007-12#1)(2008-10#1)
can in turn be used to##2##6##(1996-12#1)(2008-8#1)
can in turn be used##3##5##(1996-12#1)(2008-8#1)(2009-5#1)
can in turn##4##3##(1996-12#1)(2008-5#1)(2008-8#1)(2009-5#1)
can in##10##2##(1990-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#2)
can include##9##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-6#1)(2012-3#1)
can incorporate##5##2##(1997-7#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)
can increase our understanding of##2##5##(2008-7#1)(2012-2#1)
can increase precision in##2##4##(1993-9#1)(2008-8#1)
can increase rapidly##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
can increase the risk of##2##5##(2011-2#1)(2012-2#1)
can increase the risk##3##4##(2011-2#1)(2012-2#2)
can increase the##14##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)
can increase with##2##3##(2008-8#1)(2008-9#1)
can increase##51##2##(1990-8#1)(1991-11#1)(1993-9#1)(1994-6#1)(1996-12#2)(1997-3#2)(2007-11#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2012-5#1)
can indeed##3##2##(2007-12#1)(2009-11#1)(2009-8#1)
can indicate##6##2##(1995-11#1)(2007-2#1)(2008-10#3)(2013-1#1)
can induce a##3##3##(1997-2#1)(2007-8#1)(2011-2#1)
can induce an##3##3##(1992-3#1)(2008-11#1)(2013-1#1)
can induce apoptosis##3##3##(1993-9#1)(2008-8#1)(2008-9#1)
can induce formation of##2##4##(2008-6#1)(2011-2#1)
can induce glucose intolerance##2##4##(2008-3#2)
can induce strong##2##3##(1997-4#1)(2008-8#1)
can induce systemic resistance in##2##5##(2008-10#2)
can induce systemic resistance##3##4##(2008-10#2)(2013-8#1)
can induce the production of##2##5##(2008-10#1)(2008-11#1)
can induce the##6##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)
can induce tumor##2##3##(1992-12#1)(2011-2#1)
can induce##60##2##(1990-6#1)(1991-4#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#2)(2011-2#5)(2012-5#1)(2013-1#1)(2013-8#2)
can infect##5##2##(2008-10#4)(2013-1#1)
can influence the development of##2##5##(1993-9#1)(1995-12#1)
can influence the outcome of##2##5##(2008-12#1)(2013-1#1)
can influence the process of myelination##2##6##(2008-5#2)
can influence the##28##3##(1991-2#1)(1992-10#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
can influence##55##2##(1990-8#1)(1991-2#1)(1992-10#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-8#1)(2009-9#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
can inform##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
can ingest##2##2##(2008-10#1)(2011-2#1)
can inhibit the replication of##2##5##(1994-6#1)(2008-5#1)
can inhibit the##6##3##(1994-6#1)(2008-5#2)(2008-8#3)
can inhibit##27##2##(1990-12#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2010-2#1)(2011-2#3)(2011-3#1)(2012-3#1)
can initiate##4##2##(1990-5#1)(2008-10#1)(2011-2#1)(2013-8#1)
can insure##2##2##(1991-12#1)(1993-2#1)
can integrate the##2##3##(2008-5#1)(2013-1#1)
can integrate##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
can interact in the##2##4##(1995-2#1)(2008-7#1)
can interact with the##2##4##(1990-2#1)(1997-1#1)
can interact with this##2##4##(1992-12#1)(1995-6#1)
can interact with##10##3##(1990-2#1)(1992-12#1)(1994-3#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)
can interact##15##2##(1990-2#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)
can interfere with the activity of##2##6##(2008-2#1)(2012-3#1)
can interfere with the##7##4##(1993-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)
can interfere with##12##3##(1993-3#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
can interfere##15##2##(1993-3#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
can interpret##2##2##(2007-11#1)(2011-1#1)
can introduce##2##2##(2008-7#1)(2010-11#1)
can involve##6##2##(1991-2#1)(2008-1#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
can it##5##2##(1991-8#1)(1997-4#1)(2012-1#2)(2012-12#1)
can keep##3##2##(1993-2#1)(2008-11#1)(2008-9#1)
can lead to a##7##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2013-8#1)
can lead to adverse##3##4##(2007-7#1)(2008-11#1)(2011-1#1)
can lead to an##4##4##(1996-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
can lead to biased##2##4##(2008-12#1)(2008-8#1)
can lead to chronic##2##4##(2008-7#1)(2011-2#1)
can lead to either##2##4##(2008-10#1)(2013-8#1)
can lead to increased##4##4##(1991-12#1)(2008-3#1)(2008-4#1)(2010-11#1)
can lead to loss of##2##5##(1993-12#1)(2008-9#1)
can lead to more##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
can lead to positive##2##4##(2008-10#2)
can lead to rapid##2##4##(2008-10#1)(2012-12#1)
can lead to serious##3##4##(1997-1#1)(2008-10#1)(2009-9#1)
can lead to significant##4##4##(1995-3#1)(2008-12#1)(2008-7#1)(2013-1#1)
can lead to the development and##2##6##(2008-10#1)(2008-8#1)
can lead to the development of##4##6##(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
can lead to the development##6##5##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
can lead to the formation of##2##6##(1996-5#1)(2008-10#1)
can lead to the##13##4##(1993-12#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
can lead to their##2##4##(1992-1#1)(2012-12#1)
can lead to##136##3##(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
can lead##140##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
can learn from##8##3##(1991-6#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-11#1)(2013-1#1)
can learn to##5##3##(1993-12#1)(1997-1#1)(2008-9#1)(2009-8#1)(2013-8#1)
can learn##15##2##(1991-6#1)(1993-12#4)(1995-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)(2013-8#1)
can leave##2##2##(2009-9#1)(2010-3#1)
can limit the##3##3##(1992-6#1)(1996-4#1)(2008-7#1)
can limit##7##2##(1990-11#1)(1992-6#1)(1996-4#1)(1996-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
can lower the##4##3##(1994-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
can lower##5##2##(1994-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
can maintain a##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
can maintain##9##2##(1993-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)
can make a difference##3##4##(1994-2#1)(2010-7#1)(2013-7#1)
can make a##9##3##(1991-12#1)(1992-12#1)(1994-2#1)(1997-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)(2013-7#1)
can make##30##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
can manifest##4##2##(1993-2#1)(2008-12#1)(2010-3#1)(2013-8#1)
can manipulate##2##2##(2008-8#1)(2013-1#1)
can map##2##2##(2007-12#1)(2008-7#1)
can markedly increase the##2##4##(1990-8#1)(1995-3#1)
can markedly reduce##2##3##(2008-8#1)(2012-12#1)
can markedly##4##2##(1990-8#1)(1995-3#1)(2008-8#1)(2012-12#1)
can match##2##2##(2008-10#1)(2009-5#1)
can maximize##3##2##(1996-12#1)(2010-8#1)(2011-2#1)
can mean##2##2##(1991-1#1)(1994-12#1)
can measure the relative##2##4##(1991-9#1)(2008-3#1)
can measure the##6##3##(1991-9#1)(1997-6#1)(2008-2#3)(2008-3#1)
can measure##16##2##(1991-9#1)(1995-3#1)(1995-5#1)(1997-6#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#1)(2009-9#1)(2012-12#1)(2013-7#1)
can mediate the##3##3##(1992-8#1)(2008-7#1)(2012-2#1)
can mediate##9##2##(1992-8#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
can meet the requirements##2##4##(2008-3#1)(2011-1#1)
can meet the##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#1)
can meet these requirements##2##4##(2008-10#1)(2008-5#1)
can meet##9##2##(1992-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
can migrate##3##2##(2008-5#1)(2008-7#1)(2010-8#1)
can mimic##10##2##(2006-10#1)(2007-11#1)(2008-10#2)(2009-1#1)(2009-6#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
can miniaturize##2##2##(2007-12#1)(2008-3#1)
can minimise the##2##3##(2007-2#1)(2008-10#1)
can minimise##3##2##(2007-11#1)(2007-2#1)(2008-10#1)
can minimize the##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
can minimize##6##2##(1994-9#1)(2007-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
can moderate##2##2##(2008-10#1)(2008-12#1)
can modify the##6##3##(1990-6#1)(1991-4#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
can modify##13##2##(1990-6#1)(1991-4#1)(1992-5#1)(1992-8#1)(1994-9#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2011-2#1)
can modulate high-power##2##3##(2008-3#2)
can modulate the##5##3##(1992-12#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-7#1)
can modulate##16##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-8#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)
can move##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
can mutually##2##2##(1990-6#1)(2007-12#1)
can negatively affect the##2##4##(2007-8#1)(2008-5#1)
can negatively affect##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
can negatively##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2013-8#1)
can never##2##2##(2007-2#1)(2008-8#1)
can no longer be maintained##2##5##(2008-3#1)(2008-8#1)
can no longer be##5##4##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
can no longer##9##3##(1997-5#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#1)
can not be considered##2##4##(2008-10#1)(2013-1#1)
can not be used##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
can not be##31##3##(1990-6#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
can not only##6##3##(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)
can not##44##2##(1990-6#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
can now be treated##3##4##(1993-6#1)(1996-11#1)(1996-3#1)
can now be used to##4##5##(1990-3#1)(1994-8#1)(2008-9#1)(2011-2#1)
can now be used##5##4##(1990-3#1)(1994-8#1)(2007-11#1)(2008-9#1)(2011-2#1)
can now be##27##3##(1990-11#2)(1990-12#1)(1990-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
can now##36##2##(1990-11#2)(1990-12#1)(1990-3#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
can observe##3##2##(2007-11#1)(2008-7#1)(2012-1#1)
can obtain a##4##3##(2008-2#2)(2008-3#1)(2011-2#1)
can obtain the##2##3##(2008-10#1)(2008-3#1)
can obtain##13##2##(1992-6#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2011-2#1)(2013-8#1)
can obviate the need for##3##5##(1991-11#1)(1997-8#1)(2006-10#1)
can obviate the##4##3##(1991-11#1)(1997-8#1)(2006-10#1)(2008-10#1)
can obviously##2##2##(2008-9#2)
can occasionally##3##2##(1994-12#1)(1994-9#1)(2010-9#1)
can occur and##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
can occur anywhere##2##3##(2007-5#1)(2011-2#1)
can occur as a##3##4##(2007-8#1)(2008-9#1)(2013-7#1)
can occur as##4##3##(1994-2#1)(2007-8#1)(2008-9#1)(2013-7#1)
can occur at any##2##4##(2009-5#1)(2011-2#1)
can occur at different##2##4##(2008-7#1)(2008-8#1)
can occur at##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
can occur both##2##3##(2007-8#1)(2008-10#1)
can occur by##2##3##(2012-12#2)
can occur during##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
can occur even##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
can occur in a##2##4##(1991-3#1)(2012-12#1)
can occur in any##2##4##(2008-12#1)(2013-1#1)
can occur in the##4##4##(1995-8#1)(2008-3#2)(2010-9#1)
can occur in##21##3##(1991-3#1)(1992-3#1)(1993-11#1)(1995-5#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2010-1#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
can occur only##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
can occur when##2##3##(2008-8#1)(2008-9#1)
can occur with##4##3##(1991-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
can occur without##2##3##(2007-12#1)(2008-11#1)
can occur##88##2##(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(2006-10#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#4)(2013-1#4)(2013-7#1)
can offer the##2##3##(1990-8#1)(1994-6#1)
can offer##14##2##(1990-8#1)(1991-11#1)(1993-11#1)(1994-6#1)(1997-7#1)(2008-10#3)(2008-2#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-1#1)
can often be##11##3##(1991-6#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#1)
can often result in##2##4##(1993-12#1)(2008-12#1)
can often##20##2##(1991-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
can on##2##2##(2008-5#1)(2008-9#1)
can one##2##2##(2008-8#1)(2012-8#1)
can only be achieved by##2##5##(2008-7#1)(2010-2#1)
can only be achieved##4##4##(1992-3#1)(1994-12#1)(2008-7#1)(2010-2#1)
can only be applied##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
can only be explained##2##4##(1994-8#1)(2008-1#1)
can only be obtained##3##4##(1995-2#1)(2008-11#1)(2009-3#1)
can only be reached##2##4##(2008-1#1)(2008-5#1)
can only be removed##2##4##(1993-11#1)(1995-5#1)
can only be used##2##4##(2008-9#1)(2012-12#1)
can only be##45##3##(1990-3#1)(1990-7#1)(1991-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)
can only occur##4##3##(1993-2#1)(1994-3#1)(1995-8#1)(2008-7#1)
can only##63##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
can operate in##3##3##(2007-12#1)(2008-9#1)(2010-7#1)
can operate##9##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2010-9#1)
can overcome the##2##3##(1990-11#1)(2008-10#1)
can overcome this limitation##3##4##(1994-2#1)(2007-11#1)(2008-2#1)
can overcome##8##2##(1990-11#1)(1992-1#1)(1994-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)
can partially##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
can perform##14##2##(1992-6#1)(1993-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2013-8#1)
can permit##2##2##(2008-2#1)(2008-8#1)
can persist##2##2##(2008-10#1)(2012-3#1)
can play a crucial role##2##5##(2008-10#1)(2008-11#1)
can play a key role in the development##2##8##(1991-12#1)(1996-1#1)
can play a key role in##5##6##(1991-12#1)(1995-2#1)(1996-1#1)(2008-2#1)(2010-4#1)
can play a pivotal role in##2##6##(2008-6#1)(2010-11#1)
can play a role in##2##5##(2007-2#1)(2013-1#1)
can play a##17##3##(1991-12#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
can play an important role in reducing##2##7##(2011-2#1)(2012-2#1)
can play an important role in##10##6##(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
can play as##2##3##(1992-3#1)(1996-3#1)
can play in##2##3##(2008-11#1)(2012-12#1)
can play##32##2##(1991-12#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
can point##2##2##(2007-12#1)(2008-2#1)
can pose a##4##3##(1992-2#1)(2010-1#1)(2011-2#1)(2013-1#1)
can pose##5##2##(1992-2#1)(2010-1#1)(2011-2#1)(2013-1#2)
can positively influence##2##3##(1994-12#1)(1994-2#1)
can positively##3##2##(1994-12#1)(1994-2#1)(2009-8#1)
can possibly##4##2##(1993-6#1)(2008-10#2)(2012-3#1)
can potentially be used to##2##5##(2008-2#1)(2008-8#1)
can potentially be used##4##4##(2007-12#1)(2008-2#1)(2008-8#1)(2012-3#1)
can potentially be##8##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#3)(2012-3#1)
can potentially increase##2##3##(2007-12#1)(2008-8#1)
can potentially modulate the##2##4##(1994-9#1)(2013-1#1)
can potentially provide##2##3##(2009-9#1)(2012-3#1)
can potentially##24##2##(1994-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-9#1)(2012-3#2)(2013-1#1)
can potentiate##3##2##(2008-11#1)(2010-4#1)(2012-12#1)
can precede the##2##3##(2006-10#1)(2008-9#1)
can precipitate##2##2##(1993-2#1)(2008-5#1)
can preclude##2##2##(1994-3#1)(2013-8#1)
can predict the##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
can predict##18##2##(1991-12#1)(1992-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#2)(2013-1#2)
can prepare##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
can present a##4##3##(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#1)
can present as##5##3##(2007-7#1)(2008-10#1)(2012-12#2)(2012-3#1)
can present in a##2##4##(2008-5#1)(2012-3#1)
can present with a clinical##2##5##(2009-3#1)(2010-9#1)
can present with a##4##4##(2009-3#2)(2010-9#1)(2011-1#1)
can present with##10##3##(1990-9#1)(2008-11#1)(2009-3#2)(2010-5#1)(2010-9#1)(2011-1#2)(2013-1#2)
can present##23##2##(1990-9#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#3)(2012-12#3)(2012-3#2)(2013-1#2)
can prevent the growth##2##4##(2008-1#1)(2008-12#1)
can prevent the##8##3##(1991-12#1)(1994-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-6#1)
can prevent##22##2##(1991-12#1)(1991-2#1)(1991-8#1)(1993-8#1)(1994-2#1)(1996-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-1#1)
can probably be##2##3##(1996-1#1)(1996-12#1)
can probably##3##2##(1991-11#1)(1996-1#1)(1996-12#1)
can proceed to##2##3##(1991-5#1)(2008-1#1)
can proceed##3##2##(1991-5#1)(2008-1#1)(2008-4#1)
can process##3##2##(2007-11#1)(2008-11#1)(2008-12#1)
can produce a##10##3##(1991-1#1)(1993-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)(2013-7#1)
can produce an##3##3##(2008-10#1)(2008-3#2)
can produce good##2##3##(2008-3#1)(2008-4#1)
can produce significant##2##3##(1994-11#1)(2013-1#1)
can produce##64##2##(1990-12#2)(1991-1#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(2006-12#1)(2007-11#4)(2007-12#3)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
can profoundly##3##2##(1994-3#1)(2008-8#1)(2011-2#1)
can proliferate##2##2##(2008-11#1)(2012-12#1)
can promote crop health##2##4##(2008-10#2)
can promote the##2##3##(1994-12#1)(2012-3#1)
can promote##16##2##(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
can propagate##3##2##(2007-11#1)(2008-11#1)(2008-5#1)
can protect against##3##3##(1990-11#1)(2008-7#1)(2011-2#1)
can protect##14##2##(1990-11#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
can prove to be##3##4##(1994-6#1)(1996-1#1)(2008-10#1)
can prove##7##2##(1992-9#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
can provide a rapid##2##4##(2008-10#1)(2008-9#1)
can provide a reliable##2##4##(2008-3#1)(2011-2#1)
can provide a useful##4##4##(2008-11#1)(2010-2#1)(2012-3#2)
can provide a valuable##2##4##(2008-9#1)(2009-12#1)
can provide a##40##3##(1991-12#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#5)(2008-9#2)(2009-12#1)(2009-9#2)(2010-2#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)
can provide accurate##2##3##(2007-5#1)(2011-1#1)
can provide an efficient##2##4##(2007-11#1)(2008-3#1)
can provide an excellent##2##4##(2008-12#1)(2013-1#1)
can provide an##12##3##(1994-3#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2012-2#1)(2013-1#1)
can provide detailed##2##3##(2007-12#1)(2011-1#1)
can provide direct##2##3##(1994-3#1)(2012-3#1)
can provide high##3##3##(2007-12#2)(2008-11#1)
can provide important clues##2##4##(2008-10#1)(2008-4#1)
can provide important##6##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
can provide information about##2##4##(2008-7#1)(2013-1#1)
can provide information on##2##4##(2008-9#1)(2010-12#1)
can provide information##6##3##(1993-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
can provide insight into the##2##5##(2008-11#1)(2008-8#1)
can provide insight##3##3##(2008-11#1)(2008-8#1)(2010-4#1)
can provide insights into##2##4##(2008-9#1)(2009-12#1)
can provide insights##3##3##(2008-9#1)(2009-10#1)(2009-12#1)
can provide satisfactory##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
can provide such##2##3##(1994-3#1)(2012-2#1)
can provide the##6##3##(1990-11#1)(1991-1#1)(2008-2#1)(2009-7#1)(2011-1#1)(2012-2#1)
can provide useful information##2##4##(1991-2#1)(2008-6#1)
can provide valuable##3##3##(1995-1#1)(2008-10#1)(2008-4#1)
can provide##158##2##(1990-11#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-3#2)(1993-2#2)(1993-3#2)(1994-3#4)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#15)(2008-4#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#8)(2012-3#5)(2013-1#11)(2013-8#1)
can provoke##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
can quantitatively##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)
can raise##3##2##(2008-8#1)(2010-11#1)(2011-1#1)
can range from##8##3##(1997-2#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2011-2#1)(2013-1#1)
can range##9##2##(1997-2#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
can rapidly##4##2##(1995-2#1)(2008-10#2)(2008-6#1)
can rarely present##2##3##(2006-10#1)(2012-12#1)
can rarely##4##2##(1996-9#1)(2006-10#1)(2012-12#1)(2012-2#1)
can reach as##2##3##(2007-12#1)(2009-11#1)
can reach high##2##3##(1991-1#1)(2008-10#1)
can reach the##4##3##(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)
can reach##18##2##(1991-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#1)
can react with##9##3##(2008-10#9)
can react##11##2##(2008-10#9)(2009-11#1)(2011-2#1)
can read and write##2##4##(2008-4#1)(2008-9#1)
can readily be applied to##2##5##(2007-11#1)(2009-9#1)
can readily be used to##3##5##(2008-4#2)(2008-9#1)
can readily be used##4##4##(2008-10#1)(2008-4#2)(2008-9#1)
can readily be##11##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#3)(2008-9#1)(2009-9#1)(2011-1#1)
can readily lead to##2##4##(2007-12#1)(2008-10#1)
can readily##16##2##(1992-10#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)
can realistically be##2##3##(1995-6#1)(1997-6#1)
can realize##4##2##(2008-12#1)(2008-2#1)(2008-3#2)
can recognize##7##2##(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-7#1)
can recover##5##2##(1995-5#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
can recycling##3##2##(1996-12#1)(1996-3#2)
can reduce length of stay##2##5##(2012-2#1)(2012-3#1)
can reduce mortality##2##3##(1997-1#1)(2013-1#1)
can reduce or##2##3##(2008-5#1)(2009-10#1)
can reduce potato late blight severity##2##6##(2008-10#2)
can reduce risk##2##3##(2008-10#1)(2008-5#1)
can reduce the degree of##2##5##(1997-3#1)(2009-11#1)
can reduce the risk of##2##5##(1991-8#1)(2010-2#1)
can reduce the risk##3##4##(1991-8#1)(2010-2#1)(2013-1#1)
can reduce the##29##3##(1991-8#1)(1992-9#1)(1995-5#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#4)(2009-11#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
can reduce this##2##3##(1994-2#1)(2010-9#1)
can reduce##65##2##(1991-3#1)(1991-8#1)(1992-9#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#7)(2008-5#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
can reflect##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
can regulate the##5##3##(1997-1#1)(2008-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
can regulate##20##2##(1991-3#1)(1991-5#1)(1992-3#1)(1994-3#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-3#2)
can release##6##2##(1990-8#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-7#1)
can replace the##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
can replace##8##2##(1990-8#1)(1991-11#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
can represent##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
can repress the##2##3##(1992-12#1)(2013-7#1)
can reproduce the##2##3##(2008-11#1)(2008-3#1)
can reproduce##6##2##(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
can require##2##2##(1994-8#1)(2010-6#1)
can rescue##2##2##(1994-12#1)(2012-1#1)
can resist##2##2##(2009-10#1)(2010-7#1)
can resolve##8##2##(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)
can respond to##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
can respond##5##2##(1992-12#1)(1997-6#1)(2007-8#1)(2008-8#1)(2008-9#1)
can restore##4##2##(1991-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
can result from a variety of##2##6##(2008-6#1)(2010-6#1)
can result from a##4##4##(2008-6#1)(2008-8#1)(2010-6#1)(2013-8#1)
can result from the##2##4##(2011-2#1)(2012-2#1)
can result from##9##3##(1996-2#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
can result in a##9##4##(1991-6#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)
can result in an increase of##2##6##(2008-5#1)(2008-8#1)
can result in an##3##4##(2008-5#1)(2008-8#1)(2009-11#1)
can result in enhanced##2##4##(2008-11#1)(2008-5#1)
can result in improved##2##4##(2009-3#1)(2010-12#1)
can result in significant morbidity##2##5##(2006-10#1)(2008-7#1)
can result in significant##6##4##(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)
can result in the##7##4##(1995-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
can result in##72##3##(1991-6#1)(1991-8#1)(1992-1#1)(1992-9#2)(1994-12#2)(1994-3#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-11#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-3#1)(2010-1#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
can result##83##2##(1991-6#1)(1991-8#1)(1992-1#1)(1992-9#2)(1994-12#2)(1994-3#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-11#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-11#1)(2009-3#1)(2010-1#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-2#10)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
can reveal##9##2##(1992-12#1)(1994-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)
can reverse the##2##3##(1992-12#1)(1997-2#1)
can reverse##4##2##(1992-12#1)(1997-2#1)(2008-8#1)(2013-8#1)
can rival##2##2##(2010-7#1)(2012-2#1)
can routinely be##2##3##(2008-10#1)(2008-8#1)
can safely be##4##3##(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
can safely##9##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
can save a##2##3##(2007-12#1)(2012-3#1)
can save the##4##3##(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#1)
can save##7##2##(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-3#1)
can scan##2##2##(2007-12#1)(2008-3#1)
can search the##2##3##(2007-2#1)(2008-4#1)
can see that##2##3##(2008-11#2)
can see##3##2##(1995-1#1)(2008-11#2)
can selectively##5##2##(1990-11#1)(1994-11#1)(2008-10#2)(2008-7#1)
can sense##2##2##(2008-4#1)(2011-1#1)
can separate##2##2##(2007-12#1)(2008-10#1)
can seriously affect the##2##4##(2008-2#1)(2008-7#1)
can serve as a basis for the##2##7##(2008-11#1)(2010-6#1)
can serve as a basis for##3##6##(1994-9#1)(2008-11#1)(2010-6#1)
can serve as a useful##2##5##(2007-11#1)(2008-9#1)
can serve as a##26##4##(1990-5#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)
can serve as an##9##4##(2008-11#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-12#1)
can serve as predictors of##2##5##(2008-10#1)(2012-12#1)
can serve as the foundation for##2##6##(2008-1#1)(2010-9#1)
can serve as the##5##4##(1993-12#1)(2008-1#2)(2008-4#1)(2010-9#1)
can serve as##56##3##(1990-5#1)(1991-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-6#2)(2008-9#3)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)
can serve to##3##3##(1991-12#1)(1996-12#1)(2011-2#1)
can serve##61##2##(1990-5#1)(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-6#2)(2008-9#3)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)
can set the##2##3##(2010-4#1)(2012-2#1)
can shed##2##2##(2012-2#2)
can shift the##2##3##(1992-4#1)(2008-3#1)
can shorten##3##2##(2007-11#1)(2008-5#1)(2012-2#1)
can show that the##2##4##(2008-5#1)(2012-3#1)
can show that##5##3##(1992-9#1)(1994-2#1)(2008-5#2)(2012-3#1)
can show##8##2##(1992-9#1)(1993-12#1)(1994-2#1)(2008-5#3)(2011-2#1)(2012-3#1)
can shuttle between the nucleus and##2##6##(2012-12#1)(2012-2#1)
can signal the##3##3##(1994-8#1)(2008-4#1)(2013-8#1)
can signal##4##2##(1994-8#1)(2007-12#1)(2008-4#1)(2013-8#1)
can significantly affect the##3##4##(2007-11#1)(2008-10#1)(2013-7#1)
can significantly affect##4##3##(2007-11#1)(2008-10#2)(2013-7#1)
can significantly enhance the##2##4##(2008-6#1)(2013-1#1)
can significantly enhance##3##3##(1995-12#1)(2008-6#1)(2013-1#1)
can significantly improve the##2##4##(2008-12#1)(2008-8#1)
can significantly improve##5##3##(1994-2#1)(2007-11#1)(2008-12#1)(2008-6#1)(2008-8#1)
can significantly increase the##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#1)
can significantly increase##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-9#1)(2012-2#2)
can significantly influence the##3##4##(1992-9#1)(1993-1#1)(2008-8#1)
can significantly influence##5##3##(1992-9#1)(1993-1#1)(2008-8#1)(2010-10#1)(2012-2#1)
can significantly reduce the##4##4##(1997-4#1)(2007-12#1)(2008-5#1)(2011-2#1)
can significantly reduce##6##3##(1997-4#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)
can significantly##39##2##(1992-9#1)(1993-1#1)(1994-2#1)(1995-12#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#3)(2010-10#1)(2010-9#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
can simplify##3##2##(2008-10#1)(2011-2#2)
can simply##2##2##(2008-11#1)(2008-9#1)
can simulate the##3##3##(1992-3#1)(2008-3#2)
can simulate##7##2##(1992-3#1)(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#3)
can simultaneously##8##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
can slow##2##2##(1996-9#1)(2008-10#1)
can solve##2##2##(2008-10#1)(2008-6#1)
can sometimes be##9##3##(1994-12#1)(2008-1#1)(2008-10#2)(2009-6#1)(2011-2#2)(2013-1#2)
can sometimes##15##2##(1994-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
can spare##2##2##(1991-4#1)(2007-11#1)
can specifically##2##2##(1994-8#1)(2008-8#1)
can speed##2##2##(2011-2#1)(2013-1#1)
can spend##2##2##(1995-6#1)(2008-9#1)
can spread from##2##3##(2008-10#1)(2011-2#1)
can spread##6##2##(2007-12#1)(2008-10#3)(2008-12#1)(2011-2#1)
can stabilize the##3##3##(1994-11#1)(2008-4#1)(2008-8#1)
can stabilize##4##2##(1994-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
can still be detected in##2##5##(2006-4#1)(2007-11#1)
can still be detected##3##4##(1994-9#1)(2006-4#1)(2007-11#1)
can still be obtained##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
can still be used##2##4##(2008-10#1)(2008-2#1)
can still be##15##3##(1990-3#1)(1994-9#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2011-1#1)
can still have##2##3##(1997-6#1)(2008-3#1)
can still##23##2##(1990-3#1)(1994-9#1)(1997-5#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-8#2)(2011-1#1)(2011-2#1)
can stimulate the##5##3##(1994-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
can stimulate##18##2##(1990-2#1)(1991-12#1)(1991-5#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-11#4)(2008-4#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)
can strengthen##2##2##(1993-3#1)(1996-1#1)
can strongly##2##2##(2008-2#1)(2008-9#1)
can substantially##8##2##(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)
can substitute for##5##3##(1991-3#1)(1993-6#1)(1995-11#1)(1995-2#2)
can substitute##6##2##(1991-3#1)(1993-6#1)(1995-11#1)(1995-2#2)(2008-10#1)
can succeed##3##2##(1992-6#1)(1994-3#1)(1996-12#1)
can successfully be##2##3##(2008-10#1)(2013-8#1)
can successfully##14##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-8#1)
can suggest##3##2##(2007-11#1)(2011-1#1)(2012-2#1)
can support the##3##3##(1994-9#1)(2008-10#1)(2008-8#1)
can support##11##2##(1994-9#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
can suppress the##2##3##(1997-4#1)(2012-3#1)
can suppress##13##2##(1990-6#1)(1994-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
can survive in##3##3##(2009-12#2)(2013-8#1)
can survive##10##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-12#2)(2013-1#1)(2013-8#1)
can sustain##2##2##(2008-8#1)(2010-7#1)
can synthesize##2##2##(2009-8#1)(2012-12#1)
can take advantage of##2##4##(1996-3#1)(2008-2#1)
can take in##2##3##(1996-2#1)(2009-9#1)
can take many forms##2##4##(2008-1#1)(2012-12#1)
can take many##4##3##(1992-1#1)(2008-1#1)(2008-5#1)(2012-12#1)
can take place##5##3##(1991-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
can take the##3##3##(1990-6#1)(1996-3#1)(1997-7#1)
can take to##6##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(2011-2#1)
can take##31##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#2)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)
can target##3##2##(1995-6#1)(2008-12#1)(2008-6#1)
can tell us about##2##4##(2010-10#1)(2012-12#1)
can the##7##2##(1990-6#1)(1995-1#1)(1995-12#1)(2007-12#1)(2008-9#1)(2009-5#1)(2009-9#1)
can themselves evolve##2##3##(2008-8#1)(2013-1#1)
can themselves##3##2##(2008-4#1)(2008-8#1)(2013-1#1)
can then be analyzed##2##4##(2008-10#1)(2008-2#1)
can then be converted##2##4##(2008-3#1)(2008-4#1)
can then be determined by##2##5##(2008-2#1)(2008-8#1)
can then be used for##2##5##(2008-9#1)(2009-3#1)
can then be used to##7##5##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-11#1)
can then be used##9##4##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-3#1)(2010-11#1)
can then be##31##3##(1990-11#1)(1992-3#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#4)(2008-4#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-3#1)
can then##38##2##(1990-11#1)(1992-3#1)(1995-2#1)(1997-3#1)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#4)(2008-4#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
can therefore be used as a##2##6##(1991-12#1)(1991-9#1)
can therefore be used as##3##5##(1991-12#1)(1991-9#1)(2008-10#1)
can therefore be used##5##4##(1991-12#1)(1991-9#1)(1995-11#1)(2008-10#1)(2008-2#1)
can therefore be##12##3##(1991-12#1)(1991-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
can therefore##20##2##(1991-12#1)(1991-9#1)(1995-11#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
can they be##2##3##(1991-12#1)(1996-12#1)
can they##5##2##(1991-12#1)(1994-12#1)(1996-12#1)(2008-11#2)
can threaten the##2##3##(1995-6#1)(2007-2#1)
can thus alter##2##3##(1995-3#1)(2008-11#1)
can thus be##12##3##(1992-12#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2013-1#1)
can thus##25##2##(1990-12#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
can to##2##2##(1995-8#1)(2013-1#1)
can tolerate##2##2##(1991-6#1)(1996-4#1)
can trace##2##2##(2008-9#1)(2010-4#1)
can transfer the##2##3##(2008-10#1)(2008-3#1)
can transfer##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
can transform##2##2##(1997-7#1)(2009-8#1)
can translate into##4##3##(1991-12#1)(1991-5#1)(2008-10#1)(2013-1#1)
can trigger a##2##3##(1995-2#1)(2011-1#1)
can trigger the##3##3##(1997-6#1)(2006-10#1)(2009-3#1)
can trigger##10##2##(1995-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
can turn##3##2##(1995-2#1)(2007-7#1)(2011-1#1)
can ultimately##2##2##(1997-3#1)(2009-5#1)
can undergo##11##2##(1990-2#1)(1990-6#1)(1992-12#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
can undermine##2##2##(1995-1#1)(2008-8#1)
can understand##2##2##(2007-12#1)(2008-5#1)
can use it##2##3##(1994-11#1)(1996-1#1)
can use the##8##3##(1994-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
can use these##3##3##(1996-12#2)(2008-12#1)
can use this##3##3##(1991-12#1)(2008-2#1)(2010-11#1)
can use to##7##3##(1994-12#1)(1995-1#1)(1995-2#1)(2006-5#1)(2008-12#1)(2008-3#1)(2009-3#1)
can use##38##2##(1991-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-2#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#4)(2009-3#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
can usually be##3##3##(1990-12#1)(2008-2#2)
can utilize##4##2##(1996-12#1)(2007-12#1)(2008-11#1)(2009-6#1)
can vary by##3##3##(1995-3#1)(1997-2#1)(2013-1#1)
can vary from##2##3##(2008-10#1)(2008-12#1)
can vary in##2##3##(1994-8#1)(2008-12#1)
can vary##17##2##(1992-8#1)(1994-8#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-11#1)(2013-1#2)(2013-8#1)
can very well be##2##4##(1995-5#1)(2008-10#1)
can visualize##2##2##(2008-6#1)(2008-7#1)
can we do##2##3##(1997-1#1)(2007-12#1)
can we explain##2##3##(2008-10#1)(2008-7#1)
can we improve##2##3##(1992-5#1)(2012-2#1)
can we learn from the##2##5##(1993-6#1)(2008-7#1)
can we learn from##4##4##(1991-3#1)(1993-6#1)(2008-1#1)(2008-7#1)
can we learn##6##3##(1991-3#1)(1993-6#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#1)
can we##25##2##(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-2#2)(1993-6#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#3)(2013-7#1)
can with##2##2##(1996-4#1)(2013-1#1)
can work as a##2##4##(2008-3#1)(2011-3#1)
can work in##2##3##(1993-12#1)(2013-7#1)
can work together in a##2##5##(1993-12#1)(2013-1#1)
can work together to##2##4##(1993-1#1)(2013-8#1)
can work together##5##3##(1993-1#2)(1993-12#1)(2013-1#1)(2013-8#1)
can work with##3##3##(1994-1#1)(1996-12#1)(2008-6#1)
can work##16##2##(1991-2#1)(1993-1#2)(1993-12#2)(1994-1#1)(1995-2#1)(1996-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
can yield a##2##3##(2007-11#2)
can yield##18##2##(1990-7#1)(1991-6#1)(1992-9#1)(1997-3#1)(2007-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-9#2)(2009-10#1)(2012-12#2)(2012-2#1)(2013-8#1)
can you do?##2##3##(1997-6#1)(2013-8#1)
can you##3##2##(1996-3#1)(1997-6#1)(2013-8#1)
can!##2##1##(2010-12#1)(2010-5#1)
can##10875##1##(1990-10#2)(1990-11#32)(1990-12#34)(1990-2#23)(1990-3#12)(1990-4#1)(1990-5#24)(1990-6#19)(1990-7#10)(1990-8#30)(1990-9#19)(1991-1#11)(1991-10#1)(1991-11#17)(1991-12#47)(1991-2#22)(1991-3#38)(1991-4#8)(1991-5#34)(1991-6#12)(1991-7#2)(1991-8#11)(1991-9#37)(1992-1#19)(1992-10#6)(1992-11#15)(1992-12#44)(1992-2#27)(1992-3#50)(1992-4#6)(1992-5#17)(1992-6#37)(1992-7#2)(1992-8#16)(1992-9#31)(1993-1#10)(1993-11#28)(1993-12#63)(1993-2#41)(1993-3#42)(1993-5#4)(1993-6#24)(1993-8#19)(1993-9#21)(1994-1#16)(1994-10#2)(1994-11#30)(1994-12#74)(1994-2#47)(1994-3#61)(1994-5#29)(1994-6#16)(1994-7#4)(1994-8#53)(1994-9#40)(1995-1#33)(1995-11#26)(1995-12#44)(1995-2#59)(1995-3#41)(1995-5#29)(1995-6#34)(1995-8#15)(1995-9#12)(1996-1#32)(1996-11#21)(1996-12#60)(1996-2#49)(1996-3#44)(1996-4#10)(1996-5#29)(1996-6#10)(1996-7#5)(1996-8#6)(1996-9#8)(1997-1#42)(1997-2#48)(1997-3#47)(1997-4#34)(1997-5#7)(1997-6#36)(1997-7#35)(1997-8#18)(1997-9#1)(2006-10#19)(2006-12#11)(2006-4#6)(2006-5#3)(2006-6#4)(2007-10#22)(2007-11#253)(2007-12#337)(2007-2#27)(2007-3#1)(2007-4#2)(2007-5#12)(2007-6#6)(2007-7#39)(2007-8#58)(2007-9#11)(2008-1#154)(2008-10#1599)(2008-11#423)(2008-12#121)(2008-2#478)(2008-3#924)(2008-4#366)(2008-5#226)(2008-6#126)(2008-7#385)(2008-8#383)(2008-9#309)(2009-1#7)(2009-10#44)(2009-11#42)(2009-12#45)(2009-2#15)(2009-3#31)(2009-4#16)(2009-5#55)(2009-6#29)(2009-7#28)(2009-8#60)(2009-9#54)(2010-1#19)(2010-10#39)(2010-11#39)(2010-12#59)(2010-2#15)(2010-3#33)(2010-4#42)(2010-5#49)(2010-6#43)(2010-7#30)(2010-8#77)(2010-9#26)(2011-1#115)(2011-10#3)(2011-2#362)(2011-3#24)(2011-7#4)(2012-1#47)(2012-12#126)(2012-2#211)(2012-3#136)(2012-4#1)(2012-5#3)(2012-6#2)(2012-7#2)(2012-8#2)(2012-9#4)(2013-1#262)(2013-7#36)(2013-8#158)
can't##13##1##(1991-3#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-6#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2013-1#1)
canadensis##3##1##(2008-10#2)(2010-3#1)
canadian##6##1##(2008-10#1)(2008-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
canadienne##2##1##(1991-3#1)(2009-4#1)
canal and the##4##3##(1992-6#1)(1993-12#1)(2007-11#1)(2008-9#1)
canal and##13##2##(1992-6#1)(1993-12#1)(2007-11#2)(2008-10#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#2)(2013-1#1)
canal cell##2##2##(2007-12#2)
canal in the##2##3##(1996-12#1)(2007-8#1)
canal in##3##2##(1996-12#1)(2007-8#1)(2011-2#1)
canal is##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
canal of##6##2##(2006-10#1)(2008-10#4)(2008-5#1)
canal on the##2##3##(2011-2#2)
canal system##3##2##(2007-5#1)(2008-7#1)(2012-12#1)
canal wall##6##2##(2008-9#5)(2013-1#1)
canal was##5##2##(1994-9#1)(2008-11#1)(2008-7#1)(2013-1#2)
canal were##2##2##(2008-10#1)(2008-11#1)
canal##120##1##(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-12#4)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#7)(2008-10#7)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#14)(2008-9#13)(2009-3#1)(2011-2#10)(2011-7#1)(2012-12#4)(2012-3#2)(2013-1#27)(2013-7#1)
canal-wall##2##1##(2008-9#2)
canalicular transporters##2##2##(2008-11#2)
canalicular##20##1##(1990-12#2)(1993-3#2)(1994-12#6)(1995-2#2)(2008-11#7)(2013-1#1)
canaliculi##3##1##(1993-3#1)(2007-12#2)
canaliculus##4##1##(2008-10#2)(2009-6#1)(2013-8#1)
canalization and##2##2##(1993-1#1)(2008-8#1)
canalization##3##1##(1993-1#2)(2008-8#1)
canals and##6##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2013-1#2)
canals in##2##2##(2008-10#1)(2013-1#1)
canals were##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
canals with##2##2##(2007-5#1)(2013-1#1)
canals##29##1##(1994-12#1)(1995-6#3)(2006-12#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#2)(2012-3#2)(2013-1#8)
canariensis isolates##2##2##(2008-10#2)
canariensis##6##1##(2008-10#6)
canaries##4##1##(1994-6#1)(1997-3#3)
canary grass##2##2##(2008-10#1)(2008-6#1)
canbe##2##1##(2008-11#1)(2008-2#1)
cancel##8##1##(1992-2#1)(1993-12#1)(2007-12#2)(2008-2#1)(2008-3#2)(2012-3#1)
canceled by the##2##3##(1993-11#1)(2008-3#1)
canceled by##3##2##(1993-11#1)(2008-3#1)(2012-2#1)
canceled out##2##2##(2007-11#1)(2008-3#1)
canceled stimulatory actions of L-leucine and KIC on protein synthesis##2##10##(2008-11#2)
canceled the##3##2##(2008-11#3)
canceled##12##1##(1993-11#1)(2007-11#1)(2007-12#1)(2008-11#5)(2008-2#1)(2008-3#2)(2012-2#1)
canceling##2##1##(2009-4#1)(2009-6#1)
cancellation and##2##2##(2007-8#1)(2008-3#1)
cancellation of the##2##3##(2007-12#1)(2008-3#1)
cancellation of##4##2##(1992-12#1)(1992-3#1)(2007-12#1)(2008-3#1)
cancellation##10##1##(1992-12#1)(1992-3#1)(1996-1#1)(2007-12#2)(2007-8#1)(2008-3#4)
cancellations##3##1##(1995-1#2)(2008-6#1)
cancelled by##2##2##(1990-8#1)(2008-10#1)
cancelled##4##1##(1990-8#1)(1992-5#1)(1997-5#1)(2008-10#1)
cancellous bone volume##2##3##(1993-11#2)
cancellous bone##8##2##(1993-11#2)(2009-7#4)(2011-2#1)(2013-1#1)
cancellous screws##4##2##(2008-7#1)(2009-3#1)(2012-3#2)
cancellous##18##1##(1993-11#2)(1996-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#5)(2010-3#2)(2011-2#2)(2012-3#2)(2013-1#1)
cancer (2##2##2##(1992-8#1)(1993-9#1)
cancer (CC)##2##2##(2008-11#2)
cancer (CRC) is##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
cancer (CRC)##10##2##(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer (HNPCC)##2##2##(2009-12#2)
cancer (NSCLC)##17##2##(1990-2#1)(1991-2#1)(1993-2#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#2)(2012-1#4)(2012-2#1)(2012-3#1)(2013-8#1)
cancer (PCa)##3##2##(2013-1#3)
cancer (SIR =##2##3##(1990-2#2)
cancer (n = 1)##2##4##(1994-10#2)
cancer (n =##6##3##(1993-1#3)(1994-10#3)
cancer (odds ratio##2##3##(2008-4#1)(2009-5#1)
cancer - 1##3##3##(2007-11#3)
cancer - 5##2##3##(2007-11#2)
cancer - 6##2##3##(2007-11#2)
cancer -##12##2##(2007-11#10)(2009-4#1)(2011-2#1)
cancer HeLa cells##3##3##(2008-11#1)(2008-8#2)
cancer according to##2##3##(2008-10#1)(2011-2#1)
cancer accounted for##2##3##(1991-6#1)(2010-8#1)
cancer after##10##2##(1990-12#1)(1991-2#1)(1993-8#2)(1996-11#1)(2008-12#3)(2011-1#1)(2012-12#1)
cancer also##3##2##(1997-7#1)(2007-12#1)(2008-7#1)
cancer among##8##2##(1992-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
cancer and 14 patients with##3##5##(1990-9#2)(1995-12#1)
cancer and a##4##3##(1993-11#1)(1996-1#1)(2008-10#1)(2013-7#1)
cancer and bone metastases##3##4##(1993-11#1)(2007-10#1)(2007-11#1)
cancer and bone##4##3##(1993-11#1)(2007-10#1)(2007-11#2)
cancer and healthy##2##3##(2011-1#1)(2012-3#1)
cancer and in##4##3##(1990-2#1)(1993-9#1)(2007-10#1)(2007-11#1)
cancer and increasing##2##3##(2008-7#1)(2012-12#1)
cancer and its##4##3##(1993-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
cancer and liver metastasis##2##4##(2011-2#1)(2013-8#1)
cancer and metastatic##2##3##(1996-9#1)(2008-3#1)
cancer and multiple bone painful metastases detected by scintigraphy and by radiogram##2##12##(2007-11#2)
cancer and multiple##3##3##(2007-11#3)
cancer and normal##2##3##(1991-12#1)(2008-11#1)
cancer and other diseases##5##4##(1994-5#3)(2008-11#1)(2009-7#1)
cancer and other##12##3##(1993-3#1)(1994-5#3)(2008-11#2)(2008-7#3)(2009-2#1)(2009-5#1)(2009-7#1)
cancer and prostate cancer##2##4##(2007-11#1)(2008-7#1)
cancer and the##12##3##(1991-12#1)(1992-6#1)(1994-5#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
cancer and their families##2##4##(1992-12#1)(1994-3#1)
cancer and their##6##3##(1992-12#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-3#1)(2013-1#1)
cancer and with##3##3##(2007-11#2)(2011-2#1)
cancer and##179##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#4)(1991-12#6)(1991-3#1)(1991-6#1)(1991-8#4)(1992-10#2)(1992-12#5)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#2)(1993-3#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-8#1)(1995-12#2)(1995-2#2)(1995-4#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#9)(2008-1#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#15)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#7)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#7)
cancer antigen 125##2##3##(2007-7#1)(2011-2#1)
cancer are described##2##3##(2008-1#1)(2008-10#1)
cancer are discussed##2##3##(1990-8#1)(2008-10#1)
cancer are presented##3##3##(1992-2#1)(2010-11#1)(2010-8#1)
cancer are reported##2##3##(1991-6#1)(2007-8#1)
cancer are used to##2##4##(1991-3#1)(2008-4#1)
cancer are##24##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#1)(1996-11#2)(1997-8#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-3#2)
cancer as a##4##3##(1993-9#1)(1994-2#1)(2013-1#1)(2013-8#1)
cancer as##10##2##(1993-9#1)(1994-2#1)(1996-9#1)(2007-11#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cancer associated with##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
cancer at the##3##3##(1992-2#1)(2011-1#1)(2011-2#1)
cancer at##12##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-8#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-6#1)
cancer being##3##2##(1991-6#1)(1992-2#1)(2008-7#1)
cancer between##4##2##(1992-10#1)(1997-7#1)(2011-2#1)(2012-3#1)
cancer biology##4##2##(1992-2#1)(2008-11#1)(2009-3#1)(2009-5#1)
cancer biomarker##2##2##(2010-5#1)(2011-2#1)
cancer but##7##2##(1992-8#1)(1994-9#1)(1996-9#2)(2008-10#1)(2011-2#1)(2012-12#1)
cancer by the##2##3##(1996-6#1)(2008-4#1)
cancer by using##2##3##(1995-9#1)(2010-6#1)
cancer by##18##2##(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-4#1)(1995-9#2)(1996-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-3#1)(2013-7#1)
cancer can be##5##3##(1993-3#1)(2007-7#1)(2008-7#1)(2010-8#1)(2013-8#1)
cancer can##7##2##(1993-3#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
cancer care and##2##3##(2010-2#1)(2013-1#1)
cancer care##19##2##(2008-11#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-3#8)(2013-1#4)
cancer case##2##2##(2007-5#1)(2008-7#1)
cancer cases and##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
cancer cases##20##2##(1990-10#1)(1991-2#1)(1992-8#1)(1993-9#1)(1994-7#1)(1995-12#3)(1997-3#1)(1997-6#1)(2007-5#1)(2008-12#2)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
cancer cell biology in##2##4##(2010-1#1)(2010-12#1)
cancer cell growth and##2##4##(2012-3#1)(2013-1#1)
cancer cell growth##5##3##(2008-11#2)(2012-3#2)(2013-1#1)
cancer cell invasion##2##3##(2008-11#2)
cancer cell invasiveness##2##3##(2008-11#1)(2012-12#1)
cancer cell line##35##3##(1990-11#1)(1990-12#3)(1990-5#1)(1992-8#1)(1993-3#4)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-2#2)(2008-11#4)(2008-4#1)(2008-8#3)(2008-9#4)(2010-12#2)(2011-1#1)(2012-3#1)(2013-1#3)
cancer cell lines and##5##4##(1992-8#1)(1992-9#1)(1997-7#1)(2008-11#1)(2009-4#1)
cancer cell lines is##2##4##(1994-8#1)(2008-11#1)
cancer cell lines that##3##4##(2008-11#3)
cancer cell lines was##2##4##(2008-11#1)(2013-1#1)
cancer cell lines were##2##4##(1992-4#1)(2013-1#1)
cancer cell lines##54##3##(1990-6#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-12#1)(1997-7#3)(2008-11#16)(2008-2#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#2)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#5)
cancer cell proliferation and##3##4##(2008-11#1)(2012-2#1)(2013-8#1)
cancer cell proliferation##6##3##(1992-9#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
cancer cell##131##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1992-4#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#5)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1997-2#2)(1997-7#3)(2008-11#28)(2008-2#3)(2008-4#2)(2008-8#6)(2008-9#10)(2009-4#3)(2010-1#1)(2010-12#8)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#11)(2013-8#2)
cancer cells and has##2##4##(2008-4#1)(2009-12#1)
cancer cells and its##2##4##(2008-11#1)(2013-8#1)
cancer cells and##20##3##(1991-6#1)(1994-2#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
cancer cells are##4##3##(1990-12#1)(1992-5#1)(1993-9#1)(2013-8#1)
cancer cells but##2##3##(2008-4#1)(2013-1#1)
cancer cells by##3##3##(1997-7#1)(2008-11#1)(2010-12#1)
cancer cells have been##2##4##(1993-12#1)(2012-3#1)
cancer cells have##3##3##(1993-12#1)(2010-6#1)(2012-3#1)
cancer cells in culture##2##4##(1995-12#1)(2008-11#1)
cancer cells in vitro##4##4##(1994-8#1)(1997-7#1)(2011-2#1)(2013-1#1)
cancer cells in vitro]##2##4##(2012-2#1)(2013-1#1)
cancer cells in##18##3##(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1997-7#1)(2008-11#2)(2008-8#1)(2010-12#1)(2011-2#3)(2012-2#3)(2013-1#2)
cancer cells is##10##3##(1994-2#1)(1994-8#1)(2008-11#1)(2009-3#1)(2010-2#1)(2011-2#4)(2013-1#1)
cancer cells of##2##3##(2008-8#1)(2008-9#1)
cancer cells or##2##3##(1994-5#1)(2008-11#1)
cancer cells to##12##3##(1991-2#1)(1993-9#2)(1994-7#1)(2008-1#1)(2008-11#4)(2009-7#1)(2011-2#1)(2013-1#1)
cancer cells using##2##3##(2008-10#1)(2012-2#1)
cancer cells via##3##3##(2008-11#1)(2009-4#1)(2013-1#1)
cancer cells was##5##3##(1994-8#1)(2008-11#1)(2008-9#2)(2013-1#1)
cancer cells were##4##3##(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cancer cells with a##2##4##(2008-11#1)(2010-12#1)
cancer cells with##8##3##(1990-2#1)(1992-2#1)(2008-11#1)(2009-2#1)(2009-9#1)(2010-12#2)(2013-1#1)
cancer cells##235##2##(1990-12#3)(1990-2#2)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-6#2)(1992-2#1)(1992-4#1)(1992-5#4)(1992-8#3)(1992-9#5)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#4)(1994-11#2)(1994-12#2)(1994-2#3)(1994-5#3)(1994-7#2)(1994-8#3)(1995-10#1)(1995-12#1)(1995-2#3)(1997-4#1)(1997-7#5)(2007-11#3)(2008-1#2)(2008-10#2)(2008-11#32)(2008-2#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#8)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#4)(2009-7#1)(2009-9#5)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#30)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#11)(2013-1#18)(2013-8#10)
cancer cells)##4##2##(1993-9#1)(1994-7#1)(1995-4#1)(2008-4#1)
cancer centre within 3 months##2##5##(2008-6#2)
cancer centre##8##2##(2008-6#4)(2011-2#1)(2012-2#3)
cancer chemoprevention##4##2##(1995-9#1)(2007-4#1)(2008-6#1)(2009-11#1)
cancer chemopreventive##2##2##(1995-9#1)(2008-4#1)
cancer chemotherapy##9##2##(1994-9#1)(1995-3#1)(1995-6#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-11#1)
cancer clinical trials##2##3##(1997-8#1)(2013-1#1)
cancer compared with##2##3##(2012-12#1)(2012-2#1)
cancer compared##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
cancer conducted##2##2##(1990-12#1)(1993-9#1)
cancer continue to##2##3##(2008-11#1)(2010-11#1)
cancer continues to##2##3##(2010-12#1)(2010-8#1)
cancer control programs##5##3##(2011-3#5)
cancer control research and##2##4##(1997-1#2)
cancer control research##4##3##(1992-12#1)(1997-1#3)
cancer control##23##2##(1992-12#1)(1997-1#13)(2008-7#1)(2009-4#1)(2011-3#7)
cancer could be related to##2##5##(1992-8#1)(2010-10#1)
cancer could be##3##3##(1992-8#1)(2007-10#1)(2010-10#1)
cancer could##5##2##(1992-8#1)(2007-10#1)(2008-1#1)(2008-8#1)(2010-10#1)
cancer death##5##2##(1991-12#2)(1997-1#1)(2008-7#2)
cancer deaths in##4##3##(1991-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
cancer deaths##10##2##(1991-3#2)(1997-1#1)(2008-7#2)(2009-12#1)(2010-3#1)(2011-3#1)(2013-1#2)
cancer detection by##3##3##(1997-5#2)(2009-4#1)
cancer detection rate##3##3##(1991-12#2)(2012-12#1)
cancer detection##11##2##(1991-12#2)(1992-2#1)(1997-5#2)(2008-1#1)(2008-2#1)(2009-4#1)(2011-2#2)(2012-12#1)
cancer development##18##2##(1992-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(2008-11#1)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
cancer diagnosed##5##2##(1992-10#1)(2007-10#1)(2010-3#2)(2012-3#1)
cancer diagnosis and treatment##3##4##(2010-6#2)(2013-1#1)
cancer diagnosis and##4##3##(2008-8#1)(2010-6#2)(2013-1#1)
cancer diagnosis##19##2##(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-12#3)(2013-1#2)
cancer diseases##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
cancer drug resistance##2##3##(2013-1#2)
cancer drug##4##2##(2009-9#1)(2012-2#1)(2013-1#2)
cancer drugs##5##2##(2008-5#1)(2008-7#1)(2010-11#1)(2010-5#1)(2012-2#1)
cancer due to##2##3##(1990-8#1)(2008-11#1)
cancer during pregnancy##3##3##(1992-10#1)(2013-1#2)
cancer during##6##2##(1992-10#1)(1994-9#1)(2008-10#1)(2013-1#3)
cancer epidemiology##3##2##(1995-9#1)(2008-11#1)(2011-3#1)
cancer epigenetics##2##2##(2009-4#2)
cancer extension##2##2##(1994-9#2)
cancer family history##2##3##(2012-3#2)
cancer family##3##2##(1994-12#1)(2012-3#2)
cancer following##9##2##(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-8#1)(2012-3#1)
cancer for##6##2##(1991-7#1)(1996-9#1)(2009-9#1)(2013-1#2)(2013-7#1)
cancer from##4##2##(1991-5#1)(1991-6#1)(2008-12#1)(2013-1#1)
cancer gene therapy##7##3##(1994-5#2)(2008-5#1)(2008-8#2)(2011-2#1)(2012-3#1)
cancer gene##9##2##(1994-5#2)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-3#1)
cancer genes##2##2##(2008-8#1)(2009-6#1)
cancer group##3##2##(1997-4#2)(2011-1#1)
cancer growth and##2##3##(1992-9#1)(2011-1#1)
cancer growth##3##2##(1992-9#1)(2011-1#2)
cancer had##2##2##(1992-2#1)(2012-1#1)
cancer has a##2##3##(1990-12#1)(1997-6#1)
cancer has been##7##3##(1991-12#1)(1992-9#1)(1993-9#1)(2007-12#1)(2008-8#1)(2010-1#1)(2011-2#1)
cancer has##19##2##(1990-12#1)(1990-9#1)(1991-12#1)(1992-9#1)(1993-9#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
cancer have been##6##3##(1994-2#1)(1994-5#1)(1996-11#1)(2010-6#1)(2011-1#1)(2012-2#1)
cancer have##15##2##(1994-2#1)(1994-5#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-6#2)(2010-9#1)(2011-1#1)(2012-2#2)
cancer imaging##8##2##(2008-1#4)(2008-2#4)
cancer immunotherapy##10##2##(1990-12#1)(1993-6#1)(2008-11#5)(2008-5#2)(2012-2#1)
cancer in Japan##3##3##(1992-3#1)(1997-7#1)(2010-12#1)
cancer in Santander##4##3##(2012-12#4)
cancer in a Chinese population##2##5##(2011-2#1)(2013-7#1)
cancer in a female##2##4##(1992-12#1)(2008-4#1)
cancer in a##14##3##(1990-6#1)(1992-10#1)(1992-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
cancer in both##2##3##(1991-6#1)(1994-2#1)
cancer in elderly patients##2##4##(2008-7#1)(2011-2#1)
cancer in elderly women##2##4##(1994-12#1)(2007-8#1)
cancer in elderly##5##3##(1994-12#1)(2007-8#1)(2008-7#1)(2011-2#2)
cancer in humans##2##3##(1991-2#1)(1993-9#1)
cancer in males##4##3##(1990-8#1)(1994-12#1)(1997-7#2)
cancer in men and##2##4##(1990-2#1)(2010-1#1)
cancer in men##6##3##(1990-2#1)(2008-1#1)(2008-11#1)(2010-1#1)(2010-10#1)(2013-1#1)
cancer in order to##4##4##(1993-12#1)(1996-9#1)(2011-2#1)(2013-7#1)
cancer in patients with##4##4##(1994-12#1)(2008-12#3)
cancer in patients##7##3##(1994-12#1)(2008-12#3)(2011-2#1)(2012-12#2)
cancer in the United States##3##5##(1995-9#1)(2009-5#1)(2013-1#1)
cancer in the absence of the low dose##2##8##(2008-7#2)
cancer in the absence of##3##5##(1996-11#1)(2008-7#2)
cancer in the city of##2##5##(1991-6#1)(2007-5#1)
cancer in the world##3##4##(2009-5#1)(2010-5#1)(2013-1#1)
cancer in the##25##3##(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#2)(1992-10#1)(1995-9#1)(1996-11#1)(1996-7#1)(1997-1#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#1)(2009-5#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
cancer in these##2##3##(1995-4#1)(2008-12#1)
cancer in vivo##3##3##(1993-11#1)(2011-2#1)(2012-3#1)
cancer in##155##2##(1990-2#1)(1990-6#4)(1990-8#2)(1990-9#4)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#3)(1991-9#1)(1992-10#4)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#3)(1994-12#4)(1994-2#2)(1994-6#1)(1994-8#1)(1995-4#1)(1995-9#2)(1996-11#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#3)(1997-8#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#4)(2009-12#1)(2009-5#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#6)(2010-9#2)(2011-2#12)(2012-12#8)(2012-3#4)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#1)
cancer incidence and##4##3##(1991-4#1)(1992-2#1)(2009-5#2)
cancer incidence below the spontaneous level##2##6##(2008-7#2)
cancer incidence in##6##3##(1991-4#1)(1995-2#1)(1996-3#2)(2011-2#1)(2012-12#1)
cancer incidence rates##2##3##(1996-3#1)(2008-1#1)
cancer incidence##26##2##(1991-3#1)(1991-4#2)(1992-10#1)(1992-2#1)(1995-2#1)(1996-3#4)(1997-3#2)(2008-1#4)(2008-7#3)(2009-5#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
cancer include##2##2##(1992-3#1)(2011-2#1)
cancer includes##2##2##(1993-6#1)(2011-3#1)
cancer including##2##2##(2008-1#1)(2013-7#1)
cancer increased##2##2##(1997-7#1)(2011-3#1)
cancer induction##4##2##(1990-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
cancer initiation##5##2##(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
cancer invasion and metastasis##4##4##(1993-6#1)(2011-2#3)
cancer invasion##5##2##(1990-9#1)(1993-6#1)(2011-2#3)
cancer is a disease##2##4##(1994-9#1)(2011-2#1)
cancer is a major public health##2##6##(2010-12#1)(2013-1#1)
cancer is a major##4##4##(2009-12#1)(2010-12#1)(2010-5#1)(2013-1#1)
cancer is a##14##3##(1990-6#1)(1991-12#1)(1991-9#1)(1994-9#1)(2008-11#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-5#1)(2011-2#3)(2013-1#1)
cancer is associated with##2##4##(2008-4#1)(2008-7#1)
cancer is not##3##3##(1990-10#1)(1992-9#1)(2010-6#1)
cancer is one of the##2##5##(2009-12#1)(2012-12#1)
cancer is rare and##2##4##(2007-8#1)(2010-6#1)
cancer is still##5##3##(1994-12#1)(2007-5#1)(2007-8#1)(2011-2#1)(2013-1#1)
cancer is the most common##4##5##(1995-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
cancer is the most##6##4##(1995-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
cancer is the second leading cause of cancer-related##2##8##(2008-1#1)(2011-1#1)
cancer is the second leading##3##5##(2008-1#1)(2009-5#1)(2011-1#1)
cancer is the second most common##2##6##(2010-8#1)(2011-1#1)
cancer is the second##5##4##(2008-1#1)(2009-5#1)(2010-8#1)(2011-1#2)
cancer is the##16##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
cancer is used to##2##4##(1990-9#1)(1992-9#1)
cancer is very##2##3##(2007-5#1)(2008-10#1)
cancer is well##2##3##(2007-8#1)(2013-8#1)
cancer is##99##2##(1990-10#2)(1990-6#2)(1990-9#1)(1991-12#2)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#4)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#6)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
cancer lesions##3##2##(2008-10#2)(2011-2#1)
cancer malignancy##2##2##(2008-5#1)(2013-8#1)
cancer mammae##2##2##(1991-2#1)(1992-5#1)
cancer management##3##2##(2010-12#1)(2010-8#1)(2012-3#1)
cancer may be##4##3##(1990-2#1)(1993-9#1)(2008-7#1)(2010-12#1)
cancer may##8##2##(1990-2#1)(1991-8#1)(1992-2#1)(1993-9#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
cancer medicine##2##2##(2012-3#1)(2013-1#1)
cancer metastases and pathological##3##4##(2007-11#3)
cancer metastases and##4##3##(1990-12#1)(2007-11#3)
cancer metastases##7##2##(1990-12#1)(2007-11#5)(2008-4#1)
cancer metastasis##11##2##(2007-11#1)(2008-1#3)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
cancer model has##2##3##(2008-10#2)
cancer model##6##2##(2008-10#2)(2008-7#2)(2009-3#1)(2010-6#1)
cancer models##2##2##(2010-6#1)(2011-2#1)
cancer morbidity##2##2##(1995-2#1)(1997-1#1)
cancer mortality and##4##3##(1990-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer mortality data##3##3##(2008-5#1)(2013-1#2)
cancer mortality in the##2##4##(1996-6#1)(1997-1#1)
cancer mortality in##5##3##(1990-8#1)(1991-12#1)(1994-2#1)(1996-6#1)(1997-1#1)
cancer mortality is##2##3##(2008-9#1)(2009-10#1)
cancer mortality rate##3##3##(1993-12#1)(2012-12#1)(2013-1#1)
cancer mortality rates in##2##4##(1993-12#1)(2008-9#1)
cancer mortality rates##4##3##(1993-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
cancer mortality##43##2##(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#2)(1993-12#2)(1994-2#2)(1996-6#1)(1997-1#2)(1997-7#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#1)
cancer not##2##2##(2008-1#1)(2008-7#1)
cancer observed##3##2##(1990-9#1)(1991-12#1)(2013-1#1)
cancer occurrence in##2##3##(2008-7#1)(2011-3#1)
cancer occurrence##3##2##(2008-7#2)(2011-3#1)
cancer of breast and##2##4##(1991-12#1)(2007-8#1)
cancer of gastrointestinal tract##2##4##(1991-12#1)(1992-8#1)
cancer of the breast##2##4##(1994-2#1)(2007-8#1)
cancer of the cervix##3##4##(1996-6#1)(2008-11#1)(2008-7#1)
cancer of the colon##2##4##(1994-2#1)(2013-1#1)
cancer of the left##2##4##(1990-3#1)(2012-3#1)
cancer of the stomach##13##4##(1990-9#1)(1991-2#2)(2008-7#9)(2012-12#1)
cancer of the thyroid##2##4##(1990-8#1)(1996-11#1)
cancer of the uterine cervix##3##5##(2008-11#1)(2009-11#2)
cancer of the##50##3##(1990-3#1)(1990-8#2)(1990-9#5)(1991-11#1)(1991-2#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-9#1)(1994-2#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(2007-8#3)(2008-11#2)(2008-7#16)(2009-11#2)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
cancer of##63##2##(1990-3#1)(1990-8#2)(1990-9#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-2#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(2007-8#4)(2008-11#2)(2008-7#16)(2009-11#2)(2010-12#2)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#1)
cancer on##4##2##(2008-1#1)(2008-7#2)(2011-2#1)
cancer operations##2##2##(2008-10#1)(2010-8#1)
cancer or benign##2##3##(1990-6#1)(1993-1#1)
cancer or##10##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-9#1)(2008-8#1)(2009-12#1)(2009-2#1)
cancer outside the##2##3##(1995-5#1)(2008-7#1)
cancer pain management##3##3##(2008-7#1)(2009-12#1)(2012-2#1)
cancer pain treatment##3##3##(1997-3#3)
cancer pain##22##2##(1997-3#4)(1997-5#1)(2008-7#10)(2009-12#1)(2012-2#6)
cancer pathogenesis##3##2##(2008-8#1)(2011-2#2)
cancer patient in##2##3##(1997-5#1)(2007-5#1)
cancer patient##9##2##(1993-11#1)(1993-3#1)(1997-5#1)(2007-5#1)(2008-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
cancer patients after##5##3##(1994-12#3)(1995-4#1)(2008-10#1)
cancer patients and patients##2##4##(2007-5#1)(2011-2#1)
cancer patients and their##3##4##(1994-3#1)(1995-2#1)(1996-3#1)
cancer patients and##23##3##(1990-12#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-3#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-5#1)(2011-2#2)(2013-1#2)(2013-7#1)
cancer patients are##3##3##(1993-8#1)(2009-11#1)(2009-2#1)
cancer patients as##2##3##(1992-8#1)(1997-7#1)
cancer patients had##3##3##(1991-4#1)(1992-9#1)(2013-1#1)
cancer patients in a##2##4##(2010-2#1)(2011-2#1)
cancer patients in an##2##4##(2008-10#1)(2012-2#1)
cancer patients in##13##3##(1990-6#2)(1993-1#1)(1994-7#1)(1994-8#1)(2008-10#1)(2008-4#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
cancer patients pretreated with 5-fluorouracil##2##5##(1992-12#2)
cancer patients pretreated with##3##4##(1992-12#2)(1994-8#1)
cancer patients receiving##2##3##(2009-11#1)(2011-2#1)
cancer patients that##2##3##(2008-10#1)(2011-2#1)
cancer patients to##4##3##(1993-3#1)(1993-9#2)(2008-5#1)
cancer patients treated with##5##4##(2009-11#1)(2009-4#3)(2009-5#1)
cancer patients undergoing##2##3##(1990-9#1)(1993-12#1)
cancer patients was##2##3##(1991-4#1)(2008-5#1)
cancer patients were included in the##2##6##(2010-12#1)(2013-8#1)
cancer patients were##4##3##(1994-3#1)(2008-10#1)(2010-12#1)(2013-8#1)
cancer patients who are##2##4##(2008-10#1)(2013-8#1)
cancer patients who##5##3##(1993-1#1)(2008-10#1)(2012-3#1)(2013-8#2)
cancer patients with bone metastases##2##5##(2011-2#2)
cancer patients with multiple##2##4##(2007-11#2)
cancer patients with##16##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(2007-11#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
cancer patients##231##2##(1990-12#8)(1990-2#5)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#6)(1991-3#2)(1991-4#4)(1991-6#2)(1992-10#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-8#3)(1992-9#3)(1993-1#4)(1993-11#8)(1993-12#3)(1993-3#1)(1993-8#6)(1993-9#5)(1994-12#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#4)(1995-12#1)(1995-2#2)(1995-4#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-5#2)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#5)(2008-4#9)(2008-5#5)(2008-7#4)(2008-8#2)(2009-11#4)(2009-12#4)(2009-2#2)(2009-4#5)(2009-5#3)(2010-11#2)(2010-12#4)(2010-2#4)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#8)
cancer patients]##9##2##(1991-3#1)(1991-6#1)(1992-2#1)(1993-3#1)(1997-6#1)(2007-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer populations##2##2##(2009-4#1)(2012-2#1)
cancer precursors##2##2##(1994-1#1)(2011-2#1)
cancer prevention and control initiatives##2##5##(1996-2#1)(1997-1#1)
cancer prevention and control##3##4##(1996-2#1)(1997-1#2)
cancer prevention and treatment##2##4##(2008-7#1)(2009-12#1)
cancer prevention and##7##3##(1996-2#1)(1997-1#2)(2008-7#2)(2009-12#2)
cancer prevention programs##3##3##(1997-1#1)(2013-1#2)
cancer prevention##26##2##(1995-9#2)(1996-2#1)(1997-1#4)(1997-4#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-4#2)(2008-7#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#1)(2012-2#1)(2013-1#2)
cancer procedures##2##2##(1995-2#2)
cancer prognosis##3##2##(1990-9#1)(1993-7#1)(1993-9#1)
cancer progression in vivo##2##4##(2008-8#1)(2012-12#1)
cancer progression##13##2##(2008-1#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
cancer prone##2##2##(2008-7#2)
cancer rates##4##2##(1990-2#1)(1992-6#1)(2008-7#2)
cancer received##2##2##(1990-12#1)(2008-10#1)
cancer receiving chemotherapy##4##3##(2008-7#3)(2010-2#1)
cancer receiving##7##2##(2008-7#5)(2010-2#1)(2013-1#1)
cancer recurrence##3##2##(1990-2#1)(2008-10#1)(2008-8#1)
cancer registries##3##2##(1991-2#1)(2008-7#1)(2011-3#1)
cancer registry##4##2##(1992-10#2)(1993-9#1)(2011-2#1)
cancer remains a##2##3##(2008-2#1)(2011-2#1)
cancer repression gene p53##2##4##(2008-10#2)
cancer rescue mutants##3##3##(2009-9#3)
cancer rescue##4##2##(2009-9#4)
cancer research and##3##3##(2006-10#1)(2008-11#1)(2009-4#1)
cancer research are##2##3##(1990-2#1)(2008-11#1)
cancer research##18##2##(1990-2#2)(1994-11#1)(2006-10#1)(2008-11#2)(2008-7#2)(2009-12#1)(2009-4#6)(2010-9#1)(2011-1#1)(2012-12#1)
cancer response to##2##3##(2008-8#1)(2011-2#1)
cancer risk among##3##3##(2008-12#1)(2010-6#1)(2011-2#1)
cancer risk and##5##3##(1993-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
cancer risk assessment##4##3##(2008-7#4)
cancer risk from##3##3##(2008-7#1)(2013-1#2)
cancer risk in##8##3##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(1996-3#1)(2008-7#1)(2012-6#1)(2013-1#1)
cancer risk of##2##3##(2012-12#2)
cancer risk was##2##3##(1991-2#1)(1991-3#1)
cancer risk##60##2##(1990-6#2)(1990-8#2)(1991-2#2)(1991-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#4)(1995-6#1)(1995-9#5)(1996-3#2)(1997-8#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#8)(2010-6#2)(2011-2#3)(2012-12#6)(2012-2#1)(2012-3#2)(2012-6#6)(2013-1#3)
cancer samples##3##2##(1997-4#1)(2011-2#2)
cancer screening among##2##3##(1997-2#1)(2013-1#1)
cancer screening and##3##3##(2008-12#1)(2009-5#1)(2013-1#1)
cancer screening in African American men##2##6##(2009-5#2)
cancer screening in African American##3##5##(2008-4#1)(2009-5#2)
cancer screening in##6##3##(1990-2#1)(2008-4#1)(2009-5#2)(2011-2#2)
cancer screening methods##2##3##(1995-4#1)(2007-8#1)
cancer screening services##3##3##(1996-2#2)(1997-1#1)
cancer screening study##2##3##(1995-12#1)(2008-1#1)
cancer screening was##3##3##(1990-8#1)(2007-8#1)(2008-8#1)
cancer screening##66##2##(1990-2#1)(1990-8#1)(1992-2#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-4#2)(1995-9#3)(1996-2#2)(1997-1#4)(1997-2#1)(1997-3#1)(2007-10#1)(2007-8#5)(2008-1#2)(2008-12#2)(2008-2#3)(2008-4#2)(2008-8#2)(2008-9#1)(2009-5#7)(2009-9#1)(2010-8#2)(2011-2#6)(2012-12#4)(2013-1#6)(2013-8#1)
cancer seems to be##3##4##(1990-8#1)(1991-12#1)(2013-1#1)
cancer should be##3##3##(1994-2#2)(2008-4#1)
cancer should##6##2##(1994-2#2)(2008-1#1)(2008-4#1)(2009-5#1)(2012-2#1)
cancer showed##2##2##(1994-2#1)(2008-8#1)
cancer signaling##2##2##(2012-12#2)
cancer sites##8##2##(1990-8#1)(1993-9#1)(1996-2#1)(2008-11#1)(2009-11#1)(2011-1#1)(2011-3#1)(2012-12#1)
cancer specific human##3##3##(2008-11#3)
cancer specific monoclonal antibodies##2##4##(1992-8#1)(2008-11#1)
cancer specific##6##2##(1992-8#1)(2008-11#5)
cancer specimens##6##2##(1990-11#1)(1993-8#3)(2011-2#1)(2013-1#1)
cancer stem cells (CSCs) are##2##5##(2009-9#1)(2011-2#1)
cancer stem cells in##2##4##(2010-12#1)(2013-8#1)
cancer stem cells##6##3##(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
cancer stem##9##2##(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-8#1)
cancer still##2##2##(2008-1#1)(2008-7#1)
cancer studies of##2##3##(2008-10#1)(2008-8#1)
cancer surgery##9##2##(1991-3#1)(1991-5#1)(1992-9#1)(2007-8#1)(2008-7#2)(2010-12#1)(2010-4#1)(2012-12#1)
cancer survival##3##2##(1997-7#1)(2008-7#1)(2013-8#1)
cancer survivor##3##2##(2008-7#2)(2012-3#1)
cancer survivors##23##2##(2008-4#4)(2008-7#12)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#3)
cancer survivorship interventions##2##3##(2012-3#2)
cancer survivorship##10##2##(2008-7#5)(2012-3#5)
cancer susceptibility gene##3##3##(1994-6#1)(1994-9#1)(1995-12#1)
cancer susceptibility##7##2##(1994-6#1)(1994-9#2)(1995-12#1)(1996-10#1)(1997-7#1)(2011-2#1)
cancer syndrome##4##2##(1990-11#1)(1994-12#1)(2008-1#1)(2011-2#1)
cancer syndromes##7##2##(1990-12#1)(2009-12#2)(2011-2#3)(2012-3#1)
cancer than##4##2##(1993-1#1)(2008-12#1)(2009-5#1)(2011-2#1)
cancer that##6##2##(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
cancer the##2##2##(1993-9#1)(2008-7#1)
cancer therapeutic##4##2##(2009-11#1)(2009-3#1)(2012-12#2)
cancer therapeutics##6##2##(2008-11#1)(2009-12#1)(2011-2#2)(2013-8#2)
cancer therapies##2##2##(2007-11#1)(2012-2#1)
cancer therapy and##5##3##(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#2)
cancer therapy##52##2##(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#3)(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#18)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
cancer through##4##2##(1991-12#1)(2008-5#1)(2008-7#1)(2009-12#1)
cancer tissue##5##2##(1990-2#1)(1993-1#1)(1993-11#1)(2009-4#1)(2012-3#1)
cancer tissues##10##2##(1991-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
cancer to##8##2##(1990-12#1)(1991-8#1)(1993-6#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-12#1)(2013-1#1)
cancer treated with##7##3##(1992-10#1)(1992-8#1)(1997-7#1)(2008-7#2)(2011-2#1)(2013-1#1)
cancer treated##12##2##(1991-8#2)(1992-10#1)(1992-8#1)(1995-5#1)(1997-7#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
cancer treatment and##3##3##(2008-7#1)(2009-5#1)(2011-2#1)
cancer treatment in##4##3##(2010-8#1)(2011-2#2)(2012-3#1)
cancer treatment is##2##3##(2009-9#1)(2011-2#1)
cancer treatment##38##2##(1993-3#1)(2007-10#2)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#4)(2009-3#1)(2009-5#1)(2009-9#3)(2010-8#1)(2011-2#5)(2012-3#2)(2013-1#2)
cancer treatments##5##2##(2008-1#1)(2008-7#1)(2012-2#1)(2013-1#2)
cancer trials##2##2##(1995-2#1)(2008-7#1)
cancer type##2##2##(2009-9#1)(2011-2#1)
cancer types##3##2##(2009-12#1)(2012-2#1)(2013-8#1)
cancer using##8##2##(1995-11#1)(1995-4#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-2#1)(2012-6#1)(2013-8#1)
cancer vaccine##3##2##(2008-11#1)(2008-5#1)(2010-5#1)
cancer vaccines##7##2##(1997-4#3)(2008-5#3)(2010-5#1)
cancer was 3##3##3##(1993-9#1)(2012-12#2)
cancer was conducted##2##3##(1993-9#1)(2008-7#1)
cancer was investigated##2##3##(1991-2#1)(1993-9#1)
cancer was observed##2##3##(2011-2#1)(2012-3#1)
cancer was significantly##2##3##(1990-2#1)(2011-2#1)
cancer was##42##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-6#3)(1992-12#1)(1992-5#1)(1993-1#1)(1993-9#5)(1994-2#1)(1995-4#3)(2007-11#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#2)
cancer were 1##2##3##(1993-9#2)
cancer were analyzed##2##3##(1997-7#1)(2008-11#1)
cancer were divided into##2##4##(1995-4#1)(2007-8#1)
cancer were observed##3##3##(1990-12#1)(1992-9#1)(2011-1#1)
cancer were treated with two types of regimens##2##8##(1997-7#2)
cancer were treated with##5##4##(1990-2#1)(1991-6#1)(1992-12#1)(1997-7#2)
cancer were treated##7##3##(1990-2#1)(1991-6#1)(1992-12#1)(1994-7#1)(1997-7#2)(2011-2#1)
cancer were##35##2##(1990-12#2)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-9#2)(1993-9#2)(1994-12#1)(1994-7#1)(1995-4#2)(1996-3#1)(1997-4#1)(1997-7#3)(2007-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
cancer when##2##2##(1993-11#1)(2008-2#1)
cancer which##6##2##(1990-11#1)(1991-8#1)(2007-10#1)(2007-8#1)(2012-3#1)(2013-7#1)
cancer who are##2##3##(2008-7#1)(2011-2#1)
cancer who had been##3##4##(1991-8#1)(1995-4#1)(2008-7#1)
cancer who had##5##3##(1991-8#1)(1992-10#1)(1995-4#1)(2008-7#1)(2011-2#1)
cancer who have##2##3##(1992-10#1)(2008-7#1)
cancer who presented##2##3##(2010-6#1)(2013-1#1)
cancer who received##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
cancer who underwent##2##3##(1997-7#1)(2013-1#1)
cancer who were##3##3##(2007-11#1)(2008-8#1)(2012-3#1)
cancer who##22##2##(1991-8#1)(1992-10#2)(1995-4#1)(1997-7#1)(2007-11#1)(2008-7#4)(2008-8#1)(2010-6#1)(2011-2#3)(2012-3#2)(2013-1#5)
cancer will##2##2##(1990-3#1)(2007-11#1)
cancer with a##2##3##(1990-12#1)(2009-5#1)
cancer with an##4##3##(1990-6#1)(1991-8#2)(2008-7#1)
cancer with##34##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#2)(1992-10#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-11#1)(2009-5#2)(2009-8#1)(2010-12#2)(2011-2#3)(2012-6#1)(2013-1#3)(2013-8#2)
cancer without##3##2##(1993-11#1)(1994-12#1)(2007-8#1)
cancer worldwide##2##2##(2012-12#1)(2013-8#1)
cancer xenografts in##3##3##(1997-7#1)(2008-8#1)(2013-1#1)
cancer xenografts##7##2##(1997-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer##3948##1##(1990-10#8)(1990-11#10)(1990-12#44)(1990-2#35)(1990-3#4)(1990-5#6)(1990-6#25)(1990-7#1)(1990-8#38)(1990-9#35)(1991-11#5)(1991-12#53)(1991-2#23)(1991-3#19)(1991-4#17)(1991-5#2)(1991-6#34)(1991-7#6)(1991-8#28)(1991-9#4)(1992-10#34)(1992-11#3)(1992-12#21)(1992-2#30)(1992-3#9)(1992-4#2)(1992-5#11)(1992-6#8)(1992-7#1)(1992-8#35)(1992-9#28)(1993-1#39)(1993-11#43)(1993-12#16)(1993-2#5)(1993-3#16)(1993-5#3)(1993-6#7)(1993-7#2)(1993-8#21)(1993-9#66)(1994-1#1)(1994-10#3)(1994-11#7)(1994-12#35)(1994-2#34)(1994-3#18)(1994-5#23)(1994-6#12)(1994-7#18)(1994-8#19)(1994-9#26)(1995-10#3)(1995-11#8)(1995-12#20)(1995-2#18)(1995-3#2)(1995-4#22)(1995-5#3)(1995-6#2)(1995-8#15)(1995-9#37)(1996-1#3)(1996-10#5)(1996-11#11)(1996-12#1)(1996-2#7)(1996-3#18)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#10)(1997-1#35)(1997-2#5)(1997-3#22)(1997-4#15)(1997-5#5)(1997-6#4)(1997-7#40)(1997-8#19)(2006-10#1)(2006-8#1)(2007-10#21)(2007-11#66)(2007-12#14)(2007-2#4)(2007-4#10)(2007-5#28)(2007-6#1)(2007-7#4)(2007-8#36)(2007-9#1)(2008-1#62)(2008-10#92)(2008-11#147)(2008-12#25)(2008-2#26)(2008-3#9)(2008-4#87)(2008-5#57)(2008-6#14)(2008-7#287)(2008-8#63)(2008-9#37)(2009-1#3)(2009-10#7)(2009-11#20)(2009-12#41)(2009-2#11)(2009-3#11)(2009-4#49)(2009-5#64)(2009-6#4)(2009-7#7)(2009-8#2)(2009-9#25)(2010-1#11)(2010-10#11)(2010-11#23)(2010-12#69)(2010-2#12)(2010-3#7)(2010-4#5)(2010-5#16)(2010-6#25)(2010-7#16)(2010-8#45)(2010-9#15)(2011-1#59)(2011-2#267)(2011-3#28)(2012-1#19)(2012-12#83)(2012-2#75)(2012-3#116)(2012-6#11)(2012-8#1)(2013-1#240)(2013-7#18)(2013-8#106)
cancer) and##3##2##(1993-9#1)(1996-8#1)(2008-7#1)
cancer)##10##1##(1991-8#1)(1992-6#1)(1993-9#2)(1996-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)
cancer--a##2##1##(1992-5#1)(2011-2#1)
cancer--the##2##1##(1997-7#1)(2012-3#1)
cancer-associated carbohydrate antigens##2##3##(1994-9#1)(2010-2#1)
cancer-associated proteins##2##2##(2010-12#1)(2012-2#1)
cancer-associated##13##1##(1991-4#1)(1991-9#1)(1994-9#2)(2008-11#1)(2008-7#3)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
cancer-causing##3##1##(1991-12#1)(2011-2#1)(2011-3#1)
cancer-cell##3##1##(1993-9#1)(2008-11#2)
cancer-related death##3##2##(2008-1#1)(2012-1#1)(2013-1#1)
cancer-related deaths##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
cancer-related##24##1##(1990-8#1)(1994-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
cancer-specific##6##1##(1994-2#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
cancer?##6##1##(1994-8#1)(2007-4#1)(2008-4#1)(2011-2#2)(2013-8#1)
cancer?]##2##1##(1992-11#1)(1995-5#1)
cancer]##67##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#3)(1991-6#1)(1992-2#1)(1992-5#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-9#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#4)(2013-8#1)
cancerogenesis##2##1##(2011-2#1)(2012-3#1)
cancerous and##3##2##(1992-9#1)(2009-10#1)(2011-1#1)
cancerous##17##1##(1990-6#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-7#2)(2007-5#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
cancers and other##3##3##(2007-12#1)(2008-1#1)(2010-12#1)
cancers and##22##2##(1992-8#1)(1993-8#1)(1994-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
cancers are##8##2##(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#3)
cancers arising##2##2##(1991-6#1)(2012-2#1)
cancers develop##2##2##(2008-1#1)(2013-1#1)
cancers for which##2##3##(1991-12#1)(2011-1#1)
cancers for##3##2##(1991-12#1)(2010-8#1)(2011-1#1)
cancers have been##3##3##(2008-4#1)(2010-8#1)(2011-2#1)
cancers have##5##2##(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
cancers in patients##3##3##(1993-8#1)(1995-11#1)(2012-3#1)
cancers in the##5##3##(2008-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)
cancers in which telomerase##2##4##(2008-11#2)
cancers in##23##2##(1990-8#1)(1991-6#2)(1992-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
cancers including##5##2##(2008-10#1)(2008-2#1)(2009-11#1)(2010-8#1)(2011-2#1)
cancers is##5##2##(1993-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#1)
cancers may be##2##3##(1993-1#1)(1994-2#1)
cancers may##3##2##(1993-1#1)(1994-2#1)(1997-7#1)
cancers observed##2##2##(1991-2#1)(2010-1#1)
cancers of different##2##3##(2009-9#1)(2011-2#1)
cancers of other##2##3##(1991-12#1)(1992-10#1)
cancers of the breast##4##4##(1992-5#1)(1995-9#1)(2008-11#1)(2008-4#1)
cancers of the gastrointestinal tract##2##5##(2011-2#1)(2012-3#1)
cancers of the##11##3##(1990-8#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-5#1)(1995-9#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
cancers of##17##2##(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-5#1)(1994-2#1)(1995-9#1)(2008-11#1)(2008-4#2)(2009-9#1)(2011-2#2)(2012-3#1)
cancers principally##2##2##(2012-12#1)(2013-1#1)
cancers remain##2##2##(1994-2#1)(2011-1#1)
cancers should##2##2##(1993-11#1)(2007-12#1)
cancers such as##2##3##(2008-8#1)(2011-2#1)
cancers that##4##2##(1990-12#1)(1997-3#2)(2008-11#1)
cancers treated##4##2##(1993-11#1)(2007-8#1)(2011-2#1)(2013-8#1)
cancers was##2##2##(1990-12#1)(1994-12#1)
cancers were##12##2##(1990-2#1)(1991-2#2)(1991-3#1)(1992-8#1)(1993-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-8#1)
cancers which##3##2##(1990-2#1)(2008-11#1)(2008-5#1)
cancers with##7##2##(1990-9#1)(1993-11#1)(1995-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
cancers##357##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#4)(1990-8#6)(1990-9#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#4)(1991-6#8)(1991-8#1)(1992-10#3)(1992-12#2)(1992-3#2)(1992-5#3)(1992-8#4)(1993-1#3)(1993-11#5)(1993-2#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#3)(1995-9#4)(1996-11#1)(1997-2#1)(1997-3#5)(1997-7#6)(1997-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#7)(2008-10#7)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#17)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#6)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#6)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#8)(2011-2#35)(2011-3#4)(2012-12#15)(2012-2#8)(2012-3#7)(2013-1#24)(2013-7#3)(2013-8#7)
cancers)##2##1##(1994-8#1)(1995-12#1)
candida and##2##2##(2007-2#1)(2008-6#1)
candida##11##1##(1991-3#1)(2007-2#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#2)
candidacy assessment##2##2##(2012-2#2)
candidacy for bilateral cochlear implants##2##5##(2012-2#2)
candidacy of##3##2##(2006-10#1)(2008-10#1)(2010-2#1)
candidacy##12##1##(2006-10#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-2#8)
candidate as a new##2##4##(2008-10#1)(2010-6#1)
candidate as a##3##3##(2008-10#1)(2010-12#1)(2010-6#1)
candidate as##4##2##(1991-12#1)(2008-10#1)(2010-12#1)(2010-6#1)
candidate biomarkers##2##2##(2012-1#2)
candidate for a##8##3##(1991-9#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-2#1)
candidate for an##2##3##(1992-3#1)(1995-12#1)
candidate for biological control of##2##5##(2008-10#2)
candidate for developing##2##3##(2008-10#1)(2012-12#1)
candidate for the##7##3##(1994-6#1)(1996-12#2)(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
candidate for this##3##3##(1991-9#1)(1992-6#1)(2008-10#1)
candidate for treatment of##2##4##(2008-11#1)(2010-11#1)
candidate for use in##2##4##(1995-11#1)(2008-10#1)
candidate for use##5##3##(1993-2#1)(1995-11#1)(2008-10#1)(2008-3#1)(2009-9#1)
candidate for##58##2##(1990-12#1)(1990-7#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-2#1)(1993-9#2)(1994-6#2)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#6)
candidate gene for##7##3##(1993-11#2)(1997-5#1)(2008-6#1)(2009-7#1)(2010-2#1)(2013-8#1)
candidate gene##20##2##(1990-12#1)(1992-3#1)(1993-11#2)(1997-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-3#2)(2013-8#1)
candidate genes and##2##3##(2007-11#1)(2013-8#1)
candidate genes are##2##3##(1994-12#1)(2009-5#1)
candidate genes for Batten disease##2##5##(1994-11#2)
candidate genes for##8##3##(1994-11#2)(1994-8#1)(1996-8#1)(2007-10#1)(2008-8#1)(2009-10#1)(2009-5#1)
candidate genes have been##2##4##(2008-3#1)(2008-7#1)
candidate genes of##2##3##(2008-9#1)(2009-5#1)
candidate genes that##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
candidate genes##42##2##(1994-11#2)(1994-12#1)(1994-8#1)(1996-2#1)(1996-8#3)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-5#3)(2010-5#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
candidate in##4##2##(2008-7#1)(2009-6#1)(2010-8#1)(2013-7#1)
candidate materials for##2##3##(2007-12#1)(2008-3#1)
candidate materials##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
candidate of##3##2##(1992-6#1)(2008-11#1)(2010-1#1)
candidate protein##2##2##(2008-7#1)(2008-8#1)
candidate proteins for##2##3##(2008-7#1)(2009-10#1)
candidate reassortants##2##2##(2012-12#2)
candidate selection##2##2##(2008-1#1)(2008-8#1)
candidate strain##2##2##(2008-9#2)
candidate structures##2##2##(2008-11#1)(2008-4#1)
candidate to##5##2##(2008-10#2)(2008-11#1)(2009-2#1)(2013-1#1)
candidate transcripts##2##2##(2009-10#1)(2013-8#1)
candidate tumor suppressor gene##4##4##(2008-9#1)(2009-9#2)(2012-2#1)
candidate vaccine##2##2##(1995-5#1)(2008-9#1)
candidate vaccines##5##2##(1995-5#2)(2007-10#2)(2007-7#1)
candidate##252##1##(1990-12#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-6#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#3)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#3)(2006-6#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#4)(2008-1#4)(2008-10#27)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#11)(2008-9#8)(2009-10#7)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#10)(2011-3#3)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#10)(2013-7#1)(2013-8#3)
candidates and##4##2##(1996-3#1)(2008-3#1)(2008-9#1)(2013-1#1)
candidates are##4##2##(2008-7#1)(2011-2#2)(2011-3#1)
candidates as##3##2##(1993-11#1)(2008-10#1)(2011-1#1)
candidates for a##3##3##(1990-9#1)(2010-4#1)(2013-1#1)
candidates for studying##2##3##(2008-9#2)
candidates for surgical##2##3##(2008-1#1)(2010-6#1)
candidates for the treatment of##3##5##(1993-11#1)(2011-1#1)(2013-1#1)
candidates for the##15##3##(1990-11#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(1996-8#1)(2008-2#1)(2009-5#1)(2011-1#3)(2013-1#1)
candidates for therapeutic##2##3##(2007-5#1)(2009-10#1)
candidates for vaginal hysterectomy##2##4##(1991-3#1)(1993-12#1)
candidates for##76##2##(1990-11#1)(1990-4#3)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(1996-8#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
candidates in##6##2##(1993-3#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
candidates to##7##2##(2008-10#2)(2008-7#2)(2010-11#1)(2012-12#1)(2012-3#1)
candidates who##2##2##(2012-12#1)(2012-2#1)
candidates##147##1##(1990-11#1)(1990-4#3)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#12)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#4)(2011-3#4)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#11)(2013-8#1)
candidiasis (OPC)##2##2##(2008-5#2)
candidiasis and##2##2##(1997-1#1)(2008-5#1)
candidiasis are##3##2##(2008-5#3)
candidiasis as##2##2##(2011-1#1)(2012-3#1)
candidiasis in both mouse strains##2##5##(2008-5#2)
candidiasis in##6##2##(2008-5#6)
candidiasis is##3##2##(2008-5#2)(2012-3#1)
candidiasis##49##1##(1990-3#1)(1991-2#1)(1991-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-5#36)(2011-1#2)(2011-2#1)(2012-3#4)
candidiasis]##2##1##(1991-4#1)(2007-10#1)
candidosis in##2##2##(2008-5#2)
candidosis##13##1##(1997-3#1)(2008-5#11)(2013-1#1)
candidum and microbivorous nematodes##2##4##(2008-10#2)
candidum##7##1##(2008-10#7)
candiduria##2##1##(2007-12#1)(2008-10#1)
candollei Grah##3##2##(2008-12#3)
cane juice-based medium##2##3##(2008-6#2)
cane##9##1##(2008-10#4)(2008-6#4)(2013-1#1)
canes##6##1##(2008-10#6)
canine CSF##2##2##(2012-3#2)
canine and##3##2##(1991-2#1)(1996-9#1)(2010-3#1)
canine cardiac Purkinje##2##3##(1992-3#1)(2010-4#1)
canine complement activation##2##3##(2008-10#2)
canine distemper virus##4##3##(2008-12#1)(2009-8#1)(2012-3#2)
canine heart##2##2##(2010-12#1)(2011-2#1)
canine histamine H2 receptor##2##4##(1991-9#2)
canine kidney##4##2##(1990-11#1)(2008-11#1)(2008-8#1)(2011-2#1)
canine mammary carcinoma cell line##2##5##(2012-1#2)
canine mammary gland##2##3##(2012-3#1)(2013-8#1)
canine mammary##7##2##(2012-1#2)(2012-3#2)(2013-8#3)
canine model of##2##3##(2009-8#1)(2013-1#1)
canine model##7##2##(1991-9#1)(2008-6#1)(2009-8#3)(2013-1#2)
canine myoblasts##2##2##(2008-11#2)
canine neutrophils and##2##3##(2008-10#2)
canine neutrophils##5##2##(2008-10#5)
canine pancreatic##2##2##(1991-10#1)(2012-3#1)
canine parvovirus##3##2##(1991-6#1)(2012-3#2)
canine rabies in Colombia##2##4##(2011-2#2)
canine rabies##4##2##(2011-2#4)
canine thyroid carcinoma##2##3##(2012-3#2)
canine tooth##2##2##(2008-7#2)
canine tracheal##4##2##(1994-11#3)(1997-7#1)
canine ventricular##2##2##(2008-8#2)
canine##129##1##(1990-11#1)(1990-5#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-6#2)(1994-8#2)(1995-2#2)(1996-12#2)(1996-5#3)(1996-9#1)(1997-7#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-7#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#12)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#17)(2013-1#9)(2013-8#3)
canines are##2##2##(2008-10#1)(2010-3#1)
canines##14##1##(2008-10#3)(2009-8#1)(2010-3#3)(2012-3#3)(2013-1#4)
canis in a##2##3##(2011-2#2)
canis in##4##2##(2011-2#3)(2012-2#1)
canis is##2##2##(2008-5#1)(2012-2#1)
canis##14##1##(2008-5#4)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#1)
canister##3##1##(1992-3#1)(1996-1#1)(2008-9#1)
canker and##3##2##(2008-10#3)
canker development in##3##3##(2008-10#3)
canker disease of##2##3##(2008-10#2)
canker disease##4##2##(2008-10#4)
canker in##2##2##(2008-10#2)
canker is##4##2##(2008-10#4)
canker of peach##2##3##(2008-10#2)
canker of##10##2##(2008-10#10)
canker pathogen##2##2##(2008-10#2)
canker resistance##3##2##(2008-10#3)
canker size##3##2##(2008-10#3)
canker that##2##2##(2008-10#2)
canker was##3##2##(2008-10#3)
canker##77##1##(2008-10#76)(2010-3#1)
cankered trees##3##2##(2008-10#3)
cankered##4##1##(2008-10#4)
cankers and##2##2##(2008-10#2)
cankers in##3##2##(2008-10#3)
cankers on##4##2##(2008-10#4)
cankers sampled##2##2##(2008-10#2)
cankers were##2##2##(2008-10#2)
cankers##29##1##(2008-10#28)(2010-3#1)
cannabichromanone derivatives##2##2##(2009-10#2)
cannabichromanone##3##1##(2009-10#3)
cannabidiol##6##1##(2008-7#1)(2010-10#5)
cannabina##7##1##(2008-10#7)
cannabinoid binding##4##2##(1991-1#1)(1996-2#3)
cannabinoid receptor antagonist##2##3##(1996-2#1)(2008-7#1)
cannabinoid receptor##9##2##(1991-1#2)(1991-4#1)(1996-2#1)(1997-8#1)(2008-7#3)(2009-8#1)
cannabinoid receptors in##3##3##(1991-10#1)(1991-4#2)
cannabinoid receptors##10##2##(1991-10#1)(1991-4#3)(2008-7#6)
cannabinoid##32##1##(1991-1#4)(1991-10#1)(1991-4#4)(1996-2#5)(1997-8#1)(2008-7#12)(2009-12#2)(2009-8#2)(2010-10#1)
cannabinoids in##2##2##(2008-11#1)(2009-8#1)
cannabinoids##9##1##(1991-1#1)(1997-8#3)(2008-11#3)(2008-7#1)(2009-8#1)
cannabis and##2##2##(2013-8#2)
cannabis during##2##2##(2009-7#2)
cannabis is##2##2##(2008-1#1)(2013-8#1)
cannabis markets##2##2##(2008-12#2)
cannabis use and##2##3##(2008-1#1)(2009-9#1)
cannabis use during adolescence##2##4##(2009-7#1)(2013-8#1)
cannabis use on##2##3##(2009-7#1)(2013-8#1)
cannabis use##14##2##(2008-1#2)(2009-7#5)(2009-9#1)(2012-12#3)(2013-8#3)
cannabis users##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
cannabis##55##1##(1995-8#1)(1995-9#1)(1997-8#1)(2008-1#5)(2008-11#1)(2008-12#9)(2009-10#1)(2009-7#10)(2009-9#1)(2010-4#2)(2012-12#7)(2013-1#1)(2013-8#15)
cannabis-related problems##2##2##(2012-12#2)
cannabis-using boys##2##2##(2013-8#2)
canned##6##1##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)
cannibalism##2##1##(1991-12#1)(2009-10#1)
cannifolia starch##2##2##(2008-5#2)
canning##2##1##(2007-12#1)(2008-3#1)
cannot adequately##3##2##(2008-8#1)(2010-12#2)
cannot afford##3##2##(2008-11#1)(2010-12#1)(2012-12#1)
cannot alone##2##2##(2009-2#1)(2011-2#1)
cannot be achieved##6##3##(1994-12#1)(1995-12#1)(2008-10#1)(2008-2#2)(2013-1#1)
cannot be addressed##2##3##(1995-3#1)(2009-5#1)
cannot be applied##4##3##(1991-12#1)(2007-11#1)(2008-8#1)(2013-1#1)
cannot be ascribed##2##3##(1994-5#1)(1995-9#1)
cannot be assessed##2##3##(2008-1#1)(2008-11#1)
cannot be attributed to##2##4##(1993-3#1)(2011-2#1)
cannot be attributed##3##3##(1990-8#1)(1993-3#1)(2011-2#1)
cannot be avoided##2##3##(2008-3#1)(2008-5#1)
cannot be completely##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
cannot be confirmed##2##3##(1996-6#1)(2007-12#1)
cannot be considered as a##2##5##(1991-12#1)(2007-12#1)
cannot be considered##5##3##(1991-12#1)(1992-2#1)(2007-11#1)(2007-12#1)(2007-7#1)
cannot be controlled##5##3##(1993-3#2)(1996-3#1)(2009-6#1)(2009-8#1)
cannot be corrected##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
cannot be described##2##3##(2007-12#1)(2008-4#1)
cannot be detected##2##3##(1994-6#1)(2008-2#1)
cannot be determined in##2##4##(2008-2#1)(2008-5#1)
cannot be determined##6##3##(1995-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
cannot be directly##3##3##(2008-7#1)(2009-9#1)(2010-8#1)
cannot be discounted##2##3##(1996-12#1)(2013-1#1)
cannot be distinguished by##2##4##(1993-8#1)(2008-11#1)
cannot be distinguished##3##3##(1993-8#1)(2008-11#1)(2008-3#1)
cannot be easily##3##3##(2008-10#2)(2008-3#1)
cannot be eliminated##2##3##(1990-8#1)(2009-5#1)
cannot be entirely##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
cannot be estimated##2##3##(2008-6#1)(2008-8#1)
cannot be excluded##8##3##(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1996-3#1)(1997-4#1)(2008-10#2)
cannot be expected##3##3##(1996-4#1)(2011-2#1)(2013-1#1)
cannot be explained by##8##4##(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(2009-8#1)(2012-3#1)(2013-1#2)
cannot be explained in terms of##2##6##(1997-2#1)(2008-2#1)
cannot be explained solely by##2##5##(1997-8#1)(2008-10#1)
cannot be explained##17##3##(1992-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#2)
cannot be explored##2##3##(2013-1#2)
cannot be expressed##2##3##(2007-11#1)(2008-11#1)
cannot be extrapolated##2##3##(2008-9#1)(2009-8#1)
cannot be fully##3##3##(1997-3#1)(2008-2#1)(2008-3#1)
cannot be generalized##2##3##(2008-10#1)(2008-11#1)
cannot be given##2##3##(2011-2#1)(2012-2#1)
cannot be ignored##6##3##(1994-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)
cannot be incorporated into the##2##5##(1993-1#1)(2008-3#1)
cannot be inferred##2##3##(2008-11#1)(2008-9#1)
cannot be made##3##3##(1990-2#1)(2012-12#1)(2012-2#1)
cannot be measured##4##3##(2006-4#1)(2008-2#1)(2008-3#2)
cannot be met##2##3##(1994-8#1)(2008-7#1)
cannot be obtained by##2##4##(1994-1#1)(2007-12#1)
cannot be obtained##4##3##(1994-1#1)(1997-2#1)(2007-12#1)(2013-8#1)
cannot be overemphasized##2##3##(2008-3#1)(2010-8#1)
cannot be performed##2##3##(2008-10#1)(2009-9#1)
cannot be predicted##2##3##(2008-5#1)(2011-2#1)
cannot be recommended as##2##4##(2010-5#1)(2011-2#1)
cannot be recommended##5##3##(1991-6#1)(1997-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
cannot be reconstituted##2##3##(1997-4#1)(2008-10#1)
cannot be regarded as##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2010-6#1)
cannot be related to##3##4##(1994-8#1)(1995-5#1)(1995-6#1)
cannot be reliably##2##3##(2008-1#1)(2008-10#1)
cannot be reproduced by##2##4##(2008-2#1)(2008-3#1)
cannot be reproduced##4##3##(1997-4#1)(2008-2#1)(2008-3#1)(2011-2#1)
cannot be ruled out##5##4##(1997-4#1)(2007-11#1)(2007-7#1)(2008-11#1)(2012-2#1)
cannot be separated##2##3##(1995-5#1)(2008-6#1)
cannot be solved##2##3##(1996-8#1)(2008-2#1)
cannot be supported as a strategy to##2##7##(2007-8#2)
cannot be treated with##2##4##(2008-10#1)(2011-2#1)
cannot be treated##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
cannot be used for quantitative analysis##2##6##(2008-10#2)
cannot be used for##4##4##(2007-12#1)(2008-10#3)
cannot be used in##3##4##(2008-4#1)(2008-7#2)
cannot be used to##6##4##(2007-12#1)(2008-10#2)(2009-4#1)(2010-8#1)(2013-8#1)
cannot be used##19##3##(1991-12#1)(1992-3#1)(2007-12#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#3)(2009-4#1)(2010-5#1)(2010-8#1)(2013-8#1)
cannot be##298##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-6#3)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#12)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#29)(2008-11#13)(2008-12#2)(2008-2#11)(2008-3#20)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#12)(2008-9#9)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#11)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#4)
cannot bind to the##2##4##(2008-8#2)
cannot bind to##3##3##(2008-8#2)(2008-9#1)
cannot compensate for##2##3##(1993-11#1)(2008-10#1)
cannot completely##3##2##(1994-9#1)(2008-10#2)
cannot discriminate##2##2##(2008-10#1)(2008-9#1)
cannot easily be##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
cannot easily##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
cannot exist in##2##3##(1992-11#1)(2007-12#1)
cannot exist##3##2##(1990-2#1)(1992-11#1)(2007-12#1)
cannot explain the##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
cannot explain##7##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-2#1)
cannot fully##2##2##(2007-11#1)(2011-1#1)
cannot grow##2##2##(2009-6#1)(2009-8#1)
cannot hold##2##2##(1997-4#1)(1997-5#1)
cannot ignore##3##2##(2008-11#1)(2011-3#2)
cannot induce##4##2##(1993-8#1)(2008-11#1)(2010-3#1)(2012-1#1)
cannot mimic the##2##3##(1996-5#1)(2010-11#1)
cannot move##2##2##(2008-10#1)(2008-8#1)
cannot perform##2##2##(1995-6#1)(2008-1#1)
cannot prevent##2##2##(1993-2#1)(2008-8#1)
cannot provide##2##2##(1993-11#1)(2012-2#1)
cannot readily be##2##3##(1992-12#1)(1994-8#1)
cannot reliably##3##2##(1990-8#1)(2008-10#1)(2010-10#1)
cannot reveal##2##2##(1997-5#1)(2008-3#1)
cannot simply##2##2##(2007-12#1)(2008-7#1)
cannot tolerate the##2##3##(1992-3#1)(2010-3#1)
cannot tolerate##3##2##(1992-3#1)(2008-1#1)(2010-3#1)
cannot undergo the##2##3##(1995-6#1)(2009-5#1)
cannot uniquely##2##2##(1995-9#1)(2008-1#1)
cannot usually##2##2##(1997-7#1)(2008-10#1)
cannot yet be##3##3##(1991-11#2)(2008-10#1)
cannot##479##1##(1990-10#1)(1990-11#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#2)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#3)(1996-8#2)(1997-2#5)(1997-3#3)(1997-4#6)(1997-5#4)(1997-7#1)(1997-8#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#9)(2007-12#15)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#46)(2008-11#19)(2008-12#3)(2008-2#18)(2008-3#27)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#11)(2008-8#31)(2008-9#14)(2009-10#2)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#4)
cannula in##2##2##(2008-6#1)(2010-8#1)
cannula is##2##2##(1991-3#1)(2007-8#1)
cannula to##2##2##(1992-11#1)(2009-7#1)
cannula##30##1##(1990-7#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-8#1)(1993-12#1)(1994-2#1)(1997-2#1)(2007-8#10)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-8#3)(2012-3#1)
cannulae and##3##2##(1993-12#1)(2008-7#1)(2010-8#1)
cannulae##7##1##(1993-12#1)(2007-8#1)(2008-7#2)(2010-8#3)
cannulated##6##1##(1991-12#1)(1997-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2012-2#1)
cannulation for type A##2##4##(2007-8#2)
cannulation for##3##2##(2007-8#2)(2013-1#1)
cannulation is not##2##3##(2007-7#1)(2008-1#1)
cannulation of the fallopian tube##2##5##(1992-1#2)
cannulation of the##8##3##(1990-8#1)(1992-1#2)(1992-12#2)(2007-7#1)(2007-8#2)
cannulation of##9##2##(1990-8#1)(1992-1#2)(1992-12#2)(2007-7#1)(2007-8#2)(2008-1#1)
cannulation or##2##2##(2008-1#2)
cannulation##34##1##(1990-8#3)(1992-1#3)(1992-12#2)(2007-7#7)(2007-8#7)(2008-1#8)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
canola cultivars##2##2##(2011-2#2)
canola meal##4##2##(2008-10#4)
canola##32##1##(2008-10#25)(2008-12#2)(2011-10#1)(2011-2#4)
canonical Wnt##2##2##(2013-1#2)
canonical color##2##2##(2007-12#2)
canonical correlation analysis##3##3##(2008-10#2)(2011-2#1)
canonical correlation##4##2##(2008-10#2)(2011-2#2)
canonical correspondence analysis##2##3##(2008-10#1)(2013-7#1)
canonical discriminant##3##2##(1992-11#1)(2008-10#2)
canonical site##2##2##(1990-7#1)(1992-3#1)
canonical##44##1##(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-9#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#3)(2012-2#3)(2013-1#3)(2013-7#1)
canopies##7##1##(2008-10#6)(2008-12#1)
canopy and##4##2##(2008-10#4)
canopy at##2##2##(2008-10#1)(2008-12#1)
canopy closure##8##2##(2008-10#8)
canopy in##2##2##(2008-10#1)(2013-7#1)
canopy reflectance were##2##3##(2008-10#2)
canopy reflectance##3##2##(2008-10#3)
canopy region##2##2##(2013-7#2)
canopy size and##3##3##(2008-10#3)
canopy size##5##2##(2008-10#5)
canopy spectra##2##2##(2008-10#2)
canopy structure##2##2##(2013-7#2)
canopy was##3##2##(2008-10#3)
canopy##77##1##(1993-3#1)(2008-10#54)(2008-12#3)(2008-5#2)(2008-8#2)(2008-9#4)(2011-2#1)(2013-7#9)(2013-8#1)
canrenone##3##1##(1990-5#1)(2008-10#2)
cans##3##1##(1996-12#1)(1996-3#1)(2010-9#1)
cantabria##2##1##(2011-2#1)(2013-1#1)
cantaloupe and##3##2##(2008-10#3)
cantaloupe fruit##3##2##(2008-10#3)
cantaloupe roots##2##2##(2008-10#2)
cantaloupe##24##1##(1996-2#1)(2008-10#23)
canted periodic target##2##3##(2008-2#2)
canted##3##1##(2008-2#3)
canthaxanthin on##2##2##(1992-8#1)(2013-8#1)
canthaxanthin##8##1##(1992-8#2)(2008-12#2)(2013-8#4)
cantilever##15##1##(2008-10#2)(2008-2#1)(2008-3#6)(2008-7#1)(2010-4#1)(2010-7#3)(2012-2#1)
cantilever-based##2##1##(2008-3#1)(2010-7#1)
cantilevered##2##1##(2007-12#1)(2008-8#1)
cantilevers##7##1##(2008-3#7)
canting##2##1##(1996-2#1)(2008-3#1)
canton##3##1##(1991-6#1)(1993-9#1)(1996-11#1)
cantonal##2##1##(1996-11#2)
cantori##4##1##(2008-5#4)
canvas##2##1##(2008-10#1)(2008-7#1)
cap and##3##2##(2008-10#2)(2008-11#1)
cap of##2##2##(2011-2#1)(2012-2#1)
cap on##6##2##(1992-11#1)(1995-6#1)(1996-12#1)(1997-5#1)(2012-3#2)
cap site and##2##3##(1991-6#1)(1992-3#1)
cap site##6##2##(1990-12#1)(1991-6#2)(1992-3#2)(1995-6#1)
cap structure##9##2##(1997-2#3)(2008-10#4)(2008-11#1)(2008-9#1)
cap was##4##2##(2008-9#4)
cap##54##1##(1990-12#1)(1991-6#2)(1992-11#1)(1992-3#2)(1992-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-6#2)(1996-12#1)(1997-2#4)(1997-5#1)(2007-12#3)(2008-10#9)(2008-11#3)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-7#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#2)
cap)##2##1##(1997-2#1)(2007-7#1)
cap-dependent##2##1##(2008-11#1)(2011-2#1)
cap-independent mode##2##2##(2008-11#2)
cap-independent##4##1##(2008-11#3)(2008-9#1)
cap-shaped gold particles##2##3##(2007-11#2)
capabilities and limitations##2##3##(1996-12#1)(2008-2#1)
capabilities and the##2##3##(2008-2#1)(2008-3#1)
capabilities and tomorrow's##2##3##(1993-3#2)
capabilities and##15##2##(1993-2#1)(1993-3#2)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2011-1#2)(2012-12#1)
capabilities are illustrated##2##3##(2007-12#1)(2008-3#1)
capabilities are##5##2##(1991-3#1)(2007-12#1)(2008-10#1)(2008-3#2)
capabilities compared##2##2##(2007-12#1)(2010-8#1)
capabilities for##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
capabilities in##6##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#1)
capabilities into##2##2##(1997-2#1)(2008-7#1)
capabilities of a##4##3##(1995-2#1)(2007-11#1)(2008-10#1)(2012-12#1)
capabilities of the two##2##4##(1997-2#1)(2008-10#1)
capabilities of the##20##3##(1993-12#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)
capabilities of these##2##3##(2007-11#1)(2010-11#1)
capabilities of##48##2##(1992-2#1)(1993-12#2)(1995-2#1)(1996-1#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#11)(2008-2#7)(2008-3#6)(2008-6#1)(2008-9#3)(2010-11#2)(2011-1#2)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)
capabilities that##3##2##(2008-11#1)(2008-2#2)
capabilities to##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
capabilities##152##1##(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#2)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#3)(2007-11#5)(2007-12#7)(2007-5#1)(2008-1#2)(2008-10#22)(2008-11#8)(2008-2#13)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#9)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#7)(2011-2#8)(2011-7#1)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#2)
capability and the##2##3##(1992-10#1)(2008-2#1)
capability and##7##2##(1992-10#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
capability are##2##2##(2007-11#1)(2008-3#1)
capability by using##2##3##(2008-2#2)
capability for the##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
capability for##20##2##(1995-12#1)(1997-2#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#2)(2008-9#1)(2012-12#1)
capability in##7##2##(1991-3#1)(1992-12#1)(1994-5#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
capability is##3##2##(2007-11#1)(2009-6#1)(2013-8#1)
capability of a##2##3##(2008-2#1)(2008-3#1)
capability of detection##3##3##(2008-10#3)
capability of the method##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#1)
capability of the technique##2##4##(2008-2#1)(2008-3#1)
capability of the##32##3##(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#7)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
capability of this##3##3##(2007-11#1)(2008-10#2)
capability of##82##2##(1990-7#1)(1991-3#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
capability than##4##2##(1990-11#1)(2008-3#1)(2010-10#1)(2012-2#1)
capability that##3##2##(1990-2#1)(2008-3#2)
capability to deliver##2##3##(1993-2#1)(2008-2#1)
capability to induce##2##3##(1993-12#1)(1997-4#1)
capability to metabolize##2##3##(2008-10#1)(2008-5#1)
capability to reduce##2##3##(2008-10#1)(2008-3#1)
capability to##38##2##(1990-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
capability was##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
capability would##2##2##(2007-12#1)(2012-2#1)
capability##230##1##(1990-11#1)(1990-2#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#3)(1992-10#1)(1992-12#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#10)(2007-12#2)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#48)(2008-11#7)(2008-12#3)(2008-2#17)(2008-3#39)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#4)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
capable of accurately measuring##2##4##(2007-12#1)(2013-1#1)
capable of activating##2##3##(1990-2#1)(2012-12#1)
capable of amplifying##2##3##(2007-12#1)(2008-10#1)
capable of arresting##2##3##(1991-9#1)(1995-2#1)
capable of being used##2##4##(2007-12#1)(2008-2#1)
capable of being##4##3##(2007-12#1)(2008-2#1)(2008-7#1)(2009-6#1)
capable of binding to the##2##5##(1992-3#1)(2008-6#1)
capable of binding to##6##4##(1992-3#1)(1993-3#1)(2008-10#1)(2008-6#1)(2008-9#2)
capable of binding##13##3##(1992-3#1)(1992-8#1)(1993-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2012-2#1)
capable of causing both GLS##3##5##(2008-10#3)
capable of causing##13##3##(1993-9#1)(1994-11#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2013-8#1)
capable of collecting##2##3##(2008-9#1)(2012-2#1)
capable of converting##4##3##(1992-12#1)(1994-11#1)(2008-5#1)(2010-1#1)
capable of creating##3##3##(1996-12#1)(2008-3#1)(2009-7#1)
capable of degrading the##2##4##(1992-12#1)(2008-10#1)
capable of degrading##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
capable of destroying##2##3##(2007-10#1)(2011-2#1)
capable of detecting##18##3##(1990-12#1)(1994-11#1)(1995-3#1)(1996-12#1)(2008-10#8)(2008-3#3)(2008-9#1)(2009-8#1)(2011-2#1)
capable of determining##5##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
capable of differentiating into##3##4##(2008-9#2)(2012-12#1)
capable of digesting##2##3##(1993-11#1)(1995-8#1)
capable of directing##2##3##(1991-9#1)(2013-1#1)
capable of directly detecting##2##4##(2008-10#1)(2012-2#1)
capable of directly##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)
capable of discriminating##2##3##(2008-10#1)(2008-9#1)
capable of division##2##3##(2008-1#1)(2008-11#1)
capable of effectively##2##3##(1995-6#1)(2008-5#1)
capable of encoding a##2##4##(1995-8#1)(2008-10#1)
capable of expressing##2##3##(1993-9#1)(2013-1#1)
capable of forming##7##3##(1992-8#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)
capable of generating##11##3##(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-2#1)
capable of greater than##2##4##(1994-12#1)(2007-12#1)
capable of greater##3##3##(1994-12#1)(2007-12#1)(2008-2#1)
capable of handling##5##3##(2008-10#2)(2008-3#3)
capable of having##2##3##(2008-10#1)(2008-2#1)
capable of identifying##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
capable of imaging##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
capable of inducing a##2##4##(2008-10#2)
capable of inducing##8##3##(1991-12#1)(1992-12#1)(1994-11#1)(1995-12#1)(2008-10#3)(2008-5#1)
capable of infecting pistachio and##2##5##(2008-10#2)
capable of infecting##5##3##(2008-10#4)(2011-3#1)
capable of inhibiting##5##3##(1994-12#1)(1995-5#1)(2008-10#1)(2009-2#1)(2012-3#1)
capable of interacting with the##2##5##(1994-11#1)(1995-5#1)
capable of killing##2##3##(1993-12#1)(1995-2#1)
capable of leading##2##3##(1994-3#1)(2010-3#1)
capable of liberating iron from transferrin##2##6##(2008-5#2)
capable of measuring##11##3##(1992-9#1)(2008-10#2)(2008-2#2)(2008-3#6)
capable of mediating the electron transfer to##3##7##(2008-10#3)
capable of mediating the##4##4##(1992-9#1)(2008-10#3)
capable of metabolizing##3##3##(1990-11#1)(2012-2#2)
capable of migrating##2##3##(2011-1#1)(2012-3#1)
capable of mimicking the##2##4##(1995-2#1)(2012-2#1)
capable of neutralizing##2##3##(2008-10#2)
capable of operating in##2##4##(2007-11#1)(2008-10#1)
capable of operating##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
capable of penetrating##2##3##(2008-10#1)(2010-10#1)
capable of performing##4##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-7#1)
capable of phosphorylating the##2##4##(1993-11#1)(1993-12#1)
capable of phosphorylating##3##3##(1993-11#1)(1993-12#1)(1994-12#1)
capable of precise##2##3##(2007-12#1)(2008-10#1)
capable of predicting the##2##4##(2008-3#1)(2009-7#1)
capable of predicting##3##3##(2007-6#1)(2008-3#1)(2009-7#1)
capable of producing##13##3##(1991-9#1)(1993-9#1)(1994-5#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-9#1)(2010-3#1)
capable of protecting##3##3##(1992-8#1)(1995-12#1)(2008-10#1)
capable of providing##5##3##(1993-11#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-5#1)
capable of rapidly##2##3##(2008-2#1)(2010-7#1)
capable of real-time##2##3##(2008-3#2)
capable of recognizing the##2##4##(2007-10#1)(2008-10#1)
capable of recognizing##3##3##(2007-10#1)(2008-10#1)(2010-11#1)
capable of recording##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
capable of reducing the##2##4##(2007-11#1)(2013-1#1)
capable of reducing##3##3##(2007-11#1)(2009-9#1)(2013-1#1)
capable of releasing##2##3##(1992-9#1)(1994-6#1)
capable of reliably##2##3##(2008-10#1)(2012-2#1)
capable of responding to##2##4##(2008-10#1)(2008-4#1)
capable of simultaneous##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
capable of simultaneously##2##3##(2008-3#2)
capable of supporting##5##3##(1994-5#1)(2008-3#2)(2010-8#1)(2012-3#1)
capable of suppressing the##2##4##(2008-8#1)(2013-1#1)
capable of sustaining##2##3##(1993-5#1)(2008-2#1)
capable of triggering##2##3##(2008-1#1)(2012-7#1)
capable of##460##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#2)(1991-1#1)(1991-12#1)(1991-9#3)(1992-12#5)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#10)(2007-12#18)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#96)(2008-11#21)(2008-12#4)(2008-2#17)(2008-3#58)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#13)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#3)
capable to##8##2##(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-9#2)(2011-1#1)(2011-2#1)
capable##482##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#3)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#10)(2007-12#18)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#97)(2008-11#27)(2008-12#6)(2008-2#17)(2008-3#58)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#13)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#3)(2012-7#1)(2013-1#7)(2013-8#4)
capacitance measurement##3##2##(2008-10#2)(2008-5#1)
capacitance response is not sensitive##2##5##(2008-10#2)
capacitance##23##1##(1995-12#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-5#5)(2012-2#1)
capacitation##6##1##(2011-1#4)(2012-3#2)
capacities and##4##2##(1994-3#1)(2008-10#2)(2011-1#1)
capacities are##3##2##(2007-12#1)(2008-10#2)
capacities at##2##2##(2008-10#1)(2008-11#1)
capacities for##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)(2012-7#1)
capacities in##2##2##(2007-6#1)(2013-1#1)
capacities of the resin for##2##5##(2008-10#2)
capacities of the resin##3##4##(2008-10#3)
capacities of the##10##3##(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)
capacities of these##3##3##(1992-3#1)(2008-5#1)(2013-1#1)
capacities of##28##2##(1992-3#1)(1994-8#1)(1997-2#6)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2013-1#1)
capacities to##4##2##(1996-2#1)(2008-10#1)(2008-5#2)
capacities were found##2##3##(2008-7#1)(2013-1#1)
capacities were##6##2##(2008-10#1)(2008-7#2)(2008-9#2)(2013-1#1)
capacities##84##1##(1991-11#1)(1992-3#2)(1993-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#6)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#1)
capacitive##9##1##(1991-5#1)(2008-10#6)(2008-3#1)(2008-5#1)
capacitively coupled plasma torch##2##4##(2008-10#2)
capacitor##5##1##(2008-10#3)(2008-2#1)(2010-10#1)
capacitors##5##1##(2008-10#3)(2008-3#1)(2008-7#1)
capacity (WHC)##2##2##(2011-2#1)(2012-2#1)
capacity and a##2##3##(1991-7#1)(2008-11#1)
capacity and resolution##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
capacity and the##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)
capacity and##68##2##(1990-5#1)(1991-7#1)(1992-3#2)(1992-6#1)(1993-3#1)(1995-2#1)(1997-1#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#10)
capacity are##4##2##(2008-11#2)(2008-2#1)(2010-2#1)
capacity as##2##2##(2011-1#2)
capacity at the##2##3##(2008-5#1)(2012-2#1)
capacity at##6##2##(1990-9#1)(2008-5#2)(2008-8#1)(2010-10#1)(2012-2#1)
capacity building in##3##3##(1995-3#1)(2007-12#1)(2010-10#1)
capacity building##11##2##(1995-3#1)(1997-2#2)(1997-3#1)(2007-12#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
capacity by##5##2##(1991-12#1)(1996-2#1)(2008-11#2)(2008-3#1)
capacity can be##2##3##(2008-3#1)(2012-2#1)
capacity coefficients##2##2##(2008-10#2)
capacity compared##2##2##(2010-10#1)(2012-1#1)
capacity decreased##2##2##(2008-10#1)(2008-11#1)
capacity enhancement##3##2##(2012-2#3)
capacity factor##2##2##(1995-3#1)(2008-10#1)
capacity factors of the solutes##2##5##(1996-5#1)(2008-10#1)
capacity factors##4##2##(1996-5#1)(2008-10#3)
capacity for binding##2##3##(1993-6#1)(1994-12#1)
capacity for data-based planning##2##4##(1997-1#2)
capacity for repair##2##3##(2008-12#1)(2011-2#1)
capacity for self-renewal##2##3##(1990-5#1)(2008-9#1)
capacity for the##4##3##(1996-3#1)(1997-2#1)(2008-2#1)(2010-4#1)
capacity for##52##2##(1990-5#2)(1993-6#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#2)(2007-12#3)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
capacity gain of##2##3##(2008-3#2)
capacity gain##3##2##(2008-3#3)
capacity has##2##2##(1990-7#1)(2008-10#1)
capacity have##2##2##(2008-10#1)(2012-2#1)
capacity in rats##2##3##(2008-7#1)(2012-2#1)
capacity in the##6##3##(1995-2#1)(2008-11#1)(2008-2#2)(2009-3#1)(2012-12#1)
capacity in this##3##3##(1991-5#1)(1993-5#1)(2007-12#1)
capacity in##29##2##(1991-5#1)(1991-6#1)(1993-3#1)(1993-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)
capacity is##11##2##(1991-8#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#1)(2012-3#1)(2013-7#1)
capacity may##3##2##(2008-11#1)(2008-3#1)(2012-3#1)
capacity of 0##2##3##(2008-10#2)
capacity of 1##4##3##(1991-8#1)(2008-10#2)(2008-3#1)
capacity of 10##3##3##(1990-5#1)(1992-6#1)(2008-10#1)
capacity of OAV##2##3##(1997-3#2)
capacity of a##5##3##(1995-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)
capacity of cells##3##3##(1990-3#1)(1996-5#1)(2008-11#1)
capacity of human##2##3##(2008-4#1)(2010-6#1)
capacity of information##2##3##(2008-3#1)(2010-8#1)
capacity of protein##2##3##(1990-11#1)(2008-10#1)
capacity of some##3##3##(2008-5#1)(2010-7#1)(2013-1#1)
capacity of the immune##2##4##(2009-5#1)(2013-7#1)
capacity of the liver##2##4##(2008-10#1)(2010-12#1)
capacity of the membrane disks modified by##2##7##(2008-10#2)
capacity of the membrane disks modified##3##6##(2008-10#3)
capacity of the resin for##2##5##(2008-10#2)
capacity of the resin was##3##5##(2008-10#3)
capacity of the resin##6##4##(2008-10#6)
capacity of the surface##2##4##(2008-4#1)(2008-5#1)
capacity of the##96##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-6#2)(1993-5#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-5#2)(1997-2#1)(2007-12#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#2)(2013-8#2)
capacity of these##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
capacity of this##4##3##(1994-9#1)(2008-10#1)(2008-5#1)(2009-10#1)
capacity of##250##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#4)(1991-12#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#3)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#79)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#3)(2013-1#6)(2013-7#3)(2013-8#5)
capacity on the##2##3##(2008-10#2)
capacity on##6##2##(2008-10#6)
capacity or##2##2##(1995-2#1)(2008-11#1)
capacity than##4##2##(2008-10#2)(2009-4#1)(2010-4#1)
capacity that##2##2##(1996-8#1)(2008-2#1)
capacity to bind##2##3##(1995-2#1)(2008-4#1)
capacity to consent to##2##4##(1992-3#1)(2010-11#1)
capacity to detect##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
capacity to develop##2##3##(1991-5#1)(2008-11#1)
capacity to differentiate into##3##4##(2010-11#1)(2012-12#2)
capacity to differentiate##4##3##(1990-5#1)(2010-11#1)(2012-12#2)
capacity to hydrolyze##2##3##(2008-10#1)(2008-4#1)
capacity to induce##3##3##(1993-11#1)(1997-3#1)(2008-10#1)
capacity to inhibit##2##3##(1990-2#1)(1992-12#1)
capacity to produce##4##3##(1993-5#1)(1994-3#1)(1996-2#1)(1997-3#1)
capacity to provide##2##3##(1996-3#1)(2008-11#1)
capacity to regulate##2##3##(2008-3#1)(2009-6#1)
capacity to satisfy##2##3##(1994-2#1)(1997-3#1)
capacity to support##2##3##(2008-11#1)(2008-4#1)
capacity to use##2##3##(1994-1#1)(2008-2#1)
capacity to##114##2##(1990-2#1)(1990-5#3)(1990-6#1)(1991-11#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#6)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#2)
capacity under##2##2##(1996-5#1)(2013-1#1)
capacity using##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
capacity utilization##3##2##(2010-8#3)
capacity values##3##2##(2008-10#3)
capacity was assessed##2##3##(2008-7#1)(2012-2#1)
capacity was##15##2##(1995-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-8#1)
capacity were##6##2##(1991-2#1)(1991-8#1)(1993-6#1)(2008-10#2)(2008-9#1)
capacity with##2##2##(2008-2#2)
capacity##892##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#11)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#7)(1991-2#5)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#6)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#6)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#5)(1995-11#5)(1995-12#3)(1995-2#9)(1995-3#7)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#3)(1996-5#8)(1996-8#1)(1997-1#4)(1997-2#11)(1997-3#11)(1997-4#1)(1997-6#2)(1997-8#2)(1997-9#1)(2007-10#3)(2007-11#4)(2007-12#10)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#209)(2008-11#40)(2008-12#8)(2008-2#20)(2008-3#30)(2008-4#15)(2008-5#36)(2008-6#8)(2008-7#21)(2008-8#12)(2008-9#18)(2009-10#2)(2009-12#3)(2009-3#5)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#14)(2010-11#5)(2010-12#5)(2010-2#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#7)(2011-1#14)(2011-2#20)(2011-3#1)(2012-1#2)(2012-12#22)(2012-2#33)(2012-3#15)(2012-8#1)(2013-1#29)(2013-7#11)(2013-8#20)
capacity) and##2##2##(2008-10#1)(2008-12#1)
capacity) equipped with a 25 mL##2##6##(2008-10#2)
capacity)##8##1##(1992-3#1)(1994-8#1)(2008-10#3)(2008-12#1)(2012-2#1)(2012-6#1)
capecitabine in##4##2##(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
capecitabine##12##1##(2008-7#2)(2009-5#1)(2011-2#6)(2012-12#1)(2013-1#2)
capecitabine-induced sarcoidosis##2##2##(2012-12#2)
capecitabine-induced##3##1##(2008-7#1)(2012-12#2)
capillaries and##6##2##(1995-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
capillaries are##3##2##(1997-2#1)(2007-8#2)
capillaries by##2##2##(2008-10#1)(2008-11#1)
capillaries can##2##2##(2008-10#2)
capillaries in the##3##3##(2008-7#1)(2011-1#2)
capillaries in##4##2##(2008-7#1)(2011-1#2)(2011-2#1)
capillaries with##3##2##(2008-10#2)(2008-3#1)
capillaries##63##1##(1990-11#1)(1993-6#1)(1994-9#1)(1995-12#2)(1996-5#2)(1997-1#1)(1997-2#4)(1997-3#1)(2007-12#2)(2007-5#2)(2007-8#6)(2008-10#18)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#4)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-4#1)
capillaritis##2##1##(2006-10#2)
capillary HPLC##3##2##(2008-10#1)(2008-4#2)
capillary and a##2##3##(2008-10#2)
capillary and##11##2##(1994-9#1)(2008-10#9)(2008-4#1)
capillary at##4##2##(2008-10#4)
capillary blood##3##2##(1993-6#1)(2008-1#1)(2008-3#1)
capillary by##2##2##(2008-10#1)(2008-2#1)
capillary column and##2##3##(2008-10#1)(2011-1#1)
capillary column gas##2##3##(2008-10#2)
capillary column##17##2##(1994-9#1)(2008-10#11)(2008-5#1)(2009-8#1)(2011-1#2)(2012-2#1)
capillary columns##5##2##(2008-10#5)
capillary discharge##5##2##(2007-12#2)(2008-3#3)
capillary electrochromatography##7##2##(1997-2#2)(2008-10#5)
capillary electrophoresis (CE) for##2##4##(2008-10#2)
capillary electrophoresis (CE) has##2##4##(2008-10#2)
capillary electrophoresis (CE) method for the##2##6##(2008-10#1)(2008-4#1)
capillary electrophoresis (CE) method##5##4##(2008-10#4)(2008-4#1)
capillary electrophoresis (CE) separation##3##4##(2008-10#3)
capillary electrophoresis (CE) system##4##4##(1997-2#1)(2008-10#3)
capillary electrophoresis (CE) with##4##4##(2008-10#4)
capillary electrophoresis (CE)##33##3##(1996-5#2)(1997-2#1)(2008-10#27)(2008-4#1)(2010-5#1)(2010-7#1)
capillary electrophoresis (CE)-amperometric detection##2##4##(2008-10#2)
capillary electrophoresis (HPCE)##3##3##(1996-12#1)(1996-5#1)(2008-10#1)
capillary electrophoresis and##3##3##(1996-5#2)(2008-10#1)
capillary electrophoresis are##2##3##(1996-5#1)(2008-4#1)
capillary electrophoresis coupled##2##3##(2008-10#1)(2010-5#1)
capillary electrophoresis detection##2##3##(2008-10#1)(2008-2#1)
capillary electrophoresis for the##2##4##(2008-10#1)(2008-5#1)
capillary electrophoresis for##4##3##(2008-10#3)(2008-5#1)
capillary electrophoresis in##6##3##(1991-1#1)(2008-10#3)(2008-12#1)(2008-4#1)
capillary electrophoresis is##4##3##(2008-10#4)
capillary electrophoresis method for the analysis of##2##7##(2008-10#2)
capillary electrophoresis method for the characterization of##2##7##(1994-12#1)(2008-4#1)
capillary electrophoresis method for the##7##5##(1994-12#1)(1997-2#1)(2008-10#4)(2008-4#1)
capillary electrophoresis method for##8##4##(1994-12#1)(1997-2#1)(2008-10#5)(2008-4#1)
capillary electrophoresis method##12##3##(1994-12#1)(1997-2#1)(2008-10#9)(2008-4#1)
capillary electrophoresis of##3##3##(1994-9#1)(1996-5#1)(2008-10#1)
capillary electrophoresis separation##2##3##(2008-10#2)
capillary electrophoresis system with##2##4##(2008-10#2)
capillary electrophoresis system##6##3##(2008-10#6)
capillary electrophoresis to determine##2##4##(2008-10#2)
capillary electrophoresis to##7##3##(2008-10#7)
capillary electrophoresis using##6##3##(1996-5#2)(2008-10#4)
capillary electrophoresis with amperometric detection##4##5##(2008-10#4)
capillary electrophoresis with electrochemical detection##5##5##(2008-10#5)
capillary electrophoresis with electrochemical##7##4##(2008-10#7)
capillary electrophoresis with laser-induced##4##4##(2008-10#4)
capillary electrophoresis with wall-jet amperometric detection##2##6##(2008-10#2)
capillary electrophoresis with##29##3##(1994-9#4)(1996-5#1)(1997-2#1)(2008-10#23)
capillary electrophoresis##201##2##(1991-1#1)(1994-12#1)(1994-9#9)(1996-12#2)(1996-5#16)(1997-2#5)(2008-10#151)(2008-12#1)(2008-2#3)(2008-4#5)(2008-5#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-1#2)
capillary electrophoresis-tandem mass spectrometry##3##4##(1997-2#3)
capillary electrophoretic method was developed for the##3##7##(1996-5#1)(2008-10#2)
capillary electrophoretic method##4##3##(1996-5#1)(2008-10#3)
capillary electrophoretic separation of##2##4##(1994-9#1)(1997-2#1)
capillary electrophoretic separation##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
capillary electrophoretic##15##2##(1994-12#1)(1994-9#1)(1996-5#3)(1997-2#1)(2008-10#9)
capillary endothelial cells##3##3##(1990-2#1)(2013-8#2)
capillary endothelium##2##2##(1996-9#1)(2008-7#1)
capillary gas chromatography (GC)##3##4##(1994-9#1)(2008-5#1)(2011-1#1)
capillary gas chromatography with##2##4##(2008-10#2)
capillary gas chromatography##8##3##(1994-9#2)(2008-10#4)(2008-5#1)(2011-1#1)
capillary gas##9##2##(1994-9#2)(2008-10#4)(2008-5#1)(2011-1#2)
capillary haemangioma##2##2##(2011-1#2)
capillary ion chromatograph##2##3##(2008-10#2)
capillary ion electrophoresis##2##3##(1994-9#1)(1997-2#1)
capillary ion##5##2##(1994-9#1)(1997-2#1)(2008-10#3)
capillary isotachophoresis (CITP)##2##3##(2008-10#2)
capillary isotachophoresis##6##2##(2008-10#6)
capillary liquid chromatography##2##3##(2008-10#1)(2008-7#1)
capillary of a sampling arm assembly##3##6##(2008-10#3)
capillary of a##6##3##(2008-10#6)
capillary of##8##2##(2008-10#7)(2010-8#1)
capillary rarefaction is detectable and associated with endothelial dysfunction in##2##10##(2009-5#2)
capillary rarefaction##4##2##(2009-5#4)
capillary regeneration##2##2##(2008-5#2)
capillary structure##2##2##(1994-9#2)
capillary temperature##4##2##(2008-10#4)
capillary tube##7##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)
capillary using##3##2##(1997-2#1)(2008-10#2)
capillary wall##4##2##(1996-5#1)(1997-2#1)(2007-7#1)(2010-12#1)
capillary was selected##2##3##(2008-10#2)
capillary was used to##2##4##(1994-9#1)(2008-10#1)
capillary was##8##2##(1994-9#1)(2008-10#7)
capillary waves and##2##3##(2008-3#2)
capillary waves##5##2##(2008-3#5)
capillary where##2##2##(1997-2#1)(2008-10#1)
capillary with##3##2##(2008-10#3)
capillary zone electrophoresis (CZE) method##2##5##(2008-10#2)
capillary zone electrophoresis (CZE) with##2##5##(2008-10#2)
capillary zone electrophoresis (CZE)##14##4##(1994-9#1)(1996-5#1)(2008-10#12)
capillary zone electrophoresis method for the determination of##2##8##(2008-10#2)
capillary zone electrophoresis using##3##4##(2008-10#3)
capillary zone electrophoresis with amperometric detection##2##6##(2008-10#2)
capillary zone electrophoresis with##8##4##(2008-10#8)
capillary zone electrophoresis##60##3##(1990-8#1)(1992-12#2)(1994-9#3)(1996-5#2)(2008-10#52)
capillary##558##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-12#2)(1992-9#1)(1993-6#1)(1994-12#2)(1994-9#32)(1996-12#2)(1996-5#28)(1996-6#1)(1996-9#1)(1997-2#16)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#369)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#17)(2008-4#12)(2008-5#9)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2009-5#5)(2009-8#1)(2010-12#1)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
capillary-column liquid chromatography##2##3##(2008-10#2)
capital and health status##2##4##(2010-2#2)
capital and operating##2##3##(1992-2#1)(2013-1#1)
capital and##8##2##(1992-2#1)(1997-1#1)(2008-1#1)(2010-2#2)(2013-1#1)(2013-8#2)
capital asset management##3##3##(1994-3#3)
capital cost##2##2##(1991-2#1)(2008-10#1)
capital costs##5##2##(1992-1#1)(1992-2#2)(1993-1#1)(2008-10#1)
capital equipment##6##2##(1991-1#1)(1992-3#1)(1994-2#1)(1994-3#2)(2008-1#1)
capital funding##2##2##(1990-4#1)(1992-3#1)
capital funds##2##2##(1994-12#1)(2008-11#1)
capital investment and##2##3##(2010-5#1)(2013-8#1)
capital investment##5##2##(1995-3#1)(1996-12#1)(2010-5#2)(2013-8#1)
capital of the##2##3##(1994-3#1)(2011-1#1)
capital of##6##2##(1994-3#1)(2008-1#2)(2008-12#1)(2008-3#1)(2011-1#1)
capital payments##2##2##(1992-2#2)
capital##103##1##(1990-4#2)(1991-1#2)(1991-2#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-2#5)(1992-3#3)(1992-5#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#13)(1994-9#1)(1995-3#4)(1996-12#2)(1996-2#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#6)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2010-2#3)(2010-5#5)(2011-1#3)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#3)
capital-reimbursement approach##2##2##(1992-1#2)
capitalensis)##2##1##(2008-10#2)
capitalising on##2##2##(1996-11#1)(1997-4#1)
capitalism##5##1##(1991-6#1)(2008-11#1)(2013-1#3)
capitalize on the##4##3##(1994-12#1)(1994-3#1)(1995-2#1)(2008-4#1)
capitalize on##9##2##(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-4#1)(2009-9#1)(2010-9#1)(2011-2#1)
capitalizes on##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2010-9#1)(2012-2#1)
capitalizing on##2##2##(2008-7#1)(2008-9#1)
capitata (Wied##3##2##(2008-11#1)(2008-6#2)
capitata##13##1##(2007-12#4)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#3)(2009-9#2)
capitata)##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
capitate##2##1##(1994-12#1)(2008-8#1)
capitated and##2##2##(1994-3#1)(1995-3#1)
capitated health care##2##3##(1995-12#1)(1997-1#1)
capitated payment##3##2##(1995-12#1)(1996-12#1)(1997-2#1)
capitated payments##2##2##(1995-2#1)(1997-1#1)
capitated##18##1##(1991-1#1)(1994-3#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)
capitation and##5##2##(1993-3#1)(1994-2#1)(1997-1#3)
capitation arrangements##2##2##(1993-3#1)(1994-3#1)
capitation payment##3##2##(1992-2#1)(1995-2#1)(1997-1#1)
capitation payments##9##2##(1992-12#1)(1993-3#1)(1994-2#1)(1997-1#6)
capitation rates for##3##3##(1991-2#2)(1997-1#1)
capitation rates##5##2##(1991-2#2)(1994-3#1)(1997-1#2)
capitation##42##1##(1991-2#2)(1992-12#1)(1992-2#1)(1993-3#6)(1994-12#2)(1994-2#2)(1994-3#4)(1995-12#2)(1995-2#3)(1995-3#1)(1996-12#1)(1997-1#13)(1997-2#2)(1997-3#2)
capitis##7##1##(2008-5#5)(2010-9#1)(2013-1#1)
capped RNA##3##2##(2008-10#1)(2011-2#2)
capped and uncapped##2##3##(2008-10#2)
capped with##4##2##(1992-6#1)(2007-11#1)(2008-10#1)(2009-6#1)
capped##18##1##(1992-6#1)(1994-3#1)(1995-1#1)(2007-11#1)(2008-10#9)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#2)
capping layer##5##2##(2007-11#1)(2007-12#1)(2009-5#3)
capping of the##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
capping protein##2##2##(2010-12#2)
capping the##2##2##(2008-10#1)(2008-3#1)
capping##19##1##(1991-6#1)(1992-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-5#3)(2010-12#3)(2011-2#1)(2012-2#3)
cappuccino and spire##2##3##(1994-9#2)
capricolum##4##1##(1994-12#3)(2012-2#1)
caproate##3##1##(2008-10#2)(2012-3#1)
caproic##2##1##(1994-8#1)(1997-3#1)
caps of##2##2##(2007-12#2)
caps on##3##2##(1996-1#1)(1997-5#1)(2007-12#1)
caps##14##1##(1992-8#1)(1995-2#1)(1996-1#1)(1997-5#2)(1997-7#1)(2007-12#4)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)
capsaicin and protons##2##3##(2008-4#1)(2008-7#1)
capsaicin and##5##2##(2008-10#1)(2008-4#2)(2008-7#2)
capsaicin exposure##2##2##(2008-11#1)(2012-3#1)
capsaicin had##2##2##(2008-8#1)(2011-2#1)
capsaicin on##6##2##(1992-6#1)(1993-11#2)(2008-11#1)(2009-9#1)(2011-2#1)
capsaicin pretreatment##3##2##(1992-6#2)(1997-4#1)
capsaicin treatment on##2##3##(1992-6#1)(2008-11#1)
capsaicin treatment##5##2##(1992-6#1)(1997-4#1)(2008-11#3)
capsaicin was##2##2##(1992-6#1)(2008-11#1)
capsaicin##62##1##(1990-5#1)(1990-7#1)(1992-6#9)(1993-11#3)(1995-12#1)(1997-4#5)(2008-10#2)(2008-11#17)(2008-4#4)(2008-7#3)(2008-8#3)(2009-9#3)(2011-1#1)(2011-2#2)(2012-3#6)(2013-1#1)
capsaicin-insensitive TG neurons##2##3##(2009-12#2)
capsaicin-sensitive##5##1##(1992-6#2)(1997-4#2)(2009-12#1)
capsaicinoids##3##1##(2008-10#3)
capsaicins##2##1##(2008-10#2)
capsici and##2##2##(2008-10#2)
capsici in pepper##2##3##(2008-10#2)
capsici in##9##2##(2008-10#9)
capsici is a##2##3##(2008-10#2)
capsici isolates##2##2##(2008-10#2)
capsici was##2##2##(2008-10#2)
capsici##38##1##(2008-10#35)(2008-11#2)(2012-2#1)
capsid and##2##2##(1995-2#1)(2008-8#1)
capsid protein (CP)##3##3##(2008-10#3)
capsid protein (ORF##2##3##(2008-10#2)
capsid protein and##2##3##(2008-10#1)(2008-8#1)
capsid protein from##2##3##(2007-6#1)(2008-10#1)
capsid protein gene##4##3##(2008-10#2)(2009-5#2)
capsid protein##24##2##(1994-8#2)(2007-6#1)(2008-1#1)(2008-10#14)(2008-8#2)(2009-5#2)(2009-7#1)(2009-8#1)
capsid proteins##2##2##(2008-10#2)
capsid shell##2##2##(1991-5#1)(2008-8#1)
capsid##52##1##(1991-5#2)(1992-8#3)(1994-12#1)(1994-8#5)(1995-2#3)(1997-4#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#20)(2008-4#1)(2008-5#1)(2008-8#7)(2009-5#2)(2009-7#2)(2009-8#1)
capsids##5##1##(1994-8#5)
capstone course is##2##3##(1993-1#2)
capstone course##5##2##(1993-1#5)
capsular antigen##3##2##(1991-8#2)(2008-5#1)
capsular block syndrome##2##3##(2011-2#2)
capsular contracture##3##2##(1992-9#1)(2008-8#1)(2013-1#1)
capsular polysaccharide##9##2##(1990-12#1)(1995-11#1)(1997-3#1)(2007-10#1)(2008-5#1)(2012-3#4)
capsular polysaccharides##2##2##(1994-9#1)(1995-6#1)
capsular##34##1##(1990-12#1)(1990-5#2)(1990-6#1)(1991-8#2)(1992-9#1)(1994-9#1)(1995-11#2)(1995-6#1)(1997-3#1)(2007-10#4)(2007-11#1)(2008-11#1)(2008-5#2)(2008-8#4)(2011-1#1)(2011-2#3)(2012-3#5)(2013-1#1)
capsulated##2##1##(2008-11#1)(2009-5#1)
capsulatum is##2##2##(2008-5#2)
capsulatum was##2##2##(2008-5#2)
capsulatum##15##1##(1990-9#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#10)(2010-4#1)
capsulatus grew the best##2##4##(2008-6#2)
capsulatus##5##1##(1994-8#1)(2008-6#4)
capsule and##6##2##(1996-5#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-12#1)(2013-1#1)
capsule endoscopy (CE)##2##3##(2010-12#1)(2011-2#1)
capsule endoscopy findings##2##3##(2011-2#2)
capsule endoscopy in##2##3##(2010-12#1)(2011-2#1)
capsule endoscopy##10##2##(2009-8#1)(2010-12#2)(2011-2#7)
capsule formation##3##2##(2007-12#1)(2008-12#1)(2009-2#1)
capsule has##2##2##(2007-11#1)(2008-12#1)
capsule in##3##2##(1991-8#1)(2007-12#1)(2009-10#1)
capsule is##4##2##(1990-10#1)(2007-12#2)(2008-7#1)
capsule of the##2##3##(2011-2#1)(2012-2#1)
capsule of##6##2##(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
capsule or##2##2##(2008-7#1)(2011-2#1)
capsule switching from##2##3##(2007-12#2)
capsule switching##3##2##(2007-12#3)
capsule##89##1##(1990-10#2)(1990-11#1)(1990-6#1)(1991-8#2)(1996-12#2)(1996-5#3)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#6)(2008-5#3)(2008-7#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#23)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
capsules and##10##2##(2007-12#1)(2008-10#9)
capsules for##2##2##(2011-2#1)(2013-1#1)
capsules in##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
capsules of##3##2##(1996-5#1)(2007-12#1)(2008-5#1)
capsules##46##1##(1996-5#1)(1997-3#5)(2007-11#1)(2007-12#3)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#3)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#2)
capsulotomy##3##1##(2008-1#2)(2009-9#1)
captan##2##1##(2008-10#1)(2011-2#1)
captive and wild##2##3##(2007-12#1)(2008-8#1)
captive chimpanzees##5##2##(2007-12#5)
captive condors##2##2##(1997-6#2)
captive snakes##2##2##(1996-12#2)
captive##34##1##(1991-3#1)(1993-1#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-6#3)(1997-8#1)(2007-12#7)(2007-5#1)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#3)(2011-1#2)
captopril for##2##2##(1992-12#1)(2008-7#1)
captopril in##2##2##(1990-11#1)(2008-10#1)
captopril##37##1##(1990-11#5)(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#6)(1993-2#1)(1994-5#5)(1995-8#1)(1996-2#3)(2007-7#2)(2008-10#7)(2008-7#3)
capture a##5##2##(1993-2#1)(2008-1#1)(2008-2#2)(2011-2#1)
capture and##18##2##(1990-12#1)(1991-2#1)(1994-11#1)(1994-12#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)
capture assay##3##2##(2008-4#3)
capture by##3##2##(1992-6#1)(2008-9#2)
capture detection (GC-ECD)##3##3##(2008-10#3)
capture detection##9##2##(2008-10#9)
capture detector (ECD)##3##3##(2008-10#3)
capture detector (GC-ECD)##4##3##(2008-10#3)(2011-1#1)
capture detector##11##2##(2008-10#10)(2011-1#1)
capture important##2##2##(2008-10#1)(2008-3#1)
capture in##5##2##(2007-12#1)(2008-4#2)(2008-9#1)(2010-8#1)
capture microdissection##5##2##(2008-4#3)(2010-12#2)
capture molecules##2##2##(2008-10#1)(2008-9#1)
capture of##13##2##(1990-12#2)(1997-2#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2010-2#1)(2013-7#1)
capture potential##2##2##(2008-10#1)(2012-2#1)
capture probability##2##2##(2011-2#2)
capture rates##3##2##(2008-9#2)(2009-5#1)
capture techniques##3##2##(2009-4#3)
capture the essence of##2##4##(2008-11#1)(2009-7#1)
capture the##24##2##(1990-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
capture##217##1##(1990-12#4)(1990-8#1)(1991-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#15)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#35)(2008-11#6)(2008-2#2)(2008-3#7)(2008-4#20)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#10)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#3)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#8)(2013-7#4)(2013-8#3)
capture&quot##3##1##(2008-5#2)(2013-8#1)
capture-enrichment methods##2##2##(2012-2#2)
captured and##3##2##(2008-12#1)(2008-4#1)(2012-2#1)
captured at the##2##3##(2008-5#1)(2010-8#1)
captured at##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-8#1)
captured by the##2##3##(2011-2#2)
captured by##9##2##(1995-6#1)(2008-11#1)(2008-7#2)(2009-4#1)(2011-2#3)(2013-1#1)
captured during##2##2##(2008-10#1)(2008-6#1)
captured from the##2##3##(2008-7#2)
captured from##6##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)(2013-7#1)
captured in the##2##3##(2008-10#1)(2008-6#1)
captured in##13##2##(1994-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-6#1)(2010-8#2)
captured on##5##2##(2007-12#1)(2008-10#1)(2008-4#2)(2010-2#1)
captured with a##2##3##(2008-3#1)(2013-7#1)
captured##82##1##(1992-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#6)(2008-9#1)(2009-4#4)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#3)(2011-2#6)(2011-9#1)(2012-2#3)(2013-1#1)(2013-7#5)
captures a##2##2##(2008-10#1)(2009-11#1)
captures the##6##2##(2008-10#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-7#1)(2012-2#1)
captures##18##1##(1992-11#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
capturing a##2##2##(2008-11#1)(2011-2#1)
capturing the##3##2##(2007-12#2)(2013-1#1)
capturing##33##1##(1992-3#2)(1993-12#1)(1993-2#1)(2007-12#2)(2007-5#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
caput##10##1##(1992-3#3)(1997-8#2)(2008-12#2)(2008-7#1)(2011-1#1)(2012-2#1)
car accident in##2##3##(2007-2#1)(2013-1#1)
car accidents##2##2##(1991-3#1)(2009-3#1)
car##17##1##(1991-3#1)(1992-12#1)(1997-4#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#1)(2013-1#2)
caractéristiques##3##1##(2008-11#1)(2013-1#2)
carazolol##4##1##(1995-11#4)
carbachol and the##2##3##(1994-8#1)(2008-10#1)
carbachol and##7##2##(1994-8#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
carbachol displaced##2##2##(1990-5#2)
carbachol stimulated accumulation of labeled IP4##2##6##(1997-1#2)
carbachol stimulated##4##2##(1996-12#1)(1997-1#3)
carbachol stimulation##3##2##(1990-5#2)(2008-10#1)
carbachol was##3##2##(1994-11#1)(1996-12#1)(1996-5#1)
carbachol##48##1##(1990-5#6)(1990-7#4)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#9)(1995-12#2)(1996-12#6)(1996-5#4)(1997-1#5)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)
carbachol-##2##1##(1995-11#2)
carbachol-stimulated##5##1##(1993-11#1)(1995-2#1)(1997-1#3)
carbamate (mebendazole)##2##2##(2008-10#2)
carbamate pesticide residues in Glycyrrhizae radix et rhizoma##3##8##(2011-1#3)
carbamate pesticides##4##2##(2008-10#2)(2011-1#2)
carbamate##26##1##(1992-2#2)(1993-6#1)(1994-2#7)(2008-10#9)(2008-5#1)(2011-1#5)(2012-12#1)
carbamates and##2##2##(2008-10#1)(2009-12#1)
carbamates in the##2##3##(2008-10#2)
carbamates in##5##2##(2008-10#5)
carbamates were##2##2##(2008-10#2)
carbamates##14##1##(2008-10#13)(2009-12#1)
carbamazepine and##3##2##(2008-10#2)(2013-1#1)
carbamazepine poisoning##2##2##(2011-2#2)
carbamazepine were##2##2##(1990-5#1)(2011-2#1)
carbamazepine##22##1##(1990-5#5)(1993-12#1)(1997-4#1)(2008-10#4)(2008-8#2)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#5)(2013-1#1)
carbamoyl phosphate##3##2##(1990-8#1)(1995-6#1)(2008-7#1)
carbamoyl##7##1##(1990-8#1)(1995-3#2)(1995-6#1)(2008-7#3)
carbamyl phosphate synthetase (CPS)##2##4##(1990-7#2)
carbamyl phosphate synthetase##3##3##(1990-7#3)
carbamyl phosphate synthetases##2##3##(1990-7#2)
carbamyl phosphate##5##2##(1990-7#5)
carbamyl##6##1##(1990-7#5)(1995-5#1)
carbamylcholine chloride##4##2##(1995-8#4)
carbamylcholine##5##1##(1992-8#1)(1995-8#4)
carbanion is##2##2##(1996-5#1)(2007-11#1)
carbanion##3##1##(1996-5#1)(2007-11#2)
carbapenem antibiotic##2##2##(2008-5#1)(2008-7#1)
carbaryl and benomyl##3##3##(2008-10#3)
carbaryl and##4##2##(2008-10#4)
carbaryl##29##1##(1992-2#5)(2008-10#24)
carbazole derivative##3##2##(2008-10#3)
carbazole##4##1##(2008-10#4)
carbendazim and##2##2##(2008-10#2)
carbendazim##10##1##(1997-4#2)(2008-10#7)(2011-2#1)
carbene complex##2##2##(2010-3#1)(2010-5#1)
carbene complexes##3##2##(2009-10#2)(2010-5#1)
carbene##6##1##(2009-10#2)(2010-3#1)(2010-5#2)(2010-7#1)
carbide and##2##2##(2008-10#1)(2008-2#1)
carbide##11##1##(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)
carbinol##3##1##(2008-10#3)
carboCys##4##1##(2008-10#4)
carbocyanine##2##1##(1994-12#1)(2008-10#1)
carbocyclic##3##1##(1995-3#2)(1996-5#1)
carbocysteine##2##1##(2008-10#2)
carbodiimide and##2##2##(2008-10#2)
carbodiimide chemistry##2##2##(2008-10#1)(2013-1#1)
carbodiimide##8##1##(1997-2#1)(2008-10#5)(2008-9#1)(2013-1#1)
carbodiimide/glutaraldehyde##2##1##(2008-10#2)
carbofuran##9##1##(2008-10#9)
carbohydrate acrylates##2##2##(2008-8#2)
carbohydrate and##5##2##(2010-7#1)(2012-1#2)(2012-3#1)(2013-1#1)
carbohydrate binding protein##2##3##(1990-12#2)
carbohydrate chain attached to Asn-39##2##5##(1990-5#2)
carbohydrate chain##5##2##(1990-11#1)(1990-5#4)
carbohydrate chains##3##2##(1990-5#1)(2008-11#1)(2008-4#1)
carbohydrate composition of##2##3##(1990-8#1)(1992-12#1)
carbohydrate composition##4##2##(1990-8#1)(1992-11#1)(1992-12#1)(1997-4#1)
carbohydrate concentrations##3##2##(2008-10#3)
carbohydrate consumption##2##2##(2008-3#1)(2008-5#1)
carbohydrate content##2##2##(1993-3#1)(2010-8#1)
carbohydrate counting##3##2##(2011-2#2)(2013-8#1)
carbohydrate diet##2##2##(2008-3#2)
carbohydrate groups LewisX and sialyl##2##5##(1993-8#2)
carbohydrate groups##5##2##(1993-8#5)
carbohydrate in##2##2##(2008-6#1)(2008-8#1)
carbohydrate intake##4##2##(2008-4#1)(2008-5#1)(2013-1#2)
carbohydrate intolerance##3##2##(2008-1#3)
carbohydrate loading##2##2##(2008-5#2)
carbohydrate metabolism in##3##3##(1991-12#1)(1991-5#1)(2008-10#1)
carbohydrate metabolism##13##2##(1991-12#1)(1991-5#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-5#2)(2010-1#1)(2012-3#1)
carbohydrate moieties of the##2##4##(1992-8#1)(1994-8#1)
carbohydrate moieties of##3##3##(1992-8#1)(1994-8#1)(1994-9#1)
carbohydrate moieties##9##2##(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(2008-12#1)(2008-9#1)(2012-3#1)
carbohydrate moiety of##3##3##(1991-12#1)(1994-8#1)(2008-11#1)
carbohydrate moiety##10##2##(1990-11#2)(1990-7#1)(1991-12#2)(1992-5#1)(1994-8#1)(1995-5#1)(2006-6#1)(2008-11#1)
carbohydrate reserves##2##2##(2008-10#2)
carbohydrate source##4##2##(2008-10#3)(2008-6#1)
carbohydrate structure of##2##3##(1990-5#1)(1992-11#1)
carbohydrate structures##8##2##(1991-5#2)(1993-11#1)(1996-12#1)(2008-11#1)(2008-5#1)(2010-12#2)
carbohydrate to##2##2##(1994-5#1)(2009-10#1)
carbohydrate##170##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#7)(1990-7#2)(1990-8#2)(1991-12#3)(1991-5#4)(1992-11#2)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-3#1)(1993-8#5)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#2)(1996-5#1)(1996-6#4)(1997-2#2)(1997-4#2)(1997-6#3)(2006-6#1)(2008-1#7)(2008-10#14)(2008-11#4)(2008-12#2)(2008-3#13)(2008-4#5)(2008-5#12)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
carbohydrate-binding##6##1##(1990-7#1)(1994-8#1)(1995-5#1)(2009-3#2)(2013-1#1)
carbohydrate-derivatized##2##1##(1990-2#2)
carbohydrate-restricted diet##11##2##(2008-3#11)
carbohydrate-restricted group##2##2##(2008-3#2)
carbohydrate-restricted##14##1##(2008-3#14)
carbohydrate-specific##2##1##(1990-2#1)(2008-11#1)
carbohydrates and##9##2##(1990-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
carbohydrates in the##3##3##(2008-3#1)(2008-6#1)(2009-2#1)
carbohydrates in##9##2##(1993-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-5#1)
carbohydrates is##2##2##(2008-7#2)
carbohydrates on##3##2##(1992-6#1)(1995-8#1)(2008-5#1)
carbohydrates to##3##2##(1993-1#1)(1995-5#1)(2008-6#1)
carbohydrates were##2##2##(2008-10#1)(2008-9#1)
carbohydrates##79##1##(1990-2#2)(1990-8#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#3)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-5#2)(2013-1#6)
carbohydrates)##5##1##(1995-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
carbon (%)##2##2##(2008-10#2)
carbon (C)##3##2##(2008-6#2)(2013-8#1)
carbon (PGC)##2##2##(1996-5#1)(2008-10#1)
carbon 2##2##2##(1995-5#1)(2008-10#1)
carbon aerogel##3##2##(2008-3#3)
carbon and a##2##3##(2008-10#2)
carbon and energy##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
carbon and nitrogen contents##2##4##(2008-10#2)
carbon and nitrogen##11##3##(2008-10#7)(2008-11#1)(2009-5#1)(2012-3#2)
carbon and sulfur##2##3##(2010-11#2)
carbon and the##3##3##(2008-10#2)(2008-5#1)
carbon and##43##2##(1996-12#1)(1996-3#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#3)(2011-2#1)(2012-3#2)(2013-8#1)
carbon atom and##2##3##(1991-3#1)(2008-10#1)
carbon atom positions##2##3##(2008-7#2)
carbon atom##8##2##(1991-3#2)(2008-10#4)(2008-7#2)
carbon atoms was##3##3##(2008-10#2)(2013-8#1)
carbon atoms##19##2##(1990-7#1)(1992-6#1)(1995-2#1)(1995-3#1)(2007-11#4)(2008-10#4)(2008-7#2)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
carbon backbone##2##2##(2007-11#1)(2008-7#1)
carbon based##2##2##(2008-10#2)
carbon black suspension##3##3##(2008-3#3)
carbon black##6##2##(2008-10#2)(2008-3#4)
carbon catabolite repression by sugars in the juice##2##8##(2008-10#2)
carbon catabolite repression by##3##4##(1993-12#1)(2008-10#2)
carbon catabolite repression##4##3##(1993-12#1)(2008-10#3)
carbon centers##2##2##(1996-5#2)
carbon ceramic electrode prepared by##2##5##(2008-10#2)
carbon ceramic electrode prepared with sol-gel technique##2##7##(2008-10#2)
carbon ceramic electrode prepared##4##4##(2008-10#4)
carbon ceramic electrode##10##3##(2008-10#10)
carbon ceramic##11##2##(2008-10#11)
carbon chain##2##2##(2008-11#1)(2008-6#1)
carbon coated##2##2##(2008-10#1)(2012-12#1)
carbon column##6##2##(1996-5#1)(2008-10#5)
carbon composite electrode##3##3##(2008-10#3)
carbon composite##7##2##(2008-10#5)(2013-1#2)
carbon content of the##2##4##(2008-10#2)
carbon content of##4##3##(2008-10#2)(2008-3#1)(2012-9#1)
carbon content##8##2##(2008-10#3)(2008-3#2)(2012-9#1)(2013-7#2)
carbon cycle##2##2##(2008-3#1)(2011-2#1)
carbon dioxide (CO 2) laser##2##5##(1991-2#1)(1992-1#1)
carbon dioxide (CO(2))##4##3##(2008-11#1)(2009-6#1)(2012-2#1)(2012-3#1)
carbon dioxide (CO2)##5##3##(1996-12#4)(2008-6#1)
carbon dioxide and##7##3##(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-2#1)
carbon dioxide by##2##3##(2008-3#2)
carbon dioxide extraction of##2##4##(2008-10#2)
carbon dioxide extraction##4##3##(2008-10#4)
carbon dioxide for##2##3##(2008-10#1)(2012-3#1)
carbon dioxide from##2##3##(2008-10#1)(2008-11#1)
carbon dioxide in the##2##4##(2008-10#1)(2008-3#1)
carbon dioxide in##5##3##(1993-12#1)(2008-10#3)(2008-3#1)
carbon dioxide laser##4##3##(1991-12#2)(1992-1#1)(1993-8#1)
carbon dioxide production##6##3##(2008-11#5)(2008-4#1)
carbon dioxide was##3##3##(2008-10#3)
carbon dioxide##110##2##(1990-11#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-3#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1995-6#1)(1995-8#2)(1996-12#4)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#45)(2008-11#10)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#3)
carbon disc electrode##5##3##(2008-10#5)
carbon disk electrode##4##3##(1990-12#1)(2008-10#3)
carbon disk##5##2##(1990-12#1)(2008-10#4)
carbon electrode (GCE) using##2##4##(2008-10#2)
carbon electrode (GCE)##15##3##(2008-10#15)
carbon electrode and its##2##4##(2008-10#2)
carbon electrode and##7##3##(2008-10#6)(2013-1#1)
carbon electrode can be##2##4##(2008-10#2)
carbon electrode for##2##3##(2008-10#2)
carbon electrode in##6##3##(1995-6#1)(2008-10#5)
carbon electrode using##3##3##(2008-10#3)
carbon electrode was used##2##4##(2008-10#2)
carbon electrode was##6##3##(2008-10#6)
carbon electrode##128##2##(1990-12#1)(1995-6#3)(2008-10#123)(2013-1#1)
carbon electrodes (SPCEs)##4##3##(2008-10#4)
carbon electrodes for##2##3##(2008-10#1)(2013-1#1)
carbon electrodes have been##2##4##(2008-10#2)
carbon electrodes in##3##3##(2008-10#3)
carbon electrodes modified with##4##4##(2008-10#4)
carbon electrodes##40##2##(2008-10#38)(2013-1#2)
carbon felt##2##2##(2008-10#2)
carbon fiber microdisk electrode##3##4##(2008-10#3)
carbon fiber microelectrode##3##3##(2008-10#3)
carbon fiber microelectrodes##2##3##(2008-4#2)
carbon fiber nanoelectrodes##2##3##(2008-10#2)
carbon fiber ultramicroelectrode##2##3##(2008-10#2)
carbon fiber##18##2##(1992-11#2)(1997-2#1)(2008-10#13)(2008-4#2)
carbon fibers for SPME##2##4##(2008-10#2)
carbon fibers for##3##3##(2008-10#3)
carbon fibers##7##2##(2008-10#7)
carbon fibre##2##2##(2008-10#2)
carbon film electrodes##4##3##(2008-10#4)
carbon film##7##2##(2008-10#7)
carbon flow##3##2##(2012-1#3)
carbon flux through##2##3##(2008-11#1)(2008-7#1)
carbon flux##8##2##(2008-11#1)(2008-7#3)(2008-8#1)(2012-3#1)(2013-1#2)
carbon from##2##2##(2008-2#1)(2008-7#1)
carbon in steels##2##3##(2008-10#2)
carbon in the##4##3##(1995-11#1)(2008-10#2)(2008-3#1)
carbon in##13##2##(1995-11#1)(2008-10#10)(2008-3#2)
carbon ink##2##2##(2008-10#2)
carbon is##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
carbon isotope##3##2##(2008-10#3)
carbon layer##2##2##(2008-10#2)
carbon loading##3##2##(2008-10#3)
carbon loadings##2##2##(2008-10#2)
carbon loss##2##2##(2008-10#2)
carbon material##3##2##(2008-10#2)(2008-7#1)
carbon metabolism##6##2##(2008-10#1)(2008-7#2)(2008-9#1)(2012-7#2)
carbon modified##2##2##(2008-10#2)
carbon monoxide (CO)##8##3##(1990-5#1)(1994-2#1)(1996-12#3)(2008-3#1)(2008-4#1)(2010-12#1)
carbon monoxide and##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
carbon monoxide poisoning is##2##4##(1991-9#1)(1997-6#1)
carbon monoxide poisoning##8##3##(1990-5#3)(1991-9#1)(1997-6#2)(2009-11#2)
carbon monoxide was##2##3##(1997-6#1)(2010-10#1)
carbon monoxide##44##2##(1990-3#1)(1990-5#4)(1991-12#1)(1991-3#1)(1991-9#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#5)(1996-2#1)(1997-6#5)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2009-11#2)(2010-10#1)(2010-12#3)(2012-12#1)(2013-1#1)
carbon nanomaterials##2##2##(2008-12#2)
carbon nanotube (CNT)##5##3##(2008-10#2)(2008-7#1)(2009-11#1)(2013-8#1)
carbon nanotube suspensions##2##3##(2007-11#2)
carbon nanotube##20##2##(2007-11#2)(2008-10#8)(2008-3#1)(2008-7#6)(2009-11#1)(2012-2#1)(2013-8#1)
carbon nanotubes (CNTs)##5##3##(2008-10#1)(2008-7#2)(2009-11#1)(2010-4#1)
carbon nanotubes (MWNTs)##5##3##(2008-10#3)(2009-3#1)(2010-5#1)
carbon nanotubes (SWNTs)##7##3##(2008-10#1)(2008-7#5)(2009-11#1)
carbon nanotubes and redox polymer##2##5##(2008-10#2)
carbon nanotubes and##8##3##(2008-10#4)(2008-3#1)(2008-7#3)
carbon nanotubes are##2##3##(2008-10#1)(2008-7#1)
carbon nanotubes as##4##3##(2008-10#4)
carbon nanotubes by##4##3##(2008-10#1)(2008-7#3)
carbon nanotubes can##2##3##(2008-7#1)(2010-2#1)
carbon nanotubes film##2##3##(2008-10#2)
carbon nanotubes in##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)
carbon nanotubes on##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
carbon nanotubes to##2##3##(2008-10#1)(2008-7#1)
carbon nanotubes were##4##3##(2008-10#3)(2011-2#1)
carbon nanotubes with##2##3##(2009-3#1)(2010-2#1)
carbon nanotubes##102##2##(2007-11#4)(2008-10#40)(2008-12#1)(2008-3#4)(2008-7#28)(2009-10#2)(2009-11#5)(2009-3#2)(2010-2#4)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#4)(2012-2#2)(2013-1#1)
carbon of##3##2##(1992-8#1)(2008-12#1)(2008-8#1)
carbon or##3##2##(2008-10#2)(2008-9#1)
carbon particles##5##2##(2008-10#2)(2008-3#1)(2012-12#2)
carbon paste electrode (CPE)##11##4##(2008-10#10)(2008-6#1)
carbon paste electrode and##2##4##(2008-10#2)
carbon paste electrode for the##3##5##(2008-10#3)
carbon paste electrode for##8##4##(2008-10#8)
carbon paste electrode has been developed##3##6##(2008-10#3)
carbon paste electrode in the presence of##2##7##(2008-10#2)
carbon paste electrode in##3##4##(2008-10#3)
carbon paste electrode modified by silver nanoparticles##2##7##(2008-10#2)
carbon paste electrode modified by##3##5##(2008-10#3)
carbon paste electrode modified with##10##5##(2008-10#10)
carbon paste electrode modified##15##4##(2008-10#15)
carbon paste electrode using##3##4##(2008-10#3)
carbon paste electrode were##2##4##(2008-10#2)
carbon paste electrode##87##3##(2008-10#86)(2008-6#1)
carbon paste electrodes for##2##4##(2008-10#2)
carbon paste electrodes##12##3##(2008-10#12)
carbon paste##115##2##(2008-10#114)(2008-6#1)
carbon powder##5##2##(2008-10#5)
carbon present in the##2##4##(2008-10#1)(2008-3#1)
carbon produced##2##2##(2007-12#1)(2008-6#1)
carbon range of##2##3##(2008-6#2)
carbon range##3##2##(2008-6#3)
carbon screen-printed electrode##3##3##(2008-10#3)
carbon showed the##2##3##(2008-10#2)
carbon source and##3##3##(1994-3#1)(2008-10#1)(2011-1#1)
carbon source for##2##3##(2008-8#1)(2013-1#1)
carbon source in the##2##4##(2008-6#1)(2013-1#1)
carbon source utilization##2##3##(2008-10#1)(2008-7#1)
carbon source##51##2##(1990-5#1)(1994-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1997-2#2)(2008-10#14)(2008-11#1)(2008-6#15)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
carbon sources and##2##3##(2008-10#1)(2011-2#1)
carbon sources in the##2##4##(1991-9#1)(1997-2#1)
carbon sources in##3##3##(1991-9#1)(1997-2#1)(2008-5#1)
carbon sources##12##2##(1991-9#2)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#1)
carbon spheres##2##2##(2008-3#2)
carbon substrate utilization##2##3##(2008-10#2)
carbon substrates##3##2##(2008-10#2)(2011-2#1)
carbon surface##3##2##(1990-8#1)(2008-10#2)
carbon suspension##2##2##(2008-3#2)
carbon suspensions##2##2##(2008-3#2)
carbon tetrachloride and##4##3##(1992-3#2)(2008-10#2)
carbon tetrachloride hepatotoxicity##5##3##(1995-3#5)
carbon tetrachloride##28##2##(1991-9#1)(1992-3#2)(1992-6#1)(1995-3#13)(2007-11#1)(2007-12#1)(2008-10#6)(2009-8#1)(2010-2#1)(2013-1#1)
carbon tetrachloride-induced##2##2##(1995-3#1)(2008-11#1)
carbon to##4##2##(2008-10#3)(2008-12#1)
carbon using##2##2##(2007-12#1)(2008-10#1)
carbon were##3##2##(1993-8#1)(2008-10#2)
carbon with##2##2##(1992-11#1)(2008-11#1)
carbon##1138##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#5)(1990-7#1)(1990-8#5)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-9#4)(1992-1#2)(1992-11#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#15)(1995-5#2)(1995-6#7)(1995-8#4)(1995-9#1)(1996-12#11)(1996-2#2)(1996-3#1)(1996-5#5)(1997-2#4)(1997-4#1)(1997-6#5)(1997-7#2)(2007-11#15)(2007-12#7)(2008-10#663)(2008-11#21)(2008-12#12)(2008-2#8)(2008-3#46)(2008-4#5)(2008-5#6)(2008-6#36)(2008-7#63)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#9)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#5)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#4)(2012-12#5)(2012-2#9)(2012-3#6)(2012-5#2)(2012-7#2)(2012-9#1)(2013-1#16)(2013-7#4)(2013-8#9)
carbon) and##2##2##(2008-10#2)
carbon)##4##1##(1996-2#1)(2008-10#3)
carbon-13 labeled modified##2##3##(2008-10#2)
carbon-13##5##1##(1992-12#1)(2008-10#4)
carbon-based##2##1##(2008-10#1)(2009-8#1)
carbon-carbon bonds##2##2##(2007-12#1)(2010-12#1)
carbon-carbon##4##1##(2007-11#1)(2007-12#1)(2010-12#1)(2011-1#1)
carbon-containing##2##1##(1995-3#1)(2010-7#1)
carbon-nitrogen bond##2##2##(1993-11#2)
carbon-paste##2##1##(2008-10#2)
carbon-rich supramolecular##2##2##(2009-12#2)
carbon-rich##4##1##(2009-12#4)
carbon-supported##2##1##(2008-10#2)
carbon-working electrode##2##2##(2008-10#2)
carbon/nitrogen ratio##3##2##(2008-10#2)(2008-12#1)
carbon/nitrogen ratios##2##2##(2008-10#2)
carbon/nitrogen##5##1##(2008-10#4)(2008-12#1)
carbonaceous##7##1##(1997-5#1)(2007-12#1)(2008-10#4)(2008-12#1)
carbonate and##8##2##(1995-11#1)(2008-10#3)(2011-2#4)
carbonate apatite##2##2##(2008-10#2)
carbonate by##2##2##(2008-10#1)(2011-2#1)
carbonate complexes##3##2##(2008-10#3)
carbonate in##5##2##(2008-10#5)
carbonate ion##2##2##(2008-10#2)
carbonate or Tris##2##3##(2008-10#2)
carbonate selectivity##2##2##(2008-10#2)
carbonate species##2##2##(2008-10#2)
carbonate to##2##2##(2008-10#1)(2011-2#1)
carbonate##85##1##(1990-11#2)(1992-2#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-10#56)(2008-12#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#14)(2012-12#1)(2013-1#1)
carbonate)##6##1##(1990-11#1)(2008-10#5)
carbonate-selective##3##1##(2008-10#3)
carbonated##4##1##(2007-12#2)(2008-10#1)(2009-7#1)
carbonates##12##1##(1990-11#2)(1996-5#1)(2008-10#5)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)
carbonation of concrete##3##3##(2007-12#3)
carbonation##4##1##(2007-12#4)
carbonic acid##2##2##(1990-11#2)
carbonic anhydrase##11##2##(1991-5#5)(1993-1#2)(2006-10#1)(2009-3#2)(2013-8#1)
carbonic##13##1##(1990-11#2)(1991-5#5)(1993-1#2)(2006-10#1)(2009-3#2)(2013-8#1)
carbons of the##3##3##(1991-5#1)(1995-11#2)
carbons of##4##2##(1991-5#1)(1995-11#3)
carbons through##2##2##(2008-6#1)(2009-5#1)
carbons were##2##2##(2008-10#1)(2013-1#1)
carbons##16##1##(1990-5#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-11#3)(1995-5#1)(2008-10#3)(2008-6#1)(2009-5#1)(2009-7#1)(2013-1#1)(2013-8#1)
carbonum##7##1##(2008-10#7)
carbonyl and##6##2##(1992-6#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
carbonyl at##2##2##(1992-6#1)(2008-3#1)
carbonyl compounds##9##2##(1992-12#1)(1992-3#1)(2007-11#1)(2008-10#5)(2008-5#1)
carbonyl derivatives##2##2##(2008-1#1)(2008-5#1)
carbonyl formation##2##2##(1995-6#2)
carbonyl functional groups##2##3##(1992-6#1)(2008-10#1)
carbonyl group at##4##3##(1995-3#1)(2008-11#1)(2011-3#1)(2012-2#1)
carbonyl group##14##2##(1992-3#1)(1993-11#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-3#1)(2012-2#1)
carbonyl groups and##2##3##(1993-11#1)(2009-8#1)
carbonyl groups of##3##3##(1993-11#1)(1996-5#1)(2009-7#1)
carbonyl groups on##2##3##(1995-5#1)(1996-5#1)
carbonyl groups##8##2##(1993-11#2)(1995-5#1)(1996-5#3)(2009-7#1)(2009-8#1)
carbonyl iron##2##2##(2008-3#1)(2012-2#1)
carbonyl of P##2##3##(1993-11#2)
carbonyl of##6##2##(1993-11#4)(1995-2#1)(1995-5#1)
carbonyl oxygen atom of##2##4##(1991-3#1)(1996-5#1)
carbonyl oxygen##6##2##(1991-3#2)(1992-6#1)(1996-5#3)
carbonyl stretching frequencies are##3##4##(1995-5#3)
carbonyl stretching##4##2##(1995-5#3)(2008-8#1)
carbonyl##93##1##(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-3#3)(1992-12#1)(1992-3#3)(1992-6#4)(1993-11#8)(1995-2#1)(1995-3#3)(1995-5#8)(1995-6#3)(1996-2#3)(1996-5#8)(2007-11#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#6)(2008-5#5)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#3)
carbonylation##4##1##(1996-5#1)(2008-1#1)(2008-3#1)(2010-12#1)
carbonyls##7##1##(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2010-4#2)(2013-1#1)
carboplatin and##5##2##(1991-8#1)(2007-7#1)(2008-8#1)(2009-8#1)(2010-11#1)
carboplatin injections##2##2##(2008-10#1)(2011-1#1)
carboplatin##23##1##(1990-6#1)(1991-8#2)(1992-2#1)(1993-2#1)(1995-9#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#2)(2011-1#3)(2012-2#1)(2013-1#1)
carboplatin)##3##1##(1993-6#1)(2010-8#1)(2011-2#1)
carbopol##2##1##(2010-5#1)(2011-1#1)
carborane##2##1##(1996-2#1)(2008-10#1)
carbosilane dendrimer##2##2##(2008-10#2)
carboxamide##5##1##(1992-2#2)(1994-8#1)(1995-3#1)(2012-2#1)
carboxen-polydimethylsiloxane##2##1##(2008-10#1)(2009-8#1)
carboxin resistance##3##2##(2008-10#3)
carboxin-sensitive##2##1##(2008-10#2)
carboxy terminal##5##2##(1990-8#1)(1993-6#1)(1995-3#1)(2008-8#1)(2009-9#1)
carboxy terminus##3##2##(1992-9#1)(1993-8#1)(1995-8#1)
carboxy##11##1##(1990-8#1)(1992-9#1)(1993-6#2)(1993-8#3)(1995-3#1)(1995-8#1)(2008-8#1)(2009-9#1)
carboxy-terminal domain##3##2##(1991-9#3)
carboxy-terminal ends##2##2##(2008-4#2)
carboxy-terminal processing##2##2##(1993-11#2)
carboxy-terminal sequences##2##2##(1993-11#1)(1993-9#1)
carboxy-terminal tag##2##2##(2008-11#2)
carboxy-terminal##18##1##(1991-9#3)(1992-6#1)(1993-11#3)(1993-8#2)(1993-9#1)(1994-6#1)(1997-4#1)(2008-11#2)(2008-4#2)(2009-7#1)(2012-12#1)
carboxy-terminus of##2##2##(1991-5#1)(1992-6#1)
carboxy-terminus##5##1##(1991-12#1)(1991-5#2)(1992-6#1)(1995-6#1)
carboxy-truncated IGFBP-5##2##2##(1993-8#2)
carboxyarsenazo##2##1##(2008-10#2)
carboxyfluorescein (CF)##2##2##(2008-10#2)
carboxyfluorescein diacetate##2##2##(2008-11#1)(2008-9#1)
carboxyfluorescein##6##1##(1990-2#1)(2008-10#3)(2008-11#1)(2008-9#1)
carboxyhemoglobin##3##1##(1990-8#1)(1996-12#2)
carboxykinase (PEPCK)##5##2##(1995-3#1)(1995-6#2)(1996-2#1)(2010-11#1)
carboxykinase and citric-acid-cycle dehydrogenases##2##4##(1991-3#2)
carboxykinase##12##1##(1991-3#2)(1994-8#1)(1995-3#1)(1995-6#2)(1996-2#1)(2008-12#2)(2010-11#1)(2010-4#2)
carboxyl and##3##2##(2008-10#2)(2009-7#1)
carboxyl group of xylanase##2##4##(1993-3#2)
carboxyl group of##3##3##(1990-8#1)(1993-3#2)
carboxyl group##11##2##(1990-5#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-3#3)(2008-10#3)(2009-9#1)
carboxyl groups for##2##3##(1990-12#1)(1993-6#1)
carboxyl groups of##3##3##(1993-6#1)(2008-10#2)
carboxyl groups on the##2##4##(2008-10#2)
carboxyl groups##17##2##(1990-12#1)(1990-7#1)(1992-12#1)(1993-6#2)(1995-12#1)(1997-2#1)(2008-10#8)(2008-2#1)(2013-1#1)
carboxyl terminal##7##2##(1992-8#2)(1993-8#1)(1995-5#1)(1996-12#2)(2008-10#1)
carboxyl terminus of##3##3##(1992-8#1)(1996-12#1)(2012-2#1)
carboxyl terminus##15##2##(1991-8#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#3)(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#2)(2012-2#2)
carboxyl##69##1##(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#3)(1993-6#2)(1993-8#3)(1994-5#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-5#1)(1997-2#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
carboxyl-terminal region##2##2##(1990-8#1)(1994-11#1)
carboxyl-terminal##15##1##(1990-8#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1997-8#1)
carboxylase##15##1##(1990-5#2)(1991-3#1)(1992-9#4)(1993-11#1)(1995-2#2)(1995-8#1)(1996-12#1)(2008-11#2)(2008-7#1)
carboxylase/oxygenase (Rubisco)##2##2##(1993-12#2)
carboxylase/oxygenase##3##1##(1993-12#2)(1994-8#1)
carboxylate and##3##2##(1997-7#1)(2008-10#2)
carboxylate anion##2##2##(1994-8#1)(2011-1#1)
carboxylate group##2##2##(1997-7#2)
carboxylate groups of the##2##4##(1993-6#1)(2008-10#1)
carboxylate groups of##4##3##(1993-6#2)(1995-3#1)(2008-10#1)
carboxylate groups##8##2##(1991-5#2)(1993-6#2)(1995-3#1)(2008-10#3)
carboxylate ligands##2##2##(2009-7#1)(2012-12#1)
carboxylate matrices##3##2##(2008-7#3)
carboxylate moiety on the##2##4##(2008-10#2)
carboxylate##37##1##(1990-12#1)(1991-5#3)(1992-3#3)(1993-6#3)(1993-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-7#3)(2008-10#11)(2008-7#3)(2009-7#1)(2011-1#1)(2012-12#2)(2012-3#2)
carboxylated##6##1##(1992-12#1)(2008-10#4)(2008-4#1)
carboxylates##4##1##(2008-5#2)(2009-12#1)(2013-1#1)
carboxylation efficiency##2##2##(2008-9#1)(2012-6#1)
carboxylation##4##1##(1992-9#1)(2008-9#1)(2012-5#1)(2012-6#1)
carboxylesterase##4##1##(1995-3#1)(2008-8#1)(2009-9#1)(2010-8#1)
carboxylesterases##2##1##(1991-5#1)(1996-12#1)
carboxylic acid and##3##3##(1991-9#1)(1995-5#1)(2007-12#1)
carboxylic acid by##2##3##(2008-10#2)
carboxylic acid functional group##2##4##(2008-10#1)(2010-2#1)
carboxylic acid groups##3##3##(2010-4#2)(2012-2#1)
carboxylic acid##27##2##(1991-9#1)(1994-8#1)(1995-5#2)(1996-7#1)(2007-11#1)(2007-12#2)(2008-10#14)(2009-8#1)(2010-2#1)(2010-4#2)(2012-2#1)
carboxylic acids and##3##3##(1995-5#1)(1997-2#1)(2008-10#1)
carboxylic acids are##2##3##(2008-10#1)(2011-1#1)
carboxylic acids by##2##3##(2008-10#1)(2011-1#1)
carboxylic acids##24##2##(1992-5#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-7#1)(2010-8#1)(2011-1#4)(2012-3#1)
carboxylic functional group##2##3##(2011-2#2)
carboxylic group##3##2##(2008-10#3)
carboxylic groups in##2##3##(2008-10#2)
carboxylic groups##5##2##(2008-10#5)
carboxylic##75##1##(1991-9#2)(1992-5#1)(1993-3#1)(1994-8#1)(1995-5#4)(1996-7#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#44)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#1)
carboxyltransferase##4##1##(1992-9#4)
carboxymethyl cellulose acrylate for##2##4##(2008-5#2)
carboxymethyl cellulose##8##2##(1995-3#1)(2008-10#3)(2008-5#4)
carboxymethyl##12##1##(1995-3#1)(2008-10#5)(2008-5#5)(2008-7#1)
carboxymethylated chitosan##2##2##(2009-3#2)
carboxymethylated dextran##2##2##(2008-10#2)
carboxymethylated##7##1##(1990-7#1)(1990-8#1)(1995-5#1)(2008-10#2)(2009-3#2)
carboxymethylated-dextran##2##1##(2008-10#2)
carboxymethylcellulose (CMC)##4##2##(2008-10#2)(2009-3#1)(2011-2#1)
carboxypeptidase B##3##2##(1997-2#1)(2006-6#2)
carboxypeptidase H##2##2##(1995-8#2)
carboxypeptidase M expression##2##3##(1995-6#2)
carboxypeptidase M##7##2##(1990-5#1)(1995-6#6)
carboxypeptidase##31##1##(1990-2#1)(1990-5#1)(1992-6#2)(1992-9#3)(1993-8#6)(1994-12#2)(1995-2#2)(1995-6#7)(1995-8#2)(1997-2#1)(2006-6#4)
carcase condemnations##2##2##(1994-7#2)
carcase##4##1##(1994-7#2)(1997-5#2)
carcases with a fleece score of##2##6##(1997-5#2)
carcases with a##3##3##(1997-5#3)
carcases##10##1##(1990-3#1)(1990-9#2)(1997-5#7)
carcass and meat quality traits##2##5##(2010-4#1)(2012-2#1)
carcass and meat##3##3##(2010-4#2)(2012-2#1)
carcass and##5##2##(2010-4#2)(2012-2#1)(2013-1#2)
carcass characteristics and meat quality##2##5##(2012-2#2)
carcass characteristics were##2##3##(2008-12#2)
carcass characteristics##7##2##(2008-12#5)(2012-2#2)
carcass traits and fatty acid compositions##3##6##(2010-2#3)
carcass weight##4##2##(2010-2#2)(2010-4#1)(2012-2#1)
carcass##33##1##(1997-4#1)(2008-12#5)(2008-5#1)(2008-6#4)(2010-2#7)(2010-4#4)(2012-2#4)(2013-1#7)
carcasses of##2##2##(1992-8#1)(1997-7#1)
carcasses were##2##2##(1992-8#1)(2013-1#1)
carcasses##12##1##(1992-8#2)(1997-4#1)(1997-7#1)(2008-6#3)(2008-7#1)(2013-1#4)
carcimoma##2##1##(1994-7#2)
carcinine##2##1##(2008-5#2)
carcinoembryonic antigen (CEA) gene family##2##5##(1990-5#1)(1992-6#1)
carcinoembryonic antigen (CEA)##8##3##(1990-5#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-8#1)(2008-10#1)(2008-11#2)
carcinoembryonic antigen and epithelial membrane antigen##2##6##(1991-12#1)(1992-2#1)
carcinoembryonic antigen and##4##3##(1991-12#1)(1992-2#1)(2008-11#1)(2008-7#1)
carcinoembryonic antigen##18##2##(1990-5#1)(1991-12#1)(1991-4#4)(1992-11#2)(1992-2#1)(1992-6#1)(1993-8#1)(1994-7#1)(2008-10#2)(2008-11#3)(2008-7#1)
carcinoembryonic##19##1##(1990-5#1)(1991-12#1)(1991-4#4)(1992-11#2)(1992-2#1)(1992-6#2)(1993-8#1)(1994-7#1)(2008-10#2)(2008-11#3)(2008-7#1)
carcinogen in##3##2##(1990-6#1)(1990-8#1)(1993-11#1)
carcinogen##28##1##(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#4)(1993-8#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
carcinogen-DNA adducts##2##2##(1991-9#1)(1992-11#1)
carcinogenesis and the##2##3##(2008-7#1)(2013-8#1)
carcinogenesis and##10##2##(1995-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#2)(2011-1#1)(2013-8#1)
carcinogenesis are##2##2##(1996-6#1)(2008-7#1)
carcinogenesis by comparing##2##3##(2008-7#1)(2013-8#1)
carcinogenesis by##4##2##(1992-10#1)(2008-7#1)(2009-3#1)(2013-8#1)
carcinogenesis in the rat kidney##2##5##(1994-5#2)
carcinogenesis in the##3##3##(1992-5#1)(1994-5#2)
carcinogenesis in vivo##2##3##(1990-11#1)(1994-5#1)
carcinogenesis in##16##2##(1990-11#1)(1991-12#1)(1992-5#2)(1992-9#3)(1993-9#1)(1994-5#3)(2007-4#1)(2008-2#1)(2012-1#2)(2013-8#1)
carcinogenesis induced by##3##3##(1992-5#1)(2008-7#1)(2012-3#1)
carcinogenesis induced##4##2##(1992-5#1)(2008-7#1)(2012-1#1)(2012-3#1)
carcinogenesis is a##2##3##(1993-8#1)(2008-12#1)
carcinogenesis is##4##2##(1993-11#1)(1993-8#1)(2008-12#1)(2008-2#1)
carcinogenesis model##3##2##(1992-9#1)(2011-1#2)
carcinogenesis of##2##2##(2008-11#1)(2013-7#1)
carcinogenesis were##2##2##(1992-9#1)(1994-5#1)
carcinogenesis##108##1##(1990-11#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#5)(1992-8#1)(1992-9#5)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#5)(1994-5#4)(1994-6#3)(1995-11#1)(1995-2#2)(1995-6#1)(1995-9#7)(1996-6#1)(2007-10#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
carcinogenic activity of##6##3##(1994-5#1)(2008-8#1)(2008-9#4)
carcinogenic activity##7##2##(1992-2#1)(1994-5#1)(2008-8#1)(2008-9#4)
carcinogenic effect##4##2##(1992-5#1)(1995-11#1)(2008-10#1)(2008-8#1)
carcinogenic potential of##2##3##(1990-7#1)(2008-10#1)
carcinogenic potential##3##2##(1990-7#1)(1991-12#1)(2008-10#1)
carcinogenic##57##1##(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#6)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#2)(1994-2#3)(1994-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-7#5)(2008-8#2)(2008-9#6)(2009-6#1)(2011-1#1)(2013-1#3)(2013-8#1)
carcinogenicity of##10##2##(1990-8#1)(1991-12#5)(1991-6#1)(1992-9#1)(1993-8#1)(1994-2#1)
carcinogenicity##28##1##(1990-8#1)(1991-12#5)(1991-6#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-6#4)(2008-10#2)(2008-8#2)(2008-9#9)(2010-5#1)
carcinogens and##3##2##(1991-11#1)(1995-6#1)(2009-8#1)
carcinogens in the##3##3##(1995-9#1)(2008-4#1)(2008-7#1)
carcinogens in##6##2##(1992-8#1)(1995-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
carcinogens##42##1##(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-9#1)(1995-2#1)(1995-6#3)(1995-9#2)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#2)(2012-1#1)(2013-1#3)
carcinoid and##3##2##(1992-11#1)(2008-8#1)(2013-8#1)
carcinoid in a##2##3##(2010-2#1)(2013-1#1)
carcinoid of##2##2##(1992-5#1)(2011-2#1)
carcinoid suggests##2##2##(2011-2#1)(2013-1#1)
carcinoid syndrome##4##2##(1991-8#1)(1997-1#1)(2013-1#2)
carcinoid tumor##4##2##(1990-2#2)(1994-8#1)(2012-3#1)
carcinoid tumors##4##2##(1990-10#1)(2010-9#2)(2012-3#1)
carcinoid tumour of the##2##4##(2011-2#1)(2012-2#1)
carcinoid tumours##6##2##(1990-9#1)(1992-11#4)(2009-11#1)
carcinoid was##2##2##(2008-4#1)(2010-2#1)
carcinoid##52##1##(1990-10#2)(1990-2#3)(1990-5#1)(1990-9#1)(1991-8#1)(1992-11#6)(1992-5#1)(1994-8#2)(1997-1#1)(2008-4#3)(2008-8#3)(2009-11#1)(2009-5#1)(2010-2#3)(2010-9#2)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
carcinoids##10##1##(1991-6#1)(1993-9#2)(1997-8#1)(2011-2#2)(2013-1#4)
carcinoma (ACC) is##2##3##(1992-10#1)(2013-8#1)
carcinoma (ACC)##3##2##(1991-6#1)(1992-10#1)(2013-8#1)
carcinoma (EC) cell##3##3##(1993-9#1)(1997-2#1)(2013-1#1)
carcinoma (EC)##4##2##(1993-9#1)(1994-9#1)(1997-2#1)(2013-1#1)
carcinoma (HCC) is##5##3##(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
carcinoma (HCC) with##2##3##(1990-8#1)(2011-2#1)
carcinoma (HCC)##22##2##(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-12#2)(2011-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
carcinoma (NSCLC)##4##2##(1993-9#1)(2008-11#1)(2012-12#1)(2013-1#1)
carcinoma (TCC)##3##2##(2007-10#1)(2008-10#1)(2012-3#1)
carcinoma -##3##2##(2007-11#1)(2007-4#1)(2008-2#1)
carcinoma HeLa cells##2##3##(2008-11#2)
carcinoma and in##3##3##(1992-5#1)(1993-9#1)(1994-8#1)
carcinoma and melanoma##2##3##(1994-6#1)(2013-8#1)
carcinoma and one##2##3##(2008-4#1)(2011-2#1)
carcinoma and squamous cell carcinoma##3##5##(2008-4#1)(2010-8#2)
carcinoma and the##6##3##(1992-8#1)(1993-11#1)(1993-8#1)(2008-10#1)(2009-1#1)(2012-2#1)
carcinoma and##48##2##(1990-9#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#3)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
carcinoma are##9##2##(1990-6#1)(1990-8#1)(1993-8#1)(1993-9#1)(1995-12#1)(2007-10#1)(2007-8#1)(2010-11#1)(2010-7#1)
carcinoma arising from##5##3##(2008-10#3)(2010-7#1)(2012-1#1)
carcinoma arising##7##2##(2008-10#3)(2010-7#1)(2012-1#1)(2013-8#2)
carcinoma associated with##4##3##(2007-5#1)(2007-7#1)(2008-1#1)(2009-8#1)
carcinoma associated##5##2##(2007-5#1)(2007-7#1)(2008-1#1)(2009-8#1)(2013-1#1)
carcinoma breast##2##2##(2008-10#1)(2012-3#1)
carcinoma but##2##2##(1992-10#1)(1994-7#1)
carcinoma by##2##2##(2009-3#1)(2013-1#1)
carcinoma cases##3##2##(1990-12#1)(2008-1#1)(2011-2#1)
carcinoma cell line and##3##4##(2008-11#1)(2008-4#2)
carcinoma cell line##26##3##(1992-2#2)(1992-3#2)(1992-8#2)(1992-9#2)(1993-3#2)(1993-9#2)(1994-8#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#1)(2010-11#1)(2012-1#2)(2012-2#1)
carcinoma cell lines##15##3##(1990-7#2)(1992-7#1)(1992-8#3)(1993-8#1)(1995-6#1)(1995-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
carcinoma cell##48##2##(1990-7#2)(1991-2#2)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#5)(1992-9#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-8#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#2)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
carcinoma cells and##2##3##(1993-8#1)(2008-11#1)
carcinoma cells by##3##3##(1992-6#1)(1993-8#1)(2013-7#1)
carcinoma cells exposed to##2##4##(1992-9#1)(1993-3#1)
carcinoma cells in vitro##3##4##(1993-9#1)(1994-8#1)(2008-4#1)
carcinoma cells in##4##3##(1993-8#1)(1993-9#1)(1994-8#1)(2008-4#1)
carcinoma cells through##2##3##(2008-4#1)(2011-2#1)
carcinoma cells##47##2##(1990-11#1)(1991-9#1)(1992-12#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-3#3)(1993-8#4)(1993-9#2)(1994-11#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-2#1)(2008-11#4)(2008-4#4)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
carcinoma compared to##2##3##(2008-9#1)(2012-12#1)
carcinoma following##2##2##(1990-12#1)(2007-7#1)
carcinoma from##5##2##(2010-7#3)(2012-12#1)(2013-7#1)
carcinoma had##2##2##(1992-5#1)(1992-8#1)
carcinoma has been##2##3##(1992-8#1)(2012-12#1)
carcinoma has##3##2##(1992-8#1)(2006-8#1)(2012-12#1)
carcinoma have##2##2##(1994-2#1)(2010-6#1)
carcinoma in 17##2##3##(1991-3#1)(1993-8#1)
carcinoma in a##15##3##(1990-6#2)(1991-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(2007-2#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-8#2)
carcinoma in an##2##3##(2011-2#1)(2013-8#1)
carcinoma in children##3##3##(2007-7#1)(2012-3#2)
carcinoma in situ##15##3##(1990-2#2)(1991-9#1)(1992-10#1)(1992-8#2)(1994-1#1)(1994-12#1)(1994-8#2)(1995-4#1)(1997-3#1)(2008-1#3)
carcinoma in the right upper lobe##2##6##(2007-8#1)(2012-1#1)
carcinoma in the##8##3##(1990-8#1)(1994-12#1)(1994-7#2)(1995-12#1)(2006-8#1)(2007-8#1)(2012-1#1)
carcinoma in young women##3##4##(1994-5#3)
carcinoma in##64##2##(1990-2#2)(1990-6#2)(1990-8#2)(1991-3#3)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-8#2)(1994-1#1)(1994-12#3)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#3)(1995-12#1)(1995-4#1)(1995-8#2)(1997-3#2)(1997-7#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-4#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-3#5)(2013-1#1)(2013-8#4)
carcinoma is a##5##3##(1997-5#1)(2007-7#2)(2008-3#1)(2009-10#1)
carcinoma is extremely rare##2##4##(1993-12#1)(2013-8#1)
carcinoma is the most common##2##5##(2009-2#1)(2013-1#1)
carcinoma is the##4##3##(2007-4#1)(2009-2#1)(2013-1#1)(2013-8#1)
carcinoma is##22##2##(1990-8#2)(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)(1997-5#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#2)(2013-8#4)
carcinoma observed##2##2##(1990-3#1)(1990-6#1)
carcinoma of prostate##2##3##(1995-8#1)(2011-2#1)
carcinoma of the bladder##8##4##(1991-11#1)(1992-12#2)(1997-4#1)(2007-10#1)(2011-2#1)(2013-1#2)
carcinoma of the breast##9##4##(1992-8#1)(1993-5#1)(1994-7#1)(1995-4#1)(2007-5#1)(2008-1#1)(2012-3#2)(2013-8#1)
carcinoma of the cervix##9##4##(1990-8#3)(1991-3#1)(1994-3#2)(1996-12#1)(2012-3#1)(2013-7#1)
carcinoma of the colon##3##4##(1993-8#2)(1997-8#1)
carcinoma of the cystic duct##2##5##(1992-9#2)
carcinoma of the endometrium##3##4##(1993-9#1)(2011-2#2)
carcinoma of the esophagus##6##4##(1993-8#2)(2013-8#4)
carcinoma of the gallbladder##8##4##(1991-12#2)(2009-3#4)(2010-12#1)(2012-3#1)
carcinoma of the head and neck##5##6##(1990-6#2)(1993-8#1)(2007-10#1)(2007-11#1)
carcinoma of the head##6##4##(1990-6#2)(1990-9#1)(1993-8#1)(2007-10#1)(2007-11#1)
carcinoma of the larynx##2##4##(1993-6#1)(1993-8#1)
carcinoma of the liver##3##4##(1992-2#2)(2009-8#1)
carcinoma of the lung##5##4##(1990-8#1)(1991-6#1)(1992-12#1)(1995-9#1)(2008-1#1)
carcinoma of the lung]##2##4##(1997-5#1)(2008-1#1)
carcinoma of the ovary##2##4##(1995-12#1)(1997-8#1)
carcinoma of the pancreas##3##4##(1990-9#2)(1991-3#1)
carcinoma of the parotid gland##3##5##(1991-6#2)(2007-5#1)
carcinoma of the penis##2##4##(2009-5#2)
carcinoma of the prostate##4##4##(1993-8#1)(1994-11#1)(1995-8#2)
carcinoma of the skin##4##4##(1993-3#1)(2010-3#2)(2011-2#1)
carcinoma of the urinary##2##4##(1992-12#1)(2012-2#1)
carcinoma of the vulva##3##4##(1992-3#3)
carcinoma of the##124##3##(1990-3#1)(1990-6#3)(1990-8#4)(1990-9#4)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#6)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-5#3)(2007-7#1)(2008-1#6)(2008-10#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-3#4)(2009-5#5)(2009-8#1)(2010-12#1)(2010-3#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#5)
carcinoma of##141##2##(1990-3#1)(1990-6#3)(1990-8#4)(1990-9#4)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#7)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-5#5)(2007-7#2)(2008-1#7)(2008-10#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-3#4)(2009-5#5)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#5)
carcinoma on##2##2##(2009-6#1)(2012-3#1)
carcinoma or##6##2##(2007-12#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-3#1)
carcinoma patients and##3##3##(1990-2#1)(1997-4#1)(2011-2#1)
carcinoma patients##12##2##(1990-2#1)(1991-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#4)
carcinoma represents##2##2##(2008-1#1)(2009-1#1)
carcinoma stage##3##2##(1990-10#1)(1997-5#2)
carcinoma that##2##2##(1990-12#1)(2008-9#1)
carcinoma the##2##2##(1993-11#1)(1993-8#1)
carcinoma tissue##3##2##(1992-3#1)(1993-1#1)(2008-9#1)
carcinoma to the##2##3##(1992-3#1)(2007-4#1)
carcinoma to##7##2##(1990-6#1)(1990-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(2007-4#1)(2011-2#1)
carcinoma was diagnosed##2##3##(2011-2#1)(2012-1#1)
carcinoma was found in##2##4##(1990-11#1)(2008-9#1)
carcinoma was found##4##3##(1990-11#1)(1990-6#1)(1990-8#1)(2008-9#1)
carcinoma was##19##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-7#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
carcinoma were treated with##2##4##(1990-8#1)(1992-10#1)
carcinoma were treated##5##3##(1990-10#1)(1990-8#1)(1991-6#1)(1992-10#1)(2013-1#1)
carcinoma were##12##2##(1990-10#2)(1990-8#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-9#1)(2013-1#1)
carcinoma who##2##2##(1990-2#1)(1992-10#1)
carcinoma with extensive osseous metaplasia##2##5##(1992-2#2)
carcinoma with##17##2##(1992-2#2)(1993-12#1)(1993-2#1)(1994-12#1)(2007-5#2)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
carcinoma##995##1##(1990-10#6)(1990-11#6)(1990-12#11)(1990-2#9)(1990-3#6)(1990-5#1)(1990-6#16)(1990-7#2)(1990-8#17)(1990-9#7)(1991-11#4)(1991-12#3)(1991-2#10)(1991-3#7)(1991-4#4)(1991-6#14)(1991-8#13)(1991-9#4)(1992-10#6)(1992-12#9)(1992-2#11)(1992-3#15)(1992-5#3)(1992-6#8)(1992-7#1)(1992-8#23)(1992-9#14)(1993-1#1)(1993-11#2)(1993-12#16)(1993-2#5)(1993-3#7)(1993-5#1)(1993-6#2)(1993-8#26)(1993-9#22)(1994-1#2)(1994-11#3)(1994-12#20)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#2)(1994-7#7)(1994-8#12)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#6)(1995-4#5)(1995-5#1)(1995-6#1)(1995-8#6)(1995-9#3)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#11)(1997-4#3)(1997-5#6)(1997-6#1)(1997-7#3)(1997-8#8)(2006-10#2)(2006-8#4)(2007-10#10)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#10)(2007-5#14)(2007-6#1)(2007-7#17)(2007-8#8)(2008-1#32)(2008-10#26)(2008-11#22)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#18)(2008-5#7)(2008-7#3)(2008-8#16)(2008-9#18)(2009-1#5)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#8)(2009-4#1)(2009-5#10)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-11#4)(2010-12#12)(2010-3#5)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#14)(2010-9#1)(2011-1#4)(2011-2#52)(2012-1#14)(2012-12#10)(2012-2#12)(2012-3#27)(2013-1#53)(2013-7#9)(2013-8#40)
carcinoma&quot##2##1##(1990-8#1)(2007-5#1)
carcinoma)##12##1##(1990-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(2008-5#3)(2013-1#1)
carcinoma-associated##2##1##(1990-8#1)(1994-2#1)
carcinoma?##5##1##(1990-8#1)(2011-2#2)(2013-1#2)
carcinoma]##23##1##(1990-3#1)(1990-8#1)(1990-9#3)(1991-11#1)(1993-6#1)(1993-9#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
carcinomas and##17##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1997-3#1)(2008-11#1)(2011-2#5)(2012-3#1)(2013-8#1)
carcinomas are##6##2##(2008-1#1)(2009-5#1)(2011-2#3)(2012-3#1)
carcinomas by##3##2##(1992-2#1)(2008-12#1)(2011-2#1)
carcinomas commonly##2##2##(1994-12#1)(2008-5#1)
carcinomas from##2##2##(1994-11#1)(1994-6#1)
carcinomas has##2##2##(1997-3#1)(2007-10#1)
carcinomas in##7##2##(1990-11#1)(1994-12#2)(1996-10#1)(1997-3#1)(2008-9#1)(2011-2#1)
carcinomas is##2##2##(1993-3#1)(2013-7#1)
carcinomas may##4##2##(1990-6#1)(1994-11#1)(1995-2#1)(2009-12#1)
carcinomas of the lower lip##2##5##(1991-8#2)
carcinomas of the lung##2##4##(1991-2#1)(1997-2#1)
carcinomas of the##12##3##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1992-2#1)(1992-8#1)(1995-9#1)(1997-2#1)(2012-3#2)
carcinomas of##14##2##(1990-2#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1992-2#2)(1992-8#1)(1995-9#1)(1997-2#1)(2012-3#2)
carcinomas that##2##2##(1990-12#1)(2011-2#1)
carcinomas was##3##2##(1992-8#1)(1997-7#1)(2012-3#1)
carcinomas were##7##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-8#1)(1994-9#1)(2011-2#1)(2013-8#1)
carcinomas with##6##2##(1991-4#1)(2007-5#1)(2010-8#1)(2011-2#3)
carcinomas##172##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#3)(1991-6#1)(1991-8#3)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#7)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#7)(1994-11#2)(1994-12#6)(1994-2#2)(1994-6#5)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1997-2#1)(1997-3#4)(1997-7#3)(1997-8#5)(2006-8#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-7#1)(2010-8#3)(2011-2#27)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#7)(2013-1#2)(2013-7#4)(2013-8#4)
carcinomas)##4##1##(1991-6#1)(1992-2#1)(1997-8#1)(2012-3#1)
carcinomatosis in##2##2##(1991-2#1)(2012-3#1)
carcinomatosis##3##1##(1991-2#2)(2012-3#1)
carcinomatous and sarcomatous components##2##4##(1991-4#1)(2012-1#1)
carcinomatous component##2##2##(2009-3#1)(2011-2#1)
carcinomatous##8##1##(1990-11#1)(1991-4#1)(1991-6#1)(2009-3#1)(2011-2#2)(2012-1#2)
carcinosarcoma of the##2##3##(2010-8#1)(2012-1#1)
carcinosarcoma##9##1##(2007-8#1)(2008-11#1)(2010-8#4)(2012-1#3)
carcinosarcomas##2##1##(2011-2#2)
card access##2##2##(1997-2#2)
card is##3##2##(1994-2#2)(2008-2#1)
card to##2##2##(1995-8#1)(2007-11#1)
card##29##1##(1992-2#1)(1992-3#1)(1993-10#1)(1994-2#2)(1995-8#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#4)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2010-12#1)(2012-2#1)(2013-1#1)
cardia##3##1##(1993-6#1)(2009-3#2)
cardiac CT##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
cardiac KATP##2##2##(1995-5#2)
cardiac L-type##3##2##(1994-6#2)(1994-9#1)
cardiac MDCT##2##2##(2008-7#1)(2011-2#1)
cardiac MRI##3##2##(2008-3#1)(2012-12#1)(2012-2#1)
cardiac QT(c) interval##4##3##(2007-11#4)
cardiac abnormalities##3##2##(1990-11#1)(2010-8#1)(2012-3#1)
cardiac activity##2##2##(2008-10#1)(2011-1#1)
cardiac amyloidosis##7##2##(1992-8#2)(2010-8#4)(2011-2#1)
cardiac anaesthesia##4##2##(2007-9#4)
cardiac and cerebrovascular##2##3##(1990-5#1)(2008-11#1)
cardiac and hepatic##2##3##(2008-10#1)(2013-8#1)
cardiac and skeletal##3##3##(1995-2#3)
cardiac and##23##2##(1990-5#1)(1992-11#1)(1992-6#1)(1995-2#4)(2006-10#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-6#1)(2009-5#1)(2010-1#1)(2010-12#2)(2012-2#1)(2013-8#1)
cardiac anomalies##5##2##(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-8#1)
cardiac applications##2##2##(1992-3#1)(2010-8#1)
cardiac arrest after##2##3##(1995-3#2)
cardiac arrest and##3##3##(1990-12#1)(1990-9#1)(2010-8#1)
cardiac arrest in##3##3##(1990-9#1)(1995-3#1)(2007-8#1)
cardiac arrest##33##2##(1990-12#3)(1990-9#4)(1994-6#2)(1995-3#5)(1996-11#1)(1997-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
cardiac arrhythmia##5##2##(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
cardiac arrhythmias##13##2##(1990-9#1)(1991-11#1)(1992-5#1)(1995-11#1)(2006-10#1)(2008-8#2)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
cardiac assistance##2##2##(2007-8#1)(2012-3#1)
cardiac care##3##2##(2008-3#2)(2013-7#1)
cardiac catheter##2##2##(2008-5#1)(2011-2#1)
cardiac catheterization##11##2##(1992-1#1)(1994-3#1)(1995-12#1)(2007-8#1)(2008-3#2)(2010-10#1)(2010-8#1)(2011-2#3)
cardiac causes and##2##3##(1997-2#1)(2010-8#1)
cardiac causes##3##2##(1991-11#1)(1997-2#1)(2010-8#1)
cardiac cavities##2##2##(1993-2#1)(1993-3#1)
cardiac cell##5##2##(1991-9#1)(1997-6#2)(2008-10#1)(2008-7#1)
cardiac cells##7##2##(1996-2#2)(2008-7#4)(2008-8#1)
cardiac center##2##2##(1994-12#1)(2010-6#1)
cardiac complications##5##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)
cardiac computed tomography (CT)##2##4##(2008-12#1)(2012-2#1)
cardiac computed tomography angiography##2##4##(2008-12#2)
cardiac computed tomography##8##3##(2008-12#4)(2009-4#1)(2012-2#2)(2013-2#1)
cardiac conduction##2##2##(1997-3#1)(2008-3#1)
cardiac contractility##5##2##(1996-3#1)(2008-9#2)(2010-4#1)(2010-8#1)
cardiac cost##2##2##(2008-6#2)
cardiac cycle##2##2##(2008-10#1)(2011-2#1)
cardiac damage##2##2##(2010-7#1)(2011-2#1)
cardiac data##2##2##(1993-12#1)(1997-7#1)
cardiac death (SCD)##2##3##(2009-9#1)(2012-3#1)
cardiac death in young athletes##3##5##(2012-3#3)
cardiac death in young##4##4##(2008-12#1)(2012-3#3)
cardiac death in##5##3##(2007-2#1)(2008-12#1)(2012-3#3)
cardiac death is##3##3##(1992-6#1)(2011-2#2)
cardiac death##25##2##(1992-6#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-10#1)(2009-5#2)(2009-9#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-3#4)(2013-8#1)
cardiac deaths##3##2##(2007-8#1)(2008-3#2)
cardiac defect##3##2##(2010-10#2)(2012-2#1)
cardiac defects##6##2##(1997-3#1)(2009-12#1)(2010-10#2)(2010-11#2)
cardiac defibrillators##3##2##(2010-8#2)(2013-8#1)
cardiac development##6##2##(1997-6#5)(2009-10#1)
cardiac differentiation##2##2##(1994-11#2)
cardiac disease##11##2##(1996-9#1)(2007-10#1)(2007-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
cardiac diseases##4##2##(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
cardiac disorders##2##2##(2008-7#1)(2010-8#1)
cardiac dysfunction in##2##3##(2010-8#1)(2011-2#1)
cardiac dysfunction##8##2##(2008-12#1)(2008-3#1)(2010-3#1)(2010-8#1)(2011-2#4)
cardiac echinococcosis##2##2##(1993-6#1)(2007-8#1)
cardiac electrophysiology##7##2##(1992-3#1)(2008-12#3)(2009-10#1)(2009-5#1)(2013-1#1)
cardiac enzymes##4##2##(2008-12#4)
cardiac evaluation##3##2##(2008-7#1)(2010-11#1)(2012-3#1)
cardiac event##2##2##(1990-5#1)(2008-3#1)
cardiac events##14##2##(1994-11#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2010-12#2)(2011-2#1)(2012-2#1)
cardiac failure in##2##3##(2008-11#1)(2011-2#1)
cardiac failure on##2##3##(2008-10#1)(2013-1#1)
cardiac failure##15##2##(1996-3#1)(1996-6#2)(1996-9#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#3)(2013-1#1)
cardiac fibroblasts##3##2##(1994-11#3)
cardiac function and survival##2##4##(2011-2#2)
cardiac function and##5##3##(2010-8#1)(2011-2#3)(2012-12#1)
cardiac function in patients with##2##5##(2011-2#1)(2012-3#1)
cardiac function in the##2##4##(2008-7#1)(2012-3#1)
cardiac function in##6##3##(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#2)
cardiac function##26##2##(1991-2#1)(1991-9#1)(1992-6#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-7#3)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
cardiac glycosides##2##2##(2008-12#1)(2013-7#1)
cardiac growth##2##2##(2010-8#2)
cardiac health##5##2##(2008-11#1)(2009-7#3)(2010-8#1)
cardiac hemodynamics##4##2##(1991-5#1)(1991-6#1)(2007-10#1)(2007-8#1)
cardiac herniation after excision of pericardial##2##6##(2007-8#2)
cardiac herniation##3##2##(2007-8#3)
cardiac hormone##2##2##(1990-12#1)(1990-3#1)
cardiac hypertrophy and##2##3##(2010-12#1)(2010-6#1)
cardiac hypertrophy in##2##3##(2008-12#1)(2011-2#1)
cardiac hypertrophy that##2##3##(2011-2#1)(2012-12#1)
cardiac hypertrophy##24##2##(1994-12#1)(2008-12#2)(2008-7#1)(2010-12#10)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-12#2)
cardiac hystiocyte##3##2##(2011-1#2)(2012-3#1)
cardiac hystiocytes##2##2##(2011-1#2)
cardiac imaging and##2##3##(2008-12#1)(2012-2#1)
cardiac imaging##14##2##(1992-12#2)(2008-12#1)(2009-4#4)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
cardiac index (CI)##2##3##(1993-10#1)(2009-8#1)
cardiac index##12##2##(1991-3#3)(1991-6#1)(1993-10#1)(1993-2#2)(2007-8#1)(2008-5#1)(2009-8#1)(2012-2#2)
cardiac injuries##8##2##(2007-8#2)(2008-1#6)
cardiac ino- and chronotropic functions##2##5##(2013-1#2)
cardiac insufficiency##2##2##(1991-6#2)
cardiac involvement in##2##3##(2008-10#1)(2008-8#1)
cardiac involvement##5##2##(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
cardiac ion##3##2##(2013-1#3)
cardiac length and##2##3##(1993-12#2)
cardiac lesions##4##2##(1997-3#1)(2008-7#2)(2011-2#1)
cardiac magnetic resonance imaging (MRI)##2##5##(2008-3#1)(2012-2#1)
cardiac magnetic resonance imaging##6##4##(2008-3#2)(2012-2#1)(2013-3#2)(2013-7#1)
cardiac magnetic resonance##7##3##(2008-3#3)(2012-2#1)(2013-3#2)(2013-7#1)
cardiac malformations##3##2##(1992-2#1)(2010-11#1)(2012-2#1)
cardiac manifestation of##2##3##(1997-5#1)(2010-5#1)
cardiac manifestation##3##2##(1997-5#1)(2010-5#1)(2013-8#1)
cardiac markers##2##2##(2008-10#2)
cardiac mitochondrial##2##2##(2008-1#2)
cardiac monitoring##2##2##(2008-7#1)(2010-8#1)
cardiac muscle cells and##2##4##(1994-11#1)(2008-7#1)
cardiac muscle cells##3##3##(1994-11#1)(2008-10#1)(2008-7#1)
cardiac muscle##21##2##(1991-12#1)(1991-5#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1997-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-7#2)(2011-1#3)(2012-12#1)(2012-3#1)(2013-7#1)
cardiac muscles##3##2##(2010-4#1)(2012-3#2)
cardiac myocyte##2##2##(1994-11#1)(2008-10#1)
cardiac myocytes in culture##2##4##(2008-3#1)(2008-7#1)
cardiac myocytes in##3##3##(1993-3#1)(2008-3#1)(2008-7#1)
cardiac myocytes through##2##3##(1995-11#2)
cardiac myocytes with##2##3##(1993-3#1)(2008-11#1)
cardiac myocytes##21##2##(1992-3#1)(1993-3#6)(1994-11#2)(1995-11#2)(1996-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)
cardiac myosin##2##2##(1992-3#1)(1996-8#1)
cardiac myxoma##3##2##(2008-11#1)(2009-7#2)
cardiac nerve activity##2##3##(1995-12#2)
cardiac operations##3##2##(2007-8#2)(2007-9#1)
cardiac or pulmonary##2##3##(1990-2#1)(2011-2#1)
cardiac or##4##2##(1990-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
cardiac output and cardiac index were##2##6##(1991-6#1)(2012-2#1)
cardiac output and cardiac index##3##5##(1991-6#1)(2012-2#2)
cardiac output and##10##3##(1991-5#1)(1991-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#2)(2012-3#3)
cardiac output##31##2##(1991-3#2)(1991-5#2)(1991-6#1)(1995-12#1)(1996-9#1)(2007-10#2)(2007-8#2)(2008-12#3)(2008-3#1)(2008-7#2)(2010-10#1)(2010-3#1)(2010-8#3)(2011-1#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)
cardiac parameters##2##2##(2008-7#1)(2012-1#1)
cardiac patients##5##2##(1990-2#1)(2007-9#2)(2008-10#1)(2009-5#1)
cardiac performance##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
cardiac procedures##3##2##(1995-12#1)(1995-8#1)(2011-2#1)
cardiac puncture##2##2##(1990-12#1)(2008-4#1)
cardiac radiofrequency##2##2##(2008-5#1)(2010-6#1)
cardiac referred pain##2##3##(2008-9#2)
cardiac rehabilitation (CR)##2##3##(2007-11#1)(2013-1#1)
cardiac rehabilitation##9##2##(2007-11#3)(2008-11#2)(2008-3#2)(2011-2#1)(2013-1#1)
cardiac remodeling and##2##3##(2012-12#1)(2013-8#1)
cardiac remodelling in##2##3##(2008-7#1)(2012-3#1)
cardiac remodelling##3##2##(2008-7#1)(2012-3#2)
cardiac repair##5##2##(2007-8#2)(2007-9#1)(2012-12#2)
cardiac resynchronisation##2##2##(2008-10#1)(2012-2#1)
cardiac resynchronization therapy##5##3##(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
cardiac rhythm##7##2##(1996-2#1)(2006-10#1)(2011-1#5)
cardiac risk##5##2##(2007-8#1)(2009-3#2)(2010-9#1)(2012-2#1)
cardiac sarcoplasmic reticulum##2##3##(1990-2#2)
cardiac sodium channel##3##3##(1994-12#2)(2008-12#1)
cardiac stimulation##3##2##(1992-5#3)
cardiac structure##2##2##(2007-8#1)(2011-2#1)
cardiac structures##3##2##(2007-8#2)(2010-8#1)
cardiac surgeons##2##2##(2011-2#1)(2012-12#1)
cardiac surgery and##3##3##(2007-8#3)
cardiac surgery associated with##2##4##(2011-2#1)(2012-2#1)
cardiac surgery in##6##3##(2007-8#2)(2010-8#1)(2012-1#1)(2012-2#2)
cardiac surgery is##2##3##(2006-10#1)(2007-8#1)
cardiac surgery was##12##3##(2007-8#12)
cardiac surgery##83##2##(1991-11#1)(1991-3#1)(1997-8#1)(2006-10#6)(2007-8#33)(2007-9#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#5)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)
cardiac surgery?##3##2##(2007-8#3)
cardiac surgery]##2##2##(2012-3#2)
cardiac surgical patients##10##3##(2006-10#1)(2007-8#2)(2007-9#2)(2008-12#3)(2010-8#1)(2011-2#1)
cardiac surgical##13##2##(1997-8#1)(2006-10#2)(2007-8#2)(2007-9#2)(2008-10#1)(2008-12#3)(2010-8#1)(2011-2#1)
cardiac sympathetic nerve##5##3##(2008-9#4)(2012-2#1)
cardiac sympathetic##7##2##(2008-9#4)(2012-2#3)
cardiac syndrome X##3##3##(2008-12#2)(2011-2#1)
cardiac syndrome##4##2##(2008-12#2)(2011-2#2)
cardiac tamponade in##2##3##(1996-6#1)(2010-5#1)
cardiac tamponade##10##2##(1996-6#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-11#1)(2010-5#2)(2013-1#1)
cardiac tissue##4##2##(2007-8#1)(2008-10#1)(2008-8#1)(2010-6#1)
cardiac toxicity##5##2##(1990-10#1)(1991-1#1)(1991-8#1)(1993-6#1)(2008-10#1)
cardiac transplantation##4##2##(2007-8#3)(2010-8#1)
cardiac troponin I (cTnI)##4##4##(2008-10#2)(2010-12#1)(2011-2#1)
cardiac troponin I##9##3##(2008-10#4)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#1)
cardiac troponin T##4##3##(1991-12#2)(1996-8#1)(2007-8#1)
cardiac troponin##16##2##(1991-12#4)(1996-8#1)(2007-8#1)(2008-10#4)(2008-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#1)
cardiac tumors##2##2##(2007-8#1)(2013-1#1)
cardiac vagal##2##2##(1991-10#1)(2013-7#1)
cardiac valve##7##2##(1994-3#2)(2007-8#2)(2010-8#3)
cardiac##937##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#5)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#7)(1991-5#7)(1991-6#7)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#7)(1992-4#2)(1992-5#6)(1992-6#5)(1992-8#2)(1993-10#1)(1993-12#5)(1993-2#4)(1993-3#7)(1993-6#3)(1993-8#1)(1994-11#11)(1994-12#4)(1994-3#3)(1994-5#3)(1994-6#6)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#5)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#6)(1996-3#2)(1996-6#4)(1996-8#2)(1996-9#5)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#5)(2006-10#11)(2007-10#8)(2007-11#10)(2007-12#6)(2007-2#1)(2007-7#3)(2007-8#87)(2007-9#17)(2008-1#11)(2008-10#32)(2008-11#23)(2008-12#33)(2008-3#27)(2008-4#4)(2008-5#10)(2008-6#6)(2008-7#37)(2008-8#15)(2008-9#15)(2009-1#1)(2009-10#4)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#8)(2009-7#5)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#10)(2010-12#18)(2010-3#3)(2010-4#7)(2010-5#5)(2010-6#18)(2010-7#5)(2010-8#47)(2010-9#1)(2011-1#15)(2011-2#70)(2011-3#1)(2012-1#4)(2012-12#15)(2012-2#30)(2012-3#30)(2013-1#24)(2013-2#3)(2013-3#2)(2013-7#12)(2013-8#10)
cardiac-specific##6##1##(1994-11#2)(1995-2#1)(1995-6#1)(2011-2#1)(2012-12#1)
cardinal signs##2##2##(2009-4#1)(2012-2#1)
cardinal##18##1##(1994-8#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
cardio##2##1##(2007-8#1)(2011-1#1)
cardio-##3##1##(2011-1#1)(2013-1#2)
cardio-pulmonary##3##1##(1990-2#1)(1990-9#1)(2007-9#1)
cardio-thoracic surgeons##2##2##(2007-8#2)
cardio-thoracic##5##1##(2007-8#5)
cardio-vascular disease##2##2##(2008-3#1)(2010-2#1)
cardio-vascular system##2##2##(2011-1#1)(2013-1#1)
cardio-vascular##8##1##(2008-3#1)(2008-8#1)(2010-2#2)(2011-1#2)(2013-1#1)(2013-7#1)
cardiocyte##2##1##(1996-9#1)(2011-3#1)
cardiocytes impaired by##3##3##(2011-3#3)
cardiocytes##4##1##(2011-3#4)
cardiodepressant##2##1##(2008-7#1)(2009-2#1)
cardioembolic stroke##6##2##(2007-10#6)
cardioembolic strokes##2##2##(2007-10#2)
cardioembolic##8##1##(2007-10#8)
cardioembolism##2##1##(2007-10#1)(2012-12#1)
cardiogenesis##3##1##(2008-11#1)(2008-9#2)
cardiogenic embolism##2##2##(1991-11#1)(2007-10#1)
cardiogenic shock##13##2##(1990-9#1)(1993-12#1)(1996-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-5#1)(2012-1#1)(2013-8#2)
cardiogenic##18##1##(1990-3#1)(1990-9#1)(1991-11#1)(1993-12#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#2)
cardiogram##3##1##(2010-8#2)(2012-12#1)
cardiolipin##6##1##(1990-6#1)(1991-5#3)(1994-12#1)(2008-9#1)
cardiological evaluation##2##2##(2012-3#2)
cardiological##8##1##(1992-5#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#3)
cardiologist##5##1##(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
cardiologists and##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
cardiologists##15##1##(1993-12#1)(2007-4#1)(2008-11#2)(2008-3#4)(2008-5#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-7#1)
cardiology and##2##2##(1991-6#1)(2009-9#1)
cardiology in##2##2##(2006-10#1)(2008-12#1)
cardiology##27##1##(1991-2#1)(1991-6#1)(1994-2#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#2)
cardiology]##3##1##(1991-2#2)(1992-5#1)
cardiometabolic diseases##5##2##(2011-1#5)
cardiometabolic syndrome##2##2##(2011-2#2)
cardiometabolic variables##2##2##(2012-12#2)
cardiometabolic##14##1##(2010-5#2)(2011-1#6)(2011-2#3)(2012-12#2)(2013-1#1)
cardiomyocyte cell##2##2##(1997-6#1)(2013-7#1)
cardiomyocyte development##2##2##(2008-11#2)
cardiomyocyte##12##1##(1996-2#1)(1997-6#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2013-7#1)
cardiomyocytes and##4##2##(1997-6#1)(2008-11#1)(2010-6#1)(2012-2#1)
cardiomyocytes apoptosis##5##2##(2010-12#5)
cardiomyocytes from##2##2##(2008-11#2)
cardiomyocytes in the##2##3##(1992-9#1)(2012-12#1)
cardiomyocytes in##4##2##(1992-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
cardiomyocytes using##2##2##(1994-3#1)(2011-1#1)
cardiomyocytes##52##1##(1992-9#1)(1994-11#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-11#1)(1996-2#3)(1996-9#1)(1997-6#1)(2008-11#5)(2008-3#1)(2008-7#7)(2008-9#3)(2009-2#2)(2009-3#1)(2010-12#10)(2010-6#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
cardiomyopathic##4##1##(1995-12#2)(1996-8#1)(2013-7#1)
cardiomyopathies##7##1##(1994-3#1)(1995-12#2)(2008-10#1)(2009-10#1)(2009-3#1)(2009-5#1)
cardiomyopathy (DCM)##2##2##(2011-2#1)(2013-7#1)
cardiomyopathy and##13##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
cardiomyopathy have##2##2##(1993-2#1)(1994-12#1)
cardiomyopathy in##9##2##(1990-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-4#1)(2011-2#1)(2013-8#1)
cardiomyopathy is a##2##3##(2013-1#1)(2013-8#1)
cardiomyopathy is an##2##3##(2008-7#1)(2011-2#1)
cardiomyopathy is##9##2##(1992-9#1)(2008-7#5)(2011-2#1)(2013-1#1)(2013-8#1)
cardiomyopathy was##3##2##(2008-7#1)(2010-12#1)(2013-8#1)
cardiomyopathy with##4##2##(1991-5#1)(2008-7#1)(2010-6#1)(2013-8#1)
cardiomyopathy##127##1##(1990-3#2)(1990-9#1)(1991-5#3)(1992-6#2)(1992-9#4)(1993-2#3)(1994-12#2)(1996-3#1)(1996-8#8)(1997-7#3)(1997-8#1)(2007-8#2)(2008-10#11)(2008-11#5)(2008-3#1)(2008-4#3)(2008-7#20)(2009-10#2)(2009-5#1)(2009-6#3)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-2#10)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#9)
cardiomyopathy)##4##1##(2008-10#1)(2008-8#1)(2011-2#2)
cardiomyopathy?##2##1##(2008-10#1)(2008-7#1)
cardiopathy##5##1##(1990-2#1)(1997-5#1)(2008-10#3)
cardioplegia and##2##2##(1996-9#1)(2007-8#1)
cardioplegia##19##1##(1991-3#4)(1996-9#7)(2007-8#4)(2007-9#3)(2008-10#1)
cardioplegic solution##4##2##(2007-9#4)
cardioplegic##5##1##(2007-9#4)(2008-7#1)
cardioprotection by##2##2##(2008-7#1)(2010-12#1)
cardioprotection of##2##2##(1996-9#1)(2010-12#1)
cardioprotection##12##1##(1990-2#2)(1996-9#2)(2008-7#2)(2010-12#2)(2010-6#1)(2012-3#1)(2013-7#1)(2013-8#1)
cardioprotective activity of##2##3##(1992-5#1)(2009-8#1)
cardioprotective activity##3##2##(1992-5#1)(1996-9#1)(2009-8#1)
cardioprotective effect of##2##3##(2007-8#1)(2008-7#1)
cardioprotective effect##4##2##(1994-9#1)(2007-8#1)(2008-7#1)(2012-3#1)
cardioprotective effects of##5##3##(1994-9#1)(2008-5#1)(2008-7#1)(2013-7#2)
cardioprotective effects##6##2##(1994-9#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#2)
cardioprotective##21##1##(1991-9#1)(1992-5#1)(1994-9#2)(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-3#1)(2010-8#1)(2012-3#3)(2013-1#1)(2013-7#2)
cardiopulmonary bypass (CPB)##11##3##(1995-12#1)(2007-8#6)(2007-9#1)(2008-10#1)(2012-2#1)(2013-8#1)
cardiopulmonary bypass and##5##3##(2006-10#1)(2007-8#2)(2013-1#2)
cardiopulmonary bypass continue to##2##4##(2006-10#2)
cardiopulmonary bypass for##4##3##(2007-8#2)(2008-7#1)(2011-2#1)
cardiopulmonary bypass in##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
cardiopulmonary bypass on##2##3##(2007-8#2)
cardiopulmonary bypass system##2##3##(2010-8#2)
cardiopulmonary bypass##71##2##(1990-3#1)(1995-12#1)(1996-9#1)(2006-10#8)(2007-8#32)(2007-9#6)(2008-10#3)(2008-5#1)(2008-7#2)(2010-12#1)(2010-8#4)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
cardiopulmonary bypass]##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
cardiopulmonary effects of##2##3##(2009-2#1)(2012-3#1)
cardiopulmonary effects##3##2##(1990-5#1)(2009-2#1)(2012-3#1)
cardiopulmonary exercise##2##2##(2006-10#1)(2013-1#1)
cardiopulmonary resuscitation##10##2##(1990-9#1)(1994-9#2)(1995-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
cardiopulmonary##102##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1996-9#2)(2006-10#9)(2007-8#33)(2007-9#6)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-8#8)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
cardioregulatory##4##1##(1991-5#2)(2008-5#2)
cardiorespiratory efficiency##3##2##(2012-2#3)
cardiorespiratory fitness and/or##2##3##(2008-3#2)
cardiorespiratory fitness##6##2##(2008-3#3)(2008-5#2)(2013-1#1)
cardiorespiratory morbidity##2##2##(2007-8#2)
cardiorespiratory physical##3##2##(1993-12#3)
cardiorespiratory##25##1##(1993-12#4)(1996-9#1)(1997-3#1)(2007-8#3)(2007-9#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-4#1)(2010-5#2)(2012-2#4)(2013-1#2)
cardiothoracic##6##1##(1993-12#1)(2007-8#2)(2008-7#1)(2012-2#1)(2013-1#1)
cardiotocography##2##1##(1992-5#1)(2013-1#1)
cardiotoxic##2##1##(1992-12#1)(2008-12#1)
cardiotoxicity by##2##2##(2008-7#1)(2013-1#1)
cardiotoxicity in##2##2##(1995-3#1)(2013-1#1)
cardiotoxicity##18##1##(1992-6#1)(1995-3#2)(2008-6#1)(2008-7#1)(2009-2#1)(2013-1#5)(2013-7#6)(2013-8#1)
cardiovascular (CV)##2##2##(2008-11#1)(2010-5#1)
cardiovascular and cerebrovascular disease##3##4##(2011-1#3)
cardiovascular and cerebrovascular##4##3##(2008-7#1)(2011-1#3)
cardiovascular and interventional radiology##2##4##(1993-3#2)
cardiovascular and metabolic##4##3##(1990-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
cardiovascular and other chronic diseases##2##5##(2010-4#1)(2012-1#1)
cardiovascular and other##4##3##(2008-10#1)(2010-4#1)(2010-6#1)(2012-1#1)
cardiovascular and renal##2##3##(1993-2#1)(2008-1#1)
cardiovascular and respiratory##2##3##(1991-10#1)(2012-2#1)
cardiovascular and##28##2##(1990-5#2)(1991-1#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-3#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#2)
cardiovascular anomalies##2##2##(2008-8#1)(2010-6#1)
cardiovascular autonomic neuropathy (CAN)##2##4##(1990-9#1)(2012-2#1)
cardiovascular autonomic neuropathy##3##3##(1990-9#1)(2012-2#2)
cardiovascular autonomic##4##2##(1990-9#2)(2012-2#2)
cardiovascular biomarkers##2##2##(2010-5#1)(2012-2#1)
cardiovascular collapse##2##2##(2011-1#1)(2012-3#1)
cardiovascular complications##10##2##(1990-12#1)(1991-6#1)(1993-2#2)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
cardiovascular conditions##4##2##(1993-12#1)(2007-7#1)(2010-6#1)(2011-1#1)
cardiovascular consequences##2##2##(2008-7#1)(2010-5#1)
cardiovascular death##2##2##(2008-1#1)(2009-10#1)
cardiovascular devices##2##2##(2010-6#2)
cardiovascular disease (CVD) and##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
cardiovascular disease (CVD) has##2##4##(2008-3#1)(2010-12#1)
cardiovascular disease (CVD) risk##2##4##(2012-12#1)(2013-1#1)
cardiovascular disease (CVD)##20##3##(2008-1#1)(2008-3#4)(2008-6#1)(2008-7#2)(2009-4#2)(2010-12#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#3)
cardiovascular disease and cerebrovascular##2##4##(2011-1#2)
cardiovascular disease and its##2##4##(2011-1#1)(2013-7#1)
cardiovascular disease and##16##3##(1992-9#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-9#1)(2010-7#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-7#1)
cardiovascular disease are##5##3##(1996-11#1)(2008-7#1)(2010-4#1)(2010-9#1)(2012-12#1)
cardiovascular disease have##2##3##(1990-9#1)(2013-8#1)
cardiovascular disease in women##2##4##(2010-6#1)(2012-12#1)
cardiovascular disease in##12##3##(1993-12#1)(1994-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
cardiovascular disease is##3##3##(2008-6#1)(2009-11#1)(2010-6#1)
cardiovascular disease risk factors##4##4##(1991-6#2)(2008-7#1)(2011-2#1)
cardiovascular disease risk##9##3##(1991-6#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
cardiovascular disease than##2##3##(2011-2#1)(2012-12#1)
cardiovascular disease was##3##3##(1993-12#1)(1994-5#1)(2008-7#1)
cardiovascular disease##181##2##(1990-9#1)(1991-6#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#6)(1994-11#1)(1994-5#1)(1996-11#1)(1996-6#3)(1997-8#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#10)(2008-10#3)(2008-11#2)(2008-3#26)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#11)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#8)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#14)(2011-2#6)(2012-12#8)(2012-2#7)(2012-3#1)(2013-1#8)(2013-3#1)(2013-7#2)(2013-8#6)
cardiovascular diseases (CVD)##2##3##(2009-9#1)(2011-2#1)
cardiovascular diseases and##8##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2011-1#2)(2013-8#1)
cardiovascular diseases are##5##3##(1991-6#1)(2008-10#2)(2009-4#1)(2010-9#1)
cardiovascular diseases in an##2##4##(2009-10#1)(2010-6#1)
cardiovascular diseases in the##3##4##(2008-11#1)(2008-7#1)(2013-7#1)
cardiovascular diseases in##12##3##(1991-6#2)(2008-11#2)(2008-7#2)(2009-10#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
cardiovascular diseases##74##2##(1990-2#2)(1990-6#1)(1991-11#1)(1991-6#3)(1993-11#2)(1993-6#1)(1994-11#1)(1995-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#2)(2009-4#2)(2009-9#2)(2010-10#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
cardiovascular disorders##8##2##(2008-3#1)(2008-7#1)(2009-2#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
cardiovascular drugs##2##2##(2008-11#1)(2010-6#1)
cardiovascular effects of cocaine and##2##5##(1991-1#1)(2010-11#1)
cardiovascular effects of##8##3##(1990-5#1)(1991-1#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
cardiovascular effects##13##2##(1990-5#2)(1991-1#1)(1995-11#1)(1995-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
cardiovascular epidemiology##2##2##(1992-6#1)(2008-3#1)
cardiovascular episodes##5##2##(2008-7#5)
cardiovascular event##2##2##(2008-4#1)(2013-8#1)
cardiovascular events and##5##3##(2008-3#2)(2008-7#1)(2012-2#1)(2013-8#1)
cardiovascular events in##2##3##(2009-11#1)(2012-3#1)
cardiovascular events##38##2##(1992-8#1)(2008-10#2)(2008-3#6)(2008-4#1)(2008-7#1)(2009-1#1)(2009-11#2)(2010-1#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#7)(2012-3#6)(2013-1#1)(2013-8#4)
cardiovascular function is##2##3##(2006-10#1)(2013-1#1)
cardiovascular function##7##2##(1992-3#1)(2006-10#1)(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
cardiovascular health##9##2##(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
cardiovascular illness##3##2##(1990-5#2)(2010-4#1)
cardiovascular imaging##5##2##(2007-12#1)(2007-8#1)(2009-10#1)(2009-4#2)
cardiovascular in##2##2##(2007-7#1)(2008-1#1)
cardiovascular magnetic resonance##3##3##(2008-10#1)(2009-10#1)(2010-8#1)
cardiovascular morbidity and mortality in##2##5##(2008-1#1)(2008-7#1)
cardiovascular morbidity and mortality##10##4##(1992-6#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-7#3)(2012-12#1)
cardiovascular morbidity and##11##3##(1992-6#1)(2007-12#1)(2008-1#4)(2008-11#1)(2008-7#3)(2012-12#1)
cardiovascular morbidity##12##2##(1992-6#1)(1993-11#1)(2007-12#1)(2008-1#4)(2008-11#1)(2008-7#3)(2012-12#1)
cardiovascular mortality and##2##3##(2011-1#1)(2013-8#1)
cardiovascular mortality in##2##3##(1994-5#1)(2008-1#1)
cardiovascular mortality##6##2##(1994-5#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
cardiovascular outcomes in##2##3##(2011-2#1)(2012-3#1)
cardiovascular outcomes##5##2##(2008-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
cardiovascular parameters##4##2##(2008-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
cardiovascular pharmacology##3##2##(2008-5#2)(2010-6#1)
cardiovascular prevention##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
cardiovascular problems##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
cardiovascular protective##5##2##(2008-3#3)(2011-2#1)(2012-3#1)
cardiovascular reactivity##6##2##(2012-2#6)
cardiovascular reflex tests and##2##4##(1994-3#2)
cardiovascular reflex tests##4##3##(1994-3#4)
cardiovascular regulation##2##2##(1997-6#1)(2011-2#1)
cardiovascular response during dental##2##4##(1990-5#2)
cardiovascular response##4##2##(1990-5#3)(1995-12#1)
cardiovascular responses to##6##3##(1991-12#2)(2009-9#2)(2012-1#2)
cardiovascular responses##7##2##(1991-12#2)(2008-7#1)(2009-9#2)(2012-1#2)
cardiovascular risk and##4##3##(2008-6#1)(2009-10#1)(2012-2#1)(2013-1#1)
cardiovascular risk factor##7##3##(1991-6#1)(1994-11#1)(1996-8#1)(2008-11#1)(2008-7#2)(2013-1#1)
cardiovascular risk factors among##2##4##(2008-3#1)(2013-8#1)
cardiovascular risk factors and##3##4##(2008-11#1)(2008-2#1)(2009-9#1)
cardiovascular risk factors are##2##4##(1994-11#1)(2008-9#1)
cardiovascular risk factors in##7##4##(2008-7#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-8#2)
cardiovascular risk factors such as##2##5##(2008-7#1)(2012-2#1)
cardiovascular risk factors##41##3##(1991-4#1)(1993-9#4)(1994-11#1)(1996-8#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-9#1)(2010-4#2)(2010-6#1)(2011-1#3)(2012-2#2)(2013-3#2)(2013-8#3)
cardiovascular risk in patients with##2##5##(2008-8#1)(2013-8#1)
cardiovascular risk in the##3##4##(2009-11#1)(2009-12#1)(2011-2#1)
cardiovascular risk in these patients##2##5##(2008-1#1)(2008-3#1)
cardiovascular risk in##9##3##(2008-1#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
cardiovascular risk profile##3##3##(2008-2#1)(2010-4#1)(2011-2#1)
cardiovascular risk stratification##2##3##(2009-1#1)(2011-2#1)
cardiovascular risk##109##2##(1990-2#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-9#4)(1994-11#2)(1994-6#1)(1996-8#2)(2007-12#1)(2008-1#5)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#9)(2008-5#1)(2008-6#3)(2008-7#12)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#4)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-3#3)(2013-8#6)
cardiovascular risks##3##2##(2008-10#1)(2011-1#2)
cardiovascular surgeon##2##2##(2010-8#2)
cardiovascular surgery##13##2##(1994-3#1)(2007-8#4)(2008-8#2)(2010-8#6)
cardiovascular system are##2##3##(2011-2#1)(2013-1#1)
cardiovascular system##31##2##(1990-10#1)(1991-2#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#2)
cardiovascular systems##3##2##(1994-2#1)(2009-10#2)
cardiovascular tissues##2##2##(2008-1#1)(2011-2#1)
cardiovascular toxicity##2##2##(1990-12#2)
cardiovascular treatment##2##2##(2008-3#1)(2009-10#1)
cardiovascular treatments##2##2##(2006-10#2)
cardiovascular##758##1##(1990-10#1)(1990-12#3)(1990-2#4)(1990-5#9)(1990-6#3)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#7)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#2)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#5)(1994-1#1)(1994-11#6)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-6#1)(1996-11#3)(1996-6#3)(1996-8#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2006-10#5)(2007-10#2)(2007-12#3)(2007-7#2)(2007-8#9)(2008-1#33)(2008-10#26)(2008-11#22)(2008-12#4)(2008-2#5)(2008-3#56)(2008-4#10)(2008-5#16)(2008-6#10)(2008-7#46)(2008-8#11)(2008-9#5)(2009-1#3)(2009-10#15)(2009-11#6)(2009-12#8)(2009-2#2)(2009-4#9)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#11)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#13)(2010-5#9)(2010-6#25)(2010-7#1)(2010-8#17)(2010-9#4)(2011-1#31)(2011-2#34)(2012-1#4)(2012-12#18)(2012-2#40)(2012-3#25)(2013-1#25)(2013-3#4)(2013-7#4)(2013-8#32)
cardioversion using##2##2##(2008-10#2)
cardioversion##9##1##(1994-3#1)(2008-10#5)(2008-7#1)(2013-1#1)(2013-8#1)
cardioverter defibrillator##4##2##(2008-12#4)
cardioverter##5##1##(2008-12#4)(2010-5#1)
cardioverter-defibrillator##4##1##(2008-12#3)(2012-2#1)
cards and##4##2##(1991-3#1)(1996-3#1)(2008-5#1)(2011-1#1)
cards for##5##2##(1994-11#2)(1996-3#1)(1997-2#2)
cards##34##1##(1991-3#1)(1991-8#2)(1994-11#3)(1996-3#4)(1997-2#2)(1997-3#5)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-3#2)(2011-1#1)(2012-2#5)
care &amp##3##2##(2009-4#1)(2011-2#1)(2012-1#1)
care (FCC)##2##2##(1991-1#1)(1991-12#1)
care (PCC)##2##2##(2013-8#2)
care (e##2##2##(2008-12#1)(2008-5#1)
care (n =##2##3##(1990-5#1)(1995-2#1)
care -##2##2##(2008-12#1)(2012-12#1)
care Medicaid##4##2##(1991-3#1)(1997-2#3)
care about##3##2##(1991-2#1)(1995-12#1)(2008-7#1)
care access##11##2##(1992-12#1)(1993-3#1)(1996-1#1)(1996-3#2)(2008-11#2)(2008-4#1)(2009-5#2)(2010-3#1)
care across a continuum##2##4##(1996-2#1)(1997-3#1)
care across a##3##3##(1994-12#1)(1996-2#1)(1997-3#1)
care across providers##2##3##(2012-3#2)
care across##10##2##(1993-2#1)(1994-12#1)(1996-2#1)(1997-1#2)(1997-3#2)(2010-12#1)(2012-3#2)
care activities##2##2##(1995-3#1)(2010-4#1)
care administration and##3##3##(1991-12#1)(1994-3#1)(1995-1#1)
care administration##10##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#2)(1995-1#3)(1996-2#1)(2008-1#1)
care administrators in##2##3##(1992-3#1)(1995-1#1)
care administrators##18##2##(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-3#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2009-4#1)(2009-8#1)
care advances##2##2##(1993-2#1)(2011-2#1)
care after##6##2##(1995-6#1)(2007-10#2)(2008-12#1)(2012-12#1)(2012-2#1)
care agencies##4##2##(1994-1#1)(1994-2#1)(1995-3#2)
care agency##2##2##(1995-5#1)(1997-2#1)
care among##13##2##(1995-12#1)(1996-2#1)(1996-3#1)(2008-12#1)(2008-7#1)(2009-5#2)(2010-4#1)(2011-1#2)(2012-3#2)(2013-1#1)
care and a##3##3##(1995-3#1)(2007-10#1)(2008-3#1)
care and access to##2##4##(2008-1#1)(2008-11#1)
care and access##3##3##(1995-1#1)(2008-1#1)(2008-11#1)
care and an##2##3##(1994-3#1)(1997-2#1)
care and attention##2##3##(1995-3#1)(2008-9#1)
care and better##2##3##(1994-3#1)(2008-1#1)
care and complications##2##3##(1994-3#1)(2008-7#1)
care and cost savings##2##4##(1994-3#1)(1997-2#1)
care and cost##3##3##(1994-3#1)(1997-2#1)(1997-3#1)
care and disease prevention##2##4##(1994-12#2)
care and disease##3##3##(1994-12#2)(2008-10#1)
care and feeding##2##3##(1995-1#1)(2008-10#1)
care and financial##2##3##(1992-12#1)(1993-3#1)
care and has##2##3##(1995-12#1)(1997-3#1)
care and health systems##2##4##(1997-3#1)(2008-11#1)
care and health##4##3##(1992-1#1)(1995-2#1)(1997-3#1)(2008-11#1)
care and hospice##4##3##(2011-2#4)
care and hospitalisation##2##3##(1995-2#1)(2012-12#1)
care and how to##2##4##(1992-2#1)(1994-12#1)
care and increased##2##3##(1996-1#1)(2007-10#1)
care and its impact##2##4##(1993-2#1)(1997-1#1)
care and its##5##3##(1993-2#1)(1993-5#1)(1995-1#1)(1997-1#1)(2013-8#1)
care and management##2##3##(1992-1#1)(2008-8#1)
care and monitoring of##2##4##(1995-2#1)(1996-1#1)
care and monitoring##3##3##(1995-2#1)(1996-1#1)(2009-10#1)
care and more##2##3##(1997-8#1)(2011-2#1)
care and other##6##3##(1991-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-12#1)(2008-6#1)
care and palliative care##2##4##(2010-10#1)(2013-1#1)
care and patient##2##3##(1996-3#1)(2009-8#1)
care and primary##2##3##(1997-3#1)(1997-5#1)
care and promote##2##3##(1996-2#1)(2008-11#1)
care and provide##2##3##(1994-12#1)(2008-3#1)
care and public health##3##4##(1995-2#1)(1997-2#1)(2013-8#1)
care and rehabilitation##5##3##(1993-12#3)(1995-3#1)(2007-11#1)
care and related##2##3##(1993-12#1)(2008-12#1)
care and research##3##3##(1992-11#1)(1995-9#1)(2011-3#1)
care and results##2##3##(1990-9#1)(2011-2#1)
care and service##2##3##(1995-2#1)(2008-11#1)
care and services##6##3##(1992-3#1)(1994-1#2)(1996-1#1)(1996-3#1)(2010-8#1)
care and should##2##3##(1994-3#1)(2012-3#1)
care and skilled##2##3##(2008-11#1)(2011-1#1)
care and support for##2##4##(2008-1#1)(2008-11#1)
care and support##3##3##(2008-1#1)(2008-11#1)(2008-12#1)
care and that##3##3##(2007-10#1)(2008-11#1)(2013-1#1)
care and the##22##3##(1990-8#1)(1991-3#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-1#1)(2012-12#1)
care and to##7##3##(1992-12#1)(1994-3#2)(2007-7#1)(2008-10#1)(2008-7#1)(2010-9#1)
care and treatment of the##3##5##(2007-8#1)(2008-7#2)
care and treatment of##4##4##(1995-8#1)(2007-8#1)(2008-7#2)
care and treatment services in Tanzania##3##6##(2010-8#3)
care and treatment##10##3##(1994-1#3)(1995-8#1)(2007-8#1)(2008-7#2)(2010-8#3)
care and##281##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#2)(1993-1#2)(1993-12#7)(1993-2#7)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#6)(1994-12#10)(1994-2#3)(1994-3#10)(1995-1#8)(1995-11#1)(1995-12#3)(1995-2#11)(1995-3#6)(1995-5#2)(1995-8#1)(1995-9#3)(1996-1#6)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#7)(1996-7#1)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#1)(1997-5#2)(1997-8#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#5)(2008-11#14)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#4)(2010-2#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#8)(2013-8#3)
care applications##5##2##(1994-3#1)(2008-3#1)(2008-5#3)
care approach##3##2##(1996-12#1)(1997-2#1)(2012-3#1)
care are discussed##3##3##(1992-2#1)(1993-3#1)(2011-1#1)
care are needed##2##3##(1992-3#1)(2011-2#1)
care are the##3##3##(1994-1#2)(2010-4#1)
care are##33##2##(1991-3#3)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-3#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-11#2)(2009-11#1)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
care areas##3##2##(1995-1#1)(1996-1#1)(2013-8#1)
care arrangements##5##2##(1991-3#1)(1994-1#1)(1995-1#2)(1995-2#1)
care as a##6##3##(1995-12#1)(1996-2#1)(2008-4#1)(2009-11#1)(2010-7#1)(2011-7#1)
care as an effective##2##4##(1993-3#1)(1996-9#1)
care as an##4##3##(1993-3#1)(1996-9#1)(2007-5#1)(2010-12#1)
care as the##3##3##(1994-3#1)(2008-11#1)(2008-7#1)
care as well as the##2##5##(1996-1#1)(1997-4#1)
care as well as##8##4##(1991-1#1)(1992-1#1)(1995-12#1)(1996-1#1)(1997-4#1)(2009-3#1)(2013-1#2)
care as##31##2##(1991-1#1)(1992-1#1)(1993-3#1)(1994-3#2)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#3)
care at a##5##3##(1992-1#1)(1993-10#1)(1993-3#1)(1995-12#1)(2013-8#1)
care at baseline##2##3##(2008-11#2)
care at##15##2##(1992-1#1)(1993-10#1)(1993-3#2)(1995-12#1)(1997-2#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
care available##2##2##(2008-1#1)(2008-9#1)
care based on the##2##4##(2008-11#1)(2012-3#1)
care based on##3##3##(1991-12#1)(2008-11#1)(2012-3#1)
care based##4##2##(1991-1#1)(1991-12#1)(2008-11#1)(2012-3#1)
care be##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
care benchmarking##2##2##(1994-12#2)
care benefit##2##2##(1992-1#1)(1997-3#1)
care benefits##5##2##(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-6#1)
care by Medicare beneficiaries##2##4##(1993-12#1)(1994-1#1)
care by##16##2##(1991-12#3)(1992-3#1)(1993-12#2)(1994-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
care can be delivered##2##4##(2010-7#1)(2011-2#1)
care can be provided##3##4##(1996-3#2)(2008-11#1)
care can be##12##3##(1991-2#1)(1994-2#2)(1994-3#2)(1995-12#1)(1996-3#2)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
care can lead##2##3##(1991-12#1)(1995-12#1)
care can##25##2##(1991-12#1)(1991-2#1)(1994-2#2)(1994-3#2)(1995-12#2)(1996-1#2)(1996-3#2)(1997-1#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
care capacity##2##2##(2008-9#1)(2013-7#1)
care case##3##2##(1991-2#1)(1994-3#1)(1995-2#1)
care center and##2##3##(1994-2#1)(2012-12#1)
care center in##2##3##(1994-3#1)(2010-5#1)
care center##14##2##(1991-3#1)(1992-1#1)(1994-2#2)(1994-3#1)(1995-5#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-4#1)(2010-5#1)(2012-12#2)
care center]##3##2##(1994-3#1)(1994-6#1)(1995-6#1)
care centers in##4##3##(2007-8#1)(2011-1#1)(2011-2#2)
care centers##13##2##(1992-1#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-8#1)(2007-2#1)(2007-8#1)(2011-1#1)(2011-2#4)(2013-1#1)
care centers]##4##2##(1994-6#1)(1996-2#1)(2007-3#2)
care centre##5##2##(1995-3#1)(1995-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
care centres##8##2##(1994-2#1)(1994-6#2)(1995-1#1)(1996-1#1)(2007-12#1)(2008-7#1)(2009-5#1)
care challenges##2##2##(2007-10#1)(2008-7#1)
care choices##3##2##(1991-9#1)(1997-3#1)(2008-4#1)
care clinic setting##2##3##(1993-12#1)(2008-12#1)
care clinic##9##2##(1993-12#1)(1996-3#1)(2008-12#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
care clinical##2##2##(1993-9#1)(2010-3#1)
care clinics##3##2##(1991-12#1)(2011-1#2)
care community##4##2##(1992-12#1)(1995-12#1)(1996-12#1)(2007-12#1)
care companies are##2##3##(1994-12#1)(1995-1#1)
care companies to##2##3##(1995-1#1)(1996-3#1)
care companies##15##2##(1991-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-1#5)(1996-3#1)(1997-3#1)(2008-11#2)
care compared with##3##3##(2011-1#1)(2013-1#2)
care concepts##3##2##(1996-1#1)(1997-2#1)(2008-12#1)
care concerns##3##2##(1993-3#1)(1994-12#1)(2008-9#1)
care conference##2##2##(1991-1#1)(2007-6#1)
care continuum##2##2##(1996-1#1)(2009-8#1)
care coordination##10##2##(1993-3#2)(1995-3#3)(1996-1#2)(1997-1#1)(2012-3#2)
care coordinators##3##2##(2008-3#2)(2011-1#1)
care cosmetics##3##2##(2008-5#3)
care cost containment##3##3##(1991-2#1)(1992-1#1)(1994-1#1)
care cost##9##2##(1991-2#1)(1992-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-10#2)(2008-1#1)
care costs and##18##3##(1992-1#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-1#2)(1997-2#1)(2008-11#5)(2013-1#1)
care costs##62##2##(1991-12#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#3)(1996-2#3)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(2008-1#3)(2008-11#10)(2008-7#2)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
care courses##2##2##(2008-11#1)(2008-12#1)
care coverage for##2##3##(1995-2#1)(2008-11#1)
care coverage##5##2##(1995-2#1)(1996-1#1)(2008-1#1)(2008-11#2)
care crisis##5##2##(1991-1#1)(1993-12#1)(1997-3#2)(2009-6#1)
care currently##2##2##(1996-12#1)(1997-3#1)
care data##7##2##(1994-2#3)(1995-12#1)(1996-1#1)(1997-2#1)(1997-3#1)
care delivered in the##2##4##(1996-2#1)(2006-10#1)
care delivered to##3##3##(1995-2#1)(1997-1#1)(2010-8#1)
care delivered##8##2##(1994-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
care delivery and##5##3##(1993-2#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-6#1)
care delivery in the##2##4##(2007-10#1)(2008-11#1)
care delivery is##4##3##(1993-12#2)(1996-2#1)(2012-1#1)
care delivery of##2##3##(2010-8#1)(2013-1#1)
care delivery processes##2##3##(1994-3#2)
care delivery system##17##3##(1991-1#1)(1993-12#2)(1994-1#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(2011-1#1)(2012-3#1)
care delivery systems for##2##4##(1991-3#1)(1995-12#1)
care delivery systems##12##3##(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#3)(1996-1#1)(1996-3#1)(2008-1#2)
care delivery to##2##3##(2010-3#1)(2012-3#1)
care delivery##91##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#6)(1993-2#1)(1993-3#1)(1994-1#4)(1994-12#3)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#3)(1996-1#6)(1996-12#4)(1996-2#3)(1996-3#7)(1997-2#3)(1997-3#4)(2007-10#2)(2007-7#1)(2008-1#6)(2008-11#3)(2008-2#1)(2008-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-3#4)(2013-1#1)(2013-7#1)
care demand##3##2##(1994-2#1)(1994-3#1)(1997-3#1)
care during the preoperative##2##4##(2012-3#2)
care during the##3##3##(1995-12#1)(2012-3#2)
care during##11##2##(1995-12#1)(1997-8#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-1#5)
care education##4##2##(2008-11#2)(2008-12#1)(2013-8#1)
care encounter##2##2##(1995-2#1)(1997-2#1)
care entities##2##2##(1993-12#1)(1996-2#1)
care environment and##4##3##(1996-2#2)(1996-3#1)(2008-1#1)
care environment##36##2##(1991-12#1)(1991-2#1)(1991-3#2)(1993-12#2)(1993-3#4)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#4)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#3)(1997-3#4)(2008-1#3)(2008-11#1)(2012-12#1)
care environments##5##2##(1994-2#1)(2008-11#1)(2010-10#1)(2011-1#1)(2012-3#1)
care especially in##2##3##(1994-12#1)(2012-12#1)
care executive##4##2##(1995-2#1)(1996-2#1)(2008-1#2)
care executives are##2##3##(1996-2#1)(1996-3#1)
care executives##11##2##(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#4)(1996-3#1)
care expenditures##18##2##(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#2)(2009-5#1)(2012-2#1)(2013-7#1)
care experience and##2##3##(2012-2#2)
care experience##7##2##(1991-12#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-2#1)(2012-2#2)
care experienced##2##2##(1991-12#1)(1997-2#1)
care facilities can##2##3##(1991-12#1)(1993-12#1)
care facilities have##3##3##(1991-3#1)(1995-1#1)(1996-3#1)
care facilities in##8##3##(1992-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2007-12#3)(2008-12#1)
care facilities should##2##3##(1996-2#1)(2008-3#1)
care facilities were##2##3##(1991-1#1)(2011-2#1)
care facilities##52##2##(1990-2#1)(1990-5#1)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#2)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#1)(2007-10#1)(2007-12#7)(2008-12#1)(2008-3#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
care facility##15##2##(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1994-3#1)(1995-3#1)(1996-2#2)(1997-3#1)(2008-12#2)(2009-3#1)
care financial management##4##3##(1994-12#1)(2008-11#3)
care financing in##2##3##(1991-3#1)(1993-3#1)
care financing##15##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#2)(2008-7#2)
care firms##4##2##(1991-3#1)(1994-1#2)(1996-12#1)
care following##3##2##(1994-3#1)(1994-5#1)(2007-10#1)
care for Medicare beneficiaries##3##4##(1992-12#1)(1993-12#1)(1995-12#1)
care for Medicare##4##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)
care for a##4##3##(1992-3#1)(1997-3#1)(2012-2#1)(2013-1#1)
care for adolescents##3##3##(1995-12#2)(1996-12#1)
care for adults with##2##4##(2007-6#1)(2010-12#1)
care for all patients##2##4##(1992-3#1)(2008-3#1)
care for all##4##3##(1992-3#1)(1993-12#1)(1995-1#1)(2008-3#1)
care for cancer patients##3##4##(1990-6#1)(1996-2#1)(2009-12#1)
care for cancer##5##3##(1990-6#1)(1996-2#1)(2008-7#1)(2009-12#1)(2011-2#1)
care for children and pregnant women##2##6##(1995-2#1)(2013-8#1)
care for children and##3##4##(1995-2#1)(2008-9#1)(2013-8#1)
care for children with##4##4##(1997-2#2)(2008-11#2)
care for children##13##3##(1991-1#1)(1991-3#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-11#2)(2008-9#1)(2009-5#1)(2012-2#2)(2013-8#1)
care for elderly##2##3##(1992-1#1)(1994-1#1)
care for high-risk individuals##2##4##(2011-2#2)
care for infants##2##3##(1992-1#1)(2007-12#1)
care for older people##6##4##(2009-3#1)(2010-10#5)
care for older##7##3##(1994-2#1)(2009-3#1)(2010-10#5)
care for others##3##3##(1994-3#2)(2008-4#1)
care for patients with acute myocardial##2##6##(2008-3#2)
care for patients with##4##4##(2008-3#2)(2008-6#1)(2013-1#1)
care for patients##14##3##(1991-2#1)(1994-1#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-6#2)(2013-1#2)
care for people with mental##3##5##(1997-8#1)(2008-11#2)
care for people with##5##4##(1992-12#1)(1997-8#1)(2008-11#2)(2012-3#1)
care for persons with##3##4##(1991-12#1)(1996-1#1)(1997-2#1)
care for special populations##2##4##(1996-2#1)(1997-2#1)
care for the elderly##7##4##(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)
care for the frail elderly##2##5##(1993-1#1)(1993-3#1)
care for the uninsured##3##4##(1992-2#1)(1995-1#1)(1996-1#1)
care for the##40##3##(1990-12#3)(1991-12#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#1)(2010-10#1)(2012-12#1)(2013-1#1)
care for their##2##3##(1991-3#1)(2008-11#1)
care for these patients##2##4##(1993-3#1)(2011-1#1)
care for these##4##3##(1993-3#1)(2008-11#1)(2008-7#1)(2011-1#1)
care for this##3##3##(1996-3#1)(2008-11#1)(2011-1#1)
care for young women##2##4##(1996-12#1)(2013-1#1)
care for young##4##3##(1996-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
care for##206##2##(1990-12#3)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#3)(1991-6#2)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#3)(1994-2#3)(1994-3#5)(1994-9#1)(1995-1#4)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#6)(1996-2#6)(1996-3#4)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#17)(2008-12#3)(2008-3#7)(2008-4#2)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-10#6)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#7)(2013-8#2)
care formulations##3##2##(2008-5#3)
care fraud and##3##3##(1991-1#2)(1996-12#1)
care fraud##10##2##(1991-1#2)(1993-12#4)(1993-2#1)(1996-12#3)
care from inpatient to outpatient##2##5##(1991-12#1)(2008-3#1)
care from the##3##3##(1994-12#1)(1994-9#1)(2009-12#1)
care from##8##2##(1991-12#1)(1994-12#1)(1994-9#1)(1996-2#1)(1997-1#1)(2008-3#1)(2008-9#1)(2009-12#1)
care given to##3##3##(1990-10#1)(1996-12#1)(2011-1#1)
care givers##3##2##(1990-10#1)(2008-11#1)(2011-1#1)
care graph##2##2##(2008-9#2)
care guidelines##2##2##(2008-11#2)
care has been##10##3##(1993-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(2008-1#1)(2010-10#1)(2010-8#1)(2012-12#1)
care has led##2##3##(1991-3#1)(2008-11#1)
care has##25##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-7#1)(1997-2#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-9#1)(2010-10#2)(2010-8#1)(2012-12#2)
care have##9##2##(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-3#2)(2008-11#1)(2010-8#1)(2013-1#1)
care health##5##2##(1993-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(2011-2#1)
care hospital in##7##3##(1997-1#1)(2008-11#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
care hospital##34##2##(1990-5#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-7#2)(2008-11#2)(2008-3#1)(2009-7#1)(2010-10#2)(2010-11#3)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
care hospital]##3##2##(2011-2#2)(2012-3#1)
care hospitals and##2##3##(1993-1#1)(1997-3#1)
care hospitals##16##2##(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1996-12#1)(1997-1#2)(1997-3#1)(2008-11#3)(2010-10#1)(2010-8#1)(2011-1#1)
care improvement##3##2##(1994-12#1)(1997-1#1)(2012-2#1)
care in Brazil##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
care in Canada##3##3##(1992-1#1)(1993-12#1)(1997-1#1)
care in ED##2##3##(2007-3#1)(2011-1#1)
care in a##6##3##(1993-2#1)(1995-12#1)(1996-3#1)(2008-10#1)(2012-3#1)(2013-8#1)
care in acute##2##3##(2008-11#1)(2008-3#1)
care in america##2##3##(2009-6#1)(2009-9#1)
care in an##2##3##(1993-1#1)(1994-12#1)
care in children##2##3##(2008-11#1)(2008-3#1)
care in health##2##3##(1992-3#1)(1994-12#1)
care in intensive##2##3##(2010-12#1)(2012-3#1)
care in long-term##2##3##(2008-8#1)(2010-10#1)
care in medical schools##2##4##(1993-11#1)(1997-3#1)
care in patients with cardiac failure##2##6##(2011-2#2)
care in patients with##4##4##(2007-5#1)(2011-2#3)
care in patients##5##3##(2007-5#1)(2008-7#1)(2011-2#3)
care in post-Katrina New Orleans##2##5##(2012-2#2)
care in practice##2##3##(2008-4#1)(2008-7#1)
care in resource poor settings##2##5##(1995-9#1)(2008-4#1)
care in rural areas##3##4##(1994-3#1)(1995-3#1)(1996-3#1)
care in rural##6##3##(1994-3#1)(1995-3#1)(1996-3#2)(2008-11#1)(2009-4#1)
care in the Czech Republic##2##5##(1990-11#1)(2011-2#1)
care in the Czech##3##4##(1990-11#2)(2011-2#1)
care in the United States##9##5##(1995-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
care in the United##10##4##(1994-3#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
care in the ambulatory##2##4##(1996-3#1)(1997-3#1)
care in the community##4##4##(1995-2#1)(1995-3#1)(2010-10#1)(2012-2#1)
care in the early##2##4##(1996-12#1)(2010-8#1)
care in the face of##2##5##(1997-2#2)
care in the first##2##4##(1993-3#1)(2011-1#1)
care in the hospital##2##4##(1991-1#1)(1993-12#1)
care in the last##2##4##(1994-1#1)(2011-2#1)
care in the management of##2##5##(2008-6#1)(2008-7#1)
care in the##81##3##(1990-11#2)(1990-6#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#4)(1997-8#2)(2007-12#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
care in their##3##3##(1995-1#1)(2008-1#1)(2008-3#1)
care in which##2##3##(1995-2#1)(1997-1#1)
care in##241##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#5)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#7)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#4)(1996-2#8)(1996-3#5)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#2)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#3)(2007-7#1)(2008-1#7)(2008-10#5)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-6#1)(2008-7#8)(2008-8#9)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#10)(2013-1#10)(2013-8#7)
care include##2##2##(1996-3#1)(2008-1#1)
care including##3##2##(1994-3#1)(2012-12#1)(2012-2#1)
care increases##2##2##(1992-2#1)(1993-1#1)
care indicators for##2##3##(1993-2#1)(2008-6#1)
care indicators##18##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-6#1)(2012-3#1)
care industry and##2##3##(1991-1#1)(1997-1#1)
care industry##36##2##(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#5)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#4)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#4)(2008-1#1)(2008-11#6)(2008-4#1)
care information system##5##3##(1995-12#1)(1996-12#1)(1996-3#2)(1997-3#1)
care information systems##6##3##(1993-1#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(2010-8#1)
care information##19##2##(1992-12#1)(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#4)(1997-3#1)(2008-1#1)(2008-11#1)(2010-8#1)
care institution##4##2##(1992-1#1)(1992-2#1)(1996-3#1)(2008-7#1)
care institutions and##4##3##(1992-3#1)(1993-1#1)(1993-12#1)(2008-11#1)
care institutions in##2##3##(1995-1#1)(1996-1#1)
care institutions##26##2##(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#2)(1997-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-8#1)
care insurance policy##2##3##(1992-12#1)(1993-3#1)
care insurance##7##2##(1992-12#1)(1993-3#3)(1996-1#1)(1996-5#1)(1997-5#1)
care interventions##4##2##(1993-12#1)(1993-2#1)(1994-1#1)(2008-11#1)
care into a##2##3##(1996-2#1)(1997-3#1)
care into practice##3##3##(2008-11#2)(2008-4#1)
care into the##3##3##(1991-12#1)(1994-2#1)(2012-3#1)
care into##10##2##(1991-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-11#3)(2008-4#1)(2012-3#1)
care involved##2##2##(2007-12#1)(2012-12#1)
care is a major##2##4##(2008-12#1)(2008-3#1)
care is a##7##3##(1991-12#1)(1993-3#1)(1994-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-3#1)
care is an##5##3##(1991-2#1)(1992-3#1)(1995-2#1)(1996-3#2)
care is available##2##3##(1992-2#1)(2007-7#1)
care is being##2##3##(1993-1#1)(1996-12#1)
care is examined##2##3##(1991-12#1)(2008-9#1)
care is financed##2##3##(1996-2#1)(1997-5#1)
care is growing##2##3##(1996-11#1)(1997-3#1)
care is needed##2##3##(2008-1#1)(2012-2#1)
care is not##3##3##(1990-2#1)(2012-3#1)(2013-8#1)
care is provided##3##3##(1993-3#1)(2007-12#1)(2009-5#1)
care is required to##2##4##(2008-3#1)(2010-12#1)
care is reviewed##2##3##(1992-6#1)(1993-1#1)
care is taken to##3##4##(2008-10#1)(2008-11#1)(2010-3#1)
care is taken##4##3##(2008-10#1)(2008-11#1)(2010-3#1)(2010-4#1)
care is the##6##3##(1993-1#1)(1994-1#1)(1996-3#1)(2007-5#1)(2008-7#1)(2013-1#1)
care is to##2##3##(1993-12#1)(1996-2#1)
care is##109##2##(1990-2#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#3)(1993-12#5)(1993-3#3)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-8#1)(1997-3#6)(1997-4#1)(1997-5#2)(1997-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
care issues##5##2##(1995-3#1)(2008-11#2)(2008-6#1)(2011-2#1)
care law##3##2##(1993-1#1)(1994-3#1)(1997-8#1)
care leaders must##2##3##(1993-1#1)(1995-3#1)
care leaders##11##2##(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#2)(1995-3#1)(1997-1#1)(2008-1#2)
care leadership##4##2##(1993-1#2)(1993-12#1)(2008-1#1)
care literature##2##2##(1993-2#1)(1994-3#1)
care litigation##7##2##(1991-1#1)(1992-1#2)(1992-2#2)(1992-3#2)
care management of patients with##2##5##(1995-11#1)(2012-2#1)
care management of##5##3##(1995-1#1)(1995-11#1)(2008-9#1)(2010-7#1)(2012-2#1)
care management program##2##3##(1991-12#1)(1995-12#1)
care management##38##2##(1991-12#2)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1997-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
care managers in##3##3##(1994-1#1)(1994-2#1)(1995-2#1)
care managers##13##2##(1991-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#1)(2006-5#1)(2008-12#1)(2008-7#1)
care maps##2##2##(1996-1#1)(1997-1#1)
care market reform##3##3##(1997-3#3)
care market##10##2##(1991-1#1)(1994-12#2)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#3)
care marketers##4##2##(1994-3#1)(1995-2#1)(1996-1#1)(1997-1#1)
care marketing##5##2##(1995-1#2)(1995-3#1)(1996-1#1)(2008-12#1)
care marketplace##6##2##(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)
care may be##2##3##(1995-3#1)(2008-11#1)
care may##8##2##(1992-2#1)(1994-2#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
care means to##2##3##(2008-11#1)(2010-10#1)
care measures##4##2##(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)
care medical##4##2##(2008-3#1)(2008-4#2)(2011-2#1)
care medicine##3##2##(1997-1#1)(1997-2#1)(2010-8#1)
care might##2##2##(1997-3#1)(2010-9#1)
care ministry##2##2##(1991-1#1)(1993-12#1)
care model##14##2##(1991-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-2#2)(2012-3#1)
care models##2##2##(1997-1#1)(2012-2#1)
care must be taken to##3##5##(1993-12#1)(2008-10#1)(2008-4#1)
care must be taken##5##4##(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
care must be##7##3##(1992-1#1)(1992-11#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
care needs and##2##3##(1995-12#1)(2010-10#1)
care needs of##5##3##(1994-2#1)(1995-2#1)(2007-2#1)(2008-7#1)(2012-3#1)
care needs to be##4##4##(1996-12#1)(1996-8#1)(2012-12#1)(2012-3#1)
care needs##39##2##(1991-12#1)(1991-3#2)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#7)(1995-2#1)(1995-3#3)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-2#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-11#2)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
care network##4##2##(1995-3#3)(2008-11#1)
care networks and health##3##4##(1995-2#1)(1996-2#2)
care networks and##4##3##(1993-2#1)(1995-2#1)(1996-2#2)
care networks##11##2##(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#3)(2012-1#1)
care nurse practitioner##2##3##(1996-3#2)
care nurse##5##2##(1996-3#2)(2007-12#1)(2011-2#1)(2013-8#1)
care nursery##5##2##(1993-3#2)(1995-1#2)(2011-1#1)
care nurses##7##2##(2007-11#5)(2008-12#1)(2010-10#1)
care nursing practice##4##3##(2007-11#3)(2010-10#1)
care nursing##12##2##(1990-2#1)(2007-11#6)(2008-11#3)(2010-10#1)(2010-3#1)
care of a child with high and intermediate imperforate anus##2##10##(2009-5#2)
care of a child with##3##5##(2009-5#3)
care of a##7##3##(2008-9#1)(2009-5#3)(2012-3#1)(2013-1#2)
care of all##2##3##(2008-7#1)(2009-5#1)
care of an##2##3##(2008-11#1)(2012-3#1)
care of battered##2##3##(1995-5#2)
care of cancer patients##2##4##(2008-1#1)(2011-3#1)
care of cancer##3##3##(1992-2#1)(2008-1#1)(2011-3#1)
care of children##4##3##(1992-3#1)(2008-10#1)(2008-11#1)(2009-10#1)
care of clients##2##3##(2008-4#1)(2012-3#1)
care of diabetics##3##3##(1990-11#2)(1996-9#1)
care of elderly##6##3##(1990-10#1)(1992-3#1)(2008-11#1)(2008-7#2)(2012-3#1)
care of older adults##4##4##(2008-11#3)(2010-8#1)
care of older people##6##4##(1995-3#1)(2010-10#5)
care of older##10##3##(1995-3#1)(2008-11#3)(2010-10#5)(2010-8#1)
care of patients with##10##4##(1991-6#1)(1995-11#1)(1997-4#2)(2007-5#1)(2008-1#2)(2008-3#2)(2012-3#1)
care of patients##16##3##(1991-6#1)(1992-1#1)(1995-11#1)(1995-2#1)(1997-4#2)(2007-5#1)(2008-1#3)(2008-11#1)(2008-3#3)(2010-3#1)(2012-3#1)
care of the dying##3##4##(1991-12#1)(2010-10#1)(2010-8#1)
care of the elderly##5##4##(1993-1#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-1#1)
care of the feet##3##4##(2013-1#3)
care of the older person##4##5##(2010-10#4)
care of the patient##3##4##(2008-11#1)(2010-3#1)(2012-3#1)
care of the##39##3##(1990-10#1)(1991-11#2)(1991-12#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#2)(1995-3#2)(1996-1#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-10#5)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#5)
care of their##4##3##(1992-12#1)(1996-1#1)(2008-5#1)(2008-6#1)
care of these patients##3##4##(2006-12#1)(2008-11#1)(2012-3#1)
care of these##5##3##(1991-6#1)(1992-3#1)(2006-12#1)(2008-11#1)(2012-3#1)
care of this population##2##4##(2008-8#1)(2012-12#1)
care of this##3##3##(2008-8#1)(2012-12#1)(2013-1#1)
care of##177##2##(1990-10#2)(1990-11#2)(1990-6#2)(1991-1#2)(1991-11#3)(1991-12#2)(1991-6#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-1#2)(1997-4#3)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#3)(2008-11#14)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#6)(2009-7#2)(2010-10#10)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#8)(2013-1#11)(2013-8#1)
care officials##3##2##(1995-1#2)(1995-12#1)
care often##2##2##(1997-1#1)(2008-8#1)
care ombudsmen##2##2##(1996-2#2)
care on a##2##3##(1993-1#1)(1997-2#1)
care on the##6##3##(1990-10#1)(1992-3#1)(1994-2#1)(1995-12#1)(2007-7#1)(2010-3#1)
care on##19##2##(1990-10#1)(1991-12#1)(1991-3#3)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#2)(1997-1#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-3#1)
care options##6##2##(1991-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2012-2#1)
care or##11##2##(1992-12#1)(1994-12#1)(1996-3#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#1)
care organization with##2##3##(1993-12#1)(1996-1#1)
care organization##26##2##(1990-6#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#3)(1996-1#3)(1997-1#1)(1997-3#4)(2010-10#1)(2010-4#1)(2011-2#1)
care organization's##3##2##(1994-1#1)(1994-2#1)(1995-1#1)
care organizations (MCOs)##4##3##(1994-1#1)(1994-12#1)(1996-2#1)(1997-2#1)
care organizations and##8##3##(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-3#1)(2008-11#1)
care organizations are facing##2##4##(1994-12#1)(1997-3#1)
care organizations are##7##3##(1993-1#1)(1994-12#2)(1995-12#2)(1997-1#1)(1997-3#1)
care organizations can##3##3##(1996-12#1)(2008-1#1)(2008-6#1)
care organizations have##2##3##(1994-1#1)(1994-2#1)
care organizations must##3##3##(1993-12#1)(1994-12#1)(1997-2#1)
care organizations need##3##3##(1993-3#1)(1995-2#1)(2010-7#1)
care organizations that##2##3##(1994-3#1)(1996-2#1)
care organizations were##3##3##(1995-1#1)(2008-11#1)(2008-7#1)
care organizations##100##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-1#5)(1994-12#12)(1994-2#5)(1994-3#2)(1995-1#3)(1995-12#4)(1995-2#4)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#7)(1996-3#3)(1997-1#2)(1997-2#6)(1997-3#6)(2008-1#2)(2008-11#7)(2008-12#2)(2008-6#3)(2008-7#3)(2009-6#1)(2010-7#1)(2011-2#2)
care outcomes##5##2##(1994-3#1)(1995-3#2)(1996-1#1)(2010-9#1)
care outside##2##2##(2008-7#1)(2011-1#1)
care over the##2##3##(1996-3#1)(2008-8#1)
care over##4##2##(1996-3#1)(1997-3#1)(2008-7#1)(2008-8#1)
care partners##6##2##(1993-3#1)(1994-2#1)(1996-12#1)(2010-5#3)
care pathways##3##2##(2008-3#3)
care patients##14##2##(1990-2#3)(1995-3#2)(1997-1#2)(2007-11#1)(2007-12#2)(2008-7#2)(2011-2#1)(2012-12#1)
care performance##4##2##(1993-12#2)(1996-3#2)
care personnel##6##2##(1990-2#1)(1991-12#1)(1992-11#1)(1994-5#1)(2008-7#1)(2013-1#1)
care physician##10##2##(1995-2#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-8#1)(2011-1#1)
care physician)##2##2##(1997-2#1)(2010-1#1)
care physicians and##4##3##(2008-11#1)(2008-6#1)(2011-1#2)
care physicians in##2##3##(1996-9#1)(2013-1#1)
care physicians##21##2##(1991-3#1)(1993-6#1)(1994-12#1)(1995-3#3)(1996-11#2)(1996-9#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-9#3)(2011-1#2)(2012-2#1)(2013-1#1)
care physicians' perceptions of medication errors and error prevention and##2##10##(2011-1#2)
care physicians' perceptions of medication errors and error prevention##3##9##(2011-1#3)
care placements##3##2##(1991-1#1)(2008-11#2)
care plan and##2##3##(1992-3#1)(2012-3#1)
care plan##18##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-2#2)(2007-9#1)(2008-3#1)(2010-3#1)(2012-3#1)(2013-1#4)
care planning in##4##3##(2010-3#1)(2012-12#1)(2013-1#2)
care planning##18##2##(1992-11#1)(1994-3#1)(1996-1#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-1#6)
care plans and##2##3##(1992-2#1)(1997-3#1)
care plans have been##2##4##(2007-9#1)(2008-12#1)
care plans have##3##3##(1997-2#1)(2007-9#1)(2008-12#1)
care plans##44##2##(1991-3#1)(1992-2#1)(1994-1#4)(1994-2#3)(1994-3#4)(1995-12#7)(1995-3#2)(1996-12#3)(1996-3#1)(1997-1#3)(1997-2#5)(1997-3#4)(2007-9#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#2)
care play##2##2##(1992-3#1)(2012-12#1)
care policies##5##2##(1995-2#1)(1995-3#1)(2010-10#2)(2011-1#1)
care policy and##3##3##(1991-1#1)(1993-12#1)(2008-11#1)
care policy as a##2##4##(1997-2#1)(2008-11#1)
care policy##16##2##(1991-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-2#4)(2008-11#3)(2009-3#1)(2011-2#1)
care practice##7##2##(1993-10#1)(1994-1#1)(1995-2#2)(2008-11#1)(2011-2#1)(2013-1#1)
care practices in an##2##4##(2008-3#1)(2011-1#1)
care practices in##4##3##(2008-1#1)(2008-3#1)(2011-1#1)(2013-1#1)
care practices that##3##3##(1995-3#1)(2008-11#2)
care practices##16##2##(1995-3#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-11#3)(2008-3#1)(2010-5#1)(2011-1#4)(2012-3#1)(2013-1#1)
care practitioners##6##2##(1992-3#1)(1996-1#1)(2008-11#1)(2011-1#2)(2013-1#1)
care principles##3##2##(1994-1#1)(1997-3#1)(2008-8#1)
care problems##6##2##(1991-11#1)(1997-1#1)(1997-8#1)(2007-5#1)(2008-7#1)(2011-2#1)
care procedures##2##2##(1993-2#1)(2008-12#1)
care process##5##2##(1995-3#3)(2011-2#1)(2013-1#1)
care processes##6##2##(1995-1#1)(1996-1#1)(1997-1#1)(2013-1#3)
care product##4##2##(1995-1#1)(2008-5#3)
care products was##2##3##(2008-5#2)
care products##19##2##(1992-11#2)(1994-3#1)(1995-1#1)(1997-4#1)(2008-10#1)(2008-5#13)
care professionals##54##2##(1991-2#3)(1991-3#2)(1992-12#1)(1992-3#3)(1993-1#2)(1993-2#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-2#1)(2007-4#1)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#3)(2008-4#2)(2008-7#2)(2009-5#1)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
care professionals'##3##2##(2007-11#1)(2007-2#1)(2010-10#1)
care professions##2##2##(1995-2#1)(2008-11#1)
care program for##5##3##(1990-2#1)(1992-1#1)(1993-1#1)(1995-3#1)(2008-6#1)
care program##18##2##(1990-2#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#2)(2006-5#1)(2008-6#2)(2008-7#1)
care programme##3##2##(2008-1#2)(2008-12#1)
care programs are##2##3##(1995-12#1)(2007-10#1)
care programs in##4##3##(1990-10#1)(1991-3#1)(2009-10#1)(2012-12#1)
care programs##20##2##(1990-10#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
care protocols##4##2##(1994-3#3)(1995-3#1)
care provided by APRNs##2##4##(2012-3#2)
care provided by the##3##4##(2012-1#1)(2013-1#2)
care provided by##12##3##(1992-1#1)(1996-1#1)(1997-2#1)(2007-10#1)(2009-6#1)(2012-1#1)(2012-3#4)(2013-1#2)
care provided in##3##3##(1996-2#1)(1997-1#1)(2007-10#1)
care provided to the##3##4##(1991-3#1)(2007-9#1)(2011-1#1)
care provided to##10##3##(1991-3#1)(1992-1#1)(1994-3#1)(1996-2#2)(2007-12#1)(2007-9#1)(2008-3#1)(2010-8#1)(2011-1#1)
care provided##32##2##(1991-12#1)(1991-3#1)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#3)(1997-1#1)(1997-2#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#4)(2013-1#2)
care provider##21##2##(1992-2#1)(1994-1#3)(1995-12#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#2)(2010-1#1)(2013-1#3)(2013-7#3)
care providers are##7##3##(1994-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-2#1)
care providers can##3##3##(1994-12#1)(1994-3#1)(1996-3#1)
care providers for##2##3##(1996-1#1)(2010-9#1)
care providers have##2##3##(1996-12#1)(2008-11#1)
care providers in##10##3##(1992-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-7#1)(2011-1#1)
care providers need to##4##4##(2007-10#1)(2008-10#1)(2010-4#1)(2012-3#1)
care providers need##5##3##(2007-10#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-3#1)
care providers to##12##3##(1991-2#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
care providers were##3##3##(1991-3#1)(1993-3#1)(1996-8#1)
care providers who##5##3##(1992-12#1)(1992-2#1)(2007-2#1)(2008-1#1)(2008-12#1)
care providers##119##2##(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1992-12#4)(1992-2#4)(1992-3#1)(1993-1#4)(1993-12#3)(1993-3#1)(1994-1#1)(1994-12#5)(1994-2#3)(1994-3#5)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#7)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-8#1)(2007-10#2)(2007-12#2)(2007-2#3)(2008-1#4)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#6)
care providers'##3##2##(1994-3#1)(2008-11#1)(2010-10#1)
care providers)##2##2##(1995-2#1)(2009-10#1)
care provision##8##2##(1997-3#1)(2007-2#1)(2008-7#1)(2009-7#1)(2012-1#1)(2013-8#3)
care quality and##4##3##(1996-3#1)(2008-11#1)(2009-5#1)(2010-8#1)
care quality is##3##3##(1993-3#2)(2011-2#1)
care quality##37##2##(1991-3#2)(1993-3#5)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#2)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#1)(2009-5#1)(2010-8#3)(2011-2#1)
care rationing##3##2##(1992-12#1)(1992-2#1)(1993-3#1)
care received##2##2##(1995-3#1)(1996-2#1)
care recipients##4##2##(2008-6#2)(2009-5#1)(2010-10#1)
care redesign##2##2##(1992-12#1)(1996-2#1)
care reform and the##5##4##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)
care reform and##12##3##(1991-12#1)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(2010-8#1)
care reform has##3##3##(1995-2#1)(1996-1#1)(2011-1#1)
care reform in the United States##3##6##(1993-12#1)(1995-1#1)(1995-12#1)
care reform in the##6##4##(1993-12#1)(1995-1#2)(1995-12#1)(1996-6#1)(1997-3#1)
care reform in##10##3##(1993-12#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-2#1)
care reform is##5##3##(1993-3#1)(1994-2#1)(1995-3#1)(1996-1#2)
care reform will##2##3##(1994-3#1)(1995-1#1)
care reform##142##2##(1991-12#1)(1992-2#2)(1993-1#1)(1993-12#8)(1993-3#2)(1993-5#1)(1994-1#4)(1994-12#19)(1994-2#6)(1994-3#5)(1994-8#4)(1995-1#10)(1995-12#17)(1995-2#8)(1995-3#6)(1996-1#17)(1996-12#2)(1996-2#3)(1996-3#8)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#2)(2008-2#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
care reform?##6##2##(1993-3#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)
care reforms##4##2##(1995-3#1)(2008-1#1)(2011-2#1)(2013-8#1)
care regimen##2##2##(2008-5#2)
care report##2##2##(1997-3#1)(2008-11#1)
care require##2##2##(1997-8#1)(2008-11#1)
care required by##2##3##(2012-12#1)(2012-3#1)
care required##4##2##(1994-3#1)(2012-12#2)(2012-3#1)
care requirements of##3##3##(1994-12#1)(1995-9#1)(1996-1#1)
care requirements##4##2##(1994-12#1)(1995-9#1)(1996-1#1)(1996-2#1)
care requires##4##2##(2007-5#1)(2010-12#1)(2010-4#1)(2012-3#1)
care research##3##2##(2008-1#1)(2009-4#2)
care residents##3##2##(2010-10#1)(2012-12#2)
care risk management##2##3##(1997-2#2)
care risk##7##2##(1992-2#2)(1994-1#2)(1995-3#1)(1997-2#2)
care rose##2##2##(1991-12#1)(1992-12#1)
care safety net##2##3##(2008-4#1)(2011-2#1)
care sector##13##2##(1992-1#1)(1992-12#1)(1992-2#1)(1994-2#1)(1995-1#1)(1996-2#2)(2008-11#2)(2008-12#1)(2010-10#1)(2010-7#1)(2012-2#1)
care service delivery##2##3##(1995-2#1)(1995-3#1)
care service##13##2##(1991-12#1)(1992-1#1)(1993-12#2)(1993-3#1)(1994-2#2)(1995-2#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-7#2)
care services and##6##3##(1992-1#1)(1993-12#1)(1994-1#1)(1995-12#1)(1997-8#1)(2008-11#1)
care services as a##2##4##(2010-4#1)(2012-1#1)
care services for##5##3##(1991-2#1)(1993-3#1)(1996-2#1)(1997-2#1)(1997-8#1)
care services in the##3##4##(1995-1#2)(1995-12#1)
care services in##13##3##(1991-2#1)(1993-12#1)(1993-6#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(2008-7#1)(2010-3#1)(2013-1#1)
care services is##5##3##(1993-3#1)(1995-2#1)(1997-2#1)(2008-11#1)(2012-3#1)
care services provided##3##3##(1991-3#1)(1994-12#1)(1995-12#1)
care services to the##3##4##(1991-1#1)(2008-1#1)(2008-7#1)
care services to##6##3##(1991-1#1)(1991-3#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-7#1)
care services##113##2##(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#3)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#5)(1995-1#3)(1995-12#4)(1995-2#5)(1995-3#3)(1995-8#1)(1996-12#3)(1996-2#6)(1996-3#2)(1997-1#4)(1997-2#5)(1997-8#2)(2006-5#1)(2007-4#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
care setting and##2##3##(1997-2#1)(2010-10#1)
care setting##44##2##(1991-1#3)(1992-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
care settings##27##2##(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-12#2)(1997-1#2)(2007-12#1)(2008-11#4)(2008-12#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-4#2)(2010-8#1)(2010-9#1)(2012-3#1)
care should be taken##2##4##(2008-9#1)(2011-2#1)
care should be##7##3##(1991-6#1)(1993-12#1)(1997-3#2)(2008-9#2)(2011-2#1)
care should##11##2##(1991-6#1)(1993-12#1)(1994-3#1)(1995-1#1)(1997-3#2)(2008-4#1)(2008-9#2)(2011-2#2)
care since##2##2##(1994-3#1)(1995-12#1)
care so##2##2##(1993-12#1)(1994-3#1)
care spending##15##2##(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-11#2)(2008-7#1)
care staff in##3##3##(2008-11#1)(2011-2#2)
care staff##11##2##(1993-1#1)(1994-6#1)(1997-1#1)(2008-11#2)(2010-10#1)(2010-11#1)(2011-2#4)
care staffing##2##2##(1997-3#1)(2012-2#1)
care strategy##3##2##(1992-1#1)(1994-2#1)(2013-1#1)
care study##2##2##(1995-9#1)(2008-11#1)
care supply##2##2##(1992-3#2)
care system and##14##3##(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2010-4#1)(2011-1#1)
care system can##3##3##(1993-2#1)(1995-2#1)(1996-12#1)
care system for##2##3##(1991-3#1)(1992-2#1)
care system has##5##3##(1994-12#1)(1995-3#1)(2008-11#2)(2008-12#1)
care system in the##5##4##(1992-12#1)(1996-12#1)(2008-1#2)(2013-1#1)
care system in##9##3##(1992-12#1)(1992-2#1)(1996-12#1)(1997-3#1)(2006-10#1)(2008-1#2)(2008-5#1)(2013-1#1)
care system to address these problems##2##6##(2008-8#1)(2013-8#1)
care system to##6##3##(1994-1#1)(1994-2#1)(1995-1#1)(2008-8#1)(2013-1#1)(2013-8#1)
care system##172##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#6)(1993-6#1)(1993-9#1)(1994-1#9)(1994-12#6)(1994-2#8)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#5)(1995-2#7)(1995-3#6)(1996-1#1)(1996-12#9)(1996-2#4)(1996-3#6)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#2)(2006-10#8)(2007-11#1)(2007-12#1)(2007-2#3)(2008-1#6)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
care systems and##2##3##(1995-12#1)(2012-2#1)
care systems are##4##3##(1993-12#1)(1996-1#1)(1997-1#1)(2008-1#1)
care systems in##4##3##(1993-2#1)(1994-12#1)(1997-2#1)(2013-8#1)
care systems##50##2##(1992-1#1)(1992-12#2)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#6)(1997-2#1)(2007-2#1)(2008-1#4)(2008-11#1)(2008-12#1)(2008-7#3)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
care teaching##4##2##(2007-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
care team and##2##3##(2008-1#1)(2008-7#1)
care team can##2##3##(1993-12#1)(1993-3#1)
care team design##4##3##(1994-2#3)(1995-2#1)
care team for##2##3##(1995-3#1)(2009-9#1)
care team##30##2##(1993-12#1)(1993-3#2)(1994-2#6)(1995-11#1)(1995-2#5)(1995-3#2)(1996-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-9#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
care teams and##2##3##(1993-10#1)(2011-2#1)
care teams which##2##3##(1994-2#2)
care teams##10##2##(1993-10#1)(1993-11#1)(1994-2#2)(1995-2#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-3#1)
care technologies##2##2##(1993-2#1)(2008-5#1)
care technology##4##2##(1994-1#1)(1997-2#1)(2008-11#1)(2008-7#1)
care tends to##2##3##(1996-3#1)(2008-11#1)
care than##5##2##(1996-12#1)(1997-2#1)(2008-3#1)(2009-9#1)(2013-7#1)
care that is##2##3##(2008-4#1)(2010-8#1)
care that##13##2##(1994-12#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-8#1)(2012-12#1)(2012-3#1)
care the##2##2##(1992-8#1)(1994-6#1)
care there##2##2##(1993-2#1)(1996-12#1)
care they provide##3##3##(1996-2#1)(1997-1#1)(2008-11#1)
care they##11##2##(1991-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-10#2)(2007-2#1)(2008-11#2)(2008-8#1)
care through##8##2##(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-4#2)
care time were##2##3##(1995-3#1)(2011-2#1)
care to a##5##3##(1995-3#1)(1996-1#1)(2008-11#1)(2009-5#1)(2010-9#1)
care to an##2##3##(1996-1#1)(2008-11#1)
care to be##3##3##(1994-12#1)(2007-11#1)(2008-11#1)
care to children and##2##4##(2008-11#1)(2010-4#1)
care to children##3##3##(2008-11#2)(2010-4#1)
care to older people##2##4##(2008-6#1)(2010-10#1)
care to patients##5##3##(1994-2#1)(1994-3#1)(2007-10#1)(2007-12#1)(2011-1#1)
care to people with##3##4##(2011-1#3)
care to people##5##3##(2011-1#4)(2012-3#1)
care to the##9##3##(1992-2#1)(1996-1#1)(2008-11#3)(2010-10#1)(2010-11#1)(2011-1#1)(2012-3#1)
care to their patients##2##4##(2008-11#1)(2012-3#1)
care to their##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
care to this##2##3##(2008-9#1)(2013-8#1)
care to##76##2##(1990-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#6)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#12)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-5#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#6)(2012-12#1)(2012-3#4)(2013-8#1)
care training in##2##3##(1995-2#1)(2009-2#1)
care training##6##2##(1995-2#1)(1996-1#3)(2008-1#1)(2009-2#1)
care transitions##2##2##(2010-10#1)(2010-11#1)
care under the##3##3##(1993-12#1)(1996-2#2)
care under##9##2##(1992-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#3)(1997-2#1)
care unit in##2##3##(2008-7#1)(2012-2#1)
care unit##81##2##(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-6#2)(1996-9#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-3#2)(2009-5#3)(2010-10#2)(2010-11#5)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#3)
care units (ICUs)##5##3##(1991-2#1)(2007-11#1)(2007-7#1)(2008-8#1)(2011-2#1)
care units##44##2##(1991-12#1)(1991-2#2)(1992-3#1)(1993-6#1)(1994-3#2)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#5)(2008-4#1)(2008-8#3)(2009-5#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
care usage##2##2##(1994-3#1)(2008-1#1)
care use by Hispanic adults##2##5##(1995-12#2)
care use in##2##3##(2009-6#1)(2010-8#1)
care use##13##2##(1992-1#1)(1994-1#1)(1995-12#2)(1996-2#1)(1997-3#1)(2007-10#1)(2009-6#1)(2010-8#1)(2012-3#1)(2013-1#3)
care uses##2##2##(1994-3#1)(1996-2#1)
care using a##2##3##(1993-12#1)(1996-12#1)
care using##3##2##(1993-12#1)(1996-12#1)(2008-7#1)
care utilization and##3##3##(1997-2#1)(2007-10#2)
care utilization##16##2##(1994-2#1)(1996-2#3)(1997-1#2)(1997-2#1)(2007-10#3)(2008-11#1)(2009-5#2)(2010-12#1)(2013-1#2)
care visits##2##2##(1996-11#1)(1996-3#1)
care vs##3##2##(1996-2#1)(2008-8#1)(2009-9#1)
care was associated with##3##4##(1993-3#2)(2011-1#1)
care was not##2##3##(2008-9#1)(2010-1#1)
care was##22##2##(1990-11#1)(1992-1#1)(1993-2#1)(1993-3#3)(1994-11#1)(1995-1#1)(1995-2#2)(1995-3#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-1#1)(2011-1#1)
care were##11##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-11#1)(2009-3#1)(2011-2#1)
care when##5##2##(1994-12#1)(1994-6#1)(2007-7#1)(2008-2#1)(2012-12#1)
care which is##2##3##(1992-2#1)(1995-1#1)
care which##4##2##(1992-2#1)(1994-6#1)(1995-1#1)(1996-3#1)
care while##3##2##(1994-1#1)(1996-3#1)(2008-3#1)
care will be##3##3##(2010-10#1)(2011-2#2)
care will depend on##2##4##(1994-12#1)(1996-2#1)
care will depend##3##3##(1993-2#1)(1994-12#1)(1996-2#1)
care will have##2##3##(1991-6#1)(2008-7#1)
care will##16##2##(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#3)(1997-2#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-3#1)
care with a##2##3##(1994-12#1)(2013-8#1)
care with##17##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2013-8#2)
care within a##3##3##(1996-1#1)(2008-11#1)(2013-8#1)
care within the##5##3##(1991-6#2)(2008-1#1)(2008-7#1)(2009-8#1)
care within##8##2##(1991-6#2)(1996-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
care without##4##2##(1994-7#1)(1997-1#1)(2010-3#1)(2012-2#1)
care work##7##2##(1994-1#1)(1994-2#3)(1996-3#1)(2007-10#1)(2010-12#1)
care worker##5##2##(1993-12#1)(1995-6#1)(2007-12#1)(2007-3#2)
care workers and##3##3##(1996-3#1)(2011-1#1)(2013-1#1)
care workers in##5##3##(1992-2#1)(1993-2#1)(1996-12#1)(2008-11#1)(2009-7#1)
care workers who##2##3##(1992-1#1)(2010-11#1)
care workers##34##2##(1991-3#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-2#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-11#5)(2009-7#1)(2010-11#3)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#3)
care workforce##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
care would##4##2##(1993-1#1)(1994-12#1)(1995-6#1)(1996-1#1)
care##6140##1##(1990-10#6)(1990-11#10)(1990-12#5)(1990-2#13)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#11)(1990-8#1)(1990-9#4)(1991-1#57)(1991-11#8)(1991-12#96)(1991-2#57)(1991-3#87)(1991-4#1)(1991-6#16)(1991-8#2)(1991-9#5)(1992-1#63)(1992-11#14)(1992-12#53)(1992-2#87)(1992-3#74)(1992-4#4)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#57)(1993-10#3)(1993-11#6)(1993-12#145)(1993-2#64)(1993-3#119)(1993-5#5)(1993-6#19)(1993-8#1)(1993-9#5)(1994-1#112)(1994-11#4)(1994-12#166)(1994-2#145)(1994-3#188)(1994-5#3)(1994-6#16)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#130)(1995-11#9)(1995-12#159)(1995-2#149)(1995-3#170)(1995-5#12)(1995-6#18)(1995-8#8)(1995-9#7)(1996-1#145)(1996-11#10)(1996-12#117)(1996-2#177)(1996-3#166)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#17)(1996-9#17)(1997-1#129)(1997-2#157)(1997-3#161)(1997-4#16)(1997-5#18)(1997-6#8)(1997-7#6)(1997-8#27)(2006-10#21)(2006-12#1)(2006-5#5)(2006-9#1)(2007-10#44)(2007-11#32)(2007-12#51)(2007-2#21)(2007-3#6)(2007-4#4)(2007-5#10)(2007-6#4)(2007-7#22)(2007-8#13)(2007-9#6)(2008-1#123)(2008-10#43)(2008-11#305)(2008-12#77)(2008-2#14)(2008-3#67)(2008-4#49)(2008-5#50)(2008-6#48)(2008-7#144)(2008-8#68)(2008-9#40)(2009-1#3)(2009-10#10)(2009-11#11)(2009-12#9)(2009-2#1)(2009-3#13)(2009-4#15)(2009-5#44)(2009-6#13)(2009-7#11)(2009-8#5)(2009-9#17)(2010-1#6)(2010-10#78)(2010-11#30)(2010-12#24)(2010-2#7)(2010-3#27)(2010-4#32)(2010-5#15)(2010-6#1)(2010-7#10)(2010-8#61)(2010-9#21)(2011-1#92)(2011-2#148)(2011-3#3)(2011-7#2)(2012-1#13)(2012-12#73)(2012-2#61)(2012-3#147)(2012-8#1)(2013-1#166)(2013-7#14)(2013-8#77)
care&quot##10##1##(1991-12#3)(1991-2#1)(1995-3#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-12#1)(2012-3#1)
care'##4##1##(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
care's##8##1##(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-7#1)(2007-10#1)(2008-6#1)(2013-7#1)
care)##8##1##(1995-3#1)(1996-2#1)(1997-8#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
care--a##3##1##(1994-3#1)(1996-3#1)(2008-11#1)
care-giver##2##1##(1992-3#1)(2008-7#1)
care-givers and##2##2##(2008-9#1)(2011-1#1)
care-givers##6##1##(2008-11#1)(2008-9#3)(2011-1#2)
care/service##2##1##(1996-3#2)
care? A systematic##2##3##(1995-9#1)(2008-7#1)
care? A##4##2##(1995-9#1)(2008-7#1)(2013-1#2)
care?##26##1##(1991-2#1)(1991-3#3)(1992-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
care?]##4##1##(1994-3#1)(1995-5#1)(1996-11#1)(1997-6#1)
care]##59##1##(1990-9#1)(1991-6#2)(1991-9#1)(1992-11#1)(1993-10#1)(1993-11#3)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1996-11#1)(1996-3#3)(1996-6#4)(1996-9#2)(1997-3#1)(1997-5#2)(1997-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
cared for by##2##3##(2008-3#1)(2008-7#1)
cared for in a##2##4##(2008-11#1)(2011-1#1)
cared for in##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
cared for##14##2##(1991-1#1)(1991-11#1)(1991-6#1)(1994-6#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
cared##15##1##(1991-1#1)(1991-11#1)(1991-6#1)(1994-6#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
career advancement##3##2##(1994-1#2)(1996-1#1)
career attainment##2##2##(1995-12#2)
career development##6##2##(1991-1#1)(1994-3#2)(1997-2#1)(2008-8#1)(2012-12#1)
career for##3##2##(1990-12#1)(1996-1#1)(2008-1#1)
career in the##2##3##(1994-12#1)(2012-1#1)
career in##8##2##(1992-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(2008-1#1)(2012-1#2)
career is##2##2##(1995-5#1)(2009-10#1)
career ladder##3##2##(1994-12#1)(2008-1#2)
career of##2##2##(2008-11#1)(2008-5#1)
career path##2##2##(1994-1#1)(2008-1#1)
career##72##1##(1990-12#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-6#2)(1993-11#1)(1993-3#2)(1994-1#3)(1994-12#5)(1994-2#2)(1994-3#2)(1995-12#3)(1995-5#1)(1996-1#3)(1996-2#1)(1997-2#2)(1997-6#1)(2007-12#1)(2007-4#2)(2008-1#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#3)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)
careers in medicine##2##3##(1992-7#1)(2012-3#1)
careers in##6##2##(1992-7#1)(1992-8#1)(1996-1#1)(1996-3#1)(2012-3#2)
careers of##3##2##(1993-6#1)(1995-6#1)(2009-12#1)
careers##23##1##(1991-3#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-2#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-1#1)(2009-12#1)(2010-1#1)(2010-10#1)(2012-3#3)(2013-1#1)
careful analysis of the##4##4##(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#1)
careful analysis of##6##3##(1994-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#1)
careful and##2##2##(2008-11#1)(2012-3#1)
careful assessment of the##2##4##(2007-12#2)
careful assessment##4##2##(2007-12#2)(2011-1#1)(2012-2#1)
careful attention to the##2##4##(2007-11#1)(2008-10#1)
careful attention to##6##3##(1995-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)
careful attention##11##2##(1992-3#2)(1995-1#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)
careful clinical and##2##3##(2006-10#1)(2008-7#1)
careful clinical evaluation##2##3##(2008-1#1)(2012-3#1)
careful clinical##5##2##(1990-10#1)(2006-10#1)(2008-1#1)(2008-7#1)(2012-3#1)
careful consideration of the##2##4##(1992-3#1)(2008-4#1)
careful consideration of##5##3##(1992-3#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
careful consideration##9##2##(1992-3#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
careful design##2##2##(2008-10#1)(2008-4#1)
careful evaluation of##4##3##(1990-3#1)(1994-6#1)(2008-7#1)(2010-8#1)
careful evaluation##5##2##(1990-3#1)(1994-6#1)(1996-3#1)(2008-7#1)(2010-8#1)
careful examination of##3##3##(1990-10#1)(1993-11#1)(2010-10#1)
careful examination##6##2##(1990-10#1)(1990-6#1)(1993-11#1)(2009-10#1)(2010-10#1)(2010-6#1)
careful follow-up of##3##3##(1990-12#1)(1991-2#1)(2008-9#1)
careful follow-up##6##2##(1990-12#1)(1991-2#1)(1993-3#1)(1997-3#1)(2008-11#1)(2008-9#1)
careful history and##4##3##(1991-12#1)(1994-12#1)(2008-11#1)(2010-6#1)
careful interpretation of##2##3##(2009-8#1)(2011-2#1)
careful intraoperative##2##2##(1991-6#1)(2013-1#1)
careful planning in##2##3##(1994-12#1)(2011-2#1)
careful planning##6##2##(1992-3#1)(1994-12#1)(1996-2#1)(2007-7#1)(2007-8#1)(2011-2#1)
careful preparation##2##2##(1993-12#1)(1995-12#1)
careful process design##2##3##(2008-11#1)(2011-2#1)
careful review##2##2##(1992-2#1)(2012-12#1)
careful scrutiny##2##2##(2008-11#1)(2013-8#1)
careful selection of reagents##2##4##(2008-4#1)(2008-9#1)
careful selection of##4##3##(2008-4#1)(2008-9#1)(2012-12#1)(2013-1#1)
careful surgical approach##2##3##(1991-5#1)(2007-8#1)
careful##148##1##(1990-10#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#5)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#7)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-7#6)(2008-9#5)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#4)
carefully and##4##2##(1995-2#1)(1996-3#1)(2006-5#1)(2007-10#1)
carefully chosen to##2##3##(2008-2#1)(2008-3#1)
carefully chosen##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
carefully controlled##9##2##(2008-10#2)(2008-3#2)(2008-5#3)(2008-7#1)(2012-7#1)
carefully crafted##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
carefully defined##2##2##(1997-2#1)(2008-1#1)
carefully designed##5##2##(1991-12#1)(2007-12#1)(2008-5#2)(2012-12#1)
carefully evaluate##2##2##(1994-3#1)(1995-12#1)
carefully evaluated##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
carefully examined##4##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
carefully followed##3##2##(1991-2#1)(1991-5#1)(2008-7#1)
carefully in##2##2##(1996-4#1)(2013-7#1)
carefully monitor##2##2##(1992-11#1)(2008-11#1)
carefully planned##5##2##(1990-6#1)(1996-2#1)(2008-4#1)(2010-4#1)(2012-2#1)
carefully selected for##2##3##(1991-8#1)(2010-6#1)
carefully selected in order to##2##5##(2008-10#1)(2010-11#1)
carefully selected##12##2##(1991-8#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-6#1)(2010-11#2)(2010-6#1)(2013-1#1)
carefully structured##3##2##(1993-2#1)(1995-2#1)(2008-7#1)
carefully studied##4##2##(2008-10#4)
carefully the##4##2##(1990-5#1)(1990-6#1)(1996-12#1)(2008-8#1)
carefully##146##1##(1990-12#2)(1990-5#2)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-12#3)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#2)
caregiver and##3##2##(1996-1#2)(2009-5#1)
caregiver burden and##2##3##(2012-2#1)(2013-8#1)
caregiver burden##5##2##(2007-12#1)(2009-5#1)(2012-2#2)(2013-8#1)
caregiver of##3##2##(1997-3#1)(2012-12#1)(2012-3#1)
caregiver##35##1##(1992-2#1)(1992-3#1)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#4)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#3)
caregivers and relatives##2##3##(1990-3#1)(1997-3#1)
caregivers and to##2##3##(2008-1#1)(2009-5#1)
caregivers and##15##2##(1990-3#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-6#2)(2008-7#2)(2009-5#3)(2013-1#3)
caregivers are##4##2##(1991-12#1)(1994-2#1)(2009-5#1)(2013-8#1)
caregivers express##2##2##(1992-3#2)
caregivers face##2##2##(2008-6#2)
caregivers for##3##2##(1995-2#1)(1996-3#1)(2008-9#1)
caregivers had##2##2##(1994-1#1)(2013-8#1)
caregivers in##3##2##(1992-3#1)(1993-11#1)(2007-12#1)
caregivers of children with AIDS##2##5##(2012-3#2)
caregivers of children with##4##4##(1994-1#1)(1995-2#1)(2012-3#2)
caregivers of dementia patients##2##4##(2008-6#2)
caregivers of patients with##2##4##(2011-2#1)(2013-8#1)
caregivers of patients##3##3##(2007-10#1)(2011-2#1)(2013-8#1)
caregivers of the##2##3##(1992-1#1)(1992-3#1)
caregivers of##19##2##(1991-12#1)(1992-1#1)(1992-3#2)(1994-1#1)(1995-2#1)(1996-10#1)(2007-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
caregivers regarding##2##2##(1996-1#1)(2010-8#1)
caregivers to##4##2##(1992-3#1)(1996-12#1)(1997-2#1)(2010-12#1)
caregivers who##3##2##(1992-3#1)(2008-7#1)(2010-10#1)
caregivers with##2##2##(2010-7#2)
caregivers##137##1##(1990-3#1)(1991-1#3)(1991-12#6)(1991-2#1)(1991-3#1)(1992-1#2)(1992-3#14)(1993-11#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#2)(1996-1#5)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-5#1)(2007-10#4)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#11)(2008-7#8)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#7)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-7#7)(2010-8#3)(2011-1#1)(2011-2#4)(2011-8#1)(2012-12#3)(2012-3#3)(2013-1#7)(2013-8#10)
caregivers'##5##1##(1991-12#1)(1992-3#1)(2007-10#1)(2009-5#1)(2010-12#1)
caregivers]##2##1##(1997-3#1)(2011-2#1)
caregiving##28##1##(1991-12#1)(1992-3#2)(1994-1#1)(1994-3#1)(1995-1#2)(1995-3#2)(1996-1#2)(1997-3#1)(2008-6#3)(2008-7#3)(2010-6#2)(2010-7#1)(2012-2#5)(2013-8#2)
carer##6##1##(2008-11#1)(2008-12#3)(2009-6#1)(2011-1#1)
carers and service users##2##4##(2012-3#2)
carers and##4##2##(2008-12#1)(2009-5#1)(2012-3#2)
carers more##2##2##(2008-12#2)
carers should##2##2##(1996-11#1)(1997-8#1)
carers##23##1##(1996-11#1)(1997-8#1)(2008-11#1)(2008-12#5)(2009-5#1)(2009-6#4)(2010-12#1)(2011-1#5)(2011-2#1)(2012-3#2)(2013-8#1)
cares about##2##2##(1995-12#1)(2008-12#1)
cares for##2##2##(1995-2#1)(2008-9#1)
cares what##2##2##(1995-1#1)(2008-10#1)
cares##8##1##(1995-1#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-3#1)
caretakers##6##1##(1991-1#1)(1991-12#1)(2010-6#3)(2013-8#1)
cargo into##2##2##(2008-7#2)
cargo##12##1##(1990-6#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-8#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
cargo-specific##2##1##(2008-11#1)(2009-10#1)
cargoes##3##1##(2008-11#1)(2008-7#1)(2010-12#1)
carica##2##1##(2008-10#2)
caries and obesity##2##3##(2010-3#2)
caries and##14##2##(1990-3#2)(1991-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#2)(2011-1#2)(2012-2#3)(2013-8#1)
caries in##5##2##(2008-12#1)(2010-3#1)(2011-1#2)(2011-2#1)
caries is a##2##3##(1991-6#1)(2012-2#1)
caries is##3##2##(1991-6#1)(2012-2#1)(2013-8#1)
caries prevalence##4##2##(2008-1#2)(2013-8#2)
caries prevention##2##2##(2008-1#1)(2013-1#1)
caries risk##2##2##(2011-1#1)(2011-2#1)
caries the##2##2##(2007-11#2)
caries vaccine##2##2##(2013-8#2)
caries##75##1##(1990-3#2)(1991-6#5)(2007-11#2)(2007-7#3)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#4)(2008-9#2)(2010-10#1)(2010-3#5)(2010-9#1)(2011-1#9)(2011-2#3)(2012-2#13)(2013-1#2)(2013-7#1)(2013-8#10)
caries-related factors##2##2##(2012-2#2)
caries-related##4##1##(2012-2#4)
carina##7##1##(2007-8#1)(2010-7#2)(2011-3#1)(2012-1#2)(2012-3#1)
carinal resection##3##2##(2007-8#1)(2010-7#2)
carinal##4##1##(2007-8#1)(2010-7#2)(2012-1#1)
carinata (BC genome)##2##3##(2008-10#2)
carinata##4##1##(2008-10#4)
carinatum) and##2##2##(2008-10#1)(2012-2#1)
caring and##6##2##(1990-6#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#1)
caring are##2##2##(2008-1#1)(2008-11#1)
caring for a premature##2##4##(2011-2#2)
caring for a##8##3##(1992-12#1)(1992-3#1)(1997-8#1)(2007-10#1)(2011-2#4)
caring for children##3##3##(1995-12#1)(2008-9#1)(2012-2#1)
caring for older people##2##4##(2010-10#2)
caring for older##3##3##(2010-10#2)(2011-1#1)
caring for patients who##2##4##(2011-2#1)(2013-8#1)
caring for patients with##7##4##(2007-7#1)(2008-11#1)(2010-3#1)(2010-7#2)(2010-9#1)(2012-2#1)
caring for patients##12##3##(1994-2#1)(1997-2#1)(2007-7#1)(2008-11#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
caring for people##2##3##(1993-3#1)(2011-1#1)
caring for the##5##3##(1991-3#1)(2008-1#1)(2008-11#2)(2008-9#1)
caring for their children##2##4##(1996-1#1)(2012-3#1)
caring for their##5##3##(1996-1#1)(1996-12#1)(2009-11#1)(2011-2#1)(2012-3#1)
caring for themselves##2##3##(2007-10#1)(2012-3#1)
caring for these patients##2##4##(2008-11#1)(2011-1#1)
caring for##61##2##(1991-3#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-11#8)(2008-9#2)(2009-11#1)(2009-5#2)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
caring in the best interests of the child##2##8##(2010-9#2)
caring in##4##2##(2009-5#1)(2010-9#2)(2012-1#1)
caring of##2##2##(1992-3#1)(2012-3#1)
caring role and##2##3##(2011-1#2)
caring role##3##2##(2011-1#3)
caring roles##4##2##(2009-5#4)
caring##129##1##(1990-6#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#22)(2008-11#13)(2008-12#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#10)(2010-10#4)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#8)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#3)(2013-8#4)
caring-healing##2##1##(2008-1#2)
carinii pneumonia##5##2##(1990-6#1)(1990-9#1)(1993-2#1)(2006-10#1)(2007-12#1)
carinii##7##1##(1990-11#1)(1990-6#1)(1990-9#1)(1992-5#1)(1993-2#1)(2006-10#1)(2007-12#1)
cariogenic##4##1##(2008-9#1)(2012-2#1)(2013-1#2)
carious lesions##2##2##(2011-2#1)(2012-2#1)
carious##7##1##(2008-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
cariously involved primary teeth##2##4##(2011-2#2)
carlavirus##2##1##(2008-10#1)(2008-9#1)
carlaviruses##2##1##(2008-10#1)(2008-9#1)
carlo##7##1##(2008-2#3)(2008-3#4)
carmine##12##1##(1990-6#2)(1993-8#4)(2008-10#5)(2013-8#1)
carminic acid at##3##3##(2008-10#3)
carminic acid##8##2##(2008-10#8)
carmovirus##3##1##(2008-10#3)
carmustine##2##1##(2010-11#2)
carnation and##3##2##(2008-10#3)
carnation##9##1##(2008-10#9)
carnitine levels##2##2##(1991-2#1)(1995-12#1)
carnitine palmitoyltransferase##3##2##(1990-11#1)(1992-8#1)(2012-2#1)
carnitine was##2##2##(1991-2#2)
carnitine##19##1##(1990-11#1)(1991-2#4)(1992-8#2)(1995-12#3)(1995-6#3)(2007-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
carnivore##3##1##(2008-5#1)(2008-9#1)(2009-4#1)
carnivores##10##1##(1994-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#3)(2012-3#3)
carnivorous species##2##2##(2008-5#1)(2008-8#1)
carnivorous##5##1##(2008-5#2)(2008-8#2)(2009-8#1)
carolinensis##4##1##(2008-5#1)(2011-2#3)
carota L##4##2##(1994-11#1)(2008-8#2)(2008-9#1)
carotae##2##1##(2008-10#2)
carotene##2##1##(2008-10#1)(2012-1#1)
carotenoid content was##2##3##(2008-10#1)(2008-12#1)
carotenoid content##4##2##(2007-11#1)(2008-10#2)(2008-12#1)
carotenoid pigments##3##2##(2007-11#2)(2009-10#1)
carotenoid with##4##2##(2010-2#4)
carotenoid##38##1##(1992-8#1)(1992-9#1)(1995-2#2)(2007-11#4)(2008-10#7)(2008-12#3)(2008-8#7)(2009-10#3)(2009-9#1)(2010-10#4)(2010-2#4)(2011-1#1)
carotenoids and##3##2##(2008-12#1)(2011-2#2)
carotenoids in##7##2##(1992-9#1)(2008-10#2)(2010-2#4)
carotenoids##34##1##(1992-8#3)(1992-9#5)(2008-10#4)(2008-12#5)(2009-11#1)(2010-2#11)(2011-2#2)(2012-2#2)(2013-8#1)
carotenoprotein complexes##2##2##(2008-12#2)
carotid IMT##2##2##(2008-3#1)(2012-3#1)
carotid and##6##2##(2008-11#2)(2008-4#1)(2009-12#1)(2011-2#1)(2013-8#1)
carotid angiogram##2##2##(2008-7#2)
carotid arteries and##3##3##(1996-9#1)(2008-7#1)(2012-2#1)
carotid arteries was##2##3##(2008-7#1)(2011-2#1)
carotid arteries were##3##3##(1996-9#1)(2006-12#1)(2008-7#1)
carotid arteries##27##2##(1991-5#2)(1996-9#2)(2006-12#2)(2007-10#1)(2008-7#10)(2008-8#2)(2011-1#2)(2011-2#5)(2012-2#1)
carotid artery and##3##3##(2007-10#1)(2011-2#1)(2013-8#1)
carotid artery aneurysm##2##3##(1992-5#1)(2008-7#1)
carotid artery disease##5##3##(2008-7#2)(2008-8#2)(2011-2#1)
carotid artery for##3##3##(1995-12#1)(2009-12#1)(2011-1#1)
carotid artery in##6##3##(1995-12#1)(2007-10#1)(2008-3#1)(2008-7#3)
carotid artery intima-media thickness##2##4##(2010-10#1)(2013-8#1)
carotid artery is not##2##4##(1993-3#1)(2008-7#1)
carotid artery is##4##3##(1993-3#2)(2008-7#1)(2012-3#1)
carotid artery lesions##3##3##(2007-10#3)
carotid artery ligation##4##3##(1996-5#2)(1997-2#1)(2007-8#1)
carotid artery occlusion##5##3##(1993-12#1)(1996-12#1)(2007-10#2)(2008-7#1)
carotid artery stenosis##10##3##(2007-8#3)(2008-7#4)(2008-8#1)(2011-2#1)(2013-1#1)
carotid artery was##3##3##(2008-7#2)(2008-9#1)
carotid artery##115##2##(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1995-12#3)(1996-12#1)(1996-5#3)(1997-2#3)(1997-3#3)(1997-6#6)(1997-8#1)(2006-12#2)(2006-6#1)(2007-10#11)(2007-8#6)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#26)(2008-8#4)(2008-9#1)(2009-12#1)(2009-7#4)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#3)
carotid atherosclerosis in##2##3##(2008-1#1)(2011-2#1)
carotid atherosclerosis##4##2##(2007-9#1)(2008-1#1)(2008-8#1)(2011-2#1)
carotid bifurcation##3##2##(1991-5#1)(1992-6#1)(2008-7#1)
carotid body##5##2##(1995-12#3)(1996-8#2)
carotid cavernous##3##2##(1996-6#1)(1996-9#1)(1997-3#1)
carotid disorders##2##2##(2011-3#2)
carotid duplex##3##2##(2008-7#3)
carotid endarterectomy (CEA)##2##3##(2007-8#1)(2008-8#1)
carotid endarterectomy##18##2##(1991-5#1)(1992-6#1)(1997-2#1)(2006-7#1)(2007-10#4)(2007-8#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-7#1)(2013-8#1)
carotid intima-media thickness and brachial artery flow-mediated vasodilatation##2##8##(2008-11#2)
carotid intima-media thickness and##3##4##(2008-1#1)(2008-11#2)
carotid intima-media thickness##6##3##(2008-1#1)(2008-11#3)(2008-7#1)(2012-2#1)
carotid intima-media##7##2##(2008-1#1)(2008-11#3)(2008-7#1)(2012-2#1)(2012-3#1)
carotid occlusion##8##2##(1995-12#1)(1996-6#1)(2007-10#4)(2008-7#2)
carotid or##2##2##(2007-10#1)(2009-7#1)
carotid plaque##7##2##(2008-8#6)(2010-9#1)
carotid smooth muscle##2##3##(1990-12#2)
carotid stenoses##2##2##(1996-6#1)(2008-7#1)
carotid stenosis and##2##3##(2007-10#1)(2011-2#1)
carotid stenosis in##2##3##(2008-7#1)(2008-8#1)
carotid stenosis is##3##3##(1997-2#1)(2008-7#2)
carotid stenosis##16##2##(1991-11#1)(1993-1#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#4)(2011-2#1)
carotid stenting##2##2##(2008-11#2)
carotid surgery##3##2##(1990-9#1)(1991-11#1)(2011-3#1)
carotid surgery]##2##2##(1990-9#1)(1997-2#1)
carotid system##2##2##(1996-9#2)
carotid##284##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#5)(1992-5#2)(1992-6#4)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1995-12#7)(1996-12#1)(1996-5#3)(1996-6#4)(1996-8#2)(1996-9#8)(1997-2#6)(1997-3#4)(1997-6#6)(1997-8#2)(2006-12#4)(2006-6#1)(2006-7#1)(2007-10#24)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#12)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#55)(2008-8#19)(2008-9#2)(2009-12#2)(2009-7#6)(2010-10#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#24)(2011-3#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#12)(2013-1#4)(2013-8#7)
carotid-ophthalmic aneurysm##2##2##(2008-7#2)
carotid-subclavian bypass##2##2##(1993-3#1)(2008-7#1)
carotovora and##3##2##(2008-10#2)(2010-11#1)
carotovora subsp##9##2##(1990-5#2)(2008-10#7)
carotovora was##2##2##(2008-10#2)
carotovora##21##1##(1990-5#4)(1991-9#1)(2008-10#14)(2010-11#2)
carp Carassius##4##2##(2008-12#2)(2008-7#1)(2010-8#1)
carp Cyprinus carpio##2##3##(2010-8#2)
carp Vg##2##2##(2008-10#2)
carp and the##2##3##(2008-12#2)
carp and##5##2##(2008-12#2)(2008-9#2)(2010-5#1)
carp farming sector##2##3##(2008-12#2)
carp farming##4##2##(2008-12#4)
carp##54##1##(1990-8#2)(1993-12#2)(2008-10#6)(2008-12#10)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#9)(2010-5#7)(2010-8#3)
carpal bones were##2##3##(2012-1#2)
carpal bones##5##2##(1997-3#1)(2008-9#1)(2012-1#3)
carpal instability##2##2##(2008-9#1)(2013-1#1)
carpal tunnel is##2##3##(2008-9#2)
carpal tunnel release##7##3##(2008-5#1)(2008-9#6)
carpal tunnel surgery##3##3##(2008-9#3)
carpal tunnel syndrome (CTS)##4##4##(2008-9#3)(2010-8#1)
carpal tunnel syndrome and##3##4##(2008-9#3)
carpal tunnel syndrome as##2##4##(2008-5#2)
carpal tunnel syndrome##23##3##(1994-11#1)(2007-8#2)(2008-12#4)(2008-5#2)(2008-9#11)(2010-8#2)(2013-1#1)
carpal tunnel##44##2##(1994-11#1)(1997-2#1)(2007-8#2)(2008-12#5)(2008-5#3)(2008-9#29)(2010-8#2)(2013-1#1)
carpal##59##1##(1994-11#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-12#5)(2008-5#3)(2008-9#36)(2010-8#2)(2012-1#4)(2013-1#3)
carpelipine##2##1##(2007-1#2)
carpels##3##1##(1997-2#1)(1997-8#1)(2008-8#1)
carpenter##3##1##(2008-7#3)
carpi ulnaris##4##2##(2008-9#2)(2009-5#2)
carpi##6##1##(1996-6#1)(2008-12#1)(2008-9#2)(2009-5#2)
carpio in the##2##3##(2010-8#2)
carpio##7##1##(2010-8#5)(2012-2#2)
carpocapsae##2##1##(2011-2#2)
carpogenic germination of sclerotia##2##4##(2008-10#2)
carpogenic germination of##4##3##(2008-10#4)
carpogenic germination##10##2##(2008-10#10)
carpometacarpal joint##3##2##(2008-9#3)
carpometacarpal##4##1##(2008-9#4)
carpophila##2##1##(2008-10#2)
carprofen##3##1##(2008-10#3)
carrageenan##8##1##(1991-8#1)(2008-12#1)(2008-7#3)(2011-10#1)(2013-7#2)
carrageenan-induced##5##1##(1993-2#2)(2010-5#1)(2011-1#1)(2013-7#1)
carriage in the##2##3##(2008-5#1)(2013-1#1)
carriage in##5##2##(1996-8#1)(2008-5#1)(2013-1#3)
carriage of##5##2##(1994-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
carriage##14##1##(1994-11#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#3)
carried a mutation##2##3##(2008-10#2)
carried a##9##2##(1990-5#1)(1995-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-5#1)
carried at least##2##3##(2009-10#1)(2012-3#1)
carried at##4##2##(1995-5#1)(2009-10#1)(2012-3#1)(2013-1#1)
carried by a flow of##2##5##(2008-1#1)(2008-10#1)
carried by a##6##3##(1990-12#1)(1990-5#1)(2008-1#1)(2008-10#2)(2008-5#1)
carried by the##11##3##(1990-5#1)(1995-5#1)(1995-6#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
carried by##34##2##(1990-12#1)(1990-5#2)(1993-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2012-3#2)(2013-8#1)
carried for##2##2##(2009-2#1)(2009-5#1)
carried forward##3##2##(2009-12#1)(2013-1#2)
carried in##7##2##(1990-11#1)(1996-3#1)(2008-10#1)(2008-3#2)(2012-2#1)(2013-8#1)
carried on##8##2##(1991-3#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2013-8#1)
carried only a##2##3##(2008-5#2)
carried only##3##2##(2008-11#1)(2008-5#2)
carried out a study##3##4##(1991-6#1)(2008-10#1)(2008-7#1)
carried out a##16##3##(1991-6#2)(1994-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
carried out according to##3##4##(1993-12#1)(2008-4#1)(2008-9#1)
carried out against##3##3##(2008-10#3)
carried out among the##2##4##(2007-7#1)(2011-2#1)
carried out among##3##3##(1991-11#1)(2007-7#1)(2011-2#1)
carried out an##2##3##(1991-3#1)(1996-2#1)
carried out and the##2##4##(2008-10#1)(2012-3#1)
carried out and##12##3##(2008-10#6)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-3#1)
carried out as a##3##4##(1990-12#1)(1995-5#1)(2012-1#1)
carried out as##9##3##(1990-12#1)(1995-5#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
carried out at a##2##4##(2008-10#2)
carried out at different##2##4##(2008-10#2)
carried out at the##11##4##(1994-6#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-12#3)(2008-3#2)(2010-1#1)
carried out at##55##3##(1994-11#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
carried out between##4##3##(1991-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
carried out by a##8##4##(2008-1#1)(2008-10#6)(2008-4#1)
carried out by applying##3##4##(2008-10#3)
carried out by means of a##2##6##(2007-11#1)(2011-2#1)
carried out by means of##10##5##(1991-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-7#1)
carried out by the##21##4##(1990-12#1)(1990-3#1)(1991-12#1)(1994-12#1)(2007-10#1)(2008-1#1)(2008-10#10)(2008-7#1)(2008-8#1)(2009-10#1)(2010-9#1)(2012-2#1)
carried out by use of##4##5##(2008-2#2)(2008-3#1)(2010-6#1)
carried out by using the##2##5##(1992-12#1)(2008-10#1)
carried out by using##13##4##(1992-12#1)(2008-10#11)(2013-1#1)
carried out by##124##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#73)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)
carried out due to##2##4##(1992-6#1)(2012-3#1)
carried out during the##4##4##(2010-1#1)(2012-2#1)(2013-1#2)
carried out during##9##3##(2007-11#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
carried out either by##2##4##(2007-11#1)(2007-7#1)
carried out either##4##3##(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)
carried out for a##2##4##(2008-7#1)(2011-1#1)
carried out for six##2##4##(2008-10#2)
carried out for the determination of##2##6##(2008-10#2)
carried out for the##7##4##(1991-2#1)(1994-5#1)(2008-10#2)(2008-2#1)(2010-12#1)(2012-2#1)
carried out for this##2##4##(2008-10#1)(2008-3#1)
carried out for##34##3##(1990-12#1)(1991-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1997-7#1)(2007-7#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
carried out from##3##3##(2008-10#2)(2012-3#1)
carried out high-resolution##2##3##(1990-7#1)(2012-3#1)
carried out in 20##2##4##(1996-7#1)(2008-6#1)
carried out in a##31##4##(1990-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-5#1)(2006-4#1)(2007-11#2)(2008-10#15)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#3)
carried out in an##8##4##(2008-10#4)(2008-2#3)(2013-7#1)
carried out in aqueous##4##4##(1992-8#1)(2008-10#2)(2008-6#1)
carried out in cases of##2##5##(1994-2#1)(1996-3#1)
carried out in four different##2##5##(1990-2#1)(1990-8#1)
carried out in four##3##4##(1990-2#1)(1990-8#1)(2008-11#1)
carried out in its fluorescent band##2##6##(2008-10#2)
carried out in order to achieve the##2##7##(2008-10#2)
carried out in order to##14##5##(1991-9#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2013-1#1)
carried out in the U##2##5##(1990-6#1)(2008-5#1)
carried out in the field##2##5##(2008-10#1)(2008-7#1)
carried out in the presence of##6##6##(1996-5#1)(2008-10#3)(2008-4#1)(2011-2#1)
carried out in the same##2##5##(1994-10#1)(2008-6#1)
carried out in the##44##4##(1990-6#1)(1991-6#1)(1992-11#1)(1993-6#1)(1994-10#1)(1995-12#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#18)(2008-12#2)(2008-2#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2011-2#2)(2013-1#1)
carried out in this##2##4##(2008-10#1)(2008-5#1)
carried out in two steps##3##5##(2007-11#1)(2008-10#2)
carried out in two##5##4##(2007-11#1)(2008-10#3)(2011-1#1)
carried out in various##3##4##(2007-11#1)(2009-12#1)(2013-7#1)
carried out in which##2##4##(1997-4#1)(2008-11#1)
carried out in##226##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-8#1)(1991-11#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-3#2)(1993-6#2)(1994-10#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#3)(1997-1#1)(1997-4#2)(1997-5#1)(2006-4#1)(2007-11#8)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#75)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#7)(2008-7#7)(2008-8#1)(2008-9#3)(2009-12#2)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#3)
carried out of##2##3##(1995-12#1)(2010-3#1)
carried out on a##17##4##(1992-5#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
carried out on an##4##4##(2008-2#1)(2008-6#1)(2011-1#2)
carried out on specimens##2##4##(2008-10#1)(2008-5#1)
carried out on the##25##4##(1993-9#1)(2007-2#1)(2007-6#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
carried out on young##2##4##(2008-7#1)(2012-1#1)
carried out on##105##3##(1990-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
carried out only in##2##4##(2008-10#1)(2008-7#1)
carried out only##3##3##(2008-10#2)(2008-7#1)
carried out over a##3##4##(2008-6#1)(2008-8#1)(2012-2#1)
carried out over the##4##4##(2008-10#3)(2008-2#1)
carried out over##9##3##(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
carried out the first##2##4##(2007-4#1)(2010-12#1)
carried out the##14##3##(1991-8#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2012-3#1)
carried out through a##2##4##(1996-1#1)(2008-9#1)
carried out through##9##3##(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
carried out to analyze##2##4##(2008-11#1)(2011-1#1)
carried out to assess the##2##5##(1994-3#1)(2008-10#1)
carried out to assess##9##4##(1991-5#1)(1993-8#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
carried out to characterize the##2##5##(1990-7#1)(2008-10#1)
carried out to characterize##3##4##(1990-7#1)(2007-11#1)(2008-10#1)
carried out to clarify the##3##5##(2008-10#1)(2008-6#1)(2010-5#1)
carried out to confirm##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
carried out to demonstrate the##3##5##(2008-2#1)(2008-3#1)(2010-11#1)
carried out to demonstrate##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
carried out to determine the effects of##2##7##(2013-1#2)
carried out to determine the##14##5##(1994-3#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#2)
carried out to determine##21##4##(1991-8#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#2)
carried out to develop a##3##5##(2008-10#2)(2008-5#1)
carried out to elucidate the##3##5##(1993-11#1)(2007-11#1)(2008-1#1)
carried out to establish##2##4##(2008-5#1)(2012-3#1)
carried out to estimate##2##4##(1996-7#1)(2008-4#1)
carried out to evaluate the##9##5##(1990-2#1)(1991-2#1)(1992-6#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-5#1)
carried out to evaluate##11##4##(1990-11#1)(1990-2#1)(1991-2#1)(1992-6#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-5#1)
carried out to examine this##3##5##(2007-12#1)(2010-2#2)
carried out to find##4##4##(1995-12#1)(2011-3#1)(2013-1#1)(2013-7#1)
carried out to further##2##4##(2008-12#1)(2010-2#1)
carried out to investigate the##10##5##(1991-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-6#1)(2009-7#1)
carried out to investigate##12##4##(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-6#1)(2009-7#1)(2013-8#1)
carried out to measure##2##4##(2008-12#1)(2008-3#1)
carried out to study the##3##5##(1991-12#1)(1994-6#1)(2008-11#1)
carried out to study##5##4##(1991-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
carried out to test the##2##5##(2008-10#1)(2008-3#1)
carried out to##123##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#7)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#3)(2009-12#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#5)(2011-3#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
carried out under various##2##4##(2008-10#1)(2008-3#1)
carried out under##11##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
carried out until the##2##4##(2008-10#2)
carried out until##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
carried out using a##16##4##(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-1#1)
carried out using an##5##4##(1994-9#1)(2008-10#3)(2010-3#1)
carried out using aqueous standards##3##5##(2008-10#3)
carried out using genetic##2##4##(2009-3#1)(2013-8#1)
carried out using six##2##4##(2008-12#1)(2010-5#1)
carried out using the##9##4##(1990-11#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2012-2#1)
carried out using these##2##4##(1991-5#1)(2010-7#1)
carried out using two##4##4##(2008-10#2)(2008-5#2)
carried out using##79##3##(1990-11#1)(1991-5#1)(1991-9#1)(1994-9#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#44)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
carried out via##2##3##(1996-2#1)(2010-11#1)
carried out with a##10##4##(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-4#1)(2013-1#1)
carried out with and without##2##5##(2007-12#1)(2008-10#1)
carried out with respect to the##2##6##(1997-7#1)(2008-10#1)
carried out with the##15##4##(1990-7#1)(1994-3#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-7#1)
carried out with these##2##4##(2008-10#1)(2008-7#1)
carried out with##80##3##(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#24)(2008-2#3)(2008-3#11)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#2)
carried out within the##5##4##(1990-3#1)(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
carried out within##8##3##(1990-3#2)(1995-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
carried out without any##3##4##(2008-10#3)
carried out without##6##3##(2008-10#5)(2013-7#1)
carried out##1183##2##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#6)(1990-5#3)(1990-6#4)(1990-7#3)(1990-8#3)(1990-9#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#11)(1991-8#6)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#6)(1993-6#5)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#4)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#5)(1996-6#1)(1996-7#4)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#9)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#27)(2007-12#9)(2007-2#1)(2007-4#4)(2007-6#3)(2007-7#7)(2007-8#4)(2008-1#9)(2008-10#401)(2008-11#21)(2008-12#22)(2008-2#34)(2008-3#47)(2008-4#10)(2008-5#58)(2008-6#20)(2008-7#28)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#6)(2010-12#6)(2010-2#7)(2010-3#5)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#17)(2011-2#42)(2011-3#2)(2012-1#5)(2012-12#10)(2012-2#16)(2012-3#19)(2012-7#1)(2013-1#37)(2013-7#9)(2013-8#11)
carried the##13##2##(1991-3#1)(1995-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
carried through##2##2##(2008-6#1)(2010-11#1)
carried to the##4##3##(2007-5#1)(2008-10#3)
carried to##8##2##(1997-8#1)(2007-5#1)(2008-10#4)(2008-12#1)(2012-1#1)
carried##1308##1##(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#6)(1990-5#6)(1990-6#4)(1990-7#3)(1990-8#3)(1990-9#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#11)(1991-8#6)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#9)(1993-6#6)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#4)(1994-7#1)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#7)(1996-2#5)(1996-3#3)(1996-5#5)(1996-6#2)(1996-7#4)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#9)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#28)(2007-12#9)(2007-2#2)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#4)(2008-1#10)(2008-10#428)(2008-11#23)(2008-12#24)(2008-2#35)(2008-3#51)(2008-4#11)(2008-5#64)(2008-6#21)(2008-7#32)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#5)(2010-10#2)(2010-11#7)(2010-12#6)(2010-2#7)(2010-3#5)(2010-4#4)(2010-5#9)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#19)(2011-2#43)(2011-3#2)(2012-1#6)(2012-12#12)(2012-2#17)(2012-3#25)(2012-7#1)(2013-1#42)(2013-7#9)(2013-8#14)
carrier and an##2##3##(2008-10#2)
carrier and the##2##3##(1992-6#1)(2008-9#1)
carrier and##12##2##(1992-6#1)(1995-11#1)(1995-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)
carrier animals##2##2##(2008-1#1)(2013-1#1)
carrier are##3##2##(2008-10#2)(2008-11#1)
carrier buffer solution##2##3##(2008-10#2)
carrier buffer##6##2##(1996-5#1)(2008-10#5)
carrier by##7##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
carrier concentration in the##2##4##(2008-10#1)(2008-3#1)
carrier concentration##8##2##(1992-6#2)(2008-10#3)(2008-3#3)
carrier concentrations##2##2##(1992-6#2)
carrier containing##2##2##(2008-10#2)
carrier control##5##2##(2007-12#1)(2008-10#4)
carrier density##4##2##(2007-11#2)(2008-3#1)(2008-7#1)
carrier detection##2##2##(1996-12#2)
carrier electrolyte##5##2##(1997-2#1)(2008-10#4)
carrier family##2##2##(1997-3#1)(2013-1#1)
carrier flow##5##2##(2008-10#5)
carrier for pORF-hGMCSF##2##3##(2012-2#2)
carrier for the##3##3##(1991-5#1)(1994-11#1)(2008-10#1)
carrier for##11##2##(1991-5#1)(1994-11#1)(1996-12#1)(2008-10#5)(2010-7#1)(2012-2#2)
carrier frequencies##3##2##(2008-2#3)
carrier frequency##9##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)
carrier fringe technique##2##3##(2008-3#2)
carrier fringe##4##2##(2008-2#2)(2008-3#2)
carrier fringes##11##2##(2008-2#4)(2008-3#7)
carrier gas at a flow rate of##2##7##(2008-10#2)
carrier gas flow rate##5##4##(2008-10#5)
carrier gas flow##8##3##(2008-10#7)(2011-2#1)
carrier gas##20##2##(2008-10#17)(2008-6#1)(2008-7#1)(2011-2#1)
carrier generation##2##2##(2008-3#2)
carrier has been##2##3##(2008-10#1)(2013-1#1)
carrier has##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
carrier in a##3##3##(2008-10#2)(2008-5#1)
carrier in the##2##3##(2008-10#1)(2008-2#1)
carrier in##14##2##(1993-8#1)(1995-6#1)(2008-10#9)(2008-2#1)(2008-5#1)(2012-12#1)
carrier into##2##2##(2008-10#2)
carrier ionophore##5##2##(1990-2#5)
carrier is introduced##2##3##(2008-2#1)(2008-3#1)
carrier is##4##2##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
carrier kinetics and##2##3##(2007-12#2)
carrier lifetimes##2##2##(2007-12#2)
carrier material for##2##3##(2011-2#2)
carrier material##3##2##(2008-7#1)(2011-2#2)
carrier mediated##2##2##(1992-3#2)
carrier moiety##2##2##(1995-5#2)
carrier of E##2##3##(1994-9#2)
carrier of##15##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-9#4)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)
carrier on##2##2##(1990-11#1)(1995-11#1)
carrier phase##2##2##(2007-11#1)(2007-12#1)
carrier protein##18##2##(1990-5#1)(1990-7#1)(1992-3#1)(1992-4#3)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)
carrier proteins##6##2##(1992-3#1)(1994-9#1)(1995-6#1)(2008-2#1)(2008-5#2)
carrier rate##3##2##(2008-7#3)
carrier signal##2##2##(2007-11#1)(2009-8#1)
carrier solution##26##2##(2008-10#26)
carrier state##4##2##(1996-3#1)(1997-3#1)(2009-5#2)
carrier status##2##2##(2011-1#1)(2013-1#1)
carrier stream and##4##3##(2008-10#4)
carrier stream containing 0##2##4##(2008-10#2)
carrier stream containing##3##3##(2008-10#3)
carrier stream of##7##3##(2008-10#7)
carrier stream to##4##3##(2008-10#4)
carrier stream##35##2##(2008-10#35)
carrier system for##2##3##(2008-5#1)(2010-10#1)
carrier system##5##2##(1994-12#1)(1995-11#1)(2008-10#1)(2008-5#1)(2010-10#1)
carrier that##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
carrier to carrier transfer##5##4##(2008-11#5)
carrier to##11##2##(1991-5#1)(1993-11#1)(2008-10#2)(2008-11#5)(2008-7#1)(2011-2#1)
carrier transfer##6##2##(2008-11#5)(2009-11#1)
carrier type##2##2##(2008-7#2)
carrier was prepared##3##3##(2008-10#3)
carrier was##7##2##(1994-12#1)(1994-5#1)(2008-10#5)
carrier were prepared##2##3##(2008-10#2)
carrier with##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
carrier##452##1##(1990-11#7)(1990-12#1)(1990-2#5)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#4)(1992-11#1)(1992-3#9)(1992-4#3)(1992-6#8)(1993-11#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#7)(1994-3#1)(1994-5#5)(1994-8#1)(1994-9#6)(1995-11#4)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#7)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#4)(2007-10#1)(2007-11#11)(2007-12#18)(2008-1#3)(2008-10#192)(2008-11#19)(2008-2#20)(2008-3#25)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#17)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-7#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
carrier's##2##1##(1991-12#1)(1993-3#1)
carrier-encoded##2##1##(2007-11#2)
carrier-envelope phase changes##2##3##(2007-12#2)
carrier-envelope phase coherence##2##3##(2007-11#2)
carrier-envelope phase of the##2##4##(2007-11#2)
carrier-envelope phase of##5##3##(2007-11#4)(2007-12#1)
carrier-envelope phase##17##2##(2007-11#13)(2007-12#4)
carrier-envelope##25##1##(2007-11#21)(2007-12#4)
carrier-mediated mechanism##2##2##(1994-12#1)(1994-8#1)
carrier-mediated##9##1##(1991-5#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(2008-4#1)(2011-3#1)
carrier-suppression##2##1##(2007-12#2)
carrier-to-noise ratio (CNR)##2##3##(2008-2#1)(2008-3#1)
carrier-to-noise ratio##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
carrier-transport properties##3##2##(2010-4#3)
carriers and a##2##3##(2008-10#1)(2008-11#1)
carriers and##7##2##(1992-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-4#1)
carriers are##2##2##(2008-10#1)(2012-6#1)
carriers at##2##2##(1990-11#1)(2008-3#1)
carriers by##4##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-9#1)
carriers compared with##2##3##(2012-12#2)
carriers during##2##2##(2008-11#2)
carriers for the##3##3##(1990-11#1)(2008-10#1)(2008-8#1)
carriers for##9##2##(1990-11#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-6#1)
carriers in a##2##3##(2008-11#1)(2011-2#1)
carriers in cell culture##2##4##(2008-11#2)
carriers in cesium ion selective electrodes##2##6##(2008-10#2)
carriers in plasticized##2##3##(2008-10#2)
carriers in the##2##3##(2007-11#1)(2012-2#1)
carriers in##22##2##(2007-11#1)(2008-10#8)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)
carriers is##2##2##(2011-2#2)
carriers of cystic fibrosis##2##4##(1991-3#1)(1991-8#1)
carriers of the##3##3##(1990-7#1)(2013-1#1)(2013-8#1)
carriers of##18##2##(1990-7#1)(1991-11#1)(1991-3#1)(1991-8#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-8#3)
carriers performed the##2##3##(2008-10#2)
carriers to##3##2##(1995-9#1)(2008-10#1)(2008-8#1)
carriers was##6##2##(1990-11#1)(2008-11#4)(2008-7#1)
carriers were##4##2##(1991-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
carriers who##2##2##(1990-3#1)(1993-3#1)
carriers with##5##2##(1992-6#1)(2008-10#1)(2008-9#1)(2013-1#2)
carriers##182##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-8#2)(1992-3#3)(1992-6#3)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-5#5)(1994-8#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-3#1)(1996-5#1)(1997-1#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#44)(2008-11#24)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2011-8#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2012-6#2)(2013-1#5)(2013-8#5)
carriers)##2##1##(2008-11#1)(2008-2#1)
carries a good prognosis##2##4##(2006-10#1)(2011-1#1)
carries a high risk of severe##2##6##(1995-5#1)(2008-7#1)
carries a high##3##3##(1995-5#1)(2008-12#1)(2008-7#1)
carries a##22##2##(1990-12#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-6#1)(2011-1#3)(2012-1#1)(2013-1#2)
carries an##5##2##(1993-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-3#1)
carries both##2##2##(1997-6#1)(2008-10#1)
carries information about the##2##4##(2008-3#2)
carries little##2##2##(1992-3#1)(2009-11#1)
carries out##7##2##(1990-11#1)(1993-3#1)(2008-10#2)(2008-3#1)(2010-8#1)(2013-8#1)
carries the risk of##3##4##(1994-9#1)(2008-11#1)(2011-2#1)
carries the##15##2##(1992-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
carries two##2##2##(2008-1#1)(2008-10#1)
carries##83##1##(1990-11#1)(1990-12#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
carrion##2##1##(2008-9#1)(2013-7#1)
carrot (Daucus carota)##2##3##(2008-10#2)
carrot (Daucus##3##2##(2008-10#2)(2008-9#1)
carrot motley##2##2##(2008-10#2)
carrot roots##3##2##(2008-10#3)
carrot somatic embryo##2##3##(2008-9#2)
carrot somatic##3##2##(2008-9#3)
carrot##31##1##(1997-4#1)(2008-10#22)(2008-12#1)(2008-8#1)(2008-9#5)(2010-10#1)
carrot)##2##1##(2007-12#2)
carrots##3##1##(2008-10#3)
carry a lower risk of##2##5##(1991-11#1)(2008-12#1)
carry a poor prognosis##2##4##(2008-3#1)(2011-2#1)
carry a risk of##2##4##(1992-6#1)(2008-8#1)
carry a##19##2##(1991-11#1)(1992-6#1)(1994-12#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2011-2#1)(2013-1#2)
carry an##3##2##(2008-3#1)(2008-6#2)
carry and##3##2##(1991-2#1)(2008-10#2)
carry food to##2##3##(1993-6#2)
carry food##3##2##(1993-6#3)
carry on##2##2##(1991-9#1)(2008-2#1)
carry out a##5##3##(2007-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
carry out an##3##3##(1991-5#1)(2010-3#1)(2011-3#1)
carry out proof-reading##2##3##(1997-6#2)
carry out the##20##3##(1992-3#1)(1993-5#1)(1994-5#1)(1995-12#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#2)(2010-12#1)(2011-1#1)(2013-1#1)
carry out##69##2##(1990-2#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-6#3)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
carry the##16##2##(1991-12#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
carry them##2##2##(1994-1#1)(2008-5#1)
carry##163##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#4)(1994-1#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#3)
carry-over##4##1##(1997-4#1)(2008-10#2)(2009-6#1)
carry-to-leave when sated##2##3##(1993-6#2)
carrying a centrally located reduced AP site##2##7##(1995-2#2)
carrying a mutation in##2##4##(1993-3#1)(1996-2#1)
carrying a mutation##4##3##(1993-3#1)(1996-2#1)(1997-3#2)
carrying a##37##2##(1990-2#1)(1990-5#1)(1990-7#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
carrying both##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
carrying capacities##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
carrying capacity for##2##3##(2008-10#2)
carrying capacity##10##2##(1994-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#1)
carrying either##2##2##(1990-5#1)(2008-11#1)
carrying human##3##2##(2008-4#1)(2010-1#2)
carrying information##2##2##(2008-1#1)(2008-11#1)
carrying multiple copies of the##2##5##(1993-12#1)(1995-8#1)
carrying multiple##4##2##(1993-12#1)(1995-8#1)(2008-10#1)(2008-9#1)
carrying one##2##2##(1996-10#1)(2008-10#1)
carrying out a##5##3##(1990-9#1)(2008-10#3)(2008-11#1)
carrying out an##2##3##(1991-5#1)(2008-10#1)
carrying out the##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#1)
carrying out##34##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-5#1)(1993-3#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
carrying the Vf gene##2##4##(2008-10#2)
carrying the Vf##3##3##(2008-10#3)
carrying the gene##3##3##(2008-10#2)(2008-11#1)
carrying the human##3##3##(2008-8#1)(2010-1#2)
carrying the mutations##3##3##(1995-6#3)
carrying the resistance gene##2##4##(2008-10#2)
carrying the##57##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#3)(1997-3#2)(1997-4#2)(1997-8#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-1#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)
carrying these##2##2##(2007-12#1)(2008-10#1)
carrying##237##1##(1990-11#2)(1990-2#1)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#2)(1995-2#3)(1995-5#4)(1995-6#3)(1995-8#2)(1996-10#2)(1996-2#2)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#63)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#12)(2008-9#10)(2009-10#1)(2009-8#3)(2009-9#2)(2010-1#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#5)(2012-2#2)(2013-1#1)(2013-7#1)
carrying-to-eat##2##1##(1993-6#2)
carrying-to-leave##2##1##(1993-6#2)
carryover##9##1##(2008-10#8)(2013-8#1)
cars##6##1##(1997-6#1)(2008-10#1)(2008-11#3)(2010-11#1)
cart##2##1##(2010-7#1)(2011-2#1)
carthamin##6##1##(2008-11#6)
carthlicum##2##1##(2012-3#2)
cartilage and bone##9##3##(1991-5#2)(1994-12#1)(2007-11#3)(2008-5#1)(2008-7#1)(2011-2#1)
cartilage and tendon##2##3##(2008-9#1)(2009-7#1)
cartilage and##18##2##(1991-5#2)(1994-12#1)(1997-3#1)(2007-11#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
cartilage cell cultures##2##3##(1990-11#2)
cartilage cells to##2##3##(1990-11#2)
cartilage cells##6##2##(1990-11#4)(2007-8#1)(2008-9#1)
cartilage damage##3##2##(2008-5#1)(2010-10#2)
cartilage defect##2##2##(2011-2#2)
cartilage degradation##2##2##(1993-2#1)(2011-2#1)
cartilage differentiation##2##2##(1994-11#1)(2008-11#1)
cartilage framework##2##2##(2009-1#2)
cartilage from##4##2##(1991-9#1)(1993-12#2)(2008-7#1)
cartilage grafting##2##2##(2007-8#1)(2009-1#1)
cartilage in the##2##3##(2009-10#1)(2012-3#1)
cartilage in##4##2##(2009-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
cartilage is##2##2##(2008-3#1)(2011-2#1)
cartilage matrix##2##2##(2011-2#1)(2012-1#1)
cartilage of##4##2##(1993-12#1)(2007-11#1)(2008-7#1)(2008-9#1)
cartilage or##3##2##(1997-6#1)(2008-11#1)(2010-3#1)
cartilage proteoglycan##2##2##(1991-5#1)(1993-2#1)
cartilage regeneration##2##2##(2010-10#1)(2012-3#1)
cartilage replacement##3##2##(2009-9#3)
cartilage rings##2##2##(1990-3#2)
cartilage tissue##7##2##(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)
cartilage##139##1##(1990-11#7)(1990-3#2)(1991-5#5)(1991-9#5)(1992-8#1)(1993-12#3)(1993-2#5)(1994-11#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-6#1)(2007-11#5)(2007-7#1)(2007-8#5)(2008-1#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#11)(2008-7#6)(2008-8#1)(2008-9#7)(2009-1#3)(2009-10#1)(2009-12#3)(2009-7#1)(2009-9#5)(2010-10#4)(2010-12#1)(2010-3#1)(2010-8#3)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#4)(2013-8#1)
cartilage-producing cells##2##2##(2008-9#2)
cartilages were##2##2##(1992-3#1)(2007-11#1)
cartilages##6##1##(1992-3#1)(2007-11#3)(2008-11#2)
cartilaginous##15##1##(1990-9#1)(1992-4#1)(1997-3#1)(2007-11#2)(2007-7#2)(2008-7#1)(2008-9#2)(2009-1#2)(2009-10#1)(2009-6#1)(2010-8#1)
cartridge and##4##2##(2008-10#4)
cartridge containing##3##2##(2008-10#3)
cartridge is##6##2##(2008-10#6)
cartridge to##2##2##(2008-10#2)
cartridge was##8##2##(2008-10#8)
cartridge##61##1##(1991-5#1)(1994-12#1)(1997-2#3)(2008-10#53)(2011-1#3)
cartridges and##6##2##(1993-2#1)(2008-10#5)
cartridges to remove##2##3##(2008-10#2)
cartridges were##6##2##(2008-10#6)
cartridges with subsequent##2##3##(1996-5#1)(2008-10#1)
cartridges with##4##2##(1996-5#1)(2008-10#3)
cartridges##40##1##(1991-5#1)(1992-11#1)(1993-2#1)(1996-5#1)(2008-10#33)(2008-11#1)(2008-5#1)(2010-8#1)
cartridges)##2##1##(2008-10#2)
carvacrol in##4##2##(2008-10#2)(2008-11#2)
carvacrol were##2##2##(2008-11#2)
carvacrol##18##1##(2008-10#3)(2008-11#13)(2008-12#2)
carvedilol and##2##2##(2010-4#2)
carvedilol##15##1##(1992-5#1)(1995-12#2)(2008-10#4)(2010-4#6)(2011-1#2)
carvone##4##1##(2007-11#2)(2008-10#2)
caryophyllene oxide##2##2##(2008-11#1)(2008-12#1)
caryophyllene##3##1##(2008-10#1)(2008-11#1)(2008-12#1)
caryopsis##4##1##(2008-10#3)(2008-5#1)
cas d'abcès##2##2##(2011-2#2)
cas de##6##2##(2011-2#1)(2013-1#5)
cas pendant le##2##3##(2013-1#2)
cas##25##1##(2011-2#9)(2013-1#16)
casbene synthase cDNA##2##3##(1994-8#2)
casbene synthase##3##2##(1994-8#3)
cascade and##8##2##(1992-11#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-8#2)(2011-2#1)
cascade correlation networks##4##3##(2008-10#4)
cascade in the##3##3##(1990-12#1)(1994-12#1)(2012-12#1)
cascade in##8##2##(1990-12#1)(1994-12#1)(1995-2#2)(2007-12#1)(2008-4#1)(2012-12#1)(2013-7#1)
cascade is##4##2##(2008-2#1)(2008-3#1)(2009-8#2)
cascade leading to##2##3##(1995-12#1)(2009-8#1)
cascade occurs##2##2##(1995-2#1)(2008-7#1)
cascade of events##3##3##(1992-9#1)(1993-8#1)(2009-9#1)
cascade of reactions##2##3##(1994-6#1)(2008-5#1)
cascade of##20##2##(1992-9#1)(1993-8#1)(1994-6#2)(1995-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#2)(2009-9#1)(2010-10#1)(2010-6#1)(2012-2#2)(2012-3#1)
cascade process##2##2##(2007-12#1)(2010-2#1)
cascade quadratic##3##2##(2007-12#3)
cascade system##3##2##(2008-3#2)(2008-6#1)
cascade that##2##2##(2008-4#1)(2008-9#1)
cascade to##2##2##(1995-5#1)(2009-8#1)
cascade##126##1##(1990-12#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-6#4)(1994-8#2)(1995-12#1)(1995-2#4)(1995-5#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-11#9)(2007-12#13)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#10)(2009-9#2)(2010-10#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-7#2)(2013-8#1)
cascade&quot##2##1##(1991-9#1)(2008-2#1)
cascaded correlator##2##2##(2008-3#2)
cascaded couplers##2##2##(2008-2#1)(2008-3#1)
cascaded nonlinear couplers##2##3##(2008-3#2)
cascaded nonlinear##3##2##(2007-12#1)(2008-3#2)
cascaded second-order processes in a##2##5##(2007-12#1)(2008-2#1)
cascaded second-order processes##3##3##(2007-12#1)(2008-2#2)
cascaded second-order##4##2##(2007-12#2)(2008-2#2)
cascaded##43##1##(2007-11#5)(2007-12#12)(2008-2#8)(2008-3#18)
cascaded-focus optical##2##2##(2007-12#2)
cascades and##2##2##(2008-7#1)(2008-8#1)
cascades are##4##2##(1996-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
cascades in##5##2##(1995-8#1)(1997-1#1)(2008-1#1)(2008-8#2)
cascades of##2##2##(1994-5#1)(2013-1#1)
cascades that##5##2##(1996-2#1)(2008-4#1)(2008-7#2)(2009-8#1)
cascades##41##1##(1990-7#1)(1994-5#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#9)(2009-12#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
cascading of two##2##3##(2007-11#1)(2007-12#1)
cascading of##3##2##(2007-11#1)(2007-12#2)
cascading##16##1##(2007-11#5)(2007-12#6)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
case - control study##4##4##(2008-11#4)
case 1 waters##6##3##(2008-2#4)(2008-3#2)
case 1##12##2##(2006-12#2)(2008-2#4)(2008-3#4)(2009-2#2)
case 2 waters##4##3##(2008-2#1)(2008-3#3)
case 2##8##2##(2006-12#1)(2008-2#1)(2008-3#3)(2009-2#3)
case B##2##2##(2013-1#2)
case a##3##2##(1991-3#1)(2007-10#1)(2008-2#1)
case adds##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
case against a##2##3##(1991-3#1)(2007-2#1)
case against##7##2##(1991-3#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-2#1)(2011-2#1)
case also highlights##2##3##(2009-3#1)(2013-1#1)
case also##6##2##(2006-10#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-8#1)(2013-1#1)
case analysis##4##2##(1993-3#1)(1996-1#1)(1996-2#1)(2008-11#1)
case and it##2##3##(1996-3#1)(2008-5#1)
case and review of the literature##8##6##(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2013-1#2)
case and review of the literature]##3##6##(1990-5#1)(1990-6#1)(1997-3#1)
case and review of the##12##5##(1990-5#1)(1990-6#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-5#1)(2013-1#2)
case and review of##15##4##(1990-5#1)(1990-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#2)
case and review##18##3##(1990-5#1)(1990-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2013-1#4)
case and that##2##3##(2008-7#1)(2008-9#1)
case and the##5##3##(1993-5#1)(2007-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
case and##54##2##(1990-5#1)(1990-6#1)(1992-2#1)(1992-4#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-3#2)(1996-8#1)(1997-3#2)(2007-10#4)(2007-11#2)(2007-2#3)(2007-7#1)(2008-10#1)(2008-12#5)(2008-5#2)(2008-7#4)(2008-9#2)(2009-3#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)
case are discussed##2##3##(1990-9#1)(1991-2#1)
case are##9##2##(1990-9#1)(1991-2#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
case as a##3##3##(1996-3#1)(2009-3#1)(2010-11#1)
case as##8##2##(1996-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-6#1)(2012-1#1)(2013-1#1)
case assumes that cells grow##2##5##(2008-7#2)
case at##3##2##(1992-3#1)(2007-11#1)(2008-8#1)
case because##4##2##(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
case being##2##2##(2007-7#1)(2008-2#1)
case both##2##2##(2008-3#1)(2008-5#1)
case by case##3##3##(1993-9#1)(2008-8#2)
case by##7##2##(1993-9#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-8#3)
case constitutes##2##2##(2007-5#1)(2011-2#1)
case control study##6##3##(2006-10#1)(2007-6#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-12#1)
case control##10##2##(1995-1#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
case definition for##2##3##(1994-11#1)(2007-12#1)
case definition##7##2##(1991-11#1)(1994-11#2)(2007-12#2)(2007-5#1)(2010-4#1)
case definitions##4##2##(1994-11#1)(2007-12#1)(2008-10#1)(2009-5#1)
case demonstrated##2##2##(1992-3#1)(2007-12#1)
case demonstrates##6##2##(1994-12#1)(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
case did the##3##3##(1991-8#1)(1997-8#1)(2008-9#1)
case did##4##2##(1991-8#1)(1997-8#1)(2008-1#1)(2008-9#1)
case due to##2##3##(2008-10#1)(2013-1#1)
case each##4##2##(1996-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
case example##10##2##(1993-12#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-9#2)
case examples##4##2##(1991-1#1)(1997-2#1)(2008-6#1)(2008-7#1)
case fatality (OR--1##2##3##(2007-10#2)
case fatality rate##3##3##(2008-8#2)(2011-1#1)
case fatality rates##6##3##(2008-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
case fatality##12##2##(2007-10#2)(2008-11#1)(2008-8#3)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
case finding and##2##3##(1991-8#1)(1994-11#1)
case for a##4##3##(1992-1#1)(1995-2#1)(2007-11#1)(2010-5#1)
case for risk-based premiums in##2##5##(2008-7#2)
case for risk-based##3##3##(2008-7#3)
case for the##8##3##(1991-6#1)(1993-1#1)(1994-1#1)(1995-2#1)(2008-11#2)(2008-5#1)(2009-3#1)
case for##64##2##(1990-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-5#1)(1993-1#1)(1994-1#1)(1994-2#2)(1994-5#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-2#2)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-8#3)
case from##6##2##(1991-2#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(2012-2#1)
case group##8##2##(1995-2#1)(2011-1#1)(2011-2#6)
case had##6##2##(1991-4#1)(2008-12#1)(2008-7#2)(2012-1#1)(2013-8#1)
case has been reported in##3##5##(2010-12#1)(2010-6#1)(2012-12#1)
case has been reported##4##4##(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
case has been##5##3##(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
case has##11##2##(1990-3#1)(1991-3#2)(1993-1#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
case highlights the challenges of##2##5##(2008-11#1)(2012-8#1)
case highlights the importance of##3##5##(2007-8#1)(2011-1#1)(2013-1#1)
case highlights the##10##3##(2007-8#2)(2008-11#1)(2008-7#1)(2011-1#3)(2012-8#1)(2013-1#2)
case highlights##13##2##(2006-10#1)(2007-8#3)(2008-11#1)(2008-7#1)(2011-1#4)(2012-8#1)(2013-1#2)
case histories are##3##3##(1991-2#1)(1995-11#1)(1997-2#1)
case histories of##2##3##(1995-5#1)(1996-11#1)
case histories##9##2##(1991-2#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-2#1)(2008-4#1)(2010-11#1)(2010-3#1)(2011-7#1)
case history and##2##3##(1990-6#1)(1995-5#1)
case history is presented of a##2##6##(1992-2#1)(1993-2#1)
case history is presented of##3##5##(1992-2#1)(1993-2#1)(1996-7#1)
case history is##4##3##(1992-2#1)(1993-2#1)(1996-3#1)(1996-7#1)
case history of a##5##4##(1991-8#1)(1992-2#1)(1994-12#1)(2008-6#1)(2012-12#1)
case history of##8##3##(1991-8#1)(1992-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(2008-6#1)(2012-12#1)
case history##19##2##(1990-6#1)(1991-8#1)(1992-2#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-5#2)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
case if##3##2##(1992-2#1)(1992-3#1)(1994-5#1)
case illustrates a##2##3##(2010-8#1)(2012-2#1)
case illustrates that##3##3##(1997-8#1)(2008-7#1)(2009-8#1)
case illustrates##11##2##(1997-3#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
case in a##8##3##(1994-9#1)(2007-7#1)(2008-11#1)(2009-2#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
case in the##10##3##(1991-4#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)
case in which a##4##4##(2007-8#1)(2008-3#1)(2010-3#1)(2012-2#1)
case in which an##3##4##(2008-11#1)(2008-3#1)(2010-11#1)
case in which the##10##4##(2007-7#1)(2008-2#1)(2008-3#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
case in which##32##3##(1990-2#1)(1992-2#1)(1993-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#11)(2008-7#2)(2008-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
case in##78##2##(1990-12#1)(1990-2#2)(1991-4#1)(1991-9#2)(1992-2#1)(1993-10#1)(1993-11#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#12)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
case involving a##3##3##(2008-3#1)(2009-9#1)(2010-8#1)
case involving##4##2##(2008-3#1)(2009-2#1)(2009-9#1)(2010-8#1)
case is a##5##3##(2007-10#1)(2007-2#1)(2008-10#1)(2013-1#1)(2013-7#1)
case is considered##2##3##(2013-1#1)(2013-7#1)
case is described of a##3##5##(1991-3#1)(2008-2#1)(2012-12#1)
case is described of##4##4##(1991-3#1)(2008-2#1)(2008-4#1)(2012-12#1)
case is described##5##3##(1991-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)
case is discussed##3##3##(2007-7#1)(2008-2#1)(2010-11#1)
case is presented of a##2##5##(2008-10#1)(2013-7#1)
case is presented of##4##4##(1992-2#1)(2008-10#1)(2010-3#1)(2013-7#1)
case is presented that##2##4##(1993-1#1)(2011-2#1)
case is presented##12##3##(1992-2#1)(1993-1#1)(1994-11#1)(2008-10#1)(2008-7#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
case is rare##2##3##(2008-7#1)(2009-3#1)
case is reported of##3##4##(1990-6#2)(1991-3#1)
case is reported##6##3##(1990-6#2)(1991-3#1)(1992-6#1)(2008-2#1)(2010-5#1)
case is that##4##3##(1990-9#1)(1997-4#1)(2008-1#1)(2010-6#1)
case is the first##3##4##(2006-10#1)(2011-2#1)(2012-3#1)
case is the##6##3##(2006-10#1)(2007-10#2)(2011-2#2)(2012-3#1)
case is unusual##2##3##(2008-7#1)(2010-10#1)
case is##63##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-3#2)(1991-6#1)(1992-2#2)(1992-6#1)(1993-1#1)(1994-11#1)(1994-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#3)
case it was##2##3##(1990-2#1)(2008-11#1)
case it##3##2##(1990-2#1)(2008-1#1)(2008-11#1)
case law##7##2##(1991-2#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(2007-4#1)
case management and##3##3##(1994-12#1)(1995-12#1)(2008-1#1)
case management in long-term care##2##5##(1992-3#2)
case management in long-term##3##4##(1992-3#2)(1996-1#1)
case management in##9##3##(1992-3#2)(1995-3#1)(1996-1#5)(1997-3#1)
case management is##2##3##(1993-1#1)(2008-1#1)
case management model##2##3##(1997-1#1)(1997-3#1)
case management of##2##3##(1996-1#1)(2010-5#1)
case management on##2##3##(1993-12#1)(1996-3#1)
case management process##2##3##(1995-12#2)
case management services##2##3##(1996-2#1)(2010-6#1)
case management systems##2##3##(1997-1#1)(1997-2#1)
case management to##2##3##(1994-2#1)(1997-1#1)
case management##67##2##(1991-12#3)(1992-12#1)(1992-2#1)(1992-3#5)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#4)(1995-12#6)(1995-3#2)(1996-1#10)(1996-2#2)(1996-3#1)(1997-1#5)(1997-2#5)(1997-3#10)(2008-1#2)(2009-11#1)(2010-5#1)(2010-6#1)(2012-2#1)
case manager##4##2##(1991-12#1)(1992-3#1)(1997-2#1)(2008-1#1)
case managers##5##2##(1991-2#1)(1992-1#1)(1996-12#1)(1996-2#2)
case mix adjustment##5##3##(1994-1#1)(1995-2#4)
case mix and severity of illness##2##6##(1993-12#1)(1995-2#1)
case mix and##6##3##(1992-12#2)(1992-3#1)(1993-12#2)(1995-2#1)
case mix funding##4##3##(1991-12#1)(1995-2#3)
case mix grouping##2##3##(1993-12#1)(1995-1#1)
case mix groups##3##3##(1992-3#1)(1993-12#1)(1994-3#1)
case mix indices##2##3##(1995-2#2)
case mix management##2##3##(1992-12#1)(1994-3#1)
case mix measure##2##3##(1997-1#2)
case mix measurement using outpatient drug dispense##2##7##(1995-2#2)
case mix measurement##3##3##(1991-12#1)(1995-2#2)
case mix measures##2##3##(1995-2#2)
case mix##53##2##(1991-12#3)(1991-3#1)(1992-12#5)(1992-2#1)(1992-3#2)(1993-12#5)(1993-3#2)(1994-1#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-2#20)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#2)(2010-12#2)
case mortality##2##2##(2008-7#1)(2012-2#1)
case notes and##3##3##(1991-6#1)(2007-2#1)(2008-1#1)
case notes##7##2##(1991-6#1)(1996-9#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)
case of 44-year-old##3##3##(2008-7#1)(2011-2#1)(2013-7#1)
case of Achilles tendon rupture##2##5##(2010-3#2)
case of B##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
case of IFPs##2##3##(2013-8#2)
case of Riedel's thyroiditis##2##4##(2008-12#2)
case of Salmonella##2##3##(2007-7#1)(2009-8#1)
case of T-cell lymphoma##2##4##(1991-12#2)
case of Vietnam##2##3##(2010-3#2)
case of WDNC##2##3##(1991-6#2)
case of a 12-year-old boy with##2##6##(2008-10#1)(2008-11#1)
case of a 12-year-old boy##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
case of a 16-year-old##4##4##(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
case of a 19-year-old female##2##5##(2008-7#1)(2012-12#1)
case of a 21-year-old##2##4##(1991-8#1)(2013-1#1)
case of a 33-year-old man with##2##6##(2007-8#1)(2008-9#1)
case of a 33-year-old man##3##5##(2007-8#1)(2008-9#1)(2012-12#1)
case of a 35-year-old##4##4##(2008-11#1)(2011-2#2)(2013-1#1)
case of a 38-year-old##4##4##(1992-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
case of a 4-year-old##2##4##(2008-10#1)(2012-2#1)
case of a 41-year-old##2##4##(2012-3#2)
case of a 45-year-old woman##2##5##(2011-2#1)(2013-1#1)
case of a 45-year-old##4##4##(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
case of a 46-year-old##3##4##(2008-7#2)(2008-9#1)
case of a 48-year-old##2##4##(2008-6#1)(2010-5#1)
case of a 49-year-old##3##4##(2008-7#1)(2013-1#1)(2013-8#1)
case of a 50-year-old##2##4##(2012-2#2)
case of a 55-year-old##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
case of a 57-year-old man with##2##6##(2011-2#2)
case of a 58-year-old##2##4##(2011-2#1)(2013-1#1)
case of a 60-year-old man##3##5##(2007-4#1)(2007-8#1)(2008-7#1)
case of a 60-year-old woman##3##5##(2008-4#1)(2009-1#1)(2009-3#1)
case of a 60-year-old##7##4##(1997-2#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-3#1)
case of a 61-year-old##3##4##(2008-7#1)(2010-8#1)(2013-8#1)
case of a 63 years old##3##6##(1991-11#1)(2010-12#1)(2013-7#1)
case of a 63##4##4##(1991-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
case of a 65-year-old##3##4##(1992-10#1)(2012-2#1)(2012-3#1)
case of a 67-year-old female##2##5##(2012-3#1)(2013-1#1)
case of a 70-year-old##4##4##(2012-3#1)(2013-1#2)(2013-7#1)
case of a 72-year-old##4##4##(2008-12#1)(2008-7#1)(2010-6#1)(2012-12#1)
case of a 74-year-old##2##4##(2009-1#1)(2011-2#1)
case of a 75-year-old##2##4##(1991-11#1)(2012-1#1)
case of a 79-year-old female##2##5##(2008-11#1)(2013-7#1)
case of a boy##2##4##(1995-5#1)(2012-12#1)
case of a cardiac##2##4##(2007-8#1)(2008-11#1)
case of a child with##2##5##(2011-1#1)(2012-12#1)
case of a child##4##4##(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
case of a completely##2##4##(2008-2#1)(2012-3#1)
case of a cutaneous##2##4##(1990-8#1)(2010-6#1)
case of a female neonate##2##5##(2008-10#1)(2012-3#1)
case of a female patient with##3##6##(1992-12#1)(2008-1#1)(2012-12#1)
case of a female patient##4##5##(1992-12#1)(2008-1#1)(2012-12#2)
case of a female##6##4##(1992-12#1)(2008-1#1)(2008-10#1)(2012-12#2)(2012-3#1)
case of a giant##3##4##(2008-12#1)(2012-12#1)(2013-1#1)
case of a girl##3##4##(1991-6#1)(2008-4#1)(2011-1#1)
case of a large##5##4##(1992-5#1)(2007-8#2)(2008-7#1)(2011-2#1)
case of a male##3##4##(2010-3#1)(2011-2#1)(2012-12#1)
case of a patient with advanced##2##6##(1990-8#1)(2006-10#1)
case of a patient with##15##5##(1990-8#1)(1991-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
case of a patient##26##4##(1990-8#1)(1991-11#1)(1993-6#2)(1993-8#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-3#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
case of a previously##3##4##(2008-8#1)(2009-3#1)(2012-12#1)
case of a primary##3##4##(2008-10#2)(2013-1#1)
case of a successful##2##4##(2007-12#1)(2009-3#1)
case of a traumatic##2##4##(2008-7#1)(2011-2#1)
case of a young female##2##5##(2012-2#1)(2013-8#1)
case of a young male##3##5##(2006-10#1)(2007-8#1)(2012-2#1)
case of a young man##3##5##(2007-7#1)(2008-7#1)(2008-8#1)
case of a young woman with##2##6##(2006-10#1)(2010-12#1)
case of a young woman##3##5##(2006-10#1)(2008-7#1)(2010-12#1)
case of a young##14##4##(2006-10#2)(2007-7#1)(2007-8#1)(2008-7#2)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#3)(2013-8#1)
case of a##361##3##(1990-12#1)(1990-8#2)(1991-1#1)(1991-11#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-12#1)(1995-4#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#6)(2006-12#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#18)(2008-1#1)(2008-10#18)(2008-11#10)(2008-12#7)(2008-2#11)(2008-3#15)(2008-4#2)(2008-5#3)(2008-6#7)(2008-7#30)(2008-8#7)(2008-9#7)(2009-1#2)(2009-3#10)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#5)(2010-8#2)(2011-1#8)(2011-2#34)(2012-1#3)(2012-12#15)(2012-2#11)(2012-3#13)(2013-1#29)(2013-2#1)(2013-7#4)(2013-8#11)
case of acute##15##3##(1990-6#1)(1991-4#1)(1992-6#1)(1993-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-12#3)(2012-2#1)(2013-1#1)
case of advanced genital##2##4##(2008-11#2)
case of advanced##3##3##(1997-6#1)(2008-11#2)
case of allergic##2##3##(2009-2#1)(2012-12#1)
case of alveolar##2##3##(2010-11#1)(2011-2#1)
case of an 8-year-old##2##4##(2007-5#1)(2010-5#1)
case of an adult##3##4##(2007-8#1)(2012-2#1)(2012-3#1)
case of an elderly woman##2##5##(2011-1#1)(2013-1#1)
case of an elderly##5##4##(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
case of an immunocompetent patient##2##5##(2008-10#1)(2009-4#1)
case of an infant##2##4##(1991-2#1)(2012-2#1)
case of an unusual##2##4##(2008-10#1)(2011-1#1)
case of an##47##3##(1990-6#1)(1991-2#1)(1992-12#1)(1994-9#1)(2007-12#1)(2007-5#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
case of arsenic##2##3##(2008-10#1)(2011-2#1)
case of bacterial##2##3##(1990-8#1)(2007-7#1)
case of bilateral##14##3##(1994-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
case of bladder exstrophy##2##4##(2008-10#2)
case of bladder##4##3##(2008-10#4)
case of bone##2##3##(2008-12#1)(2013-1#1)
case of both##3##3##(2008-10#2)(2013-1#1)
case of breast cancer##2##4##(2008-10#1)(2009-1#1)
case of breast##5##3##(1992-6#1)(1992-8#1)(1993-12#1)(2008-10#1)(2009-1#1)
case of carcinoma##2##3##(1990-6#1)(1995-3#1)
case of cerebellar abscess##2##4##(2007-8#2)
case of chest##3##3##(1992-6#1)(2007-12#1)(2008-10#1)
case of child##2##3##(2007-11#1)(2008-12#1)
case of cholestatic##2##3##(1992-6#1)(1992-9#1)
case of chronic granulomatous disease##2##5##(2013-1#2)
case of chronic osteomyelitis##2##4##(2007-7#2)
case of chronic##10##3##(2007-7#2)(2008-1#1)(2008-11#1)(2010-8#1)(2011-2#2)(2013-1#3)
case of ciguatera##2##3##(2008-1#2)
case of colonic##2##3##(2007-12#1)(2013-8#1)
case of combined##2##3##(2008-9#1)(2011-2#1)
case of complete##4##3##(1993-8#1)(2008-10#2)(2013-8#1)
case of congenital pupillary-iris-lens membrane with goniodysgenesis##2##7##(2011-1#2)
case of congenital##7##3##(1993-5#1)(2008-12#1)(2010-11#1)(2010-9#1)(2011-1#2)(2012-3#1)
case of cutaneous##5##3##(2007-7#1)(2008-10#1)(2010-11#1)(2010-6#2)
case of desmoplastic##2##3##(2008-7#1)(2012-2#1)
case of diffuse##4##3##(2008-10#1)(2008-3#1)(2009-1#1)(2011-2#1)
case of double##2##3##(1990-8#1)(2007-8#1)
case of early##5##3##(1990-8#1)(2008-9#1)(2011-2#2)(2012-1#1)
case of endocarditis##2##3##(2007-12#2)
case of esophageal##2##3##(1997-8#1)(2010-6#1)
case of extracranial##2##3##(1992-5#1)(2008-7#1)
case of extreme##2##3##(2007-8#1)(2008-10#1)
case of facial##2##3##(2013-1#2)
case of failure and##2##4##(2008-11#1)(2009-4#1)
case of failure##3##3##(2008-11#1)(2009-4#1)(2012-2#1)
case of fat##2##3##(2007-10#1)(2011-2#1)
case of fatal##4##3##(1995-11#1)(2009-4#1)(2011-2#2)
case of faun tail##2##4##(2010-6#2)
case of focal##2##3##(1991-2#1)(2008-1#1)
case of fulminant amebic colitis##2##5##(2011-2#2)
case of gastric##6##3##(1991-5#1)(1992-9#2)(2007-5#1)(2008-5#1)(2009-8#1)
case of giant##7##3##(1991-6#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
case of global##2##3##(1994-8#1)(2008-6#1)
case of gout##2##3##(2006-10#1)(2011-2#1)
case of hereditary##3##3##(2010-6#1)(2012-3#1)(2013-1#1)
case of herniation of##3##4##(2007-8#1)(2009-4#1)(2011-2#1)
case of high-grade##2##3##(2011-2#1)(2013-1#1)
case of human##2##3##(2007-12#1)(2007-2#1)
case of hydatid cyst of##2##5##(1991-5#1)(2007-7#1)
case of hydatid cyst##3##4##(1991-5#1)(2007-7#1)(2010-11#1)
case of hypertension##2##3##(2008-1#1)(2009-3#1)
case of idiopathic##5##3##(1997-8#1)(2006-12#1)(2008-10#1)(2010-10#1)(2013-1#1)
case of inflammatory##2##3##(2010-6#2)
case of intestinal##2##3##(1990-5#1)(1990-6#1)
case of intractable##2##3##(2011-2#1)(2012-2#1)
case of invasive##2##3##(1996-12#1)(2008-11#1)
case of isolated##5##3##(2008-12#1)(2010-11#1)(2012-3#1)(2013-1#2)
case of lacking##2##3##(2012-2#1)(2013-8#1)
case of laryngeal##3##3##(1990-8#1)(2012-3#1)(2013-1#1)
case of late##3##3##(1993-3#1)(2008-9#1)(2013-1#1)
case of left##3##3##(1997-3#1)(2008-12#1)(2008-7#1)
case of leiomyosarcoma of##2##4##(2008-5#1)(2008-7#1)
case of leiomyosarcoma##4##3##(2008-5#1)(2008-6#2)(2008-7#1)
case of leukemia cutis at the site of a prior catheter insertion##2##12##(2010-6#2)
case of leukemia##3##3##(2010-6#2)(2011-2#1)
case of localized##2##3##(2007-7#1)(2011-2#1)
case of lung##3##3##(1994-12#1)(1996-9#1)(2011-2#1)
case of male##2##3##(2008-8#1)(2011-2#1)
case of malignant osteopetrosis##2##4##(2012-2#2)
case of malignant##5##3##(1992-10#1)(2008-7#1)(2010-1#1)(2012-2#2)
case of massive digestive hemorrhage##2##5##(1992-5#2)
case of massive##3##3##(1992-5#2)(2011-1#1)
case of medulloblastoma in##2##4##(2008-7#1)(2009-1#1)
case of membranous lipodystrophy observed in lichen amyloidosis##2##8##(2010-6#2)
case of meningitis caused by##2##5##(2007-12#1)(2009-11#1)
case of meningitis##3##3##(2007-12#1)(2009-11#1)(2011-2#1)
case of mixed##2##3##(2008-11#1)(2010-11#1)
case of multiple##7##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2012-1#1)(2013-1#2)
case of natural##3##3##(1990-8#1)(2008-10#1)(2012-12#1)
case of neonatal##2##3##(2008-5#1)(2011-1#1)
case of obstructive jaundice##2##4##(1991-3#1)(2007-10#1)
case of orbital##2##3##(2011-1#1)(2013-7#1)
case of pelvic##2##3##(2008-7#1)(2009-5#1)
case of penile fracture##2##4##(2008-10#1)(2008-7#1)
case of perpendicular##2##3##(2008-3#2)
case of persistent##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
case of pill-induced esophagitis##2##4##(2008-5#2)
case of pituitary##2##3##(2011-2#1)(2012-2#1)
case of pleural##3##3##(2007-7#1)(2007-8#2)
case of pneumocephalus secondary to##2##5##(2008-7#2)
case of pneumocephalus##3##3##(2008-7#2)(2008-9#1)
case of positive##3##3##(1993-2#1)(2011-2#1)(2012-2#1)
case of primary cutaneous##3##4##(2007-7#1)(2010-8#2)
case of primary retroperitoneal undifferentiated endometrial stromal sarcoma after concurrent chemoradiation therapy for cervical cancer##2##15##(2009-5#2)
case of primary##21##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#2)(1992-8#1)(1992-9#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#2)(2009-8#2)(2010-3#1)(2010-8#2)(2013-8#1)
case of prolonged##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
case of pulmonary alveolar##2##4##(2012-12#1)(2012-2#1)
case of pulmonary##14##3##(1990-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
case of quadricuspid aortic valve##2##5##(2008-11#1)(2012-3#1)
case of rapid##2##3##(2008-11#1)(2008-7#1)
case of reconstruction##3##3##(1990-3#1)(2007-11#1)(2009-4#1)
case of recurrent##8##3##(1991-6#1)(1993-1#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
case of retroperitoneal##3##3##(1990-6#1)(1994-6#1)(2008-1#1)
case of rhabdomyosarcoma##2##3##(2007-10#1)(2008-6#1)
case of ruptured##2##3##(2008-7#1)(2010-5#1)
case of rural##2##3##(2008-10#1)(2010-3#1)
case of salpingitis##2##3##(1997-6#2)
case of septic arthritis##2##4##(2006-10#1)(2010-12#1)
case of septic##3##3##(2006-10#1)(2010-12#1)(2012-12#1)
case of severe##15##3##(1990-10#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
case of sexual abuse##2##4##(1996-11#2)
case of sexual##3##3##(1996-11#2)(2008-8#1)
case of short bowel syndrome##2##5##(1991-12#1)(2008-10#1)
case of short bowel##3##4##(1991-12#1)(2008-10#2)
case of short##4##3##(1991-12#1)(1991-3#1)(2008-10#2)
case of small##3##3##(1991-6#1)(1992-12#1)(2008-10#1)
case of solitary##2##3##(1991-3#1)(2011-1#1)
case of spherical##2##3##(2007-12#1)(2008-3#1)
case of spontaneous hemocholecyst##2##4##(2013-1#2)
case of spontaneous##12##3##(1990-9#1)(1992-2#1)(1993-8#1)(1993-9#1)(2007-12#1)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#3)
case of stenosis##2##3##(2009-3#1)(2011-2#1)
case of successful##3##3##(2008-9#1)(2012-12#1)(2013-8#1)
case of such a lesion##2##5##(2008-7#1)(2010-7#1)
case of such a##3##4##(2008-7#1)(2010-7#1)(2012-2#1)
case of such##6##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
case of supernumerary spleen##2##4##(1990-5#2)
case of surgical##2##3##(1990-5#1)(2012-3#1)
case of symptomatic##3##3##(1993-9#1)(2008-7#1)(2012-12#1)
case of synchronous##2##3##(2008-10#1)(2009-1#1)
case of systemic lupus erythematosus##2##5##(2012-2#1)(2013-1#1)
case of systemic##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
case of the month##2##4##(2008-3#1)(2011-2#1)
case of the##86##3##(1990-11#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2006-12#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
case of this rare##2##4##(2008-6#1)(2012-3#1)
case of this type##2##4##(1990-5#1)(2010-3#1)
case of this##7##3##(1990-5#1)(1995-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
case of thyrotoxicosis##2##3##(2008-7#2)
case of trisomy##2##3##(1996-12#1)(2012-3#1)
case of type##3##3##(2009-5#1)(2013-8#2)
case of unilateral##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
case of unusual##3##3##(2008-7#1)(2008-9#1)(2010-1#1)
case of urogenital##2##3##(1990-9#1)(2008-10#1)
case of very long-term##2##4##(2011-2#2)
case of very##7##3##(2008-10#4)(2008-11#1)(2011-2#2)
case of##1774##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#5)(1990-5#8)(1990-6#9)(1990-7#1)(1990-8#8)(1990-9#5)(1991-1#2)(1991-11#11)(1991-12#9)(1991-2#6)(1991-3#8)(1991-4#2)(1991-5#5)(1991-6#16)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#9)(1992-6#11)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#5)(1993-5#4)(1993-6#9)(1993-8#8)(1993-9#5)(1994-1#3)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#6)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1996-1#1)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#3)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#4)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#8)(1997-8#6)(2006-10#9)(2006-12#4)(2006-4#2)(2006-6#1)(2007-10#14)(2007-11#12)(2007-12#28)(2007-2#7)(2007-4#2)(2007-5#12)(2007-6#4)(2007-7#34)(2007-8#44)(2007-9#1)(2008-1#23)(2008-10#196)(2008-11#50)(2008-12#43)(2008-2#34)(2008-3#54)(2008-4#10)(2008-5#29)(2008-6#25)(2008-7#94)(2008-8#26)(2008-9#26)(2009-1#7)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#16)(2009-4#7)(2009-5#14)(2009-6#1)(2009-7#6)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#8)(2010-12#14)(2010-2#1)(2010-3#18)(2010-4#7)(2010-5#12)(2010-6#24)(2010-7#5)(2010-8#11)(2010-9#2)(2011-1#43)(2011-2#122)(2011-3#2)(2012-1#11)(2012-12#52)(2012-2#43)(2012-3#48)(2013-1#113)(2013-2#1)(2013-7#12)(2013-8#38)
case on##2##2##(2008-10#1)(2008-2#1)
case only##2##2##(2008-8#1)(2013-1#1)
case or##2##2##(2007-7#1)(2008-10#1)
case presentation##6##2##(2007-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
case presented with##2##3##(2008-12#1)(2008-4#1)
case presented##6##2##(1992-4#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#2)
case rate##2##2##(1995-12#1)(1995-2#1)
case record##2##2##(2008-5#1)(2011-2#1)
case records of 300 patients##2##5##(1993-6#2)
case records of##3##3##(1993-6#2)(2011-2#1)
case records##4##2##(1993-6#2)(2009-3#1)(2011-2#1)
case regarding##2##2##(2008-7#1)(2012-2#1)
case report &amp##2##3##(2008-11#1)(2012-1#1)
case report and brief review of the literature##2##8##(2012-3#1)(2013-1#1)
case report and discussion of##3##5##(2008-7#1)(2008-8#1)(2011-2#1)
case report and discussion##4##4##(2007-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
case report and literature review##28##5##(2007-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#2)
case report and literature##29##4##(2007-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#2)
case report and review of literature##13##6##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
case report and review of the literature##31##7##(2006-12#1)(2007-2#3)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
case report and review of the literature]##3##7##(1993-9#1)(2008-10#1)(2011-2#1)
case report and review of the##35##6##(1993-9#1)(2006-12#1)(2007-2#3)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
case report and review of##49##5##(1993-9#1)(2006-12#1)(2007-2#3)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
case report and review##53##4##(1993-9#1)(2006-12#1)(2007-2#3)(2007-5#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
case report and##95##3##(1993-9#1)(2006-12#1)(2007-10#2)(2007-2#5)(2007-5#3)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#11)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#3)
case report describes a##8##4##(2008-7#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
case report describes##13##3##(2008-12#3)(2008-7#2)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
case report discusses the##2##4##(2007-12#1)(2011-2#1)
case report illustrates the##4##4##(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
case report in##3##3##(2007-11#1)(2007-8#1)(2012-12#1)
case report is a##3##4##(2009-3#1)(2013-1#2)
case report is presented##2##4##(2007-8#1)(2008-1#1)
case report is##8##3##(2007-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-9#1)(2013-1#2)
case report of a 24-year-old female patient##2##7##(2010-9#1)(2012-2#1)
case report of a patient##3##5##(2007-7#1)(2007-8#1)(2012-12#1)
case report of a##20##4##(1995-11#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-12#3)(2008-7#1)(2009-1#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
case report of an##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
case report of##42##3##(1994-7#1)(1995-11#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#5)(2008-6#1)(2008-7#2)(2009-1#1)(2009-2#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
case report suggests that##2##4##(2012-2#2)
case report suggests##3##3##(2012-12#1)(2012-2#2)
case report with##7##3##(1994-8#1)(1997-2#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
case report##483##2##(1990-10#2)(1990-12#5)(1990-3#3)(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#4)(1991-8#2)(1992-10#2)(1992-12#2)(1992-2#8)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-11#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#2)(2007-10#9)(2007-11#4)(2007-12#4)(2007-2#6)(2007-5#4)(2007-7#24)(2007-8#7)(2007-9#1)(2008-1#10)(2008-10#12)(2008-11#13)(2008-12#33)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#8)(2008-7#23)(2008-8#7)(2008-9#14)(2009-1#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#8)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#10)(2011-2#36)(2011-3#2)(2012-1#4)(2012-12#28)(2012-2#16)(2012-3#16)(2013-1#46)(2013-7#2)(2013-8#11)
case report]##33##2##(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2009-1#1)(2009-5#5)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)
case reported in##3##3##(2007-10#1)(2007-8#1)(2008-6#1)
case reported##5##2##(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-6#1)
case reports and##7##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)
case reports are##3##3##(1990-6#1)(1990-9#1)(2012-2#1)
case reports have##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
case reports in##2##3##(2011-2#1)(2013-1#1)
case reports of##13##3##(1991-12#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-3#1)(2013-1#1)
case reports or##2##3##(2012-1#1)(2013-1#1)
case reports##58##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-3#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
case reports]##3##2##(1991-11#1)(1991-5#1)(2008-10#1)
case requiring##2##2##(2008-5#1)(2011-1#1)
case revealed##2##2##(2009-1#1)(2010-12#1)
case review##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
case scenario##2##2##(2008-4#1)(2010-12#1)
case scenarios##2##2##(2009-12#1)(2010-4#1)
case selection##2##2##(1995-2#1)(2007-12#1)
case series and##5##3##(1993-5#1)(2007-10#1)(2008-2#1)(2009-6#1)(2012-12#1)
case series describes##2##3##(2008-12#1)(2013-1#1)
case series in##2##3##(2011-2#2)
case series of##4##3##(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#1)
case series to##3##3##(2007-10#1)(2012-2#1)(2013-7#1)
case series##53##2##(1993-5#1)(2007-10#5)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-6#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
case should##2##2##(2008-11#1)(2013-8#1)
case showed##3##2##(2008-7#1)(2009-5#1)(2011-2#1)
case showing##2##2##(2008-12#1)(2011-2#1)
case shows##4##2##(1996-3#1)(2008-12#1)(2011-1#1)(2011-2#1)
case studies as##3##3##(2008-11#2)(2013-1#1)
case studies illustrating##2##3##(2009-6#1)(2012-1#1)
case studies in##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
case studies of the##2##4##(2008-11#1)(2008-8#1)
case studies of##10##3##(1991-1#1)(1991-12#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-5#1)
case studies that illustrate##2##4##(1994-2#1)(2010-11#1)
case studies that##3##3##(1994-2#1)(2008-7#1)(2010-11#1)
case studies##57##2##(1990-12#1)(1990-5#1)(1991-1#3)(1991-12#2)(1991-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#3)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-11#1)(2009-6#1)(2010-11#1)(2010-5#2)(2010-7#2)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#3)(2013-8#2)
case study and##4##3##(2007-7#1)(2012-12#1)(2013-1#2)
case study approach##3##3##(1996-1#1)(2007-10#1)(2008-11#1)
case study as a teaching method##2##6##(2008-11#2)
case study data##2##3##(2008-11#2)
case study describes how##2##4##(1991-1#1)(2010-10#1)
case study describes the##3##4##(2008-4#1)(2008-9#1)(2012-12#1)
case study describes##7##3##(1991-1#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-12#2)
case study examines the##4##4##(1991-1#1)(2008-10#1)(2009-10#1)(2012-12#1)
case study for##4##3##(1992-3#1)(1997-3#1)(2008-10#1)(2011-1#1)
case study in##15##3##(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)
case study involving##3##3##(2008-10#2)(2008-6#1)
case study is to##3##4##(1993-1#1)(2012-12#2)
case study is##10##3##(1993-1#1)(1994-12#1)(1996-1#1)(2008-1#1)(2008-8#2)(2008-9#1)(2012-12#2)(2013-1#1)
case study method was used##2##5##(2008-9#1)(2010-3#1)
case study method##4##3##(1993-3#1)(1994-2#1)(2008-9#1)(2010-3#1)
case study of a##11##4##(1991-2#1)(1992-2#1)(1996-3#1)(1997-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-6#1)(2012-12#1)(2013-1#1)
case study of the effects##2##5##(1995-2#1)(2011-1#1)
case study of the##9##4##(1995-2#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
case study of##45##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-2#1)(1996-1#2)(1996-3#2)(1996-9#1)(1997-2#3)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
case study on##4##3##(1994-12#1)(1996-2#1)(2008-12#1)(2008-7#1)
case study reports on##2##4##(2008-9#2)
case study suggests that##4##4##(1992-6#1)(2008-10#1)(2013-1#2)
case study that##2##3##(1991-1#1)(2012-12#1)
case study to##2##3##(1995-6#1)(2011-2#1)
case study using##2##3##(2008-11#1)(2008-12#1)
case study was##2##3##(2010-5#1)(2012-12#1)
case study with##2##3##(2008-2#1)(2010-10#1)
case study##238##2##(1990-12#1)(1990-2#1)(1991-1#7)(1991-12#1)(1991-2#3)(1991-3#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-9#1)(1994-1#5)(1994-12#5)(1994-2#2)(1994-3#4)(1995-1#1)(1995-12#4)(1995-2#6)(1995-3#4)(1995-6#2)(1996-1#8)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#4)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#15)(2008-11#19)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#9)(2009-10#4)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#11)(2012-2#2)(2013-1#14)(2013-7#1)(2013-8#1)
case study]##3##2##(2012-12#2)(2012-3#1)
case suggests that##4##3##(1990-6#1)(2007-10#1)(2010-6#1)(2013-1#1)
case suggests the usefulness of##2##5##(1994-7#1)(2011-2#1)
case suggests the##3##3##(1994-7#1)(2011-2#1)(2012-12#1)
case suggests##7##2##(1990-6#1)(1994-7#1)(2007-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
case that was##2##3##(1991-11#1)(2012-2#1)
case that##19##2##(1990-11#1)(1991-11#1)(1992-1#1)(1993-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
case the results##2##3##(2007-8#1)(2008-10#1)
case the##42##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#3)
case there is a##2##4##(1995-5#1)(2008-7#1)
case there is##3##3##(1995-5#1)(2008-3#1)(2008-7#1)
case there was a##2##4##(1996-11#1)(2007-8#1)
case there was##4##3##(1996-11#1)(2007-8#1)(2008-5#1)(2008-7#1)
case there##7##2##(1995-5#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)
case this##2##2##(1993-9#1)(2008-7#1)
case to##10##2##(1995-2#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-3#1)
case treated##2##2##(1992-5#1)(2008-10#1)
case underscores the##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
case using a##2##3##(1991-2#1)(2013-8#1)
case using##5##2##(1991-2#1)(2008-3#1)(2013-1#2)(2013-8#1)
case was a##5##3##(1996-6#1)(2007-8#1)(2008-12#1)(2008-8#2)
case was an##4##3##(1997-5#1)(2008-7#1)(2013-1#2)
case was considered##3##3##(2007-10#1)(2008-1#1)(2008-10#1)
case was diagnosed as##2##4##(2007-7#1)(2008-5#1)
case was reported in the##2##5##(1994-9#1)(1996-5#1)
case was reported##3##3##(1994-9#1)(1996-5#1)(2012-2#1)
case was treated surgically##2##4##(2008-9#1)(2011-1#1)
case was treated##3##3##(2008-9#1)(2010-11#1)(2011-1#1)
case was##45##2##(1991-12#1)(1991-3#1)(1992-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
case we have##2##3##(1995-3#1)(2008-10#1)
case we##6##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)
case weights##3##2##(1991-12#1)(1993-3#1)(1995-12#1)
case when the##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
case when##8##2##(1991-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)
case where the##3##3##(2008-10#1)(2008-9#1)(2009-4#1)
case where##15##2##(1991-11#1)(1992-6#1)(1995-9#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2012-12#2)
case whereby##2##2##(2007-12#1)(2008-10#1)
case which##3##2##(2008-7#2)(2011-1#1)
case with a##4##3##(1991-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
case with both##2##3##(1994-6#1)(2007-5#1)
case with literature review##3##4##(2007-10#2)(2008-12#1)
case with review of##3##4##(2008-11#1)(2008-12#2)
case with the##2##3##(1992-5#1)(2012-3#1)
case with##52##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-5#3)(1993-3#1)(1994-6#1)(1995-3#2)(1996-9#1)(2006-10#1)(2007-10#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#4)(2013-7#1)
case without##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
case women##2##2##(2011-2#2)
case##4218##1##(1990-10#4)(1990-11#6)(1990-12#19)(1990-2#8)(1990-3#14)(1990-4#1)(1990-5#13)(1990-6#25)(1990-7#2)(1990-8#14)(1990-9#13)(1991-1#18)(1991-11#19)(1991-12#29)(1991-2#24)(1991-3#25)(1991-4#6)(1991-5#8)(1991-6#29)(1991-7#1)(1991-8#12)(1991-9#7)(1992-1#6)(1992-10#4)(1992-11#4)(1992-12#24)(1992-2#27)(1992-3#19)(1992-4#3)(1992-5#16)(1992-6#21)(1992-8#6)(1992-9#8)(1993-1#13)(1993-10#1)(1993-11#4)(1993-12#21)(1993-2#13)(1993-3#14)(1993-5#7)(1993-6#16)(1993-8#16)(1993-9#13)(1994-1#11)(1994-11#13)(1994-12#23)(1994-2#12)(1994-3#18)(1994-5#5)(1994-6#9)(1994-7#5)(1994-8#7)(1994-9#8)(1995-1#7)(1995-10#1)(1995-11#11)(1995-12#21)(1995-2#39)(1995-3#17)(1995-4#2)(1995-5#9)(1995-6#12)(1995-8#1)(1995-9#2)(1996-1#24)(1996-10#1)(1996-11#12)(1996-12#9)(1996-2#18)(1996-3#26)(1996-4#1)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#4)(1996-9#10)(1997-1#8)(1997-2#25)(1997-3#33)(1997-4#7)(1997-5#8)(1997-6#10)(1997-7#9)(1997-8#14)(2006-10#21)(2006-12#12)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#48)(2007-11#40)(2007-12#53)(2007-2#23)(2007-4#4)(2007-5#22)(2007-6#7)(2007-7#80)(2007-8#75)(2007-9#5)(2008-1#55)(2008-10#328)(2008-11#145)(2008-12#120)(2008-2#75)(2008-3#113)(2008-4#30)(2008-5#50)(2008-6#62)(2008-7#199)(2008-8#70)(2008-9#81)(2009-1#14)(2009-10#20)(2009-11#10)(2009-12#6)(2009-2#13)(2009-3#31)(2009-4#16)(2009-5#29)(2009-6#5)(2009-7#12)(2009-8#18)(2009-9#8)(2010-1#8)(2010-10#13)(2010-11#22)(2010-12#32)(2010-2#5)(2010-3#38)(2010-4#15)(2010-5#29)(2010-6#37)(2010-7#15)(2010-8#25)(2010-9#9)(2011-1#83)(2011-2#243)(2011-3#4)(2011-7#1)(2012-1#23)(2012-12#126)(2012-2#101)(2012-3#93)(2012-8#1)(2013-1#265)(2013-2#1)(2013-7#30)(2013-8#77)
case)##16##1##(1990-12#1)(1990-6#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#1)(2012-1#1)
case-based##4##1##(1992-12#2)(2008-12#1)(2009-6#1)
case-by-case##7##1##(1994-3#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
case-control and##2##2##(1994-2#1)(2008-7#1)
case-control association study##3##3##(1997-5#1)(2008-9#1)(2011-2#1)
case-control data##2##2##(1992-9#1)(2008-7#1)
case-control design##2##2##(1992-9#1)(2008-4#1)
case-control status##2##2##(1995-2#1)(2012-3#1)
case-control studies conducted in##2##4##(1990-8#1)(2011-2#1)
case-control studies##19##2##(1990-6#1)(1990-8#3)(1992-11#2)(1992-6#1)(1992-9#2)(1994-2#2)(1995-2#2)(1995-9#1)(2007-10#3)(2008-7#1)(2011-2#1)
case-control study conducted in##2##4##(1990-8#1)(1993-9#1)
case-control study design##2##3##(2011-1#1)(2013-1#1)
case-control study in##4##3##(1990-8#1)(1991-11#1)(1993-9#1)(2013-7#1)
case-control study of##9##3##(1992-10#3)(1992-9#1)(1993-9#3)(1996-3#1)(2007-10#1)
case-control study on the##2##4##(2011-1#1)(2012-2#1)
case-control study on##4##3##(1990-12#1)(1990-8#1)(2011-1#1)(2012-2#1)
case-control study was conducted##2##4##(1991-2#1)(2007-10#1)
case-control study was##5##3##(1991-2#1)(2007-10#1)(2007-2#1)(2011-1#1)(2011-2#1)
case-control study##47##2##(1990-12#1)(1990-8#3)(1991-11#1)(1991-2#2)(1991-8#2)(1992-10#3)(1992-6#2)(1992-9#1)(1993-9#5)(1996-3#1)(2007-10#3)(2007-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-4#2)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
case-control##85##1##(1990-12#1)(1990-6#1)(1990-8#6)(1991-11#1)(1991-2#2)(1991-8#2)(1992-10#3)(1992-11#2)(1992-6#3)(1992-9#5)(1993-9#5)(1994-2#3)(1995-2#3)(1995-9#1)(1996-3#1)(1997-5#1)(2007-10#6)(2007-2#1)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#2)(2010-6#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
case-costing and##2##2##(1992-12#1)(1996-3#1)
case-counts##2##1##(2008-6#2)
case-crossover##2##1##(2011-1#2)
case-management techniques and##2##3##(1995-3#2)
case-management techniques##3##2##(1995-3#3)
case-management##6##1##(1995-3#5)(1997-2#1)
case-mix classification##2##2##(1991-12#1)(1993-2#1)
case-mix groups##3##2##(1991-2#1)(1991-3#1)(1993-1#1)
case-mix indexes##2##2##(1992-12#1)(1993-1#1)
case-mix system##2##2##(1991-2#2)
case-mix systems##2##2##(1991-2#1)(1992-3#1)
case-mix##26##1##(1991-12#3)(1991-2#4)(1991-3#4)(1992-12#2)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#4)(1994-2#1)(1994-3#1)(1996-9#1)
case-report##3##1##(2007-8#1)(2011-2#1)(2011-3#1)
case-series##4##1##(1995-9#1)(2007-8#1)(2012-1#1)(2012-12#1)
case-study##3##1##(2007-12#1)(2008-1#1)(2008-11#1)
case]##30##1##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-5#1)(1991-6#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1996-2#1)(1996-6#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#5)
casei##9##1##(1993-11#1)(1995-6#2)(2008-5#2)(2008-7#3)(2013-1#1)
casein and##4##2##(1992-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
casein hydrolyzate##2##2##(1997-2#2)
casein kinase I##5##3##(1993-6#2)(1993-8#1)(1994-11#2)
casein kinase II and##2##4##(1991-2#1)(1997-7#1)
casein kinase II phosphorylation sites##3##5##(2008-12#1)(2008-8#1)(2008-9#1)
casein kinase II##19##3##(1990-11#2)(1990-12#2)(1991-2#1)(1993-11#1)(1993-8#3)(1994-11#1)(1997-7#1)(2008-12#1)(2008-4#5)(2008-8#1)(2008-9#1)
casein kinase##26##2##(1990-11#2)(1990-12#2)(1991-2#1)(1993-11#1)(1993-6#2)(1993-8#4)(1994-11#3)(1994-5#1)(1997-7#1)(2008-12#1)(2008-4#6)(2008-8#1)(2008-9#1)
casein kinase-2##4##2##(1992-6#1)(1993-11#2)(1994-6#1)
casein kinase-II##2##2##(1993-2#2)
casein##53##1##(1990-11#2)(1990-12#3)(1991-2#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-2#2)(1993-6#2)(1993-8#4)(1994-11#3)(1994-5#1)(1994-6#1)(1996-6#1)(1997-2#2)(1997-7#1)(2007-11#5)(2008-10#7)(2008-12#1)(2008-4#6)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#1)
caseins by hydrophobic interaction chromatography##2##5##(2008-10#2)
caseins by##3##2##(2008-10#2)(2013-8#1)
caseins##12##1##(2008-10#5)(2008-12#2)(2013-8#5)
caseload##3##1##(1994-1#1)(1995-12#2)
caseloads##2##1##(1996-2#1)(2012-3#1)
casemix##2##1##(1994-2#1)(2007-10#1)
caseous necrosis##2##2##(2008-1#1)(2008-7#1)
cases (0##2##2##(1994-6#1)(2011-1#1)
cases (12##2##2##(2007-8#1)(2013-1#1)
cases (13##2##2##(2007-8#1)(2008-5#1)
cases (15%)##4##2##(1992-12#1)(2008-6#1)(2011-2#2)
cases (16##2##2##(2007-8#1)(2008-12#1)
cases (18##2##2##(2007-7#1)(2011-2#1)
cases (2##5##2##(1997-4#1)(2008-12#1)(2012-2#1)(2012-3#2)
cases (20##2##2##(1993-8#1)(2008-6#1)
cases (24##2##2##(1990-2#1)(2008-6#1)
cases (26##3##2##(2008-10#2)(2009-8#1)
cases (3##2##2##(1993-9#1)(2013-8#1)
cases (30##3##2##(1996-11#1)(2008-12#1)(2013-8#1)
cases (36##2##2##(1990-6#1)(2007-7#1)
cases (4##3##2##(1996-6#1)(2012-12#1)(2013-8#1)
cases (40%)##2##2##(2008-1#1)(2008-10#1)
cases (50%)##2##2##(2008-3#1)(2008-7#1)
cases (53##3##2##(2008-10#2)(2009-8#1)
cases (55%)##2##2##(1992-12#1)(2008-1#1)
cases (6%)##2##2##(1991-3#1)(1997-3#1)
cases (7%)##2##2##(1993-5#1)(2011-2#1)
cases (82##2##2##(2007-11#1)(2008-10#1)
cases (85##2##2##(2008-12#1)(2011-1#1)
cases (86%)##2##2##(1992-11#1)(2008-12#1)
cases (90%)##2##2##(1990-2#1)(2008-7#1)
cases (two##2##2##(1993-9#1)(1997-3#1)
cases CT##2##2##(2007-11#1)(2007-8#1)
cases a##8##2##(1992-8#1)(1994-11#1)(1995-3#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-10#1)(2011-2#1)
cases across##2##2##(1992-12#1)(2011-1#1)
cases admitted##2##2##(2008-4#1)(2013-1#1)
cases after resection##2##3##(2007-11#2)
cases after the second##2##4##(1990-12#1)(2007-7#1)
cases after the##3##3##(1990-12#1)(2007-7#1)(2011-2#1)
cases after##9##2##(1990-12#1)(1990-2#2)(1996-12#1)(2007-11#2)(2007-7#1)(2011-2#2)
cases also##2##2##(2007-2#1)(2008-5#1)
cases among##7##2##(1991-11#1)(1991-9#1)(1993-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2013-8#1)
cases an##3##2##(1991-8#1)(2008-12#1)(2008-2#1)
cases analyzed##2##2##(1996-3#1)(1997-4#1)
cases and 1##2##3##(1995-12#1)(2011-2#1)
cases and 2##2##3##(2007-7#1)(2011-2#1)
cases and 6069 controls##2##4##(2011-2#2)
cases and a review of##4##5##(2007-7#1)(2008-10#1)(2009-3#1)(2009-5#1)
cases and a##8##3##(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)
cases and by##3##3##(1990-12#1)(2008-11#1)(2013-8#1)
cases and controls##12##3##(1990-8#2)(1991-7#1)(1992-6#1)(1992-9#1)(1996-12#2)(2007-10#1)(2008-10#1)(2011-2#3)
cases and in##2##3##(1991-1#1)(2007-11#1)
cases and is##2##3##(1996-3#1)(2008-10#1)
cases and may##2##3##(1990-6#1)(1995-3#1)
cases and reduced in one case##2##6##(2008-7#2)
cases and review of the literature##5##6##(1992-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
cases and review of the literature]##2##6##(2012-3#1)(2013-1#1)
cases and review of the##7##5##(1992-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
cases and review of##8##4##(1992-12#1)(2008-1#1)(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
cases and showed##2##3##(2007-7#1)(2013-1#1)
cases and the##4##3##(1990-12#1)(1991-1#1)(1992-2#1)(2008-7#1)
cases and to##2##3##(1992-12#1)(2013-1#1)
cases and##143##2##(1990-12#3)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-3#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#6)(2007-8#8)(2008-1#6)(2008-10#7)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#11)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-9#2)(2011-1#4)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#7)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#2)
cases are diagnosed##2##3##(1994-3#1)(2008-12#1)
cases are discussed##2##3##(1990-9#1)(2007-12#1)
cases are due to##6##4##(1995-12#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
cases are mild##2##3##(2013-1#2)
cases are presented in##2##4##(2008-7#1)(2013-1#1)
cases are presented##5##3##(1990-5#1)(1996-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
cases are reported##2##3##(1993-6#1)(2008-11#1)
cases are reviewed##2##3##(1991-2#1)(2008-7#1)
cases are the##2##3##(2007-8#1)(2009-6#1)
cases are##66##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#7)
cases as compared to##2##4##(2009-5#1)(2012-2#1)
cases as compared##3##3##(2009-5#1)(2012-2#2)
cases as good##2##3##(2007-11#1)(2009-3#1)
cases as well as##2##4##(2007-2#1)(2008-2#1)
cases as##14##2##(1991-5#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-2#2)
cases associated with##3##3##(1991-12#1)(2008-5#1)(2008-7#1)
cases at the##3##3##(1990-9#1)(1993-9#1)(2013-8#1)
cases at##11##2##(1990-9#1)(1991-3#1)(1993-9#1)(1994-7#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-1#1)(2013-8#1)
cases based on the##2##4##(1995-12#1)(2008-12#1)
cases be##2##2##(1992-12#1)(2007-11#1)
cases being##3##2##(2007-2#1)(2007-7#1)(2013-7#1)
cases but##10##2##(1990-6#1)(1990-9#1)(1992-11#1)(1993-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
cases by a##2##3##(1990-12#1)(1990-9#1)
cases by the##3##3##(1991-1#1)(1991-6#1)(2008-12#1)
cases by##19##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
cases can be##6##3##(1994-11#1)(2008-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
cases can##8##2##(1994-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#2)
cases caused##3##2##(1992-12#1)(2007-7#1)(2013-8#1)
cases classified##3##2##(1994-3#1)(2011-2#2)
cases collected##2##2##(2008-10#2)
cases compared to##5##3##(1990-8#1)(2008-12#1)(2008-3#1)(2011-2#2)
cases compared##6##2##(1990-8#1)(2007-10#1)(2008-12#1)(2008-3#1)(2011-2#2)
cases confirm##2##2##(2008-10#1)(2011-2#1)
cases considered##2##2##(1993-5#1)(2012-1#1)
cases could be analysed##2##4##(1991-8#2)
cases could##5##2##(1991-8#2)(1997-6#1)(2008-1#1)(2008-7#1)
cases described in##3##3##(1992-12#1)(1992-9#1)(2013-1#1)
cases described##5##2##(1992-12#1)(1992-9#1)(2007-2#1)(2010-4#1)(2013-1#1)
cases detected##4##2##(1990-8#2)(2007-12#1)(2008-11#1)
cases diagnosed by##2##3##(1997-3#1)(2008-5#1)
cases diagnosed in##2##3##(2012-12#1)(2013-1#1)
cases diagnosed##6##2##(1997-3#1)(1997-8#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
cases did##2##2##(1995-12#1)(2008-9#1)
cases died##2##2##(2008-7#1)(2011-2#1)
cases due to##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
cases early##2##2##(1990-6#1)(2007-11#1)
cases for the##3##3##(2006-12#1)(2007-5#1)(2008-7#1)
cases for##20##2##(1990-12#1)(1990-2#1)(1991-6#3)(1992-10#1)(1997-3#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-8#1)
cases found by the gel test##2##6##(2011-1#2)
cases found by the##3##4##(2011-1#3)
cases found##4##2##(2011-1#3)(2012-2#1)
cases from our##2##3##(1992-8#1)(2012-2#1)
cases from the##3##3##(1995-11#1)(2013-1#1)(2013-8#1)
cases from##14##2##(1991-11#1)(1992-8#1)(1993-12#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
cases had an##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
cases had associated##2##3##(2008-1#2)
cases had been##2##3##(1992-8#1)(2013-1#1)
cases had##30##2##(1990-6#2)(1991-11#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-1#3)(2008-10#1)(2008-7#4)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
cases has been##2##3##(2011-2#1)(2013-8#1)
cases has##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
cases have been described##4##4##(2006-10#1)(2009-6#1)(2013-1#2)
cases have been published##2##4##(2007-8#1)(2008-7#1)
cases have been reported in the English literature##2##8##(2006-12#1)(2010-6#1)
cases have been reported in the literature##7##7##(1990-12#1)(1996-11#1)(2007-7#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
cases have been reported in the medical literature##2##8##(1990-8#1)(2013-1#1)
cases have been reported in the##13##6##(1990-12#1)(1990-8#1)(1996-11#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-7#1)
cases have been reported in##18##5##(1990-12#1)(1990-8#1)(1991-12#1)(1996-11#1)(1997-8#2)(2006-12#1)(2007-7#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2013-1#4)(2013-7#1)
cases have been reported so far in the##2##8##(2012-12#1)(2013-8#1)
cases have been reported so far##3##6##(2008-7#1)(2012-12#1)(2013-8#1)
cases have been reported to date##2##6##(2008-7#1)(2013-1#1)
cases have been reported to##4##5##(1992-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
cases have been reported worldwide##2##5##(2009-8#1)(2013-1#1)
cases have been reported##34##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#1)(1995-8#1)(1996-11#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
cases have been##52##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#10)(2013-7#1)(2013-8#1)
cases have previously been##2##4##(2008-7#1)(2009-3#1)
cases have##67##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#3)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#11)(2013-7#1)(2013-8#1)
cases having##4##2##(1994-9#1)(1996-12#1)(1997-1#1)(2008-10#1)
cases if##2##2##(2009-5#1)(2010-8#1)
cases illustrate the##2##3##(1996-2#1)(2011-2#1)
cases illustrate##3##2##(1996-2#1)(2008-1#1)(2011-2#1)
cases illustrating##2##2##(2010-3#1)(2011-2#1)
cases in Canada##3##3##(2007-12#2)(2009-5#1)
cases in Thailand##2##3##(1995-12#2)
cases in a##2##3##(1997-8#1)(2011-2#1)
cases in order to##2##4##(2008-10#1)(2011-2#1)
cases in patients##6##3##(1992-9#1)(1995-5#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
cases in the United States##2##5##(1996-3#1)(2013-1#1)
cases in the literature##5##4##(1990-3#1)(1997-3#1)(2008-3#1)(2008-7#1)(2011-1#1)
cases in the world##2##4##(1994-9#1)(2008-6#1)
cases in the##20##3##(1990-3#1)(1993-12#1)(1994-7#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
cases in which a##3##4##(1991-8#1)(2011-2#1)(2013-1#1)
cases in which one##2##4##(2008-10#2)
cases in which the##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
cases in which##31##3##(1990-10#1)(1990-6#1)(1991-11#1)(1991-8#1)(1993-9#1)(1994-3#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#4)(2013-1#1)
cases in##110##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-7#1)(1994-9#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
cases initially##2##2##(2008-6#1)(2009-8#1)
cases involving the##2##3##(1993-12#1)(2008-8#1)
cases involving##4##2##(1991-12#1)(1993-12#1)(2008-8#1)(2013-1#1)
cases is increasing##2##3##(1992-9#1)(2007-2#1)
cases is not##2##3##(1992-8#1)(1997-3#1)
cases is##25##2##(1990-10#1)(1990-9#1)(1992-1#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-12#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
cases it is possible to##2##5##(1990-8#1)(2008-3#1)
cases it is##5##3##(1990-8#1)(1994-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
cases it was necessary to##2##5##(1990-2#1)(2011-2#1)
cases it was possible to##2##5##(2007-11#1)(2008-9#1)
cases it was##8##3##(1990-2#1)(1991-12#1)(1991-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
cases it##19##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-11#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#2)(2013-1#1)
cases leads to##2##3##(2007-11#1)(2011-2#1)
cases likely to##2##3##(1997-1#1)(2012-2#1)
cases managed##2##2##(1994-7#1)(2012-3#1)
cases may be##4##3##(1995-9#1)(1997-5#1)(2008-11#1)(2012-3#1)
cases may##7##2##(1995-9#1)(1996-11#1)(1997-5#1)(1997-8#1)(2008-11#1)(2012-1#1)(2012-3#1)
cases must be##2##3##(1996-9#1)(2012-2#1)
cases not##5##2##(1990-6#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-6#1)
cases observed##4##2##(1991-6#1)(1993-9#2)(2008-5#1)
cases occur in##2##3##(2008-3#1)(2013-1#1)
cases occur##4##2##(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
cases occurred among##3##3##(1991-12#2)(2013-1#1)
cases occurred in##3##3##(1997-6#1)(2011-1#1)(2012-12#1)
cases occurred##7##2##(1991-12#2)(1997-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
cases occurring##2##2##(1992-9#1)(2008-11#1)
cases of &quot##3##3##(1997-6#1)(2008-8#1)(2009-8#1)
cases of AIDS are##2##4##(1992-9#1)(1996-11#1)
cases of AIDS##5##3##(1992-9#1)(1994-2#1)(1996-11#1)(1997-6#2)
cases of CAS##2##3##(2011-2#2)
cases of CL##2##3##(2007-7#2)
cases of CRC##2##3##(2008-10#1)(2012-2#1)
cases of CoNS##2##3##(2011-2#2)
cases of EPTB##2##3##(2013-8#2)
cases of HCC##2##3##(1993-2#1)(2008-11#1)
cases of HIV infection are##2##5##(1995-12#1)(1996-11#1)
cases of HIV infection##3##4##(1990-3#1)(1995-12#1)(1996-11#1)
cases of HIV##5##3##(1990-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)
cases of HIV-1##2##3##(1992-9#1)(2008-5#1)
cases of MS##3##3##(2011-2#1)(2013-1#2)
cases of R##2##3##(2008-7#2)
cases of SHLI##2##3##(2011-2#2)
cases of SIDS##2##3##(1991-11#1)(1992-11#1)
cases of SLE##2##3##(2006-10#2)
cases of T1##2##3##(1990-6#1)(1991-6#1)
cases of a##6##3##(1990-9#1)(1991-8#1)(1994-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
cases of accidental##3##3##(1991-8#1)(1995-3#1)(2010-5#1)
cases of acute myocardial infarction##2##5##(1990-9#1)(2009-4#1)
cases of acute##17##3##(1990-6#1)(1990-9#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-4#2)(2011-2#1)(2012-12#1)
cases of adrenal##2##3##(1993-3#2)
cases of bacteraemia##2##3##(1995-3#1)(2013-8#1)
cases of bilateral##2##3##(2009-3#2)
cases of breast cancer##3##4##(1995-4#1)(2010-8#1)(2012-3#1)
cases of breast##4##3##(1994-12#1)(1995-4#1)(2010-8#1)(2012-3#1)
cases of cardiac##2##3##(2007-12#1)(2010-8#1)
cases of cerebral##3##3##(2007-10#1)(2008-7#1)(2009-9#1)
cases of cervical cancer##2##4##(1992-10#1)(2012-12#1)
cases of cervical##3##3##(1990-10#1)(1992-10#1)(2012-12#1)
cases of cholera##2##3##(2007-2#2)
cases of chronic##4##3##(1991-8#1)(1993-6#1)(2009-2#1)(2012-12#1)
cases of clinical##2##3##(1993-2#1)(2008-6#1)
cases of clinically##3##3##(1993-2#1)(2008-1#1)(2011-1#1)
cases of colorectal##2##3##(1990-3#1)(1997-8#1)
cases of complex##2##3##(2011-2#2)
cases of congenital##2##3##(1990-9#1)(2008-4#1)
cases of cutaneous leishmaniasis with##2##5##(2007-7#1)(2012-12#1)
cases of cutaneous##4##3##(2007-7#1)(2008-11#1)(2010-6#1)(2012-12#1)
cases of deep##2##3##(2008-5#1)(2011-2#1)
cases of different##2##3##(2007-7#1)(2008-11#1)
cases of diffuse##3##3##(1991-12#1)(1993-9#1)(2008-3#1)
cases of distal##2##3##(2007-10#1)(2007-11#1)
cases of early ovarian cancer##2##5##(2011-2#2)
cases of ectopic##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
cases of foetal##2##3##(1991-9#2)
cases of gastric##3##3##(1992-12#1)(1992-5#1)(1994-12#1)
cases of genetic##2##3##(2008-1#1)(2011-2#1)
cases of head and neck lesions##2##6##(2013-8#2)
cases of head and neck##5##5##(2008-2#1)(2008-8#1)(2011-1#1)(2013-8#2)
cases of human##4##3##(1990-3#1)(1990-5#1)(2008-10#1)(2008-4#1)
cases of idiopathic##2##3##(1992-2#1)(2012-2#1)
cases of infection##3##3##(1992-11#1)(1992-9#1)(2008-6#1)
cases of inflammatory##2##3##(1992-9#1)(1997-3#1)
cases of influenza##3##3##(2011-2#2)(2012-3#1)
cases of interstitial##2##3##(1996-12#1)(2012-12#1)
cases of invasive##3##3##(1992-8#1)(1994-2#2)
cases of juvenile##2##3##(2007-7#1)(2010-12#1)
cases of large##3##3##(1991-6#1)(1994-2#1)(2008-7#1)
cases of limited##2##3##(1990-12#1)(2008-9#1)
cases of linear alopecia##2##4##(2010-6#2)
cases of local##3##3##(2007-5#1)(2010-3#1)(2012-3#1)
cases of locally advanced breast cancer##2##6##(1991-8#2)
cases of locally##3##3##(1991-8#2)(2013-1#1)
cases of major##3##3##(2007-8#1)(2013-1#2)
cases of malaria##2##3##(2007-2#1)(2012-12#1)
cases of malignant lesions were located in the##2##8##(2013-8#2)
cases of malignant mesothelioma##2##4##(1991-12#2)
cases of malignant##8##3##(1991-12#2)(1993-6#1)(1995-12#1)(1997-5#1)(2012-3#1)(2013-8#2)
cases of multiple##2##3##(1992-6#1)(2011-2#1)
cases of nephrotic syndrome##2##4##(1996-6#2)
cases of nose plastic surgery##2##5##(1990-9#2)
cases of open fractures##2##4##(2007-11#1)(2013-8#1)
cases of open##3##3##(2007-11#1)(2010-7#1)(2013-8#1)
cases of pancreatic##2##3##(2013-1#1)(2013-7#1)
cases of patients with##5##4##(1997-8#1)(2007-8#1)(2011-1#1)(2011-2#2)
cases of patients##7##3##(1997-8#1)(2007-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
cases of petrous apex cholesteatoma presenting with double vision##2##9##(2011-2#2)
cases of petrous apex cholesteatoma##3##5##(2011-2#3)
cases of poisoning##2##3##(1990-9#1)(2008-12#1)
cases of primary##11##3##(1991-11#1)(1991-12#1)(1991-6#1)(1994-9#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2013-1#2)(2013-7#1)
cases of schistosomiasis##2##3##(1996-12#1)(2012-3#1)
cases of secondary##3##3##(1991-11#1)(1991-3#1)(2012-2#1)
cases of serious##2##3##(1992-11#1)(1994-2#1)
cases of severe##6##3##(2007-12#2)(2007-8#1)(2008-7#1)(2010-5#1)(2011-2#1)
cases of single##3##3##(1992-12#1)(2007-7#1)(2008-12#1)
cases of spinal##2##3##(2007-8#1)(2008-7#1)
cases of spontaneous##2##3##(1992-2#1)(2008-7#1)
cases of successful##2##3##(2008-10#1)(2011-3#1)
cases of such##4##3##(1997-6#1)(1997-8#1)(2007-8#1)(2011-2#1)
cases of superficial bladder##2##4##(1993-11#1)(1993-9#1)
cases of surgically##2##3##(2008-7#1)(2012-2#1)
cases of suspected acute##2##4##(1995-11#2)
cases of suspected##5##3##(1990-6#1)(1992-11#1)(1995-11#2)(2011-1#1)
cases of the disease##2##4##(1994-3#1)(2007-8#1)
cases of the new##2##4##(1997-8#1)(2008-2#1)
cases of the##14##3##(1991-12#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#2)(2013-8#2)
cases of this unusual##2##4##(2007-5#1)(2008-10#1)
cases of this##5##3##(1990-10#1)(1996-9#1)(2007-12#1)(2007-5#1)(2008-10#1)
cases of thrombosis##2##3##(2007-10#1)(2008-12#1)
cases of total##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
cases of trisomy##4##3##(2012-3#4)
cases of true##2##3##(2013-1#2)
cases of venous##2##3##(1990-3#1)(1996-11#1)
cases of##765##2##(1990-10#6)(1990-12#3)(1990-2#2)(1990-3#8)(1990-5#4)(1990-6#9)(1990-9#13)(1991-11#13)(1991-12#10)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#7)(1991-8#13)(1991-9#3)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#4)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#1)(1993-2#6)(1993-3#4)(1993-5#2)(1993-6#3)(1993-8#4)(1993-9#11)(1994-11#1)(1994-12#8)(1994-2#8)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#5)(1995-11#4)(1995-12#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#4)(1996-12#2)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#6)(1997-5#1)(1997-6#6)(1997-8#11)(2006-10#7)(2006-12#1)(2007-10#5)(2007-11#7)(2007-12#16)(2007-2#7)(2007-4#1)(2007-5#3)(2007-7#28)(2007-8#31)(2008-1#18)(2008-10#30)(2008-11#9)(2008-12#13)(2008-2#8)(2008-3#8)(2008-4#8)(2008-5#15)(2008-6#4)(2008-7#39)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#8)(2010-7#2)(2010-8#4)(2011-1#15)(2011-2#58)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#16)(2012-3#23)(2013-1#37)(2013-7#2)(2013-8#19)
cases on the##2##3##(2009-6#2)
cases on##3##2##(1996-3#1)(2009-6#2)
cases only##5##2##(1991-11#1)(1991-6#1)(1994-9#1)(1996-5#1)(2011-2#1)
cases operated##2##2##(2007-8#1)(2013-8#1)
cases or##2##2##(2007-12#1)(2012-3#1)
cases over##2##2##(2008-10#1)(2012-2#1)
cases per year##4##3##(1992-2#1)(1992-9#1)(1996-11#1)(2010-8#1)
cases per##7##2##(1990-9#1)(1992-2#1)(1992-9#1)(1996-11#1)(1996-8#1)(1997-5#1)(2010-8#1)
cases present##2##2##(2009-6#1)(2009-8#1)
cases presented##2##2##(2007-12#1)(2008-1#1)
cases previously reported##2##3##(2008-10#1)(2009-8#1)
cases provide##4##2##(1990-8#1)(2008-7#1)(2011-3#1)(2012-3#1)
cases published##2##2##(2009-3#1)(2011-2#1)
cases qualify##2##2##(1992-12#1)(2008-1#1)
cases received##5##2##(1991-9#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)
cases recorded##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
cases referred##2##2##(2007-11#1)(2008-8#1)
cases registered in##2##3##(1992-5#1)(2013-8#1)
cases registered##3##2##(1991-2#1)(1992-5#1)(2013-8#1)
cases remains##2##2##(2007-8#1)(2013-8#1)
cases reported by##2##3##(1996-1#1)(2012-3#1)
cases reported in the##4##4##(1993-8#1)(1997-8#1)(2011-2#1)(2013-8#1)
cases reported in##5##3##(1990-2#1)(1993-8#1)(1997-8#1)(2011-2#1)(2013-8#1)
cases reported##13##2##(1990-2#1)(1990-6#1)(1993-8#1)(1994-9#1)(1996-1#1)(1997-8#1)(2006-10#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-8#2)
cases required##3##2##(1992-9#1)(2011-2#1)(2012-3#1)
cases requiring##4##2##(1991-12#1)(1995-9#1)(2009-5#1)(2012-3#1)
cases respectively##4##2##(2007-7#3)(2012-3#1)
cases resulted in##2##3##(2008-7#2)
cases revealed##2##2##(1993-1#1)(2011-2#1)
cases reviewed##2##2##(2008-1#1)(2012-12#1)
cases seen between##2##3##(2008-7#1)(2008-8#1)
cases seen in##3##3##(1991-11#1)(2007-2#1)(2010-12#1)
cases seen##5##2##(1991-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
cases showed##6##2##(1991-10#1)(1994-7#1)(2008-10#1)(2008-11#1)(2013-1#2)
cases studied##7##2##(1990-12#1)(1990-6#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
cases suggest that##5##3##(1991-1#1)(1994-6#1)(1995-6#1)(2011-2#1)(2013-8#1)
cases suitable##2##2##(1997-4#1)(2008-8#1)
cases surgery is##2##3##(2007-11#1)(2013-1#1)
cases than in##2##3##(1990-8#1)(2013-1#1)
cases than the##2##3##(1997-8#1)(2008-10#1)
cases than##9##2##(1990-8#2)(1993-12#2)(1997-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
cases that had##3##3##(2011-1#2)(2013-8#1)
cases that have been##2##4##(2008-10#1)(2008-9#1)
cases that have##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
cases that require##2##3##(2009-3#1)(2009-4#1)
cases that the##2##3##(1997-2#1)(1997-3#1)
cases that##24##2##(1990-7#1)(1993-12#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
cases the treatment##2##3##(1991-8#1)(2011-2#1)
cases the##76##2##(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#5)(2007-12#1)(2008-10#12)(2008-11#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
cases there was##2##3##(2007-11#2)
cases there##5##2##(1992-5#1)(1993-8#1)(2007-11#3)
cases these##2##2##(1990-6#1)(2009-12#1)
cases this##2##2##(2011-1#1)(2012-3#1)
cases to be##2##3##(1997-2#1)(2008-10#1)
cases to prevent##2##3##(2007-7#1)(2008-10#1)
cases to##16##2##(1990-5#1)(1991-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
cases treated with##2##3##(2007-7#1)(2008-7#1)
cases treated##4##2##(2007-7#1)(2008-6#1)(2008-7#1)(2008-9#1)
cases two##2##2##(2008-10#2)
cases underwent##2##2##(1992-6#1)(2013-1#1)
cases vs##2##2##(1993-1#1)(1997-5#1)
cases was##23##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-2#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-10#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#3)
cases we observed##2##3##(2007-8#1)(2013-1#1)
cases we obtained##2##3##(2007-11#1)(2007-8#1)
cases we##10##2##(1990-8#1)(1996-3#1)(2007-11#5)(2007-8#2)(2013-1#1)
cases were also##2##3##(2009-8#1)(2012-12#1)
cases were caused by##2##4##(2007-12#1)(2013-8#1)
cases were compared##2##3##(1993-9#1)(2008-10#1)
cases were considered##3##3##(1990-10#1)(2007-8#1)(2008-7#1)
cases were diagnosed##3##3##(1994-12#1)(2011-1#1)(2013-8#1)
cases were divided into##3##4##(2007-11#1)(2011-2#2)
cases were examined##2##3##(1997-8#2)
cases were found##5##3##(1991-12#1)(1992-12#1)(2007-11#1)(2008-7#2)
cases were identified##3##3##(1996-11#1)(2008-7#1)(2013-8#1)
cases were in the##2##4##(1995-4#1)(2013-8#1)
cases were in##3##3##(1995-4#1)(2011-2#1)(2013-8#1)
cases were managed##2##3##(2013-1#2)
cases were of##2##3##(1995-4#1)(2007-7#1)
cases were recorded in##2##4##(1997-6#1)(2007-12#1)
cases were registered in##3##4##(1991-6#1)(1992-11#1)(1993-8#1)
cases were registered##4##3##(1991-11#1)(1991-6#1)(1992-11#1)(1993-8#1)
cases were reported in##2##4##(1996-8#1)(1997-3#1)
cases were reported##9##3##(1993-6#1)(1995-12#1)(1996-8#2)(1997-3#1)(1997-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
cases were selected from##2##4##(1993-9#1)(1997-8#1)
cases were strongly##2##3##(1991-8#1)(1993-8#1)
cases were studied##3##3##(2011-2#2)(2012-12#1)
cases were treated by##3##4##(1996-3#1)(2013-1#2)
cases were treated##7##3##(1990-10#1)(1996-3#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
cases were##121##2##(1990-10#3)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-4#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#7)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#15)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#5)
cases when##9##2##(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-7#1)(2012-3#1)(2013-1#1)
cases where a##3##3##(1992-6#1)(2008-8#1)(2013-1#1)
cases where only##2##3##(2008-12#1)(2008-8#1)
cases where the##8##3##(1990-9#1)(1993-1#1)(1995-11#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-9#1)
cases where there is##2##4##(1996-5#1)(2013-1#1)
cases where there##5##3##(1996-5#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
cases where##52##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-11#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
cases which have##2##3##(1993-3#1)(2013-1#1)
cases which##10##2##(1991-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(2008-3#1)(2008-7#1)(2010-3#1)(2013-1#1)(2013-8#2)
cases who##5##2##(1994-7#1)(2007-8#1)(2008-7#2)(2011-1#1)
cases will##3##2##(2007-7#1)(2011-2#2)
cases with a##8##3##(1990-9#1)(1993-8#1)(1997-1#1)(2007-10#1)(2008-10#3)(2010-12#1)
cases with an##4##3##(1993-12#1)(1993-8#1)(1994-7#1)(2006-12#1)
cases with and without MMRPE##2##5##(2013-1#2)
cases with and without##5##4##(1995-2#1)(2008-2#1)(2012-2#1)(2013-1#2)
cases with and##6##3##(1990-8#1)(1995-2#1)(2008-2#1)(2012-2#1)(2013-1#2)
cases with bone##3##3##(1994-7#1)(2008-6#1)(2011-1#1)
cases with different##3##3##(2006-12#1)(2008-11#1)(2008-3#1)
cases with eight variables for##2##5##(2008-10#2)
cases with histologic##2##3##(1991-12#1)(1992-8#1)
cases with long-term##2##3##(2010-3#1)(2012-2#1)
cases with review of##2##4##(2007-5#1)(2007-7#1)
cases with skin necrosis##2##4##(1991-8#1)(2008-9#1)
cases with the##5##3##(1992-9#1)(1993-6#1)(1997-8#1)(2007-5#1)(2012-3#1)
cases with traumatic##2##3##(1991-12#1)(2013-1#1)
cases with##149##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-5#1)(1991-8#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-6#1)(1994-7#2)(1995-11#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#4)(2006-12#2)(2007-10#6)(2007-11#7)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#3)(2009-3#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#6)(2011-2#12)(2011-8#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#5)
cases within##4##2##(1991-2#1)(1993-1#1)(1994-9#1)(2008-7#1)
cases without##9##2##(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
cases##3747##1##(1990-10#21)(1990-11#2)(1990-12#29)(1990-2#20)(1990-3#19)(1990-5#13)(1990-6#38)(1990-7#4)(1990-8#21)(1990-9#42)(1991-1#15)(1991-10#2)(1991-11#38)(1991-12#39)(1991-2#28)(1991-3#12)(1991-4#2)(1991-5#3)(1991-6#27)(1991-7#1)(1991-8#34)(1991-9#8)(1992-1#1)(1992-10#7)(1992-11#13)(1992-12#21)(1992-2#11)(1992-3#4)(1992-4#1)(1992-5#14)(1992-6#14)(1992-8#17)(1992-9#22)(1993-1#19)(1993-11#8)(1993-12#17)(1993-2#20)(1993-3#9)(1993-5#5)(1993-6#12)(1993-8#17)(1993-9#32)(1994-1#3)(1994-11#8)(1994-12#22)(1994-2#15)(1994-3#13)(1994-5#1)(1994-6#7)(1994-7#10)(1994-8#1)(1994-9#25)(1995-1#2)(1995-10#1)(1995-11#20)(1995-12#22)(1995-2#12)(1995-3#20)(1995-4#7)(1995-5#10)(1995-6#13)(1995-8#6)(1995-9#6)(1996-1#3)(1996-11#23)(1996-12#12)(1996-2#4)(1996-3#21)(1996-4#2)(1996-5#11)(1996-6#14)(1996-7#2)(1996-8#7)(1996-9#10)(1997-1#6)(1997-2#10)(1997-3#50)(1997-4#9)(1997-5#11)(1997-6#22)(1997-7#3)(1997-8#44)(2006-10#17)(2006-12#7)(2006-4#1)(2006-6#2)(2007-10#27)(2007-11#113)(2007-12#51)(2007-2#19)(2007-4#3)(2007-5#8)(2007-6#1)(2007-7#84)(2007-8#133)(2008-1#66)(2008-10#281)(2008-11#71)(2008-12#52)(2008-2#28)(2008-3#52)(2008-4#32)(2008-5#65)(2008-6#48)(2008-7#178)(2008-8#56)(2008-9#63)(2009-1#7)(2009-10#20)(2009-11#1)(2009-12#4)(2009-2#7)(2009-3#26)(2009-4#13)(2009-5#17)(2009-6#12)(2009-7#9)(2009-8#33)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#10)(2010-12#20)(2010-2#5)(2010-3#22)(2010-4#11)(2010-5#7)(2010-6#17)(2010-7#10)(2010-8#18)(2010-9#2)(2011-1#71)(2011-2#253)(2011-3#8)(2011-8#1)(2012-1#8)(2012-12#55)(2012-2#66)(2012-3#87)(2012-4#1)(2012-8#1)(2013-1#173)(2013-7#9)(2013-8#102)
cases'##2##1##(1991-7#1)(1993-9#1)
cases) and##11##2##(1990-12#1)(1990-6#1)(1991-2#1)(1994-1#1)(1994-8#1)(1995-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
cases) of##2##2##(1991-12#1)(2010-7#1)
cases) or##4##2##(1990-12#1)(1994-2#1)(2007-11#1)(2008-11#1)
cases) were##5##2##(1990-2#1)(1993-12#1)(1996-6#1)(2008-5#1)(2010-4#1)
cases)##89##1##(1990-12#4)(1990-2#1)(1990-6#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-9#1)(1994-1#2)(1994-2#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-3#1)(1995-4#2)(1996-12#1)(1996-6#4)(1997-4#1)(2007-11#7)(2007-8#5)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#2)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#9)(2012-3#2)
cases/1 000 population in##3##4##(2011-2#3)
cases]##70##1##(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-9#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#2)(1997-5#1)(2007-8#8)(2008-10#2)(2008-11#1)(2009-1#4)(2009-5#9)(2011-2#2)(2012-2#2)(2013-1#5)(2013-8#1)
casework##10##1##(1995-11#1)(2008-10#2)(2008-12#7)
cash flow to##2##3##(1992-1#1)(1996-2#1)
cash flow##9##2##(1991-9#1)(1992-1#1)(1993-12#2)(1994-1#1)(1996-2#2)(2007-9#1)(2008-11#1)
cash##12##1##(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-1#1)(1996-2#2)(2007-9#1)(2008-10#1)(2008-11#1)
cashew##6##1##(1992-2#4)(2012-2#2)
casks##2##1##(2008-10#2)
casokefamide##2##1##(1993-3#2)
caspase activation##7##2##(2008-1#1)(2008-11#4)(2008-4#1)(2008-9#1)
caspase activities##2##2##(2008-11#2)
caspase inhibitor##2##2##(2008-11#1)(2008-8#1)
caspase##18##1##(2008-1#1)(2008-11#9)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#2)
caspase-3 activation##2##2##(2008-10#1)(2008-4#1)
caspase-3 and##3##2##(2008-7#1)(2012-1#1)(2013-7#1)
caspase-3 expression was##2##3##(2008-10#1)(2012-2#1)
caspase-3 expression##3##2##(2008-10#2)(2012-2#1)
caspase-3 in##2##2##(2008-9#2)
caspase-3 was##2##2##(2011-3#1)(2012-1#1)
caspase-3##29##1##(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-6#1)(2011-2#1)(2011-3#2)(2012-1#4)(2012-2#4)(2013-1#3)(2013-7#1)
caspase-8##3##1##(2008-4#1)(2011-2#1)(2012-2#1)
caspase-9##2##1##(2008-4#1)(2011-2#1)
caspase-dependent##2##1##(2008-10#1)(2011-2#1)
caspase-like##3##1##(2009-10#3)
caspase-mediated##2##1##(2008-11#1)(2009-10#1)
caspases can##2##2##(2008-11#1)(2013-1#1)
caspases##16##1##(2007-12#1)(2008-11#7)(2008-4#4)(2008-7#2)(2008-9#1)(2013-1#1)
caspases-8##2##1##(2009-4#1)(2010-6#1)
cassava (Manihot esculenta)##2##3##(2008-10#2)
cassava and##2##2##(1991-12#1)(2008-10#1)
cassava genotypes##2##2##(2008-10#2)
cassava root rot##3##3##(2008-10#3)
cassava starch##3##2##(2008-6#3)
cassava##20##1##(1991-12#1)(2008-10#15)(2008-6#4)
cassette containing##2##2##(1997-4#1)(2008-11#1)
cassette into the##2##3##(1997-3#1)(2008-8#1)
cassette mutagenesis##2##2##(1994-5#1)(2008-8#1)
cassette was##4##2##(1993-9#1)(1997-4#1)(2008-11#1)(2013-1#1)
cassette which##2##2##(1994-12#1)(1996-6#1)
cassette##38##1##(1990-11#1)(1991-3#6)(1993-9#3)(1994-12#3)(1994-5#1)(1996-6#2)(1997-3#1)(1997-4#5)(2008-10#1)(2008-11#7)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
cassettes have been##2##3##(2008-5#1)(2008-9#1)
cassettes##10##1##(1991-6#1)(1992-3#1)(1994-12#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-5#1)
cassia##2##1##(2008-5#1)(2010-3#1)
cassini##2##1##(2008-9#2)
cast doubt on##2##3##(2008-11#1)(2008-9#1)
cast in the##3##3##(1994-12#1)(2008-2#1)(2008-5#1)
cast in##6##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
cast iron##7##2##(2008-10#7)
cast light on##2##3##(1992-3#1)(2008-1#1)
cast membranes##5##2##(2008-11#5)
cast on##2##2##(2008-10#1)(2008-11#1)
cast was##2##2##(2007-8#2)
cast##66##1##(1990-8#1)(1991-1#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-2#1)(2007-12#3)(2007-8#6)(2008-1#1)(2008-10#19)(2008-11#12)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
castaneum##6##1##(2008-12#3)(2008-9#1)(2012-2#2)
castanospermine##3##1##(1993-8#3)
castanospermine-treated cells##2##2##(1993-8#2)
caste determination##2##2##(2008-8#1)(2010-1#1)
caste##5##1##(2008-8#1)(2010-1#1)(2011-2#3)
castes##7##1##(2007-12#1)(2008-8#5)(2012-2#1)
casting a##3##2##(2008-10#1)(2008-5#2)
casting and LB methods##2##4##(2008-11#2)
casting and##3##2##(2008-11#2)(2008-9#1)
casting of##3##2##(2008-10#2)(2013-1#1)
casting##28##1##(1995-6#3)(2008-10#6)(2008-11#5)(2008-5#3)(2008-7#1)(2008-9#6)(2013-1#4)
castings##2##1##(2009-7#2)
castor bean endosperm##2##3##(1991-11#2)
castor bean pollen##2##3##(2008-6#2)
castor bean##8##2##(1991-11#3)(1994-8#1)(2008-6#3)(2013-8#1)
castor##10##1##(1991-11#3)(1994-8#1)(2008-10#1)(2008-12#1)(2008-6#3)(2013-8#1)
castrated and##2##2##(1991-12#1)(1991-5#1)
castrated male##2##2##(2008-9#1)(2012-3#1)
castrated males##4##2##(1993-8#1)(1994-2#1)(1995-2#1)(2008-5#1)
castrated plants##2##2##(2008-9#2)
castrated rat cells##2##3##(1996-2#2)
castrated rat##4##2##(1996-2#3)(1996-5#1)
castrated##24##1##(1990-11#1)(1991-12#2)(1991-5#1)(1993-8#1)(1994-2#2)(1995-2#1)(1996-2#3)(1996-5#1)(2008-10#1)(2008-5#2)(2008-9#6)(2010-4#1)(2012-3#1)(2013-8#1)
castrates##4##1##(1991-5#2)(1995-2#1)(2008-9#1)
castration and##2##2##(1994-2#2)
castration##13##1##(1991-5#2)(1993-8#1)(1994-2#4)(1995-2#2)(1996-5#1)(2008-5#1)(2008-9#1)(2009-10#1)
casts and the##2##3##(2007-11#1)(2008-5#1)
casts and##5##2##(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#2)
casts doubt on the##2##4##(1993-11#1)(2008-8#1)
casts##13##1##(1993-11#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#3)(2013-8#1)
casual sexual##2##2##(2008-11#1)(2011-2#1)
casual##22##1##(1991-8#1)(1993-1#1)(1993-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2010-8#5)(2011-2#2)(2012-2#1)(2012-3#1)
casualties##4##1##(1997-6#1)(2007-2#1)(2007-5#1)(2013-1#1)
casualty##5##1##(1992-6#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
cat dorsal##2##2##(1991-2#1)(2008-8#1)
cat expression##2##2##(1991-9#1)(1993-6#1)
cat gene##3##2##(1993-6#3)
cat visual cortex##2##3##(1993-12#1)(1994-8#1)
cat with##2##2##(2012-3#2)
cat##57##1##(1990-11#1)(1990-5#4)(1990-6#1)(1991-10#3)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-5#1)(1993-12#4)(1993-6#4)(1993-9#2)(1994-12#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-9#1)(2011-2#1)(2012-3#3)(2013-1#1)
cat's-eye##3##1##(2008-3#3)
cat-86##6##1##(1991-9#6)
cat-scratch disease##4##2##(1991-4#4)
cat-scratch##5##1##(1991-4#5)
catabolic and##2##2##(2008-10#1)(2011-1#1)
catabolic enzymes##2##2##(1994-12#1)(2012-2#1)
catabolic hormone##2##2##(2008-5#2)
catabolic products##2##2##(1993-12#1)(1993-8#1)
catabolic##21##1##(1991-4#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
catabolism and DNA synthesis##2##4##(1994-9#2)
catabolism and##3##2##(1994-9#2)(1995-6#1)
catabolism in##3##2##(1994-9#1)(2008-5#1)(2008-7#1)
catabolism of HDL apoA-I##2##4##(2008-6#2)
catabolism of hyaluronan##2##3##(2011-1#2)
catabolism of##15##2##(1990-2#1)(1991-2#2)(1991-9#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-6#5)(2011-1#3)
catabolism was##2##2##(1994-12#1)(2008-10#1)
catabolism##32##1##(1990-2#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-4#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2011-1#4)(2011-2#1)
catabolite repression by glucose##2##4##(1993-12#1)(1994-12#1)
catabolite repression by##4##3##(1993-12#1)(1994-12#1)(2008-10#2)
catabolite repression of##2##3##(1990-5#1)(2008-10#1)
catabolite repression##10##2##(1990-5#2)(1993-12#1)(1994-12#1)(1995-8#1)(2008-10#5)
catabolized##3##1##(2008-10#1)(2008-4#1)(2008-5#1)
catacombs##2##1##(2008-10#1)(2011-2#1)
catalase (CAT) and superoxide dismutase (SOD)##2##6##(1997-4#1)(2008-12#1)
catalase (CAT) and##4##3##(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)
catalase (CAT)##9##2##(1994-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
catalase activity and##2##3##(1991-9#1)(2008-7#1)
catalase activity decreased##2##3##(1991-12#2)
catalase activity in##3##3##(1990-12#1)(1994-2#1)(2008-10#1)
catalase activity was##2##3##(1991-12#1)(1996-9#1)
catalase activity##13##2##(1990-12#1)(1991-12#3)(1991-9#1)(1994-2#1)(1996-9#1)(2008-10#3)(2008-5#1)(2008-7#2)
catalase and reduced glutathione##2##4##(2012-2#2)
catalase and superoxide dismutase##2##4##(1990-2#1)(2011-2#1)
catalase and##16##2##(1990-2#1)(1990-3#1)(1993-12#1)(1994-2#1)(1995-8#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
catalase catalyzes the degradation of##2##5##(2008-10#2)
catalase decreased##2##2##(1990-3#1)(1991-12#1)
catalase enzyme##3##2##(2008-10#3)
catalase in##3##2##(2008-10#2)(2012-2#1)
catalase was secreted##2##3##(2008-10#2)
catalase was##5##2##(2008-10#4)(2008-2#1)
catalase##115##1##(1990-12#6)(1990-2#1)(1990-3#6)(1991-12#7)(1991-9#3)(1992-11#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-6#4)(1995-3#1)(1995-6#5)(1995-8#4)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#4)(1997-7#2)(2007-12#1)(2008-10#31)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#6)(2009-5#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#3)
catalase)##3##1##(1991-12#1)(1995-9#1)(2008-5#1)
catalepsy and##3##2##(2012-2#1)(2013-1#2)
catalepsy in mice##2##3##(2012-2#2)
catalepsy in##4##2##(1992-12#1)(2012-2#2)(2013-1#1)
catalepsy was##2##2##(1990-7#1)(2013-1#1)
catalepsy##18##1##(1990-7#2)(1992-12#1)(1995-3#1)(2008-6#4)(2012-2#3)(2013-1#7)
catalog of##4##2##(1995-5#1)(2008-9#3)
catalog##7##1##(1995-5#1)(2008-9#5)(2013-1#1)
cataloging##2##1##(1993-3#1)(2009-10#1)
catalogs##2##1##(1994-3#1)(2008-9#1)
catalogue of##2##2##(2008-5#1)(2008-7#1)
catalogued##3##1##(1995-5#1)(2008-6#1)(2008-8#1)
catalogues##2##1##(1997-2#1)(2008-11#1)
catalyse a##2##2##(1992-12#1)(2010-12#1)
catalyse the##7##2##(1990-7#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-5#1)
catalyse##13##1##(1990-7#1)(1992-12#1)(1992-6#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)
catalysed by the##4##3##(1997-1#1)(2008-10#2)(2011-1#1)
catalysed by##17##2##(1991-2#2)(1991-5#1)(1995-11#1)(1997-1#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
catalysed##25##1##(1991-12#2)(1991-2#2)(1991-5#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-10#12)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
catalyses the oxidation of##6##4##(2008-10#6)
catalyses the##12##2##(1992-6#1)(1993-8#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-6#1)
catalyses##17##1##(1990-5#2)(1992-6#1)(1993-8#1)(1995-12#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
catalysing the##3##2##(1990-7#1)(2008-7#1)(2011-1#1)
catalysing##5##1##(1990-7#1)(2008-7#1)(2009-9#2)(2011-1#1)
catalysis and##7##2##(1991-5#2)(1994-11#1)(1994-3#1)(1995-6#1)(2007-11#2)
catalysis but##2##2##(1993-11#1)(2008-11#1)
catalysis by##5##2##(1990-7#1)(1992-12#1)(1993-11#1)(2008-7#2)
catalysis in##3##2##(1992-6#1)(2008-5#1)(2013-1#1)
catalysis involving##2##2##(1992-12#1)(1993-8#1)
catalysis is##2##2##(2008-7#1)(2010-12#1)
catalysis of a##2##3##(1992-6#1)(1993-11#1)
catalysis of the periodate oxidation of##2##6##(2008-10#2)
catalysis of the##5##3##(1993-8#1)(1995-6#1)(2008-10#3)
catalysis of##14##2##(1990-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-6#1)(2008-10#7)(2008-4#1)(2008-8#1)
catalysis on the##3##3##(2008-10#3)
catalysis to##2##2##(1994-11#1)(2009-10#1)
catalysis using##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
catalysis was##2##2##(1995-2#1)(2008-10#1)
catalysis with a##2##3##(1991-5#1)(2008-10#1)
catalysis##98##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1991-5#4)(1991-7#1)(1992-12#3)(1992-3#2)(1992-6#2)(1993-11#6)(1993-8#5)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#4)(1997-8#2)(2007-11#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-2#2)(2009-9#1)(2010-12#5)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
catalyst and in##2##3##(2008-10#2)
catalyst and is##2##3##(2008-10#2)
catalyst and##12##2##(2007-11#1)(2008-10#9)(2008-12#1)(2009-12#1)
catalyst based on##2##3##(2008-11#1)(2010-8#1)
catalyst for the hydrolysis##2##4##(1993-8#1)(2008-10#1)
catalyst for the##7##3##(1993-8#1)(2008-10#5)(2008-6#1)
catalyst for##15##2##(1991-2#1)(1993-8#1)(1995-2#1)(2008-10#7)(2008-6#2)(2008-7#2)(2010-12#1)
catalyst has been##3##3##(2008-10#2)(2010-12#1)
catalyst in the##4##3##(1993-8#2)(2008-10#2)
catalyst in##9##2##(1993-8#2)(2008-10#4)(2011-2#1)(2012-2#1)(2013-1#1)
catalyst is##3##2##(2008-10#3)
catalyst on##2##2##(2008-10#1)(2010-4#1)
catalyst was##4##2##(2012-2#1)(2013-1#3)
catalyst with##3##2##(1996-5#1)(2008-10#1)(2012-3#1)
catalyst##122##1##(1991-2#1)(1992-3#1)(1993-11#1)(1993-8#3)(1995-2#3)(1996-5#3)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#56)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#10)(2009-10#1)(2009-12#2)(2009-2#3)(2009-8#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
catalyst-free##2##1##(2008-7#1)(2012-2#1)
catalysts and##5##2##(2008-1#1)(2008-10#2)(2010-7#1)(2013-1#1)
catalysts are##6##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#1)
catalysts for the##2##3##(2007-11#2)
catalysts for##9##2##(1996-12#1)(2007-11#3)(2008-10#3)(2008-7#1)(2009-10#1)
catalysts in the##2##3##(2007-11#1)(2008-12#1)
catalysts in##4##2##(2007-11#1)(2008-12#1)(2010-12#1)(2013-1#1)
catalysts or##2##2##(1992-8#1)(1996-3#1)
catalysts to##6##2##(2007-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-12#2)
catalysts under##2##2##(2008-7#1)(2013-1#1)
catalysts were##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
catalysts with##2##2##(2008-10#2)
catalysts##93##1##(1992-8#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-11#7)(2007-2#1)(2008-1#1)(2008-10#28)(2008-11#8)(2008-12#1)(2008-6#1)(2008-7#14)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#6)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#9)
catalytic Zn(II)##3##2##(1992-3#3)
catalytic action of##3##3##(2008-10#3)
catalytic action##6##2##(2008-10#6)
catalytic active site##2##3##(2009-9#1)(2013-1#1)
catalytic active##4##2##(2008-10#1)(2009-9#1)(2010-12#1)(2013-1#1)
catalytic activities##8##2##(1993-2#1)(1993-8#1)(1994-5#1)(1995-5#1)(1997-3#2)(2010-12#1)(2010-2#1)
catalytic activity and##3##3##(2008-10#2)(2008-7#1)
catalytic activity but##2##3##(1994-5#1)(2012-12#1)
catalytic activity for the##2##4##(2008-10#1)(2008-12#1)
catalytic activity for##3##3##(2008-10#2)(2008-12#1)
catalytic activity in##2##3##(1993-8#1)(2008-10#1)
catalytic activity of Fe(III)-HNT##2##4##(2008-10#2)
catalytic activity of the##6##4##(2008-10#4)(2008-7#1)(2009-3#1)
catalytic activity of##22##3##(1990-7#1)(1990-8#1)(1997-8#1)(2008-10#15)(2008-7#1)(2009-3#2)(2012-2#1)
catalytic activity on##2##3##(1992-3#1)(2008-10#1)
catalytic activity to##4##3##(1990-5#1)(1996-2#1)(2008-10#1)(2012-12#1)
catalytic activity toward##2##3##(2008-10#2)
catalytic activity##73##2##(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-5#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1996-2#1)(1997-8#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#2)(2010-12#1)(2012-12#3)(2012-2#2)(2013-1#1)
catalytic adsorptive stripping voltammetry (CAdSV)##2##5##(2008-10#2)
catalytic adsorptive stripping voltammetry##5##4##(2008-10#5)
catalytic adsorptive stripping##6##3##(2008-10#6)
catalytic adsorptive##8##2##(2008-10#8)
catalytic amounts of##3##3##(1990-9#1)(1996-12#1)(2008-5#1)
catalytic and regulatory##3##3##(1990-8#1)(1993-11#1)(2011-2#1)
catalytic and structural##2##3##(1997-4#1)(2010-11#1)
catalytic and##10##2##(1990-8#1)(1993-11#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-2#1)(2012-2#1)
catalytic antibodies for##2##3##(1994-8#2)
catalytic antibodies##5##2##(1994-8#2)(1995-2#2)(2008-10#1)
catalytic applications##2##2##(2008-10#1)(2012-2#1)
catalytic asymmetric##2##2##(2009-10#1)(2010-6#1)
catalytic center##2##2##(1993-8#1)(1995-6#1)
catalytic chemical vapor deposition##2##4##(2008-10#2)
catalytic chemiluminescent##2##2##(2008-10#2)
catalytic combustion##3##2##(2008-10#3)
catalytic converters##5##2##(2008-10#3)(2008-11#2)
catalytic current and##3##3##(2008-10#3)
catalytic current##9##2##(2008-10#9)
catalytic cycle##5##2##(1992-6#1)(1996-2#2)(2009-9#1)(2013-1#1)
catalytic domain of PKD##2##4##(1994-8#2)
catalytic domain of##10##3##(1990-5#1)(1991-10#1)(1992-11#2)(1994-8#3)(1997-4#1)(2008-4#1)(2009-7#1)
catalytic domain##22##2##(1990-5#1)(1991-10#1)(1991-5#2)(1992-11#2)(1993-12#1)(1994-11#1)(1994-8#4)(1995-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(2008-4#2)(2008-9#1)(2009-7#1)
catalytic domains##13##2##(1991-6#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-8#2)(1996-2#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-6#1)
catalytic effect of##19##3##(2008-10#19)
catalytic effect on the oxidation reaction of##2##7##(2008-10#2)
catalytic effect on the oxidation##8##5##(2008-10#8)
catalytic effect on the oxidative coupling of##2##7##(2008-10#2)
catalytic effect on the##13##4##(2008-10#13)
catalytic effect on##14##3##(2008-10#14)
catalytic effect##34##2##(2008-10#34)
catalytic effects on the##2##4##(2008-10#2)
catalytic effects##3##2##(2008-10#3)
catalytic efficiency of##3##3##(1992-6#1)(1995-2#1)(2009-3#1)
catalytic efficiency##9##2##(1992-6#2)(1994-5#2)(1995-2#1)(2008-11#1)(2009-11#1)(2009-3#1)(2013-1#1)
catalytic fragment of PKC alpha##3##5##(1995-11#3)
catalytic fragment of##4##3##(1992-12#1)(1995-11#3)
catalytic fragments##2##2##(1995-11#2)
catalytic function and##2##3##(1992-6#1)(1995-2#1)
catalytic function##8##2##(1990-5#1)(1990-7#1)(1992-6#3)(1995-2#1)(1996-2#1)(2008-9#1)
catalytic hydrogenation##2##2##(1992-8#1)(1996-5#1)
catalytic indicator##2##2##(2008-10#2)
catalytic kinetic spectrofluorimetric method##2##4##(2008-10#2)
catalytic kinetic spectrophotometric method##2##4##(2008-10#2)
catalytic kinetic##7##2##(2008-10#7)
catalytic mechanism##7##2##(1992-11#1)(1992-6#1)(1992-7#1)(1993-11#2)(1995-2#1)(1995-6#1)
catalytic mechanisms##2##2##(1993-8#1)(2008-4#1)
catalytic module##2##2##(1997-6#2)
catalytic pathway##2##2##(1995-5#1)(2013-1#1)
catalytic peaks on##2##3##(2008-10#2)
catalytic performance##2##2##(2008-10#1)(2013-1#1)
catalytic photometric##2##2##(2008-10#2)
catalytic process##3##2##(1994-5#1)(2008-10#1)(2010-12#1)
catalytic processes##2##2##(1994-8#1)(2010-12#1)
catalytic properties of the##2##4##(1992-6#1)(1994-11#1)
catalytic properties of##6##3##(1991-11#1)(1992-6#1)(1994-11#1)(2008-10#2)(2009-10#1)
catalytic properties##14##2##(1990-7#1)(1991-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1996-2#1)(2008-10#3)(2008-4#1)(2009-10#1)(2010-7#1)(2012-2#1)
catalytic rate constant##7##3##(1994-5#1)(1995-2#1)(2008-10#5)
catalytic rate##8##2##(1994-5#1)(1995-2#1)(2008-10#6)
catalytic reaction is proposed##3##4##(1995-2#1)(2008-10#2)
catalytic reaction is##4##3##(1995-2#1)(2008-10#3)
catalytic reaction was##2##3##(2008-10#2)
catalytic reaction##12##2##(1995-2#1)(2008-10#11)
catalytic reactions##3##2##(1995-5#1)(2008-10#1)(2010-12#1)
catalytic reduction##3##2##(2008-10#3)
catalytic residues##2##2##(1990-7#1)(1992-3#1)
catalytic site and##2##3##(1990-7#1)(1995-5#1)
catalytic site of the##3##4##(1993-11#1)(1994-5#2)
catalytic site of##6##3##(1990-11#1)(1992-3#1)(1993-11#1)(1994-5#2)(1995-2#1)
catalytic site##20##2##(1990-11#2)(1990-7#2)(1992-3#3)(1993-11#1)(1994-5#2)(1995-2#1)(1995-5#6)(2009-7#3)
catalytic sites are##2##3##(1992-3#2)
catalytic sites of##2##3##(1992-3#1)(1994-5#1)
catalytic sites##10##2##(1992-3#4)(1992-4#2)(1993-2#1)(1993-8#1)(1994-5#2)
catalytic spectrophotometric determination of##2##4##(2008-10#2)
catalytic spectrophotometric##6##2##(2008-10#6)
catalytic subunit (DNA-PKcs)##2##3##(1996-2#1)(2013-1#1)
catalytic subunit and##3##3##(1995-2#2)(2010-12#1)
catalytic subunit##37##2##(1990-8#2)(1992-12#1)(1992-3#1)(1992-9#7)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#7)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2013-1#1)
catalytic subunits and##2##3##(1990-8#2)
catalytic subunits of##3##3##(1990-8#1)(1992-6#2)
catalytic subunits##8##2##(1990-8#3)(1992-6#2)(1994-12#2)(1996-2#1)
catalytic surface for the##2##4##(2008-10#2)
catalytic surface##3##2##(2008-10#3)
catalytic triad of serine proteases##2##5##(1995-2#1)(1995-5#1)
catalytic triad of##4##3##(1992-3#1)(1995-2#1)(1995-5#2)
catalytic triad##8##2##(1992-3#2)(1995-2#1)(1995-3#1)(1995-5#3)(1997-6#1)
catalytic turnover##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
catalytic##535##1##(1990-11#2)(1990-5#5)(1990-7#6)(1990-8#10)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-3#21)(1992-4#3)(1992-6#13)(1992-7#2)(1992-8#1)(1992-9#7)(1993-11#8)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#8)(1993-9#2)(1994-11#2)(1994-12#3)(1994-5#12)(1994-8#11)(1994-9#1)(1995-11#8)(1995-2#19)(1995-3#3)(1995-5#16)(1995-6#11)(1995-8#2)(1996-12#2)(1996-2#11)(1996-5#2)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#2)(2007-11#2)(2008-1#1)(2008-10#197)(2008-11#12)(2008-12#2)(2008-2#1)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#3)(2009-2#3)(2009-3#3)(2009-6#1)(2009-7#4)(2009-9#2)(2010-11#2)(2010-12#8)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#7)(2013-1#8)(2013-8#1)
catalytical##2##1##(2008-10#2)
catalytically active##12##2##(1990-2#1)(1990-7#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(2008-7#2)(2010-12#1)
catalytically competent##2##2##(1992-3#1)(1994-8#1)
catalytically inactive##3##2##(1991-12#1)(1995-2#1)(1995-6#1)
catalytically inert##2##2##(1992-3#2)
catalytically reduced by##2##3##(2008-10#2)
catalytically##29##1##(1990-2#1)(1990-7#2)(1991-12#1)(1992-3#4)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-7#2)(2010-12#2)
catalyze the formation of##2##4##(1990-11#1)(2008-1#1)
catalyze the##23##2##(1990-11#3)(1990-12#1)(1992-3#1)(1992-5#1)(1993-8#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#8)(2009-12#1)(2009-6#1)(2009-7#1)(2012-2#2)
catalyze##40##1##(1990-11#3)(1990-12#2)(1991-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-7#1)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#2)
catalyzed a net##2##3##(1990-11#2)
catalyzed a##4##2##(1990-11#2)(1997-8#1)(2008-10#1)
catalyzed at##3##2##(1992-6#2)(2008-10#1)
catalyzed by a##10##3##(1990-10#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-2#1)(1997-7#1)(2007-11#1)(2009-5#1)(2010-3#1)(2012-2#1)
catalyzed by cysteine 419##2##4##(1995-2#2)
catalyzed by soybean##2##3##(1990-12#1)(1992-8#1)
catalyzed by the##8##3##(1990-11#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-2#1)(2007-12#1)(2013-1#1)
catalyzed by##79##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#3)(1994-8#2)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#3)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-4#4)(2008-7#5)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
catalyzed hydrolysis##2##2##(2007-2#1)(2008-10#1)
catalyzed oxidation of##2##3##(2008-10#2)
catalyzed phosphorylation of eIF-2##2##4##(1994-5#2)
catalyzed phosphorylation##4##2##(1990-11#1)(1994-5#3)
catalyzed reaction##4##2##(1990-7#1)(2008-10#3)
catalyzed reactions of##3##3##(2008-10#2)(2008-5#1)
catalyzed the formation of##2##4##(1991-9#1)(2008-10#1)
catalyzed the hydrolysis of##2##4##(1990-5#1)(1995-5#1)
catalyzed the oxidation of##2##4##(2008-10#2)
catalyzed the##15##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-5#1)(1997-8#1)(2008-10#4)
catalyzed##134##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#7)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#4)(1995-5#3)(1995-6#3)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#5)(2009-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
catalyzes a##2##2##(1992-9#1)(1994-11#1)
catalyzes an##3##2##(1990-11#1)(1994-8#1)(2008-10#1)
catalyzes the conversion of##7##4##(1990-11#1)(1992-3#1)(1993-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
catalyzes the first step in##2##5##(1990-7#1)(1997-1#1)
catalyzes the first##3##3##(1990-7#1)(1997-1#1)(1997-2#1)
catalyzes the formation of##3##4##(1990-2#1)(1996-2#1)(2008-7#1)
catalyzes the hydrolysis of##2##4##(1994-9#1)(2011-2#1)
catalyzes the oxidation##2##3##(2008-10#2)
catalyzes the reduction of##2##4##(1995-2#1)(1997-2#1)
catalyzes the reversible conversion of##2##5##(1990-11#1)(1995-2#1)
catalyzes the reversible##5##3##(1990-11#1)(1992-3#1)(1993-8#1)(1995-2#1)(1995-5#1)
catalyzes the##45##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#1)(1991-5#1)(1992-3#3)(1992-6#1)(1992-8#3)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#2)(1994-9#3)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#1)
catalyzes##60##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#1)(1991-5#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-2#3)(1995-5#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)
catalyzing the formation of##3##4##(1990-5#1)(1992-10#1)(1995-12#1)
catalyzing the##10##2##(1990-5#1)(1992-10#1)(1992-6#2)(1994-11#1)(1995-12#1)(2008-10#1)(2008-7#2)(2008-9#1)
catalyzing##16##1##(1990-5#1)(1992-10#1)(1992-6#2)(1994-11#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#3)(2009-7#1)(2013-8#1)
catamenial##2##1##(1991-3#1)(2008-7#1)
cataplexy##7##1##(1991-5#5)(1996-7#2)
catapult jumps##2##2##(1995-2#2)
catapult##3##1##(1995-2#3)
cataract and##6##2##(1994-9#1)(2008-11#1)(2010-8#3)(2011-2#1)
cataract extractions##2##2##(1991-9#1)(1994-12#1)
cataract formation##2##2##(2008-3#1)(2009-12#1)
cataract in a cynomolgus monkey##2##5##(2012-2#2)
cataract in##8##2##(1994-9#1)(2007-7#1)(2010-8#1)(2011-1#3)(2012-2#2)
cataract phenotypes##2##2##(2008-11#2)
cataract surgery##4##2##(1991-1#1)(1991-2#1)(2011-2#1)(2013-7#1)
cataract##41##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-9#2)(1997-3#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#1)(2009-1#1)(2009-12#1)(2010-8#7)(2011-1#3)(2011-2#6)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
cataractogenic##2##1##(1993-9#1)(2011-1#1)
cataractous lens##2##2##(2008-11#1)(2011-1#1)
cataractous##3##1##(1990-12#1)(2008-11#1)(2011-1#1)
cataracts##7##1##(1990-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(2008-11#1)(2010-3#1)(2011-2#1)
catarrhal##4##1##(1990-6#1)(2008-5#2)(2011-1#1)
catarrhalis##2##1##(1994-11#1)(2008-4#1)
catastrophe emissions##2##2##(2008-10#2)
catastrophe##7##1##(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#1)
catastrophes##3##1##(2008-2#1)(2008-8#1)(2010-8#1)
catastrophic antiphospholipid syndrome##2##3##(2006-10#2)
catastrophic haemorrhage##2##2##(1997-6#1)(2013-1#1)
catastrophic##18##1##(1991-12#1)(1993-2#1)(1997-5#1)(1997-6#1)(2006-10#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
catch apparatus##2##2##(2008-6#2)
catch rates##4##2##(2009-5#1)(2013-7#3)
catch##24##1##(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-5#1)(2013-7#5)
catch-up growth##2##2##(2011-1#1)(2012-2#1)
catch-up##5##1##(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
catches of##3##2##(2011-2#3)
catches##6##1##(2011-2#3)(2013-7#3)
catching up##2##2##(2009-7#1)(2010-7#1)
catching##4##1##(1990-6#1)(2008-7#1)(2009-7#1)(2010-7#1)
catchment area of##3##3##(1990-2#1)(1994-2#1)(1997-2#1)
catchment area##4##2##(1990-2#1)(1994-2#1)(1995-11#1)(1997-2#1)
catchment##6##1##(1990-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(2008-10#1)(2010-6#1)
catechin and catechol##2##3##(2011-1#2)
catechin and##5##2##(2008-10#2)(2008-11#1)(2011-1#2)
catechin or epicatechin##2##3##(1993-8#2)
catechin##20##1##(1993-8#4)(2008-10#7)(2008-11#2)(2008-5#1)(2009-11#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-3#1)
catechin-rich beverages##3##2##(2009-5#3)
catechins and##2##2##(2008-10#1)(2009-8#1)
catechins in##5##2##(2008-10#4)(2009-11#1)
catechins was##2##2##(2008-10#1)(2008-11#1)
catechins##31##1##(2008-10#20)(2008-11#5)(2009-11#4)(2009-5#1)(2009-8#1)
catechol 2##2##2##(1994-12#2)
catechol and 4-chlorophenol##2##3##(2008-10#2)
catechol and pyrogallol##2##3##(2008-10#2)
catechol and##9##2##(2008-10#9)
catechol as##2##2##(2008-10#2)
catechol derivatives in##2##3##(2008-10#2)
catechol derivatives##6##2##(2008-10#6)
catechol has been##2##3##(2008-10#2)
catechol moiety of##2##3##(2008-10#1)(2008-11#1)
catechol siderophore##4##2##(2008-10#4)
catechol to##2##2##(2008-10#2)
catechol using##2##2##(2008-10#2)
catechol was##3##2##(2008-10#3)
catechol were##2##2##(2008-10#2)
catechol within##2##2##(2008-10#2)
catechol##69##1##(1992-3#1)(1994-12#2)(1995-5#1)(1995-8#1)(2008-10#58)(2008-11#2)(2009-9#1)(2011-1#3)
catechol-O-methyltransferase##2##1##(1995-5#1)(2013-1#1)
catecholamine (CA)##4##2##(1992-6#1)(1995-3#1)(1997-6#1)(1997-7#1)
catecholamine derivatives##2##2##(2008-10#2)
catecholamine release from##2##3##(1991-5#1)(1993-3#1)
catecholamine release response##2##3##(1992-3#1)(1993-3#1)
catecholamine release##6##2##(1991-5#1)(1992-3#2)(1992-6#1)(1993-3#2)
catecholamine secretion##2##2##(1994-5#1)(1995-11#1)
catecholamine##28##1##(1991-5#1)(1992-3#2)(1992-6#2)(1993-3#3)(1994-5#1)(1995-11#1)(1995-3#2)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#2)(2011-2#1)(2013-1#2)
catecholaminergic and##2##2##(1997-2#1)(2008-7#1)
catecholaminergic nerve##2##2##(1990-5#1)(2008-7#1)
catecholaminergic polymorphic ventricular tachycardia##2##4##(2009-5#1)(2013-1#1)
catecholaminergic polymorphic ventricular##3##3##(2009-5#1)(2013-1#2)
catecholaminergic##17##1##(1990-5#1)(1994-2#3)(1995-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-10#3)(2008-7#2)(2009-5#1)(2013-1#2)
catecholamines and##9##2##(1991-1#1)(1993-3#1)(1994-3#2)(1995-11#1)(2008-10#4)
catecholamines by##2##2##(1997-7#1)(2008-10#1)
catecholamines in human urine##3##4##(1990-8#2)(2008-10#1)
catecholamines in pharmaceutical preparations##2##4##(2008-10#2)
catecholamines in the##3##3##(1990-8#1)(1997-2#2)
catecholamines in##14##2##(1990-8#3)(1994-6#1)(1995-3#1)(1997-2#2)(2008-10#6)(2008-7#1)
catecholamines were separated##2##3##(1990-8#2)
catecholamines##49##1##(1990-8#8)(1991-1#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-3#2)(1994-6#3)(1995-11#1)(1995-3#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-9#1)(2008-10#20)(2008-7#2)(2009-8#1)(2011-2#1)
catechols##4##1##(2008-10#4)
catechu L extract##3##3##(2008-5#3)
catechu L##5##2##(2008-5#5)
catechu##12##1##(2008-5#12)
categorical scale and##2##3##(2008-10#2)
categorical scale was used##2##4##(1997-8#2)
categorical scale##4##2##(1997-8#2)(2008-10#2)
categorical variables##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
categorical##20##1##(1992-3#1)(1995-12#1)(1997-3#1)(1997-4#2)(1997-8#2)(2007-11#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#2)(2013-8#2)
categories and##10##2##(1992-11#1)(1993-12#1)(2008-11#4)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
categories are##3##2##(1992-11#1)(2007-4#1)(2008-12#1)
categories as##3##2##(1992-11#1)(2008-7#1)(2011-2#1)
categories emerged from the##2##4##(2008-11#1)(2013-1#1)
categories emerged##4##2##(2008-11#2)(2013-1#2)
categories for##4##2##(1991-8#1)(2010-11#2)(2010-4#1)
categories in##7##2##(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2012-12#1)(2012-2#1)
categories of auditory performance##2##4##(2008-9#1)(2012-2#1)
categories of health##2##3##(1990-11#1)(1993-1#1)
categories of host plants##2##4##(2008-10#2)
categories of host##3##3##(2008-10#3)
categories of information##2##3##(1994-12#1)(2011-1#1)
categories of patients##3##3##(1993-9#1)(2007-9#2)
categories of the##7##3##(1994-12#2)(1995-4#1)(2008-11#2)(2008-7#1)(2012-12#1)
categories of##71##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-8#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-4#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
categories on##2##2##(1990-12#1)(1997-8#1)
categories showed##2##2##(1996-12#2)
categories significantly associated with repeat prescriptions were##2##7##(2008-11#2)
categories that##6##2##(1997-1#1)(2008-11#2)(2008-12#1)(2010-1#2)
categories to##3##2##(1997-1#1)(2008-7#1)(2012-2#1)
categories was##3##2##(1995-12#1)(2008-2#1)(2012-2#1)
categories were identified##2##3##(1996-2#1)(2013-1#1)
categories were statistically significantly improved in the##2##7##(2012-1#2)
categories were##11##2##(1991-12#1)(1992-8#1)(1995-3#1)(1996-2#1)(1996-9#1)(2008-10#2)(2008-5#1)(2012-1#2)(2013-1#1)
categories##260##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-9#1)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-3#3)(1997-4#1)(1997-8#1)(2007-11#1)(2007-4#2)(2007-9#3)(2008-1#2)(2008-10#24)(2008-11#23)(2008-12#9)(2008-2#9)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#6)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#10)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#2)
categorise##2##1##(2008-11#1)(2010-11#1)
categorised into##4##2##(2007-9#1)(2008-12#1)(2011-2#1)(2012-2#1)
categorised##12##1##(1994-7#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
categorization and##3##2##(2008-3#1)(2009-10#1)(2012-2#1)
categorization by##2##2##(1994-3#1)(2012-3#1)
categorization of the##2##3##(2008-10#1)(2008-11#1)
categorization of##12##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
categorization##34##1##(1992-11#2)(1992-9#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#4)
categorize the##4##2##(1996-12#1)(2008-11#1)(2009-6#1)(2013-8#1)
categorize##13##1##(1995-2#2)(1996-12#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
categorized as a##2##3##(2008-10#1)(2008-5#1)
categorized as either##3##3##(2012-2#1)(2013-1#2)
categorized as##20##2##(1992-1#1)(1995-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#4)
categorized based on##3##3##(2013-1#3)
categorized by the##2##3##(2011-1#1)(2013-7#1)
categorized by thematic##2##3##(2010-10#1)(2012-3#1)
categorized by##7##2##(1994-3#1)(2008-1#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-3#1)(2013-7#1)
categorized into four##3##3##(1994-11#1)(2008-11#1)(2010-3#1)
categorized into three##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
categorized into two##3##3##(1995-12#1)(2008-10#2)
categorized into##11##2##(1994-11#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-3#1)(2010-5#1)(2012-2#1)
categorized the##2##2##(2008-10#1)(2008-5#1)
categorized##56##1##(1991-11#1)(1992-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-3#1)(2013-7#1)
categorizes##2##1##(1995-2#1)(2012-2#1)
categorizing##4##1##(1992-9#1)(1997-1#1)(2008-7#1)(2008-8#1)
category &quot##3##2##(1995-6#1)(2009-10#1)(2013-1#1)
category and##4##2##(1991-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
category are##2##2##(1996-2#1)(1997-8#1)
category is##3##2##(2008-9#1)(2009-8#1)(2013-1#1)
category items##2##2##(2011-1#2)
category of patients##4##3##(1991-3#1)(1991-8#1)(2007-7#1)(2012-2#1)
category of##34##2##(1990-11#1)(1990-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#2)
category rating scale##2##3##(2012-2#2)
category to##2##2##(2008-4#1)(2008-7#1)
category were##3##2##(2011-2#3)
category##129##1##(1990-11#1)(1990-12#2)(1991-12#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#2)(2008-9#5)(2009-10#3)(2009-2#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-2#8)(2012-7#1)(2013-1#7)(2013-8#1)
catenated##3##1##(1994-6#2)(2010-2#1)
catenation and##2##2##(1994-6#1)(2008-10#1)
catenation##8##1##(1992-11#1)(1994-6#5)(2008-10#2)
catenin##2##1##(1993-6#1)(1994-9#1)
cater to##2##2##(1992-3#1)(2010-8#1)
cater##4##1##(1992-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
catering for##2##2##(1994-9#1)(1997-7#1)
catering##4##1##(1994-9#1)(1997-7#1)(2007-12#1)(2008-12#1)
caterpillar##5##1##(2008-5#3)(2009-8#1)(2010-10#1)
caterpillars##6##1##(1990-11#2)(2008-5#4)
catfish GnRH I##2##3##(1992-8#2)
catfish GnRH##4##2##(1992-8#4)
catfish and carp during the pre-monsoon season##2##7##(2008-7#2)
catfish and##3##2##(2008-7#3)
catfish muscle##2##2##(2008-10#2)
catfish##23##1##(1992-8#6)(2008-10#5)(2008-5#5)(2008-7#7)
catgut##3##1##(1991-1#2)(2013-1#1)
cath lab##3##2##(2009-5#1)(2010-5#1)(2011-2#1)
cathartic##2##1##(1996-3#1)(2007-7#1)
cathepsin A dimer##2##3##(1995-2#2)
cathepsin A##12##2##(1995-2#10)(2006-6#2)
cathepsin B##7##2##(1992-12#3)(1994-12#2)(1995-6#1)(2009-8#1)
cathepsin D activity was##2##4##(2008-7#2)
cathepsin D activity##5##3##(2008-7#5)
cathepsin D and##2##3##(1990-5#1)(2012-12#1)
cathepsin D gene##2##3##(1990-5#2)
cathepsin D##30##2##(1990-12#3)(1990-5#5)(1994-5#4)(1995-6#1)(1995-8#3)(2008-7#11)(2010-12#1)(2012-12#2)
cathepsin E gene##2##3##(1992-9#2)
cathepsin E##11##2##(1991-2#6)(1992-9#4)(1993-11#1)
cathepsin G and##6##3##(1992-5#3)(1993-3#1)(1994-5#2)
cathepsin G##16##2##(1991-9#1)(1992-5#6)(1993-3#1)(1994-5#4)(2008-6#1)(2008-7#3)
cathepsin L##3##2##(1990-2#1)(1995-6#2)
cathepsin##85##1##(1990-12#3)(1990-2#1)(1990-5#5)(1991-2#6)(1991-9#1)(1992-12#3)(1992-5#6)(1992-9#6)(1993-11#1)(1993-3#1)(1994-12#2)(1994-5#8)(1995-2#10)(1995-6#4)(1995-8#4)(2006-6#3)(2008-6#1)(2008-7#15)(2009-8#1)(2010-12#1)(2012-12#2)(2013-1#1)
cathepsin-D expression##4##2##(1993-9#4)
cathepsins B and D##9##4##(1995-6#6)(1997-1#3)
cathepsins B##10##2##(1990-2#1)(1995-6#6)(1997-1#3)
cathepsins##11##1##(1990-2#1)(1990-5#1)(1995-6#6)(1997-1#3)
catheter ablation is##2##3##(1993-2#1)(2010-12#1)
catheter ablation##4##2##(1993-2#1)(2008-5#1)(2010-11#1)(2010-12#1)
catheter and##7##2##(1993-5#1)(1994-6#1)(2007-7#1)(2010-9#1)(2011-2#2)(2012-12#1)
catheter angiography##2##2##(2008-7#1)(2008-9#1)
catheter can be##3##3##(2008-11#1)(2011-2#2)
catheter can##4##2##(2007-12#1)(2008-11#1)(2011-2#2)
catheter connected to##2##3##(2007-7#2)
catheter drainage##3##2##(1990-11#1)(1997-8#1)(2008-10#1)
catheter exit site##4##3##(2007-12#2)(2007-7#1)(2008-5#1)
catheter exit##5##2##(2007-12#2)(2007-7#2)(2008-5#1)
catheter for hemodialysis##2##3##(2007-7#2)
catheter for##8##2##(1990-8#1)(2007-12#3)(2007-7#2)(2008-11#1)(2010-8#1)
catheter fragment embolus##2##3##(2008-7#2)
catheter fragment##5##2##(2007-7#3)(2008-7#2)
catheter from the##2##3##(2008-11#1)(2012-12#1)
catheter from##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
catheter had##3##2##(1990-8#3)
catheter has been##2##3##(2007-12#1)(2010-8#1)
catheter has##4##2##(2007-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
catheter immobilization##2##2##(2011-2#2)
catheter implantation##3##2##(2011-2#3)
catheter in the##4##3##(1990-8#1)(1997-3#1)(2007-7#1)(2013-1#1)
catheter in##8##2##(1990-8#2)(1997-3#1)(2007-7#2)(2011-2#2)(2013-1#1)
catheter inserted in##2##3##(1990-8#1)(2011-2#1)
catheter inserted##3##2##(1990-8#1)(2007-9#1)(2011-2#1)
catheter insertion in##2##3##(2008-1#1)(2010-6#1)
catheter insertion is##2##3##(2008-1#2)
catheter insertion##10##2##(2007-10#1)(2007-7#1)(2008-1#3)(2010-6#3)(2012-12#1)(2012-2#1)
catheter into the##2##3##(1997-3#1)(2008-7#1)
catheter into##3##2##(1997-3#2)(2008-7#1)
catheter is##5##2##(2007-7#2)(2008-7#1)(2011-2#2)
catheter material was##2##3##(2011-2#2)
catheter material were##2##3##(2011-2#2)
catheter material##6##2##(1996-12#1)(2011-2#5)
catheter of##3##2##(1996-3#1)(2012-12#1)(2013-1#1)
catheter on##2##2##(1993-6#1)(2008-10#1)
catheter or##2##2##(2010-8#1)(2011-2#1)
catheter placement and##2##3##(2008-1#1)(2009-4#1)
catheter placement##5##2##(2007-7#2)(2008-1#1)(2008-11#1)(2009-4#1)
catheter removal##2##2##(2008-1#1)(2012-12#1)
catheter to##7##2##(1997-3#2)(2008-11#1)(2008-4#1)(2009-9#1)(2010-6#1)(2010-8#1)
catheter venography##2##2##(2012-3#1)(2013-1#1)
catheter was introduced##2##3##(1990-2#1)(1997-6#1)
catheter was removed##2##3##(2007-7#1)(2011-2#1)
catheter was##12##2##(1990-2#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#3)(2013-8#1)
catheter##247##1##(1990-11#4)(1990-2#1)(1990-3#3)(1990-8#7)(1991-11#1)(1991-3#2)(1991-5#1)(1993-10#5)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#7)(1997-6#2)(1997-8#2)(2006-12#1)(2007-10#3)(2007-12#8)(2007-7#32)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#5)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#12)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#2)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#7)(2010-8#7)(2010-9#1)(2011-2#51)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#4)
catheter-associated##2##1##(2007-12#1)(2011-2#1)
catheter-based##4##1##(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
catheter-related bloodstream##2##2##(2007-7#1)(2010-12#1)
catheter-related##3##1##(2007-7#1)(2010-12#1)(2011-2#1)
catheterisation in##2##2##(1991-3#1)(2012-2#1)
catheterisation##7##1##(1991-3#1)(1993-5#1)(2008-7#2)(2010-10#2)(2012-2#1)
catheterizable channels##2##2##(2008-10#2)
catheterization and##5##2##(1992-6#1)(1993-12#1)(2006-10#1)(2011-2#2)
catheterization in##2##2##(1993-2#1)(2010-8#1)
catheterization laboratory##5##2##(1996-6#1)(2008-3#3)(2011-2#1)
catheterization of##2##2##(1990-8#1)(2011-3#1)
catheterization was##2##2##(1993-2#1)(2008-3#1)
catheterization##39##1##(1990-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#3)(1994-3#1)(1995-12#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-7#1)(2010-10#2)(2010-8#1)(2011-2#7)(2011-3#1)(2012-3#2)
catheterizations##7##1##(1993-2#4)(1997-3#1)(2010-6#1)(2013-1#1)
catheterized##2##1##(1995-12#1)(1997-8#1)
catheters and##9##2##(1991-3#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#3)
catheters are##4##2##(2007-7#1)(2008-1#1)(2009-5#1)(2011-2#1)
catheters as##2##2##(2007-7#1)(2010-3#1)
catheters for##4##2##(1990-8#1)(2008-5#1)(2008-9#1)(2010-3#1)
catheters in##7##2##(1990-11#1)(2007-7#3)(2008-10#1)(2008-8#1)(2011-2#1)
catheters is##3##2##(1994-11#1)(2008-1#1)(2011-2#1)
catheters of##2##2##(2007-7#1)(2012-12#1)
catheters on the##2##3##(1996-5#1)(2007-7#1)
catheters were placed##4##3##(2007-7#3)(2008-1#1)
catheters were##9##2##(1997-6#1)(2007-7#5)(2008-1#1)(2008-8#2)
catheters with##2##2##(2007-7#1)(2009-9#1)
catheters##102##1##(1990-11#2)(1990-3#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-11#1)(1994-11#3)(1994-5#1)(1996-12#3)(1996-5#1)(1997-3#3)(1997-6#2)(2007-12#1)(2007-7#23)(2008-1#9)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-3#5)(2011-2#20)(2012-12#2)(2012-2#1)(2013-1#1)
cathodal##2##1##(1992-3#1)(2008-10#1)
cathode material##3##2##(2008-10#3)
cathode##24##1##(2007-12#2)(2008-10#18)(2008-11#1)(2008-3#1)(2010-5#1)(2012-12#1)
cathodic ECL##2##2##(2008-10#2)
cathodic adsorptive stripping voltammetry##2##4##(2008-10#2)
cathodic adsorptive stripping##5##3##(2008-10#5)
cathodic adsorptive##6##2##(2008-10#6)
cathodic and anodic##2##3##(2008-10#2)
cathodic current##2##2##(2008-10#2)
cathodic differential pulse##2##3##(2008-10#2)
cathodic electrolyte##3##2##(2008-10#3)
cathodic peak at##3##3##(2008-10#3)
cathodic peak current##3##3##(2008-10#2)(2010-6#1)
cathodic peak was##2##3##(2008-10#2)
cathodic peak##12##2##(2008-10#11)(2010-6#1)
cathodic reduction##2##2##(2008-10#2)
cathodic scan##3##2##(2008-10#3)
cathodic stripping square-wave voltammetry##2##4##(2008-10#2)
cathodic stripping voltammetric detection##2##4##(2008-10#2)
cathodic stripping voltammetric##8##3##(2008-10#8)
cathodic stripping voltammetry (CSV)##2##4##(2008-10#2)
cathodic stripping voltammetry at a##3##5##(2008-10#3)
cathodic stripping voltammetry at##4##4##(2008-10#4)
cathodic stripping voltammetry of##2##4##(2008-10#2)
cathodic stripping voltammetry using##3##4##(2008-10#3)
cathodic stripping voltammetry##32##3##(2008-10#32)
cathodic stripping##54##2##(2008-10#54)
cathodic##102##1##(1992-3#1)(2008-10#99)(2009-7#1)(2010-6#1)
cation and anion##2##3##(2008-10#1)(2008-7#1)
cation and##10##2##(1991-7#1)(1992-6#1)(1996-2#1)(1996-5#1)(2008-10#4)(2008-4#1)(2008-7#1)
cation channel##6##2##(1990-11#1)(1995-12#1)(2008-8#4)
cation channels##3##2##(2008-8#2)(2009-10#1)
cation complexes##2##2##(2008-10#2)
cation concentration##2##2##(1990-2#1)(2008-10#1)
cation concentrations##2##2##(1992-6#1)(2012-2#1)
cation content##2##2##(1996-9#1)(2008-10#1)
cation exchange and##2##3##(1992-11#1)(1992-8#1)
cation exchange chromatography##6##3##(1995-5#1)(1997-6#1)(2008-10#3)(2009-3#1)
cation exchange column##6##3##(1992-3#1)(2008-10#5)
cation exchange resin##3##3##(2008-10#3)
cation exchange##33##2##(1992-11#1)(1992-3#2)(1992-8#1)(1995-5#1)(1997-6#1)(2008-10#25)(2008-7#1)(2009-3#1)
cation exchanger##6##2##(1990-5#1)(1990-7#1)(2008-10#4)
cation in the##2##3##(2008-6#1)(2009-8#1)
cation in##3##2##(2008-10#1)(2008-6#1)(2009-8#1)
cation is##2##2##(1996-2#1)(1997-7#1)
cation of onium salt N(1-carbaethoxypentadecyl)-trimethyl ammonium bromide##2##7##(2008-10#2)
cation of the##3##3##(2007-12#1)(2008-10#2)
cation of##5##2##(2007-12#1)(2008-10#4)
cation radical##3##2##(1993-3#1)(1996-5#1)(2008-10#1)
cation radii##2##2##(2008-10#2)
cation selective##3##2##(1994-2#1)(2008-10#2)
cation selectivity##2##2##(2008-10#2)
cation transport##2##2##(2008-10#1)(2008-8#1)
cation uptake##4##2##(1992-6#1)(1994-5#1)(2008-10#2)
cation with##2##2##(2008-10#2)
cation##181##1##(1990-11#3)(1990-2#5)(1990-5#1)(1990-7#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-12#2)(2008-10#111)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)
cation)##3##1##(2008-10#2)(2012-2#1)
cation-exchange resin##6##2##(2008-10#6)
cation-exchange##22##1##(1990-5#1)(1990-8#1)(1991-8#1)(2008-10#18)(2008-4#1)
cation-selective##6##1##(2008-10#5)(2009-8#1)
cationic additive and 5%##2##4##(2008-10#2)
cationic additive##4##2##(2008-10#4)
cationic amino acid transporter mRNA##2##5##(2012-2#2)
cationic amino acid transporter##3##4##(2012-2#3)
cationic amino acid##4##3##(2008-11#1)(2012-2#3)
cationic amphiphiles##3##2##(2008-11#3)
cationic and anionic species##2##4##(2008-10#2)
cationic and anionic##3##3##(2008-10#3)
cationic and neutral##2##3##(1990-5#1)(2008-10#1)
cationic and non-ionic surfactants##2##4##(2008-10#2)
cationic and##10##2##(1990-5#1)(2008-10#8)(2008-4#1)
cationic arsenic compounds##2##3##(2008-10#2)
cationic arsenic##5##2##(2008-10#5)
cationic complex##2##2##(2008-10#2)
cationic compounds##3##2##(1990-8#3)
cationic dye##4##2##(1994-12#1)(2008-10#3)
cationic exchanger##3##2##(2008-10#3)
cationic lipid##5##2##(1995-2#2)(2008-1#2)(2008-5#1)
cationic lipid-mediated NGF gene transfection##2##5##(1996-12#2)
cationic lipid-mediated NGF##3##3##(1996-12#3)
cationic lipid-mediated##4##2##(1996-12#4)
cationic lipids##3##2##(1995-2#1)(2008-1#2)
cationic liposome systems##2##3##(2008-5#2)
cationic liposome##5##2##(2008-5#2)(2008-9#2)(2011-2#1)
cationic liposomes##8##2##(1994-12#5)(1994-5#2)(2008-5#1)
cationic micellar##5##2##(2008-10#5)
cationic nitronyl nitroxide##2##3##(2007-11#2)
cationic peptide##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
cationic peptides that##2##3##(2008-4#2)
cationic peptides##5##2##(2008-4#5)
cationic polyelectrolyte##3##2##(2008-10#2)(2009-12#1)
cationic polymer##7##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#4)
cationic polymers##4##2##(2008-5#4)
cationic polypeptides##3##2##(2007-11#3)
cationic porphyrin##2##2##(2008-10#2)
cationic probe##5##2##(1992-6#4)(1993-11#1)
cationic protein##2##2##(1996-12#2)
cationic resin##5##2##(2008-10#5)
cationic sites in##2##3##(2008-10#2)
cationic species##6##2##(2008-10#5)(2009-9#1)
cationic surfactant (cetyltrimethylammonium##2##3##(2008-10#2)
cationic surfactant##23##2##(1994-9#1)(1996-5#1)(2008-10#17)(2008-5#1)(2008-8#3)
cationic surfactants##7##2##(2008-10#6)(2008-5#1)
cationic templates##2##2##(2008-10#2)
cationic vesicle##2##2##(2008-11#2)
cationic##225##1##(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#4)(1991-7#1)(1992-6#5)(1993-11#1)(1994-12#7)(1994-5#2)(1994-9#1)(1995-2#5)(1995-8#1)(1996-12#6)(1996-5#2)(1997-1#1)(1997-7#1)(2007-11#6)(2008-1#4)(2008-10#114)(2008-11#12)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#21)(2008-8#3)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
cations (Ca##2##2##(2008-10#2)
cations (Na(+)##2##2##(2008-10#1)(2008-6#1)
cations (group##2##2##(2008-10#2)
cations and anions have been##3##5##(2008-10#3)
cations and anions in low##2##5##(2008-10#2)
cations and anions on the##2##5##(2008-10#2)
cations and anions on##3##4##(2008-10#3)
cations and anions were##2##4##(2008-10#2)
cations and anions##25##3##(2008-10#25)
cations and proteins##2##3##(2008-10#2)
cations and the##3##3##(2008-10#2)(2011-2#1)
cations and##43##2##(1990-7#1)(1993-6#1)(1997-7#1)(2008-10#38)(2011-2#2)
cations are##8##2##(1991-8#1)(1994-8#1)(1995-12#1)(1997-7#2)(2008-10#3)
cations as##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
cations at##3##2##(2008-10#3)
cations but##3##2##(1990-5#2)(1993-6#1)
cations by##2##2##(2008-10#1)(2008-9#1)
cations can be##3##3##(1990-7#1)(2008-10#1)(2008-9#1)
cations could##2##2##(1990-5#1)(2008-10#1)
cations for##3##2##(1990-7#1)(1991-11#1)(2008-10#1)
cations from##2##2##(2008-10#2)
cations have been##2##3##(2008-10#2)
cations in aqueous##2##3##(2008-10#2)
cations in the##5##3##(1997-7#1)(2008-10#3)(2011-2#1)
cations in##15##2##(1997-7#1)(2008-10#13)(2011-2#1)
cations increase##2##2##(1994-5#1)(2008-10#1)
cations increased the##2##3##(2008-10#1)(2008-6#1)
cations interact##3##2##(1990-7#1)(2008-10#2)
cations into the##2##3##(2008-10#2)
cations into##4##2##(2007-11#1)(2008-10#3)
cations is##8##2##(1995-3#1)(2008-10#7)
cations like##2##2##(2008-10#2)
cations of##4##2##(2008-10#4)
cations on the##6##3##(1990-11#1)(1991-2#1)(1994-5#2)(2008-10#2)
cations on##8##2##(1990-11#1)(1991-2#1)(1994-5#2)(2008-10#3)(2008-6#1)
cations present in the##2##4##(2008-10#2)
cations such as##8##3##(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#4)(2009-8#1)
cations to##2##2##(2009-8#1)(2010-12#1)
cations using##4##2##(2008-10#4)
cations was##6##2##(1995-11#1)(2008-10#5)
cations were achieved##2##3##(2008-10#2)
cations were studied##2##3##(2008-10#1)(2008-9#1)
cations were##15##2##(1990-7#1)(1995-5#1)(2008-10#12)(2008-9#1)
cations which##2##2##(2008-10#2)
cations with##7##2##(2008-10#7)
cations##315##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-7#11)(1991-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#3)(1996-2#2)(1996-5#1)(1997-1#1)(1997-7#6)(2007-11#2)(2008-10#231)(2008-2#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#5)(2009-8#2)(2010-12#1)(2011-2#3)
catla##4##1##(2008-10#2)(2008-7#2)
cats (P = 0##2##4##(2013-8#2)
cats (P##3##2##(2013-8#3)
cats and##2##2##(1990-5#1)(2013-8#1)
cats as##2##2##(1995-11#1)(2013-8#1)
cats undergoing##2##2##(2012-3#2)
cats with protruding nictitating membranes and diarrhoea##2##7##(1990-9#2)
cats with##7##2##(1990-9#4)(2008-3#1)(2012-3#2)
cats##66##1##(1990-11#2)(1990-5#1)(1990-7#1)(1990-9#6)(1993-1#2)(1993-12#4)(1993-9#1)(1994-8#1)(1995-11#2)(1995-12#2)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-6#1)(2008-3#3)(2008-4#1)(2008-8#4)(2009-9#1)(2011-1#1)(2012-3#15)(2013-1#4)(2013-7#1)(2013-8#8)
cattle (Bos indicus)##2##3##(2008-12#2)
cattle after##2##2##(1995-9#1)(1996-8#1)
cattle and buffaloes##2##3##(1991-8#1)(2013-1#1)
cattle and##9##2##(1991-8#2)(1992-12#1)(2007-2#1)(2010-7#1)(2011-2#1)(2013-1#3)
cattle breed##2##2##(2008-12#2)
cattle breeding##2##2##(2008-5#1)(2012-1#1)
cattle farms##4##2##(2010-4#4)
cattle filarial parasite Setaria digitata##2##5##(1994-11#2)
cattle from##3##2##(1996-12#3)
cattle had##2##2##(1997-8#1)(2010-1#1)
cattle herds##6##2##(2010-4#1)(2011-2#2)(2012-1#2)(2012-3#1)
cattle in##6##2##(1996-12#1)(1997-5#1)(2010-4#1)(2012-2#1)(2012-3#2)
cattle is##2##2##(1997-7#1)(2008-12#1)
cattle meat##3##2##(2010-4#3)
cattle on##2##2##(2012-2#1)(2012-3#1)
cattle tendons##6##2##(2008-5#6)
cattle to##4##2##(1990-3#1)(1994-3#1)(1996-12#1)(2011-2#1)
cattle trade routes##2##3##(2011-2#2)
cattle treated with##2##3##(1991-3#2)
cattle vaccinated with##3##3##(2010-4#3)
cattle were##7##2##(1990-3#1)(1991-8#1)(1994-3#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
cattle with tuberculous lesions##3##4##(1997-8#3)
cattle with##4##2##(1997-8#3)(2012-3#1)
cattle##161##1##(1990-3#4)(1990-6#1)(1990-9#1)(1991-3#5)(1991-8#7)(1992-12#1)(1993-2#3)(1994-11#2)(1994-3#4)(1994-7#2)(1995-8#1)(1995-9#2)(1996-12#8)(1996-3#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#5)(1997-9#1)(2007-2#4)(2008-10#4)(2008-12#6)(2008-5#7)(2008-6#1)(2008-8#1)(2010-1#3)(2010-10#1)(2010-2#6)(2010-4#26)(2010-7#1)(2011-1#5)(2011-2#10)(2012-1#3)(2012-2#6)(2012-3#10)(2013-1#8)
cattleya##3##1##(2008-8#3)
caucasian male##2##2##(2008-6#1)(2012-3#1)
caucasian##4##1##(1991-8#1)(2008-5#1)(2008-6#1)(2012-3#1)
caucasoid##2##1##(1997-8#2)
caucasus##2##1##(2008-8#2)
cauda equina syndrome during third trimester of pregnancy##2##8##(2008-12#2)
cauda equina syndrome##5##3##(2008-12#3)(2009-5#1)(2012-3#1)
cauda equina##9##2##(2008-12#3)(2008-3#4)(2009-5#1)(2012-3#1)
cauda##14##1##(1992-3#3)(2008-12#4)(2008-3#4)(2008-5#1)(2009-5#1)(2012-3#1)
caudal and##2##2##(1996-5#1)(2010-8#1)
caudal fin)##2##2##(2010-8#2)
caudal part##2##2##(2007-8#1)(2008-5#1)
caudal to the lesion##2##4##(1996-5#2)
caudal to the##3##3##(1996-5#2)(2007-8#1)
caudal vessels##2##2##(2008-5#2)
caudal##49##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1995-12#2)(1996-12#1)(1996-5#7)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#4)(2009-9#1)(2010-8#4)(2011-1#1)(2012-3#2)(2013-7#2)(2013-8#1)
caudalis##3##1##(1990-9#1)(1997-2#1)(2008-9#1)
caudally##2##1##(1993-12#1)(2012-1#1)
caudate and##2##2##(1997-7#1)(2008-7#1)
caudate nuclei##2##2##(2008-6#1)(2008-7#1)
caudate nucleus and##3##3##(1995-5#1)(1996-5#1)(2008-7#1)
caudate nucleus in##3##3##(1994-8#1)(2007-8#1)(2008-7#1)
caudate nucleus##15##2##(1991-12#2)(1994-8#2)(1995-5#3)(1996-12#1)(1996-5#2)(2007-8#1)(2008-10#1)(2008-7#3)
caudate putamen and##2##3##(1996-12#2)
caudate putamen##6##2##(1993-5#1)(1995-6#1)(1996-12#4)
caudate regions##2##2##(1997-7#2)
caudate##38##1##(1991-12#2)(1991-4#1)(1992-8#3)(1993-12#2)(1993-5#1)(1994-8#3)(1995-5#3)(1995-6#1)(1996-12#5)(1996-5#2)(1996-7#1)(1997-7#4)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#7)
caudate-lesioned##2##1##(1993-12#2)
caudate-putamen may##2##2##(1993-6#2)
caudate-putamen##14##1##(1993-6#8)(1995-12#2)(1997-4#1)(2008-7#3)
caudatus##4##1##(2008-4#2)(2008-8#2)
caught by the artisanal##2##4##(2013-7#2)
caught by the##3##3##(1995-3#1)(2013-7#2)
caught by##5##2##(1995-3#1)(2008-5#1)(2013-7#3)
caught in##4##2##(2011-2#1)(2012-12#1)(2013-7#2)
caught##17##1##(1995-3#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#6)
cauliflower and##4##2##(2008-10#4)
cauliflower mosaic virus 35S promoter##3##5##(1997-4#1)(2008-10#1)(2008-9#1)
cauliflower mosaic virus##4##3##(1997-4#1)(2008-10#2)(2008-9#1)
cauliflower plants##3##2##(2008-10#1)(2011-2#2)
cauliflower was##2##2##(2008-10#1)(2008-12#1)
cauliflower##39##1##(1997-4#1)(2008-10#32)(2008-12#2)(2008-9#1)(2011-2#3)
caulivora isolates##4##2##(2008-10#4)
caulivora##14##1##(2008-10#14)
causal agent has been##2##4##(2008-10#2)
causal agent has##4##3##(2008-10#4)
causal agent of Botryosphaeria panicle and shoot blight of pistachio##2##10##(2008-10#2)
causal agent of Fusarium head blight##2##6##(2008-10#2)
causal agent of Fusarium##4##4##(2008-10#4)
causal agent of bacterial spot##2##5##(2008-10#2)
causal agent of bacterial##5##4##(2008-10#5)
causal agent of barley##2##4##(2008-10#2)
causal agent of brown rot of stone fruits##2##8##(2008-10#2)
causal agent of sudden oak death##3##6##(2008-10#3)
causal agent of tan spot of wheat##2##7##(2008-10#2)
causal agent of tan spot##4##5##(2008-10#4)
causal agent of the disease##3##5##(2008-10#3)
causal agent of this##3##4##(2008-10#3)
causal agent of white pine blister rust##2##7##(2008-10#2)
causal agent of##94##3##(1997-4#1)(2008-10#90)(2008-12#1)(2011-10#1)(2012-2#1)
causal agent##107##2##(1990-2#1)(1997-4#1)(2008-10#100)(2008-12#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-2#1)
causal agents of##7##3##(2008-10#6)(2010-5#1)
causal agents##8##2##(1997-3#1)(2008-10#6)(2010-5#1)
causal attribution##2##2##(2010-2#2)
causal effect of##3##3##(2009-7#1)(2013-1#1)(2013-8#1)
causal factor for the##2##4##(1995-12#1)(1996-3#1)
causal factor##5##2##(1995-12#1)(1995-6#1)(1996-3#1)(2007-12#1)(2013-7#1)
causal factors of##2##3##(2009-10#1)(2011-2#1)
causal factors##4##2##(2008-1#1)(2008-3#1)(2009-10#1)(2011-2#1)
causal indicators##2##2##(2012-12#2)
causal interactions##2##2##(2008-11#2)
causal mechanisms##5##2##(1997-1#1)(2008-11#1)(2009-8#2)(2010-9#1)
causal modeling and##2##3##(1997-3#2)
causal modeling##4##2##(1997-3#3)(2008-5#1)
causal network##2##2##(2008-11#1)(2008-8#1)
causal networks##3##2##(2008-11#3)
causal or##2##2##(1991-9#1)(2010-5#1)
causal organism##5##2##(2008-10#5)
causal rare variants##2##3##(2012-3#2)
causal relation##3##2##(1990-5#1)(1997-3#1)(2012-2#1)
causal relations##2##2##(2008-7#2)
causal relationship between##8##3##(1990-3#1)(1990-6#1)(1991-12#1)(1995-2#1)(2007-10#1)(2008-7#1)(2009-4#1)(2010-2#1)
causal relationship with the##2##4##(1990-6#1)(1992-2#1)
causal relationship with##5##3##(1990-6#1)(1992-2#1)(2008-10#1)(2008-11#2)
causal relationship##14##2##(1990-3#1)(1990-6#2)(1991-12#1)(1992-2#1)(1995-2#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-2#1)
causal relationships among phenotypes##2##4##(2011-1#2)
causal role in##7##3##(1990-5#1)(1991-12#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
causal role##10##2##(1990-5#1)(1991-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-6#2)(2008-8#1)(2011-2#2)
causal therapy##5##2##(1996-3#1)(2007-10#3)(2011-2#1)
causal variants##4##2##(2012-3#4)
causal##244##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-12#3)(1991-2#1)(1991-9#1)(1992-2#2)(1992-5#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-3#5)(1997-4#2)(2007-10#4)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#122)(2008-11#12)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#4)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#9)(2012-5#1)(2013-1#1)(2013-7#3)(2013-8#1)
causality and##2##2##(2007-12#1)(2012-1#1)
causality##15##1##(1996-11#1)(2007-12#2)(2008-1#1)(2008-11#3)(2008-2#1)(2008-7#2)(2012-1#1)(2012-2#2)(2013-8#2)
causally associated with##2##3##(2008-10#1)(2013-1#1)
causally related to##2##3##(1994-6#1)(2013-1#1)
causally related##3##2##(1994-6#1)(2009-12#1)(2013-1#1)
causally##11##1##(1992-9#2)(1994-6#2)(1996-11#1)(1997-1#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#2)
causation##9##1##(1991-5#1)(1991-7#1)(2008-3#1)(2008-7#2)(2010-4#1)(2013-1#2)(2013-7#1)
causative agent in##3##3##(2007-7#1)(2008-5#1)(2012-3#1)
causative agent of##22##3##(1992-8#3)(1997-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
causative agent##32##2##(1990-7#1)(1992-8#3)(1994-5#1)(1997-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
causative agents in##2##3##(1990-6#1)(2008-1#1)
causative agents of##2##3##(2008-11#1)(2008-12#1)
causative agents##9##2##(1990-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#2)
causative allergen##2##2##(2007-7#1)(2012-12#1)
causative bacteria##3##2##(1990-6#1)(1991-8#1)(2006-6#1)
causative factor##4##2##(1997-4#1)(2008-10#1)(2008-2#1)(2009-9#1)
causative factors##6##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
causative of##2##2##(1995-2#1)(2008-8#1)
causative organism##7##2##(1990-2#1)(1992-5#1)(1997-3#1)(2007-7#2)(2008-1#1)(2013-1#1)
causative role in##2##3##(1995-6#1)(2008-7#1)
causative role##4##2##(1995-6#1)(2008-11#2)(2008-7#1)
causative##87##1##(1990-2#1)(1990-6#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-5#2)(1992-8#3)(1994-5#3)(1995-2#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-7#6)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#3)(2008-7#4)(2008-8#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#6)(2013-8#2)
cause &quot##2##2##(1993-2#1)(2012-12#1)
cause Ca(2+) mobilization##2##3##(2008-4#2)
cause Cercospora leaf spot on##2##5##(2008-10#2)
cause DNA damage##2##3##(1993-12#1)(2008-10#1)
cause DNA##5##2##(1993-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2011-2#1)
cause a more##2##3##(1991-12#1)(2008-3#1)
cause a significant##5##3##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
cause a variety of##2##4##(2009-8#1)(2012-3#1)
cause a wide range of##2##5##(2009-8#1)(2011-2#1)
cause a wide variety of##2##5##(2008-6#1)(2011-1#1)
cause a wide##4##3##(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
cause a##53##2##(1990-2#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-9#1)(1993-11#1)(1994-12#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#2)(2009-8#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)
cause abnormal##2##2##(1997-3#1)(2012-2#1)
cause about##3##2##(1992-6#1)(1996-6#1)(2009-4#1)
cause acute##2##2##(1994-8#1)(2009-8#1)
cause adverse##2##2##(2007-5#1)(2008-11#1)
cause alterations##3##2##(1997-6#1)(2008-12#1)(2008-5#1)
cause among##2##2##(1990-6#1)(2007-7#1)
cause an increase in the##2##5##(1994-5#1)(2011-1#1)
cause an##13##2##(1990-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
cause and effect##2##3##(2010-3#1)(2011-2#1)
cause and the##3##3##(1991-11#1)(2008-1#1)(2012-12#1)
cause and##15##2##(1991-11#1)(1992-3#1)(2007-10#2)(2008-1#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
cause any##10##2##(1990-2#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
cause at least##2##3##(1997-2#1)(2008-8#1)
cause bone##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
cause both##3##2##(1996-11#1)(2006-10#1)(2013-8#1)
cause building-related##2##2##(1994-9#2)
cause cancer##3##2##(2008-11#1)(2013-1#2)
cause cell death##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
cause cell stress##2##3##(2008-10#2)
cause cell##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
cause changes in##3##3##(2006-6#1)(2008-12#1)(2008-8#1)
cause complications##2##2##(2007-8#1)(2011-2#1)
cause conformational##2##2##(2008-10#1)(2013-1#1)
cause congenital##2##2##(2008-8#1)(2011-1#1)
cause considerable##2##2##(1997-2#1)(2009-4#1)
cause could##3##2##(2007-10#1)(2007-7#1)(2008-11#1)
cause cranberry stem gall##3##4##(2008-10#3)
cause cross talk##2##3##(2008-3#2)
cause damage to##2##3##(1997-4#1)(2008-10#1)
cause damage##3##2##(1997-4#1)(2006-10#1)(2008-10#1)
cause death##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
cause decreased##2##2##(1996-12#1)(1996-3#1)
cause diagnostic and##2##3##(2008-6#1)(2010-8#1)
cause diagnostic difficulties##2##3##(2007-11#1)(2011-2#1)
cause diagnostic##4##2##(2007-11#1)(2008-6#1)(2010-8#1)(2011-2#1)
cause different##3##2##(2008-10#1)(2012-2#1)(2012-7#1)
cause disease in##4##3##(2008-10#2)(2008-9#1)(2010-7#1)
cause disease on##3##3##(2008-10#3)
cause disease##12##2##(2008-10#9)(2008-9#1)(2010-7#1)(2012-2#1)
cause distress##2##2##(2008-7#1)(2011-2#1)
cause dose##2##2##(2007-10#1)(2007-4#1)
cause early##2##2##(1995-12#1)(2012-2#1)
cause either a progressive neurological disease##2##6##(2008-9#2)
cause exclusion##2##2##(2008-8#1)(2008-9#1)
cause failure##3##2##(2008-10#1)(2009-7#1)(2013-1#1)
cause familial##2##2##(1997-7#1)(2007-10#1)
cause for a pre-existing coagulopathy##2##5##(2007-10#2)
cause for acute##2##3##(1990-6#1)(2008-7#1)
cause for concern##4##3##(1992-3#1)(1997-5#1)(2010-3#1)(2013-8#1)
cause for the##7##3##(1991-2#1)(1991-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2013-8#1)
cause for these##2##3##(1991-8#1)(1997-3#1)
cause for##47##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#3)(2007-7#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#5)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
cause further##2##2##(1994-12#1)(2008-5#1)
cause harm##3##2##(1993-1#1)(1996-3#1)(2008-11#1)
cause high mortality##2##3##(2008-8#2)
cause high##3##2##(1996-11#1)(2008-8#2)
cause in##8##2##(1990-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)
cause increased##2##2##(1997-3#1)(2008-9#1)
cause infection##5##2##(2008-10#5)
cause infections in humans##2##4##(2007-12#1)(2010-4#1)
cause infections##4##2##(1992-9#1)(2007-12#1)(2008-10#1)(2010-4#1)
cause interference##2##2##(2008-10#1)(2008-8#1)
cause intestinal##2##2##(2007-12#1)(2013-1#1)
cause irreversible damage##2##3##(1992-4#1)(2008-11#1)
cause irreversible##4##2##(1992-4#1)(2008-10#1)(2008-11#1)(2009-8#1)
cause irritation or##2##3##(1991-5#1)(2008-10#1)
cause is unknown##2##3##(1991-2#1)(2008-1#1)
cause is##14##2##(1990-5#1)(1991-2#1)(1992-8#1)(1996-6#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-10#1)(2011-2#2)(2013-1#2)(2013-8#1)
cause it to##2##3##(2008-5#1)(2013-8#1)
cause less##2##2##(2008-3#1)(2008-8#1)
cause lethal##2##2##(1995-3#1)(2013-1#1)
cause liver##2##2##(1992-2#1)(2008-9#1)
cause major##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
cause many##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2013-8#1)
cause mild##2##2##(1992-3#1)(2008-10#1)
cause mortality##2##2##(2008-6#1)(2011-2#1)
cause multiple##4##2##(2008-3#1)(2011-1#1)(2013-1#2)
cause neural##2##2##(1997-8#1)(2011-2#1)
cause no##2##2##(2008-10#1)(2012-2#1)
cause observable##2##2##(2008-3#1)(2012-2#1)
cause of ESRD in##2##4##(2007-7#1)(2008-4#1)
cause of ESRD is also##2##5##(2007-7#1)(2008-1#1)
cause of ESRD##5##3##(2007-7#3)(2008-1#1)(2008-4#1)
cause of a##6##3##(2008-1#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#2)
cause of abdominal pain##2##4##(2008-11#1)(2013-1#1)
cause of abnormal##2##3##(1990-8#1)(2011-2#1)
cause of acquired##4##3##(2008-1#2)(2008-7#1)(2012-2#1)
cause of acute##9##3##(1990-6#1)(1993-6#1)(2008-1#1)(2008-10#3)(2009-5#1)(2013-8#2)
cause of anthrax##2##3##(1992-12#1)(2011-2#1)
cause of aortic##2##3##(2009-10#1)(2011-2#1)
cause of blindness in the##2##5##(2010-10#1)(2011-2#1)
cause of blindness in##4##4##(2010-10#1)(2011-1#2)(2011-2#1)
cause of blindness##8##3##(2007-11#2)(2008-1#1)(2010-10#1)(2011-1#3)(2011-2#1)
cause of cancer mortality##2##4##(2009-10#1)(2013-1#1)
cause of cancer##3##3##(2009-10#1)(2013-1#2)
cause of cancer-related deaths##2##4##(2008-5#1)(2011-2#1)
cause of cancer-related##5##3##(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
cause of chronic##8##3##(1991-2#1)(2007-2#1)(2007-7#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
cause of congenital##3##3##(1997-3#1)(2008-4#1)(2012-2#1)
cause of deafness##2##3##(2008-9#1)(2013-1#1)
cause of death among##2##4##(2008-4#1)(2013-1#1)
cause of death and disability##4##5##(1995-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
cause of death and##7##4##(1995-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-2#1)
cause of death data##4##4##(2012-12#4)
cause of death following##2##4##(2010-12#1)(2010-8#1)
cause of death in Western##2##5##(2012-2#1)(2013-8#1)
cause of death in patients with##3##6##(1993-9#1)(2010-3#1)(2011-2#1)
cause of death in patients##4##5##(1993-9#1)(2010-3#1)(2011-2#2)
cause of death in the##2##5##(2010-10#1)(2011-3#1)
cause of death in##22##4##(1992-4#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
cause of death of the##3##5##(1992-4#1)(2011-2#1)(2012-2#1)
cause of death of##6##4##(1990-6#1)(1991-12#1)(1992-4#1)(2008-1#1)(2011-2#1)(2012-2#1)
cause of death was##6##4##(1994-11#1)(1995-11#2)(1995-3#1)(2007-7#1)(2011-2#1)
cause of death##68##3##(1990-11#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-4#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-9#1)(1996-12#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
cause of dementia##2##3##(1996-11#1)(2008-7#1)
cause of diagnostic##2##3##(1991-3#1)(2008-7#1)
cause of disability in##2##4##(1990-3#1)(2013-1#1)
cause of disability##6##3##(1990-3#1)(1995-12#1)(2008-1#1)(2010-12#1)(2010-3#1)(2013-1#1)
cause of dyspnoea in##2##4##(2010-10#2)
cause of dyspnoea##3##3##(2010-10#2)(2013-8#1)
cause of end-stage renal disease##3##5##(2007-12#1)(2008-1#1)(2008-8#1)
cause of end-stage renal failure##2##5##(2008-1#2)
cause of end-stage renal##6##4##(2007-12#1)(2008-1#4)(2008-8#1)
cause of epidemic meningococcal disease in Africa##2##7##(2007-2#2)
cause of gastrointestinal##2##3##(2011-2#2)
cause of hair loss##2##4##(2008-5#2)
cause of human##3##3##(2008-4#1)(2010-10#1)(2011-2#1)
cause of illness##2##3##(2007-2#1)(2010-12#1)
cause of injury##2##3##(2008-11#1)(2008-7#1)
cause of intellectual##2##3##(2010-4#2)
cause of intestinal obstruction##3##4##(2008-12#2)(2009-8#1)
cause of intestinal##4##3##(1992-6#1)(2008-12#2)(2009-8#1)
cause of intracerebral##2##3##(2008-12#1)(2012-3#1)
cause of intractable nausea and vomiting##2##6##(2013-8#2)
cause of invasive##2##3##(1996-12#1)(2009-5#1)
cause of ischemic stroke##2##4##(2008-12#1)(2011-1#1)
cause of ischemic##3##3##(2008-12#1)(2010-12#1)(2011-1#1)
cause of late##2##3##(2008-8#1)(2012-2#1)
cause of low back pain in##2##6##(2009-4#2)
cause of low##3##3##(2009-4#2)(2011-2#1)
cause of lower gastrointestinal bleeding##2##5##(2010-8#1)(2013-1#1)
cause of lower##6##3##(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
cause of lung##2##3##(1994-3#1)(2008-7#1)
cause of mental retardation##2##4##(1992-5#1)(1995-2#1)
cause of morbidity and mortality among##3##6##(2008-1#2)(2010-8#1)
cause of morbidity and mortality and##2##6##(2008-11#1)(2008-3#1)
cause of morbidity and mortality in the United Kingdom##2##9##(2007-2#1)(2008-12#1)
cause of morbidity and mortality in the##5##7##(1993-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
cause of morbidity and mortality in##9##6##(1993-3#1)(1993-5#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)
cause of morbidity and mortality worldwide##2##6##(2011-2#2)
cause of morbidity and mortality##25##5##(1993-3#1)(1993-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
cause of morbidity and##27##4##(1992-5#1)(1993-3#1)(1993-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
cause of morbidity in##3##4##(2008-2#1)(2011-2#1)(2013-8#1)
cause of morbidity##34##3##(1992-5#1)(1993-3#1)(1993-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
cause of mortality is##2##4##(1995-8#1)(2011-2#1)
cause of mortality##10##3##(1995-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#2)(2011-3#1)
cause of muscle##2##3##(1994-2#1)(2012-3#1)
cause of neurological##2##3##(1991-8#1)(2012-2#1)
cause of obstructive##2##3##(2008-10#1)(2011-2#1)
cause of poor##2##3##(2012-12#2)
cause of pulmonary##3##3##(1991-4#1)(2010-10#1)(2012-2#1)
cause of renal##6##3##(2007-7#2)(2008-1#3)(2008-10#1)
cause of respiratory##2##3##(1990-9#1)(2008-12#1)
cause of rhabdomyolysis and##2##4##(2008-1#1)(2011-2#1)
cause of rhabdomyolysis##3##3##(2008-1#2)(2011-2#1)
cause of root rot##2##4##(2008-10#2)
cause of secondary hypertension##2##4##(2008-12#1)(2011-2#1)
cause of secondary##5##3##(2007-7#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-12#1)
cause of serious##2##3##(2011-2#1)(2013-1#1)
cause of severe##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
cause of short stature##2##4##(1993-6#1)(2013-1#1)
cause of significant##3##3##(1992-12#1)(1996-12#1)(2009-5#1)
cause of skin##3##3##(2008-5#1)(2011-2#2)
cause of spontaneous##2##3##(2012-3#1)(2013-7#1)
cause of stroke##5##3##(2008-8#3)(2011-1#1)(2013-8#1)
cause of the disease##3##4##(1992-8#1)(2008-10#1)(2011-2#1)
cause of the##31##3##(1990-3#1)(1990-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
cause of these##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
cause of this##13##3##(1990-11#2)(1991-12#1)(1991-6#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
cause of type 2 diabetes##2##5##(2008-1#1)(2008-3#1)
cause of type##3##3##(2008-1#1)(2008-3#2)
cause of visual loss##2##4##(2008-8#1)(2012-2#1)
cause of visual##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
cause of##587##2##(1990-11#3)(1990-3#3)(1990-6#5)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#4)(1992-6#2)(1992-8#1)(1992-9#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#5)(2007-5#1)(2007-7#14)(2007-8#6)(2008-1#33)(2008-10#33)(2008-11#13)(2008-12#13)(2008-2#3)(2008-3#13)(2008-4#11)(2008-5#10)(2008-7#34)(2008-8#15)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#12)(2011-2#59)(2011-3#3)(2012-1#4)(2012-12#17)(2012-2#23)(2012-3#18)(2013-1#35)(2013-7#2)(2013-8#13)
cause or##5##2##(1994-10#1)(2008-7#2)(2011-1#2)
cause other##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2013-7#1)
cause oxidative damage to##2##4##(2008-5#1)(2009-10#1)
cause oxidative stress and##2##4##(1994-8#1)(2009-5#1)
cause oxidative##4##2##(1994-8#1)(2008-5#1)(2009-10#1)(2009-5#1)
cause plant##2##2##(2008-10#2)
cause power##2##2##(2008-2#1)(2008-3#1)
cause psychological##2##2##(2010-3#1)(2012-2#1)
cause removal of##2##3##(2008-6#1)(2008-7#1)
cause repeated##2##2##(2007-7#1)(2008-7#1)
cause seedling blight##2##3##(2008-10#2)
cause serious##9##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
cause severe adverse##2##3##(1996-11#1)(2012-3#1)
cause severe##13##2##(1991-12#1)(1996-11#2)(2007-8#2)(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
cause significant changes in the##2##5##(1996-12#1)(2008-10#1)
cause significant changes in##4##4##(1996-12#1)(2008-10#2)(2009-9#1)
cause significant morbidity and mortality##3##5##(2008-7#1)(2008-8#1)(2008-9#1)
cause significant morbidity##5##3##(2008-7#2)(2008-8#1)(2008-9#1)(2012-8#1)
cause significant##19##2##(1996-12#1)(2007-10#1)(2008-10#6)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-8#1)(2013-8#1)
cause similar##2##2##(1995-2#1)(2008-5#1)
cause some##4##2##(1992-11#1)(1995-1#1)(2008-10#2)
cause stroke##3##2##(1995-2#1)(2007-10#1)(2008-8#1)
cause such##6##2##(1991-8#1)(1996-3#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-2#1)
cause symptoms in##2##3##(2008-10#2)
cause symptoms##5##2##(2008-10#5)
cause syndromes##2##2##(1995-6#1)(2012-3#1)
cause systemic##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
cause the airways to narrow##2##5##(1997-1#2)
cause the formation of##2##4##(2008-7#1)(2010-10#1)
cause the inhibition of##2##4##(1993-6#1)(1997-4#1)
cause the##40##2##(1992-3#1)(1993-2#1)(1993-6#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
cause them to##2##3##(2008-10#1)(2011-1#1)
cause these##4##2##(1993-11#1)(1994-12#1)(2008-2#1)(2012-12#1)
cause this##2##2##(2008-5#1)(2008-8#1)
cause various##4##2##(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
cause was found##2##3##(1992-2#1)(1992-5#1)
cause was##10##2##(1992-2#1)(1992-5#1)(1995-3#1)(1995-5#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)
cause yield##2##2##(2008-10#2)
cause##1460##1##(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#9)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#8)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#6)(1992-3#9)(1992-4#5)(1992-5#8)(1992-6#4)(1992-8#6)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#10)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#8)(1995-2#9)(1995-3#7)(1995-5#6)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#1)(1996-11#5)(1996-12#14)(1996-2#2)(1996-3#6)(1996-6#8)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#9)(1997-4#3)(1997-5#2)(1997-6#7)(1997-7#5)(1997-8#4)(2006-10#5)(2006-12#3)(2006-6#2)(2007-10#17)(2007-11#16)(2007-12#17)(2007-2#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#24)(2007-8#17)(2008-1#47)(2008-10#173)(2008-11#43)(2008-12#26)(2008-2#12)(2008-3#32)(2008-4#23)(2008-5#29)(2008-6#10)(2008-7#68)(2008-8#52)(2008-9#28)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#9)(2009-5#9)(2009-6#7)(2009-7#4)(2009-8#10)(2009-9#3)(2010-1#3)(2010-10#10)(2010-11#2)(2010-12#11)(2010-2#4)(2010-3#9)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#30)(2011-2#120)(2011-3#4)(2012-1#6)(2012-12#32)(2012-2#39)(2012-3#32)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#68)(2013-7#6)(2013-8#36)
cause(s) of##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
cause(s)##4##1##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
cause-and-effect relationship##3##2##(2008-7#1)(2012-2#2)
cause-and-effect##4##1##(2008-7#1)(2012-2#3)
cause-effect##3##1##(1991-3#1)(1997-5#1)(2011-2#1)
cause-of-death data##2##2##(2012-12#2)
cause-of-death##3##1##(2012-12#3)
cause-specific mortality##2##2##(1991-6#1)(1997-1#1)
cause-specific survival##4##2##(1994-12#1)(2012-3#3)
cause-specific##8##1##(1991-6#1)(1994-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2012-3#3)
cause]##3##1##(1992-4#1)(1993-6#1)(1996-11#1)
caused 3##2##2##(1994-8#1)(2008-10#1)
caused DNA##2##2##(1994-11#1)(1997-4#1)
caused O2- production##4##3##(1996-2#4)
caused a 2##3##3##(1990-7#1)(1993-6#1)(1995-9#1)
caused a 5% depression on the signal##2##7##(2008-10#2)
caused a biphasic##2##3##(1991-5#1)(1995-12#1)
caused a decrease in the##3##5##(2008-10#1)(2008-7#1)(2009-8#1)
caused a decrease in##10##4##(1995-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-8#2)(2011-2#1)
caused a decrease##11##3##(1995-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-8#2)(2011-1#1)(2011-2#1)
caused a delay in##2##4##(1993-11#1)(2008-10#1)
caused a dose dependent##2##4##(1990-12#1)(1991-4#1)
caused a dose-dependent decrease in the##2##6##(1993-11#1)(1994-8#1)
caused a dose-dependent increase in##4##5##(1992-3#1)(2006-6#1)(2008-10#1)(2008-5#1)
caused a dose-dependent##8##3##(1992-12#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-8#1)(2006-6#1)(2008-10#1)(2008-5#1)
caused a dramatic##3##3##(1995-12#1)(1995-5#1)(2013-1#1)
caused a marked decrease in##2##5##(1994-8#1)(2008-7#1)
caused a marked##4##3##(1994-8#2)(2008-10#1)(2008-7#1)
caused a partial ATP recovery##2##5##(1994-8#2)
caused a partial##3##3##(1994-8#2)(1995-5#1)
caused a progressive##2##3##(1992-8#1)(1995-2#1)
caused a rapid and##3##4##(1991-6#1)(1992-6#1)(1994-11#1)
caused a rapid increase##2##4##(1990-7#1)(1997-1#1)
caused a rapid##8##3##(1990-7#1)(1991-6#1)(1992-6#1)(1994-11#1)(1997-1#2)(2008-10#1)(2008-11#1)
caused a reduction in##4##4##(1995-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
caused a significant decrease in##5##5##(1990-7#1)(1993-1#1)(1996-2#2)(2010-5#1)
caused a significant increase in the##2##6##(2008-12#1)(2008-5#1)
caused a significant increase in##5##5##(1992-3#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-1#1)
caused a significant reduction in##4##5##(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)
caused a significant reduction##6##4##(1992-8#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)
caused a significant##23##3##(1990-7#1)(1992-3#1)(1992-8#2)(1993-1#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#3)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#3)(2010-5#1)(2012-1#1)(2013-7#1)
caused a significantly##2##3##(1991-5#1)(1997-6#1)
caused a##141##2##(1990-12#2)(1990-5#2)(1990-6#1)(1990-7#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#7)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#2)(1997-6#1)(1997-7#5)(1997-8#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2009-2#1)(2009-8#5)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-7#1)(2013-1#2)(2013-7#1)
caused aggregation of##2##3##(1992-12#1)(1994-11#1)
caused all##2##2##(2008-10#1)(2011-1#1)
caused almost no##2##3##(2008-10#1)(2008-4#1)
caused almost##3##2##(2008-10#1)(2008-4#2)
caused an alteration##2##3##(1993-8#1)(2008-2#1)
caused an immediate##3##3##(1992-6#1)(1997-7#1)(2009-6#1)
caused an increase in the muscle activity##2##7##(2008-5#2)
caused an increase in the##7##5##(1990-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-6#1)(2009-8#1)
caused an increase in##13##4##(1990-5#1)(1990-7#1)(1993-6#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-6#1)(2009-7#1)(2009-8#1)
caused an increase of##3##4##(1992-8#1)(2008-8#1)(2011-10#1)
caused an increase##18##3##(1990-5#1)(1990-7#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-10#1)(2013-1#1)
caused an initial##2##3##(1995-12#1)(2008-10#1)
caused an##35##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#3)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-6#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-10#1)(2013-1#2)
caused as##2##2##(1994-2#1)(2008-6#1)
caused both##2##2##(2008-4#1)(2012-12#1)
caused by A##3##3##(2008-10#3)
caused by ATP##2##3##(1994-2#1)(1995-2#1)
caused by Alternaria alternata##3##4##(2008-10#3)
caused by Alternaria##4##3##(2008-10#4)
caused by B##3##3##(2008-10#2)(2008-12#1)
caused by Bipolaris sorokiniana##3##4##(2008-10#3)
caused by Blumeria graminis f##2##5##(2008-10#2)
caused by Botrytis cinerea##2##4##(2008-10#2)
caused by Burkholderia##2##3##(2007-12#1)(2007-7#1)
caused by C##6##3##(2007-12#1)(2008-10#4)(2011-2#1)
caused by Cercospora zeae-maydis##2##4##(2008-10#2)
caused by Cercospora##3##3##(2008-10#3)
caused by Clostridium##2##3##(2007-7#1)(2009-5#1)
caused by Cochliobolus heterostrophus race O##3##6##(2008-10#3)
caused by Cochliobolus sativus##3##4##(2008-10#3)
caused by Cochliobolus##6##3##(2008-10#6)
caused by Colletotrichum##5##3##(2008-10#5)
caused by E##3##3##(2008-10#2)(2009-12#1)
caused by Erwinia amylovora##2##4##(2008-10#2)
caused by F##3##3##(2008-10#3)
caused by Fasciola hepatica in##2##5##(2007-10#1)(2008-8#1)
caused by Fusarium graminearum##4##4##(2008-10#3)(2011-10#1)
caused by Fusarium oxysporum f##7##5##(2008-10#7)
caused by Fusarium solani f##2##5##(2008-10#2)
caused by Fusarium##15##3##(2008-10#14)(2011-10#1)
caused by Magnaporthe grisea##4##4##(2008-10#3)(2009-10#1)
caused by Magnaporthe##5##3##(2008-10#3)(2009-10#1)(2012-2#1)
caused by Monilinia##3##3##(2008-10#3)
caused by Mycobacterium tuberculosis##2##4##(2007-8#1)(2011-2#1)
caused by Mycobacterium##3##3##(2007-8#1)(2010-4#1)(2011-2#1)
caused by Mycosphaerella citri##2##4##(2008-10#2)
caused by P##8##3##(2008-10#8)
caused by Penicillium expansum##3##4##(2008-10#3)
caused by Penicillium##4##3##(2008-10#3)(2011-2#1)
caused by Phytophthora infestans##2##4##(2008-10#1)(2009-6#1)
caused by Phytophthora ramorum##2##4##(2008-10#2)
caused by Phytophthora sojae is##2##5##(2008-10#2)
caused by Phytophthora##10##3##(2008-10#9)(2009-6#1)
caused by Pseudomonas syringae pv##5##5##(2008-10#5)
caused by Pseudomonas syringae##6##4##(2008-10#6)
caused by Puccinia coronata var##2##5##(2008-10#2)
caused by Puccinia coronata##3##4##(2008-10#3)
caused by Puccinia striiformis f##4##5##(2008-10#4)
caused by Puccinia striiformis##5##4##(2008-10#5)
caused by Puccinia triticina and P##2##6##(2008-10#2)
caused by Puccinia triticina##3##4##(2008-10#3)
caused by Puccinia##14##3##(2008-10#14)
caused by Pyrenophora##2##3##(2008-10#2)
caused by Pythium spp##2##4##(2008-10#2)
caused by Pythium ultimum##3##4##(2008-10#3)
caused by Pythium##5##3##(2008-10#5)
caused by R##5##3##(2008-10#5)
caused by Rhizoctonia solani##3##4##(2008-10#3)
caused by Rhodotorula mucilaginosa in##2##5##(2009-11#2)
caused by S##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
caused by SHLI##2##3##(2011-2#2)
caused by Salmonella##2##3##(1990-6#1)(1991-3#1)
caused by Sclerotinia sclerotiorum##3##4##(2008-10#3)
caused by Septoria passerinii##2##4##(2008-10#2)
caused by Septoria##4##3##(2008-10#4)
caused by Staphylococcus aureus##2##4##(2007-12#2)
caused by Streptococcus pneumoniae##2##4##(1994-9#1)(1997-2#1)
caused by Streptococcus##5##3##(1991-11#1)(1994-9#1)(1997-2#1)(2011-2#2)
caused by T##2##3##(2008-10#1)(2008-5#1)
caused by Trichophyton tonsurans##2##4##(2008-5#2)
caused by Tropheryma whippelii##2##4##(1996-8#2)
caused by Verticillium dahliae##2##4##(2008-10#2)
caused by Xanthomonas campestris pv##6##5##(2008-10#6)
caused by Xanthomonas oryzae pv##2##5##(2008-10#1)(2009-10#1)
caused by Xanthomonas##10##3##(2008-10#9)(2009-10#1)
caused by Xylella fastidiosa##2##4##(2008-10#2)
caused by a Fusicoccum sp##2##5##(2008-10#2)
caused by a change in##2##5##(1995-6#1)(2008-3#1)
caused by a defect in the##2##6##(1994-11#1)(2008-12#1)
caused by a defect##3##4##(1994-11#1)(2008-12#1)(2013-1#1)
caused by a large##4##4##(1992-6#1)(2008-3#1)(2009-5#1)(2013-1#1)
caused by a lesion##2##4##(1996-3#1)(2007-10#1)
caused by a microsphere resonator##2##5##(2007-12#2)
caused by a mutation in the##2##6##(2008-12#1)(2013-1#1)
caused by a mutation in##3##5##(2007-8#1)(2008-12#1)(2013-1#1)
caused by a single##5##4##(2008-1#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-8#1)
caused by a virulent##2##4##(2008-10#2)
caused by a##97##3##(1990-11#2)(1992-1#2)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#7)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
caused by accidental##2##3##(2008-10#1)(2011-2#1)
caused by actinomycosis##2##3##(2008-1#1)(2013-8#1)
caused by acute##3##3##(2007-10#2)(2008-11#1)
caused by air##3##3##(1995-5#1)(2007-11#1)(2008-11#1)
caused by airborne##2##3##(2008-2#1)(2011-2#1)
caused by all##3##3##(2008-10#2)(2008-7#1)
caused by an imbalance between##2##5##(2008-10#1)(2013-8#1)
caused by an increase in##2##5##(2008-11#1)(2008-7#1)
caused by an##18##3##(1990-12#1)(1992-2#1)(1992-9#1)(1994-2#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
caused by at least##3##4##(2008-10#2)(2008-6#1)
caused by atherosclerosis##2##3##(2008-1#1)(2012-2#1)
caused by atherosclerotic##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
caused by atmospheric turbulence##2##4##(2008-2#1)(2008-3#1)
caused by bacteria##2##3##(2008-12#1)(2011-2#1)
caused by bilateral##4##3##(1993-3#1)(1995-5#2)(2013-1#1)
caused by both##8##3##(1993-12#1)(2008-10#5)(2008-3#2)
caused by brain tumors##2##4##(2008-12#2)
caused by brain##3##3##(1995-5#1)(2008-12#2)
caused by capsaicin##2##3##(2012-3#2)
caused by cardiovascular disease##4##4##(2011-1#4)
caused by cardiovascular##5##3##(2008-5#1)(2011-1#4)
caused by cell##2##3##(2008-11#1)(2012-2#1)
caused by changes in##3##4##(1992-8#1)(2008-7#1)(2008-9#1)
caused by changes##4##3##(1992-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
caused by chronic##2##3##(1990-3#1)(2008-10#1)
caused by combined action of cadmium##2##6##(2008-11#2)
caused by consumption of##2##4##(2008-10#1)(2011-2#1)
caused by defects in##2##4##(2008-1#1)(2008-10#1)
caused by delayed##2##3##(2008-12#1)(2012-3#1)
caused by dietary##2##3##(1992-11#1)(2008-10#1)
caused by differences in##3##4##(2008-10#2)(2011-2#1)
caused by different##6##3##(1990-9#1)(1991-7#1)(2008-10#2)(2008-3#1)(2008-5#1)
caused by dysfunctional communication between##2##5##(1990-12#2)
caused by either##4##3##(2007-10#1)(2008-10#3)
caused by elective cesarean section##2##5##(2011-2#2)
caused by emerging and re-emerging pathogens##2##6##(2010-12#1)(2012-2#1)
caused by environmental##3##3##(2008-8#2)(2009-10#1)
caused by estrogen##2##3##(2008-11#1)(2008-5#1)
caused by excessive##2##3##(2008-5#1)(2011-1#1)
caused by exposure to##2##4##(1993-12#1)(1994-6#1)
caused by extraarticular infection with##2##5##(1990-6#2)
caused by group##2##3##(1995-5#1)(1995-8#1)
caused by heat##2##3##(1991-9#1)(2008-10#1)
caused by hepatitis E##2##4##(2008-7#2)
caused by high##2##3##(2008-2#1)(2009-5#1)
caused by higher##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
caused by human papillomavirus (HPV)##2##5##(2012-3#1)(2013-1#1)
caused by human##7##3##(1990-3#1)(1992-3#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
caused by impaction of##2##4##(2008-12#1)(2011-1#1)
caused by increased##3##3##(1991-6#1)(1995-5#1)(2011-2#1)
caused by infection##2##3##(2011-2#1)(2013-8#1)
caused by infections##2##3##(1994-5#1)(1995-5#1)
caused by interference##2##3##(2008-2#1)(2008-3#1)
caused by iron##2##3##(2008-10#1)(2012-2#1)
caused by lack of##2##4##(1994-8#1)(2007-11#1)
caused by large artery disease##2##5##(2007-10#2)
caused by large artery##3##4##(2007-10#3)
caused by large##4##3##(2007-10#4)
caused by laser##3##3##(1991-2#1)(2008-2#2)
caused by local##2##3##(2008-9#1)(2011-2#1)
caused by low-frequency vibrations##2##4##(2008-3#2)
caused by malaria##2##3##(2012-12#2)
caused by manipulating##2##3##(2008-11#1)(2010-12#1)
caused by many##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
caused by maternal##2##3##(2011-2#1)(2012-3#1)
caused by members of the##2##5##(2008-10#2)
caused by multiple##2##3##(1993-12#1)(2007-12#1)
caused by mutations in the gene##2##6##(1990-5#1)(2011-1#1)
caused by mutations in the##6##5##(1990-5#1)(1997-1#1)(2007-7#1)(2008-1#1)(2011-1#1)(2013-8#1)
caused by mutations in##14##4##(1990-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
caused by mutations of the##2##5##(1996-2#1)(2007-7#1)
caused by mutations of##3##4##(1995-2#1)(1996-2#1)(2007-7#1)
caused by mutations##17##3##(1990-5#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-3#1)(2007-7#3)(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
caused by nucleotide##2##3##(1994-12#1)(2010-2#1)
caused by nutrient depletion##3##4##(2008-7#3)
caused by occlusion##2##3##(2007-10#1)(2009-4#1)
caused by other##2##3##(1996-12#1)(2009-7#1)
caused by rapid##2##3##(2007-10#1)(2012-2#1)
caused by rupture of##3##4##(1991-6#1)(2007-8#1)(2011-2#1)
caused by ruptured traumatic##2##4##(2008-12#2)
caused by several factors##2##4##(2008-2#1)(2008-7#1)
caused by several##5##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
caused by severe##3##3##(2008-1#2)(2013-8#1)
caused by solar exposure##2##4##(2008-5#2)
caused by some##2##3##(2008-10#2)
caused by structural##3##3##(2007-11#1)(2008-2#1)(2009-7#1)
caused by sun##2##3##(2008-5#1)(2011-2#1)
caused by systemic##2##3##(2008-1#1)(2012-3#1)
caused by the absence of##3##5##(1993-9#1)(2008-11#1)(2011-2#1)
caused by the addition of##2##5##(2008-11#1)(2008-8#1)
caused by the ascomycete Mycosphaerella graminicola (anamorph Septoria tritici)##2##9##(2008-10#2)
caused by the ascomycete##3##4##(2008-10#3)
caused by the binding of##2##5##(1994-5#1)(1995-5#1)
caused by the decrease##2##4##(2008-10#1)(2008-3#1)
caused by the difference##3##4##(2007-12#1)(2008-2#1)(2008-9#1)
caused by the fungus Cercospora zeae-maydis##2##6##(2008-10#2)
caused by the fungus##13##4##(2008-10#12)(2010-3#1)
caused by the harmonics##2##4##(2008-3#2)
caused by the high##2##4##(1995-6#1)(2008-2#1)
caused by the mechanical##2##4##(2008-10#1)(2010-2#1)
caused by the presence of##2##5##(1995-12#1)(2008-11#1)
caused by the presence##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
caused by the release of##2##5##(2008-7#1)(2013-8#1)
caused by the soilborne##4##4##(2008-10#4)
caused by the use##2##4##(2009-3#1)(2012-3#1)
caused by the##207##3##(1990-12#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#71)(2008-11#9)(2008-12#1)(2008-2#7)(2008-3#21)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#3)
caused by their##5##3##(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)
caused by these##5##3##(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)
caused by this organism##2##4##(2007-6#1)(2012-3#1)
caused by this##11##3##(1990-11#1)(1990-8#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-3#1)
caused by various##3##3##(1995-11#1)(2007-11#1)(2011-2#1)
caused by violence##2##3##(1995-8#1)(2008-9#1)
caused by virus##2##3##(2008-11#1)(2008-9#1)
caused by viruses of##2##4##(2011-2#2)
caused by vitamin##3##3##(1993-2#1)(1996-6#1)(2008-1#1)
caused by volvulus of Meckel's diverticulum##2##6##(1990-6#2)
caused by water##2##3##(2007-7#1)(2008-2#1)
caused by##1336##2##(1990-11#5)(1990-12#7)(1990-2#4)(1990-3#6)(1990-5#7)(1990-6#10)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-2#4)(1991-3#5)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#8)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#6)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#8)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#11)(1995-6#3)(1995-8#3)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#8)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#8)(1997-4#3)(1997-5#2)(1997-6#10)(1997-8#1)(2006-10#3)(2007-10#22)(2007-11#21)(2007-12#34)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#12)(2007-8#14)(2007-9#1)(2008-1#15)(2008-10#388)(2008-11#38)(2008-12#21)(2008-2#39)(2008-3#65)(2008-4#5)(2008-5#48)(2008-6#6)(2008-7#45)(2008-8#26)(2008-9#11)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#5)(2009-2#6)(2009-3#7)(2009-4#2)(2009-5#9)(2009-6#6)(2009-7#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#10)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2011-1#18)(2011-10#1)(2011-2#64)(2011-3#2)(2012-1#3)(2012-12#12)(2012-2#16)(2012-3#23)(2013-1#22)(2013-7#1)(2013-8#21)
caused changes in##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
caused decreases in##2##3##(1994-2#1)(2008-11#1)
caused disease symptoms##3##3##(2008-10#3)
caused disease##6##2##(2008-10#6)
caused during the##2##3##(2008-10#1)(2012-2#1)
caused either by##2##3##(1991-9#1)(2008-5#1)
caused either##3##2##(1991-9#1)(2008-5#1)(2008-8#1)
caused extensive##2##2##(2009-2#1)(2009-3#1)
caused from##4##2##(1995-3#1)(2008-10#2)(2008-8#1)
caused galls on 10 to##2##5##(2008-10#2)
caused galls on##3##3##(2008-10#3)
caused higher mortality##2##3##(2008-6#2)
caused higher##5##2##(2008-10#3)(2008-6#2)
caused increases in##3##3##(1991-5#1)(1992-11#1)(1995-12#1)
caused inhibition of##2##3##(1990-2#1)(2008-4#1)
caused inhibition##3##2##(1990-2#1)(2008-4#1)(2008-8#1)
caused largely by##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
caused lesions##2##2##(2008-10#1)(2008-5#1)
caused less disease on isoline##2##5##(2008-10#2)
caused less disease on##4##4##(2008-10#4)
caused less##6##2##(2008-1#1)(2008-10#5)
caused mainly by##4##3##(1991-6#1)(2007-11#1)(2008-3#1)(2013-8#1)
caused mainly##6##2##(1990-6#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
caused more than 100##2##4##(2011-1#1)(2013-8#1)
caused more##6##2##(2007-7#1)(2008-10#1)(2008-6#1)(2011-1#2)(2013-8#1)
caused mortality##3##2##(1990-3#1)(2007-6#1)(2008-10#1)
caused much##2##2##(2008-10#1)(2008-11#1)
caused no##11##2##(1991-8#1)(1993-8#1)(1994-2#1)(1994-6#1)(2008-10#3)(2008-11#2)(2012-2#2)
caused not only by##3##4##(1993-2#1)(2008-10#2)
caused not##4##2##(1993-2#1)(1995-6#1)(2008-10#2)
caused oleander leaf scorch##2##4##(2008-10#2)
caused only a small increase in##2##6##(1990-12#1)(2008-7#1)
caused only a##4##3##(1990-12#1)(1994-2#1)(2008-10#1)(2008-7#1)
caused only##8##2##(1990-12#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-7#1)
caused primarily by##6##3##(1991-5#1)(2008-10#3)(2008-3#1)(2011-1#1)
caused rapid##2##2##(1990-12#1)(2008-10#1)
caused reduced##3##2##(2008-10#2)(2010-10#1)
caused reductions in##2##3##(2008-10#1)(2008-7#1)
caused reductions##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
caused severe epidemics##2##3##(2008-10#2)
caused severe##8##2##(1991-2#1)(1993-12#1)(1994-3#1)(2008-10#4)(2008-9#1)
caused significant cytotoxicity against dopaminergic##2##5##(2008-7#2)
caused significant declines in##2##4##(2008-10#1)(2008-5#1)
caused significant disease on##2##4##(2008-10#2)
caused significant increases in##2##4##(1990-5#1)(2008-10#1)
caused significant inhibition in the initial rate of biotin transport without affecting the substrate uptake at equilibrium##2##17##(1992-6#2)
caused significant reduction in##2##4##(2008-10#1)(2008-5#1)
caused significant##24##2##(1990-5#1)(1992-2#1)(1992-6#3)(1993-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
caused significantly less##3##3##(2008-10#2)(2011-2#1)
caused significantly##4##2##(2008-10#3)(2011-2#1)
caused similar##6##2##(2007-2#1)(2008-10#4)(2009-8#1)
caused some##2##2##(1996-12#1)(2008-10#1)
caused specific##2##2##(1997-3#1)(2008-11#1)
caused symptoms##3##2##(2008-10#3)
caused the highest##2##3##(2008-12#2)
caused the significant##2##3##(2008-10#1)(2009-8#1)
caused the##28##2##(1991-3#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
caused them to##2##3##(1992-2#1)(2007-10#1)
caused thresholds to##2##3##(1992-11#2)
caused to##4##2##(1993-3#1)(2008-10#2)(2008-5#1)
caused translocation of##2##3##(1995-11#2)
caused typical##3##2##(2008-10#3)
caused very##2##2##(2008-10#2)
caused##1889##1##(1990-11#5)(1990-12#11)(1990-2#6)(1990-3#7)(1990-5#11)(1990-6#12)(1990-7#8)(1990-8#3)(1990-9#4)(1991-1#1)(1991-11#3)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#8)(1991-6#7)(1991-7#3)(1991-8#3)(1991-9#9)(1992-1#2)(1992-11#8)(1992-12#7)(1992-2#6)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#10)(1992-7#1)(1992-8#7)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#6)(1993-8#6)(1993-9#4)(1994-11#16)(1994-12#4)(1994-2#9)(1994-3#4)(1994-5#5)(1994-6#7)(1994-8#13)(1994-9#9)(1995-11#6)(1995-12#16)(1995-2#9)(1995-3#10)(1995-5#14)(1995-6#7)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#14)(1996-3#8)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#9)(1997-4#4)(1997-5#2)(1997-6#13)(1997-7#6)(1997-8#4)(2006-10#3)(2006-6#1)(2007-10#24)(2007-11#26)(2007-12#35)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#3)(2007-7#14)(2007-8#16)(2007-9#1)(2008-1#19)(2008-10#536)(2008-11#56)(2008-12#30)(2008-2#45)(2008-3#73)(2008-4#11)(2008-5#67)(2008-6#13)(2008-7#58)(2008-8#39)(2008-9#13)(2009-1#2)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#8)(2009-3#8)(2009-4#2)(2009-5#9)(2009-6#8)(2009-7#5)(2009-8#10)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#3)(2010-4#11)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#6)(2011-1#28)(2011-10#2)(2011-2#77)(2011-3#2)(2012-1#5)(2012-12#17)(2012-2#19)(2012-3#24)(2012-7#1)(2013-1#34)(2013-7#3)(2013-8#26)
causes Alternaria##3##2##(2008-10#3)
causes Fusarium head blight (FHB)##2##5##(2008-10#2)
causes Fusarium wilt##2##3##(2008-10#2)
causes Fusarium##4##2##(2008-10#4)
causes Pierce's disease##2##3##(2008-10#2)
causes Septoria tritici blotch of##2##5##(2008-10#2)
causes a decrease in##3##4##(1992-12#1)(2008-2#1)(2008-5#1)
causes a dramatic##2##3##(1990-7#1)(2008-10#1)
causes a lot of##3##4##(2008-12#2)(2008-9#1)
causes a rapid##3##3##(1992-3#1)(1992-9#1)(2008-5#1)
causes a shift##2##3##(1994-11#2)
causes a significant##3##3##(2007-8#1)(2008-10#2)
causes a strong##2##3##(2008-10#2)
causes a##65##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#1)(1997-1#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#6)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
causes an enhancement##2##3##(2008-10#2)
causes an increase in the##4##5##(1992-3#1)(1994-5#1)(1997-7#1)(2007-8#1)
causes an increase in##6##4##(1992-3#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-7#1)(2007-8#1)
causes an##21##2##(1992-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)
causes and consequences##5##3##(1996-3#1)(2007-4#1)(2008-8#1)(2010-3#1)(2010-7#1)
causes and treatment##2##3##(2008-5#1)(2013-8#1)
causes and##26##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
causes are##8##2##(1991-11#1)(1995-6#1)(1997-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)
causes at##2##2##(1992-9#1)(1995-6#1)
causes black##2##2##(2008-10#2)
causes both the reduction of##2##5##(2007-12#1)(2009-8#1)
causes brown rot##2##3##(2008-10#2)
causes brown##3##2##(2008-10#3)
causes by##3##2##(1990-6#1)(1991-6#1)(2008-10#1)
causes cell##2##2##(1997-1#1)(2008-8#1)
causes changes in##4##3##(2008-9#1)(2009-10#1)(2009-7#1)(2010-9#1)
causes chronic##2##2##(2009-7#1)(2013-1#1)
causes conformational changes##2##3##(1990-5#1)(1995-6#1)
causes damage##3##2##(1994-12#1)(2008-5#1)(2011-2#1)
causes defects##2##2##(2008-8#1)(2011-2#1)
causes even##2##2##(1992-6#1)(1994-2#1)
causes for the##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
causes for##18##2##(1990-2#1)(1992-3#1)(1996-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#2)(2009-6#1)(2011-2#2)(2012-3#1)
causes further##2##2##(1992-6#1)(2008-10#1)
causes hyperglycemia##2##2##(2008-3#1)(2013-7#1)
causes in##4##2##(1996-12#1)(2008-10#1)(2009-4#1)(2012-3#1)
causes include trauma##2##3##(2008-10#2)
causes include##4##2##(1993-9#1)(2008-10#2)(2008-7#1)
causes including##3##2##(2008-11#1)(2008-6#1)(2011-2#1)
causes increase##2##2##(1995-3#1)(2008-10#1)
causes increased##4##2##(1996-6#1)(2008-11#1)(2008-5#1)(2012-12#1)
causes it to##2##3##(1992-4#1)(2008-10#1)
causes it##3##2##(1992-4#1)(1994-3#1)(2008-10#1)
causes less##2##2##(1993-12#1)(2008-5#1)
causes marked##2##2##(1990-5#1)(2008-11#1)
causes necrosis##2##2##(1992-9#1)(2008-10#1)
causes no##4##2##(2008-10#3)(2008-11#1)
causes of ESRD##2##3##(2007-7#1)(2008-1#1)
causes of acute pancreatitis##2##4##(2013-1#2)
causes of acute##3##3##(2007-12#1)(2013-1#2)
causes of cancer##2##3##(1994-2#1)(2009-12#1)
causes of death and the##2##5##(1994-11#1)(1994-2#1)
causes of death and##3##4##(1994-11#1)(1994-2#1)(2013-8#1)
causes of death are##2##4##(2012-12#1)(2013-8#1)
causes of death in##4##4##(2007-7#1)(2009-4#1)(2010-4#1)(2012-3#1)
causes of death were##9##4##(1991-12#1)(2008-1#2)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#3)
causes of death##36##3##(1990-6#2)(1990-9#1)(1991-12#1)(1994-11#1)(1994-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#10)
causes of diabetes##2##3##(2008-1#2)
causes of disease##3##3##(1994-9#1)(1996-12#1)(2008-10#1)
causes of end-stage renal disease##2##5##(2007-7#1)(2008-1#1)
causes of failure of##3##4##(1993-10#1)(2008-1#1)(2008-11#1)
causes of low vision among##3##5##(2010-8#3)
causes of low vision##4##4##(2010-8#4)
causes of low##6##3##(1994-3#1)(2010-12#1)(2010-8#4)
causes of medication errors##2##4##(2011-1#2)
causes of morbidity and mortality in##3##6##(2008-10#1)(2008-3#1)(2011-2#1)
causes of morbidity and mortality##5##5##(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
causes of morbidity and##6##4##(1995-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
causes of morbidity##7##3##(1995-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-11#1)(2011-2#1)
causes of mortality in##3##4##(2008-1#1)(2012-2#1)(2013-1#1)
causes of mortality##5##3##(2007-7#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
causes of occupational asthma##2##4##(2008-10#2)
causes of pain##2##3##(2007-11#1)(2010-11#1)
causes of primary##2##3##(1992-5#1)(2008-10#1)
causes of stroke##2##3##(1991-11#1)(2007-10#1)
causes of such##2##3##(2008-3#1)(2012-2#1)
causes of sudden cardiac death##2##5##(2009-5#1)(2011-2#1)
causes of the observed##2##4##(2008-8#2)
causes of the##15##3##(1990-8#1)(1996-8#2)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#6)(2011-2#1)(2012-12#1)(2013-7#1)
causes of these##4##3##(1995-5#1)(1997-7#1)(2007-7#1)(2008-7#1)
causes of this decline##2##4##(2008-9#1)(2011-2#1)
causes of this##6##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
causes of variation##2##3##(2008-7#1)(2008-8#1)
causes of##231##2##(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#2)(1992-5#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#3)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#11)(2007-8#1)(2008-1#15)(2008-10#8)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#6)(2011-1#9)(2011-2#14)(2011-3#1)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#16)
causes or##3##2##(2008-8#1)(2011-1#2)
causes other than##3##3##(1991-12#1)(2007-7#1)(2012-2#1)
causes progressive##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
causes rapid##2##2##(2008-10#1)(2008-11#1)
causes related to the##2##4##(1994-2#1)(2011-1#1)
causes retention of##2##3##(2008-9#1)(2012-12#1)
causes root rot##2##3##(2008-10#2)
causes selective##2##2##(1990-5#1)(1996-3#1)
causes serious##4##2##(2008-10#2)(2011-2#1)(2013-7#1)
causes several##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
causes severe losses in##2##4##(2008-10#2)
causes severe##7##2##(2008-10#4)(2008-7#1)(2010-11#1)(2013-1#1)
causes significant##6##2##(2008-10#3)(2008-7#2)(2013-1#1)
causes some##2##2##(1992-12#1)(2008-2#1)
causes strong##2##2##(1995-6#1)(2006-6#1)
causes such as##6##3##(2007-7#1)(2008-4#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
causes symptoms similar to##2##4##(2008-10#2)
causes symptoms##3##2##(2008-10#2)(2013-1#1)
causes the disease##3##3##(1994-8#1)(2008-10#1)(2009-10#1)
causes the##48##2##(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-6#3)(2009-8#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
causes them to##2##3##(1992-12#1)(2008-9#1)
causes thymic atrophy by##2##4##(2008-10#2)
causes thymic atrophy##3##3##(2008-10#3)
causes to##3##2##(2008-7#1)(2009-7#1)(2012-3#1)
causes toxicity##2##2##(2011-1#1)(2013-1#1)
causes various##2##2##(2007-10#1)(2008-6#1)
causes very##2##2##(2007-11#1)(2008-10#1)
causes were##3##2##(2009-3#1)(2009-8#1)(2013-1#1)
causes yellowing and##2##3##(2008-10#2)
causes##878##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#6)(1990-6#6)(1990-7#1)(1990-8#6)(1990-9#4)(1991-11#3)(1991-12#7)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#5)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#6)(1993-8#2)(1993-9#1)(1994-11#6)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#6)(1995-8#3)(1995-9#2)(1996-11#2)(1996-12#6)(1996-2#5)(1996-3#8)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#9)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#5)(2006-10#2)(2006-6#1)(2007-10#4)(2007-11#14)(2007-12#13)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#15)(2007-8#9)(2008-1#23)(2008-10#132)(2008-11#25)(2008-12#11)(2008-2#14)(2008-3#19)(2008-4#9)(2008-5#21)(2008-6#8)(2008-7#36)(2008-8#20)(2008-9#13)(2009-10#9)(2009-11#1)(2009-12#4)(2009-3#5)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#7)(2009-8#6)(2010-1#1)(2010-10#4)(2010-11#9)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#22)(2011-2#40)(2011-3#3)(2012-1#1)(2012-12#22)(2012-2#17)(2012-3#10)(2012-7#1)(2013-1#29)(2013-7#6)(2013-8#23)
causing a change in##2##4##(2008-10#1)(2008-7#1)
causing a large##2##3##(1995-5#1)(2008-10#1)
causing a significant##2##3##(1991-3#1)(2008-10#1)
causing a##29##2##(1990-7#1)(1991-3#1)(1991-9#1)(1992-11#2)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#2)
causing an##10##2##(1993-12#1)(2008-10#4)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)
causing bacterial spot##2##3##(2008-10#2)
causing both##4##2##(2008-10#3)(2008-8#1)
causing brown spot of##2##4##(2008-10#2)
causing cancer-associated##2##2##(2008-11#1)(2008-7#1)
causing cardiac##2##2##(2007-8#2)
causing chronic##2##2##(2008-7#1)(2010-12#1)
causing complete##2##2##(2008-7#1)(2009-7#1)
causing compression of the##2##4##(2008-6#1)(2008-9#1)
causing degradation of##2##3##(2007-11#1)(2012-2#1)
causing direct##2##2##(2008-10#1)(2012-3#1)
causing disease in##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
causing disease##9##2##(2008-10#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)
causing dwarfing and transmittable by A##2##6##(2008-10#2)
causing endocarditis##2##2##(2006-6#1)(2007-7#1)
causing gray leaf spot of maize##2##6##(2008-10#2)
causing gray leaf spot##3##4##(2008-10#3)
causing head##2##2##(2008-10#2)
causing high##3##2##(1996-11#1)(2012-2#1)(2013-1#1)
causing invasive##2##2##(2007-12#2)
causing it to be##2##4##(1996-6#1)(2009-12#1)
causing it to##3##3##(1996-6#1)(2009-12#1)(2011-2#1)
causing it##4##2##(1996-6#1)(2008-10#1)(2009-12#1)(2011-2#1)
causing loss of##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
causing male##2##2##(2008-2#1)(2012-2#1)
causing many##2##2##(2007-8#1)(2012-2#1)
causing more##3##2##(2008-10#2)(2013-8#1)
causing mosaic symptoms##2##3##(2008-10#2)
causing necrosis and##2##3##(2008-10#1)(2008-5#1)
causing neurological##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
causing pain##2##2##(2010-1#1)(2010-12#1)
causing perforation##2##2##(2008-12#1)(2011-2#1)
causing potato##3##2##(2008-10#3)
causing serious##5##2##(2008-10#1)(2008-7#3)(2011-1#1)
causing severe epidemics##2##3##(2008-10#2)
causing severe##6##2##(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#2)
causing significant morbidity##2##3##(2008-6#1)(2013-1#1)
causing significant##8##2##(1993-9#1)(2007-11#1)(2008-10#2)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
causing spinal cord compression##3##4##(2008-7#1)(2009-3#1)(2012-3#1)
causing sudden death##2##3##(2011-2#2)
causing symptoms##3##2##(2008-10#2)(2011-1#1)
causing the##24##2##(1990-5#1)(1994-2#1)(1994-8#1)(1995-5#1)(2006-10#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
causing this##4##2##(2008-10#1)(2009-4#1)(2012-12#2)
causing yellowing##3##2##(2008-10#3)
causing##386##1##(1990-11#3)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#2)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-7#8)(2007-8#4)(2008-1#2)(2008-10#107)(2008-11#11)(2008-12#14)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#27)(2008-8#9)(2008-9#5)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#19)(2011-3#1)(2012-12#6)(2012-2#12)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#8)
caustic test##2##2##(2008-2#2)
caustic##18##1##(2008-10#5)(2008-2#9)(2008-6#4)
caustics were##2##2##(2008-2#2)
caustics##9##1##(2008-2#8)(2008-6#1)
cautery##2##1##(1996-3#1)(2011-2#1)
caution against##2##2##(2008-9#1)(2009-9#1)
caution and##4##2##(1994-12#1)(1997-1#1)(2008-9#1)(2011-1#1)
caution in the interpretation of##2##5##(1992-11#1)(2008-11#1)
caution in##8##2##(1990-5#1)(1992-11#1)(1995-8#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-9#1)
caution is needed in##3##4##(1995-5#1)(2008-1#1)(2008-12#1)
caution is##8##2##(1991-11#1)(1992-6#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)
caution must be##2##3##(1995-1#1)(2008-10#1)
caution on##2##2##(1993-9#1)(2006-10#1)
caution should be##3##3##(1993-2#1)(1993-6#1)(2013-8#1)
caution to##3##2##(2008-11#2)(2008-9#1)
caution when##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
caution!##2##1##(2008-11#1)(2011-1#1)
caution##60##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-6#1)(2009-9#3)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
cautionary##9##1##(1994-3#1)(1995-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
cautioned that##2##2##(1994-3#1)(1996-3#1)
cautioned the##2##2##(1995-6#1)(2008-10#1)
cautioned##5##1##(1994-3#1)(1995-6#1)(1996-3#1)(2008-10#1)(2013-1#1)
cautions##5##1##(1992-3#1)(1994-8#1)(2007-4#1)(2008-10#1)(2008-9#1)
cautious in##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
cautious##12##1##(1996-11#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-2#1)
cautiously##12##1##(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
cava (IVC)##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
cava and##7##2##(1995-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2010-4#1)
cava##65##1##(1991-8#1)(1992-9#3)(1993-5#1)(1993-9#1)(1995-12#4)(1995-8#1)(1997-8#1)(2007-7#1)(2007-8#16)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#8)(2010-11#3)(2010-4#3)(2011-2#5)(2012-2#2)(2013-1#3)
caval obstruction##2##2##(2008-7#1)(2011-2#1)
caval occlusion##2##2##(1995-12#2)
caval reconstruction##2##2##(2013-1#2)
caval##7##1##(1995-12#2)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
cave##7##1##(1992-3#2)(1995-6#1)(1996-3#1)(2008-10#1)(2011-2#2)
caveat##3##1##(1993-3#1)(2008-4#2)
caveats##8##1##(1992-1#1)(1992-2#1)(1996-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
caveolae in##2##2##(1995-2#2)
caveolae may##3##2##(1995-2#2)(1995-6#1)
caveolae##16##1##(1995-2#14)(1995-6#2)
caveolin##17##1##(1995-2#5)(1995-6#11)(2012-2#1)
caveolin-1 is##2##2##(2010-1#2)
caveolin-1##8##1##(2010-1#7)(2012-3#1)
caveolin-3##4##1##(2008-7#4)
cavernomas are##2##2##(1996-6#1)(2007-8#1)
cavernomas with##2##2##(2007-8#2)
cavernomas##7##1##(1996-6#3)(2007-8#3)(2008-7#1)
cavernosa##6##1##(2008-10#4)(2008-7#1)(2013-1#1)
cavernous angiomas##3##2##(2008-7#2)(2008-9#1)
cavernous haemangioma##2##2##(2008-7#2)
cavernous hemangiolymphangioma of the##2##4##(2008-10#2)
cavernous hemangiolymphangioma##3##2##(2008-10#3)
cavernous hemangioma##2##2##(2009-1#1)(2011-1#1)
cavernous malformation##2##2##(2008-7#1)(2012-3#1)
cavernous malformations away from##2##4##(2012-3#2)
cavernous malformations##5##2##(2007-10#1)(2008-9#1)(2012-3#3)
cavernous sinus and##4##3##(1990-12#1)(1993-12#1)(2009-6#1)(2011-2#1)
cavernous sinus##14##2##(1990-12#3)(1993-12#1)(1993-9#1)(2008-7#2)(2009-6#2)(2011-2#4)(2012-3#1)
cavernous##45##1##(1990-12#3)(1990-7#1)(1993-12#2)(1993-9#1)(1996-6#1)(1996-9#2)(1997-3#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-7#7)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#2)(2009-6#2)(2011-1#2)(2011-2#6)(2012-3#6)
caviomorph##2##1##(2012-2#2)
caviomorphs##2##1##(2012-2#2)
cavitary lesions in the upper##2##5##(2008-5#1)(2013-1#1)
cavitary##3##1##(2008-5#1)(2013-1#2)
cavitated caries surfaces##2##3##(2012-2#2)
cavitated caries##4##2##(2012-2#4)
cavitated##9##1##(2007-11#1)(2008-10#2)(2008-12#1)(2012-2#5)
cavitation detection##2##2##(2008-12#2)
cavitation time##3##2##(2013-8#3)
cavitation##21##1##(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2010-8#1)(2012-5#1)(2013-8#8)
cavities and##4##2##(2007-11#1)(2008-3#2)(2008-9#1)
cavities are##3##2##(2008-2#1)(2008-3#2)
cavities can be used to##2##5##(2007-12#1)(2008-3#1)
cavities for amalgam##2##3##(1990-9#2)
cavities for##4##2##(1990-9#2)(2007-12#1)(2008-9#1)
cavities from##2##2##(2007-11#1)(2010-8#1)
cavities in the##2##3##(1992-11#1)(2008-2#1)
cavities in##10##2##(1992-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#1)
cavities is##2##2##(2007-11#1)(2008-3#1)
cavities were##2##2##(2007-11#2)
cavities with suspended mirrors##2##4##(2008-3#2)
cavities with##4##2##(2008-2#2)(2008-3#2)
cavities##104##1##(1990-9#2)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1997-6#1)(2007-11#13)(2007-12#12)(2007-8#1)(2008-10#4)(2008-2#12)(2008-3#25)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#6)(2009-2#1)(2009-5#1)(2010-8#3)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
cavity QED##2##2##(2007-11#1)(2007-12#1)
cavity a##2##2##(2008-3#1)(2012-3#1)
cavity and a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
cavity and anterior##2##3##(2007-12#1)(2011-1#1)
cavity and by##2##3##(2008-3#2)
cavity and the##9##3##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)
cavity and to##2##3##(2008-12#1)(2008-3#1)
cavity and##45##2##(1990-6#1)(1992-10#2)(1993-12#1)(1994-9#1)(2007-11#2)(2007-12#7)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-8#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
cavity are##2##2##(2008-3#2)
cavity as##5##2##(1990-3#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
cavity at##2##2##(2007-12#1)(2008-3#1)
cavity between the##2##3##(1990-8#1)(2013-8#1)
cavity between##3##2##(1990-8#1)(1993-9#1)(2013-8#1)
cavity by means of##2##4##(2007-11#1)(2008-3#1)
cavity by use of an##2##5##(2008-2#1)(2008-3#1)
cavity by use of##3##4##(2008-2#1)(2008-3#2)
cavity by##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
cavity can##6##2##(1996-5#1)(2007-12#3)(2008-3#2)
cavity configuration##9##2##(2007-11#2)(2008-2#4)(2008-3#3)
cavity consists of##2##3##(2007-12#1)(2008-3#1)
cavity containing a##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
cavity containing##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
cavity contains##2##2##(2007-12#1)(2008-2#1)
cavity design is##2##3##(2007-11#1)(2008-3#1)
cavity design##9##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2009-2#1)
cavity detuning##2##2##(2007-12#1)(2008-3#1)
cavity dispersion##2##2##(2007-11#1)(2007-12#1)
cavity dumping##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
cavity for##7##2##(1996-5#1)(2007-12#2)(2008-3#3)(2008-9#1)
cavity formed by##2##3##(1995-2#1)(2007-11#1)
cavity formed##3##2##(1995-2#1)(2007-11#1)(2008-3#1)
cavity had##2##2##(1995-6#1)(2013-1#1)
cavity has##2##2##(1996-1#1)(2008-3#1)
cavity in a##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
cavity in both##2##3##(1997-6#1)(2010-12#1)
cavity in the##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
cavity in##12##2##(1990-9#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-12#1)
cavity into##2##2##(1995-2#1)(2007-8#1)
cavity is discussed##2##3##(2008-1#1)(2008-3#1)
cavity is used##2##3##(2008-2#1)(2008-3#1)
cavity is##22##2##(1990-5#1)(1991-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#7)(2008-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
cavity leading to##2##3##(2008-12#1)(2011-1#1)
cavity leak-out##2##2##(2007-12#2)
cavity length and##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
cavity length of##3##3##(2007-12#2)(2008-3#1)
cavity length##19##2##(2007-11#6)(2007-12#5)(2008-2#2)(2008-3#6)
cavity loss and##3##3##(2007-12#2)(2008-3#1)
cavity loss##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
cavity made by the##2##4##(1996-5#1)(2008-7#1)
cavity mirror##2##2##(2007-12#1)(2008-3#1)
cavity mirrors##6##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
cavity mode##8##2##(2007-11#2)(2007-12#4)(2008-2#2)
cavity modes of##2##3##(2008-2#1)(2008-3#1)
cavity modes##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
cavity of a##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2013-1#1)
cavity of the##10##3##(1996-12#1)(2008-10#3)(2008-3#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
cavity of##30##2##(1992-2#1)(1992-6#1)(1995-9#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
cavity or##5##2##(1991-6#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-9#1)
cavity output##4##2##(2007-11#2)(2008-3#2)
cavity preparation##2##2##(1991-2#1)(2008-7#1)
cavity rare diseases##2##3##(2011-7#2)
cavity rare##3##2##(2011-7#3)
cavity resonance##2##2##(2007-12#1)(2008-3#1)
cavity ring-down spectroscopy##3##3##(2007-11#1)(2010-7#2)
cavity ringdown measurements of multiple##2##5##(2008-3#2)
cavity ringdown spectroscopy##15##3##(2007-12#1)(2008-2#1)(2008-3#13)
cavity ringdown technique##3##3##(2008-3#3)
cavity ringdown##25##2##(2007-12#1)(2008-2#2)(2008-3#22)
cavity semiconductor##3##2##(2007-11#2)(2008-3#1)
cavity structure##2##2##(2007-12#1)(2008-3#1)
cavity that##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
cavity through##3##2##(2007-12#2)(2008-2#1)
cavity to the##2##3##(2007-11#1)(2012-1#1)
cavity to##13##2##(2007-11#5)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
cavity was accessed##2##3##(2009-8#1)(2013-1#1)
cavity was##11##2##(1991-3#1)(1994-9#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#2)
cavity were##6##2##(1995-2#1)(1995-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
cavity when##2##2##(2007-11#2)
cavity with a##4##3##(2007-11#1)(2008-3#2)(2013-1#1)
cavity with##12##2##(1993-8#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#3)(2010-8#1)(2011-1#1)(2013-1#1)
cavity##630##1##(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-2#5)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#4)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#5)(1997-8#2)(2007-10#1)(2007-11#64)(2007-12#110)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#7)(2008-10#25)(2008-11#4)(2008-12#7)(2008-2#63)(2008-3#166)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#4)(2011-7#3)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#27)(2013-7#1)(2013-8#2)
cavity's##3##1##(2007-12#1)(2008-3#2)
cavity)##3##1##(1995-12#1)(2008-10#1)(2011-2#1)
cavity-dumped oscillators##2##2##(2008-3#2)
cavity-dumped##3##1##(2008-3#3)
cavity-length modulation technique##2##3##(2008-2#2)
cavity-length##7##1##(2007-11#2)(2007-12#3)(2008-2#2)
cavity-ringdown##2##1##(2007-12#1)(2008-3#1)
cavity]##4##1##(1990-10#1)(1990-5#1)(1997-4#1)(2011-2#1)
cavopulmonary shunt##4##2##(2007-8#4)
cavopulmonary##7##1##(2007-8#7)
cavus foot##2##2##(2009-10#2)
cavus##3##1##(2009-10#2)(2010-3#1)
cayenensis##3##1##(2008-5#3)
cayenensis)##2##1##(2008-5#2)
cbiXJCDETLFGAcysG(A)cbiYbtuR##2##1##(2011-1#2)
cc##7##1##(2007-10#2)(2008-5#3)(2009-11#1)(2010-11#1)
cce_0567##2##1##(2009-7#2)
cd/m(2)##2##1##(2007-12#1)(2010-9#1)
cdc17-1##2##1##(1990-5#2)
cdc17-2)##2##1##(1990-5#2)
cdc25 and##2##2##(1990-2#1)(1994-12#1)
cdc25 is##2##2##(1990-2#2)
cdc25##8##1##(1990-2#3)(1994-12#5)
cdc25+##2##1##(1990-2#2)
cdc7Δ##2##1##(2012-3#2)
cdk-cyclin A complex and DNA-dependent##2##5##(1994-8#2)
cdk-cyclin A##5##2##(1994-8#5)
cdk2 promoter##2##2##(1994-12#2)
cdk2##6##1##(1994-12#2)(1994-6#3)(1995-2#1)
cdk5##4##1##(1995-5#4)
ce##4##1##(2011-2#1)(2013-1#3)
cease to##3##2##(1994-3#1)(2008-11#1)(2012-2#1)
cease##11##1##(1991-11#1)(1991-2#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-2#1)(2012-2#1)
ceased and##2##2##(1992-3#1)(2008-4#1)
ceased in##2##2##(1993-2#1)(2008-11#1)
ceased to##3##2##(1994-9#1)(1995-3#1)(2009-12#1)
ceased##22##1##(1990-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-9#1)(1995-3#2)(1996-9#2)(1997-4#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-12#1)(2010-1#1)(2010-5#1)(2010-8#1)
ceases##8##1##(2007-12#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-5#1)(2012-2#1)(2012-3#1)
cecal impaction##3##2##(2013-8#3)
cecal ligation and puncture##2##4##(2012-3#2)
cecal ligation##3##2##(2012-3#3)
cecal volvulus##3##2##(2012-3#3)
cecal##11##1##(2012-3#6)(2013-8#5)
cecropin AD##2##2##(1994-5#2)
cecropin##8##1##(1994-5#4)(2008-10#2)(2008-8#2)
cecum and ascending colon##2##4##(2007-12#1)(2008-12#1)
cecum##8##1##(1991-5#1)(2007-12#1)(2008-11#1)(2008-12#5)
cedar pollen##7##2##(2008-11#1)(2012-1#1)(2012-12#5)
cedar pollinosis##11##2##(2008-11#2)(2012-12#9)
cedar##19##1##(2008-10#1)(2008-11#3)(2012-1#1)(2012-12#14)
cefaclor##2##1##(2008-10#2)
cefadroxil monohydrate##3##2##(2008-10#3)
cefadroxil##14##1##(2008-10#14)
cefalexin##3##1##(2008-10#3)
cefazolin sodium##7##2##(2008-10#7)
cefazolin##14##1##(2008-10#9)(2008-12#1)(2011-2#4)
cefditoren pivoxil##2##2##(2011-2#2)
cefepime and##2##2##(2008-7#2)
cefepime##5##1##(2008-7#5)
cefixime##6##1##(2008-10#6)
cefoperazone##2##1##(2007-7#1)(2008-10#1)
cefotaxime and ceftriaxone##3##3##(2008-7#3)
cefotaxime and##6##2##(1990-6#1)(2008-12#1)(2008-7#3)(2011-2#1)
cefotaxime or##2##2##(2011-2#2)
cefotaxime##16##1##(1990-6#1)(2007-7#3)(2008-10#2)(2008-12#1)(2008-7#4)(2011-2#3)(2013-1#2)
cefotetan##4##1##(1994-6#4)
cefotetan- and cephalothin-coated##2##3##(1994-6#2)
cefpodoxime##3##1##(1994-11#1)(2010-6#1)(2011-2#1)
ceftazidime for##2##2##(2007-7#1)(2011-2#1)
ceftazidime##10##1##(1991-3#2)(2007-7#2)(2008-10#3)(2008-7#2)(2011-2#1)
ceftibuten##4##1##(1994-8#4)
ceftriaxone in##2##2##(1990-5#2)
ceftriaxone##14##1##(1990-5#3)(1991-3#1)(2007-12#2)(2008-7#4)(2010-8#2)(2011-2#1)(2013-8#1)
cefuroxime##2##1##(1990-12#1)(2007-7#1)
ceiling effect##4##2##(2008-11#3)(2008-7#1)
ceiling effects##3##2##(2008-11#1)(2009-10#1)(2010-11#1)
ceiling level##2##2##(1996-12#2)
ceiling##13##1##(1993-9#1)(1995-12#1)(1996-12#2)(2008-11#4)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-7#1)
cel##2##1##(1996-12#1)(2008-11#1)
cel9-cel48 cluster##2##2##(2009-3#2)
celY gene##2##2##(1991-9#2)
celY##4##1##(1991-9#4)
celadonite##2##1##(2008-10#2)
celebrate its 50th##2##3##(1991-3#1)(2008-10#1)
celebrate##3##1##(1991-3#1)(2007-2#1)(2008-10#1)
celebrated for##2##2##(2008-11#1)(2010-1#1)
celebrated##6##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2013-1#1)
celebrating the##2##2##(1993-6#1)(2010-10#1)
celecoxib and rofecoxib##2##3##(2006-10#1)(2008-8#1)
celecoxib in pharmaceutical formulation and human serum##2##7##(2008-10#2)
celecoxib in##4##2##(2008-10#3)(2008-11#1)
celecoxib##15##1##(2006-10#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-8#1)(2011-2#4)
celery##3##1##(2008-10#3)
celestial cues##4##2##(1994-3#4)
celestial##5##1##(1994-3#5)
celestine blue##2##2##(2008-10#2)
celiac artery##3##2##(1995-12#1)(2008-12#1)(2013-1#1)
celiac disease##12##2##(2007-5#1)(2008-10#2)(2008-12#2)(2011-2#3)(2012-12#2)(2013-8#2)
celiac trunk##2##2##(2012-2#1)(2012-3#1)
celiac##24##1##(1995-12#1)(2007-5#1)(2008-10#2)(2008-12#5)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
celibacy##2##1##(2008-11#1)(2008-12#1)
celiotomies##2##1##(1992-2#2)
cell (PFC) assay##3##3##(2008-10#2)(2008-4#1)
cell (PFC)##6##2##(1993-12#1)(2008-10#2)(2008-4#3)
cell (i##2##2##(2008-1#1)(2010-9#1)
cell ATP##2##2##(2008-11#2)
cell Ca2+##3##2##(1992-12#1)(1993-3#1)(2013-7#1)
cell abundance##2##2##(2008-5#2)
cell accumulation##2##2##(1992-3#1)(2008-7#1)
cell activation and cytokine##2##4##(2008-4#2)
cell activation and##4##3##(1995-11#1)(2008-4#2)(2012-2#1)
cell activation##27##2##(1994-11#2)(1995-11#5)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)(2012-3#7)(2013-1#1)
cell activities##2##2##(1995-11#1)(2008-10#1)
cell activity and##2##3##(1991-8#1)(1994-5#1)
cell activity in the##2##4##(2008-10#1)(2008-6#1)
cell activity in##3##3##(1993-5#1)(2008-10#1)(2008-6#1)
cell activity were##3##3##(2008-10#3)
cell activity##21##2##(1991-8#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#3)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-6#1)(2013-8#1)
cell adaptation##3##2##(2008-11#3)
cell adenocarcinoma##2##2##(1993-8#1)(2012-1#1)
cell adenoma##2##2##(1990-9#1)(2012-1#1)
cell adenosine deaminase##2##3##(1992-12#2)
cell adherence##2##2##(1995-12#1)(2012-2#1)
cell adhesion and##12##3##(1994-11#1)(1994-5#1)(2008-11#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
cell adhesion molecule is##2##4##(1991-5#1)(2009-8#1)
cell adhesion molecule##14##3##(1990-11#1)(1991-5#1)(1995-12#1)(1996-12#1)(1997-6#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#4)(2009-9#1)
cell adhesion molecules##5##3##(1996-2#1)(1997-7#1)(2009-8#3)
cell adhesion on##3##3##(2008-11#2)(2009-11#1)
cell adhesion to the##3##4##(2008-11#1)(2009-10#1)(2011-1#1)
cell adhesion to##8##3##(1990-5#1)(2008-11#1)(2008-4#1)(2009-10#2)(2009-3#2)(2011-1#1)
cell adhesion##82##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-6#3)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#4)(2008-11#10)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#4)(2009-3#3)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
cell adhesiveness##2##2##(1990-11#1)(1994-11#1)
cell affinity##3##2##(2008-5#3)
cell after##5##2##(2008-10#2)(2008-11#3)
cell age##2##2##(1990-2#1)(1995-9#1)
cell aggregates of##2##3##(2008-10#2)
cell aggregates##6##2##(1997-6#1)(2007-12#1)(2008-10#4)
cell aggregation##3##2##(1990-11#1)(2008-10#2)
cell alkaline##3##2##(1992-3#2)(1994-8#1)
cell alone##3##2##(2008-11#3)
cell also##3##2##(1990-5#1)(1997-3#1)(2007-12#1)
cell anaemia##9##2##(2009-10#1)(2009-4#3)(2010-9#1)(2013-8#4)
cell analysis in##2##3##(2008-11#1)(2011-2#1)
cell analysis##8##2##(2007-12#1)(2008-11#2)(2008-4#2)(2009-12#2)(2011-2#1)
cell and T cell##2##4##(2008-4#1)(2013-1#1)
cell and a##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
cell and adsorptive polarographic determination of##3##6##(2008-10#3)
cell and anatomy ontology##2##4##(2008-7#2)
cell and gene therapy##2##4##(1997-2#1)(2008-4#1)
cell and in the##2##4##(2008-3#2)
cell and its content was determined by adsorptive polarography##2##9##(2008-10#2)
cell and its##6##3##(2008-10#3)(2008-11#1)(2009-3#1)(2009-5#1)
cell and molecular biology##4##4##(2008-1#2)(2008-4#1)(2008-9#1)
cell and squamous cell carcinomas of the face##2##8##(2012-3#2)
cell and squamous cell carcinomas##3##5##(2010-8#1)(2012-3#2)
cell and the##12##3##(2008-1#1)(2008-10#7)(2008-3#1)(2008-9#2)(2012-12#1)
cell and tissue culture##2##4##(2008-11#1)(2011-3#1)
cell and tissue##9##3##(1991-9#1)(2008-11#2)(2008-7#3)(2008-9#1)(2011-3#1)(2013-8#1)
cell and##143##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-6#1)(1995-11#1)(1996-9#1)(1997-2#2)(1997-4#1)(2007-12#2)(2008-1#4)(2008-10#40)(2008-11#10)(2008-2#6)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#13)(2009-10#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-2#1)(2010-6#2)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
cell antibodies##4##2##(1994-12#2)(1994-9#2)
cell antibody##2##2##(1992-6#1)(1996-12#1)
cell antigen receptor##2##3##(1993-11#1)(2008-4#1)
cell antigen##4##2##(1993-11#1)(1993-12#1)(2008-4#1)(2013-7#1)
cell antigens##8##2##(1992-9#2)(1993-12#1)(1994-3#1)(1995-12#1)(2007-5#1)(2008-9#1)(2011-2#1)
cell apoptosis and##2##3##(2008-11#1)(2008-9#1)
cell apoptosis in human##2##4##(2008-9#2)
cell apoptosis in##4##3##(2008-9#2)(2009-12#1)(2010-1#1)
cell apoptosis was##2##3##(2008-10#1)(2008-9#1)
cell apoptosis##29##2##(2008-10#1)(2008-11#3)(2008-8#4)(2008-9#10)(2009-12#1)(2010-1#3)(2010-12#2)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)
cell are##8##2##(1995-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
cell areas##2##2##(1995-8#1)(2012-5#1)
cell as a##3##3##(1991-6#1)(2007-11#1)(2008-4#1)
cell as##7##2##(1991-6#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
cell assay system##2##3##(1990-10#1)(1990-11#1)
cell assay##9##2##(1990-10#1)(1990-11#1)(2008-10#5)(2008-8#1)(2009-12#1)
cell assays##5##2##(1994-8#1)(2008-9#3)(2011-2#1)
cell assemblies##2##2##(1996-2#2)
cell assembly##2##2##(2008-10#2)
cell associated##2##2##(2008-11#1)(2012-12#1)
cell at a##3##3##(2008-10#2)(2009-8#1)
cell at the##2##3##(2007-12#1)(2008-10#1)
cell at##12##2##(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
cell attachment and proliferation##2##4##(2008-5#1)(2012-5#1)
cell attachment and##6##3##(1994-6#1)(1995-6#1)(2008-5#1)(2009-12#2)(2012-5#1)
cell attachment sites in entactin##2##5##(1995-6#2)
cell attachment to##2##3##(1990-2#1)(2012-5#1)
cell attachment##21##2##(1990-2#2)(1992-3#2)(1994-5#1)(1994-6#1)(1995-6#5)(2008-5#1)(2009-12#2)(2009-7#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-5#3)
cell attributes##2##2##(2008-1#1)(2008-9#1)
cell banks##4##2##(2008-11#3)(2012-3#1)
cell based on##4##3##(2008-10#2)(2008-3#2)
cell based##11##2##(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)
cell behavior and##2##3##(2010-10#1)(2013-1#1)
cell behavior##8##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
cell behaviour in continuous culture##2##5##(2008-11#2)
cell behaviour in##3##3##(2008-11#3)
cell behaviour##5##2##(2008-11#4)(2009-7#1)
cell below##2##2##(2007-12#1)(2008-7#1)
cell between##2##2##(2008-10#1)(2008-8#1)
cell binding proteins##2##3##(1993-6#2)
cell binding##7##2##(1991-9#1)(1993-6#3)(1994-11#1)(2008-10#1)(2009-7#1)
cell bioassay systems##4##3##(2008-10#4)
cell bioassay##6##2##(1991-12#1)(1995-11#1)(2008-10#4)
cell biological##8##2##(1994-8#1)(1995-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
cell biologists##2##2##(2008-9#1)(2009-8#1)
cell biology and development##2##4##(2008-10#2)
cell biology and the##2##4##(2008-11#1)(2012-12#1)
cell biology and##14##3##(2006-10#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#2)
cell biology in##4##3##(2008-4#2)(2010-1#1)(2010-12#1)
cell biology of##2##3##(1995-5#1)(2008-4#1)
cell biology##45##2##(1991-2#1)(1993-6#1)(1994-11#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
cell bleeding##2##2##(1994-5#2)
cell bodies and##7##3##(1992-12#1)(1993-12#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-7#1)
cell bodies in the dorsal##2##5##(1993-12#1)(1995-12#1)
cell bodies in the##9##4##(1993-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-7#1)(2008-9#1)
cell bodies in##10##3##(1993-12#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-7#1)(2008-9#1)
cell bodies of##3##3##(1990-5#1)(1991-5#1)(1997-3#1)
cell bodies were##2##3##(1991-10#1)(1992-12#1)
cell bodies##39##2##(1990-5#2)(1991-10#2)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#2)(1993-12#3)(1994-2#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#5)(1997-7#1)(2007-12#4)(2008-7#3)(2008-9#1)
cell body and##3##3##(2008-10#1)(2008-7#2)
cell body##14##2##(1994-6#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#8)(2013-1#1)
cell boundaries##5##2##(2008-5#2)(2008-7#1)(2011-1#1)(2012-2#1)
cell by a##3##3##(1994-9#1)(2008-10#2)
cell by##10##2##(1994-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)
cell cDNA library##2##3##(1993-2#1)(1995-12#1)
cell can be##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)
cell can##10##2##(1995-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-9#1)(2009-2#1)(2011-1#1)(2013-8#1)
cell cancers##3##2##(1997-7#1)(2011-2#2)
cell carcinoid##3##2##(2013-1#3)
cell carcinoma (BCC)##4##3##(1997-3#2)(2007-5#1)(2013-1#1)
cell carcinoma (OSCC) has##2##4##(2010-12#1)(2012-3#1)
cell carcinoma (OSCC)##4##3##(2010-12#1)(2012-3#1)(2013-1#2)
cell carcinoma (RCC) is##2##4##(2008-1#1)(2012-3#1)
cell carcinoma (RCC)##9##3##(1990-2#1)(2007-4#1)(2008-1#2)(2011-2#2)(2012-3#1)(2013-1#2)
cell carcinoma (TCC)##2##3##(2008-10#1)(2012-3#1)
cell carcinoma and##16##3##(1991-6#1)(1991-8#2)(1993-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
cell carcinoma arising from a##2##5##(2008-10#1)(2010-7#1)
cell carcinoma arising in##2##4##(2013-8#2)
cell carcinoma arising##4##3##(2008-10#1)(2010-7#1)(2013-8#2)
cell carcinoma cell line##2##4##(2008-11#1)(2012-2#1)
cell carcinoma cell##5##3##(2008-11#2)(2008-2#1)(2010-8#1)(2012-2#1)
cell carcinoma in the##2##4##(1990-8#1)(2012-1#1)
cell carcinoma in##7##3##(1990-8#2)(2007-7#1)(2012-1#1)(2012-3#2)(2013-1#1)
cell carcinoma is a##2##4##(2007-7#2)
cell carcinoma is##5##3##(1992-3#1)(2007-7#2)(2013-1#1)(2013-8#1)
cell carcinoma of the bladder##4##5##(1992-12#2)(1997-4#1)(2007-10#1)
cell carcinoma of the head and neck##4##7##(1990-6#1)(1993-8#1)(2007-10#1)(2007-11#1)
cell carcinoma of the lung##2##5##(1995-9#1)(2008-1#1)
cell carcinoma of the##37##4##(1990-6#1)(1991-6#1)(1992-12#3)(1992-3#1)(1993-12#2)(1993-3#1)(1993-8#3)(1993-9#1)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-4#2)(2009-3#3)(2009-5#1)(2009-8#1)(2013-1#1)(2013-7#1)(2013-8#4)
cell carcinoma of##44##3##(1990-6#1)(1991-6#1)(1992-12#3)(1992-3#1)(1993-12#2)(1993-3#1)(1993-8#3)(1993-9#1)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-4#2)(2009-3#3)(2009-5#1)(2009-8#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#4)
cell carcinoma or##3##3##(2007-12#1)(2009-1#1)(2009-5#1)
cell carcinoma patients##2##3##(1997-4#1)(2007-11#1)
cell carcinoma syndrome##6##3##(1997-3#4)(2007-12#1)(2007-4#1)
cell carcinoma was##3##3##(1991-8#1)(2009-3#1)(2012-1#1)
cell carcinoma with##3##3##(2007-5#1)(2010-8#1)(2011-2#1)
cell carcinoma##213##2##(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-6#3)(1991-8#6)(1992-12#3)(1992-3#6)(1992-8#1)(1993-12#4)(1993-3#1)(1993-8#5)(1993-9#1)(1994-12#1)(1995-12#4)(1995-9#1)(1996-12#1)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-4#3)(2007-5#4)(2007-7#9)(2007-8#1)(2008-1#12)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#3)(2008-8#1)(2008-9#2)(2009-1#3)(2009-10#1)(2009-3#5)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#6)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#19)(2013-7#2)(2013-8#14)
cell carcinoma?##3##2##(2011-2#1)(2013-1#2)
cell carcinoma]##6##2##(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
cell carcinomas are##2##3##(2011-2#1)(2012-3#1)
cell carcinomas with##2##3##(2010-8#1)(2011-2#1)
cell carcinomas##31##2##(1991-11#1)(1991-8#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-6#4)(1997-3#3)(2007-4#1)(2007-7#1)(2008-4#2)(2008-9#3)(2009-4#1)(2010-8#3)(2011-2#3)(2012-3#4)
cell changes##4##2##(1991-11#1)(2008-10#2)(2013-1#1)
cell chondrosarcoma##3##2##(2008-6#3)
cell clone##2##2##(1990-6#1)(2008-11#1)
cell clones was##2##3##(2008-11#1)(2008-8#1)
cell clones were obtained##2##4##(2008-8#1)(2008-9#1)
cell clones were##3##3##(1991-9#1)(2008-8#1)(2008-9#1)
cell clones##25##2##(1990-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-9#1)(2008-11#10)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#1)
cell clumping##2##2##(2008-11#1)(2008-9#1)
cell clumps##2##2##(2008-11#1)(2008-9#1)
cell cluster##2##2##(2008-12#1)(2009-12#1)
cell clusters and##2##3##(2008-12#1)(2008-7#1)
cell clusters##11##2##(1993-12#1)(1996-2#1)(2007-12#2)(2008-12#1)(2008-7#5)(2008-8#1)
cell collection##2##2##(2010-6#1)(2011-2#1)
cell colonies##6##2##(1990-7#1)(2008-11#4)(2008-8#1)
cell colony formation##2##3##(1995-3#1)(2008-10#1)
cell colony##3##2##(1995-3#1)(2008-10#1)(2012-5#1)
cell communication##4##2##(2008-5#4)
cell compartment##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
cell compartments##2##2##(1991-11#1)(2008-9#1)
cell competition##6##2##(2008-10#6)
cell component##2##2##(1992-8#1)(2010-11#1)
cell components##7##2##(1995-12#1)(2007-12#1)(2009-8#3)(2013-1#2)
cell composed of##2##3##(2008-10#1)(2010-5#1)
cell composition##2##2##(2008-7#1)(2009-8#1)
cell concentration and##3##3##(2008-11#2)(2008-7#1)
cell concentration in##2##3##(2008-11#1)(2008-7#1)
cell concentration of##4##3##(2008-11#2)(2008-7#2)
cell concentration over##2##3##(2008-11#1)(2008-7#1)
cell concentration was##4##3##(2008-11#3)(2008-6#1)
cell concentration##39##2##(1994-3#1)(1994-5#1)(2007-11#1)(2008-11#20)(2008-6#2)(2008-7#12)(2008-9#2)
cell concentrations were maintained##2##4##(1994-5#1)(2008-11#1)
cell concentrations##4##2##(1994-5#1)(2008-11#2)(2008-9#1)
cell conditioned media##2##3##(1992-3#1)(1997-7#1)
cell conditioned##3##2##(1991-2#1)(1992-3#1)(1997-7#1)
cell conditions##2##2##(1995-8#1)(2008-2#1)
cell configuration##3##2##(2008-10#2)(2008-3#1)
cell constants##3##2##(1992-11#1)(1996-2#1)(2008-8#1)
cell contact##4##2##(1991-9#1)(2009-8#1)(2011-1#2)
cell containing##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
cell contains a##3##3##(2007-12#1)(2008-10#2)
cell contains##6##2##(1995-8#1)(2007-12#2)(2008-10#2)(2008-7#1)
cell content##2##2##(2008-10#1)(2011-2#1)
cell contents##2##2##(1994-12#1)(2011-1#1)
cell cortex##3##2##(2008-9#1)(2009-10#2)
cell could##2##2##(2008-10#1)(2008-9#1)
cell count and##8##3##(1992-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)
cell count of the##2##4##(2008-11#1)(2011-2#1)
cell count of##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
cell count##33##2##(1991-6#2)(1992-2#2)(1994-3#1)(1995-11#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2011-2#5)(2012-2#3)(2013-1#2)
cell counting##12##2##(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2013-8#1)
cell counts and##5##3##(1996-3#1)(2009-12#1)(2010-4#1)(2011-1#2)
cell counts in##4##3##(1991-11#2)(1997-6#1)(2008-11#1)
cell counts of##3##3##(1993-2#1)(2008-11#1)(2013-8#1)
cell counts##24##2##(1991-11#2)(1993-2#1)(1993-3#1)(1996-3#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#4)(2012-12#1)(2013-8#1)
cell cultivation##6##2##(1994-5#1)(2008-11#5)
cell culture and animal##2##4##(2008-7#1)(2012-3#1)
cell culture and in##2##4##(1997-7#1)(2008-9#1)
cell culture and the##2##4##(2008-11#1)(2010-2#1)
cell culture and viral##2##4##(2008-11#2)
cell culture and##13##3##(1991-6#1)(1997-7#1)(2008-11#6)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-3#1)
cell culture are discussed##2##4##(2008-11#1)(2008-7#1)
cell culture assay##2##3##(1995-3#1)(2008-11#1)
cell culture at##2##3##(2008-11#2)
cell culture conditions##3##3##(1993-12#1)(2008-11#2)
cell culture engineering##2##3##(2008-11#2)
cell culture experiments##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
cell culture for##2##3##(2008-11#1)(2008-7#1)
cell culture in the##2##4##(2008-11#2)
cell culture in##4##3##(2008-11#3)(2008-7#1)
cell culture is##2##3##(2012-2#2)
cell culture may be##2##4##(2008-11#1)(2008-4#1)
cell culture media##5##3##(1991-5#1)(2008-11#3)(2011-2#1)
cell culture medium was##2##4##(1994-5#1)(2008-11#1)
cell culture medium##8##3##(1993-12#1)(1994-5#2)(2008-11#3)(2011-2#1)(2013-1#1)
cell culture method##3##3##(2010-3#1)(2012-2#2)
cell culture model##5##3##(1994-9#1)(1995-9#1)(1996-12#1)(1997-4#1)(2008-7#1)
cell culture models##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
cell culture of##3##3##(1997-6#1)(2008-5#1)(2008-9#1)
cell culture process##4##3##(2008-11#3)(2008-7#1)
cell culture processes##8##3##(2008-11#8)
cell culture production##2##3##(2008-11#2)
cell culture samples##2##3##(2008-11#2)
cell culture studies##4##3##(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
cell culture supernatants##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
cell culture supplement##2##3##(1994-2#1)(2008-11#1)
cell culture system##7##3##(1992-3#2)(2008-10#1)(2008-11#3)(2009-12#1)
cell culture systems##9##3##(1992-2#1)(1994-5#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-9#1)
cell culture techniques##2##3##(2008-11#2)
cell culture to##2##3##(2008-10#1)(2012-2#1)
cell culture using##3##3##(2008-11#2)(2008-7#1)
cell culture was##4##3##(2008-11#3)(2013-7#1)
cell culture were##3##3##(1994-2#1)(1996-2#1)(2008-11#1)
cell culture##227##2##(1991-12#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-12#3)(1994-11#1)(1994-2#4)(1994-5#3)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2008-10#8)(2008-11#118)(2008-2#4)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#1)
cell cultured##2##2##(2008-5#2)
cell cultures and##4##3##(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)
cell cultures are##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
cell cultures as##2##3##(1990-7#1)(2008-2#1)
cell cultures at##4##3##(2008-5#2)(2008-7#2)
cell cultures by##2##3##(2008-11#2)
cell cultures for##2##3##(2008-11#1)(2008-5#1)
cell cultures from##4##3##(1991-12#1)(2008-11#1)(2010-3#2)
cell cultures grown in##2##4##(2008-7#2)
cell cultures in##3##3##(2008-11#2)(2009-3#1)
cell cultures infected with##4##4##(1994-6#1)(1997-6#1)(2008-11#1)(2008-7#1)
cell cultures obtained from##2##4##(1995-11#1)(1997-2#1)
cell cultures of##5##3##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
cell cultures prepared from##2##4##(1996-5#1)(2009-3#1)
cell cultures to##3##3##(1990-11#1)(2007-12#1)(2009-6#1)
cell cultures was##2##3##(1992-9#1)(2010-3#1)
cell cultures were exposed to##2##5##(1994-9#1)(2008-7#1)
cell cultures were##7##3##(1994-2#1)(1994-9#1)(2008-11#3)(2008-7#1)(2010-3#1)
cell cultures with##6##3##(1990-11#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
cell cultures##161##2##(1990-11#4)(1990-4#1)(1990-5#2)(1990-7#1)(1991-12#3)(1991-5#1)(1992-2#3)(1992-8#2)(1992-9#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#5)(1995-12#2)(1996-12#3)(1996-2#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#57)(2008-2#6)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#2)(2009-3#2)(2009-6#2)(2010-11#1)(2010-3#4)(2011-2#1)(2013-1#2)
cell culturing##2##2##(2008-11#2)
cell cycle activity##2##3##(2008-9#1)(2012-3#1)
cell cycle after##3##3##(1997-6#1)(2008-11#2)
cell cycle analyses on##2##4##(2008-11#2)
cell cycle analyses##3##3##(2008-11#2)(2008-9#1)
cell cycle analysis in##2##4##(2008-11#1)(2008-9#1)
cell cycle analysis##10##3##(2008-11#5)(2008-2#1)(2008-9#4)
cell cycle and apoptosis##2##4##(2012-1#1)(2012-12#1)
cell cycle and its##2##4##(1997-6#1)(2011-2#1)
cell cycle and##10##3##(1997-6#1)(2008-11#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
cell cycle arrest and##6##4##(1991-5#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
cell cycle arrest at G1/S was##2##6##(1997-7#2)
cell cycle arrest at G1/S##3##5##(1997-7#3)
cell cycle arrest at##5##4##(1991-9#1)(1997-7#3)(2008-11#1)
cell cycle arrest induced by##2##5##(1995-2#1)(2008-11#1)
cell cycle arrest##29##3##(1991-5#1)(1991-9#1)(1994-11#1)(1995-2#3)(1997-1#1)(1997-3#2)(1997-7#4)(2008-11#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
cell cycle control and apoptosis##2##5##(2008-7#1)(2009-7#1)
cell cycle control##7##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
cell cycle delay##2##3##(2008-10#1)(2010-2#1)
cell cycle distribution##2##3##(1997-1#1)(2008-11#1)
cell cycle in##6##3##(1996-3#1)(2008-11#1)(2008-4#2)(2008-9#2)
cell cycle is##3##3##(1993-9#1)(2011-2#1)(2013-1#1)
cell cycle kinetics##2##3##(1996-2#1)(2008-9#1)
cell cycle phase##6##3##(2008-11#5)(2008-9#1)
cell cycle phases##5##3##(2008-11#5)
cell cycle progression and apoptosis##2##5##(2012-12#1)(2012-2#1)
cell cycle progression and##9##4##(1991-9#1)(2008-11#3)(2009-6#1)(2009-8#1)(2012-12#2)(2012-2#1)
cell cycle progression at##2##4##(2008-9#1)(2012-3#1)
cell cycle progression in yeast##2##5##(1996-3#1)(2009-6#1)
cell cycle progression in##5##4##(1996-3#1)(1997-1#1)(2008-11#1)(2009-6#1)(2012-3#1)
cell cycle progression of##2##4##(1991-9#1)(1995-9#1)
cell cycle progression were##2##4##(1993-8#1)(1994-11#1)
cell cycle progression##38##3##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-10#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-8#2)(1995-9#2)(1996-3#1)(1997-1#1)(1997-7#1)(2008-11#5)(2008-8#1)(2008-9#3)(2009-6#2)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)
cell cycle reentry##2##3##(1994-9#2)
cell cycle regulation and##2##4##(2011-2#1)(2012-12#1)
cell cycle regulation in##2##4##(2008-9#1)(2009-8#1)
cell cycle regulation##8##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)
cell cycle regulators and MMPs##2##5##(2013-1#2)
cell cycle regulators and##3##4##(2013-1#3)
cell cycle regulators##7##3##(2008-4#1)(2012-2#2)(2013-1#4)
cell cycle related##2##3##(2008-11#2)
cell cycle status##2##3##(2008-11#1)(2008-9#1)
cell cycle synchronization and##2##4##(2008-2#1)(2008-5#1)
cell cycle was##2##3##(2008-11#1)(2008-8#1)
cell cycle##257##2##(1990-11#3)(1990-2#1)(1991-2#1)(1991-5#3)(1991-9#3)(1992-10#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-3#3)(1994-8#3)(1994-9#2)(1995-2#4)(1995-9#5)(1996-2#1)(1996-3#3)(1997-1#5)(1997-3#3)(1997-6#3)(1997-7#8)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#56)(2008-2#3)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#27)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#10)(2012-2#9)(2012-3#8)(2013-1#9)
cell cycle-dependent##3##2##(1995-2#1)(1995-8#1)(2008-8#1)
cell cycles##2##2##(1994-5#1)(2008-9#1)
cell cytokines##2##2##(1996-12#1)(2008-10#1)
cell cytoplasm was##5##3##(2008-10#5)
cell cytoplasm##16##2##(1992-12#2)(1997-6#1)(2007-12#3)(2008-10#8)(2008-7#1)(2011-2#1)
cell cytoskeleton##6##2##(1991-9#1)(1993-6#1)(1994-5#1)(2007-12#1)(2009-10#1)(2009-5#1)
cell cytosol##4##2##(1994-12#1)(1994-2#1)(2010-11#1)(2013-1#1)
cell cytotoxicity##4##2##(1995-3#1)(2007-12#1)(2008-9#1)(2013-1#1)
cell damage and##3##3##(1996-12#1)(2008-11#1)(2012-12#1)
cell damage during##2##3##(1996-9#1)(1997-1#1)
cell damage in##3##3##(1992-9#1)(1997-6#1)(2007-10#1)
cell damage##22##2##(1992-9#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-9#1)(2011-3#2)(2012-12#1)(2012-3#1)
cell data##2##2##(2008-10#1)(2008-2#1)
cell death (PCD)##5##3##(1994-10#1)(2008-10#1)(2009-10#1)(2009-8#2)
cell death after##3##3##(1994-2#1)(2010-11#1)(2013-1#1)
cell death and the##2##4##(2009-8#1)(2011-2#1)
cell death and##17##3##(1990-11#1)(1992-3#1)(1993-3#1)(1996-12#1)(2007-10#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#2)(2011-2#1)(2011-9#1)
cell death as a##2##4##(2008-11#1)(2009-8#1)
cell death at##2##3##(2008-10#1)(2012-3#1)
cell death but##2##3##(1996-5#1)(2008-8#1)
cell death by apoptosis##4##4##(1991-12#1)(2008-11#1)(2009-4#1)(2010-2#1)
cell death by##10##3##(1991-12#1)(1995-5#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2013-7#1)
cell death caused by##3##4##(2008-11#2)(2008-7#1)
cell death during development##2##4##(1994-5#1)(2008-4#1)
cell death during the##2##4##(1994-2#1)(2008-11#1)
cell death during##6##3##(1994-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
cell death has##2##3##(2008-9#1)(2012-2#1)
cell death in Parkinson's disease##4##5##(1995-5#1)(2008-7#3)
cell death in both##2##4##(1994-8#1)(2008-10#1)
cell death in other##2##4##(2008-10#1)(2008-7#1)
cell death in plants##2##4##(2008-10#1)(2009-8#1)
cell death in the##11##4##(1990-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)
cell death in##41##3##(1990-5#1)(1991-12#1)(1994-10#1)(1994-8#2)(1995-12#2)(1995-3#3)(1995-5#2)(1995-8#1)(1996-12#1)(2006-10#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
cell death induced by##2##4##(2008-11#1)(2012-2#1)
cell death is##5##3##(1992-9#1)(1995-5#1)(2008-11#1)(2008-7#1)(2009-12#1)
cell death modalities##2##3##(2013-1#2)
cell death occurred##2##3##(2008-10#1)(2008-11#1)
cell death of the##2##4##(1995-8#1)(2008-11#1)
cell death of thymocytes##3##4##(2008-8#3)
cell death of tobacco cells via similar##2##7##(2009-6#2)
cell death of tobacco cells##3##5##(2009-6#3)
cell death of##10##3##(1995-8#1)(1996-12#1)(2008-11#1)(2008-8#3)(2009-3#1)(2009-6#3)
cell death or##5##3##(1994-10#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
cell death pathways##2##3##(2008-11#1)(2009-8#1)
cell death rate##3##3##(1994-3#1)(2008-11#2)
cell death under##2##3##(1994-11#1)(2008-11#1)
cell death was observed##2##4##(2008-10#2)
cell death was##7##3##(1992-3#1)(1994-11#1)(2008-10#4)(2012-12#1)
cell death with##2##3##(1994-8#1)(2012-12#1)
cell death##306##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-12#3)(1991-9#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#4)(1994-11#2)(1994-2#4)(1994-3#4)(1994-5#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#6)(1995-5#5)(1995-6#2)(1995-8#4)(1996-12#9)(1996-2#1)(1996-5#4)(1997-9#1)(2006-10#3)(2007-10#3)(2007-12#1)(2008-1#8)(2008-10#27)(2008-11#38)(2008-12#1)(2008-2#1)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#22)(2008-8#14)(2008-9#8)(2009-10#3)(2009-12#4)(2009-3#2)(2009-4#5)(2009-6#5)(2009-7#1)(2009-8#15)(2009-9#1)(2010-11#3)(2010-2#1)(2010-3#3)(2011-1#1)(2011-2#8)(2011-9#1)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#1)
cell debris##6##2##(1993-8#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#2)
cell deformation was##2##3##(2007-12#1)(2011-1#1)
cell deformation##5##2##(2007-12#1)(2008-11#1)(2011-1#3)
cell degeneration##10##2##(1994-8#4)(2008-4#1)(2008-7#4)(2012-2#1)
cell degranulation##2##2##(1994-11#1)(2010-1#1)
cell delivery##3##2##(2008-4#1)(2010-6#1)(2012-3#1)
cell densities and##4##3##(1994-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
cell densities between 2 x##2##5##(1994-5#2)
cell densities in the##2##4##(2008-11#2)
cell densities in##3##3##(2008-11#2)(2008-7#1)
cell densities of##5##3##(2008-10#1)(2008-11#2)(2008-7#2)
cell densities##29##2##(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#3)(1996-12#1)(2008-10#2)(2008-11#11)(2008-7#6)(2011-2#2)
cell density and##15##3##(1993-9#1)(2008-11#8)(2008-4#1)(2008-7#1)(2010-10#1)(2012-1#2)(2012-5#1)
cell density in a##2##4##(1993-3#1)(2012-1#1)
cell density in##7##3##(1993-3#1)(1995-3#1)(2008-11#3)(2010-10#1)(2012-1#1)
cell density is##2##3##(1993-8#1)(2008-11#1)
cell density obtained##2##3##(2008-11#2)
cell density of 1##2##4##(2008-11#2)
cell density of the##2##4##(2008-11#1)(2008-7#1)
cell density of##8##3##(2008-11#6)(2008-7#2)
cell density or##2##3##(1993-9#1)(2008-11#1)
cell density was##3##3##(2008-11#3)
cell density were##3##3##(1993-9#1)(1994-5#1)(2008-11#1)
cell density##94##2##(1993-3#2)(1993-8#2)(1993-9#5)(1994-5#2)(1995-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-11#60)(2008-4#2)(2008-6#1)(2008-7#6)(2009-7#1)(2010-10#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-5#1)
cell densityof##2##2##(2008-11#2)
cell destruction##4##2##(1992-6#1)(2008-2#1)(2011-2#1)(2012-1#1)
cell detachment##2##2##(1991-9#1)(1995-12#1)
cell detection##2##2##(1996-12#1)(2009-5#1)
cell development and##4##3##(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
cell development can##2##3##(2008-4#1)(2012-2#1)
cell development in##4##3##(2008-4#2)(2009-7#2)
cell development is##2##3##(2008-4#1)(2009-5#1)
cell development##25##2##(2008-10#1)(2008-11#1)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#3)(2009-5#1)(2009-7#2)(2010-11#1)(2012-2#4)(2013-1#1)
cell diameter##5##2##(2008-11#3)(2008-3#1)(2013-1#1)
cell differentiation and cell##2##4##(2008-4#1)(2008-7#1)
cell differentiation and##12##3##(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-8#1)(2013-1#1)
cell differentiation as##2##3##(2008-11#2)
cell differentiation by##2##3##(2008-11#2)
cell differentiation from##2##3##(2008-4#1)(2012-2#1)
cell differentiation in the##2##4##(2008-11#1)(2008-5#1)
cell differentiation in vitro##2##4##(2008-11#2)
cell differentiation in##8##3##(2007-12#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-3#1)(2013-7#1)
cell differentiation induced by##2##4##(1991-9#1)(2008-11#1)
cell differentiation into##3##3##(2008-11#1)(2012-7#1)(2013-1#1)
cell differentiation through##2##3##(1995-8#1)(2008-11#1)
cell differentiation##77##2##(1990-11#3)(1991-12#2)(1991-9#2)(1992-12#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#2)(1994-9#1)(1995-8#2)(1997-7#1)(2007-12#2)(2007-5#2)(2008-10#1)(2008-11#17)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#3)(2009-5#1)(2011-2#5)(2012-2#3)(2012-7#1)(2012-8#1)(2013-1#2)(2013-7#2)
cell dimensions##3##2##(1997-7#1)(2007-11#1)(2008-8#1)
cell discoloration##2##2##(2008-10#2)
cell disease (SCD)##3##3##(2007-7#1)(2009-4#2)
cell disease and##2##3##(2007-7#1)(2008-8#1)
cell disease is##2##3##(2012-2#1)(2013-8#1)
cell disease##20##2##(1991-6#1)(2007-10#1)(2007-7#2)(2008-11#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#3)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
cell disruption##2##2##(2008-10#2)
cell distribution in##2##3##(2008-11#1)(2008-7#1)
cell distribution##6##2##(2008-11#2)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
cell division and##5##3##(1990-5#1)(1997-4#1)(2006-10#1)(2008-5#1)(2011-2#1)
cell division as well as##2##5##(2008-3#1)(2008-9#1)
cell division at##2##3##(2008-3#1)(2009-10#1)
cell division cycle##3##3##(1994-5#1)(1995-2#1)(1997-6#1)
cell division during the##2##4##(1995-11#1)(2008-10#1)
cell division in the##3##4##(1990-11#2)(1994-12#1)
cell division in##7##3##(1990-11#2)(1993-8#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-11#1)
cell division is##3##3##(1990-2#1)(2008-2#1)(2008-7#1)
cell division occurred##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
cell division was##2##3##(2008-10#1)(2008-11#1)
cell division##73##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-9#1)(1993-12#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-5#2)(1995-11#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#4)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
cell divisions##4##2##(2008-11#1)(2008-12#1)(2009-3#1)(2012-2#1)
cell dose##2##2##(2010-11#2)
cell dry##2##2##(1996-6#1)(2008-6#1)
cell dynamics##3##2##(2008-1#1)(2009-11#1)(2011-1#1)
cell dysfunction##2##2##(2009-2#1)(2011-2#1)
cell elongation and##2##3##(2011-1#1)(2012-12#1)
cell elongation##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
cell energy##5##2##(1992-12#1)(2008-10#1)(2008-2#1)(2009-4#1)(2013-1#1)
cell engineering strategies##3##3##(2008-11#3)
cell engineering##5##2##(2008-11#5)
cell enumeration##2##2##(2008-9#2)
cell envelope##5##2##(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
cell epitope##5##2##(1997-6#2)(1997-8#1)(2007-6#1)(2008-11#1)
cell epitopes##7##2##(1995-5#4)(2008-4#2)(2008-5#1)
cell equipped with##4##3##(2008-10#4)
cell expansion and##3##3##(2008-10#1)(2009-8#2)
cell expansion in##2##3##(2008-11#1)(2009-8#1)
cell expansion##6##2##(2008-10#1)(2008-11#1)(2009-8#4)
cell expressed##3##2##(1991-11#1)(2008-1#1)(2008-4#1)
cell expression##3##2##(2008-11#2)(2008-2#1)
cell extract##6##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1994-5#1)(1997-2#1)
cell extracts and##2##3##(1994-6#1)(2012-2#1)
cell extracts by##3##3##(1992-6#1)(1992-8#1)(2008-10#1)
cell extracts containing##2##3##(1994-5#1)(2008-10#1)
cell extracts from##2##3##(1994-8#1)(2008-9#1)
cell extracts were##2##3##(1990-5#1)(2008-6#1)
cell extracts with##2##3##(1990-2#1)(2008-10#1)
cell extracts##26##2##(1990-2#1)(1990-5#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#2)(2012-2#1)
cell extravasation##2##2##(2008-7#1)(2009-10#1)
cell factor (SCF)##2##3##(1992-3#1)(2011-2#1)
cell factor##6##2##(1992-3#2)(1996-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
cell factory##2##2##(2008-11#1)(2012-3#1)
cell fate decisions##4##3##(2008-11#2)(2009-12#1)(2009-8#1)
cell fate##17##2##(1993-6#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-4#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-12#1)
cell fates during C##2##4##(1990-11#2)
cell fates is##2##3##(2009-8#1)(2012-12#1)
cell fates##13##2##(1990-11#2)(2007-12#4)(2009-12#2)(2009-8#1)(2012-1#1)(2012-12#3)
cell filled with##2##3##(2007-12#1)(2008-10#1)
cell filling##2##2##(2008-4#1)(2012-2#1)
cell firing##7##2##(1994-2#2)(2007-8#3)(2008-11#2)
cell for slab optical waveguide##2##5##(2008-10#2)
cell for the determination of##2##5##(2008-10#2)
cell for the##4##3##(2008-10#3)(2008-11#1)
cell for use with##2##4##(2008-10#2)
cell for##34##2##(1995-2#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#6)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
cell formation##7##2##(1993-8#1)(1995-3#1)(1996-3#1)(2008-5#1)(2013-1#3)
cell fraction and##2##3##(2008-7#1)(2009-3#1)
cell fraction was##2##3##(1990-5#1)(2008-6#1)
cell fraction##10##2##(1990-5#2)(1992-11#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)
cell fractionation techniques##2##3##(1995-6#1)(2008-4#1)
cell fractionation##3##2##(1995-6#1)(2008-11#1)(2008-4#1)
cell free system##4##3##(1990-12#1)(1991-2#3)
cell free##5##2##(1990-12#1)(1991-2#3)(2008-11#1)
cell frequency##2##2##(2008-7#1)(2013-1#1)
cell from the##2##3##(1992-8#1)(1997-3#1)
cell from##5##2##(1990-12#1)(1992-8#1)(1997-3#1)(2007-12#1)(2013-7#1)
cell function and##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
cell function in the##3##4##(1995-3#1)(2008-11#1)(2009-10#1)
cell function in##4##3##(1995-3#1)(2008-11#1)(2009-10#1)(2011-2#1)
cell function is##2##3##(2006-10#1)(2011-1#1)
cell function##39##2##(1990-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1995-2#1)(1995-3#2)(1995-5#2)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-11#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
cell functions and##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
cell functions in##2##3##(1996-2#1)(2010-9#1)
cell functions including##2##3##(2008-5#1)(2009-8#1)
cell functions##14##2##(1993-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-9#2)(2011-2#2)(2012-3#1)
cell fusion and##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
cell fusion##14##2##(1991-5#2)(1992-5#1)(1993-3#1)(1995-11#1)(2007-10#1)(2007-6#1)(2008-11#4)(2008-8#1)(2008-9#1)(2009-8#1)
cell gastric##2##2##(1993-12#1)(2013-1#1)
cell gel electrophoresis##4##3##(1996-2#1)(1997-4#3)
cell gel##5##2##(1996-2#1)(1997-4#3)(2013-1#1)
cell gene##7##2##(1995-8#1)(2008-11#1)(2008-2#4)(2008-5#1)
cell generations##2##2##(1995-2#2)
cell genome##2##2##(2008-11#1)(2008-4#1)
cell genomic##2##2##(2008-11#1)(2012-2#1)
cell geometries##2##2##(2008-10#1)(2008-7#1)
cell geometry##2##2##(2008-11#1)(2008-3#1)
cell glutathione##3##2##(1991-9#2)(1995-8#1)
cell granuloma##3##2##(1991-9#2)(2011-2#1)
cell group of##2##3##(1990-5#1)(1996-5#1)
cell group##7##2##(1990-5#3)(1996-5#1)(2008-8#1)(2012-1#2)
cell groups##5##2##(1995-12#1)(2007-12#1)(2008-8#1)(2012-1#1)(2012-12#1)
cell growth and antibody production##2##5##(2008-11#2)
cell growth and death##2##4##(2008-11#1)(2011-2#1)
cell growth and differentiation##6##4##(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-8#1)
cell growth and division##3##4##(2008-7#2)(2009-8#1)
cell growth and induced##2##4##(1990-2#1)(2013-1#1)
cell growth and neurite extension##2##5##(2008-11#2)
cell growth and product yield##2##5##(2008-11#1)(2008-7#1)
cell growth and proliferation##4##4##(1992-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
cell growth and recombinant protein production##3##6##(2008-11#3)
cell growth and viability##2##4##(1995-9#1)(2007-2#1)
cell growth and##63##3##(1990-2#1)(1990-4#1)(1992-8#1)(1993-12#2)(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#20)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
cell growth as well as##2##5##(2008-11#1)(2011-2#1)
cell growth as##3##3##(2008-11#2)(2011-2#1)
cell growth at##4##3##(1990-11#2)(2008-11#2)
cell growth by##5##3##(1992-8#1)(1992-9#1)(1994-2#1)(1995-2#1)(2008-11#1)
cell growth control##3##3##(1992-8#1)(2011-2#2)
cell growth factor##7##3##(1990-11#1)(1991-2#1)(1991-3#2)(1992-9#2)(2009-7#1)
cell growth in S##2##4##(1996-2#1)(1997-3#1)
cell growth in a biodegradable polymer##2##6##(2008-7#2)
cell growth in a##10##4##(1990-11#1)(2008-11#6)(2008-7#3)
cell growth in the##4##4##(2008-11#4)
cell growth in##32##3##(1990-11#1)(1990-8#1)(1992-9#1)(1994-12#1)(1996-2#2)(1997-3#1)(2008-11#18)(2008-7#3)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
cell growth inhibition by##3##4##(1990-8#2)(2008-11#1)
cell growth inhibition##7##3##(1990-8#2)(1993-12#1)(2008-11#3)(2008-3#1)
cell growth inhibitory factor##5##4##(1992-9#5)
cell growth is##3##3##(2008-11#2)(2009-9#1)
cell growth kinetics##2##3##(2007-5#1)(2008-11#1)
cell growth of##6##3##(1992-3#1)(1992-9#1)(2008-11#3)(2008-5#1)
cell growth or##3##3##(1995-6#1)(1997-7#1)(2008-4#1)
cell growth promotion##2##3##(2008-11#2)
cell growth rate##4##3##(2008-11#3)(2008-7#1)
cell growth to##3##3##(1994-11#1)(2007-11#1)(2011-2#1)
cell growth using##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
cell growth was observed##2##4##(2008-11#2)
cell growth was##11##3##(1993-9#1)(1994-5#1)(1995-2#1)(2008-11#7)(2008-9#1)
cell growth with high##2##4##(2008-11#1)(2008-8#1)
cell growth with##5##3##(2008-11#3)(2008-8#1)(2013-1#1)
cell growth##286##2##(1990-11#4)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#5)(1992-9#10)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#4)(1997-1#2)(1997-3#2)(1997-7#3)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#109)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#22)(2008-8#2)(2008-9#8)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#5)(2012-8#1)(2013-1#8)(2013-7#1)
cell has a##3##3##(1991-9#1)(2007-12#1)(2012-3#1)
cell has been developed##2##4##(2008-10#2)
cell has been##6##3##(2008-10#5)(2008-3#1)
cell has##12##2##(1991-9#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-7#1)(2012-3#1)
cell height##5##2##(2008-11#1)(2009-7#4)
cell hepatitis##3##2##(2008-5#3)
cell histiocytosis##9##2##(2006-10#1)(2007-10#2)(2007-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
cell holder##3##2##(2008-10#1)(2008-2#2)
cell homeostasis##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
cell homogenate##2##2##(1990-11#1)(2008-6#1)
cell homogenates##6##2##(1992-11#2)(1993-8#1)(1995-11#1)(1997-2#1)(2008-11#1)
cell hybrid##3##2##(1994-11#1)(1994-9#1)(1997-2#1)
cell hybridoma##4##2##(1990-12#2)(2008-11#1)(2008-4#1)
cell hybrids##7##2##(1991-6#2)(1991-9#1)(1992-3#1)(1995-2#1)(1997-2#1)(1997-9#1)
cell hyperplasia##6##2##(1996-5#1)(1996-7#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
cell hypertrophy##4##2##(1997-6#1)(2008-9#3)
cell identification##3##2##(2008-9#3)
cell identity##2##2##(1990-11#1)(2012-5#1)
cell images##2##2##(2008-10#1)(2008-2#1)
cell imaging##7##2##(2008-1#1)(2008-10#2)(2009-10#1)(2009-3#1)(2012-2#1)(2013-8#1)
cell immortalization##2##2##(2008-11#1)(2008-6#1)
cell in a##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
cell in the##15##3##(1990-11#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-12#1)(2012-2#2)
cell in##28##2##(1990-11#1)(1996-12#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
cell induced by##2##3##(2008-11#1)(2008-9#1)
cell infiltrates##4##2##(2008-10#1)(2013-1#3)
cell infiltration and##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
cell infiltration into the##2##4##(1997-3#1)(2013-1#1)
cell infiltration##10##2##(1991-8#1)(1997-3#2)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#2)
cell injection##2##2##(2009-9#1)(2012-3#1)
cell injury and##2##3##(1991-9#1)(1995-2#1)
cell injury##7##2##(1991-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(2008-11#1)(2009-9#1)
cell integrity##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
cell interaction##3##2##(1992-3#1)(1997-8#1)(2008-7#1)
cell interactions in##2##3##(2008-7#1)(2012-4#1)
cell interactions##8##2##(2008-10#1)(2008-11#1)(2008-7#4)(2011-1#1)(2012-4#1)
cell into##5##2##(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
cell invasion beneath mesothelial-cell##2##4##(2008-11#2)
cell invasion##14##2##(1992-9#1)(1994-9#1)(2008-11#9)(2012-1#1)(2012-2#1)(2013-8#1)
cell inventory management##2##3##(2008-7#2)
cell inventory##3##2##(2008-7#3)
cell involvement in##2##3##(1992-2#1)(2008-7#1)
cell is a##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
cell is designed##3##3##(2008-10#2)(2008-3#1)
cell is determined##3##3##(2008-2#1)(2008-4#1)(2009-5#1)
cell is##47##2##(1990-11#1)(1991-9#1)(1993-8#1)(1995-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
cell isolation##6##2##(1996-12#1)(2008-11#4)(2008-9#1)
cell kill##2##2##(2008-11#1)(2008-7#1)
cell killing and##2##3##(2008-7#1)(2008-9#1)
cell killing by##4##3##(1991-9#1)(1992-11#1)(1997-4#1)(2008-8#1)
cell killing of HL-60 cells by##2##6##(1993-8#2)
cell killing of HL-60 cells##3##5##(1993-8#3)
cell killing##23##2##(1991-5#1)(1991-9#3)(1992-11#1)(1992-6#1)(1993-8#4)(1995-8#3)(1997-4#2)(2007-4#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
cell kinetics##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
cell layer##13##2##(1991-9#1)(1993-9#1)(1995-12#2)(2007-11#1)(2008-4#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#3)
cell layers of##3##3##(2008-10#3)
cell layers##12##2##(1990-7#1)(1994-11#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-7#1)(2009-10#1)
cell leukemia##10##2##(1992-6#1)(1997-5#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)
cell level in##2##3##(2007-12#1)(2008-6#1)
cell level##9##2##(1990-12#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
cell levels##2##2##(1996-7#1)(2008-5#1)
cell line &gt##3##3##(1997-2#3)
cell line (AGS)##2##3##(1992-8#1)(1997-1#1)
cell line (HEK293)##2##3##(2008-11#1)(2008-4#1)
cell line (the##2##3##(1990-5#1)(1992-9#1)
cell line 293##3##3##(1990-8#2)(1992-12#1)
cell line HL-60##3##3##(1991-12#1)(1994-12#1)(1994-6#1)
cell line HUH7-ins##2##3##(2010-11#2)
cell line Jurkat##2##3##(1991-6#1)(2008-8#1)
cell line KG-1 and##2##4##(1996-10#2)
cell line KG-1##7##3##(1995-8#2)(1996-10#2)(1996-2#3)
cell line MCF-7##2##3##(2008-11#1)(2013-1#1)
cell line PC12##6##3##(1990-5#1)(2008-11#5)
cell line THP-1##2##3##(1993-6#1)(1995-6#1)
cell line allows for##2##4##(2008-11#2)
cell line and##18##3##(1997-6#2)(2008-10#1)(2008-11#9)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
cell line by##8##3##(1990-11#1)(1994-6#2)(2008-11#3)(2008-4#1)(2008-9#1)
cell line capable##2##3##(2008-11#2)
cell line cross-contamination##3##3##(2008-11#3)
cell line culture##2##3##(2008-11#1)(2008-8#1)
cell line cytotoxicity##2##3##(1995-3#1)(2008-11#1)
cell line derived from##5##4##(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)
cell line designated##2##3##(2008-4#1)(2008-9#1)
cell line development##3##3##(2008-11#3)
cell line expressing##4##3##(2008-11#2)(2012-12#1)(2013-7#1)
cell line for##5##3##(1990-11#1)(2008-11#2)(2008-9#1)(2012-2#1)
cell line from##4##3##(1995-11#2)(2008-11#1)(2013-1#1)
cell line had different##2##4##(2008-8#2)
cell line has been##2##4##(2008-11#1)(2009-4#1)
cell line has##3##3##(2008-11#2)(2009-4#1)
cell line in vitro##2##4##(1993-12#1)(2008-9#1)
cell line in##12##3##(1992-3#1)(1993-12#1)(2008-11#7)(2008-6#1)(2008-7#1)(2008-9#1)
cell line indicated that##2##4##(1992-6#1)(2013-1#1)
cell line is a##2##4##(1990-5#1)(1994-12#1)
cell line is##11##3##(1990-5#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-11#3)(2008-6#1)
cell line named##2##3##(2008-11#2)
cell line of##8##3##(1994-9#1)(2008-10#1)(2008-11#6)
cell line producing##5##3##(1994-5#1)(1997-2#1)(2008-11#3)
cell line showed##2##3##(2008-10#1)(2011-2#1)
cell line stably##2##3##(2008-8#2)
cell line that was##2##4##(2008-11#1)(2011-2#1)
cell line that##7##3##(1990-7#1)(1993-3#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
cell line the expression of##2##5##(1990-6#1)(1994-8#1)
cell line to##9##3##(1990-6#1)(1992-3#2)(1994-8#1)(2007-6#1)(2008-11#3)(2009-12#1)
cell line transfected with##4##4##(2008-11#2)(2008-4#1)(2008-7#1)
cell line under##2##3##(1993-8#1)(2008-11#1)
cell line used##2##3##(2008-11#2)
cell line using##2##3##(2008-11#2)
cell line was established##2##4##(2008-11#2)
cell line was examined##2##4##(1994-5#2)
cell line was##17##3##(1992-9#1)(1994-5#3)(2007-10#2)(2008-11#11)
cell line were##5##3##(1996-10#1)(2008-11#3)(2012-2#1)
cell line which##5##3##(1990-12#1)(1990-8#1)(2008-11#3)
cell line with a##2##4##(1996-12#1)(2008-11#1)
cell line with##7##3##(1994-11#1)(1994-12#1)(1996-12#1)(1997-1#1)(2008-11#3)
cell line##622##2##(1990-11#7)(1990-12#14)(1990-2#2)(1990-5#11)(1990-6#2)(1990-7#1)(1990-8#4)(1991-11#1)(1991-12#8)(1991-2#3)(1991-4#1)(1991-6#7)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#1)(1992-8#6)(1992-9#9)(1993-12#4)(1993-2#2)(1993-3#13)(1993-6#5)(1993-8#5)(1993-9#8)(1994-11#11)(1994-12#8)(1994-2#3)(1994-3#4)(1994-5#6)(1994-6#8)(1994-8#6)(1994-9#2)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#6)(1995-8#2)(1996-10#4)(1996-12#2)(1996-2#5)(1996-5#2)(1997-1#8)(1997-2#8)(1997-4#2)(1997-6#7)(1997-7#3)(1997-8#1)(1997-9#1)(2007-10#2)(2007-11#1)(2007-6#3)(2008-10#11)(2008-11#228)(2008-12#3)(2008-2#4)(2008-4#13)(2008-5#1)(2008-6#5)(2008-7#11)(2008-8#25)(2008-9#23)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
cell line)##8##2##(1994-11#3)(1997-4#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-2#1)
cell lineage and cell##2##4##(1990-11#1)(2007-12#1)
cell lineage and##3##3##(1990-11#1)(2007-12#2)
cell lineage of##3##3##(1995-2#1)(2007-12#1)(2012-3#1)
cell lineage##16##2##(1990-11#2)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-3#1)(2012-8#1)
cell lineages in##2##3##(1995-12#1)(1995-2#1)
cell lineages of##2##3##(1995-2#1)(2012-7#1)
cell lineages##20##2##(1990-5#1)(1993-3#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#2)(1997-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#2)(2010-11#2)(2012-12#1)(2012-7#1)(2013-8#1)
cell lines also##3##3##(1990-2#1)(1992-3#1)(1993-6#1)
cell lines and a##2##4##(2008-11#1)(2012-1#1)
cell lines and have##2##4##(2008-11#2)
cell lines and primary##2##4##(1994-5#1)(1997-7#1)
cell lines and that##3##4##(2008-11#2)(2008-8#1)
cell lines and this##2##4##(1990-11#1)(2008-11#1)
cell lines and##42##3##(1990-11#1)(1990-12#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#13)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
cell lines are##10##3##(1992-4#1)(1992-6#1)(1994-12#1)(1995-12#1)(2008-11#3)(2008-4#2)(2012-2#1)
cell lines as well as##4##5##(1996-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
cell lines as##6##3##(1996-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
cell lines but##2##3##(1992-8#1)(2008-10#1)
cell lines by FISH##2##4##(2008-11#2)
cell lines by limiting dilution##2##5##(2008-11#1)(2008-9#1)
cell lines by##13##3##(1992-9#1)(1997-7#1)(2007-10#1)(2008-11#6)(2008-12#2)(2008-9#1)(2010-2#1)
cell lines can##3##3##(1990-5#1)(1997-7#1)(2008-11#1)
cell lines compared##2##3##(2008-11#1)(2008-9#1)
cell lines containing##3##3##(2008-11#2)(2008-2#1)
cell lines derived from##13##4##(1991-2#1)(1992-2#1)(1993-8#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)
cell lines derived##14##3##(1991-2#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)
cell lines differed##2##3##(2008-11#2)
cell lines during##4##3##(1992-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
cell lines established from##2##4##(1992-8#1)(2008-2#1)
cell lines established##3##3##(1992-8#1)(2008-2#1)(2008-9#1)
cell lines examined##5##3##(1993-3#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-6#1)
cell lines exhibit##2##3##(2008-11#1)(2008-4#1)
cell lines express##2##3##(1992-9#1)(2008-7#1)
cell lines expressing##3##3##(1993-3#1)(2008-2#1)(2012-2#1)
cell lines following##3##3##(1994-10#1)(1996-12#1)(1997-7#1)
cell lines for##6##3##(2008-11#3)(2008-2#1)(2012-2#2)
cell lines from##12##3##(1990-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-7#2)(2008-11#2)(2008-9#1)(2010-3#1)(2012-12#1)
cell lines has##5##3##(1996-2#1)(2008-11#2)(2008-4#1)(2013-1#1)
cell lines have been widely used##2##6##(2008-11#2)
cell lines have been##4##4##(2008-11#4)
cell lines have##8##3##(2008-11#8)
cell lines in the##3##4##(2008-11#1)(2008-2#1)(2008-6#1)
cell lines in vitro and##3##5##(1991-6#1)(1995-6#1)(2008-4#1)
cell lines in vitro##6##4##(1991-6#1)(1993-9#1)(1995-12#1)(1995-6#1)(2008-4#1)(2011-3#1)
cell lines in##21##3##(1991-6#1)(1993-9#4)(1994-5#1)(1995-12#1)(1995-6#1)(1997-1#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-6#1)(2011-3#1)(2012-12#1)(2013-8#1)
cell lines infected with##3##4##(1991-12#2)(1997-8#1)
cell lines is##5##3##(1994-8#1)(2008-11#2)(2012-12#2)
cell lines may##2##3##(1992-5#1)(1993-12#1)
cell lines of different##2##4##(1991-9#1)(2013-1#1)
cell lines of##9##3##(1991-9#1)(1993-12#1)(1995-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
cell lines on##2##3##(2008-11#1)(2008-7#1)
cell lines or##5##3##(1993-8#1)(1997-3#1)(2008-11#3)
cell lines producing##2##3##(1997-3#1)(2008-11#1)
cell lines secreting##2##3##(2008-10#1)(2008-11#1)
cell lines sensitive##2##3##(1992-2#1)(1993-9#1)
cell lines show##2##3##(1994-12#1)(2008-11#1)
cell lines showed##4##3##(1992-8#1)(1995-2#1)(2008-11#1)(2008-7#1)
cell lines such as##3##4##(1994-6#1)(2008-11#2)
cell lines tested were##2##4##(1992-9#1)(2008-10#1)
cell lines tested##6##3##(1992-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
cell lines that are##3##4##(1992-7#1)(2008-11#2)
cell lines that##16##3##(1991-12#1)(1992-7#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
cell lines to##8##3##(1990-5#1)(1992-6#2)(1993-8#1)(2008-11#3)(2008-9#1)
cell lines transfected with##2##4##(2008-11#1)(2008-9#1)
cell lines using##5##3##(2008-1#1)(2008-11#2)(2008-6#1)(2012-2#1)
cell lines via##2##3##(2008-11#1)(2012-12#1)
cell lines was##8##3##(1990-12#1)(1992-2#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
cell lines were analyzed##2##4##(1992-2#1)(2008-9#1)
cell lines were established##2##4##(1992-8#1)(2008-11#1)
cell lines were##24##3##(1991-2#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1997-8#1)(2008-11#6)(2008-9#1)(2010-3#1)(2013-1#1)
cell lines which##5##3##(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(2008-11#1)
cell lines with particular reference to##2##6##(1992-2#1)(2008-11#1)
cell lines with the##2##4##(1992-9#1)(2010-3#1)
cell lines with##16##3##(1992-2#1)(1992-9#1)(1994-2#1)(1995-6#1)(1997-4#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
cell lines##678##2##(1990-11#3)(1990-12#4)(1990-2#5)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#3)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#5)(1991-9#2)(1992-12#4)(1992-2#18)(1992-3#10)(1992-4#4)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#13)(1992-9#15)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#9)(1993-6#8)(1993-8#6)(1993-9#18)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#7)(1994-3#1)(1994-5#4)(1994-6#11)(1994-8#6)(1995-12#15)(1995-2#8)(1995-3#1)(1995-6#5)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-7#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-7#11)(1997-8#3)(2007-10#2)(2008-1#1)(2008-10#13)(2008-11#201)(2008-12#3)(2008-2#15)(2008-4#20)(2008-5#1)(2008-6#8)(2008-7#14)(2008-8#16)(2008-9#29)(2009-12#1)(2009-4#3)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#6)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#13)(2011-3#2)(2012-1#1)(2012-12#14)(2012-2#15)(2012-3#2)(2013-1#14)(2013-8#3)
cell lipoma##3##2##(1990-12#3)
cell longevity and##2##3##(2008-11#2)
cell loss and##4##3##(2008-5#1)(2008-7#1)(2011-2#2)
cell loss by##2##3##(1994-11#1)(2010-11#1)
cell loss from the##3##4##(1992-10#1)(2009-10#1)(2012-2#1)
cell loss from##5##3##(1992-10#1)(2009-10#1)(2010-11#2)(2012-2#1)
cell loss in##2##3##(2008-7#2)
cell loss##19##2##(1992-10#1)(1994-11#1)(1994-12#1)(1996-5#1)(1997-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-11#3)(2011-2#3)(2012-2#2)
cell lung cancer (NSCLC)##11##4##(1990-2#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#2)(2012-1#1)(2012-2#1)(2013-8#1)
cell lung cancer##47##3##(1990-2#3)(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-8#3)(1996-2#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2009-1#2)(2010-8#4)(2011-2#1)(2012-1#3)(2012-2#4)(2013-1#2)(2013-8#2)
cell lung cancers##4##3##(1995-9#1)(2008-4#2)(2012-2#1)
cell lung carcinoma##7##3##(1990-12#1)(1994-3#1)(1994-8#2)(1996-12#2)(1997-5#1)
cell lung##65##2##(1990-12#1)(1990-2#3)(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#4)(2009-1#2)(2010-8#5)(2011-2#2)(2012-1#3)(2012-2#7)(2013-1#3)(2013-8#2)
cell lymphoma in##2##3##(2009-1#1)(2009-7#1)
cell lymphoma is##3##3##(2009-8#3)
cell lymphoma of##3##3##(2009-8#2)(2013-1#1)
cell lymphoma##27##2##(1997-3#2)(2007-7#2)(2008-3#1)(2008-7#2)(2009-1#2)(2009-7#5)(2009-8#8)(2011-2#3)(2012-3#1)(2013-1#1)
cell lymphomas##7##2##(1993-9#1)(2008-7#1)(2008-9#2)(2009-8#1)(2013-1#2)
cell lymphoproliferative disorders##2##3##(2008-9#1)(2009-8#1)
cell lymphoproliferative##3##2##(2008-7#1)(2008-9#1)(2009-8#1)
cell lysate was##3##3##(1992-8#1)(1994-11#1)(2010-11#1)
cell lysate##12##2##(1992-8#1)(1994-11#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2013-1#2)
cell lysates and##2##3##(1992-11#1)(2008-4#1)
cell lysates were##2##3##(2008-7#1)(2011-2#1)
cell lysates##12##2##(1991-9#1)(1992-10#1)(1992-11#1)(2008-4#3)(2008-7#4)(2008-9#1)(2011-2#1)
cell lysis by##2##3##(2008-10#1)(2008-4#1)
cell lysis##15##2##(1995-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-4#2)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#2)
cell made of glass##2##4##(2008-10#2)
cell made##3##2##(2008-10#3)
cell maintenance and##3##3##(2008-11#1)(2009-8#1)(2013-8#1)
cell maintenance##5##2##(1994-5#2)(2008-11#1)(2009-8#1)(2013-8#1)
cell marker##7##2##(1996-5#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-11#1)(2012-1#1)(2012-5#1)
cell markers##7##2##(1996-5#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-5#1)
cell mass##18##2##(1990-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-9#2)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
cell materials##2##2##(2012-1#1)(2013-8#1)
cell maturation##4##2##(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
cell mechanical properties##2##3##(2008-7#2)
cell media##2##2##(2008-11#1)(2008-8#1)
cell mediated##4##2##(1992-2#1)(2008-11#1)(2008-12#1)(2008-5#1)
cell membrane and##7##3##(1991-9#2)(2008-1#1)(2008-8#1)(2009-2#1)(2011-3#1)(2012-2#1)
cell membrane of##5##3##(1990-5#1)(2008-8#1)(2009-2#1)(2009-8#1)(2013-7#1)
cell membrane receptor##2##3##(2008-10#1)(2008-2#1)
cell membrane##80##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#3)(1994-8#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-1#2)(2011-3#2)(2012-1#1)(2012-2#5)(2013-7#1)(2013-8#1)
cell membranes and##3##3##(1991-9#1)(2008-11#1)(2008-9#1)
cell membranes at##2##3##(1990-5#1)(1991-12#1)
cell membranes is##3##3##(1992-12#1)(1992-6#1)(1994-2#1)
cell membranes was##2##3##(1993-6#1)(2008-9#1)
cell membranes##47##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#4)(1991-9#1)(1992-12#2)(1992-6#1)(1993-6#3)(1994-2#1)(1994-8#2)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#1)(2009-6#1)(2009-7#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#2)
cell metabolic##2##2##(2008-10#1)(2008-11#1)
cell metabolism and##4##3##(1996-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
cell metabolism by##2##3##(2008-11#1)(2008-7#1)
cell metabolism##21##2##(1996-7#1)(2008-1#1)(2008-11#7)(2008-7#5)(2009-5#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
cell metastasis##2##2##(1991-8#1)(2008-11#1)
cell migration and##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
cell migration are##2##3##(2008-4#1)(2008-7#1)
cell migration have##2##3##(2011-2#2)
cell migration in##2##3##(2011-2#2)
cell migration to##2##3##(2008-4#1)(2009-1#1)
cell migration##34##2##(1990-5#2)(1991-5#1)(1992-6#1)(1995-12#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#5)(2008-9#1)(2009-1#1)(2011-2#10)(2012-12#1)(2013-8#1)
cell mitogen##5##2##(1992-6#1)(1992-9#1)(1995-2#1)(2008-11#2)
cell mitosis##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
cell model##7##2##(1990-5#1)(1997-3#1)(2008-11#2)(2011-1#3)
cell models##5##2##(2008-11#2)(2008-4#2)(2012-2#1)
cell monolayer##7##2##(1993-12#2)(2008-11#2)(2011-3#3)
cell monolayers that##2##3##(2008-11#1)(2010-11#1)
cell monolayers##19##2##(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-4#2)(2010-11#4)(2011-2#1)
cell morphology and the##2##4##(1990-8#1)(2008-11#1)
cell morphology and##7##3##(1990-8#2)(2008-1#2)(2008-11#2)(2008-8#1)
cell morphology##25##2##(1990-8#3)(1994-8#2)(2008-1#2)(2008-10#1)(2008-11#7)(2008-8#2)(2008-9#2)(2009-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-7#1)
cell motility and##5##3##(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
cell motility##14##2##(1990-4#1)(1992-3#1)(1995-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
cell movement##7##2##(1995-11#1)(1996-2#1)(1997-3#2)(2009-10#3)
cell multiplication was observed##2##4##(2008-11#2)
cell multiplication##4##2##(2008-10#1)(2008-11#3)
cell myogenesis##2##2##(1993-3#2)
cell necrosis in##3##3##(2008-10#1)(2012-1#2)
cell necrosis##9##2##(1992-5#1)(2008-10#3)(2008-11#1)(2011-10#1)(2012-1#3)
cell neoplasms##4##2##(2008-6#1)(2008-9#2)(2011-2#1)
cell networks##2##2##(1992-2#1)(2010-5#1)
cell neuroendocrine carcinoma of the##2##5##(2008-8#1)(2012-3#1)
cell neuroendocrine carcinoma of##3##4##(2008-8#1)(2012-3#1)(2013-1#1)
cell neuroendocrine carcinoma##4##3##(2008-8#1)(2012-3#1)(2013-1#2)
cell neuroendocrine##5##2##(2008-8#1)(2012-3#1)(2013-1#3)
cell nodules were##2##3##(2008-11#2)
cell nodules##4##2##(2008-11#4)
cell nuclear antigen (PCNA)##9##4##(1994-12#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2011-2#1)(2012-1#1)
cell nuclear antigen##14##3##(1991-8#1)(1992-10#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
cell nuclear extracts##4##3##(1993-6#3)(1993-8#1)
cell nuclear##22##2##(1991-8#1)(1992-10#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
cell nuclei by##2##3##(2008-8#1)(2011-2#1)
cell nuclei in the##2##4##(2007-12#1)(2009-10#1)
cell nuclei in##3##3##(2007-12#1)(2008-2#1)(2009-10#1)
cell nuclei were##2##3##(1991-5#1)(2010-8#1)
cell nuclei##22##2##(1991-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(2006-12#1)(2007-12#4)(2008-2#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-8#4)(2011-2#1)
cell nucleus##8##2##(1991-2#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)
cell number and##6##3##(1991-6#1)(1995-2#1)(2008-11#2)(2008-7#1)(2012-12#1)
cell number in##3##3##(1994-10#1)(2008-11#1)(2008-4#1)
cell number##46##2##(1991-12#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-10#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-10#3)(2008-10#3)(2008-11#17)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
cell numbers and##2##3##(2008-10#1)(2012-5#1)
cell numbers in##7##3##(1994-2#1)(1995-12#2)(1996-5#1)(2008-11#1)(2008-4#1)(2013-1#1)
cell numbers were##2##3##(1996-12#1)(2008-10#1)
cell numbers##26##2##(1991-12#1)(1991-5#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-7#2)(2011-2#3)(2012-1#1)(2012-5#1)(2013-1#1)
cell of the##12##3##(1990-2#1)(1991-5#1)(1996-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
cell of##20##2##(1990-2#1)(1991-5#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
cell on##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
cell or tissue##2##3##(1996-10#1)(2008-7#1)
cell or##9##2##(1991-10#1)(1995-6#1)(1996-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)
cell origin##2##2##(1994-5#1)(2012-3#1)
cell output##3##2##(2008-11#2)(2010-2#1)
cell pH##2##2##(1995-8#2)
cell papilloma of the##5##4##(2008-10#1)(2008-9#4)
cell papilloma##10##2##(2008-10#1)(2008-9#9)
cell papillomas of the##3##4##(2008-10#1)(2008-9#2)
cell papillomas##5##2##(2008-10#1)(2008-9#4)
cell parameters##7##2##(1996-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)
cell passages##2##2##(2008-11#1)(2008-5#1)
cell patch clamp##2##3##(1993-12#1)(2008-1#1)
cell penetration##2##2##(2008-10#1)(2010-10#1)
cell permeabilization##2##2##(1991-8#1)(2008-9#1)
cell permeable##2##2##(2008-4#1)(2010-2#1)
cell phenotype##10##2##(1993-12#1)(1994-12#1)(2008-11#2)(2008-4#1)(2010-11#2)(2012-2#3)
cell phenotypes##2##2##(1992-2#1)(2013-8#1)
cell phone##3##2##(2011-1#2)(2013-1#1)
cell physiology and##2##3##(2009-4#1)(2010-10#1)
cell physiology##10##2##(1994-11#1)(1994-9#1)(2008-11#3)(2008-3#1)(2009-4#1)(2010-10#1)(2011-2#2)
cell placed##2##2##(2008-10#2)
cell plasma membrane##5##3##(1991-3#1)(1992-3#1)(1996-7#1)(2009-7#1)(2011-3#1)
cell plasma membranes##2##3##(1990-11#1)(1994-2#1)
cell plasma##7##2##(1990-11#1)(1991-3#1)(1992-3#1)(1994-2#1)(1996-7#1)(2009-7#1)(2011-3#1)
cell plasticity##2##2##(2008-11#2)
cell plate expansion during##2##4##(2009-10#2)
cell plate expansion##3##3##(2009-10#3)
cell polarity in##3##3##(1990-5#1)(2008-9#1)(2009-10#1)
cell polarity is##2##3##(2008-9#1)(2009-5#1)
cell polarity##16##2##(1990-5#2)(2007-12#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-2#2)
cell pool##6##2##(2008-11#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
cell pools##4##2##(2008-11#4)
cell population and##5##3##(1992-9#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
cell population are##2##3##(2010-11#1)(2010-7#1)
cell population as a whole##2##5##(2008-11#2)
cell population as##3##3##(1995-9#1)(2008-11#2)
cell population in the##3##4##(1997-1#1)(2008-11#1)(2010-7#1)
cell population in##8##3##(1997-1#1)(2008-11#1)(2008-7#1)(2010-11#2)(2010-7#1)(2011-2#1)(2013-1#1)
cell population is##2##3##(1990-12#1)(2008-11#1)
cell population of the##2##4##(1992-9#1)(2008-7#1)
cell population that##2##3##(2008-7#1)(2012-12#1)
cell population was##2##3##(2008-11#1)(2008-7#1)
cell population were##2##3##(2008-11#1)(2012-4#1)
cell population##72##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#18)(2008-3#1)(2008-4#4)(2008-7#7)(2008-9#3)(2009-3#1)(2010-11#4)(2010-4#1)(2010-7#3)(2011-2#2)(2012-12#5)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#2)
cell populations and##3##3##(2007-12#1)(2008-11#1)(2013-1#1)
cell populations can##2##3##(2008-11#1)(2008-4#1)
cell populations from##2##3##(2008-4#2)
cell populations in the##4##4##(1992-8#1)(2008-5#1)(2012-1#2)
cell populations in##6##3##(1992-8#1)(1995-6#1)(2008-5#1)(2009-12#1)(2012-1#2)
cell populations of##2##3##(2008-9#1)(2011-2#1)
cell populations were##2##3##(1990-6#1)(1995-11#1)
cell populations with##2##3##(2008-11#2)
cell populations##59##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#2)(2007-12#1)(2008-10#1)(2008-11#8)(2008-4#6)(2008-5#1)(2008-7#3)(2008-9#10)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
cell preparation##4##2##(2008-4#1)(2008-9#1)(2010-6#1)(2012-1#1)
cell preparations in##2##3##(1992-3#1)(1994-6#1)
cell preparations##10##2##(1990-7#1)(1992-3#1)(1994-6#1)(2008-4#5)(2008-9#2)
cell probe##2##2##(2008-11#2)
cell processes in##2##3##(1995-5#1)(2008-7#1)
cell processes##8##2##(1994-11#1)(1995-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-7#1)
cell produced##2##2##(2008-11#2)
cell production##7##2##(1992-2#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)
cell progenitor activity in culture##2##5##(2008-4#2)
cell progenitor##4##2##(1995-6#1)(2008-4#2)(2010-10#1)
cell progenitors##6##2##(1995-6#1)(2007-12#1)(2008-4#3)(2008-7#1)
cell proliferation after##3##3##(1997-8#1)(2012-2#1)(2013-1#1)
cell proliferation and cell##4##4##(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)
cell proliferation and differentiation were##2##5##(2008-9#1)(2012-2#1)
cell proliferation and differentiation##7##4##(1991-2#1)(1992-9#1)(1993-3#1)(1995-12#1)(2008-11#1)(2008-9#1)(2012-2#1)
cell proliferation and increased##3##4##(2009-12#1)(2013-1#2)
cell proliferation and migration##2##4##(2008-10#2)
cell proliferation and survival##2##4##(2013-1#1)(2013-8#1)
cell proliferation and the##4##4##(1992-3#1)(2008-11#2)(2008-4#1)
cell proliferation and transformation##2##4##(1994-9#1)(2008-11#1)
cell proliferation and##55##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#1)(2010-6#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
cell proliferation assay##4##3##(1993-8#1)(2008-11#1)(2013-1#2)
cell proliferation at##3##3##(1992-5#1)(2008-11#1)(2013-1#1)
cell proliferation by##8##3##(1992-11#1)(1992-5#1)(1993-9#1)(1995-2#2)(2008-6#1)(2008-9#2)
cell proliferation during##2##3##(1994-3#1)(2008-11#1)
cell proliferation in a dose-dependent manner##2##6##(1992-5#1)(1995-11#1)
cell proliferation in the##2##4##(1990-8#1)(1995-12#1)
cell proliferation in vitro##2##4##(2008-11#1)(2008-8#1)
cell proliferation in##24##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1992-12#1)(1992-5#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-9#1)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
cell proliferation induced by##3##4##(1990-12#1)(1994-9#1)(2008-4#1)
cell proliferation is##3##3##(2008-7#2)(2011-2#1)
cell proliferation of##6##3##(1997-1#1)(2008-11#3)(2008-5#1)(2011-2#1)
cell proliferation or##4##3##(1992-5#2)(1992-8#1)(2008-11#1)
cell proliferation rate##3##3##(1991-8#1)(2008-11#1)(2012-3#1)
cell proliferation was observed##2##4##(1994-5#1)(1997-2#1)
cell proliferation was##9##3##(1994-11#1)(1994-5#1)(1997-2#3)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
cell proliferation were##6##3##(2008-11#4)(2008-5#1)(2008-9#1)
cell proliferation##229##2##(1990-11#3)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#5)(1992-8#6)(1992-9#2)(1993-11#2)(1993-3#2)(1993-8#1)(1993-9#4)(1994-11#7)(1994-2#2)(1994-3#1)(1994-5#3)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#8)(1995-6#1)(1995-9#1)(1996-5#1)(1997-1#2)(1997-2#5)(1997-7#2)(1997-8#1)(2007-12#1)(2007-2#2)(2008-10#6)(2008-11#35)(2008-12#1)(2008-3#1)(2008-4#14)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#11)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#4)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#4)
cell proliferative##4##2##(2008-7#3)(2011-2#1)
cell properties and##2##3##(1995-6#1)(2008-5#1)
cell properties##3##2##(1995-6#1)(2008-11#1)(2008-5#1)
cell protection##2##2##(1995-11#1)(2011-1#1)
cell protein content##5##3##(1990-5#1)(1992-8#1)(1995-9#2)(2008-11#1)
cell protein per min##2##4##(1992-3#1)(2008-11#1)
cell protein##19##2##(1990-2#1)(1990-5#2)(1990-8#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#1)(1994-12#1)(1995-9#2)(1996-5#1)(2008-11#5)(2009-8#1)
cell protein)##2##2##(1990-8#1)(1994-6#1)
cell proteins##3##2##(1993-6#1)(2008-12#1)(2013-1#1)
cell protoplasts##6##2##(2008-10#1)(2008-8#5)
cell ratio##3##2##(1990-12#1)(2007-10#1)(2008-10#1)
cell reaction##3##2##(2008-10#2)(2008-5#1)
cell reactivity##3##2##(2013-1#3)
cell receptor and##2##3##(1991-9#1)(2010-8#1)
cell receptor gene##2##3##(2008-7#1)(2012-2#1)
cell receptor##22##2##(1991-9#1)(1994-3#1)(1994-6#2)(1995-6#1)(1995-8#1)(2007-12#1)(2008-11#5)(2008-4#4)(2008-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2012-2#1)
cell receptors##8##2##(1995-2#1)(2006-10#2)(2008-4#4)(2008-9#1)
cell recognition##4##2##(1990-8#1)(1995-5#1)(2008-7#1)(2012-12#1)
cell recovery and##2##3##(2008-11#2)
cell recovery##7##2##(1994-9#1)(2008-11#4)(2008-4#1)(2008-5#1)
cell recruitment to the##2##4##(2008-10#1)(2013-1#1)
cell regeneration##5##2##(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#1)(2013-7#1)
cell regulation##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
cell regulatory##2##2##(1993-2#1)(2010-10#1)
cell renewal##2##2##(2012-1#1)(2012-2#1)
cell reorientation##2##2##(2008-6#2)
cell repair##2##2##(2008-11#1)(2008-12#1)
cell replacement therapy##2##3##(2008-11#1)(2009-6#1)
cell replacement##5##2##(2008-11#2)(2008-9#1)(2009-6#1)(2012-12#1)
cell replication##2##2##(2008-6#1)(2008-9#1)
cell rescue##3##2##(1992-6#2)(2008-7#1)
cell research is##3##3##(2008-11#1)(2008-9#1)(2009-3#1)
cell research will##2##3##(2008-10#1)(2008-11#1)
cell research##15##2##(2008-10#2)(2008-11#5)(2008-9#3)(2009-3#2)(2010-11#1)(2012-12#1)(2013-8#1)
cell response to##3##3##(2008-10#1)(2008-11#1)(2010-11#1)
cell response was##2##3##(1991-9#1)(2008-11#1)
cell response##14##2##(1991-9#1)(1995-2#1)(1995-5#1)(2007-5#1)(2008-10#2)(2008-11#6)(2010-11#1)(2012-2#1)
cell responses in the##2##4##(1996-12#1)(2008-10#1)
cell responses in##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
cell responses to##6##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
cell responses##22##2##(1990-5#1)(1993-6#1)(1995-5#3)(1996-12#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-4#3)(2008-7#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
cell responsiveness to##2##3##(1990-11#1)(1990-5#1)
cell retention and##2##3##(2008-11#2)
cell retention devices##2##3##(2008-11#2)
cell retention##9##2##(2008-11#8)(2008-6#1)
cell sample##2##2##(2008-4#1)(2009-12#1)
cell samples were##2##3##(1994-3#1)(1995-3#1)
cell samples##7##2##(1990-12#1)(1991-4#1)(1994-3#2)(1995-3#1)(2008-4#1)(2009-12#1)
cell sarcoma in##2##3##(2008-6#1)(2013-1#1)
cell sarcoma##6##2##(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
cell secretion##4##2##(1992-8#1)(1994-11#1)(2008-11#1)(2008-4#1)
cell seeding##6##2##(1990-6#1)(2008-11#2)(2008-7#1)(2009-12#1)(2012-1#1)
cell senescence##3##2##(1994-11#1)(2008-11#1)(2009-12#1)
cell sensitivity##2##2##(1994-11#1)(2008-5#1)
cell separation##13##2##(2008-10#3)(2008-11#5)(2008-4#2)(2008-9#2)(2013-1#1)
cell shape and##7##3##(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)
cell shape##18##2##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-2#2)
cell shrinkage##5##2##(2008-1#1)(2008-8#4)
cell signaling and##2##3##(2008-10#1)(2008-9#1)
cell signaling pathways##4##3##(2007-12#1)(2008-1#1)(2009-12#1)(2011-2#1)
cell signaling##15##2##(1991-9#1)(1994-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#3)
cell signalling##7##2##(1993-8#1)(1994-11#1)(1994-6#1)(2010-10#3)(2012-12#1)
cell size and##3##3##(2008-11#1)(2008-4#1)(2008-7#1)
cell size during##2##3##(1995-9#1)(2008-7#1)
cell size increase##2##3##(1995-9#2)
cell size of P##2##4##(2008-10#2)
cell size when##2##3##(2008-11#1)(2008-8#1)
cell size##33##2##(1995-12#1)(1995-9#4)(1996-4#2)(2008-10#4)(2008-11#8)(2008-4#2)(2008-7#10)(2008-8#1)(2013-1#1)
cell sizes in##2##3##(2008-11#1)(2011-2#1)
cell sizes##5##2##(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
cell somata##2##2##(2007-12#1)(2008-7#1)
cell sorter##5##2##(1994-2#1)(2008-9#3)(2010-8#1)
cell sorting (FACS)##3##3##(2008-4#1)(2009-11#1)(2011-2#1)
cell sorting##17##2##(1992-6#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#5)(2009-11#1)(2009-12#1)(2011-2#2)(2012-12#1)
cell source##2##2##(2008-11#2)
cell sources##4##2##(2008-5#1)(2008-9#1)(2012-12#2)
cell specific perfusion rates##3##4##(2008-11#3)
cell specific perfusion##4##3##(2008-11#4)
cell specific##16##2##(1992-9#1)(1993-11#1)(1993-9#2)(1995-11#1)(1995-3#1)(1996-5#1)(2008-11#8)(2008-4#1)
cell specificity and##3##3##(1993-5#1)(1994-2#1)(2012-12#1)
cell specificity##5##2##(1993-5#1)(1994-2#1)(2012-12#1)(2012-2#2)
cell spreading##2##2##(2011-1#1)(2012-5#1)
cell staining##2##2##(2008-10#1)(2008-9#1)
cell state##3##2##(1994-11#1)(2009-3#2)
cell states##2##2##(1994-12#1)(2008-11#1)
cell stimulation by##2##3##(2008-3#1)(2008-5#1)
cell stimulation##5##2##(1992-6#1)(1994-9#1)(2008-3#1)(2008-5#1)(2008-7#1)
cell strain##4##2##(1991-2#4)
cell strains##2##2##(1991-2#2)
cell stress##6##2##(2008-10#4)(2008-7#1)(2011-2#1)
cell structure##9##2##(1996-9#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#2)
cell structures##2##2##(2007-12#1)(2008-6#1)
cell studies##2##2##(2008-11#1)(2012-2#1)
cell sublines##2##2##(2008-11#2)
cell subpopulation that##2##3##(2010-11#1)(2011-2#1)
cell subpopulation##4##2##(1990-12#1)(2008-11#1)(2010-11#1)(2011-2#1)
cell subpopulations from##2##3##(2008-11#1)(2008-4#1)
cell subpopulations##9##2##(1991-1#1)(1994-6#1)(2008-11#2)(2008-4#5)
cell subset##2##2##(2008-7#1)(2008-9#1)
cell subsets in the##2##4##(1993-8#1)(2012-2#1)
cell subsets in##3##3##(1993-8#1)(2008-9#1)(2012-2#1)
cell subsets using magnetic##2##4##(2008-4#2)
cell subsets##15##2##(1993-8#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-4#6)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#1)
cell substrates##2##2##(2007-12#1)(2008-11#1)
cell suicide##2##2##(2008-11#1)(2008-9#1)
cell supernatant##2##2##(2008-4#1)(2008-8#1)
cell surface FcepsilonRI expression was observed in about##2##8##(2008-11#2)
cell surface FcepsilonRI expression##3##4##(2008-11#3)
cell surface IL-1 receptors##2##4##(1995-2#2)
cell surface IL-1##3##3##(1995-2#3)
cell surface and intracellular##2##4##(2008-4#1)(2008-9#1)
cell surface and##11##3##(1990-12#1)(1992-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
cell surface antigen##5##3##(2008-10#1)(2008-11#2)(2008-9#2)
cell surface antigens##4##3##(1995-6#1)(2008-9#3)
cell surface binding##2##3##(1990-12#1)(1997-1#1)
cell surface characteristics##2##3##(2008-12#1)(2008-5#1)
cell surface expression of FcepsilonRI on##2##6##(2008-11#2)
cell surface expression of FcepsilonRI##3##5##(2008-11#3)
cell surface expression of##9##4##(1992-8#1)(1995-2#3)(1997-9#1)(2008-11#4)
cell surface expression##12##3##(1992-8#1)(1995-2#4)(1997-9#1)(2008-10#1)(2008-11#4)(2008-4#1)
cell surface glycoprotein##2##3##(1992-6#1)(1993-11#1)
cell surface glycoproteins##2##3##(1994-5#1)(1997-4#1)
cell surface in##2##3##(1995-2#1)(2012-12#1)
cell surface marker##2##3##(2008-11#2)
cell surface markers associated with##2##5##(1992-2#1)(2011-2#1)
cell surface markers##4##3##(1992-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
cell surface membrane##2##3##(2008-4#2)
cell surface molecules and##2##4##(2008-11#1)(2011-1#1)
cell surface molecules##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
cell surface of##11##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-9#1)(1994-2#1)(2008-10#2)(2008-11#3)(2008-5#1)
cell surface protein##4##3##(2008-11#1)(2008-9#1)(2009-6#1)(2010-12#1)
cell surface proteins##3##3##(1992-3#1)(2008-1#1)(2010-12#1)
cell surface receptor##8##3##(1992-12#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2008-7#1)(2010-8#1)
cell surface receptors to##3##4##(1996-2#1)(1997-4#1)(1997-7#1)
cell surface receptors##15##3##(1990-2#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-2#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
cell surface than##2##3##(1991-12#1)(1994-9#1)
cell surface##188##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-2#12)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#4)(1997-4#3)(1997-7#1)(1997-9#1)(2007-10#1)(2007-12#2)(2008-1#4)(2008-10#14)(2008-11#23)(2008-12#1)(2008-2#1)(2008-4#11)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#11)(2009-6#2)(2009-8#1)(2009-9#6)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#5)(2013-1#1)(2013-8#1)
cell surface-anchored##2##2##(1997-4#2)
cell surface-associated##2##2##(1996-12#2)
cell surface-located##2##2##(2008-4#2)
cell surfaces##12##2##(1991-9#2)(1995-2#2)(1995-5#1)(2006-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-8#1)(2013-1#1)(2013-8#1)
cell survival and differentiation in##2##5##(1997-6#2)
cell survival and##5##3##(1997-6#2)(2008-10#1)(2008-11#1)(2010-1#1)
cell survival in the##3##4##(2008-11#1)(2008-12#1)(2008-7#1)
cell survival in##6##3##(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
cell survival rate##2##3##(1993-8#1)(2008-10#1)
cell survival was##2##3##(1992-12#1)(1997-4#1)
cell survival##41##2##(1991-12#1)(1992-12#1)(1993-8#2)(1994-2#1)(1996-12#2)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
cell suspension culture##2##3##(2008-9#1)(2009-6#1)
cell suspension is##2##3##(2008-11#1)(2008-8#1)
cell suspension##19##2##(1994-8#2)(2008-10#1)(2008-11#9)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2012-1#1)
cell suspensions and##2##3##(1994-11#1)(2008-7#1)
cell suspensions in##2##3##(1993-3#1)(2008-10#1)
cell suspensions to##2##3##(2008-10#1)(2008-2#1)
cell suspensions##19##2##(1990-12#2)(1993-3#1)(1994-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)
cell swelling##5##2##(1996-5#3)(2008-10#1)(2008-8#1)
cell system and##2##3##(2011-2#1)(2012-2#1)
cell system##22##2##(1992-3#1)(1997-1#2)(1997-4#2)(1997-7#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
cell systems in the##2##4##(2007-8#1)(2008-1#1)
cell systems##16##2##(1990-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#1)(2009-3#2)(2013-1#1)(2013-8#1)
cell targeting##3##2##(1993-11#1)(1994-5#1)(1994-8#1)
cell technology##6##2##(2008-11#3)(2008-7#1)(2008-9#2)
cell that is##2##3##(2008-3#2)
cell that##13##2##(1995-6#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)
cell therapies##4##2##(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
cell therapy and tissue engineering##3##5##(2008-5#1)(2012-12#1)(2012-2#1)
cell therapy for##2##3##(1991-8#1)(2012-3#1)
cell therapy in##4##3##(1994-6#1)(2009-10#1)(2012-12#1)(2012-3#1)
cell therapy of##2##3##(2010-11#2)
cell therapy to##2##3##(2009-3#1)(2012-12#1)
cell therapy##33##2##(1991-8#1)(1994-6#6)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2012-12#4)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#2)
cell through##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
cell tissue##4##2##(1994-9#1)(2008-4#1)(2008-9#1)(2011-2#1)
cell to be##2##3##(2008-10#2)
cell to cell##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
cell to form a##2##4##(2008-10#1)(2010-4#1)
cell to the##4##3##(2007-12#2)(2008-11#1)(2009-2#1)
cell to##33##2##(1992-9#1)(1993-3#2)(1995-2#1)(1997-1#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-8#1)
cell tolerance##4##2##(2008-11#2)(2008-4#1)(2013-1#1)
cell toxicity##2##2##(1992-6#1)(2013-1#1)
cell tracking##4##2##(2008-11#1)(2009-12#1)(2013-1#2)
cell transfected with##2##3##(2008-2#1)(2008-8#1)
cell transfection##3##2##(2008-1#1)(2008-2#2)
cell transfer##4##2##(2008-11#3)(2008-4#1)
cell transferrin##2##2##(1990-8#2)
cell transformation##11##2##(1990-7#1)(1991-12#1)(1991-5#1)(1994-2#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#2)
cell transition##2##2##(2008-7#2)
cell translation##3##2##(2008-3#2)(2011-1#1)
cell transplant##7##2##(2006-10#1)(2008-10#1)(2009-10#1)(2010-10#1)(2010-11#1)(2012-12#1)(2013-1#1)
cell transplantation for##5##3##(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#2)
cell transplantation is##4##3##(1995-8#1)(1997-8#1)(2012-12#2)
cell transplantation with##2##3##(2010-10#1)(2011-1#1)
cell transplantation##46##2##(1995-8#1)(1997-3#2)(1997-8#1)(2006-10#2)(2008-10#1)(2008-11#5)(2008-7#2)(2009-10#1)(2010-10#3)(2010-11#6)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#6)(2012-2#2)(2012-7#1)(2013-1#1)
cell tumor of the salivary gland##2##6##(2009-3#2)
cell tumor of the##7##4##(1991-6#1)(1992-2#1)(2008-10#1)(2009-3#3)(2012-1#1)
cell tumor##22##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-6#3)(2009-3#3)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
cell tumors in##4##3##(1993-9#2)(2008-10#1)(2012-3#1)
cell tumors of the##3##4##(1991-8#1)(2007-8#2)
cell tumors of##4##3##(1991-8#1)(2007-8#2)(2008-10#1)
cell tumors##18##2##(1991-8#1)(1992-8#1)(1993-9#2)(1995-2#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#3)
cell tumour##4##2##(2008-12#1)(2008-6#1)(2012-2#1)(2013-7#1)
cell tumours is##2##3##(1990-2#1)(2008-2#1)
cell tumours##11##2##(1990-2#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-5#1)(2011-2#3)
cell type and##3##3##(1993-8#1)(2008-8#1)(2009-5#1)
cell type can##2##3##(2008-1#1)(2008-2#1)
cell type for##2##3##(2008-7#1)(2009-12#1)
cell type in##4##3##(1993-8#1)(1995-6#1)(2008-4#1)(2010-5#1)
cell type of interest##2##4##(2008-2#1)(2008-9#1)
cell type of##6##3##(1990-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
cell type specific##3##3##(2008-11#2)(2009-8#1)
cell type within the##2##4##(2008-3#1)(2008-9#1)
cell type##51##2##(1990-7#1)(1991-11#1)(1992-11#1)(1992-6#3)(1993-8#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#3)(2010-5#1)(2013-1#2)
cell type)##2##2##(2008-2#1)(2008-5#1)
cell type- and##2##3##(1991-9#1)(2009-10#1)
cell type-##3##2##(1991-9#1)(2008-2#1)(2009-10#1)
cell type-specific##9##2##(1992-9#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-8#1)(1996-5#2)(2008-7#1)(2012-3#1)
cell types and##9##3##(1990-5#1)(1992-8#1)(2008-11#2)(2008-4#1)(2009-12#1)(2010-9#1)(2011-1#1)(2012-3#1)
cell types are##4##3##(2007-12#1)(2008-12#1)(2008-7#1)(2009-6#1)
cell types but##2##3##(2008-4#1)(2008-6#1)
cell types for##3##3##(2008-1#1)(2008-7#1)(2012-3#1)
cell types from##3##3##(2008-4#1)(2009-3#2)
cell types have been##2##4##(2008-11#1)(2012-3#1)
cell types have##3##3##(1992-11#1)(2008-11#1)(2012-3#1)
cell types in the##5##4##(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-11#1)
cell types in##15##3##(1992-11#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#3)(2009-8#1)(2010-11#1)
cell types including##6##3##(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)
cell types is##2##3##(2008-11#1)(2012-12#1)
cell types of the##4##4##(1991-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
cell types of##7##3##(1991-2#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)
cell types such as##3##4##(2008-1#1)(2008-11#1)(2012-3#1)
cell types that are##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
cell types that##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
cell types was##3##3##(1990-2#1)(2008-5#1)(2010-3#1)
cell types with##3##3##(1992-9#1)(2008-7#1)(2012-2#1)
cell types##185##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-3#3)(1993-6#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#6)(2008-10#10)(2008-11#24)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#18)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#3)(2009-6#1)(2009-8#1)(2010-11#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#3)(2013-7#1)
cell units##3##2##(1994-12#1)(1994-9#1)(2013-1#1)
cell uptake of##3##3##(1997-1#2)(2008-4#1)
cell using##4##2##(2008-10#4)
cell variant##2##2##(1990-11#1)(2009-3#1)
cell via##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
cell viabilities##2##2##(2008-11#2)
cell viability and ultimately##2##4##(1995-12#1)(2009-7#1)
cell viability and##14##3##(1995-12#1)(1995-2#1)(1997-4#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
cell viability has##2##3##(2008-11#1)(2013-1#1)
cell viability in##5##3##(2008-11#4)(2013-1#1)
cell viability of##4##3##(2008-11#2)(2010-10#1)(2012-3#1)
cell viability was measured##2##4##(1997-4#1)(2012-3#1)
cell viability was##7##3##(1997-4#1)(2008-11#3)(2009-9#1)(2012-3#1)(2013-1#1)
cell viability##75##2##(1990-6#2)(1992-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-4#4)(2008-10#2)(2008-11#25)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
cell volume and##5##3##(1992-12#1)(1993-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
cell volume was##2##3##(1992-12#1)(2008-7#1)
cell volume##17##2##(1992-12#5)(1992-8#2)(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-12#1)(2013-8#2)
cell wall and##3##3##(2008-10#2)(2010-3#1)
cell wall appositions##2##3##(2008-10#2)
cell wall around the##2##4##(2008-10#2)
cell wall components##6##3##(2008-10#2)(2008-5#3)(2011-2#1)
cell wall degradation##2##3##(2008-10#1)(2011-10#1)
cell wall digestion##2##3##(1994-8#1)(2012-2#1)
cell wall extracts from##2##4##(2008-5#2)
cell wall extracts##5##3##(2008-5#5)
cell wall formation##2##3##(1990-7#1)(2008-10#1)
cell wall fortification of rice leaves##2##6##(2008-10#2)
cell wall glycoproteins##2##3##(2008-5#2)
cell wall materials##3##3##(2008-10#3)
cell wall of##5##3##(2008-10#2)(2008-5#2)(2009-2#1)
cell wall polymer##2##3##(1990-2#1)(2011-2#1)
cell wall protein p37##2##4##(1995-6#2)
cell wall protein##4##3##(1993-6#1)(1995-6#2)(2008-10#1)
cell wall strengthening##3##3##(2008-10#2)(2009-6#1)
cell wall thickness##3##3##(2008-10#3)
cell wall to##2##3##(1997-6#1)(2008-10#1)
cell wall was##3##3##(2008-10#2)(2008-8#1)
cell wall##131##2##(1990-2#1)(1990-5#1)(1990-7#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-6#4)(1996-12#1)(1997-6#4)(2008-10#64)(2008-11#3)(2008-2#1)(2008-5#14)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#4)(2009-12#1)(2009-2#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-2#4)(2012-1#4)(2012-2#3)(2013-1#1)
cell wall-associated##4##2##(1995-6#1)(2008-10#3)
cell wall-degrading enzymes##2##3##(2008-10#2)
cell wall-degrading##3##2##(2008-10#3)
cell walls by##2##3##(1997-6#1)(2013-8#1)
cell walls in##2##3##(2008-10#2)
cell walls of either##2##4##(2008-10#2)
cell walls of##11##3##(2008-10#9)(2008-11#1)(2008-9#1)
cell walls were##2##3##(2008-10#2)
cell walls##49##2##(1994-6#1)(1997-6#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#2)(2012-1#1)(2013-8#3)
cell was observed for the##2##5##(2008-11#2)
cell was studied##2##3##(1993-8#1)(2008-9#1)
cell was##32##2##(1990-12#1)(1993-8#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#7)(2008-3#2)(2008-7#1)(2008-9#2)(2012-1#1)(2012-2#2)
cell were found to be##2##5##(1990-5#1)(2008-11#1)
cell were##11##2##(1990-5#1)(1996-8#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#1)
cell which was##2##3##(2008-10#1)(2008-11#1)
cell which##8##2##(1991-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-1#1)(2013-8#1)
cell will##2##2##(2008-7#1)(2009-5#1)
cell with a##10##3##(2007-11#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2009-12#1)
cell with the##3##3##(1995-6#1)(2007-12#1)(2008-10#1)
cell with##35##2##(1990-8#1)(1993-9#1)(1994-6#2)(1995-6#1)(2007-11#1)(2007-12#6)(2008-10#10)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2013-1#1)
cell within##2##2##(1995-6#1)(2008-10#1)
cell without##2##2##(2008-10#1)(2008-9#1)
cell##8812##1##(1990-10#1)(1990-11#59)(1990-12#54)(1990-2#33)(1990-4#5)(1990-5#60)(1990-6#18)(1990-7#17)(1990-8#30)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#10)(1991-12#41)(1991-2#30)(1991-3#11)(1991-4#4)(1991-5#31)(1991-6#26)(1991-8#17)(1991-9#62)(1992-1#1)(1992-10#9)(1992-11#18)(1992-12#43)(1992-2#44)(1992-3#54)(1992-4#4)(1992-5#18)(1992-6#34)(1992-7#1)(1992-8#54)(1992-9#68)(1993-1#2)(1993-11#19)(1993-12#43)(1993-2#7)(1993-3#56)(1993-5#2)(1993-6#48)(1993-8#65)(1993-9#57)(1994-10#7)(1994-11#82)(1994-12#47)(1994-2#43)(1994-3#29)(1994-5#55)(1994-6#59)(1994-7#4)(1994-8#51)(1994-9#30)(1995-1#1)(1995-10#1)(1995-11#43)(1995-12#69)(1995-2#76)(1995-3#31)(1995-4#3)(1995-5#27)(1995-6#50)(1995-8#38)(1995-9#24)(1996-10#6)(1996-11#2)(1996-12#52)(1996-2#40)(1996-3#8)(1996-4#3)(1996-5#36)(1996-6#2)(1996-7#8)(1996-8#2)(1996-9#6)(1997-1#40)(1997-2#28)(1997-3#46)(1997-4#42)(1997-5#5)(1997-6#37)(1997-7#46)(1997-8#14)(1997-9#4)(2006-10#19)(2006-12#8)(2006-6#1)(2007-10#26)(2007-11#22)(2007-12#132)(2007-2#3)(2007-4#7)(2007-5#10)(2007-6#6)(2007-7#20)(2007-8#13)(2008-1#98)(2008-10#776)(2008-11#1640)(2008-12#34)(2008-2#110)(2008-3#91)(2008-4#324)(2008-5#155)(2008-6#89)(2008-7#380)(2008-8#216)(2008-9#383)(2009-1#8)(2009-10#52)(2009-11#15)(2009-12#46)(2009-2#22)(2009-3#60)(2009-4#26)(2009-5#43)(2009-6#33)(2009-7#30)(2009-8#98)(2009-9#24)(2010-1#12)(2010-10#26)(2010-11#65)(2010-12#27)(2010-2#16)(2010-3#24)(2010-4#12)(2010-5#14)(2010-6#13)(2010-7#9)(2010-8#38)(2010-9#11)(2011-1#75)(2011-10#2)(2011-2#242)(2011-3#17)(2011-9#1)(2012-1#63)(2012-12#125)(2012-2#186)(2012-3#92)(2012-4#4)(2012-5#14)(2012-7#5)(2012-8#4)(2013-1#225)(2013-7#27)(2013-8#82)
cell&quot##2##1##(2008-10#1)(2008-4#1)
cell's##9##1##(1994-11#1)(1994-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-8#2)(2011-2#1)
cell(-1)##7##1##(2008-10#2)(2008-11#5)
cell) and##3##2##(2006-10#1)(2008-11#1)(2013-7#1)
cell) are##2##2##(2008-8#1)(2010-11#1)
cell) for##2##2##(1990-5#1)(2008-3#1)
cell) were##2##2##(1993-6#1)(2008-10#1)
cell)##17##1##(1990-5#1)(1993-6#2)(2006-10#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2010-11#1)(2013-7#1)
cell- and##2##2##(1994-5#1)(2008-10#1)
cell-##7##1##(1994-5#1)(1995-8#1)(1996-2#1)(2008-10#1)(2009-8#1)(2010-5#1)(2012-2#1)
cell-adhesion molecule L1##2##3##(2008-7#2)
cell-adhesion##4##1##(2008-7#3)(2013-1#1)
cell-associated glucosyltransferase##2##2##(1992-9#2)
cell-associated##15##1##(1990-2#1)(1992-10#2)(1992-5#1)(1992-9#2)(1993-6#2)(1994-9#1)(1997-4#1)(2008-1#1)(2008-11#3)(2008-4#1)
cell-attached and inside-out patch##2##4##(1994-12#1)(1995-11#1)
cell-attached configuration##2##2##(1994-11#1)(1995-11#1)
cell-attached##5##1##(1994-11#1)(1994-12#1)(1995-11#3)
cell-attachment##3##1##(1994-8#1)(1997-1#2)
cell-autonomous##2##1##(1996-5#1)(2009-6#1)
cell-based approaches##2##2##(2008-10#1)(2012-12#1)
cell-based assay##3##2##(2008-10#1)(2011-3#2)
cell-based assays##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-6#1)
cell-based implementation of a digital optoelectronic neural-network##2##7##(2008-3#2)
cell-based regenerative##2##2##(2012-12#2)
cell-based systems##2##2##(2008-4#2)
cell-based therapies##5##2##(2008-10#1)(2008-9#1)(2012-12#3)
cell-based therapy##5##2##(2009-6#1)(2010-5#1)(2012-12#2)(2012-3#1)
cell-based##54##1##(1993-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-2#3)(2010-5#1)(2011-2#1)(2011-3#2)(2012-12#12)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
cell-binding##6##1##(1991-5#1)(1993-8#3)(1994-11#1)(2010-5#1)
cell-bound##5##1##(1991-2#2)(1994-3#1)(2008-4#1)(2008-7#1)
cell-by-cell##2##1##(2008-9#2)
cell-capture##2##1##(2010-12#2)
cell-cell adhesion##5##2##(1993-6#1)(1994-9#2)(2009-8#1)(2012-2#1)
cell-cell and##3##2##(2008-4#1)(2008-7#1)(2009-7#1)
cell-cell communication##7##2##(1993-2#1)(2008-7#1)(2008-9#1)(2010-7#3)(2012-1#1)
cell-cell contact##3##2##(1995-2#1)(2008-7#1)(2009-8#1)
cell-cell contacts##4##2##(1991-12#1)(2008-6#3)
cell-cell fusion##2##2##(2009-8#2)
cell-cell interaction and##3##3##(2008-10#1)(2009-8#2)
cell-cell interaction##4##2##(2008-10#1)(2008-11#1)(2009-8#2)
cell-cell interactions at##2##3##(2008-9#1)(2010-7#1)
cell-cell interactions##8##2##(1993-12#1)(1994-5#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
cell-cell signaling##4##2##(2008-4#1)(2010-7#2)(2013-1#1)
cell-cell##47##1##(1991-12#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-2#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#7)(2010-7#6)(2012-1#1)(2012-2#1)(2013-1#1)
cell-culture passages##2##2##(2007-6#2)
cell-culture##3##1##(2007-6#2)(2010-10#1)
cell-cycle arrestable##2##2##(2008-11#2)
cell-cycle control##2##2##(2008-4#1)(2008-8#1)
cell-cycle distribution was not##2##4##(1993-9#2)
cell-cycle distribution##3##2##(1993-9#2)(2008-11#1)
cell-cycle specific##2##2##(2008-11#2)
cell-cycle##25##1##(1990-2#1)(1990-5#1)(1993-9#3)(1994-12#1)(2008-10#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2012-2#1)(2012-3#1)(2013-8#1)
cell-dependent##4##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
cell-derived neurons##2##2##(2013-1#2)
cell-derived##18##1##(1992-9#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-6#1)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-1#2)(2013-8#1)
cell-enriched##2##1##(1994-5#1)(2013-1#1)
cell-free and concentrated ascites reinfusion therapy##2##6##(2013-1#2)
cell-free and##3##2##(1997-7#1)(2013-1#2)
cell-free culture##3##2##(2008-10#2)(2008-6#1)
cell-free expression screening##2##3##(2011-2#2)
cell-free expression##3##2##(2008-4#1)(2011-2#2)
cell-free extracts##5##2##(1992-9#1)(1994-11#1)(1994-6#1)(2008-8#1)(2008-9#1)
cell-free supernatant was##2##3##(2008-5#1)(2008-7#1)
cell-free system that##2##3##(1991-9#1)(1994-12#1)
cell-free system##20##2##(1990-11#1)(1990-5#2)(1991-5#2)(1991-8#1)(1991-9#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)
cell-free systems##3##2##(1992-11#1)(1994-8#1)(2011-1#1)
cell-free##63##1##(1990-11#1)(1990-5#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#5)(2013-1#2)
cell-growth##2##1##(1993-9#1)(2008-11#1)
cell-intrinsic##2##1##(2010-10#1)(2012-2#1)
cell-laden microcarriers##2##2##(2008-11#2)
cell-level##2##1##(2008-7#1)(2011-3#1)
cell-like##9##1##(2008-11#3)(2008-7#2)(2009-5#1)(2012-2#1)(2012-5#1)(2013-1#1)
cell-line##4##1##(1994-8#1)(1995-11#2)(2008-4#1)
cell-lines##2##1##(2008-8#1)(2012-12#1)
cell-lysates##2##1##(2008-7#2)
cell-mass##2##1##(2008-6#2)
cell-mediated and##2##2##(1995-12#1)(1995-2#1)
cell-mediated cytotoxicity (ADCC)##3##3##(1992-2#1)(2008-4#2)
cell-mediated cytotoxicity##6##2##(1992-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(2008-4#2)
cell-mediated delivery of TNF-alpha##2##4##(2013-1#2)
cell-mediated immune responses##5##3##(1995-2#1)(2008-5#2)(2012-12#1)(2013-8#1)
cell-mediated immune##8##2##(1995-2#1)(2008-10#2)(2008-5#2)(2012-12#1)(2012-3#1)(2013-8#1)
cell-mediated immunity and##2##3##(2009-12#1)(2012-3#1)
cell-mediated immunity in##2##3##(1995-12#1)(2008-8#1)
cell-mediated immunity is##2##3##(2008-4#1)(2008-5#1)
cell-mediated immunity##12##2##(1995-12#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2012-3#1)
cell-mediated##41##1##(1991-12#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#2)(1996-6#1)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#5)(2008-7#1)(2008-8#2)(2009-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
cell-membrane##3##1##(2008-9#1)(2009-8#1)(2010-10#1)
cell-penetrating peptides##4##2##(2009-8#1)(2010-10#1)(2011-3#2)
cell-penetrating##5##1##(2009-8#1)(2010-10#1)(2011-3#3)
cell-phone##2##1##(2008-7#2)
cell-retention##2##1##(2008-11#2)
cell-specific and##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
cell-specific expression of##2##3##(1995-8#1)(1997-7#1)
cell-specific expression##3##2##(1995-11#1)(1995-8#1)(1997-7#1)
cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein##2##6##(2013-7#2)
cell-specific manner and##2##3##(1994-5#1)(2009-8#1)
cell-specific transcriptional##2##2##(1992-9#1)(1994-8#1)
cell-specific##28##1##(1990-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-5#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-7#2)
cell-substrate##2##1##(2008-11#1)(2008-4#1)
cell-surface and##2##2##(1992-9#1)(2008-2#1)
cell-surface antigens##4##2##(1990-12#2)(2008-2#1)(2008-4#1)
cell-surface expression of##2##3##(1993-6#2)
cell-surface markers##3##2##(2008-4#1)(2009-6#2)
cell-surface proteins##3##2##(2008-2#1)(2008-4#1)(2009-6#1)
cell-surface receptor##3##2##(1990-12#2)(2008-11#1)
cell-surface##36##1##(1990-12#4)(1990-5#4)(1992-9#1)(1993-6#3)(1993-8#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-4#7)(2008-8#2)(2008-9#1)(2009-6#5)(2013-1#1)
cell-to-cell communication##2##2##(2008-4#1)(2011-1#1)
cell-to-cell movement of##5##3##(2008-10#5)
cell-to-cell movement##8##2##(2008-10#7)(2008-9#1)
cell-to-cell##20##1##(1996-10#1)(2008-10#13)(2008-4#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
cell-type##4##1##(1990-11#1)(1997-3#1)(2011-2#1)(2012-2#1)
cell-type-specific##3##1##(1995-2#1)(1995-8#1)(2012-12#1)
cell-volume##2##1##(2008-10#1)(2008-5#1)
cell-wall skeleton##2##2##(1991-5#2)
cell-wall##6##1##(1991-5#2)(1995-8#1)(2008-7#1)(2008-9#1)(2010-10#1)
cell/biomaterial interactions##2##2##(2008-11#2)
cell/biomaterial##3##1##(2008-11#2)(2011-3#1)
cell]##3##1##(2010-12#1)(2011-2#2)
cella##2##1##(1996-7#1)(2008-4#1)
cellar##2##1##(2008-10#1)(2008-8#1)
cellline##2##1##(2008-11#2)
cellobiohydrolase I##2##2##(1993-8#2)
cellobiose and##2##2##(1997-4#2)
cellobiose##11##1##(1995-6#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
cellodextrins##2##1##(1997-4#1)(2008-6#1)
cellophane##2##1##(2008-10#2)
cellproliferation##2##1##(2008-11#2)
cells (10(6)##2##2##(1993-8#1)(2008-4#1)
cells (150 ppm) were##2##4##(2008-10#2)
cells (150 ppm)##3##3##(2008-10#3)
cells (150##4##2##(2008-10#4)
cells (APC)##4##2##(1994-11#1)(2008-11#1)(2008-4#2)
cells (APCs)##5##2##(1995-5#1)(1997-4#1)(2008-11#1)(2008-7#1)(2012-3#1)
cells (DC)##6##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)
cells (DCs)##12##2##(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
cells (EC)##4##2##(1990-12#1)(1990-2#1)(1993-6#1)(2008-1#1)
cells (ESCs)##4##2##(2008-9#3)(2010-11#1)
cells (HSCs)##7##2##(1993-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)
cells (HeLa##2##2##(1992-3#1)(2010-3#1)
cells (LCs)##2##2##(1996-12#1)(2007-12#1)
cells (MC)##2##2##(1994-8#1)(2011-2#1)
cells (MCs)##2##2##(1992-6#1)(2013-1#1)
cells (MNC)##3##2##(1991-2#1)(1993-8#1)(2008-5#1)
cells (MNCs)##3##2##(2008-11#2)(2008-9#1)
cells (MSC)##2##2##(2008-5#1)(2011-1#1)
cells (MSCs) from##2##3##(2009-10#1)(2012-12#1)
cells (MSCs)##10##2##(2008-11#2)(2008-5#2)(2008-9#1)(2009-10#1)(2010-8#1)(2012-12#2)(2012-7#1)
cells (NPCs)##2##2##(2008-7#1)(2013-7#1)
cells (OPCs)##2##2##(2008-7#1)(2012-4#1)
cells (PBMCs)##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
cells (PCs)##2##2##(1994-2#1)(2008-11#1)
cells (Treg)##2##2##(2008-4#1)(2013-8#1)
cells (and##2##2##(1993-9#1)(2008-10#1)
cells (as##2##2##(1995-3#1)(2013-1#1)
cells (e##2##2##(2008-11#1)(2008-7#1)
cells (especially##3##2##(1996-7#1)(2008-10#1)(2008-4#1)
cells (for##3##2##(2008-4#2)(2008-9#1)
cells (human##5##2##(1994-11#2)(1994-6#1)(1997-4#1)(2008-11#1)
cells (in beads)##2##3##(1994-3#2)
cells (in##4##2##(1994-3#2)(2008-4#1)(2012-3#1)
cells (n =##2##3##(1992-6#1)(1994-6#1)
cells (or##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-11#1)
cells (r = 0##2##4##(1995-8#1)(2008-11#1)
cells (the##2##2##(2009-11#1)(2011-2#1)
cells (which are##2##3##(1994-8#1)(2008-4#1)
cells (with##2##2##(1993-8#2)
cells -##3##2##(2008-11#2)(2008-7#1)
cells 1##3##2##(1991-2#1)(2007-12#1)(2008-2#1)
cells a##6##2##(2008-11#4)(2008-7#2)
cells according to##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
cells accumulated##2##2##(1993-3#1)(1995-2#1)
cells acquire##2##2##(2008-1#1)(2013-1#1)
cells across##5##2##(1992-9#1)(2008-11#2)(2009-8#1)(2012-2#1)
cells act as##2##3##(1990-11#1)(2007-11#1)
cells activated##3##2##(1991-12#1)(1994-9#1)(1995-12#1)
cells activation##2##2##(1997-1#1)(2007-8#1)
cells actively##3##2##(1994-6#1)(2008-11#1)(2008-7#1)
cells adapted to##4##3##(2008-11#3)(2008-4#1)
cells adapted##5##2##(2008-11#4)(2008-4#1)
cells adhering to##2##3##(2008-10#1)(2011-2#1)
cells adhesion##3##2##(2008-9#2)(2012-2#1)
cells adjacent to##3##3##(2008-10#3)
cells affected##2##2##(1995-2#1)(2008-11#1)
cells after exposure to##2##4##(1993-8#1)(2008-6#1)
cells after the##2##3##(1991-5#1)(1995-3#1)
cells after##31##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2012-1#1)(2012-12#2)
cells against the##2##3##(2008-5#2)
cells against##10##2##(1991-5#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)
cells allows##2##2##(1995-11#1)(2008-9#1)
cells along with##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
cells along##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
cells also showed##2##3##(2008-10#1)(2013-7#1)
cells also##16##2##(1990-3#1)(1990-6#1)(1992-12#1)(1992-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#3)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
cells among the##2##3##(1996-5#1)(2008-11#1)
cells among##4##2##(1996-5#1)(2008-11#2)(2008-7#1)
cells and 3##2##3##(2008-9#1)(2010-1#1)
cells and T cells##2##4##(1995-2#1)(2007-8#1)
cells and T##4##3##(1995-2#1)(2006-10#1)(2007-8#1)(2008-4#1)
cells and a##10##3##(1992-2#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
cells and about##2##3##(2008-11#2)
cells and acted as a##2##5##(1995-2#1)(2008-5#1)
cells and adhesion##2##3##(1995-12#1)(2011-2#1)
cells and also##5##3##(1990-8#1)(1992-9#1)(2008-11#2)(2008-4#1)
cells and an##7##3##(1992-2#1)(1992-6#1)(1993-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2013-1#1)
cells and are##6##3##(1994-8#1)(1995-11#1)(2009-10#1)(2009-3#1)(2009-6#1)(2011-2#1)
cells and because##2##3##(1996-5#1)(2008-4#1)
cells and by##2##3##(1995-3#1)(2008-11#1)
cells and can be##3##4##(2007-12#1)(2008-5#1)(2008-9#1)
cells and can##7##3##(1992-9#1)(1995-2#1)(2007-12#1)(2008-5#1)(2008-9#2)(2012-2#1)
cells and cell lines##4##4##(1994-6#1)(2008-11#1)(2008-4#2)
cells and cell##13##3##(1991-5#1)(1992-11#1)(1993-12#1)(1994-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-9#1)
cells and cells##2##3##(1994-3#1)(2009-10#1)
cells and compared##2##3##(2008-3#1)(2008-7#1)
cells and different##2##3##(2010-5#1)(2012-3#1)
cells and embryonic stem##2##4##(1994-9#1)(2008-11#1)
cells and embryos##3##3##(1990-5#1)(2008-4#2)
cells and endothelial##2##3##(1996-5#1)(2010-1#1)
cells and eosinophils##4##3##(1990-12#1)(1992-2#2)(2013-8#1)
cells and ependymal##2##3##(1991-7#1)(2008-12#1)
cells and extracellular##3##3##(1994-6#1)(2007-11#1)(2009-3#1)
cells and few##2##3##(2008-5#2)
cells and fibers##2##3##(1992-11#2)
cells and fibroblasts##5##3##(1990-2#2)(1992-12#1)(1997-1#1)(1997-7#1)
cells and for the##2##4##(2008-11#1)(2008-9#1)
cells and for##5##3##(2008-10#1)(2008-11#1)(2008-9#2)(2009-5#1)
cells and forms##2##3##(1993-3#1)(2008-7#1)
cells and found##3##3##(1994-6#1)(1994-8#1)(2013-1#1)
cells and has##3##3##(2008-4#1)(2009-12#1)(2013-7#1)
cells and hematopoietic##2##3##(2008-11#1)(2012-12#1)
cells and human##10##3##(1991-9#1)(1993-6#1)(1995-6#1)(2008-11#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
cells and in a cell-free system##2##6##(1990-11#1)(1994-12#1)
cells and in a##3##4##(1990-11#1)(1994-12#1)(2010-11#1)
cells and in cells##2##4##(1995-2#1)(2008-4#1)
cells and in the##2##4##(1992-3#1)(1993-8#1)
cells and in vivo tumor##2##5##(2011-2#1)(2012-3#1)
cells and in##21##3##(1990-11#1)(1990-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
cells and induce##3##3##(1994-11#1)(1995-3#1)(2007-11#1)
cells and induced##3##3##(1992-9#1)(2008-8#1)(2012-12#1)
cells and inhibition of##2##4##(2008-4#1)(2013-1#1)
cells and is##3##3##(1995-2#1)(2010-3#1)(2011-1#1)
cells and its##6##3##(1994-5#1)(2008-11#2)(2009-8#1)(2010-12#1)(2013-8#1)
cells and lymphocytes##2##3##(1997-8#1)(2008-11#1)
cells and macrophages##4##3##(2007-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
cells and may be##2##4##(2008-8#1)(2008-9#1)
cells and may##4##3##(2008-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
cells and mice splenocytes##3##4##(2008-5#3)
cells and molecules##2##3##(2011-1#2)
cells and normal##3##3##(1993-12#1)(2010-12#1)(2012-12#1)
cells and not##5##3##(1990-8#1)(1992-8#1)(1993-12#1)(1994-2#1)(2008-11#1)
cells and of##7##3##(1990-2#1)(1990-5#1)(1992-9#1)(1995-2#1)(2008-11#1)(2008-9#1)(2013-8#1)
cells and on##5##3##(1990-11#1)(1990-5#1)(1993-9#1)(1994-3#1)(2007-11#1)
cells and other##8##3##(1993-12#1)(1997-1#1)(2008-11#2)(2008-4#2)(2009-2#1)(2009-3#1)
cells and peripheral##2##3##(1997-8#1)(2008-10#1)
cells and platelet aggregation##2##4##(1994-8#1)(2008-11#1)
cells and produced##2##3##(1997-4#1)(2013-1#1)
cells and production of##2##4##(2008-11#1)(2011-2#1)
cells and progenitor cells##2##4##(2008-4#1)(2008-7#1)
cells and proliferation##2##3##(2012-2#1)(2013-8#1)
cells and rat##2##3##(1992-3#1)(2007-11#1)
cells and reduced##2##3##(1995-2#1)(2008-10#1)
cells and secreted##2##3##(1993-9#1)(2008-5#1)
cells and secretions##2##3##(1994-9#1)(2008-12#1)
cells and showed##2##3##(1990-5#1)(1995-11#1)
cells and stromal fibroblasts##2##4##(2011-1#1)(2013-1#1)
cells and suggest that##3##4##(1994-6#1)(2008-8#1)(2013-1#1)
cells and suggest##5##3##(1994-3#1)(1994-6#1)(2008-8#1)(2010-6#1)(2013-1#1)
cells and supporting##2##3##(1993-9#1)(2009-10#1)
cells and syncytia##2##3##(1990-8#1)(2008-10#1)
cells and that the##2##4##(1995-2#1)(2008-11#1)
cells and that##9##3##(1990-5#1)(1991-12#1)(1993-8#1)(1994-9#1)(1995-2#2)(2008-11#1)(2008-5#1)(2008-8#1)
cells and the effects of##2##5##(1993-3#1)(1994-6#1)
cells and the importance of##2##5##(2007-5#1)(2012-12#1)
cells and the##56##3##(1990-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#4)(2013-7#1)(2013-8#1)
cells and their differentiation##2##4##(1995-12#1)(2012-4#1)
cells and their##22##3##(1993-8#1)(1994-9#1)(1995-12#2)(1995-9#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-11#2)(2008-4#3)(2008-8#1)(2010-10#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-4#1)
cells and therefore##2##3##(2008-11#1)(2009-7#1)
cells and this##4##3##(1992-3#1)(1994-9#1)(1995-2#1)(1997-1#1)
cells and those##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
cells and three##2##3##(2008-7#1)(2013-1#1)
cells and tissues could be##2##5##(2008-5#1)(2008-8#1)
cells and tissues from##2##4##(1994-11#1)(2008-3#1)
cells and tissues##21##3##(1992-5#1)(1993-5#1)(1994-11#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
cells and to detect##2##4##(2008-11#1)(2008-9#1)
cells and to##7##3##(1995-12#1)(2008-11#2)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)
cells and used to##2##4##(1992-6#1)(2008-10#1)
cells and v-src-transformed NIH3T3 cells##2##5##(1997-1#2)
cells and vascular##2##3##(2008-1#2)
cells and viruses##2##3##(1992-12#1)(2008-6#1)
cells and was##7##3##(1991-12#1)(1993-9#1)(1994-11#1)(2008-10#1)(2008-11#3)
cells and were not##2##4##(1993-9#1)(2008-10#1)
cells and were##5##3##(1992-12#1)(1992-8#1)(1993-9#1)(2008-10#1)(2008-8#1)
cells and whether##2##3##(2008-7#1)(2011-2#1)
cells and with##3##3##(1990-5#1)(1994-8#1)(2009-10#1)
cells and##738##2##(1990-11#3)(1990-12#7)(1990-2#4)(1990-5#8)(1990-7#2)(1990-8#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#6)(1992-12#6)(1992-2#5)(1992-3#7)(1992-5#3)(1992-6#7)(1992-8#3)(1992-9#7)(1993-11#2)(1993-12#5)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#8)(1994-11#11)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#8)(1994-9#6)(1995-11#9)(1995-12#8)(1995-2#13)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#6)(1997-2#5)(1997-3#3)(1997-4#5)(1997-7#3)(1997-8#4)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-6#3)(2007-8#2)(2008-1#10)(2008-10#42)(2008-11#81)(2008-12#6)(2008-2#4)(2008-3#5)(2008-4#31)(2008-5#19)(2008-6#5)(2008-7#35)(2008-8#27)(2008-9#30)(2009-10#9)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#5)(2010-5#5)(2010-6#4)(2011-1#15)(2011-2#19)(2011-3#1)(2012-1#8)(2012-12#19)(2012-2#12)(2012-3#9)(2012-4#1)(2013-1#19)(2013-7#4)(2013-8#14)
cells and/or cell##2##3##(2008-9#2)
cells and/or##5##2##(2008-4#1)(2008-9#2)(2009-4#1)(2013-1#1)
cells appear to have##2##4##(1992-5#1)(2008-11#1)
cells appear to undergo##2##4##(2008-7#2)
cells appear to##7##3##(1992-5#1)(1996-5#1)(2008-11#1)(2008-7#2)(2009-11#1)(2013-1#1)
cells appear##8##2##(1992-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2013-1#1)
cells appeared to be##2##4##(2008-11#1)(2011-2#1)
cells appeared to##3##3##(1997-3#1)(2008-11#1)(2011-2#1)
cells appeared##8##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
cells appears to be##3##4##(1992-8#1)(1997-1#1)(2008-11#1)
cells appears to##4##3##(1992-8#1)(1997-1#1)(1997-3#1)(2008-11#1)
cells appears##6##2##(1992-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#2)
cells are a##6##3##(1994-5#1)(2008-1#1)(2008-4#2)(2008-9#2)
cells are able to##5##4##(1990-12#1)(1992-3#1)(1994-11#1)(2008-7#1)(2012-12#1)
cells are activated by##2##4##(2009-7#1)(2011-2#1)
cells are activated##3##3##(2008-4#1)(2009-7#1)(2011-2#1)
cells are actively##2##3##(1992-6#1)(2009-11#1)
cells are also described##2##4##(2008-4#1)(2008-9#1)
cells are also included##2##4##(2008-4#2)
cells are also##7##3##(2008-10#1)(2008-11#1)(2008-4#4)(2008-9#1)
cells are being##2##3##(2008-11#1)(2008-9#1)
cells are capable of##6##4##(1990-2#1)(1994-11#1)(2006-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
cells are characterized by##3##4##(2008-7#1)(2009-3#1)(2010-10#1)
cells are crucial##2##3##(2008-7#1)(2012-12#1)
cells are cultured##3##3##(2008-11#2)(2008-4#1)
cells are derived from##2##4##(1995-6#1)(2008-11#1)
cells are described##3##3##(1992-5#1)(2008-4#1)(2008-9#1)
cells are discussed##5##3##(1993-9#1)(2008-11#3)(2008-4#1)
cells are exposed to##4##4##(1991-5#1)(1992-12#1)(1995-8#1)(2008-1#1)
cells are filled##2##3##(2007-12#1)(2008-5#1)
cells are found##2##3##(2007-12#1)(2008-4#1)
cells are frequently##2##3##(2008-7#1)(2008-9#1)
cells are grown##2##3##(2008-10#1)(2008-4#1)
cells are highly##3##3##(1997-4#1)(2008-4#2)
cells are induced to##2##4##(1994-9#1)(1995-6#1)
cells are influenced by##2##4##(2008-11#1)(2011-2#1)
cells are involved in##2##4##(2008-7#1)(2012-3#1)
cells are involved##3##3##(2008-4#1)(2008-7#1)(2012-3#1)
cells are isolated##2##3##(2008-4#2)
cells are labeled##2##3##(2008-7#1)(2008-9#1)
cells are located##3##3##(1997-1#1)(2007-12#1)(2012-12#1)
cells are mediated##3##3##(1991-5#1)(1992-3#1)(2008-4#1)
cells are more##3##3##(1991-12#1)(2008-11#1)(2011-2#1)
cells are not affected by##2##5##(1994-10#1)(2008-6#1)
cells are not##6##3##(1994-10#1)(2007-12#1)(2008-6#1)(2008-9#3)
cells are of##2##3##(1997-4#1)(2009-10#1)
cells are placed in##2##4##(2008-8#1)(2010-12#1)
cells are placed##3##3##(2008-2#1)(2008-8#1)(2010-12#1)
cells are present in##4##4##(2007-12#1)(2008-11#2)(2008-7#1)
cells are present##5##3##(2007-12#1)(2008-11#2)(2008-7#1)(2010-3#1)
cells are presented##2##3##(2008-9#1)(2009-9#1)
cells are removed from the##2##5##(2008-11#2)
cells are responsible for##3##4##(1994-3#1)(2009-3#1)(2011-2#1)
cells are small##2##3##(1990-11#1)(2009-8#1)
cells are stained##2##3##(2008-5#1)(2008-9#1)
cells are stimulated##4##3##(1990-12#1)(1991-5#1)(2008-4#1)(2010-10#1)
cells are suitable for##2##4##(2008-11#2)
cells are the##6##3##(2008-11#1)(2008-9#1)(2009-3#1)(2010-10#1)(2012-2#2)
cells are then##2##3##(1990-12#1)(2008-10#1)
cells are treated with##3##4##(2008-2#2)(2010-3#1)
cells are treated##6##3##(1993-8#1)(1997-3#1)(2008-2#2)(2008-4#1)(2010-3#1)
cells are used##2##3##(2009-8#1)(2012-2#1)
cells are very##3##3##(1990-11#1)(2007-12#1)(2008-6#1)
cells are well##2##3##(1993-11#1)(2013-8#1)
cells are widely used##2##4##(2008-11#2)
cells are##253##2##(1990-11#3)(1990-12#5)(1990-2#1)(1991-12#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#2)(2006-10#2)(2007-12#12)(2007-8#1)(2008-1#6)(2008-10#5)(2008-11#35)(2008-2#5)(2008-3#2)(2008-4#26)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#23)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#4)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
cells around the##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
cells around##4##2##(1994-9#1)(2008-10#2)(2012-3#1)
cells arranged in##3##3##(1991-6#1)(2010-12#1)(2012-3#1)
cells arranged##4##2##(1991-6#1)(2008-8#1)(2010-12#1)(2012-3#1)
cells arrested in the##2##4##(2008-1#1)(2008-11#1)
cells arrested##3##2##(1995-2#1)(2008-1#1)(2008-11#1)
cells as a model##2##4##(1994-10#1)(1995-12#1)
cells as a##9##3##(1990-11#1)(1992-8#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-11#1)(2009-6#2)
cells as an##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
cells as assessed by##3##4##(1991-9#1)(1995-12#1)(2008-11#1)
cells as compared to##3##4##(1991-4#1)(2008-11#2)
cells as compared with##2##4##(1992-8#1)(1993-8#1)
cells as compared##5##3##(1991-4#1)(1992-8#1)(1993-8#1)(2008-11#2)
cells as indicated by##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
cells as the##6##3##(1994-5#1)(1997-4#1)(2008-4#3)(2011-2#1)
cells as they##2##3##(2008-11#1)(2008-7#1)
cells as well as in cell lines##2##7##(1991-2#1)(2008-9#1)
cells as well as in##7##5##(1990-12#1)(1991-2#1)(1992-12#1)(1995-6#1)(1997-6#1)(2008-9#2)
cells as well as the##5##5##(1994-8#1)(2007-12#1)(2008-5#2)(2011-1#1)
cells as well as##29##4##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-2#1)(2011-1#1)(2011-2#1)
cells as##84##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#4)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#14)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
cells associated with the##2##4##(2008-10#1)(2008-7#1)
cells associated with##8##3##(2007-12#2)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
cells at 37 degrees C##4##5##(1991-2#1)(1992-11#1)(1993-8#1)(1995-2#1)
cells at a concentration of##2##5##(1992-3#1)(2008-11#1)
cells at a##8##3##(1992-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-1#1)(2012-7#1)
cells at all##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
cells at any##2##3##(1993-9#1)(2008-11#1)
cells at different stages##2##4##(2008-9#1)(2009-10#1)
cells at different##4##3##(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#1)
cells at high##3##3##(2007-11#1)(2008-11#2)
cells at the wound site##2##5##(2008-10#2)
cells at the##15##3##(1994-9#1)(1995-5#1)(1995-9#1)(2007-12#4)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
cells at##65##2##(1990-11#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(2007-11#1)(2007-12#4)(2008-10#9)(2008-11#17)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#2)
cells attached to the##2##4##(2008-11#2)
cells attached to##3##3##(2008-11#2)(2008-9#1)
cells attached##4##2##(2008-11#3)(2008-9#1)
cells based on the##2##4##(2007-12#1)(2008-11#1)
cells based on##7##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
cells bearing##4##2##(1990-8#1)(1995-5#1)(2011-2#1)(2012-2#1)
cells became##10##2##(1991-2#1)(1993-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)
cells because##3##2##(2008-10#1)(2009-3#1)(2012-12#1)
cells become##4##2##(1991-5#1)(1994-3#1)(1997-1#1)(2006-10#1)
cells before##5##2##(1991-5#1)(2008-10#2)(2012-12#1)(2013-1#1)
cells being in the##2##4##(1993-8#2)
cells being##3##2##(1993-8#2)(2012-2#1)
cells beneath##2##2##(2008-10#1)(2008-11#1)
cells between##4##2##(1995-11#1)(2007-8#1)(2008-11#2)
cells beyond the midgut epithelia##2##5##(2008-10#2)
cells born##2##2##(1996-5#2)
cells both in##4##3##(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
cells both##8##2##(1990-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)
cells but also in neoplastic cells##2##6##(2008-4#2)
cells but also in##4##4##(1991-2#1)(1995-6#1)(2008-4#2)
cells but also##7##3##(1991-2#1)(1995-6#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-11#1)
cells but has##2##3##(2008-11#1)(2008-3#1)
cells but it##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
cells but not in##5##4##(1990-12#1)(1991-12#1)(1993-11#1)(1995-11#1)(2008-11#1)
cells but not##15##3##(1990-12#1)(1991-12#1)(1991-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1997-4#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-2#1)
cells but was##3##3##(1991-4#1)(1996-5#1)(2013-1#1)
cells but##39##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#2)
cells by a##6##3##(1990-5#1)(1993-8#1)(1994-11#1)(1995-8#1)(2008-11#1)(2012-12#1)
cells by an##2##3##(1995-2#1)(2010-10#1)
cells by different##3##3##(1992-5#1)(2012-2#1)(2012-3#1)
cells by electroporation##2##3##(1997-8#1)(2008-9#1)
cells by exposure to##2##4##(1990-8#1)(1993-3#1)
cells by flow cytometry##4##4##(1996-6#1)(1997-7#1)(2008-10#1)(2008-9#1)
cells by heat##2##3##(1995-11#1)(2011-2#1)
cells by homologous recombination##2##4##(2008-8#1)(2008-9#1)
cells by human NK cells##2##5##(2008-8#2)
cells by human##3##3##(1994-8#1)(2008-8#2)
cells by increasing##2##3##(1991-5#1)(1993-3#1)
cells by inhibiting##2##3##(1992-8#1)(1997-2#1)
cells by means of##3##4##(1990-12#1)(1995-6#1)(2008-10#1)
cells by releasing##2##3##(2008-11#1)(2008-5#1)
cells by the##15##3##(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-11#3)(2008-5#1)(2011-2#1)(2012-2#1)
cells by transient transfection##2##4##(1997-7#1)(2008-11#1)
cells by using a##2##4##(1995-8#1)(2008-11#1)
cells by using##3##3##(1995-8#1)(2008-11#1)(2008-4#1)
cells by vesicular stomatitis virus##2##5##(1992-12#1)(1994-6#1)
cells by way of##2##4##(2008-9#1)(2011-2#1)
cells by##195##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#4)(1993-6#1)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#5)(1995-6#3)(1995-8#6)(1996-2#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-7#4)(1997-8#1)(2008-1#2)(2008-10#11)(2008-11#33)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#13)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-7#2)(2013-8#2)
cells can also be##2##4##(2008-1#1)(2008-4#1)
cells can be detected##2##4##(1996-12#1)(2008-9#1)
cells can be induced##2##4##(2008-11#2)
cells can be isolated from##2##5##(2008-9#2)
cells can be observed##2##4##(2008-11#1)(2008-8#1)
cells can be quantified##2##4##(2008-4#1)(2009-2#1)
cells can be used for##3##5##(1993-12#1)(2008-11#1)(2013-1#1)
cells can be used to##2##5##(2008-1#1)(2008-9#1)
cells can be used##6##4##(1993-12#1)(2008-1#1)(2008-11#2)(2008-9#1)(2013-1#1)
cells can be##41##3##(1990-12#1)(1990-2#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-11#10)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-12#1)(2009-2#1)(2012-1#1)(2013-1#1)
cells can contribute to##2##4##(2008-7#2)
cells can readily be used to##2##6##(2008-4#2)
cells can result in##2##4##(2008-11#1)(2008-5#1)
cells can stimulate##2##3##(2008-11#1)(2008-8#1)
cells can then##2##3##(2008-10#1)(2008-8#1)
cells can##71##2##(1990-12#2)(1990-2#2)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#2)(2008-1#2)(2008-10#3)(2008-11#12)(2008-2#2)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#9)(2009-12#3)(2009-2#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-12#1)(2013-1#2)
cells capable of##3##3##(2008-11#1)(2012-12#2)
cells carrying##4##2##(1990-7#1)(1994-10#1)(1994-11#1)(2008-11#1)
cells caused by##8##3##(1993-12#1)(1994-11#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#1)
cells caused##10##2##(1993-12#1)(1994-11#1)(1996-12#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
cells changed##2##2##(2008-11#1)(2011-2#1)
cells co-cultured with##3##3##(2008-11#1)(2009-7#2)
cells co-transfected with the##3##4##(1990-8#2)(2008-9#1)
cells co-transfected with##6##3##(1990-8#2)(1991-2#1)(1995-11#1)(1995-12#1)(2008-9#1)
cells collected##2##2##(1993-12#1)(2008-12#1)
cells colonized##2##2##(2008-10#2)
cells come##2##2##(2006-10#1)(2008-9#1)
cells compared to the##2##4##(1993-3#1)(2013-1#1)
cells compared to##7##3##(1992-9#1)(1993-3#1)(2007-12#1)(2008-11#2)(2008-6#1)(2013-1#1)
cells compared with##4##3##(1994-8#1)(2012-12#3)
cells compared##11##2##(1992-9#1)(1993-3#1)(1994-8#1)(2007-12#1)(2008-11#2)(2008-6#1)(2012-12#3)(2013-1#1)
cells concomitantly##2##2##(1993-3#1)(2009-9#1)
cells confirmed the##2##3##(1993-2#1)(2008-5#1)
cells constitute a##2##3##(2008-11#2)
cells constitute##3##2##(2008-11#2)(2013-8#1)
cells constitutively##2##2##(1995-12#1)(2008-11#1)
cells contain a##5##3##(1990-11#1)(1992-9#2)(2007-12#2)
cells contain##11##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-9#2)(2007-12#3)(2008-7#1)(2010-2#1)
cells contained a##2##3##(1991-5#1)(2008-10#1)
cells contained##14##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-5#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
cells containing a##3##3##(1991-7#2)(1995-5#1)
cells containing multiple##2##3##(2008-10#1)(2008-3#1)
cells containing the##2##3##(1993-9#1)(1995-2#1)
cells containing##16##2##(1990-2#1)(1991-7#2)(1993-9#1)(1995-2#2)(1995-5#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
cells contains##3##2##(1992-10#1)(2008-10#1)(2008-8#1)
cells contribute to the##2##4##(2007-12#1)(2008-5#1)
cells contribute to##3##3##(1994-12#1)(2007-12#1)(2008-5#1)
cells controlled##2##2##(1992-3#1)(2008-10#1)
cells correlated with##2##3##(1992-9#1)(2008-7#1)
cells correlated##3##2##(1992-9#1)(2008-7#1)(2013-1#1)
cells could also be##2##4##(2008-11#1)(2008-9#1)
cells could also##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
cells could be a##2##4##(1994-8#1)(2012-2#1)
cells could be identified##2##4##(1990-12#1)(1991-11#1)
cells could be the consequence of##2##6##(2008-3#1)(2008-8#1)
cells could be the##3##4##(2008-3#1)(2008-8#2)
cells could be##20##3##(1990-12#2)(1990-8#1)(1991-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
cells could not be##2##4##(1990-8#1)(1997-4#1)
cells could not##4##3##(1990-8#1)(1997-4#1)(2008-8#1)(2009-6#1)
cells could##42##2##(1990-11#1)(1990-12#2)(1990-8#2)(1991-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-4#1)(2008-8#7)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
cells cultivated in##2##3##(2008-11#2)
cells cultured at##2##3##(1990-11#2)
cells cultured for##2##3##(1992-8#2)
cells cultured in serum containing medium##3##6##(2008-11#3)
cells cultured in the presence of##2##6##(1992-8#1)(2008-11#1)
cells cultured in vitro##2##4##(1993-3#1)(2010-6#1)
cells cultured in##15##3##(1992-8#4)(1993-3#1)(1994-3#2)(1995-11#1)(2008-11#6)(2010-6#1)
cells cultured on plastic##2##4##(2008-5#1)(2012-1#1)
cells cultured on the##2##4##(2008-11#2)
cells cultured on##8##3##(1995-2#1)(2008-11#4)(2008-5#2)(2012-1#1)
cells cultured under##3##3##(1992-8#1)(2008-9#1)(2011-2#1)
cells cultured with##2##3##(1994-10#1)(2008-11#1)
cells cultured##36##2##(1990-11#2)(1991-2#1)(1992-8#7)(1993-3#1)(1994-10#1)(1994-3#2)(1995-11#1)(1995-2#1)(1997-1#1)(2008-11#12)(2008-5#2)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-1#1)
cells decreased by##2##3##(1994-6#1)(2010-1#1)
cells decreased##6##2##(1994-6#1)(1996-2#1)(2008-11#1)(2008-7#2)(2010-1#1)
cells demonstrate##4##2##(1997-7#1)(2007-11#1)(2008-4#1)(2012-12#1)
cells demonstrated a##3##3##(1994-6#1)(2008-11#2)
cells demonstrated that##3##3##(1991-5#1)(2008-11#1)(2008-8#1)
cells demonstrated##12##2##(1991-5#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1997-3#1)(2008-11#4)(2008-8#1)(2011-1#1)
cells demonstrates##2##2##(1994-8#2)
cells depend on##3##3##(2008-11#1)(2008-4#1)(2009-4#1)
cells depending on the##3##4##(1997-4#1)(2008-11#2)
cells derived from rat##3##4##(1995-11#1)(2008-11#2)
cells derived from the##7##4##(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)
cells derived from##25##3##(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-11#8)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#1)
cells derived##26##2##(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-11#9)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#1)
cells despite##2##2##(1994-8#1)(2010-6#1)
cells detected##2##2##(1997-8#1)(2010-12#1)
cells develop##3##2##(2008-5#1)(2010-5#2)
cells developed##2##2##(2008-10#1)(2012-12#1)
cells did not display##2##4##(1993-3#1)(1994-11#1)
cells did not express##2##4##(1991-2#1)(2008-11#1)
cells did not release##2##4##(1990-2#1)(2008-11#1)
cells did not##19##3##(1990-2#1)(1990-7#1)(1991-2#2)(1992-9#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-11#4)(2008-6#1)(2008-7#1)(2012-2#1)
cells did##21##2##(1990-2#1)(1990-7#1)(1991-2#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#1)(2012-2#1)
cells die by apoptosis##2##4##(1993-3#1)(2009-8#1)
cells die##4##2##(1993-3#1)(2008-11#1)(2009-8#1)(2010-3#1)
cells died##3##2##(2008-11#2)(2008-7#1)
cells differ from##2##3##(2008-5#1)(2013-1#1)
cells differ in##2##3##(1992-2#1)(2008-11#1)
cells differ##4##2##(1992-2#1)(2008-11#1)(2008-5#1)(2013-1#1)
cells differentiate into##3##3##(1992-12#1)(1994-11#1)(2009-5#1)
cells differentiate##4##2##(1992-12#1)(1994-11#1)(2009-5#1)(2012-2#1)
cells differentiated from##2##3##(2009-12#2)
cells differentiated##4##2##(1996-2#1)(2008-11#1)(2009-12#2)
cells directly from##2##3##(2007-12#1)(2008-4#1)
cells directly##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2012-1#1)
cells display the##3##3##(1994-8#2)(2008-11#1)
cells display##6##2##(1992-9#1)(1994-8#2)(2008-11#1)(2009-12#1)(2012-2#1)
cells displayed a##2##3##(2008-11#1)(2011-3#1)
cells displayed##10##2##(1992-9#1)(1997-3#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)
cells displaying##2##2##(1997-3#2)
cells divide##4##2##(2007-12#1)(2008-11#1)(2008-7#1)(2009-3#1)
cells do not contain##4##4##(1990-8#1)(1992-10#1)(1992-3#1)(2007-11#1)
cells do not express##2##4##(1994-2#1)(2008-8#1)
cells do not##13##3##(1990-8#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-2#2)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
cells do##14##2##(1990-11#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-2#2)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
cells dropped##2##2##(2008-10#1)(2008-11#1)
cells due to##2##3##(1994-3#1)(2008-11#1)
cells during cell competition##2##4##(2008-10#2)
cells during cell##3##3##(2008-10#2)(2008-11#1)
cells during infection##2##3##(2008-10#1)(2008-5#1)
cells during the##3##3##(1993-9#1)(2007-12#1)(2008-11#1)
cells during##32##2##(1990-11#1)(1990-12#1)(1990-7#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-9#1)(1997-6#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
cells either##5##2##(1994-11#1)(1996-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
cells embedded in the##2##4##(2008-11#1)(2011-1#1)
cells embedded in##3##3##(2008-11#1)(2008-6#1)(2011-1#1)
cells employing##2##2##(1995-6#1)(2008-11#1)
cells encapsulated in##3##3##(2008-11#2)(2008-5#1)
cells engineered to##2##3##(2008-11#2)
cells enhance##2##2##(2009-9#1)(2012-12#1)
cells enhanced##2##2##(1991-12#1)(1994-6#1)
cells entering##2##2##(1993-6#1)(2010-5#1)
cells evade##2##2##(2009-3#1)(2010-3#1)
cells even##2##2##(1990-12#1)(2008-11#1)
cells examined##4##2##(1992-8#1)(1993-8#1)(2008-11#1)(2008-8#1)
cells except for##2##3##(2008-11#1)(2008-5#1)
cells except##3##2##(2008-11#1)(2008-5#1)(2010-11#1)
cells exhibit a##3##3##(1994-2#1)(1994-8#1)(2008-7#1)
cells exhibit increased##2##3##(1992-6#1)(1992-8#1)
cells exhibit##17##2##(1992-11#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-8#1)(1995-9#1)(2008-1#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
cells exhibited a decreased##2##4##(1991-5#1)(2008-11#1)
cells exhibited a##7##3##(1991-5#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#1)
cells exhibited##13##2##(1990-7#1)(1991-5#1)(1992-12#1)(2008-10#1)(2008-11#5)(2008-7#2)(2009-6#2)
cells exhibiting##2##2##(1995-6#1)(2009-3#1)
cells exist##2##2##(2008-11#1)(2008-7#1)
cells exposed to a##3##4##(1990-2#1)(2008-11#1)(2008-9#1)
cells exposed to an##2##4##(1997-4#2)
cells exposed to growth##2##4##(1990-12#1)(1995-6#1)
cells exposed to the##2##4##(1991-12#1)(2009-3#1)
cells exposed to##24##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-4#2)(2008-11#2)(2008-7#1)(2008-9#2)(2009-3#1)(2013-7#1)
cells express a##3##3##(1992-3#1)(1995-12#1)(1997-6#1)
cells express both##2##3##(1994-11#1)(1995-11#1)
cells express only##2##3##(1992-12#1)(1993-3#1)
cells express the##2##3##(2008-4#1)(2012-2#1)
cells express##26##2##(1992-12#1)(1992-3#2)(1993-3#1)(1994-11#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-6#1)(2008-2#1)(2008-4#7)(2008-5#2)(2009-3#1)(2011-2#2)(2012-2#2)
cells expressed the##4##3##(1996-5#1)(2008-11#2)(2010-6#1)
cells expressed##17##2##(1990-8#1)(1992-3#1)(1993-9#1)(1996-5#1)(1997-2#1)(2008-11#7)(2008-4#1)(2008-6#1)(2010-11#1)(2010-6#2)
cells expressing SSTR1##2##3##(1995-2#2)
cells expressing a##2##3##(1992-8#1)(2013-7#1)
cells expressing glutamine synthetase##2##4##(2008-11#2)
cells expressing human##2##3##(1991-12#1)(1995-11#1)
cells expressing the##15##3##(1992-2#1)(1992-8#2)(1993-8#1)(1993-9#1)(1995-2#3)(1995-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-11#2)(2009-12#1)
cells expressing##50##2##(1991-12#1)(1992-2#1)(1992-8#3)(1993-11#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-4#2)(1997-7#1)(2008-10#1)(2008-11#11)(2008-4#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2013-1#1)(2013-7#1)
cells fail to##2##3##(2009-8#1)(2012-12#1)
cells failed to##4##3##(1990-11#1)(1993-2#1)(2008-10#1)(2013-1#1)
cells first##2##2##(1994-6#1)(2008-11#1)
cells following a##2##3##(1997-4#1)(2009-2#1)
cells following##10##2##(1990-5#1)(1992-9#1)(1994-6#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-2#1)(2012-2#1)(2013-1#1)
cells follows##2##2##(2008-8#2)
cells for apoptosis##3##3##(1995-2#2)(1996-12#1)
cells for cell##2##3##(2008-11#2)
cells for the production of##2##5##(1997-4#1)(2008-11#1)
cells for the##8##3##(1997-4#1)(2007-10#1)(2008-11#4)(2008-9#1)(2010-6#1)
cells for tissue##3##3##(2008-5#1)(2012-5#1)(2013-1#1)
cells for transplantation##2##3##(2008-11#2)
cells for##80##2##(1990-12#2)(1990-5#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-11#20)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#10)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#3)(2012-5#1)(2013-1#3)(2013-8#2)
cells form a##2##3##(1992-9#1)(2009-8#1)
cells form the##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
cells form##5##2##(1992-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)
cells formed##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
cells forming##2##2##(1991-8#1)(2007-12#1)
cells found in##3##3##(1993-6#1)(1996-5#1)(2009-9#1)
cells frequently##2##2##(2008-10#1)(2008-11#1)
cells from BALB/c##2##3##(2008-10#1)(2012-3#1)
cells from a##7##3##(1991-9#1)(1992-12#1)(1992-9#1)(1994-9#1)(2008-4#1)(2008-8#1)(2009-8#1)
cells from adult mouse##2##4##(2008-11#2)
cells from aged##2##3##(1990-3#1)(2012-2#1)
cells from all germ layers##2##5##(2008-8#2)
cells from all##3##3##(1991-2#1)(2008-8#2)
cells from apoptosis by##3##4##(1993-9#2)(2011-2#1)
cells from both##2##3##(1996-5#1)(1997-4#1)
cells from death##2##3##(2008-11#1)(2008-9#1)
cells from different##4##3##(1990-5#1)(1994-8#1)(1995-11#1)(2012-3#1)
cells from embryonic and neonatal rat retinal explants##2##8##(1996-5#2)
cells from embryonic##3##3##(1996-5#2)(2008-11#1)
cells from healthy##3##3##(1994-12#1)(1994-3#1)(2013-1#1)
cells from human cord blood##3##5##(2008-9#3)
cells from human##7##3##(1994-11#1)(2008-8#1)(2008-9#3)(2010-11#1)(2012-1#1)
cells from mice treated with##2##5##(2008-10#2)
cells from mice##6##3##(1990-7#1)(2008-10#2)(2008-11#3)
cells from mouse##4##3##(1992-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
cells from neonatal##2##3##(1993-12#1)(1996-5#1)
cells from normal human##2##4##(2008-11#1)(2008-4#1)
cells from normal##4##3##(1992-12#1)(1995-3#1)(2008-11#1)(2008-4#1)
cells from other##4##3##(2008-11#1)(2008-4#2)(2013-8#1)
cells from oxidative##2##3##(1994-2#1)(2009-12#1)
cells from patients with##4##4##(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
cells from peripheral blood##2##4##(2008-11#1)(2008-4#1)
cells from pig-tailed macaques##3##4##(1995-2#3)
cells from pregnant rats##2##4##(1990-11#2)
cells from primary##2##3##(1993-6#1)(2008-4#1)
cells from rat kidney##2##4##(1995-11#2)
cells from rat##7##3##(1990-12#1)(1990-2#1)(1995-11#2)(1995-8#2)(2012-4#1)
cells from small##2##3##(2008-11#1)(2008-4#1)
cells from the proposita##5##4##(1992-12#5)
cells from the surrounding##2##4##(2008-11#1)(2008-4#1)
cells from the##42##3##(1991-4#1)(1991-9#1)(1992-12#5)(1992-6#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
cells from these##2##3##(1994-5#1)(2008-4#1)
cells from this##2##3##(1991-12#1)(2008-12#1)
cells from tissues##2##3##(2008-4#1)(2010-6#1)
cells from umbilical##2##3##(1994-6#1)(2008-11#1)
cells from which##3##3##(1993-8#1)(2008-11#1)(2008-9#1)
cells from##261##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#2)(1992-11#2)(1992-12#8)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#3)(1993-5#2)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#6)(1995-12#1)(1995-2#6)(1995-3#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-5#4)(1997-4#3)(1997-7#2)(2007-11#1)(2007-12#5)(2007-2#1)(2008-1#3)(2008-10#11)(2008-11#36)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#17)(2008-5#7)(2008-7#5)(2008-8#6)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#5)
cells function##2##2##(2009-3#1)(2010-5#1)
cells gave rise to##2##4##(2008-11#2)
cells gave##4##2##(1995-2#1)(1997-6#1)(2008-11#2)
cells generally##2##2##(2009-10#1)(2013-1#1)
cells generate##2##2##(2007-12#2)
cells generated##2##2##(1991-5#1)(1995-2#1)
cells give rise to##2##4##(2009-3#1)(2012-2#1)
cells gives##2##2##(1994-8#1)(1997-4#1)
cells giving rise to##2##4##(1994-5#1)(2012-1#1)
cells grew faster##2##3##(2008-7#1)(2013-1#1)
cells grew##5##2##(1993-9#1)(2008-11#2)(2008-7#1)(2013-1#1)
cells grow##5##2##(1993-6#1)(2008-11#1)(2008-5#1)(2008-7#2)
cells growing in a##2##4##(1995-6#1)(2008-11#1)
cells growing in##4##3##(1995-5#1)(1995-6#1)(2008-11#2)
cells growing on##2##3##(2008-10#1)(2008-11#1)
cells growing##7##2##(1993-9#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#3)
cells grown at 0##2##4##(1991-11#2)
cells grown at 37 degrees C##2##6##(1995-8#1)(2008-5#1)
cells grown at##6##3##(1991-11#3)(1995-8#1)(2008-5#2)
cells grown in batch culture##2##5##(2008-11#2)
cells grown in culture##2##4##(1993-12#1)(2008-11#1)
cells grown in medium of low##2##6##(1991-11#2)
cells grown in permissive and non-permissive culture conditions##2##8##(1995-11#2)
cells grown in serum-free suspension culture##4##6##(2008-11#4)
cells grown in serum-free##6##4##(2008-11#6)
cells grown in the absence##2##5##(1994-11#1)(2008-10#1)
cells grown in the##3##4##(1992-3#1)(1994-11#1)(2008-10#1)
cells grown in##31##3##(1990-6#1)(1991-11#2)(1991-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-11#2)(1997-3#1)(2008-10#1)(2008-11#18)(2008-9#1)
cells grown on oleic acid##2##5##(1990-5#1)(1993-6#1)
cells grown on##9##3##(1990-5#1)(1993-6#2)(2007-12#1)(2008-1#1)(2008-11#3)(2008-7#1)
cells grown under##4##3##(1992-12#1)(1997-1#1)(2008-11#1)(2013-1#1)
cells grown##54##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#5)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1995-11#2)(1995-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#24)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)
cells growth and##2##3##(2008-8#1)(2013-1#1)
cells growth##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
cells had a high##2##4##(2008-11#2)
cells had a##4##3##(2008-11#3)(2008-4#1)
cells had different##2##3##(1993-8#1)(2008-9#1)
cells had no##2##3##(1993-9#1)(2008-9#1)
cells had the##2##3##(1993-8#1)(2008-11#1)
cells had##25##2##(1990-6#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-8#2)(1996-5#2)(2008-11#9)(2008-4#1)(2008-9#2)(2012-1#3)(2012-12#1)
cells harboring##4##2##(1993-8#1)(1996-12#1)(2008-6#1)(2011-2#1)
cells harvested at##2##3##(2008-10#2)
cells harvested from##2##3##(1994-5#1)(2008-10#1)
cells harvested##6##2##(1994-5#1)(2008-10#4)(2008-11#1)
cells has become##2##3##(2008-4#1)(2008-9#1)
cells has been demonstrated##2##4##(2008-5#1)(2008-8#1)
cells has been studied##2##4##(1992-8#1)(1993-6#1)
cells has been##14##3##(1990-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2011-1#1)
cells has not##2##3##(1993-3#1)(1995-6#1)
cells has##37##2##(1990-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
cells have a##7##3##(1991-12#1)(1992-5#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-7#1)(2009-12#1)
cells have also been##2##4##(2007-5#1)(2008-7#1)
cells have an##3##3##(1992-7#1)(2008-7#1)(2010-1#1)
cells have been found##2##4##(1992-8#1)(2008-7#1)
cells have been reported##2##4##(1991-2#1)(1992-3#1)
cells have been shown to##4##5##(1993-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
cells have been studied##2##4##(1994-11#1)(2008-11#1)
cells have been##25##3##(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1997-4#1)(1997-8#1)(2008-11#9)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
cells have indefinite##2##3##(2008-11#1)(2008-9#1)
cells have the capacity to##2##5##(2008-8#1)(2013-1#1)
cells have the potential to differentiate into##2##7##(2008-11#1)(2008-8#1)
cells have the##6##3##(2008-11#2)(2008-8#3)(2013-1#1)
cells have##72##2##(1990-7#1)(1991-12#2)(1991-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#17)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#5)(2008-9#6)(2009-12#1)(2010-1#1)(2010-11#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
cells having##2##2##(1991-11#1)(2008-4#1)
cells highly##2##2##(1993-11#1)(1997-7#1)
cells hold##2##2##(2009-12#1)(2012-12#1)
cells immobilized##2##2##(2008-11#2)
cells in 10 mM##2##4##(1992-6#2)
cells in Drosophila##2##3##(2008-7#1)(2009-3#1)
cells in G1##3##3##(1994-8#1)(1997-7#1)(2008-9#1)
cells in a concentration-dependent manner##3##5##(1995-12#1)(2008-4#1)(2013-1#1)
cells in a dose- and time-dependent manner##3##7##(1991-5#1)(2008-11#1)(2011-2#1)
cells in a dose-dependent manner##4##5##(1990-2#1)(1994-12#1)(2008-11#1)(2010-6#1)
cells in a mixed##2##4##(1992-6#1)(1993-9#1)
cells in a##45##3##(1990-2#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#14)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
cells in addition to##3##4##(2008-6#1)(2008-9#1)(2009-4#1)
cells in all the##2##4##(2008-10#1)(2008-8#1)
cells in all##4##3##(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
cells in an##7##3##(1993-8#1)(1994-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
cells in batch##3##3##(1995-9#1)(2008-11#1)(2012-3#1)
cells in bioreactor##2##3##(2008-11#2)
cells in blood##2##3##(1993-8#1)(2012-1#1)
cells in bone marrow##5##4##(2010-3#1)(2010-8#1)(2011-2#3)
cells in both##7##3##(1990-12#1)(1991-9#1)(1993-8#1)(1996-5#1)(2008-9#1)(2010-1#1)(2010-11#1)
cells in brain##3##3##(2008-7#2)(2009-3#1)
cells in culture and##3##4##(1994-8#1)(2009-3#1)(2012-2#1)
cells in culture are##2##4##(2008-4#1)(2008-7#1)
cells in culture as well as##2##6##(2008-11#1)(2008-9#1)
cells in culture##37##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-3#2)(1993-8#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-11#12)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
cells in different##2##3##(2008-11#1)(2011-2#1)
cells in female nude mice##2##5##(1994-12#2)
cells in general##3##3##(1991-12#1)(2010-12#1)(2011-1#1)
cells in humans##2##3##(1994-5#1)(2012-1#1)
cells in images##2##3##(2010-8#2)
cells in low serum or##2##5##(2008-11#2)
cells in mice##2##3##(2008-11#1)(2008-4#1)
cells in monolayer culture##4##4##(1990-2#1)(1992-9#1)(2008-11#2)
cells in mouse##2##3##(2012-2#2)
cells in multi-well##2##3##(2008-11#2)
cells in nude mice##4##4##(1994-12#1)(1994-5#1)(2011-2#1)(2013-8#1)
cells in nude##5##3##(1994-12#1)(1994-5#1)(2011-2#2)(2013-8#1)
cells in order to##2##4##(1993-3#1)(2008-11#1)
cells in other##2##3##(1994-2#1)(1997-3#1)
cells in particular##2##3##(2009-10#1)(2010-12#1)
cells in peripheral blood and##2##5##(1995-11#1)(1995-2#1)
cells in peripheral blood##3##4##(1992-2#1)(1995-11#1)(1995-2#1)
cells in primary culture##5##4##(1993-3#1)(1994-12#1)(1994-8#2)(2008-6#1)
cells in rats with##2##4##(2012-1#2)
cells in rats##3##3##(1995-12#1)(2012-1#2)
cells in response to##12##4##(1990-2#2)(1992-12#1)(1992-2#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)
cells in serum-free##2##3##(2008-11#2)
cells in short-term##2##3##(1995-3#1)(2008-6#1)
cells in situ##5##3##(1991-12#3)(2008-7#1)(2011-1#1)
cells in small##2##3##(1992-12#1)(2011-2#1)
cells in solid##2##3##(1997-4#1)(2008-9#1)
cells in some##2##3##(2007-12#1)(2008-10#1)
cells in suspension culture##4##4##(1997-1#1)(2008-11#3)
cells in suspension##17##3##(1990-8#1)(1997-1#1)(2008-1#1)(2008-11#11)(2008-4#3)
cells in the CNS and PNS##2##6##(2008-7#2)
cells in the CNS##3##4##(2008-11#1)(2008-7#2)
cells in the G1##2##4##(1994-11#1)(2008-11#1)
cells in the absence of##6##5##(1993-5#1)(1993-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
cells in the adult##2##4##(2008-11#1)(2012-2#1)
cells in the airways##2##4##(2008-3#1)(2013-8#1)
cells in the blood##2##4##(1995-3#1)(2008-7#1)
cells in the body##3##4##(2008-5#1)(2008-9#1)(2013-1#1)
cells in the bone marrow##7##5##(2008-10#1)(2008-4#1)(2008-7#1)(2010-6#2)(2012-12#1)(2012-3#1)
cells in the brain##5##4##(2008-4#1)(2008-7#1)(2012-2#3)
cells in the context of##3##5##(2008-11#1)(2008-9#1)(2009-6#1)
cells in the dermis and##2##5##(1996-12#1)(2010-6#1)
cells in the dermis##4##4##(1996-12#2)(2010-6#1)(2011-1#1)
cells in the developing##3##4##(1994-2#1)(1996-5#1)(2010-11#1)
cells in the development of##2##5##(1994-7#1)(2012-3#1)
cells in the exponential phase of growth##2##7##(1994-8#1)(2008-11#1)
cells in the hepatopancreas##2##4##(2008-6#1)(2008-7#1)
cells in the hippocampus##2##4##(1991-2#1)(2009-3#1)
cells in the interstitium##2##4##(2009-10#2)
cells in the lung##3##4##(2008-7#1)(2013-8#2)
cells in the medial medulla##2##5##(1991-5#2)
cells in the nodose ganglion##3##5##(1996-5#3)
cells in the pancreas##2##4##(2008-11#1)(2010-11#1)
cells in the pathogenesis of##3##5##(2006-10#2)(2009-5#1)
cells in the presence of the##2##6##(1990-11#1)(2008-8#1)
cells in the presence of##10##5##(1990-11#1)(1993-6#2)(1993-9#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)
cells in the process##2##4##(2008-6#1)(2013-8#1)
cells in the rat##2##4##(1995-12#1)(1996-5#1)
cells in the substantia nigra##3##5##(1995-8#1)(2008-7#2)
cells in the testis##5##4##(2008-4#1)(2008-7#2)(2009-10#1)(2012-2#1)
cells in the visual cortex##2##5##(1990-8#1)(1996-2#1)
cells in the##201##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#8)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#3)(2007-10#1)(2007-12#1)(2008-10#10)(2008-11#33)(2008-3#1)(2008-4#10)(2008-5#2)(2008-6#4)(2008-7#23)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#5)(2010-2#1)(2010-6#5)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#6)
cells in their##2##3##(1994-10#1)(2007-12#1)
cells in this##2##3##(2008-7#1)(2008-9#1)
cells in tissue engineering protocols##2##5##(2008-11#2)
cells in tissue engineering##4##4##(2008-11#3)(2012-5#1)
cells in tissue##6##3##(1997-1#1)(2008-11#4)(2012-5#1)
cells in tissues##2##3##(2008-4#1)(2009-10#1)
cells in transgenic mice##3##4##(1995-2#1)(1995-6#1)(1996-5#1)
cells in transgenic##5##3##(1995-2#1)(1995-6#2)(1996-5#1)(1997-6#1)
cells in vitro and in vivo##4##6##(1993-9#1)(1994-11#1)(1994-5#1)(2013-8#1)
cells in vitro and##8##4##(1993-9#1)(1994-11#1)(1994-5#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
cells in vitro##43##3##(1990-2#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-11#7)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cells in vitro]##4##3##(2012-2#2)(2013-1#2)
cells in vivo using##2##4##(2008-4#1)(2012-2#1)
cells in vivo##8##3##(1990-12#1)(1991-4#1)(1992-11#1)(1993-9#1)(1994-5#1)(2008-4#1)(2008-9#1)(2012-2#1)
cells in which the##2##4##(1994-12#1)(2010-10#1)
cells in which##5##3##(1994-10#1)(1994-12#1)(1995-2#1)(2010-10#1)(2011-2#1)
cells in whole##2##3##(2008-4#1)(2012-2#1)
cells in##711##2##(1990-11#2)(1990-12#3)(1990-2#6)(1990-5#2)(1990-7#2)(1990-8#2)(1991-12#7)(1991-2#6)(1991-4#1)(1991-5#9)(1991-6#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#5)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#8)(1993-9#10)(1994-10#3)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#9)(1995-11#2)(1995-12#7)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#9)(1996-2#2)(1996-5#14)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#3)(2006-10#4)(2007-10#2)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#134)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#33)(2008-5#11)(2008-6#12)(2008-7#46)(2008-8#21)(2008-9#23)(2009-1#1)(2009-10#8)(2009-12#1)(2009-2#2)(2009-3#8)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#4)(2010-10#3)(2010-11#9)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#8)(2010-8#3)(2011-1#5)(2011-2#22)(2012-1#12)(2012-12#11)(2012-2#18)(2012-3#9)(2012-5#1)(2013-1#13)(2013-8#11)
cells including neurons##2##3##(2008-2#1)(2008-4#1)
cells including##7##2##(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)
cells increased in##2##3##(1995-2#1)(2008-7#1)
cells increased the##2##3##(2008-11#2)
cells increased##14##2##(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#1)(2013-1#1)
cells increases with increasing##2##4##(2008-10#1)(2008-9#1)
cells increases##8##2##(1993-12#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-1#1)
cells increasing##2##2##(2008-8#1)(2011-2#1)
cells incubated at##2##3##(1991-8#1)(1994-3#1)
cells incubated with the medium containing##2##6##(2008-11#2)
cells incubated with##6##3##(1990-11#1)(1992-3#1)(2008-11#3)(2011-1#1)
cells incubated##9##2##(1990-11#1)(1991-8#1)(1992-3#1)(1994-3#1)(2008-11#4)(2011-1#1)
cells indicate that the##2##4##(1994-6#1)(1995-2#1)
cells indicate that##4##3##(1991-5#1)(1994-6#1)(1995-2#1)(2009-6#1)
cells indicated that##2##3##(1997-7#1)(2008-9#1)
cells indicates that##3##3##(1993-6#1)(1994-12#1)(2008-9#1)
cells indicates##4##2##(1993-6#1)(1994-12#1)(2008-9#1)(2013-1#1)
cells indicating that##2##3##(1993-6#1)(2009-4#1)
cells indicating##3##2##(1993-6#1)(2009-4#1)(2012-3#1)
cells induced by the##2##4##(2010-12#1)(2012-12#1)
cells induced by##14##3##(1991-12#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#2)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)(2012-12#1)
cells induced##21##2##(1991-12#2)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
cells induces##6##2##(1990-5#1)(1994-11#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
cells inducing##2##2##(2008-1#1)(2008-9#1)
cells infected with a baculovirus##2##5##(2008-11#2)
cells infected with a recombinant##3##5##(1991-5#1)(1993-8#1)(2008-7#1)
cells infected with a##7##4##(1991-5#1)(1993-8#1)(1997-3#1)(2008-11#2)(2008-7#1)(2012-2#1)
cells infected with re-virus showed##2##5##(1993-6#2)
cells infected with re-virus##3##4##(1993-6#3)
cells infected with recombinant##3##4##(1992-8#1)(2008-11#1)(2008-2#1)
cells infected with the##3##4##(1994-11#1)(1994-8#1)(2011-3#1)
cells infected with wild-type##2##4##(1993-6#1)(2008-11#1)
cells infected with##22##3##(1991-5#1)(1992-8#1)(1993-6#5)(1993-8#1)(1994-11#1)(1994-8#1)(1997-3#1)(2008-11#5)(2008-2#1)(2008-7#2)(2008-8#1)(2011-3#1)(2012-2#1)
cells infected##23##2##(1991-5#1)(1992-8#1)(1993-6#5)(1993-8#1)(1994-11#1)(1994-8#1)(1997-3#1)(2008-11#6)(2008-2#1)(2008-7#2)(2008-8#1)(2011-3#1)(2012-2#1)
cells infested##3##2##(2008-10#1)(2008-6#2)
cells infiltrate##2##2##(1991-9#1)(2008-7#1)
cells inhibited##4##2##(1992-7#1)(1993-6#1)(1994-11#2)
cells inhibits##2##2##(1995-6#1)(2010-1#1)
cells initially##2##2##(2008-10#1)(2008-11#1)
cells injected##2##2##(1993-8#1)(2008-7#1)
cells interact with##4##3##(1994-12#1)(2009-3#2)(2010-5#1)
cells into a##2##3##(1991-6#1)(2008-11#1)
cells into the circulation of##2##5##(2008-1#2)
cells into the medium##2##4##(1994-8#1)(2008-7#1)
cells into the##15##3##(1994-8#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
cells into##49##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-9#2)(1993-6#1)(1994-8#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
cells involved in##11##3##(1992-12#1)(1993-1#1)(1994-5#2)(1997-6#1)(2007-12#3)(2008-10#1)(2012-1#1)(2013-1#1)
cells involves the##2##3##(1990-5#1)(1995-2#1)
cells involves##4##2##(1990-5#1)(1995-2#2)(2012-12#1)
cells involving the##2##3##(1990-5#1)(2008-11#1)
cells is a##10##3##(1990-12#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
cells is also##5##3##(1990-8#1)(1991-9#1)(1994-8#1)(1996-8#1)(2008-1#1)
cells is an important##2##4##(2008-7#1)(2012-12#1)
cells is an##5##3##(2008-4#2)(2008-7#1)(2010-3#1)(2012-12#1)
cells is associated with##2##4##(2011-2#2)
cells is based on the##4##5##(2008-2#1)(2008-4#1)(2008-9#2)
cells is based on##5##4##(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)
cells is closely##2##3##(1994-9#1)(2008-9#1)
cells is controlled##5##3##(1994-9#1)(2008-2#1)(2008-4#1)(2009-12#1)(2012-2#1)
cells is described##2##3##(1990-12#1)(2008-11#1)
cells is differentially##2##3##(1993-12#1)(1993-3#1)
cells is discussed##4##3##(1994-2#2)(1997-3#1)(2008-4#1)
cells is highly##2##3##(1990-12#1)(2008-9#1)
cells is inhibited##2##3##(1993-12#1)(2011-2#1)
cells is more##2##3##(1992-5#1)(2008-9#1)
cells is negatively##3##3##(1993-3#1)(1995-8#1)(2008-8#1)
cells is not a##2##4##(2008-9#1)(2013-1#1)
cells is not##12##3##(1992-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-2#1)(2008-4#1)(2008-9#2)(2012-3#1)(2013-1#1)
cells is now##2##3##(1994-2#1)(2009-8#1)
cells is of##2##3##(2008-11#1)(2008-9#1)
cells is one of the##2##5##(2009-10#1)(2011-2#1)
cells is performed##2##3##(2008-9#2)
cells is related to##2##4##(1994-6#1)(2008-11#1)
cells is required##2##3##(2008-11#1)(2008-7#1)
cells is significantly##2##3##(1992-12#1)(2008-7#1)
cells is the##3##3##(1993-6#1)(2011-2#1)(2012-2#1)
cells is thought to##2##4##(2008-11#1)(2008-6#1)
cells is##163##2##(1990-11#3)(1990-12#7)(1990-5#1)(1990-8#2)(1991-2#1)(1991-9#2)(1992-12#1)(1992-5#2)(1992-9#2)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#20)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#14)(2009-10#2)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
cells isolated from human##3##4##(1991-5#1)(1993-3#1)(1995-11#1)
cells isolated from the##5##4##(1990-11#1)(1994-12#1)(1995-11#1)(2009-12#1)(2009-9#1)
cells isolated from tissue##2##4##(2008-9#1)(2013-1#1)
cells isolated from##24##3##(1990-11#2)(1990-6#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#2)(1994-12#1)(1995-11#3)(1995-12#1)(2008-11#2)(2008-2#1)(2008-9#2)(2009-12#1)(2009-9#1)(2012-2#1)(2013-1#2)
cells it##3##2##(1990-2#1)(1991-4#1)(1996-12#1)
cells lack the##2##3##(1995-6#1)(2012-1#1)
cells lack##7##2##(1993-3#1)(1994-9#1)(1995-6#2)(1996-2#2)(2012-1#1)
cells lacking##4##2##(1991-5#1)(1992-8#1)(1993-3#1)(1996-12#1)
cells leads to##5##3##(1995-2#1)(1995-6#1)(1997-1#1)(2011-1#1)(2012-1#1)
cells like##3##2##(1992-3#1)(2008-11#1)(2011-2#1)
cells lines##2##2##(2008-11#1)(2008-4#1)
cells lining the##3##3##(1991-12#1)(2011-2#1)(2013-1#1)
cells lining##4##2##(1991-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
cells loaded with the##2##4##(1991-9#1)(1997-1#1)
cells loaded with##4##3##(1991-9#1)(1992-6#1)(1997-1#1)(2008-9#1)
cells located in the##2##4##(1991-10#1)(1992-8#1)
cells located##4##2##(1990-12#1)(1991-10#1)(1992-8#1)(2007-12#1)
cells lose the##2##3##(1990-3#1)(2008-1#1)
cells lose##4##2##(1990-3#1)(1990-5#1)(2008-1#1)(2008-11#1)
cells loss##2##2##(2011-2#2)
cells lost##4##2##(1990-5#1)(2008-10#2)(2009-6#1)
cells mL(-1)##2##2##(2008-11#1)(2012-1#1)
cells mL-1##3##2##(2008-11#3)
cells maintain##3##2##(1990-5#2)(2008-7#1)
cells maintained at##3##3##(1995-11#2)(1995-2#1)
cells maintained in##2##3##(1994-2#1)(1994-3#1)
cells maintained on collagen gel##2##5##(1994-8#2)
cells maintained their##2##3##(2010-11#1)(2011-2#1)
cells maintained##10##2##(1994-2#1)(1994-3#1)(1994-8#3)(1995-11#2)(1995-2#1)(2010-11#1)(2011-2#1)
cells makes##2##2##(2007-12#1)(2008-9#1)
cells may also##3##3##(1994-11#1)(1995-5#1)(1996-9#1)
cells may be sufficient##2##4##(1994-5#1)(1997-8#1)
cells may be##24##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1997-8#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#2)
cells may have##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
cells may help##2##3##(2007-11#1)(2008-9#1)
cells may provide##2##3##(1994-8#1)(2008-11#1)
cells may##51##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
cells mediate##2##2##(2008-11#1)(2008-7#1)
cells mediated by##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
cells membrane and##2##3##(2010-5#1)(2013-8#1)
cells membrane##3##2##(1991-12#1)(2010-5#1)(2013-8#1)
cells might be##5##3##(1992-3#1)(1997-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
cells might represent a##2##4##(2010-11#2)
cells might##16##2##(1992-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-2#1)
cells migrated##3##2##(2008-11#1)(2008-5#1)(2012-1#1)
cells ml(-1) and##2##3##(2008-10#1)(2008-11#1)
cells ml(-1)##20##2##(2008-10#5)(2008-11#15)
cells ml(-1)) and##2##3##(2008-10#1)(2008-11#1)
cells ml(-1))##8##2##(2008-10#1)(2008-11#7)
cells more than##2##3##(1993-8#1)(1995-11#1)
cells more##7##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-8#1)
cells must be##2##3##(2008-9#1)(2011-2#1)
cells must##5##2##(2008-7#1)(2008-9#1)(2009-10#2)(2011-2#1)
cells not expressing##2##3##(1991-5#1)(2010-11#1)
cells not only##4##3##(1993-3#1)(2008-11#1)(2008-7#1)(2008-9#1)
cells not##8##2##(1991-12#1)(1991-5#1)(1993-3#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-11#1)
cells observed##2##2##(1991-6#1)(1992-12#1)
cells obtained from##5##3##(1991-9#1)(1992-2#1)(1997-1#1)(2008-4#2)
cells obtained##9##2##(1991-9#1)(1992-2#1)(1992-9#1)(1997-1#1)(2008-4#4)(2010-12#1)
cells occurred##4##2##(1990-2#1)(1994-5#1)(2008-10#1)(2010-6#1)
cells occurring##2##2##(1996-5#1)(2008-12#1)
cells occurs##4##2##(1991-9#1)(1992-11#1)(1994-6#1)(2012-3#1)
cells of T##2##3##(2008-11#1)(2011-1#1)
cells of a##5##3##(1993-6#1)(1994-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
cells of all##3##3##(2006-10#1)(2008-4#1)(2008-9#1)
cells of an##2##3##(1994-12#1)(2008-7#1)
cells of both##7##3##(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-9#1)
cells of different origin##2##4##(2008-11#1)(2009-2#1)
cells of different scolopidia##2##4##(2008-7#2)
cells of different##8##3##(1997-8#1)(2008-11#1)(2008-7#2)(2008-8#2)(2009-2#1)(2011-2#1)
cells of distinct##2##3##(2010-11#1)(2013-1#1)
cells of either##2##3##(1997-4#1)(2007-12#1)
cells of healthy##2##3##(2008-11#2)
cells of interest and##2##4##(2008-9#2)
cells of interest##5##3##(2008-11#1)(2008-9#4)
cells of mice##2##3##(1997-8#1)(2011-2#1)
cells of origin in##2##4##(2013-1#2)
cells of origin##4##3##(1992-11#1)(2013-1#3)
cells of patients with##2##4##(1990-9#1)(1994-2#1)
cells of patients##3##3##(1990-9#1)(1994-2#1)(1997-6#1)
cells of preantral##2##3##(2008-8#1)(2008-9#1)
cells of rat intestine##2##4##(1994-6#2)
cells of rat##4##3##(1994-6#2)(1995-5#1)(2013-1#1)
cells of roots##2##3##(2008-10#1)(2008-9#1)
cells of several##2##3##(2008-10#1)(2008-4#1)
cells of strain##2##3##(2008-10#2)
cells of the brain##4##4##(1990-7#1)(1994-6#1)(1996-5#1)(2008-6#1)
cells of the conducting##2##4##(2013-1#2)
cells of the dorsal##3##4##(1991-7#1)(1996-12#1)(1996-2#1)
cells of the human##2##4##(2008-11#1)(2011-2#1)
cells of the immune system##5##5##(2007-2#1)(2008-4#4)
cells of the rat##6##4##(1990-5#1)(1993-12#2)(1993-3#1)(1995-2#1)(1996-5#1)
cells of the skin##2##4##(2008-5#1)(2013-1#1)
cells of the##134##3##(1990-5#2)(1990-7#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#3)(1995-12#3)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-5#2)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#7)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#11)(2008-2#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
cells of two##2##3##(1994-3#1)(2007-12#1)
cells of young##2##3##(1994-6#1)(2009-12#1)
cells of##344##2##(1990-11#2)(1990-2#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#4)(1993-3#4)(1993-5#4)(1993-6#3)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#5)(1994-6#7)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#5)(1996-2#3)(1996-5#5)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#6)(2006-10#2)(2007-11#1)(2007-12#13)(2007-2#1)(2008-1#3)(2008-10#37)(2008-11#24)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#8)(2008-6#6)(2008-7#25)(2008-8#11)(2008-9#20)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#2)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#11)
cells often##2##2##(2008-9#1)(2010-10#1)
cells on a##3##3##(1990-2#1)(2008-11#1)(2008-12#1)
cells on day##2##3##(2008-7#1)(2008-9#1)
cells on microcarriers##4##3##(2008-11#3)(2012-3#1)
cells on neuronal##3##3##(2008-7#1)(2012-1#2)
cells on porous##2##3##(2008-11#2)
cells on some polymeric films##2##5##(2008-11#2)
cells on the##12##3##(1991-12#1)(1993-3#1)(2007-11#1)(2008-11#5)(2009-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
cells on##55##2##(1990-2#2)(1991-12#1)(1992-6#1)(1993-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-9#2)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#23)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
cells only in##3##3##(2008-5#1)(2008-7#2)
cells only##10##2##(1993-6#1)(1993-9#1)(1996-5#1)(1997-1#1)(2007-7#1)(2008-5#1)(2008-7#3)(2009-3#1)
cells onto##2##2##(2008-11#1)(2008-8#1)
cells or cells##4##3##(1993-6#2)(2008-4#1)(2010-3#1)
cells or endothelial##2##3##(1992-3#1)(2008-9#1)
cells or the##3##3##(1995-12#1)(1995-2#1)(2008-11#1)
cells or their##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
cells or tissue##3##3##(2008-4#3)
cells or tissues##3##3##(1997-8#1)(2008-1#1)(2008-2#1)
cells or to##2##3##(2008-4#1)(2008-9#1)
cells or whole##2##3##(2008-4#1)(2011-2#1)
cells or##69##2##(1991-11#2)(1991-5#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-2#4)(2008-4#15)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#8)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)
cells outside the##2##3##(1996-5#1)(2012-12#1)
cells over the##3##3##(1991-5#1)(1995-8#1)(2008-2#1)
cells over##7##2##(1990-5#1)(1991-5#1)(1995-8#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
cells over-expressing##2##2##(2010-11#1)(2011-2#1)
cells overexpress##2##2##(2009-3#1)(2012-2#1)
cells overexpressing##13##2##(1994-11#2)(1995-2#1)(1995-6#2)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#3)(2012-3#1)
cells participate in##2##3##(2008-11#1)(2008-5#1)
cells per flower##3##3##(2008-10#3)
cells per g of tissue##2##5##(2008-10#2)
cells per gram of##2##4##(2008-10#1)(2008-11#1)
cells per ml##6##3##(1994-5#1)(2008-10#4)(2008-11#1)
cells per##23##2##(1994-5#1)(1994-7#1)(1994-8#1)(1995-3#1)(2008-10#12)(2008-11#4)(2008-5#1)(2008-9#1)(2010-6#1)
cells persisted##2##2##(1992-9#1)(2008-5#1)
cells placed##2##2##(1993-12#1)(2007-12#1)
cells plated##2##2##(1990-3#1)(1997-3#1)
cells play a##4##3##(1994-9#1)(2008-11#1)(2008-7#1)(2010-5#1)
cells play##7##2##(1990-5#1)(1994-9#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-5#1)
cells played a crucial role in##2##6##(2008-10#1)(2008-8#1)
cells possess both##2##3##(1993-6#1)(1995-8#1)
cells possess##10##2##(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-8#1)(2008-11#1)(2008-7#1)(2009-9#1)
cells possessed a##2##3##(1993-9#1)(2008-5#1)
cells possessed##3##2##(1993-9#1)(2008-5#1)(2008-6#1)
cells prelabelled with##3##3##(1990-12#3)
cells prepared from the##5##4##(1992-9#1)(1996-5#4)
cells prepared from##9##3##(1992-9#1)(1995-11#1)(1996-5#6)(2008-11#1)
cells prepared##11##2##(1992-9#1)(1995-11#1)(1996-5#6)(2008-11#2)(2008-4#1)
cells present in a##2##4##(2008-4#2)
cells present in##5##3##(1996-5#1)(2008-11#1)(2008-4#2)(2008-9#1)
cells present##11##2##(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2012-3#1)
cells pretreated with##3##3##(1990-11#1)(1995-11#1)(1996-12#1)
cells previously##3##2##(1995-12#1)(2008-11#2)
cells prior to##5##3##(1992-12#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
cells probably##2##2##(1991-5#1)(1993-9#1)
cells produce a##2##3##(1990-2#1)(1996-12#1)
cells produce##11##2##(1990-2#2)(1994-11#1)(1995-2#1)(1996-12#1)(1996-9#1)(2007-12#2)(2008-11#1)(2008-9#1)(2010-3#1)
cells produced##4##2##(2008-10#1)(2008-11#3)
cells produces a##2##3##(1993-6#1)(2008-3#1)
cells produces##3##2##(1993-6#1)(2008-3#1)(2009-1#1)
cells producing the##3##3##(1993-2#1)(1995-2#1)(2008-7#1)
cells producing tissue##2##3##(2008-11#2)
cells producing##11##2##(1992-12#1)(1993-2#1)(1994-5#1)(1995-2#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)
cells proliferate and differentiate##2##4##(1995-12#1)(2010-3#1)
cells proliferate##4##2##(1995-12#1)(1995-2#1)(1997-1#1)(2010-3#1)
cells proliferated##2##2##(2008-11#1)(2012-1#1)
cells proliferation and##2##3##(2008-11#1)(2013-1#1)
cells proliferation##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
cells provide a##2##3##(1993-3#1)(1997-2#1)
cells provide an##2##3##(2008-11#1)(2008-3#1)
cells provide##7##2##(1993-3#1)(1997-2#1)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
cells rather than##5##3##(1990-5#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
cells reacted##2##2##(2008-11#1)(2011-1#1)
cells receive##2##2##(1995-2#1)(2009-2#1)
cells recovered from##2##3##(2008-10#1)(2012-2#1)
cells reduced##2##2##(1996-2#1)(2008-8#1)
cells regulate the##2##3##(2010-5#1)(2013-8#1)
cells regulate##3##2##(2010-5#1)(2012-2#1)(2013-8#1)
cells release##3##2##(2008-4#2)(2013-8#1)
cells released##2##2##(1992-12#1)(2008-11#1)
cells relevant to##3##3##(1994-6#1)(2008-10#1)(2008-2#1)
cells remain##4##2##(1993-9#1)(1997-1#1)(2008-7#1)(2009-10#1)
cells remained on##2##3##(2008-11#2)
cells remained##5##2##(2008-11#4)(2010-11#1)
cells remains poorly##2##3##(1993-9#1)(2012-12#1)
cells remains to be##2##4##(2008-11#1)(2009-8#1)
cells remains##8##2##(1993-9#1)(1996-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
cells represent a##3##3##(2007-12#1)(2008-7#1)(2009-3#1)
cells represent##4##2##(2007-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
cells represents a##3##3##(1995-9#1)(2008-9#2)
cells represents##4##2##(1995-9#1)(2008-6#1)(2008-9#2)
cells requires##8##2##(1992-9#2)(1993-8#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#1)
cells resistant to##4##3##(1993-8#1)(1994-11#1)(1997-4#1)(2008-10#1)
cells respectively##2##2##(2008-7#1)(2008-9#1)
cells respond to##3##3##(1995-11#1)(1996-2#1)(2008-11#1)
cells respond##5##2##(1995-11#1)(1996-2#1)(2008-11#3)
cells responded to##7##3##(1990-12#1)(1990-2#1)(1992-6#3)(2008-7#1)(2011-1#1)
cells responded##9##2##(1990-12#1)(1990-2#1)(1992-6#3)(1995-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
cells responding to activin A##3##5##(1994-9#3)
cells responding to##8##3##(1992-6#2)(1994-2#1)(1994-9#3)(2010-5#1)(2012-2#1)
cells responsible for##2##3##(1994-11#1)(2009-8#1)
cells responsive##2##2##(1992-9#1)(2008-11#1)
cells resulted in a##3##4##(1993-12#1)(1996-12#1)(2008-11#1)
cells resulted in an##3##4##(1992-6#1)(1995-6#1)(1996-6#1)
cells resulted in##11##3##(1992-6#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
cells resulting in##3##3##(2009-3#1)(2010-3#1)(2013-1#1)
cells resulting##4##2##(2008-9#1)(2009-3#1)(2010-3#1)(2013-1#1)
cells results in##6##3##(1992-7#1)(1992-9#2)(1994-8#1)(2008-7#2)
cells retained##3##2##(1997-6#1)(2008-10#1)(2008-7#1)
cells revealed a##3##3##(1990-8#1)(2008-5#1)(2012-2#1)
cells revealed that the##3##4##(1993-12#1)(2008-8#1)(2012-2#1)
cells revealed that##7##3##(1993-12#1)(1993-9#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
cells revealed the presence of##2##5##(1993-12#1)(2012-2#1)
cells revealed the##4##3##(1992-3#1)(1993-12#1)(2008-11#1)(2012-2#1)
cells revealed##21##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#2)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#3)
cells reveals a##2##3##(2010-6#1)(2012-2#1)
cells reveals##3##2##(2010-6#1)(2012-2#1)(2013-8#1)
cells secrete##6##2##(1991-2#1)(1994-11#1)(1995-5#1)(1997-7#1)(2007-12#1)(2013-8#1)
cells secreting##3##2##(2008-11#2)(2008-7#1)
cells seeded##2##2##(1994-2#1)(2008-5#1)
cells seems##2##2##(1995-12#1)(2009-6#1)
cells selected##3##2##(1994-5#1)(2008-9#1)(2012-12#1)
cells sensitive to##3##3##(1995-12#1)(2008-8#1)(2013-1#1)
cells sensitive##5##2##(1991-4#1)(1995-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
cells share a##3##3##(2007-12#1)(2008-1#1)(2008-9#1)
cells should be##4##3##(1991-3#1)(1995-12#1)(1997-4#1)(2008-10#1)
cells should##7##2##(1990-7#1)(1991-3#1)(1992-12#1)(1995-12#1)(1997-4#1)(2008-10#1)(2009-4#1)
cells show a##5##3##(1990-11#1)(1992-3#1)(1992-9#1)(2008-11#2)
cells show that##4##3##(1997-1#1)(2008-8#1)(2008-9#1)(2012-3#1)
cells show##14##2##(1990-11#1)(1992-3#1)(1992-9#1)(1997-1#1)(2008-11#4)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
cells showed a##8##3##(1994-6#1)(1997-6#1)(2008-11#5)(2011-1#1)
cells showed that the##4##4##(1993-11#1)(1995-6#1)(2008-11#1)(2009-8#1)
cells showed that##10##3##(1992-6#1)(1993-11#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)
cells showed the##5##3##(1993-8#1)(1994-8#1)(1994-9#1)(2008-11#1)(2008-9#1)
cells showed##44##2##(1990-5#1)(1992-2#3)(1992-6#1)(1993-11#1)(1993-8#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#13)(2008-12#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
cells showing an##2##3##(1990-2#1)(1992-6#1)
cells showing##7##2##(1990-11#1)(1990-2#1)(1992-6#1)(1994-6#1)(1997-3#2)(2013-8#1)
cells shows##2##2##(1992-9#1)(2009-8#1)
cells significantly increased##3##3##(1995-12#1)(2008-4#1)(2012-4#1)
cells significantly##7##2##(1995-12#1)(1997-4#1)(2008-4#1)(2008-8#1)(2012-2#2)(2012-4#1)
cells similar to##2##3##(1997-7#1)(2011-2#1)
cells since##3##2##(1995-11#1)(2008-4#1)(2009-10#1)
cells situated##2##2##(1994-2#1)(1997-2#1)
cells so that they are##2##5##(1994-5#2)
cells so that they##3##4##(1994-5#2)(2008-9#1)
cells so that##5##3##(1994-5#2)(2008-4#1)(2008-9#1)(2011-3#1)
cells specific for the##2##4##(2008-11#1)(2012-2#1)
cells specifically##2##2##(1993-6#1)(1997-7#1)
cells stably expressing##5##3##(1995-11#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
cells stably transfected with##2##4##(1992-9#1)(2013-1#1)
cells stably transfected##3##3##(1992-9#1)(2008-9#1)(2013-1#1)
cells stably##9##2##(1992-9#1)(1994-11#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#2)
cells stained with the##2##4##(2008-8#1)(2008-9#1)
cells stained with##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
cells stained##6##2##(1990-7#1)(2008-10#1)(2008-8#1)(2008-9#3)
cells stimulated with the##2##4##(1991-5#1)(2012-12#1)
cells stimulated with##7##3##(1990-7#3)(1991-5#1)(1993-3#1)(1995-11#1)(2012-12#1)
cells stimulated##10##2##(1990-7#3)(1991-5#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-2#1)(2009-12#1)(2012-12#1)
cells stopped##2##2##(2008-11#2)
cells studied##4##2##(1991-9#1)(2007-6#1)(2008-8#1)(2009-12#1)
cells subjected to hypoosmotic pressure##2##5##(2008-11#2)
cells subjected to##5##3##(2008-11#2)(2008-7#1)(2009-12#1)(2009-7#1)
cells such as platelets and##2##5##(2008-9#1)(2011-2#1)
cells such as##15##3##(1990-9#1)(1992-2#2)(1993-11#1)(1994-3#1)(1995-5#1)(2008-11#2)(2008-5#1)(2008-9#4)(2011-2#2)
cells suggested that##2##3##(1992-3#1)(1995-8#1)
cells suggested the##2##3##(1991-5#1)(1992-6#1)
cells suggested##5##2##(1991-5#1)(1992-3#1)(1992-6#1)(1995-8#1)(2008-8#1)
cells suggests that##4##3##(1994-11#1)(1994-6#1)(2009-9#1)(2011-2#1)
cells suggests##7##2##(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(2008-12#1)(2009-9#1)(2011-2#1)
cells supported##2##2##(1995-2#1)(2012-2#1)
cells supports##2##2##(1992-6#1)(2012-12#1)
cells surrounded##2##2##(2008-7#2)
cells surrounding the##2##3##(1997-6#1)(2008-10#1)
cells surrounding##5##2##(1995-12#1)(1997-6#1)(2008-10#1)(2008-4#1)(2012-3#1)
cells survived##6##2##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)
cells surviving##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
cells synthesize##3##2##(1997-1#1)(2008-7#1)(2013-1#1)
cells take up##2##3##(1990-2#1)(2008-7#1)
cells tested##4##2##(1992-3#1)(1994-3#1)(2008-10#1)(2011-1#1)
cells than in control cells##2##5##(1992-3#1)(2008-4#1)
cells than in##8##3##(1990-6#1)(1992-3#1)(1992-8#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
cells than the##4##3##(1990-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
cells than those in##2##4##(2008-11#2)
cells than those##3##3##(2008-11#2)(2011-2#1)
cells than##23##2##(1990-6#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1995-3#1)(1997-8#1)(2008-11#6)(2008-3#1)(2008-4#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
cells that also##2##3##(2008-7#1)(2012-12#1)
cells that are functionally##2##4##(1997-2#1)(2013-1#1)
cells that are homozygous for##2##5##(1995-2#1)(2008-9#1)
cells that are in the##2##5##(1994-3#2)
cells that are##18##3##(1990-11#2)(1993-3#1)(1994-3#2)(1994-5#1)(1995-2#1)(1997-2#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
cells that can be##2##4##(2008-4#1)(2008-9#1)
cells that can##4##3##(2008-4#1)(2008-9#1)(2012-12#1)(2013-8#1)
cells that carry##2##3##(1990-5#1)(2011-2#1)
cells that cleaves##2##3##(1990-2#1)(1994-11#1)
cells that contained##4##3##(2008-11#4)
cells that could not##2##4##(2008-7#2)
cells that enable##2##3##(2010-11#1)(2013-8#1)
cells that express the##3##4##(1995-8#1)(2008-7#1)(2011-1#1)
cells that express##8##3##(1992-3#1)(1992-8#1)(1993-12#1)(1995-8#1)(2008-7#2)(2010-11#1)(2011-1#1)
cells that form##2##3##(2007-12#1)(2013-7#1)
cells that had##2##3##(1991-9#1)(2011-2#1)
cells that have been##4##4##(2008-4#2)(2008-5#1)(2012-12#1)
cells that have##8##3##(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
cells that is##4##3##(1990-12#1)(1997-7#1)(2011-1#1)(2013-1#1)
cells that lack##2##3##(1995-2#1)(1997-7#1)
cells that maintain##2##3##(2010-10#1)(2013-1#1)
cells that may be##2##4##(2008-4#1)(2009-6#1)
cells that may have##2##4##(2008-4#2)
cells that may##7##3##(1991-5#1)(2008-4#3)(2009-3#1)(2009-6#1)(2010-11#1)
cells that produce##2##3##(2008-9#1)(2011-1#1)
cells that responded to##2##4##(1992-6#1)(2008-10#1)
cells that responded##3##3##(1992-6#1)(2007-12#1)(2008-10#1)
cells that surround##2##3##(1991-5#1)(1994-9#1)
cells that was##2##3##(2008-10#1)(2008-4#1)
cells that were##13##3##(1990-12#1)(1992-12#2)(1992-3#1)(1994-8#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-8#1)
cells that##152##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#2)(2007-12#7)(2008-1#2)(2008-10#9)(2008-11#8)(2008-2#1)(2008-3#2)(2008-4#15)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#8)(2009-12#2)(2009-3#4)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#6)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
cells the##5##2##(1991-12#1)(1992-12#1)(1993-6#1)(1993-9#1)(1997-6#1)
cells themselves##3##2##(1992-2#1)(2008-11#1)(2008-7#1)
cells through a##4##3##(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
cells through down-regulation of##2##4##(2011-2#1)(2012-12#1)
cells through the##3##3##(2008-11#2)(2009-8#1)
cells through their##3##3##(1995-2#1)(2008-4#1)(2008-8#1)
cells through##26##2##(1990-11#1)(1993-8#1)(1995-2#2)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#3)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)
cells throughout the##3##3##(1997-1#1)(2008-7#2)
cells throughout##5##2##(1993-11#1)(1997-1#1)(2007-12#1)(2008-7#2)
cells to a##10##3##(1990-11#1)(1990-5#1)(1993-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)
cells to achieve##2##3##(2008-11#1)(2009-9#1)
cells to an##2##3##(1990-11#1)(2008-8#1)
cells to be used##2##4##(2008-11#1)(2008-4#1)
cells to be##8##3##(2008-11#1)(2008-4#4)(2008-5#1)(2011-1#1)(2012-2#1)
cells to cisplatin##2##3##(2008-9#2)
cells to degrade##2##3##(1992-9#1)(1995-11#1)
cells to differentiate##5##3##(1991-9#1)(1994-11#1)(2007-12#1)(2008-8#1)(2008-9#1)
cells to express the##2##4##(1994-11#1)(1995-4#1)
cells to express##3##3##(1994-11#2)(1995-4#1)
cells to form##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
cells to generate##2##3##(1995-2#1)(2007-12#1)
cells to grow##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
cells to growth in##2##4##(2008-11#2)
cells to growth##3##3##(2008-11#2)(2011-2#1)
cells to high##3##3##(2008-11#3)
cells to induce##3##3##(2008-10#1)(2008-4#1)(2010-7#1)
cells to interleukin-2##3##3##(1994-12#3)
cells to ionizing radiation##2##4##(1994-8#1)(2008-11#1)
cells to levels##2##3##(1990-2#1)(1992-9#1)
cells to maintain##2##3##(1996-2#1)(2008-7#1)
cells to mechanical perturbation##2##4##(2007-12#2)
cells to oxidative stress##2##4##(1991-2#1)(2008-3#1)
cells to oxidative##3##3##(1991-2#2)(2008-3#1)
cells to positively charged##3##4##(2008-10#3)
cells to produce##13##3##(1990-5#1)(1993-5#3)(1994-6#2)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2010-8#2)
cells to proliferate##3##3##(1997-6#1)(2008-4#1)(2010-9#1)
cells to respond to##2##4##(2008-7#1)(2012-3#1)
cells to suppress##2##3##(2006-10#1)(2008-11#1)
cells to the##28##3##(1992-11#1)(1992-3#1)(1993-9#2)(1995-11#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#4)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
cells to these##2##3##(2008-11#2)
cells to this##2##3##(1990-5#1)(1994-6#1)
cells to undergo apoptosis##3##4##(1995-2#2)(2010-6#1)
cells to undergo##5##3##(1995-2#2)(2008-4#1)(2010-6#1)(2013-1#1)
cells to##295##2##(1990-11#6)(1990-12#1)(1990-2#3)(1990-5#5)(1991-12#3)(1991-2#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-3#4)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#4)(1994-11#6)(1994-12#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-12#6)(2007-5#1)(2008-1#3)(2008-10#22)(2008-11#49)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#16)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#13)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#4)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#2)
cells together with##5##3##(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-8#1)
cells towards##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
cells transfected with a##3##4##(1994-2#1)(1995-12#1)(2008-11#1)
cells transfected with each##2##4##(1995-8#2)
cells transfected with the##8##4##(1993-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
cells transfected with##47##3##(1990-12#1)(1992-12#4)(1993-1#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#5)(1995-8#2)(1997-7#1)(1997-9#1)(2008-10#1)(2008-11#7)(2008-4#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
cells transferred##2##2##(2008-7#1)(2008-9#1)
cells transformed by the##2##4##(1991-8#1)(1997-7#1)
cells transformed by##5##3##(1991-2#1)(1991-8#1)(1992-9#1)(1997-7#1)(2009-7#1)
cells transformed with##6##3##(1995-2#1)(1997-7#1)(2008-10#2)(2011-2#2)
cells transformed##11##2##(1991-2#1)(1991-8#1)(1992-9#1)(1995-2#1)(1997-7#2)(2008-10#2)(2009-7#1)(2011-2#2)
cells transiently transfected with##3##4##(1994-11#1)(1994-8#1)(1994-9#1)
cells transplantation##3##2##(2008-5#1)(2011-3#1)(2013-8#1)
cells transplanted into##2##3##(2011-2#1)(2013-1#1)
cells transplanted##4##2##(1994-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
cells treated by##4##3##(2008-11#3)(2013-8#1)
cells treated with 1##2##4##(1993-8#1)(2012-12#1)
cells treated with compound 1##2##5##(2012-2#2)
cells treated with##42##3##(1990-5#1)(1991-2#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-8#8)(1997-1#1)(1997-4#4)(2008-11#8)(2008-9#3)(2010-12#1)(2012-12#1)(2012-2#3)(2013-8#1)
cells treated##48##2##(1990-5#1)(1991-2#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-8#8)(1996-12#1)(1997-1#1)(1997-4#4)(2008-11#11)(2008-9#3)(2010-12#1)(2012-12#1)(2012-2#3)(2013-8#2)
cells types##2##2##(2008-10#1)(2008-2#1)
cells typically##2##2##(2010-6#2)
cells under both##2##3##(1995-11#1)(1997-1#1)
cells under physiological conditions##3##4##(1990-12#2)(2008-10#1)
cells under the control of##2##5##(2008-8#1)(2010-12#1)
cells under the##4##3##(2008-11#2)(2008-8#1)(2010-12#1)
cells under##22##2##(1990-12#2)(1990-2#1)(1992-7#1)(1993-6#1)(1994-11#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#2)(2012-2#1)
cells undergo apoptosis##3##3##(1993-9#1)(2008-5#1)(2010-3#1)
cells undergo##8##2##(1991-5#1)(1993-9#1)(2007-8#1)(2008-5#2)(2009-3#1)(2010-3#1)(2011-2#1)
cells undergoing apoptosis and##2##4##(1994-12#1)(2008-8#1)
cells undergoing##7##2##(1992-12#1)(1994-12#1)(1994-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)
cells upon treatment with##2##4##(1993-9#1)(2008-11#1)
cells upon##7##2##(1993-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
cells use##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
cells used for the production of##2##6##(2008-11#2)
cells used for the##3##4##(2008-11#3)
cells used for##4##3##(1996-2#1)(2008-11#3)
cells used in these##2##4##(2008-4#2)
cells used##7##2##(1996-2#1)(2008-11#3)(2008-4#2)(2010-6#1)
cells using a##16##3##(1990-2#1)(1993-9#1)(1994-9#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-9#2)(2009-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
cells using the##7##3##(1993-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
cells using##67##2##(1990-2#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-8#2)(1996-5#1)(2008-1#5)(2008-10#4)(2008-11#16)(2008-12#1)(2008-4#7)(2008-8#5)(2008-9#5)(2009-2#1)(2009-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
cells utilizing a##2##3##(1993-9#1)(1996-9#1)
cells versus##2##2##(2008-9#1)(2012-12#1)
cells very##2##2##(1993-5#1)(2008-5#1)
cells via a##3##3##(1993-8#1)(2008-11#1)(2009-4#1)
cells via activation of##2##4##(2008-11#1)(2008-4#1)
cells via an##2##3##(1993-3#1)(2007-12#1)
cells via similar##3##3##(1991-9#1)(2009-6#2)
cells via the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
cells via##27##2##(1991-9#1)(1993-3#1)(1993-8#1)(1994-9#1)(2007-12#2)(2008-10#2)(2008-11#7)(2008-4#4)(2008-8#1)(2009-4#1)(2009-6#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
cells was 4##2##3##(2008-12#1)(2011-2#1)
cells was about 2##2##4##(1990-7#1)(1997-1#1)
cells was about##6##3##(1990-7#2)(1993-9#1)(1997-1#1)(2008-11#2)
cells was already##2##3##(1992-5#1)(2008-11#1)
cells was also increased##2##4##(2008-11#1)(2011-2#1)
cells was also##11##3##(1991-12#1)(1994-11#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)
cells was characterized##2##3##(1992-9#1)(2008-11#1)
cells was compared##2##3##(1990-12#1)(1996-12#1)
cells was completely blocked by##2##5##(1994-8#1)(2008-9#1)
cells was confirmed##4##3##(1991-6#1)(1996-12#1)(2008-11#1)(2008-8#1)
cells was decreased##2##3##(1993-9#1)(2008-8#1)
cells was detected by##2##4##(2008-9#1)(2010-1#1)
cells was detected##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
cells was determined by##5##4##(1993-6#1)(1994-8#1)(1995-3#1)(2008-11#2)
cells was determined##7##3##(1990-2#1)(1993-6#1)(1994-8#1)(1995-3#1)(2008-11#3)
cells was diminished##2##3##(1991-12#1)(1993-9#1)
cells was enhanced##2##3##(2008-11#2)
cells was evaluated##2##3##(1994-12#1)(2013-1#1)
cells was examined##5##3##(1992-12#1)(1992-6#1)(1994-11#1)(1995-6#1)(2008-8#1)
cells was found in##2##4##(1995-11#1)(2008-7#1)
cells was found to be##3##5##(1990-6#1)(1992-9#1)(2011-1#1)
cells was found to##7##4##(1990-5#1)(1990-6#1)(1992-12#1)(1992-9#1)(2008-11#2)(2011-1#1)
cells was found##12##3##(1990-5#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-9#2)(1995-11#1)(2008-11#3)(2008-7#1)(2011-1#1)
cells was increased##4##3##(1994-11#1)(1994-6#1)(1997-1#1)(2008-11#1)
cells was inhibited by##6##4##(1991-2#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
cells was inhibited##7##3##(1991-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
cells was investigated##8##3##(1990-2#1)(1991-9#1)(1992-5#1)(1994-11#2)(2008-11#3)
cells was measured by the##2##5##(1993-12#1)(2009-8#1)
cells was measured by##3##4##(1993-12#1)(2009-8#1)(2013-7#1)
cells was measured##5##3##(1993-12#1)(1995-11#1)(1995-3#1)(2009-8#1)(2013-7#1)
cells was not##4##3##(1993-9#1)(1997-1#1)(2008-11#1)(2008-8#1)
cells was observed in##2##4##(1994-3#1)(2010-11#1)
cells was observed when##2##4##(1990-12#1)(2013-1#1)
cells was observed##10##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-9#1)(1994-3#1)(1995-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
cells was proportional to##2##4##(2008-11#2)
cells was reduced##2##3##(2008-11#1)(2008-8#1)
cells was shown##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
cells was significantly lower##2##4##(1991-6#1)(1995-11#1)
cells was significantly##5##3##(1991-6#1)(1992-8#1)(1995-11#1)(1997-4#1)(2008-11#1)
cells was studied##4##3##(1990-7#1)(1994-11#1)(2008-8#1)(2012-1#1)
cells was successfully##2##3##(1995-12#1)(2008-11#1)
cells was used##2##3##(1995-2#1)(2008-5#1)
cells was##204##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#4)(1991-12#2)(1991-2#2)(1991-6#2)(1991-9#4)(1992-12#3)(1992-3#3)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#4)(1993-12#1)(1993-3#1)(1993-6#5)(1993-8#2)(1993-9#6)(1994-11#6)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#3)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#48)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#6)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-2#2)(2013-1#5)(2013-7#2)
cells we##3##2##(1990-11#1)(2008-7#1)(2008-8#1)
cells weakly##2##2##(1992-9#1)(2008-11#1)
cells were able to##4##4##(1990-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
cells were adapted to##2##4##(2008-11#2)
cells were adapted##3##3##(2008-11#3)
cells were affected##2##3##(1991-1#1)(2008-11#1)
cells were also positive##2##4##(1992-6#1)(1996-5#1)
cells were also##19##3##(1991-10#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-5#2)(1997-1#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-3#1)(2013-1#1)
cells were amplified##2##3##(2008-11#2)
cells were analysed##2##3##(2008-11#1)(2013-1#1)
cells were assessed##4##3##(2008-11#2)(2010-6#1)(2011-2#1)
cells were both##2##3##(2008-11#1)(2010-6#1)
cells were characterized by##2##4##(1994-9#1)(2013-1#1)
cells were collected##2##3##(2008-11#1)(2011-2#1)
cells were compared for##2##4##(1993-9#1)(2008-10#1)
cells were compared##3##3##(1993-9#1)(2008-10#1)(2010-12#1)
cells were counted##2##3##(2007-11#1)(2011-1#1)
cells were cultivated in##3##4##(2008-11#3)
cells were cultivated##5##3##(1990-12#1)(2008-11#3)(2008-5#1)
cells were cultured for##2##4##(1995-3#1)(2008-11#1)
cells were cultured in serum-free medium##2##6##(1992-12#1)(2008-11#1)
cells were cultured in the presence of##4##7##(1993-3#1)(2008-11#3)
cells were cultured in the##5##5##(1993-3#1)(2008-11#4)
cells were cultured in##14##4##(1992-12#2)(1993-3#1)(1996-12#1)(1996-2#1)(2008-11#8)(2012-4#1)
cells were cultured on##2##4##(2008-11#1)(2008-6#1)
cells were cultured under##3##4##(2008-11#3)
cells were cultured##24##3##(1990-12#1)(1992-12#2)(1993-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#14)(2008-6#1)(2012-4#1)
cells were demonstrated##3##3##(1991-10#1)(1992-8#1)(2008-11#1)
cells were developed##2##3##(2008-10#1)(2008-9#1)
cells were different##2##3##(2008-12#1)(2008-7#1)
cells were diffusely##2##3##(2008-7#1)(2013-8#1)
cells were distributed##3##3##(1993-12#1)(1997-2#1)(2008-10#1)
cells were either##3##3##(1995-8#1)(2008-11#1)(2008-6#1)
cells were estimated##2##3##(1994-6#1)(2008-7#1)
cells were examined by##3##4##(2008-11#2)(2008-8#1)
cells were examined using##2##4##(2008-11#1)(2008-6#1)
cells were examined##11##3##(1990-12#1)(1990-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(2008-11#4)(2008-6#1)(2008-8#1)
cells were exposed to a##2##5##(1997-4#1)(2008-11#1)
cells were exposed to the##2##5##(1992-5#1)(2011-2#1)
cells were exposed to ultrasound##2##5##(1993-8#1)(2008-8#1)
cells were exposed to##13##4##(1990-2#1)(1990-8#1)(1992-5#1)(1993-8#2)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cells were exposed##14##3##(1990-2#1)(1990-8#1)(1992-5#1)(1993-12#1)(1993-8#2)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cells were first grown##2##4##(2008-11#2)
cells were fixed##2##3##(1990-8#1)(2011-2#1)
cells were formed##2##3##(2008-10#1)(2008-7#1)
cells were found in##5##4##(1990-2#1)(1992-12#1)(1994-2#1)(2008-5#1)(2008-8#1)
cells were found to be##3##5##(1994-8#1)(2008-7#1)(2008-8#1)
cells were found to##6##4##(1990-12#1)(1994-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
cells were found##17##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1994-2#1)(1994-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#2)
cells were grown in a##2##5##(2008-11#2)
cells were grown in##5##4##(2008-10#2)(2008-11#3)
cells were grown on##5##4##(1995-9#1)(2008-11#2)(2008-6#1)(2013-1#1)
cells were grown##14##3##(1993-8#1)(1995-9#1)(2008-10#2)(2008-11#6)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
cells were identified by##3##4##(1996-5#1)(1997-3#1)(2008-5#1)
cells were identified##4##3##(1996-5#1)(1997-3#1)(2008-5#1)(2010-11#1)
cells were immunoreactive for##2##4##(1995-5#1)(2013-1#1)
cells were in##2##3##(1996-5#1)(2008-7#1)
cells were increased##2##3##(2008-10#1)(2011-3#1)
cells were incubated for##3##4##(1993-6#1)(1995-11#1)(2012-3#1)
cells were incubated with##4##4##(1994-11#1)(1995-11#1)(2008-10#1)(2010-11#1)
cells were incubated##8##3##(1991-5#1)(1993-6#1)(1994-11#1)(1995-11#2)(2008-10#1)(2010-11#1)(2012-3#1)
cells were induced by##2##4##(2008-4#1)(2013-1#1)
cells were induced##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
cells were infected with##2##4##(1997-3#1)(2011-3#1)
cells were injected into##2##4##(2013-1#2)
cells were injected##3##3##(2008-11#1)(2013-1#2)
cells were inoculated##2##3##(1991-12#1)(1994-9#1)
cells were introduced##2##3##(2008-8#1)(2008-9#1)
cells were investigated##5##3##(1992-3#1)(2008-11#2)(2008-3#1)(2009-10#1)
cells were irradiated with##2##4##(2008-11#1)(2012-3#1)
cells were irradiated##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
cells were isolated from##5##4##(1996-5#1)(2008-11#2)(2008-6#1)(2013-1#1)
cells were isolated##7##3##(1996-5#1)(2008-11#2)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
cells were labeled with##2##4##(1992-8#1)(1994-9#1)
cells were more numerous##2##4##(1993-12#1)(1994-2#1)
cells were more##6##3##(1993-12#1)(1994-2#1)(1994-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
cells were not##13##3##(1990-7#1)(1992-2#1)(1992-6#2)(1993-8#1)(1993-9#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-6#1)
cells were observed in the##2##5##(1997-2#1)(2008-10#1)
cells were observed in##3##4##(1997-2#1)(2008-10#1)(2012-3#1)
cells were observed##10##3##(1991-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2012-3#1)
cells were obtained by##2##4##(1993-9#1)(2008-8#1)
cells were obtained##3##3##(1993-9#1)(2008-11#1)(2008-8#1)
cells were permeabilized with##2##4##(1992-5#1)(1992-6#1)
cells were placed in a##2##5##(2008-7#2)
cells were placed in##3##4##(1995-2#1)(2008-7#2)
cells were plated##2##3##(1992-6#1)(2013-1#1)
cells were positive for##2##4##(2012-1#2)
cells were prepared##2##3##(1991-5#1)(1997-3#1)
cells were present##3##3##(1992-9#1)(1994-12#1)(1994-5#1)
cells were recovered from##2##4##(2008-10#2)
cells were removed##2##3##(1990-8#1)(2013-1#1)
cells were seeded onto##3##4##(2008-11#1)(2010-11#1)(2012-4#1)
cells were seeded##5##3##(2008-11#2)(2008-5#1)(2010-11#1)(2012-4#1)
cells were seen in the##3##5##(1996-5#1)(2008-5#1)(2012-1#1)
cells were seen in##4##4##(1996-5#2)(2008-5#1)(2012-1#1)
cells were seen##6##3##(1990-2#1)(1996-5#3)(2008-5#1)(2012-1#1)
cells were selected##3##3##(1993-2#1)(1997-8#1)(2008-11#1)
cells were shown to##5##4##(1993-9#1)(2008-11#2)(2008-8#1)(2013-1#1)
cells were significantly more##2##4##(1995-11#1)(1997-4#1)
cells were significantly##3##3##(1995-11#1)(1997-4#1)(2008-9#1)
cells were similar to##2##4##(2008-5#1)(2008-6#1)
cells were similar##3##3##(2008-5#1)(2008-6#1)(2009-8#1)
cells were stably##2##3##(1993-2#1)(1995-2#1)
cells were still##2##3##(2008-11#1)(2009-12#1)
cells were stimulated by##2##4##(1991-2#1)(1995-8#1)
cells were stimulated##3##3##(1991-2#1)(1995-8#1)(1997-1#1)
cells were strongly##3##3##(1997-2#1)(2007-5#1)(2008-11#1)
cells were studied using##2##4##(1993-3#1)(1995-12#1)
cells were studied##10##3##(1990-7#1)(1991-5#1)(1992-8#1)(1993-3#1)(1995-12#1)(2008-11#2)(2008-8#2)(2008-9#1)
cells were subjected to a##2##5##(2008-11#1)(2010-1#1)
cells were subjected to##4##4##(1992-6#1)(2008-11#2)(2010-1#1)
cells were substantially##2##3##(1993-12#1)(1994-5#1)
cells were susceptible to##2##4##(1995-2#1)(2008-11#1)
cells were tested##2##3##(1990-12#1)(1995-3#1)
cells were the##2##3##(2008-8#1)(2008-9#1)
cells were then##6##3##(1990-8#1)(1992-3#1)(1994-3#1)(1994-5#1)(2008-11#1)(2008-12#1)
cells were transfected with##6##4##(1994-8#1)(2008-11#2)(2008-9#1)(2010-11#1)(2011-2#1)
cells were transfected##7##3##(1994-8#1)(2008-11#3)(2008-9#1)(2010-11#1)(2011-2#1)
cells were transferred##4##3##(2008-12#1)(2008-7#1)(2008-9#2)
cells were transformed##2##3##(2008-10#1)(2008-11#1)
cells were treated with the##2##5##(1991-5#1)(1992-6#1)
cells were treated with##11##4##(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
cells were treated##13##3##(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
cells were typsinized and replated##2##5##(2008-11#2)
cells were used as##2##4##(1991-5#1)(1996-5#1)
cells were used to##3##4##(2008-11#1)(2008-5#1)(2011-2#1)
cells were used##7##3##(1991-5#1)(1993-12#1)(1996-5#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
cells were##495##2##(1990-12#5)(1990-2#5)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#2)(1991-5#9)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#7)(1992-8#5)(1992-9#2)(1993-12#11)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#7)(1993-9#9)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#8)(1994-6#2)(1994-8#6)(1994-9#6)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#4)(1995-9#1)(1996-12#4)(1996-2#4)(1996-5#10)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#4)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#30)(2008-11#110)(2008-12#8)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#11)(2008-7#16)(2008-8#16)(2008-9#16)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#5)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#3)(2011-1#1)(2011-2#13)(2011-3#2)(2012-1#6)(2012-12#3)(2012-2#1)(2012-3#4)(2012-4#2)(2013-1#16)(2013-8#1)
cells when compared to##3##4##(2008-11#2)(2008-7#1)
cells when the##3##3##(1993-12#1)(1996-5#1)(2009-8#1)
cells when##15##2##(1991-2#1)(1991-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-11#4)(2008-3#1)(2008-7#2)(2009-8#1)
cells where it##2##3##(1997-2#1)(2008-11#1)
cells where the##2##3##(1995-6#1)(1997-4#1)
cells where##8##2##(1990-11#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-2#1)
cells whereas##2##2##(1990-12#1)(1996-5#1)
cells which are##4##3##(1994-6#1)(2008-11#1)(2008-6#1)(2013-1#1)
cells which can##2##3##(2008-11#1)(2008-9#1)
cells which did not##2##4##(1990-8#1)(1997-7#1)
cells which had##3##3##(1994-8#1)(2008-11#2)
cells which have##2##3##(2008-7#1)(2008-9#1)
cells which is a##2##4##(2008-5#1)(2008-8#1)
cells which lacked##2##3##(1994-3#1)(1997-4#1)
cells which were##7##3##(1993-1#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
cells which##47##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1992-8#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-11#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2012-2#1)(2013-1#2)
cells while in##2##3##(1996-5#1)(2008-11#1)
cells while##6##2##(1992-3#1)(1994-3#1)(1994-9#1)(1996-5#1)(2008-11#1)(2010-11#1)
cells whose##2##2##(1994-11#1)(2008-11#1)
cells will be##5##3##(2008-11#2)(2008-4#1)(2010-12#1)(2011-1#1)
cells will##13##2##(1994-5#1)(2007-5#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)
cells with 1##3##3##(1995-12#2)(1995-8#1)
cells with 12-O-tetradecanoyl-phorbol-13-acetate##2##3##(1993-3#1)(1995-6#1)
cells with 4##2##3##(1992-6#1)(2013-8#1)
cells with DNA damage##2##4##(1994-8#1)(2008-4#1)
cells with DNA##3##3##(1994-8#1)(2008-4#1)(2008-7#1)
cells with EGF##2##3##(1990-8#1)(1992-7#1)
cells with IL-1##3##3##(1990-12#1)(1993-3#1)(1995-6#1)
cells with a high efficiency##2##5##(1990-5#1)(2008-11#1)
cells with a high##3##4##(1990-5#1)(2008-11#2)
cells with a##34##3##(1990-5#2)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-12#1)(2010-3#1)
cells with an##7##3##(1994-8#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-1#1)
cells with cytoplasmic##2##3##(2009-5#1)(2012-3#1)
cells with defined##2##3##(2008-8#1)(2012-12#1)
cells with different##3##3##(1990-8#1)(1997-7#1)(2008-11#1)
cells with either##2##3##(1995-5#1)(2008-7#1)
cells with high efficiency##2##4##(2008-11#1)(2012-12#1)
cells with high expression of CD133##2##6##(2009-9#2)
cells with high##6##3##(2008-11#2)(2008-7#1)(2009-9#2)(2012-12#1)
cells with increasing##2##3##(2008-10#1)(2008-11#1)
cells with low##2##3##(2009-2#1)(2010-1#1)
cells with mercury##2##3##(2008-10#2)
cells with monoclonal antibodies##2##4##(1991-12#1)(2008-9#1)
cells with nuclear##3##3##(2008-7#1)(2010-3#1)(2011-2#1)
cells with replicative hepatitis B virus##2##6##(1995-2#2)
cells with respect to##3##4##(1995-8#1)(2008-4#1)(2013-1#1)
cells with round##2##3##(1991-8#1)(2012-1#1)
cells with sodium##2##3##(2008-5#1)(2008-8#1)
cells with that of##2##4##(1994-2#1)(2013-8#1)
cells with the##28##3##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#2)(1995-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#2)(2012-1#1)(2012-12#1)
cells with various##5##3##(1990-2#1)(2008-10#1)(2008-11#3)
cells with##326##2##(1990-12#3)(1990-2#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#4)(1993-6#2)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#10)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#6)(1995-2#5)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#4)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#7)(2008-1#6)(2008-10#17)(2008-11#60)(2008-12#1)(2008-2#4)(2008-4#11)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#17)(2009-2#1)(2009-5#2)(2009-9#2)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-6#2)(2010-9#2)(2011-1#4)(2011-2#5)(2012-1#10)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
cells within a##4##3##(1995-8#1)(2008-11#1)(2008-2#1)(2008-5#1)
cells within the##8##3##(1994-2#1)(2008-2#1)(2008-9#2)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
cells within##20##2##(1991-2#1)(1994-2#1)(1995-8#1)(2007-7#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
cells without##14##2##(1990-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-12#1)(2011-2#2)
cells would##2##2##(2008-9#1)(2009-2#1)
cells x day##4##3##(2008-11#4)
cells##11879##1##(1990-11#86)(1990-12#109)(1990-2#90)(1990-3#8)(1990-5#90)(1990-6#18)(1990-7#47)(1990-8#52)(1990-9#4)(1991-1#6)(1991-10#3)(1991-11#25)(1991-12#78)(1991-2#53)(1991-3#13)(1991-4#18)(1991-5#95)(1991-6#27)(1991-7#14)(1991-8#18)(1991-9#61)(1992-1#2)(1992-10#18)(1992-11#37)(1992-12#107)(1992-2#44)(1992-3#97)(1992-4#2)(1992-5#34)(1992-6#85)(1992-7#10)(1992-8#80)(1992-9#134)(1993-1#13)(1993-11#49)(1993-12#78)(1993-2#17)(1993-3#108)(1993-5#26)(1993-6#106)(1993-8#119)(1993-9#125)(1994-10#17)(1994-11#170)(1994-12#58)(1994-2#52)(1994-3#63)(1994-5#85)(1994-6#112)(1994-7#4)(1994-8#143)(1994-9#69)(1995-10#1)(1995-11#109)(1995-12#112)(1995-2#176)(1995-3#33)(1995-4#3)(1995-5#37)(1995-6#84)(1995-8#77)(1995-9#14)(1996-1#1)(1996-11#5)(1996-12#69)(1996-2#55)(1996-3#8)(1996-5#98)(1996-6#10)(1996-7#3)(1996-8#4)(1996-9#10)(1997-1#82)(1997-2#45)(1997-3#55)(1997-4#96)(1997-5#2)(1997-6#30)(1997-7#84)(1997-8#29)(1997-9#3)(2006-10#29)(2006-12#1)(2006-6#3)(2007-10#8)(2007-11#36)(2007-12#181)(2007-2#4)(2007-5#10)(2007-6#6)(2007-7#2)(2007-8#20)(2008-1#119)(2008-10#615)(2008-11#1864)(2008-12#59)(2008-2#90)(2008-3#68)(2008-4#522)(2008-5#235)(2008-6#102)(2008-7#455)(2008-8#366)(2008-9#545)(2009-1#4)(2009-10#53)(2009-11#21)(2009-12#71)(2009-2#19)(2009-3#92)(2009-4#22)(2009-5#17)(2009-6#38)(2009-7#22)(2009-8#62)(2009-9#30)(2010-1#33)(2010-10#27)(2010-11#89)(2010-12#45)(2010-2#18)(2010-3#46)(2010-4#6)(2010-5#41)(2010-6#48)(2010-7#8)(2010-8#22)(2010-9#10)(2011-1#84)(2011-2#304)(2011-3#21)(2012-1#88)(2012-10#1)(2012-12#166)(2012-2#176)(2012-3#116)(2012-4#9)(2012-5#7)(2012-6#1)(2012-7#3)(2013-1#262)(2013-7#27)(2013-8#116)
cells&quot##2##1##(2006-10#1)(2012-3#1)
cells' ability to##2##3##(1992-3#1)(1995-2#1)
cells'##16##1##(1992-3#1)(1995-2#1)(2006-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
cells(-1) day(-1)##2##2##(2008-11#2)
cells) and##7##2##(1992-5#1)(1992-6#1)(1996-12#1)(1997-1#1)(2008-11#1)(2009-10#1)(2013-8#1)
cells) are##7##2##(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
cells) for##2##2##(1995-8#1)(2008-7#1)
cells) or##3##2##(1993-6#1)(2008-7#2)
cells) was##4##2##(1992-6#1)(1995-4#1)(2008-5#1)(2008-7#1)
cells)##87##1##(1990-10#1)(1990-11#1)(1990-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-7#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#3)
cells/cm²##3##1##(2013-1#3)
cells/day##2##1##(2008-11#2)
cells/mL##3##1##(2007-12#1)(2008-6#1)(2008-8#1)
cells/ml for##4##2##(2008-11#1)(2010-1#3)
cells/ml##18##1##(1993-2#1)(1994-2#2)(1996-8#1)(2008-10#1)(2008-11#8)(2008-7#2)(2010-1#3)
cells/ml)##2##1##(1992-12#1)(1996-8#1)
cells/mm(3)##2##1##(2007-2#1)(2009-11#1)
cells?##3##1##(1997-4#1)(2008-11#2)
cells]##17##1##(1990-11#1)(2008-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
cellsgrowing in increased##2##3##(2008-11#2)
cellsin##3##1##(2008-11#2)(2008-8#1)
cellsshowed##2##1##(2008-11#2)
cellswas##2##1##(2008-11#2)
cellswere##3##1##(2008-11#3)
cellular ATP##4##2##(1990-11#1)(1991-9#1)(2009-4#1)(2011-2#1)
cellular DA levels##3##3##(1996-12#3)
cellular DA##4##2##(1996-12#4)
cellular DNA polymerase alpha-primase##2##4##(1994-8#2)
cellular DNA##19##2##(1992-11#2)(1994-8#5)(1995-11#1)(1997-7#1)(2008-11#3)(2008-7#1)(2008-9#4)(2012-2#2)
cellular PG##2##2##(1994-9#2)
cellular PKC##2##2##(1993-9#2)
cellular RNA##5##2##(1994-12#1)(1995-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
cellular SR proteins##4##3##(2009-2#4)
cellular accumulation##3##2##(1990-2#1)(1993-8#1)(2013-1#1)
cellular activation and##2##3##(2008-9#1)(2013-1#1)
cellular activation##6##2##(1992-12#1)(1995-11#1)(1995-6#2)(2008-9#1)(2013-1#1)
cellular activities##5##2##(1990-11#1)(2008-7#1)(2009-12#1)(2011-2#2)
cellular activity##5##2##(1991-2#1)(1992-11#1)(1994-8#1)(2008-11#1)(2012-2#1)
cellular adaptation##3##2##(1991-4#1)(1991-5#1)(2010-7#1)
cellular adhesion##4##2##(1992-9#1)(2008-11#2)(2008-4#1)
cellular aging##6##2##(1990-3#3)(2008-7#1)(2010-2#1)(2011-2#1)
cellular and humoral immune responses##3##5##(2008-10#1)(2008-11#1)(2008-12#1)
cellular and humoral immune##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
cellular and humoral immunity##2##4##(2008-10#1)(2012-2#1)
cellular and humoral##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#2)
cellular and molecular changes##2##4##(2008-7#2)
cellular and molecular interactions##2##4##(1995-6#1)(2011-2#1)
cellular and molecular levels##4##4##(2008-7#1)(2008-9#2)(2009-5#1)
cellular and molecular mechanisms that regulate##3##6##(2008-4#1)(2012-3#1)(2013-1#1)
cellular and molecular mechanisms##8##4##(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
cellular and molecular##23##3##(1994-5#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
cellular and nuclear##2##3##(1990-3#1)(2008-7#1)
cellular and tissue##5##3##(1990-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
cellular and viral##4##3##(1995-2#1)(2008-11#2)(2010-1#1)
cellular and##58##2##(1990-3#1)(1990-4#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-6#1)(1997-2#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#1)(2009-8#3)(2010-1#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
cellular antigens##2##2##(1990-12#1)(1997-3#1)
cellular antioxidant##2##2##(1992-3#1)(2008-10#1)
cellular apoptosis relative to##2##4##(2013-1#2)
cellular apoptosis##5##2##(2008-12#1)(2013-1#4)
cellular architecture##2##2##(2008-3#1)(2012-2#1)
cellular areas##3##2##(2007-4#2)(2010-6#1)
cellular automata##3##2##(1994-2#1)(2008-11#2)
cellular basis of learning and memory##2##6##(2007-8#1)(2009-8#1)
cellular basis of##3##3##(2007-8#1)(2008-7#1)(2009-8#1)
cellular basis##4##2##(1996-5#1)(2007-8#1)(2008-7#1)(2009-8#1)
cellular binding##2##2##(1994-3#1)(1994-8#1)
cellular biology##6##2##(1994-9#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
cellular changes that##2##3##(2008-4#1)(2009-12#1)
cellular changes##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)
cellular characteristics##2##2##(2008-11#1)(2013-8#1)
cellular cholesterol##3##2##(1990-8#1)(1994-11#1)(2008-6#1)
cellular compartments##7##2##(1995-2#1)(1996-9#1)(2008-1#1)(2008-7#2)(2009-8#1)(2012-12#1)
cellular component##3##2##(1992-8#1)(2008-9#1)(2013-1#1)
cellular components of##3##3##(1990-2#1)(1992-2#1)(2008-6#1)
cellular components##13##2##(1990-2#1)(1992-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
cellular composition##4##2##(1997-5#1)(2008-7#1)(2009-12#2)
cellular concentration##2##2##(2008-6#1)(2008-7#1)
cellular content##3##2##(1995-3#1)(2008-5#1)(2008-9#1)
cellular cytotoxicity##5##2##(1991-4#2)(1993-6#1)(2008-1#1)(2008-11#1)
cellular damage##2##2##(2008-6#1)(2008-8#1)
cellular death##3##2##(2008-8#2)(2013-1#1)
cellular debris##3##2##(1991-8#1)(1992-12#1)(1994-6#1)
cellular defense##2##2##(1994-6#1)(2008-7#1)
cellular degeneration##2##2##(1992-9#1)(2008-10#1)
cellular delivery##4##2##(1994-12#2)(2012-12#1)(2013-1#1)
cellular density##2##2##(2008-11#1)(2010-10#1)
cellular differentiation and proliferation##3##4##(1993-2#1)(2008-4#1)(2008-7#1)
cellular differentiation and##4##3##(1993-2#1)(1995-2#1)(2008-4#1)(2008-7#1)
cellular differentiation##9##2##(1993-2#1)(1993-9#1)(1995-2#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)
cellular disorganization##2##2##(2008-10#2)
cellular distribution of##7##3##(1995-11#1)(1995-12#1)(1996-5#2)(2008-10#1)(2008-11#1)(2012-2#1)
cellular distribution##8##2##(1995-11#2)(1995-12#1)(1996-5#2)(2008-10#1)(2008-11#1)(2012-2#1)
cellular drug accumulation##2##3##(2007-2#1)(2008-11#1)
cellular effector##2##2##(1996-10#1)(2008-4#1)
cellular effects and##2##3##(1994-2#1)(2008-7#1)
cellular effects##4##2##(1993-12#1)(1994-2#1)(2008-1#1)(2008-7#1)
cellular elements##5##2##(1995-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)
cellular energy##3##2##(1994-11#1)(1994-8#1)(2011-2#1)
cellular environment##6##2##(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
cellular environments##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
cellular enzyme##3##2##(1996-5#1)(2008-5#2)
cellular enzymes##2##2##(2008-2#1)(2008-5#1)
cellular events such as##2##4##(2009-5#1)(2011-2#1)
cellular events##13##2##(1997-4#1)(2007-12#2)(2008-12#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-5#1)(2011-2#3)
cellular excitability##3##2##(2008-8#1)(2009-3#1)(2013-8#1)
cellular expression of##2##3##(1996-12#1)(2009-3#1)
cellular expression##4##2##(1996-12#1)(2009-3#1)(2010-1#1)(2011-1#1)
cellular extracts##2##2##(1992-11#1)(2008-11#1)
cellular fatty acid##3##3##(2008-10#2)(2011-1#1)
cellular fatty##4##2##(2008-10#2)(2011-1#2)
cellular function and##2##3##(1995-12#1)(2008-5#1)
cellular function of##2##3##(1990-2#1)(2008-7#1)
cellular function##18##2##(1990-2#1)(1993-12#1)(1995-12#1)(1997-3#1)(2006-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
cellular functions and##2##3##(2008-8#1)(2009-4#1)
cellular functions of##4##3##(1995-2#1)(2008-11#1)(2009-8#1)(2010-12#1)
cellular functions##33##2##(1993-8#2)(1994-3#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
cellular genes which##2##3##(2008-8#2)
cellular genes##4##2##(1997-6#1)(2008-8#3)
cellular glutathione##3##2##(1992-11#1)(2008-7#2)
cellular growth and##3##3##(1993-6#1)(1994-3#2)
cellular growth##13##2##(1993-11#1)(1993-12#1)(1993-6#3)(1994-11#1)(1994-3#2)(1994-8#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
cellular health##2##2##(2011-2#2)
cellular heterogeneity##2##2##(2009-12#1)(2012-2#1)
cellular homeostasis and##2##3##(1994-12#1)(2008-5#1)
cellular homeostasis##4##2##(1991-5#1)(1994-12#1)(2008-5#1)(2012-2#1)
cellular imaging##2##2##(2008-10#1)(2010-11#1)
cellular immune response to##2##4##(1990-12#1)(1997-4#1)
cellular immune response##4##3##(1990-12#1)(1991-12#1)(1997-4#1)(2009-12#1)
cellular immune responses against##3##4##(1995-5#1)(2007-5#1)(2011-2#1)
cellular immune responses in##2##4##(2008-5#1)(2010-5#1)
cellular immune responses##15##3##(1991-12#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-5#1)(2008-12#2)(2008-4#3)(2008-5#2)(2010-5#1)(2011-1#1)(2011-2#1)
cellular immune##22##2##(1990-12#1)(1991-12#2)(1991-8#1)(1994-3#1)(1995-5#1)(1997-4#2)(2006-10#1)(2007-5#1)(2008-12#2)(2008-4#3)(2008-5#2)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
cellular immunity in##2##3##(2007-8#1)(2008-10#1)
cellular immunity##8##2##(1995-5#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
cellular infiltrate##4##2##(1996-12#1)(2007-9#1)(2008-9#1)(2012-3#1)
cellular infiltration of##2##3##(2012-12#2)
cellular infiltration##4##2##(1993-2#1)(2008-10#1)(2012-12#2)
cellular injury##2##2##(1995-11#1)(2008-8#1)
cellular insulin##3##2##(1991-12#2)(1991-7#1)
cellular integrity##2##2##(1991-5#1)(1996-6#1)
cellular interactions##3##2##(2008-10#1)(2009-3#1)(2009-9#1)
cellular level of##3##3##(1990-2#1)(1991-12#1)(2013-1#1)
cellular level##31##2##(1990-2#1)(1991-12#2)(1993-11#1)(1994-2#1)(1995-11#1)(1997-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
cellular levels are##2##3##(1994-6#1)(2011-2#1)
cellular levels of##6##3##(1991-12#1)(1991-3#1)(1992-8#1)(1995-2#1)(1996-12#1)(2012-2#1)
cellular levels##12##2##(1991-12#1)(1991-3#1)(1992-8#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-2#1)(2008-4#2)(2011-2#1)(2012-2#1)
cellular life/death balance##2##3##(2012-2#2)
cellular lipid##3##2##(1991-4#1)(1991-9#1)(2008-11#1)
cellular localization of##5##3##(1991-10#1)(1992-11#1)(1994-10#1)(1995-5#1)(1996-6#1)
cellular localization##6##2##(1991-10#1)(1992-11#1)(1994-10#1)(1995-5#1)(1996-6#1)(2008-4#1)
cellular location of##2##3##(2008-10#1)(2008-5#1)
cellular markers##3##2##(1996-5#1)(2008-9#1)(2012-2#1)
cellular material##4##2##(1997-3#2)(2010-5#2)
cellular mechanism for##2##3##(2008-7#1)(2009-8#1)
cellular mechanism of##2##3##(2008-10#1)(2008-11#1)
cellular mechanism##7##2##(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)
cellular mechanisms of##2##3##(1997-2#1)(2008-11#1)
cellular mechanisms that##2##3##(1990-2#1)(2009-8#1)
cellular mechanisms##12##2##(1990-2#1)(1990-5#1)(1994-8#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#2)(2011-2#1)
cellular membrane##7##2##(2008-10#1)(2008-11#1)(2008-9#2)(2009-8#1)(2010-11#1)(2011-1#1)
cellular membranes and##2##3##(1995-6#1)(2008-5#1)
cellular membranes##5##2##(1990-5#1)(1994-5#1)(1995-6#1)(1997-7#1)(2008-5#1)
cellular metabolism##10##2##(1993-8#1)(2008-10#2)(2008-11#5)(2008-7#2)
cellular microarrays##2##2##(2010-12#2)
cellular microenvironment##4##2##(2008-11#1)(2009-4#2)(2009-5#1)
cellular model of Alzheimer's disease##2##5##(2008-10#2)
cellular morphology##10##2##(1992-2#1)(1995-12#1)(1996-2#1)(2008-11#2)(2008-5#5)
cellular motion##2##2##(2007-12#1)(2009-12#1)
cellular motions##2##2##(2008-11#2)
cellular myosin##2##2##(1990-5#1)(1991-2#1)
cellular neural networks##4##3##(2008-2#4)
cellular or##5##2##(1991-12#1)(1994-6#1)(2006-10#1)(2008-11#1)(2009-8#1)
cellular organelles##4##2##(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)
cellular origin##3##2##(1996-2#2)(2013-8#1)
cellular oxidative stress##2##3##(2008-7#1)(2012-12#1)
cellular oxygen##2##2##(1992-5#1)(1997-1#1)
cellular pathways##5##2##(1992-11#2)(2008-7#1)(2009-7#1)(2011-2#1)
cellular patterns##2##2##(1991-8#1)(2009-5#1)
cellular phenotype##2##2##(1997-3#1)(2008-11#1)
cellular phenotypes##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
cellular phone##2##2##(2007-9#1)(2010-8#1)
cellular physiology##7##2##(1994-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
cellular plant pathogens##2##3##(2008-10#2)
cellular precursor mRNA splicing##2##4##(2009-2#2)
cellular process that##2##3##(1994-12#1)(2009-8#1)
cellular process##3##2##(1994-12#1)(2008-9#1)(2009-8#1)
cellular processes and##4##3##(1997-4#1)(2007-11#1)(2008-5#1)(2009-5#1)
cellular processes in##3##3##(1995-2#1)(2008-1#1)(2009-6#1)
cellular processes involving##2##3##(1991-9#1)(2009-6#1)
cellular processes such as##5##4##(2008-8#1)(2008-9#2)(2011-2#2)
cellular processes that##3##3##(2009-5#1)(2011-2#1)(2012-2#1)
cellular processes##54##2##(1991-5#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-2#3)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#3)(2010-11#1)(2010-9#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)
cellular productivity##3##2##(2008-11#3)
cellular proliferation and##2##3##(1991-12#1)(2013-1#1)
cellular proliferation in vitro##2##4##(2008-1#1)(2008-11#1)
cellular proliferation in##8##3##(1991-5#3)(1994-2#1)(1994-9#1)(2008-1#1)(2008-11#1)(2013-7#1)
cellular proliferation##27##2##(1991-12#1)(1991-5#3)(1991-9#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1996-2#1)(1996-6#1)(2008-1#2)(2008-11#3)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
cellular properties##3##2##(2008-9#1)(2009-5#1)(2009-7#1)
cellular protein##21##2##(1990-5#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-5#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)
cellular proteins are##2##3##(1997-3#1)(2008-4#1)
cellular proteins from##2##3##(1990-7#1)(2008-11#1)
cellular proteins in a##2##4##(1992-12#1)(1992-3#1)
cellular proteins in##4##3##(1990-12#1)(1992-12#1)(1992-3#1)(2008-11#1)
cellular proteins that##2##3##(1994-8#1)(1997-3#1)
cellular proteins##30##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#2)(1996-8#1)(1997-3#5)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)
cellular reactions##3##2##(1997-3#3)
cellular reactivity##2##2##(2007-8#1)(2011-2#1)
cellular receptor##5##2##(1993-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-8#1)
cellular redistribution of##2##3##(1994-6#2)
cellular redox homeostasis##4##3##(1994-8#2)(2009-6#1)(2009-9#1)
cellular redox##5##2##(1994-8#2)(2008-7#1)(2009-6#1)(2009-9#1)
cellular regulation of##2##3##(1991-5#1)(2008-4#1)
cellular regulation##3##2##(1991-5#1)(2008-1#1)(2008-4#1)
cellular release of##2##3##(1995-11#1)(1995-2#1)
cellular repair##2##2##(1997-4#2)
cellular resistance to##2##3##(2008-11#1)(2008-7#1)
cellular resolution##2##2##(1993-12#1)(2008-4#1)
cellular respiration##4##2##(1995-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
cellular response to DNA damage##4##5##(1995-2#2)(2011-2#2)
cellular response to##10##3##(1990-12#1)(1995-2#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
cellular response##18##2##(1990-12#1)(1995-12#1)(1995-2#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
cellular responses and##2##3##(2006-10#1)(2008-10#1)
cellular responses of##2##3##(2008-11#1)(2008-5#1)
cellular responses to##4##3##(1992-3#1)(1997-4#1)(1997-8#1)(2008-7#1)
cellular responses##17##2##(1991-2#1)(1992-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)
cellular responsiveness to##4##3##(1995-12#1)(2008-4#3)
cellular senescence##11##2##(1997-7#1)(2006-10#1)(2008-11#4)(2008-7#3)(2012-3#2)
cellular sensitivity to##4##3##(1990-2#1)(1993-3#2)(1995-12#1)
cellular sensitivity##5##2##(1990-2#1)(1993-3#2)(1995-12#1)(2008-11#1)
cellular shape change##2##3##(2009-9#2)
cellular signaling pathways##2##3##(1994-6#1)(2010-1#1)
cellular signaling##4##2##(1994-6#1)(2008-11#1)(2008-8#1)(2010-1#1)
cellular signalling##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
cellular site of##2##3##(2008-4#1)(2008-9#1)
cellular site##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
cellular slime##2##2##(1995-6#1)(2008-8#1)
cellular states##2##2##(1995-11#1)(2008-11#1)
cellular stimulation##2##2##(1996-2#1)(2008-10#1)
cellular stress response##2##3##(2008-7#1)(2012-2#1)
cellular stress##6##2##(1995-12#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-7#1)
cellular structure of the##2##4##(2007-12#1)(2009-7#1)
cellular structure##4##2##(2007-12#1)(2008-1#1)(2008-5#1)(2009-7#1)
cellular structures##3##2##(2007-12#1)(2008-1#1)(2008-4#1)
cellular substrate##2##2##(1997-1#1)(2008-11#1)
cellular substrates##2##2##(2008-11#1)(2008-7#1)
cellular survival##2##2##(2008-9#2)
cellular switches##2##2##(2011-1#2)
cellular system##2##2##(1997-7#1)(2008-11#1)
cellular systems##6##2##(1992-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-11#1)(2011-2#1)
cellular target##3##2##(2008-8#2)(2012-2#1)
cellular targeting##2##2##(1990-11#1)(2011-2#1)
cellular targets of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
cellular targets##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
cellular therapies##5##2##(2008-11#1)(2008-4#1)(2013-1#3)
cellular therapy##5##2##(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
cellular tissue##2##2##(2008-11#1)(2008-5#1)
cellular toxicity##4##2##(1992-12#1)(2008-9#2)(2011-1#1)
cellular transcription factor##2##3##(1992-8#1)(1995-2#1)
cellular transcription##3##2##(1992-8#1)(1995-2#1)(2012-12#1)
cellular transformation##8##2##(1994-10#1)(1994-8#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
cellular transport of##2##3##(2008-10#1)(2008-11#1)
cellular transport##3##2##(2008-10#1)(2008-11#2)
cellular uptake of##5##3##(1991-12#1)(1993-3#1)(2008-11#2)(2011-1#1)
cellular uptake##8##2##(1991-12#1)(1993-3#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-4#1)(2011-1#1)
cellular vesicles##2##2##(1997-3#2)
cellular work##2##2##(1994-5#2)
cellular##1247##1##(1990-11#5)(1990-12#7)(1990-2#8)(1990-3#4)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#12)(1991-2#5)(1991-3#1)(1991-4#5)(1991-5#12)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#8)(1992-10#1)(1992-11#12)(1992-12#11)(1992-2#2)(1992-3#6)(1992-5#6)(1992-6#2)(1992-8#6)(1992-9#4)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#8)(1993-6#7)(1993-8#7)(1993-9#5)(1994-10#2)(1994-11#12)(1994-12#9)(1994-2#6)(1994-3#7)(1994-5#5)(1994-6#9)(1994-8#20)(1994-9#6)(1995-11#10)(1995-12#11)(1995-2#21)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#8)(1995-8#6)(1995-9#1)(1996-10#1)(1996-12#9)(1996-2#8)(1996-5#5)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#18)(1997-4#10)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#5)(2007-11#3)(2007-12#9)(2007-2#3)(2007-4#2)(2007-5#1)(2007-8#6)(2007-9#3)(2008-1#20)(2008-10#56)(2008-11#112)(2008-12#10)(2008-2#13)(2008-3#8)(2008-4#54)(2008-5#39)(2008-6#9)(2008-7#80)(2008-8#30)(2008-9#55)(2009-10#6)(2009-12#13)(2009-2#8)(2009-3#8)(2009-4#6)(2009-5#13)(2009-6#6)(2009-7#4)(2009-8#25)(2009-9#6)(2010-1#5)(2010-10#3)(2010-11#8)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#16)(2011-2#54)(2011-3#2)(2012-1#1)(2012-12#20)(2012-2#30)(2012-3#15)(2013-1#37)(2013-7#4)(2013-8#9)
cellular/subcellular##2##1##(2011-1#2)
cellularity and##2##2##(2008-10#2)
cellularity##12##1##(1993-9#1)(1997-8#1)(2008-10#5)(2008-7#1)(2009-1#1)(2012-2#2)(2013-1#1)
cellulase activity##2##2##(2008-10#2)
cellulase##26##1##(1990-5#1)(1993-8#1)(2008-10#14)(2008-6#4)(2008-7#2)(2008-9#2)(2011-2#1)(2013-1#1)
cellulases and##2##2##(1990-5#1)(2008-6#1)
cellulases##10##1##(1990-5#1)(2008-6#3)(2009-3#2)(2011-2#3)(2013-1#1)
cellulite compared with##2##3##(2008-5#2)
cellulite is##4##2##(2008-5#4)
cellulite##22##1##(2008-5#22)
cellulitis in##2##2##(1991-8#1)(2008-5#1)
cellulitis##14##1##(1991-8#5)(2007-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#3)
cellulolytic and oligotrophic actinomycetes##2##4##(2008-10#2)
cellulolytic and##3##2##(2008-10#3)
cellulolytic bacteria##2##2##(2009-4#1)(2013-7#1)
cellulolytic##12##1##(1992-11#1)(2008-10#4)(2008-6#2)(2009-4#3)(2013-1#1)(2013-7#1)
cellulolyticus in##2##2##(2011-2#2)
cellulolyticus##8##1##(2008-6#2)(2011-2#6)
cellulose acetate (CA) membrane##2##4##(2008-10#2)
cellulose acetate and##2##3##(1994-3#1)(2008-5#1)
cellulose acetate##10##2##(1991-12#1)(1994-3#1)(2007-12#1)(2008-10#6)(2008-5#1)
cellulose and chitin##2##3##(2008-10#2)
cellulose and##13##2##(2008-10#5)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#3)
cellulose appeared##2##2##(2008-10#2)
cellulose as##2##2##(2008-10#1)(2010-5#1)
cellulose binding domain##4##3##(2008-7#4)
cellulose binding##5##2##(1995-5#1)(2008-7#4)
cellulose by##3##2##(2008-6#3)
cellulose carrier##2##2##(2008-10#1)(2008-7#1)
cellulose filters##2##2##(2008-10#2)
cellulose hydrolysis##2##2##(1997-4#1)(2011-2#1)
cellulose labeling##2##2##(2008-10#2)
cellulose matrix##2##2##(2008-10#2)
cellulose membrane##5##2##(2008-10#5)
cellulose membranes##2##2##(1995-2#1)(2008-5#1)
cellulose nitrate membrane filter##2##4##(2008-10#2)
cellulose nitrate##3##2##(1992-6#1)(2008-10#2)
cellulose triacetate (CTA)##2##3##(2008-10#2)
cellulose triacetate##4##2##(2008-10#4)
cellulose was##2##2##(2008-10#1)(2013-8#1)
cellulose were tested##2##3##(2008-10#2)
cellulose were##3##2##(2008-10#3)
cellulose with##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
cellulose##152##1##(1991-11#1)(1991-12#2)(1992-12#1)(1992-6#1)(1992-7#1)(1994-3#3)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#2)(2007-12#1)(2008-10#73)(2008-11#6)(2008-4#1)(2008-5#8)(2008-6#12)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-5#4)(2011-1#1)(2011-2#5)(2013-1#9)(2013-8#6)
cellulose)##3##1##(1992-1#1)(2008-10#1)(2008-11#1)
cellulose-azure##5##1##(2008-10#5)
cellulose-binding domain##2##2##(1995-5#2)
cellulose-binding##3##1##(1995-5#2)(2008-11#1)
cellulosic substrates##2##2##(1993-8#1)(2013-1#1)
cellulosic##7##1##(1993-8#1)(2008-1#1)(2008-10#3)(2012-3#1)(2013-1#1)
cement (Panavia##2##2##(2009-8#1)(2013-1#1)
cement and concrete##2##3##(2008-6#2)
cement and##10##2##(2007-11#2)(2008-10#2)(2008-6#2)(2010-3#1)(2011-2#2)(2013-1#1)
cement augmentation##2##2##(2007-11#1)(2008-7#1)
cement in##5##2##(1990-3#1)(2007-11#1)(2007-8#1)(2011-2#2)
cement matrices##2##2##(2008-10#2)
cement proteins##2##2##(2009-9#1)(2010-2#1)
cement spacer##3##2##(2008-6#3)
cement spacers##2##2##(2008-6#2)
cement##84##1##(1990-3#1)(1992-6#2)(1997-6#1)(2006-4#1)(2007-11#13)(2007-8#3)(2008-10#13)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#9)(2008-7#1)(2008-8#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-3#1)(2011-2#6)(2012-2#4)(2013-1#12)(2013-8#2)
cemented achromatic doublets##2##3##(2008-3#2)
cemented and##2##2##(2013-1#2)
cemented##24##1##(1993-1#1)(2008-11#2)(2008-2#3)(2008-3#5)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#5)
cementless femoral hip##2##3##(2008-7#2)
cementless implants##2##2##(1997-6#1)(2008-11#1)
cementless total##2##2##(2009-3#1)(2009-4#1)
cementless##14##1##(1997-6#2)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#3)(2009-3#4)(2009-4#1)
cements were##2##2##(2012-2#1)(2013-1#1)
cements##13##1##(2008-10#1)(2009-8#4)(2012-2#5)(2013-1#3)
cementum##2##1##(2013-1#2)
cemeteries##2##1##(1995-6#1)(2008-10#1)
cenocepacia from banana##2##3##(2008-10#2)
cenocepacia isolates##2##2##(2008-10#2)
cenocepacia##7##1##(2008-10#7)
censor##2##1##(1996-5#1)(1997-4#1)
censored data linear regression##2##4##(1995-9#2)
censored data##7##2##(1995-12#1)(1995-9#3)(1997-3#1)(2008-10#1)(2011-2#1)
censored if##2##2##(2011-2#1)(2013-1#1)
censored##18##1##(1992-9#3)(1995-12#2)(1995-9#3)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-6#1)(2011-2#2)(2013-1#2)
censoring indicator##3##2##(2008-10#3)
censoring##11##1##(1991-4#1)(1997-4#1)(1997-7#2)(2008-10#3)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
censorship##3##1##(1996-5#2)(2008-10#1)
census data to##3##3##(1995-9#2)(2011-2#1)
census data##8##2##(1995-9#2)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
census divisions##2##2##(1994-1#1)(1996-3#1)
census for##2##2##(2008-8#1)(2013-1#1)
census of##2##2##(1994-2#1)(2011-2#1)
census tracts##2##2##(2010-5#1)(2013-8#1)
census##37##1##(1991-11#1)(1991-5#1)(1992-12#2)(1994-1#1)(1994-2#1)(1995-9#2)(1996-3#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2010-11#3)(2010-5#3)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#1)
censuses##5##1##(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#1)
centenarians and##2##2##(2010-12#1)(2012-12#1)
centenarians##25##1##(2008-7#16)(2010-12#4)(2012-12#5)
centennial##2##1##(2009-10#1)(2011-2#1)
center and of##2##3##(1992-6#1)(2008-2#1)
center and##15##2##(1992-2#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
center around##2##2##(1992-1#1)(1997-1#1)
center as##2##2##(2008-2#1)(2008-3#1)
center at the##2##3##(1997-3#1)(2008-3#1)
center experience##10##2##(2007-8#1)(2008-1#4)(2008-3#1)(2008-4#1)(2009-5#1)(2010-5#1)(2013-1#1)
center for##15##2##(1996-6#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
center frequencies##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
center frequency##3##2##(2007-12#1)(2008-3#2)
center from##3##2##(1992-6#1)(2008-4#1)(2012-3#1)
center had##2##2##(1992-1#1)(2011-2#1)
center has##3##2##(1994-3#2)(1996-2#1)
center have been##2##3##(1990-9#1)(2008-10#1)
center in India##2##3##(2010-5#1)(2012-2#1)
center in Oslo]##2##3##(1995-11#1)(1997-6#1)
center in a##3##3##(1995-3#1)(2008-3#1)(2012-12#1)
center in diamond##2##3##(2007-11#1)(2007-12#1)
center in the##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
center in##29##2##(1990-10#1)(1990-12#1)(1991-8#1)(1994-3#5)(1995-11#1)(1995-3#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
center is##10##2##(1994-1#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#2)(2011-1#1)
center layer##4##2##(2013-8#4)
center of diversity##4##3##(2008-10#4)
center of inversion##2##3##(1996-2#1)(2013-1#1)
center of origin##5##3##(2008-10#4)(2011-2#1)
center of the##35##3##(1990-7#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#12)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#3)
center of this##2##3##(1993-8#1)(1995-2#1)
center of##80##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#2)(1995-2#2)(1995-6#1)(1996-2#2)(1996-3#1)(2007-12#4)(2008-10#13)(2008-11#3)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#4)
center over##3##2##(1991-8#1)(2011-2#2)
center that##2##2##(1995-2#1)(2012-3#1)
center to the##2##3##(1994-3#1)(1995-2#1)
center to##8##2##(1994-3#1)(1995-2#2)(2008-3#1)(2010-6#1)(2011-2#2)(2012-2#1)
center upon##2##2##(1991-8#1)(1992-3#1)
center was##5##2##(1996-12#1)(2007-10#1)(2008-10#1)(2011-2#2)
center wavelength of##13##3##(2007-11#5)(2007-12#6)(2008-3#2)
center wavelength##16##2##(2007-11#5)(2007-12#6)(2008-2#2)(2008-3#3)
center were##3##2##(2008-1#1)(2009-2#1)(2012-3#1)
center which##2##2##(1996-2#1)(2007-8#1)
center with##7##2##(1993-1#1)(1995-12#1)(2008-3#2)(2011-2#1)(2013-1#1)(2013-8#1)
center##433##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#1)(1991-8#3)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-1#2)(1993-11#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#5)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#10)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#1)(1995-5#4)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#8)(1996-3#4)(1996-6#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#14)(2007-12#20)(2007-2#1)(2007-7#7)(2007-8#8)(2007-9#5)(2008-1#13)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#49)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#4)(2008-8#13)(2008-9#9)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#22)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#13)
center's##3##1##(1993-2#1)(1996-12#1)(1997-1#1)
center)##3##1##(2008-1#1)(2008-7#1)(2011-2#1)
center-moved diffusion##2##2##(2007-12#2)
center-to-center##4##1##(2007-11#1)(2008-10#1)(2008-3#2)
center]##23##1##(1990-8#1)(1991-11#1)(1992-5#2)(1993-10#1)(1993-3#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-5#1)(2013-1#1)
centered around the##5##3##(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#2)
centered around##8##2##(1995-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)
centered at 610 nm##2##4##(2008-10#1)(2008-2#1)
centered at##22##2##(1993-11#2)(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#6)(2009-5#1)
centered on a##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
centered on the##13##3##(1993-12#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-2#3)(2008-3#2)(2009-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
centered on##26##2##(1993-12#1)(1994-9#1)(1995-8#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-10#2)(2010-3#1)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
centered##68##1##(1993-11#2)(1993-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#2)(2006-10#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#9)(2008-3#13)(2008-7#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-7#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
centering of ratio spectra##2##4##(2008-10#2)
centering of ratio##4##3##(2008-10#4)
centering of the femoral neck##3##5##(2007-8#3)
centering of the##5##3##(1995-2#1)(2007-12#1)(2007-8#3)
centering of##9##2##(1995-2#1)(2007-12#1)(2007-8#3)(2008-10#4)
centering on##3##2##(1993-3#1)(2008-10#1)(2012-3#1)
centering##23##1##(1993-3#1)(1995-2#1)(2007-12#1)(2007-8#5)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
centerline##2##1##(2007-11#1)(2008-3#1)
centerpiece##3##1##(1996-3#1)(1996-5#1)(2011-2#1)
centers and other##2##3##(1994-3#1)(2008-11#1)
centers and the##3##3##(2008-10#2)(2008-3#1)
centers and##28##2##(1991-1#1)(1992-4#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
centers are##6##2##(1993-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2009-10#1)(2013-1#1)
centers around##2##2##(1992-3#1)(2008-8#1)
centers as##2##2##(1996-2#1)(2007-12#1)
centers by##2##2##(2007-11#1)(2008-3#1)
centers despite##2##2##(1996-5#1)(2010-8#1)
centers for the##2##3##(2008-5#1)(2008-7#1)
centers for##8##2##(1991-1#1)(1992-9#1)(1997-2#1)(2007-12#1)(2008-5#2)(2008-7#1)(2013-8#1)
centers from##7##2##(2007-11#1)(2008-1#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
centers has##3##2##(1994-3#2)(2011-2#1)
centers have##3##2##(1997-2#1)(2008-11#1)(2008-3#1)
centers in Brazil##3##3##(2013-8#3)
centers in Saudi Arabia##3##4##(2007-7#1)(2008-1#2)
centers in the bulk of##2##5##(2007-12#1)(2008-3#1)
centers in the##11##3##(2007-12#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-5#1)(2010-3#1)(2010-8#1)(2012-2#1)
centers in##46##2##(1991-12#1)(1994-5#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#8)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
centers indicate that##2##3##(1996-2#1)(2012-3#1)
centers is##5##2##(2007-11#1)(2007-12#1)(2008-11#2)(2011-2#1)
centers located##2##2##(2007-12#1)(2013-8#1)
centers of Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG)##2##8##(2011-2#2)
centers of excellence##3##3##(1996-12#1)(2008-5#1)(2013-1#1)
centers of the##8##3##(1993-11#1)(1994-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)
centers of##27##2##(1991-10#1)(1993-11#2)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2011-2#4)(2013-1#2)
centers offer##2##2##(1992-12#1)(2008-4#1)
centers on the##2##3##(1991-12#1)(2008-4#1)
centers on##5##2##(1991-12#1)(1992-2#1)(2008-10#1)(2008-4#1)(2010-6#1)
centers or hospitals##2##3##(2007-9#1)(2011-1#1)
centers providing##2##2##(2007-12#1)(2007-6#1)
centers regarding##2##2##(1996-2#1)(2012-2#1)
centers that##5##2##(2007-4#1)(2007-7#1)(2011-2#2)(2012-12#1)
centers to the##2##3##(2007-10#1)(2008-1#1)
centers to##8##2##(1991-12#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-4#1)(2011-2#1)
centers using##2##2##(2008-1#1)(2008-7#1)
centers were##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
centers where##3##2##(1990-6#1)(2008-1#1)(2012-2#1)
centers which##2##2##(1994-2#1)(2009-9#1)
centers with##7##2##(1991-1#1)(1996-1#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-6#1)(2012-3#1)
centers##362##1##(1990-2#3)(1990-6#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-5#1)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-2#4)(1993-6#1)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#6)(1995-8#1)(1996-1#6)(1996-12#1)(1996-2#8)(1996-3#1)(1996-5#5)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#2)(1997-7#5)(2007-10#2)(2007-11#7)(2007-12#20)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#22)(2008-10#17)(2008-11#12)(2008-12#2)(2008-2#8)(2008-3#18)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#7)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#4)(2011-2#32)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#9)(2013-8#6)
centers)##5##1##(1996-1#1)(2007-7#1)(2008-10#2)(2008-3#1)
centers]##5##1##(1994-6#2)(1996-2#1)(2007-3#2)
centesimal##2##1##(2012-2#2)
centile##2##1##(1995-8#1)(1996-12#1)
centiles##3##1##(1994-11#3)
centimeter of##5##2##(2008-10#4)(2010-7#1)
centimeter##14##1##(1991-5#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#1)(2010-7#1)(2011-2#1)
centimeters with##2##2##(2007-12#1)(2008-3#1)
centimeters##13##1##(1993-11#1)(1994-11#1)(1995-6#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2011-2#1)
centimorgan##4##1##(1994-9#2)(2008-10#2)
centimorgans (cM)##7##2##(2008-10#7)
centimorgans##16##1##(1994-9#1)(2008-10#15)
centractin##5##1##(1995-2#5)
central 5HT##2##2##(1996-7#1)(2008-6#1)
central Andes##2##2##(2008-5#1)(2013-7#1)
central CRF##2##2##(1997-4#2)
central California##2##2##(2008-10#1)(2008-9#1)
central DI##4##2##(1997-8#4)
central ET-1##3##2##(1994-11#3)
central European##4##2##(1994-12#1)(2009-7#2)(2012-9#1)
central Florida##5##2##(1991-2#1)(2008-10#4)
central Mexico##2##2##(2008-10#1)(2013-7#1)
central New York##4##3##(1991-3#1)(2008-10#3)
central Nigeria##2##2##(2011-1#2)
central Taiwan##2##2##(2008-10#1)(2011-1#1)
central Texas##2##2##(1992-12#1)(2008-2#1)
central United States##4##3##(2008-10#3)(2008-11#1)
central action of##2##3##(1992-6#1)(1996-12#1)
central action##3##2##(1992-6#1)(1996-12#1)(2011-2#1)
central administration##3##2##(1991-1#1)(1992-1#1)(1994-2#1)
central affective##2##2##(2013-8#2)
central and autonomic nervous systems##2##5##(2009-8#1)(2009-9#1)
central and autonomic nervous##3##4##(2009-8#1)(2009-9#1)(2010-11#1)
central and northern##4##3##(2007-1#1)(2008-10#2)(2010-3#1)
central and parietal cells##2##4##(2007-12#2)
central and peripheral immune function in##2##6##(2008-10#2)
central and peripheral nervous systems##5##5##(1997-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-2#1)
central and peripheral nervous##12##4##(1996-12#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2012-2#1)(2013-8#1)
central and peripheral neurons##3##4##(1996-12#3)
central and peripheral pressor responses##2##5##(1992-8#2)
central and peripheral##27##3##(1990-8#1)(1992-8#2)(1993-5#2)(1996-12#4)(1996-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-6#1)(2012-2#1)(2013-8#1)
central and regional functions##2##4##(1990-11#2)
central and southern Somalia##2##4##(2011-2#2)
central and southern##5##3##(1997-6#1)(2008-10#2)(2011-2#2)
central and##53##2##(1990-11#2)(1990-8#1)(1992-11#1)(1992-8#3)(1993-5#2)(1995-8#1)(1996-12#4)(1996-5#1)(1997-6#2)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
central area of##2##3##(2008-10#1)(2008-3#1)
central area##3##2##(1992-10#1)(2008-10#1)(2008-3#1)
central aspects##2##2##(1991-3#1)(2012-12#1)
central auditory##3##2##(2008-9#2)(2013-8#1)
central authorities##2##2##(1992-11#1)(1997-3#1)
central autonomic##2##2##(1995-12#1)(2007-10#1)
central axis##7##2##(2007-10#1)(2008-10#2)(2008-3#2)(2009-2#1)(2013-1#1)
central catheters##2##2##(2007-7#1)(2009-4#1)
central cavity of##2##3##(2008-8#1)(2010-8#1)
central cavity##4##2##(1990-8#1)(2008-8#2)(2010-8#1)
central cell##10##2##(2007-12#2)(2008-11#2)(2008-9#6)
central cells of##3##3##(2007-12#1)(2008-5#2)
central cells##6##2##(2007-12#3)(2008-5#3)
central cholinergic##5##2##(1991-12#1)(1992-8#1)(1995-12#1)(2008-10#2)
central coast##3##2##(2008-10#2)(2008-5#1)
central compensation##2##2##(2008-5#2)
central complex##5##2##(2007-12#5)
central component of##5##3##(1997-4#1)(2008-7#2)(2012-2#1)(2013-8#1)
central component##8##2##(1994-8#1)(1997-4#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
central composite design was##5##4##(2008-10#4)(2008-11#1)
central composite design##19##3##(2008-10#16)(2008-11#2)(2008-7#1)
central composite designs##4##3##(2008-10#4)
central composite##25##2##(2008-10#21)(2008-11#3)(2008-7#1)
central control##4##2##(1996-2#1)(2008-10#2)(2008-8#1)
central core##5##2##(1995-3#1)(1997-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
central corneal thickness##2##3##(2011-1#1)(2011-2#1)
central corneal##3##2##(2011-1#1)(2011-2#2)
central cylinder##3##2##(2012-2#3)
central database##2##2##(2008-7#2)
central depressed##2##2##(2008-2#2)
central diabetes insipidus##3##3##(1997-8#1)(2011-1#2)
central diabetes##4##2##(1997-8#1)(2011-1#2)(2013-1#1)
central domain##8##2##(2008-9#8)
central fixation##2##2##(2008-2#1)(2011-1#1)
central focus is##2##3##(1994-1#1)(2011-2#1)
central focus##4##2##(1994-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
central for##2##2##(2008-10#1)(2011-1#1)
central glucagon-like peptide-1##2##3##(1996-2#2)
central goal##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
central heating##2##2##(1997-6#1)(2013-8#1)
central highlands of Mexico##2##4##(2008-10#2)
central hospital##5##2##(1995-5#1)(2008-1#2)(2010-6#1)(2010-8#1)
central in the##2##3##(2009-5#1)(2012-2#1)
central in##3##2##(2009-5#1)(2012-2#1)(2013-1#1)
central incisor##4##2##(2008-12#1)(2012-2#1)(2013-1#2)
central incisors##5##2##(2009-8#2)(2010-11#1)(2012-2#1)(2013-1#1)
central iran##3##2##(2013-1#3)
central islet necrosis##2##3##(2010-11#2)
central issue##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
central level##3##2##(1990-11#1)(2008-4#1)(2012-3#1)
central lumen##5##2##(2007-12#1)(2008-6#2)(2008-7#2)
central lung##2##2##(2009-4#1)(2010-3#1)
central mediator##2##2##(2013-1#1)(2013-8#1)
central memory CD4 cells##2##4##(2012-2#2)
central metabolic pathway##2##3##(2010-5#1)(2010-7#1)
central metabolic##3##2##(2008-11#1)(2010-5#1)(2010-7#1)
central metabolism##5##2##(2008-11#1)(2008-7#4)
central metal##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
central metals##2##2##(2008-10#2)
central necrosis##2##2##(1990-12#1)(2008-10#1)
central nervous stimulant##2##3##(2013-1#2)
central nervous system (CNS) of##2##5##(1997-2#1)(2008-8#1)
central nervous system (CNS)##50##4##(1991-12#2)(1991-2#1)(1991-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#3)(1997-2#1)(1997-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
central nervous system and in##2##5##(2008-7#1)(2008-8#1)
central nervous system and peripheral##2##5##(1993-11#1)(1997-8#1)
central nervous system and##17##4##(1992-4#1)(1993-11#1)(1995-12#1)(1996-12#2)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
central nervous system as##2##4##(1995-12#1)(2008-4#1)
central nervous system damage##2##4##(1991-3#1)(2010-12#1)
central nervous system disease##2##4##(2011-2#1)(2012-12#1)
central nervous system drugs##2##4##(2008-11#1)(2010-5#1)
central nervous system involvement##4##4##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
central nervous system lymphoma (PCNSL)##2##5##(2008-7#1)(2009-8#1)
central nervous system lymphoma##5##4##(1991-6#1)(1996-11#1)(2008-7#2)(2009-8#1)
central nervous system of##7##4##(1992-6#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#1)(2011-2#1)
central nervous system pathways##2##4##(1993-12#1)(2010-12#1)
central nervous system tumours##2##4##(1997-3#1)(2008-7#1)
central nervous system##241##3##(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#25)(2008-8#4)(2008-9#6)(2009-1#1)(2009-12#1)(2009-2#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-5#2)(2011-1#1)(2011-2#10)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#3)
central nervous##250##2##(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#25)(2008-8#4)(2008-9#7)(2009-1#1)(2009-12#1)(2009-2#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#4)(2010-5#2)(2011-1#1)(2011-2#10)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#3)
central neural pathways##3##3##(1997-2#2)(2008-4#1)
central neural##5##2##(1997-2#2)(2007-12#2)(2008-4#1)
central nicotinic##3##2##(1996-12#1)(1996-2#2)
central noradrenergic function##2##3##(2008-6#2)
central noradrenergic##3##2##(1997-2#1)(2008-6#2)
central nucleus of the amygdala##10##5##(1993-12#6)(1995-12#1)(1996-12#1)(2007-10#2)
central nucleus of the##11##4##(1993-12#6)(1995-12#1)(1996-12#1)(2007-10#2)(2012-3#1)
central nucleus##13##2##(1992-6#1)(1993-12#6)(1995-12#1)(1996-12#1)(2007-10#2)(2012-3#2)
central obesity##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
central or peripheral##4##3##(1992-8#1)(1994-11#1)(2008-7#1)(2010-7#1)
central or##6##2##(1990-11#1)(1992-8#1)(1994-11#1)(1994-12#1)(2008-7#1)(2010-7#1)
central part of the##7##4##(1994-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-8#1)
central part of##9##3##(1994-3#2)(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-1#1)(2013-8#1)
central part##13##2##(1994-3#4)(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
central parts of the##3##4##(1992-9#1)(1994-3#1)(2009-4#1)
central pathophysiological##3##2##(2008-3#1)(2010-10#1)(2011-2#1)
central pattern generator##2##3##(2007-12#1)(2009-6#1)
central pattern generators##2##3##(2008-11#1)(2009-5#1)
central pattern##4##2##(2007-12#1)(2008-11#1)(2009-5#1)(2009-6#1)
central point##2##2##(2007-8#1)(2008-10#1)
central population##2##2##(2007-1#1)(2008-10#1)
central position of##2##3##(2007-12#1)(2008-10#1)
central projections##2##2##(1997-3#1)(2007-12#1)
central region##7##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
central regulation##2##2##(1992-11#1)(1992-6#1)
central regulator of##2##3##(2008-9#1)(2013-1#1)
central retinal artery occlusion##2##4##(2007-10#1)(2013-7#1)
central retinal vein occlusion##2##4##(2011-2#2)
central retinal##5##2##(2007-10#1)(2011-2#3)(2013-7#1)
central role in the##14##4##(1990-11#1)(1991-9#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#3)
central role in##32##3##(1990-11#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#1)
central role of##12##3##(1994-5#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#2)
central role##53##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-10#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#6)(2011-3#1)(2013-1#1)(2013-8#1)
central roles##2##2##(2008-1#1)(2008-4#1)
central sensitization##3##2##(2008-9#2)(2011-2#1)
central spot##3##2##(2008-2#2)(2008-3#1)
central statistical##2##2##(1993-12#1)(2012-3#1)
central stimulation##2##2##(1991-1#1)(1991-2#1)
central sulcus hemorrhage##2##3##(2013-1#2)
central sulcus##4##2##(2007-10#1)(2008-7#1)(2013-1#2)
central terminals##2##2##(1992-6#1)(1997-3#1)
central theme##5##2##(1995-3#1)(2008-11#2)(2009-7#1)(2010-5#1)
central themes##3##2##(1997-2#1)(2008-7#1)(2011-2#1)
central thermoregulatory##2##2##(1994-2#1)(2007-10#1)
central to many##3##3##(1995-2#1)(2008-7#1)(2009-12#1)
central to the##13##3##(1990-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
central to these##3##3##(1991-4#1)(1993-1#1)(1997-3#1)
central to##40##2##(1990-5#1)(1991-4#1)(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
central vein cannulation##2##3##(2008-1#2)
central vein stenosis##2##3##(2008-1#2)
central vein##7##2##(1993-5#1)(2008-1#4)(2008-5#1)(2011-1#1)
central veins##4##2##(1993-6#1)(2007-7#2)(2008-10#1)
central venous catheter##16##3##(1991-5#1)(2007-7#7)(2008-7#5)(2011-2#3)
central venous catheters##6##3##(1990-3#1)(2007-7#1)(2008-1#1)(2008-7#3)
central venous pressure##5##3##(1990-9#1)(2007-8#2)(2008-7#1)(2010-8#1)
central venous##36##2##(1990-3#2)(1990-9#1)(1991-3#1)(1991-5#1)(1993-5#1)(2007-7#11)(2007-8#2)(2008-1#1)(2008-7#10)(2010-11#1)(2010-8#1)(2011-2#3)(2011-3#1)
central visual##2##2##(2011-2#1)(2013-8#1)
central wavelength of##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
central wavelength##7##2##(2007-11#3)(2007-12#1)(2008-3#3)
central wavelengths##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
central##1120##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#5)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#5)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#8)(1993-12#18)(1993-2#1)(1993-3#6)(1993-5#5)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#9)(1994-12#6)(1994-2#5)(1994-3#8)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-11#4)(1995-12#11)(1995-2#6)(1995-3#4)(1995-5#7)(1995-6#4)(1995-8#7)(1996-11#1)(1996-12#20)(1996-2#9)(1996-3#2)(1996-5#9)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#9)(1997-3#9)(1997-4#10)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#7)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#3)(2007-10#12)(2007-11#9)(2007-12#41)(2007-6#1)(2007-7#21)(2007-8#11)(2007-9#1)(2008-1#20)(2008-10#116)(2008-11#38)(2008-12#11)(2008-2#16)(2008-3#27)(2008-4#19)(2008-5#26)(2008-6#8)(2008-7#78)(2008-8#26)(2008-9#39)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#7)(2009-4#7)(2009-5#4)(2009-6#4)(2009-7#7)(2009-8#10)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#6)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#6)(2010-6#4)(2010-7#3)(2010-8#7)(2011-1#14)(2011-2#42)(2011-3#3)(2011-7#1)(2012-1#3)(2012-12#11)(2012-2#25)(2012-3#13)(2012-9#1)(2013-1#37)(2013-7#7)(2013-8#19)
centralis##3##1##(2008-6#1)(2010-4#2)
centrality##6##1##(1995-1#1)(2009-7#2)(2010-7#1)(2013-1#2)
centralization of##2##2##(1997-8#1)(2011-2#1)
centralization##4##1##(1997-8#1)(2008-6#1)(2011-2#2)
centralized and decentralized##3##3##(1995-3#1)(2008-10#2)
centralized departments##2##2##(1996-1#2)
centralized##40##1##(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#2)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#10)(2008-3#3)(2008-5#1)(2008-7#2)(2010-8#2)(2011-2#1)(2013-7#1)
centralizing##3##1##(1997-3#1)(2007-9#1)(2008-7#1)
centrally acting muscle relaxant##4##4##(1992-3#2)(1996-2#2)
centrally acting##7##2##(1992-3#2)(1992-6#1)(1996-2#2)(2008-7#1)(2012-3#1)
centrally located##4##2##(1995-2#2)(2007-8#1)(2008-10#1)
centrally##28##1##(1992-3#2)(1992-6#2)(1994-3#1)(1995-2#2)(1996-2#3)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#3)(2009-11#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-9#2)(2012-2#1)(2012-3#1)(2013-8#3)
centre and##6##2##(1990-2#1)(1995-10#1)(1995-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
centre experience##3##2##(2009-5#1)(2010-5#1)(2012-2#1)
centre for health##2##3##(1996-6#1)(2008-11#1)
centre for##13##2##(1991-6#1)(1995-5#3)(1996-6#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#1)
centre in the##3##3##(2007-11#1)(2008-9#1)(2012-2#1)
centre in##10##2##(1991-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
centre is##3##2##(1995-5#1)(1997-1#1)(2012-2#1)
centre located in##2##3##(2007-7#1)(2010-3#1)
centre of a##2##3##(1993-9#1)(1996-11#1)
centre of the##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-2#1)
centre of##20##2##(1993-2#1)(1993-9#1)(1996-11#2)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-7#1)
centre stage in the##2##4##(2008-7#1)(2008-8#1)
centre stage##3##2##(1997-4#1)(2008-7#1)(2008-8#1)
centre to##2##2##(1992-12#1)(2008-11#1)
centre will##2##2##(1995-9#1)(2008-7#1)
centre with##2##2##(2010-10#2)
centre##120##1##(1990-2#1)(1990-9#1)(1991-11#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#6)(1995-6#1)(1995-9#2)(1996-11#3)(1996-3#1)(1996-6#4)(1997-1#1)(1997-4#2)(1997-7#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-5#2)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#2)(2009-4#1)(2009-5#2)(2010-10#4)(2010-11#2)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#9)(2012-7#1)(2013-1#5)(2013-8#2)
centre)##2##1##(1995-5#1)(2008-10#1)
centred at##2##2##(2008-10#2)
centred on the##2##3##(2008-10#1)(2011-2#1)
centred on##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)
centred##12##1##(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2011-2#3)(2012-12#1)
centres and the##2##3##(1994-11#1)(2008-10#1)
centres and##10##2##(1990-3#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#1)
centres can##2##2##(2008-10#1)(2008-11#1)
centres for##4##2##(2008-11#1)(2008-9#1)(2012-12#1)(2013-1#1)
centres have##2##2##(1994-6#1)(2008-11#1)
centres in the##4##3##(1991-2#1)(1992-2#1)(2008-11#1)(2013-1#1)
centres in##13##2##(1991-2#1)(1992-2#1)(1996-1#1)(2007-7#1)(2008-11#3)(2008-7#2)(2012-12#3)(2013-1#1)
centres of##2##2##(1990-5#1)(2008-1#1)
centres on the##3##3##(1994-3#1)(1995-1#1)(2008-11#1)
centres that##2##2##(2008-8#1)(2013-8#1)
centres to##2##2##(1992-11#1)(1994-3#1)
centres were##2##2##(2007-11#1)(2012-12#1)
centres with##2##2##(2008-11#1)(2010-10#1)
centres##104##1##(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-5#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#17)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-12#7)(2013-1#5)(2013-8#2)
centric##6##1##(2008-7#1)(2010-3#1)(2010-9#3)(2013-8#1)
centrifugal analyser##3##2##(1990-2#1)(1995-12#2)
centrifugal partition chromatography##4##3##(1994-12#4)
centrifugal pump##4##2##(1992-1#2)(2010-8#1)(2011-2#1)
centrifugal##21##1##(1990-2#1)(1992-1#2)(1992-9#1)(1993-8#1)(1994-12#4)(1995-12#2)(1996-12#1)(2007-8#1)(2008-2#2)(2008-6#1)(2009-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
centrifugation and a##2##3##(2008-1#1)(2008-11#1)
centrifugation and##11##2##(1992-12#1)(1994-6#1)(1995-11#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2011-2#1)
centrifugation at##2##2##(2008-10#1)(2008-5#1)
centrifugation for##2##2##(2008-10#1)(2008-9#1)
centrifugation from##2##2##(1994-8#1)(2008-10#1)
centrifugation in##3##2##(1990-7#1)(1994-12#1)(1995-12#1)
centrifugation of the##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
centrifugation of##6##2##(1990-8#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
centrifugation on##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
centrifugation or##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
centrifugation##82##1##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-8#4)(1994-12#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1997-3#3)(1997-6#2)(2008-1#5)(2008-10#18)(2008-11#7)(2008-4#7)(2008-5#7)(2008-6#1)(2008-8#1)(2008-9#5)(2011-2#2)(2012-2#1)
centrifugation)##2##1##(2008-10#1)(2008-5#1)
centrifuge and##2##2##(2008-1#1)(2008-8#1)
centrifuge##10##1##(1992-6#1)(1993-2#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)
centrifuged##6##1##(1990-7#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
centrifuges and##3##2##(2008-11#1)(2008-2#2)
centrifuges##4##1##(2008-11#1)(2008-2#2)(2013-8#1)
centrin genes##2##2##(2008-9#2)
centrin##4##1##(2008-9#4)
centrin-1##3##1##(2008-9#3)
centriole adjunct##2##2##(2007-12#1)(2008-7#1)
centroid estimation##2##2##(2008-3#2)
centroid of the##3##3##(2007-11#2)(2008-3#1)
centroid of##6##2##(2007-11#2)(2008-3#4)
centroid potential##3##2##(2009-9#3)
centroid##18##1##(2007-11#3)(2008-3#8)(2008-5#1)(2009-9#3)(2010-4#1)(2010-5#1)(2010-8#1)
centroids can be##2##3##(2008-3#2)
centroids of##3##2##(2008-10#1)(2008-3#2)
centroids##9##1##(2008-10#1)(2008-3#7)(2010-4#1)
centromere##15##1##(1992-12#1)(1993-9#1)(1995-6#1)(1996-3#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-8#1)(2012-3#1)
centromere-distal##2##1##(1995-2#1)(1996-3#1)
centromere-proximal##4##1##(1995-2#1)(1996-3#3)
centromeres##2##1##(2008-5#1)(2012-3#1)
centromeric heterochromatin##2##2##(1993-12#1)(2009-3#1)
centromeric regions##2##2##(1997-6#1)(2008-5#1)
centromeric to the color pigment##2##5##(1993-3#2)
centromeric##11##1##(1993-12#1)(1993-3#3)(1996-8#1)(1997-6#1)(2008-10#1)(2008-5#2)(2009-3#1)(2010-8#1)
centroperipheral##2##1##(1996-5#1)(2012-3#1)
centroradialis##3##1##(1996-2#3)
centrosomes##5##1##(1991-5#2)(2009-3#1)(2011-2#1)(2012-12#1)
centrosymmetric##8##1##(1992-8#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-3#3)
cents per genotype##2##3##(2008-7#2)
cents##5##1##(1994-1#2)(2008-7#2)(2008-8#1)
centuries##18##1##(1991-12#1)(1991-6#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-6#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-2#1)(2013-1#1)
century ago##6##2##(1991-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
century and the##2##3##(2008-10#1)(2008-11#1)
century and##9##2##(1994-9#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
century apart##2##2##(2012-2#2)
century are##3##2##(1991-12#1)(2006-10#1)(2007-12#1)
century as the##2##3##(1995-12#1)(2013-8#1)
century as##3##2##(1995-12#1)(2008-1#1)(2013-8#1)
century b##2##2##(2008-10#2)
century has##3##2##(2008-3#1)(2010-1#1)(2011-1#1)
century health care##2##3##(1996-3#1)(1997-1#1)
century in##6##2##(1990-5#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
century is##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
century of research##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
century of##6##2##(1991-11#1)(1993-2#1)(2008-7#1)(2008-8#2)(2012-2#1)
century the##2##2##(2009-5#1)(2009-8#1)
century to##4##2##(1992-2#1)(2008-7#1)(2009-12#1)(2011-3#1)
century was##2##2##(2007-8#1)(2010-10#1)
century with##2##2##(1994-12#1)(2012-2#1)
century##278##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#3)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#7)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#3)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#8)(2008-1#14)(2008-10#26)(2008-11#7)(2008-12#12)(2008-2#2)(2008-3#4)(2008-4#9)(2008-6#3)(2008-7#9)(2008-8#7)(2008-9#2)(2009-10#6)(2009-12#3)(2009-5#2)(2009-7#12)(2009-8#4)(2010-1#12)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#12)(2011-3#2)(2011-7#1)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
century)##2##1##(2008-10#1)(2008-9#1)
century?##4##1##(1994-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
century]##8##1##(1993-11#1)(1996-6#1)(2008-10#2)(2008-11#2)(2009-10#2)
cepa L##2##2##(1993-12#1)(2008-10#1)
cepa##4##1##(1993-12#2)(2008-10#2)
cepacia 1324##3##2##(2008-10#3)
cepacia AMMDR1 on##2##3##(2008-10#2)
cepacia AMMDR1##10##2##(2008-10#10)
cepacia complex##2##2##(2007-12#1)(2008-10#1)
cepacia##26##1##(2007-12#3)(2008-10#20)(2008-4#1)(2008-7#2)
cephalexin##5##1##(1990-11#1)(1990-6#1)(2007-7#1)(2008-10#1)(2008-11#1)
cephalic##4##1##(2007-7#1)(2008-5#2)(2008-6#1)
cephalograms##2##1##(2013-1#2)
cephalometric##3##1##(2008-7#1)(2009-7#1)(2013-1#1)
cephalonica##5##1##(2008-6#5)
cephalopod##6##1##(2008-7#3)(2009-8#1)(2011-2#2)
cephalopods##5##1##(2008-7#3)(2009-8#2)
cephalosporin C production##4##3##(2008-6#4)
cephalosporin C##6##2##(2008-6#4)(2011-1#2)
cephalosporin antibiotics##5##2##(2008-10#5)
cephalosporin in##2##2##(2007-7#1)(2008-11#1)
cephalosporin or##2##2##(1994-11#1)(2011-2#1)
cephalosporin##34##1##(1990-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1996-3#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#4)(2011-1#5)(2011-2#10)
cephalosporin-resistant strains##3##2##(2011-2#3)
cephalosporin-resistant##6##1##(2007-12#1)(2011-2#5)
cephalosporines##2##1##(1997-3#1)(2012-2#1)
cephalosporins in##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
cephalosporins##17##1##(1990-11#1)(1992-12#1)(1996-3#1)(2007-12#1)(2007-7#4)(2008-10#2)(2008-7#1)(2011-1#3)(2011-2#3)
cephalotes##3##1##(2007-12#1)(2008-8#2)
cephalus in the north-west Pacific##3##5##(2010-8#3)
cephalus##5##1##(2008-7#1)(2010-8#4)
ceramic and##3##2##(2006-4#1)(2008-5#1)(2009-7#1)
ceramic glazes##3##2##(2008-10#3)
ceramic interpositional arthroplasty##2##3##(2010-11#2)
ceramic materials##4##2##(2008-10#3)(2012-2#1)
ceramic pieces##2##2##(2008-10#2)
ceramic processing##2##2##(2008-10#2)
ceramic shards##2##2##(2008-10#2)
ceramic surface##3##2##(2008-5#1)(2008-8#1)(2009-2#1)
ceramic veneer##2##2##(2013-1#2)
ceramic veneers##3##2##(2009-8#3)
ceramic was##3##2##(2008-12#1)(2013-8#2)
ceramic##91##1##(1990-5#1)(1991-3#2)(1997-4#2)(2006-4#1)(2007-11#5)(2008-10#38)(2008-12#2)(2008-2#2)(2008-3#8)(2008-5#7)(2008-6#1)(2008-8#2)(2009-2#1)(2009-7#4)(2009-8#3)(2010-11#3)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#4)
ceramics at##2##2##(2008-5#1)(2009-7#1)
ceramics is##2##2##(2007-11#1)(2009-8#1)
ceramics##27##1##(2007-11#7)(2008-10#3)(2008-3#1)(2008-5#6)(2008-8#1)(2009-7#3)(2009-8#3)(2010-12#1)(2013-8#2)
ceramide 2##5##2##(2008-5#5)
ceramide 5 and hexadecanoic acid##2##5##(2008-5#2)
ceramide 5##5##2##(2008-5#5)
ceramide and##2##2##(1995-2#1)(2008-5#1)
ceramide galactosyltransferase##2##2##(2008-7#1)(2013-8#1)
ceramide levels##4##2##(1992-8#1)(2008-5#3)
ceramide was##2##2##(1993-9#1)(1995-2#1)
ceramide##57##1##(1990-7#2)(1992-8#2)(1993-11#1)(1993-9#3)(1994-10#3)(1994-3#2)(1994-5#5)(1995-12#1)(1995-2#7)(1996-2#1)(2008-10#1)(2008-5#25)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
ceramides and##4##2##(1995-12#1)(2008-5#3)
ceramides##16##1##(1995-12#2)(2008-10#1)(2008-5#12)(2012-2#1)
cerasi##2##1##(2008-10#2)
cercosporin##4##1##(2008-10#4)
cereal and##2##2##(2008-10#2)
cereal bar##4##2##(2012-2#4)
cereal bars##2##2##(2012-2#2)
cereal crops##5##2##(2008-10#3)(2008-7#2)
cereal##33##1##(2008-10#15)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#2)(2010-1#2)(2011-2#1)(2012-2#6)(2012-3#1)
cereale##4##1##(1996-5#1)(2008-10#3)
cereale)##3##1##(2008-10#2)(2008-5#1)
cerealis##5##1##(2008-10#5)
cereals and grasses##3##3##(2008-10#3)
cereals and##6##2##(2008-10#4)(2008-12#1)(2012-3#1)
cereals##31##1##(1991-12#4)(1991-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-8#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
cerebellar Purkinje##2##2##(1991-2#1)(2012-2#1)
cerebellar and##2##2##(1997-3#1)(2012-3#1)
cerebellar artery##7##2##(2008-7#5)(2012-3#2)
cerebellar ataxia##7##2##(1995-6#1)(1997-8#1)(2008-7#2)(2011-2#2)(2013-1#1)
cerebellar blood flow##4##3##(1995-5#2)(2007-10#2)
cerebellar cell##2##2##(2008-6#2)
cerebellar cortex of##5##3##(1995-8#1)(1996-5#3)(1997-2#1)
cerebellar cortex was##2##3##(1992-11#1)(2008-7#1)
cerebellar cortex##16##2##(1992-11#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-5#3)(1997-2#2)(2008-7#1)(2012-2#1)(2013-8#2)
cerebellar cortical lesions##2##3##(1994-3#2)
cerebellar degeneration##4##2##(1992-2#1)(1997-8#3)
cerebellar granule cells in##2##4##(1991-12#1)(2009-8#1)
cerebellar granule cells##6##3##(1991-12#1)(1996-12#1)(1996-5#1)(2008-9#2)(2009-8#1)
cerebellar granule neurons##3##3##(1991-12#1)(2009-8#2)
cerebellar granule##10##2##(1991-12#2)(1996-12#1)(1996-5#2)(2008-9#2)(2009-8#3)
cerebellar hemisphere##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
cerebellar hemorrhage##2##2##(2008-7#1)(2012-2#1)
cerebellar lesion##2##2##(1993-3#1)(2013-1#1)
cerebellar metabolism in##2##3##(1996-5#2)
cerebellar metabolism##3##2##(1996-5#3)
cerebellar peduncle##4##2##(1992-11#1)(1996-5#3)
cerebellar slices##2##2##(1992-12#1)(2008-4#1)
cerebellar symptoms##3##2##(2011-2#3)
cerebellar vermis##3##2##(1995-12#1)(2008-7#1)(2010-11#1)
cerebellar white matter##3##3##(1996-5#3)
cerebellar##141##1##(1991-11#1)(1991-12#3)(1991-2#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#6)(1995-6#1)(1995-8#4)(1996-12#3)(1996-2#2)(1996-5#17)(1997-2#4)(1997-3#1)(1997-8#4)(2007-10#3)(2007-8#2)(2008-4#4)(2008-6#2)(2008-7#20)(2008-9#2)(2009-1#1)(2009-8#5)(2010-11#1)(2011-2#8)(2012-2#3)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#7)
cerebelli and##2##2##(1993-12#1)(2011-2#1)
cerebelli in##2##2##(1993-12#1)(1997-3#1)
cerebelli##7##1##(1993-12#5)(1997-3#1)(2011-2#1)
cerebellopontine angle (CPA)##2##3##(2011-2#1)(2012-3#1)
cerebellopontine angle##10##2##(1994-9#1)(2006-12#1)(2008-7#4)(2008-8#1)(2011-2#2)(2012-3#1)
cerebellopontine##11##1##(1994-9#1)(2006-12#1)(2008-7#4)(2008-8#1)(2010-11#1)(2011-2#2)(2012-3#1)
cerebellum and##8##2##(1991-12#1)(1993-6#1)(1993-9#2)(1994-2#1)(1996-12#1)(2008-8#1)(2013-8#1)
cerebellum by##3##2##(1991-1#1)(1991-12#1)(1993-11#1)
cerebellum in##7##2##(1990-7#1)(1992-6#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
cerebellum is##2##2##(1996-5#1)(2012-2#1)
cerebellum of the meander tail mutant mouse##2##7##(1992-9#2)
cerebellum of the##4##3##(1991-4#1)(1992-9#2)(1995-12#1)
cerebellum of##6##2##(1991-4#1)(1992-9#2)(1994-2#1)(1995-12#1)(2008-10#1)
cerebellum was##2##2##(1993-9#1)(2007-8#1)
cerebellum##110##1##(1990-11#1)(1990-5#1)(1990-7#2)(1991-1#3)(1991-12#3)(1991-4#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#6)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#11)(1996-2#2)(1996-5#8)(1997-2#4)(1997-4#1)(1997-8#1)(2007-8#6)(2008-10#3)(2008-11#4)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#2)(2012-2#2)(2013-1#5)(2013-8#1)
cerebral AVM##6##2##(1997-3#1)(2008-7#1)(2008-9#1)(2012-3#3)
cerebral AVMs##5##2##(1997-3#1)(2008-7#2)(2008-9#1)(2012-3#1)
cerebral abscess##5##2##(1996-3#1)(1996-6#1)(2008-1#1)(2008-7#1)(2008-8#1)
cerebral air embolism##3##3##(2008-7#3)
cerebral amyloid angiopathy##4##3##(1996-11#1)(1996-5#1)(2007-10#1)(2013-1#1)
cerebral amyloidosis##2##2##(2013-1#2)
cerebral and extracranial##2##3##(2008-11#2)
cerebral and##10##2##(1991-11#1)(1991-3#1)(2007-10#3)(2008-11#2)(2008-5#1)(2009-9#1)(2011-2#1)
cerebral aneurysm after##2##3##(2008-7#1)(2013-1#1)
cerebral aneurysm##4##2##(1997-3#1)(2008-7#2)(2013-1#1)
cerebral aneurysms##8##2##(2007-10#1)(2008-7#5)(2013-1#1)(2013-8#1)
cerebral angiography##4##2##(1997-6#1)(2008-7#3)
cerebral arteries##12##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-7#6)(2009-4#1)
cerebral arteriovenous malformation to##2##4##(2008-7#2)
cerebral arteriovenous malformation##7##3##(1992-2#1)(2008-7#6)
cerebral arteriovenous malformations (AVMs)##7##4##(1997-3#1)(2008-7#5)(2008-9#1)
cerebral arteriovenous malformations##16##3##(1996-3#1)(1997-3#2)(1997-6#1)(2007-10#1)(2008-7#8)(2008-9#3)
cerebral arteriovenous##26##2##(1992-2#1)(1996-3#3)(1997-3#3)(1997-6#1)(2007-10#1)(2008-7#14)(2008-9#3)
cerebral artery Doppler##2##3##(2011-2#2)
cerebral artery blood velocity##3##4##(2007-10#3)
cerebral artery territory##4##3##(2007-10#2)(2008-7#2)
cerebral artery using##2##3##(2007-10#1)(2008-7#1)
cerebral artery was##2##3##(1995-12#1)(2008-7#1)
cerebral artery##75##2##(1995-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#3)(2006-7#1)(2007-10#22)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-7#19)(2008-8#1)(2010-11#1)(2011-2#8)(2013-8#5)
cerebral aspergillosis##3##2##(2009-4#2)(2011-2#1)
cerebral asymmetry##4##2##(1992-2#4)
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and the##2##11##(2008-8#1)(2010-12#1)
cerebral blood flow (CBF)##8##4##(1996-5#1)(1996-7#1)(2007-8#1)(2008-7#5)
cerebral blood flow (rCBF) was##2##5##(1995-5#1)(1996-5#1)
cerebral blood flow (rCBF)##6##4##(1995-5#1)(1996-2#1)(1996-5#3)(2007-10#1)
cerebral blood flow and oxygen metabolism##2##6##(2006-7#1)(2007-10#1)
cerebral blood flow and##5##4##(1994-2#1)(2006-7#1)(2007-10#2)(2012-3#1)
cerebral blood flow changes##2##4##(1996-6#1)(2007-10#1)
cerebral blood flow in hypertensive patients with a history of##2##10##(2007-10#2)
cerebral blood flow in##7##4##(1995-5#1)(1996-5#2)(1996-6#1)(2007-10#3)
cerebral blood flow measurements##2##4##(1995-8#1)(1996-6#1)
cerebral blood flow##53##3##(1994-2#2)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#3)(1996-5#7)(1996-6#3)(1996-7#1)(2006-7#1)(2007-10#11)(2007-8#2)(2008-2#1)(2008-5#1)(2008-7#8)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
cerebral blood volume##3##3##(2007-10#1)(2008-7#1)(2011-1#1)
cerebral blood##59##2##(1994-2#2)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#3)(1996-5#7)(1996-6#3)(1996-7#1)(2006-7#1)(2007-10#13)(2007-8#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#10)(2008-9#1)(2011-1#2)(2012-1#1)(2012-3#2)(2013-1#1)
cerebral circulation##2##2##(2008-1#1)(2008-7#1)
cerebral cortex and cerebellum##2##4##(1990-7#1)(1996-12#1)
cerebral cortex and striatum##4##4##(1997-2#4)
cerebral cortex and##12##3##(1990-7#1)(1996-12#3)(1997-2#4)(2008-11#1)(2008-7#2)(2008-9#1)
cerebral cortex during##2##3##(1996-5#1)(2007-9#1)
cerebral cortex in##3##3##(1990-7#1)(1996-5#1)(1997-2#1)
cerebral cortex of##6##3##(1993-12#2)(1994-2#1)(1997-2#2)(2008-7#1)
cerebral cortex revealed##2##3##(1991-5#1)(1997-2#1)
cerebral cortex slices##3##3##(1994-8#3)
cerebral cortex##82##2##(1990-11#1)(1990-7#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#2)(1993-12#4)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#4)(1995-11#2)(1995-5#1)(1996-12#5)(1996-5#8)(1997-2#13)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#8)(2008-7#9)(2008-9#2)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)
cerebral cortical##8##2##(1990-5#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-7#2)
cerebral damage##2##2##(1995-12#1)(2007-10#1)
cerebral distribution of##2##3##(1993-9#1)(1994-2#1)
cerebral edema and##2##3##(2009-8#1)(2010-1#1)
cerebral edema##4##2##(2008-8#1)(2009-8#1)(2010-1#2)
cerebral fat embolism##4##3##(2009-3#4)
cerebral glucose metabolism##2##3##(1994-5#1)(2008-8#1)
cerebral glucose##4##2##(1994-2#1)(1994-5#2)(2008-8#1)
cerebral haemorrhage and##2##3##(1991-11#1)(2008-7#1)
cerebral haemorrhage##5##2##(1991-11#1)(1997-3#1)(2008-7#3)
cerebral hemisphere##10##2##(2008-7#2)(2008-9#1)(2011-1#3)(2011-2#1)(2013-8#3)
cerebral hemispheres##5##2##(1996-2#1)(2008-7#2)(2011-2#2)
cerebral hemorrhage##3##2##(2007-9#1)(2012-12#1)(2013-8#1)
cerebral imaging##3##2##(1996-6#1)(2008-6#1)(2008-9#1)
cerebral infarction and##4##3##(1994-9#1)(2008-7#2)(2010-11#1)
cerebral infarction caused by##2##4##(1990-3#1)(2007-10#1)
cerebral infarction##30##2##(1990-3#3)(1991-11#1)(1994-9#1)(1997-5#6)(2007-10#9)(2008-2#1)(2008-7#6)(2010-11#1)(2011-2#1)(2012-12#1)
cerebral infarctions##2##2##(1996-11#1)(2007-10#1)
cerebral infarcts and consequent focal neurologic deficits##2##7##(2011-2#2)
cerebral infarcts##6##2##(2007-10#1)(2008-8#3)(2011-2#2)
cerebral ischaemia and##2##3##(2007-10#1)(2008-7#1)
cerebral ischaemia##6##2##(2007-10#1)(2008-7#5)
cerebral ischaemia-reperfusion##2##2##(1995-12#1)(2008-7#1)
cerebral ischemia and##2##3##(2007-10#1)(2009-12#1)
cerebral ischemia in mice##2##4##(1995-12#1)(2008-11#1)
cerebral ischemia in##6##3##(1990-7#1)(1995-12#1)(1997-2#1)(2008-11#1)(2009-5#1)(2012-12#1)
cerebral ischemia##29##2##(1990-7#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#3)(2006-7#2)(2007-10#3)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2009-12#3)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
cerebral ischemia-reperfusion##3##2##(1996-12#2)(2012-3#1)
cerebral ischemia/reperfusion##2##2##(2008-10#1)(2010-11#1)
cerebral ischemic##6##2##(1992-6#1)(1994-6#1)(2007-8#1)(2007-9#1)(2009-11#1)(2013-1#1)
cerebral lesion##2##2##(1992-12#1)(2009-11#1)
cerebral lesions##3##2##(1996-11#1)(2008-12#1)(2008-7#1)
cerebral localization##2##2##(1991-6#1)(2008-9#1)
cerebral malaria##6##2##(1996-11#1)(1997-3#1)(2009-9#1)(2012-2#1)(2012-3#2)
cerebral manifestations##3##2##(2008-7#3)
cerebral metabolic rate for##2##4##(1996-5#1)(2007-10#1)
cerebral metabolic rate##3##3##(1991-1#1)(1996-5#1)(2007-10#1)
cerebral metabolic##6##2##(1991-1#2)(1994-2#1)(1996-5#1)(2007-10#1)(2011-1#1)
cerebral metabolism##7##2##(1991-10#1)(1991-5#1)(1994-2#1)(1997-7#1)(2008-9#2)(2011-1#1)
cerebral metastases##2##2##(1992-12#1)(2008-9#1)
cerebral microbleeds are associated with##2##5##(2008-8#2)
cerebral microbleeds in##2##3##(2008-8#1)(2012-2#1)
cerebral microbleeds##7##2##(2008-8#6)(2012-2#1)
cerebral microembolic signals##2##3##(2007-8#2)
cerebral mucormycosis##2##2##(2008-12#2)
cerebral oedema##2##2##(2007-10#1)(2008-7#1)
cerebral oxygen utilization##2##3##(1990-5#2)
cerebral oxygen##3##2##(1990-5#2)(2008-7#1)
cerebral palsy and##3##3##(2009-3#1)(2010-9#1)(2011-2#1)
cerebral palsy is##2##3##(1995-6#2)
cerebral palsy##27##2##(1995-6#5)(1995-8#1)(1996-11#1)(1997-5#1)(2007-11#1)(2008-11#2)(2009-3#4)(2009-4#4)(2010-9#1)(2011-2#6)(2012-12#1)
cerebral perfusion##10##2##(1996-5#1)(1996-8#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
cerebral protection##2##2##(1992-6#1)(2010-1#1)
cerebral recurrence##2##2##(1990-12#2)
cerebral sequelae##3##2##(1990-12#3)
cerebral stroke##3##2##(1996-6#1)(1996-9#1)(2013-8#1)
cerebral subdivisions##3##2##(1997-2#3)
cerebral tissue##4##2##(1993-8#1)(2008-7#1)(2008-8#1)(2010-1#1)
cerebral tissues##2##2##(1995-11#1)(2008-7#1)
cerebral toxoplasmosis and##2##3##(2007-10#2)
cerebral toxoplasmosis##4##2##(1996-3#1)(1997-3#1)(2007-10#2)
cerebral vascular##7##2##(1996-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#2)
cerebral vasculature##2##2##(2007-10#1)(2012-2#1)
cerebral vasculitis##2##2##(1996-3#1)(2008-8#1)
cerebral vasospasm##2##2##(2007-10#1)(2008-7#1)
cerebral veins and##2##3##(2008-7#1)(2012-3#1)
cerebral veins##4##2##(1995-12#1)(2008-7#2)(2012-3#1)
cerebral venoconstriction##2##2##(1995-12#2)
cerebral venous##6##2##(1996-9#1)(2007-10#4)(2012-12#1)
cerebral ventricle##3##2##(1993-12#1)(1994-2#1)(1995-12#1)
cerebral white matter##6##3##(2008-7#2)(2008-8#1)(2010-12#2)(2013-1#1)
cerebral##727##1##(1990-11#2)(1990-12#5)(1990-3#8)(1990-5#4)(1990-6#1)(1990-7#5)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#5)(1992-2#5)(1992-6#3)(1993-1#1)(1993-12#7)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#17)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#6)(1995-12#10)(1995-2#1)(1995-5#8)(1995-6#5)(1995-8#2)(1996-11#9)(1996-12#9)(1996-2#8)(1996-3#9)(1996-5#21)(1996-6#12)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#21)(1997-3#14)(1997-4#2)(1997-5#8)(1997-6#10)(1997-7#1)(1997-8#3)(2006-10#1)(2006-7#4)(2007-10#73)(2007-11#2)(2007-12#2)(2007-8#10)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#17)(2008-12#12)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#130)(2008-8#24)(2008-9#18)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#5)(2009-3#8)(2009-4#7)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#5)(2010-11#3)(2010-12#4)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#32)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#14)(2013-1#15)(2013-8#13)
cerebri##4##1##(1997-3#2)(1997-8#1)(2008-4#1)
cerebri)##2##1##(1990-12#2)
cerebro-spinal fluid##4##2##(1992-11#2)(2007-8#2)
cerebro-vascular##2##1##(2007-8#1)(2012-12#1)
cerebrocortical##2##1##(1996-2#1)(1997-1#1)
cerebroside elicitor##4##2##(2008-10#4)
cerebroside sulfate##3##2##(1993-8#3)
cerebroside##13##1##(1993-8#3)(2008-10#10)
cerebrospinal fluid (CSF) absorption##2##4##(1993-1#1)(2008-7#1)
cerebrospinal fluid (CSF) and plasma##2##5##(1995-11#1)(1995-12#1)
cerebrospinal fluid (CSF) and serum##2##5##(1993-8#1)(2007-8#1)
cerebrospinal fluid (CSF) and##5##4##(1993-8#1)(1995-11#1)(1995-12#1)(2007-8#1)(2008-7#1)
cerebrospinal fluid (CSF) is##2##4##(1991-2#1)(2012-3#1)
cerebrospinal fluid (CSF) leak##3##4##(2008-7#1)(2011-2#2)
cerebrospinal fluid (CSF) leakage##2##4##(2008-12#1)(2012-3#1)
cerebrospinal fluid (CSF)##36##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#1)
cerebrospinal fluid and##2##3##(1993-9#1)(1995-11#1)
cerebrospinal fluid fistula##2##3##(2008-12#1)(2008-7#1)
cerebrospinal fluid in##6##3##(1991-2#1)(1993-10#1)(1993-2#1)(1994-8#1)(2008-7#1)(2012-3#1)
cerebrospinal fluid leak and##2##4##(2008-9#1)(2011-2#1)
cerebrospinal fluid leak##6##3##(1993-10#1)(2008-7#1)(2008-9#1)(2011-2#3)
cerebrospinal fluid leaks##4##3##(2006-12#1)(2011-2#2)(2012-1#1)
cerebrospinal fluid of patients with##2##5##(2009-6#1)(2010-12#1)
cerebrospinal fluid of patients##3##4##(1994-8#1)(2009-6#1)(2010-12#1)
cerebrospinal fluid of##8##3##(1993-1#1)(1994-8#1)(1995-12#1)(2008-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)
cerebrospinal fluid samples from##2##4##(1993-12#1)(1993-8#1)
cerebrospinal fluid##112##2##(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-3#2)(1993-1#3)(1993-10#2)(1993-12#1)(1993-2#1)(1993-8#5)(1993-9#1)(1994-8#6)(1994-9#2)(1995-11#3)(1995-12#3)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2006-12#4)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#13)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#3)(2010-5#1)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
cerebrospinal venous insufficiency (CCSVI)##5##4##(2012-3#5)
cerebrospinal venous insufficiency in##2##4##(2012-3#2)
cerebrospinal venous insufficiency##9##3##(2012-3#8)(2013-1#1)
cerebrospinal##124##1##(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-3#2)(1993-1#3)(1993-10#2)(1993-12#1)(1993-2#1)(1993-8#5)(1993-9#1)(1994-8#6)(1994-9#2)(1995-11#3)(1995-12#3)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2006-12#5)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#13)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#3)(2010-5#1)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#13)(2013-1#4)
cerebrovascular accident##10##2##(1992-2#2)(1995-3#1)(1997-8#1)(2007-8#2)(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#1)
cerebrovascular accidents##8##2##(1992-2#2)(2007-7#1)(2007-8#1)(2008-1#2)(2012-12#1)(2013-8#1)
cerebrovascular and renal##2##3##(2008-1#1)(2008-8#1)
cerebrovascular and##3##2##(2007-8#1)(2008-1#1)(2008-8#1)
cerebrovascular complications##3##2##(2007-7#1)(2008-11#1)(2008-7#1)
cerebrovascular disease and##2##3##(2008-8#1)(2011-1#1)
cerebrovascular disease death##2##3##(2011-1#2)
cerebrovascular disease for##2##3##(2008-10#2)
cerebrovascular disease##21##2##(1990-5#1)(1996-2#1)(2007-10#3)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#3)(2011-1#8)
cerebrovascular diseases and acute myocardial infarction were##2##7##(2011-1#2)
cerebrovascular diseases and##4##3##(2010-12#1)(2011-1#3)
cerebrovascular diseases##7##2##(2010-12#2)(2011-1#5)
cerebrovascular disorders##3##2##(1990-6#1)(2007-10#2)
cerebrovascular events##2##2##(1991-11#1)(2010-9#1)
cerebrovascular ischaemic events##2##3##(1991-11#2)
cerebrovascular ischemia##2##2##(1997-2#1)(2008-5#1)
cerebrovascular lesions##3##2##(1991-6#2)(2008-7#1)
cerebrovascular malformations##3##2##(2007-10#3)
cerebrovascular risk factors##4##3##(1996-11#3)(2007-10#1)
cerebrovascular risk##5##2##(1996-11#3)(2007-10#1)(2011-2#1)
cerebrovascular syndromes##2##2##(2007-10#1)(2008-8#1)
cerebrovascular##104##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#4)(1991-6#4)(1992-12#1)(1992-2#4)(1993-3#1)(1994-11#1)(1995-3#1)(1996-11#3)(1996-2#1)(1996-5#4)(1997-2#1)(1997-8#1)(2006-7#1)(2007-10#12)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#6)(2009-10#1)(2010-12#2)(2010-9#1)(2011-1#13)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#5)(2013-8#1)
cerebrovasculature##2##1##(1994-8#1)(2007-10#1)
cerebrum and##4##2##(1990-5#1)(2008-9#3)
cerebrum is##3##2##(2008-11#1)(2008-9#2)
cerebrum##24##1##(1990-5#1)(1990-7#1)(1991-2#2)(1993-12#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-9#14)
cereulide synthetase##2##2##(2011-2#2)
cereulide##6##1##(2011-2#6)
cereus and##3##2##(2011-1#1)(2011-2#2)
cereus group population##2##3##(2011-2#2)
cereus group##9##2##(2011-2#9)
cereus strain##3##2##(2008-10#1)(2011-2#2)
cereus strains##2##2##(2008-10#2)
cereus##41##1##(1992-3#4)(1994-11#1)(2008-10#6)(2008-5#1)(2010-12#2)(2011-1#2)(2011-2#25)
cerevisiae 4C##2##2##(2013-1#2)
cerevisiae AS##3##2##(2008-8#3)
cerevisiae GRF18##2##2##(2008-8#2)
cerevisiae and contains##2##3##(1996-3#1)(1997-3#1)
cerevisiae and##12##2##(1991-12#1)(1991-5#1)(1994-12#2)(1995-2#1)(1995-6#1)(1996-3#2)(1997-3#1)(2008-4#1)(2008-7#2)
cerevisiae are##2##2##(1994-9#1)(1996-6#1)
cerevisiae as##2##2##(1997-1#1)(2008-8#1)
cerevisiae by##6##2##(1991-8#1)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-8#1)
cerevisiae cells##4##2##(1993-12#1)(1993-8#1)(1995-9#1)(2008-4#1)
cerevisiae chromosome##17##2##(1993-12#1)(1994-9#2)(1995-12#2)(1995-9#1)(1996-3#3)(1996-6#1)(1997-3#7)
cerevisiae for##3##2##(1994-3#1)(2008-2#1)(2008-6#1)
cerevisiae gene##4##2##(1990-5#1)(1996-6#1)(2012-3#2)
cerevisiae genes##3##2##(1991-2#1)(1993-2#1)(1996-3#1)
cerevisiae has two##3##3##(1997-4#1)(1997-7#2)
cerevisiae has##11##2##(1991-9#1)(1992-10#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#2)(2008-4#1)(2008-6#1)(2008-7#1)(2012-3#1)
cerevisiae hsp90##2##2##(1996-12#2)
cerevisiae in the##2##3##(2008-6#1)(2008-8#1)
cerevisiae in##5##2##(1993-12#1)(1996-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
cerevisiae is##6##2##(1993-9#2)(1996-3#1)(1996-6#1)(2009-12#1)(2012-3#1)
cerevisiae protein##4##2##(1995-6#1)(1996-6#2)(2008-7#1)
cerevisiae strains##2##2##(1993-12#1)(1995-6#1)
cerevisiae to##3##2##(1994-12#1)(2008-8#1)(2012-3#1)
cerevisiae were##3##2##(1996-6#1)(1997-6#1)(2008-10#1)
cerevisiae##334##1##(1990-11#3)(1990-12#3)(1990-2#5)(1990-5#16)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#4)(1991-7#2)(1991-8#2)(1991-9#6)(1992-10#2)(1992-11#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#3)(1993-9#9)(1994-12#10)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#19)(1995-8#4)(1995-9#7)(1996-12#4)(1996-2#4)(1996-3#21)(1996-6#23)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#23)(1997-4#6)(1997-6#3)(1997-7#8)(1997-8#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#5)(2008-4#5)(2008-6#7)(2008-7#15)(2008-8#13)(2008-9#2)(2009-12#4)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#16)(2013-1#3)
cerevisiae)##6##1##(1990-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-2#1)(2012-3#1)
ceria-zirconia##6##1##(2008-10#6)
cerium phosphate (disodium)##2##3##(2008-10#2)
cerium phosphate##4##2##(2008-10#4)
cerium phosphates with##2##3##(2008-10#2)
cerium##20##1##(2007-12#2)(2008-10#15)(2008-2#1)(2008-7#1)(2012-2#1)
cerium(IV) and##2##2##(2008-10#2)
cerium(IV) in##5##2##(2008-10#5)
cerium(IV)##18##1##(1997-4#1)(2008-10#17)
cerium-doped potassium sodium strontium barium niobate (Ce##3##7##(2007-12#1)(2008-3#2)
cerium-doped potassium sodium strontium barium niobate##6##6##(2007-12#1)(2008-3#5)
cerium-doped##7##1##(2007-12#1)(2008-3#6)
cerivastatin and##2##2##(2008-10#2)
certain advantages##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
certain amino##2##2##(2008-1#1)(2011-2#1)
certain areas of##2##3##(1992-11#1)(2011-2#1)
certain areas##5##2##(1990-8#1)(1992-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
certain aspects of the##2##4##(2008-10#1)(2010-8#1)
certain aspects of##5##3##(1994-1#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-3#1)
certain aspects##6##2##(1994-1#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-8#1)(2012-3#1)
certain assumptions##2##2##(2008-10#1)(2008-3#1)
certain behavioral##2##2##(2009-9#1)(2012-2#1)
certain brain regions##3##3##(1991-5#1)(2008-2#1)(2012-1#1)
certain cancers##6##2##(1997-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-10#1)(2011-1#1)
certain cases##9##2##(1991-2#1)(1994-12#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-8#1)
certain cell##6##2##(1992-2#1)(1993-6#1)(2008-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
certain cells##2##2##(1995-2#1)(2013-8#1)
certain changes in##2##3##(1994-12#1)(2007-5#1)
certain changes##4##2##(1994-12#1)(2007-5#1)(2008-9#1)(2012-2#1)
certain characteristics##4##2##(1996-7#1)(2007-10#1)(2008-5#1)(2011-2#1)
certain circumstances##10##2##(1990-3#1)(1994-10#1)(1994-3#1)(1995-8#1)(1996-9#1)(2007-8#1)(2008-5#1)(2011-2#2)(2012-2#1)
certain classes of##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
certain clinical##3##2##(1997-3#1)(2008-3#1)(2008-4#1)
certain combinations of##2##3##(1992-2#1)(2008-10#1)
certain combinations##3##2##(1992-2#1)(2008-10#2)
certain compounds##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
certain conditions##28##2##(1991-5#1)(1992-3#1)(1994-6#2)(1995-2#1)(1997-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)
certain criteria##2##2##(1997-3#1)(2013-8#1)
certain decisions##3##2##(2008-11#3)
certain degree of##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
certain degree##5##2##(1990-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
certain disease states##2##3##(2008-2#1)(2009-8#1)
certain diseases##4##2##(2008-10#3)(2013-1#1)
certain drugs on prescription have been distributed to patients by##2##10##(1990-2#2)
certain drugs##5##2##(1990-2#2)(1992-8#1)(2008-11#2)
certain environmental##4##2##(1993-2#1)(2008-10#2)(2012-3#1)
certain experimental##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
certain factors##2##2##(1995-2#1)(2008-9#1)
certain fatty acids##3##3##(1992-3#1)(1996-3#1)(2011-2#1)
certain features##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
certain food##2##2##(1992-9#1)(2008-10#1)
certain forms of##2##3##(2010-7#1)(2011-1#1)
certain genes##4##2##(1992-3#1)(1992-6#1)(2008-4#1)(2009-5#1)
certain genetic##3##2##(2007-5#1)(2008-7#1)(2013-7#1)
certain genomic regions##2##3##(2007-11#1)(2009-10#1)
certain genomic##3##2##(2007-11#1)(2009-10#1)(2009-5#1)
certain groups of patients##2##4##(2011-2#1)(2013-1#1)
certain groups of##4##3##(1994-2#1)(1996-11#1)(2011-2#1)(2013-1#1)
certain groups##5##2##(1994-2#1)(1996-11#1)(2011-2#1)(2013-1#2)
certain health##2##2##(1994-3#1)(2009-12#1)
certain high risk##2##3##(2007-11#1)(2011-2#1)
certain historical##2##2##(1993-6#1)(2010-3#1)
certain human##4##2##(1990-3#1)(2008-4#1)(2009-5#1)(2009-8#1)
certain incidence angles##2##3##(2007-11#1)(2008-2#1)
certain indications##2##2##(1994-2#1)(2008-12#1)
certain individuals##4##2##(1990-7#1)(1990-8#1)(2008-10#1)(2008-7#1)
certain kinds of##3##3##(1994-12#1)(1996-6#1)(2007-12#1)
certain limits##2##2##(1990-7#1)(2008-3#1)
certain medications##2##2##(2008-3#1)(2013-1#1)
certain metal##3##2##(2008-10#3)
certain motor##2##2##(1993-12#1)(2009-3#1)
certain mutant##2##2##(1996-2#1)(2009-5#1)
certain neurodegenerative diseases##2##3##(1993-3#1)(1997-7#1)
certain nucleotide##2##2##(2008-11#1)(2012-2#1)
certain of the##4##3##(2007-5#1)(2008-10#3)
certain of##5##2##(2007-5#1)(2008-10#3)(2008-3#1)
certain optimized##2##2##(1997-6#1)(2008-2#1)
certain organs##2##2##(2008-7#1)(2013-1#1)
certain other##7##2##(1990-5#1)(1993-11#1)(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
certain parts of##2##3##(1997-4#1)(2009-9#1)
certain patients##6##2##(1994-9#1)(2007-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
certain patterns##2##2##(1996-4#1)(2006-10#1)
certain peptides##2##2##(1994-5#2)
certain physiological##4##2##(1990-11#1)(1990-12#1)(2008-10#1)(2012-2#1)
certain population##2##2##(1990-12#1)(2011-2#1)
certain populations of##3##3##(1990-5#1)(2007-7#1)(2008-5#1)
certain preventive##2##2##(2008-11#1)(2011-2#1)
certain protein##2##2##(1992-12#1)(1996-2#1)
certain proteins##2##2##(1992-9#1)(1997-4#1)
certain questions##2##2##(2008-1#1)(2009-10#1)
certain range##4##2##(1995-3#1)(2008-10#2)(2013-8#1)
certain rats##2##2##(1993-6#2)
certain regions##2##2##(2008-10#2)
certain requirements##5##2##(1993-2#1)(2008-10#1)(2008-6#1)(2009-6#1)(2009-8#1)
certain risk factors##2##3##(1992-1#1)(2011-1#1)
certain risk groups##2##3##(1990-3#1)(2013-1#1)
certain risk##5##2##(1990-3#1)(1992-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
certain safety##3##2##(1993-2#1)(2008-11#1)(2010-9#1)
certain scenarios##2##2##(2010-3#1)(2011-2#1)
certain similarities##2##2##(1994-9#1)(2008-7#1)
certain skin##2##2##(1995-5#1)(2008-5#1)
certain species##2##2##(2008-8#1)(2008-9#1)
certain specific##3##2##(2008-2#2)(2011-2#1)
certain strains##2##2##(1990-2#1)(2011-1#1)
certain subgroups##3##2##(1991-6#1)(2009-11#1)(2013-1#1)
certain substrates##2##2##(1997-7#1)(2007-11#1)
certain system##2##2##(2008-3#1)(2013-8#1)
certain that##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
certain to##3##2##(1996-11#1)(2008-2#1)(2011-2#1)
certain types of##13##3##(1992-9#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
certain variables##4##2##(1992-3#1)(1993-10#1)(2008-10#2)
certain wavelength##2##2##(2007-12#1)(2008-2#1)
certain wavelengths##3##2##(2007-11#1)(2008-1#1)(2008-4#1)
certain##747##1##(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#4)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#3)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#4)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#4)(1993-6#7)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#6)(1995-1#1)(1995-11#1)(1995-2#5)(1995-3#2)(1995-5#2)(1995-8#4)(1996-1#1)(1996-11#4)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#3)(2006-10#2)(2006-12#1)(2007-10#3)(2007-11#15)(2007-12#12)(2007-5#3)(2007-7#5)(2007-8#5)(2008-1#10)(2008-10#96)(2008-11#36)(2008-12#5)(2008-2#26)(2008-3#31)(2008-4#16)(2008-5#22)(2008-6#5)(2008-7#25)(2008-8#21)(2008-9#23)(2009-10#5)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#3)(2009-8#8)(2009-9#5)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#11)(2011-2#47)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#20)(2013-7#3)(2013-8#14)
certainly help##2##2##(2009-7#1)(2010-5#1)
certainly not##2##2##(1991-11#1)(2008-5#1)
certainly provide##2##2##(1997-8#1)(2008-11#1)
certainly the##3##2##(1995-11#1)(2008-7#1)(2010-11#1)
certainly##46##1##(1990-8#1)(1991-11#1)(1991-12#1)(1992-12#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-1#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2013-1#2)
certainty about future funding##2##4##(1995-3#2)
certainty about##3##2##(1995-3#2)(2010-5#1)
certainty##17##1##(1991-11#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
certificate in##2##2##(1994-12#1)(2008-11#1)
certificate of##4##2##(1991-3#1)(1994-12#1)(2008-11#1)(2011-2#1)
certificate values##2##2##(2008-10#2)
certificate##17##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-5#1)(1994-12#2)(2007-11#1)(2008-10#4)(2008-11#2)(2011-2#1)(2013-1#1)
certificated seeds of improved varieties##3##5##(2008-12#3)
certificated seeds of improved##4##4##(2008-12#4)
certificated seeds##6##2##(2008-12#6)
certificated##10##1##(2008-10#1)(2008-12#8)(2013-8#1)
certificates##7##1##(1991-2#1)(2007-10#1)(2010-4#1)(2012-12#3)(2013-8#1)
certification and##6##2##(1991-3#1)(1993-12#1)(1996-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
certification of##6##2##(1991-9#1)(2008-10#3)(2009-10#1)(2012-12#1)
certification program##2##2##(1996-3#1)(2009-8#1)
certification programs##2##2##(1994-12#1)(2008-10#1)
certification##37##1##(1991-1#1)(1991-3#1)(1991-9#1)(1993-12#3)(1994-12#4)(1994-9#1)(1996-1#1)(1996-3#1)(1997-2#2)(2007-5#1)(2008-10#10)(2008-4#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)
certifications##2##1##(1997-5#1)(2008-10#1)
certified and##8##2##(1992-3#1)(2008-10#6)(2013-1#1)
certified as##4##2##(1991-12#1)(1991-6#1)(1991-9#1)(2013-1#1)
certified biological reference materials##2##4##(2008-10#2)
certified by##2##2##(2008-2#1)(2011-2#1)
certified contents##2##2##(2008-10#2)
certified for the##2##3##(2008-10#2)
certified for##6##2##(2008-10#5)(2012-12#1)
certified material##2##2##(2008-10#2)
certified materials##7##2##(2008-10#7)
certified nurse assistants##2##3##(2008-11#1)(2010-11#1)
certified nurse midwives##2##3##(1993-3#1)(2012-3#1)
certified nurse##5##2##(1993-3#1)(2008-11#1)(2010-11#2)(2012-3#1)
certified or##3##2##(2008-10#3)
certified range##3##2##(2008-10#3)
certified reference material (CRM)##2##4##(2008-10#2)
certified reference material (GBW##2##4##(2008-10#2)
certified reference material and##4##4##(2008-10#4)
certified reference material of##6##4##(2008-10#5)(2011-2#1)
certified reference material##34##3##(2008-1#1)(2008-10#32)(2011-2#1)
certified reference materials (CRMs)##6##4##(2008-10#6)
certified reference materials and of##2##5##(2008-10#2)
certified reference materials and##11##4##(2008-10#11)
certified reference materials are##3##4##(2008-10#3)
certified reference materials of##5##4##(2008-10#5)
certified reference materials were##2##4##(2008-10#2)
certified reference materials##63##3##(2008-10#63)
certified reference##109##2##(2008-1#1)(2008-10#106)(2011-2#1)(2013-8#1)
certified samples##3##2##(2008-10#3)
certified seeds##4##2##(2008-12#4)
certified soil##2##2##(2008-10#2)
certified to provide##2##3##(1992-2#1)(1993-12#1)
certified value of##4##3##(2008-10#4)
certified value##18##2##(2008-1#1)(2008-10#17)
certified values at a 95% confidence level##2##7##(2008-10#2)
certified values at##4##3##(2008-10#4)
certified values in##4##3##(2008-10#4)
certified values of##4##3##(2008-10#4)
certified values##48##2##(2008-10#48)
certified water##3##2##(2008-10#3)
certified##280##1##(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-2#2)(2008-1#2)(2008-10#245)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
certify the##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
certifying##3##1##(1991-9#1)(1994-12#1)(2012-3#1)
cerulenin##3##1##(1995-6#2)(2009-8#1)
ceruletide##4##1##(1994-2#4)
ceruloplasmin##14##1##(1992-12#2)(1995-3#1)(2008-10#2)(2008-9#4)(2012-2#4)(2013-1#1)
cervical HPV##2##2##(1992-3#1)(2013-1#1)
cervical IA-DSA##2##2##(2008-7#2)
cervical and endometrial##2##3##(1990-10#1)(1992-4#1)
cervical and lumbar##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
cervical and thoracic spine##2##4##(2008-12#2)
cervical and thoracic##4##3##(2008-12#4)
cervical and##13##2##(1990-10#1)(1992-3#1)(1992-4#1)(2007-11#1)(2007-8#1)(2008-12#4)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
cervical artery compromise##2##3##(2008-12#2)
cervical artery##4##2##(2008-12#3)(2009-2#1)
cervical artificial disc replacement (C-ADR)##4##5##(2012-12#4)
cervical artificial disc replacement##7##4##(2012-12#7)
cervical artificial##8##2##(2012-12#8)
cervical cancer and##9##3##(1992-8#2)(2008-1#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-7#3)
cervical cancer in the##2##4##(1991-6#1)(2013-1#1)
cervical cancer in##3##3##(1991-6#1)(2008-11#1)(2013-1#1)
cervical cancer incidence##2##3##(1992-10#1)(2011-2#1)
cervical cancer screening in##2##4##(2011-2#2)
cervical cancer screening was##2##4##(1990-8#1)(2007-8#1)
cervical cancer screening##13##3##(1990-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(2007-8#5)(2008-12#1)(2011-2#2)(2013-8#1)
cervical cancer with##2##3##(2009-5#1)(2013-1#1)
cervical cancer##86##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-6#1)(1992-10#6)(1992-2#1)(1992-8#2)(1993-2#1)(1994-1#1)(1994-10#1)(1995-9#2)(1996-10#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#3)(2009-2#1)(2009-5#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#5)(2012-12#4)(2012-3#6)(2013-1#6)(2013-7#4)(2013-8#1)
cervical cancer]##3##2##(2008-11#1)(2012-2#2)
cervical cancers##2##2##(1995-2#2)
cervical carcinogenesis##2##2##(1992-10#1)(1995-2#1)
cervical carcinoma cell line##2##4##(1992-2#2)
cervical carcinoma in young women##2##5##(1994-5#2)
cervical carcinoma in##3##3##(1994-5#2)(2010-8#1)
cervical carcinoma##15##2##(1990-10#2)(1992-2#2)(1993-12#1)(1994-5#2)(1994-8#1)(2007-10#1)(2007-4#4)(2010-8#1)(2013-7#1)
cervical carotid##2##2##(2013-8#2)
cervical cells##2##2##(2008-3#1)(2010-8#1)
cervical collar##2##2##(2010-8#2)
cervical cord injury##2##3##(2008-7#2)
cervical cord##4##2##(1997-6#1)(2008-7#3)
cervical cytology##4##2##(1990-12#1)(1992-8#1)(1994-1#1)(2008-7#1)
cervical decompression and fusion##2##4##(2008-7#1)(2012-12#1)
cervical disc##5##2##(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
cervical disk herniations##2##3##(1996-3#2)
cervical disk##3##2##(1990-9#1)(1996-3#2)
cervical dissection were##2##3##(2007-10#2)
cervical dissection##5##2##(2007-10#5)
cervical duplication##2##2##(2011-1#2)
cervical dystonia##4##2##(2008-2#1)(2008-7#2)(2011-2#1)
cervical extension##2##2##(2008-12#2)
cervical flexion AROM##2##3##(2008-12#2)
cervical flexion in patients with neck pain##2##7##(2008-12#2)
cervical flexion##4##2##(2008-12#4)
cervical fusion##3##2##(2008-7#3)
cervical injury##2##2##(2008-7#2)
cervical internal carotid##2##3##(1996-6#1)(2013-8#1)
cervical intraepithelial neoplasia (CIN)##3##4##(1991-2#1)(2011-1#1)(2011-2#1)
cervical intraepithelial neoplasia grade III##2##5##(1992-8#1)(2013-1#1)
cervical intraepithelial neoplasia grade##3##4##(1992-8#1)(1994-2#1)(2013-1#1)
cervical intraepithelial neoplasia##21##3##(1991-2#4)(1992-8#1)(1994-12#2)(1994-2#3)(2011-1#5)(2011-2#3)(2012-3#1)(2013-1#2)
cervical isometric contract-relax treatment##2##4##(2007-11#2)
cervical isometric contract-relax##3##3##(2007-11#3)
cervical lesions##6##2##(2006-10#1)(2008-11#1)(2008-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
cervical lymph nodes##6##3##(1991-3#1)(1991-9#1)(2008-2#2)(2013-8#2)
cervical lymph##7##2##(1991-3#1)(1991-9#1)(1997-3#1)(2008-2#2)(2013-8#2)
cervical lymphadenopathy##2##2##(2008-2#1)(2013-8#1)
cervical manipulation##2##2##(2007-11#2)
cervical mass##2##2##(2011-2#2)
cervical measurements##2##2##(2011-2#2)
cervical mediastinoscopy##2##2##(2007-10#1)(2007-8#1)
cervical neoplasia##4##2##(1992-10#1)(1992-2#1)(1996-8#1)(2007-10#1)
cervical oesophageal cancer##2##3##(2008-1#2)
cervical or##2##2##(1996-8#1)(2012-2#1)
cervical outline##2##2##(2011-2#2)
cervical pain##5##2##(2006-10#2)(2007-11#2)(2008-12#1)
cervical plate fixation##2##3##(2009-10#2)
cervical plate##4##2##(2009-10#4)
cervical plexus block##3##3##(2010-7#2)(2012-3#1)
cervical plexus##4##2##(2010-7#3)(2012-3#1)
cervical positional tolerance##2##3##(2008-12#2)
cervical radiculopathy and##2##3##(2008-7#2)
cervical radiculopathy##9##2##(2007-11#3)(2008-7#4)(2008-9#1)(2012-3#1)
cervical range of motion##2##4##(2008-12#2)
cervical screening##4##2##(1990-12#3)(1992-8#1)
cervical secretion sIgA##2##3##(2011-1#2)
cervical secretion##6##2##(2011-1#6)
cervical smear##2##2##(2008-3#2)
cervical smears##2##2##(1990-6#1)(1990-9#1)
cervical soft##2##2##(2007-8#1)(2013-1#1)
cervical spinal cord and##2##4##(1996-5#1)(2008-7#1)
cervical spinal cord##6##3##(1993-12#1)(1996-5#1)(2008-7#1)(2010-5#2)(2012-2#1)
cervical spinal##8##2##(1993-12#1)(1996-5#1)(2006-12#1)(2008-7#1)(2010-5#2)(2012-2#1)(2012-3#1)
cervical spine in##3##3##(2007-11#1)(2008-12#1)(2011-2#1)
cervical spine mechanical##2##3##(2009-4#2)
cervical spine##47##2##(1995-11#1)(1997-4#1)(2006-10#1)(2007-11#8)(2007-8#4)(2008-12#4)(2009-3#3)(2009-4#4)(2010-12#3)(2011-2#6)(2012-12#6)(2012-3#3)(2013-1#3)
cervical spondylitis##4##2##(2006-10#4)
cervical stroma##2##2##(1992-2#1)(2011-2#1)
cervical tissue##2##2##(1991-2#1)(1992-2#1)
cervical total disc arthroplasty (C-ADR)##2##5##(2012-12#2)
cervical##486##1##(1990-10#3)(1990-12#5)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#13)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#8)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#6)(1992-9#1)(1993-12#4)(1993-2#1)(1994-1#2)(1994-10#1)(1994-12#2)(1994-2#3)(1994-5#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-9#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#4)(1997-8#1)(2006-10#12)(2006-12#1)(2007-10#10)(2007-11#21)(2007-12#1)(2007-4#4)(2007-7#1)(2007-8#20)(2008-1#4)(2008-10#2)(2008-11#10)(2008-12#31)(2008-2#4)(2008-3#3)(2008-4#3)(2008-7#30)(2008-8#8)(2008-9#1)(2009-10#4)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-5#3)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#19)(2011-2#32)(2011-3#5)(2012-12#33)(2012-2#5)(2012-3#22)(2013-1#30)(2013-7#6)(2013-8#10)
cervicitis##4##1##(2011-2#4)
cervico-thoracic##2##1##(2007-8#1)(2013-1#1)
cervicofacial##5##1##(1997-3#1)(2007-12#3)(2012-2#1)
cervicogenic headache##5##2##(2008-12#5)
cervicotomy##4##1##(2007-8#1)(2008-12#1)(2013-1#2)
cervix and##3##2##(1990-10#1)(1996-2#1)(2013-7#1)
cervix cancer##7##2##(1990-5#1)(1990-6#2)(1993-11#1)(2008-11#1)(2011-1#2)
cervix in##6##2##(1991-3#1)(1994-5#2)(1996-6#1)(2009-7#1)(2013-1#1)
cervix of##2##2##(1990-6#1)(2013-1#1)
cervix was##3##2##(1992-2#1)(1996-12#1)(2013-1#1)
cervix##56##1##(1990-10#1)(1990-5#1)(1990-6#3)(1990-8#3)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#3)(1995-12#1)(1996-12#5)(1996-2#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#9)(2013-7#2)
ces gene##2##2##(2011-2#2)
ces transcription##3##2##(2011-2#3)
ces##13##1##(2008-11#2)(2008-5#1)(2011-2#8)(2013-1#2)
cesarean births##2##2##(1995-12#1)(2007-2#1)
cesarean delivery##4##2##(1997-1#1)(2011-2#1)(2013-1#2)
cesarean section and the##2##4##(2011-2#2)
cesarean section and##3##3##(2011-2#3)
cesarean section at##2##3##(2007-7#1)(2013-1#1)
cesarean section in##3##3##(2011-2#2)(2012-3#1)
cesarean section incidence##2##3##(1991-6#2)
cesarean section was##2##3##(2011-1#1)(2011-2#1)
cesarean section##35##2##(1991-6#4)(1992-11#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#13)(2012-12#2)(2012-3#1)(2013-1#5)
cesarean##46##1##(1991-6#4)(1992-11#1)(1994-3#1)(1994-9#1)(1995-12#4)(1997-1#3)(1997-8#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#14)(2012-12#2)(2012-3#1)(2013-1#7)
cesium chloride##6##2##(1994-8#2)(2008-10#3)(2008-9#1)
cesium ion over##5##3##(2008-10#5)
cesium ion selective##4##3##(2008-10#4)
cesium ion##10##2##(2008-10#10)
cesium ion-selective electrodes based on##2##5##(2008-10#2)
cesium ion-selective##3##2##(2008-10#3)
cesium ions##3##2##(2008-10#3)
cesium selectivity##2##2##(2008-10#2)
cesium##47##1##(1993-8#1)(1994-8#2)(2007-12#6)(2008-10#30)(2008-2#1)(2008-3#6)(2008-9#1)
cesophagitis##2##1##(2009-10#2)
cessation activities##2##2##(2013-1#2)
cessation advice##3##2##(2009-9#1)(2012-3#2)
cessation and##6##2##(1991-4#1)(1997-3#1)(2007-12#1)(2008-7#1)(2013-1#2)
cessation counselling##2##2##(2011-2#1)(2013-1#1)
cessation for adolescents##2##3##(2009-7#2)
cessation for##3##2##(1991-1#1)(2009-7#2)
cessation in the##2##3##(1997-1#1)(2011-2#1)
cessation in##7##2##(1997-1#1)(2008-11#1)(2008-6#1)(2009-7#2)(2011-1#1)(2011-2#1)
cessation intervention practices##2##3##(2011-2#2)
cessation intervention##5##2##(2008-4#2)(2008-8#1)(2011-2#2)
cessation interventions##6##2##(2007-12#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
cessation is##2##2##(1997-4#1)(2007-12#1)
cessation medication##2##2##(2013-1#2)
cessation of growth##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
cessation of phospholipid##2##3##(1995-6#2)
cessation of smoking##2##3##(1991-12#1)(2006-10#1)
cessation of therapy and##2##4##(2008-8#1)(2009-9#1)
cessation of treatment##2##3##(1995-12#1)(2008-8#1)
cessation of##35##2##(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1995-12#2)(1995-6#3)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-2#2)(2013-8#2)
cessation program##3##2##(2008-4#1)(2010-2#1)(2011-2#1)
cessation programs in##2##3##(2008-8#1)(2012-2#1)
cessation programs##3##2##(1991-12#1)(2008-8#1)(2012-2#1)
cessation rates##7##2##(2008-11#7)
cessation treatment##4##2##(2007-12#2)(2009-1#1)(2009-7#1)
cessation##136##1##(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-6#3)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#3)(2006-10#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-11#11)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#7)(2009-9#2)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#3)(2012-3#10)(2013-1#17)(2013-8#2)
cessation-related weight concerns##3##3##(2007-12#3)
cessation-related weight##4##2##(2007-12#4)
cessation-related##5##1##(2007-12#4)(2010-2#1)
cestode infected male and female rats##2##6##(2008-12#2)
cestode species##2##2##(2011-1#2)
cestode##6##1##(2008-12#3)(2011-1#2)(2011-2#1)
cestodes##3##1##(2008-12#2)(2010-8#1)
cetacean##2##1##(1996-6#1)(2012-2#1)
cetaceans##2##1##(2012-2#2)
cetirizine and##2##2##(2010-4#2)
cetirizine##11##1##(2007-11#1)(2010-4#7)(2010-5#2)(2013-8#1)
cetuximab and capecitabine plus gemcitabine##2##5##(2011-2#2)
cetuximab and##3##2##(2011-2#3)
cetuximab with##2##2##(2011-2#1)(2013-8#1)
cetuximab##12##1##(2008-10#1)(2008-5#3)(2008-7#1)(2009-5#1)(2011-2#4)(2013-8#2)
cetyl trimethyl ammonium bromide##2##4##(2008-10#2)
cetyl##9##1##(2008-10#4)(2008-5#5)
cetylpyridine bromide##2##2##(2008-10#2)
cetylpyridinium bromide (CPB)##2##3##(2008-10#2)
cetylpyridinium chloride (CPC)##7##3##(2008-10#7)
cetylpyridinium chloride##17##2##(2008-10#17)
cetylpyridinium##25##1##(2008-10#25)
cetyltrimethylammonium bromide (CTAB)##10##3##(2008-10#10)
cetyltrimethylammonium bromide (CTMAB)##2##3##(2008-10#2)
cetyltrimethylammonium bromide##17##2##(1990-5#1)(1996-5#1)(2008-10#15)
cetyltrimethylammonium chloride (CTAC)##3##3##(2008-10#3)
cetyltrimethylammonium chloride##5##2##(2008-10#5)
cetyltrimethylammonium ion##2##2##(2008-10#2)
cetyltrimethylammonium##26##1##(1990-5#1)(1996-5#1)(2008-10#24)
cf##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
cfu##4##1##(2008-5#2)(2008-9#1)(2010-4#1)
cfu/cm(2)##2##1##(2011-2#2)
cfu/cm(2))##2##1##(2012-2#2)
cgs##5##1##(2008-10#5)
ch)##2##1##(2010-12#2)
chKBP phosphorylation##2##2##(1995-5#2)
chKBP##4##1##(1995-5#4)
chacoense##3##1##(2008-10#3)
chaetigers##4##1##(2008-5#4)
chaff##3##1##(1997-5#2)(2013-7#1)
chagasi system##2##2##(2008-8#2)
chagasi##6##1##(2007-12#2)(2008-7#1)(2008-8#2)(2010-12#1)
chagasic patients##3##2##(2008-3#3)
chagasic##4##1##(2008-3#4)
chain (amino acids##2##3##(1995-6#2)
chain and the##6##3##(1990-7#1)(1993-11#2)(1994-11#1)(2008-12#1)(2008-9#1)
chain and##25##2##(1990-7#1)(1991-2#1)(1993-11#2)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-12#1)
chain antibodies##3##2##(2008-10#2)(2009-3#1)
chain at##3##2##(1992-6#1)(1995-5#1)(2008-8#1)
chain by##3##2##(1995-11#1)(2008-5#1)(2012-2#1)
chain constant region##4##3##(1997-8#2)(1997-9#2)
chain elongation and##2##3##(1994-11#1)(1996-5#1)
chain elongation##5##2##(1994-11#1)(1996-5#2)(2008-10#1)(2008-8#1)
chain ends##2##2##(1994-3#1)(1996-5#1)
chain expression in##2##3##(1991-9#1)(1997-9#1)
chain expression##5##2##(1991-9#1)(1997-9#2)(2008-5#1)(2011-2#1)
chain extension##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
chain fatty acid##5##3##(1992-3#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
chain fatty acids##3##3##(1990-6#1)(2008-10#2)
chain fatty##8##2##(1990-6#1)(1992-3#1)(1993-8#1)(2008-10#3)(2008-5#1)(2008-7#1)
chain for##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
chain from##4##2##(1990-11#1)(1992-6#1)(2013-1#1)(2013-8#1)
chain gene expression##6##3##(1992-3#4)(1994-12#1)(1997-6#1)
chain gene is##2##3##(1991-9#1)(2008-9#1)
chain gene##20##2##(1991-2#2)(1991-9#3)(1992-11#1)(1992-3#5)(1994-12#2)(1994-9#1)(1995-2#1)(1997-5#1)(1997-6#1)(2008-11#2)(2008-9#1)
chain genes##3##2##(1992-3#2)(1994-6#1)
chain has##2##2##(1990-5#1)(1995-3#1)
chain in the##6##3##(1995-5#3)(2008-10#1)(2008-9#2)
chain in##16##2##(1990-5#1)(1992-3#2)(1994-11#1)(1995-11#2)(1995-5#3)(1997-8#1)(2008-10#2)(2008-9#2)(2011-2#1)(2012-2#1)
chain increases##2##2##(1990-7#1)(1993-9#1)
chain interactions in##2##3##(2008-12#1)(2008-5#1)
chain into##2##2##(1997-2#1)(2008-11#1)
chain is##10##2##(1990-7#1)(1992-3#1)(1994-3#2)(1995-11#1)(1995-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
chain length and##3##3##(1992-7#1)(1993-11#1)(2009-12#1)
chain length is##4##3##(1992-11#1)(2008-11#3)
chain length of the##3##4##(1993-11#1)(1993-3#1)(1994-5#1)
chain length of##6##3##(1990-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(2009-3#1)
chain length##32##2##(1990-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-8#4)(1994-5#3)(1994-8#1)(1995-11#2)(1995-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#2)(2009-3#1)
chain lengths from##2##3##(1997-6#1)(2013-8#1)
chain lengths##7##2##(1990-5#1)(1994-11#1)(1997-6#2)(2008-10#1)(2008-4#1)(2013-8#1)
chain mRNA##4##2##(1996-12#1)(1997-6#3)
chain may##2##2##(1994-11#1)(2011-2#1)
chain model##3##2##(1997-3#2)(2008-9#1)
chain models##3##2##(2008-12#2)(2008-8#1)
chain mutant##2##2##(1992-3#1)(2008-9#1)
chain of bullfrog##2##3##(1997-7#2)
chain of the cofactor##3##4##(1994-5#3)
chain of the##12##3##(1991-2#1)(1993-8#1)(1994-5#3)(1994-6#2)(1995-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
chain of##64##2##(1990-5#3)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-2#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#4)(1995-11#1)(1995-2#3)(1995-5#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#4)(2007-11#3)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
chain on##3##2##(1990-11#1)(1993-11#1)(1993-8#1)
chain partially##2##2##(1992-8#1)(1993-8#1)
chain reaction (PCR) amplification of##4##5##(1993-2#1)(2008-10#3)
chain reaction (PCR) amplification##8##4##(1993-2#1)(1996-10#1)(2008-10#6)
chain reaction (PCR) based##2##4##(1990-12#1)(1997-7#1)
chain reaction (PCR) genomic##2##4##(2008-10#2)
chain reaction (PCR) primers were designed##2##6##(2008-10#2)
chain reaction (PCR) primers were##3##5##(2008-10#3)
chain reaction (PCR) primers##4##4##(2008-10#4)
chain reaction (PCR) products were##2##5##(2007-7#1)(2008-10#1)
chain reaction (PCR) using primers##2##5##(2008-10#1)(2008-7#1)
chain reaction (PCR) using##7##4##(1996-12#1)(1996-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
chain reaction (PCR)##150##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-10#2)(1996-12#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#86)(2008-11#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
chain reaction (PCR)-based##10##3##(2008-1#1)(2008-10#9)
chain reaction (QRT-PCR)##2##3##(2008-10#2)
chain reaction (RAPD-PCR)##2##3##(2007-12#1)(2011-2#1)
chain reaction (RT-PCR) analyses##2##4##(1993-3#1)(1997-2#1)
chain reaction (RT-PCR) and##8##4##(1994-11#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
chain reaction (RT-PCR) in##5##4##(1995-12#1)(2007-10#1)(2008-10#2)(2008-7#1)
chain reaction (RT-PCR) method##2##4##(2008-10#1)(2008-5#1)
chain reaction (RT-PCR) on##2##4##(2008-10#1)(2008-5#1)
chain reaction (RT-PCR) using##4##4##(1997-6#3)(2008-10#1)
chain reaction (RT-PCR) was used to amplify##2##7##(1993-8#1)(2008-10#1)
chain reaction (RT-PCR) was used##3##5##(1993-8#1)(2008-10#2)
chain reaction (RT-PCR) was##5##4##(1993-8#1)(1994-11#1)(2008-10#3)
chain reaction (RT-PCR) with##3##4##(1997-7#1)(2008-10#2)
chain reaction (RT-PCR)##63##3##(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#3)(1996-12#3)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2012-2#2)
chain reaction (rep-PCR)##10##3##(2008-10#10)
chain reaction amplification of the##4##5##(1993-8#1)(2008-10#3)
chain reaction amplification of##7##4##(1993-3#1)(1993-8#1)(2008-10#5)
chain reaction amplification##12##3##(1993-3#1)(1993-8#1)(1995-12#1)(2008-10#9)
chain reaction analysis##6##3##(1997-9#1)(2007-12#1)(2008-10#3)(2011-2#1)
chain reaction and Southern blot analyses##2##6##(2008-10#1)(2008-6#1)
chain reaction and Southern blot##3##5##(2008-10#2)(2008-6#1)
chain reaction and sequencing##2##4##(2008-10#1)(2011-1#1)
chain reaction and##28##3##(1990-8#1)(1991-9#1)(1994-12#1)(1995-12#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
chain reaction assay for the##2##5##(1996-12#1)(2008-10#1)
chain reaction assay##7##3##(1996-12#1)(2007-6#1)(2008-10#4)(2012-2#1)
chain reaction assays##11##3##(2008-10#11)
chain reaction detection and##2##4##(2007-12#1)(2008-10#1)
chain reaction detection##4##3##(2007-12#2)(2008-10#2)
chain reaction fingerprinting##2##3##(2008-10#2)
chain reaction followed by##2##4##(1992-2#1)(1993-3#1)
chain reaction for##7##3##(1996-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
chain reaction in##11##3##(1994-7#1)(1995-12#1)(1996-3#1)(1997-7#1)(2008-10#4)(2013-1#3)
chain reaction method##3##3##(1996-12#1)(1997-6#1)(1997-8#1)
chain reaction of a##2##4##(2008-10#1)(2013-1#1)
chain reaction of##9##3##(1993-8#1)(2008-10#6)(2011-2#1)(2013-1#1)
chain reaction primers##5##3##(2008-10#4)(2008-5#1)
chain reaction procedure##3##3##(1991-6#1)(2008-10#2)
chain reaction showed##3##3##(1994-11#1)(2008-10#1)(2009-8#1)
chain reaction to##7##3##(1991-9#1)(1993-11#1)(1996-12#1)(2008-11#2)(2011-2#2)
chain reaction using specific primers for##2##6##(1994-11#1)(2008-7#1)
chain reaction using##12##3##(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1997-7#2)(2008-10#4)(2008-7#1)(2012-12#1)
chain reaction was used to##7##5##(1990-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(2007-6#1)(2012-3#1)
chain reaction was##11##3##(1990-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1995-6#1)(1996-5#1)(2007-6#1)(2008-10#1)(2012-3#1)
chain reaction with##8##3##(1992-2#1)(1993-2#1)(1994-11#1)(1997-4#1)(2008-10#3)(2011-1#1)
chain reaction##560##2##(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#7)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#4)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#6)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#6)(1994-2#2)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#9)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#9)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#7)(1997-7#6)(1997-8#1)(1997-9#1)(2006-8#1)(2007-10#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#269)(2008-11#9)(2008-12#2)(2008-2#5)(2008-4#7)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-5#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#4)(2011-1#3)(2011-2#19)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#10)(2013-1#14)(2013-8#3)
chain reaction)##3##2##(1992-9#1)(1993-12#1)(2008-5#1)
chain reaction-based detection of##2##4##(2008-10#1)(2008-9#1)
chain reaction-based##13##2##(1993-8#1)(2008-10#11)(2008-9#1)
chain reaction-single strand conformation polymorphism##2##5##(1992-2#1)(1992-3#1)
chain reaction-single##3##2##(1992-2#1)(1992-3#1)(2009-7#1)
chain reaction-single-strand conformation polymorphism##2##4##(1995-6#2)
chain reactions##6##2##(1993-8#1)(1997-4#1)(2008-10#4)
chain structure##5##2##(1992-3#1)(1997-2#1)(1997-7#1)(2008-10#2)
chain termination##4##2##(1995-2#3)(2008-8#1)
chain that##2##2##(1993-9#1)(2008-9#1)
chain to##3##2##(1994-5#1)(2007-12#1)(2008-2#1)
chain transfer agent##3##3##(2008-12#2)(2009-11#1)
chain transfer##6##2##(2008-12#3)(2009-10#1)(2009-11#1)(2010-2#1)
chain was##2##2##(1990-11#1)(1995-3#1)
chain were##2##2##(1993-11#1)(2008-7#1)
chain which##2##2##(1997-7#1)(2007-12#1)
chain with##3##2##(1993-2#1)(1994-3#1)(2008-10#1)
chain##1249##1##(1990-11#14)(1990-12#13)(1990-2#4)(1990-3#2)(1990-5#16)(1990-6#1)(1990-7#8)(1990-8#7)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#9)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#18)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#7)(1992-3#20)(1992-4#2)(1992-6#15)(1992-7#1)(1992-8#14)(1992-9#4)(1993-11#16)(1993-12#4)(1993-2#10)(1993-3#4)(1993-6#8)(1993-8#26)(1993-9#6)(1994-1#1)(1994-11#24)(1994-12#8)(1994-2#6)(1994-3#12)(1994-5#13)(1994-6#10)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#1)(1995-11#14)(1995-12#13)(1995-2#11)(1995-3#9)(1995-5#14)(1995-6#10)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#13)(1996-2#1)(1996-3#1)(1996-5#8)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#8)(1997-5#3)(1997-6#15)(1997-7#13)(1997-8#10)(1997-9#9)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#4)(2007-11#6)(2007-12#11)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#357)(2008-11#27)(2008-12#23)(2008-2#10)(2008-3#2)(2008-4#20)(2008-5#20)(2008-6#4)(2008-7#18)(2008-8#19)(2008-9#24)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#9)(2009-8#8)(2009-9#5)(2010-1#1)(2010-12#1)(2010-2#3)(2010-4#3)(2010-6#4)(2010-8#1)(2011-1#6)(2011-2#33)(2012-1#3)(2012-12#3)(2012-2#17)(2012-3#11)(2012-7#1)(2013-1#20)(2013-8#15)
chain)##4##1##(1991-5#1)(1995-2#1)(2008-11#1)(2008-4#1)
chain-length dependent manner##2##3##(1990-11#2)
chain-length dependent##3##2##(1990-11#3)
chain-length##6##1##(1990-11#3)(1990-7#3)
chain-like##2##1##(2007-11#1)(2009-11#1)
chain-melting phase transition##2##3##(1994-12#2)
chain-reaction##2##1##(1996-8#2)
chainlike##2##1##(2008-2#1)(2008-3#1)
chainreaction##2##1##(2008-11#2)
chains and a##2##3##(2007-11#1)(2011-2#1)
chains and is##2##3##(1990-12#1)(1990-7#1)
chains and##12##2##(1990-12#1)(1990-7#1)(1992-10#1)(1992-9#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)
chains are##16##2##(1990-12#1)(1991-9#2)(1992-3#1)(1993-11#1)(1993-8#1)(1993-9#3)(1994-9#1)(1995-2#2)(2007-12#1)(2008-9#2)(2009-7#1)
chains as##3##2##(1993-3#1)(1994-5#1)(2011-2#1)
chains by##3##2##(1991-5#1)(2008-8#1)(2008-9#1)
chains composed of##2##3##(2008-7#1)(2010-12#1)
chains do##2##2##(1992-3#1)(2008-7#1)
chains from##3##2##(1993-9#1)(1994-9#1)(2008-4#1)
chains had##3##2##(1993-11#2)(2008-8#1)
chains have been##2##3##(1993-8#1)(2008-11#1)
chains have##4##2##(1992-9#1)(1993-8#1)(1997-2#1)(2008-11#1)
chains in the##9##3##(1990-8#2)(1991-6#1)(1993-8#1)(1997-9#1)(2008-10#3)(2012-12#1)
chains in##19##2##(1990-8#2)(1991-6#1)(1993-8#2)(1993-9#3)(1995-6#1)(1997-9#1)(2008-10#4)(2008-4#2)(2012-12#2)(2013-1#1)
chains of a##3##3##(1990-8#1)(1994-11#1)(1994-8#1)
chains of human leukocyte##2##4##(1993-11#1)(1997-4#1)
chains of the##6##3##(1992-6#1)(1994-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)
chains of##42##2##(1990-12#1)(1990-5#3)(1990-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-3#1)(1995-6#2)(1996-8#1)(1997-4#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
chains on the##2##3##(1993-12#1)(2008-10#1)
chains on##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
chains over##2##2##(2008-10#1)(2010-5#1)
chains that are##4##3##(1993-9#1)(1995-2#1)(2008-8#1)(2009-8#1)
chains that##5##2##(1993-9#1)(1995-2#1)(1997-9#1)(2008-8#1)(2009-8#1)
chains to##5##2##(1991-9#1)(1994-11#1)(1997-9#1)(2008-10#1)(2008-5#1)
chains was##3##2##(1993-11#1)(1997-9#1)(2008-8#1)
chains were##13##2##(1990-11#1)(1991-9#2)(1993-11#6)(1993-6#1)(1993-8#1)(2008-11#1)(2013-8#1)
chains which##2##2##(1993-11#1)(1995-2#1)
chains with##3##2##(1990-12#1)(1992-8#1)(2013-8#1)
chains within##2##2##(1990-7#1)(1990-8#1)
chains##281##1##(1990-11#1)(1990-12#7)(1990-5#4)(1990-7#5)(1990-8#5)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#11)(1992-10#1)(1992-12#4)(1992-3#5)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#18)(1993-12#4)(1993-3#3)(1993-6#1)(1993-8#9)(1993-9#12)(1994-11#6)(1994-3#1)(1994-5#6)(1994-6#2)(1994-8#3)(1994-9#5)(1995-11#1)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#6)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-9#5)(2006-12#4)(2007-11#3)(2007-12#1)(2008-10#23)(2008-11#12)(2008-12#2)(2008-3#3)(2008-4#13)(2008-5#8)(2008-7#4)(2008-8#13)(2008-9#7)(2009-3#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#3)
chair and##3##2##(2008-4#1)(2008-5#1)(2013-8#1)
chair##12##1##(1995-6#1)(1996-5#1)(1996-8#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-4#1)(2013-8#2)
chair/twist-boat equilibrium##2##2##(1996-5#2)
chaired by##4##2##(2008-5#3)(2008-7#1)
chaired##5##1##(2008-5#4)(2008-7#1)
chairman##3##1##(1994-3#1)(1995-12#1)(2008-11#1)
chairman-elect##3##1##(1992-12#1)(1993-12#1)(1995-3#1)
chairs##7##1##(2009-4#6)(2012-3#1)
chalazal##3##1##(2008-11#2)(2009-12#1)
chalcides##2##1##(2010-3#2)
chalcogenide glass fibers##2##3##(2008-3#2)
chalcogenide glass membrane ion-selective electrode##2##5##(2008-10#2)
chalcogenide glass##13##2##(2007-11#2)(2007-12#1)(2008-10#8)(2008-3#2)
chalcogenide glasses##8##2##(1991-1#1)(2007-11#4)(2007-12#2)(2008-10#1)
chalcogenide##31##1##(1990-4#1)(1991-1#1)(2007-11#6)(2007-12#3)(2008-10#13)(2008-3#3)(2010-5#4)
chalcogenide-based##2##1##(2008-10#1)(2010-5#1)
chalcogramma##3##1##(2010-8#3)
chalcone synthase##2##2##(2008-10#1)(2008-9#1)
chalcone##6##1##(1993-9#1)(2008-10#4)(2008-9#1)
chalcones##3##1##(2008-10#1)(2011-1#1)(2011-3#1)
chalcophile elements##2##2##(2008-10#2)
challenge and the##2##3##(2008-6#1)(2008-7#1)
challenge and##11##2##(1990-11#1)(1990-2#1)(1992-5#1)(1993-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
challenge at##3##2##(2008-1#1)(2008-5#1)(2009-5#1)
challenge because##3##2##(2008-4#1)(2008-8#1)(2011-2#1)
challenge by##4##2##(1990-11#1)(1995-6#1)(2010-4#2)
challenge current##2##2##(2009-2#1)(2010-10#1)
challenge currently##2##2##(2008-7#1)(2010-6#1)
challenge despite##2##2##(2008-10#1)(2011-1#1)
challenge due to the##4##4##(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
challenge due to##6##3##(2007-7#1)(2008-11#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
challenge facing##5##2##(1996-6#1)(2008-7#2)(2012-12#1)(2012-3#1)
challenge for a##2##3##(1991-11#1)(2008-12#1)
challenge for health##2##3##(1992-5#1)(1994-2#1)
challenge for neuroscience##2##3##(1995-2#1)(2008-11#1)
challenge for researchers##2##3##(2008-4#1)(2010-7#1)
challenge for the future is##2##5##(2008-10#1)(2008-7#1)
challenge for the##19##3##(1991-1#1)(1991-3#1)(1992-12#1)(1994-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
challenge for##62##2##(1991-1#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-3#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
challenge from the##2##3##(1997-6#1)(2012-2#1)
challenge from##3##2##(1997-6#2)(2012-2#1)
challenge in a##3##3##(1994-12#1)(2008-11#1)(2013-1#1)
challenge in terms of##3##4##(1997-2#1)(2008-11#1)(2010-12#1)
challenge in the face of##2##5##(1996-1#1)(1996-3#1)
challenge in the##7##3##(1996-1#1)(1996-3#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
challenge in treating##2##3##(2008-2#1)(2009-12#1)
challenge in##44##2##(1992-2#1)(1992-5#1)(1994-12#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
challenge inoculation##3##2##(2008-10#3)
challenge is to manage##2##4##(1996-2#1)(2008-4#1)
challenge is to##12##3##(1991-11#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-7#1)
challenge is##20##2##(1991-11#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-12#2)(2009-7#1)(2010-12#1)(2012-2#1)
challenge may##3##2##(1992-9#1)(1995-3#1)(1996-12#1)
challenge of the##5##3##(1991-3#1)(1994-9#1)(2008-11#1)(2011-2#2)
challenge of using##2##3##(1993-3#1)(2012-3#1)
challenge of##63##2##(1991-12#3)(1991-3#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
challenge or##2##2##(1991-12#1)(2008-5#1)
challenge test##9##2##(1995-3#1)(2008-5#2)(2011-2#2)(2012-3#3)(2013-1#1)
challenge tests##2##2##(1995-12#1)(2008-5#1)
challenge that##4##2##(2008-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
challenge the##13##2##(1995-1#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
challenge to clinicians##2##3##(1995-2#1)(2011-2#1)
challenge to the surgeon##3##4##(2007-12#1)(2007-8#1)(2008-10#1)
challenge to the##15##3##(1992-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-7#1)(2012-2#1)
challenge to##60##2##(1991-3#1)(1992-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-6#5)(2008-7#4)(2008-9#1)(2009-10#2)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#2)
challenge was##8##2##(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
challenge which##2##2##(1996-12#2)
challenge will be to##2##4##(2008-10#1)(2009-10#1)
challenge with a##2##3##(1990-2#1)(1997-3#1)
challenge with the##4##3##(1991-3#1)(1997-6#2)(2008-10#1)
challenge with##24##2##(1990-2#1)(1991-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#2)(1997-3#1)(1997-6#3)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
challenge##542##1##(1990-11#2)(1990-2#3)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#5)(1991-8#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#3)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#4)(1993-3#4)(1993-6#2)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#6)(1995-5#4)(1995-6#3)(1996-1#7)(1996-11#2)(1996-12#15)(1996-2#8)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#4)(1997-2#4)(1997-3#12)(1997-5#1)(1997-6#7)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#7)(2008-10#46)(2008-11#15)(2008-12#14)(2008-2#3)(2008-3#11)(2008-4#9)(2008-5#15)(2008-6#9)(2008-7#27)(2008-8#6)(2008-9#5)(2009-10#7)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#11)(2010-5#8)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#25)(2011-3#1)(2012-12#9)(2012-2#18)(2012-3#21)(2013-1#23)(2013-7#1)(2013-8#10)
challenge)##2##1##(1992-3#1)(2008-7#1)
challenge]##7##1##(1990-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-8#1)(1997-2#1)(2008-7#1)
challenged as##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
challenged at##2##2##(1991-3#1)(1997-3#1)
challenged by exposure to##2##4##(1993-12#1)(2008-5#1)
challenged by the##2##3##(1994-2#1)(2010-5#1)
challenged by##20##2##(1993-12#1)(1994-2#2)(1995-9#1)(1996-3#1)(1996-6#1)(1997-6#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)
challenged over##2##2##(2010-8#1)(2013-8#1)
challenged plants##2##2##(2008-10#2)
challenged the##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
challenged this##2##2##(2008-11#1)(2009-5#1)
challenged to develop##2##3##(2008-12#1)(2013-1#1)
challenged to##7##2##(1990-6#1)(1995-12#1)(1997-2#1)(2008-12#1)(2010-12#1)(2010-3#1)(2013-1#1)
challenged with B##2##3##(2008-10#2)
challenged with PVX containing the##2##5##(2008-10#2)
challenged with a##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
challenged with strain 1##2##4##(1991-8#2)
challenged with strain##3##3##(1991-8#3)
challenged with the##4##3##(1991-8#1)(2008-10#2)(2010-4#1)
challenged with##32##2##(1991-8#5)(1991-9#1)(1993-12#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-12#3)(2008-9#1)(2010-4#1)(2012-2#1)(2013-8#1)
challenged##99##1##(1990-6#1)(1991-3#1)(1991-8#5)(1991-9#1)(1992-2#1)(1993-12#4)(1993-6#1)(1994-2#2)(1995-12#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
challenges ahead##3##2##(1996-3#1)(2008-6#1)(2009-5#1)
challenges and opportunities for##3##4##(1995-3#1)(2008-12#1)(2009-5#1)
challenges and opportunities that##2##4##(2008-1#1)(2008-5#1)
challenges and opportunities##13##3##(1992-12#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
challenges and pitfalls##2##3##(1994-6#1)(2011-1#1)
challenges and possible solutions##2##4##(2007-12#1)(2009-6#1)
challenges and the##4##3##(1997-2#1)(2010-12#1)(2010-3#1)(2012-12#1)
challenges and##55##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
challenges are discussed##3##3##(1997-1#1)(2009-11#1)(2010-10#1)
challenges are presented##2##3##(1992-1#1)(2008-10#1)
challenges are##12##2##(1992-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-1#1)
challenges as##2##2##(2011-2#1)(2013-1#1)
challenges associated with##11##3##(1994-12#1)(1996-1#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-3#1)
challenges at##2##2##(1995-3#1)(2010-5#1)
challenges by##3##2##(1991-1#1)(1995-1#1)(2008-6#1)
challenges can be##2##3##(2008-10#1)(2008-4#1)
challenges can##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
challenges confronting##2##2##(1994-12#1)(2008-7#1)
challenges encountered##2##2##(2008-11#1)(2012-3#1)
challenges exist##3##2##(1995-3#1)(2012-2#1)(2012-3#1)
challenges faced by##6##3##(1994-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2012-12#1)
challenges faced##8##2##(1994-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-3#1)(2012-12#1)(2013-1#1)
challenges facing Catholic##2##3##(1996-1#1)(1997-3#1)
challenges facing the##3##3##(1991-1#1)(1996-3#1)(2013-1#1)
challenges facing##20##2##(1991-1#1)(1992-12#1)(1992-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2013-1#1)
challenges for nonprofit##2##3##(1992-3#1)(1994-12#1)
challenges for the future##2##4##(2008-11#1)(2010-12#1)
challenges for the##12##3##(1991-3#1)(1993-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)
challenges for##53##2##(1991-3#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-3#2)(1994-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#2)
challenges from##4##2##(1993-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
challenges in a##2##3##(2010-10#1)(2013-8#1)
challenges in monitoring##2##3##(1996-2#1)(2009-6#1)
challenges in terms of##3##4##(2008-9#1)(2010-11#1)(2011-2#1)
challenges in the##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#2)
challenges in##56##2##(1992-1#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#2)
challenges include##2##2##(1996-2#1)(1997-2#1)
challenges including##2##2##(2008-7#1)(2013-1#1)
challenges involved##2##2##(1996-2#1)(2011-1#1)
challenges lie##2##2##(1997-2#1)(2010-10#1)
challenges of cancer##2##3##(2009-10#1)(2012-2#1)
challenges of clinical##2##3##(2009-9#1)(2010-11#1)
challenges of implementing##2##3##(1997-1#1)(2012-2#1)
challenges of long-term##2##3##(1992-3#1)(2009-5#1)
challenges of the twenty-first century##3##5##(1994-2#1)(1997-1#1)(1997-3#1)
challenges of the##8##3##(1990-4#1)(1991-3#1)(1992-12#1)(1994-2#1)(1997-1#1)(1997-3#1)(2010-8#1)(2011-2#1)
challenges of##58##2##(1990-4#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-7#2)(2008-1#2)(2008-11#4)(2008-12#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-2#2)(2012-8#1)(2013-1#1)(2013-7#1)
challenges posed by##4##3##(1992-2#1)(2008-12#1)(2012-12#1)(2012-3#1)
challenges related to the##2##4##(2008-2#1)(2010-7#1)
challenges related to##5##3##(1995-1#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-7#1)
challenges remain in##2##3##(2011-2#1)(2013-1#1)
challenges remain##6##2##(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
challenges still remain##2##3##(2012-12#1)(2012-3#1)
challenges still##3##2##(2009-3#1)(2012-12#1)(2012-3#1)
challenges such as##3##3##(2007-12#1)(2008-9#1)(2012-12#1)
challenges that may##2##3##(2009-11#1)(2012-3#1)
challenges that must be##2##4##(2010-11#1)(2011-2#1)
challenges that##21##2##(1994-1#1)(1995-12#1)(2007-10#2)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
challenges the##7##2##(2008-1#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#2)
challenges they face##3##3##(2007-7#1)(2011-1#1)(2012-3#1)
challenges they##4##2##(2007-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
challenges to be met##2##4##(2008-11#1)(2008-7#1)
challenges to be##3##3##(2008-11#1)(2008-7#1)(2009-12#1)
challenges to integration##2##3##(1992-12#1)(1994-3#1)
challenges to overcome##3##3##(1996-1#1)(2009-11#2)
challenges to the##9##3##(1996-1#1)(1997-1#1)(2007-7#1)(2008-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
challenges to##42##2##(1992-12#1)(1992-2#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-3#1)(1996-1#2)(1997-1#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#3)(2009-12#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
challenges were##2##2##(2008-1#1)(2008-11#1)
challenges when##2##2##(2011-2#1)(2013-8#1)
challenges with respect to##2##4##(2008-10#1)(2009-10#1)
challenges with##5##2##(2008-10#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-8#1)
challenges##575##1##(1990-4#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#8)(1992-12#4)(1992-2#2)(1992-3#5)(1993-1#2)(1993-12#1)(1993-2#4)(1993-3#5)(1993-8#1)(1994-1#2)(1994-12#6)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#8)(1995-5#1)(1996-1#9)(1996-12#2)(1996-2#13)(1996-3#9)(1996-8#1)(1997-1#10)(1997-2#7)(1997-3#6)(1997-7#1)(2007-10#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#6)(2008-1#15)(2008-10#16)(2008-11#29)(2008-12#19)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#10)(2008-6#10)(2008-7#33)(2008-8#15)(2008-9#10)(2009-10#9)(2009-11#9)(2009-12#5)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#5)(2009-8#1)(2009-9#4)(2010-10#10)(2010-11#8)(2010-12#7)(2010-3#4)(2010-4#2)(2010-5#7)(2010-6#5)(2010-7#6)(2010-8#8)(2010-9#2)(2011-1#21)(2011-2#25)(2012-1#3)(2012-12#23)(2012-2#16)(2012-3#14)(2012-8#1)(2013-1#21)(2013-7#3)(2013-8#15)
challenges'##2##1##(2012-3#2)
challenges?##2##1##(1995-3#1)(2011-2#1)
challenges]##2##1##(2008-10#1)(2009-10#1)
challenging and controversial##2##3##(2011-2#1)(2013-1#1)
challenging and##14##2##(1997-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
challenging because##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
challenging cases##6##2##(2008-9#5)(2011-2#1)
challenging clinical##4##2##(2008-11#1)(2009-9#2)(2010-6#1)
challenging condition##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
challenging conditions##3##2##(1991-12#1)(2010-5#1)(2011-2#1)
challenging due to##2##3##(2010-5#1)(2011-2#1)
challenging environments##2##2##(2008-3#1)(2010-7#1)
challenging for##6##2##(1994-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-7#1)
challenging in##2##2##(2011-1#1)(2013-1#1)
challenging issues in##2##3##(2008-7#1)(2009-3#1)
challenging issues##3##2##(2008-7#1)(2009-3#2)
challenging population##3##2##(2007-7#1)(2012-2#1)(2013-1#1)
challenging problem for##3##3##(1994-3#1)(2008-7#1)(2012-1#1)
challenging problem in##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
challenging problem##14##2##(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
challenging problems##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
challenging procedure##2##2##(2008-10#1)(2011-2#1)
challenging since##2##2##(2008-10#1)(2010-6#1)
challenging surgery##2##2##(2008-10#1)(2010-7#1)
challenging task##11##2##(1996-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
challenging the##4##2##(2008-10#1)(2008-8#1)(2010-5#1)(2012-2#1)
challenging times##2##2##(1997-2#1)(2008-1#1)
challenging to manage##2##3##(2010-5#1)(2012-3#1)
challenging to##13##2##(1991-2#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
challenging##211##1##(1991-12#1)(1991-2#1)(1992-3#2)(1994-1#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#11)(2009-12#3)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#7)(2010-6#6)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#22)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#16)(2013-8#9)
chamber and a##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
chamber and the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
chamber and##16##2##(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-8#2)
chamber are##2##2##(2007-12#1)(2008-3#1)
chamber assay##3##2##(2008-1#1)(2008-4#1)(2013-8#1)
chamber at##6##2##(2008-10#3)(2008-6#1)(2008-7#1)(2011-2#1)
chamber enables the##2##3##(2008-1#1)(2008-10#1)
chamber experiments##9##2##(1995-12#1)(2008-10#8)
chamber for##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
chamber in the##2##3##(2008-10#1)(2008-7#1)
chamber in##4##2##(2006-11#1)(2008-10#2)(2008-7#1)
chamber is##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
chamber of a##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
chamber of the##2##3##(2008-11#1)(2008-4#1)
chamber of##11##2##(2007-11#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
chamber or##2##2##(2008-10#1)(2011-1#1)
chamber through##2##2##(2008-10#2)
chamber to##2##2##(2008-10#1)(2008-7#1)
chamber under##2##2##(2008-10#1)(2008-7#1)
chamber was designed##2##3##(2008-10#2)
chamber was##8##2##(1992-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-9#1)
chamber with a##2##3##(1990-12#1)(2008-10#1)
chamber with##5##2##(1990-12#1)(2008-10#3)(2013-1#1)
chamber##181##1##(1990-12#2)(1990-8#1)(1991-2#3)(1992-3#1)(1992-5#2)(1992-6#2)(1994-11#1)(1995-12#1)(1996-2#2)(1996-3#1)(2006-11#1)(2007-11#3)(2007-12#4)(2008-1#4)(2008-10#74)(2008-11#14)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#5)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
chamber)##2##1##(2007-12#1)(2008-10#1)
chambers and##8##2##(1996-2#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-8#1)
chambers demonstrated that##2##3##(1994-9#1)(2008-10#1)
chambers for##2##2##(2008-10#1)(2012-9#1)
chambers of##5##2##(2012-12#1)(2013-1#1)(2013-8#3)
chambers were used##2##3##(2008-11#1)(2012-1#1)
chambers were##6##2##(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
chambers##58##1##(1990-5#1)(1991-2#1)(1992-9#1)(1994-9#1)(1996-2#3)(1997-1#1)(1997-6#1)(2006-6#1)(2007-8#1)(2008-10#19)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#1)(2013-8#5)
champagne##2##1##(2008-10#2)
champion##4##1##(1996-6#1)(1996-8#1)(2008-7#1)(2013-8#1)
championed##2##1##(2009-5#1)(2012-3#1)
champions##3##1##(2008-11#1)(2008-3#1)(2008-7#1)
chance and##2##2##(1990-6#1)(2008-10#1)
chance for all##2##3##(2008-9#2)
chance for##12##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2011-2#2)
chance levels##3##2##(1993-3#1)(1994-3#1)(2008-1#1)
chance of survival##3##3##(1994-6#1)(1995-8#1)(2010-4#1)
chance of##32##2##(1990-2#2)(1990-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-6#3)(1995-8#1)(1997-3#2)(2007-7#1)(2007-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#1)
chance or##2##2##(2008-11#1)(2011-2#1)
chance that##5##2##(1991-3#1)(1995-1#1)(2007-2#1)(2008-7#1)(2008-8#1)
chance to##15##2##(1993-2#1)(1993-5#1)(1994-1#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
chance##95##1##(1990-2#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#3)(1997-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
chances for success##2##3##(1996-2#1)(2012-12#1)
chances for##8##2##(1991-2#1)(1996-2#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-12#1)
chances of##17##2##(1993-10#1)(1993-8#1)(1995-6#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-8#2)
chances to##2##2##(1995-8#1)(2008-8#1)
chances##30##1##(1991-2#1)(1992-3#1)(1993-10#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-8#2)
change (as##2##2##(2007-12#1)(2008-1#1)
change according to the##2##4##(2008-10#1)(2008-7#1)
change activity##2##2##(1991-6#2)
change after the##2##3##(2010-8#1)(2013-1#1)
change after##11##2##(1991-1#1)(1991-6#1)(2007-11#1)(2008-2#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
change agent##2##2##(1991-2#1)(1996-12#1)
change among##4##2##(1991-3#1)(2008-1#1)(2008-12#1)(2011-1#1)
change and its##3##3##(1997-2#1)(2007-12#1)(2011-2#1)
change and other##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
change and that##3##3##(2008-11#1)(2010-11#1)(2013-8#1)
change and the##3##3##(1996-12#1)(2007-12#1)(2013-1#1)
change and##55##2##(1990-4#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#3)(2013-1#1)(2013-8#1)
change appears##2##2##(1993-5#1)(2008-10#1)
change are##5##2##(1992-3#1)(1993-3#1)(2008-10#1)(2008-11#1)(2010-5#1)
change as a result of##3##5##(1992-9#1)(2009-12#1)(2012-3#1)
change as a##6##3##(1992-8#1)(1992-9#1)(1994-2#1)(2007-12#1)(2009-12#1)(2012-3#1)
change as the##3##3##(1995-2#1)(1996-4#1)(2008-7#1)
change as##15##2##(1990-9#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-2#1)(1996-4#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
change at a##3##3##(1990-12#1)(2007-12#1)(2008-3#1)
change at the##4##3##(1996-4#1)(2008-1#1)(2008-10#1)(2008-8#1)
change at##18##2##(1990-12#1)(1993-11#1)(1993-8#1)(1996-4#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-12#1)
change between the##2##3##(2008-2#1)(2008-3#1)
change between##10##2##(1991-1#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#2)(2013-1#1)
change by##9##2##(1993-6#1)(1994-12#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-12#1)(2012-12#1)(2012-2#1)
change can be##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
change can##7##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
change caused by the##2##4##(1993-8#1)(2008-10#1)
change caused by##4##3##(1993-8#1)(2007-12#1)(2008-10#2)
change clinical##2##2##(1997-2#1)(2008-8#1)
change compared to the baseline##2##5##(2011-2#2)
change compared##3##2##(2008-10#1)(2011-2#2)
change could be##2##3##(2008-10#1)(2008-9#1)
change could##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
change detection##2##2##(2007-5#1)(2008-10#1)
change did not##2##3##(1994-12#1)(2008-10#1)
change did##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
change disease##9##2##(2007-7#2)(2008-1#6)(2013-8#1)
change dramatically##3##2##(1995-12#1)(1995-5#1)(2008-11#1)
change due to the##2##4##(1996-12#1)(2008-10#1)
change due to##6##3##(1992-8#1)(1996-12#1)(2008-10#3)(2008-5#1)
change during the##7##3##(1990-5#1)(1993-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-1#1)
change during##17##2##(1990-5#1)(1993-2#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
change following##5##2##(1991-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2013-8#1)
change for the addition of the##2##6##(1990-8#2)
change for the##7##3##(1990-8#3)(1991-1#1)(1992-12#2)(1993-12#1)
change for##15##2##(1990-8#3)(1991-1#1)(1992-12#2)(1993-12#1)(1996-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)
change from a##5##3##(1994-12#1)(1995-2#1)(2009-8#1)(2010-8#1)(2011-2#1)
change from an##2##3##(1995-8#1)(2008-5#1)
change from baseline##4##3##(1992-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
change from the##3##3##(1990-8#1)(1993-2#1)(2009-8#1)
change from##38##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
change had##2##2##(1992-12#1)(2008-12#1)
change has##5##2##(1995-3#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-12#1)
change have##2##2##(2008-3#1)(2013-1#1)
change health##2##2##(1994-12#1)(2007-2#1)
change in 50##2##3##(2008-9#1)(2012-3#1)
change in BMI##4##3##(2010-8#3)(2013-1#1)
change in Medicare##2##3##(1991-2#1)(1992-12#1)
change in a##6##3##(1992-6#1)(1994-12#1)(1996-1#1)(2008-1#1)(2008-3#2)
change in absorbance##7##3##(2008-10#7)
change in activity##2##3##(1992-5#1)(2008-10#1)
change in average cell diameter##2##5##(2008-11#2)
change in average##4##3##(1992-12#1)(2008-11#3)
change in basal##2##3##(1990-5#1)(1995-11#1)
change in cell##2##3##(1993-8#1)(2008-11#1)
change in conductivity##2##3##(2008-10#1)(2008-7#1)
change in density##2##3##(2008-10#1)(2008-3#1)
change in depression##2##3##(2010-1#2)
change in dissolution kinetics##2##4##(2008-5#2)
change in distribution of##2##4##(1992-12#1)(1992-6#1)
change in either##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
change in fluorescence intensity##4##4##(1992-3#1)(1995-11#1)(2008-10#2)
change in focus##2##3##(2008-11#1)(2010-3#1)
change in function##2##3##(1995-3#1)(2010-10#1)
change in health care##4##4##(1992-1#1)(1993-2#1)(1996-2#1)(1996-3#1)
change in health##5##3##(1992-1#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-8#1)
change in heart rate##2##4##(1995-12#1)(2007-10#1)
change in incident##2##3##(2007-11#1)(2008-3#1)
change in index of refraction##2##5##(2007-12#1)(2008-3#1)
change in intracellular##2##3##(1991-9#1)(2008-9#1)
change in irrational beliefs##2##4##(2010-5#2)
change in its##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
change in local##2##3##(1996-1#1)(2009-12#1)
change in loss##3##3##(2008-3#3)
change in mitochondrial##2##3##(1992-11#1)(2008-10#1)
change in opposite directions##2##4##(2008-8#1)(2008-9#1)
change in optical path difference##2##5##(2008-3#1)(2013-8#1)
change in optical path##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
change in optical##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
change in orientation##2##3##(1995-3#1)(2010-5#1)
change in pH##3##3##(2008-10#1)(2008-6#1)(2009-12#1)
change in performance at one temperature##2##6##(2008-8#2)
change in performance at##3##4##(2008-8#3)
change in performance##4##3##(2008-8#3)(2009-9#1)
change in phase##2##3##(2007-11#1)(2008-3#1)
change in plasma##3##3##(1995-11#1)(2008-6#1)(2009-5#1)
change in population size##2##4##(2008-8#2)
change in population##3##3##(2008-10#1)(2008-8#2)
change in potential##2##3##(2008-10#2)
change in practice##4##3##(2008-11#2)(2008-8#2)
change in relation to##2##4##(2007-10#1)(2008-10#1)
change in response to the##2##5##(2008-11#1)(2011-2#1)
change in response to##4##4##(1996-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
change in response##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#2)
change in score##2##3##(1997-8#1)(2008-4#1)
change in scores##2##3##(1990-3#1)(2013-1#1)
change in self-esteem##2##3##(2007-12#1)(2008-5#1)
change in substance##2##3##(2008-12#1)(2009-7#1)
change in systemic level work##3##5##(2008-12#3)
change in the absorption##3##4##(2008-2#2)(2008-3#1)
change in the acoustic##2##4##(2009-2#1)(2009-9#1)
change in the cross-sectional##2##4##(1996-8#1)(2008-7#1)
change in the delivery##2##4##(1991-2#1)(1995-1#1)
change in the fluorescence##3##4##(2008-10#2)(2009-11#1)
change in the index of refraction##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
change in the levels of##2##5##(2008-1#1)(2010-8#1)
change in the normal##2##4##(1997-2#1)(2007-8#1)
change in the number of##7##5##(1990-6#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
change in the optical##2##4##(2007-11#1)(2008-3#1)
change in the original##2##4##(2008-10#1)(2008-2#1)
change in the practice of##2##5##(2008-9#1)(2011-1#1)
change in the presence of##2##5##(1992-5#1)(2008-10#1)
change in the pulp chamber##2##5##(1991-2#2)
change in the refractive index of the##2##7##(2007-11#1)(2008-3#1)
change in the refractive index of##3##6##(2007-11#1)(2008-3#2)
change in the refractive index##6##5##(2007-11#2)(2008-2#2)(2008-3#2)
change in the relative##3##4##(1990-3#1)(2008-10#1)(2008-3#1)
change in the two##2##4##(1995-5#1)(2011-2#1)
change in the##206##3##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-7#4)(2006-10#1)(2007-11#8)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#19)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#5)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
change in their##5##3##(1992-6#1)(1993-12#1)(1995-2#1)(1995-3#1)(2008-10#1)
change in these##2##3##(2008-3#1)(2009-9#1)
change in this##4##3##(1994-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
change in total##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
change in treatment##2##3##(1990-10#1)(2012-3#1)
change in##657##2##(1990-10#3)(1990-11#1)(1990-2#1)(1990-3#6)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#5)(1991-11#2)(1991-12#3)(1991-2#6)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#5)(1992-1#5)(1992-11#2)(1992-12#7)(1992-3#5)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#7)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#3)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#4)(2007-11#16)(2007-12#12)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#95)(2008-11#26)(2008-12#10)(2008-2#18)(2008-3#50)(2008-4#7)(2008-5#12)(2008-6#8)(2008-7#19)(2008-8#23)(2008-9#18)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#9)(2011-10#1)(2011-2#22)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#19)(2013-7#3)(2013-8#13)
change induced by##3##3##(1991-2#1)(2007-11#1)(2010-12#1)
change initiatives##2##2##(1995-12#1)(1997-1#1)
change into##4##2##(1994-12#1)(1995-5#1)(2007-12#1)(2013-8#1)
change is a##2##3##(2008-12#1)(2012-3#1)
change is positive##2##3##(1995-2#1)(2009-9#1)
change is proposed##2##3##(2008-8#1)(2010-5#1)
change is the##2##3##(2008-10#1)(2008-9#1)
change is##39##2##(1990-7#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#2)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2012-7#1)
change it##2##2##(1991-1#1)(2012-9#1)
change its##4##2##(2008-1#1)(2008-11#1)(2008-2#1)(2010-10#1)
change jobs##2##2##(2011-1#2)
change led to##2##3##(2008-10#1)(2008-11#1)
change linearly##2##2##(2008-10#1)(2008-8#1)
change management##10##2##(1996-3#1)(1997-1#1)(2008-12#2)(2011-2#2)(2012-3#4)
change may##5##2##(1992-12#1)(2008-11#1)(2008-3#1)(2009-2#1)(2012-2#1)
change mediated by##2##3##(1994-2#1)(1995-2#1)
change must be##2##3##(1994-12#1)(1996-1#1)
change observed##4##2##(1992-6#1)(1997-8#1)(2008-7#1)(2011-2#1)
change occurred following##2##3##(2008-7#1)(2013-1#1)
change occurred##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
change occurs##2##2##(1991-12#1)(2012-2#1)
change of a##2##3##(2007-12#1)(2008-10#1)
change of alpha-naphtholphthalein in##2##4##(2008-10#2)
change of an##2##3##(1997-3#1)(2008-10#1)
change of bone##2##3##(2007-8#1)(2013-1#1)
change of the nature of##2##5##(1992-6#1)(1993-2#1)
change of the polarization##2##4##(2008-3#1)(2013-7#1)
change of the##44##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#2)(2010-5#2)(2012-3#1)(2013-7#1)(2013-8#1)
change of##158##2##(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#2)(2007-11#7)(2007-12#6)(2007-8#2)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#13)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
change on the##4##3##(1993-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
change on##17##2##(1991-5#1)(1993-12#1)(1993-2#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2009-11#1)
change or a##2##3##(2008-10#1)(2010-4#1)
change or##6##2##(1993-11#1)(2008-10#2)(2009-10#1)(2010-4#1)(2011-1#1)
change orientation##2##2##(1991-12#1)(2011-1#1)
change our understanding of##2##4##(2009-4#1)(2013-1#1)
change our##3##2##(2009-4#1)(2012-2#1)(2013-1#1)
change over##6##2##(1996-3#1)(2007-12#2)(2008-1#1)(2008-11#1)(2012-12#1)
change process##11##2##(1993-12#1)(1994-1#3)(1995-3#3)(1996-12#1)(1997-2#1)(2008-11#2)
change proved##2##2##(2007-10#1)(2008-9#1)
change rate of##2##3##(2008-10#1)(2012-3#1)
change rate##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
change resulted from the##2##4##(2008-10#1)(2008-8#1)
change scores##2##2##(2008-12#1)(2011-1#1)
change should##2##2##(1990-5#1)(2008-7#1)
change significantly##18##2##(1991-12#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
change so that##2##3##(1992-3#1)(1995-2#1)
change strategy##5##2##(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)
change than##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
change that has##2##3##(1992-12#1)(1997-3#1)
change that occurs##2##3##(2008-8#1)(2009-5#1)
change that##11##2##(1992-12#1)(1993-2#2)(1994-2#1)(1995-11#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-5#1)
change the health care##2##4##(2008-11#1)(2008-8#1)
change the polarization##2##3##(2007-11#1)(2008-2#1)
change the way they##3##4##(1997-2#1)(2007-12#1)(2007-7#1)
change the way##6##3##(1995-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)
change the##87##2##(1990-11#1)(1991-1#3)(1991-12#1)(1991-8#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
change their##16##2##(1990-6#1)(1991-5#1)(1992-2#1)(1994-2#1)(1996-2#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
change this##2##2##(1994-2#1)(1995-12#1)
change through the##2##3##(2008-8#1)(2008-9#1)
change through##6##2##(1995-12#1)(2008-10#2)(2008-8#1)(2008-9#2)
change to a##5##3##(1990-5#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-7#1)
change to the##3##3##(1990-10#1)(1995-2#1)(2011-2#1)
change to##34##2##(1990-10#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-8#1)
change under##3##2##(1992-10#1)(1997-2#1)(2008-10#1)
change upon binding##2##3##(1990-8#1)(1991-12#1)
change upon##6##2##(1990-8#1)(1991-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
change varied##2##2##(2007-12#1)(2008-10#1)
change was detected in##2##4##(1990-3#1)(1991-12#1)
change was found##2##3##(2007-11#1)(2012-6#1)
change was limited to##2##4##(1990-2#1)(2012-12#1)
change was not##2##3##(2008-5#1)(2011-2#1)
change was observed for the##2##5##(2009-1#1)(2011-2#1)
change was observed in the##7##5##(1990-12#1)(1991-5#1)(1992-8#1)(1994-3#1)(1995-5#1)(2010-5#1)(2011-1#1)
change was observed in##11##4##(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-5#1)(2007-10#1)(2010-5#1)(2011-1#1)(2011-3#1)
change was observed##14##3##(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-5#1)(2007-10#1)(2008-10#1)(2009-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)
change was shown##2##3##(1990-10#1)(1991-1#1)
change was to##3##3##(1995-1#1)(1996-3#1)(2013-7#1)
change was##49##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-1#1)(2009-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-6#1)(2013-7#1)
change were##2##2##(2008-10#1)(2008-12#1)
change when the##3##3##(1992-12#1)(2007-12#1)(2013-8#1)
change when##4##2##(1992-12#1)(2007-12#1)(2013-1#1)(2013-8#1)
change while##2##2##(2008-5#1)(2012-12#1)
change will not be##2##4##(1995-8#1)(1997-1#1)
change will##6##2##(1995-8#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-8#1)(2012-5#1)
change with age##5##3##(1990-3#2)(1994-5#1)(2008-5#1)(2010-3#1)
change with an##2##3##(2010-5#1)(2011-2#1)
change with respect to##3##4##(1991-3#1)(2008-10#2)
change with temperature##2##3##(2008-3#1)(2008-8#1)
change with the##3##3##(1992-6#1)(2007-11#1)(2008-10#1)
change with##28##2##(1990-3#2)(1991-3#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-8#2)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
change within a##2##3##(2008-1#1)(2008-11#1)
change within the##2##3##(2008-5#1)(2008-6#1)
change within##7##2##(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-5#1)
change would##3##2##(2008-12#2)(2012-12#1)
change##1992##1##(1990-10#6)(1990-11#5)(1990-12#3)(1990-2#5)(1990-3#9)(1990-4#1)(1990-5#10)(1990-6#3)(1990-7#4)(1990-8#9)(1990-9#3)(1991-1#17)(1991-11#3)(1991-12#18)(1991-2#17)(1991-3#6)(1991-4#2)(1991-5#11)(1991-6#8)(1991-8#3)(1991-9#5)(1992-1#8)(1992-10#1)(1992-11#3)(1992-12#20)(1992-2#3)(1992-3#18)(1992-4#1)(1992-5#3)(1992-6#9)(1992-8#5)(1992-9#3)(1993-1#5)(1993-11#8)(1993-12#17)(1993-2#14)(1993-3#5)(1993-5#5)(1993-6#5)(1993-8#9)(1994-1#12)(1994-11#2)(1994-12#20)(1994-2#19)(1994-3#13)(1994-5#7)(1994-6#4)(1994-8#11)(1994-9#1)(1995-1#15)(1995-11#7)(1995-12#14)(1995-2#15)(1995-3#21)(1995-5#12)(1995-6#10)(1995-8#8)(1995-9#1)(1996-1#15)(1996-11#3)(1996-12#13)(1996-2#19)(1996-3#14)(1996-4#5)(1996-5#10)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#13)(1997-2#20)(1997-3#9)(1997-4#2)(1997-6#5)(1997-7#9)(1997-8#5)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#7)(2007-11#41)(2007-12#47)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#37)(2008-10#228)(2008-11#84)(2008-12#39)(2008-2#43)(2008-3#105)(2008-4#21)(2008-5#45)(2008-6#20)(2008-7#45)(2008-8#57)(2008-9#47)(2009-1#1)(2009-10#7)(2009-11#10)(2009-12#9)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#15)(2009-6#4)(2009-7#7)(2009-8#6)(2009-9#18)(2010-1#6)(2010-10#8)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#8)(2010-4#12)(2010-5#19)(2010-6#4)(2010-7#7)(2010-8#14)(2010-9#3)(2011-1#36)(2011-10#1)(2011-2#64)(2011-3#4)(2012-1#3)(2012-12#23)(2012-2#21)(2012-3#23)(2012-5#2)(2012-6#4)(2012-7#2)(2012-8#1)(2012-9#3)(2013-1#48)(2013-7#9)(2013-8#37)
change&quot##4##1##(1995-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
change)##6##1##(1992-9#1)(1995-5#1)(2008-10#1)(2008-5#2)(2008-7#1)
change/variation from antepenultimate stress words into penultimate##2##7##(2009-11#2)
change?##3##1##(1993-3#1)(2008-1#1)(2008-10#1)
change]##2##1##(1991-6#1)(2013-1#1)
changed a##2##2##(1991-12#1)(2008-10#1)
changed accordingly##2##2##(2008-10#1)(2008-3#1)
changed after##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
changed and##7##2##(1990-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-1#1)
changed as a result of##2##5##(1995-3#1)(2010-4#1)
changed as##5##2##(1992-6#1)(1995-3#1)(2008-11#1)(2008-5#1)(2010-4#1)
changed at##4##2##(1992-3#1)(2008-8#1)(2009-6#1)(2010-1#1)
changed by the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
changed by##15##2##(1992-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2011-1#1)
changed considerably over the##2##4##(1997-8#1)(2011-2#1)
changed considerably##3##2##(1996-7#1)(1997-8#1)(2011-2#1)
changed dramatically##2##2##(1990-6#1)(1996-3#1)
changed due to##2##3##(2010-8#1)(2012-12#1)
changed during long-term##2##3##(2008-11#1)(2013-1#1)
changed during the##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
changed during##8##2##(1990-3#1)(1992-5#1)(1995-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
changed every##2##2##(2008-10#1)(2008-8#1)
changed from being##2##3##(2008-11#1)(2008-3#1)
changed from##20##2##(1990-3#1)(1993-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
changed in a##2##3##(2008-10#1)(2008-8#1)
changed in parallel##2##3##(1991-12#1)(1993-11#1)
changed in the##7##3##(1994-5#1)(1995-1#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#1)
changed in##25##2##(1991-12#2)(1992-3#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#2)(2013-1#1)(2013-8#1)
changed into##5##2##(2008-10#3)(2011-3#1)(2013-1#1)
changed its##3##2##(1992-12#1)(1992-5#1)(1993-2#1)
changed little##7##2##(1991-9#1)(2007-7#1)(2008-10#2)(2008-2#1)(2010-3#1)(2012-2#1)
changed morphology##2##2##(1993-12#1)(2013-1#1)
changed on##3##2##(1996-6#1)(2012-2#1)(2012-3#1)
changed over the past##3##4##(2008-11#1)(2010-5#1)(2011-2#1)
changed over time##3##3##(2008-10#2)(2011-2#1)
changed over##6##2##(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#2)
changed phenotype##2##2##(2008-10#2)
changed shape##2##2##(2008-3#1)(2011-2#1)
changed significantly##8##2##(1991-6#1)(1993-11#1)(2008-1#1)(2008-11#2)(2010-8#1)(2012-1#1)(2013-1#1)
changed substantially##3##2##(1991-3#1)(2010-10#1)(2012-2#1)
changed the way##3##3##(1995-1#1)(1996-12#1)(2010-8#1)
changed the##25##2##(1992-4#1)(1993-8#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
changed their##7##2##(1990-6#2)(1994-3#1)(1994-8#1)(1995-1#1)(2008-11#1)(2009-9#1)
changed to a##6##3##(1991-6#1)(1995-5#2)(1997-3#1)(2008-10#2)
changed to alanine##3##3##(1994-5#1)(1995-5#1)(2008-9#1)
changed to phenotype##2##3##(2008-10#2)
changed to##30##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-5#3)(1997-3#1)(1997-8#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
changed upon##3##2##(1990-12#1)(1993-8#1)(1994-6#1)
changed when##2##2##(2008-10#1)(2008-8#1)
changed with##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
changed##314##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-6#5)(1990-9#1)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#2)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#5)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#6)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#19)(2008-12#5)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#12)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#6)
changer##3##1##(2011-1#2)(2012-3#1)
changes (e##2##2##(1994-3#1)(2008-10#1)
changes accompanying##2##2##(1997-2#1)(2008-9#1)
changes across the##2##3##(1993-12#1)(2010-3#1)
changes across##3##2##(1993-12#1)(2010-3#1)(2010-6#1)
changes affecting##6##2##(1992-1#1)(1992-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-5#1)
changes after the##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
changes after##14##2##(1990-7#1)(1991-2#1)(1995-12#1)(1995-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#1)
changes among##4##2##(1990-3#1)(1994-1#1)(2008-12#1)(2011-1#1)
changes and human##2##3##(1991-12#1)(2011-2#1)
changes and in##2##3##(1992-11#1)(2011-2#1)
changes and the##8##3##(1991-3#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
changes and their##4##3##(1990-6#1)(2007-8#1)(2008-9#1)(2009-8#1)
changes and##78##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-11#2)(1993-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-5#1)(1996-9#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
changes appear to be##2##4##(2008-6#1)(2013-1#1)
changes are associated##2##3##(1990-2#1)(1994-11#1)
changes are being##2##3##(1994-3#1)(2007-10#1)
changes are discussed##2##3##(2007-12#1)(2008-2#1)
changes are likely##2##3##(2008-3#1)(2013-8#1)
changes are observed##2##3##(1995-11#1)(2008-7#1)
changes are poorly understood##2##4##(2008-5#1)(2012-2#1)
changes are reflected##2##3##(1993-2#1)(2008-1#1)
changes are the##2##3##(1996-5#1)(2007-11#1)
changes are##54##2##(1990-11#2)(1990-2#3)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
changes as a function of the##2##6##(2007-12#1)(2008-2#1)
changes as a function of##4##5##(1992-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
changes as a result of##5##5##(1991-8#1)(1993-8#1)(2007-11#1)(2008-1#1)(2013-7#1)
changes as a##10##3##(1991-8#1)(1992-3#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
changes as compared##2##3##(1993-12#1)(2012-2#1)
changes as the##2##3##(2007-12#1)(2013-8#1)
changes as well as the changes##2##6##(1995-5#1)(2008-11#1)
changes as well as##5##4##(1995-5#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-1#1)
changes as##24##2##(1991-8#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-5#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
changes associated with paclitaxel##2##4##(2010-11#2)
changes associated with the##7##4##(1991-9#1)(1993-1#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-10#1)(2010-10#1)
changes associated with these##2##4##(1993-10#1)(2008-10#1)
changes associated with##20##3##(1991-9#1)(1993-1#1)(1993-10#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-10#2)(2010-11#2)(2011-1#1)(2012-12#1)
changes at any##2##3##(2008-9#1)(2012-2#1)
changes at the##14##3##(1990-8#1)(1992-8#1)(1995-2#2)(1995-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-8#1)(2012-3#1)(2013-1#1)
changes at##29##2##(1990-12#1)(1990-8#1)(1992-8#1)(1993-12#1)(1995-2#2)(1995-5#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
changes before##3##2##(1991-8#1)(1994-12#1)(2008-7#1)
changes between the##2##3##(2008-5#1)(2008-6#1)
changes between##11##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-7#1)(2012-12#1)(2012-2#1)
changes brought about by##2##4##(1996-3#1)(2008-7#1)
changes by##6##2##(1992-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#1)
changes can be detected##2##4##(1992-12#1)(2008-9#1)
changes can be##9##3##(1992-12#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-9#1)
changes can occur##2##3##(2007-12#1)(2008-7#1)
changes can##17##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2009-9#1)(2012-2#1)
changes caused by##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
changes characteristic of##3##3##(1994-5#1)(1997-2#1)(2008-4#1)
changes clearly##2##2##(2007-11#1)(2010-8#1)
changes consistent with##2##3##(2008-10#1)(2008-7#1)
changes contributing to##2##3##(2008-3#1)(2009-9#1)
changes correlated with##2##3##(2008-7#1)(2009-3#1)
changes could be##6##3##(1992-8#1)(1993-1#1)(1995-12#1)(1997-8#1)(2008-3#1)(2011-2#1)
changes could##7##2##(1992-6#1)(1992-8#1)(1993-1#1)(1995-12#1)(1997-8#1)(2008-3#1)(2011-2#1)
changes depending on##2##3##(2008-6#1)(2012-2#1)
changes detected##2##2##(1990-8#1)(2008-10#1)
changes did not##2##3##(1994-2#1)(2010-3#1)
changes due to##3##3##(1990-6#1)(2008-7#1)(2010-1#1)
changes during asexual reproduction##2##4##(2008-10#2)
changes during storage##2##3##(2008-10#1)(2011-2#1)
changes during the past##2##4##(2008-10#1)(2008-11#1)
changes during the##12##3##(1990-7#1)(1992-3#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-5#1)
changes during##36##2##(1990-7#1)(1991-10#1)(1992-3#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1996-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
changes followed##2##2##(2011-2#1)(2012-2#1)
changes following##5##2##(2007-10#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-1#1)
changes for the##5##3##(1990-7#1)(1990-8#1)(1996-2#1)(2009-9#1)(2010-3#1)
changes for##12##2##(1990-7#1)(1990-8#1)(1992-3#2)(1994-3#1)(1995-2#1)(1996-2#1)(2008-3#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)
changes from baseline##5##3##(1993-1#1)(2008-3#1)(2008-5#1)(2011-2#2)
changes from the##2##3##(2008-11#1)(2013-8#1)
changes from##27##2##(1990-8#2)(1993-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-7#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-9#1)(2013-8#1)
changes had##2##2##(1992-8#1)(1995-3#1)
changes has been##2##3##(2008-3#1)(2012-12#1)
changes has##3##2##(1992-9#1)(2008-3#1)(2012-12#1)
changes have been made##2##4##(1991-2#1)(1997-4#1)
changes have been observed in##3##5##(1995-12#1)(2007-7#1)(2008-6#1)
changes have been##9##3##(1991-2#1)(1992-3#1)(1994-5#1)(1995-12#1)(1996-11#1)(1997-4#1)(2007-7#1)(2008-6#1)(2013-7#1)
changes have occurred in##3##4##(1994-5#1)(2008-10#1)(2008-11#1)
changes have##21##2##(1991-2#1)(1992-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-7#1)
changes identified##2##2##(2008-11#1)(2010-11#1)
changes in CSF##2##3##(1995-11#1)(2008-7#1)
changes in Cu##2##3##(1991-12#1)(2013-8#1)
changes in LDL##2##3##(1991-6#1)(2012-2#1)
changes in Medicare##3##3##(1991-1#1)(1994-1#1)(1995-3#1)
changes in SI##2##3##(1993-10#1)(1995-12#1)
changes in [Ca2+]i##6##3##(1990-12#1)(1992-9#1)(1993-3#3)(1994-6#1)
changes in a##12##3##(1992-8#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
changes in absorption##3##3##(2008-10#1)(2008-2#2)
changes in accessible surface areas##2##5##(1997-2#2)
changes in action##2##3##(2008-11#2)
changes in adolescents' perceptions of##2##5##(2009-7#2)
changes in adolescents'##4##3##(2009-7#2)(2010-7#2)
changes in aerosol##2##3##(2008-3#2)
changes in allele##2##3##(2010-4#1)(2012-3#1)
changes in allocation to##2##4##(2008-8#1)(2008-9#1)
changes in amino##2##3##(1990-12#1)(2012-8#1)
changes in apparent##2##3##(2008-9#1)(2009-11#1)
changes in arrestin##2##3##(1992-5#2)
changes in arterial elasticity##2##4##(2013-8#2)
changes in autonomic##2##3##(2007-10#2)
changes in average##2##3##(1992-12#1)(2008-9#1)
changes in blood coagulation##2##4##(1991-3#1)(2006-6#1)
changes in blood glucose##2##4##(1990-6#1)(1991-2#1)
changes in blood pressure##3##4##(1995-12#1)(1997-8#1)(2008-8#1)
changes in blood##10##3##(1990-6#1)(1991-2#1)(1991-3#1)(1995-12#1)(1996-5#1)(1997-8#1)(2006-6#1)(2008-8#1)(2011-1#1)(2013-1#1)
changes in body weight##2##4##(2008-3#1)(2008-4#1)
changes in body##4##3##(2007-12#1)(2008-3#1)(2008-4#1)(2009-8#1)
changes in bone##5##3##(1993-11#1)(2007-11#1)(2010-10#2)(2011-2#1)
changes in both the##2##4##(1991-9#1)(2008-8#1)
changes in both##10##3##(1991-6#1)(1991-9#1)(1992-8#1)(1993-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)
changes in brain activity##2##4##(2007-8#1)(2013-8#1)
changes in brain##3##3##(2007-8#1)(2008-9#1)(2013-8#1)
changes in cell morphology and##3##5##(1990-8#1)(2008-1#1)(2008-8#1)
changes in cell morphology##6##4##(1990-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
changes in cell physiology##2##4##(1994-11#1)(2011-2#1)
changes in cell shape and##2##5##(2008-7#1)(2012-2#1)
changes in cell structure##2##4##(2008-7#1)(2008-9#1)
changes in cell##18##3##(1990-8#2)(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
changes in cells##2##3##(2008-1#1)(2008-11#1)
changes in cellular##6##3##(1993-9#1)(1994-9#1)(1995-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
changes in cerebral##3##3##(1994-2#1)(2008-8#1)(2013-1#1)
changes in chemical##2##3##(1995-2#1)(2012-2#1)
changes in clinical##2##3##(2008-5#1)(2008-9#1)
changes in colon##2##3##(1993-2#1)(2008-12#1)
changes in complement activation##2##4##(2008-10#2)
changes in concentrations of##2##4##(1992-3#1)(2008-7#1)
changes in cortical##2##3##(1995-2#1)(2008-3#1)
changes in cytoplasmic##2##3##(2006-6#1)(2012-1#1)
changes in cytoskeletal##2##3##(1994-11#1)(2011-2#1)
changes in dietary habits##2##4##(2010-1#1)(2010-6#1)
changes in direction##2##3##(2008-10#1)(2008-3#1)
changes in dopamine##2##3##(1996-5#1)(1997-7#1)
changes in drug##3##3##(1997-1#1)(2008-1#1)(2010-3#1)
changes in eating##2##3##(2010-8#1)(2012-2#1)
changes in endocrine##2##3##(1990-3#1)(1991-12#1)
changes in endogenous##2##3##(1997-6#1)(2008-10#1)
changes in enthalpy##2##3##(1997-2#1)(2008-10#1)
changes in environmental##5##3##(1992-12#1)(1995-11#1)(2008-4#1)(2008-6#1)(2009-8#1)
changes in estimated##2##3##(1997-5#1)(2008-1#1)
changes in expression of##8##4##(1994-12#1)(1996-2#1)(1996-5#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-2#1)
changes in expression##11##3##(1994-12#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-8#2)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)
changes in extracellular DA##2##4##(2008-7#2)
changes in food availability##2##4##(2008-9#2)
changes in food##4##3##(2008-11#1)(2008-9#3)
changes in free##3##3##(1990-8#1)(1991-6#1)(2010-4#1)
changes in function##2##3##(1994-5#1)(2008-10#1)
changes in gait##2##3##(1992-5#1)(2013-1#1)
changes in gene expression and##2##5##(2007-12#1)(2010-1#1)
changes in gene expression are##2##5##(2008-7#1)(2010-5#1)
changes in gene expression in rat##2##6##(1991-1#1)(2008-8#1)
changes in gene expression in##7##5##(1991-1#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
changes in gene expression that##2##5##(2008-7#1)(2008-8#1)
changes in gene expression##24##4##(1991-1#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-7#5)(2008-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)
changes in glucose##3##3##(1994-12#2)(2011-2#1)
changes in growth##2##3##(2008-7#1)(2008-8#1)
changes in health care##5##4##(1991-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(2010-4#1)
changes in health##7##3##(1991-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#2)(2010-4#1)
changes in heart rate##3##4##(2007-10#1)(2013-8#2)
changes in heart##4##3##(2007-10#1)(2013-1#1)(2013-8#2)
changes in hepatic##4##3##(1997-8#1)(2006-10#1)(2008-3#2)
changes in high##2##3##(1993-8#1)(2009-4#1)
changes in hospital##3##3##(1991-1#1)(2013-1#2)
changes in how##4##3##(1997-2#1)(2007-3#1)(2008-10#1)(2008-11#1)
changes in human##6##3##(1994-12#1)(2008-1#1)(2008-10#1)(2011-2#2)(2013-1#1)
changes in hypothalamic##2##3##(1996-12#1)(2008-4#1)
changes in immune function##3##4##(2008-10#3)
changes in immune##4##3##(2008-10#3)(2008-7#1)
changes in income-related health inequalities##2##5##(2013-1#2)
changes in individual##2##3##(2008-11#1)(2012-3#1)
changes in inositol##2##3##(1990-12#1)(1993-8#1)
changes in instrument##2##3##(2008-10#1)(2008-3#1)
changes in insulin##2##3##(2008-1#1)(2010-10#1)
changes in intracellular##6##3##(1991-9#2)(1994-2#1)(1994-3#1)(1997-4#1)(2008-11#1)
changes in ion##2##3##(1993-3#1)(1996-7#1)
changes in its environment##2##4##(2008-3#1)(2008-7#1)
changes in its##6##3##(1995-11#1)(2008-10#1)(2008-3#3)(2008-7#1)
changes in leptin##2##3##(2013-8#2)
changes in lifestyle##3##3##(2008-1#3)
changes in lipid##7##3##(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
changes in lipids##2##3##(1994-11#1)(2008-12#1)
changes in liver##3##3##(1994-6#1)(2008-10#1)(2011-2#1)
changes in local##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
changes in lung##2##3##(1991-9#1)(1995-8#1)
changes in mRNA##2##3##(1996-12#1)(2008-10#1)
changes in mechanical properties##3##4##(2008-6#2)(2009-4#1)
changes in medical##2##3##(1997-8#1)(2009-10#1)
changes in membrane potential##4##4##(1993-11#1)(1997-1#1)(2008-4#1)(2008-9#1)
changes in membrane##5##3##(1993-11#1)(1997-1#1)(2008-4#1)(2008-9#2)
changes in metabolic control##2##4##(1994-12#2)
changes in mitochondrial##3##3##(2009-8#1)(2011-1#1)(2013-8#1)
changes in mortality##2##3##(1990-8#1)(2008-9#1)
changes in multiparous##2##3##(1997-4#2)
changes in optical path length and##2##6##(2008-2#1)(2008-3#1)
changes in optical##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
changes in organ##2##3##(2008-10#1)(2008-9#1)
changes in other##3##3##(1991-12#1)(2008-10#1)(2008-4#1)
changes in otherwise##2##3##(2008-11#1)(2012-2#1)
changes in pH##6##3##(1991-12#1)(1995-6#1)(2008-10#3)(2008-9#1)
changes in patients with##2##4##(2010-6#1)(2013-8#1)
changes in performance##2##3##(1996-12#1)(2010-3#1)
changes in perfusion##3##3##(2008-11#2)(2009-11#1)
changes in peritoneal##2##3##(2007-7#1)(2011-2#1)
changes in phase##2##3##(2008-11#1)(2013-8#1)
changes in phenotype##2##3##(2008-10#1)(2010-4#1)
changes in physical##2##3##(1995-6#1)(2010-4#1)
changes in physician payment##2##4##(1994-1#2)
changes in physician##4##3##(1992-12#1)(1993-1#1)(1994-1#2)
changes in physiological##2##3##(2008-11#1)(2009-11#1)
changes in plant##2##3##(2008-10#1)(2008-8#1)
changes in plasma##4##3##(1991-2#1)(1997-2#1)(2008-7#2)
changes in policy##2##3##(1993-3#1)(2008-11#1)
changes in political##2##3##(1997-2#1)(2008-7#1)
changes in population growth rate##2##5##(2008-8#2)
changes in population##6##3##(1991-2#1)(2008-10#1)(2008-12#1)(2008-8#3)
changes in practice##2##3##(1997-7#1)(2008-12#1)
changes in preoperative##2##3##(2011-2#2)
changes in primary##3##3##(1990-5#1)(1993-2#1)(1996-12#1)
changes in protein##7##3##(2008-4#2)(2010-11#1)(2010-4#3)(2012-3#1)
changes in provider##3##3##(1994-12#2)(1997-1#1)
changes in proximal##2##3##(1994-5#1)(2007-11#1)
changes in public##3##3##(1992-2#1)(1993-1#1)(2007-12#1)
changes in quality of##2##4##(1992-2#1)(2008-7#1)
changes in rat##5##3##(1995-12#1)(2008-3#1)(2008-7#1)(2008-8#2)
changes in rats with##2##4##(2007-10#1)(2010-5#1)
changes in rats##4##3##(1991-2#1)(2007-10#1)(2010-5#1)(2013-1#1)
changes in recent years##2##4##(1992-1#1)(2008-11#1)
changes in receptor##2##3##(1994-5#1)(1995-3#1)
changes in refractive index##2##4##(2008-2#1)(2008-3#1)
changes in relative##4##3##(1994-9#1)(2008-10#1)(2008-3#2)
changes in renal function##3##4##(1994-5#1)(2008-1#2)
changes in renal##5##3##(1992-8#1)(1994-5#1)(1995-12#1)(2008-1#2)
changes in response to##6##4##(1990-11#1)(1992-2#1)(1994-5#1)(1995-11#1)(2009-10#1)(2009-11#1)
changes in response##7##3##(1990-11#1)(1992-2#1)(1994-5#1)(1995-11#1)(2008-8#1)(2009-10#1)(2009-11#1)
changes in selectivity##2##3##(1994-9#2)
changes in serotonergic signaling##2##4##(2012-3#2)
changes in serum T4##2##4##(1990-3#1)(1991-12#1)
changes in serum##5##3##(1990-3#1)(1991-12#1)(1992-11#1)(2008-3#1)(2009-12#1)
changes in service##2##3##(1991-1#1)(2008-11#1)
changes in shape##2##3##(1993-9#1)(2008-3#1)
changes in sialylation pattern of##3##5##(2008-11#3)
changes in skeletal##2##3##(1997-4#1)(2008-5#1)
changes in skin##2##3##(2008-5#2)
changes in sleep##2##3##(2008-10#1)(2013-1#1)
changes in smoking##3##3##(1992-2#1)(1994-11#1)(2013-1#1)
changes in social##2##3##(1996-12#1)(2012-12#1)
changes in soil##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
changes in some##4##3##(2008-10#1)(2008-12#2)(2008-7#1)
changes in spatial##2##3##(2008-10#1)(2008-9#1)
changes in spinal ganglion neurons##2##5##(2008-7#2)
changes in stability##2##3##(1991-6#1)(1992-6#1)
changes in surface##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
changes in synaptic##7##3##(1996-2#1)(1997-3#2)(2008-1#1)(2008-11#1)(2008-7#2)
changes in temperature##7##3##(1990-8#1)(1997-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-4#1)
changes in tertiary##2##3##(1994-2#1)(2008-4#1)
changes in the Medicare##2##4##(1991-3#1)(1995-12#1)
changes in the actin cytoskeleton required for neurite formation##2##9##(1996-12#2)
changes in the activities of##2##5##(1990-3#2)
changes in the activity of the##3##6##(1990-8#1)(2007-7#1)(2011-2#1)
changes in the blood picture of##2##6##(2008-12#2)
changes in the blood##4##4##(2008-12#2)(2008-3#1)(2013-1#1)
changes in the brain##3##4##(1996-12#1)(2013-1#2)
changes in the cell##2##4##(1992-2#1)(2008-9#1)
changes in the central##2##4##(1994-8#1)(1997-2#1)
changes in the cerebellum##2##4##(2013-1#2)
changes in the cervical spine##2##5##(2007-8#2)
changes in the cervical##3##4##(1992-9#1)(2007-8#2)
changes in the clinical##2##4##(1992-6#1)(2011-2#1)
changes in the composition of the##3##6##(2008-10#2)(2011-2#1)
changes in the composition##4##4##(2008-10#3)(2011-2#1)
changes in the conformation of the##2##6##(2008-7#1)(2012-12#1)
changes in the conformation##3##4##(2008-7#1)(2008-8#1)(2012-12#1)
changes in the criteria##2##4##(1992-3#1)(2008-8#1)
changes in the degree of##2##5##(2008-10#1)(2008-7#1)
changes in the delivery of health##2##6##(1994-1#1)(2010-8#1)
changes in the delivery of##3##5##(1994-1#1)(2010-8#2)
changes in the diffusion##2##4##(1997-6#1)(2008-7#1)
changes in the direction of##2##5##(1991-8#1)(2009-6#1)
changes in the direction##3##4##(1991-8#1)(2009-6#1)(2011-2#1)
changes in the distribution of##5##5##(1990-5#1)(1992-12#1)(1994-10#1)(2009-8#1)(2012-12#1)
changes in the distribution##7##4##(1990-5#1)(1992-12#1)(1994-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2012-12#1)
changes in the elderly##2##4##(1990-6#1)(2011-2#1)
changes in the endogenous##2##4##(1995-2#1)(2008-11#1)
changes in the environment##3##4##(1996-3#1)(2008-10#1)(2008-8#1)
changes in the expression of##5##5##(1994-3#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
changes in the extracellular##2##4##(1994-8#1)(1995-11#1)
changes in the fetal##2##4##(1994-5#1)(2008-10#1)
changes in the foot protein##3##5##(1992-3#3)
changes in the genome##2##4##(1994-8#1)(2008-7#1)
changes in the health care system##5##6##(1991-2#1)(1991-3#1)(1994-3#2)(2012-2#1)
changes in the health care##7##5##(1991-2#1)(1991-3#1)(1994-3#2)(1996-2#1)(1996-3#1)(2012-2#1)
changes in the hippocampus##2##4##(1993-5#1)(2008-11#1)
changes in the human##2##4##(2010-8#2)
changes in the immune##2##4##(1991-2#1)(2008-7#1)
changes in the intensity##2##4##(2008-10#1)(2013-8#1)
changes in the intrinsic##2##4##(2007-12#1)(2008-7#1)
changes in the knee##2##4##(1990-6#1)(2007-8#1)
changes in the levels of##5##5##(1992-8#1)(1997-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
changes in the list of reportable diseases##2##7##(1997-3#2)
changes in the liver##2##4##(1990-11#1)(1993-12#1)
changes in the local##2##4##(1994-12#1)(2009-6#1)
changes in the lungs##2##4##(2008-5#2)
changes in the membrane##2##4##(2008-10#1)(2011-1#1)
changes in the neural##4##4##(1994-3#1)(2008-11#3)
changes in the oscillation amplitude##2##5##(2008-10#2)
changes in the overall##3##4##(1994-6#1)(2008-10#1)(2009-11#1)
changes in the past##2##4##(1996-2#1)(2007-6#1)
changes in the plasma proteome##3##5##(2010-12#3)
changes in the population##3##4##(2008-10#1)(2010-8#1)(2012-2#1)
changes in the proportion of##4##5##(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
changes in the protein##6##4##(1990-5#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
changes in the radiometric##3##4##(2008-3#3)
changes in the rate of##4##5##(2008-8#2)(2008-9#1)(2012-3#1)
changes in the redox##2##4##(2008-10#2)
changes in the reflectivity of##2##5##(2008-3#2)
changes in the refractive index##3##5##(2007-11#2)(2008-2#1)
changes in the relative##2##4##(1990-3#1)(1994-9#1)
changes in the risk##2##4##(1995-12#1)(2011-1#1)
changes in the sensitivity of##2##5##(1995-12#1)(2008-4#1)
changes in the sequence##2##4##(1993-11#1)(2008-10#1)
changes in the shape of##2##5##(2008-10#1)(2009-4#1)
changes in the shape##3##4##(2008-10#1)(2009-12#1)(2009-4#1)
changes in the specific##2##4##(1991-12#1)(2008-11#1)
changes in the spectral##2##4##(2008-10#1)(2008-3#1)
changes in the strength of##2##5##(1993-1#1)(2008-4#1)
changes in the structure of##2##5##(1993-8#1)(2008-12#1)
changes in the structure##4##4##(1993-8#1)(2008-12#1)(2008-2#1)(2008-7#1)
changes in the subcellular##2##4##(1992-6#1)(1994-10#1)
changes in the thyroid##3##4##(2007-8#1)(2008-4#1)(2012-1#1)
changes in the timing of##2##5##(1995-3#1)(2008-9#1)
changes in the total##2##4##(1996-12#1)(2008-3#1)
changes in the transmission##3##4##(2008-10#1)(2008-3#2)
changes in the two##2##4##(1996-9#1)(2009-12#1)
changes in the value of##2##5##(1992-6#1)(2008-3#1)
changes in the vibrational##2##4##(1990-8#1)(2008-10#1)
changes in the##523##3##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#3)(1991-12#4)(1991-2#4)(1991-3#6)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#7)(1992-6#7)(1992-8#2)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#2)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#6)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#4)(1996-1#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-10#2)(2007-11#10)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2008-1#1)(2008-10#63)(2008-11#18)(2008-12#7)(2008-2#11)(2008-3#39)(2008-4#8)(2008-5#18)(2008-7#22)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#3)(2009-12#5)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#6)(2012-9#1)(2013-1#14)(2013-7#1)(2013-8#5)
changes in their##13##3##(1992-6#1)(1994-11#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)
changes in these##12##3##(1994-12#1)(1996-2#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
changes in this##5##3##(1990-5#1)(1993-12#1)(1996-2#1)(2008-12#1)(2008-5#1)
changes in total##3##3##(1994-12#1)(1994-6#1)(2013-1#1)
changes in virulence##2##3##(2008-10#2)
changes in viscosity and density##2##5##(2008-10#2)
changes in water##3##3##(1995-5#1)(2007-12#1)(2008-3#1)
changes in##1651##2##(1990-11#5)(1990-12#6)(1990-2#6)(1990-3#7)(1990-5#7)(1990-6#6)(1990-7#2)(1990-8#10)(1991-1#9)(1991-10#1)(1991-12#14)(1991-2#13)(1991-3#9)(1991-5#6)(1991-6#9)(1991-8#4)(1991-9#7)(1992-1#4)(1992-11#3)(1992-12#10)(1992-2#7)(1992-3#11)(1992-4#1)(1992-5#5)(1992-6#14)(1992-7#1)(1992-8#6)(1992-9#6)(1993-1#7)(1993-10#1)(1993-11#12)(1993-12#11)(1993-2#5)(1993-3#11)(1993-5#2)(1993-6#3)(1993-8#8)(1993-9#4)(1994-1#5)(1994-10#2)(1994-11#7)(1994-12#25)(1994-2#7)(1994-3#11)(1994-5#12)(1994-6#9)(1994-7#1)(1994-8#6)(1994-9#10)(1995-1#3)(1995-11#7)(1995-12#15)(1995-2#10)(1995-3#6)(1995-5#9)(1995-6#7)(1995-8#4)(1996-1#2)(1996-12#16)(1996-2#14)(1996-3#9)(1996-4#6)(1996-5#12)(1996-6#5)(1996-7#5)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#16)(1997-3#10)(1997-4#8)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#6)(2006-10#1)(2006-12#2)(2006-6#4)(2006-8#4)(2007-1#1)(2007-10#6)(2007-11#19)(2007-12#26)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#14)(2008-1#18)(2008-10#154)(2008-11#61)(2008-12#30)(2008-2#20)(2008-3#85)(2008-4#31)(2008-5#45)(2008-6#13)(2008-7#82)(2008-8#45)(2008-9#49)(2009-1#2)(2009-10#7)(2009-11#7)(2009-12#8)(2009-2#3)(2009-4#6)(2009-5#4)(2009-6#8)(2009-7#12)(2009-8#9)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#7)(2010-4#13)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#12)(2010-9#3)(2011-1#13)(2011-2#57)(2011-3#1)(2012-1#11)(2012-12#11)(2012-2#36)(2012-3#26)(2012-5#2)(2012-7#2)(2012-8#3)(2012-9#1)(2013-1#55)(2013-7#5)(2013-8#34)
changes include##3##2##(1990-9#1)(1991-2#1)(1995-1#1)
changes including##7##2##(1992-1#1)(1994-11#1)(2008-10#3)(2008-7#1)(2012-12#1)
changes indicate##2##2##(1996-5#1)(1997-4#1)
changes indicative of##3##3##(1995-5#1)(1997-3#1)(2008-7#1)
changes induced by the##2##4##(1997-7#1)(2007-11#1)
changes induced by##23##3##(1990-12#1)(1990-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
changes induced in the##4##4##(1993-6#1)(1994-3#1)(2008-2#2)
changes induced in various##2##4##(1991-5#1)(2008-8#1)
changes induced in##7##3##(1991-5#1)(1993-6#1)(1994-3#1)(2008-2#2)(2008-8#2)
changes induced##31##2##(1990-12#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-7#2)(2008-8#2)(2009-4#1)(2012-2#1)(2013-1#1)
changes into##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
changes involving the##2##3##(1994-6#1)(2008-6#1)
changes is##13##2##(1990-8#1)(1992-9#1)(1995-1#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2012-3#1)(2013-8#1)
changes its##5##2##(2007-8#1)(2008-12#1)(2008-5#2)(2013-1#1)
changes linearly##2##2##(2008-10#1)(2008-3#1)
changes made in##2##3##(1994-1#1)(2008-10#1)
changes made to the##2##4##(1997-3#1)(2009-11#1)
changes made to##3##3##(1997-3#1)(2009-11#1)(2012-2#1)
changes made##5##2##(1994-1#1)(1997-3#1)(2008-10#1)(2009-11#1)(2012-2#1)
changes may be##6##3##(1992-11#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-4#1)(2013-8#1)
changes may##17##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-8#1)
changes mean##2##2##(1995-12#1)(1996-2#1)
changes measured##2##2##(1996-12#1)(1996-2#1)
changes might be##2##3##(1991-3#1)(2008-12#1)
changes might##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
changes must##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
changes near##2##2##(1993-11#1)(2008-1#1)
changes needed to##3##3##(2008-12#1)(2013-1#2)
changes needed##4##2##(1994-1#1)(2008-12#1)(2013-1#2)
changes not only##2##3##(2008-7#2)
changes observed during the##2##4##(1994-5#1)(2008-1#1)
changes observed in the##2##4##(2008-10#1)(2011-2#1)
changes observed in##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
changes observed##13##2##(1991-12#1)(1994-5#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-5#1)
changes occur in##5##3##(1992-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)
changes occur##10##2##(1992-6#1)(1995-3#1)(2008-10#1)(2008-6#1)(2008-9#3)(2010-12#1)(2011-2#1)(2013-8#1)
changes occurred at the##2##4##(1995-6#1)(2008-7#1)
changes occurred at##3##3##(1995-6#1)(2008-7#1)(2012-2#1)
changes occurred in the##3##4##(1990-7#1)(1992-12#1)(2008-11#1)
changes occurred in##8##3##(1990-7#1)(1992-12#1)(1993-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-12#1)
changes occurred within the##2##4##(2008-10#2)
changes occurred within##3##3##(2008-10#3)
changes occurred##23##2##(1990-7#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(2006-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
changes occurring at the##2##4##(2008-11#1)(2008-5#1)
changes occurring at##3##3##(1991-3#1)(2008-11#1)(2008-5#1)
changes occurring during##2##3##(1994-2#1)(2012-2#1)
changes occurring in the##7##4##(1993-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
changes occurring in##10##3##(1993-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)
changes occurring within the##2##4##(2007-12#1)(2008-5#1)
changes occurring within##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
changes occurring##22##2##(1991-3#1)(1993-12#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
changes of Dn~0##2##3##(2007-11#2)
changes of a##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
changes of albumin##2##3##(2008-10#2)
changes of blood vessels##2##4##(2010-1#1)(2011-2#1)
changes of blood##3##3##(2010-1#1)(2011-2#2)
changes of collagen##2##3##(2008-7#1)(2012-3#1)
changes of epithelium lining the##2##5##(1993-1#1)(2008-4#1)
changes of health##2##3##(1995-11#1)(2011-1#1)
changes of human##2##3##(1993-8#1)(2008-11#1)
changes of pH##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
changes of serum##2##3##(2007-10#1)(2011-2#1)
changes of the enzyme during denaturation##2##6##(1990-5#2)
changes of the vertebra-disc junction on##2##6##(2007-11#2)
changes of the##60##3##(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1996-2#1)(1997-2#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
changes of their##2##3##(2010-4#1)(2012-2#1)
changes of these##3##3##(2007-12#1)(2010-4#1)(2012-2#1)
changes of this##2##3##(1993-12#1)(1994-5#1)
changes of##224##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#1)(2007-10#4)(2007-11#8)(2007-12#11)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#12)(2008-4#7)(2008-5#8)(2008-7#11)(2008-8#9)(2008-9#6)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-4#3)(2011-1#6)(2011-2#11)(2011-3#3)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#2)(2013-8#5)
changes on the##13##3##(1990-8#1)(1992-1#1)(1995-12#2)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)
changes on##36##2##(1990-8#1)(1991-12#1)(1992-1#2)(1994-1#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
changes or##12##2##(1992-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2012-1#1)
changes over the last decade##2##5##(1993-6#1)(2010-6#1)
changes over the##4##3##(1993-6#1)(2007-8#1)(2008-6#1)(2010-6#1)
changes over time##4##3##(1991-2#1)(1996-6#1)(2008-10#1)(2008-9#1)
changes over##10##2##(1991-2#1)(1993-6#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-6#1)(2011-2#1)
changes possibly##2##2##(2010-11#1)(2013-1#1)
changes present##2##2##(1996-3#1)(2013-1#1)
changes produced by##2##3##(1993-8#1)(2012-12#1)
changes related to##4##3##(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)
changes required##2##2##(1997-1#1)(2008-7#1)
changes resulting from##4##3##(2008-4#1)(2008-6#2)(2012-1#1)
changes reversibly##2##2##(1993-11#1)(2008-10#1)
changes reverted##2##2##(1990-7#1)(2012-1#1)
changes seen in##4##3##(1994-12#1)(1997-4#1)(2008-4#1)(2009-9#1)
changes seen on##2##3##(1996-6#1)(1997-8#1)
changes seen with##2##3##(1990-7#1)(2012-2#1)
changes seen##10##2##(1990-7#1)(1994-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
changes should##3##2##(1991-6#1)(1996-1#1)(2010-3#1)
changes shown by##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
changes sign##3##2##(2007-11#2)(2007-12#1)
changes significantly##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
changes similar to those##2##4##(2008-5#2)
changes such as##8##3##(1993-2#1)(1995-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-1#1)
changes take place in the##2##5##(1995-2#1)(2007-11#1)
changes take place##3##3##(1995-2#1)(2007-11#1)(2008-5#1)
changes taking place in##2##4##(2007-11#1)(2008-10#1)
changes than##4##2##(1992-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
changes that affect##2##3##(2008-10#1)(2011-2#1)
changes that are occurring in##2##5##(1995-1#1)(1996-2#1)
changes that are occurring##3##4##(1992-6#1)(1995-1#1)(1996-2#1)
changes that are##10##3##(1992-6#2)(1995-1#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-7#2)(2012-2#1)(2013-8#1)
changes that can be##3##4##(1993-3#1)(2010-4#1)(2012-9#1)
changes that can##4##3##(1993-3#1)(2007-11#1)(2010-4#1)(2012-9#1)
changes that occur during##2##4##(2008-10#1)(2008-3#1)
changes that occur in##8##4##(1991-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
changes that occur with puberty##2##5##(2010-4#2)
changes that occur##16##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#2)(2012-12#1)(2012-2#1)
changes that occurred in##2##4##(2007-12#1)(2008-8#1)
changes that take place in the##2##6##(2008-3#1)(2009-12#1)
changes that were##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
changes that would##3##3##(1996-1#1)(2008-2#1)(2008-4#1)
changes that##71##2##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-9#1)(2013-8#1)
changes the##20##2##(1990-5#1)(1992-4#1)(1993-12#1)(1994-5#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#3)
changes these##2##2##(1997-4#1)(2006-10#1)
changes through##2##2##(2008-10#1)(2008-3#1)
changes throughout##2##2##(1997-2#1)(2008-7#1)
changes to the payment##2##4##(1992-2#1)(1996-3#1)
changes to the##18##3##(1991-6#1)(1992-2#1)(1993-1#1)(1993-2#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
changes to##45##2##(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
changes typical of##2##3##(1994-6#1)(2007-12#1)
changes underlie##2##2##(2009-6#1)(2013-1#1)
changes underlying##3##2##(2008-5#1)(2012-12#2)
changes upon##3##2##(1992-8#1)(2007-12#1)(2008-10#1)
changes was##7##2##(1990-6#1)(1991-9#1)(1992-8#1)(1994-11#1)(2007-11#2)(2008-5#1)
changes were also##3##3##(1991-5#1)(2008-7#1)(2012-12#1)
changes were associated with a reduction##2##6##(1993-11#1)(2013-1#1)
changes were associated with the##2##5##(2008-10#1)(2008-9#1)
changes were associated with##7##4##(1990-5#1)(1991-5#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
changes were attributed##2##3##(2008-10#2)
changes were detected in##2##4##(1994-2#1)(1995-11#1)
changes were detected##3##3##(1994-2#1)(1995-11#1)(2008-10#1)
changes were examined##3##3##(2007-12#1)(2008-5#1)(2011-2#1)
changes were found in the##4##5##(1990-3#1)(1993-12#2)(2008-7#1)
changes were found in##6##4##(1990-3#1)(1992-3#1)(1993-12#2)(2008-7#1)(2013-1#1)
changes were found##12##3##(1990-3#1)(1991-7#1)(1992-3#1)(1993-12#2)(1995-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
changes were in##2##3##(2007-11#1)(2009-8#1)
changes were measured##3##3##(1996-5#1)(2007-11#1)(2008-12#1)
changes were not observed in##2##5##(2010-12#1)(2012-1#1)
changes were not##5##3##(2007-11#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-1#1)
changes were noted in##3##4##(1996-12#1)(2011-2#1)(2012-3#1)
changes were noted##4##3##(1996-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
changes were observed at##2##4##(1993-8#1)(2009-8#1)
changes were observed during##2##4##(1995-12#1)(2007-8#1)
changes were observed in the##8##5##(1990-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(2009-12#1)(2009-8#1)
changes were observed in##17##4##(1990-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#2)(1995-8#1)(1996-2#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#1)(2013-1#3)
changes were observed##26##3##(1990-12#1)(1990-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#2)(2012-2#1)(2013-1#3)
changes were seen in##8##4##(1991-12#1)(1997-2#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-11#1)(2011-2#1)
changes were seen##10##3##(1991-12#1)(1995-11#1)(1997-2#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#1)
changes were studied##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
changes were used in##2##4##(2009-7#1)(2012-2#1)
changes were used##3##3##(2009-7#1)(2011-2#1)(2012-2#1)
changes were##127##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-7#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#6)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#6)
changes when##3##2##(1992-8#1)(2008-10#1)(2008-9#1)
changes which occur in##3##4##(1993-2#1)(1994-5#1)(2010-11#1)
changes which##9##2##(1991-11#1)(1993-2#2)(1994-5#1)(1995-6#2)(1995-8#1)(2010-11#1)(2012-2#1)
changes will##5##2##(1993-2#1)(1994-1#1)(1996-3#1)(2008-10#1)(2008-6#1)
changes with a##3##3##(1992-6#1)(2009-4#1)(2012-12#1)
changes with age in##3##4##(1995-8#1)(2008-2#1)(2011-1#1)
changes with age##5##3##(1995-6#1)(1995-8#1)(1996-5#1)(2008-2#1)(2011-1#1)
changes with aging##2##3##(1993-1#1)(2008-7#1)
changes with increasing##3##3##(1991-12#1)(1994-8#1)(2008-7#1)
changes with the##4##3##(2007-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
changes with##39##2##(1991-1#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)
changes within a##2##3##(1992-8#1)(1995-5#1)
changes within the##2##3##(1995-3#1)(2010-5#1)
changes within##8##2##(1992-8#1)(1995-3#2)(1995-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2010-5#1)
changes##3435##1##(1990-11#10)(1990-12#12)(1990-2#12)(1990-3#14)(1990-5#15)(1990-6#15)(1990-7#15)(1990-8#20)(1990-9#8)(1991-1#12)(1991-10#3)(1991-11#2)(1991-12#28)(1991-2#25)(1991-3#18)(1991-5#15)(1991-6#16)(1991-7#1)(1991-8#6)(1991-9#13)(1992-1#11)(1992-10#1)(1992-11#7)(1992-12#17)(1992-2#14)(1992-3#26)(1992-4#2)(1992-5#6)(1992-6#25)(1992-7#1)(1992-8#18)(1992-9#13)(1993-1#15)(1993-10#2)(1993-11#16)(1993-12#24)(1993-2#14)(1993-3#14)(1993-5#3)(1993-6#9)(1993-8#19)(1993-9#10)(1994-1#15)(1994-10#2)(1994-11#10)(1994-12#38)(1994-2#12)(1994-3#21)(1994-5#31)(1994-6#21)(1994-7#1)(1994-8#13)(1994-9#14)(1995-1#13)(1995-11#14)(1995-12#33)(1995-2#21)(1995-3#20)(1995-5#23)(1995-6#15)(1995-8#9)(1995-9#1)(1996-1#6)(1996-11#3)(1996-12#24)(1996-2#29)(1996-3#18)(1996-4#14)(1996-5#23)(1996-6#13)(1996-7#9)(1996-8#1)(1996-9#4)(1997-1#10)(1997-2#31)(1997-3#19)(1997-4#14)(1997-5#3)(1997-6#4)(1997-7#17)(1997-8#9)(1997-9#1)(2006-10#2)(2006-12#2)(2006-6#4)(2006-8#5)(2007-1#1)(2007-10#20)(2007-11#69)(2007-12#67)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#19)(2007-8#32)(2008-1#39)(2008-10#301)(2008-11#114)(2008-12#59)(2008-2#44)(2008-3#151)(2008-4#53)(2008-5#115)(2008-6#37)(2008-7#172)(2008-8#79)(2008-9#100)(2009-1#4)(2009-10#14)(2009-11#10)(2009-12#12)(2009-2#4)(2009-3#5)(2009-4#15)(2009-5#11)(2009-6#12)(2009-7#21)(2009-8#25)(2009-9#9)(2010-1#8)(2010-10#9)(2010-11#16)(2010-12#13)(2010-2#5)(2010-3#16)(2010-4#25)(2010-5#7)(2010-6#7)(2010-7#7)(2010-8#15)(2010-9#8)(2011-1#38)(2011-2#118)(2011-3#5)(2011-7#1)(2012-1#20)(2012-12#35)(2012-2#87)(2012-3#49)(2012-5#5)(2012-7#2)(2012-8#3)(2012-9#5)(2013-1#120)(2013-7#15)(2013-8#56)
changes)##4##1##(2008-9#2)(2009-9#1)(2012-2#1)
changing and beam profile deformation of light during the##2##9##(2008-2#2)
changing and##6##2##(2008-11#1)(2008-12#1)(2008-2#3)(2008-9#1)
changing attitudes##3##2##(1992-3#1)(2007-3#1)(2008-12#1)
changing both##2##2##(2008-10#1)(2008-7#1)
changing degree##2##2##(1995-6#2)
changing demographics##4##2##(2007-2#1)(2008-9#1)(2010-8#2)
changing environment##11##2##(1991-2#1)(1991-3#1)(1994-3#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
changing environments##4##2##(1992-1#1)(1997-7#1)(2008-7#1)(2009-6#1)
changing field##2##2##(1991-12#1)(2013-8#1)
changing from the##3##3##(1992-11#1)(2008-10#1)(2012-12#1)
changing from##7##2##(1990-5#1)(1992-11#1)(1992-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
changing health care environment##5##4##(1991-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#1)
changing health care market##2##4##(1996-12#1)(1997-1#1)
changing health care##9##3##(1991-2#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
changing health##12##2##(1991-2#1)(1992-1#1)(1993-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
changing in##3##2##(1992-9#1)(2007-8#1)(2008-10#1)
changing its##3##2##(1995-5#1)(2008-6#1)(2010-8#1)
changing landscape of##3##3##(1993-2#1)(1994-1#1)(2008-11#1)
changing lifestyles and##2##3##(2007-12#2)
changing market##2##2##(1992-2#1)(1994-2#1)
changing medical##2##2##(1992-9#1)(2011-2#1)
changing needs for##2##3##(1992-1#1)(1996-2#1)
changing needs##3##2##(1992-1#1)(1995-5#1)(1996-2#1)
changing our##3##2##(1994-12#1)(2008-4#1)(2012-2#1)
changing over time and##2##4##(1994-11#1)(2008-8#1)
changing policy##2##2##(1997-8#1)(2008-11#1)
changing reimbursement##2##2##(1992-2#1)(1997-3#1)
changing risky behaviours##2##3##(2011-1#2)
changing role of##4##3##(1991-3#2)(1997-5#1)(2008-11#1)
changing roles of##2##3##(2007-10#1)(2008-12#1)
changing roles##3##2##(2007-10#1)(2008-12#1)(2011-1#1)
changing the pH##3##3##(1990-5#1)(1994-9#1)(2008-10#1)
changing the phase##2##3##(2007-12#2)
changing the temperature of##2##4##(2007-12#1)(2008-3#1)
changing the way##2##3##(1994-2#1)(1996-3#1)
changing the##106##2##(1990-11#1)(1990-5#2)(1990-6#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-2#4)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-11#4)(2007-12#8)(2007-8#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#15)(2008-6#1)(2008-7#1)(2008-9#5)(2009-11#2)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
changing their##3##2##(1996-2#1)(2008-11#1)(2009-11#1)
changing this##2##2##(1995-1#1)(1995-6#1)
changing times##2##2##(1991-1#1)(1991-3#1)
changing trends##2##2##(1997-2#1)(2012-3#1)
changing with##2##2##(2007-12#1)(2008-1#1)
changing##359##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#4)(1992-11#3)(1992-2#2)(1992-3#5)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#4)(1993-3#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#4)(1995-5#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#9)(1996-3#5)(1996-4#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#8)(2007-12#21)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#40)(2008-11#22)(2008-12#7)(2008-2#12)(2008-3#18)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#1)(2010-8#5)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#6)(2012-5#1)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#4)
channel (VDCC)##2##2##(1997-4#1)(2008-8#1)
channel activation##3##2##(1994-11#1)(1996-2#1)(2008-8#1)
channel activators##2##2##(1990-7#1)(1996-9#1)
channel activity and##3##3##(2008-8#2)(2013-1#1)
channel activity in##2##3##(1990-2#1)(1997-7#1)
channel activity##26##2##(1990-2#2)(1994-11#1)(1994-9#2)(1995-3#1)(1995-5#4)(1997-7#2)(2008-8#11)(2009-2#1)(2011-1#1)(2013-1#1)
channel and its##3##3##(1990-2#1)(2013-1#1)(2013-8#1)
channel and##22##2##(1990-2#1)(1992-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#3)(2009-12#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
channel antagonist##2##2##(1997-2#1)(2008-5#1)
channel antagonists##3##2##(1994-11#2)(2008-10#1)
channel are##2##2##(2007-11#1)(2008-3#1)
channel beta##3##2##(1994-12#1)(1996-12#1)(1997-4#1)
channel blockade##7##2##(1993-6#2)(1997-7#2)(2008-12#1)(2008-2#2)
channel blocker##26##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#1)(1995-11#1)(1995-12#2)(1996-5#3)(2008-1#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
channel blockers and##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
channel blockers were##3##3##(1992-8#1)(1996-5#1)(2010-5#1)
channel blockers##37##2##(1990-12#1)(1990-7#3)(1990-8#1)(1992-8#3)(1993-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#4)(2010-5#2)(2012-12#1)(2012-3#2)
channel by##4##2##(1994-12#1)(1995-3#1)(1997-3#1)(2008-5#1)
channel capacity##2##2##(2008-2#1)(2008-3#1)
channel clusters##3##2##(2008-7#3)
channel complex##2##2##(1995-11#1)(1996-2#1)
channel conductance of##2##3##(1994-12#1)(1994-6#1)
channel conductance##3##2##(1991-9#1)(1994-12#1)(1994-6#1)
channel cross talk##2##3##(2007-12#1)(2008-2#1)
channel currents##11##2##(1992-12#4)(1993-12#5)(1993-3#1)(2008-8#1)
channel density##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
channel domains##2##2##(2008-7#2)
channel expression and##3##3##(2008-5#1)(2008-8#2)
channel expression##6##2##(1994-8#1)(2008-5#1)(2008-8#4)
channel family##3##2##(1996-2#1)(2008-8#1)(2009-10#1)
channel flow##3##2##(2008-10#2)(2009-11#1)
channel for##9##2##(1990-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)
channel formation##3##2##(1994-2#2)(1995-11#1)
channel from##2##2##(1992-11#1)(2008-8#1)
channel function##11##2##(1995-8#1)(2008-4#4)(2008-8#5)(2010-12#1)
channel gating##6##2##(1993-5#1)(1997-2#1)(2008-7#1)(2008-8#3)
channel gene##5##2##(1990-11#1)(1991-12#1)(1992-3#2)(2008-8#1)
channel has##2##2##(1994-12#2)
channel if##2##2##(2008-2#1)(2008-4#1)
channel in the presence of noise photons##2##7##(2008-3#2)
channel in the##8##3##(1990-11#1)(1996-2#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-8#2)
channel in##20##2##(1990-11#1)(1992-6#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#3)(2009-12#1)(2009-2#1)
channel inactivation##5##2##(1991-9#1)(2008-8#4)
channel inhibition##3##2##(2010-8#3)
channel inhibitor##2##2##(1994-11#1)(2008-4#1)
channel inhibitors##3##2##(1995-11#1)(2008-8#2)
channel is an important##2##4##(2008-3#2)
channel is blocked by##2##4##(1993-3#1)(2008-8#1)
channel is demonstrated##2##3##(2008-2#2)
channel is##23##2##(1990-11#1)(1990-7#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2011-1#1)
channel isoforms##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
channel isolation##2##2##(2007-11#1)(2007-12#1)
channel mRNA##3##2##(1996-12#3)
channel mRNAs##3##2##(1996-12#3)
channel models##5##2##(2008-3#5)
channel of a##2##3##(2007-12#1)(2008-10#1)
channel of the##5##3##(1992-1#1)(2007-7#2)(2008-10#1)(2013-1#1)
channel of##12##2##(1992-1#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
channel open probability##2##3##(2008-8#2)
channel open##4##2##(1994-12#1)(2008-8#3)
channel opener##3##2##(1992-9#1)(2011-1#2)
channel opening##6##2##(1992-6#1)(1996-9#1)(2008-4#1)(2010-12#1)(2011-1#2)
channel peptide##6##2##(1995-5#6)
channel phosphorylation sites##2##3##(2008-8#2)
channel pore##2##2##(2008-8#2)
channel properties##5##2##(1994-12#1)(1995-5#2)(1996-10#1)(2008-8#1)
channel protein##7##2##(1991-12#1)(1993-12#1)(1997-2#2)(2008-5#1)(2008-8#1)(2010-12#1)
channel proteins##2##2##(1993-3#1)(2012-3#1)
channel responses##2##2##(2008-3#2)
channel separation##2##2##(2007-12#2)
channel size##2##2##(1992-12#2)
channel spacing##4##2##(2008-2#1)(2008-3#3)
channel that##2##2##(2008-3#1)(2008-8#1)
channel through##3##2##(1990-8#1)(2007-12#1)(2008-3#1)
channel to##10##2##(1990-11#1)(2007-11#2)(2008-2#2)(2008-3#2)(2008-8#2)(2013-1#1)
channel types##2##2##(1993-11#2)
channel wall##3##2##(2008-10#1)(2009-11#1)(2010-8#1)
channel walls##3##2##(2008-10#1)(2008-12#2)
channel was##9##2##(1992-6#1)(1993-3#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
channel waveguide##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
channel waveguides in##2##3##(2008-2#1)(2008-3#1)
channel waveguides##14##2##(2007-11#2)(2007-12#1)(2008-2#9)(2008-3#2)
channel were##2##2##(1990-11#1)(2008-4#1)
channel width##3##2##(2008-10#1)(2008-2#2)
channel with##2##2##(2008-10#1)(2013-8#1)
channel##682##1##(1990-11#9)(1990-12#2)(1990-2#7)(1990-5#1)(1990-7#5)(1990-8#2)(1991-12#3)(1991-2#1)(1991-9#9)(1992-1#1)(1992-11#3)(1992-12#10)(1992-3#4)(1992-6#6)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#7)(1993-3#9)(1993-5#2)(1993-6#2)(1993-8#2)(1994-11#6)(1994-12#10)(1994-2#3)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#5)(1995-11#7)(1995-12#10)(1995-2#1)(1995-3#5)(1995-5#16)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#15)(1996-2#9)(1996-5#6)(1996-6#2)(1996-9#3)(1997-2#9)(1997-3#5)(1997-4#3)(1997-7#6)(1997-8#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#43)(2008-11#6)(2008-12#6)(2008-2#52)(2008-3#50)(2008-4#22)(2008-5#9)(2008-6#5)(2008-7#20)(2008-8#89)(2008-9#3)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#6)(2009-3#1)(2009-5#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#6)(2010-5#2)(2010-8#10)(2011-1#8)(2011-2#4)(2011-3#4)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#17)(2013-8#3)
channel&quot##2##1##(2011-2#2)
channel)##4##1##(1990-2#1)(1992-6#1)(1993-11#1)(2007-11#1)
channel-containing##2##1##(1990-2#2)
channel-dropping filters##3##2##(2007-11#3)
channel-dropping##4##1##(2007-11#3)(2008-3#1)
channel-forming##3##1##(1990-11#2)(1994-11#1)
channeled##2##1##(2008-10#1)(2008-2#1)
channeling##4##1##(2007-12#1)(2008-3#2)(2012-1#1)
channelopathies##6##1##(2008-7#1)(2012-2#1)(2012-3#3)(2013-1#1)
channels (approximately##2##2##(2008-3#1)(2008-7#1)
channels 1 and 2##2##4##(2008-3#2)
channels also##2##2##(1994-6#1)(2008-8#1)
channels and a##2##3##(1990-8#1)(2008-10#1)
channels and the##3##3##(2008-3#1)(2008-9#1)(2010-4#1)
channels and transporters##2##3##(2008-4#1)(2008-8#1)
channels and##27##2##(1990-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#2)(2010-4#1)(2013-8#1)
channels are expressed in##3##4##(2008-8#2)(2009-10#1)
channels are##33##2##(1992-11#1)(1993-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#9)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
channels as a function of##2##5##(2008-2#1)(2008-3#1)
channels as##7##2##(2007-11#1)(2008-2#2)(2008-3#2)(2009-12#1)(2009-2#1)
channels at##6##2##(1995-3#1)(1996-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
channels by##13##2##(1993-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#5)(2010-12#1)
channels can be##8##3##(1993-3#1)(1994-2#2)(2007-12#1)(2008-3#2)(2008-4#1)(2010-12#1)
channels can##10##2##(1993-12#1)(1993-3#1)(1994-2#2)(2007-12#1)(2008-3#2)(2008-4#1)(2009-5#1)(2010-12#1)
channels could be##2##3##(2007-11#1)(2013-1#1)
channels did not##2##3##(1995-11#1)(2008-9#1)
channels does##2##2##(2007-8#1)(2008-8#1)
channels encoded by##2##3##(1994-12#1)(2010-8#1)
channels expressed in##3##3##(1994-9#1)(1996-2#1)(2008-8#1)
channels expressed##4##2##(1994-9#1)(1996-2#1)(2008-8#2)
channels for##5##2##(1995-3#1)(2008-2#1)(2008-3#1)(2008-8#2)
channels from##4##2##(1995-5#1)(2008-11#1)(2008-8#2)
channels guide neurite outgrowth##2##4##(2008-5#2)
channels has been##2##3##(1992-11#1)(2012-3#1)
channels has##3##2##(1992-11#1)(2008-8#1)(2012-3#1)
channels have a##2##3##(2008-10#2)
channels have been##4##3##(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
channels have##8##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
channels in a##4##3##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
channels in human##4##3##(1990-8#1)(1993-9#2)(2009-12#1)
channels in peripheral##2##3##(2008-8#2)
channels in rat brain##2##4##(1995-3#1)(1997-2#1)
channels in rat##3##3##(1995-3#1)(1997-2#1)(2008-8#1)
channels in the brain##3##4##(1993-11#1)(1993-9#1)(2009-7#1)
channels in the membrane##2##4##(1994-11#1)(2008-7#1)
channels in the##17##3##(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-7#1)(2013-1#1)
channels in##63##2##(1990-2#1)(1990-8#2)(1991-11#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#3)(1994-11#6)(1994-12#2)(1995-3#3)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#3)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#10)(2009-10#4)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
channels is demonstrated##2##3##(2007-12#2)
channels is##9##2##(1990-8#1)(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
channels located##2##2##(1994-12#1)(2008-3#1)
channels may##2##2##(1996-2#1)(2008-8#1)
channels of a##2##3##(2008-10#1)(2008-3#1)
channels of communication##2##3##(2007-9#1)(2009-10#1)
channels of imaging spectrometers##2##4##(2008-2#2)
channels of the##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
channels of##15##2##(1994-6#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
channels on##2##2##(1997-7#1)(2008-2#1)
channels suggests that##2##3##(2008-3#1)(2008-8#1)
channels that can##2##3##(2008-3#1)(2008-7#1)
channels that play##2##3##(2007-12#1)(2008-7#1)
channels that##13##2##(2007-12#1)(2008-3#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)
channels to##7##2##(1997-6#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)
channels was studied##2##3##(1990-8#1)(2013-1#1)
channels was##5##2##(1990-8#1)(1995-3#1)(2008-3#1)(2009-12#1)(2013-1#1)
channels were##10##2##(1994-11#1)(1995-11#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
channels which##2##2##(1993-11#1)(1996-2#1)
channels with##11##2##(1993-11#1)(2007-11#1)(2007-8#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
channels##560##1##(1990-2#5)(1990-7#3)(1990-8#5)(1991-11#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#7)(1993-12#5)(1993-3#4)(1993-6#1)(1993-9#4)(1994-11#13)(1994-12#8)(1994-2#5)(1994-5#2)(1994-6#3)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#10)(1995-5#6)(1995-6#1)(1996-2#11)(1996-5#6)(1997-1#2)(1997-2#3)(1997-6#1)(1997-7#7)(2007-10#4)(2007-11#11)(2007-12#10)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#21)(2008-11#3)(2008-12#3)(2008-2#25)(2008-3#65)(2008-4#17)(2008-5#8)(2008-6#1)(2008-7#26)(2008-8#120)(2008-9#13)(2009-10#9)(2009-12#5)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#3)(2010-11#2)(2010-12#7)(2010-4#2)(2010-8#7)(2011-1#6)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#19)(2013-7#3)(2013-8#2)
channels)##8##1##(1992-12#1)(1993-11#1)(1994-2#1)(2007-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
chaos and oscillations##3##3##(2008-11#3)
chaos and##4##2##(2008-11#4)
chaos in the##2##3##(2008-8#1)(2012-2#1)
chaos in##7##2##(2007-11#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
chaos of protein##2##3##(2012-2#2)
chaos of##3##2##(2007-11#1)(2012-2#2)
chaos theory##3##2##(1996-2#2)(1996-3#1)
chaos##36##1##(1994-2#1)(1994-8#2)(1995-12#1)(1995-6#1)(1996-2#3)(1996-3#1)(1997-2#1)(2007-11#5)(2007-12#1)(2008-11#7)(2008-8#4)(2008-9#4)(2012-2#3)(2012-3#1)(2013-8#1)
chaotic attractor##3##2##(2007-12#3)
chaotic communication##2##2##(2007-12#2)
chaotic dynamics in##2##3##(2008-11#2)
chaotic dynamics is##2##3##(2008-11#2)
chaotic dynamics##10##2##(1992-8#1)(2007-11#1)(2008-11#7)(2008-8#1)
chaotic mixing##2##2##(2007-10#2)
chaotic oscillations##6##2##(2007-12#5)(2008-9#1)
chaotic pulsations##2##2##(2007-11#1)(2007-12#1)
chaotic regime##3##2##(2008-11#2)(2008-9#1)
chaotic transitions##2##2##(2007-11#2)
chaotic##72##1##(1992-8#1)(1996-2#1)(1996-4#2)(2006-12#1)(2007-10#3)(2007-11#19)(2007-12#19)(2008-10#2)(2008-11#11)(2008-8#5)(2008-9#3)(2009-5#1)(2010-1#1)(2011-2#2)(2012-2#1)
chaotropic##4##1##(1990-2#1)(1991-3#1)(2008-10#1)(2009-2#1)
chaparral##4##1##(2010-6#4)
chaperone BiP##2##2##(2008-7#1)(2012-1#1)
chaperone and##2##2##(2009-8#1)(2010-9#1)
chaperone for##3##2##(1997-4#1)(2008-10#2)
chaperone proteins##2##2##(2008-4#1)(2008-7#1)
chaperone that##2##2##(1995-3#1)(2010-4#1)
chaperone##21##1##(1995-3#2)(1995-6#1)(1997-4#3)(2008-10#2)(2008-4#2)(2008-7#5)(2009-6#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
chaperones and##4##2##(2008-1#1)(2008-4#1)(2008-7#2)
chaperones in the##3##3##(1994-11#1)(2008-7#1)(2009-6#1)
chaperones in##4##2##(1994-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
chaperones such as##2##3##(2008-7#1)(2011-2#1)
chaperones##25##1##(1994-11#4)(1995-2#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-7#6)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#3)
chaperoning##5##1##(1994-11#2)(2008-4#1)(2008-7#2)
chaplain visits##2##2##(2008-12#2)
chaplain##4##1##(1993-12#1)(2008-12#3)
chaplain's role in bioethical decision-making##2##5##(1994-12#2)
chaplains##3##1##(1994-12#2)(2009-11#1)
chapter discusses##4##2##(1994-11#1)(2010-8#1)(2011-2#2)
chapter of##3##2##(1994-12#1)(1995-3#1)(2007-5#1)
chapter on##4##2##(1994-12#1)(1995-1#1)(2011-2#1)(2013-8#1)
chapter##47##1##(1994-11#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#8)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-3#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
chapters##7##1##(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#2)
character and##10##2##(1994-8#1)(2007-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-3#1)
character bases##2##2##(2007-11#2)
character displacement##3##2##(2008-8#3)
character for##2##2##(2008-11#1)(2008-12#1)
character in the##4##3##(2007-12#4)
character information##2##2##(2013-1#2)
character is##2##2##(2008-12#1)(2012-2#1)
character of both the##2##4##(2008-8#1)(2011-1#1)
character of the##15##3##(1992-12#1)(1992-6#1)(1992-9#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#1)
character of##45##2##(1992-12#2)(1992-6#1)(1992-9#1)(1994-5#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#3)(2008-9#3)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
character traits##2##2##(1991-12#1)(2007-11#1)
character##136##1##(1991-12#1)(1992-12#3)(1992-6#2)(1992-9#1)(1994-1#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#9)(2008-9#7)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#8)(2013-7#1)
character's##2##1##(2009-9#2)
characterisation and##8##2##(2008-10#5)(2008-5#1)(2012-2#2)
characterisation of the##13##3##(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
characterisation of this##2##3##(1995-11#1)(2008-10#1)
characterisation of##47##2##(1990-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2012-2#5)
characterisation##63##1##(1990-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#35)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-10#1)(2012-2#8)
characterise the##13##2##(1991-9#1)(1994-11#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
characterise##25##1##(1991-12#1)(1991-9#1)(1994-11#1)(1994-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
characterised and##3##2##(2008-10#2)(2008-12#1)
characterised as##5##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-5#1)(2013-8#1)
characterised by a##3##3##(2008-10#2)(2011-2#1)
characterised by high##3##3##(2008-12#1)(2008-6#1)(2012-2#1)
characterised by increased##2##3##(2008-1#1)(2012-2#1)
characterised by low##2##3##(2008-10#2)
characterised by the##8##3##(1993-3#1)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#1)(2013-8#1)
characterised by##55##2##(1990-3#1)(1991-3#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#1)
characterised in##5##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
characterised the##3##2##(1991-5#1)(1993-2#1)(2010-12#1)
characterised with##3##2##(2008-10#3)
characterised##103##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#4)(2012-12#3)(2012-2#5)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
characterising the##6##2##(2008-10#5)(2012-1#1)
characterising##15##1##(2008-1#1)(2008-10#6)(2008-11#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#2)
characteristic (ROC) analysis##4##3##(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)
characteristic (ROC)##9##2##(2007-8#1)(2008-10#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)
characteristic absorption##3##2##(1996-5#1)(2008-10#1)(2013-8#1)
characteristic airway dimensions##2##3##(2008-11#2)
characteristic and##4##2##(1997-2#1)(2007-11#1)(2007-12#1)(2010-10#1)
characteristic autoantibodies##2##2##(1996-11#2)
characteristic band##2##2##(2008-10#1)(2008-12#1)
characteristic bands##2##2##(2008-10#1)(2012-2#1)
characteristic behaviors##2##2##(2008-3#1)(2013-1#1)
characteristic changes##2##2##(2008-3#1)(2008-9#1)
characteristic clinical##5##2##(2008-6#1)(2009-8#1)(2011-2#2)(2012-12#1)
characteristic concentration and##2##3##(2008-10#2)
characteristic concentration##5##2##(2008-10#5)
characteristic curve of##2##3##(2008-3#2)
characteristic curve##7##2##(2008-10#3)(2008-3#3)(2012-2#1)
characteristic curves##2##2##(2008-10#1)(2013-7#1)
characteristic data of the electrochemical hydride generation and common hydride generation by NaBH(4) were compared##2##15##(2008-10#2)
characteristic differences##3##2##(2008-3#1)(2008-7#1)(2010-5#1)
characteristic disease##2##2##(2008-10#2)
characteristic feature of##4##3##(1993-9#1)(1996-11#1)(1997-8#1)(2008-7#1)
characteristic features of the##8##4##(1990-12#1)(1990-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
characteristic features of##17##3##(1990-11#1)(1990-12#1)(1990-5#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2010-7#1)(2011-1#1)(2013-1#1)
characteristic features##20##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-11#1)(2010-7#1)(2011-1#1)(2013-1#2)
characteristic findings##2##2##(1995-11#1)(2009-6#1)
characteristic for the##2##3##(2008-12#2)
characteristic for this##2##3##(2008-7#1)(2011-2#1)
characteristic for##26##2##(1990-11#1)(1990-3#1)(1993-11#1)(1995-8#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#1)
characteristic fragmentations##2##2##(1994-3#1)(2008-10#1)
characteristic frequency##2##2##(2007-12#1)(2008-11#1)
characteristic histopathological##3##2##(1992-2#1)(2009-11#1)(2010-6#1)
characteristic in the##2##3##(2008-5#1)(2012-2#1)
characteristic in##3##2##(2008-5#2)(2012-2#1)
characteristic ions##3##2##(2008-10#3)
characteristic lesions##2##2##(1997-3#1)(2008-4#1)
characteristic mass of##8##3##(2008-10#8)
characteristic mass was##3##3##(2008-10#3)
characteristic mass##21##2##(2008-10#21)
characteristic masses##3##2##(2008-10#3)
characteristic of Alzheimer's disease##3##4##(1992-6#1)(1992-8#1)(2008-5#1)
characteristic of a##8##3##(1991-12#1)(1992-3#1)(1994-12#1)(1995-5#1)(1996-10#1)(1997-7#1)(2007-7#1)(2008-2#1)
characteristic of all##4##3##(1993-2#1)(2008-11#1)(2008-12#1)(2008-8#1)
characteristic of an##4##3##(1991-2#1)(1995-5#1)(2009-4#1)(2012-12#1)
characteristic of apoptotic##2##3##(1995-12#1)(2008-4#1)
characteristic of each##2##3##(2007-12#1)(2008-10#1)
characteristic of other##2##3##(2008-10#1)(2008-2#1)
characteristic of several##3##3##(1990-5#1)(1997-7#1)(2008-11#1)
characteristic of the family##2##4##(1992-12#1)(2008-8#1)
characteristic of the hypersensitive response (HR)##2##6##(2008-10#2)
characteristic of the##41##3##(1990-10#1)(1990-6#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-3#2)(1997-4#1)(1997-7#3)(2007-12#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
characteristic of these##3##3##(1991-6#1)(1991-8#1)(2011-2#1)
characteristic of this##6##3##(1990-5#1)(1993-8#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-8#1)
characteristic of##177##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#2)(1994-8#1)(1995-12#3)(1995-2#2)(1995-5#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#6)(2007-11#3)(2007-12#4)(2007-7#2)(2008-10#32)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#7)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#3)
characteristic parameters##2##2##(2008-3#1)(2008-5#1)
characteristic pathologic##2##2##(1996-7#1)(2008-4#1)
characteristic pattern##2##2##(2008-5#1)(2011-2#1)
characteristic patterns of##2##3##(1992-8#1)(2010-8#1)
characteristic patterns##3##2##(1992-8#1)(2008-2#1)(2010-8#1)
characteristic peak##2##2##(2008-11#1)(2013-8#1)
characteristic peaks##5##2##(2008-10#4)(2008-6#1)
characteristic phenotype##2##2##(2007-7#1)(2009-5#1)
characteristic presenting symptoms##2##3##(2008-7#1)(2012-12#1)
characteristic properties##5##2##(1993-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
characteristic response##3##2##(1992-8#1)(2007-12#1)(2008-10#1)
characteristic scale lengths##2##3##(1996-4#2)
characteristic scale##4##2##(1996-4#4)
characteristic sequence##2##2##(1994-8#1)(2007-11#1)
characteristic signs and symptoms##2##4##(1997-8#2)
characteristic signs##3##2##(1997-8#2)(2012-12#1)
characteristic species evolved by the##2##5##(2008-10#2)
characteristic spectral##2##2##(2008-3#1)(2013-8#1)
characteristic symptoms of##5##3##(1990-6#1)(2008-10#3)(2011-2#1)
characteristic symptoms##7##2##(1990-6#2)(2008-10#3)(2010-2#1)(2011-2#1)
characteristic that is##2##3##(2008-2#1)(2008-3#1)
characteristic that##6##2##(1992-2#1)(1995-1#1)(2008-2#2)(2008-3#1)(2008-5#1)
characteristic time##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
characteristic to the##2##3##(2008-5#1)(2011-2#1)
characteristic##591##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#2)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#6)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#5)(1995-8#1)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#12)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#8)(1997-8#6)(2006-10#2)(2007-11#11)(2007-12#14)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#134)(2008-11#19)(2008-12#7)(2008-2#16)(2008-3#31)(2008-4#11)(2008-5#23)(2008-6#5)(2008-7#15)(2008-8#9)(2008-9#11)(2009-10#3)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#5)(2010-10#4)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#9)(2011-2#21)(2012-1#1)(2012-12#10)(2012-2#9)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#9)
characteristic)##3##1##(2008-10#2)(2008-12#1)
characteristically##12##1##(1994-1#1)(1994-8#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#2)(2013-1#1)
characteristics (e##4##2##(1992-8#1)(2008-3#1)(2008-7#1)(2010-11#1)
characteristics among##2##2##(2008-10#1)(2013-8#1)
characteristics and clinical##4##3##(2010-11#1)(2011-1#1)(2013-8#2)
characteristics and composition of the##2##5##(2008-10#1)(2008-8#1)
characteristics and distribution of the##2##5##(2011-2#1)(2012-3#1)
characteristics and durability##2##3##(2008-3#1)(2012-12#1)
characteristics and educational##2##3##(1992-3#1)(2008-12#1)
characteristics and needs of##2##4##(1991-3#1)(2008-6#1)
characteristics and potential##2##3##(2008-5#1)(2013-1#1)
characteristics and practice##2##3##(2010-9#2)
characteristics and primary##2##3##(2008-10#1)(2008-3#1)
characteristics and risk factors##2##4##(2007-7#1)(2008-8#1)
characteristics and risk##3##3##(2007-7#1)(2008-3#1)(2008-8#1)
characteristics and structural##2##3##(2008-3#1)(2010-6#1)
characteristics and the##12##3##(1990-9#1)(1994-1#1)(1995-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2013-1#1)
characteristics and their##4##3##(1995-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
characteristics and##149##2##(1990-11#1)(1990-9#1)(1991-3#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#3)(1994-1#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-10#18)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#8)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-2#4)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#8)
characteristics are altered##2##3##(2008-3#2)
characteristics are associated with##2##4##(2007-7#1)(2008-6#1)
characteristics are defined##2##3##(1991-2#1)(2008-3#1)
characteristics are different among##2##4##(2009-4#1)(2012-2#1)
characteristics are given##2##3##(2011-2#1)(2013-1#1)
characteristics are included##2##3##(2008-12#1)(2009-4#1)
characteristics are not##2##3##(2008-10#1)(2008-11#1)
characteristics are obtained##2##3##(2007-12#1)(2008-3#1)
characteristics are presented##2##3##(2008-10#1)(2008-2#1)
characteristics are##37##2##(1991-2#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
characteristics as a##2##3##(1995-2#1)(2008-5#1)
characteristics as well as##2##4##(1995-2#1)(2008-10#1)
characteristics as well##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
characteristics as##14##2##(1991-5#1)(1992-9#1)(1995-2#2)(2008-10#2)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
characteristics associated with##8##3##(1992-2#1)(1993-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-5#1)
characteristics at a##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
characteristics at##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
characteristics based on##2##3##(2007-11#1)(2008-10#1)
characteristics between the##2##3##(1990-8#1)(2013-7#1)
characteristics between##3##2##(1990-8#1)(1995-3#1)(2013-7#1)
characteristics but##2##2##(2008-10#1)(2008-8#1)
characteristics by##8##2##(2008-10#3)(2008-11#1)(2008-2#2)(2012-3#1)(2013-1#1)
characteristics can be##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
characteristics can##7##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)
characteristics compared to##4##3##(2010-3#2)(2012-2#1)(2012-3#1)
characteristics compared with##2##3##(1991-12#1)(2008-10#1)
characteristics compared##6##2##(1991-12#1)(2008-10#1)(2010-3#2)(2012-2#1)(2012-3#1)
characteristics did not##3##3##(2008-10#2)(2008-12#1)
characteristics differ##2##2##(2008-3#1)(2009-4#1)
characteristics evaluated were##2##3##(2008-10#2)
characteristics for the##4##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
characteristics for##16##2##(1992-8#1)(1995-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)
characteristics from##3##2##(1994-12#1)(2007-12#1)(2008-12#1)
characteristics had##2##2##(1991-6#1)(2008-10#1)
characteristics have been##8##3##(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#2)(2009-4#1)(2010-8#1)(2012-2#1)
characteristics have##11##2##(1992-12#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-2#1)
characteristics in terms of##2##4##(2008-10#1)(2009-9#1)
characteristics in the##4##3##(1996-5#1)(2007-8#1)(2011-2#1)(2013-1#1)
characteristics in##33##2##(1991-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-6#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
characteristics include##2##2##(2008-10#1)(2010-3#1)
characteristics including the##2##3##(2008-7#1)(2008-8#1)
characteristics including##8##2##(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
characteristics is analyzed##2##3##(2008-3#1)(2009-6#1)
characteristics is##13##2##(1992-12#1)(1994-8#1)(2008-10#2)(2008-3#4)(2008-9#2)(2009-6#1)(2011-2#1)(2012-1#1)
characteristics like##2##2##(2008-10#1)(2010-4#1)
characteristics make the##2##3##(2013-8#2)
characteristics make##5##2##(1990-3#1)(2013-1#1)(2013-8#3)
characteristics may##3##2##(1991-5#1)(1992-12#1)(2009-10#1)
characteristics near the dispersion turning points##2##6##(2007-12#2)
characteristics not##2##2##(2008-6#1)(2008-9#1)
characteristics observed##2##2##(1993-12#1)(2008-10#1)
characteristics of 2##2##3##(1994-2#1)(2008-10#1)
characteristics of 3##2##3##(2008-3#1)(2011-1#1)
characteristics of Chinese male batterers##2##5##(2009-5#2)
characteristics of a diode laser##2##5##(2008-10#1)(2008-2#1)
characteristics of a disparity detector##2##5##(1990-8#2)
characteristics of a fiber##2##4##(2008-2#1)(2008-3#1)
characteristics of a given##2##4##(2007-10#1)(2008-4#1)
characteristics of a good##2##4##(2008-11#2)
characteristics of a model##2##4##(2008-9#1)(2013-8#1)
characteristics of a novel##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
characteristics of a recently discovered group of diseases]##2##8##(1990-3#2)
characteristics of a system##2##4##(2008-10#1)(2008-9#1)
characteristics of a##71##3##(1990-11#1)(1990-3#2)(1990-8#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-3#2)(1994-5#1)(2007-10#1)(2007-11#6)(2007-12#4)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
characteristics of abnormal micro-lesions##2##4##(2012-2#2)
characteristics of acute##2##3##(1991-3#1)(2010-6#1)
characteristics of adults##2##3##(1993-2#1)(2008-8#1)
characteristics of amino acids and nucleic acids##2##7##(2008-2#2)
characteristics of an##15##3##(1990-12#2)(1992-8#1)(1993-3#1)(1995-2#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2010-3#1)
characteristics of apoptosis##3##3##(1992-9#1)(1995-12#1)(2008-7#1)
characteristics of both##4##3##(1996-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
characteristics of cell##2##3##(2008-9#1)(2012-1#1)
characteristics of cells##2##3##(2008-11#1)(2013-8#1)
characteristics of children##3##3##(2006-10#1)(2013-1#2)
characteristics of common detergents##2##4##(2008-2#2)
characteristics of composite##2##3##(1990-5#1)(2008-3#1)
characteristics of conventional##2##3##(2008-5#1)(2010-6#1)
characteristics of different##5##3##(1997-8#1)(2008-7#2)(2008-8#1)(2012-3#1)
characteristics of dry##2##3##(1997-2#1)(2008-9#1)
characteristics of dye-doped##2##3##(2007-11#1)(2008-3#1)
characteristics of each##9##3##(1991-12#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-8#1)
characteristics of early##2##3##(2011-2#1)(2013-8#1)
characteristics of enzyme##2##3##(2008-10#1)(2013-1#1)
characteristics of family##2##3##(1992-1#1)(2009-10#1)
characteristics of four##2##3##(2008-2#1)(2008-7#1)
characteristics of human##9##3##(1992-8#1)(1993-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
characteristics of individual patients##2##4##(1996-7#1)(2008-2#1)
characteristics of individual##3##3##(1996-7#1)(2008-2#1)(2008-4#1)
characteristics of individuals with##3##4##(2010-4#3)
characteristics of individuals##4##3##(2008-7#1)(2010-4#3)
characteristics of long-period##2##3##(2007-11#1)(2008-3#1)
characteristics of male##3##3##(1997-7#1)(2008-12#1)(2009-5#1)
characteristics of meat##2##3##(2010-4#2)
characteristics of men who have sex with men##2##8##(2011-1#2)
characteristics of metabolic##2##3##(1991-6#1)(2008-11#1)
characteristics of microcosmic and photosensitive damage on space structure of##2##10##(2008-8#2)
characteristics of native##2##3##(1994-5#1)(2008-10#1)
characteristics of one##2##3##(2008-10#1)(2013-8#1)
characteristics of our##2##3##(1996-3#1)(1997-2#1)
characteristics of patients and##2##4##(1991-1#1)(2010-10#1)
characteristics of patients hospitalized##2##4##(2012-12#2)
characteristics of patients with##3##4##(2007-10#1)(2008-8#1)(2012-12#1)
characteristics of patients##9##3##(1991-1#1)(2007-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#3)
characteristics of persons##2##3##(1995-6#1)(2011-2#1)
characteristics of plant##2##3##(2008-8#1)(2013-8#1)
characteristics of proteins##3##3##(1997-2#1)(1997-3#1)(2012-1#1)
characteristics of recombinant##2##3##(2008-11#2)
characteristics of several##7##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
characteristics of some##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
characteristics of tellurite-based erbium-doped fiber amplifiers##2##6##(2007-12#2)
characteristics of the &quot##2##4##(1993-11#1)(1996-9#1)
characteristics of the aerosol##2##4##(1992-3#1)(2008-10#1)
characteristics of the cardiovascular system##2##5##(2008-10#2)
characteristics of the chemical##2##4##(2008-10#1)(2008-3#1)
characteristics of the disease##2##4##(2008-10#1)(2008-7#1)
characteristics of the electrode##3##4##(2008-10#3)
characteristics of the health##2##4##(1993-12#1)(2008-12#1)
characteristics of the inclusion##2##4##(2008-10#2)
characteristics of the individual##3##4##(1994-12#1)(2008-2#1)(2009-7#1)
characteristics of the laser radiation##2##5##(2008-10#1)(2008-2#1)
characteristics of the laser##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
characteristics of the method##3##4##(2008-10#2)(2008-5#1)
characteristics of the predicted stimulus##2##5##(2013-8#2)
characteristics of the proposed##3##4##(2007-11#1)(2008-10#1)(2012-3#1)
characteristics of the protein##2##4##(1990-8#1)(1994-8#1)
characteristics of the service##2##4##(1992-12#1)(1993-12#1)
characteristics of the skin##2##4##(2008-3#2)
characteristics of the subjects##2##4##(1991-2#1)(2008-5#1)
characteristics of the##246##3##(1990-3#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#9)(2007-12#12)(2007-8#2)(2008-1#2)(2008-10#61)(2008-11#13)(2008-12#1)(2008-2#12)(2008-3#23)(2008-4#2)(2008-5#8)(2008-7#8)(2008-8#6)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
characteristics of their##4##3##(1997-4#1)(2010-3#1)(2011-1#1)(2013-1#1)
characteristics of these organizations##2##4##(1992-12#1)(1996-3#1)
characteristics of these##17##3##(1992-12#1)(1993-11#1)(1994-12#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)
characteristics of this system##2##4##(2008-10#1)(2008-3#1)
characteristics of this##24##3##(1990-3#1)(1996-2#1)(2006-12#1)(2007-11#2)(2008-10#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
characteristics of those##2##3##(2008-6#1)(2010-8#1)
characteristics of two##2##3##(1995-5#1)(2008-3#1)
characteristics of various##2##3##(2008-10#1)(2008-2#1)
characteristics of viral quasispecies##3##4##(2013-8#3)
characteristics of##856##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#6)(1990-5#2)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-6#5)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#3)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#4)(1994-7#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#6)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#7)(2007-11#24)(2007-12#25)(2007-7#4)(2007-8#7)(2008-1#6)(2008-10#134)(2008-11#34)(2008-12#8)(2008-2#56)(2008-3#79)(2008-4#12)(2008-5#18)(2008-6#4)(2008-7#30)(2008-8#20)(2008-9#17)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-3#5)(2010-4#9)(2010-6#5)(2010-7#2)(2010-8#3)(2011-1#11)(2011-2#33)(2011-3#3)(2012-1#3)(2012-12#9)(2012-2#11)(2012-3#9)(2013-1#23)(2013-7#6)(2013-8#27)
characteristics on the##3##3##(2008-3#1)(2008-9#1)(2010-6#1)
characteristics on##12##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#2)
characteristics or##3##2##(2008-10#1)(2008-12#1)(2010-6#1)
characteristics over##2##2##(1994-9#1)(2007-12#1)
characteristics regarding##2##2##(1992-6#1)(2008-5#1)
characteristics related to##2##3##(2011-2#1)(2013-7#1)
characteristics related##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
characteristics show##2##2##(2007-12#1)(2008-10#1)
characteristics similar to those##3##4##(1997-7#1)(2007-11#1)(2008-10#1)
characteristics similar to##4##3##(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)
characteristics such as sensitivity##2##4##(2008-10#2)
characteristics such as the##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
characteristics such as##23##3##(1991-12#1)(1991-5#1)(1993-12#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)
characteristics suggest that##2##3##(2008-10#1)(2011-2#1)
characteristics suggest##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
characteristics suitable for##2##3##(2008-3#1)(2009-7#1)
characteristics than the##2##3##(2008-2#2)
characteristics than##6##2##(1992-3#1)(2008-2#2)(2009-2#1)(2009-7#1)(2013-8#1)
characteristics that are##9##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)
characteristics that can be##2##4##(2008-10#1)(2013-1#1)
characteristics that can##3##3##(2008-10#2)(2013-1#1)
characteristics that distinguish##2##3##(1996-3#1)(2008-7#1)
characteristics that make##2##3##(1996-12#1)(2008-3#1)
characteristics that##33##2##(1993-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
characteristics the##2##2##(1995-3#1)(2010-4#1)
characteristics to be##2##3##(2008-3#1)(2009-3#1)
characteristics to the##3##3##(1993-8#1)(1994-3#1)(2007-5#1)
characteristics to##12##2##(1991-2#1)(1993-8#1)(1994-3#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-4#1)
characteristics typical of##3##3##(1990-5#1)(1995-8#1)(2007-12#1)
characteristics was##12##2##(1990-2#2)(1994-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-12#2)
characteristics were examined##3##3##(1990-3#1)(1994-1#1)(2008-10#1)
characteristics were found##2##3##(1993-12#1)(2008-2#1)
characteristics were investigated in##2##4##(1995-11#1)(2011-2#1)
characteristics were measured##2##3##(2008-12#1)(2010-8#1)
characteristics were not##4##3##(1991-3#1)(2008-12#1)(2008-7#1)(2011-2#1)
characteristics were obtained##5##3##(2008-10#4)(2011-2#1)
characteristics were related to##2##4##(2008-7#1)(2009-7#1)
characteristics were studied##9##3##(1991-12#1)(2008-10#6)(2010-11#1)(2010-4#1)
characteristics were used##2##3##(2008-10#2)
characteristics were##50##2##(1990-3#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-1#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
characteristics when compared with##2##4##(2008-10#2)
characteristics when##5##2##(2008-10#3)(2008-9#1)(2010-3#1)
characteristics which##3##2##(1996-11#1)(2008-2#1)(2013-7#1)
characteristics with##10##2##(1991-6#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-7#2)(2012-2#1)
characteristics within the##4##3##(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
characteristics within##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
characteristics##1844##1##(1990-10#3)(1990-11#7)(1990-12#4)(1990-2#5)(1990-3#9)(1990-5#4)(1990-6#1)(1990-8#6)(1990-9#5)(1991-1#2)(1991-11#2)(1991-12#12)(1991-2#5)(1991-3#10)(1991-5#4)(1991-6#8)(1991-8#6)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#9)(1992-2#6)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#7)(1992-9#4)(1993-1#2)(1993-11#5)(1993-12#9)(1993-2#7)(1993-3#6)(1993-6#3)(1993-8#3)(1994-1#5)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#7)(1994-5#5)(1994-7#2)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#11)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#5)(1995-6#2)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#11)(1996-3#7)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#10)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#3)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#14)(2007-11#40)(2007-12#46)(2007-4#2)(2007-5#2)(2007-7#11)(2007-8#11)(2008-1#12)(2008-10#319)(2008-11#64)(2008-12#27)(2008-2#94)(2008-3#141)(2008-4#16)(2008-5#61)(2008-6#17)(2008-7#58)(2008-8#47)(2008-9#36)(2009-10#7)(2009-11#1)(2009-12#5)(2009-2#4)(2009-3#4)(2009-4#14)(2009-5#9)(2009-6#3)(2009-7#15)(2009-8#4)(2009-9#7)(2010-1#4)(2010-10#5)(2010-11#7)(2010-12#8)(2010-2#4)(2010-3#15)(2010-4#21)(2010-5#1)(2010-6#15)(2010-7#9)(2010-8#14)(2010-9#3)(2011-1#26)(2011-2#81)(2011-3#3)(2012-1#6)(2012-12#19)(2012-2#30)(2012-3#23)(2012-4#1)(2012-9#1)(2013-1#46)(2013-7#11)(2013-8#52)
characteristics]##3##1##(1990-5#1)(2010-12#1)(2012-3#1)
characterization and application of a##2##5##(2008-11#2)
characterization and application##3##3##(2008-10#1)(2008-11#2)
characterization and differentiation of small-spored Alternaria spp##2##7##(2008-10#2)
characterization and expression of##2##4##(1992-9#1)(1994-12#1)
characterization and identification of##2##4##(1997-7#1)(2008-7#1)
characterization and isolation of##2##4##(1993-5#1)(2010-11#1)
characterization and##53##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-12#2)(1995-11#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
characterization based on##2##3##(2008-5#1)(2012-2#1)
characterization by##13##2##(1990-2#1)(1994-12#1)(2006-12#1)(2007-11#2)(2008-10#4)(2008-11#1)(2009-7#1)(2010-12#1)(2010-4#1)
characterization from##3##2##(1990-11#1)(1993-5#1)(2008-3#1)
characterization has##2##2##(2008-3#1)(2008-7#1)
characterization in a##2##3##(2007-11#1)(2008-3#1)
characterization in##6##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
characterization is presented##2##3##(1993-11#1)(2007-11#1)
characterization is##7##2##(1993-11#1)(2007-11#2)(2008-10#1)(2008-3#2)(2011-2#1)
characterization measurements##3##2##(2008-2#1)(2008-3#2)
characterization methods##3##2##(2008-1#1)(2008-3#1)(2009-8#1)
characterization of Cryptococcus neoformans var##2##5##(2008-5#2)
characterization of S##2##3##(1997-3#1)(2008-10#1)
characterization of a gene##2##4##(1993-12#1)(2012-3#1)
characterization of a new##10##4##(1992-9#1)(2008-10#6)(2008-8#1)(2009-10#1)(2011-2#1)
characterization of a novel##13##4##(1990-12#1)(1990-7#1)(1993-11#1)(1993-2#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-8#1)(2008-9#1)
characterization of a protein##2##4##(1993-3#1)(2008-4#1)
characterization of a##110##3##(1990-11#1)(1990-12#3)(1990-2#3)(1990-7#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
characterization of an endogenous##2##4##(1992-8#1)(1996-12#1)
characterization of an##13##3##(1991-9#1)(1992-8#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-3#2)(2009-5#1)
characterization of angiotensin##2##3##(1990-11#1)(1991-12#1)
characterization of biological##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-9#1)
characterization of both##2##3##(2008-10#1)(2008-3#1)
characterization of brain##2##3##(2008-7#1)(2009-7#1)
characterization of cell##2##3##(1994-8#1)(2008-11#1)
characterization of each##3##3##(1990-2#1)(1993-8#1)(2007-12#1)
characterization of extreme-ultraviolet##2##3##(2008-3#2)
characterization of femtosecond##3##3##(2007-11#2)(2007-12#1)
characterization of fiber##2##3##(2007-12#1)(2008-3#1)
characterization of five##2##3##(2008-6#1)(2008-8#1)
characterization of focal liver lesions##4##5##(2008-7#2)(2010-12#2)
characterization of human##8##3##(1991-6#1)(1994-6#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
characterization of individual##2##3##(2007-12#1)(2008-10#1)
characterization of isolates of##2##4##(1997-3#2)
characterization of isolates##4##3##(1997-3#2)(2008-10#2)
characterization of its##2##3##(2008-10#2)
characterization of molecular##2##3##(1994-3#1)(2008-10#1)
characterization of monoclonal antibodies against##2##5##(2008-8#2)
characterization of motifs##2##3##(2008-4#2)
characterization of new##5##3##(1990-7#1)(1993-12#1)(1995-5#1)(2008-10#1)(2010-4#1)
characterization of nonabsorbing and weakly absorbing thin films##2##8##(2008-3#2)
characterization of nuclear##3##3##(1990-7#1)(1991-2#1)(2008-9#1)
characterization of optical##4##3##(2008-2#2)(2008-3#2)
characterization of phospholipase##2##3##(1993-3#1)(2013-1#1)
characterization of plasmid DNA##2##4##(2008-10#2)
characterization of polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
characterization of proteins##2##3##(2008-1#1)(2010-12#1)
characterization of pulses from a##2##5##(2007-12#2)
characterization of pulses##3##3##(2007-12#3)
characterization of receptor##2##3##(1990-12#1)(2008-5#1)
characterization of recombinant human##2##4##(1990-8#1)(1995-6#1)
characterization of recombinant##7##3##(1990-8#2)(1991-9#1)(1995-11#1)(1995-6#1)(2008-4#1)(2012-3#1)
characterization of samples##2##3##(2007-11#1)(2008-10#1)
characterization of scattering##3##3##(2008-3#3)
characterization of spatial coherence##2##4##(2008-3#2)
characterization of spatial##3##3##(2008-3#3)
characterization of stem cells##2##4##(2012-1#2)
characterization of the gene encoding##4##5##(1992-12#1)(1993-2#1)(1994-12#1)(1995-8#1)
characterization of the human##2##4##(1991-5#1)(1995-11#1)
characterization of the promoter region of##2##6##(1993-3#1)(1997-7#1)
characterization of the promoter region##3##5##(1993-3#1)(1994-12#1)(1997-7#1)
characterization of the rat##4##4##(1993-3#1)(1993-8#1)(1994-2#1)(1996-2#1)
characterization of the##144##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#2)(1995-6#1)(1995-8#4)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-10#26)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
characterization of their##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
characterization of these changes##2##4##(2008-8#1)(2011-2#1)
characterization of these mutants##2##4##(2008-10#2)
characterization of these##14##3##(1990-5#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#2)(2013-8#1)
characterization of this##3##3##(2008-10#3)
characterization of three##5##3##(1992-8#1)(1993-3#1)(2007-12#1)(2008-1#1)(2009-6#1)
characterization of two new##2##4##(1992-2#1)(1996-2#1)
characterization of two##9##3##(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
characterization of##722##2##(1990-11#6)(1990-12#7)(1990-2#5)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#5)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#4)(1991-9#6)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-6#5)(1992-8#6)(1992-9#4)(1993-11#9)(1993-12#6)(1993-2#5)(1993-3#8)(1993-5#3)(1993-6#1)(1993-8#6)(1993-9#1)(1994-11#2)(1994-12#9)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#7)(1994-8#6)(1994-9#2)(1995-11#6)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#6)(1996-12#3)(1996-2#5)(1996-5#3)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#9)(1997-6#1)(1997-7#4)(1997-8#3)(2007-10#1)(2007-11#14)(2007-12#34)(2007-7#1)(2008-1#4)(2008-10#140)(2008-11#14)(2008-12#2)(2008-2#16)(2008-3#64)(2008-4#31)(2008-5#14)(2008-6#3)(2008-7#9)(2008-8#20)(2008-9#15)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#12)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#9)
characterization revealed that##2##3##(1995-6#1)(2008-10#1)
characterization shows##2##2##(1992-5#1)(2008-3#1)
characterization studies of##2##3##(2008-10#1)(2012-3#1)
characterization studies##4##2##(2008-10#3)(2012-3#1)
characterization tool for##2##3##(2008-10#1)(2008-2#1)
characterization using a##2##3##(1992-6#1)(2008-10#1)
characterization using##4##2##(1992-6#1)(1995-11#1)(2008-10#2)
characterization when##2##2##(1994-9#1)(2008-3#1)
characterization with##2##2##(2007-12#1)(2008-10#1)
characterization##940##1##(1990-11#8)(1990-12#7)(1990-2#9)(1990-5#8)(1990-6#1)(1990-7#8)(1990-8#6)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#5)(1991-9#6)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#7)(1992-8#6)(1992-9#5)(1993-11#11)(1993-12#6)(1993-2#5)(1993-3#8)(1993-5#5)(1993-6#1)(1993-8#7)(1993-9#1)(1994-11#3)(1994-12#12)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#7)(1994-8#6)(1994-9#5)(1995-11#8)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#6)(1996-12#4)(1996-2#5)(1996-5#4)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#10)(1997-6#2)(1997-7#5)(1997-8#3)(2006-12#1)(2007-10#3)(2007-11#25)(2007-12#36)(2007-7#1)(2008-1#6)(2008-10#189)(2008-11#22)(2008-12#2)(2008-2#23)(2008-3#90)(2008-4#36)(2008-5#20)(2008-6#3)(2008-7#14)(2008-8#23)(2008-9#16)(2009-10#2)(2009-11#6)(2009-2#3)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#6)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#12)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#17)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#8)(2013-1#16)(2013-7#2)(2013-8#14)
characterizations of the##4##3##(2007-11#1)(2008-2#1)(2008-9#2)
characterizations of##12##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#2)(2010-7#1)(2011-1#1)(2013-8#2)
characterizations##19##1##(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-7#1)(2013-8#2)
characterize a number of##2##4##(2008-2#1)(2011-2#1)
characterize a##9##2##(1992-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)
characterize and##12##2##(1996-12#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
characterize its##2##2##(1990-2#1)(2012-2#1)
characterize output##2##2##(1995-2#1)(2008-4#1)
characterize pathogenic##3##2##(2008-10#3)
characterize populations of##2##3##(2008-10#2)
characterize the effects of##5##4##(1990-7#1)(1994-2#1)(2008-10#2)(2008-11#1)
characterize the interaction of##2##4##(1991-5#1)(2012-2#1)
characterize the interaction##3##3##(1991-5#1)(2009-6#1)(2012-2#1)
characterize the most##2##3##(2008-3#1)(2012-12#1)
characterize the performance of a##2##5##(2008-2#1)(2008-9#1)
characterize the performance of##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
characterize the population##3##3##(2008-10#1)(2011-2#2)
characterize the shape of##2##4##(2008-3#1)(2008-7#1)
characterize the shape##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
characterize the sorption##2##3##(2008-10#2)
characterize the structure of##2##4##(1995-6#1)(2008-10#1)
characterize the structure##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
characterize the surface##3##3##(2008-3#3)
characterize the##189##2##(1990-5#1)(1990-7#2)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-5#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(2007-11#6)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#42)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#24)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
characterize their##8##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)
characterize these##10##2##(1993-1#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-9#1)(2012-12#1)
characterize this process##2##3##(2008-7#1)(2009-8#1)
characterize this##9##2##(1991-9#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
characterize##390##1##(1990-2#1)(1990-5#1)(1990-7#2)(1991-5#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#3)(1993-3#2)(1993-8#3)(1994-11#2)(1994-2#4)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#4)(2007-11#9)(2007-12#16)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#84)(2008-11#17)(2008-12#4)(2008-2#12)(2008-3#38)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#16)(2008-8#3)(2008-9#5)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#6)
characterized a##19##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#2)(1995-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
characterized according to##2##3##(2008-8#1)(2012-3#1)
characterized after##3##2##(2007-6#1)(2008-10#1)(2011-1#1)
characterized an##3##2##(1996-9#1)(2008-10#1)(2009-8#1)
characterized and compared##3##3##(1992-11#1)(2008-10#1)(2011-2#1)
characterized and developed##2##3##(2008-10#2)
characterized and evaluated for##2##4##(2008-10#1)(2008-11#1)
characterized and found to be##2##5##(1993-9#1)(1997-4#1)
characterized and found to##3##4##(1993-9#1)(1997-4#1)(2012-2#1)
characterized and optimized to##2##4##(2008-10#2)
characterized and optimized##3##3##(2007-12#1)(2008-10#2)
characterized and used for##2##4##(1995-12#1)(2008-10#1)
characterized and##32##2##(1992-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
characterized as a##16##3##(1991-12#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-3#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
characterized as being##2##3##(2008-10#1)(2008-9#1)
characterized as the##5##3##(1990-9#1)(1991-5#1)(1995-2#1)(2008-2#1)(2009-10#1)
characterized as##52##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-2#2)(1995-3#2)(1996-11#1)(1996-2#1)(1997-3#2)(1997-7#1)(2007-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
characterized at the genomic level##2##5##(1991-12#1)(2008-10#1)
characterized at the##5##3##(1991-12#1)(1991-8#1)(2008-10#2)(2008-3#1)
characterized at##10##2##(1990-6#1)(1991-12#1)(1991-8#1)(1994-5#1)(1995-2#1)(2008-10#4)(2008-3#1)
characterized before##2##2##(1992-8#1)(2008-2#1)
characterized both##4##2##(1997-6#1)(1997-7#1)(2010-7#1)(2012-2#1)
characterized by FT-IR spectroscopy##2##4##(2008-10#2)
characterized by FT-IR##4##3##(2008-10#4)
characterized by FTIR##2##3##(2008-10#1)(2008-5#1)
characterized by Fourier transform infrared spectroscopy##2##6##(2008-10#1)(2008-5#1)
characterized by Fourier transform infrared##3##5##(2008-10#2)(2008-5#1)
characterized by IR##5##3##(2008-10#4)(2008-5#1)
characterized by Southern##2##3##(1994-12#1)(2008-10#1)
characterized by UV##4##3##(1990-7#2)(1996-5#1)(2008-2#1)
characterized by UV-vis##2##3##(2008-10#2)
characterized by X-ray diffraction (XRD)##2##5##(2008-10#2)
characterized by X-ray diffraction##3##4##(1994-5#1)(2008-10#2)
characterized by X-ray powder diffraction##2##5##(2011-3#1)(2012-2#1)
characterized by X-ray##8##3##(1994-5#1)(1996-2#1)(2008-10#4)(2011-3#1)(2012-2#1)
characterized by a combination of##2##5##(2008-5#1)(2012-2#1)
characterized by a different##3##4##(1991-2#2)(2008-12#1)
characterized by a high##5##4##(1995-8#1)(2008-1#1)(2010-3#2)(2010-8#1)
characterized by a progressive##4##4##(1991-2#1)(2008-8#1)(2010-10#1)(2013-8#1)
characterized by a single##2##4##(1992-8#1)(2007-11#1)
characterized by a stochastic##2##4##(2008-6#1)(2008-7#1)
characterized by a variety of##2##5##(2008-1#1)(2008-10#1)
characterized by a##103##3##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#3)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#3)
characterized by abnormal##2##3##(2009-8#1)(2011-2#1)
characterized by absent##2##3##(2011-1#1)(2013-1#1)
characterized by accumulation of##3##4##(2007-7#1)(2010-10#1)(2010-7#1)
characterized by an##28##3##(1990-5#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-2#1)(2012-1#2)(2013-8#1)
characterized by bilateral##2##3##(2009-3#1)(2010-9#1)
characterized by both##2##3##(1990-5#1)(2013-1#1)
characterized by central##2##3##(2008-10#2)
characterized by chronic##3##3##(1991-11#1)(2008-5#1)(2008-7#1)
characterized by clinical##2##3##(2012-12#1)(2013-1#1)
characterized by decreased##2##3##(2010-3#1)(2012-2#1)
characterized by different##6##3##(1992-8#1)(2008-2#1)(2008-4#1)(2008-5#2)(2012-3#1)
characterized by distinct##2##3##(2008-10#2)
characterized by either##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
characterized by elemental analysis##7##4##(1996-2#2)(2008-10#5)
characterized by elemental##8##3##(1996-2#2)(2008-10#5)(2008-5#1)
characterized by elevated##2##3##(1994-5#1)(2011-2#1)
characterized by excessive##2##3##(2007-11#1)(2008-4#1)
characterized by fever##2##3##(1994-9#1)(2009-11#1)
characterized by five##2##3##(2008-10#1)(2008-3#1)
characterized by having##2##3##(1994-2#1)(2008-5#1)
characterized by high##13##3##(1990-11#1)(1995-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-5#1)(2012-3#1)(2013-1#2)
characterized by higher##2##3##(1990-2#1)(2011-2#1)
characterized by highly##3##3##(1990-11#1)(2007-12#1)(2008-7#1)
characterized by impaired##2##3##(2008-11#1)(2012-2#1)
characterized by impairments in##2##4##(2011-2#1)(2012-2#1)
characterized by increased##5##3##(1994-5#1)(2008-5#1)(2010-5#2)(2010-6#1)
characterized by increasing##2##3##(1993-12#1)(2009-10#1)
characterized by inflammatory##3##3##(2008-4#1)(2010-12#1)(2012-2#1)
characterized by infrared##3##3##(2008-10#2)(2008-5#1)
characterized by insulin resistance##3##4##(2010-11#1)(2012-12#1)(2013-1#1)
characterized by intense##2##3##(2008-5#2)
characterized by irregular##2##3##(2008-7#1)(2009-7#1)
characterized by its##13##3##(1990-2#1)(1994-9#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
characterized by large##3##3##(1994-5#1)(1997-6#1)(2007-7#1)
characterized by limited##2##3##(2007-11#1)(2008-10#1)
characterized by loss of##3##4##(1996-3#1)(1997-1#1)(2011-1#1)
characterized by low##6##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-1#1)
characterized by marked##2##3##(1991-11#1)(1997-6#1)
characterized by means of##8##4##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-8#1)
characterized by measuring##2##3##(2008-2#1)(2009-6#1)
characterized by multiple##2##3##(2007-4#1)(2008-7#1)
characterized by pathogenicity##4##3##(2008-10#4)
characterized by positive##2##3##(2008-10#1)(2012-2#1)
characterized by progressive##6##3##(2008-4#3)(2008-7#1)(2010-5#1)(2013-7#1)
characterized by recurrent##7##3##(1990-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
characterized by recurring##2##3##(1991-3#1)(2008-10#1)
characterized by reduced##2##3##(2008-7#1)(2010-10#1)
characterized by scanning electron microscopy (SEM)##2##6##(2008-10#1)(2009-7#1)
characterized by sequence analysis and##2##5##(1993-12#1)(1993-2#1)
characterized by severe##3##3##(1997-3#1)(2008-7#1)(2010-11#1)
characterized by single##2##3##(2007-11#1)(2008-10#1)
characterized by small##2##3##(2008-10#1)(2010-8#1)
characterized by spectroscopic##2##3##(1996-2#1)(2008-2#1)
characterized by spontaneous##2##3##(2008-9#1)(2012-3#1)
characterized by the absence of##2##5##(2007-12#1)(2008-7#1)
characterized by the development##2##4##(2008-4#1)(2010-6#1)
characterized by the formation##3##4##(1992-12#1)(2010-6#1)(2012-12#1)
characterized by the impairment of##2##5##(1995-8#1)(2008-7#1)
characterized by the presence of a##2##6##(1992-12#1)(2008-5#1)
characterized by the presence of##12##5##(1990-5#1)(1992-12#1)(1994-5#1)(2006-10#1)(2008-10#3)(2008-5#1)(2010-6#3)(2012-12#1)
characterized by the presence##13##4##(1990-5#1)(1992-12#1)(1993-2#1)(1994-5#1)(2006-10#1)(2008-10#3)(2008-5#1)(2010-6#3)(2012-12#1)
characterized by the production of##2##5##(1994-8#1)(2008-10#1)
characterized by the progressive##2##4##(2008-4#1)(2009-10#1)
characterized by the##72##3##(1990-5#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-2#1)(1994-12#1)(1994-5#2)(1994-8#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-6#7)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
characterized by their##9##3##(1992-3#1)(1994-9#2)(2007-11#1)(2008-10#3)(2008-3#1)(2010-10#1)
characterized by three##3##3##(1992-1#1)(2008-2#1)(2008-7#1)
characterized by two##4##3##(1997-7#1)(2008-10#1)(2012-3#1)(2013-1#1)
characterized by use of##6##4##(2007-11#1)(2007-12#1)(2008-3#3)(2013-1#1)
characterized by using##9##3##(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-9#2)(2011-2#1)
characterized by various##6##3##(2008-10#5)(2012-3#1)
characterized by vegetative compatibility##2##4##(2008-10#2)
characterized by very##2##3##(1994-11#1)(2008-11#1)
characterized by wide##2##3##(2008-3#1)(2008-7#1)
characterized by##767##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#5)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#5)(1992-3#4)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#8)(1994-8#4)(1994-9#5)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#3)(1996-2#9)(1996-3#2)(1996-4#1)(1996-5#3)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(2006-10#5)(2007-10#3)(2007-11#13)(2007-12#14)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#13)(2008-10#154)(2008-11#8)(2008-12#13)(2008-2#17)(2008-3#30)(2008-4#13)(2008-5#31)(2008-6#5)(2008-7#31)(2008-8#12)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#4)(2009-6#2)(2009-7#10)(2009-8#7)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#8)(2010-6#12)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#31)(2011-3#2)(2012-1#6)(2012-12#16)(2012-2#16)(2012-3#13)(2013-1#25)(2013-7#4)(2013-8#11)
characterized extensively##2##2##(1997-2#1)(2008-7#1)
characterized first##3##2##(1990-9#1)(1994-11#1)(2008-5#1)
characterized for mating type##2##4##(2008-10#2)
characterized for their##2##3##(2008-10#2)
characterized for##24##2##(1992-9#2)(1993-6#1)(1995-11#1)(2008-10#13)(2008-2#1)(2008-3#1)(2009-8#1)(2010-4#1)(2012-2#2)(2013-8#1)
characterized four##3##2##(1990-5#1)(1991-8#1)(2008-10#1)
characterized from a##2##3##(2007-10#1)(2008-11#1)
characterized from other##2##3##(1992-3#1)(1992-6#1)
characterized from the##4##3##(1992-6#1)(1992-8#1)(1997-6#1)(2008-10#1)
characterized from##12##2##(1992-3#1)(1992-6#2)(1992-8#1)(1995-6#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-8#2)
characterized genes##2##2##(1997-6#1)(2008-10#1)
characterized here##2##2##(2008-10#2)
characterized human##2##2##(2009-12#1)(2012-2#1)
characterized in a##3##3##(1993-2#1)(2008-10#1)(2012-12#1)
characterized in detail##2##3##(2008-10#1)(2008-2#1)
characterized in order to##3##4##(1992-3#1)(1993-11#2)
characterized in situ##2##3##(2007-11#1)(2008-10#1)
characterized in terms of particle size##2##6##(2008-2#1)(2008-5#1)
characterized in terms of##8##4##(1990-11#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
characterized in the##6##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-7#2)(2009-8#1)
characterized in vitro##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
characterized in##51##2##(1990-11#2)(1991-7#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
characterized its##3##2##(1991-6#1)(2007-11#1)(2008-11#1)
characterized mainly by##2##3##(2008-7#1)(2011-1#1)
characterized mainly##3##2##(2008-7#2)(2011-1#1)
characterized of##2##2##(1995-8#1)(2011-3#1)
characterized on the basis of elemental analysis and##2##8##(2008-10#1)(2010-3#1)
characterized on the basis of##6##5##(2008-10#4)(2010-3#2)
characterized on##9##2##(1992-6#1)(1994-6#1)(2008-10#4)(2010-3#2)(2013-1#1)
characterized over##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
characterized plant##2##2##(1995-6#1)(2008-10#1)
characterized previously##4##2##(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#1)
characterized primarily by##3##3##(2008-10#2)(2008-7#1)
characterized species##2##2##(1997-4#1)(2013-7#1)
characterized that##2##2##(1995-6#1)(2008-3#1)
characterized the gene expression##2##4##(1995-2#1)(2010-11#1)
characterized the##41##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-11#2)(2008-4#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
characterized their##2##2##(1994-11#1)(2008-3#1)
characterized through##4##2##(1995-12#1)(2008-10#2)(2008-5#1)
characterized to date##3##3##(1992-3#1)(1997-9#1)(2008-4#1)
characterized to##8##2##(1992-3#1)(1994-5#1)(1997-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-3#1)(2012-12#1)
characterized two##3##2##(1993-8#1)(1993-9#1)(1997-8#1)
characterized using a##5##3##(2008-10#3)(2008-6#1)(2009-12#1)
characterized using infrared##2##3##(2008-10#1)(2008-5#1)
characterized using the##2##3##(1993-6#1)(2009-10#1)
characterized using##40##2##(1991-9#1)(1993-6#1)(1994-5#1)(2008-10#23)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
characterized viruses##2##2##(2008-10#2)
characterized were##2##2##(1992-6#1)(2008-10#1)
characterized with amplified fragment length polymorphism##2##6##(2008-10#2)
characterized with high##2##3##(2008-10#1)(2008-5#1)
characterized with regard to##2##4##(1990-8#1)(2008-2#1)
characterized with respect to##5##4##(1996-2#1)(2008-10#3)(2008-11#1)
characterized with the##4##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
characterized with##27##2##(1990-8#1)(1994-12#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2013-1#1)
characterized##1401##1##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#11)(1990-6#1)(1990-7#7)(1990-8#3)(1990-9#3)(1991-11#4)(1991-12#6)(1991-2#9)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#8)(1992-1#1)(1992-11#3)(1992-12#9)(1992-3#11)(1992-6#9)(1992-8#6)(1992-9#6)(1993-1#1)(1993-11#10)(1993-12#3)(1993-2#3)(1993-3#8)(1993-6#4)(1993-8#6)(1993-9#4)(1994-11#7)(1994-12#13)(1994-2#3)(1994-3#2)(1994-5#14)(1994-6#2)(1994-8#9)(1994-9#5)(1995-11#5)(1995-12#9)(1995-2#14)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#9)(1995-8#6)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#13)(1996-3#3)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-4#6)(1997-5#2)(1997-6#7)(1997-7#10)(1997-8#6)(1997-9#1)(2006-10#6)(2007-1#1)(2007-10#4)(2007-11#21)(2007-12#21)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#5)(2008-1#13)(2008-10#337)(2008-11#28)(2008-12#16)(2008-2#31)(2008-3#49)(2008-4#19)(2008-5#48)(2008-6#8)(2008-7#43)(2008-8#25)(2008-9#12)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#17)(2009-8#16)(2009-9#4)(2010-1#5)(2010-10#5)(2010-11#8)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#9)(2010-6#12)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#21)(2011-2#41)(2011-3#4)(2012-1#7)(2012-12#20)(2012-2#29)(2012-3#19)(2013-1#40)(2013-7#9)(2013-8#17)
characterizes the##17##2##(1993-12#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-9#1)(2009-11#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
characterizes##34##1##(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-5#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
characterizing a##3##2##(1994-2#1)(2008-3#1)(2010-12#1)
characterizing and##2##2##(2008-1#1)(2008-4#1)
characterizing both##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
characterizing disease##2##2##(2008-10#2)
characterizing interspecific associations##2##3##(2008-10#2)
characterizing large##2##2##(1995-11#1)(2008-3#1)
characterizing the sorption##2##3##(2008-10#2)
characterizing the##37##2##(1992-1#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
characterizing##102##1##(1992-1#1)(1992-12#1)(1992-3#2)(1993-11#1)(1994-11#1)(1994-2#1)(1995-11#3)(1995-2#1)(1995-6#1)(1996-12#2)(1996-5#1)(2007-11#1)(2007-12#8)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#1)
characters and##6##2##(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#2)(2011-2#1)
characters are##7##2##(1995-2#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-3#1)
characters for##2##2##(2008-10#2)
characters have##2##2##(2008-10#1)(2013-7#1)
characters in this##2##3##(1996-12#1)(2008-8#1)
characters in##8##2##(1995-2#2)(1996-12#1)(2007-12#1)(2007-7#1)(2008-8#2)(2011-2#1)
characters may##2##2##(2008-1#1)(2008-9#1)
characters of the##5##3##(1996-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2013-7#1)
characters of##9##2##(1996-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2013-7#1)(2013-8#1)
characters on the##3##3##(2008-11#1)(2008-6#1)(2010-3#1)
characters that##3##2##(2007-12#1)(2008-5#1)(2010-3#1)
characters were##2##2##(2008-8#1)(2009-9#1)
characters##102##1##(1995-2#6)(1995-6#1)(1996-12#2)(1996-6#1)(2007-1#1)(2007-12#6)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#18)(2008-9#5)(2009-8#1)(2009-9#1)(2010-3#5)(2010-6#2)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
characters'##3##1##(2008-11#3)
charantia##3##1##(2008-12#3)
charcoal adsorption method##2##3##(1990-12#2)
charcoal method##2##2##(1990-12#1)(1992-10#1)
charcoal##19##1##(1990-12#3)(1991-9#1)(1992-10#1)(2008-10#10)(2008-7#1)(2012-9#1)(2013-1#2)
charge (m/z)##2##2##(2008-10#2)
charge and the##4##3##(1991-6#1)(1996-6#1)(2008-10#1)(2008-9#1)
charge and##16##2##(1990-5#1)(1991-6#2)(1991-9#1)(1993-11#2)(1993-8#2)(1994-5#1)(1996-6#1)(1997-3#1)(2008-10#4)(2008-9#1)
charge at##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
charge between##2##2##(2009-8#1)(2010-5#1)
charge carriers##2##2##(2008-10#1)(2008-7#1)
charge coupled device##2##3##(2008-10#2)
charge densities##2##2##(1991-5#1)(2007-11#1)
charge density as##2##3##(2008-10#1)(2009-8#1)
charge density of the##2##4##(2008-10#2)
charge density of##7##3##(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-8#1)
charge density##22##2##(1991-5#2)(2007-12#1)(2008-10#7)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#3)
charge determination##2##2##(2008-4#1)(2009-12#1)
charge development##3##2##(2008-10#3)
charge distribution##9##2##(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-5#1)
charge for##3##2##(1991-11#1)(1994-9#1)(2008-9#1)
charge in##2##2##(2008-5#1)(2010-5#1)
charge increased##2##2##(2008-11#2)
charge interactions in##2##3##(2008-7#2)
charge is##5##2##(1990-8#1)(2007-11#3)(2008-4#1)
charge of a##2##3##(2008-4#1)(2010-1#1)
charge of the##12##3##(1990-5#1)(1991-2#1)(1992-8#1)(1994-3#1)(1994-9#2)(2007-12#1)(2008-10#4)(2008-7#1)
charge of##35##2##(1990-5#1)(1991-2#1)(1992-5#1)(1992-8#1)(1994-3#2)(1994-9#3)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#3)
charge on the membrane##2##4##(2010-5#2)
charge on the##6##3##(1995-5#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-5#2)
charge on##11##2##(1992-3#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-5#2)(1997-3#1)(2008-10#1)(2008-5#1)(2010-5#2)
charge or##2##2##(1996-12#1)(2008-10#1)
charge separation##3##2##(2008-8#2)(2011-2#1)
charge state##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
charge through##2##2##(1997-1#1)(2008-7#1)
charge transfer and##2##3##(2007-12#1)(2008-10#1)
charge transfer between##2##3##(2009-11#1)(2013-1#1)
charge transfer complex##4##3##(2008-10#4)
charge transfer complexes##2##3##(2008-10#2)
charge transfer in##3##3##(1991-9#2)(2008-10#1)
charge transfer##23##2##(1991-9#2)(1996-5#1)(2007-12#1)(2008-10#16)(2009-11#1)(2009-9#1)(2013-1#1)
charge transport in##2##3##(2007-11#1)(2008-7#1)
charge transport##6##2##(2007-11#1)(2008-10#2)(2008-7#3)
charge##269##1##(1990-12#2)(1990-5#3)(1990-8#3)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-9#3)(1992-3#5)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#5)(1995-11#1)(1995-2#1)(1995-5#4)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#12)(2007-12#7)(2008-1#1)(2008-10#76)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#5)(2009-8#5)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#4)(2010-6#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#2)(2013-1#10)(2013-8#1)
charge) and##3##2##(2009-12#2)(2011-2#1)
charge-based weights##2##2##(1993-1#2)
charge-coupled device (CCD) camera##2##4##(2008-1#1)(2008-3#1)
charge-coupled device (CCD)##6##3##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
charge-coupled device##10##2##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2012-2#1)
charge-coupled##12##1##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-2#1)
charge-coupled-device##3##1##(2008-3#3)
charge-density##3##1##(2006-4#3)
charge-transfer (CT)##2##2##(1997-7#1)(2007-11#1)
charge-transfer complexes and##3##3##(1996-5#1)(2008-10#2)
charge-transfer complexes##4##2##(1996-5#1)(2008-10#3)
charge-transfer##15##1##(1992-1#1)(1996-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#9)
charged CE-beta-CD##2##2##(2008-10#2)
charged amino acid pairs##2##4##(1995-2#2)
charged amino acid##3##3##(1995-2#2)(1996-10#1)
charged amino acids and##2##4##(1993-8#1)(1997-8#1)
charged amino acids##9##3##(1993-8#1)(1995-5#3)(1995-6#2)(1997-8#1)(2008-8#1)(2011-1#1)
charged amino##12##2##(1993-8#1)(1995-2#2)(1995-5#3)(1995-6#2)(1996-10#1)(1997-8#1)(2008-8#1)(2011-1#1)
charged by the##2##3##(1996-12#1)(2008-10#1)
charged by##4##2##(1995-1#1)(1996-12#1)(2008-10#1)(2009-10#1)
charged carriers##2##2##(2008-10#2)
charged chromoionophores##2##2##(2008-10#2)
charged complexes##5##2##(2008-10#5)
charged gold surfaces##2##3##(2008-10#2)
charged group##2##2##(1990-5#1)(1990-8#1)
charged ligands##3##2##(1997-2#2)(2008-10#1)
charged lipid##2##2##(2008-10#1)(2009-12#1)
charged lipids##8##2##(1996-8#2)(2009-12#2)(2010-5#4)
charged membrane into##2##3##(2008-7#2)
charged membrane##4##2##(2008-11#1)(2008-7#3)
charged nylon##2##2##(2008-11#2)
charged or##2##2##(2008-10#1)(2008-7#1)
charged proteins##2##2##(1994-9#1)(2011-2#1)
charged residue at position##2##4##(1992-6#1)(1992-8#1)
charged residue##4##2##(1992-6#1)(1992-8#1)(1995-6#1)(1997-7#1)
charged residues in the##3##4##(1994-9#1)(1995-2#1)(1997-9#1)
charged residues of human##2##4##(1995-6#2)
charged residues within the##2##4##(2008-8#1)(2011-1#1)
charged residues##17##2##(1990-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-7#2)(1997-8#2)(1997-9#1)(2008-8#2)(2011-1#3)
charged side##2##2##(1992-3#1)(2006-12#1)
charged surface##3##2##(1991-9#1)(2008-11#2)
charged surfaces##3##2##(1992-12#1)(2008-10#2)
charged that##4##2##(1995-12#2)(1995-6#2)
charged with criminal##2##3##(1992-1#1)(1996-5#1)
charged with the##3##3##(1994-12#1)(2008-12#1)(2012-3#1)
charged with##19##2##(1992-1#2)(1992-2#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-5#2)(1997-5#1)(2008-11#2)(2008-12#1)(2012-3#2)(2013-1#2)
charged##209##1##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-5#3)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-5#4)(1995-6#8)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#3)(1996-8#2)(1997-2#5)(1997-5#1)(1997-7#3)(1997-8#4)(1997-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#60)(2008-11#8)(2008-12#1)(2008-4#2)(2008-7#8)(2008-8#3)(2009-1#1)(2009-10#1)(2009-12#5)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-7#2)(2010-9#1)(2011-1#6)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
charged-surface##5##1##(2008-11#5)
charges and Medicare##2##3##(1991-12#1)(1991-2#1)
charges and##10##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1993-12#1)(1996-1#2)(2008-5#1)(2010-12#1)
charges are##2##2##(1992-1#1)(2008-11#1)
charges as##2##2##(1991-12#1)(2008-10#1)
charges for##3##2##(1991-1#2)(1992-1#1)
charges in##3##2##(1992-12#1)(2008-8#1)(2011-2#1)
charges of the##3##3##(1990-7#1)(2007-12#1)(2008-10#1)
charges of##11##2##(1990-7#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-4#1)
charges on the##2##3##(1992-8#1)(2008-10#1)
charges##86##1##(1990-12#1)(1990-7#2)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#2)(1992-8#1)(1993-1#2)(1993-12#6)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-5#1)(1997-6#1)(2007-11#7)(2007-12#3)(2008-10#10)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-12#4)(2010-7#1)(2011-2#1)
charging and##2##2##(2008-8#1)(2012-2#1)
charging currents##2##2##(2008-10#2)
charging##12##1##(1994-1#1)(1995-6#2)(2007-11#2)(2008-10#3)(2008-7#1)(2008-8#2)(2012-2#1)
charitable care##3##2##(2008-11#3)
charitable mission##2##2##(1995-2#1)(2008-11#1)
charitable nonprofits##2##2##(1992-12#1)(1994-2#1)
charitable organization##2##2##(1996-3#1)(2011-1#1)
charitable##17##1##(1992-12#1)(1992-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(1997-1#1)(2007-7#1)(2008-11#5)(2011-1#1)
charity care will##2##3##(1996-2#2)
charity care##11##2##(1992-3#3)(1996-2#4)(2008-11#4)
charity##21##1##(1992-2#1)(1992-3#4)(1993-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#5)(1996-3#2)(2008-11#5)
charred##2##1##(1992-12#1)(2012-9#1)
chart audits##2##2##(1994-3#1)(1995-2#1)
chart for##5##2##(1992-2#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-3#1)
chart of##2##2##(1993-9#1)(1995-1#1)
chart review was performed of##3##5##(2008-3#1)(2008-9#1)(2011-2#1)
chart review was##6##3##(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
chart review##18##2##(1991-12#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
chart the##2##2##(1993-2#1)(2011-1#1)
chart##54##1##(1991-12#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1997-3#1)(2007-10#2)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#2)(2008-9#3)(2009-10#1)(2010-10#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
chartarum##3##1##(2008-11#3)
charted##2##1##(2008-1#1)(2010-3#1)
charter##4##1##(1992-2#1)(1992-5#1)(2012-2#2)
charting##7##1##(1992-12#1)(1996-1#3)(1997-2#1)(2008-11#1)(2008-3#1)
charts and##4##2##(1993-3#1)(1994-1#1)(1995-3#1)(2007-12#1)
charts for##5##2##(1995-12#1)(1995-8#1)(2008-12#1)(2010-8#1)(2012-12#1)
charts of patients with##3##4##(1993-1#2)(2012-2#1)
charts of patients##4##3##(1993-1#2)(2012-2#1)(2013-8#1)
charts of##8##2##(1993-1#2)(2007-10#1)(2008-4#1)(2010-6#1)(2012-2#1)(2013-8#2)
charts that##2##2##(1997-3#1)(2008-10#1)
charts the##2##2##(2008-10#1)(2008-3#1)
charts were##3##2##(2008-10#1)(2009-4#1)(2010-6#1)
charts##69##1##(1991-2#1)(1992-2#1)(1993-1#3)(1993-2#1)(1993-3#2)(1994-1#1)(1994-3#3)(1995-12#1)(1995-3#4)(1995-8#1)(1996-1#3)(1996-3#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#13)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#5)(2009-4#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
charybdotoxin##5##1##(1992-6#1)(1994-11#1)(2007-10#1)(2008-8#1)(2010-12#1)
chase times##3##2##(1992-12#3)
chase##9##1##(1990-7#1)(1992-12#4)(1992-6#1)(1995-8#1)(2007-3#1)(2008-9#1)
chasm##2##1##(1995-1#1)(2008-9#1)
chasmogamous##4##1##(2008-10#3)(2008-9#1)
chat##3##1##(2008-7#1)(2012-2#1)(2013-1#1)
cheap and can##2##3##(2008-10#1)(2011-1#1)
cheap and easily available##2##4##(2008-10#2)
cheap and simple##3##3##(2008-10#2)(2008-12#1)
cheap and##12##2##(1993-11#1)(2008-10#8)(2008-12#1)(2011-1#2)
cheap raw##2##2##(2008-6#1)(2013-1#1)
cheap to produce##2##3##(2008-8#1)(2011-2#1)
cheap to##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
cheap##34##1##(1990-2#1)(1993-11#1)(1993-3#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#2)(2013-1#1)
cheaper and##5##2##(1990-7#1)(1991-3#1)(2008-10#1)(2008-7#1)(2011-7#1)
cheaper drugs##2##2##(2008-11#1)(2011-2#1)
cheaper to##2##2##(2008-12#1)(2011-7#1)
cheaper##20##1##(1990-7#1)(1991-3#2)(1995-11#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2011-7#2)
cheapest synonymous##2##2##(1993-11#2)
cheapest##3##1##(1993-11#2)(2008-10#1)
cheaply##3##1##(2008-10#2)(2012-12#1)
cheaters##2##1##(2008-8#1)(2008-9#1)
cheating##8##1##(2008-12#2)(2008-8#3)(2008-9#1)(2010-3#2)
cheats##2##1##(2008-9#2)
check and##2##2##(2008-4#1)(2009-11#1)
check list##2##2##(2010-8#2)
check of the##2##3##(2008-2#2)
check on##3##2##(1993-3#1)(2009-1#1)(2010-3#1)
check the accuracy of the##3##5##(2008-10#2)(2008-2#1)
check the possible##2##3##(2008-5#2)
check the##20##2##(1991-2#1)(1997-3#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-8#2)
check##71##1##(1990-3#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#17)(2008-11#2)(2008-12#6)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#4)(2012-7#1)(2013-1#3)
check-in##2##1##(1995-3#1)(2008-12#1)
check-up##6##1##(1990-8#1)(1994-11#1)(2007-8#2)(2010-9#1)(2013-1#1)
check-ups for the##2##3##(1993-5#1)(2011-1#1)
check-ups##3##1##(1993-5#1)(1993-6#1)(2011-1#1)
checkbites were##2##2##(1993-1#2)
checkbites##3##1##(1993-1#3)
checked against##2##2##(2008-10#1)(2008-3#1)
checked at##2##2##(2007-2#1)(2012-3#1)
checked by a##3##3##(2008-3#1)(2012-1#1)(2013-1#1)
checked by analyzing##3##3##(2008-10#3)
checked by applying it to##2##5##(2008-10#2)
checked by##32##2##(1994-1#1)(1995-9#1)(2008-10#24)(2008-3#3)(2010-3#1)(2012-1#1)(2013-1#1)
checked for the##5##3##(2008-10#5)
checked for##11##2##(1995-2#1)(2007-7#1)(2008-10#8)(2008-5#1)
checked in##5##2##(2008-1#1)(2008-10#2)(2010-3#1)(2011-2#1)
checked on the##3##3##(1995-8#1)(2008-10#2)
checked on##4##2##(1995-8#1)(2008-10#3)
checked the##4##2##(1997-7#1)(2008-10#2)(2008-4#1)
checked through##2##2##(2008-10#1)(2008-3#1)
checked to##2##2##(2012-2#1)(2013-7#1)
checked using##4##2##(2008-10#4)
checked with##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2012-2#1)
checked##94##1##(1990-8#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#56)(2008-11#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-8#1)(2010-3#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
checkerboard assay##2##2##(1994-8#1)(2009-6#1)
checkerboard##7##1##(1990-12#1)(1992-6#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-6#1)
checking and##3##2##(1995-2#1)(2008-7#1)(2012-12#1)
checking for##2##2##(2007-7#1)(2010-9#1)
checking the##5##2##(1996-8#1)(2007-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
checking##19##1##(1993-12#1)(1994-7#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-1#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2009-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
checklist for the##2##3##(1994-1#1)(2010-3#1)
checklist for##5##2##(1994-1#1)(1994-12#1)(2010-3#1)(2010-9#1)(2013-1#1)
checklist of##3##2##(1993-2#1)(1995-2#1)(2011-2#1)
checklist to##2##2##(1990-3#1)(2010-9#1)
checklist was##2##2##(2013-1#2)
checklist##24##1##(1990-3#1)(1991-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-3#2)(2010-9#2)(2011-2#3)(2013-1#8)
checklists for##2##2##(1996-2#1)(2008-11#1)
checklists##4##1##(1996-2#3)(2008-11#1)
checkpoint control##2##2##(2009-6#1)(2013-1#1)
checkpoint in##2##2##(1994-12#1)(2008-11#1)
checkpoint##14##1##(1994-12#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-6#3)(2011-2#1)(2012-3#1)(2013-1#3)
checkpoints##6##1##(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
checks and##4##2##(1991-3#1)(1994-12#1)(2007-12#1)(2008-9#1)
checks were##2##2##(2007-12#1)(2012-12#1)
checks##17##1##(1991-3#1)(1994-12#1)(1995-6#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-9#1)(2012-12#1)
checkup##7##1##(1992-12#1)(2008-1#1)(2011-2#1)(2013-1#4)
cheek pouch##2##2##(1995-12#1)(2011-1#1)
cheek##20##1##(1993-2#1)(1994-3#1)(1995-12#1)(1995-9#1)(2008-4#2)(2008-5#12)(2011-1#1)(2013-8#1)
cheeks##5##1##(2008-5#4)(2008-8#1)
cheese and##3##2##(1990-8#1)(2008-10#1)(2009-8#1)
cheese with##2##2##(2008-10#1)(2012-2#1)
cheese##25##1##(1990-8#2)(1994-3#1)(1997-7#1)(2008-10#12)(2008-6#2)(2009-8#1)(2012-2#6)
cheeses##6##1##(2008-10#1)(2012-2#5)
cheetahs and jaguars##3##3##(2009-4#3)
cheetahs##6##1##(2009-4#6)
cheiloplasty##2##1##(2013-1#2)
chelate affinity chromatography##3##3##(1995-8#1)(1996-12#2)
chelate and##4##2##(1997-4#1)(2008-10#2)(2008-7#1)
chelate can##2##2##(2008-10#2)
chelate concentration##2##2##(2008-10#2)
chelate formed##2##2##(2008-10#2)
chelate forming##2##2##(2008-10#2)
chelate is##7##2##(2008-10#7)
chelate of##3##2##(2008-10#3)
chelate on##2##2##(2008-10#2)
chelate was##3##2##(2008-10#3)
chelate were##2##2##(2008-10#2)
chelate which##2##2##(2008-10#2)
chelate with##8##2##(2008-10#8)
chelate##83##1##(1993-8#1)(1995-8#1)(1996-12#2)(1996-2#4)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#67)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
chelated by##2##2##(1991-9#1)(1997-6#1)
chelated##5##1##(1991-9#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-6#1)
chelated&quot##2##1##(1995-2#2)
chelates can be##2##3##(2008-5#1)(2008-7#1)
chelates in##2##2##(2008-10#2)
chelates of Co(II)##2##3##(2008-10#2)
chelates of##4##2##(2008-10#4)
chelates on##2##2##(2008-10#2)
chelates was##3##2##(2008-10#3)
chelates were found##2##3##(2008-10#2)
chelates were injected##2##3##(2008-10#2)
chelates were investigated##2##3##(2008-10#2)
chelates were##13##2##(2008-10#13)
chelates with##8##2##(2008-10#8)
chelates##67##1##(1990-5#1)(1997-7#1)(2008-1#1)(2008-10#55)(2008-3#1)(2008-5#2)(2008-7#5)(2009-9#1)
chelating Sepharose beads##2##3##(2008-10#2)
chelating activity##3##2##(2009-6#1)(2010-5#1)(2013-1#1)
chelating adsorbent##2##2##(2008-10#2)
chelating agent##16##2##(1995-3#1)(2008-10#15)
chelating agents##14##2##(1994-5#3)(1995-3#4)(1996-2#1)(2008-10#6)
chelating fiber is##2##3##(2008-10#2)
chelating fiber##9##2##(2008-10#9)
chelating groups##3##2##(2008-10#3)
chelating ligand##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
chelating matrix##3##2##(2008-10#3)
chelating or reducing agents were##2##5##(1990-5#2)
chelating polymer##3##2##(2008-10#3)
chelating polymeric sorbent##5##3##(2008-10#5)
chelating polymers##2##2##(2008-10#2)
chelating reagent##3##2##(2008-10#3)
chelating resin YPA(4) as both##2##5##(2008-10#2)
chelating resin as##2##3##(1990-8#1)(2008-10#1)
chelating resin having##2##3##(2008-10#2)
chelating resin is##3##3##(2008-10#3)
chelating resin was characterized by##2##5##(2008-10#2)
chelating resin was synthesized##2##4##(1990-8#1)(2008-10#1)
chelating resin was##8##3##(1990-8#2)(2008-10#6)
chelating resin with##3##3##(2008-10#3)
chelating resin##42##2##(1990-8#3)(2008-10#39)
chelating resins##6##2##(2008-10#6)
chelating sorbent##3##2##(2008-10#3)
chelating##160##1##(1990-5#2)(1990-8#3)(1994-5#3)(1995-3#5)(1996-2#4)(2008-10#136)(2008-9#1)(2009-10#1)(2009-6#2)(2010-5#1)(2013-1#1)(2013-8#1)
chelation and##2##2##(2008-10#1)(2009-6#1)
chelation by##2##2##(1993-8#1)(2008-10#1)
chelation ion chromatography##2##3##(2008-10#2)
chelation of##3##2##(2008-10#3)
chelation with##2##2##(2008-10#2)
chelation##21##1##(1993-8#1)(1994-2#1)(1996-5#1)(2008-10#14)(2008-4#1)(2008-9#1)(2009-6#1)(2010-5#1)
chelatogen##2##1##(2008-10#2)
chelator BAPTA##2##2##(1997-1#1)(2008-4#1)
chelator##28##1##(1990-11#1)(1990-12#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-11#1)(2011-2#2)
chelators in##2##2##(1994-8#1)(2009-7#1)
chelators were##2##2##(2008-11#1)(2009-7#1)
chelators##19##1##(1991-9#1)(1992-6#2)(1994-8#1)(1995-2#1)(2007-7#1)(2008-11#2)(2008-6#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-3#5)(2013-8#1)
chelerythrine and##5##2##(2008-10#4)(2008-4#1)
chelerythrine##6##1##(1995-5#1)(2008-10#4)(2008-4#1)
chelicerae and##2##2##(2007-12#2)
chelicerates##4##1##(2007-12#4)
chelonei##3##1##(1993-9#2)(2011-2#1)
chemerin##4##1##(2012-2#4)
chemerin-deficient mice##2##2##(2012-2#2)
chemerin-deficient##3##1##(2012-2#3)
chemical DNA sequencing##3##3##(1990-11#1)(1995-6#2)
chemical activation##2##2##(1997-6#1)(2008-6#1)
chemical activity##2##2##(1994-9#1)(2013-8#1)
chemical agent##2##2##(2008-10#1)(2010-7#1)
chemical agents##7##2##(1990-8#1)(1992-4#1)(1992-5#1)(1996-12#1)(2008-11#1)(2009-11#1)(2010-7#1)
chemical alternatives to methyl bromide##2##5##(2008-10#2)
chemical alternatives##3##2##(2008-10#3)
chemical analyser##2##2##(2008-10#2)
chemical analysis and##3##3##(2008-10#3)
chemical analysis is##2##3##(2008-10#2)
chemical analysis of the##2##4##(2008-10#2)
chemical analysis of##10##3##(2008-10#7)(2008-3#1)(2010-5#1)(2013-7#1)
chemical analysis##45##2##(1994-5#1)(1995-5#1)(2007-10#1)(2008-10#31)(2008-3#1)(2010-5#2)(2010-7#4)(2013-1#1)(2013-7#1)(2013-8#2)
chemical and FI variables##3##4##(2008-10#3)
chemical and biochemical##2##3##(2008-10#1)(2010-7#1)
chemical and biological sensors##2##4##(1990-8#1)(2008-7#1)
chemical and biological##15##3##(1990-8#1)(1990-9#1)(1994-12#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-7#1)(2011-2#1)
chemical and cultural measures##2##4##(2008-10#2)
chemical and environmental analysis##3##4##(2008-2#1)(2008-3#2)
chemical and environmental##4##3##(2008-2#2)(2008-3#2)
chemical and enzymatic##5##3##(1990-12#1)(1992-3#1)(1995-5#1)(1997-2#2)
chemical and flow variables##3##4##(2008-10#3)
chemical and flow##4##3##(2008-10#4)
chemical and genetic##3##3##(1994-11#1)(2008-10#2)
chemical and instrumental variables##3##4##(2008-10#3)
chemical and instrumental##4##3##(2008-10#4)
chemical and mechanical##4##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-7#1)
chemical and physical properties of##3##5##(2008-10#1)(2008-3#1)(2010-7#1)
chemical and physical properties##5##4##(1995-11#1)(2008-10#1)(2008-3#1)(2010-7#2)
chemical and physical##16##3##(1995-11#1)(1997-5#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-7#2)
chemical and spectral proprieties and##2##5##(2007-11#2)
chemical and spectral##5##3##(1994-11#1)(2007-11#2)(2008-10#1)(2008-12#1)
chemical and thermal##2##3##(2008-10#1)(2009-12#1)
chemical and toxicological characteristics##2##4##(2008-5#2)
chemical and##93##2##(1990-12#1)(1990-8#1)(1990-9#1)(1992-3#1)(1994-11#2)(1994-12#1)(1995-11#2)(1995-5#1)(1997-2#2)(1997-5#2)(2006-12#2)(2007-10#1)(2007-11#4)(2008-10#38)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#2)(2010-5#1)(2010-7#4)(2011-2#1)
chemical at##2##2##(1993-12#1)(1995-6#1)
chemical barriers##2##2##(2008-10#2)
chemical behavior##3##2##(1997-7#1)(2008-10#2)
chemical bonding##3##2##(2008-10#1)(2009-9#1)(2010-12#1)
chemical bonds##4##2##(2008-10#2)(2008-5#1)(2009-9#1)
chemical burn##2##2##(2011-1#2)
chemical calculations##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
chemical carcinogens##2##2##(1995-9#1)(2008-7#1)
chemical changes##4##2##(1991-5#1)(1996-4#1)(2012-2#2)
chemical characterisation##3##2##(2008-10#2)(2012-2#1)
chemical characteristics of##6##3##(2008-10#4)(2010-4#2)
chemical characteristics##10##2##(2008-10#5)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#2)
chemical characterization of##6##3##(1992-9#1)(2008-10#4)(2008-11#1)
chemical characterization##10##2##(1990-2#1)(1992-9#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-4#1)
chemical class##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
chemical class&quot##2##2##(2008-10#2)
chemical classes##3##2##(2008-10#3)
chemical components of##3##3##(2012-3#1)(2013-8#2)
chemical components##6##2##(2008-10#2)(2011-3#1)(2012-3#1)(2013-8#2)
chemical composition and##6##3##(2008-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
chemical composition of the##9##4##(1990-5#1)(1991-5#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2013-8#1)
chemical composition of##23##3##(1990-5#1)(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2009-7#1)(2010-7#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
chemical composition##47##2##(1990-5#1)(1991-5#1)(1994-12#1)(1997-5#1)(2007-11#5)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-7#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
chemical compositions##2##2##(2008-10#1)(2008-12#1)
chemical compounds for##2##3##(1997-4#1)(2008-11#1)
chemical compounds that##2##3##(2008-12#1)(2008-5#1)
chemical compounds##8##2##(1995-11#1)(1997-4#2)(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)
chemical conditions of##2##3##(2008-10#2)
chemical conditions##8##2##(2007-12#1)(2008-10#5)(2008-4#2)
chemical constituents of the##3##4##(2008-11#1)(2012-3#1)(2013-1#1)
chemical constituents of##7##3##(2008-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
chemical constituents##9##2##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
chemical control##9##2##(2008-10#9)
chemical controls##2##2##(2011-2#2)
chemical conversion##2##2##(2008-10#1)(2008-7#1)
chemical corneal burn##3##3##(2010-10#3)
chemical cross linking##2##3##(2008-4#2)
chemical cross-linking##5##2##(1994-5#1)(1995-6#1)(1997-2#1)(2008-4#2)
chemical damage##3##2##(1994-6#1)(2009-10#1)(2012-2#1)
chemical data sets##3##3##(2008-10#3)
chemical data##8##2##(2008-10#6)(2008-5#1)(2012-1#1)
chemical defense##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
chemical degradation of##2##3##(2008-10#1)(2012-12#1)
chemical degradation##5##2##(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
chemical denaturants##4##2##(1997-2#2)(2008-10#1)(2009-9#1)
chemical dependency##2##2##(1992-2#1)(1994-2#1)
chemical deposition##2##2##(2008-10#2)
chemical derivatization of##2##3##(2008-10#2)
chemical derivatization##4##2##(1994-5#1)(2008-10#3)
chemical descriptors##8##2##(2007-11#1)(2008-10#6)(2012-2#1)
chemical detection##2##2##(2008-2#1)(2013-8#1)
chemical differences##3##2##(2008-10#2)(2008-11#1)
chemical disinfection##2##2##(2007-7#2)
chemical effects##3##2##(2008-3#1)(2010-12#1)(2011-1#1)
chemical elements##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
chemical energy##5##2##(1993-9#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)
chemical entities##4##2##(1995-5#1)(2009-2#2)(2010-7#1)
chemical environment and##3##3##(2008-8#1)(2010-11#1)(2012-2#1)
chemical environment##8##2##(2008-10#4)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
chemical environments##2##2##(2007-12#1)(2008-10#1)
chemical equilibrium predictions##2##3##(2008-2#1)(2008-3#1)
chemical equilibrium##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
chemical etching##8##2##(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)
chemical exposures##2##2##(1992-2#1)(2008-2#1)
chemical extraction##2##2##(1992-9#1)(2008-10#1)
chemical factors##2##2##(2008-10#1)(2011-1#1)
chemical features##5##2##(1992-3#1)(1994-8#1)(2008-10#2)(2010-12#1)
chemical fingerprints##2##2##(2008-8#1)(2010-7#1)
chemical fixation##2##2##(2008-5#1)(2008-7#1)
chemical form of##2##3##(1994-5#1)(2008-10#1)
chemical form##3##2##(1994-5#1)(2008-10#2)
chemical forms of##2##3##(2008-10#2)
chemical forms##4##2##(2008-10#4)
chemical fungicides##2##2##(2008-10#2)
chemical group in##2##3##(2008-10#1)(2013-8#1)
chemical groups##5##2##(2008-10#1)(2008-4#1)(2008-5#3)
chemical hazards##2##2##(2010-7#1)(2013-8#1)
chemical identification##3##2##(2008-10#2)(2008-2#1)
chemical image##2##2##(2007-12#2)
chemical imaging methods for the##2##5##(2008-10#2)
chemical imaging##4##2##(2008-10#4)
chemical in##2##2##(2008-9#2)
chemical indices##2##2##(2008-10#2)
chemical inducer##5##2##(2008-10#4)(2008-7#1)
chemical inducers##2##2##(1992-6#1)(2010-10#1)
chemical industries##4##2##(1991-3#1)(2008-11#1)(2012-2#1)(2012-3#1)
chemical industry##4##2##(1991-3#1)(2008-11#1)(2008-6#1)(2011-2#1)
chemical information and##2##3##(2013-8#2)
chemical information##6##2##(2008-5#1)(2013-8#5)
chemical inhibitors##2##2##(2008-10#1)(2008-11#1)
chemical insult##2##2##(2008-5#1)(2010-7#1)
chemical interaction##2##2##(1997-4#1)(2008-10#1)
chemical interactions##3##2##(1991-3#1)(1997-5#1)(2008-5#1)
chemical interference##2##2##(2008-7#1)(2009-12#1)
chemical ionization##6##2##(2008-10#5)(2013-8#1)
chemical is##6##2##(2008-10#2)(2008-5#3)(2008-9#1)
chemical kinetics and##2##3##(1991-8#1)(2008-10#1)
chemical laboratories##3##2##(1995-2#1)(2008-10#2)
chemical markers##5##2##(2012-3#5)
chemical means##2##2##(1993-8#1)(2008-4#1)
chemical mechanisms##4##2##(2008-10#1)(2009-11#2)(2009-8#1)
chemical method##4##2##(2008-10#3)(2008-4#1)
chemical methods##10##2##(2008-10#5)(2008-12#1)(2009-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
chemical model##3##2##(1990-5#1)(2008-10#2)
chemical modification and circular dichroism##2##5##(1992-5#2)
chemical modification and##6##3##(1992-5#2)(1995-6#1)(2008-10#2)(2008-4#1)
chemical modification by##2##3##(1992-6#1)(2008-4#1)
chemical modification of the##5##4##(1993-11#2)(1995-2#1)(2008-3#1)(2008-7#1)
chemical modification of##10##3##(1990-7#1)(1990-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
chemical modification to##2##3##(1993-8#1)(2008-4#1)
chemical modification##33##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#4)(1993-6#1)(1993-8#1)(1995-2#2)(1995-6#1)(2008-10#10)(2008-3#1)(2008-4#5)(2008-7#1)
chemical modifications of the##2##4##(1995-5#1)(2008-10#1)
chemical modifications of##3##3##(1992-9#1)(1995-5#1)(2008-10#1)
chemical modifications##7##2##(1992-9#1)(1995-5#1)(2008-10#3)(2008-5#1)(2013-1#1)
chemical modifier and##2##3##(2008-10#2)
chemical modifier for the##2##4##(2008-10#2)
chemical modifier for##4##3##(2008-10#4)
chemical modifier was##3##3##(2008-10#3)
chemical modifier##38##2##(2008-10#38)
chemical modifiers for##2##3##(2008-10#2)
chemical modifiers have been##2##4##(2008-10#2)
chemical modifiers##20##2##(2008-10#20)
chemical nature and##2##3##(1990-3#1)(2008-5#1)
chemical nature of the##3##4##(2008-11#3)
chemical nature of##6##3##(1993-8#1)(1996-12#1)(2008-11#3)(2008-6#1)
chemical nature##9##2##(1990-3#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)
chemical or biological##3##3##(1990-9#1)(2008-11#1)(2010-7#1)
chemical or##10##2##(1990-5#1)(1990-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-7#2)(2012-2#1)
chemical orthogonality##3##2##(2009-3#3)
chemical oxidative polymerization##2##3##(2008-7#2)
chemical oxygen demand (COD)##4##4##(2008-10#4)
chemical oxygen demand using##2##4##(2008-10#2)
chemical oxygen demand##9##3##(2008-10#8)(2013-1#1)
chemical oxygen iodine laser##2##4##(2008-3#2)
chemical oxygen##11##2##(2008-10#8)(2008-3#2)(2013-1#1)
chemical oxygen-iodine laser (COIL)##2##4##(2008-2#1)(2008-3#1)
chemical parameters and##3##3##(2013-7#3)
chemical parameters##9##2##(2008-10#3)(2008-2#1)(2013-7#4)(2013-8#1)
chemical potential of##3##3##(2008-10#2)(2011-1#1)
chemical potential##5##2##(1994-12#1)(2008-10#2)(2009-2#1)(2011-1#1)
chemical preservatives##2##2##(2008-5#1)(2010-4#1)
chemical pretreatment##2##2##(2008-10#1)(2013-1#1)
chemical procedures##5##2##(2008-10#5)
chemical process##2##2##(2007-12#1)(2008-10#1)
chemical processes##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
chemical properties and biochemical parameters##2##5##(2008-5#2)
chemical properties and##4##3##(2008-10#1)(2008-5#2)(2010-2#1)
chemical properties of the##4##4##(1992-6#1)(1997-2#1)(2008-6#1)(2011-2#1)
chemical properties of these##2##4##(1990-7#1)(2008-4#1)
chemical properties of##14##3##(1990-7#1)(1992-6#2)(1992-8#1)(1993-11#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2011-2#1)(2013-8#1)
chemical properties##37##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-6#2)(1992-8#1)(1993-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#2)(2013-8#1)
chemical property##2##2##(2008-10#1)(2013-8#1)
chemical proteomics##2##2##(2009-7#2)
chemical reaction between##2##3##(1992-6#1)(2008-10#1)
chemical reaction events##2##3##(1995-6#2)
chemical reaction of##2##3##(2007-12#1)(2008-10#1)
chemical reaction##21##2##(1992-6#1)(1995-6#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-7#1)(2008-9#1)(2011-2#1)
chemical reactions in solution##2##4##(1995-6#1)(2009-9#1)
chemical reactions in##4##3##(1993-6#1)(1995-6#1)(2008-10#1)(2009-9#1)
chemical reactions##22##2##(1993-6#2)(1995-6#2)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-9#1)(2010-12#1)(2010-7#1)
chemical reactivity and##2##3##(2008-10#2)
chemical reactivity##8##2##(2008-10#5)(2008-8#2)(2012-2#1)
chemical reagents##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
chemical recognition##2##2##(2009-12#1)(2012-3#1)
chemical reduction and##2##3##(2008-10#2)
chemical reduction method##4##3##(2012-2#4)
chemical reduction of##5##3##(1990-8#1)(1995-3#1)(2008-6#1)(2013-1#2)
chemical reduction##12##2##(1990-8#2)(1995-3#1)(2008-10#2)(2008-6#1)(2012-2#4)(2013-1#2)
chemical relationships##2##2##(2008-9#1)(2013-1#1)
chemical release##2##2##(1992-1#1)(2008-3#1)
chemical response##2##2##(2008-10#2)
chemical sciences##3##2##(2008-10#1)(2010-7#2)
chemical selectivity of##2##3##(2008-10#1)(2009-10#1)
chemical sensing##8##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
chemical sensor based on##3##4##(2008-10#3)
chemical sensor for##7##3##(2008-10#6)(2008-3#1)
chemical sensor##20##2##(2008-10#17)(2008-3#2)(2010-7#1)
chemical sensors and##5##3##(2008-10#4)(2008-3#1)
chemical sensors for##4##3##(2008-10#3)(2008-7#1)
chemical sensors with##2##3##(2008-10#1)(2008-7#1)
chemical sensors##22##2##(2007-11#1)(2008-10#17)(2008-3#1)(2008-7#3)
chemical separation of Hf##3##4##(2008-10#3)
chemical separation of##6##3##(1992-3#1)(2008-10#4)(2008-2#1)
chemical separation##10##2##(1992-3#1)(2008-10#8)(2008-2#1)
chemical sequencing reactions##2##3##(1995-6#2)
chemical sequencing##5##2##(1990-5#1)(1995-6#3)(2008-2#1)
chemical shift anisotropy (CSA)##2##4##(2008-10#1)(2008-5#1)
chemical shift assignments are##2##4##(1993-11#1)(2009-7#1)
chemical shift assignments for the##4##5##(2009-7#4)
chemical shift assignments of##4##4##(2009-7#4)
chemical shift assignments##10##3##(1993-11#1)(2009-7#9)
chemical shift data##3##3##(1991-9#1)(1992-12#1)(2008-10#1)
chemical shift for the##2##4##(1995-5#1)(2012-12#1)
chemical shift of##4##3##(1993-11#1)(2008-10#3)
chemical shift##35##2##(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#4)(1993-3#1)(1994-5#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-7#2)(2008-10#5)(2008-5#1)(2008-9#1)(2009-7#9)(2010-7#1)(2012-12#1)(2012-2#2)
chemical shifts and##2##3##(1992-4#1)(1992-8#1)
chemical shifts are##2##3##(1992-8#2)
chemical shifts for##3##3##(1995-5#2)(2010-7#1)
chemical shifts of the##4##4##(2008-10#2)(2009-7#1)(2013-1#1)
chemical shifts of##9##3##(1991-8#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-9#1)(2009-7#1)(2013-1#1)
chemical shifts that##2##3##(1992-8#1)(1994-8#1)
chemical shifts##34##2##(1991-5#2)(1991-8#1)(1992-4#1)(1992-8#5)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-5#4)(1996-2#1)(2008-10#6)(2008-9#2)(2009-7#2)(2010-7#1)(2012-2#2)(2013-1#1)
chemical signals##4##2##(1990-7#1)(2008-10#2)(2008-4#1)
chemical signatures##2##2##(2008-10#2)
chemical similarity##2##2##(2008-10#1)(2009-11#1)
chemical soil##3##2##(2008-10#1)(2008-12#2)
chemical solution##2##2##(2008-10#1)(2008-2#1)
chemical space##2##2##(2008-8#2)
chemical speciation and sequential determination of##2##6##(2008-10#2)
chemical speciation##5##2##(2008-10#5)
chemical species and##2##3##(2008-10#2)
chemical species in##2##3##(2008-10#1)(2008-3#1)
chemical species##17##2##(2007-11#1)(2008-10#10)(2008-11#1)(2008-3#4)(2011-1#1)
chemical specificity of##2##3##(2007-11#1)(2009-3#1)
chemical specificity##3##2##(2007-11#1)(2009-3#1)(2010-7#1)
chemical stability and##2##3##(2008-7#1)(2012-2#1)
chemical stability of the##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
chemical stability of##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
chemical stability##16##2##(1996-1#1)(2008-10#5)(2008-2#1)(2008-5#3)(2008-7#1)(2009-11#2)(2011-1#1)(2012-2#2)
chemical step##3##2##(1991-9#2)(2009-10#1)
chemical stimulation##2##2##(2012-2#2)
chemical stimuli##4##2##(2008-10#2)(2009-12#1)(2010-4#1)
chemical structure and##3##3##(1995-11#1)(1997-4#1)(2010-4#1)
chemical structure of##9##3##(1993-11#1)(1994-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#1)
chemical structure was##3##3##(2007-11#2)(2008-10#1)
chemical structure##25##2##(1991-6#1)(1993-11#1)(1994-2#1)(1995-11#2)(1997-4#2)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#2)(2009-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
chemical structures of the##4##4##(1990-7#1)(1996-12#1)(2007-11#1)(2011-3#1)
chemical structures of##6##3##(1990-7#1)(1996-12#1)(2007-11#1)(2008-10#2)(2011-3#1)
chemical structures##14##2##(1990-7#1)(1992-3#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
chemical substances##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
chemical such as##2##3##(1995-11#1)(2008-11#1)
chemical sunscreens##2##2##(2008-5#2)
chemical suppression##2##2##(2008-10#1)(2008-8#1)
chemical synthesis of##5##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
chemical synthesis##14##2##(1993-11#1)(1997-4#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
chemical system and##3##3##(2008-10#2)(2009-6#1)
chemical system##8##2##(2008-10#7)(2009-6#1)
chemical systems##4##2##(2008-10#4)
chemical techniques##3##2##(2008-10#2)(2010-7#1)
chemical transformations##3##2##(1997-3#1)(2007-1#1)(2008-10#1)
chemical treatment##9##2##(2008-10#4)(2008-3#1)(2008-6#3)(2012-2#1)
chemical treatments##2##2##(1990-2#1)(2009-7#1)
chemical vapor deposition (CVD)##2##4##(2008-2#1)(2008-3#1)
chemical vapor deposition and##2##4##(2008-10#2)
chemical vapor deposition using##3##4##(2008-10#3)
chemical vapor deposition##18##3##(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#7)(2009-11#1)
chemical vapor##24##2##(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#9)(2009-11#1)
chemical vapour deposition (CVD)##2##4##(2008-7#2)
chemical vapour##4##2##(2008-10#2)(2008-7#2)
chemical variables affecting the sensitivity of##2##6##(2008-10#2)
chemical variables affecting the##6##4##(2008-10#6)
chemical variables##13##2##(2008-10#13)
chemical warfare agent##5##3##(2008-10#1)(2008-11#4)
chemical warfare agents##5##3##(2008-10#1)(2008-11#4)
chemical warfare##10##2##(2008-10#2)(2008-11#8)
chemical work-up##2##2##(2008-10#2)
chemical yields##2##2##(2008-10#2)
chemical##1470##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#5)(1990-7#5)(1990-8#6)(1990-9#5)(1991-12#5)(1991-2#1)(1991-3#5)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#7)(1992-8#7)(1992-9#4)(1993-11#12)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#5)(1993-9#3)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#8)(1994-6#1)(1994-8#5)(1994-9#3)(1995-11#12)(1995-2#8)(1995-3#1)(1995-5#9)(1995-6#12)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#8)(1997-3#2)(1997-4#7)(1997-5#4)(1997-6#2)(1997-7#3)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#22)(2007-12#15)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#605)(2008-11#45)(2008-12#12)(2008-2#34)(2008-3#50)(2008-4#28)(2008-5#52)(2008-6#11)(2008-7#39)(2008-8#16)(2008-9#18)(2009-10#10)(2009-11#8)(2009-12#7)(2009-2#5)(2009-3#5)(2009-5#2)(2009-6#4)(2009-7#19)(2009-8#3)(2009-9#6)(2010-1#2)(2010-10#9)(2010-11#2)(2010-12#5)(2010-2#4)(2010-4#13)(2010-5#5)(2010-6#1)(2010-7#27)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#15)(2011-3#5)(2012-1#4)(2012-12#3)(2012-2#33)(2012-3#15)(2013-1#29)(2013-7#9)(2013-8#33)
chemical-based##2##1##(2009-8#1)(2013-7#1)
chemical-biological##2##1##(2008-10#1)(2013-1#1)
chemical-physical##4##1##(1990-9#1)(2008-2#1)(2010-4#1)(2013-7#1)
chemical-vapor deposition##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
chemical-vapor-deposited##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
chemically active##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
chemically and physically##2##3##(2007-11#1)(2012-12#1)
chemically and##8##2##(1995-2#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-12#1)
chemically bonded##4##2##(1990-8#1)(2008-10#2)(2009-8#1)
chemically by##2##2##(1997-2#1)(2008-10#1)
chemically crosslinked##2##2##(2008-5#2)
chemically defined medium##4##3##(1993-6#1)(2008-11#1)(2008-5#2)
chemically defined##9##2##(1993-6#1)(1995-2#1)(1997-4#1)(2008-11#4)(2008-5#2)
chemically disordered##2##2##(2008-10#2)
chemically distinct##3##2##(2008-10#1)(2008-9#1)(2009-12#1)
chemically diverse##2##2##(2008-10#1)(2008-11#1)
chemically etched##2##2##(2008-3#2)
chemically functionalized##2##2##(2007-8#1)(2008-5#1)
chemically identical##2##2##(1992-3#1)(1995-2#1)
chemically immobilized on the surface of##2##6##(2008-10#2)
chemically immobilized##3##2##(2008-10#3)
chemically induced##10##2##(1990-6#1)(1992-5#1)(1993-6#1)(1993-9#1)(1995-11#2)(1995-9#1)(1997-4#1)(2008-1#1)(2013-1#1)
chemically inert##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
chemically linked##2##2##(1995-5#1)(2008-10#1)
chemically modified and unmodified##2##4##(2008-10#2)
chemically modified carbon paste electrode (CMCPE) for##2##7##(2008-10#2)
chemically modified carbon paste electrode##6##5##(2008-10#6)
chemically modified carbon##7##3##(2008-10#7)
chemically modified chloromethylated polystyrene-PAN##2##4##(2008-10#2)
chemically modified electrode (CME) was prepared##2##6##(2008-10#2)
chemically modified electrode (CME)##6##4##(2008-10#6)
chemically modified electrode exhibits##2##4##(2008-10#2)
chemically modified electrode was##3##4##(2008-10#3)
chemically modified electrode##19##3##(2008-10#19)
chemically modified electrodes##3##3##(2008-10#3)
chemically modified silica gel##3##4##(2008-10#3)
chemically modified with##8##3##(1993-11#1)(2008-10#5)(2008-3#1)(2008-6#1)
chemically modified##60##2##(1993-11#1)(1993-6#2)(2008-10#54)(2008-3#1)(2008-5#1)(2008-6#1)
chemically new##2##2##(1996-4#2)
chemically or##2##2##(1994-3#1)(2008-11#1)
chemically prepared monoselenophosphate##2##3##(1993-11#2)
chemically reactive##3##2##(1992-9#1)(1993-3#1)(1997-2#1)
chemically related##2##2##(2007-12#1)(2008-5#1)
chemically selective phases##2##3##(2008-10#2)
chemically sensitive##2##2##(1994-9#1)(2008-3#1)
chemically sensitized##2##2##(2008-10#2)
chemically similar##4##2##(1992-9#1)(2008-10#3)
chemically stable##2##2##(2010-3#1)(2012-2#1)
chemically synthesized by##2##3##(1992-6#1)(1995-3#1)
chemically synthesized##12##2##(1990-7#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#1)(2009-2#1)
chemically##203##1##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#1)(1993-3#1)(1993-6#5)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-4#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#91)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2012-12#3)(2012-2#2)(2013-1#1)
chemically-defined##4##1##(2008-11#4)
chemically-induced##5##1##(1992-5#1)(1995-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
chemicals and##17##2##(1990-8#1)(1990-9#1)(1991-9#1)(1992-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
chemicals are##6##2##(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
chemicals as##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
chemicals at##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
chemicals by the##2##3##(2008-10#1)(2013-8#1)
chemicals by##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
chemicals during##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
chemicals for##4##2##(2008-10#3)(2008-9#1)
chemicals from the##2##3##(1994-3#1)(2008-10#1)
chemicals from##3##2##(1994-3#1)(2008-10#2)
chemicals identified##2##2##(2008-10#2)
chemicals in a##2##3##(2008-10#1)(2008-7#1)
chemicals in human##2##3##(1997-4#1)(2008-11#1)
chemicals in the environment##2##4##(2008-11#2)
chemicals in the##8##3##(1991-12#1)(1993-3#2)(2008-10#1)(2008-11#3)(2011-2#1)
chemicals in##20##2##(1991-12#1)(1993-3#2)(1994-3#1)(1997-4#1)(2008-10#7)(2008-11#4)(2008-7#2)(2010-7#1)(2011-2#1)
chemicals into##4##2##(1995-6#1)(2008-11#1)(2008-7#2)
chemicals investigated##2##2##(2008-10#2)
chemicals is##4##2##(2008-11#2)(2008-6#1)(2011-2#1)
chemicals on the##2##3##(2008-11#2)
chemicals on##5##2##(2008-10#1)(2008-11#2)(2013-1#1)(2013-8#1)
chemicals or##2##2##(2008-10#1)(2008-11#1)
chemicals such as##2##3##(2008-11#1)(2008-8#1)
chemicals that##2##2##(2008-10#1)(2008-11#1)
chemicals to##5##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
chemicals used##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
chemicals was##3##2##(2008-10#2)(2008-11#1)
chemicals were##7##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
chemicals which##2##2##(2008-10#1)(2011-3#1)
chemicals with a##2##3##(1995-6#1)(2009-10#1)
chemicals with##7##2##(1995-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)
chemicals##210##1##(1990-8#2)(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#2)(1992-2#1)(1993-3#3)(1994-11#1)(1994-3#4)(1994-8#1)(1995-11#1)(1995-6#6)(1996-1#1)(1996-12#3)(1997-3#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#69)(2008-11#39)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#4)
chemiluminescence (CL) detection in##2##4##(1995-3#1)(2008-10#1)
chemiluminescence (CL) detection##9##3##(1995-3#1)(2008-10#8)
chemiluminescence (CL) flow-injection method##2##4##(2008-10#2)
chemiluminescence (CL) flow-injection##3##3##(2008-10#3)
chemiluminescence (CL) method for the determination of##3##7##(2008-10#3)
chemiluminescence (CL) method for the##4##5##(2008-10#4)
chemiluminescence (CL) method for##5##4##(2008-10#5)
chemiluminescence (CL) method is proposed for the determination of##3##9##(2008-10#3)
chemiluminescence (CL) method is##4##4##(2008-10#4)
chemiluminescence (CL) method##11##3##(2008-10#11)
chemiluminescence (CL) reaction##4##3##(2008-10#4)
chemiluminescence (CL) system for##3##4##(2008-10#3)
chemiluminescence (CL) system##7##3##(2008-10#7)
chemiluminescence (CL) was##2##3##(2008-10#2)
chemiluminescence (CL)##56##2##(1991-2#1)(1991-9#1)(1995-3#1)(2008-10#50)(2008-5#1)(2010-4#1)(2013-8#1)
chemiluminescence (ECL)##3##2##(2008-10#1)(2012-2#2)
chemiluminescence analysis of##2##3##(2008-10#2)
chemiluminescence analysis##3##2##(2008-10#3)
chemiluminescence and##7##2##(2008-10#7)
chemiluminescence detection in##2##3##(2008-10#2)
chemiluminescence detection of##2##3##(2008-10#2)
chemiluminescence detection using##2##3##(2008-10#2)
chemiluminescence detection##37##2##(1990-12#1)(1990-8#2)(2008-10#33)(2008-5#1)
chemiluminescence detector##6##2##(2008-10#6)
chemiluminescence determination of##16##3##(2008-10#16)
chemiluminescence during##2##2##(2008-10#2)
chemiluminescence emission##4##2##(2008-10#4)
chemiluminescence for the##2##3##(2008-10#2)
chemiluminescence generated during##2##3##(2008-10#2)
chemiluminescence generated##3##2##(2008-10#3)
chemiluminescence immunoassay##2##2##(2008-10#2)
chemiluminescence in the##2##3##(2008-10#2)
chemiluminescence in##4##2##(2008-10#4)
chemiluminescence intensity##11##2##(2008-10#11)
chemiluminescence method for the determination of##2##6##(2008-10#2)
chemiluminescence method for##3##3##(2008-10#3)
chemiluminescence method is proposed for the determination of##2##8##(2008-10#2)
chemiluminescence method is##3##3##(2008-10#3)
chemiluminescence method was developed for the##2##6##(2008-10#1)(2010-4#1)
chemiluminescence method##8##2##(2008-10#7)(2010-4#1)
chemiluminescence of##7##2##(1991-5#1)(2008-10#6)
chemiluminescence produced##3##2##(2008-10#3)
chemiluminescence reaction of##5##3##(2008-10#5)
chemiluminescence reaction##12##2##(2008-10#12)
chemiluminescence system for##2##3##(2008-10#1)(2010-4#1)
chemiluminescence system##7##2##(2008-10#6)(2010-4#1)
chemiluminescence systems##2##2##(2008-10#2)
chemiluminescence##249##1##(1990-12#1)(1990-8#4)(1991-2#1)(1991-5#2)(1991-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#221)(2008-5#3)(2010-4#3)(2010-7#2)(2012-2#4)(2012-3#1)(2013-8#2)
chemiluminescence-based##2##1##(2008-10#2)
chemiluminescent (CL)##4##2##(2008-10#4)
chemiluminescent and##2##2##(2008-10#2)
chemiluminescent assay##7##2##(2008-10#6)(2012-12#1)
chemiluminescent behaviour##4##2##(2008-10#4)
chemiluminescent detection##8##2##(1995-6#1)(2008-10#7)
chemiluminescent determination of##3##3##(2008-10#3)
chemiluminescent method using flow injection is described for the determination of##3##11##(2008-10#3)
chemiluminescent method##5##2##(2008-10#5)
chemiluminescent polymer##2##2##(2008-10#2)
chemiluminescent reaction##5##2##(1995-6#1)(2008-10#3)(2010-11#1)
chemiluminescent reagent##2##2##(2008-10#2)
chemiluminescent responses##2##2##(1991-12#2)
chemiluminescent sensor##2##2##(2008-10#2)
chemiluminescent substrates##2##2##(2008-10#2)
chemiluminescent##68##1##(1991-12#3)(1992-9#1)(1995-6#2)(1997-2#2)(2008-10#56)(2010-11#3)(2012-12#1)
chemiluminogenic##3##1##(2008-10#3)
chemiluminometric##6##1##(2008-10#6)
chemiluminscence##2##1##(2008-10#2)
cheminformatics##2##1##(2011-2#1)(2012-1#1)
chemiresistor##2##1##(2008-10#2)
chemisorbed##2##1##(2008-10#1)(2012-2#1)
chemisorption at##2##2##(2008-10#2)
chemisorption of##2##2##(2008-10#2)
chemisorption##7##1##(2008-10#6)(2013-1#1)
chemist to##4##2##(2009-9#3)(2012-1#1)
chemist##8##1##(1994-12#2)(2008-10#2)(2009-9#3)(2012-1#1)
chemistries to##2##2##(2008-1#1)(2008-10#1)
chemistries were##2##2##(2008-5#1)(2013-1#1)
chemistries##17##1##(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#2)(2012-2#2)(2013-1#1)
chemistry -##2##2##(2008-11#2)
chemistry and##30##2##(1990-11#1)(1990-7#1)(1994-12#3)(1997-3#1)(1997-6#1)(2006-12#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#3)(2012-1#1)(2012-3#1)(2012-8#1)
chemistry are##2##2##(1994-12#1)(2008-10#1)
chemistry as##4##2##(1994-12#3)(2008-10#1)
chemistry by##2##2##(2008-10#1)(2010-7#1)
chemistry education in the United States##2##6##(1994-12#2)
chemistry enables##2##2##(2010-10#1)(2010-7#1)
chemistry for##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
chemistry has been##2##3##(1997-3#1)(2008-10#1)
chemistry has##4##2##(1997-3#1)(2008-10#1)(2010-7#1)(2012-2#1)
chemistry in the##2##3##(1997-7#1)(2012-2#1)
chemistry in##7##2##(1994-12#3)(1997-7#1)(2008-10#1)(2010-7#1)(2012-2#1)
chemistry is##12##2##(1994-12#2)(1996-5#1)(2008-10#4)(2008-4#1)(2010-12#1)(2010-7#2)(2012-12#1)
chemistry laboratories##3##2##(2008-10#3)
chemistry of the##11##3##(1995-3#1)(1997-6#1)(1997-7#2)(2008-10#4)(2008-3#1)(2008-5#1)(2010-5#1)
chemistry of##31##2##(1995-3#2)(1997-6#1)(1997-7#2)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-4#1)(2010-5#1)(2010-7#2)(2013-1#4)
chemistry on##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
chemistry or##2##2##(1993-12#1)(2008-3#1)
chemistry to##8##2##(1994-12#1)(1997-4#1)(2008-10#3)(2008-7#2)(2011-2#1)
chemistry was##3##2##(1994-12#1)(2008-10#2)
chemistry were##3##2##(2008-10#1)(2008-5#1)(2009-11#1)
chemistry with##3##2##(2008-4#1)(2008-7#1)(2010-7#1)
chemistry##293##1##(1990-11#1)(1990-7#1)(1992-11#1)(1993-12#1)(1994-12#24)(1995-11#1)(1995-3#4)(1996-1#1)(1996-5#1)(1997-3#6)(1997-4#7)(1997-6#2)(1997-7#3)(2006-12#3)(2007-10#3)(2007-11#3)(2007-12#1)(2008-10#100)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#13)(2008-5#11)(2008-7#11)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#12)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#20)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#8)(2013-8#1)
chemists and##7##2##(2008-10#1)(2008-2#1)(2008-7#4)(2010-11#1)
chemists are##2##2##(1991-12#1)(2008-7#1)
chemists##23##1##(1991-12#1)(1994-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#5)(2010-11#1)(2010-12#4)(2012-3#1)
chemo##2##1##(2008-10#1)(2013-1#1)
chemo- and##3##2##(1992-12#1)(2008-11#1)(2008-6#1)
chemo-##4##1##(1990-12#1)(1992-12#1)(2008-11#1)(2008-6#1)
chemo-radiotherapy in##2##2##(1990-6#1)(1995-8#1)
chemo-radiotherapy##7##1##(1990-6#3)(1995-8#1)(2007-5#1)(2011-3#2)
chemoanalyses results##2##2##(2008-10#2)
chemoattractant and##2##2##(1993-6#1)(1997-3#1)
chemoattractant##24##1##(1990-12#1)(1993-6#3)(1993-8#1)(1994-11#4)(1994-12#1)(1994-6#2)(1994-9#1)(1995-6#1)(1997-3#3)(2008-11#1)(2008-4#1)(2010-6#1)(2012-2#1)(2013-1#3)
chemoattractants##5##1##(1990-12#1)(2008-10#1)(2008-4#2)(2008-7#1)
chemoembolization for##2##2##(2013-1#1)(2013-7#1)
chemoembolization##7##1##(1997-8#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
chemoendocrine therapy##2##2##(1994-12#1)(1994-7#1)
chemoendocrine##3##1##(1994-12#1)(1994-7#1)(1997-7#1)
chemoenzymatic##2##1##(1992-11#1)(2008-10#1)
chemokine coreceptor##2##2##(2008-4#2)
chemokine gradient##2##2##(2009-12#2)
chemokine receptor##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
chemokine receptors##4##2##(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)
chemokine##33##1##(1994-11#2)(1994-9#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#1)(2010-11#1)(2010-5#3)(2010-6#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
chemokines and##3##2##(2008-1#1)(2008-2#1)(2012-3#1)
chemokines##23##1##(1994-12#2)(1994-9#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#2)(2010-11#1)(2010-5#1)(2012-1#7)(2012-3#1)(2013-1#1)
chemomechanical sensors##2##2##(2010-2#2)
chemometric analysis##3##2##(2008-10#3)
chemometric analytical##2##2##(2008-10#2)
chemometric approach##12##2##(2008-10#12)
chemometric approaches##3##2##(2008-10#2)(2008-3#1)
chemometric calibrations##2##2##(2008-10#2)
chemometric data##3##2##(2008-1#1)(2008-10#2)
chemometric method for##2##3##(2008-10#2)
chemometric method##7##2##(2008-10#7)
chemometric methods##8##2##(2008-10#8)
chemometric modeling##2##2##(2008-10#1)(2013-8#1)
chemometric models##2##2##(2008-10#2)
chemometric resolution method##2##3##(2008-10#2)
chemometric resolution##3##2##(2008-10#3)
chemometric study##5##2##(2008-10#5)
chemometric technique##4##2##(2008-10#3)(2008-3#1)
chemometric techniques##8##2##(2007-12#1)(2008-10#7)
chemometric tools##3##2##(2008-10#3)
chemometric##82##1##(2007-12#1)(2008-1#2)(2008-10#75)(2008-3#3)(2013-8#1)
chemometrical optimization##2##2##(2008-10#2)
chemometrical##6##1##(2008-10#6)
chemometrics and##2##2##(2008-10#2)
chemometrics methods##3##2##(2008-10#3)
chemometrics modelling##2##2##(2008-10#2)
chemometrics##24##1##(2007-12#2)(2008-1#1)(2008-10#17)(2008-3#1)(2010-5#1)(2013-8#2)
chemonucleolysis##5##1##(1996-8#1)(1997-2#2)(2007-8#2)
chemoorganotrophic##3##1##(2011-2#3)
chemopreventative properties of##2##3##(2010-1#2)
chemoprevention by##3##2##(1996-12#1)(2007-4#1)(2008-11#1)
chemoprevention of mammary##2##3##(1995-9#2)
chemoprevention of prostate cancer##3##4##(1995-9#2)(2008-6#1)
chemoprevention of##10##2##(1991-9#1)(1995-9#5)(2007-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
chemoprevention##24##1##(1991-9#1)(1995-9#6)(1996-12#1)(2007-4#2)(2008-11#3)(2008-12#2)(2008-6#2)(2009-11#2)(2009-12#1)(2009-5#1)(2011-2#2)(2013-1#1)
chemopreventive agent##3##2##(1992-9#1)(1997-7#1)(2011-2#1)
chemopreventive effects##5##2##(1992-5#2)(2008-11#1)(2008-4#1)(2009-3#1)
chemopreventive##15##1##(1992-5#2)(1992-9#1)(1995-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-3#2)(2011-2#2)
chemoprophylaxis##6##1##(1990-9#1)(1995-2#1)(2007-12#1)(2007-2#2)(2013-8#1)
chemoprotective##2##1##(2009-12#1)(2012-12#1)
chemoradiation therapy##3##2##(2008-7#1)(2009-5#2)
chemoradiation##8##1##(1994-8#1)(2008-10#3)(2008-7#1)(2009-5#2)(2010-12#1)
chemoradiotherapy for anal cancer##2##4##(2010-12#2)
chemoradiotherapy for##3##2##(2010-12#2)(2012-2#1)
chemoradiotherapy with##2##2##(1992-3#1)(2007-8#1)
chemoradiotherapy##18##1##(1992-3#1)(2007-8#1)(2008-10#2)(2010-12#4)(2010-8#1)(2012-2#1)(2012-3#3)(2013-8#5)
chemoreceptors##3##1##(1995-12#3)
chemoresistance and##4##2##(2009-4#1)(2012-12#2)(2013-1#1)
chemoresistance##10##1##(1997-5#1)(2008-11#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
chemoresponse##3##1##(1992-6#2)(2010-3#1)
chemoselective##2##1##(2008-10#2)
chemosensilla##2##1##(2007-12#1)(2010-11#1)
chemosensitive##2##1##(2008-7#1)(2013-8#1)
chemosensitivity of##2##2##(1991-2#1)(1991-8#1)
chemosensitivity##8##1##(1991-2#2)(1991-8#1)(1992-5#1)(1997-7#1)(2008-11#2)(2008-6#1)
chemosensor for##2##2##(2008-10#2)
chemosensory neurons##2##2##(1995-3#2)
chemosensory sensilla##2##2##(1995-3#1)(2007-12#1)
chemosensory##12##1##(1992-3#1)(1995-3#3)(2007-12#6)(2008-11#1)(2008-5#1)
chemostat cultivations##2##2##(1994-3#1)(2011-2#1)
chemostat culture##4##2##(2008-6#1)(2008-7#3)
chemostat cultures##4##2##(1994-5#1)(2008-11#1)(2008-6#1)(2008-7#1)
chemostat##18##1##(1994-3#1)(1994-5#1)(2008-11#1)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#1)(2011-2#1)
chemotactic N-formylamino acids##2##3##(2008-10#2)
chemotactic activities##2##2##(1994-12#1)(2008-10#1)
chemotactic activity##2##2##(1994-6#1)(2008-7#1)
chemotactic factor##2##2##(1992-3#1)(1992-6#1)
chemotactic for##4##2##(1990-12#1)(1992-6#2)(2008-9#1)
chemotactic gradients##2##2##(2009-12#2)
chemotactic peptide and##2##3##(1991-2#1)(1996-2#1)
chemotactic peptide##5##2##(1991-2#2)(1992-6#2)(1996-2#1)
chemotactic protein from Escherichia coli##2##5##(1993-11#2)
chemotactic protein-1 (MCP-1)##2##3##(1994-9#1)(2011-2#1)
chemotactic protein-1##3##2##(1994-9#1)(2011-2#2)
chemotactic response##2##2##(1992-6#1)(1997-3#1)
chemotactic##38##1##(1990-12#2)(1991-2#3)(1992-3#1)(1992-6#6)(1993-11#2)(1994-11#1)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-5#1)(2010-8#1)(2011-2#2)
chemotactically##2##1##(1994-11#1)(2008-8#1)
chemotaxis and##6##2##(1991-8#1)(1992-8#1)(1993-6#1)(1996-2#1)(2008-1#1)(2008-10#1)
chemotaxis assay##2##2##(2008-10#1)(2009-12#1)
chemotaxis assays##3##2##(2009-12#3)
chemotaxis in##3##2##(1992-8#1)(1994-11#2)
chemotaxis of LGL##3##3##(1990-12#3)
chemotaxis of##9##2##(1990-12#4)(1993-6#2)(2008-10#1)(2010-8#2)
chemotaxis to##2##2##(1990-12#2)
chemotaxis##54##1##(1990-12#7)(1991-2#2)(1991-8#1)(1992-8#2)(1992-9#1)(1993-6#7)(1994-11#5)(1994-5#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#4)(2010-5#1)(2010-8#2)(2010-9#1)(2013-8#1)
chemotaxonomic##2##1##(1990-8#1)(2011-2#1)
chemotherapeutic agent##3##2##(1990-7#1)(2012-3#2)
chemotherapeutic agents are##2##3##(1990-10#1)(2010-3#1)
chemotherapeutic agents in##3##3##(2008-5#1)(2009-12#2)
chemotherapeutic agents that##2##3##(1997-1#1)(2010-3#1)
chemotherapeutic agents were##2##3##(1997-7#1)(2013-1#1)
chemotherapeutic agents##24##2##(1990-10#1)(1990-2#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-11#4)(2008-5#3)(2008-7#1)(2009-12#2)(2010-3#2)(2012-2#3)(2013-1#2)(2013-7#1)
chemotherapeutic and##2##2##(1992-2#1)(1992-6#1)
chemotherapeutic drug##2##2##(1997-7#1)(2008-10#1)
chemotherapeutic drugs##7##2##(1997-7#3)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
chemotherapeutic effects##2##2##(1993-11#1)(2013-1#1)
chemotherapeutic protocols##2##2##(1990-10#1)(1991-2#1)
chemotherapeutic regimen##2##2##(1992-8#1)(2010-11#1)
chemotherapeutic regimens##5##2##(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-8#1)
chemotherapeutic targets##2##2##(2012-12#2)
chemotherapeutic##61##1##(1990-10#2)(1990-2#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1997-1#1)(1997-7#7)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-5#4)(2008-7#2)(2009-12#2)(2009-3#1)(2009-4#1)(2010-11#2)(2010-3#3)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
chemotherapeutics##2##1##(2008-9#1)(2012-3#1)
chemotherapy against##4##2##(1990-7#1)(1992-2#1)(1996-12#1)(2012-1#1)
chemotherapy agents##8##2##(2008-8#7)(2013-1#1)
chemotherapy alone##4##2##(1990-8#1)(2007-5#1)(2008-6#1)(2010-3#1)
chemotherapy along with radiotherapy##2##4##(2011-1#2)
chemotherapy and 5##2##3##(2008-7#1)(2012-1#1)
chemotherapy and in##2##3##(1991-8#1)(2011-1#1)
chemotherapy and radiation therapy##4##4##(1993-2#1)(2008-11#1)(2010-3#1)(2011-2#1)
chemotherapy and radiation##7##3##(1992-7#1)(1993-2#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
chemotherapy and radiotherapy##8##3##(1990-2#1)(1993-2#1)(2007-8#1)(2008-6#2)(2010-3#1)(2011-2#1)(2012-1#1)
chemotherapy and##54##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-8#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#2)(1994-8#2)(1995-6#1)(1995-9#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-6#4)(2008-7#7)(2009-10#1)(2009-4#1)(2009-8#1)(2010-3#4)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#3)(2013-1#1)
chemotherapy are##5##2##(1994-2#1)(2007-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
chemotherapy as##2##2##(1991-8#1)(2008-7#1)
chemotherapy by##5##2##(1994-5#1)(1997-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
chemotherapy can##2##2##(2010-3#1)(2012-12#1)
chemotherapy combination##3##2##(1990-2#1)(1992-2#2)
chemotherapy combined with##6##3##(1994-6#1)(2011-2#4)(2012-3#1)
chemotherapy consisting of##2##3##(1991-4#1)(1994-2#1)
chemotherapy could##2##2##(2010-3#1)(2013-1#1)
chemotherapy cycles##5##2##(1991-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
chemotherapy dose##2##2##(2008-7#2)
chemotherapy drug##4##2##(2008-8#1)(2009-12#1)(2011-1#2)
chemotherapy drugs##4##2##(2008-7#1)(2011-1#3)
chemotherapy followed by##4##3##(1992-6#1)(2008-10#1)(2008-6#1)(2012-12#1)
chemotherapy for Hodgkin's disease##2##4##(2007-7#2)
chemotherapy for a variety of##2##5##(2008-7#1)(2010-11#1)
chemotherapy for advanced##5##3##(1992-10#2)(2007-8#1)(2011-1#1)(2012-3#1)
chemotherapy for bone and soft tissue sarcomas##2##7##(2008-6#2)
chemotherapy for bone##3##3##(2008-6#3)
chemotherapy for cancer##3##3##(1992-8#1)(2008-7#1)(2009-12#1)
chemotherapy for metastatic##3##3##(1994-2#1)(2010-12#2)
chemotherapy for ovarian##2##3##(2012-12#1)(2013-1#1)
chemotherapy for the##3##3##(1995-9#1)(2008-6#1)(2013-1#1)
chemotherapy for##45##2##(1990-10#1)(1990-9#1)(1991-2#1)(1992-10#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#2)(1995-9#2)(1996-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-6#5)(2008-7#6)(2009-12#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
chemotherapy has##5##2##(1997-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-12#1)
chemotherapy have##4##2##(2008-6#1)(2008-7#1)(2010-3#1)(2013-8#1)
chemotherapy in adult patients with##2##5##(2008-6#2)
chemotherapy in advanced##3##3##(1993-2#1)(1994-8#1)(2010-8#1)
chemotherapy in breast cancer##5##4##(1995-8#3)(2007-5#1)(2008-7#1)
chemotherapy in colorectal cancer##2##4##(1990-2#1)(2008-8#1)
chemotherapy in early breast cancer##2##5##(1991-8#2)
chemotherapy in osteosarcoma##2##3##(2010-3#2)
chemotherapy in patients with##5##4##(2008-10#1)(2008-6#1)(2008-7#2)(2012-2#1)
chemotherapy in patients##6##3##(2008-10#1)(2008-6#2)(2008-7#2)(2012-2#1)
chemotherapy in the treatment of##7##5##(1992-12#2)(1993-9#1)(1997-5#1)(2007-11#1)(2012-3#1)(2013-1#1)
chemotherapy in the##10##3##(1990-6#1)(1991-8#1)(1992-12#2)(1993-9#1)(1997-5#1)(2007-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
chemotherapy in##56##2##(1990-2#1)(1990-6#1)(1991-8#3)(1991-9#1)(1992-12#4)(1992-2#3)(1992-6#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-8#3)(1996-6#1)(1997-3#2)(1997-5#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-6#7)(2008-7#4)(2008-8#1)(2010-2#2)(2010-3#4)(2010-8#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
chemotherapy is an##2##3##(2007-11#1)(2013-8#1)
chemotherapy is associated with##2##4##(2007-5#1)(2013-1#1)
chemotherapy is to##2##3##(1997-6#1)(2008-11#1)
chemotherapy is##16##2##(1991-8#1)(1993-8#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-11#3)(2008-6#1)(2008-7#1)(2010-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
chemotherapy may##2##2##(2008-6#1)(2010-3#1)
chemotherapy of liver##2##3##(1990-9#1)(2008-7#1)
chemotherapy of##13##2##(1990-9#1)(1991-11#1)(1991-3#1)(1992-10#1)(1996-6#1)(2007-5#1)(2007-7#1)(2008-6#1)(2008-7#3)(2010-2#1)(2011-2#1)
chemotherapy on##2##2##(1992-6#1)(2012-12#1)
chemotherapy only##3##2##(1992-2#1)(1993-9#1)(2011-2#1)
chemotherapy or radiation therapy##2##4##(2008-6#1)(2008-7#1)
chemotherapy or radiotherapy##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
chemotherapy or##6##2##(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)
chemotherapy regimen##5##2##(1990-6#1)(2008-7#1)(2008-8#1)(2010-3#2)
chemotherapy regimens and##2##3##(2008-7#1)(2012-1#1)
chemotherapy regimens for##2##3##(2010-4#1)(2012-3#1)
chemotherapy regimens##13##2##(1990-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#2)
chemotherapy response##2##2##(2008-7#1)(2010-3#1)
chemotherapy schedule##2##2##(1990-2#1)(1991-8#1)
chemotherapy that##2##2##(2008-7#1)(2013-8#1)
chemotherapy to##5##2##(2010-3#2)(2012-12#1)(2012-3#2)
chemotherapy trials##2##2##(1994-9#1)(1997-7#1)
chemotherapy was significantly##2##3##(1993-11#1)(2010-2#1)
chemotherapy was##23##2##(1990-12#2)(1990-9#1)(1991-4#1)(1991-6#1)(1993-11#1)(1993-9#1)(1997-3#2)(2008-10#1)(2010-12#1)(2010-2#1)(2010-3#6)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
chemotherapy were##11##2##(1991-2#1)(1991-8#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#3)(2010-11#1)(2012-3#1)
chemotherapy when##2##2##(2008-1#1)(2008-6#1)
chemotherapy will##3##2##(2008-5#1)(2010-3#1)(2010-8#1)
chemotherapy with autologous##2##3##(1996-3#1)(1997-3#1)
chemotherapy with cisplatin##2##3##(1992-12#1)(1994-12#1)
chemotherapy with cyclophosphamide##2##3##(1992-10#1)(1997-7#1)
chemotherapy with the##2##3##(1992-10#1)(1992-6#1)
chemotherapy with##28##2##(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#2)(1992-6#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
chemotherapy without##2##2##(1993-11#1)(2008-7#1)
chemotherapy##699##1##(1990-10#2)(1990-11#1)(1990-12#8)(1990-2#5)(1990-3#1)(1990-5#1)(1990-6#9)(1990-7#1)(1990-8#5)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#7)(1991-5#3)(1991-6#8)(1991-8#10)(1991-9#1)(1992-10#14)(1992-12#10)(1992-2#10)(1992-3#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#9)(1993-12#1)(1993-2#5)(1993-8#2)(1993-9#5)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#4)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#3)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#2)(1996-8#1)(1997-3#11)(1997-5#2)(1997-6#1)(1997-7#4)(2006-6#1)(2007-10#10)(2007-11#4)(2007-5#14)(2007-6#1)(2007-7#9)(2007-8#5)(2008-1#6)(2008-10#24)(2008-11#15)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#56)(2008-7#82)(2008-8#17)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#2)(2009-8#2)(2010-11#4)(2010-12#10)(2010-2#5)(2010-3#50)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#16)(2011-2#36)(2011-3#1)(2012-1#8)(2012-12#9)(2012-2#6)(2012-3#22)(2013-1#35)(2013-7#2)(2013-8#13)
chemotherapy)##2##1##(1997-5#1)(2013-7#1)
chemotherapy-##2##1##(2008-5#1)(2008-7#1)
chemotherapy-associated anemia##3##2##(2008-7#3)
chemotherapy-associated##4##1##(2008-7#3)(2012-12#1)
chemotherapy-induced anemia##8##2##(2008-7#6)(2010-11#1)(2010-9#1)
chemotherapy-induced apoptosis##2##2##(2008-11#2)
chemotherapy-induced febrile neutropenia##3##3##(2008-7#3)
chemotherapy-induced nausea and vomiting##5##4##(2008-7#1)(2010-12#3)(2010-9#1)
chemotherapy-induced neutropenia##4##2##(2008-7#4)
chemotherapy-induced##33##1##(2007-5#1)(2008-11#3)(2008-7#22)(2010-10#1)(2010-11#1)(2010-12#3)(2010-9#2)
chemotherapy]##4##1##(1990-3#1)(1991-3#2)(1994-2#1)
cherry disease##3##2##(2008-10#3)
cherry fruit##4##2##(2008-10#4)
cherry red##2##2##(2010-8#1)(2011-2#1)
cherry tomatoes##2##2##(2008-2#2)
cherry trees##2##2##(2008-10#2)
cherry##33##1##(2008-10#28)(2008-2#2)(2008-9#1)(2010-8#1)(2011-2#1)
cherubism##3##1##(2007-12#1)(2009-3#2)
chessboard##3##1##(2008-3#3)
chest CT##8##2##(2008-1#1)(2008-6#1)(2012-2#2)(2013-1#4)
chest MDCT##2##2##(2011-2#2)
chest X ray##4##3##(2008-1#3)(2013-1#1)
chest X-ray and##2##3##(2013-1#1)(2013-8#1)
chest X-ray films##3##3##(2008-1#3)
chest X-ray##16##2##(1990-6#1)(1991-11#1)(1991-12#3)(1997-3#1)(2007-10#1)(2008-1#4)(2009-9#1)(2010-11#1)(2013-1#2)(2013-8#1)
chest X-rays##2##2##(2007-8#1)(2008-7#1)
chest and##6##2##(2007-11#1)(2007-8#1)(2012-12#1)(2012-2#3)
chest compressions and epinephrine as part of##2##7##(2012-2#2)
chest compressions##3##2##(2009-10#1)(2012-2#2)
chest computed##3##2##(2008-1#2)(2010-10#1)
chest incision pain##2##3##(2007-11#2)
chest pain and weight##2##4##(2007-8#1)(2011-1#1)
chest pain and##13##3##(1997-4#1)(2007-8#2)(2008-3#2)(2008-7#1)(2010-1#1)(2010-10#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
chest pain center##5##3##(2008-3#5)
chest pain centers##6##3##(2008-3#6)
chest pain for##2##3##(1996-3#1)(2007-8#1)
chest pain in##4##3##(1991-3#1)(2008-3#2)(2013-1#1)
chest pain initiative##3##3##(2008-3#3)
chest pain patients in the ED##2##6##(2012-2#2)
chest pain patients in the emergency department##2##7##(2008-3#2)
chest pain patients in the##5##5##(2008-3#3)(2012-2#2)
chest pain patients in##6##4##(2008-3#4)(2012-2#2)
chest pain patients##9##3##(2008-3#7)(2012-2#2)
chest pain resulting from diffuse esophageal spasm and related disorders##2##10##(1992-6#2)
chest pain type##3##3##(2008-3#3)
chest pain##109##2##(1991-3#1)(1992-6#3)(1996-3#5)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#45)(2008-7#4)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#11)(2012-3#1)(2013-1#4)(2013-7#2)
chest physicians##2##2##(1995-2#1)(2008-7#1)
chest physiotherapy##2##2##(1991-2#1)(1997-3#1)
chest radiograph and##3##3##(2007-12#1)(2008-1#1)(2008-7#1)
chest radiograph##11##2##(1991-3#1)(1991-9#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
chest radiography in the##2##4##(1997-8#1)(2011-2#1)
chest radiography in##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
chest radiography##9##2##(1997-8#2)(2006-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
chest roentgenogram##2##2##(1991-12#1)(2007-8#1)
chest roentgenograms##2##2##(2008-1#1)(2008-7#1)
chest syndrome##2##2##(2013-1#2)
chest trauma is##2##3##(2007-8#1)(2012-2#1)
chest trauma##8##2##(2007-8#6)(2012-2#2)
chest tube drainage##2##3##(2007-9#1)(2008-7#1)
chest tube##8##2##(2006-10#2)(2007-9#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
chest wall abnormalities##2##3##(1991-12#1)(2007-8#1)
chest wall and##5##3##(2007-8#1)(2010-6#1)(2010-9#1)(2012-2#2)
chest wall deformities##5##3##(2012-2#5)
chest wall hydatid cysts associated with spinal canal involvement##2##9##(2007-8#2)
chest wall is a rare##3##5##(2007-12#1)(2007-8#2)
chest wall lesions##2##3##(1990-6#1)(2010-3#1)
chest wall reconstruction##11##3##(2012-2#11)
chest wall resection##3##3##(2007-8#1)(2009-3#2)
chest wall stabilization##2##3##(2012-2#2)
chest wall tuberculosis##3##3##(2007-8#3)
chest wall tumor##2##3##(2007-8#1)(2009-3#1)
chest wall tumors##2##3##(2012-2#2)
chest wall##84##2##(1990-6#1)(1991-12#3)(1992-6#1)(2006-10#2)(2007-12#2)(2007-8#21)(2008-6#7)(2009-1#1)(2009-3#4)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#35)(2013-1#2)
chest wound##2##2##(1992-6#1)(2007-8#1)
chest x-ray reports##2##3##(2010-12#2)
chest x-ray revealed##2##3##(2007-12#1)(2010-12#1)
chest x-ray##10##2##(2007-12#2)(2008-7#1)(2010-12#5)(2011-2#1)(2012-3#1)
chest##346##1##(1990-5#1)(1990-6#4)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#2)(1991-9#2)(1992-6#5)(1992-9#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-3#5)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#5)(2006-10#5)(2007-10#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#3)(2007-8#45)(2007-9#1)(2008-1#19)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#46)(2008-5#1)(2008-6#9)(2008-7#12)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#15)(2012-12#4)(2012-2#58)(2012-3#4)(2013-1#19)(2013-7#3)(2013-8#1)
chestnut blight##11##2##(2008-10#10)(2008-9#1)
chestnut tree##2##2##(2008-10#1)(2008-5#1)
chestnut##18##1##(2008-10#13)(2008-5#4)(2008-9#1)
cheveux##5##1##(2008-5#5)
chewer##2##1##(2013-1#1)(2013-7#1)
chewers##4##1##(2013-1#4)
chewing and##2##2##(2008-10#1)(2013-1#1)
chewing is a##2##3##(2008-1#1)(2013-1#1)
chewing lice##4##2##(2011-2#4)
chewing tobacco##2##2##(2010-12#1)(2013-1#1)
chewing##24##1##(1996-2#3)(1996-6#1)(2008-1#4)(2008-10#1)(2009-4#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#7)(2013-7#1)
chez la femme enceinte##2##4##(2013-1#2)
chez le##2##2##(2013-1#2)
chez un##3##2##(2013-1#3)
chez##10##1##(2008-11#1)(2013-1#9)
chi 2##3##2##(1990-9#1)(1994-9#1)(1996-3#1)
chi can##2##2##(2007-11#1)(2008-10#1)
chi on##2##2##(2007-11#1)(2008-10#1)
chi square##2##2##(1990-3#2)
chi##25##1##(1990-3#2)(1990-9#1)(1991-3#2)(1993-11#1)(1994-9#1)(1995-5#1)(1996-3#1)(2007-11#5)(2007-12#1)(2008-10#9)(2010-12#1)
chi((2)) grating##3##2##(2007-11#3)
chi((2)) photonic##2##2##(2007-12#2)
chi((2))##12##1##(2007-11#5)(2007-12#6)(2008-2#1)
chi((3))##8##1##(2007-11#3)(2007-12#2)(2008-3#2)(2010-7#1)
chi(2) test##2##2##(2008-7#1)(2009-9#1)
chi(2) tests##2##2##(2008-10#2)
chi(2)##8##1##(2008-10#4)(2008-3#2)(2008-7#1)(2009-9#1)
chi(3)##3##1##(2008-3#3)
chi-square test##6##2##(2007-8#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
chi-square##10##1##(1995-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
chi2##3##1##(2007-10#1)(2008-1#1)(2008-9#1)
chia seed##2##2##(2011-2#2)
chiasm##3##1##(2008-7#1)(2012-12#1)(2012-3#1)
chiasma frequencies##2##2##(2008-5#2)
chiasma frequency and##2##3##(2008-5#2)
chiasma frequency##3##2##(2008-5#3)
chiasma##12##1##(2008-5#12)
chiasmata were##3##2##(2008-5#3)
chiasmata##4##1##(2008-5#4)
chick and##3##2##(1993-6#1)(1996-2#2)
chick brain##5##2##(1990-7#1)(1995-11#1)(1996-12#2)(1996-2#1)
chick cerebellar##2##2##(1995-5#1)(2008-9#1)
chick chorioallantoic membrane##4##3##(1990-4#1)(2008-1#3)
chick ciliary##3##2##(1990-5#3)
chick development##3##2##(1997-4#3)
chick embryo spinal cord motoneurons##2##5##(1997-2#2)
chick embryo##9##2##(1990-8#1)(1994-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(2008-1#2)(2008-11#1)
chick embryos##6##2##(1991-12#1)(1992-5#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-8#1)
chick##77##1##(1990-11#2)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#4)(1993-12#1)(1993-6#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-5#3)(1996-12#9)(1996-2#7)(1996-5#4)(1997-1#4)(1997-2#2)(1997-4#7)(2008-1#7)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-12#2)
chick-pea##2##1##(2008-10#2)
chicken (Gallus##2##2##(2008-5#1)(2010-4#1)
chicken CaD##2##2##(1993-11#2)
chicken PTH-(1-88)##6##2##(1991-3#6)
chicken Z##4##2##(2008-5#3)(2010-3#1)
chicken adipocyte precursors##2##3##(1992-9#2)
chicken adipocyte##3##2##(1992-9#3)
chicken anaemia agent##3##3##(1991-3#3)
chicken anaemia virus (CAV) isolate##2##5##(2007-6#1)(2008-5#1)
chicken anaemia virus (CAV)##3##4##(2007-6#1)(2008-5#2)
chicken anaemia virus##6##3##(2007-6#2)(2008-5#4)
chicken anaemia##9##2##(1991-3#3)(2007-6#2)(2008-5#4)
chicken and##11##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-12#2)(1994-8#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-4#1)
chicken beta-actin promoter##2##3##(2008-11#1)(2008-9#1)
chicken bone##2##2##(2010-4#2)
chicken brain membranes##3##3##(1993-6#3)
chicken brain##9##2##(1993-6#5)(1995-3#4)
chicken breast tissue##6##3##(2007-11#3)(2008-2#3)
chicken breast##7##2##(1997-2#1)(2007-11#3)(2008-2#3)
chicken breasts##5##2##(2007-3#5)
chicken carcases##2##2##(1990-9#2)
chicken eggs##10##2##(1997-7#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#2)
chicken embryo cells##2##3##(1992-11#2)
chicken embryo fibroblasts (CEF)##2##4##(1991-5#1)(2008-11#1)
chicken embryo fibroblasts and##2##4##(1991-5#1)(1993-6#1)
chicken embryo fibroblasts##4##3##(1991-5#2)(1993-6#1)(2008-11#1)
chicken embryo##15##2##(1991-5#2)(1992-11#3)(1992-3#1)(1993-6#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-12#2)(2011-1#2)
chicken embryonic##4##2##(1993-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
chicken embryos##6##2##(1992-3#2)(1997-6#1)(2007-6#1)(2008-11#1)(2008-8#1)
chicken feather##3##2##(2008-6#3)
chicken flocks##2##2##(2008-5#2)
chicken genomic DNA##4##3##(1990-12#2)(2008-5#2)
chicken gizzard##5##2##(1991-2#1)(1992-9#1)(1993-6#1)(1993-8#2)
chicken heart and##2##3##(1997-3#1)(2008-5#1)
chicken heart##4##2##(1997-3#1)(2008-5#1)(2008-8#2)
chicken hepatic##2##2##(1990-11#1)(2010-12#1)
chicken hybridoma##3##2##(2008-11#3)
chicken intestine##2##2##(2008-12#1)(2008-5#1)
chicken is##2##2##(2008-11#1)(2008-5#1)
chicken kidney cells and##2##4##(1991-3#1)(2007-6#1)
chicken kidney cells##5##3##(1991-3#3)(2007-6#2)
chicken kidney##6##2##(1991-3#3)(1997-6#1)(2007-6#2)
chicken leg bone protein##2##4##(2010-2#2)
chicken liver##7##2##(1990-11#1)(1990-5#1)(1993-12#3)(2008-10#2)
chicken manure##5##2##(2008-10#5)
chicken meat##2##2##(2008-10#1)(2011-2#1)
chicken nebulin##3##2##(2008-6#3)
chicken ovalbumin##2##2##(1996-5#1)(2008-11#1)
chicken ovarian follicles##3##3##(2008-12#3)
chicken oviduct##3##2##(1990-8#2)(1993-8#1)
chicken respiratory viruses##2##3##(2013-8#2)
chicken respiratory##5##2##(2013-8#5)
chicken skeletal##2##2##(1990-5#1)(2008-6#1)
chicken##276##1##(1990-11#2)(1990-12#6)(1990-2#2)(1990-5#3)(1990-8#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#15)(1991-5#6)(1991-6#9)(1992-11#3)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#7)(1993-2#4)(1993-6#10)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-2#1)(1995-3#4)(1995-6#1)(1996-12#1)(1996-5#6)(1997-1#1)(1997-2#2)(1997-3#5)(1997-6#4)(1997-7#3)(1997-9#9)(2007-11#3)(2007-12#1)(2007-3#5)(2007-6#11)(2008-1#2)(2008-10#15)(2008-11#14)(2008-12#9)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#29)(2008-6#7)(2008-8#7)(2008-9#6)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#4)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#5)
chickenpox##3##1##(1991-12#1)(2008-11#1)(2011-1#1)
chickens and old hens##2##4##(2012-1#2)
chickens and pigeons##2##3##(1997-3#1)(2009-2#1)
chickens and##7##2##(1997-3#2)(2008-11#1)(2009-2#1)(2012-1#3)
chickens in##2##2##(1996-11#1)(1997-3#1)
chickens infected with##2##3##(1997-6#2)
chickens is described##2##3##(1997-6#1)(2008-5#1)
chickens is##3##2##(1997-6#2)(2008-5#1)
chickens of##3##2##(1997-3#1)(1997-6#1)(2008-5#1)
chickens using##2##2##(1997-6#1)(2007-6#1)
chickens vaccinated with##2##3##(1997-6#1)(2008-5#1)
chickens were randomly##2##3##(1997-3#1)(2011-1#1)
chickens were##9##2##(1997-3#1)(1997-6#5)(2008-5#2)(2011-1#1)
chickens with##6##2##(1997-3#2)(1997-6#2)(2008-5#2)
chickens##91##1##(1991-9#1)(1996-11#1)(1997-3#7)(1997-6#30)(2007-6#7)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#22)(2008-8#3)(2009-2#1)(2011-1#5)(2012-1#6)(2013-1#2)
chickpea (Cicer arietinum)##2##3##(2008-10#2)
chickpea (Cicer##3##2##(2008-10#3)
chickpea and faba bean##2##4##(2008-10#2)
chickpea cultivar##4##2##(2008-10#4)
chickpea cultivars##3##2##(2008-10#3)
chickpea genotypes##2##2##(2008-10#2)
chickpea plants##2##2##(2008-10#2)
chickpea seed yield##2##3##(2008-10#2)
chickpea yield##2##2##(2008-10#2)
chickpea##40##1##(2008-10#40)
chickpeas in##3##2##(2008-10#3)
chickpeas##5##1##(2008-10#5)
chicks aged##2##2##(1990-3#2)
chicks and##2##2##(1990-11#1)(2008-5#1)
chicks at##3##2##(1990-11#1)(2008-12#1)(2008-5#1)
chicks fed##3##2##(1991-9#1)(2008-12#1)(2010-4#1)
chicks from nests##2##3##(2008-8#2)
chicks from##3##2##(2008-5#1)(2008-8#2)
chicks in##2##2##(1997-3#1)(2010-4#1)
chicks inoculated with 2##2##4##(2008-5#2)
chicks learned to avoid##2##4##(2008-6#2)
chicks than in##2##3##(1990-11#1)(2008-5#1)
chicks that##3##2##(1990-11#1)(2008-6#2)
chicks were infected##2##3##(1995-9#1)(1997-6#1)
chicks were##11##2##(1995-9#1)(1997-3#3)(1997-6#3)(2008-5#1)(2008-6#2)(2010-4#1)
chicks will##2##2##(2008-6#1)(2008-9#1)
chicks##88##1##(1990-11#5)(1990-3#3)(1991-3#2)(1991-9#1)(1992-9#1)(1995-9#1)(1997-3#8)(1997-6#6)(2007-6#2)(2008-12#14)(2008-5#16)(2008-6#15)(2008-8#3)(2008-9#3)(2010-4#6)(2011-2#2)
chicory (Cichorium##2##2##(2008-10#2)
chicory##3##1##(2008-10#3)
chief cells##13##2##(1994-8#6)(1995-8#7)
chief complaint of##6##3##(2008-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
chief complaint##8##2##(2008-12#2)(2011-2#1)(2012-12#3)(2013-1#2)
chief county medical officers react more often##2##7##(1997-8#2)
chief executive officer (CEO)##2##4##(1995-2#1)(1996-2#1)
chief executive officer##3##3##(1994-1#1)(1995-2#1)(1996-2#1)
chief executive officers##2##3##(1996-2#1)(2008-1#1)
chief executive##5##2##(1994-1#1)(1995-2#1)(1996-2#2)(2008-1#1)
chief financial##2##2##(1993-2#1)(1993-3#1)
chief information officer in##2##4##(1993-2#1)(1996-3#1)
chief information##3##2##(1993-2#2)(1996-3#1)
chief technologists##5##2##(1995-1#1)(1995-2#1)(1995-3#3)
chief##64##1##(1991-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1994-1#1)(1994-2#1)(1994-8#6)(1995-1#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#7)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#5)(2012-12#3)(2013-1#6)
chiefly in##3##2##(1990-12#1)(1992-6#1)(2008-4#1)
chiefly##15##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-12#2)(1995-5#1)(2007-7#1)(2008-4#1)(2008-6#3)
chikungunya virus##3##2##(2011-1#3)
chikungunya##8##1##(2011-1#7)(2013-8#1)
child (aged##2##2##(2012-2#2)
child able to##2##3##(1995-5#1)(2012-2#1)
child abuse and neglect##5##4##(1996-2#1)(2007-12#1)(2009-7#2)(2012-2#1)
child abuse and##6##3##(1996-2#1)(2007-12#1)(2009-5#1)(2009-7#2)(2012-2#1)
child abuse##18##2##(1992-1#1)(1992-4#1)(1995-5#1)(1996-2#3)(1996-8#1)(2007-12#3)(2008-11#1)(2009-5#1)(2009-7#2)(2009-9#2)(2012-1#1)(2012-2#1)
child admitted##2##2##(2008-7#1)(2011-2#1)
child age##2##2##(1995-2#1)(2009-11#1)
child aged##2##2##(2008-9#1)(2010-3#1)
child an unhealthy diet##2##4##(2010-6#2)
child and adolescent mental health##2##5##(2008-11#1)(2011-2#1)
child and adolescent psychiatric##3##4##(1993-12#1)(1993-2#1)(1996-7#1)
child and adolescent psychiatry##2##4##(2008-11#1)(2008-4#1)
child and adolescent##12##3##(1992-1#2)(1993-1#1)(1993-12#1)(1993-2#1)(1996-7#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
child and adult##3##3##(1993-12#2)(1996-7#1)
child and family disaster mental health##2##6##(2012-12#2)
child and family##5##3##(1994-2#1)(2008-11#2)(2012-12#2)
child and the##3##3##(1995-5#1)(2007-11#1)(2013-1#1)
child and youth health##2##4##(2008-11#1)(2009-5#1)
child and youth##3##3##(2008-11#2)(2009-5#1)
child and##43##2##(1992-1#2)(1993-1#1)(1993-12#3)(1993-2#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-5#3)(1996-7#2)(2007-11#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)
child behavior problems##2##3##(1995-2#1)(2009-11#1)
child behavior##3##2##(1995-2#2)(2009-11#1)
child care centers##2##3##(1994-2#1)(2013-1#1)
child care##16##2##(1990-2#1)(1991-12#1)(1994-2#3)(1995-5#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#2)(2012-3#2)(2013-1#2)
child day care centers]##3##4##(1994-6#1)(2007-3#2)
child development in Canada##2##4##(2010-12#2)
child development in##3##3##(2008-11#1)(2010-12#2)
child development##22##2##(1995-1#1)(1996-9#3)(2008-11#4)(2009-9#1)(2010-12#8)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
child distress and##2##3##(1995-2#1)(1996-2#1)
child distress##6##2##(1995-2#2)(1996-2#4)
child due to accidental oral ingestion##2##6##(1995-11#2)
child during##2##2##(1993-3#1)(2012-2#1)
child feeding##3##2##(2010-5#2)(2010-6#1)
child from the##3##3##(1991-6#1)(1992-11#1)(2007-8#1)
child from##7##2##(1991-6#1)(1992-11#1)(1995-5#2)(2007-8#1)(2010-7#1)(2012-2#1)
child gender##2##2##(2009-11#1)(2010-6#1)
child growth##2##2##(2010-5#1)(2011-2#1)
child guidance##2##2##(2009-10#1)(2012-2#1)
child had##3##2##(1996-3#1)(2008-7#1)(2009-10#1)
child has##3##2##(2007-12#1)(2008-11#1)(2010-3#1)
child health care##4##3##(1990-6#1)(1991-3#1)(1995-1#1)(2012-3#1)
child health information##2##3##(2012-12#2)
child health input##2##3##(2008-11#2)
child health##32##2##(1990-6#1)(1991-11#1)(1991-3#2)(1992-3#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#2)(1996-12#2)(1997-2#1)(2008-11#7)(2009-6#1)(2009-7#3)(2012-12#5)(2012-3#1)
child in##5##2##(1995-5#2)(2008-11#1)(2009-7#1)(2010-6#1)
child is##10##2##(1993-12#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
child laborers##3##2##(1997-6#2)(2009-10#1)
child life program##2##3##(1993-12#2)
child life##5##2##(1991-3#1)(1992-12#1)(1993-12#3)
child molester##2##2##(1996-5#2)
child morbidity and mortality##2##4##(2009-6#1)(2009-7#1)
child mortality##5##2##(2007-11#1)(2011-1#2)(2013-1#2)
child obesity##2##2##(2012-2#1)(2013-8#1)
child of##2##2##(1994-12#1)(1994-7#1)
child on##2##2##(2008-11#2)
child or##2##2##(1995-2#1)(2011-2#1)
child perceptions##2##2##(2008-12#2)
child population##2##2##(1997-2#1)(2012-12#1)
child poverty approaches##3##3##(2010-3#3)
child poverty by 50% by##2##5##(2008-11#2)
child poverty by##3##3##(2008-11#3)
child poverty##16##2##(2008-11#12)(2010-3#4)
child presented with##4##3##(2007-12#1)(2008-10#2)(2010-11#1)
child presenting with##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
child presents with##2##3##(2008-10#1)(2008-11#1)
child presents##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
child problems##2##2##(1995-2#1)(2008-9#1)
child psychiatric##5##2##(1991-2#1)(1993-1#1)(1996-9#3)
child psychiatry##5##2##(1996-6#1)(2008-11#4)
child social development and behavior##2##5##(2009-9#2)
child social development##3##3##(2009-9#3)
child survival##4##2##(1990-12#1)(1997-4#1)(2009-4#1)(2009-6#1)
child to##8##2##(1994-3#1)(1995-5#1)(1996-2#2)(2007-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
child under the age of##2##5##(2009-5#1)(2010-6#1)
child under##3##2##(1991-8#1)(2009-5#1)(2010-6#1)
child was##12##2##(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-6#1)(2012-3#1)
child well-being##4##2##(2008-11#1)(2008-2#2)(2010-3#1)
child who is##2##3##(2008-9#1)(2010-9#1)
child who presented with an##2##5##(2009-9#1)(2012-2#1)
child who presented with##8##4##(2007-7#1)(2007-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)
child who presents with##4##4##(2006-5#3)(2010-6#1)
child who presents##6##3##(2006-5#5)(2010-6#1)
child who was treated surgically##2##5##(2011-2#1)(2013-1#1)
child who##20##2##(2006-5#5)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
child with CINCA syndrome##2##4##(2012-2#2)
child with a##8##3##(1992-3#1)(2008-10#2)(2008-9#3)(2009-5#1)(2010-1#1)
child with acute##3##3##(2008-1#1)(2009-4#1)(2011-2#1)
child with congenital##2##3##(2007-8#1)(2012-12#1)
child with severe##2##3##(2008-10#1)(2008-9#1)
child with the##2##3##(1993-2#1)(2011-1#1)
child with##59##2##(1990-10#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-3#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#7)(2009-4#1)(2009-5#3)(2010-1#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#1)
child##635##1##(1990-10#3)(1990-12#9)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#4)(1991-8#1)(1992-1#4)(1992-11#1)(1992-12#1)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#2)(1993-1#4)(1993-12#16)(1993-2#4)(1993-3#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#7)(1995-11#2)(1995-12#4)(1995-2#7)(1995-5#28)(1996-11#2)(1996-12#2)(1996-2#11)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#6)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2006-10#1)(2006-5#5)(2007-10#1)(2007-11#4)(2007-12#11)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#15)(2008-1#1)(2008-10#32)(2008-11#61)(2008-12#9)(2008-2#10)(2008-3#3)(2008-4#2)(2008-7#7)(2008-8#4)(2008-9#28)(2009-10#9)(2009-11#8)(2009-12#1)(2009-4#5)(2009-5#11)(2009-6#3)(2009-7#10)(2009-9#11)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#11)(2010-3#8)(2010-4#3)(2010-5#8)(2010-6#11)(2010-7#4)(2010-8#5)(2010-9#11)(2011-1#16)(2011-2#25)(2012-1#2)(2012-12#30)(2012-2#23)(2012-3#7)(2013-1#21)(2013-8#9)
child's diagnosis##3##2##(1990-10#3)
child's diet##2##2##(2010-6#2)
child's emotional##2##2##(1992-2#1)(1992-3#1)
child's medical##2##2##(1992-3#1)(1995-1#1)
child's##71##1##(1990-10#4)(1991-1#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-2#3)(1992-3#2)(1993-12#3)(1993-2#4)(1994-3#1)(1995-1#5)(1995-12#2)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-10#1)(2010-3#1)(2010-6#2)(2010-9#5)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#1)
child)##4##1##(1990-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
child- and##2##2##(1995-6#1)(1996-9#1)
child-bearing##3##1##(1992-12#1)(1996-12#1)(2009-7#1)
child-focused##2##1##(1991-3#1)(2009-11#1)
child-rearing##2##1##(1995-1#1)(2008-11#1)
child-related##2##1##(2008-12#1)(2012-3#1)
child-reported##2##1##(1996-1#2)
child]##5##1##(1990-10#1)(1990-12#1)(1993-5#1)(1996-9#1)(2009-5#1)
childbearing age##9##2##(1991-1#1)(1992-12#1)(1993-6#1)(2009-8#1)(2010-4#1)(2013-1#3)(2013-8#1)
childbearing and##2##2##(2009-10#1)(2009-11#1)
childbearing women and their##2##4##(1992-12#1)(2013-1#1)
childbearing women as well as##2##5##(1992-12#2)
childbearing women##8##2##(1992-12#3)(2007-2#2)(2013-1#3)
childbearing##34##1##(1990-2#1)(1991-1#1)(1992-12#4)(1993-6#1)(1995-1#1)(1997-3#1)(2007-2#2)(2007-8#1)(2008-4#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-8#1)(2010-12#3)(2010-4#1)(2012-12#1)(2013-1#9)(2013-8#1)
childbirth and##2##2##(2009-10#1)(2010-6#1)
childbirth as##5##2##(1993-3#3)(1995-1#2)
childbirth education classes##4##3##(2007-2#4)
childbirth education##6##2##(2007-2#6)
childbirth educator##3##2##(2007-2#3)
childbirth educators##4##2##(2007-2#4)
childbirth experience##3##2##(1995-1#1)(2007-2#1)(2013-1#1)
childbirth in##2##2##(1995-1#1)(2009-10#1)
childbirth##47##1##(1993-3#4)(1995-1#4)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(2007-2#21)(2009-10#2)(2010-12#1)(2010-3#4)(2010-6#2)(2011-2#2)(2013-1#3)
childbirth]##2##1##(1992-5#1)(2012-2#1)
childcare##5##1##(2008-11#1)(2008-9#3)(2012-12#1)
childhood acute lymphoblastic##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
childhood acute##6##2##(2008-11#1)(2010-11#1)(2011-2#4)
childhood and adolescence##13##3##(1995-2#1)(1996-11#1)(2007-7#1)(2008-11#1)(2008-9#3)(2009-12#2)(2010-3#1)(2011-2#2)(2013-1#1)
childhood and adolescent##4##3##(2008-11#1)(2010-3#2)(2012-2#1)
childhood and adult life##3##4##(2008-10#1)(2009-8#1)(2010-5#1)
childhood and adult##4##3##(1990-12#1)(2008-10#1)(2009-8#1)(2010-5#1)
childhood and adulthood##3##3##(1996-8#1)(2008-11#1)(2008-2#1)
childhood and early##2##3##(1990-6#1)(2010-4#1)
childhood and is##2##3##(2007-7#1)(2009-12#1)
childhood and##44##2##(1990-12#1)(1990-6#1)(1993-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2007-7#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#5)(2009-12#3)(2009-8#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
childhood are##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
childhood asthma##6##2##(2008-10#1)(2008-11#3)(2012-2#1)(2012-3#1)
childhood atopic dermatitis##2##3##(2013-1#2)
childhood cancer##3##2##(2008-11#1)(2008-6#1)(2012-2#1)
childhood conduct disorder (n =##2##5##(1994-2#2)
childhood conduct disorder##3##3##(1994-2#3)
childhood disease##2##2##(1993-11#1)(2007-12#1)
childhood diseases##2##2##(2008-8#1)(2008-9#1)
childhood epilepsy##2##2##(1995-12#1)(2008-11#1)
childhood experiences##2##2##(2009-8#2)
childhood fever##2##2##(1991-11#1)(2010-4#1)
childhood idiopathic thrombocytopenic purpura##2##4##(1997-8#2)
childhood immunization##4##2##(1995-5#1)(1996-12#2)(1996-3#1)
childhood immunizations##3##2##(1996-12#3)
childhood in##4##2##(1992-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
childhood is##7##2##(1991-6#1)(1996-11#1)(2007-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
childhood lead poisoning as##2##4##(1995-3#1)(1997-4#1)
childhood lead poisoning##3##3##(1995-3#2)(1997-4#1)
childhood lead##4##2##(1995-11#1)(1995-3#2)(1997-4#1)
childhood leukemia##3##2##(1991-3#2)(1996-2#1)
childhood malnutrition in Yemen##3##4##(2010-6#3)
childhood malnutrition in##4##3##(2010-6#4)
childhood malnutrition##5##2##(2010-6#5)
childhood maltreatment##2##2##(2009-8#2)
childhood may##2##2##(2008-1#1)(2008-12#1)
childhood obesity and physical inactivity##3##5##(2008-12#3)
childhood obesity and##4##3##(2008-12#3)(2012-2#1)
childhood obesity epidemic##3##3##(2011-1#1)(2012-2#2)
childhood obesity prevention##3##3##(2009-6#1)(2012-2#2)
childhood obesity##18##2##(2008-12#3)(2008-3#1)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#7)(2012-3#2)
childhood period##2##2##(2007-8#1)(2011-2#1)
childhood populations##2##2##(2012-2#2)
childhood through##2##2##(1995-3#1)(2010-10#1)
childhood to##3##2##(1995-6#1)(2012-3#2)
childhood trauma##4##2##(1996-3#2)(2013-8#2)
childhood##321##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#4)(1991-6#1)(1991-8#3)(1992-11#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-2#6)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#7)(1995-6#2)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#4)(1996-8#1)(1997-4#3)(1997-7#1)(1997-8#5)(2006-10#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-5#2)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#23)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#6)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#4)(2010-6#6)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#12)(2011-2#24)(2012-12#4)(2012-2#18)(2012-3#10)(2013-1#17)(2013-8#9)
childhood-onset##2##1##(2012-3#1)(2013-1#1)
childhood]##6##1##(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1994-6#1)(2013-8#1)
childless##5##1##(1996-9#2)(1997-2#1)(2009-10#1)(2011-2#1)
children &lt##2##2##(1995-3#1)(2011-2#1)
children (11##2##2##(1990-9#1)(2007-10#1)
children (3##2##2##(2011-2#2)
children (4##2##2##(1994-12#1)(2007-7#1)
children (8##2##2##(1991-6#1)(2008-1#1)
children (age##3##2##(1990-2#1)(2011-2#1)(2012-3#1)
children (aged##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
children (mean age##3##3##(1997-2#1)(2010-1#1)(2013-1#1)
children (p = 0##3##4##(2008-9#1)(2009-8#2)
children (p##4##2##(1995-12#1)(2008-9#1)(2009-8#2)
children (with##2##2##(2011-2#2)
children -##5##2##(2007-12#1)(2008-11#3)(2013-8#1)
children 6 to##2##3##(2007-11#1)(2010-5#1)
children about##2##2##(1992-3#1)(2009-11#1)
children above##3##2##(2007-11#1)(2008-2#1)(2011-2#1)
children admitted in##2##3##(2011-2#1)(2012-3#1)
children admitted##3##2##(1993-12#1)(2011-2#1)(2012-3#1)
children affected by##2##3##(2007-8#1)(2012-12#1)
children after##5##2##(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
children aged 2 to##2##4##(2008-9#1)(2012-3#1)
children aged 2##4##3##(1995-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
children aged 5 to##2##4##(2009-10#1)(2012-12#1)
children aged 6##3##3##(2010-5#1)(2013-1#2)
children aged 7 to##2##4##(2012-1#1)(2012-3#1)
children aged between##3##3##(1997-2#1)(2008-9#1)(2013-1#1)
children aged from 2 to##2##5##(2008-12#2)
children aged from##5##3##(1991-9#1)(2008-12#3)(2010-11#1)
children aged less##2##3##(2010-6#1)(2012-12#1)
children aged two##2##3##(1992-4#1)(2010-10#1)
children aged##45##2##(1990-12#2)(1991-9#1)(1992-4#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-9#4)(2009-10#3)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)
children ages 8##2##3##(1994-12#1)(2012-2#1)
children ages##4##2##(1991-8#2)(1994-12#1)(2012-2#1)
children and a##2##3##(1996-7#1)(2008-11#1)
children and adolescences##2##3##(2012-3#2)
children and adolescents according to##2##5##(2008-9#1)(2011-1#1)
children and adolescents are##3##4##(2008-11#1)(2008-3#1)(2009-6#1)
children and adolescents in the##3##5##(2008-3#1)(2010-11#1)(2011-2#1)
children and adolescents in##9##4##(2007-7#1)(2008-3#1)(2008-9#3)(2009-7#1)(2010-11#1)(2011-2#2)
children and adolescents is##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
children and adolescents who##3##4##(1996-1#1)(2009-9#1)(2011-2#1)
children and adolescents with##16##4##(1995-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
children and adolescents##100##3##(1990-6#1)(1991-2#5)(1992-1#1)(1992-3#1)(1993-1#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-7#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#4)(2010-3#2)(2010-5#4)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#2)
children and adult##2##3##(1991-12#1)(2007-11#1)
children and adults using##2##4##(2008-11#1)(2008-9#1)
children and adults with asthma##2##5##(2008-8#1)(2011-2#1)
children and adults with##6##4##(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)
children and adults##34##3##(1992-2#1)(1992-4#1)(1995-5#1)(1996-2#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#5)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#2)
children and analgesia##2##3##(1993-12#2)
children and child##2##3##(1997-6#1)(2008-11#1)
children and families##7##3##(1992-2#2)(1992-3#2)(2009-11#1)(2010-4#1)(2012-12#1)
children and infants##2##3##(1996-3#1)(2012-2#1)
children and its##5##3##(1995-5#1)(2007-12#1)(2011-2#2)(2012-3#1)
children and lowest in##2##4##(2009-7#2)
children and parents##5##3##(1992-1#1)(1995-6#1)(1997-2#1)(2009-5#1)(2013-1#1)
children and support##2##3##(2008-11#1)(2012-3#1)
children and the##7##3##(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
children and their families##13##4##(1992-3#2)(1994-1#1)(1995-3#2)(2007-12#1)(2008-11#5)(2010-12#1)(2011-1#1)
children and their parents##5##4##(1991-2#1)(1995-12#1)(1995-6#2)(2011-2#1)
children and their##22##3##(1991-2#1)(1992-2#1)(1992-3#2)(1994-1#1)(1995-12#1)(1995-3#2)(1995-6#3)(2007-12#1)(2008-11#6)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
children and to##6##3##(1990-12#1)(2007-8#1)(2008-11#2)(2010-5#1)(2011-2#1)
children and young adults##9##4##(2007-8#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
children and young people##3##4##(1991-6#1)(2009-5#1)(2013-1#1)
children and young##13##3##(1991-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
children and youth##5##3##(2008-11#2)(2008-12#2)(2012-2#1)
children and##280##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#7)(1991-3#1)(1991-6#2)(1992-1#2)(1992-2#4)(1992-3#5)(1992-4#3)(1993-1#1)(1993-12#2)(1994-1#1)(1994-8#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#4)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#2)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#2)(2008-11#27)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#14)(2009-10#3)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#7)(2010-7#1)(2011-1#7)(2011-2#26)(2011-5#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#10)(2013-1#17)(2013-7#2)(2013-8#4)
children are born##2##3##(1990-6#1)(2008-11#1)
children are##39##2##(1990-6#1)(1991-12#1)(1992-1#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-11#4)(2008-12#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#1)
children as a##2##3##(2010-10#1)(2012-12#1)
children as well##2##3##(1995-5#1)(2008-1#1)
children as##6##2##(1992-4#1)(1995-1#1)(1995-5#1)(2008-1#1)(2010-10#1)(2012-12#1)
children at each##2##3##(2007-12#1)(2008-2#1)
children at risk for##5##4##(1994-1#1)(1996-12#1)(2008-10#1)(2009-7#1)(2009-9#1)
children at risk##7##3##(1991-12#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-9#1)
children at the##2##3##(2011-1#1)(2012-2#1)
children at##21##2##(1991-12#1)(1992-1#1)(1992-6#1)(1994-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
children attending##3##2##(1991-8#1)(1992-1#1)(2011-2#1)
children because##2##2##(2008-1#1)(2013-1#1)
children being##2##2##(2008-4#1)(2008-9#1)
children believed##2##2##(1992-4#2)
children below##5##2##(2008-1#2)(2008-12#1)(2008-5#1)(2008-8#1)
children between the ages of##2##5##(1994-3#1)(1995-12#1)
children between##4##2##(1994-3#1)(1995-12#1)(2007-2#1)(2013-7#1)
children born through ART##2##4##(2011-1#2)
children born to##3##3##(1992-5#1)(1994-11#1)(2008-10#1)
children born##10##2##(1991-11#1)(1992-5#1)(1994-11#1)(1994-3#1)(1996-9#1)(2008-10#1)(2008-12#1)(2011-1#2)(2013-1#1)
children but##7##2##(1990-5#1)(1994-2#1)(1995-8#1)(2008-8#2)(2011-2#1)(2012-2#1)
children can be##3##3##(1993-12#1)(2010-6#1)(2012-2#1)
children can##5##2##(1993-12#1)(2008-11#1)(2008-9#1)(2010-6#1)(2012-2#1)
children completed##5##2##(2008-3#1)(2008-9#1)(2009-4#1)(2010-7#1)(2010-8#1)
children demonstrated a##2##3##(2010-10#1)(2012-2#1)
children demonstrated##3##2##(2010-10#1)(2012-2#2)
children develop##2##2##(2008-2#1)(2008-9#1)
children diagnosed with##3##3##(2007-11#1)(2008-11#1)(2012-12#1)
children diagnosed##4##2##(2007-11#1)(2007-8#1)(2008-11#1)(2012-12#1)
children did not##5##3##(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-2#1)
children die each day from##2##5##(1990-2#2)
children die each day##4##4##(1990-2#4)
children died##2##2##(2011-2#2)
children do not##4##3##(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
children during the first##2##4##(1994-2#1)(2013-1#1)
children during the##4##3##(1994-2#1)(2010-2#1)(2013-1#2)
children during their first##2##4##(2013-1#2)
children during##10##2##(1992-2#1)(1994-2#1)(2006-10#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#4)
children eat a healthy diet##2##5##(2011-1#2)
children enrolled in##2##3##(1993-6#1)(1996-1#1)
children exhibited##3##2##(1991-8#1)(2008-12#2)
children face##2##2##(1995-9#1)(2013-1#1)
children for the##2##3##(2009-5#1)(2010-10#1)
children for##5##2##(1995-1#1)(2009-5#1)(2010-10#1)(2012-12#1)(2013-8#1)
children from different##2##3##(2012-12#1)(2012-2#1)
children from low-income families##2##4##(2007-9#1)(2008-11#1)
children from the##4##3##(2007-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
children from##29##2##(1990-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-12#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-1#3)(2012-12#3)(2012-2#1)(2013-1#4)
children had been##3##3##(1997-6#1)(2006-10#1)(2008-9#1)
children had##12##2##(1994-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
children has been##2##3##(2007-12#1)(2008-11#1)
children has##4##2##(1994-12#1)(2007-12#1)(2008-11#1)(2010-9#1)
children have been##5##3##(1991-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(2012-2#1)
children have##14##2##(1991-3#3)(1991-8#1)(1992-5#1)(1993-12#1)(1996-9#1)(2008-11#2)(2008-2#2)(2010-12#1)(2012-2#1)(2013-1#1)
children having##2##2##(1995-3#1)(2007-7#1)
children hospitalized in the Department of##3##6##(2009-5#2)(2013-1#1)
children hospitalized in##5##3##(1992-2#2)(2009-5#2)(2013-1#1)
children hospitalized##7##2##(1992-2#2)(1994-2#1)(2009-12#1)(2009-5#2)(2013-1#1)
children implanted with the Nucleus##2##5##(2008-9#2)
children implanted##3##2##(2008-9#3)
children in Africa##3##3##(1995-1#1)(1997-4#2)
children in a##8##3##(1994-12#1)(2008-11#1)(2009-10#1)(2011-2#3)(2012-3#1)(2013-8#1)
children in health care##2##4##(1992-3#2)
children in the United States##2##5##(1995-3#1)(2009-11#1)
children in the##29##3##(1991-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-7#1)
children in their##3##3##(2007-9#1)(2010-8#1)(2012-2#1)
children in these##2##3##(1996-12#1)(2011-2#1)
children in this age group were##2##6##(1991-8#1)(1995-12#1)
children in this age group##3##5##(1991-8#1)(1995-12#1)(1997-1#1)
children in this study##2##4##(1992-2#1)(2008-10#1)
children in this##6##3##(1991-8#1)(1992-2#1)(1995-12#1)(1997-1#1)(2008-10#1)(2013-7#1)
children in two##3##3##(1997-4#1)(2008-11#1)(2012-2#1)
children in urban poverty##2##4##(2013-1#2)
children in urban##3##3##(2008-10#1)(2013-1#2)
children in whom##2##3##(2008-10#1)(2012-12#1)
children in##136##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#2)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#6)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#7)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#9)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-11#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
children included##3##2##(1997-4#1)(2012-12#1)(2013-1#1)
children interrogation##2##2##(2011-2#2)
children is a##2##3##(2008-9#1)(2011-2#1)
children is an##2##3##(2008-12#1)(2011-2#1)
children is not##2##3##(2008-12#1)(2010-5#1)
children is##23##2##(1991-12#1)(1991-8#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-12#3)(2008-9#2)(2009-9#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
children it##3##2##(1995-5#1)(2010-4#1)(2011-2#1)
children less than##5##3##(1990-2#1)(1995-8#1)(1996-11#1)(2011-2#1)(2013-8#1)
children living in##5##3##(2008-11#2)(2008-9#1)(2011-2#1)(2013-8#1)
children living##6##2##(2008-11#2)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
children may be##2##3##(1996-12#1)(2010-7#1)
children may##9##2##(1992-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-7#1)(2011-2#2)
children more##2##2##(1991-11#1)(2011-2#1)
children must be##3##3##(1995-3#1)(2008-11#1)(2011-1#1)
children need##2##2##(2010-5#1)(2012-2#1)
children not##2##2##(1992-2#1)(2012-2#1)
children of mothers##2##3##(2011-1#1)(2011-2#1)
children of parents with##3##4##(2013-1#3)
children of the##5##3##(2008-1#1)(2009-7#1)(2011-1#3)
children of these##2##3##(2008-9#1)(2010-8#1)
children of##35##2##(1991-1#1)(1991-11#1)(1991-4#1)(1994-3#1)(1994-6#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#3)(2010-8#1)(2011-1#5)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
children on the##2##3##(1992-5#1)(2013-7#1)
children on##9##2##(1991-8#1)(1992-5#1)(2008-11#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
children or adolescents##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
children or##5##2##(1995-6#1)(1997-6#1)(2008-10#1)(2008-6#1)(2013-1#1)
children over 1 year of age##3##6##(2011-2#3)
children over 1 year##5##4##(2011-2#5)
children over##11##2##(1990-12#1)(1992-4#1)(1995-12#1)(1996-2#1)(2011-2#6)(2012-12#1)
children participated in##3##3##(2010-11#1)(2010-7#1)(2010-9#1)
children presenting with##3##3##(2008-11#1)(2013-7#1)(2013-8#1)
children presenting##6##2##(2008-1#1)(2008-11#2)(2009-10#1)(2013-7#1)(2013-8#1)
children protection##2##2##(2011-2#2)
children ranged in age from##2##5##(2007-11#1)(2010-10#1)
children received##2##2##(2006-10#1)(2008-6#1)
children receiving##6##2##(1991-2#1)(1996-1#1)(2007-11#2)(2008-10#1)(2012-2#1)
children scanned##2##2##(2007-11#2)
children sequentially##2##2##(2008-9#1)(2012-2#1)
children served##2##2##(1996-3#1)(2012-2#1)
children should be##2##3##(1990-2#1)(2013-1#1)
children should##3##2##(1990-2#1)(2011-1#1)(2013-1#1)
children show##2##2##(2011-2#1)(2013-8#1)
children showed##5##2##(1991-6#1)(1995-6#1)(2007-7#1)(2008-2#2)
children showing##2##2##(1997-4#1)(2008-12#1)
children studied##2##2##(1993-6#1)(2013-1#1)
children suffering from##4##3##(2006-8#1)(2007-8#1)(2011-2#1)(2013-7#1)
children than in##3##3##(1994-12#1)(2011-2#2)
children than##5##2##(1994-12#1)(2009-7#1)(2011-2#2)(2013-8#1)
children that##4##2##(2007-12#1)(2010-10#1)(2012-2#1)(2013-8#1)
children the##8##2##(1991-8#1)(1996-11#1)(1996-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
children they##2##2##(2008-10#1)(2009-9#1)
children to##21##2##(1991-2#3)(1993-3#1)(1994-9#1)(1995-5#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
children treated with inhaled##3##4##(2007-11#3)
children treated with##10##3##(1992-4#1)(2007-11#5)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)
children treated##13##2##(1992-4#1)(1996-11#1)(2007-11#5)(2008-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
children two years##2##3##(2010-10#1)(2011-2#1)
children under 10 years of age##2##6##(2008-10#1)(2012-12#1)
children under 15##2##3##(2011-1#1)(2011-2#1)
children under 16 years of age##3##6##(1991-8#2)(1995-2#1)
children under 5 years##3##4##(1996-12#1)(2009-5#1)(2012-12#1)
children under 5##4##3##(1996-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
children under five years##3##4##(2008-1#3)
children under five##4##3##(2008-1#3)(2008-2#1)
children under the age of##2##5##(2008-12#1)(2011-2#1)
children under##28##2##(1990-12#1)(1991-8#2)(1994-9#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
children undergoing cochlear implantation##2##4##(2008-9#2)
children undergoing treatment##2##3##(1990-8#1)(2010-7#1)
children undergoing##9##2##(1990-8#1)(1991-2#1)(2008-10#1)(2008-9#2)(2009-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
children used a##2##3##(2008-9#2)
children used both implants##2##4##(2012-2#2)
children used##5##2##(1994-6#1)(2008-9#2)(2012-2#2)
children using cochlear implants##5##4##(2008-9#5)
children using the Nucleus 24 cochlear implant##2##7##(2008-9#2)
children using the Nucleus##3##4##(2008-9#3)
children using the##4##3##(2008-9#3)(2013-1#1)
children using##12##2##(2008-10#1)(2008-9#9)(2009-3#1)(2013-1#1)
children was not significantly##2##4##(1991-11#1)(2008-6#1)
children was##11##2##(1991-11#1)(1994-3#1)(1995-12#1)(2006-10#1)(2008-2#1)(2008-6#1)(2011-1#2)(2012-12#1)(2013-8#2)
children were asked to##2##4##(2007-12#1)(2008-2#1)
children were born at the##2##5##(1990-2#1)(2008-12#1)
children were born##3##3##(1990-12#1)(1990-2#1)(2008-12#1)
children were identified##2##3##(2008-9#1)(2011-1#1)
children were randomly##2##3##(1993-12#1)(2008-12#1)
children were treated##2##3##(2007-11#1)(2007-8#1)
children were##57##2##(1990-12#3)(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#2)(1996-11#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-9#3)(2009-10#3)(2010-6#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
children when##2##2##(2012-12#1)(2012-2#1)
children who are##16##3##(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#2)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
children who clutter##5##3##(2011-1#5)
children who completed##2##3##(2009-11#1)(2012-2#1)
children who did not receive##2##5##(1994-6#1)(1995-1#1)
children who did not##3##4##(1994-6#1)(1995-1#1)(2008-9#1)
children who did##4##3##(1994-6#1)(1995-1#1)(2008-2#1)(2008-9#1)
children who had received cochlear implants##2##6##(2008-9#2)
children who had received##3##4##(2008-9#2)(2010-10#1)
children who had##6##3##(1994-6#1)(2008-6#1)(2008-9#2)(2010-10#1)(2013-7#1)
children who have complex and continuing##2##6##(2008-11#2)
children who have##6##3##(1991-1#1)(1994-9#1)(2008-11#2)(2008-2#1)(2012-2#1)
children who receive##3##3##(1994-6#2)(2010-4#1)
children who received##8##3##(1994-6#1)(2008-11#3)(2008-6#2)(2010-4#1)(2011-1#1)
children who stutter##2##3##(2008-2#2)
children who were not##2##4##(1996-3#1)(2012-1#1)
children who were##9##3##(1994-1#2)(1994-6#1)(1995-1#1)(1995-12#1)(1996-3#1)(2008-12#1)(2011-2#1)(2012-1#1)
children who##83##2##(1991-1#1)(1991-8#3)(1992-1#3)(1992-2#1)(1992-3#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#6)(1994-9#1)(1995-1#3)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#6)(2008-6#6)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#2)(2011-1#6)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
children whose mothers##5##3##(2008-9#1)(2009-9#3)(2011-2#1)
children whose parents were##2##4##(1994-6#1)(2013-8#1)
children whose parents##4##3##(1994-6#1)(2008-12#1)(2010-11#1)(2013-8#1)
children whose##11##2##(1994-6#1)(2008-12#2)(2008-9#1)(2009-9#3)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
children with ADHD and##2##4##(2010-8#1)(2012-2#1)
children with ADHD##5##3##(1996-6#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
children with AIDS##5##3##(1995-6#2)(2012-3#3)
children with ALL##4##3##(2011-2#4)
children with CAS##2##3##(2011-1#2)
children with CDGP##7##3##(2011-1#4)(2011-2#3)
children with CNS##2##3##(2007-7#1)(2011-2#1)
children with CP##3##3##(2011-2#3)
children with English as an additional language##2##7##(2008-2#2)
children with HIV indicated##2##4##(1996-1#2)
children with HIV##4##3##(1996-1#3)(1996-8#1)
children with HIV/AIDS##3##3##(2008-9#1)(2009-7#2)
children with IDDM##2##3##(1995-3#2)
children with SLI##3##3##(2011-1#3)
children with SLOS##2##3##(2010-7#2)
children with Waardenburg syndrome##3##4##(2008-9#3)
children with a mean age of##3##6##(2007-8#1)(2012-2#1)(2013-7#1)
children with a range of##2##5##(2009-5#1)(2010-7#1)
children with a##14##3##(1992-3#1)(1993-1#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
children with acute lymphoblastic leukemia##2##5##(2011-2#2)
children with acute lymphoblastic##3##4##(2011-2#3)
children with acute myeloid leukemia##3##5##(1994-5#1)(2011-2#2)
children with acute respiratory infections in##3##6##(2013-1#1)(2013-8#2)
children with acute respiratory##4##4##(2013-1#1)(2013-8#3)
children with acute##16##3##(1994-5#1)(2008-1#1)(2011-1#1)(2011-2#7)(2013-1#2)(2013-8#4)
children with an##4##3##(1991-2#1)(2007-5#1)(2008-8#1)(2008-9#1)
children with asthma##10##3##(1992-1#1)(1993-12#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-9#2)
children with autism##2##3##(2007-8#1)(2013-1#1)
children with bacterial meningitis##2##4##(1992-11#1)(2008-11#1)
children with cancer and their##2##5##(1992-12#1)(1995-2#1)
children with cancer and##3##4##(1992-12#1)(1995-2#1)(2008-11#1)
children with cancer##13##3##(1992-12#2)(1995-2#1)(1996-1#1)(2008-11#3)(2008-5#1)(2010-7#1)(2010-9#2)(2012-2#2)
children with cerebral palsy and##2##5##(2009-3#1)(2011-2#1)
children with cerebral palsy##6##4##(2007-11#1)(2009-3#2)(2009-4#1)(2011-2#1)(2012-12#1)
children with chronic illness##4##4##(1992-12#1)(1992-2#1)(1993-1#1)(1997-2#1)
children with chronic illnesses##4##4##(1991-8#1)(1995-12#2)(1996-3#1)
children with chronic##17##3##(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#3)(1995-12#2)(1996-3#1)(1997-2#3)(2006-10#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
children with classic CAH##2##4##(2010-2#2)
children with classic##3##3##(2010-2#3)
children with cochlear implants##17##4##(2008-9#16)(2010-10#1)
children with cochlear##18##3##(2008-9#17)(2010-10#1)
children with complex needs##5##4##(2008-11#1)(2012-2#4)
children with complex##7##3##(2008-11#3)(2012-2#4)
children with congenital heart disease##3##5##(1990-11#1)(2006-10#1)(2008-11#1)
children with congenital thyroid deficiency##2##5##(2013-1#2)
children with congenital##6##3##(1990-11#1)(1990-12#1)(2006-10#1)(2008-11#1)(2013-1#2)
children with cystic fibrosis##2##4##(2007-11#1)(2010-5#1)
children with developmental disabilities##2##4##(1991-12#1)(1993-1#1)
children with developmental disorders##2##4##(1995-1#2)
children with developmental##5##3##(1991-12#1)(1993-1#1)(1995-1#2)(2012-2#1)
children with diabetes and##2##4##(1995-2#1)(2010-9#1)
children with diabetes mellitus##2##4##(1994-6#2)
children with diabetes##9##3##(1994-6#3)(1995-2#3)(1995-3#1)(2009-10#1)(2010-9#1)
children with different##2##3##(2011-2#1)(2012-2#1)
children with disabilities##6##3##(1994-1#2)(1995-1#1)(1995-12#1)(1996-1#2)
children with epilepsy##2##3##(1996-3#1)(2013-1#1)
children with failed##2##3##(2008-10#2)
children with idiopathic hypercalciuria##2##4##(2008-10#1)(2008-7#1)
children with intestinal malrotation##2##4##(2012-3#2)
children with learning difficulties##4##4##(2008-11#4)
children with learning disabilities##4##4##(2011-1#4)
children with learning##8##3##(2008-11#4)(2011-1#4)
children with liver disease##4##4##(1996-1#4)
children with low vision##2##4##(2010-8#2)
children with low##4##3##(1992-11#1)(1996-11#1)(2010-8#2)
children with mental retardation##2##4##(1993-3#2)
children with mental##3##3##(1991-8#1)(1993-3#2)
children with mild##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
children with moderate or severe asthma##2##6##(2008-11#2)
children with moderate##4##3##(1993-3#2)(2008-11#2)
children with neuroblastoma##2##3##(2011-2#2)
children with newly diagnosed##3##4##(1993-1#2)(2011-2#1)
children with no##3##3##(1995-1#1)(1996-1#1)(2007-12#1)
children with normal hearing thresholds##2##5##(2008-9#2)
children with normal hearing##3##4##(2008-9#2)(2010-10#1)
children with normal##6##3##(2008-12#1)(2008-9#2)(2010-10#1)(2011-1#1)(2013-1#1)
children with osteosarcoma##2##3##(2008-6#1)(2010-3#1)
children with pneumonia##2##3##(2010-4#1)(2013-1#1)
children with postlingual deafness##2##4##(2008-9#2)
children with profound hearing loss and severe language delay##2##9##(2008-9#2)
children with profound##3##3##(1990-8#1)(2008-9#2)
children with recurrent##4##3##(2008-1#1)(2011-1#2)(2013-7#1)
children with respiratory##2##3##(1994-6#1)(1997-1#1)
children with severe mental retardation##2##5##(1991-3#1)(1993-3#1)
children with severe##11##3##(1991-3#1)(1993-3#3)(1996-1#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)
children with sickle cell##3##4##(2009-4#2)(2010-11#1)
children with special health care needs##10##6##(1991-12#1)(1991-3#1)(1993-1#1)(1995-1#1)(1995-12#4)(1995-3#2)
children with special health##11##4##(1991-12#1)(1991-3#1)(1993-1#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)
children with special needs##4##4##(1991-12#1)(1991-3#1)(1997-2#2)
children with special##15##3##(1991-12#2)(1991-3#2)(1993-1#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)
children with steroid resistant MesGN##2##5##(2007-7#2)
children with suspected##2##3##(1990-11#1)(2013-1#1)
children with type##2##3##(2008-11#1)(2011-1#1)
children with unilateral Perthes disease##3##5##(2007-11#3)
children with unilateral##4##3##(2007-11#3)(2011-1#1)
children with##469##2##(1990-11#2)(1990-12#3)(1990-8#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-6#1)(1991-8#4)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#9)(1993-12#1)(1993-3#7)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1995-1#6)(1995-12#7)(1995-2#4)(1995-3#5)(1995-6#3)(1995-8#1)(1996-1#12)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#1)(1997-8#2)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#7)(2008-1#9)(2008-10#18)(2008-11#21)(2008-12#8)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#39)(2009-10#2)(2009-3#7)(2009-4#5)(2009-5#7)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#7)(2011-1#33)(2011-2#41)(2011-5#1)(2012-12#5)(2012-2#21)(2012-3#6)(2013-1#25)(2013-7#5)(2013-8#7)
children within 10##2##3##(2010-12#1)(2012-2#1)
children within##4##2##(2008-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
children without##7##2##(1990-6#1)(1991-3#1)(1994-12#1)(1996-6#1)(2008-11#1)(2009-10#1)(2012-2#1)
children working in the##3##4##(2012-12#3)
children younger than three##2##4##(2008-11#2)
children younger than##5##3##(1993-2#1)(2008-11#2)(2010-3#1)(2013-1#1)
children##2588##1##(1990-10#3)(1990-11#7)(1990-12#17)(1990-2#15)(1990-3#1)(1990-5#1)(1990-6#5)(1990-8#5)(1990-9#3)(1991-1#7)(1991-11#5)(1991-12#16)(1991-2#19)(1991-3#10)(1991-4#1)(1991-6#15)(1991-8#22)(1991-9#5)(1992-1#11)(1992-11#4)(1992-12#4)(1992-2#16)(1992-3#19)(1992-4#19)(1992-5#7)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#16)(1993-12#17)(1993-2#9)(1993-3#14)(1993-6#6)(1993-8#2)(1993-9#1)(1994-1#10)(1994-11#2)(1994-12#18)(1994-2#10)(1994-3#12)(1994-5#1)(1994-6#30)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#21)(1995-11#2)(1995-12#23)(1995-2#12)(1995-3#17)(1995-5#23)(1995-6#12)(1995-8#6)(1995-9#1)(1996-1#23)(1996-11#9)(1996-12#13)(1996-2#9)(1996-3#12)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#7)(1997-1#6)(1997-2#21)(1997-3#4)(1997-4#16)(1997-5#1)(1997-6#6)(1997-8#10)(2006-10#15)(2006-8#4)(2007-1#1)(2007-10#4)(2007-11#48)(2007-12#52)(2007-2#8)(2007-3#1)(2007-5#4)(2007-7#29)(2007-8#30)(2007-9#3)(2008-1#45)(2008-10#88)(2008-11#151)(2008-12#68)(2008-2#30)(2008-3#12)(2008-4#24)(2008-5#4)(2008-6#23)(2008-7#20)(2008-8#17)(2008-9#160)(2009-1#1)(2009-10#20)(2009-11#11)(2009-12#9)(2009-2#2)(2009-3#17)(2009-4#12)(2009-5#26)(2009-6#6)(2009-7#32)(2009-8#13)(2009-9#26)(2010-1#6)(2010-10#18)(2010-11#14)(2010-12#11)(2010-2#5)(2010-3#13)(2010-4#9)(2010-5#29)(2010-6#16)(2010-7#19)(2010-8#17)(2010-9#17)(2011-1#105)(2011-2#199)(2011-5#2)(2012-1#10)(2012-12#66)(2012-2#114)(2012-3#42)(2013-1#128)(2013-7#18)(2013-8#51)
children's academic and social##2##4##(2008-12#1)(2012-12#1)
children's academic performance##3##3##(2009-7#3)
children's academic##5##2##(2008-12#1)(2009-7#3)(2012-12#1)
children's behavior problems##3##3##(2009-11#1)(2010-11#2)
children's behavior##10##2##(1991-2#2)(1994-6#5)(2009-11#1)(2010-11#2)
children's development##2##2##(2009-9#1)(2012-12#1)
children's early##4##2##(2008-11#1)(2008-2#1)(2011-2#2)
children's eating##2##2##(2008-11#1)(2009-6#1)
children's exposure to##2##3##(2009-5#1)(2009-9#1)
children's general##2##2##(1992-4#1)(2010-1#1)
children's growth##2##2##(2010-7#1)(2013-1#1)
children's health and##2##3##(2009-7#1)(2011-2#1)
children's health care##2##3##(1991-3#1)(2008-11#1)
children's health in##2##3##(2008-3#1)(2012-12#1)
children's health##13##2##(1991-2#1)(1991-3#1)(2008-11#5)(2008-3#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
children's healthy##2##2##(2010-5#1)(2011-2#1)
children's hospital##8##2##(1991-1#1)(1992-3#1)(1993-2#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-1#1)
children's hospitals in##2##3##(2008-11#1)(2010-9#1)
children's hospitals##3##2##(2008-11#1)(2010-9#2)
children's learning##2##2##(1991-3#1)(1992-3#1)
children's mental health##6##3##(1993-1#1)(1994-3#1)(2008-4#1)(2010-12#3)
children's nursing##4##2##(2008-11#4)
children's perceptions of the classroom##2##5##(2008-12#2)
children's perceptions of##3##3##(2008-12#3)
children's perceptions##7##2##(2008-12#6)(2009-4#1)
children's performance on a##2##4##(2012-3#2)
children's performance on##3##3##(2012-3#2)(2013-8#1)
children's physical##2##2##(2008-2#1)(2010-12#1)
children's recurrent pain##2##3##(2008-11#2)
children's shyness##2##2##(2012-12#2)
children's social behavior##2##3##(2009-9#1)(2012-12#1)
children's social competence##3##3##(2010-11#3)
children's social##6##2##(1996-1#1)(2009-9#1)(2010-11#3)(2012-12#1)
children's speech##3##2##(2008-9#2)(2011-1#1)
children's teeth in##2##3##(1991-6#2)
children's teeth##4##2##(1991-6#2)(2008-9#2)
children's temperament to##2##3##(2009-10#2)
children's time of day##2##4##(2007-12#2)
children's usual##3##2##(1991-2#3)
children's well-being##3##2##(1995-1#2)(2010-1#1)
children's##211##1##(1990-2#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#7)(1991-3#2)(1991-6#2)(1992-1#3)(1992-2#1)(1992-3#5)(1992-4#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-6#2)(1994-2#1)(1994-3#5)(1994-6#6)(1995-1#6)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-11#19)(2008-12#9)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#9)(2009-9#5)(2010-1#3)(2010-11#7)(2010-12#5)(2010-3#2)(2010-5#1)(2010-7#1)(2010-9#3)(2011-1#4)(2011-2#13)(2012-12#13)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#2)
children) and##2##2##(2007-11#1)(2013-1#1)
children) treated with##2##3##(2008-1#2)
children)##14##1##(1991-12#1)(2007-11#3)(2007-7#1)(2008-1#2)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
children/adolescents##3##1##(2008-11#1)(2008-9#2)
children?##8##1##(2007-8#1)(2008-11#5)(2008-9#1)(2012-2#1)
children?]##3##1##(1994-11#1)(1996-11#1)(1996-7#1)
children]##42##1##(1990-11#2)(1990-2#1)(1990-6#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1994-6#1)(1995-2#1)(1995-5#3)(1996-11#2)(1996-6#2)(1996-7#1)(1997-8#2)(2007-6#1)(2008-11#1)(2009-5#5)(2009-7#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#5)
childrens'##2##1##(2008-11#1)(2010-3#1)
chile pepper##3##2##(2008-10#3)
chile##4##1##(2008-10#3)(2008-3#1)
chili powder##3##2##(2008-10#3)
chili##4##1##(2008-10#4)
chill accumulation##4##2##(2012-4#3)(2012-8#1)
chill##11##1##(1992-11#1)(2008-10#1)(2012-4#4)(2012-8#4)(2013-8#1)
chill-hours and degree-days##2##3##(2008-10#2)
chill-hours##6##1##(2008-10#6)
chilled##4##1##(2008-10#2)(2011-2#1)(2012-3#1)
chilling periods##3##2##(2008-10#2)(2012-4#1)
chilling requirement##2##2##(2008-10#1)(2012-8#1)
chilling temperatures##3##2##(2012-4#1)(2012-8#2)
chilling##19##1##(2008-10#7)(2008-5#1)(2012-4#8)(2012-8#3)
chills and severe##2##3##(1997-6#1)(2007-12#1)
chills##5##1##(1997-6#1)(2006-10#1)(2007-12#2)(2009-3#1)
chilopods##2##1##(2007-12#2)
chimaera##3##1##(1994-6#3)
chimaeric##2##1##(1994-6#1)(2008-7#1)
chimera led to##2##3##(1995-2#1)(1997-3#1)
chimera was##2##2##(1991-12#1)(2008-11#1)
chimera##16##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1994-11#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-11#3)(2008-8#2)(2013-1#2)
chimeras in##2##2##(2008-1#2)
chimeras of##3##2##(1990-12#1)(2008-8#2)
chimeras were##2##2##(1997-8#1)(2009-6#1)
chimeras##18##1##(1990-12#2)(1997-8#1)(2008-1#3)(2008-11#1)(2008-4#3)(2008-8#3)(2008-9#2)(2009-6#2)(2013-7#1)
chimeric animals##2##2##(1995-2#1)(2008-4#1)
chimeric antibody##4##2##(1994-12#1)(1994-3#1)(2008-11#2)
chimeric bispecific antibody##5##3##(1994-3#5)
chimeric construct##2##2##(1997-9#1)(2013-7#1)
chimeric constructs##4##2##(1992-6#1)(2008-10#2)(2013-7#1)
chimeric gene##6##2##(1991-10#1)(1993-12#1)(1993-3#1)(1994-5#2)(2009-10#1)
chimeric genes encoding##2##3##(2008-1#1)(2008-4#1)
chimeric genes that##2##3##(2008-6#2)
chimeric genes##5##2##(1990-11#1)(2008-1#1)(2008-4#1)(2008-6#2)
chimeric mice##2##2##(2008-8#2)
chimeric protein##3##2##(1991-5#1)(1997-8#1)(2008-6#1)
chimeric proteins in##2##3##(1994-6#1)(2008-6#1)
chimeric proteins were##2##3##(1994-6#2)
chimeric proteins##4##2##(1994-6#3)(2008-6#1)
chimeric receptors##2##2##(1990-12#1)(2008-11#1)
chimeric transcription factors##3##3##(2008-6#3)
chimeric transcription##4##2##(2008-6#4)
chimeric virus##3##2##(1997-3#1)(2008-11#2)
chimeric##103##1##(1990-11#1)(1990-12#1)(1990-8#2)(1991-10#2)(1991-5#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#9)(1994-5#2)(1994-6#3)(1994-8#1)(1995-2#2)(1997-2#4)(1997-3#5)(1997-4#1)(1997-8#1)(1997-9#2)(2007-4#1)(2008-1#4)(2008-10#10)(2008-11#12)(2008-4#3)(2008-5#1)(2008-6#8)(2008-8#5)(2008-9#5)(2009-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#4)
chimiothérapie##2##1##(2013-1#2)
chimpanzee communities##3##2##(2009-10#2)(2012-2#1)
chimpanzee facial##2##2##(2008-11#2)
chimpanzee##12##1##(1991-12#1)(1993-8#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-11#2)(2009-10#2)(2010-5#1)(2012-12#1)(2012-2#1)
chimpanzees (Pan troglodytes)##3##3##(2007-12#1)(2009-10#1)(2009-5#1)
chimpanzees and##2##2##(2007-12#1)(2008-7#1)
chimpanzees##26##1##(2007-12#15)(2008-11#2)(2008-7#1)(2009-10#1)(2009-5#2)(2012-12#1)(2012-2#3)(2013-1#1)
chin##13##1##(1992-12#1)(2007-5#2)(2008-5#5)(2011-2#1)(2012-2#1)(2012-3#3)
china##3##1##(1991-8#1)(2008-9#1)(2012-1#1)
chinaï##3##1##(2008-10#3)
chinchilla##6##1##(2008-1#1)(2009-5#3)(2013-8#2)
chinense##7##1##(2008-10#3)(2008-11#2)(2012-3#2)
chinensis (Lour##3##2##(2008-10#3)
chinensis##7##1##(2008-10#3)(2008-11#2)(2008-5#1)(2012-3#1)
chinensis]##2##1##(2011-2#1)(2012-3#1)
chinese hamster ovary cells##2##4##(2008-11#1)(2011-2#1)
chinese hamster ovary##4##3##(1992-8#1)(2008-11#2)(2011-2#1)
chinese##11##1##(1992-8#1)(2006-10#1)(2008-10#2)(2008-11#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
chip allows##2##2##(2008-10#1)(2008-12#1)
chip and a##2##3##(2007-12#1)(2011-1#1)
chip and##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
chip by##2##2##(2008-10#2)
chip design##2##2##(2008-4#1)(2012-3#1)
chip for##5##2##(2008-10#4)(2008-12#1)
chip has##2##2##(2008-10#1)(2008-5#1)
chip is##5##2##(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)
chip surface##3##2##(2008-10#2)(2008-4#1)
chip using a##2##3##(2008-10#2)
chip was used to##2##4##(2008-10#2)
chip was##6##2##(2008-10#4)(2008-12#2)
chip were##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
chip with a##2##3##(2007-11#1)(2007-12#1)
chip with##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2013-1#1)
chip##90##1##(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#44)(2008-11#1)(2008-12#6)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#2)(2010-11#1)(2010-8#3)(2011-1#3)(2012-3#2)(2013-1#1)
chip-to-chip##2##1##(2008-2#1)(2008-3#1)
chipmunks adhered##2##2##(2008-5#2)
chipmunks in boxes##2##3##(2008-5#2)
chipmunks##11##1##(2008-5#11)
chips and##2##2##(2008-3#1)(2008-9#1)
chips are assembled on a single##2##6##(2008-3#2)
chips to##3##2##(2008-2#2)(2008-3#1)
chips##35##1##(1994-1#1)(2008-10#9)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)
chips)##2##1##(2008-2#2)
chiral 2##2##2##(2007-11#1)(2008-10#1)
chiral HPLC##2##2##(1997-2#2)
chiral amino acids##3##3##(2008-10#3)
chiral center##2##2##(1997-2#1)(2008-10#1)
chiral discrimination and##2##3##(2008-10#1)(2010-4#1)
chiral discrimination of##2##3##(2008-10#1)(2010-4#1)
chiral discrimination##6##2##(2008-10#4)(2010-4#2)
chiral drugs##2##2##(1990-6#1)(2008-10#1)
chiral evolution##3##2##(2008-9#3)
chiral phase##2##2##(1990-12#1)(2008-10#1)
chiral polyamines are##3##3##(2009-10#3)
chiral polyamines##6##2##(2009-10#6)
chiral recognition is##2##3##(1994-5#1)(2008-10#1)
chiral recognition##7##2##(1994-5#1)(1995-3#1)(2008-10#5)
chiral resolution##3##2##(2008-10#3)
chiral sculptured thin films##2##4##(2008-3#2)
chiral selector and##2##3##(1996-5#1)(2008-10#1)
chiral selector for the##2##4##(2008-10#1)(2013-1#1)
chiral selector for##3##3##(2008-10#1)(2013-1#2)
chiral selector in##2##3##(2008-10#2)
chiral selector##17##2##(1996-5#1)(2008-10#13)(2010-4#1)(2013-1#2)
chiral selectors##7##2##(1995-6#1)(1996-5#2)(2008-10#3)(2010-4#1)
chiral separation of##5##3##(1990-8#2)(1996-5#1)(2008-10#2)
chiral separation##8##2##(1990-8#3)(1996-5#1)(2008-10#4)
chiral smectic A##2##3##(2007-11#2)
chiral solvating agent##4##3##(1995-2#2)(2008-10#2)
chiral stationary phase (CSP) in##2##5##(2008-10#2)
chiral stationary phase (CSP)##4##4##(2008-10#4)
chiral stationary phase by##2##4##(2008-10#2)
chiral stationary phase##14##3##(1995-3#1)(2008-10#13)
chiral stationary phases##5##3##(1996-5#1)(2008-10#4)
chiral stationary##20##2##(1995-3#2)(1996-5#1)(2008-10#17)
chiral surfactant##3##2##(1994-9#3)
chiral template##2##2##(2012-3#2)
chiral##159##1##(1990-12#1)(1990-6#1)(1990-8#4)(1992-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-2#3)(1995-3#5)(1995-6#7)(1996-5#8)(1997-2#5)(2007-11#5)(2008-10#71)(2008-3#2)(2008-7#2)(2008-9#5)(2009-10#9)(2010-12#2)(2010-2#1)(2010-4#7)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#2)
chirality in##2##2##(2008-9#1)(2010-12#1)
chirality of the##2##3##(1990-7#1)(2008-7#1)
chirality of##4##2##(1990-12#1)(1990-7#1)(2008-10#1)(2008-7#1)
chirality##14##1##(1990-12#1)(1990-7#1)(1995-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#2)(2012-2#1)
chiropractic and osteopathic##3##3##(2007-11#3)
chiropractic and osteopathy##2##3##(2007-11#2)
chiropractic and##6##2##(1990-6#1)(2007-11#5)
chiropractic colleges##2##2##(2008-5#2)
chiropractic##18##1##(1990-6#1)(1996-12#4)(2007-11#7)(2008-12#2)(2008-5#3)(2011-1#1)
chiropractors and osteopaths##3##3##(2007-11#3)
chirp and##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
chirp of the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
chirp of##8##2##(2007-11#2)(2007-12#4)(2008-3#2)
chirp##43##1##(2007-11#12)(2007-12#14)(2008-2#8)(2008-3#9)
chirp)##2##1##(2008-2#1)(2008-3#1)
chirp-free##5##1##(2007-12#5)
chirped Bragg gratings##2##3##(2008-3#2)
chirped fiber gratings##4##3##(2007-11#2)(2008-3#2)
chirped fiber##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
chirped optical##2##2##(2007-12#1)(2008-3#1)
chirped pulse amplification laser system##3##5##(2008-2#2)(2008-3#1)
chirped pulse amplification laser##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
chirped pulse amplification##11##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#5)
chirped pulse##12##2##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#5)
chirped pulses that##2##3##(2007-11#2)
chirped pulses##9##2##(2007-11#4)(2007-12#4)(2008-2#1)
chirped##50##1##(2007-11#14)(2007-12#17)(2008-2#4)(2008-3#15)
chirped-grating##3##1##(2008-3#3)
chirped-pulse amplification scheme##2##3##(2007-11#2)
chirped-pulse amplification systems by##2##4##(2007-12#2)
chirped-pulse amplification systems##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
chirped-pulse amplification##12##2##(2007-11#7)(2007-12#3)(2008-2#2)
chirped-pulse##15##1##(2007-11#8)(2007-12#5)(2008-2#2)
chirping##7##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
chirps##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
chirurgicale##2##1##(2011-2#1)(2013-1#1)
chirurgie##3##1##(2011-2#3)
chit33 gene##3##2##(2008-10#3)
chitin affinity chromatography##2##3##(2008-10#2)
chitin affinity##3##2##(2008-10#2)(2008-7#1)
chitin as the##2##3##(2008-10#2)
chitin deacetylase##2##2##(1997-3#2)
chitin in the##3##3##(2008-10#3)
chitin membranes##2##2##(2008-7#2)
chitin synthase##2##2##(1997-4#1)(2008-10#1)
chitin was##3##2##(2008-10#3)
chitin##50##1##(1992-12#1)(1992-8#1)(1997-3#4)(1997-4#2)(2007-12#1)(2008-1#1)(2008-10#34)(2008-7#4)(2011-2#2)
chitin-containing##3##1##(1997-6#1)(2008-7#1)(2013-1#1)
chitinase activity of##2##3##(2008-10#2)
chitinase activity##10##2##(2008-10#10)
chitinase and beta-1##6##3##(2008-10#6)
chitinase and##8##2##(2008-10#8)
chitinase was##2##2##(2008-10#2)
chitinase##42##1##(1993-9#1)(2008-10#39)(2009-2#1)(2013-1#1)
chitinase-deficient##2##1##(2008-10#2)
chitinases and beta-1##3##3##(2008-10#3)
chitinases##15##1##(1992-8#4)(2008-10#11)
chitinolytic and##2##2##(2008-10#2)
chitinolytic bacteria##2##2##(2008-10#2)
chitinolytic enzymes##2##2##(2008-10#2)
chitinolytic fractions##2##2##(2008-10#2)
chitinolytic##12##1##(2008-10#11)(2008-5#1)
chitobiase gene##6##2##(1992-10#6)
chitobiase##13##1##(1992-10#13)
chitobiase-deficient##2##1##(1992-10#2)
chitooligosaccharides##3##1##(1997-3#1)(2011-1#2)
chitosan against##2##2##(2008-5#2)
chitosan and##8##2##(2008-10#5)(2008-5#2)(2012-6#1)
chitosan are##2##2##(2008-10#2)
chitosan as##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
chitosan for##2##2##(2008-10#2)
chitosan membranes##3##2##(2008-10#3)
chitosan solution##2##2##(2008-10#2)
chitosan to##2##2##(2008-10#1)(2008-5#1)
chitosan##72##1##(2008-10#49)(2008-5#14)(2009-2#1)(2009-3#3)(2009-7#2)(2010-5#1)(2012-2#1)(2012-6#1)
chitosan-entrapped carbon paste electrode (CCPE)##2##5##(2008-10#2)
chitosan-entrapped carbon paste electrode##3##4##(2008-10#3)
chitosan-gelatin##4##1##(2008-5#4)
chitosan-modified##2##1##(2008-10#2)
chitosan-starch as##2##2##(2008-5#2)
chitosan/pGM-CSF complexes##3##2##(2012-2#3)
chitosan/pGM-CSF##4##1##(2012-2#4)
chitosanase##3##1##(2009-2#3)
chitwoodi and M##13##3##(2008-10#13)
chitwoodi or M##2##3##(2008-10#2)
chitwoodi##27##1##(2008-10#27)
chl##2##1##(1990-5#2)
chlamydia##5##1##(1990-2#1)(1990-5#1)(2007-7#1)(2012-1#1)(2012-3#1)
chlamydial infection##2##2##(1990-2#1)(2007-12#1)
chlamydial infections##3##2##(1995-12#1)(2007-12#1)(2009-8#1)
chlamydial##14##1##(1990-2#2)(1990-5#1)(1990-6#2)(1995-12#1)(2007-12#2)(2009-8#2)(2011-2#4)
chlamydiosis##2##1##(1992-2#1)(2008-5#1)
chlamydospore production##4##2##(2008-10#4)
chlamydospore##9##1##(2008-10#7)(2010-10#2)
chlamydospores g(1) of soil##3##4##(2008-10#3)
chlamydospores in##4##2##(2008-10#2)(2010-10#2)
chlamydospores of##4##2##(2008-10#4)
chlamydospores per g of soil##2##5##(2008-10#2)
chlamydospores per g of##3##4##(2008-10#3)
chlamydospores per gram of soil##4##5##(2008-10#4)
chlamydospores per gram of##8##4##(2008-10#8)
chlamydospores per##11##2##(2008-10#11)
chlamydospores that##2##2##(2008-10#2)
chlamydospores were##2##2##(2008-10#1)(2010-10#1)
chlamydospores##36##1##(2008-10#29)(2010-10#6)(2010-3#1)
chlamydosporia##3##1##(2008-10#3)
chloral hydrate##5##2##(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2013-1#1)
chloral##6##1##(1994-2#1)(1997-2#1)(2007-12#2)(2008-10#1)(2013-1#1)
chlorambucil##11##1##(1993-6#1)(1995-3#3)(2007-10#2)(2008-11#5)
chloramine-T (CAT)##2##2##(2008-10#2)
chloramine-T##4##1##(2008-10#4)
chloramphenicol acetyl transferase##4##3##(1992-12#2)(1994-11#1)(1997-7#1)
chloramphenicol acetyltransferase (CAT) assay##2##4##(1991-6#1)(2008-4#1)
chloramphenicol acetyltransferase (CAT) gene##3##4##(1992-6#1)(1993-8#1)(1997-8#1)
chloramphenicol acetyltransferase (CAT) reporter##2##4##(1991-2#1)(1995-2#1)
chloramphenicol acetyltransferase (CAT)##12##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-2#1)(1997-8#1)(2008-4#1)(2008-7#1)
chloramphenicol acetyltransferase gene##3##3##(1990-12#1)(1991-2#1)(1993-3#1)
chloramphenicol acetyltransferase reporter##2##3##(1995-2#1)(1995-6#1)
chloramphenicol acetyltransferase##22##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-4#1)(2008-7#1)
chloramphenicol to##2##2##(2008-10#2)
chloramphenicol##54##1##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#2)(1995-6#2)(1996-8#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#2)(2011-2#1)(2013-1#1)
chloranilate complex##3##2##(2008-10#3)
chloranilate##4##1##(2008-10#4)
chlorate in##5##2##(2008-10#5)
chlorate##26##1##(2008-10#26)
chlorate-resistant isolates##2##2##(2008-10#2)
chlorate-resistant sectors##2##2##(2008-10#2)
chlorate-resistant##7##1##(2008-10#7)
chlordiazepoxide in##2##2##(1992-7#2)
chlordiazepoxide##10##1##(1992-7#8)(1993-12#2)
chlordiazepoxide's##2##1##(1992-7#2)
chlordimeform##3##1##(2008-10#3)
chlorhexidine gluconate##4##2##(2012-3#2)(2013-1#2)
chlorhexidine##7##1##(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
chloride (BC)##2##2##(2008-10#2)
chloride (DDPC)##2##2##(2008-10#2)
chloride (INT)##2##2##(2008-10#2)
chloride (PDDA)##2##2##(2008-8#1)(2010-4#1)
chloride (PVC)##12##2##(2007-7#1)(2008-10#11)
chloride and nitrate##3##3##(2008-10#3)
chloride and phosphate##3##3##(2008-10#3)
chloride and potassium##2##3##(1997-2#1)(2008-10#1)
chloride and##39##2##(1990-5#1)(1991-12#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#2)(2007-7#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)
chloride anions##3##2##(1997-7#1)(2008-10#2)
chloride are##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
chloride as a##3##3##(2008-10#3)
chloride as##8##2##(2008-10#7)(2008-6#1)
chloride at##4##2##(2008-10#3)(2008-2#1)
chloride buffer##5##2##(2008-10#5)
chloride channel blocker##2##3##(1990-5#1)(2008-9#1)
chloride channel##7##2##(1990-2#1)(1990-5#1)(1994-6#1)(1997-3#1)(2007-7#1)(2008-9#1)(2011-3#1)
chloride channels in colonic##2##4##(2008-8#1)(2013-1#1)
chloride channels##6##2##(2007-7#1)(2008-4#1)(2008-8#1)(2013-1#3)
chloride complex##2##2##(2008-10#2)
chloride concentration was##2##3##(2008-10#2)
chloride concentration##13##2##(1995-11#2)(2008-10#10)(2011-2#1)
chloride conductance in mesangial cells from the H-2Kb-tsA58 transgenic mouse##2##10##(1995-11#2)
chloride conductance in##4##3##(1995-11#4)
chloride conductance##6##2##(1995-11#6)
chloride current##5##2##(1995-11#1)(1995-12#1)(2008-8#1)(2011-3#2)
chloride currents##4##2##(1995-11#2)(1995-2#1)(1997-2#1)
chloride determination by hydride generation gas phase molecular absorption spectrometry##2##10##(2008-10#2)
chloride determination##7##2##(2008-10#7)
chloride effect&quot##2##2##(1997-2#2)
chloride for##6##2##(1990-8#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-7#1)
chloride has##2##2##(1993-12#1)(2008-10#1)
chloride in a##2##3##(2008-10#2)
chloride in cigarettes##2##3##(2008-10#2)
chloride in drinking##3##3##(2008-10#3)
chloride in the##6##3##(2008-10#4)(2008-7#1)(2011-2#1)
chloride in##27##2##(1990-8#1)(1992-11#1)(1996-12#1)(1997-7#1)(2008-10#19)(2008-2#1)(2008-7#2)(2011-2#1)
chloride interference##2##2##(1991-12#1)(2008-10#1)
chloride into##2##2##(2008-10#2)
chloride ion channel##3##3##(1995-12#1)(2011-3#1)(2013-8#1)
chloride ion##14##2##(1995-12#1)(1997-4#1)(2008-10#10)(2011-3#1)(2013-8#1)
chloride ions and the##2##4##(1997-7#2)
chloride ions and##5##3##(1990-8#1)(1995-12#1)(1997-7#2)(2009-8#1)
chloride ions in##2##3##(2008-10#2)
chloride ions##15##2##(1990-8#1)(1991-9#1)(1995-12#1)(1997-2#1)(1997-7#3)(2008-10#7)(2009-8#1)
chloride is used as##2##4##(2008-10#2)
chloride is##6##2##(1994-5#1)(2008-10#4)(2008-3#1)
chloride media##4##2##(2008-10#4)
chloride membrane entrapped in a cellulose support##2##7##(2008-10#2)
chloride of##2##2##(2008-10#2)
chloride on microcrystalline naphthalene##2##4##(2008-10#2)
chloride on the##3##3##(1994-5#2)(2008-10#1)
chloride on##9##2##(1994-5#2)(1995-12#1)(2008-10#4)(2008-12#1)(2011-1#1)
chloride or##5##2##(1990-2#1)(1994-11#1)(1995-8#1)(2008-10#1)(2008-6#1)
chloride reactant ion##2##3##(2008-10#2)
chloride reactant ions##2##3##(2008-10#2)
chloride reactant##4##2##(2008-10#4)
chloride secretion##2##2##(1990-5#2)
chloride sodalites##3##2##(2008-10#3)
chloride solution was##2##3##(2008-10#2)
chloride solution##11##2##(1992-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2013-1#1)
chloride solutions##4##2##(2008-10#4)
chloride to give the##2##4##(2007-11#2)
chloride to##6##2##(1995-2#1)(2007-11#3)(2008-10#2)
chloride was added##2##3##(2008-10#2)
chloride was##12##2##(2008-10#8)(2008-3#2)(2011-1#1)(2013-1#1)
chloride were##3##2##(2008-10#2)(2008-11#1)
chloride with##7##2##(1994-5#1)(1996-5#1)(2008-10#5)
chloride##558##1##(1990-2#2)(1990-5#6)(1990-8#5)(1991-12#3)(1991-9#1)(1992-10#1)(1992-11#7)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#4)(1993-6#1)(1994-11#1)(1994-5#10)(1994-6#1)(1994-8#3)(1995-11#13)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#5)(1996-12#9)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#1)(1997-2#8)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#7)(2006-6#1)(2007-11#12)(2007-12#1)(2007-3#1)(2007-7#5)(2008-10#330)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#2)(2011-3#4)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
chloride) (PVC) matrix##3##3##(2008-10#3)
chloride) (PVC) membrane electrode##3##4##(2008-10#3)
chloride) (PVC) membrane##6##3##(2008-10#6)
chloride) (PVC) membranes containing those deoxycholic##2##6##(2008-10#2)
chloride) (PVC) membranes##5##3##(2008-10#5)
chloride) (PVC)##19##2##(2008-10#19)
chloride) and##4##2##(2008-10#4)
chloride) membrane electrode##3##3##(2008-10#3)
chloride) membrane##14##2##(2008-10#14)
chloride) were##2##2##(1990-8#1)(2008-10#1)
chloride)##62##1##(1990-8#1)(1997-2#1)(2006-6#1)(2008-10#59)
chloride)-based##3##1##(2008-10#2)(2010-5#1)
chloride+zwitterionic##2##1##(2008-10#2)
chloride-channel##4##1##(1995-11#4)
chlorides and##4##2##(2008-10#3)(2010-5#1)
chlorides in##3##2##(1996-2#1)(2007-11#2)
chlorides##21##1##(1990-8#1)(1992-11#1)(1996-2#1)(1996-5#1)(2007-11#2)(2008-10#7)(2009-11#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#1)(2013-1#1)
chlorinated biphenyls##5##2##(1993-12#3)(2008-10#2)
chlorinated hydrocarbons are##2##3##(2008-10#2)
chlorinated hydrocarbons##6##2##(2008-10#6)
chlorinated organic compounds##2##3##(1992-5#1)(2011-1#1)
chlorinated species##2##2##(2008-2#2)
chlorinated##36##1##(1990-7#1)(1992-5#2)(1993-12#4)(1994-3#1)(1997-4#1)(2008-10#21)(2008-11#1)(2008-2#2)(2010-4#1)(2011-1#2)
chlorination by-products##4##2##(2008-10#4)
chlorination of##4##2##(1992-5#1)(1995-6#1)(2008-10#1)(2008-9#1)
chlorination##13##1##(1992-5#2)(1995-6#1)(2008-10#8)(2008-9#2)
chlorine and##5##2##(2008-10#3)(2008-9#1)(2009-8#1)
chlorine atom##3##2##(1997-7#1)(2008-5#2)
chlorine atoms##4##2##(1997-7#1)(2008-10#3)
chlorine dioxide in water##3##4##(2008-10#3)
chlorine dioxide in##6##3##(2008-10#6)
chlorine dioxide##11##2##(2008-10#11)
chlorine in##5##2##(2008-10#5)
chlorine is##2##2##(2008-10#2)
chlorine species##4##2##(2008-10#4)
chlorine to##2##2##(2008-10#2)
chlorine using##2##2##(2008-10#2)
chlorine was##2##2##(2008-10#2)
chlorine with##2##2##(2008-10#2)
chlorine##76##1##(1991-5#2)(1991-6#3)(1992-11#2)(1992-5#1)(1995-6#1)(1996-1#1)(1997-7#2)(2008-10#57)(2008-2#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-4#1)
chlorine-based##2##1##(2008-3#2)
chlorine-containing disinfectants##2##2##(2008-10#2)
chlorite dismutase##2##2##(2009-2#2)
chlorite##11##1##(2008-10#7)(2009-2#4)
chloro-organic##5##1##(2008-10#2)(2009-8#3)
chloroacetate##2##1##(1994-8#1)(2008-10#1)
chloroacetic acid##3##2##(2008-10#2)(2008-11#1)
chloroacetic acids##4##2##(2008-10#4)
chloroacetic##8##1##(2008-10#7)(2008-11#1)
chloroaluminum##3##1##(1990-11#1)(2008-10#2)
chlorobenzene##7##1##(2008-10#6)(2008-2#1)
chlorocomplexes with##2##2##(2008-10#2)
chloroethylating species##3##2##(2010-11#3)
chloroethylating##4##1##(1992-3#1)(2010-11#3)
chloroethylclonidine##6##1##(1995-12#6)
chloroethylclonidine-treated##2##1##(1995-12#2)
chlorofluorocarbon (CFC) propellants##3##3##(1992-3#2)(1996-1#1)
chlorofluorocarbon (CFC)##5##2##(1992-3#2)(1996-1#2)(1996-2#1)
chlorofluorocarbon##6##1##(1992-3#3)(1996-1#2)(1996-2#1)
chlorofluorocarbons (CFCs)##3##2##(1996-1#2)(1996-2#1)
chloroform and dichloromethane##3##3##(2008-10#3)
chloroform and##12##2##(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#1)
chloroform as##5##2##(1991-8#1)(2007-12#1)(2008-10#3)
chloroform extraction##3##2##(2008-10#3)
chloroform or##2##2##(2007-11#1)(2008-10#1)
chloroform phase##2##2##(2008-10#2)
chloroform solution of##2##3##(2008-10#2)
chloroform solution##4##2##(2008-10#4)
chloroform solvent##2##2##(2008-10#1)(2009-9#1)
chloroform was##5##2##(1991-8#1)(2007-12#1)(2008-10#2)(2013-8#1)
chloroform with##2##2##(2008-10#2)
chloroform##111##1##(1991-8#3)(1991-9#1)(1993-8#1)(1994-3#1)(1995-2#1)(2007-11#5)(2007-12#5)(2007-7#1)(2008-10#80)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#2)(2012-2#2)(2013-8#2)
chloroformate##9##1##(1995-2#1)(1996-5#1)(2008-10#7)
chloroformates##2##1##(2008-10#2)
chloroformic##3##1##(2008-10#3)
chlorogenic acid were##2##3##(2008-10#1)(2008-11#1)
chlorogenic acid##17##2##(2008-10#13)(2008-11#4)
chlorogenic##21##1##(2008-10#15)(2008-11#6)
chloroguaiacol##5##1##(2008-10#5)
chlorohexidine##2##1##(1994-11#2)
chlorohydrin##5##1##(1996-5#1)(2008-9#4)
chloromethyl ketone##2##2##(1992-8#2)
chloromethyl##3##1##(1992-8#2)(1995-6#1)
chloromethylated polystyrene resin beads##2##4##(2007-12#2)
chloromethylated polystyrene##3##2##(2007-12#2)(2008-10#1)
chloromethylated##14##1##(2007-12#2)(2008-10#11)(2008-5#1)
chloromethylketone##2##1##(1990-2#2)
chloronaphthalene##2##1##(2008-10#2)
chloropentamminecobalt(III) ion##2##2##(2008-10#2)
chloroperoxidase in the oxidation of##2##5##(1994-5#2)
chloroperoxidase##6##1##(1994-5#4)(1994-6#2)
chlorophenolicum##2##1##(2009-3#2)
chlorophenols and##2##2##(2008-10#2)
chlorophenols from##3##2##(2012-1#3)
chlorophenols##18##1##(1991-11#1)(1996-12#1)(2008-10#12)(2012-1#4)
chlorophenoxy##2##1##(1991-11#1)(2008-11#1)
chlorophyll a and b##2##4##(2008-12#2)
chlorophyll a concentration##2##3##(2008-3#2)
chlorophyll a fluorescence##2##3##(2008-3#1)(2013-1#1)
chlorophyll a retrieval##2##3##(2008-3#2)
chlorophyll a##17##2##(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#10)(2008-8#1)(2013-1#1)
chlorophyll and##2##2##(2008-10#1)(2008-9#1)
chlorophyll concentration##11##2##(2008-2#1)(2008-3#8)(2008-9#1)(2012-9#1)
chlorophyll concentrations##2##2##(2008-3#2)
chlorophyll content and##4##3##(2008-12#1)(2008-3#1)(2013-7#2)
chlorophyll content##12##2##(2008-12#7)(2008-2#1)(2008-3#1)(2012-7#1)(2013-7#2)
chlorophyll contents##3##2##(2008-12#2)(2008-9#1)
chlorophyll fluorescence##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
chlorophyll in##2##2##(2008-10#1)(2008-12#1)
chlorophyll synthesis##2##2##(1992-8#1)(2008-10#1)
chlorophyll with##2##2##(2008-3#1)(2008-9#1)
chlorophyll##85##1##(1992-8#2)(1994-8#1)(1995-2#1)(2008-10#9)(2008-11#2)(2008-12#15)(2008-2#6)(2008-3#27)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-7#1)(2012-9#2)(2013-1#1)(2013-7#2)
chlorophyll-a##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
chlorophyll-related##2##1##(2008-11#2)
chlorophylls a##4##2##(2008-10#4)
chlorophylls##7##1##(2008-10#6)(2008-12#1)
chloropicrin##6##1##(2008-10#6)
chloroplast DNA (cpDNA)##2##3##(1996-4#1)(1997-2#1)
chloroplast DNA##5##2##(1996-4#1)(1997-2#2)(1997-6#1)(2008-5#1)
chloroplast and mitochondrial proteins##2##4##(2008-7#2)
chloroplast and mitochondrial##3##3##(2008-7#3)
chloroplast envelope##3##2##(1994-11#1)(1995-2#2)
chloroplast envelopes##3##2##(1994-11#3)
chloroplast genome##5##2##(1997-2#1)(2008-12#2)(2008-9#1)(2010-6#1)
chloroplast protein##4##2##(1995-2#1)(2008-1#1)(2008-9#1)(2009-5#1)
chloroplast repositioning##2##2##(2008-11#1)(2009-8#1)
chloroplast thioredoxin##2##2##(1990-12#1)(2009-10#1)
chloroplast transit##2##2##(1995-2#1)(2009-5#1)
chloroplast##59##1##(1990-12#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-8#1)(1994-11#4)(1995-2#4)(1996-4#1)(1997-2#3)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#4)(2009-7#2)(2009-8#2)(2010-10#1)(2010-6#1)(2012-3#5)
chloroplastic##3##1##(1991-12#1)(1997-7#1)(2008-8#1)
chloroplasts and mitochondria##2##3##(2008-7#2)
chloroplasts and##8##2##(1993-12#1)(1997-6#2)(2008-10#1)(2008-7#2)(2008-9#1)(2009-8#1)
chloroplasts of##2##2##(1990-5#1)(2008-10#1)
chloroplasts##24##1##(1990-5#2)(1992-3#1)(1993-12#1)(1994-11#1)(1995-2#3)(1995-8#1)(1997-6#3)(2008-1#2)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2012-3#1)
chloropropyl and aminopropyl sol-gel##2##4##(2008-10#2)
chloropropyl bonded silica##2##3##(2008-10#2)
chloropropyl##4##1##(2008-10#4)
chloroquine and##4##2##(1990-7#1)(1993-8#1)(1995-8#1)(1996-8#1)
chloroquine diphosphate##2##2##(1994-3#2)
chloroquine solution##3##2##(1994-3#3)
chloroquine treatment##2##2##(1990-2#1)(1994-3#1)
chloroquine was##2##2##(2008-10#1)(2011-2#1)
chloroquine##37##1##(1990-2#1)(1990-7#1)(1992-12#1)(1992-6#3)(1992-9#2)(1993-8#5)(1994-12#1)(1994-3#8)(1994-6#1)(1995-8#1)(1996-8#1)(2008-10#9)(2009-4#2)(2011-2#1)
chloroquine-induced myopathy##2##2##(1995-12#2)
chloroquine-induced##5##1##(1992-9#1)(1995-12#4)
chlorosis and##3##2##(2008-10#3)
chlorosis in##7##2##(2008-10#7)
chlorosis on##2##2##(2008-10#2)
chlorosis toxin##5##2##(2008-10#5)
chlorosis virus##9##2##(2008-10#9)
chlorosis##47##1##(2008-10#46)(2011-1#1)
chlorosis-inducing##2##1##(2008-10#2)
chlorosomes from the green##2##4##(1996-2#2)
chlorosomes##3##1##(1996-2#3)
chlorothalonil##7##1##(1997-4#1)(2008-10#5)(2011-2#1)
chlorothiazide##3##1##(2008-10#3)
chlorotic area##2##2##(2008-10#2)
chlorotic leaf areas##2##3##(2008-10#2)
chlorotic leaf##8##2##(2008-10#8)
chlorotic mottle virus##5##3##(2008-10#5)
chlorotic mottle##7##2##(2008-10#7)
chlorotic spot virus##5##3##(2008-10#5)
chlorotic streaks##5##2##(2008-10#5)
chlorotic stunt virus##6##3##(2008-10#6)
chlorotic##40##1##(2008-10#40)
chlorotoxin fused to##3##3##(2013-1#3)
chlorotoxin##6##1##(1995-12#1)(2013-1#5)
chlorotriazines##3##1##(2008-10#3)
chlorotrimethylsilane##2##1##(2007-11#1)(2009-12#1)
chlorphenamine##4##1##(2008-10#4)
chlorphenamine-imprinted polymer##2##2##(2008-10#2)
chlorpheniramine##2##1##(2008-10#1)(2010-5#1)
chlorpromazine and##2##2##(2008-10#1)(2012-2#1)
chlorpromazine hydrochloride##5##2##(2008-10#5)
chlorpromazine##13##1##(1996-7#1)(2008-10#10)(2008-3#1)(2012-2#1)
chlorpyrifos and##2##2##(2008-10#2)
chlorpyrifos##18##1##(2007-10#1)(2008-10#12)(2011-1#2)(2011-2#3)
chlorsulfuron##3##1##(2008-10#1)(2008-9#2)
chlortetracycline (CTC)##5##2##(2008-10#4)(2008-8#1)
chlortetracycline and##3##2##(2008-10#3)
chlortetracycline hydrochloride##4##2##(2008-10#4)
chlortetracycline in##3##2##(2008-10#3)
chlortetracycline were##2##2##(2008-10#2)
chlortetracycline##23##1##(2008-10#22)(2008-8#1)
chlorzoxazone and acetaminophen##2##3##(2008-10#2)
chlorzoxazone##5##1##(2008-10#5)
choanoflagellate##3##1##(2010-2#3)
choanoflagellates##4##1##(2010-2#4)
chocoensis##4##1##(2013-7#4)
chocolate and##3##2##(2009-3#1)(2012-1#1)(2012-3#1)
chocolate milk##2##2##(2008-10#2)
chocolate##8##1##(2008-10#4)(2008-12#1)(2009-3#1)(2012-1#1)(2012-3#1)
chocolates##3##1##(2008-10#1)(2012-2#2)
choice among##3##2##(1991-3#1)(1995-2#1)(2008-9#1)
choice and predicted SWB rankings##2##5##(2013-1#2)
choice and sexual##2##3##(2008-9#1)(2013-1#1)
choice and the##3##3##(1991-3#1)(2009-5#1)(2011-2#1)
choice and##26##2##(1990-6#1)(1991-3#2)(1992-9#1)(1995-1#2)(1995-2#1)(1996-11#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#4)
choice are##3##2##(2007-8#1)(2008-11#1)(2008-12#1)
choice behavior##2##2##(1990-9#1)(1992-2#1)
choice between##9##2##(1990-3#1)(1991-3#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-5#1)(2008-7#1)(2011-10#1)(2012-2#1)
choice boxes##2##2##(1993-12#1)(2011-2#1)
choice by##2##2##(1994-7#1)(1996-11#1)
choice criteria##2##2##(1994-2#1)(1995-3#1)
choice due to##2##3##(2008-10#1)(2012-3#1)
choice for patients with##5##4##(1997-4#1)(2007-7#1)(2009-12#1)(2010-10#1)(2013-8#1)
choice for routine##2##3##(2008-10#2)
choice for the treatment of##2##5##(2008-2#1)(2008-3#1)
choice for the##14##3##(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
choice for this##2##3##(2008-10#1)(2010-2#1)
choice for water##2##3##(2008-10#1)(2008-2#1)
choice for##86##2##(1991-10#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1994-12#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
choice has##4##2##(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
choice in cases##2##3##(1993-9#1)(2007-8#1)
choice in evaluating##2##3##(2008-10#1)(2011-2#1)
choice in patients with##2##4##(2010-6#1)(2013-1#1)
choice in the treatment of##2##5##(2007-11#1)(2007-8#1)
choice in the##13##3##(1990-2#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
choice in their##2##3##(2007-11#1)(2007-2#1)
choice in treating##3##3##(2010-8#1)(2011-2#1)(2012-3#1)
choice in##62##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-9#1)(2007-11#7)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2008-8#7)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
choice is##18##2##(1990-2#1)(1992-12#1)(1992-9#1)(1994-5#1)(1994-7#1)(1995-1#1)(1996-9#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
choice model##4##2##(1992-2#1)(2008-12#3)
choice of a provider##2##4##(1995-12#1)(1995-3#1)
choice of a##12##3##(1991-6#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)
choice of an##3##3##(1990-3#1)(2008-8#1)(2009-11#1)
choice of antimicrobial##2##3##(2008-7#1)(2013-1#1)
choice of contraceptive##2##3##(1996-11#2)
choice of drug##2##3##(1997-1#1)(2009-8#1)
choice of filter##2##3##(2008-3#2)
choice of health care##2##4##(1992-3#1)(1997-3#1)
choice of health##3##3##(1992-3#1)(1997-3#2)
choice of imaging##2##3##(2010-5#1)(2012-2#1)
choice of mates##2##3##(2008-8#1)(2008-9#1)
choice of model##2##3##(1994-11#1)(2008-10#1)
choice of optical##2##3##(2008-2#1)(2008-6#1)
choice of solvent##2##3##(2008-10#2)
choice of sowing date##2##4##(2008-10#2)
choice of specialty##3##3##(1991-6#2)(1993-6#1)
choice of surgical##2##3##(2007-11#2)
choice of the appropriate##3##4##(2007-11#1)(2007-12#1)(2011-2#1)
choice of the best##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
choice of the treatment##2##4##(2007-11#1)(2013-8#1)
choice of the##32##3##(1990-2#1)(1990-3#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
choice of therapy##7##3##(1992-2#2)(1993-11#1)(2007-6#1)(2007-7#1)(2011-2#1)(2013-1#1)
choice of these##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
choice of treatment for##2##4##(1991-3#1)(2013-8#1)
choice of treatment##6##3##(1991-3#1)(1995-1#1)(2007-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
choice of which##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
choice of##218##2##(1990-2#1)(1990-3#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#4)(1991-9#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-6#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#5)(1997-8#1)(2007-11#11)(2007-12#5)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#19)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#9)(2009-11#3)(2009-2#1)(2009-6#2)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-10#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
choice paradigm##2##2##(1990-11#1)(1992-12#1)
choice reaction##2##2##(2008-7#2)
choice tests with##2##3##(2009-9#1)(2011-2#1)
choice tests##3##2##(2008-9#1)(2009-9#1)(2011-2#1)
choice to the##2##3##(2009-6#1)(2013-8#1)
choice to##6##2##(1994-1#1)(1994-2#1)(2009-6#1)(2011-7#1)(2012-12#1)(2013-8#1)
choice was##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
choice were examined by comparing##2##5##(2008-8#2)
choice were##4##2##(2008-6#1)(2008-8#2)(2008-9#1)
choice which##2##2##(1990-3#1)(1997-8#1)
choice with##4##2##(1990-2#1)(2008-9#1)(2010-3#1)(2011-2#1)
choice##646##1##(1990-11#1)(1990-2#5)(1990-3#5)(1990-6#4)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#8)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#7)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#9)(1993-1#3)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#3)(1995-1#6)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#5)(1995-5#4)(1995-8#2)(1996-1#3)(1996-11#11)(1996-2#4)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#9)(1997-4#4)(1997-6#1)(1997-8#2)(2006-12#2)(2007-11#20)(2007-12#8)(2007-2#2)(2007-6#1)(2007-7#8)(2007-8#15)(2008-1#7)(2008-10#53)(2008-11#9)(2008-12#12)(2008-2#12)(2008-3#27)(2008-4#11)(2008-5#3)(2008-6#4)(2008-7#23)(2008-8#24)(2008-9#36)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#9)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#8)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#7)(2011-1#4)(2011-10#2)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#8)(2012-2#11)(2012-3#7)(2013-1#29)(2013-7#1)(2013-8#9)
choice)##2##1##(2008-7#1)(2009-6#1)
choice-offering##4##1##(2008-4#4)
choice]##2##1##(1992-3#2)
choices about##3##2##(1991-3#1)(2008-11#1)(2012-1#1)
choices among##2##2##(1991-3#1)(2007-4#1)
choices and medical##2##3##(1991-12#1)(1994-1#1)
choices and##14##2##(1991-12#1)(1992-12#1)(1994-1#1)(1994-9#1)(1996-9#1)(1997-1#1)(2008-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-2#3)(2013-1#1)
choices are##5##2##(1991-9#1)(2008-8#2)(2012-2#1)(2013-1#1)
choices for##5##2##(1994-1#1)(2007-11#1)(2008-3#1)(2013-1#2)
choices may be##2##3##(2007-4#1)(2013-1#1)
choices of the##2##3##(2008-3#1)(2009-5#1)
choices of##12##2##(1993-12#2)(1997-3#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-8#1)(2013-8#1)
choices that##2##2##(1994-3#1)(1996-3#1)
choices to##2##2##(1994-1#1)(2013-1#1)
choices will##2##2##(1996-3#1)(2008-8#1)
choices##96##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#4)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-1#2)(1997-3#6)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-8#5)(2009-10#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#2)
choix##2##1##(2011-2#2)
choke##2##1##(2012-2#1)(2013-7#1)
chokecherry##3##1##(2008-10#3)
choking##3##1##(2009-5#1)(2010-4#2)
cholangiocarcinoma##10##1##(1992-2#1)(1993-5#1)(2008-2#2)(2009-9#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
cholangiocytes##2##1##(2008-11#1)(2008-8#1)
cholangiography##3##1##(1990-8#1)(2008-5#1)(2012-2#1)
cholangioscopy system##2##2##(2010-12#2)
cholangioscopy##3##1##(2010-12#3)
cholangitis and##3##2##(1997-8#1)(2013-1#2)
cholangitis in##2##2##(2006-10#1)(2009-8#1)
cholangitis##16##1##(1997-6#1)(1997-8#1)(2006-10#4)(2008-4#3)(2009-8#1)(2010-12#1)(2013-1#5)
cholate uptake##3##2##(1992-3#3)
cholate##14##1##(1990-2#4)(1992-3#6)(1993-11#1)(1994-9#3)
cholecalciferol and##3##2##(2008-5#3)
cholecystectomy and##2##2##(1993-3#1)(1995-12#1)
cholecystectomy complication##2##2##(2012-3#2)
cholecystectomy for##2##2##(1993-3#1)(1997-8#1)
cholecystectomy in bariatric##2##3##(1993-3#2)
cholecystectomy in##8##2##(1991-3#1)(1993-3#2)(1997-8#2)(2008-12#1)(2009-8#2)
cholecystectomy is the treatment of choice##2##6##(1990-6#1)(2009-3#1)
cholecystectomy##50##1##(1990-6#2)(1990-9#3)(1991-1#1)(1991-3#4)(1991-6#1)(1992-9#2)(1993-3#7)(1995-12#1)(1997-8#5)(2008-10#1)(2008-12#4)(2008-8#1)(2009-3#3)(2009-8#3)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#2)
cholecystectomy]##3##1##(1990-6#1)(1990-9#1)(1991-6#1)
cholecystitis and##4##2##(1991-3#1)(1991-8#1)(1992-9#1)(1997-8#1)
cholecystitis associated with gallbladder##2##4##(1991-8#1)(2008-5#1)
cholecystitis##23##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-9#1)(1995-11#1)(1997-8#4)(2008-5#3)(2010-12#1)(2013-8#6)
cholecystitis]##3##1##(1990-2#1)(1990-9#1)(1997-8#1)
cholecystokinin (CCK)##7##2##(1990-12#1)(1991-8#1)(1992-8#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-7#1)
cholecystokinin (CCK)-B##2##2##(1995-12#1)(1996-2#1)
cholecystokinin and##5##2##(1992-8#1)(1993-12#2)(1995-12#1)(1997-1#1)
cholecystokinin receptors##2##2##(1993-6#1)(1995-2#1)
cholecystokinin##30##1##(1990-12#1)(1991-12#1)(1991-8#2)(1992-8#5)(1993-12#2)(1993-6#4)(1994-6#1)(1995-12#3)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-7#2)
cholecystokinin-58##2##1##(1991-8#2)
choledochal cyst##2##2##(2009-9#2)
choledochal##5##1##(1990-6#1)(1990-8#1)(2009-9#3)
choledochoduodenostomy##3##1##(1990-5#1)(1990-6#2)
choledocholithiasis##10##1##(1990-5#1)(1994-3#1)(1997-8#1)(2008-5#5)(2009-9#2)
cholelithiasis##8##1##(1991-3#1)(1993-9#2)(1995-10#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
cholera antitoxin##3##2##(2008-10#3)
cholera epidemic in##3##3##(1992-5#1)(1993-3#2)
cholera epidemic##4##2##(1992-5#1)(1992-6#1)(1993-3#2)
cholera in##5##2##(1992-5#2)(1993-3#1)(2007-2#2)
cholera to the##2##3##(1992-6#1)(2007-2#1)
cholera to##5##2##(1992-6#2)(2007-2#3)
cholera toxin B subunit##3##4##(2008-11#3)
cholera toxin B##6##3##(1996-5#1)(2008-11#3)(2008-7#1)(2009-2#1)
cholera toxin##19##2##(1991-12#2)(1991-3#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-5#2)(1997-3#1)(2008-11#3)(2008-4#3)(2008-7#1)(2009-2#1)
cholera##58##1##(1991-12#2)(1991-3#1)(1991-9#1)(1992-5#5)(1992-6#5)(1993-3#9)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-5#2)(1997-3#1)(2007-10#1)(2007-2#11)(2008-10#3)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#2)(2013-1#1)
cholerae isolates##2##2##(2012-3#2)
cholerae strains##2##2##(2007-10#1)(2012-3#1)
cholerae##32##1##(1990-5#2)(1991-3#1)(1992-5#1)(1993-9#3)(1994-11#1)(2007-10#2)(2007-7#3)(2008-10#1)(2008-8#3)(2008-9#5)(2009-8#3)(2012-3#7)
cholestane##2##1##(1990-2#1)(1994-3#1)
cholestanol to##2##2##(1992-6#2)
cholestanol##6##1##(1992-6#6)
cholestasis##16##1##(1992-5#1)(1993-3#3)(1993-9#4)(1996-3#2)(2006-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
cholestatic diseases##2##2##(2008-8#2)
cholestatic hepatitis##4##2##(1996-3#3)(2006-10#1)
cholestatic liver##4##2##(1995-10#1)(2008-8#2)(2013-1#1)
cholestatic rats##4##2##(2008-8#4)
cholestatic syndromes##3##2##(2006-10#2)(2008-8#1)
cholestatic##22##1##(1992-6#1)(1992-9#1)(1993-3#1)(1995-10#1)(1996-3#4)(2006-10#3)(2008-8#9)(2013-1#2)
cholesteatoma##20##1##(2008-9#6)(2011-2#13)(2013-1#1)
cholesteatomas##2##1##(2011-2#2)
cholesteric liquid crystal##3##3##(2007-11#1)(2007-12#2)
cholesteric liquid crystals##5##3##(1995-6#1)(2007-11#2)(2008-3#1)(2008-7#1)
cholesteric liquid##8##2##(1995-6#1)(2007-11#3)(2007-12#2)(2008-3#1)(2008-7#1)
cholesteric##9##1##(1995-6#1)(2007-11#3)(2007-12#3)(2008-3#1)(2008-7#1)
cholesterol (P##2##2##(1991-9#1)(2011-1#1)
cholesterol (by##3##2##(2008-4#1)(2011-2#2)
cholesterol accumulation and##2##3##(1990-8#1)(1991-5#1)
cholesterol accumulation##5##2##(1990-8#2)(1991-5#1)(1992-6#1)(2013-1#1)
cholesterol acyltransferase (ACAT) inhibitors##2##4##(1994-8#1)(1995-3#1)
cholesterol acyltransferase (ACAT)##4##3##(1994-8#2)(1995-3#2)
cholesterol acyltransferase (LCAT)##2##3##(1993-6#2)
cholesterol acyltransferase##11##2##(1991-12#1)(1993-6#2)(1993-8#2)(1994-8#2)(1995-3#2)(1995-5#1)(2012-12#1)
cholesterol and Brij((R))30##2##3##(2008-10#2)
cholesterol and LDL##3##3##(1990-3#1)(1993-12#1)(2011-2#1)
cholesterol and apoB##2##3##(1992-3#2)
cholesterol and fatty acids##2##4##(2008-5#2)
cholesterol and fatty##3##3##(2008-5#2)(2010-2#1)
cholesterol and plasma##3##3##(1990-8#1)(1991-2#1)(2010-2#1)
cholesterol and sphingolipid enriched membrane fractions##2##6##(2008-8#2)
cholesterol and sphingolipid enriched##4##4##(2008-8#4)
cholesterol and the##3##3##(1994-3#1)(2008-10#2)
cholesterol and triglyceride##3##3##(1991-4#1)(2007-11#1)(2011-1#1)
cholesterol and triglycerides were##2##4##(1990-8#2)
cholesterol and triglycerides##10##3##(1990-8#3)(1991-12#1)(1991-6#1)(1993-2#1)(2008-1#1)(2008-7#2)(2013-1#1)
cholesterol and##63##2##(1990-3#1)(1990-7#1)(1990-8#6)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-12#2)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2009-4#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#3)
cholesterol are##5##2##(1992-6#1)(1994-5#1)(2008-3#1)(2012-2#2)
cholesterol as well as##2##4##(1992-11#1)(2012-2#1)
cholesterol as##5##2##(1992-11#1)(1993-12#1)(2012-2#2)(2013-1#1)
cholesterol biosensor##4##2##(2008-10#4)
cholesterol biosynthesis##2##2##(1995-12#1)(2008-11#1)
cholesterol blood##2##2##(2008-1#2)
cholesterol by##4##2##(1991-6#1)(1996-5#1)(2009-7#1)(2012-2#1)
cholesterol can##2##2##(1990-2#1)(2008-8#1)
cholesterol concentration with##2##3##(2008-10#2)
cholesterol concentration##9##2##(1991-6#1)(1992-6#2)(2008-10#5)(2008-5#1)
cholesterol concentrations were reduced##2##4##(1991-6#1)(2010-2#1)
cholesterol concentrations##10##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-6#3)(2007-11#1)(2008-3#1)(2010-12#1)(2010-2#1)
cholesterol content in serum##2##4##(2013-8#2)
cholesterol content in##5##3##(2008-10#1)(2010-2#1)(2013-8#3)
cholesterol content of##3##3##(1990-8#1)(1995-5#1)(2008-6#1)
cholesterol content##14##2##(1990-8#2)(1995-5#2)(1997-7#2)(2008-10#1)(2008-6#1)(2010-2#1)(2013-8#5)
cholesterol determination in##2##3##(2008-10#2)
cholesterol did not##2##3##(2008-3#1)(2008-5#1)
cholesterol efflux from##3##3##(1990-12#2)(1994-11#1)
cholesterol efflux in##2##3##(1994-11#1)(2011-1#1)
cholesterol efflux##10##2##(1990-12#3)(1994-11#3)(2011-1#4)
cholesterol ester##5##2##(1992-12#2)(1995-12#1)(2008-7#1)(2013-1#1)
cholesterol esterase##2##2##(2008-10#2)
cholesterol esterification in##4##3##(1990-8#2)(1994-8#2)
cholesterol esterification##7##2##(1990-8#2)(1992-6#1)(1994-8#3)(1995-3#1)
cholesterol for##3##2##(1991-12#1)(1993-6#1)(1995-5#1)
cholesterol from the##2##3##(1990-2#1)(2012-2#1)
cholesterol from##7##2##(1990-2#2)(1994-8#2)(2008-8#1)(2009-4#1)(2012-2#1)
cholesterol homeostasis##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
cholesterol in the##2##3##(2008-3#1)(2008-5#1)
cholesterol in##27##2##(1990-2#2)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-6#2)(1992-9#1)(1995-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-7#3)(2010-2#1)(2011-1#2)(2013-1#1)
cholesterol increased##2##2##(1995-8#1)(2008-3#1)
cholesterol intake##2##2##(1990-2#1)(1990-8#1)
cholesterol into the##2##3##(1990-2#1)(1992-6#1)
cholesterol into##4##2##(1990-2#1)(1992-6#1)(1993-6#1)(1994-8#1)
cholesterol is##8##2##(1990-2#1)(1992-6#1)(1994-11#1)(1996-8#1)(2008-10#3)(2013-1#1)
cholesterol level in##2##3##(1994-11#1)(2008-1#1)
cholesterol level is##2##3##(1991-8#1)(2008-3#1)
cholesterol level##14##2##(1991-6#2)(1991-8#1)(1994-11#1)(2007-10#1)(2008-1#2)(2008-3#3)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)
cholesterol levels and##3##3##(1994-12#1)(2007-11#1)(2013-1#1)
cholesterol levels by##2##3##(2008-5#1)(2013-1#1)
cholesterol levels in##5##3##(1991-6#1)(1994-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
cholesterol levels was##2##3##(1994-3#1)(2012-2#1)
cholesterol levels were##3##3##(1990-3#1)(1993-3#1)(1994-11#1)
cholesterol levels##33##2##(1990-2#1)(1990-3#1)(1991-6#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-11#1)(1996-6#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#3)(2013-1#5)
cholesterol lowering treatment##2##3##(2008-1#2)
cholesterol lowering##8##2##(1991-6#1)(1991-8#2)(2008-1#2)(2008-4#1)(2010-12#1)(2013-8#1)
cholesterol management##2##2##(1996-11#1)(2008-6#1)
cholesterol metabolism and##2##3##(1993-3#1)(2008-10#1)
cholesterol metabolism##9##2##(1993-3#2)(1993-6#1)(1995-6#1)(2008-1#1)(2008-10#2)(2009-7#1)(2013-1#1)
cholesterol molar fraction##2##3##(1992-6#2)
cholesterol molecules##2##2##(2012-2#2)
cholesterol on the##2##3##(1990-2#1)(1993-12#1)
cholesterol on##5##2##(1990-2#1)(1992-6#2)(1993-12#1)(1997-5#1)
cholesterol or##2##2##(1994-12#1)(2011-1#1)
cholesterol oxidase (ChOx)##3##3##(2008-10#3)
cholesterol oxidase##7##2##(1990-12#1)(1997-7#1)(2008-10#5)
cholesterol ratio was the best##2##5##(2013-1#2)
cholesterol ratio was##3##3##(2013-1#3)
cholesterol ratio##8##2##(2008-3#2)(2008-5#1)(2013-1#5)
cholesterol recognition##2##2##(2012-2#2)
cholesterol removal##2##2##(2008-4#2)
cholesterol sulfate##2##2##(2008-10#1)(2008-5#1)
cholesterol synthesis##6##2##(1991-5#1)(1991-6#3)(1995-12#1)(2012-2#1)
cholesterol to##7##2##(1990-3#1)(1991-2#1)(1992-6#1)(1994-3#1)(1994-8#1)(2008-10#2)
cholesterol transfer##2##2##(1995-5#2)
cholesterol translocation from intracellular##2##4##(1990-12#1)(1994-11#1)
cholesterol translocation from##3##3##(1990-12#1)(1994-11#1)(1995-12#1)
cholesterol translocation##7##2##(1990-12#1)(1994-11#1)(1995-12#5)
cholesterol transport into##2##3##(2012-2#2)
cholesterol transport##8##2##(1994-3#1)(1995-6#1)(1996-2#1)(2006-12#1)(2008-6#1)(2009-10#1)(2012-2#2)
cholesterol was lower##3##3##(1992-8#1)(2007-7#2)
cholesterol was within normal range in TT##2##7##(2007-7#2)
cholesterol was##16##2##(1990-8#1)(1991-11#1)(1991-6#3)(1992-8#1)(2007-7#4)(2008-10#2)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
cholesterol were##6##2##(1991-11#1)(1991-6#1)(1991-8#1)(2008-12#1)(2011-1#2)
cholesterol with##6##2##(1996-5#1)(2008-10#3)(2008-6#1)(2012-6#1)
cholesterol##603##1##(1990-11#1)(1990-12#6)(1990-2#18)(1990-3#4)(1990-5#1)(1990-7#2)(1990-8#21)(1991-11#6)(1991-12#8)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#18)(1991-8#6)(1991-9#3)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#28)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#11)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#2)(1994-11#10)(1994-12#5)(1994-3#6)(1994-5#6)(1994-8#15)(1994-9#2)(1995-11#1)(1995-12#14)(1995-2#2)(1995-3#4)(1995-5#9)(1995-6#3)(1995-8#1)(1996-11#3)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-7#7)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-7#5)(2008-1#14)(2008-10#67)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#26)(2008-4#8)(2008-5#13)(2008-6#7)(2008-7#15)(2008-8#9)(2009-10#1)(2009-12#1)(2009-4#3)(2009-7#7)(2010-12#8)(2010-2#7)(2010-3#1)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#13)(2011-2#11)(2012-12#1)(2012-2#31)(2012-3#3)(2012-6#3)(2013-1#38)(2013-8#9)
cholesterol&quot##2##1##(2013-8#2)
cholesterol-depleted##2##1##(1994-8#1)(2012-2#1)
cholesterol-lowering drugs##2##2##(1991-6#1)(2012-2#1)
cholesterol-lowering effect##2##2##(1991-6#2)
cholesterol-lowering##14##1##(1991-6#5)(2008-12#1)(2008-4#1)(2008-6#2)(2010-7#1)(2011-1#1)(2012-2#3)
cholesterol/HDL ratio##2##2##(2008-3#1)(2008-5#1)
cholesterol]##2##1##(1990-9#1)(1997-3#1)
cholesterolemia##7##1##(1991-12#5)(2012-12#1)(2012-2#1)
cholesteryl ester accumulation##2##3##(1990-8#1)(1994-11#1)
cholesteryl ester formation##2##3##(1990-8#1)(1991-5#1)
cholesteryl ester transfer activity##2##4##(1995-5#2)
cholesteryl ester transfer protein##8##4##(1995-5#2)(1995-8#1)(2008-12#5)
cholesteryl ester transfer##11##3##(1992-3#1)(1995-5#4)(1995-8#1)(2008-12#5)
cholesteryl ester##21##2##(1990-8#2)(1991-5#1)(1992-3#5)(1994-11#1)(1995-5#4)(1995-8#1)(2008-12#5)(2009-8#2)
cholesteryl esters##6##2##(1992-3#3)(1996-5#1)(2009-8#2)
cholesteryl##28##1##(1990-8#3)(1991-5#1)(1992-3#8)(1994-11#1)(1995-5#4)(1995-8#1)(1996-5#1)(2008-12#5)(2009-8#4)
cholestyramine##6##1##(1991-12#1)(1991-2#2)(1992-11#2)(2008-10#1)
cholic##3##1##(2008-10#3)
choline acetyltransferase (ChAT) activity in##2##5##(1992-8#1)(1993-3#1)
choline acetyltransferase (ChAT)##4##3##(1992-8#1)(1993-3#1)(2009-11#1)(2009-3#1)
choline acetyltransferase activity##3##3##(1992-8#1)(1993-12#2)
choline acetyltransferase##12##2##(1992-8#2)(1993-12#2)(1993-3#1)(1996-12#3)(1996-2#1)(2008-10#1)(2009-11#1)(2009-3#1)
choline and##6##2##(1990-12#1)(1990-7#2)(1992-12#1)(1995-3#1)(2008-10#1)
choline biosensor was##3##3##(2008-10#3)
choline biosensor##4##2##(2008-10#4)
choline chloride##4##2##(1992-6#1)(1993-12#1)(2008-11#2)
choline has##2##2##(1995-6#2)
choline oxidase on the##2##4##(1992-11#1)(2008-10#1)
choline oxidase##5##2##(1992-11#1)(2008-10#4)
choline transport##2##2##(1990-11#2)
choline##62##1##(1990-11#3)(1990-12#1)(1990-7#2)(1991-5#2)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-12#4)(1993-3#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#5)(1996-12#4)(1996-2#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-3#1)(2010-6#1)
cholinergic activity in##2##3##(1990-7#1)(1993-9#1)
cholinergic activity##5##2##(1990-7#1)(1993-12#3)(1993-9#1)
cholinergic agonist##3##2##(1993-3#1)(1994-8#1)(2006-10#1)
cholinergic and glutamatergic systems##2##4##(1994-6#2)
cholinergic and glutamatergic##5##3##(1993-12#1)(1994-6#2)(2008-7#2)
cholinergic and serotonergic##2##3##(1991-7#1)(1993-5#1)
cholinergic and##10##2##(1991-7#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-6#2)(1994-8#1)(2008-7#2)(2013-8#1)
cholinergic antagonist##2##2##(2008-7#2)
cholinergic assessment##2##2##(2011-1#2)
cholinergic deficit##3##2##(1992-8#1)(1994-5#2)
cholinergic function##2##2##(1992-10#2)
cholinergic hypofunction##2##2##(1993-12#2)
cholinergic mechanisms##3##2##(1996-2#1)(2008-11#1)(2008-5#1)
cholinergic neuron##2##2##(1991-9#1)(1994-8#1)
cholinergic neurons in the release of dopamine##2##7##(1997-2#2)
cholinergic neurons in##3##3##(1995-12#1)(1997-2#2)
cholinergic neurons##21##2##(1991-12#2)(1991-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#3)(1996-5#3)(1997-2#3)(2008-5#2)(2009-3#4)
cholinergic neurotransmission were discussed##2##4##(2008-5#2)
cholinergic projections##2##2##(1996-5#1)(2013-8#1)
cholinergic septal grafts##2##3##(1993-12#2)
cholinergic system in##3##3##(1991-12#1)(1996-5#1)(2010-8#1)
cholinergic system##10##2##(1991-12#1)(1991-9#1)(1993-12#1)(1994-8#1)(1996-5#1)(2008-10#3)(2010-8#2)
cholinergic systems##2##2##(1996-12#1)(2008-5#1)
cholinergic transmission and##2##3##(2008-8#1)(2011-1#1)
cholinergic transmission in##3##3##(2008-8#1)(2013-8#2)
cholinergic transmission##8##2##(2008-8#4)(2011-1#1)(2013-8#3)
cholinergic urticaria##2##2##(1991-11#1)(2013-1#1)
cholinergic##137##1##(1990-5#1)(1990-7#5)(1991-11#1)(1991-12#3)(1991-7#2)(1991-9#3)(1992-10#2)(1992-11#1)(1992-6#1)(1992-8#6)(1993-12#14)(1993-3#1)(1993-5#1)(1993-9#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#1)(1995-12#2)(1996-12#6)(1996-2#1)(1996-5#9)(1997-1#1)(1997-2#4)(1997-4#1)(2006-10#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-3#3)(2008-5#9)(2008-7#7)(2008-8#5)(2009-3#5)(2010-1#1)(2010-5#1)(2010-8#2)(2011-1#4)(2012-12#1)(2013-1#3)(2013-8#7)
cholinergic-serotonergic##2##1##(1991-7#2)
cholinesterase activities##3##2##(2008-10#1)(2013-1#2)
cholinesterase in##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
cholinesterase inhibitors##5##2##(1991-12#1)(1994-6#1)(2008-10#3)
cholinesterase##23##1##(1990-5#1)(1991-12#1)(1994-6#1)(2008-10#9)(2008-7#1)(2010-9#1)(2011-1#2)(2013-1#7)
cholinesterases##3##1##(2008-10#3)
cholinolytics##2##1##(1991-12#2)
chondral##7##1##(2007-11#1)(2008-8#1)(2011-2#5)
chondritic##2##1##(1997-5#2)
chondroblastic osteosarcoma##5##2##(2008-6#1)(2010-3#1)(2013-1#3)
chondroblastic##7##1##(2008-6#1)(2010-3#2)(2013-1#4)
chondroblastoma of the os calcis##2##5##(2008-6#2)
chondroblastoma##3##1##(2008-6#3)
chondrocalcinosis##4##1##(1991-11#2)(1992-5#1)(1993-2#1)
chondrocyte culture##2##2##(2008-11#1)(2009-7#1)
chondrocyte nuclear##2##2##(1991-11#2)
chondrocyte water transport properties##2##4##(2009-12#2)
chondrocyte##18##1##(1991-11#3)(1992-1#2)(2007-11#1)(2008-11#5)(2008-7#1)(2009-12#3)(2009-7#1)(2011-2#1)(2012-12#1)
chondrocytes and##5##2##(1992-8#1)(2008-11#2)(2011-2#1)(2012-4#1)
chondrocytes are##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
chondrocytes culture##3##2##(2007-11#3)
chondrocytes into##2##2##(2011-2#1)(2012-12#1)
chondrocytes of##4##2##(1993-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
chondrocytes were isolated##2##3##(2008-11#1)(2009-12#1)
chondrocytes were##3##2##(2008-11#1)(2008-7#1)(2009-12#1)
chondrocytes##59##1##(1991-11#3)(1992-1#1)(1992-8#1)(1993-12#2)(1994-6#2)(2007-11#7)(2008-11#17)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2011-2#5)(2012-12#8)(2012-4#1)(2013-8#1)
chondrogenesis and##3##2##(1991-5#1)(2008-11#1)(2008-4#1)
chondrogenesis of##2##2##(2008-11#1)(2008-5#1)
chondrogenesis##10##1##(1991-5#2)(1994-11#2)(2008-11#3)(2008-4#1)(2008-5#2)
chondrogenic and osteogenic differentiation##2##4##(2008-11#2)
chondrogenic differentiation potential##2##3##(2008-11#2)
chondrogenic differentiation##10##2##(1994-11#1)(2008-11#8)(2010-7#1)
chondrogenic media supplemented##2##3##(2008-5#2)
chondrogenic media##4##2##(2008-5#4)
chondrogenic##21##1##(1994-11#1)(2008-11#15)(2008-5#4)(2010-7#1)
chondroid##2##1##(2008-6#1)(2009-1#1)
chondroitin sulfate##3##2##(1993-3#1)(2008-10#2)
chondroitin sulphate##4##2##(1996-5#1)(2010-4#1)(2012-6#2)
chondroitin##9##1##(1992-9#1)(1993-3#1)(1996-5#1)(2008-10#3)(2010-4#1)(2012-6#2)
chondromatosis is##3##2##(1992-4#3)
chondromatosis##5##1##(1992-4#3)(2008-8#1)(2010-5#1)
chondrosarcoma and##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
chondrosarcoma in##2##2##(2008-6#1)(2010-3#1)
chondrosarcoma is##2##2##(2008-6#1)(2011-2#1)
chondrosarcoma of##4##2##(2008-5#2)(2008-6#1)(2008-7#1)
chondrosarcoma##26##1##(1993-2#1)(1993-8#1)(1997-8#1)(2008-5#4)(2008-6#7)(2008-7#2)(2008-8#2)(2009-1#1)(2010-3#1)(2011-2#4)(2012-1#1)(2013-7#1)
chondrosarcomas##5##1##(1993-8#1)(2008-1#1)(2008-6#2)(2013-7#1)
chondrosarcomatous##2##1##(1992-8#1)(2010-3#1)
choose a##5##2##(1993-11#1)(1997-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
choose and##2##2##(1994-1#1)(2012-1#1)
choose between##4##2##(1992-2#1)(1994-9#1)(2008-7#2)
choose diagnostic##2##2##(2007-4#2)
choose from##4##2##(1993-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
choose not to##3##3##(2008-12#1)(2013-1#2)
choose one of two##2##4##(2008-3#2)
choose the##10##2##(1990-11#1)(1992-2#1)(1993-5#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)
choose their own##2##3##(1991-3#1)(2008-7#1)
choose their##5##2##(1991-3#1)(1994-12#1)(2008-12#1)(2008-7#1)(2008-9#1)
choose to##7##2##(2008-4#1)(2008-7#1)(2009-6#1)(2010-4#2)(2012-1#1)(2012-3#1)
choose which stapler##2##3##(2010-8#2)
choose##77##1##(1990-11#2)(1990-12#1)(1991-3#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-2#1)(1996-2#1)(1997-2#2)(1997-3#2)(2007-11#3)(2007-12#1)(2007-4#2)(2008-10#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#6)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#2)(2012-3#4)(2013-1#4)
choosen##2##1##(2010-8#1)(2011-7#1)
chooses##4##1##(1994-12#1)(1995-2#1)(2008-9#1)(2013-8#1)
choosing a##15##2##(1991-2#1)(1992-12#1)(1992-8#1)(1994-1#1)(1994-7#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
choosing an appropriate##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
choosing an##5##2##(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
choosing friends##5##2##(2009-7#5)
choosing one##6##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)
choosing the appropriate##4##3##(1992-1#1)(2008-2#1)(2008-4#2)
choosing the optimum##2##3##(1992-8#1)(2010-6#1)
choosing the right##2##3##(1995-6#1)(2008-2#1)
choosing the##18##2##(1992-1#1)(1992-8#1)(1995-6#1)(1997-5#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2009-5#2)(2010-6#1)(2011-2#1)(2013-1#3)
choosing to##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
choosing which##2##2##(2008-3#1)(2010-4#1)
choosing##89##1##(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-3#2)(1994-1#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#5)(2009-6#2)(2009-7#5)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
chopped##4##1##(2007-11#2)(2009-4#2)
chopper##6##1##(2008-2#2)(2008-3#4)
choppers##2##1##(2008-2#1)(2008-3#1)
chopping in the case of##2##5##(2008-3#2)
chopping##5##1##(2008-2#1)(2008-3#4)
chopstick##4##1##(2011-2#4)
chord##2##1##(1994-7#1)(2008-7#1)
chorda tympani##4##2##(1992-11#3)(2008-9#1)
chordae##2##1##(2007-8#1)(2013-1#1)
chordal##5##1##(1990-3#1)(2007-8#2)(2009-7#1)(2013-1#1)
chordee and##2##2##(2009-5#2)
chordee##3##1##(2009-5#3)
chordoma##6##1##(2007-5#2)(2010-9#1)(2011-2#3)
chordotonal organ##3##2##(1993-12#1)(2008-7#2)
chordotonal organs##2##2##(2007-12#2)
chordotonal##5##1##(1993-12#1)(2007-12#2)(2008-7#2)
chorea and##4##2##(2008-5#1)(2008-7#2)(2011-10#1)
chorea in##3##2##(2008-7#1)(2011-10#2)
chorea was##2##2##(2011-10#2)
chorea##21##1##(1991-3#1)(2008-5#1)(2008-7#9)(2011-10#10)
choreographed##2##1##(2008-9#1)(2009-12#1)
chores##2##1##(2008-1#1)(2011-2#1)
chorioallantoic##5##1##(1990-4#1)(1991-12#1)(2008-1#3)
chorioamnionitis##2##1##(2012-3#2)
choriocarcinoma cells##3##2##(1994-6#2)(2008-10#1)
choriocarcinoma##8##1##(1994-6#2)(2007-10#5)(2008-10#1)
chorion##19##1##(1990-11#1)(1993-1#1)(1993-6#4)(2007-12#4)(2008-12#8)(2012-3#1)
chorionic cells##2##2##(1993-6#2)
chorionic gonadotrophin##2##2##(1996-3#1)(2007-7#1)
chorionic gonadotropin (hCG)##7##3##(1992-8#2)(1993-6#1)(1994-8#1)(1995-8#1)(1997-1#1)(2011-1#1)
chorionic gonadotropin##17##2##(1992-8#2)(1993-12#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#3)(1997-1#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2011-1#1)
chorionic villus sampling##2##3##(1991-2#1)(2008-4#1)
chorionic##32##1##(1991-11#1)(1991-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#4)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-3#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#2)(2011-1#1)
chorioretinal lacunae##4##2##(2011-1#3)(2011-2#1)
chorioretinal##5##1##(2010-2#1)(2011-1#3)(2011-2#1)
chorioretinitis##2##1##(1990-9#1)(2008-5#1)
choroid plexus and##4##3##(1993-12#2)(1996-12#1)(2008-10#1)
choroid plexus##20##2##(1993-12#4)(1994-2#1)(1996-12#4)(1996-5#5)(2008-10#3)(2008-12#1)(2008-7#1)(2012-1#1)
choroid##33##1##(1993-12#4)(1994-2#1)(1996-12#4)(1996-5#5)(1997-3#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-7#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)
choroidal metastases##3##2##(1990-12#3)
choroidal neovascular membrane##3##3##(2010-10#2)(2010-9#1)
choroidal neovascularization##2##2##(2010-2#1)(2011-1#1)
choroidal##16##1##(1990-12#3)(2010-1#1)(2010-10#3)(2010-2#1)(2010-9#1)(2011-1#2)(2011-7#1)(2013-1#4)
chose a##3##2##(2007-12#2)(2013-1#1)
chose an##2##2##(2008-3#1)(2011-10#1)
chose the##6##2##(1990-9#1)(1992-11#1)(1997-4#1)(2009-5#1)(2011-1#1)(2013-7#1)
chose their##2##2##(1994-6#1)(2010-2#1)
chose to participate##2##3##(2009-6#1)(2013-1#1)
chose to##13##2##(1992-2#1)(1996-12#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-2#1)(2013-1#1)(2013-8#1)
chose##44##1##(1990-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#2)(2009-6#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-10#1)(2011-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
chosen according to the##4##4##(1992-3#1)(1997-3#1)(2007-8#1)(2008-2#1)
chosen according to##5##3##(1992-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)
chosen and the##2##3##(2008-10#2)
chosen and##6##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
chosen arbitrarily##2##2##(1990-12#1)(2008-2#1)
chosen as a model##2##4##(2008-10#1)(2008-7#1)
chosen as a##8##3##(2008-10#5)(2008-11#1)(2008-7#1)(2010-2#1)
chosen as model##3##3##(2008-10#3)
chosen as the##11##3##(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)
chosen as##46##2##(1991-5#1)(1992-5#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2011-3#2)(2012-3#1)
chosen at random##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
chosen at##4##2##(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
chosen because##4##2##(1993-12#1)(1996-2#1)(2006-10#1)(2008-10#1)
chosen by the##5##3##(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)
chosen by##11##2##(1993-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
chosen for each##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
chosen for further##2##3##(1991-12#1)(2009-6#1)
chosen for the determination##2##4##(2008-10#2)
chosen for the##9##3##(1993-10#1)(2008-10#4)(2008-11#1)(2008-3#3)
chosen for this##3##3##(2008-10#2)(2008-11#1)
chosen for##31##2##(1991-12#1)(1991-8#1)(1992-2#1)(1993-10#1)(1996-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#5)(2009-2#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
chosen from the##5##3##(1996-7#1)(1997-3#1)(2008-10#2)(2008-8#1)
chosen from##11##2##(1996-7#1)(1997-3#1)(2008-10#6)(2008-8#1)(2009-12#1)(2012-3#1)
chosen in##6##2##(1990-11#1)(1994-2#1)(1995-3#1)(2008-10#2)(2013-7#1)
chosen on##2##2##(1990-6#1)(1993-9#1)
chosen only##2##2##(1991-12#1)(2008-10#1)
chosen so that the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
chosen to be##4##3##(1995-5#1)(2008-10#2)(2008-2#1)
chosen to test##2##3##(1996-3#1)(2008-12#1)
chosen to##36##2##(1990-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-5#2)(1996-3#1)(1996-8#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#2)
chosen was##2##2##(1993-8#1)(2008-10#1)
chosen##269##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#2)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#81)(2008-11#13)(2008-12#2)(2008-2#12)(2008-3#22)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#2)(2012-1#3)(2012-12#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
chroma##2##1##(2010-4#1)(2011-2#1)
chromaffin cell##4##2##(1990-11#1)(1992-3#1)(1993-12#2)
chromaffin cells in##2##3##(1994-8#1)(1996-5#1)
chromaffin cells##22##2##(1990-11#1)(1990-5#3)(1992-6#3)(1993-12#2)(1993-3#1)(1994-5#2)(1994-8#1)(1995-11#3)(1996-5#4)(1997-7#2)
chromaffin granule##4##2##(1990-11#4)
chromaffin granules##5##2##(1990-5#4)(1996-5#1)
chromaffin##35##1##(1990-11#6)(1990-5#7)(1992-3#1)(1992-6#3)(1993-12#4)(1993-3#1)(1994-5#2)(1994-8#1)(1995-11#3)(1996-5#5)(1997-7#2)
chromanoxyl##3##1##(1991-2#3)
chromate buffer##2##2##(2008-10#2)
chromate ions##2##2##(2008-10#2)
chromate##10##1##(2008-10#10)
chromate(VI)##2##1##(2008-10#2)
chromatic aberration circle##2##3##(2008-3#2)
chromatic aberration##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
chromatic aberrations##2##2##(2008-2#1)(2008-3#1)
chromatic dispersion is##2##3##(2007-12#1)(2008-3#1)
chromatic dispersion##9##2##(2007-11#2)(2007-12#4)(2008-3#3)
chromatic distortion##4##2##(2007-11#3)(2008-2#1)
chromatic scintillation were##2##3##(2008-3#2)
chromatic scintillation##4##2##(2008-3#4)
chromatic##43##1##(1992-11#1)(1996-2#1)(2007-11#5)(2007-12#5)(2008-10#2)(2008-2#8)(2008-3#20)(2011-2#1)
chromaticities##3##1##(2008-3#3)
chromaticity and##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
chromaticity coordinates##4##2##(2008-2#1)(2008-3#3)
chromaticity##12##1##(1996-2#1)(2007-12#1)(2008-2#3)(2008-3#7)
chromatid exchange (SCE)##3##3##(1990-6#1)(1992-8#1)(2008-11#1)
chromatid exchange##6##2##(1990-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(2008-11#1)
chromatid segregation##2##2##(2008-11#1)(2012-2#1)
chromatid##17##1##(1990-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1996-2#1)(1997-7#2)(2008-11#5)(2008-7#1)(2012-2#1)(2013-1#1)
chromatin alterations##2##2##(2012-12#2)
chromatin and##7##2##(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
chromatin assembly system##2##3##(2008-2#2)
chromatin by##2##2##(1995-2#2)
chromatin cleavage##2##2##(2008-1#2)
chromatin clumping##2##2##(2008-7#2)
chromatin condensation and##2##3##(2008-7#2)
chromatin condensation##12##2##(1991-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#1)(2012-3#1)
chromatin immunoprecipitation (ChIP)##2##3##(2008-2#2)
chromatin immunoprecipitation assay##2##3##(2008-11#2)
chromatin immunoprecipitation##9##2##(2008-11#3)(2008-2#5)(2011-2#1)
chromatin in##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
chromatin modifications##2##2##(2010-2#1)(2011-9#1)
chromatin modifier##2##2##(2009-8#2)
chromatin of##2##2##(2008-8#1)(2009-12#1)
chromatin remodeling and##2##3##(2011-1#1)(2013-1#1)
chromatin remodeling##9##2##(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-12#1)(2013-1#1)
chromatin structure and##2##3##(2008-2#1)(2010-2#1)
chromatin structure by##2##3##(1996-2#1)(2011-2#1)
chromatin structure in##2##3##(1994-6#1)(2007-12#1)
chromatin structure##21##2##(1992-3#1)(1993-11#1)(1994-5#2)(1994-6#1)(1995-2#3)(1996-2#1)(2007-12#1)(2008-2#3)(2008-7#1)(2008-9#1)(2010-2#3)(2011-2#3)
chromatin texture##2##2##(2010-8#2)
chromatin that##2##2##(1994-5#1)(1995-2#1)
chromatin to##2##2##(2011-2#1)(2012-2#1)
chromatin##162##1##(1990-11#2)(1990-2#3)(1990-7#1)(1990-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-5#6)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#9)(1996-2#1)(1997-3#3)(1997-6#1)(2007-12#5)(2008-1#6)(2008-10#4)(2008-11#6)(2008-12#4)(2008-2#14)(2008-4#8)(2008-6#1)(2008-7#12)(2008-8#7)(2008-9#7)(2009-12#1)(2009-5#4)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-8#2)(2011-1#2)(2011-2#12)(2011-9#2)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#3)
chromatin-associated##3##1##(1991-5#2)(1995-2#1)
chromatin-mediated##2##1##(1994-8#1)(1996-2#1)
chromatofocusing##4##1##(1992-9#1)(1993-8#1)(2008-4#2)
chromatogram of##2##2##(2008-10#1)(2008-12#1)
chromatogram##11##1##(1991-5#1)(2008-10#7)(2008-12#1)(2008-5#1)(2013-1#1)
chromatograms and mass spectra##2##4##(2008-10#2)
chromatograms and##4##2##(2008-10#4)
chromatograms for the detection of the investigated##2##7##(2008-10#2)
chromatograms for##3##2##(2008-10#3)
chromatograms obtained##3##2##(2008-10#3)
chromatograms##20##1##(2008-10#20)
chromatograph##19##1##(1997-2#1)(2008-10#14)(2008-11#1)(2008-8#1)(2011-1#1)(2012-1#1)
chromatographed on a##2##3##(1990-8#1)(2008-10#1)
chromatographed##6##1##(1990-8#2)(1997-2#1)(2008-10#3)
chromatographic analysis of##9##3##(2008-10#8)(2008-11#1)
chromatographic analysis##22##2##(1990-7#1)(1994-8#1)(2006-6#1)(2008-10#17)(2008-11#1)(2010-5#1)
chromatographic and##10##2##(1990-12#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#1)(2010-11#1)
chromatographic approach##3##2##(1997-4#1)(2008-10#2)
chromatographic assay##9##2##(1990-5#1)(1991-5#3)(1996-5#2)(1997-2#1)(2008-10#2)
chromatographic assays##4##2##(1991-5#2)(1997-2#1)(2008-6#1)
chromatographic behavior of some##3##4##(2008-10#3)
chromatographic behavior of##7##3##(2008-10#6)(2012-1#1)
chromatographic behavior##11##2##(1994-6#1)(1997-2#1)(2008-10#8)(2012-1#1)
chromatographic behaviors##2##2##(2008-10#2)
chromatographic behaviour of##3##3##(1996-5#1)(2008-10#2)
chromatographic behaviour##4##2##(1996-5#1)(2008-10#2)(2008-5#1)
chromatographic characteristics##2##2##(2008-10#2)
chromatographic column is##2##3##(2008-10#2)
chromatographic column##13##2##(1991-2#1)(1991-5#1)(2008-10#11)
chromatographic columns##6##2##(2008-10#6)
chromatographic conditions were optimized##3##4##(2008-10#3)
chromatographic conditions were##6##3##(2008-10#4)(2010-3#1)(2011-1#1)
chromatographic conditions##13##2##(1990-8#1)(1994-12#1)(2008-10#9)(2010-3#1)(2011-1#1)
chromatographic data##7##2##(2008-10#6)(2011-1#1)
chromatographic detection##3##2##(2008-10#2)(2008-5#1)
chromatographic determination of##27##3##(1991-5#2)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#22)
chromatographic determination##32##2##(1991-5#2)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#27)
chromatographic elution##2##2##(2008-10#2)
chromatographic fractions##3##2##(2008-10#3)
chromatographic method for determination of##2##5##(2008-10#1)(2012-12#1)
chromatographic method for the determination of##6##6##(1990-8#1)(1993-9#1)(1996-5#1)(2008-10#3)
chromatographic method for the separation of##2##6##(2008-10#2)
chromatographic method for the simultaneous determination of##2##7##(2008-10#2)
chromatographic method for the simultaneous##3##5##(2008-10#3)
chromatographic method for the##16##4##(1990-8#1)(1991-5#1)(1992-3#1)(1993-9#1)(1996-5#1)(2008-10#11)
chromatographic method for##23##3##(1990-8#1)(1991-5#1)(1992-3#1)(1993-9#1)(1996-5#1)(1997-2#1)(2008-10#15)(2011-1#1)(2012-12#1)
chromatographic method has been developed for the simultaneous determination of##2##10##(2008-10#2)
chromatographic method has been developed for the simultaneous##3##8##(2008-10#2)(2010-3#1)
chromatographic method has been developed for the##4##7##(2008-10#2)(2010-3#1)(2012-12#1)
chromatographic method has been developed##7##5##(2008-10#4)(2010-3#2)(2012-12#1)
chromatographic method of analysis of##2##5##(2008-10#2)
chromatographic method using##2##3##(1995-2#1)(2010-5#1)
chromatographic method was##5##3##(1997-2#1)(2008-10#3)(2010-3#1)
chromatographic method with##4##3##(1990-8#1)(1991-5#1)(2008-10#2)
chromatographic method##62##2##(1990-8#4)(1991-5#5)(1992-3#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-5#2)(1997-2#3)(2008-10#34)(2008-4#1)(2010-3#3)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)
chromatographic methods for the##2##4##(1992-11#1)(1995-2#1)
chromatographic methods for##4##3##(1992-11#1)(1995-2#1)(2010-7#1)(2012-12#1)
chromatographic methods##16##2##(1990-8#1)(1992-11#1)(1995-2#1)(2008-10#8)(2010-4#2)(2010-7#2)(2012-12#1)
chromatographic parameters##3##2##(1994-12#1)(1997-2#1)(2008-10#1)
chromatographic peak##3##2##(2008-10#3)
chromatographic peaks and##2##3##(2008-10#2)
chromatographic peaks were##2##3##(1996-5#1)(2008-10#1)
chromatographic peaks##7##2##(1990-8#1)(1996-5#1)(2008-10#4)(2008-7#1)
chromatographic performance and##2##3##(2008-10#1)(2011-1#1)
chromatographic performance##4##2##(2008-10#2)(2011-1#2)
chromatographic probe##2##2##(2008-10#2)
chromatographic procedure for the##2##4##(1996-5#1)(2008-10#1)
chromatographic procedure##8##2##(1994-11#1)(1996-5#1)(2008-10#4)(2008-5#1)(2008-8#1)
chromatographic procedures##3##2##(1990-7#1)(1992-3#1)(2008-10#1)
chromatographic profiles##3##2##(2008-10#3)
chromatographic resolution##10##2##(2008-10#10)
chromatographic response function (CRF)##3##4##(2008-10#3)
chromatographic response##5##2##(2008-10#5)
chromatographic retention index of##2##4##(2008-10#2)
chromatographic retention indices of##3##4##(2008-10#3)
chromatographic retention indices##4##3##(2008-10#4)
chromatographic retention##8##2##(2008-10#8)
chromatographic run was##2##3##(2008-10#2)
chromatographic run##8##2##(1990-8#1)(1997-2#1)(2008-10#6)
chromatographic separation and##2##3##(2008-10#2)
chromatographic separation of inorganic##2##4##(2008-10#2)
chromatographic separation of the##4##4##(2008-10#3)(2008-4#1)
chromatographic separation of##17##3##(1997-2#1)(2008-10#15)(2008-4#1)
chromatographic separation##37##2##(1990-8#1)(1991-5#1)(1997-2#1)(2008-10#32)(2008-4#1)(2012-1#1)
chromatographic separations and##2##3##(2008-4#1)(2010-11#1)
chromatographic separations##7##2##(1997-2#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-11#1)
chromatographic stationary phase##3##3##(2008-10#3)
chromatographic stationary##4##2##(2008-10#4)
chromatographic step##3##2##(1990-7#1)(1990-8#1)(2008-10#1)
chromatographic steps##2##2##(1992-6#1)(2008-4#1)
chromatographic studies##2##2##(2008-10#1)(2008-5#1)
chromatographic system for##3##3##(2008-10#1)(2013-1#2)
chromatographic system##15##2##(2008-10#11)(2008-5#1)(2010-11#1)(2013-1#2)
chromatographic systems##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
chromatographic technique##5##2##(1992-6#1)(1993-9#1)(2008-10#3)
chromatographic techniques##8##2##(1997-4#2)(2008-10#2)(2008-11#1)(2010-11#1)(2010-4#1)(2011-2#1)
chromatographic##475##1##(1990-12#1)(1990-5#2)(1990-7#3)(1990-8#16)(1991-2#1)(1991-5#17)(1991-8#2)(1992-11#1)(1992-3#2)(1992-6#3)(1993-2#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-6#1)(1996-12#3)(1996-5#11)(1997-1#1)(1997-2#14)(1997-4#3)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#312)(2008-11#3)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#5)(2010-3#4)(2010-4#4)(2010-5#3)(2010-7#2)(2011-1#8)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#4)
chromatographic-mass##2##1##(1992-8#1)(2008-10#1)
chromatographically identical to##2##3##(1991-12#1)(1994-11#1)
chromatographically##5##1##(1991-12#1)(1994-11#1)(2008-10#3)
chromatographies##12##1##(1990-11#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-8#2)(1992-9#1)(1994-3#1)(1994-6#1)(1997-4#1)(2011-3#1)
chromatography (C(18))##2##2##(2008-10#2)
chromatography (GC)##24##2##(1993-12#1)(1994-9#1)(2008-10#19)(2008-12#1)(2008-5#1)(2011-1#1)
chromatography (GLC) and##2##3##(2008-10#1)(2008-7#1)
chromatography (HPLC)##114##2##(1990-8#3)(1991-5#2)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#2)(2008-10#73)(2008-11#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#1)
chromatography (IC)##11##2##(2008-10#11)
chromatography (MEKC) with##4##3##(1994-9#1)(2008-10#3)
chromatography (MEKC)##13##2##(1990-8#1)(1994-9#2)(2008-10#9)(2010-7#1)
chromatography (R=0##3##2##(2008-10#3)
chromatography (SEC) and##2##3##(1996-5#1)(1997-2#1)
chromatography (SEC) with##3##3##(2008-10#3)
chromatography (SEC)##7##2##(1996-5#1)(1997-2#1)(2008-10#4)(2008-8#1)
chromatography (TLC)##6##2##(1992-11#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-4#1)
chromatography after derivatization##2##3##(1995-2#1)(2008-11#1)
chromatography after##4##2##(1991-12#1)(1995-2#1)(2008-11#1)(2008-7#1)
chromatography analysis of##3##3##(2008-10#3)
chromatography analysis##9##2##(2008-10#9)
chromatography and a##3##3##(1994-6#1)(2008-10#2)
chromatography and gel filtration##4##4##(1994-8#1)(1997-1#1)(2008-10#1)(2008-8#1)
chromatography and gel-filtration##2##3##(1990-12#1)(1990-2#1)
chromatography and high##2##3##(1996-2#1)(2008-10#1)
chromatography and inductively coupled##2##4##(2008-10#2)
chromatography and mass spectrometry##5##4##(2008-1#1)(2008-10#2)(2008-4#1)(2010-11#1)
chromatography and preparative##3##3##(1990-2#1)(1991-9#1)(2012-2#1)
chromatography and the##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
chromatography and##97##2##(1990-12#2)(1990-2#4)(1990-5#2)(1990-7#2)(1990-8#2)(1991-5#5)(1991-9#1)(1992-11#1)(1992-6#3)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#2)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#3)(1997-6#1)(2008-1#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#3)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#2)
chromatography as a##2##3##(2008-10#1)(2008-11#1)
chromatography as##4##2##(2008-10#3)(2008-11#1)
chromatography assay##2##2##(1990-11#1)(2008-10#1)
chromatography at##3##2##(1992-12#1)(1994-11#1)(2008-9#1)
chromatography can##2##2##(2008-10#2)
chromatography combined with##5##3##(2008-10#4)(2008-11#1)
chromatography coupled to##7##3##(2008-10#5)(2010-5#1)(2012-1#1)
chromatography coupled with chemiluminescence detection##2##5##(2008-10#2)
chromatography coupled with mass spectrometry##3##5##(1997-4#1)(2008-10#1)(2008-5#1)
chromatography coupled with mass##5##4##(1997-4#1)(2008-10#3)(2008-5#1)
chromatography coupled with##19##3##(1995-11#1)(1997-4#1)(2008-10#14)(2008-5#2)(2012-3#1)
chromatography coupled##28##2##(1995-11#1)(1997-4#1)(2008-10#21)(2008-5#2)(2010-5#1)(2012-1#1)(2012-3#1)
chromatography followed by gel filtration##2##5##(1994-8#1)(2012-2#1)
chromatography followed by##7##3##(1993-11#2)(1994-8#1)(1996-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
chromatography for the analysis of##3##5##(2008-10#3)
chromatography for the determination of##5##5##(1994-9#1)(2008-10#3)(2009-8#1)
chromatography for the separation##2##4##(1991-5#1)(2008-10#1)
chromatography for the##16##3##(1991-5#2)(1994-9#1)(2008-10#12)(2009-8#1)
chromatography for##22##2##(1991-5#3)(1993-9#1)(1994-9#1)(2008-10#16)(2009-8#1)
chromatography fraction##2##2##(2008-10#2)
chromatography fractions##2##2##(2008-10#2)
chromatography has been used##2##4##(2008-10#2)
chromatography has been##4##3##(1997-2#1)(2008-10#3)
chromatography has##5##2##(1997-2#1)(2008-10#3)(2008-11#1)
chromatography have been##2##3##(2008-10#2)
chromatography in the##5##3##(1990-12#1)(1994-9#1)(2008-10#2)(2012-2#1)
chromatography in##21##2##(1990-12#1)(1990-8#4)(1991-5#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)
chromatography is an##2##3##(2008-10#2)
chromatography is##8##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-5#1)
chromatography mass spectrometry##3##3##(2008-10#3)
chromatography mass##4##2##(2008-10#3)(2013-1#1)
chromatography method for the separation of##2##6##(1991-12#1)(1991-5#1)
chromatography method for the##3##4##(1991-12#1)(1991-5#1)(2008-10#1)
chromatography method for##6##3##(1991-12#1)(1991-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
chromatography method##15##2##(1990-8#1)(1991-12#1)(1991-5#1)(1997-2#1)(2008-10#9)(2008-5#1)(2012-2#1)
chromatography of some##2##3##(1990-8#1)(2008-10#1)
chromatography of the##8##3##(1990-5#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-7#1)
chromatography of##26##2##(1990-11#1)(1990-5#1)(1990-8#3)(1991-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-5#2)(1997-3#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)
chromatography on DEAE cellulose##2##4##(2008-4#1)(2008-8#1)
chromatography on DEAE-Sepharose and##2##4##(1996-6#1)(2009-9#1)
chromatography on DEAE-Sepharose##3##3##(1991-12#1)(1996-6#1)(2009-9#1)
chromatography on Mono S##2##4##(1990-7#1)(1991-12#1)
chromatography on a column of##2##5##(1990-8#1)(2008-4#1)
chromatography on a##13##3##(1990-11#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-9#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-4#1)
chromatography on an##2##3##(1992-3#1)(1993-9#1)
chromatography on##52##2##(1990-11#3)(1990-5#1)(1990-7#2)(1990-8#3)(1991-12#6)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-9#2)(2010-4#1)
chromatography or##2##2##(2008-10#1)(2008-9#1)
chromatography resolved##2##2##(1990-2#1)(1993-11#1)
chromatography revealed##2##2##(1990-2#1)(2010-11#1)
chromatography showed that the##2##4##(1990-10#1)(1990-11#1)
chromatography showed##3##2##(1990-10#1)(1990-11#1)(1994-11#1)
chromatography stationary phase##2##3##(2008-10#2)
chromatography steps##3##2##(1991-12#1)(1992-11#1)(1995-12#1)
chromatography study of##2##3##(2008-10#2)
chromatography systems##2##2##(1990-12#1)(1996-5#1)
chromatography techniques##2##2##(2008-1#1)(2008-10#1)
chromatography to the##4##3##(1991-5#2)(2008-10#2)
chromatography to##9##2##(1990-11#1)(1991-5#2)(1994-11#1)(2008-10#4)(2008-4#1)
chromatography under##2##2##(2008-10#2)
chromatography using a##4##3##(2008-10#2)(2009-8#1)(2011-1#1)
chromatography using##25##2##(1991-5#2)(1995-6#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)
chromatography was##9##2##(1990-8#3)(1992-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
chromatography were##3##2##(1993-6#1)(1994-3#1)(2008-10#1)
chromatography with UV##5##3##(1996-5#1)(2008-10#4)
chromatography with atomic##2##3##(2008-10#2)
chromatography with chemiluminescence detection##2##4##(1990-8#1)(2008-10#1)
chromatography with direct sample injection##2##5##(1990-8#1)(2008-10#1)
chromatography with direct##3##3##(1990-8#1)(2008-10#2)
chromatography with electron capture detection##4##5##(2008-10#4)
chromatography with electron##6##3##(2008-10#6)
chromatography with mass##6##3##(1997-6#1)(2008-10#4)(2010-4#1)
chromatography with on-line light scattering##2##5##(2008-4#2)
chromatography with on-line##4##3##(1990-8#1)(2008-10#1)(2008-4#2)
chromatography with pulsed amperometric detection##2##5##(1991-7#1)(1992-1#1)
chromatography with the##4##3##(1997-2#1)(2008-10#3)
chromatography with##110##2##(1990-8#7)(1991-5#4)(1991-7#2)(1992-1#1)(1993-2#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-5#3)(1997-2#3)(1997-6#1)(2008-10#75)(2008-11#1)(2008-4#2)(2008-5#4)(2009-8#1)(2010-4#1)
chromatography##1184##1##(1990-10#1)(1990-11#10)(1990-12#9)(1990-2#9)(1990-5#8)(1990-7#9)(1990-8#46)(1991-12#11)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#36)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#2)(1992-3#5)(1992-6#10)(1992-8#7)(1992-9#4)(1993-1#1)(1993-11#9)(1993-12#2)(1993-2#1)(1993-6#6)(1993-8#4)(1993-9#9)(1994-11#6)(1994-12#8)(1994-3#4)(1994-5#3)(1994-6#7)(1994-8#5)(1994-9#14)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#10)(1995-8#1)(1996-12#4)(1996-2#4)(1996-5#20)(1996-6#1)(1997-1#2)(1997-2#21)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#601)(2008-11#26)(2008-12#3)(2008-2#1)(2008-4#27)(2008-5#29)(2008-6#8)(2008-7#12)(2008-8#10)(2008-9#11)(2009-12#1)(2009-2#2)(2009-3#4)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#2)(2010-11#5)(2010-12#1)(2010-2#5)(2010-4#5)(2010-5#6)(2010-7#6)(2011-1#16)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)
chromatography)##3##1##(2008-10#2)(2012-2#1)
chromatography-Fourier transform infrared##3##3##(1997-2#1)(2008-10#2)
chromatography-electron capture detection##2##3##(2008-10#2)
chromatography-electron capture##4##2##(2008-10#3)(2011-1#1)
chromatography-electrospray ionisation-mass spectrometry (LC-ESI-MS)##2##4##(2010-4#2)
chromatography-electrospray mass spectrometry##4##3##(2008-10#4)
chromatography-electrospray##18##1##(2008-10#8)(2008-8#2)(2010-4#2)(2011-1#3)(2011-2#2)(2012-3#1)
chromatography-high resolution mass spectrometry##5##4##(2008-10#4)(2010-5#1)
chromatography-high##6##1##(2008-10#5)(2010-5#1)
chromatography-hydride generation-atomic fluorescence spectrometry##2##4##(2008-10#2)
chromatography-hydride##3##1##(2008-10#3)
chromatography-mass spectrometry (GC-MS)##24##3##(1990-5#1)(1992-5#1)(1993-12#1)(1995-2#1)(2008-10#17)(2008-5#1)(2012-1#2)
chromatography-mass spectrometry detection##2##3##(2008-10#2)
chromatography-mass spectrometry##72##2##(1990-5#2)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-2#1)(2007-10#1)(2008-10#43)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#4)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
chromatography-mass spectrometry]##3##2##(2011-1#3)
chromatography-mass##80##1##(1990-5#2)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2008-10#47)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#7)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
chromatography-olfactometry##3##1##(2008-10#3)
chromatography-tandem mass spectrometry##9##3##(2008-10#6)(2011-1#2)(2013-1#1)
chromatography-tandem mass##13##2##(2008-10#6)(2011-1#6)(2013-1#1)
chromatography/ion trap mass spectrometry##2##4##(2008-10#2)
chromatography/mass spectrometry##12##2##(1992-8#1)(1995-11#1)(2008-10#9)(2013-1#1)
chromatography/mass##13##1##(1992-8#1)(1995-11#1)(2008-10#10)(2013-1#1)
chromatography/sniffing port analysis##2##3##(2008-10#2)
chromatography]##9##1##(2011-1#7)(2011-2#1)(2012-2#1)
chromatomembrane cell (CMC) was##3##4##(2008-10#3)
chromatomembrane cell and its##2##4##(2008-10#2)
chromatomembrane cell and##3##3##(2008-10#3)
chromatomembrane cell##12##2##(2008-10#12)
chromatomembrane cells##4##2##(2008-10#4)
chromatomembrane method##2##2##(2008-10#2)
chromatomembrane##19##1##(2008-10#19)
chromatophore##2##1##(1993-11#1)(1993-8#1)
chromatophores##8##1##(2008-5#6)(2008-7#2)
chrome azurol S##2##3##(2008-10#2)
chrome##6##1##(2008-10#5)(2008-3#1)
chromic acid##2##2##(2008-10#2)
chromic##4##1##(1990-6#1)(2008-10#3)
chromium (III) species##3##3##(2008-10#3)
chromium (III)##10##2##(2008-10#10)
chromium (VI) in##3##3##(2008-10#3)
chromium (VI)##17##2##(1994-11#2)(1996-12#2)(2008-10#13)
chromium (VI)-treated mothers##2##3##(1996-12#2)
chromium agents##2##2##(2008-10#2)
chromium alloy##2##2##(2008-3#1)(2013-1#1)
chromium and aluminium in human urine##2##6##(2008-10#2)
chromium and cobalt##2##3##(2008-10#2)
chromium and lead in drinking water by##2##7##(2008-10#2)
chromium and lead in##3##4##(2008-10#3)
chromium and##17##2##(2008-10#14)(2008-12#1)(2008-2#1)(2011-2#1)
chromium at##3##2##(2008-10#3)
chromium by##3##2##(2008-10#3)
chromium complexed arene diradical##2##4##(2009-10#2)
chromium determination in##2##3##(2008-10#2)
chromium determination##4##2##(2008-10#4)
chromium has##2##2##(2008-10#2)
chromium in PACS-2##2##3##(2008-10#2)
chromium in heavy crude oil##2##5##(2008-10#2)
chromium in tanning sewage##2##4##(2008-10#2)
chromium in##40##2##(2008-10#40)
chromium ions##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
chromium isotope ratios##3##3##(2008-10#3)
chromium isotope##4##2##(2008-10#4)
chromium matrices##2##2##(2008-10#2)
chromium speciation##6##2##(2008-10#6)
chromium species in##3##3##(2008-10#3)
chromium species##12##2##(2008-10#12)
chromium using##3##2##(2008-10#3)
chromium was##9##2##(2008-10#9)
chromium with##3##2##(2008-10#3)
chromium##227##1##(1994-11#2)(1994-5#3)(1995-11#1)(1996-12#5)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#185)(2008-12#7)(2008-2#5)(2008-3#2)(2008-5#1)(2009-10#3)(2009-12#2)(2009-7#1)(2011-2#4)(2012-2#1)(2013-1#2)
chromium(III) and chromium(VI)##2##3##(2008-10#2)
chromium(III) by##2##2##(2008-10#2)
chromium(III) in##3##2##(2008-10#3)
chromium(III) propionate##2##2##(2008-10#2)
chromium(III)##16##1##(2008-10#16)
chromium(V) in##3##2##(2008-10#3)
chromium(V)##7##1##(2008-10#7)
chromium(VI) and its##2##3##(2008-10#2)
chromium(VI) and molybdenum(VI) in natural##2##5##(2008-10#2)
chromium(VI) and molybdenum(VI)##3##3##(2008-10#3)
chromium(VI) and##9##2##(2008-10#9)
chromium(VI) by##6##2##(2008-10#6)
chromium(VI) content##2##2##(2008-10#2)
chromium(VI) in electroplating baths##2##4##(2008-10#2)
chromium(VI) in##15##2##(2008-10#15)
chromium(VI) ion associates##2##3##(2008-10#2)
chromium(VI) ion##3##2##(2008-10#3)
chromium(VI) using##3##2##(2008-10#3)
chromium(VI)##68##1##(2008-10#68)
chromium(total)##2##1##(2008-10#2)
chromium-reducible##2##1##(2008-10#2)
chromoendoscopy and narrow band imaging##2##5##(2011-2#2)
chromogen##4##1##(1990-12#1)(1997-2#1)(2008-10#2)
chromogenic reagent for##6##3##(2008-10#6)
chromogenic reagent##25##2##(2008-10#25)
chromogenic reagents##3##2##(2008-10#3)
chromogenic substrate##6##2##(1990-12#1)(1993-12#1)(2008-10#2)(2008-9#1)(2013-8#1)
chromogenic system##2##2##(2008-10#2)
chromogenic##54##1##(1990-12#1)(1990-2#1)(1990-8#2)(1992-12#1)(1993-12#1)(1996-12#1)(1996-5#1)(2008-10#39)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
chromogranin A and##2##3##(1994-11#2)
chromogranin A##16##2##(1990-5#1)(1992-9#1)(1993-8#5)(1994-11#3)(2008-11#1)(2010-11#3)(2011-2#2)
chromogranin B and secretogranin II##2##5##(1992-12#2)
chromogranin B##7##2##(1992-12#7)
chromogranin##25##1##(1990-5#1)(1991-8#1)(1992-12#7)(1992-9#1)(1993-8#5)(1994-11#4)(2008-11#1)(2010-11#3)(2011-2#2)
chromogranins##2##1##(2010-11#1)(2011-2#1)
chromoionophore##9##1##(2008-10#9)
chromoionophores and anion ionophores in solvent polymeric##2##7##(2008-10#2)
chromoionophores##5##1##(2008-10#5)
chromone derivatives##3##2##(2009-3#3)
chromone##4##1##(2009-3#3)(2010-6#1)
chromophobe renal cell carcinoma and small lymphocytic lymphoma##2##8##(2008-11#2)
chromophore and a##2##3##(1994-5#1)(2007-12#1)
chromophore and##5##2##(1991-3#1)(1992-8#1)(1994-5#1)(2007-12#1)(2008-10#1)
chromophore concentrations##2##2##(2008-3#1)(2008-5#1)
chromophore content##3##2##(2008-2#3)
chromophore for##2##2##(2008-4#1)(2008-5#1)
chromophore in the##2##3##(2007-12#1)(2008-10#1)
chromophore in##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
chromophore substitution at##2##3##(2008-2#1)(2008-3#1)
chromophore with##2##2##(2007-12#1)(2012-2#1)
chromophore##66##1##(1991-3#2)(1992-8#1)(1993-11#1)(1994-5#4)(1996-5#1)(1997-2#1)(1997-7#1)(2007-12#6)(2008-10#16)(2008-2#12)(2008-3#10)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-9#1)(2012-2#2)
chromophores and##2##2##(2007-12#1)(2008-5#1)
chromophores at##2##2##(2008-5#2)
chromophores in##6##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-9#1)
chromophores on the##3##3##(1994-5#3)
chromophores was##2##2##(2008-5#1)(2008-8#1)
chromophores##42##1##(1993-11#1)(1994-5#6)(1995-6#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-8#3)(2009-9#2)(2011-2#1)
chromophoric dissolved organic matter##3##4##(2008-2#2)(2008-3#1)
chromophoric##4##1##(2008-10#1)(2008-2#2)(2008-3#1)
chromosomal DNA containing##2##3##(1993-9#1)(2012-12#1)
chromosomal DNA##16##2##(1990-12#1)(1991-9#1)(1992-11#1)(1993-9#2)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)
chromosomal DNAs of##2##3##(1994-9#1)(1997-2#1)
chromosomal DNAs##3##2##(1991-9#1)(1994-9#1)(1997-2#1)
chromosomal aberrations (CAs) and##2##4##(1996-2#1)(2010-1#1)
chromosomal aberrations and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
chromosomal aberrations in##2##3##(2008-9#1)(2012-12#1)
chromosomal aberrations##15##2##(1991-12#1)(1996-2#2)(1997-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
chromosomal abnormalities and##2##3##(1990-8#1)(2010-1#1)
chromosomal abnormalities have##2##3##(1996-12#1)(2008-4#1)
chromosomal abnormalities were##2##3##(1994-12#1)(2012-3#1)
chromosomal abnormalities##17##2##(1990-8#1)(1993-9#1)(1994-12#2)(1995-8#5)(1996-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-3#4)
chromosomal alterations##2##2##(2008-7#1)(2009-7#1)
chromosomal analysis##5##2##(1990-2#1)(2008-6#1)(2012-3#3)
chromosomal and plasmid-borne cpe-carrying##2##4##(2011-2#2)
chromosomal and##5##2##(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
chromosomal aneuploidy##2##2##(1990-3#1)(2008-9#1)
chromosomal assignment##2##2##(1991-9#1)(1994-9#1)
chromosomal blocks in##2##3##(2008-8#2)
chromosomal damage##3##2##(1992-8#1)(2010-1#1)(2012-2#1)
chromosomal ends##2##2##(1993-12#1)(2008-11#1)
chromosomal evolution in##2##3##(2010-3#2)
chromosomal evolution##3##2##(2010-3#3)
chromosomal fragile sites##2##3##(2011-2#2)
chromosomal fragment##2##2##(1991-9#1)(2008-2#1)
chromosomal gene cluster##2##3##(2008-10#1)(2011-1#1)
chromosomal gene transfer##2##3##(2008-10#2)
chromosomal gene##9##2##(1990-11#1)(1995-8#1)(1995-9#2)(2008-10#4)(2011-1#1)
chromosomal instability in##4##3##(2008-10#1)(2008-7#3)
chromosomal instability is##2##3##(2008-7#2)
chromosomal instability##7##2##(2008-10#2)(2008-7#5)
chromosomal inversion##5##2##(2008-10#1)(2008-7#3)(2013-1#1)
chromosomal localization and##2##3##(1991-6#1)(1996-12#1)
chromosomal localization##8##2##(1990-12#1)(1991-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-9#2)
chromosomal location of the##6##4##(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)
chromosomal location of##8##3##(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)
chromosomal location##9##2##(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-9#1)
chromosomal locations of the##3##4##(2008-10#3)
chromosomal locations##4##2##(1997-6#1)(2008-10#3)
chromosomal locus##3##2##(1997-2#2)(2008-10#1)
chromosomal looping##3##2##(2011-2#3)
chromosomal marker##2##2##(1991-6#1)(2008-12#1)
chromosomal mutations##2##2##(2008-6#2)
chromosomal organization##5##2##(1996-12#1)(2009-10#2)(2010-3#1)(2010-5#1)
chromosomal position##2##2##(1995-2#1)(2008-10#1)
chromosomal protein##3##2##(1993-2#2)(1997-4#1)
chromosomal races##2##2##(2008-12#1)(2010-3#1)
chromosomal rearrangements##8##2##(2008-10#1)(2008-4#1)(2009-2#1)(2010-3#1)(2011-3#1)(2012-3#3)
chromosomal region##5##2##(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-4#1)
chromosomal regions##10##2##(1995-6#1)(1997-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#3)(2011-2#2)
chromosomal segment##4##2##(1995-12#1)(2008-10#3)
chromosomal segmental duplications##2##3##(2009-10#2)
chromosomal segments##2##2##(1991-9#1)(2009-10#1)
chromosomal sequence##2##2##(1996-6#1)(2009-10#1)
chromosomal sequences##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
chromosomal targets of DNA-binding proteins##2##5##(2008-2#2)
chromosomal translocation in##3##3##(1993-2#1)(1995-11#1)(2008-6#1)
chromosomal translocation##9##2##(1993-2#2)(1994-10#1)(1995-11#1)(2008-6#2)(2012-3#3)
chromosomal translocations are##2##3##(2008-6#1)(2009-8#1)
chromosomal translocations##3##2##(1994-8#1)(2008-6#1)(2009-8#1)
chromosomal variation##5##2##(2008-5#1)(2010-3#4)
chromosomal##269##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-6#2)(1991-7#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-6#2)(1993-9#3)(1994-10#1)(1994-12#6)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#9)(1995-9#2)(1996-12#6)(1996-2#2)(1996-6#2)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#2)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#5)(2008-12#8)(2008-2#5)(2008-4#5)(2008-5#4)(2008-6#8)(2008-7#15)(2008-8#9)(2008-9#5)(2009-10#6)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-3#15)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#14)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#16)(2013-1#7)
chromosomally encoded##2##2##(1994-12#2)
chromosomally##5##1##(1994-12#2)(2008-7#1)(2012-12#1)(2012-3#1)
chromosome 1 and the##2##4##(1995-8#1)(2008-10#1)
chromosome 1 and##4##3##(1991-2#1)(1995-8#1)(2008-10#2)
chromosome 1 with##2##3##(1996-10#1)(2008-9#1)
chromosome 1##29##2##(1991-2#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-8#3)(1996-10#7)(1997-8#1)(2007-11#2)(2008-10#8)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
chromosome 10##4##2##(1990-3#1)(1996-12#1)(2008-9#1)(2012-3#1)
chromosome 11 by##2##3##(2008-10#2)
chromosome 11##11##2##(1991-6#1)(1995-11#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-8#3)(2012-12#1)
chromosome 11q13##3##2##(1997-7#1)(1997-8#2)
chromosome 12##7##2##(1996-12#2)(2008-10#5)
chromosome 13##5##2##(1993-11#1)(1994-12#1)(2008-9#1)(2013-1#2)
chromosome 13q12-13##2##2##(1994-9#2)
chromosome 13q14##2##2##(2008-9#1)(2010-3#1)
chromosome 16##10##2##(1993-12#2)(1994-11#1)(1996-2#2)(1997-2#1)(1997-5#3)(2008-7#1)
chromosome 17##6##2##(1995-5#1)(2008-10#1)(2008-7#4)
chromosome 17p13##3##2##(1993-11#1)(2008-8#1)(2010-3#1)
chromosome 18##2##2##(1997-3#1)(1997-5#1)
chromosome 19##2##2##(1991-6#1)(2008-6#1)
chromosome 1A##3##2##(2008-10#3)
chromosome 1B##6##2##(2008-10#6)
chromosome 1H##3##2##(2008-10#3)
chromosome 2 between##2##3##(2008-8#1)(2008-9#1)
chromosome 2##9##2##(1990-12#1)(1993-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)
chromosome 21##9##2##(1991-2#1)(1993-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-8#1)(2008-7#1)
chromosome 21q22##3##2##(1997-2#2)(1997-8#1)
chromosome 22##5##2##(1997-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
chromosome 2q23##2##2##(2012-3#2)
chromosome 2q33##3##2##(1996-12#2)(2008-1#1)
chromosome 3 (Chr##2##3##(1994-12#2)
chromosome 3 using##2##3##(1991-9#1)(2008-8#1)
chromosome 3##23##2##(1990-5#2)(1991-9#1)(1994-12#2)(1995-10#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#3)(2010-3#1)(2011-2#1)(2012-3#1)
chromosome 3(3H)##2##2##(2008-10#2)
chromosome 3A##2##2##(2008-10#2)
chromosome 3H##5##2##(2008-10#5)
chromosome 4##19##2##(1994-11#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#6)(2010-3#1)(2012-3#3)
chromosome 4(4H)##2##2##(2008-10#2)
chromosome 4H##2##2##(2008-10#2)
chromosome 4J##2##2##(2008-10#2)
chromosome 5 and##2##3##(1993-2#1)(2010-1#1)
chromosome 5##24##2##(1993-2#1)(1996-10#6)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#4)(2008-10#4)(2008-7#1)(2010-1#1)(2012-12#1)
chromosome 5(1H)##5##2##(2008-10#5)
chromosome 6##14##2##(1990-5#1)(1992-3#1)(1994-11#1)(1995-2#2)(1995-6#2)(1996-10#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
chromosome 6p21##3##2##(1997-6#1)(2008-1#2)
chromosome 7##10##2##(1990-8#1)(1994-12#1)(1996-10#1)(1996-6#3)(1997-2#1)(2008-9#1)(2009-10#1)(2010-3#1)
chromosome 7(5H)##4##2##(2008-10#4)
chromosome 7A##7##2##(2008-10#7)
chromosome 7D##3##2##(2008-10#2)(2008-5#1)
chromosome 7DS##5##2##(2008-10#5)
chromosome 8 and##4##3##(1996-12#1)(1997-7#1)(1997-8#1)(2010-1#1)
chromosome 8##8##2##(1993-2#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-8#1)(2008-9#2)(2010-1#1)
chromosome 9 and 22##2##4##(2007-11#2)
chromosome 9##9##2##(1994-6#1)(1996-12#1)(2007-11#3)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#1)
chromosome 9p21##2##2##(1997-7#2)
chromosome 9q22##2##2##(1994-6#1)(2008-1#1)
chromosome DNA##3##2##(1992-11#1)(2008-5#1)(2008-8#1)
chromosome I##4##2##(1995-6#2)(1996-6#1)(1997-7#1)
chromosome II##5##2##(1993-12#1)(1995-11#1)(1996-6#2)(2012-3#1)
chromosome III##2##2##(1996-3#1)(2012-3#1)
chromosome IV of S##2##4##(1996-6#2)
chromosome IV of##3##3##(1996-3#1)(1996-6#2)
chromosome IV##10##2##(1996-3#1)(1996-6#5)(1997-8#1)(2008-5#2)(2012-3#1)
chromosome IX##7##2##(1995-6#4)(1995-9#1)(1996-3#2)
chromosome V##3##2##(1995-6#1)(1996-6#1)(1997-4#1)
chromosome VI##8##2##(1990-5#1)(1995-12#2)(1997-6#5)
chromosome VII of Saccharomyces cerevisiae##5##5##(1995-6#2)(1995-9#1)(1996-3#1)(1997-3#1)
chromosome VII reveals the presence of##2##6##(1997-3#2)
chromosome VII reveals##3##3##(1995-9#1)(1997-3#2)
chromosome VII##23##2##(1995-6#5)(1995-9#2)(1996-3#3)(1996-6#3)(1997-3#9)(2008-5#1)
chromosome VIII##6##2##(1994-9#2)(1995-6#4)
chromosome X of Saccharomyces cerevisiae##2##5##(1995-6#1)(1996-6#1)
chromosome X reveals##3##3##(1995-6#1)(1995-9#1)(1996-6#1)
chromosome X##8##2##(1993-12#1)(1995-6#2)(1995-9#2)(1996-6#2)(2007-7#1)
chromosome XI##4##2##(1993-9#1)(1996-6#2)(1997-3#1)
chromosome XIV reveals##2##3##(1996-3#2)
chromosome XIV##6##2##(1995-9#2)(1996-3#3)(1996-6#1)
chromosome XV##6##2##(1995-6#2)(1996-3#1)(1996-6#1)(1997-3#2)
chromosome Xq28##3##2##(1994-8#1)(1996-10#2)
chromosome aberration (CA)##2##3##(1992-8#1)(2013-1#1)
chromosome aberration##3##2##(1992-8#1)(2008-7#1)(2013-1#1)
chromosome aberrations in##3##3##(1993-9#1)(2008-9#1)(2012-3#1)
chromosome aberrations##8##2##(1993-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-3#1)(2012-3#1)
chromosome abnormalities##7##2##(1992-8#1)(1994-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)
chromosome analysis##6##2##(1992-2#1)(1997-3#1)(2008-4#1)(2008-9#3)
chromosome and the##2##3##(1996-12#1)(2008-5#1)
chromosome and##11##2##(1996-12#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2010-3#1)(2011-2#1)(2011-3#1)
chromosome arm 1S##2##3##(2012-3#2)
chromosome arm##6##2##(2008-10#3)(2012-3#3)
chromosome arms##6##2##(1993-9#1)(1994-12#1)(2008-5#2)(2008-9#1)(2010-2#1)
chromosome as##2##2##(1994-8#1)(2012-3#1)
chromosome assignment##2##2##(1991-2#1)(2008-4#1)
chromosome at##4##2##(1995-2#1)(2008-12#1)(2008-9#2)
chromosome band##4##2##(1994-12#1)(1994-8#1)(1997-7#1)(2011-3#1)
chromosome breakage in##2##3##(1997-3#1)(2012-3#1)
chromosome breakage is##2##3##(2012-3#2)
chromosome breakage##7##2##(1997-3#1)(2012-3#6)
chromosome by##2##2##(1995-5#1)(1997-4#1)
chromosome can##2##2##(1995-2#1)(2011-2#1)
chromosome changes##2##2##(1992-8#1)(1994-12#1)
chromosome complement of##4##3##(2008-12#1)(2008-5#3)
chromosome configurations##2##2##(2008-11#1)(2009-12#1)
chromosome conservation##2##2##(1993-12#1)(2010-3#1)
chromosome containing the##2##3##(1994-12#1)(2008-10#1)
chromosome copy number##3##3##(2009-7#1)(2012-3#2)
chromosome counting##2##2##(2007-12#1)(2008-9#1)
chromosome damage##2##2##(2008-11#1)(2013-8#1)
chromosome ends##3##2##(2008-11#2)(2010-2#1)
chromosome evolution in##2##3##(2010-3#2)
chromosome evolution##6##2##(2010-3#3)(2010-5#3)
chromosome found##2##2##(2008-10#2)
chromosome from##4##2##(1993-9#1)(2008-10#2)(2008-5#1)
chromosome fusions##2##2##(2007-11#1)(2008-9#1)
chromosome identification##2##2##(2008-5#1)(2010-3#1)
chromosome in the##4##3##(2008-10#2)(2008-5#1)(2010-3#1)
chromosome in##14##2##(1997-3#1)(2007-11#1)(2008-10#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)
chromosome instability##3##2##(1994-8#1)(2008-7#1)(2013-8#1)
chromosome involvement##2##2##(1994-12#1)(2010-1#1)
chromosome is##5##2##(1995-5#1)(2008-4#1)(2008-5#3)
chromosome length##3##2##(1996-10#1)(2008-12#2)
chromosome loss and##2##3##(1993-9#1)(1995-6#1)
chromosome loss##3##2##(1993-9#2)(1995-6#1)
chromosome mapping##2##2##(2008-8#2)
chromosome morphology##2##2##(1996-2#1)(2010-3#1)
chromosome number of##4##3##(1990-8#1)(2008-10#1)(2008-12#2)
chromosome number was##2##3##(2008-10#1)(2008-12#1)
chromosome number##10##2##(1990-8#1)(2008-10#2)(2008-12#4)(2008-5#1)(2009-12#1)(2012-3#1)
chromosome numbers and##2##3##(2008-10#1)(2010-3#1)
chromosome numbers vary##2##3##(2008-12#2)
chromosome numbers##9##2##(2008-10#3)(2008-12#3)(2009-12#1)(2010-3#1)(2012-3#1)
chromosome of S##3##3##(1996-6#1)(2008-8#2)
chromosome of the##2##3##(2008-11#1)(2008-5#1)
chromosome of##19##2##(1993-9#1)(1994-11#1)(1994-12#1)(1996-6#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)
chromosome or##2##2##(1997-2#1)(2012-3#1)
chromosome painting##8##2##(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#3)(2012-3#1)
chromosome pair and##2##3##(2008-12#2)
chromosome pair##7##2##(2008-12#3)(2008-5#3)(2010-5#1)
chromosome pairing##4##2##(2008-5#3)(2008-7#1)
chromosome pairs##2##2##(2008-11#1)(2008-5#1)
chromosome preparation##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
chromosome rearrangements##3##2##(1992-11#1)(2008-11#1)(2010-3#1)
chromosome regions##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
chromosome replication##3##2##(1994-12#1)(2008-7#2)
chromosome segments##2##2##(2008-8#1)(2012-3#1)
chromosome segregation##5##2##(2008-12#1)(2008-7#2)(2012-2#1)(2013-1#1)
chromosome sequences##3##2##(1992-11#1)(1993-9#1)(1996-12#1)
chromosome set##2##2##(2008-12#2)
chromosome sizes##2##2##(1997-2#1)(2008-10#1)
chromosome structure##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
chromosome substitution line##3##3##(2008-10#3)
chromosome substitution##4##2##(2008-10#4)
chromosome that##3##2##(1996-6#1)(2008-9#1)(2012-12#1)
chromosome to##2##2##(2008-5#1)(2008-6#1)
chromosome transfer experiments##2##3##(1996-6#1)(2008-11#1)
chromosome translocations or##2##3##(1997-7#1)(2008-9#1)
chromosome translocations##4##2##(1994-12#1)(1997-7#1)(2008-10#1)(2008-9#1)
chromosome using##3##2##(1994-9#1)(2008-10#1)(2008-4#1)
chromosome was##5##2##(1993-2#1)(1995-8#1)(1997-5#2)(1997-7#1)
chromosome##917##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#5)(1990-8#2)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-9#3)(1992-11#5)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#9)(1993-2#8)(1993-9#11)(1994-11#5)(1994-12#20)(1994-6#3)(1994-8#4)(1994-9#8)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#8)(1995-5#6)(1995-6#28)(1995-8#10)(1995-9#8)(1996-10#20)(1996-12#14)(1996-2#7)(1996-3#13)(1996-5#2)(1996-6#29)(1996-8#6)(1997-2#12)(1997-3#19)(1997-4#4)(1997-5#19)(1997-6#11)(1997-7#14)(1997-8#19)(2007-11#10)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#7)(2008-1#11)(2008-10#148)(2008-11#17)(2008-12#30)(2008-2#3)(2008-4#16)(2008-5#51)(2008-6#3)(2008-7#30)(2008-8#31)(2008-9#37)(2009-10#13)(2009-12#7)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-2#2)(2010-3#30)(2010-4#1)(2010-5#6)(2010-8#4)(2011-1#2)(2011-2#12)(2011-3#2)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#41)(2013-1#5)(2013-8#3)
chromosome-specific##2##1##(2008-10#2)
chromosomes 1 and##3##3##(1995-5#1)(1996-10#1)(2008-10#1)
chromosomes 1##15##2##(1995-5#1)(1996-10#1)(1996-12#1)(1997-5#4)(2008-10#4)(2008-8#3)(2008-9#1)
chromosomes 10 and 12##5##4##(1996-12#5)
chromosomes 10 and##6##3##(1996-12#6)
chromosomes 10##7##2##(1996-12#6)(2008-10#1)
chromosomes 18 and##2##3##(1997-5#1)(2008-11#1)
chromosomes 2 and##2##3##(2008-10#1)(2009-2#1)
chromosomes 2##9##2##(1993-11#2)(1997-5#3)(2008-10#3)(2009-2#1)
chromosomes 3 and##2##3##(2008-10#2)
chromosomes 3##8##2##(1997-5#2)(2008-10#4)(2008-8#1)(2010-3#1)
chromosomes 4##4##2##(1997-2#2)(1997-5#2)
chromosomes 5 and##2##3##(1992-12#1)(2008-5#1)
chromosomes 6 and##2##3##(2008-10#1)(2008-4#1)
chromosomes 7A##3##2##(2008-5#3)
chromosomes 8 and 9##4##4##(1996-12#4)
chromosomes 8##6##2##(1991-4#1)(1993-9#1)(1996-12#4)
chromosomes 9 and##2##3##(1993-12#1)(2012-12#1)
chromosomes I##2##2##(1995-6#1)(1996-3#1)
chromosomes II and IV##2##4##(1996-6#2)
chromosomes and the##3##3##(2008-1#1)(2008-8#1)(2010-3#1)
chromosomes and their##3##3##(1990-3#1)(2008-9#1)(2010-5#1)
chromosomes and##19##2##(1990-3#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-3#3)(2010-5#1)(2012-3#1)
chromosomes are also##2##3##(1991-4#1)(2008-8#1)
chromosomes are##11##2##(1991-4#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-3#2)(2012-2#1)
chromosomes as well as##2##4##(2010-3#1)(2010-5#1)
chromosomes as##3##2##(2008-10#1)(2010-3#1)(2010-5#1)
chromosomes by##6##2##(2008-10#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)
chromosomes for##2##2##(2008-12#1)(2008-9#1)
chromosomes from##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)
chromosomes had a##2##3##(2008-12#2)
chromosomes had##3##2##(2008-12#2)(2008-8#1)
chromosomes has been##2##3##(2008-11#1)(2008-5#1)
chromosomes has##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
chromosomes have##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
chromosomes in the##4##3##(1990-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
chromosomes in##23##2##(1990-3#1)(1991-6#1)(1994-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2010-3#2)(2011-3#1)(2012-3#1)(2013-1#1)
chromosomes is##2##2##(1994-12#1)(1994-6#1)
chromosomes of mammals##2##3##(2010-3#1)(2010-5#1)
chromosomes of the##4##3##(1997-6#1)(1997-8#1)(2008-12#1)(2008-7#1)
chromosomes of##18##2##(1993-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-3#1)(2010-5#2)(2010-8#1)
chromosomes studied##2##2##(2008-11#1)(2008-8#1)
chromosomes that##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
chromosomes was found##2##3##(2008-12#2)
chromosomes was##4##2##(2008-12#2)(2008-5#1)(2012-3#1)
chromosomes were##8##2##(1991-4#2)(1997-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
chromosomes will##2##2##(1996-12#1)(2008-10#1)
chromosomes with##3##2##(2007-11#1)(2008-12#1)(2010-3#1)
chromosomes##389##1##(1990-3#3)(1990-5#2)(1991-2#1)(1991-4#6)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-9#2)(1994-12#5)(1994-6#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-10#3)(1996-12#14)(1996-3#2)(1996-6#4)(1996-8#1)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#14)(1997-6#6)(1997-8#1)(1997-9#2)(2006-10#1)(2007-11#7)(2007-12#9)(2008-1#10)(2008-10#39)(2008-11#11)(2008-12#31)(2008-2#1)(2008-4#10)(2008-5#39)(2008-7#10)(2008-8#19)(2008-9#25)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#1)(2009-7#1)(2010-1#2)(2010-3#30)(2010-5#10)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#12)(2013-1#6)
chromotropic acid (1##2##3##(2008-10#2)
chromotropic acid##13##2##(2008-10#13)
chronic (1##2##2##(2010-4#2)
chronic (8##2##2##(1991-9#1)(1994-2#1)
chronic Achilles tendinosis##3##3##(2009-10#2)(2010-3#1)
chronic B-lymphocytic leukemia##2##3##(1995-2#2)
chronic EtOH treatment##3##3##(2008-10#3)
chronic EtOH##6##2##(2008-10#5)(2008-8#1)
chronic GVHD that##2##3##(2006-10#2)
chronic GVHD##4##2##(2006-10#2)(2009-10#2)
chronic H##4##2##(1997-1#4)
chronic HBV infection##4##3##(2007-12#1)(2009-8#2)(2010-8#1)
chronic HBV##9##2##(2007-12#3)(2009-8#3)(2010-8#1)(2013-1#1)(2013-8#1)
chronic HCV infection##4##3##(2009-4#2)(2009-8#1)(2013-1#1)
chronic HCV##11##2##(2009-3#1)(2009-4#6)(2009-8#1)(2013-1#3)
chronic LBP##4##2##(2010-12#3)(2013-1#1)
chronic TRZ##3##2##(1996-12#3)
chronic abdominal pain associated with##2##5##(1995-2#2)
chronic abdominal pain##4##3##(1995-2#2)(1996-12#1)(2012-2#1)
chronic abscess##2##2##(1994-12#1)(2007-8#1)
chronic active hepatitis in##2##4##(2007-2#1)(2008-1#1)
chronic active hepatitis##9##3##(1990-3#2)(1991-6#2)(1993-5#1)(2007-2#1)(2008-1#1)(2009-8#2)
chronic active inflammation in##3##4##(2008-9#3)
chronic active inflammation of the dermis##5##6##(2008-9#5)
chronic active inflammation of the##8##5##(2008-9#8)
chronic active inflammation##20##3##(2008-9#20)
chronic active##33##2##(1990-3#2)(1991-6#3)(1993-5#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-9#21)(2009-12#1)(2009-8#2)
chronic administration of##3##3##(1990-3#1)(1994-5#1)(2008-10#1)
chronic administration to##2##3##(1992-12#1)(2009-12#1)
chronic administration##8##2##(1990-3#1)(1992-12#1)(1992-3#2)(1994-5#1)(2008-10#1)(2008-7#1)(2009-12#1)
chronic airway##2##2##(1994-12#1)(2008-7#1)
chronic airways obstruction##3##3##(1995-12#1)(2008-12#2)
chronic alcohol##2##2##(1993-12#1)(2011-2#1)
chronic alcoholism##2##2##(1991-11#1)(1996-2#1)
chronic allograft dysfunction##2##3##(2008-8#1)(2011-3#1)
chronic ambulatory##2##2##(1990-2#1)(2007-7#1)
chronic and acute##6##3##(1991-11#1)(1993-11#1)(1997-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
chronic and aggressive##2##3##(2012-3#2)
chronic and##20##2##(1990-6#1)(1991-11#2)(1993-11#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2012-12#1)(2012-3#3)(2013-1#2)
chronic anemia##3##2##(1992-6#1)(1993-9#1)(1997-3#1)
chronic angina##3##2##(2008-12#3)
chronic animal##2##2##(1992-6#1)(2008-10#1)
chronic ankle pain##3##3##(2010-5#1)(2010-7#1)(2011-2#1)
chronic ankle##4##2##(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
chronic antral gastritis##3##3##(2008-5#3)
chronic arthritis##3##2##(1990-6#1)(1995-11#1)(2013-8#1)
chronic asthma##2##2##(1990-9#1)(1997-1#1)
chronic atrial fibrillation##2##3##(2007-8#2)
chronic atrophic##2##2##(1994-2#1)(1997-1#1)
chronic autoimmune##4##2##(1996-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
chronic bacterial prostatitis##3##3##(2008-10#3)
chronic bacterial##4##2##(2008-10#3)(2010-7#1)
chronic benign pain##3##3##(1997-1#2)(2008-4#1)
chronic blood##2##2##(2009-10#1)(2012-5#1)
chronic brain ischemia##2##3##(1997-2#2)
chronic bronchitis (CB)##2##3##(1991-4#1)(1997-1#1)
chronic bronchitis##16##2##(1990-2#2)(1991-4#2)(1992-5#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-7#2)(2013-1#1)
chronic cancer pain##2##3##(2008-7#2)
chronic care and rehabilitation##3##4##(1993-12#3)
chronic care and##4##3##(1993-12#3)(1994-12#1)
chronic care patients##2##3##(1997-1#2)
chronic care##16##2##(1992-1#1)(1992-2#1)(1993-12#4)(1994-12#1)(1997-1#7)(1997-2#1)(2011-2#1)
chronic cerebral hypoperfusion (CCH)##2##4##(2008-7#2)
chronic cerebral hypoperfusion##5##3##(2008-7#4)(2009-6#1)
chronic cerebral##6##2##(2008-7#5)(2009-6#1)
chronic cerebrospinal venous insufficiency (CCSVI)##3##5##(2012-3#3)
chronic cerebrospinal venous insufficiency##6##4##(2012-3#5)(2013-1#1)
chronic cholecystitis##3##2##(1997-8#1)(2010-12#1)(2013-8#1)
chronic clinical##2##2##(2011-1#1)(2011-2#1)
chronic complaints##2##2##(2008-10#1)(2011-2#1)
chronic complications##2##2##(2008-10#1)(2012-2#1)
chronic compression##2##2##(1992-6#1)(2011-2#1)
chronic condition##4##2##(1992-12#1)(1992-2#1)(2009-5#1)(2012-3#1)
chronic conditions that share##2##4##(2011-2#2)
chronic conditions##27##2##(1992-12#1)(1996-1#2)(1997-1#3)(1997-2#5)(2007-6#1)(2008-7#1)(2009-10#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
chronic confusion##2##2##(2012-12#2)
chronic congestive heart failure##4##4##(2008-7#4)
chronic congestive heart failure]##2##4##(1991-3#1)(2008-7#1)
chronic congestive heart##6##3##(1991-3#1)(2008-7#5)
chronic constipation##2##2##(1993-6#1)(2008-6#1)
chronic constriction injury (CCI)##2##4##(1996-5#1)(1997-2#1)
chronic constriction injury##4##3##(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#1)
chronic consumption##2##2##(2009-5#1)(2013-1#1)
chronic cough##2##2##(1991-4#1)(2010-12#1)
chronic course##2##2##(1991-2#1)(2012-2#1)
chronic degenerative diseases##3##3##(1994-11#1)(2009-9#1)(2012-12#1)
chronic degenerative##5##2##(1994-11#1)(2009-10#1)(2009-4#1)(2009-9#1)(2012-12#1)
chronic demyelinating##2##2##(2008-7#2)
chronic demyelination##2##2##(2008-7#2)
chronic dialysis patients##2##3##(2007-7#1)(2007-8#1)
chronic dialysis treatment##2##3##(2008-1#1)(2008-4#1)
chronic dialysis using##2##3##(2007-7#1)(2008-1#1)
chronic dialysis##11##2##(1993-9#1)(2006-10#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-4#1)(2013-1#1)
chronic diarrhea##6##2##(1991-8#2)(1992-5#1)(1997-3#1)(2012-2#1)(2013-1#1)
chronic disease and##4##3##(1993-6#1)(2008-7#1)(2010-1#1)(2011-2#1)
chronic disease is##3##3##(2008-5#1)(2008-8#1)(2010-1#1)
chronic disease of##3##3##(2008-10#1)(2012-3#2)
chronic disease prevention##2##3##(1997-1#1)(1997-2#1)
chronic disease risk factors##2##4##(1993-3#1)(2008-10#1)
chronic disease##46##2##(1993-11#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#4)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
chronic diseases and a##2##4##(1997-1#1)(2011-1#1)
chronic diseases and##9##3##(1992-5#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#2)
chronic diseases in the elderly##2##5##(1991-3#1)(1997-8#1)
chronic diseases in##5##3##(1991-3#1)(1997-8#1)(2008-7#1)(2010-1#1)(2012-2#1)
chronic diseases including##2##3##(2008-10#1)(2008-6#1)
chronic diseases of##3##3##(1991-2#1)(2009-2#2)
chronic diseases such as##4##4##(2008-10#1)(2008-11#1)(2013-1#2)
chronic diseases##59##2##(1991-2#1)(1991-3#1)(1992-4#1)(1992-5#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-8#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
chronic disorders##2##2##(1990-6#1)(2011-1#1)
chronic duodenal##2##2##(1992-11#1)(2008-12#1)
chronic ear##3##2##(2008-9#1)(2011-2#2)
chronic effect##2##2##(2010-12#1)(2013-1#1)
chronic effects##5##2##(1994-5#1)(1996-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
chronic elephantiasis##3##2##(1994-11#3)
chronic empyema##4##2##(2010-1#4)
chronic eosinophilic pneumonia##3##3##(1991-12#2)(2008-1#1)
chronic ethanol##3##2##(1991-1#1)(2008-10#1)(2008-6#1)
chronic exposure of##2##3##(2008-7#1)(2013-1#1)
chronic exposure to nicotine##2##4##(1995-12#2)
chronic exposure to##13##3##(1991-4#2)(1995-12#2)(1997-4#2)(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#2)
chronic exposure##16##2##(1991-4#2)(1995-12#2)(1997-4#2)(2008-10#2)(2008-5#1)(2008-7#3)(2009-7#1)(2013-1#3)
chronic fatigue syndrome##8##3##(1993-2#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-1#1)(2012-3#1)
chronic fatigue##13##2##(1993-2#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-10#1)(2010-1#1)(2012-3#1)(2013-1#1)
chronic forced swim stress##2##4##(1995-12#2)
chronic fracture dislocation of the ankle##3##6##(2012-2#3)
chronic gastritis and##3##3##(2008-5#3)
chronic gastritis##11##2##(1990-11#1)(1996-6#1)(2007-2#1)(2008-5#5)(2009-8#1)(2012-12#2)
chronic gastritis)##2##2##(2008-5#2)
chronic graft-versus-host disease##4##3##(1997-7#2)(2009-10#1)(2013-8#1)
chronic granulomatous disease##6##3##(1992-5#1)(1993-11#1)(2007-8#1)(2012-12#1)(2013-1#2)
chronic granulomatous inflammation##2##3##(1990-3#2)
chronic granulomatous##11##2##(1990-3#2)(1992-5#1)(1993-11#1)(2007-8#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#2)
chronic headache##4##2##(1996-11#1)(1996-2#1)(2008-7#1)(2008-9#1)
chronic health##7##2##(1992-3#1)(1993-1#2)(1995-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
chronic heart failure (CHF)##5##4##(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
chronic heart failure##23##3##(1991-3#2)(1991-6#1)(2008-3#3)(2008-7#6)(2008-8#1)(2009-10#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
chronic heart failure]##4##3##(1992-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
chronic heart##27##2##(1991-3#2)(1991-6#1)(1992-6#1)(2008-3#3)(2008-7#6)(2008-8#1)(2009-10#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
chronic hemodialysis (HD) patients##2##4##(2007-7#1)(2008-1#1)
chronic hemodialysis (HD)##3##3##(2007-7#2)(2008-1#1)
chronic hemodialysis patients##4##3##(2007-7#3)(2008-1#1)
chronic hemodialysis##15##2##(1991-6#1)(2007-7#6)(2008-1#5)(2013-1#1)(2013-8#2)
chronic hepatitis B and##2##4##(2006-10#1)(2011-2#1)
chronic hepatitis B virus (HBV) infection##4##6##(2008-10#1)(2009-12#1)(2009-8#1)(2012-12#1)
chronic hepatitis B virus (HBV)##5##5##(2008-10#1)(2009-12#1)(2009-8#2)(2012-12#1)
chronic hepatitis B##25##3##(1993-2#1)(1995-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-8#11)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
chronic hepatitis C and##3##4##(2007-12#1)(2012-2#1)(2013-8#1)
chronic hepatitis C infection##2##4##(2010-6#1)(2012-12#1)
chronic hepatitis C patients with HCV genotype 4##3##8##(2012-12#3)
chronic hepatitis C patients##5##4##(2009-8#1)(2012-12#3)(2013-7#1)
chronic hepatitis C virus (HCV)##2##5##(2009-4#1)(2009-8#1)
chronic hepatitis C virus infection##3##5##(2009-8#1)(2011-2#1)(2013-1#1)
chronic hepatitis C virus##5##4##(2009-4#1)(2009-8#2)(2011-2#1)(2013-1#1)
chronic hepatitis C##31##3##(1994-8#1)(2007-12#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#3)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#6)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
chronic hepatitis##62##2##(1991-8#1)(1993-2#1)(1994-8#1)(1995-10#2)(2006-10#1)(2007-12#2)(2008-10#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#16)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-12#7)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#4)
chronic hepatopathies]##2##2##(1992-5#2)
chronic hypertension and diabetes mellitus##2##5##(2008-4#2)
chronic hypertension##4##2##(2008-4#4)
chronic hypoxia exposure##2##3##(2010-4#2)
chronic hypoxia##9##2##(1996-12#1)(2010-11#1)(2010-4#6)(2013-1#1)
chronic idiopathic interstitial pneumonia##2##4##(2008-1#2)
chronic idiopathic##3##2##(2008-1#2)(2008-8#1)
chronic if##2##2##(2008-7#1)(2013-1#1)
chronic illness and##7##3##(1991-3#1)(1996-3#1)(1997-2#1)(2008-4#1)(2010-10#1)(2013-1#2)
chronic illness care##2##3##(1991-12#1)(1997-1#1)
chronic illness##32##2##(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1996-3#1)(1997-1#6)(1997-2#3)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-10#2)(2011-1#1)(2012-12#4)(2013-1#3)
chronic illnesses such as##2##4##(1992-3#1)(2008-7#1)
chronic illnesses##15##2##(1991-8#1)(1992-3#1)(1993-3#4)(1994-12#1)(1995-12#3)(1996-3#2)(2008-11#1)(2008-7#1)(2012-12#1)
chronic in##3##2##(1991-5#1)(2013-1#2)
chronic infection##15##2##(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
chronic infections##5##2##(2007-2#1)(2008-1#2)(2008-7#1)(2011-2#1)
chronic inflammation and##5##3##(2009-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
chronic inflammation in the##2##4##(1995-8#1)(2011-2#1)
chronic inflammation in##3##3##(1995-8#1)(2009-10#1)(2011-2#1)
chronic inflammation of the##2##4##(2008-4#1)(2011-2#1)
chronic inflammation##27##2##(1991-3#1)(1992-6#1)(1995-8#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#1)(2013-8#2)
chronic inflammatory bowel disease##2##4##(1994-2#2)
chronic inflammatory bowel##3##3##(1994-2#2)(1996-2#1)
chronic inflammatory demyelinating polyneuropathy##3##4##(1995-5#1)(2008-1#1)(2012-3#1)
chronic inflammatory demyelinating##5##3##(1995-5#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#1)
chronic inflammatory diseases##3##3##(2008-10#1)(2010-6#1)(2011-1#1)
chronic inflammatory nonbacterial prostatitis##2##4##(2008-10#2)
chronic inflammatory process of the##2##5##(2008-3#1)(2010-6#1)
chronic inflammatory process##4##3##(2008-1#1)(2008-3#1)(2010-6#1)(2013-1#1)
chronic inflammatory processes##3##3##(2008-4#2)(2011-2#1)
chronic inflammatory tissue##2##3##(2008-6#2)
chronic inflammatory##36##2##(1994-2#2)(1994-5#2)(1995-5#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
chronic insomnia##2##2##(2013-1#1)(2013-7#1)
chronic interstitial nephritis with##2##4##(1992-5#1)(2008-5#1)
chronic interstitial nephritis##3##3##(1992-5#1)(2008-1#1)(2008-5#1)
chronic interstitial##5##2##(1991-2#1)(1992-5#1)(2008-1#1)(2008-5#1)(2011-2#1)
chronic ischaemia##2##2##(2011-2#2)
chronic ischemia##2##2##(2007-8#2)
chronic joint##3##2##(2009-3#2)(2010-11#1)
chronic kidney disease (CKD) patients##2##5##(2011-2#1)(2013-1#1)
chronic kidney disease (CKD)##7##4##(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
chronic kidney disease and##2##4##(2008-11#1)(2011-2#1)
chronic kidney disease in##2##4##(2012-2#1)(2012-3#1)
chronic kidney disease##28##3##(2008-11#1)(2008-8#2)(2009-1#2)(2009-5#1)(2010-10#2)(2010-4#2)(2010-8#2)(2011-2#8)(2012-2#1)(2012-3#4)(2013-1#3)
chronic kidney disease)##6##3##(2013-8#6)
chronic kidney##35##2##(2008-11#1)(2008-8#2)(2009-1#2)(2009-5#1)(2010-10#2)(2010-4#2)(2010-8#2)(2011-2#8)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#6)
chronic knee##2##2##(2007-8#1)(2012-2#1)
chronic lateral##2##2##(1994-2#1)(1997-6#1)
chronic liver disease##25##3##(1991-11#1)(1991-8#1)(2006-10#3)(2007-7#1)(2008-1#6)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#5)(2010-12#1)(2013-1#2)(2013-8#2)
chronic liver##27##2##(1991-11#1)(1991-8#1)(2006-10#3)(2007-7#1)(2008-1#6)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#5)(2010-12#1)(2011-2#1)(2013-1#3)(2013-8#2)
chronic low back pain##8##4##(2007-11#1)(2008-10#2)(2010-1#1)(2012-12#2)(2013-1#2)
chronic lung disease##10##3##(1992-2#2)(1994-6#2)(2006-10#1)(2008-8#1)(2008-9#1)(2009-3#2)(2012-2#1)
chronic lung diseases##2##3##(2012-2#1)(2013-1#1)
chronic lung##14##2##(1992-11#1)(1992-2#2)(1994-3#1)(1994-6#2)(2006-10#1)(2008-8#1)(2008-9#1)(2009-3#2)(2012-2#2)(2013-1#1)
chronic lymphatic##3##2##(1990-6#1)(1990-9#1)(2008-11#1)
chronic lymphocytic leukemia (CLL)##5##4##(1991-4#1)(2008-4#1)(2009-12#1)(2009-2#1)(2011-2#1)
chronic lymphocytic leukemia##12##3##(1991-4#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-2#2)(2009-6#1)(2011-2#1)
chronic lymphocytic leukemia]##3##3##(2008-7#1)(2012-2#2)
chronic lymphocytic##16##2##(1991-4#2)(1991-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-2#2)(2009-6#1)(2011-2#1)(2012-2#2)
chronic marijuana##2##2##(1996-5#2)
chronic medical diagnoses##2##3##(1995-1#2)
chronic medical##6##2##(1995-1#2)(1996-12#1)(2008-7#1)(2010-2#1)(2013-8#1)
chronic mental illness##3##3##(1994-2#1)(1997-2#1)(2012-12#1)
chronic mental##4##2##(1993-3#1)(1994-2#1)(1997-2#1)(2012-12#1)
chronic moderate##2##2##(2010-7#1)(2012-2#1)
chronic motor##3##2##(2008-4#1)(2008-7#1)(2012-3#1)
chronic mucocutaneous##2##2##(2011-2#1)(2012-3#1)
chronic muscle pain##2##3##(1997-4#2)
chronic myelogenous leukemia (CML)##3##4##(2006-10#1)(2009-7#1)(2012-12#1)
chronic myelogenous leukemia##7##3##(1992-9#1)(2006-10#2)(2008-5#1)(2009-7#1)(2010-4#1)(2012-12#1)
chronic myeloid leukemia (CML) cells##2##5##(1990-2#1)(1991-4#1)
chronic myeloid leukemia (CML)##4##4##(1990-2#1)(1991-4#1)(2010-11#1)(2010-4#1)
chronic myeloid leukemia cells##3##4##(1990-2#1)(2011-2#1)(2012-12#1)
chronic myeloid leukemia##20##3##(1990-2#2)(1991-4#1)(1993-8#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#2)(2010-4#1)(2011-2#5)(2012-12#2)(2012-2#1)
chronic myeloid##23##2##(1990-2#2)(1990-9#1)(1991-4#1)(1993-8#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#2)(2010-4#1)(2011-2#5)(2012-12#2)(2012-2#1)
chronic neurodegenerative##2##2##(2008-7#1)(2011-2#1)
chronic neuropathic##2##2##(2008-8#1)(2009-12#1)
chronic neutropenia##2##2##(2008-7#2)
chronic neutrophilic leukemia##2##3##(2009-8#2)
chronic nonmalignant pain##5##3##(2010-3#5)
chronic obstructive lung disease##3##4##(1990-6#1)(1995-2#1)(2008-7#1)
chronic obstructive lung disease]##2##4##(2008-1#2)
chronic obstructive lung##6##3##(1990-6#1)(1995-2#2)(2008-1#2)(2008-7#1)
chronic obstructive pulmonary disease (COPD) and##2##6##(2011-2#2)
chronic obstructive pulmonary disease (COPD) in##2##6##(1995-12#1)(2011-2#1)
chronic obstructive pulmonary disease (COPD)##23##5##(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-7#1)(2008-1#1)(2008-7#2)(2010-10#1)(2010-5#1)(2011-2#7)(2012-12#1)(2013-8#2)
chronic obstructive pulmonary disease and##4##5##(2007-10#1)(2008-7#2)(2009-1#1)
chronic obstructive pulmonary disease in the##2##6##(1995-12#1)(2012-2#1)
chronic obstructive pulmonary disease in##4##5##(1995-12#1)(2010-2#1)(2012-2#2)
chronic obstructive pulmonary disease##59##4##(1991-4#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-12#3)(1996-1#2)(1997-7#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-5#2)(2011-2#14)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#2)
chronic obstructive pulmonary##66##3##(1991-4#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#3)(1996-1#2)(1997-7#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-5#2)(2011-2#18)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
chronic obstructive rhinitis##5##3##(2008-4#5)
chronic obstructive##80##2##(1990-6#1)(1991-4#4)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#3)(1995-2#2)(1996-1#2)(1997-7#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-5#2)(2011-2#18)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
chronic or acute##2##3##(2008-8#1)(2010-3#1)
chronic or##6##2##(1996-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-8#1)(2010-3#1)
chronic oral##2##2##(2013-7#1)(2013-8#1)
chronic orthopedic pain in dogs although it was not as effective as carprofen##2##13##(2008-10#2)
chronic osteomyelitis##9##2##(2007-7#2)(2008-11#1)(2008-9#2)(2010-3#1)(2010-6#3)
chronic otitis media##3##3##(1990-3#1)(2008-9#1)(2013-8#1)
chronic otitis##4##2##(1990-3#1)(1991-3#1)(2008-9#1)(2013-8#1)
chronic pain and##4##3##(1997-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
chronic pain in##3##3##(2008-12#1)(2010-12#1)(2010-4#1)
chronic pain patients##4##3##(1991-1#1)(2008-4#1)(2008-7#1)(2010-9#1)
chronic pain syndrome##4##3##(2008-4#2)(2009-11#1)(2012-3#1)
chronic pain syndromes##3##3##(1995-6#1)(2008-4#2)
chronic pain##57##2##(1991-1#1)(1992-9#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#8)(2008-7#8)(2008-8#3)(2008-9#3)(2009-11#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2012-3#3)(2013-1#6)
chronic pancreatitis##16##2##(1991-8#2)(1992-11#2)(1994-3#1)(2008-10#2)(2008-6#1)(2009-7#6)(2011-2#1)(2013-8#1)
chronic patients with##2##3##(2008-12#1)(2011-1#1)
chronic patients##5##2##(1997-2#1)(2008-12#1)(2011-1#2)(2012-12#1)
chronic pelvic pain##6##3##(1991-2#2)(2008-10#1)(2008-8#3)
chronic pelvic##7##2##(1991-2#2)(1994-3#1)(2008-10#1)(2008-8#3)
chronic periodontitis and peri-implantitis##2##4##(2013-1#2)
chronic periodontitis and##3##3##(2012-3#1)(2013-1#2)
chronic periodontitis by##2##3##(2008-12#2)
chronic periodontitis patients##4##3##(2008-12#3)(2012-3#1)
chronic periodontitis with##3##3##(2008-12#3)
chronic periodontitis##20##2##(2008-12#11)(2012-3#5)(2013-1#4)
chronic peritoneal dialysis##3##3##(2011-2#3)
chronic peritoneal##4##2##(2011-2#4)
chronic phase of##3##3##(1997-3#1)(2008-12#1)(2013-8#1)
chronic phase##5##2##(1994-2#1)(1997-3#1)(2008-12#2)(2013-8#1)
chronic polyarthritis]##2##2##(1990-6#1)(1993-11#1)
chronic progressive##2##2##(2010-12#1)(2012-12#1)
chronic psychotic patients##2##3##(2012-12#2)
chronic psychotic##4##2##(2008-3#1)(2011-2#1)(2012-12#2)
chronic pulmonary heart disease##2##4##(2011-2#2)
chronic pulmonary##3##2##(2010-5#1)(2011-2#2)
chronic pyelonephritis##4##2##(2011-1#1)(2011-2#3)
chronic rejection##2##2##(2008-1#2)
chronic relapsing##4##2##(1991-2#1)(1993-8#1)(2009-7#1)(2013-7#1)
chronic renal disease##8##3##(1994-3#1)(2008-1#3)(2008-10#3)(2011-2#1)
chronic renal failure (CRF)##7##4##(2007-7#3)(2008-1#3)(2011-2#1)
chronic renal failure and##3##4##(1991-5#1)(1993-3#1)(2008-12#1)
chronic renal failure in##5##4##(1995-5#1)(2007-7#2)(2008-1#2)
chronic renal failure is##2##4##(1994-5#1)(2011-2#1)
chronic renal failure patients##9##4##(2007-7#2)(2008-1#3)(2008-4#1)(2011-1#3)
chronic renal failure who##3##4##(1993-2#1)(1994-12#1)(2013-1#1)
chronic renal failure##58##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-5#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(2007-7#10)(2007-8#1)(2008-1#17)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#3)(2011-2#5)(2012-3#1)(2013-1#2)
chronic renal failure]##2##3##(1997-2#1)(2008-10#1)
chronic renal insufficiency##6##3##(1993-3#1)(2006-10#2)(2011-2#2)(2011-3#1)
chronic renal##80##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-5#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-5#1)(1997-2#1)(2006-10#2)(2007-7#10)(2007-8#1)(2008-1#22)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
chronic respiratory diseases##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
chronic respiratory failure and##2##4##(2010-8#1)(2013-1#1)
chronic respiratory failure##4##3##(1992-3#1)(2008-1#1)(2010-8#1)(2013-1#1)
chronic respiratory##9##2##(1992-3#1)(2007-2#1)(2008-1#1)(2008-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
chronic rheumatic##4##2##(1993-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
chronic rhinitis##2##2##(1996-3#1)(2011-1#1)
chronic rhinosinusitis with polyps and obstructive sleep apnoea syndrome##2##9##(2010-6#2)
chronic rhinosinusitis with polyps and##3##5##(2010-6#3)
chronic rhinosinusitis with##4##3##(2010-6#3)(2012-1#1)
chronic rhinosinusitis##12##2##(2010-6#3)(2011-1#1)(2011-2#2)(2012-1#6)
chronic schizophrenic patients##4##3##(1996-7#1)(2008-6#3)
chronic schizophrenic##5##2##(1996-7#2)(2008-6#3)
chronic sclerosing dacryoadenitis with high level of IgG4##2##8##(2011-2#2)
chronic sclerosing dacryoadenitis with high level of##3##7##(2011-2#3)
chronic sera##3##2##(1992-8#3)
chronic sinus inflammation##2##3##(2008-2#2)
chronic sinusitis##4##2##(1995-8#1)(2008-5#2)(2013-1#1)
chronic skin##6##2##(1991-12#1)(1991-6#1)(1997-8#1)(2006-10#1)(2012-3#2)
chronic sorrow##3##2##(2009-9#3)
chronic stable angina##2##3##(2008-3#2)
chronic stable##5##2##(2008-1#2)(2008-3#2)(2010-10#1)
chronic steroid##3##2##(2008-7#1)(2009-3#1)(2013-1#1)
chronic stress##7##2##(1991-1#1)(1995-12#3)(2008-11#2)(2008-12#1)
chronic stressors##2##2##(2008-12#1)(2010-12#1)
chronic stroke survivors##2##3##(2007-10#1)(2010-7#1)
chronic stroke##4##2##(2007-10#3)(2010-7#1)
chronic subdural hematoma##6##3##(2008-7#5)(2012-2#1)
chronic sun exposure##2##3##(2008-5#1)(2010-8#1)
chronic suppurative lung disease##2##4##(1994-12#1)(1997-1#1)
chronic suppurative lung##4##3##(1994-12#3)(1997-1#1)
chronic suppurative otitis media##2##4##(2008-9#2)
chronic suppurative##8##2##(1994-12#4)(1997-1#1)(2008-9#2)(2010-12#1)
chronic symptoms##2##2##(2013-1#1)(2013-8#1)
chronic thromboembolic pulmonary hypertension (CTEPH)##4##5##(2010-6#4)
chronic thromboembolic pulmonary hypertension##6##4##(2009-10#1)(2010-6#4)(2013-1#1)
chronic thromboembolic pulmonary hypertension]##7##4##(2010-6#7)
chronic thromboembolic pulmonary##14##3##(2009-10#1)(2010-10#1)(2010-6#11)(2013-1#1)
chronic thromboembolic##15##2##(2009-10#1)(2010-10#2)(2010-6#11)(2013-1#1)
chronic total occlusion##5##3##(2008-11#3)(2008-12#2)
chronic total occlusions##4##3##(2008-11#1)(2008-12#3)
chronic total##9##2##(2008-11#4)(2008-12#5)
chronic toxicity##2##2##(2008-5#1)(2008-7#1)
chronic treatment with haloperidol##2##4##(1995-12#2)
chronic treatment with the##3##4##(1993-3#2)(2010-6#1)
chronic treatment with vigabatrin##2##4##(1992-3#2)
chronic treatment with##10##3##(1992-3#2)(1993-3#2)(1995-12#2)(1997-1#1)(1997-2#1)(2010-6#1)(2013-1#1)
chronic treatment##13##2##(1992-3#2)(1993-3#2)(1994-6#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-2#1)(2008-5#1)(2010-6#1)(2013-1#1)
chronic tubulointerstitial##2##2##(2007-7#1)(2011-2#1)
chronic uremia##2##2##(2010-3#1)(2011-2#1)
chronic urticaria##2##2##(2007-7#1)(2010-5#1)
chronic use is associated with##2##5##(2008-2#1)(2010-12#1)
chronic use of cocaine##2##4##(1991-1#1)(1996-5#1)
chronic use of##7##3##(1991-1#1)(1996-5#2)(2008-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
chronic use##11##2##(1991-1#2)(1996-5#2)(2008-12#1)(2008-2#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
chronic vasculitis mainly involving##2##4##(1997-8#2)
chronic venous disorders##3##3##(2010-7#3)
chronic venous insufficiency##4##3##(1990-3#1)(2013-1#3)
chronic venous##7##2##(1990-3#1)(2010-7#3)(2013-1#3)
chronic viral hepatitis##3##3##(2007-12#2)(2009-5#1)
chronic viral##6##2##(2007-12#3)(2008-8#1)(2009-5#1)(2010-5#1)
chronic whiplash##3##2##(2008-12#2)(2013-1#1)
chronic wounds and##2##3##(2008-9#1)(2012-12#1)
chronic wounds##7##2##(2008-9#5)(2012-12#1)(2012-3#1)
chronic wrist pain##9##3##(2008-10#1)(2008-9#8)
chronic##1833##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#6)(1990-3#11)(1990-6#10)(1990-9#6)(1991-1#10)(1991-11#7)(1991-12#6)(1991-2#9)(1991-3#10)(1991-4#13)(1991-5#3)(1991-6#11)(1991-8#8)(1991-9#6)(1992-1#1)(1992-10#3)(1992-11#5)(1992-12#5)(1992-2#7)(1992-3#8)(1992-4#1)(1992-5#9)(1992-6#7)(1992-8#4)(1992-9#6)(1993-1#4)(1993-11#7)(1993-12#5)(1993-2#5)(1993-3#15)(1993-5#3)(1993-6#3)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#9)(1994-2#12)(1994-3#9)(1994-5#11)(1994-6#7)(1994-8#2)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#19)(1995-2#8)(1995-3#8)(1995-5#5)(1995-6#1)(1995-8#3)(1996-1#6)(1996-11#2)(1996-12#12)(1996-2#5)(1996-3#9)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#32)(1997-2#28)(1997-3#10)(1997-4#7)(1997-5#4)(1997-6#6)(1997-7#4)(1997-8#14)(2006-10#18)(2006-12#1)(2007-10#7)(2007-11#14)(2007-12#11)(2007-2#4)(2007-4#1)(2007-6#2)(2007-7#29)(2007-8#18)(2007-9#1)(2008-1#61)(2008-10#67)(2008-11#26)(2008-12#47)(2008-2#7)(2008-3#19)(2008-4#41)(2008-5#38)(2008-6#12)(2008-7#99)(2008-8#24)(2008-9#55)(2009-1#4)(2009-10#17)(2009-11#6)(2009-12#7)(2009-2#5)(2009-3#10)(2009-4#11)(2009-5#10)(2009-6#2)(2009-7#15)(2009-8#33)(2009-9#6)(2010-1#12)(2010-10#10)(2010-11#5)(2010-12#26)(2010-2#4)(2010-3#13)(2010-4#18)(2010-5#10)(2010-6#23)(2010-7#10)(2010-8#9)(2010-9#3)(2011-1#25)(2011-2#122)(2011-3#2)(2012-1#9)(2012-12#44)(2012-2#41)(2012-3#53)(2012-5#4)(2013-1#118)(2013-7#9)(2013-8#47)
chronic)##2##1##(2008-11#2)
chronic-phase##2##1##(2010-11#1)(2010-4#1)
chronical##2##1##(1996-6#1)(2011-2#1)
chronically HIV-infected##2##2##(2008-4#1)(2012-2#1)
chronically administered##2##2##(1990-3#1)(1994-5#1)
chronically exposed to##2##3##(1993-12#1)(2011-2#1)
chronically exposed##3##2##(1993-12#1)(2011-2#1)(2013-1#1)
chronically ill and##3##3##(1995-2#1)(1996-1#1)(2013-8#1)
chronically ill children##5##3##(1990-10#3)(1994-12#1)(1996-1#1)
chronically ill patients##6##3##(1996-12#1)(1997-1#3)(2007-12#1)(2012-3#1)
chronically ill##21##2##(1990-10#5)(1991-3#1)(1994-12#2)(1995-2#1)(1996-1#2)(1996-12#1)(1997-1#4)(2007-12#1)(2008-1#1)(2012-3#2)(2013-8#1)
chronically implanted with##2##3##(1993-12#1)(2008-11#1)
chronically implanted##3##2##(1993-12#1)(1994-8#1)(2008-11#1)
chronically in##2##2##(1995-3#1)(2008-7#1)
chronically infected cell lines##2##4##(1994-6#1)(2008-4#1)
chronically infected with##3##3##(1992-8#1)(2009-7#1)(2013-1#1)
chronically infected##7##2##(1992-8#2)(1994-6#1)(2008-4#1)(2009-5#1)(2009-7#1)(2013-1#1)
chronically intoxicated with##3##3##(1994-6#1)(2009-8#2)
chronically mentally ill Medicaid beneficiaries##2##5##(1994-2#2)
chronically mentally ill Medicaid##3##4##(1994-2#3)
chronically mentally ill##7##3##(1992-1#1)(1994-2#3)(1997-2#3)
chronically obstructed coronary arteries##2##4##(1992-9#2)
chronically obstructed##3##2##(1992-9#2)(2013-1#1)
chronically stressed##3##2##(2008-11#2)(2008-7#1)
chronically treated with##4##3##(1992-5#1)(1993-2#1)(1994-8#1)(2006-10#1)
chronically treated##5##2##(1992-5#1)(1993-2#1)(1994-8#1)(2006-10#1)(2008-7#1)
chronically##93##1##(1990-10#5)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#2)(1997-1#5)(1997-2#4)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
chronicity of##3##2##(1995-11#1)(2007-11#1)(2008-11#1)
chronicity##4##1##(1995-11#1)(2007-11#1)(2008-11#1)(2008-4#1)
chronicle##2##1##(1997-2#1)(2008-12#1)
chronicled##2##1##(2008-10#1)(2008-7#1)
chronicles the##2##2##(1993-2#1)(1993-3#1)
chronicles##4##1##(1993-2#1)(1993-3#1)(2008-4#1)(2010-6#1)
chronics##2##1##(2008-12#2)
chronoamperometric##3##1##(2008-10#3)
chronoamperometry##7##1##(2008-10#7)
chronobiology##2##1##(2008-5#2)
chronocoulometry##3##1##(2008-10#3)
chronologic##3##1##(2007-10#1)(2011-1#1)(2011-2#1)
chronological age##6##2##(1995-5#1)(2008-7#1)(2010-10#2)(2010-4#1)(2012-12#1)
chronological##13##1##(1995-5#1)(1997-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
chronology of the##2##3##(1996-11#1)(2008-10#1)
chronology of##4##2##(1993-12#1)(1996-11#1)(2008-10#2)
chronology##7##1##(1993-12#1)(1996-11#1)(2008-10#5)
chronopharmacology##2##1##(2008-5#2)
chronopotentiometric##8##1##(2008-10#8)
chronopotentiometry##5##1##(2008-10#5)
chronotropic effect##2##2##(1992-6#1)(2008-1#1)
chronotropic##5##1##(1992-6#1)(2008-1#1)(2008-5#1)(2013-1#2)
chrysantha##2##1##(2009-8#2)
chrysanthemi##8##1##(1991-9#6)(2008-10#2)
chrysanthemum##8##1##(2008-10#5)(2008-6#3)
chrysemydis##2##1##(2008-9#2)
chrysene##8##1##(1994-5#1)(2008-10#7)
chrysoscelis##3##1##(2009-5#1)(2009-9#2)
chrysoscelis)##2##1##(2009-9#2)
chrysosporium##17##1##(1990-12#2)(1991-11#2)(1993-3#1)(1994-11#2)(2008-11#2)(2008-6#3)(2008-7#2)(2009-9#3)
chrysotile and amosite##2##3##(1991-12#2)
chrysotile and##3##2##(1991-12#3)
chrysotile fibers were##2##3##(1991-12#2)
chrysotile fibers##3##2##(1991-12#3)
chrysotile##14##1##(1991-12#14)
chrysotile/tremolite##2##1##(1991-12#2)
chuanxiong and##2##2##(2012-3#1)(2013-8#1)
chum salmon##3##2##(1993-3#3)
chunks##2##1##(2010-4#2)
church and##3##2##(1990-8#1)(2009-11#2)
church readiness to engage in##2##5##(2012-3#2)
church##19##1##(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#1)(2008-10#4)(2009-11#2)(2010-10#1)(2010-2#3)(2012-3#2)
church's healing mission##2##3##(1991-3#1)(1997-3#1)
church-academic##2##1##(2012-3#2)
churches and##2##2##(1990-8#1)(2008-11#1)
churches in##2##2##(2008-10#1)(2012-3#1)
churches##12##1##(1990-8#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2012-3#4)(2013-1#1)
chyle leak##2##2##(2007-8#2)
chyle##7##1##(2007-8#6)(2008-10#1)
chylomicron metabolism##2##2##(2008-10#2)
chylomicron production##2##2##(2008-10#2)
chylomicron##6##1##(1990-8#1)(1993-12#1)(2008-10#4)
chylomicrons and very low density lipoproteins##2##6##(1992-3#1)(1995-2#1)
chylomicrons##6##1##(1990-8#1)(1992-3#1)(1995-2#1)(2008-10#3)
chylothorax##3##1##(1990-9#2)(1991-11#1)
chyluria##8##1##(2008-1#4)(2008-10#2)(2008-4#2)
chymase##2##1##(1996-8#1)(2008-6#1)
chymosin##5##1##(1995-6#1)(2008-7#4)
chymotrypsin and##2##2##(1990-2#1)(1995-5#1)
chymotrypsin inhibitors 1a and 1b##2##5##(1994-6#2)
chymotrypsin##23##1##(1990-12#1)(1990-2#2)(1990-5#2)(1991-5#1)(1991-9#2)(1992-8#1)(1992-9#2)(1993-11#1)(1994-6#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
chymotrypsin-like##2##1##(1994-5#1)(2008-5#1)
chymotryptic cleavage of##2##3##(1995-5#2)
chymotryptic##6##1##(1992-4#1)(1993-8#1)(1995-5#2)(2008-5#2)
cibarial armature##4##2##(1991-9#1)(2008-5#3)
cibarial##6##1##(1991-9#1)(2008-5#5)
cicada##4##1##(2007-12#2)(2008-8#2)
cicadas##8##1##(2008-9#8)
cicatricial##5##1##(2011-1#1)(2012-1#4)
ciceris and the##2##3##(2008-10#2)
ciceris and##6##2##(2008-10#6)
ciceris in##3##2##(2008-10#3)
ciceris isolates##2##2##(2008-10#2)
ciceris on##3##2##(2008-10#3)
ciceris race 5 in##2##4##(2008-10#2)
ciceris race 5 was##2##4##(2008-10#2)
ciceris race 5##9##3##(2008-10#9)
ciceris race##11##2##(2008-10#11)
ciceris##37##1##(2008-10#37)
cichlid fishes##2##2##(1996-6#1)(2013-1#1)
cichlid lineages##3##2##(2013-1#3)
cichlid##15##1##(1996-6#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-8#5)(2013-1#4)
cichlids##3##1##(1996-6#3)
cichoracearum##3##1##(2008-10#3)
cichoric acid##2##2##(2008-10#2)
ciclesonide##3##1##(2008-8#3)
cider##3##1##(2008-10#3)
cigar##2##1##(1994-6#1)(2008-3#1)
cigarette and the control rats##2##5##(2011-1#2)
cigarette and##4##2##(1997-7#1)(2011-1#3)
cigarette samples##3##2##(2008-10#3)
cigarette smoke and##3##3##(1993-8#1)(2008-1#1)(2008-5#1)
cigarette smoke exposure##2##3##(1992-9#1)(2008-5#1)
cigarette smoke##27##2##(1991-9#2)(1992-9#2)(1993-8#4)(2008-1#1)(2008-5#11)(2008-7#1)(2011-1#5)(2013-8#1)
cigarette smokers##4##2##(1992-2#1)(2007-12#1)(2008-7#1)(2008-8#1)
cigarette smoking among##3##3##(1991-9#1)(2011-2#1)(2013-1#1)
cigarette smoking and##4##3##(1991-11#1)(1991-5#1)(2010-5#1)(2011-1#1)
cigarette smoking##38##2##(1991-11#1)(1991-12#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-4#1)(1992-6#1)(1992-9#1)(1996-3#1)(2007-12#3)(2008-10#3)(2008-12#3)(2008-2#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
cigarette use among peers and##2##5##(2013-1#2)
cigarette use among##3##3##(2013-1#3)
cigarette use##8##2##(1996-1#1)(2009-7#3)(2013-1#4)
cigarette##97##1##(1990-2#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-9#5)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-8#4)(1996-1#1)(1996-11#1)(1996-3#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#6)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#12)(2008-7#4)(2008-8#1)(2009-5#1)(2009-7#5)(2010-12#1)(2010-5#1)(2011-1#13)(2011-2#2)(2012-3#2)(2013-1#8)(2013-8#5)
cigarettes a day##2##3##(2007-12#1)(2009-5#1)
cigarettes and##5##2##(1991-9#2)(2008-9#1)(2011-1#1)(2012-12#1)
cigarettes daily##3##2##(1991-11#1)(2013-1#2)
cigarettes per day)##3##3##(1994-6#3)
cigarettes per##5##2##(1991-11#1)(1994-6#4)
cigarettes smoked daily##2##3##(2013-1#2)
cigarettes smoked##3##2##(2013-1#3)
cigarettes##37##1##(1991-11#2)(1991-12#1)(1991-9#2)(1993-11#1)(1993-2#1)(1994-6#4)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-6#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#4)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#2)
cigarettes/day##3##1##(1997-4#3)
ciguatera poisoning##2##2##(2008-1#2)
ciguatera##6##1##(2008-1#3)(2008-5#3)
cilia##8##1##(1996-9#1)(2008-3#1)(2008-9#1)(2010-9#1)(2013-1#4)
ciliary body##5##2##(1990-11#1)(1997-2#1)(1997-3#2)(2011-2#1)
ciliary epithelium##3##2##(1992-8#1)(2012-12#2)
ciliary neurotrophic factor (CNTF)##3##4##(1990-5#1)(1996-2#1)(1996-5#1)
ciliary neurotrophic factor##5##3##(1990-5#1)(1991-6#1)(1996-2#2)(1996-5#1)
ciliary processes##4##2##(1992-8#1)(2008-4#3)
ciliary reversal##2##2##(2008-3#2)
ciliary##35##1##(1990-11#1)(1990-5#4)(1991-6#1)(1992-8#4)(1995-11#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#2)
ciliata##4##1##(2008-10#3)(2012-7#1)
ciliate##3##1##(1994-12#1)(2010-4#1)(2012-3#1)
ciliated cells##2##2##(1996-1#1)(2011-2#1)
ciliated protozoan##2##2##(1994-12#1)(2007-12#1)
ciliated##10##1##(1994-12#1)(1996-1#1)(2007-12#1)(2008-11#2)(2008-6#2)(2011-2#2)(2012-1#1)
ciliates##4##1##(2008-4#4)
cilicica##2##1##(2008-11#2)
cilium##9##1##(2008-7#2)(2013-1#7)
cimetidine##14##1##(1991-5#2)(1994-2#1)(1995-12#2)(2008-11#9)
cimetropium bromide##2##2##(1990-12#2)
cinacalcet##5##1##(2009-5#1)(2012-12#4)
cinchona-alkaloid##3##1##(2008-10#3)
cinchona-alkaloids##2##1##(2008-10#2)
cinchonidine##2##1##(2007-11#1)(2008-10#1)
cine and phase contrast##2##4##(2013-3#2)
cine and##3##2##(2007-12#1)(2013-3#2)
cine computed tomographic##3##3##(2013-1#3)
cine##10##1##(1997-8#1)(2007-12#1)(2010-8#1)(2013-1#5)(2013-3#2)
cinerea and U##3##3##(2008-10#3)
cinerea and the##3##3##(2008-10#3)
cinerea and##15##2##(1991-5#1)(2008-10#13)(2008-5#1)
cinerea as##2##2##(2008-10#2)
cinerea by##5##2##(2008-10#5)
cinerea collected from##2##3##(2008-10#2)
cinerea colonies##2##2##(2008-10#2)
cinerea colonized##2##2##(2008-10#2)
cinerea conidia##6##2##(2008-10#6)
cinerea development##2##2##(2008-10#2)
cinerea during pathogen sporulation##2##4##(2008-10#2)
cinerea in##9##2##(2008-10#9)
cinerea infection##4##2##(2008-10#4)
cinerea inoculation##3##2##(2008-10#3)
cinerea is a##2##3##(2008-10#2)
cinerea is##3##2##(2008-10#3)
cinerea isolates##2##2##(2008-10#2)
cinerea on geranium##2##3##(2008-10#2)
cinerea on kiwifruit##2##3##(2008-10#2)
cinerea on##14##2##(2008-10#14)
cinerea or##2##2##(2008-10#2)
cinerea showed##2##2##(2008-10#2)
cinerea was tested##2##3##(2008-10#2)
cinerea was##12##2##(2008-10#12)
cinerea were subcultured##2##3##(2008-10#2)
cinerea were##5##2##(2008-10#5)
cinerea##195##1##(1991-5#1)(2008-10#189)(2008-5#1)(2008-8#2)(2009-6#1)(2011-10#1)
cinerea)##4##1##(1997-2#1)(2008-10#3)
cinereus##5##1##(2010-7#1)(2010-8#4)
cingulata capable of causing both GLS and bitter rot##2##9##(2008-10#2)
cingulata from the United States##2##5##(2008-10#2)
cingulata were##2##2##(2008-10#2)
cingulata##17##1##(2008-10#14)(2008-5#2)(2008-6#1)
cingulate cortex##17##2##(1993-12#4)(1994-3#1)(1995-12#2)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-6#2)(2009-10#1)(2013-8#1)
cingulate gyrus##3##2##(1996-5#1)(2012-1#1)(2012-12#1)
cingulate lesioned##2##2##(1994-3#2)
cingulate##34##1##(1991-5#1)(1993-12#5)(1994-3#4)(1995-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-11#5)(2008-6#6)(2009-10#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
cingulotomy##2##1##(2008-1#1)(2009-9#1)
cinnabar and##2##2##(2008-5#2)
cinnabar##8##1##(2008-10#6)(2008-5#2)
cinnamaldehyde##2##1##(2007-11#1)(2013-1#1)
cinnamate##5##1##(2008-5#3)(2011-1#2)
cinnamic acid derived cross-linker##2##4##(2010-4#2)
cinnamic acid##7##2##(2008-10#3)(2008-11#1)(2010-4#2)(2013-1#1)
cinnamic aldehyde##2##2##(2008-5#2)
cinnamic##11##1##(2008-10#4)(2008-11#1)(2008-5#3)(2010-4#2)(2013-1#1)
cinnamomi in##3##2##(2008-10#3)
cinnamomi##22##1##(2008-10#22)
cinnamon teal##3##2##(2013-1#3)
cinnamon##6##1##(2008-5#2)(2010-11#1)(2013-1#3)
cinnamyl alcohol dehydrogenase##2##3##(2008-10#2)
cinnamyl##4##1##(1993-6#2)(2008-10#2)
ciprofibrate##6##1##(1990-12#3)(1990-5#2)(1997-5#1)
ciprofloxacin 0##2##2##(2012-3#2)
ciprofloxacin and##6##2##(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
ciprofloxacin hydrochloride and##2##3##(2008-10#2)
ciprofloxacin hydrochloride##3##2##(2008-10#3)
ciprofloxacin in##8##2##(2007-8#1)(2008-10#5)(2011-2#2)
ciprofloxacin with##2##2##(2007-7#1)(2013-1#1)
ciprofloxacin##57##1##(1991-4#3)(1991-5#1)(1997-6#1)(2007-12#2)(2007-6#1)(2007-7#7)(2007-8#1)(2008-10#20)(2008-7#5)(2010-12#1)(2010-8#2)(2011-2#7)(2012-3#4)(2013-1#1)(2013-8#1)
circa##4##1##(1992-1#1)(2007-5#1)(2008-10#2)
circadian and##2##2##(2009-7#1)(2011-1#1)
circadian changes##2##2##(1991-2#1)(2008-5#1)
circadian clock and##4##3##(1995-2#1)(2009-8#3)
circadian clock##8##2##(1995-2#3)(2009-8#5)
circadian clock-##2##2##(1995-2#2)
circadian oscillator##4##2##(1990-5#1)(1993-12#2)(1994-5#1)
circadian pacemaker##6##2##(1994-2#3)(1996-2#1)(2008-5#2)
circadian pattern##3##2##(1992-8#1)(2008-3#1)(2013-7#1)
circadian phase##2##2##(2008-5#2)
circadian rhythm and the##2##4##(1997-6#1)(2008-5#1)
circadian rhythm and##3##3##(1997-6#1)(2008-5#2)
circadian rhythm in DD##2##4##(2008-5#2)
circadian rhythm in##5##3##(1994-2#1)(1997-2#1)(2008-5#3)
circadian rhythm of##3##3##(1991-12#1)(1992-2#1)(2008-12#1)
circadian rhythm##21##2##(1991-12#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-6#3)(2008-11#2)(2008-12#1)(2008-5#6)(2011-2#1)
circadian rhythms and##2##3##(1996-2#1)(2013-1#1)
circadian rhythms of##2##3##(1993-12#1)(1995-12#1)
circadian rhythms##9##2##(1990-5#1)(1993-12#1)(1995-12#1)(1996-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
circadian variation##3##2##(1992-11#1)(1997-2#1)(2008-11#1)
circadian variations##2##2##(1993-12#1)(2008-8#1)
circadian##91##1##(1990-5#3)(1991-12#1)(1991-2#1)(1992-10#3)(1992-11#2)(1992-2#1)(1992-8#1)(1993-12#6)(1993-6#1)(1994-2#4)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#6)(1996-2#2)(1997-2#2)(1997-6#3)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#16)(2008-6#1)(2008-7#2)(2008-8#3)(2009-7#3)(2009-8#7)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#3)
circannual##2##1##(2008-11#2)
circasemiseptan##3##1##(2008-11#3)
circaseptan##6##1##(2008-11#6)
circinatum##2##1##(2008-10#2)
circle in##2##2##(2007-11#1)(2008-3#1)
circle of##5##2##(1993-12#1)(1995-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
circle##31##1##(1990-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#10)(2008-7#1)(2008-8#4)(2010-3#1)(2011-2#2)
circle)) of##3##2##(2008-10#3)
circles##14##1##(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2011-1#1)(2013-8#1)
circling##11##1##(1993-3#8)(1995-12#2)(2011-1#1)
circovirus##4##1##(2008-5#3)(2013-1#1)
circovirus-2##7##1##(2012-3#7)
circuit and the##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
circuit and##11##2##(2007-8#1)(2008-10#3)(2008-11#3)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
circuit for##8##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)
circuit in##5##2##(2007-12#1)(2008-11#4)
circuit is##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)
circuit librarianship##4##2##(1995-1#2)(1995-3#2)
circuit of the##2##3##(2008-3#1)(2008-4#1)
circuit of##7##2##(1996-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2011-1#1)(2012-3#1)
circuit or##2##2##(2008-10#1)(2011-2#1)
circuit support arm##2##3##(2011-2#2)
circuit that##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
circuit to##3##2##(1995-12#1)(1997-4#1)(2009-5#1)
circuit using##2##2##(2010-11#1)(2012-2#1)
circuit was##2##2##(1992-1#1)(2011-1#1)
circuit##156##1##(1992-1#4)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#2)(1996-5#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#5)(2008-10#23)(2008-11#23)(2008-2#5)(2008-3#22)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#6)(2011-2#5)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#3)
circuitry and the##2##3##(2008-11#1)(2009-8#1)
circuitry and##3##2##(2008-11#1)(2009-8#1)(2010-2#1)
circuitry is##2##2##(2008-11#1)(2008-7#1)
circuitry of##2##2##(2008-4#2)
circuitry that##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
circuitry underlying##4##2##(2008-11#4)
circuitry##47##1##(1992-6#1)(1994-3#1)(1994-8#2)(1996-5#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-2#2)(2008-4#3)(2008-7#4)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#7)
circuits and the##3##3##(1995-3#1)(2008-2#1)(2009-5#1)
circuits and##14##2##(1995-3#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-9#2)(2009-5#1)(2009-9#2)(2010-9#2)(2013-8#1)
circuits are##2##2##(1990-5#1)(2008-11#1)
circuits can be##2##3##(1997-6#1)(2009-5#1)
circuits for##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
circuits in the##3##3##(1990-5#1)(2008-7#1)(2013-8#1)
circuits in##5##2##(1990-5#1)(1994-8#1)(2007-11#1)(2008-7#1)(2013-8#1)
circuits is##2##2##(2008-11#1)(2013-8#1)
circuits of##5##2##(1994-8#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)
circuits that##11##2##(1994-8#1)(1996-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-5#2)(2009-9#1)(2013-8#1)
circuits##109##1##(1990-5#3)(1992-1#2)(1993-12#1)(1994-8#5)(1995-3#1)(1996-5#2)(1997-6#2)(2007-11#6)(2007-12#2)(2007-8#2)(2008-1#2)(2008-11#12)(2008-2#15)(2008-3#14)(2008-7#6)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#7)(2009-6#2)(2009-9#4)(2010-8#1)(2010-9#2)(2011-2#1)(2012-2#4)(2013-8#7)
circulans GRS 243 and##2##4##(2008-10#2)
circular DNA##4##2##(1990-5#1)(1995-2#1)(1995-3#1)(2008-10#1)
circular Gaussian##2##2##(2008-2#1)(2008-6#1)
circular TEM(00)##2##2##(2007-12#1)(2008-3#1)
circular and linear##2##3##(1990-5#1)(2008-10#1)
circular and##6##2##(1990-5#1)(2008-10#3)(2008-3#1)(2009-8#1)
circular aperture##10##2##(2007-11#2)(2008-2#5)(2008-3#3)
circular apertures##2##2##(2008-3#2)
circular birefringence##3##2##(2007-11#1)(2008-2#2)
circular cross-sectional##2##2##(2008-2#2)
circular cylinder##3##2##(2008-2#2)(2008-3#1)
circular cylinders is##2##3##(2008-2#1)(2008-3#1)
circular cylinders##4##2##(2008-2#3)(2008-3#1)
circular dichroic##2##2##(1992-8#1)(2009-2#1)
circular dichroism (CD) spectrum of##2##5##(1990-5#1)(1992-6#1)
circular dichroism (CD) spectrum##3##4##(1990-5#1)(1992-6#1)(2008-10#1)
circular dichroism (CD)##12##3##(1990-5#2)(1990-8#1)(1992-6#2)(1994-11#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-7#1)
circular dichroism and fluorescence##2##4##(1990-5#1)(1993-11#1)
circular dichroism and##9##3##(1990-5#2)(1991-12#1)(1993-11#2)(1994-5#1)(2006-4#1)(2008-10#1)(2009-10#1)
circular dichroism in##3##3##(1992-8#1)(1993-8#1)(2006-4#1)
circular dichroism measurements##2##3##(1992-5#1)(1995-2#1)
circular dichroism shows that##3##4##(1992-8#2)(1994-8#1)
circular dichroism spectra##4##3##(1992-1#1)(1992-5#1)(2006-4#1)(2008-9#1)
circular dichroism spectroscopy##3##3##(1990-7#1)(1992-3#1)(1995-5#1)
circular dichroism study##2##3##(1990-8#1)(2008-10#1)
circular dichroism##65##2##(1990-5#4)(1990-7#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#4)(1992-6#4)(1992-8#4)(1993-11#6)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-5#5)(1997-2#1)(2006-4#4)(2008-10#9)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2013-1#1)
circular in##2##2##(2007-12#1)(2008-11#1)
circular lesions##2##2##(2008-10#1)(2008-12#1)
circular motion##3##2##(2008-6#3)
circular muscle##6##2##(1996-5#2)(1997-3#1)(1997-4#3)
circular objects##2##2##(2012-1#2)
circular or helical SPECT##3##4##(2009-8#3)
circular or##7##2##(2008-10#2)(2008-3#2)(2009-8#3)
circular plasmid DNA##3##3##(1990-11#1)(2008-1#1)(2008-2#1)
circular plasmids##2##2##(2011-2#2)
circular polariscope##3##2##(2008-2#1)(2008-3#2)
circular polarization##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
circular resonator##2##2##(2007-12#1)(2008-3#1)
circular single-stranded##2##2##(1995-2#1)(2008-10#1)
circular waveguides##2##2##(2007-12#2)
circular##237##1##(1990-11#3)(1990-5#6)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#4)(1992-6#5)(1992-8#5)(1993-11#6)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#2)(1995-2#5)(1995-3#1)(1995-5#5)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#3)(2006-4#4)(2007-11#5)(2007-12#13)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#29)(2008-3#48)(2008-4#2)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#2)(2009-8#5)(2010-2#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#2)
circular-harmonic##3##1##(2008-2#1)(2008-3#2)
circular-polarization-maintaining optical fiber##2##3##(2008-2#2)
circularization##6##1##(1994-5#1)(1997-6#1)(2008-3#2)(2008-4#2)
circularized##2##1##(1994-12#1)(2008-4#1)
circularly polarized incident light##2##4##(2008-2#1)(2008-3#1)
circularly polarized light##6##3##(2007-12#1)(2008-3#4)(2010-12#1)
circularly polarized pump waves##2##4##(2007-11#2)
circularly polarized##17##2##(2006-4#1)(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#6)(2010-12#1)
circularly##19##1##(2006-4#1)(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#6)(2010-12#1)
circulate##6##1##(1991-5#1)(1997-2#1)(2008-1#1)(2008-8#1)(2013-8#2)
circulated in##2##2##(2011-1#1)(2013-8#1)
circulated##5##1##(2008-10#2)(2010-2#1)(2011-1#1)(2013-8#1)
circulating AFP mRNA in##2##4##(2008-10#2)
circulating AFP mRNA##6##3##(2008-10#6)
circulating IGFBP-4##2##2##(2011-1#2)
circulating O-DMA##2##2##(2012-2#2)
circulating and##2##2##(2008-7#1)(2013-1#1)
circulating antibody##2##2##(2006-6#1)(2012-2#1)
circulating autoantibodies##2##2##(2007-5#1)(2012-3#1)
circulating blood##3##2##(2008-5#1)(2008-7#2)
circulating cells##4##2##(2008-11#1)(2009-2#2)(2010-8#1)
circulating concentration##2##2##(1994-8#1)(1995-11#1)
circulating concentrations of##2##3##(2008-1#1)(2010-11#1)
circulating factors##3##2##(1992-3#1)(2010-6#2)
circulating hormone##4##2##(1991-5#1)(1992-5#1)(1992-6#1)(2008-1#1)
circulating immune complexes##4##3##(1990-12#2)(1997-8#2)
circulating immune##6##2##(1990-12#2)(1997-8#2)(2009-7#1)(2011-1#1)
circulating in the##4##3##(2008-3#1)(2008-7#2)(2012-3#1)
circulating in##8##2##(2008-3#2)(2008-4#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
circulating leukocytes##4##2##(1997-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
circulating levels of##4##3##(1990-12#1)(1990-2#1)(1991-12#1)(2010-8#1)
circulating levels##6##2##(1990-12#1)(1990-2#2)(1991-12#1)(1992-9#1)(2010-8#1)
circulating lipid and glucose levels##2##5##(2008-10#2)
circulating lymphocytes##3##2##(1995-5#1)(2008-9#1)(2011-2#1)
circulating melatonin##2##2##(1994-5#1)(1994-6#1)
circulating peptides##2##2##(2008-4#2)
circulating platelets in##2##3##(1993-6#1)(2008-9#1)
circulating platelets##5##2##(1993-6#1)(2006-6#1)(2008-4#1)(2008-9#2)
circulating powers##2##2##(2008-2#2)
circulating strains##2##2##(2008-7#1)(2011-2#1)
circulating testosterone##2##2##(2008-8#1)(2008-9#1)
circulating through##2##2##(2007-12#1)(2008-6#1)
circulating virus##2##2##(2012-12#2)
circulating##166##1##(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#3)(1997-4#1)(1997-7#1)(1997-8#3)(2006-6#3)(2007-12#5)(2007-2#1)(2007-5#1)(2008-1#5)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#6)(2009-11#1)(2009-2#4)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
circulation and the##2##3##(2007-10#1)(2009-5#1)
circulation and##19##2##(1994-8#2)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-6#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
circulation are##4##2##(2006-10#1)(2008-5#1)(2009-10#1)(2010-8#1)
circulation can##3##2##(1996-1#1)(1997-1#1)(2013-8#1)
circulation during##3##2##(1991-8#1)(1993-11#1)(2010-8#1)
circulation for##2##2##(2010-8#1)(2013-8#1)
circulation from##2##2##(1992-8#1)(2008-7#1)
circulation in##11##2##(1990-6#1)(1991-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#2)(2007-8#1)(2010-3#1)(2010-8#1)(2012-12#1)
circulation is##5##2##(1992-11#1)(1992-3#1)(1994-11#1)(2010-8#2)
circulation may##3##2##(1990-8#1)(2010-8#1)(2013-8#1)
circulation of the virus##3##4##(2007-10#2)(2008-10#1)
circulation of the##8##3##(1992-7#1)(2007-10#3)(2008-10#2)(2008-3#1)(2009-10#1)
circulation of##22##2##(1992-3#1)(1992-7#1)(1993-3#1)(1994-6#1)(2007-10#3)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2012-12#2)
circulation through##3##2##(2008-7#1)(2009-10#2)
circulation were##2##2##(2008-10#2)
circulation with##2##2##(1996-3#1)(2007-8#1)
circulation##176##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#2)(1992-11#1)(1992-3#3)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-3#1)(1996-1#4)(1996-11#1)(1996-3#2)(1997-1#6)(1997-2#2)(1997-3#1)(1997-7#2)(2006-10#3)(2006-6#1)(2007-10#7)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#9)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#10)(2011-1#2)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#2)(2013-8#8)
circulation)##3##1##(1990-9#1)(2011-1#2)
circulations##4##1##(1992-7#1)(1996-3#1)(2006-10#1)(2007-10#1)
circulative transmission##2##2##(2008-10#2)
circulative##3##1##(2008-10#3)
circulator##2##1##(2007-12#1)(2008-3#1)
circulatory arrest##8##2##(2007-8#2)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#3)
circulatory disorders##2##2##(1990-9#1)(2011-2#1)
circulatory failure##3##2##(1992-5#1)(1996-3#1)(2008-5#1)
circulatory pattern##2##2##(1996-3#2)
circulatory phases##2##2##(2008-7#2)
circulatory status##2##2##(1993-12#1)(2006-10#1)
circulatory support##12##2##(2008-11#1)(2009-10#1)(2010-6#3)(2010-8#1)(2011-2#5)(2012-3#1)
circulatory system in##3##3##(2007-12#2)(2008-7#1)
circulatory system##11##2##(1991-2#1)(1996-6#1)(2007-12#3)(2008-7#2)(2009-9#1)(2010-7#2)(2013-8#1)
circulatory systems##2##2##(2007-12#1)(2008-10#1)
circulatory##62##1##(1990-9#2)(1991-2#2)(1992-5#1)(1993-12#1)(1995-2#1)(1995-9#1)(1996-3#3)(1996-6#2)(1996-9#1)(2006-10#1)(2007-12#5)(2007-5#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-9#1)(2010-6#4)(2010-7#2)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
circumcincta##2##1##(1996-12#2)
circumcision can##2##2##(1991-8#1)(2011-1#1)
circumcision##13##1##(1991-8#3)(1997-4#1)(1997-5#1)(2008-10#3)(2011-1#5)
circumference and##6##2##(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
circumference in##2##2##(2008-7#1)(2011-2#1)
circumference measurements##2##2##(1995-6#1)(2008-5#1)
circumference of the thigh##3##4##(2007-11#3)
circumference of the##7##3##(1991-11#1)(2007-11#3)(2007-8#2)(2013-1#1)
circumference ratio##2##2##(1990-9#1)(2008-12#1)
circumference urethroplasty is required##2##4##(2009-5#2)
circumference were##2##2##(2011-1#1)(2013-1#1)
circumference##74##1##(1990-9#1)(1991-11#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-4#1)(2007-11#3)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#8)(2008-9#1)(2009-11#1)(2009-5#2)(2010-4#1)(2010-8#2)(2011-1#8)(2011-2#7)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#1)
circumferences of##2##2##(2007-8#1)(2012-3#1)
circumferential fusion##5##2##(2008-11#4)(2009-3#1)
circumferential upper extremity##2##3##(2011-2#2)
circumferential wall##2##2##(1997-8#1)(2009-7#1)
circumferential##29##1##(1997-8#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-7#3)(2008-8#4)(2009-3#1)(2009-7#3)(2010-10#1)(2010-6#1)(2011-2#7)(2013-1#1)
circumferentially##2##1##(2008-8#1)(2009-7#1)
circumflex artery##5##2##(2007-8#1)(2008-8#1)(2013-1#2)(2013-7#1)
circumflex coronary artery##2##3##(2007-8#1)(2008-12#1)
circumflex humeral artery##2##3##(2008-7#2)
circumflex territory##2##2##(2007-8#1)(2013-1#1)
circumflex##12##1##(2007-8#4)(2008-12#1)(2008-7#2)(2008-8#1)(2013-1#3)(2013-7#1)
circumnutation##9##1##(2009-6#9)
circumnutations##3##1##(2009-6#3)
circumpherency##2##1##(2011-1#2)
circumpolar indigenous##4##2##(2013-1#4)
circumscribed##13##1##(1990-11#1)(1990-2#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#2)
circumsporozoite protein##3##2##(1990-12#1)(1991-5#1)(2008-3#1)
circumsporozoite##4##1##(1990-12#1)(1991-5#2)(2008-3#1)
circumstance of##2##2##(2007-11#1)(2011-2#1)
circumstance##8##1##(1994-8#1)(2007-11#2)(2008-6#2)(2010-4#1)(2011-2#2)
circumstances (e##2##2##(2010-11#1)(2011-2#1)
circumstances and##8##2##(1991-3#1)(1992-6#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
circumstances are##2##2##(2008-10#1)(2010-10#1)
circumstances as##2##2##(1992-2#1)(1996-9#1)
circumstances for##2##2##(2007-11#1)(2009-9#1)
circumstances in which##5##3##(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)
circumstances in##6##2##(1996-5#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)
circumstances is##2##2##(1990-9#1)(2010-5#1)
circumstances it##2##2##(1997-3#1)(2011-2#1)
circumstances of the##2##3##(2008-12#1)(2011-2#1)
circumstances of##9##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
circumstances that##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
circumstances the##3##2##(1990-8#1)(1993-12#1)(2008-5#1)
circumstances under which##5##3##(1992-3#1)(1994-3#1)(1997-2#1)(2008-11#1)(2008-12#1)
circumstances where##6##2##(1991-12#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
circumstances##134##1##(1990-2#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-12#4)(1993-3#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-2#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
circumstantial constraints##2##2##(2008-12#2)
circumstantial evidence##6##2##(1991-2#1)(1997-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
circumstantial##11##1##(1991-2#1)(1992-3#1)(1994-12#1)(1997-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2012-12#1)
circumvent the difficulty##3##3##(2008-10#2)(2012-3#1)
circumvent the##10##2##(1995-2#1)(2008-10#3)(2010-1#1)(2010-3#2)(2012-2#1)(2012-3#2)
circumvent these problems##4##3##(1997-8#1)(2007-11#1)(2008-4#1)(2011-2#1)
circumvent these##7##2##(1994-11#1)(1994-12#1)(1997-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
circumvent this limitation##2##3##(2008-9#1)(2012-2#1)
circumvent this##5##2##(2007-12#1)(2008-10#2)(2008-9#1)(2012-2#1)
circumvent##30##1##(1992-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)
circumvented by##2##2##(2008-10#2)
circumvented##5##1##(1991-9#1)(2008-10#3)(2008-3#1)
circumventing the##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
circumventing##7##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
circumvents the##4##2##(1992-6#1)(2007-12#1)(2008-10#1)(2010-5#1)
circumvents##6##1##(1991-3#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
cirrhosis (Child's class##2##3##(2009-8#2)
cirrhosis and death##2##3##(2009-12#1)(2013-1#1)
cirrhosis and hepatocellular carcinoma##2##4##(2009-8#1)(2013-8#1)
cirrhosis and portal hypertension##7##4##(1991-5#1)(2006-10#2)(2009-8#2)(2010-10#1)(2013-1#1)
cirrhosis and##24##2##(1990-3#1)(1991-5#1)(1992-2#1)(1993-2#1)(1997-7#2)(2006-10#2)(2007-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
cirrhosis in patients with chronic##2##5##(2010-8#2)
cirrhosis in##3##2##(2010-8#3)
cirrhosis is##4##2##(1997-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
cirrhosis of the##2##3##(1991-5#1)(1997-7#1)
cirrhosis of##3##2##(1991-5#1)(1997-7#1)(2012-3#1)
cirrhosis was##2##2##(1993-2#1)(2013-8#1)
cirrhosis were##2##2##(1994-7#1)(2013-8#1)
cirrhosis with##6##2##(1995-3#1)(2007-12#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
cirrhosis##121##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#3)(1991-5#4)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#3)(1993-5#1)(1993-9#2)(1994-2#1)(1994-7#4)(1995-3#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-7#6)(2006-10#8)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#3)(2009-8#10)(2010-10#1)(2010-12#2)(2010-8#4)(2011-2#6)(2012-2#1)(2012-3#6)(2013-1#16)(2013-8#9)
cirrhosis-associated HCC##2##2##(2011-2#2)
cirrhosis]##3##1##(1991-11#1)(1991-5#1)(2009-1#1)
cirrhotic liver##4##2##(2008-1#2)(2010-12#2)
cirrhotic patient with ascites##2##4##(2011-2#2)
cirrhotic patient##5##2##(2011-2#3)(2013-8#2)
cirrhotic patients was##2##3##(1994-7#1)(2013-1#1)
cirrhotic patients with##3##3##(2007-12#1)(2009-8#1)(2010-6#1)
cirrhotic patients##13##2##(1992-6#1)(1993-3#1)(1994-7#2)(2007-12#1)(2009-8#2)(2010-6#1)(2013-1#5)
cirrhotic##24##1##(1992-5#1)(1992-6#1)(1993-3#1)(1994-7#2)(2007-12#1)(2008-1#2)(2009-8#3)(2010-12#2)(2010-6#1)(2011-2#3)(2013-1#5)(2013-8#2)
cirrhotics and##2##2##(1991-11#1)(2012-3#1)
cirrhotics##13##1##(1991-11#1)(1991-4#1)(2009-8#2)(2012-3#9)
cirri and##2##2##(2008-10#1)(2008-5#1)
cirri##4##1##(2008-10#3)(2008-5#1)
cirrus cloud##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
cirrus clouds and the##2##4##(2008-3#2)
cirrus clouds are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
cirrus clouds##16##2##(2007-12#1)(2008-2#4)(2008-3#11)
cirrus particle##3##2##(2008-3#3)
cirrus##37##1##(2007-11#1)(2007-12#1)(2008-2#12)(2008-3#23)
cis and trans isomers##3##4##(1990-9#1)(2010-2#2)
cis element of##2##3##(2008-9#1)(2009-8#1)
cis elements##3##2##(1993-3#1)(2008-10#1)(2009-8#1)
cis isomer##6##2##(1996-5#1)(2007-12#1)(2010-2#4)
cis isomers of##5##3##(1990-9#1)(1992-9#1)(2007-11#1)(2010-2#2)
cis isomers##6##2##(1990-9#1)(1992-9#1)(1995-6#1)(2007-11#1)(2010-2#2)
cis peptide bond##2##3##(2008-9#2)
cis regulatory##5##2##(1995-2#3)(2008-10#1)(2008-9#1)
cis##44##1##(1990-9#4)(1991-11#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-2#4)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-9#4)(2009-8#2)(2010-2#10)(2013-1#1)
cis)##4##1##(1990-2#4)
cis- and trans-acting elements in##2##5##(1996-5#2)
cis- and trans-acting##4##3##(1992-8#1)(1996-5#2)(2008-10#1)
cis- and##10##2##(1992-8#1)(1996-5#3)(2007-11#1)(2008-10#2)(2009-8#1)(2012-2#1)(2012-3#1)
cis-##12##1##(1992-8#1)(1993-6#1)(1995-2#1)(1996-5#3)(2007-11#1)(2008-10#2)(2009-8#1)(2012-2#1)(2012-3#1)
cis-1##2##1##(1995-11#1)(2012-12#1)
cis-2##2##1##(1991-9#1)(1996-5#1)
cis-DCE transformation##2##2##(2012-12#2)
cis-Golgi##2##1##(2008-1#1)(2009-7#1)
cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O##2##3##(2013-1#2)
cis-[Pt(1-apt)(2)Cl(2)]·H(2)O##4##1##(2013-1#4)
cis-[Pt(2-abt)(2)Cl(2)]·H(2)O##4##1##(2013-1#4)
cis-aconitic##3##1##(1997-7#2)(2010-6#1)
cis-acting DNA##2##2##(1993-3#1)(1993-8#1)
cis-acting element in##2##3##(1993-6#1)(1995-6#1)
cis-acting element##6##2##(1993-6#1)(1995-6#2)(2008-8#2)(2012-2#1)
cis-acting elements for##2##3##(1993-8#1)(2012-3#1)
cis-acting elements were##2##3##(1991-6#1)(1993-12#1)
cis-acting elements##10##2##(1990-8#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
cis-acting repressive sequence##3##3##(1994-8#3)
cis-acting sequences##2##2##(1992-6#1)(2009-3#1)
cis-acting##34##1##(1990-5#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-12#1)(1994-8#3)(1995-6#3)(1997-4#3)(2008-10#2)(2008-7#2)(2008-8#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
cis-diamminedichloroplatinum(II)##3##1##(1993-9#2)(2008-11#1)
cis-element##4##1##(1996-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
cis-elements##4##1##(1993-12#2)(2008-9#2)
cis-flupenthixol##6##1##(1993-6#6)
cis-fused##2##1##(2008-6#1)(2009-8#1)
cis-isomer##4##1##(1994-8#1)(2008-10#1)(2010-2#2)
cis-platin and##3##2##(1994-5#1)(2008-10#2)
cis-platin##7##1##(1994-5#3)(2008-10#4)
cis-regulatory elements##6##2##(2008-7#2)(2009-10#2)(2010-1#1)(2012-3#1)
cis-regulatory##10##1##(1994-11#1)(1995-2#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-1#1)(2012-3#2)
cis-trans##2##1##(2008-3#1)(2011-2#1)
cis/trans isomerization##2##2##(1991-5#1)(1992-6#1)
cis/trans##3##1##(1991-5#2)(1992-6#1)
cisapride and BRL 24924##3##4##(1990-5#3)
cisapride and##4##2##(1990-5#4)
cisapride##9##1##(1990-5#6)(1994-2#2)(2010-8#1)
cisatracurium and mivacurium##2##3##(2008-10#2)
cisatracurium##7##1##(2008-10#7)
cisplatin (CDDP)##3##2##(1993-9#1)(2007-10#1)(2013-1#1)
cisplatin (DDP)##2##2##(1992-2#1)(1992-5#1)
cisplatin (EAP)##2##2##(1992-10#2)
cisplatin and etoposide##4##3##(1992-10#1)(1993-9#1)(1994-12#1)(2013-1#1)
cisplatin and radiotherapy##2##3##(1991-2#1)(1993-9#1)
cisplatin and##16##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-10#1)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-3#1)(2013-1#1)
cisplatin at##2##2##(2012-2#2)
cisplatin chemotherapy##2##2##(1990-12#1)(2012-3#1)
cisplatin dose##2##2##(1991-2#1)(2008-6#1)
cisplatin for##3##2##(1994-3#1)(1995-10#1)(2008-6#1)
cisplatin in##8##2##(1991-6#1)(1991-8#1)(1993-8#2)(2007-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
cisplatin infusion##2##2##(1990-12#2)
cisplatin nephrotoxicity##2##2##(1990-12#2)
cisplatin or oxaliplatin##2##3##(2008-4#1)(2009-4#1)
cisplatin or##3##2##(1990-6#1)(2008-4#1)(2009-4#1)
cisplatin ototoxicity in##2##3##(2008-2#2)
cisplatin resistance in##2##3##(2008-4#1)(2012-2#1)
cisplatin were##2##2##(1993-8#1)(2012-2#1)
cisplatin##121##1##(1990-10#2)(1990-12#10)(1990-2#2)(1990-6#2)(1991-2#2)(1991-6#2)(1991-8#2)(1991-9#5)(1992-10#3)(1992-12#2)(1992-2#2)(1992-5#2)(1993-1#1)(1993-2#3)(1993-5#1)(1993-8#5)(1993-9#3)(1994-12#1)(1994-3#2)(1995-10#2)(1995-12#1)(2007-10#4)(2007-4#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-4#4)(2008-6#10)(2008-7#1)(2008-9#2)(2009-4#1)(2010-11#3)(2010-12#1)(2010-3#9)(2012-2#5)(2012-3#1)(2013-1#9)
cisplatin)##2##1##(2008-11#1)(2010-3#1)
cisplatin-induced apoptosis##2##2##(1993-2#2)
cisplatin-induced emesis##2##2##(1990-12#1)(2008-5#1)
cisplatin-induced##8##1##(1990-12#2)(1990-6#1)(1993-2#2)(2008-5#1)(2012-2#1)(2013-1#1)
cisplatin-resistant##3##1##(2008-11#1)(2008-4#1)(2013-1#1)
cisplatinum and##2##2##(1990-12#1)(2010-3#1)
cisplatinum##6##1##(1990-12#1)(1991-2#2)(1995-9#1)(2009-8#1)(2010-3#1)
cistern##10##1##(1993-1#3)(1996-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#2)
cisterna chyli##2##2##(2012-3#2)
cisterna##4##1##(2008-7#1)(2012-3#2)(2013-1#1)
cisternae of##2##2##(1993-12#1)(2008-7#1)
cisternae##7##1##(1993-12#1)(2008-7#6)
cisternography##3##1##(2008-12#1)(2011-2#2)
cisterns##4##1##(2008-7#4)
cistron##6##1##(1993-12#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
cistrons##3##1##(1990-5#1)(1993-12#1)(2008-10#1)
cit##2##1##(1992-9#1)(1996-6#1)
citA##4##1##(1997-4#4)
citalopram and venlafaxine##2##3##(2012-2#2)
citalopram##12##1##(1991-3#1)(1997-5#1)(2008-7#1)(2009-7#1)(2012-2#3)(2012-3#5)
citation##12##1##(1995-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-12#3)(2013-1#4)
citations##14##1##(1994-3#1)(1996-2#1)(1996-3#1)(2008-2#1)(2010-12#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)
cite##11##1##(1996-3#1)(2011-2#10)
cited as the most##2##4##(1996-2#1)(2008-11#1)
cited as the##3##3##(1996-2#1)(2008-11#1)(2008-12#1)
cited as##13##2##(1994-1#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2013-1#3)
cited by##2##2##(1991-1#1)(2010-4#1)
cited in the##2##3##(1994-1#1)(2008-5#1)
cited in##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#2)
cited ions in##2##3##(2008-10#2)
cited to##2##2##(2007-4#1)(2010-12#1)
cited##47##1##(1990-8#1)(1991-1#2)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#2)(1995-12#2)(1996-2#1)(2007-10#1)(2007-4#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#4)
cites the##2##2##(1991-3#1)(1993-2#1)
cites##5##1##(1990-8#1)(1991-3#1)(1993-2#1)(1994-3#1)(2009-5#1)
cities and states##2##3##(1990-11#2)
cities and##6##2##(1990-11#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
cities in##8##2##(1990-11#2)(1991-6#1)(2008-10#3)(2008-3#2)
cities of Colombia##2##3##(2012-12#2)
cities of##11##2##(1996-12#1)(2008-10#2)(2008-9#1)(2012-12#4)(2012-2#1)(2013-8#2)
cities##65##1##(1990-11#5)(1990-6#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-5#2)(1992-6#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-4#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#7)(2012-2#1)(2013-1#5)(2013-8#3)
cities]##2##1##(1995-12#1)(2013-1#1)
citing a##2##2##(1992-11#1)(1995-12#1)
citing##8##1##(1992-11#1)(1995-12#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)
citizen participation in health care policy reform##2##7##(1997-2#2)
citizen participation in##4##3##(1992-2#1)(1996-2#1)(1997-2#2)
citizen participation##5##2##(1992-2#1)(1993-3#1)(1996-2#1)(1997-2#2)
citizen##8##1##(1992-2#2)(1993-3#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#1)
citizens in##4##2##(1995-3#1)(2009-4#1)(2009-5#1)(2012-3#1)
citizens of##7##2##(1990-6#1)(1992-5#1)(1994-3#1)(1996-9#1)(2008-12#1)(2009-10#1)(2009-3#1)
citizens##27##1##(1990-6#1)(1992-12#1)(1992-5#3)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2011-2#1)(2012-3#1)
citizens'##4##1##(1993-6#3)(2008-12#1)
citizenship##2##1##(2008-7#1)(2009-5#1)
citrate (SC)##3##2##(2008-10#2)(2011-2#1)
citrate and l-lactate##2##3##(2008-10#2)
citrate and##9##2##(1997-4#1)(2008-10#5)(2010-3#2)(2010-4#1)
citrate as##2##2##(2010-3#1)(2011-2#1)
citrate at##2##2##(2012-2#2)
citrate buffer solution##2##3##(2008-10#2)
citrate buffer##4##2##(2008-10#4)
citrate concentration##2##2##(1990-3#1)(2008-10#1)
citrate for##3##2##(1992-11#2)(2007-7#1)
citrate ions##2##2##(1992-9#2)
citrate lyase##2##2##(1996-6#1)(2013-1#1)
citrate synthase (CS)##2##3##(1995-5#1)(2013-1#1)
citrate synthase gene##3##3##(1995-12#1)(1997-4#1)(1997-8#1)
citrate synthase of##2##3##(1997-4#2)
citrate synthase##14##2##(1995-12#1)(1995-5#1)(1997-4#4)(1997-8#3)(2008-10#1)(2008-7#1)(2009-11#2)(2013-1#1)
citrate was##2##2##(1993-10#1)(2011-2#1)
citrate##105##1##(1990-12#1)(1990-3#1)(1990-9#1)(1992-11#4)(1992-9#6)(1993-10#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-2#2)(1997-4#5)(1997-7#2)(1997-8#3)(2007-7#2)(2008-10#35)(2008-12#1)(2008-5#1)(2008-7#4)(2009-11#2)(2010-3#12)(2010-4#3)(2011-2#8)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#4)
citratus##2##1##(2008-12#2)
citrella##3##1##(2008-6#3)
citri adults##3##2##(2011-2#3)
citri and##4##2##(2008-10#3)(2011-2#1)
citri by##2##2##(2008-10#2)
citri causes##2##2##(2008-10#2)
citri in##8##2##(2008-10#5)(2011-2#3)
citri infection##2##2##(2008-10#2)
citri on##2##2##(2008-10#2)
citri population sizes##2##3##(2008-10#2)
citri population##3##2##(2008-10#3)
citri populations##2##2##(2008-10#1)(2011-2#1)
citri proteins##3##2##(2008-10#3)
citri to##3##2##(2008-10#3)
citri##84##1##(2008-10#70)(2011-2#14)
citri-infected shoots##3##2##(2008-10#3)
citri-infected##7##1##(2008-10#7)
citric acid and##2##3##(2008-10#1)(2012-2#1)
citric acid content##3##3##(2008-5#3)
citric acid in##2##3##(2010-3#1)(2013-1#1)
citric acid production##6##3##(2008-10#1)(2008-7#5)
citric acid was##4##3##(2008-10#4)
citric acid##49##2##(1993-12#1)(2008-10#28)(2008-4#1)(2008-5#3)(2008-7#5)(2010-3#2)(2012-2#3)(2013-1#6)
citric and gluconic##2##3##(2008-10#2)
citric and##3##2##(1997-4#1)(2008-10#2)
citric##60##1##(1993-12#1)(1994-9#1)(1997-4#1)(2008-10#36)(2008-4#1)(2008-5#4)(2008-7#5)(2010-3#2)(2012-2#3)(2013-1#6)
citricarpa##5##1##(2008-10#5)
citricida##9##1##(2008-10#9)
citricola##2##1##(2008-10#1)(2010-3#1)
citrinin##8##1##(1993-12#8)
citronellyl acetate##2##2##(2008-6#2)
citrophthora in California##2##3##(2008-10#2)
citrulli was detected##2##3##(2008-10#2)
citrulli was##3##2##(2008-10#3)
citrulli##16##1##(2008-10#16)
citrullinated peptide##3##2##(2012-2#1)(2013-1#2)
citrullinated##7##1##(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
citrulline and##2##2##(1996-2#1)(2008-10#1)
citrulline levels (p &lt##3##4##(2006-10#3)
citrulline levels were significantly higher##2##5##(2008-7#2)
citrulline levels were##4##3##(2006-10#1)(2008-7#3)
citrulline levels##14##2##(2006-10#8)(2008-7#6)
citrulline##22##1##(1996-2#2)(2006-10#11)(2008-10#1)(2008-7#7)(2009-4#1)
citrumelo##9##1##(2008-10#9)
citrus (Citrus spp##2##3##(2011-2#2)
citrus and coffee##2##3##(2008-10#2)
citrus and noncitrus hosts##2##4##(2008-10#2)
citrus and noncitrus##3##3##(2008-10#2)(2011-2#1)
citrus and##10##2##(2008-10#9)(2011-2#1)
citrus are##2##2##(2008-10#2)
citrus bacterial canker##2##3##(2008-10#2)
citrus bacterial##3##2##(2008-10#3)
citrus black rot##3##3##(2008-10#3)
citrus black##4##2##(2008-10#4)
citrus canker epidemic in Florida##2##5##(2008-10#2)
citrus canker##7##2##(2008-10#7)
citrus cultivars##2##2##(2008-10#2)
citrus fruit##12##2##(2008-10#12)
citrus fruits##9##2##(2008-10#8)(2012-12#1)
citrus groves and##3##3##(2008-10#2)(2011-2#1)
citrus groves##6##2##(2008-10#3)(2011-2#2)(2013-8#1)
citrus host##2##2##(2008-10#2)
citrus in Florida##2##3##(2008-10#2)
citrus in##4##2##(2008-10#4)
citrus isolates##2##2##(2008-10#2)
citrus leaves##4##2##(2008-10#4)
citrus orchard##3##2##(2008-10#3)
citrus orchards##3##2##(2008-10#2)(2008-6#1)
citrus roots##3##2##(2008-10#3)
citrus species and##2##3##(2008-10#2)
citrus species##4##2##(2008-10#3)(2008-5#1)
citrus strains##3##2##(2008-10#3)
citrus trees##4##2##(2008-10#4)
citrus tristeza virus (CTV)##4##4##(2008-10#3)(2008-5#1)
citrus tristeza virus##11##3##(2008-10#9)(2008-5#2)
citrus tristeza##12##2##(2008-10#10)(2008-5#2)
citrus variegated chlorosis##4##3##(2008-10#4)
citrus viroids other than CEVd##2##5##(2008-10#2)
citrus viroids##7##2##(2008-10#7)
citrus##174##1##(2007-11#1)(2008-10#145)(2008-5#8)(2008-6#3)(2011-2#12)(2012-12#1)(2013-1#1)(2013-8#3)
city and a##2##3##(1997-6#1)(2008-11#1)
city and##6##2##(1997-6#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
city center##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
city has##2##2##(1995-12#1)(1996-1#1)
city in the##2##3##(1994-1#1)(2010-9#1)
city in##5##2##(1994-1#1)(1997-4#1)(1997-8#1)(2008-12#1)(2010-9#1)
city of Florence##2##3##(1991-6#1)(2008-5#1)
city of##65##2##(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1997-1#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#4)(2009-7#4)(2011-1#3)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#8)(2013-8#1)
city were##3##2##(2008-12#1)(2009-7#1)(2013-1#1)
city##160##1##(1990-11#3)(1991-1#1)(1991-6#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-9#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-4#3)(1997-6#4)(1997-8#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#17)(2008-11#8)(2008-12#10)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#5)(2009-4#1)(2009-7#6)(2010-3#1)(2010-9#2)(2011-1#5)(2011-2#11)(2012-12#8)(2012-2#2)(2012-3#5)(2013-1#16)(2013-8#2)
city's##8##1##(1995-12#2)(1996-5#1)(1997-3#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
civil and##2##2##(2011-2#1)(2012-3#1)
civil disorders and wars##2##4##(2007-7#2)
civil money penalties##2##3##(1991-12#2)
civil penalty##2##2##(1996-5#2)
civil registration and vital statistics systems##3##6##(2012-12#3)
civil registration and vital statistics##4##5##(2012-12#4)
civil registration and##5##3##(2012-12#5)
civil registration systems##2##3##(2012-12#2)
civil registration##10##2##(2008-11#1)(2011-2#1)(2012-12#8)
civil rights##2##2##(1996-1#1)(2008-11#1)
civil society##3##2##(2009-5#2)(2013-1#1)
civil war##3##2##(1994-9#1)(1997-6#1)(2007-7#1)
civil##39##1##(1990-3#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-1#1)(1994-3#2)(1994-9#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-6#1)(2007-7#4)(2008-11#2)(2008-8#1)(2009-5#2)(2010-8#1)(2011-2#3)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#1)
civilian##8##1##(1991-11#1)(1992-3#2)(1995-6#1)(2007-8#1)(2008-9#1)(2009-7#1)(2010-1#1)
civilians##4##1##(1992-12#1)(1992-6#1)(2007-8#1)(2010-7#1)
civilization##6##1##(1991-6#1)(1995-5#2)(1997-5#1)(2008-9#1)(2012-3#1)
cladding and##5##2##(2007-11#4)(2007-12#1)
cladding layer##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#2)
cladding layers##2##2##(2007-11#2)
cladding mode##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
cladding modes in##4##3##(2007-12#1)(2008-3#3)
cladding modes##14##2##(2007-12#4)(2008-3#10)
cladding of the##2##3##(2007-11#2)
cladding of##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
cladding radius##3##2##(2008-3#3)
cladding##57##1##(2007-11#15)(2007-12#16)(2008-10#1)(2008-2#1)(2008-3#22)(2010-8#2)
cladding-pumped planar waveguide##3##3##(2007-11#3)
cladding-pumped##5##1##(2007-11#5)
clade IR-I##2##2##(2008-10#2)
clade and##6##2##(2008-10#6)
clade as##3##2##(2008-10#2)(2008-6#1)
clade in which the##2##4##(2008-10#2)
clade is##2##2##(2009-8#1)(2010-3#1)
clade of the##2##3##(2010-3#1)(2012-3#1)
clade of##8##2##(2008-10#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-6#2)(2012-3#1)
clade that##2##2##(2008-10#1)(2008-8#1)
clade was##2##2##(2008-10#2)
clade were##3##2##(2008-10#3)
clade with##2##2##(2008-10#2)
clade##74##1##(2008-10#42)(2008-5#1)(2008-6#2)(2008-8#6)(2008-9#1)(2009-5#1)(2009-8#2)(2010-3#6)(2010-4#1)(2010-6#2)(2010-8#5)(2011-2#1)(2012-3#2)(2013-8#2)
clades are##3##2##(1996-6#1)(2008-7#1)(2008-8#1)
clades based on##2##3##(2008-10#2)
clades of##4##2##(2008-10#2)(2008-12#1)(2009-8#1)
clades that##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
clades within##2##2##(2008-10#1)(2010-6#1)
clades##55##1##(1996-6#1)(2007-12#1)(2008-10#26)(2008-12#2)(2008-7#2)(2008-8#9)(2008-9#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-4#2)(2010-6#2)(2010-8#2)(2013-8#2)
cladistic##4##1##(2007-12#2)(2010-3#2)
cladogram##2##1##(1997-5#1)(2010-3#1)
cladograms##6##1##(2008-10#2)(2010-3#4)
claim for##3##2##(1995-6#1)(2008-10#1)(2012-3#1)
claim of##5##2##(1995-12#2)(1995-6#1)(1997-5#1)(2008-5#1)
claim that the##5##3##(1990-11#1)(1992-2#1)(1992-9#1)(2008-2#1)(2008-8#1)
claim that##19##2##(1990-11#1)(1992-2#1)(1992-9#1)(1993-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-2#1)(2013-8#2)
claim to have##2##3##(1995-11#1)(2008-12#1)
claim to##5##2##(1995-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)
claim##59##1##(1990-11#1)(1991-12#2)(1991-9#1)(1992-2#1)(1992-9#2)(1993-1#1)(1993-3#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-6#3)(1995-8#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#2)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-8#2)
claimed as##2##2##(1991-11#1)(1997-4#1)
claimed he##3##2##(1995-12#1)(1995-6#1)(1997-5#1)
claimed in##2##2##(1992-10#1)(2008-5#1)
claimed that the##2##3##(2008-10#1)(2010-3#1)
claimed that their##2##3##(1995-2#1)(1996-2#1)
claimed that they##2##3##(1995-11#1)(2010-5#1)
claimed that##13##2##(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-8#1)
claimed to be##3##3##(1990-5#1)(1991-4#1)(2011-2#1)
claimed to have##3##3##(1990-6#1)(2009-7#1)(2009-9#1)
claimed to##9##2##(1990-5#1)(1990-6#1)(1991-4#1)(1994-6#1)(2008-8#1)(2009-7#1)(2009-9#2)(2011-2#1)
claimed values by the##2##4##(2008-10#2)
claimed values##3##2##(2008-10#3)
claimed##47##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-4#1)(1992-10#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1996-2#1)(1997-4#3)(1997-5#2)(2007-5#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
claiming that##2##2##(1995-2#1)(2008-4#1)
claiming##7##1##(1994-1#1)(1994-12#1)(1995-2#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
claims against##2##2##(1992-2#1)(1994-1#1)
claims and##8##2##(1993-12#2)(1995-12#1)(1996-3#1)(2009-6#1)(2012-2#1)(2013-8#2)
claims cost##2##2##(1993-1#2)
claims data to##4##3##(1993-12#1)(1995-3#1)(1996-1#2)
claims data##13##2##(1991-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)(2009-9#1)(2013-1#1)
claims for##5##2##(1992-2#1)(1993-2#1)(1996-2#1)(2008-5#1)(2009-10#1)
claims in##7##2##(1994-2#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-3#1)
claims is##2##2##(2009-5#1)(2012-2#1)
claims of##11##2##(1996-2#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-2#1)
claims processing##2##2##(1994-12#1)(1995-12#1)
claims that the##2##3##(1993-2#1)(2011-2#1)
claims that##8##2##(1990-2#1)(1992-3#1)(1993-2#1)(1996-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)
claims to##4##2##(1997-1#1)(1997-5#1)(1997-6#1)(2009-7#1)
claims##124##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#6)(1992-3#1)(1993-1#4)(1993-12#5)(1993-2#4)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#8)(1994-6#1)(1995-1#4)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#5)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#2)(1997-6#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
clam##11##1##(1990-8#1)(1992-11#3)(2008-5#4)(2008-8#1)(2009-7#1)(2011-2#1)
clamp and tie##3##3##(2011-2#3)
clamp and##7##2##(2007-5#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#3)
clamp experiments##2##2##(1995-11#1)(2009-12#1)
clamp technique##10##2##(1993-12#3)(1993-3#1)(1994-11#1)(1995-12#1)(2008-3#2)(2008-8#2)
clamp##42##1##(1990-7#3)(1991-5#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#5)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-9#3)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#4)(2008-8#4)(2009-12#2)(2010-8#1)(2011-2#4)
clamped##6##1##(1993-12#1)(1995-12#1)(2007-12#2)(2008-10#1)(2008-5#1)
clamping and##2##2##(1992-6#1)(2011-2#1)
clamping in##4##2##(1992-6#1)(1993-2#3)
clamping of the##2##3##(1996-5#1)(2008-7#1)
clamping of##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
clamping the##2##2##(1992-9#1)(2008-10#1)
clamping##22##1##(1992-6#4)(1992-9#1)(1993-2#3)(1995-12#1)(1996-5#1)(1996-9#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#1)
clamps were##2##2##(2008-3#1)(2011-3#1)
clamps##4##1##(1996-2#1)(1996-5#1)(2008-3#1)(2011-3#1)
clams and##2##2##(2008-5#2)
clams##11##1##(1994-12#1)(2008-5#9)(2008-9#1)
clan##3##1##(2008-1#2)(2012-12#1)
clandestine abortions##2##2##(1996-8#1)(2013-1#1)
clandestine tablets##3##2##(2008-10#3)
clandestine##6##1##(1990-3#1)(1996-8#1)(2008-10#3)(2013-1#1)
claratris##5##1##(2008-10#5)
clarification of##6##2##(1991-11#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-5#1)
clarification##19##1##(1990-9#1)(1991-11#1)(1991-12#2)(1994-1#2)(1994-2#1)(1995-11#1)(1995-3#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-5#1)
clarifications##3##1##(1992-1#1)(1995-3#1)(2008-2#1)
clarified and##4##2##(2007-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
clarified by##6##2##(1994-3#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)
clarified in##3##2##(2009-3#1)(2011-2#1)(2013-1#1)
clarified that the##2##3##(2008-10#1)(2012-12#1)
clarified that##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-12#1)(2013-8#1)
clarified the##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
clarified##53##1##(1990-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#2)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#9)(2008-11#6)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#2)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
clarifies and##2##2##(2008-12#1)(2008-8#1)
clarifies the##6##2##(1995-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-8#1)
clarifies##12##1##(1992-2#1)(1995-3#1)(2007-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-8#1)
clarify and##2##2##(1995-1#1)(2008-2#1)
clarify how##2##2##(2008-11#1)(2010-8#1)
clarify its##4##2##(1990-2#1)(2008-10#1)(2008-2#1)(2010-11#1)
clarify that##2##2##(2008-11#1)(2010-2#1)
clarify the current##2##3##(2008-10#1)(2013-8#1)
clarify the functional##3##3##(1992-3#1)(1994-8#1)(1994-9#1)
clarify the mechanism of##4##4##(2007-10#1)(2008-9#1)(2009-7#1)(2011-2#1)
clarify the mechanism##6##3##(1993-3#1)(2007-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
clarify the molecular##3##3##(2008-6#1)(2010-12#1)(2012-12#1)
clarify the nature of the##2##5##(2008-10#1)(2008-7#1)
clarify the nature of##3##4##(2008-10#2)(2008-7#1)
clarify the relationship between##4##4##(1991-12#1)(2008-9#1)(2009-11#1)(2012-2#1)
clarify the relationship##5##3##(1991-12#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-8#1)
clarify the role of##9##4##(1991-12#1)(1991-2#1)(1993-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
clarify the role##10##3##(1991-12#1)(1991-2#1)(1993-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#2)(2011-3#1)(2013-8#1)
clarify the roles of##2##4##(1992-6#1)(2012-3#1)
clarify the situation##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
clarify the##89##2##(1991-12#2)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#5)
clarify this issue##3##3##(2007-10#1)(2008-9#1)(2012-12#1)
clarify this##5##2##(2007-10#2)(2008-9#1)(2009-5#1)(2012-12#1)
clarify whether the##3##3##(1990-6#1)(2007-10#1)(2008-1#1)
clarify whether##12##2##(1990-6#1)(1991-3#1)(1995-3#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)
clarify which##2##2##(2009-2#1)(2011-2#1)
clarify##144##1##(1990-12#2)(1990-2#1)(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-5#1)(1997-8#1)(1997-9#1)(2007-10#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
clarifying some of the##2##4##(1993-12#1)(2010-12#1)
clarifying the##9##2##(1994-11#2)(1994-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
clarifying##12##1##(1993-12#1)(1994-11#2)(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
clarithromycin and##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
clarithromycin##13##1##(2007-11#1)(2007-12#2)(2008-10#6)(2010-12#1)(2012-12#3)
clarity about the##3##3##(2007-10#1)(2008-9#1)(2013-1#1)
clarity about##4##2##(1995-1#1)(2007-10#1)(2008-9#1)(2013-1#1)
clarity and##6##2##(1996-1#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
clarity is##2##2##(1997-1#1)(2008-12#1)
clarity of##5##2##(1990-12#2)(1997-3#1)(2008-3#1)(2009-5#1)
clarity regarding##2##2##(1994-12#1)(2006-10#1)
clarity to##2##2##(1990-8#1)(2008-11#1)
clarity##35##1##(1990-12#2)(1990-8#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-10#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-9#2)(2009-5#4)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-7#1)(2013-1#3)(2013-8#1)
clarkii clarkii##2##2##(2010-8#2)
clarkii##11##1##(2008-5#1)(2008-6#2)(2010-8#8)
clarus##2##1##(2009-9#2)
clash of##2##2##(1992-11#1)(2009-8#1)
clash##4##1##(1992-11#1)(2007-9#1)(2009-8#1)(2010-3#1)
class 1 and class##2##4##(2007-12#1)(2008-10#1)
class 1 and##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
class 1##13##2##(1990-2#2)(1995-2#1)(1997-7#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#1)
class 2##5##2##(1997-7#1)(2006-10#1)(2008-10#3)
class 3##11##2##(1995-12#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-12#1)(2009-7#1)
class A##6##2##(2008-12#2)(2008-8#1)(2011-2#1)(2013-1#2)
class Archaeoglobi##2##2##(2011-2#2)
class B##6##2##(2007-11#2)(2009-8#2)(2011-2#2)
class C##3##2##(1992-6#2)(2008-8#1)
class I MHC##4##3##(1990-5#1)(1994-5#2)(2008-4#1)
class I and II##4##4##(2011-2#1)(2012-12#3)
class I and beta 2-microglobulin gene expression in##2##8##(1995-12#2)
class I and beta 2-microglobulin gene expression##4##7##(1995-12#4)
class I and class II molecules##2##6##(1995-5#1)(2008-4#1)
class I and class II##4##5##(1995-5#1)(2008-4#2)(2008-9#1)
class I and##16##3##(1994-11#1)(1995-12#4)(1995-5#1)(2008-4#3)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#3)
class I antigens##4##3##(1992-7#1)(1994-5#2)(2008-8#1)
class I expression##4##3##(1997-9#3)(2008-4#1)
class I heavy chain##3##4##(1997-9#2)(2008-4#1)
class I heavy##5##3##(1997-9#4)(2008-4#1)
class I mGluR##2##3##(1995-12#2)
class I molecule##3##3##(2008-4#2)(2008-8#1)
class I molecules of##2##4##(1990-5#1)(2008-8#1)
class I molecules##11##3##(1990-5#2)(1995-2#1)(1995-5#1)(1997-9#1)(2008-11#1)(2008-4#1)(2008-8#4)
class I or##3##3##(2008-4#3)
class I##91##2##(1990-11#1)(1990-5#3)(1991-2#1)(1992-7#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#4)(1994-9#1)(1995-12#7)(1995-2#1)(1995-5#4)(1997-6#1)(1997-8#1)(1997-9#10)(2008-1#8)(2008-10#2)(2008-11#1)(2008-4#18)(2008-5#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#3)
class II MHC molecules##2##4##(1993-3#1)(1993-6#1)
class II MHC##8##3##(1993-3#6)(1993-6#1)(1995-11#1)
class II alleles##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
class II antigen expression##2##4##(1993-6#2)
class II antigen##4##3##(1993-6#4)
class II antigens##5##3##(1991-8#1)(1993-6#1)(1997-8#2)(2008-4#1)
class II genes##4##3##(1997-2#1)(1997-8#3)
class II histocompatibility##2##3##(1995-11#2)
class II major histocompatibility complex##2##5##(1993-6#1)(1997-4#1)
class II molecule##2##3##(1991-11#1)(1994-8#1)
class II molecules of the##2##5##(2008-4#1)(2008-8#1)
class II molecules##9##3##(1991-2#1)(1994-11#2)(1995-12#1)(1995-5#2)(2008-4#1)(2008-5#1)(2008-8#1)
class II tetramers##2##3##(2008-9#2)
class II##56##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-3#6)(1993-6#7)(1994-11#3)(1994-8#1)(1995-11#3)(1995-12#2)(1995-5#3)(1997-2#1)(1997-4#1)(1997-8#8)(1997-9#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
class II/III##2##2##(1992-3#2)
class III anti-arrhythmic agent##2##4##(2008-8#2)
class III##17##2##(1992-3#2)(1992-9#1)(1997-6#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)
class III/IV##2##2##(2008-4#1)(2011-2#1)
class IV chitinase##2##3##(2008-10#2)
class IV##4##2##(1995-8#1)(2008-10#2)(2008-5#1)
class action lawsuit##2##3##(1997-5#1)(2008-11#1)
class action lawsuits##2##3##(2008-11#2)
class action##6##2##(1997-5#2)(2008-11#4)
class agonist##2##2##(1995-11#2)
class and##7##2##(1992-8#1)(1995-8#1)(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#2)
class are##2##2##(1994-9#1)(2008-10#1)
class because of its acute toxicity##2##6##(2008-9#2)
class composed of##2##3##(2008-11#2)
class encodes##2##2##(1994-12#2)
class has##3##2##(2008-5#1)(2008-7#1)(2009-12#1)
class health care##2##3##(1994-1#2)
class identity of a##2##4##(2008-10#2)
class identity of##3##3##(2008-10#3)
class in a##3##3##(1992-8#1)(2007-10#1)(2008-11#1)
class in the##2##3##(1996-9#1)(2011-2#1)
class in##9##2##(1992-8#1)(1993-12#1)(1996-9#1)(2007-10#2)(2008-11#1)(2008-2#1)(2011-2#2)
class of agents##2##3##(2008-5#1)(2008-7#1)
class of antibacterial agents##2##4##(2008-10#1)(2010-2#1)
class of antibiotics##2##3##(1995-2#1)(2007-7#1)
class of binding sites##3##4##(1990-2#1)(1990-8#1)(1993-12#1)
class of compounds##8##3##(1993-8#2)(1996-5#1)(2008-10#4)(2008-5#1)
class of drugs##5##3##(1996-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
class of enzymes that##2##4##(1990-8#1)(2008-1#1)
class of evidenceIIIThe definiton of the different classes of evidence is available on page 55##2##15##(2012-12#2)
class of fiber##2##3##(2007-12#1)(2008-10#1)
class of high affinity binding sites##2##6##(1990-5#1)(1993-3#1)
class of high affinity##3##4##(1990-11#1)(1990-5#1)(1993-3#1)
class of hydroxyproline-containing proteins##2##4##(1992-8#2)
class of low##2##3##(1990-5#1)(1993-6#1)
class of models##3##3##(1995-5#1)(2008-7#1)(2013-8#1)
class of molecules##2##3##(2008-1#1)(2009-3#1)
class of neutral##2##3##(2008-10#2)
class of proteins##4##3##(1994-12#1)(1995-2#1)(2008-11#1)(2008-4#1)
class of recA-like##2##3##(1995-6#2)
class of small RNAs##2##4##(2009-3#2)
class of small##5##3##(1990-5#1)(2009-3#2)(2012-3#2)
class of specific##2##3##(1991-5#1)(1995-2#1)
class of synthetic##2##3##(1990-7#1)(2008-5#1)
class of tests##2##3##(2008-10#2)
class of the##3##3##(2008-1#1)(2008-12#1)(2008-3#1)
class of therapeutic agents##2##4##(2008-10#1)(2008-7#1)
class of therapeutic##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
class of therapy##2##3##(2008-3#1)(2012-3#1)
class of these##2##3##(1993-12#1)(1994-12#1)
class of##260##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#3)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#10)(2007-12#5)(2007-7#1)(2008-1#5)(2008-10#28)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#18)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#9)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
class or##3##2##(2007-2#1)(2008-11#1)(2008-3#1)
class showing##2##2##(1993-1#2)
class size##3##2##(1993-3#1)(2008-11#1)(2013-1#1)
class switch of##2##3##(1994-2#2)
class switch##5##2##(1994-2#4)(1994-8#1)
class that##2##2##(2008-3#1)(2011-1#1)
class theta##3##2##(1991-12#3)
class was##5##2##(2007-10#2)(2008-10#1)(2010-3#1)(2012-3#1)
class were##2##2##(1992-8#1)(2007-12#1)
class##716##1##(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#1)(1990-5#7)(1990-7#4)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-12#3)(1992-2#3)(1992-3#6)(1992-6#2)(1992-7#1)(1992-8#11)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#11)(1993-6#12)(1993-8#4)(1993-9#1)(1994-1#3)(1994-11#9)(1994-12#8)(1994-2#6)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#2)(1995-11#7)(1995-12#14)(1995-2#6)(1995-3#1)(1995-5#8)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#6)(1997-8#10)(1997-9#12)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#7)(2007-11#13)(2007-12#18)(2007-2#3)(2007-7#1)(2007-8#4)(2008-1#15)(2008-10#73)(2008-11#26)(2008-12#8)(2008-2#7)(2008-3#24)(2008-4#33)(2008-5#24)(2008-6#5)(2008-7#16)(2008-8#21)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#6)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#4)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#25)(2011-3#1)(2012-12#14)(2012-2#8)(2012-3#9)(2013-1#20)(2013-7#2)(2013-8#6)
class-II##3##1##(1990-11#1)(1993-9#2)
classed##2##1##(2007-8#1)(2011-2#1)
classes III and IV##2##4##(2008-1#1)(2009-10#1)
classes according to the##2##4##(1995-11#1)(2013-1#1)
classes and##9##2##(1990-3#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
classes are##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
classes as a##2##3##(2008-10#2)
classes at##2##2##(2007-6#1)(2008-10#1)
classes based on their##2##4##(2009-10#1)(2012-12#1)
classes based on##3##3##(2008-7#1)(2009-10#1)(2012-12#1)
classes by##2##2##(2008-10#1)(2008-2#1)
classes for##4##2##(1991-8#1)(2008-10#1)(2012-3#2)
classes have##2##2##(2008-11#1)(2012-2#1)
classes in the##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2010-1#1)
classes in##8##2##(1992-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-1#1)
classes of CB agonists##2##4##(2009-12#2)
classes of antibiotics##2##3##(1996-11#1)(2007-7#1)
classes of binding sites##2##4##(1993-9#1)(1994-3#1)
classes of compounds that##2##4##(2008-10#1)(2011-2#1)
classes of compounds##5##3##(2008-10#1)(2008-4#1)(2010-2#2)(2011-2#1)
classes of drugs and##2##4##(2008-10#1)(2010-6#1)
classes of drugs##5##3##(1996-3#1)(2008-10#2)(2010-6#1)(2011-2#1)
classes of ionotropic##3##3##(1995-11#2)(2008-7#1)
classes of neurons##2##3##(1996-6#1)(2008-11#1)
classes of organic##2##3##(1992-3#1)(2008-10#1)
classes of pesticides##2##3##(2008-10#2)
classes of process startup problems##2##5##(2008-11#2)
classes of the##2##3##(2008-10#1)(2008-4#1)
classes of##150##2##(1990-5#2)(1990-8#2)(1991-2#2)(1992-3#1)(1992-5#1)(1992-9#4)(1993-1#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#18)(2008-11#11)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#7)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#1)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
classes relative to##2##3##(2008-10#1)(2008-3#1)
classes showed##2##2##(2008-10#2)
classes that##2##2##(2008-8#1)(2009-12#1)
classes was##2##2##(2008-10#1)(2008-5#1)
classes were##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)
classes with##5##2##(1990-12#1)(2008-10#3)(2013-7#1)
classes within the##2##3##(2008-10#1)(2008-7#1)
classes##316##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#5)(1993-1#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#60)(2008-11#16)(2008-12#4)(2008-2#9)(2008-3#6)(2008-4#11)(2008-5#16)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#1)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#3)
classic Kaposi's sarcoma##3##3##(1990-6#2)(1992-12#1)
classic aortic dissection##2##3##(2011-2#2)
classic method##3##2##(2008-10#1)(2008-2#1)(2010-7#1)
classic model##4##2##(2008-10#2)(2009-11#1)(2010-4#1)
classic triad of##2##3##(2007-2#1)(2010-6#1)
classic##121##1##(1990-3#1)(1990-6#2)(1990-8#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#5)(2008-3#8)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#5)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
classic&quot##2##1##(1990-5#1)(2008-5#1)
classical HPLC##2##2##(2008-10#2)
classical analytical##2##2##(2008-10#1)(2010-11#1)
classical and individual-based approaches##2##4##(2008-9#2)
classical and##9##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2012-2#1)
classical conditioning in##2##3##(1996-2#1)(2008-5#1)
classical conditioning##5##2##(1993-12#1)(1994-3#1)(1996-2#2)(2008-5#1)
classical features of##2##3##(2008-10#1)(2011-2#1)
classical friction##2##2##(1996-4#2)
classical glutathione peroxidase##2##3##(1993-6#2)
classical group##2##2##(2008-5#2)
classical hypersensitive##3##2##(2008-10#3)
classical injection##2##2##(2008-10#2)
classical lacunar syndrome##3##3##(2007-10#3)
classical least squares (CLS)##6##4##(2008-10#6)
classical least squares##9##3##(2007-12#1)(2008-10#7)(2008-3#1)
classical least##10##2##(2007-12#1)(2008-10#8)(2008-3#1)
classical least-squares##3##2##(2008-10#3)
classical linear##2##2##(2008-10#1)(2008-3#1)
classical mechanics##2##2##(2008-2#1)(2012-2#1)
classical medical##2##2##(2010-7#1)(2013-8#1)
classical metapopulation##2##2##(2008-8#1)(2008-9#1)
classical methods and##2##3##(2008-10#1)(2012-2#1)
classical methods##10##2##(2007-12#1)(2008-10#5)(2009-9#1)(2010-11#1)(2012-2#2)
classical model##3##2##(2008-9#1)(2009-5#1)(2013-8#1)
classical music##4##2##(2007-6#2)(2008-5#2)
classical mutant strains##2##3##(2012-3#2)
classical or##3##2##(2010-5#1)(2012-2#1)(2012-3#1)
classical pathway##3##2##(1994-11#2)(2008-4#1)
classical problem of##2##3##(2008-3#1)(2009-8#1)
classical receptive field##3##3##(1995-11#2)(2012-2#1)
classical resistance##2##2##(2009-6#1)(2012-3#1)
classical risk factors##2##3##(2012-2#1)(2012-3#1)
classical swine##2##2##(2007-6#1)(2011-2#1)
classical techniques##3##2##(2007-12#1)(2008-12#1)(2011-2#1)
classical test##2##2##(2009-10#1)(2011-2#1)
classical theories of##2##3##(2008-7#1)(2008-8#1)
classical treatment##2##2##(1996-6#1)(2007-11#1)
classical##339##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#6)(1991-3#2)(1991-6#1)(1991-8#1)(1993-12#2)(1993-6#2)(1993-8#3)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#7)(2007-12#9)(2007-2#1)(2007-4#1)(2007-6#4)(2008-1#5)(2008-10#73)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#17)(2008-4#4)(2008-5#18)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#14)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#4)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#17)(2012-3#12)(2013-1#7)(2013-8#3)
classical&quot##5##1##(1990-8#2)(2008-7#1)(2008-8#1)(2011-2#1)
classically considered as##2##3##(2008-7#1)(2009-3#1)
classically thought to##2##3##(2008-8#1)(2012-3#1)
classically used to##2##3##(2008-7#1)(2011-2#1)
classically used##4##2##(1992-9#1)(2008-7#1)(2011-2#1)(2013-7#1)
classically##20##1##(1992-9#1)(1994-3#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
classification accuracy and##2##3##(2008-10#1)(2008-6#1)
classification accuracy of##4##3##(2008-10#1)(2010-8#2)(2012-12#1)
classification accuracy##12##2##(1995-6#1)(2008-10#2)(2008-6#6)(2010-8#2)(2012-12#1)
classification and the##2##3##(1990-2#1)(2013-1#1)
classification and##32##2##(1990-2#1)(1990-3#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-9#1)(1996-4#1)(2007-10#1)(2007-11#3)(2008-10#6)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
classification approach##2##2##(2008-12#1)(2009-10#1)
classification approaches##2##2##(2009-10#1)(2010-8#1)
classification are##2##2##(2008-11#1)(2009-10#1)
classification as a##2##3##(1995-2#1)(2011-1#1)
classification as well as##2##4##(2008-10#1)(2009-4#1)
classification as##7##2##(1991-3#1)(1992-12#1)(1995-2#1)(2008-10#2)(2009-4#1)(2011-1#1)
classification at the##2##3##(1994-10#1)(2013-8#1)
classification based on the##3##4##(1997-3#2)(2008-10#1)
classification based on##10##3##(1996-7#1)(1997-3#2)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)
classification by means of##2##4##(2008-10#1)(2008-3#1)
classification by##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
classification capability##2##2##(2008-10#2)
classification criteria##2##2##(1990-6#2)
classification for the##2##3##(2007-8#1)(2013-8#1)
classification for##10##2##(1991-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-7#1)(2012-12#1)(2013-8#1)
classification framework##3##2##(2008-10#3)
classification in the##7##3##(1993-12#2)(2007-10#1)(2008-10#2)(2008-8#1)(2012-12#1)
classification in##13##2##(1993-12#2)(1997-3#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2012-12#1)
classification into##3##2##(1991-3#1)(1995-6#1)(2012-3#1)
classification is based on the##2##5##(2008-3#1)(2011-3#1)
classification is based on##5##4##(2008-3#2)(2008-5#2)(2011-3#1)
classification is##11##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
classification lists##2##2##(2011-2#2)
classification methods##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
classification model##5##2##(2007-11#1)(2008-2#1)(2010-8#2)(2013-8#1)
classification of different##2##3##(2008-10#1)(2012-3#1)
classification of each##2##3##(2008-10#1)(2008-7#1)
classification of human##2##3##(2008-5#1)(2008-9#1)
classification of new##2##3##(2008-10#2)
classification of samples##2##3##(2008-10#1)(2008-7#1)
classification of spontaneous intraventricular haemorrhage##2##5##(2008-7#2)
classification of tan spot##2##4##(2008-10#2)
classification of the samples##2##4##(2008-10#2)
classification of the##21##3##(1990-3#1)(1990-6#2)(1991-9#1)(1995-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#1)(2013-1#1)
classification of these##4##3##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
classification of this##3##3##(1993-2#1)(2010-12#1)(2013-1#1)
classification of tumor##2##3##(2009-12#1)(2009-6#1)
classification of##155##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-2#2)(1994-5#1)(1995-5#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#38)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
classification on##2##2##(1993-1#1)(1997-8#1)
classification performance of##2##3##(2008-10#1)(2008-3#1)
classification probabilities##2##2##(2008-10#1)(2008-12#1)
classification rates##2##2##(2008-6#2)
classification reported##2##2##(1990-3#1)(2013-1#1)
classification results##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
classification scheme##7##2##(1996-6#1)(2007-8#3)(2008-10#2)(2011-2#1)
classification schemes##2##2##(2007-7#1)(2010-7#1)
classification strategy for##2##3##(2008-10#1)(2008-6#1)
classification strategy##6##2##(2008-10#1)(2008-6#5)
classification system and##2##3##(2008-10#1)(2011-2#1)
classification system based on##2##4##(1996-6#1)(2007-5#1)
classification system for##6##3##(1991-9#1)(1992-2#1)(1994-3#2)(2008-12#1)(2012-1#1)
classification system has##2##3##(1990-11#1)(2011-2#1)
classification system of##3##3##(2008-12#2)(2008-4#1)
classification system##36##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-12#3)(1994-3#3)(1995-2#2)(1996-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-7#1)(2010-12#2)(2011-2#6)(2012-1#1)(2012-3#1)
classification systems for##3##3##(1993-12#1)(2007-8#1)(2011-2#1)
classification systems of##2##3##(2007-11#1)(2008-2#1)
classification systems used##2##3##(2007-8#2)
classification systems were##2##3##(2007-11#1)(2011-2#1)
classification systems##25##2##(1993-12#2)(1994-2#4)(1997-1#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)
classification to##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
classification tool##2##2##(1995-2#1)(2008-10#1)
classification was based on##2##4##(2008-10#1)(2008-7#1)
classification was only##2##3##(2007-5#1)(2008-10#1)
classification was used to describe##2##5##(1997-8#1)(2007-8#1)
classification was used##4##3##(1997-8#1)(2007-7#1)(2007-8#1)(2009-3#1)
classification was##12##2##(1991-2#1)(1991-9#1)(1997-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-3#1)(2011-2#1)
classification were##3##2##(1990-6#1)(2008-10#1)(2008-7#1)
classification will##2##2##(1991-12#1)(2011-2#1)
classification with##5##2##(2008-10#1)(2008-3#1)(2008-7#2)(2013-8#1)
classification##569##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#5)(1990-6#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-6#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-1#3)(1993-11#1)(1993-12#6)(1993-2#3)(1993-5#2)(1993-9#1)(1994-10#1)(1994-12#5)(1994-2#8)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#4)(1995-5#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#6)(2006-8#1)(2007-10#2)(2007-11#19)(2007-12#3)(2007-2#3)(2007-5#4)(2007-7#4)(2007-8#19)(2008-1#4)(2008-10#107)(2008-11#6)(2008-12#13)(2008-2#6)(2008-3#12)(2008-4#6)(2008-5#21)(2008-6#21)(2008-7#28)(2008-8#5)(2008-9#6)(2009-10#6)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2010-1#1)(2010-10#3)(2010-12#10)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#12)(2010-9#2)(2011-1#4)(2011-2#36)(2011-3#2)(2012-1#1)(2012-12#7)(2012-2#12)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#18)
classification)##7##1##(1991-6#1)(1995-6#1)(2007-11#2)(2007-8#2)(2012-2#1)
classification]##4##1##(1991-9#1)(1995-6#1)(1995-8#1)(1997-8#1)
classifications and##4##2##(1991-8#1)(2007-8#1)(2008-6#1)(2012-12#1)
classifications are made##2##3##(2008-10#1)(2013-8#1)
classifications are##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
classifications of the##2##3##(2010-11#1)(2011-2#1)
classifications of##13##2##(1995-8#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#2)
classifications to##2##2##(1996-2#1)(2008-10#1)
classifications were##2##2##(2008-10#1)(2012-2#1)
classifications##46##1##(1991-8#1)(1991-9#1)(1993-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#8)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
classified according to the##18##4##(1990-6#1)(1991-8#1)(1993-12#1)(1994-9#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-2#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
classified according to##28##3##(1990-6#1)(1991-8#1)(1993-12#1)(1994-9#1)(1996-3#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
classified and##3##2##(2008-12#1)(2008-8#1)(2013-1#1)
classified as &quot##4##3##(1992-8#1)(2007-5#1)(2008-12#1)(2010-3#1)
classified as M##2##3##(2008-10#1)(2013-1#1)
classified as a new##2##4##(1990-7#1)(2008-10#1)
classified as a##10##3##(1990-5#1)(1990-7#1)(1997-2#1)(2007-8#1)(2008-10#1)(2010-10#2)(2010-8#1)(2012-3#1)(2013-1#1)
classified as an##3##3##(1993-1#1)(1994-11#1)(1995-6#1)
classified as being##4##3##(1993-8#1)(1995-6#1)(1997-2#1)(2011-2#1)
classified as controls##2##3##(2008-12#1)(2010-4#1)
classified as having##6##3##(1993-1#1)(1995-11#1)(1996-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
classified as low##2##3##(1993-3#1)(2013-8#1)
classified as overweight or obese##2##5##(2008-10#1)(2012-2#1)
classified as overweight##3##3##(1993-2#1)(2008-10#1)(2012-2#1)
classified as type##2##3##(1995-6#1)(2009-3#1)
classified as##136##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-2#2)(1993-3#1)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#3)(1997-8#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#17)(2008-11#1)(2008-12#4)(2008-5#6)(2008-6#2)(2008-7#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#11)(2013-8#3)
classified based##2##2##(2007-11#1)(2008-4#1)
classified by a##2##3##(1996-12#1)(2008-10#1)
classified by the##4##3##(2008-8#1)(2010-3#1)(2011-2#1)(2013-7#1)
classified by their##2##3##(1997-1#1)(2008-11#1)
classified by##17##2##(1995-12#1)(1996-12#1)(1997-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
classified correctly##2##2##(2008-10#2)
classified in four##3##3##(1992-6#1)(2013-7#2)
classified in the##8##3##(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-9#1)
classified in two##2##3##(2008-10#2)
classified in##20##2##(1990-2#1)(1990-9#1)(1992-6#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#1)(2008-9#2)(2009-9#1)(2011-10#1)(2013-7#2)
classified into eight##3##3##(1992-9#1)(1997-3#1)(2008-12#1)
classified into five##3##3##(1997-6#1)(2008-9#1)(2010-12#1)
classified into four categories##2##4##(2009-12#1)(2011-2#1)
classified into four##6##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
classified into one of##2##4##(1992-7#1)(2008-10#1)
classified into one##3##3##(1992-7#1)(2008-10#1)(2009-5#1)
classified into six##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
classified into the following##2##4##(2007-10#1)(2011-3#1)
classified into the##7##3##(1996-2#1)(1997-6#2)(1997-8#1)(2007-10#1)(2008-11#1)(2011-3#1)
classified into three types##2##4##(1990-8#1)(2013-8#1)
classified into three##11##3##(1990-12#1)(1990-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#2)
classified into two broad##2##4##(1994-2#1)(2008-10#1)
classified into two groups##3##4##(1996-6#1)(1997-2#1)(2013-1#1)
classified into two types##2##4##(1997-2#1)(2007-12#1)
classified into two##12##3##(1994-2#1)(1996-6#1)(1997-2#2)(2007-12#1)(2008-10#4)(2010-8#1)(2012-2#1)(2013-1#1)
classified into##79##2##(1990-12#1)(1990-8#1)(1992-7#1)(1992-9#1)(1994-2#1)(1996-10#1)(1996-2#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#4)(1997-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
classified on the basis of##2##5##(2008-10#1)(2010-3#1)
classified with##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)
classified##337##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-6#3)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#4)(1997-8#3)(2006-12#1)(2007-10#8)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#5)(2008-1#2)(2008-10#66)(2008-11#7)(2008-12#12)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#6)(2011-1#5)(2011-10#1)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#16)(2013-7#4)(2013-8#6)
classifier accuracy##2##2##(2009-9#2)
classifier is##2##2##(2008-10#1)(2010-8#1)
classifier##24##1##(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-3#1)(2010-7#2)(2010-8#2)
classifiers##9##1##(2008-11#2)(2008-2#1)(2008-3#2)(2010-8#4)
classifies##2##1##(1992-8#1)(2008-3#1)
classify each##2##2##(2008-10#1)(2008-5#1)
classify the##9##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#1)(2013-8#1)
classify##65##1##(1990-8#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#20)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#9)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
classifying the##2##2##(2010-8#2)
classifying##25##1##(1992-12#1)(1992-3#1)(1993-12#2)(1994-2#1)(1994-6#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-7#1)(2010-2#1)(2010-8#4)(2010-9#1)(2012-12#1)(2012-2#1)
classmates##5##1##(2008-9#1)(2009-7#3)(2011-2#1)
classroom and##6##2##(2008-11#1)(2008-12#4)(2009-7#1)
classroom context##2##2##(2008-12#2)
classroom environment and##2##3##(2008-12#1)(2011-2#1)
classroom environment##6##2##(2008-12#4)(2011-2#2)
classroom organization##2##2##(2008-12#2)
classroom setting##3##2##(2008-11#2)(2011-1#1)
classroom##54##1##(1996-1#1)(2008-10#1)(2008-11#11)(2008-12#33)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#3)
classroom-based##2##1##(2008-11#1)(2008-12#1)
classrooms in Study##2##3##(2008-12#2)
classrooms of##2##2##(2011-2#2)
classrooms were##3##2##(2008-12#1)(2011-2#2)
classrooms##25##1##(2008-11#1)(2008-12#13)(2008-3#1)(2009-7#1)(2010-8#1)(2011-2#8)
classwide REMS for##2##3##(2013-1#2)
classwide REMS##3##2##(2013-1#3)
classwide##4##1##(2013-1#4)
clastogenic##2##1##(2008-11#1)(2010-1#1)
clathrin and##2##2##(1993-9#1)(2012-2#1)
clathrin##4##1##(1993-9#2)(2012-2#2)
clathrin-coated vesicles##2##2##(2008-1#1)(2009-6#1)
clathrin-coated##3##1##(1995-6#1)(2008-1#1)(2009-6#1)
claudication and##2##2##(1995-2#1)(2009-3#1)
claudication##11##1##(1995-2#4)(1997-3#2)(2007-8#2)(2008-1#1)(2008-8#1)(2009-3#1)
clauses##5##1##(2007-4#2)(2008-11#2)(2011-2#1)
clavicle##9##1##(2007-8#3)(2008-3#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
clavicles##2##1##(2011-1#1)(2013-1#1)
clavicular##5##1##(1993-3#1)(2009-1#1)(2011-1#1)(2012-2#2)
clavigerum population##2##2##(2008-10#2)
clavigerum populations##3##2##(2008-10#3)
clavigerum##8##1##(2008-10#8)
clavulanic acid and##2##3##(1990-3#1)(1994-11#1)
clavulanic acid by##2##3##(2008-10#1)(2011-2#1)
clavulanic acid##10##2##(1990-3#3)(1994-11#1)(2007-7#1)(2008-10#3)(2011-2#2)
claw and##2##2##(2011-1#1)(2011-2#1)
claw of##2##2##(2011-2#2)
claw##9##1##(2010-3#1)(2011-1#3)(2011-2#5)
claws and##2##2##(1997-5#1)(2011-2#1)
claws of##2##2##(2011-2#2)
claws##8##1##(1997-5#1)(2007-12#1)(2011-1#1)(2011-2#5)
clay and##5##2##(1995-6#1)(2008-10#4)
clay content##3##2##(1993-8#1)(2008-10#2)
clay loam and##2##3##(2008-10#2)
clay loam or##2##3##(2008-10#2)
clay loam than##2##3##(2008-10#2)
clay loam##6##2##(2008-10#6)
clay mineralogy##3##2##(2008-10#3)
clay minerals##3##2##(1993-8#1)(2008-10#2)
clay samples##2##2##(2012-12#2)
clay soil##2##2##(2008-10#2)
clay##51##1##(1993-8#2)(1995-6#1)(2006-4#1)(2007-11#2)(2008-10#37)(2008-7#1)(2009-7#2)(2012-12#4)(2013-1#1)
clay-enriched sediments##2##2##(2007-5#2)
clays##5##1##(2008-10#5)
clean air##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
clean and##6##2##(1997-5#1)(2008-10#3)(2010-3#1)(2012-2#1)
clean mass spectra##2##3##(2008-10#1)(2011-2#1)
clean the##5##2##(2007-8#1)(2008-5#1)(2008-8#1)(2012-3#2)
clean up##11##2##(1991-5#1)(1996-5#1)(2008-10#8)(2009-10#1)
clean##70##1##(1991-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#29)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
clean-up and##4##2##(1996-5#1)(2008-10#3)
clean-up and/or enrichment##3##3##(2008-10#3)
clean-up followed by##2##3##(2008-10#2)
clean-up method##3##2##(2008-10#3)
clean-up of##3##2##(2008-10#2)(2008-11#1)
clean-up procedure##3##2##(2008-10#3)
clean-up procedures##6##2##(1990-8#1)(2008-10#5)
clean-up was##3##2##(2008-10#2)(2008-11#1)
clean-up##52##1##(1990-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#44)(2008-11#2)(2008-12#1)(2008-7#1)
cleaned and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
cleaned with a##2##3##(2008-10#1)(2008-4#1)
cleaned with##4##2##(2008-10#1)(2008-4#1)(2009-6#2)
cleaned##18##1##(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#4)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
cleaned-up by##2##2##(2008-10#2)
cleaner sample##2##2##(2008-10#1)(2010-11#1)
cleaner##10##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2010-11#1)(2010-3#1)
cleaning and disinfection##2##3##(1997-3#2)
cleaning and##6##2##(1997-3#2)(2007-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
cleaning methods##2##2##(1997-2#2)
cleaning of the electrode##2##4##(2008-10#2)
cleaning of the##3##3##(2008-10#3)
cleaning of##5##2##(2008-10#4)(2013-1#1)
cleaning on##2##2##(1997-2#1)(2008-3#1)
cleaning or##3##2##(2008-10#2)(2008-11#1)
cleaning procedure##2##2##(2008-10#1)(2008-2#1)
cleaning the##4##2##(2008-10#2)(2013-1#2)
cleaning##52##1##(1997-2#5)(1997-3#2)(2007-11#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#4)(2013-1#4)(2013-8#1)
cleanliness##4##1##(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
cleanly##3##1##(1992-4#1)(2008-7#1)(2010-8#1)
cleanroom environments##3##2##(2012-2#3)
cleanroom##6##1##(2012-2#6)
cleansed their face##2##3##(2010-8#2)
cleansed##4##1##(2008-1#1)(2008-10#1)(2010-8#2)
cleanser and##3##2##(2010-8#3)
cleanser##7##1##(2008-5#2)(2010-8#5)
cleansers##4##1##(2008-5#3)(2010-8#1)
cleansing agent##2##2##(2007-12#2)
cleansing agents in##2##3##(2013-1#2)
cleansing agents##7##2##(2007-12#2)(2013-1#5)
cleansing gel##2##2##(2008-5#2)
cleansing is##2##2##(2007-12#1)(2013-1#1)
cleansing of the##2##3##(2008-5#1)(2008-7#1)
cleansing product##2##2##(2008-5#2)
cleansing products##6##2##(2008-5#5)(2010-8#1)
cleansing with##3##2##(2008-5#1)(2011-2#2)
cleansing##40##1##(1991-10#1)(1991-12#1)(2007-12#9)(2008-5#17)(2008-7#1)(2010-8#1)(2011-2#4)(2013-1#6)
cleanup and preconcentration##2##3##(2008-10#2)
cleanup and##4##2##(2008-10#4)
cleanup of##5##2##(2008-10#3)(2008-2#2)
cleanup using##2##2##(2008-10#2)
cleanup with##3##2##(2008-10#2)(2011-1#1)
cleanup##24##1##(2007-12#1)(2008-10#19)(2008-11#1)(2008-2#2)(2011-1#1)
cleanup/preconcentration##2##1##(2008-10#2)
clear HCV##2##2##(2012-2#2)
clear advantages##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
clear and convincing evidence##2##4##(1990-11#1)(1992-12#1)
clear and##15##2##(1990-11#1)(1990-5#1)(1992-12#2)(1993-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-6#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)
clear artery##2##2##(2011-1#2)
clear at##2##2##(2008-1#1)(2008-4#1)
clear cell##5##2##(2008-1#1)(2008-6#1)(2011-2#1)(2013-1#2)
clear clinical benefits##2##3##(2008-10#1)(2011-2#1)
clear clinical##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
clear contrast to##2##3##(1996-12#1)(2008-7#1)
clear correlation between the##2##4##(2008-3#1)(2008-5#1)
clear correlation##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
clear cytoplasm##2##2##(1991-8#1)(2009-8#1)
clear dependence##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
clear dependency of##2##3##(2008-5#1)(2008-8#1)
clear diagnosis##2##2##(2011-1#2)
clear difference in##3##3##(1990-8#1)(1991-8#1)(2013-1#1)
clear difference##5##2##(1990-8#2)(1991-8#1)(2008-10#1)(2013-1#1)
clear differences##2##2##(2007-12#1)(2008-7#1)
clear distinction between##2##3##(1990-12#1)(2008-10#1)
clear distinction##3##2##(1990-12#1)(1995-11#1)(2008-10#1)
clear dose-response##3##2##(1990-6#1)(1994-5#1)(1996-2#1)
clear effect##4##2##(1991-9#1)(1997-7#1)(2008-10#1)(2008-6#1)
clear evidence for##3##3##(1997-5#1)(2010-4#1)(2013-1#1)
clear evidence of a##2##4##(1990-6#1)(2007-12#1)
clear evidence of##5##3##(1990-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
clear evidence that##4##3##(1993-3#1)(1996-3#1)(2008-8#1)(2013-1#1)
clear evidence##14##2##(1990-6#1)(1993-3#1)(1996-3#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#3)
clear expectations##3##2##(1995-12#1)(2012-1#1)(2013-1#1)
clear explanation for the##2##4##(1994-8#1)(2012-12#1)
clear explanation##4##2##(1994-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
clear for##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
clear from##6##2##(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-1#1)
clear functional##2##2##(2007-12#1)(2009-8#1)
clear holographic images##2##3##(2008-3#2)
clear if##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
clear images##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
clear in##2##2##(1993-11#1)(2008-10#1)
clear indication of##3##3##(1992-3#1)(2008-9#1)(2012-2#1)
clear indication##5##2##(1992-3#1)(1992-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
clear is that##2##3##(2008-7#1)(2008-9#1)
clear is##5##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
clear layer##3##2##(2008-3#2)(2008-5#1)
clear margin and##2##3##(2008-7#1)(2013-1#1)
clear margins after##2##3##(2008-6#2)
clear margins##3##2##(2008-6#2)(2008-9#1)
clear now##2##2##(2008-5#1)(2008-7#1)
clear pattern of##2##3##(2008-10#2)
clear pattern##3##2##(2008-10#2)(2008-5#1)
clear physical##3##2##(2007-12#1)(2008-6#1)(2012-5#1)
clear relationship between##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
clear relationship to the##3##4##(1993-11#1)(2008-7#2)
clear relationship##7##2##(1993-11#1)(2008-10#1)(2008-5#2)(2008-7#2)(2011-2#1)
clear seasonal##2##2##(1991-8#1)(2010-8#1)
clear selection of##2##3##(1993-12#1)(2007-10#1)
clear separation##2##2##(1990-12#1)(2008-11#1)
clear sky##2##2##(2007-12#1)(2008-3#1)
clear spaces##2##2##(2008-7#2)
clear support for the##2##4##(2008-1#1)(2013-8#1)
clear that both##2##3##(1995-5#1)(2008-7#1)
clear that even##2##3##(2008-2#1)(2011-2#1)
clear that the##16##3##(1990-3#1)(1990-7#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
clear that there are##3##4##(1996-3#1)(2010-11#1)(2010-12#1)
clear that these##3##3##(2007-11#1)(2008-11#1)(2012-3#1)
clear that##69##2##(1990-11#1)(1990-3#1)(1990-7#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#2)
clear the##5##2##(1995-6#1)(1997-3#1)(2008-10#1)(2010-3#1)(2013-1#1)
clear understanding of the##4##4##(1996-7#1)(1997-1#1)(2010-3#1)(2011-2#1)
clear understanding of##8##3##(1996-7#1)(1997-1#1)(1997-2#1)(2008-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
clear visualization of##2##3##(2008-2#1)(2011-2#1)
clear waters##2##2##(2008-10#1)(2008-3#1)
clear with##2##2##(2010-10#1)(2011-2#1)
clear##513##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#7)(1991-9#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-5#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#56)(2008-11#28)(2008-12#8)(2008-2#10)(2008-3#28)(2008-4#7)(2008-5#19)(2008-6#7)(2008-7#28)(2008-8#12)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#7)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#25)(2012-1#4)(2012-12#5)(2012-2#11)(2012-3#4)(2012-5#1)(2013-1#19)(2013-7#3)(2013-8#12)
clear&quot##2##1##(2011-1#2)
clear-cell renal##3##2##(1992-6#1)(1995-10#1)(2008-10#1)
clear-cell##4##1##(1992-6#1)(1993-9#1)(1995-10#1)(2008-10#1)
clear-cut##16##1##(1991-2#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
clear-sky##4##1##(2008-2#3)(2008-3#1)
clearability##3##1##(1997-1#3)
clearance after##2##2##(2010-8#1)(2013-8#1)
clearance and the##2##3##(1992-3#1)(2007-12#1)
clearance and##12##2##(1992-3#2)(1993-2#1)(1994-8#2)(1996-12#1)(2007-12#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-3#1)(2013-1#1)
clearance by##3##2##(1996-2#1)(1997-1#1)(2007-2#1)
clearance from the airways was##2##5##(1997-1#2)
clearance from the##4##3##(1993-8#1)(1997-1#2)(2008-5#1)
clearance from##5##2##(1992-10#1)(1993-8#1)(1997-1#2)(2008-5#1)
clearance in the##2##3##(1996-2#1)(2011-2#1)
clearance in##14##2##(1991-12#1)(1991-8#2)(1995-2#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-7#1)(2008-8#1)(2010-5#2)(2011-2#1)(2012-2#1)
clearance is##4##2##(1992-3#1)(1997-1#1)(1997-2#1)(2007-11#1)
clearance mechanisms##2##2##(1990-6#1)(2013-1#1)
clearance of bilirubin##2##3##(2008-5#2)
clearance of hepatitis C virus (HCV)##2##6##(2012-12#1)(2012-2#1)
clearance of hepatitis C virus##3##5##(2012-12#1)(2012-2#2)
clearance of hepatitis##4##3##(1997-5#1)(2012-12#1)(2012-2#2)
clearance of the##2##3##(2013-1#1)(2013-8#1)
clearance of##37##2##(1991-1#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-1#2)(1997-5#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#1)
clearance rates of##2##3##(2008-5#1)(2011-1#1)
clearance rates##6##2##(1990-11#1)(2008-5#4)(2011-1#1)
clearance was achieved##3##3##(1991-3#1)(2007-7#1)(2007-8#1)
clearance was##12##2##(1991-3#1)(1991-8#3)(1993-6#1)(1996-12#1)(1997-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)
clearance##155##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#8)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#3)(1995-12#2)(1995-2#2)(1996-1#5)(1996-12#2)(1996-2#7)(1997-1#7)(1997-2#1)(1997-4#2)(1997-5#1)(2007-11#4)(2007-12#4)(2007-2#4)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#5)(2009-12#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#7)(2011-3#4)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#4)(2013-8#5)
clearances of##2##2##(2008-1#1)(2011-2#1)
clearances##6##1##(2007-12#1)(2008-1#2)(2011-2#3)
clearcut##2##1##(1992-12#1)(2013-8#1)
cleared HCV##2##2##(2012-2#2)
cleared and##2##2##(2011-1#1)(2013-7#1)
cleared from the##3##3##(1991-12#1)(1991-8#1)(2010-3#1)
cleared from##5##2##(1991-12#1)(1991-8#1)(1994-5#1)(2009-3#1)(2010-3#1)
cleared##25##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-8#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-8#2)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
clearer##20##1##(1991-1#1)(1992-6#1)(1992-9#1)(1996-3#2)(1996-6#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-11#1)(2012-1#1)(2012-12#4)
clearest##4##1##(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
clearing the##2##2##(1995-12#1)(2007-7#1)
clearing##12##1##(1995-12#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)
clearinghouse##3##1##(1992-8#1)(1994-1#2)
clearinghouses and##2##2##(1996-3#2)
clearinghouses##3##1##(1996-3#3)
clearly a##2##2##(2008-9#1)(2012-12#1)
clearly affected##2##2##(1991-2#1)(2011-10#1)
clearly and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
clearly articulated##2##2##(2008-12#2)
clearly associated with##2##3##(2008-10#2)
clearly be##4##2##(1993-11#1)(2008-10#1)(2008-9#1)(2012-3#1)
clearly decreased##2##2##(2008-7#2)
clearly define##2##2##(2008-7#1)(2011-1#1)
clearly defined &quot##2##3##(1994-3#1)(2009-8#1)
clearly defined in the##2##4##(1995-12#1)(2008-5#1)
clearly defined##17##2##(1994-3#1)(1995-12#2)(1997-4#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#3)
clearly delineated##4##2##(2007-10#1)(2008-2#1)(2008-6#1)(2012-1#1)
clearly demonstrate that##8##3##(1994-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2011-3#1)
clearly demonstrate the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
clearly demonstrate##15##2##(1991-2#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-3#1)(2012-2#1)
clearly demonstrated by##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
clearly demonstrated in##2##3##(1992-9#1)(2011-2#1)
clearly demonstrated that##5##3##(2008-10#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
clearly demonstrated the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
clearly demonstrated##17##2##(1992-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#3)(2013-1#2)
clearly demonstrates the##4##3##(2007-12#1)(2008-10#2)(2009-6#1)
clearly demonstrates##5##2##(2007-12#1)(2008-10#3)(2009-6#1)
clearly demonstrating that##2##3##(2008-10#1)(2008-11#1)
clearly dependent on##2##3##(1990-5#1)(2008-10#1)
clearly different from that of the##2##6##(1993-3#1)(2008-10#1)
clearly different from##3##3##(1993-3#1)(2008-10#2)
clearly different##7##2##(1993-3#1)(2008-1#1)(2008-10#4)(2008-5#1)
clearly differentiated##5##2##(2008-10#3)(2008-5#1)(2010-8#1)
clearly discriminate##2##2##(1992-9#1)(2008-10#1)
clearly distinct from##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
clearly distinct##4##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
clearly distinguishable##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
clearly distinguished from##3##3##(1991-2#1)(2008-10#1)(2008-6#1)
clearly distinguished the##2##3##(1990-7#1)(2008-10#1)
clearly distinguished##8##2##(1990-7#1)(1991-2#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-6#1)
clearly divided##2##2##(1992-11#1)(2008-10#1)
clearly documented##4##2##(2008-11#1)(2008-6#2)(2010-11#1)
clearly enhanced##2##2##(1995-12#1)(2008-10#1)
clearly established##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
clearly evident##4##2##(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
clearly explained##2##2##(2007-11#1)(2008-10#1)
clearly expressed in##2##3##(1991-9#1)(2008-3#1)
clearly have##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
clearly higher##2##2##(1996-11#1)(2008-7#1)
clearly highlight##2##2##(2008-1#1)(2009-12#1)
clearly how##3##2##(1996-3#1)(2008-3#2)
clearly identifiable##2##2##(1995-1#1)(2010-6#1)
clearly identified by##2##3##(1995-5#1)(2008-10#1)
clearly identified##10##2##(1990-7#1)(1990-8#1)(1991-6#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
clearly identify the##2##3##(2008-9#1)(2010-11#1)
clearly identify##4##2##(2008-10#2)(2008-9#1)(2010-11#1)
clearly implicated##2##2##(2008-4#1)(2010-6#1)
clearly improved##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
clearly indicate that##6##3##(1997-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2013-1#1)
clearly indicate the##2##3##(2008-10#1)(2008-11#1)
clearly indicate##10##2##(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
clearly indicated that##4##3##(1991-5#1)(2008-10#2)(2012-2#1)
clearly indicated##7##2##(1991-5#1)(1996-9#1)(2008-10#2)(2008-7#1)(2010-11#1)(2012-2#1)
clearly indicates the##2##3##(2008-11#1)(2008-6#1)
clearly indicates##4##2##(1994-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
clearly into##2##2##(1995-12#1)(2008-10#1)
clearly linked##2##2##(2008-5#1)(2010-3#1)
clearly lower##2##2##(2008-10#1)(2012-3#1)
clearly marked##2##2##(2008-10#1)(2008-5#1)
clearly needed##3##2##(2010-10#1)(2011-1#1)(2012-12#1)
clearly not##3##2##(1996-12#1)(2008-10#2)
clearly observe##2##2##(2007-11#1)(2012-2#1)
clearly observed when the##2##4##(2008-11#1)(2008-2#1)
clearly observed##8##2##(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)
clearly preferred##2##2##(1992-12#1)(2008-10#1)
clearly reacted with##2##3##(1991-9#1)(1995-12#1)
clearly reduced##3##2##(1992-3#1)(2008-10#1)(2008-2#1)
clearly reduces##2##2##(2007-8#1)(2008-1#1)
clearly related to##3##3##(1991-12#1)(1997-7#1)(2007-6#1)
clearly resolved##2##2##(2007-12#1)(2008-10#1)
clearly revealed the##3##3##(2006-4#1)(2008-10#1)(2008-11#1)
clearly revealed##6##2##(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)
clearly satisfies the typical requirements for control processes##2##8##(2008-10#2)
clearly seen##4##2##(2007-12#1)(2008-3#1)(2009-11#1)(2012-2#1)
clearly separated from##2##3##(1996-5#1)(2008-5#1)
clearly separated the##2##3##(2008-5#1)(2013-1#1)
clearly separated##5##2##(1996-5#1)(2008-10#1)(2008-5#2)(2013-1#1)
clearly show that the##3##4##(1990-5#1)(1996-2#1)(2008-11#1)
clearly show that##10##3##(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
clearly show the##3##3##(2008-2#1)(2008-6#1)(2009-7#1)
clearly show##15##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2012-3#1)
clearly showed a##2##3##(1992-9#1)(2008-10#1)
clearly showed that the##5##4##(2008-10#3)(2008-5#1)(2008-7#1)
clearly showed that##9##3##(1993-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
clearly showed the##3##3##(1995-2#1)(2008-10#2)
clearly showed##17##2##(1992-9#1)(1993-11#1)(1995-2#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
clearly showing the##2##3##(2007-11#1)(2009-5#1)
clearly showing##4##2##(2007-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
clearly shown that##4##3##(1990-6#1)(1995-12#1)(2007-7#1)(2013-1#1)
clearly shown##7##2##(1990-6#1)(1995-12#1)(2007-7#1)(2008-3#1)(2008-9#1)(2009-6#1)(2013-1#1)
clearly shows that##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
clearly shows the##2##3##(1996-1#1)(2008-3#1)
clearly shows##8##2##(1992-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)
clearly suggest that##2##3##(1993-1#1)(1997-8#1)
clearly suggested##2##2##(2008-10#1)(2010-6#1)
clearly superior to##2##3##(1996-12#1)(2008-4#1)
clearly that##9##2##(1995-12#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)
clearly the##4##2##(2007-11#1)(2007-12#1)(2007-4#1)(2011-2#1)
clearly to##2##2##(1990-8#1)(2010-9#1)
clearly understand##2##2##(2009-8#1)(2011-1#1)
clearly understood##4##2##(1992-2#1)(1997-2#1)(2011-1#1)(2011-2#1)
clearly visible##5##2##(2007-11#1)(2008-11#2)(2008-5#1)(2009-7#1)
clearly visualized##2##2##(2007-12#1)(2008-10#1)
clearly with##2##2##(1991-12#1)(2008-3#1)
clearly##480##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#3)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-4#2)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#92)(2008-11#30)(2008-12#4)(2008-2#8)(2008-3#23)(2008-4#5)(2008-5#28)(2008-6#6)(2008-7#20)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#16)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#14)(2012-3#8)(2013-1#8)(2013-8#2)
clears##4##1##(1991-6#1)(1995-6#1)(1997-1#1)(2007-11#1)
cleavable complex assay##3##3##(1995-3#3)
cleavable complexes##6##2##(1995-5#6)
cleavable signal peptide##2##3##(1990-5#1)(1991-12#1)
cleavable##16##1##(1990-2#1)(1990-5#1)(1991-12#1)(1992-3#1)(1993-5#1)(1995-3#3)(1995-5#6)(2008-12#1)(2009-3#1)
cleavage activity in##2##3##(2008-9#2)
cleavage activity##4##2##(1997-2#1)(2008-9#3)
cleavage and functionalization##2##3##(2010-12#2)
cleavage and##14##2##(1990-11#2)(1990-2#1)(1990-7#1)(1993-11#1)(1993-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#2)(2013-1#1)
cleavage as##2##2##(1994-12#1)(2011-2#1)
cleavage at the##3##3##(1993-8#1)(1996-2#1)(2008-4#1)
cleavage at three##2##3##(1993-6#1)(1995-6#1)
cleavage at##11##2##(1990-5#1)(1991-11#1)(1992-6#1)(1993-6#2)(1993-8#2)(1995-6#1)(1996-12#1)(1996-2#1)(2008-4#1)
cleavage between##3##2##(1990-12#1)(1990-8#1)(2009-6#1)
cleavage by RNA polymerase II##2##5##(1994-8#2)
cleavage by##5##2##(1991-3#1)(1992-4#1)(1994-8#3)
cleavage efficiency##2##2##(1991-12#1)(2008-9#1)
cleavage from##3##2##(1997-3#1)(2013-1#2)
cleavage in the##2##3##(1990-8#1)(1996-5#1)
cleavage in##3##2##(1990-8#1)(1996-5#1)(2008-11#1)
cleavage is##2##2##(1993-11#1)(2010-12#1)
cleavage occurred##2##2##(1991-2#1)(1993-8#1)
cleavage occurs##5##2##(1991-9#1)(1994-9#2)(2008-4#2)
cleavage of a##6##3##(1993-11#1)(1995-6#1)(1997-7#1)(2008-11#2)(2008-7#1)
cleavage of proteins in solution##2##5##(2008-4#2)
cleavage of the##28##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-11#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-5#2)(1997-4#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-8#2)(2009-8#1)(2011-1#1)
cleavage of##74##2##(1990-11#1)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-9#2)(1992-11#2)(1992-12#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)
cleavage on##3##2##(1994-11#1)(2008-12#1)(2010-12#1)
cleavage pattern##2##2##(2008-4#2)
cleavage products##9##2##(1993-11#2)(1993-6#1)(1994-11#1)(2007-12#5)
cleavage rates##2##2##(1995-6#1)(2008-9#1)
cleavage sequence##2##2##(1995-6#1)(2008-10#1)
cleavage site of##4##3##(1991-12#1)(1991-9#1)(2007-6#1)(2008-5#1)
cleavage site was##3##3##(1991-10#1)(1995-5#1)(1997-4#1)
cleavage site##20##2##(1990-5#1)(1991-10#2)(1991-12#1)(1991-6#3)(1991-9#3)(1993-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-4#1)(2007-6#2)(2008-10#2)(2008-5#1)
cleavage sites and##2##3##(2008-10#1)(2008-11#1)
cleavage sites on##2##3##(1990-7#1)(2011-1#1)
cleavage sites##12##2##(1990-7#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2011-1#1)
cleavage to##2##2##(1995-3#1)(2008-12#1)
cleavage was##3##2##(1991-5#1)(1993-11#1)(2008-5#1)
cleavage with##5##2##(1990-5#2)(1991-9#1)(1992-8#1)(1993-11#1)
cleavage##270##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#10)(1990-7#6)(1990-8#4)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-9#10)(1992-10#1)(1992-11#2)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#11)(1993-3#1)(1993-6#6)(1993-8#7)(1994-11#5)(1994-12#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#5)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#7)(1995-8#3)(1996-12#2)(1996-2#1)(1996-5#5)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#3)(2007-12#7)(2007-6#3)(2008-1#2)(2008-10#14)(2008-11#7)(2008-12#3)(2008-2#2)(2008-4#20)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#12)(2009-3#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#6)(2013-7#1)
cleavage)##2##1##(2008-4#2)
cleavages##3##1##(1991-9#1)(1992-12#1)(2008-4#1)
cleave the RNA##2##3##(2009-2#2)
cleave the##7##2##(1990-12#1)(1991-10#1)(1991-9#1)(2008-8#2)(2009-2#2)
cleave##21##1##(1990-12#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-2#2)(2009-5#1)(2012-12#1)(2013-8#1)
cleaved and##2##2##(1997-6#1)(2007-11#1)
cleaved at the##4##3##(1990-5#1)(1991-2#3)
cleaved at##6##2##(1990-5#1)(1991-2#3)(1992-11#1)(1995-6#1)
cleaved by an##2##3##(1991-10#1)(1991-9#1)
cleaved by the##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
cleaved by##14##2##(1991-10#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-5#2)
cleaved in a##2##3##(1991-9#1)(2008-4#1)
cleaved in the##3##3##(1991-9#1)(1996-12#1)(2008-4#1)
cleaved in##5##2##(1991-9#2)(1996-12#1)(2008-4#2)
cleaved the##5##2##(1990-12#1)(1992-6#1)(1993-11#2)(2008-8#1)
cleaved to##5##2##(1990-2#1)(1991-9#1)(2008-4#1)(2009-2#1)(2009-6#1)
cleaved with##4##2##(1993-8#1)(1994-12#1)(1994-5#1)(1997-4#1)
cleaved within##3##2##(1992-9#1)(2008-4#1)(2009-6#1)
cleaved##84##1##(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#5)(1991-3#1)(1991-5#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-12#2)(1997-4#2)(1997-6#3)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-6#2)(2009-7#1)(2010-3#1)(2012-12#1)
cleaves at##6##2##(1995-8#1)(2008-4#5)
cleaves the##8##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(2008-4#1)
cleaves##29##1##(1990-2#1)(1990-5#1)(1991-3#1)(1991-9#3)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-12#1)(2008-11#1)(2008-4#6)(2009-6#1)
cleaving##12##1##(1992-4#1)(1992-6#1)(1993-9#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-9#1)(2011-1#1)
cleft and##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
cleft cysts##3##2##(2008-7#2)(2012-3#1)
cleft lip and palate repair##2##5##(2007-12#1)(2011-2#1)
cleft lip and palate##13##4##(2007-12#3)(2008-10#1)(2009-8#1)(2011-2#3)(2013-1#5)
cleft lip and##14##3##(2007-12#3)(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#3)(2013-1#5)
cleft lip##26##2##(1997-3#1)(2007-12#5)(2008-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#8)
cleft lip/palate##3##2##(2011-1#1)(2011-2#2)
cleft lips##2##2##(2009-7#1)(2013-1#1)
cleft of the##2##3##(2012-12#1)(2012-3#1)
cleft of##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
cleft palate##16##2##(1995-3#2)(2007-12#2)(2008-12#1)(2009-6#2)(2009-7#1)(2011-1#1)(2012-12#4)(2013-1#3)
cleft patient##4##2##(2007-12#3)(2011-2#1)
cleft##87##1##(1991-12#1)(1992-3#2)(1993-11#1)(1993-12#2)(1995-3#2)(1995-5#1)(1997-3#1)(2007-12#14)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#5)(2009-10#1)(2009-6#4)(2009-7#2)(2009-8#1)(2010-11#2)(2010-4#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#12)(2012-3#2)(2013-1#14)(2013-8#1)
clefting##4##1##(2007-12#1)(2009-6#3)
clefts##10##1##(2009-10#6)(2009-6#1)(2012-12#2)(2013-8#1)
cleistogamous##3##1##(2008-10#1)(2008-9#1)(2011-2#1)
clenbuterol administration##2##2##(2010-5#2)
clenbuterol and##2##2##(2010-6#2)
clenbuterol##24##1##(2008-10#11)(2010-12#1)(2010-5#3)(2010-6#9)
clenching effort##5##2##(2010-9#5)
clenching##7##1##(2010-6#2)(2010-9#5)
clergy##4##1##(2010-2#4)
clerical staff and##2##3##(1994-1#1)(1994-2#1)
clerical##3##1##(1994-1#1)(1994-2#1)(2008-7#1)
clerking##2##1##(2010-12#2)
clerks##3##1##(1996-1#1)(1996-3#1)(2008-11#1)
clerkship##2##1##(2011-2#1)(2012-3#1)
clerkships##3##1##(1994-3#1)(2009-12#1)(2012-3#1)
cleveland clinic##2##2##(2008-7#1)(2011-2#1)
clevelandii line##2##2##(2008-10#2)
clevelandii##10##1##(2008-10#10)
clever##2##1##(2008-1#1)(2008-8#1)
click transformations##2##2##(2012-3#2)
click##10##1##(2008-4#2)(2009-11#4)(2012-3#3)(2013-1#1)
clicking##7##1##(2012-2#1)(2012-3#6)
clicks is##2##2##(2008-4#2)
clicks##3##1##(2007-12#1)(2008-4#2)
client and##2##2##(1993-12#1)(2009-6#1)
client group##5##2##(1997-7#1)(2008-11#3)(2008-7#1)
client groups and education settings##2##5##(2013-8#2)
client groups and##3##3##(2013-8#3)
client groups##4##2##(2013-8#4)
client proteins##3##2##(2008-7#1)(2009-5#1)(2010-4#1)
client screening##2##2##(1991-1#1)(1996-12#1)
client was##2##2##(1994-2#1)(2007-6#1)
client with##4##2##(2008-11#1)(2010-6#1)(2012-3#2)
client##60##1##(1991-1#2)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-2#3)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#3)(2007-6#2)(2008-11#6)(2008-12#2)(2008-4#3)(2008-7#2)(2008-9#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-4#1)(2010-6#1)(2010-8#3)(2012-2#1)(2012-3#3)(2013-8#6)
client's##3##1##(1996-3#1)(2008-1#1)(2010-8#1)
client-centered##2##1##(1992-3#1)(1996-3#1)
clientele##8##1##(1991-12#1)(1992-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-2#1)(2012-3#1)
clients and a##2##3##(1991-1#1)(1994-12#1)
clients and##9##2##(1991-1#1)(1994-12#1)(1995-3#1)(1996-3#2)(2007-10#1)(2009-6#1)(2010-5#1)(2010-9#1)
clients are##2##2##(1996-2#1)(2008-6#1)
clients at##2##2##(1993-1#1)(1995-5#1)
clients by##2##2##(2011-1#2)
clients in##5##2##(1991-1#1)(1993-12#1)(1994-1#2)(1996-3#1)
clients may##2##2##(1996-3#1)(2009-7#1)
clients to##3##2##(1993-2#1)(2010-3#1)(2013-1#1)
clients were##2##2##(1991-12#1)(1993-1#1)
clients who are##2##3##(2010-5#1)(2012-2#1)
clients with schizophrenia##2##3##(2013-8#2)
clients with##11##2##(1991-12#1)(1994-3#1)(2007-6#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-8#2)
clients##97##1##(1991-1#3)(1991-12#5)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#4)(1993-12#3)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#7)(1997-2#1)(2007-10#2)(2007-6#2)(2008-1#1)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
clients'##4##1##(1991-1#1)(1995-12#1)(1996-11#1)(2008-11#1)
climacteric##6##1##(1990-6#1)(1992-12#2)(2008-11#3)
climate and##13##2##(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#4)(2009-11#1)(2009-7#1)(2010-1#1)(2012-2#1)
climate change and other##2##4##(2008-8#1)(2008-9#1)
climate change and##5##3##(1992-3#1)(2008-8#3)(2008-9#1)
climate change could##2##3##(2008-9#1)(2012-12#1)
climate change on##3##3##(2008-11#3)
climate change##44##2##(1992-3#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#7)(2012-5#1)(2012-6#3)(2012-7#1)(2012-8#1)(2012-9#3)(2013-8#3)
climate changes##5##2##(2008-6#1)(2010-3#1)(2012-5#1)(2012-9#2)
climate conditions##5##2##(2008-6#1)(2008-8#1)(2012-2#1)(2012-9#2)
climate data##3##2##(2008-10#1)(2008-8#2)
climate in##3##2##(1990-11#1)(2008-10#1)(2011-1#1)
climate information for##3##3##(2008-8#3)
climate information##4##2##(2008-8#4)
climate is##2##2##(1994-1#1)(2012-9#1)
climate may##2##2##(1991-2#1)(2010-10#1)
climate of the##3##3##(1992-3#1)(2007-10#1)(2012-3#1)
climate of their##2##3##(2009-7#1)(2012-5#1)
climate of##9##2##(1992-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2009-7#1)(2012-2#1)(2012-3#1)(2012-5#1)
climate scenarios##3##2##(2008-8#2)(2012-2#1)
climate strength##6##2##(2010-6#6)
climate##170##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-7#1)(1993-2#2)(1994-1#1)(1994-12#1)(1995-9#1)(2007-10#1)(2007-2#1)(2008-10#20)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#27)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#4)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#7)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#1)(2012-5#5)(2012-6#4)(2012-7#5)(2012-8#1)(2012-9#12)(2013-1#1)(2013-8#3)
climates##18##1##(1995-2#1)(1995-9#1)(2008-10#8)(2008-8#1)(2008-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2012-4#1)(2012-9#1)
climatic and##4##2##(2011-2#2)(2012-2#2)
climatic area##3##2##(2008-10#3)
climatic chamber##2##2##(2008-6#1)(2013-8#1)
climatic conditions and##2##3##(2008-5#1)(2013-7#1)
climatic conditions##11##2##(1990-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
climatic data##2##2##(2008-8#2)
climatic factors##5##2##(2008-10#2)(2008-8#1)(2012-3#2)
climatic forecast indices and##2##4##(2008-8#2)
climatic suitability##3##2##(2008-10#2)(2008-8#1)
climatic##49##1##(1990-8#2)(1992-3#2)(2007-7#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#11)(2008-9#1)(2009-10#1)(2010-3#3)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
climatically sensitive##2##2##(2010-3#2)
climatically##5##1##(2008-10#2)(2010-3#3)
climatological factors##2##2##(2008-12#2)
climatological##5##1##(2008-12#3)(2008-3#2)
climb##2##1##(2013-7#1)(2013-8#1)
climbazole concentration##2##2##(2008-5#2)
climbazole##10##1##(2008-5#10)
climbing stairs##2##2##(2008-9#1)(2013-1#1)
climbing##13##1##(1992-6#1)(1994-2#1)(1995-3#2)(1997-2#1)(2008-5#1)(2008-9#3)(2010-8#1)(2011-2#1)(2013-1#2)
clindamycin and##3##2##(2007-7#3)
clindamycin##13##1##(2007-11#4)(2007-2#1)(2007-7#6)(2010-8#1)(2011-2#1)
cling##2##1##(2007-12#1)(2008-10#1)
clinic and##7##2##(1990-2#1)(1991-8#1)(1995-11#1)(2008-11#1)(2008-2#1)(2009-10#1)(2012-12#1)
clinic are##4##2##(2007-11#1)(2008-1#1)(2010-8#1)(2011-3#1)
clinic as##3##2##(2008-11#2)(2008-7#1)
clinic at##2##2##(2007-7#1)(2008-8#1)
clinic because of##2##3##(1997-4#1)(2011-1#1)
clinic between##2##2##(2010-3#1)(2012-3#1)
clinic for the##2##3##(1994-12#1)(2010-2#1)
clinic for##12##2##(1994-1#1)(1994-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-2#4)(2013-1#1)
clinic in the##4##3##(2011-1#1)(2012-3#1)(2013-1#2)
clinic in##16##2##(1994-2#1)(1996-12#1)(1996-3#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
clinic is##4##2##(2008-2#1)(2010-12#1)(2012-3#1)(2013-8#1)
clinic network##4##2##(1991-3#1)(1994-1#2)(1996-3#1)
clinic of the##3##3##(1997-3#1)(2008-1#1)(2011-2#1)
clinic of##7##2##(1993-2#1)(1997-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
clinic or##6##2##(1995-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)
clinic setting##6##2##(1993-12#2)(2008-1#1)(2008-12#1)(2008-9#1)(2011-7#1)
clinic since##2##2##(2007-8#1)(2008-11#1)
clinic staff##4##2##(1996-1#2)(2008-6#1)(2012-1#1)
clinic to##3##2##(1992-9#1)(2008-11#1)(2010-6#1)
clinic using##2##2##(1994-1#1)(2008-3#1)
clinic visits##4##2##(1991-1#1)(1995-12#1)(1996-12#1)(2008-1#1)
clinic was##4##2##(1996-3#1)(2007-8#1)(2011-1#1)(2011-2#1)
clinic were##7##2##(1991-8#1)(1993-2#1)(2008-3#1)(2009-5#1)(2009-9#1)(2011-1#1)(2013-1#1)
clinic with##5##2##(1995-2#1)(1996-3#1)(2007-10#1)(2008-11#1)(2012-2#1)
clinic##239##1##(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#5)(1993-9#1)(1994-1#6)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#10)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#8)(2008-1#6)(2008-10#9)(2008-11#12)(2008-12#3)(2008-2#5)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#22)(2011-3#3)(2011-7#1)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#1)
clinic's##3##1##(1996-12#1)(2007-7#1)(2008-2#1)
clinic-based MVA is##2##3##(2011-1#2)
clinic-based MVA##3##2##(2011-1#3)
clinic-based##10##1##(1996-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#4)(2013-1#1)
clinic]##5##1##(1994-11#1)(1996-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
clinical (bio)chemistry##2##2##(1994-12#2)
clinical PCVAD in##2##3##(2012-3#1)(2013-1#1)
clinical RESULTS##2##2##(2007-4#2)
clinical Stage##2##2##(1994-12#2)
clinical accuracy##2##2##(1996-1#1)(2007-11#1)
clinical activities audit##2##3##(2007-11#2)
clinical activities##5##2##(1994-12#1)(2007-11#2)(2007-4#1)(2008-11#1)
clinical activity##4##2##(2008-11#1)(2010-8#1)(2012-1#1)(2013-1#1)
clinical acute##2##2##(1991-9#1)(2011-2#1)
clinical advancement##4##2##(1992-3#1)(1995-2#2)(2013-1#1)
clinical adverse##2##2##(2008-4#1)(2010-12#1)
clinical agents##2##2##(2008-5#1)(2009-5#1)
clinical alterations##2##2##(2008-12#1)(2013-1#1)
clinical analysis of##5##3##(1991-9#1)(2007-11#2)(2012-2#1)(2013-1#1)
clinical analysis##15##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#1)(2007-11#2)(2008-10#5)(2011-2#1)(2012-2#1)(2013-1#2)
clinical and academic##2##3##(2008-11#1)(2013-8#1)
clinical and administrative##3##3##(1992-1#1)(2010-8#2)
clinical and angiographic##2##3##(1994-9#1)(2008-11#1)
clinical and basic research##3##4##(2008-8#2)(2009-12#1)
clinical and basic##5##3##(2008-3#1)(2008-8#2)(2009-12#1)(2011-7#1)
clinical and biochemical##3##3##(2007-7#1)(2008-11#1)(2008-3#1)
clinical and biological##8##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)
clinical and computed##2##3##(2007-12#1)(2008-7#1)
clinical and cytogenetic##2##3##(1994-12#1)(1997-5#1)
clinical and cytological##2##3##(1994-5#1)(1997-2#1)
clinical and demographic##3##3##(1994-3#1)(2007-12#1)(2011-2#1)
clinical and diagnostic##4##3##(1990-9#1)(2007-8#1)(2010-10#2)
clinical and economic outcomes##3##4##(2008-6#1)(2011-2#2)
clinical and economic##5##3##(1997-2#1)(2007-11#1)(2008-6#1)(2011-2#2)
clinical and environmental##2##3##(2008-10#2)
clinical and epidemiological##4##3##(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
clinical and experimental data##2##4##(2008-10#1)(2008-8#1)
clinical and experimental##6##3##(2006-10#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
clinical and financial##4##3##(1994-12#1)(1997-1#1)(1997-3#1)(2008-8#1)
clinical and functional outcomes##2##4##(2013-1#2)
clinical and functional results##2##4##(2013-1#2)
clinical and functional##5##3##(2011-1#1)(2013-1#4)
clinical and genetic##5##3##(1994-3#1)(2008-11#1)(2008-7#1)(2008-8#2)
clinical and haemodynamic##2##3##(2008-3#1)(2011-2#1)
clinical and health##2##3##(2007-10#1)(2008-8#1)
clinical and hemodynamic##3##3##(2010-6#1)(2010-8#1)(2011-2#1)
clinical and histologic##2##3##(2006-10#1)(2008-9#1)
clinical and histological features##3##4##(1991-11#1)(2008-7#1)(2010-8#1)
clinical and histological##5##3##(1991-11#1)(1991-8#1)(2008-7#1)(2010-8#1)(2013-1#1)
clinical and histopathological findings##3##4##(1996-12#1)(2008-4#1)(2010-6#1)
clinical and histopathological##4##3##(1996-12#1)(2008-1#1)(2008-4#1)(2010-6#1)
clinical and imaging##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
clinical and immunological##2##3##(1990-2#1)(2011-2#1)
clinical and instrumental##5##3##(1990-3#2)(2008-5#2)(2012-2#1)
clinical and laboratory data##2##4##(2008-1#1)(2013-1#1)
clinical and laboratory features of systemic##2##6##(2008-8#1)(2011-2#1)
clinical and laboratory features of##4##5##(1997-7#1)(2008-8#2)(2011-2#1)
clinical and laboratory features##5##4##(1997-7#1)(2008-8#2)(2011-2#2)
clinical and laboratory investigations##2##4##(1990-2#1)(2011-2#1)
clinical and laboratory procedures##2##4##(2008-7#1)(2009-8#1)
clinical and laboratory variables##3##4##(2011-1#2)(2011-2#1)
clinical and laboratory##22##3##(1990-2#1)(1992-9#1)(1994-12#1)(1997-7#1)(2008-1#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#1)
clinical and microbiological characteristics of##2##5##(2007-12#2)
clinical and microbiological##4##3##(1990-9#1)(2007-12#2)(2008-5#1)
clinical and microscopic##2##3##(1991-6#1)(2006-10#1)
clinical and molecular##3##3##(2008-1#1)(2010-5#1)(2012-12#1)
clinical and morphological##3##3##(1997-6#1)(2009-8#1)(2011-2#1)
clinical and mycological cure##2##4##(2008-5#2)
clinical and mycological##3##3##(2008-5#3)
clinical and neuroradiological##2##3##(2008-7#1)(2013-1#1)
clinical and non-clinical##2##3##(2009-6#1)(2012-1#1)
clinical and nonclinical##2##3##(1993-12#1)(1994-1#1)
clinical and parasitological signs##3##4##(2012-12#3)
clinical and pathologic features of##3##5##(1990-6#1)(1992-2#1)(2008-1#1)
clinical and pathologic##5##3##(1990-6#1)(1991-8#1)(1992-2#1)(2007-9#1)(2008-1#1)
clinical and pathological features of this##2##6##(1991-6#1)(2008-2#1)
clinical and pathological features of##4##5##(1991-12#1)(1991-6#1)(2008-2#1)(2010-11#1)
clinical and pathological features##5##4##(1991-12#1)(1991-6#1)(2008-2#1)(2010-11#1)(2012-2#1)
clinical and pathological##12##3##(1991-12#1)(1991-6#1)(1991-8#1)(1994-3#1)(2008-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
clinical and patient##2##3##(2008-12#1)(2012-3#1)
clinical and prognostic##2##3##(1990-6#1)(1992-2#1)
clinical and radiographic features of##2##5##(1993-12#1)(2008-12#1)
clinical and radiographic outcomes##2##4##(2011-2#1)(2013-1#1)
clinical and radiographic##10##3##(1993-12#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
clinical and radiologic features##2##4##(1991-6#1)(2007-12#1)
clinical and radiologic##4##3##(1991-6#1)(2007-12#1)(2008-7#1)(2011-2#1)
clinical and radiological examination##5##4##(1995-9#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
clinical and radiological findings##4##4##(2008-6#1)(2012-12#3)
clinical and radiological results##2##4##(2007-11#1)(2007-8#1)
clinical and radiological##27##3##(1990-5#1)(1991-11#1)(1995-9#1)(1997-3#1)(2006-7#1)(2007-11#2)(2007-8#4)(2008-10#1)(2008-6#2)(2008-7#3)(2010-11#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-8#1)
clinical and research##4##3##(2008-6#1)(2010-8#2)(2013-1#1)
clinical and scientific##2##3##(2008-5#1)(2010-5#1)
clinical and serologic##2##3##(1990-3#1)(2011-2#1)
clinical and subclinical##2##3##(2009-10#1)(2012-3#1)
clinical and surgical##3##3##(1993-9#1)(2008-9#1)(2010-3#1)
clinical and technical##2##3##(1990-5#1)(2011-2#1)
clinical and theoretical##2##3##(2008-11#1)(2008-9#1)
clinical and therapeutic aspects of##2##5##(1990-9#1)(1992-5#1)
clinical and therapeutic##5##3##(1990-9#1)(1992-5#1)(1994-2#1)(2008-7#1)(2009-6#1)
clinical and urodynamic##2##3##(2008-10#2)
clinical and##304##2##(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#2)(1990-9#4)(1991-11#2)(1991-12#2)(1991-6#3)(1991-8#3)(1992-1#2)(1992-2#2)(1992-5#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#4)(1994-9#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#4)(2006-7#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#8)(2008-10#10)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#19)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-10#3)(2010-11#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-8#8)(2010-9#1)(2011-1#5)(2011-2#26)(2011-7#2)(2012-1#1)(2012-12#11)(2012-2#7)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#3)
clinical anemia in##2##3##(2012-3#2)
clinical anesthesia research trial##2##4##(2008-8#2)
clinical anesthesia research##3##3##(2008-8#3)
clinical anesthesia##4##2##(2008-8#4)
clinical appearance of a##2##4##(1991-2#1)(2012-3#1)
clinical appearance of##3##3##(1991-2#1)(2008-5#1)(2012-3#1)
clinical appearance##6##2##(1991-2#1)(1996-6#1)(2008-5#2)(2010-6#1)(2012-3#1)
clinical applicability##5##2##(1994-1#1)(2010-6#1)(2011-1#2)(2011-2#1)
clinical application as a##2##4##(1996-9#2)
clinical application in##2##3##(2010-8#1)(2011-2#1)
clinical application of nursing##3##4##(1990-2#3)
clinical application of the##3##4##(2008-1#1)(2008-10#1)(2010-12#1)
clinical application of this##2##4##(2008-7#1)(2010-11#1)
clinical application of##17##3##(1990-2#3)(1991-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#2)
clinical application##45##2##(1990-2#4)(1991-6#1)(1991-9#1)(1996-9#2)(2007-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-3#3)(2012-7#1)(2013-8#3)
clinical application]##2##2##(2013-1#1)(2013-8#1)
clinical applications and##2##3##(1995-8#1)(2010-8#1)
clinical applications are##2##3##(2008-8#2)
clinical applications for##2##3##(2008-9#1)(2011-7#1)
clinical applications in##2##3##(2007-10#1)(2008-10#1)
clinical applications of the##3##4##(1997-4#1)(2008-4#1)(2008-7#1)
clinical applications of##13##3##(1994-10#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2012-2#2)
clinical applications##55##2##(1991-8#1)(1992-2#1)(1994-10#1)(1994-11#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#2)(2012-2#5)(2013-1#1)(2013-8#1)
clinical approach to##3##3##(1993-2#1)(2008-11#1)(2008-3#1)
clinical approach##4##2##(1993-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
clinical area##7##2##(1996-7#1)(2008-11#5)(2008-12#1)
clinical areas##6##2##(1997-2#1)(2007-10#1)(2008-11#4)
clinical as well as##2##4##(1997-8#1)(2012-3#1)
clinical aspects and##2##3##(1991-2#1)(2008-1#1)
clinical aspects of the##3##4##(1990-9#1)(1995-6#1)(2008-4#1)
clinical aspects of this##2##4##(1992-6#1)(1996-5#1)
clinical aspects of##10##3##(1990-9#1)(1992-2#1)(1992-6#1)(1995-6#1)(1996-5#1)(2008-4#2)(2008-5#1)(2009-8#1)(2012-2#1)
clinical aspects##23##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#2)(2012-2#1)(2013-1#1)
clinical assesment##2##2##(2007-11#1)(2013-1#1)
clinical assessment and##3##3##(2008-12#1)(2008-3#1)(2008-5#1)
clinical assessment of##11##3##(1990-6#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
clinical assessment to##2##3##(2008-1#1)(2008-3#1)
clinical assessment##34##2##(1990-6#1)(1992-12#1)(1993-12#1)(1994-5#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
clinical assessments##2##2##(2012-1#1)(2013-1#1)
clinical attachment level##2##3##(2008-12#2)
clinical attachment loss##3##3##(2012-12#2)(2013-1#1)
clinical attachment##5##2##(2008-12#2)(2012-12#2)(2013-1#1)
clinical audit##4##2##(2010-8#1)(2012-2#1)(2013-1#2)
clinical backgrounds and##2##3##(2008-11#1)(2012-12#1)
clinical backgrounds##3##2##(2008-11#2)(2012-12#1)
clinical bacteriology##2##2##(1990-8#1)(2010-12#1)
clinical basis##2##2##(1990-3#1)(2012-3#1)
clinical behavior and##2##3##(1997-7#1)(2010-3#1)
clinical behavior##7##2##(1997-7#1)(2008-12#1)(2008-8#1)(2009-5#2)(2010-3#1)(2013-1#1)
clinical behaviors and responses to treatment##2##6##(2013-1#2)
clinical behaviour##5##2##(2007-8#1)(2008-4#2)(2012-3#1)(2013-1#1)
clinical benefit of##4##3##(1997-7#2)(2008-10#1)(2008-8#1)
clinical benefit##19##2##(1996-3#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-10#1)(2010-5#1)(2011-2#1)
clinical benefits of##4##3##(2008-10#1)(2009-6#1)(2011-2#2)
clinical benefits that##3##3##(2007-11#1)(2008-1#1)(2008-7#1)
clinical benefits##15##2##(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-6#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)
clinical biochemistry exists##2##3##(1994-12#2)
clinical biochemistry in##2##3##(1994-12#2)
clinical biochemistry##22##2##(1994-12#19)(2008-5#3)
clinical biochemists##5##2##(1994-12#5)
clinical blood##4##2##(1991-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
clinical breast##2##2##(2010-8#1)(2013-1#1)
clinical cancer##2##2##(2008-4#1)(2013-1#1)
clinical cardiac electrophysiology##3##3##(2008-12#3)
clinical cardiac##4##2##(1990-10#1)(2008-12#3)
clinical care and##3##3##(1994-3#1)(2007-5#1)(2008-8#1)
clinical care in##3##3##(1995-2#1)(1995-9#1)(1996-12#1)
clinical care is##2##3##(2008-3#1)(2009-6#1)
clinical care to##2##3##(2008-11#1)(2008-12#1)
clinical care##18##2##(1994-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#2)
clinical case is##2##3##(1991-3#1)(2013-1#1)
clinical case of a 63##2##5##(2010-12#1)(2011-2#1)
clinical case of a##4##4##(2010-12#1)(2011-2#1)(2013-1#2)
clinical case of##7##3##(1990-5#1)(1991-3#1)(2010-12#1)(2011-2#1)(2013-1#3)
clinical case##24##2##(1990-3#1)(1990-5#2)(1991-3#2)(1991-5#1)(1993-5#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#6)
clinical case]##8##2##(1990-3#1)(1990-5#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#2)(2012-12#1)
clinical cases of##4##3##(1993-2#1)(1993-3#1)(1993-6#1)(1995-9#1)
clinical cases##18##2##(1990-3#1)(1990-5#1)(1991-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-9#1)(1996-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
clinical cases]##5##2##(1990-2#1)(1990-5#1)(1993-3#1)(2008-10#1)(2013-8#1)
clinical challenge##8##2##(1993-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
clinical challenges##2##2##(2008-6#1)(2010-6#1)
clinical change##3##2##(1996-3#3)
clinical characteristics and##6##3##(1993-12#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical characteristics of patients##2##4##(2008-8#1)(2011-2#1)
clinical characteristics of these diseases##2##5##(2007-7#1)(2008-7#1)
clinical characteristics of##16##3##(1992-2#1)(1993-12#1)(1994-12#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#2)
clinical characteristics##37##2##(1990-6#1)(1992-2#1)(1993-12#2)(1994-12#1)(1995-10#1)(1995-2#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#4)(2008-8#1)(2009-4#2)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
clinical characterization##2##2##(2008-9#1)(2013-1#1)
clinical chemist##2##2##(1994-12#2)
clinical chemistry and biochemical pathology##2##5##(1994-12#2)
clinical chemistry and laboratory##2##4##(1994-12#1)(2012-1#1)
clinical chemistry and##4##3##(1994-12#3)(2012-1#1)
clinical chemistry as##2##3##(1994-12#2)
clinical chemistry in##3##3##(1994-12#3)
clinical chemistry laboratories##2##3##(2008-10#2)
clinical chemistry system##3##3##(2008-10#3)
clinical chemistry##31##2##(1994-12#21)(1995-3#2)(2008-10#7)(2012-1#1)
clinical chemists##3##2##(1991-12#1)(1994-12#2)
clinical circumstances##2##2##(1992-9#1)(2008-10#1)
clinical cohort##2##2##(2007-12#2)
clinical commentary##2##2##(2008-12#1)(2011-1#1)
clinical competence##3##2##(1994-2#1)(2008-11#1)(2008-12#1)
clinical complications##4##2##(2008-3#1)(2009-10#1)(2009-4#1)(2012-12#1)
clinical compounds##2##2##(1992-5#1)(2013-8#1)
clinical concern##4##2##(1993-9#1)(1994-3#1)(2007-8#1)(2011-2#1)
clinical concerns##2##2##(1992-12#1)(2008-11#1)
clinical condition and##3##3##(1991-12#1)(1991-6#1)(2013-1#1)
clinical condition in##2##3##(2012-2#1)(2013-8#1)
clinical condition of the##3##4##(1991-3#1)(2007-8#1)(2008-11#1)
clinical condition##20##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
clinical conditions in##2##3##(1990-2#1)(1995-9#1)
clinical conditions##17##2##(1990-2#1)(1991-3#1)(1995-9#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-12#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
clinical consequences of##5##3##(1995-8#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
clinical consequences##8##2##(1991-3#1)(1995-8#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)(2013-8#1)
clinical considerations##3##2##(1993-12#1)(2007-8#1)(2013-1#1)
clinical context##2##2##(1996-11#1)(2008-6#1)
clinical controlled##2##2##(1990-3#1)(2013-1#1)
clinical correlates##5##2##(2008-2#1)(2008-8#1)(2011-2#1)(2013-8#2)
clinical correlation##2##2##(2011-1#1)(2011-2#1)
clinical course and##12##3##(1991-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-6#2)(2012-12#2)
clinical course in##2##3##(1997-5#1)(2007-12#1)
clinical course of patients with##3##5##(2007-12#1)(2008-7#1)(2010-11#1)
clinical course of the##5##4##(1990-11#1)(1993-6#1)(2007-2#1)(2008-7#1)(2011-2#1)
clinical course of##18##3##(1990-11#1)(1991-4#1)(1993-6#1)(1994-7#2)(1996-11#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-7#2)(2010-1#1)(2010-11#1)(2011-2#2)(2013-1#2)
clinical course##63##2##(1990-11#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-7#2)(1996-11#2)(1997-3#5)(1997-5#2)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-6#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
clinical courses##3##2##(1991-2#1)(2008-8#1)(2012-12#1)
clinical credibility and competence##2##4##(2008-11#2)
clinical credibility##4##2##(2008-11#4)
clinical criteria##12##2##(1990-8#1)(1991-8#1)(1992-9#1)(1997-2#1)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-3#1)
clinical cure##4##2##(1992-6#1)(2007-7#1)(2008-5#1)(2010-5#1)
clinical cytogenetics##5##2##(1997-3#1)(2008-4#4)
clinical data and##5##3##(1996-11#1)(1997-2#1)(2008-7#1)(2010-6#1)(2011-2#1)
clinical data are presented##2##4##(1996-3#1)(2008-2#1)
clinical data are##4##3##(1996-3#1)(2008-11#1)(2008-2#1)(2012-2#1)
clinical data available##2##3##(1990-9#1)(2008-7#1)
clinical data for##3##3##(2007-10#1)(2010-11#1)(2011-2#1)
clinical data from##2##3##(2011-2#2)
clinical data of##4##3##(1991-3#1)(1997-7#1)(2011-2#1)(2013-1#1)
clinical data on##2##3##(2007-8#1)(2013-1#1)
clinical data such as##2##4##(1994-10#1)(2013-7#1)
clinical data suggest that##2##4##(2009-4#1)(2011-2#1)
clinical data were##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
clinical data##66##2##(1990-3#1)(1990-9#1)(1991-3#1)(1993-11#2)(1993-9#1)(1994-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1997-2#3)(1997-3#2)(1997-7#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
clinical decision making##9##3##(1992-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2010-11#1)(2010-12#1)(2012-12#2)
clinical decision support to##3##4##(1996-12#1)(1997-3#1)(2010-4#1)
clinical decision support##7##3##(1991-9#1)(1993-2#1)(1996-12#2)(1997-3#1)(2010-4#1)(2010-6#1)
clinical decision##20##2##(1991-1#1)(1991-9#1)(1992-12#1)(1993-2#1)(1996-12#2)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2012-12#2)
clinical decision-making abilities of the##2##5##(2007-10#2)
clinical decision-making and##2##3##(2008-11#1)(2013-1#1)
clinical decision-making in the##2##4##(2008-11#1)(2008-12#1)
clinical decision-making skills##2##3##(2008-11#1)(2012-2#1)
clinical decision-making##23##2##(2007-10#5)(2008-10#1)(2008-11#10)(2008-12#2)(2009-4#1)(2010-8#1)(2011-10#1)(2012-2#1)(2013-1#1)
clinical decisions regarding the##2##4##(2008-12#1)(2011-2#1)
clinical decisions##4##2##(1993-5#1)(2008-12#2)(2011-2#1)
clinical dental##2##2##(2008-8#1)(2012-1#1)
clinical department##2##2##(1995-1#1)(2010-8#1)
clinical departments##3##2##(1991-3#1)(1992-1#1)(2011-1#1)
clinical depression##6##2##(1991-2#2)(2008-10#1)(2008-11#1)(2008-7#2)
clinical description##2##2##(1992-1#1)(2010-6#1)
clinical deterioration##2##2##(2012-3#1)(2013-8#1)
clinical development are##2##3##(2008-8#2)
clinical development of##6##3##(1990-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
clinical development##19##2##(1990-3#1)(2008-10#2)(2008-5#4)(2008-8#6)(2009-4#2)(2010-10#1)(2010-11#2)(2013-1#1)
clinical diabetes##2##2##(2008-1#2)
clinical diagnoses##2##2##(2012-2#1)(2013-1#1)
clinical diagnosis and the##2##4##(2007-11#1)(2009-7#1)
clinical diagnosis and##7##3##(1995-12#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-9#1)(2009-7#1)(2012-12#1)
clinical diagnosis of##17##3##(1992-12#1)(1993-5#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
clinical diagnosis or##3##3##(2008-10#1)(2010-1#1)(2010-12#1)
clinical diagnosis was##3##3##(2008-5#1)(2009-2#1)(2012-12#1)
clinical diagnosis##46##2##(1990-3#1)(1991-6#1)(1992-12#1)(1993-5#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)
clinical diagnostic tools##2##3##(2008-10#1)(2011-1#1)
clinical diagnostic##9##2##(1992-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#2)(2011-1#1)
clinical diagnostics##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
clinical differences##4##2##(1995-2#1)(1997-3#1)(2007-11#2)
clinical dilemma##2##2##(1994-8#1)(2008-7#1)
clinical disciplines##2##2##(1994-12#1)(2008-1#1)
clinical disease##6##2##(1991-6#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-1#1)
clinical diseases##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
clinical disorder##2##2##(2008-4#1)(2012-3#1)
clinical disorders##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
clinical division##2##2##(2007-11#1)(2010-8#1)
clinical doctors##2##2##(2008-5#1)(2012-3#1)
clinical documents##2##2##(2010-8#2)
clinical drug development##2##3##(2008-8#1)(2010-5#1)
clinical drug##4##2##(1991-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
clinical drugs##2##2##(2008-4#1)(2010-8#1)
clinical education for undergraduate nurses##2##5##(2008-12#2)
clinical education##8##2##(2008-12#6)(2012-12#1)(2013-8#1)
clinical educators##3##2##(2008-11#1)(2008-12#2)
clinical effect of##5##3##(1997-5#1)(1997-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
clinical effect##11##2##(1997-5#1)(1997-6#1)(2008-8#3)(2009-9#1)(2011-1#1)(2011-2#2)(2013-8#2)
clinical effectiveness of##4##3##(2008-7#2)(2011-2#1)(2012-3#1)
clinical effectiveness##9##2##(1993-12#1)(2008-11#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
clinical effects and treatments##3##4##(2010-8#3)
clinical effects##11##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#3)(2011-2#2)(2013-8#1)
clinical efficacy and##5##3##(1990-3#1)(1994-6#1)(2008-5#1)(2010-5#1)(2013-8#1)
clinical efficacy in##2##3##(1997-4#1)(2009-10#1)
clinical efficacy of##6##3##(2007-7#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
clinical efficacy##22##2##(1990-3#1)(1990-9#1)(1993-12#1)(1994-6#1)(1997-4#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
clinical efficiency##2##2##(1994-2#1)(1995-3#1)
clinical endpoint##4##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
clinical endpoints##5##2##(1994-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2013-1#1)
clinical engineering##3##2##(2008-7#2)(2011-2#1)
clinical entity and##3##3##(1990-3#1)(2009-10#1)(2013-1#1)
clinical entity that##2##3##(2012-1#1)(2013-1#1)
clinical entity whose##2##3##(1991-6#1)(1993-10#1)
clinical entity##25##2##(1990-3#1)(1991-6#1)(1993-10#1)(1995-11#1)(1996-11#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)
clinical environment##7##2##(1996-12#1)(2008-11#3)(2008-12#2)(2008-7#1)
clinical evaluation and##3##3##(1993-2#1)(2007-11#1)(2013-8#1)
clinical evaluation in##3##3##(1990-2#1)(1992-12#1)(1997-2#1)
clinical evaluation of the##2##4##(2011-2#2)
clinical evaluation of##11##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
clinical evaluation units##2##3##(1994-12#2)
clinical evaluation##43##2##(1990-2#1)(1990-3#1)(1992-12#1)(1993-2#1)(1994-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1997-2#5)(1997-3#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#4)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
clinical events and the##2##4##(2008-11#1)(2009-12#1)
clinical events##6##2##(1997-4#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-12#1)(2012-2#1)
clinical evidence for the##2##4##(2007-8#1)(2011-2#1)
clinical evidence for##5##3##(2007-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
clinical evidence has##2##3##(2008-6#1)(2012-2#1)
clinical evidence of##14##3##(1991-2#3)(1991-4#1)(2006-10#1)(2007-7#1)(2008-10#3)(2009-10#2)(2010-11#1)(2011-2#1)(2012-2#1)
clinical evidence suggest##2##3##(2008-8#1)(2011-2#1)
clinical evidence that##2##3##(1992-9#1)(2008-7#1)
clinical evidence##33##2##(1991-2#3)(1991-4#1)(1992-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-11#1)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
clinical evolution of##2##3##(2008-8#1)(2008-9#1)
clinical evolution##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
clinical examination and a##2##4##(1995-2#1)(2007-11#1)
clinical examination and the##2##4##(2008-9#1)(2012-2#1)
clinical examination and##12##3##(1990-10#1)(1990-5#1)(1991-2#1)(1992-5#1)(1995-2#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
clinical examination##44##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-5#2)(1992-9#1)(1993-5#1)(1994-2#2)(1994-7#1)(1995-2#1)(1995-9#1)(1996-9#1)(2007-11#4)(2008-11#4)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
clinical examinations##2##2##(2008-12#1)(2013-1#1)
clinical examples##3##2##(2008-4#1)(2009-2#1)(2012-12#1)
clinical experience and##6##3##(2007-11#2)(2008-12#2)(2008-5#1)(2013-1#1)
clinical experience for##2##3##(2008-12#2)
clinical experience in##4##3##(1993-9#1)(2007-12#1)(2008-11#1)(2013-1#1)
clinical experience of##2##3##(2009-4#1)(2013-1#1)
clinical experience using##2##3##(2010-6#1)(2011-2#1)
clinical experience with##5##3##(2006-7#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#1)
clinical experience##45##2##(1990-3#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#5)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#5)
clinical experiences and##2##3##(2008-10#1)(2008-12#1)
clinical experiences for##2##3##(2008-11#2)
clinical experiences in##2##3##(2008-12#1)(2012-3#1)
clinical experiences##9##2##(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#3)(2009-2#1)(2012-3#1)
clinical experimentation##2##2##(2008-2#1)(2008-8#1)
clinical expertise##2##2##(2008-12#1)(2010-12#1)
clinical expression and##2##3##(2010-12#1)(2011-2#1)
clinical expression of##4##3##(1990-2#1)(2008-3#1)(2008-4#1)(2010-1#1)
clinical expression##8##2##(1990-2#1)(1997-5#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
clinical factors including age##2##4##(2011-2#2)
clinical factors including##3##3##(2008-7#1)(2011-2#2)
clinical factors##13##2##(1990-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-2#4)(2012-12#1)
clinical failures##2##2##(2007-12#1)(2011-2#1)
clinical feature of##2##3##(1990-9#1)(2011-2#1)
clinical feature##6##2##(1990-12#1)(1990-6#1)(1990-9#1)(2007-10#2)(2011-2#1)
clinical features and management of##2##5##(2010-5#1)(2012-3#1)
clinical features and management##3##4##(2008-7#1)(2010-5#1)(2012-3#1)
clinical features and##18##3##(1991-2#1)(1992-12#1)(1992-6#1)(2007-7#2)(2008-1#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
clinical features are##3##3##(1992-4#1)(1993-6#1)(2012-12#1)
clinical features associated with##2##4##(2007-10#1)(2013-1#1)
clinical features in##4##3##(1997-5#1)(2007-7#1)(2008-7#1)(2010-11#1)
clinical features of the##6##4##(1993-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
clinical features of##31##3##(1991-11#1)(1993-5#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#2)(2010-3#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
clinical features were##5##3##(2007-1#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#1)
clinical features##101##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-6#1)(1996-12#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#8)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#7)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#12)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#6)(2013-8#3)
clinical finding was##2##3##(2008-9#1)(2013-1#1)
clinical finding##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
clinical findings and##4##3##(1997-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
clinical findings are##2##3##(1997-8#1)(2007-7#1)
clinical findings of##2##3##(2007-7#1)(2009-7#1)
clinical findings##33##2##(1990-5#1)(1993-12#1)(1993-2#2)(1995-5#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-9#5)(2009-5#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
clinical follow-up##9##2##(2007-8#1)(2008-1#1)(2009-8#1)(2010-5#1)(2011-1#3)(2012-12#2)
clinical form##2##2##(2008-9#1)(2011-2#1)
clinical forms of the##2##4##(1993-2#1)(2008-10#1)
clinical forms of##7##3##(1993-2#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-9#1)(2012-3#1)
clinical forms##10##2##(1993-2#1)(2008-10#1)(2008-5#4)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
clinical gene therapy##4##3##(1994-5#1)(2007-11#1)(2008-1#1)(2008-8#1)
clinical governance and##2##3##(2008-11#1)(2012-12#1)
clinical governance##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
clinical grade##2##2##(2008-11#1)(2008-7#1)
clinical grading##2##2##(1997-3#1)(2012-3#1)
clinical grounds##5##2##(1994-7#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-8#1)
clinical group##2##2##(2008-9#1)(2012-3#1)
clinical groups##2##2##(1995-5#2)
clinical guideline development##2##3##(1996-1#1)(2012-2#1)
clinical guideline for##2##3##(1996-1#1)(2010-9#1)
clinical guideline##5##2##(1996-1#3)(2010-9#1)(2012-2#1)
clinical guidelines on the##2##4##(2008-3#1)(2008-8#1)
clinical guidelines##22##2##(1991-12#1)(1993-12#1)(1996-1#4)(1997-1#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-3#4)(2008-6#1)(2008-8#2)(2012-12#1)(2013-1#1)
clinical health##2##2##(2008-12#2)
clinical history and##4##3##(1996-9#1)(2009-4#1)(2012-2#2)
clinical history of##2##3##(2007-8#1)(2012-12#1)
clinical history##16##2##(1991-12#1)(1992-5#1)(1995-11#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
clinical illness##2##2##(1995-2#1)(2013-8#1)
clinical imaging##4##2##(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)
clinical immunology##4##2##(2006-10#1)(2012-12#3)
clinical impact of##7##3##(2008-10#2)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#2)
clinical impact##11##2##(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
clinical implication of these##2##4##(2008-5#1)(2009-7#1)
clinical implication of##4##3##(2008-1#1)(2008-5#1)(2009-7#1)(2012-3#1)
clinical implication##6##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-7#1)(2012-3#1)
clinical implications and##2##3##(2010-4#1)(2011-2#1)
clinical implications for##5##3##(2008-3#1)(2008-4#1)(2009-11#1)(2012-12#1)(2013-1#1)
clinical implications in##2##3##(2008-4#1)(2010-11#1)
clinical implications of##4##3##(1995-2#1)(2008-11#1)(2008-6#1)(2011-2#1)
clinical implications##40##2##(1991-6#1)(1992-3#1)(1993-12#2)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#3)(2010-2#1)(2010-4#2)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#4)(2013-7#1)
clinical importance of##3##3##(1997-8#1)(2008-5#1)(2008-6#1)
clinical importance##10##2##(1993-3#2)(1997-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-2#1)
clinical improvement and##5##3##(1991-2#1)(2008-11#1)(2010-7#1)(2011-1#1)(2013-1#1)
clinical improvement was observed##2##4##(2013-1#2)
clinical improvement was##4##3##(2008-3#1)(2013-1#2)(2013-8#1)
clinical improvement##21##2##(1990-2#1)(1991-2#1)(1996-1#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#6)(2013-8#1)
clinical indication##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
clinical indications for##4##3##(1991-2#1)(2008-7#1)(2013-8#2)
clinical indications##13##2##(1991-2#1)(1992-3#1)(1995-5#1)(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-8#2)
clinical indicator##2##2##(2008-4#1)(2012-2#1)
clinical indicators##3##2##(1993-8#1)(2008-4#1)(2013-8#1)
clinical indices##2##2##(2011-2#1)(2013-1#1)
clinical information and##2##3##(2008-9#1)(2012-2#1)
clinical information in##2##3##(1995-9#1)(1997-8#1)
clinical information may##2##3##(2008-10#1)(2008-9#1)
clinical information system##2##3##(1992-12#1)(1993-12#1)
clinical information systems##2##3##(1993-3#1)(1996-12#1)
clinical information##27##2##(1991-12#1)(1991-3#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-3#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
clinical inspection##2##2##(2008-10#1)(2013-8#1)
clinical interest##2##2##(1990-3#1)(2008-5#1)
clinical interpretation of##2##3##(1991-11#1)(1991-5#1)
clinical intervention##5##2##(1993-3#1)(1997-2#2)(2007-12#1)(2008-7#1)
clinical interventions are##2##3##(2007-11#1)(2009-9#1)
clinical interventions##3##2##(2007-11#1)(2009-9#1)(2012-12#1)
clinical interview##5##2##(2007-11#1)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
clinical investigation##8##2##(1993-11#1)(1993-8#1)(1996-9#1)(2007-11#1)(2008-12#1)(2010-6#1)(2011-1#1)(2013-8#1)
clinical investigations##8##2##(1992-3#1)(1994-7#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
clinical investigators##2##2##(1992-3#1)(1993-11#1)
clinical isolates from HIV-infected##2##4##(2008-5#2)
clinical isolates of C##2##4##(2008-5#2)
clinical isolates of Candida albicans##2##5##(2008-5#2)
clinical isolates of Candida##3##4##(2008-5#3)
clinical isolates of Pseudomonas aeruginosa##3##5##(2012-2#3)
clinical isolates of##18##3##(1995-2#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2012-2#3)
clinical isolates were revealed AluI(+)##2##5##(2011-1#2)
clinical isolates were revealed##3##4##(2011-1#3)
clinical isolates##34##2##(1995-2#1)(1997-3#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#11)(2008-7#2)(2008-8#2)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-2#4)
clinical issues##9##2##(1991-12#1)(1992-9#1)(2008-11#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-8#2)
clinical journal##2##2##(2007-10#2)
clinical judgement##5##2##(1996-9#1)(2008-4#1)(2011-2#1)(2013-8#2)
clinical judgment and##2##3##(1993-12#1)(2008-1#1)
clinical judgment##5##2##(1991-12#1)(1993-12#1)(2007-9#1)(2008-1#1)(2008-6#1)
clinical knowledge##6##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)
clinical laboratories in##2##3##(2008-11#1)(2011-2#1)
clinical laboratories##15##2##(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)
clinical laboratory professionals##2##3##(1994-12#2)
clinical laboratory sciences##2##3##(1994-12#2)
clinical laboratory##27##2##(1993-1#1)(1993-12#1)(1994-1#2)(1994-12#12)(1997-4#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#3)(2011-2#1)
clinical lacunar syndrome##3##3##(2009-10#3)
clinical leaders##2##2##(1997-2#2)
clinical leadership##2##2##(1997-2#1)(2008-12#1)
clinical learning environment##8##3##(2007-10#1)(2008-11#1)(2008-12#5)(2009-12#1)
clinical learning environments##2##3##(2008-11#2)
clinical learning##20##2##(2007-10#1)(2008-11#8)(2008-12#10)(2009-12#1)
clinical level##3##2##(2008-11#2)(2008-7#1)
clinical literature and##2##3##(1993-12#1)(2012-2#1)
clinical literature##9##2##(1992-12#1)(1993-12#3)(2008-1#1)(2008-10#1)(2008-12#1)(2010-6#1)(2012-2#1)
clinical malaria##2##2##(1994-11#1)(1997-4#1)
clinical management and##3##3##(1992-12#1)(2011-1#1)(2013-1#1)
clinical management of patients with##2##5##(2009-7#1)(2012-3#1)
clinical management of patients##3##4##(2008-11#1)(2009-7#1)(2012-3#1)
clinical management of##16##3##(2007-2#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
clinical management##38##2##(1992-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#2)(2009-5#1)(2009-7#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
clinical manifestation of primary##2##4##(1995-11#1)(2006-10#1)
clinical manifestation of##8##3##(1990-12#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)
clinical manifestation##13##2##(1990-12#1)(1991-11#1)(1995-11#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)
clinical manifestations and##4##3##(2006-10#1)(2008-1#1)(2008-7#1)(2013-1#1)
clinical manifestations of the disease##2##5##(2007-7#1)(2012-3#1)
clinical manifestations of##12##3##(1994-6#1)(2007-10#1)(2007-7#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
clinical manifestations were##3##3##(2007-10#2)(2013-1#1)
clinical manifestations##48##2##(1991-11#1)(1991-3#2)(1994-6#1)(1997-3#1)(1997-8#1)(2006-10#4)(2007-10#4)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#5)(2009-2#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#8)
clinical markers of##2##3##(2012-12#1)(2013-1#1)
clinical markers##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
clinical mastitis##5##2##(1990-6#1)(1992-2#1)(1993-2#1)(1996-8#2)
clinical material##5##2##(1993-1#1)(2007-8#3)(2011-1#1)
clinical materials##2##2##(2007-11#1)(2007-7#1)
clinical measures##2##2##(1996-3#1)(2008-10#1)
clinical medicine##22##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-3#2)
clinical method##2##2##(2008-10#1)(2008-7#1)
clinical methods##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
clinical model for##2##3##(1997-2#1)(2007-11#1)
clinical model##3##2##(1997-2#2)(2007-11#1)
clinical models##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
clinical monitoring of##4##3##(1995-2#1)(2007-12#1)(2008-7#1)(2013-1#1)
clinical monitoring##6##2##(1994-9#1)(1995-2#1)(2007-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
clinical needs##2##2##(2008-10#1)(2011-1#1)
clinical notes##2##2##(1992-3#1)(2012-3#1)
clinical nurse##6##2##(2008-11#2)(2012-3#1)(2013-1#2)(2013-8#1)
clinical nurses##5##2##(1991-2#1)(2008-1#1)(2008-12#1)(2013-1#2)
clinical nursing care##3##3##(2009-10#1)(2011-1#2)
clinical nursing diagnosis##3##3##(1990-2#3)
clinical nursing##12##2##(1990-2#3)(2008-11#1)(2008-12#4)(2009-10#1)(2010-3#1)(2011-1#2)
clinical nutrition##6##2##(1992-2#2)(1993-2#2)(1995-12#1)(1997-4#1)
clinical observation and##2##3##(2008-12#1)(2012-12#1)
clinical observation of##2##3##(1991-4#1)(2013-7#1)
clinical observation##11##2##(1990-10#2)(1991-4#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2012-12#1)(2013-7#1)
clinical observations##10##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-3#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)
clinical occurrence##2##2##(2008-1#1)(2013-8#1)
clinical oncology##10##2##(1994-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
clinical or pathological features of Sjögren's syndrome##2##7##(2008-7#2)
clinical or radiological##2##3##(2009-3#1)(2013-1#1)
clinical or##23##2##(1990-6#1)(1990-9#1)(1992-12#1)(1992-2#1)(1994-3#1)(1996-9#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#2)(2013-1#2)
clinical outcome after##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
clinical outcome at##2##3##(1995-11#1)(2008-7#1)
clinical outcome between the##2##4##(1997-3#1)(2011-2#1)
clinical outcome between##3##3##(1997-3#1)(2008-6#1)(2011-2#1)
clinical outcome in patients##2##4##(2008-7#1)(2011-2#1)
clinical outcome in##8##3##(1995-12#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
clinical outcome indicators for##2##4##(1997-1#2)
clinical outcome indicators##3##3##(1997-1#3)
clinical outcome is##4##3##(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
clinical outcome of##8##3##(1990-6#1)(2006-10#1)(2006-6#1)(2008-6#1)(2009-3#1)(2012-3#1)(2013-1#2)
clinical outcome with##2##3##(2007-12#2)
clinical outcome##64##2##(1990-6#1)(1991-2#1)(1992-10#1)(1995-11#1)(1995-12#1)(1997-1#4)(1997-3#3)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
clinical outcomes and patient satisfaction##2##5##(1995-1#1)(1997-1#1)
clinical outcomes and##9##3##(1994-1#1)(1995-1#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
clinical outcomes associated with##2##4##(2008-12#1)(2008-3#1)
clinical outcomes in patients##2##4##(2008-3#1)(2011-2#1)
clinical outcomes in##8##3##(2007-3#1)(2008-3#3)(2009-12#1)(2011-2#2)(2013-1#1)
clinical outcomes of##4##3##(2008-10#1)(2008-7#1)(2009-7#2)
clinical outcomes research##2##3##(1994-3#1)(1996-1#1)
clinical outcomes to##2##3##(2007-12#1)(2013-1#1)
clinical outcomes##68##2##(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#9)(2008-7#3)(2008-8#2)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2010-2#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#1)
clinical parameter##2##2##(2008-6#1)(2013-1#1)
clinical parameters and##3##3##(1995-3#1)(2010-12#1)(2011-1#1)
clinical parameters in##3##3##(1992-9#1)(2008-6#1)(2011-2#1)
clinical parameters of##3##3##(2008-7#1)(2011-1#1)(2012-3#1)
clinical parameters##27##2##(1990-5#1)(1992-9#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#3)
clinical pathology conference held by the##4##6##(2008-8#3)(2012-2#1)
clinical pathology##11##2##(1994-12#3)(2007-2#1)(2008-8#3)(2008-9#3)(2012-2#1)
clinical pathway##8##2##(2008-3#2)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#1)
clinical pathways##11##2##(1995-12#1)(1997-1#1)(1997-2#1)(2008-3#2)(2010-8#5)(2012-2#1)
clinical patients with##2##3##(2008-10#1)(2010-8#1)
clinical pattern##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
clinical patterns##2##2##(1993-5#1)(2008-12#1)
clinical pediatric##2##2##(2010-8#1)(2011-2#1)
clinical penetrance##5##2##(2008-5#5)
clinical performance of##3##3##(2008-1#1)(2009-8#1)(2011-2#1)
clinical performance##9##2##(1996-12#3)(2008-1#1)(2009-8#2)(2010-8#1)(2011-2#1)(2011-7#1)
clinical periodontal##3##2##(2008-12#3)
clinical perspective##3##2##(1997-8#1)(2008-11#2)
clinical perspectives##5##2##(1993-3#1)(1994-2#1)(2008-11#1)(2008-4#2)
clinical pharmacology##2##2##(1997-5#1)(2008-8#1)
clinical phase##3##2##(1992-6#1)(2006-6#1)(2008-10#1)
clinical phenomena##2##2##(2009-10#1)(2013-8#1)
clinical phenotype##7##2##(1992-3#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
clinical phenotypes##4##2##(2008-11#1)(2009-9#1)(2010-1#1)(2013-1#1)
clinical picture is##5##3##(1990-8#2)(1993-2#1)(1994-6#1)(1995-11#1)
clinical picture of##4##3##(1990-3#1)(1992-10#1)(2008-7#1)(2011-2#1)
clinical picture should##2##3##(2008-7#1)(2012-12#1)
clinical picture##33##2##(1990-2#1)(1990-3#2)(1990-8#2)(1990-9#1)(1991-3#1)(1992-10#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-7#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
clinical pictures##5##2##(1990-8#1)(2007-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
clinical placement opportunities##2##3##(2012-12#1)(2012-3#1)
clinical placement settings##2##3##(2008-11#2)
clinical placement##26##2##(1996-2#1)(2007-10#1)(2008-11#7)(2008-12#11)(2012-12#4)(2012-3#1)(2013-8#1)
clinical placements for##2##3##(2008-11#1)(2012-3#1)
clinical placements in##2##3##(2008-11#1)(2008-12#1)
clinical placements##19##2##(1995-3#2)(2008-11#6)(2008-12#7)(2010-3#2)(2012-12#1)(2012-3#1)
clinical point of view##2##4##(2008-10#1)(2009-7#1)
clinical potential of##2##3##(2008-7#2)
clinical potential##4##2##(2006-6#1)(2008-7#2)(2011-1#1)
clinical practice and outcomes##2##4##(1994-1#1)(2008-11#1)
clinical practice and research##3##4##(2008-6#1)(2010-11#1)(2012-2#1)
clinical practice and the##4##4##(1997-1#1)(2008-12#1)(2008-6#1)(2008-7#1)
clinical practice and##27##3##(1994-1#1)(1995-11#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#4)(2012-2#1)(2012-3#1)
clinical practice are discussed##2##4##(1994-12#1)(1994-3#1)
clinical practice are##3##3##(1994-12#1)(1994-3#1)(2010-9#1)
clinical practice evaluation##2##3##(1997-2#2)
clinical practice for##6##3##(1997-8#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-1#1)
clinical practice guideline##4##3##(2008-6#2)(2010-8#1)(2012-3#1)
clinical practice guidelines##5##3##(1993-12#2)(1994-12#1)(1996-2#1)(1996-3#1)
clinical practice has##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
clinical practice improvement##4##3##(1996-1#2)(1996-12#1)(1997-3#1)
clinical practice in the##2##4##(2008-11#1)(2010-11#1)
clinical practice in##7##3##(1993-3#1)(2008-11#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#2)
clinical practice is##9##3##(1994-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
clinical practice of##7##3##(1993-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
clinical practice through##2##3##(1997-2#1)(2008-12#1)
clinical practice to##4##3##(1993-3#1)(2008-11#1)(2009-8#1)(2010-12#1)
clinical practice using##2##3##(2007-11#1)(2013-1#1)
clinical practice was##4##3##(1990-5#1)(2008-12#1)(2012-1#1)(2013-8#1)
clinical practice with##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
clinical practice##262##2##(1990-5#2)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-5#2)(2007-8#3)(2008-1#4)(2008-10#7)(2008-11#32)(2008-12#10)(2008-3#7)(2008-5#2)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#13)(2010-11#5)(2010-12#9)(2010-3#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#14)(2012-1#4)(2012-12#5)(2012-2#9)(2012-3#8)(2013-1#10)(2013-7#1)(2013-8#6)
clinical practice]##7##2##(1991-3#1)(1993-5#1)(1996-3#1)(1997-5#1)(2009-5#1)(2012-3#1)(2013-1#1)
clinical practices and##3##3##(1992-12#1)(1992-3#1)(1997-2#1)
clinical practices##6##2##(1992-12#1)(1992-3#1)(1994-8#1)(1997-2#2)(2009-11#1)
clinical predictors of##2##3##(2008-7#1)(2013-1#1)
clinical predictors##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
clinical presentation and treatment##2##4##(2010-8#1)(2011-1#1)
clinical presentation and##11##3##(2007-7#1)(2008-1#1)(2008-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
clinical presentation in##2##3##(2008-7#1)(2011-2#1)
clinical presentation is##2##3##(1995-1#1)(2012-2#1)
clinical presentation may##2##3##(2007-8#1)(2008-1#1)
clinical presentation of the##3##4##(2007-4#1)(2008-11#1)(2013-7#1)
clinical presentation of this##2##4##(1990-6#1)(2011-2#1)
clinical presentation of##16##3##(1990-12#1)(1990-6#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)(2012-2#2)(2013-7#1)
clinical presentation was##2##3##(1996-3#1)(2007-8#1)
clinical presentation##69##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1995-1#1)(1996-3#2)(1997-8#1)(2007-10#1)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#3)(2008-11#5)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)
clinical presentations and##2##3##(1996-9#1)(2012-12#1)
clinical presentations##13##2##(1996-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
clinical preventive services##5##3##(1995-12#2)(1996-2#1)(2008-1#2)
clinical preventive##7##2##(1995-12#3)(1996-2#1)(1997-2#1)(2008-1#2)
clinical problem in the##2##4##(2010-12#1)(2011-2#1)
clinical problem in##4##3##(2008-7#1)(2010-12#2)(2011-2#1)
clinical problem of##2##3##(1997-8#1)(2007-9#1)
clinical problem##21##2##(1994-11#1)(1994-7#1)(1995-3#1)(1997-4#1)(1997-8#1)(2007-11#4)(2007-7#1)(2007-9#1)(2008-6#1)(2008-7#4)(2010-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
clinical problems##11##2##(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-6#1)(2013-1#1)
clinical procedures##2##2##(1992-3#1)(2008-2#1)
clinical process##4##2##(1993-3#1)(1995-3#1)(1997-3#1)(2008-11#1)
clinical processes##6##2##(1994-1#1)(1994-12#1)(1995-12#3)(1995-3#1)
clinical profile of##4##3##(2009-1#1)(2010-12#1)(2011-1#1)(2012-3#1)
clinical profile##8##2##(2009-1#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)
clinical profiles##3##2##(2011-2#1)(2012-3#2)
clinical program##4##2##(1991-1#2)(1994-12#1)(2010-4#1)
clinical programs##2##2##(1997-2#1)(2008-10#1)
clinical progress in this##2##4##(2007-5#1)(2011-2#1)
clinical progress##6##2##(2007-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
clinical progression and##2##3##(2011-1#1)(2012-2#1)
clinical progression##5##2##(1991-6#1)(1997-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
clinical properties##2##2##(1991-6#1)(2010-9#1)
clinical protocol##3##2##(2007-11#1)(2008-5#1)(2010-7#1)
clinical protocols##4##2##(1993-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
clinical purposes##3##2##(1990-8#1)(2010-11#1)(2013-8#1)
clinical quality improvement##2##3##(1994-3#1)(1996-1#1)
clinical quality##5##2##(1991-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-1#1)
clinical question##14##2##(2007-5#2)(2007-8#9)(2012-12#1)(2012-2#2)
clinical range##2##2##(2008-10#1)(2010-10#1)
clinical rationale##2##2##(2010-10#1)(2011-2#1)
clinical reality##4##2##(2010-10#1)(2010-5#1)(2011-2#2)
clinical realm##2##2##(2010-10#1)(2013-7#1)
clinical reasoning##3##2##(2008-11#1)(2008-12#2)
clinical recognition of this##2##4##(1997-3#1)(2008-10#1)
clinical records##4##2##(1992-9#1)(1993-11#1)(2006-10#1)(2012-3#1)
clinical recovery##5##2##(1992-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
clinical relevance of##5##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-4#1)(2012-3#1)
clinical relevant disease##2##3##(2010-11#2)
clinical remission in Japanese patients with##2##6##(2012-2#2)
clinical remission##6##2##(1990-3#1)(1993-2#1)(2008-8#1)(2010-12#1)(2012-2#2)
clinical report##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
clinical reports suggest##2##3##(2008-7#1)(2011-2#1)
clinical reports##8##2##(2008-7#1)(2011-2#4)(2011-7#1)(2012-1#1)(2013-7#1)
clinical research in##2##3##(1995-5#1)(1996-9#1)
clinical research##43##2##(1990-10#1)(1991-3#2)(1991-9#1)(1994-12#1)(1995-5#2)(1996-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#3)(2010-11#2)(2010-8#3)(2010-9#1)(2012-12#1)(2012-2#4)(2013-1#2)
clinical resistance to##3##3##(1993-9#1)(2008-11#1)(2013-1#1)
clinical resource##2##2##(1996-12#1)(2008-12#1)
clinical response of##5##3##(1991-3#1)(2008-5#2)(2008-8#1)(2013-1#1)
clinical response to treatment##3##4##(1993-2#1)(1996-8#1)(2013-8#1)
clinical response to##5##3##(1993-2#1)(1996-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
clinical response##25##2##(1991-3#2)(1991-6#3)(1993-2#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#4)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
clinical responses in##2##3##(1990-12#1)(2010-8#1)
clinical responses to##4##3##(1995-3#1)(2009-9#1)(2012-3#2)
clinical responses##10##2##(1990-12#1)(1991-3#1)(1995-3#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)
clinical result##2##2##(1995-11#1)(2007-11#1)
clinical results and##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
clinical results have been##2##4##(2010-8#1)(2013-1#1)
clinical results have##3##3##(2009-5#1)(2010-8#1)(2013-1#1)
clinical results of a##2##4##(2008-6#1)(2011-2#1)
clinical results of##5##3##(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
clinical results##28##2##(1990-2#1)(1990-6#3)(1991-3#1)(1993-11#1)(1993-9#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
clinical review##7##2##(1991-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
clinical risk factors##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
clinical role##6##2##(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
clinical routine##6##2##(1991-11#1)(1997-1#1)(2008-1#1)(2012-2#3)
clinical safety##5##2##(2007-11#1)(2008-8#2)(2011-2#1)(2011-3#1)
clinical sample##4##2##(1994-6#1)(1996-7#1)(1997-8#1)(2007-7#1)
clinical samples is included##2##4##(2008-4#1)(2008-9#1)
clinical samples of##2##3##(2007-7#1)(2008-10#1)
clinical samples were##2##3##(2007-7#1)(2013-8#1)
clinical samples##21##2##(1997-3#1)(1997-5#1)(2007-7#2)(2008-10#3)(2008-4#1)(2008-5#5)(2008-9#1)(2009-9#1)(2013-1#2)(2013-8#4)
clinical scenario##2##2##(2008-7#1)(2011-2#1)
clinical scenarios##7##2##(2008-3#1)(2008-7#3)(2010-12#2)(2012-3#1)
clinical sciences##3##2##(1994-12#3)
clinical score##2##2##(2007-11#1)(2008-5#1)
clinical scores of scaling##2##4##(2008-5#2)
clinical scores##3##2##(2008-5#2)(2011-2#1)
clinical scoring##2##2##(2008-5#1)(2011-2#1)
clinical screening##3##2##(1990-2#1)(1991-12#1)(2008-10#1)
clinical sequelae##2##2##(2011-2#2)
clinical services to##3##3##(1994-3#1)(1996-2#1)(2008-11#1)
clinical services##13##2##(1991-10#1)(1994-3#1)(1996-1#1)(1996-2#2)(1997-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-12#1)
clinical setting and##4##3##(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
clinical setting of##4##3##(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
clinical setting##42##2##(1991-11#1)(1992-3#2)(1993-11#1)(1993-3#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
clinical settings##33##2##(1995-1#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-7#1)
clinical severity of##4##3##(1997-6#1)(2007-6#1)(2008-7#1)(2011-1#1)
clinical severity##7##2##(1995-2#1)(1997-6#1)(2007-6#1)(2008-7#1)(2009-6#2)(2011-1#1)
clinical sign##5##2##(1991-8#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-7#1)
clinical significance and##2##3##(2008-10#1)(2013-2#1)
clinical significance as##2##3##(2008-10#1)(2008-3#1)
clinical significance of the##2##4##(1994-2#1)(2011-1#1)
clinical significance of##19##3##(1990-12#1)(1992-5#1)(1994-2#1)(1994-9#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-6#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
clinical significance##39##2##(1990-12#1)(1992-5#1)(1994-2#1)(1994-9#1)(1997-7#3)(2007-11#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-2#1)
clinical signs and symptoms##6##4##(1992-1#1)(1992-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
clinical signs and##9##3##(1992-1#1)(1992-5#1)(1992-9#1)(1994-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
clinical signs associated with##2##4##(1990-3#1)(1991-8#1)
clinical signs could be##2##4##(2008-5#1)(2010-8#1)
clinical signs of infective mononucleosis and##2##6##(2011-2#2)
clinical signs of##18##3##(1991-11#1)(1992-11#1)(1994-7#1)(1995-2#1)(1996-12#1)(2007-11#2)(2008-5#2)(2009-1#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
clinical signs were##2##3##(2007-11#1)(2008-5#1)
clinical signs##57##2##(1990-3#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-7#2)(1995-2#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#3)(2008-5#6)(2009-1#1)(2010-1#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#5)(2013-8#1)
clinical site availability##2##3##(2008-11#2)
clinical sites##4##2##(1996-12#1)(1997-5#1)(2007-10#1)(2012-12#1)
clinical situation and##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
clinical situation##11##2##(1990-2#1)(1990-9#1)(1992-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
clinical situations in##2##3##(2008-3#1)(2013-1#1)
clinical situations##13##2##(1992-11#1)(1992-6#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-3#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
clinical skill##3##2##(2008-11#3)
clinical skills and##3##3##(1992-3#1)(1996-1#1)(2008-12#1)
clinical skills in##3##3##(2008-11#1)(2008-12#1)(2012-1#1)
clinical skills may be##2##4##(1992-6#1)(2008-11#1)
clinical skills##19##2##(1992-3#2)(1992-6#3)(1994-2#1)(1995-6#2)(1996-1#1)(2008-11#4)(2008-12#3)(2011-1#1)(2012-1#1)(2012-12#1)
clinical specimens of##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
clinical specimens##11##2##(1992-6#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#3)
clinical spectrum of##2##3##(2008-4#1)(2010-9#1)
clinical spectrum##9##2##(1995-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
clinical staff##3##2##(1991-12#1)(1996-1#1)(2011-2#1)
clinical stage##13##2##(1990-8#1)(1990-9#1)(1992-9#1)(1996-9#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2012-3#1)
clinical stages I##2##3##(2008-1#2)
clinical stages##6##2##(1994-9#1)(1997-3#2)(2008-1#3)
clinical staging and##3##3##(1990-9#1)(1995-11#1)(2011-2#1)
clinical staging##7##2##(1990-9#3)(1995-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
clinical state of the patient##2##5##(1995-12#1)(2009-7#1)
clinical state##6##2##(1992-5#1)(1992-6#1)(1995-12#1)(1996-3#1)(2007-11#1)(2009-7#1)
clinical states##2##2##(1994-6#1)(2008-3#1)
clinical status and##3##3##(1995-5#1)(2008-4#1)(2013-1#1)
clinical status of the##3##4##(1994-12#1)(1995-11#1)(2008-7#1)
clinical status of##5##3##(1994-12#1)(1995-11#1)(2006-10#1)(2008-7#1)(2009-5#1)
clinical status##17##2##(1994-12#1)(1995-11#1)(1995-5#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#2)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#3)
clinical steps##2##2##(2009-8#2)
clinical strains##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
clinical strategies##2##2##(2008-6#1)(2012-12#1)
clinical studies and ADR reports##2##5##(2011-2#2)
clinical studies and##8##3##(1994-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)
clinical studies are necessary##2##4##(2011-2#1)(2013-8#1)
clinical studies are##9##3##(1997-3#1)(2008-10#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
clinical studies as##2##3##(2010-8#1)(2012-5#1)
clinical studies has##2##3##(2008-7#1)(2009-10#1)
clinical studies have been##2##4##(1993-3#1)(2012-2#1)
clinical studies have shown that##5##5##(2008-7#1)(2011-2#2)(2012-1#1)(2013-7#1)
clinical studies have shown##7##4##(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)(2013-7#1)
clinical studies have##16##3##(1992-2#1)(1993-3#1)(1994-11#1)(1996-9#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
clinical studies in##4##3##(2008-8#1)(2009-10#1)(2010-3#1)(2013-8#1)
clinical studies of this##2##4##(2008-1#1)(2008-5#1)
clinical studies of##10##3##(1990-8#1)(1990-9#1)(1992-2#1)(1996-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#2)(2011-7#1)
clinical studies on##3##3##(1994-2#1)(2009-7#1)(2013-8#1)
clinical studies suggesting##2##3##(2008-7#1)(2009-3#1)
clinical studies that focus on high-risk subjects as well as first-episode patients##2##12##(2009-8#2)
clinical studies that##5##3##(2008-7#2)(2009-8#2)(2010-5#1)
clinical studies to##8##3##(1994-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
clinical studies using##2##3##(2008-3#1)(2013-8#1)
clinical studies with##4##3##(2008-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
clinical studies##128##2##(1990-8#1)(1990-9#1)(1991-6#1)(1992-2#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-11#3)(2007-4#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#3)(2009-10#2)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#10)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#9)
clinical study in##3##3##(2007-9#1)(2011-2#1)(2013-1#1)
clinical study of the##2##4##(2012-2#1)(2012-3#1)
clinical study of##8##3##(1990-6#1)(2007-12#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)
clinical study on the##2##4##(1990-3#1)(1990-5#1)
clinical study on##6##3##(1990-3#1)(1990-5#1)(1995-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
clinical study##41##2##(1990-3#1)(1990-5#2)(1990-6#1)(1992-12#1)(1994-8#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-5#8)(2009-12#1)(2010-11#2)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)
clinical study]##2##2##(1990-3#1)(1990-5#1)
clinical subgroups with back pain and related disorders is offered##2##10##(2008-12#2)
clinical subgroups##4##2##(1995-12#1)(2008-12#2)(2008-7#1)
clinical subjects##2##2##(1994-12#1)(2008-3#1)
clinical success of##3##3##(2006-5#1)(2007-11#1)(2008-6#1)
clinical success##13##2##(1994-11#1)(1995-11#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#3)(2010-10#1)(2011-2#2)(2012-2#1)
clinical supervision in##2##3##(1996-7#1)(2008-4#1)
clinical supervision##7##2##(1996-7#2)(1997-7#1)(2008-11#3)(2008-4#1)
clinical support##5##2##(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
clinical surgery##2##2##(2007-5#1)(2008-7#1)
clinical survey was##2##3##(2013-1#2)
clinical suspicion to##2##3##(1997-2#1)(2010-6#1)
clinical suspicion##7##2##(1997-2#1)(2007-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
clinical symptom was##2##3##(2007-8#1)(2008-12#1)
clinical symptom##4##2##(1996-9#1)(2007-8#1)(2008-12#1)(2011-2#1)
clinical symptoms and signs##3##4##(1995-2#1)(2008-10#1)(2008-3#1)
clinical symptoms and##10##3##(1990-9#1)(1994-6#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
clinical symptoms are##3##3##(1991-6#1)(1997-1#1)(1997-3#1)
clinical symptoms caused by##2##4##(2009-6#1)(2011-2#1)
clinical symptoms of##10##3##(1992-2#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#2)(2008-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
clinical symptoms were##5##3##(1990-2#1)(1990-9#1)(2007-11#1)(2008-5#1)(2013-1#1)
clinical symptoms##53##2##(1990-11#1)(1990-2#1)(1990-9#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-6#1)(1995-2#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-6#1)(2006-10#1)(2007-11#5)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
clinical symptoms]##2##2##(1993-5#1)(2013-8#1)
clinical syndrome of##2##3##(2008-1#1)(2011-2#1)
clinical syndrome##10##2##(1993-10#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
clinical syndromes##3##2##(1990-3#1)(2008-5#1)(2009-4#1)
clinical system##4##2##(1994-12#1)(2008-7#1)(2013-8#2)
clinical systems##7##2##(1994-3#1)(2008-1#1)(2010-4#1)(2013-8#4)
clinical target volumes were##2##4##(2012-12#2)
clinical target volumes##4##3##(2012-12#4)
clinical target##5##2##(2008-2#1)(2012-12#4)
clinical teaching and##2##3##(2008-11#1)(2008-12#1)
clinical teaching##5##2##(1992-6#1)(2008-11#3)(2008-12#1)
clinical team##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
clinical techniques##2##2##(1995-2#1)(2012-3#1)
clinical test##5##2##(1991-2#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
clinical testing of sunscreens##2##4##(2008-5#2)
clinical testing of##5##3##(1995-5#1)(1996-6#1)(2008-5#3)
clinical testing##11##2##(1993-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-6#1)(2008-4#1)(2008-5#3)(2013-1#1)(2013-8#1)
clinical tests##2##2##(1992-6#1)(2008-12#1)
clinical therapies##2##2##(2010-11#2)
clinical thinking##2##2##(1994-2#1)(2013-1#1)
clinical tool for##4##3##(1993-12#2)(2008-10#1)(2009-11#1)
clinical tool in##3##3##(2008-3#1)(2008-5#1)(2012-3#1)
clinical tool##11##2##(1993-12#2)(1995-2#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-5#1)(2012-3#1)
clinical tools##2##2##(2007-11#1)(2013-1#1)
clinical training and##2##3##(1996-1#1)(2008-10#1)
clinical training##5##2##(1995-6#1)(1996-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
clinical translation##2##2##(2012-3#1)(2013-1#1)
clinical treatment of##2##3##(1991-1#1)(2012-12#1)
clinical treatment##9##2##(1991-1#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
clinical treatments##2##2##(2008-11#1)(2008-8#1)
clinical trial are##2##3##(1996-3#1)(2011-3#1)
clinical trial data##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
clinical trial design##4##3##(2007-9#1)(2010-3#1)(2010-7#1)(2012-3#1)
clinical trial evaluating##2##3##(2008-5#1)(2008-7#1)
clinical trial evidence##6##3##(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)
clinical trial for##7##3##(1994-5#1)(1995-9#1)(1997-4#1)(2008-5#3)(2010-10#1)
clinical trial has been##2##4##(1990-2#1)(2013-1#1)
clinical trial information##2##3##(2009-2#1)(2013-1#1)
clinical trial is the##2##4##(1996-6#1)(2011-2#1)
clinical trial of##17##3##(1994-2#1)(1994-9#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
clinical trial on##4##3##(1993-5#1)(2011-2#1)(2013-1#2)
clinical trial participation##2##3##(2008-11#1)(2012-3#1)
clinical trial showed that##2##4##(2008-6#1)(2013-8#1)
clinical trial showed##3##3##(2008-3#1)(2008-6#1)(2013-8#1)
clinical trial that##3##3##(1995-2#1)(1997-4#1)(2009-6#1)
clinical trial to evaluate##2##4##(1997-4#1)(2008-5#1)
clinical trial to##4##3##(1997-4#1)(1997-7#1)(2008-5#1)(2010-6#1)
clinical trial was conducted##2##4##(2010-8#2)
clinical trial was performed##3##4##(1991-3#1)(1994-6#1)(1996-9#1)
clinical trial was##8##3##(1991-2#1)(1991-3#1)(1994-6#1)(1996-1#1)(1996-9#1)(2010-12#1)(2010-8#2)
clinical trial with##7##3##(2008-3#1)(2008-5#2)(2008-6#1)(2010-2#1)(2013-1#2)
clinical trial##155##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-9#2)(1993-5#1)(1993-9#1)(1994-2#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-5#2)(1995-9#1)(1996-1#1)(1996-3#2)(1996-6#4)(1996-9#1)(1997-3#1)(1997-4#5)(1997-7#1)(1997-8#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#6)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#7)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#11)(2013-8#2)
clinical trials (RCTs)##4##3##(2008-10#1)(2009-8#1)(2010-11#1)(2010-3#1)
clinical trials -##2##3##(2012-3#2)
clinical trials allow##2##3##(1995-2#1)(2010-6#1)
clinical trials and other##2##4##(1996-3#1)(2008-11#1)
clinical trials and##16##3##(1990-9#1)(1992-2#1)(1995-9#1)(1996-3#1)(2007-4#1)(2008-11#1)(2008-5#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-12#1)
clinical trials are needed to##3##5##(2008-7#1)(2011-2#2)
clinical trials are warranted##2##4##(1992-12#1)(2011-2#1)
clinical trials are##12##3##(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#4)
clinical trials as a potential treatment for##3##7##(2008-5#3)
clinical trials as##6##3##(2008-5#5)(2009-6#1)
clinical trials by##2##3##(1996-9#1)(2008-5#1)
clinical trials comparing##2##3##(2008-6#1)(2010-5#1)
clinical trials conducted##2##3##(2008-2#1)(2008-5#1)
clinical trials dealing with##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
clinical trials designed to##2##4##(1997-4#1)(2008-11#1)
clinical trials for other##2##4##(2008-5#1)(2010-10#1)
clinical trials for the##2##4##(2008-5#1)(2008-7#1)
clinical trials for##6##3##(2008-5#2)(2008-7#1)(2009-4#1)(2010-10#1)(2012-3#1)
clinical trials have been##2##4##(2008-10#1)(2012-1#1)
clinical trials have demonstrated##2##4##(2008-8#2)
clinical trials have##12##3##(1991-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2010-5#1)(2012-1#1)(2012-12#2)(2013-1#1)
clinical trials in humans##2##4##(2006-6#1)(2010-5#1)
clinical trials in oncology##2##4##(2009-12#1)(2010-1#1)
clinical trials in the US for##2##6##(2008-5#2)
clinical trials in the##3##4##(2008-11#1)(2008-5#2)
clinical trials in##26##3##(1991-6#1)(1993-9#1)(1994-8#1)(1997-4#1)(2006-6#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#6)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
clinical trials is##8##3##(1996-6#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-6#1)(2013-7#1)
clinical trials of the##2##4##(1993-2#1)(2008-2#1)
clinical trials of##29##3##(1990-11#1)(1991-9#1)(1993-2#1)(1994-5#2)(1995-5#2)(2007-11#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
clinical trials on the##2##4##(2008-7#1)(2012-3#1)
clinical trials on##9##3##(1991-5#1)(1991-6#1)(1992-10#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
clinical trials should be##2##4##(2010-4#1)(2010-8#1)
clinical trials should##4##3##(1993-12#1)(2008-6#1)(2010-4#1)(2010-8#1)
clinical trials testing##3##3##(2008-11#1)(2012-12#2)
clinical trials that##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
clinical trials to##7##3##(2007-10#1)(2008-6#1)(2008-8#2)(2012-2#2)(2013-1#1)
clinical trials using##5##3##(1994-9#1)(1996-9#1)(1997-4#1)(2008-1#1)(2010-12#1)
clinical trials which##2##3##(1996-6#1)(2012-3#1)
clinical trials with these##2##4##(2007-9#1)(2008-5#1)
clinical trials with##10##3##(1992-9#1)(1995-2#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)
clinical trials##348##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#5)(1995-2#4)(1995-5#2)(1995-9#3)(1996-3#4)(1996-6#8)(1996-8#1)(1996-9#2)(1997-3#3)(1997-4#6)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#19)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#32)(2008-6#4)(2008-7#16)(2008-8#20)(2008-9#5)(2009-10#1)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#6)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#6)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#12)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#6)(2012-3#19)(2013-1#12)(2013-7#1)(2013-8#2)
clinical type##3##2##(1993-11#1)(2007-7#1)(2013-1#1)
clinical units##4##2##(1995-12#4)
clinical use for##4##3##(1996-11#1)(2008-10#1)(2008-5#1)(2009-7#1)
clinical use in##11##3##(1991-9#1)(1993-11#1)(1994-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-6#1)(2009-12#1)(2011-2#1)(2011-3#1)
clinical use is##2##3##(2008-9#1)(2012-12#1)
clinical use of the##3##4##(2007-11#1)(2008-12#1)(2010-6#1)
clinical use of these##2##4##(1995-12#1)(2008-10#1)
clinical use of ziprasidone##2##4##(2008-6#2)
clinical use of##23##3##(1990-3#1)(1991-12#1)(1992-3#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#3)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
clinical use without##2##3##(1993-2#1)(2007-11#1)
clinical use##73##2##(1990-3#1)(1991-12#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-7#2)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
clinical usefulness of the##4##4##(1991-1#1)(1992-10#1)(1992-9#1)(2013-8#1)
clinical usefulness of##8##3##(1991-1#1)(1992-10#1)(1992-9#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical usefulness##12##2##(1991-1#1)(1992-10#1)(1992-9#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical uses##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
clinical utility of##5##3##(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
clinical utility##13##2##(1997-3#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
clinical validation##4##2##(1996-2#1)(2008-1#1)(2010-5#1)(2012-2#1)
clinical value for##2##3##(2007-9#1)(2008-10#1)
clinical value of##9##3##(2007-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
clinical value##13##2##(2007-11#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
clinical variables##6##2##(1994-2#1)(2007-12#1)(2008-3#1)(2009-4#1)(2012-12#1)(2013-8#1)
clinical variations##2##2##(2007-7#1)(2011-1#1)
clinical work with##3##3##(1995-5#2)(2007-10#1)
clinical work##7##2##(1992-6#1)(1995-5#4)(2007-10#1)(2011-1#1)
clinical work-up in##2##3##(2013-8#2)
clinical work-up##7##2##(2013-8#7)
clinical worsening##2##2##(1995-11#1)(2008-8#1)
clinical##5340##1##(1990-10#7)(1990-11#4)(1990-12#11)(1990-2#22)(1990-3#35)(1990-5#22)(1990-6#20)(1990-8#10)(1990-9#23)(1991-1#8)(1991-10#1)(1991-11#11)(1991-12#20)(1991-2#24)(1991-3#32)(1991-4#4)(1991-5#3)(1991-6#22)(1991-8#11)(1991-9#11)(1992-1#7)(1992-10#6)(1992-11#3)(1992-12#20)(1992-2#18)(1992-3#25)(1992-4#1)(1992-5#16)(1992-6#22)(1992-8#1)(1992-9#19)(1993-1#2)(1993-10#2)(1993-11#19)(1993-12#37)(1993-2#22)(1993-3#23)(1993-5#12)(1993-6#7)(1993-8#5)(1993-9#14)(1994-1#9)(1994-10#2)(1994-11#12)(1994-12#97)(1994-2#22)(1994-3#18)(1994-5#11)(1994-6#15)(1994-7#8)(1994-8#6)(1994-9#11)(1995-1#11)(1995-10#1)(1995-11#14)(1995-12#24)(1995-2#27)(1995-3#16)(1995-5#19)(1995-6#7)(1995-8#5)(1995-9#11)(1996-1#20)(1996-10#1)(1996-11#11)(1996-12#17)(1996-2#18)(1996-3#27)(1996-5#3)(1996-6#19)(1996-7#6)(1996-8#6)(1996-9#23)(1997-1#19)(1997-2#42)(1997-3#50)(1997-4#25)(1997-5#15)(1997-6#13)(1997-7#19)(1997-8#33)(2006-10#27)(2006-12#6)(2006-5#1)(2006-6#7)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#55)(2007-11#96)(2007-12#62)(2007-2#9)(2007-3#1)(2007-4#8)(2007-5#12)(2007-6#2)(2007-7#51)(2007-8#67)(2007-9#10)(2008-1#83)(2008-10#193)(2008-11#266)(2008-12#158)(2008-2#30)(2008-3#102)(2008-4#66)(2008-5#199)(2008-6#70)(2008-7#237)(2008-8#129)(2008-9#98)(2009-1#5)(2009-10#31)(2009-11#21)(2009-12#21)(2009-2#6)(2009-3#15)(2009-4#34)(2009-5#25)(2009-6#23)(2009-7#15)(2009-8#27)(2009-9#18)(2010-1#10)(2010-10#35)(2010-11#53)(2010-12#64)(2010-2#9)(2010-3#32)(2010-4#16)(2010-5#45)(2010-6#46)(2010-7#11)(2010-8#80)(2010-9#14)(2011-1#90)(2011-10#1)(2011-2#301)(2011-3#11)(2011-7#10)(2011-8#1)(2012-1#27)(2012-12#146)(2012-2#142)(2012-3#158)(2012-5#2)(2012-7#1)(2012-8#1)(2013-1#287)(2013-2#1)(2013-7#20)(2013-8#141)
clinical&quot##2##1##(1991-12#1)(1994-12#1)
clinical-laboratory##2##1##(2008-4#1)(2008-5#1)
clinical/diagnostic##2##1##(1991-12#2)
clinical/pathological##2##1##(2009-4#1)(2010-11#1)
clinically acceptable##2##2##(1996-3#1)(2008-6#1)
clinically aggressive##2##2##(2006-12#1)(2008-6#1)
clinically and histologically##4##3##(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
clinically and radiologically##2##3##(2007-8#1)(2010-11#1)
clinically and statistically significant##2##4##(1997-6#1)(2008-12#1)
clinically and##28##2##(1990-9#1)(1991-11#1)(1992-2#1)(1994-2#1)(1994-7#1)(1995-12#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
clinically applicable##2##2##(2009-12#1)(2012-8#1)
clinically apply##2##2##(2008-11#1)(2008-3#1)
clinically approved##3##2##(2011-2#1)(2011-3#1)(2012-3#1)
clinically as an##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
clinically as##8##2##(1991-8#1)(1997-4#1)(2008-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
clinically asymptomatic##4##2##(2008-1#1)(2012-3#2)(2013-1#1)
clinically attractive##2##2##(1997-2#1)(2012-2#1)
clinically based service limitation##2##4##(1993-12#2)
clinically based##4##2##(1993-12#2)(2006-10#1)(2008-12#1)
clinically by##5##2##(1991-2#1)(1995-5#1)(1997-8#1)(2008-5#2)
clinically defined##3##2##(1997-2#2)(2012-3#1)
clinically diagnosed as##2##3##(2007-11#1)(2012-1#1)
clinically diagnosed##11##2##(1991-12#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-3#1)
clinically distinct##3##2##(2007-7#1)(2008-1#1)(2009-5#1)
clinically effective##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
clinically evaluated##4##2##(1991-5#1)(1992-2#1)(2008-11#1)(2011-3#1)
clinically evident##5##2##(1990-6#1)(1997-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
clinically healthy##7##2##(1991-11#1)(1991-6#1)(1994-11#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
clinically important differences##2##3##(1997-8#1)(2012-3#1)
clinically important for##2##3##(1994-9#1)(2008-7#1)
clinically important##27##2##(1992-5#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
clinically in##3##2##(1992-5#1)(2007-12#1)(2008-8#1)
clinically inexperienced student therapists##2##4##(2012-2#2)
clinically irrelevant##2##2##(2008-11#2)
clinically manifest##2##2##(1990-2#2)
clinically manifested##2##2##(2008-10#2)
clinically meaningful improvements##2##3##(2008-12#2)
clinically meaningful##7##2##(1995-5#1)(2008-12#4)(2008-7#1)(2012-12#1)
clinically more##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
clinically negative##2##2##(1991-2#1)(2008-10#1)
clinically normal##6##2##(1992-5#1)(1992-6#1)(1993-2#1)(2008-5#2)(2010-9#1)
clinically or##2##2##(2008-6#1)(2009-8#1)
clinically proven##4##2##(1996-12#1)(2011-2#3)
clinically related##2##2##(1996-1#1)(2008-11#1)
clinically relevant in##2##3##(2008-8#1)(2010-11#1)
clinically relevant information##2##3##(2008-11#1)(2012-3#1)
clinically relevant levels##3##3##(2008-10#2)(2008-11#1)
clinically relevant thrombotic vascular##2##4##(2008-7#2)
clinically relevant##56##2##(1991-6#1)(1995-2#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#6)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#5)
clinically significant improvement in##2##4##(2008-5#1)(2009-1#1)
clinically significant##31##2##(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
clinically silent##4##2##(2008-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
clinically similar##3##2##(1991-2#1)(2008-7#1)(2009-5#1)
clinically stable##2##2##(2008-7#1)(2013-8#1)
clinically suspect##3##2##(1997-2#1)(2011-2#2)
clinically suspected##5##2##(1996-8#1)(2012-12#2)(2012-3#1)(2013-8#1)
clinically to##4##2##(2008-8#1)(2009-12#1)(2010-11#1)(2010-7#1)
clinically used##4##2##(2008-4#2)(2009-8#1)(2010-8#1)
clinically useful drug##2##3##(1990-9#1)(2007-11#1)
clinically useful drugs##2##3##(2008-5#1)(2012-3#1)
clinically useful information##2##3##(2008-10#1)(2008-12#1)
clinically useful##23##2##(1990-9#1)(1991-12#1)(1992-3#1)(1994-11#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
clinically validated##3##2##(2008-8#1)(2010-11#1)(2011-2#1)
clinically well##2##2##(1992-2#1)(2007-12#1)
clinically with##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
clinically##427##1##(1990-10#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#2)(1993-12#4)(1993-2#3)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-7#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#3)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#4)(2006-12#1)(2007-11#10)(2007-12#4)(2007-4#1)(2007-7#5)(2007-8#5)(2008-1#13)(2008-10#17)(2008-11#22)(2008-12#10)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#20)(2008-6#5)(2008-7#23)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#4)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-3#1)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#13)(2011-2#29)(2011-3#2)(2012-1#4)(2012-12#11)(2012-2#17)(2012-3#18)(2012-4#1)(2012-8#1)(2013-1#17)(2013-8#9)
clinician and##6##2##(1991-1#1)(1992-9#1)(2008-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
clinician must##6##2##(1993-2#1)(2007-12#1)(2008-4#1)(2008-8#1)(2013-8#2)
clinician satisfaction##2##2##(2010-8#1)(2012-2#1)
clinician to obtain##2##3##(2010-12#1)(2013-1#1)
clinician to##10##2##(1991-2#1)(1994-12#1)(1996-1#1)(2006-10#1)(2007-9#1)(2008-12#2)(2008-7#1)(2010-12#1)(2013-1#1)
clinician will##2##2##(2008-7#1)(2012-3#1)
clinician##69##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#3)(2008-11#3)(2008-12#5)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#2)(2013-8#2)
clinician's##11##1##(1997-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#1)
clinicians and managers##4##3##(1994-1#1)(1995-3#1)(1997-1#1)(1997-4#1)
clinicians and patients##3##3##(2009-8#1)(2010-9#1)(2013-1#1)
clinicians and public health##2##4##(2009-3#1)(2013-1#1)
clinicians and researchers to##2##4##(2008-7#1)(2010-10#1)
clinicians and researchers##6##3##(2008-12#2)(2008-4#1)(2008-7#1)(2010-10#1)(2012-12#1)
clinicians and scientists##2##3##(2009-11#1)(2009-9#1)
clinicians and the##3##3##(2008-5#1)(2011-1#1)(2013-8#1)
clinicians and##36##2##(1990-6#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
clinicians are##2##2##(2008-9#1)(2011-2#1)
clinicians better##2##2##(2008-11#1)(2013-1#1)
clinicians can##2##2##(2011-2#1)(2012-2#1)
clinicians have##7##2##(1997-2#1)(1997-6#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-2#1)
clinicians in the##5##3##(1996-6#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)
clinicians in##12##2##(1994-9#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
clinicians is##3##2##(2008-3#1)(2010-4#1)(2011-1#1)
clinicians make##2##2##(1993-3#1)(2010-4#1)
clinicians must##3##2##(1992-3#1)(1993-2#1)(2008-2#1)
clinicians of##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
clinicians should be##2##3##(2008-7#1)(2008-8#1)
clinicians should##6##2##(2006-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-6#1)
clinicians to administer##2##3##(2008-3#1)(2013-1#1)
clinicians to focus##2##3##(2010-5#1)(2011-2#1)
clinicians to the##3##3##(2007-7#1)(2008-7#1)(2013-8#1)
clinicians to##26##2##(1991-1#1)(1992-3#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
clinicians were##4##2##(1993-8#1)(2008-12#1)(2009-4#1)(2010-12#1)
clinicians who##2##2##(2008-6#1)(2008-9#1)
clinicians with##6##2##(2008-11#2)(2008-7#2)(2008-8#2)
clinicians working##2##2##(2007-12#1)(2008-12#1)
clinicians##233##1##(1990-3#1)(1990-6#2)(1991-1#1)(1991-12#3)(1992-12#1)(1992-2#1)(1992-3#7)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#10)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#15)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#3)(2009-11#3)(2009-3#3)(2009-4#2)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#10)(2012-1#1)(2012-12#11)(2012-2#11)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#3)
clinicians' beliefs about biological##2##4##(2010-4#2)
clinicians' confidence in##2##3##(2011-2#1)(2012-2#1)
clinicians'##9##1##(2007-10#2)(2007-11#1)(2010-4#2)(2011-2#1)(2012-2#2)(2013-7#1)
clinico##2##1##(1990-3#1)(2009-11#1)
clinico-diagnostic perspective in##2##3##(2008-7#2)
clinico-pathologic characteristics##2##2##(2008-10#2)
clinico-pathologic##8##1##(1991-2#1)(1991-6#1)(1991-8#2)(2008-10#3)(2013-8#1)
clinico-pathological##5##1##(1990-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
clinicochemical##2##1##(1993-2#2)
clinicopathologic and##2##2##(1993-8#1)(2013-1#1)
clinicopathologic features and##2##3##(2008-11#1)(2011-2#1)
clinicopathologic features of##3##3##(1991-2#1)(1994-6#1)(2010-1#1)
clinicopathologic features##6##2##(1990-8#1)(1991-2#1)(1994-6#1)(2008-11#1)(2010-1#1)(2011-2#1)
clinicopathologic study of##3##3##(1990-6#1)(1993-6#1)(2012-1#1)
clinicopathologic study##4##2##(1990-6#1)(1993-6#1)(2007-10#1)(2012-1#1)
clinicopathologic##21##1##(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-7#1)(1995-4#1)(2007-10#1)(2008-11#2)(2009-5#1)(2010-1#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
clinicopathological and immunohistochemical##2##3##(2007-8#2)
clinicopathological and##3##2##(2007-8#3)
clinicopathological characteristics of##2##3##(2012-2#1)(2013-8#1)
clinicopathological characteristics##4##2##(2008-10#1)(2012-2#1)(2013-8#2)
clinicopathological##28##1##(1990-5#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#3)(1997-7#1)(2007-8#4)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#3)
clinics and hospitals##2##3##(1994-12#1)(1997-8#1)
clinics and##14##2##(1990-6#1)(1991-1#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-8#1)
clinics are##3##2##(1991-12#1)(2008-1#1)(2008-2#1)
clinics as well as##2##4##(2008-2#2)
clinics as##3##2##(2008-2#2)(2010-5#1)
clinics at##2##2##(1994-8#1)(2007-2#1)
clinics by##3##2##(1994-1#2)(1995-12#1)
clinics in the##4##3##(1991-6#1)(2008-11#1)(2008-2#1)(2012-12#1)
clinics in##16##2##(1990-3#1)(1991-6#1)(1996-12#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2009-7#1)(2011-1#3)(2012-12#1)(2013-1#1)
clinics of the##2##3##(2008-2#1)(2008-5#1)
clinics of##3##2##(2007-7#1)(2008-2#1)(2008-5#1)
clinics to##2##2##(2008-1#1)(2008-9#1)
clinics were##2##2##(2008-10#1)(2008-12#1)
clinics##127##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#5)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-9#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-5#1)(1997-8#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#4)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#6)(2008-2#7)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-7#2)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#7)(2011-2#3)(2011-3#1)(2012-12#5)(2013-1#5)(2013-8#4)
clinics]##2##1##(1996-2#1)(2013-8#1)
clinique et##2##2##(2013-1#2)
clinique##4##1##(2013-1#4)
cliniques##2##1##(2011-2#2)
clinodactyly of the##2##3##(1997-3#2)
clip##11##1##(1996-8#1)(2007-7#2)(2008-1#1)(2008-12#4)(2008-9#1)(2011-2#1)(2013-8#1)
clipped and##2##2##(1997-2#1)(2008-7#1)
clipped or##2##2##(1995-11#1)(2008-7#1)
clipped##11##1##(1995-11#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
clipping of##2##2##(1990-12#1)(2007-8#1)
clipping the##2##2##(1997-6#2)
clipping##19##1##(1990-12#1)(1995-11#1)(1996-9#3)(1997-3#1)(1997-6#3)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
clippings##2##1##(2008-12#1)(2008-8#1)
clips of##2##2##(2008-1#1)(2008-12#1)
clips were##2##2##(1997-5#1)(2008-12#1)
clips##10##1##(1997-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#4)(2012-2#1)
clitoral##2##1##(2007-7#1)(2008-10#1)
clival##2##1##(2006-12#1)(2011-2#1)
clivus##5##1##(2008-12#1)(2011-2#4)
cln2##2##1##(1991-5#2)
cloaca##3##1##(1996-12#1)(2007-12#1)(2008-6#1)
cloacae##13##1##(1992-6#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#4)(2010-6#3)(2011-2#1)
cloacal exstrophy##6##2##(2008-10#6)
cloacal samples##3##2##(1996-12#3)
cloacal sampling##2##2##(1996-12#2)
cloacal swab##2##2##(1996-12#2)
cloacal swabs##2##2##(2008-5#2)
cloacal##19##1##(1996-12#7)(2008-10#9)(2008-5#3)
cloak##4##1##(2012-2#4)
cloaking##2##1##(2012-2#2)
clobutinol##2##1##(2008-10#2)
clock and##5##2##(1995-2#1)(1995-3#1)(2009-8#3)
clock components##2##2##(2009-8#2)
clock is##2##2##(1997-1#1)(2008-4#1)
clock rate##2##2##(2008-3#2)
clock transition##4##2##(2007-12#3)(2008-2#1)
clock##33##1##(1991-12#1)(1994-5#4)(1995-2#3)(1995-3#2)(1997-1#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#6)
clock&quot##3##1##(1994-5#2)(2013-7#1)
clock- and phytochrome-regulated##2##3##(1995-2#2)
clock-##3##1##(1995-2#3)
clocks##3##1##(2007-12#1)(2008-11#1)(2009-7#1)
clodronate##4##1##(1993-11#1)(2007-11#1)(2008-7#1)(2012-1#1)
clofibrate##14##1##(1990-12#3)(1990-2#1)(1991-4#2)(1992-11#6)(1992-8#1)(2008-11#1)
clofibrate-inducible##2##1##(1992-8#2)
clofibric acid##2##2##(1992-11#1)(1995-3#1)
clogP##2##1##(2007-11#2)
clogging##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
clomiphene citrate##2##2##(1990-9#1)(2008-12#1)
clomiphene##4##1##(1990-9#1)(2008-12#1)(2011-1#2)
clomipramine##5##1##(2008-10#2)(2008-3#1)(2008-8#1)(2013-8#1)
clonal analysis of fine needle aspirates##2##6##(1994-7#2)
clonal analysis of##3##3##(1994-7#2)(2013-1#1)
clonal analysis##4##2##(1994-7#2)(2008-9#1)(2013-1#1)
clonal cell##2##2##(1992-8#1)(1993-12#1)
clonal chromosome##2##2##(1992-8#1)(1993-9#1)
clonal disorder##2##2##(2010-1#1)(2013-1#1)
clonal diversity##2##2##(1997-8#1)(2012-3#1)
clonal endocrine pancreatic glucagon-secreting##2##4##(1994-11#2)
clonal expansion of##2##3##(2008-1#1)(2013-8#1)
clonal expansion##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
clonal lineage of P##2##4##(2008-10#2)
clonal lineage##13##2##(2008-10#13)
clonal lineages of P##2##4##(2008-10#1)(2009-2#1)
clonal lineages of the##2##4##(2008-10#1)(2009-2#1)
clonal lineages of##5##3##(2008-10#3)(2009-2#2)
clonal lineages were identified in##2##5##(2008-10#2)
clonal lineages were identified##3##4##(2008-10#3)
clonal lineages were##4##3##(2008-10#4)
clonal lineages##28##2##(2008-10#25)(2009-2#3)
clonal or##2##2##(2008-10#1)(2008-9#1)
clonal organisms##2##2##(2008-9#1)(2009-2#1)
clonal population of##2##3##(2008-10#1)(2009-3#1)
clonal population##5##2##(2008-10#4)(2009-3#1)
clonal reproduction##4##2##(2008-10#3)(2008-9#1)
clonal spread##3##2##(2008-10#1)(2008-9#2)
clonal variation##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
clonal##136##1##(1990-9#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-7#2)(1995-2#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#63)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-9#11)(2009-2#8)(2009-3#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-4#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
clonality##10##1##(2008-10#3)(2008-5#3)(2009-8#3)(2012-2#1)
clonally propagated##2##2##(2008-10#2)
clonally related##2##2##(2008-10#1)(2008-9#1)
clonally##11##1##(1993-12#1)(2008-10#6)(2008-4#2)(2008-9#1)(2009-2#1)
clonazepam##5##1##(1991-12#2)(1997-4#1)(2008-10#1)(2010-3#1)
clone (P##2##2##(2011-2#2)
clone Y31##2##2##(1997-7#2)
clone analysis##2##2##(1993-2#1)(1995-6#1)
clone and the##2##3##(1991-12#1)(2008-8#1)
clone and##6##2##(1990-2#1)(1991-12#1)(1993-2#1)(1997-8#1)(2008-8#1)(2013-1#1)
clone as a probe##2##4##(1995-12#1)(1997-2#1)
clone as a##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
clone by##2##2##(1993-6#1)(2008-9#1)
clone coding for a##2##4##(1997-2#1)(2008-8#1)
clone contained a##2##3##(1993-8#1)(2008-8#1)
clone contained##4##2##(1993-8#2)(1997-9#1)(2008-8#1)
clone containing the##4##3##(1990-5#1)(1994-12#1)(1996-8#1)(1997-9#1)
clone containing##10##2##(1990-5#1)(1993-12#1)(1993-8#1)(1994-12#1)(1996-8#1)(1997-9#1)(2008-10#1)(2008-8#3)
clone contains a##2##3##(1993-12#1)(1994-11#1)
clone contains##3##2##(1990-11#1)(1993-12#1)(1994-11#1)
clone encoding the##5##3##(1990-5#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-6#1)
clone encoding##17##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-9#1)
clone expressing##2##2##(1990-5#1)(1993-8#1)
clone from a##8##3##(1990-7#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-3#1)
clone from##11##2##(1990-7#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-8#2)(1996-3#1)(2008-10#1)(2008-8#1)
clone had##2##2##(1995-8#1)(1997-8#1)
clone harboring##3##2##(1997-6#2)(2009-6#1)
clone in##5##2##(1990-12#1)(1993-6#1)(1994-8#1)(2008-4#1)(2008-8#1)
clone inserts##2##2##(1991-5#1)(1997-8#1)
clone is##7##2##(1991-9#1)(1993-6#3)(1994-6#1)(2008-8#1)(2008-9#1)
clone isolated from##2##3##(1994-11#1)(1995-11#1)
clone of a##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
clone of an##2##3##(1997-3#1)(2008-10#1)
clone of the##5##3##(1991-9#1)(1992-8#1)(1993-6#1)(1997-4#1)(2008-10#1)
clone of##19##2##(1990-11#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-6#1)(1994-12#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)
clone recognized a##2##3##(1991-12#1)(1997-7#1)
clone recognized##3##2##(1991-12#2)(1997-7#1)
clone showed that the##2##4##(1994-11#1)(1995-2#1)
clone that contains##2##3##(1993-3#1)(2008-4#1)
clone that##8##2##(1991-9#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-10#2)(2008-10#1)(2008-4#1)
clone the##6##2##(1991-9#1)(1993-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
clone to##2##2##(1990-2#1)(1996-2#1)
clone was identified##2##3##(2008-8#2)
clone was isolated and##2##4##(1991-9#1)(1994-11#1)
clone was isolated from a##2##5##(1993-6#1)(1995-8#1)
clone was isolated##4##3##(1991-9#1)(1993-6#1)(1994-11#1)(1995-8#1)
clone was##25##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-8#5)(2008-9#1)
clone which##3##2##(1993-6#1)(1994-11#1)(2008-8#1)
clone will##2##2##(1990-11#1)(1992-10#1)
clone with the##2##3##(1990-12#1)(1993-3#1)
clone with##6##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-8#1)(2008-11#1)(2008-9#1)
clone##322##1##(1990-11#9)(1990-12#8)(1990-2#6)(1990-5#8)(1990-6#1)(1990-7#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#5)(1991-7#1)(1991-9#8)(1992-10#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#8)(1993-2#7)(1993-3#5)(1993-6#10)(1993-8#5)(1993-9#1)(1994-11#13)(1994-12#8)(1994-6#3)(1994-8#7)(1994-9#1)(1995-11#7)(1995-12#1)(1995-2#10)(1995-6#5)(1995-8#9)(1996-10#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#8)(1997-8#4)(1997-9#3)(2007-2#1)(2008-10#22)(2008-11#25)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#4)(2008-8#21)(2008-9#14)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
clone)##2##1##(1992-6#1)(1995-6#1)
clone-corrected data##2##2##(2008-10#2)
clone-corrected##3##1##(2008-10#3)
cloned 4-cell embryos derived from##2##5##(2008-9#2)
cloned CLCrV##2##2##(2008-10#2)
cloned DNA fragment##2##3##(1991-9#1)(1994-6#1)
cloned DNA##11##2##(1991-9#1)(1994-12#1)(1994-6#1)(1997-4#2)(2008-10#5)(2008-2#1)
cloned RAPD markers##2##3##(2008-10#2)
cloned RAPD##3##2##(2008-10#3)
cloned a cDNA encoding a##2##5##(1992-8#1)(1995-11#1)
cloned a cDNA encoding##3##4##(1992-8#1)(1995-11#1)(2008-6#1)
cloned a cDNA##6##3##(1990-12#1)(1992-8#1)(1993-2#1)(1995-11#1)(2008-6#1)(2008-8#1)
cloned a novel human##2##4##(1997-6#1)(1997-7#1)
cloned a##13##2##(1990-12#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-6#1)(2008-8#1)(2008-9#1)
cloned and a##2##3##(1990-5#1)(2008-6#1)
cloned and analyzed##2##3##(2008-10#1)(2008-11#1)
cloned and characterised##3##3##(1993-3#1)(1993-6#1)(2008-7#1)
cloned and characterized a##3##4##(1991-9#1)(1993-3#1)(2008-10#1)
cloned and characterized##11##3##(1991-2#1)(1991-9#1)(1993-3#1)(1994-12#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-8#1)(2011-1#1)
cloned and expressed in Escherichia coli##3##6##(1993-12#1)(1997-3#1)(2008-10#1)
cloned and expressed in##7##4##(1993-12#2)(1993-3#1)(1994-12#1)(1997-3#1)(1997-6#1)(2008-10#1)
cloned and expressed##8##3##(1993-12#2)(1993-3#1)(1994-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)
cloned and its##5##3##(1990-11#1)(1994-12#1)(1997-7#2)(2008-10#1)
cloned and sequenced a##4##4##(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)
cloned and sequenced and##2##4##(1996-12#1)(2008-8#1)
cloned and sequenced the##8##4##(1992-12#1)(1993-9#1)(1994-11#1)(1995-6#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#1)
cloned and sequenced##57##3##(1990-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-7#1)(2008-10#18)(2008-2#1)(2008-5#3)(2008-8#3)(2008-9#1)(2013-1#1)
cloned and the##3##3##(2008-8#2)(2009-5#1)
cloned and##109##2##(1990-11#1)(1990-5#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#5)(1993-3#4)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-7#2)(2008-10#27)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#2)(2009-5#1)(2011-1#1)(2013-1#1)
cloned autolysin##2##2##(1997-6#2)
cloned based on its##2##4##(1993-9#1)(1995-8#1)
cloned based on##3##3##(1993-9#1)(1995-8#1)(2010-5#1)
cloned behind a##2##3##(1991-9#1)(2008-2#1)
cloned between##2##2##(2008-8#1)(2009-3#1)
cloned by a##3##3##(1993-2#1)(2008-11#1)(2009-2#1)
cloned by polymerase chain reaction##2##5##(1996-8#1)(2008-10#1)
cloned by screening##3##3##(1997-4#1)(1997-8#1)(2008-8#1)
cloned by##14##2##(1991-6#1)(1991-9#1)(1993-2#1)(1994-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#3)(2009-2#1)
cloned cDNA##6##2##(1992-12#1)(1992-3#1)(1994-11#1)(2008-10#3)
cloned cDNAs##4##2##(1990-11#1)(1991-5#1)(2008-10#2)
cloned embryos##4##2##(2008-9#3)(2013-1#1)
cloned foreign##3##2##(1997-4#3)
cloned fragments##4##2##(1990-12#1)(2008-10#3)
cloned from a human##2##4##(1994-11#1)(1997-2#1)
cloned from a single##2##4##(1993-12#1)(2008-10#1)
cloned from a##9##3##(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#2)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)
cloned from an##2##3##(1990-5#1)(1997-8#1)
cloned from human##4##3##(1993-11#1)(1994-6#1)(1995-6#2)
cloned from rat heart##2##4##(1991-12#1)(1992-11#1)
cloned from rat##4##3##(1991-12#1)(1992-11#1)(1993-3#1)(1996-12#1)
cloned from rice##2##3##(2008-8#2)
cloned from the##9##3##(1991-5#1)(1993-9#1)(1995-8#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-1#1)
cloned from##47##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-9#2)(1994-11#3)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#5)(2008-9#3)(2010-5#1)(2011-1#1)
cloned gene for##2##3##(1992-1#1)(1993-6#1)
cloned gene##15##2##(1991-9#2)(1992-1#1)(1993-6#1)(1994-3#6)(1995-6#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-8#1)
cloned genes##5##2##(1990-2#1)(1990-5#1)(1991-9#1)(1993-9#1)(1997-2#1)
cloned human##7##2##(1991-12#1)(1991-6#1)(1993-11#1)(1993-8#1)(1995-11#1)(2008-11#1)(2008-4#1)
cloned in a##5##3##(1990-11#1)(1992-8#1)(1993-6#1)(1997-3#2)
cloned in our laboratory##2##4##(1994-12#1)(2008-8#1)
cloned in the plasmid##2##4##(1990-5#1)(1994-12#1)
cloned in the##5##3##(1990-5#1)(1994-12#1)(1995-11#1)(1995-8#1)(2008-9#1)
cloned in##24##2##(1990-11#2)(1990-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#4)(1995-11#1)(1995-8#1)(1997-3#2)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2010-10#1)
cloned into Escherichia coli##2##4##(1993-9#1)(1997-4#1)
cloned into a plasmid vector##2##5##(1994-12#1)(2008-10#1)
cloned into a##10##3##(1990-5#1)(1993-12#1)(1993-6#2)(1994-12#2)(1997-6#1)(2008-10#3)
cloned into the plasmid##3##4##(1992-3#1)(1994-9#1)(2008-10#1)
cloned into the##8##3##(1991-6#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-8#2)
cloned into various##2##3##(2008-11#1)(2008-9#1)
cloned into##41##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-6#2)(1993-9#2)(1994-12#3)(1994-9#1)(1995-2#1)(1995-8#1)(1997-4#3)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-8#6)(2008-9#4)(2009-5#1)(2010-6#1)(2013-1#1)
cloned isolate 10##2##3##(2007-6#2)
cloned mu-##2##2##(1995-11#2)
cloned probes##2##2##(2008-10#1)(2008-9#1)
cloned recently##3##2##(1992-3#1)(1994-12#1)(1995-6#1)
cloned sequence##2##2##(2008-8#1)(2011-1#1)
cloned sequences##2##2##(1993-12#2)
cloned the cDNA##2##3##(1994-8#1)(2008-9#1)
cloned the human##2##3##(1994-8#1)(1997-7#1)
cloned the##16##2##(1990-11#1)(1991-6#1)(1991-9#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)
cloned two##3##2##(1993-6#1)(1994-12#1)(1994-9#1)
cloned using##3##2##(1991-9#1)(1996-10#1)(2010-6#1)
cloned viral##2##2##(2008-10#2)
cloned##505##1##(1990-11#9)(1990-12#6)(1990-2#2)(1990-5#8)(1990-8#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#8)(1991-7#1)(1991-9#14)(1992-1#1)(1992-10#3)(1992-11#4)(1992-12#2)(1992-3#8)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#14)(1993-2#2)(1993-3#7)(1993-6#11)(1993-8#2)(1993-9#9)(1994-11#6)(1994-12#20)(1994-3#8)(1994-6#3)(1994-8#3)(1994-9#5)(1995-11#7)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#9)(1995-8#8)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#4)(1996-8#2)(1997-2#9)(1997-3#4)(1997-4#14)(1997-6#5)(1997-7#11)(1997-8#5)(2007-6#5)(2007-7#2)(2008-10#87)(2008-11#16)(2008-2#4)(2008-4#9)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#41)(2008-9#27)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#3)(2011-1#3)(2013-1#4)(2013-8#1)
clones and by##2##3##(1993-2#1)(1996-2#1)
clones and functional##2##3##(2008-4#1)(2008-7#1)
clones and the##3##3##(1991-9#1)(1997-8#1)(2008-9#1)
clones and##18##2##(1991-9#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-6#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
clones appeared##2##2##(1992-2#1)(1996-2#1)
clones are genes##3##3##(2008-9#3)
clones are##10##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#6)
clones by##3##2##(1992-9#1)(1995-11#1)(2008-9#1)
clones can be##2##3##(1991-9#1)(1992-9#1)
clones consistently##2##2##(1991-6#1)(2012-3#1)
clones contain##2##2##(1997-4#1)(1997-8#1)
clones contained a##3##3##(1992-8#1)(1997-7#1)(2008-10#1)
clones contained##6##2##(1992-8#1)(1993-6#1)(1995-11#2)(1997-7#1)(2008-10#1)
clones containing the##2##3##(1990-5#1)(1990-8#1)
clones containing##6##2##(1990-5#1)(1990-8#1)(1994-12#2)(1996-12#1)(2008-5#1)
clones corresponding to##3##3##(1993-6#1)(1995-2#1)(1997-2#1)
clones could be##2##3##(1997-2#1)(2012-2#1)
clones could##3##2##(1997-2#1)(1997-7#1)(2012-2#1)
clones derived from the##2##4##(2008-10#1)(2012-2#1)
clones derived from##4##3##(1996-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
clones differed##2##2##(2008-10#1)(2008-9#1)
clones encoding the##2##3##(1991-6#1)(1995-8#1)
clones encoding##9##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-8#1)(1993-3#1)(1995-8#1)(1997-2#1)(2008-2#1)(2008-5#1)
clones exhibiting##4##2##(1991-9#1)(2008-11#3)
clones expressing##2##2##(2008-11#2)
clones for##9##2##(1992-10#1)(1992-2#1)(1992-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2012-3#1)
clones from a##5##3##(1991-12#1)(1994-12#1)(2008-10#2)(2008-11#1)
clones from the##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#3)
clones from##31##2##(1990-12#1)(1991-12#1)(1991-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-8#1)(1997-2#1)(2007-10#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#5)(2009-10#1)
clones had##4##2##(1993-8#1)(1994-9#1)(1997-3#1)(2008-11#1)
clones has##2##2##(1993-6#1)(2008-10#1)
clones have been##3##3##(1996-10#1)(1997-8#1)(2010-10#1)
clones have##5##2##(1990-12#1)(1996-10#1)(1997-8#1)(2008-11#1)(2010-10#1)
clones homoplasmic for the##2##4##(1994-8#2)
clones hybridized##2##2##(2008-10#2)
clones in##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-8#1)
clones into##2##2##(1997-7#2)
clones isolated from##3##3##(1991-2#1)(1993-11#1)(2008-11#1)
clones mapped to##3##3##(1997-8#1)(2012-3#2)
clones mapped##4##2##(1996-10#1)(1997-8#1)(2012-3#2)
clones may##2##2##(2008-10#1)(2008-11#1)
clones obtained##2##2##(1997-3#1)(2008-10#1)
clones of RNA##2##3##(2008-10#1)(2008-9#1)
clones of a##3##3##(1991-5#1)(1991-9#1)(1996-12#1)
clones of the##8##3##(1991-9#1)(1992-9#1)(1993-6#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-5#1)
clones of##37##2##(1991-2#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
clones on##3##2##(1993-12#1)(1996-12#1)(2011-2#1)
clones produced##2##2##(1995-3#1)(2008-11#1)
clones putatively##2##2##(1996-10#1)(2008-5#1)
clones reported##2##2##(1993-12#1)(2008-11#1)
clones representing##2##2##(1990-11#1)(2008-10#1)
clones revealed that##5##3##(1990-12#1)(1991-6#1)(1997-4#1)(1997-6#1)(1997-8#1)
clones revealed##9##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-12#1)(2008-3#1)
clones show##2##2##(2008-9#2)
clones showed##8##2##(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#2)
clones showing a##2##3##(2008-9#2)
clones showing##3##2##(2008-10#1)(2008-9#2)
clones spanning the##2##3##(1990-8#1)(1994-12#1)
clones spanning##4##2##(1990-5#1)(1990-8#1)(1994-12#1)(1996-12#1)
clones that are##2##3##(1996-10#1)(2008-4#1)
clones that##11##2##(1990-12#1)(1992-11#1)(1994-11#1)(1994-12#1)(1996-10#1)(1997-7#1)(2008-10#2)(2008-4#1)(2010-3#1)(2012-3#1)
clones to##4##2##(1996-8#1)(2007-2#1)(2008-10#1)(2008-11#1)
clones was##12##2##(1991-6#1)(1991-9#1)(1994-8#1)(1996-10#2)(2008-10#4)(2008-11#2)(2008-8#1)
clones were capable of##2##4##(2008-10#1)(2008-11#1)
clones were expressed##2##3##(1993-8#1)(1997-8#1)
clones were found to be##2##5##(1990-8#1)(1997-2#1)
clones were found to have##3##5##(1991-9#1)(1997-7#1)(2008-11#1)
clones were found to##7##4##(1990-8#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#1)
clones were found##8##3##(1990-8#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
clones were isolated and##2##4##(1992-3#1)(1993-3#1)
clones were isolated from##5##4##(1991-1#1)(1991-9#1)(2008-8#3)
clones were isolated which##2##4##(1992-3#1)(1993-2#1)
clones were isolated##12##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-3#1)(1997-7#1)(2008-8#3)
clones were obtained by a##2##5##(1993-12#1)(1996-8#1)
clones were obtained by##3##4##(1993-12#1)(1996-8#1)(2008-9#1)
clones were obtained from##2##4##(1997-7#1)(2008-9#1)
clones were obtained##9##3##(1993-12#1)(1996-8#1)(1997-7#1)(2008-8#3)(2008-9#3)
clones were screened from##2##4##(1997-4#1)(2008-8#1)
clones were sequenced##5##3##(1991-12#1)(1993-6#2)(1996-2#1)(1997-3#1)
clones were successfully##2##3##(1996-2#1)(2008-8#1)
clones were then##2##3##(2008-10#2)
clones were##75##2##(1990-5#2)(1990-8#2)(1991-1#1)(1991-12#2)(1991-9#2)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#2)(2008-10#11)(2008-11#4)(2008-5#1)(2008-8#9)(2008-9#8)(2010-10#1)(2010-3#1)(2012-3#1)
clones which##3##2##(1993-11#1)(1996-10#1)(2008-8#1)
clones whose expression was##2##4##(1993-6#1)(1994-12#1)
clones with an average insert size of##2##7##(1997-6#1)(2008-8#1)
clones with##10##2##(1992-9#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)
clones##554##1##(1990-11#2)(1990-12#8)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#8)(1991-1#1)(1991-12#4)(1991-2#3)(1991-5#1)(1991-6#7)(1991-9#11)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-6#2)(1992-8#7)(1992-9#10)(1993-11#5)(1993-12#5)(1993-2#4)(1993-3#4)(1993-6#13)(1993-8#8)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#16)(1994-2#1)(1994-5#2)(1994-8#4)(1994-9#4)(1995-11#5)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#5)(1996-10#18)(1996-12#11)(1996-2#13)(1996-6#4)(1996-8#8)(1997-2#13)(1997-3#4)(1997-4#7)(1997-6#5)(1997-7#10)(1997-8#20)(1997-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#87)(2008-11#48)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#12)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#21)(2008-9#43)(2009-10#3)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#2)
clones)##2##1##(1996-8#1)(2008-10#1)
clonidine and##2##2##(1990-11#1)(1997-4#1)
clonidine##16##1##(1990-11#1)(1992-8#2)(1993-12#3)(1997-4#4)(2008-10#1)(2008-5#1)(2008-7#2)(2009-4#2)
cloning and DNA##2##3##(1993-12#1)(2008-8#1)
cloning and LIC##2##3##(1997-4#2)
cloning and analysis of##2##4##(1991-9#1)(1994-12#1)
cloning and characterization of the##4##5##(1993-11#1)(1993-3#1)(1995-8#1)(1997-8#1)
cloning and characterization of##13##4##(1990-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-8#2)(1997-8#1)(2010-5#1)
cloning and chromosomal localization of##2##5##(1990-12#1)(1994-8#1)
cloning and chromosomal##3##3##(1990-12#1)(1994-8#1)(1997-8#1)
cloning and expression of a human##2##6##(1992-8#1)(1993-6#1)
cloning and expression of a##3##5##(1990-11#1)(1992-8#1)(1993-6#1)
cloning and expression of##8##4##(1990-11#1)(1990-5#1)(1991-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1997-4#1)(2012-3#1)
cloning and expression vectors##2##4##(1994-12#2)
cloning and expression##14##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#2)(1997-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
cloning and function##2##3##(2008-9#2)
cloning and functional expression of##2##5##(1990-8#1)(2008-4#1)
cloning and identification of##2##4##(1997-3#1)(2008-8#1)
cloning and sequence analysis of a##2##6##(1993-2#1)(1997-4#1)
cloning and sequence analysis of##3##5##(1991-5#1)(1993-2#1)(1997-4#1)
cloning and sequence of##3##4##(1990-7#1)(1992-3#1)(1993-2#1)
cloning and sequence##6##3##(1990-7#1)(1991-5#1)(1992-3#1)(1993-2#2)(1997-4#1)
cloning and sequencing of a cDNA encoding a##2##8##(1994-12#1)(1997-1#1)
cloning and sequencing of a##3##5##(1994-12#1)(1997-1#1)(1997-4#1)
cloning and sequencing of the##3##5##(1995-6#1)(1995-8#1)(2008-4#1)
cloning and sequencing of##8##4##(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)
cloning and sequencing##12##3##(1990-5#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-4#1)(2011-2#1)
cloning and##73##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-9#2)(1992-3#4)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#6)(1994-8#2)(1995-6#2)(1995-8#3)(1997-1#1)(1997-3#1)(1997-4#6)(1997-8#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-8#3)(2008-9#3)(2010-5#1)(2011-2#1)(2012-3#1)
cloning data indicate that##2##4##(1993-2#1)(1994-12#1)
cloning efficiency##6##2##(1993-11#1)(1994-12#1)(1997-4#1)(2008-7#1)(2008-9#2)
cloning in##3##2##(1991-7#1)(1997-4#1)(2008-2#1)
cloning method##3##2##(2008-11#1)(2008-4#2)
cloning of PCR products##2##4##(2008-2#2)
cloning of a cDNA encoding##2##5##(1992-8#1)(1993-3#1)
cloning of a full-length cDNA##3##5##(1991-2#1)(1994-12#1)(1996-3#1)
cloning of a novel##5##4##(1994-12#2)(1994-6#1)(1995-8#1)(1997-7#1)
cloning of a##18##3##(1990-5#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#3)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-9#1)
cloning of cDNAs##2##3##(1990-8#1)(2008-2#1)
cloning of genes##2##3##(1991-7#1)(2008-1#1)
cloning of human##4##3##(1991-12#1)(1993-3#1)(1994-11#2)
cloning of the cDNA##2##4##(1995-2#1)(2008-8#1)
cloning of the gene##2##4##(1997-3#1)(2008-10#1)
cloning of the genes##2##4##(1992-9#1)(2008-8#1)
cloning of the human##3##4##(1994-11#1)(1994-3#1)(1995-11#1)
cloning of the mouse##2##4##(1992-11#1)(2008-4#1)
cloning of the##32##3##(1990-11#1)(1991-12#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#1)
cloning of this##5##3##(1992-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2012-3#1)
cloning of two##2##3##(1994-11#1)(2008-7#1)
cloning of##99##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#4)(1994-11#8)(1994-12#5)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-12#1)(2009-8#1)(2011-1#1)(2012-3#1)
cloning procedures##2##2##(1997-4#1)(2008-11#1)
cloning sites##8##2##(1990-5#1)(1991-9#1)(1993-12#2)(1993-8#2)(1994-12#1)(2011-1#1)
cloning system##3##2##(1991-9#2)(2008-4#1)
cloning techniques##2##2##(1994-6#1)(2008-8#1)
cloning vector##7##2##(1991-9#1)(1993-6#1)(1993-8#1)(1995-8#1)(2008-6#1)(2008-9#1)(2011-1#1)
cloning vectors##3##2##(1991-9#1)(1993-12#2)
cloning was##3##2##(1993-12#1)(2008-8#1)(2010-6#1)
cloning##306##1##(1990-11#2)(1990-12#2)(1990-5#7)(1990-7#1)(1990-8#2)(1991-12#5)(1991-2#5)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#8)(1992-11#2)(1992-12#1)(1992-3#6)(1992-6#2)(1992-8#6)(1992-9#1)(1993-11#5)(1993-12#11)(1993-2#9)(1993-3#7)(1993-6#5)(1993-8#10)(1994-11#9)(1994-12#29)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#5)(1995-8#6)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#14)(1997-5#2)(1997-7#3)(1997-8#2)(1997-9#1)(2007-6#1)(2008-1#1)(2008-10#17)(2008-11#11)(2008-2#10)(2008-4#14)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#17)(2008-9#16)(2009-12#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#2)(2012-3#3)(2013-1#1)
clonogen##2##1##(1995-2#1)(1995-9#1)
clonogenic assay##4##2##(1993-9#1)(1995-3#1)(2008-11#1)(2008-7#1)
clonogenic assays##2##2##(1990-12#1)(2008-11#1)
clonogenic##11##1##(1990-12#1)(1993-9#2)(1994-8#1)(1995-2#1)(1995-3#1)(2008-11#3)(2008-7#2)
clonogens per##2##2##(1995-2#2)
clonogens##5##1##(1995-2#5)
clonus##2##1##(1995-12#1)(2010-3#1)
clopidogrel alone##2##2##(2008-11#1)(2008-8#1)
clopidogrel and##4##2##(2006-6#1)(2008-3#1)(2011-2#2)
clopidogrel bisulphate##4##2##(2008-10#4)
clopidogrel has been##2##3##(2008-4#1)(2009-5#1)
clopidogrel is##2##2##(2008-4#1)(2008-8#1)
clopidogrel resistance##2##2##(2008-4#1)(2009-5#1)
clopidogrel##35##1##(2006-6#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-4#8)(2008-8#4)(2009-5#2)(2011-2#6)(2012-12#1)(2013-8#1)
cloramphenicol and##2##2##(2008-10#1)(2008-5#1)
cloramphenicol##3##1##(2008-10#2)(2008-5#1)
clorpirifos##2##1##(2007-10#2)
closantel##4##1##(1991-8#2)(2011-1#2)
close agreement between##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
close agreement##12##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
close analysis of##2##3##(1994-6#1)(2008-11#1)
close association between##6##3##(1993-1#1)(1996-5#1)(1997-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
close association of##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
close association with##10##3##(1992-1#1)(1995-12#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-9#1)(2011-1#1)
close association##21##2##(1992-1#1)(1993-1#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
close attention##3##2##(1995-2#1)(2011-1#1)(2012-2#1)
close by##2##2##(2009-5#1)(2009-8#1)
close co-operation##2##2##(2008-2#1)(2008-6#1)
close collaboration between##3##3##(1991-2#1)(2008-10#1)(2010-10#1)
close collaboration##5##2##(1991-2#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-2#1)
close communication with##2##3##(1996-12#1)(2009-2#1)
close connection with the##2##4##(1994-12#1)(2008-10#1)
close connection with##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
close connection##5##2##(1993-6#1)(1994-12#1)(2008-10#2)(2008-8#1)
close contact with##7##3##(1995-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#2)
close contact##16##2##(1990-12#1)(1991-11#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-5#2)(2011-1#1)(2011-2#2)
close cooperation between the##2##4##(1995-5#1)(2011-4#1)
close cooperation between##3##3##(1991-2#1)(1995-5#1)(2011-4#1)
close cooperation##5##2##(1991-2#1)(1995-5#1)(2007-11#1)(2010-7#1)(2011-4#1)
close correlation between the##2##4##(1996-12#1)(2008-12#1)
close correlation between##4##3##(1996-12#1)(2008-10#2)(2008-12#1)
close correlation with##3##3##(1996-3#1)(2008-11#1)(2008-3#1)
close correlation##12##2##(1990-2#1)(1990-9#1)(1991-12#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)
close enough to the##2##4##(2008-10#1)(2008-3#1)
close enough to##7##3##(1991-8#2)(1994-5#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
close enough##8##2##(1991-8#2)(1994-5#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
close examination of the##2##4##(1997-2#1)(2008-2#1)
close examination##3##2##(1997-2#1)(2008-2#1)(2008-8#1)
close follow-up##4##2##(1992-9#1)(1996-11#1)(1997-4#1)(2009-6#1)
close friend##3##2##(2007-12#3)
close friends with##2##3##(2009-7#1)(2011-2#1)
close friends##4##2##(2009-5#1)(2009-7#2)(2011-2#1)
close look at##2##3##(2008-10#1)(2010-8#1)
close monitoring and##3##3##(2007-11#1)(2010-1#1)(2010-6#1)
close monitoring of visual function##2##5##(2013-1#2)
close monitoring##7##2##(2007-11#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#3)
close of##3##2##(2006-10#1)(2008-1#1)(2012-3#1)
close or##2##2##(2008-11#1)(2008-12#1)
close phylogenetic##3##2##(1994-11#1)(1996-12#1)(2007-12#1)
close proximity in##2##3##(1993-11#1)(2008-2#1)
close proximity of the##2##4##(1994-5#1)(2008-3#1)
close proximity of##3##3##(1994-5#1)(2008-3#1)(2013-1#1)
close proximity to the##7##4##(1992-9#1)(1994-5#1)(1996-4#1)(1996-7#1)(2008-10#2)(2010-5#1)
close proximity to##12##3##(1992-9#1)(1994-5#1)(1996-4#1)(1996-7#1)(2008-10#5)(2009-12#1)(2010-5#1)(2012-12#1)
close proximity##24##2##(1992-9#1)(1993-11#1)(1994-5#2)(1995-2#1)(1996-4#1)(1996-7#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#1)(2009-12#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
close relation between##4##3##(1992-11#1)(1994-6#1)(1996-12#1)(2008-7#1)
close relations##2##2##(1991-8#1)(2008-10#1)
close relationship between the##5##4##(1992-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
close relationship between##12##3##(1992-8#1)(1995-12#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-8#1)
close relationship of##4##3##(1996-8#1)(2008-10#1)(2008-5#1)(2010-6#1)
close relationship with##5##3##(1994-12#2)(2008-10#2)(2011-2#1)
close relationship##23##2##(1992-8#1)(1993-2#1)(1994-12#2)(1995-12#1)(1996-8#1)(2007-5#1)(2008-10#7)(2008-5#2)(2008-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-8#1)
close relationships among##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
close relationships##7##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#2)
close relative of##3##3##(1995-2#1)(2008-10#2)
close relative##4##2##(1995-2#1)(2008-10#2)(2008-8#1)
close relatives of##2##3##(1994-2#1)(1997-4#1)
close relatives##10##2##(1990-11#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-5#2)
close resemblance to##4##3##(1992-8#1)(1993-11#1)(2007-5#1)(2008-3#1)
close the gap between##2##4##(2009-8#1)(2010-12#1)
close the gap##3##3##(1993-2#1)(2009-8#1)(2010-12#1)
close the##10##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-3#1)(2008-11#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)
close ties##3##2##(1993-6#1)(2010-5#1)(2011-2#1)
close to 0 and##2##4##(2008-10#1)(2008-8#1)
close to 0##4##3##(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
close to 1##7##3##(2007-11#1)(2008-10#3)(2008-8#1)(2012-2#2)
close to 100% for##3##4##(2008-10#2)(2008-5#1)
close to 100%##12##3##(2008-10#9)(2008-5#3)
close to 2##2##3##(2008-2#1)(2008-9#1)
close to 2%##2##3##(2008-10#2)
close to 30%##2##3##(2008-7#1)(2012-3#1)
close to 7##2##3##(2008-10#1)(2008-5#1)
close to Xgwm295##2##3##(2008-10#2)
close to a##3##3##(1992-6#1)(2007-11#1)(2008-5#1)
close to and far from the source##2##7##(2008-3#2)
close to and far from the##3##6##(1993-8#1)(2008-3#2)
close to each other##3##4##(2006-6#1)(2008-2#1)(2013-8#1)
close to its##4##3##(1991-9#1)(2008-10#1)(2008-7#1)(2009-4#1)
close to that of the##2##5##(1995-11#1)(2008-5#1)
close to that of##8##4##(1995-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)
close to that##10##3##(1990-12#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)
close to the angle of total reflection##2##7##(2008-3#2)
close to the catalytic##2##4##(2009-7#1)(2011-1#1)
close to the diffraction limit##2##5##(2007-11#1)(2007-12#1)
close to the edge of a##2##6##(2008-3#1)(2013-7#1)
close to the edge of the##2##6##(2008-2#1)(2008-3#1)
close to the edge of##4##5##(2008-2#1)(2008-3#2)(2013-7#1)
close to the edge##5##4##(2008-2#1)(2008-3#2)(2008-6#1)(2013-7#1)
close to the hip##2##4##(2008-4#2)
close to the ideal##2##4##(1995-6#1)(2008-3#1)
close to the real##2##4##(2007-4#1)(2013-1#1)
close to the source##3##4##(1994-9#1)(2008-3#2)
close to the tissue surface##2##5##(2008-3#2)
close to the zero##2##4##(2007-11#1)(2008-11#1)
close to the##127##3##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#3)(1990-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#5)(2008-3#19)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
close to theoretical##2##3##(2008-3#1)(2011-2#1)
close to those of##4##4##(2008-3#1)(2008-8#1)(2009-5#1)(2009-7#1)
close to those##9##3##(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)
close to unity##2##3##(2008-3#2)
close to zero##3##3##(1990-8#1)(1994-11#1)(2008-3#1)
close to##276##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-11#9)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#54)(2008-11#7)(2008-2#15)(2008-3#33)(2008-4#7)(2008-5#11)(2008-6#5)(2008-7#5)(2008-8#7)(2008-9#8)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#6)
close together in atomic number##2##5##(2006-4#2)
close together##6##2##(1993-3#1)(2006-4#2)(2008-10#1)(2008-3#1)(2012-2#1)
close vicinity##4##2##(1994-8#1)(2007-12#1)(2012-3#1)(2013-1#1)
close##595##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#3)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#7)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-4#3)(2006-6#1)(2007-10#1)(2007-11#12)(2007-12#14)(2007-4#1)(2007-5#3)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#105)(2008-11#15)(2008-12#7)(2008-2#21)(2008-3#46)(2008-4#13)(2008-5#23)(2008-6#9)(2008-7#10)(2008-8#16)(2008-9#13)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#7)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#7)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#14)(2011-4#1)(2012-12#5)(2012-2#12)(2012-3#5)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#10)
close-packed##4##1##(1995-3#1)(2008-3#3)
close-proximity##3##1##(2009-5#3)
closed and##8##2##(1992-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
closed by##5##2##(1993-11#1)(1994-2#1)(2007-8#1)(2008-11#1)(2008-2#1)
closed circuit##3##2##(2010-8#1)(2011-2#2)
closed circular##6##2##(1990-11#2)(1992-11#1)(1995-2#1)(1995-3#1)(2008-10#1)
closed colonies##2##2##(2012-3#2)
closed down##2##2##(1996-5#1)(1997-8#1)
closed form and##2##3##(2008-3#1)(2008-6#1)
closed form##5##2##(1993-3#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-9#1)
closed fringes##2##2##(2008-2#2)
closed from##2##2##(1994-2#1)(2007-8#1)
closed head injury##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
closed head##4##2##(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
closed intramedullary##2##2##(2007-11#2)
closed loop##4##2##(2007-11#1)(2008-10#1)(2008-7#2)
closed loops in##2##3##(2008-3#1)(2008-7#1)
closed loops##4##2##(2008-3#1)(2008-7#3)
closed questions##2##2##(2008-11#1)(2012-12#1)
closed reduction and##5##3##(2007-8#2)(2009-3#1)(2013-7#2)
closed reduction of developmental##2##4##(2007-8#1)(2013-7#1)
closed reduction of##4##3##(2007-8#1)(2011-2#1)(2013-7#2)
closed reduction##15##2##(2007-8#6)(2009-3#1)(2011-2#3)(2013-7#5)
closed shell##2##2##(1992-8#1)(2013-1#1)
closed state##2##2##(2008-8#2)
closed system##4##2##(2008-10#4)
closed to##10##2##(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
closed using##2##2##(1991-12#1)(1992-2#1)
closed vessel microwave##3##3##(2008-10#3)
closed vessel##5##2##(2008-10#5)
closed vessels##2##2##(2008-10#2)
closed with##3##2##(1993-2#1)(2007-8#1)(2008-10#1)
closed##200##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#3)(2006-7#1)(2007-11#5)(2007-12#4)(2007-8#14)(2008-1#2)(2008-10#38)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#3)(2010-2#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#12)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#6)(2013-8#5)
closed-chamber##2##1##(2008-3#2)
closed-form expression for the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
closed-form expression for##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
closed-form expression##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
closed-form solution##3##2##(2007-12#1)(2008-6#1)(2012-1#1)
closed-form##17##1##(2007-11#2)(2007-12#3)(2008-2#5)(2008-3#4)(2008-6#2)(2012-1#1)
closed-fringe pattern is##2##3##(2008-3#2)
closed-fringe pattern##4##2##(2008-3#4)
closed-fringe##6##1##(2008-2#1)(2008-3#5)
closed-loop bandwidth is##2##3##(2008-2#2)
closed-loop bandwidth settings are##2##4##(2008-2#2)
closed-loop bandwidth settings to maximize imaging-system performance##2##7##(2008-2#2)
closed-loop bandwidth settings##4##3##(2008-2#4)
closed-loop bandwidth##7##2##(2008-2#7)
closed-loop control##5##2##(2008-7#1)(2009-9#1)(2013-1#3)
closed-loop feedback control##2##3##(2008-2#2)
closed-loop operation##2##2##(2007-12#1)(2008-2#1)
closed-loop##30##1##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#1)(2008-7#1)(2009-11#1)(2009-9#4)(2010-5#1)(2012-2#1)(2013-1#3)
closed-mouth##5##1##(2010-2#5)
closed-states and##2##2##(2008-8#2)
closed-states##6##1##(2008-8#6)
closely approximate##2##2##(1994-1#1)(2008-11#1)
closely as##2##2##(1993-12#1)(2013-1#1)
closely associated with insulin resistance##2##5##(2008-7#1)(2013-1#1)
closely associated with the##11##4##(1990-5#1)(1992-3#1)(1993-8#1)(2008-10#4)(2008-9#1)(2010-8#1)(2012-2#2)
closely associated with##31##3##(1990-5#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#2)(1995-2#1)(2008-10#7)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
closely associated##34##2##(1990-5#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#2)(1995-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
closely connected##2##2##(1991-9#1)(2008-11#1)
closely correlate with##2##3##(1991-6#1)(1994-9#1)
closely correlated to the##3##4##(1992-5#1)(1993-12#1)(2007-8#1)
closely correlated with the##4##4##(1992-9#1)(1993-8#1)(1994-6#1)(2008-10#1)
closely correlated with##7##3##(1990-5#1)(1992-9#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-5#2)
closely correlated##11##2##(1990-5#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-5#2)
closely followed the##5##3##(1991-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)
closely followed##8##2##(1991-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2011-1#1)
closely for##3##2##(2008-3#1)(2008-9#1)(2011-1#1)
closely homologous##2##2##(1993-2#1)(1994-5#1)
closely interrelated##3##2##(1995-3#1)(2008-4#1)(2011-3#1)
closely involved with##3##3##(1995-5#1)(1996-2#1)(2008-1#1)
closely involved##4##2##(1995-5#1)(1996-2#1)(2008-1#1)(2008-7#1)
closely linked to Rsp genes##2##5##(2008-10#2)
closely linked to the##5##4##(2008-10#3)(2008-5#1)(2012-5#1)
closely linked to##16##3##(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-5#1)
closely linked with##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
closely linked##29##2##(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-5#1)
closely match those of##2##4##(2008-5#1)(2009-7#1)
closely match those##3##3##(1992-9#1)(2008-5#1)(2009-7#1)
closely matched##3##2##(2008-1#1)(2008-12#1)(2008-3#1)
closely matches the##3##3##(2007-12#2)(2008-9#1)
closely matches##7##2##(1995-5#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-9#1)(2013-1#1)
closely mimic##2##2##(2008-5#1)(2008-9#1)
closely overlapping##2##2##(1991-1#1)(2008-10#1)
closely packed##6##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)
closely packing##2##2##(2008-10#2)
closely parallels##2##2##(1994-9#1)(2008-10#1)
closely positioned##2##2##(2008-4#1)(2012-1#1)
closely reflect##2##2##(1991-12#1)(1995-2#1)
closely reflects the##2##3##(2011-2#2)
closely reflects##3##2##(1990-8#1)(2011-2#2)
closely regulated##3##2##(1994-3#1)(1994-9#1)(2008-1#1)
closely related and##2##3##(2008-10#1)(2008-6#1)
closely related fungi##2##3##(2008-10#1)(2008-5#1)
closely related genes##3##3##(1990-8#1)(1992-3#1)(2008-8#1)
closely related isolates##2##3##(2008-10#1)(2011-2#1)
closely related sexual species##2##4##(2009-2#2)
closely related species##16##3##(1991-5#1)(1995-11#1)(1997-4#2)(2008-10#4)(2008-7#1)(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
closely related to P##3##4##(2008-5#2)(2012-3#1)
closely related to avian myeloblastosis-associated virus type##2##7##(2007-6#2)
closely related to avian##3##4##(2007-6#2)(2012-3#1)
closely related to cell##2##4##(2008-4#1)(2008-6#1)
closely related to each other##5##5##(2008-10#3)(2008-8#1)(2011-2#1)
closely related to one##3##4##(2007-12#1)(2007-6#1)(2008-10#1)
closely related to the geometry of the##2##7##(1990-5#1)(2007-12#1)
closely related to the##27##4##(1990-11#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-7#1)(1991-8#1)(1994-9#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
closely related to##114##3##(1990-11#3)(1990-2#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#4)(1997-8#1)(2007-10#1)(2007-12#4)(2007-6#3)(2008-10#39)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-7#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-3#4)(2013-1#3)(2013-8#3)
closely related with the##2##4##(2008-10#1)(2012-3#1)
closely related with##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
closely related##214##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#4)(1996-6#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-12#5)(2007-6#3)(2007-7#1)(2008-1#1)(2008-10#65)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#7)(2008-8#12)(2008-9#12)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#6)(2012-3#8)(2012-5#2)(2013-1#4)(2013-7#1)(2013-8#3)
closely resemble those##2##3##(2008-1#1)(2008-7#1)
closely resemble##7##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)
closely resembled##2##2##(2008-10#1)(2008-2#1)
closely resembles that of##2##4##(2008-5#1)(2009-5#1)
closely resembles that##3##3##(2007-12#1)(2008-5#1)(2009-5#1)
closely resembles the##2##3##(1993-6#1)(2011-2#1)
closely resembles##10##2##(1990-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(2007-12#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)
closely resembling the##2##3##(1996-12#1)(1997-7#1)
closely resembling##3##2##(1996-12#1)(1997-7#1)(2007-7#1)
closely similar to##4##3##(1994-5#1)(1994-6#1)(1997-7#1)(2008-6#1)
closely similar##8##2##(1994-5#1)(1994-6#1)(1995-5#1)(1997-7#1)(2008-4#1)(2008-6#1)(2008-9#2)
closely situated##2##2##(1994-8#1)(1996-2#1)
closely spaced##14##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2009-8#1)(2012-3#1)
closely surrounding the##2##3##(1991-10#1)(2008-10#1)
closely the##2##2##(1993-9#1)(2008-9#1)
closely tied to the##2##4##(2007-11#1)(2010-11#1)
closely tied to##5##3##(1992-3#1)(2007-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
closely to the##3##3##(1996-5#1)(2008-2#2)
closely to##7##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
closely together##3##2##(1996-1#1)(2008-11#1)(2008-9#1)
closely with the##2##3##(1996-2#1)(2008-10#1)
closely with their##2##3##(2008-12#1)(2010-9#1)
closely with##17##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-3#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2010-1#1)(2010-9#1)(2012-12#1)(2012-2#1)
closely##492##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#4)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#6)(1992-5#1)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#6)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#5)(1995-8#4)(1996-1#2)(1996-12#5)(1996-2#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#2)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#12)(2007-6#3)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#111)(2008-11#12)(2008-12#7)(2008-2#8)(2008-3#12)(2008-4#15)(2008-5#22)(2008-6#5)(2008-7#13)(2008-8#19)(2008-9#22)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#10)(2012-5#3)(2013-1#9)(2013-7#1)(2013-8#4)
closeness of##2##2##(2007-1#1)(2008-4#1)
closeness##8##1##(1996-5#1)(2007-1#1)(2007-2#1)(2008-4#2)(2010-9#2)(2013-1#1)
closer agreement between the##2##4##(2012-7#1)(2013-1#1)
closer collaboration##2##2##(1991-6#1)(2013-1#1)
closer examination##2##2##(1993-12#1)(2008-10#1)
closer look at the##3##4##(1993-1#1)(1994-11#1)(1997-6#1)
closer look at##4##3##(1993-1#1)(1994-11#1)(1997-6#1)(2008-8#1)
closer look##7##2##(1993-1#1)(1993-3#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-8#2)
closer than##2##2##(2008-10#1)(2008-8#1)
closer the##3##2##(2008-2#1)(2011-2#1)(2012-2#1)
closer to the##22##3##(1990-2#2)(1992-1#1)(1995-2#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-7#1)
closer to##37##2##(1990-2#2)(1991-8#1)(1992-1#1)(1992-6#1)(1993-1#1)(1994-1#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
closer##81##1##(1990-12#1)(1990-2#3)(1991-12#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#2)(2013-7#2)
closes with a##3##3##(1997-4#1)(2008-4#1)(2010-9#1)
closes##6##1##(1997-4#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-9#1)
closest RGAP##2##2##(2008-10#2)
closest marker##2##2##(2008-10#2)
closest relationship##2##2##(2008-10#1)(2008-9#1)
closest to the##7##3##(1995-12#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-7#1)
closest to##11##2##(1991-3#1)(1995-12#1)(1997-6#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-2#1)
closest##38##1##(1991-3#1)(1995-12#1)(1997-6#1)(2006-6#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-7#1)(2010-11#3)(2010-2#1)(2011-1#1)(2012-12#1)
closing of the##3##3##(1995-11#1)(2007-8#2)
closing of##6##2##(1991-8#1)(1993-3#1)(1995-11#1)(2007-8#2)(2009-10#1)
closing pressure gradient##2##3##(1991-5#2)
closing pressure##3##2##(1991-5#3)
closing the protein inadequacy gap##2##5##(2012-2#2)
closing the##11##2##(1992-3#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
closing time##2##2##(1997-2#1)(2009-8#1)
closing##41##1##(1991-5#3)(1991-8#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-8#2)(2010-3#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
closings##2##1##(1995-2#1)(2008-12#1)
closterovirus associated with LChD##2##4##(2008-10#2)
closterovirus associated with##4##3##(2008-10#4)
closterovirus##11##1##(2008-10#11)
closteroviruses##12##1##(2008-10#12)
clostridia##7##1##(2011-2#7)
clostridial##3##1##(1997-8#1)(2009-7#1)(2011-2#1)
closure and##13##2##(1995-11#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#2)(2013-1#1)
closure as##2##2##(2008-7#1)(2012-1#1)
closure between##2##2##(2008-3#1)(2008-4#1)
closure by##3##2##(2011-2#1)(2012-1#1)(2012-12#1)
closure for##2##2##(2008-10#1)(2008-3#1)
closure in the##2##3##(1995-6#1)(2012-6#1)
closure in##9##2##(1992-2#1)(1995-6#1)(1996-6#1)(2008-11#2)(2012-12#2)(2012-2#1)(2012-6#1)
closure is##10##2##(1991-2#1)(1992-1#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
closure of a patent##2##4##(1997-8#1)(2007-8#1)
closure of a postinfarction interventricular septal rupture##2##7##(1993-12#2)
closure of a##9##3##(1993-12#2)(1996-6#1)(1997-8#1)(2007-8#3)(2008-11#1)(2008-3#1)
closure of atrial septal defects##2##5##(1997-8#1)(2012-1#1)
closure of atrial septal##3##4##(1997-8#1)(2007-8#1)(2012-1#1)
closure of fossa ovalis atrial septal##2##6##(2008-11#2)
closure of perimembranous##2##3##(2010-6#1)(2013-1#1)
closure of the anterior##3##4##(1991-1#2)(2011-1#1)
closure of the##22##3##(1991-1#2)(1991-12#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-5#1)(2009-8#4)(2011-1#1)(2011-2#2)(2012-12#1)
closure of their##2##3##(1996-3#1)(2013-8#1)
closure of##62##2##(1991-1#2)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#2)(2006-12#2)(2007-11#1)(2007-5#1)(2007-8#11)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#4)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#1)
closure rate was##2##3##(2006-12#2)
closure rate##4##2##(1997-8#1)(2006-12#2)(2008-5#1)
closure the##2##2##(1990-10#1)(2008-7#1)
closure therapy##2##2##(2008-11#1)(2012-2#1)
closure time##5##2##(1992-2#1)(2011-1#4)
closure using##2##2##(2008-11#1)(2011-2#1)
closure was##7##2##(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2013-8#1)
closure with##5##2##(1991-12#1)(1992-1#1)(2007-8#1)(2008-3#1)(2011-2#1)
closure##214##1##(1990-10#1)(1990-6#3)(1991-1#2)(1991-12#2)(1991-2#2)(1992-1#3)(1992-12#1)(1992-2#4)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-3#3)(1996-6#5)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#6)(2006-12#4)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#21)(2008-10#18)(2008-11#18)(2008-3#8)(2008-4#3)(2008-5#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#5)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#17)(2012-1#7)(2012-12#9)(2012-2#4)(2012-3#7)(2012-6#1)(2013-1#7)(2013-8#3)
closure]##2##1##(1996-3#1)(2013-1#1)
closures##9##1##(1996-3#3)(2007-8#3)(2008-12#1)(2008-8#1)(2009-8#1)
clot and##2##2##(2008-10#1)(2011-2#1)
clot extension##2##2##(1992-1#1)(2008-8#1)
clot formation##6##2##(1992-1#1)(1997-4#2)(2007-7#1)(2013-1#2)
clot lysis##5##2##(1994-3#2)(1994-5#1)(1995-6#1)(2008-7#1)
clot##22##1##(1990-12#1)(1992-1#3)(1994-3#2)(1994-5#1)(1995-6#2)(1997-3#1)(1997-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#3)
cloth##8##1##(2008-10#2)(2010-8#6)
clothes##10##1##(1992-4#1)(2009-12#1)(2011-1#3)(2012-12#1)(2012-3#4)
clothing and##4##2##(1990-2#2)(2010-4#1)(2011-2#1)
clothing of##2##2##(1990-3#1)(2008-10#1)
clothing##17##1##(1990-2#3)(1990-3#1)(1992-6#1)(1996-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#4)
clotrimazole 1% cream in##2##4##(2008-5#2)
clotrimazole in##3##2##(2007-7#2)(2008-5#1)
clotrimazole or##2##2##(2008-5#1)(2008-8#1)
clotrimazole##15##1##(2007-7#6)(2008-5#8)(2008-8#1)
clots in the##2##3##(1993-2#1)(2013-7#1)
clots##11##1##(1993-2#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
clotted##3##1##(1990-12#1)(1992-1#1)(1993-12#1)
clotting activity of##2##3##(1990-7#1)(2008-9#1)
clotting activity##3##2##(1990-7#1)(1993-11#1)(2008-9#1)
clotting factor IX (hFIX)##3##4##(2008-8#3)
clotting factor IX##8##3##(1990-5#1)(2008-8#4)(2008-9#3)
clotting factors##3##2##(1993-11#1)(1997-4#1)(2011-2#1)
clotting of blood##2##3##(2007-7#1)(2008-1#1)
clotting of##3##2##(1993-11#1)(2007-7#1)(2008-1#1)
clotting products##6##2##(1996-5#4)(1997-5#2)
clotting time was used by only##2##6##(2007-7#2)
clotting time##6##2##(1997-2#1)(2007-7#4)(2008-7#1)
clotting##35##1##(1990-5#1)(1990-7#1)(1992-6#1)(1993-11#3)(1996-5#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-7#6)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#4)(2008-9#4)(2011-2#3)
cloud (tau =##2##3##(2008-2#2)
cloud and aerosol##5##3##(2008-2#1)(2008-3#4)
cloud and##7##2##(2008-2#1)(2008-3#5)(2008-5#1)
cloud base height##2##3##(2008-2#2)
cloud base##5##2##(2008-2#3)(2008-3#2)
cloud components##2##2##(2008-2#2)
cloud conditions##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
cloud cover##2##2##(2008-2#1)(2008-3#1)
cloud covers##2##2##(2008-2#1)(2008-3#1)
cloud detection##2##2##(2008-3#2)
cloud forest##3##2##(2008-5#3)
cloud imaging##2##2##(2008-2#2)
cloud layer##2##2##(2008-2#2)
cloud optical depth##3##3##(2008-2#1)(2008-3#2)
cloud optical##6##2##(2008-2#3)(2008-3#3)
cloud particles##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
cloud point extraction of##2##4##(2008-10#2)
cloud point extraction was##2##4##(2008-10#2)
cloud point extraction##15##3##(2008-10#15)
cloud point temperature##3##3##(2008-10#3)
cloud point##21##2##(2008-10#21)
cloud scattering##2##2##(2008-2#1)(2008-3#1)
cloud top height##2##3##(2008-2#1)(2008-3#1)
cloud top##5##2##(2008-2#3)(2008-3#2)
cloud water##4##2##(2008-10#4)
cloud##145##1##(1991-5#2)(1992-3#3)(1992-7#1)(1993-3#1)(1994-2#1)(2007-11#4)(2008-10#27)(2008-2#53)(2008-3#41)(2008-5#5)(2010-5#4)(2013-1#1)(2013-7#1)(2013-8#1)
cloud-free conditions##2##2##(2008-11#1)(2008-2#1)
cloud-free##4##1##(2008-11#1)(2008-2#1)(2008-3#2)
cloud-level##2##1##(1992-7#2)
cloud-particle scattering##2##2##(2008-3#2)
cloud-particle##3##1##(2008-3#3)
cloud-point extraction##3##2##(2008-10#3)
cloud-point temperature##2##2##(2008-10#2)
cloud-point##5##1##(2008-10#5)
clouds and##13##2##(1991-5#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#9)
clouds are##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
clouds generated in a##2##4##(2008-3#2)
clouds is##2##2##(2008-3#2)
clouds of##2##2##(2008-3#2)
clouds on the##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
clouds on##5##2##(1990-8#1)(1992-3#1)(2008-2#1)(2008-3#2)
clouds or##2##2##(2008-3#2)
clouds with a##3##3##(2008-2#1)(2008-3#2)
clouds with##6##2##(2008-2#2)(2008-3#4)
clouds##89##1##(1990-8#1)(1991-5#4)(1992-3#3)(1992-7#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-2#30)(2008-3#44)(2013-1#2)
cloudy##11##1##(2006-10#1)(2008-10#4)(2008-2#4)(2008-3#2)
clout##3##1##(1991-3#1)(1994-12#1)(2008-11#1)
clover and##2##2##(2008-10#2)
clover proliferation##3##2##(2008-10#3)
clover yellow vein virus##2##4##(2008-10#2)
clover yellow vein##3##3##(2008-10#3)
clover##20##1##(1995-12#2)(2008-10#15)(2008-12#1)(2011-2#2)
clovers##4##1##(2008-10#1)(2011-2#3)
cloxacillin##5##1##(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#2)
clozapine and ECT##2##3##(2008-12#2)
clozapine and##3##2##(2008-12#2)(2008-7#1)
clozapine in##3##2##(1996-5#1)(1996-7#1)(2008-12#1)
clozapine##18##1##(1995-3#1)(1996-5#2)(1996-7#1)(2008-12#8)(2008-3#1)(2008-6#3)(2008-7#1)(2008-9#1)
club attendance##2##2##(2009-8#2)
club##11##1##(2007-7#1)(2008-10#2)(2008-12#3)(2008-4#1)(2009-8#2)(2012-1#1)(2012-3#1)
club-shaped##2##1##(2008-5#1)(2009-12#1)
clubroot##2##1##(2008-10#2)
clubs##10##1##(1994-3#2)(1996-2#1)(2007-11#1)(2008-12#2)(2009-8#3)(2011-2#1)
clue for##2##2##(2007-2#1)(2007-8#1)
clue to the##5##3##(2007-12#1)(2007-7#2)(2008-8#2)
clue to##8##2##(2007-12#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-8#2)(2012-2#1)
clue##12##1##(1990-7#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2012-2#1)
clues about the##5##3##(1991-2#1)(2007-12#1)(2008-10#1)(2010-10#1)(2012-12#1)
clues about##8##2##(1991-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2012-12#1)
clues as to the##4##4##(1990-2#1)(1994-11#1)(2008-11#1)(2013-8#1)
clues as to##5##3##(1990-2#1)(1994-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
clues for##4##2##(1997-6#1)(2008-11#1)(2009-2#1)(2012-2#1)
clues into the##2##3##(2010-12#1)(2010-5#1)
clues on the##5##3##(1991-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)
clues on##6##2##(1991-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)
clues regarding the##2##3##(1996-2#1)(2010-12#1)
clues regarding##3##2##(1996-2#1)(2008-4#1)(2010-12#1)
clues to the##7##3##(1997-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#2)
clues to##15##2##(1990-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
clues##49##1##(1990-2#1)(1990-8#2)(1991-2#1)(1991-6#1)(1994-11#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
clump##3##1##(2008-10#1)(2008-6#2)
clumped into##2##2##(1992-6#1)(2008-7#1)
clumped##4##1##(1992-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
clumping and##2##2##(2008-12#1)(2008-7#1)
clumping##8##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-7#1)
clumps of##3##2##(1992-2#1)(2008-10#1)(2008-7#1)
clumps##13##1##(1992-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)
cluster 1##3##2##(2008-10#1)(2012-3#2)
cluster analyses identified four##2##4##(2008-10#1)(2013-7#1)
cluster analyses##7##2##(2008-10#3)(2008-12#1)(2008-5#2)(2013-7#1)
cluster analysis (CA)##2##3##(2008-10#1)(2010-5#1)
cluster analysis and##4##3##(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
cluster analysis in##2##3##(1997-7#1)(2008-10#1)
cluster analysis of##5##3##(2008-10#4)(2013-8#1)
cluster analysis with##2##3##(1990-5#1)(2008-10#1)
cluster analysis##40##2##(1990-5#1)(1992-11#1)(1996-5#1)(1997-7#1)(2007-1#1)(2008-10#27)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)(2013-8#1)
cluster and to##2##3##(1997-8#1)(2008-7#1)
cluster and##10##2##(1997-8#1)(2008-10#5)(2008-7#1)(2009-5#1)(2010-10#1)(2013-1#1)
cluster as the##2##3##(2008-10#1)(2008-12#1)
cluster as##3##2##(2008-10#2)(2008-12#1)
cluster assignment##2##2##(2009-11#1)(2010-10#1)
cluster by##2##2##(2008-10#1)(2012-2#1)
cluster centers##2##2##(2008-10#1)(2010-8#1)
cluster consisting of##2##3##(2008-8#1)(2009-11#1)
cluster contained##3##2##(2008-10#3)
cluster containing##2##2##(2008-10#2)
cluster controlling##3##2##(2008-10#3)
cluster for##2##2##(2011-1#1)(2013-8#1)
cluster formation##3##2##(2008-10#2)(2008-12#1)
cluster from the##4##3##(1994-6#1)(2008-10#2)(2009-3#1)
cluster has been##2##3##(2008-6#1)(2008-8#1)
cluster headache##2##2##(1992-2#1)(2008-6#1)
cluster in Hazafon##2##3##(2009-2#2)
cluster in the##3##3##(1991-5#1)(1993-8#1)(2013-8#1)
cluster in##14##2##(1991-5#1)(1993-3#1)(1993-8#2)(1994-5#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-2#2)(2013-8#1)
cluster is##4##2##(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#1)
cluster leaves##2##2##(2008-10#2)
cluster of markers##2##3##(1997-5#1)(2008-5#1)
cluster of the##2##3##(1990-5#1)(2008-5#1)
cluster of##51##2##(1990-5#3)(1990-8#2)(1992-12#1)(1992-4#2)(1992-9#1)(1994-2#1)(1995-9#1)(1996-12#3)(1996-6#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-6#1)(2010-11#2)(2012-3#2)(2013-1#1)
cluster randomization##3##2##(2009-11#1)(2011-1#1)(2013-1#1)
cluster sampling method##2##3##(2008-1#1)(2011-1#1)
cluster sampling##4##2##(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
cluster size##7##2##(2008-10#4)(2009-11#2)(2012-3#1)
cluster sizes##2##2##(2008-8#1)(2010-10#1)
cluster the##3##2##(2008-7#1)(2008-8#2)
cluster to##2##2##(1993-3#1)(1996-8#1)
cluster together in##2##3##(2008-10#1)(2011-2#1)
cluster together##6##2##(2008-10#3)(2008-5#1)(2009-10#1)(2011-2#1)
cluster types##2##2##(2013-1#2)
cluster was##4##2##(1996-6#1)(2008-10#3)
cluster were##2##2##(1994-5#1)(2008-10#1)
cluster with##5##2##(1993-9#2)(2007-12#2)(2011-1#1)
cluster##347##1##(1990-5#7)(1990-7#1)(1990-8#2)(1991-5#4)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#4)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#6)(1994-6#1)(1995-6#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#6)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2006-10#1)(2007-1#1)(2007-12#9)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#117)(2008-11#4)(2008-12#6)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#6)(2008-7#8)(2008-8#10)(2008-9#4)(2009-10#1)(2009-11#13)(2009-12#2)(2009-2#5)(2009-3#3)(2009-5#2)(2009-6#1)(2010-10#6)(2010-11#7)(2010-3#1)(2010-4#3)(2010-5#4)(2010-8#2)(2011-1#7)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#4)
cluster)##2##1##(2008-10#1)(2008-4#1)
cluster-correlate##3##1##(2013-1#3)
clustered according to##2##3##(2008-10#1)(2010-12#1)
clustered and##3##2##(1991-2#1)(2010-4#1)(2012-2#1)
clustered around the##2##3##(1990-5#1)(2008-5#1)
clustered around##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
clustered at##2##2##(2008-10#2)
clustered in a##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
clustered in the##4##3##(1993-2#1)(1994-12#1)(1997-6#1)(2008-10#1)
clustered in three##3##3##(2008-10#3)
clustered in##16##2##(1990-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1997-6#1)(2008-10#9)(2008-11#1)(2012-3#1)
clustered into the##2##3##(2008-10#2)
clustered into three##3##3##(2008-10#3)
clustered into##10##2##(2008-10#8)(2011-1#1)(2013-8#1)
clustered separately##3##2##(2008-10#2)(2008-2#1)
clustered to##3##2##(2008-10#2)(2010-10#1)
clustered together and##3##3##(2008-10#3)
clustered together##7##2##(2008-10#6)(2009-5#1)
clustered with isolates##2##3##(2008-10#2)
clustered with members of X##2##5##(2008-10#2)
clustered with other##2##3##(2008-10#2)
clustered with phytoplasmas##2##3##(2008-10#2)
clustered with##17##2##(2008-10#17)
clustered within a##3##3##(1996-12#1)(1996-6#1)(2008-10#1)
clustered within##5##2##(1996-12#1)(1996-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
clustered##109##1##(1990-5#2)(1991-2#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-2#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-5#1)(2008-10#58)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#5)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
clustering algorithm##4##2##(2008-7#1)(2009-10#1)(2010-8#1)(2013-1#1)
clustering analysis##3##2##(2008-5#2)(2008-8#1)
clustering and decision tree analyses##2##5##(2008-10#2)
clustering and##5##2##(2008-10#3)(2008-4#1)(2010-4#1)
clustering for##3##2##(2008-10#1)(2008-7#2)
clustering in the##2##3##(2008-10#1)(2012-2#1)
clustering in##4##2##(1996-4#1)(2007-10#1)(2008-10#1)(2012-2#1)
clustering is##4##2##(2008-2#2)(2009-8#1)(2011-1#1)
clustering method for analysing##2##4##(2008-7#2)
clustering method##3##2##(2008-7#3)
clustering methods##4##2##(2008-4#2)(2008-5#1)(2008-7#1)
clustering of discontinuity sources##2##4##(2008-3#2)
clustering of small scatterers##2##4##(2008-3#2)
clustering of the##6##3##(1990-11#1)(1996-12#1)(1997-4#1)(2008-7#1)(2012-1#1)(2012-5#1)
clustering of##33##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-5#1)(1992-8#1)(1996-12#3)(1997-4#1)(2008-10#5)(2008-12#1)(2008-3#5)(2008-7#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-6#2)(2012-1#2)(2012-3#1)(2012-5#1)
clustering over##2##2##(2008-10#1)(2008-5#1)
clustering processes of##2##3##(2008-10#2)
clustering technique##2##2##(2010-8#1)(2011-2#1)
clustering techniques##2##2##(2008-7#1)(2011-2#1)
clustering tendency##2##2##(2007-11#1)(2008-10#1)
clustering##128##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-8#1)(1994-2#1)(1996-12#3)(1996-4#2)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#18)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#5)(2011-1#2)(2011-2#2)(2012-1#5)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#2)
clustering&quot##2##1##(2008-11#1)(2012-3#1)
clusterings##2##1##(1997-7#1)(2008-10#1)
clusters (I##2##2##(2008-10#2)
clusters and their##2##3##(2008-12#2)
clusters and##13##2##(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
clusters are due to##2##4##(1997-8#2)
clusters are##11##2##(1990-5#1)(1993-11#1)(1994-2#1)(1997-8#2)(2007-12#2)(2008-10#2)(2009-11#1)(2011-1#1)
clusters based on##2##3##(2008-10#2)
clusters by##3##2##(2008-1#1)(2010-11#1)(2013-1#1)
clusters consisting of##2##3##(1991-5#1)(2008-10#1)
clusters defined##2##2##(2008-10#2)
clusters during##2##2##(2008-10#1)(2012-3#1)
clusters from##2##2##(2008-7#1)(2010-10#1)
clusters have been##2##3##(1995-6#1)(2012-2#1)
clusters in the##5##3##(1993-12#1)(1993-8#1)(2008-7#1)(2013-1#2)
clusters in##18##2##(1991-6#1)(1993-12#1)(1993-8#1)(1996-12#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-7#1)(2009-2#1)(2010-10#3)(2013-1#3)
clusters is##2##2##(2008-8#1)(2010-8#1)
clusters mainly##2##2##(1996-2#1)(2008-10#1)
clusters of V##2##3##(2008-10#2)
clusters of different##2##3##(1995-12#1)(2008-11#1)
clusters of isolates##6##3##(2008-10#6)
clusters of sensory##2##3##(2007-12#1)(2009-12#1)
clusters of spheres##2##3##(2008-3#2)
clusters of##67##2##(1991-9#2)(1992-11#1)(1992-2#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-12#3)(2007-5#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-1#1)(2013-1#1)
clusters on a##2##3##(2008-3#1)(2010-12#1)
clusters on the##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
clusters on##6##2##(1995-6#1)(2008-10#2)(2008-3#2)(2010-12#1)
clusters or##2##2##(1991-2#1)(2008-10#1)
clusters over the##2##3##(2008-10#1)(2012-3#1)
clusters separate from##3##3##(2008-10#3)
clusters similar##2##2##(2007-12#1)(2008-12#1)
clusters that correlated with##2##4##(2008-10#2)
clusters that##7##2##(1995-2#1)(2008-10#4)(2009-11#1)(2010-5#1)
clusters using##3##2##(2008-10#2)(2009-10#1)
clusters was##4##2##(2008-10#4)
clusters were found##2##3##(2008-10#1)(2008-5#1)
clusters were identified##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
clusters were##9##2##(2007-12#1)(2008-10#4)(2008-5#2)(2011-2#1)(2013-1#1)
clusters which##2##2##(1996-1#1)(2008-12#1)
clusters with##2##2##(2008-10#1)(2008-12#1)
clusters##308##1##(1990-5#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#3)(1992-2#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-5#1)(1995-12#2)(1995-2#3)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-5#3)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#3)(2007-12#16)(2007-5#1)(2008-1#7)(2008-10#99)(2008-11#2)(2008-12#8)(2008-2#3)(2008-3#9)(2008-5#8)(2008-6#1)(2008-7#21)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#4)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#10)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#3)(2012-2#4)(2012-3#7)(2013-1#9)
clusters)##4##1##(1995-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
clutch laying##2##2##(2008-9#2)
clutch size and##2##3##(2008-9#2)
clutch size in bethylid wasps##2##5##(2008-9#2)
clutch size in##3##3##(2008-9#3)
clutch size##15##2##(1991-5#1)(2008-11#1)(2008-8#1)(2008-9#12)
clutch thickness##4##2##(2008-9#4)
clutch##26##1##(1991-5#3)(2008-11#1)(2008-8#3)(2008-9#19)
clutches are##2##2##(2008-9#2)
clutches##16##1##(1991-5#3)(2008-9#13)
clutter##10##1##(2007-12#2)(2008-2#2)(2008-3#1)(2011-1#5)
cluttered##2##1##(2008-3#1)(2011-1#1)
cly5 and cly7##4##3##(1997-3#4)
clypeatus Fabricius##2##2##(2008-6#2)
clypeatus##4##1##(2008-6#4)
clypeo-labrum##2##1##(2007-12#2)
cm (-1)##2##2##(2007-11#1)(2007-12#1)
cm (mean 3##2##3##(2013-1#2)
cm H(2)O (range##3##3##(1993-10#3)
cm H(2)O##8##2##(1993-10#5)(2007-8#3)
cm H(2)O)##5##2##(1993-10#3)(2010-7#2)
cm [controls##3##2##(2013-8#3)
cm above the burner##2##4##(2008-3#2)
cm above the##4##3##(1992-9#1)(2008-10#1)(2008-3#2)
cm above##5##2##(1992-9#1)(2008-10#2)(2008-3#2)
cm and 1##2##3##(2010-9#1)(2013-1#1)
cm and the##2##3##(2007-8#1)(2008-5#1)
cm and##16##2##(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-5#4)(2010-9#1)(2012-12#1)(2013-1#1)
cm at##2##2##(2008-10#1)(2013-1#1)
cm below the##3##3##(2008-10#2)(2011-1#1)
cm below##4##2##(1992-9#1)(2008-10#2)(2011-1#1)
cm between rows and within rows##2##6##(2008-12#2)
cm between##4##2##(2008-10#1)(2008-12#2)(2011-2#1)
cm deep##2##2##(2008-10#2)
cm diameter##3##2##(1992-3#1)(2008-5#1)(2009-11#1)
cm for##2##2##(2008-10#2)
cm from the LES##2##4##(2013-8#2)
cm from the##11##3##(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2013-8#3)
cm from##14##2##(2007-11#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#3)
cm h(-1)##3##2##(2008-10#1)(2008-12#2)
cm high##2##2##(1996-2#1)(2008-2#1)
cm in diameter and##3##4##(2007-8#1)(2008-3#1)(2008-6#1)
cm in diameter##13##3##(1992-10#1)(1992-2#1)(1994-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
cm in diameter)##6##3##(1990-10#1)(1991-6#1)(2007-5#1)(2008-10#1)(2008-2#1)(2012-3#1)
cm in size##2##3##(2008-3#1)(2010-6#1)
cm in size)##2##3##(2012-12#2)
cm in the##5##3##(2008-10#1)(2009-3#2)(2011-2#2)
cm in##44##2##(1990-10#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-2#1)(1994-6#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-3#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#3)
cm is##2##2##(2007-12#1)(2008-6#1)
cm length and##2##3##(2008-10#2)
cm length capillary at##3##4##(2008-10#3)
cm length##7##2##(2008-10#6)(2010-5#1)
cm lesion##2##2##(2007-5#1)(2010-12#1)
cm long separation channel at a separation voltage of##2##9##(2008-10#2)
cm long##11##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2012-12#1)(2013-8#1)
cm of##7##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)
cm on##2##2##(2011-2#1)(2012-2#1)
cm or##5##2##(1991-3#1)(1995-4#1)(2007-8#1)(2010-6#1)(2012-2#1)
cm plate##2##2##(2008-8#2)
cm reaction coil was transported to the detector with an Ar flow##2##12##(2008-10#2)
cm s(-1)##3##2##(2008-10#3)
cm s(-1))##2##2##(2008-10#1)(2012-12#1)
cm soil depth##2##3##(2008-10#2)
cm stool height##2##3##(2008-6#2)
cm than at##2##3##(2008-10#2)
cm than##3##2##(2008-10#3)
cm thick##3##2##(1992-6#1)(2008-2#2)
cm to 5 cm##2##4##(2013-1#1)(2013-8#1)
cm to the##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
cm to##10##2##(1993-12#1)(1996-5#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
cm was##7##2##(1991-12#2)(1994-7#1)(1995-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
cm with##2##2##(2007-12#1)(2008-10#1)
cm x 0##2##3##(2008-10#2)
cm x 2 cm##3##4##(2008-3#2)(2010-3#1)
cm x 4##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
cm x 40##2##3##(2008-2#1)(2008-3#1)
cm x 75##2##3##(1994-9#2)
cm x##18##2##(1994-9#2)(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#6)(2008-9#1)(2009-8#1)(2010-3#1)
cm × 0##2##3##(2012-3#2)
cm##390##1##(1990-10#1)(1990-3#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-10#8)(1993-12#2)(1993-3#2)(1993-9#1)(1994-6#1)(1994-7#2)(1994-9#2)(1995-3#2)(1995-4#5)(1996-2#2)(1996-5#4)(1997-1#2)(1997-4#3)(1997-8#3)(2007-10#2)(2007-11#10)(2007-12#13)(2007-5#3)(2007-8#13)(2008-1#4)(2008-10#86)(2008-11#3)(2008-12#20)(2008-2#14)(2008-3#24)(2008-4#1)(2008-5#13)(2008-6#11)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#4)(2009-11#5)(2009-2#2)(2009-3#2)(2009-5#1)(2009-8#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#8)(2012-12#15)(2012-2#2)(2012-3#6)(2013-1#19)(2013-7#1)(2013-8#17)
cm(-)(1)##20##1##(1996-2#3)(1997-7#17)
cm(-)(1))##5##1##(1996-5#1)(1997-7#4)
cm(-1) (0##2##2##(2008-2#1)(2008-8#1)
cm(-1) Hz(-1/2)##4##2##(2007-12#1)(2008-3#3)
cm(-1) across the##2##3##(2008-2#2)
cm(-1) and 1##2##3##(2008-10#2)
cm(-1) and 2##3##3##(2008-10#2)(2008-3#1)
cm(-1) and the##3##3##(2008-10#3)
cm(-1) and##27##2##(2008-10#20)(2008-2#2)(2008-3#3)(2008-5#1)(2013-8#1)
cm(-1) at 494 nm##2##4##(2007-12#2)
cm(-1) at##19##2##(2007-12#2)(2008-10#13)(2008-3#3)(2010-12#1)
cm(-1) atm(-1) HWHM]##2##3##(2008-3#2)
cm(-1) band was used for the quantification of##2##8##(2008-10#2)
cm(-1) bands##2##2##(2008-10#2)
cm(-1) between the##2##3##(2007-12#1)(2008-3#1)
cm(-1) between##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
cm(-1) for##10##2##(2008-10#6)(2008-2#3)(2008-3#1)
cm(-1) in the##6##3##(2007-12#1)(2008-2#2)(2008-5#1)(2009-11#2)
cm(-1) in##10##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-5#1)(2009-11#2)
cm(-1) of##2##2##(2007-11#1)(2013-8#1)
cm(-1) over##2##2##(2007-12#1)(2008-2#1)
cm(-1) region##3##2##(2007-12#1)(2008-10#2)
cm(-1) respectively##2##2##(2008-10#1)(2013-8#1)
cm(-1) to##2##2##(2008-5#1)(2013-8#1)
cm(-1) was measured on##2##4##(2007-11#1)(2007-12#1)
cm(-1) was selected##2##3##(2008-3#2)
cm(-1) was##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
cm(-1) were##7##2##(2008-10#4)(2008-2#1)(2008-3#1)(2013-8#1)
cm(-1) with a##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
cm(-1) with the##2##3##(2007-12#1)(2008-8#1)
cm(-1) with##8##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
cm(-1)##219##1##(1996-2#1)(2007-11#6)(2007-12#14)(2008-10#93)(2008-11#2)(2008-12#1)(2008-2#38)(2008-3#41)(2008-5#3)(2008-8#4)(2009-11#2)(2010-12#1)(2013-8#13)
cm(-1)) and##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
cm(-1)) of##2##2##(2008-10#1)(2008-3#1)
cm(-1))##30##1##(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#9)(2008-5#1)(2012-12#1)
cm(-1)]##2##1##(2008-3#2)
cm(-2) and##5##2##(2008-10#2)(2008-5#2)(2011-3#1)
cm(-2) for##7##2##(2008-10#5)(2008-3#2)
cm(-2) is##3##2##(2008-10#1)(2008-5#2)
cm(-2) of##2##2##(2008-10#2)
cm(-2) respectively##2##2##(2008-10#2)
cm(-2) was##2##2##(2008-10#1)(2008-5#1)
cm(-2) were##2##2##(2008-10#2)
cm(-2)##59##1##(2007-12#1)(2008-10#40)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#8)(2009-11#1)(2011-3#2)
cm(-2))##7##1##(2007-11#1)(2008-10#3)(2008-5#2)(2008-7#1)
cm(-3) and##2##2##(2008-10#1)(2008-3#1)
cm(-3) in a##2##3##(2008-10#1)(2008-11#1)
cm(-3) in##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
cm(-3)##21##1##(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2010-8#2)(2013-8#1)
cm(-3))##2##1##(2008-10#2)
cm(2) V(-1) s(-1)##2##3##(2008-10#1)(2008-7#1)
cm(2) and##2##2##(2008-3#2)
cm(2) at##3##2##(2008-3#2)(2012-2#1)
cm(2) of leaf##2##3##(2008-10#1)(2008-5#1)
cm(2) of##3##2##(2008-10#1)(2008-5#2)
cm(2) s(-1)##3##2##(2008-10#2)(2008-3#1)
cm(2) s(-1))##4##2##(2008-10#4)
cm(2)##32##1##(2008-10#10)(2008-2#3)(2008-3#10)(2008-5#3)(2008-7#2)(2010-12#1)(2012-12#1)(2012-2#2)
cm(2)) and##2##2##(2008-3#1)(2008-5#1)
cm(2))##10##1##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#1)(2009-11#1)
cm(2)/W##3##1##(2007-12#1)(2008-3#2)
cm(2)/s (R=-0##2##2##(2008-7#2)
cm(2)/s in the##2##3##(2008-7#2)
cm(2)/s##6##1##(2008-7#6)
cm(3) fractions##2##2##(2008-10#2)
cm(3) min(-1)##3##2##(2008-10#3)
cm(3) of##4##2##(2008-10#4)
cm(3) s(- 1) at##2##4##(2008-7#2)
cm(3)##16##1##(1996-2#1)(2008-10#13)(2008-7#2)
cm(3))##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
cm) and the##2##3##(2008-12#1)(2011-2#1)
cm) and##10##2##(2008-10#1)(2008-12#5)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
cm) with##2##2##(1992-12#1)(2007-8#1)
cm)##43##1##(1991-6#1)(1992-12#1)(1993-9#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#12)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-9#2)(2011-2#4)(2013-1#3)(2013-8#1)
cm-1 for the##3##3##(2008-10#3)
cm-1 in the##2##3##(1995-5#2)
cm-1 in##4##2##(1991-5#1)(1995-5#3)
cm-1##16##1##(1990-11#1)(1991-5#1)(1994-6#1)(1995-2#1)(1995-5#7)(2008-10#5)
cm-1)##3##1##(1990-7#1)(2008-10#2)
cm-1/MV/cm for##2##2##(2008-10#2)
cm-2##6##1##(1991-5#2)(1994-5#1)(1995-2#1)(2008-10#2)
cm-2)##2##1##(1990-12#1)(2008-5#1)
cm-5##2##1##(1997-5#1)(2007-9#1)
cm-long##2##1##(1996-5#1)(2007-12#1)
cm/GW at##3##2##(2008-3#3)
cm/GW##4##1##(2007-12#1)(2008-3#3)
cm/J and##2##2##(2007-11#1)(2008-3#1)
cm/W##2##1##(2007-11#1)(2008-3#1)
cm/s and##3##2##(2008-7#2)(2011-2#1)
cm/s##16##1##(1992-3#2)(1995-11#1)(2008-6#3)(2008-7#6)(2011-2#2)(2013-1#2)
cm2 or##4##2##(1996-1#4)
cm2##12##1##(1990-12#1)(1990-5#1)(1996-1#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#1)
cm2)##8##1##(1993-9#1)(2008-5#2)(2011-2#5)
cm3##5##1##(1992-2#1)(1997-4#1)(2011-1#2)(2012-12#1)
cmCs coated MWNTs##2##3##(2009-3#2)
cmCs##3##1##(2009-3#3)
cmk rpsA##2##2##(1997-2#2)
cmk##3##1##(1997-2#3)
cms##2##1##(2011-1#2)
cms-T cytoplasm##2##2##(2008-10#2)
cms-T##5##1##(2008-10#5)
cnidarian##2##1##(2008-7#1)(2009-8#1)
cnidarians##2##1##(2009-8#1)(2010-4#1)
co##4##1##(2008-11#1)(2009-8#1)(2010-11#1)(2012-2#1)
co- and##4##2##(2008-11#1)(2008-9#1)(2013-1#2)
co-##7##1##(2008-1#1)(2008-11#3)(2008-9#1)(2013-1#2)
co-activator##5##1##(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#2)
co-added##2##1##(2008-10#1)(2011-1#1)
co-administered with##2##2##(2011-2#1)(2013-1#1)
co-administered##4##1##(1995-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
co-administration of##3##2##(2010-12#1)(2011-1#1)(2013-1#1)
co-administration##4##1##(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
co-agonist##2##1##(2011-1#1)(2012-2#1)
co-artemether##4##1##(2007-2#4)
co-assemble with##2##2##(2008-1#1)(2008-8#1)
co-calibration##2##1##(2012-2#2)
co-chaired##3##1##(2008-5#2)(2010-11#1)
co-chaperone##3##1##(1995-6#1)(2009-6#1)(2011-2#1)
co-contaminants##2##1##(2008-10#2)
co-crystallized##2##1##(2012-2#2)
co-cultivation with##2##2##(1993-9#1)(2006-12#1)
co-cultivation##3##1##(1993-9#1)(2006-12#1)(2011-1#1)
co-culture conditions##2##2##(2008-11#2)
co-culture model##3##2##(2010-9#3)
co-culture models##2##2##(2012-4#2)
co-culture of##3##2##(2008-11#3)
co-culture system##3##2##(2008-11#2)(2008-8#1)
co-culture systems##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2008-9#1)
co-culture with##3##2##(2008-11#3)
co-culture##24##1##(1993-3#1)(2008-10#2)(2008-11#11)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#3)(2012-2#1)(2012-4#2)
co-cultured EC/HRP##3##2##(2012-4#3)
co-cultured in##2##2##(2008-10#1)(2012-4#1)
co-cultured on##2##2##(1996-12#2)
co-cultured with##6##2##(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#2)
co-cultured##16##1##(1996-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#2)(2012-4#6)
co-cultures of##3##2##(2008-10#1)(2008-7#2)
co-cultures##5##1##(1994-2#1)(2008-10#1)(2008-7#2)(2013-1#1)
co-deposition of##2##2##(2008-10#2)
co-digestion##6##1##(2013-1#6)
co-disposal precipitates##2##2##(2008-10#2)
co-disposal##3##1##(2008-10#3)
co-dominant##2##1##(1992-6#1)(2008-6#1)
co-eluted with##5##2##(1990-2#1)(1991-8#2)(2008-10#2)
co-eluted##6##1##(1990-2#1)(1991-8#2)(2008-10#3)
co-eluting with authentic##2##3##(1990-2#2)
co-eluting##3##1##(1990-2#2)(2008-10#1)
co-evolved with##2##2##(2008-6#1)(2013-8#1)
co-evolved##3##1##(2008-6#1)(2010-3#1)(2013-8#1)
co-evolving##3##1##(2011-2#1)(2012-2#2)
co-exist in##2##2##(2008-10#1)(2009-5#1)
co-exist with##2##2##(2008-10#2)
co-exist##7##1##(2008-10#3)(2008-9#1)(2009-5#1)(2012-5#1)(2013-1#1)
co-existence of##12##2##(1991-5#1)(1993-8#1)(1995-12#2)(1996-5#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-11#2)(2012-3#1)(2013-1#1)
co-existence##13##1##(1991-5#1)(1993-8#1)(1995-12#2)(1996-5#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-11#2)(2012-3#2)(2013-1#1)
co-existing##13##1##(1995-10#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)
co-express##4##1##(1993-3#1)(2007-12#1)(2008-4#1)(2012-2#1)
co-expressed in##3##2##(1993-12#1)(1994-11#1)(2009-10#1)
co-expressed with##4##2##(1993-3#1)(1997-7#1)(2008-2#1)(2008-8#1)
co-expressed##13##1##(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-3#1)(1997-4#3)(1997-7#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-3#1)
co-expressing##2##1##(2007-12#1)(2008-11#1)
co-expression in##2##2##(1995-6#1)(2008-4#1)
co-expression of##11##2##(1990-12#1)(1991-9#1)(1997-4#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-12#1)(2012-12#1)
co-expression##15##1##(1990-12#1)(1991-9#1)(1993-2#1)(1995-6#1)(1997-4#1)(1997-9#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-7#1)(2009-12#1)(2012-12#1)
co-extracted##3##1##(2008-10#3)
co-factor##8##1##(1990-9#1)(1992-9#1)(1997-1#1)(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)
co-factors##3##1##(1992-6#1)(2008-3#1)(2010-12#1)
co-formulated##2##1##(2008-10#2)
co-grafts##4##1##(2008-7#4)
co-immobilized Zymomonas##2##2##(2008-6#2)
co-immobilized on##3##2##(2008-10#3)
co-immobilized##9##1##(2008-10#6)(2008-6#3)
co-immunoprecipitates with##3##2##(1993-8#1)(1997-7#1)(2012-2#1)
co-immunoprecipitation##3##1##(1993-8#1)(2008-11#1)(2012-2#1)
co-incubation##4##1##(1995-11#1)(2008-11#1)(2008-4#1)(2011-1#1)
co-infected plants##3##2##(2008-10#3)
co-infected with HIV##2##3##(2010-4#1)(2010-5#1)
co-infected with human immunodeficiency virus##2##5##(2008-1#1)(2009-7#1)
co-infected with##5##2##(2008-1#1)(2008-10#1)(2009-7#1)(2010-4#1)(2010-5#1)
co-infected##8##1##(2008-1#1)(2008-10#4)(2009-7#1)(2010-4#1)(2010-5#1)
co-infecting##2##1##(2008-10#1)(2011-2#1)
co-infection of##2##2##(2007-7#1)(2012-3#1)
co-infection was##2##2##(2008-10#1)(2011-2#1)
co-infection with##3##2##(2008-10#1)(2011-2#2)
co-infection##14##1##(2007-7#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#7)(2012-3#1)(2013-8#1)
co-infections by genotypes B and C##2##6##(2008-12#2)
co-infections##4##1##(2008-12#4)
co-injected with##4##2##(1992-6#1)(1993-12#1)(1993-6#1)(1995-12#1)
co-injection##6##1##(1991-12#1)(1993-12#1)(2008-12#2)(2010-5#1)(2012-12#1)
co-inoculated with##4##2##(2008-10#3)(2011-1#1)
co-inoculated##9##1##(2008-10#8)(2011-1#1)
co-inoculations##2##1##(2008-10#2)
co-integrates##2##1##(1995-8#2)
co-leadership##2##1##(1995-12#2)
co-ligands##4##1##(1996-2#3)(2012-3#1)
co-linear##2##1##(2011-1#2)
co-linearity##2##1##(2007-11#1)(2008-10#1)
co-localization of##6##2##(1990-5#1)(2008-10#1)(2010-12#2)(2012-12#1)(2013-8#1)
co-localization##9##1##(1990-5#1)(1992-8#1)(2008-10#1)(2010-12#2)(2011-1#1)(2012-12#2)(2013-8#1)
co-localized in##3##2##(1990-5#1)(1995-6#1)(2008-7#1)
co-localized with actin##2##3##(2008-10#1)(2012-2#1)
co-localized with the##2##3##(2008-10#1)(2012-2#1)
co-localized with##7##2##(1992-6#1)(1992-8#1)(2008-10#2)(2012-2#3)
co-localized##12##1##(1990-5#1)(1992-6#1)(1992-8#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#3)
co-morbid conditions##4##2##(2007-7#1)(2008-1#3)
co-morbid##13##1##(1994-2#1)(2007-7#2)(2008-1#6)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
co-morbidities such as##3##3##(2011-2#1)(2011-3#1)(2013-1#1)
co-morbidities##8##1##(2007-10#1)(2007-7#1)(2008-9#1)(2011-2#1)(2011-3#2)(2013-1#2)
co-morbidity with##4##2##(1991-1#1)(2011-1#1)(2013-1#2)
co-morbidity##15##1##(1990-2#1)(1991-1#1)(1995-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)
co-occupancy##3##1##(2008-2#3)
co-occur with##2##2##(2008-8#1)(2008-9#1)
co-occur##9##1##(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#2)(2012-2#2)
co-occurred##2##1##(2008-12#1)(2012-3#1)
co-occurrence is##2##2##(2008-7#1)(2011-2#1)
co-occurrence matrices##3##2##(2008-2#2)(2010-8#1)
co-occurrence of##7##2##(1994-6#2)(2008-10#2)(2008-8#1)(2010-11#1)(2012-12#1)
co-occurrence##17##1##(1994-6#2)(1997-5#1)(2008-10#3)(2008-2#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#1)
co-occurring conditions##2##2##(2011-2#1)(2012-3#1)
co-occurring disorders##3##2##(2008-6#2)(2012-3#1)
co-occurring internalizing and externalizing disorders##2##5##(2012-12#2)
co-occurring internalizing and externalizing##3##4##(2012-12#3)
co-occurring substance abuse##4##3##(2008-6#1)(2013-8#3)
co-occurring substance##5##2##(2008-6#1)(2013-8#4)
co-occurring with##2##2##(2008-10#1)(2009-2#1)
co-occurring##24##1##(2008-10#2)(2008-6#6)(2008-9#1)(2009-2#2)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
co-operation between##3##2##(1996-7#1)(1997-8#1)(2008-6#1)
co-operation with##2##2##(2007-6#1)(2010-8#1)
co-operation##11##1##(1992-8#1)(1996-7#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)
co-operative##9##1##(1990-7#1)(1991-2#1)(1992-8#1)(1994-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)
co-ordinate##2##1##(2008-7#1)(2010-2#1)
co-ordinated by##2##2##(1992-8#1)(2008-8#1)
co-ordinated##4##1##(1992-8#1)(1997-3#1)(2008-8#1)(2011-2#1)
co-ordination and##2##2##(2008-11#1)(2013-8#1)
co-ordination of##3##2##(1991-2#1)(1991-3#1)(2008-4#1)
co-ordination##7##1##(1991-2#1)(1991-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
co-ordinator##2##1##(2008-11#1)(2008-12#1)
co-polymer trimethylamine microcarriers##3##3##(2008-11#3)
co-polymer##4##1##(2008-10#1)(2008-11#3)
co-precipitated##2##1##(2008-10#2)
co-precipitation##5##1##(2008-10#3)(2008-11#1)(2009-8#1)
co-prescription##2##1##(2011-2#2)
co-presence of low##2##3##(2012-6#2)
co-produced in##2##2##(1997-7#1)(2011-2#1)
co-produced##3##1##(1997-7#1)(2011-2#2)
co-provenance##2##1##(2008-10#2)
co-purified with##4##2##(1990-12#1)(1995-5#1)(1997-4#1)(2008-10#1)
co-purified##5##1##(1990-11#1)(1990-12#1)(1995-5#1)(1997-4#1)(2008-10#1)
co-reactants##3##1##(2008-10#1)(2012-3#2)
co-receptors##2##1##(2008-9#1)(2013-8#1)
co-registration of##2##2##(2009-11#1)(2011-1#1)
co-regulated genes##2##2##(2008-7#2)
co-regulated in##2##2##(2009-8#1)(2010-10#1)
co-regulated##5##1##(2008-10#1)(2008-7#2)(2009-8#1)(2010-10#1)
co-regulation of##3##2##(2007-12#1)(2009-8#1)(2012-3#1)
co-regulation##4##1##(1992-12#1)(2007-12#1)(2009-8#1)(2012-3#1)
co-researchers##3##1##(2008-11#2)(2008-12#1)
co-segregated with##3##2##(2008-10#3)
co-segregated##5##1##(2008-10#4)(2012-2#1)
co-segregation##2##1##(2006-12#1)(2008-10#1)
co-seismic##2##1##(2012-2#2)
co-solvent media##3##2##(2013-1#3)
co-solvent##7##1##(2008-10#4)(2013-1#3)
co-solvents##2##1##(2008-10#2)
co-stimulation##4##1##(2007-5#2)(2008-11#1)(2012-2#1)
co-stimulatory molecule##2##2##(2008-10#1)(2012-3#1)
co-stimulatory molecules##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
co-stimulatory##6##1##(2007-11#1)(2008-10#3)(2008-11#1)(2012-3#1)
co-suppression##4##1##(2008-9#4)
co-surfactant##2##1##(2008-10#2)
co-transcribed from##2##2##(1990-11#1)(1991-7#1)
co-transcribed##3##1##(1990-11#1)(1991-7#1)(2008-8#1)
co-transcription##2##1##(2011-2#1)(2013-1#1)
co-transfectant##2##1##(1994-12#1)(2008-11#1)
co-transfected into##2##2##(1994-9#1)(1995-12#1)
co-transfected with##7##2##(1990-8#2)(1991-2#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-9#1)
co-transfected##12##1##(1990-8#2)(1991-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(2008-11#2)(2008-9#1)(2011-3#1)
co-transfection with##2##2##(1991-9#1)(1995-6#1)
co-transfection##5##1##(1991-9#1)(1993-3#1)(1995-6#1)(2008-8#1)(2011-3#1)
co-transformed plants##2##2##(2008-8#2)
co-transmitter in##2##2##(1994-8#1)(2008-7#1)
co-transmitter##3##1##(1994-8#1)(2008-7#2)
co-treatment of##2##2##(2008-5#1)(2011-2#1)
co-treatment with##4##2##(1991-1#1)(1997-4#1)(2008-11#1)(2008-4#1)
co-treatment##6##1##(1991-1#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
co-vary##2##1##(2008-8#1)(2013-7#1)
co-worker##2##1##(2008-10#1)(2011-1#1)
co-workers##9##1##(1992-1#1)(1993-2#1)(1994-12#1)(1994-5#2)(1995-12#1)(1996-5#1)(1997-6#1)(2008-10#1)
coabsorption system##2##2##(2008-10#2)
coacervation occurred at##2##3##(2010-5#2)
coacervation occurred##3##2##(2010-5#3)
coacervation##8##1##(2010-5#8)
coach##4##1##(1993-3#1)(1995-3#1)(1996-2#1)(1997-3#1)
coaches##6##1##(1993-2#1)(1995-3#2)(2008-5#1)(2011-2#2)
coaches'##3##1##(1995-3#3)
coaching##2##1##(1993-2#1)(2006-10#1)
coactivator##4##1##(2008-1#2)(2008-9#1)(2011-2#1)
coadministered##2##1##(1991-8#1)(1996-3#1)
coadministration of##2##2##(2008-2#1)(2008-5#1)
coadministration with##4##2##(2011-1#4)
coadministration##7##1##(2008-2#1)(2008-5#1)(2011-1#5)
coaggregation of##3##2##(1997-5#1)(2008-5#2)
coaggregation##15##1##(1997-5#10)(2008-5#5)
coaggregations##2##1##(2008-5#2)
coagulant##3##1##(2008-11#1)(2008-5#2)
coagulase##2##1##(2008-8#2)
coagulase-negative Staphylococcus##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
coagulase-negative staphylococci##7##2##(1990-6#1)(2007-12#1)(2008-7#2)(2010-12#1)(2010-4#2)
coagulase-negative staphylococcus##2##2##(1991-3#1)(2007-12#1)
coagulase-negative##14##1##(1990-6#1)(1991-3#2)(2007-12#2)(2008-10#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-4#2)(2011-2#1)(2013-1#1)
coagulating##3##1##(1993-12#1)(2008-12#1)(2008-9#1)
coagulation analysers##5##2##(2008-10#5)
coagulation and fibrinolysis##4##3##(1991-6#1)(2008-7#1)(2010-3#2)
coagulation and##8##2##(1991-6#1)(1992-12#1)(2006-12#1)(2008-7#1)(2010-12#1)(2010-3#2)(2010-8#1)
coagulation artifact##2##2##(1994-12#2)
coagulation by##2##2##(1991-3#1)(2008-7#1)
coagulation disorders##2##2##(1991-3#2)
coagulation factor IX##4##3##(2008-7#1)(2008-8#2)(2008-9#1)
coagulation factor XIII##3##3##(1995-12#1)(2008-11#2)
coagulation factor##12##2##(1992-12#1)(1993-11#1)(1995-12#2)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#1)
coagulation in##2##2##(2006-6#1)(2013-1#1)
coagulation occurred##2##2##(1992-1#1)(2011-2#1)
coagulation of the##2##3##(2006-12#1)(2008-9#1)
coagulation of##5##2##(1991-9#1)(2006-12#1)(2008-9#1)(2009-11#1)(2009-4#1)
coagulation profile##2##2##(2007-7#1)(2008-7#1)
coagulation proteins##3##2##(1995-2#1)(2008-9#1)(2012-12#1)
coagulation status##2##2##(2011-2#1)(2012-2#1)
coagulation system in##2##3##(2007-10#1)(2013-1#1)
coagulation system##3##2##(2007-10#1)(2010-8#1)(2013-1#1)
coagulation therapy##2##2##(2010-8#2)
coagulation time##4##2##(2008-12#1)(2008-9#3)
coagulation waveform on##2##3##(1992-12#2)
coagulation waveform##3##2##(1992-12#3)
coagulation##122##1##(1990-11#1)(1991-3#3)(1991-6#1)(1991-9#4)(1992-1#2)(1992-12#5)(1992-9#1)(1993-11#3)(1993-3#1)(1994-12#2)(1994-9#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#1)(1996-8#1)(1997-4#2)(2006-10#1)(2006-12#2)(2006-6#2)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#10)(2008-8#6)(2008-9#6)(2009-11#1)(2009-4#1)(2010-12#1)(2010-3#4)(2010-6#1)(2010-8#7)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
coagulative##2##1##(2008-1#1)(2008-9#1)
coagulopathies##2##1##(1996-9#1)(2008-7#1)
coagulopathy##18##1##(1990-2#1)(1991-3#1)(2007-10#6)(2008-10#1)(2008-7#6)(2008-9#1)(2009-1#1)(2011-2#1)
coal analysis##2##2##(2008-10#2)
coal by ICP##2##3##(2008-10#2)
coal by##6##2##(2008-10#6)
coal combustion##2##2##(2010-5#2)
coal fly ash and##4##4##(2008-10#4)
coal fly ash samples##3##4##(2008-10#3)
coal fly ash##7##3##(2008-10#7)
coal fly##8##2##(2008-10#8)
coal sample##2##2##(2008-10#2)
coal samples##7##2##(2008-1#1)(2008-10#5)(2008-6#1)
coal using##2##2##(2008-1#1)(2008-6#1)
coal##57##1##(1997-5#1)(2008-1#2)(2008-10#41)(2008-6#8)(2008-9#1)(2010-5#2)(2011-2#1)(2013-8#1)
coal-fired power stations##3##3##(2008-10#2)(2008-3#1)
coalesce##3##1##(1993-5#1)(2009-10#1)(2011-2#1)
coalesced##7##1##(1997-6#3)(2007-12#1)(2008-10#2)(2008-3#1)
coalescence and##2##2##(2008-10#1)(2008-5#1)
coalescence of##4##2##(2008-2#1)(2008-3#2)(2009-7#1)
coalescence or##2##2##(2008-10#2)
coalescence##14##1##(1994-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#5)(2009-7#1)(2010-6#1)
coalescent analyses##2##2##(2009-2#1)(2013-7#1)
coalescent##10##1##(2008-1#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-6#3)(2010-8#1)(2012-3#1)(2013-7#1)
coalescent-based##3##1##(2009-2#1)(2010-6#1)(2012-3#1)
coalfield##2##1##(2007-10#2)
coalfields##3##1##(2007-10#3)
coalition building##2##2##(1994-12#1)(1997-1#1)
coalition for##2##2##(2008-10#1)(2009-11#1)
coalition of##4##2##(1994-12#1)(1996-3#1)(2008-5#1)(2008-8#1)
coalition was##3##2##(2009-10#2)(2009-11#1)
coalition##22##1##(1994-1#1)(1994-12#2)(1996-1#2)(1996-3#2)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#4)(2009-11#2)(2010-5#4)
coalitions and##4##2##(1995-12#2)(2008-6#1)(2009-5#1)
coalitions in##2##2##(1995-12#1)(2009-10#1)
coalitions##16##1##(1991-9#1)(1992-1#1)(1993-1#1)(1994-12#2)(1995-12#4)(2008-6#1)(2008-8#1)(2009-10#2)(2009-5#2)(2010-12#1)
coals##7##1##(2008-10#7)
coamplified with##2##2##(2008-10#2)
coanalgesics##2##1##(1997-3#2)
coarctation of the aorta##8##4##(1996-11#1)(2007-11#1)(2007-8#4)(2012-1#1)(2013-1#1)
coarctation of##10##2##(1996-11#1)(2007-11#1)(2007-8#5)(2011-2#1)(2012-1#1)(2013-1#1)
coarctation##19##1##(1996-11#1)(2007-11#1)(2007-8#11)(2011-2#4)(2012-1#1)(2013-1#1)
coarse and##2##2##(2008-3#1)(2009-7#1)
coarse coding or suppression##2##4##(2012-3#2)
coarse coding##4##2##(2012-3#4)
coarse##36##1##(1991-6#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-8#5)(2009-7#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#5)(2013-7#1)
coarse-grained##5##1##(2007-9#1)(2008-8#4)
coarsely##3##1##(2007-12#1)(2008-3#1)(2012-3#1)
coarsening of##2##2##(2008-7#2)
coarsening##4##1##(2008-3#1)(2008-7#3)
coarser##4##1##(2008-10#1)(2008-5#1)(2008-8#2)
coarticulation in##2##2##(2013-8#2)
coarticulation than##3##2##(2013-8#3)
coarticulation##11##1##(2009-11#1)(2013-8#10)
coast and##6##2##(1990-6#1)(1996-4#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-12#1)
coast live oak##2##3##(2008-10#2)
coast of Australia##2##3##(2009-12#1)(2012-2#1)
coast of Cuba##3##3##(2008-5#3)
coast of the##3##3##(2008-5#1)(2010-8#2)
coast of##28##2##(1991-11#1)(1995-5#1)(2007-5#1)(2008-10#3)(2008-5#10)(2009-12#2)(2009-2#1)(2010-8#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
coast##60##1##(1990-11#2)(1990-6#1)(1991-11#1)(1995-5#1)(1996-4#1)(1997-4#2)(1997-6#1)(2007-5#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#14)(2009-12#2)(2009-2#1)(2010-8#6)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#1)
coastal California##3##2##(2008-10#3)
coastal and inland waters##3##4##(2008-3#3)
coastal and inland##5##3##(2007-5#1)(2008-2#1)(2008-3#3)
coastal and##11##2##(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#2)(2010-8#1)
coastal area of##2##3##(2008-10#1)(2013-7#1)
coastal areas of California##2##4##(2008-10#2)
coastal areas of##4##3##(2008-10#2)(2008-5#1)(2013-8#1)
coastal areas##6##2##(2007-12#1)(2008-10#2)(2008-5#1)(2012-5#1)(2013-8#1)
coastal development##2##2##(2007-5#2)
coastal region of##2##3##(2008-10#1)(2010-8#1)
coastal regions##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
coastal seawater##3##2##(2008-10#3)
coastal sediments##2##2##(2007-5#2)
coastal site##2##2##(2008-10#1)(2013-1#1)
coastal sites##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
coastal waters and##2##3##(2008-3#2)
coastal waters of##2##3##(2008-5#1)(2012-2#1)
coastal waters##21##2##(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
coastal zone##3##2##(2007-5#1)(2008-8#2)
coastal##107##1##(1990-11#1)(1992-3#1)(1997-4#1)(2007-12#1)(2007-5#6)(2008-10#26)(2008-12#1)(2008-2#13)(2008-3#13)(2008-5#6)(2008-8#7)(2010-1#1)(2010-4#3)(2010-8#6)(2011-2#5)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#4)
coastline##3##1##(2010-8#1)(2011-2#1)(2013-7#1)
coasts of##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
coasts##6##1##(2008-10#2)(2008-5#2)(2010-8#1)(2013-7#1)
coat and##3##2##(2008-7#1)(2010-4#1)(2013-8#1)
coat color spotting##3##3##(1994-12#3)
coat color##6##2##(1994-12#4)(2008-8#1)(2010-4#1)
coat is##3##2##(2008-10#2)(2008-8#1)
coat of##5##2##(1993-6#3)(1994-11#1)(1995-2#1)
coat protein (CP) and##4##4##(2008-10#4)
coat protein (CP) coding region##2##5##(2008-10#2)
coat protein (CP) coding##3##4##(2008-10#3)
coat protein (CP) gene was amplified##2##6##(2008-10#2)
coat protein (CP) gene was##3##5##(2008-10#2)(2008-8#1)
coat protein (CP) gene##13##4##(1997-6#1)(2008-10#11)(2008-8#1)
coat protein (CP) of##2##4##(2008-10#2)
coat protein (CP)##27##3##(1997-6#1)(2008-10#25)(2008-8#1)
coat protein gene and##3##4##(2008-10#2)(2008-8#1)
coat protein gene of##5##4##(1997-2#1)(1997-6#1)(2008-10#3)
coat protein gene##16##3##(1997-2#1)(1997-6#1)(2008-10#13)(2008-8#1)
coat protein genes##4##3##(2008-10#4)
coat protein in the##2##4##(1991-5#1)(2008-10#1)
coat protein in##3##3##(1991-5#1)(1997-3#1)(2008-10#1)
coat protein of##5##3##(1997-2#2)(2008-10#2)(2008-7#1)
coat protein##95##2##(1991-5#9)(1994-12#1)(1997-2#5)(1997-3#2)(1997-6#2)(2008-10#66)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#4)(2011-2#1)
coat proteins (CPs)##3##3##(2008-10#3)
coat proteins##7##2##(2008-10#5)(2009-6#1)(2011-2#1)
coat the##3##2##(1995-2#1)(2008-10#2)
coat##168##1##(1990-9#1)(1991-5#9)(1993-6#4)(1994-11#1)(1994-12#5)(1995-2#3)(1997-2#5)(1997-3#3)(1997-6#2)(2007-5#1)(2008-10#94)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#8)(2009-6#1)(2010-4#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#7)
coated GCE in##2##3##(2008-10#2)
coated GCE##4##2##(2008-10#4)
coated QCM##3##2##(2008-10#3)
coated amylose tris-(3##2##3##(2008-10#2)
coated by a##3##3##(1997-4#1)(2008-2#1)(2009-6#1)
coated by the osmiophilic material##2##5##(2008-10#2)
coated by the##3##3##(2008-10#2)(2012-1#1)
coated by##11##2##(1997-4#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-6#1)(2009-7#1)(2012-1#1)(2013-1#1)
coated capillary##5##2##(2008-10#5)
coated cylinders##2##2##(2008-2#2)
coated electrode##4##2##(2008-10#4)
coated electrodes##5##2##(2008-10#5)
coated film##2##2##(2007-12#1)(2008-10#1)
coated for##2##2##(2008-3#2)
coated glass##4##2##(2008-10#3)(2009-7#1)
coated glassy carbon electrode##6##4##(2008-10#6)
coated glassy carbon##7##3##(2008-10#7)
coated graphite##6##2##(2007-12#1)(2008-10#5)
coated membranes##2##2##(1993-9#1)(1995-2#1)
coated on a##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
coated on glassy carbon##2##4##(2008-10#2)
coated on the surface of##2##5##(2008-10#2)
coated on the##4##3##(2008-10#4)
coated on##16##2##(2008-10#13)(2008-2#1)(2008-3#2)
coated onto the##2##3##(1994-8#1)(2008-10#1)
coated onto##3##2##(1994-8#1)(1997-3#1)(2008-10#1)
coated or##2##2##(1997-3#1)(2008-3#1)
coated plastic substrata##2##3##(1994-8#2)
coated plate##2##2##(2008-10#1)(2010-5#1)
coated silicon##2##2##(2008-5#1)(2009-11#1)
coated sugar spheres##2##3##(2008-11#2)
coated superparamagnetic iron oxide nanoparticles##2##5##(2012-12#2)
coated surface##5##2##(1997-7#3)(2008-10#1)(2012-2#1)
coated vesicles##3##2##(1997-1#3)
coated wire electrodes##3##3##(2008-10#3)
coated wire##4##2##(2008-10#4)
coated with APDC##2##3##(2008-10#2)
coated with a self-assembled monolayer##2##5##(2008-10#1)(2008-3#1)
coated with a thin##2##4##(2008-10#1)(2008-5#1)
coated with a##21##3##(1990-12#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-5#1)(2009-5#1)(2012-2#1)
coated with an##3##3##(1997-2#1)(2008-2#1)(2010-5#1)
coated with different##2##3##(1990-12#1)(2009-8#1)
coated with either##2##3##(1994-6#1)(1995-12#1)
coated with pipDTC##2##3##(2008-10#2)
coated with the##6##3##(1992-9#1)(2008-10#4)(2008-5#1)
coated with##93##2##(1990-12#5)(1992-9#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#46)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#3)(2008-5#3)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)
coated zirconia-magnesia chromatography##2##3##(2008-10#2)
coated zirconia-magnesia##3##2##(2008-10#3)
coated##276##1##(1990-12#5)(1990-9#1)(1991-3#1)(1992-9#1)(1993-9#1)(1994-3#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#3)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#4)(2007-12#5)(2007-8#4)(2008-10#143)(2008-11#8)(2008-12#2)(2008-2#15)(2008-3#21)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2009-11#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
coated-antigen format##2##2##(1995-12#2)
coating a##3##2##(2008-10#3)
coating and the##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
coating and##14##2##(2008-10#4)(2008-2#4)(2008-3#3)(2008-7#1)(2009-11#1)(2009-8#1)
coating antigen##2##2##(1995-12#1)(2011-1#1)
coating by##2##2##(2007-12#1)(2008-2#1)
coating for resolving rhodamine B##2##5##(2008-10#2)
coating for##9##2##(2008-10#5)(2008-2#1)(2008-3#1)(2009-11#1)(2009-7#1)
coating has##2##2##(2008-10#1)(2008-3#1)
coating have##2##2##(2007-11#1)(2010-7#1)
coating increased the##2##3##(2008-10#1)(2008-3#1)
coating is##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)
coating material##5##2##(2008-10#1)(2008-3#3)(2008-5#1)
coating materials##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
coating may##2##2##(2008-11#1)(2008-3#1)
coating method##5##2##(1994-6#1)(2008-10#3)(2008-2#1)
coating methods##3##2##(2009-7#3)
coating of the##8##3##(1993-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
coating of##25##2##(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#2)(2013-1#1)
coating on the##9##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-1#1)
coating on##10##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#2)(2010-8#1)(2012-1#1)
coating or##4##2##(2008-10#2)(2008-3#1)(2010-5#1)
coating procedure##2##2##(2008-10#1)(2009-11#1)
coating process##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
coating properties##2##2##(2008-2#1)(2013-1#1)
coating showed##2##2##(2008-10#1)(2012-1#1)
coating solution##2##2##(2008-10#2)
coating technique##2##2##(2008-10#1)(2008-2#1)
coating the##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2013-1#1)
coating thickness##7##2##(2007-11#1)(2008-10#1)(2008-3#4)(2010-5#1)
coating was applied##2##3##(2007-11#1)(2008-10#1)
coating was investigated##2##3##(2012-1#1)(2013-8#1)
coating was##13##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2012-1#1)(2013-8#1)
coating were##2##2##(2007-11#1)(2008-10#1)
coating with##5##2##(2008-10#1)(2008-2#2)(2008-7#1)(2013-1#1)
coating##235##1##(1993-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(2007-11#10)(2007-12#9)(2008-10#78)(2008-11#4)(2008-2#30)(2008-3#50)(2008-4#2)(2008-5#5)(2008-7#4)(2008-9#2)(2009-11#3)(2009-7#6)(2009-8#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#3)(2012-2#1)(2013-1#6)(2013-8#6)
coating)##2##1##(2008-10#1)(2008-3#1)
coatings and the##2##3##(2008-3#1)(2010-5#1)
coatings and their##2##3##(2007-11#1)(2008-10#1)
coatings and##10##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-5#1)(2010-7#1)
coatings are designed##2##3##(2008-3#1)(2009-11#1)
coatings are presented##2##3##(2008-2#1)(2008-3#1)
coatings are##10##2##(2008-10#1)(2008-2#3)(2008-3#2)(2009-11#2)(2010-5#1)(2010-7#1)
coatings as##2##2##(2008-3#2)
coatings based on##2##3##(2008-2#1)(2008-3#1)
coatings can##2##2##(2008-3#1)(2008-7#1)
coatings for implantable##2##3##(2009-11#2)
coatings for silicon##2##3##(2008-2#2)
coatings for the##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
coatings for##20##2##(2008-10#2)(2008-2#6)(2008-3#7)(2008-5#1)(2009-11#2)(2010-4#2)
coatings has##2##2##(2008-3#2)
coatings in the##3##3##(2008-2#1)(2008-3#2)
coatings in##7##2##(2008-2#3)(2008-3#3)(2010-4#1)
coatings is##3##2##(2008-2#1)(2008-3#2)
coatings may##2##2##(2008-5#1)(2008-7#1)
coatings of##5##2##(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#1)
coatings on a variety of##2##5##(2008-2#1)(2010-4#1)
coatings on a##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
coatings on glassy carbon##2##4##(2008-10#2)
coatings on the##2##3##(2008-2#1)(2008-5#1)
coatings on##17##2##(2008-10#7)(2008-2#3)(2008-3#2)(2008-5#1)(2009-5#1)(2010-4#3)
coatings onto glassy carbon##2##4##(2008-10#2)
coatings to##4##2##(2007-12#1)(2008-10#1)(2009-11#1)(2010-7#1)
coatings was##3##2##(2008-10#1)(2008-2#2)
coatings were##7##2##(2008-10#3)(2008-2#1)(2008-3#2)(2010-4#1)
coatings with different##2##3##(2008-2#1)(2008-3#1)
coatings with high##2##3##(2008-2#1)(2008-3#1)
coatings with##12##2##(2008-2#5)(2008-3#5)(2010-4#2)
coatings##195##1##(1997-2#1)(2007-11#3)(2007-12#4)(2008-10#36)(2008-11#1)(2008-2#42)(2008-3#58)(2008-5#5)(2008-7#4)(2008-9#5)(2009-11#6)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#20)(2010-5#3)(2010-7#3)(2012-1#1)
coatomer mutants##2##2##(1994-12#2)
coatomer##6##1##(1994-12#4)(2009-7#1)(2011-2#1)
coats the##2##2##(1992-11#1)(2008-5#1)
coats##14##1##(1992-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#5)(2009-9#1)(2011-2#1)(2012-2#1)
coauthor##2##1##(1992-3#1)(1993-2#1)
coaveraging##2##1##(2007-11#2)
coaxial fiber##2##2##(2007-11#2)
coaxial##13##1##(1992-11#1)(1993-9#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-8#1)
cobalamin (B(12))##2##2##(2008-3#2)
cobalamin is##2##2##(2008-10#1)(2013-1#1)
cobalamin may##2##2##(2008-10#2)
cobalamin##15##1##(1992-9#1)(2008-10#5)(2008-3#2)(2008-7#1)(2011-1#3)(2013-1#3)
cobalt (II)##2##2##(2008-10#2)
cobalt and chromium in human urine##2##6##(2008-10#2)
cobalt and chromium##3##3##(2008-10#3)
cobalt and nickel by marine brown alga Sargassum sp##2##9##(2008-12#2)
cobalt and nickel in##2##4##(2008-10#2)
cobalt and nickel##8##3##(2008-10#6)(2008-12#2)
cobalt and##16##2##(2008-10#13)(2008-11#1)(2008-12#2)
cobalt by##3##2##(2008-10#3)
cobalt chloride##2##2##(1993-12#1)(2007-7#1)
cobalt chromium##2##2##(2009-7#1)(2013-1#1)
cobalt concentrations##2##2##(2008-10#1)(2013-8#1)
cobalt determination in##3##3##(2008-10#3)
cobalt hexacyanoferrate (CoHCF)##2##3##(2008-10#2)
cobalt hexacyanoferrate##4##2##(2008-10#4)
cobalt in the##3##3##(2008-10#3)
cobalt in water samples by##2##5##(2008-10#2)
cobalt in water samples##3##4##(2008-10#3)
cobalt in##20##2##(2008-10#20)
cobalt metal##2##2##(2008-10#2)
cobalt phthalocyanine##4##2##(2008-10#4)
cobalt was##2##2##(2008-10#2)
cobalt with nitroso-R-salt##3##3##(2008-10#3)
cobalt with##7##2##(2008-10#7)
cobalt##150##1##(1990-11#1)(1990-4#1)(1993-12#1)(1997-3#1)(2006-4#1)(2007-7#1)(2008-10#131)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#2)(2009-7#2)(2010-11#1)(2013-1#1)(2013-8#1)
cobalt(II) and nickel(II)##2##3##(2008-10#2)
cobalt(II) and##10##2##(2008-10#10)
cobalt(II) ion##4##2##(1996-2#3)(2008-10#1)
cobalt(II) ions##4##2##(1992-11#1)(1996-2#1)(2008-10#2)
cobalt(II) was##3##2##(2008-10#3)
cobalt(II)##58##1##(1992-11#1)(1996-2#5)(2008-10#52)
cobalt(II)-hydrogen peroxide-hydrogencarbonate##2##2##(2008-10#2)
cobalt(III)##3##1##(2007-11#1)(2008-10#2)
cobalt-60##4##1##(1991-2#1)(2008-7#3)
cobalt-wire##4##1##(2008-10#4)
cobia##3##1##(2008-7#3)
coblation for##2##2##(2010-3#2)
cobrotoxin and cardiotoxin 4 genes##2##5##(1997-7#2)
coca var##2##2##(2008-10#2)
coca##11##1##(2008-10#11)
coca-growing regions##2##2##(2008-10#2)
cocaethylene administration##2##2##(1996-12#2)
cocaethylene##7##1##(1996-12#7)
cocaine (0##2##2##(1991-5#1)(1993-6#1)
cocaine abuse in##2##3##(1991-1#2)
cocaine abuse##4##2##(1991-1#3)(2008-6#1)
cocaine addiction##4##2##(1991-1#1)(2008-11#1)(2008-6#1)(2009-7#1)
cocaine administration##4##2##(1991-1#1)(1993-12#1)(2011-2#2)
cocaine and lidocaine##2##3##(1991-1#1)(1996-12#1)
cocaine and opiate##3##3##(2010-11#3)
cocaine and##12##2##(1991-1#3)(1994-8#1)(1996-12#1)(2008-10#2)(2010-11#3)(2010-4#1)(2013-8#1)
cocaine consumption##2##2##(2012-2#2)
cocaine dependence##4##2##(1991-1#3)(2008-11#1)
cocaine exposure is##2##3##(1991-5#1)(1996-12#1)
cocaine exposure##7##2##(1991-1#1)(1991-5#4)(1992-12#1)(1996-12#1)
cocaine hydrochloride##2##2##(2008-10#1)(2010-5#1)
cocaine in the##3##3##(1993-6#1)(2013-8#2)
cocaine in##5##2##(1991-1#1)(1993-6#1)(2013-8#3)
cocaine induced##4##2##(1991-1#1)(1994-3#1)(2009-7#1)(2011-2#1)
cocaine is a##2##3##(1990-7#1)(2008-1#1)
cocaine on the##2##3##(1991-1#1)(2011-2#1)
cocaine on##6##2##(1991-1#2)(1993-12#1)(1993-6#1)(2011-2#2)
cocaine self-administration by rhesus##2##4##(1991-1#2)
cocaine self-administration##7##2##(1991-1#3)(1993-6#2)(2009-11#1)(2009-7#1)
cocaine use##9##2##(1991-1#3)(1992-12#2)(1997-5#1)(2008-4#1)(2010-6#2)
cocaine users##2##2##(1991-1#1)(2013-8#1)
cocaine was##4##2##(1993-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
cocaine##172##1##(1990-7#4)(1991-1#45)(1991-11#1)(1991-12#9)(1991-2#1)(1991-5#6)(1992-11#3)(1992-12#3)(1992-7#1)(1993-12#7)(1993-3#1)(1993-6#8)(1994-3#1)(1994-8#1)(1996-12#6)(1996-5#1)(1997-5#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-4#1)(2008-6#3)(2009-11#2)(2009-7#9)(2010-1#1)(2010-11#4)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#3)(2012-3#2)(2013-8#14)
cocaine's##2##1##(2008-6#1)(2012-3#1)
cocaine-induced locomotor activity##3##3##(2008-10#3)
cocaine-induced##5##1##(1991-1#1)(2008-10#4)
cocaine-like discriminative stimulus effects##2##4##(1991-12#2)
cocaine-like##3##1##(1991-12#3)
cocamide DEA##2##2##(2008-5#2)
cocamide##3##1##(2008-5#3)
cocarcinogenic##2##1##(1992-2#1)(1992-8#1)
cocci##7##1##(1991-3#1)(1996-12#1)(2006-10#1)(2007-7#1)(2010-12#1)(2010-2#1)(2013-8#1)
coccidian parasite##3##2##(2007-7#1)(2013-1#2)
coccidioidomycosis##9##1##(2007-12#3)(2007-2#3)(2008-5#2)(2011-2#1)
coccidiosis##6##1##(1997-6#2)(2007-6#1)(2008-5#2)(2013-7#1)
coccineus L##2##2##(2008-3#2)
coccineus##5##1##(2008-10#3)(2008-3#2)
coccodes isolates##4##2##(2008-10#4)
coccodes##19##1##(2008-10#19)
coccoid##2##1##(1990-11#1)(1997-6#1)
coccus##2##1##(2011-2#1)(2012-12#1)
cochaperones##2##1##(2008-4#1)(2008-7#1)
cochlea and##5##2##(2008-9#2)(2012-2#3)
cochlea to##2##2##(2012-2#1)(2013-1#1)
cochlea##22##1##(2008-9#14)(2009-5#2)(2009-9#1)(2012-2#4)(2013-1#1)
cochleae##5##1##(2008-9#5)
cochlear function in mice##2##4##(2008-4#2)
cochlear hair cells##3##3##(2009-8#1)(2012-2#2)
cochlear implant (CI)##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
cochlear implant and##3##3##(2008-9#1)(2012-2#2)
cochlear implant candidates##3##3##(2008-9#3)
cochlear implant electrode##5##3##(2008-9#4)(2012-2#1)
cochlear implant electrodes##4##3##(2008-9#4)
cochlear implant experience##3##3##(2008-9#3)
cochlear implant in##2##3##(2008-9#2)
cochlear implant patients##10##3##(2008-9#10)
cochlear implant programme##3##3##(2008-9#3)
cochlear implant recipients and##3##4##(2008-9#3)
cochlear implant recipients##9##3##(2008-9#8)(2012-2#1)
cochlear implant speech##2##3##(2008-9#2)
cochlear implant subjects##2##3##(2008-9#2)
cochlear implant surgery##5##3##(2008-9#2)(2012-2#3)
cochlear implant system##5##3##(2008-9#5)
cochlear implant technology##2##3##(2008-9#2)
cochlear implant use##3##3##(2008-9#3)
cochlear implant users##27##3##(2008-9#24)(2011-1#2)(2012-2#1)
cochlear implant wearers##2##3##(2008-9#2)
cochlear implant##149##2##(2008-9#132)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#12)(2013-1#1)
cochlear implantation in a##5##4##(2008-9#3)(2012-2#1)(2013-1#1)
cochlear implantation in adults##2##4##(2008-9#2)
cochlear implantation in children##6##4##(2008-9#2)(2012-2#4)
cochlear implantation in##25##3##(2008-9#18)(2012-2#6)(2013-1#1)
cochlear implantation is a##2##4##(2008-9#1)(2012-2#1)
cochlear implantation is##5##3##(2008-9#3)(2012-2#2)
cochlear implantation surgery##2##3##(2008-9#1)(2012-2#1)
cochlear implantation was##2##3##(2008-9#2)
cochlear implantation with##2##3##(2008-9#1)(2012-2#1)
cochlear implantation##89##2##(2008-9#69)(2012-2#19)(2013-1#1)
cochlear implantations##3##2##(2008-9#3)
cochlear implanted##2##2##(2008-9#2)
cochlear implantees##7##2##(2008-9#7)
cochlear implants (CIs)##2##3##(2012-2#2)
cochlear implants and##5##3##(2008-9#5)
cochlear implants are##3##3##(2008-9#2)(2012-2#1)
cochlear implants at##2##3##(2008-9#2)
cochlear implants have##2##3##(2008-9#1)(2012-2#1)
cochlear implants in##4##3##(2008-9#4)
cochlear implants were##2##3##(2008-9#2)
cochlear implants##86##2##(2008-9#75)(2010-10#1)(2012-2#10)
cochlear implants?##2##2##(2008-9#2)
cochlear models##2##2##(2012-2#2)
cochlear nerve##2##2##(2008-9#2)
cochlear nucleus complex##2##3##(2013-8#2)
cochlear nucleus##7##2##(1993-12#1)(1996-2#3)(2013-8#3)
cochlear##372##1##(1993-12#2)(1995-5#1)(1996-12#1)(1996-2#3)(2008-1#2)(2008-4#2)(2008-9#300)(2009-5#2)(2009-8#2)(2010-10#2)(2011-1#2)(2011-2#3)(2012-2#45)(2013-1#2)(2013-8#3)
cochlear-implanted children##2##2##(2008-9#2)
cochlear-implanted##3##1##(2008-9#3)
cochleostomies##2##1##(2008-9#2)
cochleostomy and##2##2##(2008-9#2)
cochleostomy##7##1##(2008-9#7)
cochlioides cultures##2##2##(2008-10#2)
cochlioides##10##1##(2008-10#9)(2013-1#1)
cockatiel##3##1##(2008-5#3)
cockatoo (Cacatua moluccensis) and a blue and gold macaw (Ara ararauna)##2##11##(1997-3#2)
cockatoo##4##1##(1997-3#4)
cockle##8##1##(1996-12#7)(2008-5#1)
cockroach##11##1##(1990-5#1)(1993-12#1)(1995-11#1)(2007-12#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#2)(2013-1#1)
cockroaches##6##1##(1995-11#1)(2007-12#2)(2009-4#1)(2011-2#1)(2013-1#1)
cocktail of##7##2##(1990-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
cocktail party##2##2##(2009-5#2)
cocktail##16##1##(1990-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-5#2)(2011-2#2)(2012-2#1)(2013-1#1)
cocktail&quot##2##1##(2007-11#1)(2011-1#1)
cocktail-party-like##2##1##(2009-5#2)
cocktails##4##1##(1997-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
cocktails&quot##2##1##(2010-5#2)
cocoa##12##1##(1996-11#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-4#3)(2012-3#5)
cocoamidopropyl betaine##3##2##(2008-10#1)(2008-5#2)
cocoampho-acetate##2##1##(2008-5#2)
coconut (Cocos nucifera)##2##3##(2008-10#1)(2008-5#1)
coconut oil##7##2##(2008-10#1)(2008-3#4)(2013-1#2)
coconut palm##4##2##(2008-10#4)
coconut tinangaja viroid##2##3##(2008-10#2)
coconut##24##1##(2008-10#13)(2008-3#4)(2008-5#2)(2008-6#3)(2013-1#2)
cocoon##2##1##(2007-12#1)(2008-11#1)
cocultivation##5##1##(2008-10#5)
coculture of##3##2##(1990-11#1)(1994-6#1)(2008-7#1)
coculture system##7##2##(1995-2#1)(2008-11#3)(2008-5#3)
coculture with##4##2##(2008-4#1)(2008-6#1)(2008-9#2)
coculture##22##1##(1990-11#1)(1994-6#1)(1995-2#1)(2008-11#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)
cocultured for##2##2##(1995-8#1)(2008-8#1)
cocultured with##3##2##(1995-2#1)(2008-7#1)(2010-11#1)
cocultured##9##1##(1995-2#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-11#2)(2011-2#1)
cocultures of##2##2##(1995-2#1)(2008-10#1)
cocultures##17##1##(1995-2#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2012-1#2)
coculturing with fullydifferentiated##2##3##(2008-11#2)
coculturing with##4##2##(2008-11#3)(2012-1#1)
coculturing##7##1##(2008-11#4)(2012-1#3)
cod Gadus morhua in##3##4##(2010-8#3)
cod Gadus morhua##6##3##(2010-8#6)
cod liver##2##2##(2008-10#1)(2011-2#1)
cod##15##1##(2008-10#2)(2009-7#1)(2010-8#8)(2011-2#1)(2012-3#3)
coda Q-1 and##3##3##(1996-4#3)
coda Q-1##4##2##(1996-4#4)
coda##6##1##(1996-3#1)(1996-4#4)(2008-8#1)
code 163##3##2##(1992-11#3)
code and##8##2##(1990-3#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#3)
code are##5##2##(1996-2#1)(2008-3#4)
code based on##2##3##(2008-3#2)
code compression##2##2##(2012-3#2)
code division##3##2##(2008-3#3)
code for a##7##3##(1993-6#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
code for the##5##3##(1990-5#1)(1997-3#1)(2008-2#1)(2008-3#1)(2010-5#1)
code for##29##2##(1990-5#4)(1993-6#6)(1994-12#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
code in the##2##3##(1992-2#1)(2008-2#1)
code is proposed##2##3##(2008-3#2)
code is##11##2##(2008-2#1)(2008-3#9)(2013-8#1)
code of ethics##2##3##(1992-3#1)(2007-10#1)
code of##8##2##(1992-11#1)(1992-3#1)(1994-7#1)(1995-12#1)(1997-5#1)(2007-10#1)(2008-3#1)(2013-8#1)
code package##3##2##(2011-1#3)
code suitable for##2##3##(2008-2#2)
code to##4##2##(1991-3#1)(1992-2#1)(2008-3#2)
code was##3##2##(1990-9#1)(2008-2#1)(2011-1#1)
code##176##1##(1990-3#1)(1990-5#5)(1990-9#3)(1991-2#1)(1991-3#2)(1992-11#5)(1992-2#3)(1992-3#1)(1993-6#6)(1994-12#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#19)(2008-3#54)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-8#4)
code-division multiple-access##2##2##(2008-2#2)
code-division##7##1##(2008-2#5)(2008-3#2)
code-related##2##1##(2013-1#2)
codebook generation##2##2##(2008-3#2)
codebook##6##1##(2008-3#4)(2008-6#1)(2013-1#1)
coded aperture imaging##2##3##(2008-2#1)(2008-3#1)
coded by sgcD##2##3##(2008-9#2)
coded by the##3##3##(1993-2#1)(2007-8#1)(2009-9#1)
coded by##8##2##(1992-8#1)(1993-2#1)(2007-8#1)(2008-1#1)(2008-9#2)(2009-9#1)(2012-12#1)
coded excitation##3##2##(2012-3#3)
coded for a##5##3##(1990-12#1)(1990-5#1)(1994-6#1)(2008-10#1)(2010-6#1)
coded for##10##2##(1990-12#1)(1990-5#2)(1994-11#2)(1994-6#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)
coded in##2##2##(2008-1#1)(2009-8#1)
coded using##2##2##(2012-12#1)(2013-1#1)
coded##51##1##(1990-12#1)(1990-5#2)(1992-8#1)(1993-2#1)(1994-11#2)(1994-6#1)(1996-1#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#4)(2012-3#4)(2013-1#2)(2013-8#1)
codeine##8##1##(1990-8#2)(1995-11#1)(2008-10#2)(2008-3#2)(2008-6#1)
codeposition##3##1##(2008-3#3)
coders and non-coders##3##3##(2007-12#3)
coders and##4##2##(2007-12#4)
coders##10##1##(2007-12#10)
codes and##5##2##(1991-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
codes for a protein of##3##5##(1990-2#1)(1994-12#1)(1995-2#1)
codes for a protein which##2##5##(1995-8#1)(1997-3#1)
codes for a protein##7##4##(1990-2#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-3#1)(2011-2#1)(2013-1#1)
codes for a putative##2##4##(1997-3#1)(1997-7#1)
codes for a##20##3##(1990-2#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
codes for an##2##3##(1990-12#2)
codes for the##8##3##(1991-8#1)(1991-9#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-7#1)
codes for##38##2##(1990-12#2)(1990-2#1)(1991-8#1)(1991-9#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#2)(1995-8#1)(1996-2#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#3)(2008-10#3)(2008-2#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
codes in##5##2##(1997-3#1)(2007-12#2)(2008-3#1)(2008-4#1)
codes is proposed##2##3##(2008-2#1)(2008-3#1)
codes is##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
codes used in the##2##4##(1995-8#1)(2008-3#1)
codes##106##1##(1990-12#2)(1990-2#1)(1991-3#4)(1991-8#1)(1991-9#1)(1993-12#3)(1993-2#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-2#2)(1995-8#3)(1996-2#2)(1996-4#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#3)(2007-10#1)(2007-12#8)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#14)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
codeswitching##2##1##(2011-2#2)
codified##3##1##(1991-5#1)(2007-8#1)(2008-3#1)
codifying##2##1##(2008-10#1)(2010-8#1)
coding and classification systems are##2##5##(1994-2#2)
coding and classification systems##5##4##(1994-2#4)(2007-12#1)
coding and classification##6##3##(1994-2#5)(2007-12#1)
coding and non-coding regions of the##2##6##(1991-2#1)(2008-7#1)
coding and non-coding##6##3##(1991-2#1)(2007-12#1)(2008-7#2)(2010-7#1)(2011-2#1)
coding and noncoding sequences##2##4##(2008-10#1)(2008-4#1)
coding and suppression##2##3##(2012-3#2)
coding and##25##2##(1991-12#1)(1991-2#1)(1992-9#1)(1994-2#5)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#3)
coding by##2##2##(1995-12#1)(2008-1#1)
coding domain##4##2##(1991-6#1)(1993-8#1)(1994-5#2)
coding domains##4##2##(1993-8#1)(2008-3#3)
coding exon##4##2##(1990-8#3)(2008-7#1)
coding exons##3##2##(1993-6#1)(2008-9#2)
coding for COX subunit VIb##2##5##(1991-6#2)
coding for a protein of##2##5##(1997-2#1)(1997-3#1)
coding for a protein##3##4##(1993-12#1)(1997-2#1)(1997-3#1)
coding for a##11##3##(1991-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-8#1)
coding for an##5##3##(1993-2#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-11#1)
coding for cytochrome##2##3##(1991-6#1)(1993-2#1)
coding for human##2##3##(1992-3#1)(1992-8#1)
coding for plasminogen##2##3##(1992-3#1)(1994-11#1)
coding for proteins of##2##4##(2008-10#2)
coding for the mature##2##4##(1991-6#1)(1995-8#1)
coding for the##26##3##(1991-6#1)(1992-1#1)(1992-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-8#2)(1996-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2008-10#1)(2008-6#1)(2013-7#1)
coding for these##2##3##(1990-3#1)(2008-4#1)
coding for##92##2##(1990-3#1)(1991-6#4)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#5)(1992-8#1)(1993-12#2)(1993-2#4)(1993-6#4)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#5)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
coding gene##3##2##(1991-2#1)(1994-12#1)(1997-7#1)
coding in##4##2##(2007-12#1)(2008-11#3)
coding instructions##2##2##(2012-12#2)
coding is##5##2##(1993-12#1)(2008-1#1)(2008-3#3)
coding of the##4##3##(1994-6#1)(2008-1#1)(2010-5#1)(2013-1#1)
coding of##9##2##(1990-5#1)(1994-6#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2010-5#1)(2013-1#1)
coding procedures##2##2##(2007-10#1)(2009-12#1)
coding professionals##2##2##(2007-12#2)
coding region and an##2##4##(1990-6#1)(2008-6#1)
coding region and##8##3##(1990-5#1)(1990-6#1)(1993-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
coding region assays##3##3##(2008-12#3)
coding region for the##2##4##(1990-7#1)(2008-10#1)
coding region for##3##3##(1990-7#2)(2008-10#1)
coding region is##2##3##(1993-6#1)(1995-6#1)
coding region of the human##3##5##(1990-7#1)(1994-9#1)(2008-4#1)
coding region of the##14##4##(1990-5#2)(1990-7#1)(1992-8#1)(1993-6#3)(1994-12#1)(1994-8#1)(1994-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-4#1)
coding region of##33##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#2)(1992-8#3)(1993-2#1)(1993-6#3)(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)
coding region that##2##3##(1997-3#1)(1997-4#1)
coding region was##3##3##(1990-7#1)(1997-2#1)(1997-7#1)
coding region##96##2##(1990-11#2)(1990-12#4)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#4)(1993-12#1)(1993-2#3)(1993-6#6)(1994-12#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#3)(1996-2#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2010-5#1)(2010-7#2)(2013-1#3)(2013-8#2)
coding regions and##4##3##(1993-8#1)(1997-2#1)(2011-2#1)(2012-3#1)
coding regions are##2##3##(2008-9#1)(2010-7#1)
coding regions of the##3##4##(1993-6#1)(2010-7#1)(2013-8#1)
coding regions of##5##3##(1993-6#1)(1997-4#1)(2010-7#1)(2013-8#2)
coding regions were##2##3##(1991-9#1)(1995-12#1)
coding regions within the##2##4##(1995-12#1)(1996-12#1)
coding regions##24##2##(1991-9#1)(1993-6#2)(1993-8#1)(1995-12#3)(1996-12#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-8#2)
coding scheme##4##2##(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)
coding sequence and##2##3##(1997-4#1)(2008-10#1)
coding sequence for the##3##4##(1991-12#1)(1995-8#1)(1997-3#1)
coding sequence for##5##3##(1991-12#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-11#1)
coding sequence of the##4##4##(1992-12#1)(1992-8#1)(1997-8#1)(2012-12#1)
coding sequence of this pseudogene is##2##6##(1993-2#1)(1994-11#1)
coding sequence of##14##3##(1992-10#1)(1992-12#1)(1992-8#1)(1993-2#2)(1994-11#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)(2012-12#1)
coding sequence was##4##3##(1993-12#1)(1997-2#1)(1997-4#1)(2008-8#1)
coding sequence##46##2##(1990-5#1)(1991-12#1)(1991-7#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#2)(1994-11#1)(1994-12#1)(1995-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#1)
coding sequences and##3##3##(1997-7#1)(2008-11#1)(2011-2#1)
coding sequences of##11##3##(1995-8#3)(1996-10#3)(1996-2#5)
coding sequences##25##2##(1992-3#2)(1993-3#1)(1994-12#1)(1995-12#2)(1995-8#3)(1996-10#3)(1996-2#5)(1996-5#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2011-3#1)
coding should be##2##3##(2010-8#1)(2012-12#1)
coding strand of##2##3##(1997-7#1)(2008-10#1)
coding strand##4##2##(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
coding system##2##2##(1992-2#1)(2008-11#1)
coding technique##3##2##(2008-2#1)(2008-3#1)(2010-3#1)
coding##449##1##(1990-11#2)(1990-12#5)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#5)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#5)(1991-7#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#10)(1992-6#1)(1992-8#7)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#10)(1993-3#1)(1993-6#13)(1993-8#6)(1993-9#3)(1994-11#3)(1994-12#11)(1994-2#6)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#8)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#9)(1996-10#3)(1996-12#3)(1996-2#11)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#8)(1997-3#8)(1997-4#11)(1997-6#3)(1997-7#12)(1997-8#6)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#10)(2007-2#1)(2007-7#1)(2008-1#10)(2008-10#23)(2008-11#23)(2008-12#9)(2008-2#5)(2008-3#18)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#13)(2008-8#13)(2008-9#15)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#3)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#9)(2012-2#3)(2012-3#10)(2013-1#9)(2013-7#1)(2013-8#5)
codirectional coupler filters##2##3##(2008-3#2)
codirectional coupler##3##2##(2008-3#3)
codirectional##4##1##(2008-3#4)
codlemone##4##1##(2011-2#4)
codominant RFLP##2##2##(2008-5#2)
codominant##17##1##(1990-8#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-5#10)(2012-3#1)
codon 2153##2##2##(1990-11#1)(1990-7#1)
codon 249 mutation in##2##4##(1991-11#2)
codon 249 mutation##4##3##(1991-11#4)
codon 249##5##2##(1991-11#5)
codon 4##2##2##(1991-9#2)
codon ATG##2##2##(1992-11#1)(2008-4#1)
codon adaptation##2##2##(1997-6#1)(2012-2#1)
codon and##4##2##(1992-3#1)(1993-12#1)(2008-9#1)(2011-3#1)
codon at##2##2##(1990-7#1)(1997-6#1)
codon bias##3##2##(1993-8#1)(1996-3#1)(2008-10#1)
codon for##4##2##(1993-8#1)(2008-10#3)
codon in the##2##3##(1990-5#1)(2013-1#1)
codon in##5##2##(1990-5#3)(1990-7#1)(2013-1#1)
codon of the c-Ki-ras##2##4##(1992-8#2)
codon of the##5##3##(1992-8#2)(1993-8#1)(2008-10#1)(2008-8#1)
codon of##10##2##(1992-8#2)(1993-8#1)(1994-12#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-8#2)
codon positions##3##2##(1991-9#1)(1994-12#1)(2008-7#1)
codon to##2##2##(1991-6#1)(1997-7#1)
codon usage and##2##3##(2008-5#1)(2008-9#1)
codon usage of##3##3##(1991-7#1)(1993-9#1)(1997-8#1)
codon usage##8##2##(1991-7#1)(1993-9#1)(1997-4#1)(1997-8#3)(2008-5#1)(2008-9#1)
codon##135##1##(1990-11#3)(1990-12#1)(1990-5#5)(1990-7#7)(1990-8#1)(1991-1#1)(1991-11#5)(1991-12#4)(1991-6#4)(1991-7#1)(1991-9#4)(1992-11#4)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#3)(1993-11#3)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#7)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#3)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-9#1)(2010-2#2)(2010-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
codons and##3##2##(1992-12#1)(1993-12#1)(1993-9#1)
codons in##4##2##(2008-11#1)(2008-8#1)(2013-8#2)
codons of##2##2##(1995-11#1)(1997-4#1)
codons was##4##2##(1996-3#1)(1996-8#1)(1997-4#1)(1997-6#1)
codons were##2##2##(1993-8#1)(1993-9#1)
codons##50##1##(1990-5#2)(1991-1#2)(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#4)(1995-11#1)(1995-12#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#4)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-3#1)(2013-8#3)
codons)##2##1##(1991-9#2)
codoped fiber##4##2##(2007-11#2)(2007-12#2)
codoped optical##2##2##(2007-11#2)
codoped silicate glass##2##3##(2008-3#2)
codoped##13##1##(2007-11#5)(2007-12#3)(2008-2#1)(2008-3#4)
coecus##2##1##(2008-5#2)
coefficient &gt##2##2##(2007-5#1)(2008-10#1)
coefficient (log##4##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
coefficient (r##3##2##(2011-1#1)(2011-3#1)(2013-1#1)
coefficient 0##5##2##(2008-10#5)
coefficient = 0##2##3##(1990-12#1)(2009-2#1)
coefficient =##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2009-2#1)
coefficient D##2##2##(2008-10#1)(2008-5#1)
coefficient R = 0##2##4##(1995-6#1)(2013-8#1)
coefficient R(2)##2##2##(2008-10#2)
coefficient alpha##2##2##(2008-10#1)(2008-3#1)
coefficient and 1##2##3##(2008-10#1)(2008-3#1)
coefficient and the##14##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#9)
coefficient and##42##2##(1997-2#1)(2007-12#1)(2008-10#11)(2008-2#5)(2008-3#16)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-1#1)(2011-1#1)
coefficient are##3##2##(2007-12#1)(2008-2#2)
coefficient as##2##2##(2008-10#1)(2008-3#1)
coefficient at 412 nm ranged from 0##2##7##(2008-3#2)
coefficient at##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
coefficient b##3##2##(2008-3#2)(2008-5#1)
coefficient between the##3##3##(2008-2#2)(2008-3#1)
coefficient between##8##2##(1992-6#1)(1993-3#1)(2008-10#2)(2008-2#2)(2008-3#2)
coefficient can be##4##3##(2007-12#1)(2008-3#2)(2008-5#1)
coefficient can##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
coefficient depends on##3##3##(2007-11#2)(2008-2#1)
coefficient differences##2##2##(2008-6#2)
coefficient during##2##2##(2008-3#1)(2008-6#1)
coefficient for a##2##3##(2007-12#1)(2008-10#1)
coefficient for the##7##3##(1993-1#1)(2008-10#4)(2008-3#1)(2009-7#1)
coefficient for##21##2##(1990-11#1)(1991-5#1)(1993-1#1)(1995-5#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#1)
coefficient from##3##2##(2008-2#2)(2008-3#1)
coefficient function##2##2##(2008-3#1)(2010-1#1)
coefficient has been##2##3##(2008-3#1)(2013-1#1)
coefficient has##4##2##(2008-3#3)(2013-1#1)
coefficient in the##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
coefficient in##11##2##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-5#1)
coefficient increases##2##2##(1995-3#1)(2008-3#1)
coefficient is 0##4##3##(2008-10#4)
coefficient is found to##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
coefficient is retrieved##2##3##(2007-12#1)(2008-3#1)
coefficient is##25##2##(1996-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-10#4)(2008-2#4)(2008-3#7)
coefficient k##5##2##(2008-2#2)(2008-3#2)(2013-8#1)
coefficient measurements##5##2##(1995-3#1)(2008-10#3)(2008-3#1)
coefficient model##2##2##(2008-3#1)(2013-1#1)
coefficient models##2##2##(2008-3#1)(2011-1#1)
coefficient of 0##51##3##(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#38)(2008-2#2)(2010-2#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
coefficient of 1##5##3##(1993-12#1)(1994-6#1)(2008-2#1)(2008-3#1)(2011-1#1)
coefficient of 2##2##3##(2007-12#1)(2013-8#1)
coefficient of 3##2##3##(2008-10#2)
coefficient of 5##3##3##(1997-8#1)(2007-11#1)(2008-3#1)
coefficient of a##5##3##(2008-2#3)(2008-3#2)
coefficient of air##2##3##(2007-12#1)(2008-3#1)
coefficient of association##2##3##(2008-10#2)
coefficient of determination##5##3##(2008-10#3)(2008-12#1)(2011-2#1)
coefficient of gene differentiation##3##4##(2008-10#3)
coefficient of genetic differentiation##2##4##(2008-10#2)
coefficient of pure water##2##4##(2008-2#1)(2008-3#1)
coefficient of the organic##2##4##(2007-12#2)
coefficient of the##27##3##(1990-5#2)(2007-10#1)(2007-12#3)(2008-10#9)(2008-2#3)(2008-3#8)(2010-4#1)
coefficient of variability##2##3##(2008-10#1)(2008-5#1)
coefficient of variance##2##3##(1990-2#1)(2008-10#1)
coefficient of variation (C##2##4##(1993-8#1)(1996-5#1)
coefficient of variation (CV)##4##4##(1990-12#1)(1993-2#1)(2008-10#1)(2008-8#1)
coefficient of variation for##4##4##(1990-2#1)(1993-8#1)(2008-10#2)
coefficient of variation in##2##4##(1990-9#1)(2010-3#1)
coefficient of variation is##2##4##(1992-3#1)(1996-3#1)
coefficient of variation less than##2##5##(2008-10#1)(2011-2#1)
coefficient of variation of the##3##5##(1990-8#1)(2008-10#2)
coefficient of variation of##8##4##(1990-8#1)(1995-2#1)(2008-10#6)
coefficient of variation##39##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1992-3#2)(1993-2#1)(1993-8#2)(1995-2#1)(1996-3#1)(1996-5#1)(2008-10#16)(2008-3#1)(2008-5#3)(2008-8#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
coefficient of##222##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#11)(2008-1#1)(2008-10#89)(2008-12#1)(2008-2#21)(2008-3#26)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
coefficient profile with an error##2##5##(2008-2#2)
coefficient profiles in##2##3##(2008-3#1)(2008-7#1)
coefficient profiles##3##2##(2008-3#2)(2008-7#1)
coefficient to##2##2##(2008-3#1)(2010-8#1)
coefficient values for##3##3##(2008-10#2)(2013-7#1)
coefficient values##12##2##(1991-5#1)(2008-10#9)(2008-3#1)(2013-7#1)
coefficient was 0##12##3##(1990-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-7#2)(2013-1#1)(2013-8#1)
coefficient was calculated##2##3##(2011-2#1)(2013-1#1)
coefficient was determined to##2##4##(2007-12#1)(2012-2#1)
coefficient was estimated##2##3##(2007-11#1)(2008-6#1)
coefficient was used to##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
coefficient was##33##2##(1990-11#1)(1990-12#1)(1993-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#10)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#3)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
coefficient were##6##2##(2008-10#4)(2008-11#1)(2010-5#1)
coefficient when##3##2##(1992-9#1)(2008-10#1)(2008-2#1)
coefficient##735##1##(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#2)(1990-7#4)(1990-8#3)(1990-9#2)(1991-12#1)(1991-5#3)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#4)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#5)(2007-11#29)(2007-12#32)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#225)(2008-11#4)(2008-12#3)(2008-2#82)(2008-3#157)(2008-4#1)(2008-5#17)(2008-6#9)(2008-7#15)(2008-8#6)(2008-9#7)(2009-11#2)(2009-2#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-1#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#3)(2011-1#6)(2011-2#13)(2011-3#5)(2012-1#1)(2012-2#7)(2013-1#15)(2013-7#3)(2013-8#8)
coefficient)##6##1##(1993-8#1)(1997-2#1)(2008-10#3)(2008-3#1)
coefficient=0##3##1##(2008-10#3)
coefficients among##2##2##(2008-10#2)
coefficients and the##7##3##(1995-6#1)(2008-10#4)(2008-3#2)
coefficients and##29##2##(1990-7#1)(1990-8#1)(1995-6#1)(2007-11#1)(2008-10#10)(2008-2#4)(2008-3#7)(2008-5#2)(2008-6#1)(2010-10#1)
coefficients are determined##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
coefficients are obtained##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
coefficients are##20##2##(1997-8#1)(2007-12#2)(2008-2#5)(2008-3#8)(2008-5#2)(2010-11#1)(2011-1#1)
coefficients as##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
coefficients at 355##2##3##(2008-3#2)
coefficients at multiple##3##3##(2008-3#3)
coefficients at the##2##3##(1996-2#1)(2008-2#1)
coefficients at##11##2##(1996-2#1)(2007-12#2)(2008-2#2)(2008-3#6)
coefficients between 0##3##3##(1994-9#1)(2008-2#2)
coefficients between##8##2##(1991-12#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#2)
coefficients by use of##3##4##(2007-12#1)(2008-2#2)
coefficients by##6##2##(1997-6#1)(2007-12#1)(2008-2#2)(2008-3#2)
coefficients can be##2##3##(2008-3#2)
coefficients deduced##2##2##(2008-3#2)
coefficients derived##2##2##(2007-11#1)(2008-3#1)
coefficients determined##2##2##(2008-10#2)
coefficients equal##2##2##(2008-10#2)
coefficients estimated##2##2##(2008-10#2)
coefficients for different##2##3##(2008-10#1)(2008-7#1)
coefficients for the##9##3##(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)
coefficients for##41##2##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#2)(2010-1#1)(2010-8#2)(2013-7#1)
coefficients from##7##2##(2008-10#2)(2008-2#2)(2008-3#3)
coefficients in the range##2##4##(2008-10#1)(2008-3#1)
coefficients in the##8##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2012-3#1)(2013-1#1)
coefficients in##15##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#1)
coefficients is##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
coefficients measured by##2##3##(2008-10#1)(2008-3#1)
coefficients measured##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
coefficients obtained##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
coefficients of 0##6##3##(2007-12#1)(2008-10#3)(2011-1#2)
coefficients of a##8##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)
coefficients of atmospheric##2##3##(2008-3#2)
coefficients of determination and##2##4##(2008-10#2)
coefficients of determination##7##3##(2008-10#6)(2012-1#1)
coefficients of the background##2##4##(2007-12#1)(2008-2#1)
coefficients of the nonlinear##2##4##(2007-11#1)(2008-2#1)
coefficients of the two##3##4##(2008-2#2)(2008-3#1)
coefficients of the##34##3##(1990-5#2)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#9)(2008-3#8)(2008-6#1)(2009-9#1)
coefficients of these##2##3##(1995-9#1)(2008-10#1)
coefficients of turbid##2##3##(2008-2#2)
coefficients of variation are##3##4##(1991-2#1)(1996-3#1)(2008-10#1)
coefficients of variation for##2##4##(2008-10#1)(2008-5#1)
coefficients of variation of##2##4##(1996-3#1)(2008-10#1)
coefficients of variation were below##2##5##(2008-10#2)
coefficients of variation were##12##4##(1990-12#1)(1995-12#1)(2008-10#8)(2008-3#1)(2010-5#1)
coefficients of variation##29##3##(1990-11#1)(1990-12#1)(1991-2#1)(1995-12#1)(1996-3#3)(1996-5#1)(2008-10#17)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)
coefficients of variations##2##3##(2008-10#2)
coefficients of##161##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-2#1)(1992-7#1)(1995-12#1)(1995-9#1)(1996-3#3)(1996-5#1)(1997-2#1)(2007-11#4)(2007-12#6)(2008-10#65)(2008-11#1)(2008-2#21)(2008-3#28)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
coefficients on the##3##3##(1990-8#1)(2007-11#1)(2011-2#1)
coefficients on##4##2##(1990-8#1)(2007-11#2)(2011-2#1)
coefficients ranged from##3##3##(1993-12#2)(2008-3#1)
coefficients that are##4##3##(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
coefficients that##6##2##(2008-2#1)(2008-3#2)(2008-6#1)(2010-1#1)(2011-2#1)
coefficients to##6##2##(1990-7#2)(2007-11#1)(2008-10#2)(2008-2#1)
coefficients using##2##2##(1991-11#1)(2008-7#1)
coefficients was##2##2##(2008-10#1)(2010-8#1)
coefficients were calculated##2##3##(2008-10#2)
coefficients were determined##2##3##(1991-11#1)(2008-10#1)
coefficients were estimated##2##3##(2008-10#1)(2008-3#1)
coefficients were evaluated##2##3##(2008-10#1)(2008-3#1)
coefficients were obtained##2##3##(2008-10#1)(2011-2#1)
coefficients were##29##2##(1991-11#1)(1992-3#1)(2008-10#14)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#3)(2011-1#1)(2011-2#2)
coefficients with##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
coefficients##537##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#4)(1990-8#3)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#2)(1992-3#2)(1992-7#2)(1993-12#3)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#3)(1996-5#2)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#18)(2007-12#13)(2008-10#172)(2008-11#4)(2008-12#4)(2008-2#80)(2008-3#118)(2008-5#12)(2008-6#8)(2008-7#9)(2008-8#2)(2008-9#2)(2009-2#1)(2009-6#3)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#7)(2011-2#10)(2012-1#2)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#2)(2013-8#2)
coefficients)##6##1##(2008-10#2)(2008-2#1)(2008-3#3)
coeliac disease in##2##3##(1990-11#1)(1991-11#1)
coeliac disease patients##2##3##(1991-11#2)
coeliac disease##19##2##(1990-11#2)(1990-9#1)(1991-11#8)(1991-12#2)(1992-12#3)(1996-3#1)(2008-10#1)(2008-8#1)
coeliac mucosal digestion of fraction 9##2##6##(1992-12#2)
coeliac##28##1##(1990-11#2)(1990-3#1)(1990-9#1)(1991-11#8)(1991-12#5)(1992-12#5)(1996-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-7#1)
coeliac-toxic##2##1##(1991-12#2)
coeliacs##2##1##(1991-12#2)
coelicolor A3(2)##7##2##(1990-5#6)(2011-2#1)
coelicolor##19##1##(1990-5#6)(1994-12#4)(1995-8#2)(2008-8#5)(2011-2#1)(2012-2#1)
coeloconic sensilla of##2##3##(2008-7#2)
coelomic cavity##2##2##(2007-6#2)
coelomic compartments##2##2##(2011-2#2)
coelomic fluid##7##2##(1990-5#1)(1995-8#5)(1996-12#1)
coelomic##13##1##(1990-5#1)(1995-8#5)(1996-12#1)(2007-6#2)(2008-5#1)(2011-2#3)
coelomitis##3##1##(2011-1#3)
coeluted with a##2##3##(1990-7#1)(1992-3#1)
coeluted##3##1##(1990-7#1)(1990-8#1)(1992-3#1)
coeluting##2##1##(1997-2#1)(2008-4#1)
coelution##3##1##(1992-9#1)(1993-11#1)(1995-5#1)
coenospermia##5##1##(2007-12#5)
coenzyme A##8##2##(1990-2#1)(1990-9#1)(1991-6#1)(1993-6#1)(1994-8#3)(2012-12#1)
coenzyme Q##5##2##(1990-5#1)(1992-11#3)(2008-8#1)
coenzyme Q10##2##2##(1993-3#1)(1996-9#1)
coenzyme specificity##3##2##(1990-7#3)
coenzyme to##2##2##(1992-6#1)(2013-8#1)
coenzyme##40##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#4)(1990-9#1)(1991-6#1)(1992-11#3)(1992-6#5)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#3)(1995-2#1)(1996-9#1)(2008-10#9)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#3)
coenzyme-binding##2##1##(1991-5#2)
coenzymes##8##1##(2008-10#3)(2008-5#1)(2008-7#3)(2013-8#1)
coerced##2##1##(1996-11#1)(2008-7#1)
coercion and##3##2##(1997-2#1)(2009-11#1)(2009-4#1)
coercion##13##1##(1993-1#1)(1994-3#1)(1997-2#1)(2007-7#1)(2008-11#2)(2009-11#1)(2009-4#3)(2011-2#2)(2012-2#1)
coercive##5##1##(1993-2#1)(1996-11#1)(2007-12#1)(2009-6#1)(2010-11#1)
coeruleum##4##1##(2008-10#4)
coethnic##2##1##(2011-2#2)
coevolution between host##2##3##(2008-10#1)(2008-8#1)
coevolution between##5##2##(2008-10#1)(2008-8#3)(2008-9#1)
coevolution can##2##2##(2008-8#1)(2008-9#1)
coevolution in##2##2##(2012-3#2)
coevolution of##4##2##(1995-5#1)(2008-1#1)(2008-8#2)
coevolution##24##1##(1995-5#1)(2008-1#1)(2008-10#4)(2008-8#12)(2008-9#4)(2012-3#2)
coevolutionary dynamics##3##2##(2008-10#3)
coevolutionary##11##1##(1995-5#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#2)(2013-1#1)
coevolve with##2##2##(2008-8#2)
coevolve##3##1##(2008-8#2)(2008-9#1)
coevolved##4##1##(2008-10#2)(2010-3#1)(2013-1#1)
coexist in the##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
coexist in##13##2##(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-3#1)
coexist with##5##2##(1995-5#1)(2007-11#1)(2011-1#1)(2013-1#2)
coexist##36##1##(1994-2#1)(1995-5#3)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#12)(2008-9#4)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
coexisted in the##3##3##(1994-12#1)(2008-10#1)(2009-10#1)
coexisted in##4##2##(1994-12#1)(2007-11#1)(2008-10#1)(2009-10#1)
coexisted system##2##2##(2008-10#2)
coexisted with##3##2##(1993-5#1)(2008-10#1)(2008-11#1)
coexisted##13##1##(1993-5#1)(1994-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
coexistence among##2##2##(2008-8#1)(2008-9#1)
coexistence and##2##2##(1994-5#1)(2008-8#1)
coexistence between##5##2##(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)
coexistence can occur##2##3##(2008-10#1)(2008-8#1)
coexistence can##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
coexistence equilibrium##3##2##(2008-8#2)(2012-2#1)
coexistence in##5##2##(2008-8#3)(2008-9#2)
coexistence is possible##2##3##(2008-8#2)
coexistence of both##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
coexistence of competing species##2##4##(2008-8#2)
coexistence of competitors##3##3##(2008-8#1)(2008-9#2)
coexistence of multiple##2##3##(2008-8#1)(2012-2#1)
coexistence of the two##2##4##(2008-10#1)(2011-2#1)
coexistence of the##3##3##(2008-10#1)(2011-2#2)
coexistence of##49##2##(1990-5#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-9#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#10)(2008-9#7)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
coexistence requires##2##2##(2008-8#1)(2008-9#1)
coexistence##114##1##(1990-5#1)(1992-10#1)(1992-6#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#43)(2008-9#21)(2009-7#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
coexistent COPD and HF##2##4##(2011-2#2)
coexistent COPD-HF##2##2##(2011-2#2)
coexistent proximal and distal##2##4##(1993-1#2)
coexistent proximal##3##2##(1993-1#3)
coexistent substances##2##2##(2008-10#2)
coexistent##23##1##(1992-3#1)(1993-1#3)(1993-8#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-7#2)(2009-11#1)(2009-7#2)(2011-2#5)(2012-2#1)
coexisting conditions##2##2##(1997-1#1)(2012-12#1)
coexisting diseases##2##2##(2007-11#2)
coexisting electrolytes in the sample solution and##2##7##(2008-10#2)
coexisting injuries##2##2##(2007-11#1)(2008-12#1)
coexisting ions##6##2##(2008-10#6)
coexisting junctions##2##2##(2012-2#2)
coexisting medical conditions##3##3##(1997-1#1)(2007-10#1)(2012-3#1)
coexisting medical##4##2##(1992-8#1)(1997-1#1)(2007-10#1)(2012-3#1)
coexisting metal ions##4##3##(2008-10#4)
coexisting substances##2##2##(2008-10#2)
coexisting with type##2##3##(1995-5#1)(2012-2#1)
coexisting with##8##2##(1994-7#1)(1995-4#1)(1995-5#1)(2007-8#2)(2009-7#1)(2012-2#1)(2013-1#1)
coexisting##68##1##(1991-3#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-4#1)(1995-5#1)(1997-1#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#20)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
coexists with a##2##3##(2007-12#1)(2010-11#1)
coexists with##3##2##(2007-12#1)(2008-11#1)(2010-11#1)
coexists##4##1##(2007-11#1)(2007-12#1)(2008-11#1)(2010-11#1)
coexpress##2##1##(1995-5#1)(1996-12#1)
coexpressed in##5##2##(1994-8#1)(2008-11#1)(2008-4#2)(2009-6#1)
coexpressed with the##2##3##(1994-8#1)(2008-8#1)
coexpressed with##7##2##(1994-8#2)(1995-11#1)(1996-12#1)(2008-11#2)(2008-8#1)
coexpressed##18##1##(1992-11#1)(1994-8#3)(1995-11#1)(1995-2#1)(1996-12#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)
coexpressing alpha##2##2##(1995-11#1)(1995-6#1)
coexpressing##9##1##(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-7#1)
coexpression in##2##2##(1993-6#1)(2009-8#1)
coexpression of##6##2##(1993-6#1)(1995-11#1)(2008-9#3)(2011-2#1)
coexpression##9##1##(1993-6#2)(1994-8#1)(1995-11#1)(2008-9#3)(2009-8#1)(2011-2#1)
cofactor and##4##2##(1991-5#1)(1994-5#1)(1995-5#2)
cofactor dependence##2##2##(1990-5#1)(1996-5#1)
cofactor in##9##2##(1993-8#1)(1995-5#2)(1996-2#1)(2008-10#1)(2008-12#1)(2012-2#2)(2013-1#1)
cofactor of##3##2##(1991-9#1)(1993-8#1)(2012-2#1)
cofactor requirements##3##2##(1992-6#1)(1993-8#2)
cofactor##56##1##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-8#4)(1994-11#1)(1994-5#4)(1994-6#1)(1995-3#1)(1995-5#9)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-5#1)(2012-2#3)(2013-1#1)
cofactors for##6##2##(1994-11#1)(1997-7#1)(2008-3#1)(2011-2#1)(2012-12#2)
cofactors##31##1##(1990-5#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#2)(2012-12#5)(2012-2#1)(2013-8#1)
cofermentation of##2##2##(2008-6#2)
cofermentation##7##1##(2008-6#7)
coffee and other##2##3##(1993-9#1)(2008-10#1)
coffee and##10##2##(1993-11#1)(1993-9#2)(2008-10#7)
coffee beans##10##2##(1994-2#1)(2008-10#9)
coffee consumption##6##2##(1990-6#5)(2008-5#1)
coffee farms##3##2##(2008-5#3)
coffee leaves##3##2##(2008-10#3)
coffee samples##2##2##(2008-10#2)
coffee seedlings##4##2##(2008-5#4)
coffee varieties##4##2##(2008-10#4)
coffee##88##1##(1990-6#6)(1993-11#1)(1993-3#1)(1993-9#3)(1994-2#1)(1995-11#2)(1996-11#1)(1996-3#1)(2008-10#47)(2008-11#3)(2008-5#15)(2008-6#4)(2009-5#1)(2011-2#1)(2012-12#1)
coffee)##3##1##(2008-10#3)
coffees##3##1##(2008-10#3)
coffin##3##1##(2008-10#2)(2011-2#1)
cofoundress associations##2##2##(2008-9#2)
cofoundress##3##1##(2008-9#3)
cogent##2##1##(1996-6#1)(2012-12#1)
cognate SP1 target site##2##4##(1991-2#2)
cognate mRNA##3##2##(1993-8#1)(2008-9#2)
cognate protein##4##2##(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)
cognate resistance##3##2##(2008-10#1)(2009-8#2)
cognate##40##1##(1990-3#1)(1991-2#3)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-5#2)(1997-8#1)(1997-9#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-2#1)
cognition and##19##2##(1991-6#1)(1996-9#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-7#5)(2009-10#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
cognition in##7##2##(1994-6#1)(2008-4#1)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#2)
cognition##76##1##(1991-5#1)(1991-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-7#6)(2008-8#2)(2009-10#5)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#10)(2009-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
cognitions##8##1##(1995-2#2)(2009-8#1)(2010-1#2)(2010-4#2)(2010-6#1)
cognitive abilities and##2##3##(2008-9#2)
cognitive abilities##9##2##(1993-12#1)(2008-8#1)(2008-9#3)(2009-8#1)(2012-2#1)(2013-1#2)
cognitive ability in##2##3##(2009-8#2)
cognitive ability##4##2##(2008-11#1)(2009-4#1)(2009-8#2)
cognitive abnormalities##2##2##(2008-7#1)(2013-8#1)
cognitive analysis##3##2##(2008-5#3)
cognitive and affective##3##3##(1991-2#1)(2008-1#1)(2008-11#1)
cognitive and behavioral##6##3##(1991-6#2)(2008-1#1)(2008-2#1)(2009-8#1)(2012-3#1)
cognitive and emotional##5##3##(1994-5#1)(2008-12#1)(2008-5#1)(2009-7#1)(2013-1#1)
cognitive and functional decline##2##4##(2008-7#2)
cognitive and functional##4##3##(2008-7#4)
cognitive and language##2##3##(2010-4#2)
cognitive and neural##2##3##(2007-8#1)(2009-4#1)
cognitive and psychological##2##3##(2008-2#1)(2010-9#1)
cognitive and##39##2##(1991-2#1)(1991-6#2)(1993-1#1)(1994-5#1)(1996-11#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#2)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-7#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
cognitive appraisal##2##2##(2008-2#1)(2012-1#1)
cognitive appraisals of##2##3##(2009-10#1)(2012-1#1)
cognitive aspects of##2##3##(2012-12#2)
cognitive aspects##3##2##(2008-7#1)(2012-12#2)
cognitive behavior therapy##2##3##(2012-2#2)
cognitive behavior##3##2##(2012-2#2)(2012-3#1)
cognitive behavioral therapy##5##3##(2012-2#5)
cognitive behavioral##7##2##(2008-4#2)(2012-2#5)
cognitive behaviour therapy##2##3##(1993-12#1)(2011-1#1)
cognitive behavioural##2##2##(1991-2#1)(2008-10#1)
cognitive biases##2##2##(2007-12#1)(2010-4#1)
cognitive capacities##2##2##(2013-1#1)(2013-8#1)
cognitive changes##2##2##(2013-1#2)
cognitive characteristics##2##2##(2008-2#1)(2008-7#1)
cognitive control##3##2##(2009-8#1)(2012-12#1)(2013-8#1)
cognitive damage##2##2##(1994-6#2)
cognitive decline and##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
cognitive decline##21##2##(1990-3#1)(1991-1#1)(1991-6#2)(2008-3#1)(2008-6#2)(2008-7#8)(2009-5#1)(2009-8#2)(2013-1#2)(2013-8#1)
cognitive deficits are##2##3##(2008-7#1)(2011-2#1)
cognitive deficits in##3##3##(1990-7#1)(2008-7#1)(2013-7#1)
cognitive deficits##15##2##(1990-7#1)(1993-12#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#6)(2011-2#1)(2013-7#1)(2013-8#1)
cognitive deterioration##2##2##(2008-7#2)
cognitive development and##4##3##(2008-11#2)(2009-10#1)(2012-2#1)
cognitive development##8##2##(1993-1#2)(2008-11#3)(2009-10#1)(2009-7#1)(2012-2#1)
cognitive disturbances##3##2##(2008-7#2)(2010-6#1)
cognitive domains##2##2##(2008-7#1)(2012-12#1)
cognitive dysfunction##5##2##(1992-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
cognitive effects##2##2##(2008-8#1)(2009-10#1)
cognitive evaluation##4##2##(2008-7#1)(2008-9#2)(2009-2#1)
cognitive failures and##2##3##(2012-1#2)
cognitive failures##4##2##(2012-1#4)
cognitive flexibility##5##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2013-7#1)
cognitive function and##2##3##(1994-6#1)(2011-2#1)
cognitive function disorders##2##3##(2012-1#1)(2013-7#1)
cognitive function in##5##3##(1995-8#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
cognitive function is##4##3##(1993-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
cognitive function of##2##3##(2008-7#1)(2010-10#1)
cognitive function##35##2##(1993-11#1)(1993-5#1)(1994-6#2)(1995-11#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#5)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
cognitive functioning among##2##3##(2009-10#1)(2010-12#1)
cognitive functioning and relational behavior##2##5##(1990-3#2)
cognitive functioning and##6##3##(1990-3#3)(1996-1#1)(2008-1#1)(2009-10#1)
cognitive functioning is##2##3##(1995-5#1)(2012-12#1)
cognitive functioning##18##2##(1990-3#4)(1993-11#1)(1995-5#1)(1996-1#2)(2008-1#1)(2008-11#2)(2009-10#4)(2010-12#1)(2012-12#2)
cognitive functions and##2##3##(2007-11#1)(2013-8#1)
cognitive functions in##2##3##(2010-1#1)(2012-12#1)
cognitive functions##15##2##(1991-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-7#5)(2009-10#1)(2010-1#1)(2012-12#1)(2013-8#1)
cognitive growth fostering##3##3##(1990-12#3)
cognitive growth##4##2##(1990-12#3)(2009-10#1)
cognitive impairment (MCI)##5##3##(2008-6#1)(2009-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
cognitive impairment and##4##3##(2008-6#1)(2009-11#1)(2012-12#1)(2013-8#1)
cognitive impairment are##2##3##(2008-2#1)(2013-1#1)
cognitive impairment in##4##3##(2008-6#1)(2009-10#1)(2009-6#1)(2013-8#1)
cognitive impairment is##3##3##(1995-2#1)(2008-2#1)(2012-2#1)
cognitive impairment##58##2##(1991-11#1)(1993-12#1)(1995-2#2)(1996-7#1)(2008-11#2)(2008-2#7)(2008-6#5)(2008-7#3)(2009-10#6)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#7)
cognitive impairments##8##2##(1991-1#1)(1991-7#1)(1993-3#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
cognitive level##2##2##(2008-12#2)
cognitive levels##2##2##(2008-12#2)
cognitive load##2##2##(2007-8#1)(2009-11#1)
cognitive measure##2##2##(2012-12#1)(2013-1#1)
cognitive measures##2##2##(2009-10#1)(2010-10#1)
cognitive mechanism##2##2##(2009-8#1)(2012-12#1)
cognitive model of##2##3##(2008-10#1)(2008-4#1)
cognitive models of##3##3##(1996-11#1)(2008-4#1)(2009-11#1)
cognitive models##4##2##(1995-6#1)(1996-11#1)(2008-4#1)(2009-11#1)
cognitive neuropsychology##2##2##(1996-11#1)(2008-2#1)
cognitive neuroscience##4##2##(2007-8#1)(2011-2#1)(2013-1#2)
cognitive or##2##2##(1991-5#1)(2008-12#1)
cognitive performance were##2##3##(2011-1#1)(2013-1#1)
cognitive performance##11##2##(1993-11#1)(1994-6#1)(1995-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
cognitive performances##2##2##(1994-6#1)(2013-1#1)
cognitive problems in##2##3##(1995-3#1)(2010-9#1)
cognitive problems##3##2##(1995-3#1)(2008-8#1)(2010-9#1)
cognitive process##2##2##(2008-11#1)(2008-12#1)
cognitive processes in##2##3##(2007-8#1)(2012-12#1)
cognitive processes##12##2##(1990-3#1)(2007-8#2)(2008-5#2)(2009-10#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
cognitive processing##5##2##(2008-11#2)(2009-11#1)(2010-3#1)(2012-3#1)
cognitive rehabilitation##2##2##(2008-10#1)(2009-10#1)
cognitive representations##2##2##(2007-8#1)(2008-1#1)
cognitive research##2##2##(1996-11#2)
cognitive science and##2##3##(1995-6#1)(2008-9#1)
cognitive science##5##2##(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
cognitive services##2##2##(1996-1#1)(2010-3#1)
cognitive skills##3##2##(2008-11#2)(2012-3#1)
cognitive slowing##2##2##(2008-7#1)(2008-9#1)
cognitive state in##2##3##(2008-7#2)
cognitive state##3##2##(2008-7#3)
cognitive status and##3##3##(2008-7#3)
cognitive status##4##2##(2008-7#3)(2012-3#1)
cognitive studies##2##2##(2008-11#1)(2010-7#1)
cognitive style and##2##3##(2010-10#1)(2012-3#1)
cognitive style was##2##3##(2010-1#1)(2012-3#1)
cognitive style##11##2##(2010-1#7)(2010-10#2)(2012-3#2)
cognitive tasks##6##2##(2009-8#3)(2010-1#1)(2012-1#1)(2012-12#1)
cognitive test performance##2##3##(2008-6#2)
cognitive test##3##2##(2008-6#2)(2009-10#1)
cognitive tests##2##2##(2008-6#1)(2012-12#1)
cognitive therapy##2##2##(1996-6#1)(2012-3#1)
cognitive training##5##2##(1991-5#5)
cognitive##516##1##(1990-12#4)(1990-3#7)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#6)(1991-6#4)(1991-7#1)(1992-12#1)(1992-8#1)(1993-1#3)(1993-11#4)(1993-12#5)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#2)(1994-5#1)(1994-6#11)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#6)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#11)(2008-1#8)(2008-10#5)(2008-11#27)(2008-12#12)(2008-2#19)(2008-3#2)(2008-4#10)(2008-5#9)(2008-6#14)(2008-7#55)(2008-8#4)(2008-9#12)(2009-10#29)(2009-11#7)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#12)(2010-1#10)(2010-10#5)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#10)(2012-1#11)(2012-12#22)(2012-2#21)(2012-3#14)(2013-1#26)(2013-7#5)(2013-8#20)
cognitive-behavioral therapy##6##2##(2008-1#1)(2008-3#1)(2009-11#3)(2012-2#1)
cognitive-behavioral treatment##2##2##(2008-3#1)(2013-1#1)
cognitive-behavioral##13##1##(1994-12#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2009-11#3)(2009-6#1)(2012-2#1)(2013-1#1)
cognitive-behavioural therapy (CBT)##3##3##(2007-12#2)(2011-2#1)
cognitive-behavioural therapy for##2##3##(2007-12#1)(2012-1#1)
cognitive-behavioural therapy##6##2##(1990-11#1)(2007-12#3)(2011-2#1)(2012-1#1)
cognitive-behavioural##7##1##(1990-11#1)(2007-12#3)(2008-11#1)(2011-2#1)(2012-1#1)
cognitive-motor##4##1##(2008-1#3)(2008-2#1)
cognitively impaired##5##2##(1993-2#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-7#1)
cognitively##11##1##(1993-2#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-4#1)(2010-11#1)(2010-7#2)(2011-1#1)
cognizant of##4##2##(1992-1#1)(1995-2#1)(1997-2#1)(2007-2#1)
cognizant##5##1##(1992-1#1)(1995-2#1)(1997-2#1)(2007-2#1)(2008-12#1)
cohabitating##2##1##(1997-5#1)(2009-4#1)
cohabitation##2##1##(1990-2#1)(2011-2#1)
cohabiting##2##1##(2008-6#1)(2009-4#1)
cohered structures##3##2##(1991-7#3)
cohered##6##1##(1991-7#6)
coherence and an##2##3##(2007-11#1)(2008-12#1)
coherence and##14##2##(1994-3#1)(2007-11#6)(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
coherence factor##2##2##(2008-2#1)(2008-3#1)
coherence function by##2##3##(2008-3#2)
coherence function synthesis##2##3##(2008-3#2)
coherence function##13##2##(2007-12#4)(2008-3#9)
coherence gate##2##2##(2007-11#1)(2007-12#1)
coherence imaging in##2##3##(2007-12#1)(2008-2#1)
coherence imaging##4##2##(2007-12#2)(2008-2#2)
coherence in the##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
coherence in##5##2##(1993-3#1)(2008-2#1)(2008-3#2)(2012-3#1)
coherence is##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
coherence length and the##2##4##(2007-11#1)(2008-3#1)
coherence length of the##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
coherence length of##8##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
coherence length##17##2##(2007-11#5)(2007-12#2)(2008-2#3)(2008-3#7)
coherence microscopy##3##2##(2007-11#2)(2007-12#1)
coherence of a##3##3##(2007-11#1)(2008-2#2)
coherence of light##4##3##(2008-3#4)
coherence of the##10##3##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
coherence of##26##2##(1991-7#1)(2006-4#1)(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#14)
coherence properties of a##2##4##(2007-11#1)(2008-2#1)
coherence properties of##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
coherence properties##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
coherence time##3##2##(2007-11#2)(2009-5#1)
coherence tomographic##2##2##(2008-3#2)
coherence tomography (OCT) has##5##4##(2011-2#1)(2011-7#3)(2013-1#1)
coherence tomography (OCT)##26##3##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#3)(2008-5#2)(2010-12#1)(2011-2#1)(2011-7#8)(2012-2#1)(2013-1#2)
coherence tomography and##4##3##(2007-11#3)(2009-5#1)
coherence tomography for##7##3##(2007-11#2)(2007-12#2)(2009-3#1)(2011-7#1)(2012-2#1)
coherence tomography in##4##3##(2008-3#1)(2011-7#3)
coherence tomography##116##2##(2007-11#37)(2007-12#22)(2008-10#1)(2008-2#2)(2008-3#13)(2008-5#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#2)(2011-7#19)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
coherence##293##1##(1991-7#2)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#2)(2006-4#1)(2007-11#74)(2007-12#51)(2007-9#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#22)(2008-3#79)(2008-5#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#3)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#2)(2011-7#19)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
coherence-multiplexed##3##1##(2008-2#3)
coherency##2##1##(2008-10#1)(2009-6#1)
coherent DIAL##2##2##(2008-3#2)
coherent Doppler lidar measurements of wind fields##2##7##(2008-2#2)
coherent Doppler lidar##10##3##(2008-2#4)(2008-3#6)
coherent Doppler##11##2##(2008-2#4)(2008-3#7)
coherent Rayleigh scattering##2##3##(2007-11#2)
coherent and incoherent##2##3##(2008-10#1)(2008-2#1)
coherent and##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2013-8#1)
coherent anti-Stokes Raman scattering (CARS)##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
coherent anti-Stokes Raman scattering microscopy with##2##6##(2007-11#1)(2007-12#1)
coherent anti-Stokes Raman scattering microscopy##5##5##(2007-11#3)(2007-12#2)
coherent anti-Stokes Raman scattering##10##4##(2007-11#4)(2007-12#4)(2008-3#2)
coherent anti-Stokes Raman spectroscopy (CARS)##5##5##(2007-12#1)(2008-2#3)(2008-3#1)
coherent anti-Stokes Raman spectroscopy##9##4##(2007-12#2)(2008-2#4)(2008-3#3)
coherent anti-Stokes Raman##19##3##(2007-11#4)(2007-12#6)(2008-2#4)(2008-3#5)
coherent anti-Stokes##21##2##(2007-11#4)(2007-12#7)(2008-2#4)(2008-3#6)
coherent anti-stokes Raman scattering for##2##5##(2008-3#2)
coherent anti-stokes Raman##3##3##(2008-2#1)(2008-3#2)
coherent artifacts in##2##3##(2008-3#2)
coherent artifacts##3##2##(2008-3#3)
coherent beam##3##2##(2007-12#1)(2008-2#2)
coherent beams is##2##3##(2007-11#2)
coherent beams##7##2##(2007-11#5)(2007-12#1)(2008-3#1)
coherent blue##2##2##(2007-11#1)(2007-12#1)
coherent control##2##2##(2007-11#1)(2007-12#1)
coherent coupling##2##2##(2007-11#1)(2008-3#1)
coherent detection##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
coherent differential absorption lidar##2##4##(2008-3#2)
coherent emission##2##2##(2007-11#2)
coherent extreme-ultraviolet##2##2##(2007-11#2)
coherent illumination##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
coherent image is##2##3##(2008-3#2)
coherent image##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
coherent imaging##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
coherent laser radar##4##3##(2007-12#2)(2008-3#2)
coherent laser##9##2##(2007-12#3)(2008-2#1)(2008-3#5)
coherent lidar performance##3##3##(2008-3#3)
coherent lidar return##2##3##(2008-3#2)
coherent lidar##9##2##(2008-2#3)(2008-3#6)
coherent lidars##3##2##(2008-3#3)
coherent light source##4##3##(2007-12#1)(2008-3#3)
coherent light##14##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#6)
coherent noise##3##2##(2007-11#1)(2008-3#2)
coherent optical spectrum##2##3##(2007-11#2)
coherent optical##15##2##(1992-11#1)(2007-11#6)(2007-12#2)(2008-3#6)
coherent population trapping##4##3##(2007-11#1)(2007-12#3)
coherent radiation in the##2##4##(2007-11#1)(2008-2#1)
coherent radiation##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
coherent source##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
coherent sources##2##2##(2007-11#1)(2007-12#1)
coherent speckle##4##2##(2007-11#2)(2008-3#2)
coherent state##2##2##(2007-11#1)(2007-12#1)
coherent transient continuously programmed continuous processor##2##6##(2007-12#2)
coherent transient##5##2##(2007-12#5)
coherent with##4##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)
coherent x-ray sources##2##3##(2008-3#2)
coherent x-ray##3##2##(2007-11#1)(2008-3#2)
coherent##305##1##(1990-5#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-4#1)(2006-4#1)(2007-11#76)(2007-12#54)(2007-6#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#34)(2008-3#98)(2008-4#1)(2008-6#3)(2008-7#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-5#1)(2010-8#2)(2012-2#3)(2013-1#2)(2013-8#2)
coherently##9##1##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#4)
cohesion and##3##2##(1996-1#1)(2008-5#1)(2009-9#1)
cohesion in##2##2##(2010-8#1)(2013-7#1)
cohesion##19##1##(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-9#1)(2010-8#3)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
cohesive groups##2##2##(1992-1#1)(2009-8#1)
cohesive##14##1##(1992-1#1)(1993-11#3)(1994-12#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-1#2)
cohesiveness##4##1##(1991-12#1)(1996-3#1)(2008-5#1)(2010-8#1)
cohort had a mean##2##4##(2008-9#2)
cohort had##3##2##(2007-10#1)(2008-9#2)
cohort in##4##2##(2006-10#1)(2008-11#1)(2010-6#1)(2011-2#1)
cohort included##2##2##(1997-4#1)(2008-9#1)
cohort of 19 patients with##2##5##(2008-9#1)(2011-2#1)
cohort of 50##2##3##(2007-7#1)(2008-8#1)
cohort of individuals##4##3##(1994-12#1)(1997-3#1)(2011-1#1)(2013-1#1)
cohort of patients with##4##4##(2008-1#1)(2011-2#1)(2012-3#1)(2012-6#1)
cohort of patients##7##3##(2007-10#1)(2008-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-6#1)
cohort of street-involved youth##2##4##(2013-1#2)
cohort of##83##2##(1990-5#1)(1990-9#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-12#2)(1994-12#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#6)
cohort studies##14##2##(1991-12#1)(1994-2#3)(1995-9#1)(1996-3#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-2#1)(2013-1#1)
cohort study comparing##2##3##(2008-11#1)(2013-1#1)
cohort study of patients with##2##5##(2008-7#1)(2012-2#1)
cohort study of##14##3##(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
cohort study on the##2##4##(2011-1#2)
cohort study on##3##3##(2011-1#2)(2013-1#1)
cohort study##53##2##(1991-1#1)(1991-11#1)(1992-11#1)(1994-2#1)(1995-9#1)(1996-11#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#11)(2013-8#2)
cohort was##8##2##(1995-9#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)
cohort who##2##2##(1993-3#1)(2008-4#1)
cohort with##3##2##(1994-2#1)(2007-10#1)(2008-7#1)
cohort##256##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-5#1)(1995-8#2)(1995-9#7)(1996-11#2)(1996-3#4)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#11)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#10)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#10)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#19)(2012-1#3)(2012-12#14)(2012-2#7)(2012-3#7)(2012-6#1)(2012-7#4)(2013-1#29)(2013-7#2)(2013-8#4)
cohort)##3##1##(1996-3#1)(2013-7#2)
cohorts and##2##2##(2008-1#1)(2012-3#1)
cohorts are established##2##3##(2008-11#1)(2008-8#1)
cohorts are##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
cohorts born in the##2##4##(2011-2#2)
cohorts born##3##2##(2011-2#3)
cohorts graduating in##2##3##(2012-3#1)(2013-1#1)
cohorts of patients with bleeding esophageal varices##2##7##(2013-1#2)
cohorts of patients with##3##4##(2012-2#1)(2013-1#2)
cohorts of patients##6##3##(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#3)
cohorts of students##3##3##(2008-11#2)(2013-1#1)
cohorts of##17##2##(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#6)
cohorts were##3##2##(1990-2#1)(2011-2#1)(2013-7#1)
cohorts##61##1##(1990-2#1)(1992-5#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#2)
coil (GDC)##2##2##(1997-6#1)(2008-7#1)
coil and a##2##3##(2008-10#2)
coil and the##2##3##(2008-10#2)
coil and##13##2##(1992-3#1)(2008-10#10)(2008-7#1)(2008-9#1)
coil atomizer##6##2##(2008-10#6)
coil embolization##8##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
coil group)##2##2##(2013-7#2)
coil in the##2##3##(1996-9#1)(2008-8#1)
coil length of##2##3##(2008-10#2)
coil length##9##2##(2008-10#9)
coil lifetime##2##2##(2008-10#2)
coil occlusion of##2##3##(1997-8#1)(2008-7#1)
coil occlusion##3##2##(1997-8#1)(2008-11#1)(2008-7#1)
coil of the##2##3##(2008-10#1)(2008-9#1)
coil of##4##2##(2008-10#3)(2008-9#1)
coil over##2##2##(1992-9#1)(2010-7#1)
coil placement##2##2##(1997-3#1)(2008-7#1)
coil positioning##2##2##(2010-7#2)
coil to the##3##3##(2008-10#1)(2012-2#2)
coil to##9##2##(2008-10#5)(2010-7#1)(2012-2#2)(2012-3#1)
coil was##6##2##(1996-9#1)(2008-10#5)
coil##152##1##(1990-8#1)(1992-3#3)(1992-9#1)(1993-11#6)(1993-12#1)(1996-2#1)(1996-9#2)(1997-3#5)(1997-6#1)(1997-8#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#82)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2010-7#7)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#5)(2013-8#1)
coiled around##2##2##(2008-10#2)
coiled carbon nanotubes were##2##4##(2008-10#2)
coiled carbon nanotubes##3##3##(2008-10#3)
coiled coil polypeptides##2##3##(1993-11#2)
coiled coil##9##2##(1992-9#1)(1993-11#6)(2011-1#1)(2011-2#1)
coiled high-birefringent fibers##3##3##(2008-2#3)
coiled reactor positioned at the output antenna of a domestic microwave oven at 700 W is##2##16##(2008-10#2)
coiled reactor positioned##3##3##(2008-10#3)
coiled reactor##4##2##(2008-10#4)
coiled##32##1##(1992-9#1)(1993-11#7)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-2#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
coiled-coil structure and##2##3##(1992-9#1)(1996-12#1)
coiled-coil##14##1##(1992-6#4)(1992-9#6)(1995-3#1)(1996-12#1)(1997-4#1)(2009-8#1)
coiling and##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
coiling of##3##2##(2011-3#1)(2012-12#1)(2012-3#1)
coiling##12##1##(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-7#1)
coils is##2##2##(1997-8#2)
coils were used##2##3##(1996-9#1)(2012-12#1)
coils were##3##2##(1996-9#1)(2008-10#1)(2012-12#1)
coils with##3##2##(1993-11#1)(2006-12#1)(2008-10#1)
coils##28##1##(1990-10#1)(1993-11#1)(1995-11#2)(1995-3#1)(1996-9#1)(1997-3#3)(1997-8#6)(2006-12#3)(2008-10#5)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
coin##4##1##(1991-9#1)(2007-8#2)(2008-4#1)
coincide in##2##2##(2009-10#1)(2013-1#1)
coincide with a##3##3##(2008-11#1)(2008-3#2)
coincide with the##6##3##(1993-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-8#1)
coincide with those of the##2##5##(1997-7#1)(2008-3#1)
coincide with those##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
coincide with##20##2##(1993-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2010-8#1)(2011-2#1)
coincide##26##1##(1992-3#1)(1993-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
coincided with a##4##3##(1994-7#1)(2008-11#2)(2008-8#1)
coincided with an##2##3##(1993-9#1)(2008-11#1)
coincided with the increase##2##4##(2008-10#1)(2008-11#1)
coincided with the##19##3##(1993-8#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
coincided with those of##2##4##(1995-2#1)(2008-3#1)
coincided with those##3##3##(1994-11#1)(1995-2#1)(2008-3#1)
coincided with##44##2##(1990-6#1)(1992-8#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-7#2)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
coincided##46##1##(1990-6#1)(1992-8#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#2)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#13)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
coincidence between##2##2##(2007-11#1)(2008-4#1)
coincidence coefficient##2##2##(2007-10#2)
coincidence of the##2##3##(2007-11#1)(2008-8#1)
coincidence of##6##2##(1996-6#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
coincidence##23##1##(1991-11#1)(1996-6#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
coincidence-count rate##2##2##(2007-11#2)
coincident in##2##2##(2008-10#1)(2008-3#1)
coincident nuclear##2##2##(2008-3#2)
coincident with an##2##3##(1991-12#1)(2010-8#1)
coincident with the inhibition of##2##5##(1991-2#1)(1992-3#1)
coincident with the##13##3##(1991-2#1)(1992-3#1)(1994-6#1)(1995-2#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-5#1)
coincident with those##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
coincident with##24##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-3#1)
coincident##39##1##(1990-7#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-6#1)(1995-2#4)(1995-3#1)(1996-9#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#10)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
coincidental with##2##2##(2008-11#1)(2008-5#1)
coincidental##6##1##(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
coincidentally##4##1##(2008-1#1)(2008-7#1)(2008-9#1)(2013-8#1)
coincides with the##14##3##(1993-8#1)(1995-6#1)(1995-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
coincides with##23##2##(1990-5#1)(1992-3#2)(1993-8#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
coincides##30##1##(1990-5#1)(1992-3#2)(1993-8#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-8#1)
coinciding with the##2##3##(2008-10#1)(2010-3#1)
coinciding with##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2010-3#1)
coinciding##5##1##(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)
coined in##3##2##(2012-12#1)(2013-8#2)
coined##8##1##(1995-3#1)(1997-8#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
coinfect##4##1##(1997-3#1)(2008-10#3)
coinfected with HIV##2##3##(2008-10#1)(2011-2#1)
coinfected with##5##2##(1997-4#1)(2006-10#1)(2008-10#2)(2011-2#1)
coinfected##13##1##(1997-4#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
coinfecting##3##1##(2008-10#2)(2008-7#1)
coinfection with##3##2##(2008-10#2)(2008-7#1)
coinfection##14##1##(2007-12#1)(2008-10#8)(2008-7#4)(2011-2#1)
coinfiltration##2##1##(2008-10#2)
coinjection of##2##2##(1993-12#1)(2008-6#1)
coinjection##3##1##(1993-12#1)(1997-2#1)(2008-6#1)
coinoculated into##2##2##(2008-10#2)
coinoculated with A1 + A2 sporangia of##2##7##(2008-10#2)
coinoculated with##12##2##(1995-2#1)(2008-10#11)
coinoculated##17##1##(1995-2#1)(2008-10#16)
coinoculation##3##1##(2008-10#3)
coins##9##1##(1991-6#1)(2007-8#4)(2008-10#1)(2013-8#3)
coinsurance##2##1##(1990-5#1)(1992-2#1)
coioides##5##1##(2008-12#3)(2010-5#2)
coitus interruptus##3##2##(2011-1#3)
coitus##6##1##(1994-7#2)(2008-11#1)(2011-1#3)
col-36 and col-40##3##3##(1993-12#3)
col-36##4##1##(1993-12#4)
col-40##4##1##(1993-12#4)
colcemid##2##1##(2008-11#1)(2008-6#1)
colchicine and##3##2##(1993-6#1)(1995-5#1)(2008-8#1)
colchicine site##2##2##(1995-5#2)
colchicine##21##1##(1990-2#1)(1992-9#3)(1993-6#1)(1995-11#1)(1995-2#1)(1995-5#6)(1997-6#5)(2007-7#1)(2008-11#1)(2008-8#1)
cold acclimated##2##2##(2008-7#2)
cold adaptation##2##2##(2008-9#1)(2013-1#1)
cold and dry air##2##4##(2012-3#2)
cold and##7##2##(1993-3#1)(1993-8#1)(2008-10#1)(2009-8#1)(2012-3#2)(2013-1#1)
cold atoms##5##2##(2007-11#4)(2008-2#1)
cold chain##5##2##(1993-2#1)(1994-9#2)(1997-8#1)(2011-2#1)
cold denaturation##2##2##(1995-2#1)(2011-2#1)
cold exposure##2##2##(2012-12#2)
cold in##2##2##(2008-7#1)(2012-3#1)
cold knife##3##2##(1994-12#3)
cold or##2##2##(2008-8#1)(2012-7#1)
cold pressor test##3##3##(1990-5#2)(2012-2#1)
cold rolling with##2##3##(2013-8#2)
cold season##2##2##(2008-10#1)(2011-2#1)
cold shock##2##2##(2008-7#2)
cold storage in##3##3##(2007-8#2)(2008-10#1)
cold storage##15##2##(2007-8#2)(2008-10#9)(2008-5#1)(2011-2#3)
cold stress##5##2##(1995-3#1)(1997-7#2)(2008-10#2)
cold trap system##2##3##(2008-10#2)
cold vapor atomic absorption spectrometry (CV-AAS)##2##6##(2008-10#2)
cold vapor atomic absorption spectrometry (CVAAS)##2##6##(2008-10#2)
cold vapor atomic absorption spectrometry##8##5##(2008-10#8)
cold vapor atomic absorption##9##4##(2008-10#9)
cold vapor##13##2##(2008-10#13)
cold vapour atomic absorption spectrometry (CVAAS)##4##6##(2008-10#4)
cold vapour atomic absorption spectrometry##6##5##(2008-10#6)
cold vapour atomic absorption##8##4##(2008-10#8)
cold vapour atomic fluorescence##4##4##(2008-10#4)
cold vapour atomic##12##3##(2008-10#12)
cold vapour generation##2##3##(2008-10#2)
cold vapour##15##2##(2008-10#15)
cold##203##1##(1990-11#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-9#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-3#4)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-9#3)(1995-11#3)(1995-2#1)(1995-3#2)(1995-6#1)(1997-6#5)(1997-7#3)(1997-8#1)(2006-11#1)(2007-11#6)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#55)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#3)(2008-5#5)(2008-7#10)(2008-8#10)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#4)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#15)(2012-12#3)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#5)(2013-8#7)
cold&quot##3##1##(1990-5#1)(1997-2#2)
cold-adapted##2##1##(2008-9#1)(2012-3#1)
cold-exposed animals##2##2##(2008-7#2)
cold-exposed##5##1##(1995-3#1)(2008-7#3)(2012-12#1)
cold-hardiness strategies##3##2##(2008-8#3)
cold-induced##2##1##(1992-3#1)(2008-3#1)
cold-regulated##3##1##(1992-3#2)(2008-10#1)
cold-shock response in mammalian cells##2##5##(2008-11#2)
cold-shock response in mammalian##3##4##(2008-11#3)
cold-shock##6##1##(1997-7#2)(2008-11#4)
cold-vapor atomic##2##2##(2008-10#2)
cold-vapor##3##1##(2008-10#3)
cold-vapour##2##1##(2008-10#2)
colder than##2##2##(1992-7#1)(2008-5#1)
colder##6##1##(1992-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
colds##5##1##(2008-10#2)(2008-7#3)
colectomy performed for##2##3##(2009-5#2)
colectomy was performed##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
colectomy was##4##2##(1994-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
colectomy##12##1##(1994-2#1)(2008-11#1)(2008-12#1)(2009-12#2)(2009-5#3)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
colemani##7##1##(2008-6#7)
coleopteran and##2##2##(2008-10#2)
coleopteran##8##1##(1997-2#2)(2007-12#1)(2008-10#5)
coli 0127##2##2##(1994-7#2)
coli B WP2 strains##2##4##(2008-9#2)
coli BL21 (DE3) cells##2##4##(1994-5#2)
coli BL21##3##2##(1994-5#2)(2013-1#1)
coli BLSE##2##2##(2010-4#2)
coli DNA polymerase I##3##4##(1997-6#1)(1997-8#1)(2008-4#1)
coli DNA polymerase III holoenzyme##2##5##(1992-3#1)(1994-12#1)
coli DNA polymerase III##3##4##(1992-3#1)(1994-12#1)(1995-6#1)
coli DNA polymerase##7##3##(1992-3#1)(1994-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-4#1)
coli DNA##8##2##(1992-3#2)(1994-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-4#1)
coli K-12 bacterial cells to##3##5##(2008-10#3)
coli K-12##21##2##(1990-11#1)(1990-5#1)(1991-11#2)(1993-9#1)(1996-12#6)(1996-6#3)(2008-10#4)(2008-7#1)(2009-6#1)(2011-1#1)
coli K1##3##2##(2009-12#3)
coli K12 on##3##3##(2008-7#3)
coli K12##10##2##(1990-5#1)(2008-12#2)(2008-7#4)(2008-9#1)(2013-1#2)
coli Nissle 1917##3##3##(2011-2#3)
coli Nissle##4##2##(2010-10#1)(2011-2#3)
coli O157##16##2##(1995-2#2)(1996-3#1)(1997-3#1)(2008-10#6)(2008-9#2)(2010-4#2)(2012-2#2)
coli O26##2##2##(1993-9#2)
coli ORF##2##2##(1990-11#1)(1994-12#1)
coli RNA polymerase##4##3##(1995-2#2)(1995-3#1)(1995-6#1)
coli RNase##2##2##(1995-6#1)(2008-8#1)
coli RecA and yeast RAD51 homolog##2##6##(1997-4#2)
coli RecA antibody##2##3##(1993-9#2)
coli RecA##5##2##(1993-9#2)(1997-4#2)(2008-4#1)
coli SSB##2##2##(1997-2#2)
coli W3110##2##2##(1994-11#2)
coli alkaline phosphatase does not##2##5##(1993-6#2)
coli alkaline phosphatase##3##3##(1993-6#3)
coli and Bacillus subtilis##2##4##(1997-2#1)(2011-1#1)
coli and K##2##3##(2007-7#1)(2012-2#1)
coli and Salmonella##5##3##(1990-5#1)(1994-8#2)(2007-12#1)(2011-1#1)
coli and purified to homogeneity##2##5##(1995-2#1)(2008-8#1)
coli and##54##2##(1990-11#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-3#3)(1992-8#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#3)(1995-2#2)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#3)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-5#2)(2011-1#4)(2011-2#2)(2012-2#2)(2013-8#1)
coli are##4##2##(1997-2#1)(1997-6#1)(2008-10#1)(2010-8#1)
coli aspartate##5##2##(1990-8#1)(1992-6#2)(1995-6#2)
coli beta-galactosidase##4##2##(1991-5#1)(1995-12#1)(1997-8#1)(2008-7#1)
coli by##9##2##(1990-8#1)(1991-5#1)(1993-11#1)(1993-9#1)(1995-5#1)(1997-6#1)(2008-11#1)(2009-6#1)(2010-4#1)
coli cell##3##2##(1990-11#1)(2008-10#1)(2008-7#1)
coli cells containing##2##3##(1995-2#1)(2008-10#1)
coli cells harboring##2##3##(1993-8#1)(1996-12#1)
coli cells##14##2##(1990-11#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#3)
coli challenge##4##2##(2010-4#4)
coli chromosome##4##2##(1990-11#1)(1994-12#1)(1995-2#2)
coli clone##2##2##(1997-4#1)(1997-6#1)
coli enzyme##2##2##(1993-6#1)(1995-2#1)
coli exhibited##2##2##(2008-10#1)(2008-11#1)
coli expression system##3##3##(1994-12#1)(1994-5#1)(1997-7#1)
coli expression##4##2##(1994-12#1)(1994-5#1)(1997-4#1)(1997-7#1)
coli extracts##2##2##(2008-4#2)
coli fermentation##2##2##(1997-2#1)(2008-7#1)
coli fldA##2##2##(1997-7#2)
coli for##2##2##(2011-1#1)(2013-1#1)
coli from a single colony is described along with considerations for growing larger cultures##2##14##(2008-2#1)(2008-9#1)
coli from a##4##3##(1991-5#1)(1993-12#1)(2008-2#1)(2008-9#1)
coli from##5##2##(1991-5#1)(1993-12#1)(2008-2#1)(2008-9#1)(2011-1#1)
coli genetic map)##2##3##(1992-9#2)
coli genome##2##2##(1994-3#1)(2008-7#1)
coli glutamate##2##2##(1995-2#1)(2008-8#1)
coli immobilized on sepiolite##4##4##(2008-10#4)
coli in the presence of##2##5##(1990-5#1)(1993-11#1)
coli in##12##2##(1990-5#1)(1993-11#1)(1997-3#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)
coli inclusion bodies##2##3##(2008-4#2)
coli infection##2##2##(1996-8#1)(2011-2#1)
coli initiation factor IF2##2##4##(1991-12#2)
coli is a##2##3##(1990-8#1)(1995-2#1)
coli is##11##2##(1990-8#3)(1991-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-2#1)(2008-4#1)(2011-1#1)
coli isolates##7##2##(1991-8#3)(2008-12#4)
coli lacZ gene##4##3##(1993-12#1)(1997-4#1)(1997-8#1)(2008-11#1)
coli lacZ##7##2##(1993-12#2)(1994-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-11#1)
coli mimotopes##2##2##(2008-7#2)
coli of a##4##3##(1992-12#1)(1993-9#1)(2008-6#1)(2008-7#1)
coli ogt##2##2##(1992-8#2)
coli or##3##2##(1990-12#1)(1990-5#1)(2008-10#1)
coli outer membrane##2##3##(1990-11#1)(1997-8#1)
coli pathogens##2##2##(1991-8#1)(2009-12#1)
coli phosphotransferase system##2##3##(1991-10#1)(2008-7#1)
coli recA-##3##2##(1993-9#3)
coli ribonucleotide reductase##3##3##(1990-12#1)(1991-12#1)(1993-11#1)
coli septic shock##3##3##(1995-2#3)
coli shuttle vectors##2##3##(1993-12#1)(1994-12#1)
coli shuttle##4##2##(1990-11#1)(1993-12#1)(1994-12#1)(2008-8#1)
coli strain##13##2##(1993-8#1)(1994-11#1)(1994-12#3)(1995-5#1)(2008-1#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)
coli strains using##2##3##(1990-8#1)(2008-7#1)
coli strains with##3##3##(1991-12#1)(1993-9#1)(2011-1#1)
coli strains##15##2##(1990-8#1)(1991-12#2)(1993-12#1)(1993-9#1)(1994-12#1)(2008-10#2)(2008-12#3)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
coli tRNA##2##2##(1995-6#1)(2008-4#1)
coli tRNA(fMet) genes##2##3##(1995-6#2)
coli tRNA(fMet)##3##2##(1995-6#3)
coli to##10##2##(1990-5#1)(1993-12#1)(1994-6#2)(1995-2#1)(1996-12#1)(1997-3#1)(2008-4#1)(2009-3#1)(2010-8#1)
coli under##3##2##(1990-11#1)(1992-3#1)(1994-12#1)
coli using##9##2##(1990-11#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-4#2)(2008-7#1)
coli was the most common##2##5##(2008-12#1)(2011-1#1)
coli was##19##2##(1990-5#2)(1991-3#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
coli were isolated##2##3##(1990-8#1)(2008-12#1)
coli were##7##2##(1990-7#1)(1990-8#1)(1994-12#1)(1995-11#1)(1996-12#1)(2008-12#1)(2011-2#1)
coli with a##4##3##(1991-9#1)(1993-8#1)(1994-6#1)(2008-7#1)
coli with the##2##3##(1997-4#1)(2012-2#1)
coli with##10##2##(1990-11#2)(1991-9#1)(1993-8#1)(1994-6#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-7#1)(2012-2#1)
coli##869##1##(1990-11#31)(1990-12#3)(1990-3#1)(1990-5#26)(1990-6#1)(1990-7#5)(1990-8#10)(1991-10#2)(1991-11#2)(1991-12#12)(1991-3#5)(1991-5#11)(1991-7#4)(1991-8#5)(1991-9#14)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#8)(1992-4#2)(1992-6#10)(1992-8#11)(1992-9#5)(1993-11#15)(1993-12#13)(1993-2#2)(1993-6#13)(1993-8#10)(1993-9#18)(1994-11#9)(1994-12#30)(1994-2#3)(1994-3#2)(1994-5#8)(1994-6#7)(1994-7#3)(1994-8#13)(1994-9#4)(1995-11#4)(1995-12#6)(1995-2#31)(1995-3#4)(1995-5#5)(1995-6#16)(1995-8#12)(1995-9#1)(1996-12#15)(1996-3#3)(1996-6#7)(1996-8#2)(1997-2#12)(1997-3#7)(1997-4#22)(1997-6#17)(1997-7#9)(1997-8#6)(2006-5#1)(2007-11#2)(2007-12#9)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#10)(2008-1#5)(2008-10#51)(2008-11#15)(2008-12#17)(2008-2#2)(2008-4#22)(2008-5#5)(2008-6#7)(2008-7#38)(2008-8#25)(2008-9#20)(2009-10#1)(2009-12#8)(2009-2#2)(2009-3#3)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#4)(2010-4#18)(2010-6#8)(2010-8#3)(2011-1#18)(2011-2#20)(2011-3#1)(2012-1#2)(2012-2#10)(2012-3#6)(2013-1#11)(2013-8#3)
coli)##6##1##(2008-10#3)(2008-7#1)(2012-2#2)
coli-expressed##3##1##(1997-2#1)(1997-6#2)
coli-like##4##1##(2013-1#4)
colic##7##1##(1990-11#1)(1990-12#1)(1997-4#1)(2007-10#2)(2008-10#2)
colicin E1 channel peptide##3##4##(1995-5#3)
colicin E1##4##2##(1995-5#4)
colicin##7##1##(1990-11#1)(1994-2#2)(1995-5#4)
colicins##2##1##(1994-2#2)
colicky abdominal pain##2##3##(1995-3#1)(2013-1#1)
coliform##7##1##(2007-5#3)(2008-10#4)
coliforms##5##1##(1990-6#1)(2008-10#2)(2008-5#2)
colinear with##2##2##(1992-11#1)(2008-10#1)
colinear##3##1##(1992-11#1)(2008-10#2)
colipase##6##1##(1990-2#3)(1992-12#2)(1995-5#1)
colipase-lipase interaction##2##2##(1992-12#2)
colipases##2##1##(1990-2#2)
colistin##3##1##(1991-8#1)(2008-10#2)
colitic mice##3##2##(2011-3#3)
colitis (UC)##7##2##(2009-12#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#2)
colitis and##7##2##(1992-6#1)(1992-9#1)(1994-2#3)(1995-8#1)(2013-8#1)
colitis caused by##3##3##(1990-5#1)(2010-6#2)
colitis in##4##2##(1992-6#1)(2007-2#1)(2008-4#1)(2010-12#1)
colitis is##7##2##(1990-5#1)(1990-6#1)(1992-9#1)(2007-10#1)(2009-5#1)(2010-12#1)(2013-1#1)
colitis that##2##2##(2010-12#1)(2011-2#1)
colitis were##4##2##(1992-9#1)(1994-2#1)(1995-10#1)(2011-3#1)
colitis with##2##2##(2008-5#1)(2011-2#1)
colitis##118##1##(1990-5#2)(1990-6#2)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-9#5)(1994-2#7)(1994-6#2)(1995-10#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-8#1)(2007-10#4)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#6)(2008-9#1)(2009-12#1)(2009-5#5)(2010-11#2)(2010-12#20)(2010-6#3)(2011-2#8)(2011-3#3)(2012-12#4)(2012-2#4)(2013-1#8)(2013-8#3)
colitis]##5##1##(1990-6#1)(1992-3#1)(1993-2#1)(2008-12#1)(2011-3#1)
collaborate in##3##2##(1995-3#1)(2008-7#1)(2012-2#1)
collaborate with##6##2##(1991-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2013-1#1)
collaborate##15##1##(1991-5#1)(1992-3#1)(1995-3#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
collaborated to##4##2##(1991-2#1)(1997-2#1)(2007-10#1)(2008-11#1)
collaborated with##3##2##(1997-5#1)(2008-10#1)(2013-1#1)
collaborated##7##1##(1991-2#1)(1997-2#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2013-1#1)
collaborating##2##1##(1991-9#1)(2008-5#1)
collaboration among##3##2##(1995-1#1)(2008-1#1)(2008-12#1)
collaboration and coordination##2##3##(2007-7#1)(2008-11#1)
collaboration and partnership##2##3##(2008-1#1)(2008-11#1)
collaboration and##15##2##(1991-3#1)(1993-12#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#5)(2008-12#2)(2009-3#1)
collaboration between the##5##3##(1996-1#1)(2008-11#3)(2013-8#1)
collaboration between##27##2##(1990-8#1)(1991-2#2)(1992-3#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-2#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
collaboration has##2##2##(1996-3#1)(2009-5#1)
collaboration in developing##2##3##(2008-11#2)
collaboration in##5##2##(1992-12#1)(1992-3#1)(2008-11#2)(2010-12#1)
collaboration is##2##2##(1996-1#1)(2010-3#1)
collaboration of##4##2##(2007-7#1)(2008-11#1)(2012-12#1)(2013-1#1)
collaboration on##2##2##(2010-12#1)(2013-1#1)
collaboration to##3##2##(1995-1#1)(2009-12#1)(2013-1#1)
collaboration with health##2##3##(1991-12#1)(2010-5#1)
collaboration with many##2##3##(2008-10#1)(2008-2#1)
collaboration with other##2##3##(2008-11#2)
collaboration with the##19##3##(1991-6#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
collaboration with##40##2##(1991-12#1)(1991-6#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
collaboration##163##1##(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#4)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-3#1)(1996-1#7)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#8)(2008-11#21)(2008-12#11)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-3#5)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
collaborations and##2##2##(2008-10#1)(2010-10#1)
collaborations between##3##2##(2008-7#2)(2013-8#1)
collaborations##11##1##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-3#1)(2010-10#1)(2013-8#1)
collaborative activities##2##2##(1995-2#1)(1996-1#1)
collaborative approach between##2##3##(2008-11#1)(2008-12#1)
collaborative approach##5##2##(1997-3#1)(2007-5#1)(2008-11#2)(2008-12#1)
collaborative capital##3##2##(2011-1#3)
collaborative care##3##2##(2012-2#2)(2012-3#1)
collaborative effort by##2##3##(1996-12#1)(1997-1#1)
collaborative effort to##4##3##(1995-11#2)(1996-12#1)(2012-3#1)
collaborative effort##14##2##(1994-12#2)(1995-11#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-9#1)(2012-3#1)
collaborative efforts of##5##3##(1993-3#1)(1994-9#1)(1996-1#1)(2010-10#1)(2013-1#1)
collaborative efforts##8##2##(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(2009-9#1)(2010-10#1)(2013-1#1)
collaborative exercise on##2##3##(2008-12#2)
collaborative exercise##5##2##(2008-12#5)
collaborative learning##3##2##(2008-12#2)(2012-2#1)
collaborative management##3##2##(1994-3#1)(2007-12#1)(2008-10#1)
collaborative practice##2##2##(2008-12#1)(2012-2#1)
collaborative relationship between##2##3##(1992-2#1)(2008-11#1)
collaborative relationship##3##2##(1992-2#1)(2008-11#1)(2008-4#1)
collaborative relationships##2##2##(2008-1#1)(2010-4#1)
collaborative research##3##2##(2010-10#1)(2011-3#1)(2012-3#1)
collaborative structures to##2##3##(2008-11#2)
collaborative structures##3##2##(2008-10#1)(2008-11#2)
collaborative studies##3##2##(1994-7#1)(2008-1#1)(2008-5#1)
collaborative study was##2##3##(1997-7#1)(2008-10#1)
collaborative study##4##2##(1995-11#1)(1997-7#1)(2008-10#1)(2009-11#1)
collaborative venture##2##2##(1991-2#1)(2008-11#1)
collaborative work in##2##3##(1993-12#1)(2013-1#1)
collaborative work##9##2##(1993-12#4)(1994-1#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
collaborative working##3##2##(2008-11#3)
collaborative##139##1##(1991-2#2)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#6)(1993-3#1)(1994-1#2)(1994-12#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#4)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#5)(2008-11#15)(2008-12#13)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#3)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2011-9#3)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#10)(2013-8#1)
collaboratively with##4##2##(1995-3#1)(2008-12#1)(2008-6#1)(2011-1#1)
collaboratively##12##1##(1995-3#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
collaboratives##2##1##(2013-1#2)
collaborator##2##1##(1991-5#1)(2009-10#1)
collaborators##7##1##(1994-9#1)(1995-1#1)(1995-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)
collagen I and III##4##4##(1995-12#1)(2008-9#1)(2011-2#2)
collagen I and##5##3##(1995-12#2)(2008-9#1)(2011-2#2)
collagen I fibrils##2##3##(1992-6#2)
collagen I##15##2##(1992-6#5)(1994-8#2)(1994-9#1)(1995-12#3)(2008-9#1)(2011-2#2)(2012-3#1)
collagen II##2##2##(1991-11#2)
collagen III##2##2##(1995-12#2)
collagen IV##2##2##(2010-11#2)
collagen alpha 1 (IV)##2##4##(1994-12#2)
collagen alpha 1##4##3##(1994-12#4)
collagen alpha##5##2##(1990-5#1)(1994-12#4)
collagen and elastic fibers##2##4##(2007-8#1)(2012-2#1)
collagen and glycosaminoglycans##2##3##(2008-5#2)
collagen and##18##2##(1990-2#1)(1993-12#1)(1994-7#1)(2007-11#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
collagen beads##3##2##(2008-11#3)
collagen biosynthesis##3##2##(1997-7#1)(2008-5#2)
collagen by##3##2##(1993-12#1)(1995-3#1)(2008-8#1)
collagen cDNA##2##2##(1992-3#1)(1997-7#1)
collagen concentration##2##2##(2008-5#1)(2012-3#1)
collagen content##2##2##(1991-9#1)(2009-8#1)
collagen cross-links##2##2##(1994-12#2)
collagen degradation##5##2##(1997-3#1)(2009-7#1)(2013-1#2)(2013-8#1)
collagen denaturation##2##2##(2008-8#2)
collagen fiber##2##2##(2012-2#1)(2013-1#1)
collagen fibers##10##2##(1994-11#1)(2008-8#2)(2009-7#1)(2012-1#2)(2012-3#3)(2013-8#1)
collagen fibre##2##2##(1992-6#1)(2008-5#1)
collagen fibres types I and III in the##2##8##(2008-7#2)
collagen fibrils in##2##3##(1995-6#1)(2008-7#1)
collagen fibrils##12##2##(1995-6#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-8#3)(2010-8#1)
collagen film##2##2##(2008-10#2)
collagen fleece##3##2##(2007-8#1)(2013-8#2)
collagen formation##5##2##(1991-12#1)(1994-12#1)(1997-3#1)(2008-5#1)(2013-8#1)
collagen gel culture##3##3##(1990-7#2)(2012-3#1)
collagen gel matrix##2##3##(1990-12#2)
collagen gel substrata##2##3##(1994-8#2)
collagen gel##15##2##(1990-12#2)(1990-7#2)(1994-11#2)(1994-8#6)(2008-11#1)(2008-7#1)(2012-3#1)
collagen gels##5##2##(1990-12#1)(1991-2#1)(1994-8#1)(1994-9#1)(2008-7#1)
collagen gene expression in##2##4##(1992-8#1)(1994-12#1)
collagen gene##5##2##(1992-8#3)(1994-12#1)(2008-9#1)
collagen hydrogel##2##2##(2012-3#2)
collagen hydrolysate##5##2##(2008-5#5)
collagen in a##2##3##(2008-11#1)(2009-7#1)
collagen in the##5##3##(1992-6#1)(1994-7#2)(2008-5#1)(2008-9#1)
collagen in##13##2##(1990-8#1)(1992-6#1)(1993-3#1)(1994-7#2)(1995-12#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2012-12#1)
collagen is##3##2##(1992-6#1)(1992-8#1)(1997-7#1)
collagen mineralization##3##2##(2009-7#1)(2009-8#2)
collagen models##2##2##(2008-5#1)(2013-1#1)
collagen network##6##2##(2008-5#2)(2008-7#2)(2009-10#2)
collagen of##4##2##(1992-6#1)(1997-7#1)(2008-11#1)(2009-8#1)
collagen or##2##2##(1997-7#1)(2010-8#1)
collagen production##2##2##(2008-5#2)
collagen promoter##2##2##(1991-5#2)
collagen scaffolds##4##2##(2009-7#4)
collagen solubility##3##2##(2010-4#2)(2013-1#1)
collagen stimulation##3##2##(1997-7#2)(2008-8#1)
collagen synthesis and##2##3##(2008-5#2)
collagen synthesis in##2##3##(2008-5#2)
collagen synthesis##17##2##(1992-9#1)(2008-5#8)(2008-7#1)(2008-9#7)
collagen turnover##2##2##(1993-3#1)(2007-11#1)
collagen type I##10##3##(1996-5#1)(2008-11#5)(2008-5#3)(2010-2#1)
collagen type IV##6##3##(1990-12#1)(1991-8#1)(1992-6#2)(2008-11#2)
collagen type IV)##2##3##(2008-5#1)(2009-11#1)
collagen type##20##2##(1990-12#2)(1991-8#1)(1992-6#2)(1996-5#1)(2008-11#8)(2008-5#4)(2009-11#1)(2010-2#1)
collagen types I and##2##4##(1990-12#1)(2008-11#1)
collagen was##4##2##(1993-3#1)(2008-5#1)(2008-9#1)(2009-7#1)
collagen were##3##2##(2008-5#2)(2008-8#1)
collagen##372##1##(1990-12#7)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#5)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#7)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#4)(1992-6#14)(1992-8#4)(1992-9#3)(1993-12#4)(1993-3#8)(1993-5#1)(1994-11#3)(1994-12#9)(1994-5#1)(1994-7#4)(1994-8#13)(1994-9#2)(1995-12#6)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#1)(1997-1#2)(1997-3#2)(1997-7#16)(2006-6#1)(2007-10#2)(2007-11#5)(2007-8#5)(2008-1#2)(2008-10#4)(2008-11#31)(2008-3#2)(2008-5#53)(2008-6#1)(2008-7#17)(2008-8#17)(2008-9#14)(2009-10#2)(2009-11#1)(2009-7#17)(2009-8#9)(2009-9#1)(2010-11#3)(2010-2#3)(2010-4#3)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#15)(2013-1#9)(2013-8#8)
collagen)##2##1##(1990-8#1)(2008-7#1)
collagen-binding domain##2##2##(2009-7#2)
collagen-binding##4##1##(1997-7#1)(2009-7#3)
collagen-blended membranes##3##2##(2008-11#3)
collagen-coated##6##1##(2008-11#6)
collagen-encoding genes##2##2##(1993-12#1)(1994-12#1)
collagen-encoding##3##1##(1993-12#1)(1994-12#2)
collagen-induced platelet##2##2##(2006-6#1)(2008-5#1)
collagen-induced##5##1##(2006-6#3)(2008-11#1)(2008-5#1)
collagen-like polymer synthesis##2##3##(2009-12#2)
collagen-like##4##1##(1990-8#1)(1993-3#1)(2009-12#2)
collagen/gelatin binding##2##2##(1995-5#2)
collagenase IV and##2##3##(2008-8#2)
collagenase IV##6##2##(2008-8#6)
collagenase activity by##2##3##(1992-5#2)
collagenase activity##4##2##(1992-5#2)(1994-3#2)
collagenase and tissue inhibitor of##2##5##(1992-2#1)(2008-5#1)
collagenase and##6##2##(1992-2#2)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
collagenase digestion##2##2##(2007-10#1)(2008-11#1)
collagenase perfusion##2##2##(1993-3#1)(1994-6#1)
collagenase secretion##2##2##(2008-11#2)
collagenase were##2##2##(1992-5#1)(2009-7#1)
collagenase##48##1##(1991-5#1)(1992-2#4)(1992-5#7)(1992-9#1)(1993-3#1)(1994-3#7)(1994-6#1)(1996-11#1)(1997-8#1)(2007-10#2)(2008-11#5)(2008-5#2)(2008-8#10)(2008-9#1)(2009-7#2)(2010-11#2)
collagenases##5##1##(1992-2#1)(1992-6#1)(2008-5#1)(2009-7#1)(2010-11#1)
collagenous hydrolysates##2##2##(2008-5#2)
collagenous##17##1##(1990-8#1)(1992-9#1)(2007-5#3)(2007-7#1)(2008-11#2)(2008-5#2)(2008-7#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)
collagens and##6##2##(1992-8#1)(1997-7#1)(2008-11#1)(2008-5#3)
collagens##15##1##(1991-5#1)(1992-8#1)(1992-9#3)(1994-12#2)(1997-7#1)(2008-11#2)(2008-5#4)(2008-9#1)
collapse and##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
collapse in##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
collapse of the##15##3##(1995-11#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
collapse of##24##2##(1991-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#2)(2012-2#1)(2013-8#1)
collapse suppression##2##2##(2007-12#2)
collapse time of the bubble##2##5##(2008-11#2)
collapse##68##1##(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-2#2)(2007-11#1)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
collapsed and##3##2##(1995-3#1)(2007-11#1)(2008-10#1)
collapsed in##2##2##(1995-3#1)(2008-10#1)
collapsed replication forks##3##3##(2012-3#3)
collapsed##23##1##(1992-6#1)(1995-3#2)(1995-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-8#1)(2012-12#1)(2012-3#9)
collapses to a single##2##4##(2008-7#1)(2008-8#1)
collapses to##3##2##(1991-9#1)(2008-7#1)(2008-8#1)
collapses##6##1##(1991-9#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)
collapsing##12##1##(1991-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-3#5)
collar incision##2##2##(2007-8#1)(2008-12#1)
collar##18##1##(1991-8#1)(1995-12#4)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#1)
collared lemurs##3##2##(2011-2#3)
collared##7##1##(1995-12#2)(2008-8#1)(2008-9#1)(2011-2#3)
collars##2##1##(2008-8#1)(2010-8#1)
collated##7##1##(1997-3#1)(2007-11#1)(2008-12#2)(2008-6#1)(2012-2#1)(2013-8#1)
collateral blood##2##2##(1997-8#1)(2007-8#1)
collateral branches##2##2##(1997-3#1)(2007-12#1)
collateral channels##2##2##(1997-6#1)(2007-10#1)
collateral circulation##6##2##(1994-1#1)(2007-10#1)(2007-8#1)(2008-7#2)(2013-8#1)
collateral flow##2##2##(2007-8#1)(2008-4#1)
collateral ligament##4##2##(2008-8#1)(2009-7#1)(2012-2#2)
collateral pathway##3##2##(1993-3#1)(2007-7#2)
collateral veins##2##2##(2008-1#1)(2012-3#1)
collateral venous##2##2##(2009-8#1)(2012-3#1)
collateral##45##1##(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1995-2#1)(1997-3#3)(1997-6#1)(1997-8#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#2)
collaterally sprout##2##2##(1997-3#2)
collaterals of the##2##3##(1996-5#1)(2008-11#1)
collaterals of##5##2##(1996-5#2)(1997-3#2)(2008-11#1)
collaterals##14##1##(1994-2#1)(1995-12#1)(1996-5#2)(1997-3#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2012-3#2)
collation of##2##2##(2008-10#1)(2008-11#1)
collation##4##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
colleague##5##1##(2008-11#1)(2010-7#1)(2011-2#2)(2013-8#1)
colleagues and##6##2##(1994-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-8#1)
colleagues have##2##2##(2010-11#1)(2012-2#1)
colleagues in##3##2##(1995-3#1)(1996-1#1)(2008-10#1)
colleagues##59##1##(1990-6#1)(1991-6#1)(1992-9#1)(1994-12#2)(1994-2#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
collect a##3##2##(2007-11#1)(2008-4#1)(2009-9#1)
collect an##2##2##(2008-7#1)(2010-8#1)
collect and##8##2##(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)
collect data on##4##3##(1992-11#1)(1995-12#1)(2007-11#1)(2008-1#1)
collect data##18##2##(1992-11#1)(1992-2#1)(1994-2#1)(1995-12#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-9#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
collect from##2##2##(2008-10#1)(2008-11#1)
collect information on##2##3##(1993-2#1)(1996-2#1)
collect information##6##2##(1993-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
collect the##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
collect##96##1##(1992-11#1)(1992-2#1)(1993-2#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-3#3)(1997-5#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#14)(2008-11#10)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
collected 5##2##2##(2008-10#1)(2008-12#1)
collected after##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
collected along##2##2##(2008-10#1)(2013-7#1)
collected and analyzed for##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
collected and analyzed##10##3##(1992-1#1)(2008-10#4)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
collected and divided##2##3##(2008-3#1)(2008-5#1)
collected and hemoglobin##2##3##(2011-2#1)(2012-5#1)
collected and preconcentrated##2##3##(2008-10#2)
collected and the##5##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
collected and##51##2##(1992-1#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(2007-5#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
collected are##2##2##(2008-10#1)(2008-9#1)
collected around##2##2##(2008-10#2)
collected as part of the NIMH Genetics Initiative##2##8##(1997-5#2)
collected as part of the##4##5##(1996-3#1)(1997-5#2)(2008-11#1)
collected as part of##5##4##(1996-3#1)(1997-5#2)(2007-12#1)(2008-11#1)
collected as##10##2##(1996-3#1)(1997-5#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-12#1)
collected at a##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
collected at different times##3##4##(2008-8#1)(2008-9#1)(2012-1#1)
collected at different##7##3##(2008-10#2)(2008-8#2)(2008-9#1)(2011-3#1)(2012-1#1)
collected at each##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
collected at harvest##2##3##(2008-10#2)
collected at rest##2##3##(2008-7#1)(2013-1#1)
collected at the##11##3##(1995-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
collected at various times##2##4##(2008-10#1)(2012-1#1)
collected at various##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
collected at##51##2##(1991-6#1)(1992-7#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
collected before and after the##2##5##(2008-12#1)(2013-1#1)
collected before and after##3##4##(1990-8#1)(2008-12#1)(2013-1#1)
collected before and##4##3##(1990-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
collected before##7##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
collected between##9##2##(1991-6#1)(1992-3#1)(2008-10#3)(2008-5#2)(2010-10#1)(2011-2#1)
collected by CCD##2##3##(2008-10#1)(2008-3#1)
collected by a##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)
collected by the##11##3##(1991-7#1)(1992-2#1)(1994-6#1)(2008-12#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
collected by two##2##3##(2008-10#1)(2008-3#1)
collected by using a##2##4##(2008-10#1)(2011-2#1)
collected by using##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
collected by##58##2##(1990-8#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-6#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
collected data from the##2##4##(1995-3#1)(2008-3#1)
collected data from##4##3##(1995-3#1)(2008-3#1)(2010-11#1)(2010-5#1)
collected data on##3##3##(2008-1#1)(2008-11#1)(2009-4#1)
collected data##22##2##(1992-1#1)(1992-3#1)(1994-1#1)(1995-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-8#1)
collected during 1993##2##3##(1995-12#1)(2008-10#1)
collected during the last 50 years##2##6##(2008-10#2)
collected during the##12##3##(1990-8#1)(1991-12#2)(1994-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
collected during##37##2##(1990-8#1)(1991-12#2)(1991-6#1)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#12)(2008-12#3)(2008-5#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
collected for each child##2##4##(1992-11#1)(2008-11#1)
collected for each##4##3##(1992-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
collected for the##2##3##(1997-2#1)(2008-12#1)
collected for##31##2##(1992-11#1)(1992-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
collected from 11##2##3##(2008-10#1)(2008-7#1)
collected from 15##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
collected from 5##2##3##(2009-5#1)(2010-1#1)
collected from February##2##3##(2008-5#1)(2011-1#1)
collected from a##21##3##(1990-11#1)(1993-12#1)(1993-5#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
collected from all##4##3##(1990-3#1)(2008-10#3)
collected from an##4##3##(2008-10#4)
collected from apple##2##3##(2008-10#2)
collected from both##3##3##(2008-10#2)(2008-12#1)
collected from citrus##2##3##(2008-10#2)
collected from commercial##2##3##(2008-10#2)
collected from common wheat in##2##5##(2008-10#2)
collected from cultivated potatoes##2##4##(2008-10#2)
collected from different geographic##2##4##(2008-10#1)(2008-5#1)
collected from different host plant species##2##6##(2008-10#2)
collected from different##10##3##(2008-10#8)(2008-5#1)(2013-8#1)
collected from diseased##2##3##(2008-10#2)
collected from dogs in##2##4##(2011-1#2)
collected from dogs##3##3##(2011-1#3)
collected from durum wheat##3##4##(2008-10#3)
collected from durum##4##3##(2008-10#4)
collected from each##6##3##(2007-5#1)(2008-10#5)
collected from eight##2##3##(2008-10#2)
collected from farms##2##3##(2008-10#1)(2008-12#1)
collected from five##5##3##(2008-10#4)(2013-1#1)
collected from four##3##3##(2008-10#2)(2011-2#1)
collected from healthy##2##3##(2010-11#1)(2011-1#1)
collected from infected tomato plants in##2##6##(2008-10#2)
collected from infected##3##3##(2008-10#3)
collected from local##2##3##(2008-12#1)(2013-1#1)
collected from naturally infected##2##4##(2008-10#2)
collected from naturally##3##3##(1996-12#1)(2008-10#2)
collected from patients with##2##4##(2010-8#1)(2011-2#1)
collected from patients##5##3##(1991-7#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
collected from pistachio and other##2##5##(2008-10#2)
collected from potato##6##3##(2008-10#6)
collected from quarters infected with##2##5##(2012-3#2)
collected from records of##2##4##(2008-10#1)(2008-9#1)
collected from rice##2##3##(2008-10#1)(2013-8#1)
collected from seven##3##3##(2008-10#2)(2010-8#1)
collected from several##2##3##(2008-10#2)
collected from six##3##3##(2008-10#1)(2009-2#1)(2010-6#1)
collected from soybean##3##3##(2008-10#3)
collected from the commercial##2##4##(2008-10#2)
collected from the field##4##4##(2008-10#4)
collected from the patient's##2##4##(2011-1#1)(2013-1#1)
collected from the##45##3##(1991-12#1)(1991-6#1)(2008-10#22)(2008-12#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#1)
collected from three##7##3##(2008-10#5)(2008-5#1)(2011-2#1)
collected from tomato##3##3##(2008-10#3)
collected from two##3##3##(2008-10#2)(2008-5#1)
collected from various##5##3##(2008-10#3)(2008-11#1)(2009-2#1)
collected from##377##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-9#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#5)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#199)(2008-11#7)(2008-12#18)(2008-2#2)(2008-3#2)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-5#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#9)(2011-2#13)(2012-12#3)(2012-2#5)(2012-3#9)(2013-1#12)(2013-7#4)(2013-8#9)
collected in 1993##2##3##(2008-10#1)(2011-2#1)
collected in 2002##2##3##(2008-10#2)
collected in Indonesia##2##3##(2008-8#1)(2010-2#1)
collected in South##2##3##(2008-10#1)(2009-9#1)
collected in a liquid nitrogen cryogenic trap##3##7##(2008-10#3)
collected in a##18##3##(1990-6#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
collected in an urban##2##4##(2008-10#2)
collected in an##3##3##(2008-10#3)
collected in different##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
collected in each##2##3##(1996-12#1)(2008-10#1)
collected in fractions##2##3##(2008-10#2)
collected in the course of##2##5##(2007-12#1)(2008-10#1)
collected in the field##2##4##(2008-10#2)
collected in the##35##3##(1990-12#1)(1992-8#1)(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-8#2)(2013-1#1)(2013-7#1)
collected in this##4##3##(2007-5#1)(2008-10#2)(2012-3#1)
collected in three##3##3##(2008-10#3)
collected in two##3##3##(2008-10#2)(2008-11#1)
collected in##151##2##(1990-12#1)(1990-6#1)(1992-8#2)(1993-6#1)(1994-6#1)(1994-9#1)(1996-12#2)(1997-4#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#84)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
collected information on##2##3##(2008-11#1)(2013-8#1)
collected information##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
collected monthly from##3##3##(2008-10#3)
collected monthly##5##2##(2008-10#3)(2008-12#1)(2013-7#1)
collected near the##2##3##(2008-10#1)(2011-2#1)
collected near##6##2##(2008-10#4)(2008-5#1)(2011-2#1)
collected on a##4##3##(1997-2#1)(2008-10#2)(2008-3#1)
collected on the walls of a knotted##3##7##(2008-10#3)
collected on the##12##3##(1994-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2013-8#1)
collected on##41##2##(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-8#1)
collected over 2##2##3##(2008-10#1)(2010-8#1)
collected over a range of##2##5##(2007-11#1)(2008-10#1)
collected over a##9##3##(2007-11#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-12#1)(2012-2#1)
collected over the##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
collected over##23##2##(1990-8#1)(1991-2#1)(2007-11#1)(2007-6#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#2)(2012-12#1)(2012-2#1)
collected randomly from##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
collected randomly##4##2##(1997-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
collected simultaneously##2##2##(1997-7#1)(2011-1#1)
collected species##2##2##(2008-10#1)(2011-2#1)
collected through a##4##3##(1996-1#1)(2008-11#1)(2008-12#1)(2008-7#1)
collected through the same##2##4##(2007-11#1)(2013-1#1)
collected through the##5##3##(1995-9#1)(1997-5#1)(2007-11#1)(2012-3#1)(2013-1#1)
collected through##23##2##(1990-12#1)(1992-10#1)(1994-2#1)(1995-9#1)(1996-1#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
collected to##9##2##(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
collected up to##2##3##(1993-11#1)(2013-1#1)
collected using a##5##3##(2008-10#2)(2010-6#1)(2011-2#1)(2013-1#1)
collected using##16##2##(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
collected via coitus interruptus##2##4##(2011-1#2)
collected via masturbation##2##3##(2011-1#2)
collected via##10##2##(1991-8#2)(1997-4#1)(2008-5#1)(2009-9#1)(2011-1#4)(2011-2#1)
collected were##4##2##(1990-8#1)(2007-8#1)(2008-12#1)(2008-5#1)
collected while##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
collected with a##4##3##(2008-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
collected with an##2##3##(2008-2#1)(2008-3#1)
collected with the##3##3##(2007-7#1)(2010-3#1)(2013-8#1)
collected with##15##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
collected worldwide##2##2##(2008-10#2)
collected##1176##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#2)(1990-8#5)(1991-12#3)(1991-2#4)(1991-6#4)(1991-7#2)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#3)(1994-1#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#5)(1997-2#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#8)(2007-12#9)(2007-2#3)(2007-5#10)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#7)(2008-10#450)(2008-11#30)(2008-12#54)(2008-2#15)(2008-3#27)(2008-4#2)(2008-5#52)(2008-6#16)(2008-7#17)(2008-8#14)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#4)(2009-4#6)(2009-5#6)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#7)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#15)(2010-9#1)(2011-1#27)(2011-10#2)(2011-2#53)(2011-3#2)(2011-9#1)(2012-1#4)(2012-12#13)(2012-2#17)(2012-3#24)(2012-5#1)(2013-1#46)(2013-7#16)(2013-8#25)
collecting and##4##2##(1992-1#1)(1993-3#1)(2008-9#1)(2012-3#1)
collecting data##7##2##(1991-12#1)(1993-3#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)
collecting duct##2##2##(2008-10#1)(2008-8#1)
collecting information on the##2##4##(1996-1#1)(2008-10#1)
collecting information on##3##3##(1996-1#1)(1996-2#1)(2008-10#1)
collecting information##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2011-2#1)
collecting samples##2##2##(2008-10#1)(2013-1#1)
collecting services##3##2##(2008-12#3)
collecting system##6##2##(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-8#1)
collecting the##9##2##(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#2)(2012-2#1)(2013-1#2)
collecting##90##1##(1991-12#1)(1992-1#1)(1992-12#1)(1993-3#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-6#5)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#6)(2008-2#7)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
collection and analysis of##5##4##(1993-3#1)(1994-2#1)(1995-12#1)(2008-1#1)(2008-10#1)
collection and analysis##11##3##(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2012-2#1)
collection and management##2##3##(2008-10#1)(2010-5#1)
collection and processing##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
collection and##48##2##(1992-11#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#7)
collection are##3##2##(1992-1#1)(2008-3#1)(2008-8#1)
collection as##6##2##(2008-10#5)(2008-5#1)
collection bioremediation strains##2##3##(2008-6#2)
collection but##2##2##(2007-10#1)(2008-2#1)
collection by##3##2##(2008-10#3)
collection can##2##2##(2008-7#1)(2010-4#1)
collection date##2##2##(2008-10#2)
collection efficiency for##2##3##(2008-10#1)(2011-1#1)
collection efficiency of##2##3##(2007-11#1)(2008-10#1)
collection efficiency##9##2##(2007-11#1)(2008-10#4)(2011-1#2)(2011-2#1)(2013-8#1)
collection for the##2##3##(2008-11#1)(2010-3#1)
collection for##7##2##(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)(2012-12#1)
collection from the##2##3##(2008-4#2)
collection from##4##2##(2008-10#1)(2008-11#1)(2008-4#2)
collection in##7##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-8#1)
collection includes##2##2##(2008-10#1)(2008-5#1)
collection instruments##3##2##(1990-8#1)(1996-3#1)(2010-3#1)
collection methods##5##2##(1995-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2012-2#1)
collection of P##3##3##(2008-10#3)
collection of a##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
collection of airborne##3##3##(2008-10#3)
collection of blood##4##3##(1990-12#1)(2008-2#1)(2008-4#1)(2009-3#1)
collection of boron##2##3##(2008-10#2)
collection of data on the##2##5##(1997-4#1)(2008-3#1)
collection of data##9##3##(1990-12#1)(1991-3#1)(1995-12#1)(1996-9#1)(1997-3#2)(1997-4#1)(2008-3#1)(2012-12#1)
collection of documents##2##3##(1996-3#1)(2009-10#1)
collection of information##2##3##(1997-1#1)(2008-11#1)
collection of isolates##4##3##(2008-10#4)
collection of large##2##3##(2008-10#1)(2010-12#1)
collection of random##2##3##(2008-10#1)(2008-4#1)
collection of the##9##3##(2008-10#6)(2008-6#1)(2010-1#1)(2013-7#1)
collection of##161##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-5#4)(2007-6#1)(2007-8#1)(2008-10#67)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-1#2)(2010-12#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
collection on##2##2##(2007-12#1)(2007-5#1)
collection or##2##2##(2008-10#1)(2010-6#1)
collection process##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
collection sites##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
collection strategies for##3##3##(1995-2#1)(2010-5#2)
collection strategies##5##2##(1995-2#1)(2007-10#1)(2008-6#1)(2010-5#2)
collection time of##2##3##(2008-3#1)(2012-3#1)
collection time##4##2##(2008-10#1)(2008-3#2)(2012-3#1)
collection using##2##2##(2008-10#2)
collection was undertaken##2##3##(2008-11#2)
collection was##12##2##(1990-12#1)(1993-12#1)(1994-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#1)
collection were##5##2##(2008-10#4)(2008-5#1)
collection##485##1##(1990-12#3)(1990-8#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1993-12#4)(1993-2#1)(1993-3#6)(1994-12#7)(1994-2#2)(1994-3#4)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#8)(1995-3#5)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#7)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#1)(1997-5#1)(2007-10#3)(2007-11#5)(2007-12#6)(2007-4#1)(2007-5#6)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#157)(2008-11#20)(2008-12#7)(2008-2#9)(2008-3#15)(2008-4#9)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#7)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#1)(2010-1#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#4)(2010-6#5)(2010-8#11)(2010-9#1)(2011-1#7)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#15)
collection)##4##1##(2008-5#1)(2011-2#1)(2013-1#2)
collection/concentration of trace amounts of formaldehyde in air##2##8##(2008-10#2)
collection/concentration of##4##2##(2008-10#4)
collections and##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2010-8#1)
collections are##2##2##(2007-5#1)(2008-10#1)
collections from the##3##3##(2008-10#2)(2011-2#1)
collections from##13##2##(1995-12#1)(2008-10#10)(2011-2#1)(2013-7#1)
collections of P##2##3##(2008-10#2)
collections of##20##2##(1995-5#1)(1996-5#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2013-7#1)
collections were carried out##2##4##(2008-5#1)(2008-8#1)
collections were##7##2##(2008-10#3)(2008-5#2)(2008-8#1)(2009-4#1)
collections##86##1##(1991-12#1)(1991-3#1)(1991-8#1)(1994-1#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-5#1)(1997-3#1)(2007-5#1)(2008-10#41)(2008-11#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-8#1)(2013-7#2)
collective approach to##2##3##(1993-5#1)(2008-12#1)
collective approach##3##2##(1993-5#1)(2008-12#2)
collective dynamics##2##2##(2009-8#1)(2012-2#1)
collective efficacy##2##2##(2009-9#1)(2012-2#1)
collective experiences##2##2##(1994-1#1)(2011-1#1)
collective level##2##2##(1997-3#1)(2008-12#1)
collective memory##2##2##(2008-2#2)
collective modes##2##2##(1992-8#1)(2009-8#1)
collective##65##1##(1990-5#1)(1991-11#1)(1991-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#2)(2008-5#2)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)
collectively as##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
collectively called##3##2##(1992-10#1)(2008-1#1)(2009-11#1)
collectively known as##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
collectively referred to as##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
collectively termed##2##2##(1995-2#1)(2011-2#1)
collectively the##2##2##(2008-8#1)(2011-2#1)
collectively they##2##2##(1997-7#1)(2008-9#1)
collectively##40##1##(1991-1#1)(1991-11#1)(1991-12#1)(1992-10#1)(1994-6#1)(1995-2#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-11#2)(2009-5#1)(2010-10#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)
collectivity##2##1##(2008-9#1)(2012-12#1)
collector for##2##2##(2008-10#2)
collector##15##1##(1990-4#1)(2008-10#12)(2008-3#2)
collectors##6##1##(1990-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)
collects the##2##2##(2008-10#1)(2008-3#1)
collects##12##1##(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2010-2#1)(2012-12#1)
college as##2##2##(2008-4#1)(2013-1#1)
college classroom##2##2##(1996-1#1)(2011-1#1)
college graduates##3##2##(1991-3#1)(1995-2#1)(1997-2#1)
college group was higher than high school group##2##8##(1990-12#2)
college in##2##2##(2008-11#1)(2008-7#1)
college of##5##2##(1997-8#1)(2008-11#1)(2009-6#1)(2012-12#1)(2012-3#1)
college student##2##2##(2007-12#1)(2008-11#1)
college students have##2##3##(2008-11#1)(2013-8#1)
college students in##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
college students to##2##3##(1992-7#1)(2008-12#1)
college students were##2##3##(1992-12#1)(2012-2#1)
college students##31##2##(1992-12#1)(1992-7#1)(2007-12#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#7)
college women resist sexual attacks##2##5##(2009-11#2)
college women##11##2##(2007-12#2)(2008-12#4)(2009-11#3)(2012-2#2)
college##90##1##(1990-12#2)(1991-3#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-7#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-8#1)(2007-12#10)(2007-3#1)(2007-7#1)(2008-11#9)(2008-12#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#3)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-10#4)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#9)
colleges in##2##2##(1992-1#1)(2008-12#1)
colleges##14##1##(1991-1#1)(1991-2#1)(1992-1#2)(2008-11#1)(2008-12#1)(2008-5#2)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#3)
collegial##3##1##(2008-1#1)(2011-1#1)(2012-12#1)
collegiate strength/power athletes##2##3##(2008-5#2)
collegiate##3##1##(2008-12#1)(2008-5#2)
collembola-biotest##3##1##(2008-11#3)
collembolans##2##1##(2008-10#2)
colleters##3##1##(2008-5#3)
colletotrichum species##3##2##(2008-10#3)
colletotrichum##5##1##(2008-10#5)
collicular##3##1##(1991-5#1)(1993-12#1)(1993-3#1)
colliculus to##2##2##(1993-3#1)(2008-10#1)
colliculus##15##1##(1991-5#5)(1993-12#1)(1993-3#4)(1997-3#1)(2008-10#1)(2008-7#3)
colliding##2##1##(2008-9#2)
collimated Gaussian##2##2##(2008-2#1)(2008-3#1)
collimated and##2##2##(1996-2#1)(2008-3#1)
collimated beam##6##2##(2007-12#2)(2008-11#1)(2008-3#3)
collimated beams##2##2##(2007-12#1)(2008-2#1)
collimated laser##2##2##(2007-11#1)(2008-3#1)
collimated ratemeter##2##2##(1996-2#2)
collimated##28##1##(1996-2#3)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#5)(2008-3#15)
collimating lens##2##2##(2007-12#1)(2008-2#1)
collimating##8##1##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
collimation and##4##2##(2007-11#1)(2008-3#3)
collimation of the##2##3##(2008-2#1)(2008-3#1)
collimation of##6##2##(2008-2#2)(2008-3#3)(2008-7#1)
collimation##19##1##(1993-9#1)(1994-8#1)(2007-11#1)(2008-2#4)(2008-3#9)(2008-7#3)
collimator arrays##2##2##(2008-10#2)
collimator can##2##2##(2008-2#2)
collimator##12##1##(1996-2#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#4)
collimators for##2##2##(2008-3#2)
collimators##10##1##(2008-2#1)(2008-3#7)(2009-8#2)
collinear configuration##3##2##(2007-12#2)(2008-3#1)
collinear pump##2##2##(2007-12#1)(2008-3#1)
collinear##27##1##(2007-11#5)(2007-12#8)(2008-10#6)(2008-2#1)(2008-3#5)(2009-9#1)(2013-1#1)
collinearity##2##1##(2008-10#1)(2008-7#1)
collinearly propagating##2##2##(2007-11#1)(2007-12#1)
collision complex##2##2##(1992-5#1)(2008-3#1)
collision fraction##2##2##(2012-12#2)
collision induced dissociation (CID)##2##4##(2008-10#2)
collision induced dissociation##3##3##(2008-10#3)
collision of##4##2##(1994-1#1)(2007-12#1)(2008-10#1)(2010-5#1)
collision rates##2##2##(2008-8#2)
collision with a##2##3##(2009-11#1)(2012-12#1)
collision##38##1##(1991-9#1)(1992-5#1)(1993-3#4)(1994-1#1)(1995-5#1)(1997-5#1)(2007-12#4)(2008-10#14)(2008-11#1)(2008-3#2)(2008-8#2)(2009-11#1)(2010-5#1)(2012-12#4)
collision-induced absorption##2##2##(2008-11#1)(2008-3#1)
collision-induced dissociation##4##2##(2008-10#3)(2011-1#1)
collision-induced##8##1##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
collisional deactivation of##2##3##(2008-2#2)
collisional quenching##2##2##(1997-2#1)(2008-2#1)
collisional##10##1##(1991-9#1)(1997-2#2)(2008-2#6)(2008-3#1)
collisions##21##1##(1990-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-2#1)(1997-6#2)(2007-12#7)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
collocated##7##1##(2008-10#1)(2008-2#2)(2008-3#4)
colloid analysis by single particle inductively coupled plasma-mass spectrometry##2##9##(2008-10#2)
colloid analysis##3##2##(2008-10#3)
colloid cyst of the third ventricle##3##6##(2008-7#3)
colloid cyst##6##2##(2008-7#5)(2011-2#1)
colloid cysts of##2##3##(2008-7#1)(2012-12#1)
colloid cysts##4##2##(2008-7#3)(2012-12#1)
colloid mixing##2##2##(2010-5#2)
colloid precipitate flotation##2##3##(2008-10#2)
colloid precipitate##3##2##(2008-10#3)
colloid resorption was##2##3##(2008-7#2)
colloid##44##1##(1990-6#1)(1990-8#1)(1991-11#2)(1994-2#2)(1997-1#1)(2007-11#1)(2007-12#5)(2008-10#12)(2008-2#5)(2008-7#10)(2010-5#2)(2011-2#1)(2012-12#1)
colloidal Au nanoparticles and##2##4##(2008-10#2)
colloidal PbSe nanocrystals were##2##4##(2013-8#2)
colloidal PbSe nanocrystals##5##3##(2013-8#5)
colloidal PbSe##6##2##(2013-8#6)
colloidal and particulate##2##3##(2008-10#2)
colloidal and##6##2##(1992-5#1)(2008-10#5)
colloidal chitin##4##2##(2008-10#4)
colloidal crystal##2##2##(2007-12#2)
colloidal dispersions##2##2##(2008-9#1)(2010-4#1)
colloidal gold particles##2##3##(1992-12#1)(2007-12#1)
colloidal gold##6##2##(1992-12#1)(2007-12#1)(2008-10#2)(2010-6#1)(2011-2#1)
colloidal graphite##2##2##(2008-3#2)
colloidal material##2##2##(2008-10#2)
colloidal particle in the plasma torch can be detected and measured##2##11##(2008-10#2)
colloidal particle##3##2##(2008-10#3)
colloidal particles were added##2##4##(2008-2#2)
colloidal particles##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
colloidal semiconductor##4##2##(2008-10#1)(2008-7#1)(2008-8#2)
colloidal silica##2##2##(1995-2#1)(2013-1#1)
colloidal silver##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
colloidal stability##2##2##(2008-12#1)(2010-4#1)
colloidal suspension##3##2##(2008-10#3)
colloidal suspensions##2##2##(2007-11#1)(2008-3#1)
colloidal##82##1##(1990-6#1)(1992-12#1)(1992-5#1)(1995-2#1)(1997-1#1)(2007-11#3)(2007-12#5)(2008-10#33)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#6)
colloidal-gold cysteamine-modified##2##2##(2008-10#2)
colloids in a single particle analysis mode##2##7##(2008-10#2)
colloids in##4##2##(2008-10#3)(2008-3#1)
colloids with##4##2##(2008-10#4)
colloids##24##1##(2008-10#15)(2008-2#1)(2008-3#4)(2010-4#1)(2011-2#2)(2013-8#1)
colloids)##2##1##(2008-10#2)
coloanal anastomosis##2##2##(2007-8#2)
colobine##2##1##(2011-2#2)
colocalised##3##1##(1993-6#1)(1997-3#2)
colocalization of octopamine with##2##4##(1994-2#2)
colocalization of##8##2##(1993-12#1)(1994-2#2)(1997-2#2)(2008-4#2)(2011-2#1)
colocalization with##2##2##(1994-8#1)(2010-5#1)
colocalization##15##1##(1993-12#1)(1994-2#2)(1994-8#1)(1997-2#3)(2008-11#1)(2008-4#3)(2010-5#2)(2011-2#2)
colocalized with##4##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
colocalized##10##1##(1993-12#1)(1995-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2013-8#1)
colocalizes with##2##2##(1994-12#1)(1995-6#1)
colocated##2##1##(2008-2#1)(2008-3#1)
colon (SW1222##2##2##(2008-11#2)
colon adenocarcinoma##4##2##(1990-12#1)(1992-8#1)(1993-2#1)(2008-11#1)
colon adenocarcinoma)##2##2##(2008-11#2)
colon and breast cancer##3##4##(1991-3#1)(1992-8#1)(2008-5#1)
colon and rectal cancer##3##4##(1992-8#1)(2011-2#2)
colon and rectum##10##3##(1991-2#1)(1991-6#2)(1992-8#1)(1993-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
colon and the##2##3##(2008-12#1)(2012-12#1)
colon and##28##2##(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-8#3)(1993-9#1)(1994-12#1)(1995-6#2)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-10#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
colon cancer are##2##3##(2007-8#1)(2010-8#1)
colon cancer cell lines##5##4##(1990-6#1)(1994-8#2)(1997-7#1)(2008-11#1)
colon cancer cell##9##3##(1990-6#1)(1992-8#2)(1993-3#1)(1994-8#2)(1997-2#1)(1997-7#1)(2008-11#1)
colon cancer cells##11##3##(1990-8#1)(1992-8#1)(1993-3#1)(1994-8#2)(1995-2#1)(2009-9#1)(2011-2#3)(2013-1#1)
colon cancer in##5##3##(1990-6#1)(1991-6#1)(1997-4#1)(2006-8#1)(2011-2#1)
colon cancer mortality rates##2##4##(1993-12#1)(2008-5#1)
colon cancer mortality##4##3##(1993-12#2)(2008-5#2)
colon cancer patients##3##3##(1992-12#1)(2009-4#1)(2012-3#1)
colon cancer screening##2##3##(2008-1#1)(2011-2#1)
colon cancer were##2##3##(1993-9#1)(1997-4#1)
colon cancer##86##2##(1990-6#2)(1990-8#3)(1991-3#3)(1991-6#2)(1992-12#1)(1992-8#4)(1993-11#3)(1993-12#3)(1993-3#2)(1993-9#3)(1994-3#1)(1994-8#4)(1995-12#1)(1995-2#1)(1995-9#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-8#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-11#6)(2009-12#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
colon cancers##2##2##(2008-1#2)
colon carcinogenesis##2##2##(1995-9#1)(2010-6#1)
colon carcinoma cell##5##3##(1992-3#2)(1992-9#2)(1993-8#1)
colon carcinoma cells##3##3##(1994-8#1)(1995-5#1)(2008-4#1)
colon carcinoma in##2##3##(2006-8#2)
colon carcinoma##20##2##(1990-8#1)(1992-10#1)(1992-3#2)(1992-9#2)(1993-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(2006-8#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)
colon cell##2##2##(1992-2#1)(1992-9#1)
colon cells of##2##3##(1997-4#2)
colon cells##10##2##(1997-4#9)(2013-1#1)
colon epithelial cells##2##3##(2010-1#2)
colon examinations##2##2##(1997-8#2)
colon in comparison##2##3##(1991-6#1)(2006-8#1)
colon in##5##2##(1991-6#2)(2006-8#2)(2008-5#1)
colon lamina propria##3##3##(2008-11#3)
colon mucosa##2##2##(1991-12#1)(2008-3#1)
colon polyps##5##2##(1990-8#1)(2008-3#2)(2008-4#1)(2009-12#1)
colon segment##2##2##(1990-3#1)(2008-10#1)
colon tissue##5##2##(1997-4#1)(2008-11#1)(2008-3#1)(2011-1#2)
colon tumorigenesis##2##2##(1990-6#1)(1992-8#1)
colon was##4##2##(2008-11#1)(2008-12#1)(2009-1#1)(2011-2#1)
colon with a##2##3##(1990-3#1)(2007-12#1)
colon with##3##2##(1990-3#1)(2007-12#1)(2008-11#1)
colon##329##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#4)(1990-6#4)(1990-8#7)(1990-9#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-4#3)(1991-5#1)(1991-6#9)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#7)(1992-3#2)(1992-6#2)(1992-8#10)(1992-9#4)(1993-11#7)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#4)(1993-9#12)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-8#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#6)(1996-5#1)(1997-2#1)(1997-4#20)(1997-5#1)(1997-7#1)(1997-8#3)(2006-8#11)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#8)(2008-10#7)(2008-11#21)(2008-12#15)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#6)(2009-12#7)(2009-4#2)(2009-5#3)(2009-9#1)(2010-1#2)(2010-12#3)(2010-6#5)(2010-8#1)(2011-1#4)(2011-2#21)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
colon/rectum##2##1##(1990-9#1)(1991-2#1)
colonial species was##2##3##(2008-8#2)
colonial##14##1##(1995-9#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-11#1)(2009-8#2)(2010-1#4)(2011-2#1)
coloniality and##2##2##(2008-9#2)
coloniality##7##1##(2008-9#7)
colonic and##2##2##(1997-8#1)(2013-1#1)
colonic cancer##2##2##(1994-9#1)(2012-2#1)
colonic carcinoma##3##2##(1990-7#1)(2009-1#2)
colonic cell line##2##3##(1994-3#2)
colonic cells##2##2##(1992-9#1)(1993-9#1)
colonic diverticulitis##7##2##(2009-8#3)(2010-8#3)(2012-2#1)
colonic diverticulosis##2##2##(1990-11#1)(2010-8#1)
colonic epithelial cell scrapings of##2##5##(2008-10#2)
colonic epithelial##4##2##(1993-8#1)(2008-10#2)(2013-1#1)
colonic lesions##2##2##(1991-6#1)(1997-8#1)
colonic lipoma##3##2##(1993-9#1)(2008-10#2)
colonic lipomas are##2##3##(1993-9#1)(2008-10#1)
colonic mucosa of##2##3##(1992-8#1)(2008-3#1)
colonic mucosa##9##2##(1992-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#3)(2011-3#1)
colonic mucosal##4##2##(1990-6#1)(1991-12#1)(2011-2#1)(2012-2#1)
colonic perforation##2##2##(2011-2#2)
colonic polyps and##2##3##(2009-1#1)(2012-3#1)
colonic secretory cells##2##3##(2008-8#2)
colonic tissue##2##2##(1995-12#2)
colonic tumour##3##2##(1993-9#3)
colonic##107##1##(1990-11#1)(1990-6#3)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-6#3)(1992-10#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-5#1)(1993-8#1)(1993-9#11)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#2)(1995-3#1)(1996-5#2)(1997-8#2)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-1#4)(2009-12#3)(2009-8#3)(2010-12#4)(2010-8#5)(2011-1#1)(2011-2#10)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#2)
colonies adjust##2##2##(2008-8#2)
colonies and the##2##3##(2007-5#1)(2008-10#1)
colonies and##8##2##(1991-3#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#1)
colonies are##3##2##(2008-10#1)(2008-6#1)(2009-2#1)
colonies by##5##2##(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)
colonies formed##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
colonies from the##2##3##(2008-8#1)(2012-3#1)
colonies from##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
colonies grown on##2##3##(2008-11#2)
colonies in##6##2##(1994-8#1)(2008-11#1)(2008-6#2)(2008-8#1)(2013-1#1)
colonies of the##6##3##(1995-6#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
colonies of##10##2##(1995-6#1)(1996-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-5#1)
colonies on berries##2##3##(2008-10#2)
colonies on##9##2##(1993-12#1)(1997-4#2)(2007-7#1)(2008-10#4)(2008-11#1)
colonies per leaf##3##3##(2008-10#3)
colonies that##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
colonies was##6##2##(1997-3#1)(2008-10#4)(2008-8#1)
colonies were counted##2##3##(1994-11#1)(2008-10#1)
colonies were isolated from##2##4##(1992-9#2)
colonies were recovered from##2##4##(2008-10#2)
colonies were screened for their##2##5##(1990-5#1)(2012-2#1)
colonies were stained##2##3##(1997-8#1)(2008-10#1)
colonies were##19##2##(1990-5#1)(1992-9#2)(1994-11#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
colonies##176##1##(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-9#2)(1992-9#2)(1993-12#2)(1993-8#1)(1994-11#3)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#2)(1996-11#2)(1997-3#5)(1997-4#3)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-10#50)(2008-11#8)(2008-2#2)(2008-5#6)(2008-6#7)(2008-7#1)(2008-8#22)(2008-9#12)(2009-2#4)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-2#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
colonisation of the##2##3##(2006-6#1)(2008-11#1)
colonisation##5##1##(2006-6#2)(2008-11#1)(2008-7#1)(2011-2#1)
colonization and infection of##2##4##(2008-10#1)(2011-2#1)
colonization and infection##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
colonization and##20##2##(1991-12#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
colonization as##2##2##(2008-10#2)
colonization at##2##2##(2008-10#2)
colonization between##2##2##(1996-4#1)(2008-10#1)
colonization by both##3##3##(2008-10#3)
colonization by the fungus##2##4##(2008-10#2)
colonization by the##7##3##(2008-10#6)(2008-5#1)
colonization by##36##2##(1992-9#4)(2008-10#26)(2008-5#2)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
colonization events##3##2##(1996-6#2)(2013-1#1)
colonization in the##2##3##(2008-10#2)
colonization in##11##2##(2007-12#1)(2008-10#10)
colonization is##2##2##(2008-11#1)(2008-9#1)
colonization occurred##2##2##(2008-10#2)
colonization of apple##2##3##(2008-10#2)
colonization of dead##2##3##(2008-10#2)
colonization of leaf##2##3##(2008-10#2)
colonization of leaves and##2##4##(2008-10#2)
colonization of leaves##4##3##(2008-10#4)
colonization of plant roots##2##4##(2008-10#2)
colonization of potato##2##3##(2008-10#2)
colonization of roots by##2##4##(2008-10#2)
colonization of roots##5##3##(2008-10#5)
colonization of the host##3##4##(2008-10#3)
colonization of the root##2##4##(2008-10#2)
colonization of the##13##3##(2008-10#10)(2008-5#1)(2011-1#1)(2013-1#1)
colonization of tomato##3##3##(2008-10#3)
colonization of wounds##2##3##(2008-10#2)
colonization of##69##2##(1991-3#1)(1997-3#1)(2008-10#58)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#4)
colonization on the##2##3##(2008-10#1)(2008-12#1)
colonization on##5##2##(2008-10#4)(2008-12#1)
colonization or infection and##2##4##(2008-11#1)(2009-8#1)
colonization probabilities##4##2##(2008-8#4)
colonization probability##2##2##(2008-8#2)
colonization rate was##2##3##(2013-8#2)
colonization rate##4##2##(2008-10#1)(2013-8#3)
colonization strategies##3##2##(2008-10#3)
colonization was observed##3##3##(2008-10#3)
colonization was##21##2##(2007-6#1)(2008-10#17)(2008-8#1)(2009-6#1)(2010-8#1)
colonization were##6##2##(2007-7#1)(2008-10#5)
colonization when##2##2##(2008-10#2)
colonization with##4##2##(1991-3#1)(2007-6#1)(2008-10#2)
colonization##284##1##(1991-12#1)(1991-3#2)(1992-9#5)(1996-2#1)(1996-4#2)(1996-6#2)(1997-1#1)(1997-3#1)(2007-12#2)(2007-6#3)(2007-7#1)(2008-10#187)(2008-11#6)(2008-12#2)(2008-5#9)(2008-7#2)(2008-8#22)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#4)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2013-1#9)(2013-8#6)
colonizations##2##1##(2008-10#1)(2008-2#1)
colonize agronomic crops##2##3##(2008-10#2)
colonize surfaces##2##2##(2008-8#2)
colonize the##10##2##(1992-9#1)(2007-6#3)(2008-10#5)(2011-1#1)
colonize##30##1##(1992-9#1)(2007-6#3)(2008-10#16)(2008-5#1)(2008-8#4)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
colonized a##2##2##(2008-10#2)
colonized areas##2##2##(1997-3#1)(2008-10#1)
colonized by S##3##3##(1991-3#2)(2010-8#1)
colonized by the pathogen##2##4##(2008-10#2)
colonized by the##6##3##(2008-10#6)
colonized by##35##2##(1991-3#3)(1995-8#1)(1997-3#1)(2008-10#26)(2008-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
colonized flowers that opened##2##4##(2008-10#2)
colonized flowers##3##2##(2008-10#3)
colonized root##2##2##(2008-10#2)
colonized roots##2##2##(2008-10#2)
colonized senesced leaves##2##3##(2008-10#2)
colonized the host##2##3##(2008-10#2)
colonized the##10##2##(2008-10#10)
colonized with##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
colonized##95##1##(1991-3#3)(1992-9#1)(1995-8#1)(1997-3#2)(2007-12#3)(2008-10#75)(2008-12#1)(2008-5#1)(2008-9#3)(2010-8#1)(2013-1#3)(2013-8#1)
colonizer and successor species##3##4##(2008-9#3)
colonizer##6##1##(2008-10#2)(2008-9#3)(2011-2#1)
colonizers##7##1##(2008-5#6)(2008-8#1)
colonizes##5##1##(2008-10#4)(2008-5#1)
colonizing##13##1##(1996-6#2)(2007-10#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)
colonnades##2##1##(2007-12#2)
colonoscopic##4##1##(1992-9#1)(2009-12#1)(2011-2#2)
colonoscopies##4##1##(2008-12#2)(2009-7#1)(2011-2#1)
colonoscopy and##2##2##(2008-5#1)(2009-1#1)
colonoscopy in##2##2##(1990-6#1)(2008-1#1)
colonoscopy with##2##2##(2011-2#1)(2013-8#1)
colonoscopy##39##1##(1990-6#2)(1991-6#1)(1993-9#3)(1995-10#3)(1997-8#3)(2008-1#4)(2008-10#1)(2008-3#1)(2008-5#2)(2009-1#1)(2011-2#11)(2012-3#4)(2013-1#1)(2013-8#2)
colons of mice##2##3##(2008-11#1)(2009-9#1)
colons##4##1##(2008-11#2)(2008-4#1)(2009-9#1)
colony and Southern hybridization##2##4##(1996-10#1)(1996-12#1)
colony and##6##2##(1996-10#1)(1996-12#1)(2008-10#2)(2008-5#1)(2009-5#1)
colony blot assay##3##3##(1996-11#3)
colony blot##4##2##(1991-8#1)(1996-11#3)
colony counting method##3##3##(2008-10#3)
colony counts##6##2##(1996-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
colony density##5##2##(2008-10#5)
colony development##3##2##(2008-10#2)(2012-12#1)
colony diameter##2##2##(2008-10#2)
colony formation and##2##3##(2008-10#1)(2012-12#1)
colony formation assay##3##3##(1994-8#1)(2008-11#1)(2012-12#1)
colony formation of##2##3##(1990-2#2)
colony formation on##2##3##(1993-12#1)(2008-8#1)
colony formation##17##2##(1990-12#2)(1990-2#2)(1991-12#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-12#2)
colony forming ability##2##3##(2008-8#2)
colony forming efficiency##3##3##(1992-11#3)
colony forming units (CFU)##2##4##(1996-12#1)(2008-10#1)
colony forming units##6##3##(1996-12#1)(2008-10#3)(2008-5#2)
colony forming##14##2##(1990-12#1)(1992-11#3)(1996-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#2)
colony growth##7##2##(1993-9#1)(1994-8#1)(2008-10#4)(2008-8#1)
colony hybridization##5##2##(1996-10#1)(1996-12#1)(2008-10#3)
colony in##3##2##(2008-5#2)(2008-6#1)
colony losses##3##2##(2008-11#1)(2011-2#2)
colony management##2##2##(2008-2#2)
colony morphologies##2##2##(2008-10#1)(2013-1#1)
colony morphology and##3##3##(2008-10#2)(2009-2#1)
colony morphology##9##2##(2008-10#6)(2008-11#1)(2009-2#1)(2013-1#1)
colony of##6##2##(1996-6#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-4#1)
colony productivity##2##2##(2008-8#2)
colony size##8##2##(1990-3#1)(2008-10#2)(2008-9#5)
colony sizes of##2##3##(1991-12#1)(2012-1#1)
colony sizes##3##2##(1991-12#1)(2008-9#1)(2012-1#1)
colony staining##2##2##(2008-10#1)(2008-11#1)
colony starvation resistance##2##3##(2008-6#2)
colony stimulating factor (GM-CSF)##5##4##(1992-3#3)(1992-8#1)(2008-11#1)
colony stimulating factor##12##3##(1990-5#1)(1991-5#1)(1992-3#3)(1992-8#1)(2007-10#1)(2008-11#2)(2012-2#3)
colony stimulating##14##2##(1990-5#1)(1991-5#1)(1992-3#3)(1992-8#1)(1995-12#2)(2007-10#1)(2008-11#2)(2012-2#3)
colony types##2##2##(1990-7#1)(2008-10#1)
colony##202##1##(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-1#3)(1992-11#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-6#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#53)(2008-11#14)(2008-2#6)(2008-5#7)(2008-6#11)(2008-7#1)(2008-8#12)(2008-9#13)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#4)(2012-5#2)(2013-1#2)(2013-8#3)
colony)##3##1##(1996-2#1)(2008-10#1)(2013-8#1)
colony-forming units##9##2##(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2010-4#2)(2012-2#1)(2013-1#1)(2013-7#1)
colony-forming##17##1##(1992-9#1)(1993-12#2)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
colony-stimulating factor (G-CSF)##5##3##(1994-11#1)(1994-3#1)(2006-10#1)(2008-7#2)
colony-stimulating factor (GM-CSF)##3##3##(1995-6#1)(2008-4#1)(2008-7#1)
colony-stimulating factor##30##2##(1990-5#1)(1991-8#1)(1993-11#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#1)(2006-10#1)(2008-11#5)(2008-4#1)(2008-7#5)(2009-7#2)(2010-6#1)(2012-3#2)(2013-1#1)
colony-stimulating##34##1##(1990-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-11#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#1)(2006-10#1)(2008-11#5)(2008-4#1)(2008-7#6)(2009-7#2)(2010-6#1)(2012-3#2)(2013-1#1)
colopathy##4##1##(2013-8#4)
colophony##3##1##(1997-2#3)
color Doppler##8##2##(1995-3#6)(2007-12#1)(2010-12#1)
color and a##3##3##(2008-1#1)(2008-3#1)(2010-4#1)
color and granularity##2##3##(2011-2#2)
color and odor of##2##4##(2008-5#2)
color and odor##3##3##(2008-5#3)
color and texture##2##3##(2008-6#2)
color and##26##2##(1994-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#7)(2008-5#4)(2008-6#2)(2008-9#1)(2009-8#1)(2010-4#3)(2011-2#2)
color are##2##2##(2008-3#1)(2009-7#1)
color backgrounds (Vitadur Alpha##2##4##(2009-8#2)
color can be##3##3##(1994-5#1)(2008-2#1)(2008-3#1)
color centers in diamond##2##4##(2007-11#1)(2007-12#1)
color centers##9##2##(2007-11#2)(2007-12#3)(2008-3#4)
color change##8##2##(1993-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2010-4#1)
color changes##2##2##(2008-10#1)(2011-1#1)
color charge transfer complex##3##4##(2008-10#3)
color filters##5##2##(2008-3#4)(2008-5#1)
color forming##2##2##(2008-10#2)
color holograms##2##2##(2008-3#2)
color images##4##2##(2007-11#1)(2008-3#2)(2008-5#1)
color in the##4##3##(2008-10#2)(2008-2#2)
color in##8##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-5#1)
color index##3##2##(2008-2#2)(2008-3#1)
color intensity of the##2##4##(2008-10#2)
color intensity of##4##3##(2008-10#4)
color is##8##2##(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#2)(2011-1#2)
color match##2##2##(2007-12#2)
color of a##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
color of the dye##2##4##(1993-11#1)(2008-10#1)
color of the##7##3##(1993-11#1)(2008-10#2)(2008-3#2)(2011-2#1)(2012-3#1)
color of##22##2##(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-8#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
color or gray-scale##2##3##(2012-2#2)
color or##6##2##(2008-10#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#2)
color parameters##2##2##(2010-4#1)(2011-2#1)
color pattern-recognition experiment with##2##4##(2007-11#1)(2008-3#1)
color performance##2##2##(2009-8#2)
color photographs##2##2##(2008-2#2)
color pigment gene cluster##2##4##(1993-3#2)
color pigment gene##3##3##(1993-3#3)
color pigment##5##2##(1993-3#4)(1993-6#1)
color reaction##7##2##(2008-10#7)
color remote sensing##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
color reproduction##3##2##(2008-2#1)(2008-3#2)
color scale##4##2##(1993-6#1)(2008-10#1)(2008-5#1)(2010-2#1)
color scanner##4##2##(2011-1#4)
color separation grating##2##3##(2008-2#1)(2008-3#1)
color separation##7##2##(2008-2#3)(2008-3#4)
color space##3##2##(2008-3#1)(2008-5#1)(2008-6#1)
color stability of##5##3##(2010-3#1)(2012-6#1)(2012-7#2)(2013-1#1)
color stability##6##2##(2009-8#1)(2010-3#1)(2012-6#1)(2012-7#2)(2013-1#1)
color temperature of##2##3##(1995-6#1)(2008-3#1)
color temperature##4##2##(1995-6#1)(2008-3#3)
color that##2##2##(1997-4#1)(2007-12#1)
color transition##2##2##(2008-10#2)
color values##3##2##(2008-6#1)(2010-4#2)
color vision##2##2##(1993-6#1)(2007-5#1)
color was higher (P &lt##2##5##(2010-2#2)
color was##5##2##(2008-10#1)(2008-5#1)(2010-2#2)(2010-4#1)
color with##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
color##357##1##(1990-12#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#1)(1994-12#7)(1994-5#1)(1995-3#6)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-4#2)(2007-10#1)(2007-11#8)(2007-12#16)(2007-5#2)(2008-1#1)(2008-10#58)(2008-11#2)(2008-2#29)(2008-3#86)(2008-4#1)(2008-5#20)(2008-6#18)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#3)(2009-8#13)(2010-1#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#12)(2010-7#1)(2011-1#11)(2011-2#6)(2012-2#8)(2012-3#1)(2012-6#1)(2012-7#2)(2013-1#4)(2013-8#1)
color&quot##2##1##(2008-10#1)(2008-9#1)
color)##3##1##(2008-10#1)(2008-4#1)(2011-1#1)
color-center formation##2##2##(2008-3#2)
color-changing##2##1##(2008-3#2)
color-coded##7##1##(1996-3#1)(2007-10#2)(2008-2#1)(2008-3#2)(2009-6#1)
colorants in##5##2##(2008-10#4)(2008-5#1)
colorants were##2##2##(2008-10#1)(2008-5#1)
colorants##16##1##(2008-10#11)(2008-5#5)
coloration in the##2##3##(2008-6#1)(2008-8#1)
coloration in##3##2##(2008-5#1)(2008-6#1)(2008-8#1)
coloration of##2##2##(2008-10#1)(2012-3#1)
coloration##19##1##(2008-10#4)(2008-5#4)(2008-6#3)(2008-8#4)(2012-3#4)
colorectal adenocarcinoma##6##2##(1991-12#1)(1992-8#1)(2008-11#1)(2008-12#1)(2009-12#1)(2012-12#1)
colorectal adenoma##5##2##(2008-11#2)(2008-7#1)(2010-12#2)
colorectal adenomas and##3##3##(1990-11#2)(1993-9#1)
colorectal adenomas##4##2##(1990-11#2)(1993-9#1)(1995-9#1)
colorectal and breast##2##3##(2008-4#1)(2013-1#1)
colorectal and##5##2##(1991-12#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
colorectal cancer (CRC)##7##3##(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
colorectal cancer and##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
colorectal cancer are##3##3##(1991-3#1)(1992-8#1)(1997-8#1)
colorectal cancer development##2##3##(2011-1#2)
colorectal cancer has##2##3##(1993-9#1)(2009-12#1)
colorectal cancer have##2##3##(2009-12#1)(2010-9#1)
colorectal cancer in the##3##4##(1991-3#1)(1991-6#1)(2010-6#1)
colorectal cancer in##6##3##(1991-3#1)(1991-6#1)(1993-9#2)(2010-6#1)(2011-2#1)
colorectal cancer is##2##3##(1992-9#1)(2008-10#1)
colorectal cancer liver metastases##3##4##(2008-10#2)(2013-1#1)
colorectal cancer liver##4##3##(2008-10#3)(2013-1#1)
colorectal cancer patients##9##3##(1990-2#1)(1990-6#1)(1991-4#2)(1992-12#1)(1997-8#2)(2008-8#1)(2009-4#1)
colorectal cancer prevention##2##3##(1997-8#1)(2007-4#1)
colorectal cancer resistant to fluorouracil##2##5##(1990-2#2)
colorectal cancer screening##3##3##(1995-9#1)(2010-8#1)(2011-2#1)
colorectal cancer syndromes##2##3##(2009-12#2)
colorectal cancer was##4##3##(1991-6#1)(1993-9#2)(1994-2#1)
colorectal cancer were##2##3##(1990-6#1)(1991-4#1)
colorectal cancer##143##2##(1990-12#3)(1990-2#4)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#4)(1991-6#2)(1992-12#1)(1992-2#2)(1992-8#3)(1992-9#2)(1993-12#3)(1993-3#2)(1993-7#1)(1993-9#10)(1994-2#5)(1994-6#2)(1995-10#1)(1995-5#1)(1995-9#3)(1997-4#1)(1997-8#6)(2007-4#3)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2009-12#7)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#11)(2012-2#2)(2012-3#5)(2013-1#9)(2013-8#2)
colorectal cancer]##3##2##(1993-3#1)(2008-10#2)
colorectal cancers##6##2##(2008-12#1)(2008-4#1)(2010-6#2)(2011-1#1)(2013-1#1)
colorectal carcinogenesis##7##2##(1993-9#2)(2007-4#1)(2008-10#1)(2009-9#1)(2011-1#2)
colorectal carcinoma in##2##3##(1992-9#1)(1995-12#1)
colorectal carcinoma were##2##3##(1990-8#1)(1992-8#1)
colorectal carcinoma##29##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-8#7)(1992-9#2)(1993-12#4)(1993-3#1)(1995-12#1)(1995-6#1)(2008-5#1)(2008-8#1)(2009-12#2)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#2)
colorectal carcinomas##5##2##(1991-12#1)(1992-5#1)(1993-9#1)(1994-2#1)(2008-7#1)
colorectal diseases##3##2##(1992-5#1)(2010-12#1)(2011-2#1)
colorectal endometriosis##2##2##(2013-1#2)
colorectal neoplasms##2##2##(1992-5#2)
colorectal polyps##6##2##(1993-9#2)(1997-8#1)(2007-4#1)(2008-11#2)
colorectal surgeons##2##2##(2008-10#1)(2011-2#1)
colorectal surgery using a##2##4##(1992-9#1)(2013-1#1)
colorectal surgery##6##2##(1992-9#1)(2012-1#1)(2013-1#4)
colorectal tumor##2##2##(1995-6#1)(2007-4#1)
colorectal tumorigenesis##2##2##(1993-8#1)(2009-9#1)
colorectal tumors##7##2##(1991-6#1)(1992-9#2)(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
colorectal##276##1##(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#1)(1990-6#2)(1990-8#2)(1991-11#1)(1991-12#4)(1991-3#4)(1991-4#4)(1991-5#1)(1991-6#4)(1992-12#2)(1992-2#2)(1992-5#5)(1992-8#11)(1992-9#10)(1993-12#7)(1993-3#5)(1993-7#1)(1993-8#2)(1993-9#19)(1994-2#6)(1994-6#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-9#4)(1997-4#1)(1997-8#8)(2007-4#6)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#7)(2008-12#4)(2008-4#4)(2008-5#3)(2008-7#7)(2008-8#5)(2009-12#11)(2009-4#3)(2009-8#1)(2009-9#4)(2010-12#6)(2010-6#4)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#17)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#21)(2013-8#2)
colorectum##3##1##(1990-11#1)(2008-4#2)
colored complex with##4##3##(2008-10#4)
colored complex##10##2##(2008-10#10)
colored compound##3##2##(2008-10#3)
colored microspheres##2##2##(2008-10#2)
colored species##2##2##(2008-10#2)
colored##50##1##(1990-2#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-10#34)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#3)
colorful##3##1##(1992-3#1)(2008-2#2)
colorimeter##3##1##(2008-10#3)
colorimetric and##2##2##(2008-10#2)
colorimetric assay##7##2##(1991-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2009-12#1)
colorimetric detection of##4##3##(1992-9#1)(2008-10#2)(2008-4#1)
colorimetric detection##10##2##(1992-9#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-4#1)
colorimetric determination of##4##3##(2008-10#4)
colorimetric determination##7##2##(2008-10#7)
colorimetric flow##3##2##(2008-10#3)
colorimetric method and##2##3##(2008-10#2)
colorimetric method for the##2##4##(1992-12#1)(2008-10#1)
colorimetric method for##3##3##(1992-12#1)(2008-10#2)
colorimetric method using##2##3##(2008-10#2)
colorimetric method##21##2##(1992-12#1)(1993-9#1)(1994-3#2)(2008-1#1)(2008-10#14)(2009-8#1)(2011-3#1)
colorimetric methods##4##2##(2008-1#2)(2008-10#1)(2008-5#1)
colorimetric or##2##2##(2008-10#1)(2009-7#1)
colorimetric reaction##4##2##(2008-1#1)(2008-10#2)(2008-12#1)
colorimetric reagent##5##2##(2008-10#5)
colorimetric##93##1##(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#3)(1995-2#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#5)(2008-10#59)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)
colorimetrically##3##1##(2008-10#2)(2008-5#1)
colorimetry##10##1##(2008-10#9)(2008-5#1)
coloring reagents##2##2##(2008-10#2)
coloring##6##1##(2008-10#2)(2008-3#1)(2008-5#3)
colorless##12##1##(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-10#2)
colors and##4##2##(1995-6#1)(2007-12#1)(2008-5#1)(2008-9#1)
colors are##4##2##(2008-3#2)(2008-6#1)(2012-2#1)
colors of##3##2##(2007-12#1)(2008-1#1)(2008-9#1)
colors##30##1##(1995-6#1)(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#4)(2008-5#4)(2008-6#5)(2008-8#1)(2008-9#3)(2009-10#1)(2012-2#3)
coloscopy were##2##2##(1990-11#2)
coloscopy##4##1##(1990-11#4)
colostomy closure is##2##3##(2010-12#1)(2010-8#1)
colostomy##9##1##(1990-2#1)(1993-6#1)(1993-9#1)(2008-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-8#1)
colostrum and milk##2##3##(2012-2#2)
colostrum##14##1##(1991-11#1)(1994-2#2)(2012-2#11)
colour and##8##2##(2008-10#2)(2008-5#2)(2010-4#3)(2012-2#1)
colour bleaching of methylene blue (MB) in##2##7##(2008-10#2)
colour bleaching##3##2##(2008-10#3)
colour categorization##2##2##(1992-11#2)
colour change##3##2##(2008-10#2)(2008-5#1)
colour developed##2##2##(1990-12#1)(2008-5#1)
colour development##2##2##(2008-10#2)
colour intensity of the##2##4##(2008-10#2)
colour intensity of##3##3##(2008-10#3)
colour intensity##4##2##(2008-10#4)
colour is measured##2##3##(1993-12#1)(2008-10#1)
colour is##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
colour of the solution##2##4##(2008-10#2)
colour of the##8##3##(1995-6#1)(1997-4#1)(2008-10#5)(2010-4#1)
colour of##13##2##(1995-6#1)(1997-4#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)
colour on##2##2##(1990-9#1)(2008-10#1)
colour parameters##2##2##(2010-4#1)(2011-1#1)
colour pattern##3##2##(2010-8#2)(2013-1#1)
colour reaction##4##2##(1993-8#1)(2008-10#3)
colour reactions##2##2##(2008-10#2)
colour systems##2##2##(2008-10#2)
colour was measured##2##3##(2008-10#1)(2008-5#1)
colour was##6##2##(2008-10#2)(2008-5#3)(2010-4#1)
colour##131##1##(1990-12#3)(1990-9#1)(1991-6#1)(1992-11#7)(1992-5#1)(1993-12#1)(1993-8#1)(1995-5#1)(1995-6#5)(1996-5#2)(1997-4#2)(2008-10#43)(2008-12#1)(2008-5#32)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#1)(2010-4#9)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#2)
colour-coded IR imaging##2##3##(2008-7#2)
colour-coded##3##1##(1996-3#1)(2008-7#2)
colouration##2##1##(2008-5#1)(2010-8#1)
coloured complex formed##2##3##(2008-10#2)
coloured complex##6##2##(2008-10#6)
coloured compound##2##2##(2008-10#2)
coloured hair##5##2##(2008-5#4)(2011-1#1)
coloured product##2##2##(2008-10#2)
coloured products##4##2##(1990-5#1)(2008-10#2)(2011-1#1)
coloured##47##1##(1990-5#1)(1991-6#1)(1993-8#1)(1996-5#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-10#28)(2008-5#8)(2009-3#1)(2011-1#3)
colourimetric##3##1##(2008-10#3)
colouring##3##1##(2008-10#1)(2008-5#2)
colourless##7##1##(1993-12#1)(2008-10#5)(2011-2#1)
colours##12##1##(1993-8#1)(1995-6#1)(2008-10#2)(2008-5#5)(2011-1#1)(2013-8#2)
colposcopic examination##2##2##(1996-12#2)
colposcopic##10##1##(1991-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1996-12#4)(2008-4#1)(2012-3#1)
colposcopically##2##1##(1992-10#1)(1994-1#1)
colposcopy and##2##2##(1996-12#1)(2008-11#1)
colposcopy directed biopsy##4##3##(2008-11#4)
colposcopy directed cytology and##2##4##(2008-11#2)
colposcopy directed cytology##3##3##(2008-11#3)
colposcopy directed##8##2##(2008-11#8)
colposcopy in the##2##3##(1990-6#1)(1992-10#1)
colposcopy in##3##2##(1990-6#1)(1992-10#2)
colposcopy##24##1##(1990-6#1)(1992-10#4)(1992-3#3)(1992-8#1)(1994-1#1)(1994-2#1)(1996-12#2)(2008-11#10)(2012-3#1)
colposuspension##3##1##(1994-3#2)(2008-1#1)
colpotomy##2##1##(1994-9#1)(1995-1#1)
colt was##2##2##(2012-3#2)
colt##4##1##(2012-3#4)
colt's##2##1##(2012-3#2)
columbia##4##1##(2008-10#1)(2009-3#2)(2013-1#1)
columbiense##2##1##(2013-7#2)
columella##3##1##(2008-10#1)(2008-11#1)(2009-8#1)
column (100 mm x##2##4##(2011-1#2)
column (150mm x##2##3##(2008-10#2)
column (250 mm x 4##3##5##(1991-5#1)(1997-2#1)(2011-1#1)
column (250 mm##4##3##(1991-5#1)(1997-2#1)(2008-10#1)(2011-1#1)
column (250##5##2##(1991-5#1)(1996-5#1)(1997-2#1)(2008-10#1)(2011-1#1)
column abundance##2##2##(1991-5#1)(2008-2#1)
column after##2##2##(2008-10#1)(2008-4#1)
column allows##2##2##(2007-12#1)(2008-10#1)
column amount##2##2##(2008-3#2)
column amounts##2##2##(2008-2#1)(2008-3#1)
column and a mobile phase of##4##6##(1996-5#1)(2008-10#3)
column and a##11##3##(1991-5#1)(1995-3#1)(1996-5#1)(2008-10#8)
column and an##2##3##(2008-10#2)
column and detected by##2##4##(1990-8#1)(2008-10#1)
column and detected##3##3##(1990-8#1)(2008-10#2)
column and determined by##2##4##(2008-10#1)(2011-1#1)
column and determined##7##3##(2008-10#6)(2011-1#1)
column and eluted##2##3##(1990-12#1)(2008-5#1)
column and gradient elution##2##4##(2008-10#1)(2013-1#1)
column and immunoaffinity##2##3##(2008-10#1)(2008-2#1)
column and subsequently##2##3##(2008-10#2)
column and the##6##3##(1994-8#1)(1995-3#1)(2008-10#4)
column and##61##2##(1990-12#1)(1990-8#2)(1991-5#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-5#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-2#2)(2013-1#1)
column are##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
column as a stationary phase##2##5##(2008-10#2)
column as a##3##3##(2008-10#2)(2008-3#1)
column as##7##2##(1993-11#1)(2008-10#4)(2008-11#1)(2008-3#1)
column at##5##2##(2008-10#4)(2011-2#1)
column before##2##2##(2008-10#2)
column but##2##2##(1992-6#1)(2008-10#1)
column by##6##2##(1990-8#1)(1995-11#1)(2008-10#3)(2011-1#1)
column can##2##2##(2008-10#2)
column capacity##2##2##(2008-10#2)
column chromatographic##2##2##(1997-2#1)(2008-10#1)
column chromatographies on##2##3##(1990-7#1)(1997-4#1)
column chromatographies##4##2##(1990-11#1)(1990-7#1)(1992-8#1)(1997-4#1)
column chromatography and##4##3##(2008-12#1)(2008-8#1)(2011-3#1)(2012-2#1)
column chromatography on##2##3##(2008-8#1)(2009-6#1)
column chromatography using##2##3##(2008-10#1)(2008-11#1)
column chromatography##32##2##(1990-11#2)(1991-12#1)(1992-9#1)(1993-11#2)(1994-11#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
column coated with##3##3##(2008-10#2)(2008-5#1)
column conditioning##2##2##(2008-10#2)
column containing##7##2##(1993-9#1)(2008-10#6)
column could be used##2##4##(2008-10#2)
column could be##4##3##(2008-10#4)
column could##6##2##(2008-10#6)
column filled with Amberlite##2##4##(2008-10#2)
column filled with##3##3##(2008-10#3)
column filled##4##2##(2008-10#4)
column filtration##2##2##(1994-5#1)(2008-4#1)
column followed by##3##3##(1990-2#1)(1992-12#1)(2008-10#1)
column for separation and##2##4##(2008-10#2)
column for separation##3##3##(2008-10#3)
column for the##5##3##(2008-10#5)
column for##14##2##(1990-7#1)(2008-10#11)(2008-3#1)(2011-2#1)
column fractions##2##2##(2008-2#1)(2008-4#1)
column from##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
column has been developed##2##4##(2008-10#2)
column has been##3##3##(2008-10#2)(2008-3#1)
column has##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
column in patients with##2##4##(2008-7#1)(2011-2#1)
column in the presence of##2##5##(1990-8#1)(2008-10#1)
column in the##7##3##(1990-8#1)(2008-10#6)
column in##15##2##(1990-8#2)(1996-5#1)(2008-10#10)(2008-7#1)(2011-2#1)
column is##18##2##(1992-3#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-3#5)(2009-9#2)
column length##4##2##(2008-10#4)
column lengthening##4##2##(2009-10#4)
column liquid chromatography##2##3##(1992-2#1)(2008-10#1)
column maintained at##2##3##(2008-10#2)
column material was##2##3##(2008-10#2)
column material##4##2##(2008-10#4)
column method and##2##3##(2008-10#2)
column method in##2##3##(2008-10#2)
column method##10##2##(2008-10#10)
column of the##2##3##(2008-4#2)
column of##18##2##(1990-8#2)(1993-6#1)(1994-9#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)
column operation##5##2##(2008-10#5)
column or##3##2##(2007-11#1)(2008-10#2)
column ozone retrievals##2##3##(2008-2#2)
column ozone##6##2##(2008-2#6)
column packed with 0##2##4##(2008-10#2)
column packed with a##2##4##(2008-10#2)
column packed with iminodiacetate resin##2##5##(2008-10#2)
column packed with##19##3##(1990-8#1)(2008-10#16)(2008-11#1)(2008-7#1)
column placed##2##2##(2008-10#2)
column preconcentration and##4##3##(2008-10#4)
column preconcentration of##2##3##(2008-10#2)
column preconcentration##11##2##(2008-10#11)
column prior to##3##3##(1997-2#1)(2008-10#2)
column procedure##2##2##(2008-10#1)(2008-6#1)
column reactor##3##2##(2008-10#1)(2008-6#2)
column recovery##2##2##(2008-10#2)
column separation and preconcentration##2##4##(2008-10#2)
column separation##4##2##(2008-10#3)(2008-7#1)
column stationary phase##2##3##(2008-10#2)
column supercritical fluid chromatographic##2##4##(2008-10#2)
column supercritical fluid##8##3##(2008-10#8)
column switching##3##2##(1992-11#1)(2008-10#2)
column system for##2##3##(2008-10#2)
column system using##2##3##(1990-11#1)(2008-10#1)
column system was##3##3##(2008-10#3)
column system##9##2##(1990-11#1)(2008-10#8)
column technique##5##2##(2008-10#5)
column techniques##4##2##(2008-10#4)
column temperature and##2##3##(2008-10#1)(2011-1#1)
column temperature was##2##3##(2011-1#2)
column temperature##16##2##(2008-10#13)(2011-1#3)
column to separate##2##3##(2008-10#1)(2008-4#1)
column to the##3##3##(2007-8#1)(2008-11#1)(2008-6#1)
column to##10##2##(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
column used##3##2##(2008-10#3)
column using a mixture of 0##2##6##(2008-10#2)
column using a##5##3##(1995-6#1)(2008-10#4)
column using anti-solamargine monoclonal antibody##2##5##(2008-11#2)
column using##21##2##(1995-6#1)(1996-5#2)(2008-10#13)(2008-11#3)(2008-6#1)(2010-4#1)
column was able to##2##4##(2008-10#2)
column was used##2##3##(2008-10#2)
column was##28##2##(1990-8#1)(1992-6#1)(2007-11#1)(2008-10#24)(2008-11#1)
column were##5##2##(1996-5#1)(2007-5#1)(2008-10#3)
column where##2##2##(2008-10#2)
column which is##2##3##(2008-10#1)(2008-5#1)
column which##3##2##(2008-10#2)(2008-5#1)
column will##2##2##(1993-1#1)(1995-1#1)
column with 0##4##3##(1990-12#1)(2008-10#3)
column with 5##3##3##(2008-10#3)
column with a 0##2##4##(2008-10#2)
column with a gradient##2##4##(2008-10#2)
column with a mobile phase##3##5##(2008-10#3)
column with a##14##3##(1990-8#3)(1995-3#1)(2008-10#9)(2008-3#1)
column with gradient elution##4##4##(2008-10#3)(2011-1#1)
column with the mobile phase##3##5##(2008-10#1)(2011-1#1)(2011-3#1)
column with the##5##3##(1992-12#1)(2008-10#1)(2011-1#2)(2011-3#1)
column with##51##2##(1990-12#1)(1990-8#3)(1991-11#1)(1992-12#1)(1995-3#1)(1997-2#1)(2008-10#35)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#3)(2011-3#1)
column##899##1##(1990-11#8)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#4)(1990-8#25)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#9)(1991-7#2)(1991-8#2)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#4)(1993-2#2)(1993-6#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#9)(1995-6#2)(1996-12#1)(1996-5#13)(1997-2#13)(1997-4#3)(1997-6#1)(2006-10#1)(2007-11#7)(2007-12#3)(2007-2#12)(2007-5#1)(2007-8#3)(2008-10#524)(2008-11#17)(2008-12#3)(2008-2#20)(2008-3#32)(2008-4#13)(2008-5#9)(2008-6#13)(2008-7#6)(2008-8#9)(2008-9#4)(2009-10#4)(2009-12#1)(2009-6#2)(2009-8#4)(2009-9#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2011-1#16)(2011-2#11)(2011-3#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#1)
column)##3##1##(2008-10#2)(2008-3#1)
column-FIA system##2##2##(2008-10#2)
column-coupling##2##1##(2008-10#2)
column-switching technique##2##2##(1992-11#2)
column-switching techniques##2##2##(1992-11#1)(2008-10#1)
column-switching##9##1##(1990-8#1)(1992-11#3)(2008-10#5)
columnar aerosol##3##2##(2008-2#3)
columnar and layered##2##3##(2007-12#2)
columnar and##3##2##(2007-12#3)
columnar growth##2##2##(2008-3#1)(2010-4#1)
columnar liquid##2##2##(2008-7#2)
columnar##24##1##(1990-6#1)(1991-2#2)(2007-12#4)(2008-2#5)(2008-3#4)(2008-7#4)(2008-8#1)(2009-10#1)(2010-4#1)(2012-3#1)
columnar-lined mucosa##3##2##(2009-3#3)
columnar-lined##5##1##(1996-8#1)(2009-3#4)
columnare##7##1##(2008-9#3)(2013-1#4)
columns and plates##2##3##(2007-12#1)(2008-3#1)
columns and##15##2##(1990-11#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2010-8#1)(2013-1#1)
columns are##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
columns at##2##2##(1992-6#1)(2008-10#1)
columns by##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
columns could be##2##3##(2008-10#2)
columns for the##2##3##(1997-2#1)(2008-10#1)
columns for##7##2##(1997-2#2)(2008-10#4)(2008-3#1)
columns has been##3##3##(2008-10#2)(2008-11#1)
columns has##4##2##(1994-11#1)(2008-10#2)(2008-11#1)
columns have##2##2##(2008-10#2)
columns in the##2##3##(2008-11#1)(2009-5#1)
columns in##9##2##(1990-8#1)(2008-10#1)(2008-11#4)(2008-2#1)(2009-5#2)
columns is##2##2##(1997-2#1)(2008-10#1)
columns may##2##2##(2008-11#2)
columns of##10##2##(1992-12#1)(1994-1#1)(1996-5#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-2#1)
columns or##3##2##(1992-6#1)(1994-11#1)(2008-4#1)
columns packed with##2##3##(2008-10#2)
columns to the##2##3##(2008-3#2)
columns to##3##2##(2008-10#1)(2008-3#2)
columns together##2##2##(2008-10#1)(2011-1#1)
columns under the same##2##4##(2008-10#1)(2008-7#1)
columns using##2##2##(2008-10#1)(2008-3#1)
columns was##2##2##(1990-8#1)(2008-10#1)
columns were tested and similar##2##5##(2008-10#2)
columns were tested##3##3##(2008-10#3)
columns were##13##2##(1990-8#1)(2008-10#10)(2011-1#1)(2013-1#1)
columns with##6##2##(1996-2#1)(2008-10#3)(2008-3#2)
columns##185##1##(1990-11#1)(1990-5#1)(1990-8#5)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-7#1)(1992-9#2)(1994-1#1)(1994-11#2)(1994-3#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-2#5)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#87)(2008-11#9)(2008-2#4)(2008-3#18)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#3)(2009-5#5)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
columns)##2##1##(1990-8#1)(1994-9#1)
colymycin M and##2##3##(2008-10#2)
com##9##1##(2007-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2012-12#1)(2013-7#1)
com)##5##1##(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
com/locate/withdrawalpolicy)##8##1##(2008-10#4)(2008-11#4)
coma aberration##4##2##(2008-3#4)
coma and##7##2##(1993-6#1)(2008-11#1)(2008-3#4)(2008-7#1)
coma in##3##2##(1990-9#1)(2008-2#1)(2009-8#1)
coma of##2##2##(1990-9#1)(2008-3#1)
coma or##2##2##(1991-9#1)(2011-1#1)
coma with##2##2##(1991-8#1)(2008-1#1)
coma##54##1##(1990-9#5)(1991-11#2)(1991-12#1)(1991-8#4)(1991-9#1)(1993-6#2)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#15)(2008-7#7)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
coma)##2##1##(1997-2#2)
comatose##3##1##(2008-7#3)
comb generation##3##2##(2007-12#3)
comb is##4##2##(2007-12#4)
comb of##2##2##(2007-12#1)(2008-3#1)
comb##35##1##(2007-11#2)(2007-12#22)(2008-3#8)(2008-5#1)(2011-2#1)(2012-3#1)
comb-shaped##2##1##(1993-11#2)
combability and##2##2##(2008-5#2)
combat operations##2##2##(2011-2#1)(2012-2#1)
combat##45##1##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-12#4)(2012-2#7)(2013-1#3)(2013-8#2)
combating the##2##2##(2007-6#1)(2012-2#1)
combating##7##1##(2007-6#1)(2008-1#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
combatting##2##1##(1995-5#1)(2007-7#1)
combi 40+##2##2##(2008-9#2)
combi##4##1##(2008-9#4)
combinability##2##1##(2007-7#1)(2008-10#1)
combination after##2##2##(1992-8#1)(2011-3#1)
combination allows##2##2##(2008-10#1)(2008-3#1)
combination and##2##2##(2010-5#1)(2012-2#1)
combination antifungal therapy##2##3##(2011-2#2)
combination antiviral##2##2##(2006-10#1)(2008-5#1)
combination aperture##3##2##(2007-12#3)
combination are##2##2##(1996-3#1)(2008-3#1)
combination between##2##2##(2008-7#1)(2008-9#1)
combination can be##2##3##(1995-1#1)(2008-10#1)
combination chemotherapies##2##2##(1990-6#1)(2011-2#1)
combination chemotherapy and##2##3##(2008-10#1)(2008-7#1)
combination chemotherapy in##5##3##(1992-12#2)(1993-2#1)(2007-5#1)(2008-7#1)
combination chemotherapy regimens##2##3##(2008-6#1)(2010-4#1)
combination chemotherapy was##2##3##(1991-6#1)(2010-12#1)
combination chemotherapy##22##2##(1991-4#1)(1991-6#2)(1992-10#1)(1992-12#2)(1993-2#1)(1993-8#1)(1994-3#1)(1997-7#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-3#1)(2010-4#1)
combination demonstrated##2##2##(1993-9#1)(2008-10#1)
combination for the##3##3##(1997-2#1)(2008-10#1)(2009-12#1)
combination for##7##2##(1991-4#1)(1994-1#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
combination has##5##2##(1995-5#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-2#1)
combination in the treatment of##2##5##(2008-6#1)(2009-8#1)
combination in the##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
combination in##11##2##(1992-2#1)(1993-3#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2013-8#1)
combination is##9##2##(1990-2#1)(1995-5#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)
combination may##5##2##(2007-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
combination of 6##2##3##(1991-12#1)(2008-2#1)
combination of CPIB##2##3##(1991-4#2)
combination of DTPA and BHT showed##2##6##(2008-5#2)
combination of DTPA and BHT##3##5##(2008-5#3)
combination of Gaussian##2##3##(2008-3#1)(2013-1#1)
combination of Nep1 and P##3##5##(2008-10#3)
combination of PLS##2##3##(2008-10#1)(2013-8#1)
combination of RFA##2##3##(2012-2#2)
combination of V(H)-gp130 and##2##4##(2008-11#2)
combination of a##25##3##(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
combination of agents##2##3##(2011-2#2)
combination of all##2##3##(2011-2#1)(2013-8#1)
combination of an##6##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2011-10#1)
combination of approaches##2##3##(2008-10#1)(2010-11#1)
combination of attenuated total##2##4##(2008-10#1)(2008-5#1)
combination of bioactive##2##3##(2007-12#1)(2010-12#1)
combination of both methods##2##4##(2008-10#1)(2011-2#1)
combination of both##18##3##(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
combination of characteristics##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
combination of clinical signs##2##4##(2010-8#2)
combination of clinical##4##3##(2008-7#1)(2010-8#2)(2013-1#1)
combination of different##3##3##(2007-12#1)(2008-10#2)
combination of diffraction##2##3##(2006-4#1)(2008-2#1)
combination of diverse##2##3##(2008-10#1)(2010-6#1)
combination of doxorubicin##2##3##(1990-10#2)
combination of drugs##3##3##(1991-6#1)(1994-7#1)(2008-5#1)
combination of factors##2##3##(2008-12#1)(2010-6#1)
combination of flow injection##3##4##(2008-10#3)
combination of functional##2##3##(2012-2#2)
combination of gender##2##3##(1990-9#2)
combination of genes##2##3##(2008-9#2)
combination of heparin##2##3##(2008-10#1)(2011-2#1)
combination of high heritability and low reproductive success##2##8##(2012-3#2)
combination of high##6##3##(1995-3#1)(2008-10#2)(2008-12#1)(2012-3#2)
combination of increased##2##3##(2009-12#1)(2013-7#1)
combination of ketamine##2##3##(2009-5#1)(2012-2#1)
combination of low pH and QCT##2##6##(1994-8#2)
combination of low pH and##3##5##(1994-8#3)
combination of low##5##3##(1994-8#3)(2007-12#1)(2012-2#1)
combination of measured##2##3##(2008-3#1)(2011-1#1)
combination of mechanisms##2##3##(2006-12#1)(2009-7#1)
combination of methods##3##3##(2008-11#1)(2008-4#1)(2008-7#1)
combination of methotrexate##2##3##(1995-8#1)(2007-10#1)
combination of molecular##4##3##(1993-8#1)(2007-11#1)(2008-8#1)(2008-9#1)
combination of nonlinear##2##3##(2007-12#1)(2008-8#1)
combination of nurses##2##3##(2008-11#2)
combination of on-line##2##3##(2008-10#2)
combination of optical##2##3##(2008-11#1)(2009-9#1)
combination of procedures##2##3##(2007-8#1)(2008-4#1)
combination of properties##2##3##(1993-1#1)(2008-9#1)
combination of protein##2##3##(2008-5#1)(2009-2#1)
combination of recombinant##2##3##(1991-9#1)(1995-2#1)
combination of reduced##2##3##(2008-7#1)(2008-8#1)
combination of reverse transcription##2##4##(1995-12#1)(2008-10#1)
combination of reverse##3##3##(1995-12#1)(1996-5#1)(2008-10#1)
combination of reversed-phase high-performance liquid chromatography##2##6##(1996-5#1)(2008-10#1)
combination of several##5##3##(1990-8#1)(1991-5#1)(1994-6#1)(2008-9#1)(2011-2#1)
combination of such##2##3##(1991-12#1)(2008-10#1)
combination of surgical##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
combination of techniques##2##3##(2008-10#1)(2008-12#1)
combination of the different##2##4##(1990-12#1)(2008-10#1)
combination of the following##2##4##(2007-11#1)(2013-1#1)
combination of the most##2##4##(1993-11#1)(1997-3#1)
combination of the two##8##4##(1996-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-5#1)(2012-6#1)
combination of the variables##2##4##(1994-3#1)(2012-12#1)
combination of the##66##3##(1990-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#1)(2013-8#2)
combination of these 2##2##4##(2009-1#1)(2013-7#1)
combination of these techniques##2##4##(2008-9#1)(2010-11#1)
combination of these two##3##4##(2008-10#2)(2010-4#1)
combination of these##24##3##(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-7#1)(2013-8#1)
combination of these)##2##3##(1991-8#1)(2010-8#1)
combination of three##4##3##(2008-10#4)
combination of two##13##3##(1994-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2010-5#1)(2012-1#1)(2012-3#1)
combination of unique##2##3##(2008-10#1)(2010-5#1)
combination of##757##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#7)(1990-9#5)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#5)(1992-12#1)(1992-2#2)(1992-3#5)(1992-8#2)(1993-1#2)(1993-11#2)(1993-12#6)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#8)(1997-4#5)(1997-7#3)(1997-8#4)(1997-9#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-10#5)(2007-11#16)(2007-12#21)(2007-3#1)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#129)(2008-11#22)(2008-12#9)(2008-2#15)(2008-3#48)(2008-4#13)(2008-5#27)(2008-6#13)(2008-7#24)(2008-8#22)(2008-9#25)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#7)(2010-12#1)(2010-2#2)(2010-3#8)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#27)(2011-3#3)(2012-1#5)(2012-12#8)(2012-2#16)(2012-3#14)(2012-5#1)(2012-6#1)(2012-9#1)(2013-1#24)(2013-7#2)(2013-8#16)
combination on##2##2##(1996-12#1)(2009-8#1)
combination pharmacological##2##2##(2013-1#2)
combination products##3##2##(1995-5#2)(2012-2#1)
combination provided##2##2##(2008-5#1)(2011-2#1)
combination regimen##2##2##(2008-3#1)(2013-1#1)
combination regimens##6##2##(1994-2#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#2)
combination resulted in##2##3##(1990-5#1)(1992-12#1)
combination significantly##2##2##(2011-2#1)(2012-12#1)
combination therapies##5##2##(2007-10#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
combination therapy (OR##2##3##(2008-6#1)(2010-11#1)
combination therapy for##3##3##(2007-2#1)(2013-1#2)
combination therapy in alcoholism##2##4##(2008-2#2)
combination therapy in pulmonary arterial hypertension##2##6##(2010-10#2)
combination therapy in##5##3##(2008-2#2)(2010-10#3)
combination therapy is##2##3##(2010-10#1)(2010-4#1)
combination therapy may be##2##4##(1997-7#1)(2010-10#1)
combination therapy of##2##3##(2008-6#1)(2013-8#1)
combination therapy was##2##3##(2012-3#1)(2013-1#1)
combination therapy with##9##3##(1992-11#1)(1993-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
combination therapy##45##2##(1992-11#1)(1993-9#1)(1996-11#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#6)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
combination to##10##2##(2007-11#2)(2008-10#4)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)
combination treatment with##3##3##(1992-2#1)(2011-2#1)(2012-2#1)
combination treatment##13##2##(1992-2#1)(1997-5#1)(2008-12#2)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
combination use##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
combination vaccine##3##2##(1995-5#3)
combination vaccines##10##2##(1995-5#9)(2012-12#1)
combination versus##2##2##(2008-6#1)(2011-2#1)
combination was used##2##3##(2008-10#1)(2009-9#1)
combination was##12##2##(2008-10#3)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
combination with a##38##3##(1992-3#1)(1993-12#1)(1994-5#1)(1996-5#1)(2007-12#4)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
combination with conventional##3##3##(2008-3#1)(2010-4#1)(2011-2#1)
combination with high##3##3##(1996-7#1)(2008-10#1)(2008-9#1)
combination with other##16##3##(1991-4#1)(1992-3#1)(1994-9#1)(1995-2#1)(1996-9#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
combination with specific##2##3##(2008-8#1)(2011-1#1)
combination with the##28##3##(1990-8#1)(1992-1#1)(1993-12#1)(1994-2#1)(1995-5#2)(1996-10#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)
combination with these##2##3##(2008-11#1)(2013-7#1)
combination with##311##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#1)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(2006-6#1)(2007-11#3)(2007-12#6)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#54)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#4)(2008-5#18)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#9)(2009-10#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#7)(2012-1#5)(2012-12#3)(2012-2#10)(2012-3#7)(2012-7#1)(2013-1#17)(2013-7#2)(2013-8#4)
combination would##2##2##(2008-10#1)(2010-12#1)
combination##1432##1##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#5)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#10)(1990-9#7)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#1)(1991-4#5)(1991-5#4)(1991-6#8)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#7)(1992-3#9)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#17)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#7)(1993-9#5)(1994-1#2)(1994-11#6)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#3)(1994-8#7)(1994-9#5)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#27)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#5)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#8)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#7)(1997-8#4)(1997-9#1)(2006-10#2)(2006-12#1)(2006-4#3)(2006-6#1)(2007-1#1)(2007-10#9)(2007-11#22)(2007-12#33)(2007-2#2)(2007-3#3)(2007-5#2)(2007-7#13)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#224)(2008-11#38)(2008-12#18)(2008-2#29)(2008-3#73)(2008-4#18)(2008-5#60)(2008-6#27)(2008-7#40)(2008-8#36)(2008-9#38)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#6)(2009-7#2)(2009-8#12)(2009-9#7)(2010-1#4)(2010-10#10)(2010-11#9)(2010-12#9)(2010-2#3)(2010-3#16)(2010-4#9)(2010-5#10)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#22)(2011-10#1)(2011-2#55)(2011-3#5)(2012-1#11)(2012-12#16)(2012-2#34)(2012-3#26)(2012-5#2)(2012-6#2)(2012-7#2)(2012-9#2)(2013-1#60)(2013-7#6)(2013-8#24)
combination)##3##1##(1996-5#1)(2011-2#1)(2012-3#1)
combination]##3##1##(1990-3#1)(1991-3#1)(1991-6#1)
combinational##2##1##(2008-3#1)(2008-7#1)
combinations against##2##2##(2007-7#1)(2008-10#1)
combinations among the##2##3##(2008-10#1)(2008-9#1)
combinations among##3##2##(2008-10#2)(2008-9#1)
combinations and##7##2##(2008-10#3)(2008-12#1)(2009-12#1)(2011-2#2)
combinations are##4##2##(1997-7#1)(2008-3#3)
combinations by##2##2##(2008-10#1)(2008-11#1)
combinations containing##2##2##(2008-10#2)
combinations detected##2##2##(2008-10#1)(2008-4#1)
combinations exhibited##2##2##(2008-8#1)(2009-8#1)
combinations for##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
combinations in the##2##3##(2008-10#1)(2008-12#1)
combinations in##5##2##(1991-1#1)(2008-10#3)(2008-12#1)
combinations of four##2##3##(2008-10#2)
combinations of genes##2##3##(1997-7#1)(2008-8#1)
combinations of parameters##2##3##(2008-8#1)(2008-9#1)
combinations of temperature##3##3##(2008-10#2)(2012-4#1)
combinations of the original##2##4##(2008-10#2)
combinations of the##13##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
combinations of these agents##2##4##(2007-7#1)(2010-4#1)
combinations of these##11##3##(1991-5#1)(1993-1#1)(2007-10#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
combinations of three##3##3##(2008-10#1)(2008-12#1)(2010-4#1)
combinations of treatments##2##3##(2008-10#1)(2009-8#1)
combinations of two##5##3##(1992-12#1)(2007-11#1)(2008-10#2)(2012-2#1)
combinations of##145##2##(1991-12#1)(1991-5#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#10)(2009-12#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#3)
combinations on##2##2##(2008-12#1)(2012-3#1)
combinations that##6##2##(2007-7#1)(2008-10#2)(2008-2#1)(2010-4#1)(2012-3#1)
combinations was##2##2##(2008-10#1)(2008-8#1)
combinations were##4##2##(2008-10#3)(2008-8#1)
combinations with##6##2##(1993-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
combinations##297##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-11#4)(1993-8#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#5)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#86)(2008-11#9)(2008-12#5)(2008-2#6)(2008-3#23)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#18)(2008-9#13)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2012-4#1)(2013-1#9)(2013-8#3)
combinations)##4##1##(2008-10#2)(2008-5#2)
combinatorial and##3##2##(1997-9#1)(2009-8#2)
combinatorial chemistry and HTS##2##4##(2008-10#2)
combinatorial chemistry and high-throughput screening##2##5##(2008-10#2)
combinatorial chemistry and##6##3##(1997-3#1)(2008-10#4)(2008-5#1)
combinatorial chemistry will##2##3##(1997-4#1)(2008-10#1)
combinatorial chemistry##19##2##(1997-3#4)(1997-4#4)(1997-7#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-5#2)
combinatorial interactions##2##2##(1996-3#1)(2009-12#1)
combinatorial libraries##7##2##(1997-3#4)(1997-4#1)(2008-4#2)
combinatorial library##3##2##(2007-12#1)(2008-4#1)(2011-2#1)
combinatorial mutagenesis##2##2##(2009-9#1)(2011-2#1)
combinatorial phage display##2##3##(2008-4#1)(2012-2#1)
combinatorial##67##1##(1994-8#2)(1995-12#1)(1996-3#1)(1997-3#11)(1997-4#5)(1997-7#1)(1997-9#1)(2007-12#2)(2008-1#2)(2008-10#10)(2008-4#7)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#5)(2009-9#1)(2010-4#1)(2011-2#5)(2012-2#2)(2013-1#2)
combinatorially##2##1##(1991-9#1)(2009-6#1)
combine a##6##2##(1995-5#1)(2007-12#1)(2008-3#1)(2009-12#1)(2011-1#1)(2012-12#1)
combine high##3##2##(2008-10#2)(2008-2#1)
combine optical##2##2##(2008-10#1)(2008-2#1)
combine the advantages of each##2##5##(2008-12#1)(2013-1#1)
combine the advantages of##3##4##(2008-12#1)(2008-8#1)(2013-1#1)
combine the##17##2##(1994-12#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#2)(2011-1#1)(2013-1#2)
combine their##2##2##(1993-2#1)(2011-1#1)
combine these##6##2##(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)
combine this##2##2##(2010-4#1)(2013-1#1)
combine to form##2##3##(1997-4#1)(2007-12#1)
combine to##8##2##(1990-8#1)(1991-12#1)(1992-12#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-7#1)(2012-2#1)
combine with the##2##3##(2008-10#1)(2008-4#1)
combine with##5##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
combine##90##1##(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-5#3)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#9)(2008-8#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
combined 24-hr##2##2##(1996-3#2)
combined action of##8##3##(2007-12#2)(2008-10#2)(2008-11#4)
combined activity##2##2##(1995-12#1)(2008-10#1)
combined addition of##3##3##(1990-7#1)(1994-11#1)(2008-11#1)
combined administration of##4##3##(1992-3#1)(1996-2#1)(1997-4#1)(2011-2#1)
combined aerobic and resistance##2##4##(2013-1#2)
combined aerobic and##3##3##(2008-7#1)(2013-1#2)
combined analysis of##4##3##(1996-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
combined and##9##2##(1991-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-3#1)(2012-3#1)
combined anesthesia##5##2##(2011-2#1)(2012-3#4)
combined anterior and posterior##2##4##(2008-9#1)(2009-3#1)
combined anterior/posterior surgical approach##2##4##(2012-3#2)
combined application of##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
combined approach in##2##3##(1990-6#1)(2007-8#1)
combined approach##7##2##(1990-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
combined at##3##2##(1993-11#1)(2008-3#1)(2008-9#1)
combined by##2##2##(2008-3#2)
combined chemometric##2##2##(2008-10#2)
combined chemotherapy##2##2##(2008-10#1)(2011-2#1)
combined compression algorithm##2##3##(2013-8#2)
combined data from##2##3##(2008-10#1)(2011-2#1)
combined data set##5##3##(2008-10#4)(2008-11#1)
combined data##12##2##(2008-10#8)(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
combined diphtheria##2##2##(1992-2#1)(1995-5#1)
combined effect of##12##3##(1990-2#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-4#1)(2013-1#1)
combined effect##13##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
combined effects of##17##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#2)(2011-2#1)
combined effects##18##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#2)(2011-2#1)
combined efficacy of##2##3##(2008-4#1)(2013-8#1)
combined endpoint of##2##3##(1997-4#1)(2007-8#1)
combined endpoint##4##2##(1992-9#2)(1997-4#1)(2007-8#1)
combined exercise training group##2##4##(2013-1#2)
combined exercise##3##2##(2013-1#2)(2013-8#1)
combined exposure of##2##3##(1993-8#1)(2011-1#1)
combined exposure to##2##3##(1993-8#1)(2011-1#1)
combined exposure##5##2##(1993-8#3)(2011-1#2)
combined for##3##2##(2008-10#2)(2008-9#1)
combined gemcitabine##2##2##(2008-10#2)
combined hormone stimulation##2##3##(2009-4#2)
combined imaging##2##2##(2008-3#1)(2012-2#1)
combined immunodeficiency##2##2##(2009-5#1)(2012-12#1)
combined in a##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)
combined in the same##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
combined in the##6##3##(1991-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
combined in##18##2##(1991-2#1)(1992-9#1)(1993-2#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-12#1)
combined influence of##2##3##(2008-10#1)(2010-1#1)
combined influences##2##2##(1997-6#1)(2008-6#1)
combined interventions##2##2##(2009-11#2)
combined into a single##2##4##(2007-12#1)(2009-11#1)
combined into a##3##3##(2007-12#1)(2009-11#1)(2012-1#1)
combined into##4##2##(2007-11#1)(2007-12#1)(2009-11#1)(2012-1#1)
combined lateral##2##2##(2011-2#2)
combined measurements##2##2##(2008-3#1)(2008-6#1)
combined medial plantar and medial pedis free##2##7##(2011-2#2)
combined method of##4##3##(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#1)
combined method##6##2##(2008-10#1)(2008-2#1)(2010-3#1)(2012-3#1)(2013-1#2)
combined methods##4##2##(2008-6#1)(2010-3#2)(2011-2#1)
combined mode##2##2##(2008-5#1)(2013-1#1)
combined molecular##4##2##(2008-10#1)(2008-7#1)(2010-11#1)(2012-3#1)
combined open heart surgery and urologic tumor##2##7##(2007-8#2)
combined open##4##2##(2007-8#2)(2008-9#2)
combined optical##2##2##(2007-12#1)(2008-3#1)
combined pharmacotherapy##2##2##(2006-10#1)(2013-8#1)
combined phase##2##2##(1991-3#1)(2012-2#1)
combined pretreatment##3##2##(2013-1#3)
combined procedure##4##2##(2008-10#1)(2008-11#2)(2009-8#1)
combined procedures##2##2##(2007-8#2)
combined program##2##2##(1995-3#1)(1996-12#1)
combined rates##3##2##(1993-6#1)(2012-12#2)
combined results##8##2##(1990-3#1)(1992-3#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
combined serotonin/norepinephrine reuptake inhibitor##2##4##(2008-4#2)
combined species densities##3##3##(2008-8#3)
combined spinal epidural anaesthesia##2##4##(2007-8#1)(2008-7#1)
combined spinal##3##2##(2007-8#1)(2008-7#2)
combined standard uncertainty of##3##4##(2008-2#1)(2008-3#2)
combined studies##2##2##(1990-8#1)(2013-8#1)
combined supra- and infratentorial##3##4##(2008-7#3)
combined surgery and##3##3##(2008-11#1)(2010-3#1)(2013-1#1)
combined the advantages of##2##4##(2008-10#2)
combined the use of##4##4##(2007-11#1)(2008-10#3)
combined the##14##2##(2007-11#2)(2008-10#8)(2008-8#1)(2012-3#2)(2013-1#1)
combined therapy in##2##3##(2007-10#1)(2008-1#1)
combined therapy##9##2##(1992-6#1)(2007-10#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
combined these##3##2##(2008-3#2)(2013-1#1)
combined to create##2##3##(2008-10#1)(2009-11#1)
combined to produce##2##3##(2008-2#1)(2008-3#1)
combined to##24##2##(1990-12#1)(1991-3#1)(1991-8#1)(1994-11#1)(1994-8#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-1#1)(2013-8#2)
combined together##2##2##(1992-6#1)(2008-2#1)
combined training##3##2##(2013-8#3)
combined treatment for##2##3##(1996-3#1)(2007-8#1)
combined treatment of##6##3##(1991-9#1)(2007-8#1)(2008-5#1)(2008-6#1)(2013-1#2)
combined treatment with##5##3##(1996-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
combined treatment##22##2##(1990-2#1)(1991-9#1)(1992-3#1)(1995-8#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-6#3)(2013-1#3)
combined use of##15##3##(1993-2#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2013-1#1)
combined use##16##2##(1993-2#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2013-1#1)
combined vaccine##2##2##(1995-5#2)
combined vaccines##3##2##(1995-5#3)
combined were##2##2##(2008-6#1)(2009-11#1)
combined with HPLC##2##3##(2008-10#1)(2008-8#1)
combined with a simple##3##4##(1996-12#1)(2007-12#1)(2008-10#1)
combined with a##46##3##(1990-11#1)(1992-3#1)(1995-12#1)(1996-12#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-2#1)
combined with additional##2##3##(2008-3#1)(2008-9#1)
combined with an analysis of the##2##6##(2008-8#1)(2012-2#1)
combined with an##12##3##(1995-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#1)(2012-12#1)(2012-2#1)
combined with atomic##2##3##(2008-10#2)
combined with chemometrics##2##3##(2013-8#2)
combined with chemotherapy##2##3##(1991-2#1)(2010-8#1)
combined with cisplatin##3##3##(2008-6#1)(2009-4#1)(2012-3#1)
combined with corticosteroid##2##3##(2008-1#2)
combined with each other##2##4##(2010-4#1)(2013-1#1)
combined with either##2##3##(2008-3#1)(2008-6#1)
combined with electrothermal##2##3##(2008-10#2)
combined with flow injection analysis##2##5##(2008-10#2)
combined with flow-injection##3##3##(2008-10#3)
combined with gas chromatography##2##4##(2008-10#1)(2008-2#1)
combined with gas##4##3##(2008-10#3)(2008-2#1)
combined with good##2##3##(1993-2#1)(2008-10#1)
combined with heat##2##3##(2007-12#1)(2008-3#1)
combined with inductively coupled plasma mass spectrometry##2##7##(2008-10#2)
combined with involved-field##2##3##(2007-5#1)(2011-2#1)
combined with ion##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
combined with multi-class##2##3##(2013-8#2)
combined with other##11##3##(1993-11#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
combined with our##2##3##(1996-5#1)(2008-10#1)
combined with radiation##2##3##(1993-9#1)(2008-6#1)
combined with radiotherapy##3##3##(1992-8#1)(1997-3#1)(2012-3#1)
combined with solid-phase extraction##2##4##(2008-10#2)
combined with solid-phase##4##3##(2008-10#4)
combined with tandem mass spectrometry##2##5##(1994-12#1)(2008-10#1)
combined with tandem##3##3##(1994-12#1)(2008-10#1)(2011-3#1)
combined with the presence of##2##5##(1995-2#1)(2008-10#1)
combined with the sensitivity of##2##5##(2008-10#2)
combined with the##53##3##(1994-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-1#2)(2007-11#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
combined with tissue plasminogen activator##2##5##(2008-7#2)
combined with various##2##3##(2008-10#2)
combined with##461##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#16)(2007-12#12)(2007-5#1)(2007-7#1)(2007-8#14)(2008-1#6)(2008-10#109)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#28)(2008-4#6)(2008-5#10)(2008-6#12)(2008-7#16)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#16)(2012-7#1)(2013-1#15)(2013-2#1)(2013-8#15)
combined##1144##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#8)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#6)(1995-5#10)(1995-6#2)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#5)(1997-6#2)(1997-7#4)(1997-8#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#5)(2007-11#33)(2007-12#26)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#32)(2008-1#14)(2008-10#220)(2008-11#26)(2008-12#11)(2008-2#31)(2008-3#73)(2008-4#13)(2008-5#22)(2008-6#22)(2008-7#38)(2008-8#21)(2008-9#25)(2009-10#1)(2009-11#7)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#12)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#10)(2011-2#46)(2011-3#3)(2012-1#5)(2012-12#14)(2012-2#20)(2012-3#38)(2012-6#4)(2012-7#1)(2013-1#51)(2013-2#2)(2013-7#1)(2013-8#32)
combined&quot##2##1##(2008-10#2)
combined)##2##1##(1993-5#1)(2011-2#1)
combiner##3##1##(2007-11#1)(2008-3#1)(2010-5#1)
combines a##18##2##(1996-3#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-10#1)(2009-11#1)(2010-6#1)
combines an##5##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
combines both##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
combines conventional##2##2##(1993-2#1)(2008-10#1)
combines in situ##2##3##(2008-6#1)(2008-7#1)
combines optical##2##2##(2007-11#2)
combines spectral##2##2##(2008-3#1)(2013-8#1)
combines the advantages of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
combines the benefits of both##2##5##(2008-5#1)(2008-7#1)
combines the##41##2##(1993-3#1)(1995-1#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-2#1)(2011-1#1)(2012-1#2)(2012-2#1)
combines with##2##2##(2008-10#2)
combines##146##1##(1990-6#1)(1990-7#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#9)(2007-12#9)(2007-6#1)(2007-8#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#22)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#6)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
combing force measurements##2##3##(2008-5#2)
combing##7##1##(2008-5#3)(2008-6#1)(2008-9#3)
combining a##9##2##(2007-12#2)(2008-10#4)(2008-3#1)(2008-7#1)(2011-1#1)
combining ability##2##2##(2008-10#2)
combining an##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
combining biocontrol##2##2##(2008-10#2)
combining both##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2009-9#1)
combining data from##2##3##(2008-7#1)(2011-2#1)
combining data##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
combining different##2##2##(1997-6#1)(2012-3#1)
combining gene##2##2##(2008-5#1)(2013-1#1)
combining mindfulness##2##2##(2013-1#2)
combining of##6##2##(2007-12#3)(2008-10#1)(2012-12#1)(2013-1#1)
combining several##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
combining the two##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2010-11#1)
combining the##32##2##(1992-6#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#4)(2013-8#1)
combining them##2##2##(2008-10#1)(2012-2#1)
combining these##3##2##(1994-2#1)(2008-7#1)(2012-2#1)
combining was##2##2##(2007-12#2)
combining with##3##2##(2008-10#2)(2008-9#1)
combining##185##1##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-2#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#16)(2008-10#39)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
combs##8##1##(2007-11#4)(2007-12#1)(2008-6#3)
combusted##3##1##(1995-6#1)(2008-10#1)(2008-2#1)
combusting##2##1##(2008-2#2)
combustion applications##2##2##(2008-2#1)(2008-3#1)
combustion atmospheres##2##2##(1996-12#2)
combustion diagnostics##3##2##(2008-2#1)(2008-3#2)
combustion engine##2##2##(2008-3#2)
combustion gases with##2##3##(2008-2#2)
combustion gases##9##2##(1996-12#3)(2008-2#6)
combustion method##2##2##(2008-10#2)
combustion of the sample##2##4##(2008-10#2)
combustion of the##3##3##(1995-6#1)(2008-10#2)
combustion of##7##2##(1995-6#1)(2008-10#4)(2008-11#1)(2008-2#1)
combustion product flow##2##3##(2008-2#2)
combustion product##3##2##(1996-12#1)(2008-2#2)
combustion products are##2##3##(1996-12#2)
combustion products##9##2##(1996-12#7)(2008-2#1)(2008-3#1)
combustion systems##2##2##(2008-2#1)(2008-3#1)
combustion to##2##2##(2008-10#1)(2008-11#1)
combustion toxicology##4##2##(1996-12#4)
combustion##90##1##(1995-6#1)(1996-12#24)(2008-10#17)(2008-11#5)(2008-2#24)(2008-3#15)(2010-12#1)(2010-5#2)(2010-7#1)
combustion-emissions##2##1##(2008-2#2)
combustion-generated##2##1##(1996-12#1)(2008-2#1)
come a long way##6##4##(1991-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)
come a##8##2##(1991-1#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)
come about##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)
come at##2##2##(2008-8#1)(2011-2#1)
come back##2##2##(1993-2#1)(2010-9#1)
come from a##2##3##(1996-2#1)(2008-8#1)
come from studies##2##3##(2008-11#1)(2008-7#1)
come from the##7##3##(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
come from##31##2##(1993-12#1)(1995-2#1)(1995-6#1)(1996-2#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
come in contact with##2##4##(1995-11#1)(2012-12#1)
come in##7##2##(1995-11#1)(2006-10#1)(2008-1#1)(2010-8#1)(2010-9#1)(2012-12#2)
come into contact with##3##4##(1997-2#1)(2008-10#1)(2012-12#1)
come into contact##4##3##(1990-11#1)(1997-2#1)(2008-10#1)(2012-12#1)
come into play##2##3##(2007-12#1)(2008-9#1)
come into##16##2##(1990-11#1)(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-1#1)(2012-12#2)(2013-1#1)
come of##3##2##(1992-1#1)(1994-3#1)(2008-11#1)
come the##2##2##(1996-3#1)(2010-6#1)
come to a##5##3##(1993-6#1)(1997-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
come to fruition##2##3##(2010-10#1)(2011-2#1)
come to light##3##3##(2008-6#1)(2009-10#1)(2009-8#1)
come to terms with##2##4##(1995-11#1)(2012-3#1)
come to the##5##3##(1990-2#1)(1992-5#1)(1995-6#1)(2008-3#1)(2012-2#1)
come to##37##2##(1990-2#1)(1991-1#1)(1992-5#1)(1993-1#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
come together in##2##3##(1996-12#1)(2009-10#1)
come together##5##2##(1996-12#1)(2007-12#1)(2008-9#1)(2009-10#1)(2010-11#1)
come with the##3##3##(1991-12#1)(2007-10#1)(2007-5#1)
come with##7##2##(1991-12#1)(1995-1#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-7#1)
come##162##1##(1990-11#1)(1990-2#2)(1990-4#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#3)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
comes a##2##2##(2008-3#1)(2008-9#1)
comes from a##4##3##(1994-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
comes from and##2##3##(2008-10#1)(2011-2#1)
comes from the##8##3##(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
comes from##28##2##(1991-12#1)(1992-12#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
comes in contact with the##2##5##(2008-10#2)
comes in##4##2##(1995-2#1)(2008-10#2)(2009-9#1)
comes into##2##2##(2007-12#1)(2008-5#1)
comes of age##2##3##(1995-2#1)(2010-9#1)
comes the##3##2##(1991-12#1)(1997-3#1)(2009-12#1)
comes to the##3##3##(1995-2#1)(1996-3#1)(2009-11#1)
comes to##16##2##(1991-3#1)(1991-4#1)(1994-12#1)(1995-2#1)(1996-3#2)(1996-9#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-11#2)(2010-12#1)(2011-2#1)
comes##75##1##(1990-2#1)(1990-4#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
comet Shoemaker-Levy 9##2##3##(1995-6#2)
comet assay and##3##3##(1997-4#3)
comet assay as a##3##4##(1997-4#3)
comet assay is##2##3##(1997-4#1)(2010-5#1)
comet assay##28##2##(1997-4#22)(2008-10#2)(2010-5#2)(2013-1#2)
comet length##2##2##(1997-4#2)
comet tail##5##2##(1997-4#3)(2010-5#2)
comet##54##1##(1995-6#2)(1997-4#31)(1997-5#4)(2008-10#4)(2010-5#4)(2010-8#7)(2013-1#2)
comet's##2##1##(1991-3#1)(1991-8#1)
cometabolic##2##1##(2008-7#2)
cometabolism##3##1##(2008-7#3)
comets##4##1##(1995-11#1)(1997-5#2)(2008-10#1)
comfirmed##2##1##(1997-6#1)(2008-6#1)
comfort and##11##2##(1992-3#1)(1992-5#1)(1993-12#1)(2007-10#1)(2007-8#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
comfort in##5##2##(1996-9#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
comfort level##4##2##(1995-1#1)(2007-12#1)(2008-9#2)
comfort levels##2##2##(2008-11#1)(2008-9#1)
comfort of life##3##3##(2007-11#3)
comfort of the##3##3##(1994-1#1)(2007-11#1)(2011-2#1)
comfort of##7##2##(1994-1#1)(2007-11#5)(2011-2#1)
comfort to##2##2##(2007-7#1)(2013-1#1)
comfort##49##1##(1992-3#2)(1992-5#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-9#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)(2009-3#1)(2010-10#1)(2010-3#2)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
comfortable levels##2##2##(2008-9#2)
comfortable with the##3##3##(2007-2#1)(2008-8#1)(2011-2#1)
comfortable with##10##2##(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-11#1)(2011-2#2)
comfortable##35##1##(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#6)(2009-11#1)(2009-5#1)(2011-2#5)(2012-3#2)(2013-1#2)
comfortably##3##1##(2007-10#1)(2008-10#1)(2008-6#1)
comforter##2##1##(1993-12#1)(2008-4#1)
comigrated with the single P##2##5##(2008-10#2)
comigrated with##5##2##(1990-11#1)(1992-12#1)(2008-10#3)
comigrated##7##1##(1990-11#1)(1992-12#1)(1994-8#1)(1995-6#1)(2008-10#3)
comigrating##3##1##(1990-11#1)(2008-10#2)
comigration##2##1##(1993-11#1)(2008-10#1)
coming back##3##2##(1992-5#1)(1997-8#1)(2007-9#1)
coming from different##2##3##(1990-3#1)(2008-10#1)
coming from the same##2##4##(2013-1#2)
coming from the##11##3##(1994-3#1)(1996-4#1)(2008-10#4)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#2)
coming from##30##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-3#1)(1996-1#1)(1996-4#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#3)(2013-8#1)
coming into contact with##2##4##(1995-2#1)(2010-1#1)
coming of age##3##3##(2008-12#1)(2008-9#1)(2010-5#1)
coming of##5##2##(1993-2#1)(2008-12#1)(2008-9#1)(2010-1#1)(2010-5#1)
coming to a##3##3##(1995-8#1)(2008-7#1)(2013-1#1)
coming to the##3##3##(1995-1#1)(2008-7#2)
coming to##13##2##(1991-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2013-1#1)
coming years##7##2##(1993-12#1)(1995-5#1)(1996-1#1)(2006-10#1)(2007-7#1)(2008-7#1)(2012-3#1)
coming##85##1##(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#5)(1996-4#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#2)
command of the##2##3##(1993-3#1)(2012-3#1)
command of##4##2##(1993-3#1)(2008-7#1)(2010-8#1)(2012-3#1)
command##6##1##(1993-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-3#1)
commandments of##2##2##(1995-3#1)(2009-9#1)
commandments##5##1##(1995-3#1)(2008-12#2)(2009-12#1)(2009-9#1)
commands##6##1##(1995-1#1)(2007-12#1)(2011-1#1)(2011-2#3)
comme##4##1##(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
commence##5##1##(1992-9#1)(1994-9#1)(2008-11#1)(2008-5#2)
commenced in##2##2##(2008-1#1)(2008-5#1)
commenced##21##1##(1990-7#1)(1990-9#1)(1991-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#6)(2008-6#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-8#1)(2013-8#1)
commencement of##10##2##(1992-2#1)(1992-9#1)(2007-5#1)(2007-8#2)(2008-6#2)(2008-7#1)(2009-6#1)(2012-12#1)
commencement##12##1##(1992-2#1)(1992-9#1)(2007-5#1)(2007-8#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2012-12#1)
commences##2##1##(2008-7#1)(2012-2#1)
commencing##6##1##(1991-11#1)(1996-12#1)(1996-2#1)(2007-6#1)(2008-11#1)(2008-12#1)
commensal organisms##2##2##(2008-7#1)(2010-4#1)
commensal##13##1##(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)
commensals##2##1##(2011-2#2)
commensurate with the##2##3##(1992-11#1)(2008-10#1)
commensurate with##6##2##(1991-9#1)(1992-11#1)(1994-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
commensurate##11##1##(1990-4#1)(1991-9#1)(1992-11#1)(1994-1#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
comment by##8##2##(2008-3#1)(2010-6#1)(2012-3#6)
comment is##2##2##(2008-3#1)(2010-7#1)
comment of##2##2##(1995-3#1)(2008-8#1)
comment on our##2##3##(2007-12#1)(2009-6#1)
comment on the##5##3##(1993-12#1)(1995-3#1)(2008-3#1)(2008-5#1)(2009-8#1)
comment on##16##2##(1991-12#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-9#1)
comment that##2##2##(2008-12#1)(2008-5#1)
comment to##2##2##(1993-3#1)(1995-8#1)
comment##62##1##(1991-12#1)(1993-12#1)(1993-3#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#2)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#7)(2013-1#1)(2013-8#3)
commentaries##2##1##(2010-2#1)(2013-1#1)
commentary calls for##2##3##(1996-12#1)(2008-11#1)
commentary discusses the##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
commentary discusses##5##2##(1996-2#1)(2008-10#1)(2008-4#1)(2009-11#1)(2013-1#1)
commentary is to##3##3##(2009-5#1)(2011-1#1)(2012-2#1)
commentary on the##3##3##(2008-11#1)(2008-4#1)(2008-6#1)
commentary on##6##2##(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#2)
commentary##57##1##(1992-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#8)(2009-11#1)(2009-5#4)(2010-2#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#5)
commented on##3##2##(1993-3#1)(1997-2#1)(2012-2#1)
commented##9##1##(1991-8#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#1)
comments about##2##2##(1992-3#1)(2008-10#1)
comments by##2##2##(2008-9#1)(2009-9#1)
comments from##2##2##(1992-9#1)(2008-7#1)
comments on a##2##3##(1991-9#1)(1994-1#1)
comments on the##6##3##(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(2008-3#1)
comments on##21##2##(1991-9#1)(1994-1#1)(1994-6#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#2)(2012-3#2)
comments were##4##2##(2007-12#1)(2008-11#2)(2013-7#1)
comments##49##1##(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-1#1)(1994-6#1)(1995-12#1)(1996-1#5)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#4)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
commercial Calimyrna##2##2##(2008-10#2)
commercial TxD##2##2##(2008-10#2)
commercial agriculture##3##2##(2008-10#2)(2011-2#1)
commercial and##7##2##(1991-12#1)(2008-10#3)(2008-11#2)(2008-2#1)
commercial apple orchard##2##3##(2008-10#2)
commercial application of##2##3##(1996-3#1)(2011-2#1)
commercial applications##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
commercial availability of##2##3##(2008-4#1)(2008-5#1)
commercial broiler##2##2##(1997-3#1)(2012-1#1)
commercial camera##2##2##(2008-3#1)(2010-11#1)
commercial citrus plantings##3##3##(2008-10#3)
commercial citrus##5##2##(2008-10#4)(2011-2#1)
commercial composting facilities##2##3##(2008-10#2)
commercial cosmetics##2##2##(2008-5#2)
commercial cultivars##4##2##(2008-10#3)(2008-6#1)
commercial devices##6##2##(2008-10#6)
commercial drinking##4##2##(2008-10#4)
commercial exploitation##2##2##(1994-11#1)(2008-8#1)
commercial fields in##3##3##(2008-10#3)
commercial fields##8##2##(2008-10#7)(2011-2#1)
commercial food##3##2##(1997-4#1)(2008-10#1)(2013-7#1)
commercial formulations containing##2##3##(2008-10#2)
commercial formulations of##2##3##(2008-10#2)
commercial formulations using##2##3##(2008-10#2)
commercial formulations##15##2##(2008-10#14)(2010-5#1)
commercial fruit juices##2##3##(2008-10#2)
commercial fruit##3##2##(2008-10#2)(2011-2#1)
commercial glucose oxidase##2##3##(2008-6#2)
commercial glucose##4##2##(2008-10#2)(2008-6#2)
commercial greenhouse##3##2##(2008-10#3)
commercial greenhouses##4##2##(2008-10#4)
commercial harvest##3##2##(2008-10#2)(2011-2#1)
commercial herbal shampoos##3##3##(2008-5#3)
commercial honey samples##3##3##(2008-10#3)
commercial hybrid##2##2##(2008-10#1)(2008-8#1)
commercial hybrids##2##2##(2008-10#2)
commercial image analysis system##2##4##(2008-10#2)
commercial imaging##2##2##(2007-11#1)(2008-3#1)
commercial importance##3##2##(2008-2#1)(2010-8#1)(2013-7#1)
commercial jet##2##2##(1995-3#2)
commercial kit##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
commercial kits##2##2##(2008-12#1)(2008-4#1)
commercial lettuce##2##2##(2008-10#2)
commercial manufacturing##2##2##(2008-10#2)
commercial mineral waters##2##3##(2008-10#2)
commercial or##3##2##(2008-10#1)(2008-4#2)
commercial orchards##7##2##(2008-10#7)
commercial pharmaceutical preparations##4##3##(2008-10#4)
commercial pharmaceutical products##2##3##(2008-10#2)
commercial pharmaceutical##9##2##(2008-10#9)
commercial pharmaceuticals##2##2##(2008-10#2)
commercial pheasant##2##2##(2007-6#2)
commercial pig##3##2##(2008-7#1)(2008-8#2)
commercial pistachio orchards in##2##4##(2008-10#2)
commercial pistachio orchards##3##3##(2008-10#3)
commercial plant activators##2##3##(2008-10#2)
commercial potato fields in##2##4##(2008-10#2)
commercial potato fields##3##3##(2008-10#3)
commercial potato##6##2##(2008-10#6)
commercial poultry##2##2##(1990-3#1)(2008-6#1)
commercial preparations##3##2##(2008-10#2)(2012-3#1)
commercial producers##2##2##(1997-4#1)(2008-10#1)
commercial product##3##2##(2008-10#3)
commercial production of##5##3##(1994-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
commercial production##7##2##(1994-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
commercial products##8##2##(2008-10#5)(2008-2#1)(2011-1#1)(2012-2#1)
commercial reagents##2##2##(2008-10#2)
commercial sample##4##2##(2008-10#3)(2008-7#1)
commercial samples and##2##3##(2008-10#2)
commercial samples of##4##3##(2008-10#3)(2008-5#1)
commercial samples##15##2##(2008-10#13)(2008-5#2)
commercial scale##3##2##(2007-5#1)(2008-11#1)(2011-2#1)
commercial seed##2##2##(2008-10#2)
commercial sex##2##2##(2009-7#1)(2011-2#1)
commercial software##5##2##(1997-2#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
commercial sources##3##2##(2008-4#1)(2008-5#1)(2013-1#1)
commercial species##2##2##(2007-5#1)(2013-7#1)
commercial stock of chickens##2##4##(2007-6#2)
commercial storage##2##2##(2008-10#2)
commercial strawberry fields in##2##4##(2008-10#2)
commercial tablet##2##2##(2008-10#1)(2010-3#1)
commercial tea##3##2##(2008-10#2)(2012-2#1)
commercial vaccines##3##2##(1997-6#2)(2013-1#1)
commercial vendors##2##2##(2008-3#1)(2008-9#1)
commercial wines##2##2##(2008-10#2)
commercial##549##1##(1990-3#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(2007-11#9)(2007-12#8)(2007-2#2)(2007-5#2)(2007-6#4)(2007-8#1)(2008-1#4)(2008-10#303)(2008-11#7)(2008-12#4)(2008-2#11)(2008-3#20)(2008-4#7)(2008-5#30)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#18)(2011-7#2)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#8)(2013-8#1)
commercialism##2##1##(1990-6#1)(1993-2#1)
commercialization##5##1##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
commercialize##3##1##(2008-5#1)(2008-7#1)(2010-10#1)
commercialized##10##1##(1992-11#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2012-3#1)
commercially and##2##2##(2012-2#1)(2013-1#1)
commercially available InGaAs/InP avalanche photodiodes##3##5##(2008-3#3)
commercially available cosmetic##2##3##(2008-10#1)(2008-5#1)
commercially available enzyme-linked immunosorbent##4##4##(1997-4#1)(2008-10#2)(2010-5#1)
commercially available formulations##2##3##(2008-10#1)(2008-5#1)
commercially available immunochemistry##3##3##(2008-10#3)
commercially available instrument##2##3##(2008-10#1)(2008-9#1)
commercially available instruments##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
commercially available kits##2##3##(2008-2#1)(2012-2#1)
commercially available pharmaceutical##2##3##(2008-10#2)
commercially available products##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
commercially available reagents##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
commercially available##176##2##(1990-12#1)(1990-8#1)(1991-12#2)(1991-3#2)(1992-2#2)(1992-4#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#66)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#14)(2008-4#9)(2008-5#15)(2008-7#4)(2008-8#1)(2008-9#8)(2009-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#4)
commercially grown##2##2##(2008-10#1)(2011-10#1)
commercially important##6##2##(2008-10#2)(2011-1#1)(2013-1#1)(2013-7#2)
commercially produced##2##2##(2008-10#2)
commercially pure titanium##3##3##(2008-11#1)(2009-7#1)(2013-1#1)
commercially relevant##2##2##(2008-11#1)(2011-1#1)
commercially ripe##2##2##(2011-2#2)
commercially used##2##2##(2008-10#2)
commercially viable##2##2##(2012-2#2)
commercially##221##1##(1990-12#1)(1990-8#1)(1991-12#2)(1991-3#2)(1992-11#1)(1992-2#2)(1992-4#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#79)(2008-11#9)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#9)(2008-5#15)(2008-7#4)(2008-8#1)(2008-9#8)(2009-11#1)(2009-7#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#6)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#2)
commercially-available##2##1##(2008-10#1)(2012-2#1)
commercials led to increased##2##4##(2007-12#2)
commercials##7##1##(2007-12#5)(2012-2#2)
comminuted fractures##3##2##(2007-8#2)(2011-2#1)
comminuted##6##1##(2007-8#3)(2008-12#2)(2011-2#1)
commission##4##1##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
commissioned by the##2##3##(1991-2#1)(2008-11#1)
commissioned by##3##2##(1991-2#1)(2008-11#1)(2009-7#1)
commissioned##6##1##(1991-2#1)(1993-12#1)(1994-12#1)(1996-1#1)(2008-11#1)(2009-7#1)
commissioners##2##1##(2008-10#1)(2009-6#1)
commissions and##2##2##(1992-9#1)(1997-2#1)
commissions##7##1##(1992-9#1)(1993-3#1)(1996-1#1)(1996-12#1)(1997-2#2)(2009-5#1)
commissural##5##1##(1991-2#1)(1995-11#1)(1997-2#1)(2008-7#1)(2008-8#1)
commissure and##2##2##(2007-12#2)
commissure or##2##2##(1991-4#1)(2007-12#1)
commissure pioneers##2##2##(2007-12#2)
commissure##17##1##(1991-4#1)(1993-3#1)(1996-7#1)(2007-12#13)(2012-12#1)
commissures##3##1##(2007-12#3)
commit##7##1##(1996-9#1)(2007-2#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#2)
commitment and##10##2##(1990-11#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-12#2)
commitment for##2##2##(1996-1#1)(2012-2#1)
commitment from##2##2##(1993-2#1)(1995-12#1)
commitment in##2##2##(1994-12#1)(2008-11#1)
commitment is##2##2##(1996-1#1)(2008-11#1)
commitment of##5##2##(1992-12#1)(1994-9#1)(2007-11#1)(2008-11#1)(2012-3#1)
commitment on the part of##2##5##(1994-1#1)(1997-3#1)
commitment on##3##2##(1994-1#1)(1996-5#1)(1997-3#1)
commitment regarding##2##2##(2008-11#1)(2013-1#1)
commitment to a##3##3##(1993-2#1)(1997-3#1)(2008-7#1)
commitment to excellence##2##3##(2008-4#1)(2011-2#1)
commitment to provide##2##3##(2008-11#1)(2008-6#1)
commitment to quality##2##3##(1994-1#1)(1995-2#1)
commitment to the##4##3##(1991-2#1)(1995-2#1)(2008-11#1)(2012-2#1)
commitment to##38##2##(1991-2#1)(1992-1#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#5)(1995-1#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#2)(2011-2#3)(2012-2#1)
commitment with##2##2##(1993-3#1)(2011-2#1)
commitment##106##1##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#2)(1993-12#3)(1993-2#6)(1993-3#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#7)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#4)(2007-10#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#8)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#4)(2010-12#2)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)
commitments##6##1##(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2009-9#1)
committed by##3##2##(1996-12#1)(2007-11#1)(2012-12#1)
committed in##2##2##(1995-3#1)(2011-1#1)
committed relationship##2##2##(2012-2#2)
committed to the##3##3##(1992-1#1)(1994-12#1)(2009-7#1)
committed to##19##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(2008-11#1)(2008-5#1)(2009-7#1)(2012-2#1)(2012-3#1)(2012-7#1)
committed##41##1##(1990-8#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)
committee and##2##2##(1996-2#1)(2012-2#1)
committee for##3##2##(1993-3#1)(1994-12#1)(1995-12#1)
committee in##2##2##(1996-5#1)(2008-5#1)
committee of the##4##3##(1993-1#1)(1997-5#1)(2007-9#1)(2008-10#1)
committee of##6##2##(1993-1#1)(1997-3#1)(1997-5#1)(2007-9#1)(2008-10#1)(2012-12#1)
committee on##3##2##(1993-6#1)(1996-3#1)(2008-3#1)
committee was##5##2##(1996-2#1)(2008-10#3)(2008-4#1)
committee##55##1##(1991-12#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1996-2#4)(1996-3#2)(1996-5#1)(1997-3#3)(1997-5#1)(1997-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
committees and##5##2##(1990-3#1)(1994-12#1)(1996-1#1)(1997-2#1)(2012-2#1)
committees for##9##2##(2008-10#8)(2010-3#1)
committees in##4##2##(1991-3#1)(1993-1#2)(2008-5#1)
committees or task forces##2##4##(1992-1#1)(1995-2#1)
committees to##2##2##(1990-2#1)(1995-2#1)
committees##47##1##(1990-2#2)(1990-3#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#3)(1993-1#2)(1993-2#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-11#3)(1997-2#2)(1997-3#1)(2007-11#1)(2008-10#8)(2008-5#2)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
committing suicide##3##2##(1993-9#2)(2008-12#1)
committing##6##1##(1991-3#1)(1993-9#2)(1994-1#1)(2008-12#1)(2008-7#1)
commodities could##2##2##(1996-12#1)(2008-10#1)
commodities##6##1##(1996-12#2)(2008-10#3)(2010-7#1)
commodity##9##1##(1992-1#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-6#1)(2010-7#1)(2012-12#1)
common 5'##2##2##(1993-12#1)(2008-8#1)
common SNPs##5##2##(2012-3#5)
common active##2##2##(1990-5#1)(1991-6#1)
common acute##2##2##(2008-6#1)(2011-2#1)
common additives##2##2##(2008-10#2)
common alleles##2##2##(1997-3#1)(2008-10#1)
common alpha subunit##2##3##(1995-8#2)
common among patients with##2##4##(2007-10#1)(2012-3#1)
common among the##2##3##(2008-10#1)(2011-1#1)
common among##19##2##(1996-11#1)(1997-4#1)(2007-10#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#3)(2013-8#1)
common analytical methods##5##3##(2008-10#5)
common analytical##6##2##(2008-10#5)(2008-2#1)
common ancestor##13##2##(1997-4#1)(1997-6#1)(2008-10#6)(2008-7#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-3#1)
common ancestry##2##2##(1990-2#1)(2008-5#1)
common and appears##2##3##(2007-10#1)(2012-2#1)
common and can result##2##4##(2011-2#1)(2012-2#1)
common and comet##3##3##(2010-8#3)
common and costly##2##3##(2008-3#1)(2012-12#1)
common and destructive##2##3##(2008-10#2)
common and it is##2##4##(2008-6#1)(2008-7#1)
common and often##3##3##(2008-9#1)(2010-7#1)(2010-8#1)
common and rare##2##3##(2008-5#1)(2012-3#1)
common and specific##3##3##(1991-5#1)(2012-2#2)
common and that##2##3##(2008-10#1)(2008-11#1)
common and treatable disease##2##4##(1991-8#1)(2008-1#1)
common and usually##2##3##(2008-11#1)(2008-8#1)
common and##70##2##(1991-5#1)(1991-8#2)(1993-11#1)(1994-2#1)(1996-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#2)(2010-10#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#5)
common anions and##2##3##(2008-10#2)
common anions##4##2##(2008-10#4)
common antigen##2##2##(1993-11#1)(2011-2#1)
common applications##2##2##(2008-4#1)(2008-7#1)
common approach##5##2##(2008-11#2)(2008-2#1)(2013-1#2)
common approaches##2##2##(2008-11#1)(2008-4#1)
common are##2##2##(1993-6#1)(2008-4#1)
common as##7##2##(1992-11#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)
common associated##2##2##(2007-10#1)(2013-1#1)
common at the##3##3##(1997-3#1)(2007-11#1)(2008-10#1)
common background##2##2##(2008-10#1)(2008-7#1)
common bacterial##2##2##(2008-10#1)(2010-8#1)
common bean (Phaseolous vulgaris L##2##5##(2008-12#2)
common bean (Phaseolus vulgaris) plants##2##5##(2008-10#2)
common bean (Phaseolus vulgaris)##9##4##(2008-10#9)
common bean (Phaseolus##11##3##(2008-10#9)(2008-12#2)
common bean gene##2##3##(2008-10#2)
common bean##37##2##(2008-10#32)(2008-12#4)(2013-8#1)
common beans##3##2##(2008-10#1)(2013-8#2)
common belief that##2##3##(1990-12#1)(2008-5#1)
common belief##3##2##(1990-12#1)(2008-2#1)(2008-5#1)
common benign##4##2##(1993-9#1)(2007-8#1)(2008-10#1)(2013-8#1)
common bile duct stones##2##4##(1997-8#2)
common bile duct##16##3##(1990-5#2)(1990-6#1)(1990-9#3)(1991-3#2)(1993-9#1)(1996-11#1)(1997-8#2)(2009-9#2)(2010-12#1)(2013-1#1)
common bile##17##2##(1990-5#2)(1990-6#1)(1990-9#3)(1991-3#2)(1993-9#2)(1996-11#1)(1997-8#2)(2009-9#2)(2010-12#1)(2013-1#1)
common biological##2##2##(2008-4#1)(2009-5#1)
common breast##2##2##(1992-9#1)(1993-1#1)
common cancers##4##2##(1990-8#1)(2008-4#1)(2008-8#1)(2012-2#1)
common carbon##2##2##(2008-10#2)
common carotid arteries##4##3##(2007-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
common carotid artery##6##3##(1996-12#1)(1996-5#1)(2008-7#3)(2009-12#1)
common carotid##12##2##(1996-12#1)(1996-5#1)(1997-8#1)(2007-10#2)(2008-7#4)(2009-12#1)(2011-1#1)(2011-2#1)
common carp (Cyprinus##2##3##(2008-8#1)(2008-9#1)
common carp and##3##3##(2008-12#1)(2008-9#2)
common carp##6##2##(2008-12#1)(2008-8#1)(2008-9#3)(2010-8#1)
common cations and anions##2##4##(2008-10#2)
common cations##4##2##(2008-10#4)
common cause for##4##3##(1990-11#1)(1990-6#1)(2007-7#1)(2008-11#1)
common cause of congenital##2##4##(1997-3#1)(2008-4#1)
common cause of death in##2##5##(1993-9#1)(2007-8#1)
common cause of death##5##4##(1991-6#1)(1993-3#1)(1993-9#1)(2007-8#1)(2008-11#1)
common cause of lower##2##4##(2010-8#1)(2013-1#1)
common cause of renal##3##4##(2007-7#2)(2008-1#1)
common cause of##47##3##(1990-6#1)(1991-6#1)(1993-3#1)(1993-9#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
common cause##55##2##(1990-11#1)(1990-6#2)(1991-6#1)(1993-3#1)(1993-9#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
common causes of##12##3##(1990-3#1)(1990-6#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
common cavity##3##2##(1993-9#1)(2008-7#1)(2008-9#1)
common challenges##2##2##(1993-3#1)(1996-2#1)
common characteristic##2##2##(2008-2#1)(2011-1#1)
common characteristics of##2##3##(2008-10#1)(2011-2#1)
common characteristics##6##2##(1992-11#1)(1997-2#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
common childhood illness##2##3##(2008-11#1)(2010-2#1)
common childhood##5##2##(2008-11#1)(2008-9#1)(2010-2#1)(2011-2#2)
common chromosomal##2##2##(1991-6#1)(2011-3#1)
common chronic##6##2##(1991-2#1)(2008-1#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
common clinical applications##2##3##(2008-8#1)(2010-8#1)
common clinical##17##2##(1991-8#1)(1993-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
common cold##7##2##(1992-3#1)(2008-10#4)(2012-3#1)(2013-8#1)
common complaint##4##2##(1990-6#1)(2008-5#1)(2008-9#1)(2013-8#1)
common complication of##8##3##(1991-6#2)(2007-11#2)(2008-6#1)(2008-7#2)(2011-2#1)
common complication##12##2##(1991-6#2)(1996-9#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
common complications in##2##3##(1992-2#1)(2008-1#1)
common complications of##4##3##(2008-7#1)(2009-1#1)(2010-8#1)(2011-2#1)
common complications##8##2##(1991-2#1)(1992-2#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-8#1)(2011-2#1)
common condition##4##2##(1991-4#1)(1991-5#1)(2010-5#1)(2011-2#1)
common conditions##7##2##(1991-12#1)(2008-11#1)(2008-4#1)(2012-12#3)(2012-2#1)
common congenital anomaly##2##3##(2012-2#1)(2013-1#1)
common congenital##6##2##(2008-11#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
common consequence of##2##3##(2007-10#1)(2008-6#1)
common conversion factors##3##3##(2008-2#2)(2008-9#1)
common denominator##5##2##(1990-8#1)(1991-9#1)(2007-4#1)(2008-11#1)(2008-8#1)
common descent##2##2##(2008-1#1)(2008-8#1)
common diagnoses##3##2##(1994-6#1)(2012-3#1)(2013-8#1)
common diagnosis##4##2##(2006-8#1)(2011-2#2)(2012-3#1)
common diagnostic##6##2##(1991-8#1)(2007-11#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-2#1)
common disease in##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
common disease of the##3##4##(2007-8#1)(2008-11#1)(2010-12#1)
common disease##10##2##(1994-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
common disease/rare variant hypothesis##2##4##(2012-3#2)
common disease/rare variant##3##3##(2012-3#3)
common diseases##6##2##(1997-3#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2013-1#1)
common disorder##10##2##(1993-6#1)(1995-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#2)
common drug##2##2##(2008-7#1)(2013-8#1)
common duct##2##2##(1990-5#1)(2007-12#1)
common dural##2##2##(2012-3#2)
common during##4##2##(2008-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
common early##2##2##(1991-5#1)(2011-2#1)
common elements of##2##3##(2012-2#2)
common elements##6##2##(1991-5#1)(1993-5#1)(2008-10#1)(2008-4#1)(2012-2#2)
common entity##2##2##(2007-12#1)(2012-2#1)
common environmental##2##2##(2008-10#1)(2008-3#1)
common enzyme##2##2##(2008-10#1)(2010-5#1)
common epitopes##3##2##(1991-5#1)(1996-12#1)(1997-4#1)
common event in##3##3##(2008-12#1)(2008-7#1)(2010-11#1)
common event##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)
common excipients##6##2##(2008-10#5)(2010-5#1)
common factor##3##2##(2008-1#1)(2008-11#1)(2012-2#1)
common factors##5##2##(2007-10#1)(2012-12#1)(2012-2#3)
common feature of the##2##4##(1995-6#1)(2008-11#1)
common feature of these##2##4##(1991-3#1)(2008-11#1)
common feature of those##2##4##(1991-10#1)(2008-7#1)
common feature of##17##3##(1991-10#1)(1991-3#2)(1991-9#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)
common feature##20##2##(1991-10#1)(1991-3#2)(1991-9#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
common features of##7##3##(1996-10#1)(2008-1#1)(2008-12#2)(2008-6#1)(2009-8#1)(2012-2#1)
common features##12##2##(1990-6#1)(1996-10#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-6#1)(2009-12#1)(2009-8#1)(2010-10#1)(2012-2#1)
common fibular nerve palsy##2##4##(2012-3#2)
common fibular##3##2##(2012-3#3)
common finding in##7##3##(1992-9#1)(1996-6#1)(2008-7#2)(2009-8#1)(2012-2#1)(2013-8#1)
common finding##12##2##(1992-9#1)(1993-9#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
common findings during##2##3##(2009-8#1)(2011-2#1)
common findings##5##2##(1997-3#1)(2007-10#1)(2009-8#1)(2009-9#1)(2011-2#1)
common fixed point##4##3##(2011-2#4)
common for the##2##3##(2008-10#1)(2008-8#1)
common for##9##2##(1992-3#1)(1996-4#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#1)
common form of##15##3##(1991-11#1)(1992-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
common format##2##2##(1992-12#1)(2008-4#1)
common functional##2##2##(2012-3#1)(2013-1#1)
common genetic variation##2##3##(2011-2#1)(2012-2#1)
common genetic##6##2##(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
common genotypes##3##2##(2008-10#1)(2009-2#2)
common goal of##3##3##(1991-2#1)(1992-1#1)(2008-6#1)
common goal##5##2##(1991-2#1)(1992-1#1)(1996-3#1)(2008-10#1)(2008-6#1)
common goals##3##2##(1995-1#1)(2008-1#1)(2010-4#1)
common ground##3##2##(1994-12#1)(2008-9#2)
common group of##2##3##(1997-8#1)(2009-5#1)
common group##3##2##(1997-8#1)(2009-5#1)(2013-7#1)
common hand illnesses##2##3##(2008-9#2)
common haplotypes##5##2##(2008-10#3)(2008-2#1)(2008-6#1)
common herbicide##2##2##(2008-10#1)(2008-11#1)
common history##2##2##(2008-1#1)(2011-4#1)
common human##5##2##(1994-5#1)(2009-3#1)(2009-4#1)(2012-3#2)
common iliac artery##4##3##(2006-6#1)(2007-7#1)(2011-2#2)
common imaging##2##2##(2008-1#1)(2012-2#1)
common in Asian##2##3##(2007-5#1)(2012-1#1)
common in KSA##2##3##(2008-1#2)
common in New Zealand##2##4##(1990-2#2)
common in adults##2##3##(2009-1#1)(2010-3#1)
common in biomedical##2##3##(1997-4#1)(2010-11#1)
common in both##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
common in children and young adults##2##6##(2011-2#1)(2013-1#1)
common in children and##3##4##(2011-2#1)(2013-1#1)(2013-7#1)
common in children##7##3##(2008-1#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
common in individuals##2##3##(1991-11#1)(1992-2#1)
common in infants##2##3##(2006-5#1)(2012-12#1)
common in many##2##3##(2008-3#1)(2009-7#1)
common in older##2##3##(2007-7#1)(2013-1#1)
common in our##2##3##(1990-9#1)(2012-3#1)
common in patients with hematologic malignancies##2##6##(2008-7#2)
common in patients with##7##4##(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
common in patients##10##3##(2007-7#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
common in the elderly##3##4##(2008-1#2)(2012-3#1)
common in the general population and##2##6##(2010-12#1)(2013-1#1)
common in the general##3##4##(2010-12#1)(2013-1#1)(2013-7#1)
common in the##37##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1993-12#1)(1994-12#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
common in this##5##3##(1992-3#1)(2007-7#1)(2008-12#1)(2008-5#2)
common in women##2##3##(2008-9#1)(2013-1#1)
common in young##2##3##(2007-11#1)(2010-8#1)
common in##174##2##(1990-12#1)(1990-2#4)(1990-3#1)(1990-9#1)(1991-11#3)(1991-6#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-12#3)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#4)(2008-1#9)(2008-10#13)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#4)(2009-1#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#1)
common incidental##2##2##(1990-9#1)(2011-2#1)
common inflammatory skin##2##3##(2008-3#1)(2008-5#1)
common inflammatory##3##2##(2008-3#1)(2008-5#1)(2012-12#1)
common injuries##4##2##(1990-2#1)(2008-9#1)(2010-12#1)(2013-1#1)
common injury##2##2##(2010-1#2)
common inorganic##2##2##(2008-10#2)
common insect##2##2##(2008-10#1)(2011-2#1)
common interest in##3##3##(2008-7#1)(2008-8#2)
common interferents##3##2##(2008-10#3)
common interfering species##2##3##(2008-10#2)
common interfering##4##2##(2008-10#4)
common ions##13##2##(2008-10#13)
common is the##2##3##(2008-12#1)(2012-12#1)
common is##3##2##(2008-12#1)(2008-4#1)(2012-12#1)
common issues##3##2##(2008-11#1)(2010-3#1)(2012-12#1)
common laboratory##3##2##(1996-6#1)(2007-11#1)(2008-4#1)
common lambsquarters emergence##2##3##(2008-12#2)
common lambsquarters##5##2##(2008-12#5)
common law requirement##2##3##(2007-11#2)
common law##5##2##(1990-11#1)(1995-12#2)(2007-11#2)
common maize##2##2##(2012-2#2)
common malignancies##2##2##(2007-11#1)(2012-12#1)
common malignant epithelial tumors of the ovary##3##7##(1993-9#3)
common malignant##5##2##(1993-9#3)(1995-11#1)(2012-2#1)
common mechanism is##2##3##(1994-8#1)(2011-2#1)
common mechanism of##2##3##(1994-5#1)(2010-1#1)
common mechanism##11##2##(1990-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
common mechanisms##2##2##(2007-6#1)(2011-2#1)
common medical##4##2##(1997-8#1)(2008-1#2)(2008-7#1)
common mental##2##2##(2008-11#1)(2010-5#1)
common metal ions##2##3##(2008-10#2)
common method for##2##3##(2008-10#1)(2008-9#1)
common method##6##2##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
common methods##7##2##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-3#1)
common misconceptions##2##2##(1997-1#1)(2011-2#1)
common mode##2##2##(2007-12#1)(2008-3#1)
common modes of##2##3##(2008-11#1)(2008-9#1)
common molecular##4##2##(1990-7#2)(2011-2#2)
common mosaic##12##2##(2008-10#12)
common motif in##2##3##(1993-11#1)(2009-8#1)
common movement##3##2##(1995-3#1)(2008-7#1)(2009-9#1)
common mutation in##3##3##(1990-8#1)(1997-3#1)(2008-7#1)
common mutation##5##2##(1990-8#1)(1997-3#1)(2008-7#2)(2013-1#1)
common mutations##2##2##(1997-7#1)(2008-3#1)
common name##2##2##(2008-10#1)(2012-2#1)
common nosocomial bacterial##2##3##(2013-8#2)
common occurrence in the##3##4##(2008-10#1)(2008-6#1)(2012-12#1)
common occurrence in##4##3##(1993-3#1)(2008-10#1)(2008-6#1)(2012-12#1)
common occurrence##9##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
common of the##3##3##(2008-11#1)(2008-2#1)(2009-5#1)
common of##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
common ones##2##2##(2008-10#1)(2008-9#1)
common opportunistic##2##2##(2007-8#1)(2008-5#1)
common or##3##2##(1990-3#1)(1997-5#1)(2008-5#1)
common oral##3##2##(2008-7#1)(2012-1#1)(2012-2#1)
common organic and inorganic anions##2##5##(2008-10#2)
common organic##3##2##(2008-10#3)
common origin##5##2##(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
common pancreatic##2##2##(2009-4#1)(2012-2#1)
common path##2##2##(2008-10#1)(2008-3#1)
common pathogens##4##2##(1994-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
common pathology##3##2##(1991-6#1)(2008-1#1)(2008-7#1)
common pathways##3##2##(1993-12#1)(2011-2#2)
common pattern of##3##3##(1997-3#1)(2010-3#2)
common pattern##4##2##(1997-3#1)(1997-8#1)(2010-3#2)
common patterns of##3##3##(2008-1#1)(2008-7#1)(2012-12#1)
common patterns##5##2##(1991-5#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
common pharmaceutical##5##2##(2008-10#5)
common pitfalls in##2##3##(1993-1#1)(1995-2#1)
common pitfalls##3##2##(1993-1#1)(1995-2#1)(2010-5#1)
common place##2##2##(2007-11#1)(2009-5#1)
common practice among##2##3##(1991-6#1)(1996-11#1)
common practice to##2##3##(2008-10#1)(2008-2#1)
common practice##9##2##(1991-6#1)(1996-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
common precursor##3##2##(1993-5#1)(1994-2#1)(2012-3#1)
common presentation##3##2##(2007-11#1)(2009-8#1)(2010-5#1)
common presenting feature##2##3##(2008-11#1)(2011-1#1)
common presenting##5##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
common primary bone##2##3##(2008-2#1)(2010-3#1)
common primary##8##2##(2008-12#1)(2008-2#1)(2008-6#1)(2010-3#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
common problem with##2##3##(2008-4#1)(2013-1#1)
common problem##20##2##(1993-2#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
common problems in##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
common problems##13##2##(1992-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#2)(2011-2#1)(2012-12#2)
common procedure for##4##3##(1992-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
common procedure##9##2##(1991-5#1)(1992-5#1)(2008-10#2)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
common procedures##2##2##(2008-10#1)(2008-4#1)
common processes##3##2##(1993-6#1)(2008-9#1)(2012-2#1)
common psychiatric##3##2##(2008-4#1)(2008-6#1)(2011-1#1)
common questions##2##2##(2008-11#1)(2008-7#1)
common reason for##6##3##(2008-5#1)(2009-5#1)(2010-8#2)(2012-2#1)(2013-1#1)
common reason##7##2##(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#2)(2012-2#1)(2013-1#1)
common reasons for##5##3##(2007-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
common reasons##6##2##(2007-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
common region (CR) sequences of##2##5##(2008-10#2)
common region (CR)##3##3##(2008-10#2)(2008-8#1)
common region of##2##3##(1990-11#1)(2008-10#1)
common region##8##2##(1990-11#1)(2008-10#6)(2008-8#1)
common renal manifestations of##2##4##(2008-8#1)(2013-1#1)
common renal##5##2##(1997-7#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
common resistance##2##2##(2008-10#1)(2009-2#1)
common response curve##2##3##(1995-9#2)
common response##3##2##(1995-9#2)(2010-4#1)
common risk factor##2##3##(2007-10#1)(2011-2#1)
common risk factors for##3##4##(2007-10#1)(2008-7#1)(2009-7#1)
common risk factors##6##3##(2007-10#1)(2008-1#1)(2008-7#1)(2009-7#2)(2012-12#1)
common risk##9##2##(2007-10#2)(2008-1#1)(2008-7#1)(2009-7#2)(2011-2#2)(2012-12#1)
common rust##4##2##(2008-10#4)
common salt##2##2##(2008-10#2)
common scab##3##2##(2008-10#3)
common sense##4##2##(1994-2#1)(1996-3#1)(2008-1#1)(2010-4#1)
common sequel##2##2##(1996-11#1)(2007-11#1)
common sequence motif##2##3##(1995-6#2)
common side effect##3##3##(2007-10#1)(2011-1#1)(2013-8#1)
common side effects##4##3##(1994-11#1)(1996-8#1)(2010-12#1)(2013-1#1)
common side##9##2##(1994-11#1)(1996-8#1)(2007-10#1)(2008-4#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
common signalling##2##2##(1995-8#1)(2008-8#1)
common single##2##2##(1992-5#1)(2009-9#1)
common site for##2##3##(1994-8#1)(2008-6#1)
common site of##6##3##(2007-11#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
common site##9##2##(1992-3#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-6#2)(2008-9#1)(2011-2#1)(2012-2#1)
common skin##3##2##(2010-8#2)(2013-8#1)
common solvents##2##2##(1994-3#1)(2008-10#1)
common spatial origin##3##3##(2009-9#3)
common spatial##6##2##(1993-8#1)(2008-3#1)(2009-9#4)
common species of##2##3##(2008-5#1)(2010-8#1)
common species##4##2##(2008-10#1)(2008-5#2)(2010-8#1)
common spectrophotometric##3##2##(2008-10#3)
common standards of care##3##4##(2013-8#3)
common standards##6##2##(2008-11#1)(2008-7#2)(2013-8#3)
common stimulus##2##2##(2008-4#1)(2011-1#1)
common structural##5##2##(1990-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-5#1)
common symptom in##2##3##(2007-7#1)(2008-5#1)
common symptom##7##2##(1990-9#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-5#1)
common symptoms##4##2##(1996-6#1)(2008-6#1)(2008-7#1)(2012-3#1)
common target##6##2##(1991-9#2)(1994-12#1)(1997-4#1)(2013-1#2)
common terms##2##2##(2008-4#1)(2008-9#1)
common than##10##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-8#2)(2011-2#3)(2013-1#1)
common theme##4##2##(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)
common themes##7##2##(1993-3#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-1#1)
common thread##2##2##(2012-12#1)(2012-3#1)
common tissue phantoms##2##3##(2008-3#2)
common to a##2##3##(2008-4#1)(2011-2#1)
common to all raters##3##4##(2012-2#3)
common to all three##3##4##(1991-7#1)(1996-1#1)(2008-9#1)
common to all##15##3##(1990-2#1)(1991-7#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#5)
common to both proteins##2##4##(1995-12#1)(2009-5#1)
common to both##18##3##(1990-8#1)(1991-5#1)(1991-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2009-5#1)(2012-2#1)
common to other##4##3##(1990-5#1)(2007-6#1)(2008-1#1)(2008-5#1)
common to the two##4##4##(1997-7#1)(2008-10#1)(2008-2#2)
common to the##10##3##(1995-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-10#1)
common to##91##2##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#2)(1991-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2007-10#1)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#2)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#6)
common toxicity##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
common training##2##2##(1990-3#1)(1996-12#1)
common traits##2##2##(2009-11#1)(2011-4#1)
common transcription##2##2##(2008-4#1)(2010-10#1)
common treatment for##3##3##(1993-6#1)(2009-5#1)(2013-8#1)
common treatment##5##2##(1993-6#1)(1995-12#1)(2007-12#1)(2009-5#1)(2013-8#1)
common treatments##2##2##(2007-11#1)(2008-2#1)
common type##17##2##(1993-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
common types of cancer##2##4##(1990-8#1)(2010-10#1)
common types of##7##3##(1990-8#1)(1995-5#1)(2008-6#1)(2010-10#1)(2013-1#3)
common types##11##2##(1990-8#1)(1995-5#1)(2008-1#1)(2008-6#1)(2010-10#1)(2012-3#1)(2013-1#5)
common underlying##3##2##(2008-1#1)(2008-12#1)(2009-8#1)
common use##2##2##(1995-12#1)(2012-2#1)
common variant##4##2##(2008-7#1)(2012-3#3)
common variants in##2##3##(2010-2#1)(2012-3#1)
common variants##5##2##(2010-2#1)(2012-3#4)
common vascular##2##2##(1991-9#1)(2008-1#1)
common waterhemp##5##2##(2008-10#5)
common wheat (Triticum aestivum##2##4##(2008-10#1)(2008-5#1)
common wheat from##3##3##(2008-10#3)
common wheat##20##2##(2008-10#15)(2008-5#2)(2008-8#3)
common with##18##2##(1993-11#3)(1993-12#2)(1994-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
common within##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
common yet##2##2##(2008-10#1)(2013-8#1)
common##2448##1##(1990-11#5)(1990-12#2)(1990-2#13)(1990-3#4)(1990-5#12)(1990-6#8)(1990-7#6)(1990-8#9)(1990-9#12)(1991-10#1)(1991-11#5)(1991-12#7)(1991-2#4)(1991-3#6)(1991-4#1)(1991-5#13)(1991-6#13)(1991-7#1)(1991-8#9)(1991-9#8)(1992-1#4)(1992-11#3)(1992-12#3)(1992-2#6)(1992-3#6)(1992-4#1)(1992-5#8)(1992-6#2)(1992-7#1)(1992-8#8)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#7)(1993-12#13)(1993-2#6)(1993-3#5)(1993-5#2)(1993-6#10)(1993-8#1)(1993-9#12)(1994-11#9)(1994-12#7)(1994-2#8)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#6)(1994-9#1)(1995-1#5)(1995-11#4)(1995-12#11)(1995-2#6)(1995-3#6)(1995-5#9)(1995-6#10)(1995-8#4)(1995-9#5)(1996-1#5)(1996-10#1)(1996-11#5)(1996-12#11)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#19)(1997-4#8)(1997-5#6)(1997-6#7)(1997-7#6)(1997-8#16)(1997-9#1)(2006-10#9)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#20)(2007-11#38)(2007-12#35)(2007-2#6)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#24)(2007-8#20)(2008-1#66)(2008-10#381)(2008-11#62)(2008-12#49)(2008-2#38)(2008-3#43)(2008-4#55)(2008-5#53)(2008-6#33)(2008-7#94)(2008-8#61)(2008-9#71)(2009-1#4)(2009-10#9)(2009-11#4)(2009-12#14)(2009-2#5)(2009-3#4)(2009-4#8)(2009-5#18)(2009-6#8)(2009-7#6)(2009-8#21)(2009-9#13)(2010-1#6)(2010-10#12)(2010-11#11)(2010-12#27)(2010-2#2)(2010-3#9)(2010-4#17)(2010-5#18)(2010-6#7)(2010-7#5)(2010-8#36)(2010-9#4)(2011-1#35)(2011-2#133)(2011-3#1)(2011-4#3)(2012-1#8)(2012-12#40)(2012-2#90)(2012-3#78)(2012-5#2)(2013-1#94)(2013-7#8)(2013-8#50)
common-mode##4##1##(2007-11#2)(2008-3#1)(2011-1#1)
common-path##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
commonalities and differences##2##3##(2010-10#1)(2011-2#1)
commonalities and##3##2##(2010-10#1)(2010-9#1)(2011-2#1)
commonalities##8##1##(1994-12#1)(1995-1#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-2#1)
commonality##2##1##(2007-12#1)(2009-5#1)
commoner than##2##2##(2008-1#1)(2008-8#1)
commoner##5##1##(1996-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
commonest cause##9##2##(1992-4#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)
commonest##59##1##(1990-2#1)(1990-6#1)(1991-8#1)(1992-4#1)(1993-9#2)(1996-11#1)(1997-8#1)(2007-7#11)(2008-1#12)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
commonly abused by humans also##2##5##(2008-4#1)(2012-3#1)
commonly accepted##6##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#2)(2013-8#1)
commonly adopted##5##2##(2008-3#1)(2009-11#1)(2009-7#1)(2010-4#1)(2013-1#1)
commonly affected##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)
commonly affects young##2##3##(1991-9#1)(2010-4#1)
commonly affects##3##2##(1991-9#1)(1992-4#1)(2010-4#1)
commonly assayed##2##2##(2008-10#1)(2008-6#1)
commonly associated metal ions##2##4##(2008-10#2)
commonly associated with the##2##4##(2008-10#2)
commonly associated with##15##3##(1991-12#1)(1991-4#1)(1992-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
commonly associated##19##2##(1991-12#1)(1991-4#1)(1992-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
commonly assumed##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-3#1)
commonly been##3##2##(2008-5#1)(2008-7#2)
commonly by##2##2##(2007-7#1)(2012-3#1)
commonly called##3##2##(2008-5#1)(2008-7#1)(2010-4#1)
commonly caused by##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
commonly co-occurring##2##2##(2008-10#1)(2008-6#1)
commonly considered##4##2##(2008-10#1)(2008-5#1)(2012-7#1)(2013-8#1)
commonly consumed by##2##3##(1995-8#1)(2007-4#1)
commonly consumed##3##2##(1995-8#1)(2007-4#1)(2008-1#1)
commonly described in##2##3##(2008-8#1)(2012-12#1)
commonly described##5##2##(2008-10#2)(2008-8#1)(2012-12#2)
commonly detected in##2##3##(2008-11#1)(2010-6#1)
commonly detected##5##2##(1995-12#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
commonly due to##2##3##(1991-3#1)(2010-11#1)
commonly employed in##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
commonly employed##13##2##(1992-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
commonly encountered by##2##3##(2011-1#1)(2012-3#1)
commonly encountered in the##2##4##(2008-2#1)(2011-2#1)
commonly encountered in##6##3##(2007-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#1)
commonly encountered##13##2##(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
commonly experienced by patients##2##4##(1996-2#1)(2007-7#1)
commonly for##2##2##(1995-3#1)(2008-12#1)
commonly found in the##5##4##(1990-9#1)(1991-1#1)(1997-3#1)(2008-10#1)(2011-2#1)
commonly found in##21##3##(1990-9#1)(1991-1#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
commonly found on##3##3##(2008-10#3)
commonly found##34##2##(1990-9#1)(1991-1#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#2)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
commonly grown in##2##3##(2008-10#1)(2012-2#1)
commonly grown##3##2##(2008-10#2)(2012-2#1)
commonly in the##11##3##(1993-6#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
commonly in##23##2##(1993-6#1)(2007-10#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
commonly included##2##2##(1990-3#1)(1995-6#1)
commonly involved##5##2##(2007-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2013-1#1)
commonly involves##2##2##(2008-5#1)(2008-6#1)
commonly isolated from##4##3##(1996-11#1)(2008-10#3)
commonly isolated##7##2##(1996-11#1)(2008-10#6)
commonly known as &quot##2##4##(2009-3#1)(2012-3#1)
commonly known as##9##3##(2007-12#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
commonly known##10##2##(2007-12#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
commonly located##2##2##(1992-2#1)(2007-8#1)
commonly made##2##2##(2008-7#1)(2008-9#1)
commonly observed in##6##3##(1994-12#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#2)
commonly observed##14##2##(1994-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#2)
commonly occur in##5##3##(1997-8#1)(2008-10#1)(2008-9#1)(2012-1#1)(2013-1#1)
commonly occur##7##2##(1997-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2012-1#1)(2013-1#1)
commonly occurring in the##2##4##(2010-11#1)(2012-3#1)
commonly occurring##6##2##(1993-2#1)(2008-10#1)(2010-11#1)(2010-6#1)(2012-3#2)
commonly occurs in the##2##4##(2010-3#2)
commonly occurs##3##2##(2009-5#1)(2010-3#2)
commonly on##3##2##(1991-2#1)(2008-10#2)
commonly performed procedures##2##3##(2011-2#2)
commonly performed##14##2##(1992-2#1)(1994-8#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#4)(2012-2#2)
commonly prescribed for##2##3##(2010-12#1)(2012-12#1)
commonly prescribed in##2##3##(2007-11#1)(2012-3#1)
commonly prescribed medications##3##3##(2008-8#1)(2010-12#1)(2011-1#1)
commonly prescribed##12##2##(2007-11#1)(2008-3#1)(2008-8#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#3)(2013-8#2)
commonly present at##2##3##(2008-11#1)(2012-3#1)
commonly present in the##2##4##(2008-10#2)
commonly present in##7##3##(2008-10#6)(2008-4#1)
commonly present##12##2##(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2012-3#1)(2013-7#1)
commonly presenting##2##2##(2010-5#1)(2010-8#1)
commonly presents as##2##3##(2011-2#1)(2012-3#1)
commonly presents##3##2##(2011-2#2)(2012-3#1)
commonly recognized##3##2##(2007-10#1)(2008-2#1)(2011-2#1)
commonly recorded processes of##2##4##(1994-12#2)
commonly recovered##3##2##(2008-10#2)(2010-8#1)
commonly referred to as##10##4##(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
commonly related##2##2##(1992-11#1)(2008-3#1)
commonly reported##14##2##(1991-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
commonly results in##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
commonly seen in the##2##4##(2008-10#1)(2008-8#1)
commonly seen in##13##3##(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
commonly seen on##2##3##(1992-12#1)(2010-8#1)
commonly seen##23##2##(1992-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
commonly studied##3##2##(1996-3#1)(2006-6#1)(2012-1#1)
commonly targeted##2##2##(2010-9#1)(2011-1#1)
commonly thought to##2##3##(1991-7#1)(2008-9#1)
commonly thought##3##2##(1991-7#1)(2008-3#1)(2008-9#1)
commonly to##2##2##(1995-8#1)(2013-1#1)
commonly transmitted##2##2##(1994-8#1)(2012-1#1)
commonly use##2##2##(1995-9#1)(2008-3#1)
commonly used as a##7##4##(1992-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#1)
commonly used as##11##3##(1992-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
commonly used by##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
commonly used classifications##2##3##(2007-11#1)(2007-8#1)
commonly used drugs##5##3##(1994-12#1)(2006-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
commonly used dural sealing techniques##2##5##(2012-3#2)
commonly used for the##2##4##(2008-10#2)
commonly used for##18##3##(1992-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)
commonly used in cytometry##2##4##(2008-9#2)
commonly used in the analysis of##3##6##(1990-2#1)(2008-4#1)(2008-6#1)
commonly used in the treatment of##2##6##(1995-12#1)(1996-12#1)
commonly used in the##10##4##(1990-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2011-2#1)(2012-2#1)
commonly used in##48##3##(1990-2#1)(1993-12#2)(1993-5#1)(1994-6#1)(1995-12#2)(1996-12#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)
commonly used method##2##3##(2008-4#1)(2008-9#1)
commonly used methods to##2##4##(2008-2#1)(2008-9#1)
commonly used methods##8##3##(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)
commonly used surfactants##2##3##(1996-1#1)(2008-10#1)
commonly used to study##2##4##(2008-1#1)(2008-10#1)
commonly used to##18##3##(1990-11#1)(1994-12#1)(1995-1#1)(2008-1#2)(2008-10#3)(2008-4#3)(2008-5#1)(2008-8#3)(2012-1#1)(2012-5#1)(2013-8#1)
commonly used##254##2##(1990-11#1)(1990-2#1)(1990-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#2)(2006-10#4)(2006-12#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#7)(2008-10#48)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#9)(2008-4#23)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#13)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#5)(2013-8#3)
commonly##737##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#3)(2006-10#4)(2006-12#1)(2006-6#2)(2007-10#3)(2007-11#7)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#14)(2007-8#7)(2008-1#14)(2008-10#135)(2008-11#21)(2008-12#13)(2008-2#15)(2008-3#28)(2008-4#32)(2008-5#15)(2008-6#11)(2008-7#22)(2008-8#21)(2008-9#28)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#9)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#7)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#12)(2011-2#40)(2011-3#1)(2012-1#7)(2012-12#8)(2012-2#22)(2012-3#31)(2012-5#1)(2012-7#1)(2013-1#25)(2013-3#1)(2013-7#2)(2013-8#11)
commonplace in##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-10#1)
commonplace##16##1##(1991-3#1)(1992-2#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2010-10#1)(2011-1#1)(2012-2#1)
commons##3##1##(2008-10#1)(2008-12#2)
commonsense##2##1##(1993-12#1)(1995-3#1)
commotio##2##1##(2012-12#1)(2012-3#1)
communal activities##2##2##(2008-11#2)
communal##6##1##(2008-11#4)(2008-9#1)(2009-9#1)
commune##7##1##(1996-6#1)(2008-10#6)
communicable disease surveillance##5##3##(1996-11#1)(1997-3#3)(2008-1#1)
communicable disease##7##2##(1991-8#1)(1996-11#1)(1997-3#4)(2008-1#1)
communicable diseases##7##2##(1994-3#1)(1996-6#2)(2007-7#1)(2008-11#1)(2010-4#1)(2012-12#1)
communicable##17##1##(1991-8#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-6#2)(1997-3#4)(2007-7#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
communicate effectively##2##2##(1997-2#1)(2008-11#1)
communicate in##2##2##(2008-4#1)(2009-5#1)
communicate the##4##2##(1992-2#1)(2008-5#1)(2013-1#2)
communicate with each other##2##4##(1996-2#1)(1997-6#1)
communicate with the##2##3##(2008-10#1)(2011-2#1)
communicate with##7##2##(1995-12#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-7#2)(2011-2#1)
communicate##46##1##(1992-2#2)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#2)(1997-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-5#2)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
communicated through##2##2##(2008-1#1)(2008-7#1)
communicated to the public##2##4##(1996-4#1)(2008-7#1)
communicated to the##3##3##(1996-11#1)(1996-4#1)(2008-7#1)
communicated to##4##2##(1995-1#1)(1996-11#1)(1996-4#1)(2008-7#1)
communicated with##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
communicated##19##1##(1990-8#1)(1991-5#2)(1995-1#1)(1996-11#1)(1996-4#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
communicates##3##1##(1990-6#1)(1992-2#1)(2008-10#1)
communicating artery##12##2##(1996-3#2)(2008-2#1)(2008-7#9)
communicating science##2##2##(2013-1#2)
communicating the##5##2##(1994-3#1)(1997-1#1)(2008-7#1)(2010-5#1)(2013-1#1)
communicating their##2##2##(2011-1#1)(2013-1#1)
communicating with patients##3##3##(2008-11#1)(2013-8#2)
communicating with people##3##3##(2008-11#1)(2013-8#2)
communicating with the##2##3##(2010-5#1)(2012-2#1)
communicating with##13##2##(2007-11#1)(2008-11#3)(2008-5#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#4)
communicating##58##1##(1990-8#1)(1992-3#1)(1992-6#1)(1993-2#2)(1994-3#1)(1995-2#1)(1996-3#2)(1997-1#1)(1997-3#3)(2007-11#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#12)(2009-5#2)(2010-4#5)(2010-5#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
communication about##5##2##(2008-10#2)(2008-3#1)(2010-4#1)(2010-5#1)
communication activities##2##2##(2008-12#2)
communication among##10##2##(1991-12#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-1#1)(2013-8#2)
communication amongst##2##2##(2009-10#1)(2011-1#1)
communication and collaboration##2##3##(2008-6#1)(2009-5#1)
communication and the##2##3##(2007-11#1)(2008-1#1)
communication and##40##2##(1993-12#1)(1994-1#2)(1994-2#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
communication are##4##2##(1992-3#1)(1995-12#1)(2007-11#1)(2010-11#1)
communication as the##2##3##(2010-7#1)(2013-8#1)
communication as##4##2##(2008-9#2)(2010-7#1)(2013-8#1)
communication at##2##2##(2008-7#1)(2013-8#1)
communication behaviors involved##2##3##(2008-8#1)(2009-11#1)
communication behaviors##5##2##(2008-8#1)(2009-11#4)
communication behaviours##2##2##(2010-10#1)(2012-3#1)
communication between astrocytes and neurons##2##5##(2008-4#1)(2009-3#1)
communication between health professionals and##2##5##(2008-11#1)(2008-3#1)
communication between health professionals##3##4##(1995-5#1)(2008-11#1)(2008-3#1)
communication between individuals##2##3##(2008-10#1)(2008-8#1)
communication between parents and##3##4##(1990-12#1)(2008-11#1)(2013-1#1)
communication between patients##2##3##(2011-1#1)(2013-1#1)
communication between the model student family and the delinquent adolescent##2##10##(1990-12#2)
communication between the##12##3##(1990-12#3)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
communication between##59##2##(1990-12#4)(1992-4#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-8#2)(2009-9#2)(2010-12#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
communication bottleneck##2##2##(2008-3#2)
communication channels##7##2##(2007-11#1)(2008-3#5)(2011-1#1)
communication characteristics of individuals with Down syndrome##2##7##(2010-4#2)
communication development##2##2##(1995-5#1)(2008-12#1)
communication difficulties##3##2##(2008-7#1)(2010-4#1)(2012-3#1)
communication for##2##2##(2007-11#1)(2010-7#1)
communication has been##2##3##(1997-6#1)(2008-2#1)
communication has##3##2##(1997-6#1)(2008-2#1)(2008-9#1)
communication have##3##2##(2007-8#1)(2010-12#1)(2011-1#1)
communication in human##2##3##(2008-8#1)(2008-9#1)
communication in the##2##3##(1996-1#1)(2008-5#1)
communication in##11##2##(1996-1#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
communication is a##2##3##(1991-12#1)(2008-9#1)
communication is to##2##3##(1992-2#1)(2012-12#1)
communication is##11##2##(1990-9#1)(1991-12#2)(1992-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
communication issues##2##2##(1995-12#1)(2008-3#1)
communication lines##2##2##(2008-12#1)(2011-1#1)
communication link##2##2##(2008-2#1)(2008-3#1)
communication links##3##2##(2008-2#3)
communication may##2##2##(2008-10#1)(2012-2#1)
communication mediated by##2##3##(2008-4#1)(2008-7#1)
communication mode##2##2##(2008-9#2)
communication network##2##2##(1990-12#1)(2008-2#1)
communication networks##3##2##(2008-3#2)(2008-6#1)
communication of##7##2##(1990-12#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)
communication partners'##2##2##(2012-3#2)
communication patterns##3##2##(1997-2#1)(2008-2#1)(2009-8#1)
communication presents a##2##3##(2007-10#1)(2008-10#1)
communication problems##3##2##(1994-1#1)(1997-6#1)(2007-11#1)
communication process##2##2##(2007-11#1)(2008-11#1)
communication processes##2##2##(1996-3#1)(2009-11#1)
communication related impairments##7##3##(2011-1#7)
communication reports the##2##3##(1993-11#1)(2013-7#1)
communication reports##5##2##(1990-12#1)(1993-11#1)(1997-7#1)(2008-10#1)(2013-7#1)
communication signal##2##2##(2008-2#1)(2012-3#1)
communication skills and the##2##4##(1992-3#1)(1993-2#1)
communication skills and##5##3##(1992-3#1)(1993-2#1)(2008-11#1)(2008-12#2)
communication skills program for##2##4##(2008-12#2)
communication skills##24##2##(1992-2#2)(1992-3#1)(1992-6#1)(1993-2#1)(1997-3#1)(2008-11#5)(2008-12#5)(2008-7#1)(2008-9#1)(2010-10#1)(2012-2#4)(2012-3#1)
communication strategies##6##2##(1997-2#1)(2012-2#1)(2012-3#4)
communication system performance##3##3##(2008-2#3)
communication system##11##2##(1990-12#2)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#3)(2010-11#1)
communication systems##16##2##(1992-11#1)(1997-8#2)(2007-11#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2010-3#1)
communication technologies##2##2##(2011-1#1)(2012-12#1)
communication that##3##2##(1994-11#1)(2008-11#1)(2011-1#1)
communication theory##2##2##(2008-12#1)(2008-2#1)
communication through##3##2##(2008-11#2)(2008-2#1)
communication to##3##2##(1994-7#1)(2007-9#1)(2008-8#1)
communication tool##4##2##(1992-4#1)(1996-1#2)(2008-11#1)
communication was##2##2##(2008-9#1)(2009-11#1)
communication when##2##2##(2010-3#1)(2011-2#1)
communication will##3##2##(2008-11#1)(2010-3#2)
communication with children##2##3##(1990-12#1)(2008-11#1)
communication with patients##3##3##(2007-11#2)(2013-8#1)
communication with the##7##3##(2007-12#1)(2007-8#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
communication with their##2##3##(1990-12#1)(2007-9#1)
communication with##33##2##(1990-12#3)(1993-1#1)(1994-11#1)(1996-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
communication within##3##2##(1996-2#1)(1997-3#1)(2007-12#1)
communication##554##1##(1990-12#15)(1990-2#1)(1990-7#5)(1990-9#1)(1991-11#2)(1991-12#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#6)(1995-3#1)(1995-5#4)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#17)(2007-12#12)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#23)(2008-11#36)(2008-12#25)(2008-2#31)(2008-3#33)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#18)(2008-8#7)(2008-9#23)(2009-10#5)(2009-11#7)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#8)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#9)(2010-4#7)(2010-5#4)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#20)(2011-2#10)(2012-1#5)(2012-12#7)(2012-2#13)(2012-3#19)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#16)
communication)##3##1##(1996-5#1)(2008-11#1)(2008-2#1)
communication]##3##1##(1991-8#1)(1995-2#1)(2012-3#1)
communications among##3##2##(1996-2#1)(2008-2#1)(2010-5#1)
communications and information##2##3##(1995-12#1)(2008-3#1)
communications and##12##2##(1995-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#3)
communications band##2##2##(2007-11#2)
communications between##4##2##(1990-7#1)(1994-3#1)(2008-7#1)(2010-2#1)
communications can##3##2##(1993-2#1)(1994-1#2)
communications for##2##2##(1994-3#1)(1997-3#1)
communications from##3##2##(1997-3#1)(2008-10#2)
communications in##2##2##(1992-12#1)(1992-2#1)
communications is##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
communications modes##2##2##(2008-3#2)
communications networks##2##2##(1997-3#1)(2008-1#1)
communications skills##2##2##(1993-1#1)(1994-2#1)
communications systems##3##2##(1996-2#2)(2007-11#1)
communications that##2##2##(1997-1#1)(2008-10#1)
communications to##2##2##(1995-1#1)(2007-12#1)
communications with##2##2##(1996-11#1)(2008-10#1)
communications##95##1##(1990-7#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#3)(1993-2#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-7#1)(2007-11#11)(2007-12#7)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
communicative hand gestures and object-directed hand movements##2##7##(2008-11#2)
communicative hand gestures and##3##4##(2008-11#3)
communicative hand gestures##4##3##(2008-11#4)
communicative intent##3##2##(2008-11#2)(2008-2#1)
communicative##14##1##(2007-12#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
communis L##2##2##(1991-11#1)(2013-8#1)
communis##17##1##(1991-11#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2011-2#7)(2013-1#2)(2013-8#1)
communis)##3##1##(2008-10#2)(2009-10#1)
communist##2##1##(1997-6#1)(2012-1#1)
communities and community##2##3##(2008-1#1)(2010-4#1)
communities and health##2##3##(1997-3#1)(2010-8#1)
communities and##25##2##(1994-1#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-9#2)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#3)(2013-1#2)(2013-7#2)
communities are##4##2##(2008-10#1)(2008-9#2)(2012-3#1)
communities can be##2##3##(2007-5#1)(2009-2#1)
communities from##4##2##(1996-2#1)(2008-10#1)(2008-8#1)(2010-1#1)
communities have##6##2##(1996-3#1)(2008-9#2)(2010-8#1)(2012-2#1)(2012-6#1)
communities in Canada##2##3##(1995-1#1)(1996-3#1)
communities in the##8##3##(1995-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
communities in which different##2##4##(2008-8#2)
communities in which##8##3##(1995-3#1)(1996-12#1)(1996-3#2)(2008-1#1)(2008-8#2)(2012-2#1)
communities in##39##2##(1994-9#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-3#3)(1997-1#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-5#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#2)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)
communities is##2##2##(2008-8#1)(2010-9#1)
communities may##2##2##(2009-6#1)(2012-2#1)
communities of the##3##3##(2008-5#1)(2013-7#2)
communities of##22##2##(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#3)
communities or##2##2##(1994-3#1)(2008-8#1)
communities participating in the##2##4##(1991-5#1)(2013-1#1)
communities residing in##4##3##(2008-10#1)(2012-12#3)
communities than##2##2##(2008-9#1)(2009-8#1)
communities that##5##2##(1991-12#1)(2008-11#1)(2009-2#1)(2010-10#1)(2011-2#1)
communities to##4##2##(1995-3#1)(1997-1#1)(2008-1#1)(2008-10#1)
communities under##2##2##(1995-3#1)(2009-8#1)
communities using##2##2##(2008-8#1)(2008-9#1)
communities was##2##2##(2008-1#1)(2013-7#1)
communities were##4##2##(2008-10#3)(2008-5#1)
communities where##2##2##(2009-10#1)(2011-2#1)
communities with##5##2##(1996-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-2#1)
communities##338##1##(1991-1#2)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#1)(1992-12#2)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-9#1)(1995-1#4)(1995-2#4)(1995-3#10)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#7)(1996-4#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-8#1)(2007-11#1)(2007-2#1)(2007-5#8)(2007-7#1)(2008-1#13)(2008-10#33)(2008-11#9)(2008-12#4)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#22)(2008-9#27)(2009-10#4)(2009-12#1)(2009-2#4)(2009-6#4)(2009-8#5)(2010-1#1)(2010-10#4)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#7)(2011-1#4)(2011-2#20)(2012-12#5)(2012-2#16)(2012-3#3)(2012-6#1)(2013-1#20)(2013-7#15)
community about##3##2##(1992-12#1)(2011-2#1)(2013-1#1)
community acquired pneumonia##3##3##(2013-1#3)
community acquired##6##2##(2012-3#1)(2013-1#3)(2013-8#2)
community agencies##6##2##(1993-1#1)(1996-12#1)(2009-5#1)(2012-2#3)
community and health##4##3##(1991-2#1)(1996-2#1)(1997-3#1)(2010-5#1)
community and hospital##3##3##(1990-6#1)(1996-9#1)(2008-11#1)
community and institutional residents##2##4##(1995-3#2)
community and managed mental health##2##5##(1995-1#2)
community and the##5##3##(1994-1#2)(1995-3#1)(1996-2#1)(2011-2#1)
community and to##2##3##(2008-1#1)(2013-8#1)
community and##48##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-12#1)(1994-1#3)(1994-12#1)(1994-3#1)(1995-1#3)(1995-2#2)(1995-3#3)(1996-2#2)(1996-3#2)(1996-9#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
community approach##3##2##(1992-1#2)(2013-1#1)
community are##5##2##(1993-6#1)(1995-12#1)(2007-2#1)(2010-10#1)(2013-1#1)
community as a##4##3##(1995-2#1)(2008-8#1)(2013-1#2)
community as well as##3##4##(2008-7#1)(2010-12#1)(2012-12#1)
community as##10##2##(1995-2#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2012-12#2)(2013-1#2)
community assessment##2##2##(2008-1#1)(2008-12#1)
community at large##2##3##(1992-12#1)(2008-7#1)
community based care##2##3##(2008-12#2)
community based nursing##2##3##(2008-12#2)
community based##14##2##(1991-2#1)(1993-12#1)(2007-7#1)(2008-1#1)(2008-12#6)(2008-4#1)(2008-7#1)(2013-1#1)(2013-7#1)
community benefit initiative##2##3##(1995-2#2)
community benefit##15##2##(1993-1#1)(1993-12#1)(1995-2#8)(1997-1#5)
community benefits##3##2##(1996-2#1)(2008-11#2)
community building##3##2##(1991-2#2)(2008-4#1)
community buildings##2##2##(2013-8#2)
community by##3##2##(1992-1#1)(2008-8#2)
community can##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
community care and treatment##2##4##(1994-1#1)(1995-8#1)
community care and##3##3##(1994-1#1)(1995-8#1)(1996-7#1)
community care initiatives##2##3##(1995-2#2)
community care##13##2##(1994-1#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-7#1)(1997-8#1)(2010-10#5)
community characteristics##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
community composition##5##2##(2007-5#1)(2008-10#1)(2010-6#3)
community configurations##2##2##(2008-9#2)
community contexts##3##2##(2010-7#2)(2010-9#1)
community continues to##2##3##(2011-2#1)(2012-2#1)
community controls##2##2##(1994-11#1)(2007-10#1)
community development and##2##3##(1997-3#1)(2011-1#1)
community development##4##2##(1992-1#1)(1997-3#1)(2010-5#1)(2011-1#1)
community dwelling older##4##3##(2008-12#3)(2013-1#1)
community dwelling##6##2##(2008-1#1)(2008-12#3)(2011-2#1)(2013-1#1)
community dynamics##6##2##(2008-8#3)(2008-9#2)(2012-12#1)
community emergency##2##2##(2008-3#2)
community engagement strategies##2##3##(2012-2#2)
community engagement##8##2##(2008-4#1)(2009-6#1)(2012-2#6)
community experience##2##2##(1996-11#1)(2011-2#1)
community family planning##2##3##(1993-2#2)
community for##3##2##(1995-1#1)(2008-1#1)(2008-12#1)
community genetic services##2##3##(2013-1#2)
community genetics##2##2##(2009-2#2)
community groups##6##2##(1992-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2011-2#1)
community has##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-7#1)
community health agents##3##3##(2008-9#1)(2011-2#2)
community health assessment and improvement initiative##2##6##(1996-2#2)
community health care centres##2##4##(1995-1#1)(1996-1#1)
community health care providers##2##4##(1996-8#1)(2008-11#1)
community health care##7##3##(1991-3#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-8#1)(2008-11#1)
community health center##7##3##(1990-9#1)(1996-2#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#1)
community health centers in##2##4##(2010-3#1)(2011-2#1)
community health centers##7##3##(1996-2#2)(1997-2#2)(2008-11#1)(2010-3#1)(2011-2#1)
community health centre##2##3##(1990-9#1)(2013-8#1)
community health information##4##3##(1996-1#3)(2013-1#1)
community health service##3##3##(1996-11#1)(2008-1#1)(2010-3#1)
community health workers##2##3##(2009-5#1)(2010-3#1)
community health##58##2##(1990-9#3)(1991-2#1)(1991-3#1)(1992-2#1)(1995-1#1)(1996-1#7)(1996-11#2)(1996-2#7)(1996-3#1)(1996-8#1)(1997-2#7)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#5)(2008-11#3)(2008-12#2)(2008-9#1)(2009-5#1)(2010-3#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
community health-care##2##2##(2011-1#1)(2012-12#1)
community hospital and##3##3##(1991-3#1)(2007-10#1)(2008-11#1)
community hospital statistics##5##3##(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
community hospital to##2##3##(1995-3#2)
community hospital##25##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#2)(2009-2#1)(2011-2#2)
community hospitals and##2##3##(1991-3#1)(2007-10#1)
community hospitals##13##2##(1990-6#1)(1991-3#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-3#2)(2011-2#1)
community in South##2##3##(2008-11#1)(2011-2#1)
community in a##2##3##(1997-1#1)(2008-5#1)
community in the##7##3##(1992-12#1)(1995-12#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2013-7#1)
community in##31##2##(1990-2#1)(1992-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-4#1)(2007-5#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-6#3)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
community integration##3##2##(1996-1#1)(1996-3#1)(1997-1#1)
community involvement##5##2##(1995-12#1)(2010-3#3)(2010-8#1)
community is##9##2##(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-6#1)(2013-7#1)
community leaders##4##2##(1994-12#1)(1996-1#1)(2010-9#1)(2012-2#1)
community learning##2##2##(2008-11#1)(2010-3#1)
community level##14##2##(1994-8#1)(1996-12#1)(1996-3#2)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#3)
community levels##4##2##(1997-1#1)(2008-9#1)(2010-8#2)
community medicine##5##2##(1993-5#1)(1997-6#2)(2008-1#1)(2008-3#1)
community meetings##2##2##(1997-1#1)(2009-4#1)
community members in##2##3##(1991-2#1)(2012-12#1)
community members to##2##3##(2010-8#1)(2012-12#1)
community members##14##2##(1991-2#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-3#4)(2010-8#1)(2012-12#2)(2012-2#1)
community mental health care##2##4##(1995-1#2)
community mental health teams##2##4##(2008-12#2)
community mental health##16##3##(1992-1#1)(1993-1#1)(1995-1#2)(1996-1#3)(1997-1#1)(1997-3#4)(2008-12#2)(2010-4#2)
community mobilization##2##2##(1997-5#1)(2008-1#1)
community must##2##2##(1995-2#1)(2008-11#1)
community needs##4##2##(1994-1#1)(1995-12#1)(2008-12#1)(2010-3#1)
community nurses##5##2##(1996-2#2)(2008-11#1)(2011-1#1)(2012-12#1)
community nursing students##2##3##(2008-11#2)
community nursing##3##2##(1997-2#1)(2008-11#2)
community of practice##2##3##(2008-4#1)(2009-9#1)
community of research and practice is##2##6##(2010-10#2)
community of research and practice##4##5##(2010-10#4)
community of the##3##3##(1993-12#1)(1994-1#1)(2008-10#1)
community of##27##2##(1993-12#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-10#4)(2011-2#2)(2012-1#1)(2013-1#3)
community or hospital##2##3##(1992-2#1)(2008-11#1)
community organization##2##2##(2008-8#2)
community organizations##3##2##(1997-2#1)(2008-1#1)(2008-2#1)
community outreach##4##2##(1992-1#1)(1995-1#1)(1996-4#1)(2013-1#1)
community over##2##2##(1990-3#1)(2008-10#1)
community participation##4##2##(1992-1#1)(1992-12#1)(2007-10#1)(2010-3#1)
community pharmacies in##2##3##(2008-11#1)(2012-2#1)
community pharmacies##5##2##(2008-11#3)(2010-9#1)(2012-2#1)
community pharmacists in##4##3##(2010-5#1)(2011-1#3)
community pharmacists##16##2##(2008-11#1)(2008-3#1)(2010-5#3)(2011-1#9)(2013-1#2)
community pharmacists'##2##2##(2008-3#1)(2011-1#1)
community physicians and##2##3##(1996-9#1)(1997-8#1)
community physicians##6##2##(1996-9#3)(1997-8#2)(2007-10#1)
community planning##5##2##(1997-2#4)(1997-3#1)
community problems##2##2##(1995-3#2)
community programs##3##2##(1992-12#1)(2011-2#1)(2013-8#1)
community providers##2##2##(1997-2#1)(2012-2#1)
community quality initiative##2##3##(1994-12#2)
community resident##3##2##(1991-1#1)(2008-10#2)
community residents##7##2##(1995-3#4)(1997-1#3)
community resilience##3##2##(2010-8#1)(2012-2#2)
community resources##7##2##(1996-1#1)(1996-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)
community sample of##7##3##(1992-1#1)(2007-12#1)(2009-11#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
community sample##11##2##(1992-1#1)(2007-12#1)(2009-11#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#3)
community service##2##2##(1996-7#1)(1997-3#1)
community services##4##2##(1991-1#1)(1991-12#1)(1992-1#1)(1996-3#1)
community setting##7##2##(1991-1#1)(2008-1#1)(2008-11#3)(2011-2#1)(2012-12#1)
community settings##11##2##(1994-2#1)(1997-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
community should##2##2##(1995-2#1)(1996-3#1)
community stability##2##2##(2008-9#2)
community structure and##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
community structure##17##2##(2008-10#3)(2008-6#2)(2008-8#6)(2008-9#4)(2009-2#1)(2012-3#1)
community structures##2##2##(2008-10#2)
community study##2##2##(2009-11#1)(2011-2#1)
community support##5##2##(1995-1#2)(2008-12#1)(2009-6#1)(2013-1#1)
community survey##2##2##(1994-12#1)(2009-10#1)
community surveys##3##2##(1996-12#1)(2008-8#1)(2013-8#1)
community that##2##2##(1997-1#1)(2008-4#1)
community through##2##2##(2008-4#1)(2009-4#1)
community to##8##2##(1992-1#1)(1992-5#1)(1995-11#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-5#1)
community treatment##3##2##(1994-1#1)(2008-6#2)
community violence exposure##2##3##(2009-12#2)
community violence##6##2##(2008-11#1)(2009-11#1)(2009-12#3)(2009-2#1)
community wants##2##2##(1994-12#1)(1995-2#1)
community was##4##2##(2008-10#1)(2010-9#1)(2011-2#2)
community were##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
community who##2##2##(2008-6#1)(2013-1#1)
community with##8##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-8#2)(2010-3#2)(2011-2#1)
community within##2##2##(2012-2#1)(2013-8#1)
community##1051##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#4)(1990-9#6)(1991-1#7)(1991-12#4)(1991-2#10)(1991-3#6)(1992-1#11)(1992-12#9)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#3)(1993-1#6)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#1)(1994-1#20)(1994-11#1)(1994-12#9)(1994-2#4)(1994-3#8)(1994-5#1)(1994-8#1)(1995-1#16)(1995-11#1)(1995-12#9)(1995-2#28)(1995-3#17)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#21)(1996-11#6)(1996-12#14)(1996-2#18)(1996-3#17)(1996-4#1)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#19)(1997-2#23)(1997-3#13)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#3)(2006-10#3)(2007-10#9)(2007-11#3)(2007-12#5)(2007-2#6)(2007-3#1)(2007-5#5)(2007-7#6)(2007-8#2)(2008-1#30)(2008-10#45)(2008-11#48)(2008-12#35)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#6)(2008-6#14)(2008-7#31)(2008-8#40)(2008-9#29)(2009-10#7)(2009-11#3)(2009-12#4)(2009-2#5)(2009-3#1)(2009-4#11)(2009-5#8)(2009-6#7)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#12)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#18)(2010-4#7)(2010-5#8)(2010-6#8)(2010-7#10)(2010-8#14)(2010-9#8)(2011-1#24)(2011-2#43)(2012-1#8)(2012-12#18)(2012-2#35)(2012-3#8)(2012-6#1)(2013-1#44)(2013-7#6)(2013-8#15)
community's##8##1##(1992-12#1)(1995-3#1)(1997-1#1)(2008-12#2)(2010-12#1)(2011-2#1)(2013-8#1)
community)##3##1##(1994-3#1)(1995-3#1)(2008-8#1)
community-acquired pneumonia in##6##3##(1992-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-5#1)
community-acquired pneumonia##12##2##(1992-5#1)(2007-12#3)(2008-10#1)(2008-3#1)(2010-5#1)(2013-1#5)
community-acquired secondary peritonitis##2##3##(2013-8#2)
community-acquired##22##1##(1992-12#1)(1992-5#2)(1997-3#1)(2007-12#6)(2008-10#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#5)(2013-8#2)
community-associated methicillin-resistant##5##2##(2008-10#1)(2008-11#3)(2012-2#1)
community-based agencies##2##2##(1995-1#1)(2012-2#1)
community-based and##3##2##(2007-10#1)(2008-1#1)(2012-12#1)
community-based care##2##2##(1993-2#1)(1995-3#1)
community-based drug abuse treatment##2##4##(2008-6#2)
community-based education in basic nursing education##2##6##(2010-3#2)
community-based education is##2##3##(2010-3#2)
community-based education##5##2##(2010-3#5)
community-based focus##2##2##(1993-12#1)(1994-3#1)
community-based health promotion##2##3##(1994-2#1)(2008-3#1)
community-based health##3##2##(1994-2#1)(2008-3#1)(2013-1#1)
community-based intervention##2##2##(2008-11#1)(2010-10#1)
community-based interventions##3##2##(1996-4#1)(2007-7#1)(2008-10#1)
community-based neurologists##2##2##(2007-10#2)
community-based participatory research##3##3##(2011-2#2)(2012-12#1)
community-based participatory##4##2##(2009-12#1)(2011-2#2)(2012-12#1)
community-based prevention##2##2##(1995-3#2)
community-based primary prevention programs##2##4##(1995-3#2)
community-based primary prevention##3##3##(1995-3#3)
community-based primary##4##2##(1995-3#3)(2008-4#1)
community-based programmes##2##2##(1991-6#1)(2010-8#1)
community-based quality improvement initiative##2##4##(2013-1#2)
community-based reports##3##2##(2008-7#2)(2013-1#1)
community-based research##3##2##(2008-1#1)(2008-6#2)
community-based sample of##5##3##(2008-3#1)(2009-8#1)(2011-2#2)(2012-1#1)
community-based sample##9##2##(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-1#1)
community-based services##2##2##(1994-2#1)(2008-1#1)
community-based studies##2##2##(2008-7#1)(2012-2#1)
community-based study##5##2##(2007-12#1)(2008-3#1)(2008-7#2)(2013-8#1)
community-based##109##1##(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#2)(1995-3#8)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1997-3#1)(2007-10#5)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#5)(2008-3#4)(2008-4#1)(2008-6#7)(2008-7#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#5)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#1)
community-dwelling elderly##2##2##(2008-3#1)(2008-7#1)
community-dwelling elders##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#2)
community-dwelling##9##1##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)(2011-2#1)(2012-12#1)
community-level patterns##2##2##(2008-8#2)
community-level##10##1##(1995-2#1)(2008-8#2)(2008-9#2)(2009-6#2)(2013-1#3)
community-oriented##2##1##(1993-2#1)(1995-6#1)
community-partnered##3##1##(2012-2#3)
community-residing##2##1##(1994-2#1)(2008-11#1)
community-wide effort##2##2##(1994-12#1)(1996-1#1)
community-wide report card##2##3##(1997-3#2)
community-wide report##3##2##(1997-3#3)
community-wide##10##1##(1992-12#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#4)(2008-8#1)(2012-2#1)
community?##2##1##(1994-2#1)(1995-2#1)
communitywide##4##1##(2013-1#4)
commutation times##2##2##(2008-10#2)
commutation##3##1##(2008-10#3)
commutator##2##1##(2008-10#2)
commuters##2##1##(2010-5#2)
commuting patterns##3##2##(2010-5#3)
commuting to##2##2##(2012-12#1)(2013-1#1)
commuting##8##1##(1993-5#1)(2008-10#1)(2010-5#4)(2012-12#1)(2013-1#1)
comorbid Axis I##2##3##(1993-12#1)(2009-9#1)
comorbid conditions##8##2##(2007-12#1)(2007-8#1)(2008-1#1)(2010-6#1)(2010-7#1)(2013-1#2)(2013-8#1)
comorbid depression##2##2##(2008-1#1)(2009-5#1)
comorbid diagnoses##2##2##(2012-2#2)
comorbid disorders##2##2##(2008-1#1)(2013-1#1)
comorbid medical##3##2##(2008-1#1)(2008-8#1)(2011-1#1)
comorbid psychiatric diagnoses##2##3##(2008-6#1)(2012-2#1)
comorbid psychiatric disorders##3##3##(2008-6#2)(2009-10#1)
comorbid psychiatric##6##2##(2008-6#3)(2008-7#1)(2009-10#1)(2012-2#1)
comorbid##41##1##(1993-12#3)(1996-7#1)(1997-5#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#2)(2009-9#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#3)(2012-2#5)(2013-1#3)(2013-8#2)
comorbidities and##4##2##(2012-2#1)(2013-1#3)
comorbidities in these patients##2##4##(2011-2#1)(2013-1#1)
comorbidities in##3##2##(2011-2#1)(2013-1#2)
comorbidities of##3##2##(2011-2#2)(2013-1#1)
comorbidities that##2##2##(2010-6#1)(2013-1#1)
comorbidities##53##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#12)(2013-7#1)(2013-8#1)
comorbidity and disability##2##3##(2008-4#1)(2013-8#1)
comorbidity and##4##2##(1991-6#1)(2008-4#1)(2013-1#1)(2013-8#1)
comorbidity in##3##2##(1991-1#1)(2008-6#1)(2009-10#1)
comorbidity index##2##2##(2008-1#1)(2011-2#1)
comorbidity of##4##2##(2009-7#1)(2009-9#1)(2010-6#1)(2011-2#1)
comorbidity scores##2##2##(2007-10#1)(2013-1#1)
comorbidity##38##1##(1991-1#1)(1991-6#1)(1993-12#2)(1996-7#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-6#3)(2009-10#1)(2009-7#1)(2009-9#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
comovirus##3##1##(1995-12#2)(2008-10#1)
compact all-solid-state##2##2##(2008-2#2)
compact and##20##2##(1991-7#1)(1994-2#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2011-1#2)(2013-1#1)
compact antibodies##3##2##(2009-2#3)
compact arrangement of##2##3##(1995-8#1)(1996-6#1)
compact arrangement##3##2##(1995-8#1)(1996-6#1)(2007-11#1)
compact as##2##2##(1993-8#1)(2007-12#1)
compact configuration##2##2##(2007-12#1)(2008-10#1)
compact disc (CD)##2##3##(2008-10#1)(2008-3#1)
compact disc##4##2##(2008-10#1)(2008-3#3)
compact disk pickup##3##3##(2008-2#3)
compact disk##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
compact film##4##2##(2008-10#4)
compact form##2##2##(2008-10#1)(2011-1#1)
compact in##3##2##(1997-1#1)(2008-3#1)(2008-7#1)
compact myelin proteome##2##3##(2008-7#2)
compact myelin##4##2##(2008-7#4)
compact optical system##2##3##(2008-3#2)
compact optical##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
compact size##3##2##(2008-10#1)(2008-2#2)
compact source##2##2##(2007-11#1)(2008-3#1)
compact structure##3##2##(1994-5#1)(1995-5#1)(2008-2#1)
compact system##2##2##(2008-3#2)
compact unit##2##2##(2008-10#1)(2008-2#1)
compact##213##1##(1991-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-11#20)(2007-12#18)(2008-1#1)(2008-10#37)(2008-12#1)(2008-2#26)(2008-3#68)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-2#3)(2009-5#2)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#1)(2013-1#2)
compacta (SNpc)##4##2##(1993-12#1)(1995-3#1)(1996-12#1)(2013-7#1)
compacta##9##1##(1991-12#1)(1993-12#1)(1995-3#1)(1996-12#2)(2008-5#2)(2008-7#1)(2013-7#1)
compacted##6##1##(1997-4#1)(2007-12#1)(2008-11#1)(2009-4#3)
compactibility of##2##2##(2010-5#2)
compactibility##3##1##(2010-5#3)
compacting##2##1##(2009-4#2)
compaction in##3##2##(1997-3#1)(2008-2#1)(2008-7#1)
compaction##12##1##(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)(2011-1#2)(2011-2#2)
compactly##2##1##(2009-12#1)(2012-2#1)
compactness of the##2##3##(2008-10#1)(2008-5#1)
compactness##7##1##(1992-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)
companies and research##2##3##(2008-11#1)(2010-8#1)
companies and their##2##3##(1995-1#1)(2009-5#1)
companies and##11##2##(1993-2#1)(1995-1#1)(1996-3#2)(1997-5#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-5#1)(2010-8#1)
companies are##11##2##(1991-3#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-1#2)(1996-5#2)(2008-11#1)(2008-5#1)(2010-8#1)
companies have##9##2##(1993-12#1)(1994-3#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
companies in the##3##3##(1990-2#1)(1993-3#1)(2008-10#1)
companies in##7##2##(1990-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(2008-10#1)(2012-12#1)
companies providing##2##2##(1997-3#1)(2011-2#1)
companies that are##2##3##(1994-12#1)(2008-5#1)
companies that##8##2##(1990-4#1)(1993-3#1)(1994-12#1)(1995-1#1)(2008-11#2)(2008-5#1)(2008-7#1)
companies to##6##2##(1993-12#1)(1995-1#1)(1996-3#1)(1997-5#1)(2007-9#1)(2008-11#1)
companies were##3##2##(2008-11#2)(2008-5#1)
companies will##2##2##(1994-3#1)(1997-5#1)
companies##139##1##(1990-2#1)(1990-4#2)(1991-12#2)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-3#6)(1994-7#1)(1995-1#9)(1995-2#3)(1995-6#2)(1996-1#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#5)(1997-1#1)(1997-3#3)(1997-5#6)(1997-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#12)(2008-11#18)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#12)(2008-7#7)(2009-5#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#2)
companies'##4##1##(1992-5#1)(1993-8#1)(1996-5#1)(1996-8#1)
companion animals##3##2##(2011-2#2)(2013-1#1)
companion article##2##2##(1991-2#1)(2009-8#1)
companion paper##6##2##(1991-8#1)(2008-2#1)(2008-3#2)(2009-8#1)(2012-2#1)
companion##22##1##(1991-2#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-12#1)(1997-1#1)(2007-6#1)(2008-2#2)(2008-3#4)(2009-3#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
company A##3##2##(2010-4#3)
company has##6##2##(2008-10#1)(2008-5#4)(2010-9#1)
company of##3##2##(1992-11#1)(1996-12#1)(2010-4#1)
company records##3##2##(1992-3#1)(1996-2#1)(1997-1#1)
company stock##2##2##(2011-2#2)
company that##2##2##(1992-3#1)(1993-3#1)
company with##5##2##(1996-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-8#1)
company##74##1##(1991-12#1)(1992-11#1)(1992-12#4)(1992-3#3)(1993-1#1)(1993-12#4)(1993-3#1)(1994-1#1)(1994-3#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-3#1)(2008-10#4)(2008-11#6)(2008-5#11)(2008-8#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
company's##16##1##(1990-2#1)(1992-3#3)(1993-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-5#4)(2011-1#1)(2011-2#2)
comparability of data##2##3##(1996-3#1)(2008-10#1)
comparability of the##2##3##(2008-10#1)(2008-5#1)
comparability of##12##2##(1990-3#1)(1990-6#1)(1996-3#1)(2008-10#6)(2008-5#1)(2008-8#1)(2012-2#1)
comparability with##2##2##(2008-10#1)(2008-3#1)
comparability##24##1##(1990-3#1)(1990-6#1)(1992-6#1)(1994-3#1)(1996-3#1)(2008-10#9)(2008-3#3)(2008-5#1)(2008-8#4)(2009-10#1)(2012-2#1)
comparable according to##2##3##(1993-1#1)(2008-6#1)
comparable accuracy##2##2##(2008-8#1)(2012-3#1)
comparable across##2##2##(1996-12#1)(2008-10#1)
comparable activity##2##2##(1995-12#1)(2008-4#1)
comparable amounts of##2##3##(2009-6#1)(2009-7#1)
comparable and##4##2##(1992-6#1)(1995-5#1)(2007-12#1)(2008-10#1)
comparable between the two##2##4##(2008-10#1)(2010-3#1)
comparable between##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2010-3#1)
comparable effects##2##2##(1995-12#1)(1996-5#1)
comparable even##2##2##(2008-10#1)(2008-3#1)
comparable for##4##2##(1997-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
comparable in terms of##6##4##(1993-11#1)(1995-6#1)(2008-11#1)(2008-5#1)(2012-12#2)
comparable in the##5##3##(1990-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
comparable in##18##2##(1990-11#1)(1993-11#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
comparable levels of##4##3##(1993-11#1)(2008-7#1)(2008-8#1)(2009-4#1)
comparable or better than##2##4##(2008-10#1)(2008-3#1)
comparable or even##2##3##(2008-10#1)(2012-3#1)
comparable or superior##3##3##(2008-11#1)(2008-3#1)(2010-8#1)
comparable or##8##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-8#1)(2012-3#1)
comparable results to##3##3##(2008-10#2)(2010-12#1)
comparable results with those obtained##2##5##(2008-10#2)
comparable results with##3##3##(2008-10#2)(2008-7#1)
comparable results##12##2##(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
comparable studies##2##2##(2008-8#2)
comparable to a##4##3##(2007-8#1)(2008-10#1)(2010-5#1)(2012-1#1)
comparable to or##2##3##(2007-11#1)(2008-2#1)
comparable to other##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
comparable to that in##7##4##(1990-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-3#1)
comparable to that obtained with##2##5##(2008-10#2)
comparable to that obtained##3##4##(2008-10#2)(2008-11#1)
comparable to that of a##2##5##(2007-11#1)(2011-1#1)
comparable to that of conventional##2##5##(2007-12#1)(2012-2#1)
comparable to that of free##2##5##(1995-2#1)(1997-7#1)
comparable to that of other##2##5##(2007-10#1)(2008-10#1)
comparable to that of the##8##5##(1993-6#1)(1994-2#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#2)
comparable to that of##33##4##(1990-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#3)(1996-5#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#3)(2012-2#1)
comparable to that##53##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#3)(1996-5#2)(1997-4#2)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#3)(2012-2#1)
comparable to the##37##3##(1990-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#4)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
comparable to those achieved##2##4##(1993-6#1)(2008-10#1)
comparable to those determined##2##4##(2008-10#2)
comparable to those found##2##4##(1990-2#1)(2008-10#1)
comparable to those from##2##4##(2008-10#1)(2010-6#1)
comparable to those obtained by##5##5##(2008-10#3)(2008-5#1)(2012-2#1)
comparable to those obtained with the##2##6##(2008-10#2)
comparable to those obtained with##4##5##(2008-10#4)
comparable to those obtained##14##4##(1995-5#1)(2007-8#1)(2008-10#10)(2008-5#1)(2012-2#1)
comparable to those of conventional##3##5##(2007-12#1)(2007-8#1)(2008-10#1)
comparable to those of the##3##5##(1991-12#1)(2008-10#1)(2008-6#1)
comparable to those of##13##4##(1991-12#2)(1991-2#1)(1992-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)
comparable to those reported in##2##5##(2008-10#2)
comparable to those reported##3##4##(2008-10#3)
comparable to those##50##3##(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1992-11#1)(1993-6#1)(1995-5#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#27)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-8#1)
comparable to##205##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-6#2)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-4#2)(1997-7#2)(2006-10#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-8#3)(2008-1#3)(2008-10#55)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#2)(2009-5#1)(2009-6#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#6)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
comparable values for##2##3##(1991-6#1)(2008-5#1)
comparable values##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
comparable with or better than##2##5##(2007-11#1)(2008-10#1)
comparable with or##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-7#1)
comparable with other##2##3##(1997-4#1)(2008-11#1)
comparable with respect to##3##4##(2008-10#2)(2011-2#1)
comparable with that of##18##4##(1990-8#2)(1991-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
comparable with that##22##3##(1990-8#2)(1991-3#1)(1993-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#8)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
comparable with the wavelength##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
comparable with the##25##3##(1992-3#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#9)(2008-5#2)(2010-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
comparable with those obtained by the##2##6##(2008-10#2)
comparable with those obtained by##8##5##(1997-7#1)(2008-10#6)(2008-3#1)
comparable with those obtained with##2##5##(2007-12#1)(2008-10#1)
comparable with those obtained##12##4##(1997-7#1)(2007-12#1)(2008-10#9)(2008-3#1)
comparable with those of the##2##5##(1991-11#1)(2008-10#1)
comparable with those of##10##4##(1991-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2013-1#1)(2013-8#1)
comparable with those##28##3##(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1997-7#1)(2007-12#2)(2008-10#12)(2008-2#1)(2008-3#4)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
comparable with##106##2##(1990-2#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#2)(1992-3#2)(1993-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#6)(2008-10#25)(2008-11#2)(2008-2#7)(2008-3#23)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
comparable##533##1##(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-6#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#5)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#6)(1993-3#3)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#3)(1996-12#1)(1996-3#1)(1996-5#5)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-7#6)(2006-10#1)(2007-10#5)(2007-11#11)(2007-12#14)(2007-4#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#125)(2008-11#26)(2008-12#5)(2008-2#11)(2008-3#38)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#21)(2008-8#15)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#9)(2011-2#13)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#10)(2013-1#11)(2013-8#4)
comparably to##3##2##(2008-10#1)(2009-8#1)(2012-3#1)
comparably##7##1##(1994-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
comparative advantage##2##2##(1997-3#1)(2011-1#1)
comparative analyses indicate##2##3##(2009-8#1)(2010-3#1)
comparative analyses##9##2##(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-10#1)(2009-8#1)(2010-3#1)(2013-1#1)
comparative analysis between##2##3##(2011-2#1)(2012-12#1)
comparative analysis can##2##3##(1991-9#1)(2008-7#1)
comparative analysis is##2##3##(2008-10#1)(2012-2#1)
comparative analysis of the##5##4##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
comparative analysis of these##2##4##(1993-6#1)(2012-1#1)
comparative analysis of##22##3##(1993-6#1)(1993-9#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
comparative analysis##40##2##(1991-6#1)(1991-9#1)(1993-6#1)(1993-9#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)
comparative and functional genomics##2##4##(2008-7#1)(2011-1#1)
comparative and##8##2##(2008-11#1)(2008-4#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
comparative approach##2##2##(2009-8#1)(2012-3#1)
comparative assessment of the##2##4##(2008-5#1)(2009-10#1)
comparative assessment of##3##3##(2008-5#1)(2009-10#1)(2013-1#1)
comparative assessment##4##2##(2008-11#1)(2008-5#1)(2009-10#1)(2013-1#1)
comparative data are##2##3##(2007-12#1)(2008-11#1)
comparative data of##2##3##(2008-9#1)(2011-2#1)
comparative data##12##2##(1993-12#1)(1995-12#1)(2007-12#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
comparative delineation##2##2##(2012-12#2)
comparative effectiveness##2##2##(2008-10#1)(2008-7#1)
comparative epidemiology##2##2##(2008-10#2)
comparative evaluation of##6##3##(2008-10#2)(2008-3#1)(2008-4#1)(2010-3#1)(2013-1#1)
comparative evaluation##8##2##(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-3#2)(2013-1#1)
comparative evidence##2##2##(2008-9#1)(2011-2#1)
comparative genetic##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
comparative genome##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
comparative genomic analysis##3##3##(2008-4#1)(2008-7#1)(2009-10#1)
comparative genomic hybridization (CGH)##3##4##(2008-9#1)(2012-3#2)
comparative genomic hybridization##8##3##(2008-4#2)(2008-9#1)(2009-5#1)(2012-1#1)(2012-3#3)
comparative genomic##12##2##(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2012-1#1)(2012-3#3)
comparative genomics##13##2##(2008-7#6)(2008-8#1)(2009-5#3)(2011-2#1)(2012-3#2)
comparative health##2##2##(1997-3#1)(2013-1#1)
comparative mapping##3##2##(2008-10#1)(2008-7#2)
comparative method##8##2##(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)
comparative methods##2##2##(2008-10#1)(2008-8#1)
comparative molecular field analysis (CoMFA)##2##5##(2010-12#1)(2011-2#1)
comparative molecular field analysis##3##4##(1995-3#1)(2010-12#1)(2011-2#1)
comparative molecular##4##2##(1995-3#1)(2010-12#1)(2011-2#2)
comparative performance##2##2##(2008-10#2)
comparative perspective##5##2##(1991-12#1)(1992-3#1)(1995-2#1)(2009-8#2)
comparative proteomics##2##2##(2010-12#2)
comparative purposes##3##2##(1997-4#1)(2008-10#2)
comparative research##2##2##(2007-11#1)(2008-11#1)
comparative results##2##2##(1993-1#1)(2008-7#1)
comparative sequence analysis of##2##4##(1997-6#1)(2008-5#1)
comparative sequence analysis##4##3##(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
comparative studies between##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
comparative studies of##4##3##(2008-2#1)(2008-9#1)(2010-5#1)(2011-2#1)
comparative studies with##6##3##(1997-8#1)(2008-10#2)(2008-11#2)(2012-12#1)
comparative studies##25##2##(1990-8#1)(1997-8#2)(2006-6#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-12#1)
comparative study between##3##3##(2007-8#1)(2008-2#1)(2008-8#1)
comparative study for the##3##4##(1993-3#1)(2008-10#1)(2008-5#1)
comparative study in##4##3##(2007-11#1)(2008-1#1)(2008-10#2)
comparative study of the##12##4##(1993-6#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-1#1)
comparative study of##46##3##(1990-6#1)(1991-3#1)(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)
comparative study on##7##3##(1990-12#1)(1990-9#2)(2007-10#1)(2008-10#1)(2010-12#1)(2010-6#1)
comparative study was##6##3##(1992-5#1)(2008-10#4)(2012-3#1)
comparative study with##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
comparative study##99##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)
comparative study]##2##2##(1991-3#1)(1994-6#1)
comparative test of##2##3##(2008-8#2)
comparative tests##2##2##(1997-4#1)(2008-10#1)
comparative value of##2##3##(2012-3#1)(2013-1#1)
comparative value##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
comparative##390##1##(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-3#2)(1991-6#1)(1991-9#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-5#1)(1994-6#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#5)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#72)(2008-11#18)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#10)(2008-5#9)(2008-6#1)(2008-7#28)(2008-8#19)(2008-9#11)(2009-10#4)(2009-3#1)(2009-5#6)(2009-6#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#7)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#6)(2011-2#22)(2012-1#3)(2012-12#7)(2012-2#8)(2012-3#18)(2013-1#16)(2013-7#1)(2013-8#2)
comparatively for##2##2##(2008-10#1)(2008-3#1)
comparatively high##2##2##(1993-3#1)(2008-5#1)
comparatively higher##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
comparatively little attention##2##3##(1995-6#1)(2012-2#1)
comparatively little research has been##2##5##(2010-12#1)(2010-6#1)
comparatively little##5##2##(1995-6#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-2#1)
comparatively low##3##2##(1992-9#1)(1997-2#1)(2008-10#1)
comparatively lower##2##2##(1995-12#1)(2011-1#1)
comparatively simple##2##2##(2008-3#1)(2009-5#1)
comparatively##46##1##(1991-8#1)(1992-2#1)(1992-9#3)(1993-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#2)
comparator##10##1##(2008-1#1)(2008-11#1)(2008-5#4)(2010-8#1)(2012-3#2)(2013-1#1)
comparators##3##1##(2008-5#1)(2012-3#2)
compare a##3##2##(2008-8#2)(2008-9#1)
compare and evaluate##2##3##(2013-7#1)(2013-8#1)
compare and##6##2##(2008-10#2)(2008-3#1)(2008-9#1)(2013-7#1)(2013-8#1)
compare both##6##2##(1992-1#1)(1994-5#1)(2007-8#1)(2008-11#1)(2010-8#1)(2013-1#1)
compare data##4##2##(2007-12#1)(2008-10#1)(2013-7#1)(2013-8#1)
compare echocardiography##2##2##(2012-1#2)
compare fairly well with data obtained using##2##7##(2008-10#2)
compare favorably to##2##3##(1992-2#1)(2008-11#1)
compare favorably with a##2##4##(2008-3#2)
compare favorably with those obtained##4##5##(2008-10#4)
compare favorably with those##6##4##(2008-10#4)(2008-2#1)(2008-3#1)
compare favorably with##14##3##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#5)(2008-9#1)(2009-5#1)
compare favorably##16##2##(1992-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-9#1)(2009-5#1)
compare favourably with the results##2##5##(2008-10#1)(2012-2#1)
compare favourably with##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
compare favourably##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
compare four##4##2##(1992-6#1)(1997-5#1)(2007-7#1)(2008-10#1)
compare gene expression##2##3##(2008-11#2)
compare it with the##4##4##(1990-7#1)(2008-11#1)(2008-2#1)(2011-2#1)
compare it with##9##3##(1990-7#1)(1994-5#1)(1996-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2011-2#1)
compare it##11##2##(1990-7#1)(1994-5#1)(1996-11#1)(1997-3#1)(2007-12#2)(2008-11#1)(2008-2#2)(2011-2#1)(2013-1#1)
compare its##6##2##(1995-3#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
compare measurements##2##2##(2008-2#1)(2008-5#1)
compare of##2##2##(2008-12#1)(2011-2#1)
compare our results##2##3##(2008-10#1)(2008-7#1)
compare our##8##2##(1994-3#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
compare results##2##2##(2008-3#1)(2009-5#1)
compare the analytical##2##3##(2007-11#1)(2008-10#1)
compare the calculated##2##3##(2008-3#2)
compare the effectiveness of##4##4##(1994-7#1)(1995-4#1)(2008-10#1)(2013-1#1)
compare the effects of##5##4##(1994-12#1)(2008-11#1)(2008-3#1)(2012-5#1)(2013-1#1)
compare the effects##6##3##(1994-12#1)(1994-5#1)(2008-11#1)(2008-3#1)(2012-5#1)(2013-1#1)
compare the efficacy of##4##4##(1993-9#1)(1997-2#1)(2010-7#1)(2013-1#1)
compare the efficacy##5##3##(1993-9#1)(1997-2#1)(2007-8#1)(2010-7#1)(2013-1#1)
compare the information##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
compare the levels of##3##4##(2008-9#1)(2013-8#2)
compare the output of our##2##5##(2008-3#2)
compare the performance of the##3##5##(2008-2#2)(2011-1#1)
compare the performance of##10##4##(2007-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2011-1#1)(2013-1#1)
compare the performance##11##3##(2007-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
compare the relative##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
compare the response of##3##4##(2008-11#1)(2008-2#1)(2010-2#1)
compare the results from##2##4##(2008-10#1)(2008-4#1)
compare the results obtained with##2##5##(2008-10#1)(2013-1#1)
compare the results obtained##3##4##(2008-10#2)(2013-1#1)
compare the results of two##2##5##(2007-8#1)(2008-5#1)
compare the results of##8##4##(1995-3#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
compare the results with those from##2##6##(2007-11#1)(2012-3#1)
compare the results with those obtained##2##6##(2008-2#1)(2009-3#1)
compare the results with those##5##5##(2007-10#1)(2007-11#1)(2008-2#1)(2009-3#1)(2012-3#1)
compare the results with##9##4##(1997-8#1)(2007-10#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2012-3#1)
compare the results##26##3##(1991-3#1)(1995-3#1)(1996-1#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
compare the safety and efficacy of##3##6##(1996-3#1)(2006-10#1)(2007-10#1)
compare the safety and##4##4##(1996-3#1)(2006-10#1)(2007-10#1)(2012-2#1)
compare the sensitivity##3##3##(1997-3#1)(2007-12#1)(2008-3#1)
compare the size##2##3##(1996-3#1)(2008-10#1)
compare the temporal##4##3##(1996-7#1)(2006-6#1)(2007-10#1)(2008-10#1)
compare the use of##4##4##(2008-11#1)(2008-7#1)(2010-9#1)(2012-3#1)
compare the values##2##3##(2007-11#1)(2012-3#1)
compare the##256##2##(1990-7#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-6#1)(1993-1#2)(1993-12#3)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#2)(1996-1#1)(1996-2#1)(1996-3#5)(1996-7#1)(1997-2#2)(1997-3#2)(1997-8#3)(2006-10#1)(2006-6#1)(2007-10#4)(2007-11#8)(2007-12#6)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#14)(2008-3#21)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#11)(2012-12#3)(2012-2#6)(2012-3#6)(2012-5#1)(2013-1#21)(2013-8#8)
compare their##11##2##(1994-12#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-10#1)(2012-12#2)(2013-1#2)
compare them to##4##3##(1991-7#1)(2008-11#1)(2010-2#1)(2012-3#1)
compare them with##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)
compare them##12##2##(1991-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
compare these##12##2##(1992-10#1)(1992-3#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-3#3)(2008-9#1)(2011-1#2)(2012-3#1)
compare this##7##2##(2008-2#3)(2008-3#2)(2009-12#1)(2012-1#1)
compare three##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
compare to##4##2##(1995-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
compare two methods of##2##4##(2008-3#1)(2013-1#1)
compare two##10##2##(1994-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
compare various##3##2##(2007-12#1)(2008-11#1)(2012-12#1)
compare very favourably with##2##4##(2007-11#1)(2008-10#1)
compare very##3##2##(2007-11#1)(2008-10#2)
compare well with the##2##4##(1990-8#1)(2008-10#1)
compare well with those##2##4##(2008-10#2)
compare well with##6##3##(1990-8#1)(2007-11#1)(2008-10#3)(2008-3#1)
compare well##7##2##(1990-8#1)(2007-11#1)(2008-10#4)(2008-3#1)
compare with the##4##3##(1995-1#1)(2008-1#1)(2008-4#1)(2012-3#1)
compare with those##2##3##(2008-7#1)(2012-3#1)
compare with##12##2##(1994-1#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#2)
compare##581##1##(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#2)(1993-1#3)(1993-12#7)(1993-9#1)(1994-1#2)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#7)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#5)(2006-10#1)(2006-6#1)(2007-10#6)(2007-11#15)(2007-12#13)(2007-4#1)(2007-7#7)(2007-8#7)(2008-1#3)(2008-10#65)(2008-11#15)(2008-12#10)(2008-2#31)(2008-3#47)(2008-4#4)(2008-5#18)(2008-6#7)(2008-7#15)(2008-8#17)(2008-9#19)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#12)(2011-2#28)(2012-1#5)(2012-12#8)(2012-2#7)(2012-3#20)(2012-5#1)(2013-1#34)(2013-7#3)(2013-8#14)
compared GM-CSF versus##2##3##(2008-7#2)
compared a##6##2##(1993-12#1)(1995-11#1)(2007-12#1)(2008-1#1)(2009-11#1)(2012-12#1)
compared according to the##3##4##(2008-10#3)
compared according to##7##3##(2008-10#3)(2008-7#1)(2010-5#1)(2013-1#2)
compared across##5##2##(1993-2#1)(1996-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
compared against##4##2##(1994-5#1)(2008-7#1)(2009-5#1)(2010-2#1)
compared among these##2##3##(2007-7#1)(2008-10#1)
compared among##8##2##(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2012-2#1)
compared and contrasted in##2##4##(1996-6#1)(2013-8#1)
compared and contrasted with##2##4##(2008-5#1)(2013-8#1)
compared and contrasted##7##3##(1996-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#2)
compared and discussed##4##3##(2008-10#3)(2008-3#1)
compared and the##3##3##(2008-10#2)(2008-11#1)
compared and##28##2##(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2012-2#2)(2013-8#2)
compared as##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
compared at##8##2##(1990-7#1)(1992-3#1)(1994-11#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-3#2)
compared between control and##2##4##(1995-12#1)(2008-7#1)
compared between groups##2##3##(2011-2#1)(2013-1#1)
compared between the two groups using##2##6##(1996-2#1)(2012-2#1)
compared between the two groups##3##5##(1996-2#1)(2011-2#1)(2012-2#1)
compared between the##10##3##(1995-4#1)(1996-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
compared between two##2##3##(2008-7#1)(2011-2#1)
compared between##32##2##(1995-12#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-11#1)(2011-2#4)(2012-2#3)(2012-5#1)(2013-1#3)
compared both##2##2##(2008-10#2)
compared by measuring##2##3##(1993-2#1)(1994-9#1)
compared by the##2##3##(1990-7#1)(2008-6#1)
compared by use of##3##4##(1991-12#1)(2007-12#1)(2008-2#1)
compared by##21##2##(1990-7#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
compared data##2##2##(1990-12#1)(1994-5#1)
compared directly with the##2##4##(2008-2#1)(2008-3#1)
compared favorably to##4##3##(1993-12#1)(2008-10#2)(2008-9#1)
compared favorably with##4##3##(2008-10#2)(2008-3#1)(2008-6#1)
compared favorably##8##2##(1993-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)
compared favourably with the##2##4##(2008-10#2)
compared for a##4##3##(1995-11#1)(1995-2#1)(2008-10#1)(2008-3#1)
compared for each##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
compared for the##15##3##(1990-8#1)(1996-12#1)(1996-5#1)(2007-2#1)(2008-10#7)(2008-3#2)(2008-7#1)(2013-1#1)
compared for their##6##3##(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2012-3#1)
compared for##50##2##(1990-8#2)(1991-1#1)(1991-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#19)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
compared in a##4##3##(1995-9#1)(2007-12#1)(2008-10#1)(2008-5#1)
compared in terms of their##2##5##(1996-5#1)(2008-10#1)
compared in terms of##10##4##(1996-5#1)(2008-10#5)(2008-2#2)(2008-3#1)(2013-1#1)
compared in the three##2##4##(2010-4#1)(2011-2#1)
compared in the##6##3##(1994-8#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#1)
compared in##55##2##(1990-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
compared it with the##2##4##(2007-10#1)(2008-9#1)
compared it with##7##3##(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
compared it##9##2##(1992-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-1#1)
compared its performance with##2##4##(2008-3#1)(2008-5#1)
compared its##3##2##(1991-2#1)(2008-3#1)(2008-5#1)
compared mortality##2##2##(2006-8#1)(2013-1#1)
compared on a##2##3##(1996-12#1)(2008-10#1)
compared on the basis of##4##5##(2008-10#2)(2008-7#1)(2011-2#1)
compared on##10##2##(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
compared our##4##2##(2008-3#3)(2009-4#1)
compared over##3##2##(1990-12#1)(1991-2#1)(2011-2#1)
compared quantitatively with##2##3##(2008-3#2)
compared rates of##2##3##(2008-5#2)
compared responses##2##2##(2008-9#1)(2009-8#1)
compared results##2##2##(1990-8#1)(2008-10#1)
compared sequences##3##2##(1996-6#3)
compared single##2##2##(2009-4#1)(2010-8#1)
compared statistically with those obtained##2##5##(2008-10#1)(2008-11#1)
compared statistically##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
compared the ability of##2##4##(1994-2#1)(2011-2#1)
compared the clinical##2##3##(1994-9#1)(2008-7#1)
compared the data##4##3##(1990-8#1)(1994-7#1)(2008-11#1)(2008-5#1)
compared the effectiveness and##2##4##(1993-2#1)(2008-10#1)
compared the effectiveness of##2##4##(2008-4#1)(2008-7#1)
compared the effectiveness##4##3##(1993-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
compared the effects of a##2##5##(2009-11#1)(2012-2#1)
compared the effects of##10##4##(1991-12#1)(1993-3#1)(1993-5#1)(1995-11#1)(1995-12#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2012-2#1)
compared the effects##11##3##(1991-12#1)(1993-3#1)(1993-5#1)(1995-11#1)(1995-12#1)(2008-10#2)(2009-11#1)(2009-8#1)(2010-1#1)(2012-2#1)
compared the efficacy and##2##4##(1993-1#1)(2008-10#1)
compared the efficacy of##2##4##(2011-2#1)(2012-3#1)
compared the efficacy##4##3##(1993-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
compared the expression of##2##4##(1990-12#1)(2013-8#1)
compared the expression##3##3##(1990-12#1)(2008-7#1)(2013-8#1)
compared the performance of##2##4##(1993-8#1)(2010-2#1)
compared the power of the##2##5##(1996-3#2)
compared the results at##2##4##(2008-1#1)(2008-8#1)
compared the results of the##2##5##(2008-11#1)(2008-3#1)
compared the results of##9##4##(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
compared the results with##2##4##(2008-10#1)(2008-3#1)
compared the results##19##3##(1995-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
compared the two##3##3##(1996-1#1)(2008-10#1)(2008-7#1)
compared the yield##2##3##(2008-10#2)
compared the##140##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-1#2)(2008-10#15)(2008-11#6)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-11#2)(2009-3#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
compared their##6##2##(1990-5#1)(1995-12#2)(1996-1#1)(2008-11#1)(2008-3#1)
compared these##8##2##(2007-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-8#2)
compared three##2##2##(2008-10#1)(2008-11#1)
compared through##2##2##(2008-10#1)(2008-5#1)
compared to 0##6##3##(1993-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
compared to 1##7##3##(1994-11#1)(1997-5#1)(2008-10#1)(2008-11#3)(2010-8#1)
compared to 15##2##3##(1994-2#1)(1994-8#1)
compared to 2##2##3##(2008-11#1)(2008-5#1)
compared to 3##2##3##(2008-7#1)(2008-9#1)
compared to 35##2##3##(2010-10#1)(2011-1#1)
compared to 48%##2##3##(2013-1#1)(2013-7#1)
compared to 5##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
compared to 66##3##3##(1990-6#1)(2008-1#1)(2008-10#1)
compared to 89##2##3##(1990-8#1)(1997-5#1)
compared to 9##2##3##(2008-9#1)(2010-6#1)
compared to A7##2##3##(2008-11#2)
compared to AS##2##3##(2013-8#2)
compared to B##3##3##(1994-12#1)(2008-10#1)(2008-6#1)
compared to CECT##2##3##(2012-12#2)
compared to Caucasians##2##3##(2012-2#2)
compared to European##2##3##(2008-1#1)(2010-10#1)
compared to M##2##3##(2008-6#1)(2013-7#1)
compared to S##2##3##(2008-12#1)(2012-3#1)
compared to SD rats and##4##5##(1996-12#4)
compared to SD rats##7##4##(1993-12#1)(1996-12#6)
compared to WT mice##2##4##(2010-2#1)(2012-3#1)
compared to White women##2##4##(2011-2#2)
compared to a bare capillary##2##5##(1997-2#2)
compared to a bare##3##4##(1997-2#2)(2008-10#1)
compared to a conventional##2##4##(1991-6#1)(2008-10#1)
compared to a group of##2##5##(1994-2#1)(2008-5#1)
compared to a reference##3##4##(1996-9#1)(2008-4#1)(2009-10#1)
compared to a standard##2##4##(2008-3#1)(2008-5#1)
compared to a##43##3##(1991-6#2)(1994-2#1)(1995-11#1)(1996-9#1)(1997-2#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-7#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
compared to age-matched controls##2##4##(2008-3#1)(2013-1#1)
compared to age-matched##3##3##(2008-3#1)(2012-3#1)(2013-1#1)
compared to all other##2##4##(1996-5#1)(2010-3#1)
compared to an##6##3##(1997-1#1)(2008-10#2)(2008-5#2)(2012-2#1)
compared to analogous##2##3##(1994-5#1)(2008-10#1)
compared to aqueous##2##3##(2008-10#2)
compared to assess the##2##4##(2008-10#1)(2012-1#1)
compared to bare metal stents##3##5##(2008-11#2)(2008-12#1)
compared to baseline)##2##3##(2011-2#1)(2013-1#1)
compared to both##2##3##(2008-4#1)(2013-8#1)
compared to cells cultured in##2##5##(1992-8#2)
compared to cells transfected with##2##5##(1995-2#1)(2008-11#1)
compared to cells##7##3##(1992-6#1)(1992-8#2)(1994-8#1)(1995-12#1)(1995-2#1)(2008-11#1)
compared to children##2##3##(2008-1#1)(2013-1#1)
compared to commercial##3##3##(2008-10#2)(2010-3#1)
compared to control cultures##2##4##(1995-12#1)(2008-11#1)
compared to control groups##2##4##(1995-12#1)(2008-7#1)
compared to control##24##3##(1991-2#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#3)(1997-2#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
compared to controls with##2##4##(2008-11#1)(2008-5#1)
compared to controls##31##3##(1990-11#1)(1990-5#1)(1990-8#2)(1993-12#1)(1993-6#1)(1994-6#2)(1994-9#1)(1995-3#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-2#2)(2013-1#1)
compared to conventional methods##2##4##(2008-10#1)(2010-3#1)
compared to conventional##15##3##(1994-3#1)(2008-10#4)(2008-5#1)(2008-7#2)(2010-3#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
compared to corresponding##2##3##(1993-9#1)(2010-4#1)
compared to data##2##3##(1993-1#1)(1994-2#1)
compared to day##2##3##(2008-12#1)(2008-8#1)
compared to experimental##2##3##(1997-2#1)(2008-7#1)
compared to experiments##2##3##(2008-7#1)(2008-8#1)
compared to female controls##2##4##(2008-10#2)
compared to females##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
compared to free##2##3##(1994-3#1)(2008-5#1)
compared to glass##2##3##(2008-10#2)
compared to group##4##3##(2007-8#1)(2008-11#1)(2009-3#2)
compared to healthy controls##3##4##(1993-2#1)(2008-1#1)(2013-1#1)
compared to healthy individuals##3##4##(2009-11#1)(2009-8#1)(2012-2#1)
compared to healthy subjects##2##4##(2012-3#1)(2013-1#1)
compared to healthy##11##3##(1993-2#1)(2007-10#1)(2008-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
compared to high##2##3##(2012-1#1)(2012-3#1)
compared to human##2##3##(2008-11#1)(2008-6#1)
compared to individual##3##3##(2008-10#1)(2008-11#2)
compared to individuals##2##3##(2007-12#1)(2012-2#1)
compared to initiating##2##3##(2008-8#1)(2012-2#1)
compared to intact##2##3##(1991-5#1)(2008-8#1)
compared to its##11##3##(1992-9#1)(1997-3#1)(2007-8#1)(2008-11#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
compared to known##2##3##(1992-12#1)(2008-5#1)
compared to levels in##2##4##(1991-2#1)(1992-12#1)
compared to low##2##3##(2010-7#1)(2011-2#1)
compared to males##2##3##(2008-11#1)(2013-7#1)
compared to mammalian##2##3##(1991-6#1)(1992-11#1)
compared to manual##2##3##(2008-10#1)(2010-8#1)
compared to many##2##3##(2008-10#1)(2008-5#1)
compared to men##3##3##(2011-2#1)(2012-1#1)(2013-8#1)
compared to minor##2##3##(2008-4#1)(2011-2#1)
compared to naive mice##3##4##(2008-10#3)
compared to naive##5##3##(1994-3#1)(1995-12#1)(2008-10#3)
compared to natural##3##3##(1994-12#1)(1994-9#1)(2008-10#1)
compared to non-Hispanic Whites##3##4##(2012-12#3)
compared to non-obese##2##3##(2012-2#2)
compared to non-tolerant##2##3##(2008-12#1)(2011-10#1)
compared to nonobese##2##3##(2013-1#2)
compared to normal weight##2##4##(2007-12#1)(2009-1#1)
compared to normal##13##3##(1991-9#1)(1992-8#1)(1993-11#2)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-12#1)(2010-3#1)(2011-2#1)
compared to older##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
compared to one##2##3##(2008-5#1)(2008-9#1)
compared to other CARICOMP sites##2##5##(2011-2#2)
compared to other available##2##4##(1991-12#1)(2008-7#1)
compared to other studies##2##4##(2008-5#1)(2013-7#1)
compared to other##49##3##(1990-11#1)(1991-12#1)(1993-2#1)(1996-3#2)(1996-6#1)(1997-4#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
compared to pH 4 and 6##2##6##(2008-5#2)
compared to pH##3##3##(2008-5#2)(2013-1#1)
compared to parent##3##3##(1991-4#1)(1995-3#1)(2008-12#1)
compared to parental##2##3##(1994-11#1)(1994-8#1)
compared to patients with##2##4##(2008-1#1)(2013-1#1)
compared to patients without##2##4##(2007-10#1)(2008-10#1)
compared to patients##9##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-2#1)(2013-1#2)
compared to placebo##2##3##(2008-10#1)(2008-7#1)
compared to previous results##2##4##(1991-8#1)(2011-2#1)
compared to previous##4##3##(1991-8#1)(1993-8#1)(2008-7#1)(2011-2#1)
compared to primary##2##3##(1992-3#1)(2008-9#1)
compared to rats fed##3##4##(1993-12#1)(2012-2#1)(2013-1#1)
compared to results obtained##2##4##(2008-10#1)(2008-6#1)
compared to results##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2012-1#1)
compared to roach##2##3##(2008-7#2)
compared to saline##3##3##(1993-1#1)(1995-12#1)(1995-2#1)
compared to serum##2##3##(1990-12#1)(1993-11#1)
compared to sham##5##3##(1993-6#1)(1995-11#1)(1996-12#1)(1996-9#1)(2008-7#1)
compared to simple##2##3##(2008-4#1)(2008-7#1)
compared to specimens##2##3##(2011-1#1)(2013-1#1)
compared to standard##5##3##(1990-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2013-1#1)
compared to states##2##3##(1994-2#2)
compared to subjects##3##3##(2008-1#1)(2008-8#1)(2012-3#1)
compared to tasks##2##3##(2008-11#1)(2009-7#1)
compared to that in the##2##5##(2007-12#1)(2008-9#1)
compared to that in##9##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2012-1#1)(2012-3#1)(2013-1#1)
compared to that observed in##2##5##(1992-12#1)(2013-1#1)
compared to that obtained in##2##5##(1992-12#1)(1996-12#1)
compared to that obtained##6##4##(1992-12#2)(1996-12#1)(2008-11#1)(2008-6#1)(2012-2#1)
compared to that of a##5##5##(2008-10#2)(2008-7#1)(2008-9#1)(2013-1#1)
compared to that of control##3##5##(1992-10#1)(2008-10#1)(2008-11#1)
compared to that of the##12##5##(1990-5#1)(1992-6#1)(1994-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
compared to that of##41##4##(1990-5#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#1)(1997-3#2)(1997-4#3)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
compared to that##64##3##(1990-5#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-3#2)(1997-4#3)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#3)(2009-12#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
compared to the Asian-African##2##4##(2013-1#2)
compared to the ELISA##2##4##(2008-10#2)
compared to the GC-HRMS##2##4##(2008-10#2)
compared to the LAVH group##2##5##(2010-3#2)
compared to the USA##2##4##(2009-4#2)
compared to the acid-washed PM 1648##2##6##(2008-10#2)
compared to the alphanumeric##2##4##(2010-8#2)
compared to the baseline##3##4##(2011-2#2)(2013-1#1)
compared to the cells##2##4##(1992-8#1)(2010-12#1)
compared to the children##2##4##(2008-3#1)(2013-8#1)
compared to the control PFS##2##5##(2008-11#2)
compared to the control group##12##5##(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-2#2)
compared to the control##26##4##(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-6#2)(2013-7#1)
compared to the controls##4##4##(1992-12#1)(1994-5#1)(2008-7#2)
compared to the conventional method##2##5##(2008-11#2)
compared to the conventional##6##4##(2007-10#1)(2008-10#1)(2008-11#3)(2008-4#1)
compared to the corresponding##2##4##(1995-8#1)(2008-10#1)
compared to the current##2##4##(2008-10#1)(2008-7#1)
compared to the data##4##4##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
compared to the direct##2##4##(2008-10#1)(2008-5#1)
compared to the ePTFE##2##4##(2007-7#2)
compared to the effects##2##4##(1994-3#1)(2008-11#1)
compared to the expected##2##4##(1993-8#1)(1994-12#1)
compared to the fish from the control site##2##8##(2008-7#2)
compared to the flat##2##4##(1991-2#1)(1995-2#1)
compared to the general population##2##5##(1994-2#1)(1997-3#1)
compared to the group##3##4##(1991-9#1)(2008-8#1)(2013-8#1)
compared to the human##2##4##(1993-6#1)(2009-10#1)
compared to the left##2##4##(2007-7#1)(2010-9#1)
compared to the levels in the control group##2##8##(2009-12#1)(2011-1#1)
compared to the middle and##2##5##(2007-12#1)(2007-5#1)
compared to the native##5##4##(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#1)
compared to the negative##2##4##(1990-6#1)(2009-8#1)
compared to the non-stimulated side##2##5##(1990-7#2)
compared to the normal##5##4##(1990-7#1)(1994-9#1)(2008-5#1)(2008-7#1)(2011-3#1)
compared to the number of##2##5##(2008-11#1)(2008-8#1)
compared to the one##2##4##(2008-10#1)(2008-2#1)
compared to the other three##2##5##(2008-7#1)(2009-11#1)
compared to the other two##2##5##(1993-2#1)(1996-12#1)
compared to the other##14##4##(1991-3#1)(1993-2#1)(1994-6#1)(1995-1#1)(1996-12#2)(2008-10#6)(2008-7#1)(2009-11#1)
compared to the reference method##2##5##(2008-10#2)
compared to the reference##4##4##(2008-10#3)(2008-12#1)
compared to the remaining##2##4##(1997-3#1)(2007-10#1)
compared to the respective##3##4##(2008-10#2)(2012-2#1)
compared to the rest of##2##5##(2007-12#1)(2011-2#1)
compared to the rest##3##4##(2007-12#1)(2010-4#1)(2011-2#1)
compared to the retinol deficient group##2##6##(1994-8#2)
compared to the single##2##4##(2008-10#1)(2013-1#1)
compared to the standard##6##4##(2008-10#1)(2008-11#2)(2008-7#1)(2010-5#1)(2011-1#1)
compared to the static##2##4##(2008-11#1)(2013-8#1)
compared to the traditional##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
compared to the two##2##4##(2008-7#1)(2010-3#1)
compared to the untreated##2##4##(1995-12#1)(2008-5#1)
compared to the use of##2##5##(1994-9#1)(2008-3#1)
compared to the usual method##2##5##(2008-10#1)(2008-12#1)
compared to the usual##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
compared to the values##2##4##(2008-5#1)(2011-2#1)
compared to the widely used##2##5##(2010-11#1)(2012-2#1)
compared to the wild-type##6##4##(1993-6#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#1)
compared to the youngest##2##4##(1996-2#1)(2008-10#1)
compared to the zero##2##4##(1994-8#1)(2008-10#1)
compared to the##382##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#4)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#2)(1996-12#6)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#65)(2008-11#26)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#14)(2008-6#4)(2008-7#21)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#12)(2012-3#3)(2012-6#2)(2012-9#1)(2013-1#7)(2013-7#4)(2013-8#5)
compared to their control##3##4##(1991-5#1)(2008-12#1)(2012-2#1)
compared to their##16##3##(1991-2#1)(1991-5#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
compared to those calculated##3##4##(2008-5#1)(2012-12#2)
compared to those described##2##4##(2008-10#2)
compared to those from the##2##5##(1994-3#1)(2008-10#1)
compared to those from##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
compared to those grown##2##4##(1993-6#1)(2008-10#1)
compared to those in 2009##2##5##(2012-3#2)
compared to those in Group##2##5##(2011-1#1)(2011-2#1)
compared to those in the control group##2##7##(2011-1#1)(2013-8#1)
compared to those in the##3##5##(2011-1#1)(2012-5#1)(2013-8#1)
compared to those in##12##4##(1991-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-8#1)
compared to those obtained by the##3##6##(2008-10#3)
compared to those obtained by##7##5##(2008-10#6)(2010-4#1)
compared to those obtained with##4##5##(1994-9#1)(2008-10#3)
compared to those obtained##13##4##(1994-9#1)(2008-10#11)(2010-4#1)
compared to those of the##3##5##(1995-2#1)(2008-10#1)(2013-8#1)
compared to those of##15##4##(1990-5#1)(1990-9#1)(1994-5#1)(1995-2#1)(1996-12#1)(2008-10#3)(2010-4#2)(2011-2#2)(2012-3#1)(2013-8#2)
compared to those that##2##4##(2007-11#1)(2008-9#1)
compared to those who##3##4##(1994-1#1)(1997-4#1)(2007-2#1)
compared to those with##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
compared to those without##7##4##(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
compared to those##84##3##(1990-5#1)(1990-9#1)(1991-4#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#25)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-4#3)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#4)
compared to traditional##5##3##(2007-7#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-2#1)
compared to tumors from##2##4##(1993-11#1)(2008-6#1)
compared to tumors##3##3##(1993-11#2)(2008-6#1)
compared to ultrasound##2##3##(2010-9#1)(2012-12#1)
compared to uninfected##2##3##(1994-9#1)(1995-2#1)
compared to untreated##7##3##(1992-5#1)(1995-3#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
compared to various##2##3##(1992-3#1)(1993-9#1)
compared to what##2##3##(2008-11#1)(2008-5#1)
compared to when##2##3##(2008-8#1)(2011-1#1)
compared to wild type##4##4##(1997-7#1)(2009-8#1)(2012-2#2)
compared to wild-type##6##3##(1995-2#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
compared to women##3##3##(1991-12#1)(2008-1#1)(2008-3#1)
compared to young##5##3##(1991-12#2)(2008-7#1)(2009-12#1)(2013-7#1)
compared to younger##2##3##(1996-2#1)(2008-7#1)
compared to##1544##2##(1990-10#2)(1990-11#8)(1990-12#4)(1990-2#2)(1990-5#9)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#2)(1991-12#10)(1991-2#7)(1991-3#3)(1991-4#4)(1991-5#5)(1991-6#7)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#4)(1992-12#9)(1992-3#5)(1992-5#3)(1992-6#5)(1992-8#6)(1992-9#3)(1993-1#9)(1993-11#8)(1993-12#13)(1993-2#8)(1993-3#2)(1993-5#1)(1993-6#6)(1993-8#4)(1993-9#5)(1994-1#3)(1994-10#1)(1994-11#8)(1994-12#11)(1994-2#11)(1994-3#7)(1994-5#8)(1994-6#4)(1994-8#11)(1994-9#12)(1995-1#1)(1995-11#5)(1995-12#16)(1995-2#17)(1995-3#8)(1995-5#4)(1995-6#1)(1995-8#5)(1996-1#3)(1996-12#19)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#8)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#10)(1997-3#6)(1997-4#9)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#4)(2007-10#10)(2007-11#8)(2007-12#17)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#21)(2007-8#11)(2008-1#19)(2008-10#205)(2008-11#101)(2008-12#31)(2008-2#5)(2008-3#18)(2008-4#14)(2008-5#57)(2008-6#23)(2008-7#66)(2008-8#30)(2008-9#32)(2009-1#2)(2009-10#7)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#5)(2009-7#12)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#16)(2010-4#13)(2010-5#6)(2010-6#4)(2010-7#7)(2010-8#13)(2010-9#4)(2011-1#28)(2011-10#1)(2011-2#70)(2011-3#1)(2011-7#1)(2012-1#10)(2012-12#27)(2012-2#51)(2012-3#30)(2012-5#3)(2012-6#2)(2012-9#2)(2013-1#59)(2013-7#16)(2013-8#33)
compared two groups##2##3##(2009-3#1)(2012-2#1)
compared two##5##2##(2008-3#2)(2008-4#1)(2009-3#1)(2012-2#1)
compared under##2##2##(2008-10#2)
compared using a##4##3##(1995-3#1)(1997-4#1)(2008-10#2)
compared using the##2##3##(2010-3#1)(2012-12#1)
compared using##27##2##(1992-8#1)(1995-12#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-12#2)
compared very##2##2##(2008-10#2)
compared well with the results##2##5##(2008-10#2)
compared well with the##4##4##(2008-10#4)
compared well with those obtained by##4##6##(2008-10#4)
compared well with those obtained##5##5##(2008-10#5)
compared well with those##9##4##(2008-10#8)(2010-5#1)
compared well with##15##3##(2008-10#13)(2008-2#1)(2010-5#1)
compared well##18##2##(2008-10#15)(2008-2#1)(2008-3#1)(2010-5#1)
compared when##4##2##(2008-2#1)(2008-8#1)(2008-9#1)(2011-3#1)
compared with 'incorrect' and##3##4##(2008-11#3)
compared with -0##2##3##(2007-12#1)(2008-10#1)
compared with 0##11##3##(2008-10#2)(2008-12#1)(2008-2#1)(2009-3#2)(2011-2#2)(2012-12#1)(2013-1#2)
compared with 1##2##3##(2008-7#2)
compared with 16##2##3##(2008-10#1)(2011-2#1)
compared with 18##2##3##(1995-3#1)(2011-2#1)
compared with 2##3##3##(2009-12#1)(2010-12#1)(2013-1#1)
compared with 20##4##3##(1990-7#1)(2006-8#1)(2008-10#1)(2008-3#1)
compared with 24##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
compared with 25##2##3##(1993-12#1)(2008-10#1)
compared with 3##3##3##(1995-3#1)(1997-8#1)(2009-11#1)
compared with 4##5##3##(2008-10#2)(2012-2#1)(2012-3#2)
compared with 6##2##3##(2008-11#1)(2013-1#1)
compared with 8##2##3##(2008-1#1)(2012-12#1)
compared with 85##2##3##(2008-7#1)(2008-8#1)
compared with ACDF##3##3##(2012-12#3)
compared with CS and NC participants##2##6##(2008-11#2)
compared with CS##3##3##(2008-10#1)(2008-11#2)
compared with Caucasian##2##3##(2008-5#1)(2009-9#1)
compared with P##4##3##(2008-10#4)
compared with S##2##3##(2008-5#1)(2012-3#1)
compared with SRP alone##2##4##(2012-3#2)
compared with a control group##4##5##(1991-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
compared with a control##6##4##(1991-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2013-1#1)
compared with a conventional##3##4##(2008-10#1)(2008-12#1)(2008-2#1)
compared with a more##2##4##(2008-3#2)
compared with a new single compound##2##6##(2008-11#2)
compared with a placebo##2##4##(2008-5#1)(2008-7#1)
compared with a previous##2##4##(2008-10#1)(2008-9#1)
compared with a similar##2##4##(2008-10#2)
compared with a simple##2##4##(1991-2#1)(2007-12#1)
compared with a single##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
compared with a standard##3##4##(2008-10#2)(2008-2#1)
compared with a traditional##2##4##(2008-10#1)(2008-5#1)
compared with a##81##3##(1991-2#2)(1991-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#15)(2008-5#4)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
compared with aerobic##4##3##(1992-9#3)(2011-1#1)
compared with all other groups##3##5##(2009-2#1)(2009-8#1)(2011-2#1)
compared with all other species##3##5##(2009-4#3)
compared with all other##7##4##(1995-6#1)(2009-2#1)(2009-4#3)(2009-8#1)(2011-2#1)
compared with alpha-tocopherol##2##3##(1994-9#1)(2008-10#1)
compared with an##11##3##(1990-6#2)(1991-7#1)(1993-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)
compared with analytical##2##3##(2008-10#1)(2008-3#1)
compared with another##3##3##(1997-4#1)(2007-7#1)(2008-1#1)
compared with approximately##2##3##(1991-3#1)(2011-2#1)
compared with available##2##3##(2010-8#1)(2013-1#1)
compared with average##2##3##(1995-3#2)
compared with bare##2##3##(2008-10#2)
compared with baseline##5##3##(2007-10#1)(2011-2#2)(2013-1#2)
compared with best##2##3##(2010-12#1)(2013-1#1)
compared with bone##2##3##(2011-2#1)(2012-12#1)
compared with both##4##3##(2007-7#1)(2008-3#1)(2010-3#1)(2013-8#1)
compared with brief pulse##2##4##(2012-12#2)
compared with calculated spectra##3##4##(1996-2#1)(2008-2#2)
compared with cheetahs and jaguars##2##5##(2009-4#2)
compared with classical##3##3##(2008-10#1)(2008-3#2)
compared with clinical##3##3##(1994-10#1)(1996-9#1)(2008-11#1)
compared with column technique##2##4##(2008-10#2)
compared with common##2##3##(2008-10#1)(2012-3#1)
compared with commonly used##2##4##(2008-10#1)(2008-7#1)
compared with control plants##2##4##(2008-10#2)
compared with control##23##3##(1990-7#1)(1993-12#2)(1994-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2012-2#1)
compared with controls (P = 0##2##6##(1995-12#1)(1997-5#1)
compared with controls (P##3##4##(1995-12#1)(1997-5#1)(2008-10#1)
compared with controls which##2##4##(1994-8#1)(2008-10#1)
compared with controls##27##3##(1991-9#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-10#5)(2008-7#3)(2008-8#1)(2010-6#1)(2011-2#4)(2012-12#1)(2013-8#1)
compared with conventional treatments##2##4##(1997-5#1)(2008-6#1)
compared with conventional##26##3##(1991-5#1)(1994-5#1)(1997-5#1)(2007-12#1)(2008-10#10)(2008-2#5)(2008-3#3)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
compared with corresponding##4##3##(1994-2#1)(2008-10#1)(2008-3#2)
compared with data from##6##4##(1992-2#1)(1993-6#1)(2008-10#2)(2010-6#1)(2012-2#1)
compared with data obtained##2##4##(2008-10#1)(2008-2#1)
compared with data##9##3##(1992-2#1)(1993-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-6#1)(2012-2#1)
compared with different##2##3##(2008-2#1)(2013-1#1)
compared with each other##8##4##(1995-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)
compared with earlier##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
compared with existing##2##3##(2008-2#2)
compared with experimental data for##2##5##(2008-2#1)(2008-3#1)
compared with experimental data##8##4##(2008-10#1)(2008-2#6)(2008-3#1)
compared with experimental measurements##2##4##(2008-3#2)
compared with experimental results obtained##2##5##(2007-11#1)(2008-3#1)
compared with experimental results##3##4##(2007-11#1)(2008-3#2)
compared with experimental##17##3##(2007-11#1)(2008-10#1)(2008-2#6)(2008-3#6)(2008-7#1)(2009-12#1)(2013-1#1)
compared with external##2##3##(1992-12#1)(1994-8#1)
compared with extracts##2##3##(2008-10#1)(2008-11#1)
compared with female##2##3##(1997-7#1)(2008-5#1)
compared with flowers##2##3##(2008-10#2)
compared with four##2##3##(1993-12#1)(2008-10#1)
compared with free##2##3##(2008-10#2)
compared with full term infants##2##5##(2011-2#2)
compared with full term##3##4##(2011-2#3)
compared with full##4##3##(2008-3#1)(2011-2#3)
compared with furrow irrigation##2##4##(2008-10#2)
compared with gene##2##3##(2008-10#1)(2012-3#1)
compared with group##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2010-7#1)
compared with growth##2##3##(2008-10#1)(2011-2#1)
compared with healthy controls##4##4##(1997-8#1)(2008-10#1)(2008-6#1)(2012-1#1)
compared with healthy individuals##2##4##(1991-7#1)(2010-12#1)
compared with healthy##9##3##(1990-11#1)(1990-6#1)(1991-7#1)(1997-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-1#2)
compared with high##2##3##(2008-10#1)(2012-12#1)
compared with identical##2##3##(2008-11#1)(2008-3#1)
compared with in##5##3##(1990-11#1)(1990-7#1)(2008-10#2)(2008-5#1)
compared with inductively coupled##2##4##(2008-10#2)
compared with international##2##3##(1990-8#1)(2006-10#1)
compared with isolates from 'Minneola'##2##5##(2008-10#2)
compared with isolates from##3##4##(2008-10#3)
compared with its##5##3##(1994-3#1)(1995-3#1)(2008-5#3)
compared with known##2##3##(2007-11#1)(2008-8#1)
compared with linear##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
compared with literature##2##3##(1993-5#1)(2013-7#1)
compared with males##2##3##(1995-6#1)(2012-12#1)
compared with many##2##3##(1996-9#1)(2008-10#1)
compared with matched##2##3##(2010-12#2)
compared with mean##3##3##(1992-6#1)(2012-2#1)(2013-1#1)
compared with measurements of##2##4##(1991-3#1)(2008-3#1)
compared with measurements##5##3##(1991-3#1)(2008-2#2)(2008-3#2)
compared with men##5##3##(1991-7#1)(1994-6#1)(2008-4#1)(2008-5#1)(2009-11#1)
compared with model predictions##2##4##(2008-10#1)(2008-2#1)
compared with model##3##3##(1991-9#1)(2008-10#1)(2008-2#1)
compared with no##4##3##(2008-10#2)(2011-1#1)(2012-12#1)
compared with non-Medicare##2##3##(1991-12#1)(1994-12#1)
compared with non-obese##2##3##(2011-2#1)(2012-12#1)
compared with nontreated controls##2##4##(2008-10#2)
compared with normal subjects##2##4##(1990-6#1)(1995-5#1)
compared with normal##11##3##(1990-6#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-6#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-5#1)(2012-2#1)
compared with normative##2##3##(1994-12#1)(2009-10#1)
compared with numerically##2##3##(2008-3#1)(2009-11#1)
compared with older##2##3##(2008-6#1)(2011-1#1)
compared with one another##3##4##(1992-9#1)(2008-10#1)(2013-1#1)
compared with one##6##3##(1991-2#1)(1992-6#1)(1992-9#1)(2008-10#2)(2013-1#1)
compared with only##4##3##(1993-1#1)(2007-10#1)(2007-12#1)(2008-8#1)
compared with other groups##2##4##(1992-11#1)(2009-10#1)
compared with other methods##4##4##(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)
compared with other resistant##2##4##(2008-10#2)
compared with other##54##3##(1990-12#1)(1990-6#1)(1992-11#2)(1993-11#1)(1994-1#1)(1995-3#1)(1995-6#1)(2007-1#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#2)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
compared with others##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
compared with our##2##3##(1993-9#1)(2008-10#1)
compared with pH##3##3##(2008-10#3)
compared with pamidronate##2##3##(2008-7#2)
compared with patients treated with##2##5##(1997-3#1)(2008-3#1)
compared with patients with##3##4##(2011-2#2)(2012-3#1)
compared with patients without##2##4##(2008-7#1)(2013-1#1)
compared with patients##14##3##(1995-2#1)(1996-3#2)(1997-3#1)(2006-10#1)(2008-3#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
compared with placebo##4##3##(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
compared with plants##3##3##(2008-10#3)
compared with populations from##2##4##(2008-10#2)
compared with populations##3##3##(2008-10#3)
compared with positive control##2##4##(2008-10#1)(2008-11#1)
compared with predictions of##4##4##(2008-2#1)(2008-3#3)
compared with predictions##5##3##(2008-2#1)(2008-3#4)
compared with previous##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
compared with previously reported##2##4##(2008-2#1)(2008-3#1)
compared with previously##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
compared with primary##3##3##(2011-2#2)(2012-3#1)
compared with reference##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
compared with regard to##2##4##(2008-7#1)(2011-10#1)
compared with results from##3##4##(2008-3#2)(2011-2#1)
compared with results obtained with##2##5##(2006-6#1)(2008-10#1)
compared with results obtained##4##4##(2006-6#1)(2008-10#2)(2008-3#1)
compared with results##10##3##(2006-6#1)(2007-11#1)(2008-10#4)(2008-3#3)(2011-2#1)
compared with seedlings##2##3##(2008-10#2)
compared with similar##4##3##(1991-12#1)(1996-3#1)(2007-12#1)(2008-11#1)
compared with simulated##2##3##(2008-3#1)(2008-7#1)
compared with single##3##3##(2008-10#3)
compared with single-level##2##3##(2012-12#2)
compared with standard##11##3##(1993-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2012-12#1)(2013-1#2)(2013-8#1)
compared with studies##2##3##(2008-7#1)(2008-8#1)
compared with subjects##2##3##(2008-12#1)(2013-1#1)
compared with susceptible ones##3##4##(2008-10#2)(2008-12#1)
compared with that at##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
compared with that determined by##2##5##(2008-10#2)
compared with that from##2##4##(1993-8#1)(2008-3#1)
compared with that in a##2##5##(2008-2#2)
compared with that in the##4##5##(1990-2#1)(2008-10#1)(2010-8#1)(2011-3#1)
compared with that in##19##4##(1990-2#1)(1994-11#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-3#1)(2013-8#1)
compared with that observed in##2##5##(1996-12#1)(2008-10#1)
compared with that observed##4##4##(1996-12#1)(2008-10#2)(2008-11#1)
compared with that of a conventional##3##6##(2007-11#1)(2007-12#1)(2008-10#1)
compared with that of a##11##5##(1995-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-2#1)
compared with that of conventional##5##5##(2007-11#1)(2007-12#2)(2008-3#2)
compared with that of other##2##5##(2008-10#1)(2008-3#1)
compared with that of the susceptible##2##6##(2008-10#2)
compared with that of the##24##5##(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-11#1)(1995-12#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
compared with that of##89##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-11#2)(1995-12#1)(1995-2#2)(1995-6#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-2#4)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
compared with that on##3##4##(2008-10#3)
compared with that predicted##2##4##(1993-6#1)(2008-3#1)
compared with that reported in the literature##2##7##(1991-2#1)(1991-3#1)
compared with that##141##3##(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#41)(2008-11#7)(2008-2#6)(2008-3#14)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-6#3)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
compared with the CP##2##4##(2008-10#2)
compared with the Kjeldahl##3##4##(2008-10#3)
compared with the Marquardt-Levenberg##2##4##(2008-2#2)
compared with the PC##2##4##(2010-2#2)
compared with the PL-free diet group##2##6##(2008-7#2)
compared with the baseline##2##4##(2008-10#1)(2008-7#1)
compared with the common##2##4##(2008-3#1)(2009-8#1)
compared with the control group##10##5##(1994-3#1)(2007-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
compared with the control treatment##2##5##(2008-10#2)
compared with the control##35##4##(1993-1#1)(1993-12#2)(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-8#1)
compared with the controls##10##4##(1993-12#1)(2007-7#1)(2008-10#3)(2008-7#2)(2011-2#2)(2012-3#1)
compared with the conventional##7##4##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
compared with the corresponding##11##4##(1994-2#1)(1995-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2011-1#2)(2011-2#1)
compared with the current##2##4##(1996-1#2)
compared with the data obtained##2##5##(2008-10#1)(2013-1#1)
compared with the data##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
compared with the earlier##2##4##(1991-12#1)(2008-10#1)
compared with the effect of the##2##6##(1996-5#1)(2008-10#1)
compared with the effect of##3##5##(1996-2#1)(1996-5#1)(2008-10#1)
compared with the equivalent##2##4##(2007-12#1)(2008-3#1)
compared with the experimental##2##4##(2008-2#1)(2013-1#1)
compared with the findings##3##4##(1991-2#1)(1997-8#1)(2008-11#1)
compared with the first##4##4##(1996-12#1)(2007-10#1)(2011-2#1)(2012-1#1)
compared with the gelatin capsule technique##3##6##(2011-2#3)
compared with the general##2##4##(1992-2#1)(2008-8#1)
compared with the group##2##4##(2007-11#1)(2011-2#1)
compared with the healthy controls##2##5##(1997-8#1)(2011-2#1)
compared with the healthy##3##4##(1997-8#1)(2011-2#1)(2013-1#1)
compared with the high##3##4##(2008-10#1)(2008-9#1)(2009-4#1)
compared with the historical##2##4##(2007-7#1)(2008-10#1)
compared with the incidence##3##4##(1993-12#1)(2008-10#1)(2011-2#1)
compared with the more##2##4##(1997-3#1)(2008-5#1)
compared with the nontransformed##2##4##(2008-10#2)
compared with the normal population##3##5##(2008-6#1)(2010-10#1)(2010-3#1)
compared with the normal##8##4##(1991-2#1)(1995-11#1)(1996-2#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-3#1)
compared with the number of##3##5##(1993-6#1)(1995-2#1)(2008-3#1)
compared with the ones obtained##2##5##(2008-10#1)(2008-3#1)
compared with the other two##3##5##(2008-10#2)(2010-6#1)
compared with the other##12##4##(2007-7#1)(2008-1#1)(2008-10#7)(2008-8#1)(2010-6#1)(2011-2#1)
compared with the parental strain##2##5##(2008-10#2)
compared with the performance of other##2##6##(1993-2#1)(2008-3#1)
compared with the performance of##4##5##(1993-2#1)(2008-2#1)(2008-3#2)
compared with the placebo group##5##5##(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)
compared with the placebo##6##4##(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)
compared with the placebo-treated##2##4##(2008-5#1)(2011-2#1)
compared with the predictions of a##2##6##(2007-11#1)(2007-12#1)
compared with the predictions of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
compared with the predictions##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
compared with the prevalence##2##4##(1995-8#1)(2011-1#1)
compared with the previous##4##4##(1993-12#1)(1996-11#1)(2010-9#1)(2011-1#1)
compared with the recommended##2##4##(1993-2#1)(2010-6#1)
compared with the reference##7##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
compared with the rest of the##2##6##(2008-3#1)(2009-2#1)
compared with the rest of##3##5##(2008-3#1)(2009-2#1)(2011-2#1)
compared with the results obtained by##2##6##(2008-10#2)
compared with the results obtained##5##5##(2008-10#5)
compared with the results of a##2##6##(1996-11#1)(2008-7#1)
compared with the results of the##2##6##(2008-10#1)(2008-3#1)
compared with the results of##9##5##(1996-11#1)(2008-10#1)(2008-3#5)(2008-7#1)(2011-2#1)
compared with the results##18##4##(1996-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2011-2#1)
compared with the simulated##2##4##(1994-3#1)(2008-10#1)
compared with the single center results obtained##2##7##(2008-5#2)
compared with the spectrum##2##4##(2008-10#1)(2008-3#1)
compared with the standard##11##4##(1996-3#1)(2008-10#4)(2008-3#3)(2011-1#1)(2012-3#2)
compared with the susceptible##3##4##(2008-10#3)
compared with the theoretical##2##4##(2007-12#1)(2008-10#1)
compared with the total##3##4##(2008-3#1)(2010-4#1)(2012-1#1)
compared with the traditional##4##4##(1992-1#1)(2008-2#1)(2008-3#1)(2010-12#1)
compared with the use of a##2##6##(2008-3#2)
compared with the usual##3##4##(2008-10#2)(2008-3#1)
compared with the value obtained##2##5##(1995-6#1)(2008-11#1)
compared with the value##4##4##(1995-6#1)(2007-8#2)(2008-11#1)
compared with the values obtained##3##5##(2008-10#2)(2008-3#1)
compared with the values##5##4##(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
compared with the vehicle##3##4##(2008-4#1)(2010-1#1)(2013-8#1)
compared with the wild-type strain##3##5##(2008-10#3)
compared with the##508##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#1)(1993-1#1)(1993-12#7)(1993-2#3)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#2)(2007-10#1)(2007-11#9)(2007-12#8)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#144)(2008-11#7)(2008-12#1)(2008-2#32)(2008-3#57)(2008-4#1)(2008-5#16)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#29)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#11)
compared with their counterparts##2##4##(2008-10#1)(2008-2#1)
compared with their respective formulation controls##2##6##(2008-10#2)
compared with their##18##3##(1990-7#1)(1992-8#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
compared with theoretical predictions##5##4##(2008-2#3)(2008-3#2)
compared with theoretical results##3##4##(2007-11#1)(2008-3#2)
compared with theoretical values##2##4##(2008-3#2)
compared with theoretical##13##3##(2007-11#1)(2008-2#3)(2008-3#9)
compared with theory##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
compared with thermocouple measurements##2##4##(2008-2#1)(2008-3#1)
compared with those achieved##3##4##(2007-12#1)(2008-10#2)
compared with those determined by the##2##6##(2008-10#1)(2011-2#1)
compared with those determined by##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
compared with those determined##5##4##(1990-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
compared with those fed the NC##2##6##(2010-2#2)
compared with those fed##3##4##(2008-11#1)(2010-2#2)
compared with those for##2##4##(2007-12#1)(2008-3#1)
compared with those from a##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
compared with those from the##2##5##(1997-8#1)(2008-7#1)
compared with those from##9##4##(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)
compared with those generated##2##4##(2008-10#1)(2008-2#1)
compared with those in the##4##5##(2008-10#1)(2008-11#1)(2009-3#1)(2012-12#1)
compared with those in##15##4##(1995-11#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
compared with those obtained by conventional##2##6##(2008-10#1)(2008-3#1)
compared with those obtained by high performance liquid chromatography (HPLC)##2##10##(2008-10#2)
compared with those obtained by the##5##6##(1997-7#1)(2008-10#4)
compared with those obtained by##21##5##(1997-7#1)(2008-10#14)(2008-2#1)(2008-3#4)(2008-5#1)
compared with those obtained from##7##5##(1990-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
compared with those obtained in##3##5##(1993-9#1)(1996-5#1)(2008-3#1)
compared with those obtained using##6##5##(1995-6#1)(2008-10#5)
compared with those obtained with a##4##6##(2008-10#1)(2008-2#2)(2008-3#1)
compared with those obtained with the##2##6##(2008-10#2)
compared with those obtained with##12##5##(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-6#1)
compared with those obtained##53##4##(1990-12#1)(1993-9#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#31)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#1)
compared with those of a##6##5##(1991-3#1)(1994-8#1)(1994-9#1)(2008-10#3)
compared with those of control##2##5##(2007-10#1)(2008-10#1)
compared with those of healthy##2##5##(2008-10#1)(2013-8#1)
compared with those of other##14##5##(1990-11#1)(1990-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)
compared with those of the corresponding##2##6##(1997-2#1)(2008-10#1)
compared with those of the##15##5##(1997-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-6#1)
compared with those of##78##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#2)(1993-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
compared with those on##2##4##(2008-10#1)(2008-6#1)
compared with those predicted##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
compared with those reported##2##4##(2008-10#2)
compared with those that##2##4##(2007-12#1)(2008-10#1)
compared with those who did not##3##6##(2007-10#2)(2008-11#1)
compared with those who##6##4##(2007-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)
compared with those with##6##4##(1991-2#1)(1996-12#1)(2008-10#2)(2010-4#1)(2012-12#1)
compared with those##218##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#5)(2007-12#6)(2008-10#87)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#25)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2013-1#2)(2013-8#1)
compared with three##2##3##(2008-10#1)(2010-4#1)
compared with total##2##3##(2008-2#1)(2009-6#1)
compared with traditional##6##3##(2006-10#1)(2008-3#3)(2008-6#1)(2011-2#1)
compared with two##2##3##(2008-4#1)(2013-1#1)
compared with untreated##4##3##(1993-8#1)(1995-2#1)(2008-12#1)(2010-11#1)
compared with values##6##3##(1991-8#1)(2008-10#1)(2008-3#3)(2011-2#1)
compared with warfarin##2##3##(2012-12#2)
compared with water##3##3##(2008-10#3)
compared with white##3##3##(2013-1#1)(2013-7#2)
compared with wild-type (WT)##2##4##(2008-8#1)(2008-9#1)
compared with wild-type##8##3##(1996-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
compared with women with##2##4##(1991-11#1)(2013-8#1)
compared with women##3##3##(1991-11#1)(2010-6#1)(2013-8#1)
compared with young ones##2##4##(1990-5#1)(2008-7#1)
compared with young##4##3##(1990-5#1)(1996-2#1)(2008-7#2)
compared with##2090##2##(1990-11#4)(1990-12#7)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#6)(1990-7#4)(1990-8#1)(1990-9#6)(1991-11#3)(1991-12#6)(1991-2#11)(1991-3#6)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#3)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#5)(1992-5#5)(1992-6#6)(1992-8#4)(1992-9#5)(1993-1#5)(1993-11#6)(1993-12#14)(1993-2#5)(1993-5#1)(1993-6#5)(1993-8#7)(1993-9#5)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#7)(1994-3#7)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#2)(1995-1#3)(1995-11#10)(1995-12#9)(1995-2#8)(1995-3#13)(1995-5#5)(1995-6#10)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#8)(1996-2#16)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#11)(1997-8#8)(2006-10#8)(2006-11#1)(2006-6#3)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#13)(2007-11#39)(2007-12#38)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#8)(2007-8#9)(2007-9#1)(2008-1#15)(2008-10#553)(2008-11#64)(2008-12#16)(2008-2#104)(2008-3#208)(2008-4#8)(2008-5#55)(2008-6#22)(2008-7#60)(2008-8#29)(2008-9#26)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#10)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#7)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#6)(2010-3#5)(2010-4#6)(2010-5#2)(2010-6#7)(2010-7#2)(2010-8#16)(2010-9#2)(2011-1#24)(2011-10#1)(2011-2#96)(2011-3#4)(2012-1#8)(2012-12#39)(2012-2#32)(2012-3#33)(2013-1#47)(2013-7#9)(2013-8#27)
compared within##3##2##(1992-12#1)(2012-2#1)(2013-1#1)
compared##4490##1##(1990-10#2)(1990-11#14)(1990-12#14)(1990-2#7)(1990-3#2)(1990-5#16)(1990-6#10)(1990-7#13)(1990-8#9)(1990-9#10)(1991-1#2)(1991-11#4)(1991-12#21)(1991-2#22)(1991-3#10)(1991-4#4)(1991-5#7)(1991-6#10)(1991-7#3)(1991-8#9)(1991-9#6)(1992-1#2)(1992-10#5)(1992-11#9)(1992-12#16)(1992-2#6)(1992-3#7)(1992-5#8)(1992-6#11)(1992-8#11)(1992-9#9)(1993-1#17)(1993-11#18)(1993-12#31)(1993-2#17)(1993-3#5)(1993-5#3)(1993-6#12)(1993-8#13)(1993-9#13)(1994-1#6)(1994-10#2)(1994-11#14)(1994-12#15)(1994-2#20)(1994-3#18)(1994-5#14)(1994-6#8)(1994-7#1)(1994-8#22)(1994-9#17)(1995-1#4)(1995-11#18)(1995-12#33)(1995-2#32)(1995-3#24)(1995-4#3)(1995-5#13)(1995-6#13)(1995-8#8)(1995-9#2)(1996-1#8)(1996-11#4)(1996-12#34)(1996-2#21)(1996-3#14)(1996-4#2)(1996-5#18)(1996-6#9)(1996-7#4)(1996-8#2)(1996-9#6)(1997-1#3)(1997-2#23)(1997-3#12)(1997-4#17)(1997-5#6)(1997-6#13)(1997-7#17)(1997-8#14)(2006-10#8)(2006-11#1)(2006-6#3)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#31)(2007-11#53)(2007-12#69)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#3)(2007-7#31)(2007-8#27)(2007-9#1)(2008-1#40)(2008-10#972)(2008-11#197)(2008-12#58)(2008-2#132)(2008-3#285)(2008-4#25)(2008-5#138)(2008-6#60)(2008-7#158)(2008-8#72)(2008-9#73)(2009-1#2)(2009-10#13)(2009-11#14)(2009-12#8)(2009-2#7)(2009-3#13)(2009-4#18)(2009-5#9)(2009-6#10)(2009-7#15)(2009-8#19)(2009-9#6)(2010-1#9)(2010-10#8)(2010-11#7)(2010-12#23)(2010-2#13)(2010-3#26)(2010-4#21)(2010-5#12)(2010-6#12)(2010-7#9)(2010-8#34)(2010-9#8)(2011-1#55)(2011-10#2)(2011-2#195)(2011-3#6)(2011-7#2)(2012-1#20)(2012-12#84)(2012-2#108)(2012-3#75)(2012-4#1)(2012-5#4)(2012-6#2)(2012-9#3)(2013-1#137)(2013-7#26)(2013-8#75)
compares favorably to##2##3##(2008-10#1)(2008-5#1)
compares favorably with that##2##4##(2008-10#1)(2008-3#1)
compares favorably with##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)
compares favorably##7##2##(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)
compares favourably with##4##3##(1991-9#1)(2007-8#1)(2008-10#1)(2008-7#1)
compares the performance of##2##4##(2010-12#1)(2012-1#1)
compares the##32##2##(1991-12#2)(1993-12#2)(1993-8#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#2)(2012-1#1)(2012-2#1)(2013-8#1)
compares these##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
compares well with the##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
compares well with##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
compares with the##2##3##(1991-12#1)(2008-10#1)
compares with##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
compares##85##1##(1991-12#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-8#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
comparing CHM##2##2##(2008-10#2)
comparing a##5##2##(1994-3#2)(1995-3#1)(2007-7#1)(2012-12#1)
comparing and##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
comparing apples##2##2##(2008-12#1)(2008-8#1)
comparing between##3##2##(2008-10#1)(2008-9#2)
comparing both##5##2##(1997-7#1)(2007-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
comparing changes in##2##3##(1994-12#1)(2007-12#1)
comparing clinical##2##2##(2008-11#1)(2013-1#1)
comparing data##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
comparing different##3##2##(2008-7#1)(2009-8#1)(2010-5#1)
comparing experimental##3##2##(2008-2#1)(2008-7#1)(2008-9#1)
comparing gene##3##2##(2008-4#2)(2010-4#1)
comparing it to##3##3##(1996-12#1)(2010-4#1)(2012-2#1)
comparing it with the##3##4##(1990-2#1)(1992-8#1)(2008-3#1)
comparing it with##8##3##(1990-2#1)(1990-6#1)(1992-8#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
comparing it##11##2##(1990-2#1)(1990-6#1)(1992-8#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
comparing long-term##2##2##(2008-10#1)(2012-12#1)
comparing multilevel C-ADR with##2##4##(2012-12#2)
comparing multilevel##3##2##(2012-12#3)
comparing patients##4##2##(1997-3#1)(2008-3#1)(2008-8#1)(2012-12#1)
comparing preoperative##2##2##(1994-8#1)(2008-7#1)
comparing results obtained##2##3##(2008-5#2)
comparing results##6##2##(1994-1#1)(2008-10#2)(2008-5#2)(2008-8#1)
comparing the effects of##3##4##(2008-2#1)(2008-6#1)(2008-9#1)
comparing the expression##2##3##(2007-12#1)(2008-7#1)
comparing the findings##2##3##(1994-3#1)(2013-1#1)
comparing the measured##2##3##(2008-3#2)
comparing the number of##2##4##(1996-4#1)(2008-10#1)
comparing the number##3##3##(1991-6#1)(1996-4#1)(2008-10#1)
comparing the performance of##2##4##(1995-3#1)(1996-1#1)
comparing the result of##2##4##(2008-10#1)(2008-3#1)
comparing the results with those##2##5##(2008-10#1)(2010-11#1)
comparing the results with##6##4##(1993-2#1)(2008-10#4)(2010-11#1)
comparing the results##12##3##(1993-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2010-11#1)
comparing the two groups##2##4##(1992-12#1)(2008-11#1)
comparing the two##5##3##(1992-12#1)(1996-1#1)(2008-11#1)(2012-1#1)(2013-1#1)
comparing the##132##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-3#3)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-4#3)(1996-5#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-12#2)(2008-10#37)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
comparing their##6##2##(1990-5#1)(1994-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
comparing them with##5##3##(2007-11#1)(2008-10#2)(2011-2#1)(2011-3#1)
comparing them##6##2##(2007-11#1)(2008-10#2)(2008-9#1)(2011-2#1)(2011-3#1)
comparing to patients##2##3##(2011-2#1)(2012-3#1)
comparing to the##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
comparing to##10##2##(1997-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
comparing two##7##2##(1993-1#1)(1997-4#2)(2007-6#1)(2007-8#1)(2008-4#1)(2011-2#1)
comparing with standard##2##3##(2008-10#1)(2012-2#1)
comparing with the##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
comparing with##14##2##(1993-3#1)(1997-7#1)(2008-10#5)(2008-5#2)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
comparing##377##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#4)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#78)(2008-11#8)(2008-12#2)(2008-2#12)(2008-3#12)(2008-4#12)(2008-5#16)(2008-6#3)(2008-7#12)(2008-8#14)(2008-9#13)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#3)(2012-1#1)(2012-12#12)(2012-2#7)(2012-3#11)(2013-1#14)(2013-8#3)
comparision##2##1##(2012-12#1)(2012-2#1)
comparison against##2##2##(2008-3#2)
comparison among##8##2##(2008-10#3)(2008-6#1)(2008-9#2)(2009-11#1)(2011-2#1)
comparison analysis##2##2##(2008-10#2)
comparison and##12##2##(1993-2#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2010-8#1)(2013-8#1)
comparison are##2##2##(2008-8#1)(2010-2#1)
comparison as a##2##3##(1991-9#1)(1992-11#1)
comparison as##3##2##(1991-9#2)(1992-11#1)
comparison at##2##2##(1991-3#1)(2008-11#1)
comparison between a##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
comparison between different##3##3##(1991-11#1)(2008-10#1)(2008-4#1)
comparison between measured##2##3##(2008-2#1)(2008-3#1)
comparison between patients with##3##4##(1991-12#1)(1997-5#1)(2013-1#1)
comparison between the measured##2##4##(2007-11#1)(2008-3#1)
comparison between the results##2##4##(2008-10#1)(2008-3#1)
comparison between the two##2##4##(1991-6#1)(2008-11#1)
comparison between the##23##3##(1991-6#2)(1992-5#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#6)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)
comparison between these##2##3##(2008-10#1)(2008-3#1)
comparison between two##5##3##(1992-8#1)(1996-3#1)(2008-8#1)(2010-11#1)(2013-8#1)
comparison between##87##2##(1990-2#1)(1991-11#1)(1991-12#2)(1991-6#2)(1992-5#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#15)(2008-11#3)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
comparison for##3##2##(1996-2#1)(2007-12#1)(2008-2#1)
comparison group##9##2##(1992-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-3#1)
comparison groups##3##2##(1996-1#1)(2008-11#1)(2011-1#1)
comparison in##9##2##(1994-6#1)(1995-5#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#1)
comparison indicated that##2##3##(2008-3#1)(2008-9#1)
comparison indicates that##2##3##(1991-5#1)(1993-12#1)
comparison is made of the##2##5##(2007-12#1)(2012-3#1)
comparison is made with the##2##5##(2007-12#1)(2010-7#1)
comparison is made with##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)
comparison is made##9##3##(1992-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-3#1)
comparison is##21##2##(1992-5#1)(1994-9#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-2#2)(2010-7#1)(2012-3#1)(2013-1#1)
comparison may##2##2##(2007-12#1)(2008-7#1)
comparison of 2##2##3##(1994-2#1)(1997-4#1)
comparison of a Shack-Hartmann##2##4##(2008-3#2)
comparison of a##9##3##(1991-2#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-4#1)
comparison of amino acid sequences of##2##6##(2008-10#1)(2008-8#1)
comparison of amino##3##3##(2008-10#1)(2008-8#2)
comparison of benefits##2##3##(1992-3#1)(2008-5#1)
comparison of both##3##3##(1991-6#1)(1995-12#1)(2007-8#1)
comparison of clinical##2##3##(2007-11#1)(2009-7#1)
comparison of different##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
comparison of expression##2##3##(2008-7#1)(2008-9#1)
comparison of four##2##3##(2007-11#1)(2008-11#1)
comparison of gene##2##3##(1996-12#1)(2008-10#1)
comparison of indicators##2##3##(2012-12#2)
comparison of its structure##2##4##(1997-7#2)
comparison of its##3##3##(1990-11#1)(1997-7#2)
comparison of measurements##2##3##(2008-2#1)(2008-3#1)
comparison of methods for##3##4##(1995-2#1)(1995-9#1)(2008-10#1)
comparison of methods##4##3##(1995-2#1)(1995-9#1)(2008-10#1)(2008-5#1)
comparison of percutaneous##2##3##(1992-5#1)(2008-9#1)
comparison of performance##2##3##(2008-3#1)(2008-7#1)
comparison of placental##2##3##(2008-11#1)(2009-7#1)
comparison of results obtained##2##4##(2008-10#1)(2013-1#1)
comparison of results##6##3##(2008-10#3)(2008-11#1)(2008-2#1)(2013-1#1)
comparison of that##2##3##(2008-10#1)(2008-3#1)
comparison of the 5'##2##4##(1994-12#1)(2008-10#1)
comparison of the amino acid sequences of##3##7##(1990-7#1)(1991-12#1)(1993-3#1)
comparison of the amino acid##4##5##(1990-7#1)(1991-12#1)(1993-3#1)(2008-10#1)
comparison of the analytical##2##4##(2008-10#2)
comparison of the deduced##5##4##(1991-6#1)(1993-2#1)(1993-6#2)(2008-10#1)
comparison of the effects of##3##5##(1993-1#1)(1995-12#1)(2012-12#1)
comparison of the electrochemical##2##4##(2008-10#2)
comparison of the experimental##3##4##(2007-12#1)(2008-3#2)
comparison of the five##2##4##(1990-10#1)(1995-11#1)
comparison of the performance of##3##5##(2008-10#2)(2008-3#1)
comparison of the present##2##4##(2008-2#1)(2013-8#1)
comparison of the results of##4##5##(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
comparison of the results with those##3##6##(2008-10#3)
comparison of the results##11##4##(1997-8#1)(2008-10#5)(2008-3#2)(2008-5#1)(2009-9#1)(2011-2#1)
comparison of the total##2##4##(2007-12#1)(2008-2#1)
comparison of the two##5##4##(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)
comparison of the##136##3##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#3)(1996-2#1)(1996-8#2)(1997-3#1)(1997-8#2)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#3)
comparison of their##2##3##(2008-10#2)
comparison of these##7##3##(1992-8#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-7#1)
comparison of this##2##3##(2008-2#1)(2008-5#1)
comparison of three##4##3##(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
comparison of two different##3##4##(1992-9#1)(2008-10#1)(2008-4#1)
comparison of two##24##3##(1991-1#1)(1992-3#1)(1992-9#1)(1994-9#3)(1995-2#1)(1996-4#1)(1996-6#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#3)
comparison of various##3##3##(2008-10#2)(2008-7#1)
comparison of##447##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#5)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#5)(2007-11#8)(2007-12#11)(2007-2#2)(2007-8#6)(2008-1#2)(2008-10#88)(2008-11#12)(2008-12#5)(2008-2#18)(2008-3#38)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#15)(2008-8#5)(2008-9#11)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#5)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#7)(2012-3#3)(2012-7#1)(2012-9#2)(2013-1#10)(2013-8#7)
comparison on##2##2##(2008-10#1)(2011-1#1)
comparison permits##2##2##(1997-2#1)(2008-7#1)
comparison processes##2##2##(2007-10#1)(2012-12#1)
comparison purposes##4##2##(1994-2#1)(2008-10#2)(2009-11#1)
comparison revealed that##3##3##(1994-12#1)(2008-9#1)(2012-12#1)
comparison revealed##4##2##(1990-6#1)(1994-12#1)(2008-9#1)(2012-12#1)
comparison showed that##3##3##(1991-6#1)(2008-3#1)(2008-8#1)
comparison shows that##3##3##(2008-3#2)(2011-2#1)
comparison studies##3##2##(1997-3#2)(2011-2#1)
comparison study##7##2##(1992-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-1#1)
comparison to a##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2013-8#1)
comparison to an##2##3##(1997-2#1)(2008-3#1)
comparison to conventional##4##3##(2008-10#1)(2009-12#2)(2010-5#1)
comparison to other##8##3##(1991-4#1)(1992-5#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-8#1)
comparison to preoperative##2##3##(2007-8#1)(2008-7#1)
comparison to the control group##4##5##(1995-12#1)(2008-12#1)(2009-12#1)(2012-3#1)
comparison to the control##6##4##(1995-12#1)(2008-10#1)(2008-12#2)(2009-12#1)(2012-3#1)
comparison to the##49##3##(1990-2#1)(1990-9#1)(1991-6#1)(1993-2#2)(1994-3#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2009-12#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
comparison to those##9##3##(1990-9#1)(1991-5#1)(1994-11#1)(2008-10#5)(2013-1#1)
comparison to##163##2##(1990-12#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#10)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#6)(2008-8#3)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#4)
comparison types##2##2##(2009-5#2)
comparison was made between the##2##5##(2007-10#1)(2008-10#1)
comparison was made between##6##4##(1994-3#2)(2007-10#1)(2008-10#1)(2011-2#1)(2013-7#1)
comparison was made of##2##4##(1991-3#1)(1996-12#1)
comparison was made##11##3##(1991-3#1)(1994-3#2)(1996-12#1)(2007-10#1)(2008-10#4)(2011-2#1)(2013-7#1)
comparison was##21##2##(1991-3#1)(1993-1#1)(1994-3#3)(1996-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-7#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-7#1)
comparison we##2##2##(2008-2#1)(2008-3#1)
comparison were##7##2##(2008-10#2)(2008-3#1)(2008-5#2)(2009-5#1)(2011-2#1)
comparison with 3##2##3##(1995-8#1)(2008-10#1)
comparison with a conventional##2##4##(2008-3#2)
comparison with a reference##2##4##(2008-10#2)
comparison with a standard##2##4##(2008-1#1)(2008-10#1)
comparison with a##20##3##(1992-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#6)(2008-8#1)
comparison with an##8##3##(1993-12#1)(1994-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
comparison with cells##2##3##(1992-6#1)(2012-1#1)
comparison with clinical##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
comparison with commercial##2##3##(2008-10#1)(2008-5#1)
comparison with control##3##3##(1993-8#1)(1995-12#1)(2008-12#1)
comparison with controls##2##3##(1994-6#1)(2011-2#1)
comparison with conventional##5##3##(1992-10#1)(2008-10#2)(2008-3#1)(2009-4#1)
comparison with experimentally##2##3##(2007-11#1)(2008-3#1)
comparison with known##2##3##(1994-5#1)(2008-5#1)
comparison with modern##4##3##(2013-1#4)
comparison with other##20##3##(1990-3#1)(1994-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2010-5#1)(2011-2#2)(2012-1#1)
comparison with results##3##3##(2008-11#1)(2008-3#1)(2009-9#1)
comparison with some##3##3##(2008-10#3)
comparison with standard##2##3##(2008-10#1)(2008-11#1)
comparison with that in##2##4##(2008-8#2)
comparison with that of##11##4##(1994-11#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)
comparison with that##16##3##(1994-11#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-8#5)(2008-9#1)
comparison with the control group##5##5##(1993-3#1)(2007-10#1)(2007-11#2)(2008-10#1)
comparison with the control##8##4##(1993-3#2)(1997-2#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-12#1)
comparison with the conventional##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
comparison with the previous##3##4##(1996-5#1)(2008-10#2)
comparison with the previously##2##4##(2008-10#1)(2008-5#1)
comparison with the reference##2##4##(2008-10#2)
comparison with the sequences in protein and EST databases and analysis with computer programs for gene modeling##2##17##(1997-6#1)(1997-8#1)
comparison with the standard##2##4##(2008-10#1)(2008-11#1)
comparison with the##90##3##(1990-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2010-4#2)(2011-2#4)(2013-8#2)
comparison with those##7##3##(1991-9#1)(1992-11#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
comparison with traditional##2##3##(2008-10#1)(2008-2#1)
comparison with##374##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1997-2#2)(1997-4#2)(1997-6#5)(1997-8#2)(2006-11#2)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#5)(2008-10#89)(2008-11#20)(2008-12#11)(2008-2#14)(2008-3#27)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#10)(2008-8#13)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#2)
comparison##1383##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#6)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#7)(1991-11#2)(1991-12#8)(1991-2#5)(1991-3#6)(1991-4#1)(1991-5#4)(1991-6#11)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#4)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#6)(1992-5#4)(1992-6#4)(1992-8#9)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#12)(1993-3#7)(1993-6#5)(1993-8#4)(1993-9#4)(1994-1#3)(1994-11#5)(1994-12#6)(1994-2#6)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#10)(1995-1#3)(1995-11#3)(1995-12#6)(1995-2#10)(1995-3#7)(1995-4#1)(1995-5#4)(1995-6#6)(1995-8#3)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#5)(1996-8#3)(1997-1#1)(1997-2#9)(1997-3#9)(1997-4#8)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#7)(2006-11#2)(2006-8#1)(2007-1#1)(2007-10#9)(2007-11#18)(2007-12#29)(2007-2#4)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#9)(2008-10#289)(2008-11#53)(2008-12#29)(2008-2#51)(2008-3#100)(2008-4#16)(2008-5#37)(2008-6#6)(2008-7#41)(2008-8#29)(2008-9#22)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#11)(2009-6#4)(2009-7#6)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#5)(2010-3#3)(2010-4#8)(2010-5#6)(2010-6#3)(2010-7#3)(2010-8#10)(2010-9#4)(2011-1#8)(2011-2#45)(2011-3#2)(2012-1#8)(2012-12#16)(2012-2#18)(2012-3#11)(2012-5#1)(2012-7#1)(2012-9#2)(2013-1#40)(2013-7#6)(2013-8#18)
comparison)##5##1##(1994-12#2)(1994-3#1)(2009-5#2)
comparisons across time##2##3##(2009-2#1)(2011-2#1)
comparisons across##4##2##(2008-10#1)(2009-2#1)(2010-1#1)(2011-2#1)
comparisons among##7##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)
comparisons and##15##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-3#1)
comparisons are made##2##3##(1990-5#1)(1991-3#1)
comparisons are##6##2##(1990-5#1)(1991-3#1)(1997-4#1)(2008-3#1)(2009-7#1)(2011-2#1)
comparisons between different##2##3##(1991-11#1)(2011-2#1)
comparisons between the##5##3##(1990-6#1)(1991-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
comparisons between this model and##2##5##(2007-12#1)(2013-1#1)
comparisons between##24##2##(1990-6#1)(1991-11#1)(1991-9#1)(1992-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
comparisons but also##2##3##(2008-10#1)(2013-8#1)
comparisons by using##2##3##(2011-2#1)(2011-3#1)
comparisons could##2##2##(2008-1#1)(2010-3#1)
comparisons demonstrate that##2##3##(1997-9#1)(2009-5#1)
comparisons demonstrated that the##2##4##(2007-8#1)(2008-10#1)
comparisons highlight##2##2##(2008-5#1)(2009-10#1)
comparisons indicate that##2##3##(1993-6#1)(2008-10#1)
comparisons indicate##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
comparisons indicated that##3##3##(1997-4#1)(2008-10#2)
comparisons of performance##2##3##(1996-12#1)(2008-3#1)
comparisons of the##5##3##(1996-7#1)(2008-10#2)(2008-8#1)(2009-7#1)
comparisons of this##2##3##(1995-2#1)(2008-2#1)
comparisons of##45##2##(1992-12#1)(1992-8#1)(1995-2#3)(1996-12#1)(1996-7#1)(1997-5#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
comparisons on##2##2##(1997-4#1)(2008-1#1)
comparisons revealed that##6##3##(2008-10#3)(2008-4#1)(2009-7#1)(2012-2#1)
comparisons revealed##7##2##(1997-7#1)(2008-10#3)(2008-4#1)(2009-7#1)(2012-2#1)
comparisons show that##2##3##(1990-2#1)(2008-3#1)
comparisons show##3##2##(1990-2#1)(2008-2#1)(2008-3#1)
comparisons showed that##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
comparisons showed##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)
comparisons suggest that##2##3##(2008-3#1)(2012-12#1)
comparisons to national##4##3##(1994-3#4)
comparisons to other##3##3##(2008-8#1)(2010-8#1)(2011-2#1)
comparisons to##13##2##(1992-8#1)(1994-3#4)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
comparisons using the##2##3##(2008-4#1)(2008-9#1)
comparisons using##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)
comparisons were made by##2##4##(2008-10#1)(2008-5#1)
comparisons were made##3##3##(2008-10#2)(2008-5#1)
comparisons were##5##2##(1992-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
comparisons with a##3##3##(1992-4#1)(2008-3#2)
comparisons with the##3##3##(1992-4#1)(1995-12#1)(2008-11#1)
comparisons with thin models are##2##5##(2007-12#2)
comparisons with##23##2##(1992-10#1)(1992-4#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-12#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2013-7#1)
comparisons within##3##2##(1991-12#1)(1992-3#1)(2008-10#1)
comparisons##265##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#6)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#8)(1996-1#2)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#13)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#53)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#6)(2008-5#10)(2008-7#7)(2008-8#10)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
comparsion##2##1##(2007-2#1)(2008-10#1)
compartment analysis of temporal activity by##2##6##(2008-4#2)
compartment and##5##2##(1990-6#1)(2006-12#1)(2008-7#1)(2009-10#1)(2009-3#1)
compartment in##4##2##(1991-5#1)(1993-6#1)(1994-8#1)(2008-11#1)
compartment of a##3##3##(2008-10#2)(2008-7#1)
compartment of the##7##3##(1992-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-10#1)
compartment of##13##2##(1992-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-8#1)
compartment syndrome is##2##3##(2007-11#1)(2008-10#1)
compartment syndrome##13##2##(2007-11#3)(2008-10#3)(2009-1#4)(2009-3#3)
compartment to the##2##3##(1995-3#1)(2009-9#1)
compartment to##3##2##(1995-11#1)(1995-3#1)(2009-9#1)
compartment was##2##2##(2009-3#1)(2012-1#1)
compartment where the##2##3##(1994-11#1)(2008-7#1)
compartment##99##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#4)(2009-10#2)(2009-2#1)(2009-3#5)(2009-5#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-7#1)(2013-1#1)
compartmental models##2##2##(1995-12#1)(2008-11#1)
compartmental##11##1##(1992-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-10#1)(2013-8#2)
compartmentalisation##2##1##(2008-4#1)(2012-7#1)
compartmentalization is##2##2##(1994-12#1)(2008-7#1)
compartmentalization of the##2##3##(1997-3#1)(2012-2#1)
compartmentalization of##13##2##(1992-5#1)(1994-8#2)(1995-11#1)(1997-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
compartmentalization##22##1##(1992-5#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#1)(1997-3#1)(2007-8#2)(2008-2#1)(2008-7#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)
compartmentalized##9##1##(1994-11#1)(1994-12#2)(1995-2#1)(2008-10#2)(2008-7#1)(2009-8#1)(2012-2#1)
compartmentalizing##2##1##(2008-7#1)(2009-6#1)
compartmentation of##3##2##(1995-8#1)(1996-6#1)(2012-7#1)
compartmentation##6##1##(1995-6#1)(1995-8#1)(1996-6#1)(2012-2#2)(2012-7#1)
compartments and##2##2##(2008-10#1)(2012-2#1)
compartments are##4##2##(2007-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
compartments for##2##2##(2008-5#1)(2010-10#1)
compartments in the##2##3##(1994-6#1)(2008-7#1)
compartments in##6##2##(1994-6#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-7#2)
compartments of the##5##3##(1994-12#1)(2007-11#1)(2008-10#2)(2008-7#1)
compartments of##10##2##(1994-10#1)(1994-11#1)(1994-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
compartments that##2##2##(2009-10#2)
compartments with##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
compartments##98##1##(1990-12#1)(1990-5#1)(1991-11#1)(1992-10#2)(1992-9#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-6#1)(1995-2#3)(1995-8#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-3#1)(2008-4#5)(2008-5#6)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#5)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#4)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)
compartments)##3##1##(2008-5#1)(2009-10#1)(2011-2#1)
compass##2##1##(2007-12#1)(2008-1#1)
compassion in##3##2##(2007-10#3)
compassion##13##1##(1994-1#1)(1996-6#1)(2007-10#7)(2007-12#1)(2008-1#2)(2008-12#1)
compassionate##7##1##(1991-2#1)(1995-1#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
compatibilities##4##1##(2008-10#1)(2009-2#1)(2010-8#1)(2012-3#1)
compatibility and##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
compatibility between##4##2##(2008-10#1)(2008-9#1)(2009-3#1)(2013-1#1)
compatibility group##9##2##(2008-10#9)
compatibility groups##22##2##(2008-10#22)
compatibility has##2##2##(2008-10#1)(2008-5#1)
compatibility in##2##2##(2008-10#2)
compatibility of a##3##3##(2008-5#1)(2009-12#1)(2012-3#1)
compatibility of the##6##3##(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
compatibility of wax and oil##2##5##(2008-5#2)
compatibility of##28##2##(1993-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-8#3)(2008-9#1)(2009-12#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)
compatibility rate##2##2##(2013-1#2)
compatibility tests##3##2##(1997-5#1)(2008-10#2)
compatibility to##2##2##(1995-5#1)(2008-10#1)
compatibility type##4##2##(2008-10#4)
compatibility was##2##2##(2008-10#1)(2010-5#1)
compatibility with the##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
compatibility with##12##2##(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
compatibility##126##1##(1993-8#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-5#1)(2008-10#72)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#12)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-3#3)(2013-1#7)(2013-8#1)
compatible (i##2##2##(2008-10#2)
compatible and incompatible##2##3##(2008-10#2)
compatible and##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
compatible hosts##3##2##(2008-10#3)
compatible interaction##3##2##(2008-10#3)
compatible interactions##2##2##(2008-10#2)
compatible solutes##2##2##(2012-7#2)
compatible with a##9##3##(1995-6#1)(2007-11#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
compatible with all##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
compatible with an##4##3##(1990-3#1)(1997-1#1)(2008-1#1)(2008-10#1)
compatible with both##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
compatible with normal##2##3##(2008-2#1)(2008-4#1)
compatible with the hypothesis that##2##5##(1991-2#1)(2008-5#1)
compatible with the hypothesis##3##4##(1991-2#1)(2008-5#1)(2011-2#1)
compatible with the recent##2##4##(1995-3#1)(2009-5#1)
compatible with the##32##3##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1993-12#1)(1995-12#2)(1995-3#1)(1996-5#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
compatible with##116##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1996-5#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#18)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#5)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#4)(2011-7#1)(2012-3#4)(2013-1#4)
compatible##174##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-3#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#49)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#6)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#10)(2011-7#1)(2012-2#1)(2012-3#5)(2012-7#2)(2013-1#4)
compel##3##1##(1994-2#1)(1996-12#1)(2008-12#1)
compelled to##2##2##(1991-2#1)(2008-6#1)
compelled##4##1##(1991-12#1)(1991-2#1)(2008-2#1)(2008-6#1)
compelling business##2##2##(1997-1#2)
compelling evidence of##2##3##(1995-3#1)(2010-8#1)
compelling evidence that##4##3##(2008-2#1)(2009-8#1)(2011-2#2)
compelling evidence##12##2##(1995-3#2)(1996-12#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
compelling##35##1##(1992-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-1#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
compendium of##2##2##(2008-8#1)(2008-9#1)
compensate for deficiencies in##2##4##(2007-12#1)(2008-10#1)
compensate for the##30##3##(1994-12#1)(1994-5#1)(1995-8#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
compensate for their##2##3##(2008-11#1)(2012-2#1)
compensate for these##2##3##(1994-5#1)(2007-11#1)
compensate for this##3##3##(2008-11#1)(2008-12#1)(2008-3#1)
compensate for##61##2##(1993-11#1)(1994-12#1)(1994-5#2)(1995-8#1)(1997-3#1)(2007-11#10)(2007-12#4)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#12)(2008-5#3)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
compensate the##5##2##(1991-12#1)(1997-7#1)(2008-10#2)(2008-3#1)
compensate##80##1##(1990-11#1)(1990-8#1)(1991-12#1)(1993-11#2)(1994-12#1)(1994-5#2)(1995-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#10)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#17)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
compensated by a##4##3##(1995-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
compensated by an increase in##2##5##(2007-12#1)(2013-8#1)
compensated by an##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
compensated by the##6##3##(2007-12#1)(2008-3#2)(2008-5#1)(2010-7#1)(2011-2#1)
compensated by##24##2##(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
compensated cirrhosis##2##2##(2013-1#2)
compensated for by a##3##4##(1990-2#1)(2007-12#1)(2008-2#1)
compensated for by##10##3##(1990-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2013-1#1)
compensated for in the##2##4##(2007-11#2)
compensated for in##3##3##(2007-11#2)(2008-3#1)
compensated for to##2##3##(2007-11#1)(2007-12#1)
compensated for with a##2##4##(2007-11#1)(2008-3#1)
compensated for with##3##3##(2007-11#1)(2008-3#2)
compensated for##29##2##(1990-2#1)(2007-11#7)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#7)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
compensated from##2##2##(2008-3#2)
compensated state##3##2##(1991-2#3)
compensated with##3##2##(1991-2#1)(1992-11#1)(1996-3#1)
compensated##87##1##(1990-2#1)(1991-2#6)(1992-11#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#8)(2007-12#6)(2008-10#9)(2008-2#6)(2008-3#16)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
compensated)##2##1##(2008-3#1)(2008-7#1)
compensates for the##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
compensates for##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
compensates the##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
compensates##11##1##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#4)
compensating effects##2##2##(2007-12#1)(2008-2#1)
compensating for the##4##3##(1995-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
compensating for##6##2##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
compensating the##2##2##(2008-10#1)(2008-3#1)
compensating##22##1##(1995-3#1)(1996-12#1)(1997-3#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#8)
compensation algorithm##2##2##(2007-11#1)(2011-1#1)
compensation and##8##2##(1994-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
compensation are##4##2##(2007-11#1)(2007-12#2)(2008-9#1)
compensation based on##2##3##(1997-1#1)(2008-2#1)
compensation can be achieved##2##4##(2007-12#1)(2008-2#1)
compensation can be##3##3##(1996-1#1)(2007-12#1)(2008-2#1)
compensation can##4##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-2#1)
compensation costs##2##2##(1993-3#1)(1996-12#1)
compensation during##2##2##(2007-11#1)(2008-11#1)
compensation foils##2##2##(2008-3#2)
compensation for the##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#2)
compensation for##18##2##(1991-7#1)(1994-2#1)(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-12#1)
compensation in the##5##3##(1991-2#2)(2007-11#1)(2007-12#2)
compensation in##12##2##(1991-2#2)(1995-9#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-3#2)
compensation is demonstrated##2##3##(2008-3#2)
compensation is presented##2##3##(2008-3#1)(2013-8#1)
compensation is##21##2##(1993-3#1)(1995-1#1)(1996-3#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#8)(2008-9#2)(2013-8#2)
compensation method##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
compensation of a##2##3##(2007-11#2)
compensation of the##10##3##(1990-11#1)(1991-2#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2012-1#1)
compensation of##26##2##(1990-11#1)(1991-12#1)(1991-2#2)(1992-11#1)(1993-5#1)(2007-11#5)(2007-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2009-6#1)(2012-1#1)
compensation patients##2##2##(1996-2#1)(2008-8#1)
compensation performance##2##2##(2008-2#1)(2008-3#1)
compensation scheme is##2##3##(2008-2#1)(2008-3#1)
compensation scheme##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
compensation schemes##3##2##(2008-7#3)
compensation status##3##2##(1996-2#2)(2012-12#1)
compensation systems##3##2##(1994-12#1)(1997-1#1)(2008-2#1)
compensation technique##4##2##(2007-12#2)(2008-3#2)
compensation was##2##2##(2007-12#1)(2008-10#1)
compensation with##6##2##(2007-11#3)(2008-10#1)(2008-3#2)
compensation##268##1##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#8)(1991-3#2)(1991-7#1)(1992-1#2)(1992-11#4)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-3#3)(1993-5#1)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#4)(1995-12#3)(1995-2#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#6)(1996-3#4)(1997-1#5)(1997-4#1)(2007-11#34)(2007-12#26)(2008-10#10)(2008-11#7)(2008-2#20)(2008-3#50)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#1)(2008-9#17)(2009-6#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#6)
compensator with##2##2##(2008-3#2)
compensator##14##1##(2007-11#1)(2007-12#2)(2008-3#11)
compensators##3##1##(2007-11#2)(2008-3#1)
compensatory damages##2##2##(1991-1#1)(1995-6#1)
compensatory evolution##2##2##(2013-1#2)
compensatory homeostasis##5##2##(2012-2#5)
compensatory increases in##2##3##(2011-1#1)(2013-8#1)
compensatory mechanisms##5##2##(2006-10#1)(2008-4#1)(2008-5#1)(2009-2#2)
compensatory pathways##2##2##(2009-2#2)
compensatory vasodilatory##2##2##(2008-4#2)
compensatory β-cell##2##2##(2010-11#2)
compensatory##55##1##(1991-1#1)(1991-5#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-2#5)(2009-7#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#4)(2013-8#1)
compete for a common##2##4##(1992-3#1)(1994-5#1)
compete for the##3##3##(1991-12#1)(1991-5#1)(1995-6#1)
compete for their##2##3##(1995-3#1)(1995-8#1)
compete for##27##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#1)
compete in an##2##3##(1994-2#1)(2008-8#1)
compete in##4##2##(1994-2#1)(1997-1#1)(2008-11#1)(2008-8#1)
compete to##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
compete with each other for##2##5##(1995-6#1)(1997-7#1)
compete with the##3##3##(1995-5#1)(2008-11#1)(2008-6#1)
compete with##26##2##(1990-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2009-3#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
compete##77##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#2)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
competed for binding##2##3##(1990-5#1)(2008-10#1)
competed for##5##2##(1990-5#1)(1993-6#2)(1993-8#1)(2008-10#1)
competed with the##4##3##(1995-6#1)(1997-7#1)(2008-8#2)
competed with##7##2##(1993-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-8#2)
competed##17##1##(1990-11#1)(1990-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-8#2)
competence after##2##2##(1990-6#1)(1996-1#1)
competence and confidence##3##3##(2008-11#2)(2008-12#1)
competence and##20##2##(1993-6#1)(1996-2#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-12#4)(2009-7#2)(2010-11#2)(2010-9#1)(2012-3#3)
competence in##10##2##(1992-2#1)(1992-3#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2012-3#1)(2013-1#1)
competence is##4##2##(1994-12#1)(2008-12#3)
competence of the##2##3##(1993-8#1)(1996-2#1)
competence of##15##2##(1991-11#1)(1993-2#2)(1993-8#2)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#2)(2009-11#1)(2013-1#1)
competence that##2##2##(1993-6#1)(2008-1#1)
competence to##5##2##(1996-6#1)(2007-4#1)(2008-11#2)(2009-6#1)
competence##116##1##(1990-11#1)(1990-6#1)(1991-11#1)(1991-6#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-6#5)(1993-8#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#3)(2008-10#6)(2008-11#21)(2008-12#14)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#3)(2009-2#2)(2009-6#1)(2009-7#4)(2010-11#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#8)(2013-1#4)
competencies and##2##2##(1994-2#1)(1996-2#1)
competencies are##2##2##(2008-11#1)(2013-1#1)
competencies in the##2##3##(2008-12#1)(2011-1#1)
competencies in##5##2##(1995-1#1)(2008-1#1)(2008-12#2)(2011-1#1)
competencies needed##2##2##(1996-2#1)(2008-1#1)
competencies that##2##2##(1997-3#1)(2008-1#1)
competencies to customer needs##2##4##(1994-2#2)
competencies to##4##2##(1994-2#2)(1996-3#1)(2008-1#1)
competencies##44##1##(1992-1#1)(1992-3#1)(1994-2#6)(1995-1#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#9)(2008-11#1)(2008-12#3)(2010-3#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
competency and##4##2##(1997-3#2)(2008-1#1)(2008-7#1)
competency assessment##5##2##(1995-3#3)(2008-11#2)
competency compared to##2##3##(2007-12#1)(2010-4#1)
competency for##2##2##(2008-1#1)(2008-12#1)
competency in##5##2##(1993-1#1)(2007-10#1)(2008-1#2)(2008-11#1)
competency of##3##2##(2008-10#1)(2008-11#1)(2010-3#1)
competency scales##2##2##(1993-2#2)
competency##49##1##(1991-2#1)(1993-1#1)(1993-2#2)(1994-1#1)(1994-12#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#3)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#2)(2008-8#2)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
competency-based assessment##2##2##(2008-11#2)
competency-based##7##1##(1995-1#1)(1995-3#1)(2008-11#4)(2013-1#1)
competent and##5##2##(1992-3#1)(2008-11#2)(2012-2#1)(2012-3#1)
competent as##2##2##(1992-3#1)(2008-12#1)
competent authorities at##2##3##(2011-2#2)
competent authorities##4##2##(2010-3#1)(2011-2#3)
competent care##4##2##(1994-12#1)(2007-3#1)(2008-4#1)(2010-8#1)
competent cells##3##2##(1990-11#2)(2008-5#1)
competent for##4##2##(1990-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
competent health##3##2##(1995-1#1)(2008-12#1)(2009-5#1)
competent immune##2##2##(2008-10#1)(2008-3#1)
competent in##3##2##(1993-2#1)(2010-11#1)(2010-3#1)
competent medical##2##2##(1995-3#1)(2008-12#1)
competent nursing##3##2##(1991-2#1)(2008-12#2)
competent practitioners##4##2##(2008-11#2)(2008-12#2)
competent to respond to##2##4##(1994-3#1)(2007-12#1)
competent to##7##2##(1990-2#1)(1992-11#1)(1992-3#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-12#1)
competent##76##1##(1990-11#4)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#4)(1993-2#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#3)(2009-5#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-8#1)
competently##2##1##(1996-12#1)(2008-11#1)
competes for##3##2##(1991-2#1)(1993-11#2)
competes with##5##2##(1994-5#1)(1995-3#1)(1995-6#1)(2008-10#1)(2012-12#1)
competes##10##1##(1991-2#1)(1992-11#1)(1993-11#2)(1994-5#1)(1995-3#1)(1995-6#1)(2006-6#1)(2008-10#1)(2012-12#1)
competing anions##2##2##(2013-1#2)
competing demands for##2##3##(2008-11#1)(2008-8#1)
competing demands##5##2##(2008-11#2)(2008-12#1)(2008-8#1)(2012-12#1)
competing for the##2##3##(1992-3#1)(1994-12#1)
competing for##9##2##(1991-5#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
competing health##2##2##(1993-2#1)(1996-3#1)
competing in##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
competing models##2##2##(2008-10#1)(2008-11#1)
competing nonlinearities##2##2##(2007-11#1)(2007-12#1)
competing objectives##2##2##(2008-11#1)(2011-2#1)
competing plant pathogens##2##3##(2008-10#2)
competing risks##3##2##(1995-9#1)(1997-4#2)
competing species##12##2##(2008-8#10)(2008-9#2)
competing theories##2##2##(1990-12#1)(1994-3#1)
competing with##4##2##(1991-3#1)(2008-8#1)(2008-9#2)
competing##101##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-3#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#2)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#18)(2008-9#7)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
competition among##9##2##(1991-3#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-8#1)(2008-9#2)
competition and predation##3##3##(2007-7#1)(2008-8#1)(2008-9#1)
competition and the##2##3##(2008-4#1)(2008-9#1)
competition and##33##2##(1991-3#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#1)(2007-7#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-1#1)(2009-7#1)(2010-2#1)
competition are##5##2##(2008-11#2)(2008-9#3)
competition as##3##2##(1995-2#1)(2008-5#1)(2008-9#1)
competition assay to##2##3##(1996-5#1)(2008-4#1)
competition assay##3##2##(1995-2#1)(1996-5#1)(2008-4#1)
competition assays##5##2##(1992-8#1)(1993-6#1)(1995-2#1)(2012-2#1)(2012-3#1)
competition between relatives##3##3##(2009-10#3)
competition between species##2##3##(2008-8#2)
competition between the two##2##4##(1993-8#1)(2008-3#1)
competition between the##5##3##(1993-8#1)(1996-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
competition between two##3##3##(1993-6#1)(2008-9#1)(2012-2#1)
competition between##35##2##(1990-7#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#3)(2010-11#1)(2010-5#1)(2012-2#2)
competition binding assay for##2##4##(1990-7#2)
competition binding##3##2##(1990-7#2)(1997-4#1)
competition by##4##2##(1992-3#1)(1993-12#1)(1996-12#1)(2008-10#1)
competition can##2##2##(2008-10#1)(2008-8#1)
competition could be##2##3##(1997-2#1)(2008-8#1)
competition could##4##2##(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
competition data##2##2##(1997-2#1)(2010-11#1)
competition dialysis assay##2##3##(2008-4#2)
competition dialysis##3##2##(2008-4#3)
competition experiments##5##2##(1990-7#1)(1995-12#1)(1995-6#1)(1996-3#1)(2010-12#1)
competition for nutrients##4##3##(2008-10#4)
competition for resources##5##3##(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
competition for space##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
competition for territories##2##3##(2008-8#2)
competition for the##2##3##(2008-11#1)(2008-8#1)
competition for##31##2##(1993-1#1)(1993-2#2)(1996-1#1)(1996-5#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#4)(2009-4#1)(2012-2#1)
competition from indigenous##2##3##(2008-10#2)
competition in the##3##3##(1997-1#1)(2008-11#1)(2013-8#1)
competition in##21##2##(1992-2#1)(1994-3#2)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#6)(2008-9#2)(2009-6#1)(2013-1#1)(2013-8#1)
competition increases##2##2##(2008-8#1)(2013-1#1)
competition is##8##2##(1994-3#1)(2008-11#1)(2008-8#4)(2008-9#2)
competition leads to##2##3##(2008-8#1)(2008-9#1)
competition may##3##2##(1995-3#1)(2008-9#1)(2009-10#1)
competition model##3##2##(2008-8#3)
competition models##3##2##(2008-8#2)(2008-9#1)
competition occurred##2##2##(2008-10#1)(2008-9#1)
competition of##11##2##(1991-9#1)(1996-5#1)(2008-10#3)(2008-5#3)(2008-7#1)(2012-12#1)(2012-2#1)
competition on##7##2##(1991-3#1)(1994-3#1)(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
competition over##3##2##(2009-10#1)(2010-1#1)(2012-2#1)
competition that##2##2##(2008-3#1)(2008-8#1)
competition was##4##2##(2008-10#1)(2008-8#3)
competition will##2##2##(1997-3#1)(2013-8#1)
competition with##17##2##(1994-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-8#2)
competition within##2##2##(2008-10#1)(2008-3#1)
competition##393##1##(1990-2#1)(1990-7#4)(1991-1#1)(1991-2#1)(1991-3#4)(1991-9#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#6)(1993-6#2)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#13)(1994-8#1)(1995-1#6)(1995-12#2)(1995-2#10)(1995-3#3)(1995-6#1)(1996-1#7)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(2007-11#2)(2007-7#3)(2008-1#3)(2008-10#44)(2008-11#19)(2008-12#4)(2008-3#5)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#7)(2008-8#82)(2008-9#54)(2009-1#1)(2009-10#7)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#6)(2013-8#6)
competition)##3##1##(2008-8#2)(2008-9#1)
competition-colonization models##3##2##(2008-8#3)
competition-colonization trade-off##4##2##(2008-8#4)
competition-colonization##11##1##(2008-8#8)(2008-9#3)
competition-increasing##2##1##(2013-1#2)
competition?##3##1##(1991-2#1)(2008-8#1)(2013-8#1)
competitions##5##1##(1993-3#2)(2009-8#1)(2011-2#2)
competitive ELISA##10##2##(1990-12#1)(1995-12#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-4#1)
competitive Langmuir##2##2##(2008-10#2)
competitive NMDA receptor antagonist##2##4##(1991-1#1)(1992-8#1)
competitive ability of##2##3##(2008-12#1)(2008-9#1)
competitive ability##11##2##(2008-10#1)(2008-12#2)(2008-8#5)(2008-9#3)
competitive adsorption##3##2##(2008-10#3)
competitive advantage##5##2##(1994-2#1)(2008-11#1)(2008-5#1)(2009-5#2)
competitive advantages over##2##3##(1993-6#1)(2008-10#1)
competitive advantages##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
competitive and non-competitive##2##3##(1990-7#1)(2008-10#1)
competitive and##7##2##(1990-7#1)(1993-2#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-7#1)(2013-8#1)
competitive anions##2##2##(2008-10#2)
competitive antagonist of##3##3##(1995-12#1)(2008-11#1)(2012-3#1)
competitive antagonist##6##2##(1995-12#2)(1997-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
competitive assay##5##2##(2008-10#5)
competitive athletes##2##2##(2009-2#1)(2009-7#1)
competitive binding of##2##3##(1993-6#1)(2008-10#1)
competitive binding##10##2##(1990-12#1)(1990-5#1)(1992-3#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-8#1)
competitive dominance##2##2##(2008-8#1)(2008-9#1)
competitive effects##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
competitive employment##2##2##(1993-3#2)
competitive environment##6##2##(1991-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-1#1)
competitive enzyme-linked immunosorbent assay (ELISA)##2##5##(2008-10#2)
competitive enzyme-linked immunosorbent assay##6##4##(1991-9#2)(2008-10#3)(2011-2#1)
competitive enzyme-linked immunosorbent##7##3##(1991-9#2)(2008-10#3)(2011-2#2)
competitive exclusion of##2##3##(2008-10#2)
competitive exclusion##12##2##(1995-9#1)(1997-3#3)(2008-10#4)(2008-8#2)(2008-9#1)(2009-8#1)
competitive for##2##2##(2008-10#1)(2010-2#1)
competitive health care##2##3##(1994-12#1)(2008-11#1)
competitive health##4##2##(1994-12#1)(2008-11#1)(2008-7#2)
competitive immune##2##2##(2008-10#2)
competitive immunoassay for##2##3##(2008-10#2)
competitive immunoassay##10##2##(1990-8#1)(2008-10#8)(2010-5#1)
competitive immunoreaction##2##2##(2008-10#2)
competitive inhibition of##2##3##(1992-12#1)(2008-11#1)
competitive inhibition with the##2##4##(2008-5#1)(2008-7#1)
competitive inhibition with##4##3##(1995-11#1)(1995-3#1)(2008-5#1)(2008-7#1)
competitive inhibition##11##2##(1992-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)
competitive inhibitor##9##2##(1990-5#1)(1991-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-10#2)
competitive inhibitors of the##3##4##(1994-5#1)(1995-5#2)
competitive inhibitors of##7##3##(1991-5#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-5#3)
competitive inhibitors##12##2##(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-5#3)(1997-2#1)
competitive interaction of##2##3##(1995-12#1)(2008-10#1)
competitive interaction##4##2##(1990-5#1)(1995-12#1)(2008-10#2)
competitive interactions##10##2##(2008-10#3)(2008-8#3)(2010-2#2)(2010-8#1)(2012-2#1)
competitive market##2##2##(1991-3#1)(1994-12#1)
competitive marketplace##2##2##(1992-3#1)(1994-2#1)
competitive markets##3##2##(1994-3#1)(1997-1#2)
competitive or##2##2##(1995-11#1)(2008-8#1)
competitive polymerase chain reaction (PCR)##2##5##(2008-10#1)(2012-3#1)
competitive polymerase chain reaction##4##4##(1995-12#1)(2008-10#2)(2012-3#1)
competitive reaction##4##2##(2008-10#4)
competitive reactions##2##2##(2008-10#2)
competitive relationship between##2##3##(2008-10#1)(2008-4#1)
competitive sport participation##2##3##(2009-7#1)(2010-1#1)
competitive strategies for##2##3##(1996-1#1)(1997-1#1)
competitive substrate colonization##2##3##(2008-10#2)
competitive than##2##2##(2008-10#1)(2010-8#1)
competitive toward##2##2##(1992-8#2)
competitive type##4##2##(1993-3#1)(1994-9#1)(2008-10#2)
competitive with that##2##3##(2008-3#1)(2008-6#1)
competitive with the##4##3##(1990-5#1)(1996-5#1)(2008-10#1)(2008-3#1)
competitive with##13##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-3#2)(2008-6#1)
competitive##343##1##(1990-11#1)(1990-12#2)(1990-5#5)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-5#3)(1991-9#4)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#5)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#5)(1993-3#4)(1993-6#2)(1993-8#1)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#9)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-3#2)(1996-5#1)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#93)(2008-11#15)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#28)(2008-9#10)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#5)(2009-8#2)(2010-1#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#2)
competitive-type immunoassay##2##2##(2008-10#2)
competitively exclude##2##2##(2008-10#1)(2008-8#1)
competitively inhibit##3##2##(1990-2#1)(1994-12#1)(1994-5#1)
competitively inhibited##6##2##(1990-2#1)(1990-8#1)(1994-5#1)(1995-8#1)(1996-2#1)(2008-8#1)
competitively with##2##2##(1992-8#1)(1994-8#1)
competitively##23##1##(1990-2#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#1)(2011-2#1)
competitiveness and##2##2##(2007-5#1)(2012-1#1)
competitiveness in##2##2##(2008-10#1)(2011-2#1)
competitiveness of##2##2##(2008-10#1)(2013-1#1)
competitiveness##7##1##(1995-2#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-1#1)(2013-1#1)
competitor and##2##2##(1996-3#1)(2008-8#1)
competitor for##2##2##(2008-10#1)(2012-12#1)
competitor has a##2##3##(2008-8#2)
competitor is##2##2##(2008-8#1)(2008-9#1)
competitor of##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
competitor to##2##2##(2008-8#1)(2010-2#1)
competitor##30##1##(1991-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-5#1)(2008-8#14)(2008-9#2)(2010-2#2)(2010-5#1)(2012-12#1)
competitors for##4##2##(2008-8#4)
competitors of##4##2##(1993-12#1)(1993-3#1)(1994-9#1)(2010-2#1)
competitors to coexist##2##3##(2008-8#1)(2008-9#1)
competitors to##4##2##(1993-1#1)(1995-1#1)(2008-8#1)(2008-9#1)
competitors##50##1##(1990-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#22)(2008-9#7)(2009-10#1)(2009-9#2)(2010-2#1)
competitors'##2##1##(1996-3#2)
compilation of the##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
compilation of##8##2##(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2012-3#1)
compilation##13##1##(1992-2#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2012-3#1)
compile##7##1##(1990-3#1)(1996-12#1)(1996-2#1)(2008-3#1)(2008-9#1)(2010-9#1)(2013-1#1)
compiled and##2##2##(1993-2#1)(2008-10#1)
compiled codons##2##2##(2008-11#2)
compiled expression profiles##2##3##(1996-10#2)
compiled from##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
compiled in##2##2##(2008-11#1)(2008-2#1)
compiled##35##1##(1991-6#1)(1991-8#1)(1993-12#1)(1993-2#3)(1996-10#3)(1997-1#1)(1997-5#1)(2006-10#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
compiles##2##1##(2008-4#1)(2011-2#1)
compiling and##2##2##(2008-11#1)(2008-4#1)
compiling##4##1##(2008-11#2)(2008-4#1)(2010-5#1)
complacency##2##1##(1994-12#1)(1996-3#1)
complain##5##1##(1993-12#2)(1993-3#1)(1997-4#1)(2008-9#1)
complained of a##2##3##(2008-7#1)(2013-1#1)
complained of dyspnea##2##3##(1990-12#1)(2008-1#1)
complained of pain in the##3##5##(2008-6#1)(2008-8#1)(2009-1#1)
complained of severe pain##2##4##(2008-12#1)(2012-3#1)
complained of severe##4##3##(1990-3#1)(1993-10#1)(2008-12#1)(2012-3#1)
complained of##32##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-1#1)(1993-10#1)(1994-6#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
complained##36##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-6#1)(1993-10#1)(1994-6#1)(1995-12#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2009-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
complaining of##9##2##(1992-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
complaining##10##1##(1992-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
complains##3##1##(2006-12#1)(2008-9#1)(2013-1#1)
complaint in##3##2##(1990-6#1)(2008-11#1)(2008-5#1)
complaint of##15##2##(2007-8#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
complaint was##3##2##(1996-12#1)(2010-3#1)(2012-12#1)
complaint with the##2##3##(1995-6#1)(1996-5#1)
complaint##38##1##(1990-6#2)(1991-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#4)(2012-3#3)(2013-1#3)(2013-8#1)
complaints about##2##2##(1997-1#2)
complaints and the##2##3##(1990-9#1)(1992-11#1)
complaints and##9##2##(1990-3#1)(1990-9#1)(1991-6#1)(1992-11#2)(1994-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
complaints are##2##2##(1992-11#1)(2008-7#1)
complaints associated with##2##3##(1997-6#1)(2009-1#1)
complaints by##2##2##(1995-12#1)(1996-2#1)
complaints in##5##2##(1990-3#1)(2007-8#2)(2008-10#1)(2011-2#1)
complaints is##2##2##(2008-4#1)(2012-12#1)
complaints may##2##2##(1990-11#1)(2009-11#1)
complaints of patients##2##3##(2007-11#1)(2013-1#1)
complaints of##23##2##(1992-2#1)(1994-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
complaints or##2##2##(2008-1#1)(2009-8#1)
complaints were##2##2##(1990-6#1)(1994-6#1)
complaints##109##1##(1990-11#1)(1990-3#3)(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-11#4)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#2)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#3)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
complement C3##2##2##(2008-1#1)(2008-6#1)
complement DNA##2##2##(1993-9#1)(1997-4#1)
complement a##4##2##(1995-5#1)(1996-3#1)(1996-6#1)(2009-8#1)
complement activation or##2##3##(2008-10#1)(2008-4#1)
complement activation##10##2##(1994-11#4)(2008-10#5)(2008-4#1)
complement activity##3##2##(1994-11#2)(1995-2#1)
complement and##3##2##(1993-3#1)(2008-4#1)(2011-2#1)
complement component##2##2##(1991-3#1)(1995-2#1)
complement components C4A and C4B##2##5##(2008-4#2)
complement components##4##2##(1991-8#1)(2008-4#3)
complement consumption##3##2##(1991-9#1)(1994-11#2)
complement deficiencies##2##2##(2007-2#2)
complement each other to##2##4##(1997-3#1)(2013-8#1)
complement each other##6##3##(1995-2#1)(1997-3#2)(2008-5#1)(2010-12#1)(2013-8#1)
complement factor H##2##3##(1997-9#1)(2009-6#1)
complement factor##3##2##(1991-3#1)(1997-9#1)(2009-6#1)
complement fixation test##2##3##(1992-5#1)(1992-6#1)
complement fixation##5##2##(1992-5#1)(1992-6#1)(1994-8#1)(2008-1#1)(2008-5#1)
complement in##2##2##(1993-3#1)(2008-7#1)
complement of##13##2##(1992-8#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
complement or##2##2##(2008-1#1)(2013-8#1)
complement pathways##2##2##(1993-11#2)
complement proteins encoded in the class III region of##2##9##(2008-4#2)
complement proteins##7##2##(1994-2#2)(1995-2#1)(2008-4#4)
complement receptor##2##2##(1994-6#1)(1997-3#1)
complement receptors##2##2##(2008-10#2)
complement system##5##2##(1991-2#1)(2007-7#1)(2008-10#1)(2009-6#1)(2012-3#1)
complement the##16##2##(1993-12#1)(1994-12#2)(1994-8#1)(1995-1#1)(1996-5#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)
complement this##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
complement those##3##2##(1994-5#1)(2008-10#1)(2010-5#1)
complement to the##2##3##(1993-3#1)(2008-11#1)
complement to##10##2##(1990-3#1)(1993-3#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
complement##172##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#4)(1993-12#3)(1993-3#4)(1993-9#1)(1994-11#8)(1994-12#3)(1994-2#4)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#14)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
complement)##2##1##(2008-2#1)(2008-7#1)
complement-dependent cytotoxicity##2##2##(2008-9#1)(2011-2#1)
complement-dependent##3##1##(1997-5#1)(2008-9#1)(2011-2#1)
complement-mediated##3##1##(1994-2#1)(1995-5#1)(2008-10#1)
complementarity between##2##2##(1994-5#1)(2009-5#1)
complementarity of##3##2##(1991-2#1)(1994-5#1)(1996-5#1)
complementarity to##6##2##(1993-12#1)(1997-7#3)(2008-7#1)(2008-8#1)
complementarity##18##1##(1991-2#1)(1993-12#2)(1994-5#2)(1994-8#3)(1996-5#1)(1997-7#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)
complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values##2##11##(1992-8#2)
complementarity-determining##4##1##(1992-8#2)(1995-2#2)
complementary DNA (cDNA) encoding##2##4##(2008-7#1)(2008-9#1)
complementary DNA (cDNA)##5##3##(1990-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
complementary DNA clones##3##3##(2008-10#3)
complementary DNA##21##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-2#1)(1991-5#2)(1994-12#1)(1996-2#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
complementary DNAs##3##2##(1991-5#1)(1994-11#2)
complementary RNA##2##2##(2008-4#2)
complementary and alternative medicine (CAM)##4##5##(2008-10#4)
complementary and alternative medicine##9##4##(2008-10#6)(2009-5#1)(2009-6#2)
complementary and alternative##11##3##(1991-3#1)(2008-10#6)(2008-11#1)(2009-5#1)(2009-6#2)
complementary and##15##2##(1990-3#1)(1991-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-5#1)(2009-6#2)(2012-3#1)(2013-1#1)
complementary approaches##2##2##(1996-12#1)(2008-9#1)
complementary base##2##2##(2008-7#1)(2009-5#1)
complementary effects on##2##3##(2008-10#1)(2008-7#1)
complementary feeding practices and behaviours##2##5##(2010-6#2)
complementary feeding##3##2##(2010-6#3)
complementary foods##3##2##(2010-5#1)(2010-6#2)
complementary in##2##2##(1991-2#1)(2008-9#1)
complementary information##5##2##(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
complementary log-log##2##2##(2008-10#2)
complementary metal-oxide semiconductor##5##3##(2008-3#5)
complementary metal-oxide semiconductor-self-electro-optic device##2##4##(2008-2#1)(2008-3#1)
complementary metal-oxide semiconductor-self-electro-optic##3##3##(2008-2#2)(2008-3#1)
complementary metal-oxide##11##2##(2008-2#3)(2008-3#8)
complementary method to HRMS for##2##5##(2008-10#2)
complementary method to##4##3##(2008-10#4)
complementary method##6##2##(2008-10#4)(2008-7#1)(2012-2#1)
complementary methods of treatment##2##4##(1997-6#2)
complementary methods##3##2##(1997-6#2)(1997-8#1)
complementary models##2##2##(1997-7#1)(2008-8#1)
complementary oligonucleotides##3##2##(1993-6#1)(2008-10#1)(2008-7#1)
complementary procedures##3##2##(1995-2#1)(1997-8#1)(2008-7#1)
complementary regions##2##2##(1997-6#1)(2008-7#1)
complementary sense##3##2##(2008-9#3)
complementary sequence##3##2##(1993-11#1)(1995-12#1)(2008-10#1)
complementary sequences##5##2##(2008-10#2)(2008-4#2)(2012-2#1)
complementary strand##6##2##(1994-12#1)(1997-3#1)(2008-10#3)(2008-4#1)
complementary strands of##2##3##(1995-3#1)(1997-6#1)
complementary strands##3##2##(1995-3#1)(1997-6#1)(2008-10#1)
complementary target##9##2##(2008-10#8)(2008-9#1)
complementary technique##2##2##(1996-3#1)(2008-10#1)
complementary techniques##2##2##(2006-4#1)(2010-5#1)
complementary therapies##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
complementary therapy##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
complementary to a##2##3##(1997-7#2)
complementary to the internal portion of an intron##2##8##(1991-9#2)
complementary to the target##2##4##(2008-10#2)
complementary to the##12##3##(1991-9#2)(1992-11#1)(1994-8#2)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)
complementary to##38##2##(1990-5#1)(1991-9#5)(1992-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-7#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)
complementary treatment##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
complementary window##2##2##(2007-11#2)
complementary##280##1##(1990-11#2)(1990-12#4)(1990-3#2)(1990-5#4)(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-9#5)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#5)(1997-7#3)(1997-8#3)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#7)(2008-10#76)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#20)(2008-4#13)(2008-5#3)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#10)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#6)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#1)
complementary-metal-oxide-semiconductor (CMOS)##2##2##(2008-2#2)
complementary-metal-oxide-semiconductor##3##1##(2008-2#2)(2008-3#1)
complementation assays##2##2##(1997-2#1)(2008-10#1)
complementation groups##3##2##(1991-5#1)(1996-3#2)
complementation of a##7##3##(1993-9#1)(1994-8#3)(1995-8#1)(1995-9#1)(2008-6#1)
complementation of##17##2##(1990-5#1)(1991-5#1)(1992-5#1)(1993-9#2)(1994-8#4)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-4#2)(2008-10#1)(2008-6#1)
complementation system##2##2##(2008-8#2)
complementation using##2##2##(1995-12#1)(2008-9#1)
complementation was##2##2##(1997-7#1)(2008-10#1)
complementation with##2##2##(1995-2#1)(2008-11#1)
complementation##50##1##(1990-5#2)(1991-5#2)(1991-7#1)(1992-5#1)(1993-9#2)(1994-12#2)(1994-8#4)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#7)(2008-11#1)(2008-4#4)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2012-2#2)
complemented by an##2##3##(2008-1#1)(2010-2#1)
complemented by the wild-type##2##4##(1991-12#2)
complemented by the##4##3##(1991-12#2)(2011-2#2)
complemented by##16##2##(1991-12#2)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)
complemented the##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
complemented with a##2##3##(2008-11#1)(2009-8#1)
complemented with data from##2##4##(2008-5#1)(2013-7#1)
complemented with##6##2##(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-8#1)(2013-7#1)
complemented##32##1##(1991-12#2)(1991-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-7#1)
complementing the##3##2##(1994-12#1)(1996-6#1)(2012-3#1)
complementing##13##1##(1991-12#1)(1993-9#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#2)(2011-3#1)(2012-3#1)
complements of##2##2##(2009-5#1)(2010-3#1)
complements the##5##2##(1997-7#1)(2007-6#1)(2008-7#1)(2009-2#1)(2012-1#1)
complements traditional##2##2##(2008-4#1)(2008-8#1)
complements##18##1##(1995-6#1)(1997-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-3#2)(2013-8#1)
complete 1##2##2##(1995-8#1)(2008-5#1)
complete DNA##2##2##(2008-10#1)(2012-3#1)
complete NMR chemical shift assignments##3##5##(2009-7#3)
complete a##12##2##(1990-11#1)(1990-5#1)(1992-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-7#1)(2013-8#1)
complete absence in##2##3##(2008-11#1)(2009-2#1)
complete absence of Ce(IV) and##2##5##(2008-10#2)
complete absence of the##2##4##(2007-8#1)(2013-1#1)
complete absence of##13##3##(1992-5#1)(1993-12#1)(1995-6#1)(1995-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2013-1#1)
complete absence##15##2##(1992-5#1)(1993-12#1)(1995-6#1)(1995-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-2#1)(2013-1#1)
complete agreement with##2##3##(2008-1#1)(2008-10#1)
complete analysis of##4##3##(1991-1#1)(2008-10#2)(2008-3#1)
complete analysis##8##2##(1991-1#1)(2008-10#5)(2008-3#2)
complete and accurate##2##3##(2010-5#1)(2010-8#1)
complete and##23##2##(1990-8#1)(1992-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#4)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
complete arterial revascularization with composite T-graft##2##6##(2007-8#2)
complete arterial##3##2##(1997-8#1)(2007-8#2)
complete as##3##2##(1990-6#1)(2008-10#1)(2008-2#1)
complete assessment##2##2##(2008-4#1)(2008-9#1)
complete assignment of##2##3##(1995-5#1)(2013-1#1)
complete assignment##3##2##(1995-5#1)(2009-7#1)(2013-1#1)
complete atrioventricular block##2##3##(1992-4#1)(2008-7#1)
complete atrioventricular##3##2##(1992-4#1)(2008-3#1)(2008-7#1)
complete backbone and##2##3##(2009-7#2)
complete backbone##3##2##(2009-7#3)
complete block design with##4##4##(2008-10#1)(2008-12#3)
complete block design##7##3##(2008-10#4)(2008-12#3)
complete blood count (CBC)##2##4##(2008-10#1)(2013-1#1)
complete blood count##5##3##(2008-10#3)(2011-2#1)(2013-1#1)
complete blood counts and##2##4##(2008-10#2)
complete blood counts##4##3##(2008-10#4)
complete blood##10##2##(2008-10#7)(2008-7#1)(2011-2#1)(2013-1#1)
complete brachial plexus##3##3##(2008-9#3)
complete by##2##2##(1994-11#1)(2008-11#1)
complete cDNA##3##2##(1993-8#1)(1996-12#1)(2010-5#1)
complete carcinogenic##2##2##(1992-2#2)
complete carcinogens##2##2##(1992-2#2)
complete characterization of##3##3##(2007-11#2)(2008-3#1)
complete clearance##2##2##(1991-2#1)(2007-7#1)
complete cleft##2##2##(2011-2#1)(2012-12#1)
complete clinical##3##2##(1990-6#1)(1997-8#1)(2011-2#1)
complete closure##4##2##(1997-8#3)(2013-8#1)
complete coding region##2##3##(1997-4#1)(1997-7#1)
complete coding##5##2##(1991-12#1)(1993-2#1)(1994-12#1)(1997-4#1)(1997-7#1)
complete control of##5##3##(2007-10#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-9#1)
complete control##7##2##(2007-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-9#1)
complete conversion##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
complete cross protection##3##3##(2008-10#3)
complete cure of##2##3##(2006-12#1)(2011-2#1)
complete cure##6##2##(2006-12#2)(2008-7#2)(2011-2#1)(2013-7#1)
complete data sets##2##3##(2008-3#2)
complete data##4##2##(2008-10#1)(2008-3#2)(2009-5#1)
complete decomposition##2##2##(2008-10#1)(2013-8#1)
complete deletion of the##2##4##(1995-8#1)(2008-10#1)
complete denture##4##2##(2013-1#4)
complete dentures##4##2##(2011-7#1)(2013-1#3)
complete description of the##6##4##(2007-12#1)(2007-8#1)(2008-3#3)(2008-8#1)
complete digestion of samples##2##4##(2008-10#2)
complete digestion##3##2##(1996-2#1)(2008-10#2)
complete dissolution of##2##3##(1995-8#1)(2008-10#1)
complete dissolution##3##2##(1995-8#1)(2008-10#2)
complete drainage##2##2##(1990-8#1)(2008-5#1)
complete elimination of##2##3##(2008-11#1)(2008-7#1)
complete elution of##2##3##(2008-10#2)
complete elution##3##2##(2008-10#3)
complete emergence##2##2##(2008-10#2)
complete eradication of##3##3##(2008-7#1)(2010-12#1)(2011-2#1)
complete excision of CIN or worse##2##6##(1994-2#2)
complete excision of the##2##4##(2012-3#1)(2013-1#1)
complete excision of##4##3##(1994-2#2)(2012-3#1)(2013-1#1)
complete excision##5##2##(1994-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
complete explanation of##2##3##(1990-12#1)(2008-11#1)
complete explanation##3##2##(1990-12#1)(2008-11#1)(2012-1#1)
complete extraction of##3##3##(2008-10#3)
complete extraction##4##2##(2008-10#4)
complete functional##3##2##(1993-6#1)(2008-7#1)(2009-5#1)
complete fusion##3##2##(1991-5#2)(1995-6#1)
complete gene##4##2##(1993-2#1)(1993-8#1)(2008-9#1)(2010-5#1)
complete genome of##4##3##(2007-6#1)(2008-10#1)(2008-8#1)(2012-3#1)
complete genome sequence of the genus##2##6##(2011-2#2)
complete genome sequence of the##5##5##(2008-7#1)(2008-9#1)(2011-2#3)
complete genome sequence of##14##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#10)(2013-8#1)
complete genome sequence##43##3##(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#37)(2013-8#2)
complete genome sequences of##2##4##(2008-10#2)
complete genome sequences##5##3##(2008-10#3)(2008-4#2)
complete genome##56##2##(2007-6#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#38)(2012-3#1)(2013-8#2)
complete genomes##2##2##(2008-10#1)(2008-8#1)
complete genomic sequence of##2##4##(2008-10#1)(2008-8#1)
complete genomic sequences##2##3##(2008-7#1)(2008-9#1)
complete genomic##6##2##(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)
complete healing of##3##3##(1994-2#1)(2008-5#1)(2009-10#1)
complete human##2##2##(2008-7#2)
complete hydrolysis of##4##3##(1990-2#1)(1995-6#1)(2008-5#1)(2008-8#1)
complete imaging##2##2##(2008-3#1)(2011-1#1)
complete in##10##2##(1990-9#1)(1991-8#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-8#1)
complete inactivation##2##2##(1990-2#1)(2011-2#1)
complete information##4##2##(1994-2#1)(2007-12#1)(2008-3#1)(2011-3#1)
complete inhibition of the PAM process##2##6##(2008-7#2)
complete inhibition of##4##3##(1994-8#1)(2008-4#1)(2008-7#2)
complete inhibition##7##2##(1992-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(2008-4#1)(2008-7#2)
complete internal transcribed spacer (ITS) region##3##6##(2008-10#3)
complete interruption of##2##3##(1993-3#1)(2012-2#1)
complete its life cycle##2##4##(2008-10#1)(2012-2#1)
complete linkage##2##2##(2008-8#1)(2012-2#1)
complete list of##3##3##(1991-8#1)(1996-12#1)(2010-3#1)
complete loss of activity##2##4##(1995-6#2)
complete loss of the##4##4##(1994-3#1)(1994-9#1)(2008-12#1)(2013-1#1)
complete loss of##17##3##(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
complete medical history##2##3##(1995-5#1)(2012-5#1)
complete medical##3##2##(1993-12#1)(1995-5#1)(2012-5#1)
complete medium##3##2##(1992-11#1)(1995-11#1)(2008-4#1)
complete mineralization##2##2##(1995-11#1)(2008-10#1)
complete mitochondrial##2##2##(2008-5#1)(2008-6#1)
complete necrosis##2##2##(1992-9#1)(2008-9#1)
complete nucleotide and##2##3##(1993-12#1)(2008-4#1)
complete nucleotide sequence of a##6##5##(1993-3#1)(1995-9#1)(1996-6#1)(1997-4#1)(2008-10#2)
complete nucleotide sequence of the gene##3##6##(1992-3#1)(1994-12#2)
complete nucleotide sequence of the##12##5##(1990-5#1)(1992-3#1)(1993-2#1)(1994-12#2)(1995-6#1)(1997-7#1)(2008-10#5)
complete nucleotide sequence of##26##4##(1990-5#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#10)(2008-8#1)
complete nucleotide sequence was determined##2##5##(1994-12#1)(2008-10#1)
complete nucleotide sequence##29##3##(1990-5#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#4)(1994-9#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#11)(2008-8#1)
complete nucleotide sequences of the##3##5##(2008-10#3)
complete nucleotide sequences of##6##4##(2008-10#5)(2013-8#1)
complete nucleotide sequences##7##3##(1996-10#1)(2008-10#5)(2013-8#1)
complete nucleotide##41##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#4)(1994-9#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#2)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-4#1)(2008-8#1)(2013-8#1)
complete obliteration##4##2##(2008-7#4)
complete occlusion of the##6##4##(1996-9#1)(1997-3#1)(2006-12#1)(2008-12#2)(2008-7#1)
complete occlusion##7##2##(1996-9#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-12#2)(2008-7#1)
complete one##2##2##(1990-5#1)(1992-7#1)
complete open reading frame##3##4##(1993-3#1)(2008-8#2)
complete open reading frames (ORFs)##3##5##(1995-9#1)(1997-3#2)
complete open reading frames##5##4##(1995-12#1)(1995-9#2)(1997-3#2)
complete open reading##8##3##(1993-3#1)(1995-12#1)(1995-9#2)(1997-3#2)(2008-8#2)
complete or incomplete##2##3##(2008-10#1)(2008-12#1)
complete or partial responses##2##4##(1990-10#1)(1993-9#1)
complete or partial##11##3##(1990-10#1)(1990-11#1)(1991-6#1)(1993-9#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-12#1)(2010-3#1)(2010-5#1)
complete or##16##2##(1990-10#1)(1990-11#1)(1991-6#1)(1992-11#1)(1993-9#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-3#1)(2010-5#1)(2013-1#1)
complete oxidation of##2##3##(2008-6#1)(2011-2#1)
complete pain relief##2##3##(1992-1#1)(2007-6#1)
complete pathologic##2##2##(1990-12#1)(2008-10#1)
complete phase##2##2##(2008-2#1)(2008-3#1)
complete physical##2##2##(2008-3#1)(2009-10#1)
complete picture of the##2##4##(2008-10#1)(2010-4#1)
complete picture##4##2##(2008-10#1)(2009-8#2)(2010-4#1)
complete primary structure##2##3##(1992-8#1)(2010-4#1)
complete primary##3##2##(1992-3#1)(1992-8#1)(2010-4#1)
complete procedure##4##2##(2008-10#2)(2010-7#2)
complete protection##5##2##(1990-6#1)(1992-9#1)(1996-12#1)(2008-9#1)(2010-3#1)
complete proteins##3##2##(1992-3#1)(2011-2#2)
complete radiological##2##2##(2008-7#1)(2010-5#1)
complete recovery of function##2##4##(1991-2#1)(2008-2#1)
complete recovery of the##2##4##(2007-11#1)(2008-10#1)
complete recovery of##8##3##(1991-11#1)(1991-2#1)(1996-9#2)(2007-11#1)(2008-10#2)(2008-2#1)
complete recovery##16##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1996-6#1)(1996-9#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#1)
complete regression of##3##3##(1990-2#1)(1990-3#1)(1990-6#1)
complete regression##5##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)
complete relief##2##2##(1995-2#1)(2008-6#1)
complete remission (CR)##2##3##(2008-10#2)
complete remission and##3##3##(2007-5#1)(2007-7#2)
complete remission in##5##3##(1997-3#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-3#1)
complete remission without##2##3##(1993-2#1)(2013-1#1)
complete remission##36##2##(1990-6#1)(1990-8#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-2#1)(1995-3#1)(1997-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#5)(2012-12#2)(2012-3#3)(2013-1#1)
complete remissions of both diseases by##2##6##(2013-8#2)
complete remissions##3##2##(1991-2#1)(2013-8#2)
complete removal of the##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
complete removal of##9##3##(1994-11#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-2#1)(2011-1#1)(2012-12#1)
complete replacement of##3##3##(1991-9#1)(1992-3#1)(1993-8#1)
complete replacement##4##2##(1991-9#1)(1992-3#1)(1993-8#1)(2008-10#1)
complete resection of the##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
complete resection of##4##3##(2007-10#1)(2007-8#1)(2008-6#1)(2011-2#1)
complete resection##12##2##(1990-8#2)(1992-12#1)(2007-10#1)(2007-8#1)(2008-6#2)(2011-2#3)(2012-12#1)(2013-8#1)
complete resistance against##2##3##(2008-10#2)
complete resistance to##12##3##(1993-3#1)(2008-10#11)
complete resistance##17##2##(1993-3#1)(2008-10#16)
complete resolution of her symptoms##2##5##(2008-7#1)(2013-8#1)
complete resolution of the##3##4##(2007-10#1)(2008-7#1)(2009-6#1)
complete resolution of##12##3##(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-8#1)
complete resolution##15##2##(1992-12#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-8#1)
complete responders##3##2##(1991-2#1)(1992-10#1)(1994-8#1)
complete response (CR)##3##3##(1997-7#1)(2007-10#1)(2008-5#1)
complete response at##2##3##(1991-8#1)(1994-1#1)
complete response##22##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-4#1)(1991-8#1)(1994-1#1)(1997-7#1)(2007-10#2)(2007-8#1)(2008-5#1)(2008-6#3)(2012-3#4)(2013-1#3)
complete responses##5##2##(1991-2#1)(1992-2#1)(1992-8#1)(2007-10#2)
complete right##2##2##(1996-2#1)(2008-7#1)
complete rupture of the anal sphincter##3##6##(2011-2#3)
complete rupture of the##4##4##(1997-6#1)(2011-2#3)
complete rupture##5##2##(1997-6#1)(2008-7#1)(2011-2#3)
complete separation of the##3##4##(1990-12#2)(2008-10#1)
complete separation of##7##3##(1990-12#2)(1997-2#1)(2008-10#4)
complete separation##9##2##(1990-12#2)(1990-8#1)(1997-2#1)(2008-10#5)
complete sequence of the##4##4##(1993-2#1)(2008-10#2)(2008-8#1)
complete sequence of##13##3##(1993-2#2)(1997-4#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)(2010-5#1)
complete sequence specific##2##3##(2008-9#1)(2009-7#1)
complete sequence##20##2##(1993-11#1)(1993-2#2)(1995-6#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-5#1)(2011-2#1)
complete sequences##2##2##(2008-10#1)(2012-3#1)
complete set of the##2##4##(2008-3#1)(2008-6#1)
complete set of##10##3##(1994-2#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
complete spatial##2##2##(2007-11#1)(2011-2#1)
complete structure of the##2##4##(1990-5#1)(1992-12#1)
complete study##2##2##(1990-12#1)(2013-1#1)
complete suppression of the##2##4##(2007-12#1)(2008-5#1)
complete suppression of##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
complete surgical excision##2##3##(1990-6#1)(2012-3#1)
complete surgical resection of metachronous##2##5##(2013-1#2)
complete surgical resection##3##3##(2008-6#1)(2013-1#2)
complete surgical##7##2##(1990-6#1)(2008-6#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
complete thallium##2##2##(1991-12#1)(2008-10#1)
complete the##25##2##(1995-2#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
complete their##2##2##(1991-2#1)(1996-3#1)
complete theoretical analysis of##2##4##(2007-12#1)(2008-3#1)
complete theoretical##3##2##(2007-12#1)(2008-3#2)
complete three-dimensional velocity reconstruction##2##4##(2008-3#2)
complete tumor resection##2##3##(2011-2#1)(2012-3#1)
complete tumor##5##2##(1991-8#1)(1992-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
complete understanding of the##8##4##(1992-3#1)(1996-12#1)(1996-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)
complete understanding of##11##3##(1992-3#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
complete urethral transection##2##3##(2008-10#2)
complete within##3##2##(1990-2#1)(2007-1#1)(2008-10#1)
complete##1168##1##(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#6)(1990-3#2)(1990-5#4)(1990-6#9)(1990-7#2)(1990-8#9)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#8)(1991-4#2)(1991-5#6)(1991-6#7)(1991-8#7)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#9)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#7)(1993-3#5)(1993-6#3)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#9)(1994-2#5)(1994-3#4)(1994-6#2)(1994-8#4)(1994-9#3)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#7)(1995-6#9)(1995-8#12)(1995-9#4)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#5)(1996-5#4)(1996-6#2)(1996-8#4)(1996-9#6)(1997-1#1)(1997-2#3)(1997-3#9)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#11)(1997-8#7)(2006-10#1)(2006-12#3)(2007-1#1)(2007-10#11)(2007-11#18)(2007-12#26)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#15)(2008-1#9)(2008-10#199)(2008-11#27)(2008-12#12)(2008-2#19)(2008-3#42)(2008-4#19)(2008-5#15)(2008-6#21)(2008-7#55)(2008-8#36)(2008-9#33)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-4#4)(2009-5#4)(2009-6#4)(2009-7#14)(2009-8#4)(2010-12#4)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#9)(2010-6#2)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#7)(2011-2#83)(2011-3#2)(2011-7#2)(2012-1#2)(2012-12#11)(2012-2#10)(2012-3#27)(2012-5#1)(2013-1#33)(2013-7#4)(2013-8#18)
completed 3##3##2##(2008-3#1)(2010-6#1)(2012-12#1)
completed a comprehensive##2##3##(1997-2#1)(2009-3#1)
completed a questionnaire that##2##4##(2008-11#1)(2013-1#1)
completed a questionnaire##9##3##(1990-2#1)(1991-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
completed a survey##2##3##(2010-11#1)(2010-8#1)
completed a##46##2##(1990-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-5#1)(1997-2#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-11#6)(2008-7#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
completed after##3##2##(1995-12#1)(2008-12#1)(2012-12#1)
completed an electronic##2##3##(2010-10#1)(2012-3#1)
completed an##12##2##(1991-9#1)(1992-12#1)(2008-1#2)(2008-3#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
completed and returned##2##3##(1997-2#1)(2013-1#1)
completed and##5##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
completed as part of##3##4##(2008-11#1)(2013-1#2)
completed as##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
completed at##3##2##(2008-3#1)(2010-5#1)(2013-8#1)
completed both##3##2##(1994-12#1)(1997-2#1)(2011-2#1)
completed by a##6##3##(1996-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
completed by the##8##3##(1993-2#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-8#1)
completed by##32##2##(1992-12#1)(1992-5#1)(1993-2#1)(1994-11#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
completed for##4##2##(2007-12#1)(2008-2#1)(2010-3#1)(2012-1#1)
completed genome sequence of a member of the class##2##9##(2011-2#2)
completed genome sequence of a member of the family##2##9##(2011-2#2)
completed genome sequence of a member of the genus##3##9##(2011-2#3)
completed genome sequence of a member of the##8##8##(2011-2#8)
completed genome sequence of a member##9##6##(2011-2#9)
completed genome sequence of a##10##5##(2011-2#10)
completed genome sequence of the family##6##6##(2011-2#6)
completed genome sequence of the##9##5##(2011-2#9)
completed genome sequence of##19##4##(2011-2#19)
completed genome sequence##23##3##(2011-2#23)
completed in 1996##2##3##(2008-5#2)
completed in less than##5##4##(1995-11#1)(1996-11#1)(2008-10#2)(2011-1#1)
completed in the##2##3##(2008-5#1)(2011-2#1)
completed in##41##2##(1990-8#1)(1991-11#2)(1994-12#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
completed measures of##10##3##(2007-12#2)(2008-11#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)
completed measures##12##2##(2007-12#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)
completed on##4##2##(2007-9#1)(2008-10#1)(2012-3#1)(2013-7#1)
completed online##2##2##(2008-12#1)(2013-1#1)
completed over##2##2##(2007-12#1)(2008-10#1)
completed pre- and##3##3##(2007-12#1)(2008-12#1)(2013-1#1)
completed questionnaires and##2##3##(2007-12#1)(2010-2#1)
completed questionnaires at##2##3##(2007-12#1)(2011-1#1)
completed questionnaires on##2##3##(2007-12#1)(2012-2#1)
completed questionnaires##9##2##(2007-12#3)(2008-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
completed structured##2##2##(1995-1#1)(2009-5#1)
completed suicide##5##2##(2008-11#1)(2009-7#3)(2011-2#1)
completed surveys##5##2##(1996-3#1)(2008-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
completed the questionnaire##3##3##(1992-6#1)(2010-10#1)(2012-2#1)
completed the screening##3##3##(1996-12#1)(2013-1#2)
completed the study##12##3##(1992-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#3)(2008-7#2)(2008-9#1)(2013-1#1)
completed the survey##3##3##(2009-8#1)(2011-2#1)(2012-1#1)
completed the##50##2##(1992-11#1)(1992-6#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
completed their##7##2##(1992-10#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-3#1)
completed three##2##2##(2010-8#1)(2013-8#1)
completed to##3##2##(1991-12#1)(2008-10#1)(2012-12#1)
completed treatment##3##2##(1993-1#1)(1996-3#1)(1997-2#1)
completed two##3##2##(1994-3#1)(2008-7#1)(2012-1#1)
completed under##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
completed with a##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
completed with##15##2##(1992-12#1)(1994-7#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#3)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
completed within 5##2##3##(2008-10#2)
completed within##11##2##(1990-7#1)(1992-11#1)(1992-2#1)(2008-10#6)(2008-5#1)(2010-12#1)
completed without##2##2##(1994-2#1)(2008-10#1)
completed##431##1##(1990-2#1)(1990-7#2)(1990-8#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-7#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#19)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#48)(2008-11#18)(2008-12#9)(2008-2#3)(2008-3#10)(2008-4#7)(2008-5#16)(2008-6#1)(2008-7#16)(2008-8#8)(2008-9#8)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#38)(2012-1#6)(2012-12#10)(2012-2#4)(2012-3#5)(2013-1#22)(2013-7#1)(2013-8#9)
completely abolished by##2##3##(1997-6#1)(1997-8#1)
completely abolished the##4##3##(1993-6#1)(1995-5#1)(1996-2#1)(1997-7#1)
completely abolished##22##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-11#2)(2008-7#1)(2009-8#1)(2011-1#1)
completely abolishes##2##2##(2008-8#1)(2010-11#1)
completely abrogated##4##2##(1993-11#1)(1994-6#1)(2008-8#1)(2013-1#1)
completely absent##2##2##(2010-8#1)(2011-2#1)
completely absorbed by##2##3##(1995-12#1)(2007-11#1)
completely accurate##2##2##(2009-12#1)(2010-12#1)
completely after##3##2##(1991-5#1)(2008-7#1)(2013-1#1)
completely and##2##2##(1996-11#1)(2008-10#1)
completely asymmetric competition##2##3##(2008-8#2)
completely asymmetric##3##2##(2008-2#1)(2008-8#2)
completely asymptomatic##3##2##(1993-9#1)(2008-5#1)(2011-2#1)
completely at##4##2##(1997-8#2)(2009-12#1)(2009-7#1)
completely avoided##2##2##(2008-7#1)(2011-2#1)
completely blocked by the##5##4##(1994-8#1)(1994-9#1)(1995-6#1)(1997-6#1)(2008-8#1)
completely blocked by##13##3##(1990-5#1)(1990-7#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-6#1)(1997-6#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)
completely blocked the increase in##2##5##(1990-7#1)(1992-12#1)
completely blocked the##6##3##(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1995-12#1)(2011-2#1)
completely blocked##26##2##(1990-11#1)(1990-5#2)(1990-7#2)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)
completely by##4##2##(1993-1#1)(1997-1#1)(2008-10#2)
completely castrated##4##2##(2008-5#2)(2008-9#2)
completely compensated##2##2##(2007-12#2)
completely conserved##3##2##(1990-11#1)(1992-11#1)(1993-12#1)
completely consistent##2##2##(1994-5#1)(2008-2#1)
completely cured##4##2##(1994-2#1)(2006-12#1)(2007-7#2)
completely defined##2##2##(1997-4#1)(2008-5#1)
completely depleted##3##2##(1995-6#1)(2008-11#1)(2013-8#1)
completely described were##2##3##(2008-10#2)
completely destroyed##2##2##(1991-3#1)(1993-3#1)
completely determined##2##2##(2008-9#1)(2010-12#1)
completely developed##2##2##(2008-12#1)(2011-1#1)
completely devoid of##2##3##(1992-12#1)(1995-2#1)
completely different from##3##3##(1997-6#1)(2008-11#1)(2012-3#1)
completely different##8##2##(1991-5#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2009-7#1)(2012-3#1)
completely diminished##2##2##(1992-3#1)(2008-11#1)
completely disappeared in##3##3##(1990-8#1)(2008-9#2)
completely disappeared##5##2##(1990-8#1)(2008-7#1)(2008-9#2)(2011-2#1)
completely dominant##2##2##(2008-10#2)
completely eliminated in##2##3##(1991-12#1)(2010-2#1)
completely eliminated##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)
completely elucidated##6##2##(2008-1#1)(2008-10#2)(2009-12#1)(2010-6#1)(2010-7#1)
completely for##2##2##(1990-8#1)(1991-12#1)
completely free##2##2##(2007-12#1)(2013-1#1)
completely from the##2##3##(2008-10#1)(2008-9#1)
completely from##3##2##(2008-10#2)(2008-9#1)
completely in the##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
completely in##4##2##(2008-10#2)(2008-5#1)(2009-10#1)
completely independent##4##2##(1991-9#1)(2008-10#1)(2008-2#2)
completely ineffective##2##2##(1990-7#1)(1993-9#1)
completely inhibit##3##2##(1991-5#1)(2008-4#1)(2010-4#1)
completely inhibited by##8##3##(1990-2#1)(1992-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)
completely inhibited lipolytic activity##2##4##(2010-10#2)
completely inhibited the##9##3##(1990-2#1)(1994-11#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
completely inhibited this effect##2##4##(1995-12#2)
completely inhibited##34##2##(1990-2#2)(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-11#2)(1994-9#2)(1995-12#5)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#2)(2011-2#1)
completely inhibits##2##2##(1994-8#1)(1997-1#1)
completely lacking##2##2##(1995-2#1)(1995-6#1)
completely lost##4##2##(1993-11#1)(1994-6#1)(2008-10#1)(2008-9#1)
completely natural##3##2##(2008-5#3)
completely necrotic##2##2##(1990-8#1)(2008-10#1)
completely new##5##2##(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#2)
completely occluded##2##2##(1996-9#1)(1997-3#1)
completely occluding##2##2##(2010-2#1)(2011-1#1)
completely on the##2##3##(2009-5#1)(2013-1#1)
completely on##3##2##(1991-5#1)(2009-5#1)(2013-1#1)
completely or##5##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
completely overcome##2##2##(2008-10#2)
completely overlapped##2##2##(1993-2#1)(2008-8#1)
completely oxidized##2##2##(1995-2#1)(2008-10#1)
completely prevent##2##2##(1997-3#1)(2008-10#1)
completely prevented by##2##3##(1992-3#1)(2008-4#1)
completely prevented the##4##3##(1996-2#1)(1997-7#1)(2008-1#1)(2008-11#1)
completely prevented##11##2##(1992-3#1)(1994-11#1)(1995-12#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2013-1#1)
completely prevents##3##2##(2008-8#1)(2013-1#2)
completely randomized##7##2##(2008-10#1)(2008-12#2)(2008-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
completely recovered##3##2##(2007-12#1)(2013-8#2)
completely remove the##2##3##(2007-8#1)(2008-8#1)
completely remove##3##2##(2007-8#1)(2008-4#1)(2008-8#1)
completely removed##7##2##(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
completely replaced##2##2##(1994-2#1)(2008-4#1)
completely replacing##3##2##(1993-8#1)(1996-9#1)(2008-4#1)
completely repressed##2##2##(1990-5#1)(2008-6#1)
completely resected##7##2##(1993-9#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2012-2#1)
completely resistant to##2##3##(1992-12#1)(2008-10#1)
completely resistant##5##2##(1992-12#1)(2008-10#4)
completely resolved after##2##3##(2008-8#1)(2010-2#1)
completely resolved##4##2##(2008-11#1)(2008-8#1)(2010-2#1)(2013-8#1)
completely restored##2##2##(1990-2#1)(1991-2#1)
completely reverse the##2##3##(2008-7#1)(2011-2#1)
completely reversed by##3##3##(1993-5#1)(1995-12#1)(2008-9#1)
completely reversed this##2##3##(1991-2#2)
completely reversed##7##2##(1991-2#2)(1993-5#1)(1995-12#1)(2008-5#1)(2008-9#2)
completely reversible##6##2##(1991-3#1)(1992-8#1)(1993-1#1)(1994-11#1)(2008-8#1)(2013-1#1)
completely satisfactory##2##2##(1997-3#1)(2010-10#1)
completely separate##2##2##(2008-10#2)
completely separated from##2##3##(2008-10#2)
completely separated##9##2##(1997-2#1)(1997-6#1)(2008-10#6)(2011-1#1)
completely sequenced##13##2##(1990-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#2)(2009-5#1)(2012-3#1)
completely serum-free##2##2##(2008-11#2)
completely silence##2##2##(2012-12#1)(2012-3#1)
completely stable##5##2##(2006-12#1)(2008-4#3)(2009-3#1)
completely stereoselective##2##2##(1996-5#1)(2008-6#1)
completely subsided##2##2##(2007-7#1)(2012-2#1)
completely suppressed##7##2##(1994-8#1)(1996-5#1)(2008-10#3)(2008-6#1)(2012-2#1)
completely than##2##2##(1991-8#1)(2008-10#1)
completely the##3##2##(1992-12#1)(2008-3#1)(2009-11#1)
completely to##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
completely understood##11##2##(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2013-8#1)
completely wilted##2##2##(2008-10#2)
completely with the##2##3##(2008-1#1)(2008-3#1)
completely with##6##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
completely within##3##2##(1990-12#1)(2007-12#1)(2008-5#1)
completely##608##1##(1990-11#3)(1990-12#3)(1990-2#6)(1990-5#6)(1990-7#5)(1990-8#4)(1990-9#2)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#6)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#7)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#5)(1993-9#4)(1994-11#4)(1994-12#1)(1994-2#5)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#1)(1995-11#2)(1995-12#10)(1995-2#8)(1995-5#3)(1995-6#7)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#6)(1997-7#7)(1997-8#4)(2006-12#2)(2006-5#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#8)(2008-1#5)(2008-10#103)(2008-11#23)(2008-12#7)(2008-2#13)(2008-3#14)(2008-4#11)(2008-5#17)(2008-6#7)(2008-7#21)(2008-8#19)(2008-9#16)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#12)(2012-12#3)(2012-2#12)(2012-3#7)(2013-1#19)(2013-7#2)(2013-8#9)
completeness and##2##2##(2010-5#1)(2013-7#1)
completeness of the##3##3##(2008-10#2)(2008-4#1)
completeness of##9##2##(2006-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)
completeness##18##1##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-5#2)(2010-8#1)(2012-2#1)(2013-7#1)
completes the##5##2##(1992-3#1)(1994-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
completes##8##1##(1992-3#1)(1993-5#1)(1994-12#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
completesmall bowel obstruction##2##3##(2009-8#2)
completing Koch's postulates##2##3##(2008-10#2)
completing the##10##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
completing##25##1##(1990-11#1)(1991-8#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
completion and##3##2##(2008-11#2)(2011-2#1)
completion in##2##2##(1994-3#1)(2008-5#1)
completion of a##6##3##(1990-7#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-8#1)
completion of an##5##3##(1996-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
completion of chemotherapy##3##3##(1991-6#1)(1991-8#1)(2008-6#1)
completion of the##28##3##(1991-11#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
completion of their##2##3##(2011-1#1)(2012-12#1)
completion of therapy##5##3##(1991-2#1)(1991-6#1)(1996-3#1)(2009-10#1)(2011-1#1)
completion of##87##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-6#3)(1991-8#2)(1992-3#2)(1992-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-8#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
completion rate was##2##3##(2011-2#2)
completion rate##3##2##(2008-10#1)(2011-2#2)
completion rates##2##2##(1996-12#1)(2008-6#1)
completion##120##1##(1990-12#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-6#3)(1991-8#2)(1992-3#2)(1992-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#7)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
complex (MHC)##10##2##(1990-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-9#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
complex (PAC-1)##2##2##(1993-8#1)(2008-4#1)
complex (PIC)##2##2##(2009-11#1)(2010-3#1)
complex (SC)##2##2##(2008-5#1)(2009-11#1)
complex (TAT)##2##2##(1991-3#1)(2010-3#1)
complex 2##2##2##(1997-7#1)(2007-11#1)
complex C##3##2##(1992-6#3)
complex DNA##4##2##(1995-12#1)(2008-7#3)
complex Gaussian statistics##2##3##(2008-3#2)
complex I activity##2##3##(2008-7#2)
complex I and##2##3##(1995-5#1)(2008-7#1)
complex I##7##2##(1993-12#1)(1995-5#2)(2008-7#3)(2011-1#1)
complex IV##2##2##(1990-2#1)(1994-11#1)
complex SDF filters##2##3##(2008-3#2)
complex a##3##2##(1991-5#1)(2008-10#1)(2012-2#1)
complex activity##3##2##(2008-4#1)(2009-8#2)
complex after##2##2##(2008-10#1)(2008-9#1)
complex against##2##2##(2008-10#1)(2008-11#1)
complex along with##2##3##(1991-3#1)(2008-10#1)
complex also bound to##2##4##(1990-11#1)(1991-12#1)
complex also##3##2##(1990-11#1)(1991-12#1)(1992-3#1)
complex amplitude of the object##2##5##(2007-11#1)(2008-3#1)
complex amplitude of the##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
complex amplitude##12##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#4)
complex and a##4##3##(1995-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
complex and are##4##3##(1992-3#1)(1993-6#1)(2012-2#2)
complex and confusing##2##3##(1992-3#1)(2012-2#1)
complex and continuing health needs##2##5##(2008-11#2)
complex and continuing##3##3##(2008-11#3)
complex and determination of##3##4##(2008-10#3)
complex and dynamic##2##3##(2008-7#1)(2009-7#1)
complex and heterogeneous##2##3##(2010-12#1)(2013-1#1)
complex and its application##2##4##(2008-10#2)
complex and its##6##3##(1994-11#1)(2008-10#4)(2012-3#1)
complex and may##2##3##(1992-9#1)(2008-3#1)
complex and must##2##3##(1996-3#1)(2011-2#1)
complex and naphthalene was dissolved with 5 ml of dimethylformamide (DMF) and the metal##2##14##(2008-10#2)
complex and naphthalene was dissolved with 5 ml of##3##9##(2008-10#3)
complex and potentially##2##3##(1995-3#1)(2008-10#1)
complex and serious##2##3##(1995-6#1)(2008-10#1)
complex and the##14##3##(1993-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
complex and therefore##2##3##(1995-12#1)(2008-9#1)
complex and to##2##3##(1995-2#1)(2007-12#1)
complex and variable##2##3##(2008-8#1)(2010-8#1)
complex and##143##2##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#2)(1996-3#3)(1996-4#1)(1997-1#1)(1997-3#2)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#34)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#4)(2009-2#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#3)
complex anions##3##2##(2008-10#3)
complex appears to##2##3##(1993-11#1)(1995-11#1)
complex architecture##2##2##(2007-12#1)(2011-2#1)
complex are examined using##2##4##(2008-10#2)
complex are##19##2##(1990-5#1)(1990-7#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-1#1)(1995-2#1)(1995-6#2)(2008-10#8)(2008-2#1)(2009-10#1)
complex array of##4##3##(1992-8#1)(2008-4#1)(2010-10#1)(2013-1#1)
complex as a##5##3##(1996-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
complex as an##2##3##(1991-5#1)(2008-10#1)
complex as carrier##2##3##(2008-10#2)
complex as the##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
complex as well as the##3##5##(2007-12#1)(2008-10#2)
complex as well##4##3##(2007-12#1)(2008-10#3)
complex as##24##2##(1991-5#1)(1996-12#1)(2007-12#1)(2008-10#15)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#2)
complex at a##3##3##(2008-10#2)(2008-7#1)
complex at pH 5##2##4##(1992-4#1)(2008-10#1)
complex at pH##3##3##(1992-4#1)(2008-10#2)
complex at the##3##3##(1994-8#1)(2008-10#1)(2012-12#1)
complex at##25##2##(1990-8#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#15)(2008-3#1)(2008-7#1)(2012-12#1)
complex behavior##4##2##(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)
complex between the drug##2##4##(2008-10#2)
complex between the##4##3##(1995-2#1)(2008-10#2)(2009-7#1)
complex between##18##2##(1993-11#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(2008-10#11)(2009-7#1)
complex biological process##2##3##(2009-10#1)(2013-8#1)
complex biological systems##2##3##(2009-3#1)(2013-8#1)
complex biological##17##2##(1993-3#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-8#3)
complex biology##2##2##(2011-2#1)(2012-3#1)
complex blocks##2##2##(1992-8#1)(1995-8#1)
complex brain networks##2##3##(2009-8#2)
complex but##5##2##(1991-7#1)(2008-10#3)(2010-11#1)
complex by the##3##3##(2007-12#1)(2008-10#2)
complex by using##2##3##(2008-10#2)
complex by##19##2##(1990-12#1)(1990-5#1)(1992-2#2)(1992-8#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#9)(2009-10#1)(2009-11#1)
complex can alternatively be quantitatively adsorbed on##2##7##(2008-10#2)
complex can alternatively be quantitatively##3##5##(2008-10#3)
complex can be adsorbed##2##4##(2008-10#2)
complex can be##5##3##(2008-10#4)(2010-11#1)
complex can##11##2##(1997-7#1)(2008-10#9)(2010-11#1)
complex carbohydrates##7##2##(1995-2#1)(1997-2#1)(1997-8#2)(2008-3#1)(2008-5#1)(2012-12#1)
complex case of##2##3##(2008-10#1)(2013-1#1)
complex case##4##2##(2008-10#1)(2008-2#1)(2013-1#2)
complex cases##4##2##(1996-4#1)(2008-12#1)(2009-3#1)(2011-2#1)
complex cellular##6##2##(1995-6#1)(2008-10#1)(2008-4#2)(2009-8#1)(2012-2#1)
complex challenge##2##2##(1996-1#1)(1996-12#1)
complex changes from##2##3##(1997-7#1)(2008-10#1)
complex changes##3##2##(1996-12#1)(1997-7#1)(2008-10#1)
complex chemical##4##2##(1991-3#1)(2008-10#3)
complex clinical##5##2##(1995-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
complex coacervation##3##2##(2010-5#3)
complex cognitive##2##2##(2010-1#1)(2013-1#1)
complex composite is##2##3##(2008-10#2)
complex composite##4##2##(2008-10#4)
complex composition of##2##3##(2008-5#2)
complex composition##4##2##(2008-10#2)(2008-5#2)
complex compounds##2##2##(2008-10#2)
complex concept##2##2##(1991-9#1)(2007-11#1)
complex congenital##2##2##(2008-11#1)(2011-2#1)
complex consisting of the##2##4##(1991-2#1)(2008-4#1)
complex consisting of##3##3##(1991-2#1)(2008-4#2)
complex containing both##2##3##(1994-8#1)(1995-2#1)
complex containing##9##2##(1994-3#2)(1994-8#1)(1994-9#2)(1995-2#2)(2008-9#1)(2010-10#1)
complex contains##3##2##(1992-11#1)(2007-12#1)(2008-11#1)
complex coronary##2##2##(2009-4#1)(2011-2#1)
complex could be##2##3##(1990-5#1)(1993-8#1)
complex could##4##2##(1990-5#1)(1993-8#3)
complex course of##2##3##(1997-3#1)(2011-1#1)
complex cysts##2##2##(2011-1#2)
complex defects##3##2##(2011-2#3)
complex developmental##2##2##(2007-11#1)(2011-2#1)
complex diagnostic##2##2##(1990-5#1)(2008-8#1)
complex dielectric##2##2##(2008-2#1)(2009-5#1)
complex disability##2##2##(1995-5#1)(2008-11#1)
complex disease##5##2##(2007-10#1)(2008-1#1)(2008-7#2)(2012-3#1)
complex diseases##10##2##(2008-11#1)(2008-2#1)(2008-4#2)(2009-4#1)(2010-12#2)(2011-3#1)(2012-3#2)
complex disorder##4##2##(1997-5#1)(2008-7#2)(2009-7#1)
complex disorders##3##2##(2008-7#1)(2010-5#1)(2011-2#1)
complex displayed a##2##3##(1994-11#1)(2008-10#1)
complex dissolved in##2##3##(2008-10#2)
complex division##2##2##(2008-2#1)(2009-12#1)
complex during the##3##3##(1992-3#1)(1992-8#1)(2008-4#1)
complex during##5##2##(1992-3#1)(1992-8#1)(2008-4#1)(2011-2#1)(2013-1#1)
complex dynamics##3##2##(2008-10#1)(2008-8#2)
complex effects on##2##3##(1994-8#1)(1995-12#1)
complex effects##5##2##(1994-8#2)(1995-11#1)(1995-12#1)(1996-2#1)
complex eluted with##2##3##(1992-6#1)(2008-10#1)
complex eluted##3##2##(1992-6#1)(2008-10#2)
complex entity##3##2##(1994-12#1)(1996-12#1)(2010-6#1)
complex environment##2##2##(1991-3#1)(2008-12#1)
complex environmental##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
complex equipment##2##2##(1991-6#1)(2008-11#1)
complex ethical##2##2##(1991-3#1)(2010-3#1)
complex event##2##2##(1995-12#1)(2008-9#1)
complex evolutionary##4##2##(2008-10#1)(2009-5#1)(2012-3#1)(2013-1#1)
complex expressed##2##2##(1991-11#1)(1995-6#1)
complex extracted##2##2##(2008-10#2)
complex extraction##2##2##(2008-10#2)
complex field##2##2##(2007-11#1)(2008-1#1)
complex films on##2##3##(2008-10#2)
complex filters##3##2##(2007-12#1)(2008-3#2)
complex fistulas##2##2##(2010-12#2)
complex food##2##2##(2008-10#2)
complex for the##4##3##(2008-10#4)
complex for##8##2##(2008-10#7)(2008-12#1)
complex form##2##2##(1994-11#1)(2008-10#1)
complex formation between##12##3##(1992-2#1)(1997-6#1)(2008-10#9)(2008-7#1)
complex formation constants##5##3##(2008-10#5)
complex formation equilibria are##2##4##(2008-10#2)
complex formation equilibria##3##3##(2008-10#3)
complex formation in the##2##4##(1995-6#1)(2008-10#1)
complex formation in##4##3##(1995-6#1)(2008-10#3)
complex formation is##4##3##(1992-11#1)(1994-8#1)(2008-10#2)
complex formation of##9##3##(2008-10#9)
complex formation reaction##3##3##(2008-10#3)
complex formation reactions##2##3##(2008-10#2)
complex formation was##5##3##(1996-5#1)(2008-10#4)
complex formation with##8##3##(1995-6#1)(1997-7#1)(2008-10#6)
complex formation##85##2##(1992-11#1)(1992-2#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-6#3)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#63)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
complex formed at##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
complex formed between##10##3##(1994-5#2)(2007-11#1)(2008-10#7)
complex formed by##3##3##(1993-11#1)(2008-10#1)(2009-8#1)
complex formed in the##2##4##(2008-10#2)
complex formed in##3##3##(2008-10#3)
complex formed is monitored spectrophotometrically##2##5##(2008-10#2)
complex formed is##3##3##(2008-10#3)
complex formed##26##2##(1992-12#1)(1993-11#1)(1994-5#2)(2007-11#1)(2008-10#19)(2008-4#1)(2009-8#1)
complex from the##2##3##(1996-2#1)(2008-10#1)
complex from##10##2##(1990-11#1)(1993-12#1)(1995-2#1)(1996-2#1)(2008-10#4)(2010-2#1)(2010-8#1)
complex function##4##2##(2008-11#1)(2008-3#3)
complex functional##2##2##(2008-4#1)(2010-12#1)
complex functions##4##2##(2007-12#1)(2008-3#2)(2009-5#1)
complex genetic##6##2##(1997-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2013-1#1)
complex genome##2##2##(1992-6#1)(2012-3#1)
complex genomes##2##2##(1993-9#1)(2008-2#1)
complex geometries##3##2##(2007-11#1)(2008-6#1)(2010-8#1)
complex glomerulonephritis##3##2##(2008-1#3)
complex group of##2##3##(2007-7#1)(2008-9#1)
complex group##3##2##(2007-7#1)(2008-9#1)(2013-7#1)
complex had the##2##3##(1993-8#1)(2008-10#1)
complex had##5##2##(1990-5#1)(1993-8#1)(2008-10#2)(2008-8#1)
complex has a##2##3##(1996-2#1)(2008-10#1)
complex has been investigated by##2##5##(1993-8#1)(2008-10#1)
complex has been##8##3##(1990-11#1)(1993-8#1)(1994-5#1)(2007-11#1)(2008-10#4)
complex has##11##2##(1990-11#1)(1993-8#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#5)(2013-8#1)
complex have been##2##3##(1991-12#1)(2010-3#1)
complex have##4##2##(1991-12#1)(1997-7#1)(2009-8#1)(2010-3#1)
complex having##2##2##(2008-10#2)
complex health care##2##3##(1991-3#1)(1994-3#1)
complex health##4##2##(1991-3#1)(1994-3#1)(2008-11#1)(2010-8#1)
complex heterozygotes##2##2##(2008-12#2)
complex history##3##2##(2008-12#1)(2010-10#1)(2012-2#1)
complex hologram##2##2##(2007-12#2)
complex immune##2##2##(1996-11#1)(2012-3#1)
complex impedance##4##2##(2008-10#3)(2008-7#1)
complex in a##5##3##(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#1)
complex in an##2##3##(2008-10#2)
complex in aqueous solution##2##4##(2008-10#1)(2008-5#1)
complex in aqueous##3##3##(2008-10#2)(2008-5#1)
complex in chloroform##2##3##(2008-10#2)
complex in solution##2##3##(2008-10#2)
complex in terms of##2##4##(2007-4#1)(2008-10#1)
complex in the presence of##2##5##(2007-11#1)(2008-10#1)
complex in the##19##3##(1991-12#1)(1992-3#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-5#2)(2009-6#1)(2009-7#1)(2010-4#1)
complex in this##2##3##(2008-10#1)(2012-2#1)
complex in vitro##2##3##(1997-6#1)(2013-1#1)
complex in vivo##2##3##(1995-2#1)(2013-1#1)
complex in##73##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-6#1)(2007-11#2)(2007-4#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
complex including##2##2##(1995-2#1)(1996-12#1)
complex index of refraction and size distribution##4##7##(2008-2#2)(2008-3#2)
complex index of refraction and##7##5##(2008-2#5)(2008-3#2)
complex index of refraction##12##4##(2008-2#10)(2008-3#2)
complex indices of refraction##2##4##(2008-2#1)(2008-3#1)
complex indices##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
complex industrial##2##2##(2008-10#1)(2013-1#1)
complex information##2##2##(2008-7#1)(2009-12#1)
complex interaction between the##2##4##(1992-9#1)(2007-12#1)
complex interaction between##6##3##(1992-9#1)(2007-12#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
complex interaction of##2##3##(2008-11#2)
complex interaction##11##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
complex interactions between the##3##4##(2008-1#1)(2008-4#2)
complex interactions between##7##3##(1991-6#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)
complex interactions of##3##3##(1992-5#1)(1993-8#1)(2011-2#1)
complex interactions with##3##3##(1995-2#1)(2008-8#1)(2012-3#1)
complex interactions##17##2##(1991-6#1)(1992-5#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-3#1)
complex interplay between the##2##4##(2008-8#1)(2009-3#1)
complex interplay between##4##3##(2007-12#1)(2008-8#1)(2009-12#1)(2009-3#1)
complex interplay of##2##3##(2008-10#1)(2008-2#1)
complex interplay##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-3#1)
complex invasive therapies##2##3##(2008-11#2)
complex involving##2##2##(2008-7#1)(2010-12#1)
complex ion##6##2##(1992-9#1)(2008-10#5)
complex ionic matrices##2##3##(2008-10#2)
complex is 1##3##3##(2008-10#3)
complex is a##2##3##(1990-5#1)(2007-12#1)
complex is at##2##3##(2008-10#2)
complex is extracted##2##3##(2008-10#2)
complex is formed and##2##4##(2008-10#2)
complex is formed##4##3##(1993-6#1)(2008-10#3)
complex is measured at##2##4##(2008-10#2)
complex is monitored at##2##4##(2008-10#2)
complex is monitored##3##3##(2008-10#3)
complex is oxidized##2##3##(2008-10#2)
complex is proposed##2##3##(1993-11#1)(2008-10#1)
complex is quantitatively##2##3##(2008-10#2)
complex is required for the##2##5##(1995-2#1)(1996-2#1)
complex is stable##2##3##(1994-8#1)(2008-10#1)
complex is then##4##3##(2008-10#4)
complex is##83##2##(1990-2#1)(1990-5#1)(1991-3#5)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#3)(1997-2#1)(1997-7#1)(2007-12#3)(2008-10#45)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#2)
complex issues##4##2##(1995-6#1)(1996-3#1)(1997-2#1)(2012-12#1)
complex karyotypes in##2##3##(2010-1#2)
complex lesions##3##2##(2007-11#1)(2011-2#2)
complex lipid##2##2##(1994-12#2)
complex logic operations##2##3##(2008-3#2)
complex macromolecular##2##2##(1993-12#1)(2013-1#1)
complex material##2##2##(2008-10#1)(2008-2#1)
complex materials##3##2##(2008-10#3)
complex matrices and##2##3##(2008-10#1)(2008-5#1)
complex matrices with##2##3##(2008-10#2)
complex matrices##27##2##(2008-10#23)(2008-5#2)(2010-11#1)(2011-1#1)
complex matrix samples##2##3##(2008-10#2)
complex matrix##5##2##(2008-10#4)(2009-10#1)
complex may##3##2##(1996-2#1)(1997-7#1)(2009-10#1)
complex mechanism##4##2##(1995-12#1)(2008-11#1)(2009-8#1)(2010-3#1)
complex mechanisms##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
complex media##2##2##(2008-10#1)(2008-9#1)
complex medical and##2##3##(1995-5#1)(2013-1#1)
complex medical history##2##3##(1992-9#2)
complex medical##7##2##(1992-12#1)(1992-9#2)(1995-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
complex metabolic pathways##2##3##(2011-1#1)(2011-2#1)
complex metabolic##4##2##(1991-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
complex methods##3##2##(1993-3#1)(2008-6#1)(2009-11#1)
complex mixture of##10##3##(1992-6#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-3#1)
complex mixture##18##2##(1992-6#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2012-3#1)
complex mixtures and##2##3##(2008-10#1)(2008-5#1)
complex mixtures of##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
complex mixtures##12##2##(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-5#1)(2009-7#1)
complex model##3##2##(2008-10#1)(2008-3#2)
complex models##3##2##(1992-11#1)(2008-8#1)(2011-2#1)
complex modified##3##2##(2008-10#3)
complex modulation##2##2##(1990-12#1)(2008-3#1)
complex molecular##3##2##(2008-10#1)(2008-11#1)(2009-4#1)
complex molecules##4##2##(1992-4#1)(1997-4#1)(2008-8#1)(2012-2#1)
complex movements##3##2##(2008-1#1)(2008-7#2)
complex nature of##8##3##(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)
complex needs##11##2##(1992-2#2)(2008-11#3)(2009-11#1)(2012-2#5)
complex networks##2##2##(2008-7#1)(2012-2#1)
complex neural network##2##3##(1993-12#1)(2008-8#1)
complex neural##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
complex object##2##2##(2008-3#1)(2008-5#1)
complex odontoma##3##2##(2013-1#3)
complex of [Ag(BTA)](n)##2##3##(2013-1#2)
complex of banana##3##3##(2008-10#3)
complex of enzyme and substrate##2##5##(1993-11#1)(1995-2#1)
complex of morphologically##2##3##(2008-10#2)
complex of silver##2##3##(1992-12#1)(2008-10#1)
complex of the##9##3##(1990-6#1)(1991-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-6#1)
complex of two##2##3##(1992-2#1)(1992-9#1)
complex of zinc##2##3##(2008-10#2)
complex of##115##2##(1990-5#1)(1990-6#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#8)(1993-9#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-8#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#52)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#3)
complex oligosaccharides##3##2##(1990-12#1)(2008-5#1)(2012-2#1)
complex on a hanging mercury drop electrode##2##7##(2008-10#2)
complex on a##4##3##(2008-10#4)
complex on activated carbon##2##4##(2008-10#2)
complex on amberlite##2##3##(2008-10#2)
complex on microcrystalline naphthalene##2##4##(2008-10#2)
complex on the##3##3##(1995-8#1)(2008-10#2)
complex on to##2##3##(2008-10#2)
complex on##21##2##(1995-8#1)(2008-10#19)(2012-12#1)
complex one##2##2##(2008-10#1)(2008-7#1)
complex onto a##3##3##(2008-10#3)
complex onto##7##2##(2008-10#7)
complex open##2##2##(2010-3#1)(2011-1#1)
complex optical##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
complex or##3##2##(2008-10#1)(2009-12#1)(2013-1#1)
complex organisms##4##2##(2008-7#2)(2010-9#2)
complex organization##4##2##(1994-11#1)(1995-3#1)(1997-7#1)(2012-3#1)
complex oxalate-Alizarin Red##2##3##(2008-10#2)
complex partial epilepsy and##2##4##(1996-9#1)(2011-1#1)
complex partial epilepsy##3##3##(1996-9#2)(2011-1#1)
complex partial##4##2##(1996-9#3)(2011-1#1)
complex pathotypes##4##2##(2008-10#4)
complex pattern of##4##3##(1992-1#1)(2008-10#2)(2011-2#1)
complex pattern##8##2##(1992-1#1)(1993-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)
complex phenotypes##2##2##(2008-4#1)(2011-2#1)
complex phenotypic##2##2##(2011-2#1)(2012-2#1)
complex phosphorylation##2##2##(2012-3#2)
complex physiological##2##2##(1995-8#1)(2010-2#1)
complex population##2##2##(2008-4#1)(2008-9#1)
complex presents##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
complex problems##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
complex procedure##2##2##(2008-10#1)(2008-11#1)
complex procedures##3##2##(1992-9#1)(2007-8#1)(2011-2#1)
complex process involving##3##3##(1992-9#1)(2008-8#1)(2012-2#1)
complex process of##3##3##(1995-12#1)(2008-3#1)(2009-6#1)
complex process that##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
complex process##26##2##(1992-9#1)(1995-12#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
complex processes##5##2##(1992-6#1)(1993-5#1)(2008-11#1)(2013-1#1)(2013-8#1)
complex protein##3##2##(2008-1#1)(2008-4#1)(2010-5#1)
complex proteomes##2##2##(2008-4#1)(2010-7#1)
complex purified from##3##3##(1990-8#1)(1994-11#2)
complex race##2##2##(2008-10#1)(2008-8#1)
complex reaction##7##2##(2008-10#4)(2009-11#1)(2010-1#1)(2012-1#1)
complex recurrent##2##2##(2011-2#2)
complex reflectance ratio##2##3##(2008-3#2)
complex reflection##4##2##(2008-3#4)
complex refractive index and the size##2##6##(2008-2#2)
complex refractive index is##4##4##(2008-2#1)(2008-3#3)
complex refractive index of##7##4##(2008-2#1)(2008-3#6)
complex refractive index##26##3##(2008-10#1)(2008-2#6)(2008-3#19)
complex refractive indices##6##3##(2007-11#2)(2008-3#4)
complex refractive##33##2##(2007-11#2)(2008-10#1)(2008-2#6)(2008-3#24)
complex regional pain syndrome##3##4##(2008-12#1)(2009-2#2)
complex regional##4##2##(2008-12#1)(2008-7#1)(2009-2#2)
complex regulation##2##2##(2011-1#1)(2013-8#1)
complex regulatory network##2##3##(2008-5#1)(2010-5#1)
complex regulatory systems##2##3##(2008-7#2)
complex regulatory##7##2##(2008-5#1)(2008-7#3)(2010-5#1)(2012-2#1)(2013-1#1)
complex relation##2##2##(1993-9#1)(2008-5#1)
complex relationship between##5##3##(2008-11#1)(2009-11#1)(2009-5#1)(2011-2#2)
complex relationship##7##2##(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)(2011-2#3)
complex relationships among##2##3##(1997-3#1)(2010-8#1)
complex relationships##6##2##(1992-11#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-8#1)
complex required for##2##3##(1993-9#1)(2007-12#1)
complex retained on##2##3##(2008-10#2)
complex revealed by##2##3##(2011-2#1)(2012-3#1)
complex reveals##2##2##(2010-11#1)(2011-1#1)
complex role of##2##3##(2008-4#1)(2008-7#1)
complex role##4##2##(1992-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
complex sample##6##2##(2008-10#4)(2008-3#1)(2013-8#1)
complex samples##17##2##(1994-9#1)(2008-10#11)(2008-4#1)(2010-11#3)(2013-1#1)
complex set of##6##3##(1993-8#1)(1994-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-2#1)
complex showed a##2##3##(1995-11#1)(2007-11#1)
complex showed that##2##3##(2008-10#1)(2008-9#1)
complex showed##5##2##(1995-11#1)(2007-11#1)(2008-10#2)(2008-9#1)
complex shows##2##2##(2008-10#2)
complex signaling##5##2##(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
complex social behavior##3##3##(2008-10#2)(2008-11#1)
complex social##4##2##(2008-10#2)(2008-11#2)
complex spatial##3##2##(2008-8#2)(2011-7#1)
complex species formed##3##3##(2008-10#3)
complex species##14##2##(2008-10#14)
complex spectral grating##3##3##(2007-12#3)
complex spectral optical coherence tomography##2##5##(2007-11#2)
complex spectral##11##2##(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#2)(2011-1#1)
complex stability constants for##2##4##(2008-10#2)
complex stability constants##4##3##(2008-10#4)
complex stability##6##2##(2008-10#5)(2011-2#1)
complex steps##2##2##(2008-7#1)(2012-2#1)
complex structure and##3##3##(1993-8#1)(2007-12#1)(2010-11#1)
complex structure of##3##3##(1994-9#1)(1995-9#1)(2012-2#1)
complex structure##14##2##(1990-5#1)(1991-12#1)(1993-8#1)(1994-9#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-2#2)
complex structures in the##2##4##(2011-1#1)(2013-8#1)
complex structures##6##2##(1990-11#1)(1991-12#1)(2008-3#1)(2009-11#1)(2011-1#1)(2013-8#1)
complex synthetic##4##2##(2008-10#3)(2008-3#1)
complex system##10##2##(1990-11#1)(1991-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
complex systems##6##2##(1990-2#1)(2007-12#1)(2008-10#1)(2008-8#2)(2012-2#1)
complex tachycardia##2##2##(2008-1#1)(2012-3#1)
complex task##5##2##(1991-6#1)(2010-2#1)(2011-2#1)(2012-2#2)
complex than those##2##3##(1994-3#1)(2009-2#1)
complex than##18##2##(1993-3#1)(1994-2#1)(1994-3#2)(1994-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2012-12#1)(2013-8#1)
complex that is required for##2##5##(1995-2#1)(2008-9#1)
complex that is required##3##4##(1995-2#1)(2008-5#1)(2008-9#1)
complex that is##5##3##(1995-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
complex that##16##2##(1992-9#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
complex the##3##2##(2008-10#2)(2008-3#1)
complex therapy in##2##3##(2007-11#1)(2011-3#1)
complex therapy##5##2##(1994-7#1)(2007-11#2)(2011-1#1)(2011-3#1)
complex three-dimensional structures##2##3##(2008-2#1)(2008-3#1)
complex three-dimensional##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
complex tissue##2##2##(2008-10#1)(2009-4#1)
complex to be##3##3##(1990-2#1)(1993-11#1)(1997-2#1)
complex to form##2##3##(2008-10#1)(2008-11#1)
complex to the##7##3##(1991-12#1)(1994-12#1)(1994-8#1)(1997-6#1)(2009-7#2)(2012-2#1)
complex to##27##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-5#1)(2009-7#2)(2012-2#1)(2013-1#1)
complex together with##4##3##(1995-2#1)(2008-10#3)
complex trait##5##2##(2007-10#1)(2008-3#1)(2008-4#2)(2012-3#1)
complex traits in##2##3##(2008-3#1)(2012-3#1)
complex traits##11##2##(1994-9#2)(1995-6#2)(2008-3#2)(2010-7#1)(2012-3#4)
complex translocation (4##2##3##(2007-11#2)
complex translocation##3##2##(2007-11#3)
complex treatment##3##2##(1992-12#1)(2007-11#1)(2013-1#1)
complex undertaking##3##2##(1994-1#1)(1994-3#1)(1996-1#1)
complex using##3##2##(1992-9#1)(2007-12#1)(2008-10#1)
complex visual##3##2##(2011-2#1)(2012-1#2)
complex was 1##3##3##(2008-10#3)
complex was accumulated##2##3##(2008-10#2)
complex was evaluated##2##3##(2008-10#2)
complex was formed##5##3##(1995-11#1)(1997-7#1)(2008-10#3)
complex was from 5##2##4##(2008-10#2)
complex was from##3##3##(2008-10#3)
complex was observed at##2##4##(2008-10#2)
complex was observed##5##3##(1995-11#1)(1995-3#1)(2007-12#1)(2008-10#2)
complex was tested##2##3##(2008-10#2)
complex was used##2##3##(2008-10#2)
complex was##76##2##(1990-5#4)(1990-7#1)(1990-8#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#45)(2008-5#3)(2009-10#2)(2011-2#1)
complex were determined by##2##4##(1997-4#1)(2012-12#1)
complex were determined##3##3##(1995-2#1)(1997-4#1)(2012-12#1)
complex were##13##2##(1991-3#1)(1991-5#2)(1995-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2011-2#1)(2012-12#1)
complex when the##2##3##(2008-10#1)(2008-8#1)
complex when##4##2##(2008-10#3)(2008-8#1)
complex which has a##2##4##(2008-10#2)
complex which has##3##3##(2008-10#3)
complex which is##2##3##(2008-10#2)
complex which##8##2##(1990-5#1)(1995-12#1)(2008-10#6)
complex with 1##4##3##(2008-10#4)
complex with DNA##2##3##(1993-3#1)(1994-5#1)
complex with RNA##2##3##(1992-3#1)(2009-7#1)
complex with a suitable absorption at##2##6##(2008-10#2)
complex with a##19##3##(1990-12#2)(1990-2#1)(1990-8#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#7)(2009-9#1)
complex with absorption maximum at##2##5##(2008-10#2)
complex with an##3##3##(1996-12#1)(2008-10#2)
complex with the##11##3##(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)
complex with##123##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#3)(1992-11#2)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#4)(1993-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#60)(2008-2#1)(2008-5#1)(2008-8#4)(2009-10#1)(2009-7#3)(2009-9#1)(2010-5#1)(2011-1#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
complex world##2##2##(2008-1#1)(2010-2#1)
complex##3131##1##(1990-11#13)(1990-12#10)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#25)(1990-6#2)(1990-7#11)(1990-8#13)(1991-1#4)(1991-11#2)(1991-12#13)(1991-2#11)(1991-3#17)(1991-5#10)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#10)(1992-2#12)(1992-3#22)(1992-4#3)(1992-5#4)(1992-6#17)(1992-8#8)(1992-9#15)(1993-1#1)(1993-11#28)(1993-12#7)(1993-2#3)(1993-3#13)(1993-5#2)(1993-6#9)(1993-8#31)(1993-9#8)(1994-1#5)(1994-11#25)(1994-12#12)(1994-2#15)(1994-3#13)(1994-5#20)(1994-6#8)(1994-7#1)(1994-8#28)(1994-9#9)(1995-1#1)(1995-11#12)(1995-12#15)(1995-2#46)(1995-3#14)(1995-5#15)(1995-6#23)(1995-8#9)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#17)(1996-2#29)(1996-3#6)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#9)(1997-2#10)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#10)(1997-7#32)(1997-8#4)(1997-9#3)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#5)(2007-11#50)(2007-12#71)(2007-2#1)(2007-4#1)(2007-5#4)(2007-7#9)(2007-8#7)(2008-1#31)(2008-10#967)(2008-11#82)(2008-12#20)(2008-2#57)(2008-3#104)(2008-4#52)(2008-5#59)(2008-6#21)(2008-7#79)(2008-8#55)(2008-9#53)(2009-1#2)(2009-10#31)(2009-11#12)(2009-12#7)(2009-2#7)(2009-3#9)(2009-4#5)(2009-5#14)(2009-6#7)(2009-7#17)(2009-8#29)(2009-9#6)(2010-1#8)(2010-10#7)(2010-11#15)(2010-12#18)(2010-2#6)(2010-3#14)(2010-4#5)(2010-5#16)(2010-6#5)(2010-7#8)(2010-8#14)(2010-9#5)(2011-1#26)(2011-2#89)(2011-3#3)(2011-7#1)(2012-1#7)(2012-12#25)(2012-2#65)(2012-3#43)(2012-4#1)(2013-1#62)(2013-7#3)(2013-8#22)
complex)##7##1##(1990-5#1)(1992-11#1)(2007-2#1)(2008-10#2)(2012-6#1)(2013-1#1)
complex-coupled distributed-feedback laser##2##3##(2008-3#2)
complex-coupled##4##1##(2008-3#4)
complex-formation equilibria of##2##3##(2008-10#2)
complex-formation##6##1##(2008-10#6)
complex-forming##6##1##(1996-5#2)(2008-10#4)
complex-type sugar chains had the##2##5##(1993-11#2)
complex-type sugar chains##4##3##(1993-11#4)
complex-type##9##1##(1993-11#4)(1994-5#3)(1995-2#1)(2008-9#1)
complex-valued##9##1##(2007-12#1)(2008-2#5)(2008-3#3)
complexant reactions##2##2##(2008-10#2)
complexant##4##1##(2008-10#4)
complexants##2##1##(2008-10#2)
complexation and solvent extraction##2##4##(2008-10#2)
complexation and##8##2##(2008-10#7)(2013-1#1)
complexation behavior of##2##3##(2008-10#2)
complexation behavior##3##2##(2008-10#3)
complexation between##6##2##(2008-10#6)
complexation by the##2##3##(2008-10#2)
complexation by##5##2##(2008-10#5)
complexation constant##2##2##(2008-10#2)
complexation constants##7##2##(2008-10#7)
complexation equilibria of##2##3##(2008-10#2)
complexation equilibria##7##2##(2008-10#7)
complexation in water##3##3##(2008-10#3)
complexation in##5##2##(2008-10#5)
complexation is##3##2##(2008-10#2)(2010-12#1)
complexation mechanism was##2##3##(2008-10#2)
complexation of metal##2##3##(2008-10#2)
complexation of the##5##3##(1994-3#1)(2008-10#4)
complexation of these##3##3##(1994-3#1)(2008-10#1)(2009-7#1)
complexation of##31##2##(1992-6#1)(1994-3#2)(2008-10#25)(2008-12#1)(2008-7#1)(2009-7#1)
complexation process##2##2##(2008-10#2)
complexation properties of##4##3##(2008-10#3)(2009-7#1)
complexation properties##5##2##(2008-10#4)(2009-7#1)
complexation reaction between##2##3##(2008-10#2)
complexation reaction of Cu(II) with##3##5##(2008-10#3)
complexation reaction of##4##3##(2008-10#4)
complexation reaction##12##2##(2008-10#12)
complexation reactions##3##2##(2008-10#3)
complexation was##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
complexation with ammonium##4##3##(2008-10#4)
complexation with two high molecular weight poly(acrylic acids)##2##8##(2008-10#2)
complexation with two##3##3##(2008-10#3)
complexation with##27##2##(1993-6#1)(1995-2#1)(2008-10#24)(2013-1#1)
complexation##164##1##(1992-6#2)(1993-6#1)(1994-3#2)(1995-2#1)(1996-2#1)(2008-10#143)(2008-12#1)(2008-7#2)(2009-7#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
complexed by##3##2##(2008-10#3)
complexed to##7##2##(1990-12#1)(1990-2#1)(1992-3#1)(1994-2#1)(1994-5#1)(2008-10#1)(2012-12#1)
complexed with O##2##3##(2008-10#2)
complexed with a##3##3##(1991-5#1)(1992-11#2)
complexed with the##6##3##(1992-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-6#1)
complexed with##46##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-3#2)(1992-8#1)(1993-8#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-11#1)(2008-10#20)(2008-6#1)(2009-5#1)
complexed##71##1##(1990-12#3)(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-8#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-11#1)(2008-10#34)(2008-6#1)(2009-10#2)(2009-5#1)(2012-12#1)
complexes (COCs)##2##2##(2013-1#2)
complexes also##2##2##(1995-5#1)(2010-11#1)
complexes and the##2##3##(2008-10#2)
complexes and##31##2##(1990-12#2)(1991-12#1)(1993-11#1)(1995-3#2)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#14)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-3#1)
complexes appear##2##2##(1992-3#1)(1995-5#1)
complexes are formed at##2##4##(2008-10#2)
complexes are formed in##2##4##(2008-10#2)
complexes are formed##5##3##(2008-10#5)
complexes are more##2##3##(1993-8#1)(2008-10#1)
complexes are of##2##3##(1995-5#1)(2009-11#1)
complexes are then##2##3##(2008-10#2)
complexes are##46##2##(1990-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-2#2)(1997-7#1)(2007-12#1)(2008-10#24)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-6#1)(2013-1#1)
complexes as well as##3##4##(1992-2#1)(2008-10#2)
complexes as##9##2##(1992-2#1)(1995-3#1)(2008-10#5)(2008-5#2)
complexes at##9##2##(1993-11#1)(1995-8#1)(1996-2#2)(2008-10#3)(2008-7#1)(2012-2#1)
complexes between##15##2##(1994-8#1)(1995-6#1)(1996-3#1)(2008-10#8)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
complexes by capillary##2##3##(2008-10#2)
complexes by the##2##3##(2008-10#2)
complexes by##18##2##(1995-11#1)(1995-5#1)(1995-8#2)(2008-10#10)(2008-4#2)(2010-3#1)(2010-4#1)
complexes can be used to##2##5##(2008-4#1)(2008-7#1)
complexes can be##4##3##(1994-8#1)(1997-7#1)(2008-4#1)(2008-7#1)
complexes can##5##2##(1994-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2010-6#1)
complexes containing##9##2##(1994-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-9#1)
complexes exhibit a##2##3##(2008-10#2)
complexes exhibit##5##2##(1994-5#1)(1997-7#1)(2008-10#3)
complexes extracted into##2##3##(2008-10#2)
complexes for##5##2##(1994-6#1)(2008-10#1)(2008-3#1)(2013-8#2)
complexes formed at##2##3##(1997-3#1)(2008-10#1)
complexes formed between##7##3##(1990-7#1)(2008-10#5)(2008-4#1)
complexes formed by##3##3##(2008-10#3)
complexes formed in solution##2##4##(2008-10#2)
complexes formed in the##4##4##(1993-3#1)(1995-8#1)(2008-10#2)
complexes formed in##7##3##(1993-3#1)(1995-8#1)(1997-3#1)(2008-10#4)
complexes formed with##2##3##(1995-6#1)(2008-10#1)
complexes formed##27##2##(1990-7#1)(1990-8#1)(1993-3#1)(1995-6#2)(1995-8#1)(1997-3#2)(2008-10#18)(2008-4#1)
complexes from the##3##3##(1994-3#1)(1996-5#1)(2008-10#1)
complexes from##10##2##(1994-3#1)(1996-5#1)(2008-10#3)(2008-2#3)(2010-2#2)
complexes had##2##2##(1990-12#1)(1997-7#1)
complexes has##3##2##(1995-3#1)(2010-2#2)
complexes have been determined##4##4##(1992-9#1)(1997-7#1)(2008-10#2)
complexes have been##19##3##(1990-12#1)(1992-9#1)(1994-5#1)(1997-7#3)(2008-10#11)(2008-5#2)
complexes have##22##2##(1990-12#1)(1992-9#1)(1993-8#1)(1994-5#1)(1997-7#3)(2008-10#12)(2008-5#3)
complexes in human##2##3##(1995-8#1)(2008-10#1)
complexes in the presence of##3##5##(1994-6#1)(2008-10#2)
complexes in the##14##3##(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#1)(2008-10#9)(2008-4#1)
complexes in vivo##3##3##(1995-6#1)(2010-11#2)
complexes in which a##2##4##(2008-10#1)(2010-7#1)
complexes in which##3##3##(2007-11#1)(2008-10#1)(2010-7#1)
complexes in##53##2##(1992-3#1)(1992-9#3)(1994-5#1)(1994-6#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-2#2)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
complexes increased##2##2##(1990-5#1)(2008-10#1)
complexes induced by SN-38##2##4##(1995-5#2)
complexes involved in the oxidative phosphorylation##2##6##(1990-2#2)
complexes involved in the##3##4##(1990-2#2)(2008-10#1)
complexes involving##5##2##(1997-7#3)(2008-10#2)
complexes is discussed##3##3##(1996-2#1)(2008-10#2)
complexes is##18##2##(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-7#2)(2008-10#8)(2008-2#1)(2010-2#2)(2011-2#1)
complexes may be##2##3##(2008-7#1)(2012-2#1)
complexes may##4##2##(1993-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
complexes obtained##2##2##(2008-10#1)(2013-1#1)
complexes of Co(II)##2##3##(2008-10#1)(2008-5#1)
complexes of Cu(II)##3##3##(2008-10#3)
complexes of inosine##2##3##(2008-10#2)
complexes of known##2##3##(2008-10#1)(2008-7#1)
complexes of lanthanides##2##3##(2008-10#2)
complexes of some##2##3##(2008-10#2)
complexes of stronger acids##2##4##(1995-5#2)
complexes of the##6##3##(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#2)(2009-11#1)
complexes of##78##2##(1991-2#1)(1992-3#2)(1992-4#1)(1993-11#3)(1993-3#1)(1993-8#2)(1995-5#4)(1996-2#1)(1997-3#2)(2007-11#3)(2007-12#2)(2008-10#49)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)
complexes on a##3##3##(2008-10#3)
complexes on the##2##3##(2008-10#2)
complexes on##12##2##(2008-10#10)(2012-2#2)
complexes or##5##2##(1990-12#1)(1994-5#1)(2008-10#1)(2008-4#2)
complexes present##2##2##(2007-11#1)(2008-10#1)
complexes react##2##2##(1996-2#1)(2008-11#1)
complexes resulting##2##2##(2008-10#1)(2012-3#1)
complexes show##2##2##(2008-10#1)(2008-5#1)
complexes studied##6##2##(1993-8#1)(2008-10#4)(2010-7#1)
complexes that are##2##3##(2008-4#1)(2009-10#1)
complexes that have##2##3##(2010-5#2)
complexes that##13##2##(1990-12#1)(1992-3#1)(1997-3#2)(2008-4#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-5#2)(2012-3#1)
complexes the##4##2##(1995-3#1)(1996-2#1)(2008-10#2)
complexes to##8##2##(1994-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2013-8#1)
complexes under##2##2##(1997-3#1)(2008-7#1)
complexes using the##4##3##(1995-6#1)(2008-10#3)
complexes using##6##2##(1995-6#1)(2008-10#4)(2008-2#1)
complexes via##2##2##(1997-4#1)(2008-10#1)
complexes was studied potentiometrically##2##4##(2008-10#2)
complexes was studied##4##3##(2008-10#4)
complexes was##13##2##(1995-11#1)(1995-5#1)(2007-11#1)(2008-10#9)(2008-4#1)
complexes were characterized by##2##4##(2008-5#2)
complexes were determined at 25 degrees C##3##7##(2008-10#3)
complexes were determined by##3##4##(1991-8#1)(2008-10#2)
complexes were determined##12##3##(1991-8#1)(2008-10#11)
complexes were eluted##2##3##(2008-10#2)
complexes were evaluated##2##3##(2008-10#2)
complexes were found to##2##4##(2008-10#2)
complexes were investigated##2##3##(2008-10#2)
complexes were measured##2##3##(1992-5#1)(2008-10#1)
complexes were prepared in##2##4##(2008-11#1)(2013-1#1)
complexes were prepared##4##3##(1997-7#1)(2008-11#1)(2012-2#1)(2013-1#1)
complexes were stable##2##3##(2008-10#2)
complexes were used##2##3##(2008-10#2)
complexes were##48##2##(1991-8#1)(1992-5#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#33)(2008-11#2)(2008-5#3)(2012-2#3)(2013-1#1)
complexes where##2##2##(1997-7#1)(2010-6#1)
complexes which did not##2##4##(1991-5#1)(2012-12#1)
complexes which##9##2##(1991-5#1)(1993-8#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
complexes with a##4##3##(2008-10#3)(2009-9#1)
complexes with and##2##3##(1991-9#1)(2008-10#1)
complexes with carboxylic ligands##2##4##(2008-10#2)
complexes with different##3##3##(2008-10#2)(2010-11#1)
complexes with inorganic##2##3##(2008-10#2)
complexes with other##2##3##(1991-2#1)(2008-10#1)
complexes with some##3##3##(2008-10#2)(2010-11#1)
complexes with the##13##3##(1990-7#1)(1994-9#1)(1995-5#1)(2008-10#8)(2009-10#1)(2011-2#1)
complexes with##110##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-6#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-10#64)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#3)(2009-8#1)(2009-9#1)(2010-11#5)(2010-12#2)(2011-2#1)(2012-3#1)(2013-7#1)
complexes within the##3##3##(1992-3#1)(1992-6#1)(2008-10#1)
complexes##969##1##(1990-11#1)(1990-12#13)(1990-2#2)(1990-5#6)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#6)(1991-5#1)(1991-8#3)(1991-9#6)(1992-11#2)(1992-2#4)(1992-3#9)(1992-4#4)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#6)(1993-11#11)(1993-3#2)(1993-6#3)(1993-8#14)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#11)(1994-6#4)(1994-8#7)(1994-9#3)(1995-11#5)(1995-12#1)(1995-2#5)(1995-3#5)(1995-5#25)(1995-6#7)(1995-8#11)(1996-2#30)(1996-3#2)(1996-5#5)(1997-1#3)(1997-2#2)(1997-3#8)(1997-4#1)(1997-7#31)(1997-8#2)(2007-11#10)(2007-12#5)(2007-6#1)(2008-10#436)(2008-11#10)(2008-12#5)(2008-2#14)(2008-3#3)(2008-4#29)(2008-5#21)(2008-7#28)(2008-8#1)(2008-9#5)(2009-10#5)(2009-11#5)(2009-2#1)(2009-5#1)(2009-8#5)(2009-9#6)(2010-10#2)(2010-11#10)(2010-12#2)(2010-2#9)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#6)(2010-7#6)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#11)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#5)
complexes)##4##1##(1995-2#1)(2007-12#1)(2008-10#2)
complexing ability of##2##3##(2008-10#2)
complexing agent and##2##3##(2008-10#2)
complexing agent concentration##2##3##(2008-10#2)
complexing agent for##2##3##(2008-10#2)
complexing agent##25##2##(2008-10#25)
complexing agent)##3##2##(2008-10#3)
complexing agents##12##2##(2008-10#12)
complexing dyes##3##2##(2008-6#3)
complexing ligands##2##2##(2008-10#2)
complexing of##2##2##(2008-10#2)
complexing power##2##2##(2008-10#2)
complexing properties of##5##3##(2008-10#5)
complexing properties##8##2##(2008-10#8)
complexing reaction##2##2##(2008-10#2)
complexing reagent##5##2##(2008-10#5)
complexing with##5##2##(1991-12#1)(2008-10#3)(2008-8#1)
complexing##80##1##(1990-12#1)(1991-12#1)(2008-10#72)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)
complexion##2##1##(2008-5#1)(2008-9#1)
complexities involved##2##2##(1994-1#2)
complexities of the##2##3##(2008-12#1)(2011-2#1)
complexities of##10##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
complexities that##2##2##(2008-4#1)(2008-8#1)
complexities##20##1##(1992-1#1)(1994-1#2)(1994-12#1)(1996-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
complexity and the##3##3##(2008-3#1)(2009-3#1)(2010-11#1)
complexity and##22##2##(1995-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
complexity as##2##2##(2008-10#1)(2008-2#1)
complexity by##2##2##(2007-12#1)(2008-3#1)
complexity can##2##2##(2008-9#1)(2012-3#1)
complexity in##11##2##(1996-4#2)(2008-1#1)(2008-2#1)(2008-6#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
complexity is##6##2##(2008-3#2)(2009-5#1)(2009-8#1)(2012-12#1)(2012-3#1)
complexity may##2##2##(1992-12#1)(2012-2#1)
complexity of different##2##3##(1997-6#1)(2008-4#1)
complexity of disease##3##3##(1995-3#2)(2008-12#1)
complexity of resistance##2##3##(2008-10#2)
complexity of the disease##2##4##(2008-7#1)(2013-8#1)
complexity of the problems##2##4##(2007-11#1)(2009-5#1)
complexity of the##51##3##(1992-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
complexity of these##3##3##(1994-2#1)(2008-5#1)(2008-9#1)
complexity of##121##2##(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-4#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
complexity that##4##2##(1992-3#1)(1996-4#1)(2007-11#1)(2013-1#1)
complexity to##3##2##(2007-11#1)(2008-1#1)(2013-1#1)
complexity was##3##2##(2008-10#2)(2008-11#1)
complexity##263##1##(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-4#10)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#5)(2007-12#6)(2007-6#1)(2007-8#5)(2008-1#6)(2008-10#28)(2008-11#12)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#7)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#1)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#10)(2013-1#9)(2013-7#1)(2013-8#3)
complexity-based##2##1##(2012-12#2)
complexly##2##1##(2008-1#1)(2008-10#1)
complexometric titration##2##2##(2008-10#2)
complexometric titrations##2##2##(2008-10#2)
complexometric##8##1##(2008-10#8)
complexone##3##1##(2008-10#3)
compliance and the##2##3##(1991-9#1)(1994-11#1)
compliance and##12##2##(1991-11#1)(1991-9#1)(1992-8#1)(1994-1#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
compliance by##3##2##(1992-3#1)(1993-11#1)(2010-3#1)
compliance can be##2##3##(1995-9#1)(1996-12#1)
compliance for the##2##3##(1993-11#1)(2007-7#1)
compliance in the##2##3##(1993-11#1)(1997-2#1)
compliance in##8##2##(1990-3#1)(1993-11#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2013-8#1)
compliance is often##2##3##(1993-11#2)
compliance is##8##2##(1993-11#5)(1997-3#1)(2008-9#1)(2012-3#1)
compliance issues##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
compliance monitoring##2##2##(2008-10#1)(2011-2#1)
compliance of the##3##3##(1996-3#1)(2009-5#1)(2012-3#1)
compliance of##11##2##(1991-6#1)(1993-11#1)(1994-8#1)(1996-3#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#1)
compliance on##2##2##(1996-3#1)(2009-11#1)
compliance program##3##2##(1996-12#2)(2007-9#1)
compliance to##6##2##(1992-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)
compliance was##6##2##(1991-6#1)(2008-3#1)(2011-2#1)(2013-7#3)
compliance with a##4##3##(1994-3#1)(2008-1#1)(2012-3#1)(2013-1#1)
compliance with current##2##3##(1995-2#1)(2013-1#1)
compliance with infection control##2##4##(2008-11#1)(2012-12#1)
compliance with instructions on how to use the##2##8##(1990-2#2)
compliance with medical##2##3##(2007-7#1)(2008-11#1)
compliance with pharmacotherapy##2##3##(1993-11#2)
compliance with the##11##3##(1992-3#1)(1993-11#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-8#1)(2013-8#1)
compliance with this##2##3##(1991-12#1)(1996-2#1)
compliance with##52##2##(1990-2#2)(1991-12#2)(1991-8#1)(1992-3#1)(1993-11#3)(1994-3#1)(1994-5#1)(1995-2#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#3)
compliance##211##1##(1990-2#2)(1990-3#2)(1990-6#1)(1991-11#2)(1991-12#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-8#2)(1993-11#13)(1993-3#1)(1994-1#1)(1994-11#4)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#5)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-5#1)(2007-12#7)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#4)(2008-1#3)(2008-10#22)(2008-11#6)(2008-12#3)(2008-3#5)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#4)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#6)(2013-8#7)
compliance-breathing frequency relationship##2##3##(2013-7#2)
compliances##3##1##(1991-3#1)(1995-2#1)(2012-2#1)
compliant with##2##2##(2008-3#1)(2012-2#1)
compliant##16##1##(1993-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)
complicate the##8##2##(1997-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
complicate##23##1##(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
complicated anatomical##2##2##(2007-11#1)(2008-5#1)
complicated and time consuming##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
complicated and##9##2##(1991-6#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#1)
complicated because of the##2##4##(2008-2#1)(2010-8#1)
complicated because of##4##3##(2008-2#2)(2010-8#1)(2012-2#1)
complicated by a##4##3##(1997-3#1)(2008-2#1)(2010-1#2)
complicated by acute##5##3##(2006-10#1)(2008-9#2)(2013-1#1)(2013-8#1)
complicated by an##2##3##(2007-8#1)(2008-7#1)
complicated by infection##2##3##(2007-7#2)
complicated by pulmonary##2##3##(2008-1#1)(2012-12#1)
complicated by severe##2##3##(2011-2#1)(2013-8#1)
complicated by the fact that##2##5##(2008-1#1)(2008-11#1)
complicated by the presence of##4##5##(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
complicated by the##17##3##(1994-9#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#2)(2009-5#1)(2010-6#1)
complicated by##98##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(2006-10#3)(2007-10#1)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#6)
complicated cases##2##2##(1997-3#1)(2008-7#1)
complicated cellular##3##2##(2008-11#1)(2008-4#2)
complicated chemical##2##2##(2008-10#1)(2009-6#1)
complicated disease##4##2##(1997-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
complicated diverticulitis##2##2##(2008-10#1)(2010-8#1)
complicated features##2##2##(2008-6#1)(2012-3#1)
complicated for##2##2##(2008-10#1)(2012-3#1)
complicated in##2##2##(2008-10#1)(2008-12#1)
complicated issue##2##2##(2008-2#1)(2013-1#1)
complicated malaria##3##2##(2012-12#3)
complicated or##2##2##(1995-6#1)(2010-12#1)
complicated porto-systemic shunt##2##3##(2011-2#2)
complicated procedures##2##2##(1993-12#1)(2010-8#1)
complicated process of##2##3##(1992-3#1)(2008-11#1)
complicated process##7##2##(1992-3#1)(1993-12#1)(2008-11#1)(2008-7#2)(2009-10#1)(2012-2#1)
complicated structural component##2##3##(2013-8#2)
complicated structure##2##2##(2008-3#1)(2010-12#1)
complicated the##4##2##(1992-6#1)(2007-8#1)(2008-4#1)(2008-6#1)
complicated urinary infection##3##3##(2007-12#3)
complicated urinary##4##2##(2007-12#4)
complicated with##14##2##(1993-2#1)(1993-5#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-4#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
complicated##299##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#4)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#1)(2007-7#4)(2007-8#7)(2008-1#9)(2008-10#22)(2008-11#10)(2008-12#2)(2008-2#11)(2008-3#18)(2008-4#9)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#11)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#5)(2011-1#3)(2011-2#19)(2012-12#11)(2012-2#15)(2012-3#7)(2013-1#12)(2013-8#10)
complicates the##5##2##(1995-3#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)
complicates##14##1##(1995-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-12#2)(2010-5#1)(2011-2#1)(2013-1#2)
complicating a##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
complicating action##2##2##(1996-3#2)
complicating alpha-interferon therapy##2##3##(1996-6#2)
complicating factors##4##2##(1997-2#1)(2008-1#1)(2008-4#2)
complicating lumbar##2##2##(2012-12#2)
complicating rhabdomyolysis##2##2##(2008-12#2)
complicating the##2##2##(1997-7#1)(2008-5#1)
complicating##45##1##(1993-2#1)(1996-3#2)(1996-6#3)(1997-2#2)(1997-7#1)(2006-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#4)(2011-2#2)(2012-12#2)(2013-1#5)
complication after renal transplantation##2##4##(2008-1#2)
complication after the##2##3##(2007-8#1)(2013-8#1)
complication after##16##2##(1992-11#1)(2007-10#1)(2007-8#3)(2008-1#3)(2008-12#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
complication and mortality##2##3##(2008-3#1)(2013-1#1)
complication and##9##2##(2008-3#1)(2010-4#1)(2010-8#2)(2012-12#1)(2013-1#4)
complication associated with##3##3##(2009-7#1)(2011-2#1)(2012-12#1)
complication following##6##2##(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
complication in patients with##5##4##(2007-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
complication in patients##7##3##(1996-9#1)(2007-10#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
complication in the##8##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-8#1)(2013-1#3)
complication in##29##2##(1991-11#1)(1996-9#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
complication is a##2##3##(2008-1#1)(2013-1#1)
complication is##12##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
complication may##2##2##(2008-7#1)(2013-1#1)
complication occurred##5##2##(1992-8#2)(1997-3#1)(2013-1#2)
complication of HIV##2##3##(1996-3#1)(2008-1#1)
complication of a##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
complication of an##2##3##(2009-1#1)(2010-5#1)
complication of bone##2##3##(2007-11#1)(2008-6#1)
complication of chronic pancreatitis##2##4##(1991-8#1)(2011-2#1)
complication of chronic##4##3##(1991-8#1)(2008-1#1)(2011-2#2)
complication of cochlear##2##3##(2012-2#2)
complication of diabetes##2##3##(2007-11#1)(2008-4#1)
complication of heparin##2##3##(2008-10#1)(2013-1#1)
complication of human##2##3##(2008-2#1)(2009-2#1)
complication of laparoscopic##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
complication of myocardial##2##3##(2011-2#1)(2012-1#1)
complication of percutaneous##2##3##(1995-11#2)
complication of pulmonary##2##3##(2007-12#1)(2007-8#1)
complication of surgery##3##3##(1990-6#1)(1993-1#1)(2009-5#1)
complication of the##8##3##(1991-8#1)(2006-10#1)(2008-7#1)(2010-11#1)(2011-2#3)(2012-12#1)
complication of this##3##3##(1991-3#1)(2007-11#1)(2008-7#1)
complication of total hip arthroplasty##2##5##(2008-8#1)(2013-1#1)
complication of total knee arthroplasty##2##5##(2013-1#2)
complication of total##5##3##(2008-8#1)(2009-5#1)(2013-1#3)
complication of##153##2##(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-5#2)(1993-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1996-3#1)(1997-3#1)(2006-10#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#9)(2008-1#3)(2008-10#4)(2008-12#4)(2008-2#2)(2008-4#1)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#19)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#2)
complication rate and##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
complication rate in##3##3##(2008-9#1)(2010-3#1)(2012-3#1)
complication rate of##4##3##(1996-9#1)(2008-1#1)(2012-3#1)(2013-1#1)
complication rate was##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
complication rate##33##2##(1991-3#1)(1993-12#1)(1993-6#2)(1995-1#2)(1996-9#1)(1997-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-9#1)(2009-5#1)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)
complication rates and##3##3##(2009-5#1)(2011-2#1)(2012-2#1)
complication rates in##2##3##(2011-2#2)
complication rates of##4##3##(1994-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
complication rates##27##2##(1994-8#1)(1996-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-3#1)(2010-6#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
complication related to the##2##4##(2007-8#1)(2013-1#1)
complication required##2##2##(2008-6#1)(2010-7#1)
complication requiring##2##2##(1994-3#1)(2011-2#1)
complication that may##2##3##(2011-2#1)(2013-1#1)
complication that##7##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
complication to##2##2##(1992-11#1)(1996-9#1)
complication was##8##2##(2007-8#2)(2008-10#1)(2008-7#3)(2011-3#1)(2012-12#1)
complication with##3##2##(1992-5#1)(1996-8#1)(2008-1#1)
complication##432##1##(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#2)(1991-3#5)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#3)(1997-3#4)(1997-6#1)(1997-8#2)(2006-10#4)(2007-10#4)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#7)(2007-8#26)(2008-1#21)(2008-10#9)(2008-11#2)(2008-12#11)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#23)(2008-8#5)(2008-9#8)(2009-1#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#5)(2009-5#6)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#8)(2011-1#5)(2011-2#50)(2011-3#3)(2012-1#4)(2012-12#21)(2012-2#18)(2012-3#21)(2013-1#34)(2013-7#1)(2013-8#5)
complications (including##2##2##(2011-2#1)(2013-1#1)
complications -##2##2##(2007-11#1)(2007-8#1)
complications affecting##2##2##(2008-1#2)
complications after heart surgery##2##4##(1997-3#2)
complications after##15##2##(1997-3#2)(2007-11#2)(2007-8#2)(2008-1#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#2)
complications and improvement of##2##4##(2007-11#1)(2011-2#1)
complications and in##2##3##(1994-12#1)(2009-3#1)
complications and morbidity##3##3##(2008-11#1)(2011-2#2)
complications and mortality##7##3##(1996-2#2)(1997-3#1)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
complications and quality##2##3##(1990-11#1)(1996-3#1)
complications and surgical##3##3##(2008-11#2)(2013-1#1)
complications and the##4##3##(1991-8#1)(1996-3#1)(2008-10#1)(2013-8#1)
complications and treatment##2##3##(1997-6#1)(2007-10#1)
complications and##78##2##(1990-11#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-12#1)(1996-2#3)(1996-3#3)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#4)(2008-8#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#2)
complications are associated with##2##4##(2010-10#1)(2011-3#1)
complications are less##2##3##(1991-11#1)(2011-1#1)
complications are seen in##2##4##(2012-12#1)(2012-8#1)
complications are##21##2##(1991-11#1)(1991-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-10#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#2)(2012-3#1)(2012-8#1)(2013-1#1)
complications arising from##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
complications arising##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-3#1)
complications as well as##4##4##(1990-9#1)(2007-10#1)(2011-2#1)(2012-12#1)
complications as well##5##3##(1990-9#1)(1996-3#1)(2007-10#1)(2011-2#1)(2012-12#1)
complications as##9##2##(1990-9#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-7#1)(2009-11#1)(2011-2#2)(2012-12#1)
complications associated with the##2##4##(2008-7#1)(2010-7#1)
complications associated with this disease##2##5##(2008-1#1)(2008-3#1)
complications associated with this##5##4##(2007-7#1)(2008-1#1)(2008-3#1)(2009-12#1)(2012-12#1)
complications associated with##17##3##(1990-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
complications at##2##2##(2008-9#1)(2011-2#1)
complications but##7##2##(1995-12#1)(2008-12#1)(2008-3#1)(2011-2#3)(2013-1#1)
complications by##5##2##(2008-10#1)(2009-5#1)(2010-12#1)(2010-8#1)(2013-1#1)
complications can be##3##3##(1992-5#1)(2007-11#1)(2008-10#1)
complications can occur##2##3##(2007-8#1)(2011-2#1)
complications can##7##2##(1992-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#2)
complications compared with the##2##4##(2010-12#1)(2010-8#1)
complications compared with##3##3##(2010-12#1)(2010-8#1)(2012-3#1)
complications could be##2##3##(2008-3#1)(2008-9#1)
complications develop##2##2##(2010-12#1)(2013-1#1)
complications due to##5##3##(1990-11#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
complications during or after##3##4##(2008-5#1)(2010-3#1)(2012-12#1)
complications during##10##2##(1991-5#1)(1991-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-5#1)(2010-3#1)(2012-12#2)(2013-1#1)
complications encountered##2##2##(2008-1#1)(2010-8#1)
complications following##6##2##(1990-6#1)(1995-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-3#1)
complications for##4##2##(1991-6#1)(1992-10#1)(2011-2#1)(2012-2#1)
complications from the##2##3##(2008-12#1)(2012-3#1)
complications from##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
complications has##2##2##(2011-2#2)
complications have been##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
complications have##4##2##(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)
complications if##2##2##(2007-11#1)(2012-3#1)
complications in a##2##3##(1997-2#1)(2011-1#1)
complications in children##3##3##(1994-6#2)(2011-2#1)
complications in clinical##2##3##(1995-12#1)(2008-1#1)
complications in patients with##7##4##(1990-12#1)(1994-3#2)(2007-8#1)(2008-3#1)(2008-7#2)
complications in patients##11##3##(1990-12#1)(1994-3#2)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-12#1)
complications in renal transplant##3##4##(2008-1#1)(2008-3#2)
complications in the##9##3##(1991-9#1)(1992-12#1)(1993-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#2)(2013-1#1)
complications in these##2##3##(1990-2#1)(1996-9#1)
complications in type##2##3##(2008-1#2)
complications in##72##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#3)(1991-9#2)(1992-12#1)(1992-2#1)(1993-9#2)(1994-3#2)(1994-6#2)(1995-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#8)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-3#3)(2013-1#4)
complications included##6##2##(2007-7#1)(2007-8#1)(2008-1#2)(2008-7#1)(2008-9#1)
complications including##6##2##(2008-4#1)(2008-7#1)(2010-8#1)(2011-3#1)(2012-12#1)(2013-1#1)
complications involved##2##2##(1996-12#1)(2007-8#1)
complications is##12##2##(1991-9#1)(1994-9#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
complications like##4##2##(2007-8#1)(2008-1#2)(2008-10#1)
complications may##6##2##(1994-5#1)(1996-6#1)(1997-8#1)(2007-7#1)(2012-3#1)(2013-1#1)
complications observed##3##2##(1996-3#1)(2007-8#1)(2012-2#1)
complications occurred in##10##3##(1991-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
complications occurred##18##2##(1991-2#1)(1994-9#1)(1995-11#2)(1995-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-11#1)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
complications of Crohn disease##2##4##(1997-8#2)
complications of anorexia nervosa##2##4##(2007-7#2)
complications of diabetes mellitus##2##4##(2008-1#1)(2012-2#1)
complications of diabetes##8##3##(1990-5#1)(2008-1#5)(2012-2#1)(2013-1#1)
complications of lung##2##3##(2011-3#2)
complications of orthopedic surgery for##2##5##(2011-2#2)
complications of orthopedic surgery##3##4##(2011-2#3)
complications of pneumocoeles##2##3##(2012-2#2)
complications of pregnancy##2##3##(1996-12#1)(2008-4#1)
complications of the disease##4##4##(1990-5#1)(1990-6#1)(2012-12#1)(2012-3#1)
complications of the##10##3##(1990-5#1)(1990-6#2)(1991-11#1)(1993-9#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
complications of this operation are##2##5##(1990-9#1)(1991-5#1)
complications of this##6##3##(1990-9#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-6#1)(2011-1#1)
complications of type 2 diabetes##2##5##(2007-5#1)(2008-1#1)
complications of##132##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#10)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#4)(2012-12#3)(2012-2#7)(2012-3#2)(2012-8#2)(2013-1#7)(2013-8#3)
complications or mortality##2##3##(2008-10#1)(2012-3#1)
complications or##15##2##(1990-2#1)(1993-11#1)(1996-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#2)
complications rate was##2##3##(2007-11#1)(2007-8#1)
complications rate##5##2##(2007-11#3)(2007-8#1)(2009-3#1)
complications related to the##5##4##(1991-6#1)(1997-3#1)(2007-12#1)(2008-7#1)(2008-9#1)
complications related to##9##3##(1990-5#1)(1991-6#1)(1993-3#1)(1997-3#1)(2007-12#1)(2008-7#1)(2008-9#2)(2012-2#1)
complications relating to##2##3##(2008-8#1)(2012-2#1)
complications resulting##2##2##(2008-8#1)(2012-3#1)
complications should##2##2##(2010-5#1)(2013-1#1)
complications such as hypertension##2##4##(1996-11#1)(2009-5#1)
complications such as##28##3##(1990-11#1)(1995-11#1)(1996-11#1)(1996-8#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)
complications than##4##2##(1991-6#1)(2009-3#1)(2013-1#2)
complications that are##2##3##(1990-3#1)(2008-3#1)
complications that can##3##3##(1991-3#1)(2007-11#1)(2010-12#1)
complications that have been##2##4##(1994-6#1)(2013-1#1)
complications that have##3##3##(1994-6#1)(2009-3#1)(2013-1#1)
complications that may##4##3##(1994-3#1)(2012-2#2)(2013-1#1)
complications that##17##2##(1990-3#1)(1991-3#1)(1994-3#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#2)(2013-1#4)
complications the##5##2##(1993-9#1)(1996-3#1)(2008-10#1)(2011-2#1)(2011-3#1)
complications was 7##2##3##(2008-1#1)(2012-3#1)
complications was low##2##3##(2008-8#1)(2008-9#1)
complications was performed##2##3##(1992-12#1)(2008-7#1)
complications was##16##2##(1990-3#1)(1991-8#1)(1992-12#2)(2007-7#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-1#1)(2012-3#2)(2013-8#1)
complications were encountered##3##3##(1991-2#1)(2007-8#1)(2008-9#1)
complications were evaluated##3##3##(2008-9#1)(2009-8#1)(2013-1#1)
complications were not##2##3##(1990-3#1)(2012-2#1)
complications were noted in##2##4##(1992-1#1)(2013-1#1)
complications were noted##5##3##(1990-8#1)(1992-1#1)(1994-2#1)(2007-11#1)(2013-1#1)
complications were observed in##2##4##(1995-1#1)(2007-8#1)
complications were observed##15##3##(1990-3#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
complications were##52##2##(1990-3#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-3#1)(2007-11#4)(2007-8#6)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#8)(2013-7#1)
complications when##2##2##(2007-8#1)(2008-11#1)
complications will be##2##3##(2008-8#1)(2009-5#1)
complications will##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
complications with a##2##3##(1992-5#1)(2011-2#1)
complications with##8##2##(1990-3#1)(1992-5#1)(2007-9#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
complications within##3##2##(2006-12#1)(2010-3#1)(2012-3#1)
complications##1123##1##(1990-11#9)(1990-12#2)(1990-2#2)(1990-3#9)(1990-5#4)(1990-6#4)(1990-8#4)(1990-9#7)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#4)(1991-5#5)(1991-6#8)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#6)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#9)(1994-1#1)(1994-12#6)(1994-2#5)(1994-3#6)(1994-5#4)(1994-6#5)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#6)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#8)(1996-12#3)(1996-2#6)(1996-3#11)(1996-6#3)(1996-8#3)(1996-9#5)(1997-2#1)(1997-3#6)(1997-6#3)(1997-8#5)(2006-10#11)(2006-12#1)(2006-7#1)(2007-10#8)(2007-11#35)(2007-12#11)(2007-5#4)(2007-6#2)(2007-7#27)(2007-8#58)(2007-9#1)(2008-1#57)(2008-10#23)(2008-11#19)(2008-12#8)(2008-2#3)(2008-3#19)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#62)(2008-8#17)(2008-9#25)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#8)(2009-4#3)(2009-5#8)(2009-6#3)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#18)(2010-3#9)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#10)(2011-1#14)(2011-2#103)(2011-3#20)(2012-1#3)(2012-12#35)(2012-2#44)(2012-3#32)(2012-8#4)(2013-1#112)(2013-7#5)(2013-8#13)
complications--in##2##1##(2011-2#2)
complications]##4##1##(1991-11#1)(1993-9#1)(1994-3#1)(1997-2#1)
complied with the##2##3##(2012-3#2)
complied with##6##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
compliers##2##1##(1991-8#1)(2008-12#1)
complies with##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
compliment##3##1##(1993-12#2)(2011-2#1)
complimentary##10##1##(1996-12#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#2)(2010-12#1)
complimented by##2##2##(2008-1#1)(2011-2#1)
comply with the##11##3##(1991-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(2006-5#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
comply with##24##2##(1991-2#1)(1991-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#1)
comply##26##1##(1991-2#1)(1991-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
complying with the##2##3##(2008-8#1)(2011-2#1)
complying with##5##2##(2008-10#1)(2008-8#1)(2011-2#2)(2012-12#1)
compomer##4##1##(2008-5#1)(2011-2#2)(2013-1#1)
component A##4##2##(1991-12#2)(2008-9#2)
component alignment##2##2##(2013-1#2)
component alone##2##2##(1995-11#1)(2008-10#1)
component analysis (ICA)##6##3##(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-8#1)
component analysis (PCA) and cluster analysis##2##6##(2008-10#1)(2010-5#1)
component analysis (PCA) and##12##4##(2008-10#11)(2010-5#1)
component analysis (PCA) is##2##4##(2008-10#1)(2013-8#1)
component analysis (PCA) was##5##4##(1996-5#1)(2008-10#4)
component analysis (PCA)##43##3##(1996-5#2)(2008-1#1)(2008-10#32)(2010-5#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
component analysis and cluster analysis##4##5##(2008-10#4)
component analysis and cluster##5##4##(2008-10#4)(2008-12#1)
component analysis and##13##3##(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2011-2#1)(2013-8#2)
component analysis of##2##3##(2008-10#1)(2008-7#1)
component analysis was##3##3##(2008-1#1)(2008-10#1)(2010-5#1)
component analysis##111##2##(1996-5#2)(2008-1#2)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-5#5)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#4)
component and a##2##3##(2007-12#1)(2010-8#1)
component and partial least##2##4##(2008-10#2)
component and the##3##3##(2008-1#1)(2008-10#2)
component and##22##2##(1990-7#1)(1991-3#1)(1992-3#1)(1992-5#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)
component are##4##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
component at##2##2##(1992-3#1)(2011-2#1)
component cells##2##2##(1992-6#2)
component characters##2##2##(2008-8#2)
component coatings##2##2##(2008-10#2)
component equilibrium constants##3##3##(2008-10#3)
component factor analysis##2##3##(2008-10#1)(2008-11#1)
component failures##2##2##(1990-11#1)(2011-2#1)
component for the##5##3##(1994-3#1)(1996-12#1)(2007-1#1)(2012-2#2)
component for##13##2##(1994-3#1)(1996-12#1)(1996-3#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#2)
component from the##3##3##(1990-2#1)(1992-3#1)(1994-12#1)
component from##5##2##(1990-2#1)(1992-3#1)(1994-12#1)(2008-3#1)(2008-9#1)
component has##3##2##(2007-12#1)(2008-3#2)
component have been studied##2##4##(2008-2#1)(2008-3#1)
component in a##4##3##(2007-12#1)(2009-4#1)(2011-2#1)(2013-7#1)
component in an##2##3##(1992-8#1)(2008-3#1)
component in the response##2##4##(1990-5#1)(2010-1#1)
component in the transduction of##2##5##(1990-12#1)(1994-8#1)
component in the##29##3##(1990-11#1)(1990-12#1)(1990-5#1)(1994-8#2)(1995-2#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
component in##68##2##(1990-11#2)(1990-12#1)(1990-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-5#1)(1994-8#3)(1995-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
component involved##2##2##(1992-3#1)(1993-1#1)
component is a major##2##4##(1994-5#1)(2008-12#1)
component is a##4##3##(1992-9#1)(1994-5#1)(2008-12#1)(2013-1#1)
component is of##2##3##(1997-7#1)(2008-2#1)
component is the##3##3##(2008-10#1)(2008-8#1)(2009-4#1)
component is##15##2##(1990-7#1)(1991-2#1)(1992-9#1)(1994-5#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2013-1#1)
component may##3##2##(1992-6#1)(1995-12#1)(2008-7#1)
component model##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
component named##2##2##(1995-2#1)(2008-1#1)
component number##2##2##(2008-10#2)
component of a larger##4##4##(1990-8#1)(2008-12#1)(2009-9#1)(2010-10#1)
component of a##19##3##(1990-8#2)(1993-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2013-8#1)
component of an image##2##4##(2008-9#2)
component of an integrated##2##4##(1992-2#1)(2013-8#1)
component of an##7##3##(1992-2#1)(1996-3#1)(2007-12#1)(2008-5#1)(2008-9#2)(2013-8#1)
component of any##2##3##(2007-7#1)(2012-3#1)
component of both##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
component of breast##2##3##(2007-11#1)(2013-1#1)
component of cluster##2##3##(2008-10#2)
component of comprehensive##2##3##(1992-1#1)(2013-1#1)
component of functional##2##3##(2008-7#2)
component of genetic##2##3##(2008-3#1)(2008-8#1)
component of human telomerase##2##4##(2008-11#1)(2008-9#1)
component of human##4##3##(2008-10#1)(2008-11#2)(2008-9#1)
component of many##3##3##(2008-10#2)(2012-2#1)
component of more than##2##4##(2008-10#1)(2013-8#1)
component of senile plaques##2##4##(1993-3#1)(2008-7#1)
component of the LE model##2##5##(2008-10#2)
component of the analyte##2##4##(2008-10#1)(2013-8#1)
component of the complex##3##4##(1994-11#2)(2007-12#1)
component of the homeostatic##2##4##(2008-7#2)
component of the human##3##4##(1991-9#1)(2011-2#2)
component of the immune system##2##5##(1990-9#1)(2012-2#1)
component of the karyosome##2##4##(2007-12#2)
component of the protein##3##4##(1991-5#1)(1995-2#1)(1997-7#1)
component of the rat##2##4##(1990-5#1)(1992-3#1)
component of the secretory machinery##2##5##(1991-5#1)(1997-3#1)
component of the system##2##4##(2008-10#2)
component of the transcription factor##2##5##(1993-9#1)(2008-10#1)
component of the##161##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#3)(1992-6#3)(1992-9#2)(1993-3#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#2)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#5)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
component of this##9##3##(1993-9#1)(1997-4#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
component of which is##2##4##(1992-12#1)(2008-5#1)
component of yeast##2##3##(1992-8#1)(2008-11#1)
component of##369##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#7)(1992-6#4)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#5)(1994-9#1)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#3)(1996-1#1)(1996-11#2)(1996-2#5)(1996-3#3)(1996-5#2)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#2)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#11)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#55)(2008-11#19)(2008-12#3)(2008-2#5)(2008-3#21)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#14)(2008-8#7)(2008-9#14)(2009-1#1)(2009-11#6)(2009-4#1)(2009-8#2)(2009-9#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#12)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#10)(2013-1#8)(2013-8#8)
component on the##2##3##(2008-10#2)
component pairs##2##2##(2008-10#1)(2008-7#1)
component parts##2##2##(1997-1#1)(2013-1#1)
component plus##2##2##(1991-8#1)(2008-3#1)
component position##2##2##(2008-8#1)(2009-3#1)
component present in##2##3##(1993-3#1)(1995-6#1)
component proteins##4##2##(1992-12#1)(1992-9#1)(2008-7#1)(2012-3#1)
component pure stands (P = 0##3##6##(2008-10#3)
component pure stands##4##3##(2008-10#4)
component regression##18##2##(2007-12#1)(2008-10#16)(2013-8#1)
component responsible for##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
component spectra##4##2##(2007-12#3)(2008-10#1)
component spectral##2##2##(2008-10#2)
component summary##2##2##(2007-8#2)
component technologies##2##2##(2008-2#1)(2008-3#1)
component that is##5##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)
component that##13##2##(1990-3#1)(1992-3#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-12#1)
component through##2##2##(2007-12#1)(2008-3#1)
component to the##5##3##(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)
component to##12##2##(1995-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-8#1)
component was found##2##3##(1996-2#1)(2007-8#1)
component was##18##2##(1991-2#1)(1991-8#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2013-1#1)
component were##5##2##(1994-11#1)(1997-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
component which##2##2##(1995-12#1)(1997-7#1)
component with a##3##3##(2008-10#2)(2008-11#1)
component with##7##2##(1995-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-5#1)(2013-1#1)
component within##3##2##(2008-11#2)(2013-1#1)
component##1074##1##(1990-11#7)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#4)(1990-9#1)(1991-12#7)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#6)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#14)(1992-5#1)(1992-6#10)(1992-8#8)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#4)(1993-6#1)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#6)(1994-12#6)(1994-2#4)(1994-3#6)(1994-5#8)(1994-8#10)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#13)(1995-3#9)(1995-5#6)(1995-6#6)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#11)(1996-3#6)(1996-5#6)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#10)(1997-4#3)(1997-5#1)(1997-7#5)(1997-8#2)(1997-9#1)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#28)(2007-7#1)(2007-8#6)(2008-1#11)(2008-10#240)(2008-11#48)(2008-12#10)(2008-2#27)(2008-3#58)(2008-4#9)(2008-5#24)(2008-6#3)(2008-7#23)(2008-8#34)(2008-9#26)(2009-1#4)(2009-10#3)(2009-11#9)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#2)(2009-6#3)(2009-8#5)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-5#8)(2010-6#1)(2010-7#4)(2010-8#7)(2011-1#9)(2011-10#1)(2011-2#32)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#5)(2012-2#18)(2012-3#21)(2013-1#30)(2013-7#4)(2013-8#24)
component&quot##2##1##(1992-8#1)(1997-3#1)
component) and##3##2##(1993-5#1)(1995-4#1)(2007-11#1)
component)##11##1##(1993-5#2)(1995-4#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
components (i##2##2##(2007-12#1)(2008-11#1)
components against the##2##3##(2008-10#1)(2008-11#1)
components against##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-3#1)
components alone##2##2##(2008-3#1)(2008-6#1)
components also##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
components analysis (PCA)##6##3##(2008-10#5)(2010-7#1)
components analysis##23##2##(1992-1#1)(1992-2#1)(1992-6#2)(1996-7#1)(2008-10#13)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
components and a##2##3##(1995-12#1)(2007-11#1)
components and is##3##3##(2008-4#2)(2010-2#1)
components and the##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)
components and their##5##3##(2008-10#1)(2008-3#1)(2009-10#1)(2010-7#1)(2011-1#1)
components and##58##2##(1990-11#1)(1990-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)
components are obtained##2##3##(2008-2#1)(2008-3#1)
components are two##2##3##(1993-11#1)(2009-8#1)
components are used##2##3##(2008-10#1)(2008-3#1)
components are##49##2##(1990-11#1)(1991-1#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-8#2)(2009-1#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
components as a##2##3##(2008-7#1)(2009-12#1)
components as well as##2##4##(2008-11#2)
components as##10##2##(1990-7#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-7#1)
components associated with##2##3##(2008-10#1)(2008-5#1)
components at ground##2##3##(2008-3#2)
components at the##3##3##(2008-3#1)(2009-10#1)(2010-9#1)
components at##7##2##(1997-7#1)(2008-10#1)(2008-3#3)(2009-10#1)(2010-9#1)
components by##13##2##(1995-5#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#3)(2009-7#1)(2010-7#1)(2012-12#1)
components can be##4##3##(1993-2#1)(2008-8#2)(2011-2#1)
components can##9##2##(1993-2#1)(2008-10#1)(2008-8#3)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
components caused##2##2##(2008-10#1)(2011-2#1)
components consist of##2##3##(2008-11#1)(2008-2#1)
components contained##2##2##(1996-9#1)(2008-10#1)
components contribute to##2##3##(2007-8#1)(2008-7#1)
components could##2##2##(2008-10#1)(2008-5#1)
components designed for##2##3##(2009-11#1)(2009-12#1)
components for the##4##3##(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)
components for##23##2##(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
components found##2##2##(2008-10#2)
components from the##4##3##(1992-8#1)(1995-3#1)(2008-10#1)(2008-11#1)
components from##10##2##(1992-8#1)(1995-3#1)(2008-10#3)(2008-11#3)(2008-2#1)(2009-10#1)
components had##2##2##(2011-2#2)
components has##2##2##(2008-10#1)(2008-3#1)
components have been##5##3##(2008-10#1)(2008-2#1)(2008-5#2)(2009-4#1)
components have##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-4#1)
components in a##7##3##(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
components in an##2##3##(1991-12#1)(2008-3#1)
components in the##22##3##(1995-3#1)(1996-6#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2013-1#2)(2013-8#1)
components in this##3##3##(2007-12#1)(2008-8#1)(2009-12#1)
components in##85##2##(1991-12#1)(1992-11#2)(1993-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#3)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
components including##3##2##(1991-12#1)(2008-10#1)(2010-6#1)
components interact with one another##2##5##(2007-11#1)(2010-12#1)
components into the##2##3##(2008-7#1)(2013-8#1)
components into##5##2##(1997-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
components involved in the##2##4##(2007-12#1)(2013-8#1)
components involved in##5##3##(1991-12#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
components involved##6##2##(1991-12#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
components is introduced##2##3##(2007-11#1)(2008-3#1)
components is##19##2##(1992-9#1)(1995-3#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#5)(2009-8#2)
components isolated##2##2##(2011-3#2)
components like##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
components makes the##2##3##(2008-3#2)
components may be##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
components may##6##2##(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)
components named##2##2##(1993-8#1)(2008-8#1)
components of DEJ##2##3##(2008-5#2)
components of a comprehensive##2##4##(1996-2#1)(2011-2#1)
components of a##22##3##(1993-1#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
components of aggressiveness##4##3##(2008-10#4)
components of all##3##3##(2008-12#1)(2008-5#1)(2012-2#1)
components of an##6##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)
components of any##2##3##(1997-3#1)(2008-12#1)
components of both##2##3##(2008-10#1)(2010-8#1)
components of essential oil##2##4##(2012-3#2)
components of essential##3##3##(2008-10#1)(2012-3#2)
components of fitness##2##3##(2008-9#2)
components of hospital care##2##4##(1991-3#2)
components of impulsive behavior##2##4##(2010-6#2)
components of metabolic syndrome##4##4##(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
components of movement##2##3##(1990-5#2)
components of pain##2##3##(2008-11#1)(2010-4#1)
components of partial resistance##4##4##(2008-10#4)
components of plant##2##3##(2008-10#1)(2008-8#1)
components of primary inoculum dispersal##2##5##(2008-10#2)
components of resistance to blast##2##5##(2008-10#2)
components of resistance##4##3##(2008-10#4)
components of skin##2##3##(2008-5#2)
components of support##2##3##(1994-3#1)(1996-3#1)
components of the cell##2##4##(2008-11#1)(2008-9#1)
components of the health##3##4##(1991-3#1)(1993-3#1)(2008-7#1)
components of the host##2##4##(2009-8#1)(2010-1#1)
components of the immune system##2##5##(2008-10#2)
components of the intervention##2##4##(2008-4#1)(2008-8#1)
components of the metabolic syndrome##5##5##(2008-1#2)(2008-11#1)(2008-3#1)(2010-5#1)
components of the optical##2##4##(2007-11#1)(2008-3#1)
components of the program##2##4##(1996-3#1)(1997-1#1)
components of the protein##2##4##(1997-3#1)(2008-11#1)
components of the scattered##2##4##(2007-12#1)(2008-3#1)
components of the signal##3##4##(2008-2#2)(2009-8#1)
components of the##178##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#11)(2008-1#3)(2008-10#31)(2008-11#6)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#2)(2010-11#3)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
components of these##7##3##(1996-12#1)(1996-2#1)(2008-10#2)(2008-3#2)(2008-8#1)
components of this system##2##4##(1990-11#1)(1995-2#1)
components of this##10##3##(1990-11#1)(1993-8#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)
components of variance##2##3##(1996-3#1)(2008-10#1)
components of vascular##2##3##(2008-3#1)(2008-4#1)
components of##433##2##(1990-11#2)(1990-2#2)(1990-5#5)(1990-7#2)(1990-8#1)(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#6)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#19)(2007-2#1)(2007-6#2)(2008-1#7)(2008-10#80)(2008-11#16)(2008-12#7)(2008-2#9)(2008-3#23)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#14)(2008-8#21)(2008-9#12)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#4)(2009-8#4)(2010-1#3)(2010-11#4)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#12)(2011-3#2)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#6)
components on the##8##3##(1991-2#1)(1992-8#1)(1995-6#1)(2008-11#3)(2008-3#1)(2011-2#1)
components on##20##2##(1991-2#2)(1992-8#1)(1995-6#1)(2008-10#4)(2008-11#4)(2008-3#3)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
components only##2##2##(2008-3#1)(2012-3#1)
components or##3##2##(1995-2#1)(2008-8#1)(2013-1#1)
components play##2##2##(2007-12#1)(2013-8#1)
components present in the##2##4##(2008-1#1)(2008-10#1)
components present in##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
components rather than##2##3##(2008-11#1)(2008-3#1)
components represent##2##2##(2008-10#1)(2008-8#1)
components required for##3##3##(1994-8#1)(2008-10#1)(2013-1#1)
components required##5##2##(1990-8#1)(1994-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
components responsible for##3##3##(1992-8#1)(2011-1#1)(2013-8#1)
components resulted in##2##3##(2008-10#1)(2009-8#1)
components show##3##2##(2008-10#1)(2008-7#2)
components similar to##2##3##(2008-5#1)(2008-8#1)
components such as collagen and##2##5##(2008-5#1)(2012-2#1)
components such as##11##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
components suitable for##2##3##(1995-6#1)(2008-4#1)
components that are not##2##4##(2007-12#1)(2013-8#1)
components that are##8##3##(2007-12#3)(2008-2#2)(2008-3#1)(2010-5#1)(2013-8#1)
components that##22##2##(1994-3#1)(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
components to be##2##3##(2008-3#1)(2008-7#1)
components to##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)
components used in##2##3##(2008-11#1)(2008-2#1)
components used##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
components was investigated##2##3##(2008-10#1)(2008-9#1)
components was##17##2##(2007-11#1)(2007-12#2)(2008-10#7)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-1#1)(2013-1#2)
components were all##2##3##(2007-9#1)(2008-3#1)
components were determined##2##3##(2008-10#1)(2013-1#1)
components were identified##3##3##(2008-12#1)(2008-3#2)
components were infectious by biolistic inoculation to##2##7##(2008-10#2)
components were investigated##2##3##(1992-8#1)(2008-9#1)
components were measured##2##3##(2008-10#2)
components were observed##2##3##(1994-3#1)(2012-1#1)
components were obtained##2##3##(2008-10#1)(2008-8#1)
components were studied##2##3##(2007-1#1)(2008-11#1)
components were##47##2##(1991-12#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
components will##2##2##(1994-1#1)(2010-2#1)
components with a##4##3##(1992-6#1)(2008-2#2)(2008-3#1)
components with##22##2##(1991-12#1)(1992-6#1)(1996-2#2)(1997-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-6#1)(2010-11#1)
components within##2##2##(1991-12#1)(2010-11#1)
components##1479##1##(1990-11#5)(1990-12#3)(1990-2#2)(1990-5#7)(1990-7#4)(1990-8#8)(1991-1#4)(1991-12#12)(1991-2#5)(1991-3#6)(1991-4#1)(1991-5#2)(1991-8#2)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#5)(1992-8#7)(1992-9#4)(1993-1#2)(1993-11#8)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#5)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#8)(1995-4#1)(1995-5#10)(1995-6#5)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#14)(1996-2#9)(1996-3#7)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#9)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#1)(2006-12#2)(2007-1#3)(2007-10#1)(2007-11#31)(2007-12#53)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#12)(2008-10#304)(2008-11#82)(2008-12#20)(2008-2#62)(2008-3#119)(2008-4#24)(2008-5#37)(2008-6#14)(2008-7#40)(2008-8#61)(2008-9#30)(2009-1#1)(2009-10#14)(2009-11#3)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#9)(2009-7#6)(2009-8#16)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#11)(2010-12#2)(2010-2#5)(2010-4#3)(2010-5#6)(2010-6#6)(2010-7#7)(2010-8#10)(2010-9#6)(2011-1#14)(2011-2#41)(2011-3#10)(2012-1#5)(2012-12#11)(2012-2#15)(2012-3#18)(2013-1#33)(2013-7#5)(2013-8#22)
components)##6##1##(1996-5#1)(2008-10#1)(2008-2#1)(2008-7#2)(2012-12#1)
comportement##3##1##(2008-11#1)(2008-5#2)
compose##7##1##(1993-6#1)(2008-10#3)(2008-2#2)(2012-3#1)
composed by##9##2##(2007-12#1)(2008-10#5)(2008-12#1)(2011-2#2)
composed mainly of##7##3##(1994-5#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-12#1)(2010-2#1)(2010-8#1)
composed mainly##8##2##(1994-5#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-8#1)
composed mostly of##2##3##(2008-10#1)(2008-3#1)
composed of 0##2##3##(2008-10#2)
composed of 10##2##3##(2008-3#1)(2008-8#1)
composed of 18##4##3##(1991-6#1)(1993-3#1)(1994-11#1)(2008-10#1)
composed of 5##2##3##(1994-9#1)(2008-10#1)
composed of a mass of##2##5##(2008-10#1)(2008-5#1)
composed of a mixture of##2##5##(2008-10#1)(2013-1#1)
composed of a single##2##4##(1993-12#1)(2008-3#1)
composed of a thin##2##4##(2008-7#1)(2013-8#1)
composed of a##43##3##(1992-1#1)(1993-12#2)(1993-8#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#2)(2013-8#1)
composed of alpha##2##3##(1995-11#1)(2008-11#1)
composed of alternating##2##3##(1996-2#1)(2008-10#1)
composed of an##4##3##(2008-10#1)(2010-4#1)(2011-2#2)
composed of at least two##2##5##(1997-4#1)(2008-6#1)
composed of both##3##3##(2008-10#2)(2008-9#1)
composed of cells##2##3##(2007-12#1)(2012-12#1)
composed of different##4##3##(1997-7#1)(2007-5#1)(2008-12#1)(2008-7#1)
composed of directly repeated half-sites##2##5##(1995-8#2)
composed of epidermal##2##3##(2008-7#1)(2013-7#1)
composed of fibrous##2##3##(2010-5#1)(2011-2#1)
composed of five different##2##4##(2008-10#1)(2008-9#1)
composed of four##8##3##(1992-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(2008-12#2)(2008-5#1)(2013-1#1)
composed of highly##2##3##(2008-7#2)
composed of human##2##3##(1990-8#1)(2008-11#1)
composed of keratinocytes##2##3##(2008-5#2)
composed of large##3##3##(1991-6#1)(2009-7#1)(2011-1#1)
composed of one##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
composed of phosphatidylcholine##2##3##(1993-11#1)(2008-8#1)
composed of six##2##3##(2008-10#1)(2008-2#1)
composed of the##12##3##(1990-5#2)(1994-5#2)(1994-6#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-4#1)(2010-6#1)(2013-1#1)
composed of three##9##3##(1997-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-8#2)
composed of two parts##2##4##(2013-1#2)
composed of two##20##3##(1992-2#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#3)
composed of##343##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#5)(1990-6#1)(1990-8#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#4)(1995-2#4)(1995-5#3)(1995-6#7)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#4)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#16)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#56)(2008-11#10)(2008-12#4)(2008-2#10)(2008-3#28)(2008-4#4)(2008-5#14)(2008-6#2)(2008-7#12)(2008-8#13)(2008-9#4)(2009-2#2)(2009-3#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#6)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#5)
composed primarily of##3##3##(1997-5#1)(2007-11#1)(2008-10#1)
composed the##2##2##(2008-10#1)(2008-8#1)
composed##379##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#4)(1995-2#4)(1995-5#3)(1995-6#8)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#18)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#66)(2008-11#10)(2008-12#6)(2008-2#10)(2008-3#32)(2008-4#4)(2008-5#14)(2008-6#2)(2008-7#13)(2008-8#14)(2008-9#4)(2009-2#2)(2009-3#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#12)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#6)
composer##2##1##(2013-1#2)
composes##2##1##(2008-5#1)(2012-12#1)
composing gratings##2##2##(2008-8#2)
composing the##3##2##(2008-10#3)
composing##11##1##(1991-6#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#2)(2011-2#1)
composite (1% mass fraction) is dominated by semiconducting##2##8##(2008-10#2)
composite (1% mass fraction) shows##2##5##(2008-10#2)
composite (1% mass fraction)##4##4##(2008-10#4)
composite Nd##2##2##(2008-2#2)
composite OWG with 10nm##2##4##(2008-10#2)
composite OWG##5##2##(2008-10#5)
composite Tm##2##2##(2008-2#2)
composite and##4##2##(2008-10#2)(2008-12#1)(2009-7#1)
composite as##5##2##(1994-3#1)(2008-10#4)
composite biosensors##3##2##(2008-10#3)
composite body part##2##3##(2008-9#2)
composite cements with##2##3##(2012-2#2)
composite cements##3##2##(2009-8#1)(2012-2#2)
composite design##21##2##(2008-10#17)(2008-11#2)(2008-7#1)(2011-2#1)
composite designs##5##2##(2008-10#5)
composite electrode##7##2##(2008-10#7)
composite electrodes##6##2##(2008-10#6)
composite fiber##2##2##(2008-11#2)
composite film##10##2##(2008-10#7)(2008-3#2)(2013-1#1)
composite films are##2##3##(2008-10#1)(2008-3#1)
composite films##12##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#4)(2013-1#1)
composite filtering##3##2##(2008-2#1)(2008-3#2)
composite frame##2##2##(2008-2#2)
composite graft##5##2##(2007-8#1)(2008-12#1)(2008-9#2)(2012-2#1)
composite grafts##2##2##(2008-9#1)(2010-8#1)
composite hydrogel##3##2##(2009-7#3)
composite image##2##2##(2011-1#2)
composite in##2##2##(2008-10#1)(2009-2#1)
composite interval mapping##6##3##(2008-10#6)
composite interval##7##2##(2008-10#7)
composite is reported##2##3##(2008-10#2)
composite is##5##2##(1990-5#1)(2008-10#4)
composite laser##2##2##(2008-2#1)(2008-3#1)
composite material films##2##3##(2008-10#2)
composite material##14##2##(1991-5#1)(2007-11#2)(2007-12#1)(2008-10#7)(2009-7#3)
composite materials was##2##3##(2008-3#1)(2009-7#1)
composite materials##6##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#2)
composite matrix##6##2##(2007-11#1)(2008-10#5)
composite membrane##2##2##(2008-5#2)
composite membranes##3##2##(1994-3#1)(2008-5#2)
composite modified##2##2##(2008-10#2)
composite nanofiber mat electrospun from an emulsion##2##7##(2009-11#2)
composite nanofiber mat electrospun from##3##5##(2009-11#3)
composite nanofiber mat##5##3##(2009-11#5)
composite neurologic##2##2##(2007-10#2)
composite of##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
composite optical waveguide##2##3##(2008-10#2)
composite optical waveguides##2##3##(2008-10#2)
composite optical##4##2##(2008-10#4)
composite resin##19##2##(2008-12#9)(2008-7#2)(2009-8#3)(2013-1#5)
composite resins##7##2##(1990-3#1)(1990-9#1)(2008-12#1)(2012-2#3)(2013-1#1)
composite restorations##4##2##(1990-9#1)(2009-8#2)(2013-1#1)
composite score##2##2##(1996-1#1)(2010-4#1)
composite that##2##2##(2008-10#1)(2010-8#1)
composite thin films##2##3##(2008-10#2)
composite tissue transplants##2##3##(2008-9#2)
composite tissue##5##2##(2008-9#3)(2011-2#2)
composite was##2##2##(2008-10#2)
composite with##3##2##(2008-10#2)(2009-7#1)
composite##365##1##(1990-3#1)(1990-5#2)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-6#1)(1994-3#3)(1995-2#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-4#1)(2007-10#4)(2007-11#7)(2007-12#11)(2007-8#5)(2008-1#1)(2008-10#140)(2008-11#8)(2008-12#18)(2008-2#17)(2008-3#24)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#12)(2009-10#1)(2009-11#6)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#8)(2009-7#16)(2009-8#6)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#12)(2013-1#12)
composite-multichannel##2##1##(2008-2#2)
composites and##2##2##(1997-1#1)(2008-10#1)
composites are##3##2##(2008-10#1)(2009-11#1)(2010-4#1)
composites as##5##2##(2008-3#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
composites can be##2##3##(2009-11#1)(2010-4#1)
composites have been##2##3##(2008-10#1)(2009-3#1)
composites in##7##2##(1990-5#1)(2009-2#4)(2010-4#1)(2013-1#1)
composites is##3##2##(2008-2#1)(2009-11#1)(2013-1#1)
composites of##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-4#1)
composites subjected to different periods of accelerated artificial aging##2##9##(2013-1#2)
composites to##2##2##(2009-2#1)(2009-7#1)
composites was##3##2##(2008-5#1)(2009-2#1)(2012-2#1)
composites were obtained##2##3##(2010-4#2)
composites were##9##2##(1990-2#1)(2008-12#1)(2008-5#2)(2009-11#2)(2009-7#1)(2010-4#2)
composites with##3##2##(2007-12#1)(2008-2#2)
composites##87##1##(1990-2#2)(1990-5#1)(1997-1#1)(2007-12#2)(2008-10#7)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#9)(2009-2#8)(2009-3#3)(2009-7#7)(2010-10#1)(2010-4#11)(2011-2#2)(2012-2#5)(2012-6#1)(2013-1#8)
composition analysis and##2##3##(1990-8#1)(1997-4#1)
composition analysis of##2##3##(1997-2#1)(2008-11#1)
composition analysis##8##2##(1990-8#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
composition and antibacterial activity of##2##5##(2008-12#1)(2012-3#1)
composition and concentration##2##3##(1990-2#1)(2010-11#1)
composition and content##2##3##(2009-8#1)(2012-8#1)
composition and fatty acid profiles##2##5##(2010-11#1)(2011-2#1)
composition and fatty acid##3##4##(2010-11#2)(2011-2#1)
composition and fluidity##3##3##(1990-7#2)(1991-5#1)
composition and function##4##3##(1990-7#1)(2008-5#1)(2009-6#1)(2012-2#1)
composition and in##2##3##(1994-3#1)(2008-11#1)
composition and inflammation##3##3##(2011-2#3)
composition and its##2##3##(2008-5#1)(2008-7#1)
composition and pH of the##2##5##(2008-10#1)(2011-1#1)
composition and pH##3##3##(2008-10#2)(2011-1#1)
composition and physical##2##3##(2009-11#1)(2012-3#1)
composition and properties##2##3##(2008-4#1)(2008-5#1)
composition and sequence##3##3##(1990-7#1)(2009-10#1)(2012-1#1)
composition and size##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
composition and structure of##3##4##(2008-10#1)(2008-7#2)
composition and the##6##3##(1990-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)
composition and##118##2##(1990-2#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-4#3)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#9)(2012-3#3)(2012-8#1)(2013-1#3)(2013-8#3)
composition are##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
composition as a##2##3##(2010-10#1)(2012-9#1)
composition as##3##2##(1991-12#1)(2010-10#1)(2012-9#1)
composition at##3##2##(2009-10#1)(2012-3#1)(2013-7#1)
composition between##5##2##(2008-10#2)(2008-11#1)(2011-2#2)
composition by##2##2##(1997-2#1)(2012-12#1)
composition can##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
composition changes##2##2##(2008-7#1)(2008-9#1)
composition could##2##2##(2008-10#1)(2008-11#1)
composition for##2##2##(2008-10#1)(2008-6#1)
composition has also been##2##4##(2008-10#1)(2008-11#1)
composition has been##4##3##(1994-12#1)(1994-9#1)(2007-11#1)(2010-9#1)
composition has##6##2##(1994-12#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-9#1)
composition in the##7##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-1#1)(2013-7#1)
composition in##32##2##(1990-5#2)(1992-3#1)(1993-12#1)(1995-8#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#5)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#3)(2013-8#2)
composition is a##2##3##(2009-5#1)(2009-7#1)
composition is known##2##3##(2008-10#1)(2008-2#1)
composition is##11##2##(2008-10#4)(2008-2#2)(2009-5#2)(2009-7#1)(2012-2#2)
composition measurements##2##2##(2008-7#2)
composition obtained from##2##3##(1992-12#1)(2008-7#1)
composition of a##7##3##(1990-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
composition of an##2##3##(2008-7#1)(2008-8#1)
composition of councils##2##3##(2008-7#2)
composition of different##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
composition of individual##2##3##(1992-12#1)(1995-8#1)
composition of organic##2##3##(1991-7#1)(2008-11#1)
composition of plasma##2##3##(1994-12#1)(1995-8#1)
composition of populations of##2##4##(2008-10#2)
composition of populations##3##3##(2008-10#2)(2008-8#1)
composition of samples##3##3##(2007-12#1)(2008-10#2)
composition of sequence variants##2##4##(2008-10#2)
composition of some##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
composition of the affected areas##2##5##(2011-2#2)
composition of the bacterial##2##4##(2008-10#2)
composition of the complex##3##4##(2008-10#3)
composition of the enzyme##2##4##(1990-5#1)(1992-12#1)
composition of the essential oil of##2##6##(2008-11#2)
composition of the essential##3##4##(2008-11#3)
composition of the extracted##2##4##(2008-10#2)
composition of the human##2##4##(1990-8#1)(2011-2#1)
composition of the membrane##3##4##(1990-7#1)(1994-2#1)(2008-10#1)
composition of the mixed##2##4##(1990-11#1)(2008-10#1)
composition of the planktonic community##2##5##(2008-3#2)
composition of the population##2##4##(2008-10#1)(2008-9#1)
composition of the##104##3##(1990-11#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-9#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-7#1)(2008-10#39)(2008-11#6)(2008-3#6)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#1)(2010-1#1)(2010-3#1)(2010-4#3)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
composition of these##5##3##(1993-2#1)(2008-10#1)(2008-11#2)(2010-7#1)
composition of various##2##3##(2008-10#2)
composition of##302##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#2)(1992-9#1)(1993-2#1)(1993-8#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-3#1)(1996-6#1)(1996-7#2)(1997-4#4)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#93)(2008-11#13)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#7)(2008-7#11)(2008-8#10)(2008-9#10)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-7#3)(2011-1#2)(2011-2#13)(2012-1#1)(2012-2#3)(2012-3#3)(2012-8#1)(2013-1#12)(2013-7#3)(2013-8#5)
composition on the##10##3##(1990-2#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)
composition on##15##2##(1990-2#2)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
composition or the##2##3##(2010-4#1)(2011-2#1)
composition or##4##2##(2008-1#1)(2008-5#1)(2010-4#1)(2011-2#1)
composition profiles##2##2##(2008-3#1)(2012-12#1)
composition range##3##2##(2007-12#1)(2008-10#2)
composition ratio##3##2##(2008-10#3)
composition that##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)
composition to##10##2##(1992-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2010-3#1)
composition was also##2##3##(1990-2#1)(2011-1#1)
composition was studied##3##3##(1997-3#1)(2008-10#1)(2010-4#1)
composition was##17##2##(1990-2#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
composition were##12##2##(1992-6#1)(1994-9#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-8#1)
composition with a##3##3##(1994-8#1)(2008-12#1)(2010-4#1)
composition with##7##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
composition##859##1##(1990-11#1)(1990-12#2)(1990-2#8)(1990-5#8)(1990-7#9)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#2)(1991-5#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#8)(1992-3#4)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#8)(1995-1#1)(1995-11#3)(1995-12#2)(1995-3#2)(1995-5#5)(1995-6#1)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#6)(1997-5#2)(1997-7#1)(1997-8#2)(2007-11#10)(2007-12#11)(2007-5#2)(2008-1#1)(2008-10#234)(2008-11#35)(2008-12#7)(2008-2#13)(2008-3#30)(2008-4#6)(2008-5#51)(2008-6#4)(2008-7#37)(2008-8#17)(2008-9#15)(2009-10#3)(2009-11#6)(2009-12#3)(2009-5#8)(2009-6#3)(2009-7#8)(2009-8#7)(2010-1#4)(2010-10#2)(2010-11#3)(2010-2#4)(2010-3#3)(2010-4#16)(2010-5#5)(2010-6#3)(2010-7#6)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#35)(2012-1#5)(2012-12#3)(2012-2#27)(2012-3#10)(2012-8#4)(2012-9#1)(2013-1#23)(2013-7#12)(2013-8#12)
compositional analysis##2##2##(1994-11#1)(2008-4#1)
compositional and##2##2##(1997-4#1)(2008-2#1)
compositional compartments##2##2##(1994-12#2)
compositional data##2##2##(2008-10#1)(2008-5#1)
compositional differences##3##2##(2008-10#2)(2008-5#1)
compositional specifications##2##2##(2010-4#2)
compositional##23##1##(1992-6#2)(1993-3#1)(1994-11#1)(1994-12#3)(1997-4#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2010-4#2)(2011-1#1)(2012-12#1)
compositionally##3##1##(1994-12#1)(2008-10#1)(2009-5#1)
compositions and##5##2##(1994-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-8#1)
compositions based on##3##3##(2008-10#1)(2008-5#2)
compositions by##2##2##(1991-4#1)(2012-2#1)
compositions for##3##2##(2008-10#2)(2013-1#1)
compositions have##2##2##(1996-2#1)(2008-5#1)
compositions in the##2##3##(2008-2#1)(2013-8#1)
compositions in##5##2##(2008-10#1)(2008-2#1)(2010-2#2)(2013-8#1)
compositions of the##7##3##(2008-10#4)(2008-3#1)(2010-4#1)(2012-1#1)
compositions of##27##2##(1990-5#1)(1990-7#1)(1990-9#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#1)(2010-4#1)(2011-10#1)(2012-1#1)
compositions to##3##2##(2008-11#1)(2012-2#2)
compositions were similar##2##3##(1993-8#1)(2008-10#1)
compositions were##4##2##(1993-8#1)(2008-10#2)(2008-5#1)
compositions##92##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#3)(2010-4#3)(2011-10#1)(2012-1#1)(2012-2#5)(2013-1#2)(2013-8#3)
compost amendments##2##2##(2008-10#2)
compost and##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
compost as##2##2##(2008-10#1)(2008-12#1)
compost in##2##2##(1995-11#1)(2008-10#1)
compost is##3##2##(1995-11#1)(2008-12#2)
compost mix##9##2##(2008-10#9)
compost samples##2##2##(2008-10#2)
compost tea##7##2##(2008-10#7)
compost to##2##2##(2008-10#2)
compost was##5##2##(2008-10#5)
compost water extract##3##3##(2008-10#3)
compost water##4##2##(2008-10#4)
compost##77##1##(1995-11#4)(2008-10#61)(2008-11#1)(2008-12#8)(2008-6#2)(2013-8#1)
compost-amended media##2##2##(2008-10#2)
compost-amended mix##2##2##(2008-10#2)
compost-amended potting mix##2##3##(2008-10#2)
compost-amended potting##3##2##(2008-10#3)
compost-amended##9##1##(2008-10#9)
composted cotton-gin trash##3##3##(2008-10#3)
composted pine bark##2##3##(2008-10#2)
composted swine##2##2##(2008-10#2)
composted##16##1##(2008-10#16)
composting##11##1##(1995-11#2)(2008-10#5)(2008-12#4)
composts that##2##2##(2008-10#2)
composts with##2##2##(2008-10#2)
composts##8##1##(1995-11#1)(2008-10#7)
compound (i##2##2##(2008-1#1)(2008-10#1)
compound 1##11##2##(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-6#1)(2012-2#5)
compound 2##3##2##(1997-7#2)(2008-8#1)
compound 48/80##5##2##(1992-3#4)(2008-10#1)
compound I of##2##3##(1994-6#2)
compound I##5##2##(1994-5#1)(1994-6#4)
compound action potential##3##3##(1990-7#1)(1992-3#1)(2008-9#1)
compound action##5##2##(1990-7#1)(1992-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
compound also##3##2##(1994-6#1)(1995-11#1)(2008-5#1)
compound analysis##2##2##(2008-10#2)
compound and used##2##3##(2008-10#2)
compound and##14##2##(1990-5#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#7)(2008-11#1)
compound are##4##2##(1995-2#1)(1996-2#1)(2008-10#1)(2008-4#1)
compound as##2##2##(1990-5#1)(2008-10#1)
compound at a##2##3##(2008-10#1)(2008-11#1)
compound at##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2012-8#1)
compound can be##2##3##(1991-5#1)(1992-6#1)
compound can##3##2##(1991-5#1)(1992-6#1)(2008-10#1)
compound chaetae##2##2##(2008-5#2)
compound content##2##2##(2008-10#1)(2008-11#1)
compound could##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
compound did not##2##3##(1991-11#1)(1994-6#1)
compound distribution##3##2##(2008-10#2)(2008-11#1)
compound exhibits a##2##3##(2008-10#1)(2008-11#1)
compound exhibits##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
compound eye##6##2##(2007-12#5)(2008-3#1)
compound eyes##2##2##(2007-12#2)
compound fertilizer##3##2##(2008-10#3)
compound for the##2##3##(2008-10#1)(2008-11#1)
compound for##9##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)
compound formation##3##2##(2008-10#2)(2010-12#1)
compound found in the##2##4##(2008-10#1)(2012-2#1)
compound found in##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
compound from##6##2##(1991-5#1)(1992-12#1)(1994-2#1)(2008-10#2)(2008-5#1)
compound had##2##2##(1992-8#1)(2008-10#1)
compound has been##4##3##(1990-8#1)(1992-12#1)(2008-10#1)(2008-2#1)
compound has##8##2##(1990-8#1)(1992-12#1)(2008-10#2)(2008-2#1)(2008-5#3)
compound have been##2##3##(2008-5#1)(2013-1#1)
compound have##3##2##(1995-5#1)(2008-5#1)(2013-1#1)
compound heterozygote##2##2##(2011-2#2)
compound in the##5##3##(1990-8#1)(2008-10#2)(2009-5#1)(2010-12#1)
compound in##21##2##(1990-8#1)(1994-3#1)(2008-10#10)(2008-11#2)(2008-5#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
compound involved##2##2##(2007-11#1)(2008-10#1)
compound is##19##2##(1992-11#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-6#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#4)(2010-11#1)(2013-1#1)
compound libraries##2##2##(2008-10#1)(2010-12#1)
compound library##2##2##(1997-3#1)(2013-1#1)
compound may##4##2##(1993-9#1)(1995-2#3)
compound microscope##2##2##(2008-3#2)
compound of a##2##3##(2008-3#1)(2008-5#1)
compound of the##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
compound of##11##2##(1990-5#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
compound on the##2##3##(1995-6#1)(2008-10#1)
compound on##3##2##(1995-6#1)(2008-1#1)(2008-10#1)
compound parabolic concentrator (CPC)##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
compound parabolic concentrator##6##3##(2008-2#2)(2008-3#1)(2013-8#3)
compound parabolic concentrators##2##3##(2007-12#1)(2008-3#1)
compound parabolic##8##2##(2007-12#1)(2008-2#2)(2008-3#2)(2013-8#3)
compound refractive lens was##2##4##(2007-11#2)
compound refractive lens##3##3##(2007-11#2)(2008-3#1)
compound refractive lenses##2##3##(2007-11#1)(2008-2#1)
compound refractive##5##2##(2007-11#3)(2008-2#1)(2008-3#1)
compound screening##2##2##(2013-1#2)
compound selectivity##2##2##(2008-10#2)
compound separately##2##2##(2008-10#2)
compound showed a##4##3##(1990-5#1)(1993-6#1)(1995-3#1)(2008-11#1)
compound showed##5##2##(1990-5#1)(1993-6#1)(1995-3#1)(2008-11#2)
compound stimulus##2##2##(1993-6#1)(2008-4#1)
compound studied##2##2##(1996-5#1)(2008-10#1)
compound that caused the##2##4##(2009-8#1)(2013-1#1)
compound that interferes with##2##4##(1997-6#1)(2008-10#1)
compound that is##3##3##(1996-2#1)(2008-5#1)(2008-8#1)
compound that was##2##3##(2008-2#1)(2012-2#1)
compound that##21##2##(1990-5#1)(1993-8#1)(1993-9#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-2#2)(2008-5#3)(2008-8#3)(2009-8#1)(2011-3#1)(2012-2#2)(2013-1#1)
compound to##11##2##(1991-12#1)(1993-1#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)
compound transgenic mice##2##3##(2013-1#2)
compound used for its determination##2##5##(1997-2#2)
compound used##3##2##(1997-2#2)(2008-10#1)
compound using##2##2##(2008-10#1)(2010-11#1)
compound was a very##2##4##(1990-7#1)(1991-8#1)
compound was a##4##3##(1990-7#1)(1991-8#2)(1995-3#1)
compound was shown##2##3##(1990-7#1)(1995-3#1)
compound was the##2##3##(2007-11#1)(2008-10#1)
compound was##29##2##(1990-7#2)(1991-8#2)(1992-12#1)(1995-3#2)(1996-2#1)(2007-1#1)(2007-11#1)(2008-10#13)(2008-11#2)(2009-6#1)(2010-11#1)(2011-1#1)(2012-2#1)
compound were investigated##2##3##(2008-10#1)(2013-1#1)
compound were##3##2##(2008-10#2)(2013-1#1)
compound when##2##2##(2008-10#1)(2008-6#1)
compound with a##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
compound with##16##2##(1990-7#1)(1993-6#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-5#1)(2009-4#1)(2011-1#1)
compound within##2##2##(2008-10#1)(2009-8#1)
compound##607##1##(1990-12#2)(1990-5#7)(1990-7#4)(1990-8#6)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#3)(1992-10#2)(1992-11#1)(1992-12#5)(1992-3#8)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#4)(1993-6#3)(1993-8#5)(1993-9#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#7)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#16)(1995-5#3)(1995-6#5)(1996-2#13)(1996-5#6)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#8)(1997-8#1)(2007-1#1)(2007-11#18)(2007-12#13)(2007-7#1)(2008-1#4)(2008-10#195)(2008-11#30)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#9)(2008-5#34)(2008-6#3)(2008-7#2)(2008-8#9)(2008-9#4)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#3)(2010-11#4)(2010-12#5)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#9)(2011-3#8)(2012-1#1)(2012-12#1)(2012-2#15)(2012-3#5)(2012-8#1)(2013-1#18)(2013-8#5)
compound's##3##1##(2008-10#2)(2008-5#1)
compound)##3##1##(2008-10#3)
compound-US pairings##2##2##(2008-5#2)
compound-specific##5##1##(2008-10#2)(2008-11#1)(2010-3#2)
compounded by##4##2##(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
compounded if##2##2##(2010-12#1)(2010-7#1)
compounded##10##1##(1994-2#1)(1995-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
compounding factors##2##2##(2008-5#1)(2009-4#1)
compounding##3##1##(2008-5#1)(2009-4#1)(2010-7#1)
compounds (CALUX TEQ values are##2##5##(2008-10#2)
compounds 1 and 2##3##4##(2008-10#1)(2008-11#2)
compounds 1 and##4##3##(2008-10#2)(2008-11#2)
compounds 1##6##2##(1994-2#1)(2008-10#2)(2008-11#2)(2010-6#1)
compounds 1-3##3##2##(2008-11#2)(2011-3#1)
compounds 2 and##2##3##(1995-3#1)(2007-11#1)
compounds 3 and##2##3##(1996-2#1)(2007-11#1)
compounds 3##3##2##(1996-2#1)(2007-11#1)(2008-11#1)
compounds accumulated at##2##3##(2008-10#2)
compounds adsorbed onto##2##3##(2008-10#1)(2008-11#1)
compounds against HIV-1##2##3##(1992-9#1)(2011-3#1)
compounds against##5##2##(1992-9#1)(2008-10#3)(2011-3#1)
compounds along##2##2##(2008-10#1)(2008-8#1)
compounds also showed##2##3##(1992-8#1)(2008-11#1)
compounds also##8##2##(1991-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
compounds and blood##2##3##(1990-8#1)(2007-10#1)
compounds and by##2##3##(1994-5#1)(1996-5#1)
compounds and the##8##3##(2008-10#5)(2010-2#1)(2011-1#1)(2012-12#1)
compounds and their##5##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
compounds and to##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
compounds and##80##2##(1990-7#2)(1990-8#1)(1990-9#1)(1994-3#1)(1994-5#2)(1995-12#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-10#43)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
compounds are present in##3##4##(1992-8#1)(2008-10#1)(2013-1#1)
compounds are reported##3##3##(2008-3#1)(2010-5#1)(2012-12#1)
compounds are useful for##2##4##(2008-4#2)
compounds are##60##2##(1990-7#1)(1990-8#1)(1991-9#1)(1992-11#2)(1992-8#2)(1993-11#1)(1994-2#1)(1996-2#2)(1996-5#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#24)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
compounds as well as##5##4##(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#2)
compounds as##27##2##(1993-12#1)(1993-8#1)(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
compounds at a##2##3##(2008-10#1)(2011-2#1)
compounds at##16##2##(1993-12#1)(1995-3#1)(2008-10#10)(2010-12#1)(2011-2#2)(2011-3#1)
compounds behave as##2##3##(1992-8#1)(1996-2#1)
compounds being##2##2##(2008-10#2)
compounds belonged to##2##3##(2008-10#1)(2012-2#1)
compounds between##2##2##(2008-10#1)(2008-8#1)
compounds bind##3##2##(1991-12#1)(1992-11#1)(2008-11#1)
compounds but##3##2##(2008-10#3)
compounds by capillary electrophoresis##3##4##(2008-10#3)
compounds by capillary##4##3##(1994-9#1)(2008-10#3)
compounds by means of##2##4##(2007-11#1)(2008-8#1)
compounds by the##2##3##(2008-10#2)
compounds by##30##2##(1990-10#1)(1990-8#2)(1994-9#1)(2007-11#1)(2008-10#22)(2008-8#1)(2010-5#1)(2013-1#1)
compounds can be##10##3##(1990-8#1)(1992-8#1)(2008-10#4)(2008-5#1)(2009-12#1)(2010-5#1)(2011-3#1)
compounds can##12##2##(1990-8#1)(1991-11#1)(1992-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-12#1)(2010-5#1)(2011-3#1)
compounds capable of##2##3##(2008-11#1)(2008-9#1)
compounds combined with##2##3##(2008-10#2)
compounds commonly##2##2##(2008-10#2)
compounds consist of##2##3##(1993-12#1)(1996-2#1)
compounds containing one##2##3##(1996-5#1)(2008-10#1)
compounds containing the##2##3##(1991-6#1)(2008-10#1)
compounds containing##8##2##(1991-6#1)(1996-5#1)(2007-11#1)(2008-10#4)(2010-5#1)
compounds could be##3##3##(2008-10#2)(2009-12#1)
compounds could##9##2##(2008-10#4)(2008-11#1)(2008-8#1)(2009-12#1)(2010-5#2)
compounds demonstrated##2##2##(1992-3#1)(1992-8#1)
compounds derived from##4##3##(1996-5#1)(2008-11#1)(2011-3#2)
compounds detected in##3##3##(2008-10#3)
compounds detected##5##2##(2008-10#4)(2011-2#1)
compounds directly into##2##3##(2008-10#2)
compounds displayed##2##2##(1992-11#1)(2012-2#1)
compounds do not##3##3##(1995-5#1)(2008-10#2)
compounds emitted by##3##3##(2008-10#1)(2009-8#1)(2011-10#1)
compounds except##4##2##(1994-8#1)(2007-11#1)(2008-10#2)
compounds exhibited##4##2##(1991-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
compounds extracted##2##2##(2008-10#2)
compounds for the##5##3##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
compounds for their##2##3##(1991-1#1)(1993-12#1)
compounds for##19##2##(1990-8#1)(1991-1#2)(1993-12#1)(1995-12#2)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-4#1)(2009-5#1)
compounds found in the##2##4##(2008-10#1)(2010-11#1)
compounds found in##4##3##(2008-10#2)(2010-11#1)(2011-2#1)
compounds found##6##2##(1997-2#1)(2008-10#3)(2010-11#1)(2011-2#1)
compounds from the##7##3##(2007-12#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-8#1)
compounds from their##2##3##(2007-11#1)(2008-10#1)
compounds from##39##2##(1995-6#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#20)(2008-11#4)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2013-1#1)
compounds gave##2##2##(1995-3#1)(2009-5#1)
compounds had a##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
compounds had##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
compounds has already been##2##4##(1991-12#1)(2008-10#1)
compounds has been##7##3##(1994-5#1)(2008-10#6)
compounds has##10##2##(1991-12#1)(1994-5#1)(2008-10#7)(2008-11#1)
compounds have also been##2##4##(1995-3#1)(2008-10#1)
compounds have also##3##3##(1995-3#1)(2008-10#1)(2012-3#1)
compounds have been##15##3##(1991-9#1)(2007-11#1)(2008-10#9)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
compounds have not##2##3##(1994-3#1)(2008-3#1)
compounds have##25##2##(1991-9#1)(1992-5#1)(1994-3#1)(1995-3#1)(2007-11#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#2)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
compounds having a##3##3##(1991-5#2)(2008-11#1)
compounds having the##2##3##(1992-12#1)(2008-11#1)
compounds having##8##2##(1991-5#2)(1992-12#1)(2008-10#2)(2008-11#2)(2008-5#1)
compounds identified##2##2##(2008-10#1)(2010-7#1)
compounds in a##4##3##(1990-9#1)(2007-11#1)(2008-10#2)
compounds in air##3##3##(2008-10#2)(2013-1#1)
compounds in an##2##3##(2008-10#1)(2010-12#1)
compounds in biological##2##3##(2008-10#2)
compounds in commercial##3##3##(2008-10#3)
compounds in complex##2##3##(2008-10#1)(2013-1#1)
compounds in cooked beef meat##2##5##(2008-10#2)
compounds in different##2##3##(2008-10#1)(2008-5#1)
compounds in each##2##3##(1990-8#1)(2008-10#1)
compounds in environmental##2##3##(2008-10#2)
compounds in human##3##3##(2008-10#2)(2008-8#1)
compounds in landfill##3##3##(2008-10#3)
compounds in mainstream##2##3##(2011-1#2)
compounds in order to##2##4##(1995-6#1)(2008-10#1)
compounds in samples containing##2##4##(2008-10#1)(2009-8#1)
compounds in samples##3##3##(2008-10#2)(2009-8#1)
compounds in synthetic##2##3##(2008-10#2)
compounds in the environment##3##4##(2008-10#2)(2010-5#1)
compounds in the##29##3##(1990-5#1)(1991-1#1)(1994-5#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-5#1)(2008-6#1)(2009-5#1)(2010-5#1)
compounds in their##3##3##(2008-10#2)(2008-5#1)
compounds in this series##2##4##(1995-3#2)
compounds in wastewater from##2##4##(2008-10#2)
compounds in wastewater##3##3##(2008-10#3)
compounds in water and##2##4##(2008-10#2)
compounds in water samples##3##4##(2008-10#3)
compounds in water with a##2##5##(2008-10#2)
compounds in water##8##3##(2008-10#8)
compounds in##177##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#1)(2008-10#111)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2012-8#3)(2013-1#4)
compounds including##7##2##(2008-10#5)(2008-11#1)(2008-4#1)
compounds into##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
compounds investigated##4##2##(2008-10#3)(2008-11#1)
compounds is also##2##3##(2008-10#1)(2013-1#1)
compounds is of great##2##4##(2008-10#2)
compounds is of##3##3##(2008-10#3)
compounds is reported##2##3##(2008-10#2)
compounds is##24##2##(1990-8#1)(1991-9#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-4#1)(2008-6#2)(2008-7#1)(2010-12#1)(2013-1#3)
compounds known##2##2##(1994-8#1)(2008-5#1)
compounds like##3##2##(1994-9#1)(2009-8#1)(2011-1#1)
compounds made##2##2##(2008-10#2)
compounds may also##2##3##(1993-2#1)(1997-4#1)
compounds may##8##2##(1991-5#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-5#1)
compounds normally##2##2##(2008-10#2)
compounds obtained from the##2##4##(2008-10#1)(2013-7#1)
compounds obtained##5##2##(2007-11#1)(2008-10#2)(2008-6#1)(2013-7#1)
compounds of biomedical interest##2##4##(1990-8#2)
compounds of interest##3##3##(1991-5#1)(2008-10#2)
compounds of the##4##3##(1994-8#1)(2008-10#1)(2008-12#1)(2010-2#1)
compounds of two commercial Irish beef meats##2##7##(2008-10#2)
compounds of which##2##3##(2008-10#1)(2011-2#1)
compounds of wine##2##3##(2008-10#2)
compounds of##33##2##(1990-8#2)(1991-5#2)(1992-5#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)
compounds on the##11##3##(1991-1#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-11#1)
compounds on##24##2##(1990-11#1)(1991-1#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-10#10)(2008-11#4)(2013-1#1)
compounds or##8##2##(1991-6#1)(2008-10#6)(2011-1#1)
compounds over##2##2##(2008-10#1)(2013-1#1)
compounds possess##5##2##(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-3#1)
compounds prepared##2##2##(1997-3#1)(2007-11#1)
compounds present in the##6##4##(1993-11#1)(2008-10#5)
compounds present in##13##3##(1993-11#1)(2008-10#11)(2013-1#1)
compounds present##14##2##(1993-11#1)(2008-10#12)(2013-1#1)
compounds prior to##2##3##(2008-10#2)
compounds produced a##2##3##(1991-2#1)(1997-4#1)
compounds produced by##2##3##(2008-5#1)(2008-6#1)
compounds produced in##2##3##(2008-10#2)
compounds produced##7##2##(1991-2#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)
compounds range from##2##3##(2008-10#1)(2008-11#1)
compounds reacted with##2##3##(1995-6#1)(2013-1#1)
compounds responsible for the discolouration and##2##6##(2008-10#2)
compounds responsible for the discolouration##3##5##(2008-10#3)
compounds seemed to##2##3##(2008-10#1)(2008-7#1)
compounds should be##3##3##(1992-6#1)(2008-10#2)
compounds show##4##2##(1997-7#1)(2008-5#1)(2008-8#1)(2011-3#1)
compounds showed an##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
compounds showed##16##2##(1992-12#1)(1992-8#1)(1995-3#2)(2007-11#2)(2008-10#3)(2008-11#3)(2009-12#1)(2010-5#1)(2011-1#1)(2012-2#1)
compounds spiked##2##2##(2008-10#1)(2011-2#1)
compounds studied were##2##3##(2008-10#2)
compounds studied##9##2##(1994-5#1)(1994-8#1)(2008-10#6)(2011-1#1)
compounds such as##18##3##(1991-12#1)(1992-9#1)(1994-11#2)(2008-10#12)(2008-5#1)(2008-8#1)
compounds synthesized##2##2##(2007-11#1)(2008-5#1)
compounds tested##10##2##(1990-12#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-4#1)(2009-8#1)
compounds than##2##2##(2008-10#2)
compounds that are##6##3##(1992-11#1)(1993-11#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)
compounds that bind to##2##4##(1995-12#1)(1995-5#1)
compounds that have been used as##2##6##(2008-10#1)(2010-4#1)
compounds that have been##3##4##(1997-6#1)(2008-10#1)(2010-4#1)
compounds that have##6##3##(1997-6#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-4#1)
compounds that inhibit##3##3##(2008-10#3)
compounds that may##4##3##(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)
compounds that were##3##3##(2008-10#3)
compounds that##45##2##(1992-11#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#19)(2008-12#1)(2008-4#2)(2008-5#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#4)
compounds the##2##2##(2008-10#1)(2008-5#1)
compounds to inhibit##2##3##(1995-12#1)(2008-11#1)
compounds to##25##2##(1992-8#2)(1993-11#2)(1994-2#1)(1995-12#1)(1995-8#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#1)
compounds under##2##2##(2007-11#1)(2008-10#1)
compounds used##3##2##(2008-10#2)(2008-5#1)
compounds using the inside needle capillary adsorption trap##2##8##(2008-10#2)
compounds using the##4##3##(2008-10#4)
compounds using##8##2##(1994-9#1)(2008-10#7)
compounds via##2##2##(2007-11#1)(2011-1#1)
compounds was affected##2##3##(1990-8#1)(2008-10#1)
compounds was determined##3##3##(2008-10#2)(2012-2#1)
compounds was observed##3##3##(2008-10#2)(2008-11#1)
compounds was performed##3##3##(2008-10#2)(2008-4#1)
compounds was tested##2##3##(2008-10#2)
compounds was##39##2##(1990-8#1)(1991-2#1)(1993-11#2)(1995-2#1)(1995-3#2)(2007-11#1)(2008-10#23)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
compounds were also##6##3##(1992-9#1)(1997-3#1)(2008-10#3)(2008-8#1)
compounds were characterized##2##3##(1996-2#1)(2010-3#1)
compounds were compared with##2##4##(1992-10#1)(2008-11#1)
compounds were confirmed##2##3##(2007-11#1)(2009-10#1)
compounds were designed and synthesized##2##5##(2008-11#1)(2011-3#1)
compounds were detected by##2##4##(2008-10#2)
compounds were detected in##3##4##(2007-5#1)(2008-10#2)
compounds were detected##5##3##(2007-5#1)(2008-10#4)
compounds were determined by##2##4##(2008-5#1)(2009-8#1)
compounds were determined in##2##4##(2008-10#2)
compounds were determined##5##3##(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
compounds were established by##2##4##(2007-11#1)(2008-11#1)
compounds were established##3##3##(2007-11#2)(2008-11#1)
compounds were evaluated for##3##4##(1991-11#1)(2008-7#1)(2011-1#1)
compounds were evaluated in##2##4##(1995-3#1)(2010-5#1)
compounds were evaluated##8##3##(1991-11#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)
compounds were examined##2##3##(2008-10#1)(2009-4#1)
compounds were extracted from##3##4##(2008-10#3)
compounds were extracted##4##3##(2008-10#4)
compounds were formed by##2##4##(1991-5#1)(2007-11#1)
compounds were formed##3##3##(1991-5#1)(1994-9#1)(2007-11#1)
compounds were found to be##4##5##(1990-2#1)(1995-3#1)(2008-10#1)(2008-5#1)
compounds were found to##6##4##(1990-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2011-3#1)(2012-2#1)
compounds were identified##2##3##(2008-10#1)(2009-6#1)
compounds were in the##2##4##(1990-5#1)(2008-10#1)
compounds were investigated##2##3##(2008-10#1)(2011-2#1)
compounds were isolated and purified from##2##6##(2008-10#1)(2008-12#1)
compounds were isolated by##2##4##(2008-10#1)(2008-11#1)
compounds were isolated from##3##4##(2008-10#3)
compounds were isolated##9##3##(2008-10#7)(2008-11#1)(2008-12#1)
compounds were measured##3##3##(1993-1#1)(2008-11#2)
compounds were prepared##2##3##(1995-3#1)(2007-11#1)
compounds were present at##2##4##(2008-10#1)(2011-3#1)
compounds were screened##4##3##(2010-5#2)(2011-3#2)
compounds were separated##3##3##(2008-10#3)
compounds were studied##3##3##(1996-5#1)(2008-10#2)
compounds were tested as##2##4##(1994-11#1)(1995-3#1)
compounds were tested for##4##4##(2008-11#1)(2008-4#1)(2008-5#1)(2011-3#1)
compounds were tested##7##3##(1994-11#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-3#1)
compounds were then##2##3##(2008-10#1)(2008-5#1)
compounds were used##2##3##(1995-6#1)(2008-10#1)
compounds were##142##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-5#2)(1992-10#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#5)(1995-6#2)(1996-2#2)(1996-5#1)(1997-3#1)(2007-11#8)(2007-5#1)(2008-10#53)(2008-11#11)(2008-12#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#4)(2011-3#7)(2012-1#1)(2012-2#1)(2013-1#2)
compounds when##2##2##(2008-10#1)(2009-8#1)
compounds which are in##2##4##(2008-10#1)(2008-5#1)
compounds which are##6##3##(1991-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
compounds which##19##2##(1991-12#1)(1991-2#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(2008-10#4)(2008-5#2)(2010-3#1)(2011-2#1)(2012-2#1)
compounds whose##3##2##(1991-5#1)(2008-10#1)(2011-3#1)
compounds widely##2##2##(2008-10#1)(2013-8#1)
compounds with a##4##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
compounds with affinity for##2##4##(2008-10#2)
compounds with affinity##3##3##(2008-10#3)
compounds with anti-inflammatory##2##3##(2008-10#2)
compounds with different structures##2##4##(2008-10#1)(2008-5#1)
compounds with different##5##3##(1993-12#1)(1995-11#1)(2008-10#2)(2008-5#1)
compounds with high##3##3##(2008-11#2)(2008-5#1)
compounds with##59##2##(1991-5#2)(1992-11#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#4)(2008-5#5)(2008-7#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#4)(2012-3#1)(2012-8#1)
compounds within the##2##3##(2008-10#1)(2008-5#1)
compounds within##4##2##(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
compounds without##3##2##(1997-4#1)(2008-10#2)
compounds##1913##1##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#1)(1990-5#5)(1990-7#6)(1990-8#16)(1990-9#3)(1991-1#6)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#16)(1991-6#7)(1991-9#6)(1992-10#1)(1992-11#11)(1992-12#7)(1992-2#3)(1992-3#8)(1992-5#5)(1992-6#3)(1992-8#20)(1992-9#7)(1993-1#1)(1993-11#9)(1993-12#9)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#4)(1994-11#15)(1994-12#2)(1994-2#4)(1994-3#9)(1994-5#15)(1994-6#2)(1994-8#14)(1994-9#7)(1995-11#6)(1995-12#7)(1995-2#2)(1995-3#27)(1995-5#5)(1995-6#12)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#14)(1996-5#17)(1997-2#2)(1997-3#4)(1997-4#16)(1997-6#1)(1997-7#9)(1997-8#1)(2006-12#1)(2006-6#3)(2007-1#1)(2007-10#2)(2007-11#50)(2007-12#8)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#900)(2008-11#97)(2008-12#7)(2008-2#6)(2008-3#12)(2008-4#25)(2008-5#60)(2008-6#11)(2008-7#13)(2008-8#21)(2008-9#7)(2009-10#5)(2009-11#1)(2009-12#7)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#15)(2009-9#1)(2010-10#2)(2010-11#9)(2010-12#8)(2010-2#8)(2010-3#8)(2010-4#3)(2010-5#16)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#31)(2011-10#3)(2011-2#39)(2011-3#30)(2012-1#5)(2012-12#8)(2012-2#16)(2012-3#13)(2012-8#5)(2013-1#35)(2013-7#4)(2013-8#5)
compounds)##9##1##(2008-10#7)(2008-11#1)(2010-5#1)
compounds]##2##1##(1997-3#1)(2011-3#1)
comprehend the##5##2##(2008-12#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)
comprehend##7##1##(1996-3#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)(2011-1#1)
comprehended##3##1##(1993-1#1)(2009-4#1)(2012-3#1)
comprehenders##3##1##(2013-1#3)
comprehension and that##2##3##(2007-12#1)(2012-3#1)
comprehension and##9##2##(1997-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-9#4)(2012-3#1)
comprehension of its##2##3##(2009-8#1)(2013-1#1)
comprehension of quality indicators##2##4##(1997-3#2)
comprehension of the##5##3##(1992-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
comprehension of their##2##3##(1994-11#1)(2008-7#1)
comprehension of##17##2##(1992-12#1)(1994-11#1)(1995-12#1)(1997-3#3)(2007-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
comprehension processes##3##2##(2012-3#3)
comprehension##58##1##(1992-12#1)(1994-11#1)(1995-12#1)(1997-3#7)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#7)(2010-7#2)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#5)(2013-1#6)
comprehensive analysis of the##4##4##(1990-5#1)(1996-8#1)(1997-6#1)(2011-2#1)
comprehensive analysis of##11##3##(1990-5#1)(1992-1#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-12#1)
comprehensive analysis##12##2##(1990-5#1)(1992-1#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
comprehensive and effective##2##3##(1995-12#1)(2013-1#1)
comprehensive and##14##2##(1994-2#1)(1995-12#1)(1995-2#1)(2007-5#2)(2008-10#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
comprehensive approach to##5##3##(1992-12#1)(1993-1#1)(1994-2#1)(2008-7#1)(2011-2#1)
comprehensive approach##10##2##(1992-12#1)(1993-1#1)(1994-2#1)(1995-12#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
comprehensive assessment and##2##3##(1994-1#1)(2009-9#1)
comprehensive assessment of the##2##4##(1994-2#1)(2009-10#1)
comprehensive assessment of##6##3##(1994-2#1)(2009-10#2)(2010-12#1)(2011-2#2)
comprehensive assessment##10##2##(1994-1#1)(1994-2#1)(2008-6#1)(2009-10#2)(2009-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
comprehensive assessments of##2##3##(2009-5#1)(2013-8#1)
comprehensive audit##2##2##(1992-1#1)(1994-2#1)
comprehensive auditing##2##2##(1992-1#1)(1994-12#1)
comprehensive breast cancer screening services##2##5##(1996-2#2)
comprehensive care and##2##3##(2008-7#1)(2012-3#1)
comprehensive care for##2##3##(1992-3#1)(1994-2#1)
comprehensive care of##2##3##(2007-12#1)(2007-5#1)
comprehensive care##11##2##(1992-3#1)(1994-2#1)(1996-1#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-3#2)
comprehensive characterization of##2##3##(2012-2#1)(2013-8#1)
comprehensive clinical##5##2##(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2013-1#1)
comprehensive community support systems##2##4##(1995-1#2)
comprehensive community##3##2##(1995-1#2)(2008-1#1)
comprehensive computerized system##2##3##(2013-1#2)
comprehensive control measures##2##3##(2012-3#2)
comprehensive control##4##2##(2012-3#4)
comprehensive data##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
comprehensive effort##2##2##(1994-1#1)(2008-4#1)
comprehensive evaluation of the##2##4##(2010-7#1)(2013-1#1)
comprehensive evaluation of##6##3##(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
comprehensive evaluation##8##2##(2007-12#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#2)
comprehensive examination of##2##3##(1996-2#1)(2010-6#1)
comprehensive explanation of##2##3##(2008-11#1)(2013-8#1)
comprehensive health care reform##3##4##(1994-12#1)(1994-8#1)(1996-1#1)
comprehensive health##8##2##(1994-1#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)
comprehensive human linkage map##2##4##(1994-9#2)
comprehensive implementation##2##2##(1997-2#1)(2010-5#1)
comprehensive information on##2##3##(1991-12#1)(2008-3#1)
comprehensive information##4##2##(1991-12#1)(1993-2#1)(2008-1#1)(2008-3#1)
comprehensive investigation of##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
comprehensive list of##4##3##(1995-1#1)(2008-4#1)(2008-9#1)(2010-2#1)
comprehensive marketing##2##2##(1993-12#1)(2008-12#1)
comprehensive medical##4##2##(1993-3#1)(2007-5#1)(2008-7#1)(2009-3#1)
comprehensive model of##4##3##(2008-3#1)(2009-8#1)(2010-5#1)(2010-8#1)
comprehensive model##10##2##(1992-9#2)(1994-2#1)(1997-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2013-1#1)
comprehensive overview##11##2##(1992-12#1)(1992-3#2)(1993-12#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
comprehensive program##2##2##(1996-3#1)(2013-1#1)
comprehensive programs##2##2##(1994-2#1)(2013-1#1)
comprehensive public health##2##3##(1997-1#2)
comprehensive reform##3##2##(1994-8#1)(1995-3#1)(1996-12#1)
comprehensive research##2##2##(1997-1#1)(2012-3#1)
comprehensive review of the literature##6##5##(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)
comprehensive review of the##8##4##(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
comprehensive review of##13##3##(1995-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#3)
comprehensive review##23##2##(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#3)(2008-8#2)(2010-2#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-1#3)
comprehensive school reintegration##2##3##(1993-1#2)
comprehensive school##3##2##(1993-1#2)(2009-9#1)
comprehensive screening##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2012-12#1)
comprehensive search##5##2##(2009-11#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
comprehensive sequence##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
comprehensive studies##2##2##(1995-1#1)(2008-1#1)
comprehensive study of the##3##4##(2008-10#1)(2008-3#1)(2009-3#1)
comprehensive study of##4##3##(2008-10#2)(2008-3#1)(2009-3#1)
comprehensive study##6##2##(1997-1#1)(2008-10#2)(2008-3#1)(2009-3#1)(2013-1#1)
comprehensive theory##3##2##(1994-2#1)(1997-6#1)(2009-8#1)
comprehensive treatment##3##2##(2007-11#1)(2008-3#1)(2012-3#1)
comprehensive two-dimensional gas##2##3##(2008-10#2)
comprehensive two-dimensional##3##2##(2008-10#3)
comprehensive understanding of the##4##4##(2007-12#1)(2011-2#1)(2012-3#2)
comprehensive understanding of##6##3##(2007-12#1)(2009-2#1)(2011-2#1)(2012-3#2)(2013-1#1)
comprehensive way##2##2##(1994-1#1)(1995-5#1)
comprehensive##421##1##(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#3)(1992-9#2)(1993-1#6)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#8)(1994-12#4)(1994-2#12)(1994-3#5)(1994-8#2)(1994-9#4)(1995-1#6)(1995-12#6)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#4)(1996-12#3)(1996-2#6)(1996-3#5)(1996-5#1)(1996-8#2)(1997-1#7)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#5)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-5#4)(2007-8#2)(2008-1#6)(2008-10#27)(2008-11#11)(2008-12#7)(2008-2#3)(2008-3#16)(2008-4#14)(2008-5#6)(2008-6#4)(2008-7#21)(2008-8#6)(2008-9#9)(2009-10#4)(2009-11#2)(2009-2#1)(2009-3#3)(2009-5#3)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#12)(2013-1#23)(2013-8#6)
comprehensively assess the##2##3##(2008-10#1)(2012-3#1)
comprehensively assess##3##2##(2008-10#2)(2012-3#1)
comprehensively review##2##2##(2008-6#1)(2008-7#1)
comprehensively studied##2##2##(1993-2#1)(2008-10#1)
comprehensively##24##1##(1993-2#1)(1996-12#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-3#2)(2008-6#4)(2008-7#2)(2008-8#2)(2009-5#1)(2010-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
comprehensiveness of information##2##3##(2008-12#1)(2011-1#1)
comprehensiveness of##6##2##(2008-12#2)(2011-1#4)
comprehensiveness##9##1##(2008-12#4)(2008-7#1)(2011-1#4)
compress the##4##2##(2007-11#1)(2007-12#2)(2013-1#1)
compress##6##1##(2007-11#1)(2007-12#2)(2008-10#1)(2011-2#1)(2013-1#1)
compressa##4##1##(2008-9#1)(2011-2#3)
compressed air##3##2##(1991-12#1)(1996-3#2)
compressed and##2##2##(1992-7#1)(2008-11#1)
compressed because##2##2##(1992-12#2)
compressed pulses##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
compressed to##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2012-2#1)
compressed##41##1##(1991-12#1)(1991-3#1)(1992-12#2)(1992-7#2)(1996-12#1)(1996-3#2)(2007-11#7)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
compresses##3##1##(2011-2#2)(2013-1#1)
compressibility d(ln##2##2##(1991-5#2)
compressibility##10##1##(1991-5#3)(2008-10#4)(2008-7#1)(2010-5#2)
compressible to a##2##3##(2007-11#1)(2008-2#1)
compressible##7##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-5#2)
compressing the##10##2##(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#3)(2013-8#1)
compressing##12##1##(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
compression algorithm##4##2##(2008-3#1)(2013-8#3)
compression and the##2##3##(2008-10#1)(2013-8#1)
compression and##23##2##(1990-3#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#2)(2009-7#1)(2010-7#1)(2013-1#1)(2013-8#2)
compression arithmetic##2##2##(2012-3#2)
compression at the level of##2##5##(1994-7#1)(2012-12#1)
compression at the##3##3##(1994-7#1)(2011-2#1)(2012-12#1)
compression at##4##2##(1994-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
compression by an##2##3##(2008-9#1)(2012-3#1)
compression by the##3##3##(1993-3#1)(2008-2#1)(2008-7#1)
compression by##14##2##(1993-3#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2012-3#1)(2013-1#3)
compression can##2##2##(1991-9#1)(2006-12#1)
compression effect##3##2##(2013-8#3)
compression fractures##9##2##(2007-8#2)(2008-7#6)(2008-8#1)
compression from##3##2##(2007-11#1)(2007-12#1)(2009-1#1)
compression in patients with##3##4##(1996-9#2)(2007-11#1)
compression in the##3##3##(1992-12#1)(2007-11#1)(2008-9#1)
compression in##16##2##(1992-12#1)(1996-6#1)(1996-9#2)(2007-11#5)(2007-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2012-2#1)
compression injury##2##2##(1993-12#1)(2008-2#1)
compression is##9##2##(1996-9#1)(2007-11#2)(2008-2#2)(2008-3#1)(2010-1#1)(2010-4#1)(2010-7#1)
compression isotherms of##2##3##(1994-3#1)(2008-10#1)
compression may be##2##3##(1992-6#1)(2008-3#1)
compression may##5##2##(1992-6#1)(1994-9#1)(2007-8#1)(2008-3#1)(2011-2#1)
compression modulation##2##2##(2007-12#2)
compression neuropathy##3##2##(2008-12#1)(2008-9#1)(2009-5#1)
compression occurred##2##2##(2007-11#1)(2008-3#1)
compression of a##2##3##(2007-11#1)(2007-12#1)
compression of pulmonary tissue and mediastinal shift##2##7##(2007-12#2)
compression of pulses##2##3##(2007-11#1)(2007-12#1)
compression of the recurrent motor branch##2##6##(2008-9#2)
compression of the trigeminal##2##4##(2008-7#1)(2011-2#1)
compression of the##25##3##(1992-12#1)(1992-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#4)(2009-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
compression of##49##2##(1992-12#1)(1992-9#1)(2007-11#6)(2007-12#6)(2007-8#4)(2008-10#3)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#2)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
compression or##3##2##(2007-11#1)(2010-10#1)(2011-2#1)
compression pressure revealed the##2##4##(2010-5#2)
compression ratio##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
compression ratios##3##2##(2007-11#1)(2008-3#2)
compression scheme is##2##3##(2008-3#2)
compression suture##2##2##(2011-2#2)
compression symptoms##5##2##(1991-5#1)(1992-6#1)(2007-11#3)
compression tests##2##2##(2009-7#1)(2013-1#1)
compression therapy##3##2##(2008-7#3)
compression to##4##2##(2007-11#2)(2008-6#1)(2010-4#1)
compression using##2##2##(2010-8#1)(2013-1#1)
compression was##2##2##(2009-4#1)(2012-3#1)
compression were##2##2##(2008-3#1)(2012-3#1)
compression with##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
compression##315##1##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#6)(1992-6#4)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-11#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-9#6)(1997-8#1)(2006-12#3)(2007-11#40)(2007-12#18)(2007-5#1)(2007-8#11)(2008-1#1)(2008-10#9)(2008-12#4)(2008-2#18)(2008-3#27)(2008-4#1)(2008-5#1)(2008-6#11)(2008-7#23)(2008-8#2)(2008-9#14)(2009-1#1)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#7)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#14)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#10)(2013-1#10)(2013-8#12)
compression)##2##1##(2008-7#1)(2010-1#1)
compression]##2##1##(1991-11#1)(1996-9#1)
compressions and epinephrine##3##3##(2012-2#3)
compressions##8##1##(1991-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#3)
compressive Young's##2##2##(2009-7#2)
compressive and##2##2##(2009-7#1)(2011-3#1)
compressive dressing##2##2##(1992-6#2)
compressive strength##2##2##(2008-11#1)(2012-2#1)
compressive stress##3##2##(2007-11#1)(2008-3#1)(2009-7#1)
compressive##27##1##(1991-11#1)(1992-6#2)(1994-11#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#6)(2010-4#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
compressor and##2##2##(2008-2#1)(2008-3#1)
compressor of a##2##3##(2007-11#1)(2008-2#1)
compressor##19##1##(1995-3#1)(2007-11#5)(2007-12#4)(2008-2#6)(2008-3#2)(2012-3#1)
compressors##2##1##(2007-12#1)(2008-3#1)
comprise 4% of##2##3##(1993-12#1)(2013-1#1)
comprise a family of##2##4##(1995-12#1)(2008-10#1)
comprise a heterogeneous##2##3##(1995-11#1)(2008-6#1)
comprise a##14##2##(1991-7#1)(1992-8#1)(1993-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
comprise approximately##2##2##(2008-7#1)(2013-7#1)
comprise both##3##2##(1994-12#1)(2008-2#1)(2011-1#1)
comprise only##2##2##(1995-11#1)(1996-12#1)
comprise the process of##2##4##(1993-12#1)(2011-2#1)
comprise the##14##2##(1991-6#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-6#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
comprise##77##1##(1990-2#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#3)(1995-12#3)(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
comprised 10##2##2##(2008-10#1)(2008-7#1)
comprised 11##2##2##(2008-10#1)(2011-2#1)
comprised 8##4##2##(1991-9#1)(2008-3#1)(2008-7#1)(2010-3#1)
comprised a set of three-way solenoid valves##2##7##(2008-10#2)
comprised a##12##2##(1996-5#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
comprised all##2##2##(2008-10#1)(2008-11#1)
comprised between##6##2##(2007-12#1)(2008-10#4)(2013-7#1)
comprised four##4##2##(2008-10#1)(2008-6#2)(2010-10#1)
comprised in##2##2##(2008-11#1)(2009-12#1)
comprised negative##2##2##(2013-1#2)
comprised of a##12##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
comprised of an##2##3##(2008-9#1)(2010-2#1)
comprised of at least##2##4##(1990-8#1)(2008-10#1)
comprised of either##2##3##(2008-10#1)(2013-8#1)
comprised of one##2##3##(1991-8#1)(2008-11#1)
comprised of the##3##3##(1995-5#1)(2008-10#1)(2013-8#1)
comprised of two##3##3##(1997-4#1)(2008-11#1)(2008-9#1)
comprised of various##2##3##(2008-10#1)(2011-1#1)
comprised of##69##2##(1990-12#1)(1990-8#2)(1991-8#1)(1992-4#1)(1993-12#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#4)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
comprised six##3##2##(2008-10#2)(2008-6#1)
comprised the##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
comprised three##2##2##(2008-10#1)(2012-6#1)
comprised##169##1##(1990-12#1)(1990-8#2)(1991-12#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-9#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#40)(2008-11#8)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#8)(2013-7#2)(2013-8#7)
comprises 14##2##2##(2008-2#1)(2012-2#1)
comprises 4##2##2##(2011-2#1)(2012-12#1)
comprises a pair of##2##4##(2007-11#2)
comprises a##19##2##(2007-11#2)(2007-12#5)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#2)
comprises an##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
comprises many##2##2##(2008-10#1)(2012-2#1)
comprises of##4##2##(1997-8#1)(2008-10#2)(2009-9#1)
comprises several##4##2##(2008-11#1)(2008-5#1)(2010-8#1)(2012-3#1)
comprises the##12##2##(1990-2#1)(1990-7#1)(1991-2#1)(1992-4#1)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-3#1)
comprises three##2##2##(2009-8#1)(2010-10#1)
comprises two##6##2##(1994-12#2)(1996-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
comprises##103##1##(1990-2#1)(1990-7#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-8#2)(2007-11#3)(2007-12#7)(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
comprising 1##2##2##(1990-6#1)(1991-6#1)
comprising 11##3##2##(1995-3#1)(2008-10#1)(2010-8#1)
comprising 12##2##2##(2008-10#1)(2011-1#1)
comprising 14##2##2##(1997-3#1)(2012-2#1)
comprising 99##2##2##(2008-10#1)(2012-3#1)
comprising a total of##2##4##(1994-12#1)(2007-12#1)
comprising a##20##2##(1994-12#1)(1995-12#1)(1996-11#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#2)(2011-2#1)(2012-1#1)(2012-3#1)
comprising an##2##2##(1995-2#1)(2008-10#1)
comprising both##2##2##(1997-7#1)(2008-5#1)
comprising isolates##2##2##(2008-10#2)
comprising of##7##2##(2008-10#1)(2008-7#1)(2009-12#1)(2010-10#2)(2010-6#1)(2013-1#1)
comprising the##20##2##(1990-5#3)(1990-8#1)(1991-2#1)(1995-12#1)(1995-2#2)(1996-10#1)(2008-1#1)(2008-10#4)(2008-7#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
comprising two##5##2##(1997-8#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-8#1)
comprising##150##1##(1990-5#3)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#3)(1992-4#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#5)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
compromise between the##3##3##(2008-10#2)(2008-3#1)
compromise between##8##2##(1995-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2011-2#1)
compromise in##5##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
compromise of##6##2##(1997-7#1)(2007-8#1)(2008-10#2)(2009-7#1)(2012-2#1)
compromise on##2##2##(2008-11#1)(2009-9#1)
compromise the accuracy of the##2##5##(2008-3#2)
compromise the##15##2##(1996-12#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#3)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-8#1)
compromise their##2##2##(1997-5#1)(2008-11#1)
compromise was##2##2##(2008-12#1)(2012-2#1)
compromise with##2##2##(1993-12#1)(2009-5#1)
compromise##91##1##(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#1)(1993-12#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#8)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#5)(2012-8#1)(2013-1#3)(2013-8#5)
compromised because##2##2##(2008-10#1)(2013-1#1)
compromised by the##6##3##(1997-4#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
compromised by##13##2##(1993-1#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#1)
compromised cells##3##2##(2008-7#2)(2008-9#1)
compromised in##9##2##(1995-5#1)(1996-7#1)(2008-1#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
compromised patients##6##2##(1993-1#3)(2006-10#1)(2008-12#1)(2012-3#1)
compromised##78##1##(1990-3#1)(1993-1#5)(1993-10#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-3#2)(2010-4#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#2)
compromises the##2##2##(1993-11#1)(2010-4#1)
compromises##6##1##(1993-11#1)(1996-3#1)(2008-1#1)(2010-3#1)(2010-4#1)(2013-1#1)
compromising the##12##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
compromising##22##1##(1992-2#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
compulsion##3##1##(1996-5#1)(2009-11#2)
compulsive disorder##4##2##(2009-9#2)(2012-2#2)
compulsive disorders##3##2##(1997-6#1)(2008-3#2)
compulsive##14##1##(1993-6#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-3#3)(2009-7#2)(2009-9#2)(2010-4#1)(2012-2#2)
compulsory health insurance##2##3##(1994-2#1)(2013-8#1)
compulsory treatment of allegedly mentally disordered persons within the community##2##10##(1994-1#2)
compulsory##14##1##(1991-6#1)(1992-11#1)(1992-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1996-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
computation and##3##2##(2008-3#2)(2008-6#1)
computation has##2##2##(2008-11#2)
computation in##2##2##(2008-2#1)(2008-3#1)
computation is##2##2##(2008-2#2)
computation of the##12##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#5)
computation of##30##2##(1997-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#1)(2008-8#1)(2011-2#1)
computation results##2##2##(2008-2#1)(2008-3#1)
computation rules involved##2##3##(2008-2#1)(2008-3#1)
computation speed##2##2##(2008-3#1)(2013-8#1)
computation time and##2##3##(2008-2#2)
computation time by a factor of##2##6##(2008-3#1)(2012-2#1)
computation time##10##2##(2008-2#2)(2008-3#5)(2009-5#1)(2011-1#1)(2012-2#1)
computation times##2##2##(2007-11#1)(2008-3#1)
computation to##2##2##(2008-3#2)
computation##101##1##(1990-11#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#16)(2008-3#43)(2008-4#2)(2008-6#2)(2008-8#1)(2009-11#1)(2009-12#2)(2009-5#3)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
computational analysis##3##2##(2008-12#1)(2012-2#2)
computational and##6##2##(1992-9#1)(2008-3#1)(2008-7#2)(2009-10#1)(2012-2#1)
computational approach##2##2##(2008-7#1)(2012-2#1)
computational approaches have been developed##2##5##(2011-2#1)(2011-3#1)
computational approaches to##2##3##(2008-7#2)
computational approaches##5##2##(2008-11#1)(2008-7#2)(2011-2#1)(2011-3#1)
computational biology##2##2##(2008-7#1)(2013-8#1)
computational burden##3##2##(2008-2#1)(2009-9#2)
computational challenges##2##2##(2009-4#1)(2009-5#1)
computational chemistry##2##2##(2008-10#1)(2011-2#1)
computational complexity of##2##3##(2008-3#1)(2012-2#1)
computational complexity##7##2##(2007-11#1)(2008-2#2)(2008-3#2)(2009-9#1)(2012-2#1)
computational cost##5##2##(2008-3#1)(2008-6#2)(2009-11#1)(2009-12#1)
computational demands##2##2##(2007-9#1)(2011-1#1)
computational domain##4##2##(2008-3#1)(2008-7#3)
computational efficiency##6##2##(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)
computational effort##5##2##(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
computational fluid dynamic simulation##2##4##(2008-11#1)(2008-3#1)
computational fluid dynamic##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
computational fluid dynamics (CFD)##2##4##(2008-11#1)(2008-6#1)
computational fluid dynamics##6##3##(1996-12#1)(2007-8#1)(2008-11#2)(2008-6#1)(2010-4#1)
computational fluid##9##2##(1996-12#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#1)
computational method of##2##3##(2008-3#1)(2010-10#1)
computational method##4##2##(2008-3#2)(2010-10#1)(2010-2#1)
computational methods##7##2##(1992-9#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-12#2)
computational model for##2##3##(2009-9#1)(2010-7#1)
computational model of the##2##4##(2008-11#1)(2013-1#1)
computational model of##5##3##(2008-11#3)(2013-1#1)(2013-8#1)
computational model that##2##3##(2010-10#1)(2011-2#1)
computational model##17##2##(2008-11#6)(2008-2#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
computational modeling and##2##3##(2010-10#1)(2012-2#1)
computational modeling##6##2##(1990-8#1)(2008-11#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-8#1)
computational modelling##3##2##(2009-7#1)(2012-2#1)(2013-1#1)
computational models that##2##3##(2008-11#1)(2008-4#1)
computational models##7##2##(2008-11#4)(2008-4#1)(2009-5#1)(2010-10#1)
computational program##3##2##(2008-10#2)(2008-3#1)
computational resources##2##2##(2008-9#1)(2012-2#1)
computational results##2##2##(2008-3#1)(2008-7#1)
computational speed##2##2##(2008-3#2)
computational strategy for##2##3##(2008-10#1)(2008-7#1)
computational strategy##6##2##(1995-5#1)(2008-10#3)(2008-3#1)(2008-7#1)
computational studies##4##2##(2008-10#1)(2008-11#1)(2009-12#1)(2012-2#1)
computational study##2##2##(1997-8#1)(2013-1#1)
computational techniques##4##2##(2008-2#1)(2008-7#1)(2009-3#1)(2012-2#1)
computational time##4##2##(2008-2#2)(2008-3#1)(2008-6#1)
computational tools##6##2##(2008-7#5)(2008-8#1)
computational##206##1##(1990-11#1)(1990-5#1)(1990-8#1)(1992-9#2)(1994-8#1)(1995-5#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#18)(2008-12#1)(2008-2#15)(2008-3#27)(2008-4#5)(2008-6#6)(2008-7#26)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-2#15)(2012-3#3)(2013-1#7)(2013-8#4)
computationally efficient##5##2##(2008-2#1)(2008-3#2)(2009-8#1)(2012-3#1)
computationally expensive##2##2##(2007-9#1)(2008-11#1)
computationally fast##2##2##(2008-3#1)(2010-8#1)
computationally##26##1##(2007-9#2)(2008-11#3)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#2)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
computations and##3##2##(2008-2#1)(2008-3#2)
computations are##3##2##(1990-8#1)(2007-12#1)(2008-2#1)
computations for Gaussian##2##3##(2008-3#2)
computations for a##2##3##(2008-3#2)
computations for##6##2##(2008-10#1)(2008-3#5)
computations of##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
computations show that##2##3##(1994-3#1)(2008-2#1)
computations##49##1##(1990-8#2)(1994-3#2)(1996-12#2)(1996-5#1)(1997-7#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#12)(2008-3#15)(2008-8#1)(2009-5#2)(2012-2#4)
compute a##5##2##(2008-2#2)(2008-6#2)(2009-9#1)
compute and##5##2##(1995-9#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
compute the##30##2##(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-2#2)(2011-3#1)(2012-2#1)
compute##63##1##(1995-9#1)(2007-11#3)(2008-10#1)(2008-2#10)(2008-3#15)(2008-4#4)(2008-6#7)(2008-7#7)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-2#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
computed and##6##2##(1990-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)
computed at##2##2##(1994-8#1)(2008-3#1)
computed by means of##2##4##(2008-3#2)
computed by the##2##3##(2007-11#1)(2008-3#1)
computed by##10##2##(1993-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)
computed directly from##2##3##(2008-2#1)(2008-3#1)
computed flow##2##2##(2008-7#2)
computed for each##2##3##(1993-1#1)(2008-3#1)
computed for##8##2##(1993-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2010-12#1)
computed from a##4##3##(1993-12#1)(2007-11#1)(2008-3#2)
computed from the##9##3##(1997-2#1)(2008-10#1)(2008-3#4)(2009-6#1)(2012-3#1)(2013-1#1)
computed from##23##2##(1990-11#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)(2012-5#1)(2013-1#1)
computed in##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
computed result##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
computed the##2##2##(1994-3#1)(2012-2#1)
computed through##2##2##(2008-11#1)(2008-2#1)
computed to##4##2##(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)
computed tomographic (CT) films##2##4##(2008-1#2)
computed tomographic (CT) scan##6##4##(2008-1#1)(2008-7#4)(2012-3#1)
computed tomographic (CT) scans##3##4##(2008-1#3)
computed tomographic (CT)##13##3##(2007-5#1)(2008-1#6)(2008-7#5)(2012-3#1)
computed tomographic angiography##2##3##(2008-2#1)(2010-9#1)
computed tomographic coronary angiography##2##4##(2009-10#1)(2010-5#1)
computed tomographic images##2##3##(2011-2#1)(2013-1#1)
computed tomographic scans##3##3##(1992-2#1)(1993-6#1)(2011-2#1)
computed tomographic##37##2##(1992-2#1)(1993-6#1)(1994-8#1)(1996-5#2)(1997-5#1)(2007-5#1)(2008-1#7)(2008-2#1)(2008-7#7)(2009-10#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
computed tomography (CT) and magnetic resonance##2##6##(2010-9#1)(2011-2#1)
computed tomography (CT) and##8##4##(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
computed tomography (CT) in##2##4##(2007-7#1)(2013-1#1)
computed tomography (CT) is##3##4##(2007-10#1)(2008-7#1)(2012-3#1)
computed tomography (CT) of the brain##2##6##(2008-8#1)(2011-1#1)
computed tomography (CT) of the##5##5##(1991-3#1)(2008-8#2)(2011-1#2)
computed tomography (CT) or##4##4##(2009-3#1)(2010-1#1)(2013-1#1)(2013-8#1)
computed tomography (CT) scan and##2##5##(2007-10#1)(2013-8#1)
computed tomography (CT) scan showed##2##5##(2008-7#1)(2010-1#1)
computed tomography (CT) scan was##2##5##(2009-8#1)(2012-3#1)
computed tomography (CT) scan##14##4##(2007-10#2)(2008-12#1)(2008-7#6)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
computed tomography (CT) scans##3##4##(2008-7#2)(2011-2#1)
computed tomography (CT)##66##3##(1991-3#1)(1995-2#1)(2007-10#4)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#11)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#8)(2012-3#2)(2013-1#5)(2013-8#2)
computed tomography (HRCT)##4##3##(1991-12#1)(2007-8#1)(2011-2#2)
computed tomography (MDCT) in##4##4##(2008-12#1)(2011-2#2)(2012-2#1)
computed tomography (MDCT)##8##3##(2008-12#1)(2008-7#2)(2011-2#2)(2012-2#3)
computed tomography (MSCT)##2##3##(2008-7#2)
computed tomography and magnetic resonance imaging##5##6##(1990-12#1)(1997-8#1)(2008-2#1)(2008-7#1)(2011-2#1)
computed tomography and##20##3##(1990-12#1)(1990-9#1)(1991-11#1)(1996-2#1)(1997-8#1)(2007-9#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)
computed tomography angiography (CTA)##2##4##(2008-12#1)(2012-2#1)
computed tomography angiography in##2##4##(2008-11#1)(2011-2#1)
computed tomography angiography of##2##4##(2008-12#1)(2009-5#1)
computed tomography angiography##17##3##(2008-11#3)(2008-12#7)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
computed tomography are##2##3##(2008-7#1)(2012-2#1)
computed tomography examinations##2##3##(2007-11#1)(2012-1#1)
computed tomography has##3##3##(2008-3#1)(2008-7#2)
computed tomography imaging##3##3##(2008-12#1)(2008-3#1)(2012-1#1)
computed tomography in patients with##2##5##(2008-12#1)(2012-2#1)
computed tomography in the##2##4##(2008-7#1)(2012-2#1)
computed tomography in##8##3##(1994-1#1)(1996-5#1)(2008-12#2)(2008-7#1)(2012-2#2)(2013-2#1)
computed tomography or magnetic resonance imaging##2##6##(1997-8#1)(2010-12#1)
computed tomography or magnetic resonance##3##5##(1997-8#1)(2010-12#1)(2011-2#1)
computed tomography or##5##3##(1997-4#1)(1997-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
computed tomography revealed##3##3##(2008-7#1)(2010-10#1)(2013-1#1)
computed tomography scan of the##2##5##(2007-12#1)(2013-1#1)
computed tomography scan##11##3##(2007-12#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
computed tomography scans##4##3##(2008-11#1)(2008-7#3)
computed tomography showed no##2##4##(2006-10#1)(2013-8#1)
computed tomography showed##6##3##(1990-3#1)(1993-3#1)(2006-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
computed tomography to detect the##2##5##(2008-10#1)(2009-10#1)
computed tomography was##3##3##(2009-4#1)(2011-2#1)(2013-1#1)
computed tomography##262##2##(1990-12#1)(1990-3#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#2)(1997-4#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#7)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#18)(2008-2#4)(2008-3#8)(2008-7#36)(2008-8#6)(2008-9#5)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#4)(2010-12#5)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#26)(2012-1#6)(2012-12#3)(2012-2#27)(2012-3#5)(2013-1#15)(2013-2#1)(2013-7#1)(2013-8#6)
computed tomography-guided##2##2##(2008-6#1)(2008-8#1)
computed using##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
computed with##6##2##(2008-2#2)(2008-3#2)(2008-6#1)(2010-7#1)
computed within##2##2##(2008-3#2)
computed##440##1##(1990-11#1)(1990-12#2)(1990-3#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#4)(1996-7#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#8)(2007-11#12)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#9)(2008-10#16)(2008-11#8)(2008-12#19)(2008-2#16)(2008-3#45)(2008-4#2)(2008-5#3)(2008-6#7)(2008-7#48)(2008-8#8)(2008-9#7)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#4)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#30)(2012-1#6)(2012-12#5)(2012-2#30)(2012-3#8)(2012-5#1)(2013-1#23)(2013-2#1)(2013-7#1)(2013-8#7)
computer access##2##2##(2008-7#1)(2009-5#1)
computer age##2##2##(1996-2#1)(2008-10#1)
computer aided##2##2##(2008-10#1)(2013-8#1)
computer algorithm##2##2##(2008-3#1)(2008-7#1)
computer analysis as compared with##2##5##(2007-10#2)
computer analysis of##5##3##(1996-9#1)(1997-3#1)(2007-10#1)(2008-10#1)(2009-11#1)
computer analysis##13##2##(1996-9#1)(1997-3#1)(1997-4#1)(2007-10#8)(2008-10#1)(2009-11#1)
computer and information literacy##2##4##(2008-11#2)
computer and the##2##3##(1995-6#1)(2008-11#1)
computer and##14##2##(1995-12#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-11#4)(2008-3#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-12#1)(2013-8#1)
computer application##2##2##(1996-2#1)(2013-8#1)
computer applications##6##2##(1992-12#4)(1996-12#1)(1996-2#1)
computer assisted##4##2##(2006-12#1)(2008-11#2)(2008-12#1)
computer based system##2##3##(2009-10#2)
computer by##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
computer code##3##2##(2008-2#1)(2008-3#2)
computer control##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
computer controlled##5##2##(2008-10#3)(2009-12#1)(2011-2#1)
computer database##4##2##(1992-3#1)(1995-3#1)(2008-1#1)(2013-1#1)
computer for##4##2##(1992-4#1)(1995-5#1)(2008-10#1)(2008-7#1)
computer graphics##3##2##(1991-8#1)(2008-2#1)(2008-6#1)
computer hardware and##2##3##(1996-12#1)(2010-3#1)
computer is##3##2##(1993-2#1)(2008-10#1)(2010-8#1)
computer leases##3##2##(1993-2#3)
computer literacy##6##2##(1992-12#1)(1996-1#5)
computer memory##2##2##(2007-11#1)(2008-3#1)
computer model of##3##3##(1992-12#1)(1992-3#1)(2010-5#1)
computer model##7##2##(1992-12#1)(1992-3#1)(2008-2#3)(2010-5#1)(2012-2#1)
computer modeling of##2##3##(1996-12#1)(2008-2#1)
computer modeling##3##2##(1995-2#1)(1996-12#1)(2008-2#1)
computer modelling##2##2##(1997-1#1)(2008-10#1)
computer models of the##2##4##(2008-7#1)(2012-2#1)
computer models##4##2##(1990-9#1)(2008-2#1)(2008-7#1)(2012-2#1)
computer navigation##6##2##(2007-8#3)(2008-11#1)(2013-1#2)
computer or##3##2##(2008-11#1)(2010-2#1)(2010-3#1)
computer processing##2##2##(2008-2#2)
computer program for##5##3##(1993-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(2008-10#1)
computer program is##2##3##(2008-10#1)(2008-3#1)
computer program that implements the##2##5##(2008-2#1)(2008-3#1)
computer program that##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
computer program to##2##3##(2008-10#2)
computer program with##2##3##(2008-3#1)(2013-1#1)
computer program##44##2##(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-8#1)(1995-9#1)(1997-2#2)(1997-6#1)(2006-4#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)
computer programme##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
computer programs##10##2##(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-4#2)(2008-8#1)(2013-1#1)
computer reconstruction##3##2##(2007-12#1)(2008-8#2)
computer resources##2##2##(2008-3#2)
computer screen##2##2##(2008-10#1)(2008-2#1)
computer search of##4##3##(1990-2#1)(1995-8#1)(1996-2#1)(2008-8#1)
computer simulation and##5##3##(2008-2#2)(2008-3#3)
computer simulation of##6##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-9#1)
computer simulation results##4##3##(2007-11#1)(2008-3#3)
computer simulation##38##2##(1995-2#2)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#7)(2008-3#16)(2008-4#2)(2009-9#1)(2010-8#1)(2013-1#1)
computer simulations and experimental results##3##5##(2008-3#3)
computer simulations and##4##3##(2008-3#4)
computer simulations are##3##3##(2008-2#2)(2008-3#1)
computer simulations for##2##3##(2008-2#1)(2008-3#1)
computer simulations of the##2##4##(2008-3#2)
computer simulations of##7##3##(1995-3#1)(2008-2#2)(2008-3#2)(2009-12#1)(2010-3#1)
computer simulations that##3##3##(2008-3#2)(2009-8#1)
computer simulations##45##2##(1995-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#21)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-3#1)(2012-2#1)
computer skills##3##2##(1992-12#2)(2008-12#1)
computer software that##3##3##(1992-12#1)(1993-12#1)(2012-2#1)
computer software##11##2##(1992-12#1)(1993-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#4)(2012-2#1)
computer system has##2##3##(1997-3#2)
computer system##14##2##(1992-4#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#4)(2008-10#1)(2008-3#2)(2008-7#1)(2010-8#1)
computer systems##6##2##(1994-3#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#2)
computer technologies##4##2##(1996-12#1)(2008-11#1)(2008-3#1)(2010-3#1)
computer technology##9##2##(1993-2#1)(1994-2#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-3#1)(2008-9#2)(2010-8#1)
computer time##2##2##(2008-10#1)(2008-3#1)
computer tomography (CT)##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
computer tomography with three-dimensional reconstruction##2##5##(2007-8#2)
computer tomography##15##2##(1996-8#1)(2007-11#3)(2007-7#2)(2007-8#6)(2008-3#1)(2011-2#1)(2012-2#1)
computer training programs##2##3##(1992-12#2)
computer training##4##2##(1992-12#4)
computer vision##9##2##(1991-8#1)(2008-3#2)(2008-6#2)(2010-5#1)(2012-3#3)
computer with##4##2##(1991-12#1)(2008-10#1)(2009-10#1)(2010-8#1)
computer workstation##2##2##(2006-12#2)
computer##467##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#3)(1991-9#1)(1992-12#17)(1992-3#2)(1992-4#4)(1993-1#1)(1993-12#1)(1993-2#7)(1993-3#4)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2006-10#1)(2006-12#4)(2006-4#1)(2007-10#8)(2007-11#14)(2007-12#8)(2007-7#3)(2007-8#10)(2008-1#3)(2008-10#56)(2008-11#18)(2008-12#6)(2008-2#36)(2008-3#76)(2008-4#10)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#10)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-12#2)(2010-2#2)(2010-3#4)(2010-5#2)(2010-8#8)(2011-2#3)(2012-12#1)(2012-2#10)(2012-3#6)(2013-1#8)(2013-8#3)
computer-aided design##3##2##(2008-2#2)(2010-3#1)
computer-aided reconstruction##2##2##(1993-12#1)(2011-2#1)
computer-aided##23##1##(1990-11#1)(1991-1#1)(1993-12#1)(1995-6#2)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)
computer-aided-design##2##1##(2008-2#2)
computer-animated##5##1##(2008-10#1)(2008-11#4)
computer-assisted image analysis##3##3##(2008-10#2)(2009-10#1)
computer-assisted self-interview##3##2##(2013-1#3)
computer-assisted##17##1##(1990-6#1)(1991-12#1)(1992-12#1)(1994-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-10#1)(2013-1#4)
computer-based auditory rehabilitation tool##2##4##(2008-9#2)
computer-based data##2##2##(2008-3#1)(2011-2#1)
computer-based decision##2##2##(1993-12#1)(2011-1#1)
computer-based decision-support tools##2##3##(1993-12#2)
computer-based journal##3##2##(1994-6#3)
computer-based methods##2##2##(2008-10#2)
computer-based spatial filtering##2##3##(2008-2#1)(2008-3#1)
computer-based spatial-filtering method##2##3##(2008-2#1)(2008-3#1)
computer-based spatial-filtering velocimeter to measure the surface velocity of##2##9##(2008-2#1)(2008-3#1)
computer-based spatial-filtering##4##2##(2008-2#2)(2008-3#2)
computer-based tool##2##2##(2008-10#1)(2008-12#1)
computer-based##42##1##(1990-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#3)(1994-2#2)(1994-6#5)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
computer-controlled environmental chamber##3##3##(2008-10#3)
computer-controlled##25##1##(2007-11#3)(2008-10#14)(2008-2#2)(2008-3#5)(2008-4#1)
computer-driven##2##1##(2006-10#1)(2008-9#1)
computer-generated diffractive optical elements##2##4##(2008-3#2)
computer-generated hologram (CGH)##2##3##(2008-3#2)
computer-generated hologram##12##2##(2007-12#1)(2008-3#11)
computer-generated holograms##15##2##(2007-11#2)(2008-2#4)(2008-3#9)
computer-generated holographic##2##2##(2007-12#1)(2008-3#1)
computer-generated masks##2##2##(2008-2#1)(2008-3#1)
computer-generated phase holograms##2##3##(2008-2#2)
computer-generated space-variant subwavelength dielectric##2##4##(2007-11#2)
computer-generated subwavelength gratings##2##3##(2007-11#2)
computer-generated subwavelength##3##2##(2007-11#3)
computer-generated waveguide##2##2##(2007-12#2)
computer-generated##48##1##(2007-11#7)(2007-12#5)(2008-2#9)(2008-3#27)
computer-graphic animations##2##2##(2010-9#2)
computer-guided##4##1##(2008-11#1)(2008-8#2)(2013-1#1)
computer-intensive##2##1##(2008-10#2)
computer-simulated data##2##2##(2008-3#2)
computer-simulated##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
computer-simulation results##4##2##(2008-2#3)(2008-3#1)
computerised##13##1##(1991-3#2)(1994-7#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-2#1)
computerization of##3##2##(1992-5#1)(1994-2#1)(2013-1#1)
computerization##5##1##(1992-5#1)(1994-2#2)(1995-1#1)(2013-1#1)
computerized and##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
computerized clinical##2##2##(2008-7#1)(2013-1#1)
computerized freezing milling technique##2##4##(2012-3#2)
computerized image analysis##2##3##(2008-12#1)(2008-5#1)
computerized image##3##2##(1992-9#1)(2008-12#1)(2008-5#1)
computerized imaging##3##2##(2008-2#1)(2008-9#2)
computerized medical records##4##3##(1996-9#1)(1997-2#1)(2008-11#2)
computerized medical##6##2##(1994-6#1)(1996-9#1)(1997-2#1)(2008-11#2)(2010-8#1)
computerized patient##3##2##(1994-3#1)(2008-11#1)(2012-3#1)
computerized pharmacy##2##2##(2008-11#2)
computerized physician##2##2##(1996-3#1)(2010-8#1)
computerized psychiatric treatment planning##2##4##(1997-3#2)
computerized system for##2##3##(2013-1#2)
computerized system##4##2##(1992-12#1)(2013-1#3)
computerized tomography (CT)##5##3##(2007-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-8#1)
computerized tomography (HRCT) scan##2##4##(1991-12#1)(2008-7#1)
computerized tomography and magnetic resonance imaging##2##6##(1996-8#1)(2008-9#1)
computerized tomography showed##2##3##(1997-3#1)(2008-12#1)
computerized tomography##23##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-9#1)(1996-8#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#2)
computerized treatment for insomnia##2##4##(2013-1#2)
computerized treatment##3##2##(2013-1#3)
computerized##109##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#1)(1992-12#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#6)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(2007-10#2)(2008-1#2)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#11)
computers and##4##2##(1993-12#1)(1994-3#1)(1996-2#1)(2008-12#1)
computers at##2##2##(2013-8#2)
computers for##3##2##(1997-3#1)(2013-8#2)
computers in##4##2##(2006-10#1)(2008-11#1)(2008-5#1)(2009-9#1)
computers to##4##2##(1994-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
computers##41##1##(1991-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#2)(1996-1#2)(1996-2#1)(1996-4#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#2)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#5)
computes##4##1##(1997-6#1)(2008-3#1)(2009-5#1)(2010-9#1)
computing and##2##2##(1996-2#2)
computing architectures##4##2##(1990-11#1)(2008-2#3)
computing power of##2##3##(2008-3#1)(2009-11#1)
computing system##3##2##(2008-3#2)(2012-2#1)
computing the absorption##3##3##(2008-2#1)(2008-3#2)
computing the spectral##2##3##(2008-2#1)(2013-8#1)
computing the##27##2##(1990-2#1)(1992-9#2)(1994-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#8)(2008-6#3)(2009-3#1)(2009-7#1)(2009-9#1)(2011-3#1)(2012-3#1)(2013-8#1)
computing these##2##2##(2008-10#1)(2008-2#1)
computing time##5##2##(2008-3#3)(2008-7#1)(2010-3#1)
computing##90##1##(1990-11#1)(1990-2#1)(1992-9#2)(1994-1#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2007-11#4)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#11)(2008-3#27)(2008-6#3)(2008-7#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-8#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
con##2##1##(1993-8#1)(2007-2#1)
concanavalin A &gt##2##3##(1995-11#2)
concanavalin A (Con A)##5##4##(1990-6#1)(1994-11#1)(1995-2#1)(2008-10#2)
concanavalin A and##2##3##(1995-11#1)(2008-10#1)
concanavalin A##24##2##(1990-6#1)(1993-6#5)(1993-8#1)(1994-11#1)(1995-11#8)(1995-12#1)(1995-2#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-7#1)
concanavalin##26##1##(1990-6#1)(1993-6#6)(1993-8#1)(1994-11#1)(1995-11#8)(1995-12#1)(1995-2#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-7#1)
concanavalin-A##2##1##(1992-12#1)(1994-8#1)
concatemers##2##1##(1993-6#2)
concatenated long-period##2##2##(2007-11#2)
concatenated##11##1##(2007-11#4)(2008-10#1)(2008-2#1)(2008-8#2)(2012-1#1)(2012-3#1)(2013-8#1)
concatenations of##2##2##(2007-12#1)(2011-2#1)
concave and convex##4##3##(2007-8#2)(2008-3#2)
concave curve##2##2##(2007-8#1)(2013-1#1)
concave diffraction##3##2##(2008-3#3)
concave grating##5##2##(2008-2#3)(2008-3#2)
concave mirror##2##2##(2007-11#1)(2008-3#1)
concave mirrors##2##2##(2008-3#2)
concave##35##1##(1993-11#1)(1995-11#1)(1996-5#1)(2007-11#2)(2007-8#3)(2008-10#1)(2008-2#3)(2008-3#14)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
concealed##10##1##(2007-12#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-2#2)
concealing the##2##2##(2007-8#1)(2013-1#1)
concealing##3##1##(2007-8#1)(2008-3#1)(2013-1#1)
concealment##5##1##(2007-12#1)(2008-1#1)(2008-10#2)(2010-11#1)
conceded##3##1##(1995-6#1)(2008-8#2)
conceivable that the##2##3##(1995-6#1)(1997-8#1)
conceivable that##6##2##(1995-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
conceivable##12##1##(1990-2#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-8#1)
conceivably be##2##2##(1992-11#1)(1996-4#1)
conceivably##5##1##(1992-11#1)(1996-4#1)(2008-5#1)(2009-8#1)(2010-11#1)
conceived and##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
conceived as a##2##3##(1991-1#1)(2008-11#1)
conceived in##2##2##(2007-8#1)(2012-1#1)
conceived of as##2##3##(2010-4#1)(2012-2#1)
conceived of##3##2##(2008-12#1)(2010-4#1)(2012-2#1)
conceived to##3##2##(2008-11#2)(2013-1#1)
conceived##28##1##(1991-1#1)(1991-12#1)(1991-2#1)(1993-2#1)(1994-3#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
concentrate and##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
concentrate contained##2##2##(2012-2#2)
concentrate from bovine milk##2##4##(2012-2#2)
concentrate in the##3##3##(1990-12#1)(2010-4#1)(2011-2#1)
concentrate in##4##2##(1990-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
concentrate is##3##2##(2008-10#2)(2012-2#1)
concentrate on the##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2010-12#1)
concentrate on##9##2##(1994-9#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-12#1)(2013-8#1)
concentrate their##2##2##(1990-12#1)(1991-12#1)
concentrate##83##1##(1990-12#2)(1991-12#1)(1991-8#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#2)(2007-12#1)(2007-7#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#7)(2011-2#1)(2012-2#8)(2013-8#1)
concentrated H(2)SO(4)##3##2##(2008-10#3)
concentrated HCl and##3##3##(2008-10#3)
concentrated HCl##6##2##(2008-10#6)
concentrated HF##2##2##(2008-10#2)
concentrated NaCl##3##2##(2008-5#2)(2008-6#1)
concentrated about##3##2##(2008-10#1)(2008-12#2)
concentrated acid##2##2##(2008-10#2)
concentrated acids##2##2##(2008-10#2)
concentrated and##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
concentrated around##2##2##(2008-10#1)(2008-3#1)
concentrated as##3##2##(2008-10#3)
concentrated ascites##3##2##(2007-12#1)(2013-1#2)
concentrated at the##3##3##(2008-5#1)(2008-9#1)(2009-8#1)
concentrated at##4##2##(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
concentrated by the##3##3##(1996-12#1)(2008-10#2)
concentrated by##14##2##(1992-11#1)(1992-8#1)(1996-12#1)(2008-10#9)(2011-1#1)(2012-2#1)
concentrated collagen hydrogels at 5 mg/ml##2##6##(2012-3#2)
concentrated collagen hydrogels##3##3##(2012-3#3)
concentrated conditioned##2##2##(1990-2#1)(2008-4#1)
concentrated dye##2##2##(2008-2#1)(2008-9#1)
concentrated effort##2##2##(1993-3#1)(2011-1#1)
concentrated emulsion and suspension instability analysis##2##6##(2008-10#2)
concentrated from##2##2##(2008-10#2)
concentrated hydrochloric acid##4##3##(2008-10#4)
concentrated hydrochloric##5##2##(2008-10#5)
concentrated hydrofluoric acid##3##3##(2008-10#3)
concentrated in a##2##3##(1994-3#1)(2008-10#1)
concentrated in the##15##3##(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-3#1)
concentrated in##33##2##(1990-11#2)(1990-5#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
concentrated inocula##3##2##(2008-10#3)
concentrated nitric acid##7##3##(2008-10#7)
concentrated nitric##8##2##(2008-10#8)
concentrated on the analysis of##2##5##(1996-12#1)(2008-10#1)
concentrated on the##6##3##(1994-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
concentrated on##12##2##(1992-11#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-5#2)(2012-12#2)(2012-3#1)
concentrated samples##2##2##(2008-10#2)
concentrated solutions of##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
concentrated solutions##4##2##(1990-8#1)(2008-10#2)(2008-9#1)
concentrated sulfuric acid##4##3##(2008-10#4)
concentrated sulphuric acid##3##3##(2008-10#3)
concentrated to##4##2##(2008-10#2)(2010-10#1)(2013-7#1)
concentrated tomato pasta##2##3##(2008-10#2)
concentrated within##3##2##(1996-6#1)(2008-3#1)(2008-8#1)
concentrated##224##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-8#3)(1991-11#1)(1991-12#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-10#107)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
concentrates and##3##2##(2008-10#3)
concentrates for hemodialysis##3##3##(2008-10#3)
concentrates on the##3##3##(1991-12#1)(2008-2#1)(2008-9#1)
concentrates on##8##2##(1991-11#1)(1991-12#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-9#1)
concentrates##31##1##(1991-11#1)(1991-12#1)(1993-6#2)(1994-3#1)(1995-9#1)(1997-3#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-4#4)(2010-9#1)(2011-2#1)
concentrating by the##2##3##(2008-10#2)
concentrating mechanism##4##2##(2013-1#4)
concentrating on the##3##3##(2008-4#2)(2008-8#1)
concentrating on their##2##3##(1991-2#1)(2008-11#1)
concentrating on##9##2##(1991-2#1)(1994-1#1)(1995-3#1)(2007-7#1)(2008-11#2)(2008-4#2)(2008-8#1)
concentrating the##2##2##(2008-10#2)
concentrating##28##1##(1991-2#1)(1993-12#1)(1994-1#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#4)
concentration &lt##2##2##(2008-10#1)(2008-7#1)
concentration (&lt##4##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
concentration (0##7##2##(1994-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-9#2)(2012-3#1)
concentration (1##2##2##(1991-8#1)(1992-11#1)
concentration (10##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
concentration (2##4##2##(1991-5#1)(2008-11#1)(2008-5#1)(2008-7#1)
concentration (20##2##2##(1996-2#1)(2011-1#1)
concentration (5##3##2##(1995-5#1)(2008-10#2)
concentration (CMC) of##2##3##(2008-10#2)
concentration (CMC)##5##2##(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#1)
concentration (Cmax)##2##2##(2012-12#1)(2012-3#1)
concentration (IC50) of##2##3##(1991-8#1)(1995-11#1)
concentration ([Ca(2+)](i)) in##2##3##(2008-8#1)(2008-9#1)
concentration ([Ca(2+)](i))##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
concentration ([Ca2+]i) in##2##3##(1992-6#1)(1994-6#1)
concentration ([Ca2+]i)##7##2##(1990-5#1)(1992-6#2)(1992-9#1)(1994-6#2)(1995-11#1)
concentration (cmc)##2##2##(2008-10#2)
concentration 0##4##2##(1990-10#1)(1992-9#1)(2008-10#2)
concentration 1##3##2##(2008-10#2)(2008-5#1)
concentration 10##2##2##(1993-1#1)(2008-10#1)
concentration a##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
concentration above##3##2##(1993-6#1)(2008-1#2)
concentration achieved##3##2##(1992-9#1)(2008-11#1)(2008-12#1)
concentration affected the##2##3##(1997-2#1)(2008-10#1)
concentration after##4##2##(2008-7#3)(2010-2#1)
concentration alone##2##2##(2008-3#1)(2008-6#1)
concentration along with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
concentration also##2##2##(1993-3#1)(2008-7#1)
concentration and a##4##3##(2008-10#4)
concentration and composition##2##3##(1994-8#1)(2008-5#1)
concentration and correlated##2##3##(2008-10#1)(2008-2#1)
concentration and decreased##2##3##(1992-3#1)(2008-12#1)
concentration and determination of##3##4##(2008-10#3)
concentration and frequency##2##3##(2008-10#1)(2010-4#1)
concentration and its##3##3##(2008-10#2)(2008-5#1)
concentration and pH of##3##4##(2008-10#3)
concentration and pH were##2##4##(2008-10#1)(2008-7#1)
concentration and pH##12##3##(1994-11#1)(2008-10#9)(2008-7#1)(2009-12#1)
concentration and production##2##3##(2008-11#2)
concentration and separation of##3##4##(2008-10#3)
concentration and temperature on the##2##5##(2008-10#2)
concentration and temperature on##3##4##(2008-10#3)
concentration and temperature##6##3##(2008-10#5)(2008-3#1)
concentration and that##4##3##(1990-11#1)(1990-12#1)(1994-6#1)(2008-3#1)
concentration and the hemoglobin oxygen saturation##2##6##(2008-3#2)
concentration and the##29##3##(1990-7#1)(1992-6#1)(1994-8#1)(2008-10#14)(2008-11#1)(2008-3#3)(2008-7#1)(2009-11#1)(2009-3#1)(2010-10#1)(2011-1#2)(2013-1#1)(2013-8#1)
concentration and then##2##3##(2008-2#1)(2013-1#1)
concentration and time of##2##4##(2008-10#1)(2010-2#1)
concentration and time##4##3##(1994-6#1)(2008-10#2)(2010-2#1)
concentration and volume of eluent##2##5##(2008-10#2)
concentration and volume of##5##4##(2008-10#5)
concentration and##205##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#2)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1996-11#1)(1996-12#1)(1996-3#3)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#93)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#12)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#5)
concentration and/or##2##2##(2007-12#1)(2008-10#1)
concentration are##6##2##(1994-3#1)(2007-12#1)(2008-10#3)(2011-2#1)
concentration as a function of##2##5##(2008-3#1)(2011-2#1)
concentration as a##3##3##(2008-3#1)(2010-1#1)(2011-2#1)
concentration as an##3##3##(1994-7#2)(2008-7#1)
concentration as high as##2##4##(1994-5#1)(1995-8#1)
concentration as low as 0##2##5##(1992-3#1)(2008-10#1)
concentration as low as##6##4##(1992-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-10#2)
concentration as well as##2##4##(1993-3#1)(2008-3#1)
concentration as##20##2##(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-12#1)(2010-1#1)(2011-2#1)
concentration at a##2##3##(1997-2#1)(2008-7#1)
concentration at the##7##3##(1991-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2012-9#1)
concentration at which##3##3##(2008-10#2)(2008-2#1)
concentration at##29##2##(1991-12#2)(1991-7#1)(1992-12#1)(1993-1#1)(1995-8#2)(1997-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-7#3)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-9#1)(2013-1#1)
concentration below which##2##3##(1992-5#1)(2008-10#1)
concentration below##5##2##(1992-5#1)(1993-6#1)(2008-10#2)(2008-8#1)
concentration between 0##3##3##(2008-10#3)
concentration between##12##2##(1990-12#1)(1992-12#1)(1995-3#1)(2008-10#8)(2012-12#1)
concentration but##5##2##(1990-3#1)(1990-5#1)(1994-9#1)(2008-10#1)(2008-3#1)
concentration by the##2##3##(2008-10#1)(2008-12#1)
concentration by##12##2##(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)
concentration can be obtained##2##4##(2008-10#1)(2008-2#1)
concentration can be##8##3##(2008-10#5)(2008-11#2)(2008-2#1)
concentration can##10##2##(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#1)
concentration change of##2##3##(2008-10#2)
concentration change##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
concentration changes##2##2##(2008-10#1)(2011-1#1)
concentration compared to##2##3##(2008-7#1)(2013-8#1)
concentration compared##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
concentration conditions##5##2##(2008-10#1)(2008-9#4)
concentration contrast##2##2##(2008-7#2)
concentration correlated##3##2##(1992-9#1)(2008-1#1)(2011-2#1)
concentration could be##4##3##(2008-10#2)(2008-11#1)(2009-3#1)
concentration could##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)
concentration data##4##2##(1994-3#1)(2008-10#2)(2013-8#1)
concentration decreased##6##2##(1994-11#1)(2008-10#1)(2008-11#2)(2008-6#2)
concentration decreases##2##2##(2008-10#1)(2008-12#1)
concentration dependence of the##5##4##(1992-6#2)(1995-6#1)(2007-12#1)(2008-10#1)
concentration dependence of##8##3##(1992-6#2)(1993-11#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)
concentration dependence##10##2##(1992-6#2)(1993-11#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-2#1)
concentration dependency##2##2##(1997-4#1)(2008-4#1)
concentration dependent and##4##3##(1990-12#1)(1994-8#1)(2008-7#1)(2009-8#1)
concentration dependent increase in##2##4##(1993-6#1)(2008-10#1)
concentration dependent inhibition of##2##4##(1990-11#1)(1997-2#1)
concentration dependent##20##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-7#2)(2009-8#1)(2012-2#1)(2013-8#1)
concentration dependently##3##2##(1995-11#1)(1995-12#2)
concentration depending on the##2##4##(2008-10#1)(2008-11#1)
concentration depending on##3##3##(2008-10#2)(2008-11#1)
concentration detection##3##2##(2008-10#2)(2008-3#1)
concentration determination##2##2##(1992-8#1)(2008-3#1)
concentration determined##2##2##(2008-10#1)(2008-7#1)
concentration did not##6##3##(1992-6#1)(1996-8#1)(2008-11#1)(2008-6#2)(2008-7#1)
concentration distribution of the##2##4##(2008-10#2)
concentration distribution of##4##3##(2008-10#4)
concentration distribution##7##2##(2008-10#4)(2008-2#1)(2008-3#2)
concentration during the##2##3##(1997-6#1)(2010-8#1)
concentration during##6##2##(1990-3#1)(1992-9#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-8#1)
concentration effect##2##2##(2008-10#2)
concentration effects on##2##3##(2008-10#1)(2008-7#1)
concentration enhanced##2##2##(2008-10#2)
concentration enhancement##2##2##(2008-10#2)
concentration exceeded##2##2##(1994-5#1)(2008-6#1)
concentration factor was##2##3##(2008-10#2)
concentration factor##9##2##(2008-10#8)(2008-2#1)
concentration fluctuations##2##2##(2008-10#1)(2008-3#1)
concentration following##2##2##(1990-5#1)(1992-8#1)
concentration for each##4##3##(1992-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
concentration for the##6##3##(1995-5#2)(2008-10#2)(2008-11#1)(2008-5#1)
concentration for##28##2##(1990-11#1)(1992-9#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-5#3)(1997-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2012-2#1)
concentration from 0##4##3##(1994-3#1)(2008-10#2)(2008-8#1)
concentration from 1##4##3##(2008-10#3)(2008-11#1)
concentration from 4 to##2##4##(2007-11#1)(2008-5#1)
concentration from##23##2##(1990-3#1)(1994-3#1)(2007-11#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)
concentration giving a signal equal to three times the standard deviation of the##2##13##(2008-10#2)
concentration giving a signal equal to three times##3##8##(2008-10#3)
concentration giving##4##2##(1990-5#1)(2008-10#3)
concentration gradient of##2##3##(1991-5#1)(2008-10#1)
concentration gradient shell##3##3##(2012-2#3)
concentration gradient##15##2##(1991-5#1)(2008-10#8)(2009-9#1)(2011-2#1)(2012-2#4)
concentration gradients##6##2##(2008-10#3)(2008-3#1)(2008-5#2)
concentration greater than##3##3##(1997-4#2)(2011-2#1)
concentration group##3##2##(1996-12#1)(2008-10#2)
concentration groups##3##2##(2008-9#3)
concentration had a##2##3##(2011-2#1)(2013-1#1)
concentration had##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
concentration has been##5##3##(2008-10#3)(2008-3#1)(2008-6#1)
concentration has##10##2##(2008-10#6)(2008-3#2)(2008-6#1)(2010-4#1)
concentration have been##4##3##(2008-10#3)(2008-3#1)
concentration have##5##2##(2008-10#3)(2008-3#1)(2013-8#1)
concentration in a##20##3##(1990-7#1)(1993-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-11#1)(2011-1#1)
concentration in aqueous##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
concentration in batch##2##3##(1994-5#1)(2008-10#1)
concentration in biological##3##3##(2008-10#2)(2013-8#1)
concentration in blood##3##3##(1991-2#1)(1993-8#1)(1996-3#1)
concentration in both the##2##4##(2008-10#1)(2011-2#1)
concentration in both##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
concentration in erythrocytes##2##3##(1990-2#1)(1991-2#1)
concentration in grain and##2##4##(2008-10#2)
concentration in grain##4##3##(2008-10#4)
concentration in human##4##3##(1990-12#1)(1993-8#1)(1996-2#1)(2008-10#1)
concentration in kernels of##2##4##(2008-10#2)
concentration in patients with##4##4##(1996-12#2)(2008-3#1)(2012-2#1)
concentration in plasma##2##3##(1993-2#1)(2011-1#1)
concentration in serum##4##3##(1991-12#1)(1993-2#2)(2008-7#1)
concentration in solution##2##3##(2008-10#2)
concentration in the blood##2##4##(1990-12#1)(2008-10#1)
concentration in the culture##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
concentration in the dialysate##2##4##(1995-12#2)
concentration in the extract##2##4##(2008-10#2)
concentration in the liquid##2##4##(2008-10#2)
concentration in the medium##3##4##(1993-12#1)(2008-6#1)(2011-1#1)
concentration in the mobile phase##2##5##(2008-10#2)
concentration in the organic##2##4##(2008-10#2)
concentration in the plants##2##4##(2008-10#2)
concentration in the plasma##2##4##(1992-9#1)(2008-10#1)
concentration in the range 0##4##5##(2008-10#4)
concentration in the range 1##2##5##(2008-10#2)
concentration in the range 1-10##2##5##(2008-10#2)
concentration in the range of 0##6##6##(2008-10#6)
concentration in the range of 2##2##6##(2008-10#2)
concentration in the range of 5##2##6##(2008-10#2)
concentration in the range of##15##5##(2008-10#15)
concentration in the range##29##4##(2008-10#29)
concentration in the root##2##4##(2008-10#1)(2008-7#1)
concentration in the sample##3##4##(2008-10#3)
concentration in the water##2##4##(1992-11#1)(2008-10#1)
concentration in the##139##3##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#3)(1995-8#1)(1997-7#2)(2008-1#1)(2008-10#74)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#11)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
concentration in upper phase is much higher than that of##2##10##(2008-10#2)
concentration in urine##2##3##(1995-12#1)(2008-10#1)
concentration in vivo##2##3##(2008-10#1)(2009-9#1)
concentration in water##5##3##(2008-10#2)(2008-3#1)(2010-5#1)(2011-1#1)
concentration in waters##2##3##(2008-10#2)
concentration in whole##2##3##(1993-2#1)(2008-4#1)
concentration in##312##2##(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-8#2)(1996-12#5)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#2)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#129)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#16)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#14)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#7)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
concentration increase##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
concentration increased to##2##3##(1993-3#1)(2008-11#1)
concentration increased##13##2##(1990-3#1)(1990-7#1)(1990-9#1)(1993-3#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
concentration increases##7##2##(2007-11#1)(2007-12#2)(2008-10#3)(2009-8#1)
concentration induced##6##2##(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)(2008-8#1)
concentration interval##2##2##(2008-10#2)
concentration is achieved##2##3##(2008-10#1)(2008-3#1)
concentration is as low as 0##2##6##(2008-10#2)
concentration is associated with the##2##5##(2008-10#1)(2010-4#1)
concentration is determined##3##3##(2008-10#1)(2008-3#2)
concentration is higher##2##3##(2008-10#1)(2013-8#1)
concentration is in the##2##4##(1994-6#1)(2008-10#1)
concentration is linear##3##3##(2008-10#3)
concentration is lower##2##3##(1996-8#1)(2008-10#1)
concentration is not##3##3##(1994-11#1)(2008-10#1)(2009-10#1)
concentration is presented##2##3##(2008-10#1)(2008-3#1)
concentration is##63##2##(1990-12#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-8#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-8#1)
concentration leads to##2##3##(2008-3#1)(2008-7#1)
concentration level and exposure time##2##5##(2008-10#2)
concentration level and##3##3##(2008-10#3)
concentration level of 0##2##4##(2008-10#2)
concentration level of 1##3##4##(2008-10#2)(2012-1#1)
concentration level of 5##2##4##(2008-10#1)(2009-8#1)
concentration level of##14##3##(2008-10#11)(2008-11#1)(2009-8#1)(2012-1#1)
concentration level##28##2##(2008-10#23)(2008-11#1)(2009-3#1)(2009-8#2)(2012-1#1)
concentration levels and##4##3##(2008-10#4)
concentration levels between##4##3##(2008-10#4)
concentration levels by##2##3##(2008-10#2)
concentration levels from 3##2##4##(2008-10#2)
concentration levels from##5##3##(2008-10#4)(2011-2#1)
concentration levels in the##2##4##(2008-10#2)
concentration levels in##3##3##(2008-10#3)
concentration levels of the##2##4##(2008-10#2)
concentration levels of##9##3##(2008-10#8)(2008-11#1)
concentration levels##58##2##(1991-12#1)(2008-10#52)(2008-11#1)(2008-5#2)(2011-2#1)(2011-3#1)
concentration limit of detection##4##4##(1997-2#2)(2008-10#2)
concentration limit of##6##3##(1997-2#2)(2008-10#4)
concentration limits##2##2##(2008-10#1)(2008-11#1)
concentration may be##3##3##(1993-11#1)(2008-7#1)(2011-2#1)
concentration may##5##2##(1993-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
concentration means##2##2##(2008-10#2)
concentration measured##5##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
concentration measurement##3##2##(2008-10#1)(2008-3#2)
concentration measurements are##3##3##(2008-10#2)(2008-3#1)
concentration measurements by##2##3##(2008-3#2)
concentration measurements in a##4##4##(2008-2#3)(2008-3#1)
concentration measurements of##2##3##(2008-10#1)(2008-11#1)
concentration measurements##20##2##(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#8)
concentration method##3##2##(2008-10#2)(2009-10#1)
concentration monitoring of##2##3##(2007-11#2)
concentration monitoring##4##2##(2007-11#4)
concentration obtained in##2##3##(2008-10#1)(2011-2#1)
concentration obtained##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
concentration occurred##2##2##(2008-10#1)(2008-6#1)
concentration occurs##2##2##(2008-10#1)(2013-1#1)
concentration of 0##25##3##(1992-11#1)(1992-9#1)(1994-12#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#1)
concentration of 1 mug/ml##2##4##(2008-2#1)(2008-5#1)
concentration of 1 x##2##4##(1992-8#1)(2008-10#1)
concentration of 1##25##3##(1990-12#1)(1992-3#1)(1992-8#1)(1995-11#2)(1997-1#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2012-3#1)
concentration of 1-hydroxypyrene##2##3##(1992-3#2)
concentration of 10 muM##2##4##(2008-10#1)(2008-11#1)
concentration of 10##14##3##(1991-2#1)(1992-6#1)(1994-12#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#2)
concentration of 10%##3##3##(1994-2#1)(2007-11#1)(2008-11#1)
concentration of 10(-6) M##3##4##(1991-9#1)(1993-12#1)(1997-4#1)
concentration of 100 microM##2##4##(1992-3#1)(1995-12#1)
concentration of 100##8##3##(1992-3#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)
concentration of 2##11##3##(2008-10#8)(2008-12#1)(2008-5#1)(2010-12#1)
concentration of 20##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
concentration of 25##3##3##(2008-10#1)(2010-1#1)(2012-3#1)
concentration of 250##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
concentration of 3##10##3##(1990-5#2)(1991-12#1)(1995-5#1)(1997-4#2)(2008-10#2)(2008-11#1)(2011-1#1)
concentration of 4##4##3##(2008-10#3)(2008-11#1)
concentration of 40##2##3##(1995-2#1)(2008-10#1)
concentration of 40μg/ml##2##3##(2012-3#2)
concentration of 5##13##3##(1990-11#1)(1992-3#1)(1994-6#1)(2008-10#8)(2008-5#1)(2011-1#1)
concentration of 50##3##3##(2008-10#1)(2010-3#1)(2012-3#1)
concentration of 6##7##3##(1990-6#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-8#1)
concentration of 60##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
concentration of 80 mM##2##4##(1991-9#1)(1992-9#1)
concentration of Ca2+##2##3##(1991-12#1)(2013-1#1)
concentration of Cu(II)##2##3##(2008-10#1)(2008-5#1)
concentration of DETA##2##3##(2008-10#2)
concentration of ECP in vaginal fluid##2##6##(1996-12#2)
concentration of Fe(II)##2##3##(2008-10#2)
concentration of H(2)O(2) in the range##2##6##(2008-10#2)
concentration of H(2)O(2)##4##3##(2008-10#4)
concentration of I##2##3##(1992-6#1)(2008-10#1)
concentration of MVA in##2##4##(1995-12#2)
concentration of MeOH##2##3##(2008-10#2)
concentration of NAD+##2##3##(1990-10#1)(1992-3#1)
concentration of NO in##2##4##(1993-8#1)(2008-10#1)
concentration of NO##4##3##(1993-6#1)(1993-8#1)(2008-10#2)
concentration of NaCl##2##3##(1990-5#1)(2008-10#1)
concentration of PIBs/ml was obtained##2##5##(2008-11#2)
concentration of PRL##2##3##(2008-7#1)(2011-2#1)
concentration of Triton##2##3##(2008-10#2)
concentration of VB(2)##2##3##(2008-10#2)
concentration of a few##2##4##(2008-10#1)(2013-8#1)
concentration of a##16##3##(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#3)(2008-9#1)(2013-8#1)
concentration of about 0##2##4##(2008-10#2)
concentration of about##3##3##(1990-7#1)(2008-10#2)
concentration of acid##4##3##(1996-12#1)(2008-10#3)
concentration of alveomucin##2##3##(2013-1#2)
concentration of an##3##3##(1996-5#1)(2008-11#1)(2011-2#1)
concentration of analyte and##2##4##(2008-10#2)
concentration of analyte##4##3##(2008-10#4)
concentration of approximately##7##3##(1991-2#1)(1993-8#1)(2008-11#3)(2008-5#1)(2008-8#1)
concentration of arsenic##2##3##(2008-10#2)
concentration of ascorbic acid##4##4##(2008-10#4)
concentration of blood##2##3##(1994-12#1)(2013-1#1)
concentration of both##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
concentration of buffer##3##3##(2008-10#2)(2008-6#1)
concentration of calcium and##2##4##(2008-10#1)(2013-1#1)
concentration of calcium##4##3##(1995-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
concentration of cobalt(II)##2##3##(2008-10#2)
concentration of cysteine##2##3##(1991-5#1)(2008-10#1)
concentration of dopamine in the range of##2##7##(2008-10#2)
concentration of each component##2##4##(1996-9#1)(2008-2#1)
concentration of each##6##3##(1996-9#1)(2008-10#4)(2008-2#1)
concentration of effluent##2##3##(2008-10#1)(2008-12#1)
concentration of either##3##3##(1990-11#1)(1992-3#2)
concentration of electrolyte##2##3##(2008-10#2)
concentration of electrolytes##2##3##(2008-10#1)(2008-7#1)
concentration of eluent##2##3##(2008-10#2)
concentration of elution solution##2##4##(2008-10#2)
concentration of ethanol##2##3##(2008-10#1)(2011-1#1)
concentration of extract##2##3##(2008-12#2)
concentration of ferritin in the##3##5##(1993-11#1)(2012-1#2)
concentration of ferritin in##4##4##(1993-11#1)(2008-10#1)(2012-1#2)
concentration of free##9##3##(1994-12#1)(2008-10#3)(2008-2#2)(2011-2#1)(2013-8#2)
concentration of glucose##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2010-5#1)
concentration of glutamine##2##3##(2008-11#2)
concentration of growth##2##3##(1990-12#1)(2008-5#1)
concentration of guanidine##2##3##(1992-6#1)(1995-5#1)
concentration of hormones##4##3##(1997-4#1)(2008-8#3)
concentration of hydrogen##3##3##(2008-10#3)
concentration of immunoreactive (ir-)##2##4##(1991-5#1)(1993-11#1)
concentration of immunoreactive##4##3##(1990-5#1)(1991-5#1)(1993-11#1)(1994-12#1)
concentration of individual##2##3##(2008-3#1)(2011-1#1)
concentration of inhibitor##2##3##(2008-4#1)(2008-5#1)
concentration of internal##2##3##(2008-10#2)
concentration of intracellular##2##3##(1993-3#1)(2008-10#1)
concentration of iron and##3##4##(1995-3#1)(1996-2#1)(2008-10#1)
concentration of iron##6##3##(1995-3#1)(1996-2#2)(2008-10#3)
concentration of l-cysteine##3##3##(2008-10#3)
concentration of less than##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
concentration of melatonin##2##3##(2008-10#1)(2011-2#1)
concentration of mercury##2##3##(2008-10#2)
concentration of metal ions##4##4##(2008-10#4)
concentration of metal##6##3##(2008-10#6)
concentration of methanol##3##3##(1996-5#3)
concentration of modifier##2##3##(2008-10#2)
concentration of natural##2##3##(1992-5#1)(2012-2#1)
concentration of neopterin##2##3##(1996-12#1)(2008-10#1)
concentration of nitrite##4##3##(2008-10#4)
concentration of other##2##3##(1993-3#1)(2008-10#1)
concentration of palmitic saturated fatty acid##2##6##(2013-1#2)
concentration of potassium##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
concentration of protein D##2##4##(1992-3#2)
concentration of proteins in##2##4##(2008-10#1)(2011-2#1)
concentration of proteins##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
concentration of recombinant##2##3##(2008-8#1)(2013-8#1)
concentration of serum##4##3##(1995-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
concentration of solubilized xylan##2##4##(2013-1#2)
concentration of some##2##3##(2008-10#1)(2008-12#1)
concentration of styrene##2##3##(2008-10#2)
concentration of substrate##2##3##(2008-7#2)
concentration of sulfur##2##3##(2008-10#2)
concentration of the amine##2##4##(1990-5#1)(2008-10#1)
concentration of the analyte##4##4##(2008-10#3)(2013-8#1)
concentration of the aqueous##2##4##(2008-12#1)(2008-2#1)
concentration of the dissolved ligand##2##5##(2008-10#2)
concentration of the ligand##2##4##(2008-10#2)
concentration of the metal ions##2##5##(2008-10#2)
concentration of the respective##2##4##(1990-5#1)(2008-5#1)
concentration of the sample##2##4##(2008-10#2)
concentration of the solute##2##4##(2008-10#2)
concentration of the solution##3##4##(1995-3#1)(1996-3#1)(2008-3#1)
concentration of the substrate##2##4##(1991-8#1)(1993-3#1)
concentration of the##124##3##(1990-5#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(2008-10#61)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
concentration of these##10##3##(1994-8#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)
concentration of total##3##3##(2008-10#2)(2008-11#1)
concentration of trace elements##2##4##(2008-10#2)
concentration of trace##3##3##(2008-10#3)
concentration of unbound##2##3##(1997-7#1)(2008-10#1)
concentration of urea##4##3##(2008-10#2)(2008-4#2)
concentration of vanadium in##2##4##(2008-10#2)
concentration of vanadium##6##3##(1990-5#1)(2008-10#5)
concentration of various##2##3##(2008-10#1)(2013-8#1)
concentration of vitamin##2##3##(2008-10#1)(2008-12#1)
concentration of##1096##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#9)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#9)(1991-2#4)(1991-5#5)(1991-6#2)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#5)(1992-9#2)(1993-1#4)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#5)(1993-6#5)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#8)(1994-2#3)(1994-5#6)(1994-6#4)(1994-8#5)(1994-9#2)(1995-11#5)(1995-12#6)(1995-2#8)(1995-3#6)(1995-5#6)(1995-6#3)(1995-8#1)(1996-12#8)(1996-2#6)(1996-3#1)(1996-5#7)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#8)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#2)(2008-1#8)(2008-10#484)(2008-11#48)(2008-12#20)(2008-2#17)(2008-3#23)(2008-4#17)(2008-5#30)(2008-6#15)(2008-7#32)(2008-8#17)(2008-9#18)(2009-11#3)(2009-12#3)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#10)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#14)(2012-3#10)(2012-6#1)(2013-1#19)(2013-7#1)(2013-8#14)
concentration on the##20##3##(1990-8#1)(1992-6#1)(1994-5#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-8#2)
concentration on##36##2##(1990-8#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)
concentration only##2##2##(1992-10#1)(2008-10#1)
concentration or a##2##3##(2008-7#2)
concentration or##7##2##(1991-2#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)
concentration over a range of##2##5##(2008-10#1)(2008-3#1)
concentration over the range of##2##5##(2008-10#1)(2008-11#1)
concentration over the range##3##4##(2008-10#2)(2008-11#1)
concentration over the##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
concentration over##9##2##(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#2)
concentration plot##3##2##(2008-10#3)
concentration present in the##2##4##(2008-10#1)(2010-10#1)
concentration present in##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
concentration profile of##3##3##(2008-10#3)
concentration profile##5##2##(1993-2#1)(1996-3#1)(2008-10#3)
concentration profiles of the##2##4##(2008-10#1)(2008-11#1)
concentration profiles of##6##3##(2008-10#2)(2008-11#2)(2008-3#2)
concentration profiles were##2##3##(2008-10#1)(2008-3#1)
concentration profiles##17##2##(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#6)
concentration range (1##10##3##(2008-10#10)
concentration range 0##26##3##(1996-5#1)(2008-10#25)
concentration range 1##10##3##(2008-10#10)
concentration range 2##6##3##(2008-10#6)
concentration range 3##3##3##(1996-5#1)(2008-10#2)
concentration range 5##7##3##(2008-10#7)
concentration range and##4##3##(1990-12#1)(2008-10#3)
concentration range between##6##3##(1992-3#1)(2008-10#5)
concentration range for the##2##4##(2008-10#2)
concentration range for##3##3##(2008-10#3)
concentration range from 0 to##2##5##(2008-10#2)
concentration range from 0##5##4##(2008-10#4)(2008-2#1)
concentration range from 1##4##4##(2008-10#4)
concentration range from 5##7##4##(2008-10#7)
concentration range from##38##3##(1993-8#1)(2008-10#36)(2008-2#1)
concentration range is##3##3##(1990-12#1)(2008-10#2)
concentration range of 0##37##4##(1990-12#1)(2008-10#33)(2011-1#2)(2011-3#1)
concentration range of 0-2##2##4##(2008-10#2)
concentration range of 1##13##4##(1995-11#1)(2008-10#11)(2011-2#1)
concentration range of 2##5##4##(2008-10#5)
concentration range of 3##3##4##(2008-10#2)(2008-12#1)
concentration range of 5##5##4##(2008-10#5)
concentration range of 7##3##4##(2008-10#3)
concentration range of linear##2##4##(2008-10#2)
concentration range of the##3##4##(1995-2#1)(2008-10#2)
concentration range of two orders of magnitude##2##7##(2008-10#2)
concentration range of##122##3##(1990-12#1)(1995-11#1)(1995-2#1)(2008-10#108)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#2)(2011-1#2)(2011-2#1)(2011-3#2)(2013-1#1)
concentration range over which##2##4##(2008-10#2)
concentration range was##8##3##(2008-10#7)(2011-2#1)
concentration range##366##2##(1990-12#5)(1990-2#1)(1991-5#1)(1992-3#2)(1993-12#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#3)(1997-4#1)(2007-12#1)(2008-10#328)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-5#2)(2011-1#2)(2011-2#3)(2011-3#2)(2013-1#1)
concentration ranged from##4##3##(1993-6#1)(2008-5#2)(2013-8#1)
concentration ranges are##2##3##(2008-10#2)
concentration ranges for the##4##4##(2008-10#4)
concentration ranges for##5##3##(2008-10#5)
concentration ranges of##10##3##(2008-10#9)(2008-7#1)
concentration ranges to##2##3##(2008-10#2)
concentration ranges##51##2##(1995-8#1)(2008-10#47)(2008-11#1)(2008-7#1)(2012-2#1)
concentration ratio and varied pH##2##5##(2008-10#2)
concentration ratio of##5##3##(2008-10#3)(2011-1#1)(2013-1#1)
concentration ratio##14##2##(1993-8#1)(2008-10#7)(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
concentration ratios of Fe(II)##2##4##(2008-10#2)
concentration ratios of##8##3##(2007-12#1)(2008-10#6)(2008-6#1)
concentration ratios##14##2##(2007-12#1)(2008-10#11)(2008-3#1)(2008-6#1)
concentration reached##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
concentration reaches##2##2##(2008-11#1)(2008-6#1)
concentration reduced the##2##3##(2008-10#1)(2008-7#1)
concentration represent##2##2##(2008-11#1)(2009-7#1)
concentration required for##3##3##(1990-5#1)(2008-10#2)
concentration required##4##2##(1990-5#1)(1997-5#1)(2008-10#2)
concentration results in##2##3##(2008-10#2)
concentration samples##2##2##(2008-10#1)(2009-11#1)
concentration sensitivity##3##2##(2008-10#1)(2008-2#1)(2010-7#1)
concentration should##2##2##(2008-10#2)
concentration showed that##2##3##(1990-2#1)(2008-10#1)
concentration showed##8##2##(1990-2#1)(1990-7#1)(1994-11#1)(1994-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
concentration significantly##2##2##(2008-7#1)(2008-8#1)
concentration step##2##2##(2008-10#2)
concentration such##2##2##(2008-10#1)(2008-8#1)
concentration technique##3##2##(2008-10#2)(2013-8#1)
concentration tested##2##2##(1991-3#1)(2008-5#1)
concentration than the##2##3##(2008-10#1)(2011-2#1)
concentration than##5##2##(1992-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)
concentration that##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2012-3#1)
concentration time curve##3##3##(1996-3#1)(2008-11#1)(2008-12#1)
concentration to the##2##3##(1993-8#1)(2008-10#1)
concentration to##11##2##(1990-2#1)(1993-12#1)(1993-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)
concentration up to 1##2##4##(1994-3#1)(2008-10#1)
concentration up to 60##2##4##(1992-12#1)(2008-8#1)
concentration up to##11##3##(1992-12#1)(1994-11#1)(1994-3#1)(2008-10#4)(2008-7#1)(2008-8#2)(2011-2#1)
concentration used##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
concentration using a##2##3##(2008-10#1)(2008-11#1)
concentration using##7##2##(1994-12#2)(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
concentration value##2##2##(2008-10#1)(2008-11#1)
concentration values in##2##3##(2008-10#1)(2010-5#1)
concentration values of##3##3##(2008-10#3)
concentration values##12##2##(2008-10#7)(2008-9#3)(2010-5#1)(2013-1#1)
concentration versus time curve (AUC)##2##5##(2008-6#1)(2008-7#1)
concentration versus time##5##3##(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#2)
concentration versus##7##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#2)
concentration was 0##6##3##(2008-10#1)(2008-9#2)(2012-1#2)(2012-2#1)
concentration was 1##2##3##(2008-10#2)
concentration was also##2##3##(2008-11#1)(2008-5#1)
concentration was decreased##2##3##(2008-10#1)(2008-11#1)
concentration was determined by##3##4##(2008-10#2)(2011-2#1)
concentration was determined##11##3##(1990-5#1)(1990-7#1)(2008-10#5)(2008-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
concentration was found in##2##4##(2008-10#1)(2008-11#1)
concentration was found to be##3##5##(1992-9#1)(2008-10#2)
concentration was found##7##3##(1992-9#1)(2008-10#3)(2008-11#2)(2008-5#1)
concentration was increased##6##3##(1990-5#1)(1997-2#1)(2008-10#3)(2008-11#1)
concentration was less than##2##4##(2008-10#1)(2008-7#1)
concentration was low##2##3##(2008-3#1)(2013-1#1)
concentration was measured by##2##4##(2008-10#1)(2010-4#1)
concentration was measured##6##3##(1990-7#1)(1995-8#1)(2008-10#2)(2008-12#1)(2010-4#1)
concentration was monitored##2##3##(1997-2#1)(2008-10#1)
concentration was not##2##3##(1990-3#1)(1993-12#1)
concentration was observed##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
concentration was obtained in the range##3##6##(2008-10#2)(2008-12#1)
concentration was obtained##4##3##(2008-10#3)(2008-12#1)
concentration was only##2##3##(1991-5#1)(2008-11#1)
concentration was significantly higher in##3##5##(2008-10#1)(2009-3#1)(2011-2#1)
concentration was significantly higher##5##4##(2008-10#2)(2009-3#1)(2011-2#2)
concentration was significantly lower##2##4##(2008-7#1)(2011-1#1)
concentration was significantly##7##3##(2008-10#2)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)
concentration was so##2##3##(2008-10#1)(2008-3#1)
concentration was##127##2##(1990-3#2)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-8#2)(1994-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#3)(2008-1#1)(2008-10#49)(2008-11#11)(2008-12#3)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#4)(2009-3#2)(2010-4#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#3)(2013-1#3)(2013-8#3)
concentration were achieved##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
concentration were determined##2##3##(2008-10#1)(2008-3#1)
concentration were found for##2##4##(2008-10#2)
concentration were investigated in##3##4##(1993-12#1)(1995-2#1)(2008-10#1)
concentration were linear##2##3##(2008-10#2)
concentration were obtained with##3##4##(2008-10#3)
concentration were obtained##6##3##(2008-10#4)(2010-12#1)(2013-8#1)
concentration were selected##2##3##(1995-11#1)(2008-10#1)
concentration were studied##4##3##(2008-10#4)
concentration were##34##2##(1991-9#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#20)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-8#1)
concentration which##8##2##(1992-9#1)(1994-7#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)
concentration will##3##2##(1993-12#1)(2008-7#1)(2008-8#1)
concentration with an##4##3##(1994-8#1)(2008-10#1)(2008-6#1)(2011-10#1)
concentration with the##4##3##(1990-11#1)(2007-12#1)(2008-10#2)
concentration with##21##2##(1990-11#1)(1990-7#1)(1990-8#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-6#1)(2011-10#1)
concentration within the##3##3##(2008-10#3)
concentration within##8##2##(1994-6#1)(1996-1#1)(1996-2#1)(2008-10#3)(2008-11#1)(2012-12#1)
concentration without##2##2##(1990-8#1)(2008-6#1)
concentration would##2##2##(1990-8#1)(2008-11#1)
concentration##3965##1##(1990-10#3)(1990-11#10)(1990-12#21)(1990-2#14)(1990-3#10)(1990-5#27)(1990-6#4)(1990-7#17)(1990-8#12)(1990-9#5)(1991-11#2)(1991-12#25)(1991-2#8)(1991-3#2)(1991-5#18)(1991-6#4)(1991-7#1)(1991-8#7)(1991-9#12)(1992-1#1)(1992-10#1)(1992-11#10)(1992-12#10)(1992-2#2)(1992-3#31)(1992-4#1)(1992-5#6)(1992-6#20)(1992-8#12)(1992-9#19)(1993-1#8)(1993-11#14)(1993-12#17)(1993-2#7)(1993-3#11)(1993-6#15)(1993-8#23)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#13)(1994-12#18)(1994-2#12)(1994-3#10)(1994-5#15)(1994-6#18)(1994-7#4)(1994-8#15)(1994-9#8)(1995-11#16)(1995-12#14)(1995-2#17)(1995-3#18)(1995-5#11)(1995-6#7)(1995-8#16)(1996-1#1)(1996-11#2)(1996-12#23)(1996-2#11)(1996-3#11)(1996-5#16)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#17)(1997-3#2)(1997-4#17)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2007-1#2)(2007-10#3)(2007-11#22)(2007-12#22)(2007-7#3)(2008-1#22)(2008-10#1848)(2008-11#168)(2008-12#46)(2008-2#56)(2008-3#156)(2008-4#38)(2008-5#102)(2008-6#48)(2008-7#147)(2008-8#50)(2008-9#57)(2009-10#3)(2009-11#6)(2009-12#8)(2009-3#9)(2009-4#4)(2009-6#7)(2009-7#4)(2009-8#14)(2009-9#4)(2010-1#4)(2010-10#8)(2010-11#11)(2010-12#6)(2010-2#8)(2010-3#11)(2010-4#12)(2010-5#15)(2010-7#1)(2010-8#6)(2011-1#31)(2011-10#3)(2011-2#63)(2011-3#5)(2012-1#13)(2012-12#11)(2012-2#39)(2012-3#21)(2012-6#1)(2012-9#2)(2013-1#45)(2013-7#2)(2013-8#43)
concentration) and##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
concentration) of##2##2##(2008-5#1)(2011-3#1)
concentration) on the##2##3##(2008-10#1)(2008-3#1)
concentration) was##2##2##(2008-10#2)
concentration) were##4##2##(2008-10#3)(2010-3#1)
concentration)##29##1##(1995-6#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
concentration- and time-dependent##4##3##(1995-2#1)(1997-4#1)(2008-4#1)(2012-3#1)
concentration- and##6##2##(1992-6#1)(1992-7#1)(1995-2#1)(1997-4#1)(2008-4#1)(2012-3#1)
concentration-##7##1##(1992-6#1)(1992-7#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-4#1)(2012-3#1)
concentration-based##3##1##(2008-1#1)(2008-10#1)(2012-2#1)
concentration-dependent decrease in##2##3##(1993-12#1)(1996-12#1)
concentration-dependent decrease##3##2##(1993-12#1)(1996-12#1)(2008-7#1)
concentration-dependent fashion##7##2##(1990-5#1)(1993-11#1)(1994-6#1)(1997-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
concentration-dependent increase in##4##3##(1991-5#1)(1996-12#1)(1997-4#1)(2008-10#1)
concentration-dependent inhibition of##3##3##(1992-11#1)(1992-12#1)(1992-2#1)
concentration-dependent manner##41##2##(1990-5#1)(1990-7#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#5)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-5#2)(1997-1#2)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
concentration-dependent release of##2##3##(1992-11#1)(1997-7#1)
concentration-dependent##93##1##(1990-5#2)(1990-7#5)(1990-8#1)(1991-1#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#6)(1992-8#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#5)(1995-12#8)(1995-5#2)(1996-12#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#2)
concentration-dependently##3##1##(1994-11#1)(1997-4#1)(2008-10#1)
concentration-function approach##2##2##(2012-2#2)
concentration-related##3##1##(1995-12#1)(2008-8#1)(2008-9#1)
concentration-response curve##3##2##(1990-12#1)(1992-3#1)(1992-8#1)
concentration-response relationships##2##2##(1991-1#1)(2008-10#1)
concentration-response##7##1##(1990-12#1)(1991-1#1)(1992-3#1)(1992-8#1)(1995-12#1)(2008-10#2)
concentration-time curve (AUC)##2##3##(1996-5#1)(2012-3#1)
concentration-time curve##5##2##(1996-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
concentration-time##7##1##(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
concentrations &gt##4##2##(1994-8#1)(1995-8#1)(2008-10#1)(2009-12#1)
concentrations &lt##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
concentrations (&gt##3##2##(1994-11#1)(2008-7#1)(2009-6#1)
concentrations (&lt##3##2##(1995-3#1)(2008-10#2)
concentrations (0##19##2##(1990-5#2)(1992-8#2)(1995-12#1)(1995-3#1)(2006-6#1)(2008-10#6)(2008-12#2)(2008-5#2)(2010-3#1)(2012-2#1)
concentrations (1##5##2##(1990-2#1)(1991-5#1)(2008-10#1)(2008-3#1)(2010-5#1)
concentrations (10##2##2##(2008-10#2)
concentrations (3##4##2##(1990-5#1)(2008-10#3)
concentrations (5##2##2##(1994-12#1)(2008-6#1)
concentrations (C##3##2##(1993-8#2)(2011-2#1)
concentrations (P##2##2##(1991-9#1)(2008-4#1)
concentrations ([Ca2+]i)##2##2##(1994-2#1)(1997-1#1)
concentrations (from 0##2##3##(1997-2#1)(2008-10#1)
concentrations (from##3##2##(1997-2#1)(2008-10#2)
concentrations (i##2##2##(1992-8#1)(2008-10#1)
concentrations (up to##5##3##(1992-9#1)(1993-12#1)(2008-10#2)(2008-5#1)
concentrations 0##3##2##(2008-10#2)(2011-1#1)
concentrations 3##2##2##(1990-7#1)(2008-10#1)
concentrations above 1##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
concentrations above##12##2##(1990-5#1)(1990-6#1)(1994-6#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)
concentrations after##7##2##(1995-11#1)(2008-10#3)(2008-11#1)(2010-11#1)(2012-3#1)
concentrations also##2##2##(1990-5#1)(2008-10#1)
concentrations among##2##2##(1990-8#1)(2012-2#1)
concentrations and in##2##3##(1994-8#1)(2013-1#1)
concentrations and increasing##2##3##(1994-12#1)(2008-3#1)
concentrations and pH were##2##4##(1997-4#1)(2008-10#1)
concentrations and pH##5##3##(1997-4#1)(2008-10#3)(2013-8#1)
concentrations and personal exposure##2##4##(2008-11#2)
concentrations and the effect of##2##5##(2008-5#1)(2013-8#1)
concentrations and the##12##3##(1992-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#2)
concentrations and their##2##3##(2007-10#1)(2007-12#1)
concentrations and volumes##2##3##(2008-10#2)
concentrations and was##2##3##(1990-12#1)(2008-10#1)
concentrations and##90##2##(1990-12#1)(1991-12#2)(1992-11#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#2)(1994-9#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#32)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
concentrations are higher for materials with##2##6##(1996-12#2)
concentrations are less##2##3##(1990-5#1)(1993-12#1)
concentrations are measured##3##3##(2008-3#1)(2010-11#1)(2011-1#1)
concentrations are observed##2##3##(1993-8#1)(2008-10#1)
concentrations are##38##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1992-3#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-12#3)(1996-2#2)(1997-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#2)
concentrations as low as 0##4##5##(2008-10#2)(2008-11#2)
concentrations as low as##9##4##(2008-10#7)(2008-11#2)
concentrations as well as##5##4##(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)
concentrations as##28##2##(1990-7#1)(1991-9#1)(1993-12#1)(2007-11#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-2#1)
concentrations associated with##3##3##(1995-12#1)(1995-2#1)(2008-3#1)
concentrations at which##3##3##(1992-6#1)(1997-4#1)(2007-12#1)
concentrations at##11##2##(1992-3#1)(1992-6#2)(1995-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)
concentrations below 2##2##3##(2008-11#1)(2012-12#1)
concentrations below##7##2##(1992-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2012-12#1)
concentrations between 0##10##3##(2008-10#7)(2008-7#2)(2009-6#1)
concentrations between##27##2##(1992-12#2)(1993-9#1)(1994-8#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#1)(2013-1#1)
concentrations but also##2##3##(2008-3#1)(2011-1#1)
concentrations but inhibited at##2##4##(1992-5#1)(2009-3#1)
concentrations but not with##2##4##(1990-3#1)(1990-5#1)
concentrations but##7##2##(1990-3#1)(1990-5#1)(1992-5#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#1)
concentrations by##8##2##(1993-2#1)(2008-10#5)(2008-11#1)(2011-2#1)
concentrations can be##3##3##(2008-10#2)(2008-11#1)
concentrations can##6##2##(1992-12#1)(1992-3#1)(1996-12#1)(2008-10#2)(2008-11#1)
concentrations cannot be##2##3##(2009-4#1)(2011-2#1)
concentrations compared to##2##3##(1991-9#1)(2008-10#1)
concentrations correlated##2##2##(1990-2#1)(1994-11#1)
concentrations could be##4##3##(1994-8#1)(2008-10#1)(2009-4#1)(2009-5#1)
concentrations decreased##6##2##(1993-8#1)(1995-3#1)(2008-10#2)(2008-11#2)
concentrations determined by##2##3##(1996-2#1)(2008-10#1)
concentrations determined##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
concentrations did not##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
concentrations down to##3##3##(2008-10#3)
concentrations during##7##2##(1991-5#1)(1992-3#1)(1995-12#1)(1996-11#1)(2008-5#1)(2008-9#1)(2010-8#1)
concentrations for all##2##3##(2008-10#1)(2008-7#1)
concentrations for the##2##3##(1992-6#1)(2008-10#1)
concentrations for##28##2##(1992-5#1)(1992-6#3)(1994-9#1)(1995-5#1)(1996-7#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
concentrations found in##4##3##(1991-9#1)(2008-10#2)(2008-7#1)
concentrations found were##2##3##(2008-10#2)
concentrations found##9##2##(1991-9#1)(2008-10#6)(2008-7#1)(2013-1#1)
concentrations from 0##8##3##(1993-6#2)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)
concentrations from the##2##3##(2008-11#1)(2008-3#1)
concentrations from##18##2##(1993-6#2)(1994-11#1)(1994-8#1)(1995-12#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-7#1)(2011-2#1)
concentrations greater than 0##2##4##(2008-10#2)
concentrations greater than##7##3##(1997-6#1)(2008-10#5)(2008-5#1)
concentrations had a##2##3##(1993-11#1)(2013-1#1)
concentrations had##4##2##(1993-11#1)(2008-10#1)(2012-7#1)(2013-1#1)
concentrations has been##2##3##(1992-3#1)(2008-10#1)
concentrations has##3##2##(1992-3#1)(1992-7#1)(2008-10#1)
concentrations have been##4##3##(2007-10#1)(2008-1#1)(2008-10#2)
concentrations have##6##2##(1995-5#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#2)
concentrations higher than 1##2##4##(2008-10#2)
concentrations higher than those##2##4##(2008-10#1)(2008-11#1)
concentrations higher than##9##3##(1991-5#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)
concentrations in a##11##3##(1996-12#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-7#1)(2013-1#1)
concentrations in all##3##3##(1993-12#1)(1994-5#1)(2008-10#1)
concentrations in both##2##3##(2007-12#1)(2008-10#1)
concentrations in humans##3##3##(1991-1#1)(2010-11#2)
concentrations in patients with##5##4##(1990-2#1)(1992-11#2)(1993-8#1)(2008-3#1)
concentrations in plasma##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
concentrations in relation to##2##4##(1990-12#1)(2007-10#1)
concentrations in response to##3##4##(1992-11#1)(1995-8#1)(2010-10#1)
concentrations in seawater##2##3##(2008-10#2)
concentrations in serum##7##3##(1990-12#1)(1992-11#1)(1993-12#1)(1993-2#1)(1995-12#1)(2006-7#1)(2008-10#1)
concentrations in some##2##3##(1991-12#1)(2008-10#1)
concentrations in the range 0##2##5##(2008-10#2)
concentrations in the range of 0##2##6##(2008-10#2)
concentrations in the range of##4##5##(2008-10#3)(2009-11#1)
concentrations in the range##11##4##(1990-12#1)(2008-10#8)(2008-11#1)(2009-11#1)
concentrations in the samples were##2##5##(2008-10#2)
concentrations in the samples##3##4##(2008-10#3)
concentrations in the##69##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-2#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-10#33)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#2)(2009-9#1)
concentrations in tissue##2##3##(1991-8#1)(2008-3#1)
concentrations in urban##2##3##(2008-3#1)(2012-2#1)
concentrations in urine##3##3##(1995-12#2)(1997-4#1)
concentrations in various##2##3##(2008-10#1)(2008-5#1)
concentrations in water samples##3##4##(2008-10#3)
concentrations in water##6##3##(2008-10#5)(2008-3#1)
concentrations in##216##2##(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#4)(1992-12#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-8#3)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-8#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-4#5)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#78)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#2)
concentrations increased in the##2##4##(1992-2#1)(2013-1#1)
concentrations increased in##3##3##(1992-2#1)(1997-4#1)(2013-1#1)
concentrations increased significantly##5##3##(1994-12#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
concentrations increased##16##2##(1992-2#1)(1994-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
concentrations induced##2##2##(2010-3#1)(2010-8#1)
concentrations is also##2##3##(2008-10#1)(2008-3#1)
concentrations is##5##2##(1992-6#1)(2008-10#2)(2008-3#2)
concentrations levels##2##2##(2008-10#1)(2008-5#1)
concentrations lower than##3##3##(1993-9#1)(2008-10#1)(2008-2#1)
concentrations lower##5##2##(1993-9#1)(1996-5#1)(2008-10#2)(2008-2#1)
concentrations may have##2##3##(2008-10#1)(2008-3#1)
concentrations may##5##2##(2008-10#1)(2008-3#1)(2009-4#1)(2010-7#1)(2011-2#1)
concentrations measured in##3##3##(2008-3#2)(2013-1#1)
concentrations measured##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
concentrations observed##2##2##(2010-5#1)(2013-1#1)
concentrations obtained##5##2##(2008-10#4)(2008-5#1)
concentrations of 0##14##3##(1992-9#1)(1996-12#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)
concentrations of 1 x##2##4##(1992-8#1)(1994-5#1)
concentrations of 1##7##3##(1990-7#1)(1992-8#1)(1994-5#1)(2007-2#1)(2008-10#2)(2008-3#1)
concentrations of 100##2##3##(2008-10#2)
concentrations of 2##6##3##(2008-10#3)(2008-12#2)(2008-3#1)
concentrations of 5##4##3##(1994-5#2)(2008-10#1)(2008-5#1)
concentrations of 5-10##2##3##(1992-6#1)(1992-9#1)
concentrations of 50 ppm##2##4##(2008-11#1)(2008-5#1)
concentrations of 50##3##3##(2008-11#1)(2008-5#1)(2012-3#1)
concentrations of ANP##2##3##(1990-12#1)(2009-5#1)
concentrations of ATP##4##3##(1991-9#1)(1994-2#2)(2008-4#1)
concentrations of Al##2##3##(1996-12#2)
concentrations of CO2 and##2##4##(1993-6#1)(1995-8#1)
concentrations of CO2##3##3##(1993-6#1)(1995-8#1)(2007-12#1)
concentrations of CaO##2##3##(2013-1#2)
concentrations of Cr##2##3##(2008-10#1)(2008-2#1)
concentrations of Cu##2##3##(1997-4#1)(2008-10#1)
concentrations of HA##2##3##(2008-10#1)(2008-5#1)
concentrations of IL-2##2##3##(2008-11#1)(2008-7#1)
concentrations of IL-6sR##2##3##(2008-4#2)
concentrations of K+##2##3##(1992-6#1)(1993-11#1)
concentrations of KCl##2##3##(1993-11#1)(2008-11#1)
concentrations of LIF##2##3##(2008-11#2)
concentrations of Mg2+##4##3##(1992-3#3)(1995-3#1)
concentrations of NAA##2##3##(2007-10#1)(2008-10#1)
concentrations of NOM##2##3##(2008-11#2)
concentrations of PEG##2##3##(2008-12#1)(2011-2#1)
concentrations of PGRs##2##3##(2008-12#2)
concentrations of T3##2##3##(1994-11#1)(2008-10#1)
concentrations of VEGF and VEGFR2##2##5##(2012-1#2)
concentrations of Zn and Cu were##2##6##(1997-4#2)
concentrations of a##4##3##(2008-10#3)(2008-3#1)
concentrations of acetylcholine##4##3##(1994-8#3)(1995-11#1)
concentrations of adenosine or the##2##5##(1994-6#2)
concentrations of adenosine##4##3##(1992-9#1)(1993-12#1)(1994-6#2)
concentrations of aflatoxin##5##3##(2008-12#5)
concentrations of airborne##2##3##(2008-10#2)
concentrations of alkali##2##3##(2008-10#2)
concentrations of all##9##3##(1990-11#1)(1991-8#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-1#2)
concentrations of aluminium##3##3##(2008-10#3)
concentrations of aluminum##4##3##(2007-5#2)(2012-3#2)
concentrations of ammonium##3##3##(1990-12#1)(2008-10#2)
concentrations of antibodies against##2##4##(1992-2#1)(1993-3#1)
concentrations of antibodies##3##3##(1990-6#1)(1992-2#1)(1993-3#1)
concentrations of antiendometrial antibodies##2##4##(1995-2#2)
concentrations of approximately##4##3##(1995-2#2)(2008-3#2)
concentrations of benzo(a)pyrene##2##3##(1993-8#1)(2010-5#1)
concentrations of bicuculline##3##3##(1996-5#3)
concentrations of both##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
concentrations of calcium and##2##4##(1992-9#1)(2008-10#1)
concentrations of calcium##4##3##(1992-9#1)(1997-5#1)(2008-10#1)(2011-1#1)
concentrations of chromium and##2##4##(2008-10#1)(2008-12#1)
concentrations of chromium##3##3##(2008-10#2)(2008-12#1)
concentrations of citrinin##2##3##(1993-12#2)
concentrations of combustion##2##3##(1996-12#2)
concentrations of copper and##2##4##(2007-5#1)(2008-10#1)
concentrations of copper##5##3##(1992-12#1)(1995-3#1)(2007-5#1)(2008-10#2)
concentrations of cystine##2##3##(1991-9#1)(2008-10#1)
concentrations of different##2##3##(2008-10#1)(2008-2#1)
concentrations of each##2##3##(2008-3#1)(2010-3#1)
concentrations of either##3##3##(1990-11#2)(2008-2#1)
concentrations of ellagic acid in##2##5##(1994-6#2)
concentrations of estrogen##2##3##(1997-6#1)(2013-1#1)
concentrations of ethanol##3##3##(1990-12#1)(1992-7#2)
concentrations of extracellular##4##3##(1990-7#1)(1995-12#1)(2008-11#1)(2013-8#1)
concentrations of glucose##8##3##(1990-5#1)(1991-2#1)(1994-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
concentrations of hepatic##2##3##(1990-5#1)(1994-8#1)
concentrations of high-density lipoprotein (HDL)##2##5##(2008-6#2)
concentrations of human##2##3##(1990-5#1)(1994-11#1)
concentrations of hydrogen peroxide##2##4##(2008-10#2)
concentrations of hydrogen##3##3##(1992-12#1)(2008-10#2)
concentrations of individual##2##3##(1995-8#1)(2008-10#1)
concentrations of interest##2##3##(2008-10#1)(2008-3#1)
concentrations of ions##2##3##(2008-10#1)(2008-9#1)
concentrations of iron and##2##4##(2008-10#1)(2013-8#1)
concentrations of iron##3##3##(2008-10#2)(2013-8#1)
concentrations of lead##4##3##(1997-4#2)(2008-10#1)(2008-12#1)
concentrations of less than##2##4##(1997-4#1)(2008-10#1)
concentrations of lipoproteins##2##3##(1993-9#1)(1995-5#1)
concentrations of liver##2##3##(1996-11#1)(2009-8#1)
concentrations of mercury##2##3##(1995-6#1)(2008-10#1)
concentrations of metal ions##2##4##(2008-10#2)
concentrations of metal##3##3##(2008-10#3)
concentrations of metallothionein##2##3##(1990-5#2)
concentrations of metals in##2##4##(2008-10#1)(2011-2#1)
concentrations of metals##6##3##(2008-10#3)(2010-5#1)(2011-2#1)(2013-1#1)
concentrations of methotrexate##2##3##(2008-11#2)
concentrations of mixtures##3##3##(1992-5#1)(2008-10#1)(2013-8#1)
concentrations of more than##2##4##(1994-2#1)(2008-10#1)
concentrations of naproxen##2##3##(2008-10#2)
concentrations of natriuretic peptides##2##4##(2009-5#2)
concentrations of nitrite##3##3##(1996-11#1)(2008-10#2)
concentrations of organic solvents##2##4##(2008-10#1)(2011-2#1)
concentrations of organic##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
concentrations of other##3##3##(1990-2#1)(1994-9#1)(2008-10#1)
concentrations of phorbol ester##2##4##(1992-8#1)(2008-11#1)
concentrations of phorbol##3##3##(1990-12#1)(1992-8#1)(2008-11#1)
concentrations of phosphate##2##3##(2008-10#2)
concentrations of phosphatidylinositol##2##3##(1991-8#2)
concentrations of scatterers##2##3##(2008-2#1)(2008-3#1)
concentrations of seed extract##2##4##(2012-2#2)
concentrations of serum##3##3##(1991-12#1)(1992-6#1)(2008-11#1)
concentrations of several##2##3##(2008-10#1)(2012-3#1)
concentrations of sodium chloride##2##4##(1994-5#1)(2008-12#1)
concentrations of sodium##6##3##(1994-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
concentrations of specific##2##3##(2009-9#1)(2011-2#1)
concentrations of suspended##3##3##(2008-3#1)(2008-5#2)
concentrations of the analyte##2##4##(2008-10#2)
concentrations of the analytes in##2##5##(2008-10#2)
concentrations of the analytes##4##4##(2008-10#4)
concentrations of the antifungals##2##4##(2008-5#2)
concentrations of the dyes##2##4##(1990-6#1)(2008-3#1)
concentrations of the elements were##2##5##(2008-10#2)
concentrations of the elements##4##4##(2008-10#4)
concentrations of the metal##2##4##(1992-11#1)(2008-10#1)
concentrations of the peptides were##2##5##(1992-9#1)(2012-1#1)
concentrations of the products of incomplete combustion##2##7##(1996-12#2)
concentrations of the second##2##4##(1992-3#1)(2013-7#1)
concentrations of the three##5##4##(2008-10#2)(2008-7#2)(2010-5#1)
concentrations of the##99##3##(1990-11#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-2#1)(2007-5#1)(2008-1#1)(2008-10#41)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#6)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#2)
concentrations of these drugs##2##4##(2008-10#2)
concentrations of these##13##3##(1990-12#1)(1990-7#1)(1993-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2011-1#1)
concentrations of thiobarbituric acid reactive substances##2##6##(1992-3#2)
concentrations of this##5##3##(1990-2#1)(1991-6#1)(1991-9#1)(2008-10#2)
concentrations of three##2##3##(2008-5#1)(2013-8#1)
concentrations of total##4##3##(1991-6#1)(2008-10#1)(2008-5#1)(2009-4#1)
concentrations of two##4##3##(1995-3#1)(1996-5#1)(2008-10#2)
concentrations of up to##4##4##(1991-2#1)(1996-1#1)(1997-4#2)
concentrations of various##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
concentrations of vitamin##2##3##(2010-10#1)(2013-1#1)
concentrations of vitamins##2##3##(1997-3#1)(2008-11#1)
concentrations of##842##2##(1990-10#1)(1990-11#7)(1990-12#7)(1990-2#6)(1990-3#1)(1990-5#9)(1990-6#2)(1990-7#5)(1990-8#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#2)(1991-8#4)(1991-9#7)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#12)(1992-5#5)(1992-6#8)(1992-7#3)(1992-8#6)(1992-9#5)(1993-1#2)(1993-11#5)(1993-12#7)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#9)(1994-6#13)(1994-8#9)(1994-9#5)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#6)(1996-1#2)(1996-11#2)(1996-12#13)(1996-2#4)(1996-4#3)(1996-5#6)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#20)(1997-5#1)(1997-6#2)(1997-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#4)(2007-8#2)(2008-1#3)(2008-10#257)(2008-11#44)(2008-12#15)(2008-2#11)(2008-3#29)(2008-4#10)(2008-5#22)(2008-6#7)(2008-7#18)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#3)(2010-3#3)(2010-5#5)(2010-8#4)(2011-1#6)(2011-2#15)(2011-3#2)(2012-1#9)(2012-12#4)(2012-2#9)(2012-3#8)(2012-7#1)(2012-9#1)(2013-1#18)(2013-7#3)(2013-8#7)
concentrations on##7##2##(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
concentrations or the##2##3##(2008-10#1)(2008-3#1)
concentrations or##7##2##(1992-3#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-8#1)
concentrations over the##2##3##(2008-11#1)(2010-3#1)
concentrations over##7##2##(1993-11#1)(1993-12#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)
concentrations possible in##2##3##(2008-10#1)(2012-2#1)
concentrations produced##2##2##(2008-7#1)(2013-7#1)
concentrations ranged between##2##3##(2008-10#1)(2011-2#1)
concentrations ranged from##4##3##(2008-10#3)(2008-6#1)
concentrations ranged##7##2##(2008-10#5)(2008-6#1)(2011-2#1)
concentrations ranging from 0##4##4##(1993-12#1)(1997-8#1)(2008-11#1)(2013-1#1)
concentrations ranging from 1##3##4##(2008-10#2)(2008-11#1)
concentrations ranging from 4##2##4##(2008-10#2)
concentrations ranging from##23##3##(1991-2#1)(1991-9#1)(1993-12#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-6#1)(2013-1#1)
concentrations ranging##24##2##(1991-2#1)(1991-9#1)(1993-12#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#12)(2008-11#3)(2008-4#1)(2008-6#1)(2013-1#1)
concentrations showed significant##2##3##(1995-8#1)(2008-7#1)
concentrations showed##6##2##(1990-2#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#2)
concentrations similar to##2##3##(1991-12#1)(1995-12#1)
concentrations studied##5##2##(1994-8#1)(2008-10#4)
concentrations tended to##2##3##(1995-3#1)(1996-9#1)
concentrations tested##5##2##(2008-10#2)(2008-11#2)(2008-7#1)
concentrations than in##2##3##(1994-3#1)(2013-8#1)
concentrations than##10##2##(1990-12#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1997-3#1)(2008-11#1)(2012-2#1)(2013-8#1)
concentrations that are##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
concentrations that##16##2##(1990-11#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
concentrations thus##2##2##(1994-8#1)(2008-10#1)
concentrations to an accuracy of +/-50%##2##6##(2008-3#2)
concentrations to##9##2##(1993-6#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-9#1)
concentrations typically##2##2##(2008-10#1)(2008-2#1)
concentrations up to 0##2##4##(2008-10#2)
concentrations up to 1##2##4##(1994-11#1)(2008-10#1)
concentrations up to 100##2##4##(1995-5#1)(2008-12#1)
concentrations up to##19##3##(1990-2#1)(1994-11#1)(1995-5#1)(2008-10#13)(2008-12#1)(2008-5#1)(2013-1#1)
concentrations used in the##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
concentrations used in##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
concentrations used##10##2##(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2011-2#1)
concentrations using##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
concentrations vary##2##2##(1992-3#1)(2013-1#1)
concentrations was between##2##3##(2008-10#2)
concentrations was not##2##3##(1990-5#1)(2008-10#1)
concentrations was##10##2##(1990-5#1)(2008-10#5)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
concentrations well below the##2##4##(1995-2#1)(2008-3#1)
concentrations were 2##2##3##(1996-12#1)(2011-2#1)
concentrations were achieved##2##3##(2008-3#1)(2013-1#1)
concentrations were also##2##3##(1995-11#1)(2008-9#1)
concentrations were analyzed##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
concentrations were detected##2##3##(2008-10#2)
concentrations were determined by the##2##5##(2007-10#1)(2009-8#1)
concentrations were determined by##3##4##(2007-10#1)(2008-2#1)(2009-8#1)
concentrations were determined from##2##4##(1991-9#1)(2008-3#1)
concentrations were determined in##4##4##(1994-7#1)(2008-10#2)(2009-4#1)
concentrations were determined##16##3##(1990-12#1)(1991-9#1)(1994-7#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-8#1)
concentrations were found in##2##4##(1990-2#1)(1994-6#1)
concentrations were found##6##3##(1990-2#1)(1994-6#1)(1997-4#1)(2008-10#2)(2013-7#1)
concentrations were higher##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
concentrations were in general##2##4##(2008-10#1)(2008-2#1)
concentrations were in the##2##4##(1992-2#1)(2013-8#1)
concentrations were in##4##3##(1992-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
concentrations were increased##5##3##(1990-7#1)(1994-8#1)(2008-10#1)(2009-4#1)(2012-2#1)
concentrations were investigated in##2##4##(1993-1#1)(2008-10#1)
concentrations were low##2##3##(1992-6#1)(2008-10#1)
concentrations were lower than##2##4##(2010-8#1)(2013-1#1)
concentrations were lowered##2##3##(1990-12#1)(1993-8#1)
concentrations were measured in the##2##5##(1994-2#1)(1994-7#1)
concentrations were measured in##4##4##(1994-2#1)(1994-7#1)(2008-10#1)(2013-1#1)
concentrations were measured using##3##4##(1993-2#1)(2009-8#1)(2011-2#1)
concentrations were measured##11##3##(1993-2#1)(1994-2#1)(1994-6#1)(1994-7#1)(2008-10#2)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
concentrations were not##2##3##(1992-11#1)(2008-10#1)
concentrations were obtained##2##3##(2008-10#2)
concentrations were reduced##3##3##(1991-6#1)(1994-6#1)(2010-2#1)
concentrations were significantly higher in##2##5##(1993-2#1)(2011-1#1)
concentrations were significantly##6##3##(1990-2#1)(1993-2#2)(2008-10#1)(2011-1#1)(2011-2#1)
concentrations were similar in##3##4##(1991-12#1)(2008-10#1)(2008-3#1)
concentrations were similar to##2##4##(1994-12#1)(2008-10#1)
concentrations were similar##5##3##(1991-12#1)(1994-12#1)(2008-10#2)(2008-3#1)
concentrations were studied##2##3##(1995-8#1)(2008-10#1)
concentrations were used in##2##4##(2008-10#1)(2008-3#1)
concentrations were##138##2##(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#5)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#3)(2009-8#2)(2010-2#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#3)
concentrations when compared to##2##4##(1995-3#1)(2008-7#1)
concentrations when##3##2##(1990-12#1)(1995-3#1)(2008-7#1)
concentrations which##5##2##(1990-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-1#1)
concentrations with a##2##3##(2008-10#1)(2008-3#1)
concentrations with the##2##3##(1993-11#1)(2008-10#1)
concentrations with##11##2##(1993-11#1)(2007-5#1)(2008-10#5)(2008-3#1)(2012-12#1)(2013-1#2)
concentrations within##2##2##(2008-3#1)(2013-1#1)
concentrations##2427##1##(1990-10#1)(1990-11#12)(1990-12#27)(1990-2#20)(1990-3#7)(1990-5#33)(1990-6#3)(1990-7#11)(1990-8#8)(1990-9#3)(1991-1#2)(1991-12#21)(1991-2#9)(1991-3#2)(1991-5#11)(1991-6#4)(1991-8#7)(1991-9#18)(1992-10#1)(1992-11#17)(1992-12#14)(1992-2#9)(1992-3#29)(1992-4#1)(1992-5#9)(1992-6#26)(1992-7#4)(1992-8#14)(1992-9#12)(1993-1#5)(1993-11#11)(1993-12#21)(1993-2#13)(1993-3#6)(1993-6#12)(1993-8#18)(1993-9#8)(1994-11#13)(1994-12#8)(1994-2#14)(1994-3#6)(1994-5#15)(1994-6#19)(1994-7#2)(1994-8#32)(1994-9#8)(1995-11#11)(1995-12#17)(1995-2#18)(1995-3#13)(1995-5#10)(1995-6#3)(1995-8#13)(1996-1#4)(1996-11#3)(1996-12#32)(1996-2#11)(1996-3#1)(1996-4#4)(1996-5#11)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#4)(1997-2#13)(1997-3#5)(1997-4#41)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#5)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#14)(2007-2#2)(2007-5#7)(2007-8#4)(2008-1#9)(2008-10#741)(2008-11#113)(2008-12#43)(2008-2#37)(2008-3#97)(2008-4#21)(2008-5#63)(2008-6#21)(2008-7#63)(2008-8#21)(2008-9#12)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#15)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#6)(2010-11#11)(2010-12#1)(2010-2#3)(2010-3#7)(2010-4#4)(2010-5#13)(2010-7#3)(2010-8#14)(2011-1#22)(2011-10#2)(2011-2#39)(2011-3#7)(2012-1#9)(2012-12#8)(2012-2#40)(2012-3#16)(2012-5#4)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#66)(2013-7#11)(2013-8#24)
concentrations) and##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
concentrations) in##3##2##(2008-10#2)(2008-3#1)
concentrations) were##2##2##(2008-10#1)(2008-7#1)
concentrations)##18##1##(1991-8#1)(1992-3#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#1)(2013-8#1)
concentrator##13##1##(2008-10#2)(2008-2#2)(2008-3#6)(2013-8#3)
concentrators and##2##2##(2008-3#2)
concentrators##12##1##(2007-12#1)(2008-3#11)
concentric ring electrodes##2##3##(2007-12#2)
concentric rings##2##2##(2008-10#1)(2008-2#1)
concentric tube##2##2##(2012-1#2)
concentric vanes##2##2##(2008-3#2)
concentric##26##1##(1991-3#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-8#1)(2011-1#1)(2012-1#2)(2013-1#1)
concentrically##3##1##(2008-10#2)(2012-1#1)
concept &quot##2##2##(2007-2#1)(2013-1#1)
concept allows for##2##3##(2007-8#1)(2008-3#1)
concept among##2##2##(2008-1#1)(2009-10#1)
concept analysis##3##2##(2008-11#1)(2013-1#2)
concept and its##2##3##(1994-2#1)(2008-10#1)
concept and the##4##3##(1995-2#1)(2007-8#1)(2008-3#1)(2009-12#1)
concept and##25##2##(1990-6#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-2#1)(2007-8#1)(2008-10#3)(2008-3#4)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#2)(2010-8#1)(2012-2#2)(2013-8#1)
concept based on the##2##4##(2008-10#1)(2008-11#1)
concept based on##6##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-1#1)
concept behind##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
concept could##2##2##(1991-6#1)(2008-11#1)
concept for a##4##3##(1997-6#1)(2007-11#1)(2008-3#1)(2008-6#1)
concept for an##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
concept for the##3##3##(2008-10#1)(2008-2#1)(2010-10#1)
concept for##20##2##(1992-12#1)(1997-6#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-6#1)(2010-10#1)(2011-2#1)
concept formulated by##2##3##(1991-9#1)(2010-4#1)
concept has been##6##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-8#1)
concept has##8##2##(1992-1#1)(1992-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-8#1)
concept in a##2##3##(1995-2#1)(2011-2#1)
concept in the##3##3##(1992-12#1)(2007-7#1)(2010-7#1)
concept in##21##2##(1991-12#1)(1992-12#1)(1995-2#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
concept is based on a##2##5##(2008-2#1)(2008-3#1)
concept is based on the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
concept is based on##8##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)
concept is demonstrated##2##3##(2008-10#1)(2008-3#1)
concept is illustrated with##2##4##(2007-12#1)(2008-10#1)
concept is that##3##3##(1992-2#1)(2008-3#1)(2010-8#1)
concept is the##2##3##(1995-2#1)(2010-4#1)
concept is##29##2##(1992-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#2)(2013-1#1)
concept mapping##3##2##(2008-11#1)(2008-12#2)
concept maps##4##2##(2008-12#4)
concept of &quot##12##3##(1990-6#1)(1991-12#1)(1992-3#2)(1995-5#1)(1997-1#1)(2007-12#1)(2009-10#1)(2012-12#2)(2012-2#1)(2012-3#1)
concept of a &quot##2##4##(1995-6#1)(2012-2#1)
concept of a threshold##2##4##(2008-10#1)(2009-5#1)
concept of a##19##3##(1990-3#1)(1991-1#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-1#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-5#1)(2012-2#1)
concept of acute##3##3##(1996-9#2)(2010-12#1)
concept of an##4##3##(1994-11#1)(1997-8#1)(2008-10#1)(2008-3#1)
concept of childhood##2##3##(1995-5#2)
concept of ice-like-water capture&quot##2##4##(2008-5#2)
concept of mentorship##2##3##(2008-11#2)
concept of mixed##3##3##(2008-10#1)(2012-2#2)
concept of nursing advocacy##2##4##(2009-12#2)
concept of nursing##3##3##(2009-12#2)(2010-3#1)
concept of prevention##2##3##(2009-8#1)(2010-4#1)
concept of rehabilitation##2##3##(2010-10#1)(2013-1#1)
concept of residual confounding##2##4##(1992-9#2)
concept of self##2##3##(2008-11#1)(2010-8#1)
concept of stewardship##3##3##(2012-2#3)
concept of the limbic system##2##5##(1992-12#2)
concept of the##24##3##(1990-6#1)(1991-9#1)(1992-12#2)(1993-1#1)(1994-2#1)(1996-9#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-2#2)(2008-3#1)(2009-5#3)(2009-7#1)(2010-12#2)(2012-12#2)(2013-8#1)
concept of##263##2##(1990-2#2)(1990-3#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#5)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#18)(2008-11#6)(2008-12#6)(2008-2#10)(2008-3#18)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#6)(2009-10#3)(2009-12#2)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#6)(2010-3#3)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#8)(2012-2#15)(2012-3#6)(2013-1#8)(2013-7#4)(2013-8#2)
concept presented##3##2##(1991-3#1)(2012-2#2)
concept provides##2##2##(2007-12#1)(2008-3#1)
concept that can##2##3##(2008-3#1)(2010-6#1)
concept that##45##2##(1990-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#2)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#1)(2009-10#2)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
concept to a##2##3##(1994-12#1)(2008-6#1)
concept to##12##2##(1993-12#2)(1994-12#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#2)(2010-8#1)
concept was##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)
concept we##3##2##(2007-12#1)(2011-1#1)(2012-2#1)
concept which##2##2##(2008-12#1)(2009-5#1)
concept will##3##2##(1990-2#1)(2008-3#1)(2011-2#1)
concept with##5##2##(1997-1#1)(2007-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
concept##592##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#5)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#4)(1992-1#4)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#2)(1992-9#3)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#4)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#8)(1995-3#1)(1995-5#5)(1995-6#3)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#5)(1997-1#5)(1997-3#4)(1997-4#3)(1997-6#7)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#13)(2007-12#14)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#8)(2008-1#8)(2008-10#66)(2008-11#16)(2008-12#15)(2008-2#21)(2008-3#54)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#21)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#7)(2009-12#3)(2009-5#9)(2009-6#4)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#9)(2010-11#2)(2010-12#7)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#6)(2010-7#1)(2010-8#9)(2011-1#5)(2011-2#14)(2011-9#1)(2012-1#3)(2012-12#10)(2012-2#27)(2012-3#10)(2013-1#18)(2013-7#4)(2013-8#5)
concept]##2##1##(1993-3#1)(1995-6#1)
conception and##2##2##(2008-10#1)(2010-11#1)
conception in##2##2##(1990-9#1)(2011-1#1)
conception of the##3##3##(1992-1#1)(2009-10#1)(2012-2#1)
conception of##5##2##(1992-1#1)(1992-3#1)(2007-11#1)(2009-10#1)(2012-2#1)
conception rate in Japanese Black cows##2##6##(2013-1#2)
conception rate##3##2##(2013-1#3)
conception through##2##2##(2012-12#1)(2012-2#1)
conception to##2##2##(1994-7#1)(2008-11#1)
conception##43##1##(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1996-9#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
conceptions about##2##2##(2009-7#1)(2013-8#1)
conceptions of human##2##3##(2010-5#1)(2013-1#1)
conceptions of##10##2##(1993-1#1)(1995-3#3)(1996-6#1)(2008-5#1)(2009-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
conceptions##16##1##(1993-1#1)(1995-3#3)(1996-6#1)(2008-5#1)(2009-7#1)(2009-9#2)(2010-5#1)(2012-12#2)(2013-1#1)(2013-8#3)
concepts about##2##2##(2008-10#1)(2011-2#1)
concepts and clinical implications##2##4##(1996-2#1)(2008-7#1)
concepts and clinical##3##3##(1996-2#1)(2007-11#1)(2008-7#1)
concepts and methods##2##3##(2008-1#1)(2012-1#1)
concepts and##28##2##(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
concepts are##12##2##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-5#1)
concepts can be##2##3##(2008-7#1)(2013-8#1)
concepts for##6##2##(1990-3#1)(1990-6#1)(1994-12#1)(2008-10#1)(2008-3#1)(2010-7#1)
concepts from the##2##3##(1995-3#1)(2012-3#1)
concepts from##4##2##(1995-3#1)(1996-2#1)(2012-3#2)
concepts have been##4##3##(1993-12#1)(1997-2#1)(2007-2#1)(2008-7#1)
concepts have##6##2##(1993-12#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-5#1)
concepts identified in the journals##2##5##(2012-12#2)
concepts in forest pathology##2##4##(2008-10#2)
concepts in the##3##3##(1993-11#1)(2007-12#1)(2008-11#1)
concepts in##23##2##(1992-1#1)(1992-8#1)(1993-11#1)(1995-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
concepts into##3##2##(1995-12#1)(2008-12#1)(2008-5#1)
concepts of self-organization##2##3##(2008-9#2)
concepts of##60##2##(1990-11#1)(1992-2#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
concepts presented in##2##3##(2008-10#1)(2013-1#1)
concepts regarding the##2##3##(1997-1#1)(2009-11#1)
concepts regarding##4##2##(1994-8#1)(1997-1#1)(2009-11#1)(2009-6#1)
concepts related to##2##3##(2007-12#1)(2010-8#1)
concepts such as##5##3##(1995-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
concepts that are##4##3##(2008-1#1)(2008-7#2)(2013-1#1)
concepts that##9##2##(1992-2#1)(1994-8#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2012-3#1)(2013-1#1)
concepts to the##2##3##(1991-3#1)(2008-7#1)
concepts to##8##2##(1991-3#1)(1993-3#1)(1996-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
concepts underlying##3##2##(1993-6#1)(1995-1#1)(2011-2#1)
concepts were##2##2##(2010-10#1)(2012-12#1)
concepts will##2##2##(1993-2#1)(1995-2#1)
concepts##256##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#4)(1996-12#2)(1996-2#4)(1996-3#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-4#1)(2007-8#2)(2008-1#6)(2008-10#22)(2008-11#10)(2008-12#5)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#21)(2008-8#5)(2008-9#11)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#3)
conceptual advances##2##2##(2008-8#2)
conceptual and empirical##2##3##(2010-10#1)(2010-3#1)
conceptual and practical##2##3##(1997-1#1)(1997-2#1)
conceptual and##11##2##(1995-3#1)(1997-1#1)(1997-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
conceptual applications employed in this technology set are provided by way of illustration##4##13##(2010-8#4)
conceptual approach to##2##3##(1992-3#1)(2007-11#1)
conceptual approach##3##2##(1992-3#2)(2007-11#1)
conceptual basis##3##2##(2008-7#1)(2008-8#1)(2013-8#1)
conceptual categories##2##2##(1991-2#1)(2008-11#1)
conceptual change##3##2##(2011-2#3)
conceptual changes##2##2##(2007-7#1)(2008-11#1)
conceptual developments##3##2##(1996-1#1)(2008-10#1)(2011-1#1)
conceptual disorganization##2##2##(2008-6#2)
conceptual framework and##3##3##(1993-2#1)(1997-2#1)(2007-12#1)
conceptual framework for all##2##4##(1997-3#1)(2008-7#1)
conceptual framework for##9##3##(1992-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)
conceptual framework of##5##3##(1992-3#1)(2008-7#1)(2011-1#1)(2013-1#2)
conceptual framework to##2##3##(2008-12#1)(2008-7#1)
conceptual framework##30##2##(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#4)(1997-3#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-7#3)(2008-8#1)(2010-3#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
conceptual frameworks##2##2##(1996-12#1)(2012-12#1)
conceptual issues##3##2##(1996-2#1)(1997-4#1)(2009-7#1)
conceptual model for##2##3##(2010-5#1)(2012-3#1)
conceptual model##6##2##(1992-12#1)(1996-12#1)(2008-10#1)(2010-5#1)(2012-3#1)(2013-8#1)
conceptual models##4##2##(2008-4#1)(2009-9#1)(2012-12#2)
conceptual revolution##2##2##(1995-4#2)
conceptual skills##2##2##(1996-3#2)
conceptual work##2##2##(1995-5#1)(1997-3#1)
conceptual##138##1##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#5)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#5)
conceptualisation of clinical decision-making##2##4##(2008-11#2)
conceptualisation of##3##2##(2008-11#3)
conceptualised##2##1##(2008-10#1)(2009-5#1)
conceptualization and measurement of##2##4##(1995-1#1)(2008-11#1)
conceptualization of##3##2##(1992-3#1)(2009-9#1)(2012-12#1)
conceptualization##8##1##(1992-3#2)(1995-1#1)(1997-1#1)(2008-11#1)(2009-9#1)(2010-10#1)(2012-12#1)
conceptualizations and##2##2##(2008-2#1)(2009-9#1)
conceptualizations of illness##2##3##(1993-1#1)(1993-12#1)
conceptualizations of##4##2##(1993-1#2)(1993-12#1)(2009-9#1)
conceptualizations##8##1##(1993-1#3)(1993-12#1)(2008-2#1)(2009-9#3)
conceptualize##4##1##(2010-4#1)(2012-2#1)(2013-1#2)
conceptualized and##2##2##(2007-12#1)(2008-6#1)
conceptualized##4##1##(2007-12#1)(2008-2#1)(2008-6#1)(2010-10#1)
conceptualizing##2##1##(2012-2#1)(2012-3#1)
conceptually simple and##2##3##(2008-10#1)(2008-3#1)
conceptually##12##1##(1993-1#2)(1995-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
concern about AIDS as an epidemic##2##6##(1992-2#2)
concern about the high##2##4##(1993-12#1)(1993-6#1)
concern about the possibility of##2##5##(1992-12#1)(2008-11#1)
concern about the##10##3##(1992-12#1)(1993-12#1)(1993-6#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)
concern about##26##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#3)(1993-6#2)(1994-2#1)(1995-11#1)(1996-1#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)
concern all##2##2##(1994-2#1)(2010-8#1)
concern among##7##2##(1992-2#1)(1992-3#1)(1997-3#1)(2008-11#1)(2010-12#1)(2010-4#1)(2012-1#1)
concern and##7##2##(1990-12#1)(1991-1#1)(1994-3#1)(2006-10#1)(2007-7#1)(2008-11#1)(2010-1#1)
concern are##3##2##(2008-11#2)(2008-2#1)
concern as##4##2##(1991-3#1)(2008-10#1)(2008-12#1)(2010-11#1)
concern at##2##2##(2008-11#1)(2010-8#1)
concern because##4##2##(1994-2#1)(2007-12#1)(2007-2#1)(2008-8#1)
concern due to their##2##4##(2008-10#1)(2009-4#1)
concern due to##3##3##(2008-10#1)(2008-12#1)(2009-4#1)
concern for patients##2##3##(1996-1#1)(2008-1#1)
concern for the##6##3##(1992-4#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
concern for their children's well-being##2##5##(1995-1#2)
concern for##27##2##(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-1#2)(1996-1#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
concern has been##2##3##(2012-2#1)(2012-3#1)
concern in the##6##3##(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
concern in##27##2##(1991-4#1)(1993-2#1)(1994-1#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
concern is the##2##3##(1997-4#1)(2008-11#1)
concern is##11##2##(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
concern of the##2##3##(2008-1#1)(2008-12#1)
concern of##7##2##(1995-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
concern on the##3##3##(1990-2#1)(1993-3#1)(2009-3#1)
concern on##5##2##(1990-2#1)(1993-3#1)(1996-1#1)(2009-3#1)(2011-1#1)
concern over##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
concern regarding##4##2##(1992-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
concern that this##2##3##(1992-8#1)(1997-8#1)
concern that##13##2##(1992-8#1)(1994-9#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#1)
concern the##6##2##(1992-12#1)(1995-2#1)(1995-9#1)(2008-8#1)(2012-2#1)(2013-8#1)
concern to##11##2##(1992-1#1)(1994-3#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
concern was the##2##3##(2009-10#1)(2011-2#1)
concern was##10##2##(1997-2#1)(2007-6#1)(2008-10#3)(2009-10#2)(2011-2#2)(2012-3#1)
concern when##2##2##(1995-3#1)(2011-2#1)
concern with weight and food##2##5##(2011-2#2)
concern with##8##2##(1995-1#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
concern##268##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-1#2)(1992-12#2)(1992-2#5)(1992-3#2)(1992-4#1)(1992-8#3)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#5)(1994-3#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#5)(2008-10#31)(2008-11#18)(2008-12#13)(2008-2#5)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#4)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#5)
concerned about the##3##3##(1992-3#2)(1994-3#1)
concerned about their##4##3##(1991-2#1)(1995-6#1)(2008-1#1)(2013-8#1)
concerned about##19##2##(1991-1#1)(1991-2#2)(1992-3#2)(1993-11#1)(1993-3#1)(1994-3#1)(1995-6#3)(1996-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-8#1)(2013-8#2)
concerned or##2##2##(2008-3#1)(2013-1#1)
concerned that the##2##3##(2008-7#1)(2010-5#1)
concerned that##6##2##(1996-2#1)(1996-5#1)(2007-5#1)(2008-1#1)(2008-7#1)(2010-5#1)
concerned the##3##2##(2008-1#1)(2008-10#2)
concerned with a##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
concerned with the relationship between##2##5##(1992-3#1)(2011-2#1)
concerned with the##20##3##(1991-2#2)(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
concerned with##57##2##(1991-2#2)(1992-1#1)(1992-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-1#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#2)
concerned##133##1##(1990-10#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#6)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#4)(1993-11#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1996-2#1)(1996-5#2)(1997-1#1)(1997-4#2)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#9)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-12#2)(2009-5#2)(2010-1#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#5)(2013-8#2)
concerning Treg##2##2##(2013-8#2)
concerning a##7##2##(2008-5#1)(2008-7#4)(2010-6#1)(2012-12#1)
concerning asbestos##2##2##(1992-11#2)
concerning attitudes##2##2##(1993-3#1)(2008-9#1)
concerning carboxylate and inorganic anions##2##5##(2008-10#2)
concerning childbirth##2##2##(2010-3#2)
concerning clinical##2##2##(2008-11#1)(2008-2#1)
concerning health care##2##3##(1993-12#1)(2008-11#1)
concerning how##2##2##(2009-5#1)(2012-1#1)
concerning its##6##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
concerning objective##2##2##(1990-10#1)(2009-7#1)
concerning oral##2##2##(1990-6#1)(2008-1#1)
concerning patients suffering from coxarthrosis##2##5##(2007-11#2)
concerning potential##2##2##(1990-8#1)(2008-7#1)
concerning protein##3##2##(1997-6#1)(2008-2#1)(2008-5#1)
concerning quality##2##2##(1992-3#1)(1995-3#1)
concerning risk##2##2##(2008-11#1)(2010-11#1)
concerning the application of##2##4##(2008-10#1)(2011-2#1)
concerning the diagnosis and##2##4##(1996-3#1)(2009-10#1)
concerning the effects of##3##4##(1991-12#1)(1995-12#1)(2008-9#1)
concerning the future##2##3##(2008-11#1)(2008-7#1)
concerning the interaction between##2##4##(2008-10#1)(2008-5#1)
concerning the interaction##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
concerning the management of##2##4##(1994-12#1)(2012-3#1)
concerning the mechanisms of##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
concerning the mechanisms##4##3##(1991-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
concerning the nature of##3##4##(1995-4#1)(2007-8#1)(2008-5#1)
concerning the nature##4##3##(1995-4#1)(2007-2#1)(2007-8#1)(2008-5#1)
concerning the origin of##2##4##(2009-6#1)(2010-1#1)
concerning the performance##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
concerning the recovery of##2##4##(2008-10#1)(2008-3#1)
concerning the role of##3##4##(1994-5#1)(1997-8#1)(2008-12#1)
concerning the solvolyses of##2##4##(2011-1#2)
concerning the structure of##2##4##(1997-3#1)(2007-11#1)
concerning the treatment of##2##4##(1996-11#1)(2007-12#1)
concerning the treatment##3##3##(1994-6#1)(1996-11#1)(2007-12#1)
concerning the use of##3##4##(2009-5#1)(2010-10#1)(2013-8#1)
concerning the##147##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#22)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
concerning their##7##2##(1995-1#1)(1995-12#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)
concerning these lesions##2##3##(1991-3#1)(1991-5#1)
concerning these##4##2##(1990-6#1)(1991-3#1)(1991-5#1)(2010-11#1)
concerning this issue##2##3##(1995-6#1)(2007-11#1)
concerning this##5##2##(1995-6#1)(1997-7#1)(2007-11#1)(2008-7#1)(2013-8#1)
concerning two##3##2##(1991-2#1)(1997-2#1)(2008-3#1)
concerning what##3##2##(1993-3#1)(2008-11#1)(2012-2#1)
concerning which##2##2##(1992-12#1)(2008-5#1)
concerning##386##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#2)(1991-5#2)(1992-1#1)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1993-3#3)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#3)(2007-5#4)(2007-8#6)(2008-1#3)(2008-10#40)(2008-11#23)(2008-12#6)(2008-2#8)(2008-3#14)(2008-4#2)(2008-5#14)(2008-6#4)(2008-7#18)(2008-8#11)(2008-9#3)(2009-10#4)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#5)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#5)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#10)
concerns a##2##2##(1990-3#1)(2008-11#1)
concerns about body##2##3##(2007-12#2)
concerns about the costs of##2##5##(1992-1#1)(2008-11#1)
concerns about the quality of##2##5##(1991-9#1)(1993-3#1)
concerns about the quality##3##4##(1991-9#1)(1993-3#1)(1996-12#1)
concerns about the##15##3##(1991-9#1)(1992-1#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)
concerns about##41##2##(1991-12#1)(1991-9#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#2)(2008-7#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
concerns also##2##2##(2007-12#1)(2010-10#1)
concerns among##2##2##(1993-3#1)(2007-12#1)
concerns and needs##2##3##(1993-1#1)(2009-5#1)
concerns and##16##2##(1991-2#1)(1993-1#1)(1993-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)
concerns are##5##2##(1995-1#1)(2008-12#2)(2008-5#1)(2008-8#1)
concerns as##2##2##(1996-3#1)(2012-1#1)
concerns by##3##2##(1993-1#1)(2008-4#1)(2012-3#1)
concerns can be##2##3##(1995-1#1)(2009-5#1)
concerns expressed##2##2##(1996-1#1)(2008-5#1)
concerns for##9##2##(1993-12#1)(1995-1#1)(2007-6#1)(2008-5#1)(2009-11#1)(2009-5#1)(2012-2#1)(2012-3#2)
concerns have##5##2##(1997-1#1)(2008-11#1)(2010-7#1)(2012-2#1)(2013-8#1)
concerns highlighted by the##2##4##(2008-11#1)(2010-5#1)
concerns in##6##2##(2007-12#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-8#2)
concerns may##3##2##(1996-1#1)(2008-3#1)(2010-12#1)
concerns of a##2##3##(1994-9#1)(2008-1#1)
concerns of##11##2##(1991-3#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-7#2)(2011-2#1)
concerns over the##3##3##(1994-3#1)(1996-2#1)(2013-8#1)
concerns over##11##2##(1994-1#1)(1994-3#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-8#3)(2012-3#1)(2013-8#1)
concerns raised by##3##3##(1991-12#1)(1991-3#1)(2008-11#1)
concerns raised##4##2##(1991-12#1)(1991-3#1)(2008-11#1)(2008-3#1)
concerns regarding the##4##3##(1993-3#1)(1996-12#1)(2008-11#1)(2013-1#1)
concerns regarding##10##2##(1993-3#1)(1996-12#1)(2007-8#1)(2008-11#3)(2008-7#2)(2011-1#1)(2013-1#1)
concerns related to##2##3##(2008-7#1)(2010-8#1)
concerns than##2##2##(2007-7#1)(2008-12#1)
concerns that are##2##3##(1993-3#1)(2008-7#1)
concerns that##11##2##(1990-9#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-4#1)(2013-1#1)
concerns the##14##2##(1990-12#1)(1991-2#1)(1992-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-9#1)(2012-1#1)
concerns were##2##2##(2008-12#2)
concerns whether##2##2##(1995-6#1)(2012-2#1)
concerns with##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
concerns##302##1##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#7)(1994-1#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#5)(1995-12#1)(1995-2#5)(1995-6#1)(1996-1#5)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#23)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#19)(2008-12#16)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#13)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#8)(2011-1#4)(2011-2#8)(2012-1#5)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#7)(2013-8#6)
concert with other##2##3##(2008-10#1)(2008-3#1)
concert with##15##2##(1990-2#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#2)
concert##26##1##(1990-2#1)(1993-3#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)
concerted action of##7##3##(1991-5#1)(1995-6#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)
concerted effort to##3##3##(1991-1#1)(1996-12#1)(2009-9#1)
concerted effort##7##2##(1991-1#1)(1991-3#1)(1995-1#1)(1996-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
concerted evolution##2##2##(2008-8#2)
concerted integration##3##2##(2009-11#3)
concerted models##2##2##(1997-2#2)
concerted##32##1##(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#4)(1997-2#3)(2008-10#2)(2008-7#2)(2008-8#2)(2009-11#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
concha bullosa##2##2##(2008-5#1)(2012-12#1)
conchs##2##1##(2013-7#2)
concise and##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)
concise overview of##3##3##(1992-3#1)(2008-11#1)(2010-9#1)
concise overview##6##2##(1992-3#1)(2008-10#3)(2008-11#1)(2010-9#1)
concise##29##1##(1992-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
conclude a##3##2##(2008-10#1)(2008-6#1)(2010-12#1)
conclude by##18##2##(1990-9#1)(1992-6#1)(1993-3#1)(1994-1#2)(1996-2#1)(2008-8#3)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
conclude from the##3##3##(1992-7#1)(2008-1#1)(2008-8#1)
conclude from these##2##3##(2008-10#2)
conclude from##7##2##(1991-8#1)(1992-7#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-8#1)
conclude that P##2##3##(2008-10#1)(2013-7#1)
conclude that a##14##3##(1991-1#1)(1993-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)
conclude that all the##3##4##(1990-8#1)(2006-6#1)(2008-5#1)
conclude that an##2##3##(1995-2#1)(2011-2#1)
conclude that both##7##3##(1990-11#1)(1990-12#1)(1992-9#1)(1993-8#1)(2008-8#1)(2009-10#1)(2012-12#1)
conclude that despite##2##3##(2008-1#1)(2008-7#1)
conclude that in##12##3##(1991-2#1)(1991-5#1)(1994-5#1)(1995-10#1)(2008-11#3)(2008-5#1)(2009-11#1)(2009-2#1)(2009-6#1)(2012-2#1)
conclude that one##2##3##(1994-6#1)(1995-3#1)
conclude that oospores##2##3##(2008-10#2)
conclude that oral##2##3##(1991-3#1)(2008-7#1)
conclude that systemic##2##3##(2008-10#2)
conclude that the##102##3##(1990-12#1)(1990-5#5)(1990-9#1)(1991-12#3)(1991-5#1)(1992-12#3)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
conclude that there are##4##4##(1994-2#1)(2007-7#1)(2008-10#1)(2008-9#1)
conclude that there is a##4##5##(2007-10#1)(2008-10#1)(2013-1#2)
conclude that there is no##2##5##(2007-8#1)(2008-3#1)
conclude that there is##11##4##(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#2)
conclude that there##18##3##(1994-2#1)(1995-2#1)(1996-7#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
conclude that these##6##3##(1990-2#1)(1991-2#1)(1993-6#1)(1997-2#1)(2008-10#1)(2010-8#1)
conclude that this##8##3##(1990-2#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
conclude that with##2##3##(1991-3#1)(2009-10#1)
conclude that##482##2##(1990-11#1)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#4)(1995-1#1)(1995-10#1)(1995-12#5)(1995-2#7)(1995-3#6)(1995-5#2)(1995-6#3)(1996-12#3)(1996-2#4)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#5)(2007-11#5)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#11)(2007-8#15)(2007-9#2)(2008-1#14)(2008-10#48)(2008-11#16)(2008-12#1)(2008-2#4)(2008-3#16)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#23)(2008-8#15)(2008-9#15)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#14)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#7)
conclude the##3##2##(1994-5#1)(2008-11#1)(2008-7#1)
conclude this##3##2##(1993-12#1)(2007-11#1)(2008-1#1)
conclude with a discussion of the##2##6##(1992-3#1)(1994-3#1)
conclude with a discussion of##4##5##(1992-3#1)(1994-3#1)(2009-6#1)(2010-4#1)
conclude with a##7##3##(1992-3#1)(1994-3#1)(2008-6#1)(2009-6#1)(2010-4#1)(2011-2#2)
conclude with an##2##3##(2008-11#1)(2008-8#1)
conclude with##17##2##(1992-3#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#2)
conclude##554##1##(1990-11#1)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#9)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#3)(1994-8#5)(1995-1#1)(1995-10#1)(1995-12#5)(1995-2#7)(1995-3#6)(1995-5#2)(1995-6#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#6)(2007-11#6)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#11)(2007-8#15)(2007-9#2)(2008-1#16)(2008-10#53)(2008-11#18)(2008-12#2)(2008-2#6)(2008-3#16)(2008-4#5)(2008-5#14)(2008-6#6)(2008-7#26)(2008-8#21)(2008-9#16)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#21)(2011-7#1)(2012-1#4)(2012-12#5)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#16)(2013-7#2)(2013-8#8)
concluded from the##2##3##(1990-6#1)(2008-12#1)
concluded from this##2##3##(2008-6#1)(2010-2#1)
concluded from##5##2##(1990-6#1)(2008-12#1)(2008-6#1)(2010-2#1)(2011-2#1)
concluded that (1)##2##3##(1994-8#1)(2008-10#1)
concluded that IL-1##2##3##(1990-11#1)(2007-2#1)
concluded that a##7##3##(1997-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2013-1#1)
concluded that an##2##3##(1996-6#1)(2008-12#1)
concluded that at least##2##4##(1995-12#1)(2013-1#1)
concluded that at##5##3##(1995-12#1)(2007-12#1)(2008-10#2)(2013-1#1)
concluded that both##4##3##(1990-2#1)(1993-2#1)(1995-11#1)(2013-7#1)
concluded that by using##2##4##(1996-12#1)(2011-1#1)
concluded that by##3##3##(1996-12#1)(2009-12#1)(2011-1#1)
concluded that for##3##3##(1990-3#1)(2008-10#1)(2008-11#1)
concluded that growth##2##3##(1990-12#1)(2012-3#1)
concluded that if##2##3##(1990-9#1)(2007-6#1)
concluded that in##4##3##(1994-2#1)(2007-7#1)(2010-9#1)(2013-8#1)
concluded that it is##5##4##(1990-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2013-1#1)
concluded that it was##2##4##(2008-10#1)(2013-1#1)
concluded that it##8##3##(1990-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2013-1#2)
concluded that one##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
concluded that sodium##2##3##(1995-12#1)(2008-10#1)
concluded that the high##2##4##(1990-6#1)(2008-10#1)
concluded that the main##2##4##(1995-5#1)(2008-10#1)
concluded that the release of##2##5##(1990-11#1)(1994-2#1)
concluded that the##106##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-11#2)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
concluded that there is##3##4##(2007-8#1)(2008-10#2)
concluded that there##5##3##(2007-8#1)(2008-10#2)(2008-7#1)(2009-3#1)
concluded that this##6##3##(1991-12#1)(1994-7#1)(1996-8#1)(2008-3#1)(2008-5#1)(2009-7#1)
concluded that with the##2##4##(1990-9#1)(2007-2#1)
concluded that##391##2##(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#6)(1991-6#5)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(1997-9#1)(2006-12#1)(2007-10#7)(2007-11#1)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#55)(2008-11#16)(2008-12#12)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#17)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-4#3)(2010-5#2)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#6)(2012-9#1)(2013-1#14)(2013-7#4)(2013-8#5)
concluded the##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
concluded therefore that##2##3##(2008-10#1)(2010-2#1)
concluded to##4##2##(1993-11#1)(2008-10#2)(2012-1#1)
concluded##420##1##(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#6)(1991-6#5)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#5)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(1997-9#1)(2006-12#1)(2007-10#7)(2007-11#1)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#60)(2008-11#16)(2008-12#13)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#17)(2008-6#5)(2008-7#13)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#3)(2010-10#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#7)(2012-9#1)(2013-1#16)(2013-7#4)(2013-8#5)
concludes by discussing##3##3##(1996-2#1)(2008-11#1)(2008-12#1)
concludes by emphasizing that##2##4##(1993-2#1)(2008-11#1)
concludes by suggesting##2##3##(1991-3#1)(2008-7#1)
concludes by##18##2##(1991-3#1)(1992-1#1)(1992-12#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
concludes his##2##2##(1992-12#1)(1994-3#1)
concludes that the##11##3##(1990-8#1)(1991-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-3#1)
concludes that##31##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
concludes with a discussion of how##2##6##(2008-11#1)(2008-9#1)
concludes with a discussion of the##6##6##(1995-3#1)(2007-7#1)(2008-12#2)(2010-5#1)(2012-2#1)
concludes with a discussion of##10##5##(1992-3#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)
concludes with a##12##3##(1992-3#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#2)
concludes with recommendations##3##3##(1995-12#1)(1996-12#1)(2008-11#1)
concludes with some thoughts about##2##5##(2008-2#1)(2010-11#1)
concludes with some thoughts##3##4##(2008-2#1)(2010-11#2)
concludes with some##7##3##(1996-6#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-11#2)(2012-2#1)
concludes with##34##2##(1992-3#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)
concludes##87##1##(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#5)(1997-3#2)(2007-7#1)(2008-11#8)(2008-12#5)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
concluding that the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
concluding that##9##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
concluding the##2##2##(2007-10#1)(2007-8#1)
concluding with##3##2##(2008-11#1)(2008-6#1)(2013-8#1)
concluding##19##1##(1991-2#1)(1994-3#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
conclusion about##2##2##(2008-1#1)(2008-9#1)
conclusion can be##2##3##(1990-8#1)(2008-9#1)
conclusion from##5##2##(1997-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
conclusion is that the##7##4##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-3#1)
conclusion is that##20##3##(1990-12#1)(1990-2#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-11#1)(2010-4#1)(2012-3#2)
conclusion is##35##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-7#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#3)
conclusion of the study is that##2##6##(2008-3#1)(2013-8#1)
conclusion of the study##3##4##(2008-11#1)(2008-3#1)(2013-8#1)
conclusion of the##11##3##(1992-3#1)(1997-3#1)(1997-4#2)(2008-11#2)(2008-3#2)(2013-1#1)(2013-8#2)
conclusion of this work is that##2##6##(1990-7#1)(2008-5#1)
conclusion of this##4##3##(1990-7#1)(1991-3#1)(2008-12#1)(2008-5#1)
conclusion of##25##2##(1990-3#1)(1990-7#1)(1991-3#1)(1992-3#3)(1994-1#1)(1994-11#1)(1995-5#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#2)
conclusion that the##18##3##(1990-7#1)(1992-2#1)(1992-6#1)(1992-9#1)(1996-7#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#1)
conclusion that##56##2##(1990-12#2)(1990-6#1)(1990-7#1)(1991-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-5#1)(1996-7#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
conclusion##496##1##(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#7)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#4)(1993-3#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#5)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2007-10#2)(2007-11#3)(2007-4#1)(2007-7#4)(2007-8#9)(2008-1#18)(2008-10#41)(2008-11#18)(2008-12#10)(2008-2#8)(2008-3#14)(2008-4#8)(2008-5#24)(2008-6#3)(2008-7#24)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#3)(2010-11#5)(2010-12#7)(2010-2#3)(2010-3#5)(2010-4#4)(2010-6#3)(2010-8#5)(2011-1#5)(2011-2#24)(2011-3#1)(2012-1#5)(2012-12#8)(2012-2#10)(2012-3#11)(2012-7#1)(2013-1#26)(2013-7#5)(2013-8#14)
conclusions about the##4##3##(1991-8#1)(1995-5#1)(2009-12#1)(2010-9#1)
conclusions about##11##2##(1991-8#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-9#1)
conclusions across##2##2##(2008-8#1)(2012-1#1)
conclusions and##6##2##(1990-12#1)(1991-5#1)(1992-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
conclusions are that the##2##4##(1991-6#1)(2008-7#1)
conclusions are##13##2##(1990-6#1)(1991-5#1)(1991-6#1)(1992-3#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)
conclusions can be drawn from the##3##6##(1993-12#1)(2008-11#1)(2008-2#1)
conclusions can be drawn from##5##5##(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
conclusions can be drawn##10##4##(1993-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2010-12#1)
conclusions can be##11##3##(1993-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
conclusions can##12##2##(1991-12#1)(1993-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
conclusions drawn from##5##3##(1995-2#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)
conclusions for##3##2##(1991-12#1)(2008-5#1)(2010-12#1)
conclusions from##5##2##(1991-1#1)(1992-11#1)(1994-12#1)(2008-11#1)(2012-1#1)
conclusions have been reached##2##4##(1990-6#1)(2008-5#1)
conclusions have been##3##3##(1990-6#1)(2007-11#1)(2008-5#1)
conclusions have##4##2##(1990-6#1)(2007-11#1)(2008-1#1)(2008-5#1)
conclusions hold##2##2##(2008-7#1)(2008-9#1)
conclusions is##4##2##(1990-12#1)(1993-12#1)(1996-3#1)(2008-8#1)
conclusions led##2##2##(1994-12#1)(2009-3#1)
conclusions may##2##2##(1992-3#1)(2013-1#1)
conclusions of an earlier##2##4##(1993-12#1)(2008-9#1)
conclusions of the##5##3##(1993-12#1)(1993-3#1)(2008-12#1)(2008-3#1)(2013-1#1)
conclusions of##12##2##(1991-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(2008-12#1)(2008-3#2)(2008-9#1)(2012-3#1)(2013-1#1)
conclusions on the##2##3##(1992-12#1)(2009-8#1)
conclusions on##3##2##(1992-12#1)(2007-11#1)(2009-8#1)
conclusions reached##2##2##(2008-2#1)(2010-5#1)
conclusions regarding the##3##3##(1990-9#1)(1996-12#1)(2008-8#1)
conclusions regarding##4##2##(1990-9#1)(1996-12#1)(2008-6#1)(2008-8#1)
conclusions that can be drawn##2##5##(2008-10#1)(2008-12#1)
conclusions were drawn##2##3##(2008-10#1)(2013-1#1)
conclusions were##6##2##(1993-6#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
conclusions##161##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#6)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-3#4)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-11#7)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#5)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
conclusive evidence that##2##3##(1995-2#1)(2008-10#1)
conclusive evidence##6##2##(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)
conclusive##25##1##(1991-12#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
conclusively demonstrated##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
conclusively show that##2##3##(2008-1#1)(2013-8#1)
conclusively that##3##2##(1995-2#1)(1997-1#1)(2008-10#1)
conclusively##19##1##(1995-2#1)(1997-1#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2013-7#1)(2013-8#1)
concolor)##3##1##(1996-12#1)(2008-10#1)(2013-1#1)
concomitant AR##3##2##(2012-12#3)
concomitant HD##2##2##(2011-2#2)
concomitant PC or BCP mutations##2##5##(2013-1#2)
concomitant administration of##2##3##(2008-7#1)(2011-1#1)
concomitant aortoesophageal and aortobronchial fistula##2##5##(2007-8#2)
concomitant boost##2##2##(1995-9#1)(2007-10#1)
concomitant changes##3##2##(1994-6#1)(1996-2#1)(2008-7#1)
concomitant chemoradiation##2##2##(2008-10#2)
concomitant cisplatin and##2##3##(1993-9#1)(1994-3#1)
concomitant determination of##2##3##(1990-8#1)(2008-5#1)
concomitant drug##2##2##(1991-3#1)(2011-2#1)
concomitant food##2##2##(1997-6#1)(2012-2#1)
concomitant increase in##3##3##(1992-8#1)(1996-2#1)(2008-5#1)
concomitant increase##4##2##(1992-8#1)(1994-11#1)(1996-2#1)(2008-5#1)
concomitant infection##2##2##(2007-7#1)(2007-8#1)
concomitant infections##2##2##(2008-8#1)(2011-3#1)
concomitant ions were studied##3##4##(2008-10#3)
concomitant ions##5##2##(2008-10#5)
concomitant lesions##2##2##(2009-9#1)(2011-2#1)
concomitant presence of two anomalous##2##5##(2008-9#2)
concomitant pulmonary##2##2##(1996-11#1)(2011-2#1)
concomitant reduction in##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
concomitant reduction##4##2##(1990-12#1)(1994-3#1)(2008-10#1)(2011-2#1)
concomitant reductions in##2##3##(1997-4#1)(2008-10#1)
concomitant to##2##2##(2007-8#1)(2008-6#1)
concomitant treatment with##2##3##(1991-11#1)(1997-2#1)
concomitant treatment##4##2##(1991-11#1)(1997-2#1)(2007-11#1)(2008-2#1)
concomitant use of other##2##4##(2008-8#1)(2013-8#1)
concomitant use of##5##3##(2008-10#1)(2008-8#1)(2011-2#2)(2013-8#1)
concomitant use##6##2##(2008-10#2)(2008-8#1)(2011-2#2)(2013-8#1)
concomitant with an increase in##2##5##(1990-2#1)(2008-10#1)
concomitant with the##2##3##(1994-8#1)(2010-4#1)
concomitant with##17##2##(1990-2#1)(1991-5#1)(1992-6#3)(1994-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(2008-10#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
concomitant##187##1##(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#6)(1992-8#2)(1993-11#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-2#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#10)
concomitantly decreased##2##2##(1994-8#1)(2013-8#1)
concomitantly increased##2##2##(1997-4#1)(2008-5#1)
concomitantly with the##3##3##(1992-12#1)(2008-9#1)(2013-1#1)
concomitantly with##14##2##(1992-12#2)(1993-11#2)(2008-10#1)(2008-11#1)(2008-9#2)(2009-9#1)(2011-2#3)(2013-1#2)
concomitantly##45##1##(1990-8#1)(1991-8#2)(1992-12#2)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-8#2)(1995-5#1)(1997-4#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#4)(2008-9#3)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
concomitants##7##1##(1996-5#1)(2007-10#1)(2008-10#4)(2008-11#1)
concordance between the##2##3##(2008-10#1)(2012-3#1)
concordance between##10##2##(1991-2#1)(1992-3#1)(1995-12#1)(2007-8#1)(2008-10#3)(2008-8#1)(2012-3#1)(2013-1#1)
concordance of the##2##3##(2008-5#1)(2008-7#1)
concordance of##11##2##(1990-12#1)(1992-6#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#3)
concordance rate##4##2##(1990-12#1)(1990-8#1)(2008-7#1)(2013-8#1)
concordance values##2##2##(1990-12#1)(2007-10#1)
concordance with the##3##3##(2008-7#1)(2010-12#1)(2013-1#1)
concordance with##4##2##(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
concordance##42##1##(1990-12#3)(1990-3#1)(1990-8#1)(1991-2#1)(1992-3#1)(1992-6#1)(1995-12#2)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#4)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
concordancy##2##1##(2009-8#2)
concordant with the##5##3##(2008-1#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
concordant with##8##2##(2008-1#1)(2008-10#2)(2008-12#2)(2010-12#1)(2010-3#1)(2012-2#1)
concordant##15##1##(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-2#1)
concrete by##2##2##(2007-12#2)
concrete sample##2##2##(2007-12#2)
concrete words##2##2##(1991-2#1)(1996-2#1)
concrete##34##1##(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-3#1)(1996-12#1)(1996-2#1)(2007-12#7)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#4)(2009-11#1)(2010-1#1)(2013-1#1)
concur with the##2##3##(1996-12#1)(2008-10#1)
concur with##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
concurrence with the##2##3##(1990-11#1)(2013-1#1)
concurrence##5##1##(1990-11#1)(2007-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
concurrency##3##1##(2008-2#1)(2011-2#2)
concurrent administration of##2##3##(1993-5#1)(2011-2#1)
concurrent chemo-radiotherapy##2##2##(1990-6#1)(2011-3#1)
concurrent chemoradiotherapy##5##2##(2008-10#1)(2012-2#1)(2012-3#3)
concurrent chemotherapy##3##2##(2008-6#2)(2011-2#1)
concurrent downwelling irradiance measurements##2##4##(2008-2#2)
concurrent drug##2##2##(1994-6#1)(2010-5#1)
concurrent infection of HBV and##2##5##(2007-7#1)(2009-8#1)
concurrent infection##3##2##(2007-7#1)(2009-8#2)
concurrent measurement##2##2##(2008-10#1)(2012-12#1)
concurrent object discrimination##2##3##(1993-5#2)
concurrent object##3##2##(1993-5#3)
concurrent p53 and c-erbB-2 expression##2##5##(1994-7#2)
concurrent partnerships##4##2##(2011-2#4)
concurrent pazopanib and RT##2##4##(2013-1#2)
concurrent sexual partnerships##4##3##(2011-2#4)
concurrent treatment##2##2##(2008-10#1)(2008-11#1)
concurrent use of##2##3##(1991-12#1)(2013-8#1)
concurrent validity##2##2##(2012-2#2)
concurrent##142##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#5)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-5#3)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#5)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#8)(2013-8#4)
concurrently and##2##2##(2008-12#1)(2009-10#1)
concurrently by##2##2##(2007-12#1)(2008-10#1)
concurrently infected##2##2##(2009-8#1)(2013-1#1)
concurrently with##4##2##(2008-2#1)(2008-9#1)(2010-8#1)(2013-7#1)
concurrently##38##1##(1993-12#1)(1994-7#1)(1995-5#1)(1995-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
concurs with##2##2##(2008-11#1)(2008-5#1)
concussion complicated by##2##3##(2010-1#2)
concussion##10##1##(2008-6#1)(2010-1#5)(2012-3#2)(2013-1#2)
concussions##4##1##(2010-1#2)(2013-1#2)
condemned to##2##2##(1996-12#1)(2011-2#1)
condemned##3##1##(1995-12#1)(1996-12#1)(2011-2#1)
condensate in##3##2##(1992-11#1)(2011-1#2)
condensate##8##1##(1992-11#1)(1997-4#1)(2007-12#1)(2008-10#1)(2010-5#2)(2011-1#2)
condensates##5##1##(2007-12#1)(2008-10#3)(2008-3#1)
condensation and##7##2##(1991-3#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#3)
condensation growth##2##2##(2013-1#2)
condensation of the##4##3##(1992-3#1)(1995-3#1)(2008-10#1)(2011-1#1)
condensation of##26##2##(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#2)(2010-12#1)(2011-1#2)(2011-3#1)
condensation product##3##2##(1990-7#1)(2008-10#2)
condensation products##3##2##(2007-11#2)(2010-12#1)
condensation reaction between##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
condensation reaction of##2##3##(2008-10#1)(2008-7#1)
condensation reaction##8##2##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#2)
condensation reactions##3##2##(2008-10#2)(2008-7#1)
condensation technique##3##2##(1991-3#1)(2013-1#2)
condensation##88##1##(1990-7#2)(1991-3#3)(1991-9#1)(1992-12#2)(1992-3#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-5#1)(1997-3#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#12)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#5)(2010-2#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#6)
condensations between##2##2##(2007-11#2)
condensations##4##1##(1995-5#1)(2007-11#3)
condense##3##1##(1996-5#2)(2008-7#1)
condensed and##2##2##(2008-9#1)(2013-8#1)
condensed chromatin##3##2##(1990-2#1)(2008-1#1)(2008-7#1)
condensed chromosomes##2##2##(1995-2#1)(2008-7#1)
condensed in##2##2##(1995-11#1)(2008-7#1)
condensed phase##5##2##(2008-10#4)(2008-7#1)
condensed tannin##4##2##(2008-10#3)(2011-2#1)
condensed tannins##2##2##(1993-8#1)(2008-10#1)
condensed##38##1##(1990-2#1)(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
condenser##2##1##(2007-11#1)(2008-3#1)
condenses##2##1##(2007-12#1)(2008-7#1)
condensin complex##2##2##(2007-12#2)
condensing a##2##2##(2008-1#1)(2008-4#1)
condensing##7##1##(1996-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
condition (0##2##2##(1997-2#1)(2008-10#1)
condition affecting##3##2##(2008-4#1)(2011-2#1)(2012-12#1)
condition also##2##2##(1996-9#1)(2008-6#1)
condition and changes in##2##4##(1994-2#1)(2008-11#1)
condition and in##2##3##(1994-9#1)(2012-3#1)
condition and its##4##3##(1992-5#1)(2008-11#1)(2010-12#1)(2011-2#1)
condition and the##9##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2013-8#1)
condition and tooth loss##2##4##(2012-12#2)
condition and##65##2##(1990-6#1)(1990-8#1)(1991-12#2)(1991-6#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#4)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
condition are##8##2##(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
condition as well as##2##4##(1990-9#1)(2011-2#1)
condition associated with##3##3##(2007-8#1)(2008-1#1)(2008-5#1)
condition at the time of##2##5##(1996-9#1)(2007-11#1)
condition at the##3##3##(1996-9#1)(2007-11#2)
condition at##5##2##(1996-9#1)(2007-11#2)(2007-12#1)(2008-8#1)
condition between##2##2##(2008-2#1)(2013-1#1)
condition but##3##2##(1991-11#1)(2008-3#1)(2013-1#1)
condition by use of a##2##5##(2008-2#1)(2008-3#1)
condition by##6##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
condition can be##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
condition can##7##2##(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-7#1)
condition caused by##4##3##(1993-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
condition characterized by##6##3##(2008-1#1)(2008-5#2)(2009-7#1)(2010-1#1)(2011-2#1)
condition commonly##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
condition dependent##2##2##(2008-8#2)
condition deteriorated##2##2##(2007-12#1)(2011-2#1)
condition during the##3##3##(1994-6#1)(2011-2#1)(2012-2#1)
condition during##4##2##(1994-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
condition elicited greater activation in##2##5##(2008-11#2)
condition factor##5##2##(2008-5#3)(2010-8#1)(2013-7#1)
condition for the##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
condition for##25##2##(1992-9#1)(1994-12#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
condition from##3##2##(2008-11#1)(2008-8#1)(2011-1#1)
condition had##2##2##(1990-3#1)(2007-2#1)
condition has been##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
condition has##10##2##(1995-2#1)(1995-8#1)(1997-8#1)(2008-1#2)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
condition improved##2##2##(2008-12#1)(2011-2#1)
condition in a##2##3##(2008-3#1)(2009-5#1)
condition in our##2##3##(2010-11#1)(2012-3#1)
condition in terms of##2##4##(2008-6#2)
condition in the##7##3##(2008-10#2)(2008-5#1)(2011-2#2)(2011-3#1)(2013-8#1)
condition in which the##6##4##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
condition in which##15##3##(1992-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
condition in##46##2##(1991-5#1)(1992-4#1)(1994-3#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
condition is important##2##3##(2009-12#1)(2012-12#1)
condition is most##3##3##(1992-5#1)(1996-12#1)(2011-1#1)
condition is studied##2##3##(2007-11#1)(2008-3#1)
condition is usually##2##3##(2008-10#1)(2011-2#1)
condition is##42##2##(1990-9#1)(1992-5#1)(1993-12#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
condition known##2##2##(1997-2#1)(2008-5#1)
condition mainly by##2##3##(2008-1#1)(2012-2#1)
condition may be##6##3##(1990-6#1)(1996-3#1)(2007-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
condition may##9##2##(1990-6#1)(1992-12#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-1#1)
condition occurs##2##2##(1996-12#1)(2008-8#1)
condition of Icelandic cod Gadus morhua##2##6##(2010-8#2)
condition of the baby##2##4##(2008-11#1)(2012-3#1)
condition of the patient##6##4##(1990-6#1)(1991-3#1)(2007-11#3)(2007-7#1)
condition of the patients##2##4##(1990-6#1)(1991-6#1)
condition of the skin##2##4##(1990-6#1)(1996-12#1)
condition of the##29##3##(1990-6#3)(1991-3#2)(1991-6#1)(1992-7#1)(1996-12#1)(1997-5#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#2)
condition of##85##2##(1990-6#3)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-7#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#7)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-8#5)(2011-1#3)(2011-2#4)(2012-3#4)(2013-1#3)(2013-8#3)
condition or##4##2##(2008-9#1)(2009-10#1)(2010-12#1)(2013-1#1)
condition prior to##2##3##(2008-10#1)(2010-10#1)
condition remains##2##2##(2009-3#1)(2011-1#1)
condition resistance##2##2##(2008-10#2)
condition should be##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
condition should##6##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
condition showed##2##2##(1996-2#1)(2008-5#1)
condition showing the##2##3##(2008-11#2)
condition than##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
condition that has##4##3##(2006-10#1)(2008-8#1)(2009-1#1)(2012-2#1)
condition that is##4##3##(2008-1#1)(2008-2#1)(2013-1#1)(2013-8#1)
condition that may##2##3##(2006-10#1)(2012-3#1)
condition that occurs##3##3##(1992-5#1)(2011-1#1)(2013-1#1)
condition that the##2##3##(1993-9#1)(2008-2#1)
condition that##28##2##(1992-5#1)(1993-9#1)(1997-6#1)(2006-10#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-1#1)(2009-3#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
condition the##5##2##(2008-10#3)(2009-5#1)(2009-7#1)
condition these##2##2##(1996-9#1)(2008-10#1)
condition they##2##2##(2008-10#2)
condition to##6##2##(1997-5#1)(2007-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
condition under##2##2##(2008-1#1)(2009-9#1)
condition using##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
condition usually##2##2##(2008-7#1)(2009-4#1)
condition was evaluated##2##3##(2008-10#1)(2013-1#1)
condition was first##3##3##(1997-8#1)(2008-6#1)(2013-1#1)
condition was obtained##2##3##(2008-10#2)
condition was##26##2##(1995-12#1)(1996-8#1)(1997-8#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
condition were##8##2##(1991-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-8#1)
condition which is##2##3##(1995-12#1)(2007-11#1)
condition which##5##2##(1995-12#1)(2007-11#1)(2008-1#1)(2011-1#1)(2013-1#1)
condition who##2##2##(2008-9#1)(2012-3#1)
condition with a##3##3##(1992-9#1)(2008-11#1)(2012-3#1)
condition with##19##2##(1992-4#1)(1992-9#1)(1993-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
condition##958##1##(1990-12#3)(1990-3#3)(1990-5#2)(1990-6#5)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#2)(1994-6#5)(1994-7#1)(1994-9#5)(1995-11#2)(1995-12#4)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#5)(1995-8#3)(1996-11#6)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#5)(2006-10#8)(2007-10#3)(2007-11#32)(2007-12#22)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#13)(2008-1#20)(2008-10#92)(2008-11#35)(2008-12#25)(2008-2#19)(2008-3#47)(2008-4#21)(2008-5#37)(2008-6#11)(2008-7#30)(2008-8#23)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#6)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#10)(2010-7#2)(2010-8#12)(2010-9#1)(2011-1#32)(2011-2#48)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#18)(2012-2#17)(2012-3#27)(2013-1#62)(2013-7#6)(2013-8#29)
condition')##2##1##(2008-11#2)
condition) or##2##2##(2013-1#1)(2013-8#1)
condition)##8##1##(2008-6#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
condition-dependent ornaments##2##2##(2008-8#2)
condition-dependent##4##1##(2008-8#3)(2013-1#1)
condition-specific performance measures##3##3##(1997-3#3)
condition-specific##6##1##(1994-2#1)(1997-3#3)(2008-9#1)(2010-10#1)
condition]##3##1##(1991-9#1)(2011-2#1)(2013-8#1)
conditional confidence limits on##2##4##(1995-9#2)
conditional confidence limits##3##3##(1995-9#3)
conditional discrimination##4##2##(1992-12#2)(1993-3#1)(2011-2#1)
conditional discriminations##2##2##(1992-10#2)
conditional formation##3##2##(2008-10#3)
conditional gene##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
conditional likelihood##2##2##(1995-2#2)
conditional on the##2##3##(2008-10#1)(2011-2#1)
conditional on##3##2##(2008-10#1)(2011-2#2)
conditional selection##2##2##(1993-8#1)(2008-3#1)
conditional stability constants##7##3##(2008-10#7)
conditional stability##8##2##(2008-10#8)
conditional##87##1##(1991-1#1)(1992-10#2)(1992-12#2)(1992-6#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-9#6)(1996-3#2)(1996-4#1)(1997-3#1)(1997-7#1)(2008-10#24)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
conditionally##13##1##(1993-8#2)(1994-9#1)(1995-11#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2012-2#2)(2012-3#1)
conditioned at##2##2##(2008-10#1)(2011-1#1)
conditioned avoidance##3##2##(1992-12#1)(2008-6#2)
conditioned by a single dominant gene##2##6##(2008-10#2)
conditioned by a single dominant##3##5##(2008-10#3)
conditioned by a single##4##4##(2008-10#4)
conditioned by a##5##3##(2008-10#4)(2008-5#1)
conditioned by the##6##3##(2008-10#5)(2008-3#1)
conditioned by##20##2##(1990-8#1)(1991-5#1)(1992-9#1)(1994-5#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
conditioned emotional response and##2##4##(1993-5#1)(2008-4#1)
conditioned emotional response##3##3##(1993-5#2)(2008-4#1)
conditioned fear##3##2##(1997-7#2)(2008-4#1)
conditioned in##2##2##(2008-10#2)
conditioned inhibition##2##2##(2008-5#1)(2009-11#1)
conditioned inhibitor##2##2##(2009-11#2)
conditioned media from##3##3##(1992-3#1)(1993-9#1)(1997-3#1)
conditioned media of##3##3##(1994-11#1)(1995-11#1)(2008-4#1)
conditioned media##15##2##(1990-2#1)(1992-3#3)(1993-9#2)(1994-11#1)(1995-11#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2012-4#1)
conditioned medium at##2##3##(2008-11#2)
conditioned medium from##4##3##(1990-11#1)(1990-2#1)(1992-12#1)(1995-2#1)
conditioned medium of##2##3##(1994-6#1)(1997-1#1)
conditioned medium##24##2##(1990-11#2)(1990-2#2)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-1#2)(2008-11#11)
conditioned on the##2##3##(1992-12#1)(2008-10#1)
conditioned place preference##3##3##(1993-6#2)(1994-2#1)
conditioned reinforcement and##2##3##(1993-6#2)
conditioned reinforcement##5##2##(1993-6#5)
conditioned reinforcer##2##2##(1993-6#2)
conditioned response##2##2##(1996-2#1)(2008-5#1)
conditioned stimulus (CS)##3##3##(1995-12#1)(2008-4#1)(2008-5#1)
conditioned stimulus##7##2##(1995-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-4#1)(2008-5#1)
conditioned suppression##5##2##(1993-5#3)(2008-4#2)
conditioned taste aversion##4##3##(1991-1#1)(1995-12#1)(2008-5#2)
conditioned the##2##2##(2008-10#2)
conditioned to##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2010-6#1)
conditioned upon##2##2##(1991-2#1)(2008-11#1)
conditioned##144##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#1)(1992-12#3)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#3)(1993-5#5)(1993-6#10)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-2#3)(1996-5#3)(1997-1#2)(1997-3#2)(1997-7#5)(2007-11#1)(2008-1#1)(2008-10#25)(2008-11#17)(2008-3#2)(2008-4#6)(2008-5#9)(2008-6#2)(2008-8#1)(2009-11#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#1)
conditioner##5##1##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
conditioners##9##1##(1992-2#1)(2008-10#4)(2008-5#2)(2013-1#2)
conditioning agent##2##2##(2008-10#1)(2008-5#1)
conditioning and germination##3##3##(2008-10#3)
conditioning and##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
conditioning chemotherapy##2##2##(2008-7#1)(2012-12#1)
conditioning does not##2##3##(2008-5#1)(2013-1#1)
conditioning effects##4##2##(2008-5#4)
conditioning in##3##2##(1996-2#1)(2008-5#1)(2010-2#1)
conditioning of the##5##3##(1994-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
conditioning of##10##2##(1994-8#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)
conditioning on##3##2##(2008-3#1)(2008-7#2)
conditioning procedures##2##2##(1995-5#1)(2008-5#1)
conditioning resistance to##2##3##(2008-10#2)
conditioning sensitivity##2##2##(2008-10#2)
conditioning stimuli##2##2##(1995-12#2)
conditioning the hypersensitive reaction##2##4##(2008-10#2)
conditioning the##3##2##(2008-10#3)
conditioning to##2##2##(2008-11#1)(2008-4#1)
conditioning##104##1##(1991-5#1)(1992-10#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#3)(1995-12#2)(1995-5#1)(1996-2#2)(1997-7#5)(2007-12#1)(2007-4#1)(2008-10#27)(2008-11#10)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#4)(2009-6#1)(2010-2#4)(2012-12#2)(2012-2#2)(2013-1#6)
conditions (0##3##2##(2008-10#3)
conditions (2##2##2##(1995-8#1)(2008-10#1)
conditions (37 degrees C##2##4##(1992-6#1)(2008-10#1)
conditions (5##2##2##(1992-8#1)(2008-10#1)
conditions (e##5##2##(1992-8#1)(2008-9#2)(2009-9#1)(2011-2#1)
conditions (for##2##2##(2011-2#1)(2012-12#1)
conditions (high##2##2##(1992-3#1)(1993-8#1)
conditions (i##4##2##(2008-10#3)(2013-1#1)
conditions (in##2##2##(2008-11#1)(2008-3#1)
conditions (number of##2##3##(2008-10#2)
conditions (pH 10##2##3##(1997-4#1)(2008-10#1)
conditions (pH##11##2##(1991-12#1)(1991-7#1)(1997-4#1)(2008-10#5)(2008-6#1)(2010-4#1)(2010-7#1)
conditions (temperature##2##2##(1996-12#1)(2007-5#1)
conditions a pKa##2##3##(2008-10#2)
conditions a##8##2##(2007-11#1)(2007-12#1)(2008-10#5)(2009-10#1)
conditions above##2##2##(1990-8#1)(2008-10#1)
conditions affecting the##5##3##(1992-9#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
conditions affecting##10##2##(1992-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
conditions allow##2##2##(2008-10#2)
conditions along with##2##3##(2008-10#2)
conditions also##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)
conditions among##4##2##(2008-12#2)(2010-12#1)(2010-2#1)
conditions and 2##2##3##(2008-10#1)(2013-1#1)
conditions and a##5##3##(1997-2#1)(1997-5#1)(2008-10#2)(2012-2#1)
conditions and after##3##3##(1997-2#1)(2008-7#2)
conditions and also##2##3##(2008-11#1)(2008-2#1)
conditions and are##2##3##(1990-8#1)(2008-9#1)
conditions and by the##2##4##(2008-10#1)(2013-7#1)
conditions and by##3##3##(2008-10#2)(2013-7#1)
conditions and compared to##2##4##(2008-5#1)(2008-8#1)
conditions and compared##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
conditions and environments##2##3##(2008-8#1)(2009-5#1)
conditions and fibre##2##3##(2008-10#2)
conditions and have##2##3##(2008-10#1)(2009-1#1)
conditions and in##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2009-12#1)
conditions and on##2##3##(2008-3#1)(2010-7#1)
conditions and other##2##3##(2008-10#1)(2012-2#1)
conditions and pathological##2##3##(1990-9#1)(2006-6#1)
conditions and sample##2##3##(2008-10#2)
conditions and the##25##3##(1990-5#1)(1990-9#1)(1991-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
conditions and their##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-3#1)
conditions and to##8##3##(1992-10#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
conditions and were##2##3##(2008-10#2)
conditions and with##6##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2012-2#1)
conditions and##192##2##(1990-5#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-5#1)(1992-10#1)(1992-3#2)(1992-5#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-2#3)(1997-5#1)(1997-6#2)(2006-6#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#59)(2008-11#8)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#2)(2009-3#1)(2009-5#2)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#6)(2013-7#5)
conditions appears to##2##3##(2010-6#1)(2011-1#1)
conditions applied##3##2##(2008-4#2)(2012-9#1)
conditions are also discussed##2##4##(2008-10#1)(2008-2#1)
conditions are also##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
conditions are determined##3##3##(2007-12#1)(2008-10#2)
conditions are discussed##4##3##(2007-12#1)(2008-10#2)(2010-5#1)
conditions are established##2##3##(2008-10#2)
conditions are found to be##2##5##(2008-10#2)
conditions are given##2##3##(2008-10#1)(2008-2#1)
conditions are of##2##3##(1991-4#1)(2008-10#1)
conditions are often##2##3##(1992-12#1)(1997-4#1)
conditions are optimized##2##3##(2008-10#2)
conditions are presented##4##3##(1995-12#1)(1997-2#1)(2008-3#1)(2012-1#1)
conditions are rare and##2##4##(2010-4#1)(2011-1#1)
conditions are the##2##3##(2009-9#1)(2013-8#1)
conditions are##87##2##(1990-2#2)(1990-8#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-6#1)(2007-12#3)(2007-7#1)(2008-10#29)(2008-11#5)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
conditions as well as##6##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
conditions as##20##2##(1990-5#1)(1994-1#1)(1995-12#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
conditions associated with the##2##4##(2008-4#1)(2013-1#1)
conditions associated with##9##3##(1995-2#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-12#1)(2010-1#1)(2013-1#1)(2013-8#1)
conditions at room temperature##4##4##(1995-2#1)(2008-10#2)(2013-8#1)
conditions at the##2##3##(2008-10#1)(2008-7#1)
conditions at##21##2##(1992-6#1)(1995-2#1)(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2011-2#1)(2013-8#1)
conditions based on the##2##4##(2008-10#1)(2008-3#1)
conditions based on##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
conditions because of##2##3##(1995-8#1)(2011-1#1)
conditions because##3##2##(1995-8#1)(2008-10#1)(2011-1#1)
conditions become##3##2##(1996-12#1)(2007-12#1)(2011-2#1)
conditions before##2##2##(2008-10#2)
conditions both##3##2##(2008-10#2)(2012-12#1)
conditions but in##2##3##(2008-10#2)
conditions but##6##2##(1990-11#1)(1991-5#1)(1991-9#1)(2008-10#3)
conditions by means of##3##4##(1993-2#1)(2008-10#2)
conditions by the##2##3##(1991-12#1)(1997-7#1)
conditions by##12##2##(1991-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-9#1)
conditions can be obtained##2##4##(2007-12#1)(2008-3#1)
conditions can be##10##3##(1993-6#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-8#1)
conditions can##18##2##(1992-9#1)(1993-6#2)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-3#1)(2013-8#1)
conditions caused by##2##3##(1996-9#1)(2009-5#1)
conditions caused##3##2##(1990-12#1)(1996-9#1)(2009-5#1)
conditions characterized by##2##3##(1993-3#1)(2008-10#1)
conditions commonly##2##2##(1992-12#1)(2007-10#1)
conditions compared##2##2##(2012-12#1)(2012-3#1)
conditions conducive to##2##3##(2008-10#1)(2008-7#1)
conditions considered##2##2##(1997-3#1)(2008-3#1)
conditions constant##2##2##(2008-1#1)(2008-5#1)
conditions could be##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
conditions could##5##2##(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)
conditions described##2##2##(1997-2#1)(2008-10#1)
conditions detected##2##2##(2008-11#1)(2008-8#1)
conditions developed were##3##3##(1994-12#1)(2008-10#2)
conditions developed##5##2##(1994-11#1)(1994-12#1)(2008-10#3)
conditions did not##2##3##(2007-10#1)(2008-11#1)
conditions different from##2##3##(2008-1#2)
conditions do not##3##3##(2010-2#1)(2013-1#2)
conditions do##4##2##(2008-7#1)(2010-2#1)(2013-1#2)
conditions does not require the##2##5##(1991-2#1)(1992-9#1)
conditions does not##5##3##(1991-2#1)(1992-12#1)(1992-9#1)(2007-12#1)(2013-1#1)
conditions during the##3##3##(2007-11#1)(2009-2#1)(2012-2#1)
conditions during##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-2#1)(2012-2#1)
conditions employed in##2##3##(2008-10#1)(2008-9#1)
conditions employed##14##2##(1994-9#3)(2008-10#8)(2008-6#2)(2008-9#1)
conditions encountered##2##2##(2008-2#1)(2008-7#1)
conditions established##3##2##(2008-10#3)
conditions even##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
conditions exhibits##2##2##(2008-10#1)(2008-3#1)
conditions experienced##2##2##(2008-8#1)(2013-1#1)
conditions favorable##2##2##(2008-10#1)(2011-2#1)
conditions for a##6##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2012-1#1)
conditions for agonists##2##3##(1997-7#2)
conditions for an##2##3##(1992-9#1)(2008-8#1)
conditions for both the##2##4##(2008-10#2)
conditions for both##6##3##(1997-4#1)(2007-12#1)(2008-10#4)
conditions for determination of##4##4##(2008-10#4)
conditions for determination##6##3##(2008-10#6)
conditions for determining##5##3##(2008-10#5)
conditions for each##2##3##(2008-10#1)(2008-4#1)
conditions for infection##2##3##(2008-10#2)
conditions for its##2##3##(2008-10#2)
conditions for maintaining##5##3##(2008-11#5)
conditions for maximum##2##3##(2008-11#1)(2012-2#1)
conditions for measuring the##2##4##(2008-10#2)
conditions for metal##2##3##(2008-10#2)
conditions for patients##2##3##(1997-7#1)(2012-12#1)
conditions for preparing##2##3##(1990-11#1)(2008-10#1)
conditions for sample##4##3##(2008-10#4)
conditions for second-harmonic generation##2##4##(2007-11#1)(2008-3#1)
conditions for separation and##2##4##(2008-10#2)
conditions for separation of##3##4##(2008-10#3)
conditions for separation##6##3##(2008-10#6)
conditions for sequential##2##3##(2008-10#2)
conditions for successful##5##3##(2007-12#1)(2008-11#2)(2008-2#1)(2008-9#1)
conditions for the CL##3##4##(2008-10#3)
conditions for the analysis of##2##5##(2008-10#2)
conditions for the assay##2##4##(1992-9#1)(2008-10#1)
conditions for the determination of##8##5##(2008-10#8)
conditions for the extraction of##2##5##(2008-10#2)
conditions for the formation of the##2##6##(2008-10#2)
conditions for the formation of##3##5##(2008-10#3)
conditions for the generation of##2##5##(2007-11#1)(2008-3#1)
conditions for the reaction##2##4##(2008-10#2)
conditions for the separation of the##2##6##(2008-10#2)
conditions for the separation of##5##5##(2008-10#5)
conditions for the treatment##2##4##(2010-8#1)(2013-8#1)
conditions for the##79##3##(1990-9#1)(1992-3#1)(1992-9#1)(1994-12#2)(1994-3#1)(1997-2#1)(2007-11#1)(2008-10#53)(2008-11#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
conditions for thermal##2##3##(2008-10#1)(2008-3#1)
conditions for which##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
conditions for##278##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-9#2)(1993-9#1)(1994-12#3)(1994-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#4)(2007-11#6)(2007-12#4)(2007-5#1)(2008-10#141)(2008-11#23)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#7)(2009-1#1)(2009-6#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#1)
conditions found##4##2##(1997-2#1)(2008-10#3)
conditions from##9##2##(1990-8#1)(1992-12#1)(1992-3#1)(1996-6#1)(2008-10#2)(2008-3#1)(2009-12#1)(2013-7#1)
conditions has been##9##3##(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-2#1)(2012-3#1)(2013-1#1)
conditions has##11##2##(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2012-3#1)(2013-1#1)
conditions have been established##3##4##(2008-10#3)
conditions have been optimized##3##4##(2008-10#3)
conditions have been##13##3##(1991-2#1)(1991-3#1)(1991-6#1)(2007-11#1)(2008-10#8)(2011-2#1)
conditions have##15##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#1)(2007-11#1)(2008-10#8)(2008-7#1)(2011-2#1)
conditions however##2##2##(1991-12#1)(1997-7#1)
conditions if##2##2##(2008-10#1)(2008-4#1)
conditions imposed##2##2##(1991-6#1)(2007-11#1)
conditions in a##4##3##(1990-12#1)(2008-3#1)(2008-6#1)(2011-1#1)
conditions in order to##4##4##(2008-10#2)(2008-7#1)(2009-7#1)
conditions in our##2##3##(1990-6#1)(2008-8#1)
conditions in the##27##3##(1992-11#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
conditions in their##4##3##(2008-7#1)(2011-2#1)(2013-1#2)
conditions in this##2##3##(2008-10#1)(2008-9#1)
conditions in vitro##2##3##(1993-9#1)(1995-5#1)
conditions in vivo##3##3##(1990-11#1)(2008-5#2)
conditions in which a##2##4##(1993-11#1)(1993-3#1)
conditions in which the##2##4##(2008-7#1)(2008-8#1)
conditions in which##11##3##(1990-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
conditions in##99##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-6#2)(1990-8#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(2007-11#3)(2007-12#1)(2008-10#22)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
conditions include##2##2##(1996-6#1)(2008-10#1)
conditions including heat##2##3##(2008-10#1)(2011-2#1)
conditions including the##3##3##(2008-1#1)(2008-10#1)(2009-6#1)
conditions including##17##2##(1992-2#1)(1994-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#2)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
conditions increased##2##2##(2008-11#1)(2008-2#1)
conditions indicated that##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
conditions influence the##2##3##(2008-6#1)(2008-9#1)
conditions influencing##2##2##(1990-7#1)(2010-11#1)
conditions involving the##2##3##(1996-6#1)(2012-2#1)
conditions involving##4##2##(1994-8#1)(1996-6#1)(2012-2#1)(2013-8#1)
conditions is a##2##3##(2007-12#1)(2008-10#1)
conditions is described##4##3##(1992-8#1)(2008-10#3)
conditions is discussed##2##3##(2008-2#1)(2008-3#1)
conditions is increasing##2##3##(2007-12#1)(2011-1#1)
conditions is presented##2##3##(2008-4#1)(2008-5#1)
conditions is##34##2##(1990-7#1)(1992-8#1)(1994-2#1)(1997-4#2)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-10#1)(2011-1#2)(2012-7#1)
conditions it is possible to##2##5##(1994-5#1)(2008-3#1)
conditions it is##5##3##(1994-5#1)(1997-4#1)(2008-3#2)(2008-7#1)
conditions it##7##2##(1994-5#2)(1997-4#1)(2008-12#1)(2008-3#2)(2008-7#1)
conditions leading to##3##3##(1997-6#1)(2008-5#1)(2013-1#1)
conditions leads to##2##3##(1995-5#1)(1996-2#1)
conditions led to##2##3##(2008-10#1)(2013-1#1)
conditions like##2##2##(2009-10#1)(2010-8#1)
conditions may be##2##3##(2007-12#1)(2008-1#1)
conditions may##9##2##(1993-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-3#1)(2011-1#1)
conditions might##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
conditions more##2##2##(2008-10#1)(2013-1#1)
conditions near##2##2##(2008-10#1)(2008-2#1)
conditions necessary for##3##3##(2007-11#1)(2008-2#1)(2008-5#1)
conditions not##4##2##(1995-9#1)(2008-2#1)(2008-5#1)(2008-9#1)
conditions obtained by the##3##4##(2008-10#2)(2009-7#1)
conditions obtained by##4##3##(2008-10#2)(2008-6#1)(2009-7#1)
conditions obtained##7##2##(2008-10#4)(2008-11#1)(2008-6#1)(2009-7#1)
conditions occurred##2##2##(1994-12#1)(2008-10#1)
conditions of a##5##3##(1995-5#1)(2008-10#2)(2008-3#2)
conditions of amino acid##2##4##(1990-8#1)(1993-6#1)
conditions of an##2##3##(2008-10#2)
conditions of ischemic heart disease##2##5##(2012-3#2)
conditions of ischemic heart##3##4##(2012-3#3)
conditions of low ionic strength##2##5##(1994-5#1)(2011-2#1)
conditions of low##5##3##(1994-5#1)(2007-12#2)(2008-10#1)(2011-2#1)
conditions of pH##3##3##(1995-2#1)(1997-2#1)(2011-1#1)
conditions of partial##3##3##(1996-2#1)(2008-4#1)(2011-2#1)
conditions of production##3##3##(2008-11#1)(2012-2#2)
conditions of separation##2##3##(2008-10#1)(2008-6#1)
conditions of severe##2##3##(2008-2#1)(2008-9#1)
conditions of stress##2##3##(1995-5#1)(2012-12#1)
conditions of temperature##2##3##(2008-10#2)
conditions of the system##2##4##(2008-10#2)
conditions of the##46##3##(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#2)(1993-3#1)(1996-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
conditions of these##6##3##(2008-10#1)(2008-9#4)(2009-12#1)
conditions of this##9##3##(1990-6#1)(1991-5#1)(1992-4#1)(2008-10#1)(2008-8#1)(2008-9#3)(2013-1#1)
conditions of women##2##3##(2013-1#2)
conditions of##261##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#3)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#3)(2007-8#3)(2008-10#66)(2008-11#5)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#11)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-7#4)(2010-9#1)(2011-1#6)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#3)
conditions on a##2##3##(2012-3#1)(2013-1#1)
conditions on functional properties##2##4##(1991-2#1)(2010-4#1)
conditions on the##13##3##(2007-11#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-3#1)
conditions on##38##2##(1990-7#1)(1991-2#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)
conditions only##3##2##(2008-10#1)(2008-11#2)
conditions or after##2##3##(1994-2#1)(2008-10#1)
conditions or during##3##3##(1995-5#1)(2011-2#1)(2012-1#1)
conditions or in the##2##4##(2008-10#1)(2013-1#1)
conditions or in##4##3##(1997-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
conditions or##19##2##(1994-2#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
conditions over a##4##3##(1993-6#1)(2008-3#2)(2008-8#1)
conditions over##7##2##(1993-6#1)(2008-3#2)(2008-8#2)(2012-12#1)(2012-3#1)
conditions prevailing in the##2##4##(1991-12#1)(2008-11#1)
conditions recovered##2##2##(2008-10#1)(2011-1#1)
conditions reported##2##2##(1994-6#1)(2009-11#1)
conditions required for##6##3##(2007-12#1)(2008-10#2)(2008-4#2)(2008-9#1)
conditions required to##2##3##(2008-10#2)
conditions required##9##2##(2007-12#1)(2008-10#5)(2008-4#2)(2008-9#1)
conditions requires##2##2##(1997-1#1)(2008-7#1)
conditions requiring##3##2##(2008-1#1)(2008-3#1)(2011-2#1)
conditions resistance##2##2##(2008-10#2)
conditions resulted in##3##3##(1990-5#1)(1992-12#1)(2008-3#1)
conditions revealed a##2##3##(1990-5#1)(1994-5#1)
conditions revealed##4##2##(1990-5#1)(1990-9#1)(1994-5#1)(2013-8#1)
conditions selected##3##2##(2008-10#3)
conditions should be##3##3##(1997-4#1)(2007-11#1)(2007-7#1)
conditions show that##2##3##(2008-12#1)(2010-10#1)
conditions showed that##2##3##(2008-10#1)(2011-2#1)
conditions showed##5##2##(1995-5#1)(1997-1#1)(2008-10#1)(2009-11#1)(2011-2#1)
conditions shows a##2##3##(2008-10#1)(2009-7#1)
conditions similar to those##4##4##(1990-11#1)(2007-11#1)(2008-10#2)
conditions similar to##5##3##(1990-11#1)(2007-11#1)(2008-10#2)(2008-12#1)
conditions simulating##2##2##(2008-7#1)(2012-2#1)
conditions since##2##2##(2010-8#1)(2011-2#1)
conditions studied##4##2##(1994-9#1)(2008-11#1)(2008-6#1)(2008-7#1)
conditions such as headspace##2##4##(2008-10#1)(2011-1#1)
conditions such as pH##8##4##(2008-10#8)
conditions such as##36##3##(1992-2#1)(1994-11#1)(1995-1#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-4#2)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
conditions such##38##2##(1992-2#1)(1994-11#1)(1995-1#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
conditions tested##8##2##(1992-8#1)(2008-10#2)(2008-11#3)(2012-3#1)(2013-1#1)
conditions than##4##2##(2007-11#1)(2008-1#1)(2008-10#2)
conditions that are##10##3##(1990-2#1)(1991-9#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
conditions that can##4##3##(2007-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
conditions that exist##2##3##(2008-3#1)(2008-7#1)
conditions that favour##2##3##(1991-5#1)(1997-4#1)
conditions that lead to##3##4##(1991-6#1)(2008-10#1)(2013-1#1)
conditions that lead##4##3##(1991-6#1)(2008-10#2)(2013-1#1)
conditions that maximize##2##3##(2008-11#1)(2008-7#1)
conditions that may be##2##4##(2010-8#1)(2012-2#1)
conditions that may mimic##2##4##(2008-3#1)(2011-2#1)
conditions that may##4##3##(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
conditions that promote##2##3##(2008-10#1)(2008-6#1)
conditions that the##3##3##(1991-12#1)(1992-5#1)(1996-8#1)
conditions that were##2##3##(1996-12#1)(2008-10#1)
conditions that would##2##3##(2008-9#1)(2011-2#1)
conditions that##67##2##(1990-2#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-5#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
conditions the enzyme##2##3##(1994-6#1)(1997-4#1)
conditions the linear##4##3##(2008-10#4)
conditions the##27##2##(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-4#1)(2008-10#14)(2008-3#4)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
conditions through##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
conditions thus##2##2##(2008-10#1)(2008-3#1)
conditions to a##2##3##(1990-12#1)(1995-3#1)
conditions to be used in##2##5##(2008-10#1)(2008-4#1)
conditions to be##5##3##(2008-1#1)(2008-10#2)(2008-4#1)(2013-8#1)
conditions to the##5##3##(1990-8#1)(2007-12#1)(2008-10#3)
conditions to##40##2##(1990-12#1)(1990-8#1)(1993-12#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
conditions treated by##2##3##(2012-12#1)(2012-3#1)
conditions triggering##2##2##(2006-6#1)(2011-2#1)
conditions typical of##2##3##(2008-3#1)(2008-9#1)
conditions under which the##3##4##(2008-2#1)(2012-2#1)(2013-8#1)
conditions under which##23##3##(1994-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#5)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
conditions used##13##2##(1991-2#1)(1992-2#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#5)(2010-11#1)
conditions using the##2##3##(2008-10#2)
conditions using##6##2##(1996-5#1)(2007-12#1)(2008-10#4)
conditions was 0##2##3##(2008-10#2)
conditions was evaluated by##2##4##(2008-10#1)(2011-2#1)
conditions was evaluated##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
conditions was performed##2##3##(2008-10#1)(2008-3#1)
conditions was required##2##3##(1996-2#1)(2008-8#1)
conditions was studied##3##3##(2008-3#1)(2010-11#1)(2013-8#1)
conditions was##33##2##(1990-8#1)(1991-5#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#2)(2011-2#2)(2013-8#1)
conditions we##2##2##(2008-3#1)(2011-2#1)
conditions were 1##2##3##(2008-10#2)
conditions were achieved##3##3##(1996-5#1)(2008-10#2)
conditions were also##3##3##(2008-10#1)(2011-3#1)(2012-12#1)
conditions were applied##3##3##(2008-10#2)(2012-8#1)
conditions were as follows##2##4##(2008-10#1)(2011-1#1)
conditions were chosen##2##3##(2008-10#2)
conditions were collected##2##3##(2008-11#1)(2010-8#1)
conditions were compared##3##3##(1991-6#1)(1995-11#1)(2008-10#1)
conditions were conducted##2##3##(2008-10#2)
conditions were determined##5##3##(1996-12#1)(2008-10#2)(2008-11#2)
conditions were established##5##3##(2008-10#5)
conditions were evaluated##5##3##(1991-5#1)(2008-10#4)
conditions were examined##2##3##(2008-10#1)(2008-11#1)
conditions were found for##2##4##(2008-10#2)
conditions were found to be##7##5##(2008-10#7)
conditions were found to##9##4##(2008-10#8)(2010-3#1)
conditions were found##14##3##(1992-6#1)(2008-10#12)(2010-3#1)
conditions were investigated##9##3##(2008-10#7)(2009-12#1)(2010-4#1)
conditions were not##2##3##(2008-10#1)(2008-7#1)
conditions were obtained##4##3##(2008-10#3)(2013-7#1)
conditions were optimised##4##3##(2008-10#4)
conditions were optimized by##2##4##(2008-10#2)
conditions were optimized for the##3##5##(2008-10#3)
conditions were optimized for##6##4##(2008-10#5)(2010-5#1)
conditions were optimized##14##3##(2008-10#12)(2010-5#1)(2013-8#1)
conditions were previously##2##3##(2008-10#1)(2008-8#1)
conditions were selected##2##3##(2008-10#2)
conditions were studied by##2##4##(2008-10#2)
conditions were studied##5##3##(2008-10#5)
conditions were tested##2##3##(2008-10#2)
conditions were the##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
conditions were used to##2##4##(1994-9#1)(2008-11#1)
conditions were used##3##3##(1994-9#1)(2008-11#1)(2010-4#1)
conditions were##160##2##(1990-9#1)(1991-5#1)(1991-6#1)(1992-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#109)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-8#1)(2013-7#1)(2013-8#1)
conditions when the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
conditions when##11##2##(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)
conditions where the##6##3##(1991-8#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(2008-10#1)
conditions where##18##2##(1990-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
conditions which may##3##3##(1993-3#1)(2008-2#1)(2010-3#1)
conditions which##13##2##(1992-8#1)(1993-3#1)(1994-11#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
conditions while##2##2##(2008-2#1)(2012-3#1)
conditions will##3##2##(2008-5#1)(2008-7#1)(2009-12#1)
conditions with a##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
conditions with an##2##3##(2008-10#2)
conditions with different##2##3##(2007-10#1)(2008-3#1)
conditions with minimal##2##3##(1991-2#1)(2008-3#1)
conditions with the##3##3##(1991-3#1)(1996-5#1)(2011-10#1)
conditions with##29##2##(1991-2#2)(1991-3#1)(1994-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#6)(2008-6#1)(2008-7#1)(2008-9#1)(2011-10#1)(2013-7#1)
conditions within a##2##3##(2008-11#1)(2010-3#1)
conditions within##4##2##(1991-6#1)(2008-11#2)(2010-3#1)
conditions without any##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
conditions without##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)
conditions##3828##1##(1990-10#1)(1990-11#9)(1990-12#21)(1990-2#16)(1990-5#8)(1990-6#4)(1990-7#6)(1990-8#23)(1990-9#6)(1991-1#1)(1991-11#2)(1991-12#18)(1991-2#16)(1991-3#7)(1991-4#1)(1991-5#14)(1991-6#10)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#2)(1992-11#7)(1992-12#16)(1992-2#5)(1992-3#20)(1992-4#1)(1992-5#5)(1992-6#9)(1992-7#1)(1992-8#12)(1992-9#10)(1993-1#2)(1993-11#6)(1993-12#13)(1993-2#6)(1993-3#13)(1993-6#11)(1993-8#14)(1993-9#7)(1994-1#2)(1994-10#1)(1994-11#12)(1994-12#13)(1994-2#11)(1994-3#10)(1994-5#9)(1994-6#12)(1994-7#1)(1994-8#5)(1994-9#12)(1995-1#2)(1995-11#13)(1995-12#12)(1995-2#20)(1995-3#6)(1995-5#16)(1995-6#7)(1995-8#9)(1995-9#4)(1996-1#4)(1996-12#16)(1996-2#20)(1996-3#1)(1996-4#2)(1996-5#19)(1996-6#7)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#11)(1997-2#36)(1997-3#8)(1997-4#16)(1997-5#4)(1997-6#11)(1997-7#14)(1997-8#4)(2006-10#1)(2006-4#1)(2006-6#6)(2007-10#8)(2007-11#53)(2007-12#52)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#12)(2007-8#14)(2007-9#1)(2008-1#30)(2008-10#1263)(2008-11#173)(2008-12#40)(2008-2#99)(2008-3#157)(2008-4#58)(2008-5#72)(2008-6#57)(2008-7#122)(2008-8#87)(2008-9#85)(2009-1#2)(2009-10#21)(2009-11#14)(2009-12#20)(2009-2#3)(2009-3#6)(2009-4#1)(2009-5#8)(2009-6#12)(2009-7#15)(2009-8#7)(2009-9#12)(2010-1#8)(2010-10#18)(2010-11#11)(2010-12#7)(2010-2#8)(2010-3#13)(2010-4#17)(2010-5#12)(2010-6#8)(2010-7#11)(2010-8#12)(2010-9#6)(2011-1#52)(2011-10#2)(2011-2#98)(2011-3#4)(2011-7#1)(2011-9#1)(2012-1#16)(2012-12#40)(2012-2#52)(2012-3#39)(2012-4#2)(2012-5#1)(2012-7#3)(2012-8#1)(2012-9#2)(2013-1#105)(2013-7#19)(2013-8#48)
conditions)##8##1##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)
conditions]##7##1##(1991-2#1)(1991-5#1)(1992-3#1)(1994-2#1)(1995-8#1)(2011-2#1)(2013-1#1)
condom and personal lubricant samples##2##5##(2008-10#2)
condom and personal##3##3##(2008-10#3)
condom catheter##2##2##(2009-5#2)
condom distribution programs##2##3##(1995-12#1)(1997-5#1)
condom failure##2##2##(1993-2#2)
condom use among##2##3##(2008-11#1)(2011-1#1)
condom use and other##2##4##(1997-6#1)(2008-1#1)
condom use and##3##3##(1993-2#1)(1997-6#1)(2008-1#1)
condom use is##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
condom use##22##2##(1990-3#1)(1992-2#1)(1993-2#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-11#2)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
condom was##2##2##(1990-6#1)(2011-1#1)
condom##52##1##(1990-3#1)(1990-6#3)(1992-2#2)(1993-2#5)(1995-12#2)(1997-5#1)(1997-6#3)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#6)(2009-5#3)(2010-8#2)(2011-1#6)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)
condoms and##2##2##(2008-4#1)(2011-2#1)
condoms during##4##2##(2010-7#2)(2011-1#1)(2011-2#1)
condoms##39##1##(1990-6#5)(1993-2#3)(1994-3#2)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#4)(2008-11#1)(2008-4#4)(2008-8#1)(2009-5#1)(2010-7#3)(2011-1#2)(2011-2#5)(2012-12#2)(2013-1#3)
condors##5##1##(1997-6#5)
conducive for##5##2##(1997-2#1)(2008-10#4)
conducive soil##4##2##(2008-10#4)
conducive to downy mildew development##2##5##(2008-10#2)
conducive to ectoparasitic nematode damage on##2##6##(2008-10#2)
conducive to sporulation##2##3##(2008-10#2)
conducive to the##3##3##(2008-10#2)(2012-3#1)
conducive to##25##2##(1993-2#1)(1994-12#1)(1997-3#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-3#1)
conducive##40##1##(1993-2#1)(1994-12#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-3#1)
conduct a systematic review##2##4##(2013-1#1)(2013-8#1)
conduct a##16##2##(1994-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#3)
conduct and##5##2##(2008-10#1)(2009-7#1)(2010-5#2)(2012-2#1)
conduct disorder and##2##3##(1994-2#2)
conduct disorder##6##2##(1994-2#4)(2008-2#1)(2008-4#1)
conduct of a##2##3##(1992-2#1)(2008-11#1)
conduct of##13##2##(1992-2#1)(1996-2#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-4#1)(2010-10#1)(2011-1#1)(2012-2#1)
conduct problems##8##2##(2008-12#1)(2009-7#7)
conduct research##5##2##(1997-3#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-10#1)
conduct the##4##2##(2008-10#2)(2010-3#1)(2013-8#1)
conduct these tests##2##3##(1995-2#1)(2008-11#1)
conduct this##2##2##(2007-12#1)(2008-10#1)
conduct##117##1##(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1994-2#6)(1994-3#2)(1995-12#2)(1995-2#1)(1995-3#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-5#2)(1997-8#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#9)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-5#4)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
conductance and##3##2##(1990-7#1)(1994-12#1)(2008-5#1)
conductance are##3##2##(1990-7#1)(1996-2#1)(2008-8#1)
conductance in a##2##3##(1991-9#1)(1995-11#1)
conductance in##8##2##(1990-7#1)(1991-9#1)(1994-3#1)(1995-11#4)(2008-10#1)
conductance level##3##2##(2008-7#3)
conductance of the##4##3##(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
conductance of##19##2##(1994-11#1)(1994-12#2)(1994-6#1)(1995-11#2)(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-11#1)(2009-8#2)(2011-2#1)(2013-1#2)
conductance or conversion factors for##2##5##(2008-11#2)
conductance regulator##4##2##(1990-8#2)(1994-5#1)(2011-3#1)
conductance that##2##2##(1995-12#1)(2008-8#1)
conductance to##2##2##(1995-11#1)(2008-10#1)
conductance was##3##2##(1995-11#2)(1995-12#1)
conductance##96##1##(1990-2#1)(1990-7#5)(1990-8#2)(1991-3#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#10)(1995-12#6)(1995-2#1)(1995-5#1)(1996-2#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#11)(2008-8#5)(2009-11#1)(2009-6#1)(2009-8#6)(2011-2#1)(2011-3#1)(2012-12#1)(2012-7#1)(2013-1#2)
conductances and##2##2##(2008-8#2)
conductances##4##1##(1990-8#1)(2008-8#3)
conducted 2 months later##2##4##(1992-10#1)(2007-8#1)
conducted HIV##2##2##(2011-1#1)(2011-2#1)
conducted a cross sectional study##2##5##(2008-7#1)(2009-10#1)
conducted a pilot##3##3##(2008-12#1)(2010-11#1)(2013-8#1)
conducted a retrospective##6##3##(1991-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
conducted a review of the##3##5##(2008-8#1)(2011-2#1)(2013-8#1)
conducted a review of##4##4##(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
conducted a review##5##3##(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#2)
conducted a series of##2##4##(2008-10#1)(2008-2#1)
conducted a study##4##3##(1996-3#1)(2008-3#1)(2009-6#1)(2013-1#1)
conducted a survey##2##3##(1995-11#1)(2010-8#1)
conducted a systematic review##3##4##(2007-7#1)(2008-10#1)(2013-1#1)
conducted a systematic##6##3##(2007-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
conducted a##72##2##(1990-5#1)(1991-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#5)
conducted according to##3##3##(1995-6#1)(2008-2#1)(2011-2#1)
conducted across##4##2##(1996-3#1)(2008-2#1)(2008-8#1)(2013-8#1)
conducted after##4##2##(1994-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
conducted among the##4##3##(1991-12#1)(1996-1#1)(1997-3#1)(2012-3#1)
conducted among##11##2##(1991-12#1)(1992-6#1)(1996-1#1)(1997-3#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
conducted an##5##2##(1994-12#1)(2008-3#1)(2009-5#1)(2010-5#1)(2013-8#1)
conducted and##8##2##(1991-12#1)(2007-2#1)(2008-11#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-8#2)
conducted as a##2##3##(1995-1#1)(2012-2#1)
conducted as##3##2##(1995-1#1)(2010-10#1)(2012-2#1)
conducted at 25 degrees C##3##5##(2008-10#2)(2009-7#1)
conducted at a##2##3##(1996-12#1)(2008-10#1)
conducted at the University of##2##5##(2008-12#1)(2012-12#1)
conducted at the##16##3##(1994-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
conducted at two##3##3##(2008-10#2)(2008-11#1)
conducted at##51##2##(1991-11#1)(1994-1#1)(1996-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
conducted based on##2##3##(2008-10#1)(2012-12#1)
conducted between##8##2##(1993-2#1)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#2)(2013-8#1)
conducted both##4##2##(1991-1#1)(2008-11#1)(2008-3#1)(2010-12#1)
conducted by a##4##3##(1993-3#1)(2007-8#1)(2008-10#1)(2008-12#1)
conducted by the##17##3##(1991-6#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-5#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
conducted by##60##2##(1990-12#1)(1991-6#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
conducted during a##2##3##(1995-11#1)(1997-4#1)
conducted during the##3##3##(2007-5#1)(2008-11#1)(2013-1#1)
conducted during##15##2##(1990-8#1)(1995-11#1)(1997-4#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
conducted focus group discussions##2##4##(2009-6#1)(2010-2#1)
conducted for the##5##3##(1992-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
conducted for##14##2##(1990-4#1)(1992-1#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2012-2#1)(2013-1#1)
conducted from##11##2##(2008-10#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-3#1)(2012-2#1)(2013-7#2)
conducted in 1989##2##3##(1991-3#1)(1994-3#1)
conducted in 1994##2##3##(2008-10#2)
conducted in 2001##2##3##(2008-12#1)(2012-3#1)
conducted in 2005##2##3##(2008-10#1)(2011-2#1)
conducted in 2006##3##3##(2009-10#1)(2011-2#1)(2013-8#1)
conducted in Athens (1989-1991)##2##4##(1993-9#2)
conducted in Athens##3##3##(1993-9#3)
conducted in December##2##3##(1993-1#1)(1995-12#1)
conducted in South##2##3##(2008-10#1)(2013-1#1)
conducted in a##19##3##(1990-11#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2011-2#3)(2012-2#1)
conducted in an##4##3##(2008-10#2)(2008-12#1)(2013-1#1)
conducted in both##2##3##(2008-10#1)(2009-6#1)
conducted in commercial##2##3##(2008-10#1)(2011-2#1)
conducted in field##2##3##(2008-10#2)
conducted in four##2##3##(2008-10#1)(2008-5#1)
conducted in hot##2##3##(2013-8#2)
conducted in order to##9##4##(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-11#1)(2012-3#1)
conducted in other##2##3##(2008-2#1)(2013-7#1)
conducted in patients##2##3##(2008-1#1)(2008-3#1)
conducted in rural##2##3##(2008-11#1)(2010-12#1)
conducted in the US##3##4##(1996-9#1)(2008-5#1)(2013-8#1)
conducted in the United States##2##5##(2007-2#1)(2010-11#1)
conducted in the United##3##4##(2007-2#2)(2010-11#1)
conducted in the past##2##4##(2007-12#1)(2008-11#1)
conducted in the same##2##4##(1994-9#1)(2007-7#1)
conducted in the visible##3##4##(2008-3#2)(2013-8#1)
conducted in the##41##3##(1990-8#2)(1992-2#1)(1993-8#1)(1994-9#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#3)(2013-8#9)
conducted in this##5##3##(1993-1#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-7#1)
conducted in two##3##3##(1994-9#1)(2008-10#1)(2013-1#1)
conducted in vitro##2##3##(2008-9#1)(2012-1#1)
conducted in##244##2##(1990-11#1)(1990-3#1)(1990-8#3)(1991-2#1)(1991-3#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#4)(1993-3#1)(1993-8#1)(1993-9#5)(1994-12#1)(1994-3#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#7)(2008-10#41)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#18)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#17)
conducted interviews with##2##3##(2008-5#1)(2012-3#1)
conducted its##2##2##(1994-3#1)(1997-5#1)
conducted of##5##2##(1994-2#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#1)
conducted on 100##2##3##(1992-5#1)(2013-8#1)
conducted on 30##2##3##(1997-5#1)(2008-11#1)
conducted on a##9##3##(1991-7#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-5#1)(2013-1#1)
conducted on samples##2##3##(2008-10#2)
conducted on the##14##3##(1990-12#1)(1994-8#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
conducted on##76##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#5)(2013-8#2)
conducted over a period of##2##5##(2007-8#1)(2008-5#1)
conducted over a##4##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
conducted over the past##2##4##(1990-6#1)(1996-2#1)
conducted over the##6##3##(1990-6#1)(1992-10#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
conducted over##12##2##(1990-6#1)(1992-10#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
conducted pre-##3##2##(2010-7#1)(2013-1#2)
conducted retrospectively##2##2##(2012-3#1)(2013-1#1)
conducted semistructured interviews with##3##4##(2010-11#1)(2010-8#1)(2013-1#1)
conducted show##2##2##(1997-4#1)(2008-2#1)
conducted since##2##2##(1990-12#1)(2008-5#1)
conducted studies##3##2##(2007-11#1)(2008-5#1)(2010-10#1)
conducted the##5##2##(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
conducted this study##4##3##(2007-7#1)(2008-1#1)(2010-7#1)(2011-2#1)
conducted through##5##2##(1991-3#1)(2008-10#1)(2008-9#2)(2012-1#1)
conducted to ascertain the##3##4##(1994-2#1)(2008-11#1)(2008-7#1)
conducted to assess the##8##4##(2007-7#1)(2008-10#4)(2010-5#1)(2011-1#1)(2012-12#1)
conducted to assess##12##3##(2007-7#1)(2008-10#5)(2008-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
conducted to characterize##2##3##(2008-3#1)(2008-5#1)
conducted to compare the##8##4##(1991-5#1)(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
conducted to compare##9##3##(1991-5#1)(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
conducted to demonstrate the##2##4##(2011-1#1)(2012-3#1)
conducted to determine if##5##4##(1992-3#2)(1995-3#1)(2008-10#2)
conducted to determine the effect of##4##6##(2008-10#1)(2008-12#2)(2011-2#1)
conducted to determine the relative##2##5##(2008-10#2)
conducted to determine the##24##4##(1992-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#4)(2013-8#1)
conducted to determine whether the##2##5##(2008-10#2)
conducted to determine whether##7##4##(1995-2#1)(1995-8#1)(2008-10#3)(2008-7#1)(2012-1#1)
conducted to determine##44##3##(1991-5#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(2007-10#1)(2008-10#12)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-8#1)
conducted to elucidate the##2##4##(1995-2#1)(2008-10#1)
conducted to establish the##3##4##(1996-2#1)(2008-10#1)(2013-8#1)
conducted to establish##6##3##(1996-2#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
conducted to evaluate the effects of##4##6##(2008-10#1)(2008-12#2)(2010-4#1)
conducted to evaluate the##17##4##(1994-11#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
conducted to evaluate##23##3##(1994-11#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
conducted to examine the##6##4##(1996-1#1)(2008-10#2)(2008-11#2)(2008-12#1)
conducted to examine whether##3##4##(1995-9#1)(2008-11#1)(2012-2#1)
conducted to examine##12##3##(1994-1#1)(1995-1#1)(1995-9#1)(1996-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2012-2#1)(2013-1#1)
conducted to further##2##3##(2008-10#1)(2010-8#1)
conducted to identify the##6##4##(1995-10#1)(1995-12#1)(2008-10#2)(2009-10#1)(2011-1#1)
conducted to identify##17##3##(1994-9#1)(1995-10#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
conducted to investigate the effect of the##2##7##(2008-12#1)(2011-2#1)
conducted to investigate the effect of##4##6##(2008-12#3)(2011-2#1)
conducted to investigate the effects of##4##6##(1992-2#1)(2008-10#1)(2010-2#1)(2011-2#1)
conducted to investigate the##13##4##(1992-2#1)(2008-10#2)(2008-12#3)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
conducted to investigate##14##3##(1991-3#1)(1992-2#1)(2008-10#2)(2008-12#3)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
conducted to obtain##4##3##(2008-3#1)(2011-2#1)(2013-1#2)
conducted to study the effect of##2##6##(2008-10#2)
conducted to study the effects of##4##6##(2008-10#2)(2008-12#1)(2010-4#1)
conducted to study the##9##4##(2008-10#5)(2008-12#2)(2008-3#1)(2010-4#1)
conducted to study##11##3##(2007-7#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-7#1)(2010-4#1)
conducted to test the##3##4##(1991-2#1)(2008-10#1)(2012-2#1)
conducted to test##6##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
conducted to##204##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-10#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#45)(2008-11#9)(2008-12#19)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#5)(2011-1#7)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#9)(2013-8#5)
conducted under the auspices of the##2##6##(1994-12#1)(2008-11#1)
conducted under the##5##3##(1994-12#1)(2008-10#1)(2008-11#2)(2012-1#1)
conducted under##8##2##(1994-12#1)(2008-10#2)(2008-11#2)(2012-1#1)(2012-12#1)(2013-7#1)
conducted using a##11##3##(1991-12#1)(1992-3#1)(1994-8#1)(2008-10#3)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
conducted using the##6##3##(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
conducted using##44##2##(1991-12#2)(1992-3#1)(1993-8#1)(1994-8#1)(1996-2#3)(1996-5#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
conducted with a##7##3##(1997-3#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-4#1)(2011-2#1)
conducted with the aim of##2##5##(2011-1#1)(2013-8#1)
conducted with the aim##3##4##(2011-1#1)(2013-7#1)(2013-8#1)
conducted with the##8##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
conducted with this##2##3##(2008-3#1)(2012-3#1)
conducted with##69##2##(1990-7#1)(1991-12#2)(1991-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#2)(2007-12#3)(2008-10#8)(2008-12#3)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#2)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
conducted worldwide##2##2##(2008-8#1)(2009-7#1)
conducted##1142##1##(1990-11#1)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#3)(1992-12#3)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1993-1#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-8#2)(1993-9#6)(1994-1#3)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#4)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#7)(1996-12#14)(1996-2#10)(1996-3#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#4)(1997-6#4)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#6)(2007-11#6)(2007-12#7)(2007-2#4)(2007-5#4)(2007-6#3)(2007-7#13)(2007-8#6)(2007-9#1)(2008-1#13)(2008-10#193)(2008-11#39)(2008-12#49)(2008-2#14)(2008-3#39)(2008-4#6)(2008-5#35)(2008-6#12)(2008-7#25)(2008-8#17)(2008-9#31)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#5)(2009-3#2)(2009-4#4)(2009-5#12)(2009-6#5)(2009-7#7)(2009-8#1)(2009-9#6)(2010-10#6)(2010-11#9)(2010-12#5)(2010-2#6)(2010-3#6)(2010-4#9)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#18)(2010-9#2)(2011-1#24)(2011-2#60)(2011-3#1)(2012-1#6)(2012-12#26)(2012-2#22)(2012-3#27)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#69)(2013-7#9)(2013-8#42)
conductimetric##5##1##(2008-10#4)(2008-5#1)
conducting a randomized controlled trial##2##5##(2008-8#1)(2010-8#1)
conducting a##15##2##(1992-12#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
conducting airways##5##2##(1991-12#2)(1991-6#1)(2013-1#2)
conducting an##5##2##(1992-2#1)(1994-12#1)(2010-10#2)(2011-1#1)
conducting and non-conducting##3##3##(2008-10#1)(2008-7#2)
conducting and##8##2##(2008-10#4)(2008-7#2)(2010-5#1)(2012-3#1)
conducting canal##2##2##(2007-12#2)
conducting clinical##2##2##(2009-10#2)
conducting media##2##2##(2008-10#1)(2008-3#1)
conducting polymer layer##3##3##(2008-10#3)
conducting polymer solid contact##2##4##(2008-10#2)
conducting polymer##20##2##(1990-4#1)(2008-10#16)(2008-3#1)(2008-5#1)(2009-11#1)
conducting polymers##4##2##(1990-8#1)(2008-10#2)(2008-9#1)
conducting polypyrrole##3##2##(2008-10#3)
conducting research##4##2##(2009-6#1)(2010-11#1)(2010-3#1)(2010-9#1)
conducting studies##4##2##(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
conducting the##8##2##(1995-12#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
conducting this##3##2##(1996-1#1)(2008-10#2)
conducting##154##1##(1990-4#1)(1990-8#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-3#2)(2007-12#3)(2007-7#1)(2008-1#4)(2008-10#41)(2008-11#4)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#3)(2009-4#2)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#7)(2013-8#2)
conduction along##2##2##(2008-12#1)(2010-7#1)
conduction and##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
conduction band of CdS##2##4##(2008-8#2)
conduction band##4##2##(2007-12#1)(2008-10#1)(2008-8#2)
conduction block of the##2##4##(2007-8#1)(2008-9#1)
conduction block##6##2##(2007-8#1)(2008-9#1)(2010-8#3)(2013-1#1)
conduction defects##2##2##(1995-1#1)(2010-7#1)
conduction from##2##2##(2008-3#1)(2010-4#1)
conduction in##6##2##(2008-10#2)(2008-5#1)(2009-11#1)(2010-12#1)(2013-1#1)
conduction mechanism is##2##3##(1991-3#1)(2009-11#1)
conduction mechanism##5##2##(1991-3#2)(2009-11#3)
conduction of##2##2##(2009-11#1)(2013-1#1)
conduction studies and electromyography##2##4##(2012-2#1)(2012-3#1)
conduction studies##6##2##(2008-6#4)(2012-2#1)(2012-3#1)
conduction system##4##2##(2008-3#1)(2008-7#2)(2009-5#1)
conduction velocities##2##2##(1997-3#1)(2008-12#1)
conduction velocity##3##2##(2013-1#3)
conduction##78##1##(1991-3#2)(1992-6#2)(1994-3#1)(1995-1#1)(1997-3#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#7)(2009-5#1)(2010-12#2)(2010-4#1)(2010-7#5)(2010-8#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#8)
conduction-cooled##3##1##(2007-12#3)
conductive carbon##2##2##(2008-10#1)(2013-1#1)
conductive films##3##2##(2008-10#3)
conductive paper##2##2##(2009-11#2)
conductive polymer##3##2##(2008-10#3)
conductive type##2##2##(2013-8#2)
conductive##30##1##(1990-2#1)(1992-2#1)(1996-4#2)(2008-10#12)(2008-2#1)(2009-11#6)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
conductivities##7##1##(2008-10#2)(2008-2#1)(2008-3#4)
conductivity and corrosion stability##2##4##(2010-4#2)
conductivity and##14##2##(1997-5#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-4#2)(2012-5#1)(2013-1#2)
conductivity detection##8##2##(1994-9#1)(2008-10#7)
conductivity detector##5##2##(2008-10#4)(2011-1#1)
conductivity in##2##2##(2007-12#1)(2008-7#1)
conductivity measurement##2##2##(2008-10#1)(2009-10#1)
conductivity measurements##3##2##(2008-1#1)(2008-10#2)
conductivity media##2##2##(2008-11#2)
conductivity of a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
conductivity of the##7##3##(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#1)
conductivity of##17##2##(1992-8#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2012-12#1)(2012-2#1)(2013-1#1)
conductivity##96##1##(1991-9#1)(1992-8#1)(1994-9#1)(1996-4#2)(1996-5#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#42)(2008-11#4)(2008-2#4)(2008-3#8)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#3)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#5)(2012-5#1)(2013-1#5)(2013-8#1)
conductometric titration data##2##3##(2008-10#2)
conductometric titration##4##2##(2008-10#4)
conductometric##9##1##(2008-10#9)
conductometry##4##1##(2008-10#4)
conductor is##2##2##(2008-10#1)(2008-3#1)
conductor was##2##2##(2008-10#2)
conductor##10##1##(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)
conductors##6##1##(1992-8#1)(1996-5#1)(2008-10#1)(2008-3#3)
conducts##10##1##(1992-3#1)(1996-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
conduit and##2##2##(2007-8#1)(2008-10#1)
conduit for##4##2##(1992-8#1)(2007-7#1)(2008-1#1)(2008-5#1)
conduit from the##2##3##(2007-8#2)
conduit in##2##2##(2007-8#2)
conduit of##2##2##(2007-7#1)(2008-12#1)
conduit##23##1##(1992-8#1)(2007-12#2)(2007-7#2)(2007-8#9)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
conduits for##2##2##(2008-1#1)(2012-12#1)
conduits of##4##2##(2008-10#3)(2012-12#1)
conduits##12##1##(1991-11#2)(2007-8#2)(2008-1#1)(2008-10#4)(2011-1#1)(2012-12#2)
condylar cartilage from##2##3##(1993-12#2)
condylar cartilage##3##2##(1993-12#2)(1994-6#1)
condylar plate##2##2##(2007-11#1)(2009-3#1)
condylar position##2##2##(1993-1#2)
condylar process##2##2##(2008-7#2)
condylar##17##1##(1992-3#1)(1993-1#2)(1993-12#2)(1994-6#3)(1996-9#1)(2007-11#2)(2008-10#1)(2008-7#2)(2009-3#1)(2013-1#2)
condyle##11##1##(1993-1#1)(2008-7#1)(2011-2#1)(2013-1#8)
condyloma acuminatum##6##2##(2007-8#2)(2011-1#2)(2012-12#1)(2012-3#1)
condyloma##10##1##(2007-8#2)(2011-1#3)(2012-12#2)(2012-3#3)
condylomata acuminata##4##2##(1994-1#1)(2012-12#2)(2013-1#1)
condylomata##6##1##(1994-1#1)(2011-1#2)(2012-12#2)(2013-1#1)
cone and##3##2##(2007-12#1)(2013-1#2)
cone angle##2##2##(2008-2#1)(2008-3#1)
cone beam CT##2##3##(2007-12#1)(2009-3#1)
cone beam breast CT imaging##3##5##(2008-5#3)
cone beam computed tomography##3##4##(2009-12#1)(2013-1#2)
cone beam##9##2##(2007-12#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-3#1)(2013-1#2)
cone is##2##2##(2011-1#2)
cone penetrometer##2##2##(2008-12#1)(2008-2#1)
cone photoreceptor##2##2##(1990-7#1)(2010-1#1)
cone prism##2##2##(2008-3#2)
cone types##3##2##(2007-5#3)
cone##53##1##(1990-12#1)(1990-7#1)(1991-1#3)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-2#5)(2007-12#3)(2007-5#6)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#2)(2013-1#7)
cone-beam##2##1##(2008-3#1)(2013-1#1)
cone-shaped##4##1##(1996-5#1)(2008-10#1)(2008-12#1)(2011-1#1)
coneflower (Echinacea purpurea)##3##3##(2008-10#3)
coneflower##4##1##(2008-10#4)
cones and##2##2##(2008-10#1)(2008-8#1)
cones in##2##2##(1995-12#1)(2008-8#1)
cones of##4##2##(1995-12#3)(2007-12#1)
cones##25##1##(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#5)(1996-5#1)(2007-12#1)(2007-5#3)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#5)
confabulation and##2##2##(1996-11#1)(2008-7#1)
confabulation##9##1##(1996-11#1)(2008-4#5)(2008-7#3)
confectionery sunflower##3##2##(2008-10#3)
confederation##2##1##(1991-3#1)(2008-11#1)
confer a##11##2##(1990-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
confer an##2##2##(2008-10#1)(2008-4#1)
confer benefits##3##2##(2008-5#1)(2009-11#2)
confer protection against##3##3##(1995-5#1)(2008-7#1)(2013-1#1)
confer protection##4##2##(1995-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
confer resistance in##2##3##(2008-10#2)
confer resistance to##9##3##(1997-7#1)(2008-10#6)(2012-12#1)(2013-1#1)
confer resistance##12##2##(1997-7#1)(2008-10#9)(2012-12#1)(2013-1#1)
confer the##3##2##(2008-5#1)(2008-7#1)(2010-4#1)
confer##78##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-12#3)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-12#1)(2008-10#20)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#4)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
conference &quot##2##2##(1997-3#1)(2009-5#1)
conference evaluation##2##2##(2012-2#2)
conference for student##2##3##(1991-1#1)(2008-11#1)
conference in##9##2##(1992-3#1)(1994-1#1)(1994-7#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
conference is##2##2##(2010-11#2)
conference on the##3##3##(1994-6#1)(1995-3#1)(2007-12#1)
conference on##13##2##(1990-2#1)(1991-11#1)(1991-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-2#2)(2007-12#1)(2007-5#1)(2008-11#1)(2008-7#1)
conference was designed to##2##4##(1995-3#1)(2008-5#1)
conference was the##2##3##(1995-6#1)(2008-5#1)
conference was##8##2##(1995-3#1)(1995-6#1)(2008-3#1)(2008-5#3)(2010-11#1)(2010-5#1)
conference##121##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-12#1)(1994-1#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-12#4)(2007-5#5)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#8)(2008-8#7)(2008-9#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-11#4)(2010-2#1)(2010-4#4)(2010-5#3)(2011-2#3)(2012-2#7)(2012-3#1)(2013-1#1)
conferences and##2##2##(1992-9#1)(2007-11#1)
conferences have##2##2##(1990-2#1)(1997-2#1)
conferences##20##1##(1990-2#1)(1990-6#1)(1991-3#1)(1992-9#1)(1993-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-4#1)(2012-2#1)
conferred a##4##2##(1994-8#1)(2008-10#2)(2012-12#1)
conferred an##2##2##(1995-11#1)(2011-2#1)
conferred by a single gene##2##5##(2008-10#2)
conferred by a single##4##4##(2008-10#4)
conferred by a##6##3##(1995-2#1)(2008-10#5)
conferred by the##5##3##(1992-12#1)(2008-10#4)
conferred by##30##2##(1992-12#1)(1992-8#1)(1993-2#1)(1995-2#1)(2008-10#17)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
conferred complete resistance##2##3##(1993-3#1)(2008-10#1)
conferred complete##3##2##(1993-3#1)(2008-10#2)
conferred on##3##2##(1994-10#1)(1995-2#1)(2008-10#1)
conferred protection against##2##3##(2008-10#1)(2011-2#1)
conferred resistance to##5##3##(2008-10#4)(2011-2#1)
conferred resistance##8##2##(2008-10#7)(2011-2#1)
conferred the##6##2##(1995-3#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
conferred##75##1##(1990-11#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(2008-10#36)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
conferring a##4##2##(1994-9#1)(1997-4#1)(2009-5#1)(2010-12#1)
conferring resistance against##2##3##(2008-10#1)(2008-7#1)
conferring resistance to the##2##4##(2008-10#2)
conferring resistance to##14##3##(1994-12#2)(2008-10#11)(2011-2#1)
conferring resistance##19##2##(1994-12#2)(2008-10#15)(2008-7#1)(2011-2#1)
conferring##48##1##(1994-12#4)(1994-6#1)(1994-9#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-10#25)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
confers a high level of##2##5##(2008-10#2)
confers a high##3##3##(1994-9#1)(2008-10#2)
confers a##9##2##(1992-8#1)(1994-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)
confers enhanced resistance to##2##4##(1995-6#1)(2008-10#1)
confers protection##2##2##(1994-11#2)
confers resistance to the##2##4##(2008-10#2)
confers resistance to##12##3##(1995-2#1)(1995-6#1)(2008-10#8)(2008-11#1)(2009-5#1)
confers resistance##14##2##(1995-2#1)(1995-6#1)(2008-10#10)(2008-11#1)(2009-5#1)
confers the##2##2##(1994-12#1)(2013-8#1)
confers to##2##2##(2010-10#1)(2013-1#1)
confers##60##1##(1992-12#1)(1992-8#2)(1992-9#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#3)(1995-6#2)(1997-3#1)(2008-10#24)(2008-11#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
confidence and competence##2##3##(2008-11#2)
confidence and##9##2##(2008-11#3)(2008-12#3)(2008-2#1)(2011-1#1)(2013-1#1)
confidence bands##2##2##(1997-4#1)(2010-11#1)
confidence by##2##2##(1996-2#1)(2008-12#1)
confidence can##2##2##(1991-12#1)(2008-9#1)
confidence in beef##2##3##(1996-3#1)(1996-6#1)
confidence in the##6##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
confidence in their##5##3##(1996-1#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
confidence in##35##2##(1992-11#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-9#4)(2009-10#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#3)
confidence interval (CI)##15##3##(1992-10#1)(1993-9#2)(2007-10#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
confidence interval 0##7##3##(1990-6#1)(1991-11#1)(1991-8#2)(2008-3#1)(2010-6#1)(2012-12#1)
confidence interval 1##7##3##(2007-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2011-2#2)
confidence interval 2##3##3##(2008-2#1)(2008-6#1)(2009-5#1)
confidence interval =##2##3##(1991-2#1)(2008-3#1)
confidence interval [CI]##8##3##(1993-12#1)(2006-10#1)(2009-9#1)(2010-10#1)(2010-4#3)(2012-2#1)
confidence interval for the##2##4##(1991-5#1)(1996-3#1)
confidence interval for theta##3##4##(1996-3#3)
confidence interval for##12##3##(1991-2#1)(1991-5#1)(1994-2#1)(1996-3#5)(2008-10#1)(2009-12#1)(2013-8#2)
confidence interval of 95%##3##4##(2008-10#2)(2013-1#1)
confidence interval of##6##3##(1991-7#1)(2008-10#3)(2010-3#1)(2013-1#1)
confidence interval##105##2##(1990-5#2)(1990-6#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#1)(1993-12#1)(1993-9#3)(1994-2#2)(1995-9#1)(1996-3#6)(1997-3#1)(1997-4#1)(2006-10#3)(2007-10#4)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#5)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#5)
confidence intervals (CI)##3##3##(2010-9#1)(2011-2#1)(2013-1#1)
confidence intervals (CIs)##2##3##(2008-8#1)(2011-2#1)
confidence intervals 1##3##3##(2013-1#2)(2013-8#1)
confidence intervals about##2##3##(1995-2#1)(1997-4#1)
confidence intervals are##3##3##(1994-11#1)(2008-10#1)(2012-3#1)
confidence intervals for the##4##4##(1997-7#1)(2008-10#2)(2011-2#1)
confidence intervals for##8##3##(1994-11#1)(1994-9#1)(1997-7#1)(2008-10#3)(2011-2#1)(2012-1#1)
confidence intervals of the##2##4##(2008-10#1)(2008-9#1)
confidence intervals of##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
confidence intervals were##2##3##(1994-11#1)(2011-2#1)
confidence intervals##51##2##(1990-2#1)(1994-11#3)(1994-9#2)(1995-2#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
confidence intervals)##2##2##(1993-9#1)(2013-1#1)
confidence is##4##2##(2008-11#2)(2011-1#1)(2012-2#1)
confidence level and##4##3##(2008-10#4)
confidence level of 95%##3##4##(2008-10#3)
confidence level##65##2##(1995-5#1)(1995-9#1)(2008-10#61)(2008-3#1)(2012-12#1)
confidence level)##6##2##(2008-10#6)
confidence levels##2##2##(2008-12#1)(2008-7#1)
confidence limit##6##2##(1991-5#1)(1992-5#1)(2008-10#3)(2008-4#1)
confidence limits on##3##3##(1995-9#2)(2009-5#1)
confidence limits##18##2##(1990-6#1)(1990-7#1)(1991-4#1)(1992-10#1)(1994-3#2)(1994-9#1)(1995-9#3)(1997-3#2)(2008-10#3)(2009-5#1)(2013-1#2)
confidence of##10##2##(1994-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-10#2)(2010-11#1)
confidence that the##2##3##(1991-12#1)(2008-1#1)
confidence that##4##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
confidence to##4##2##(2008-3#1)(2012-2#3)
confidence was##2##2##(2008-10#1)(2008-11#1)
confidence##393##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-5#1)(1993-12#1)(1993-9#4)(1994-11#3)(1994-2#2)(1994-3#3)(1994-9#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-9#5)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#8)(1996-6#1)(1997-3#4)(1997-4#3)(1997-7#1)(2006-10#3)(2007-10#5)(2007-7#1)(2008-1#3)(2008-10#121)(2008-11#23)(2008-12#16)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#4)(2009-12#2)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#4)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#19)(2013-8#6)
confidence)##2##1##(2008-10#2)
confident in##2##2##(2008-11#1)(2009-7#1)
confident that the##3##3##(1996-5#1)(2008-10#1)(2008-2#1)
confident that##4##2##(1996-1#1)(1996-5#1)(2008-10#1)(2008-2#1)
confident they##2##2##(2010-8#2)
confident##18##1##(1996-1#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-8#2)(2013-7#1)(2013-8#1)
confidential##4##1##(1995-6#1)(1997-5#2)(2008-9#1)
confidentiality and##2##2##(1990-2#1)(2008-11#1)
confidentiality breaches##2##2##(2007-12#2)
confidentiality of medical and mental health records##3##7##(1991-12#2)(1992-3#1)
confidentiality of##7##2##(1991-12#2)(1991-3#1)(1992-3#1)(1993-3#1)(1997-5#1)(2008-7#1)
confidentiality##36##1##(1990-2#1)(1991-12#2)(1991-3#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-7#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#3)(2007-12#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#2)
confidentiality]##2##1##(1994-6#1)(2010-3#1)
confidently and##2##2##(2008-11#2)
confidently##12##1##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
configurable##4##1##(2008-3#3)(2013-8#1)
configural processing##3##2##(2008-11#3)
configural stimuli##3##2##(1993-12#3)
configural##14##1##(1993-12#5)(2008-11#8)(2012-12#1)
configuration a##2##2##(2007-12#1)(2008-3#1)
configuration allows the##3##3##(2008-10#2)(2008-3#1)
configuration also##2##2##(2008-3#1)(2010-8#1)
configuration and a##2##3##(2008-2#2)
configuration and the##2##3##(2008-3#1)(2008-7#1)
configuration and##13##2##(1991-3#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-7#1)(2009-11#1)(2013-1#1)
configuration are##5##2##(2008-10#1)(2008-3#3)(2008-5#1)
configuration as the##2##3##(2007-11#1)(2008-2#1)
configuration at##5##2##(1996-2#1)(1996-5#3)(2008-4#1)
configuration based on##3##3##(2007-11#2)(2008-10#1)
configuration by##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
configuration can##2##2##(2008-2#1)(2008-3#1)
configuration for measuring##2##3##(2007-11#2)
configuration for##14##2##(2007-11#4)(2007-12#3)(2008-10#2)(2008-3#5)
configuration gives##2##2##(1995-11#1)(2007-11#1)
configuration has been developed##2##4##(2007-11#1)(2007-12#1)
configuration has been##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
configuration has##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
configuration in the##3##3##(1995-3#1)(1996-5#1)(2009-7#1)
configuration in which##2##3##(2008-2#1)(2008-3#1)
configuration in##12##2##(1994-2#1)(1995-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2013-1#1)
configuration include##2##2##(2007-11#2)
configuration is a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
configuration is presented##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
configuration is proposed##2##3##(2007-12#1)(2008-3#1)
configuration is##25##2##(1995-5#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#7)(2008-9#1)(2012-3#1)(2013-8#1)
configuration of a##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)
configuration of the device##2##4##(2008-10#1)(2008-11#1)
configuration of the##21##3##(1991-12#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#1)(1994-11#1)(1995-3#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-6#1)(2013-1#1)
configuration of these##2##3##(2008-4#1)(2009-10#1)
configuration of##53##2##(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#1)(1994-11#1)(1995-3#3)(1996-4#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
configuration on the##2##3##(1992-12#1)(2008-10#1)
configuration on##4##2##(1992-12#1)(2008-10#1)(2009-10#1)(2011-1#1)
configuration opens the##2##3##(2007-11#2)
configuration opens##3##2##(2007-11#2)(2007-12#1)
configuration provides##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
configuration space##4##2##(1995-3#1)(2008-1#1)(2008-4#2)
configuration that##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
configuration the##2##2##(2008-3#2)
configuration to provide##2##3##(2007-11#1)(2008-3#1)
configuration to route##2##3##(2008-2#2)
configuration to##9##2##(1993-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
configuration under##2##2##(2007-11#1)(2008-3#1)
configuration was##3##2##(2008-2#2)(2008-3#1)
configuration which##2##2##(1996-2#1)(2010-8#1)
configuration with a##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
configuration with##14##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-8#1)
configuration without##2##2##(2007-12#1)(2008-10#1)
configuration##392##1##(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#4)(1995-12#1)(1995-3#6)(1995-5#3)(1996-2#2)(1996-4#1)(1996-5#4)(1997-7#1)(2007-11#42)(2007-12#41)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#38)(2008-11#8)(2008-2#58)(2008-3#105)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
configuration) and##2##2##(1995-3#1)(2008-3#1)
configuration)##4##1##(1995-3#3)(2008-3#1)
configurational##2##1##(1992-12#1)(1992-4#1)
configurations and##4##2##(1991-1#2)(1997-6#1)(2011-1#1)
configurations are presented##4##3##(2008-2#1)(2008-3#3)
configurations are##7##2##(2008-2#2)(2008-3#4)(2008-4#1)
configurations at##3##2##(1990-5#1)(2008-11#1)(2008-3#1)
configurations by changing the##2##4##(1990-5#1)(2008-10#1)
configurations by##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
configurations can be used##2##4##(2008-2#1)(2008-3#1)
configurations can be##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
configurations for##5##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
configurations in which##3##3##(2008-3#3)
configurations in##6##2##(2008-3#3)(2008-7#1)(2009-3#1)(2009-8#1)
configurations of psychological##2##3##(1996-1#1)(2008-2#1)
configurations of the##4##3##(1995-2#1)(1996-5#1)(2008-10#1)(2013-8#1)
configurations of##16##2##(1995-11#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2013-8#1)
configurations on the##2##3##(2008-10#1)(2008-9#1)
configurations on##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
configurations that are##2##3##(2008-3#2)
configurations that##6##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)
configurations were##7##2##(1994-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-3#1)(2013-8#1)
configurations with##6##2##(1993-12#1)(2007-12#2)(2008-10#1)(2008-3#2)
configurations##139##1##(1990-5#2)(1990-7#1)(1991-1#3)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-5#3)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#6)(2007-12#9)(2008-10#12)(2008-11#5)(2008-12#3)(2008-2#15)(2008-3#34)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#2)(2010-10#1)(2011-1#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
configure a##2##2##(2008-10#1)(2009-11#1)
configure##6##1##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)
configured as##2##2##(2007-12#1)(2008-3#1)
configured in##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
configured to##3##2##(2007-11#1)(2008-10#2)
configured##15##1##(1991-5#1)(1992-3#1)(1993-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2011-1#1)
configures##2##1##(2008-2#1)(2008-4#1)
configuring##2##1##(2007-11#1)(2008-10#1)
confined between##2##2##(2008-6#1)(2010-2#1)
confined by##3##2##(1991-6#1)(1991-8#1)(2007-12#1)
confined in a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
confined in the##2##3##(2007-12#1)(2008-5#1)
confined in##8##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-5#1)(2012-2#2)
confined only##2##2##(2008-2#1)(2009-5#1)
confined to a single##2##4##(2007-7#1)(2010-12#1)
confined to a##7##3##(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
confined to the liver##2##4##(1990-8#1)(2012-2#1)
confined to the##30##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-8#1)(1993-12#2)(1993-9#2)(1994-12#1)(1994-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#3)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
confined to##63##2##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
confined##107##1##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#2)
confinement and##2##2##(2007-11#2)
confinement in##4##2##(1991-6#1)(2008-10#1)(2008-7#2)
confinement of the##2##3##(2008-10#1)(2008-3#1)
confinement of##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
confinement that is due to the##2##6##(2007-11#1)(2008-3#1)
confinement##37##1##(1991-6#1)(1991-9#1)(1993-11#1)(1993-5#1)(2007-11#9)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#11)(2008-5#1)(2008-7#4)(2009-7#1)(2012-2#1)(2013-1#1)
confines the##3##2##(2008-11#2)(2008-3#1)
confines##12##1##(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
confining##8##1##(1995-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
confirm a##4##2##(1995-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
confirm an##2##2##(2008-7#1)(2013-7#1)
confirm and extend the##2##4##(2008-10#1)(2012-3#1)
confirm and extend##3##3##(1994-3#1)(2008-10#1)(2012-3#1)
confirm and##5##2##(1994-3#1)(2008-10#2)(2010-12#1)(2012-3#1)
confirm earlier##2##2##(1993-2#1)(2008-10#1)
confirm experimentally that##2##3##(2007-11#1)(2008-3#1)
confirm in##2##2##(1991-6#1)(2007-7#1)
confirm its potential as a##2##5##(2008-2#1)(2010-12#1)
confirm its##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
confirm or rule out##2##4##(2007-10#2)
confirm or##8##2##(1990-2#1)(1991-11#1)(1997-8#1)(2007-10#2)(2008-1#1)(2008-3#1)(2008-9#1)
confirm our hypothesis that##2##4##(1994-3#1)(2011-2#1)
confirm our##5##2##(1994-3#1)(1997-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
confirm previous reports##2##3##(1994-8#1)(1995-12#1)
confirm previous##5##2##(1991-2#1)(1994-8#1)(1995-12#1)(2008-3#1)(2008-6#1)
confirm previously reported##2##3##(2008-6#1)(2011-2#1)
confirm some##3##2##(1991-8#1)(2008-5#1)(2008-8#1)
confirm such##2##2##(2008-3#1)(2012-12#1)
confirm that a##5##3##(1994-11#1)(2007-8#1)(2008-3#2)(2010-1#1)
confirm that the##26##3##(1990-6#1)(1990-8#1)(1993-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
confirm that there##2##3##(1991-6#1)(2008-5#1)
confirm that these##2##3##(2008-3#1)(2008-4#1)
confirm that##78##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#3)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
confirm the applicability of##2##4##(2007-8#1)(2008-3#1)
confirm the association of##2##4##(1996-8#1)(2008-10#1)
confirm the diagnosis##16##3##(1990-9#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
confirm the effectiveness of##2##4##(2007-11#1)(2008-10#1)
confirm the efficacy##2##3##(2008-11#1)(2008-7#1)
confirm the existence of two##2##5##(2007-12#1)(2008-11#1)
confirm the existence of##6##4##(1994-6#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-11#1)(2010-2#1)
confirm the identity of##2##4##(1997-4#1)(2008-7#1)
confirm the importance of these##2##5##(2008-10#1)(2009-4#1)
confirm the importance of##5##4##(1997-6#1)(2008-10#3)(2009-4#1)
confirm the important role of##2##5##(1995-12#1)(2008-10#1)
confirm the important##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
confirm the performance##2##3##(2008-2#2)
confirm the presence of##9##4##(1990-6#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
confirm the previous##2##3##(1997-6#1)(2008-10#1)
confirm the theoretical##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
confirm the validity of the##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
confirm the validity of##5##4##(1992-5#1)(1992-6#1)(2008-2#2)(2008-3#1)
confirm the##151##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#22)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
confirm their##6##2##(1991-3#1)(2008-10#4)(2012-3#1)
confirm these characteristics##2##3##(2007-11#1)(2008-3#1)
confirm these results##3##3##(1996-12#1)(2006-8#1)(2011-2#1)
confirm these##15##2##(1994-10#1)(1996-12#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#3)
confirm this finding##2##3##(1994-11#1)(2008-8#1)
confirm this observation##2##3##(2008-3#1)(2013-1#1)
confirm this result##2##3##(2008-11#1)(2008-3#1)
confirm this##16##2##(1990-5#1)(1991-11#1)(1992-8#1)(1994-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#1)(2013-1#1)
confirm##361##1##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#4)(1995-12#5)(1995-2#3)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#2)(1997-3#2)(1997-4#2)(1997-6#7)(1997-7#2)(1997-8#4)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#52)(2008-11#12)(2008-12#4)(2008-2#14)(2008-3#23)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#12)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#17)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#4)
confirmation and##7##2##(1994-9#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-7#1)(2012-12#1)
confirmation by##4##2##(2008-1#1)(2008-10#1)(2010-5#1)(2013-1#1)
confirmation from##3##2##(1990-8#1)(2008-10#1)(2009-8#1)
confirmation is##4##2##(2007-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
confirmation of the##10##3##(1991-2#1)(1992-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2011-2#2)
confirmation of this##2##3##(2008-2#1)(2008-3#1)
confirmation of##32##2##(1991-2#1)(1992-3#3)(1992-9#1)(1993-5#1)(1995-11#1)(1996-3#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#3)(2013-1#2)
confirmation that##2##2##(2007-12#1)(2008-8#1)
confirmation was##5##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)
confirmation##79##1##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#3)(1992-9#1)(1993-5#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
confirmation-seeking questions by##2##3##(2013-8#2)
confirmations##2##1##(2012-3#1)(2013-8#1)
confirmatory factor analysis##4##3##(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)
confirmatory factor##5##2##(2008-10#1)(2008-11#2)(2010-1#1)(2011-1#1)
confirmatory response requirement##2##3##(2011-2#2)
confirmatory test##2##2##(2007-8#1)(2008-12#1)
confirmatory testing##3##2##(1997-2#1)(2009-3#2)
confirmatory##33##1##(1992-11#1)(1997-2#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#2)(2009-3#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#2)
confirmatory&quot##2##1##(1997-2#2)
confirmed a diagnosis of##2##4##(2008-6#1)(2010-6#1)
confirmed a high##2##3##(1997-1#1)(2010-3#1)
confirmed a##19##2##(1992-6#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-6#2)(2009-1#1)(2009-5#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
confirmed after birth##2##3##(1990-8#1)(2012-3#1)
confirmed after##8##2##(1990-8#2)(2007-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
confirmed an##6##2##(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
confirmed and characterized##2##3##(2008-10#1)(2008-9#1)
confirmed and extended##3##3##(2008-10#2)(2008-7#1)
confirmed and##15##2##(1993-8#1)(1994-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-7#2)(2008-9#1)(2011-2#1)
confirmed as##10##2##(1992-11#1)(1997-3#1)(2008-10#2)(2008-7#2)(2010-8#1)(2011-1#2)(2011-2#1)
confirmed at histological examination##2##4##(2011-2#2)
confirmed at the##3##3##(1996-5#1)(2008-10#2)
confirmed at##7##2##(1996-5#1)(2008-10#4)(2011-2#2)
confirmed by Northern blot##2##4##(1993-3#1)(2008-9#1)
confirmed by PCR and##2##4##(1992-8#1)(2008-8#1)
confirmed by PCR##5##3##(1992-8#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
confirmed by Southern analysis##2##4##(1997-2#1)(2008-10#1)
confirmed by Southern##5##3##(1990-11#1)(1997-2#2)(2008-10#1)(2008-11#1)
confirmed by Western##3##3##(1997-4#1)(2008-11#1)(2011-2#1)
confirmed by X-ray photoelectron spectroscopy (XPS)##2##6##(2008-10#2)
confirmed by X-ray##3##3##(1996-5#1)(2008-10#2)
confirmed by a##10##3##(1990-12#1)(1992-1#1)(1992-10#1)(1994-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
confirmed by an##5##3##(2007-8#1)(2008-10#1)(2008-7#1)(2009-1#1)(2012-3#1)
confirmed by analysing##3##3##(2008-10#2)(2008-4#1)
confirmed by analyzing##2##3##(2008-10#2)
confirmed by biopsy##2##3##(2011-2#2)
confirmed by conventional##2##3##(2007-7#1)(2009-12#1)
confirmed by direct##3##3##(1992-9#1)(1993-11#1)(2008-10#1)
confirmed by elemental analysis##2##4##(2007-11#1)(2008-10#1)
confirmed by elemental##4##3##(2007-11#2)(2008-10#2)
confirmed by experiments##4##3##(2007-11#1)(2008-11#2)(2008-3#1)
confirmed by further##3##3##(2007-8#1)(2010-12#1)(2010-4#1)
confirmed by histology##2##3##(1992-6#1)(2013-1#1)
confirmed by histopathology##2##3##(1994-7#1)(2007-7#1)
confirmed by immunochemical##2##3##(1996-2#1)(1997-2#1)
confirmed by in##2##3##(1997-2#1)(2008-10#1)
confirmed by laboratory testing##2##4##(2008-10#1)(2010-4#1)
confirmed by means of##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
confirmed by measurement of the##2##5##(2007-12#1)(2008-3#1)
confirmed by nucleotide##2##3##(1990-12#1)(2008-10#1)
confirmed by numerical simulations##2##4##(2007-12#2)
confirmed by others##2##3##(1997-6#1)(2008-12#1)
confirmed by polymerase chain reaction##4##5##(2008-10#3)(2012-12#1)
confirmed by scanning electron microscopy##2##5##(2008-6#1)(2011-2#1)
confirmed by scanning##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
confirmed by sequence analysis of##2##5##(1993-12#1)(2008-10#1)
confirmed by sequencing##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
confirmed by the results of##4##5##(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#1)
confirmed by the##46##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-5#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#2)(2013-1#1)
confirmed by use of##3##4##(2008-3#2)(2013-1#1)
confirmed by using##2##3##(2008-10#2)
confirmed by##314##2##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#2)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-1#2)(1997-2#4)(1997-4#3)(1997-6#1)(1997-8#2)(2007-11#7)(2007-12#5)(2007-7#8)(2007-8#6)(2008-1#3)(2008-10#78)(2008-11#15)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#3)(2009-1#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-5#1)(2010-11#2)(2010-12#4)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#16)(2011-3#1)(2012-12#9)(2012-2#3)(2012-3#3)(2013-1#9)
confirmed cases##2##2##(2010-4#1)(2013-1#1)
confirmed clinically##2##2##(1992-5#1)(2012-3#1)
confirmed diagnosis##2##2##(1990-11#1)(2011-1#1)
confirmed experimentally##8##2##(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
confirmed expression of##2##3##(2008-4#1)(2008-8#1)
confirmed for the##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2010-3#1)
confirmed for##12##2##(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-6#1)(2010-3#2)(2012-3#2)
confirmed from##3##2##(1991-8#1)(2009-6#2)
confirmed histologically##3##2##(2007-8#1)(2011-1#1)(2013-1#1)
confirmed in a##6##3##(1992-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
confirmed in all##2##3##(2008-4#1)(2013-8#1)
confirmed in the##10##3##(1992-2#1)(1992-6#1)(1995-11#1)(2008-1#1)(2008-10#4)(2008-2#2)
confirmed in this##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
confirmed in##53##2##(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-11#2)(1997-7#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
confirmed it to be##2##4##(2012-2#1)(2013-1#1)
confirmed its##4##2##(1992-12#1)(2008-10#1)(2008-9#1)(2009-1#1)
confirmed on a##2##3##(2008-7#2)
confirmed on##9##2##(1993-9#1)(2008-1#1)(2008-11#1)(2008-7#3)(2012-2#1)(2013-7#1)(2013-8#1)
confirmed only##2##2##(1991-3#1)(2008-10#1)
confirmed or##2##2##(1991-11#1)(2010-10#1)
confirmed our hypothesis##2##3##(2010-8#1)(2013-8#1)
confirmed our previous findings##3##4##(1994-3#1)(1994-8#1)(1996-12#1)
confirmed our##5##2##(1994-3#1)(1994-8#1)(1996-12#1)(2010-8#1)(2013-8#1)
confirmed patients##2##2##(2011-2#1)(2012-3#1)
confirmed previous##2##2##(2007-12#1)(2008-10#1)
confirmed subdivision##2##2##(2008-10#2)
confirmed that all##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
confirmed that it##2##3##(1994-12#1)(2008-10#1)
confirmed that the expression of##2##5##(1997-7#1)(2008-10#1)
confirmed that the##36##3##(1991-2#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#3)(2009-4#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
confirmed that there was a##2##5##(2008-10#1)(2009-3#1)
confirmed that they were##2##4##(1997-8#1)(2008-10#1)
confirmed that this##4##3##(1990-8#1)(1995-11#1)(2008-3#1)(2008-5#1)
confirmed that##122##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#29)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#9)(2008-9#4)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
confirmed the accuracy of the##2##5##(2007-12#1)(2008-3#1)
confirmed the close relationship of##2##5##(2008-10#1)(2008-5#1)
confirmed the diagnosis as##4##4##(2007-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
confirmed the diagnosis of a##2##5##(2007-8#1)(2010-3#1)
confirmed the diagnosis of##20##4##(1992-6#1)(1994-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#3)
confirmed the diagnosis##30##3##(1991-8#1)(1992-6#1)(1994-9#1)(1995-11#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
confirmed the existence of the##2##5##(1990-8#1)(1993-11#1)
confirmed the existence of##8##4##(1990-8#1)(1993-11#1)(1993-2#1)(1995-2#1)(2008-10#2)(2008-11#1)(2009-5#1)
confirmed the feasibility of##3##4##(1992-6#1)(2007-8#1)(2008-3#1)
confirmed the formation of##3##4##(2009-11#1)(2011-2#2)
confirmed the high##3##3##(1993-11#1)(2008-10#2)
confirmed the importance of##2##4##(2010-10#1)(2011-2#1)
confirmed the potential##2##3##(2010-6#1)(2012-12#1)
confirmed the presence of a##3##5##(2008-10#2)(2009-7#1)
confirmed the presence of the##4##5##(1990-7#1)(1992-6#1)(2008-10#1)(2009-9#1)
confirmed the presence of##20##4##(1990-7#1)(1992-6#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)
confirmed the presence##21##3##(1990-7#1)(1992-6#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)
confirmed the results##2##3##(1994-8#1)(2008-8#1)
confirmed the role of the##2##5##(2008-10#1)(2008-5#1)
confirmed the specificity of the##2##5##(2008-10#2)
confirmed the usefulness of the##2##5##(2008-10#2)
confirmed the validity of the##2##5##(2010-8#1)(2011-2#1)
confirmed the validity of##3##4##(2008-3#1)(2010-8#1)(2011-2#1)
confirmed the##169##2##(1990-5#2)(1990-7#2)(1990-8#1)(1991-8#1)(1992-6#4)(1993-11#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#2)(1997-8#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#38)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#2)
confirmed their##4##2##(1992-6#1)(2008-10#1)(2010-6#1)(2012-2#1)
confirmed these findings##3##3##(2007-10#1)(2008-3#1)(2010-3#1)
confirmed these results and##2##4##(1992-6#1)(1993-8#1)
confirmed these results##3##3##(1992-6#1)(1993-8#1)(2008-10#1)
confirmed these##8##2##(1992-6#1)(1993-8#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-3#1)
confirmed this finding in##2##4##(1992-8#1)(2008-12#1)
confirmed this hypothesis##2##3##(1994-8#1)(2008-8#1)
confirmed this##7##2##(1992-8#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
confirmed through##4##2##(1995-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
confirmed to be in##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
confirmed to be##13##3##(1997-1#1)(2007-8#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#1)
confirmed to have##4##3##(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
confirmed to##28##2##(1994-2#1)(1996-12#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
confirmed using a##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
confirmed using##13##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-3#1)(1994-6#1)(2008-10#4)(2008-5#3)(2011-2#1)
confirmed when##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
confirmed with a##2##3##(1993-11#1)(2007-11#1)
confirmed with the##3##3##(1997-7#1)(2012-12#1)(2012-3#1)
confirmed with##19##2##(1993-11#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#2)(2010-5#1)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#1)
confirmed##1033##1##(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#4)(1990-5#6)(1990-6#7)(1990-7#3)(1990-8#6)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#12)(1992-8#4)(1992-9#3)(1993-11#7)(1993-12#6)(1993-2#4)(1993-3#2)(1993-5#1)(1993-8#3)(1993-9#8)(1994-11#3)(1994-12#9)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#11)(1994-9#1)(1995-11#6)(1995-12#5)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#8)(1995-8#3)(1996-12#6)(1996-2#5)(1996-3#1)(1996-5#5)(1996-6#2)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#6)(1997-9#1)(2006-12#2)(2006-6#1)(2007-10#3)(2007-11#15)(2007-12#16)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#19)(2008-1#13)(2008-10#220)(2008-11#32)(2008-12#15)(2008-2#12)(2008-3#27)(2008-4#7)(2008-5#24)(2008-6#11)(2008-7#34)(2008-8#27)(2008-9#14)(2009-1#4)(2009-10#2)(2009-11#4)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#12)(2010-2#2)(2010-3#8)(2010-4#8)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#6)(2011-1#12)(2011-2#56)(2011-3#3)(2012-1#1)(2012-12#24)(2012-2#19)(2012-3#22)(2012-8#1)(2013-1#33)(2013-7#3)(2013-8#9)
confirming a##2##2##(1997-8#1)(2012-2#1)
confirming an##2##2##(1993-8#1)(2012-2#1)
confirming its##3##2##(1995-8#1)(2008-3#1)(2012-6#1)
confirming our##3##2##(1990-8#1)(1996-5#1)(2010-6#1)
confirming previous##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
confirming that this##3##3##(1992-8#1)(1994-12#1)(2012-6#1)
confirming that##14##2##(1991-2#1)(1992-8#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-8#1)(2012-2#1)(2012-6#1)
confirming the diagnosis of##3##4##(1990-8#1)(2007-10#1)(2013-1#1)
confirming the diagnosis##4##3##(1990-8#1)(2007-10#1)(2008-12#1)(2013-1#1)
confirming the importance of##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
confirming the presence of##2##4##(1991-5#1)(2008-10#1)
confirming the validity of##4##4##(1990-9#1)(2008-10#2)(2008-2#1)
confirming the##53##2##(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-12#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#2)(1997-3#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#3)
confirming##106##1##(1990-2#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#1)(1997-3#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#5)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-2#4)(2012-6#2)(2013-1#5)
confirms a##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
confirms its excellent##2##3##(1994-6#1)(2008-10#1)
confirms our##5##2##(1993-2#1)(2008-3#3)(2012-3#1)
confirms that the##8##3##(1990-8#2)(1993-8#1)(2008-1#1)(2008-10#3)(2008-11#1)
confirms that there##2##3##(2008-10#1)(2008-2#1)
confirms that##31##2##(1990-2#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-5#1)(1993-8#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
confirms the importance##2##3##(2008-2#1)(2012-3#1)
confirms the need##2##3##(2009-8#1)(2012-3#1)
confirms the presence of##2##4##(2010-3#1)(2013-1#1)
confirms the presence##3##3##(2009-10#1)(2010-3#1)(2013-1#1)
confirms the suitability of##2##4##(2007-8#1)(2008-3#1)
confirms the##43##2##(1991-3#2)(1991-6#2)(1992-3#1)(1992-5#1)(1992-8#1)(1994-6#1)(1995-2#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#1)
confirms##100##1##(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
conflation##3##1##(2010-7#1)(2013-1#2)
conflict and academic achievement##2##4##(2010-1#2)
conflict and perceived relationship satisfaction##2##5##(2009-7#2)
conflict and perceived##3##3##(2009-7#2)(2010-1#1)
conflict and the##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
conflict and##20##2##(1990-2#4)(1991-2#1)(1996-12#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#2)(2010-1#5)(2012-12#1)
conflict between the##3##3##(2007-8#1)(2010-3#1)(2010-7#1)
conflict between##9##2##(1991-2#1)(1993-12#1)(2007-8#1)(2008-8#2)(2010-10#1)(2010-3#1)(2010-7#1)(2013-1#1)
conflict in the##2##3##(2008-1#1)(2008-8#1)
conflict in##5##2##(2007-1#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)
conflict is##4##2##(1995-5#1)(2008-8#1)(2009-9#1)(2010-1#1)
conflict occurred##5##2##(2009-7#5)
conflict of interest between the##2##5##(1992-9#1)(2008-9#1)
conflict of interest##6##3##(1992-9#1)(1995-9#1)(2008-12#1)(2008-9#1)(2009-4#1)(2013-8#1)
conflict of interest?##2##3##(2007-4#1)(2012-12#1)
conflict of##10##2##(1992-9#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-4#1)(2008-12#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-8#1)
conflict on##2##2##(2009-9#1)(2012-3#1)
conflict over reproductive allocation##5##4##(2008-8#5)
conflict over sex##2##3##(2008-8#2)
conflict over the##2##3##(2008-8#1)(2012-3#1)
conflict over##17##2##(2008-8#13)(2008-9#3)(2012-3#1)
conflict related##2##2##(2008-7#1)(2008-8#1)
conflict resolution##4##2##(1993-12#1)(2011-1#1)(2011-2#2)
conflict that##2##2##(2009-6#1)(2012-12#1)
conflict to##3##2##(1996-11#1)(2009-9#1)(2011-1#1)
conflict with parents##3##3##(2009-7#2)(2013-1#1)
conflict with##14##2##(1994-6#1)(1995-2#1)(1996-6#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-7#3)(2011-2#1)(2013-1#1)
conflict##153##1##(1990-2#5)(1991-1#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#32)(2008-9#12)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#15)(2009-9#12)(2010-1#10)(2010-10#1)(2010-3#2)(2010-7#1)(2011-1#5)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#2)(2013-8#1)
conflicting and##3##2##(2007-7#1)(2009-11#1)(2013-1#1)
conflicting evidence##2##2##(1995-1#1)(2010-10#1)
conflicting interests##2##2##(1991-2#1)(2008-11#1)
conflicting reports##2##2##(2008-5#1)(2010-5#1)
conflicting results have been reported##2##5##(2008-6#1)(2012-3#1)
conflicting results regarding the##2##4##(2008-1#1)(2011-2#1)
conflicting results##15##2##(1995-5#1)(1997-1#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-3#1)
conflicting theories##2##2##(2008-5#1)(2009-6#1)
conflicting##49##1##(1990-8#1)(1991-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
conflicts and##2##2##(2008-11#1)(2008-9#1)
conflicts between the##2##3##(2008-4#1)(2010-10#1)
conflicts between##4##2##(2008-4#1)(2008-8#1)(2010-10#1)(2010-6#1)
conflicts have##2##2##(2008-1#1)(2011-2#1)
conflicts in the##2##3##(2008-10#1)(2012-12#1)
conflicts in##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
conflicts of interest##3##3##(2008-9#1)(2009-4#2)
conflicts of##6##2##(1996-7#1)(2007-7#1)(2008-3#1)(2008-9#1)(2009-4#2)
conflicts with##3##2##(1990-8#1)(1996-3#1)(2008-8#1)
conflicts##40##1##(1990-8#1)(1992-12#2)(1994-1#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-7#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#7)(2008-9#2)(2009-10#1)(2009-4#3)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)
confluence and##2##2##(2007-12#1)(2008-11#1)
confluence of the##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
confluence of##5##2##(1992-4#1)(1996-1#1)(2008-10#1)(2008-7#1)(2010-8#1)
confluence point##2##2##(2008-10#2)
confluence##19##1##(1992-4#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#5)(2008-11#7)(2008-7#1)(2010-8#1)
confluency##6##1##(1994-11#1)(2008-11#4)(2013-1#1)
confluent and##2##2##(1992-3#1)(2008-7#1)
confluent cultures##2##2##(2008-11#2)
confluent growth##2##2##(2008-10#2)
confluent monolayer##3##2##(1992-5#1)(2008-7#1)(2013-1#1)
confluent monolayers of##3##3##(1992-12#1)(1992-5#1)(2007-12#1)
confluent monolayers##4##2##(1992-12#1)(1992-5#1)(2007-12#1)(2008-11#1)
confluent##28##1##(1991-5#2)(1992-12#1)(1992-3#1)(1992-5#2)(1994-6#1)(1994-9#1)(1996-5#1)(1997-7#1)(2007-12#3)(2008-10#5)(2008-11#4)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#2)
confluent-phase cells##2##2##(1995-12#2)
confluent-phase##3##1##(1995-12#3)
confocal Raman##3##2##(2008-3#2)(2010-4#1)
confocal and conventional##4##3##(2007-12#1)(2008-3#3)
confocal and##7##2##(2007-12#1)(2008-10#1)(2008-3#3)(2008-9#1)(2011-1#1)
confocal enhanced optical coherence tomography##2##5##(2007-12#2)
confocal fluorescence imaging of##2##4##(2008-5#1)(2009-8#1)
confocal fluorescence imaging##3##3##(2008-2#1)(2008-5#1)(2009-8#1)
confocal fluorescence microscopy in##2##4##(2008-3#1)(2008-5#1)
confocal fluorescence microscopy##6##3##(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)
confocal fluorescence##11##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-8#1)
confocal image##5##2##(2008-3#5)
confocal images##6##2##(2008-2#1)(2008-3#3)(2008-4#1)(2010-12#1)
confocal imaging of##2##3##(2008-2#1)(2008-3#1)
confocal imaging##6##2##(2008-2#3)(2008-3#2)(2008-7#1)
confocal laser heterodyne interferometry##2##4##(1995-5#2)
confocal laser microscopy##2##3##(2007-12#1)(2008-5#1)
confocal laser scanning microscope (CLSM)##2##5##(2008-4#1)(2008-8#1)
confocal laser scanning microscope##6##4##(1993-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
confocal laser scanning microscopy##7##4##(1992-9#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-8#1)
confocal laser scanning##15##3##(1992-9#1)(1993-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#3)(2008-9#1)(2010-8#1)
confocal laser##21##2##(1992-9#2)(1993-11#1)(1994-9#1)(1995-5#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)
confocal microendoscope##3##2##(2007-12#2)(2008-3#1)
confocal microscope in which##2##4##(2007-12#2)
confocal microscope with##3##3##(2007-11#1)(2008-2#2)
confocal microscope##28##2##(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-9#1)(2009-6#1)(2011-2#1)
confocal microscopes##4##2##(2007-11#1)(2008-3#1)(2008-9#2)
confocal microscopic##2##2##(1994-9#1)(2008-11#1)
confocal microscopy and##10##3##(2007-11#3)(2007-12#2)(2008-11#1)(2008-3#1)(2008-9#2)(2010-10#1)
confocal microscopy in##2##3##(2007-11#1)(2007-12#1)
confocal microscopy is##4##3##(2008-3#2)(2008-4#1)(2008-9#1)
confocal microscopy to##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
confocal microscopy##66##2##(1992-11#1)(1995-5#1)(1996-5#1)(1997-1#1)(2007-11#4)(2007-12#9)(2008-1#2)(2008-10#2)(2008-11#10)(2008-2#1)(2008-3#10)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#10)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
confocal optical system##2##3##(2008-3#2)
confocal optical##3##2##(2008-3#3)
confocal receiver##2##2##(2008-3#2)
confocal reflectance imaging##2##3##(2008-2#1)(2009-8#1)
confocal reflectance##3##2##(2007-12#1)(2008-2#1)(2009-8#1)
confocal scanning laser microscope for##2##5##(2008-3#2)
confocal scanning laser microscope##3##4##(2008-3#2)(2008-5#1)
confocal scanning laser microscopy (CSLM)##2##5##(2008-1#1)(2008-7#1)
confocal scanning laser ophthalmoscope##3##4##(2011-1#3)
confocal scanning laser##10##3##(2007-11#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#4)
confocal scanning microscope##2##3##(2008-2#1)(2008-9#1)
confocal scanning microscopy##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
confocal scanning##20##2##(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#4)
confocal system##3##2##(2008-11#1)(2008-3#2)
confocal unstable resonator##4##3##(2008-2#2)(2008-3#2)
confocal unstable resonators##2##3##(2008-2#1)(2008-3#1)
confocal unstable##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
confocal##234##1##(1992-11#1)(1992-9#2)(1993-11#1)(1994-9#3)(1995-5#3)(1996-5#1)(1997-1#1)(2007-11#17)(2007-12#32)(2008-1#4)(2008-10#9)(2008-11#15)(2008-2#22)(2008-3#60)(2008-4#8)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#18)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-2#2)(2012-2#5)(2013-1#2)
conform to the##6##3##(1992-9#1)(1995-8#1)(1996-6#1)(2008-11#1)(2010-6#1)(2011-2#1)
conform to##13##2##(1991-12#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
conform with the##2##3##(1990-5#1)(1992-2#1)
conform##17##1##(1990-11#1)(1990-5#1)(1991-12#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
conformal radiotherapy##5##2##(1995-8#1)(2008-2#1)(2008-6#2)(2013-1#1)
conformal transform##2##2##(2008-3#2)
conformal##12##1##(1995-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#2)(2012-12#2)(2013-1#1)
conformance##2##1##(2008-11#1)(2008-2#1)
conformation and the##2##3##(2008-11#1)(2008-3#1)
conformation and##19##2##(1993-11#1)(1994-12#1)(1994-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2009-2#1)(2009-3#2)(2010-4#1)
conformation as a##2##3##(1993-8#1)(2008-7#1)
conformation as##3##2##(1993-8#1)(2008-7#1)(2009-7#1)
conformation at the C-10##2##4##(1992-3#2)
conformation at the##3##3##(1992-3#2)(1993-11#1)
conformation at##4##2##(1992-3#2)(1993-11#1)(1995-2#1)
conformation by##2##2##(1990-5#1)(1992-6#1)
conformation changes##2##2##(1997-7#1)(2008-10#1)
conformation decreased##2##2##(2008-8#2)
conformation in a##2##3##(1991-5#1)(2008-8#1)
conformation in the##2##3##(1993-11#1)(2008-10#1)
conformation in##7##2##(1991-5#1)(1993-11#1)(1995-2#2)(1996-5#1)(2008-10#1)(2008-8#1)
conformation is##6##2##(1990-2#1)(1990-5#1)(1992-5#1)(1992-6#1)(1993-3#1)(1995-2#1)
conformation may##2##2##(1991-11#1)(1992-5#1)
conformation of a##3##3##(1993-11#1)(1997-6#1)(2008-10#1)
conformation of the pocket region##2##5##(2008-8#2)
conformation of the##35##3##(1991-1#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-3#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-11#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
conformation of these##3##3##(1991-12#1)(1993-11#1)(1995-6#1)
conformation of##72##2##(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#3)(1991-5#1)(1991-8#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-5#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#3)(2009-11#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#3)
conformation on##3##2##(1995-3#1)(1995-6#1)(2009-2#1)
conformation polymorphism (SSCP) analysis of##3##5##(1992-8#1)(2008-10#2)
conformation polymorphism (SSCP) analysis##4##4##(1992-8#1)(2008-10#3)
conformation polymorphism (SSCP)##6##3##(1992-8#1)(2008-10#3)(2008-4#1)(2008-8#1)
conformation polymorphism analysis of##2##4##(2008-10#1)(2011-2#1)
conformation polymorphism analysis##7##3##(1991-12#1)(1992-2#1)(1992-8#2)(2008-10#1)(2008-4#1)(2011-2#1)
conformation polymorphism and##2##3##(1992-2#1)(2008-10#1)
conformation polymorphism##19##2##(1991-12#1)(1992-2#2)(1992-3#1)(1992-8#3)(1995-6#2)(2008-10#6)(2008-4#2)(2008-8#1)(2011-2#1)
conformation that##6##2##(1992-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-2#1)
conformation to##2##2##(1992-12#1)(1995-3#1)
conformation were examined##2##3##(2008-10#1)(2008-9#1)
conformation were##3##2##(2008-10#1)(2008-9#1)(2009-2#1)
conformation with##2##2##(1991-9#1)(1993-11#1)
conformation##241##1##(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-5#7)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#6)(1992-8#6)(1992-9#1)(1993-11#14)(1993-3#4)(1993-5#1)(1993-8#3)(1994-11#3)(1994-12#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#10)(1995-3#6)(1995-5#4)(1995-6#12)(1995-8#2)(1996-2#2)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#24)(2008-9#7)(2009-10#1)(2009-11#2)(2009-2#4)(2009-3#2)(2009-7#2)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#2)(2011-2#3)(2012-12#1)(2012-2#4)(2013-8#1)
conformation(s)##3##1##(1993-11#1)(1993-8#2)
conformation-dependent##2##1##(1993-3#1)(2008-9#1)
conformational analysis##2##2##(1994-11#1)(2007-11#1)
conformational change during##2##3##(1990-5#1)(2009-3#1)
conformational change in the##4##4##(1990-8#1)(1991-12#1)(1995-6#1)(2008-5#1)
conformational change in##7##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-9#1)(1995-6#1)(2008-4#1)(2008-5#1)
conformational change of G(o)alpha##3##4##(2008-9#3)
conformational change of the##3##4##(1990-5#1)(1990-7#1)(2009-3#1)
conformational change of##10##3##(1990-5#1)(1990-7#1)(1997-7#1)(2008-11#1)(2008-9#3)(2009-3#2)(2013-1#1)
conformational change##39##2##(1990-11#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-12#2)(1992-9#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-6#5)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#3)(2009-5#3)(2013-1#2)
conformational changes from##2##3##(1990-8#2)
conformational changes in the foot protein moiety##2##7##(1992-3#2)
conformational changes in the protein##2##5##(1990-5#1)(1995-6#1)
conformational changes in the##8##4##(1990-5#1)(1992-3#2)(1992-6#1)(1994-5#1)(1995-6#2)(2009-7#1)
conformational changes in##14##3##(1990-3#1)(1990-5#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#2)(2009-7#1)(2013-8#1)
conformational changes of the##7##4##(1990-5#1)(1990-7#1)(1994-5#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
conformational changes of##13##3##(1990-5#1)(1990-7#1)(1993-8#1)(1994-5#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
conformational changes##46##2##(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#4)(1993-11#1)(1993-8#1)(1994-5#2)(1995-2#1)(1995-5#1)(1995-6#4)(2008-10#3)(2008-3#2)(2008-4#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-7#2)(2012-2#2)(2013-1#1)(2013-8#3)
conformational coupling##2##2##(2008-8#2)
conformational differences##4##2##(1993-8#1)(1995-3#3)
conformational disorder##2##2##(2008-5#1)(2008-7#1)
conformational dynamics of##3##3##(1992-6#1)(1995-2#2)
conformational dynamics##5##2##(1992-6#1)(1995-11#1)(1995-2#2)(2009-5#1)
conformational flexibility of##2##3##(1991-9#1)(1995-11#1)
conformational flexibility##3##2##(1991-9#1)(1995-11#1)(1995-8#1)
conformational freedom##2##2##(1995-11#1)(2011-2#1)
conformational mobility##2##2##(1992-6#1)(2008-10#1)
conformational polymorphism##3##2##(2008-10#2)(2009-7#1)
conformational polymorphisms##2##2##(1994-12#1)(2008-12#1)
conformational properties##4##2##(1992-6#1)(1993-8#2)(1994-5#1)
conformational restriction##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-2#1)
conformational states##6##2##(1992-5#1)(1996-2#1)(1997-2#2)(2008-4#1)(2010-10#1)
conformational study of##2##3##(1993-5#1)(2007-11#1)
conformational study on##2##3##(1993-3#1)(2008-10#1)
conformational study##4##2##(1993-3#1)(1993-5#1)(2007-11#1)(2008-10#1)
conformational transition##4##2##(1990-11#1)(1990-8#1)(1996-2#1)(2012-1#1)
conformational##187##1##(1990-11#3)(1990-3#1)(1990-5#7)(1990-7#3)(1990-8#7)(1991-12#1)(1991-5#4)(1991-9#2)(1992-12#2)(1992-3#4)(1992-5#2)(1992-6#8)(1992-8#6)(1992-9#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-8#5)(1994-11#1)(1994-12#1)(1994-5#5)(1994-6#1)(1994-8#1)(1995-11#3)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#10)(1995-8#2)(1996-2#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#2)(2011-2#3)(2012-1#2)(2012-2#5)(2013-1#4)(2013-8#3)
conformationally##9##1##(1992-11#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-4#1)(2008-5#2)
conformations and##2##2##(1992-3#1)(2012-3#1)
conformations are##2##2##(1995-2#1)(2007-11#1)
conformations as##2##2##(1995-2#1)(2012-12#1)
conformations is##3##2##(1993-11#1)(2008-10#1)(2008-7#1)
conformations of the##4##3##(1990-8#1)(1993-11#1)(1993-3#1)(2013-8#1)
conformations of##12##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-11#1)(1993-11#2)(1993-3#3)(2008-8#2)(2013-8#1)
conformations that##3##2##(1997-2#1)(2008-5#1)(2012-2#1)
conformations with##3##2##(1992-11#1)(1995-3#1)(2012-2#1)
conformations##69##1##(1990-11#1)(1990-5#1)(1990-8#3)(1991-3#2)(1991-5#2)(1992-11#3)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#7)(1993-3#3)(1994-11#1)(1994-3#1)(1995-11#2)(1995-2#4)(1995-3#2)(1996-5#1)(1997-2#3)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
conformed to the##3##3##(1995-3#1)(1997-4#1)(2008-10#1)
conformed to##5##2##(1994-12#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
conformed with##2##2##(2008-10#2)
conformed##7##1##(1994-12#1)(1995-3#1)(1997-4#1)(2008-10#3)(2008-5#1)
conformer of##2##2##(1996-2#1)(2011-2#1)
conformer##7##1##(1990-5#1)(1996-2#3)(2007-12#1)(2008-8#1)(2011-2#1)
conformers of##3##2##(1993-8#1)(1995-11#1)(2011-2#1)
conformers##11##1##(1993-11#1)(1993-8#2)(1994-5#1)(1995-11#2)(1996-5#1)(2008-12#1)(2010-4#1)(2011-2#2)
conforming to##2##2##(2008-1#1)(2008-11#1)
conforming##3##1##(2008-1#1)(2008-11#1)(2008-5#1)
conformity and##2##2##(2011-1#1)(2013-1#1)
conformity of##2##2##(2008-10#1)(2008-7#1)
conformity to##2##2##(2008-10#1)(2008-2#1)
conformity with##4##2##(1997-2#1)(2008-11#1)(2008-3#1)(2008-7#1)
conformity##14##1##(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-8#2)(2011-1#1)(2013-1#1)
conforms to the##6##3##(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)
conforms to##9##2##(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-9#2)
conforms##11##1##(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-9#2)(2011-2#1)
confound the relationship##2##3##(1997-4#1)(2012-12#1)
confound the##5##2##(1993-11#1)(1997-4#1)(2008-10#1)(2010-4#1)(2012-12#1)
confound##10##1##(1993-11#1)(1995-11#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)(2012-12#1)
confounded by##5##2##(1994-9#1)(2008-10#2)(2010-10#1)(2013-1#1)
confounded##8##1##(1993-3#1)(1994-9#1)(2008-10#3)(2008-8#1)(2010-10#1)(2013-1#1)
confounder##4##1##(1992-11#1)(1992-9#1)(2008-7#1)(2008-8#1)
confounders such as##2##3##(2008-3#1)(2009-9#1)
confounders##18##1##(1992-6#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#3)
confounding and##3##2##(1992-9#1)(2008-7#1)(2008-8#1)
confounding effect of##2##3##(1992-9#1)(1995-12#1)
confounding effects##3##2##(1997-1#1)(2008-9#1)(2010-2#1)
confounding factors are##3##3##(1991-12#1)(2008-6#1)(2008-7#1)
confounding factors such as##2##4##(2008-6#1)(2012-12#1)
confounding factors that##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
confounding factors##25##2##(1991-12#2)(1993-9#1)(1996-12#1)(2008-2#1)(2008-6#2)(2008-7#5)(2008-9#1)(2010-1#4)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)
confounding influences##2##2##(1993-9#1)(2009-5#1)
confounding or##2##2##(1990-6#1)(2008-7#1)
confounding variables are##2##3##(1992-3#1)(2008-12#1)
confounding variables##8##2##(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(2006-10#1)(2008-12#1)(2010-6#1)(2012-1#1)
confounding##70##1##(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#8)(1993-9#2)(1995-12#1)(1996-12#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-5#1)(2010-1#4)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)
confounds##5##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)
confront in their##2##3##(2008-6#1)(2013-1#1)
confront the##4##2##(1990-12#1)(2008-4#1)(2013-1#1)(2013-7#1)
confront##15##1##(1990-12#1)(1995-2#1)(1996-2#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2011-2#1)(2013-1#2)(2013-7#1)
confrontation##3##1##(1996-2#1)(2012-3#2)
confrontations and##2##2##(1993-12#1)(2007-5#1)
confronted by##5##2##(1992-2#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-4#1)
confronted with the##5##3##(1992-1#1)(1992-2#1)(1993-11#1)(2007-7#1)(2008-10#1)
confronted with##13##2##(1990-11#1)(1992-1#1)(1992-2#1)(1993-11#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-3#1)
confronted##21##1##(1990-11#1)(1992-1#1)(1992-2#2)(1993-11#1)(1994-3#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-3#1)
confronting the##5##2##(1990-10#2)(1994-2#1)(1995-3#1)(2008-7#1)
confronting##13##1##(1990-10#2)(1992-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
confrontive##3##1##(2010-10#3)
confuse##3##1##(1991-12#1)(2008-1#1)(2008-8#1)
confused with other##3##3##(1992-4#1)(2008-4#1)(2010-12#1)
confused with##15##2##(1990-5#1)(1992-11#1)(1992-4#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
confused##23##1##(1990-5#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#3)
confusing the##2##2##(2008-8#1)(2010-3#1)
confusing##16##1##(1991-3#2)(1992-3#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-8#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
confusion about the##2##3##(2008-11#1)(2011-2#1)
confusion about##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
confusion among##2##2##(1994-3#1)(2008-12#1)
confusion and##10##2##(1991-2#1)(1994-2#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-4#1)(2008-7#2)(2013-1#2)
confusion exists regarding the##2##4##(2008-10#1)(2008-3#1)
confusion in the literature##3##4##(1991-12#1)(1994-8#1)(2008-10#1)
confusion in the##4##3##(1991-12#1)(1994-8#1)(1995-3#1)(2008-10#1)
confusion in this##2##3##(1997-3#1)(2008-11#1)
confusion in##11##2##(1991-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
confusion increased##2##2##(2007-8#1)(2012-12#1)
confusion of##2##2##(1991-12#1)(1995-5#1)
confusion regarding##2##2##(2010-3#1)(2012-3#1)
confusion that##2##2##(2008-1#1)(2008-7#1)
confusion with other##2##3##(1991-2#1)(2011-2#1)
confusion##70##1##(1991-12#2)(1991-2#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-6#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
confusional##2##1##(1991-8#1)(2009-5#1)
confusions##2##1##(2013-8#2)
congener profiles##2##2##(2008-10#2)
congener##15##1##(1995-12#1)(1996-12#1)(2007-8#2)(2008-10#10)(2008-5#1)
congeneric##6##1##(1995-6#1)(2008-1#1)(2008-10#3)(2010-8#1)
congeners of##2##2##(2008-10#1)(2009-12#1)
congeners were##3##2##(2008-10#2)(2008-11#1)
congeners with##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
congeners##34##1##(1991-8#1)(1993-1#1)(1993-12#1)(1995-11#3)(1995-3#1)(1996-12#1)(2008-10#17)(2008-11#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-7#1)
congenic lines##2##2##(2012-3#2)
congenic##7##1##(1990-3#1)(1991-5#1)(1993-3#1)(2012-3#2)(2013-1#2)
congenita##5##1##(1992-3#2)(2008-11#2)(2008-4#1)
congenital abnormalities##5##2##(2007-8#1)(2012-2#2)(2013-1#2)
congenital adrenal hyperplasia (CAH)##4##4##(2008-4#3)(2008-8#1)
congenital adrenal hyperplasia##12##3##(2008-1#2)(2008-4#6)(2008-8#2)(2010-2#1)(2012-3#1)
congenital adrenal##13##2##(2008-1#2)(2008-4#6)(2008-8#2)(2010-2#1)(2011-1#1)(2012-3#1)
congenital and acquired##6##3##(2007-12#1)(2007-7#1)(2009-12#1)(2009-3#1)(2012-2#2)
congenital anomalies in##2##3##(2008-11#2)
congenital anomalies of##2##3##(2008-11#1)(2008-7#1)
congenital anomalies##24##2##(1991-6#1)(1997-3#5)(2008-11#10)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#3)(2012-2#1)(2013-1#1)
congenital anomaly##14##2##(1991-8#1)(2006-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
congenital aphakia##2##2##(2010-9#2)
congenital benign##2##2##(2007-8#1)(2008-12#1)
congenital cardiac anomalies##2##3##(2008-7#1)(2010-6#1)
congenital cardiac##5##2##(2007-8#1)(2008-7#1)(2010-11#1)(2010-6#1)(2012-2#1)
congenital coronary arteriovenous fistula##2##4##(2007-8#2)
congenital coronary##3##2##(2007-8#2)(2012-3#1)
congenital defect##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
congenital defects##2##2##(1990-5#1)(2007-8#1)
congenital deformities##2##2##(1990-9#1)(2011-2#1)
congenital diaphragmatic hernia in##2##4##(2008-11#1)(2011-1#1)
congenital diaphragmatic hernia##5##3##(2008-11#2)(2011-1#2)(2012-3#1)
congenital diaphragmatic##6##2##(2008-11#2)(2011-1#2)(2012-3#2)
congenital dysplasia of the hip##3##5##(2007-11#3)
congenital heart defects##3##3##(1997-8#2)(2012-2#1)
congenital heart disease (CHD)##4##4##(2008-3#1)(2010-10#1)(2010-9#1)(2012-2#1)
congenital heart disease in##2##4##(2008-11#1)(2013-8#1)
congenital heart disease##37##3##(1990-11#1)(1993-12#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2009-10#5)(2009-5#2)(2010-10#2)(2010-6#2)(2010-9#3)(2011-2#4)(2012-2#3)(2012-3#3)(2013-8#1)
congenital heart##43##2##(1990-11#2)(1992-5#1)(1993-12#1)(1997-8#2)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2009-10#5)(2009-5#2)(2010-10#2)(2010-6#2)(2010-9#3)(2011-2#4)(2012-2#4)(2012-3#3)(2013-8#1)
congenital hip dysplasia##2##3##(2007-11#2)
congenital hip##3##2##(1994-9#1)(2007-11#2)
congenital hydrocephalus##4##2##(2008-7#1)(2012-2#3)
congenital hydronephrosis##3##2##(2008-10#1)(2008-4#2)
congenital hypothyroidism##9##2##(2008-1#3)(2008-4#1)(2011-1#4)(2013-1#1)
congenital infection##2##2##(1990-9#1)(1991-6#1)
congenital jaw and oral##2##4##(2013-1#2)
congenital jaw##3##2##(2013-1#3)
congenital kyphosis##5##2##(2012-12#5)
congenital limb deformity##3##3##(2009-3#3)
congenital malformations in##2##3##(1995-5#1)(2012-3#1)
congenital malformations is##2##3##(1995-12#1)(2008-11#1)
congenital malformations##23##2##(1990-5#2)(1992-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
congenital myasthenic##3##2##(2013-1#3)
congenital nephrogenic diabetes insipidus##3##4##(1994-11#2)(1997-3#1)
congenital neutropenia##4##2##(2008-7#4)
congenital or acquired##4##3##(1990-6#1)(1991-6#1)(2007-12#1)(2008-1#1)
congenital or##8##2##(1990-6#1)(1991-6#1)(1992-5#1)(1996-11#1)(2007-12#1)(2008-1#1)(2010-6#1)(2013-8#1)
congenital rubella##2##2##(2008-11#1)(2011-2#1)
congenital small bowel##2##3##(2012-3#2)
congenital splenic cyst##5##3##(1993-5#1)(1997-8#4)
congenital venous##2##2##(2010-11#2)
congenital##331##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#8)(1991-3#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-5#3)(1992-6#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-9#2)(1995-12#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-5#2)(1997-3#9)(1997-6#1)(1997-8#8)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#12)(2008-1#8)(2008-10#11)(2008-11#27)(2008-12#3)(2008-3#1)(2008-4#14)(2008-7#14)(2008-8#5)(2008-9#6)(2009-10#5)(2009-12#1)(2009-3#11)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#14)(2011-2#12)(2012-12#11)(2012-2#28)(2012-3#17)(2013-1#17)(2013-8#4)
congenitally##9##1##(1990-11#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#1)
congested##3##1##(1995-3#1)(2008-7#1)(2011-2#1)
congestion##10##1##(2007-11#1)(2008-3#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
congestive cardiac failure from##2##4##(1996-3#1)(1996-6#1)
congestive cardiac failure##6##3##(1996-3#1)(1996-6#2)(2007-7#1)(2010-5#1)(2011-2#1)
congestive heart failure (CHF)##2##4##(1995-12#1)(2008-3#1)
congestive heart failure is##3##4##(1991-3#1)(2010-3#1)(2010-8#1)
congestive heart failure was##3##4##(1992-6#1)(2007-8#1)(2008-7#1)
congestive heart failure##42##3##(1990-2#1)(1990-9#2)(1991-3#1)(1992-6#1)(1993-5#1)(1995-12#1)(1996-9#1)(1997-8#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#9)(2008-5#1)(2008-7#9)(2010-3#1)(2010-8#2)(2011-2#2)(2012-3#3)
congestive heart##45##2##(1990-2#1)(1990-9#2)(1991-3#2)(1992-6#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-9#1)(1997-8#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#9)(2008-5#1)(2008-7#10)(2010-3#1)(2010-8#2)(2011-2#2)(2012-3#3)
congestive##52##1##(1990-2#1)(1990-3#1)(1990-9#2)(1991-3#2)(1992-6#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-8#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#9)(2008-5#1)(2008-7#10)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-3#3)
conglomerate##3##1##(2008-2#1)(2009-8#1)(2013-7#1)
conglutin##2##1##(2008-10#2)
conglutinin was##3##2##(1992-9#3)
conglutinin##9##1##(1992-9#9)
congolensis##5##1##(1991-8#5)
congregating in a Senior##2##4##(2008-1#2)
congregational##4##1##(2008-1#2)(2010-2#2)
congregatus##3##1##(1991-9#3)
congress of##2##2##(1993-12#1)(2006-9#1)
congress was organized by##2##4##(2008-5#1)(2008-8#1)
congress was organized##3##3##(2008-5#1)(2008-8#1)(2010-11#1)
congress was##6##2##(2008-5#3)(2008-8#1)(2010-11#2)
congress##14##1##(1993-12#1)(1996-12#1)(2006-10#1)(2006-9#1)(2008-5#4)(2008-8#1)(2010-11#3)(2011-2#1)(2012-3#1)
congresses##7##1##(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(2007-8#1)(2008-11#1)(2011-4#1)
congressional##4##1##(1992-12#1)(1995-12#1)(2008-4#2)
congressionally mandated##2##2##(1991-1#1)(1991-3#1)
congruence between##3##2##(1996-1#1)(2012-2#1)(2012-3#1)
congruence in end-of-life treatment preferences##2##5##(2010-4#2)
congruence of##2##2##(2010-12#1)(2011-2#1)
congruence with##3##2##(2008-12#1)(2010-4#1)(2010-6#1)
congruence##13##1##(1996-1#1)(2007-8#3)(2008-12#1)(2010-12#1)(2010-4#3)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
congruency##5##1##(2007-8#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-8#1)
congruent face and name##2##4##(2012-1#2)
congruent face and##3##3##(2012-1#3)
congruent results##2##2##(2008-10#1)(2008-5#1)
congruent with##12##2##(1991-12#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-8#3)(2009-11#1)(2010-3#1)(2012-3#1)
congruent##40##1##(1990-12#1)(1991-12#1)(1991-5#1)(1997-5#1)(1997-7#1)(2007-12#5)(2008-1#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#4)(2009-11#1)(2009-4#2)(2010-3#1)(2010-6#1)(2012-1#5)(2012-3#1)(2013-8#2)
congruity of the##3##3##(2007-8#3)
congruity##6##1##(2007-8#3)(2012-3#2)(2013-8#1)
congénitales##2##1##(2013-1#2)
conic##5##1##(2008-3#4)(2008-5#1)
conical emission##2##2##(2007-11#2)
conical radiation##2##2##(2008-2#2)
conical##29##1##(1993-5#1)(1994-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2008-10#5)(2008-12#2)(2008-2#5)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)
conically sculpted tips##3##3##(1995-2#3)
conically sculpted##5##2##(1995-2#5)
conidia and appressoria##4##3##(2008-10#4)
conidia and ascospores##3##3##(2008-10#2)(2010-3#1)
conidia and hyphae##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
conidia and##21##2##(2008-10#16)(2008-3#2)(2008-5#1)(2010-3#1)(2011-1#1)
conidia application##2##2##(2008-6#2)
conidia are##2##2##(2008-10#2)
conidia at##2##2##(2008-10#2)
conidia can##2##2##(2008-10#2)
conidia contributed##2##2##(2008-10#2)
conidia deposited on##2##3##(2008-10#2)
conidia formed##2##2##(2008-10#2)
conidia from##10##2##(2008-10#10)
conidia germinate##2##2##(2008-10#1)(2011-1#1)
conidia germinated in##2##3##(2008-10#2)
conidia germinated##11##2##(2008-10#11)
conidia germination##6##2##(2008-10#6)
conidia in rainwater##2##3##(2008-10#2)
conidia in the##2##3##(2008-10#2)
conidia in##8##2##(2008-10#8)
conidia initiated germination##2##3##(2008-10#2)
conidia of B##2##3##(2008-10#2)
conidia of C##2##3##(2008-10#2)
conidia of F##2##3##(2008-10#2)
conidia of M##2##3##(2008-10#2)
conidia of P##2##3##(2008-10#2)
conidia of S##2##3##(2008-10#2)
conidia of the##4##3##(2008-10#4)
conidia of##25##2##(2008-10#24)(2008-5#1)
conidia on leaves and coverslips##2##5##(2008-10#2)
conidia on the##2##3##(2008-10#2)
conidia on##11##2##(2008-10#11)
conidia or germinating conidia of##2##5##(2008-10#2)
conidia or##6##2##(2008-10#6)
conidia over##2##2##(2008-10#2)
conidia per ml##4##3##(2008-10#4)
conidia per ml) at intervals of##2##6##(2008-10#2)
conidia per ml) of##2##4##(2008-10#2)
conidia per ml)##5##3##(2008-10#5)
conidia per##12##2##(2008-10#12)
conidia produced in##3##3##(2008-10#3)
conidia produced##5##2##(2008-10#5)
conidia production##6##2##(2008-10#5)(2008-5#1)
conidia reduced##2##2##(2008-10#2)
conidia stored at -20 degrees C##2##6##(2008-10#2)
conidia than##2##2##(2008-10#2)
conidia that had##3##3##(2008-10#3)
conidia that##4##2##(2008-10#4)
conidia to##4##2##(2008-10#4)
conidia treated with##2##3##(2008-10#2)
conidia was##7##2##(1992-8#1)(2008-10#5)(2008-5#1)
conidia were##14##2##(2008-10#14)
conidia with appressoria##3##3##(2008-10#3)
conidia with##7##2##(2008-10#7)
conidia##272##1##(1992-8#5)(2008-10#250)(2008-3#2)(2008-5#4)(2008-6#4)(2008-8#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#3)
conidia/ml for F##2##3##(2008-10#2)
conidia/ml were##2##2##(2008-10#2)
conidia/ml##6##1##(1997-6#1)(2008-10#5)
conidial germ tubes##2##3##(2008-10#2)
conidial germ##3##2##(2008-10#3)
conidial germination and appressorium formation##3##5##(2008-10#3)
conidial germination and##7##3##(2008-10#7)
conidial germination in##2##3##(2008-10#2)
conidial germination of##2##3##(2008-10#2)
conidial germination was##2##3##(2008-10#2)
conidial germination##26##2##(2008-10#25)(2010-10#1)
conidial inoculations##4##2##(2008-10#4)
conidial inoculum from##2##3##(2008-10#2)
conidial inoculum##3##2##(2008-10#3)
conidial morphology##2##2##(2008-10#2)
conidial suspension of##4##3##(2008-10#4)
conidial suspension##11##2##(2008-10#9)(2008-6#2)
conidial suspensions of M##2##4##(2008-10#2)
conidial suspensions of##5##3##(2008-10#5)
conidial suspensions##8##2##(2008-10#8)
conidial##70##1##(2008-10#66)(2008-6#2)(2008-8#1)(2010-10#1)
conidiation is##2##2##(2008-10#2)
conidiation was##2##2##(2008-10#2)
conidiation##9##1##(2008-10#9)
conidiogenesis##2##1##(2010-10#2)
conidiophores##5##1##(2008-10#4)(2010-10#1)
conidium germination##2##2##(2008-10#2)
conidium##3##1##(2008-10#3)
conifer species was##2##3##(2008-7#2)
conifer species##4##2##(2008-10#2)(2008-7#2)
conifer##18##1##(2008-10#9)(2008-11#1)(2008-7#3)(2008-8#3)(2011-10#1)(2013-7#1)
coniferous##2##1##(2008-10#1)(2011-2#1)
conifers and##2##2##(2008-10#1)(2008-3#1)
conifers##11##1##(2008-10#5)(2008-3#1)(2009-8#3)(2010-10#1)(2010-5#1)
coniine binding to nicotinic receptors##2##5##(1996-12#2)
coniine for##4##2##(1996-12#4)
coniine in##2##2##(1996-12#2)
coniine##11##1##(1996-12#11)
coniine-induced##4##1##(1996-12#4)
conization by##3##2##(1992-2#1)(1992-3#2)
conization in##2##2##(1991-1#1)(1994-12#1)
conization##11##1##(1991-1#3)(1992-2#2)(1992-3#2)(1994-12#3)(2012-3#1)
conjecture of##2##2##(2008-12#1)(2008-8#1)
conjecture that##3##2##(1996-4#1)(2007-11#1)(2008-3#1)
conjecture##11##1##(1996-4#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-10#1)(2010-11#1)(2012-2#1)(2013-8#1)
conjectures about##2##2##(2008-7#1)(2013-1#1)
conjectures##4##1##(2008-7#2)(2008-8#1)(2013-1#1)
conjoined twins##3##2##(2008-10#1)(2010-7#2)
conjoined##5##1##(2008-10#1)(2010-7#3)(2013-1#1)
conjoint analysis to##3##3##(1994-3#2)(1995-1#1)
conjoint##4##1##(1994-3#2)(1995-1#1)(1995-2#1)
conjugal violence##4##2##(2008-2#4)
conjugal##9##1##(1992-4#1)(1992-7#1)(1993-6#1)(1997-5#1)(2008-2#4)(2008-8#1)
conjugate and##8##2##(1991-9#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
conjugate as signal generator##3##4##(2008-7#3)
conjugate as##6##2##(1994-12#1)(2008-10#2)(2008-7#3)
conjugate base##2##2##(2008-10#2)
conjugate formation was enhanced by##2##5##(2006-6#2)
conjugate formation##11##2##(1993-6#1)(2006-6#10)
conjugate gradient algorithm in##2##4##(2010-8#2)
conjugate gradient algorithm##3##3##(2010-8#3)
conjugate gradient method##2##3##(2007-12#1)(2008-3#1)
conjugate gradient##8##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#3)
conjugate images##2##2##(2007-12#1)(2008-3#1)
conjugate is the##2##3##(2008-10#1)(2008-11#1)
conjugate is##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
conjugate of##10##2##(1990-8#1)(1993-6#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#2)
conjugate to the##3##3##(2008-10#3)
conjugate vaccination##2##2##(1995-5#2)
conjugate vaccine for##2##3##(2010-10#2)
conjugate vaccine##13##2##(1994-9#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2010-10#6)(2013-1#1)(2013-8#1)
conjugate vaccines##4##2##(1994-9#1)(1995-5#1)(2007-11#1)(2008-10#1)
conjugate was determined by matrix-assisted laser desorption/ionization##2##7##(2008-11#2)
conjugate was##8##2##(2008-10#6)(2008-11#2)
conjugate were determined##2##3##(2008-10#1)(2008-11#1)
conjugate were##3##2##(2008-10#2)(2008-11#1)
conjugate with##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
conjugate##152##1##(1990-11#1)(1990-12#3)(1990-8#5)(1991-9#2)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-9#2)(1995-5#5)(1995-8#1)(1996-5#3)(1997-3#1)(1997-4#1)(2006-6#11)(2007-10#3)(2007-11#3)(2007-12#8)(2008-10#38)(2008-11#9)(2008-2#6)(2008-3#9)(2008-4#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2010-10#6)(2010-5#1)(2010-6#1)(2010-8#3)(2013-1#1)(2013-8#1)
conjugate-gradient method##3##2##(2008-2#2)(2008-3#1)
conjugate-gradient##5##1##(2008-2#4)(2008-3#1)
conjugated NA##5##2##(1997-7#5)
conjugated and unconjugated##2##3##(2008-11#1)(2009-5#1)
conjugated and##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)
conjugated bile acid##2##3##(1992-3#1)(2008-4#1)
conjugated bile acids were##3##4##(1993-2#3)
conjugated bile acids##5##3##(1993-2#5)
conjugated bile##7##2##(1992-3#1)(1993-2#5)(2008-4#1)
conjugated dienes##8##2##(1992-3#3)(2009-8#5)
conjugated double bond##2##3##(2007-11#1)(2009-9#1)
conjugated linoleic acid##2##3##(2008-5#1)(2012-2#1)
conjugated polymer##5##2##(2008-7#2)(2009-11#1)(2009-2#1)(2009-8#1)
conjugated polymers##4##2##(2007-12#1)(2008-10#2)(2009-11#1)
conjugated to a##3##3##(2008-4#1)(2008-9#1)(2012-2#1)
conjugated to horseradish peroxidase##2##4##(1991-2#1)(1997-3#1)
conjugated to the##2##3##(2008-10#2)
conjugated to##27##2##(1990-12#3)(1991-2#1)(1991-5#1)(1993-3#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-10#7)(2008-4#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-2#2)
conjugated with bovine serum albumin (BSA)##2##6##(2008-10#1)(2009-9#1)
conjugated with bovine serum albumin##3##5##(2008-10#1)(2008-5#1)(2009-9#1)
conjugated with horseradish peroxidase##2##4##(1996-12#1)(2008-10#1)
conjugated with ovalbumin##2##3##(1994-9#1)(2008-10#1)
conjugated with##26##2##(1992-3#1)(1993-11#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-1#1)(2013-1#2)
conjugated##141##1##(1990-12#5)(1990-8#1)(1991-2#2)(1991-5#4)(1992-11#1)(1992-3#5)(1993-11#1)(1993-2#5)(1993-3#2)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1997-3#1)(1997-7#13)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#28)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#2)(2009-11#3)(2009-2#1)(2009-5#2)(2009-8#6)(2009-9#3)(2010-12#1)(2010-2#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)
conjugated)##4##1##(1997-7#3)(2007-12#1)
conjugates and##4##2##(1995-3#1)(1997-3#1)(1997-6#1)(2008-10#1)
conjugates are##2##2##(2008-4#2)
conjugates for##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
conjugates has been##2##3##(1994-9#1)(2008-7#1)
conjugates of antiretroviral##2##3##(1990-8#1)(1992-6#1)
conjugates of the##3##3##(1991-5#1)(1995-11#1)(1995-3#1)
conjugates of##11##2##(1990-8#1)(1991-5#1)(1992-2#2)(1992-6#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-3#1)(2008-10#2)
conjugates were##2##2##(1992-3#1)(2008-11#1)
conjugates##60##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#2)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#4)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-6#1)(2006-6#1)(2007-10#2)(2008-10#7)(2008-11#1)(2008-4#12)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#2)(2011-2#1)
conjugates)##3##1##(1990-8#2)(2008-11#1)
conjugating enzyme##3##2##(2008-8#1)(2009-7#2)
conjugating##10##1##(1995-11#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#2)
conjugation enzyme##2##2##(2008-11#1)(2008-7#1)
conjugation in##5##2##(2008-10#1)(2008-2#4)
conjugation length##2##2##(2007-12#1)(2009-9#1)
conjugation of maleimide reporter groups to##2##6##(2008-4#2)
conjugation of the##2##3##(1995-11#1)(1997-7#1)
conjugation of##13##2##(1991-5#1)(1993-8#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#5)(2009-9#2)
conjugation to##4##2##(1997-1#1)(2008-10#2)(2008-3#1)
conjugation with##4##2##(1995-11#1)(2007-12#1)(2008-4#1)(2009-9#1)
conjugation##59##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1993-8#2)(1995-11#2)(1997-1#1)(1997-7#1)(2007-11#3)(2007-12#5)(2008-10#10)(2008-11#2)(2008-2#9)(2008-3#3)(2008-4#9)(2008-7#1)(2008-9#2)(2009-9#5)
conjugations##2##1##(2008-2#1)(2008-4#1)
conjugative##4##1##(1991-7#2)(2008-10#1)(2008-8#1)
conjugator##7##1##(2007-12#1)(2008-2#3)(2008-3#3)
conjunction with a##33##3##(1992-9#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-11#2)(2007-12#4)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#2)(2010-10#1)(2012-1#1)
conjunction with the##36##3##(1994-3#1)(1995-3#1)(1996-2#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#1)(2010-10#1)(2012-2#1)(2013-1#2)
conjunction with##204##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#45)(2008-11#11)(2008-12#4)(2008-2#14)(2008-3#22)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)
conjunction##209##1##(1990-10#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#46)(2008-11#11)(2008-12#4)(2008-2#14)(2008-3#22)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
conjunctiva##10##1##(1997-7#1)(2008-11#1)(2008-2#1)(2010-10#2)(2011-1#5)
conjunctival petechiae##2##2##(1995-11#2)
conjunctival swabs from##2##3##(2011-2#2)
conjunctival##15##1##(1991-8#1)(1995-11#3)(1997-7#1)(2008-11#2)(2009-4#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)
conjunctivitis##8##1##(1991-2#1)(1994-2#2)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
connect the##7##2##(1997-3#1)(2007-11#1)(2008-3#1)(2008-7#2)(2013-1#2)
connect to the##2##3##(1996-9#1)(2008-5#1)
connect to##6##2##(1996-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#1)
connect with##2##2##(2008-8#2)
connect##26##1##(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#3)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
connected and##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
connected by a##4##3##(1992-6#2)(2008-10#1)(2011-2#1)
connected by##14##2##(1992-6#2)(1993-11#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
connected in series##8##3##(1990-8#2)(2008-10#4)(2008-5#1)(2011-1#1)
connected to a UV detector##2##5##(2008-10#2)
connected to a video camera in##2##6##(2008-5#2)
connected to a##22##3##(2007-11#1)(2007-2#1)(2007-7#3)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-1#1)(2010-7#1)
connected to an##3##3##(2007-7#1)(2008-10#1)(2008-4#1)
connected to the##22##3##(1990-6#1)(1991-9#1)(1992-11#1)(1994-2#1)(1994-6#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#2)(2012-2#2)(2012-5#1)(2013-8#1)
connected to##74##2##(1990-6#2)(1991-2#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#2)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#5)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-2#4)(2012-5#1)(2013-8#1)
connected with a##2##3##(2007-12#1)(2008-12#1)
connected with interactions##2##3##(1990-2#1)(1997-6#1)
connected with significant risk##2##4##(2007-11#1)(2011-2#1)
connected with the sample##2##4##(2008-10#2)
connected with the use of##2##5##(2008-5#1)(2012-12#1)
connected with the##19##3##(1995-3#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2009-8#1)(2012-12#1)
connected with##53##2##(1990-2#1)(1990-6#1)(1991-9#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)
connected##187##1##(1990-2#1)(1990-6#3)(1990-8#3)(1991-2#1)(1991-9#2)(1992-11#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-3#2)(1995-6#1)(1996-4#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#14)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#3)(2013-7#2)(2013-8#2)
connectedness and##7##2##(2008-9#1)(2009-7#2)(2010-10#3)(2010-11#1)
connectedness levels were##2##3##(2012-1#2)
connectedness measures##4##2##(2012-1#4)
connectedness##27##1##(1993-8#1)(2008-9#2)(2009-7#6)(2010-10#5)(2010-11#2)(2012-1#9)(2013-1#2)
connecting peptides##4##2##(2008-10#3)(2008-9#1)
connecting the two##3##3##(1990-11#1)(1991-5#1)(1994-5#1)
connecting the##13##2##(1990-11#1)(1991-5#1)(1992-10#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
connecting two##2##2##(2008-10#1)(2008-3#1)
connecting##42##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-6#1)(1994-5#1)(1995-6#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
connection between a##2##3##(2007-12#1)(2008-2#1)
connection between the##12##3##(1992-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
connection between these##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
connection between##38##2##(1991-2#1)(1992-11#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#2)
connection by##2##2##(2007-8#1)(2008-11#1)
connection could be##2##3##(2008-10#1)(2008-12#1)
connection data##6##2##(1995-5#6)
connection exists between##2##3##(1993-6#1)(1997-6#1)
connection is##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
connection may be##2##3##(1993-3#1)(2012-3#1)
connection of the##5##3##(1996-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
connection of##9##2##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2011-1#1)
connection to the##2##3##(2006-12#1)(2008-11#1)
connection to##11##2##(2006-12#1)(2007-11#1)(2008-11#3)(2009-7#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#1)
connection with the##16##3##(1990-2#1)(1991-3#1)(1992-5#1)(1994-12#1)(1995-3#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-7#1)
connection with##44##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-3#1)(1995-8#1)(1996-6#1)(2007-11#2)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-7#1)
connection##158##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-11#3)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#4)(1993-6#2)(1994-12#2)(1994-2#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#6)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#9)(2007-8#7)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)
connectional##2##1##(1995-5#2)
connections among##3##2##(2008-11#2)(2013-1#1)
connections and prosocial norms##3##4##(2013-1#3)
connections and##5##2##(2008-11#1)(2009-5#1)(2013-1#3)
connections appear##2##2##(1992-11#1)(1994-5#1)
connections between research and practice##2##5##(2010-10#2)
connections between the##8##3##(1994-8#2)(1995-11#1)(2007-12#1)(2008-12#1)(2009-2#1)(2012-5#1)(2013-1#1)
connections between##21##2##(1992-5#1)(1993-12#1)(1994-8#2)(1995-11#1)(1995-5#2)(1996-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-10#2)(2012-5#1)(2013-1#1)
connections from##2##2##(2007-8#1)(2008-11#1)
connections have been##2##3##(1993-6#1)(2008-11#1)
connections in the##2##3##(1996-2#1)(2011-2#1)
connections in##4##2##(1996-2#1)(2009-8#1)(2011-2#2)
connections of the##4##3##(1991-6#1)(1997-3#2)(2007-8#1)
connections of##7##2##(1991-6#1)(1996-2#1)(1997-3#3)(2007-8#1)(2008-11#1)
connections that##3##2##(1997-2#1)(2008-11#1)(2008-2#1)
connections to family and peers##2##5##(2013-1#2)
connections to##7##2##(1996-2#1)(2007-12#2)(2008-4#1)(2008-8#1)(2013-1#2)
connections with the##4##3##(1993-6#1)(1997-3#1)(2008-7#1)(2013-8#1)
connections with##8##2##(1993-6#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
connections within a##2##3##(2008-11#2)
connections within the##2##3##(1997-3#2)
connections within##6##2##(1997-3#2)(2008-11#2)(2008-4#1)(2008-7#1)
connections##110##1##(1991-5#1)(1991-6#1)(1992-11#2)(1992-5#1)(1993-12#1)(1993-6#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-5#2)(1996-2#4)(1997-2#1)(1997-3#7)(2007-12#5)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#22)(2008-12#2)(2008-2#2)(2008-4#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#8)(2010-10#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#12)(2013-8#1)
connective tissue and##4##3##(2008-12#1)(2008-7#1)(2010-2#1)(2013-1#1)
connective tissue cells##4##3##(1996-2#1)(2007-8#2)(2008-5#1)
connective tissue disease and##2##4##(1991-11#1)(2012-12#1)
connective tissue disease with##2##4##(1995-11#1)(2011-2#1)
connective tissue disease##10##3##(1991-11#1)(1995-11#2)(1997-4#1)(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
connective tissue diseases##6##3##(1995-5#2)(2008-8#1)(2012-1#1)(2013-1#2)
connective tissue diseases]##2##3##(1993-2#1)(1995-5#1)
connective tissue glycoprotein##2##3##(1990-11#2)
connective tissue graft##3##3##(2012-3#2)(2013-1#1)
connective tissue growth factor##3##4##(2012-1#2)(2013-8#1)
connective tissue of the##2##4##(1994-9#1)(2011-2#1)
connective tissue of##3##3##(1994-9#1)(2011-2#1)(2012-12#1)
connective tissue##81##2##(1990-11#3)(1990-2#1)(1991-11#1)(1993-2#1)(1994-9#1)(1995-11#2)(1995-5#3)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-5#11)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#13)(2013-8#1)
connective tissues and##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
connective tissues##10##2##(1990-11#1)(1990-2#2)(1993-3#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#3)
connective##94##1##(1990-11#4)(1990-2#3)(1991-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-11#2)(1995-5#3)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-11#2)(2008-12#1)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#17)(2013-8#1)
connectivities##2##1##(2008-8#1)(2008-9#1)
connectivity among##2##2##(1996-2#1)(2013-8#1)
connectivity and##3##2##(1992-6#1)(2008-7#1)(2012-12#1)
connectivity between the##2##3##(2008-11#1)(2013-1#1)
connectivity between##3##2##(2008-11#1)(2010-6#1)(2013-1#1)
connectivity data##2##2##(1995-5#2)
connectivity in##2##2##(2008-1#1)(2012-2#1)
connectivity index##6##2##(2007-11#6)
connectivity indices##5##2##(1996-5#1)(2007-11#2)(2008-10#2)
connectivity map##2##2##(2009-12#2)
connectivity of##5##2##(2007-11#1)(2007-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
connectivity##57##1##(1992-6#1)(1994-3#2)(1995-5#4)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#10)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#3)(2009-9#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
connector##12##1##(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#3)(2010-9#3)(2011-2#1)
connectors and##2##2##(2008-3#1)(2011-1#1)
connectors##10##1##(2008-3#6)(2010-9#1)(2011-1#2)(2011-2#1)
connects a##2##2##(2008-10#1)(2009-5#1)
connects it to##2##3##(1996-1#1)(2008-3#1)
connects the##10##2##(1992-3#1)(1997-2#1)(2007-12#2)(2007-9#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-2#1)
connects to the##2##3##(1996-9#1)(2008-9#1)
connects##25##1##(1992-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
connexin 43##2##2##(2008-11#1)(2008-7#1)
connexin##5##1##(2008-11#1)(2008-4#1)(2008-7#2)(2009-5#1)
connexins##4##1##(2008-7#3)(2013-1#1)
connotations##2##1##(2007-12#1)(2008-5#1)
conorii##2##1##(2010-10#1)(2013-8#1)
conotoxin present in##2##3##(2008-12#2)
conotoxins##2##1##(2008-8#2)
conotruncal cardiac defects##2##3##(1997-3#1)(2009-12#1)
cons of changing##2##3##(2008-11#2)
cons of##17##2##(1992-1#1)(1996-6#1)(2008-11#3)(2008-3#1)(2008-4#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cons##22##1##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
consanguineous marriages##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
consanguineous##6##1##(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
consanguinity##3##1##(1993-6#1)(2008-10#1)(2008-2#1)
conscientious##6##1##(1991-3#1)(2008-11#1)(2011-2#4)
conscientiousness##5##1##(2008-5#2)(2009-8#1)(2011-2#1)(2012-1#1)
conscious and willful##2##3##(2010-4#2)
conscious and##3##2##(1995-9#1)(2010-4#2)
conscious experience##2##2##(1995-8#1)(2007-9#1)
conscious perception of the stimulus##2##5##(2007-9#2)
conscious perception of##4##3##(2007-9#4)
conscious perception##7##2##(2007-9#7)
conscious rats##3##2##(1991-12#1)(1995-12#2)
conscious sedation##6##2##(1993-1#1)(1995-1#2)(2010-3#2)(2012-2#1)
conscious state##2##2##(2008-7#2)
conscious##53##1##(1990-5#1)(1991-1#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#5)(1995-2#1)(1995-8#2)(1995-9#1)(1996-12#1)(1997-6#2)(2007-10#1)(2007-9#8)(2008-1#1)(2008-11#2)(2008-7#2)(2010-3#3)(2010-4#4)(2010-5#1)(2012-12#1)(2012-2#3)(2012-3#2)
consciously##7##1##(1992-12#1)(1995-6#1)(1997-3#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-2#1)
consciousness and##9##2##(1991-11#1)(1997-3#1)(2008-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
consciousness is##4##2##(1995-8#1)(2008-11#3)
consciousness##42##1##(1990-9#1)(1991-11#1)(1992-6#2)(1994-8#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-2#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-8#3)
consecutive A##2##2##(1991-8#2)
consecutive PD##2##2##(2008-7#1)(2011-2#1)
consecutive admissions##2##2##(1992-12#1)(2008-11#1)
consecutive aromatic residues in the##2##5##(2008-11#2)
consecutive aromatic##3##2##(2008-11#3)
consecutive cases of##3##3##(1996-3#1)(2008-10#1)(2009-10#1)
consecutive cases##10##2##(1990-10#1)(1993-2#1)(1996-3#1)(1997-3#1)(2007-8#2)(2008-10#1)(2009-10#1)(2010-3#1)(2012-3#1)
consecutive chest pain patients##2##4##(2008-3#2)
consecutive cohort##2##2##(1994-3#1)(2012-2#1)
consecutive days and the##2##4##(1995-3#1)(2011-2#1)
consecutive days and##5##3##(1995-3#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
consecutive days of##2##3##(1995-6#1)(2012-12#1)
consecutive days##23##2##(1991-2#1)(1992-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
consecutive days)##2##2##(2008-10#2)
consecutive group of##2##3##(1991-9#1)(2012-2#1)
consecutive injections of##2##3##(1996-12#1)(2008-10#1)
consecutive intensive##2##2##(2008-1#1)(2011-2#1)
consecutive layers##2##2##(1992-9#1)(2008-3#1)
consecutive measurements and##2##3##(2008-10#2)
consecutive measurements of##3##3##(2008-10#3)
consecutive measurements##6##2##(2008-10#6)
consecutive miscarriages##2##2##(2013-8#2)
consecutive months##2##2##(1991-3#1)(1997-2#1)
consecutive operations##2##2##(1993-5#1)(1994-3#1)
consecutive passages##2##2##(2007-6#1)(2013-8#1)
consecutive patients (mean age##3##4##(2007-8#1)(2008-7#1)(2009-3#1)
consecutive patients admitted to##3##4##(1991-8#1)(2007-10#1)(2012-2#1)
consecutive patients diagnosed##2##3##(2008-11#1)(2008-6#1)
consecutive patients from##2##3##(2010-12#1)(2011-2#1)
consecutive patients operated##2##3##(1990-6#1)(2007-8#1)
consecutive patients presenting with##3##4##(1995-10#1)(2008-8#1)(2013-1#1)
consecutive patients receiving##2##3##(2007-8#1)(2012-2#1)
consecutive patients undergoing##3##3##(2008-5#1)(2008-8#1)(2009-3#1)
consecutive patients were##5##3##(1997-3#1)(2007-12#1)(2007-7#1)(2008-9#1)(2012-2#1)
consecutive patients who underwent##2##4##(2008-7#1)(2011-2#1)
consecutive patients who##4##3##(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
consecutive patients with acute##2##4##(1991-8#1)(1997-8#1)
consecutive patients with chronic##2##4##(2012-12#1)(2013-1#1)
consecutive patients with##27##3##(1990-6#2)(1991-2#1)(1991-8#1)(1992-4#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-3#4)(2008-9#2)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)
consecutive patients##82##2##(1990-12#1)(1990-3#1)(1990-6#3)(1991-2#1)(1991-8#2)(1991-9#1)(1992-4#1)(1994-3#1)(1995-10#1)(1996-9#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-3#2)(2010-12#2)(2010-3#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#6)
consecutive phases##3##2##(2008-10#3)
consecutive reactions##2##2##(2008-10#2)
consecutive sensor errors##2##3##(2009-9#2)
consecutive series of##10##3##(1990-12#1)(1990-8#1)(1991-8#1)(1997-8#1)(2007-8#1)(2008-9#2)(2010-11#1)(2012-5#1)(2013-1#1)
consecutive to##2##2##(1990-9#2)
consecutive weeks##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2013-1#1)
consecutive years##13##2##(1991-8#1)(1992-6#1)(2008-10#4)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
consecutive##340##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#7)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#6)(2007-11#1)(2007-12#6)(2007-6#1)(2007-7#3)(2007-8#13)(2008-1#5)(2008-10#45)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#12)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#19)(2011-7#1)(2012-12#6)(2012-2#9)(2012-3#7)(2012-5#2)(2013-1#18)(2013-7#1)(2013-8#4)
consecutively admitted to##2##3##(1996-3#1)(2011-2#1)
consecutively admitted##3##2##(1996-3#1)(1997-3#1)(2011-2#1)
consecutively treated patients##3##3##(1996-9#1)(2012-1#2)
consecutively treated##4##2##(1996-8#1)(1996-9#1)(2012-1#2)
consecutively##24##1##(1990-9#1)(1992-11#1)(1993-8#1)(1994-5#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
consensual##3##1##(2008-11#1)(2011-1#1)(2011-2#1)
consensus (ERIC)##3##2##(2008-10#3)
consensus about the##3##3##(1994-2#1)(1997-1#1)(2009-6#1)
consensus among##6##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
consensus and##3##2##(1997-3#1)(2008-10#1)(2009-7#1)
consensus as to whether##2##4##(1990-11#1)(2013-1#1)
consensus as to##5##3##(1990-11#1)(1993-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
consensus binding##4##2##(1991-11#1)(1993-3#1)(1995-6#1)(1995-8#1)
consensus building##2##2##(1995-12#1)(1997-2#1)
consensus conference on the##2##4##(1994-6#1)(2007-12#1)
consensus conference on##3##3##(1991-11#1)(1994-6#1)(2007-12#1)
consensus conference##5##2##(1991-11#1)(1994-6#1)(2007-12#2)(2008-4#1)
consensus conferences##2##2##(1992-9#1)(1993-12#1)
consensus development##2##2##(2008-9#1)(2012-12#1)
consensus document##2##2##(2007-12#1)(2008-10#1)
consensus for##2##2##(1990-5#1)(2010-10#1)
consensus guidelines have##2##3##(2008-3#1)(2011-1#1)
consensus guidelines##4##2##(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
consensus has been##2##3##(1995-2#1)(2012-12#1)
consensus has##3##2##(1995-2#1)(2012-12#1)(2013-8#1)
consensus in the##3##3##(1996-1#1)(2008-10#1)(2012-2#1)
consensus is now emerging on##2##5##(2008-8#2)
consensus is##6##2##(1996-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)
consensus model##4##2##(1992-1#3)(1996-3#1)
consensus motif##2##2##(1994-9#1)(2008-8#1)
consensus motifs##3##2##(1995-6#2)(1997-4#1)
consensus of the##2##3##(2009-5#1)(2011-2#1)
consensus of##3##2##(2008-11#1)(2009-5#1)(2011-2#1)
consensus on the##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
consensus on##20##2##(1994-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
consensus over##3##2##(1997-7#1)(2008-7#1)(2010-10#1)
consensus panel##3##2##(2007-4#3)
consensus primers##2##2##(2008-10#1)(2008-9#1)
consensus recommendations##2##2##(2008-3#1)(2008-9#1)
consensus regarding the optimal##2##4##(1994-12#1)(1995-5#1)
consensus regarding the##4##3##(1994-12#1)(1995-5#1)(2008-11#1)(2012-2#1)
consensus regarding##7##2##(1994-12#1)(1995-1#1)(1995-5#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-8#1)
consensus sequence for##2##3##(1993-6#1)(1997-8#1)
consensus sequence of the##2##4##(1997-4#1)(2009-8#1)
consensus sequence of##9##3##(1990-8#1)(1991-12#1)(1992-8#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-8#2)(2009-8#1)
consensus sequence was##2##3##(1994-12#1)(2008-9#1)
consensus sequence##38##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)
consensus sequences and##2##3##(1993-12#1)(2008-4#1)
consensus sequences for##3##3##(1991-2#1)(1991-6#1)(1992-6#1)
consensus sequences##11##2##(1991-2#1)(1991-6#1)(1992-6#2)(1993-12#2)(1993-6#1)(1994-11#1)(1995-8#1)(1997-2#1)(2008-4#1)
consensus statement on##4##3##(1993-3#1)(2009-8#2)(2012-2#1)
consensus statement##11##2##(1990-2#1)(1991-11#1)(1993-3#1)(1995-5#1)(2008-2#1)(2008-6#2)(2009-8#2)(2012-2#1)(2013-1#1)
consensus statements##3##2##(2011-2#3)
consensus suggestions##2##2##(2008-6#2)
consensus that##9##2##(1993-11#1)(1993-12#1)(1997-3#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-2#1)
consensus values##3##2##(2008-10#3)
consensus was##2##2##(1991-11#1)(1995-1#1)
consensus##266##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-1#3)(1992-2#1)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#3)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#4)(1997-7#4)(1997-8#1)(2007-12#4)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#25)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#8)(2008-7#7)(2008-8#11)(2008-9#5)(2009-11#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#17)(2013-8#3)
consensus-based##2##1##(1996-1#1)(2011-1#1)
consensus-building##2##1##(1996-1#1)(1996-3#1)
consent and the##2##3##(1993-3#1)(2011-2#1)
consent and##7##2##(1990-2#1)(1993-3#1)(1994-2#1)(1997-3#1)(2007-11#1)(2011-2#1)(2012-12#1)
consent for##8##2##(1994-12#1)(1997-6#1)(2008-4#3)(2011-2#2)(2012-1#1)
consent form##4##2##(2009-4#2)(2012-3#1)(2013-1#1)
consent forms##4##2##(1993-2#1)(1997-5#1)(2008-7#1)(2009-4#1)
consent in##3##2##(1992-3#1)(2008-7#1)(2008-8#1)
consent is##3##2##(1992-3#1)(2008-7#1)(2010-11#1)
consent of the##3##3##(1992-12#1)(2011-2#1)(2012-3#1)
consent of##6##2##(1992-12#1)(1992-3#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
consent or##3##2##(1994-2#2)(2008-8#1)
consent process##8##2##(2008-4#1)(2008-8#5)(2010-7#1)(2012-2#1)
consent regarding the##2##3##(1991-3#1)(1995-9#1)
consent to donation of##2##4##(1993-2#2)
consent to donation##4##3##(1993-2#2)(2011-2#2)
consent to participate##3##3##(2009-6#1)(2010-11#1)(2012-1#1)
consent to research##2##3##(1995-2#1)(2010-11#1)
consent to##25##2##(1992-1#1)(1992-3#5)(1993-2#2)(1994-1#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-6#3)(2010-11#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#1)
consent was##3##2##(1995-2#1)(2008-12#1)(2008-7#1)
consent were##2##2##(2008-8#1)(2009-6#1)
consent will##2##2##(1994-1#1)(1996-11#1)
consent##136##1##(1990-2#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#10)(1993-2#6)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#4)(1995-2#6)(1995-5#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#5)(2008-5#2)(2008-7#10)(2008-8#10)(2009-4#7)(2009-6#7)(2009-9#1)(2010-11#5)(2010-5#1)(2010-7#1)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
consent'##2##1##(2009-9#2)
consenting##5##1##(1996-8#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#1)
consequence is##4##2##(1990-6#1)(2010-10#1)(2013-7#1)(2013-8#1)
consequence of a##14##3##(1992-8#1)(1994-8#1)(1995-12#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#2)
consequence of adaptation to different##2##5##(2008-8#1)(2008-9#1)
consequence of allostery##2##3##(1997-2#2)
consequence of an##3##3##(1995-12#1)(2008-10#2)
consequence of defective##2##3##(2012-3#1)(2013-1#1)
consequence of extracellular##2##3##(1990-2#1)(2011-2#1)
consequence of increased##3##3##(1991-1#1)(1995-2#1)(2008-3#1)
consequence of reduced##2##3##(2008-8#1)(2013-8#1)
consequence of the##31##3##(1990-11#1)(1990-2#1)(1990-8#1)(1992-6#1)(1994-2#1)(1994-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
consequence of these##3##3##(1995-3#1)(2008-2#1)(2008-6#1)
consequence of this##6##3##(1997-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)
consequence of which##2##3##(2008-11#1)(2013-1#1)
consequence of##153##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-10#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#1)
consequence on##2##2##(1994-12#1)(2008-10#1)
consequence that##2##2##(2011-2#1)(2013-1#1)
consequence to##2##2##(2008-7#1)(2013-1#1)
consequence##233##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-10#35)(2008-11#12)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#16)(2008-8#12)(2008-9#6)(2009-10#3)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#20)(2013-7#2)(2013-8#3)
consequences and##11##2##(1990-11#1)(1991-6#1)(1992-5#2)(1994-8#1)(1997-4#1)(2007-11#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#1)
consequences are##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
consequences as##2##2##(2007-11#1)(2012-2#1)
consequences associated with##5##3##(1994-2#1)(2008-1#1)(2008-6#1)(2009-5#1)(2010-11#1)
consequences due to##2##3##(2010-7#1)(2011-2#1)
consequences for adult##2##3##(2008-4#1)(2012-2#1)
consequences for individual##2##3##(2008-9#1)(2010-5#1)
consequences for many##2##3##(2010-11#1)(2012-2#1)
consequences for the##12##3##(1990-2#1)(1992-2#1)(1994-11#1)(1994-5#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)
consequences for##51##2##(1990-2#1)(1990-6#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1997-2#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#2)(2008-8#8)(2008-9#4)(2009-10#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
consequences in the##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
consequences in##8##2##(1991-2#2)(2007-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)
consequences of AHP failures##2##4##(1994-3#2)
consequences of a##5##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#1)
consequences of an##2##3##(2007-12#1)(2008-11#1)
consequences of asymmetric dispersal rates##2##5##(2008-8#2)
consequences of its##2##3##(1993-12#1)(2013-1#1)
consequences of mutations##2##3##(1990-7#1)(2008-9#1)
consequences of organized violence##2##4##(1990-6#2)
consequences of paediatric##2##3##(2008-11#1)(2008-9#1)
consequences of pain##2##3##(2008-11#2)
consequences of public health##2##4##(2008-8#1)(2010-8#1)
consequences of sexual abuse##2##4##(2010-10#2)
consequences of sexual##3##3##(2010-10#2)(2012-3#1)
consequences of such##5##3##(1993-3#1)(2007-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
consequences of the results for##2##5##(2008-10#2)
consequences of the use of##2##5##(2008-9#1)(2013-8#1)
consequences of the##30##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-3#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
consequences of their##6##3##(2008-11#1)(2008-8#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#1)
consequences of these##6##3##(1990-2#1)(1992-3#1)(1994-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
consequences of this behavior##2##4##(2008-11#1)(2013-1#1)
consequences of this##8##3##(1995-8#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
consequences of##221##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#4)(1993-9#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#16)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#29)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#5)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
consequences on the##4##3##(1995-12#1)(1996-5#1)(2008-7#1)(2013-1#1)
consequences on##10##2##(1995-12#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#3)(2013-1#1)(2013-8#1)
consequences resulting from##2##3##(2008-11#1)(2008-7#1)
consequences that cause##2##3##(2008-11#1)(2008-7#1)
consequences that##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
consequences to##5##2##(1992-12#1)(2008-1#1)(2009-3#1)(2012-2#1)(2013-8#1)
consequences##426##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#4)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#8)(2008-10#19)(2008-11#27)(2008-12#5)(2008-2#11)(2008-3#10)(2008-4#11)(2008-5#7)(2008-6#6)(2008-7#21)(2008-8#42)(2008-9#15)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#3)(2013-1#17)(2013-7#2)(2013-8#9)
consequences]##2##1##(1993-3#1)(2011-3#1)
consequent loss of##2##3##(1992-9#1)(1995-5#1)
consequent loss##3##2##(1992-9#1)(1995-5#1)(2008-3#1)
consequent on##3##2##(1994-12#1)(2007-7#1)(2008-6#1)
consequent reduction in##2##3##(1995-12#1)(2008-10#1)
consequent reduction##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
consequent to the##3##3##(1992-9#1)(1994-6#1)(2008-4#1)
consequent to##6##2##(1992-9#1)(1993-10#1)(1994-2#1)(1994-6#1)(2008-4#1)(2008-7#1)
consequent##54##1##(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
consequential##5##1##(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
consequently a##3##2##(2008-3#1)(2008-5#1)(2013-7#1)
consequently not##2##2##(2008-10#2)
consequently the##9##2##(1997-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-7#1)(2010-9#1)
consequently##116##1##(1990-3#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#3)(2008-1#3)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-4#1)(2013-1#3)(2013-7#1)
conservation among##3##2##(1991-6#1)(2008-8#1)(2011-1#1)
conservation and management of##3##4##(2007-5#1)(2013-1#1)(2013-7#1)
conservation and management##8##3##(2007-5#1)(2008-6#1)(2008-8#2)(2012-3#1)(2013-1#1)(2013-7#2)
conservation and the##2##3##(1993-3#1)(2009-5#1)
conservation and##18##2##(1993-3#1)(1994-11#1)(2007-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
conservation at the##2##3##(1994-12#1)(2013-7#1)
conservation between##8##2##(1991-12#1)(1993-12#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-3#1)
conservation for##3##2##(1994-8#1)(2012-2#1)(2013-7#1)
conservation in multiwavelength binary phase shift-keying##2##6##(2007-12#2)
conservation in##10##2##(1990-2#1)(1993-8#1)(2007-12#2)(2007-9#2)(2008-11#1)(2008-7#2)(2010-7#1)
conservation is##7##2##(1991-6#1)(1994-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
conservation management##2##2##(2008-8#1)(2013-1#1)
conservation of the##11##3##(1990-2#1)(1991-6#2)(1993-12#1)(1993-2#1)(1997-6#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)
conservation of this##3##3##(1993-12#1)(1993-6#1)(2008-8#1)
conservation of##48##2##(1990-2#1)(1991-6#3)(1991-7#3)(1992-6#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-9#1)(2010-11#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
conservation state of##4##3##(2008-10#4)
conservation suggests##2##2##(1990-11#1)(1995-12#1)
conservation therapy##6##2##(1995-4#1)(2007-11#5)
conservation was##2##2##(1993-2#1)(1994-11#1)
conservation##183##1##(1990-11#1)(1990-2#3)(1990-8#2)(1991-12#1)(1991-6#6)(1991-7#3)(1992-1#1)(1992-2#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#6)(2007-12#2)(2007-5#3)(2007-9#3)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#12)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#3)(2009-9#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#13)(2013-8#2)
conservatism##2##1##(1994-9#1)(2008-8#1)
conservative amino acid##3##3##(1993-6#1)(2008-9#2)
conservative and surgical treatment##5##4##(1994-2#1)(2007-11#1)(2007-8#3)
conservative and surgical##8##3##(1994-2#1)(1997-6#1)(2007-11#2)(2007-8#4)
conservative and##11##2##(1994-2#1)(1997-6#1)(2007-11#3)(2007-8#4)(2008-10#1)(2012-2#1)
conservative approach##8##2##(1990-9#1)(1993-8#2)(1995-8#1)(1996-6#1)(2008-1#1)(2008-8#1)(2009-8#1)
conservative as##2##2##(1990-6#1)(1994-5#1)
conservative care##2##2##(2009-12#1)(2013-1#1)
conservative estimate##2##2##(1991-12#1)(2008-10#1)
conservative functional##2##2##(1992-6#1)(2011-2#1)
conservative group##2##2##(2013-1#2)
conservative management of##5##3##(1990-2#1)(1993-9#1)(2007-11#1)(2011-2#1)(2013-1#1)
conservative management##20##2##(1990-2#1)(1990-9#1)(1993-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#2)(2013-1#10)(2013-8#1)
conservative measures##4##2##(2008-10#1)(2008-9#1)(2009-11#1)(2012-12#1)
conservative or surgical##2##3##(2010-5#1)(2012-2#1)
conservative or##4##2##(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
conservative revision&quot##2##2##(2009-4#2)
conservative stems##2##2##(2009-4#2)
conservative surgery and radiation##2##4##(1995-8#1)(1995-9#1)
conservative surgery and##3##3##(1995-8#1)(1995-9#1)(2011-2#1)
conservative surgery##12##2##(1990-12#2)(1990-2#2)(1995-5#1)(1995-8#2)(1995-9#1)(2010-12#2)(2011-2#1)(2013-7#1)
conservative surgical##4##2##(1991-6#1)(1993-8#1)(1995-4#1)(2007-12#1)
conservative therapy##8##2##(1993-12#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2011-3#1)(2013-1#1)(2013-7#1)
conservative treatment and##2##3##(1991-5#1)(2013-1#1)
conservative treatment for##2##3##(2010-3#1)(2013-1#1)
conservative treatment had failed##2##4##(1997-8#1)(2007-11#1)
conservative treatment had##3##3##(1997-8#1)(2007-11#1)(2007-8#1)
conservative treatment is##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
conservative treatment of appendicitis##2##4##(2011-2#2)
conservative treatment of developmental##2##4##(2007-8#2)
conservative treatment of##9##3##(1993-8#1)(1994-3#1)(2007-11#1)(2007-8#3)(2011-2#2)(2013-1#1)
conservative treatment with##3##3##(1991-3#1)(1997-6#1)(2013-1#1)
conservative treatment##45##2##(1990-9#1)(1991-3#2)(1991-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1997-6#1)(1997-8#1)(2007-11#7)(2007-8#7)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#2)(2011-2#5)(2012-3#1)(2013-1#7)
conservative treatments##2##2##(2011-2#1)(2013-1#1)
conservative##198##1##(1990-12#2)(1990-2#3)(1990-6#2)(1990-9#3)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#4)(1993-8#4)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#12)(2007-12#2)(2007-7#1)(2007-8#12)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#7)(2009-11#2)(2009-12#1)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-3#2)(2010-5#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#27)(2013-7#2)(2013-8#1)
conservatively and##3##2##(2008-7#1)(2013-1#2)
conservatively treated##4##2##(1992-1#1)(1993-9#1)(2008-7#1)(2011-2#1)
conservatively with##4##2##(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
conservatively##35##1##(1991-12#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-9#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#5)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#5)(2013-8#2)
conservatrice##2##1##(2011-2#2)
conserve natural##2##2##(2010-4#1)(2010-7#1)
conserve the##2##2##(1991-5#1)(1994-1#1)
conserve##8##1##(1991-5#1)(1992-2#1)(1994-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-7#1)
conserved 5' untranslated##2##3##(1992-11#2)
conserved Arg residues in##2##4##(1990-11#1)(2008-4#1)
conserved Arg##4##2##(1990-11#1)(2008-4#1)(2008-8#2)
conserved GC-rich##2##2##(2012-3#2)
conserved across##4##2##(1993-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
conserved amino acid sequence##3##4##(1990-2#1)(1992-8#1)(1997-7#1)
conserved amino acid##5##3##(1990-2#1)(1991-2#1)(1992-3#1)(1992-8#1)(1997-7#1)
conserved amino##6##2##(1990-2#1)(1991-2#2)(1992-3#1)(1992-8#1)(1997-7#1)
conserved among different##2##3##(1994-11#1)(1997-2#1)
conserved among insects##2##3##(2007-12#2)
conserved among isolates##2##3##(2008-10#2)
conserved among species##2##3##(1993-3#1)(2008-7#1)
conserved among the##5##3##(1990-8#1)(1992-11#1)(1996-8#1)(2008-10#1)(2008-5#1)
conserved among##23##2##(1990-8#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1995-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-12#3)(2008-10#4)(2008-5#1)(2008-7#1)(2010-9#1)
conserved and##18##2##(1993-6#1)(1993-8#1)(1994-11#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
conserved as##3##2##(1994-11#1)(1995-5#1)(2008-10#1)
conserved at##3##2##(1995-6#1)(2012-2#2)
conserved between species##2##3##(1990-12#1)(2012-3#1)
conserved between the two##2##4##(1991-6#1)(2012-3#1)
conserved between the##4##3##(1991-5#1)(1991-6#1)(2012-2#1)(2012-3#1)
conserved between##16##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-8#2)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2009-5#1)(2010-9#1)(2012-2#2)(2012-3#2)
conserved cysteine residue##2##3##(1991-9#1)(1995-2#1)
conserved cysteine residues##2##3##(1992-10#1)(1995-5#1)
conserved cysteine##6##2##(1991-9#1)(1992-10#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-6#1)
conserved domain of the##2##4##(1992-9#1)(1993-8#1)
conserved domain##3##2##(1992-9#1)(1993-12#1)(1993-8#1)
conserved domains in##2##3##(2008-4#2)
conserved domains of##2##3##(1997-2#1)(2008-10#1)
conserved domains##7##2##(1993-6#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-8#1)
conserved during evolution##2##3##(1995-9#1)(1997-2#1)
conserved during##5##2##(1992-12#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-9#1)
conserved elements##2##2##(1990-5#1)(2008-4#1)
conserved family##2##2##(1993-6#1)(2008-7#1)
conserved for##5##2##(1990-8#1)(1992-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
conserved from##3##2##(2008-4#1)(2008-7#1)(2012-1#1)
conserved gene##2##2##(2008-10#1)(2009-10#1)
conserved histidine##2##2##(1995-5#1)(2010-10#1)
conserved hydrophobic##2##2##(1990-11#1)(1997-9#1)
conserved in a##2##3##(1992-6#1)(1994-8#1)
conserved in all known##3##4##(1993-11#1)(1994-5#1)(2008-4#1)
conserved in all members of the Ras superfamily##2##8##(1995-2#2)
conserved in all##9##3##(1991-6#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-2#3)(1995-5#1)(2008-4#1)
conserved in both##2##3##(1994-5#1)(1997-9#1)
conserved in evolution##4##3##(1990-8#1)(1991-5#1)(1991-6#1)(2009-6#1)
conserved in many##2##3##(1996-12#1)(2008-8#1)
conserved in other##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
conserved in plant##2##3##(2009-8#1)(2013-1#1)
conserved in the porcine##2##4##(1995-8#1)(2012-2#1)
conserved in the##9##3##(1994-11#1)(1994-12#2)(1994-6#1)(1995-6#1)(1995-8#2)(2012-2#1)(2013-8#1)
conserved in##53##2##(1990-8#1)(1991-5#1)(1991-6#2)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-9#1)(2007-12#2)(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2012-2#2)(2013-1#1)(2013-8#1)
conserved lysine##2##2##(2008-4#2)
conserved motif##4##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-8#1)
conserved motifs in##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
conserved motifs of the##3##4##(2007-12#1)(2008-10#2)
conserved motifs of##4##3##(2007-12#1)(2008-10#3)
conserved motifs##9##2##(1994-12#1)(2007-12#1)(2008-10#6)(2008-4#1)
conserved on##2##2##(1991-7#1)(2008-10#1)
conserved or##2##2##(1994-11#1)(1997-6#1)
conserved over##3##2##(1993-6#1)(1994-12#1)(2008-3#1)
conserved protein##5##2##(1994-12#1)(1997-1#1)(1997-7#1)(2008-8#1)(2009-8#1)
conserved proteins##6##2##(1990-5#1)(1994-6#1)(2008-11#1)(2008-9#1)(2009-10#1)(2013-8#1)
conserved region of the##2##4##(1992-11#1)(2012-12#1)
conserved region of##7##3##(1990-11#1)(1992-11#1)(1994-12#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
conserved region##17##2##(1990-11#1)(1992-11#1)(1992-6#1)(1994-11#3)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#1)(2012-12#1)(2013-1#1)
conserved regions are##2##3##(1995-6#1)(2008-9#1)
conserved regions of the##5##4##(1993-6#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-9#1)
conserved regions of##9##3##(1993-6#1)(1994-12#2)(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-9#1)
conserved regions##23##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-4#2)(1997-7#1)(2008-10#4)(2008-9#2)
conserved regulatory##4##2##(1995-2#2)(2008-11#1)(2010-3#1)
conserved repetitive##2##2##(2008-10#2)
conserved residue in##2##3##(1993-12#1)(1995-2#1)
conserved residues in the##5##4##(1990-7#2)(1992-3#1)(1995-5#1)(1997-8#1)
conserved residues in##6##3##(1990-7#2)(1992-3#1)(1995-5#2)(1997-8#1)
conserved residues##11##2##(1990-7#2)(1991-5#1)(1992-3#2)(1993-2#1)(1995-5#3)(1995-8#1)(1997-8#1)
conserved sequence##9##2##(1992-3#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-10#1)
conserved sequences among##2##3##(1994-12#1)(1995-8#1)
conserved sequences in##2##3##(1997-3#1)(2008-10#1)
conserved sequences##11##2##(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
conserved structural##5##2##(1992-6#1)(1994-8#1)(2013-1#3)
conserved threonine residue##2##3##(1991-12#1)(2008-8#1)
conserved through##2##2##(1990-5#1)(2008-10#1)
conserved throughout evolution##5##3##(1993-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
conserved throughout##7##2##(1992-3#1)(1993-12#1)(1997-7#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
conserved transcription##2##2##(2008-4#1)(2008-9#1)
conserved with##2##2##(1993-6#1)(2008-6#1)
conserved within the##2##3##(1994-8#1)(2008-4#1)
conserved within##4##2##(1992-6#1)(1994-8#1)(2008-4#1)(2008-8#1)
conserved##478##1##(1990-11#4)(1990-12#5)(1990-2#1)(1990-5#4)(1990-7#2)(1990-8#4)(1991-12#6)(1991-2#2)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#8)(1992-6#6)(1992-8#9)(1992-9#5)(1993-11#1)(1993-12#13)(1993-2#7)(1993-3#3)(1993-6#9)(1993-8#6)(1993-9#3)(1994-11#14)(1994-12#14)(1994-2#2)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#17)(1995-3#1)(1995-5#9)(1995-6#14)(1995-8#6)(1995-9#1)(1996-12#4)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#5)(1997-6#4)(1997-7#7)(1997-8#2)(1997-9#6)(2007-11#1)(2007-12#12)(2008-1#2)(2008-10#49)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#18)(2008-5#3)(2008-6#2)(2008-7#16)(2008-8#16)(2008-9#7)(2009-10#5)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#5)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#5)
conserving the##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
conserving##17##1##(1992-11#1)(1994-12#1)(1995-4#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#4)(2012-2#2)
consider a model##2##3##(1990-8#1)(2013-8#1)
consider a number of##2##4##(1991-3#1)(2010-10#1)
consider a##23##2##(1990-8#2)(1991-3#1)(1997-2#1)(2008-10#1)(2008-3#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-8#4)
consider all##2##2##(1991-2#1)(2012-3#1)
consider an##5##2##(1997-4#1)(2008-2#1)(2008-7#3)
consider as they develop##2##4##(1993-1#1)(2008-10#1)
consider as##6##2##(1993-1#1)(1996-12#1)(2008-10#1)(2011-2#3)
consider before##4##2##(1997-4#1)(2008-10#1)(2008-7#1)(2013-7#1)
consider both##2##2##(2008-10#1)(2008-8#1)
consider each##2##2##(1995-2#1)(2007-12#1)
consider how the##2##3##(2008-10#1)(2008-8#1)
consider how##10##2##(1996-2#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
consider in detail##2##3##(2008-10#1)(2008-12#1)
consider in developing##2##3##(1997-1#1)(2012-12#1)
consider in##12##2##(1993-1#1)(1995-12#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2012-12#2)(2012-2#1)
consider it##4##2##(1991-2#1)(1994-3#1)(2008-7#2)
consider its##2##2##(2007-11#1)(2010-6#1)
consider new##3##2##(1995-1#1)(1996-2#1)(2008-3#1)
consider not only its##2##4##(1992-3#1)(2010-6#1)
consider only##2##2##(2008-8#1)(2012-1#1)
consider other##2##2##(2008-7#1)(2012-2#1)
consider pain##2##2##(1993-2#2)
consider possible##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
consider relevant##2##2##(2008-9#1)(2011-1#1)
consider some of the##2##4##(2008-11#1)(2012-3#1)
consider some##5##2##(1993-3#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
consider such##2##2##(2009-9#1)(2013-8#1)
consider testing##2##2##(1996-4#1)(2011-2#1)
consider that a##2##3##(2008-5#1)(2008-7#1)
consider that for a##3##4##(2008-10#3)
consider that##21##2##(1992-6#1)(1994-12#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
consider the clinical##2##3##(2011-1#1)(2012-2#1)
consider the context of##2##4##(2007-2#1)(2007-9#1)
consider the effect##2##3##(2007-12#2)
consider the effects of##3##4##(2007-11#1)(2008-3#1)(2010-8#1)
consider the impact of##2##4##(1995-3#1)(2012-3#1)
consider the implications of##2##4##(2008-10#1)(2008-8#1)
consider the implications##3##3##(2007-9#1)(2008-10#1)(2008-8#1)
consider the interaction between##2##4##(2008-2#1)(2008-8#1)
consider the possibility##2##3##(2006-10#1)(2013-1#1)
consider the problem of##5##4##(1994-11#1)(2007-11#1)(2008-2#1)(2009-9#1)(2011-3#1)
consider the relationship##2##3##(2008-10#1)(2012-12#1)
consider the role##3##3##(1992-3#1)(2008-3#1)(2013-8#1)
consider the support##2##3##(1992-3#1)(2010-5#1)
consider the use of##4##4##(2008-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
consider the##112##2##(1991-3#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#14)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#4)
consider their##7##2##(1994-5#1)(1996-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)
consider these##3##2##(2008-3#1)(2009-5#1)(2011-2#1)
consider this##5##2##(1994-5#1)(2008-7#1)(2009-11#1)(2012-12#1)(2012-3#1)
consider to be of##2##4##(1990-10#1)(2008-9#1)
consider to be##5##3##(1990-10#1)(1996-1#1)(2007-11#1)(2008-9#1)(2011-2#1)
consider to##6##2##(1990-10#1)(1996-1#1)(2006-5#1)(2007-11#1)(2008-9#1)(2011-2#1)
consider two##4##2##(2008-2#1)(2009-5#1)(2012-2#1)(2013-8#1)
consider using##2##2##(1992-3#1)(1993-1#1)
consider whether##3##2##(1991-12#1)(2008-12#1)(2009-6#1)
consider##415##1##(1990-10#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-9#1)(1992-1#1)(1992-3#5)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#5)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#2)(1996-1#5)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-7#1)(2006-10#3)(2006-5#1)(2007-11#6)(2007-12#8)(2007-2#6)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#27)(2008-11#19)(2008-12#7)(2008-2#19)(2008-3#25)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#22)(2008-8#18)(2008-9#9)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#20)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#13)(2012-3#16)(2013-1#12)(2013-7#1)(2013-8#12)
considerable activity##2##2##(1992-1#1)(1992-9#1)
considerable amount of##7##3##(1991-1#1)(1991-12#1)(1994-6#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)
considerable amount##8##2##(1991-1#1)(1991-12#1)(1994-6#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2012-3#1)
considerable amounts of##7##3##(1992-3#1)(2008-12#1)(2008-6#2)(2008-8#1)(2009-3#1)(2011-2#1)
considerable amounts##11##2##(1992-3#1)(2008-10#4)(2008-12#1)(2008-6#2)(2008-8#1)(2009-3#1)(2011-2#1)
considerable and##5##2##(1992-2#1)(1993-5#1)(2007-11#1)(2009-7#1)(2012-12#1)
considerable attention has been##2##4##(2008-10#1)(2009-3#1)
considerable attention##8##2##(1991-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2013-1#1)
considerable body of##2##3##(2008-9#1)(2010-10#1)
considerable challenges##2##2##(2008-11#1)(2010-5#1)
considerable change##5##2##(1995-8#1)(2008-10#3)(2008-11#1)
considerable changes##3##2##(1994-3#1)(2008-10#1)(2010-3#1)
considerable clinical##3##2##(1992-9#1)(2008-11#1)(2008-7#1)
considerable concern##3##2##(1995-1#1)(2008-11#1)(2009-4#1)
considerable consequences for##2##3##(2008-2#1)(2008-6#1)
considerable controversy regarding##2##3##(2008-6#1)(2008-7#1)
considerable controversy##3##2##(2008-6#1)(2008-7#1)(2009-12#1)
considerable damage##2##2##(1996-4#1)(2008-10#1)
considerable debate##2##2##(2008-7#1)(2009-10#1)
considerable decrease in the##3##4##(1993-3#1)(2008-6#2)
considerable decrease in##6##3##(1993-3#1)(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
considerable decrease##7##2##(1993-3#1)(1994-8#1)(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
considerable detail##3##2##(1995-1#1)(2008-9#1)(2011-2#1)
considerable difference##3##2##(2008-10#2)(2008-3#1)
considerable differences between##4##3##(1990-9#1)(1995-1#1)(1997-8#1)(2010-4#1)
considerable differences in##2##3##(1993-11#1)(2008-10#1)
considerable differences##8##2##(1990-9#1)(1993-11#1)(1995-1#1)(1997-8#1)(2008-10#2)(2008-7#1)(2010-4#1)
considerable effort##2##2##(2009-7#1)(2010-5#1)
considerable efforts##2##2##(2012-1#1)(2013-1#1)
considerable evidence that##4##3##(1996-5#1)(2008-5#1)(2008-9#1)(2009-10#1)
considerable experimental##2##2##(2008-3#1)(2008-7#1)
considerable financial##2##2##(1997-5#1)(2008-11#1)
considerable flexibility##3##2##(2008-7#1)(2008-9#1)(2010-1#1)
considerable genetic##3##2##(2008-10#3)
considerable heterogeneity##5##2##(1990-8#1)(1993-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
considerable homology##4##2##(1990-7#1)(1995-11#1)(1996-3#1)(2008-5#1)
considerable impact##4##2##(1993-6#1)(2008-6#1)(2008-9#1)(2012-5#1)
considerable improvement of the##2##4##(1990-9#1)(2008-10#1)
considerable improvement##5##2##(1990-11#1)(1990-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
considerable increase in##3##3##(2008-2#1)(2008-4#1)(2008-7#1)
considerable increase##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
considerable influence on##2##3##(1995-2#1)(2008-3#1)
considerable information##2##2##(2008-10#1)(2013-1#1)
considerable interest because of##2##4##(1993-1#1)(2008-3#1)
considerable interest in the##4##4##(1997-7#1)(2008-10#1)(2008-4#1)(2009-6#1)
considerable interest in##8##3##(1991-9#1)(1992-6#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)
considerable interest##19##2##(1991-9#1)(1992-6#1)(1993-1#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2011-2#1)(2012-2#1)
considerable international##2##2##(2008-10#1)(2008-8#1)
considerable morbidity and mortality##2##4##(2011-2#2)
considerable morbidity and##4##3##(2007-12#1)(2007-8#1)(2011-2#2)
considerable morbidity##8##2##(2007-12#2)(2007-8#1)(2008-7#1)(2011-2#3)(2012-3#1)
considerable number of##3##3##(1996-5#2)(2007-5#1)
considerable number##4##2##(1996-5#2)(2007-5#1)(2008-4#1)
considerable numbers##2##2##(1997-6#1)(2011-2#1)
considerable opportunity##2##2##(2008-11#1)(2013-1#1)
considerable overlap##2##2##(1994-12#1)(1997-8#1)
considerable percentage##2##2##(2008-10#1)(2013-1#1)
considerable potential for##3##3##(1996-2#1)(2007-1#1)(2007-11#1)
considerable potential##7##2##(1994-1#1)(1996-2#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
considerable power to##2##3##(2008-9#1)(2012-3#1)
considerable progress has been made in##2##6##(2008-11#1)(2008-5#1)
considerable progress has been made##3##5##(2008-11#1)(2008-3#1)(2008-5#1)
considerable progress##6##2##(2007-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
considerable promise for##2##3##(1991-2#1)(2008-10#1)
considerable promise##4##2##(1991-2#1)(1994-3#1)(2008-10#1)(2012-3#1)
considerable proportion of##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
considerable rate of##2##3##(1996-5#1)(2011-2#1)
considerable reduction in the##2##4##(1991-12#1)(1992-11#1)
considerable reduction in##8##3##(1991-12#1)(1992-11#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
considerable reduction of the##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
considerable reduction##11##2##(1991-12#1)(1991-2#1)(1992-11#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)
considerable research has##3##3##(1993-3#1)(1995-1#1)(2008-2#1)
considerable research##5##2##(1993-3#1)(1995-1#1)(1996-7#1)(2008-2#1)(2008-3#1)
considerable risk of##2##3##(1991-3#1)(2010-5#1)
considerable risk##3##2##(1991-3#1)(2010-5#1)(2012-2#1)
considerable savings##3##2##(1992-1#1)(2008-3#1)(2008-7#1)
considerable structural##2##2##(2008-10#1)(2008-11#1)
considerable success in##3##3##(1996-6#1)(2008-7#1)(2011-1#1)
considerable success##5##2##(1993-3#1)(1996-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
considerable support##2##2##(2007-11#1)(2008-8#1)
considerable time savings in##2##4##(1994-2#1)(2007-7#1)
considerable time##5##2##(1990-3#1)(1994-2#1)(1994-3#1)(1996-2#1)(2007-7#1)
considerable uncertainty##2##2##(1995-6#1)(2008-7#1)
considerable variability in##3##3##(1997-5#1)(2008-10#1)(2008-9#1)
considerable variability##4##2##(1997-5#1)(2007-10#1)(2008-10#1)(2008-9#1)
considerable variation in the##3##4##(1991-11#1)(1995-11#1)(2011-2#1)
considerable variation in##8##3##(1991-11#1)(1995-11#1)(1995-2#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
considerable variation##14##2##(1991-11#1)(1995-11#1)(1995-2#1)(1996-3#1)(2008-10#3)(2010-2#1)(2010-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
considerable variations##3##2##(2008-3#1)(2009-7#1)(2011-2#1)
considerable work##2##2##(2008-3#1)(2008-8#1)
considerable yield##2##2##(2008-10#2)
considerable##414##1##(1990-11#3)(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-6#3)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#4)(1995-2#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#65)(2008-11#20)(2008-12#3)(2008-2#8)(2008-3#18)(2008-4#9)(2008-5#10)(2008-6#8)(2008-7#21)(2008-8#9)(2008-9#13)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#3)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#5)(2010-9#1)(2011-1#3)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#9)(2012-5#1)(2013-1#14)(2013-8#2)
considerably affected the##2##3##(2008-10#2)
considerably among the##2##3##(2008-10#2)
considerably among##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
considerably and##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
considerably better##2##2##(1997-3#1)(2008-5#1)
considerably between the##2##3##(1992-3#1)(2013-1#1)
considerably between##4##2##(1992-3#1)(1992-6#1)(1997-1#1)(2013-1#1)
considerably changed##2##2##(1993-3#1)(2007-10#1)
considerably different between##3##3##(2008-10#1)(2008-7#2)
considerably different from the##2##4##(1994-12#1)(2008-3#1)
considerably different from##3##3##(1994-12#1)(2008-3#1)(2008-5#1)
considerably different##10##2##(1990-12#1)(1990-3#1)(1994-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)
considerably enhanced##2##2##(2008-10#1)(2010-11#1)
considerably enlarged##2##2##(2008-5#1)(2008-7#1)
considerably for##2##2##(1990-2#1)(2013-1#1)
considerably from##9##2##(1992-4#1)(1995-12#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-7#1)(2010-3#1)
considerably greater##3##2##(1994-1#1)(2008-10#1)(2008-7#1)
considerably higher concentrations##2##3##(1995-12#1)(1997-3#1)
considerably higher in##3##3##(1992-8#1)(1995-12#1)(2013-1#1)
considerably higher levels##2##3##(2009-10#1)(2012-12#1)
considerably higher than in other##2##5##(2011-1#1)(2011-2#1)
considerably higher than##4##3##(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
considerably higher##17##2##(1992-8#1)(1993-8#1)(1995-12#2)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
considerably improved the##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
considerably improved##5##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
considerably in the##3##3##(1991-12#1)(2008-12#1)(2008-7#1)
considerably in##14##2##(1991-12#1)(1991-3#1)(1994-2#1)(1996-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
considerably increased in##2##3##(2007-11#1)(2008-5#1)
considerably increased##5##2##(1993-11#1)(1994-11#1)(1994-8#1)(2007-11#1)(2008-5#1)
considerably less potent##2##3##(1992-6#1)(1994-11#1)
considerably less##12##2##(1991-12#1)(1991-2#1)(1992-6#1)(1994-11#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2010-10#1)(2011-2#1)
considerably limits##2##2##(2008-5#1)(2011-2#1)
considerably longer##3##2##(1991-2#1)(2007-6#1)(2012-12#1)
considerably lower in##2##3##(2007-11#1)(2008-10#1)
considerably lower than that of##3##5##(1991-8#1)(1997-5#1)(2009-7#1)
considerably lower than that##4##4##(1991-8#1)(1997-5#1)(2008-10#1)(2009-7#1)
considerably lower than##6##3##(1991-8#1)(1997-5#1)(2007-11#1)(2008-10#1)(2009-7#1)(2012-12#1)
considerably lower##16##2##(1990-6#1)(1991-8#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-11#2)(2008-10#4)(2008-8#1)(2009-7#1)(2012-12#2)(2013-1#1)
considerably more sensitive##2##3##(1992-12#1)(2008-2#1)
considerably more##12##2##(1992-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)(2012-3#1)
considerably over the past##2##4##(1997-1#1)(2011-2#1)
considerably over the##3##3##(1997-1#1)(1997-8#1)(2011-2#1)
considerably reduced by##2##3##(1993-2#1)(1994-3#1)
considerably reduced in the##2##4##(1992-3#1)(2008-10#1)
considerably reduced in##3##3##(1992-3#1)(2008-10#1)(2008-12#1)
considerably reduced##10##2##(1990-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-12#1)(2011-1#1)
considerably slower##2##2##(2008-10#1)(2008-11#1)
considerably smaller##3##2##(2008-10#2)(2008-2#1)
considerably the##2##2##(1990-3#1)(1996-2#1)
considerably to##4##2##(1991-5#1)(1996-2#1)(2008-10#1)(2008-7#1)
considerably with##2##2##(2011-1#1)(2011-2#1)
considerably##237##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#40)(2008-11#11)(2008-12#3)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)
consideration and##3##2##(1992-6#1)(2008-7#1)(2008-9#1)
consideration are##2##2##(2008-4#1)(2012-2#1)
consideration as##3##2##(1992-3#1)(2011-2#1)(2012-2#1)
consideration being given to##3##4##(1990-6#1)(1993-11#1)(2009-6#1)
consideration by the##3##3##(1994-12#1)(1995-12#1)(2008-11#1)
consideration for the##2##3##(1994-11#1)(2008-2#1)
consideration for##13##2##(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-6#2)(2011-2#2)
consideration given to##2##3##(1997-1#1)(2008-8#1)
consideration in the design and##2##5##(1991-1#1)(2013-8#1)
consideration in the##5##3##(1991-1#1)(1991-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
consideration in##15##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
consideration is being given to##2##5##(1992-3#1)(1993-1#1)
consideration is##4##2##(1992-3#1)(1992-9#1)(1993-1#1)(2013-8#1)
consideration must be##2##3##(1991-2#1)(2011-1#1)
consideration needs to be given to##2##6##(2008-5#1)(2011-1#1)
consideration of a##3##3##(1995-6#1)(1997-2#1)(2008-3#1)
consideration of clinical##2##3##(1992-9#1)(2013-1#1)
consideration of how##2##3##(1996-6#1)(2008-8#1)
consideration of other##2##3##(1993-2#1)(2011-2#1)
consideration of such##2##3##(2008-10#1)(2008-9#1)
consideration of the role of##2##5##(1993-3#1)(2008-9#1)
consideration of the##26##3##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
consideration of their##2##3##(1993-6#1)(2008-3#1)
consideration of this##2##3##(2008-7#1)(2009-9#1)
consideration of various##2##3##(1994-2#1)(1996-1#1)
consideration of##81##2##(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-6#3)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
consideration on##2##2##(1990-6#1)(2011-2#1)
consideration should be given to##4##5##(1992-11#1)(1996-12#1)(1997-2#1)(2011-1#1)
consideration to##4##2##(2007-11#1)(2008-10#1)(2008-6#1)(2012-2#1)
consideration when##8##2##(1993-2#1)(2008-10#2)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
consideration with##2##2##(2007-11#2)
consideration##224##1##(1990-12#3)(1990-6#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(2007-10#1)(2007-11#7)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#21)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#9)(2009-12#1)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#2)(2010-5#1)(2010-6#5)(2010-8#4)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
considerations about the##2##3##(2008-10#1)(2008-5#1)
considerations and clinical##2##3##(1993-11#1)(2011-7#1)
considerations and##15##2##(1990-11#1)(1993-11#1)(1995-1#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
considerations are##7##2##(1991-12#1)(1993-11#1)(1995-5#1)(1996-2#1)(2008-2#1)(2008-3#1)(2010-8#1)
considerations for the##7##3##(1992-3#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#2)
considerations for##37##2##(1992-12#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-3#1)(1994-5#1)(1995-9#1)(1997-4#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
considerations in the##10##3##(1991-2#1)(1991-6#1)(1992-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(2007-11#1)(2009-3#1)(2010-6#1)(2012-12#1)
considerations in##33##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1994-2#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
considerations involved in##2##3##(1993-1#1)(2008-7#1)
considerations may be##2##3##(2008-7#1)(2010-11#1)
considerations may##3##2##(2008-7#2)(2010-11#1)
considerations of##15##2##(1993-12#1)(1993-5#1)(1995-3#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2013-1#1)
considerations on##11##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-12#1)(1994-9#1)(1997-3#1)(2008-1#1)(2009-7#1)(2012-3#1)(2013-1#1)
considerations regarding the##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
considerations relating to##2##3##(1994-1#1)(1996-6#1)
considerations such as##2##3##(2008-10#1)(2009-12#1)
considerations that are##2##3##(2007-12#1)(2008-4#1)
considerations that led to the##2##5##(1995-12#1)(2008-3#1)
considerations that##8##2##(1992-3#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2013-1#1)
considerations to##5##2##(1991-6#1)(1997-1#1)(2008-11#1)(2010-8#1)(2011-1#1)
considerations when##4##2##(1993-12#1)(2007-12#1)(2008-2#1)(2012-12#1)
considerations will##2##2##(2008-10#1)(2010-8#1)
considerations##252##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-1#1)(1992-12#4)(1992-2#3)(1992-3#5)(1992-6#1)(1993-1#2)(1993-11#3)(1993-12#5)(1993-3#1)(1993-5#2)(1993-6#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#6)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#21)(2008-11#12)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#9)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#3)(2011-2#9)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#10)
considerations]##5##1##(1990-10#1)(1990-9#1)(1991-6#2)(2012-3#1)
considered &quot##2##2##(2008-4#1)(2010-7#1)
considered a contraindication##2##3##(2011-2#1)(2013-1#1)
considered a hallmark of##2##4##(2009-10#1)(2012-2#1)
considered a highly##2##3##(2008-7#1)(2009-6#1)
considered a major##9##3##(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
considered a model##2##3##(1996-12#1)(2008-6#1)
considered a potential##3##3##(1994-12#1)(2010-11#1)(2010-5#1)
considered a primary##3##3##(1990-10#1)(2007-7#1)(2008-2#1)
considered a priority##2##3##(2009-5#1)(2011-2#1)
considered a public health problem##2##5##(2008-11#1)(2013-1#1)
considered a rare event##2##4##(2007-7#1)(2008-1#1)
considered a rare##5##3##(2007-7#2)(2008-1#1)(2008-10#1)(2013-8#1)
considered a suitable##2##3##(1993-1#1)(1995-5#1)
considered a useful##2##3##(1991-12#1)(2007-12#1)
considered a valid##4##3##(1991-6#1)(2008-7#1)(2010-12#1)(2011-3#1)
considered a valuable##2##3##(2008-10#2)
considered a##116##2##(1990-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-12#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#4)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#3)
considered according to##2##3##(1992-8#1)(2008-12#1)
considered adequate##2##2##(1997-8#1)(2008-5#1)
considered an early##2##3##(2009-5#1)(2011-1#1)
considered an important##2##3##(2008-10#1)(2008-8#1)
considered an##30##2##(1990-6#1)(1991-12#1)(1993-3#2)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)
considered and analyzed##3##3##(1992-2#1)(2012-3#1)(2013-1#1)
considered and discussed##4##3##(2008-10#3)(2010-1#1)
considered and the##3##3##(2010-5#1)(2012-12#2)
considered and##23##2##(1992-2#1)(1992-3#1)(1997-1#1)(2007-10#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
considered appropriate for##2##3##(2008-6#1)(2010-12#1)
considered appropriate##4##2##(2008-6#1)(2010-12#3)
considered are##7##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-3#1)(2012-1#1)
considered as &quot##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
considered as a form of##2##5##(2008-9#1)(2011-1#1)
considered as a good##2##4##(1992-3#1)(2012-3#1)
considered as a marker of##2##5##(2011-2#1)(2013-1#1)
considered as a new##2##4##(1991-5#1)(2013-1#1)
considered as a potential##2##4##(2009-11#1)(2011-2#1)
considered as a promising##3##4##(2012-2#2)(2013-1#1)
considered as a##79##3##(1991-12#2)(1991-5#1)(1992-3#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
considered as an alternative to##3##5##(2008-10#1)(2011-2#2)
considered as an alternative##4##4##(1991-1#1)(2008-10#1)(2011-2#2)
considered as an important##4##4##(1996-8#1)(2008-11#1)(2008-4#1)(2010-6#1)
considered as an##20##3##(1991-1#1)(1991-2#1)(1992-9#1)(1994-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
considered as factors##2##3##(2008-10#2)
considered as having a##2##4##(2011-2#2)
considered as having##3##3##(1997-2#1)(2011-2#2)
considered as one of the##2##5##(2008-8#1)(2011-1#1)
considered as one##4##3##(2008-12#1)(2008-8#1)(2010-8#1)(2011-1#1)
considered as part of the##2##5##(1994-12#1)(1994-6#1)
considered as possible##2##3##(1992-9#1)(2008-11#1)
considered as the first step##2##5##(2008-10#1)(2012-2#1)
considered as the first##3##4##(1996-7#1)(2008-10#1)(2012-2#1)
considered as the gold standard##2##5##(2008-12#1)(2012-2#1)
considered as the main##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
considered as the##16##3##(1996-7#1)(1997-8#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2012-2#2)
considered as well##2##3##(2008-3#1)(2012-2#1)
considered as##219##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#2)(2007-8#3)(2008-1#3)(2008-10#39)(2008-11#5)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#8)(2008-7#9)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#7)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#3)
considered at the##2##3##(1996-1#1)(2012-6#1)
considered at##7##2##(1990-5#1)(1996-1#1)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2012-6#1)
considered beneficial##2##2##(2008-7#1)(2010-1#1)
considered by introducing##2##3##(2007-11#1)(2011-2#1)
considered by some##3##3##(1995-3#1)(1997-3#1)(2008-7#1)
considered by the##3##3##(1992-6#1)(2012-2#1)(2013-1#1)
considered by##20##2##(1992-6#1)(1993-11#2)(1993-12#1)(1994-1#1)(1995-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2011-2#2)(2012-2#1)(2013-1#1)
considered clinically##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
considered critical##2##2##(2008-9#1)(2012-2#1)
considered distinct##2##2##(2008-10#2)
considered effective##2##2##(2007-11#1)(2008-5#1)
considered essential in##2##3##(2008-5#1)(2008-8#1)
considered essential##5##2##(1992-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2013-1#1)
considered ethically##2##2##(2011-2#2)
considered for a##6##3##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
considered for comparison##2##3##(2008-10#2)
considered for the##8##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-7#1)
considered for this##2##3##(2008-10#1)(2008-2#1)
considered for use in##2##4##(1997-1#1)(2011-2#1)
considered for##57##2##(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
considered if##9##2##(1992-5#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)
considered important##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
considered in all##2##3##(2008-10#1)(2012-12#1)
considered in an##2##3##(2007-12#1)(2008-10#1)
considered in designing##3##3##(1997-4#1)(2008-2#1)(2008-3#1)
considered in detail##3##3##(2007-4#1)(2008-10#1)(2008-3#1)
considered in each##2##3##(2010-8#1)(2013-1#1)
considered in order to##3##4##(1992-9#1)(2008-10#2)
considered in relation to##5##4##(1991-9#1)(2007-12#1)(2008-10#2)(2012-12#1)
considered in terms of##4##4##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
considered in the development of##2##5##(2012-2#1)(2012-3#1)
considered in the differential diagnosis of a##2##7##(1992-2#1)(2010-12#1)
considered in the differential diagnosis of##15##6##(1992-2#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)
considered in the differential diagnosis##18##5##(1992-2#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
considered in the framework of##2##5##(1997-7#1)(2008-3#1)
considered in the light of##3##5##(1993-3#1)(1996-3#1)(2008-7#1)
considered in the##51##3##(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-5#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-3#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
considered in this study##3##4##(2008-10#2)(2008-5#1)
considered in this##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
considered in##147##2##(1990-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-6#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#7)(2013-8#3)
considered inoperable##3##2##(1994-11#1)(2007-10#1)(2010-3#1)
considered it##5##2##(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-1#1)
considered metal ions in##4##4##(2008-10#4)
considered more##6##2##(1990-6#1)(1992-1#1)(1993-12#1)(2008-11#1)(2009-4#1)(2009-6#1)
considered necessary to##2##3##(1991-6#1)(2008-5#1)
considered necessary##4##2##(1991-12#1)(1991-6#1)(2008-5#1)(2013-1#1)
considered negligible##2##2##(2008-10#1)(2008-5#1)
considered normal##5##2##(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-2#1)
considered of##4##2##(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
considered on the basis of##2##5##(1992-5#1)(2008-10#1)
considered on the##3##3##(1992-5#1)(2008-10#1)(2008-5#1)
considered one of the##6##4##(1997-4#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
considered one##7##2##(1997-4#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
considered only##5##2##(1990-6#1)(1990-9#1)(2008-10#1)(2011-2#1)(2012-4#1)
considered poor candidates for##2##4##(1991-3#1)(2007-7#1)
considered poor##3##2##(1991-3#1)(2007-7#1)(2012-12#1)
considered potential##3##2##(1992-11#1)(2009-10#1)(2011-1#1)
considered previously##3##2##(2008-3#1)(2008-7#1)(2009-2#1)
considered rare##3##2##(1991-2#1)(2008-1#1)(2008-4#1)
considered regarding##2##2##(2008-8#1)(2011-2#1)
considered relevant##2##2##(1993-2#1)(2008-5#1)
considered representative##2##2##(1990-11#1)(2011-2#1)
considered risk factors##2##3##(1991-4#1)(2011-2#1)
considered safe for##2##3##(1991-12#1)(1992-11#1)
considered safe##6##2##(1991-12#1)(1992-11#1)(2010-12#2)(2013-1#2)
considered significant##7##2##(1995-1#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
considered suitable for making##2##4##(1992-2#1)(2008-10#1)
considered suitable for##3##3##(1992-2#1)(2008-10#1)(2013-8#1)
considered that a##2##3##(1992-4#1)(2012-1#1)
considered that the##11##3##(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#2)
considered that##23##2##(1992-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
considered the gold standard for##2##5##(2008-4#1)(2011-2#1)
considered the gold standard in##2##5##(2008-1#1)(2011-2#1)
considered the gold standard##4##4##(2008-1#1)(2008-4#1)(2011-2#2)
considered the gold##5##3##(2008-1#1)(2008-4#1)(2010-1#1)(2011-2#2)
considered the main##2##3##(2008-1#1)(2008-10#1)
considered the most important##3##4##(2008-10#2)(2008-5#1)
considered the most##7##3##(1993-12#2)(2008-10#3)(2008-5#1)(2012-2#1)
considered the treatment of choice##2##5##(2008-2#1)(2013-1#1)
considered the##51##2##(1991-2#1)(1992-11#1)(1992-2#1)(1993-12#2)(1994-3#1)(1997-1#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2010-1#2)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
considered their##2##2##(2007-8#1)(2013-7#1)
considered themselves##2##2##(2007-7#1)(2013-7#1)
considered to arise##2##3##(2008-10#1)(2011-1#1)
considered to be &quot##2##4##(2010-8#1)(2011-2#1)
considered to be a##31##4##(1990-11#1)(1990-12#1)(1990-7#1)(1994-6#1)(1995-11#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
considered to be at##3##4##(1990-5#2)(2012-12#1)
considered to be caused by##2##5##(2008-11#1)(2011-2#1)
considered to be clinically##2##4##(1990-10#1)(2006-10#1)
considered to be derived from##2##5##(1995-8#1)(2012-2#1)
considered to be due to##6##5##(1991-12#2)(1995-3#1)(2008-10#1)(2008-7#2)
considered to be highly##2##4##(2008-1#1)(2011-2#1)
considered to be important for##2##5##(1994-8#1)(2008-11#1)
considered to be important##4##4##(1994-8#1)(1995-6#1)(2008-11#1)(2013-8#1)
considered to be involved##2##4##(2007-10#1)(2008-11#1)
considered to be more##2##4##(1997-3#1)(2011-2#1)
considered to be one of the##3##6##(2008-8#1)(2012-12#1)(2013-8#1)
considered to be present##2##4##(1991-11#1)(2010-3#1)
considered to be related to##3##5##(1996-10#1)(2008-9#1)(2012-3#1)
considered to be the main##2##5##(1996-8#1)(2008-5#1)
considered to be the most##3##5##(1994-6#1)(2007-10#1)(2008-7#1)
considered to be the##16##4##(1994-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-7#1)
considered to be unique##2##4##(2008-10#1)(2013-8#1)
considered to be very##3##4##(1992-11#1)(1994-9#1)(2008-11#1)
considered to be##146##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#2)(2006-10#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#10)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#7)
considered to belong to##2##4##(2008-10#2)
considered to form##2##3##(2008-10#1)(2012-2#1)
considered to have a##3##4##(1996-9#1)(2008-4#1)(2009-2#1)
considered to have##14##3##(1993-2#1)(1995-11#1)(1996-12#1)(1996-9#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-3#1)(2010-3#1)(2013-1#2)
considered to play a##2##4##(2008-7#1)(2011-2#1)
considered to play an important role in##2##7##(1996-12#1)(2010-8#1)
considered to play##5##3##(1996-12#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
considered to represent##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
considered to result from##3##4##(1994-11#1)(2008-10#1)(2008-7#1)
considered to##205##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#18)(2008-11#15)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#13)(2008-8#3)(2008-9#3)(2009-2#3)(2009-3#2)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#7)
considered together with##2##3##(2011-2#2)
considered together##4##2##(2008-6#1)(2011-10#1)(2011-2#2)
considered too##2##2##(1992-6#1)(2009-6#1)
considered under##2##2##(1992-6#1)(2012-12#1)
considered universal##2##2##(1991-6#1)(2011-1#1)
considered unsuitable for##2##3##(2008-9#1)(2011-2#1)
considered useful as a##2##4##(1990-6#2)
considered useful##4##2##(1990-6#2)(1997-1#1)(2008-5#1)
considered valid##2##2##(2008-8#1)(2013-1#1)
considered very##2##2##(1992-2#1)(2008-10#1)
considered were##4##2##(1996-9#1)(2008-10#2)(2011-2#1)
considered when designing##4##3##(1996-3#1)(1997-3#1)(2008-9#1)(2011-1#1)
considered when##39##2##(1992-4#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-5#1)(1995-1#2)(1996-3#1)(1997-3#1)(1997-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#2)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
considered with##6##2##(1993-1#1)(1994-11#1)(2008-10#2)(2008-3#1)(2009-10#1)
considered##1621##1##(1990-10#2)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#8)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#10)(1991-8#5)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#6)(1992-12#6)(1992-2#8)(1992-3#5)(1992-4#2)(1992-5#8)(1992-6#5)(1992-8#3)(1992-9#6)(1993-1#4)(1993-10#1)(1993-11#7)(1993-12#8)(1993-2#6)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#11)(1994-12#3)(1994-2#4)(1994-3#9)(1994-5#3)(1994-6#6)(1994-8#4)(1994-9#11)(1995-1#5)(1995-11#3)(1995-12#7)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#4)(1997-2#6)(1997-3#12)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#8)(2006-10#8)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#14)(2007-11#21)(2007-12#23)(2007-2#7)(2007-4#2)(2007-6#1)(2007-7#15)(2007-8#16)(2007-9#1)(2008-1#24)(2008-10#241)(2008-11#50)(2008-12#34)(2008-2#36)(2008-3#90)(2008-4#28)(2008-5#46)(2008-6#11)(2008-7#66)(2008-8#30)(2008-9#28)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#7)(2009-3#12)(2009-4#8)(2009-5#6)(2009-6#7)(2009-7#7)(2009-8#11)(2009-9#2)(2010-1#7)(2010-10#5)(2010-11#9)(2010-12#18)(2010-2#5)(2010-3#11)(2010-4#7)(2010-5#5)(2010-6#4)(2010-7#5)(2010-8#13)(2010-9#2)(2011-1#25)(2011-10#1)(2011-2#107)(2011-3#2)(2012-1#6)(2012-12#24)(2012-2#29)(2012-3#31)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#57)(2013-7#7)(2013-8#32)
considering a##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
considering all##2##2##(1990-12#1)(1991-12#1)
considering both##5##2##(2007-8#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-7#1)
considering developing##2##2##(1996-1#1)(2010-4#1)
considering differences##2##2##(2008-10#1)(2010-8#1)
considering how the##2##3##(2008-10#1)(2008-3#1)
considering its##3##2##(1994-12#1)(2009-6#1)(2012-3#1)
considering multiple##2##2##(2008-2#1)(2008-3#1)
considering only##2##2##(1997-6#1)(2008-9#1)
considering other##2##2##(1994-12#1)(2013-1#1)
considering some##2##2##(2008-10#1)(2008-8#1)
considering that the##3##3##(1993-9#1)(2008-10#1)(2011-2#1)
considering that##9##2##(1991-4#1)(1993-9#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#3)
considering the complexity of the##2##5##(2008-10#2)
considering the complexity of##3##4##(2008-10#2)(2009-11#1)
considering the different##2##3##(2008-10#1)(2010-11#1)
considering the effect of##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
considering the high##2##3##(1990-2#1)(2008-3#1)
considering the impact of##2##4##(2008-4#1)(2011-1#1)
considering the##69##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#3)(2013-7#3)(2013-8#1)
considering their##5##2##(1997-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)
considering them##2##2##(1995-5#1)(2013-8#1)
considering##211##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#13)(2013-7#5)(2013-8#3)
considers a##3##2##(1995-9#1)(2008-10#1)(2008-7#1)
considers how##2##2##(2007-8#1)(2008-11#1)
considers some of the current##2##5##(2008-11#1)(2009-4#1)
considers some of the##4##4##(2008-11#2)(2009-4#1)(2009-7#1)
considers that##4##2##(2008-10#3)(2013-8#1)
considers the issues##2##3##(2008-12#1)(2008-9#1)
considers the use of##2##4##(1997-3#1)(2008-10#1)
considers the##35##2##(1990-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
considers their##3##2##(2008-7#2)(2009-10#1)
considers whether##3##2##(2008-12#1)(2010-2#1)(2011-2#1)
considers##90##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#13)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#5)(2013-8#3)
consist in##5##2##(1990-2#1)(1990-6#1)(1995-5#1)(2007-5#1)(2008-3#1)
consist of a##18##3##(1992-3#1)(1993-12#1)(1993-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)
consist of an##2##3##(2008-3#1)(2008-5#1)
consist of multiple##2##3##(1994-9#1)(2012-3#1)
consist of one##3##3##(1993-2#1)(1996-2#1)(2008-7#1)
consist of several##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
consist of the##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
consist of three##2##3##(2008-2#1)(2008-3#1)
consist of two##10##3##(1990-8#1)(1991-10#1)(1992-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-7#1)
consist of##111##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#2)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(2007-11#5)(2007-12#4)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#22)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
consist##119##1##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(2007-11#5)(2007-12#4)(2007-5#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#23)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
consisted either of##3##3##(1990-3#1)(1991-12#1)(2008-10#1)
consisted in##7##2##(1991-10#1)(1993-5#1)(2007-8#2)(2008-10#1)(2008-7#1)(2011-1#1)
consisted mainly of##5##3##(1993-8#1)(1997-6#1)(2008-11#2)(2008-3#1)
consisted of 1##3##3##(1991-12#1)(2008-10#1)(2010-1#1)
consisted of 10##2##3##(2008-10#1)(2013-1#1)
consisted of 102##2##3##(1996-9#1)(2007-8#1)
consisted of 119##2##3##(1995-6#1)(2013-8#1)
consisted of 16##3##3##(1992-3#1)(1994-7#1)(2008-5#1)
consisted of 2##3##3##(1990-2#1)(2008-10#1)(2010-1#1)
consisted of 20 ascosporic isolates##2##5##(2008-10#2)
consisted of 20##3##3##(2008-10#2)(2012-3#1)
consisted of 3##3##3##(2008-9#1)(2010-1#1)(2013-8#1)
consisted of 30##3##3##(1995-1#1)(2007-8#2)
consisted of 34##2##3##(2011-2#2)
consisted of 35##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
consisted of 4##2##3##(2008-8#1)(2013-8#1)
consisted of 40##2##3##(2013-1#2)
consisted of 5##2##3##(1991-2#1)(1994-6#1)
consisted of 50##2##3##(1991-2#1)(1995-11#1)
consisted of 53 patients##2##4##(1994-3#1)(2011-2#1)
consisted of 53##3##3##(1994-3#1)(2011-2#1)(2012-2#1)
consisted of 60##2##3##(1991-2#1)(2013-1#1)
consisted of 8##4##3##(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)
consisted of a clinical##2##4##(2008-9#1)(2012-12#1)
consisted of a highly##2##4##(2007-11#1)(2008-10#1)
consisted of a mixture of##3##5##(1995-2#1)(2008-10#2)
consisted of a##38##3##(1991-5#1)(1992-11#1)(1992-3#1)(1995-2#1)(1996-7#1)(1997-2#1)(1997-8#1)(2007-11#2)(2008-10#12)(2008-2#1)(2008-3#1)(2008-7#6)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#1)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
consisted of an##11##3##(1990-2#1)(1992-3#1)(1993-3#1)(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-3#1)
consisted of early##2##3##(2008-12#1)(2008-5#1)
consisted of fathers who##2##4##(2010-3#2)
consisted of five##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
consisted of only one##2##4##(2008-10#2)
consisted of oral##2##3##(1997-5#1)(2009-4#1)
consisted of recording##2##3##(2007-6#1)(2008-12#1)
consisted of secretory##2##3##(1990-12#1)(2012-1#1)
consisted of the##7##3##(1991-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
consisted of three##10##3##(1990-3#1)(1991-2#1)(1993-12#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
consisted of two##15##3##(1990-8#3)(1993-12#1)(1994-6#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)
consisted of various##2##3##(1993-9#1)(2008-12#1)
consisted of##322##2##(1990-12#1)(1990-2#4)(1990-3#4)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#5)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#3)(1994-7#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#5)(2007-6#2)(2007-7#2)(2007-8#13)(2007-9#1)(2008-1#2)(2008-10#55)(2008-11#7)(2008-12#13)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#18)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#4)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-8#6)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#12)(2013-8#6)
consisted on##2##2##(2007-8#1)(2013-7#1)
consisted##346##1##(1990-12#1)(1990-2#4)(1990-3#5)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#5)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#3)(1994-7#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#5)(2007-6#2)(2007-7#2)(2007-8#16)(2007-9#1)(2008-1#2)(2008-10#61)(2008-11#9)(2008-12#13)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#19)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#4)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-8#6)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#6)
consistence##2##1##(2008-10#1)(2008-9#1)
consistency across##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
consistency and accuracy##2##3##(2008-11#1)(2011-2#1)
consistency and##16##2##(1992-3#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
consistency as##3##2##(2008-10#1)(2013-1#2)
consistency coefficient##2##2##(2011-2#2)
consistency in the##2##3##(2008-11#1)(2008-2#1)
consistency in##11##2##(1992-3#1)(1993-2#1)(1995-6#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-2#1)(2010-1#1)(2011-2#1)
consistency of the##10##3##(1992-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-11#1)(2010-3#1)
consistency of##20##2##(1992-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
consistency was observed##2##3##(2009-2#1)(2010-4#1)
consistency was##4##2##(1996-12#2)(2009-2#1)(2010-4#1)
consistency with the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
consistency with##7##2##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
consistency##116##1##(1992-3#2)(1992-9#2)(1993-2#1)(1994-2#1)(1995-12#1)(1995-5#4)(1995-6#2)(1996-12#2)(1996-3#3)(1996-7#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#14)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-6#1)(2010-1#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#13)(2013-8#2)
consistent across##7##2##(1993-9#1)(2008-10#2)(2009-2#1)(2009-7#1)(2011-1#1)(2013-8#1)
consistent among##4##2##(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
consistent and reliable##2##3##(2008-10#2)
consistent and##18##2##(1990-12#1)(1990-8#1)(1996-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
consistent approach to##3##3##(1993-3#1)(1995-3#1)(2008-6#1)
consistent association##2##2##(1990-12#1)(2008-10#1)
consistent associations##3##2##(1993-9#1)(2009-7#1)(2011-1#1)
consistent between##4##2##(2007-10#1)(2008-10#3)
consistent definition of##2##3##(2008-9#1)(2011-2#1)
consistent differences in##2##3##(1991-5#1)(1991-8#1)
consistent differences##6##2##(1991-5#1)(1991-8#1)(2008-6#1)(2009-11#1)(2009-4#1)(2011-2#1)
consistent effect##2##2##(2008-10#1)(2008-2#1)
consistent effects##3##2##(1995-12#1)(2008-10#2)
consistent evidence##4##2##(2008-6#1)(2008-8#1)(2010-10#1)(2012-12#1)
consistent findings##2##2##(2012-1#1)(2012-12#1)
consistent for##4##2##(1990-2#1)(1996-7#1)(2007-12#1)(2010-8#1)
consistent force##2##2##(2007-11#1)(2008-10#1)
consistent gradient##2##2##(2008-2#2)
consistent improvement##2##2##(2008-7#1)(2012-2#1)
consistent in##7##2##(1993-8#1)(2008-10#4)(2008-11#1)(2010-12#1)
consistent levels of##2##3##(2008-10#1)(2008-8#1)
consistent or##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
consistent over##2##2##(2008-10#1)(2011-2#1)
consistent pattern of##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
consistent pattern##6##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#1)(2012-2#1)
consistent performance##2##2##(2008-3#1)(2008-5#1)
consistent protective effect##2##3##(1994-2#2)
consistent results were##2##3##(1990-3#1)(2010-5#1)
consistent results##7##2##(1990-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)
consistent solution##2##2##(2008-2#1)(2008-8#1)
consistent use of##3##3##(2008-4#1)(2008-7#1)(2010-3#1)
consistent use##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
consistent with Elsevier Policy on Article Withdrawal (http##3##8##(2008-10#1)(2008-11#2)
consistent with Elsevier Policy on Article Withdrawal##5##7##(2008-10#1)(2008-11#4)
consistent with a 1##2##4##(2008-10#2)
consistent with a diagnosis of##4##5##(1991-8#1)(1997-8#1)(2008-11#1)(2011-1#1)
consistent with a direct##2##4##(1994-11#1)(1996-5#1)
consistent with a model for##2##5##(2007-1#1)(2008-5#1)
consistent with a model in which the##2##7##(1993-11#1)(2008-10#1)
consistent with a model in which##4##6##(1990-2#1)(1992-2#1)(1993-11#1)(2008-10#1)
consistent with a model where##2##5##(1995-2#1)(2009-12#1)
consistent with a model##9##4##(1990-2#1)(1992-2#1)(1992-6#1)(1993-11#1)(1995-2#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-12#1)
consistent with a role for##3##5##(1990-3#1)(1993-12#1)(1996-12#1)
consistent with a role in##3##5##(2009-10#1)(2010-10#1)(2012-3#1)
consistent with a role##6##4##(1990-3#1)(1993-12#1)(1996-12#1)(2009-10#1)(2010-10#1)(2012-3#1)
consistent with a scenario of##2##5##(2008-10#2)
consistent with a single##3##4##(1993-11#1)(1995-6#1)(1996-2#1)
consistent with a##78##3##(1990-2#3)(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
consistent with an inflammatory response related to the dermatitis observed histopathologically##4##11##(2008-9#4)
consistent with an##17##3##(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#5)(2012-3#1)(2013-1#1)
consistent with both##2##3##(2008-10#1)(2008-11#1)
consistent with current##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
consistent with data##4##3##(1995-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
consistent with earlier##3##3##(1992-10#1)(2008-10#2)
consistent with experimental results##2##4##(2013-1#2)
consistent with experimental##4##3##(2008-12#1)(2010-10#1)(2013-1#2)
consistent with in##2##3##(1995-5#1)(2013-1#1)
consistent with inflammatory##2##3##(2007-7#1)(2012-12#1)
consistent with molecular##2##3##(1992-4#1)(1995-5#1)
consistent with neuronal##2##3##(1991-8#1)(1995-11#1)
consistent with observed##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
consistent with one another##2##4##(2008-2#1)(2008-7#1)
consistent with one##3##3##(1994-5#1)(2008-2#1)(2008-7#1)
consistent with other studies##3##4##(1997-9#1)(2008-12#1)(2008-5#1)
consistent with other##6##3##(1991-6#1)(1996-12#1)(1997-9#1)(2008-12#1)(2008-5#1)(2008-6#1)
consistent with our hypothesis that##2##5##(1991-12#1)(1995-11#1)
consistent with our hypothesis##3##4##(1991-12#1)(1992-3#1)(1995-11#1)
consistent with our previous##2##4##(1996-2#1)(2008-2#1)
consistent with our##7##3##(1991-12#1)(1992-3#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
consistent with predictions##2##3##(1997-5#1)(2008-8#1)
consistent with previous experimental observations##2##5##(2008-3#1)(2009-9#1)
consistent with previous findings##4##4##(1994-8#1)(2008-6#1)(2008-7#1)(2011-2#1)
consistent with previous studies##2##4##(1997-5#1)(2011-2#1)
consistent with previous##18##3##(1991-8#1)(1992-9#1)(1994-8#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
consistent with previously published##3##4##(2007-12#1)(2008-7#1)(2010-2#1)
consistent with previously reported results##2##5##(2008-10#1)(2012-2#1)
consistent with previously reported##4##4##(2008-10#2)(2008-4#1)(2012-2#1)
consistent with previously##7##3##(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
consistent with random mating##3##4##(2008-10#3)
consistent with recent##3##3##(1990-5#1)(1995-11#1)(2008-9#1)
consistent with recently##2##3##(1996-4#1)(2012-3#1)
consistent with reduced##2##3##(1996-12#1)(2009-10#1)
consistent with results from##2##4##(2008-11#1)(2012-3#1)
consistent with results##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
consistent with strong##2##3##(1997-7#1)(2008-8#1)
consistent with that of the##3##5##(1990-5#1)(1995-12#1)(1995-6#1)
consistent with that of##6##4##(1990-5#1)(1995-12#1)(1995-6#1)(2008-10#3)
consistent with that##9##3##(1990-5#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#4)
consistent with the conclusion that##3##5##(1991-12#1)(1993-3#1)(1996-5#1)
consistent with the definition of##2##5##(2008-10#1)(2013-8#1)
consistent with the distribution of##2##5##(1991-9#1)(2008-8#1)
consistent with the expected##3##4##(1992-3#1)(1997-5#1)(2013-8#1)
consistent with the experimental##2##4##(1995-6#1)(1996-5#1)
consistent with the formation of a##2##6##(1990-5#1)(2007-12#1)
consistent with the formation of the##2##6##(1997-7#1)(2008-5#1)
consistent with the formation of##6##5##(1990-5#1)(1993-11#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-5#1)
consistent with the hypotheses that the##2##6##(1994-3#1)(2008-10#1)
consistent with the hypothesis of a##3##6##(2008-10#2)(2009-10#1)
consistent with the hypothesis of##6##5##(2008-10#4)(2009-10#1)(2013-8#1)
consistent with the hypothesis that the##7##6##(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2012-1#1)
consistent with the hypothesis that##27##5##(1990-7#1)(1992-12#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-2#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#3)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
consistent with the hypothesis##33##4##(1990-7#1)(1992-12#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-2#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
consistent with the idea that the##2##6##(1990-10#1)(2009-10#1)
consistent with the idea that##6##5##(1990-10#1)(1990-11#1)(1991-9#1)(1995-3#1)(2008-10#1)(2009-10#1)
consistent with the idea##7##4##(1990-10#1)(1990-11#1)(1991-9#1)(1995-3#1)(2008-10#2)(2009-10#1)
consistent with the known##3##4##(1993-9#1)(1994-12#1)(1995-3#1)
consistent with the limited##2##4##(2008-8#1)(2009-8#1)
consistent with the model##4##4##(1991-1#1)(2008-2#1)(2012-3#1)(2013-8#1)
consistent with the notion that the##2##6##(1990-8#1)(1992-3#1)
consistent with the notion that##6##5##(1990-8#1)(1991-2#1)(1992-3#1)(2007-8#1)(2009-5#1)(2011-2#1)
consistent with the observed##2##4##(2008-10#1)(2008-8#1)
consistent with the occurrence of##2##5##(1991-10#1)(2007-12#1)
consistent with the overall##2##4##(1996-4#1)(2008-7#1)
consistent with the phenomenon of##2##5##(2011-2#1)(2013-1#1)
consistent with the possibility##2##4##(1995-2#1)(1997-8#1)
consistent with the prediction##2##4##(1993-12#2)
consistent with the presence of##3##5##(1993-1#1)(2007-9#1)(2008-5#1)
consistent with the previous##3##4##(1991-12#1)(2008-5#1)(2013-8#1)
consistent with the previously reported##2##5##(2008-2#1)(2010-5#1)
consistent with the previously##3##4##(1994-3#1)(2008-2#1)(2010-5#1)
consistent with the proposed##2##4##(1993-9#1)(2008-10#1)
consistent with the reference##2##4##(2008-10#2)
consistent with the reported##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
consistent with the results of Western blotting##2##7##(2008-9#2)
consistent with the results of##4##5##(2007-12#1)(2008-9#2)(2012-1#1)
consistent with the results##5##4##(1990-7#1)(2007-12#1)(2008-9#2)(2012-1#1)
consistent with the theoretical##4##4##(2008-2#1)(2008-3#2)(2008-7#1)
consistent with the##245##3##(1990-10#1)(1990-11#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#7)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#7)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#3)(1996-12#2)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#14)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#8)
consistent with their##6##3##(1993-11#1)(1997-7#1)(2007-12#1)(2008-7#1)(2009-10#1)(2012-3#1)
consistent with theoretical predictions##3##4##(2007-12#1)(2008-7#1)(2012-3#1)
consistent with theoretical##6##3##(2007-11#2)(2007-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
consistent with these##3##3##(2008-10#2)(2012-3#1)
consistent with this hypothesis##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
consistent with this##8##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)
consistent with those of previous##2##5##(2008-2#1)(2008-3#1)
consistent with those of##9##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-8#1)
consistent with those##21##3##(1990-9#1)(1991-11#1)(1993-3#1)(1994-5#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-8#1)
consistent with variations in the##2##5##(2008-9#1)(2011-2#1)
consistent with what##3##3##(2007-12#1)(2008-12#1)(2008-7#1)
consistent with##680##2##(1990-10#1)(1990-11#3)(1990-2#3)(1990-3#3)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#7)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#11)(1992-4#1)(1992-6#6)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#11)(1993-12#11)(1993-3#4)(1993-6#2)(1993-8#6)(1993-9#5)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#6)(1994-6#2)(1994-8#5)(1994-9#2)(1995-11#4)(1995-12#6)(1995-2#12)(1995-3#3)(1995-5#7)(1995-6#7)(1995-8#1)(1996-12#7)(1996-2#3)(1996-4#2)(1996-5#5)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-5#5)(1997-6#2)(1997-7#10)(1997-8#3)(1997-9#2)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#15)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#106)(2008-11#24)(2008-12#5)(2008-2#17)(2008-3#24)(2008-4#7)(2008-5#14)(2008-6#7)(2008-7#19)(2008-8#23)(2008-9#20)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#5)(2010-10#3)(2010-11#6)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#6)(2011-2#15)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#15)(2013-1#18)(2013-8#11)
consistent##941##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#5)(1990-5#7)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-8#8)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#12)(1992-4#1)(1992-6#6)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#12)(1993-12#11)(1993-3#5)(1993-6#2)(1993-8#7)(1993-9#8)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#7)(1994-5#6)(1994-6#2)(1994-8#6)(1994-9#2)(1995-11#4)(1995-12#7)(1995-2#12)(1995-3#7)(1995-5#8)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#7)(1996-2#4)(1996-4#3)(1996-5#6)(1996-7#3)(1997-1#1)(1997-2#5)(1997-3#9)(1997-4#5)(1997-5#5)(1997-6#2)(1997-7#10)(1997-8#4)(1997-9#2)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#17)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#160)(2008-11#37)(2008-12#7)(2008-2#23)(2008-3#29)(2008-4#11)(2008-5#20)(2008-6#15)(2008-7#27)(2008-8#28)(2008-9#28)(2009-1#1)(2009-10#7)(2009-11#4)(2009-12#4)(2009-2#3)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#5)(2010-11#8)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#11)(2011-2#25)(2012-1#5)(2012-12#8)(2012-2#12)(2012-3#20)(2013-1#26)(2013-8#15)
consistently accurate##2##2##(2008-2#1)(2013-1#1)
consistently and significantly##3##3##(1997-2#1)(2008-10#2)
consistently and##6##2##(1997-2#1)(2008-10#4)(2010-10#1)
consistently associated with##7##3##(2008-10#3)(2012-12#2)(2013-1#1)(2013-7#1)
consistently associated##8##2##(1994-3#1)(2008-10#3)(2012-12#2)(2013-1#1)(2013-7#1)
consistently been##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
consistently demonstrate##2##2##(2008-12#1)(2012-3#1)
consistently demonstrated##3##2##(1996-12#1)(2008-3#1)(2011-2#1)
consistently detected##6##2##(2008-10#4)(2008-9#1)(2012-3#1)
consistently different##2##2##(2008-10#2)
consistently during##2##2##(2008-7#2)
consistently good##2##2##(2008-10#1)(2008-12#1)
consistently greater##3##2##(1995-12#1)(2008-10#2)
consistently has##2##2##(2008-11#1)(2008-12#1)
consistently high##3##2##(2008-12#1)(2008-2#1)(2008-5#1)
consistently higher than##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
consistently higher##10##2##(1991-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#2)
consistently identified##3##2##(2008-10#2)(2009-7#1)
consistently in##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2012-3#1)
consistently increased##3##2##(2008-10#3)
consistently isolated from##4##3##(1997-6#1)(2008-10#3)
consistently larger than##2##3##(1995-11#1)(2013-7#1)
consistently larger##3##2##(1995-11#1)(2008-3#1)(2013-7#1)
consistently less than##2##3##(2008-10#1)(2012-2#1)
consistently look##2##2##(2010-10#2)
consistently more##4##2##(2008-10#1)(2008-12#1)(2008-6#1)(2009-9#1)
consistently observed in##4##3##(1995-5#1)(2008-10#2)(2010-3#1)
consistently observed##7##2##(1995-5#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
consistently predicted to##2##3##(1990-5#2)
consistently present##3##2##(2008-10#3)
consistently produced##4##2##(1990-12#1)(2008-10#2)(2012-12#1)
consistently reduced##4##2##(2008-10#3)(2008-11#1)
consistently reported##5##2##(2008-6#1)(2009-2#1)(2012-12#2)(2012-3#1)
consistently shorter than##3##3##(2008-5#1)(2010-2#2)
consistently show that the##2##4##(2008-2#1)(2008-3#1)
consistently show##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
consistently suppress##4##2##(2008-10#4)
consistently suppressed##2##2##(2008-10#2)
consistently understood##2##2##(1993-2#2)
consistently with##3##2##(1992-6#1)(2008-10#2)
consistently##237##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#4)(1997-6#2)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#83)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#8)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#9)(2013-1#4)(2013-7#2)(2013-8#1)
consisting almost completely of##2##4##(1997-6#1)(2008-5#1)
consisting almost##3##2##(1997-6#2)(2008-5#1)
consisting in##8##2##(1993-11#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-1#1)
consisting mainly of##5##3##(1992-12#1)(1997-6#2)(2008-5#1)(2008-7#1)
consisting of 0##2##3##(2007-12#1)(2011-1#1)
consisting of 10##7##3##(2008-10#3)(2008-8#1)(2009-11#1)(2009-7#1)(2013-1#1)
consisting of 14##2##3##(1991-5#1)(2008-10#1)
consisting of 2##2##3##(1991-5#1)(2007-10#1)
consisting of 243##2##3##(1990-11#1)(2008-10#1)
consisting of 340 amino acid residues##2##6##(1995-6#1)(1995-8#1)
consisting of 50##2##3##(1996-1#1)(1996-5#1)
consisting of 697##2##3##(2008-10#1)(2012-3#1)
consisting of 7##2##3##(2008-7#1)(2011-1#1)
consisting of N x N##2##5##(2008-3#2)
consisting of N##3##3##(2008-10#1)(2008-3#2)
consisting of a single##2##4##(2008-3#1)(2009-11#1)
consisting of a two-dimensional##2##4##(2008-3#1)(2008-7#1)
consisting of a##59##3##(1990-12#1)(1990-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-4#1)(2007-11#7)(2007-12#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
consisting of about##3##3##(1990-2#1)(1995-8#1)(2011-1#1)
consisting of all##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
consisting of amino##2##3##(1990-12#1)(1995-2#1)
consisting of an optical##2##4##(2008-3#1)(2011-1#1)
consisting of an##8##3##(1992-6#1)(1994-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2012-12#1)
consisting of approximately##3##3##(1993-11#1)(1996-9#1)(2012-1#1)
consisting of both##2##3##(2008-1#1)(2012-3#1)
consisting of different##2##3##(1996-3#1)(2008-11#1)
consisting of eight##2##3##(2008-10#1)(2013-1#1)
consisting of either##4##3##(2008-10#1)(2008-2#1)(2008-9#2)
consisting of five##2##3##(2008-11#1)(2013-1#1)
consisting of four##5##3##(1993-12#1)(1993-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
consisting of methanol##2##3##(2008-10#1)(2010-3#1)
consisting of more than##2##4##(1990-2#1)(1990-7#1)
consisting of multiple##3##3##(1990-11#1)(2009-9#1)(2012-2#1)
consisting of one##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
consisting of only##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#2)
consisting of residues##2##3##(1997-4#2)
consisting of six##2##3##(2008-11#1)(2008-3#1)
consisting of the##31##3##(1991-2#2)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-12#3)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)
consisting of three##12##3##(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
consisting of two tandem##2##4##(1994-12#1)(2008-9#1)
consisting of two##20##3##(1990-8#1)(1992-6#1)(1994-12#2)(1995-12#1)(1995-5#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-3#5)(2008-8#1)(2008-9#3)(2012-2#1)
consisting of##403##2##(1990-11#5)(1990-12#4)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-8#1)(1992-11#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#7)(1997-7#3)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#17)(2007-12#18)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#83)(2008-11#15)(2008-12#6)(2008-2#8)(2008-3#27)(2008-4#5)(2008-5#5)(2008-6#6)(2008-7#16)(2008-8#9)(2008-9#7)(2009-11#6)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#3)
consisting only of##2##3##(1996-2#1)(2008-10#1)
consisting##427##1##(1990-11#5)(1990-12#4)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#7)(1997-6#5)(1997-7#3)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#18)(2007-12#18)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#86)(2008-11#17)(2008-12#6)(2008-2#9)(2008-3#27)(2008-4#5)(2008-5#8)(2008-6#6)(2008-7#19)(2008-8#9)(2008-9#7)(2009-11#7)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#6)(2012-1#4)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#3)
consists in the##8##3##(1991-11#1)(1992-8#1)(2008-10#3)(2012-12#1)(2012-2#1)(2013-1#1)
consists in##21##2##(1991-11#1)(1992-8#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
consists mainly of##3##3##(1990-6#1)(2008-10#1)(2008-4#1)
consists mainly##4##2##(1990-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
consists of 12##3##3##(1995-6#2)(2008-7#1)
consists of 13##3##3##(1991-5#1)(1997-3#1)(2007-11#1)
consists of 15##2##3##(1995-8#1)(2011-2#1)
consists of 3##2##3##(2008-10#1)(2008-3#1)
consists of 7##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
consists of a 1##2##4##(1991-2#1)(1997-3#1)
consists of a 40##2##4##(1992-11#1)(1994-11#1)
consists of a large##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
consists of a laser diode##2##5##(2008-2#1)(2008-3#1)
consists of a laser##3##4##(2008-2#1)(2008-3#2)
consists of a pair of##2##5##(2007-12#1)(2008-10#1)
consists of a relatively##2##4##(2008-10#1)(2011-2#1)
consists of a set of##3##5##(2008-10#1)(2008-11#1)(2008-6#1)
consists of a short##2##4##(1993-2#1)(2007-11#1)
consists of a single##7##4##(1994-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-7#1)
consists of a standard##2##4##(2007-11#1)(2009-5#1)
consists of a##132##3##(1991-2#1)(1991-5#1)(1992-11#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#10)(2007-12#13)(2007-7#1)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#9)(2008-3#27)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-7#1)
consists of about##2##3##(2007-12#1)(2013-8#1)
consists of an##16##3##(1992-9#1)(1994-5#1)(1995-6#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
consists of at least##2##4##(1993-8#1)(1996-5#1)
consists of both##2##3##(1991-2#1)(2008-12#1)
consists of either##2##3##(2008-2#1)(2010-8#1)
consists of five##5##3##(1991-6#1)(1993-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
consists of four exons##2##4##(1993-2#1)(1994-12#1)
consists of four##7##3##(1991-9#1)(1993-2#1)(1994-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-2#1)
consists of monoterpene hydrocarbons##2##4##(2008-11#2)
consists of more than##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
consists of multiple##3##3##(2008-2#1)(2008-4#1)(2009-12#1)
consists of one##4##3##(1990-5#1)(1993-11#1)(2007-12#1)(2008-9#1)
consists of over##2##3##(2007-5#1)(2010-3#1)
consists of seven##2##3##(1991-9#1)(2007-12#1)
consists of several##2##3##(2007-12#1)(2013-1#1)
consists of six##3##3##(1991-6#1)(2008-12#1)(2010-7#1)
consists of the##13##3##(1994-12#1)(1995-2#1)(1995-6#2)(1997-8#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
consists of three major##2##4##(1997-8#1)(2008-10#1)
consists of three##12##3##(1991-2#1)(1993-11#1)(1994-12#1)(1995-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
consists of two mutually##2##4##(2007-11#1)(2008-11#1)
consists of two phases##2##4##(1996-4#1)(2011-2#1)
consists of two silicon##2##4##(2008-5#1)(2012-12#1)
consists of two##37##3##(1990-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
consists of using a##2##4##(2008-3#2)
consists of using##4##3##(2008-3#4)
consists of##440##2##(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#2)(1991-2#4)(1991-5#4)(1991-6#3)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#6)(1993-12#2)(1993-2#3)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#8)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#1)(2007-11#23)(2007-12#31)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#54)(2008-11#19)(2008-12#9)(2008-2#21)(2008-3#51)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#17)(2008-8#10)(2008-9#4)(2009-12#3)(2009-2#2)(2009-5#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#15)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#6)
consists only of##2##3##(1997-6#1)(2008-11#1)
consists##470##1##(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#4)(1991-5#4)(1991-6#3)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#6)(1993-12#2)(1993-2#3)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#3)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#8)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#4)(2006-10#1)(2007-11#23)(2007-12#32)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#60)(2008-11#21)(2008-12#9)(2008-2#23)(2008-3#53)(2008-4#10)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#10)(2008-9#4)(2009-12#3)(2009-2#2)(2009-5#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#16)(2011-3#1)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#7)
consolidate##6##1##(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
consolidated by##2##2##(1995-6#1)(2011-2#1)
consolidated in##2##2##(2011-1#1)(2012-12#1)
consolidated##16##1##(1992-12#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
consolidates##2##1##(2008-11#1)(2009-10#1)
consolidating##3##1##(1996-12#1)(1997-3#1)(2008-2#1)
consolidation CCRT##2##2##(2008-10#2)
consolidation chemotherapy##2##2##(2008-10#2)
consolidation docetaxel##2##2##(2008-10#2)
consolidation in##2##2##(2007-8#1)(2008-1#1)
consolidation of the##3##3##(1994-12#1)(2008-11#1)(2008-5#1)
consolidation of##11##2##(1994-12#3)(1997-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-7#1)(2013-1#1)(2013-8#1)
consolidation processes##4##2##(1994-8#1)(2007-8#3)
consolidation was##2##2##(1994-12#1)(2010-3#1)
consolidation##46##1##(1994-12#6)(1994-3#1)(1994-8#1)(1997-1#1)(1997-8#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
consommation de Tramadol##3##3##(2013-1#3)
consommation##5##1##(2013-1#5)
consonant##8##1##(1995-12#1)(2007-7#1)(2008-9#2)(2009-12#2)(2012-3#1)(2013-8#1)
consonants##8##1##(2007-7#1)(2009-11#1)(2009-12#2)(2013-8#4)
consortia of##2##2##(2011-1#2)
consortia##8##1##(1992-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#4)
consortium members##2##2##(2008-7#2)
consortium of##10##2##(1991-1#1)(1993-2#1)(1996-1#2)(1997-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-11#1)
consortium##26##1##(1991-1#2)(1993-12#2)(1993-2#1)(1996-1#2)(1996-2#1)(1997-1#1)(2008-11#3)(2008-6#3)(2008-7#6)(2009-11#1)(2010-5#2)(2010-8#1)(2012-12#1)
conspecific and##2##2##(2008-9#1)(2009-5#1)
conspecific attraction##2##2##(2008-8#1)(2008-9#1)
conspecific brood parasitism##2##3##(2008-8#2)
conspecific brood##4##2##(2008-8#4)
conspecific females##2##2##(2008-8#1)(2008-9#1)
conspecific males##2##2##(2008-8#1)(2008-9#1)
conspecific pulse rate##2##3##(2009-9#2)
conspecific pulse##3##2##(2009-9#3)
conspecific sperm##3##2##(2008-8#3)
conspecific strains##2##2##(2008-10#1)(2008-5#1)
conspecific##35##1##(1994-8#1)(1995-12#1)(2008-10#4)(2008-5#1)(2008-8#14)(2008-9#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-8#1)(2013-1#1)(2013-8#1)
conspecifics##6##1##(1994-8#1)(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
conspicuity and##2##2##(1997-8#1)(2008-7#1)
conspicuity##7##1##(1997-8#5)(2008-7#2)
conspicuous with##2##2##(2008-5#1)(2008-7#1)
conspicuous##32##1##(1990-8#1)(1990-9#1)(1994-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(2006-10#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#6)(2009-5#1)(2009-8#1)(2012-12#1)(2013-7#1)
conspicuously##2##1##(2008-5#1)(2008-8#1)
conspiracy##4##1##(1993-1#1)(2013-1#3)
conspurcata##3##1##(2008-12#3)
constancy =##2##2##(2008-6#2)
constancy of the##2##3##(2008-10#1)(2008-2#1)
constancy##6##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)
constant (K)##3##2##(2008-10#3)
constant (Ki)##2##2##(1995-5#1)(2008-7#1)
constant K(m)##3##2##(2008-10#3)
constant RH##2##2##(2008-10#2)
constant across##5##2##(1992-11#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
constant added##2##2##(2008-10#1)(2008-2#1)
constant and the##6##3##(1993-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#2)
constant and##22##2##(1993-1#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#3)
constant as##2##2##(1995-12#1)(2008-10#1)
constant at##16##2##(1993-11#1)(1993-3#1)(1993-8#1)(1996-2#2)(2008-10#6)(2008-6#2)(2008-7#2)(2008-9#1)
constant between the##2##3##(2008-10#2)
constant between##5##2##(1995-9#1)(2008-10#3)(2008-5#1)
constant cell##2##2##(2008-11#1)(2008-5#1)
constant comparative method##3##3##(2008-11#2)(2008-12#1)
constant comparison##2##2##(2013-1#2)
constant component of the##3##4##(2007-12#1)(2008-3#2)
constant component of##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
constant concentration of##2##3##(2008-10#2)
constant concentration##3##2##(2008-10#3)
constant current coulometric titration method##2##5##(2008-10#2)
constant current stripping analysis##2##4##(2008-10#2)
constant current stripping##3##3##(2008-10#3)
constant current##13##2##(2008-10#11)(2008-4#1)(2010-1#1)
constant darkness##6##2##(1994-8#1)(1995-11#1)(2008-10#1)(2008-5#2)(2010-8#1)
constant depth film fermentor (CDFF)##2##5##(2008-9#2)
constant determination##3##2##(1992-3#1)(2008-11#1)(2009-4#1)
constant diameter##3##2##(2008-2#2)(2008-3#1)
constant domain##4##2##(1993-6#2)(1994-6#1)(2008-10#1)
constant domains##2##2##(1991-9#1)(1997-2#1)
constant during the##5##3##(1990-11#1)(1992-12#1)(2008-10#2)(2008-11#1)
constant during##7##2##(1990-11#1)(1990-12#1)(1992-12#1)(2008-10#3)(2008-11#1)
constant flow##3##2##(2008-10#3)
constant for a##2##3##(1997-2#1)(2008-10#1)
constant for different##2##3##(2008-11#1)(2008-3#1)
constant for the reaction of##3##5##(1990-7#1)(1994-5#1)(2008-10#1)
constant for the reaction##5##4##(1990-7#1)(1994-5#1)(2008-10#3)
constant for the two##2##4##(2008-10#2)
constant for the##24##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-5#2)(1994-5#1)(1995-2#2)(1995-8#1)(1996-5#1)(2008-10#10)(2008-7#1)(2008-8#1)
constant for##56##2##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#2)(1992-3#2)(1992-5#2)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#4)(1995-8#1)(1996-5#1)(1997-2#2)(2008-10#21)(2008-11#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-2#1)
constant from the##2##3##(2008-11#1)(2013-1#1)
constant growth##2##2##(1997-6#1)(2011-2#1)
constant in##12##2##(1994-5#1)(2007-12#2)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
constant incidence##2##2##(1994-9#1)(1995-12#1)
constant increase##2##2##(1990-6#1)(2007-11#1)
constant ionic medium##4##3##(2008-10#4)
constant ionic strength##5##3##(2008-10#4)(2008-5#1)
constant ionic##9##2##(2008-10#8)(2008-5#1)
constant is not##2##3##(2008-11#1)(2008-3#1)
constant is reduced##2##3##(1997-2#1)(2008-10#1)
constant is##12##2##(1993-8#1)(1994-12#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)
constant level of##5##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
constant level##6##2##(1993-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
constant levels##2##2##(1997-6#1)(2008-5#1)
constant light at##2##3##(2008-10#2)
constant light##6##2##(1995-11#1)(2008-10#3)(2008-5#1)(2010-8#1)
constant obtained##2##2##(2008-10#1)(2008-7#1)
constant of 0##3##3##(1992-6#1)(1995-6#1)(2008-10#1)
constant of 2##3##3##(1992-6#1)(2008-10#2)
constant of 3##2##3##(1997-7#1)(2008-10#1)
constant of 4##3##3##(1996-5#1)(2008-10#2)
constant of 6##2##3##(1993-8#1)(1994-5#1)
constant of a##3##3##(2008-10#3)
constant of the 1st antibody##2##5##(2008-10#2)
constant of the complex##4##4##(2008-10#3)(2008-11#1)
constant of the inclusion complex of##2##6##(2008-10#2)
constant of the##33##3##(1993-8#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#25)(2008-11#1)(2008-3#1)
constant of##105##2##(1990-5#1)(1990-8#1)(1992-6#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-3#1)(1996-5#1)(1997-7#3)(1997-8#1)(2007-11#1)(2008-10#67)(2008-11#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
constant on the##2##3##(1996-5#1)(2008-10#1)
constant on##3##2##(1996-5#1)(2008-10#2)
constant or##6##2##(2008-10#4)(2008-9#1)(2012-4#1)
constant osmotic pressure##2##3##(2008-11#2)
constant over a##3##3##(2007-11#1)(2008-10#2)
constant over the##5##3##(1994-6#1)(2007-12#1)(2008-6#1)(2013-8#2)
constant over time##2##3##(1992-6#1)(2008-10#1)
constant over##11##2##(1992-6#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2013-8#2)
constant pH##3##2##(2007-3#1)(2008-10#1)(2008-11#1)
constant potential##5##2##(2008-10#5)
constant pressure to##2##3##(1996-2#1)(2008-9#1)
constant pressure##4##2##(1991-12#1)(1996-2#1)(2008-9#1)(2009-6#1)
constant rate##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
constant ratio##5##2##(1992-9#1)(2008-10#3)(2009-8#1)
constant region##7##2##(1994-8#1)(1997-8#2)(1997-9#2)(2008-4#2)
constant regions##2##2##(1990-8#1)(1994-3#1)
constant speed##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
constant stimuli method##2##3##(1990-11#2)
constant stimuli##6##2##(1990-11#6)
constant surface##3##2##(1997-5#1)(2008-3#1)(2009-6#1)
constant temperature in the##2##4##(2008-10#1)(2008-9#1)
constant temperature in##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
constant temperature##8##2##(1997-2#1)(2007-12#1)(2008-10#5)(2008-9#1)
constant temperatures of##3##3##(2008-10#3)
constant temperatures##7##2##(2008-10#6)(2008-8#1)
constant the##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
constant through##2##2##(1997-7#1)(2008-10#1)
constant throughout the course of the##2##6##(1992-6#1)(2008-7#1)
constant throughout the##3##3##(1992-6#1)(1993-3#1)(2008-7#1)
constant time##3##2##(1996-5#1)(2008-2#1)(2008-3#1)
constant to within##2##3##(1991-5#1)(2008-3#1)
constant to##10##2##(1990-11#1)(1991-5#1)(1995-2#3)(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
constant total##4##2##(2007-11#1)(2008-10#3)
constant value at##2##3##(1990-5#1)(2008-10#1)
constant value of##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
constant value##10##2##(1990-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)
constant values of##2##3##(2008-10#2)
constant values##9##2##(2008-10#9)
constant variance##2##2##(2008-3#1)(2012-3#1)
constant voltage##2##2##(2008-10#2)
constant was calculated##2##3##(2008-10#2)
constant was determined to be##2##5##(2008-10#2)
constant was determined##4##3##(2008-10#4)
constant was##13##2##(1992-6#1)(1993-8#1)(1994-3#1)(2008-10#9)(2008-2#1)
constant were##5##2##(2008-10#4)(2008-8#1)
constant when##2##2##(2008-3#1)(2008-5#1)
constant while##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
constant with##5##2##(2008-10#2)(2008-5#2)(2013-1#1)
constant##874##1##(1990-11#10)(1990-12#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#8)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#4)(1992-5#2)(1992-6#7)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#5)(1993-6#4)(1993-8#13)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#11)(1994-6#2)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#15)(1995-3#5)(1995-5#4)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#6)(1996-8#2)(1997-2#9)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#3)(1997-9#2)(2006-12#1)(2007-1#1)(2007-11#17)(2007-12#20)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#348)(2008-11#27)(2008-12#6)(2008-2#27)(2008-3#58)(2008-4#8)(2008-5#21)(2008-6#10)(2008-7#28)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#1)(2009-12#3)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#14)(2012-12#2)(2012-2#6)(2012-3#7)(2012-4#1)(2012-8#1)(2013-1#8)(2013-7#3)(2013-8#4)
constant(s) of##2##2##(2008-10#2)
constant)##6##1##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)
constant-bandwidth##2##1##(2008-3#2)
constant-current##4##1##(2007-11#1)(2008-10#2)(2008-3#1)
constant-energy synchronous##2##2##(2008-10#2)
constant-height##2##1##(2008-2#1)(2008-3#1)
constant-start version of the Morris water maze##2##7##(1993-12#2)
constant-start version of the Morris water##3##6##(1993-12#3)
constant-temperature##3##1##(2008-10#2)(2008-3#1)
constantly being##2##2##(2008-10#1)(2011-2#1)
constantly changing##2##2##(2008-10#1)(2012-3#1)
constantly expanding##2##2##(2007-7#1)(2010-6#1)
constantly formed##2##2##(1991-9#1)(2008-8#1)
constantly increased##2##2##(2008-9#1)(2011-2#1)
constantly increasing##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
constantly present##2##2##(2008-10#1)(2008-5#1)
constantly##44##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
constants (K(ex)##2##2##(2008-10#2)
constants (K(ex))##3##2##(2008-10#3)
constants (logK(ex))##2##2##(2008-10#2)
constants (pK(a)) of##2##3##(2008-10#2)
constants a =##4##3##(1996-2#2)(2008-8#1)(2013-8#1)
constants a##5##2##(1996-2#2)(2008-10#1)(2008-8#1)(2013-8#1)
constants and the##8##3##(1990-8#2)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
constants and their##2##3##(2008-10#2)
constants and##37##2##(1990-8#2)(1992-6#1)(1995-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-2#2)(2008-3#5)(2008-4#1)(2009-4#1)(2011-2#1)
constants are evaluated##2##3##(1990-8#1)(2008-10#1)
constants are presented##2##3##(1990-8#1)(2008-3#1)
constants are##18##2##(1990-8#2)(1992-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-5#1)
constants at##6##2##(1996-2#1)(2008-10#4)(2008-3#1)
constants by##5##2##(1995-8#1)(2008-10#4)
constants calculated##2##2##(1995-6#1)(2008-10#1)
constants determination of##2##3##(2008-10#2)
constants determination##5##2##(2008-10#5)
constants determined by##2##3##(2008-10#2)
constants for a##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
constants for each##2##3##(1995-2#1)(2008-10#1)
constants for the##10##3##(1993-8#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-10#5)(2008-5#1)
constants for##50##2##(1990-8#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-7#1)(2008-10#25)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)
constants from##4##2##(2008-10#3)(2008-7#1)
constants has been##2##3##(2008-10#1)(2008-3#1)
constants has##3##2##(2008-10#2)(2008-3#1)
constants in the##3##3##(2008-10#1)(2008-3#2)
constants in##12##2##(1992-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#2)
constants is developed##2##3##(2008-10#2)
constants is##4##2##(2007-11#1)(2008-10#3)
constants obtained by this method##2##5##(1992-4#1)(2008-5#1)
constants obtained by##4##3##(1992-4#1)(2008-10#2)(2008-5#1)
constants obtained##8##2##(1992-4#1)(2008-10#6)(2008-5#1)
constants of 1##3##3##(2008-10#3)
constants of a##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
constants of carbonate##2##3##(2008-10#2)
constants of complexes##6##3##(2008-10#6)
constants of five##2##3##(2008-10#2)
constants of metal-ligand complexes##2##4##(2008-10#2)
constants of organic##2##3##(2008-10#1)(2008-3#1)
constants of some##5##3##(1993-1#1)(2008-10#4)
constants of the above##2##4##(2008-10#2)
constants of the complexes##4##4##(2008-10#4)
constants of the##50##3##(1990-8#1)(1993-8#1)(1994-8#1)(2007-12#1)(2008-10#39)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)
constants of these##3##3##(1992-9#1)(2008-10#2)
constants of thin##6##3##(2008-2#2)(2008-3#4)
constants of two##2##3##(2008-10#1)(2008-3#1)
constants of##179##2##(1990-8#1)(1990-9#1)(1991-5#2)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#119)(2008-2#10)(2008-3#16)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#2)
constants ranged from##2##3##(2008-10#1)(2008-7#1)
constants showed that##2##3##(1991-9#1)(2008-10#1)
constants than##2##2##(2008-10#2)
constants that##5##2##(1990-8#2)(2008-10#2)(2010-5#1)
constants to##2##2##(1995-2#1)(2008-3#1)
constants used##2##2##(2008-3#2)
constants was##3##2##(2008-10#2)(2008-5#1)
constants were also##2##3##(2008-10#2)
constants were calculated##5##3##(2008-10#5)
constants were determined##4##3##(2008-10#3)(2008-9#1)
constants were found to be##5##5##(2008-10#5)
constants were found##6##3##(2008-10#6)
constants were obtained##4##3##(2008-10#3)(2008-2#1)
constants were##32##2##(1991-5#2)(1993-1#1)(2008-10#26)(2008-2#1)(2008-3#1)(2008-9#1)
constants which##3##2##(1990-8#1)(1991-3#1)(1992-3#1)
constants with##3##2##(2008-10#2)(2008-2#1)
constants##602##1##(1990-8#15)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#8)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#7)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-3#1)(1994-5#4)(1994-8#4)(1995-11#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-2#7)(1996-5#1)(1996-7#1)(1997-2#10)(1997-6#2)(1997-7#5)(2007-11#8)(2007-12#6)(2008-1#1)(2008-10#361)(2008-11#3)(2008-2#31)(2008-3#46)(2008-4#8)(2008-5#6)(2008-7#7)(2008-8#7)(2008-9#3)(2009-4#3)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-8#1)
constants)##2##1##(1992-3#1)(2008-10#1)
constellation of##13##2##(1994-2#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#3)(2012-3#1)(2013-8#1)
constellations of fit##2##3##(2009-10#2)
constellations of##4##2##(2007-10#1)(2009-10#2)(2009-12#1)
constellations##7##1##(2007-10#1)(2008-7#1)(2009-10#4)(2009-12#1)
constipation in the adult##2##4##(1993-6#2)
constipation in##3##2##(1993-6#2)(2008-7#1)
constipation with##2##2##(2008-10#1)(2011-2#1)
constipation##22##1##(1990-11#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-6#2)(1993-9#1)(1994-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#2)
constituencies##4##1##(1993-1#1)(1993-12#1)(2008-1#1)(2008-12#1)
constituent of the##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
constituent of##15##2##(1990-8#1)(1991-12#1)(1992-12#1)(1993-8#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2012-2#1)
constituent proteins##3##2##(1991-11#1)(2008-5#1)(2009-7#1)
constituent##55##1##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
constituents and##6##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-3#1)
constituents are##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
constituents by##5##2##(2008-10#4)(2008-2#1)
constituents from the##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
constituents from##8##2##(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
constituents in a##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
constituents in the##5##3##(2008-10#2)(2012-12#1)(2012-2#1)(2013-8#1)
constituents in##19##2##(1990-8#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
constituents including##2##2##(2009-11#1)(2012-2#1)
constituents of a##2##3##(2008-10#1)(2008-2#1)
constituents of medicinal##2##3##(2008-11#1)(2012-2#1)
constituents of the essential oil##2##5##(2008-12#1)(2013-1#1)
constituents of the##12##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-4#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
constituents of##31##2##(1994-9#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
constituents on##2##2##(2008-10#1)(2008-3#1)
constituents such as##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)
constituents that are##2##3##(1995-9#1)(2008-2#1)
constituents that##3##2##(1995-9#1)(2008-10#1)(2008-2#1)
constituents was##2##2##(2008-10#2)
constituents were##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
constituents with##2##2##(2008-10#1)(2008-3#1)
constituents##161##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-6#3)(1995-9#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(2007-11#2)(2007-12#4)(2008-10#51)(2008-11#12)(2008-12#5)(2008-2#12)(2008-3#8)(2008-4#1)(2008-5#6)(2008-7#4)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#2)(2010-11#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#5)
constituents/extracts##2##1##(2008-5#2)
constitute a class of##4##4##(2008-10#1)(2009-8#1)(2012-3#1)(2013-7#1)
constitute a high-risk group for##2##5##(2007-8#1)(2013-1#1)
constitute a large family of##2##5##(2007-12#1)(2008-4#1)
constitute a large##4##3##(2007-12#1)(2008-4#1)(2009-10#1)(2012-2#1)
constitute a major##5##3##(1992-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-3#1)
constitute a new class of##2##5##(1990-5#1)(1992-8#1)
constitute a new##6##3##(1990-5#1)(1991-5#1)(1992-8#1)(2008-10#1)(2008-11#1)(2010-10#1)
constitute a powerful tool##2##4##(2008-10#1)(2011-1#1)
constitute a significant##2##3##(2006-4#1)(2008-11#1)
constitute a small##2##3##(2007-7#1)(2008-10#1)
constitute a useful##2##3##(2008-10#1)(2013-1#1)
constitute a##79##2##(1990-5#4)(1990-8#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
constitute about##3##2##(1990-6#1)(1992-4#1)(2013-1#1)
constitute an important##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
constitute an##9##2##(1992-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
constitute good##2##2##(2008-2#1)(2010-10#1)
constitute one of the most##2##5##(2011-2#1)(2013-7#1)
constitute one of the##4##4##(1990-11#1)(1994-2#1)(2011-2#1)(2013-7#1)
constitute one##5##2##(1990-11#1)(1994-2#1)(2011-2#2)(2013-7#1)
constitute part of##2##3##(1994-6#1)(2008-5#1)
constitute potential##2##2##(1995-8#1)(2008-10#1)
constitute the major##3##3##(1997-8#2)(2008-9#1)
constitute the##36##2##(1991-6#1)(1993-12#1)(1993-6#2)(1994-3#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-8#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-6#1)(2012-1#1)(2012-2#3)(2013-8#1)
constitute two##3##2##(1991-9#1)(2007-12#1)(2010-8#1)
constitute##172##1##(1990-11#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-4#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#22)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
constituted a##8##2##(1993-1#1)(1995-6#1)(2008-10#3)(2010-5#1)(2012-2#1)(2013-1#1)
constituted an important##2##3##(2008-10#1)(2012-12#1)
constituted an##3##2##(2008-10#2)(2012-12#1)
constituted by a##2##3##(1993-11#1)(2008-10#1)
constituted by an##2##3##(2008-10#2)
constituted by the##5##3##(2008-10#3)(2008-5#1)(2010-8#1)
constituted by##21##2##(1990-3#1)(1993-11#1)(2008-10#6)(2008-5#2)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
constituted in##2##2##(2012-3#1)(2012-7#1)
constituted of##4##2##(2008-5#2)(2008-9#1)(2013-1#1)
constituted the main##2##3##(1992-9#1)(2008-12#1)
constituted the study group##2##4##(2007-7#1)(2011-1#1)
constituted the##10##2##(1992-9#1)(1993-1#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-1#1)(2011-1#1)
constituted##67##1##(1990-3#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#13)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#1)
constitutes a genetically heterogeneous group of##2##6##(1995-5#1)(2009-10#1)
constitutes a good##3##3##(2008-11#1)(2010-10#1)(2012-2#1)
constitutes a high##2##3##(1991-5#1)(1995-2#1)
constitutes a major##2##3##(2008-11#1)(2011-2#1)
constitutes a novel##2##3##(2007-11#1)(2009-6#1)
constitutes a significant##3##3##(2008-1#1)(2008-11#1)(2009-8#1)
constitutes a##45##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
constitutes an essential##2##3##(1994-6#1)(2008-3#1)
constitutes an##17##2##(1994-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-12#3)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
constitutes less than 1% of##2##5##(2008-5#1)(2013-7#1)
constitutes one of the##3##4##(1994-12#1)(2008-7#1)(2012-12#1)
constitutes the first##5##3##(2007-5#1)(2008-10#3)(2013-8#1)
constitutes the highest##2##3##(2008-10#1)(2012-7#1)
constitutes the second##2##3##(1991-11#1)(1996-10#1)
constitutes the##20##2##(1990-11#1)(1991-11#1)(1996-10#1)(2007-12#1)(2007-5#2)(2008-10#7)(2008-8#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-7#1)(2013-8#2)
constitutes##108##1##(1990-11#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-5#2)(1996-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#4)
constituting a##7##2##(1992-8#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)
constituting the##5##2##(1990-7#1)(1994-6#1)(2008-11#1)(2008-7#1)(2012-12#1)
constituting##20##1##(1990-7#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-6#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-12#1)
constitution of the##2##3##(2008-10#1)(2008-11#1)
constitution of##5##2##(2008-10#2)(2008-11#1)(2009-5#2)
constitution##12##1##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-5#2)(2009-7#2)(2010-4#1)(2011-2#1)(2012-12#1)
constitutional delay of growth and puberty##4##6##(2011-1#2)(2011-2#2)
constitutional descriptors##3##2##(2007-11#1)(2008-10#2)
constitutional right to##2##3##(1992-1#1)(1996-9#1)
constitutional symptoms##6##2##(2007-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
constitutional##31##1##(1992-1#1)(1992-2#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2013-1#2)
constitutions##2##1##(2008-11#1)(2008-12#1)
constitutive activation of the##3##4##(1997-3#1)(2012-12#1)(2013-1#1)
constitutive activation of this##2##4##(1990-12#1)(2012-12#1)
constitutive activation of##5##3##(1990-12#1)(1997-3#1)(2012-12#2)(2013-1#1)
constitutive activity##2##2##(1990-12#1)(2008-10#1)
constitutive and inducible##4##3##(1992-12#1)(1994-8#1)(2008-11#1)(2009-2#1)
constitutive and##12##2##(1992-12#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-2#1)(2012-1#1)(2013-8#1)
constitutive blast secretion of##2##4##(2006-6#2)
constitutive cytokine secretion##2##3##(2006-6#2)
constitutive equation##2##2##(2008-7#1)(2009-4#1)
constitutive equations##3##2##(1996-4#1)(2009-4#2)
constitutive expression and##4##3##(1994-6#1)(1995-11#1)(2008-6#1)(2009-3#1)
constitutive expression of the##2##4##(1997-8#2)
constitutive expression of##7##3##(1990-11#1)(1992-9#1)(1995-11#1)(1995-8#1)(1997-8#2)(2008-10#1)
constitutive expression##14##2##(1990-11#1)(1990-12#1)(1992-9#1)(1994-6#1)(1995-11#2)(1995-8#1)(1996-5#1)(1997-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)
constitutive law##5##2##(1996-4#5)
constitutive levels of the##2##4##(1991-12#1)(1992-2#1)
constitutive levels of##3##3##(1991-12#1)(1992-2#1)(2008-10#1)
constitutive levels##4##2##(1990-5#1)(1991-12#1)(1992-2#1)(2008-10#1)
constitutive or##2##2##(2008-11#1)(2010-12#1)
constitutive processing##2##2##(1992-12#2)
constitutive promoter##3##2##(2008-10#2)(2012-2#1)
constitutive resistance##2##2##(2008-8#2)
constitutive secretory vesicles##2##3##(1992-12#2)
constitutive secretory##4##2##(1992-12#4)
constitutive##123##1##(1990-11#1)(1990-12#4)(1990-5#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-12#11)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#5)(1995-12#2)(1995-2#1)(1995-8#2)(1995-9#1)(1996-4#10)(1996-5#3)(1997-3#1)(1997-8#2)(2006-6#5)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2009-2#3)(2009-3#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-8#1)
constitutively activated##7##2##(1994-12#1)(1997-7#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#1)
constitutively active##8##2##(1995-5#1)(1996-2#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
constitutively express##4##2##(1993-12#1)(1993-6#1)(2008-11#1)(2012-12#1)
constitutively expressed by##2##3##(1993-3#1)(2008-7#1)
constitutively expressed in all##2##4##(1995-6#1)(1997-7#1)
constitutively expressed in##7##3##(1995-6#1)(1997-7#1)(2007-12#2)(2008-5#1)(2008-6#1)(2010-3#1)
constitutively expressed##18##2##(1990-12#1)(1991-12#1)(1993-3#1)(1995-11#2)(1995-3#1)(1995-6#2)(1997-7#2)(2007-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)
constitutively phosphorylated##2##2##(1995-6#1)(2013-1#1)
constitutively present##2##2##(1993-6#1)(2008-11#1)
constitutively secreted##2##2##(1992-8#1)(2008-1#1)
constitutively##63##1##(1990-12#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-11#4)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#6)(1996-10#2)(1996-2#1)(1997-4#1)(1997-7#3)(2007-12#2)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
constrain the evolution of##3##4##(2008-7#1)(2008-8#2)
constrain the##9##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
constrain##22##1##(1991-12#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-7#1)(2012-3#1)(2013-1#1)
constrained DET##2##2##(2008-10#2)
constrained by a##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
constrained by the##5##3##(1995-1#1)(2008-6#1)(2009-7#1)(2012-12#2)
constrained by##14##2##(1993-2#1)(1994-12#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#2)
constrained compression##2##2##(2009-7#2)
constrained optimization##5##2##(2008-2#3)(2008-7#1)(2012-1#1)
constrained to##4##2##(2008-1#2)(2008-3#1)(2008-8#1)
constrained##67##1##(1992-4#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-1#2)(1996-3#2)(1996-5#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-7#3)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#6)(2012-12#3)(2012-2#1)(2013-1#1)
constraining the##3##2##(1990-8#1)(2007-10#1)(2012-2#1)
constraining##10##1##(1990-8#1)(2007-10#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-8#1)(2012-1#1)(2012-2#1)
constrains##3##1##(1995-2#1)(2008-9#1)(2009-6#1)
constraint equation##2##2##(2009-5#2)
constraint in the##2##3##(2008-10#1)(2011-2#1)
constraint in##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
constraint is##5##2##(2008-3#2)(2008-9#2)(2012-12#1)
constraint of##5##2##(1993-1#1)(1994-9#1)(2008-1#1)(2008-3#1)(2008-8#1)
constraint on activity##3##3##(2008-10#1)(2008-8#2)
constraint on the point estimate of GMR##2##7##(2012-3#2)
constraint on the##3##3##(2008-3#1)(2012-3#2)
constraint on##10##2##(2008-10#3)(2008-3#1)(2008-8#3)(2012-3#2)(2013-1#1)
constraint to##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
constraint##71##1##(1990-8#1)(1993-1#2)(1994-9#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#5)(2008-3#9)(2008-8#11)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#4)
constraint&quot##3##1##(2008-8#1)(2012-12#1)(2012-3#1)
constraints and##18##2##(2008-11#1)(2008-3#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-1#1)
constraints are##5##2##(1992-2#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-9#1)
constraints can##2##2##(2008-7#1)(2008-8#1)
constraints for##3##2##(1994-2#1)(2008-10#1)(2012-1#1)
constraints imposed by##4##3##(2008-3#2)(2008-9#1)(2010-3#1)
constraints imposed##5##2##(1991-5#1)(2008-3#2)(2008-9#1)(2010-3#1)
constraints in the##5##3##(1995-5#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
constraints in##11##2##(1993-11#1)(1994-5#1)(1995-5#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
constraints is##2##2##(2008-3#1)(2010-6#1)
constraints mentioned##2##2##(2011-1#2)
constraints of the##4##3##(2008-1#1)(2008-7#1)(2011-1#1)(2012-2#1)
constraints of##10##2##(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
constraints on page registration##2##4##(2007-11#2)
constraints on the##14##3##(1991-5#1)(1993-5#1)(1994-5#1)(1994-8#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-5#1)(2009-7#1)
constraints on##32##2##(1991-5#2)(1992-6#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-11#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-8#4)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#2)(2012-12#1)
constraints that##9##2##(1994-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-2#1)
constraints to##7##2##(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-8#1)
constraints were##4##2##(1994-5#1)(1995-5#1)(2007-7#1)(2008-8#1)
constraints##221##1##(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#4)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-5#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#8)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-5#1)(1997-8#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-7#8)(2008-1#4)(2008-10#12)(2008-11#13)(2008-12#6)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#15)(2008-8#26)(2008-9#11)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-3#1)(2010-6#2)(2010-8#3)(2011-1#8)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
constrict##2##1##(2009-2#1)(2011-2#1)
constricted##3##1##(1993-1#1)(2013-1#2)
constriction induced##2##2##(2011-1#1)(2013-8#1)
constriction injury##6##2##(1995-12#2)(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#1)
constriction of the##3##3##(1996-8#1)(2010-3#1)(2013-8#1)
constriction of##4##2##(1994-9#1)(1996-8#1)(2010-3#1)(2013-8#1)
constriction##23##1##(1992-8#1)(1994-9#1)(1995-12#2)(1996-5#2)(1996-8#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#2)
constrictive pericarditis##3##2##(2007-8#2)(2012-12#1)
constrictive##5##1##(1992-3#1)(2007-8#2)(2009-10#1)(2012-12#1)
constrictor##2##1##(2009-11#1)(2011-2#1)
construct a compact##2##3##(2008-2#1)(2008-3#1)
construct a recombinant##3##3##(1992-3#1)(2008-11#1)(2008-8#1)
construct a simple##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
construct a##56##2##(1990-7#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#1)(2010-10#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)
construct an##14##2##(1991-8#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#1)(2010-1#1)(2010-5#1)(2011-2#1)
construct and to##2##3##(1995-6#1)(2009-9#1)
construct and##9##2##(1995-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-1#1)
construct containing a##2##3##(1993-3#1)(2008-10#1)
construct containing the##2##3##(1993-3#1)(1996-3#1)
construct containing##5##2##(1993-3#2)(1994-2#1)(1996-3#1)(2008-10#1)
construct for##2##2##(1994-1#1)(2008-10#1)
construct has##2##2##(2007-12#1)(2010-6#1)
construct in##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2012-2#1)
construct into##2##2##(1995-2#1)(2008-10#1)
construct is##4##2##(2008-12#1)(2008-5#1)(2009-11#1)(2013-8#1)
construct it##2##2##(2008-11#1)(2008-9#1)
construct of##5##2##(1991-12#1)(1993-3#1)(2008-10#1)(2009-10#1)(2013-1#1)
construct or##2##2##(1996-12#1)(2008-11#1)
construct that is##2##3##(2008-11#1)(2012-3#1)
construct that##4##2##(1993-2#1)(2008-11#1)(2009-7#1)(2012-3#1)
construct the##12##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)(2012-3#1)
construct validity of##6##3##(2007-12#2)(2009-12#1)(2013-1#3)
construct validity##17##2##(1995-2#1)(1996-2#1)(2007-12#3)(2009-12#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#4)
construct was introduced into##2##4##(1997-6#1)(2008-8#1)
construct was##9##2##(1993-12#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-8#3)(2008-9#1)(2013-1#1)
construct with##3##2##(1997-2#1)(2012-2#2)
construct##281##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-8#2)(1997-9#1)(2006-12#2)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#41)(2008-11#18)(2008-12#6)(2008-2#9)(2008-3#10)(2008-4#8)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#16)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#6)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#3)
constructed a mathematical model##2##4##(2008-11#1)(2008-9#1)
constructed a new##3##3##(1996-2#1)(2008-11#1)(2008-8#1)
constructed a novel##2##3##(2008-11#1)(2008-3#1)
constructed a physical map of##2##5##(1996-10#1)(1997-2#1)
constructed a series of##5##4##(1990-12#1)(1991-6#1)(1994-12#1)(1997-2#1)(2008-11#1)
constructed a##52##2##(1990-12#1)(1991-6#2)(1992-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#2)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#7)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-10#1)(2011-1#1)(2012-2#2)(2012-3#2)
constructed an##7##2##(1992-9#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
constructed and a##2##3##(2008-8#1)(2008-9#1)
constructed and analyzed##3##3##(1997-3#1)(2008-10#1)(2008-6#1)
constructed and characterized##3##3##(1993-11#1)(1995-2#1)(2008-10#1)
constructed and evaluated##3##3##(2008-10#2)(2013-1#1)
constructed and is##4##3##(2008-3#3)(2010-1#1)
constructed and tested##6##3##(2007-9#1)(2008-10#3)(2008-3#2)
constructed and the##2##3##(1992-3#1)(2008-10#1)
constructed and transferred into##2##4##(2008-8#1)(2008-9#1)
constructed and used to##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
constructed and used##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
constructed and##55##2##(1991-7#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#4)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
constructed around the##2##3##(1994-11#1)(2008-2#1)
constructed as a##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)
constructed as##6##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
constructed at##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
constructed based on the##2##4##(1995-6#1)(2008-9#1)
constructed based on##5##3##(1995-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
constructed by employing##2##3##(2009-10#1)(2009-11#1)
constructed by insertion of a##2##5##(1995-2#1)(2008-3#1)
constructed by means of##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
constructed by site-directed mutagenesis##4##4##(1991-9#1)(1995-2#2)(1995-5#1)
constructed by the##2##3##(2008-10#1)(2008-6#1)
constructed by this##2##3##(1990-11#1)(1996-2#1)
constructed by use of##2##4##(2007-11#1)(2007-12#1)
constructed by using##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-3#1)
constructed by##68##2##(1990-11#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-3#2)(2012-2#1)(2013-1#1)
constructed either##2##2##(1995-2#1)(1995-8#1)
constructed for determination of##2##4##(1992-11#1)(2008-10#1)
constructed for the##7##3##(2008-10#5)(2008-11#1)(2008-5#1)
constructed for##27##2##(1992-11#1)(1993-12#1)(1993-6#1)(1995-9#1)(1997-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)
constructed from a##10##3##(1990-5#1)(1990-7#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-8#1)
constructed from six QbD elements plus a communication/training team##2##9##(2012-2#2)
constructed from six##3##3##(2010-4#1)(2012-2#2)
constructed from the##8##3##(1994-6#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2010-8#1)(2012-2#1)
constructed from##50##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-10#15)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#4)(2013-1#1)
constructed in Escherichia coli##2##4##(1991-9#1)(2008-11#1)
constructed in a##4##3##(1995-11#1)(2007-11#2)(2008-10#1)
constructed in the##5##3##(1990-5#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-2#1)
constructed in vitro##3##3##(1990-5#1)(1992-3#1)(2008-11#1)
constructed in##27##2##(1990-5#3)(1991-9#1)(1992-3#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#1)
constructed of blends##2##3##(2009-7#2)
constructed of##9##2##(2008-10#2)(2008-2#1)(2009-11#2)(2009-7#2)(2011-2#1)(2012-1#1)
constructed on the basis of##5##5##(1990-7#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-6#1)
constructed on##6##2##(1990-7#1)(1994-5#1)(2008-10#2)(2008-2#1)(2008-6#1)
constructed physical map##2##3##(1997-6#1)(2008-10#1)
constructed plasmids##2##2##(1990-11#1)(1997-7#1)
constructed recombinant##2##2##(1994-8#1)(2008-11#1)
constructed several##2##2##(1993-2#1)(1997-4#1)
constructed that uses##2##3##(2008-3#2)
constructed that##11##2##(1990-11#1)(1990-5#1)(1994-3#1)(1997-4#1)(2008-2#1)(2008-3#3)(2009-5#1)(2011-2#1)(2012-12#1)
constructed the##2##2##(1995-6#1)(2008-9#1)
constructed their##2##2##(2008-11#1)(2011-2#1)
constructed three##2##2##(1992-5#1)(2008-9#1)
constructed through##2##2##(2007-11#1)(2008-8#1)
constructed to determine##2##3##(1991-1#1)(2008-9#1)
constructed to measure the##3##4##(2008-12#1)(2008-2#1)(2008-3#1)
constructed to##23##2##(1991-1#1)(1993-12#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-8#1)(2013-1#1)
constructed using a##5##3##(1990-5#1)(1995-8#1)(2007-8#1)(2011-2#1)(2012-1#1)
constructed using the##10##3##(1993-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)
constructed using##35##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-8#1)(1995-8#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-8#4)(2008-9#3)(2009-2#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
constructed was##2##2##(2008-10#2)
constructed were##2##2##(2008-10#1)(2008-11#1)
constructed wetland##3##2##(2013-1#3)
constructed which allows##2##3##(1990-5#1)(1997-6#1)
constructed which##5##2##(1990-5#1)(1993-12#1)(1994-6#1)(1997-6#1)(2011-1#1)
constructed with a##4##3##(1990-9#1)(2008-10#2)(2008-2#1)
constructed with the##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
constructed with this##2##3##(2008-10#1)(2008-3#1)
constructed with##28##2##(1990-11#1)(1990-9#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)
constructed##590##1##(1990-11#7)(1990-12#2)(1990-5#8)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#3)(1991-6#4)(1991-7#2)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#6)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#5)(1995-11#1)(1995-12#1)(1995-2#10)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#4)(1995-9#1)(1996-10#3)(1996-12#2)(1996-2#5)(1996-3#1)(1996-9#1)(1997-2#10)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#7)(1997-7#1)(1997-8#2)(2007-11#10)(2007-12#6)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#125)(2008-11#30)(2008-12#6)(2008-2#20)(2008-3#45)(2008-4#3)(2008-5#7)(2008-6#11)(2008-7#9)(2008-8#43)(2008-9#33)(2009-10#2)(2009-11#3)(2009-2#1)(2009-5#3)(2009-7#3)(2009-8#1)(2010-1#4)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#13)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#9)(2013-8#3)
constructing a##12##2##(1994-12#1)(1996-10#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
constructing an##6##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
constructing and##2##2##(1996-3#1)(2008-6#1)
constructing recombinant##2##2##(1992-9#1)(1993-2#1)
constructing the##4##2##(1997-3#1)(2008-10#1)(2008-2#1)(2009-10#1)
constructing##52##1##(1990-5#2)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1996-10#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#5)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
construction and maintenance##2##3##(1990-8#1)(2008-7#1)
construction and performance of##2##4##(2008-10#2)
construction and performance##5##3##(2008-10#4)(2008-2#1)
construction and use of##2##4##(1993-9#1)(1997-1#1)
construction and use##3##3##(1993-9#1)(1997-1#1)(2008-10#1)
construction and validation##2##3##(2008-10#1)(2011-1#1)
construction and##44##2##(1990-10#1)(1990-8#1)(1993-9#2)(1995-2#1)(1995-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
construction as##2##2##(1992-12#1)(2008-10#1)
construction cost##3##2##(1991-2#1)(1992-2#2)
construction for##2##2##(2008-10#1)(2011-1#1)
construction from##2##2##(1991-2#1)(2008-4#1)
construction in##4##2##(2008-10#3)(2008-9#1)
construction industry##3##2##(1991-12#3)
construction is##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
construction methods##2##2##(2008-2#1)(2008-4#1)
construction of a variety of##2##5##(1993-2#1)(2013-8#1)
construction of a##44##3##(1990-12#1)(1990-8#1)(1991-5#2)(1993-11#1)(1993-2#1)(1995-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-5#1)(2012-3#1)(2013-8#1)
construction of an##4##3##(1997-4#1)(2008-11#1)(2008-2#1)(2013-8#1)
construction of appropriate##2##3##(1994-11#1)(2008-11#1)
construction of composite##2##3##(1991-6#1)(1995-2#1)
construction of deletion mutants##2##4##(1993-2#1)(1994-8#1)
construction of functional##2##3##(2008-10#1)(2008-7#1)
construction of immuno-PCR gene probe##2##5##(2008-8#2)
construction of multiantennary oligonucleotide glycoconjugates on a solid support##2##9##(2008-4#2)
construction of the##27##3##(1991-6#1)(1992-6#1)(1993-11#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-8#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
construction of##165##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#2)(1991-6#3)(1992-6#1)(1993-11#2)(1993-2#4)(1994-11#1)(1994-12#5)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#32)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#4)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
construction or##4##2##(1991-12#1)(1994-3#1)(2008-10#1)(2012-2#1)
construction projects##4##2##(1993-3#4)
construction was##2##2##(1996-5#1)(2013-1#1)
construction worker##3##2##(1992-5#1)(1995-12#1)(1997-7#1)
construction workers who##2##3##(1995-12#2)
construction workers##6##2##(1995-12#2)(2008-12#3)(2009-10#1)
construction##317##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#10)(1991-2#4)(1991-5#2)(1991-6#3)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#4)(1993-3#4)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#2)(1994-8#1)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#8)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#60)(2008-11#15)(2008-12#5)(2008-2#14)(2008-3#17)(2008-4#16)(2008-5#6)(2008-6#6)(2008-7#16)(2008-8#8)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#6)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#4)
constructional##3##1##(1990-3#1)(2008-7#2)
constructions of##2##2##(2008-11#1)(2010-2#1)
constructions##17##1##(1997-4#1)(1997-6#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-6#4)(2008-8#1)(2010-2#1)(2011-2#1)
constructive and destructive interference##2##4##(2008-3#2)
constructive and##3##2##(2008-11#1)(2008-3#2)
constructive##17##1##(1995-3#1)(1996-1#1)(1997-1#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#5)(2009-7#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
constructively##4##1##(1994-12#1)(1994-3#1)(2008-3#1)(2008-6#1)
constructivist##3##1##(2008-12#3)
constructs and##3##2##(2008-1#1)(2010-11#1)(2013-1#1)
constructs are##2##2##(2008-4#1)(2012-2#1)
constructs as##3##2##(2008-11#1)(2009-10#1)(2010-8#1)
constructs between##2##2##(1992-6#1)(1993-3#1)
constructs by##2##2##(1994-2#1)(2012-12#1)
constructs carrying the##2##3##(1991-12#1)(1994-11#1)
constructs carrying##3##2##(1991-12#1)(1994-11#1)(2011-1#1)
constructs containing##5##2##(1994-11#1)(1995-2#1)(1996-5#2)(2008-10#1)
constructs for##2##2##(2008-4#1)(2009-3#1)
constructs from##2##2##(2009-9#1)(2012-1#1)
constructs generated##2##2##(1996-9#1)(2009-9#1)
constructs have##3##2##(1991-5#1)(1993-3#1)(1994-2#1)
constructs in##7##2##(1993-8#1)(1994-6#1)(1995-6#1)(2008-11#2)(2008-8#1)(2012-2#1)
constructs of the##3##3##(1992-1#1)(2008-10#2)
constructs of##7##2##(1992-1#1)(2008-10#4)(2008-11#2)
constructs should be##2##3##(1993-12#1)(2008-12#1)
constructs that##4##2##(1990-8#1)(1994-8#1)(2008-11#1)(2012-12#1)
constructs to##2##2##(1992-9#1)(1994-5#1)
constructs was##2##2##(1997-2#1)(2008-10#1)
constructs were##7##2##(1991-2#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)
constructs with##5##2##(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)(2013-1#1)
constructs##126##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-6#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)
construed##4##1##(1993-1#1)(2007-2#1)(2008-2#1)(2010-2#1)
consult a##3##2##(1997-6#1)(2010-11#1)(2013-8#1)
consult for##2##2##(2008-5#1)(2009-1#1)
consult##12##1##(1994-11#1)(1996-12#1)(1997-6#1)(2007-10#1)(2008-11#2)(2008-5#1)(2009-1#1)(2009-4#1)(2010-11#1)(2013-1#1)(2013-8#1)
consultant in##2##2##(1996-2#1)(2008-4#1)
consultant to##2##2##(1990-3#1)(1992-12#1)
consultant##19##1##(1990-2#1)(1990-3#2)(1991-12#1)(1992-12#2)(1992-4#2)(1995-3#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-4#1)(2010-12#2)(2012-3#1)(2013-8#3)
consultants and##3##2##(1990-3#1)(1997-2#1)(2013-8#1)
consultants in paediatrics##2##3##(1990-3#2)
consultants in##3##2##(1990-3#2)(2007-2#1)
consultants##16##1##(1990-3#3)(1993-1#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-2#1)(2009-11#1)(2012-2#1)(2013-8#2)
consultation and##8##2##(1992-12#1)(1992-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
consultation for##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
consultation in the##2##3##(2008-10#2)
consultation in##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
consultation is##5##2##(1991-11#1)(1991-6#1)(1994-11#1)(2011-2#2)
consultation oceurring##2##2##(2013-8#2)
consultation of##4##2##(1993-11#1)(1995-12#1)(2007-5#1)(2008-2#1)
consultation on##2##2##(1993-5#1)(1994-1#1)
consultation services for##2##3##(1991-12#1)(1994-1#1)
consultation services##3##2##(1991-12#1)(1994-1#2)
consultation with the##2##3##(1996-5#1)(1996-6#1)
consultation with##7##2##(1996-5#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
consultation##84##1##(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#4)(1992-11#1)(1992-12#2)(1992-2#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-1#3)(1994-11#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-2#3)(2007-5#1)(2007-8#1)(2008-1#6)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#4)
consultations in##7##2##(1990-12#1)(1990-9#1)(1991-3#1)(1993-3#1)(1993-6#1)(2011-2#1)(2013-8#1)
consultations on##2##2##(1994-6#1)(1997-8#1)
consultations were##2##2##(1990-6#1)(1990-8#1)
consultations with##3##2##(1991-2#1)(1992-9#1)(2008-8#1)
consultations##30##1##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-4#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-6#2)(1995-5#1)(1996-11#1)(1997-6#3)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-6#1)(2008-8#1)(2011-2#3)(2013-8#1)
consulted##17##1##(1990-6#1)(1992-2#1)(1992-5#1)(1994-11#1)(1995-1#1)(1996-6#2)(1997-4#1)(1997-6#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#2)(2013-1#1)
consulting##17##1##(1991-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#1)(1995-1#1)(1995-5#2)(1997-2#1)(1997-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-4#1)(2010-5#1)
consumable##3##1##(2008-10#1)(2008-11#1)(2012-2#1)
consume a##2##2##(1997-2#1)(2008-7#1)
consume the##3##2##(1995-12#1)(2012-2#1)(2013-1#1)
consume them##2##2##(2008-10#1)(2008-8#1)
consume##33##1##(1992-2#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#2)
consumed a##3##2##(2008-7#1)(2010-8#1)(2012-1#1)
consumed an average of##2##4##(2008-9#2)
consumed by a factor of 6##2##6##(2008-10#2)
consumed by a factor of##3##5##(2008-10#3)
consumed by a##4##3##(2008-10#3)(2008-8#1)
consumed by the##2##3##(2008-3#1)(2008-5#1)
consumed by##21##2##(1990-3#1)(1992-12#1)(1994-9#1)(1995-8#1)(1997-4#3)(2007-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
consumed during##2##2##(1995-6#1)(2008-10#1)
consumed each##2##2##(2008-3#1)(2008-7#1)
consumed for##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
consumed in the##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2013-7#1)
consumed in##11##2##(1993-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-7#1)(2013-7#2)
consumed more##2##2##(2009-8#2)
consumed or##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
consumed oxygen##2##2##(2008-10#2)
consumed per determination##3##3##(2008-10#3)
consumed per##5##2##(1993-9#1)(1995-11#1)(2008-10#3)
consumed the##2##2##(2008-10#1)(2010-8#1)
consumed##110##1##(1990-2#1)(1990-3#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#4)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#5)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#6)(2013-8#2)
consumer academic##2##2##(2008-11#2)
consumer and##5##2##(1991-3#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#1)
consumer awareness##3##2##(1993-1#1)(2008-5#1)(2013-1#1)
consumer behavior##2##2##(1993-12#2)
consumer choice##11##2##(1993-1#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-7#1)
consumer consumption##3##2##(2009-8#1)(2010-10#2)
consumer decision making##2##3##(2012-3#2)
consumer demand##3##2##(1994-3#2)(2010-7#1)
consumer demands##2##2##(1996-2#1)(2008-5#1)
consumer electronics component##2##3##(2007-12#1)(2008-2#1)
consumer engagement behaviors##2##3##(2013-1#2)
consumer engagement##7##2##(2013-1#7)
consumer health information##7##3##(1993-1#3)(1997-3#4)
consumer health##12##2##(1993-1#3)(1996-12#1)(1997-3#6)(2009-5#1)(2009-7#1)
consumer information##6##2##(1997-3#6)
consumer involvement in##3##3##(1994-1#1)(1995-2#2)
consumer involvement##4##2##(1994-1#1)(1995-2#2)(2013-1#1)
consumer medication information##2##3##(2011-1#2)
consumer needs##3##2##(1996-2#1)(1996-3#1)(1997-3#1)
consumer participation##2##2##(1997-3#1)(2008-11#1)
consumer participation&quot##2##2##(1997-3#2)
consumer population##2##2##(1997-3#1)(2008-8#1)
consumer preferences##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
consumer satisfaction and willingness to recommend the provider##2##8##(1993-12#2)
consumer satisfaction and##4##3##(1993-12#2)(1995-1#1)(2012-3#1)
consumer satisfaction information##2##3##(1996-2#1)(1996-3#1)
consumer satisfaction ratings##2##3##(1997-3#2)
consumer satisfaction with dental##2##4##(1993-12#2)
consumer satisfaction##17##2##(1993-12#6)(1994-12#1)(1994-2#1)(1995-1#1)(1996-2#3)(1996-3#2)(1997-3#2)(2012-3#1)
consumer species##6##2##(2008-8#3)(2008-9#3)
consumer survey##2##2##(1996-2#1)(1997-3#1)
consumer surveys##6##2##(1996-2#1)(1996-3#4)(1997-2#1)
consumer use##2##2##(1996-3#1)(2008-5#1)
consumer##180##1##(1991-3#2)(1992-1#1)(1992-12#2)(1993-1#5)(1993-12#10)(1993-3#1)(1994-1#2)(1994-12#3)(1994-2#3)(1994-3#4)(1995-1#3)(1995-2#4)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#10)(1996-3#10)(1997-2#1)(1997-3#30)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#5)(2008-2#1)(2008-5#13)(2008-7#2)(2008-8#12)(2008-9#9)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#4)(2013-1#10)(2013-8#1)
consumer's perspective##2##2##(1997-2#1)(2008-5#1)
consumer's##7##1##(1994-2#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#2)
consumer-independent processing##3##2##(2008-12#3)
consumer-oriented##3##1##(1991-2#1)(1994-12#1)(2007-5#1)
consumer-resource##3##1##(2008-8#1)(2008-9#2)
consumer/survivor involvement##2##2##(1997-3#2)
consumer/survivor participation##2##2##(1997-3#2)
consumer/survivor##4##1##(1997-3#4)
consumerism##5##1##(1994-12#2)(1997-2#1)(2008-1#1)(2011-1#1)
consumers and##15##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
consumers are##5##2##(1996-1#1)(1996-2#1)(1997-3#1)(2008-8#1)(2010-4#1)
consumers as##2##2##(1995-1#1)(2013-1#1)
consumers in##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
consumers of##7##2##(1992-1#1)(1992-11#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
consumers should be##2##3##(1992-11#1)(2008-12#1)
consumers that##2##2##(2008-8#1)(2013-8#1)
consumers to make##2##3##(1995-2#1)(2008-12#1)
consumers to##9##2##(1993-3#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-9#1)
consumers view##3##2##(1997-3#2)(2008-12#1)
consumers who are##2##3##(1993-3#1)(1995-1#1)
consumers who##5##2##(1993-3#1)(1995-1#2)(1997-3#1)(2008-8#1)
consumers with##4##2##(1991-12#1)(1997-3#1)(2008-5#1)(2013-1#1)
consumers##131##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#4)(1995-1#8)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#6)(1996-3#5)(1997-1#3)(1997-2#1)(1997-3#13)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#9)(2008-2#2)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#6)(2008-9#2)(2010-1#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#11)(2013-8#1)
consumers' perceived##2##2##(1994-3#1)(2008-12#1)
consumers' perceptions##2##2##(2010-4#1)(2011-1#1)
consumers' preferences for dental##2##4##(1994-3#2)
consumers' valuation of GAP##2##4##(2013-1#2)
consumers' valuation of##3##3##(2013-1#3)
consumers'##15##1##(1994-3#3)(1995-1#1)(1997-3#1)(2008-12#2)(2008-2#1)(2010-4#1)(2011-1#2)(2013-1#4)
consumers/survivors##3##1##(1997-3#3)
consumes at least##2##3##(2008-10#1)(2008-5#1)
consumes##13##1##(2007-7#1)(2008-10#5)(2008-5#1)(2008-8#1)(2012-2#3)(2013-7#1)(2013-8#1)
consuming a##4##2##(1997-6#1)(2008-3#1)(2008-5#1)(2011-1#1)
consuming and##14##2##(1990-12#1)(1991-12#1)(1993-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2011-2#3)(2013-8#1)
consuming than##2##2##(1996-9#1)(2008-10#1)
consuming##68##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1996-9#1)(1997-4#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-8#1)(2013-8#1)
consummatory##4##1##(1990-7#2)(1993-12#1)(2012-3#1)
consumption (p = 0##3##4##(2011-2#3)
consumption (p##4##2##(2009-5#1)(2011-2#3)
consumption affects##2##2##(1996-2#1)(2012-2#1)
consumption after##2##2##(1995-5#1)(2009-3#1)
consumption among##3##2##(1991-12#1)(1994-5#1)(2008-7#1)
consumption and allows##2##3##(2008-10#1)(2009-8#1)
consumption and damage##2##3##(2008-5#2)
consumption and lactate##5##3##(2008-11#3)(2008-7#2)
consumption and other##2##3##(2007-12#1)(2008-3#1)
consumption and the##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)(2013-1#1)
consumption and waste##3##3##(2008-10#2)(2008-11#1)
consumption and##56##2##(1990-8#1)(1991-8#1)(1992-6#1)(1994-11#1)(1994-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#10)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
consumption are##4##2##(2008-10#2)(2008-7#1)(2010-10#1)
consumption as a##2##3##(2009-2#1)(2013-7#1)
consumption as##4##2##(2008-10#1)(2008-12#1)(2009-2#1)(2013-7#1)
consumption by the##6##3##(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)
consumption by##23##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#1)(1994-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#9)
consumption can be##3##3##(1991-5#1)(2008-1#1)(2008-2#1)
consumption can##5##2##(1991-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-2#1)
consumption decreased by##2##3##(1990-8#1)(2008-12#1)
consumption decreased##3##2##(1990-8#1)(2008-12#1)(2008-9#1)
consumption dramatically##2##2##(1991-3#1)(1993-12#1)
consumption during the##2##3##(2008-10#1)(2008-7#1)
consumption during##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2010-6#1)
consumption for##7##2##(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-4#1)
consumption has##3##2##(1993-12#1)(2008-11#1)(2008-5#1)
consumption have been##2##3##(2009-12#1)(2009-7#1)
consumption in a##4##3##(1993-3#1)(1997-1#1)(2008-5#1)(2008-7#1)
consumption in an##3##3##(1991-5#1)(2009-1#1)(2009-5#1)
consumption in both##3##3##(1990-8#1)(1991-9#1)(2008-7#1)
consumption in the##6##3##(1990-8#2)(1991-5#1)(1993-12#1)(1995-6#1)(1997-1#1)
consumption in##30##2##(1990-8#3)(1991-5#2)(1991-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
consumption is usually##2##3##(1995-11#1)(2008-10#1)
consumption is##18##2##(1990-2#3)(1994-2#1)(1994-6#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
consumption may##3##2##(1990-8#1)(2009-9#1)(2011-2#1)
consumption of 0##4##3##(2008-10#3)(2008-6#1)
consumption of a##5##3##(1991-8#1)(1996-2#1)(2008-2#1)(2008-3#1)(2010-4#1)
consumption of alcohol and##2##4##(1994-2#2)
consumption of alcohol##3##3##(1994-2#2)(1994-5#1)
consumption of animal protein##2##4##(2011-2#1)(2013-7#1)
consumption of butter##2##3##(1990-8#1)(1992-8#1)
consumption of calories##2##3##(2012-12#2)
consumption of ethanol##2##3##(1996-2#1)(2009-10#1)
consumption of fresh##3##3##(1990-8#1)(2007-12#1)(2008-1#1)
consumption of fruits and vegetables in six countries in Latin##2##10##(2012-2#2)
consumption of fruits and vegetables in##3##6##(2012-2#3)
consumption of fruits and vegetables##4##5##(2011-1#1)(2012-2#3)
consumption of game meat##2##4##(2013-7#2)
consumption of reagents##2##3##(2008-10#2)
consumption of sample and reagents##2##5##(2008-10#2)
consumption of sugar-sweetened beverages##2##4##(2011-2#2)
consumption of the probiotic##2##4##(2013-1#2)
consumption of the##6##3##(1995-11#1)(2008-10#1)(2008-3#2)(2013-1#2)
consumption of vegetables and##2##4##(2011-2#1)(2012-2#1)
consumption of vegetables##4##3##(1992-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
consumption of##116##2##(1990-6#2)(1990-8#4)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#3)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#5)(2008-6#2)(2009-10#1)(2009-5#4)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#4)(2013-7#5)
consumption on##6##2##(1992-9#1)(1996-2#1)(2009-3#1)(2012-2#2)(2013-1#1)
consumption patterns##2##2##(1994-2#1)(2012-2#1)
consumption rate of##2##3##(2008-7#1)(2013-1#1)
consumption rate##12##2##(2007-12#1)(2008-1#1)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#1)
consumption rates of##2##3##(2008-11#1)(2008-9#1)
consumption rates##7##2##(2008-11#2)(2008-7#4)(2008-9#1)
consumption significantly##2##2##(2008-1#1)(2008-11#1)
consumption to##3##2##(1994-2#2)(2013-1#1)
consumption was associated with##4##4##(2009-5#2)(2012-2#1)(2013-1#1)
consumption was increased about 2##2##5##(1997-4#2)
consumption was inversely associated with##2##5##(2009-9#2)
consumption was reduced##2##3##(2008-10#2)
consumption was##24##2##(1993-12#1)(1994-7#1)(1997-4#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-9#1)(2009-5#2)(2009-9#2)(2012-2#1)(2013-1#2)(2013-7#1)
consumption with##5##2##(1990-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
consumption##544##1##(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#8)(1990-8#11)(1990-9#3)(1991-12#3)(1991-3#3)(1991-5#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#11)(1994-3#1)(1994-5#3)(1994-6#3)(1994-7#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#6)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-4#9)(1997-6#2)(2007-12#5)(2007-2#2)(2008-1#9)(2008-10#80)(2008-11#44)(2008-12#5)(2008-2#4)(2008-3#18)(2008-4#4)(2008-5#22)(2008-6#7)(2008-7#29)(2008-8#7)(2008-9#14)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#5)(2009-3#5)(2009-4#2)(2009-5#10)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#5)(2010-2#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#20)(2012-1#6)(2012-12#6)(2012-2#28)(2012-3#4)(2013-1#24)(2013-7#9)(2013-8#9)
consumption)##4##1##(1996-5#1)(1997-7#1)(2008-11#1)(2013-8#1)
consumption]##5##1##(1990-9#2)(1996-3#1)(1997-2#2)
consumptions of##2##2##(1990-8#1)(2008-10#1)
consumptive coagulopathy##2##2##(2008-7#2)
consumptive##4##1##(2008-10#2)(2008-7#2)
contact activity##2##2##(2008-11#2)
contact aggression##2##2##(2009-4#2)
contact allergens##3##2##(2008-5#3)
contact allergic dermatitis##2##3##(2007-7#2)
contact and adhesion##3##3##(2011-1#3)
contact and##12##2##(1990-9#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-1#3)(2011-2#1)
contact angle and##5##3##(1997-1#1)(2008-5#2)(2008-7#1)(2009-7#1)
contact angle hysteresis##2##3##(2009-11#2)
contact angle measurement##2##3##(2008-5#1)(2009-7#1)
contact angle of##2##3##(2008-11#1)(2012-2#1)
contact angle##17##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#3)(2009-11#3)(2009-7#4)(2012-2#1)
contact are##3##2##(1997-6#1)(1997-9#1)(2008-7#1)
contact area##6##2##(2013-1#6)
contact areas were determined##2##4##(2013-1#2)
contact areas##4##2##(2009-8#2)(2013-1#2)
contact at##2##2##(2007-12#1)(2010-10#1)
contact between the two##2##4##(1993-3#1)(1994-5#1)
contact between the##9##3##(1993-3#1)(1994-5#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
contact between##22##2##(1990-12#1)(1993-3#1)(1994-3#1)(1994-5#2)(1997-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
contact dermatitis due to##2##4##(2008-5#1)(2012-3#1)
contact dermatitis##12##2##(1997-2#1)(2007-11#1)(2007-7#3)(2008-5#5)(2012-3#2)
contact during##2##2##(1990-11#1)(2008-6#1)
contact each other##2##3##(2007-12#1)(2009-9#1)
contact electrodes were##2##3##(2008-10#2)
contact electrodes##6##2##(2008-10#6)
contact forces##2##2##(2008-12#1)(2011-2#1)
contact from##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
contact in##4##2##(1994-5#1)(1997-3#1)(2008-6#1)(2010-5#1)
contact influences##2##2##(2008-11#2)
contact information##2##2##(2011-1#1)(2013-1#1)
contact inhibition##6##2##(1992-3#1)(1995-2#2)(2008-11#3)
contact investigations##2##2##(2008-10#1)(2010-5#1)
contact is##3##2##(1996-11#1)(2010-12#1)(2011-2#1)
contact lens wearers##2##3##(2011-1#1)(2011-2#1)
contact lens##6##2##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)
contact lenses##9##2##(1993-11#3)(2011-2#2)(2012-12#4)
contact loading##3##2##(2011-2#3)
contact microsoldering device##2##3##(2008-2#2)
contact mode##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
contact model##2##2##(2012-4#2)
contact normalization##3##2##(2012-12#3)
contact of##7##2##(1991-5#1)(1991-9#1)(2008-10#3)(2008-7#1)(2011-1#1)
contact on##2##2##(1992-3#1)(2008-10#1)
contact or##4##2##(1995-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
contact pairs##2##2##(2007-12#2)
contact prostheses##3##2##(2009-1#3)
contact residues in the##2##4##(1991-8#1)(1995-5#1)
contact residues in##3##3##(1991-8#2)(1995-5#1)
contact residues##6##2##(1991-8#4)(1995-5#1)(1997-9#1)
contact sensitization##2##2##(2008-10#2)
contact sensitizers##4##2##(2008-10#4)
contact shift pattern##2##3##(1994-5#2)
contact site##5##2##(1991-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(2008-10#1)
contact site-enriched fractions##2##3##(1990-12#2)
contact sites on##2##3##(1991-2#1)(1991-3#1)
contact sites##4##2##(1990-12#1)(1991-2#1)(1991-3#1)(2012-2#1)
contact slider##2##2##(2007-12#2)
contact such##2##2##(2007-12#1)(2008-3#1)
contact surface##7##2##(2008-10#2)(2009-4#1)(2013-1#4)
contact the##5##2##(1991-9#1)(2007-8#1)(2008-7#2)(2010-6#1)
contact time between##2##3##(2008-1#1)(2008-10#1)
contact time of the##2##4##(2008-10#2)
contact time of##4##3##(2008-10#4)
contact time##15##2##(2008-1#1)(2008-10#9)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
contact times##2##2##(2008-5#1)(2008-7#1)
contact to##4##2##(1991-12#1)(1995-11#1)(1997-8#1)(2013-1#1)
contact was present##2##3##(2007-7#1)(2012-3#1)
contact was##5##2##(1995-2#2)(2007-7#1)(2011-2#1)(2012-3#1)
contact were##3##2##(1992-9#1)(2008-10#2)
contact with HIV-infected##2##3##(1993-1#1)(1996-9#1)
contact with a##7##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)
contact with an##4##3##(2007-12#1)(2007-2#1)(2009-5#1)(2010-10#1)
contact with animals##2##3##(2008-11#1)(2013-1#1)
contact with it##2##3##(2008-3#1)(2008-7#1)
contact with other##2##3##(1992-5#1)(2010-1#1)
contact with patients##2##3##(1995-11#1)(2012-12#1)
contact with the antagonist##3##4##(2008-10#3)
contact with the basement membrane##2##5##(2009-10#2)
contact with the enzyme solution##2##5##(2008-10#2)
contact with the skin##2##4##(1992-3#1)(2008-10#1)
contact with the tissue##2##4##(2008-2#1)(2011-1#1)
contact with the##48##3##(1991-11#1)(1991-12#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1997-3#1)(2007-12#3)(2007-8#1)(2008-10#14)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#3)(2009-5#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
contact with their##2##3##(2009-11#1)(2012-2#1)
contact with water##2##3##(2008-10#2)
contact with##148##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-9#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-8#1)(2008-10#35)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#3)(2009-11#1)(2009-5#5)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
contact zone##2##2##(2010-4#1)(2010-8#1)
contact##540##1##(1990-11#1)(1990-12#5)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#6)(1991-9#4)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#5)(1993-11#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#8)(1994-6#4)(1994-8#2)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#11)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#2)(2007-10#1)(2007-11#3)(2007-12#17)(2007-2#1)(2007-7#8)(2007-8#2)(2008-1#1)(2008-10#110)(2008-11#17)(2008-12#8)(2008-2#4)(2008-3#19)(2008-4#4)(2008-5#23)(2008-6#6)(2008-7#22)(2008-8#4)(2008-9#6)(2009-1#4)(2009-10#3)(2009-11#7)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#8)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#6)(2010-4#3)(2010-5#8)(2010-6#2)(2010-8#3)(2011-1#14)(2011-2#24)(2011-7#1)(2012-1#3)(2012-12#17)(2012-2#8)(2012-3#5)(2012-4#2)(2013-1#16)(2013-7#2)(2013-8#3)
contacted by##5##2##(1991-12#1)(1997-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
contacted the##5##2##(1991-9#1)(1992-3#1)(2007-11#1)(2010-3#1)(2012-3#1)
contacted with##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
contacted##25##1##(1990-7#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-3#2)(1995-1#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#2)(2009-10#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
contacting with##2##2##(2008-10#1)(2008-8#1)
contacting##9##1##(1991-9#1)(1996-6#1)(2008-10#3)(2008-8#1)(2012-3#3)
contactor##2##1##(2008-7#2)
contacts are##2##2##(1992-6#1)(2010-5#1)
contacts between the protein and the##2##6##(1992-6#1)(1994-3#1)
contacts between the##7##3##(1992-6#1)(1994-3#1)(1996-2#1)(2008-6#2)(2008-7#2)
contacts between##11##2##(1991-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1996-2#1)(2008-6#2)(2008-7#2)
contacts for cough##2##3##(1993-12#2)
contacts from##2##2##(2011-1#1)(2013-8#1)
contacts in the##2##3##(1994-2#1)(1995-1#1)
contacts in##4##2##(1994-2#1)(1994-6#2)(1995-1#1)
contacts is##3##2##(1992-9#1)(1996-11#1)(2008-10#1)
contacts of asbestos##2##3##(1991-12#2)
contacts of##4##2##(1991-12#2)(1994-6#1)(2012-2#1)
contacts to##2##2##(2010-7#1)(2012-2#1)
contacts were##2##2##(1993-3#1)(2013-1#1)
contacts with##4##2##(1993-12#1)(1994-6#1)(1995-2#1)(2013-8#1)
contacts##82##1##(1990-7#1)(1991-11#1)(1991-12#4)(1991-3#1)(1992-12#2)(1992-4#1)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#5)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-4#1)(2008-6#3)(2008-7#8)(2008-9#2)(2010-5#4)(2010-7#1)(2011-1#4)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
contacts)##3##1##(2008-10#1)(2008-9#1)(2009-7#1)
contagion##8##1##(1991-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-8#2)
contagiosum in children##2##3##(2007-7#2)
contagiosum##4##1##(2007-7#3)(2008-5#1)
contagious and##2##2##(1990-6#1)(2009-4#1)
contagious##4##1##(1990-6#1)(2007-6#1)(2009-4#1)(2011-2#1)
contain 0##2##2##(1991-9#1)(2008-10#1)
contain DNA##2##2##(2008-10#1)(2009-5#1)
contain a complex mixture of##2##5##(1994-12#1)(1996-12#1)
contain a consensus sequence##2##4##(1994-12#1)(2009-8#1)
contain a high##2##3##(2011-1#1)(2012-2#1)
contain a large##2##3##(2007-12#1)(2008-2#1)
contain a novel##2##3##(1993-11#1)(1995-12#1)
contain a number of##4##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
contain a small number of##2##5##(1992-8#1)(2010-5#1)
contain a specific##4##3##(1990-11#1)(1990-5#2)(1994-8#1)
contain a variety of##3##4##(1997-8#1)(2008-7#1)(2008-9#1)
contain a wide variety of##2##5##(1995-3#1)(2008-5#1)
contain a##74##2##(1990-11#3)(1990-3#1)(1990-5#5)(1991-1#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#2)(1993-9#1)(1994-12#3)(1994-8#2)(1995-12#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
contain an##11##2##(1990-11#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-3#2)(2007-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
contain appreciable##2##2##(1990-8#1)(1991-12#1)
contain approximately##3##2##(1993-6#2)(1997-4#1)
contain at least three##2##4##(2008-10#1)(2008-9#1)
contain at least two##2##4##(1992-10#1)(2008-10#1)
contain at least##5##3##(1992-10#1)(2008-10#3)(2008-9#1)
contain both##5##2##(1990-12#1)(1993-12#1)(1995-12#1)(2011-2#1)(2012-2#1)
contain costs and##2##3##(1991-1#1)(1994-1#1)
contain costs##6##2##(1991-1#1)(1992-12#1)(1994-1#1)(1994-3#2)(1996-2#1)
contain detectable levels of##2##4##(1992-10#1)(1992-11#1)
contain detectable##3##2##(1992-10#1)(1992-11#1)(1992-12#1)
contain different##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
contain distinct##2##2##(1996-2#1)(1997-3#1)
contain either##4##2##(1994-12#1)(1995-5#1)(2008-5#1)(2012-12#1)
contain electron##2##2##(2008-7#2)
contain few##2##2##(2008-4#1)(2010-9#1)
contain genes##2##2##(2007-12#1)(2009-6#1)
contain glycine##2##2##(1994-2#1)(1997-2#1)
contain high levels of##2##4##(2008-10#1)(2008-5#1)
contain high##5##2##(2008-10#1)(2008-5#2)(2010-11#1)(2012-2#1)
contain higher##2##2##(1997-4#1)(2008-10#1)
contain information##4##2##(1996-3#1)(2008-11#1)(2008-3#1)(2010-10#1)
contain item-writing flaws##2##3##(2008-12#2)
contain loci##2##2##(2008-1#1)(2008-10#1)
contain low##2##2##(1990-5#1)(1992-12#1)
contain many different##3##3##(2008-2#1)(2008-4#1)(2012-1#1)
contain many##8##2##(1992-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-3#1)(2012-1#1)
contain more than one##2##4##(2008-10#1)(2008-8#1)
contain more than##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
contain more##7##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
contain multiple##5##2##(1995-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)
contain no##2##2##(1990-11#1)(1996-12#1)
contain one or more##3##4##(1993-2#1)(1996-12#1)(2008-2#1)
contain one or##4##3##(1993-2#1)(1996-12#1)(1996-5#1)(2008-2#1)
contain one##5##2##(1993-2#1)(1996-12#1)(1996-5#1)(2008-2#1)(2008-9#1)
contain only a few##2##4##(2007-12#1)(2008-9#1)
contain only a##3##3##(1991-2#1)(2007-12#1)(2008-9#1)
contain only##7##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
contain organic##3##2##(2008-10#2)(2008-11#1)
contain predominantly##2##2##(2007-12#2)
contain proteins##2##2##(1995-5#1)(2008-7#1)
contain relatively##2##2##(2008-10#2)
contain secretory##2##2##(2007-12#1)(2008-7#1)
contain sequences##3##2##(1993-8#1)(1995-2#1)(2008-7#1)
contain several##5##2##(1993-6#1)(1995-6#1)(1995-8#1)(2008-10#1)(2009-12#1)
contain short regions##2##3##(1995-5#1)(2008-10#1)
contain short##3##2##(1995-5#1)(1997-7#1)(2008-10#1)
contain some##4##2##(1997-3#1)(2006-6#1)(2008-12#1)(2008-2#1)
contain stress##2##2##(2008-3#2)
contain the gene##2##3##(1997-3#1)(2008-10#1)
contain the pathogen##2##3##(2008-10#2)
contain the same##2##3##(1995-8#1)(2007-11#1)
contain the##46##2##(1990-11#1)(1990-12#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#2)(2008-8#2)(2012-2#1)(2012-3#1)
contain three##2##2##(2010-11#1)(2013-1#1)
contain two##16##2##(1990-5#1)(1992-12#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-2#2)(2007-12#1)(2008-3#1)(2008-8#2)(2011-1#1)
contain various##2##2##(1997-3#1)(2008-10#1)
contain water##2##2##(1992-8#1)(2008-7#1)
contain##529##1##(1990-11#8)(1990-12#2)(1990-3#1)(1990-5#11)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#8)(1992-3#3)(1992-6#1)(1992-8#6)(1992-9#5)(1993-11#6)(1993-12#5)(1993-2#2)(1993-6#11)(1993-8#7)(1993-9#5)(1994-1#1)(1994-11#6)(1994-12#8)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#5)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#4)(1995-6#5)(1995-8#4)(1996-1#2)(1996-12#7)(1996-2#6)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#1)(1997-2#5)(1997-3#5)(1997-4#4)(1997-7#4)(1997-8#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#21)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#63)(2008-11#16)(2008-12#3)(2008-2#10)(2008-3#18)(2008-4#11)(2008-5#16)(2008-6#1)(2008-7#25)(2008-8#12)(2008-9#16)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#10)
contained &gt##2##2##(1997-2#1)(2008-10#1)
contained 0##2##2##(1992-11#1)(1997-2#1)
contained 13##2##2##(2009-9#1)(2012-2#1)
contained 43##2##2##(2008-10#1)(2008-6#1)
contained 6##2##2##(2011-3#1)(2013-8#1)
contained 80##2##2##(1995-12#1)(2007-11#1)
contained a 14##2##3##(2008-10#1)(2008-6#1)
contained a higher##2##3##(1997-2#1)(2009-10#1)
contained a large##2##3##(1990-12#1)(1996-5#1)
contained a mixture of##3##4##(1990-9#1)(1997-2#1)(2008-10#1)
contained a number of##2##4##(1996-3#1)(2008-10#1)
contained a sequence##3##3##(1992-9#1)(1997-8#1)(2008-10#1)
contained a single open reading frame##2##6##(1997-7#1)(2008-10#1)
contained a single##10##3##(1991-2#1)(1993-11#1)(1995-2#1)(1997-7#1)(2008-10#6)
contained a unique##2##3##(2008-10#1)(2009-5#1)
contained a##78##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#26)(2008-12#2)(2008-6#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#2)
contained about##3##2##(1990-10#1)(1991-6#1)(1992-3#1)
contained all eleven##2##3##(1997-4#1)(1997-7#1)
contained all of the##2##4##(1990-7#1)(2008-10#1)
contained all##6##2##(1990-7#1)(1991-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)
contained an internal standard##2##4##(2008-10#2)
contained an open reading frame encoding a##2##7##(1990-5#1)(1992-9#1)
contained an open reading frame of##4##6##(1990-11#1)(1996-10#1)(1996-3#1)(1997-9#1)
contained an open reading frame##7##5##(1990-11#1)(1990-5#1)(1992-9#1)(1993-12#1)(1996-10#1)(1996-3#1)(1997-9#1)
contained an##20##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-9#2)(1993-11#1)(1993-12#2)(1994-12#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-3#1)(1997-9#1)(2008-10#4)
contained approximately##2##2##(1995-6#1)(2011-2#1)
contained at least one##2##4##(1995-11#1)(2008-8#1)
contained at least##6##3##(1993-1#1)(1993-11#1)(1995-11#1)(1996-12#2)(2008-8#1)
contained both##7##2##(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#2)
contained clusters of isolates of the same##2##7##(2008-10#2)
contained dense##2##2##(2008-10#2)
contained either##3##2##(1995-12#1)(1995-6#1)(2008-5#1)
contained elevated levels of##2##4##(1990-2#2)
contained fungal##2##2##(1997-3#1)(2008-10#1)
contained gamma-aminobutyric acid##2##3##(1997-3#2)
contained gene##2##2##(2008-10#1)(2009-10#1)
contained glucose##2##2##(1991-9#1)(2008-10#1)
contained glycine##2##2##(1997-3#2)
contained greater##2##2##(1990-11#1)(2009-7#1)
contained high amounts of##2##4##(2008-5#1)(2011-2#1)
contained high levels of##3##4##(2008-10#1)(2008-11#2)
contained high##7##2##(1992-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
contained higher##2##2##(2008-10#1)(2010-5#1)
contained identical##2##2##(1992-12#1)(2008-10#1)
contained in a##10##3##(1990-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)
contained in many##2##3##(2008-10#1)(2008-3#1)
contained in some##2##3##(1991-6#1)(2008-10#1)
contained in the membrane##2##4##(1994-12#1)(1996-8#1)
contained in the##29##3##(1990-2#1)(1990-5#1)(1990-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2009-8#1)(2013-1#1)
contained in##70##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#2)(2008-10#22)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#5)(2008-7#2)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
contained increased##2##2##(1990-12#1)(1990-2#1)
contained information##2##2##(2011-2#1)(2013-1#1)
contained isolates from##4##3##(2008-10#4)
contained isolates of##2##3##(2008-10#2)
contained isolates##6##2##(2008-10#6)
contained large##2##2##(2007-6#1)(2008-12#1)
contained less##4##2##(2008-10#3)(2008-5#1)
contained mainly##2##2##(1991-10#1)(1993-9#1)
contained maximum##3##2##(2013-1#3)
contained measurable##2##2##(2008-10#1)(2013-1#1)
contained more than##4##3##(2008-10#3)(2008-8#1)
contained more##11##2##(1993-11#1)(1994-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
contained most##2##2##(1990-7#1)(2008-7#1)
contained no detectable##3##3##(1991-12#1)(2008-11#2)
contained no##9##2##(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)
contained numerous##4##2##(1995-3#1)(2008-10#1)(2008-4#1)(2011-2#1)
contained on##2##2##(1994-3#1)(1997-6#1)
contained oncogenic##2##2##(1994-1#2)
contained one##4##2##(1990-5#1)(2008-10#3)
contained only the##2##3##(1997-2#1)(2008-10#1)
contained only##11##2##(1990-5#1)(1993-6#1)(1997-2#2)(2008-10#7)
contained plasmids##2##2##(2008-10#2)
contained predominantly##2##2##(1997-2#1)(2008-10#1)
contained race##2##2##(2008-10#2)
contained sequences of##2##3##(2008-10#2)
contained several##4##2##(1990-11#1)(1993-12#1)(1997-7#1)(2012-3#1)
contained significant##2##2##(1995-3#1)(2008-7#1)
contained some##2##2##(1992-10#1)(2008-8#1)
contained the same##3##3##(2008-10#2)(2008-5#1)
contained the##42##2##(1990-11#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-6#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#3)
contained this##2##2##(1992-6#1)(1997-3#1)
contained three##7##2##(1990-11#1)(1992-3#1)(1993-3#1)(1997-8#1)(2008-10#2)(2008-5#1)
contained two##10##2##(1991-9#1)(1992-2#1)(1992-6#1)(2008-10#6)(2010-8#1)
contained various##2##2##(1996-6#1)(2008-10#1)
contained within a##5##3##(1995-2#1)(1995-5#1)(2009-10#1)(2010-11#1)(2012-2#1)
contained within an##2##3##(1995-2#1)(2008-2#1)
contained within the##9##3##(1993-12#1)(1993-8#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
contained within##21##2##(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-11#1)(2012-12#1)(2012-2#1)
contained##612##1##(1990-10#1)(1990-11#7)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#8)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#6)(1992-6#3)(1992-8#7)(1992-9#7)(1993-1#1)(1993-11#5)(1993-12#8)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#6)(1995-11#11)(1995-12#6)(1995-2#6)(1995-3#5)(1995-5#2)(1995-6#6)(1995-8#2)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#14)(1997-3#11)(1997-4#5)(1997-6#1)(1997-7#6)(1997-8#5)(1997-9#1)(2007-11#3)(2007-12#7)(2007-6#2)(2008-10#180)(2008-11#23)(2008-12#10)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#20)(2008-6#6)(2008-7#18)(2008-8#13)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#10)(2013-8#6)
container##12##1##(1993-6#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#3)(2011-2#1)(2012-12#1)
containers and##2##2##(2011-2#1)(2013-8#1)
containers during##2##2##(2008-10#1)(2011-2#1)
containers with##3##2##(2008-11#1)(2008-5#2)
containers##29##1##(1990-3#1)(2008-10#13)(2008-11#2)(2008-5#5)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-12#1)(2013-8#1)
containing 0##80##2##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1995-6#1)(1996-2#1)(2008-10#48)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#12)(2009-9#1)(2010-3#1)(2011-2#2)(2013-1#1)
containing 1 mM of##2##4##(2010-4#1)(2010-5#1)
containing 1##21##2##(1991-12#1)(1991-8#1)(1992-11#1)(1995-6#1)(1996-12#1)(2007-11#2)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-3#1)
containing 1%##8##2##(1997-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#1)
containing 10 mM##4##3##(1996-5#1)(1997-1#1)(2008-10#2)
containing 10 mg##2##3##(1993-1#1)(2012-12#1)
containing 10##11##2##(1993-1#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-10#4)(2008-5#2)(2012-12#1)
containing 10%##7##2##(2008-11#5)(2008-5#1)(2013-1#1)
containing 100 mM##2##3##(1996-5#1)(2008-10#1)
containing 100##7##2##(1993-9#1)(1996-5#1)(2008-10#3)(2008-5#1)(2008-6#1)
containing 10mM##2##2##(2008-10#2)
containing 150 mg calcium and##2##4##(2013-7#2)
containing 2 x##2##3##(2008-10#1)(2008-7#1)
containing 2##14##2##(1991-7#1)(1992-12#1)(2008-10#10)(2008-7#1)(2009-3#1)
containing 2%##5##2##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
containing 20 mM##2##3##(1996-5#1)(2009-6#1)
containing 20##9##2##(1990-2#2)(1994-5#2)(1996-5#1)(2008-10#1)(2008-9#1)(2009-6#1)(2012-3#1)
containing 20%##4##2##(2008-10#2)(2008-5#2)
containing 20mugl(-1) of Cu(II)##2##4##(2008-10#2)
containing 21##2##2##(2008-10#1)(2010-3#1)
containing 3##6##2##(1994-5#1)(2008-10#3)(2008-5#1)(2012-1#1)
containing 30##3##2##(1994-5#2)(2008-12#1)
containing 4##3##2##(2008-10#2)(2012-2#1)
containing 4%##2##2##(2008-10#1)(2010-3#1)
containing 40##2##2##(2008-10#1)(2009-12#1)
containing 40% (v/v)##2##3##(2008-10#2)
containing 5 mM##6##3##(1990-8#1)(1995-6#1)(2008-10#2)(2008-11#2)
containing 5##13##2##(1990-8#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-11#2)(2011-2#1)
containing 5% DEET (w/w)##2##4##(2008-5#2)
containing 5% of the##2##4##(2008-5#2)
containing 5% of##3##3##(2008-5#3)
containing 5%##12##2##(2008-10#2)(2008-11#1)(2008-5#7)(2008-6#1)(2010-4#1)
containing 50##4##2##(1995-2#1)(2008-10#3)
containing 50%##2##2##(2008-10#1)(2008-3#1)
containing 6##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
containing 6%##2##2##(2010-2#1)(2010-4#1)
containing 7##3##2##(2008-10#2)(2008-11#1)
containing 70%##2##2##(1993-12#1)(2008-10#1)
containing 8##7##2##(2008-10#3)(2011-2#4)
containing AA##2##2##(2008-10#1)(2008-5#1)
containing As##2##2##(2008-10#2)
containing B##2##2##(2008-10#2)
containing Cu(II)##2##2##(2008-10#2)
containing DMPC##2##2##(1994-12#1)(1994-3#1)
containing EDTA##3##2##(1990-12#1)(2008-10#2)
containing HNO(3)##2##2##(2008-10#2)
containing L(1)##2##2##(2008-10#2)
containing N-acetylglucosamine or sialic acid##2##5##(2008-11#2)
containing Ni(II)##2##2##(1993-8#1)(2008-10#1)
containing ODN##3##2##(2008-10#3)
containing RNA##2##2##(1991-2#1)(2012-2#1)
containing a 0##2##3##(1997-3#1)(2008-11#1)
containing a 1##3##3##(1990-7#1)(2008-10#2)
containing a 4##2##3##(1993-9#1)(1994-12#1)
containing a CWP##2##3##(2008-10#2)
containing a functional##3##3##(1991-7#1)(2008-11#1)(2008-5#1)
containing a human##2##3##(2008-10#1)(2010-1#1)
containing a large number of##3##5##(1995-5#1)(2009-3#1)(2012-2#1)
containing a large##4##3##(1995-5#1)(2008-10#1)(2009-3#1)(2012-2#1)
containing a lipophilic##3##3##(2008-10#3)
containing a mixture of##3##4##(2008-10#2)(2010-3#1)
containing a plasmid with##3##4##(1991-7#1)(1995-2#2)
containing a random##2##3##(2007-11#1)(2008-10#1)
containing a reduced apyrimidinic##2##4##(1995-2#2)
containing a single##10##3##(1990-7#1)(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#5)(2011-1#1)
containing a variety of##3##4##(1994-12#1)(2008-5#1)(2008-8#1)
containing a very##2##3##(2007-12#1)(2008-7#1)
containing a##158##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-6#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#4)(2008-10#58)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
containing about##5##2##(1992-11#1)(1994-11#1)(1995-9#1)(2008-7#2)
containing acetic acid-sodium acetate buffer (pH##3##6##(2008-10#3)
containing acetic##4##2##(2008-10#4)
containing acetonitrile##2##2##(2008-10#2)
containing active##2##2##(1992-3#1)(2007-11#1)
containing air sample matrix##2##4##(2008-10#2)
containing alkaline##2##2##(1993-6#1)(2008-10#1)
containing all##4##2##(2008-10#4)
containing alpha-nitroso-beta-naphthol as##2##3##(2008-10#2)
containing ammonium##2##2##(2008-10#2)
containing an open reading frame##3##5##(1994-12#1)(1995-6#1)(2008-9#1)
containing an##31##2##(1990-8#1)(1992-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)
containing approximately##2##2##(2008-3#1)(2012-3#1)
containing as much as##2##4##(1997-4#1)(2009-11#1)
containing as##6##2##(1997-4#1)(2008-10#3)(2009-11#2)
containing at least##4##3##(1996-5#1)(2008-7#2)(2010-10#1)
containing between##3##2##(2008-10#2)(2008-9#1)
containing both the##2##3##(2008-10#1)(2008-11#1)
containing both##20##2##(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#1)
containing bromide##4##2##(2008-10#1)(2008-9#2)(2010-5#1)
containing cationic##2##2##(1994-9#1)(2008-11#1)
containing cell##2##2##(2008-11#1)(2008-8#1)
containing cells##3##2##(1995-11#1)(2008-11#1)(2011-2#1)
containing cholesterol are##2##3##(1992-6#1)(1994-5#1)
containing cholesterol##4##2##(1990-11#1)(1992-6#2)(1994-5#1)
containing chromogranin##2##2##(1990-5#1)(1992-12#1)
containing compounds##3##2##(2008-10#2)(2010-5#1)
containing corn##2##2##(2008-10#2)
containing covalently bound##2##3##(2008-10#2)
containing covalently##5##2##(1990-7#2)(2008-10#2)(2008-5#1)
containing data on##2##3##(2008-11#1)(2011-2#1)
containing different concentration ratios of##3##5##(2008-10#2)(2008-6#1)
containing different concentration##4##3##(2008-10#3)(2008-6#1)
containing different concentrations of##6##4##(2008-10#4)(2008-12#1)(2010-10#1)
containing different lengths of##2##4##(1991-7#1)(1997-2#1)
containing different##22##2##(1991-7#1)(1992-6#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)
containing dilute##2##2##(2007-12#1)(2008-10#1)
containing dinucleotides##3##2##(2008-4#3)
containing dissolved##2##2##(1994-12#1)(2008-11#1)
containing either 5##2##3##(1992-8#2)
containing either a##3##3##(1995-2#1)(2008-4#1)(2008-5#1)
containing either##23##2##(1992-8#2)(1993-11#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-4#3)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#5)(2010-8#1)
containing equimolar##2##2##(2008-10#1)(2008-5#1)
containing fetal calf serum (FCS)##2##5##(2008-11#1)(2008-7#1)
containing fetal calf serum##5##4##(1992-6#1)(2008-11#3)(2008-7#1)
containing five##3##2##(1991-7#1)(1995-8#1)(2008-3#1)
containing four##6##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
containing from##2##2##(2008-10#1)(2012-1#1)
containing glucose and##2##3##(1994-6#1)(2008-6#1)
containing glucose##6##2##(1994-6#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-2#1)
containing heat-killed##3##2##(1997-6#1)(2011-1#2)
containing high concentrations of##3##4##(2008-10#3)
containing high levels of##2##4##(2008-10#2)
containing high##10##2##(1992-6#1)(2008-10#8)(2009-8#1)
containing human##7##2##(1996-6#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#2)
containing hydrogen##2##2##(2008-10#2)
containing immobilized##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
containing information on##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
containing information##4##2##(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
containing inosine##2##2##(1991-7#1)(2008-10#1)
containing ionophores##2##2##(2008-10#2)
containing iron##2##2##(2008-10#1)(2008-11#1)
containing its##2##2##(1993-11#1)(1996-3#1)
containing known##2##2##(2008-5#1)(2008-7#1)
containing lacZ gene in##2##4##(2008-11#2)
containing lacZ##3##2##(2008-11#2)(2008-8#1)
containing large##5##2##(2008-10#2)(2008-6#1)(2008-9#1)(2011-1#1)
containing less##4##2##(1991-6#1)(1997-4#1)(2008-10#1)(2008-2#1)
containing lipoproteins are##2##3##(1990-2#1)(1994-12#1)
containing lipoproteins##5##2##(1990-2#2)(1994-12#2)(2008-7#1)
containing low concentrations of##3##4##(2008-10#2)(2008-3#1)
containing low##5##2##(2008-10#3)(2008-3#1)(2010-4#1)
containing medium##8##2##(2008-11#7)(2008-12#1)
containing membrane##2##2##(1994-12#1)(2008-10#1)
containing metal##2##2##(2008-10#1)(2008-7#1)
containing metastases##2##2##(2013-1#2)
containing methanol##3##2##(1996-5#2)(2008-10#1)
containing mixtures of##2##3##(2008-10#1)(2008-3#1)
containing moniliformin##2##2##(2008-5#2)
containing monovalent and divalent##2##4##(2008-10#1)(2011-2#1)
containing more than 20##2##4##(1990-2#1)(2007-12#1)
containing more than##8##3##(1990-2#1)(1991-12#1)(1993-11#2)(2007-12#2)(2008-10#2)
containing multiple copies of##2##4##(1995-5#1)(2008-10#1)
containing multiple##9##2##(1991-6#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)
containing mutations##2##2##(1992-9#1)(2009-7#1)
containing nitrate##2##2##(2008-10#1)(2008-11#1)
containing nitric##2##2##(1995-12#1)(2008-10#1)
containing no##11##2##(1990-5#1)(1991-8#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2009-8#1)(2010-4#1)
containing numerous##7##2##(1991-12#1)(1993-2#1)(2007-12#1)(2011-2#1)(2013-8#3)
containing one of##2##3##(1995-2#1)(2008-10#1)
containing one or both##2##4##(1995-11#1)(2008-10#1)
containing one or more##2##4##(2008-10#1)(2010-11#1)
containing one or##5##3##(1995-11#1)(1996-5#1)(2008-10#2)(2010-11#1)
containing one##12##2##(1993-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-11#1)
containing only##16##2##(1991-5#1)(1993-6#1)(1993-8#1)(2008-10#7)(2008-11#4)(2008-6#1)(2012-12#1)
containing organic##2##2##(2008-10#1)(2008-11#1)
containing other##4##2##(1994-5#1)(2008-10#3)
containing palmitate##2##2##(1992-9#1)(1995-8#1)
containing paracetamol##3##2##(2008-10#2)(2010-3#1)
containing particles##2##2##(1993-2#1)(2008-10#1)
containing peptide sequences biochemically related to##2##6##(1992-12#1)(1994-11#1)
containing peptide##3##2##(1990-8#1)(1992-12#1)(1994-11#1)
containing perfect##2##2##(2008-10#1)(2008-9#1)
containing peroxidase##2##2##(2008-10#1)(2008-5#1)
containing phosphate##3##2##(1992-12#1)(2008-10#2)
containing phosphorus##2##2##(1995-11#1)(2008-10#1)
containing potassium##2##2##(2008-10#2)
containing predominantly##2##2##(1997-7#1)(2008-2#1)
containing product##2##2##(2008-10#1)(2010-5#1)
containing proline##2##2##(1994-11#2)
containing protein##6##2##(1991-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-8#1)
containing proteins in##2##3##(2008-11#1)(2009-8#1)
containing proteins##4##2##(1992-6#1)(2008-11#1)(2009-8#1)(2011-2#1)
containing pyridine##2##2##(1996-2#1)(2008-10#1)
containing pyrrole##2##2##(2008-10#2)
containing reference##2##2##(2008-10#2)
containing relatively high concentrations of##2##5##(1996-1#1)(2012-12#1)
containing relatively high##3##3##(1996-1#1)(2008-10#1)(2012-12#1)
containing residues##2##2##(1995-3#1)(1997-9#1)
containing sample##3##2##(1994-2#1)(2008-10#2)
containing scattering##2##2##(2007-11#1)(2008-2#1)
containing sections##2##2##(1995-3#1)(2008-6#1)
containing sequences##6##2##(1990-12#1)(1991-9#1)(1993-8#1)(1994-3#1)(2008-11#1)(2008-9#1)
containing serovars A##2##3##(1997-6#2)
containing serum##5##2##(1994-8#1)(2008-11#2)(2008-5#1)(2013-8#1)
containing several##6##2##(1995-2#1)(2008-10#2)(2008-7#1)(2010-11#1)(2013-1#1)
containing single##4##2##(1995-6#1)(2007-11#1)(2008-10#2)
containing site 8 O-acetylated sialomucins##2##5##(1990-2#2)
containing six##4##2##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
containing skin##2##2##(2010-8#1)(2012-12#1)
containing small##5##2##(1990-6#1)(1991-2#1)(1994-12#1)(2009-12#1)(2010-4#1)
containing sodium##5##2##(1994-9#1)(2008-10#4)
containing solutions##2##2##(2008-10#2)
containing specific##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
containing standard##2##2##(1992-12#1)(1996-1#1)
containing structured##2##2##(2008-9#1)(2011-1#1)
containing substances##2##2##(2008-7#1)(2009-9#1)
containing sulfur##2##2##(2008-10#1)(2008-11#1)
containing surfactants##2##2##(1996-5#1)(2008-10#1)
containing suspended##2##2##(2008-10#2)
containing ten##2##2##(2008-10#2)
containing tetra-butylammonium perchlorate##2##3##(2008-10#2)
containing the 3'##2##3##(1994-9#2)
containing the 5'##4##3##(1991-7#1)(1992-12#1)(1994-12#1)(2008-8#1)
containing the 5'-upstream region of##2##5##(1996-3#2)
containing the HIV-1##2##3##(2008-11#2)
containing the Kunitz-type protease inhibitor (KPI) insert##2##7##(1996-12#2)
containing the N##2##3##(2008-10#2)
containing the RGD sequence##2##4##(1994-11#2)
containing the TPR##2##3##(1996-2#1)(1997-7#1)
containing the analyte##2##3##(2008-10#2)
containing the anions##2##3##(2008-10#2)
containing the beta##2##3##(1992-8#1)(2008-11#1)
containing the chicken##2##3##(1997-9#1)(2008-11#1)
containing the complete##2##3##(1993-2#1)(2012-3#1)
containing the consensus##2##3##(2008-8#1)(2009-6#1)
containing the entire##4##3##(1990-2#1)(1990-5#1)(1991-12#1)(1996-8#1)
containing the extract##2##3##(2008-5#2)
containing the growth##2##3##(1992-2#1)(1995-1#1)
containing the major##4##3##(1994-12#1)(1994-8#1)(2008-10#1)(2013-1#1)
containing the promoter##2##3##(1992-8#1)(1994-12#1)
containing the promoterless##2##3##(1993-12#1)(1994-12#1)
containing the purine units##2##4##(2008-10#2)
containing the putative##2##3##(2008-10#1)(2008-9#1)
containing the reporter gene##2##4##(1994-12#1)(2008-9#1)
containing the same##4##3##(1993-9#1)(1997-4#1)(2007-12#1)(2008-10#1)
containing the synthetic##2##3##(2008-10#1)(2008-5#1)
containing the target##2##3##(2008-10#1)(2008-8#1)
containing the##258##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#5)(1990-8#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#4)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#10)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-2#7)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#3)(1997-2#2)(1997-3#3)(1997-4#3)(1997-7#4)(1997-8#3)(1997-9#2)(2007-11#1)(2007-12#4)(2008-10#60)(2008-11#15)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
containing these##9##2##(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-4#1)(2010-10#1)
containing this##8##2##(1990-5#1)(1992-11#1)(1993-9#1)(1996-5#2)(2008-10#1)(2008-11#1)(2009-11#1)
containing three##8##2##(1990-7#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
containing two##9##2##(1991-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
containing tyrosine##2##2##(1994-6#1)(1995-6#1)
containing unsaturated phosphatidylethanolamine##2##3##(1994-3#2)
containing unsaturated##3##2##(1990-8#1)(1994-3#2)
containing up to##8##3##(1996-12#1)(2007-12#1)(2008-10#6)
containing uracil##2##2##(1992-3#2)
containing variable##2##2##(1993-11#1)(2013-1#1)
containing various concentrations of##3##4##(1991-9#1)(2008-10#1)(2012-7#1)
containing various organic and inorganic substances##2##6##(2008-10#1)(2008-11#1)
containing various##14##2##(1991-12#1)(1991-9#1)(1992-12#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2012-7#1)
containing varying concentrations of##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
containing varying##6##2##(2008-10#4)(2008-11#1)(2011-1#1)
containing vegetable##2##2##(2008-5#2)
containing viral RNA##2##3##(2008-10#1)(2010-5#1)
containing viral##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
containing water##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
containing weak##2##2##(2008-10#1)(2008-3#1)
containing yellow##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
containing zinc##2##2##(2008-10#1)(2008-5#1)
containing##2142##1##(1990-11#4)(1990-12#11)(1990-2#11)(1990-3#1)(1990-5#16)(1990-6#5)(1990-7#9)(1990-8#10)(1991-12#12)(1991-2#9)(1991-3#2)(1991-5#5)(1991-6#3)(1991-7#9)(1991-8#3)(1991-9#7)(1992-10#1)(1992-11#4)(1992-12#14)(1992-2#2)(1992-3#10)(1992-6#16)(1992-8#10)(1992-9#4)(1993-1#2)(1993-11#13)(1993-12#10)(1993-2#6)(1993-3#3)(1993-5#1)(1993-6#11)(1993-8#15)(1993-9#17)(1994-10#2)(1994-11#14)(1994-12#26)(1994-2#2)(1994-3#7)(1994-5#19)(1994-6#10)(1994-8#9)(1994-9#9)(1995-1#1)(1995-11#7)(1995-12#5)(1995-2#28)(1995-3#10)(1995-5#17)(1995-6#20)(1995-8#13)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#12)(1996-2#10)(1996-3#4)(1996-5#23)(1996-6#4)(1996-8#6)(1997-1#2)(1997-2#7)(1997-3#8)(1997-4#20)(1997-5#1)(1997-6#10)(1997-7#15)(1997-8#8)(1997-9#3)(2006-12#2)(2007-10#1)(2007-11#23)(2007-12#29)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#776)(2008-11#109)(2008-12#14)(2008-2#29)(2008-3#27)(2008-4#30)(2008-5#96)(2008-6#20)(2008-7#33)(2008-8#50)(2008-9#53)(2009-10#3)(2009-11#7)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#7)(2009-8#10)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#3)(2010-2#6)(2010-3#10)(2010-4#18)(2010-5#9)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#13)(2011-2#36)(2011-3#2)(2012-1#5)(2012-12#13)(2012-2#11)(2012-3#12)(2012-7#1)(2013-1#31)(2013-7#5)(2013-8#8)
containment and##10##2##(1994-12#2)(1995-3#1)(1996-2#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#1)
containment measures##6##2##(1992-1#1)(2008-11#1)(2011-2#3)(2011-3#1)
containment on##3##2##(1991-3#1)(1992-1#1)(2008-9#1)
containment strategies##2##2##(2008-11#1)(2011-2#1)
containment strategy##2##2##(1994-2#1)(2011-2#1)
containment##78##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#5)(1992-12#1)(1992-3#3)(1993-2#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#7)(2010-12#1)(2011-2#13)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
contains 1##2##2##(1994-5#1)(2007-12#1)
contains 12##4##2##(1995-2#1)(2008-10#2)(2010-4#1)
contains a 1##2##3##(1993-12#1)(2008-10#1)
contains a binding site for the##2##6##(1992-8#1)(1995-6#1)
contains a central##2##3##(1995-8#1)(2007-12#1)
contains a high concentration of##2##5##(2008-11#1)(2008-4#1)
contains a highly conserved##2##4##(1993-12#1)(2008-8#1)
contains a large##4##3##(1991-8#1)(1997-3#1)(2007-12#2)
contains a non-heme##2##3##(1991-12#2)
contains a number of##3##4##(2008-4#1)(2008-7#1)(2012-2#1)
contains a potential##3##3##(1992-3#1)(1992-6#1)(2008-8#1)
contains a putative##4##3##(1993-3#1)(1994-12#3)
contains a single##5##3##(1990-11#1)(1993-12#1)(1993-3#1)(2007-12#1)(2008-10#1)
contains a small##3##3##(1996-3#1)(2007-12#1)(2013-8#1)
contains a unique##2##3##(1993-11#1)(1996-2#1)
contains a##123##2##(1990-11#4)(1990-12#1)(1990-5#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#3)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#5)(1994-5#1)(1994-8#1)(1995-2#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1997-3#2)(2007-11#2)(2007-12#8)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
contains about##2##2##(1995-8#1)(2008-10#1)
contains all of the conserved##2##5##(1990-5#1)(1997-7#1)
contains all of the##3##4##(1990-5#1)(1997-7#1)(2008-10#1)
contains all the##4##3##(1990-11#2)(2008-2#1)(2008-7#1)
contains all three##2##3##(1995-2#1)(1995-3#1)
contains all##11##2##(1990-11#2)(1990-5#1)(1991-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
contains an N-terminal##2##3##(1991-6#1)(1993-12#1)
contains an additional##2##3##(1994-8#1)(2008-7#1)
contains an open reading frame (ORF)##3##6##(1994-12#1)(1995-8#1)(2008-10#1)
contains an open reading frame encoding##4##6##(1990-11#1)(1994-12#1)(1995-6#1)(2008-5#1)
contains an open reading frame of##6##6##(1990-5#1)(1993-2#2)(1994-8#1)(1995-6#1)(1997-2#1)
contains an open reading frame##14##5##(1990-11#1)(1990-5#1)(1993-11#1)(1993-2#2)(1994-12#2)(1994-8#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#1)(2008-5#1)
contains an##46##2##(1990-11#3)(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#2)(1994-12#4)(1994-8#2)(1995-6#3)(1995-8#1)(1997-2#2)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)
contains approximately##6##2##(1991-5#1)(1992-8#1)(2007-11#1)(2009-3#2)(2010-1#1)
contains at least one##2##4##(1990-11#1)(1994-11#1)
contains at least##8##3##(1990-11#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#2)(2008-10#1)
contains both the##2##3##(1991-12#1)(2008-7#1)
contains both##4##2##(1991-12#1)(1992-8#1)(2008-7#1)(2010-10#1)
contains consensus##2##2##(1993-3#1)(2008-8#1)
contains covalently##3##2##(1992-11#1)(1993-6#1)(2008-8#1)
contains cysteines##2##2##(1990-5#1)(1993-2#1)
contains data from##2##3##(1993-1#1)(2008-7#1)
contains data##3##2##(1993-1#1)(2008-7#1)(2011-2#1)
contains either##2##2##(1993-11#1)(2010-6#1)
contains five##7##2##(1990-8#1)(1994-11#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
contains four exons##3##3##(1993-2#1)(1993-3#1)(1994-11#1)
contains four open reading frames##4##5##(1995-6#2)(2008-10#2)
contains four##14##2##(1990-12#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-11#2)(1995-6#4)(2008-10#2)(2008-5#1)(2009-5#1)
contains functional##2##2##(1996-12#1)(2012-2#1)
contains highly##2##2##(1997-4#1)(2008-2#1)
contains information about the##2##4##(2007-12#1)(2008-3#1)
contains information about##5##3##(1992-11#1)(2007-12#1)(2008-3#3)
contains information on##3##3##(2007-11#1)(2008-4#2)
contains information##9##2##(1991-12#1)(1992-11#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-4#2)
contains large##2##2##(2007-12#1)(2011-2#1)
contains lipids##2##2##(2008-5#1)(2013-1#1)
contains mainly##2##2##(1993-11#1)(2008-10#1)
contains many##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
contains membrane##2##2##(1994-8#1)(2008-11#1)
contains more##3##2##(1991-12#1)(1995-9#1)(2008-5#1)
contains motifs##2##2##(2008-5#1)(2008-7#1)
contains multiple##8##2##(1991-9#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-1#1)
contains new##2##2##(1991-12#1)(1991-2#1)
contains nine##2##2##(1994-12#1)(2008-6#1)
contains no##3##2##(1993-2#1)(1993-6#1)(1997-3#1)
contains one##14##2##(1990-12#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#2)
contains only one##2##3##(1990-5#1)(1995-3#1)
contains only##6##2##(1990-5#1)(1993-11#1)(1995-3#1)(2008-3#2)(2008-9#1)
contains other##2##2##(1996-9#1)(2008-11#1)
contains over##2##2##(2008-7#1)(2013-1#1)
contains potential##2##2##(1992-10#1)(1994-11#1)
contains protocols that##2##3##(2008-4#1)(2008-9#1)
contains protocols##6##2##(2008-1#2)(2008-4#1)(2008-9#3)
contains putative##2##2##(2009-8#1)(2010-11#1)
contains sequences##3##2##(1993-12#1)(1997-2#1)(2010-7#1)
contains several different##2##3##(2008-1#1)(2008-4#1)
contains several##18##2##(1991-5#1)(1993-2#3)(1993-3#1)(1993-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
contains some##2##2##(2008-11#1)(2008-3#1)
contains sulfated##2##2##(1992-10#1)(2008-4#1)
contains supplementary material##17##3##(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
contains ten##2##2##(1993-3#1)(1996-3#1)
contains the Kunitz protease inhibitor##2##5##(1991-2#1)(1992-12#1)
contains the active site##2##4##(1992-11#1)(1994-8#1)
contains the first##2##3##(1991-5#1)(1993-12#1)
contains the high affinity binding region of GIP and is a potent inhibitor of##2##14##(1997-4#2)
contains the results of##2##4##(1997-3#1)(2008-2#1)
contains the##78##2##(1990-5#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#4)(1994-8#1)(1995-2#3)(1995-6#2)(1996-3#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#2)(2010-5#1)(2010-7#1)(2013-1#1)
contains three##13##2##(1992-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-3#2)(2008-8#1)(2013-8#1)
contains two additional##2##3##(1990-5#1)(1993-6#1)
contains two copies of##2##4##(1995-8#1)(2008-10#1)
contains two open reading frames##2##5##(1990-11#1)(1996-6#1)
contains two##32##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-8#3)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
contains##672##1##(1990-11#12)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#11)(1990-7#2)(1990-8#1)(1991-11#4)(1991-12#11)(1991-2#7)(1991-3#4)(1991-5#7)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#6)(1992-10#3)(1992-11#8)(1992-12#5)(1992-3#6)(1992-4#3)(1992-6#4)(1992-8#6)(1992-9#4)(1993-1#3)(1993-11#12)(1993-12#15)(1993-2#12)(1993-3#9)(1993-6#12)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#9)(1994-12#19)(1994-2#3)(1994-5#3)(1994-6#1)(1994-8#7)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#10)(1995-3#4)(1995-5#2)(1995-6#17)(1995-8#12)(1995-9#3)(1996-10#1)(1996-12#3)(1996-2#8)(1996-3#3)(1996-6#5)(1996-8#1)(1996-9#1)(1997-2#7)(1997-3#9)(1997-4#5)(1997-6#3)(1997-7#6)(1997-8#1)(1997-9#1)(2007-11#7)(2007-12#22)(2007-8#1)(2008-1#5)(2008-10#53)(2008-11#18)(2008-12#1)(2008-2#15)(2008-3#27)(2008-4#20)(2008-5#7)(2008-6#4)(2008-7#21)(2008-8#22)(2008-9#15)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#14)(2012-1#6)(2012-12#3)(2012-2#11)(2012-3#7)(2013-1#7)(2013-8#6)
contaminant elements of##2##3##(2008-10#2)
contaminant elements##3##2##(2008-10#3)
contaminant in##4##2##(2008-10#3)(2008-6#1)
contaminant of##4##2##(1991-3#1)(1993-12#1)(1997-3#1)(2008-7#1)
contaminant trichloroethylene##2##2##(2008-10#2)
contaminant##28##1##(1991-3#1)(1993-12#1)(1997-3#1)(1997-4#2)(2008-10#14)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-9#1)
contaminant-free##2##1##(2008-10#2)
contaminant-specific##3##1##(2008-10#3)
contaminants and##4##2##(1991-3#1)(2008-10#2)(2008-11#1)
contaminants from the##2##3##(2008-10#2)
contaminants from##5##2##(1994-3#1)(2008-10#4)
contaminants have been##2##3##(2008-10#1)(2008-5#1)
contaminants in foods##3##3##(1994-3#2)(2011-2#1)
contaminants in soil##2##3##(2008-10#1)(2008-11#1)
contaminants in the environment##2##4##(2008-10#2)
contaminants in the##4##3##(1994-3#1)(2008-10#3)
contaminants in water##2##3##(2008-10#2)
contaminants in##21##2##(1994-3#3)(1997-4#1)(2008-10#10)(2008-11#4)(2008-5#1)(2011-2#2)
contaminants of the##2##3##(2008-10#1)(2008-11#1)
contaminants of##6##2##(1990-12#1)(2008-10#2)(2008-11#2)(2011-2#1)
contaminants##75##1##(1990-12#1)(1991-3#2)(1994-3#9)(1997-4#3)(2008-10#30)(2008-11#14)(2008-4#3)(2008-5#3)(2008-9#5)(2011-2#4)(2013-1#1)
contaminate food and##2##3##(2008-10#1)(2010-7#1)
contaminate the grain with mycotoxins##2##5##(2008-10#2)
contaminate the##5##2##(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#1)
contaminate##10##1##(1997-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)
contaminated and##2##2##(1990-3#1)(1994-3#1)
contaminated blood##2##2##(1997-5#1)(2007-7#1)
contaminated by the##5##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)
contaminated by##13##2##(1994-9#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2009-11#1)(2013-8#1)
contaminated clotting products##2##3##(1996-5#2)
contaminated environments##3##2##(2008-10#1)(2011-1#2)
contaminated food##3##2##(2007-2#1)(2007-7#1)(2008-7#1)
contaminated samples##4##2##(1997-6#1)(2008-10#2)(2012-12#1)
contaminated site##3##2##(2008-10#2)(2008-11#1)
contaminated soil samples##2##3##(2008-10#2)
contaminated soil##12##2##(1992-12#1)(2008-10#8)(2008-11#2)(2011-1#1)
contaminated soils from##2##3##(2008-10#2)
contaminated soils##9##2##(2008-10#7)(2008-12#1)(2008-6#1)
contaminated water and##2##3##(2011-2#1)(2013-1#1)
contaminated water##8##2##(2008-10#3)(2008-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
contaminated with saliva and##2##4##(2008-12#2)
contaminated with saliva##3##3##(2008-12#2)(2010-5#1)
contaminated with the##4##3##(2007-6#1)(2007-7#2)(2008-9#1)
contaminated with##36##2##(1991-12#2)(1992-12#1)(1993-10#1)(1993-8#1)(1995-11#1)(1997-4#1)(1997-5#1)(2007-6#1)(2007-7#4)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
contaminated##165##1##(1990-10#1)(1990-3#1)(1991-12#2)(1992-12#2)(1993-10#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-11#2)(1996-5#2)(1997-4#4)(1997-5#3)(1997-6#1)(2007-12#1)(2007-2#2)(2007-6#2)(2007-7#7)(2008-10#57)(2008-11#20)(2008-12#7)(2008-2#1)(2008-3#6)(2008-6#6)(2008-7#3)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
contaminating fungus##2##2##(2008-10#2)
contaminating organisms##2##2##(2008-10#1)(2008-5#1)
contaminating the##3##2##(1993-8#1)(1997-3#1)(2012-1#1)
contaminating##25##1##(1992-12#1)(1993-8#2)(1995-12#1)(1995-6#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
contamination and##13##2##(1994-3#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#1)(2012-2#1)
contamination are##3##2##(1994-3#1)(2008-10#2)
contamination as well##2##3##(2008-10#2)
contamination at##2##2##(1991-12#1)(1997-5#1)
contamination by##15##2##(1990-11#1)(2008-10#7)(2008-11#3)(2008-2#1)(2009-10#1)(2011-2#1)(2012-2#1)
contamination during##3##2##(2008-10#3)
contamination for##3##2##(2008-10#3)
contamination from the##3##3##(1991-12#1)(1997-5#1)(2008-3#1)
contamination from##7##2##(1991-12#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-3#3)
contamination has##2##2##(2008-10#1)(2008-3#1)
contamination in maize##2##3##(2008-10#1)(2008-12#1)
contamination in soil##2##3##(2008-10#2)
contamination in the##12##3##(1994-9#1)(1997-4#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
contamination in##28##2##(1994-11#1)(1994-7#1)(1994-9#1)(1997-4#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
contamination is less than##2##4##(2008-10#1)(2008-3#1)
contamination is##3##2##(2008-10#2)(2008-3#1)
contamination level##3##2##(1997-4#1)(2008-11#1)(2012-1#1)
contamination levels##4##2##(2008-10#1)(2008-11#3)
contamination occurred##2##2##(2008-10#2)
contamination of a##2##3##(2008-11#1)(2012-2#1)
contamination of cell cultures##2##4##(2008-11#2)
contamination of soil with##2##4##(2008-10#2)
contamination of soil##4##3##(2008-10#4)
contamination of the##13##3##(1991-12#1)(1995-6#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
contamination of water##2##3##(1994-3#1)(2007-6#1)
contamination of##59##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
contamination on the##2##3##(1991-5#1)(2008-10#1)
contamination on##6##2##(1991-5#1)(2008-10#3)(2008-3#1)(2009-6#1)
contamination or##9##2##(1990-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)
contamination rate##5##2##(2008-10#1)(2008-12#3)(2011-2#1)
contamination resulted in##2##3##(2008-10#2)
contamination risk##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
contamination should##2##2##(2008-10#2)
contamination sources##2##2##(2008-10#2)
contamination through##2##2##(1995-11#1)(2008-10#1)
contamination to##2##2##(2008-2#1)(2012-1#1)
contamination was##5##2##(1995-6#1)(1997-4#1)(2008-10#1)(2008-12#2)
contamination with##5##2##(1991-6#1)(1995-11#1)(2010-5#1)(2010-7#1)(2011-2#1)
contamination##300##1##(1990-11#2)(1990-2#2)(1991-11#1)(1991-12#5)(1991-3#2)(1991-5#2)(1991-6#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#4)(1994-7#2)(1994-9#4)(1995-11#4)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#8)(1997-5#4)(1997-6#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#107)(2008-11#30)(2008-12#14)(2008-2#5)(2008-3#14)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-10#1)(2011-2#9)(2012-1#4)(2012-2#13)(2012-3#1)(2013-1#4)(2013-8#2)
contamination)##2##1##(2008-10#1)(2011-2#1)
contaminations as well as##2##4##(2008-11#2)
contaminations as##3##2##(2008-11#3)
contaminations in a##2##3##(2008-11#2)
contaminations in animal cell##2##4##(2008-11#2)
contaminations in##7##2##(2008-10#2)(2008-11#5)
contaminations of##2##2##(2008-11#2)
contaminations##18##1##(2008-10#3)(2008-11#15)
contemplate##2##1##(1995-2#1)(2011-2#1)
contemplated##3##1##(2010-6#1)(2011-2#1)(2012-12#1)
contemplating##9##1##(1991-1#1)(1991-3#1)(1994-1#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
contemplation##6##1##(2008-11#1)(2008-4#4)(2010-2#1)
contemplative education##2##2##(2010-4#2)
contemporaneous##5##1##(1990-8#1)(1991-2#1)(1997-4#1)(2011-3#1)(2013-1#1)
contemporarily##3##1##(1992-12#1)(2008-10#1)(2008-3#1)
contemporary and##2##2##(1995-6#1)(2008-11#1)
contemporary dance##4##2##(2008-2#4)
contemporary health care##2##3##(2010-1#1)(2011-1#1)
contemporary healthcare##4##2##(2008-7#1)(2009-8#2)(2010-10#1)
contemporary isolates##3##2##(2008-10#2)(2008-7#1)
contemporary issues##2##2##(2008-1#1)(2008-5#1)
contemporary knowledge##2##2##(2008-12#1)(2013-7#1)
contemporary literature##6##2##(2007-12#1)(2008-11#1)(2010-8#1)(2011-2#2)(2012-12#1)
contemporary management##2##2##(1994-12#1)(2007-12#1)
contemporary methods##2##2##(2011-1#1)(2012-12#1)
contemporary nursing##2##2##(2008-1#1)(2008-12#1)
contemporary perspective##2##2##(1995-12#1)(1996-1#1)
contemporary series##2##2##(2008-10#1)(2008-6#1)
contemporary theories of##2##3##(2008-5#1)(2009-10#1)
contemporary theories##3##2##(2008-1#1)(2008-5#1)(2009-10#1)
contemporary use of##2##3##(1997-3#1)(2009-10#1)
contemporary##126##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-12#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#7)(2008-10#9)(2008-11#4)(2008-12#10)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#16)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
contend that##3##2##(1996-2#1)(2007-10#1)(2008-1#1)
contend with##2##2##(1991-12#1)(2010-12#1)
contend##6##1##(1991-12#1)(1994-1#1)(1996-2#1)(2007-10#1)(2008-1#1)(2010-12#1)
contended that##7##2##(1995-6#1)(1996-11#1)(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#1)
contended##8##1##(1995-6#1)(1996-11#1)(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#2)
contends that the##3##3##(1995-12#1)(1996-5#1)(2008-1#1)
contends that##7##2##(1993-12#1)(1995-12#1)(1996-5#2)(2008-1#1)(2008-11#1)(2012-12#1)
contends##8##1##(1993-12#1)(1995-12#1)(1996-5#2)(2008-1#2)(2008-11#1)(2012-12#1)
content (0##3##2##(2008-10#3)
content (fructose plus glucose concentrations) in the concentration range from##2##10##(2008-10#2)
content also##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
content analysed##2##2##(2012-2#1)(2012-3#1)
content analysis according to##2##4##(2007-8#1)(2008-11#1)
content analysis approach##2##3##(2008-11#1)(2009-5#1)
content analysis of the##2##4##(2008-10#1)(2012-12#1)
content analysis of##8##3##(1993-12#1)(1994-1#1)(1994-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-12#2)
content analysis using##2##3##(2009-3#1)(2012-12#1)
content analysis was##2##3##(2008-11#1)(2008-12#1)
content analysis##41##2##(1993-12#1)(1994-1#1)(1994-2#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#2)
content and a##5##3##(1994-8#1)(1995-12#1)(2008-10#2)(2013-1#1)
content and clinical##2##3##(2012-2#1)(2012-3#1)
content and composition in##2##4##(2012-1#1)(2012-2#1)
content and composition##3##3##(1995-5#1)(2012-1#1)(2012-2#1)
content and construct validity##2##4##(1995-2#1)(2009-12#1)
content and disease##2##3##(2008-10#2)
content and distribution##2##3##(2008-8#1)(2012-3#1)
content and implementation of##2##4##(2008-12#1)(2011-1#1)
content and in##3##3##(2008-8#1)(2010-3#2)
content and of##2##3##(1992-9#1)(2008-10#1)
content and pH##2##3##(2008-10#1)(2010-3#1)
content and provides##2##3##(1991-9#1)(2008-9#1)
content and quality##2##3##(1993-1#1)(2008-10#1)
content and salary##5##3##(1991-12#1)(1991-3#1)(1995-1#1)(1995-3#2)
content and soil##2##3##(1995-3#1)(2013-8#1)
content and structure##3##3##(1996-3#1)(2009-12#1)(2012-12#1)
content and the##11##3##(1993-1#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2011-1#1)
content and to##2##3##(1996-3#1)(2013-7#1)
content and##145##2##(1990-5#2)(1991-12#2)(1991-3#1)(1991-9#1)(1992-9#2)(1993-1#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-10#25)(2008-11#8)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#11)(2009-12#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-3#3)(2010-4#2)(2010-7#1)(2011-1#3)(2011-10#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-7#2)(2013-1#1)(2013-7#2)(2013-8#3)
content areas##4##2##(1993-12#1)(1993-3#2)(1996-2#1)
content as a##4##3##(1992-8#1)(1994-12#1)(2008-10#1)(2008-7#1)
content as well as##3##4##(1990-7#1)(1995-5#1)(2009-11#1)
content as##8##2##(1990-7#1)(1992-8#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-7#2)(2009-11#1)
content at##3##2##(2008-11#1)(2012-2#2)
content between##3##2##(1994-8#1)(2008-8#2)
content but##3##2##(1995-11#1)(2008-5#1)(2008-7#1)
content by##14##2##(1992-3#1)(1994-12#1)(1994-9#1)(2008-10#7)(2008-11#1)(2008-6#1)(2010-2#1)(2013-1#1)
content can be##2##3##(2008-10#2)
content could be##2##3##(1992-12#1)(2008-10#1)
content could##3##2##(1990-10#1)(1992-12#1)(2008-10#1)
content decreased##5##2##(2010-4#2)(2011-2#2)(2013-1#1)
content decreases##2##2##(1991-9#1)(2008-11#1)
content determination##4##2##(2008-10#4)
content determined by##2##3##(2008-10#1)(2013-8#1)
content determined##5##2##(2008-10#3)(2012-2#1)(2013-8#1)
content did not##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
content during##4##2##(1994-6#1)(2008-4#1)(2011-1#1)(2012-2#1)
content for##6##2##(1995-3#2)(2008-10#2)(2011-1#1)(2012-2#1)
content from##2##2##(2008-10#2)
content has been##2##3##(1996-12#1)(2008-10#1)
content has##4##2##(1994-12#1)(1996-12#1)(2008-10#1)(2008-12#1)
content higher than##2##3##(2008-10#1)(2010-4#1)
content in 704##2##3##(2008-12#2)
content in a##7##3##(1994-3#1)(1995-3#2)(2008-10#3)(2008-7#1)
content in breast##2##3##(1993-1#1)(1997-7#1)
content in cells##2##3##(1994-6#1)(2008-7#1)
content in commercially available##2##4##(2008-10#2)
content in different##3##3##(2008-10#2)(2012-2#1)
content in food##3##3##(2008-10#3)
content in human##2##3##(1991-6#1)(1993-12#1)
content in natural water by graphite furnace atomic absorption spectrometry after collection as##2##13##(2008-10#2)
content in natural waters##2##4##(2008-10#2)
content in natural##4##3##(2008-10#4)
content in periwinkles infected with##2##5##(2008-10#2)
content in real##2##3##(2008-10#2)
content in rice##2##3##(2008-12#1)(2013-1#1)
content in sample##2##3##(2008-10#1)(2008-12#1)
content in some##2##3##(2008-10#2)
content in the brain##2##4##(2008-6#2)
content in the leaves##2##4##(2008-12#1)(2011-10#1)
content in the umbilical cord##2##5##(2009-8#2)
content in the##44##3##(1990-12#1)(1993-9#1)(1994-9#1)(1995-12#1)(1997-4#2)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#5)(2008-6#4)(2008-7#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-10#1)(2011-2#1)(2013-1#1)
content in these##2##3##(1993-6#1)(1996-12#1)
content in##188##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#5)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#2)(1995-8#1)(1996-12#3)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#2)(2007-12#2)(2008-10#80)(2008-11#4)(2008-12#9)(2008-5#9)(2008-6#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#7)(2010-2#1)(2010-4#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#8)(2013-8#4)
content increased##7##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
content is a good##2##4##(1995-9#1)(2007-10#1)
content is a##3##3##(1995-9#1)(2007-10#1)(2008-9#1)
content is an##2##3##(2008-10#1)(2008-9#1)
content is evaluated##2##3##(2008-10#2)
content is feasible##2##3##(2008-10#1)(2013-8#1)
content is increased##2##3##(1994-8#1)(2008-10#1)
content is low##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
content is##31##2##(1992-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1995-9#1)(2007-10#1)(2007-5#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#3)(2012-3#1)(2013-8#3)
content may be##4##3##(1996-11#1)(2008-8#2)(2012-12#1)
content may##5##2##(1996-11#1)(2008-5#1)(2008-8#2)(2012-12#1)
content measurement##3##2##(1994-7#1)(2008-9#2)
content of 0##2##3##(2008-10#1)(2008-11#1)
content of 4##2##3##(2008-10#1)(2010-4#1)
content of DNA##2##3##(1991-5#1)(1993-6#1)
content of NaCl##2##3##(2008-10#2)
content of a number of##2##5##(2008-10#2)
content of a sample##2##4##(2008-10#1)(2008-9#1)
content of a##13##3##(1991-12#1)(1993-9#1)(1995-9#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#2)
content of an##2##3##(1994-8#1)(2008-12#1)
content of arachidonic acid##2##4##(1991-12#1)(1991-2#1)
content of autobiographical memory##2##4##(2008-2#1)(2010-8#1)
content of blood##2##3##(2006-10#1)(2007-7#1)
content of both the##2##4##(2008-6#1)(2013-1#1)
content of both##6##3##(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(2008-6#1)(2013-1#1)
content of chlorophyll##2##3##(2008-12#2)
content of diets##2##3##(2008-12#2)
content of each##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
content of free##4##3##(2008-5#1)(2012-2#1)(2013-7#2)
content of human##5##3##(1990-7#4)(1994-9#1)
content of iron##2##3##(2012-2#2)
content of lead in##2##4##(2008-10#2)
content of lead##3##3##(2008-10#3)
content of leaves##3##3##(2008-10#2)(2008-12#1)
content of malondialdehyde##2##3##(2008-12#1)(2009-8#1)
content of mouse##2##3##(1991-12#1)(1993-8#1)
content of phospholipids##2##3##(2008-5#1)(2009-8#1)
content of polyunsaturated##2##3##(2010-4#1)(2011-1#1)
content of possible selves##2##4##(2010-6#2)
content of primary##2##3##(1997-3#1)(2008-5#1)
content of protected##2##3##(2008-10#2)
content of protein##2##3##(1994-5#1)(2008-5#1)
content of rat##2##3##(1990-12#1)(1996-5#1)
content of raw##2##3##(2010-4#2)
content of serum phospholipids##2##4##(2008-3#2)
content of some##4##3##(2008-10#4)
content of the database##2##4##(1994-1#1)(2010-5#1)
content of the fume is determined by##2##7##(2008-10#2)
content of the fume##3##4##(2008-10#3)
content of the isolated##2##4##(1996-12#1)(2008-10#1)
content of the##80##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
content of their##2##3##(1991-12#1)(2008-4#1)
content of these##4##3##(1994-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
content of training##2##3##(1997-2#1)(2011-2#1)
content of unicameral bone cysts##2##5##(2013-1#2)
content of vanadium in the##2##5##(2008-10#2)
content of vanadium in##3##4##(2008-10#3)
content of water##2##3##(2008-10#2)
content of wheat##2##3##(2008-10#2)
content of wine##2##3##(2008-10#2)
content of##414##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-5#1)(1991-6#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-1#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#124)(2008-11#15)(2008-12#19)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#21)(2008-6#5)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#6)(2012-12#1)(2012-2#6)(2012-3#6)(2012-8#3)(2012-9#1)(2013-1#14)(2013-7#2)(2013-8#4)
content on the##2##3##(1993-12#1)(2008-2#1)
content on##8##2##(1993-12#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-2#1)(2009-11#1)(2010-5#1)
content or##3##2##(2008-12#1)(2009-12#1)(2012-7#1)
content per##2##2##(2008-11#1)(2008-5#1)
content range##2##2##(2007-12#1)(2008-5#1)
content relative to##2##3##(2008-5#1)(2008-7#1)
content relative##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
content required##2##2##(1996-1#1)(2012-2#1)
content showed##3##2##(1994-11#1)(1996-9#1)(2008-5#1)
content than##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-6#1)
content that##4##2##(1995-12#1)(2007-12#1)(2008-2#1)(2013-1#1)
content to a##2##3##(1990-8#1)(2010-2#1)
content to##6##2##(1990-2#1)(1990-8#1)(1993-3#1)(2008-3#1)(2008-9#1)(2010-2#1)
content uniformity##4##2##(2008-10#2)(2010-3#2)
content using##2##2##(2008-10#1)(2008-9#1)
content validity##6##2##(2007-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#2)
content was calculated##2##3##(2008-10#2)
content was determined by adsorptive polarography##3##6##(2008-10#3)
content was determined by##6##4##(2008-10#5)(2012-2#1)
content was determined##8##3##(2008-10#6)(2010-4#1)(2012-2#1)
content was established##2##3##(2008-10#2)
content was found to be##2##5##(2009-6#1)(2013-7#1)
content was found##3##3##(1994-7#1)(2009-6#1)(2013-7#1)
content was measured in##2##4##(2008-10#1)(2008-5#1)
content was not##2##3##(2008-10#2)
content was observed##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
content was quantified##2##3##(2008-5#1)(2013-8#1)
content was##53##2##(1990-11#1)(1990-6#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-7#1)(1995-11#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
content were found##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
content were lower##2##3##(1996-5#1)(2008-7#1)
content were significantly##2##3##(2008-12#2)
content were##21##2##(1991-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-12#3)(2008-5#2)(2008-7#2)(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
content which was##2##3##(1992-8#1)(1996-12#1)
content which##3##2##(1992-8#1)(1996-12#1)(2007-12#1)
content with##4##2##(1991-12#1)(1992-6#1)(2008-10#1)(2009-12#1)
content word##7##2##(2008-2#7)
content words##12##2##(2008-2#12)
content##1494##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#3)(1991-11#3)(1991-12#14)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#5)(1991-8#1)(1991-9#5)(1992-11#3)(1992-12#3)(1992-3#6)(1992-6#4)(1992-8#3)(1992-9#5)(1993-1#5)(1993-11#4)(1993-12#11)(1993-2#1)(1993-3#6)(1993-6#6)(1993-8#10)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#9)(1994-2#7)(1994-3#10)(1994-5#5)(1994-6#13)(1994-7#3)(1994-8#12)(1994-9#7)(1995-1#2)(1995-11#6)(1995-12#8)(1995-2#5)(1995-3#11)(1995-5#7)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#6)(1996-3#4)(1996-5#6)(1996-7#2)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#8)(1997-4#12)(1997-5#1)(1997-6#2)(1997-7#7)(2006-10#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#18)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#436)(2008-11#58)(2008-12#65)(2008-2#36)(2008-3#18)(2008-4#11)(2008-5#68)(2008-6#13)(2008-7#28)(2008-8#17)(2008-9#42)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#6)(2009-7#7)(2009-8#16)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#5)(2010-12#3)(2010-2#5)(2010-3#6)(2010-4#17)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#19)(2011-10#2)(2011-2#26)(2011-3#3)(2012-1#12)(2012-12#13)(2012-2#35)(2012-3#16)(2012-6#1)(2012-7#5)(2012-8#6)(2012-9#2)(2013-1#44)(2013-7#16)(2013-8#27)
content) and##2##2##(1995-11#1)(2012-6#1)
content) in##2##2##(1992-3#1)(2007-12#1)
content)##16##1##(1990-7#1)(1992-3#1)(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-6#1)
content-addressable##4##1##(2007-12#1)(2008-3#3)
content-free##2##1##(2008-11#2)
contention that the##5##3##(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-6#1)
contention that##13##2##(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-6#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)
contention##14##1##(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-6#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)
contentious##10##1##(1994-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-12#1)(2012-2#1)
contents and the##2##3##(2008-10#1)(2013-1#1)
contents and##23##2##(1991-11#1)(1991-12#1)(1992-12#1)(1993-12#1)(1996-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-5#1)(2012-3#3)(2013-1#1)
contents are##7##2##(1993-10#1)(1994-12#1)(2008-12#3)(2008-3#1)(2013-1#1)
contents at##3##2##(1997-6#2)(2008-10#1)
contents by##3##2##(1992-12#1)(1997-6#1)(2008-12#1)
contents decreased##3##2##(2008-12#1)(2008-9#1)(2010-2#1)
contents in geological##3##3##(2013-8#3)
contents in human##4##3##(1990-2#1)(2008-10#2)(2008-5#1)
contents in pharmaceutical formulations##2##4##(2008-10#2)
contents in pharmaceutical##3##3##(2008-10#3)
contents in the##7##3##(1995-12#1)(2007-12#1)(2008-10#4)(2009-8#1)
contents in##41##2##(1990-2#2)(1990-8#1)(1991-12#1)(1994-9#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2013-8#5)
contents into the##2##3##(2007-8#1)(2009-4#1)
contents into##3##2##(1994-12#1)(2007-8#1)(2009-4#1)
contents of 0##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
contents of CK##2##3##(2011-3#2)
contents of a##2##3##(2008-10#1)(2008-5#1)
contents of glucose transporters##2##4##(1993-6#1)(1994-12#1)
contents of glutathione##2##3##(1991-12#1)(2008-7#1)
contents of several##2##3##(2008-10#2)
contents of such##2##3##(2008-10#2)
contents of the skin##2##4##(2008-10#1)(2008-5#1)
contents of the##22##3##(1992-11#1)(1992-12#2)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#2)
contents of these##2##3##(2008-10#2)
contents of three##2##3##(2008-10#2)
contents of total cholesterol##2##4##(1991-2#1)(2012-2#1)
contents of##97##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-12#3)(1993-12#1)(1993-6#1)(1994-12#2)(1994-5#1)(1994-6#2)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#44)(2008-11#3)(2008-12#6)(2008-5#5)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#2)(2013-1#1)(2013-8#2)
contents ranged from##2##3##(2008-10#2)
contents were determined by##2##4##(1990-12#1)(2008-10#1)
contents were determined##4##3##(1990-12#1)(2008-10#2)(2012-2#1)
contents were estimated by##2##4##(2008-10#2)
contents were found##2##3##(2008-10#1)(2012-3#1)
contents were significantly##2##3##(1995-12#1)(1996-7#1)
contents were##18##2##(1990-12#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-7#1)(2008-10#10)(2008-5#1)(2012-2#1)(2012-3#1)
contents##306##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#8)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#6)(1994-5#1)(1994-6#5)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#2)(1996-7#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#110)(2008-11#12)(2008-12#19)(2008-3#1)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#4)(2009-7#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-5#5)(2011-1#3)(2011-2#5)(2011-3#3)(2012-12#4)(2012-2#8)(2012-3#12)(2013-1#3)(2013-8#8)
contents)##3##1##(2008-10#1)(2008-7#1)(2008-8#1)
contest competition##2##2##(2008-8#1)(2013-1#1)
contest##11##1##(1991-12#1)(1995-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-9#3)(2012-3#2)(2013-1#1)
contestants##2##1##(2008-9#1)(2009-9#1)
contested##3##1##(1996-5#1)(2008-7#1)(2010-10#1)
contests##6##1##(2009-9#4)(2011-2#1)(2013-1#1)
context and the##2##3##(2008-11#1)(2008-12#1)
context and to##2##3##(2007-11#1)(2008-7#1)
context and##14##2##(1996-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#3)
context are##2##2##(2008-10#1)(2008-9#1)
context as##3##2##(1996-3#1)(2008-10#2)
context by##2##2##(2010-10#1)(2010-3#1)
context can##4##2##(1995-3#1)(2008-8#1)(2009-8#1)(2010-8#1)
context for the##2##3##(2009-6#1)(2013-1#1)
context for this##2##3##(1991-3#1)(2008-11#1)
context for##13##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-2#1)(1997-5#1)(2008-11#2)(2008-8#2)(2009-6#1)(2010-11#1)(2010-5#1)(2013-1#1)
context in the##2##3##(1997-7#1)(2008-11#1)
context in which the##2##4##(1992-1#1)(2010-4#1)
context in which they##2##4##(2008-1#1)(2009-10#1)
context in which##6##3##(1992-1#1)(2008-1#1)(2009-10#1)(2009-6#1)(2010-4#1)(2012-3#1)
context in##14##2##(1992-1#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
context is a##2##3##(2008-1#2)
context is##11##2##(1993-1#1)(2007-12#1)(2008-1#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
context might be##2##3##(1992-2#1)(2013-1#1)
context of a single##2##4##(1991-11#1)(2008-11#1)
context of a##31##3##(1991-11#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#2)(1997-4#1)(2007-12#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
context of health##3##3##(1994-2#1)(2008-7#1)(2009-6#1)
context of increasing##2##3##(2008-12#1)(2008-7#1)
context of protein##2##3##(2008-10#1)(2011-2#1)
context of the suicidal##2##4##(2010-6#2)
context of the##56##3##(1991-3#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
context of their##4##3##(1993-1#1)(2007-11#1)(2010-10#1)(2012-2#1)
context of these##5##3##(2007-8#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-2#1)
context of this##2##3##(2008-10#1)(2008-12#1)
context of work##2##3##(2008-2#1)(2013-1#1)
context of##306##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#3)(1996-3#4)(1996-5#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#19)(2008-12#5)(2008-2#9)(2008-3#11)(2008-4#4)(2008-5#4)(2008-6#9)(2008-7#14)(2008-8#13)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#6)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#14)(2011-7#1)(2012-1#3)(2012-12#4)(2012-2#14)(2012-3#7)(2012-8#1)(2013-1#6)(2013-8#9)
context that##6##2##(2008-1#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-12#1)(2012-3#1)
context to##4##2##(1995-1#1)(2008-12#1)(2010-8#1)(2013-1#1)
context was##2##2##(2008-10#1)(2013-1#1)
context when##2##2##(2010-10#1)(2012-3#1)
context##560##1##(1990-11#2)(1990-7#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#1)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#8)(1996-5#1)(1996-8#4)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#6)(2007-12#13)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#29)(2008-11#32)(2008-12#14)(2008-2#15)(2008-3#13)(2008-4#4)(2008-5#7)(2008-6#10)(2008-7#25)(2008-8#22)(2008-9#17)(2009-1#1)(2009-10#8)(2009-11#6)(2009-2#2)(2009-3#1)(2009-5#6)(2009-6#8)(2009-7#11)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#8)(2010-11#3)(2010-12#3)(2010-2#4)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#11)(2010-9#3)(2011-1#7)(2011-2#24)(2011-7#1)(2012-1#3)(2012-12#9)(2012-2#20)(2012-3#16)(2012-7#2)(2012-8#1)(2013-1#18)(2013-7#1)(2013-8#16)
context-dependent##5##1##(2007-12#1)(2008-8#1)(2009-6#1)(2012-2#1)(2012-3#1)
context-free##2##1##(2008-7#2)
context-sensitive##5##1##(2008-11#1)(2008-7#1)(2009-12#3)
contexts and##4##2##(1991-12#1)(2008-10#1)(2008-8#1)(2009-5#1)
contexts for##2##2##(2008-11#1)(2009-5#1)
contexts in the##2##3##(2008-12#1)(2012-3#1)
contexts in which##5##3##(2008-7#1)(2009-5#1)(2010-3#1)(2013-1#2)
contexts in##8##2##(2008-12#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#3)
contexts of adolescent##2##3##(2009-5#1)(2009-7#1)
contexts of##12##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-5#3)(2009-7#1)(2010-12#1)(2011-2#1)
contexts such as##2##3##(2008-10#1)(2012-2#1)
contexts was##2##2##(2009-7#1)(2012-12#1)
contexts##93##1##(1991-1#1)(1991-12#2)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-3#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#5)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#6)(2009-7#5)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#7)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#5)
contextual and##2##2##(2010-10#1)(2011-1#1)
contextual dimensions##2##2##(2013-1#2)
contextual factors##10##2##(1995-1#1)(1996-3#1)(2008-1#1)(2008-11#1)(2009-7#1)(2012-12#1)(2012-2#4)
contextual framework##2##2##(1996-2#1)(2012-12#1)
contextual information##2##2##(2008-12#1)(2012-2#1)
contextual modulation##2##2##(2012-2#2)
contextual##44##1##(1993-12#2)(1995-1#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-10#4)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#4)
contextual-level##2##1##(2009-6#2)
contextualize##2##1##(2008-12#1)(2012-2#1)
contextualized##2##1##(2010-10#1)(2013-8#1)
contextualizes##2##1##(2008-11#1)(2012-2#1)
contig map encompassing##2##3##(1997-8#2)
contig map##7##2##(1996-12#1)(1996-2#1)(1997-8#5)
contig##18##1##(1994-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#5)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
contigs which covered a total length of##2##7##(1997-2#2)
contigs which##3##2##(1995-6#1)(1997-2#2)
contigs##18##1##(1993-6#1)(1994-11#1)(1995-6#4)(1996-10#4)(1996-6#2)(1997-2#3)(2008-9#1)(2010-4#1)(2011-2#1)
contiguous gene##3##2##(1997-3#1)(2008-10#1)(2009-5#1)
contiguous genomic sequence##2##3##(1995-12#1)(1997-9#1)
contiguous quadrats##3##2##(2008-10#3)
contiguous sequence of##2##3##(1995-8#1)(1996-12#1)
contiguous with the##2##3##(1994-5#1)(2011-2#1)
contiguous##41##1##(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#3)(1997-9#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
continence##5##1##(1993-6#2)(1996-7#1)(2008-10#2)
continent and is##2##3##(2008-10#1)(2011-2#1)
continent urinary##3##2##(2008-10#3)
continent##24##1##(1990-6#1)(1996-12#1)(1996-4#1)(2007-2#1)(2008-10#13)(2008-12#1)(2008-6#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
continent)##2##1##(2008-9#2)
continental North America##2##3##(2008-10#2)
continental North##3##2##(2008-10#3)
continental margin##2##2##(2008-10#2)
continental scale##2##2##(2008-10#2)
continental shelf##3##2##(2008-3#1)(2010-8#2)
continental##24##1##(1995-6#1)(1997-6#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-8#4)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
continents and##3##2##(2008-10#2)(2013-8#1)
continents were##2##2##(2008-10#2)
continents##33##1##(2008-10#20)(2008-12#2)(2008-5#1)(2008-8#3)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
contingencies associated with##2##3##(1991-12#1)(2010-10#1)
contingencies to##2##2##(2008-11#1)(2010-4#1)
contingencies##5##1##(1991-12#1)(2007-8#1)(2008-11#1)(2010-10#1)(2010-4#1)
contingency and##2##2##(2009-9#1)(2011-2#1)
contingency management##3##2##(2009-11#3)
contingency##11##1##(1993-1#1)(1997-2#1)(2008-10#1)(2009-11#3)(2009-9#2)(2010-10#1)(2011-2#1)(2013-8#1)
contingent on##7##2##(1991-1#1)(1992-11#1)(1995-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)
contingent self-worth##2##2##(2009-9#2)
contingent##15##1##(1991-1#1)(1991-12#1)(1992-11#1)(1993-6#1)(1995-2#1)(1996-1#1)(2008-8#2)(2008-9#1)(2009-9#5)(2010-3#1)
continua##3##1##(1993-5#1)(1996-4#1)(2008-2#1)
continual improvement##3##2##(1995-12#2)(1997-2#1)
continual reassessment method##3##3##(1994-9#2)(2012-3#1)
continual reassessment##4##2##(1994-9#2)(2008-7#1)(2012-3#1)
continual##19##1##(1993-12#1)(1994-9#2)(1995-12#2)(1997-2#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-11#1)(2012-3#1)
continually strive to##3##3##(1991-12#1)(1994-3#2)
continually##24##1##(1991-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
continuation of the inferior vena##2##5##(2007-8#1)(2009-5#1)
continuation of the##6##3##(1996-9#1)(1997-7#1)(2007-8#1)(2008-5#1)(2009-5#1)(2012-2#1)
continuation of##18##2##(1992-2#1)(1993-1#1)(1993-12#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2011-1#3)(2011-2#2)(2012-2#1)
continuation##30##1##(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#1)
continue MAP or to receive##2##5##(2010-3#2)
continue a##2##2##(2008-8#1)(2013-1#1)
continue for##2##2##(1995-2#1)(2007-7#1)
continue into the##2##3##(2007-5#1)(2007-7#1)
continue on##2##2##(1997-1#1)(2011-7#1)
continue our##2##2##(1991-12#1)(2008-2#1)
continue the##4##2##(1997-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
continue their##4##2##(1992-12#1)(2008-12#1)(2008-4#1)(2012-3#1)
continue this##2##2##(1991-3#1)(2008-12#1)
continue throughout##2##2##(2008-10#1)(2008-9#1)
continue to be a##6##4##(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-6#1)
continue to be the##2##4##(1993-11#1)(1997-1#1)
continue to be##37##3##(1992-1#1)(1993-11#1)(1993-12#1)(1995-2#2)(1995-3#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-5#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
continue to cause##3##3##(2008-7#1)(2013-1#2)
continue to decrease##2##3##(2008-11#1)(2011-2#1)
continue to deliver##2##3##(1994-3#1)(2013-1#1)
continue to develop##4##3##(1995-3#1)(2008-11#1)(2008-12#1)(2013-1#1)
continue to do##4##3##(2008-11#1)(2008-5#1)(2010-3#1)(2012-6#1)
continue to evolve rapidly##2##4##(2007-12#1)(2008-6#1)
continue to evolve##5##3##(2007-12#1)(2008-3#1)(2008-6#1)(2010-8#1)(2013-1#1)
continue to exist##3##3##(1991-6#1)(1995-12#1)(1997-3#1)
continue to expand##2##3##(2008-10#1)(2008-11#1)
continue to experience##2##3##(2008-3#1)(2013-1#1)
continue to grow##4##3##(1993-1#1)(2008-11#1)(2008-9#2)
continue to improve##4##3##(1992-2#1)(1996-9#1)(2008-10#1)(2008-7#1)
continue to increase in the##2##5##(1994-6#1)(2011-2#1)
continue to increase##5##3##(1994-6#1)(2008-10#1)(2010-11#1)(2011-2#2)
continue to operate in##2##4##(1997-1#1)(2011-2#1)
continue to pose a##2##4##(2008-11#1)(2010-9#1)
continue to present##3##3##(1993-9#1)(2010-1#1)(2010-8#1)
continue to provide the##2##4##(1995-12#1)(1997-2#1)
continue to provide##4##3##(1995-12#1)(1995-2#1)(1997-2#1)(2012-2#1)
continue to rise##2##3##(1992-2#1)(1994-12#1)
continue to use##5##3##(1990-3#1)(1992-4#1)(2007-12#1)(2012-12#1)(2012-2#1)
continue to work##3##3##(1991-12#1)(1994-2#1)(2007-2#1)
continue to##181##2##(1990-11#1)(1990-3#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#1)(2006-10#4)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#1)(2008-1#6)(2008-10#11)(2008-11#17)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-4#2)(2009-5#3)(2009-7#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#11)(2013-8#4)
continue with##2##2##(1993-11#1)(2008-11#1)
continue##269##1##(1990-11#1)(1990-3#2)(1990-6#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#7)(1995-2#5)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#6)(2008-10#17)(2008-11#21)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#1)(2009-4#2)(2009-5#3)(2009-7#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#8)(2011-7#1)(2012-12#6)(2012-2#3)(2012-3#7)(2012-6#1)(2013-1#14)(2013-8#4)
continued after##2##2##(1992-3#1)(1994-5#1)
continued at##5##2##(1990-2#1)(1994-1#1)(1997-4#1)(2008-10#1)(2011-1#1)
continued development##2##2##(2008-10#1)(2008-11#1)
continued evolution##2##2##(1993-12#1)(1994-12#1)
continued existence##2##2##(1993-12#1)(1997-1#1)
continued exposure##2##2##(2008-4#1)(2008-7#1)
continued focus##2##2##(2008-9#1)(2010-1#1)
continued for 24##2##3##(2007-8#1)(2008-5#1)
continued for one##2##3##(1992-11#1)(2008-6#1)
continued for the##2##3##(2008-10#1)(2008-5#1)
continued for##27##2##(1990-9#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-9#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2009-12#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)
continued growth and##2##3##(2008-11#1)(2008-4#1)
continued growth in##3##3##(1995-1#1)(2011-1#1)(2011-7#1)
continued growth##6##2##(1991-1#1)(1995-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-7#1)
continued improvement##2##2##(2009-11#1)(2012-1#1)
continued in the##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
continued in##9##2##(1990-11#1)(1991-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
continued indefinitely##2##2##(2008-11#1)(2013-8#1)
continued need to##2##3##(2008-11#1)(2010-12#1)
continued need##3##2##(1996-1#1)(2008-11#1)(2010-12#1)
continued on##2##2##(2008-7#1)(2008-9#1)
continued over##2##2##(2008-3#1)(2008-4#1)
continued research##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
continued search##2##2##(2008-7#1)(2013-1#1)
continued smoking##2##2##(2008-11#1)(2010-2#1)
continued surveillance##2##2##(1991-12#1)(2007-12#1)
continued the##3##2##(2007-11#1)(2008-10#1)(2010-11#1)
continued to be##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-3#2)(2013-1#1)
continued to decline##2##3##(2008-10#1)(2010-10#1)
continued to decrease##3##3##(1991-2#1)(1997-4#1)(2008-6#1)
continued to evolve##2##3##(1994-12#1)(2011-2#1)
continued to glow for##2##4##(1997-4#1)(2008-3#1)
continued to grow##5##3##(1991-12#1)(1997-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
continued to have a##2##4##(2010-1#1)(2011-2#1)
continued to have##7##3##(1990-5#1)(1997-3#2)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
continued to increase##5##3##(1991-2#1)(1996-2#1)(1997-2#1)(2008-10#2)
continued to rise##3##3##(1996-3#1)(1996-5#1)(2013-8#1)
continued to show##3##3##(1993-1#1)(1995-12#1)(2011-2#1)
continued to##65##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
continued treatment##2##2##(2011-1#1)(2012-2#1)
continued until##8##2##(1991-3#1)(1994-8#1)(2007-10#1)(2008-10#2)(2010-1#1)(2012-3#1)(2013-8#1)
continued up to##2##3##(1993-11#1)(1995-6#1)
continued use of the##2##4##(2007-12#1)(2008-5#1)
continued use of##8##3##(1992-3#1)(1997-8#1)(2007-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
continued use##9##2##(1992-3#1)(1997-8#1)(2007-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
continued with##7##2##(1991-3#1)(1997-2#1)(2008-10#1)(2010-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
continued##257##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-12#5)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#4)(2008-1#5)(2008-10#23)(2008-11#12)(2008-12#3)(2008-3#4)(2008-4#8)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#10)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#8)(2013-8#7)
continues in##5##2##(1996-2#1)(1996-6#1)(2007-12#1)(2009-10#1)(2013-1#1)
continues regarding the##2##3##(2008-4#1)(2008-7#1)
continues the##2##2##(2008-10#1)(2008-2#1)
continues to be a major##2##5##(2008-10#1)(2010-10#1)
continues to be a serious##2##5##(2009-9#1)(2010-5#1)
continues to be a significant problem##2##6##(1996-12#1)(2008-4#1)
continues to be a significant##3##5##(1995-3#1)(1996-12#1)(2008-4#1)
continues to be a##13##4##(1991-12#1)(1992-1#1)(1993-6#1)(1995-3#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2009-9#1)(2010-10#1)(2010-5#1)
continues to be an##3##4##(1997-2#1)(2008-10#1)(2012-2#1)
continues to be one of the most##3##7##(2011-2#1)(2012-3#1)(2013-8#1)
continues to be the##2##4##(2008-8#1)(2010-6#1)
continues to be##37##3##(1991-12#1)(1992-1#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
continues to characterize##2##3##(2008-10#1)(2008-6#1)
continues to develop##2##3##(2009-3#1)(2010-8#1)
continues to emerge##3##3##(1996-5#1)(2011-1#1)(2013-1#1)
continues to evolve##7##3##(1994-12#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
continues to expand##6##3##(1994-3#1)(1994-5#1)(1996-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
continues to grow##2##3##(1996-2#1)(2009-8#1)
continues to have##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
continues to increase##6##3##(1995-3#1)(1997-7#1)(2008-1#1)(2010-6#1)(2010-8#1)(2011-1#1)
continues to pose##2##3##(1994-7#1)(2009-3#1)
continues to present a##2##4##(2008-10#1)(2008-6#1)
continues to represent a significant##2##5##(1994-5#1)(2010-6#1)
continues to represent a##3##4##(1994-5#1)(2008-7#1)(2010-6#1)
continues to rise##2##3##(1994-12#1)(2012-2#1)
continues to##107##2##(1991-12#2)(1992-1#1)(1992-2#1)(1993-6#1)(1994-12#2)(1994-3#4)(1994-5#2)(1994-7#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#3)(2011-1#2)(2011-2#6)(2011-7#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
continues##147##1##(1991-12#2)(1991-6#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-12#2)(1994-3#4)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#7)(2011-7#1)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#4)(2013-8#3)
continuing care retirement##4##3##(1991-2#1)(1993-2#1)(1994-2#2)
continuing care##6##2##(1991-12#1)(1991-2#1)(1993-2#1)(1994-2#2)(1995-9#1)
continuing challenge is##2##3##(1995-2#1)(2012-2#1)
continuing challenge##4##2##(1995-2#1)(2007-2#1)(2008-3#1)(2012-2#1)
continuing disparities##2##2##(1994-12#1)(2008-1#1)
continuing education and##5##3##(1991-3#1)(1992-3#1)(1993-11#1)(2008-6#1)(2013-1#1)
continuing education for##4##3##(1994-3#1)(1996-2#1)(1996-3#1)(2013-1#1)
continuing education in##2##3##(1994-12#1)(1997-5#1)
continuing education needs##2##3##(1992-3#1)(1993-2#1)
continuing education requirements##2##3##(1995-1#1)(1996-3#1)
continuing education##45##2##(1991-2#2)(1991-3#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#7)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#5)(1996-8#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#5)(2013-8#1)
continuing education]##2##2##(1996-3#1)(2008-4#1)
continuing efforts to##3##3##(1994-2#1)(1996-2#1)(2007-11#1)
continuing interest in##2##3##(2006-10#1)(2008-8#1)
continuing medical education##4##3##(2008-1#1)(2008-3#1)(2008-8#2)
continuing participation##2##2##(1994-1#1)(2008-6#1)
continuing physiological needs##2##3##(2008-11#2)
continuing professional development##5##3##(2007-11#1)(2008-11#1)(2008-12#1)(2010-5#2)
continuing professional education##3##3##(1996-1#2)(2008-11#1)
continuing professional##8##2##(1996-1#2)(2007-11#1)(2008-11#2)(2008-12#1)(2010-5#2)
continuing the##2##2##(1995-2#1)(1996-5#1)
continuing to rise##2##3##(2010-3#1)(2012-3#1)
continuing to##11##2##(1996-1#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
continuing##163##1##(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#2)(1992-2#2)(1992-3#4)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#5)(1993-8#2)(1994-1#3)(1994-12#8)(1994-2#3)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-9#1)(1996-1#4)(1996-2#2)(1996-3#6)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#4)(2008-10#8)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#4)(2009-3#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#2)
continuity and##10##2##(1990-5#1)(1993-1#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-3#2)(2013-1#1)
continuity as##2##2##(1996-2#1)(2011-2#1)
continuity cases##3##2##(1993-1#3)
continuity for##2##2##(2008-11#1)(2013-1#1)
continuity in the##5##3##(2008-10#1)(2008-3#1)(2009-1#1)(2009-4#1)(2009-8#1)
continuity in##7##2##(1993-12#1)(2008-10#1)(2008-3#2)(2009-1#1)(2009-4#1)(2009-8#1)
continuity is##4##2##(1990-2#1)(1996-2#1)(2009-4#1)(2011-1#1)
continuity of care and##2##4##(1994-3#1)(2007-10#1)
continuity of care##21##3##(1991-12#1)(1993-1#4)(1993-12#1)(1994-3#3)(1995-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-10#1)(2007-12#2)(2008-1#1)(2011-1#2)(2013-8#1)
continuity of medication management during##2##5##(2012-12#2)
continuity of medication management##3##4##(2012-12#3)
continuity of the##2##3##(1991-7#1)(1994-12#1)
continuity of##37##2##(1991-12#1)(1991-7#1)(1993-1#4)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#3)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-11#4)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
continuity resection##2##2##(2008-6#2)
continuity was##3##2##(1991-6#1)(1993-12#1)(2008-10#1)
continuity with##4##2##(1990-5#1)(1995-2#1)(2008-2#1)(2009-10#1)
continuity##99##1##(1990-2#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-6#2)(1991-7#1)(1993-1#10)(1993-12#3)(1993-8#1)(1994-12#1)(1994-3#5)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#4)(1996-3#2)(1997-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#6)(2008-2#3)(2008-3#3)(2008-6#3)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#3)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
continuity&quot##2##1##(1993-1#1)(2009-1#1)
continuous addition of##3##3##(2008-10#3)
continuous agitation##2##2##(2008-11#2)
continuous ambulatory peritoneal dialysis (CAPD) has##2##6##(2007-12#2)
continuous ambulatory peritoneal dialysis (CAPD)##11##5##(1995-12#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#1)(2011-2#1)
continuous ambulatory peritoneal dialysis patients by##2##6##(2007-12#2)
continuous ambulatory peritoneal dialysis patients##8##5##(2007-12#8)
continuous ambulatory peritoneal dialysis##28##4##(1992-5#1)(1995-12#1)(2007-12#18)(2007-7#1)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
continuous ambulatory peritoneal##30##3##(1992-5#1)(1995-12#1)(2007-12#20)(2007-7#1)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
continuous ambulatory peritoneál dialysis##3##4##(1997-8#3)
continuous ambulatory##34##2##(1992-5#1)(1995-12#1)(1995-2#1)(1997-8#3)(2007-12#20)(2007-7#1)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
continuous analysis##6##2##(2008-10#6)
continuous and ordered categorical outcomes##2##5##(1997-4#2)
continuous and##23##2##(1991-2#1)(1991-9#1)(1997-2#1)(1997-4#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
continuous application##2##2##(1996-12#2)
continuous bed##3##2##(2008-11#3)
continuous beer fermentation##3##3##(2008-10#3)
continuous cardiac##2##2##(2009-3#1)(2010-8#1)
continuous cell cultures derived from##2##5##(1992-2#2)
continuous cell lines##2##3##(1992-6#1)(2008-11#1)
continuous cell##6##2##(1992-2#2)(1992-6#1)(2008-11#2)(2011-2#1)
continuous change in the##2##4##(2008-10#1)(2013-7#1)
continuous contact brachiation##4##3##(2012-12#4)
continuous covariates##2##2##(2008-10#1)(2013-1#1)
continuous cultivation##4##2##(1994-5#3)(1997-2#1)
continuous cultivations##2##2##(1994-3#1)(2008-11#1)
continuous culture and##2##3##(2008-11#2)
continuous culture mode##2##3##(2008-11#2)
continuous culture of##3##3##(2008-11#2)(2008-7#1)
continuous culture##17##2##(1994-5#1)(2008-11#12)(2008-6#2)(2008-7#1)(2008-9#1)
continuous cultures##2##2##(2008-11#2)
continuous cyclic##2##2##(1990-9#1)(2008-10#1)
continuous data collection##2##3##(2011-1#1)(2012-12#1)
continuous data##4##2##(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#1)
continuous derivatisation##2##2##(2008-10#2)
continuous determination of##2##3##(2008-10#2)
continuous disease-free##2##2##(1990-12#1)(1992-6#1)
continuous distribution##2##2##(2008-10#1)(2008-2#1)
continuous education##6##2##(1992-11#1)(1994-12#2)(1994-3#1)(2009-11#1)(2010-10#1)
continuous evaporation##2##2##(2008-10#2)
continuous exposure to##4##3##(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
continuous exposure##5##2##(1992-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
continuous expression##2##2##(1997-7#1)(2008-8#1)
continuous feedback##3##2##(1991-9#1)(1996-12#1)(2008-7#1)
continuous fermentation##3##2##(2008-7#3)
continuous films##2##2##(2008-7#1)(2009-5#1)
continuous flow analysis (CFA)##2##4##(2008-10#2)
continuous flow analysis##5##3##(2008-10#5)
continuous flow hydride generation##2##4##(2008-10#2)
continuous flow system##9##3##(2008-10#9)
continuous flow##51##2##(1990-12#3)(1991-12#1)(2008-10#41)(2008-11#2)(2008-7#2)(2010-6#1)(2011-2#1)
continuous frequency##4##2##(2007-11#2)(2007-12#2)
continuous glucose monitoring (CGM)##2##4##(2012-4#2)
continuous glucose monitoring system##2##4##(2008-1#1)(2012-5#1)
continuous glucose monitoring##7##3##(2008-1#1)(2009-11#3)(2012-4#2)(2012-5#1)
continuous glucose##8##2##(1995-8#1)(2008-1#1)(2009-11#3)(2012-4#2)(2012-5#1)
continuous hybridoma##4##2##(2008-11#3)(2008-7#1)
continuous hydride generation##4##3##(2008-10#4)
continuous illumination##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
continuous improvement in##2##3##(1996-2#1)(1996-3#1)
continuous improvement of the##2##4##(1995-3#1)(2011-2#1)
continuous improvement of##3##3##(1993-12#1)(1995-3#1)(2011-2#1)
continuous improvement##10##2##(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(2011-2#1)
continuous improvements##2##2##(1995-3#1)(2008-3#1)
continuous increase##5##2##(1993-11#1)(1996-12#2)(1997-7#1)(2008-1#1)
continuous infusion of##7##3##(1991-3#1)(1992-11#1)(1992-5#2)(1994-12#1)(2007-10#1)(2012-3#1)
continuous infusion##12##2##(1990-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-5#2)(1994-12#1)(1994-3#1)(2007-10#1)(2008-7#1)(2012-3#2)
continuous input##2##2##(2008-11#1)(2008-3#1)
continuous intravenous infusion of fluorouracil##2##5##(1991-3#2)
continuous intravenous infusion of##3##4##(1990-8#1)(1991-3#2)
continuous intravenous infusion##5##3##(1990-8#1)(1991-3#2)(2008-6#1)(2010-11#1)
continuous intravenous##6##2##(1990-8#1)(1991-3#2)(2008-6#1)(2010-10#1)(2010-11#1)
continuous laser##2##2##(2008-2#1)(2008-3#1)
continuous light##5##2##(1996-10#1)(2008-10#2)(2008-7#1)(2010-8#1)
continuous maize##2##2##(2008-10#1)(2008-12#1)
continuous measurements of##3##3##(2008-10#2)(2008-3#1)
continuous measurements##5##2##(2008-10#4)(2008-3#1)
continuous methods##2##2##(2008-10#1)(2008-7#1)
continuous mode##6##2##(1997-2#1)(2008-10#5)
continuous monitoring of the##3##4##(2008-2#1)(2010-10#1)(2011-2#1)
continuous monitoring of##16##3##(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-8#1)
continuous monitoring##17##2##(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-8#1)
continuous operation##7##2##(1992-5#1)(2007-9#1)(2008-10#3)(2008-7#1)(2013-1#1)
continuous or##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)
continuous oral##2##2##(2008-3#1)(2009-12#1)
continuous passive motion (CPM)##2##4##(2007-8#2)
continuous perfusion mode##2##3##(2008-11#2)
continuous perfusion##5##2##(2008-11#5)
continuous phase##6##2##(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)
continuous positive airway pressure##2##4##(2010-5#1)(2011-1#1)
continuous potato##4##2##(2008-10#4)
continuous precipitation-dissolution flow system##3##4##(2008-10#3)
continuous presence##2##2##(2008-11#1)(2009-11#1)
continuous prisoner's dilemma##2##3##(2008-8#2)
continuous process##4##2##(1992-9#1)(1995-2#1)(1995-3#1)(2008-10#1)
continuous production of MnP##2##4##(2008-7#2)
continuous production of##6##3##(2008-11#1)(2008-6#2)(2008-7#3)
continuous production##7##2##(2008-11#2)(2008-6#2)(2008-7#3)
continuous progestin administration##2##3##(1992-2#2)
continuous quality improvement (CQI)##7##4##(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)
continuous quality improvement efforts##2##4##(1992-12#1)(1997-1#1)
continuous quality improvement in the##2##5##(1993-3#1)(1994-2#1)
continuous quality improvement in##4##4##(1993-2#1)(1993-3#1)(1994-2#1)(1996-1#1)
continuous quality improvement##42##3##(1992-12#2)(1993-12#5)(1993-2#5)(1993-3#4)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#5)(1995-1#2)(1995-2#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)
continuous quality##43##2##(1992-12#2)(1993-12#5)(1993-2#5)(1993-3#5)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#5)(1995-1#2)(1995-2#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)
continuous quantitative##2##2##(2008-10#2)
continuous range of##2##3##(2007-11#1)(2008-10#1)
continuous reagent addition##2##3##(2008-10#2)
continuous real-time##2##2##(2007-12#1)(2008-2#1)
continuous recording##2##2##(2008-10#1)(2013-1#1)
continuous relapse-free survival##2##3##(2010-3#2)
continuous relief##3##2##(2008-3#3)
continuous renal replacement therapy (CRRT)##2##5##(2008-4#1)(2011-2#1)
continuous renal replacement therapy##3##4##(2008-4#1)(2011-2#2)
continuous retrieval##2##2##(1994-12#1)(2008-2#1)
continuous sampling##2##2##(2008-10#1)(2012-7#1)
continuous scan##2##2##(2008-3#2)
continuous scanning##4##2##(2008-4#1)(2011-1#3)
continuous spectrum##4##2##(1992-8#1)(2008-2#1)(2008-3#1)(2013-8#1)
continuous subcutaneous insulin infusion##3##4##(2008-1#1)(2008-7#1)(2009-11#1)
continuous subcutaneous##4##2##(1992-5#1)(2008-1#1)(2008-7#1)(2009-11#1)
continuous surveillance##3##2##(2011-2#1)(2013-8#2)
continuous suture technique##2##3##(2007-8#2)
continuous suture##4##2##(2007-8#4)
continuous therapy with 1 tablet##2##5##(1990-8#2)
continuous titration based on a flow ratiometry##2##7##(2008-10#2)
continuous titration##3##2##(2008-10#3)
continuous tracking of##2##3##(1994-12#1)(2012-2#1)
continuous treatment with##2##3##(1991-5#1)(1995-2#1)
continuous treatment##3##2##(1991-5#1)(1991-6#1)(1995-2#1)
continuous tuning##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
continuous twin screw-driven reactor (CTSR)##3##5##(2013-1#3)
continuous twin screw-driven reactor##4##4##(2013-1#4)
continuous ultrasound assisted dissolution##2##4##(2008-10#2)
continuous updating##2##2##(1995-12#1)(2008-7#1)
continuous use##5##2##(2008-10#5)
continuous variables##4##2##(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
continuous variation of##2##3##(2008-10#2)
continuous warm blood cardioplegia##2##4##(1991-3#1)(1996-9#1)
continuous wave (cw)##2##3##(2008-2#1)(2011-1#1)
continuous wave CO2 laser##2##4##(1996-1#2)
continuous wave and##2##3##(1990-8#1)(2008-3#1)
continuous wave lasers##2##3##(1991-3#1)(2008-3#1)
continuous wave##14##2##(1990-8#1)(1991-3#1)(1992-1#1)(1996-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2011-1#1)
continuous wavelet transform (CWT)##2##4##(2008-10#1)(2008-3#1)
continuous wavelet transform##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
continuous wetness##6##2##(2008-10#6)
continuous with the##2##3##(1997-6#1)(2008-10#1)
continuous with##5##2##(1997-6#2)(2007-12#1)(2008-10#1)(2011-2#1)
continuous##902##1##(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#8)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#5)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#4)(1992-5#6)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#6)(1993-3#8)(1993-6#2)(1994-1#6)(1994-11#2)(1994-12#10)(1994-2#7)(1994-3#10)(1994-5#7)(1994-6#3)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#9)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#2)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#6)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#4)(2006-10#4)(2007-10#1)(2007-11#14)(2007-12#34)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#10)(2008-10#231)(2008-11#59)(2008-12#8)(2008-2#30)(2008-3#51)(2008-4#11)(2008-5#7)(2008-6#16)(2008-7#32)(2008-8#10)(2008-9#5)(2009-10#3)(2009-11#7)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#5)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#5)(2011-1#13)(2011-2#22)(2012-1#4)(2012-12#7)(2012-2#7)(2012-3#6)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#17)(2013-7#2)(2013-8#13)
continuous-emission monitor##3##2##(2008-2#3)
continuous-flow dialysis##2##2##(2008-10#2)
continuous-flow extraction##2##2##(2008-10#2)
continuous-flow manifold##2##2##(2008-10#2)
continuous-flow pumps##2##2##(2010-6#2)
continuous-flow system##4##2##(2008-10#3)(2008-7#1)
continuous-flow systems##2##2##(2008-1#1)(2008-9#1)
continuous-flow##28##1##(1997-3#1)(2008-1#1)(2008-10#19)(2008-7#2)(2008-9#1)(2010-6#4)
continuous-profile##3##1##(2008-3#3)
continuous-relief diffractive##3##2##(2007-12#2)(2008-2#1)
continuous-relief##4##1##(2007-12#2)(2008-2#2)
continuous-time##3##1##(2008-10#1)(2008-2#1)(2008-8#1)
continuous-variable##2##1##(2007-11#1)(2007-12#1)
continuous-wave (cw)##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
continuous-wave CO(2)##2##2##(2008-2#1)(2008-3#1)
continuous-wave CO2 laser##2##3##(2008-2#1)(2008-3#1)
continuous-wave CO2##4##2##(2008-2#2)(2008-3#2)
continuous-wave Cr(4+)##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
continuous-wave Nd##3##2##(2007-11#3)
continuous-wave Raman laser##2##3##(2007-11#1)(2007-12#1)
continuous-wave Ti##2##2##(2007-12#1)(2008-3#1)
continuous-wave cavity ringdown spectroscopy##2##4##(2008-3#2)
continuous-wave diffuse reflectance##2##3##(2008-3#1)(2011-1#1)
continuous-wave diode-pumped##2##2##(2007-12#1)(2008-2#1)
continuous-wave laser##10##2##(2007-12#3)(2008-2#4)(2008-3#3)
continuous-wave lasers##2##2##(2007-12#1)(2008-3#1)
continuous-wave operation of##2##3##(2007-11#1)(2008-2#1)
continuous-wave operation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
continuous-wave optical parametric oscillator##3##4##(2007-12#3)
continuous-wave optical parametric##4##3##(2007-12#4)
continuous-wave output##2##2##(2008-2#1)(2008-3#1)
continuous-wave photon-migration techniques##2##3##(2007-12#2)
continuous-wave semiconductor##2##2##(2007-11#1)(2008-3#1)
continuous-wave ultraviolet##2##2##(2007-12#1)(2008-3#1)
continuous-wave##124##1##(2007-11#20)(2007-12#37)(2007-9#1)(2008-2#25)(2008-3#39)(2011-1#2)
continuously and##9##2##(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-5#1)(2012-3#2)
continuously at##3##2##(2007-11#1)(2008-3#1)(2009-6#1)
continuously but##2##2##(1993-6#1)(2008-2#1)
continuously by##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
continuously changing##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
continuously during##3##2##(1991-10#1)(1994-12#1)(2013-1#1)
continuously evolving##2##2##(1996-1#1)(2010-12#1)
continuously exposed to##3##3##(1994-5#1)(2008-12#1)(2010-11#1)
continuously flowing##3##2##(2008-10#3)
continuously for##4##2##(1993-12#1)(1995-2#1)(2008-11#1)(2008-9#1)
continuously from##4##2##(2007-11#1)(2008-11#1)(2008-8#1)(2009-7#1)
continuously improving##2##2##(1995-1#1)(2008-1#1)
continuously in a##2##3##(1997-2#1)(2011-2#1)
continuously in##6##2##(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
continuously increases##2##2##(2008-3#1)(2008-7#1)
continuously increasing##3##2##(2007-7#1)(2008-3#1)(2010-11#1)
continuously monitored##7##2##(2008-10#4)(2008-11#1)(2008-4#1)(2011-1#1)
continuously over##2##2##(2007-11#1)(2013-1#1)
continuously perfused##2##2##(1991-3#1)(2008-11#1)
continuously self-imaging gratings##2##3##(2007-11#2)
continuously stable##2##2##(2008-9#2)
continuously the##2##2##(2008-10#1)(2008-3#1)
continuously throughout the##2##3##(2008-9#1)(2012-2#1)
continuously throughout##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
continuously to the##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
continuously to##5##2##(1996-5#1)(2008-10#2)(2008-11#1)(2010-10#1)
continuously tunable from##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
continuously tunable operation of a##2##5##(2007-12#2)
continuously tunable operation##3##3##(2007-12#2)(2008-2#1)
continuously tunable##14##2##(2007-11#3)(2007-12#3)(2008-2#5)(2008-3#3)
continuously tuned##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
continuously until##2##2##(2008-5#1)(2009-11#1)
continuously varied##2##2##(2007-11#1)(2008-3#1)
continuously varying##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
continuously with##2##2##(1992-3#1)(1995-12#1)
continuously##207##1##(1990-12#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#13)(2007-12#13)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#42)(2008-11#14)(2008-12#1)(2008-2#16)(2008-3#15)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#5)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
continuum between##3##2##(2008-3#1)(2009-9#1)(2012-2#1)
continuum from##3##2##(1995-12#1)(2007-11#1)(2008-1#1)
continuum generated##4##2##(2007-11#1)(2007-12#3)
continuum generation##5##2##(2007-11#4)(2008-3#1)
continuum in##3##2##(2007-12#1)(2010-2#1)(2013-1#1)
continuum is##2##2##(2007-11#1)(2013-1#1)
continuum model##3##2##(2008-10#1)(2008-4#1)(2011-3#1)
continuum of care for##2##4##(1994-12#2)
continuum of care##15##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1994-12#4)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#3)
continuum of services##2##3##(1996-2#1)(1997-3#1)
continuum of##35##2##(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#2)(1994-12#4)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#4)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
continuum radiation##2##2##(2008-2#2)
continuum spanning##2##2##(2007-11#1)(2010-4#1)
continuum that##3##2##(1994-9#1)(1997-3#1)(2013-1#1)
continuum##104##1##(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#3)(1994-12#4)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#7)(2007-11#14)(2007-12#8)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)
contortus in##2##2##(1991-8#2)
contortus on##2##2##(1991-8#1)(1996-12#1)
contortus##8##1##(1991-8#4)(1994-12#1)(1996-12#1)(2011-1#1)(2012-2#1)
contour advance##2##2##(2008-9#2)
contour functions##2##2##(2008-3#2)
contour length##2##2##(2008-10#1)(2009-5#1)
contour maps of##2##3##(2008-10#1)(2008-3#1)
contour maps##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
contour objects##5##2##(2008-3#5)
contour of the##2##3##(2006-12#1)(2013-8#1)
contour of##3##2##(2006-12#1)(2013-1#1)(2013-8#1)
contour plots of##3##3##(2008-10#2)(2010-12#1)
contour plots##5##2##(2008-10#3)(2008-8#1)(2010-12#1)
contour##40##1##(1991-2#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-3#9)(2008-6#1)(2008-8#3)(2008-9#4)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
contour-clamped homogeneous##2##2##(1991-9#1)(2008-10#1)
contour-clamped##3##1##(1991-9#1)(2008-10#2)
contoured by##4##2##(2008-7#1)(2009-2#1)(2012-12#2)
contoured##5##1##(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#2)
contouring of##2##2##(2008-3#1)(2008-9#1)
contouring protocol for PET/CT treatment planning##2##6##(2009-2#2)
contouring protocol##5##2##(2009-2#5)
contouring with##2##2##(2008-2#1)(2009-2#1)
contouring##16##1##(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#7)(2010-8#1)(2012-12#1)(2013-1#1)
contours and##3##2##(2008-3#1)(2008-6#1)(2009-2#1)
contours are##3##2##(2008-3#1)(2008-9#2)
contours of##3##2##(2008-5#1)(2008-8#1)(2012-2#1)
contours##26##1##(1994-8#1)(1995-6#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#6)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
contra-indicated##2##1##(1996-3#1)(2008-1#1)
contraband##4##1##(2008-10#4)
contraception among##2##2##(1993-2#1)(2013-1#1)
contraception and##2##2##(1991-1#1)(2008-11#1)
contraception at the time of##3##5##(1991-6#1)(1993-2#1)(2013-1#1)
contraception in##2##2##(2011-2#1)(2012-12#1)
contraception##40##1##(1991-1#2)(1991-4#1)(1991-6#1)(1993-2#5)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#3)(1996-11#2)(1996-3#1)(1996-8#2)(2008-11#2)(2009-12#1)(2011-1#1)(2011-2#3)(2012-12#7)(2013-1#5)(2013-8#1)
contraception&quot##2##1##(1994-9#1)(1996-9#1)
contraceptive choice##2##2##(1996-11#2)
contraceptive counseling##4##2##(2013-1#4)
contraceptive gel##3##2##(1996-9#3)
contraceptive implant users##2##3##(2011-2#2)
contraceptive implants##5##2##(1996-11#3)(2011-2#2)
contraceptive method##6##2##(1993-2#1)(1994-8#1)(1996-11#1)(2013-1#3)
contraceptive methods to##2##3##(1994-9#1)(2012-12#1)
contraceptive methods##7##2##(1990-6#1)(1993-2#1)(1994-8#1)(1994-9#2)(1996-11#1)(2012-12#1)
contraceptive pill##4##2##(1997-6#1)(2007-12#1)(2010-1#1)(2012-3#1)
contraceptive pills##2##2##(1993-2#1)(2013-1#1)
contraceptive usage##3##2##(1990-6#1)(1991-4#1)(2012-12#1)
contraceptive use among##2##3##(2012-12#1)(2013-1#1)
contraceptive use##12##2##(1990-6#1)(1991-3#1)(1996-11#1)(2008-8#1)(2011-1#1)(2012-12#5)(2013-1#2)
contraceptive users##3##2##(1990-12#1)(1994-9#1)(2012-12#1)
contraceptive##77##1##(1990-12#1)(1990-6#3)(1991-3#1)(1991-4#1)(1993-2#5)(1994-5#1)(1994-8#3)(1994-9#4)(1996-11#12)(1996-9#3)(1997-6#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#2)(2010-1#1)(2011-1#1)(2011-2#5)(2012-12#11)(2012-3#1)(2013-1#12)
contraceptives and the##2##3##(1994-9#1)(2008-10#1)
contraceptives and their##2##3##(1990-6#1)(2011-3#1)
contraceptives and##10##2##(1990-6#1)(1994-9#1)(1997-2#1)(1997-5#4)(2008-10#1)(2011-3#1)(2012-12#1)
contraceptives are##2##2##(1996-11#1)(2012-2#1)
contraceptives in##3##2##(1990-6#1)(1996-11#1)(2012-2#1)
contraceptives##51##1##(1990-12#1)(1990-2#1)(1990-6#5)(1990-9#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-9#3)(1996-11#5)(1996-2#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-5#4)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#2)(2009-8#1)(2011-2#1)(2011-3#2)(2012-12#3)(2012-2#3)(2013-1#1)
contract and##4##2##(1992-1#1)(1992-4#1)(1997-5#1)(2008-11#1)
contract between##2##2##(1992-2#1)(2008-1#1)
contract security##2##2##(1996-12#1)(1996-2#1)
contract terms and##2##3##(1994-1#2)
contract terms##4##2##(1994-1#3)(2007-9#1)
contract with##6##2##(1992-11#1)(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
contract##63##1##(1990-3#2)(1991-1#2)(1991-3#2)(1992-1#5)(1992-11#1)(1992-2#3)(1992-3#2)(1992-4#1)(1993-12#2)(1994-1#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#4)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#2)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-5#2)(2009-1#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)
contract-relax##6##1##(2007-11#5)(2009-1#1)
contracted the##3##2##(1996-5#1)(2008-11#1)(2008-12#1)
contracted##27##1##(1990-8#1)(1993-3#1)(1994-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#3)(1997-4#1)(1997-5#2)(1997-7#2)(2007-2#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#2)(2010-1#1)(2010-11#1)(2013-1#1)
contractile action##3##2##(1990-8#2)(1997-4#1)
contractile activity##5##2##(1994-11#2)(1994-9#1)(1997-4#1)(2013-1#1)
contractile dysfunction##2##2##(2008-12#1)(2013-7#1)
contractile effect of##5##3##(1990-12#1)(1994-11#2)(1995-12#1)(1997-4#1)
contractile effect##6##2##(1990-12#1)(1994-11#2)(1995-12#2)(1997-4#1)
contractile effects of##2##3##(1994-11#1)(2010-3#1)
contractile function##2##2##(1996-9#2)
contractile properties##3##2##(1996-2#1)(2008-3#1)(2013-7#1)
contractile protein##2##2##(2008-11#1)(2010-6#1)
contractile proteins##6##2##(1991-6#1)(2008-5#2)(2009-9#2)(2010-8#1)
contractile response in##3##3##(1997-6#1)(2008-2#2)
contractile response induced by##2##4##(1997-6#1)(2008-2#1)
contractile response##10##2##(1990-5#1)(1991-5#1)(1995-12#1)(1997-6#3)(2008-2#4)
contractile responses in##2##3##(1997-6#1)(2009-11#1)
contractile responses to##2##3##(2008-3#1)(2013-8#1)
contractile responses##5##2##(1990-5#1)(1997-6#1)(2008-3#1)(2009-11#1)(2013-8#1)
contractile##62##1##(1990-12#1)(1990-5#2)(1990-8#2)(1991-5#2)(1991-6#1)(1991-9#1)(1993-6#1)(1994-11#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1996-2#1)(1996-9#2)(1997-4#3)(1997-6#5)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-9#2)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
contractility and##3##2##(1990-3#1)(2010-4#1)(2010-8#1)
contractility of##2##2##(1997-7#1)(2012-1#1)
contractility##28##1##(1990-3#1)(1996-3#2)(1997-7#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-4#1)(2010-8#2)(2012-1#3)(2012-12#2)(2013-1#2)
contracting and##2##2##(1992-2#2)
contracting for##2##2##(1991-3#2)
contracting process##4##2##(1993-3#1)(1994-1#2)(1994-3#1)
contracting with##5##2##(1992-11#1)(1995-2#2)(1996-2#1)(1997-1#1)
contracting##47##1##(1991-3#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1993-12#1)(1993-3#2)(1994-1#4)(1994-12#6)(1994-2#2)(1994-3#2)(1995-12#2)(1995-2#2)(1995-3#1)(1996-2#3)(1997-1#1)(1997-3#1)(2007-2#2)(2007-4#1)(2010-10#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)
contraction (MVC)##3##2##(1993-12#1)(2010-6#1)(2013-8#1)
contraction and transit##2##3##(2013-8#2)
contraction and##10##2##(1994-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2013-8#2)
contraction by##2##2##(2008-12#1)(2008-5#1)
contraction force##5##2##(2008-12#5)
contraction forces##2##2##(2008-12#1)(2012-7#1)
contraction in##12##2##(1990-12#2)(1990-5#1)(1991-12#1)(1994-3#1)(1995-12#2)(1997-4#1)(1997-7#1)(2008-3#2)(2010-6#1)
contraction induced by bombesin##3##4##(1991-12#3)
contraction induced by##9##3##(1991-12#4)(1992-3#1)(1992-9#2)(1995-12#1)(1997-7#1)
contraction induced##10##2##(1991-12#5)(1992-3#1)(1992-9#2)(1995-12#1)(1997-7#1)
contraction is##3##2##(1991-12#1)(1994-8#1)(2008-10#1)
contraction of airway smooth muscle##2##5##(1997-1#1)(2010-1#1)
contraction of collagen gel##2##4##(1994-11#2)
contraction of collagen##3##3##(1992-9#1)(1994-11#2)
contraction of ileum##2##3##(2008-12#2)
contraction of the guinea pig ileum##2##6##(1995-12#2)
contraction of the##14##3##(1990-2#1)(1993-3#1)(1995-12#2)(1995-2#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#3)(2013-1#2)
contraction of##31##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-7#2)(2010-1#1)(2010-6#1)(2013-1#2)
contraction or##2##2##(1992-8#1)(2009-11#1)
contraction than##2##2##(1993-12#1)(1995-12#1)
contraction to##2##2##(1990-6#1)(1997-4#1)
contraction under##2##2##(1995-12#1)(2008-8#1)
contraction velocity##2##2##(1991-2#1)(2009-7#1)
contraction was##6##2##(1995-12#1)(1997-7#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
contraction were##2##2##(1997-4#1)(2010-9#1)
contraction with##2##2##(1995-12#1)(2011-1#1)
contraction##176##1##(1990-12#3)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-12#9)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#3)(1993-3#3)(1993-8#1)(1994-11#4)(1994-3#1)(1994-8#3)(1994-9#1)(1995-12#17)(1995-2#1)(1995-6#1)(1996-2#2)(1996-5#4)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#9)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#5)(2008-10#7)(2008-11#1)(2008-12#11)(2008-3#6)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-6#3)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#2)(2013-1#2)(2013-8#7)
contraction)##2##1##(1997-5#1)(2008-7#1)
contractions and##5##2##(1995-12#2)(1996-2#1)(1997-4#1)(1997-7#1)
contractions at##2##2##(1997-7#1)(2013-8#1)
contractions by##2##2##(1994-8#1)(2009-2#1)
contractions due to KCl##2##4##(1995-12#2)
contractions in##7##2##(1990-2#1)(1994-11#1)(1995-12#2)(1997-7#1)(2008-7#1)(2008-9#1)
contractions induced by##2##3##(1995-12#1)(1997-4#1)
contractions of the##6##3##(1990-5#1)(1992-3#1)(1997-4#1)(2008-12#1)(2008-3#2)
contractions of##9##2##(1990-5#1)(1991-5#2)(1992-3#1)(1995-12#1)(1997-4#1)(2008-12#1)(2008-3#2)
contractions was##2##2##(1990-8#1)(1993-3#1)
contractions were##11##2##(1990-8#1)(1992-3#2)(1994-6#1)(1995-12#2)(1996-5#1)(2007-10#2)(2011-1#1)(2013-8#1)
contractions which##2##2##(1997-4#1)(2010-3#1)
contractions##85##1##(1990-2#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-5#2)(1992-2#1)(1992-3#5)(1992-8#2)(1993-3#2)(1993-9#1)(1994-11#3)(1994-6#3)(1994-8#2)(1995-12#13)(1996-2#1)(1996-5#4)(1997-4#6)(1997-7#5)(2007-10#3)(2008-12#1)(2008-3#4)(2008-7#5)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-3#3)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#4)
contractor##7##1##(1990-2#2)(1993-1#2)(1994-1#1)(1994-2#1)(2013-7#1)
contractors##5##1##(1993-1#1)(1993-3#1)(1994-3#1)(1996-2#1)(1997-2#1)
contracts and##2##2##(1996-3#1)(1997-4#1)
contracts are##2##2##(1996-2#1)(2008-11#1)
contracts between##2##2##(1995-2#1)(1997-2#1)
contracts in the##2##3##(1994-2#1)(2008-7#1)
contracts in##4##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
contracts that##2##2##(1992-3#1)(1997-1#1)
contracts with managed care##2##4##(1996-2#1)(1997-1#1)
contracts with##7##2##(1992-12#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-2#1)
contracts##53##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-7#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#4)(1995-2#1)(1996-2#4)(1996-3#1)(1997-1#4)(1997-2#4)(1997-4#1)(2007-4#1)(2008-11#12)(2008-2#1)(2008-7#1)(2008-9#3)(2011-2#1)(2013-1#1)
contracts?##3##1##(1992-2#1)(1996-12#1)(2008-11#1)
contractual##5##1##(1991-12#1)(1991-2#1)(1994-12#1)(2008-11#1)(2009-3#1)
contracture and##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
contracture in##3##2##(1992-9#1)(1997-5#1)(2008-9#1)
contracture of the knee##2##4##(2007-11#2)
contracture of the##4##3##(2007-11#3)(2007-8#1)
contracture of##5##2##(2007-11#3)(2007-8#1)(2008-9#1)
contracture##23##1##(1992-9#2)(1997-3#1)(1997-5#1)(2007-11#4)(2007-8#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2012-3#1)(2013-1#2)(2013-8#2)
contractures of##2##2##(2007-11#1)(2013-1#1)
contractures##7##1##(2007-11#2)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#2)
contradict the##2##2##(2006-10#1)(2008-10#1)
contradict##6##1##(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)
contradicting##2##1##(2010-8#1)(2012-3#1)
contradiction between the##3##3##(2007-10#1)(2007-11#1)(2011-2#1)
contradiction between##4##2##(2007-10#1)(2007-11#1)(2011-2#2)
contradiction in##2##2##(2008-3#1)(2012-2#1)
contradiction##12##1##(1991-6#1)(1992-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#2)(2012-2#1)
contradictions of##2##2##(1991-3#1)(1996-6#1)
contradictions##8##1##(1991-3#2)(1996-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
contradictory and##4##2##(1997-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
contradictory results##5##2##(1993-12#1)(2008-10#1)(2009-10#1)(2010-11#1)(2013-1#1)
contradictory##32##1##(1990-9#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
contradicts the##2##2##(2008-8#1)(2011-2#1)
contradicts##4##1##(2008-8#2)(2008-9#1)(2011-2#1)
contraindicate##3##1##(1992-8#1)(2011-2#2)
contraindicated in patients with##2##4##(1992-5#1)(1995-2#1)
contraindicated in the##2##3##(1991-9#1)(2012-3#1)
contraindicated in##5##2##(1991-9#1)(1992-5#1)(1995-2#1)(2008-7#1)(2012-3#1)
contraindicated or when there is a strong suspicion of vasospasm as a dominant mechanism in angina##2##16##(2008-3#2)
contraindicated or##5##2##(2007-8#1)(2008-3#2)(2011-1#1)(2012-12#1)
contraindicated##25##1##(1990-11#1)(1991-9#1)(1992-5#1)(1995-2#1)(1996-3#1)(2007-8#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
contraindication for##6##2##(1990-8#1)(1993-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
contraindication to the##3##3##(1994-8#1)(2007-5#1)(2011-2#1)
contraindication to##8##2##(1994-3#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-9#1)(2010-6#1)(2011-2#1)
contraindication##19##1##(1990-8#1)(1991-6#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-9#1)(2010-6#1)(2011-2#5)(2013-1#2)(2013-8#1)
contraindications and##2##2##(1996-9#1)(2013-8#1)
contraindications for##5##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
contraindications to##4##2##(1991-2#1)(2010-12#1)(2011-3#1)(2013-8#1)
contraindications##29##1##(1991-2#1)(1991-6#1)(1993-12#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2010-12#1)(2011-2#7)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#3)
contralateral SHM##3##2##(2011-2#3)
contralateral breast##6##2##(1990-12#2)(1994-12#1)(2007-10#2)(2008-10#1)
contralateral circling and/or rearing behavior in##2##6##(1995-12#2)
contralateral eye##2##2##(1990-12#1)(2010-10#1)
contralateral head turns and rotations##3##5##(1995-12#3)
contralateral head turns##4##3##(1995-12#4)
contralateral head##5##2##(1995-12#4)(2009-4#1)
contralateral knee##2##2##(2008-8#1)(2013-1#1)
contralateral metachronous breast##2##3##(1990-8#2)
contralateral metachronous##3##2##(1990-12#1)(1990-8#2)
contralateral or##2##2##(2007-12#1)(2011-2#1)
contralateral ovary was##2##3##(1992-3#2)
contralateral primary##2##2##(1990-8#1)(2008-11#1)
contralateral surgery##3##2##(2010-7#1)(2013-1#2)
contralateral testis##2##2##(2008-10#2)
contralateral to the cortical stimulus site##2##6##(1990-9#2)
contralateral to the##3##3##(1990-9#2)(1992-10#1)
contralateral to##5##2##(1990-9#2)(1992-10#1)(2007-7#1)(2008-7#1)
contralateral##135##1##(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#3)(1990-9#3)(1991-2#1)(1992-10#2)(1992-3#2)(1992-8#2)(1993-12#14)(1993-3#4)(1994-12#1)(1994-2#2)(1995-12#11)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#2)(1996-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-10#4)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-7#1)(2011-2#7)(2012-1#1)(2012-12#1)(2013-1#8)(2013-8#1)
contralaterally##2##1##(2007-12#1)(2010-5#1)
contralesional##2##1##(1996-2#1)(2009-2#1)
contrary results##2##2##(1993-12#1)(2008-7#1)
contrary to previous##2##3##(1992-3#1)(2010-8#1)
contrary to the view##2##4##(2013-8#2)
contrary to the##5##3##(1994-8#1)(2007-8#1)(2008-9#1)(2013-8#2)
contrary to what##3##3##(1990-2#1)(1994-12#1)(2010-2#1)
contrary to##26##2##(1990-2#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#2)
contrary##107##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#10)(2008-11#6)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-7#2)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#3)(2013-8#4)
contrast administration##4##2##(1997-8#1)(2008-7#3)
contrast agent can##2##3##(2010-12#2)
contrast agent with##2##3##(2008-7#1)(2012-2#1)
contrast agent##22##2##(1993-9#1)(1997-7#1)(2007-10#2)(2008-5#1)(2008-7#7)(2009-6#2)(2010-11#1)(2010-12#3)(2012-12#1)(2012-2#1)(2013-8#2)
contrast agents and##2##3##(2008-3#1)(2008-7#1)
contrast agents are##2##3##(2010-9#2)
contrast agents for##3##3##(2008-7#1)(2010-2#1)(2010-9#1)
contrast agents have further improved the##2##6##(2008-1#1)(2010-12#1)
contrast agents in##7##3##(2008-7#6)(2011-1#1)
contrast agents or##2##3##(2008-3#1)(2008-8#1)
contrast agents that##2##3##(2009-6#1)(2013-1#1)
contrast agents##41##2##(1990-3#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#16)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-9#5)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#1)
contrast and the##5##3##(2007-11#1)(2008-3#2)(2008-9#1)(2011-2#1)
contrast and##26##2##(1994-9#1)(1997-4#1)(1997-8#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
contrast are##4##2##(1990-2#1)(2007-12#1)(2008-3#2)
contrast at the##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
contrast between the##2##3##(2007-11#1)(2009-10#1)
contrast between##11##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)
contrast by##2##2##(2007-11#1)(2008-3#1)
contrast echocardiography##3##2##(2010-8#1)(2011-2#2)
contrast echocardiography]##2##2##(2008-9#1)(2013-8#1)
contrast enhanced##8##2##(2007-11#2)(2007-5#2)(2008-7#2)(2010-11#2)
contrast enhancement and scan timing##2##5##(2008-7#2)
contrast enhancement and##4##3##(2008-3#1)(2008-7#2)(2010-5#1)
contrast enhancement for##2##3##(2008-2#1)(2008-7#1)
contrast enhancement in##2##3##(2008-12#1)(2008-3#1)
contrast enhancement of##2##3##(2007-11#1)(2008-3#1)
contrast enhancement##20##2##(2007-10#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#4)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-8#1)
contrast for##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)
contrast group##3##2##(2012-1#3)
contrast in the##5##3##(2008-2#1)(2008-3#4)
contrast in##10##2##(1990-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#4)(2010-2#1)(2012-2#1)
contrast is##7##2##(2008-3#4)(2008-7#1)(2011-1#2)
contrast levels of##2##3##(2008-3#1)(2012-1#1)
contrast levels##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
contrast material administration##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
contrast material##13##2##(2007-10#2)(2008-12#1)(2008-7#8)(2011-2#2)
contrast measurement##2##2##(2008-3#2)
contrast mechanism##5##2##(2007-11#1)(2007-12#1)(2008-5#1)(2010-8#1)(2012-12#1)
contrast media##19##2##(1990-3#3)(1991-1#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-3#1)(1997-8#2)(2007-5#1)(2008-12#1)(2008-7#2)(2009-4#2)(2009-6#1)(2012-12#1)(2012-2#1)
contrast medium and##2##3##(1992-12#1)(2008-1#1)
contrast medium##15##2##(1990-11#1)(1990-3#1)(1992-12#2)(1996-9#1)(2008-1#1)(2008-7#7)(2009-1#1)(2011-2#1)
contrast method##4##2##(1997-4#2)(2006-4#1)(2008-9#1)
contrast microscope##2##2##(2008-3#1)(2013-1#1)
contrast microscopy##7##2##(1991-3#1)(1997-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-7#1)
contrast obtained##2##2##(1997-8#1)(2008-3#1)
contrast of a##4##3##(2007-11#2)(2008-3#2)
contrast of the##8##3##(2007-12#2)(2008-3#6)
contrast of##22##2##(1996-2#1)(2007-11#3)(2007-12#7)(2008-3#8)(2008-5#1)(2008-6#1)(2009-10#1)
contrast over##2##2##(2012-2#2)
contrast parameter##3##2##(2008-6#2)(2011-1#1)
contrast ratio and##2##3##(2008-2#1)(2008-3#1)
contrast ratio of##8##3##(2007-12#1)(2008-2#2)(2008-3#5)
contrast ratio##18##2##(2007-12#1)(2008-2#7)(2008-3#9)(2010-1#1)
contrast reversals##3##2##(2008-2#3)
contrast sensitivity##5##2##(1996-5#1)(2008-7#2)(2012-1#2)
contrast showed a##2##3##(2010-2#1)(2012-2#1)
contrast stimuli##4##2##(1996-5#4)
contrast the##9##2##(1994-1#1)(1996-12#2)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
contrast to a##5##3##(1990-10#1)(1990-2#1)(1992-10#1)(1992-12#1)(2008-10#1)
contrast to acute##2##3##(1994-6#1)(2011-2#1)
contrast to all other##3##4##(1990-7#1)(2007-12#1)(2011-2#1)
contrast to classical##2##3##(1993-6#1)(1996-12#1)
contrast to common##2##3##(2008-10#2)
contrast to controls##4##3##(1992-12#1)(1996-12#1)(2008-7#1)(2010-7#1)
contrast to conventional##6##3##(2007-11#1)(2008-3#2)(2008-5#1)(2009-7#1)(2012-2#1)
contrast to earlier##3##3##(1993-6#1)(2008-5#1)(2008-8#1)
contrast to its##3##3##(1991-6#1)(1994-2#1)(1997-7#1)
contrast to many other##2##4##(2010-3#1)(2011-2#1)
contrast to other##15##3##(1990-5#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-9#1)(2013-1#1)
contrast to previous reports##2##4##(1993-6#1)(2008-10#1)
contrast to previous##7##3##(1993-5#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
contrast to prior findings##2##4##(2007-9#1)(2009-11#1)
contrast to the findings in##2##5##(1991-8#1)(1996-7#1)
contrast to the other##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
contrast to the usual##2##4##(1997-8#1)(2008-9#1)
contrast to the##99##3##(1990-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#3)(1992-6#3)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-2#1)
contrast to their##6##3##(1991-2#1)(1993-6#1)(2008-10#1)(2008-5#1)(2010-10#1)(2013-1#1)
contrast to this##7##3##(1990-12#1)(1992-4#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-3#1)(2012-3#1)
contrast to what has been##2##5##(2008-3#1)(2010-4#1)
contrast to what##4##3##(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)
contrast to##308##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#3)(1990-7#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#6)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#7)(1993-8#4)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#3)(1996-12#5)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#4)(1997-8#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#39)(2008-11#15)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#15)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-9#1)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#8)(2013-2#1)(2013-7#1)(2013-8#2)
contrast ultrasound##5##2##(2008-7#5)
contrast was##2##2##(1990-9#1)(2007-10#1)
contrast were##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
contrast with previous##3##3##(2008-2#1)(2009-12#1)(2010-8#1)
contrast with the##13##3##(1992-12#1)(1992-3#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
contrast with those of##2##4##(1996-5#1)(2008-10#1)
contrast with##46##2##(1990-2#1)(1991-11#2)(1991-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1995-2#1)(1995-6#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(2007-11#5)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)
contrast##1542##1##(1990-10#3)(1990-11#8)(1990-12#7)(1990-2#11)(1990-3#7)(1990-5#7)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#7)(1991-12#11)(1991-2#6)(1991-3#5)(1991-4#1)(1991-5#13)(1991-6#4)(1991-8#3)(1991-9#7)(1992-10#3)(1992-11#1)(1992-12#9)(1992-2#2)(1992-3#14)(1992-4#1)(1992-5#3)(1992-6#14)(1992-7#1)(1992-8#11)(1992-9#7)(1993-1#1)(1993-11#6)(1993-12#13)(1993-2#3)(1993-3#7)(1993-5#2)(1993-6#12)(1993-8#9)(1993-9#6)(1994-1#2)(1994-10#1)(1994-11#11)(1994-12#7)(1994-2#10)(1994-3#3)(1994-5#9)(1994-6#4)(1994-8#9)(1994-9#6)(1995-1#1)(1995-11#10)(1995-12#14)(1995-2#30)(1995-3#7)(1995-5#8)(1995-6#9)(1995-8#9)(1995-9#1)(1996-11#1)(1996-12#17)(1996-2#14)(1996-4#2)(1996-5#16)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#10)(1997-3#6)(1997-4#12)(1997-5#1)(1997-6#5)(1997-7#11)(1997-8#9)(2006-10#2)(2006-4#1)(2007-10#9)(2007-11#36)(2007-12#35)(2007-2#1)(2007-4#2)(2007-5#4)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#10)(2008-10#188)(2008-11#50)(2008-12#8)(2008-2#39)(2008-3#99)(2008-4#12)(2008-5#34)(2008-6#12)(2008-7#104)(2008-8#40)(2008-9#29)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#7)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#9)(2009-7#6)(2009-8#9)(2009-9#5)(2010-1#3)(2010-10#2)(2010-11#11)(2010-12#9)(2010-2#5)(2010-3#5)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#9)(2010-9#7)(2011-1#15)(2011-2#32)(2011-9#1)(2012-1#21)(2012-12#18)(2012-2#34)(2012-3#18)(2012-7#1)(2013-1#32)(2013-2#1)(2013-3#2)(2013-7#5)(2013-8#13)
contrast-agent##3##1##(2007-11#1)(2008-2#1)(2009-11#1)
contrast-enhanced CT##6##2##(2012-12#1)(2013-1#5)
contrast-enhanced MR mammography##4##3##(1997-8#4)
contrast-enhanced MR##5##2##(1997-8#4)(2008-1#1)
contrast-enhanced MRI##4##2##(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
contrast-enhanced US##4##2##(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
contrast-enhanced computed tomography##4##3##(2008-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
contrast-enhanced harmonic US##2##3##(2010-12#2)
contrast-enhanced magnetic resonance imaging##3##4##(2008-1#1)(2008-8#1)(2010-3#1)
contrast-enhanced magnetic resonance##4##3##(1997-8#1)(2008-1#1)(2008-8#1)(2010-3#1)
contrast-enhanced ultrasound (CEUS)##2##3##(2008-7#1)(2012-2#1)
contrast-enhanced ultrasound in##2##3##(2008-7#2)
contrast-enhanced ultrasound##7##2##(2008-7#5)(2010-12#1)(2012-2#1)
contrast-enhanced##49##1##(1997-8#8)(2008-1#4)(2008-7#11)(2008-8#2)(2010-12#7)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#2)
contrast-specific##2##1##(2008-7#1)(2010-12#1)
contrasted between##2##2##(2007-9#1)(2008-5#1)
contrasted with the##6##3##(1991-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
contrasted with##14##2##(1991-12#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
contrasted##28##1##(1991-12#1)(1992-1#1)(1994-1#1)(1995-2#1)(1996-6#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
contrasting effects##2##2##(1993-8#1)(2008-8#1)
contrasting environments##2##2##(2008-8#1)(2008-9#1)
contrasting results##2##2##(2013-1#1)(2013-8#1)
contrasting##30##1##(1991-2#1)(1993-8#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#1)(2010-3#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#2)
contrasts and##2##2##(2008-10#1)(2012-1#1)
contrasts between##3##2##(1991-2#1)(2008-5#1)(2012-2#1)
contrasts in##4##2##(2008-10#2)(2010-3#1)(2013-8#1)
contrasts of##2##2##(2008-10#1)(2013-7#1)
contrasts the use##2##3##(1994-2#1)(2009-10#1)
contrasts the##3##2##(1994-2#1)(2008-10#1)(2009-10#1)
contrasts to##3##2##(1992-3#1)(2009-7#1)(2010-5#1)
contrasts with its##2##3##(1990-5#1)(2011-2#1)
contrasts with the##7##3##(1990-2#1)(1991-5#1)(1993-11#1)(1993-2#1)(1996-6#1)(2006-6#1)(2008-3#1)
contrasts with##20##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-2#1)(2011-2#1)(2012-3#1)
contrasts##64##1##(1990-2#1)(1990-5#1)(1991-2#2)(1991-5#2)(1992-3#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-4#3)(2006-6#1)(2007-11#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#10)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
contribute considerably to##2##3##(1991-5#1)(1996-2#1)
contribute greatly to a##2##4##(2008-3#1)(2010-6#1)
contribute greatly to##5##3##(2008-11#1)(2008-3#1)(2010-6#2)(2012-3#1)
contribute in##4##2##(1994-3#1)(1996-2#1)(2008-10#1)(2012-3#1)
contribute more to##2##3##(2008-10#2)
contribute significantly to the##7##4##(1995-2#1)(1996-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)
contribute significantly to##12##3##(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-3#2)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
contribute significantly##14##2##(1992-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
contribute substantially to##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
contribute the##2##2##(2008-9#1)(2012-3#1)
contribute to Kir3 current inhibition##2##5##(2008-8#2)
contribute to a better understanding of the##4##7##(1990-12#1)(2008-10#3)
contribute to a better understanding of##7##6##(1990-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#1)
contribute to a better##8##4##(1990-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
contribute to a decrease##2##4##(2008-6#1)(2013-1#1)
contribute to a significant##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
contribute to a##33##3##(1990-12#1)(1991-12#1)(1991-5#1)(1994-12#1)(1994-8#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
contribute to active##2##3##(2008-10#1)(2009-8#1)
contribute to alterations in##2##4##(1996-6#1)(2008-7#1)
contribute to alterations##3##3##(1996-5#1)(1996-6#1)(2008-7#1)
contribute to an understanding of##2##5##(2008-9#1)(2011-2#1)
contribute to an##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
contribute to both##2##3##(2009-6#1)(2009-8#1)
contribute to cellular homeostasis##2##4##(1991-5#1)(1994-12#1)
contribute to development##2##3##(2011-2#1)(2012-2#1)
contribute to differences in##2##4##(1997-7#1)(2008-5#1)
contribute to different##2##3##(1991-12#1)(2012-2#1)
contribute to disease##4##3##(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
contribute to establish##2##3##(2008-10#1)(2011-7#1)
contribute to further##2##3##(1996-12#1)(2011-2#1)
contribute to future##4##3##(2007-8#1)(2008-7#1)(2008-9#1)(2010-11#1)
contribute to greater##2##3##(1994-2#1)(2008-12#1)
contribute to health##2##3##(1991-1#1)(2012-1#1)
contribute to high##2##3##(1994-3#1)(2008-12#1)
contribute to increased##4##3##(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)
contribute to initial##2##3##(2008-10#1)(2008-8#1)
contribute to its##4##3##(1997-2#1)(2008-10#1)(2010-3#1)(2012-2#1)
contribute to knowledge##2##3##(2007-8#1)(2013-8#1)
contribute to learning##2##3##(1996-5#1)(2008-11#1)
contribute to many##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
contribute to more##2##3##(1996-1#1)(2006-10#1)
contribute to neuronal##2##3##(1994-11#1)(2009-12#1)
contribute to our understanding of the##2##6##(2008-11#1)(2008-7#1)
contribute to pathogenesis##2##3##(2008-7#1)(2008-9#1)
contribute to reducing##2##3##(2008-10#1)(2013-8#1)
contribute to resistance in##2##4##(2008-10#2)
contribute to resistance##3##3##(2008-10#3)
contribute to specific##2##3##(2008-10#1)(2010-1#1)
contribute to synaptic##2##3##(2009-8#2)
contribute to the ability to##2##5##(1994-3#1)(2008-9#1)
contribute to the ability##3##4##(1994-3#1)(1997-3#1)(2008-9#1)
contribute to the biological##2##4##(1994-11#1)(2008-10#1)
contribute to the current##2##4##(2008-10#1)(2008-12#1)
contribute to the defense##2##4##(1992-8#1)(1993-2#1)
contribute to the design of##2##5##(2008-12#2)
contribute to the development of a##3##6##(1995-1#1)(2008-10#2)
contribute to the development of##17##5##(1991-12#1)(1992-10#1)(1994-11#1)(1995-1#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
contribute to the development##18##4##(1991-12#1)(1992-10#1)(1994-11#1)(1995-1#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
contribute to the differential##2##4##(1993-11#1)(1995-5#1)
contribute to the enrichment##2##4##(2013-7#2)
contribute to the formation of##3##5##(1994-2#1)(2009-8#1)(2010-5#1)
contribute to the generation of##3##5##(2008-11#1)(2008-5#1)(2009-2#1)
contribute to the genetic##2##4##(2008-1#1)(2008-10#1)
contribute to the incidence of##2##5##(1995-12#1)(2008-3#1)
contribute to the increased##2##4##(2011-2#1)(2012-2#1)
contribute to the international##2##4##(2008-11#1)(2012-3#1)
contribute to the known##2##4##(1995-12#1)(2008-5#1)
contribute to the large effective##2##5##(2007-12#1)(2008-10#1)
contribute to the lower##3##4##(2008-11#2)(2009-9#1)
contribute to the maintenance of##2##5##(2008-5#1)(2009-6#1)
contribute to the morbidity and##2##5##(1997-8#1)(2007-7#1)
contribute to the observed differences in##2##6##(1995-5#1)(2008-9#1)
contribute to the observed##4##4##(1995-5#1)(2007-12#1)(2008-5#1)(2008-9#1)
contribute to the onset##2##4##(2008-7#1)(2011-2#1)
contribute to the overall##4##4##(1990-2#1)(1997-4#1)(2008-10#1)(2011-2#1)
contribute to the pathogenesis of##2##5##(2012-2#1)(2012-3#1)
contribute to the perception of##2##5##(2007-8#1)(2013-8#1)
contribute to the persistence of##2##5##(2010-6#1)(2013-1#1)
contribute to the process of##2##5##(1994-11#1)(2008-11#1)
contribute to the process##3##4##(1994-11#1)(1996-6#1)(2008-11#1)
contribute to the reduction of##3##5##(1990-5#1)(1995-12#1)(2012-3#1)
contribute to the reduction##4##4##(1990-5#1)(1995-12#1)(2008-10#1)(2012-3#1)
contribute to the understanding of the##3##6##(2008-10#1)(2010-5#1)(2012-3#1)
contribute to the understanding of##7##5##(2008-10#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
contribute to the##223##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#3)(1995-6#1)(1996-10#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#22)(2008-11#10)(2008-12#5)(2008-3#5)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#8)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#6)(2013-7#2)(2013-8#5)
contribute to their##3##3##(1991-9#1)(2008-1#1)(2008-11#1)
contribute to these##8##3##(1990-11#1)(1991-3#1)(2007-12#1)(2008-5#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
contribute to this##5##3##(1995-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)
contribute to tumor development##2##4##(2009-4#1)(2013-8#1)
contribute to tumor##4##3##(2008-7#2)(2009-4#1)(2013-8#1)
contribute to tumorigenesis##2##3##(1994-12#1)(2008-6#1)
contribute to understanding##4##3##(2008-11#2)(2009-12#1)(2012-9#1)
contribute to variation in##2##4##(2008-1#1)(2009-10#1)
contribute to variation##3##3##(2008-1#1)(2009-10#1)(2012-3#1)
contribute to##526##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#4)(1991-3#2)(1991-5#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#8)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#3)(1997-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#53)(2008-11#25)(2008-12#10)(2008-2#4)(2008-3#9)(2008-4#9)(2008-5#21)(2008-6#4)(2008-7#23)(2008-8#13)(2008-9#17)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#8)(2011-2#25)(2011-3#1)(2011-7#2)(2012-1#3)(2012-12#13)(2012-2#18)(2012-3#16)(2012-9#1)(2013-1#14)(2013-7#4)(2013-8#12)
contribute towards the##3##3##(2008-7#1)(2009-6#1)(2010-9#1)
contribute towards##5##2##(2008-5#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-12#1)
contribute##605##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#4)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#8)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#7)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#3)(1996-1#2)(1996-10#1)(1996-12#9)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#3)(1997-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#11)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#7)(2008-10#60)(2008-11#27)(2008-12#10)(2008-2#5)(2008-3#14)(2008-4#10)(2008-5#25)(2008-6#4)(2008-7#29)(2008-8#16)(2008-9#19)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#7)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#8)(2011-2#27)(2011-3#1)(2011-7#2)(2012-1#4)(2012-12#15)(2012-2#22)(2012-3#20)(2012-9#1)(2013-1#15)(2013-7#5)(2013-8#14)
contributed by the##5##3##(2008-10#4)(2013-1#1)
contributed by##11##2##(2008-10#6)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
contributed from the##2##3##(2008-2#1)(2008-3#1)
contributed more##2##2##(2008-8#1)(2013-1#1)
contributed significant##3##2##(2008-10#2)(2008-2#1)
contributed significantly to the##2##4##(1997-2#2)
contributed significantly to##4##3##(1993-2#1)(1997-2#2)(2008-10#1)
contributed significantly##5##2##(1993-2#1)(1997-2#2)(2008-10#1)(2012-2#1)
contributed the resistance##2##3##(2008-10#2)
contributed the##3##2##(2008-10#2)(2008-8#1)
contributed to a##5##3##(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
contributed to body##2##3##(2007-12#2)
contributed to greater##2##3##(1995-6#1)(2008-9#1)
contributed to higher##2##3##(2008-10#2)
contributed to our understanding of##2##5##(2008-7#1)(2012-1#1)
contributed to reduced##2##3##(2008-10#1)(2009-3#1)
contributed to the development of the##2##6##(2010-4#1)(2011-2#1)
contributed to the development of##6##5##(1996-1#1)(2008-12#2)(2010-4#1)(2011-10#1)(2011-2#1)
contributed to the functional##2##4##(2008-3#1)(2008-5#1)
contributed to the improvement##2##4##(1991-6#1)(2008-1#1)
contributed to the understanding of##3##5##(1997-8#1)(2009-12#1)(2012-2#1)
contributed to the##69##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-11#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-7#1)(2013-8#1)
contributed to their##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
contributed to##135##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#1)
contributed##183##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-8#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#32)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#4)(2012-7#1)(2013-1#5)(2013-8#1)
contributes half of the##2##4##(2008-3#1)(2008-8#1)
contributes only##4##2##(1992-3#1)(2007-11#1)(2008-11#1)(2008-2#1)
contributes significantly to the##3##4##(1993-6#1)(2008-10#1)(2012-3#1)
contributes significantly to##6##3##(1993-6#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2012-3#1)
contributes the##3##2##(1995-8#1)(2013-1#2)
contributes to a##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-11#1)
contributes to both##2##3##(2007-8#1)(2010-8#1)
contributes to higher##2##3##(2008-11#1)(2012-2#1)
contributes to its##2##3##(1997-2#1)(2009-12#1)
contributes to reduce##2##3##(1993-11#1)(2009-5#1)
contributes to the development and progression of##2##7##(2011-2#1)(2012-12#1)
contributes to the development of##4##5##(1991-12#1)(2008-11#1)(2009-2#1)(2012-2#1)
contributes to the development##6##4##(1991-12#1)(2008-11#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
contributes to the high##2##4##(1992-3#1)(1994-8#1)
contributes to the ongoing debate##2##5##(2007-7#1)(2009-10#1)
contributes to the##59##3##(1990-11#1)(1991-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-9#1)(1997-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
contributes to##147##2##(1990-11#1)(1991-12#2)(1991-6#2)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
contributes##176##1##(1990-11#2)(1991-12#2)(1991-6#2)(1992-3#4)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#3)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#3)
contributing factor to the##2##4##(2008-10#1)(2010-5#1)
contributing factor to##4##3##(1992-6#1)(2008-10#1)(2010-5#1)(2011-2#1)
contributing factor##7##2##(1992-6#1)(1995-8#1)(1996-6#1)(2008-10#1)(2009-3#1)(2010-5#1)(2011-2#1)
contributing factors to the##2##4##(1996-12#1)(2012-2#1)
contributing factors to##3##3##(1996-12#1)(2008-4#1)(2012-2#1)
contributing factors##17##2##(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
contributing most to the##2##4##(2008-11#1)(2008-5#1)
contributing risk##2##2##(1994-5#1)(2008-10#1)
contributing the##4##2##(1994-9#1)(2008-10#2)(2009-6#1)
contributing to a##4##3##(1990-8#1)(1997-4#1)(2008-10#1)(2011-2#1)
contributing to an##2##3##(2008-5#1)(2009-12#1)
contributing to health##2##3##(2008-1#1)(2008-7#1)
contributing to our##2##3##(2008-9#1)(2010-5#1)
contributing to skin##2##3##(2008-9#1)(2009-9#1)
contributing to the development of a##2##6##(2011-2#2)
contributing to the development of##3##5##(2007-7#1)(2011-2#2)
contributing to the maintenance of##2##5##(2008-10#1)(2009-6#1)
contributing to the##48##3##(1991-1#2)(1991-5#1)(1994-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-7#1)
contributing to their##2##3##(1992-2#1)(2008-11#1)
contributing to these##2##3##(2008-3#1)(2008-5#1)
contributing to##118##2##(1990-8#1)(1991-1#2)(1991-5#2)(1992-11#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#4)(2008-10#13)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-1#2)(2009-12#3)(2009-4#2)(2009-6#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#1)(2013-7#1)
contributing towards##3##2##(1994-11#1)(2008-11#1)(2008-5#1)
contributing##172##1##(1990-8#1)(1991-1#2)(1991-5#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#6)(2008-10#22)(2008-11#10)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-1#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-6#4)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#4)(2011-2#10)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#1)
contribution and##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
contribution by##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
contribution from the##9##3##(1990-8#1)(1994-6#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#4)
contribution from##24##2##(1990-8#1)(1992-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-8#1)(2009-4#1)(2010-7#1)(2013-1#2)
contribution in the##4##3##(1994-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
contribution in##6##2##(1994-2#1)(1995-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
contribution is##2##2##(2008-12#1)(2009-9#1)
contribution of Raman scattering##3##4##(2008-3#3)
contribution of an##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
contribution of both##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
contribution of different##4##3##(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
contribution of each##9##3##(1992-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
contribution of genetic factors to##2##5##(1994-2#1)(1997-5#1)
contribution of genetic##3##3##(1994-2#1)(1997-5#1)(2008-10#1)
contribution of social##2##3##(2011-1#1)(2013-1#1)
contribution of such##2##3##(2008-10#1)(2008-12#1)
contribution of the various##2##4##(1990-11#1)(2008-8#1)
contribution of the##32##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1997-4#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#1)
contribution of these##5##3##(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
contribution of this##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
contribution of various##2##3##(1993-12#1)(1995-5#1)
contribution of##206##2##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-12#2)(2007-10#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#10)(2008-12#9)(2008-2#3)(2008-3#17)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#2)
contribution that##2##2##(2007-11#1)(2008-11#1)
contribution to backscattering##2##3##(2008-2#1)(2008-3#1)
contribution to health##2##3##(2008-11#1)(2008-12#1)
contribution to the development##2##4##(2007-12#1)(2008-12#1)
contribution to the local##2##4##(2007-5#1)(2008-9#1)
contribution to the observed##3##4##(1993-11#1)(2008-2#1)(2011-2#1)
contribution to the overall##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
contribution to the signal##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2010-7#1)
contribution to the total##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
contribution to the understanding of##2##5##(1993-11#1)(2008-9#1)
contribution to the##59##3##(1990-5#1)(1991-1#1)(1991-11#1)(1992-5#1)(1993-11#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#5)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-10#1)(2010-3#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#2)
contribution to total##2##3##(2008-11#1)(2012-12#1)
contribution to##112##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#2)(2008-10#10)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#5)
contribution towards the##2##3##(1990-6#1)(1992-2#1)
contribution towards##3##2##(1990-6#1)(1992-2#1)(2012-12#1)
contribution was##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
contribution##425##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#3)(1992-6#3)(1993-1#2)(1993-11#4)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#4)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#1)(1997-8#1)(2006-12#3)(2007-10#4)(2007-11#7)(2007-12#15)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#56)(2008-11#20)(2008-12#15)(2008-2#15)(2008-3#40)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#12)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#4)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#6)(2011-2#20)(2011-3#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#20)(2013-7#1)(2013-8#9)
contribution]##2##1##(1990-10#1)(1991-9#1)
contributions and##4##2##(2008-3#1)(2012-12#1)(2012-3#2)
contributions are##2##2##(2007-11#2)
contributions due to##3##3##(1992-6#1)(2013-1#2)
contributions for##2##2##(2007-11#1)(2008-3#1)
contributions from the##2##3##(1992-3#1)(2007-12#1)
contributions from##12##2##(1990-8#1)(1992-3#1)(1992-5#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)
contributions in##6##2##(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#2)
contributions of a methylene group##2##5##(2008-10#2)
contributions of a##3##3##(2008-10#2)(2008-9#1)
contributions of both##2##3##(2008-10#2)
contributions of the##10##3##(1992-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#4)(2013-1#1)
contributions of these##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
contributions of##66##2##(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#3)(1995-9#1)(1996-2#1)(1997-8#1)(2007-12#3)(2008-10#12)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
contributions on##2##2##(2008-10#1)(2013-8#1)
contributions that##4##2##(1996-11#1)(2008-10#1)(2008-3#1)(2010-7#1)
contributions to the field##3##4##(2008-12#1)(2012-1#1)(2012-12#1)
contributions to the##25##3##(1990-6#1)(1990-8#2)(1992-5#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
contributions to this##2##3##(1990-12#1)(2012-1#1)
contributions to##64##2##(1990-12#1)(1990-6#1)(1990-8#3)(1991-8#1)(1991-9#1)(1992-5#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#2)
contributions was##2##2##(2007-12#1)(2008-3#1)
contributions were##4##2##(1992-6#1)(1994-2#1)(2008-2#1)(2008-3#1)
contributions##209##1##(1990-12#1)(1990-6#1)(1990-8#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#4)(1992-6#6)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-2#3)(1995-3#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#9)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#9)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#10)(2013-8#4)
contributor to the##7##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#2)
contributor to##17##2##(1993-12#1)(1994-8#1)(1997-2#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#2)(2011-9#1)(2012-12#1)
contributor##20##1##(1993-12#1)(1994-8#1)(1997-2#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-3#1)(2011-9#1)(2012-12#1)
contributors to secondary##2##3##(1993-12#1)(2012-12#1)
contributors to the##4##3##(2008-1#1)(2008-3#1)(2008-8#1)(2013-1#1)
contributors to this##2##3##(2008-10#1)(2008-9#1)
contributors to##16##2##(1992-5#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
contributors##22##1##(1992-5#1)(1993-12#1)(1996-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
contributory factors##2##2##(2008-1#1)(2008-9#1)
contributory##12##1##(1993-2#1)(1994-2#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
control &quot##2##2##(2012-3#1)(2013-1#1)
control (2##2##2##(1992-2#1)(2013-1#1)
control (P &lt##4##3##(2008-10#2)(2010-1#1)(2011-1#1)
control (e##2##2##(2008-10#1)(2013-8#1)
control (phosphate##2##2##(2012-12#1)(2013-1#1)
control 0##2##2##(2007-10#1)(2010-11#1)
control HIV##2##2##(1996-11#1)(2012-2#1)
control HUVEC##2##2##(2013-8#2)
control Medicare##2##2##(1993-12#1)(2012-3#1)
control NCDs##2##2##(2012-12#2)
control NS/0 cells##2##3##(2008-11#2)
control a##5##2##(2008-10#2)(2009-11#1)(2009-6#1)(2011-2#1)
control abilities##4##2##(2011-2#4)
control access##3##2##(1996-1#1)(1997-1#1)(2012-2#1)
control action##2##2##(2008-10#1)(2008-7#1)
control actions of##2##3##(2008-8#1)(2012-12#1)
control actions##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
control activities##3##2##(1997-1#1)(2008-1#1)(2013-8#1)
control activity##5##2##(1994-8#1)(2008-10#3)(2008-8#1)
control adolescents##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
control affected##2##2##(2008-10#1)(2011-2#1)
control after##6##2##(1990-6#1)(1993-9#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-5#1)
control agent##15##2##(2008-10#13)(2008-5#1)(2010-10#1)
control agents##19##2##(2008-10#17)(2008-8#1)(2010-7#1)
control algorithm##2##2##(2008-2#1)(2013-1#1)
control algorithms##2##2##(2008-9#1)(2009-9#1)
control among##4##2##(1991-6#1)(2008-3#1)(2011-2#2)
control analyses##2##2##(2007-10#1)(2008-10#1)
control analysis##11##2##(1990-7#4)(2008-10#5)(2011-2#1)(2012-2#1)
control and Csb##2##3##(1990-12#2)
control and HKD##2##3##(1991-5#2)
control and MCT-treated rats##2##4##(1994-5#2)
control and a##4##3##(2008-12#1)(2008-7#2)(2013-1#1)
control and diabetic##2##3##(1993-8#1)(2008-7#1)
control and experimental group##2##4##(2008-11#1)(2011-1#1)
control and experimental##4##3##(1996-5#1)(2008-11#1)(2010-9#1)(2011-1#1)
control and individual##2##3##(2009-8#2)
control and patient##2##3##(2008-10#1)(2008-12#1)
control and prevention##2##3##(1992-2#1)(2011-1#1)
control and quality##2##3##(2008-10#1)(2008-7#1)
control and study groups##2##4##(2007-7#2)
control and surveillance of##2##4##(2008-10#1)(2012-3#1)
control and survival##2##3##(2007-8#1)(2008-6#1)
control and that##2##3##(2008-10#1)(2008-7#1)
control and the##11##3##(1995-11#1)(1995-2#1)(1997-5#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#1)
control and treated##3##3##(2008-10#1)(2008-12#1)(2009-11#1)
control and treatment##4##3##(1993-9#1)(2007-11#1)(2008-11#2)
control and##210##2##(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#22)(2008-11#9)(2008-12#7)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#17)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#3)(2009-8#4)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#3)(2011-1#4)(2011-2#3)(2011-3#4)(2012-12#1)(2012-2#2)(2012-3#6)(2012-6#1)(2013-1#7)(2013-8#3)
control angiography##2##2##(2007-8#2)
control animals##30##2##(1990-12#1)(1992-1#3)(1992-11#2)(1992-5#1)(1992-9#2)(1993-12#4)(1993-6#2)(1994-2#1)(1994-6#2)(1995-11#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
control approach##2##2##(2007-11#1)(2008-2#1)
control are discussed##3##3##(1993-6#1)(1996-12#1)(2008-10#1)
control are##10##2##(1993-6#1)(1995-1#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-3#1)
control areas##2##2##(2008-8#2)
control as well as##2##4##(1996-9#1)(2013-1#1)
control as well##3##3##(1996-9#1)(2007-8#1)(2013-1#1)
control as##5##2##(1996-9#1)(2007-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
control at the##2##3##(1997-1#1)(2011-2#1)
control at##18##2##(1990-2#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-10#3)(2009-4#1)(2011-2#1)(2012-5#1)
control based on##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
control behavior##3##2##(2008-2#1)(2008-5#1)(2010-7#1)
control between##2##2##(1994-12#1)(2008-5#1)
control biofilm formation##3##3##(2008-7#1)(2011-1#2)
control blood glucose##2##3##(2010-10#1)(2010-11#1)
control blood##3##2##(1993-2#1)(2010-10#1)(2010-11#1)
control both##2##2##(2007-11#1)(2008-7#1)
control but##3##2##(2008-2#1)(2011-1#1)(2012-2#1)
control by a##2##3##(1997-2#1)(2007-11#1)
control by the##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
control by##29##2##(1990-11#1)(1990-5#1)(1993-6#1)(1993-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-1#1)
control can be##5##3##(1993-6#1)(1996-11#1)(2008-10#2)(2011-1#1)
control can##6##2##(1993-6#1)(1996-11#1)(2008-10#2)(2008-5#1)(2011-1#1)
control cell growth##2##3##(2008-11#2)
control cell line##3##3##(2008-11#2)(2011-2#1)
control cell proliferation and##2##4##(2008-4#1)(2008-9#1)
control cell##13##2##(1990-8#1)(2008-11#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-2#2)(2011-2#1)(2012-1#1)(2012-3#1)
control cells in##2##3##(2008-11#1)(2008-8#1)
control cells##37##2##(1990-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#2)(1994-3#1)(1994-6#2)(1994-8#1)(1997-4#3)(2008-1#1)(2008-11#13)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-2#1)
control center data##2##3##(2010-8#2)
control center##3##2##(2008-3#1)(2010-8#2)
control charting##3##2##(1996-1#3)
control charts##14##2##(1993-3#2)(1995-3#3)(1996-1#1)(2008-10#7)(2010-8#1)
control chicken##2##2##(2007-3#1)(2013-8#1)
control children##2##2##(2008-2#1)(2010-8#1)
control coefficients##4##2##(1990-7#4)
control condition##10##2##(1992-12#1)(2008-12#2)(2008-4#3)(2009-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
control conditions##7##2##(1993-8#1)(1995-12#1)(2007-6#1)(2008-11#2)(2008-7#1)(2011-2#1)
control cost##2##2##(1997-2#1)(2008-11#1)
control costs##6##2##(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-2#1)(2009-6#1)
control could##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
control counterparts##2##2##(1991-5#1)(2008-12#1)
control counties##2##2##(1991-3#2)
control cream##2##2##(2008-5#2)
control culture##6##2##(1994-11#1)(2008-11#3)(2012-12#2)
control cultures##8##2##(1995-12#1)(1995-8#2)(2008-11#5)
control data##2##2##(2008-10#1)(2009-10#1)
control devices##6##2##(2009-12#4)(2010-1#2)
control diet##6##2##(1993-12#1)(2008-11#2)(2008-12#1)(2010-2#1)(2012-2#1)
control diets##2##2##(1993-12#1)(2010-2#1)
control discs##2##2##(2012-3#2)
control disease##2##2##(2007-11#1)(2008-8#1)
control during##5##2##(1993-12#1)(1994-8#1)(2009-5#1)(2010-8#1)(2012-2#1)
control efficacy of##2##3##(2008-10#2)
control efficacy##7##2##(2008-10#7)
control efforts##2##2##(1997-1#1)(2010-1#1)
control elements##7##2##(1990-11#1)(1990-5#1)(1992-5#2)(1993-12#1)(1993-2#1)(2008-9#1)
control experiment##5##2##(1992-11#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-12#1)
control experiments##6##2##(1990-5#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
control expression of##2##3##(1991-11#1)(1995-6#1)
control failure##2##2##(2008-10#2)
control fibroblasts##3##2##(1990-8#1)(1995-12#1)(1996-12#1)
control flies##3##2##(1995-6#3)
control following##2##2##(1993-9#1)(1995-12#1)
control for colposcopy##2##3##(1992-10#2)
control for the##6##3##(1993-2#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
control for these##3##3##(2008-10#2)(2010-12#1)
control for##44##2##(1992-10#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#12)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#3)(2011-2#1)(2012-2#2)(2012-3#2)
control from##2##2##(2008-3#1)(2013-8#1)
control fruits##2##2##(2008-10#2)
control function##2##2##(1992-11#1)(2011-2#1)
control functions##2##2##(2007-8#1)(2010-12#1)
control gene expression##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
control gene##5##2##(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
control goats##2##2##(1996-12#2)
control group (0##2##3##(2008-12#1)(2008-7#1)
control group (C##2##3##(2008-10#1)(2013-1#1)
control group (P &lt##3##4##(1994-3#1)(2011-3#1)(2012-3#1)
control group (P##4##3##(1994-3#1)(2009-8#1)(2011-3#1)(2012-3#1)
control group (n =##3##4##(2007-10#1)(2010-4#1)(2012-3#1)
control group (p&lt##7##3##(1994-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
control group and the##2##4##(1993-3#1)(2009-5#1)
control group and##14##3##(1991-12#1)(1992-12#1)(1993-3#1)(1997-6#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-12#3)(2009-5#2)(2013-1#1)
control group consisted of##6##4##(1990-2#1)(2007-8#1)(2008-7#3)(2011-2#1)
control group for##3##3##(1990-8#1)(2011-2#1)(2012-12#1)
control group had##3##3##(1991-5#1)(2012-3#1)(2013-8#1)
control group in##8##3##(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
control group included##3##3##(2011-2#2)(2013-1#1)
control group of##22##3##(1991-4#1)(1992-6#1)(1994-12#1)(1994-3#1)(1996-3#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
control group oocytes##2##3##(2013-1#2)
control group showed##2##3##(2007-10#1)(2008-5#1)
control group that##3##3##(1990-5#1)(2013-1#2)
control group to##2##3##(1994-7#1)(2008-10#1)
control group underwent##2##3##(2008-11#1)(2008-8#1)
control group was treated with##2##5##(2013-1#2)
control group was##16##3##(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-3#1)(2013-1#2)
control group were##5##3##(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2013-8#1)
control group with##7##3##(1990-6#1)(1992-2#1)(1995-2#1)(2008-5#1)(2008-9#2)(2011-1#1)
control group without##3##3##(2011-1#1)(2013-1#1)(2013-7#1)
control group##396##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-8#2)(1994-12#4)(1994-3#6)(1994-5#4)(1994-7#2)(1994-8#4)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-7#2)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#4)(2007-10#14)(2007-11#12)(2007-12#2)(2007-5#1)(2007-6#4)(2007-7#6)(2007-8#10)(2007-9#3)(2008-1#4)(2008-10#16)(2008-11#10)(2008-12#29)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#18)(2008-8#4)(2008-9#13)(2009-1#1)(2009-10#3)(2009-12#7)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#6)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#23)(2011-2#23)(2011-3#7)(2012-12#6)(2012-2#13)(2012-3#6)(2013-1#30)(2013-7#3)(2013-8#8)
control group)##5##2##(1991-8#1)(1993-12#1)(1997-6#1)(2013-1#2)
control groups and##2##3##(1992-11#1)(2011-2#1)
control groups at##2##3##(2008-9#2)
control groups in both studies##3##5##(2008-9#3)
control groups in##5##3##(1997-5#1)(2007-2#1)(2008-9#3)
control groups of rats##2##4##(2011-2#2)
control groups of##4##3##(2009-5#1)(2011-2#3)
control groups received##2##3##(2012-2#1)(2012-3#1)
control groups showed##2##3##(1993-3#1)(2009-6#1)
control groups throughout both studies##2##5##(2008-9#2)
control groups throughout##7##3##(2008-8#2)(2008-9#5)
control groups were##8##3##(1991-12#1)(1992-8#1)(2007-2#1)(2008-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
control groups with##2##3##(1993-3#1)(2008-7#1)
control groups##94##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-8#2)(1993-12#2)(1993-3#3)(1995-1#1)(1995-11#1)(1995-12#1)(1997-5#2)(1997-6#1)(2007-10#1)(2007-2#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#28)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
control growth##7##2##(1997-2#1)(2008-11#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
control has been##2##3##(2008-10#2)
control has##5##2##(1995-6#1)(2008-10#2)(2009-10#1)(2013-8#1)
control have been##5##3##(1997-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
control have##9##2##(1997-2#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
control hearts##4##2##(1996-9#2)(2007-8#2)
control hospitals##2##2##(1996-1#2)
control in a##9##3##(1991-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
control in adaptive##2##3##(2007-12#1)(2012-2#1)
control in comparison##2##3##(1992-10#1)(2008-10#1)
control in diabetic patients##2##4##(1991-2#1)(1995-2#1)
control in diabetic##3##3##(1991-2#1)(1995-2#1)(2012-3#1)
control in diagnostic##2##3##(1993-8#1)(2008-4#1)
control in different environmental settings##3##5##(2008-8#3)
control in early##2##3##(2008-2#1)(2010-12#1)
control in livestock##2##3##(1997-7#2)
control in mice##2##3##(2008-4#1)(2011-2#1)
control in patients with type 2##2##6##(2011-2#1)(2012-5#1)
control in patients with##4##4##(2011-2#1)(2012-12#1)(2012-5#1)(2013-8#1)
control in the community##2##4##(2010-4#1)(2011-1#1)
control in the field##2##4##(2008-10#2)
control in the##23##3##(1990-6#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
control in this##2##3##(1997-8#1)(2008-10#1)
control in type 2 diabetic##3##5##(2011-2#2)(2012-3#1)
control in type 2##4##4##(2009-5#1)(2011-2#2)(2012-3#1)
control in##144##2##(1990-12#1)(1990-6#1)(1991-2#3)(1991-4#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-8#1)(1997-1#1)(1997-7#2)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-12#2)(2012-2#1)(2012-3#5)(2012-5#2)(2013-1#2)(2013-7#1)(2013-8#3)
control individuals##6##2##(1990-12#1)(1992-11#2)(1997-3#1)(1997-7#1)(2009-6#1)
control infants##3##2##(1997-4#2)(2011-1#1)
control infection##2##2##(1994-6#1)(2008-3#1)
control initiatives##3##2##(1996-2#1)(1997-1#2)
control institutions##2##2##(2011-2#1)(2012-3#1)
control is a##2##3##(1994-12#1)(1997-7#1)
control is often##2##3##(2008-8#1)(2013-8#1)
control is the##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
control is##33##2##(1992-11#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
control islets##2##2##(1994-8#2)
control issues##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
control its##3##2##(1997-1#1)(2007-12#1)(2011-2#1)
control laboratory##2##2##(2008-10#1)(2010-4#1)
control larvae##4##2##(2008-7#4)
control leaves##2##2##(2008-10#2)
control level##10##2##(1993-12#1)(1994-12#2)(1996-5#1)(1997-6#1)(2008-11#1)(2008-6#2)(2012-1#2)
control levels by##2##3##(1995-12#1)(2013-8#1)
control levels##19##2##(1991-5#2)(1993-12#2)(1994-5#1)(1994-9#1)(1995-12#3)(1995-3#2)(1996-12#2)(1996-5#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2013-8#1)
control light##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
control line##2##2##(2008-10#2)
control link nurse##3##3##(2008-11#3)
control link##4##2##(2008-11#4)
control loop##5##2##(2008-3#5)
control many##3##2##(2007-12#1)(2009-8#1)(2010-10#1)
control material##4##2##(2008-10#4)
control may be##2##3##(2008-3#1)(2008-5#1)
control may##7##2##(1992-8#1)(1993-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-3#1)(2013-7#1)
control mean##7##2##(1996-7#4)(2012-2#3)
control measure##7##2##(1996-12#1)(2008-10#4)(2011-2#2)
control measures and##3##3##(1996-1#1)(1997-7#1)(2013-8#1)
control measures are##3##3##(1991-9#1)(1992-9#1)(2009-6#1)
control measures for##3##3##(2008-10#2)(2011-2#1)
control measures should be##2##4##(2011-2#1)(2012-3#1)
control measures that##3##3##(2008-8#1)(2010-1#1)(2011-2#1)
control measures to reduce the##2##5##(2010-4#1)(2011-2#1)
control measures to##6##3##(2008-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
control measures was##3##3##(2008-1#2)(2008-10#1)
control measures were##2##3##(2008-10#1)(2008-12#1)
control measures##60##2##(1991-9#1)(1992-9#1)(1993-12#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#2)(2008-1#4)(2008-10#13)(2008-12#2)(2008-8#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
control mechanism##4##2##(1990-11#1)(1990-8#1)(2008-10#1)(2011-2#1)
control mechanisms in the##2##4##(1995-8#1)(2013-8#1)
control mechanisms in##3##3##(1995-8#1)(2008-2#1)(2013-8#1)
control mechanisms##12##2##(1994-9#1)(1995-8#2)(1996-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
control medium##2##2##(1990-5#1)(2008-11#1)
control method for##4##3##(2007-11#1)(2008-10#2)(2013-8#1)
control method of##2##3##(2008-10#1)(2013-8#1)
control method##12##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2013-8#4)
control methods##9##2##(1991-12#1)(1991-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2012-2#3)
control mice injected with saline##2##5##(2008-12#1)(2008-8#1)
control mice##21##2##(1990-6#1)(1990-7#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#3)(1997-3#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
control microbial##2##2##(2008-5#1)(2011-1#1)
control might##2##2##(2010-6#1)(2013-1#1)
control modality##2##2##(1994-3#2)
control model##2##2##(2012-3#1)(2013-8#1)
control monkeys##2##2##(1994-3#2)
control mouse##2##2##(1990-12#1)(2008-9#1)
control must##2##2##(2008-10#1)(2012-2#1)
control necessary##2##2##(1997-5#1)(2009-8#1)
control obtained##2##2##(2008-10#1)(2013-1#1)
control of Botrytis##2##3##(2008-10#2)
control of DNA##2##3##(1990-11#1)(1996-2#1)
control of Fusarium wilt##3##4##(2008-10#3)
control of LLS##4##3##(2008-10#4)
control of P##2##3##(2008-10#2)
control of Phytophthora##2##3##(2008-10#2)
control of R##2##3##(2008-10#2)
control of S##2##3##(2008-10#2)
control of SV40##2##3##(2008-11#2)
control of Swede midge##2##4##(2011-2#2)
control of TB##2##3##(2010-5#1)(2013-7#1)
control of a##22##3##(1991-9#1)(1992-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
control of actin##2##3##(1996-5#1)(1997-7#1)
control of all##2##3##(2008-10#1)(2011-2#1)
control of an##8##3##(1992-3#1)(1994-11#1)(2007-11#2)(2007-12#3)(2008-3#1)
control of ascites was##2##4##(2013-1#2)
control of asthma##2##3##(2008-11#1)(2008-7#1)
control of avirulence toward##2##4##(2008-10#2)
control of avirulence##4##3##(2008-10#4)
control of bacterial##2##3##(1992-12#1)(2008-10#1)
control of behavior##2##3##(2008-4#1)(2008-8#1)
control of biological##2##3##(1992-12#1)(2008-9#1)
control of black rot##3##4##(2008-10#3)
control of blood pressure and##2##5##(2008-8#1)(2012-12#1)
control of blood pressure##5##4##(1993-11#1)(1993-2#1)(2008-1#1)(2008-8#1)(2012-12#1)
control of blood##7##3##(1993-11#1)(1993-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
control of blue##2##3##(2008-10#2)
control of both##3##3##(1991-8#1)(2009-2#1)(2012-2#1)
control of calcium##2##3##(1993-5#1)(1993-6#1)
control of cell growth and##2##5##(2008-11#1)(2008-7#1)
control of cell growth##5##4##(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#1)
control of cell proliferation##6##4##(1992-12#1)(1993-3#1)(1997-1#1)(2008-4#2)(2009-5#1)
control of cell##16##3##(1990-5#1)(1992-12#1)(1993-3#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)
control of cellular##4##3##(1996-2#2)(2008-4#2)
control of cerebral##3##3##(1994-5#1)(2008-7#1)(2012-3#1)
control of chemotherapy-induced nausea and vomiting##2##6##(2010-12#1)(2010-9#1)
control of coccidiosis##2##3##(1997-6#2)
control of crown##2##3##(2008-10#2)
control of dialysis##2##3##(2008-1#2)
control of drug##2##3##(1994-2#1)(2013-8#1)
control of environmental##2##3##(1993-1#1)(2008-11#1)
control of femtosecond##2##3##(2007-11#2)
control of fire blight##7##4##(2008-10#7)
control of food intake##3##4##(1996-2#1)(1997-3#1)(2008-3#1)
control of fruit infection##2##4##(2008-10#2)
control of fruit##3##3##(2008-10#3)
control of gene expression##2##4##(2008-7#1)(2012-3#1)
control of growth and##2##4##(1993-9#1)(1997-7#1)
control of growth##6##3##(1993-9#2)(1994-10#1)(1997-7#1)(2007-10#1)(2010-5#1)
control of human##4##3##(1991-9#1)(1994-8#2)(1997-4#1)
control of hybridoma cells##2##4##(2008-11#2)
control of hypertension##6##3##(1990-9#1)(1992-8#1)(2008-1#1)(2008-11#2)(2011-1#1)
control of infection##3##3##(2007-12#1)(2008-10#1)(2009-5#1)
control of infectious##2##3##(2008-7#1)(2012-3#1)
control of its##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
control of leaf spot on tall fescue (Festuca arundinacea)##2##9##(2008-10#2)
control of leaf spot##3##4##(2008-10#3)
control of leaf##5##3##(2008-10#5)
control of malaria##3##3##(2007-2#2)(2012-3#1)
control of many##4##3##(2007-12#1)(2008-10#2)(2008-8#1)
control of maternal##4##3##(1996-11#1)(2007-12#3)
control of molecular##2##3##(1992-10#1)(2010-12#1)
control of optical##2##3##(2007-12#1)(2008-3#1)
control of other##3##3##(1997-7#1)(2008-9#1)(2010-8#1)
control of pathogenic##3##3##(1994-11#1)(2008-10#2)
control of plant##4##3##(2008-10#4)
control of postharvest##5##3##(2008-10#5)
control of posture and##2##4##(2007-12#2)
control of quantitative##2##3##(2008-10#1)(2009-10#1)
control of resistance to##4##4##(2008-10#4)
control of rice blast##2##4##(2008-10#2)
control of risk##3##3##(2007-10#1)(2010-9#1)(2011-2#1)
control of ruminants##2##3##(1997-7#2)
control of several##4##3##(1994-10#1)(2008-7#1)(2010-10#1)(2011-1#1)
control of soilborne pathogens##2##4##(2008-10#2)
control of soilborne plant pathogens##3##5##(2008-10#3)
control of soilborne##5##3##(2008-10#5)
control of some##2##3##(2007-11#1)(2008-7#1)
control of symptoms##2##3##(2008-10#1)(2013-8#1)
control of the circadian##2##4##(1993-6#1)(2008-5#1)
control of the disease in##2##5##(1991-8#1)(2008-10#1)
control of the disease##9##4##(1991-8#1)(1993-6#1)(2008-10#3)(2008-9#1)(2011-2#2)(2012-3#1)
control of the electrode##2##4##(2008-9#2)
control of the expression of##2##5##(2008-4#1)(2008-6#1)
control of the gastric##2##4##(1992-8#1)(1997-4#1)
control of the heart##2##4##(2008-7#1)(2011-2#1)
control of the laser frequency##2##5##(2008-2#1)(2008-3#1)
control of the laser##4##4##(2008-2#2)(2008-3#2)
control of the optical##2##4##(2007-12#2)
control of the process##2##4##(1996-1#1)(2008-7#1)
control of the spectral response##2##5##(2008-2#1)(2008-3#1)
control of the spectral##3##4##(2008-2#1)(2008-3#2)
control of the##168##3##(1990-11#2)(1990-12#1)(1990-3#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#3)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#2)
control of their##3##3##(2007-10#1)(2008-12#1)(2009-11#1)
control of these##3##3##(2008-1#1)(2011-2#2)
control of this disease##5##4##(2007-6#1)(2008-10#3)(2008-5#1)
control of this##14##3##(1994-12#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#1)(2010-4#1)
control of transcription##2##3##(1995-6#1)(2012-2#1)
control of ultrashort##2##3##(2007-12#2)
control of up to##2##4##(2007-12#1)(2008-10#1)
control of various##4##3##(1994-2#1)(1996-5#1)(2008-3#1)(2011-1#1)
control of ventricular response##2##4##(2008-7#2)
control of ventricular##3##3##(1991-2#1)(2008-7#2)
control of vertical-cavity##2##3##(2008-3#2)
control of##783##2##(1990-11#5)(1990-12#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#5)(1992-3#6)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#6)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#3)(1995-5#2)(1995-6#6)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#2)(1996-5#5)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#9)(1997-6#3)(1997-7#11)(2006-10#1)(2007-10#5)(2007-11#19)(2007-12#36)(2007-2#3)(2007-5#3)(2007-6#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#165)(2008-11#26)(2008-12#2)(2008-2#11)(2008-3#29)(2008-4#13)(2008-5#13)(2008-6#8)(2008-7#32)(2008-8#18)(2008-9#19)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#3)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#8)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#6)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#11)(2011-10#2)(2011-2#29)(2011-3#2)(2012-12#5)(2012-2#15)(2012-3#10)(2013-1#10)(2013-7#3)(2013-8#12)
control on the##3##3##(1994-3#1)(2008-10#1)(2013-8#1)
control on##8##2##(1992-5#1)(1994-3#1)(1997-4#1)(2008-10#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
control ones##2##2##(1991-5#1)(1991-6#1)
control or##23##2##(1991-5#1)(1995-1#1)(1995-3#2)(1996-11#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)
control outcomes##2##2##(2012-3#1)(2013-8#1)
control over behaviour##4##3##(1993-6#4)
control over resource allocation##2##4##(1995-1#1)(2008-8#1)
control over the placement of##2##5##(2009-10#2)
control over the release##2##4##(2008-12#2)
control over the##15##3##(1991-2#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2011-2#1)
control over their##5##3##(1992-1#1)(1995-1#1)(1996-1#1)(2007-12#1)(2007-6#1)
control over##48##2##(1990-6#2)(1991-2#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-12#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
control pain##5##2##(1995-1#1)(2008-10#2)(2010-11#2)
control parameter##5##2##(1996-4#1)(2007-11#1)(2008-11#1)(2008-7#2)
control participants##3##2##(2007-8#1)(2009-10#1)(2012-12#1)
control patients had##2##3##(1990-5#1)(2011-1#1)
control patients with cancer but no heart disease##2##8##(1996-9#2)
control patients with##4##3##(1996-9#2)(2007-10#1)(2008-5#1)
control patients##20##2##(1990-5#1)(1993-8#3)(1996-9#2)(1997-3#1)(1997-4#1)(2007-10#1)(2008-5#2)(2008-7#3)(2008-8#3)(2011-1#1)(2013-1#1)(2013-8#1)
control pattern##2##2##(2008-9#2)
control period##3##2##(2007-7#1)(2008-10#2)
control plant##4##2##(2008-10#2)(2008-7#1)(2009-8#1)
control plants##14##2##(1997-6#1)(2008-10#12)(2011-10#1)
control plots##6##2##(2008-10#6)
control points##5##2##(1997-3#1)(1997-4#1)(2008-6#1)(2011-2#2)
control policies in##2##3##(2007-2#1)(2010-1#1)
control policies##5##2##(2007-2#2)(2008-10#2)(2010-1#1)
control policy and programs##2##4##(2012-12#2)
control policy##3##2##(2012-1#1)(2012-12#2)
control population##9##2##(1993-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-11#2)(2009-10#1)(2013-1#1)
control populations##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
control potential##3##2##(1990-9#1)(2008-10#2)
control practices##9##2##(1993-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
control principles##3##2##(1990-11#1)(2008-9#1)(2011-2#1)
control procedure##2##2##(2008-3#1)(2008-9#1)
control procedures##3##2##(2008-1#1)(2008-11#1)(2008-9#1)
control processes##3##2##(2008-10#3)
control product##6##2##(1990-6#1)(2008-11#2)(2008-5#3)
control program and##2##3##(1994-12#1)(2008-11#1)
control program##5##2##(1994-12#1)(1996-12#2)(2008-11#1)(2008-9#1)
control programme in##2##3##(2009-7#1)(2010-4#1)
control programme##8##2##(1995-9#3)(2008-8#1)(2009-7#1)(2010-4#1)(2013-8#2)
control programmes##5##2##(1995-9#1)(1997-7#1)(2010-4#1)(2010-8#1)(2011-2#1)
control programs##14##2##(1994-2#1)(1995-3#1)(2007-11#2)(2011-2#1)(2011-3#5)(2012-12#2)(2012-3#1)(2013-1#1)
control purposes##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
control rates were##2##3##(2008-11#1)(2008-6#1)
control rates##8##2##(2007-11#1)(2008-11#3)(2008-6#1)(2010-3#2)(2011-2#1)
control rats in##2##3##(1991-12#1)(1997-2#1)
control rats##54##2##(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-5#2)(1993-6#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#3)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#2)(2008-10#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#3)(2011-1#3)(2011-2#3)
control recovery and high dose recovery##2##6##(2013-1#2)
control regimes##2##2##(2008-10#1)(2011-2#1)
control region of##2##3##(1996-6#1)(2010-8#1)
control region##20##2##(1995-11#1)(1996-6#1)(2008-12#9)(2008-8#2)(2009-2#1)(2010-3#1)(2010-8#4)(2011-2#1)
control regions##3##2##(2009-8#1)(2009-9#1)(2010-3#1)
control remains##2##2##(1996-12#1)(2010-4#1)
control requires##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
control research##5##2##(1992-12#1)(1997-1#3)(2008-9#1)
control resistance##2##2##(2008-10#2)
control sample##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
control samples##8##2##(1997-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-6#1)(2012-2#1)
control scheme##3##2##(2008-3#1)(2008-6#2)
control schemes##2##2##(1997-7#1)(2008-10#1)
control science##3##2##(1997-1#2)(2010-1#1)
control sequences##2##2##(1993-9#1)(2011-2#1)
control sera##3##2##(1994-9#1)(2007-10#1)(2012-12#1)
control serum##3##2##(2008-10#2)(2008-6#1)
control set##3##2##(2008-7#3)
control several##2##2##(2008-4#1)(2008-9#1)
control sheep##2##2##(1991-8#1)(2008-7#1)
control side##2##2##(2012-3#1)(2012-7#1)
control signals##2##2##(1990-5#1)(2008-11#1)
control since##2##2##(1992-10#1)(2008-10#1)
control site##10##2##(2007-5#1)(2008-10#2)(2008-5#3)(2008-7#4)
control sites##3##2##(2011-2#2)(2012-3#1)
control software##2##2##(2008-10#2)
control standard##2##2##(2008-10#1)(2009-6#1)
control stimuli##2##2##(2009-2#2)
control stimulus##3##2##(1996-2#1)(2009-11#2)
control strategies and##2##3##(2008-10#1)(2008-11#1)
control strategies are discussed##2##4##(2008-10#1)(2011-2#1)
control strategies based on##3##4##(1991-8#1)(2008-10#2)
control strategies for##3##3##(2008-10#2)(2008-11#1)
control strategies to##2##3##(2008-10#1)(2008-11#1)
control strategies##23##2##(1991-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2010-11#1)(2011-1#1)(2011-2#2)
control strategy##20##2##(1996-12#1)(1997-2#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
control study##12##2##(2006-10#1)(2007-6#1)(2008-11#5)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#2)
control subjects (n =##3##4##(1993-9#1)(1995-5#1)(1996-7#1)
control subjects and##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
control subjects in##3##3##(1995-5#1)(2009-11#1)(2013-1#1)
control subjects participated in this study##2##6##(2007-10#1)(2013-1#1)
control subjects was##2##3##(1991-5#1)(2013-1#1)
control subjects were##4##3##(1997-8#1)(2008-7#2)(2013-1#1)
control subjects##80##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#3)(1991-5#2)(1992-12#1)(1992-3#2)(1993-12#2)(1993-9#1)(1995-12#3)(1995-5#9)(1995-9#1)(1996-12#1)(1996-7#10)(1997-8#4)(2007-10#5)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#8)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
control subjects)##2##2##(1995-5#2)
control success##2##2##(2008-8#2)
control system is##2##3##(2008-2#1)(2009-5#1)
control system of##2##3##(1997-2#1)(2008-7#1)
control system was##2##3##(2008-10#1)(2013-8#1)
control system##33##2##(1990-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#8)(2008-7#4)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#2)(2013-8#2)
control systems in##2##3##(1992-1#1)(2012-2#1)
control systems is##2##3##(2008-10#1)(2009-5#1)
control systems##14##2##(1992-1#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
control tactic##2##2##(2008-10#1)(2011-2#1)
control task##3##2##(1995-5#1)(2008-10#2)
control tasks##2##2##(1994-8#1)(1995-12#1)
control techniques##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
control temperature##2##2##(2008-12#1)(2008-2#1)
control tests##2##2##(2008-11#1)(2012-1#1)
control than for the##2##4##(2008-10#1)(2010-4#1)
control than##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)
control that##7##2##(1994-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-10#1)
control the expression of##3##4##(1994-5#1)(1996-3#1)(2013-1#1)
control the flow##2##3##(2010-5#1)(2012-2#1)
control the growth##2##3##(2008-7#1)(2010-8#1)
control the magnitude##2##3##(2008-3#1)(2008-7#1)
control the production##2##3##(1995-5#1)(2008-5#1)
control the##145##2##(1990-7#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#2)(2007-11#9)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#9)(2008-2#5)(2008-3#11)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
control their##11##2##(1994-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-12#1)
control theory##3##2##(2008-11#1)(2008-3#2)
control this##4##2##(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)
control through##5##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-7#2)
control tissue##4##2##(1995-12#1)(2008-11#1)(2011-1#2)
control to the##2##3##(1995-12#1)(1997-7#1)
control to##21##2##(1995-12#4)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
control tomato plants##2##3##(2008-10#2)
control treated with##2##3##(2010-5#2)
control treated##3##2##(2010-5#3)
control treatment##10##2##(2008-10#7)(2008-5#1)(2009-9#1)(2010-9#1)
control treatments##2##2##(2008-10#2)
control trees##2##2##(2008-10#2)
control trial##5##2##(2008-10#2)(2010-7#1)(2013-1#1)(2013-8#1)
control trials and##2##3##(1993-12#1)(2012-2#1)
control trials##3##2##(1993-12#1)(2008-10#1)(2012-2#1)
control used##2##2##(1996-12#1)(2008-10#1)
control using##7##2##(1992-1#1)(2009-1#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
control value##7##2##(1990-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1996-7#1)(1997-2#1)
control values for##2##3##(1997-2#1)(2009-11#1)
control values##21##2##(1990-5#1)(1991-5#1)(1992-3#2)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2009-11#1)(2011-2#1)(2013-1#3)
control variables##2##2##(2008-5#1)(2008-6#1)
control vectors##3##2##(2008-11#3)
control viral##2##2##(1992-8#1)(2012-12#1)
control was achieved##4##3##(1991-8#1)(1997-4#1)(2008-10#1)(2010-3#1)
control was obtained in##2##4##(1991-8#1)(2007-8#1)
control was significantly##2##3##(2008-10#1)(2008-5#1)
control was##28##2##(1991-8#2)(1992-1#1)(1994-11#1)(1994-6#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-6#2)(2010-3#2)(2011-2#1)(2013-1#2)
control waveguide##6##2##(2008-3#6)
control were found to##2##4##(2008-7#1)(2011-1#1)
control were##14##2##(1990-6#1)(1990-7#1)(1992-10#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)
control when weather supported##2##4##(2008-10#2)
control when##5##2##(2008-10#3)(2012-12#1)(2013-1#1)
control which##3##2##(1990-12#1)(1997-7#1)(2012-2#1)
control with a##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
control with##17##2##(1992-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#2)
control within##4##2##(1996-12#1)(2007-11#1)(2009-7#1)(2010-12#1)
control without##2##2##(2008-11#1)(2012-12#1)
control words##2##2##(2007-12#2)
control would##3##2##(2008-10#1)(2009-2#1)(2009-9#1)
control##4617##1##(1990-10#1)(1990-11#12)(1990-12#17)(1990-2#3)(1990-3#5)(1990-5#14)(1990-6#11)(1990-7#18)(1990-8#8)(1990-9#2)(1991-1#3)(1991-11#6)(1991-12#20)(1991-2#11)(1991-3#11)(1991-4#4)(1991-5#19)(1991-6#5)(1991-8#11)(1991-9#7)(1992-1#8)(1992-10#10)(1992-11#14)(1992-12#17)(1992-2#8)(1992-3#16)(1992-4#2)(1992-5#6)(1992-6#5)(1992-8#12)(1992-9#13)(1993-1#7)(1993-11#4)(1993-12#51)(1993-2#9)(1993-3#24)(1993-5#3)(1993-6#28)(1993-8#14)(1993-9#18)(1994-1#6)(1994-10#2)(1994-11#20)(1994-12#30)(1994-2#13)(1994-3#19)(1994-5#16)(1994-6#17)(1994-7#2)(1994-8#30)(1994-9#9)(1995-1#11)(1995-11#12)(1995-12#53)(1995-2#15)(1995-3#18)(1995-5#17)(1995-6#13)(1995-8#14)(1995-9#12)(1996-1#16)(1996-10#2)(1996-11#11)(1996-12#35)(1996-2#20)(1996-3#11)(1996-4#1)(1996-5#19)(1996-6#1)(1996-7#20)(1996-8#2)(1996-9#9)(1997-1#27)(1997-2#28)(1997-3#17)(1997-4#26)(1997-5#7)(1997-6#18)(1997-7#42)(1997-8#9)(2006-10#6)(2006-5#1)(2006-6#1)(2007-10#45)(2007-11#87)(2007-12#89)(2007-2#12)(2007-3#5)(2007-4#1)(2007-5#8)(2007-6#16)(2007-7#26)(2007-8#36)(2007-9#5)(2008-1#57)(2008-10#763)(2008-11#186)(2008-12#99)(2008-2#55)(2008-3#151)(2008-4#44)(2008-5#102)(2008-6#47)(2008-7#179)(2008-8#100)(2008-9#127)(2009-1#3)(2009-10#27)(2009-11#18)(2009-12#23)(2009-2#13)(2009-3#4)(2009-4#10)(2009-5#28)(2009-6#21)(2009-7#15)(2009-8#37)(2009-9#12)(2010-1#13)(2010-10#13)(2010-11#23)(2010-12#26)(2010-2#15)(2010-3#25)(2010-4#33)(2010-5#28)(2010-6#5)(2010-7#18)(2010-8#23)(2010-9#9)(2011-1#93)(2011-10#3)(2011-2#208)(2011-3#24)(2011-9#2)(2012-1#9)(2012-12#56)(2012-2#90)(2012-3#81)(2012-4#3)(2012-5#4)(2012-6#4)(2012-7#1)(2012-8#1)(2013-1#142)(2013-7#17)(2013-8#82)
control'##2##1##(1992-11#1)(2008-1#1)
control) and##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
control) was##2##2##(2008-10#2)
control) were##3##2##(1994-2#1)(2008-8#1)(2012-1#1)
control)##32##1##(1992-1#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#2)(2008-10#11)(2008-11#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
control</QualifierName> <QualifierName MajorTopicYN="Y">surgery</QualifierName> </MeshHeading>##2##4##(1996-12#2)
control]##5##1##(1997-4#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
controllability##3##1##(2008-11#2)(2012-3#1)
controllable and##2##2##(1992-2#1)(2013-8#1)
controllable sensitivity##3##2##(2008-2#1)(2008-3#2)
controllable##31##1##(1991-9#1)(1992-2#2)(1996-12#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-2#5)(2008-3#3)(2008-8#1)(2009-11#2)(2009-12#1)(2009-3#2)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
controlled analgesia (PCA)##2##3##(2007-7#1)(2012-3#1)
controlled analgesia##4##2##(1992-2#1)(2007-7#1)(2009-5#1)(2012-3#1)
controlled and field conditions##3##4##(2008-10#3)
controlled and the##2##3##(2008-11#1)(2008-3#1)
controlled and##23##2##(1994-12#2)(2007-11#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#2)
controlled at 6##2##3##(2008-6#2)
controlled at the##3##3##(1997-1#1)(2006-12#1)(2008-7#1)
controlled at##12##2##(1991-6#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)
controlled by a complex##2##4##(1994-12#1)(2008-4#1)
controlled by a computer##3##4##(2008-10#1)(2008-3#2)
controlled by a personal computer##2##5##(2008-10#2)
controlled by a single dominant##5##5##(2008-10#5)
controlled by a single gene##3##5##(2008-10#3)
controlled by a single##14##4##(2008-10#11)(2008-5#2)(2008-9#1)
controlled by a##41##3##(1990-5#1)(1990-9#1)(1991-3#1)(1994-12#2)(1995-2#2)(2007-12#1)(2008-10#25)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#2)
controlled by adjustment of##3##4##(2007-11#1)(2008-3#2)
controlled by altering the##2##4##(2009-12#1)(2011-2#1)
controlled by an##3##3##(2007-11#2)(2008-7#1)
controlled by both##2##3##(2008-10#1)(2008-7#1)
controlled by different##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
controlled by its##3##3##(1995-2#1)(1996-3#1)(2008-9#1)
controlled by light##2##3##(2008-3#1)(2008-4#1)
controlled by mass##2##3##(1997-2#1)(2008-10#1)
controlled by only##2##3##(2008-10#1)(2008-5#1)
controlled by operating##3##3##(2008-7#3)
controlled by single##2##3##(2008-10#1)(2008-8#1)
controlled by specific##2##3##(2008-7#1)(2010-8#1)
controlled by the interaction##2##4##(1996-5#1)(2008-10#1)
controlled by the same##2##4##(2007-12#1)(2007-8#1)
controlled by the##46##3##(1990-11#2)(1993-8#1)(1994-2#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
controlled by two##5##3##(1990-8#1)(2008-10#2)(2008-9#1)(2010-4#1)
controlled by use of##2##4##(2007-11#1)(2008-3#1)
controlled by various##2##3##(1993-8#1)(2008-11#1)
controlled by varying the##2##4##(2008-10#1)(2009-7#1)
controlled by##219##2##(1990-11#3)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#7)(2007-12#7)(2007-8#4)(2008-1#2)(2008-10#64)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#4)(2008-5#6)(2008-7#11)(2008-8#5)(2008-9#9)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#7)(2012-2#3)(2012-3#1)(2013-8#2)
controlled carefully##2##2##(2008-10#1)(2013-8#1)
controlled challenge by##2##3##(2010-4#2)
controlled clinical trial of##2##4##(1997-8#1)(2010-5#1)
controlled clinical trial##7##3##(1997-8#1)(2008-10#1)(2010-12#1)(2010-5#2)(2013-1#2)
controlled clinical trials##17##3##(1991-6#1)(1993-2#1)(1995-12#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-3#3)
controlled clinical##29##2##(1990-3#2)(1991-6#1)(1993-2#1)(1995-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2012-2#1)(2012-3#3)(2013-1#3)
controlled conditions in the##2##4##(2008-10#2)
controlled conditions##32##2##(1993-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
controlled continuously##2##2##(2008-10#1)(2008-2#1)
controlled cross##2##2##(2008-10#2)
controlled delivery of##2##3##(2010-6#1)(2012-6#1)
controlled dispersion and##2##3##(2007-12#1)(2008-10#1)
controlled dispersion##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
controlled double-blind##2##2##(1992-5#1)(1993-3#1)
controlled drug delivery##2##3##(2009-11#1)(2010-6#1)
controlled drug##3##2##(2009-11#1)(2010-10#1)(2010-6#1)
controlled during##2##2##(2008-10#1)(2011-1#1)
controlled environment experiments##2##3##(2008-10#2)
controlled environment studies##3##3##(2008-10#3)
controlled environment##21##2##(2007-11#1)(2008-10#14)(2008-3#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-4#1)
controlled environmental conditions##7##3##(2008-10#6)(2008-11#1)
controlled environmental##8##2##(2008-10#7)(2008-11#1)
controlled environments##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
controlled experiment##2##2##(1993-12#1)(2008-6#1)
controlled experimental##2##2##(2008-10#1)(2010-7#1)
controlled experiments##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
controlled expression of the##2##4##(1997-8#1)(2008-10#1)
controlled expression of##6##3##(1991-9#1)(1994-12#1)(1997-8#2)(2008-10#1)(2008-11#1)
controlled fashion##3##2##(2006-12#1)(2008-3#1)(2010-10#1)
controlled field experiment on the##2##5##(1993-6#2)
controlled field##3##2##(1993-6#2)(2008-8#1)
controlled flow##2##2##(2008-10#1)(2009-12#1)
controlled for##5##2##(1990-6#1)(1996-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
controlled formation of##2##3##(1993-11#1)(2007-12#1)
controlled group##2##2##(2008-12#2)
controlled growth##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
controlled human##3##2##(1992-2#1)(2008-5#1)(2011-2#1)
controlled in a##2##3##(1990-12#1)(1995-12#1)
controlled in order to##2##4##(2008-10#2)
controlled in part by##2##4##(1992-9#1)(2008-5#1)
controlled in the##3##3##(2007-12#1)(2012-12#1)(2012-3#1)
controlled in##18##2##(1990-12#1)(1990-6#1)(1992-6#1)(1992-9#1)(1995-12#1)(1996-5#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)
controlled laboratory experiments##3##3##(2008-10#2)(2008-2#1)
controlled laboratory##5##2##(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
controlled laser##2##2##(2008-3#2)
controlled manner to##2##3##(2008-2#1)(2008-7#1)
controlled manner##9##2##(1994-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-5#1)
controlled medium##2##2##(2008-10#1)(2008-11#1)
controlled molecular weight##2##3##(2009-10#2)
controlled motivation##3##2##(2013-1#3)
controlled only##2##2##(1993-12#1)(2011-1#1)
controlled optical##2##2##(2007-12#1)(2008-3#1)
controlled or##6##2##(1992-3#1)(1993-3#1)(2007-10#1)(2008-7#1)(2010-1#1)(2012-2#1)
controlled ovarian hyperstimulation##2##3##(1994-9#2)
controlled ovarian##3##2##(1994-9#3)
controlled phase composition##2##3##(2009-7#2)
controlled phase##5##2##(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#2)
controlled pilot study##2##3##(2009-11#2)
controlled pilot##3##2##(2009-11#2)(2010-10#1)
controlled pore silica##2##3##(2008-10#1)(2008-6#1)
controlled pore##10##2##(2008-10#9)(2008-6#1)
controlled process##3##2##(2008-10#2)(2011-2#1)
controlled production of##2##3##(2008-11#1)(2008-5#1)
controlled prospective studies##2##3##(1996-11#1)(1997-5#1)
controlled prospective##3##2##(1991-3#1)(1996-11#1)(1997-5#1)
controlled randomized##3##2##(1990-6#1)(1994-7#1)(1995-4#1)
controlled rate##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
controlled release of##7##3##(1995-11#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-4#1)(2012-6#1)
controlled release##11##2##(1994-6#1)(1995-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-4#2)(2012-6#1)
controlled resistance to##4##3##(2008-10#4)
controlled rewarming##3##2##(2007-10#3)
controlled solid-phase microextraction##2##3##(2008-10#2)
controlled studies and the##2##4##(2008-7#1)(2010-12#1)
controlled studies and##3##3##(1997-3#1)(2008-7#1)(2010-12#1)
controlled studies are##4##3##(1991-2#1)(2008-10#1)(2010-5#1)(2012-3#1)
controlled studies on##4##3##(1997-6#1)(2006-10#1)(2010-11#1)(2010-5#1)
controlled studies##27##2##(1991-2#1)(1994-6#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-1#2)(2012-3#1)
controlled study of##6##3##(1990-3#1)(2008-10#1)(2008-9#1)(2010-9#1)(2012-1#1)(2013-1#1)
controlled study was to investigate the##2##6##(1997-3#1)(2009-12#1)
controlled study##26##2##(1990-3#2)(1991-7#1)(1993-11#1)(1997-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
controlled study]##2##2##(1997-3#1)(2012-3#1)
controlled substances##3##2##(1992-1#1)(2008-3#1)(2012-12#1)
controlled surface functionalization##2##3##(2010-5#2)
controlled surface##4##2##(2007-12#1)(2008-3#1)(2010-5#2)
controlled temperature##3##2##(2008-10#3)
controlled the##7##2##(2007-11#1)(2008-10#4)(2008-7#1)(2012-6#1)
controlled through the##3##3##(2008-10#3)
controlled through##5##2##(2007-5#1)(2008-10#3)(2008-5#1)
controlled to##5##2##(1995-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
controlled trial in##2##3##(2008-7#1)(2013-1#1)
controlled trial of a##2##4##(1990-5#1)(2012-3#1)
controlled trial of##15##3##(1990-5#1)(1990-6#1)(1991-12#1)(1992-3#1)(1997-7#2)(2007-7#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
controlled trial was conducted##2##4##(2007-7#1)(2013-1#1)
controlled trial was##3##3##(2007-7#1)(2013-1#2)
controlled trial with##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
controlled trial##60##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#4)(2009-12#1)(2010-10#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#15)(2013-7#1)
controlled trials (RCTs) of##2##4##(2008-10#1)(2012-12#1)
controlled trials (RCTs)##7##3##(1993-12#1)(2007-7#1)(2008-10#2)(2009-11#1)(2011-2#1)(2012-12#1)
controlled trials are needed##2##4##(2009-7#1)(2012-2#1)
controlled trials are##6##3##(2007-11#1)(2007-7#1)(2007-9#1)(2009-7#2)(2012-2#1)
controlled trials have##4##3##(1996-8#1)(2008-8#1)(2011-2#1)(2013-1#1)
controlled trials in##2##3##(1993-12#1)(2008-11#1)
controlled trials involving##2##3##(2007-10#1)(2008-6#1)
controlled trials of##7##3##(1991-10#1)(1991-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2009-9#1)(2010-10#1)
controlled trials to##4##3##(1995-5#1)(2007-10#1)(2011-2#2)
controlled trials using##2##3##(2009-2#1)(2012-3#1)
controlled trials with##2##3##(2007-11#1)(2008-1#1)
controlled trials##75##2##(1991-10#1)(1991-6#1)(1993-12#5)(1994-6#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#6)
controlled under##2##2##(1990-12#1)(2008-10#1)
controlled using##2##2##(2007-12#1)(2008-10#1)
controlled via the##2##3##(2010-4#1)(2012-2#1)
controlled via##5##2##(1992-12#1)(2008-12#1)(2009-2#1)(2010-4#1)(2012-2#1)
controlled vocabularies##5##2##(2008-7#4)(2010-8#1)
controlled vocabulary##3##2##(2008-7#3)
controlled with a##3##3##(1993-9#1)(1997-1#1)(2011-1#1)
controlled with##14##2##(1993-9#1)(1994-12#1)(1994-2#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#2)(2013-1#1)
controlled##1024##1##(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#5)(1990-5#7)(1990-6#5)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#7)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#7)(2006-10#2)(2006-12#2)(2007-10#7)(2007-11#22)(2007-12#20)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#10)(2007-9#3)(2008-1#6)(2008-10#232)(2008-11#30)(2008-12#13)(2008-2#19)(2008-3#47)(2008-4#11)(2008-5#25)(2008-6#11)(2008-7#51)(2008-8#20)(2008-9#13)(2009-10#3)(2009-11#7)(2009-12#11)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#7)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#10)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#13)(2010-5#8)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#41)(2012-1#4)(2012-12#11)(2012-2#18)(2012-3#22)(2012-4#1)(2012-6#4)(2012-7#1)(2012-8#2)(2013-1#37)(2013-7#1)(2013-8#6)
controlled)##2##1##(1995-11#1)(2007-8#1)
controlled-environment##3##1##(2008-10#3)
controlled-pore glass##2##2##(2008-10#2)
controlled-pore##3##1##(2008-10#3)
controlled-release##8##1##(1992-8#2)(1993-1#3)(2008-7#1)(2013-1#1)(2013-8#1)
controller and##2##2##(2008-10#1)(2008-2#1)
controller for##2##2##(2007-12#1)(2008-3#1)
controller is##3##2##(1997-2#1)(2008-3#2)
controller output voltage##2##3##(2008-10#2)
controller output##5##2##(2008-10#5)
controller that##2##2##(2007-12#1)(2008-2#1)
controller using##2##2##(2007-12#1)(2008-9#1)
controller voltage##3##2##(2008-10#3)
controller##48##1##(1997-2#4)(2007-11#4)(2007-12#7)(2008-10#16)(2008-2#6)(2008-3#5)(2008-9#1)(2009-5#1)(2010-3#2)(2012-3#1)(2013-1#1)
controllers and##2##2##(2008-2#1)(2012-2#1)
controllers##13##1##(1996-7#1)(1997-2#1)(2007-11#1)(2008-2#3)(2008-3#1)(2011-2#1)(2012-2#5)
controlling a##5##2##(1994-5#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-2#1)
controlling an##2##2##(2008-11#1)(2008-6#1)
controlling and monitoring the effective bioload on the outside of the gloves##2##12##(2012-2#2)
controlling and##5##2##(2008-10#2)(2010-8#1)(2012-2#2)
controlling both##3##2##(2007-11#1)(2008-11#1)(2008-9#1)
controlling cancer##2##2##(1997-1#1)(2009-11#1)
controlling cell##2##2##(2008-11#1)(2009-6#1)
controlling costs##2##2##(1992-1#1)(1995-6#1)
controlling diabetes##2##2##(2008-1#1)(2009-11#1)
controlling different##2##2##(1993-6#1)(2008-7#1)
controlling expenditures##3##2##(1992-2#1)(1994-3#1)(2008-11#1)
controlling factor##2##2##(2008-10#1)(2012-2#1)
controlling flowering##3##2##(1997-2#1)(1997-8#1)(2008-7#1)
controlling for a##4##3##(1995-2#1)(2008-11#1)(2009-10#1)(2013-7#1)
controlling for age##5##3##(2008-1#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
controlling for demographic##5##3##(1993-9#1)(2010-12#1)(2012-3#1)(2013-1#2)
controlling for other##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
controlling for patient##2##3##(1996-3#1)(1997-2#1)
controlling for the##4##3##(1995-12#1)(2008-11#1)(2008-8#1)(2010-1#1)
controlling for##56##2##(1992-1#1)(1992-8#1)(1993-9#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-2#2)(2007-12#2)(2008-1#1)(2008-11#4)(2008-12#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-7#4)(2010-1#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
controlling genes##2##2##(2008-11#1)(2010-1#1)
controlling human##2##2##(1993-12#1)(1994-11#1)
controlling it##2##2##(1990-11#1)(1991-12#1)
controlling pain##2##2##(2008-10#1)(2010-11#1)
controlling parameters##2##2##(2008-10#1)(2008-3#1)
controlling prices##2##2##(1994-1#2)
controlling spikelet differentiation##2##3##(2008-9#2)
controlling the diffusion##2##3##(2008-5#1)(2009-11#1)
controlling the expression##2##3##(2008-5#1)(2008-9#1)
controlling the levels of##3##4##(1992-12#2)(2009-10#1)
controlling the number of##2##4##(2008-9#1)(2009-11#1)
controlling the pH##2##3##(2008-10#1)(2008-5#1)
controlling the phase##2##3##(1994-12#1)(2009-11#1)
controlling the time##2##3##(2008-10#1)(2008-9#1)
controlling the##87##2##(1991-12#2)(1991-9#1)(1992-12#2)(1994-11#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
controlling their##2##2##(2008-10#1)(2010-2#1)
controlling this##2##2##(2008-10#1)(2010-8#1)
controlling##360##1##(1990-11#1)(1991-12#5)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#63)(2008-11#15)(2008-12#4)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#12)(2008-8#10)(2008-9#12)(2009-10#7)(2009-11#9)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#6)
controls (0##2##2##(1991-12#1)(2009-4#1)
controls (22 Women##2##3##(2008-12#2)
controls (40##2##2##(2008-7#1)(2009-12#1)
controls (79##2##2##(1990-5#1)(2008-4#1)
controls (P &lt##6##3##(2008-10#1)(2010-12#1)(2011-1#3)(2012-3#1)
controls (P = 0##4##4##(1995-12#1)(1997-5#1)(2013-1#1)(2013-8#1)
controls (P##11##2##(1995-12#1)(1997-5#1)(2008-10#1)(2010-12#1)(2011-1#3)(2012-3#2)(2013-1#1)(2013-8#1)
controls (P&lt##2##2##(1997-8#1)(2009-3#1)
controls (for##2##2##(2008-10#1)(2011-2#1)
controls (group##2##2##(2007-11#1)(2008-11#1)
controls (mean age##2##3##(2008-1#2)
controls (mean##4##2##(1996-12#2)(2008-1#2)
controls (mycelium##2##2##(2008-10#2)
controls (n =##4##3##(1990-8#1)(1996-7#1)(2008-7#1)(2010-7#1)
controls (p &gt##2##3##(2008-7#2)
controls (p &lt##2##3##(1996-11#1)(2006-10#1)
controls (p = 0##5##4##(2008-10#2)(2008-12#2)(2008-9#1)
controls (p less than 0##4##5##(1991-5#1)(1991-9#2)(1992-2#1)
controls (p##13##2##(1991-5#1)(1991-9#2)(1992-2#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-12#2)(2008-7#2)(2008-9#1)
controls (z =##2##3##(1995-8#2)
controls actin##2##2##(2012-2#1)(2013-8#1)
controls admitted##2##2##(1993-9#1)(2013-8#1)
controls after 3##2##3##(1994-3#1)(1996-5#1)
controls after##8##2##(1994-3#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
controls and patients with inactive##2##5##(2008-7#2)
controls and patients with##3##4##(1993-9#1)(2008-7#2)
controls and patients##4##3##(1993-9#1)(2008-7#2)(2012-3#1)
controls and the##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
controls and##46##2##(1990-9#1)(1991-1#1)(1991-12#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-12#4)(1996-12#2)(1996-7#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#6)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
controls are##3##2##(1992-9#1)(2009-8#1)(2011-2#1)
controls as##2##2##(1994-12#1)(1995-8#1)
controls at the end of the study##4##7##(2008-9#4)
controls at##13##2##(1993-3#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#6)(2011-2#1)(2013-1#1)
controls both##2##2##(2008-5#1)(2009-8#1)
controls but##2##2##(1992-9#1)(2011-2#1)
controls by##4##2##(1991-12#1)(1997-4#1)(2008-5#1)(2008-9#1)
controls cell##3##2##(1995-12#1)(2009-7#1)(2011-2#1)
controls did not##2##3##(2008-7#1)(2013-1#1)
controls did##3##2##(1995-8#1)(2008-7#1)(2013-1#1)
controls during most of the study##2##6##(2008-9#2)
controls during##4##2##(2007-7#1)(2008-9#3)
controls for the##4##3##(1997-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
controls for##14##2##(1992-12#1)(1992-2#1)(1997-5#1)(1997-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#3)(2011-2#2)
controls from##6##2##(1992-11#2)(1997-8#1)(2008-8#1)(2009-10#1)(2013-8#1)
controls had##2##2##(2011-1#1)(2013-1#1)
controls if##2##2##(1996-5#2)
controls in the##5##3##(1990-3#1)(1995-12#1)(1997-5#1)(2008-11#1)(2008-9#1)
controls in##22##2##(1990-3#1)(1990-8#3)(1991-12#1)(1995-12#2)(1995-2#1)(1997-5#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
controls included only subjects without A or B##2##8##(1997-5#2)
controls included only subjects without A##3##6##(1997-5#3)
controls included##4##2##(1997-5#4)
controls it was##2##3##(1993-12#1)(1994-8#1)
controls matched for##2##3##(1992-2#1)(1996-3#1)
controls of the##3##3##(1993-5#1)(1995-5#1)(2008-5#1)
controls of##7##2##(1993-12#1)(1993-5#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
controls on the DOF##2##4##(2010-8#2)
controls on the##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-8#2)(2012-3#1)
controls on##12##2##(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#2)(2012-3#1)(2013-1#3)
controls or##3##2##(1993-9#1)(2009-10#1)(2009-8#1)
controls over the##2##3##(1996-5#1)(2008-10#1)
controls received##3##2##(2008-7#1)(2008-9#2)
controls respectively##2##2##(2011-2#1)(2013-1#1)
controls showed no##2##3##(1990-3#1)(1997-3#1)
controls showed##5##2##(1990-3#1)(1994-9#1)(1997-3#1)(2008-5#1)(2013-8#1)
controls than##2##2##(1997-5#1)(2013-8#1)
controls that##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2010-1#1)
controls the blood##2##3##(2008-3#2)
controls the structure of##2##4##(2008-8#1)(2013-7#1)
controls the##37##2##(1990-11#1)(1992-3#1)(1993-3#1)(1996-12#2)(1996-4#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
controls throughout the study##3##4##(2008-8#1)(2008-9#2)
controls throughout##5##2##(2008-8#1)(2008-9#4)
controls to##9##2##(1991-8#1)(1992-2#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
controls using##4##2##(1996-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
controls was performed##2##3##(1990-6#1)(1992-10#1)
controls was##5##2##(1990-6#1)(1992-10#1)(1994-12#1)(1994-8#1)(2008-10#1)
controls were also evaluated##2##4##(1993-12#1)(2008-7#1)
controls were compared to##2##4##(1991-5#1)(2011-2#1)
controls were compared##3##3##(1991-11#1)(1991-5#1)(2011-2#1)
controls were evaluated##2##3##(1991-12#1)(1996-11#1)
controls were examined##3##3##(2008-7#1)(2009-6#1)(2009-8#1)
controls were selected##3##3##(2008-8#1)(2009-9#1)(2011-2#1)
controls were tested##3##3##(1992-11#1)(1997-5#2)
controls were##40##2##(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-8#3)(1993-12#1)(1993-3#3)(1996-11#1)(1997-3#1)(1997-5#3)(2007-10#1)(2008-1#1)(2008-12#2)(2008-7#4)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#2)
controls which##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
controls while##2##2##(1994-8#1)(2011-2#1)
controls who had##2##3##(1994-12#1)(2008-11#1)
controls with##13##2##(1993-2#1)(1996-11#1)(1996-2#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-1#2)
controls within##2##2##(2011-2#1)(2013-1#1)
controls without##4##2##(2007-10#1)(2008-7#1)(2009-12#1)(2013-1#1)
controls##1028##1##(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#8)(1990-5#3)(1990-6#2)(1990-8#12)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#16)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#4)(1992-10#2)(1992-11#4)(1992-12#6)(1992-2#12)(1992-3#2)(1992-6#2)(1992-8#6)(1992-9#7)(1993-10#1)(1993-11#1)(1993-12#15)(1993-2#3)(1993-3#12)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#7)(1994-1#1)(1994-11#2)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#5)(1994-6#4)(1994-8#8)(1994-9#4)(1995-1#2)(1995-12#21)(1995-2#7)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#8)(1996-11#4)(1996-12#18)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#11)(1996-7#9)(1996-9#1)(1997-2#5)(1997-3#2)(1997-4#10)(1997-5#18)(1997-6#2)(1997-8#7)(1997-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#10)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#8)(2007-8#2)(2008-1#8)(2008-10#115)(2008-11#34)(2008-12#17)(2008-2#3)(2008-3#14)(2008-4#5)(2008-5#23)(2008-6#5)(2008-7#72)(2008-8#21)(2008-9#67)(2009-10#4)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#4)(2011-1#22)(2011-2#62)(2012-1#3)(2012-12#7)(2012-2#11)(2012-3#22)(2012-5#1)(2012-7#1)(2013-1#46)(2013-7#3)(2013-8#23)
controls) and##2##2##(1997-5#1)(2007-2#1)
controls) were##4##2##(1993-9#1)(2007-7#1)(2008-10#2)
controls)##21##1##(1990-3#1)(1990-8#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#2)(1996-12#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
controversa and T##5##3##(2008-10#5)
controversa populations##2##2##(2008-10#2)
controversa##8##1##(2008-10#8)
controversial and##13##2##(1990-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#3)(2013-1#2)
controversial association##2##2##(1991-3#1)(2013-1#1)
controversial for a long time##2##5##(1990-5#1)(2008-11#1)
controversial for##3##2##(1990-5#1)(1992-8#1)(2008-11#1)
controversial in##8##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
controversial issue of##2##3##(1994-1#1)(2012-2#1)
controversial issue##6##2##(1994-1#2)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
controversial issues##9##2##(1991-3#1)(1994-1#1)(1995-3#1)(2008-1#2)(2010-5#1)(2012-3#2)(2013-1#1)
controversial results##2##2##(2008-3#1)(2012-2#1)
controversial views##3##2##(1993-12#1)(2008-11#1)(2008-7#1)
controversial whether##3##2##(1994-12#1)(2008-7#1)(2008-8#1)
controversial##139##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#8)(2008-1#5)(2008-10#5)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#8)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-5#3)(2010-6#2)(2010-8#2)(2011-2#7)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#1)
controversially discussed##2##2##(2007-12#1)(2008-5#1)
controversially##3##1##(1995-3#1)(2007-12#1)(2008-5#1)
controversies and##2##2##(2008-9#1)(2009-10#1)
controversies are##3##2##(1994-12#1)(2008-11#1)(2008-7#1)
controversies in the##4##3##(1991-8#1)(2007-7#1)(2010-11#1)(2011-1#1)
controversies in##8##2##(1991-8#1)(1995-12#1)(2007-7#1)(2008-3#1)(2010-11#2)(2011-1#1)(2013-8#1)
controversies regarding##2##2##(2008-4#1)(2012-12#1)
controversies surrounding##4##2##(2008-11#3)(2008-3#1)
controversies that##3##2##(2008-11#2)(2013-8#1)
controversies##41##1##(1991-8#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-2#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#10)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
controversy about the##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
controversy about##6##2##(1990-9#1)(1991-11#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
controversy and debate##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
controversy and##7##2##(1991-5#1)(2009-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
controversy as to whether##2##4##(1992-11#1)(2008-8#1)
controversy as to##3##3##(1992-11#1)(2008-8#1)(2009-12#1)
controversy over the##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
controversy over##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-9#1)
controversy regarding the##2##3##(1995-11#1)(2008-7#1)
controversy regarding##4##2##(1990-12#1)(1995-11#1)(2008-6#1)(2008-7#1)
controversy surrounding the##3##3##(2006-10#1)(2010-7#1)(2010-8#1)
controversy surrounding##4##2##(2006-10#1)(2008-3#1)(2010-7#1)(2010-8#1)
controversy##66##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#2)(2009-7#2)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
contusion##12##1##(1991-6#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-12#4)(2012-12#2)(2012-2#1)
contusions were##2##2##(2008-7#2)
contusions##7##1##(2008-7#5)(2010-1#1)(2013-1#1)
conundrum without##2##2##(2007-7#2)
conundrum##6##1##(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-8#1)
conus medullaris##7##2##(1991-11#2)(2008-4#1)(2008-7#3)(2009-5#1)
conus##8##1##(1991-11#2)(2008-4#1)(2008-7#3)(2009-5#1)(2012-2#1)
convalescence##6##1##(1992-5#1)(2007-2#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
convalescent##3##1##(2007-12#1)(2009-6#1)(2012-2#1)
convection in##2##2##(1992-8#1)(1995-6#1)
convection##11##1##(1990-4#1)(1992-8#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-10#2)(2009-8#1)(2013-1#1)
convective boundary layer##2##3##(2008-2#2)
convective flow##3##2##(2008-2#2)(2008-3#1)
convective gas##2##2##(1997-2#2)
convective motion##2##2##(1992-8#1)(2008-3#1)
convective term##2##2##(2013-8#2)
convective##24##1##(1992-3#1)(1992-5#1)(1992-8#1)(1994-9#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#4)(2008-6#1)(2008-7#1)(2013-8#2)
convened by##2##2##(1992-3#1)(1993-12#1)
convened in##3##2##(2007-2#1)(2009-11#1)(2010-12#1)
convened##10##1##(1992-3#1)(1993-12#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2011-2#1)
convenience and##5##2##(1990-12#1)(2008-3#2)(2008-8#1)(2013-8#1)
convenience of##4##2##(1994-12#1)(1996-12#1)(2008-3#1)(2011-2#1)
convenience sample of 10##2##4##(1993-3#1)(2007-10#1)
convenience sample of##19##3##(1990-10#1)(1992-2#1)(1993-2#1)(1993-3#1)(2007-10#1)(2007-11#1)(2008-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
convenience sample##21##2##(1990-10#1)(1992-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(2007-10#1)(2007-11#1)(2008-12#2)(2009-5#2)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
convenience sampling##3##2##(2011-2#2)(2013-8#1)
convenience##52##1##(1990-10#1)(1990-12#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-12#3)(2008-3#4)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
convenient and effective##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
convenient and rapid##3##3##(2008-10#2)(2008-4#1)
convenient and##14##2##(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
convenient for the##2##3##(2008-10#2)
convenient for##7##2##(1993-12#1)(2007-12#2)(2008-10#4)
convenient in##2##2##(2008-10#2)
convenient method for the determination of##2##6##(2008-10#2)
convenient method for the##3##4##(1990-12#1)(2008-10#2)
convenient method for##6##3##(1990-12#1)(2008-10#4)(2008-3#1)
convenient method of##2##3##(2007-11#1)(2008-10#1)
convenient method##11##2##(1990-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)
convenient methodology##2##2##(2008-10#1)(2008-4#1)
convenient model##2##2##(2009-5#1)(2011-1#1)
convenient procedure##2##2##(2008-10#1)(2008-11#1)
convenient source of##2##3##(1994-12#1)(2008-11#1)
convenient to##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)
convenient use of the##2##4##(2008-9#1)(2010-4#1)
convenient##128##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#7)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-2#1)(2009-5#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
conveniently and accurately##2##3##(1996-2#1)(2008-4#1)
conveniently and##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
conveniently be##3##2##(2008-3#2)(2009-12#1)
conveniently by##3##2##(1994-12#1)(2008-10#1)(2012-12#1)
conveniently##23##1##(1994-12#2)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2009-11#1)(2009-12#1)(2012-12#1)
convening##2##1##(1995-12#1)(2011-2#1)
convention##5##1##(1992-12#1)(2008-10#2)(2008-12#1)(2012-2#1)
conventional CD4 T cells##2##4##(2012-12#1)(2013-8#1)
conventional CT##4##2##(1995-11#1)(2008-7#2)(2013-1#1)
conventional CoMFA##2##2##(1995-3#2)
conventional DNA##2##2##(1990-8#1)(2008-10#1)
conventional ELISA##2##2##(2008-10#1)(2008-4#1)
conventional Fourier##3##2##(2008-2#1)(2008-3#2)
conventional ILS##2##2##(2008-2#2)
conventional ISE##2##2##(2008-10#2)
conventional K(+)-doped##2##2##(2008-10#2)
conventional MR##2##2##(1997-8#1)(2008-7#1)
conventional MRI##2##2##(2008-7#2)
conventional NSAIDs##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
conventional OCT##2##2##(2007-12#1)(2011-7#1)
conventional ODS##2##2##(2008-10#2)
conventional RT-PCR##2##2##(2013-8#2)
conventional Soxhlet extraction##2##3##(2008-10#2)
conventional Soxhlet##4##2##(2008-10#4)
conventional T-flask and spinner flask cultures##2##6##(2008-11#2)
conventional X-ray##2##2##(1995-2#1)(2013-8#1)
conventional acid digestion##2##3##(2008-10#2)
conventional acid##3##2##(1997-1#1)(2008-10#2)
conventional agents##3##2##(2008-7#1)(2008-8#2)
conventional amphotericin B##2##3##(2008-7#2)
conventional analysis##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
conventional analytical techniques##2##3##(2008-10#2)
conventional analytical##4##2##(2008-10#3)(2008-9#1)
conventional and##23##2##(1991-6#1)(1993-3#1)(2007-2#1)(2007-8#2)(2008-10#9)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#1)
conventional angiography##4##2##(2008-11#1)(2008-12#1)(2008-7#2)
conventional approach##6##2##(2008-11#1)(2008-2#2)(2008-7#1)(2009-5#1)(2012-12#1)
conventional approaches##4##2##(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
conventional assays##2##2##(2009-12#2)
conventional bacteriological##4##2##(2007-7#1)(2008-9#2)(2010-6#1)
conventional batch##3##2##(2008-10#3)
conventional biopsy##3##2##(2012-2#3)
conventional capillary##2##2##(1996-5#1)(2008-2#1)
conventional cardiac surgery##2##3##(2007-8#2)
conventional care##4##2##(2008-3#3)(2011-2#1)
conventional chemical sequencing##2##3##(1990-5#1)(1995-6#1)
conventional chemostat##2##2##(1994-5#1)(2008-8#1)
conventional chemotherapeutic##2##2##(2009-12#1)(2013-8#1)
conventional chemotherapy##3##2##(2007-10#1)(2010-4#1)(2013-1#1)
conventional clinical##3##2##(1993-8#1)(2008-11#1)(2010-8#1)
conventional colonoscopy##2##2##(2008-1#1)(2008-5#1)
conventional commercial##2##2##(2010-3#1)(2011-7#1)
conventional complete dentures##2##3##(2013-1#2)
conventional confocal##3##2##(2008-2#2)(2008-4#1)
conventional data##2##2##(1994-11#1)(2008-10#1)
conventional diagnostic##3##2##(1992-12#1)(2007-5#1)(2013-8#1)
conventional digital##2##2##(2008-7#1)(2009-5#1)
conventional disease-modifying antirheumatic drugs##2##4##(2010-5#1)(2011-2#1)
conventional dose of##2##3##(1994-7#1)(2007-7#1)
conventional electrode##2##2##(2008-10#2)
conventional electron##4##2##(1993-9#1)(2008-3#1)(2008-5#1)(2008-8#1)
conventional electronic packaging##2##3##(2008-3#2)
conventional electronic##6##2##(2007-11#1)(2008-3#4)(2013-8#1)
conventional expression vectors##2##3##(1996-12#1)(1997-8#1)
conventional extraction##6##2##(2008-10#5)(2013-1#1)
conventional fibers##4##2##(2007-12#3)(2008-10#1)
conventional filtration##3##2##(2008-10#3)
conventional flame atomic absorption spectrometry##2##5##(2008-10#2)
conventional fluorescence##2##2##(2008-10#2)
conventional fluorescent##2##2##(2008-10#1)(2011-1#1)
conventional gamma camera techniques##2##4##(2008-1#2)
conventional glass##3##2##(2008-10#1)(2010-3#1)(2013-1#1)
conventional glass-ionomer restorative material##2##4##(2009-7#2)
conventional glass-ionomer##4##2##(2009-7#4)
conventional gold##2##2##(2008-10#2)
conventional group##5##2##(2009-2#1)(2009-6#1)(2013-1#3)
conventional heating##6##2##(2007-11#1)(2008-10#2)(2008-5#3)
conventional holographic##2##2##(2007-12#1)(2008-3#1)
conventional holography##2##2##(2007-12#1)(2008-3#1)
conventional image##3##2##(2008-3#2)(2008-6#1)
conventional instruments##2##2##(2008-10#1)(2008-2#1)
conventional ion-selective electrodes##3##3##(2008-10#3)
conventional laser##3##2##(2008-3#2)(2008-9#1)
conventional length##4##2##(2012-2#4)
conventional lens##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
conventional light##3##2##(2008-10#2)(2008-3#1)
conventional linear##2##2##(2008-2#1)(2008-3#1)
conventional liquid-liquid extraction##2##3##(2008-10#2)
conventional liver tests##2##3##(1991-6#2)
conventional low-solids##2##2##(2008-6#2)
conventional lung function##2##3##(1997-2#2)
conventional machining##2##2##(2008-2#1)(2008-3#1)
conventional management##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
conventional means##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
conventional measurements##3##2##(2008-10#1)(2012-1#2)
conventional mechanical##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
conventional medical##3##2##(2006-12#1)(2008-11#1)(2010-10#1)
conventional memory##2##2##(2008-3#1)(2009-11#1)
conventional method of##2##3##(2008-10#1)(2008-11#1)
conventional method##22##2##(1990-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-8#1)(2010-6#1)
conventional methods (i##2##3##(2010-12#1)(2012-12#1)
conventional methods for##4##3##(2008-10#2)(2012-2#2)
conventional methods of##4##3##(1996-11#1)(2008-3#1)(2010-8#1)(2012-3#1)
conventional methods##29##2##(1994-3#1)(1994-8#1)(1996-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
conventional microscopy##3##2##(2008-3#3)
conventional modes##2##2##(2008-10#1)(2008-3#1)
conventional nebulization##4##2##(2008-10#4)
conventional one##2##2##(2008-3#2)
conventional one-way alphanumeric##2##3##(2010-8#2)
conventional open##3##2##(2007-11#2)(2008-10#1)
conventional optical##12##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)(2011-1#1)
conventional optics##2##2##(2008-3#2)
conventional or##4##2##(1990-11#1)(1995-2#1)(2008-3#1)(2011-2#1)
conventional osteosarcoma##3##2##(2010-3#3)
conventional peak area##2##3##(2008-10#1)(2008-6#1)
conventional photoresist##2##2##(2008-3#2)
conventional plain##2##2##(2007-11#1)(2007-8#1)
conventional planar##3##2##(1994-1#1)(2007-11#1)(2008-3#1)
conventional plots##4##2##(2008-10#4)
conventional polarization##4##2##(2007-11#1)(2008-3#3)
conventional procedure##9##2##(2008-10#7)(2011-2#1)(2011-3#1)
conventional procedures##5##2##(1994-9#1)(2008-10#1)(2008-5#1)(2009-2#1)(2012-3#1)
conventional protein##2##2##(2008-10#1)(2012-2#1)
conventional quick dry##2##3##(2008-5#2)
conventional radiography##9##2##(2007-11#3)(2007-4#1)(2008-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
conventional radiotherapy##2##2##(2008-6#1)(2008-7#1)
conventional refractive##2##2##(2007-11#1)(2008-2#1)
conventional restorative##2##2##(2009-7#1)(2010-3#1)
conventional risk factors##3##3##(2008-8#1)(2010-9#1)(2011-1#1)
conventional risk##5##2##(2008-8#1)(2010-9#2)(2011-1#1)(2012-3#1)
conventional scanning##2##2##(2008-3#1)(2010-6#1)
conventional semiconductor##2##2##(2007-12#1)(2008-3#1)
conventional solid phase##2##3##(2008-10#2)
conventional solid-state##2##2##(2007-12#1)(2012-2#1)
conventional solution##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
conventional solvent extraction##2##3##(2008-10#2)
conventional spectrophotometric##3##2##(2008-10#2)(2008-3#1)
conventional spectroscopic##2##2##(2008-3#1)(2008-7#1)
conventional static##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
conventional stationary##2##2##(2008-11#1)(2008-5#1)
conventional straight##3##2##(2008-10#1)(2009-7#2)
conventional surgery##2##2##(2007-8#1)(2008-11#1)
conventional surgical##3##2##(1992-6#1)(1993-1#1)(2009-2#1)
conventional tablet##2##2##(2008-7#1)(2010-3#1)
conventional technique##7##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2011-7#1)
conventional techniques for##2##3##(2008-10#1)(2011-2#1)
conventional techniques##9##2##(1994-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
conventional terminal##2##2##(1994-12#1)(2008-10#1)
conventional tests for##2##3##(1992-9#1)(1994-9#1)
conventional tests##3##2##(1992-9#1)(1994-9#1)(2013-8#1)
conventional therapeutic##3##2##(2007-7#1)(2008-6#1)(2012-2#1)
conventional therapies##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
conventional therapy##13##2##(1993-11#1)(1994-6#1)(2008-1#3)(2008-3#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#1)
conventional thermal##2##2##(2008-2#1)(2008-3#1)
conventional tillage##13##2##(2008-10#13)
conventional treatment##9##2##(2008-10#2)(2008-12#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
conventional treatments##3##2##(1997-5#1)(2008-1#1)(2008-6#1)
conventional two-dimensional##2##2##(2008-11#1)(2008-3#1)
conventional type##2##2##(2008-2#2)
conventional vaccinology approaches##2##3##(2010-8#2)
conventional variety##3##2##(2011-2#3)
conventional vascular##2##2##(2007-10#1)(2008-1#1)
conventional ventilation##3##2##(1994-6#3)
conventional way##2##2##(2008-6#1)(2010-7#1)
conventional well##2##2##(2013-1#2)
conventional wisdom##3##2##(2008-9#1)(2009-5#1)(2010-10#1)
conventional##1151##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#5)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1992-10#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-5#5)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#3)(1995-11#2)(1995-2#5)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#4)(2006-12#2)(2007-10#3)(2007-11#42)(2007-12#45)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#10)(2008-1#15)(2008-10#266)(2008-11#38)(2008-12#7)(2008-2#67)(2008-3#144)(2008-4#7)(2008-5#32)(2008-6#25)(2008-7#33)(2008-8#8)(2008-9#11)(2009-10#5)(2009-11#3)(2009-12#7)(2009-2#6)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#12)(2009-8#3)(2009-9#6)(2010-10#4)(2010-12#4)(2010-2#1)(2010-3#12)(2010-4#2)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#14)(2010-9#4)(2011-1#12)(2011-2#40)(2011-3#1)(2011-7#4)(2012-1#4)(2012-12#8)(2012-2#28)(2012-3#9)(2012-8#1)(2013-1#31)(2013-7#3)(2013-8#14)
conventional-till fields (P = 0##2##5##(2008-10#2)
conventional-till fields##4##2##(2008-10#4)
conventionally reared##3##2##(1996-5#3)
conventionally tilled plots##2##3##(2008-10#2)
conventionally tilled##3##2##(2008-10#3)
conventionally used for##3##3##(1996-5#1)(2007-7#1)(2008-10#1)
conventionally used##7##2##(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
conventionally##35##1##(1990-3#1)(1993-2#1)(1995-3#1)(1996-5#4)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#1)
conventions##6##1##(1995-1#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2011-1#1)
converge at the##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
converge in##2##2##(2008-3#1)(2013-1#1)
converge on the##3##3##(2009-4#1)(2010-6#1)(2012-12#1)
converge on##6##2##(2008-4#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#1)(2012-12#1)
converge to##7##2##(1992-7#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)
converge with##3##2##(2008-1#2)(2012-2#1)
converge##25##1##(1992-10#1)(1992-7#1)(1997-1#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
converged to##4##2##(1995-11#1)(1997-7#3)
converged##9##1##(1995-11#1)(1997-1#1)(1997-7#3)(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#1)
convergence and##3##2##(2008-2#1)(2008-3#1)(2010-8#1)
convergence has been##2##3##(2008-10#1)(2012-1#1)
convergence in the##2##3##(1995-3#1)(2011-2#1)
convergence in##4##2##(1995-3#1)(2009-10#1)(2010-3#1)(2011-2#1)
convergence is##2##2##(2008-10#1)(2008-2#1)
convergence of##12##2##(1991-12#1)(1992-6#1)(1992-9#1)(1996-3#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-3#1)(2012-3#1)(2013-8#1)
convergence rate##7##2##(2007-12#3)(2007-9#1)(2008-7#1)(2010-12#2)
convergence to the global##2##4##(2008-10#1)(2008-8#1)
convergence to the##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
convergence to##8##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
convergence##68##1##(1990-11#1)(1991-12#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-3#5)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#5)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#6)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
convergent and discriminant validity##2##4##(2007-12#1)(2008-10#1)
convergent and##3##2##(2007-10#1)(2007-12#1)(2008-10#1)
convergent evolution in##3##3##(1996-6#1)(2011-2#2)
convergent evolution##9##2##(1996-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#4)(2013-1#1)
convergent validity##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
convergent##39##1##(1992-10#1)(1993-11#1)(1996-6#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#5)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#4)(2012-3#1)(2013-1#2)
convergently##3##1##(2008-10#1)(2009-8#1)(2013-1#1)
converges on##2##2##(1997-2#1)(2012-12#1)
converges to a##2##3##(1992-5#1)(2009-7#1)
converges to##4##2##(1992-5#1)(2008-2#1)(2008-5#1)(2009-7#1)
converges##9##1##(1992-5#1)(1997-2#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2012-12#1)
converging laser##3##2##(2008-3#3)
converging of interests##2##3##(1996-11#2)
converging research##3##2##(2011-2#3)
converging to a##2##3##(1992-8#1)(2008-6#1)
converging wave##2##2##(2007-11#1)(2008-2#1)
converging##26##1##(1990-12#1)(1992-8#1)(1996-11#3)(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#7)(2008-6#1)(2009-9#1)(2011-2#4)
conversation between##2##2##(2008-11#1)(2008-9#1)
conversation orientation##3##2##(2009-8#3)
conversation with##2##2##(2010-7#1)(2012-3#1)
conversation##24##1##(2007-11#5)(2008-11#2)(2008-12#1)(2008-6#2)(2008-9#3)(2009-8#3)(2010-7#1)(2012-3#5)(2013-1#2)
conversational##4##1##(2008-9#2)(2009-5#1)(2011-2#1)
conversations on##2##2##(2009-6#1)(2011-1#1)
conversations##16##1##(1995-12#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#7)(2012-3#4)
converse piezoelectric effect##2##3##(1990-8#1)(2008-3#1)
converse##6##1##(1990-8#1)(1994-8#1)(2008-3#1)(2008-8#1)(2010-11#1)(2012-3#1)
conversely##11##1##(1990-11#1)(1991-8#1)(1992-6#1)(1994-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
conversion and##18##2##(1990-5#2)(1990-6#1)(1994-8#1)(1995-8#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
conversion at##2##2##(2007-12#1)(2008-3#1)
conversion between a##2##3##(2008-3#2)
conversion between##5##2##(1992-5#1)(2007-12#1)(2008-3#2)(2010-10#1)
conversion by use of the photorefractive##2##6##(2008-2#1)(2008-3#1)
conversion by use of##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
conversion by##7##2##(2007-12#5)(2008-2#1)(2008-3#1)
conversion decreased##3##2##(2008-7#2)(2013-1#1)
conversion disorder##2##2##(2008-6#2)
conversion efficiencies of##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
conversion efficiencies##9##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2009-2#1)(2011-2#1)
conversion efficiency and##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
conversion efficiency from##4##3##(2007-11#2)(2008-3#2)
conversion efficiency in##2##3##(2007-11#1)(2008-2#1)
conversion efficiency is greater than##2##5##(2007-12#1)(2008-3#1)
conversion efficiency is##9##3##(2007-12#4)(2008-2#2)(2008-3#2)(2008-8#1)
conversion efficiency of 2##2##4##(2007-12#2)
conversion efficiency of as much as##2##6##(2007-11#1)(2007-12#1)
conversion efficiency of more than##2##5##(2008-2#2)
conversion efficiency of the##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
conversion efficiency of transient stimulated Raman scattering##2##7##(2007-12#2)
conversion efficiency of##30##3##(2007-11#8)(2007-12#12)(2008-2#6)(2008-3#3)(2013-1#1)
conversion efficiency to##2##3##(2007-12#1)(2008-6#1)
conversion efficiency was observed##2##4##(2008-6#1)(2010-8#1)
conversion efficiency was##5##3##(2008-6#3)(2009-2#1)(2010-8#1)
conversion efficiency##90##2##(2007-11#23)(2007-12#26)(2008-10#1)(2008-2#16)(2008-3#12)(2008-6#4)(2008-8#3)(2009-2#1)(2010-1#1)(2010-8#2)(2013-1#1)
conversion factor##3##2##(2007-12#1)(2008-10#2)
conversion factors for##3##3##(2008-11#2)(2008-9#1)
conversion factors##8##2##(1992-2#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-9#2)
conversion for##5##2##(2007-12#1)(2008-3#2)(2008-6#1)(2013-1#1)
conversion from a##2##3##(2007-8#1)(2011-2#1)
conversion from##9##2##(1994-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
conversion in a##3##3##(1992-11#1)(2007-12#2)
conversion in an##2##3##(2007-11#2)
conversion in the##2##3##(1993-12#1)(2009-2#1)
conversion in##16##2##(1992-11#1)(1993-12#1)(1994-3#1)(2007-1#1)(2007-11#6)(2007-12#4)(2009-2#1)(2013-1#1)
conversion into##7##2##(1991-7#1)(2008-10#5)(2008-11#1)
conversion is proposed##2##3##(2007-11#1)(2008-2#1)
conversion is##11##2##(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)
conversion occurs##2##2##(1993-11#1)(1994-5#1)
conversion of Cr(III) to Cr(VI)##2##5##(2008-10#2)
conversion of D##2##3##(1995-3#2)
conversion of L-arginine to L-citrulline##2##5##(1991-12#1)(1995-11#1)
conversion of L-arginine##3##3##(1991-12#1)(1992-3#1)(1995-11#1)
conversion of Se(VI) in##2##4##(2008-10#2)
conversion of Se(VI) to Se(IV)##2##5##(2008-10#2)
conversion of Se(VI)##5##3##(2008-10#5)
conversion of T(4) to T(3)##2##5##(2009-12#2)
conversion of a##2##3##(2007-12#1)(2008-3#1)
conversion of an##3##3##(2007-11#1)(2007-12#2)
conversion of azide##2##3##(1993-11#2)
conversion of cellulose##2##3##(2008-6#1)(2013-1#1)
conversion of glucose##4##3##(1995-8#3)(2008-6#1)
conversion of the latter##2##4##(1991-12#1)(1997-4#1)
conversion of the##24##3##(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#2)(1994-5#1)(1995-3#1)(1996-12#1)(1997-4#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)
conversion of these##2##3##(2008-4#1)(2012-3#1)
conversion of##166##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-5#4)(1991-9#1)(1992-11#2)(1992-12#4)(1992-3#2)(1992-9#1)(1993-11#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#3)(1995-3#5)(1995-6#2)(1995-8#4)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#3)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#2)(2007-12#10)(2007-8#1)(2008-10#40)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#7)(2008-7#3)(2008-8#2)(2009-11#2)(2009-12#3)(2009-6#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#4)
conversion process##4##2##(1993-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
conversion rate of 11##2##4##(2007-8#1)(2008-7#1)
conversion rate of##5##3##(1990-7#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-7#1)
conversion rate was##3##3##(1995-12#1)(2007-8#1)(2008-6#1)
conversion rate##13##2##(1990-7#1)(1994-3#1)(1995-12#3)(2007-12#2)(2007-8#3)(2008-6#1)(2008-7#1)(2013-7#1)
conversion rates##9##2##(2008-6#2)(2008-7#1)(2009-8#2)(2010-2#2)(2010-8#1)(2013-1#1)
conversion ratio##10##2##(2008-12#6)(2008-3#1)(2008-5#2)(2013-1#1)
conversion ratios##3##2##(1997-6#1)(2008-12#1)(2008-5#1)
conversion system##4##2##(1995-3#1)(2008-6#3)
conversion to an##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2010-3#1)
conversion to the corresponding##2##4##(1995-3#1)(1996-5#1)
conversion to the##6##3##(1995-3#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-12#1)
conversion to##41##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#2)(2007-12#3)(2007-8#2)(2008-10#4)(2008-12#4)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
conversion was observed##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
conversion was##11##2##(1990-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#3)
conversion with##6##2##(2007-12#2)(2008-3#2)(2008-4#1)(2008-6#1)
conversion##549##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#4)(1991-2#1)(1991-5#5)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#4)(1994-5#2)(1994-8#6)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#7)(1995-6#2)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-1#2)(2007-11#44)(2007-12#77)(2007-8#9)(2008-10#70)(2008-11#4)(2008-12#15)(2008-2#30)(2008-3#40)(2008-4#8)(2008-5#11)(2008-6#27)(2008-7#19)(2008-8#7)(2008-9#2)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#24)(2013-7#2)
conversions and##2##2##(2008-11#1)(2013-8#1)
conversions for centrifuges and rotors##2##5##(2008-2#2)
conversions for##4##2##(2008-2#2)(2008-3#2)
conversions in##2##2##(2009-4#1)(2011-1#1)
conversions of##2##2##(1994-8#1)(2008-3#1)
conversions##17##1##(1993-12#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
convert the##9##2##(1995-11#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-12#1)(2011-2#1)
convert##52##1##(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-12#3)(1993-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(2007-12#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#3)(2009-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
convertase subtilisin/kexin type 9##2##4##(2013-1#2)
convertase subtilisin/kexin##3##2##(2008-6#1)(2013-1#2)
convertase##8##1##(1992-12#2)(1993-2#2)(2008-4#1)(2008-6#1)(2013-1#2)
convertases##4##1##(1992-12#1)(1993-5#2)(2008-4#1)
converted back##2##2##(2008-3#2)
converted by a##2##3##(2008-10#2)
converted by##5##2##(1991-5#2)(2008-10#2)(2008-3#1)
converted coherent image##2##3##(2008-3#2)
converted in the##3##3##(1993-9#1)(2008-10#1)(2008-8#1)
converted in##8##2##(1993-11#1)(1993-9#1)(1994-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
converted into a##12##3##(1991-2#1)(1995-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
converted into an##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
converted into the corresponding##3##4##(1992-6#1)(1993-9#1)(2008-4#1)
converted into the##10##3##(1990-12#1)(1992-6#1)(1993-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-5#1)(2012-3#1)
converted into##56##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-8#2)(1995-3#1)(1995-6#2)(1996-5#1)(1997-3#1)(2007-11#5)(2007-12#4)(2008-1#2)(2008-10#8)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
converted the##3##2##(1990-5#2)(1996-5#1)
converted to a sequence characterized amplified region (SCAR)##2##8##(2008-10#2)
converted to a##15##3##(1992-12#1)(1992-8#2)(1993-8#1)(1996-5#1)(2008-10#7)(2008-4#2)(2011-2#1)
converted to an##3##3##(1992-12#1)(2008-3#1)(2008-6#1)
converted to its##2##3##(2008-10#2)
converted to laparotomy##3##3##(1994-2#1)(1995-3#1)(1996-1#1)
converted to the##8##3##(1990-7#1)(1990-8#1)(1992-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#1)
converted to their respective##2##4##(2008-7#1)(2010-5#1)
converted to their##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
converted to##102##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-5#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#4)(1993-11#2)(1993-3#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-1#1)(2007-11#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#5)(2008-7#1)(2009-11#2)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
converted##204##1##(1990-12#3)(1990-5#5)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#4)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#3)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#5)(1997-1#1)(1997-3#1)(2007-11#6)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#53)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#7)(2008-5#3)(2008-6#10)(2008-7#2)(2008-8#2)(2009-11#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#3)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
converter based on##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
converter scheme##2##2##(2008-3#2)
converter##27##1##(2007-11#1)(2007-12#4)(2008-10#7)(2008-2#7)(2008-3#7)(2011-1#1)
converters for##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
converters##17##1##(2007-11#4)(2007-12#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)
converting a##3##2##(1990-7#1)(2008-3#1)(2008-6#1)
converting enzyme (ACE)##4##3##(1993-12#1)(2008-1#1)(2008-7#1)(2010-2#1)
converting enzyme inhibitors##6##3##(1991-9#1)(1995-12#1)(1996-6#1)(2006-8#1)(2008-1#2)
converting enzyme##23##2##(1990-12#1)(1990-5#4)(1991-3#1)(1991-9#1)(1992-9#1)(1993-12#2)(1995-12#2)(1996-6#1)(2006-8#1)(2007-8#1)(2008-1#5)(2008-7#1)(2010-2#2)
converting it to ADP##2##4##(2013-1#2)
converting it to##5##3##(1995-2#1)(2008-6#1)(2008-7#1)(2013-1#2)
converting it##6##2##(1995-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#2)
converting the##9##2##(1991-8#1)(1992-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)
converting them##2##2##(2012-2#1)(2013-1#1)
converting to##2##2##(2008-5#1)(2012-12#1)
converting##63##1##(1990-12#1)(1990-5#4)(1990-7#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#2)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-6#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
converts a##3##2##(1990-5#1)(2008-3#2)
converts esterified cholesterol to free cholesterol##2##6##(2008-10#2)
converts from a##2##3##(1994-2#1)(2008-3#1)
converts the##10##2##(1990-8#1)(1997-1#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
converts##33##1##(1990-11#1)(1990-5#2)(1990-8#1)(1991-8#1)(1992-8#1)(1994-11#2)(1994-2#1)(1997-1#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-9#1)(2009-7#1)(2012-2#1)
convex aspherical##2##2##(2008-3#2)
convex hull##2##2##(2007-12#1)(2008-6#1)
convex mirror##2##2##(2008-2#2)
convex polygon##2##2##(2008-2#2)
convex toward the##2##3##(1997-8#2)
convex##33##1##(1992-3#1)(1996-5#2)(1997-8#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#4)(2008-3#12)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#2)(2013-1#1)
convexity is##4##2##(2008-6#3)(2008-7#1)
convexity measure##8##2##(2008-6#8)
convexity sharp waves##2##3##(1990-5#2)
convexity##18##1##(1990-5#2)(1992-2#1)(2008-6#12)(2008-7#1)(2009-7#1)(2012-2#1)
convey a##4##2##(1996-12#1)(1996-3#1)(2008-10#1)(2012-3#1)
convey information##2##2##(1997-3#1)(2008-2#1)
convey##19##1##(1992-12#1)(1992-2#1)(1993-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
conveyed to##2##2##(1993-12#1)(2009-8#1)
conveyed##10##1##(1993-12#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-2#1)
conveying Liq pH##2##3##(2011-3#2)
conveying the##2##2##(1997-3#1)(2008-11#1)
conveying##7##1##(1994-8#1)(1997-3#1)(2008-11#1)(2010-3#1)(2011-3#3)
conveyor##2##1##(2008-10#1)(2011-1#1)
conveys##4##1##(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)
convicted of sexual offenses##2##4##(1992-9#1)(1996-5#1)
convicted of##5##2##(1991-11#1)(1991-2#1)(1992-9#1)(1996-5#1)(1997-5#1)
convicted prostitute##2##2##(1992-9#2)
convicted##11##1##(1991-11#1)(1991-2#1)(1992-9#3)(1994-2#1)(1995-12#1)(1996-5#2)(1997-5#1)(2008-8#1)
conviction##8##1##(1992-9#2)(1995-6#1)(1997-5#2)(2012-1#1)(2013-1#1)(2013-8#1)
convictions##5##1##(1990-6#1)(1991-2#1)(2008-11#1)(2008-12#1)(2012-12#1)
convince##4##1##(1990-3#1)(1991-5#1)(1992-8#1)(1997-7#1)
convinced that##4##2##(1996-2#2)(2008-10#1)(2011-2#1)
convinced##11##1##(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)
convincing and##2##2##(1995-6#1)(2013-1#1)
convincing evidence for##4##3##(2008-4#1)(2009-5#1)(2010-2#1)(2011-2#1)
convincing evidence of##4##3##(1990-11#1)(1992-2#1)(2008-8#1)(2013-1#1)
convincing evidence that the##2##4##(1992-12#1)(1992-9#1)
convincing evidence that##6##3##(1990-12#1)(1992-12#1)(1992-9#1)(1995-11#1)(2007-8#1)(2010-1#1)
convincing evidence##17##2##(1990-11#2)(1990-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-2#2)(2013-1#1)
convincing for##2##2##(2012-12#1)(2013-8#1)
convincing##35##1##(1990-11#2)(1990-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#2)
convincingly demonstrated##3##2##(2010-11#1)(2011-1#1)(2013-1#1)
convincingly##7##1##(1991-12#1)(1993-12#1)(1997-5#1)(2008-5#1)(2010-11#1)(2011-1#1)(2013-1#1)
convoluted##5##1##(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
convolution of the##6##3##(2008-10#1)(2008-2#2)(2008-3#3)
convolution of##7##2##(2008-10#1)(2008-2#3)(2008-3#3)
convolution with the##3##3##(2008-3#2)(2008-7#1)
convolution with##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
convolution##25##1##(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#11)(2008-7#2)(2013-8#2)
convulsant##2##1##(1991-1#1)(1995-12#1)
convulsion##2##1##(2010-8#1)(2013-1#1)
convulsions and##2##2##(1994-8#1)(2008-1#1)
convulsions in##2##2##(1995-12#1)(2010-3#1)
convulsions induced by##2##3##(1991-12#1)(1993-12#1)
convulsions##28##1##(1991-11#2)(1991-12#1)(1992-11#1)(1993-12#7)(1993-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-7#1)(2008-1#2)(2009-10#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-8#1)
convulsive activity and##2##3##(2008-11#1)(2010-1#1)
convulsive seizures##2##2##(2013-8#2)
convulsive##9##1##(2008-11#2)(2010-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
conyzoides##3##1##(2008-10#3)
cooccurrence##2##1##(1997-5#1)(2008-6#1)
cook loss##3##2##(2010-4#3)
cooked beef meat##3##3##(2008-10#3)
cooked beef##7##2##(2008-10#4)(2010-4#3)
cooked for##3##2##(2010-2#3)
cooked frankfurters##2##2##(2010-4#2)
cooked meat products##2##3##(2010-4#2)
cooked meat##5##2##(2010-2#2)(2010-4#3)
cooked##34##1##(1997-2#3)(1997-4#3)(2008-10#6)(2010-2#5)(2010-4#13)(2011-2#1)(2012-1#1)(2012-12#2)
cooking and##2##2##(1990-8#1)(2008-9#1)
cooking loss and##2##3##(2010-4#2)
cooking loss##4##2##(2010-4#4)
cooking losses##2##2##(2010-4#2)
cooking time##6##2##(2010-2#6)
cooking##24##1##(1990-8#1)(1992-10#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-9#1)(2009-8#1)(2010-2#8)(2010-4#7)(2010-5#2)
cool diamonds##2##2##(1990-11#2)
cool##21##1##(1990-11#2)(1992-3#1)(1993-12#1)(1994-2#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2012-12#1)(2012-7#1)
cool&quot##2##1##(2009-7#2)
cool-season##2##1##(2008-10#1)(2008-8#1)
coolable spectroscopic cell for##2##4##(2008-3#2)
cooled CCD##2##2##(2008-10#1)(2008-3#1)
cooled from##2##2##(2007-12#1)(2008-3#1)
cooled##30##1##(1991-2#1)(1992-11#1)(1996-2#1)(2007-10#2)(2007-11#3)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2008-7#2)(2008-8#1)(2012-2#1)
cooler##9##1##(2008-10#6)(2008-8#1)(2011-2#1)(2012-4#1)
coolers##3##1##(2008-10#1)(2008-3#2)
cooling and##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
cooling effluents##2##2##(2008-10#2)
cooling in##4##2##(1994-5#1)(2007-10#1)(2007-11#2)
cooling is##2##2##(1995-3#1)(2008-3#1)
cooling of the##4##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
cooling of##7##2##(1991-2#1)(1992-8#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
cooling rate##4##2##(2008-10#1)(2008-8#3)
cooling system##2##2##(2007-10#1)(2008-3#1)
cooling temperatures##2##2##(2008-10#1)(2008-7#1)
cooling to##2##2##(2007-8#1)(2008-9#1)
cooling##87##1##(1990-5#1)(1990-7#2)(1991-2#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-3#3)(1996-6#1)(1996-8#1)(2007-10#7)(2007-11#6)(2007-12#3)(2007-8#1)(2008-10#17)(2008-12#1)(2008-2#2)(2008-3#13)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#1)(2009-1#1)(2009-11#2)(2010-1#3)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
cooperate in##5##2##(1993-2#1)(1997-3#1)(2008-9#1)(2010-3#1)(2011-2#1)
cooperate to##2##2##(1993-12#1)(1995-8#1)
cooperate with the##2##3##(1990-2#1)(1991-5#1)
cooperate with##9##2##(1990-2#1)(1991-5#1)(1994-12#1)(1996-2#1)(1996-3#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)
cooperate##19##1##(1990-2#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-1#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
cooperated##2##1##(1993-2#1)(2008-11#1)
cooperates with##2##2##(2012-2#2)
cooperating oncogenes##2##2##(1991-5#2)
cooperating with##3##2##(1997-4#2)(2008-11#1)
cooperating##8##1##(1991-5#2)(1991-6#1)(1996-12#1)(1997-4#2)(2008-11#1)(2008-8#1)
cooperation among##2##2##(1991-12#1)(1995-1#1)
cooperation and collaboration##2##3##(2008-10#1)(2010-3#1)
cooperation and##9##2##(1996-1#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)
cooperation between clinicians##2##3##(2007-11#1)(2007-12#1)
cooperation between the##4##3##(1995-5#1)(1995-6#1)(2010-3#1)(2011-4#1)
cooperation between##22##2##(1991-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#2)(2007-11#2)(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-4#1)(2012-12#1)(2012-3#2)
cooperation for##2##2##(1996-3#1)(2012-2#1)
cooperation from the##2##3##(1996-1#1)(2010-9#1)
cooperation from##3##2##(1996-1#1)(2008-8#1)(2010-9#1)
cooperation in health care##2##4##(1993-12#1)(1995-2#1)
cooperation in the##2##3##(2008-12#1)(2010-4#1)
cooperation in##9##2##(1992-2#1)(1993-11#1)(1993-12#1)(1995-2#1)(2007-12#1)(2008-12#1)(2008-8#2)(2010-4#1)
cooperation is##5##2##(1994-3#1)(1995-5#1)(2007-11#1)(2008-8#1)(2012-3#1)
cooperation of the##3##3##(1991-3#1)(2007-11#1)(2008-10#1)
cooperation of##10##2##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
cooperation with a##2##3##(1996-6#1)(2007-8#1)
cooperation with community pharmacists##2##4##(2011-1#2)
cooperation with its##2##3##(1993-2#1)(1996-12#1)
cooperation with other##2##3##(1994-6#1)(2013-1#1)
cooperation with the##4##3##(1993-2#1)(1993-6#1)(2008-10#1)(2009-5#1)
cooperation with##20##2##(1993-2#2)(1993-6#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-7#3)(2011-1#2)(2013-1#1)
cooperation##118##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#20)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#3)(2010-7#3)(2010-9#1)(2011-1#4)(2011-2#3)(2011-4#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
cooperative amplification##2##2##(1997-6#2)
cooperative and##2##2##(1995-12#1)(2012-3#1)
cooperative behavior##2##2##(1990-8#1)(2008-8#1)
cooperative binding of##4##3##(1990-11#1)(1994-6#1)(1995-2#1)(2008-10#1)
cooperative binding##5##2##(1990-11#2)(1994-6#1)(1995-2#1)(2008-10#1)
cooperative breeding in##3##3##(2008-8#3)
cooperative breeding##8##2##(2008-8#8)
cooperative care##4##2##(1995-1#3)(2008-3#1)
cooperative effort##3##2##(1991-2#1)(1994-12#1)(1996-1#1)
cooperative emission##2##2##(2007-12#2)
cooperative free energy level##2##4##(1990-8#2)
cooperative free energy##6##3##(1990-8#5)(1997-2#1)
cooperative free##7##2##(1990-8#6)(1997-2#1)
cooperative interaction##2##2##(1996-2#1)(2008-4#1)
cooperative interactions##5##2##(1997-2#2)(2008-10#2)(2008-8#1)
cooperative ligand binding##2##3##(1990-8#1)(1997-2#1)
cooperative manner##5##2##(1991-5#1)(1993-11#1)(1994-6#1)(2008-10#1)(2008-11#1)
cooperative mode of##2##3##(1993-11#1)(2008-11#1)
cooperative nature of##3##3##(1990-8#2)(1995-6#1)
cooperative nature##4##2##(1990-8#2)(1992-9#1)(1995-6#1)
cooperative protective processes##2##3##(2008-7#2)
cooperative repression##2##2##(1995-3#2)
cooperative tendencies##2##2##(2008-8#2)
cooperative##124##1##(1990-11#2)(1990-8#14)(1991-2#3)(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#5)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-7#1)(1995-1#4)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#10)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#17)(2008-9#1)(2009-5#1)(2009-8#2)(2010-12#4)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
cooperatively to##3##2##(1995-2#2)(1997-2#1)
cooperatively with##3##2##(2008-1#2)(2008-12#1)
cooperatively##16##1##(1994-12#1)(1995-2#5)(1997-2#1)(1997-7#1)(2008-1#2)(2008-12#1)(2008-9#3)(2010-8#1)(2012-12#1)
cooperativity and##4##2##(1993-11#1)(1997-2#3)
cooperativity between##2##2##(1995-12#1)(1997-2#1)
cooperativity for##2##2##(1997-2#2)
cooperativity in O2 binding##3##4##(1991-10#3)
cooperativity in the binding##2##4##(1990-8#1)(1997-2#1)
cooperativity in the##4##3##(1990-8#2)(1997-2#2)
cooperativity in##7##2##(1990-8#2)(1991-10#3)(1997-2#2)
cooperativity of##2##2##(1991-12#1)(1997-2#1)
cooperativity with##2##2##(1994-5#1)(1997-2#1)
cooperativity##53##1##(1990-7#1)(1990-8#15)(1991-10#4)(1991-12#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-5#3)(1995-12#1)(1995-2#1)(1997-2#18)(2008-10#2)(2011-1#1)(2012-2#1)
cooperators and##2##2##(2008-8#1)(2012-3#1)
cooperators##5##1##(2008-8#1)(2012-3#4)
coordinate and##3##2##(2007-11#1)(2008-2#1)(2010-6#1)
coordinate frames##2##2##(1990-5#2)
coordinate regulation##2##2##(1991-2#1)(1991-5#1)
coordinate system##8##2##(2008-11#1)(2008-2#3)(2008-3#4)
coordinate systems##2##2##(2008-3#1)(2009-4#1)
coordinate the##8##2##(1992-1#1)(1992-2#1)(1995-5#1)(2008-10#1)(2009-10#1)(2009-6#1)(2012-2#2)
coordinate transformation##2##2##(2008-2#1)(2008-3#1)
coordinate##69##1##(1990-5#2)(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-5#1)(1997-2#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#2)(2012-3#1)
coordinated action##2##2##(2008-4#1)(2010-11#1)
coordinated and##4##2##(1994-2#2)(2008-11#1)(2008-5#1)
coordinated by the##5##3##(1990-3#1)(1991-3#1)(2008-10#1)(2008-9#1)(2011-1#1)
coordinated by##9##2##(1990-3#1)(1991-3#1)(2007-11#1)(2008-10#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-1#1)
coordinated effort##3##2##(1994-3#1)(2009-10#2)
coordinated genomic##2##2##(2008-10#1)(2008-7#1)
coordinated to the##4##3##(1997-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
coordinated to##6##2##(1997-7#2)(2007-11#1)(2008-10#2)(2013-1#1)
coordinated with the##2##3##(2011-2#2)
coordinated with##6##2##(1994-12#1)(1994-2#1)(1995-6#1)(2008-7#1)(2011-2#2)
coordinated##84##1##(1990-3#1)(1991-3#1)(1992-1#2)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-9#1)(1997-3#2)(1997-7#3)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
coordinately with##2##2##(2008-10#1)(2008-8#1)
coordinately##5##1##(1991-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
coordinates and##3##2##(2008-3#2)(2008-6#1)
coordinates are based on the##2##5##(1990-5#2)
coordinates are##3##2##(1990-5#2)(2008-7#1)
coordinates for##3##2##(1993-9#1)(1995-5#1)(2008-3#1)
coordinates into##2##2##(2008-2#1)(2008-3#1)
coordinates is##2##2##(1992-4#1)(2007-12#1)
coordinates of a##3##3##(1995-2#1)(2008-2#1)(2008-3#1)
coordinates of the##8##3##(1992-4#1)(1994-1#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-2#1)
coordinates of##19##2##(1991-6#1)(1992-12#1)(1992-4#1)(1994-1#1)(1995-2#2)(1997-2#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2009-2#1)
coordinates the##4##2##(1993-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
coordinates were##2##2##(2008-7#1)(2009-8#1)
coordinates with the##3##3##(2008-10#2)(2013-1#1)
coordinates with##5##2##(2008-10#2)(2008-9#1)(2010-7#1)(2013-1#1)
coordinates##74##1##(1990-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#2)(1995-2#2)(1995-5#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#17)(2008-4#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
coordinating solvents##2##2##(2009-11#1)(2009-9#1)
coordinating the operation of##2##4##(1996-1#1)(2008-10#1)
coordinating the##8##2##(1994-1#2)(1996-1#1)(1997-3#1)(2008-10#2)(2010-5#1)(2013-8#1)
coordinating to##2##2##(1994-8#1)(1996-2#1)
coordinating with##2##2##(1996-2#1)(1997-2#1)
coordinating##34##1##(1992-1#1)(1992-6#1)(1993-2#1)(1994-1#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#2)(2007-12#2)(2007-7#1)(2008-10#4)(2008-7#1)(2009-11#1)(2009-9#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
coordination among providers##2##3##(2013-8#2)
coordination among##4##2##(2009-7#1)(2012-3#1)(2013-8#2)
coordination and balance in##2##4##(2008-4#2)
coordination and balance##3##3##(2008-4#3)
coordination and the##2##3##(1996-1#1)(2011-1#1)
coordination and##13##2##(1993-12#1)(1993-3#1)(1994-8#1)(1996-1#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#3)(2011-1#2)(2011-3#1)
coordination between##2##2##(2011-2#1)(2013-8#1)
coordination by##2##2##(2008-10#1)(2012-12#1)
coordination chemistry##2##2##(1997-7#1)(2010-6#1)
coordination complexes##2##2##(2007-11#1)(2010-12#1)
coordination for##2##2##(1997-1#1)(2008-1#1)
coordination geometry of##2##3##(1995-5#1)(2006-4#1)
coordination geometry##4##2##(1995-5#2)(1996-2#1)(2006-4#1)
coordination in##4##2##(1994-5#1)(2008-7#1)(2009-1#1)(2009-8#1)
coordination is a##2##3##(1995-3#1)(2007-11#1)
coordination is##3##2##(1995-3#1)(2007-11#1)(2009-5#1)
coordination numbers of##2##3##(1997-7#1)(2011-2#1)
coordination of care##3##3##(1995-12#2)(2008-11#1)
coordination of efforts##2##3##(2008-10#1)(2008-4#1)
coordination of the##10##3##(1991-5#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-5#1)(1997-7#1)(2008-10#2)(2012-12#1)(2013-7#1)
coordination of##39##2##(1990-6#1)(1991-5#1)(1992-1#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-5#1)(1997-7#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
coordination on##2##2##(1995-3#1)(1996-2#1)
coordination polymer##2##2##(1997-7#1)(2008-7#1)
coordination polymers##2##2##(1997-7#1)(2010-12#1)
coordination sites are occupied by##2##5##(1997-7#2)
coordination sites##4##2##(1997-7#2)(2008-10#1)(2010-6#1)
coordination sphere of##2##3##(1996-2#1)(1997-7#1)
coordination sphere##3##2##(1996-2#1)(1997-7#1)(2009-11#1)
coordination to##2##2##(2010-11#1)(2010-6#1)
coordination was##3##2##(1995-3#1)(1997-2#1)(2008-9#1)
coordination with##5##2##(1990-3#1)(1991-9#1)(1996-2#1)(2008-10#2)
coordination##164##1##(1990-3#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-1#2)(1993-11#1)(1993-12#2)(1993-3#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#3)(1996-1#3)(1996-12#1)(1996-2#5)(1996-7#1)(1997-1#3)(1997-2#2)(1997-7#11)(2006-4#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#6)
coordinator of care##2##3##(1997-2#1)(2011-1#1)
coordinator##8##1##(1991-2#1)(1997-2#1)(2008-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#2)
coordinators##11##1##(1991-2#1)(1996-12#2)(2008-1#1)(2008-3#3)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
cop##3##1##(2008-10#1)(2009-2#2)
copayments##3##1##(1991-3#1)(1995-1#1)(2009-9#1)
cope and manage##2##3##(2009-5#1)(2013-8#1)
cope and##3##2##(1995-9#1)(2009-5#1)(2013-8#1)
cope with the##13##3##(1992-6#1)(1993-1#1)(1993-6#1)(1994-12#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-5#1)(2012-1#1)
cope with their##3##3##(1993-12#1)(1993-3#1)(1995-9#1)
cope with this##3##3##(1994-8#1)(2008-2#1)(2011-2#1)
cope with##44##2##(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#4)(1994-8#1)(1995-12#1)(1995-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#1)
cope##59##1##(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#4)(1994-8#1)(1995-12#1)(1995-9#2)(1996-1#1)(1996-8#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2010-10#4)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
coped##2##1##(2008-11#1)(2011-2#1)
copepod Calanus finmarchicus##2##3##(2009-6#1)(2013-1#1)
copepod##5##1##(2008-5#2)(2009-6#1)(2010-8#1)(2013-1#1)
copepods##6##1##(2008-5#3)(2010-8#1)(2011-2#1)(2013-7#1)
cophenetic correlation##2##2##(2008-5#2)
cophylogenetic##5##1##(2008-1#3)(2012-3#1)(2013-1#1)
copied and##3##2##(1993-12#1)(2008-7#1)(2009-10#1)
copied##4##1##(1993-12#1)(2008-7#1)(2008-9#1)(2009-10#1)
copies and showed##2##3##(1995-11#2)
copies and the level of##2##5##(1995-8#1)(2008-10#1)
copies and##6##2##(1995-11#3)(1995-8#1)(2008-10#1)(2011-2#1)
copies are##2##2##(1995-8#1)(2007-11#1)
copies in##4##2##(1990-6#1)(1995-8#1)(2008-10#1)(2013-8#1)
copies mul(-1)##2##2##(2008-10#2)
copies of (C##2##3##(2008-7#2)
copies of DNA##2##3##(1996-10#1)(2008-8#1)
copies of an##3##3##(1994-12#1)(1995-8#1)(2012-3#1)
copies of each##2##3##(2008-7#1)(2012-2#1)
copies of the human##2##4##(1993-12#1)(1996-12#1)
copies of the##30##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#1)(1997-7#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-1#1)
copies of these##3##3##(1996-10#1)(2008-10#1)(2008-5#1)
copies of this##4##3##(2008-10#4)
copies of##65##2##(1990-11#1)(1990-12#2)(1990-5#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-5#1)(1995-8#3)(1996-10#2)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
copies per cell##3##3##(1991-2#1)(1993-8#1)(1995-2#1)
copies per##4##2##(1991-2#1)(1993-8#1)(1995-2#1)(2009-8#1)
copies that##2##2##(1995-11#1)(2009-10#1)
copies##113##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1991-2#2)(1992-11#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-11#8)(1995-2#1)(1995-5#1)(1995-8#8)(1996-10#3)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#2)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#4)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
copies)##2##1##(2008-10#2)
copies/10(5)##2##1##(1990-2#2)
copies/diploid##2##1##(1990-5#2)
copies/ml of##2##2##(2008-5#1)(2012-2#1)
copies/ml##9##1##(2008-5#2)(2009-3#2)(2011-1#3)(2012-2#1)(2012-3#1)
coping (hesitation to report pain##2##5##(2010-11#2)
coping ability##2##2##(1996-3#1)(2013-1#1)
coping and anxiety##2##3##(1995-1#2)
coping and problem-oriented##2##3##(2010-5#2)
coping and stress##2##3##(2009-7#1)(2011-2#1)
coping and##14##2##(1990-10#1)(1995-1#2)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#2)(2011-2#3)(2012-1#2)(2012-12#1)
coping are##2##2##(1997-8#1)(2012-2#1)
coping as a##2##3##(2009-11#1)(2013-1#1)
coping as##3##2##(2009-11#1)(2011-2#1)(2013-1#1)
coping behavior and##2##3##(1995-1#1)(2009-7#1)
coping behavior##3##2##(1995-1#1)(2009-7#2)
coping in##4##2##(1990-10#1)(1996-1#1)(2011-1#1)(2011-2#1)
coping is##2##2##(1994-12#1)(2010-4#1)
coping may##2##2##(2011-2#1)(2012-2#1)
coping mechanisms##4##2##(1997-2#1)(2007-6#1)(2008-12#1)(2013-8#1)
coping method##2##2##(1990-10#2)
coping methods##3##2##(1990-10#2)(2010-10#1)
coping patterns##2##2##(1990-10#1)(2013-7#1)
coping scores##3##2##(2010-5#3)
coping skills in##2##3##(2007-10#2)
coping skills##9##2##(1992-2#1)(1994-2#1)(2007-10#2)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#2)
coping strategies and##4##3##(1995-9#1)(1996-3#1)(2008-11#1)(2012-1#1)
coping strategies employed in##2##4##(2008-1#1)(2008-11#1)
coping strategies in##2##3##(2007-6#1)(2010-10#1)
coping strategies used by##2##4##(1994-12#1)(2010-10#1)
coping strategies##32##2##(1991-1#1)(1992-3#1)(1994-12#2)(1995-9#1)(1996-3#1)(2007-6#1)(2008-1#2)(2008-11#8)(2008-8#1)(2010-10#4)(2011-1#5)(2011-2#3)(2012-1#2)
coping strategy##2##2##(2008-11#1)(2008-12#1)
coping style##3##2##(2010-5#3)
coping styles##9##2##(2008-12#1)(2009-11#3)(2009-7#2)(2010-5#2)(2012-12#1)
coping was associated with##2##4##(2009-5#2)
coping was##3##2##(2009-5#2)(2010-5#1)
coping with the##3##3##(1996-9#1)(2008-10#1)(2009-7#1)
coping with##17##2##(1990-10#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#3)(2011-2#1)(2012-3#1)
coping##197##1##(1990-10#11)(1991-1#3)(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-12#4)(1994-2#3)(1995-1#8)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#2)(2007-6#2)(2008-1#3)(2008-10#1)(2008-11#16)(2008-12#11)(2008-4#7)(2008-8#1)(2009-11#8)(2009-12#2)(2009-5#2)(2009-7#13)(2010-1#1)(2010-10#5)(2010-11#4)(2010-4#4)(2010-5#13)(2011-1#8)(2011-2#18)(2012-1#7)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
coping&quot##2##1##(2007-6#2)
copious##2##1##(1990-5#1)(2008-9#1)
coplanar and##2##2##(2008-10#1)(2008-7#1)
coplanar congener 3##2##3##(1995-12#1)(1996-12#1)
coplanar congener##3##2##(1995-12#1)(1996-12#1)(2008-10#1)
coplanar##13##1##(1995-12#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-7#2)
copolarized intensity peak##2##3##(2008-2#2)
copolarized signal##2##2##(2007-12#2)
copolarized##6##1##(2007-12#2)(2008-2#3)(2008-3#1)
copolyester##2##1##(2008-6#2)
copolyesters of##2##2##(2008-6#2)
copolyesters##4##1##(2008-6#4)
copolymer (EVA)##3##2##(2008-10#1)(2008-11#2)
copolymer and##3##2##(2008-10#2)(2008-7#1)
copolymer for##2##2##(2008-10#1)(2013-1#1)
copolymer micelles##2##2##(2008-10#2)
copolymer of##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
copolymer with##3##2##(2008-10#2)(2008-12#1)
copolymer##59##1##(1990-12#1)(1990-8#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#8)(2008-12#2)(2008-3#3)(2008-5#3)(2008-7#3)(2009-7#1)(2010-2#1)(2010-4#3)(2012-12#1)(2013-1#4)
copolymerization of styrene and##3##4##(2008-10#2)(2010-2#1)
copolymerization of tau with tubulin and actin filaments##2##8##(1993-6#2)
copolymerization of##11##2##(1993-6#2)(2007-12#1)(2008-10#5)(2010-2#1)(2012-12#2)
copolymerization##16##1##(1993-6#2)(2007-12#1)(2008-10#5)(2008-11#1)(2009-10#1)(2010-2#1)(2012-12#5)
copolymerized with##3##2##(2008-3#1)(2008-5#1)(2010-4#1)
copolymerized##5##1##(2008-3#1)(2008-5#2)(2009-7#1)(2010-4#1)
copolymers of acrylic acid##2##4##(2008-5#1)(2009-9#1)
copolymers of##8##2##(1993-11#1)(2008-3#1)(2008-5#2)(2009-10#2)(2009-9#1)(2010-2#1)
copolymers with##4##2##(2008-5#1)(2009-10#1)(2010-2#2)
copolymers##32##1##(1993-11#1)(2007-11#1)(2008-10#6)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#3)(2009-11#2)(2009-9#2)(2010-2#4)(2013-1#1)
copper (II)##5##2##(2008-10#5)
copper ISE##2##2##(2010-5#2)
copper and 0##3##3##(2008-10#3)
copper and aluminium in##2##4##(1992-3#2)
copper and aluminium##3##3##(1992-3#3)
copper and cadmium##5##3##(2008-10#5)
copper and cobalt##2##3##(2008-10#1)(2013-8#1)
copper and iron##13##3##(1995-2#1)(2008-10#12)
copper and lead in soils##2##5##(2008-10#2)
copper and lead in##5##4##(2007-5#1)(2008-10#4)
copper and lead##9##3##(2007-5#2)(2008-10#6)(2010-2#1)
copper and manganese in biological materials and##2##7##(2008-10#2)
copper and manganese##5##3##(2008-10#5)
copper and mercury ions##5##4##(2008-10#5)
copper and mercury##6##3##(2008-10#6)
copper and zinc in non-ferroalloys by flame atomic absorption spectrometry##2##10##(2008-10#2)
copper and zinc in##3##4##(2008-10#3)
copper and zinc were##3##4##(2008-10#2)(2008-5#1)
copper and zinc##14##3##(1992-3#1)(2008-10#11)(2008-5#1)(2010-5#1)
copper and##83##2##(1992-12#1)(1992-3#4)(1993-11#1)(1993-2#1)(1995-2#1)(1995-5#1)(2007-5#2)(2008-10#65)(2008-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-8#2)
copper are##3##2##(1992-12#1)(2008-10#2)
copper as##2##2##(2008-10#2)
copper at##7##2##(2008-10#7)
copper binding##4##2##(1993-11#1)(1995-11#1)(2011-2#1)(2012-2#1)
copper by flame atomic absorption spectrometry##2##6##(2008-10#2)
copper by flame##3##3##(2008-10#3)
copper by##13##2##(2008-10#12)(2008-8#1)
copper can be##2##3##(2008-10#2)
copper chelator##2##2##(1997-2#1)(2009-11#1)
copper complex##5##2##(1996-2#2)(2008-10#3)
copper complexes##3##2##(2008-10#3)
copper concentration in serum##2##4##(1993-2#2)
copper concentration of##2##3##(2008-10#1)(2008-11#1)
copper concentration##5##2##(1993-2#2)(2008-10#1)(2008-11#1)(2008-5#1)
copper concentrations in the range##2##5##(2008-10#2)
copper concentrations in the##3##4##(1990-5#1)(2008-10#2)
copper concentrations in##4##3##(1990-5#1)(2008-10#3)
copper concentrations##8##2##(1990-5#1)(2008-10#6)(2008-12#1)
copper content##2##2##(2008-10#2)
copper deficiency is##3##3##(2012-2#3)
copper deficiency##12##2##(2008-10#6)(2008-12#1)(2011-1#1)(2012-2#4)
copper determination by##3##3##(2008-10#3)
copper determination in natural##2##4##(2008-10#2)
copper determination in##11##3##(2008-10#11)
copper determination##17##2##(2008-10#17)
copper electrode in##2##3##(2008-10#2)
copper electrodes##3##2##(2008-10#3)
copper filter##2##2##(1997-8#2)
copper filtration##2##2##(1997-8#2)
copper formed##2##2##(2008-10#2)
copper from##4##2##(2008-10#4)
copper has been##2##3##(2008-10#2)
copper hexacyanoferrate##2##2##(2008-10#2)
copper hydroxide##2##2##(2008-10#1)(2011-2#1)
copper hydroxide/mancozeb##2##2##(2008-10#2)
copper in aqueous##2##3##(2008-10#2)
copper in river water##3##4##(2008-10#3)
copper in river waters##3##4##(2008-10#3)
copper in river##6##3##(2008-10#6)
copper in##54##2##(1995-6#1)(1997-4#1)(2008-10#48)(2008-9#3)(2010-5#1)
copper ion##4##2##(2008-10#4)
copper ions in##2##3##(2008-10#1)(2008-9#1)
copper ions##19##2##(2008-10#16)(2008-5#1)(2008-9#1)(2012-2#1)
copper is##5##2##(1995-11#1)(2008-10#4)
copper mass##2##2##(2008-10#2)
copper matrices##2##2##(2008-10#2)
copper microparticles##2##2##(2008-10#2)
copper of##2##2##(2008-10#2)
copper on##5##2##(2008-10#3)(2008-12#1)(2008-9#1)
copper oxide and glucose oxidase##2##5##(2008-10#2)
copper oxide##7##2##(1993-5#1)(2008-10#4)(2008-2#2)
copper phosphate##2##2##(2008-10#2)
copper proteins##3##2##(1993-11#3)
copper recovery##2##2##(2008-10#2)
copper resistance##3##2##(2008-10#3)
copper solid amalgam electrode##2##4##(2008-10#2)
copper solid amalgam##4##3##(2008-10#4)
copper solutions##2##2##(2008-10#2)
copper sulfate (CuSO(4))##2##3##(2008-10#1)(2008-11#1)
copper sulfate pentahydrate (200 mug/ml)##2##5##(2008-10#2)
copper sulfate##8##2##(1990-8#1)(2008-10#5)(2008-11#2)
copper transport protein##2##3##(2008-10#1)(2010-11#1)
copper transport##4##2##(2008-10#1)(2010-11#2)(2011-2#1)
copper uptake##3##2##(1995-11#1)(2010-11#1)(2011-2#1)
copper using##4##2##(2008-10#3)(2013-8#1)
copper vapor laser (CVL)##2##4##(2008-2#1)(2008-3#1)
copper vapor laser##4##3##(2008-2#2)(2008-3#2)
copper was##8##2##(1990-8#1)(2008-10#6)(2008-5#1)
copper were##6##2##(2008-10#5)(2010-2#1)
copper which##2##2##(2008-10#2)
copper wire##4##2##(2007-11#1)(2008-10#3)
copper with detection limits##2##4##(2008-10#2)
copper with detection##3##3##(2008-10#3)
copper with the##2##3##(2008-10#2)
copper with##10##2##(2008-10#10)
copper##580##1##(1990-5#4)(1990-8#5)(1991-3#1)(1992-11#1)(1992-12#3)(1992-3#5)(1992-9#2)(1993-11#8)(1993-2#3)(1993-5#1)(1995-11#5)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#1)(1996-2#3)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#5)(2007-11#3)(2007-12#1)(2007-5#2)(2008-10#423)(2008-11#4)(2008-12#6)(2008-2#5)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#10)(2009-11#2)(2009-12#1)(2010-11#5)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#6)(2011-1#1)(2011-2#7)(2012-2#16)(2013-1#1)(2013-7#1)(2013-8#6)
copper(I) chloride##3##2##(2008-10#3)
copper(I)##6##1##(2008-10#6)
copper(I)oxide##2##1##(2008-10#2)
copper(II) and cadmium(II)##3##3##(2008-10#3)
copper(II) and cobalt(II)##2##3##(2008-10#2)
copper(II) and iron(II)##2##3##(2008-10#2)
copper(II) and nickel(II) in##3##4##(2008-10#3)
copper(II) and##23##2##(2008-10#23)
copper(II) ion##6##2##(2008-10#6)
copper(II) ions##11##2##(1997-7#1)(2008-10#10)
copper(II) is##3##2##(2008-10#3)
copper(II) phosphate##2##2##(2008-10#2)
copper(II) using octadecyl silica membrane disks modified by##2##8##(2008-10#2)
copper(II) using##4##2##(2008-10#4)
copper(II) was##3##2##(2008-10#3)
copper(II) with a##2##3##(2008-10#2)
copper(II) with##5##2##(2008-10#5)
copper(II)##125##1##(1997-7#2)(2008-10#122)(2008-12#1)
copper(II)-neocuproine reagent in##2##3##(2008-10#2)
copper(II)-neocuproine##3##1##(2008-10#3)
copper(II)-sensitive membrane##2##2##(2008-10#2)
copper)##4##1##(2008-10#2)(2008-3#1)(2010-4#1)
copper-based##2##1##(2008-10#1)(2008-9#1)
copper-catalyzed oxidative##4##2##(1991-12#3)(2011-2#1)
copper-deficient##2##1##(2008-10#1)(2012-2#1)
copper-induced##2##1##(1994-9#1)(2008-7#1)
copper-modified##3##1##(2008-10#3)
copper-protein complex##2##2##(2008-10#2)
copper-protein complexes##3##2##(2008-10#3)
copper-protein##5##1##(2008-10#5)
copper-resistant strains##2##2##(2008-10#2)
copper-resistant##6##1##(2008-10#6)
copper-sensitive strains##3##2##(2008-10#3)
copper-sensitive##5##1##(2008-10#5)
copper-smelting site##2##2##(2008-10#2)
copper-tolerant clones##3##2##(2008-10#3)
copper-tolerant strains##3##2##(2008-10#3)
copper-tolerant##6##1##(2008-10#6)
copper-vapor laser##5##2##(2007-12#4)(2008-2#1)
copperised cadmium reductor column##3##4##(2008-10#3)
copperised cadmium##4##2##(2008-10#4)
copperized cadmium##2##2##(2008-10#2)
copperized##3##1##(2008-10#3)
coprecipitated in##2##2##(1996-2#1)(2008-10#1)
coprecipitated with##3##2##(1997-6#1)(2008-10#2)
coprecipitated##7##1##(1996-2#1)(1997-6#1)(2008-10#5)
coprecipitation and##2##2##(2008-10#2)
coprecipitation of##2##2##(2008-10#2)
coprecipitation preconcentration##2##2##(2008-10#2)
coprecipitation technique##2##2##(2008-10#1)(2013-8#1)
coprecipitation##17##1##(2008-10#15)(2008-4#1)(2013-8#1)
coprecipitative preconcentration of##2##3##(2008-10#2)
copro-antigen detection##2##2##(2013-8#2)
copropagating and counterpropagating##3##3##(2007-11#2)(2007-12#1)
copropagating##7##1##(2007-11#3)(2007-12#4)
coprophilous##2##1##(2008-11#2)
coproporphyrin##2##1##(2008-10#2)
coptisine##4##1##(2008-11#4)
copula##3##1##(2008-5#3)
copulating##2##1##(1995-12#1)(1995-2#1)
copulation site##2##2##(2007-12#2)
copulation##15##1##(2007-12#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-12#2)(2013-8#1)
copulatory performance##2##2##(1991-2#1)(1995-12#1)
copulatory##7##1##(1991-2#1)(1995-12#1)(2008-11#1)(2008-5#2)(2011-2#2)
copurified with the##2##3##(1992-11#1)(2008-10#1)
copurified with##3##2##(1992-11#1)(1997-6#1)(2008-10#1)
copurifies with##3##2##(1992-6#1)(1992-8#1)(1995-2#1)
copy number alterations##3##3##(2008-9#3)
copy number and the##2##4##(1994-12#1)(2010-10#1)
copy number and##8##3##(1991-9#1)(1994-12#1)(1995-11#1)(1997-6#1)(2008-11#2)(2008-8#1)(2010-10#1)
copy number changes##2##3##(2008-7#1)(2012-3#1)
copy number in##4##3##(1993-12#1)(1995-8#1)(1996-12#1)(2012-3#1)
copy number of MDR1##3##4##(1995-11#3)
copy number of the L-A dsRNA virus##2##7##(1997-3#2)
copy number of the L-A##3##5##(1997-3#3)
copy number of the##5##4##(1997-3#3)(1997-4#1)(2008-10#1)
copy number of##16##3##(1991-7#1)(1993-6#1)(1994-11#1)(1995-11#3)(1997-3#3)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)
copy number or expression##2##4##(1995-11#1)(2008-10#1)
copy number plasmid##2##3##(2008-10#2)
copy number variation##2##3##(2009-5#1)(2012-3#1)
copy number##64##2##(1990-5#2)(1990-7#1)(1991-7#1)(1991-9#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-11#5)(1995-8#1)(1996-12#3)(1997-3#3)(1997-4#1)(1997-6#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#3)(2012-3#5)
copy numbers##5##2##(1990-2#2)(1993-9#1)(2008-10#1)(2009-10#1)
copy of the##17##3##(1990-11#1)(1993-3#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#3)(2013-1#1)
copy of##32##2##(1990-11#1)(1990-5#2)(1991-3#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#5)(2013-1#1)
copy on##2##2##(1993-2#1)(2012-3#1)
copy the mate choice of##3##5##(2008-9#1)(2009-6#2)
copy their##2##2##(1990-2#2)
copy##148##1##(1990-11#1)(1990-2#4)(1990-5#4)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-8#1)(1995-11#6)(1995-5#1)(1995-8#3)(1996-10#1)(1996-12#5)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#5)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#5)(2009-10#3)(2009-2#2)(2009-5#1)(2009-6#3)(2009-7#3)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#11)(2013-1#1)
copying##3##1##(2009-3#1)(2009-6#1)(2009-9#1)
copyright##3##1##(1993-3#1)(1994-3#1)(2008-11#1)
cor pulmonale##3##2##(1991-11#1)(2012-12#2)
cor##5##1##(1991-11#1)(2008-10#1)(2008-12#1)(2012-12#2)
cor15##2##1##(1992-3#2)
coracoid##4##1##(2013-1#4)
coral bleaching##3##2##(2008-9#1)(2012-2#2)
coral cover##4##2##(2007-5#1)(2008-5#1)(2011-2#2)
coral family##2##2##(2008-6#2)
coral goby Gobiodon erythrospilus##2##4##(2010-8#2)
coral reef at##2##3##(2007-5#1)(2008-5#1)
coral reef bleaching##2##3##(2008-9#2)
coral reef environments##2##3##(2007-5#2)
coral reef##14##2##(2007-5#8)(2008-5#2)(2008-9#2)(2011-2#1)(2013-1#1)
coral reefs at##2##3##(2008-3#1)(2008-5#1)
coral reefs##10##2##(2007-5#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#3)
coral skeletal##2##2##(1992-7#1)(2013-8#1)
coral stones##2##2##(2008-1#2)
coral##58##1##(1992-7#3)(1993-2#1)(2007-5#18)(2008-1#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-9#4)(2010-5#1)(2010-8#3)(2011-2#9)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
coral-reef##3##1##(2010-8#3)
coralliilyticus/neptunius-like isolate##2##2##(2009-6#2)
corals##18##1##(1992-7#1)(2007-5#3)(2008-3#2)(2008-5#6)(2008-6#1)(2008-9#1)(2010-2#2)(2012-2#2)
cord after##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
cord and in##3##3##(1990-7#1)(1991-4#1)(2013-7#1)
cord and##28##2##(1990-11#2)(1990-7#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-12#1)(1994-8#2)(1995-12#2)(1996-12#1)(1996-2#2)(1996-5#2)(1997-6#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2009-3#1)(2013-7#1)(2013-8#1)
cord at##2##2##(2008-5#1)(2013-1#1)
cord blood CD34(+) cells##3##4##(2008-8#3)
cord blood HBV-DNA positive##3##4##(2011-1#3)
cord blood HBV-DNA##6##3##(2011-1#6)
cord blood and##4##3##(2008-11#2)(2008-9#1)(2013-1#1)
cord blood by##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
cord blood cells##3##3##(2008-11#3)
cord blood contains##2##3##(2008-11#1)(2008-9#1)
cord blood is##2##3##(2008-11#1)(2008-9#1)
cord blood samples##3##3##(2008-10#3)
cord blood transplantation##3##3##(2008-11#1)(2013-1#2)
cord blood unit##2##3##(2010-11#2)
cord blood units##2##3##(2010-11#2)
cord blood##59##2##(2007-2#1)(2008-10#5)(2008-11#19)(2008-4#2)(2008-8#5)(2008-9#9)(2010-11#4)(2010-7#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
cord clamping##4##2##(1993-2#3)(2010-5#1)
cord compression due to##2##4##(2009-3#1)(2012-3#1)
cord compression##44##2##(1991-9#2)(1992-12#4)(1993-9#1)(1996-9#5)(2007-11#11)(2007-5#1)(2008-10#1)(2008-12#1)(2008-6#6)(2008-7#8)(2009-3#2)(2012-3#2)
cord in##6##2##(1990-5#1)(1996-5#1)(2007-12#2)(2008-5#1)(2008-7#1)
cord injuries##10##2##(1991-6#3)(1992-6#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
cord injury is a##2##4##(2007-8#1)(2012-1#1)
cord injury##27##2##(1991-12#1)(1993-12#2)(1993-2#1)(1995-11#2)(2007-11#4)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#5)(2009-12#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#5)
cord is##5##2##(1992-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
cord of brachial plexus##2##4##(2008-7#2)
cord of the rat##2##4##(1991-1#1)(1991-4#1)
cord of the##5##3##(1991-1#1)(1991-4#1)(1995-5#1)(1996-5#1)(1997-2#1)
cord of##13##2##(1991-1#1)(1991-4#1)(1993-12#1)(1995-5#1)(1996-5#1)(1997-2#4)(1997-3#1)(2008-7#3)
cord palsy##3##2##(2008-8#1)(2009-7#1)(2010-7#1)
cord plasma##2##2##(1990-12#1)(1995-8#1)
cord signal changes##2##3##(2012-12#2)
cord signal##4##2##(2012-12#4)
cord stricture##2##2##(2008-11#2)
cord was##4##2##(1996-5#1)(2008-5#2)(2010-11#1)
cord were##4##2##(1991-5#1)(1993-12#1)(1995-3#1)(2008-7#1)
cord##436##1##(1990-11#3)(1990-12#1)(1990-5#4)(1990-7#4)(1991-1#2)(1991-12#1)(1991-4#3)(1991-5#5)(1991-6#7)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#5)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#12)(1993-2#5)(1993-5#2)(1993-6#1)(1993-9#3)(1994-2#1)(1994-3#2)(1994-8#5)(1995-11#4)(1995-12#8)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-12#5)(1996-2#8)(1996-5#14)(1996-9#6)(1997-2#11)(1997-3#5)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#21)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#29)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#12)(2008-6#11)(2008-7#48)(2008-8#6)(2008-9#13)(2009-11#1)(2009-12#3)(2009-3#5)(2009-5#1)(2009-7#1)(2009-8#7)(2010-11#8)(2010-12#5)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#10)(2011-2#6)(2011-8#1)(2012-1#2)(2012-12#9)(2012-2#4)(2012-3#8)(2013-1#15)(2013-7#1)(2013-8#6)
cord)##2##1##(1990-11#1)(1991-4#1)
cord-blood##2##1##(2012-2#2)
cordata Thunb##3##2##(2008-10#3)
cordata##6##1##(2008-10#6)
cordectomy##2##1##(2012-2#2)
cordifolia##8##1##(2010-5#3)(2012-2#5)
cordis##2##1##(2012-3#1)(2013-8#1)
cords of##3##2##(1993-8#1)(1995-12#1)(2007-12#1)
cords##24##1##(1990-5#1)(1990-6#1)(1993-8#1)(1995-12#1)(2007-12#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#2)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)
core and a##5##3##(1995-2#1)(2007-11#3)(2013-1#1)
core and cladding modes##2##4##(2007-12#1)(2008-3#1)
core and the##4##3##(1991-9#1)(1994-8#1)(2008-3#1)(2008-5#1)
core and to##2##3##(1994-3#1)(2010-6#1)
core and##26##2##(1990-2#1)(1991-9#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-7#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-9#1)(2013-1#2)
core antigen##3##2##(1995-5#1)(1996-12#1)(2006-10#1)
core binding factor I (Cbfa I)##2##6##(2008-11#2)
core binding factor##3##3##(2008-11#2)(2011-2#1)
core binding##4##2##(1993-2#1)(2008-11#2)(2011-2#1)
core biopsy##4##2##(2010-11#1)(2011-2#2)(2012-2#1)
core body temperature##2##3##(2007-10#1)(2008-8#1)
core can be##2##3##(2008-3#1)(2008-7#1)
core clinical skills##2##3##(2008-12#2)
core coding region##2##3##(2013-1#2)
core competencies##4##2##(1994-2#3)(2008-1#1)
core competency##2##2##(1997-3#1)(2007-10#1)
core component##2##2##(1996-12#1)(2011-1#1)
core components of the##2##4##(2010-5#1)(2011-1#1)
core consists of##2##3##(1995-2#1)(1995-3#1)
core curriculum##4##2##(1991-11#1)(1992-1#1)(2012-2#2)
core diameter##2##2##(2007-11#1)(2008-3#1)
core fiber##2##2##(2007-12#1)(2008-3#1)
core formation##2##2##(2008-10#1)(2010-12#1)
core from##2##2##(1991-8#1)(1992-3#1)
core functions of public health##4##5##(1995-12#2)(1996-1#1)(1996-3#1)
core functions##13##2##(1995-12#4)(1996-1#1)(1996-2#2)(1996-3#3)(1997-2#2)(2009-10#1)
core genome##2##2##(2011-2#2)
core have##2##2##(2010-1#1)(2010-6#1)
core in a##2##3##(1991-8#1)(2008-10#1)
core in##3##2##(1991-8#1)(1992-3#1)(2008-10#1)
core is##2##2##(2007-12#1)(2008-8#1)
core ischemic##2##2##(1997-2#2)
core layer##2##2##(2007-12#2)
core like particles##2##3##(1996-12#2)
core mannose)##2##2##(1993-11#2)
core material (Spinell or Alumina)##2##5##(2009-8#2)
core material##5##2##(1995-6#1)(2009-8#4)
core matrix##4##2##(2008-4#3)(2009-11#1)
core microcapsules##6##2##(2008-11#6)
core mode and the##3##4##(2008-3#3)
core mode and##5##3##(2007-12#1)(2008-3#4)
core modes and cladding modes in##2##6##(2008-3#2)
core modes##3##2##(2008-3#3)
core motif##2##2##(1992-3#1)(1997-2#1)
core of a##5##3##(1991-2#1)(1997-2#2)(2008-3#1)(2012-2#1)
core of the molecule##2##4##(1992-6#1)(1994-6#1)
core of the protein##2##4##(1994-5#1)(1995-5#1)
core of the##27##3##(1992-6#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
core of##67##2##(1990-3#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-8#1)
core part##4##2##(1994-8#4)
core particle##2##2##(1995-2#1)(1996-12#1)
core peptide##2##2##(1993-1#1)(1995-2#1)
core processes##2##2##(1995-2#1)(1996-2#1)
core promoter##5##2##(1995-2#2)(2008-4#1)(2012-2#1)(2013-1#1)
core protein##16##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-1#2)(1994-9#1)(1995-5#1)(1997-4#1)(2008-11#2)(2008-8#6)
core proteins##3##2##(1990-5#1)(1997-9#1)(2008-5#1)
core public health functions##4##4##(1996-2#3)(1996-3#1)
core public health##7##3##(1995-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)
core region##9##2##(1991-2#1)(1995-2#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)
core sample##2##2##(2011-1#1)(2011-2#1)
core samples##7##2##(2008-10#2)(2008-5#1)(2011-1#3)(2013-7#1)
core sequence##5##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
core services##2##2##(1994-12#1)(1997-3#1)
core set of##3##3##(2008-10#2)(2011-2#1)
core structure##3##2##(1994-5#1)(2008-11#1)(2010-2#1)
core temperature##12##2##(1992-3#3)(2007-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2010-7#1)(2011-2#1)
core thickness##2##2##(2007-11#1)(2007-12#1)
core to##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
core values and##2##3##(1995-12#2)
core values##4##2##(1995-12#4)
core waveguide##8##2##(2007-11#1)(2008-10#7)
core with a##2##3##(2008-2#1)(2010-2#1)
core with##5##2##(2007-11#2)(2008-2#1)(2009-8#1)(2010-2#1)
core##495##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-12#1)(1992-3#12)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#11)(1994-9#1)(1995-12#10)(1995-2#14)(1995-3#5)(1995-5#5)(1995-6#3)(1996-1#2)(1996-12#7)(1996-2#12)(1996-3#6)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#5)(1997-4#3)(1997-7#2)(1997-9#2)(2006-10#1)(2007-10#4)(2007-11#14)(2007-12#18)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#45)(2008-11#23)(2008-12#8)(2008-2#16)(2008-3#28)(2008-4#8)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#23)(2008-9#4)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#7)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#12)(2011-2#9)(2012-1#1)(2012-2#10)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#3)
core&quot##4##1##(1993-11#1)(1995-3#1)(2008-4#1)(2009-10#1)
core)##3##1##(1992-3#1)(1994-3#1)(2010-6#1)
core-doped rod##2##2##(2008-2#2)
core-doped##4##1##(2008-2#4)
core-like particles##2##2##(1997-4#2)
core-needle biopsy##3##2##(2007-8#1)(2012-2#2)
core-shell structure##2##2##(2009-9#1)(2013-1#1)
core-shell##9##1##(2007-11#1)(2007-12#1)(2008-10#5)(2009-9#1)(2013-1#1)
core/shell particles##2##2##(2008-11#2)
core/shell##3##1##(2008-11#2)(2008-7#1)
coregistered##2##1##(2008-3#1)(2009-2#1)
coregulated##2##1##(2008-4#1)(2009-3#1)
cores from##2##2##(2008-10#1)(2013-8#1)
cores of the##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
cores of##10##2##(1990-5#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-8#1)
cores were taken##2##3##(2008-10#1)(2013-8#1)
cores were##5##2##(2008-10#2)(2010-12#1)(2013-8#2)
cores##38##1##(1990-5#1)(1991-12#1)(1992-3#1)(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-7#2)(2013-8#4)
coriacea##5##1##(2007-5#1)(2013-7#4)
corkscrew-shaped vessels##2##2##(1997-8#2)
corms of##3##2##(2008-10#3)
corms##4##1##(2008-10#3)(2008-12#1)
corn (Zea mays L##2##4##(2008-10#2)
corn (Zea mays)##3##3##(2008-10#3)
corn (Zea##5##2##(2008-10#5)
corn also##2##2##(2008-10#1)(2009-4#1)
corn and soybean##4##3##(2008-10#3)(2011-2#1)
corn and##9##2##(2007-11#1)(2008-10#7)(2011-2#1)
corn borer##8##2##(1995-6#2)(2008-10#2)(2008-7#2)(2011-2#2)
corn crops##2##2##(2008-10#2)
corn fiber oil##3##3##(2008-6#3)
corn fiber##11##2##(2008-11#1)(2008-6#8)(2013-1#2)
corn flea beetles ranged from 0##2##6##(2008-10#2)
corn flea beetles##7##3##(2008-10#7)
corn flea##8##2##(2008-10#8)
corn genotypes##4##2##(2008-10#4)
corn grain##2##2##(2008-10#1)(2011-2#1)
corn grits and green coffee beans ranged##2##7##(2008-10#2)
corn grits##4##2##(2008-10#4)
corn in##2##2##(2008-10#1)(2011-2#1)
corn kernels##5##2##(2008-10#5)
corn lines##2##2##(2008-10#2)
corn meal agar##3##3##(2008-10#2)(2008-5#1)
corn oil and##3##3##(1990-7#2)(2008-10#1)
corn oil##16##2##(1990-7#3)(2008-10#5)(2008-3#2)(2008-9#4)(2009-5#1)(2013-1#1)
corn plants##3##2##(2008-10#2)(2011-2#1)
corn plots##2##2##(2008-10#2)
corn price volatility##4##3##(2012-12#4)
corn rootworm##7##2##(2008-10#1)(2011-2#6)
corn rust##2##2##(2008-10#2)
corn starch##2##2##(2008-5#2)
corn steep liquor##3##3##(2008-6#1)(2008-7#2)
corn steep##4##2##(2008-6#1)(2008-7#2)(2013-1#1)
corn stover##4##2##(2008-6#1)(2011-2#2)(2013-1#1)
corn syrup##2##2##(1997-4#1)(2008-10#1)
corn trypsin inhibitor##2##3##(2008-10#2)
corn##188##1##(1990-7#3)(1995-3#1)(1995-6#2)(1997-4#1)(2007-11#2)(2008-10#107)(2008-11#2)(2008-3#2)(2008-5#5)(2008-6#12)(2008-7#4)(2008-8#2)(2008-9#4)(2009-4#2)(2009-5#1)(2009-8#1)(2011-2#26)(2012-12#5)(2012-2#1)(2013-1#5)
corn) was##2##2##(2008-10#1)(2011-2#1)
corn)##4##1##(2008-10#2)(2008-6#1)(2011-2#1)
corn-barley-soybean##2##1##(2010-2#2)
corn-growing season##2##2##(2008-10#2)
corn-growing##3##1##(2008-10#2)(2012-12#1)
corn-soybean##3##1##(2008-10#1)(2010-2#2)
cornea are##2##2##(2008-3#1)(2010-1#1)
cornea in a##2##3##(2007-11#1)(2013-1#1)
cornea in##4##2##(2007-11#1)(2007-12#1)(2011-1#1)(2013-1#1)
cornea retention##4##2##(2011-3#4)
cornea##44##1##(1993-12#1)(1997-3#2)(2007-11#1)(2007-12#3)(2008-11#4)(2008-3#3)(2008-4#5)(2008-7#2)(2008-9#2)(2009-7#4)(2010-1#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#5)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
corneal endothelial cell##2##3##(2011-2#1)(2013-1#1)
corneal endothelial cells##3##3##(2008-11#2)(2011-2#1)
corneal endothelial##6##2##(2008-11#3)(2011-2#2)(2013-1#1)
corneal epithelia##2##2##(2008-11#2)
corneal epithelium##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
corneal lesions##2##2##(1991-8#1)(2007-7#1)
corneal opacities##2##2##(2007-7#1)(2011-1#1)
corneal scar##2##2##(2010-8#1)(2012-3#1)
corneal stroma##2##2##(2007-11#1)(2008-2#1)
corneal surface##6##2##(2009-7#2)(2010-10#1)(2011-1#2)(2011-7#1)
corneal thickness measurements##2##3##(2011-2#1)(2012-12#1)
corneal thickness##4##2##(2011-1#1)(2011-2#2)(2012-12#1)
corneal topography##2##2##(2008-3#2)
corneal transplantation##4##2##(2010-1#2)(2011-1#1)(2013-1#1)
corneal##78##1##(1991-8#1)(1993-12#1)(2007-11#3)(2007-7#3)(2008-11#7)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#4)(2009-4#1)(2009-7#2)(2010-1#2)(2010-10#8)(2010-8#2)(2011-1#6)(2011-2#16)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#3)(2013-1#4)
corneas##4##1##(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
corneocyte envelope##2##2##(2008-5#2)
corneocyte keratin##3##2##(2008-5#3)
corneocyte##11##1##(2008-5#11)
corneocytes on the##2##3##(2008-5#2)
corneocytes##22##1##(2008-5#21)(2011-2#1)
corneodesmolysis##4##1##(2008-5#4)
corneodesmosomal##3##1##(2008-5#3)
corneodesmosomes##5##1##(2008-5#5)
corneometer##7##1##(2008-5#7)
corneosomes##2##1##(2008-5#2)
corneosurfametry##3##1##(2008-5#3)
corneous##2##1##(2011-2#2)
corner and##2##2##(2008-2#1)(2010-3#1)
corner injuries of the knee##2##5##(2012-2#2)
corner injuries of the##3##4##(2012-2#3)
corner injuries##4##2##(2012-2#4)
corner of the##4##3##(1990-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
corner of##7##2##(1990-3#1)(2008-10#2)(2008-8#2)(2011-2#1)(2012-2#1)
corner##23##1##(1990-3#1)(1996-4#1)(1996-5#1)(2007-4#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#6)(2013-1#1)
corners of the##2##3##(2008-10#1)(2008-4#1)
corners##5##1##(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#2)
cornerstone of##19##2##(1991-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
cornerstone##20##1##(1991-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
cornerstones of##6##2##(1994-7#1)(1997-3#2)(2008-10#1)(2008-3#1)(2011-2#1)
cornerstones##8##1##(1994-7#1)(1995-1#1)(1997-3#2)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
corneum (SC) lipid##2##3##(2008-10#1)(2008-5#1)
corneum (SC)##10##2##(2008-10#1)(2008-5#9)
corneum barrier##3##2##(2008-5#3)
corneum cohesion##2##2##(2008-5#2)
corneum keratin##2##2##(2008-5#2)
corneum##129##1##(1992-8#2)(2008-10#3)(2008-5#119)(2010-8#2)(2012-2#3)
corneum)##2##1##(2008-5#2)
cornified envelope##2##2##(1994-3#1)(2008-5#1)
cornified##6##1##(1994-3#1)(2008-5#4)(2011-2#1)
cornmeal agar##4##2##(2008-10#4)
cornstarch and waxy cornstarch##2##4##(2007-11#2)
cornstarch##4##1##(2007-11#4)
cornuarietis##7##1##(2008-11#7)
corollary is##2##2##(1991-5#1)(2009-8#1)
corollary##3##1##(1991-5#1)(2008-7#1)(2009-8#1)
corona discharge ion mobility spectrometry##4##5##(2008-10#4)
corona discharge##5##2##(2008-10#5)
corona discharges##2##2##(2008-3#2)
corona radiata infarcts##4##3##(2007-10#4)
corona radiata##9##2##(2007-10#7)(2008-12#1)(2008-7#1)
corona was##2##2##(2008-2#2)
corona##24##1##(2007-10#7)(2008-10#5)(2008-12#1)(2008-2#7)(2008-3#3)(2008-7#1)
coronagraph##6##1##(2007-11#4)(2008-3#2)
coronal and root caries##2##4##(2008-1#1)(2008-5#1)
coronal and##4##2##(1995-5#1)(2008-1#1)(2008-5#1)(2013-1#1)
coronal harmony##3##2##(2009-12#3)
coronal laxity testing##2##3##(2013-1#2)
coronal##26##1##(1995-5#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#3)(2011-2#1)(2013-1#11)(2013-8#1)
coronally##2##1##(2013-1#2)
coronaria ischaemia##2##2##(2008-10#2)
coronarography##2##1##(2008-4#1)(2013-8#1)
coronary anatomy##2##2##(2008-10#1)(2012-2#1)
coronary and peripheral##2##3##(2011-2#1)(2013-8#1)
coronary and##5##2##(2007-8#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
coronary aneurysm with##2##3##(2007-8#1)(2008-11#1)
coronary aneurysm##4##2##(2007-8#1)(2008-11#3)
coronary angiography and angioplasty##2##4##(2011-2#2)
coronary angiography and interventions##2##4##(2011-2#2)
coronary angiography and##8##3##(1992-9#1)(2008-3#1)(2009-10#1)(2011-2#5)
coronary angiography for the##2##4##(2009-4#1)(2011-2#1)
coronary angiography for##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
coronary angiography showed##2##3##(2007-8#1)(2013-1#1)
coronary angiography to##2##3##(2008-7#1)(2009-11#1)
coronary angiography##39##2##(1992-4#1)(1992-9#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-3#3)(2008-7#6)(2009-10#3)(2009-11#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#9)(2012-2#1)(2013-1#1)
coronary angioplasty (PTCA) is a##2##5##(1992-9#1)(1996-8#1)
coronary angioplasty (PTCA)##12##3##(1992-4#1)(1992-9#1)(1994-11#2)(1996-8#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-5#2)(2008-7#1)(2013-8#1)
coronary angioplasty in##2##3##(2007-8#1)(2008-3#1)
coronary angioplasty##28##2##(1992-4#2)(1992-9#2)(1993-12#1)(1994-11#3)(1995-2#1)(1995-8#1)(1996-8#1)(2006-8#1)(2007-10#2)(2007-8#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2013-8#1)
coronary arterial bypass grafting?##2##4##(2007-8#2)
coronary arterial##7##2##(1992-11#1)(1994-11#1)(2007-8#2)(2011-2#1)(2013-1#1)(2013-2#1)
coronary arteries and##4##3##(1994-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
coronary arteries in conditions of ischemic heart##2##7##(2012-3#2)
coronary arteries in##4##3##(2008-7#1)(2012-3#3)
coronary arteries is##2##3##(1997-8#1)(2008-7#1)
coronary arteries were##4##3##(1994-11#1)(2007-8#1)(2012-3#2)
coronary arteries##43##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-9#2)(1994-11#8)(1997-8#2)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#3)(2009-5#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#7)(2013-7#1)
coronary arteriography##2##2##(1991-9#1)(1996-6#1)
coronary arteriovenous fistula##3##3##(2007-8#2)(2012-2#1)
coronary artery and##4##3##(2008-1#1)(2008-3#1)(2013-2#1)(2013-8#1)
coronary artery aneurysm (CAA)##2##4##(2007-8#1)(2010-5#1)
coronary artery aneurysm##4##3##(2007-2#1)(2007-8#1)(2007-9#1)(2010-5#1)
coronary artery aneurysms##2##3##(2008-11#1)(2011-2#1)
coronary artery arising from the##2##5##(2007-8#1)(2010-5#1)
coronary artery arising from##3##4##(2007-8#1)(2010-5#2)
coronary artery bypass graft (CABG) surgery##2##6##(1994-12#1)(2007-11#1)
coronary artery bypass graft (CABG)##3##5##(1994-12#1)(2007-11#1)(2008-12#1)
coronary artery bypass graft surgery##8##5##(1994-2#1)(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2012-12#1)
coronary artery bypass graft##14##4##(1992-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-11#2)(2008-12#1)(2012-12#1)
coronary artery bypass grafting (CABG)##8##5##(2006-8#1)(2007-8#5)(2010-8#1)(2013-1#1)
coronary artery bypass grafting and##2##5##(2007-8#2)
coronary artery bypass grafting on##2##5##(2007-8#2)
coronary artery bypass grafting or##2##5##(2007-8#2)
coronary artery bypass grafting##48##4##(1993-12#1)(2006-8#1)(2007-8#34)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#1)
coronary artery bypass grafts##3##4##(2007-8#1)(2011-2#2)
coronary artery bypass surgery can##2##5##(1990-2#1)(2007-8#1)
coronary artery bypass surgery##12##4##(1990-2#1)(2006-10#1)(2006-6#1)(2007-8#4)(2008-11#3)(2010-8#1)(2012-12#1)
coronary artery bypass##86##3##(1990-2#2)(1992-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#45)(2007-9#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-8#2)(2010-8#5)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)
coronary artery disease (CAD) is##2##5##(2008-12#1)(2012-3#1)
coronary artery disease (CAD)##16##4##(1991-8#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#3)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
coronary artery disease (n =##2##5##(2008-11#2)
coronary artery disease and a##2##5##(2007-9#1)(2008-10#1)
coronary artery disease and##7##4##(1990-3#1)(2007-5#1)(2007-9#2)(2008-10#1)(2010-11#1)(2011-2#1)
coronary artery disease are##3##4##(2008-11#2)(2008-7#1)
coronary artery disease in##6##4##(1996-3#1)(2008-3#1)(2010-12#1)(2013-1#2)(2013-7#1)
coronary artery disease mortality##3##4##(2010-2#3)
coronary artery disease with##3##4##(1993-12#1)(2008-11#1)(2010-5#1)
coronary artery disease##108##3##(1990-12#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#1)(1994-11#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#10)(2008-12#3)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#3)(2010-11#2)(2010-12#2)(2010-2#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#8)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
coronary artery disease]##2##3##(2008-9#1)(2013-8#1)
coronary artery diseases##3##3##(2007-8#1)(2008-1#1)(2010-8#1)
coronary artery from the pulmonary##2##5##(2008-12#1)(2013-8#1)
coronary artery from the##3##4##(2007-8#1)(2008-12#1)(2013-8#1)
coronary artery in##2##3##(2008-11#1)(2013-8#1)
coronary artery lesion in##2##4##(1997-8#1)(2013-1#1)
coronary artery lesion##4##3##(1991-11#1)(1997-8#2)(2013-1#1)
coronary artery lesions in patients##2##5##(2008-11#1)(2008-3#1)
coronary artery lesions##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
coronary artery spasm and##2##4##(2008-7#2)
coronary artery spasm##5##3##(2007-8#1)(2008-7#4)
coronary artery stenoses##2##3##(2008-3#1)(2012-2#1)
coronary artery stenosis##7##3##(1994-11#2)(2009-10#1)(2009-12#1)(2011-2#2)(2013-1#1)
coronary artery stenosis]##2##3##(2008-7#1)(2013-1#1)
coronary artery stenting##2##3##(2010-12#1)(2011-2#1)
coronary artery surgery##5##3##(1994-9#1)(2007-8#2)(2008-12#2)
coronary artery to##2##3##(1992-9#1)(2007-8#1)
coronary artery was##2##3##(2008-4#1)(2008-7#1)
coronary artery with##2##3##(2007-8#1)(2008-12#1)
coronary artery##310##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-8#2)(1992-9#3)(1993-12#5)(1993-2#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#5)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#75)(2007-9#5)(2008-1#4)(2008-10#3)(2008-11#22)(2008-12#14)(2008-3#12)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#4)(2008-9#1)(2009-10#3)(2009-12#2)(2009-4#4)(2010-11#2)(2010-12#3)(2010-2#4)(2010-5#5)(2010-8#7)(2010-9#1)(2011-1#1)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#15)(2013-2#4)(2013-7#2)(2013-8#7)
coronary atherosclerosis##7##2##(1995-12#2)(2008-10#1)(2008-3#1)(2008-7#3)
coronary bifurcation##2##2##(2008-11#1)(2013-1#1)
coronary blood flow##3##3##(2008-7#3)
coronary bypass grafting##3##3##(1991-9#1)(2007-8#1)(2013-1#1)
coronary bypass operations##2##3##(1991-8#1)(2008-10#1)
coronary bypass patients##4##3##(1995-12#3)(2007-8#1)
coronary bypass surgery with extracorporeal##2##5##(2012-3#2)
coronary bypass surgery##10##3##(1995-12#1)(1995-3#1)(1996-9#3)(2007-8#1)(2008-3#1)(2012-3#3)
coronary bypass##24##2##(1991-8#1)(1991-9#1)(1995-12#4)(1995-3#2)(1996-9#4)(2007-8#5)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#3)(2013-1#1)
coronary care unit##3##3##(2008-3#2)(2012-2#1)
coronary care##5##2##(2007-8#2)(2008-3#2)(2012-2#1)
coronary circulation##3##2##(1990-8#1)(1994-11#2)
coronary disease and##3##3##(1995-11#1)(2007-8#2)
coronary disease##17##2##(1991-11#1)(1992-5#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-8#1)(2007-8#4)(2008-3#1)(2008-5#1)(2011-2#2)(2013-1#1)
coronary disease]##2##2##(1994-11#1)(1996-8#1)
coronary endothelial function##2##3##(2008-7#1)(2012-3#1)
coronary endothelial##3##2##(1992-9#1)(2008-7#1)(2012-3#1)
coronary events##7##2##(1990-5#2)(1992-6#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
coronary flow##10##2##(1992-6#1)(1995-3#1)(1996-9#1)(2007-8#2)(2008-12#1)(2008-4#4)
coronary heart disease (CHD)##10##4##(1990-3#1)(1993-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
coronary heart disease and the##2##5##(2008-12#1)(2008-7#1)
coronary heart disease and##9##4##(1993-12#3)(1993-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
coronary heart disease in##6##4##(1995-11#1)(1996-3#1)(1996-8#2)(2008-12#2)
coronary heart disease is##4##4##(1991-2#1)(1991-6#1)(1993-2#1)(2008-4#1)
coronary heart disease risk##4##4##(1991-6#2)(2009-12#1)(2012-2#1)
coronary heart disease##80##3##(1990-3#3)(1990-8#3)(1991-12#2)(1991-2#1)(1991-6#5)(1991-8#1)(1992-5#1)(1992-6#2)(1993-12#4)(1993-2#4)(1995-11#1)(1996-3#2)(1996-8#2)(2007-10#1)(2008-1#2)(2008-11#3)(2008-12#8)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)
coronary heart diseases##2##3##(1995-12#1)(2013-1#1)
coronary heart##85##2##(1990-3#3)(1990-8#3)(1991-12#2)(1991-2#1)(1991-6#5)(1991-8#1)(1992-5#1)(1992-6#2)(1993-12#4)(1993-2#4)(1994-11#1)(1995-11#1)(1995-12#1)(1996-3#3)(1996-8#2)(2007-10#1)(2008-1#2)(2008-11#3)(2008-12#8)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)
coronary imaging##2##2##(2009-10#1)(2010-8#1)
coronary intensive care##2##3##(2007-7#1)(2012-3#1)
coronary intervention (PCI)##7##3##(2008-11#1)(2008-3#3)(2013-1#2)(2013-8#1)
coronary intervention and##2##3##(2008-3#1)(2009-12#1)
coronary intervention##33##2##(2008-11#2)(2008-3#12)(2008-7#1)(2009-10#1)(2009-12#3)(2009-5#4)(2011-2#4)(2013-1#4)(2013-8#2)
coronary interventionism##3##2##(2008-10#3)
coronary interventions in the United States##2##6##(2011-2#2)
coronary interventions in##3##3##(2009-12#1)(2011-2#2)
coronary interventions##10##2##(2008-11#2)(2009-12#1)(2010-8#1)(2011-2#6)
coronary lesion##3##2##(2008-11#1)(2009-7#1)(2011-2#1)
coronary lesions##3##2##(2007-8#1)(2008-11#1)(2010-12#1)
coronary mortality and SCD##3##4##(2009-9#3)
coronary mortality and##4##3##(1992-8#1)(2009-9#3)
coronary mortality was##2##3##(2009-9#2)
coronary mortality##9##2##(1992-8#1)(2009-9#7)(2012-2#1)
coronary occlusion##3##2##(1990-12#1)(1995-12#1)(2008-4#1)
coronary operations##2##2##(2008-10#2)
coronary ostium##3##2##(2007-8#2)(2009-11#1)
coronary oxygen persufflation##5##3##(2007-8#5)
coronary plaque##2##2##(2008-7#1)(2009-5#1)
coronary plaques##4##2##(2007-11#1)(2008-7#2)(2009-4#1)
coronary procedures##5##2##(2011-2#5)
coronary revascularisation##2##2##(2007-8#2)
coronary revascularization in patients with##2##5##(2007-8#1)(2012-3#1)
coronary revascularization##17##2##(1996-9#3)(2007-8#5)(2008-10#4)(2008-12#2)(2008-5#2)(2012-3#1)
coronary risk factors##4##3##(1991-3#1)(2007-8#1)(2008-2#1)(2010-7#1)
coronary risk##8##2##(1991-3#1)(1993-2#1)(2006-10#1)(2007-8#1)(2008-2#1)(2009-4#2)(2010-7#1)
coronary score##2##2##(2008-3#2)
coronary sinus##6##2##(2007-8#1)(2010-5#1)(2012-2#3)(2013-1#1)
coronary spasm##6##2##(1991-3#1)(1994-11#1)(2007-8#1)(2008-7#3)
coronary stenosis##2##2##(1990-9#1)(2008-3#1)
coronary stent##9##2##(2008-7#3)(2010-5#1)(2011-2#5)
coronary stents##3##2##(2009-7#1)(2011-2#1)(2012-3#1)
coronary surgery##7##2##(2007-8#5)(2013-8#2)
coronary surgery]##2##2##(1997-3#1)(2013-8#1)
coronary syndrome (ACS)##2##3##(2010-4#1)(2012-2#1)
coronary syndrome##51##2##(2008-10#3)(2008-11#9)(2008-3#22)(2008-5#1)(2008-7#3)(2009-10#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-2#6)(2012-2#1)(2013-8#1)
coronary syndromes##52##2##(2008-10#3)(2008-11#1)(2008-3#34)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#5)
coronary syndromes]##5##2##(2008-10#5)
coronary system##3##2##(2007-8#3)
coronary targets##2##2##(2007-8#1)(2010-8#1)
coronary vascular smooth muscle cells##3##5##(1990-8#2)(1994-11#1)
coronary vasoconstriction##3##2##(1991-9#2)(2008-7#1)
coronary vasodilation##2##2##(2008-7#1)(2009-4#1)
coronary vasospasm##2##2##(1992-9#1)(2008-7#1)
coronary vessels##5##2##(1990-2#1)(2008-7#2)(2009-5#1)(2012-3#1)
coronary##986##1##(1990-12#3)(1990-2#4)(1990-3#4)(1990-5#2)(1990-8#7)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#5)(1991-6#5)(1991-8#3)(1991-9#6)(1992-11#2)(1992-4#6)(1992-5#4)(1992-6#5)(1992-8#3)(1992-9#12)(1993-12#10)(1993-2#6)(1993-3#1)(1994-11#24)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#3)(1995-12#11)(1995-2#3)(1995-3#5)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-6#2)(1996-8#6)(1996-9#10)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#9)(2006-10#3)(2006-6#1)(2006-8#2)(2007-10#4)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#140)(2007-9#5)(2008-1#6)(2008-10#40)(2008-11#51)(2008-12#30)(2008-2#1)(2008-3#103)(2008-4#19)(2008-5#11)(2008-6#3)(2008-7#56)(2008-8#8)(2008-9#2)(2009-10#14)(2009-11#3)(2009-12#12)(2009-4#10)(2009-5#7)(2009-7#3)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#12)(2010-6#3)(2010-7#1)(2010-8#12)(2010-9#4)(2011-1#1)(2011-2#85)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#25)(2012-3#29)(2013-1#28)(2013-2#6)(2013-7#3)(2013-8#18)
coronary-artery##2##1##(1992-6#1)(1996-2#1)
coronas##3##1##(2008-11#2)(2008-2#1)
coronata f##3##2##(2008-10#3)
coronata from Israel##2##3##(2008-10#2)
coronata from##3##2##(2008-10#3)
coronata in##2##2##(2008-10#2)
coronata on##2##2##(2008-10#2)
coronata var##3##2##(2008-10#3)
coronata##15##1##(2008-10#15)
coronatine gene expression##2##3##(2008-10#2)
coronatine##5##1##(2008-10#5)
coronatus##3##1##(1997-4#2)(2008-5#1)
coronavirus##5##1##(1997-3#1)(2007-6#1)(2007-7#2)(2009-7#1)
coronoid process##5##2##(1991-2#1)(2008-7#2)(2011-2#1)(2012-3#1)
coronoid##6##1##(1991-2#1)(2008-7#2)(2011-2#2)(2012-3#1)
coronoid-maxillary space##3##2##(1991-2#3)
corpora allata (CA)##2##3##(1995-11#1)(2008-7#1)
corpora allata##4##2##(1995-11#2)(2008-7#2)
corpora cavernosa##5##2##(2008-10#4)(2008-7#1)
corpora lutea (CL)##2##3##(2008-8#1)(2008-9#1)
corpora lutea##9##2##(1992-3#2)(1992-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(2008-8#2)(2008-9#1)
corpora##23##1##(1991-12#1)(1992-3#2)(1992-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-7#4)(2008-8#2)(2008-9#2)(2010-12#1)
corporal punishment##2##2##(1995-5#1)(2008-11#1)
corporal##5##1##(1990-3#1)(1995-5#1)(2008-11#1)(2008-9#1)(2013-8#1)
corporate and##2##2##(1993-2#1)(1997-1#1)
corporate identity##3##2##(2008-12#3)
corporate responsibility##2##2##(1991-1#1)(1991-2#1)
corporate visual identity##2##3##(2008-12#2)
corporate##36##1##(1990-4#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-3#1)(1993-1#2)(1993-12#2)(1993-2#1)(1994-3#1)(1995-12#1)(1995-3#3)(1997-1#2)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#5)(2009-10#1)(2012-2#1)(2013-1#1)
corporation to##2##2##(1993-3#1)(2008-12#1)
corporation##7##1##(1992-2#1)(1993-12#1)(1993-3#2)(1995-3#1)(2007-3#1)(2008-12#1)
corporations##9##1##(1992-11#1)(1993-3#2)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-3#1)(2008-10#1)
corporeal##4##1##(1993-12#1)(2007-6#1)(2008-1#2)
corporis gladiatorum presenting as a##2##5##(2012-3#2)
corporis gladiatorum##3##2##(2012-3#3)
corporis##9##1##(2007-7#4)(2008-5#2)(2012-3#3)
corpse##2##1##(1995-2#1)(2008-10#1)
corpses##8##1##(1995-2#2)(1995-3#1)(1995-6#2)(2008-10#1)(2008-6#1)(2013-1#1)
corpus allatum##2##2##(1995-11#2)
corpus and cauda##3##3##(1992-3#2)(2008-12#1)
corpus and##4##2##(1992-3#2)(1993-12#1)(2008-12#1)
corpus callosum##22##2##(1996-12#1)(1996-2#1)(1996-5#7)(2008-6#1)(2008-7#6)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)
corpus cardiacum##2##2##(1992-12#2)
corpus cavernosum##3##2##(2009-5#2)(2012-3#1)
corpus epididymal##2##2##(1992-3#1)(2008-12#1)
corpus luteum (CL)##2##3##(1994-11#1)(2008-9#1)
corpus luteum##10##2##(1992-11#1)(1992-9#1)(1994-11#1)(1994-6#2)(1995-12#1)(2008-4#1)(2008-9#2)(2010-3#1)
corpus of##5##2##(1994-1#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-8#1)
corpus spongiosum##3##2##(2009-5#2)(2013-1#1)
corpus striatum##4##2##(1992-7#1)(1997-2#2)(2012-3#1)
corpus##67##1##(1992-11#1)(1992-12#2)(1992-3#4)(1992-7#1)(1992-9#1)(1993-12#3)(1994-1#1)(1994-11#1)(1994-6#2)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#7)(1997-1#1)(1997-2#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#1)(2009-5#4)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
corpuscles##5##1##(1990-11#2)(2008-12#1)(2010-7#1)(2013-1#1)
correct answers##6##2##(1993-12#2)(1993-2#1)(1996-9#1)(2008-12#1)(2013-8#1)
correct assessment of##2##3##(1991-3#1)(2010-5#1)
correct classification of##2##3##(2008-10#1)(2012-3#1)
correct classification rate was##2##4##(2008-10#1)(2013-8#1)
correct classification rate##3##3##(1994-2#1)(2008-10#1)(2013-8#1)
correct classification##9##2##(1994-2#1)(2007-7#1)(2008-10#5)(2012-3#1)(2013-8#1)
correct classifications##2##2##(2008-10#2)
correct conformation##2##2##(1995-8#1)(2008-1#1)
correct determination of the##2##4##(1990-8#1)(2012-12#1)
correct determination of##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
correct diagnosis and adequate treatment##2##5##(1990-9#1)(2010-11#1)
correct diagnosis and##7##3##(1990-9#1)(1991-3#1)(2007-12#2)(2010-11#1)(2011-2#1)(2012-3#1)
correct diagnosis of the##3##4##(1991-2#1)(2010-10#1)(2013-1#1)
correct diagnosis of##7##3##(1991-2#1)(2007-7#1)(2008-6#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-1#1)
correct diagnosis was##3##3##(1990-12#1)(1997-5#1)(2008-6#1)
correct diagnosis##32##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1995-1#1)(1997-5#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-6#2)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
correct dosage##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
correct evaluation of the##2##4##(1990-8#1)(2007-8#1)
correct for the effect of##2##5##(2008-2#2)
correct for the##9##3##(1991-3#1)(2008-11#1)(2008-2#3)(2008-3#4)
correct for##22##2##(1991-3#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#8)(2009-8#1)(2011-1#1)
correct identification of##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
correct identification##5##2##(2008-10#2)(2008-6#1)(2010-12#1)(2013-1#1)
correct images##2##2##(2008-9#1)(2010-8#1)
correct in##2##2##(1990-11#1)(2008-11#1)
correct information##2##2##(2009-12#1)(2011-2#1)
correct interpretation of the##2##4##(2008-3#1)(2010-8#1)
correct interpretation of##4##3##(2008-1#1)(2008-3#1)(2009-8#1)(2010-8#1)
correct or##3##2##(1997-5#1)(2008-2#1)(2012-2#1)
correct patient##2##2##(1995-2#1)(2012-2#1)
correct phase##4##2##(2008-3#4)
correct prediction of##2##3##(2008-10#2)
correct prediction rate##2##3##(2010-8#2)
correct prediction##4##2##(2008-10#2)(2010-8#2)
correct procedure##2##2##(1990-10#1)(2008-10#1)
correct response##2##2##(1993-12#1)(2011-2#1)
correct responses##5##2##(1991-2#1)(1993-3#2)(2008-11#1)(2013-8#1)
correct results##4##2##(1994-3#1)(2007-2#1)(2008-10#1)(2008-2#1)
correct routes##2##2##(1992-12#2)
correct setting of the##2##4##(2008-3#2)
correct splicing##3##2##(1990-5#1)(1995-6#1)(2008-8#1)
correct structure##7##2##(2008-4#6)(2008-9#1)
correct the##22##2##(1992-8#1)(1995-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2009-10#1)(2010-1#1)(2012-2#1)(2012-3#1)
correct tours##2##2##(1992-12#2)
correct use of##6##3##(1991-6#1)(1993-8#1)(1994-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
correct##378##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#3)(1991-9#1)(1992-11#4)(1992-12#4)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#2)(1997-7#1)(2007-11#8)(2007-12#8)(2007-2#2)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#40)(2008-11#10)(2008-12#4)(2008-2#21)(2008-3#42)(2008-4#9)(2008-5#6)(2008-6#7)(2008-7#10)(2008-8#6)(2008-9#20)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#7)
correctable##5##1##(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)
corrected Q-T interval##2##3##(1994-6#2)
corrected age##2##2##(1993-12#1)(2012-12#1)
corrected and##2##2##(2009-7#2)
corrected by a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
corrected by##15##2##(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#2)(2010-8#1)(2012-1#1)(2013-1#1)
corrected excess##2##2##(1997-7#2)
corrected for differences in##2##4##(1995-11#1)(2008-9#1)
corrected for the effects of##2##5##(1991-5#1)(2007-11#1)
corrected for the##4##3##(1990-3#1)(1991-5#1)(2007-11#1)(2008-10#1)
corrected for toxicokinetics##2##3##(1995-3#2)
corrected for within-person variability##2##4##(1992-6#2)
corrected for##25##2##(1990-3#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-6#2)(1995-11#1)(1995-3#2)(1996-12#3)(1997-5#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
corrected telescope##2##2##(2007-11#1)(2008-3#1)
corrected to##6##2##(1996-6#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
corrected using a baseline##2##4##(2008-10#2)
corrected visual acuity of##2##4##(2010-10#1)(2011-2#1)
corrected visual acuity##4##3##(2010-10#1)(2011-2#3)
corrected visual##5##2##(2010-10#1)(2011-2#3)(2012-3#1)
corrected with a##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
corrected with##8##2##(2007-11#2)(2008-10#4)(2008-2#1)(2008-9#1)
corrected##115##1##(1990-3#1)(1990-8#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-6#3)(1993-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#2)(1996-12#3)(1996-2#1)(1996-6#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#10)(2007-12#3)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#9)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
correcting for##4##2##(1997-2#1)(2007-11#1)(2008-2#2)
correcting method for##2##3##(2013-8#2)
correcting soft##2##2##(2012-12#2)
correcting the##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
correcting##32##1##(1995-6#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-12#3)(2013-8#2)
correction (MSC)##2##2##(2008-10#1)(2013-8#1)
correction after##2##2##(2007-12#1)(2008-12#1)
correction algorithm for hyperspectral remote sensing of ocean color##2##9##(2008-3#2)
correction algorithm for##3##3##(2008-3#3)
correction algorithm##8##2##(2008-10#1)(2008-3#7)
correction algorithms##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
correction and##14##2##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-9#1)(2012-2#1)
correction by use of##2##4##(2007-12#1)(2008-3#1)
correction by##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
correction can be##2##3##(2008-2#1)(2012-1#1)
correction done by##2##3##(2013-8#2)
correction done##3##2##(2013-8#3)
correction effectiveness##2##2##(2008-3#2)
correction factor for##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
correction factor is##2##3##(2007-11#1)(2008-2#1)
correction factor##14##2##(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-9#1)(2009-9#1)(2011-1#1)
correction factors for##2##3##(2008-3#1)(2008-9#1)
correction factors##8##2##(2008-10#3)(2008-2#2)(2008-3#2)(2008-9#1)
correction for multiple testing##2##4##(2010-2#1)(2011-2#1)
correction for the##5##3##(1990-8#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)
correction for this##2##3##(1990-3#1)(2008-2#1)
correction for##30##2##(1990-12#1)(1990-3#1)(1990-8#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
correction function##4##2##(2007-12#1)(2008-3#2)(2013-8#1)
correction has been##2##3##(2008-8#1)(2012-1#1)
correction has##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#2)(2012-1#1)
correction in the##3##3##(2008-3#1)(2012-2#1)(2013-7#1)
correction in##16##2##(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
correction is given##2##3##(2008-2#2)
correction is##9##2##(2007-12#1)(2008-2#3)(2008-3#3)(2010-11#1)(2012-3#1)
correction method is##2##3##(2008-10#1)(2013-8#1)
correction method that##2##3##(2008-3#2)
correction method##9##2##(2007-12#1)(2008-10#3)(2008-3#2)(2013-8#3)
correction of a##5##3##(1994-3#1)(2007-11#1)(2008-3#2)(2008-9#1)
correction of an##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
correction of beam##2##3##(2008-3#1)(2012-1#1)
correction of hallux valgus##2##4##(2009-10#1)(2012-2#1)
correction of instrumental line-shape distortions##2##5##(2008-3#2)
correction of satellite ocean color imagery##3##6##(2008-3#3)
correction of satellite##4##3##(2008-2#1)(2008-3#3)
correction of the deformity##2##4##(2007-12#1)(2007-8#1)
correction of the##31##3##(1992-5#1)(1994-11#1)(1994-3#1)(1995-9#1)(1997-1#1)(1997-3#1)(2007-11#3)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
correction of##99##2##(1992-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#2)(1995-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#8)(2007-12#8)(2007-8#7)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#5)(2008-3#18)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#4)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#5)(2013-1#3)(2013-8#3)
correction procedure##2##2##(2008-3#1)(2009-8#1)
correction procedures##3##2##(2008-10#3)
correction results##3##2##(2008-10#1)(2013-8#2)
correction scheme##3##2##(2008-3#3)
correction surgery##2##2##(2010-3#1)(2012-12#1)
correction the##3##2##(2007-11#1)(2008-3#2)
correction to the##2##3##(2007-11#1)(2010-2#1)
correction to##4##2##(2007-11#1)(2008-3#1)(2010-2#1)(2013-7#1)
correction using##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
correction was##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2010-3#1)
correction with##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)
correction##374##1##(1990-12#1)(1990-3#1)(1990-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#4)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#24)(2007-12#27)(2007-6#1)(2007-7#1)(2007-8#15)(2008-1#2)(2008-10#60)(2008-11#2)(2008-12#3)(2008-2#38)(2008-3#79)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#9)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#21)
correctional##4##1##(2007-12#1)(2008-11#1)(2008-3#1)(2010-6#1)
corrections and##2##2##(2008-2#1)(2009-11#1)
corrections are##4##2##(1995-5#1)(2008-2#2)(2008-3#1)
corrections for the##2##3##(2007-11#1)(2008-3#1)
corrections for##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
corrections in the##2##3##(1997-2#1)(2012-3#1)
corrections of##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
corrections that##3##2##(1992-6#1)(2008-3#2)
corrections to the##3##3##(1990-3#1)(2008-2#1)(2008-3#1)
corrections to##4##2##(1990-3#1)(2008-2#2)(2008-3#1)
corrections were##4##2##(1996-2#1)(1996-5#1)(2008-10#1)(2008-2#1)
corrections##44##1##(1990-3#1)(1992-6#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#5)(2008-10#5)(2008-2#12)(2008-3#10)(2009-11#2)(2010-6#1)(2012-3#1)(2013-7#1)
corrective action##2##2##(1993-1#1)(2012-2#1)
corrective effect of sorbinil on##2##5##(1994-8#2)
corrective##22##1##(1991-12#1)(1992-9#2)(1993-1#1)(1994-1#1)(1994-8#2)(1996-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)(2012-2#3)
correctly and##2##2##(1996-8#1)(2012-1#1)
correctly before##2##2##(2007-8#1)(2011-2#1)
correctly by the##2##3##(2008-10#1)(2011-1#1)
correctly classified as being##2##4##(1993-8#1)(1995-6#1)
correctly classified as##3##3##(1993-8#2)(1995-6#1)
correctly classified##16##2##(1991-12#1)(1992-2#1)(1992-6#1)(1993-8#2)(1995-6#1)(2008-10#8)(2008-7#2)
correctly detected##2##2##(1990-9#1)(2012-2#1)
correctly folded##2##2##(1997-4#1)(2008-4#1)
correctly identified all##2##3##(1993-2#1)(2008-1#1)
correctly identified by##2##3##(1996-11#1)(2008-11#1)
correctly identified##15##2##(1993-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2009-5#1)(2012-2#1)(2013-1#1)
correctly in##3##2##(1990-11#1)(2007-11#1)(2008-11#1)
correctly is##2##2##(2008-11#1)(2008-2#1)
correctly positioned##3##2##(1992-9#1)(1994-12#1)(2008-12#1)
correctly predicted a##2##3##(1996-12#1)(2008-7#1)
correctly predicted##12##2##(1992-6#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
correctly processed##2##2##(1993-6#1)(1995-6#1)
correctly reflect##2##2##(2007-12#1)(2008-8#1)
correctly the##6##2##(1991-9#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-2#1)
correctly to##2##2##(1994-8#1)(2007-11#1)
correctly##153##1##(1990-11#2)(1990-5#2)(1990-9#2)(1991-12#3)(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#3)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
correctly?]##2##1##(1994-3#1)(1996-6#1)
correctness and##4##2##(1990-3#1)(2008-11#2)(2009-5#1)
correctness of the##5##3##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
correctness of##6##2##(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
correctness##15##1##(1990-3#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#2)(2008-3#1)(2009-5#1)
corrector designs##2##2##(2008-3#2)
corrector##14##1##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#7)(2013-1#2)
correctors are##3##2##(2008-3#3)
correctors for##2##2##(2008-3#2)
correctors##10##1##(2008-3#10)
corrects for##3##2##(1995-12#1)(2007-12#1)(2008-3#1)
corrects the article on p##17##5##(2008-11#3)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
corrects the article##20##3##(2008-11#3)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
corrects the##24##2##(1997-7#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
corrects##33##1##(1995-12#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-11#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
correlate directly##2##2##(1990-8#1)(1994-9#1)
correlate of##8##2##(1992-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(2008-12#2)(2009-5#1)(2012-12#1)
correlate or##2##2##(1993-3#1)(2010-3#1)
correlate the##6##2##(1993-8#1)(1994-6#1)(2008-2#1)(2008-6#1)(2012-9#1)(2013-8#1)
correlate them with##3##3##(2008-12#1)(2011-2#1)(2012-4#1)
correlate this##3##2##(2008-10#2)(2008-11#1)
correlate to the##3##3##(2008-5#1)(2012-2#2)
correlate to##8##2##(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#3)
correlate very well with the##2##5##(1992-6#1)(2010-12#1)
correlate very well with##4##4##(1992-6#1)(1993-3#1)(2007-12#1)(2010-12#1)
correlate well with the##2##4##(1992-9#1)(1997-6#1)
correlate well with##10##3##(1992-2#1)(1992-9#1)(1994-8#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-5#1)
correlate with age##2##3##(2008-7#2)
correlate with better##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
correlate with disease##2##3##(2008-10#1)(2013-1#1)
correlate with reduced##2##3##(2011-2#1)(2013-7#1)
correlate with the degree of##2##5##(1991-9#1)(2008-7#1)
correlate with the##28##3##(1990-11#1)(1990-2#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
correlate with##97##2##(1990-11#1)(1990-2#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-6#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#9)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
correlate##185##1##(1990-11#2)(1990-2#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-9#2)(1993-3#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#5)
correlated (P &lt##4##3##(2008-10#2)(2011-2#2)
correlated (P##5##2##(2008-10#3)(2011-2#2)
correlated (r = 0##4##4##(1991-12#1)(1992-12#1)(2008-10#1)(2009-11#1)
correlated and##2##2##(2008-8#2)
correlated better with QoL##2##4##(2012-1#2)
correlated better with##4##3##(1991-3#1)(2008-10#1)(2012-1#2)
correlated between the##2##3##(2008-11#1)(2013-8#1)
correlated between##5##2##(1990-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
correlated by##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
correlated closely with##4##3##(1990-2#1)(1990-3#1)(2008-10#2)
correlated closely##5##2##(1990-2#2)(1990-3#1)(2008-10#2)
correlated color##2##2##(2008-3#2)
correlated error patterns##2##3##(2008-2#2)
correlated evolution##3##2##(1997-4#2)(2008-9#1)
correlated expression of##2##3##(1993-6#1)(2008-4#1)
correlated highly with##3##3##(1993-1#1)(2008-10#1)(2013-1#1)
correlated in##10##2##(1990-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#3)
correlated independently##2##2##(2008-9#1)(2013-8#1)
correlated inversely##2##2##(1995-11#1)(2013-1#1)
correlated negatively with##5##3##(1992-9#1)(1994-3#1)(1995-8#2)(2013-1#1)
correlated negatively##7##2##(1992-9#1)(1994-3#1)(1995-8#2)(2008-4#1)(2008-7#1)(2013-1#1)
correlated noise##2##2##(2008-2#1)(2009-5#1)
correlated only with##2##3##(2007-12#1)(2008-7#1)
correlated photons for##2##3##(2007-12#1)(2008-2#1)
correlated photons##4##2##(2007-12#2)(2008-2#2)
correlated positively to##2##3##(1997-7#1)(2013-1#1)
correlated positively with each other##2##5##(1996-5#1)(2008-10#1)
correlated positively with the##3##4##(1995-8#1)(2013-8#2)
correlated positively with##16##3##(1990-2#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-8#1)(2010-8#2)(2011-10#1)(2011-2#2)(2013-1#3)(2013-8#2)
correlated positively##19##2##(1990-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#2)(2011-10#1)(2011-2#2)(2013-1#4)(2013-8#2)
correlated response to selection##2##4##(2008-8#2)
correlated response to##3##3##(2008-8#3)
correlated response##4##2##(2008-8#4)
correlated responses to##2##3##(2008-8#2)
correlated responses##3##2##(2008-8#3)
correlated significantly with the##4##4##(1991-2#1)(1995-11#1)(2010-2#2)
correlated significantly with##21##3##(1991-12#1)(1991-2#1)(1993-12#2)(1994-11#1)(1995-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-2#3)(2011-1#1)(2012-4#1)(2013-7#1)(2013-8#2)
correlated significantly##24##2##(1991-12#1)(1991-2#1)(1993-12#2)(1994-11#1)(1995-11#1)(1996-7#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2010-2#3)(2011-1#1)(2012-4#1)(2013-7#1)(2013-8#2)
correlated strongly with##6##3##(1993-2#2)(2008-10#2)(2008-11#1)(2012-4#1)
correlated to a##4##3##(1993-3#1)(2008-10#1)(2008-9#1)(2011-2#1)
correlated to cell##2##3##(2008-11#2)
correlated to the concentration of##2##5##(1996-12#1)(2008-10#1)
correlated to the number of##4##5##(1990-8#1)(1992-12#1)(1995-8#1)(1996-12#1)
correlated to the##32##3##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-8#1)(1996-12#3)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
correlated to##67##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-8#1)(1996-12#3)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-4#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
correlated well with eye counts##2##5##(2008-10#2)
correlated well with the##14##4##(1991-12#1)(1991-9#1)(1994-7#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2012-1#1)(2013-8#1)
correlated well with their estrogen receptor content##2##7##(2008-11#2)
correlated well with those##2##4##(1995-12#1)(2008-10#1)
correlated well with##31##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-6#2)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
correlated well##33##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
correlated with CRP binding to##2##5##(1997-6#2)
correlated with VCG##2##3##(2008-10#2)
correlated with a 3-D##2##4##(2008-2#1)(2008-3#1)
correlated with a decrease##2##4##(2008-10#1)(2008-7#1)
correlated with a marked##2##4##(1997-7#1)(2008-7#1)
correlated with a##22##3##(1991-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-9#1)(2013-8#1)
correlated with age and##2##4##(1994-6#1)(2013-1#1)
correlated with age##5##3##(1994-6#1)(2008-9#1)(2013-1#3)
correlated with alterations in##2##4##(2008-4#1)(2013-8#1)
correlated with an increase in##2##5##(1992-3#1)(1993-11#1)
correlated with an##9##3##(1991-8#1)(1992-3#1)(1993-11#1)(1993-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)
correlated with bacterial##2##3##(2008-10#1)(2013-7#1)
correlated with baseline##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
correlated with better##4##3##(2008-11#1)(2009-10#1)(2009-4#2)
correlated with body mass##2##4##(2011-1#1)(2013-8#1)
correlated with body##3##3##(2008-5#1)(2011-1#1)(2013-8#1)
correlated with both##2##3##(1995-2#1)(2008-5#1)
correlated with changes in##6##4##(1993-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-7#1)
correlated with children's##4##3##(2010-11#3)(2013-1#1)
correlated with common##2##3##(2009-8#1)(2012-3#1)
correlated with differences##2##3##(2008-10#2)
correlated with disease##2##3##(2008-10#2)
correlated with each other##4##4##(2006-10#2)(2008-10#2)
correlated with geographic##4##3##(2008-10#3)(2012-3#1)
correlated with hepatic##2##3##(1990-5#1)(2013-8#1)
correlated with hexose sugars##2##4##(2011-2#2)
correlated with high##6##3##(1991-11#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-6#1)
correlated with host density##2##4##(2008-10#2)
correlated with host##3##3##(2008-10#3)
correlated with incidence##2##3##(2008-10#2)
correlated with increased blood##2##4##(2008-11#1)(2011-2#1)
correlated with increased##9##3##(1992-12#1)(1992-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
correlated with increasing##2##3##(2008-10#1)(2012-12#1)
correlated with its##3##3##(1991-6#1)(1995-2#1)(1995-5#1)
correlated with known##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
correlated with left##2##3##(2009-9#1)(2010-6#1)
correlated with loss of##2##4##(2008-10#1)(2010-7#1)
correlated with low disease severity soils##2##6##(2008-10#2)
correlated with mRNA##2##3##(1994-11#1)(2012-1#1)
correlated with maximum##2##3##(2008-10#2)
correlated with mean##2##3##(1990-3#1)(2008-10#1)
correlated with modifications of##2##4##(1996-12#1)(2008-7#1)
correlated with more##2##3##(2008-10#1)(2013-1#1)
correlated with percentage of##3##4##(2008-10#2)(2012-1#1)
correlated with plant##4##3##(2008-10#4)
correlated with plasma##3##3##(1990-12#1)(1992-9#1)(1994-12#1)
correlated with poor##2##3##(2008-11#1)(2013-1#1)
correlated with potato##2##3##(2008-10#2)
correlated with reduced##5##3##(2008-10#2)(2008-7#1)(2009-4#1)(2013-1#1)
correlated with resistance##3##3##(2008-10#3)
correlated with serum##2##3##(2006-10#1)(2011-2#1)
correlated with sucrose and##2##4##(2011-2#2)
correlated with survival##2##3##(2008-7#1)(2010-3#1)
correlated with temperature##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
correlated with that##3##3##(2008-10#2)(2012-1#1)
correlated with the amount of##4##5##(1991-12#1)(1996-9#1)(2008-10#2)
correlated with the clinical##2##4##(1994-6#1)(2009-11#1)
correlated with the concentration of##2##5##(2008-10#2)
correlated with the degree of##5##5##(1991-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-5#1)
correlated with the duration of##3##5##(1991-12#1)(2008-10#1)(2008-7#1)
correlated with the in vivo##2##5##(1993-12#1)(1995-5#1)
correlated with the in##3##4##(1990-2#1)(1993-12#1)(1995-5#1)
correlated with the increase in##2##5##(1993-3#1)(2006-10#1)
correlated with the length of##2##5##(2012-12#1)(2013-1#1)
correlated with the level of##3##5##(1992-6#1)(1997-3#1)(2008-10#1)
correlated with the minimum##2##4##(2008-10#1)(2013-8#1)
correlated with the number of##2##5##(1990-2#1)(2008-10#1)
correlated with the occurrence of##2##5##(2008-8#1)(2009-5#1)
correlated with the presence of a##2##6##(2008-10#1)(2008-5#1)
correlated with the presence of##5##5##(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
correlated with the severity of symptoms##2##6##(2008-10#1)(2008-7#1)
correlated with the severity of##5##5##(1997-5#1)(1997-8#1)(2008-10#1)(2008-7#2)
correlated with the temperature##2##4##(2008-10#1)(2013-7#1)
correlated with the##169##3##(1990-2#3)(1990-7#1)(1990-8#1)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-6#3)(1995-11#2)(1995-2#1)(1995-5#5)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#2)(2009-11#2)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#2)(2013-1#2)(2013-7#2)(2013-8#3)
correlated with their ability to##3##5##(1992-12#1)(1993-8#1)(2008-10#1)
correlated with their##11##3##(1992-11#1)(1992-12#1)(1993-8#1)(1995-11#1)(1996-5#2)(1997-6#1)(2008-10#2)(2008-9#1)(2009-5#1)
correlated with those##3##3##(1990-2#1)(2008-10#2)
correlated with villous height##2##4##(2013-1#2)
correlated with virulence##5##3##(2008-10#5)
correlated with##601##2##(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#2)(1991-11#1)(1991-12#4)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#2)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#5)(1994-8#2)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#6)(1995-8#2)(1996-1#2)(1996-12#6)(1996-2#1)(1996-4#2)(1996-5#6)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#4)(2006-10#6)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-8#4)(2008-1#4)(2008-10#161)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#7)(2008-5#17)(2008-6#6)(2008-7#26)(2008-8#13)(2008-9#15)(2009-10#4)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#7)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#5)(2010-1#1)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2011-1#7)(2011-10#2)(2011-2#17)(2011-9#1)(2012-1#6)(2012-12#5)(2012-2#7)(2012-3#15)(2012-5#3)(2012-7#2)(2013-1#23)(2013-7#4)(2013-8#13)
correlated##937##1##(1990-12#3)(1990-2#8)(1990-3#2)(1990-5#2)(1990-7#5)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#10)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#2)(1992-11#5)(1992-12#8)(1992-3#3)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#6)(1994-7#1)(1994-8#3)(1995-11#9)(1995-12#4)(1995-2#6)(1995-3#5)(1995-5#7)(1995-8#6)(1995-9#1)(1996-1#2)(1996-12#9)(1996-2#2)(1996-4#2)(1996-5#7)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#4)(2006-10#9)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#9)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#8)(2008-10#237)(2008-11#23)(2008-12#5)(2008-2#14)(2008-3#15)(2008-4#10)(2008-5#21)(2008-6#10)(2008-7#40)(2008-8#33)(2008-9#22)(2009-10#5)(2009-11#4)(2009-12#2)(2009-3#2)(2009-4#7)(2009-5#8)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#8)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#7)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#5)(2011-1#9)(2011-10#3)(2011-2#29)(2011-9#1)(2012-1#10)(2012-12#5)(2012-2#12)(2012-3#17)(2012-4#2)(2012-5#3)(2012-7#2)(2013-1#34)(2013-7#5)(2013-8#23)
correlates and##3##2##(2008-11#1)(2008-5#1)(2009-5#1)
correlates best with##2##3##(2008-11#1)(2008-7#1)
correlates in##5##2##(1993-3#1)(2008-7#1)(2008-8#1)(2013-8#2)
correlates inversely with##3##3##(2008-7#1)(2010-3#1)(2012-2#1)
correlates of protection against##3##4##(1995-5#2)(2009-12#1)
correlates of protection##4##3##(1995-5#2)(2009-12#2)
correlates of readiness##2##3##(2012-3#2)
correlates of the##3##3##(2008-11#1)(2008-7#1)(2009-8#1)
correlates of##56##2##(1991-1#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-1#1)(1994-2#2)(1995-11#2)(1995-3#1)(1995-5#3)(1997-7#1)(2007-8#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#2)(2009-2#2)(2009-5#4)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#9)(2013-8#3)
correlates significantly with##2##3##(1993-12#2)
correlates the##2##2##(1995-12#1)(2008-2#1)
correlates to##4##2##(1994-2#1)(1997-4#1)(2011-1#1)(2013-8#1)
correlates well with the##4##4##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
correlates well with##8##3##(1992-6#1)(1992-9#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
correlates well##9##2##(1992-6#1)(1992-9#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
correlates were##2##2##(1994-12#1)(2009-5#1)
correlates with a##7##3##(1997-7#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-4#1)(2013-1#1)
correlates with cell##2##3##(1995-9#1)(2008-11#1)
correlates with disease##2##3##(1990-3#1)(2006-10#1)
correlates with increased##4##3##(2008-8#1)(2009-8#2)(2013-1#1)
correlates with labeling of the##2##5##(1995-6#2)
correlates with resistance##2##3##(2008-10#1)(2008-5#1)
correlates with the amount of##2##5##(1996-5#1)(2008-4#1)
correlates with the##25##3##(1990-12#1)(1991-12#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-6#1)(2011-1#1)(2012-1#1)
correlates with their##4##3##(1990-12#1)(2009-3#1)(2010-8#1)(2012-2#1)
correlates with##85##2##(1990-12#2)(1990-3#1)(1991-12#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-8#2)(1994-10#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-9#1)(1996-5#1)(1997-7#2)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
correlates##194##1##(1990-12#2)(1990-3#1)(1991-1#1)(1991-12#1)(1991-6#2)(1992-11#2)(1992-6#2)(1992-9#3)(1993-1#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-8#2)(1994-10#2)(1994-12#1)(1994-2#4)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#3)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#8)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-2#6)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#7)
correlating the##5##2##(2008-10#2)(2008-3#1)(2010-12#1)(2010-5#1)
correlating with the##2##3##(1993-6#1)(1995-2#1)
correlating with##5##2##(1991-12#1)(1991-2#1)(1993-6#1)(1995-2#1)(1995-9#1)
correlating##24##1##(1991-12#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-10#1)(2010-12#1)(2010-5#1)
correlation (P##2##2##(2008-10#1)(2008-7#1)
correlation (R =##3##3##(1990-12#1)(2008-10#2)
correlation (r = 0##13##4##(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)
correlation (r =##14##3##(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
correlation (r=0##7##2##(2008-10#4)(2008-7#3)
correlation algorithm##2##2##(2008-3#2)
correlation among##8##2##(1994-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2010-3#1)(2011-2#1)
correlation analysis and##2##3##(2008-10#1)(2008-8#1)
correlation analysis was##3##3##(2008-10#1)(2009-2#1)(2013-7#1)
correlation analysis##19##2##(2007-12#1)(2008-10#7)(2008-3#2)(2008-8#1)(2009-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2013-7#1)
correlation and scattering##2##3##(2008-3#2)
correlation and##22##2##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#3)
correlation as a##2##3##(2008-10#1)(2008-3#1)
correlation as##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
correlation based on the fractional Fourier transform##2##7##(2008-2#2)
correlation based on##4##3##(2008-2#3)(2008-3#1)
correlation being##2##2##(1990-9#1)(1996-3#1)
correlation between BMI and##3##4##(2007-8#1)(2008-3#1)(2011-2#1)
correlation between DNA content and##2##5##(1994-12#1)(2008-9#1)
correlation between DNA##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
correlation between WB##2##3##(2008-10#2)
correlation between a##5##3##(1992-9#1)(2007-10#1)(2007-2#1)(2008-3#1)(2013-1#1)
correlation between baseline##2##3##(1995-2#1)(2011-2#1)
correlation between changes in##2##4##(1992-6#1)(2007-11#1)
correlation between chronic##2##3##(2009-8#1)(2013-8#1)
correlation between clinical##3##3##(1997-7#1)(2011-2#1)(2013-1#1)
correlation between disease##2##3##(2008-10#2)
correlation between drug##2##3##(2008-10#1)(2008-8#1)
correlation between electrical and mechanical asynchrony in##2##7##(2008-10#2)
correlation between elevated##3##3##(1997-7#2)(2007-7#1)
correlation between experimental##2##3##(2008-10#2)
correlation between expression of##2##4##(2008-8#1)(2013-8#1)
correlation between expression##3##3##(2008-8#1)(2012-3#1)(2013-8#1)
correlation between genetic and##3##4##(2008-10#2)(2011-2#1)
correlation between genetic##7##3##(1994-2#1)(2008-10#5)(2011-2#1)
correlation between growth##2##3##(2008-10#1)(2008-12#1)
correlation between in vitro and in vivo##3##7##(1992-6#1)(2008-5#2)
correlation between metabolic##2##3##(2008-1#1)(2008-3#1)
correlation between osteocalcin and##2##4##(1991-11#2)
correlation between p53##2##3##(2007-8#1)(2008-5#1)
correlation between plasma##2##3##(1995-11#1)(2008-6#1)
correlation between preoperative weight change and postoperative##2##7##(2010-8#2)
correlation between real##2##3##(2007-8#1)(2008-10#1)
correlation between repeated##4##3##(1996-3#2)(2008-1#1)(2009-12#1)
correlation between results##3##3##(2007-10#1)(2008-10#2)
correlation between semen##2##3##(2007-10#1)(2011-1#1)
correlation between serum fructosamine and HbA1##2##6##(1991-5#2)
correlation between serum##6##3##(1991-12#1)(1991-5#2)(2011-2#2)(2013-7#1)
correlation between some##2##3##(1990-5#1)(2008-5#1)
correlation between the degree of##3##5##(1992-11#1)(2008-12#1)(2010-12#1)
correlation between the in vitro##3##5##(1997-7#1)(2008-5#2)
correlation between the increase in##2##5##(1994-5#1)(1996-12#1)
correlation between the length of the##2##6##(1994-11#1)(2007-8#1)
correlation between the level of##3##5##(1990-10#1)(2008-10#1)(2011-1#1)
correlation between the measured##2##4##(2008-3#1)(2008-7#1)
correlation between the number##2##4##(2008-10#1)(2008-9#1)
correlation between the proportion of##2##5##(2009-5#1)(2010-6#1)
correlation between the results##2##4##(1996-12#1)(2008-10#1)
correlation between the two##4##4##(1995-5#1)(2008-3#3)
correlation between the##134##3##(1990-10#1)(1990-2#2)(1990-7#2)(1991-1#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-12#1)(1995-5#1)(1995-8#2)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#11)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#6)
correlation between these two##2##4##(1994-5#1)(2011-2#1)
correlation between these##6##3##(1994-5#2)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
correlation between those##2##3##(1991-6#1)(2008-5#1)
correlation between total##3##3##(1991-12#2)(1992-12#1)
correlation between two##3##3##(2008-10#1)(2008-3#2)
correlation between##422##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-11#3)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#6)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#8)(1997-8#1)(2006-10#1)(2007-10#6)(2007-11#2)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#7)(2008-1#5)(2008-10#85)(2008-11#7)(2008-12#8)(2008-2#4)(2008-3#20)(2008-4#2)(2008-5#18)(2008-6#6)(2008-7#13)(2008-8#14)(2008-9#11)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#7)(2011-2#21)(2012-1#2)(2012-12#2)(2012-3#7)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#15)(2013-7#3)(2013-8#14)
correlation by use of##2##4##(2007-12#1)(2008-3#1)
correlation by##3##2##(2007-12#1)(2008-3#2)
correlation can be##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)
correlation coefficient (ICC) was##2##4##(2008-7#1)(2013-1#1)
correlation coefficient (R(2))##3##3##(2008-10#3)
correlation coefficient (r##2##3##(2011-1#1)(2011-3#1)
correlation coefficient (r) of 0##2##5##(2008-10#2)
correlation coefficient (r)##5##3##(2008-10#4)(2011-2#1)
correlation coefficient 0##4##3##(2008-10#4)
correlation coefficient R2##2##3##(1995-3#1)(2013-8#1)
correlation coefficient and##3##3##(2008-10#3)
correlation coefficient between the##2##4##(2008-2#1)(2008-3#1)
correlation coefficient between##5##3##(1992-6#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
correlation coefficient for##2##3##(2008-10#2)
correlation coefficient is##2##3##(2007-10#1)(2008-10#1)
correlation coefficient of 0##42##4##(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#35)(2010-2#1)(2010-4#1)(2013-7#1)(2013-8#1)
correlation coefficient of linear regression##3##5##(2008-10#3)
correlation coefficient of##51##3##(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#40)(2008-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
correlation coefficient showed##2##3##(2008-7#1)(2008-9#1)
correlation coefficient was 0##6##4##(1990-12#1)(2008-10#4)(2013-8#1)
correlation coefficient was used to##2##5##(2008-12#1)(2008-7#1)
correlation coefficient was##11##3##(1990-12#1)(2008-10#5)(2008-12#2)(2008-7#1)(2012-2#1)(2013-8#1)
correlation coefficient##124##2##(1990-12#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-3#1)(1995-6#1)(1997-4#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#79)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-3#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
correlation coefficient)##2##2##(1993-8#1)(2008-10#1)
correlation coefficients (r)##3##3##(2008-10#3)
correlation coefficients and##2##3##(2008-10#1)(2008-5#1)
correlation coefficients between##5##3##(1991-12#1)(1994-9#1)(2008-10#3)
correlation coefficients for all##2##4##(2008-10#2)
correlation coefficients for##3##3##(2008-10#2)(2008-12#1)
correlation coefficients of 0##4##4##(2008-10#2)(2011-1#2)
correlation coefficients of##6##3##(2008-10#3)(2011-1#2)(2013-8#1)
correlation coefficients were 0##2##4##(2008-10#2)
correlation coefficients were##8##3##(2008-10#5)(2008-3#1)(2011-1#1)(2011-2#1)
correlation coefficients##47##2##(1991-12#1)(1992-3#1)(1993-12#2)(1994-9#1)(2008-10#27)(2008-12#4)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#4)(2011-2#2)(2013-8#1)
correlation compared##2##2##(2008-10#1)(2008-9#1)
correlation could be##6##3##(1993-5#1)(2007-7#1)(2008-10#1)(2008-8#2)(2009-7#1)
correlation equations##2##2##(2007-11#2)
correlation existed between##3##3##(1993-12#1)(2008-10#1)(2008-12#1)
correlation existed##4##2##(1993-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
correlation exists between##4##3##(1990-2#1)(1995-3#1)(2008-3#1)(2008-8#1)
correlation factor of 0##5##4##(2008-10#5)
correlation factor##8##2##(2008-10#8)
correlation filter##8##2##(2007-12#3)(2008-2#1)(2008-3#4)
correlation filters##2##2##(2008-3#2)
correlation for the##2##3##(1997-2#1)(2008-3#1)
correlation for##8##2##(1997-2#1)(2008-10#3)(2008-3#3)(2008-7#1)
correlation function and##2##3##(2008-3#2)
correlation function in the near field##2##6##(2008-3#2)
correlation function of the##2##4##(2008-3#2)
correlation function of##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
correlation function##19##2##(1992-9#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#12)
correlation functions of##2##3##(2007-12#1)(2008-3#1)
correlation functions##8##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-2#2)
correlation has##2##2##(2008-3#1)(2011-1#1)
correlation in a##3##3##(2007-12#2)(2008-2#1)
correlation in the##6##3##(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
correlation in##21##2##(1991-6#1)(1993-5#1)(1994-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
correlation indicates that##2##3##(2008-10#1)(2008-3#1)
correlation is demonstrated##2##3##(1994-3#1)(2007-12#1)
correlation is observed##2##3##(2008-10#1)(2012-2#1)
correlation is##25##2##(1992-6#3)(1994-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#11)(2008-8#1)(2009-5#1)(2012-2#3)
correlation length##6##2##(2007-11#2)(2007-12#1)(2008-3#2)(2012-2#1)
correlation lengths##2##2##(2008-2#1)(2008-3#1)
correlation matrix##3##2##(1997-3#1)(2008-10#1)(2010-11#1)
correlation may##3##2##(2008-10#1)(2008-12#2)
correlation method##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
correlation of 0##2##3##(2008-10#2)
correlation of disease status of##3##5##(2008-10#3)
correlation of gene expression for##2##5##(2008-7#2)
correlation of gene expression##3##4##(2008-7#3)
correlation of results##2##3##(2008-10#1)(2008-7#1)
correlation of the##21##3##(1993-8#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
correlation of this##2##3##(2008-10#1)(2008-2#1)
correlation of total##2##3##(2008-10#1)(2011-2#1)
correlation of two##2##3##(2008-2#1)(2008-3#1)
correlation of##78##2##(1990-2#1)(1990-5#1)(1992-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
correlation output##3##2##(2008-2#1)(2008-3#2)
correlation peak##9##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)
correlation peaks##5##2##(2008-2#4)(2008-3#1)
correlation performance##2##2##(2008-2#1)(2008-3#1)
correlation plane##2##2##(2008-2#2)
correlation processor##2##2##(2008-3#2)
correlation properties of the##2##4##(2008-11#1)(2008-3#1)
correlation properties##5##2##(2008-11#2)(2008-2#2)(2008-3#1)
correlation results##2##2##(2007-11#1)(2008-7#1)
correlation signal##4##2##(2008-2#3)(2008-3#1)
correlation signals at the output plane##2##6##(2008-2#2)
correlation signals##4##2##(2008-2#3)(2008-3#1)
correlation spectra##2##2##(2008-2#1)(2012-2#1)
correlation spectroscopy and##3##3##(1997-6#1)(2007-12#1)(2010-9#1)
correlation spectroscopy to##2##3##(2008-8#1)(2010-9#1)
correlation spectroscopy##25##2##(1990-5#1)(1992-12#1)(1997-6#3)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2010-9#3)(2011-1#4)(2013-1#1)
correlation spectrum##2##2##(2008-8#2)
correlation structures##3##2##(1992-9#1)(2010-1#1)(2013-8#1)
correlation study##2##2##(2009-12#1)(2009-8#1)
correlation suggested##2##2##(1997-3#1)(2010-2#1)
correlation suggests##2##2##(1995-3#1)(2008-10#1)
correlation system##2##2##(2008-2#1)(2008-3#1)
correlation technique##2##2##(2008-3#2)
correlation test##2##2##(1997-3#1)(2008-7#1)
correlation tests##2##2##(1994-3#1)(2011-2#1)
correlation time##11##2##(1995-5#3)(2008-10#3)(2008-3#5)
correlation to the##9##3##(1990-12#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2012-12#1)
correlation to##13##2##(1990-12#2)(2007-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
correlation using##2##2##(2008-3#1)(2009-12#1)
correlation value was##2##3##(2008-10#2)
correlation value##3##2##(2008-10#3)
correlation via##2##2##(1992-3#1)(2007-12#1)
correlation was demonstrated between##2##4##(2007-11#1)(2009-8#1)
correlation was established between the##2##5##(2008-10#2)
correlation was established##3##3##(2008-10#3)
correlation was found between the expression of##2##7##(1990-12#1)(2013-8#1)
correlation was found between the##26##5##(1990-12#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-3#1)(1994-6#1)(1994-7#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
correlation was found between##50##4##(1990-12#2)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
correlation was found in##2##4##(2008-11#1)(2011-2#1)
correlation was found with##4##4##(1990-2#1)(1991-12#1)(1992-2#1)(2008-7#1)
correlation was found##57##3##(1990-12#2)(1990-2#1)(1991-12#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
correlation was observed between the##7##5##(1994-6#1)(2008-1#1)(2008-10#4)(2008-7#1)
correlation was observed between##16##4##(1991-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#2)(2010-8#1)
correlation was observed##19##3##(1991-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#2)(2010-8#1)
correlation was obtained between##2##4##(1993-2#1)(2008-10#1)
correlation was obtained##3##3##(1993-2#1)(2008-10#2)
correlation was##101##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#3)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
correlation with a##2##3##(2008-3#1)(2011-2#1)
correlation with age##4##3##(1990-2#1)(1996-3#1)(2008-7#1)(2011-2#1)
correlation with clinical##2##3##(2008-5#1)(2012-2#1)
correlation with disease##2##3##(1990-12#1)(2008-10#1)
correlation with each other##2##4##(2008-7#1)(2013-8#1)
correlation with glycemic status##2##4##(2012-2#2)
correlation with plasma##2##3##(1996-8#2)
correlation with serum##3##3##(2008-6#1)(2009-5#1)(2011-2#1)
correlation with the obliteration rate##2##5##(2008-7#2)
correlation with the ratio of##2##5##(1995-5#1)(2010-6#1)
correlation with the##40##3##(1990-12#1)(1991-11#2)(1991-12#1)(1991-2#2)(1993-11#1)(1995-5#2)(1996-4#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
correlation with those##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
correlation with##131##2##(1990-12#2)(1990-2#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-5#2)(1996-10#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
correlation##1446##1##(1990-10#1)(1990-12#8)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#9)(1991-2#2)(1991-5#2)(1991-6#6)(1991-8#4)(1991-9#4)(1992-10#2)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#8)(1992-6#7)(1992-8#2)(1992-9#10)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#3)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#9)(1994-7#2)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#6)(1995-5#9)(1995-6#2)(1995-8#6)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#3)(1997-6#6)(1997-7#9)(1997-8#3)(2006-10#2)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#11)(2007-11#20)(2007-12#41)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#8)(2008-1#14)(2008-10#349)(2008-11#26)(2008-12#25)(2008-2#65)(2008-3#167)(2008-4#6)(2008-5#34)(2008-6#13)(2008-7#51)(2008-8#33)(2008-9#23)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#3)(2010-8#13)(2010-9#3)(2011-1#26)(2011-2#51)(2011-3#3)(2012-1#2)(2012-12#9)(2012-2#22)(2012-3#12)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#33)(2013-7#12)(2013-8#30)
correlation)##2##1##(1996-1#1)(2012-2#1)
correlation-based pattern recognition##2##3##(2007-12#1)(2008-3#1)
correlation-based##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
correlation-filter##2##1##(2008-3#2)
correlation-peak moment analysis##2##3##(2008-2#2)
correlation-peak moment##3##2##(2008-2#3)
correlation-peak##5##1##(2008-2#4)(2008-3#1)
correlation-plane##2##1##(2008-3#2)
correlational analysis##3##2##(1996-5#1)(2008-4#1)(2011-1#1)
correlational study##6##2##(2007-2#1)(2009-5#1)(2010-10#2)(2010-11#1)(2013-1#1)
correlational##14##1##(1991-3#1)(1996-5#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-10#2)(2010-11#2)(2011-1#1)(2012-3#1)(2013-1#2)
correlations (P##2##2##(1991-12#1)(2008-10#1)
correlations (up to##2##3##(2010-4#2)
correlations among different##2##3##(2008-10#2)
correlations among the##2##3##(1997-3#1)(2008-10#1)
correlations among twig##2##3##(2008-9#2)
correlations among##16##2##(1997-3#1)(2008-10#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2012-12#1)(2012-3#2)
correlations and##8##2##(1992-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2013-1#1)
correlations are##4##2##(1994-5#1)(2008-2#1)(2008-3#1)(2008-8#1)
correlations between both##2##3##(2007-2#1)(2013-8#1)
correlations between disease##2##3##(2008-10#2)
correlations between heavy##2##3##(2011-2#1)(2013-8#1)
correlations between maternal##2##3##(2008-8#1)(2009-11#1)
correlations between the##17##3##(1992-2#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
correlations between these##2##3##(1993-12#1)(2008-10#1)
correlations between variables##2##3##(1995-2#1)(2008-10#1)
correlations between##98##2##(1992-2#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-2#2)(1997-4#1)(2007-10#3)(2007-11#1)(2007-2#2)(2007-6#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#5)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#3)
correlations can be##4##3##(1994-8#1)(1997-4#1)(2008-8#1)(2012-2#1)
correlations can##5##2##(1994-8#2)(1997-4#1)(2008-8#1)(2012-2#1)
correlations existed between the##2##4##(2008-10#1)(2013-1#1)
correlations for##7##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-7#1)
correlations in the##5##3##(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-8#1)
correlations in##16##2##(1994-8#1)(1996-4#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#3)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#2)
correlations may be##2##3##(1997-4#1)(2008-8#1)
correlations may##3##2##(1997-4#1)(2008-8#2)
correlations of the##2##3##(2007-12#1)(2008-10#1)
correlations of##16##2##(1992-6#1)(1994-11#1)(1996-7#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-12#1)(2010-4#1)(2011-1#1)
correlations that##2##2##(2008-2#1)(2008-3#1)
correlations to##3##2##(2008-3#2)(2008-7#1)
correlations was##2##2##(2007-11#1)(2008-10#1)
correlations were calculated##2##3##(2011-1#1)(2012-1#1)
correlations were demonstrated between the expression of##2##7##(2011-3#2)
correlations were demonstrated between the##3##5##(1994-5#1)(2011-3#2)
correlations were found between the##3##5##(1991-6#1)(1995-12#1)(2013-8#1)
correlations were found between##9##4##(1990-8#1)(1991-6#1)(1993-2#1)(1995-12#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-8#1)
correlations were found##12##3##(1990-8#1)(1991-6#1)(1993-2#1)(1995-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
correlations were observed between##4##4##(2008-10#2)(2008-8#1)(2011-1#1)
correlations were observed##5##3##(2008-10#3)(2008-8#1)(2011-1#1)
correlations were obtained##2##3##(2008-10#2)
correlations were##38##2##(1990-8#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-12#1)(2007-10#1)(2007-11#1)(2008-10#12)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#4)(2011-10#1)(2011-3#2)(2012-1#1)(2012-2#1)(2013-8#1)
correlations with the##5##3##(1997-7#1)(2008-11#1)(2008-2#1)(2010-10#1)(2012-1#1)
correlations with##27##2##(1991-3#1)(1992-3#2)(1993-2#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
correlations##323##1##(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-6#9)(1992-9#1)(1993-12#2)(1993-2#3)(1994-11#1)(1994-2#1)(1994-5#2)(1994-7#1)(1994-8#8)(1995-11#1)(1995-12#1)(1995-2#3)(1996-12#1)(1996-4#1)(1996-7#2)(1997-3#1)(1997-4#4)(1997-7#2)(2007-10#5)(2007-11#8)(2007-12#9)(2007-2#2)(2007-6#1)(2008-10#49)(2008-11#5)(2008-12#4)(2008-2#12)(2008-3#16)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#21)(2008-9#19)(2009-10#2)(2009-11#3)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-10#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#9)(2011-10#2)(2011-2#11)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#10)(2012-4#1)(2013-1#6)(2013-7#3)(2013-8#9)
correlationship between##2##2##(2012-2#2)
correlationship##3##1##(2012-2#3)
correlative analyses##2##2##(1993-5#2)
correlative study##2##2##(2009-11#1)(2010-5#1)
correlative##20##1##(1991-8#1)(1993-5#2)(1996-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-2#2)
correlator and##3##2##(2008-2#1)(2008-3#2)
correlator architecture is##2##3##(2007-12#1)(2008-3#1)
correlator architecture##3##2##(2007-12#1)(2008-3#2)
correlator by use of##2##4##(2008-2#1)(2008-3#1)
correlator by##3##2##(2008-2#1)(2008-3#2)
correlator configuration##3##2##(2008-2#1)(2008-3#2)
correlator for##10##2##(2008-2#2)(2008-3#8)
correlator in##2##2##(2008-2#1)(2008-3#1)
correlator is proposed and demonstrated##2##5##(2008-3#2)
correlator is proposed##4##3##(2008-2#1)(2008-3#3)
correlator is##16##2##(2008-2#8)(2008-3#8)
correlator system##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
correlator was##2##2##(2007-12#1)(2008-3#1)
correlator with a##2##3##(2008-3#2)
correlator with##6##2##(2008-3#6)
correlator##103##1##(2007-11#2)(2007-12#5)(2008-2#32)(2008-3#64)
correlators##18##1##(2007-12#1)(2008-2#3)(2008-3#14)
correlograms##4##1##(2008-3#2)(2008-7#1)(2013-7#1)
correspond to a##11##3##(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)
correspond to an##2##3##(1993-11#1)(2008-5#1)
correspond to different##2##3##(1991-7#1)(2007-11#1)
correspond to known##3##3##(1995-9#1)(2008-10#1)(2008-11#1)
correspond to previously##4##3##(1995-6#1)(1995-9#1)(1997-3#1)(2008-10#1)
correspond to several##2##3##(2008-11#1)(2008-8#1)
correspond to small##2##3##(2007-12#1)(2008-9#1)
correspond to the##36##3##(1991-11#1)(1991-6#1)(1992-6#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#2)(2010-8#1)
correspond to those of##2##4##(1994-5#1)(2008-10#1)
correspond to those previously reported##2##5##(2008-10#2)
correspond to those##5##3##(1994-5#1)(1994-8#1)(2008-10#3)
correspond to##124##2##(1990-5#3)(1990-7#1)(1991-11#3)(1991-6#1)(1991-7#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-9#4)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#8)(2008-10#31)(2008-11#4)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-11#1)(2009-4#1)(2009-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
correspond with the##3##3##(1992-1#1)(2008-10#1)(2009-10#1)
correspond with##9##2##(1991-12#1)(1992-1#1)(1995-11#1)(1995-12#1)(2008-10#2)(2009-10#1)(2010-8#1)(2012-3#1)
correspond##140##1##(1990-5#3)(1990-7#1)(1991-11#3)(1991-12#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-9#4)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#8)(2008-10#36)(2008-11#5)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
corresponded to a##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
corresponded to early##2##3##(2009-3#1)(2012-3#1)
corresponded to that of##2##4##(1991-2#1)(2008-7#1)
corresponded to the degree of##2##5##(2008-10#1)(2008-11#1)
corresponded to the##12##3##(1990-5#1)(1995-8#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2012-12#1)
corresponded to their##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
corresponded to##72##2##(1990-5#1)(1991-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-10#25)(2008-11#3)(2008-2#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2009-3#1)(2010-2#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
corresponded well with##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
corresponded well##7##2##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
corresponded with the##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
corresponded with##12##2##(1993-6#1)(1995-5#1)(1996-12#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
corresponded##100##1##(1990-5#1)(1991-2#1)(1992-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#32)(2008-11#8)(2008-12#1)(2008-2#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#4)(2009-3#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
correspondence analysis##11##2##(2008-10#8)(2008-5#2)(2013-7#1)
correspondence between the##2##3##(2008-10#1)(2012-12#1)
correspondence between##7##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-12#1)
correspondence in##2##2##(2008-11#1)(2013-1#1)
correspondence of##2##2##(2012-1#1)(2013-1#1)
correspondence problem in##2##3##(2008-2#1)(2008-6#1)
correspondence to##4##2##(1995-2#1)(1997-4#1)(2008-2#1)(2008-5#1)
correspondence with the##2##3##(2008-10#1)(2008-9#1)
correspondence with##4##2##(2008-10#3)(2008-9#1)
correspondence##46##1##(1991-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
correspondences##5##1##(2008-6#2)(2008-8#1)(2010-4#1)(2011-2#1)
corresponding &quot##2##2##(1994-8#1)(2008-10#1)
corresponding 5'-N-triphosphate nucleotides##2##3##(2008-4#2)
corresponding absorption##2##2##(2008-10#1)(2008-3#1)
corresponding aldehyde##2##2##(2008-10#2)
corresponding amino acid sequence##3##4##(1990-2#1)(1995-8#1)(2008-6#1)
corresponding amino acid##4##3##(1990-2#1)(1995-8#1)(2008-10#1)(2008-6#1)
corresponding antibodies##2##2##(2008-10#2)
corresponding antigen##2##2##(2008-8#2)
corresponding avirulence gene##3##3##(2008-10#3)
corresponding avirulence##4##2##(2008-10#4)
corresponding binary##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
corresponding binding##3##2##(1992-10#1)(2008-10#1)(2008-4#1)
corresponding complex##3##2##(2008-10#2)(2008-11#1)
corresponding controls##3##2##(1995-8#1)(1996-2#1)(2006-6#1)
corresponding data##4##2##(1990-7#1)(2006-10#1)(2008-2#1)(2010-8#1)
corresponding decrease in##4##3##(1995-12#1)(1995-9#1)(2008-11#1)(2008-4#1)
corresponding detection limits##3##3##(2008-10#3)
corresponding detection##4##2##(2008-10#4)
corresponding differences in##2##3##(1993-12#1)(2008-10#1)
corresponding enzymes##3##2##(1990-5#1)(1995-11#1)(1997-3#1)
corresponding experimental##2##2##(1997-7#1)(2008-10#1)
corresponding free##2##2##(1994-12#1)(2008-10#1)
corresponding gene##13##2##(1990-11#1)(1992-8#1)(1993-2#1)(1995-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-2#1)
corresponding genes##8##2##(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
corresponding groups##2##2##(2008-10#1)(2008-5#1)
corresponding high##3##2##(1995-11#1)(2008-10#2)
corresponding hydroxylamines##2##2##(1993-11#1)(1994-11#1)
corresponding idler##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
corresponding image deformation##2##3##(2010-5#2)
corresponding increase in##6##3##(1991-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(2008-5#1)(2011-1#1)
corresponding increase##7##2##(1991-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
corresponding increases##2##2##(1995-2#1)(2011-10#1)
corresponding measures##2##2##(2009-10#1)(2009-7#1)
corresponding mechanisms##2##2##(2007-11#1)(2013-1#1)
corresponding monoclonal antibodies##2##3##(1997-4#1)(2008-12#1)
corresponding monoclonal##3##2##(1997-4#1)(2008-10#1)(2008-12#1)
corresponding neural##2##2##(2008-1#1)(2013-8#1)
corresponding nontransgenic##2##2##(2008-10#2)
corresponding normal tissues##2##3##(1994-2#2)
corresponding normal##4##2##(1992-3#1)(1994-2#2)(2009-10#1)
corresponding observations##2##2##(2008-11#1)(2013-1#1)
corresponding ones##2##2##(1995-5#1)(2008-3#1)
corresponding peaks##2##2##(1990-8#1)(1994-9#1)
corresponding positions##2##2##(1990-2#1)(2008-7#1)
corresponding protein##2##2##(1991-12#1)(1992-3#1)
corresponding rates##4##2##(1995-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
corresponding reference##2##2##(2008-10#1)(2008-12#1)
corresponding region in##2##3##(1991-6#1)(1997-7#1)
corresponding region##4##2##(1990-12#1)(1991-6#1)(1997-7#1)(2007-11#1)
corresponding regions of##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
corresponding relative##2##2##(2008-2#1)(2011-1#1)
corresponding residues##2##2##(1992-4#2)
corresponding resistance gene##3##3##(2008-10#3)
corresponding results##3##2##(2008-10#1)(2008-3#2)
corresponding standard##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
corresponding theoretical##2##2##(2008-2#1)(2008-3#1)
corresponding thermodynamic##2##2##(2008-10#2)
corresponding to 0##4##3##(2007-5#1)(2008-10#1)(2008-3#1)(2010-12#1)
corresponding to 1##3##3##(2008-10#3)
corresponding to 16##2##3##(1996-5#1)(2007-12#1)
corresponding to 3##2##3##(2008-10#1)(2013-1#1)
corresponding to M##2##3##(1993-3#1)(2011-2#1)
corresponding to a given##2##4##(2007-11#1)(2008-10#1)
corresponding to a molecular##2##4##(1992-3#1)(1995-2#1)
corresponding to a single##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
corresponding to a specific##2##4##(2008-2#1)(2008-9#1)
corresponding to a##48##3##(1990-2#3)(1990-5#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-2#2)(1996-10#1)(1996-3#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
corresponding to about##3##3##(1995-11#1)(2008-10#1)(2012-2#1)
corresponding to an efficiency of##2##5##(2007-12#2)
corresponding to an estimated delta Ka##2##6##(1995-2#2)
corresponding to an estimated##3##4##(1991-11#1)(1995-2#2)
corresponding to an increase in##2##5##(2008-2#1)(2008-5#1)
corresponding to an##19##3##(1991-11#1)(1992-3#1)(1995-2#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#3)(2012-3#1)
corresponding to any##2##3##(2008-4#1)(2011-1#1)
corresponding to both##2##3##(2008-10#2)
corresponding to different##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
corresponding to each##6##3##(2008-10#4)(2008-11#1)(2008-3#1)
corresponding to its##2##3##(2008-5#1)(2013-1#1)
corresponding to residues##8##3##(1991-12#1)(1992-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-8#1)
corresponding to some##2##3##(2008-10#2)
corresponding to the 28##3##4##(1996-12#3)
corresponding to the 40##3##4##(1996-12#3)
corresponding to the N-terminal 27##2##5##(1990-7#2)
corresponding to the N-terminal##3##4##(1990-7#2)(2011-1#1)
corresponding to the alpha##2##4##(1991-2#1)(1992-2#1)
corresponding to the equivalence point was sensed##2##7##(2008-10#2)
corresponding to the four##2##4##(2008-10#2)
corresponding to the maximum##2##4##(2008-10#2)
corresponding to the previously##2##4##(2008-10#2)
corresponding to the putative##2##4##(1993-2#1)(1994-5#1)
corresponding to the reduction of##2##5##(2008-10#2)
corresponding to the region##2##4##(1994-8#1)(1996-6#1)
corresponding to the three##3##4##(1992-8#1)(1994-2#1)(2008-10#1)
corresponding to the##125##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#6)(1996-6#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
corresponding to their##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
corresponding to these##6##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
corresponding to this conserved sequence##2##5##(1992-3#1)(1994-8#1)
corresponding to this##3##3##(1992-3#1)(1994-12#1)(1994-8#1)
corresponding to three times the standard deviation of##6##8##(2008-10#6)
corresponding to three##7##3##(1991-9#1)(2008-10#6)
corresponding to two##2##3##(2008-10#2)
corresponding to various##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
corresponding to##377##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#2)(1992-8#3)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-2#10)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#8)(1996-3#1)(1996-5#2)(1996-6#4)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#3)(2007-10#2)(2007-11#8)(2007-12#7)(2007-5#1)(2008-10#112)(2008-11#6)(2008-12#1)(2008-2#14)(2008-3#23)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-1#1)(2012-2#9)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#7)(2013-8#6)
corresponding values for##8##3##(1991-2#1)(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
corresponding values##20##2##(1990-7#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-11#1)(2008-10#6)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)
corresponding with the##2##3##(1993-8#1)(2007-12#1)
corresponding with##3##2##(1993-8#1)(2007-12#1)(2008-10#1)
corresponding##1005##1##(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#8)(1990-7#5)(1990-8#7)(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#5)(1991-8#4)(1991-9#7)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#8)(1992-4#3)(1992-6#5)(1992-8#9)(1993-1#1)(1993-11#6)(1993-12#4)(1993-2#3)(1993-3#3)(1993-6#4)(1993-8#6)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#5)(1994-3#3)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#7)(1994-9#2)(1995-11#7)(1995-12#1)(1995-2#16)(1995-3#7)(1995-5#1)(1995-6#4)(1995-8#7)(1995-9#4)(1996-10#3)(1996-12#10)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#17)(1996-6#5)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#7)(1997-6#5)(1997-7#12)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#37)(2007-12#16)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#260)(2008-11#13)(2008-12#5)(2008-2#38)(2008-3#63)(2008-4#16)(2008-5#25)(2008-6#7)(2008-7#19)(2008-8#18)(2008-9#10)(2009-10#9)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#4)(2011-1#12)(2011-10#2)(2011-2#20)(2011-3#1)(2012-1#6)(2012-2#13)(2012-3#6)(2012-5#1)(2012-8#2)(2013-1#14)(2013-8#14)
correspondingly##16##1##(1993-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
corresponds closely to the##2##4##(1996-5#1)(2008-2#1)
corresponds to a##27##3##(1992-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#7)(2008-7#1)(2009-12#1)(2012-2#1)
corresponds to an increase of##2##5##(2008-3#1)(2011-2#1)
corresponds to an optical##2##4##(2007-12#1)(2008-2#1)
corresponds to an##10##3##(1995-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#1)(2011-2#1)(2012-12#1)
corresponds to approximately##2##3##(1991-11#1)(2008-10#1)
corresponds to that of the##2##5##(2008-11#1)(2008-2#1)
corresponds to that of##3##4##(2008-11#1)(2008-2#1)(2011-2#1)
corresponds to the##44##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#4)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
corresponds to two##3##3##(1993-6#1)(2008-3#1)(2008-8#1)
corresponds to##118##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#1)(2007-11#6)(2007-12#10)(2007-2#1)(2008-10#22)(2008-11#3)(2008-2#10)(2008-3#15)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
corresponds well to##2##3##(1996-6#1)(1997-2#1)
corresponds well##3##2##(1996-6#1)(1997-2#1)(2008-10#1)
corresponds with the##2##3##(2008-10#1)(2008-3#1)
corresponds with##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
corresponds##128##1##(1990-11#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#6)(2007-12#10)(2007-2#1)(2008-10#24)(2008-11#3)(2008-2#11)(2008-3#16)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
corridor##2##1##(1991-3#1)(2006-12#1)
corridors##4##1##(2008-9#3)(2012-2#1)
corroborate the##6##2##(1995-5#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-11#1)
corroborate this##2##2##(2008-12#1)(2013-8#1)
corroborate##17##1##(1995-5#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-9#1)(2010-7#2)(2013-8#1)
corroborated by measurements##2##3##(2008-10#1)(2008-2#1)
corroborated by the presence of##2##5##(2007-10#1)(2008-10#1)
corroborated by the##3##3##(1990-7#1)(2007-10#1)(2008-10#1)
corroborated by##17##2##(1990-7#1)(1991-6#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)
corroborated in##2##2##(1992-3#1)(2008-10#1)
corroborated that##2##2##(2008-10#1)(2008-2#1)
corroborated the##4##2##(2008-10#2)(2008-3#1)(2009-8#1)
corroborated##31##1##(1990-7#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#2)(2009-8#1)(2011-1#1)
corroborates the##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2009-8#1)
corroborates##9##1##(1992-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
corroborating evidence##2##2##(2007-8#1)(2008-7#1)
corroborating##4##1##(1991-9#1)(2007-8#1)(2008-7#1)(2013-8#1)
corroboration##2##1##(1992-3#1)(2008-3#1)
corrodens##5##1##(1997-8#1)(2007-7#3)(2013-8#1)
corrole##2##1##(2008-10#2)
corrosion and##3##2##(2008-10#2)(2008-11#1)
corrosion beneath the paint##2##4##(2007-12#2)
corrosion beneath the##3##3##(2007-12#3)
corrosion beneath##4##2##(2007-12#4)
corrosion in##2##2##(2007-12#2)
corrosion inhibition of##2##3##(2013-1#2)
corrosion inhibition##4##2##(2013-1#4)
corrosion of##2##2##(2007-12#1)(2011-2#1)
corrosion process##2##2##(2008-3#2)
corrosion stability##4##2##(2010-4#4)
corrosion##46##1##(1992-11#1)(2007-12#12)(2008-10#8)(2008-11#1)(2008-3#3)(2010-4#5)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#8)
corrosive##4##1##(2008-10#2)(2008-11#1)(2013-1#1)
corrugated long-period fiber##2##3##(2008-3#2)
corrugated long-period##4##2##(2008-3#4)
corrugated metal##2##2##(2007-12#2)
corrugated structure can be##2##4##(2008-3#2)
corrugated structure##3##2##(2008-3#3)
corrugated waveguide##2##2##(2007-9#1)(2008-2#1)
corrugated waveguides##2##2##(2007-12#2)
corrugated##17##1##(2007-12#5)(2007-9#3)(2008-2#1)(2008-3#8)
corrupt##3##1##(1996-5#1)(2008-3#2)
corrupted by##3##2##(2008-2#2)(2008-3#1)
corrupted with##2##2##(2008-2#1)(2008-3#1)
corrupted##7##1##(2008-2#3)(2008-3#4)
corruption##4##1##(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
corset##2##1##(1996-8#1)(2012-1#1)
cortex &gt##2##2##(1993-9#1)(1996-12#1)
cortex (areas##2##2##(1994-3#1)(2013-8#1)
cortex (mPFC)##4##2##(2008-11#2)(2008-6#2)
cortex activation##3##2##(1994-8#1)(1996-6#1)(2007-10#1)
cortex after##4##2##(1996-12#1)(2007-10#1)(2008-11#1)(2008-2#1)
cortex and basal ganglia##2##4##(1996-12#1)(1996-5#1)
cortex and hippocampus of the##3##5##(1993-3#1)(1995-12#1)(2013-1#1)
cortex and hippocampus of##4##4##(1993-3#1)(1995-12#2)(2013-1#1)
cortex and hippocampus##14##3##(1992-7#1)(1992-8#1)(1993-3#1)(1994-2#2)(1994-6#2)(1995-12#3)(1996-12#1)(1996-2#1)(2013-1#1)(2013-8#1)
cortex and medulla##2##3##(1996-5#2)
cortex and nucleus##2##3##(1991-9#1)(1997-2#1)
cortex and striatum##5##3##(1996-5#1)(1997-2#4)
cortex and the##11##3##(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
cortex and##72##2##(1990-7#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#4)(1994-3#3)(1994-6#5)(1994-8#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#4)(1997-2#7)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2010-7#1)(2013-1#1)(2013-8#3)
cortex as a##4##3##(1991-8#1)(1995-8#1)(2008-11#1)(2008-9#1)
cortex as##5##2##(1991-8#1)(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
cortex at the##2##3##(2009-10#1)(2011-1#1)
cortex at##3##2##(2009-10#1)(2011-1#1)(2013-1#1)
cortex both##2##2##(1996-2#1)(2011-1#1)
cortex but not in the hippocampus##2##6##(1994-3#1)(2008-11#1)
cortex but not in the##3##5##(1990-5#1)(1994-3#1)(2008-11#1)
cortex but not##4##3##(1990-5#1)(1993-3#1)(1994-3#1)(2008-11#1)
cortex by##3##2##(1990-12#1)(2008-9#1)(2012-2#1)
cortex differentiate##2##2##(2008-11#1)(2008-7#1)
cortex during##5##2##(1995-11#1)(1995-12#1)(1996-5#1)(2007-9#1)(2008-9#1)
cortex excitability##2##2##(2010-7#1)(2011-2#1)
cortex for##3##2##(1995-6#1)(1996-5#1)(2010-7#1)
cortex from the##2##3##(1993-9#1)(2008-11#1)
cortex from##6##2##(1992-8#1)(1993-9#1)(1994-3#1)(1996-5#1)(2008-11#1)(2011-2#1)
cortex have##2##2##(1993-3#1)(2009-10#1)
cortex homogenate##2##2##(1990-12#1)(2010-4#1)
cortex in the##7##3##(1990-7#1)(1997-8#1)(2008-1#2)(2008-5#1)(2008-9#1)(2009-10#1)
cortex in##21##2##(1990-5#1)(1990-7#1)(1991-6#1)(1993-12#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-1#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-7#2)(2012-1#1)
cortex induced by##3##3##(1992-12#1)(1994-8#1)(1997-2#1)
cortex is associated with##3##4##(2008-6#3)
cortex is##9##2##(1990-8#1)(1995-11#1)(1996-5#1)(2008-11#1)(2008-6#3)(2009-10#2)
cortex may play a##2##4##(1990-11#1)(2012-2#1)
cortex may##3##2##(1990-11#1)(1996-2#1)(2012-2#1)
cortex neurons##3##2##(1991-6#2)(1995-8#1)
cortex of Wistar##2##3##(1995-8#1)(2008-10#1)
cortex of adult cats##2##4##(1993-12#1)(1994-8#1)
cortex of adult##5##3##(1992-10#1)(1993-12#1)(1994-8#1)(1995-12#2)
cortex of each##2##3##(1994-5#1)(1996-5#1)
cortex of the rat##2##4##(1994-3#1)(1996-5#1)
cortex of the##17##3##(1992-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)
cortex of##54##2##(1992-10#1)(1992-9#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#6)(1997-2#3)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
cortex on##2##2##(1993-6#1)(2011-2#1)
cortex or##3##2##(1993-6#2)(2008-7#1)
cortex produces##2##2##(1994-3#1)(2008-4#1)
cortex slices##4##2##(1994-8#3)(1995-12#1)
cortex that##2##2##(2007-8#1)(2010-7#1)
cortex to##3##2##(1991-8#1)(2008-11#1)(2008-5#1)
cortex was##9##2##(1991-12#1)(1992-11#1)(1992-12#1)(1992-7#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)
cortex were##8##2##(1990-8#1)(1993-6#1)(1995-6#1)(1996-2#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
cortex which##4##2##(1991-9#1)(1993-6#1)(1994-3#1)(2008-11#1)
cortex with##5##2##(1993-12#2)(1995-3#1)(1996-5#1)(2008-7#1)
cortex##628##1##(1990-11#5)(1990-12#2)(1990-5#6)(1990-7#4)(1990-8#3)(1990-9#1)(1991-12#6)(1991-2#3)(1991-4#2)(1991-5#7)(1991-6#5)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#19)(1993-3#3)(1993-6#7)(1993-8#2)(1993-9#4)(1994-12#1)(1994-2#11)(1994-3#26)(1994-5#2)(1994-6#6)(1994-8#22)(1994-9#1)(1995-11#9)(1995-12#16)(1995-2#5)(1995-3#2)(1995-5#5)(1995-6#5)(1995-8#4)(1996-12#17)(1996-2#17)(1996-5#29)(1996-6#1)(1997-2#38)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-10#5)(2007-8#9)(2007-9#2)(2008-1#6)(2008-10#28)(2008-11#59)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#8)(2008-7#30)(2008-8#9)(2008-9#15)(2009-10#11)(2009-12#2)(2009-5#4)(2009-9#3)(2010-12#1)(2010-3#3)(2010-4#3)(2010-7#20)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#5)(2012-12#2)(2012-2#17)(2013-1#9)(2013-8#15)
cortex's##2##1##(2011-3#2)
cortex) was##2##2##(1994-2#1)(2013-1#1)
cortex)##4##1##(1994-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
cortexin##5##1##(2010-4#5)
cortical F-actin accumulation##2##3##(2009-10#2)
cortical Lbs##3##2##(2008-7#3)
cortical activation during##2##3##(2008-11#2)
cortical activation in##2##3##(1996-2#1)(2008-2#1)
cortical activation##9##2##(1994-3#2)(1996-2#1)(2008-11#2)(2008-2#2)(2012-12#2)
cortical activity and##2##3##(1992-12#1)(2010-7#1)
cortical activity##8##2##(1992-12#1)(2008-11#4)(2009-6#1)(2010-7#1)(2013-8#1)
cortical allograft##5##2##(2011-2#5)
cortical and hippocampal##3##3##(1994-2#2)(2013-8#1)
cortical and stelar cells of##2##5##(2008-9#2)
cortical and stelar cells##3##4##(2008-9#3)
cortical and subcortical##4##3##(2008-11#3)(2013-1#1)
cortical and##20##2##(1991-10#3)(1991-5#1)(1994-2#2)(1995-11#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-9#3)(2009-7#1)(2013-1#1)(2013-8#1)
cortical area##5##2##(1991-2#1)(1996-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
cortical areas and##2##3##(1995-5#1)(1997-2#1)
cortical areas##12##2##(1990-8#1)(1993-9#1)(1995-2#1)(1995-5#1)(1997-2#2)(2007-8#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-6#1)
cortical atrophy##4##2##(2008-7#1)(2009-9#1)(2011-1#2)
cortical bone is##3##3##(1996-3#1)(2009-7#2)
cortical bone regions that were##2##5##(1995-6#2)
cortical bone remodelling##2##3##(2013-1#2)
cortical bone##31##2##(1992-3#1)(1993-11#3)(1995-6#5)(1996-3#2)(2007-11#3)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-7#7)(2011-2#1)(2012-3#1)(2013-1#4)
cortical cell##4##2##(1995-2#1)(2008-10#3)
cortical cells in##5##3##(2008-10#2)(2008-8#3)
cortical cells of##5##3##(2008-10#4)(2011-2#1)
cortical cells##31##2##(1990-8#2)(1996-12#1)(1996-2#3)(2008-10#16)(2008-11#4)(2008-8#3)(2008-9#1)(2011-2#1)
cortical cholinergic##2##2##(1992-10#1)(1996-5#1)
cortical circuit##2##2##(2008-11#2)
cortical circuitry##3##2##(1994-3#1)(2008-11#1)(2012-2#1)
cortical circuits##2##2##(2008-11#1)(2011-2#1)
cortical computation##3##2##(2008-11#3)
cortical concentrations of##2##3##(1990-5#1)(1992-11#1)
cortical control##2##2##(1993-3#2)
cortical cultures##3##2##(1994-2#1)(1995-5#2)
cortical development##2##2##(2007-8#1)(2012-2#1)
cortical dopamine##3##2##(2008-6#2)(2008-7#1)
cortical excitability##2##2##(2008-9#1)(2012-2#1)
cortical infarct##2##2##(2007-10#1)(2008-4#1)
cortical infarcts##2##2##(2007-10#2)
cortical layers and##3##3##(1993-12#1)(2007-8#1)(2008-10#1)
cortical layers##13##2##(1993-12#7)(1994-2#1)(1995-2#2)(2007-8#1)(2008-10#2)
cortical lesion##3##2##(1991-2#1)(2008-4#1)(2008-7#1)
cortical lesions in##2##3##(1994-3#1)(2008-4#1)
cortical lesions##4##2##(1994-3#2)(1996-2#1)(2008-4#1)
cortical levels of##2##3##(1990-5#1)(1996-12#1)
cortical mechanisms##3##2##(1995-11#1)(1996-5#1)(2007-8#1)
cortical membranes##4##2##(1990-5#1)(1993-6#2)(1996-2#1)
cortical network##4##2##(1995-5#1)(2008-11#1)(2009-8#2)
cortical neurons in##3##3##(1995-12#1)(1997-2#1)(2008-11#1)
cortical neurons to##2##3##(1995-12#1)(1996-2#1)
cortical neurons##18##2##(1991-5#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#3)(2008-11#3)(2008-4#2)(2008-7#1)(2009-8#1)(2012-2#1)
cortical or##2##2##(1993-6#1)(1995-11#1)
cortical parenchyma##2##2##(2008-10#2)
cortical plasticity##2##2##(2008-11#1)(2008-2#1)
cortical plate##2##2##(1996-12#1)(2012-3#1)
cortical processing##5##2##(1994-8#2)(1996-2#1)(1996-5#1)(2008-11#1)
cortical pyramidal##2##2##(1993-12#1)(1996-5#1)
cortical region##6##2##(1990-11#1)(1996-2#1)(2008-11#2)(2010-7#2)
cortical regions and##2##3##(1996-12#1)(2008-11#1)
cortical regions in##2##3##(1996-12#1)(1996-5#1)
cortical regions##14##2##(1991-10#1)(1996-12#2)(1996-5#2)(2007-8#2)(2008-11#4)(2012-2#2)(2013-8#1)
cortical screws##2##2##(2013-1#2)
cortical sensory##2##2##(2008-7#1)(2009-6#1)
cortical sites##2##2##(1993-11#1)(1994-3#1)
cortical slices##7##2##(1990-7#1)(1993-12#1)(1994-5#2)(1995-12#2)(1997-1#1)
cortical spreading depression##2##3##(2007-10#2)
cortical stimulation##4##2##(2009-9#1)(2010-7#2)(2011-2#1)
cortical stroke##2##2##(2008-2#1)(2012-1#1)
cortical structures##6##2##(1991-10#1)(1993-9#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-7#1)
cortical sulci##2##2##(1991-12#1)(2008-7#1)
cortical thickness##6##2##(1997-3#1)(2013-1#5)
cortical tissue and##2##3##(1996-12#1)(2008-10#1)
cortical tissue##3##2##(1996-12#1)(2008-10#2)
cortical tissues##2##2##(2008-10#1)(2008-12#1)
cortical veins##2##2##(1996-9#1)(2008-7#1)
cortical zones##2##2##(1996-5#1)(2008-10#1)
cortical##425##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#5)(1990-7#1)(1990-8#4)(1990-9#2)(1991-10#6)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#4)(1993-12#10)(1993-3#2)(1993-6#4)(1993-9#2)(1994-11#1)(1994-2#6)(1994-3#6)(1994-5#2)(1994-8#4)(1995-11#3)(1995-12#11)(1995-2#7)(1995-3#1)(1995-5#8)(1995-6#5)(1996-12#10)(1996-2#12)(1996-3#2)(1996-5#20)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#1)(2007-10#8)(2007-11#3)(2007-12#2)(2007-8#9)(2008-1#4)(2008-10#30)(2008-11#40)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#4)(2008-7#28)(2008-8#6)(2008-9#9)(2009-10#4)(2009-5#2)(2009-6#3)(2009-7#10)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#9)(2010-9#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#16)(2013-8#7)
cortically##2##1##(1990-9#1)(2011-2#1)
cortices in##3##2##(1996-5#1)(2007-8#1)(2012-12#1)
cortices##25##1##(1993-12#1)(1994-3#1)(1996-12#3)(1996-5#5)(1997-2#1)(2007-8#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-7#2)(2012-1#1)(2012-12#3)(2013-8#1)
cortices)##3##1##(1991-5#2)(1992-11#1)
cortico-hippocampal circuits##2##2##(2013-8#2)
cortico-striatal##2##1##(1996-2#1)(2009-7#1)
corticogeniculate##2##1##(2008-1#2)
corticoid##3##1##(1996-6#1)(1997-2#1)(2010-12#1)
corticoids##4##1##(2008-1#1)(2009-6#1)(2010-12#1)(2011-2#1)
corticomedullary##2##1##(1994-5#1)(2007-7#1)
corticopontine projections##2##2##(2008-11#2)
corticopontine##3##1##(2008-11#3)
corticospinal##4##1##(1995-11#1)(2007-10#1)(2008-9#1)(2013-8#1)
corticosteroid in##2##2##(2008-1#1)(2009-5#1)
corticosteroid or##2##2##(2008-9#2)
corticosteroid receptors##2##2##(1995-11#1)(2008-11#1)
corticosteroid therapy in##2##3##(2008-1#1)(2012-1#1)
corticosteroid therapy is##2##3##(2008-1#1)(2010-6#1)
corticosteroid therapy##13##2##(1992-2#1)(1993-2#1)(2006-10#1)(2007-7#1)(2008-1#4)(2008-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
corticosteroid treatment##3##2##(2007-11#1)(2008-11#1)(2009-6#1)
corticosteroid##54##1##(1991-8#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-5#1)(1997-7#1)(2006-10#3)(2007-11#3)(2007-7#2)(2008-1#8)(2008-11#7)(2008-7#2)(2008-9#5)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)
corticosteroid-treated##2##1##(2008-9#2)
corticosteroids and##13##2##(1990-3#1)(1994-6#1)(2006-10#2)(2007-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#1)
corticosteroids are##8##2##(2007-11#3)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
corticosteroids can##2##2##(1996-7#1)(2007-11#1)
corticosteroids has##2##2##(1997-5#1)(2007-11#1)
corticosteroids in the treatment of##2##5##(1992-3#1)(2007-7#1)
corticosteroids in##3##2##(1992-3#1)(2007-7#1)(2011-2#1)
corticosteroids may##3##2##(1993-9#1)(2007-11#1)(2007-7#1)
corticosteroids or##3##2##(2010-4#1)(2013-1#1)(2013-8#1)
corticosteroids should##2##2##(2007-11#2)
corticosteroids to##2##2##(2008-3#1)(2011-2#1)
corticosteroids##89##1##(1990-3#1)(1990-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-5#2)(1997-8#1)(2006-10#5)(2007-11#16)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#2)
corticosterone (CS)##2##2##(1995-3#1)(1997-2#1)
corticosterone and 18-hydroxycorticosterone##2##3##(1990-11#1)(2008-4#1)
corticosterone and##5##2##(1990-11#2)(1994-2#1)(1996-12#1)(2008-4#1)
corticosterone concentrations##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
corticosterone in##2##2##(2008-10#1)(2012-1#1)
corticosterone level##4##2##(2008-10#1)(2012-1#1)(2013-1#2)
corticosterone levels and##3##3##(2008-7#3)
corticosterone levels were##3##3##(2008-10#1)(2008-7#2)
corticosterone levels##10##2##(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#7)
corticosterone synthesis##3##2##(1996-2#2)(2008-7#1)
corticosterone to 11-dehydrocorticosterone##2##3##(1990-11#2)
corticosterone to##3##2##(1990-11#2)(2008-7#1)
corticosterone was##3##2##(1990-5#1)(1994-6#1)(2013-1#1)
corticosterone##59##1##(1990-11#6)(1990-5#2)(1994-2#1)(1994-6#4)(1995-12#1)(1995-3#2)(1996-12#5)(1996-2#2)(1997-2#2)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#14)(2008-8#1)(2008-9#1)(2012-1#2)(2013-1#3)
corticostriatal EPSCs##4##2##(2009-12#4)
corticostriatal##5##1##(2009-12#5)
corticothalamic##2##1##(1996-2#1)(2008-1#1)
corticotherapy##2##1##(2009-5#1)(2013-7#1)
corticotrophin-releasing factor (CRF)##2##3##(1997-4#1)(2008-3#1)
corticotrophin-releasing##4##1##(1997-4#1)(2008-3#1)(2008-4#2)
corticotropin releasing##4##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-6#1)
corticotropin secretion##2##2##(1991-11#1)(1995-11#1)
corticotropin##8##1##(1990-12#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#1)
corticotropin-releasing factor (CRF)##2##3##(1996-12#1)(2008-4#1)
corticotropin-releasing factor##5##2##(1990-3#1)(1992-12#1)(1996-12#1)(2008-4#2)
corticotropin-releasing hormone (CRH)##3##3##(1990-12#2)(2008-11#1)
corticotropin-releasing hormone##9##2##(1990-12#2)(1990-5#1)(1991-10#1)(1992-9#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-6#1)
corticotropin-releasing##16##1##(1990-12#2)(1990-3#1)(1990-5#2)(1991-10#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-4#3)(2008-6#1)
cortisectomies##2##1##(2012-3#2)
cortisol after##3##2##(2008-1#1)(2008-6#1)(2013-1#1)
cortisol and##8##2##(1990-12#1)(1991-6#1)(2008-5#2)(2011-1#2)(2012-3#1)(2013-1#1)
cortisol concentrations##3##2##(1990-11#1)(2008-5#1)(2013-1#1)
cortisol in##5##2##(1990-11#1)(1992-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
cortisol level##4##2##(2011-2#4)
cortisol levels increased after##2##4##(2008-6#2)
cortisol levels##11##2##(2007-7#1)(2008-3#1)(2008-6#6)(2008-8#1)(2010-4#1)(2011-2#1)
cortisol regulation or##2##3##(2012-12#2)
cortisol regulation##3##2##(2008-11#1)(2012-12#2)
cortisol##95##1##(1990-11#2)(1990-12#4)(1990-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-6#1)(1995-11#9)(1996-12#1)(1997-1#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-3#1)(2008-5#8)(2008-6#10)(2008-8#1)(2010-2#3)(2010-4#3)(2011-1#2)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#12)(2013-8#1)
cortisol) as well as##2##4##(2008-5#1)(2012-2#1)
cortisol)##3##1##(1997-1#1)(2008-5#1)(2012-2#1)
cortisol-binding##2##1##(1990-2#1)(2008-10#1)
cortisone##4##1##(1990-5#1)(2008-10#2)(2010-5#1)
cortistatin##4##1##(2009-11#4)
cortistatins##3##1##(2009-10#2)(2009-11#1)
corvid##2##1##(1994-3#2)
coryli##2##1##(2008-10#2)
corymbifera##7##1##(2008-5#7)
cos region##2##2##(1990-11#2)
cos site##3##2##(1990-5#1)(1996-2#2)
cos##9##1##(1990-11#4)(1990-5#1)(1996-2#2)(2008-3#2)
cos-1 cells##3##2##(1992-3#1)(1995-5#2)
cos-containing##2##1##(1990-11#2)
cosegregate with##2##2##(1991-6#1)(2008-10#1)
cosegregated##2##1##(2008-10#2)
cosegregation##3##1##(1994-8#1)(2008-10#1)(2013-1#1)
cosine of the##7##3##(2007-12#1)(2008-10#1)(2008-3#4)(2008-7#1)
cosine of##9##2##(2007-12#1)(2008-10#1)(2008-3#6)(2008-7#1)
cosine phase modulation##2##3##(2007-12#2)
cosine transform##2##2##(2008-2#2)
cosine##22##1##(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#11)(2008-7#1)
cosines##4##1##(2008-2#2)(2008-3#2)
cosmesis and function##2##3##(2008-9#1)(2013-8#1)
cosmesis is##2##2##(2007-8#1)(2010-11#1)
cosmesis##12##1##(1991-2#1)(1994-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
cosmetic and functional results##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
cosmetic and functional##5##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
cosmetic and pharmaceutical products##2##4##(2008-5#2)
cosmetic and pharmaceutical##4##3##(2008-10#1)(2008-5#3)
cosmetic and##16##2##(1991-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#6)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
cosmetic applications##2##2##(2008-5#2)
cosmetic creams##3##2##(2008-10#2)(2008-5#1)
cosmetic effect##3##2##(2012-12#2)(2013-1#1)
cosmetic effects##2##2##(2008-5#2)
cosmetic efficacy##2##2##(2008-5#2)
cosmetic emulsions##2##2##(2008-5#2)
cosmetic facial surgery##2##3##(2008-7#2)
cosmetic formulae##2##2##(2008-5#2)
cosmetic formulation##6##2##(2008-5#6)
cosmetic formulations##16##2##(2008-5#16)
cosmetic industry##9##2##(2008-5#8)(2008-9#1)
cosmetic ingredient##7##2##(2008-5#7)
cosmetic ingredients and##2##3##(2008-5#2)
cosmetic ingredients##9##2##(2008-5#9)
cosmetic materials##4##2##(2007-12#1)(2008-5#3)
cosmetic or pharmaceutical##2##3##(2008-5#2)
cosmetic or##3##2##(2008-5#3)
cosmetic outcome and##2##3##(1993-9#1)(2011-2#1)
cosmetic outcome##4##2##(1993-9#1)(1995-8#1)(2011-2#1)(2012-12#1)
cosmetic outcomes##3##2##(2009-5#1)(2012-12#2)
cosmetic preparations##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
cosmetic problem##2##2##(2008-5#1)(2013-1#1)
cosmetic product##8##2##(2008-10#1)(2008-5#7)
cosmetic products can be##3##4##(2008-5#3)
cosmetic products to##2##3##(2008-5#2)
cosmetic products##38##2##(2008-10#3)(2008-5#35)
cosmetic properties##2##2##(2008-5#2)
cosmetic result##6##2##(1991-8#1)(2006-12#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
cosmetic results##8##2##(1991-2#2)(2007-8#1)(2008-7#1)(2009-5#2)(2011-2#1)(2013-1#1)
cosmetic samples##3##2##(2008-10#1)(2008-5#2)
cosmetic skin##2##2##(2007-12#1)(2007-7#1)
cosmetic surgery##12##2##(1997-3#1)(2007-12#4)(2010-8#7)
cosmetic treatment##3##2##(2008-5#2)(2013-7#1)
cosmetic treatments##3##2##(2008-5#3)
cosmetic use##5##2##(2008-5#5)
cosmetic vehicle used##2##3##(2008-5#2)
cosmetic##256##1##(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#7)(2007-7#3)(2007-8#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#171)(2008-7#4)(2008-9#2)(2009-5#4)(2009-9#1)(2010-8#10)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
cosmetically acceptable##2##2##(2007-7#1)(2007-8#1)
cosmetically##9##1##(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#4)(2008-9#1)(2013-1#1)
cosmetics and##3##2##(2008-5#3)
cosmetics are##2##2##(2008-5#2)
cosmetics as##2##2##(2008-10#2)
cosmetics have been##4##3##(2008-5#4)
cosmetics in##2##2##(2007-7#1)(2008-5#1)
cosmetics should##2##2##(2007-7#1)(2008-5#1)
cosmetics such as##2##3##(2008-5#2)
cosmetics using##3##2##(2008-5#3)
cosmetics##90##1##(1994-1#1)(2007-7#6)(2008-10#5)(2008-11#1)(2008-5#74)(2010-4#1)(2010-8#1)(2013-1#1)
cosmetics)##2##1##(2008-5#2)
cosmetiques##2##1##(2008-5#2)
cosmetology##4##1##(2008-5#4)
cosmic##5##1##(1996-6#1)(1997-5#2)(2008-2#1)(2008-4#1)
cosmid DNA##2##2##(2008-4#2)
cosmid clone##7##2##(1995-8#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-9#1)(2008-10#1)
cosmid clones from##2##3##(1994-11#1)(2008-10#1)
cosmid clones##4##2##(1994-11#1)(1996-10#1)(1996-6#1)(2008-10#1)
cosmid contigs##2##2##(1994-11#1)(1997-2#1)
cosmid library##5##2##(1990-11#1)(1993-12#1)(1994-11#1)(1996-8#1)(1997-7#1)
cosmid vector##3##2##(1996-2#2)(2008-6#1)
cosmid##34##1##(1990-11#1)(1990-5#1)(1993-12#2)(1993-3#1)(1994-11#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#4)(1996-3#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-9#2)(2008-10#2)(2008-4#2)(2008-6#3)
cosmids were##2##2##(1990-11#1)(1997-7#1)
cosmids##7##1##(1990-11#1)(1993-12#1)(1993-6#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-4#1)
cosmogenesis and##2##2##(2013-1#2)
cosmopolitan species##2##2##(2008-12#1)(2010-8#1)
cosmopolitan##6##1##(2008-10#2)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)
cosolvent concentrations##2##2##(2008-7#2)
cosolvent##8##1##(2008-10#2)(2008-7#5)(2010-2#1)
cosolvents##2##1##(2008-10#1)(2008-7#1)
cosputtering##2##1##(2008-3#2)
cost accounting##6##2##(1993-1#1)(1993-2#2)(1995-12#2)(2007-4#1)
cost analysis of##2##3##(1997-2#1)(2010-5#1)
cost analysis##4##2##(1997-2#1)(2007-4#1)(2008-10#1)(2010-5#1)
cost and effectiveness of##3##4##(1992-5#1)(2010-8#1)(2013-1#1)
cost and effectiveness##4##3##(1992-5#1)(1993-12#1)(2010-8#1)(2013-1#1)
cost and efficiency##2##3##(2008-9#1)(2009-5#1)
cost and improve the##2##4##(1996-12#1)(2008-10#1)
cost and improve##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
cost and performance##2##3##(1995-2#1)(2008-7#1)
cost and quality##4##3##(1995-12#1)(1995-2#1)(2009-8#1)(2012-3#1)
cost and the##5##3##(1992-12#1)(1992-5#1)(2008-10#1)(2008-2#2)
cost and##67##2##(1991-3#2)(1992-11#1)(1992-12#2)(1992-5#2)(1993-12#1)(1993-3#1)(1994-3#2)(1995-12#2)(1995-2#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#5)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
cost associated with the##2##4##(2008-7#1)(2008-8#1)
cost associated with##5##3##(2008-10#1)(2008-7#2)(2008-8#2)
cost at the##2##3##(2008-8#2)
cost comparison and patient satisfaction##2##5##(1997-2#2)
cost comparison##4##2##(1995-1#1)(1997-2#3)
cost containment and##5##3##(1994-12#2)(1995-3#1)(1996-2#1)(2008-11#1)
cost containment has##2##3##(1992-1#1)(1994-1#1)
cost containment in##4##3##(1992-1#1)(1995-12#1)(1996-12#1)(2008-7#1)
cost containment measures##2##3##(1992-1#1)(2008-11#1)
cost containment##45##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#5)(1992-3#3)(1993-2#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(2008-11#4)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)
cost control##14##2##(1992-1#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-7#1)
cost data##4##2##(1991-12#1)(1993-1#1)(2007-10#1)(2008-1#1)
cost debate##2##2##(1993-8#1)(2010-9#1)
cost effective and##3##3##(2008-11#1)(2010-3#1)(2012-2#1)
cost effective to##3##3##(1994-1#2)(2008-12#1)
cost effective with##2##3##(1994-12#1)(2012-12#1)
cost effective without##2##3##(2008-7#1)(2011-1#1)
cost effective##42##2##(1991-12#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)
cost effectively##2##2##(2007-12#1)(2008-10#1)
cost effectiveness league tables##2##4##(1993-2#2)
cost effectiveness of these##2##4##(2008-8#1)(2011-2#1)
cost effectiveness of this##2##4##(2007-12#2)
cost effectiveness of##12##3##(1991-12#1)(1992-2#1)(1993-12#1)(1995-2#1)(2007-12#2)(2007-7#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
cost effectiveness##29##2##(1991-12#1)(1992-2#1)(1993-12#1)(1993-2#3)(1995-1#2)(1995-2#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
cost efficiency and##2##3##(2008-11#1)(2012-2#1)
cost efficiency##4##2##(1991-2#1)(1996-3#1)(2008-11#1)(2012-2#1)
cost efficient##4##2##(1991-1#1)(1991-12#1)(2008-10#1)(2008-5#1)
cost experience##3##2##(1993-1#3)
cost for health care##2##4##(1991-3#1)(2008-7#1)
cost for the##3##3##(2008-10#2)(2012-3#1)
cost for##13##2##(1991-1#1)(1991-12#2)(1991-3#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-9#1)(2012-3#1)
cost function##11##2##(1992-12#1)(2007-11#1)(2008-2#5)(2008-3#2)(2008-9#1)(2012-12#1)
cost functional##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
cost growth##5##2##(1991-12#1)(1992-12#2)(1993-3#1)(1997-2#1)
cost in a##2##3##(1994-2#1)(2008-10#1)
cost in##11##2##(1994-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-7#3)(2008-8#1)(2008-9#2)
cost increases##4##2##(1992-12#2)(1992-2#1)(2008-1#1)
cost incurred by##2##3##(1995-1#1)(2011-2#1)
cost index##2##2##(1992-2#1)(1994-1#1)
cost information##2##2##(1992-12#1)(1995-2#1)
cost is##12##2##(1991-8#1)(1992-3#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-9#1)(2011-1#1)(2012-2#1)
cost items##2##2##(1992-12#1)(2010-8#1)
cost less than##2##3##(1994-2#1)(1997-2#1)
cost less##4##2##(1992-11#1)(1994-2#2)(1997-2#1)
cost make##2##2##(2008-10#1)(2008-3#1)
cost management##3##2##(1993-1#1)(1994-2#1)(1994-3#1)
cost models##2##2##(1992-3#2)
cost of Medicare##2##3##(1993-1#1)(1995-3#1)
cost of a##10##3##(1995-1#2)(1996-2#1)(2008-3#1)(2008-8#2)(2010-8#1)(2012-12#2)(2012-2#1)
cost of analysis##3##3##(2008-10#2)(2008-7#1)
cost of care for##2##4##(2008-8#1)(2012-3#1)
cost of care##8##3##(1992-3#1)(1994-3#1)(1996-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-2#1)(2012-3#1)
cost of different##2##3##(1996-1#1)(2010-5#1)
cost of each of##2##4##(1993-12#1)(1995-12#1)
cost of each##4##3##(1990-2#1)(1991-9#1)(1993-12#1)(1995-12#1)
cost of goods##2##3##(2008-10#1)(2008-11#1)
cost of health care##4##4##(1993-12#1)(1994-12#1)(1995-3#1)(2013-8#1)
cost of home##2##3##(1995-2#1)(1995-3#1)
cost of hospitalization##3##3##(2011-1#1)(2013-1#2)
cost of not##2##3##(1991-2#1)(2010-8#1)
cost of parasitism in##2##4##(2008-8#2)
cost of parasitism##3##3##(2008-8#3)
cost of producing##2##3##(2008-10#1)(2008-6#1)
cost of reproduction##3##3##(2008-8#2)(2008-9#1)
cost of screening##2##3##(1992-5#1)(1997-4#1)
cost of the burden of##2##5##(2012-12#2)
cost of the##17##3##(1992-12#2)(1993-1#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
cost of therapy##2##3##(2008-10#1)(2008-3#1)
cost of treatment##3##3##(1990-12#1)(2007-7#1)(2013-1#1)
cost of unnecessary virulence##2##4##(2008-10#2)
cost of##188##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#5)(1992-3#1)(1992-5#1)(1993-1#4)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#4)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#12)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#7)(2008-8#16)(2008-9#7)(2009-12#1)(2009-4#1)(2009-9#1)(2010-5#2)(2010-8#6)(2011-1#3)(2011-2#3)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
cost offset##2##2##(1995-1#2)
cost on##2##2##(2008-11#1)(2008-8#1)
cost only##3##2##(1990-2#1)(1992-3#1)(2007-8#1)
cost or##3##2##(1992-12#1)(1992-2#1)(2010-8#1)
cost per case##6##3##(1992-12#4)(1996-3#2)
cost per participant day##2##4##(1992-1#2)
cost per patient##2##3##(1997-2#1)(2007-8#1)
cost per square foot##2##4##(1991-2#1)(1992-2#1)
cost per visit##2##3##(1995-12#1)(1995-3#1)
cost per##27##2##(1991-2#1)(1992-1#2)(1992-12#4)(1992-2#1)(1992-5#1)(1993-1#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-3#2)(1997-2#1)(2007-8#2)(2008-11#2)(2009-8#4)(2012-12#1)
cost reduction from##2##3##(1994-3#1)(2008-6#1)
cost reduction##8##2##(1994-3#2)(1996-2#1)(1996-3#1)(1997-2#1)(2007-4#1)(2008-6#2)
cost reductions##5##2##(1994-12#1)(1995-1#1)(1997-3#1)(2006-10#1)(2008-2#1)
cost saving##4##2##(1992-2#1)(2007-8#1)(2008-1#1)(2008-10#1)
cost savings and##3##3##(1992-2#1)(1994-12#1)(1994-3#1)
cost savings for##2##3##(1995-2#1)(1997-2#1)
cost savings in##2##3##(1991-1#1)(2008-11#1)
cost savings of##2##3##(1995-2#1)(2008-1#1)
cost savings##29##2##(1991-1#1)(1991-12#1)(1992-2#2)(1993-12#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#3)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2010-8#1)(2013-1#1)
cost shares##3##2##(1994-1#3)
cost sharing for##2##3##(1993-12#1)(1995-3#1)
cost sharing##4##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-3#1)
cost structure##3##2##(1996-1#1)(2008-11#2)
cost to society##4##3##(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
cost to the signal##2##4##(2008-3#2)
cost to the##5##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
cost to##19##2##(1991-2#1)(1992-1#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2012-3#1)
cost was NOK##2##3##(1995-2#1)(1997-4#1)
cost was##3##2##(1995-2#1)(1997-4#1)(2012-12#1)
cost with##2##2##(2007-7#1)(2008-10#1)
cost##881##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#2)(1991-1#6)(1991-12#12)(1991-2#11)(1991-3#7)(1991-8#1)(1991-9#1)(1992-1#11)(1992-11#3)(1992-12#28)(1992-2#11)(1992-3#12)(1992-5#4)(1992-8#1)(1993-1#12)(1993-12#9)(1993-2#9)(1993-3#10)(1993-5#1)(1993-8#3)(1994-1#14)(1994-11#1)(1994-12#12)(1994-2#14)(1994-3#17)(1994-5#1)(1994-9#3)(1995-1#16)(1995-12#17)(1995-2#17)(1995-3#11)(1995-5#4)(1995-6#1)(1996-1#10)(1996-11#3)(1996-12#9)(1996-2#9)(1996-3#14)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#19)(1997-3#7)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#9)(2007-8#8)(2008-1#13)(2008-10#89)(2008-11#49)(2008-12#6)(2008-2#21)(2008-3#25)(2008-4#6)(2008-5#2)(2008-6#18)(2008-7#27)(2008-8#38)(2008-9#27)(2009-1#4)(2009-11#2)(2009-12#3)(2009-4#3)(2009-5#2)(2009-8#7)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#4)(2010-7#2)(2010-8#13)(2010-9#8)(2011-1#5)(2011-2#14)(2011-7#1)(2012-1#3)(2012-12#15)(2012-2#14)(2012-3#10)(2013-1#16)(2013-7#1)(2013-8#6)
cost)##5##1##(1993-3#1)(1997-1#2)(2008-10#1)(2008-7#1)
cost-##2##1##(2008-4#1)(2011-1#1)
cost-accounting##2##1##(1996-1#1)(2007-4#1)
cost-based weights##3##2##(1993-1#3)
cost-based##7##1##(1991-1#1)(1992-1#2)(1993-1#3)(2008-3#1)
cost-benefit analysis of##4##3##(1990-9#1)(2008-4#1)(2009-12#1)(2010-12#1)
cost-benefit analysis##6##2##(1990-9#1)(1991-12#1)(1992-3#1)(2008-4#1)(2009-12#1)(2010-12#1)
cost-benefit ratio##4##2##(1996-11#1)(2007-7#1)(2008-7#1)(2009-4#1)
cost-benefit##18##1##(1990-9#1)(1991-12#1)(1992-3#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-12#1)(2010-8#1)
cost-containment acts##2##2##(1992-1#2)
cost-containment efforts##2##2##(1994-1#1)(1995-3#1)
cost-containment##14##1##(1992-1#2)(1992-2#2)(1993-3#2)(1994-1#2)(1994-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-4#1)
cost-control##3##1##(1992-2#1)(1994-2#1)(1996-1#1)
cost-effective alternative##4##2##(1991-1#1)(1993-3#1)(2008-10#1)(2013-1#1)
cost-effective and##10##2##(1993-2#1)(1996-1#1)(2008-10#4)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
cost-effective benefits##2##2##(1993-3#1)(1994-2#1)
cost-effective care##2##2##(1997-1#1)(1997-3#1)
cost-effective health##2##2##(1993-12#1)(1996-12#1)
cost-effective imaging##2##2##(2007-4#1)(2008-3#1)
cost-effective manner##5##2##(1993-12#1)(1993-9#1)(1996-12#1)(2008-7#1)(2011-2#1)
cost-effective means of##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
cost-effective method to##2##3##(1996-3#1)(2008-10#1)
cost-effective method##5##2##(1994-3#2)(1996-3#1)(2008-10#1)(2008-3#1)
cost-effective option##2##2##(2011-1#1)(2012-2#1)
cost-effective production##2##2##(2008-11#2)
cost-effective strategy##4##2##(1997-4#1)(2011-1#1)(2012-12#2)
cost-effective treatment##3##2##(1997-8#1)(2007-8#1)(2008-7#1)
cost-effective use of##3##3##(1994-3#1)(1996-11#1)(1997-3#1)
cost-effective way of##2##3##(2008-3#1)(2010-8#1)
cost-effective way to##6##3##(1994-3#2)(1995-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
cost-effective way##9##2##(1994-3#2)(1995-2#1)(1997-7#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)
cost-effective##119##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#6)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#2)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)
cost-effectively##2##1##(2012-2#1)(2012-3#1)
cost-effectiveness analyses##2##2##(2009-11#1)(2010-4#1)
cost-effectiveness analysis##3##2##(1997-1#1)(2009-8#1)(2012-12#1)
cost-effectiveness evaluations##2##2##(2008-2#2)
cost-effectiveness in##3##2##(2008-11#1)(2011-2#2)
cost-effectiveness of enzyme replacement therapy (ERT) for the##2##8##(2012-12#2)
cost-effectiveness of open or thoracoscopic thymectomy compared to medical##2##9##(2012-12#2)
cost-effectiveness of the##2##3##(1996-6#1)(1997-1#1)
cost-effectiveness of##22##2##(1990-12#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-9#1)(2011-1#1)(2011-2#4)(2012-12#4)
cost-effectiveness studies##2##2##(1995-12#1)(2008-10#1)
cost-effectiveness##62##1##(1990-12#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-6#1)(1997-1#2)(1997-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#2)(2009-8#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#11)(2012-12#9)(2013-1#2)
cost-efficiency##2##1##(1994-9#1)(2013-1#1)
cost-efficient and##2##2##(1995-1#1)(2008-7#1)
cost-efficient##10##1##(1991-2#1)(1992-12#1)(1995-1#1)(1996-2#2)(1997-1#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)
cost-free##2##1##(1995-5#1)(1997-2#1)
cost-per-case##2##1##(1995-12#2)
cost-saving##2##1##(1991-2#1)(1994-11#1)
cost-savings##4##1##(1992-12#1)(1992-2#1)(1994-3#1)(2011-1#1)
cost-sharing##4##1##(1997-2#1)(2010-5#2)(2012-1#1)
cost-shifting##4##1##(1995-3#1)(2008-11#3)
cost-utility analysis comparing##2##3##(2007-8#1)(2009-8#1)
cost-utility analysis##4##2##(2007-8#3)(2009-8#1)
cost/benefit analysis##2##2##(1994-3#1)(2008-10#1)
cost/benefit ratio##3##2##(1991-3#1)(1992-2#2)
cost/benefit##7##1##(1991-3#2)(1992-2#2)(1993-3#1)(1994-3#1)(2008-10#1)
cost?##3##1##(1996-3#1)(2007-8#1)(2011-2#1)
costal cartilage##2##2##(2007-8#2)
costal margin##2##2##(1991-12#1)(2011-1#1)
costal##6##1##(1991-12#1)(1992-6#1)(2007-8#2)(2009-1#1)(2011-1#1)
costimulation##2##1##(2008-7#1)(2012-1#1)
costimulatory molecules##9##2##(2007-12#5)(2008-10#1)(2008-11#2)(2008-4#1)
costimulatory##13##1##(2007-12#6)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#1)
costing and##2##2##(1995-1#1)(1996-9#1)
costing##10##1##(1993-3#1)(1995-1#1)(1995-12#1)(1996-9#4)(2007-12#1)(2008-1#1)(2012-12#1)
costly and##13##2##(1994-1#1)(1995-1#1)(1995-5#1)(2007-10#1)(2008-10#3)(2008-8#2)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
costly equipment##3##2##(1990-11#1)(2012-2#2)
costly than##2##2##(1992-3#1)(2007-11#1)
costly to##7##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)
costly##72##1##(1990-11#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#7)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
costs (the##2##2##(1994-3#1)(1996-12#1)
costs DM##2##2##(1996-11#1)(1997-4#1)
costs about##3##2##(1990-2#1)(1997-4#1)(2008-10#1)
costs across##3##2##(1991-3#1)(1992-12#1)(2008-8#1)
costs among##3##2##(1992-12#1)(1995-2#1)(1997-1#1)
costs and a##3##3##(1992-2#1)(1992-3#1)(1995-2#1)
costs and benefits of##5##4##(1991-2#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-11#1)
costs and benefits##8##3##(1991-2#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-11#1)(2013-1#1)
costs and financial##3##3##(1992-1#1)(2010-8#2)
costs and increased##3##3##(1996-2#1)(2010-12#1)(2012-12#1)
costs and profitability of##2##4##(1991-1#1)(2008-12#1)
costs and quality##4##3##(1992-2#1)(1995-2#2)(1997-2#1)
costs and the##9##3##(1992-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-12#1)
costs and utilization##3##3##(1993-1#1)(1995-1#1)(1996-12#1)
costs and##104##2##(1990-4#2)(1991-1#2)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#3)(1993-3#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#3)(1995-1#2)(1995-12#2)(1995-2#6)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1997-1#3)(1997-2#3)(2007-12#2)(2007-4#2)(2007-6#1)(2007-9#1)(2008-10#6)(2008-11#7)(2008-12#4)(2008-5#1)(2008-6#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#5)(2011-2#2)(2012-12#3)(2013-1#4)
costs are high##2##3##(2008-8#2)
costs are##18##2##(1990-4#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-6#3)(2008-8#4)(2013-1#1)
costs as well as##3##4##(1991-1#1)(1994-12#1)(2008-1#1)
costs as##5##2##(1991-1#1)(1994-12#1)(1996-3#1)(2008-1#1)(2008-10#1)
costs associated with treatment##2##4##(1997-3#1)(2008-9#1)
costs associated with##17##3##(1993-3#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-2#3)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
costs attributable to##4##3##(1995-2#1)(1996-3#1)(2008-11#2)
costs by##10##2##(1991-12#1)(1991-9#1)(1994-3#2)(1995-1#2)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)
costs can be reduced##2##4##(1994-3#1)(1997-2#1)
costs can be##3##3##(1994-3#1)(1997-2#1)(2008-11#1)
costs can##4##2##(1994-3#1)(1996-11#1)(1997-2#1)(2008-11#1)
costs during##3##2##(1993-3#2)(2008-1#1)
costs for the##4##3##(1995-3#1)(1997-3#1)(1997-4#1)(2008-8#1)
costs for##19##2##(1991-3#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-11#1)(2013-1#1)
costs have##6##2##(1992-2#1)(1996-3#2)(1997-3#1)(2008-11#1)(2008-6#1)
costs in a##3##3##(1994-2#1)(1997-2#1)(2008-9#1)
costs in the##6##3##(1991-6#1)(1993-1#2)(1994-3#1)(1995-2#1)(2011-2#1)
costs in##27##2##(1990-4#1)(1991-6#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#3)(1996-3#2)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
costs incurred by the##2##4##(1991-3#1)(2011-1#1)
costs incurred by##3##3##(1991-3#1)(2010-8#1)(2011-1#1)
costs incurred##4##2##(1991-3#1)(2010-8#2)(2011-1#1)
costs into##2##2##(1992-12#1)(1996-1#1)
costs involved##2##2##(1994-12#1)(2008-10#1)
costs may##2##2##(1994-12#1)(1995-11#1)
costs of a##2##3##(1996-3#1)(2008-2#1)
costs of care##5##3##(1995-12#1)(1996-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
costs of health care##3##4##(1993-12#1)(2007-12#1)(2008-11#1)
costs of health##4##3##(1993-12#1)(1993-2#1)(2007-12#1)(2008-11#1)
costs of plasticity##2##3##(2008-8#2)
costs of reproduction for##2##4##(2008-9#2)
costs of reproduction##5##3##(2008-9#5)
costs of the##9##3##(1990-8#1)(1990-9#1)(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
costs of using##2##3##(1995-3#1)(2008-11#1)
costs of##132##2##(1990-12#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#2)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-1#4)(1997-2#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#10)(2008-11#10)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#19)(2008-9#16)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
costs on a##2##3##(1995-12#1)(1996-1#1)
costs on##4##2##(1991-12#1)(1995-12#1)(1996-1#1)(2008-8#1)
costs or##3##2##(1991-1#1)(1991-12#1)(1995-2#1)
costs per##3##2##(1994-1#1)(2008-7#1)(2012-12#1)
costs related to##2##3##(1991-12#1)(2008-3#1)
costs the##2##2##(1995-2#1)(2008-7#1)
costs through##4##2##(1996-3#1)(1997-2#1)(1997-3#2)
costs to society##2##3##(1995-11#1)(1997-4#1)
costs to##9##2##(1995-1#1)(1995-11#1)(1995-6#1)(1997-4#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-1#1)
costs was##3##2##(1994-1#1)(2008-11#1)(2011-2#1)
costs were##11##2##(1991-12#1)(1992-1#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-7#1)(2009-5#1)(2012-12#2)
costs while##4##2##(1991-1#1)(1991-12#1)(1992-2#1)(1994-2#1)
costs will##2##2##(1994-3#1)(2008-2#1)
costs with##2##2##(1996-1#1)(2007-4#1)
costs##696##1##(1990-12#1)(1990-2#1)(1990-4#6)(1990-8#1)(1990-9#3)(1991-1#8)(1991-12#16)(1991-2#3)(1991-3#5)(1991-6#3)(1991-9#4)(1992-1#9)(1992-12#14)(1992-2#13)(1992-3#11)(1992-5#2)(1993-1#6)(1993-12#9)(1993-2#5)(1993-3#11)(1993-8#1)(1994-1#8)(1994-12#12)(1994-2#14)(1994-3#21)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#25)(1995-11#3)(1995-12#12)(1995-2#21)(1995-3#9)(1995-6#4)(1995-9#1)(1996-1#14)(1996-11#3)(1996-12#9)(1996-2#14)(1996-3#26)(1996-8#1)(1996-9#1)(1997-1#13)(1997-2#16)(1997-3#7)(1997-4#6)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#7)(2007-6#1)(2007-7#3)(2007-9#2)(2008-1#7)(2008-10#32)(2008-11#46)(2008-12#7)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#7)(2008-7#11)(2008-8#38)(2008-9#28)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#6)(2009-5#3)(2009-6#2)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#10)(2010-9#5)(2011-1#8)(2011-2#14)(2011-7#1)(2012-12#16)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#6)
costs)##2##1##(1993-1#1)(1996-3#1)
costs?##3##1##(1995-12#1)(1997-4#1)(2013-1#1)
costs]##3##1##(1992-9#1)(1994-8#1)(1996-3#1)
cosubstrate##5##1##(1994-11#1)(2008-10#4)
cosuppression##2##1##(2008-10#1)(2008-2#1)
cosurfactant##3##1##(2008-10#1)(2008-5#2)
cot death##2##2##(1990-11#1)(1992-4#1)
cot##4##1##(1990-11#1)(1992-4#2)(2011-1#1)
cotiara##3##1##(2008-5#3)
cotinine in urine##2##3##(1993-8#1)(1995-6#1)
cotinine##5##1##(1993-8#3)(1995-6#1)(2008-12#1)
cotransfected with##2##2##(1995-6#1)(2008-2#1)
cotransfected##5##1##(1990-5#1)(1995-6#1)(2008-2#1)(2008-4#1)(2008-9#1)
cotransfection experiments##2##2##(1994-11#1)(1997-4#1)
cotransfection of the##2##3##(2008-2#1)(2008-9#1)
cotransfection of##10##2##(1993-2#1)(1993-8#1)(1994-8#1)(1995-2#2)(2008-2#2)(2008-4#2)(2008-9#1)
cotransfection with##2##2##(1993-8#1)(1994-8#1)
cotransfection##17##1##(1993-2#1)(1993-8#2)(1994-11#1)(1994-8#3)(1995-2#2)(1997-4#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-9#1)
cotransformed with##2##2##(2008-10#1)(2008-9#1)
cotranslational##2##1##(1991-5#1)(2012-1#1)
cotransmitters##2##1##(1994-8#1)(1995-2#1)
cotransport##8##1##(1991-8#5)(1994-6#1)(2008-8#2)
cotransporter in##2##2##(2008-8#2)
cotransporter##14##1##(1991-12#2)(2007-7#2)(2008-11#1)(2008-7#1)(2008-8#8)
cotransporters##3##1##(2008-8#3)
cotransporting green##2##2##(2008-11#2)
cotransporting##3##1##(2008-11#3)
cotrimoxazole and##3##2##(2008-11#2)(2008-12#1)
cotrimoxazole##15##1##(2007-12#5)(2007-7#1)(2008-11#7)(2008-12#1)(2012-3#1)
cotton (Gossypium hirsutum L##2##4##(2011-2#2)
cotton (Gossypium hirsutum)##4##3##(2008-10#3)(2008-9#1)
cotton (Gossypium spp##2##3##(2008-10#1)(2011-2#1)
cotton (Gossypium##8##2##(2008-10#4)(2008-9#1)(2011-2#3)
cotton and olive##2##3##(2008-10#2)
cotton and##9##2##(2008-10#7)(2008-7#2)
cotton boll##2##2##(2011-2#2)
cotton cv##2##2##(2008-10#2)
cotton fiber##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
cotton fibers##3##2##(2008-2#1)(2008-9#2)
cotton fields and##2##3##(2008-10#1)(2011-2#1)
cotton fields in##2##3##(2008-10#1)(2008-12#1)
cotton fields##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
cotton from##2##2##(2008-10#2)
cotton fruit##2##2##(1993-3#2)
cotton in the##2##3##(2008-10#1)(2011-2#1)
cotton in##4##2##(2008-10#3)(2011-2#1)
cotton is##2##2##(2008-10#1)(2011-2#1)
cotton leaf curl##2##3##(2008-10#1)(2008-9#1)
cotton leafworm##6##2##(2008-12#2)(2008-6#1)(2010-10#2)(2013-8#1)
cotton leaves##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
cotton planting##4##2##(2011-2#4)
cotton roots and##2##3##(2008-10#2)
cotton roots##6##2##(2008-10#6)
cotton seedling disease##2##3##(2008-10#2)
cotton seedlings##4##2##(2008-10#2)(2008-8#2)
cotton square##4##2##(2011-2#4)
cotton swab was##2##3##(2008-10#2)
cotton swab##4##2##(2008-10#3)(2011-2#1)
cotton swabs##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
cotton terpenoid production##2##3##(2008-10#2)
cotton were##2##2##(2008-10#2)
cotton wilt disease##3##3##(2008-12#3)
cotton##152##1##(1993-3#2)(1995-3#1)(2007-11#1)(2007-6#2)(2008-10#84)(2008-12#8)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#8)(2010-10#2)(2010-8#1)(2011-2#30)(2013-8#2)
cotton-gin trash##6##2##(2008-10#6)
cotton-tipped applicator##2##2##(1992-1#2)
cottonball##5##1##(2008-10#5)
cottonseed##9##1##(2008-10#9)
cottonwood##3##1##(2008-10#2)(2009-8#1)
cotyledon petiole was##2##3##(2008-10#2)
cotyledon##16##1##(1994-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#6)(2012-1#1)
cotyledonary leaves##3##2##(1991-12#1)(2008-10#2)
cotyledonary node##2##2##(2008-10#1)(2008-12#1)
cotyledonary##9##1##(1991-12#1)(2008-10#3)(2008-12#2)(2013-8#3)
cotyledons and##3##2##(2008-10#3)
cotyledons of##2##2##(1994-8#1)(2008-10#1)
cotyledons with##2##2##(2008-10#2)
cotyledons##23##1##(1990-5#2)(1994-8#2)(2008-10#15)(2008-8#1)(2009-8#2)(2013-8#1)
couched in##2##2##(2009-11#1)(2011-2#1)
cough and fever##2##3##(1997-7#2)
cough and##9##2##(1995-8#1)(1997-7#2)(2007-8#1)(2008-1#2)(2008-12#1)(2008-6#1)(2012-3#1)
cough as##2##2##(1991-2#1)(1991-4#1)
cough due to##2##3##(1991-8#1)(2011-2#1)
cough for##3##2##(1992-5#1)(2008-1#1)(2008-7#1)
cough syrup##3##2##(2008-10#2)(2008-7#1)
cough were##2##2##(1993-12#2)
cough with##3##2##(1995-8#1)(2008-1#1)(2008-7#1)
cough##66##1##(1990-6#2)(1991-2#2)(1991-4#1)(1991-8#1)(1992-5#1)(1993-12#4)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#2)(1997-7#4)(1997-8#2)(2007-12#2)(2007-8#2)(2008-1#11)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)
coughing##13##1##(1990-3#1)(1991-11#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-8#1)
could accelerate the##2##3##(2008-10#2)
could accommodate##4##2##(1993-8#2)(2008-10#2)
could account for a##2##4##(1994-9#1)(2008-10#1)
could account for the##8##4##(1993-11#1)(1993-12#1)(1996-5#1)(2008-10#2)(2008-5#2)(2009-11#1)
could account for##14##3##(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)
could accurately##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
could achieve##6##2##(1993-1#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-7#1)
could act as a##3##4##(1994-8#1)(2008-7#1)(2009-8#1)
could act as an##2##4##(2008-11#1)(2013-8#1)
could act as##6##3##(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
could act##9##2##(1994-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2013-8#1)
could activate##2##2##(1993-8#1)(1995-8#1)
could affect the performance of##3##5##(2008-10#3)
could affect the##18##3##(1990-5#1)(2006-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-7#1)
could affect##27##2##(1990-5#1)(2006-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
could allow the##3##3##(1996-9#1)(2008-5#1)(2008-7#1)
could allow##6##2##(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
could already##2##2##(2008-11#1)(2008-7#1)
could also affect the human health##2##6##(2013-1#2)
could also affect the##4##4##(1996-2#1)(2010-5#1)(2013-1#2)
could also affect##5##3##(1996-2#1)(2008-8#1)(2010-5#1)(2013-1#2)
could also be applied to##4##5##(1990-5#1)(1991-5#1)(2008-10#1)(2010-5#1)
could also be considered##2##4##(1992-6#1)(2011-1#1)
could also be detected in##3##5##(1996-12#1)(2008-11#1)(2008-9#1)
could also be detected##5##4##(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
could also be involved##2##4##(2008-10#1)(2012-3#1)
could also be measured##2##4##(1992-12#1)(2008-10#1)
could also be seen##2##4##(1992-9#1)(2008-10#1)
could also be used as##2##5##(2008-10#1)(2013-8#1)
could also be used to##5##5##(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
could also be used##8##4##(1994-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
could also be##46##3##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
could also contribute to##2##4##(2008-10#2)
could also have##2##3##(1995-11#1)(2008-5#1)
could also help to##3##4##(2008-10#1)(2010-3#1)(2011-2#1)
could also play a role in##2##6##(1992-8#1)(1995-8#1)
could also provide##2##3##(2009-6#1)(2013-8#1)
could also##80##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
could alter the##2##3##(2008-10#1)(2008-9#1)
could alter##5##2##(2008-10#1)(2008-11#1)(2008-9#2)(2013-1#1)
could amplify##3##2##(1993-12#1)(2008-8#1)(2012-2#1)
could appear##2##2##(2008-2#1)(2008-3#1)
could apply to##2##3##(2008-11#1)(2011-2#1)
could arise##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
could assist##2##2##(2008-11#1)(2010-3#1)
could augment the##2##3##(2008-11#1)(2008-8#1)
could be a cause of##2##5##(2008-5#1)(2008-7#1)
could be a good##2##4##(2008-12#1)(2011-2#1)
could be a key##2##4##(2008-10#1)(2009-8#1)
could be a major##2##4##(1991-4#1)(2008-10#1)
could be a potential##3##4##(1993-8#1)(2008-1#1)(2008-10#1)
could be a powerful##2##4##(2007-12#1)(2010-10#1)
could be a promising##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
could be a simple##3##4##(1991-3#1)(2008-5#1)(2012-7#1)
could be a source of##2##5##(1990-12#1)(2008-5#1)
could be a source##3##4##(1990-12#1)(2008-12#1)(2008-5#1)
could be a useful adjunct to##2##6##(1993-2#1)(2012-3#1)
could be a useful##6##4##(1993-2#1)(2008-10#3)(2008-2#1)(2012-3#1)
could be a valuable##2##4##(1996-3#1)(2013-1#1)
could be a##71##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-3#1)(1996-4#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#5)
could be abolished by##2##4##(1990-8#1)(1994-3#1)
could be abolished##3##3##(1990-8#1)(1994-3#1)(1996-5#1)
could be accelerated##2##3##(2007-8#1)(2010-5#1)
could be accomplished##2##3##(2008-10#1)(2008-11#1)
could be accounted for by##7##5##(1990-11#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-1#1)
could be accounted for##8##4##(1990-11#1)(1990-8#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-1#1)
could be accurately##2##3##(2007-12#1)(2008-10#1)
could be achieved by##8##4##(1990-2#1)(1996-2#1)(2008-10#2)(2008-3#2)(2012-2#1)(2013-1#1)
could be achieved using##3##4##(2008-10#1)(2008-12#1)(2009-12#1)
could be achieved with##4##4##(2008-10#2)(2008-2#1)(2011-2#1)
could be achieved without##2##4##(1994-8#1)(1997-8#1)
could be achieved##28##3##(1990-2#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
could be acquired##2##3##(2008-10#2)
could be acting##2##3##(1990-11#1)(1993-6#1)
could be activated by##2##4##(1993-8#1)(2008-9#1)
could be activated##3##3##(1993-12#1)(1993-8#1)(2008-9#1)
could be adapted to##2##4##(2008-10#1)(2008-12#1)
could be adapted##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
could be addressed##3##3##(1992-3#1)(2007-7#1)(2013-7#1)
could be adopted to##2##4##(2008-10#1)(2010-10#1)
could be adopted##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
could be advantageously used##2##4##(2008-10#1)(2008-5#1)
could be affected by##2##4##(1994-3#1)(2013-1#1)
could be also determined##2##4##(2008-10#1)(2008-8#1)
could be altered##2##3##(1996-9#1)(2008-10#1)
could be amplified by##2##4##(2008-10#1)(2008-11#1)
could be an effective means of##2##6##(1993-11#1)(2008-5#1)
could be an effective means##3##5##(1993-11#1)(2008-5#1)(2008-6#1)
could be an effective##5##4##(1993-11#1)(1997-7#1)(2008-5#1)(2008-6#1)(2012-3#1)
could be an important##2##4##(2009-8#1)(2011-2#1)
could be an##17##3##(1993-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-3#1)
could be analogous to the##2##5##(1995-8#1)(2012-2#1)
could be analysed##4##3##(1990-8#1)(1991-8#2)(2008-10#1)
could be analyzed in##2##4##(2008-10#2)
could be analyzed##3##3##(2008-10#3)
could be applicable##2##3##(2008-10#1)(2010-12#1)
could be applied in##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
could be applied successfully to the determination of the investigated##2##10##(2008-10#2)
could be applied successfully to the##3##6##(2008-10#3)
could be applied to other##2##5##(2008-10#1)(2008-5#1)
could be applied to the determination##2##6##(2008-10#2)
could be applied to the##3##5##(2008-10#3)
could be applied to##12##4##(1993-12#1)(1995-2#1)(2007-10#1)(2008-10#7)(2008-3#1)(2008-5#1)
could be applied##27##3##(1992-4#1)(1993-12#2)(1995-2#1)(2007-10#1)(2008-10#17)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)
could be approximately##2##3##(2008-3#1)(2010-4#1)
could be as##5##3##(1997-6#1)(2007-10#1)(2008-2#1)(2012-12#1)(2012-3#1)
could be ascribed to the##2##5##(1991-2#1)(2008-8#1)
could be ascribed to##3##4##(1991-2#1)(2007-12#1)(2008-8#1)
could be asked##2##3##(2008-11#1)(2010-10#1)
could be assessed##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
could be assigned to##3##4##(1992-6#1)(2008-10#2)
could be assigned##6##3##(1992-6#1)(2008-10#5)
could be associated with##3##4##(2008-10#1)(2011-10#1)(2013-1#1)
could be associated##4##3##(2008-10#2)(2011-10#1)(2013-1#1)
could be attained##4##3##(2008-10#4)
could be attributable to##2##4##(2010-8#1)(2011-2#1)
could be attributed to a##4##5##(1992-3#1)(2011-1#2)(2011-2#1)
could be attributed to the##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
could be attributed to##18##4##(1992-3#2)(1992-6#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)
could be attributed##19##3##(1992-3#2)(1992-6#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)
could be avoided##4##3##(1994-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
could be based on##3##4##(1992-2#1)(2008-5#1)(2008-9#1)
could be beneficial##4##3##(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
could be better##2##3##(1996-11#1)(2008-12#1)
could be blocked by##2##4##(1994-12#1)(1997-7#1)
could be blocked##4##3##(1993-9#1)(1994-12#1)(1996-5#1)(1997-7#1)
could be calculated in##2##4##(2008-6#1)(2012-12#1)
could be calculated##5##3##(1991-8#1)(2008-10#1)(2008-6#1)(2009-7#1)(2012-12#1)
could be called##2##3##(1990-11#1)(1994-9#1)
could be carried out##2##4##(1997-4#1)(2008-10#1)
could be caused by##4##4##(1991-5#1)(2008-2#1)(2008-7#2)
could be characterized by##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
could be characterized##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
could be classified as##2##4##(1990-11#1)(2009-10#1)
could be classified into two##2##5##(1997-2#1)(2008-10#1)
could be classified into##6##4##(1996-6#1)(1997-2#1)(2007-6#1)(2008-10#3)
could be classified##11##3##(1990-11#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-6#1)(2008-10#4)(2009-10#1)(2011-10#1)
could be combined to##2##4##(1994-8#1)(2008-10#1)
could be combined##4##3##(1994-8#1)(2008-10#3)
could be compared to##2##4##(2008-10#1)(2013-1#1)
could be compared with the##2##5##(2008-10#1)(2008-2#1)
could be compared with##3##4##(2008-10#2)(2008-2#1)
could be compared##6##3##(1990-9#1)(2008-10#3)(2008-2#1)(2013-1#1)
could be completed in##4##4##(2008-10#4)
could be completed##6##3##(2008-10#5)(2008-8#1)
could be completely blocked by##2##5##(1997-6#1)(2008-8#1)
could be completely##5##3##(1995-8#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
could be concentrated by##2##4##(2008-10#2)
could be confirmed##5##3##(1991-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
could be connected##2##3##(2008-10#1)(2011-2#1)
could be considered a##5##4##(1991-12#1)(1994-9#1)(1995-12#1)(2011-2#1)(2012-12#1)
could be considered as a##6##5##(2008-1#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-1#1)
could be considered as##8##4##(2008-1#1)(2008-10#2)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
could be considered in##2##4##(2009-6#1)(2010-3#1)
could be considered##23##3##(1991-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
could be constructed and##2##4##(2008-10#1)(2008-5#1)
could be constructed##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
could be contained##2##3##(2008-7#2)
could be controlled by##2##4##(2008-10#2)
could be controlled##3##3##(2008-10#2)(2009-12#1)
could be corrected##2##3##(2008-3#1)(2009-7#1)
could be correlated with the##3##5##(1992-6#1)(1995-11#1)(2007-12#1)
could be correlated with##5##4##(1992-6#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-5#1)
could be correlated##7##3##(1992-6#1)(1995-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)
could be crucial##4##3##(2008-10#1)(2009-6#1)(2011-2#1)(2012-5#1)
could be decreased##2##3##(1995-3#1)(2007-12#1)
could be demonstrated in##3##4##(1995-12#1)(1997-6#1)(2007-10#1)
could be demonstrated##12##3##(1992-9#1)(1993-1#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-6#1)(2007-10#2)(2007-12#1)(2008-3#1)(2008-5#1)
could be derived from##2##4##(2008-10#1)(2008-8#1)
could be derived##4##3##(2008-10#2)(2008-8#1)(2011-3#1)
could be described by a##2##5##(2008-10#1)(2008-7#1)
could be described by##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
could be described##5##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-2#1)
could be detected at##2##4##(1995-8#1)(2008-6#1)
could be detected by the##2##5##(2008-10#1)(2008-2#1)
could be detected by##8##4##(1991-8#1)(1993-2#1)(1994-9#1)(2007-11#1)(2008-10#3)(2008-2#1)
could be detected in the##12##5##(1990-5#1)(1993-6#1)(1994-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-8#3)(2012-3#1)
could be detected in this##2##5##(1995-6#1)(2008-5#1)
could be detected in##34##4##(1990-5#1)(1991-2#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#2)(1996-5#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#5)(2012-2#1)(2012-3#1)(2013-1#1)
could be detected on##2##4##(1991-12#1)(2008-7#1)
could be detected throughout##2##4##(2008-9#1)(2013-8#1)
could be detected with a##2##5##(2008-10#1)(2008-3#1)
could be detected with##4##4##(1994-11#1)(2008-10#2)(2008-3#1)
could be detected##83##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#4)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-7#2)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
could be determined by the method##2##6##(2008-10#2)
could be determined by the##3##5##(2008-10#3)
could be determined by##7##4##(2008-10#5)(2008-11#1)(2012-12#1)
could be determined in 44##2##5##(1992-5#1)(2008-6#1)
could be determined in the##5##5##(2008-10#5)
could be determined in##13##4##(1992-5#1)(2008-10#11)(2008-6#1)
could be determined over the##2##5##(2008-10#2)
could be determined simultaneously with##2##5##(2008-10#2)
could be determined with a 90%##2##6##(2008-10#2)
could be determined with a##3##5##(2008-10#3)
could be determined with##6##4##(2008-10#6)
could be determined##47##3##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(2008-10#37)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#1)
could be developed##8##3##(2008-10#5)(2008-11#1)(2008-3#1)(2011-3#1)
could be differentiated##5##3##(1997-4#1)(1997-6#1)(2008-10#2)(2011-2#1)
could be directly injected##2##4##(2008-10#2)
could be directly##9##3##(1993-12#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#1)
could be discriminated from##2##4##(2008-7#2)
could be discriminated##4##3##(2008-10#2)(2008-7#2)
could be distinguished from##4##4##(1997-6#1)(2008-10#1)(2009-12#1)(2012-3#1)
could be distinguished##9##3##(1993-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
could be divided into two##4##5##(2008-10#3)(2008-5#1)
could be divided into##7##4##(1993-2#1)(1995-11#1)(2008-10#4)(2008-5#1)
could be divided##8##3##(1993-2#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-5#1)
could be done to##3##4##(1996-8#1)(2008-9#1)(2011-1#1)
could be done##5##3##(1991-1#1)(1996-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
could be drawn##2##3##(2008-10#1)(2008-5#1)
could be due to the##9##5##(1992-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
could be due to##23##4##(1991-2#1)(1992-9#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-5#1)(2013-1#1)
could be easily achieved##2##4##(2008-10#2)
could be easily and##2##4##(2008-10#1)(2008-11#1)
could be easily detected##2##4##(1990-2#1)(2008-10#1)
could be easily separated##2##4##(2008-10#2)
could be easily##21##3##(1990-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2013-1#1)
could be effective##2##3##(2008-10#1)(2013-1#1)
could be effectively##3##3##(1997-7#1)(2008-10#1)(2010-4#1)
could be efficiently##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
could be eliminated by the##2##5##(2008-10#1)(2008-7#1)
could be eliminated by##5##4##(2008-10#3)(2008-3#1)(2008-7#1)
could be eliminated##7##3##(1996-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
could be eluted##4##3##(2008-10#4)
could be employed to##2##4##(2008-10#1)(2008-3#1)
could be employed##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
could be enhanced by##5##4##(1996-2#1)(2008-10#2)(2008-11#1)(2009-7#1)
could be enhanced more than 2##2##6##(2008-11#1)(2008-6#1)
could be enhanced##9##3##(1996-2#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-7#1)
could be established between the##2##5##(2007-7#1)(2008-10#1)
could be established##12##3##(1991-9#1)(1992-3#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)
could be estimated##3##3##(2008-10#2)(2008-2#1)
could be evaluated##5##3##(1990-3#2)(1991-8#1)(2007-5#1)(2008-5#1)
could be excluded##3##3##(1997-5#2)(2009-2#1)
could be explained by a##3##5##(2008-10#3)
could be explained by the##4##5##(2008-10#1)(2008-11#2)(2008-3#1)
could be explained by##15##4##(1993-1#1)(1995-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#2)(2013-1#1)
could be explained in##2##4##(1991-3#1)(2008-5#1)
could be explained##19##3##(1991-3#1)(1993-1#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2009-7#2)(2013-1#1)
could be exploited for##2##4##(1992-8#1)(2008-10#1)
could be exploited##4##3##(1992-8#1)(2008-10#2)(2011-2#1)
could be explored##2##3##(2008-10#2)
could be expressed in the##3##5##(1991-2#1)(2008-8#2)
could be expressed##7##3##(1991-2#1)(1991-9#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
could be extended to##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
could be extended##4##3##(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
could be extracted##2##3##(2008-10#2)
could be facilitated by##2##4##(2008-5#1)(2008-9#1)
could be facilitated##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
could be fitted with a##2##5##(1991-12#1)(1997-7#1)
could be followed up##2##4##(1997-2#1)(2008-7#1)
could be followed##3##3##(1995-12#1)(1997-2#1)(2008-7#1)
could be formed##3##3##(2008-10#2)(2008-7#1)
could be found between##4##4##(1990-6#1)(1993-5#1)(1995-8#1)(2008-10#1)
could be found in the##2##5##(2008-11#1)(2008-5#1)
could be found in##7##4##(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
could be found##26##3##(1990-11#1)(1990-6#1)(1992-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
could be functionally##3##3##(1995-2#1)(2008-10#1)(2010-1#1)
could be further divided into##2##5##(2008-10#2)
could be further##6##3##(2008-10#4)(2008-5#1)(2013-1#1)
could be given##2##3##(1994-12#1)(2008-6#1)
could be greatly enhanced by##2##5##(2008-10#2)
could be greatly enhanced##3##4##(2008-10#3)
could be grouped into two##2##5##(2008-10#2)
could be grouped into##3##4##(1991-2#1)(2008-10#2)
could be grown in##2##4##(2008-1#1)(2008-10#1)
could be harnessed##2##3##(2009-6#1)(2011-1#1)
could be helpful for##2##4##(2008-5#1)(2012-2#1)
could be helpful in##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
could be helpful##6##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#2)(2012-2#1)
could be identified as##2##4##(2007-11#1)(2013-1#1)
could be identified in##2##4##(1997-1#1)(2008-11#1)
could be identified with##2##4##(1991-11#1)(1997-6#1)
could be identified##22##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-8#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
could be implemented##3##3##(1992-3#1)(2008-11#1)(2009-8#1)
could be important for the##2##5##(2008-5#1)(2009-6#1)
could be important for##3##4##(2008-5#1)(2009-6#1)(2013-7#1)
could be important in the##2##5##(2008-10#1)(2011-2#1)
could be important in##3##4##(2008-10#1)(2010-4#1)(2011-2#1)
could be important##8##3##(2008-10#2)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
could be improved by##4##4##(1996-12#1)(1996-9#1)(2008-9#1)(2012-3#1)
could be improved##13##3##(1996-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
could be in##2##3##(2011-1#1)(2011-2#1)
could be incorporated into##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
could be incorporated##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-8#1)
could be increased by##2##4##(1994-9#1)(1995-11#1)
could be increased##5##3##(1993-12#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-8#1)
could be indicative##2##3##(2008-10#1)(2010-7#1)
could be induced##6##3##(1990-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(2008-7#1)(2009-12#1)
could be inferred##4##3##(2008-11#2)(2008-8#1)(2010-6#1)
could be influenced by##2##4##(2008-11#1)(2011-2#1)
could be inhibited by##8##4##(1990-2#2)(1990-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2010-3#1)
could be inhibited##10##3##(1990-2#2)(1990-8#1)(1991-5#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-5#1)(2010-3#1)
could be interpreted as##2##4##(2006-10#1)(2008-10#1)
could be interpreted##6##3##(1993-9#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-5#2)
could be involved in the##4##5##(1994-11#1)(1995-2#1)(2008-10#1)(2009-8#1)
could be involved in##7##4##(1994-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)
could be involved##9##3##(1994-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
could be isolated##5##3##(1996-5#1)(1996-6#1)(1997-3#1)(2008-5#1)(2012-2#1)
could be labeled##3##3##(1991-3#1)(1991-9#1)(2011-2#1)
could be less##2##3##(2008-10#1)(2008-9#1)
could be located##2##3##(2008-10#1)(2008-3#1)
could be made in##2##4##(1992-1#1)(2008-10#1)
could be made##12##3##(1990-2#1)(1991-9#1)(1992-1#1)(1994-2#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
could be mainly##2##3##(1995-12#1)(2008-6#1)
could be maintained at##2##4##(2008-6#2)
could be maintained##6##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-6#2)(2008-7#1)
could be manipulated##2##3##(2008-10#1)(2009-12#1)
could be measured quantitatively at##2##5##(2008-10#2)
could be measured##9##3##(1996-5#1)(2008-10#5)(2008-2#1)(2010-4#1)(2013-8#1)
could be mediated by##2##4##(1990-12#1)(1993-9#1)
could be misleading##2##3##(2008-8#1)(2010-8#1)
could be modeled##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
could be modified by##3##4##(1993-12#1)(2008-5#1)(2011-2#1)
could be modulated by##2##4##(1993-3#1)(2013-8#1)
could be modulated##4##3##(1993-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
could be monitored by the##2##5##(2008-10#1)(2008-11#1)
could be monitored by##3##4##(1994-5#1)(2008-10#1)(2008-11#1)
could be monitored##6##3##(1994-5#1)(2008-10#4)(2008-11#1)
could be more##13##3##(1991-5#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)
could be observed between##2##4##(1993-1#1)(2008-8#1)
could be observed in the##3##5##(1991-12#1)(2008-10#2)
could be observed in##8##4##(1991-12#1)(1994-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
could be observed##30##3##(1991-12#1)(1992-9#1)(1993-1#1)(1994-6#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-6#2)(2012-2#1)(2013-8#1)
could be obtained by##4##4##(1992-11#1)(2008-10#2)(2008-5#1)
could be obtained from##2##4##(2007-11#1)(2008-10#1)
could be obtained in##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
could be obtained using##2##4##(2008-10#1)(2008-5#1)
could be obtained when##2##4##(2008-10#1)(2008-12#1)
could be obtained with##4##4##(2007-11#1)(2008-3#2)(2012-7#1)
could be obtained##35##3##(1992-11#1)(1993-12#1)(1994-12#1)(1997-4#1)(1997-7#1)(2007-11#3)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-7#1)
could be of great##2##4##(2008-8#1)(2010-7#1)
could be of interest##2##4##(2010-11#1)(2011-2#1)
could be of potential##2##4##(2008-5#2)
could be of##10##3##(1991-9#1)(1994-8#1)(2008-2#1)(2008-5#3)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)
could be offered##2##3##(2011-2#1)(2013-1#1)
could be one of the##2##5##(1995-12#1)(2008-10#1)
could be one##3##3##(1995-12#1)(2008-10#1)(2010-10#1)
could be operated under physiological conditions (0##2##7##(2008-10#2)
could be overcome by##2##4##(2008-10#1)(2008-11#1)
could be partially##7##3##(1990-2#1)(1993-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
could be partly##2##3##(1990-7#1)(2008-3#1)
could be performed in 1 min##2##6##(2008-10#2)
could be performed in 1##3##5##(2008-10#3)
could be performed in##5##4##(2008-10#5)
could be performed with the ratio 1##2##7##(2008-10#2)
could be performed with##4##4##(2007-11#1)(2008-10#2)(2008-6#1)
could be performed##13##3##(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
could be placed##2##3##(2008-10#1)(2008-5#1)
could be possible##3##3##(2008-10#2)(2008-5#1)
could be predicted from##3##4##(1992-7#1)(2008-10#1)(2008-8#1)
could be predicted with##2##4##(2008-9#1)(2011-1#1)
could be predicted##11##3##(1992-7#1)(1996-4#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-3#1)
could be preformed##2##3##(2007-11#1)(2008-10#1)
could be prepared##3##3##(2008-10#3)
could be present##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
could be presented##2##3##(2008-12#1)(2008-9#1)
could be preserved##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
could be prevented by##4##4##(1990-8#1)(1995-12#1)(2008-11#1)(2011-2#1)
could be prevented##6##3##(1990-8#1)(1995-12#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)
could be produced by##3##4##(1995-6#1)(2008-6#1)(2008-9#1)
could be produced##5##3##(1995-6#1)(2008-6#3)(2008-9#1)
could be promising##2##3##(2011-2#1)(2012-2#1)
could be provided##5##3##(1992-6#1)(1996-12#1)(2008-10#2)(2011-2#1)
could be purified##3##3##(1994-5#2)(1994-8#1)
could be quantified##2##3##(2008-10#2)
could be quantitatively adsorbed##2##4##(2008-10#2)
could be quantitatively##5##3##(2008-10#5)
could be rapidly##2##3##(2011-2#1)(2012-2#1)
could be readily##4##3##(1995-8#1)(2008-10#3)
could be recognized from##2##4##(1996-4#1)(2008-4#1)
could be recognized##4##3##(1996-4#1)(2008-4#1)(2008-9#1)(2011-2#1)
could be recorded##5##3##(1996-6#1)(2007-12#1)(2008-10#2)(2013-1#1)
could be recovered##2##3##(1997-2#1)(2008-10#1)
could be reduced by##3##4##(1997-8#1)(2008-3#2)
could be reduced in##2##4##(1993-2#1)(2008-7#1)
could be reduced to##2##4##(2007-11#1)(2008-10#1)
could be reduced with##2##4##(1996-1#1)(2008-7#1)
could be reduced##13##3##(1993-2#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#3)(2011-2#1)
could be regenerated by##2##4##(2008-10#2)
could be regenerated##3##3##(2008-10#3)
could be related to the##7##5##(1990-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(2008-3#1)(2010-10#1)(2011-2#1)
could be related to##16##4##(1990-5#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#1)
could be related##17##3##(1990-5#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#1)
could be relevant for the##2##5##(2012-2#2)
could be relevant##4##3##(1994-8#1)(2008-7#1)(2012-2#2)
could be reliably##3##3##(2008-10#2)(2008-12#1)
could be removed by##3##4##(1993-6#1)(1993-8#1)(2008-10#1)
could be replaced by##3##4##(1993-11#1)(2008-10#1)(2011-2#1)
could be reproduced with a##2##5##(1992-3#1)(2008-10#1)
could be required##3##3##(2008-10#1)(2013-1#2)
could be rescued##2##3##(1994-3#1)(2012-12#1)
could be resolved##3##3##(1994-9#1)(2008-10#1)(2009-12#1)
could be responsible for the##3##5##(1997-5#1)(2008-8#1)(2012-3#1)
could be responsible for##5##4##(1997-5#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
could be restored##2##3##(2008-11#1)(2008-8#1)
could be reused##6##3##(2008-10#6)
could be reversed##6##3##(1990-6#1)(1993-8#1)(1996-9#1)(2008-1#1)(2008-8#1)(2013-8#1)
could be rotated##2##3##(2007-12#1)(2008-4#1)
could be safely##2##3##(1995-1#1)(2008-12#1)
could be satisfactorily##2##3##(2008-10#2)
could be seen in the##2##5##(1992-12#1)(2008-10#1)
could be seen##9##3##(1991-9#1)(1992-12#1)(1993-12#1)(2008-10#3)(2008-12#1)(2012-12#1)(2013-1#1)
could be separated from##2##4##(2008-10#2)
could be separated into three##2##5##(1992-11#1)(2008-10#1)
could be separated into##4##4##(1992-11#1)(2008-10#2)(2010-10#1)
could be separated##13##3##(1990-8#1)(1991-5#1)(1992-11#1)(2008-10#8)(2010-10#1)(2012-2#1)
could be serious##2##3##(2008-12#1)(2012-12#1)
could be shown that the##2##5##(1995-12#1)(1997-1#1)
could be shown that##6##4##(1990-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#1)
could be shown to##2##4##(1993-12#1)(1995-12#1)
could be shown##12##3##(1990-8#1)(1993-12#1)(1993-2#1)(1995-12#2)(1996-12#1)(1997-1#2)(2008-10#2)(2008-5#1)(2008-8#1)
could be significantly##4##3##(1996-8#1)(2008-3#1)(2008-5#1)(2008-9#1)
could be solubilized with the##2##5##(1990-11#1)(1994-11#1)
could be solved##2##3##(1990-2#1)(2008-3#1)
could be strongly##2##3##(2008-10#1)(2011-2#1)
could be substituted for standard LPA##2##6##(2011-2#2)
could be successfully used for##2##5##(2007-2#1)(2011-1#1)
could be successfully used##3##4##(2007-2#1)(2008-10#1)(2011-1#1)
could be successfully##6##3##(2007-2#1)(2008-10#4)(2011-1#1)
could be suitable for the routine control analysis##2##8##(2008-10#2)
could be suppressed by##3##4##(1993-8#1)(2008-10#1)(2008-9#1)
could be that the##4##4##(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
could be that##6##3##(1997-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
could be the consequence of##4##5##(1990-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
could be the result of a##2##6##(2008-9#1)(2013-1#1)
could be the result of##5##5##(1993-12#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
could be the##31##3##(1990-2#1)(1992-12#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#3)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
could be to##2##3##(2008-7#1)(2011-2#1)
could be tolerated##4##3##(1994-12#1)(2008-10#3)
could be traced back to##2##5##(2008-10#2)
could be traced##4##3##(2008-10#4)
could be transferred into##2##4##(2007-5#1)(2008-8#1)
could be transferred##3##3##(2007-5#1)(2008-11#1)(2008-8#1)
could be transmitted##3##3##(2008-10#2)(2008-9#1)
could be treated##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
could be tuned from##2##4##(2007-12#2)
could be tuned over##3##4##(2007-11#2)(2007-12#1)
could be tuned##6##3##(2007-11#3)(2007-12#3)
could be understood##2##3##(2012-2#1)(2013-1#1)
could be used along with##2##5##(1993-2#1)(2008-5#1)
could be used as a new##2##6##(2008-5#1)(2008-9#1)
could be used as a simple and##2##7##(2008-10#1)(2010-5#1)
could be used as a##25##5##(1990-7#1)(1993-2#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#3)
could be used as an##7##5##(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
could be used as##51##4##(1990-7#1)(1992-12#2)(1993-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
could be used by##3##4##(2009-3#1)(2012-12#1)(2013-1#1)
could be used for at least##2##6##(2008-10#2)
could be used for diagnostic##2##5##(1996-12#1)(2011-2#1)
could be used for more than##3##6##(2008-10#3)
could be used for rapid##2##5##(2008-10#1)(2008-5#1)
could be used for the determination of##6##7##(2008-10#6)
could be used for the##11##5##(1993-1#1)(2008-10#9)(2009-3#1)
could be used for##35##4##(1992-1#1)(1993-1#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-10#21)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
could be used in a pH range of 3##2##9##(2008-10#2)
could be used in a pH range of##6##8##(2008-10#6)
could be used in a##7##5##(2008-10#6)(2008-2#1)
could be used in the##8##5##(1990-12#1)(1990-2#1)(2007-7#1)(2008-10#3)(2012-3#1)(2013-1#1)
could be used in##22##4##(1990-12#1)(1990-2#1)(1997-7#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
could be used to calculate the##2##6##(2008-10#1)(2008-3#1)
could be used to detect##8##5##(2008-10#5)(2013-1#1)(2013-8#2)
could be used to determine##7##5##(2008-10#6)(2008-11#1)
could be used to enhance##2##5##(2008-11#1)(2012-2#1)
could be used to improve the##2##6##(2008-12#1)(2010-12#1)
could be used to improve##4##5##(2007-10#1)(2008-12#1)(2009-10#1)(2010-12#1)
could be used to monitor##3##5##(1995-11#1)(2008-10#1)(2008-11#1)
could be used to predict##2##5##(1997-4#1)(2008-12#1)
could be used to reliably monitor##2##6##(2008-10#1)(2008-8#1)
could be used to study##2##5##(2008-2#1)(2009-4#1)
could be used to##59##4##(1991-12#1)(1993-6#1)(1995-11#1)(1995-8#1)(1997-4#1)(2007-10#2)(2008-10#26)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
could be used##186##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#2)(1993-1#1)(1993-2#2)(1993-6#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#75)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#2)(2009-3#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#6)
could be useful for the##3##5##(2008-4#1)(2012-3#1)(2013-1#1)
could be useful for##11##4##(1995-12#1)(1995-2#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
could be useful in the treatment of##2##7##(2008-5#1)(2009-5#1)
could be useful in the##4##5##(2006-11#1)(2008-5#1)(2009-11#1)(2009-5#1)
could be useful in##12##4##(1991-8#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2013-1#1)
could be useful to##2##4##(2008-10#2)
could be useful##27##3##(1990-12#1)(1991-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(2006-11#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
could be utilized as##2##4##(2008-10#1)(2009-11#1)
could be utilized##6##3##(1992-9#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-9#1)(2012-3#1)
could be varied##2##3##(2007-11#1)(2008-10#1)
could be very useful##2##4##(2008-10#1)(2008-8#1)
could be very##5##3##(1992-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)
could be visualized by##2##4##(2008-10#1)(2008-8#1)
could be visualized##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
could be well##4##3##(2008-10#3)(2013-1#1)
could be##1835##2##(1990-11#10)(1990-12#7)(1990-2#11)(1990-3#2)(1990-5#8)(1990-6#2)(1990-7#5)(1990-8#9)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#6)(1991-2#6)(1991-3#5)(1991-4#2)(1991-5#7)(1991-8#7)(1991-9#8)(1992-1#2)(1992-11#3)(1992-12#10)(1992-2#4)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#6)(1993-1#6)(1993-11#3)(1993-12#15)(1993-2#8)(1993-3#5)(1993-5#1)(1993-6#7)(1993-8#11)(1993-9#8)(1994-11#6)(1994-12#9)(1994-2#8)(1994-3#4)(1994-5#10)(1994-6#2)(1994-8#7)(1994-9#6)(1995-1#3)(1995-11#11)(1995-12#12)(1995-2#14)(1995-3#5)(1995-5#3)(1995-6#6)(1995-8#8)(1996-1#3)(1996-11#2)(1996-12#13)(1996-2#4)(1996-3#4)(1996-4#5)(1996-5#8)(1996-6#3)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#8)(1997-5#7)(1997-6#6)(1997-7#7)(1997-8#4)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#7)(2007-11#20)(2007-12#19)(2007-2#3)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#5)(2007-9#1)(2008-1#18)(2008-10#546)(2008-11#71)(2008-12#31)(2008-2#24)(2008-3#48)(2008-4#7)(2008-5#74)(2008-6#22)(2008-7#49)(2008-8#53)(2008-9#32)(2009-10#4)(2009-11#5)(2009-12#7)(2009-2#2)(2009-3#7)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#10)(2010-11#6)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#8)(2010-5#7)(2010-6#8)(2010-7#4)(2010-8#7)(2011-1#22)(2011-10#2)(2011-2#65)(2011-3#4)(2012-1#5)(2012-12#11)(2012-2#36)(2012-3#22)(2012-5#1)(2012-7#2)(2013-1#47)(2013-7#4)(2013-8#21)
could become##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#2)
could benefit from a##2##4##(1992-12#1)(1993-2#1)
could benefit from##11##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(1995-2#1)(2007-12#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-1#1)
could best##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
could bind the##2##3##(1994-6#1)(2010-12#1)
could bind to##4##3##(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
could bind##11##2##(1990-8#1)(1992-11#1)(1994-5#1)(1994-6#2)(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-12#1)
could block the##2##3##(1994-8#1)(2008-8#1)
could block##5##2##(1993-8#1)(1994-8#1)(1995-12#1)(2008-8#2)
could bring about##2##3##(1992-3#1)(2007-7#1)
could cause the##3##3##(2008-8#1)(2011-2#2)
could cause##13##2##(1995-2#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)
could change the##2##3##(1996-5#1)(2008-3#1)
could change##5##2##(1996-5#1)(2008-3#1)(2008-9#1)(2009-7#1)(2012-3#1)
could clearly##3##2##(2007-11#1)(2008-11#1)(2011-3#1)
could code for a##2##4##(1994-12#1)(2008-11#1)
could complement##2##2##(1997-3#1)(2008-1#1)
could completely##2##2##(2012-2#1)(2013-1#1)
could compromise##2##2##(2011-2#1)(2012-2#1)
could confer##2##2##(1997-7#1)(2013-1#1)
could contain##3##2##(1994-12#1)(1994-2#1)(1995-12#1)
could contribute to a##2##4##(1991-5#1)(2008-2#1)
could contribute to the reduction##2##5##(1990-5#1)(2008-10#1)
could contribute to the##12##4##(1990-5#1)(1994-11#2)(1994-2#1)(2007-8#1)(2008-10#3)(2008-5#3)(2010-2#1)
could contribute to##21##3##(1990-5#1)(1991-5#1)(1994-11#2)(1994-2#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#3)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)
could contribute##23##2##(1990-5#1)(1991-5#1)(1994-11#2)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#3)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)
could control##2##2##(1996-5#1)(2012-2#1)
could damage##2##2##(1994-3#1)(1996-9#1)
could decrease or##2##3##(2007-8#1)(2012-12#1)
could decrease the##4##3##(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
could decrease##9##2##(1991-6#1)(1994-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
could degrade##2##2##(2008-10#2)
could delay##2##2##(2010-9#1)(2011-2#1)
could demonstrate that rapid##2##4##(1990-8#1)(2011-1#1)
could demonstrate that##3##3##(1990-8#1)(1995-12#1)(2011-1#1)
could demonstrate##5##2##(1990-8#1)(1995-12#2)(2008-11#1)(2011-1#1)
could detect no##2##3##(1995-12#1)(2008-9#1)
could detect##20##2##(1991-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-10#9)(2008-9#1)(2011-3#1)(2013-1#1)(2013-7#1)
could determine the##5##3##(1995-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
could determine##8##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)
could develop##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
could differ##3##2##(1994-2#1)(2008-1#1)(2008-10#1)
could differentiate##2##2##(2008-10#1)(2008-12#1)
could directly##5##2##(2007-11#1)(2007-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
could discriminate##3##2##(1992-10#1)(2008-10#2)
could distinguish##6##2##(1997-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)
could drastically##2##2##(1994-3#1)(2013-1#1)
could easily be##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2012-3#2)
could easily##16##2##(1990-8#1)(1992-12#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-1#1)(2010-3#1)(2012-12#2)(2012-3#2)
could effectively##7##2##(2008-10#5)(2008-5#1)(2013-1#1)
could elicit##4##2##(1996-2#1)(2008-8#1)(2011-2#2)
could encode a protein of##2##5##(1991-9#1)(1994-12#1)
could encode a##4##3##(1990-11#1)(1991-9#1)(1994-12#1)(2008-10#1)
could encode##5##2##(1990-11#1)(1991-9#1)(1994-12#1)(1995-8#1)(2008-10#1)
could encourage##3##2##(1997-1#1)(2008-12#2)
could enhance the sensitivity##2##4##(2008-10#2)
could enhance the##8##3##(1995-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-4#1)
could enhance##13##2##(1995-1#1)(1995-8#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#1)
could exceed##2##2##(2008-10#1)(2009-8#1)
could exert a modulatory action on the##2##7##(1990-5#1)(1993-12#1)
could exist##3##2##(1991-2#1)(2008-10#2)
could explain the greater##2##4##(2008-8#1)(2011-2#1)
could explain the##9##3##(1993-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
could explain their##2##3##(2011-10#1)(2011-2#1)
could explain##19##2##(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
could facilitate the##4##3##(1994-8#1)(1996-12#1)(2010-12#1)(2012-3#1)
could facilitate##10##2##(1992-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-3#1)
could find##5##2##(1993-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-2#1)
could fit##2##2##(2008-10#1)(2010-11#1)
could form the basis of##2##5##(2008-7#1)(2011-2#1)
could form##8##2##(1992-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-2#1)
could function##2##2##(1995-6#1)(1996-9#1)
could further##6##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
could generate##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
could give##4##2##(1994-9#1)(2008-10#2)(2010-10#1)
could go##2##2##(1997-3#1)(2010-3#1)
could greatly improve the##2##4##(2008-10#1)(2010-8#1)
could greatly##4##2##(2008-10#2)(2009-6#1)(2010-8#1)
could grow on##2##3##(2010-6#1)(2013-1#1)
could grow##5##2##(2008-11#1)(2008-5#1)(2010-6#1)(2013-1#2)
could hardly be detected##2##4##(1993-8#1)(2008-3#1)
could hardly##3##2##(1993-8#1)(1997-8#1)(2008-3#1)
could have a significant influence on##2##6##(2008-3#1)(2008-7#1)
could have a significant##3##4##(2008-3#1)(2008-7#1)(2009-5#1)
could have a##13##3##(1993-9#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-7#3)(2009-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
could have an##4##3##(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
could have been##16##3##(1990-5#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-1#2)(1997-3#1)(1997-6#2)(2008-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-12#1)
could have had##2##3##(2008-7#1)(2013-1#1)
could have implications##2##3##(2007-6#1)(2008-1#1)
could have important implications##2##4##(1996-12#1)(2012-12#1)
could have influenced the##2##4##(1990-3#1)(2007-8#1)
could have made##2##3##(1993-12#1)(1997-5#1)
could have##77##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1993-12#1)(1993-9#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-1#2)(1996-12#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#2)(2007-10#3)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#6)(2013-8#1)
could help in##2##3##(1992-8#1)(2008-10#1)
could help to improve##2##4##(2008-10#1)(2012-8#1)
could help to##8##3##(1991-12#1)(2008-10#1)(2008-3#1)(2012-12#3)(2012-3#1)(2012-8#1)
could help us##2##3##(1993-12#1)(2011-2#1)
could help##26##2##(1991-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
could identify##3##2##(1995-6#1)(2009-4#1)(2013-8#1)
could improve clinical##2##3##(1990-6#1)(1995-11#1)
could improve the quality of##2##5##(2007-2#1)(2009-6#1)
could improve the##11##3##(1994-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-6#1)(2013-1#1)
could improve##22##2##(1990-6#1)(1994-12#1)(1995-11#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
could include##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
could increase the chances of##2##5##(1993-8#1)(2008-7#1)
could increase the##14##3##(1993-8#1)(1994-8#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
could increase##23##2##(1993-8#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
could indicate##3##2##(2007-10#1)(2008-10#1)(2013-8#1)
could indirectly##2##2##(1993-8#1)(2012-2#1)
could induce the##2##3##(2008-8#2)
could induce##26##2##(1990-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-8#4)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
could infect##2##2##(2008-10#2)
could influence the##6##3##(1990-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
could influence their##2##3##(2012-3#2)
could influence##16##2##(1990-10#1)(1992-6#1)(1992-8#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
could inhibit the##9##3##(1991-12#1)(1991-3#1)(1996-2#1)(2008-8#2)(2008-9#2)(2010-6#1)(2012-3#1)
could inhibit##18##2##(1991-12#2)(1991-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-6#1)(2012-3#1)
could interact with##4##3##(1996-2#1)(2008-10#2)(2008-11#1)
could interact##5##2##(1996-2#1)(2008-10#2)(2008-11#1)(2013-8#1)
could interfere with the##2##4##(1997-7#1)(2008-2#1)
could interfere with##3##3##(1997-7#2)(2008-2#1)
could interfere##4##2##(1997-7#2)(2008-10#1)(2008-2#1)
could invade##2##2##(2008-10#2)
could involve##5##2##(1990-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2013-7#1)
could jeopardize##2##2##(1994-1#1)(2013-1#1)
could largely##2##2##(2010-11#1)(2012-2#1)
could lead to a##5##4##(1990-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
could lead to an##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
could lead to better##2##4##(2008-11#1)(2010-10#1)
could lead to both##2##4##(1992-8#1)(1994-6#1)
could lead to improved##2##4##(2008-10#1)(2008-3#1)
could lead to new##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
could lead to novel##2##4##(2008-7#2)
could lead to significant##2##4##(2008-10#2)
could lead to the development of##2##6##(2008-10#1)(2008-7#1)
could lead to the##9##4##(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
could lead to##57##3##(1990-11#1)(1990-8#1)(1992-8#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#9)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
could lead##61##2##(1990-11#1)(1990-8#1)(1992-3#1)(1992-8#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#9)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
could learn to discriminate between##2##5##(2010-2#2)
could learn##3##2##(2009-8#1)(2010-2#2)
could limit the##2##3##(2008-10#1)(2008-8#1)
could limit##3##2##(1996-11#1)(2008-10#1)(2008-8#1)
could maintain##2##2##(1991-9#1)(2008-8#1)
could make##2##2##(2008-3#1)(2013-1#1)
could measure##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
could mediate##4##2##(1997-7#1)(2007-11#1)(2008-9#1)(2012-3#1)
could modify the##5##3##(1992-2#1)(2011-10#1)(2011-2#3)
could modify##6##2##(1992-2#1)(2008-7#1)(2011-10#1)(2011-2#3)
could modulate##3##2##(1994-6#1)(2008-11#1)(2008-5#1)
could name the##2##3##(2008-11#1)(2008-5#1)
could name##3##2##(1993-12#1)(2008-11#1)(2008-5#1)
could neutralize the##2##3##(1993-3#1)(2008-8#1)
could never##2##2##(2008-2#1)(2008-7#1)
could not be accounted for by##2##6##(1990-10#1)(2011-2#1)
could not be achieved with##2##5##(1996-6#1)(2007-12#1)
could not be ascribed##2##4##(2008-11#1)(2009-6#1)
could not be assigned##2##4##(2008-10#2)
could not be attributed to##2##5##(1993-6#1)(2008-7#1)
could not be confirmed##4##4##(2008-10#1)(2008-12#1)(2010-4#1)(2012-2#1)
could not be demonstrated in##2##5##(1990-11#1)(1994-11#1)
could not be demonstrated##5##4##(1990-11#1)(1990-9#1)(1994-11#1)(2008-10#2)
could not be detected by##4##5##(1991-3#1)(1996-12#1)(1996-5#1)(2008-10#1)
could not be detected in##4##5##(1991-9#1)(1995-6#1)(2009-8#1)(2011-2#1)
could not be detected on##2##5##(2008-10#1)(2008-7#1)
could not be detected##14##4##(1991-3#1)(1991-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)
could not be determined##4##4##(1995-2#1)(2008-10#2)(2008-3#1)
could not be differentiated##3##4##(2008-10#3)
could not be distinguished from##2##5##(2008-10#2)
could not be distinguished##5##4##(1993-12#1)(2008-10#4)
could not be eliminated##2##4##(1997-4#1)(2008-10#1)
could not be evaluated##2##4##(1995-3#1)(2008-10#1)
could not be excluded##3##4##(1997-5#1)(2008-7#1)(2009-12#1)
could not be explained by##4##5##(1993-2#1)(1995-5#1)(2008-7#1)(2012-2#1)
could not be explained in##2##5##(1990-8#2)
could not be explained##7##4##(1990-8#2)(1993-2#1)(1995-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
could not be forced to##2##5##(1996-5#2)
could not be further##2##4##(2008-10#2)
could not be grouped##2##4##(2008-10#2)
could not be identified##8##4##(1992-6#1)(1994-8#1)(1997-3#1)(2008-10#4)(2008-7#1)
could not be induced##2##4##(1990-7#1)(1994-8#1)
could not be isolated##3##4##(1990-8#1)(1996-6#1)(2007-11#1)
could not be observed##2##4##(2007-12#1)(2008-10#1)
could not be obtained##2##4##(2008-10#1)(2008-2#1)
could not be performed##2##4##(2007-8#1)(2008-10#1)
could not be related##2##4##(1992-10#1)(1996-12#1)
could not be reversed by##2##5##(2008-7#1)(2008-8#1)
could not be ruled out##2##5##(2008-1#1)(2008-10#1)
could not be shown##2##4##(1992-12#1)(2008-11#1)
could not be used to##3##5##(2008-2#1)(2008-7#1)(2012-2#1)
could not be used##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
could not be##159##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#43)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#3)(2008-6#3)(2008-7#13)(2008-8#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)
could not communicate with##2##4##(1995-12#1)(1997-6#1)
could not confirm##2##3##(2011-2#2)
could not detect large##2##4##(1993-8#1)(2008-11#1)
could not detect##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)
could not distinguish##2##3##(1994-9#1)(2008-10#1)
could not encode##2##3##(1993-2#1)(2008-10#1)
could not find a##2##4##(2008-8#1)(2013-8#1)
could not find##3##3##(2008-8#1)(2012-3#1)(2013-8#1)
could not fully##2##3##(2007-12#1)(2008-7#1)
could not have##2##3##(2009-3#1)(2010-5#1)
could not inhibit the##2##4##(1990-8#1)(1991-2#1)
could not inhibit##3##3##(1990-8#1)(1991-2#1)(1991-3#1)
could not interact with##2##4##(2008-8#1)(2008-9#1)
could not prevent##2##3##(2008-10#1)(2011-2#1)
could not prove##2##3##(1990-2#1)(1995-6#1)
could not reach a##2##4##(1993-1#1)(2013-1#1)
could not recover the##2##4##(2008-8#2)
could not reveal##3##3##(2007-11#2)(2008-10#1)
could not##271##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#5)(1990-9#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#62)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#18)(2008-8#13)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#3)
could observe##3##2##(1997-2#1)(2008-11#1)(2008-12#1)
could obtain##3##2##(1995-12#1)(2008-11#1)(2013-8#1)
could obviously##2##2##(2008-10#1)(2008-8#1)
could occur at##2##3##(2007-2#1)(2011-2#1)
could occur from##2##3##(1991-12#1)(2008-9#1)
could occur in the##2##4##(1995-6#1)(2008-12#1)
could occur in##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
could occur##16##2##(1990-5#1)(1991-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
could offer##4##2##(2008-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
could only be##12##3##(1990-10#1)(1990-3#1)(1990-5#1)(1991-7#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)
could only##18##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-7#1)(1992-4#1)(1993-8#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#2)
could operate##2##2##(1992-2#1)(2008-3#1)
could otherwise##3##2##(1992-3#1)(2008-8#2)
could phosphorylate##4##2##(1993-11#2)(1993-6#2)
could play a role in the##2##6##(1996-12#1)(2008-8#1)
could play a role in##7##5##(1994-11#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(2008-8#1)(2012-1#1)
could play a##15##3##(1994-11#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
could play an important role in the##2##7##(2008-10#1)(2008-4#1)
could play an important role in##3##6##(1997-7#1)(2008-10#1)(2008-4#1)
could play an important##4##4##(1997-7#1)(2008-10#2)(2008-4#1)
could play##19##2##(1994-11#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
could possibly be used##2##4##(2008-11#1)(2008-3#1)
could possibly be##7##3##(1990-5#1)(1993-11#1)(1996-5#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)
could possibly##9##2##(1990-12#1)(1990-5#1)(1993-11#1)(1996-5#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-1#1)
could potentially be involved in the host infection process##2##9##(2010-10#2)
could potentially be used##3##4##(2008-11#1)(2009-12#1)(2009-4#1)
could potentially be##9##3##(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-10#2)(2011-2#1)(2013-1#2)
could potentially##26##2##(1990-5#1)(1994-5#1)(2007-12#2)(2007-5#1)(2008-10#7)(2008-11#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2011-2#3)(2013-1#3)
could predict the##2##3##(2010-3#1)(2011-2#1)
could predict##4##2##(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
could predispose to##2##3##(1992-2#1)(2008-12#1)
could present##2##2##(2008-10#1)(2010-12#1)
could prevent the##2##3##(2008-9#1)(2009-8#1)
could prevent##7##2##(1991-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)
could produce##9##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-1#1)
could promote the##4##3##(1992-12#1)(2008-8#2)(2013-1#1)
could promote##6##2##(1992-12#1)(1993-6#1)(2008-8#2)(2008-9#1)(2013-1#1)
could protect against##2##3##(2011-2#1)(2012-2#1)
could protect##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
could prove to be##2##4##(2007-11#1)(2008-10#1)
could prove to##3##3##(2007-11#1)(2008-10#1)(2009-12#1)
could prove useful for##2##4##(1991-6#1)(2008-8#1)
could prove useful##3##3##(1991-6#1)(2008-2#1)(2008-8#1)
could prove##12##2##(1991-6#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)
could provide a new##4##4##(1996-2#1)(1997-7#1)(2011-1#1)(2013-8#1)
could provide a useful model for##2##6##(1990-5#1)(1997-4#1)
could provide a useful##3##4##(1990-5#1)(1997-4#1)(2010-3#1)
could provide a##15##3##(1990-5#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
could provide an alternative##2##4##(2008-10#1)(2008-9#1)
could provide an##4##3##(1997-4#1)(1997-7#1)(2008-10#1)(2008-9#1)
could provide the##4##3##(1992-6#1)(2008-2#1)(2009-2#1)(2011-2#1)
could provide valuable##2##3##(2011-2#1)(2013-7#1)
could provide##51##2##(1990-5#1)(1991-11#1)(1991-8#1)(1992-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
could put##2##2##(1990-2#1)(2013-8#1)
could quench##2##2##(2008-10#2)
could raise a##2##3##(1994-12#1)(2011-2#1)
could range from##3##3##(2007-12#1)(2008-10#2)
could rapidly##2##2##(1997-6#1)(2008-9#1)
could reach##10##2##(1997-6#1)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
could react with##2##3##(2008-10#2)
could react##3##2##(2008-10#2)(2008-2#1)
could reactivate##2##2##(1995-6#1)(2008-9#1)
could readily be##2##3##(1990-3#1)(2011-1#1)
could readily##5##2##(1990-3#1)(1992-8#1)(2008-5#1)(2008-8#1)(2011-1#1)
could receive##2##2##(1992-2#1)(2008-3#1)
could recognize##4##2##(1997-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
could recover##3##2##(1990-5#1)(2008-10#2)
could reduce the##6##3##(1997-3#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)
could reduce##14##2##(1995-6#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
could reflect the##4##3##(1992-6#1)(1994-2#1)(2006-10#1)(2008-10#1)
could reflect##10##2##(1992-12#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-6#1)(2013-8#2)
could regulate##2##2##(1995-2#1)(2013-1#1)
could replace serum##2##3##(1993-6#1)(1996-12#1)
could replace##5##2##(1993-6#1)(1996-12#1)(2008-10#1)(2008-3#2)
could represent a##4##3##(1996-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
could represent##9##2##(1993-1#1)(1994-12#1)(1996-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
could resolve##2##2##(1997-5#1)(2008-10#1)
could restore##3##2##(1991-7#1)(2007-11#1)(2008-8#1)
could result from##5##3##(1993-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
could result in a##4##4##(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)
could result in the##3##4##(1994-2#1)(2008-10#1)(2008-9#1)
could result in##22##3##(1991-6#1)(1992-1#1)(1993-8#1)(1994-2#1)(1996-12#2)(1996-9#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-9#3)(2009-9#1)(2010-9#1)(2011-2#4)
could result##27##2##(1991-6#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-9#4)(2009-9#1)(2010-9#1)(2011-2#4)
could reveal##2##2##(2008-10#1)(2011-2#1)
could reverse##2##2##(1991-7#1)(1995-2#1)
could save##3##2##(1996-12#1)(2008-11#1)(2013-1#1)
could selectively##2##2##(1990-11#1)(2012-3#1)
could serve as a new##2##5##(2008-11#1)(2010-4#1)
could serve as a##15##4##(1991-9#1)(1993-1#1)(1993-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
could serve as the##2##4##(2008-11#1)(2013-8#1)
could serve as##25##3##(1991-3#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
could serve to##2##3##(2010-8#1)(2012-3#1)
could serve##31##2##(1991-3#1)(1991-9#2)(1992-3#2)(1993-1#1)(1993-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
could show a##3##3##(2008-5#2)(2009-12#1)
could show that the##3##4##(1997-7#1)(2008-11#2)
could show that##5##3##(1997-7#1)(2008-11#2)(2009-6#1)(2011-1#1)
could show##9##2##(1996-8#1)(1997-7#1)(2008-11#2)(2008-5#2)(2009-12#1)(2009-6#1)(2011-1#1)
could significantly decrease##2##3##(2008-9#1)(2012-2#1)
could significantly increase the##2##4##(2008-3#1)(2008-9#1)
could significantly inhibit##2##3##(2008-8#1)(2008-9#1)
could significantly reduce##2##3##(1995-8#1)(1996-3#1)
could significantly##13##2##(1995-8#1)(1996-3#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#4)(2010-12#1)(2012-1#1)(2012-2#1)
could similarly##2##2##(2008-8#1)(2009-12#1)
could specifically##4##2##(1990-5#1)(2008-10#2)(2008-9#1)
could spread in##2##3##(2008-10#1)(2008-8#1)
could spread##3##2##(2007-6#1)(2008-10#1)(2008-8#1)
could stably##2##2##(2008-9#1)(2013-8#1)
could steadily##2##2##(2008-10#1)(2012-2#1)
could still be##4##3##(2008-7#1)(2008-8#2)(2012-2#1)
could still##8##2##(1996-2#1)(1996-8#1)(2007-7#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-2#1)
could stimulate the##2##3##(2008-7#1)(2012-3#1)
could stimulate##5##2##(1995-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
could strengthen##2##2##(2010-7#1)(2013-8#1)
could strongly##2##2##(2008-8#1)(2011-1#1)
could subsequently be##2##3##(1990-12#1)(2008-10#1)
could substitute for##3##3##(1992-6#1)(1995-11#1)(2008-3#1)
could successfully##4##2##(2008-1#1)(2008-10#2)(2012-3#1)
could suggest that##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
could suggest##4##2##(1990-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
could supply##2##2##(2008-5#1)(2011-3#1)
could support the##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
could support##6##2##(1992-1#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
could suppress##4##2##(1990-8#1)(1992-3#1)(1993-8#1)(2013-8#1)
could take##3##2##(1991-3#1)(1994-12#1)(2008-10#1)
could then be##6##3##(1997-4#1)(2008-10#3)(2008-8#1)(2013-1#1)
could then##8##2##(1995-1#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-1#1)
could theoretically##2##2##(2008-3#1)(2013-1#1)
could therefore be##6##3##(1990-8#1)(1992-11#1)(1992-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
could therefore##11##2##(1990-11#1)(1990-8#1)(1992-11#1)(1992-3#1)(2008-10#4)(2008-8#1)(2010-12#1)(2011-2#1)
could they##2##2##(1994-6#1)(2008-11#1)
could this##2##2##(2011-2#1)(2012-12#1)
could thus be used##2##4##(2008-11#1)(2008-5#1)
could thus be##4##3##(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
could thus serve as##2##4##(1992-6#1)(2008-11#1)
could thus##11##2##(1992-6#1)(1993-8#1)(2008-11#2)(2008-5#3)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
could trans-replicate##2##2##(2008-10#2)
could transfer##2##2##(1990-2#1)(2008-8#1)
could transiently##2##2##(2010-6#1)(2013-1#1)
could transmit##2##2##(2008-10#1)(2012-3#1)
could treat##2##2##(1996-2#1)(1997-3#1)
could ultimately be##2##3##(1993-2#1)(2010-8#1)
could undergo##3##2##(1991-3#1)(2010-8#2)
could underlie##4##2##(1993-11#1)(1996-2#1)(1996-5#1)(2007-11#1)
could use some standard##2##4##(2013-1#2)
could use##7##2##(1997-2#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#3)
could usefully##2##2##(2007-12#1)(2010-5#1)
could walk##2##2##(2007-11#1)(2012-1#1)
could we##2##2##(1990-12#1)(2008-1#1)
could well be##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
could well##6##2##(1995-1#1)(2007-11#1)(2008-10#2)(2012-12#1)(2013-8#1)
could work##2##2##(1997-2#1)(2008-10#1)
could yield##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
could##3668##1##(1990-10#4)(1990-11#16)(1990-12#11)(1990-2#15)(1990-3#6)(1990-4#1)(1990-5#22)(1990-6#4)(1990-7#9)(1990-8#21)(1990-9#3)(1991-1#2)(1991-11#6)(1991-12#12)(1991-2#14)(1991-3#11)(1991-4#2)(1991-5#11)(1991-6#4)(1991-7#4)(1991-8#8)(1991-9#14)(1992-1#4)(1992-10#2)(1992-11#8)(1992-12#19)(1992-2#10)(1992-3#22)(1992-4#4)(1992-5#2)(1992-6#14)(1992-7#1)(1992-8#7)(1992-9#11)(1993-1#10)(1993-11#9)(1993-12#25)(1993-2#13)(1993-3#7)(1993-5#1)(1993-6#13)(1993-8#28)(1993-9#14)(1994-1#3)(1994-11#10)(1994-12#17)(1994-2#20)(1994-3#11)(1994-5#13)(1994-6#14)(1994-7#2)(1994-8#18)(1994-9#13)(1995-1#8)(1995-11#17)(1995-12#25)(1995-2#26)(1995-3#9)(1995-5#4)(1995-6#19)(1995-8#19)(1996-1#7)(1996-11#5)(1996-12#34)(1996-2#19)(1996-3#8)(1996-4#7)(1996-5#21)(1996-6#6)(1996-8#5)(1996-9#12)(1997-1#9)(1997-2#22)(1997-3#21)(1997-4#13)(1997-5#14)(1997-6#17)(1997-7#17)(1997-8#5)(2006-10#8)(2006-11#1)(2006-8#2)(2007-10#14)(2007-11#37)(2007-12#34)(2007-2#6)(2007-4#1)(2007-5#6)(2007-6#3)(2007-7#19)(2007-8#16)(2007-9#1)(2008-1#38)(2008-10#858)(2008-11#179)(2008-12#56)(2008-2#41)(2008-3#99)(2008-4#18)(2008-5#119)(2008-6#38)(2008-7#111)(2008-8#137)(2008-9#102)(2009-10#6)(2009-11#10)(2009-12#17)(2009-2#6)(2009-3#8)(2009-4#6)(2009-5#10)(2009-6#14)(2009-7#12)(2009-8#17)(2009-9#6)(2010-1#7)(2010-10#17)(2010-11#9)(2010-12#20)(2010-2#5)(2010-3#15)(2010-4#13)(2010-5#18)(2010-6#13)(2010-7#9)(2010-8#19)(2010-9#4)(2011-1#43)(2011-10#4)(2011-2#141)(2011-3#10)(2011-7#1)(2012-1#11)(2012-12#30)(2012-2#80)(2012-3#46)(2012-5#2)(2012-7#2)(2012-8#1)(2013-1#105)(2013-7#16)(2013-8#57)
couldn't happen##2##2##(1991-12#1)(1995-12#1)
couldn't##3##1##(1991-12#1)(1995-12#1)(2010-6#1)
coulombic interactions between##2##3##(1991-11#1)(2008-10#1)
coulombic interactions##4##2##(1991-11#1)(2008-10#3)
coulombic##5##1##(1991-11#1)(1996-5#1)(2008-10#3)
coulometric detection##2##2##(2008-10#2)
coulometric iodimetric##2##2##(2008-10#2)
coulometric method##2##2##(2008-10#2)
coulometric methods##2##2##(1991-8#1)(2008-10#1)
coulometric titration method##3##3##(2008-10#3)
coulometric titration of##3##3##(2008-10#3)
coulometric titration with the anodically generated chlorine##2##7##(2008-10#2)
coulometric titration##11##2##(2008-10#11)
coulometric##29##1##(1991-8#1)(2008-10#27)(2009-8#1)
coulometrically##2##1##(2008-10#2)
coumaphos##4##1##(2008-10#4)
coumarin derivatives##2##2##(1992-8#1)(2007-11#1)
coumarin##17##1##(1990-6#2)(1991-11#1)(1992-8#2)(1994-3#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-8#1)(2009-2#1)
coumarinic compound formation##2##3##(2008-10#2)
coumarins##6##1##(1990-6#1)(2008-10#1)(2008-11#3)(2011-3#1)
coumestrol##6##1##(1995-11#5)(2008-10#1)
council##6##1##(1995-6#2)(1996-6#1)(2009-12#1)(2013-1#2)
councils##6##1##(1997-8#3)(2008-11#1)(2008-7#2)
counsel and##2##2##(1993-12#1)(2013-1#1)
counsel##18##1##(1990-6#1)(1991-1#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#2)
counseled##2##1##(2008-11#1)(2008-3#1)
counseling and testing##3##3##(2008-3#1)(2013-1#2)
counseling and##20##2##(1994-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#4)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
counseling as##2##2##(1995-6#1)(1997-3#1)
counseling by##2##2##(1996-5#1)(2008-7#1)
counseling during##2##2##(2008-11#1)(2011-1#1)
counseling for##3##2##(1997-4#2)(2008-4#1)
counseling in##7##2##(1992-4#1)(1995-11#1)(1997-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-1#1)
counseling is##2##2##(1996-5#1)(2011-2#1)
counseling on##2##2##(1993-2#1)(1997-3#1)
counseling or##2##2##(2008-4#1)(2013-1#1)
counseling programs##3##2##(1997-3#2)(1997-5#1)
counseling psychology##2##2##(2010-12#2)
counseling service##2##2##(1993-12#1)(2012-3#1)
counseling services##3##2##(1992-1#1)(1994-2#1)(2008-6#1)
counseling to##4##2##(1995-12#1)(1997-2#1)(2008-4#1)(2013-1#1)
counseling was##2##2##(2008-4#1)(2013-1#1)
counseling##119##1##(1990-8#1)(1991-1#2)(1991-6#1)(1992-1#1)(1992-4#1)(1993-1#2)(1993-12#1)(1993-2#3)(1994-1#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-5#7)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#2)(1997-8#1)(2007-7#6)(2008-1#3)(2008-11#5)(2008-3#6)(2008-4#8)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#10)(2013-8#2)
counselling and testing##3##3##(2007-12#1)(2009-7#1)(2013-1#1)
counselling and##11##2##(2006-10#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
counselling in the##2##3##(1993-2#1)(2011-2#1)
counselling in##5##2##(1993-2#2)(1996-9#2)(2011-2#1)
counselling is##2##2##(2008-7#1)(2010-5#1)
counselling of##3##2##(1991-11#1)(2008-10#1)(2012-2#1)
counselling on the##3##3##(2008-10#1)(2013-8#2)
counselling##53##1##(1991-11#2)(1991-3#1)(1993-2#3)(1995-12#1)(1996-11#1)(1996-6#1)(1996-9#3)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-7#3)(2008-9#3)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#8)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#7)
counsellors##3##1##(2010-9#3)
counselor##2##1##(2007-12#1)(2008-12#1)
counselors##12##1##(1994-2#1)(1996-5#1)(2007-2#1)(2008-12#4)(2008-6#2)(2010-11#3)
counselors'##3##1##(2008-6#3)
count above##2##2##(1990-12#1)(1996-8#1)
count and morphology of##2##4##(2008-10#1)(2008-12#1)
count and morphology##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
count and platelet##2##3##(2007-10#1)(2010-5#1)
count and the##4##3##(1991-2#1)(2008-1#1)(2008-3#1)(2013-8#1)
count and viral load##2##4##(2008-6#1)(2012-2#1)
count and##30##2##(1990-2#1)(1990-9#1)(1991-2#1)(1992-2#1)(2006-10#1)(2007-10#4)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
count as##2##2##(1991-12#1)(2008-8#1)
count in##8##2##(2006-6#1)(2007-10#1)(2008-5#1)(2009-7#1)(2011-2#3)(2013-8#1)
count increased##2##2##(2012-3#2)
count is##2##2##(2008-10#1)(2008-5#1)
count of##10##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
count on the##2##3##(2008-10#2)
count on##3##2##(2008-10#3)
count rate##3##2##(1996-12#1)(2008-3#2)
count rates##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
count than##2##2##(1993-12#1)(1996-8#1)
count the##2##2##(2008-6#1)(2009-12#1)
count to##2##2##(1993-6#1)(2008-11#1)
count was##10##2##(1994-3#1)(1994-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#2)(2011-2#1)
count were##4##2##(2007-3#1)(2010-11#1)(2011-1#2)
count within##2##2##(2012-3#1)(2013-1#1)
count##196##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#3)(1992-2#6)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-8#2)(1997-4#4)(1997-5#2)(2006-10#1)(2006-6#3)(2007-10#8)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#5)(2011-2#17)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#4)
count)##2##1##(2008-9#1)(2013-1#1)
countable##4##1##(2008-10#2)(2008-11#1)(2012-2#1)
counted after##2##2##(2008-10#1)(2008-12#1)
counted and the##2##3##(2007-11#1)(2013-1#1)
counted and##5##2##(2007-11#1)(2007-5#1)(2008-10#2)(2013-1#1)
counted as##2##2##(1995-3#1)(2012-12#1)
counted by##3##2##(1992-12#1)(2008-5#1)(2011-1#1)
counted in##8##2##(1991-11#1)(1992-10#1)(2007-11#2)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
counted##43##1##(1991-11#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-3#1)(1996-12#1)(2007-11#6)(2007-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#2)
counter and reference##2##3##(2008-10#2)
counter and##5##2##(1992-10#1)(2008-10#3)(2008-3#1)
counter anion##3##2##(2008-10#3)
counter electrode and a##2##4##(2008-10#2)
counter electrode##4##2##(2008-10#4)
counter ion in methanol##2##4##(1995-6#2)
counter ion in##3##3##(1995-6#2)(2008-10#1)
counter ion##8##2##(1995-6#2)(2008-10#4)(2008-5#2)
counter ion)##2##2##(1990-8#1)(2008-10#1)
counter it##2##2##(1996-8#1)(2008-5#1)
counter some##2##2##(1994-6#1)(2008-3#1)
counter the##3##2##(2008-2#1)(2008-5#1)(2012-12#1)
counter##60##1##(1990-8#1)(1992-10#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-6#2)(1996-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#3)(2009-5#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
counter-current chromatography (HSCCC)##3##3##(2008-10#1)(2011-1#2)
counter-current chromatography##4##2##(2008-10#2)(2011-1#2)
counter-current##6##1##(2008-10#2)(2011-1#4)
counter-ion##4##1##(1997-2#2)(2008-10#2)
counter-regulatory##2##1##(2010-11#1)(2012-5#1)
counter-terrorist##2##1##(2008-10#2)
counter-transport##6##1##(1992-6#5)(2008-10#1)
counteract the effect of##2##4##(1995-3#1)(2008-6#1)
counteract the##11##2##(1990-9#1)(1992-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-6#2)(2013-8#1)
counteract these##2##2##(1994-11#1)(2007-10#1)
counteract this##2##2##(1996-2#1)(2008-5#1)
counteract##22##1##(1990-9#1)(1992-3#1)(1994-11#2)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2012-4#1)(2013-8#1)
counteracted by##7##2##(1990-5#2)(1992-11#1)(1992-9#1)(1993-1#1)(2008-3#1)(2008-4#1)
counteracted the##3##2##(1994-8#1)(2008-11#2)
counteracted##14##1##(1990-5#2)(1992-11#1)(1992-9#1)(1993-1#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
counteracting##11##1##(1992-2#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-3#1)(2012-12#1)
counteractive##3##1##(1995-12#1)(2009-12#1)(2012-2#1)
counteracts##6##1##(1995-5#1)(2007-12#1)(2008-11#2)(2008-9#1)(2012-2#1)
counterarguments##2##1##(2008-8#2)
counterbalance order II##3##3##(2013-8#3)
counterbalance order##5##2##(2013-8#5)
counterbalance##6##1##(2008-3#1)(2013-8#5)
counterbalanced##7##1##(1992-12#1)(1992-6#1)(1995-12#1)(2007-11#1)(2009-5#1)(2013-8#2)
counterbalances##2##1##(1993-11#1)(2008-8#1)
countercurrent gas flow rate##3##4##(2008-10#3)
countercurrent gas flow rates##2##4##(2008-10#2)
countercurrent gas flow##5##3##(2008-10#5)
countercurrent gas##6##2##(2008-10#6)
countercurrent##8##1##(2008-10#6)(2013-1#2)
countered by##2##2##(1991-12#1)(2008-8#1)
counterexample to##2##2##(2008-8#2)
counterexample##3##1##(2008-12#1)(2008-8#2)
counterfactual and future-temporal##2##3##(2009-5#2)
counterfactual##4##1##(2009-5#4)
counterfeit##4##1##(2008-10#1)(2010-4#3)
counterflow##5##1##(1996-12#1)(2008-2#1)(2008-3#3)
counterimmunoelectrophoresis##2##1##(2007-7#1)(2008-5#1)
countering##3##1##(1991-3#1)(2007-12#1)(2008-9#1)
counterintuitive findings##2##2##(2009-9#1)(2012-12#1)
counterintuitive result is##2##3##(2007-11#1)(2008-8#1)
counterintuitive result##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
counterintuitive##11##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#4)(2008-9#2)(2009-9#1)(2012-12#1)
counterion##9##1##(1997-2#3)(2008-10#6)
counterions##3##1##(2007-11#1)(2008-10#2)
countermeasure##2##1##(2013-1#1)(2013-8#1)
countermeasures may be##2##3##(2010-7#2)
countermeasures##4##1##(2007-7#1)(2008-11#1)(2010-7#2)
countermovement##3##1##(1995-2#2)(2009-1#1)
counterpart and##2##2##(2010-12#1)(2011-2#1)
counterpart in the##2##3##(1993-8#1)(2012-2#1)
counterpart in##3##2##(1993-8#1)(2008-10#1)(2012-2#1)
counterpart of##2##2##(1994-11#1)(2013-1#1)
counterpart with##2##2##(1994-11#1)(2009-5#1)
counterpart##40##1##(1992-8#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#3)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#2)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
counterparts and##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-2#1)
counterparts from##3##2##(1997-6#1)(2008-10#1)(2009-6#1)
counterparts in the##2##3##(1996-12#1)(2008-7#1)
counterparts in##9##2##(1996-12#1)(1996-3#1)(2007-6#1)(2008-11#3)(2008-7#1)(2010-2#1)(2012-12#1)
counterparts of the##2##3##(1993-6#1)(2008-10#1)
counterparts of##4##2##(1992-1#1)(1993-6#1)(2008-10#2)
counterparts with##3##2##(1992-3#1)(2008-12#1)(2012-3#1)
counterparts##103##1##(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
counterpoint##2##1##(2008-1#1)(2010-3#1)
counterproductive##2##1##(1996-11#1)(2011-2#1)
counterpropagating acoustic waves##2##3##(2007-12#2)
counterpropagating modes##2##2##(2007-11#1)(2007-12#1)
counterpropagating pumps##2##2##(2007-11#2)
counterpropagating two-beam##3##2##(2008-2#3)
counterpropagating with##2##2##(2008-2#1)(2008-3#1)
counterpropagating##24##1##(2007-11#8)(2007-12#8)(2008-2#6)(2008-3#2)
counterpulsation##3##1##(2008-3#1)(2011-2#2)
counterregulatory##4##1##(1992-8#1)(1995-12#1)(1997-2#1)(2010-2#1)
counterrotating##2##1##(2007-12#2)
counters##3##1##(2007-12#1)(2008-3#2)
counterselected##2##1##(2008-10#1)(2008-11#1)
countertransference##2##1##(2012-12#2)
countertransport##2##1##(1990-9#1)(1991-8#1)
counties and##2##2##(1991-1#1)(2008-10#1)
counties are##4##2##(1991-3#1)(1991-6#1)(1996-3#2)
counties during the##2##3##(1991-3#1)(1997-3#1)
counties in##10##2##(1991-3#1)(1991-6#1)(1992-1#1)(1996-3#2)(2008-10#3)(2009-11#1)(2012-12#1)
counties of California##3##3##(2008-10#3)
counties of##6##2##(1995-5#1)(1997-3#1)(2008-10#3)(2008-8#1)
counties were##3##2##(1994-1#1)(2008-10#1)(2010-5#1)
counties with##4##2##(1991-3#3)(2008-10#1)
counties##63##1##(1991-1#1)(1991-11#2)(1991-3#9)(1991-6#6)(1992-1#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-1#2)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#8)(1997-3#3)(2008-10#14)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
counties]##2##1##(1991-6#2)
counting and##7##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
counting at##4##2##(2007-11#1)(2008-3#2)(2008-9#1)
counting cells using a hemacytometer##2##5##(2008-4#1)(2008-9#1)
counting cells using##3##3##(2008-4#1)(2008-9#2)
counting cells##4##2##(2008-4#1)(2008-6#1)(2008-9#2)
counting fingers at##3##3##(2010-10#1)(2011-1#2)
counting is##2##2##(2008-9#1)(2013-8#1)
counting method##6##2##(1993-2#1)(2008-10#3)(2008-9#1)(2013-8#1)
counting methods##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
counting of##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
counting process##3##2##(2007-12#1)(2008-7#2)
counting task##3##2##(2013-8#3)
counting the number of##4##4##(1990-3#1)(2008-10#1)(2008-3#2)
counting the##6##2##(1990-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-3#2)
counting with##2##2##(2007-11#1)(2008-9#1)
counting##117##1##(1990-3#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#1)(2008-10#15)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#14)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#12)(2009-8#2)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#8)
countless##5##1##(1997-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
countries affected##2##2##(1990-12#1)(2013-8#1)
countries among top ten in prevalence of##2##7##(2012-3#2)
countries and among##2##3##(2008-10#1)(2011-2#1)
countries and##31##2##(1993-11#1)(1993-12#1)(1993-2#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)
countries are##19##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-6#1)(1996-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
countries around the globe##2##4##(2008-10#1)(2013-1#1)
countries around the##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
countries as regards##2##3##(1990-6#1)(1996-3#1)
countries as well as##2##4##(1993-9#1)(1997-7#1)
countries as##8##2##(1990-6#1)(1992-3#1)(1993-9#1)(1996-3#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-5#1)
countries because of the##2##4##(2010-8#1)(2011-2#1)
countries because of##5##3##(2007-7#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
countries because##6##2##(2007-7#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
countries cannot##2##2##(2008-9#1)(2012-12#1)
countries for##5##2##(1990-6#1)(1992-6#1)(1993-3#1)(1994-2#1)(2008-10#1)
countries from##3##2##(1994-5#1)(2011-2#1)(2013-8#1)
countries has been##2##3##(1992-1#1)(2011-1#1)
countries has##4##2##(1992-1#1)(2008-1#1)(2011-1#1)(2012-2#1)
countries have been##2##3##(1996-9#1)(1997-8#1)
countries have shown##2##3##(1990-6#1)(2008-7#1)
countries have##17##2##(1990-6#1)(1992-3#1)(1992-5#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
countries in Asia##2##3##(2007-12#1)(2009-4#1)
countries in Europe##4##3##(1995-3#1)(2009-4#1)(2011-2#2)
countries in Latin America##2##4##(2008-5#1)(2012-2#1)
countries in Latin##3##3##(2008-5#1)(2012-2#2)
countries in order to##2##4##(1991-6#1)(2010-12#1)
countries in the region##4##4##(1997-8#1)(2007-7#1)(2008-1#1)(2008-8#1)
countries in the world##2##4##(2008-12#1)(2012-12#1)
countries in the##13##3##(1991-4#1)(1994-12#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#1)
countries in which##2##3##(2008-4#1)(2008-7#1)
countries in##35##2##(1991-11#1)(1991-4#1)(1991-6#1)(1993-3#1)(1994-12#1)(1995-3#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)
countries including##2##2##(1996-2#1)(2008-1#1)
countries indicate##2##2##(1993-3#1)(2013-1#1)
countries involved##2##2##(1990-6#1)(1997-8#1)
countries is low##2##3##(1990-11#1)(1991-6#1)
countries is##13##2##(1990-11#1)(1991-11#1)(1991-6#1)(1993-2#1)(1994-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2012-2#1)
countries like India##2##3##(2012-12#1)(2012-2#1)
countries like##6##2##(1992-3#1)(1992-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
countries mortality##2##2##(2008-11#1)(2011-2#1)
countries of origin##3##3##(2008-10#2)(2013-1#1)
countries of the##8##3##(1993-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
countries of##21##2##(1993-2#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
countries on##3##2##(2008-10#2)(2009-6#1)
countries or continents##2##3##(2008-10#1)(2008-8#1)
countries or regions##2##3##(2007-7#1)(2008-11#1)
countries or##7##2##(1994-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
countries outside the##2##3##(2008-10#1)(2008-4#1)
countries outside##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
countries over the past##3##4##(2012-12#1)(2013-1#2)
countries over the##4##3##(1992-5#1)(2012-12#1)(2013-1#2)
countries responded##2##2##(2008-1#2)
countries such as India##3##4##(2007-12#1)(2009-4#1)(2010-12#1)
countries such as##8##3##(2007-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#1)
countries that have been##2##4##(1993-2#1)(2012-12#1)
countries that##7##2##(1993-2#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
countries the##2##2##(1990-6#1)(1994-3#1)
countries to determine the##2##4##(1991-11#1)(2009-4#1)
countries to##14##2##(1991-11#1)(1993-2#1)(1993-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-4#2)(2011-1#2)(2011-2#1)
countries was##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
countries were##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
countries where the##5##3##(1992-4#1)(1995-3#1)(2007-2#1)(2012-12#1)(2013-1#1)
countries where##19##2##(1990-6#1)(1991-6#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-2#2)(2008-10#2)(2008-11#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
countries will##2##2##(1992-6#1)(2012-12#1)
countries with a low##2##4##(1993-3#1)(2007-2#1)
countries with a##4##3##(1991-8#1)(1993-3#1)(2007-2#1)(2008-4#1)
countries with the##2##3##(1995-5#1)(2009-7#1)
countries with##21##2##(1990-12#2)(1991-8#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#2)(2009-7#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
countries without##2##2##(2008-10#1)(2011-2#1)
countries##797##1##(1990-11#6)(1990-12#6)(1990-2#3)(1990-3#2)(1990-6#9)(1990-8#3)(1990-9#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#7)(1991-5#2)(1991-6#5)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#8)(1992-6#7)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#13)(1993-3#11)(1993-6#5)(1993-9#3)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#1)(1994-9#6)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#3)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#5)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-4#1)(1997-6#4)(1997-7#4)(1997-8#8)(2006-10#2)(2007-10#4)(2007-11#9)(2007-12#10)(2007-2#22)(2007-5#3)(2007-6#2)(2007-7#21)(2007-8#1)(2008-1#28)(2008-10#65)(2008-11#33)(2008-12#8)(2008-2#3)(2008-3#6)(2008-4#11)(2008-5#11)(2008-6#1)(2008-7#27)(2008-8#16)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#7)(2009-4#13)(2009-5#8)(2009-6#10)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#17)(2010-2#6)(2010-3#5)(2010-4#5)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#9)(2011-1#19)(2011-2#57)(2011-3#2)(2011-4#3)(2012-1#2)(2012-12#36)(2012-2#27)(2012-3#10)(2013-1#25)(2013-7#3)(2013-8#12)
countries) to##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
countries)##11##1##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#4)
countries]##5##1##(1991-6#1)(1996-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
country and##9##2##(1991-1#1)(1991-6#1)(1993-1#1)(1993-2#1)(1996-1#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
country are##5##2##(1991-12#1)(1992-2#1)(1995-2#1)(2009-12#1)(2011-2#1)
country for##2##2##(1996-1#1)(2008-12#1)
country has a##2##3##(1995-12#1)(2007-7#1)
country has been##2##3##(1996-8#1)(2008-4#1)
country has##5##2##(1994-3#1)(1995-12#1)(1996-8#1)(2007-7#1)(2008-4#1)
country health##2##2##(2008-7#1)(2013-1#1)
country hospital##2##2##(2011-1#1)(2013-1#1)
country in the##3##3##(1994-9#1)(1996-7#1)(2008-7#1)
country in##8##2##(1994-9#1)(1996-7#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)
country is##8##2##(1992-2#1)(1992-9#1)(1994-1#2)(1995-1#1)(1995-3#1)(1997-6#1)(2008-11#1)
country located##2##2##(2008-1#1)(2008-7#1)
country music##3##2##(1992-3#3)
country of origin##2##3##(1994-2#1)(2008-10#1)
country of##19##2##(1992-8#1)(1993-6#1)(1994-2#1)(2007-8#12)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
country that##2##2##(2008-10#1)(2011-2#1)
country to##4##2##(1993-2#1)(1994-1#1)(2008-11#1)(2008-7#1)
country was##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
country were##6##2##(1992-12#3)(2008-12#1)(2011-2#1)(2012-12#1)
country where##5##2##(1997-6#1)(2007-2#1)(2008-10#2)(2013-8#1)
country with##4##2##(1995-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
country##257##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#4)(1992-1#1)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#5)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-9#3)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#8)(1997-8#4)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#5)(2007-8#14)(2008-1#4)(2008-10#21)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#12)(2008-8#8)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#16)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#3)
country's health##2##2##(1997-6#1)(2008-7#1)
country's##8##1##(1993-12#1)(1994-3#1)(1995-12#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
counts &lt##2##2##(2009-8#1)(2011-1#1)
counts after##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
counts and the##3##3##(1997-5#1)(2010-3#1)(2011-2#1)
counts and white blood cell differentials were##2##7##(2008-10#2)
counts and##27##2##(1994-7#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-3#1)(2008-10#6)(2008-11#2)(2009-12#2)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#1)(2012-4#1)
counts are##2##2##(2010-8#1)(2011-1#1)
counts as##3##2##(1994-9#1)(2008-7#1)(2011-2#1)
counts at##2##2##(2010-3#1)(2010-8#1)
counts by##3##2##(1997-3#1)(2008-10#2)
counts can##2##2##(2008-4#1)(2011-2#1)
counts for most compounds##2##4##(2008-10#2)
counts for most##3##3##(2008-10#3)
counts for##5##2##(2008-10#4)(2008-11#1)
counts from##4##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
counts in the##6##3##(1996-12#1)(1997-6#1)(2008-10#3)(2013-1#1)
counts in##17##2##(1991-11#2)(1996-12#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
counts increased##2##2##(2008-10#2)
counts obtained##2##2##(2008-10#1)(2012-2#1)
counts of &lt##2##3##(2010-8#1)(2013-8#1)
counts of##30##2##(1992-8#1)(1993-2#1)(1994-11#1)(1995-12#2)(1996-12#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#3)
counts on##9##2##(1997-5#1)(2007-10#2)(2008-10#3)(2008-2#1)(2008-8#1)(2013-1#1)
counts only##2##2##(1996-12#1)(2008-9#1)
counts over##2##2##(2007-10#1)(2008-10#1)
counts ranged from##2##3##(2008-10#2)
counts that##2##2##(2011-1#2)
counts was##2##2##(1990-10#1)(2008-10#1)
counts were##17##2##(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-9#1)(2012-2#1)(2013-8#1)
counts when##2##2##(2008-10#1)(2011-1#1)
counts##238##1##(1990-10#5)(1990-2#1)(1991-11#2)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-7#2)(1994-9#1)(1995-12#2)(1996-12#7)(1996-3#3)(1996-5#4)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#3)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#6)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#55)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-8#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-8#5)(2011-1#16)(2011-2#9)(2011-9#1)(2012-12#2)(2012-2#9)(2012-3#2)(2012-4#1)(2013-1#4)(2013-7#3)(2013-8#8)
county and##2##2##(2011-1#1)(2012-3#1)
county health departments in Kansas##2##5##(1995-3#2)
county health departments in##3##4##(1995-3#3)
county health departments##4##3##(1995-3#3)(1996-12#1)
county health##5##2##(1995-3#4)(1996-12#1)
county hospital]##2##2##(1996-3#1)(1996-9#1)
county hospitals##3##2##(1991-2#1)(1991-6#1)(1994-3#1)
county level##3##2##(1991-3#1)(2008-8#1)(2011-1#1)
county of##11##2##(1991-1#1)(1991-9#1)(1992-11#1)(1993-6#2)(1994-11#1)(1996-9#2)(2011-2#3)
county population density##3##3##(1993-1#1)(1996-3#1)(2009-7#1)
county population size##2##3##(1991-3#1)(1992-12#1)
county population##6##2##(1991-3#1)(1992-12#1)(1993-1#1)(1996-3#1)(2009-7#1)(2010-9#1)
county##69##1##(1990-11#1)(1991-1#2)(1991-2#1)(1991-3#5)(1991-6#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1993-1#2)(1993-3#1)(1993-6#4)(1994-11#2)(1994-3#1)(1994-6#1)(1995-3#4)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#4)(1997-3#1)(1997-5#1)(1997-8#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#3)(2012-3#3)(2013-7#1)
county's##2##1##(1992-2#1)(2008-11#1)
couple a##2##2##(2008-2#1)(2008-3#1)
couple and##3##2##(2008-10#2)(2008-12#1)
couple at about -0##2##4##(2008-10#2)
couple is##2##2##(1990-6#1)(2008-5#1)
couple of##12##2##(1995-5#1)(1997-2#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#3)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
couple relationship education##2##3##(2010-5#1)(2012-2#1)
couple relationship##3##2##(2010-5#2)(2012-2#1)
couple the##7##2##(2008-10#2)(2008-2#3)(2008-3#1)(2013-1#1)
couple therapy and relationship education##3##5##(2012-2#3)
couple therapy outcome##2##3##(2012-2#2)
couple therapy##13##2##(2012-2#13)
couple to##3##2##(1992-3#1)(2008-7#1)(2010-7#1)
couple with a sequential injection hydride generation##2##7##(2008-10#2)
couple with##5##2##(2008-10#4)(2008-3#1)
couple##102##1##(1990-3#1)(1990-6#1)(1992-3#1)(1993-2#1)(1994-7#1)(1995-5#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#29)(2008-12#1)(2008-2#6)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#19)(2013-1#1)
couple's##2##1##(2012-2#2)
couple-based##2##1##(2012-2#2)
couple-relationship education##2##2##(2007-2#2)
coupled atmosphere-ocean system##2##3##(2008-2#1)(2008-3#1)
coupled by a##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
coupled by##5##2##(1993-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
coupled cells##3##2##(1996-8#2)(2009-8#1)
coupled chitosan##2##2##(2008-10#2)
coupled column##2##2##(2008-10#2)
coupled differential equations##2##3##(2008-3#1)(2008-8#1)
coupled directly to the##2##4##(1990-7#1)(1995-12#1)
coupled directly to##4##3##(1990-7#1)(1995-12#1)(2008-10#1)(2008-3#1)
coupled dissolution/diffusion model##2##3##(2008-10#2)
coupled enzyme##5##2##(1996-8#1)(2008-10#4)
coupled in situ##2##3##(2008-10#2)
coupled in##5##2##(2007-12#1)(2008-10#3)(2011-2#1)
coupled into a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
coupled into the##3##3##(2007-12#1)(2008-3#2)
coupled into##10##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#4)
coupled mass##4##2##(2008-10#3)(2013-1#1)
coupled microring##3##2##(2007-11#1)(2007-12#2)
coupled modes##2##2##(2008-3#1)(2013-8#1)
coupled nonlinear##2##2##(2007-11#1)(2007-12#1)
coupled on-line to##2##3##(2008-10#1)(2008-7#1)
coupled on-line with##4##3##(2008-10#4)
coupled on-line##6##2##(2008-10#5)(2008-7#1)
coupled online##2##2##(2008-10#1)(2010-11#1)
coupled optical##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
coupled out##2##2##(2007-11#1)(2008-3#1)
coupled phase and amplitude##2##4##(2008-3#2)
coupled phase##3##2##(2008-3#3)
coupled plasma (ICP)##4##3##(1992-3#1)(2008-10#2)(2012-2#1)
coupled plasma atomic emission spectrometric##2##5##(2008-10#2)
coupled plasma atomic emission spectrometry (ETV-ICP-AES)##2##6##(2008-10#2)
coupled plasma atomic emission spectrometry (ICP-AES)##13##6##(2008-10#13)
coupled plasma atomic emission spectrometry##49##5##(1992-3#1)(2008-10#48)
coupled plasma atomic emission##62##4##(1992-3#1)(2008-10#61)
coupled plasma atomic##64##3##(1992-3#1)(2008-10#63)
coupled plasma mass spectrometry (ICP-MS) is##2##6##(2008-10#2)
coupled plasma mass spectrometry (ICP-MS)##25##5##(2008-10#23)(2013-8#2)
coupled plasma mass spectrometry##73##4##(1993-9#1)(2008-10#67)(2010-11#3)(2013-8#2)
coupled plasma mass##80##3##(1993-9#1)(2008-10#72)(2010-11#3)(2013-8#4)
coupled plasma optical emission spectrometry (ICP OES)##2##7##(2008-10#2)
coupled plasma optical emission spectrometry (ICP-OES) was##2##7##(2008-10#2)
coupled plasma optical emission spectrometry (ICP-OES)##11##6##(2008-10#11)
coupled plasma optical emission spectrometry##26##5##(2008-10#26)
coupled plasma optical emission spectroscopy##2##5##(2011-2#2)
coupled plasma optical emission##29##4##(2008-10#27)(2011-2#2)
coupled plasma time-of-flight mass##2##4##(2008-10#2)
coupled plasma##202##2##(1992-3#2)(1993-9#1)(2007-12#2)(2008-10#184)(2008-3#2)(2010-11#3)(2011-2#2)(2012-2#1)(2013-8#5)
coupled plasma-mass spectrometry##16##3##(2008-10#16)
coupled plasma-mass##19##2##(2008-10#19)
coupled plasma-optical emission spectrometry (ICP-OES)##3##5##(2008-10#2)(2010-5#1)
coupled plasma-optical emission spectrometry##4##4##(2008-10#3)(2010-5#1)
coupled plasma-optical emission##7##3##(2008-10#6)(2010-5#1)
coupled reactions of##3##3##(1992-11#1)(1997-2#1)(2008-10#1)
coupled receptor (such as##2##4##(1997-2#2)
coupled receptor##4##2##(1997-2#3)(2012-2#1)
coupled receptors##8##2##(1992-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-3#1)
coupled resonators##3##2##(2007-11#2)(2007-12#1)
coupled system##6##2##(1996-8#2)(2008-10#2)(2008-2#1)(2013-8#1)
coupled techniques##2##2##(2008-10#2)
coupled through##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
coupled to HPLC##4##3##(2008-10#4)
coupled to Sepharose##3##3##(1991-8#1)(1992-12#1)(1993-12#1)
coupled to a direct extraction device##2##6##(2008-10#2)
coupled to a flame atomic absorption spectrometer##3##7##(2008-10#3)
coupled to a flow##2##4##(2008-10#2)
coupled to a mass spectrometer##2##5##(2008-10#1)(2008-4#1)
coupled to a##38##3##(1991-5#1)(1992-11#1)(1993-8#1)(1995-2#1)(1997-1#1)(2007-12#3)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
coupled to adenylate cyclase##3##4##(1993-5#1)(1993-6#1)(2008-4#1)
coupled to an##8##3##(1992-3#1)(1994-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-1#1)
coupled to atomic##2##3##(2008-10#2)
coupled to electrospray##2##3##(1997-4#1)(2008-10#1)
coupled to electrothermal atomic absorption##2##5##(2008-10#2)
coupled to flame atomic absorption spectrophotometry##2##6##(2008-10#2)
coupled to flame atomic absorption##3##5##(2008-10#3)
coupled to geographical information systems##2##5##(2008-10#2)
coupled to headspace solid-phase microextraction##2##5##(2008-10#2)
coupled to high resolution mass spectrometry##2##6##(2008-10#1)(2010-5#1)
coupled to high##3##3##(2008-10#2)(2010-5#1)
coupled to inductively coupled plasma optical emission spectrometry##2##8##(2008-10#2)
coupled to inductively coupled plasma##3##5##(2008-10#3)
coupled to inhibition of##2##4##(1993-11#1)(1993-3#1)
coupled to multivariate calibration##2##4##(2008-10#2)
coupled to multivariate##3##3##(2008-10#3)
coupled to proton##2##3##(1994-11#1)(2008-6#1)
coupled to qPCR to take approximately##2##6##(2010-6#2)
coupled to quadrupole time-of-flight##2##4##(2008-10#2)
coupled to the flow##2##4##(2008-10#2)
coupled to the##18##3##(1990-12#2)(1991-5#1)(1992-11#1)(1994-5#1)(1995-3#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-4#2)(2008-7#1)
coupled to two##2##3##(2007-11#1)(2008-4#1)
coupled to##192##2##(1990-12#3)(1990-5#1)(1991-2#1)(1991-5#4)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#89)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
coupled transcription-translation##2##2##(1991-9#1)(1995-6#1)
coupled transcription/translation##2##2##(1994-12#1)(2008-1#1)
coupled vertical-cavity surface-emitting lasers##2##4##(2007-11#2)
coupled waveguide##2##2##(2008-3#1)(2012-2#1)
coupled waveguides##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
coupled with Franz cell##2##4##(2008-10#2)
coupled with a flame ionization detector##2##6##(2008-10#1)(2008-11#1)
coupled with a flame##3##4##(2008-10#2)(2008-11#1)
coupled with a flow injection##2##5##(2008-10#2)
coupled with a similar##2##4##(1994-1#1)(1996-5#1)
coupled with a##40##3##(1994-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#1)
coupled with amperometric detection##2##4##(2008-10#2)
coupled with an##15##3##(1994-12#1)(1994-5#1)(1997-7#1)(2008-10#6)(2008-2#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-9#1)
coupled with atomic fluorescence##2##4##(2008-10#2)
coupled with capillary electrophoresis##2##4##(2008-10#2)
coupled with capillary##3##3##(2008-10#3)
coupled with catalytic##2##3##(2008-10#2)
coupled with colorimetric detection##2##4##(2008-10#2)
coupled with conventional##2##3##(1997-5#1)(2008-10#1)
coupled with diode array##2##4##(2008-10#2)
coupled with existing##2##3##(2008-10#1)(2008-3#1)
coupled with flame atomic absorption spectrometry (FAAS)##2##7##(2008-10#2)
coupled with flame atomic absorption spectrometry for##2##7##(2008-10#2)
coupled with flame atomic absorption spectrometry##4##6##(2008-10#4)
coupled with flame##5##3##(2008-10#4)(2008-5#1)
coupled with flow injection##2##4##(2008-10#2)
coupled with fluorimetric detection##4##4##(2008-10#4)
coupled with gas chromatography-mass spectrometry (GC-MS)##2##6##(2008-10#2)
coupled with gas chromatography-mass spectrometry##3##5##(2008-10#3)
coupled with gas##6##3##(2008-10#6)
coupled with high-performance liquid chromatography (HPLC) for the##2##8##(2008-10#2)
coupled with high-performance liquid chromatography (HPLC)##3##6##(2008-10#3)
coupled with high-performance liquid chromatography##5##5##(2008-10#5)
coupled with inductively coupled##2##4##(2008-10#1)(2010-11#1)
coupled with mass spectrometry and##2##5##(2008-5#1)(2012-2#1)
coupled with mass spectrometry##7##4##(1997-4#2)(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)
coupled with mass##10##3##(1997-4#2)(2008-1#1)(2008-10#4)(2008-5#1)(2010-8#1)(2012-2#1)
coupled with microdialysis##2##3##(2008-10#2)
coupled with modern##2##3##(2008-10#1)(2010-7#1)
coupled with novel##2##3##(2008-10#1)(2009-5#1)
coupled with on-line##3##3##(2008-10#3)
coupled with reduced##2##3##(2011-1#1)(2012-5#1)
coupled with the increasing##2##4##(1993-2#1)(2008-7#1)
coupled with the##22##3##(1990-11#1)(1993-2#1)(1993-3#1)(1995-11#2)(1995-5#1)(1997-8#1)(2008-10#8)(2008-3#2)(2008-7#3)(2008-8#1)(2009-6#1)
coupled with##251##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#128)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#6)(2009-11#2)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#2)
coupled##914##1##(1990-11#2)(1990-12#3)(1990-5#1)(1990-7#1)(1991-11#2)(1991-2#1)(1991-5#7)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#2)(1992-3#4)(1992-6#3)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#3)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#5)(1997-1#3)(1997-2#4)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#30)(2007-12#34)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#497)(2008-11#14)(2008-12#1)(2008-2#20)(2008-3#38)(2008-4#12)(2008-5#9)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#9)(2009-10#2)(2009-11#5)(2009-12#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#9)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#5)(2012-1#3)(2012-2#14)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#9)
coupled-cavity##2##1##(2007-11#1)(2008-2#1)
coupled-mode analysis##2##2##(2008-3#2)
coupled-mode equations##2##2##(2007-11#1)(2008-3#1)
coupled-mode formalism##2##2##(2008-3#2)
coupled-mode theory is##2##3##(2007-11#1)(2008-3#1)
coupled-mode theory to##2##3##(2007-11#1)(2008-2#1)
coupled-mode theory##9##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)
coupled-mode##17##1##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#10)
coupled-resonator optical waveguide##4##3##(2007-11#4)
coupled-resonator optical waveguides##2##3##(2007-11#1)(2007-12#1)
coupled-resonator optical##6##2##(2007-11#5)(2007-12#1)
coupled-wave analysis##3##2##(2007-12#1)(2008-3#2)
coupled-wave equations##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
coupled-wave theory that##2##3##(2007-12#1)(2008-2#1)
coupled-wave theory##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
coupled-wave##15##1##(2007-12#6)(2008-2#3)(2008-3#6)
coupler and##9##2##(2007-11#1)(2008-2#6)(2008-3#2)
coupler by##3##2##(2008-2#1)(2008-3#2)
coupler for##8##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#4)(2008-3#1)
coupler in a##3##3##(2007-11#1)(2008-2#2)
coupler in##6##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
coupler is##3##2##(2007-12#2)(2008-2#1)
coupler of##2##2##(2008-2#1)(2008-3#1)
coupler that##2##2##(2007-12#1)(2008-3#1)
coupler to##2##2##(2008-3#2)
coupler were##2##2##(2008-3#2)
coupler with a##6##3##(2007-11#1)(2007-12#3)(2008-3#2)
coupler##113##1##(2007-11#14)(2007-12#18)(2007-9#2)(2008-10#1)(2008-2#38)(2008-3#39)(2008-8#1)
coupler's reflectivity##2##2##(2007-12#1)(2008-3#1)
coupler's##4##1##(2007-12#3)(2008-3#1)
couplers and fiber##2##3##(2008-2#1)(2008-3#1)
couplers and##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
couplers are##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
couplers can##2##2##(2008-2#1)(2008-3#1)
couplers for##3##2##(2007-12#2)(2008-2#1)
couplers in##2##2##(2008-2#2)
couplers of##3##2##(1990-3#1)(2007-12#2)
couplers using##2##2##(2008-10#2)
couplers were##2##2##(2007-11#1)(2008-3#1)
couplers with##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
couplers##48##1##(1990-3#1)(2007-11#9)(2007-12#7)(2008-10#3)(2008-2#9)(2008-3#18)(2008-5#1)
couples and##2##2##(2008-10#1)(2009-9#1)
couples are##4##2##(1996-9#1)(2008-11#1)(2012-12#1)(2012-2#1)
couples in##4##2##(2007-2#1)(2011-2#2)(2012-2#1)
couples into##2##2##(2009-5#1)(2009-6#1)
couples of##3##2##(2008-10#2)(2011-1#1)
couples relationship education##2##3##(2012-2#2)
couples the##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-6#1)(2013-8#1)
couples to##5##2##(1994-11#1)(1994-7#1)(1997-2#1)(2010-7#2)
couples who are##2##3##(1994-7#1)(1997-2#1)
couples who##5##2##(1994-7#1)(1997-2#1)(2007-10#1)(2012-2#2)
couples with##6##2##(1992-12#1)(1993-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
couples##84##1##(1990-11#1)(1992-12#1)(1993-8#2)(1994-11#1)(1994-7#3)(1996-2#1)(1996-9#5)(1997-2#2)(1997-7#1)(2007-10#1)(2007-12#3)(2007-2#3)(2007-7#2)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#11)(2013-1#1)(2013-8#2)
couples'##2##1##(2007-2#1)(2009-10#1)
coupling a##8##2##(2008-10#5)(2008-2#2)(2008-8#1)
coupling agent##6##2##(2007-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#1)
coupling among##5##2##(1990-8#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
coupling and the##2##3##(2008-2#1)(2008-3#1)
coupling and##13##2##(1997-1#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#2)(2009-5#1)
coupling are##2##2##(2008-3#1)(2012-2#1)
coupling between a##3##3##(1994-6#1)(2007-11#1)(2008-3#1)
coupling between channels##2##3##(1994-12#1)(2008-3#1)
coupling between the two##5##4##(1990-8#1)(1996-5#1)(2007-11#2)(2008-10#1)
coupling between the##16##3##(1990-8#1)(1993-8#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#4)
coupling between two##2##3##(2007-11#1)(2008-3#1)
coupling between##42##2##(1990-8#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#12)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#1)
coupling by##4##2##(2008-2#2)(2008-4#2)
coupling can##2##2##(2007-11#1)(2008-3#1)
coupling coefficient and the##2##4##(2008-3#2)
coupling coefficient##10##2##(2007-11#1)(2007-12#1)(2008-3#7)(2013-8#1)
coupling coefficients##4##2##(2007-11#2)(2008-3#2)
coupling constant##3##2##(1990-4#1)(1997-7#1)(2007-12#1)
coupling constants in##2##3##(1992-4#1)(2007-12#1)
coupling constants##15##2##(1991-12#1)(1991-5#1)(1992-3#2)(1992-4#6)(1993-11#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-3#1)
coupling efficiencies##4##2##(2007-12#1)(2008-3#1)(2010-2#2)
coupling efficiency and a##2##4##(2008-2#1)(2008-3#1)
coupling efficiency and##6##3##(2008-2#3)(2008-3#3)
coupling efficiency of##7##3##(2007-11#1)(2008-2#2)(2008-3#3)(2009-9#1)
coupling efficiency##28##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#12)(2008-3#10)(2009-9#2)
coupling factor##5##2##(1994-3#1)(2008-3#4)
coupling for##2##2##(2007-11#1)(2007-12#1)
coupling from##3##2##(2008-2#1)(2008-3#2)
coupling gain of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
coupling impairment##2##2##(2010-7#2)
coupling in a##2##3##(2008-3#2)
coupling in the##2##3##(2007-11#1)(2010-2#1)
coupling in tilted##2##3##(2008-3#2)
coupling in##22##2##(1995-6#1)(1997-7#1)(2007-11#5)(2007-12#1)(2008-3#7)(2009-11#2)(2010-2#1)(2010-7#1)(2013-1#1)(2013-8#2)
coupling induced by##2##3##(2007-12#2)
coupling interactions##2##2##(1997-7#1)(2008-8#1)
coupling into##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
coupling is likely##2##3##(1992-3#1)(2010-7#1)
coupling is##9##2##(1991-9#1)(1992-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2010-7#1)(2013-8#1)
coupling laser##2##2##(2007-11#1)(2008-3#1)
coupling leads to##2##3##(2007-12#1)(2013-1#1)
coupling lengths##2##2##(2007-11#1)(2008-3#1)
coupling light from##2##3##(2007-11#2)
coupling loss of##2##3##(2008-2#2)
coupling loss##6##2##(2007-11#2)(2008-2#2)(2008-3#2)
coupling losses##2##2##(2008-2#1)(2008-3#1)
coupling mechanisms##3##2##(1990-8#1)(2007-11#2)
coupling method is##2##3##(2007-12#1)(2008-3#1)
coupling method##8##2##(1990-2#1)(2007-12#2)(2008-10#2)(2008-3#3)
coupling of N-phenyl-p-phenylenediamine with N##2##5##(2008-10#2)
coupling of a##7##3##(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#2)
coupling of aldehydes##2##3##(2010-12#2)
coupling of an##6##3##(1994-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
coupling of capillary##2##3##(2008-10#2)
coupling of flow##2##3##(2008-10#2)
coupling of optical##2##3##(2007-11#1)(2008-7#1)
coupling of peptides##2##3##(2008-4#2)
coupling of power##2##3##(2008-3#2)
coupling of the electrically stored energy to the##2##8##(2008-3#2)
coupling of the##14##3##(1991-5#2)(1993-3#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)
coupling of two##4##3##(1997-7#1)(2007-11#1)(2010-2#1)(2012-2#1)
coupling of##92##2##(1991-12#1)(1991-5#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-2#4)(2008-3#12)(2008-4#3)(2008-7#4)(2009-11#2)(2009-5#1)(2010-12#3)(2010-2#1)(2012-2#3)(2013-1#2)
coupling on##2##2##(2007-11#1)(2008-3#1)
coupling optics##2##2##(2008-2#1)(2008-3#1)
coupling phase##5##2##(2008-10#5)
coupling power##3##2##(2007-11#3)
coupling process##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
coupling rate of##2##3##(2008-2#1)(2008-3#1)
coupling rate##4##2##(2008-2#2)(2008-3#2)
coupling ratio was obtained##2##4##(2007-11#2)
coupling ratio##6##2##(1994-8#1)(1996-12#1)(2007-11#2)(2008-2#2)
coupling ratios##2##2##(2007-12#2)
coupling reaction of##5##3##(2008-10#4)(2012-3#1)
coupling reaction##13##2##(1996-5#1)(2008-10#6)(2008-4#3)(2008-7#1)(2009-9#1)(2012-3#1)
coupling reactions##2##2##(1995-3#1)(2008-10#1)
coupling reagents##3##2##(2008-2#1)(2008-4#2)
coupling scheme that uses##2##4##(2008-2#1)(2008-3#1)
coupling scheme##4##2##(2008-2#2)(2008-3#2)
coupling strength##3##2##(1996-8#1)(2007-12#1)(2008-3#1)
coupling strengths##2##2##(2008-11#1)(2008-3#1)
coupling structure##2##2##(2007-11#2)
coupling system##2##2##(2008-10#1)(2008-2#1)
coupling terms##4##2##(2008-3#1)(2010-2#2)(2013-8#1)
coupling the##10##2##(2008-10#4)(2008-3#1)(2008-4#3)(2008-7#2)
coupling through##3##2##(1996-6#1)(2007-11#1)(2010-11#1)
coupling to G-proteins##2##3##(1996-5#2)
coupling to a##4##3##(2007-12#3)(2008-3#1)
coupling to##29##2##(1992-11#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-6#2)(1996-5#2)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-5#1)
coupling was observed in##2##4##(2007-12#2)
coupling were##2##2##(1990-2#1)(2008-10#1)
coupling with the##2##3##(2008-10#1)(2008-12#1)
coupling with##22##2##(1993-11#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)
coupling##598##1##(1990-2#2)(1990-4#1)(1990-8#4)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#6)(1992-4#6)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#3)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#4)(1996-12#1)(1996-5#4)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#7)(2006-12#1)(2007-11#63)(2007-12#47)(2007-9#1)(2008-1#2)(2008-10#112)(2008-11#5)(2008-12#2)(2008-2#50)(2008-3#122)(2008-4#23)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#7)(2009-2#2)(2009-3#1)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#14)
coupling&quot##2##1##(1991-9#1)(1993-5#1)
couplings among##2##2##(2008-2#1)(2012-2#1)
couplings are##2##2##(2008-11#1)(2008-5#1)
couplings of##2##2##(2008-11#1)(2008-3#1)
couplings##14##1##(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2012-2#1)(2012-8#2)(2013-8#1)
coupons##8##1##(2013-8#8)
courage and##2##2##(1990-8#1)(1994-1#1)
courage##6##1##(1990-8#1)(1994-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#1)
course and a##2##3##(2008-12#1)(2008-9#1)
course and outcome of##2##4##(2011-1#1)(2013-1#1)
course and prognosis of##2##4##(1997-3#1)(2009-5#1)
course and prognosis##3##3##(1997-3#1)(2009-5#1)(2010-6#1)
course and the##3##3##(2008-11#1)(2010-4#1)(2010-6#1)
course and was##2##3##(1991-6#1)(1992-4#1)
course and##37##2##(1991-6#1)(1992-4#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#2)
course are##2##2##(1992-1#1)(1993-1#1)
course at a##2##3##(2008-11#1)(2013-1#1)
course at##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
course between##2##2##(2007-8#1)(2011-2#1)
course content##3##2##(1994-12#1)(1995-1#1)(2011-1#1)
course for nurses##2##3##(2008-11#2)
course for##16##2##(1992-1#1)(1993-12#2)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-7#1)(2008-11#5)(2008-7#1)(2008-8#1)(2013-1#1)
course from##2##2##(1997-3#1)(2008-10#1)
course had##4##2##(1991-9#1)(1996-1#1)(2008-11#2)
course in a##2##3##(1996-2#1)(2010-10#1)
course in health##2##3##(1995-1#1)(1996-3#1)
course in the##5##3##(1993-6#1)(1997-5#1)(2008-11#2)(2011-2#1)
course in##28##2##(1991-6#1)(1993-6#2)(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
course is##16##2##(1991-12#1)(1993-1#2)(1996-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
course management systems that foster##2##5##(2008-12#2)
course management##3##2##(2008-12#3)
course of action##4##3##(1997-2#1)(2008-11#1)(2010-3#1)(2013-1#1)
course of acute pancreatitis##2##4##(2013-1#2)
course of acute##3##3##(2008-7#1)(2013-1#2)
course of an##4##3##(1990-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
course of changes in##3##4##(1997-3#1)(2009-11#1)(2013-1#1)
course of changes##4##3##(1997-3#1)(2009-11#1)(2013-1#2)
course of chemotherapy##2##3##(1990-6#1)(2007-11#1)
course of chronic##4##3##(2009-4#1)(2010-1#1)(2011-2#1)(2013-7#1)
course of degenerative changes in##2##5##(1997-3#1)(2007-8#1)
course of diabetes##2##3##(2008-7#1)(2010-10#1)
course of distraction osteogenesis##3##4##(2007-8#3)
course of evolution##2##3##(1997-6#1)(2009-5#1)
course of her##2##3##(1994-7#1)(2013-8#1)
course of infection##3##3##(1990-8#1)(2008-5#1)(2008-7#1)
course of multiple sclerosis##2##4##(1994-9#1)(2012-2#1)
course of multiple##3##3##(1994-9#1)(2012-2#2)
course of our##3##3##(1990-6#1)(2008-11#1)(2008-2#1)
course of patients##4##3##(2007-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
course of pregnancy and labor in patients##2##7##(2012-3#2)
course of pregnancy and labor##3##5##(2012-3#3)
course of pregnancy##7##3##(1995-12#1)(2012-3#6)
course of schizophrenia##2##3##(1990-11#1)(2011-1#1)
course of the disease and##2##5##(1992-11#1)(2007-8#1)
course of the disease is##2##5##(1996-6#1)(2008-7#1)
course of the disease##24##4##(1990-11#1)(1990-6#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-11#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-7#5)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
course of the experiment##4##4##(2008-10#2)(2008-7#1)(2011-1#1)
course of the infection##2##4##(2007-2#1)(2008-10#1)
course of the reaction##2##4##(1991-5#1)(1996-5#1)
course of the study##3##4##(1993-1#1)(2008-10#2)
course of the##96##3##(1990-11#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-5#3)(1996-6#3)(1997-3#2)(1997-4#2)(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#15)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#9)(2008-9#3)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
course of therapy##5##3##(2007-12#1)(2008-1#1)(2008-8#1)(2012-2#2)
course of these##6##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)
course of this##7##3##(1991-8#1)(1996-11#1)(2008-10#2)(2009-8#1)(2011-1#1)(2011-2#1)
course of treatment##14##3##(1991-12#1)(1991-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(2008-12#2)(2008-2#1)(2008-4#1)(2009-11#1)(2010-11#1)(2012-2#1)(2013-8#1)
course of##412##2##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#4)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-7#3)(1994-9#1)(1995-11#2)(1995-12#5)(1995-3#5)(1995-5#3)(1995-6#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#4)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2006-10#2)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#9)(2007-2#2)(2007-7#1)(2007-8#13)(2008-1#3)(2008-10#40)(2008-11#19)(2008-12#10)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#23)(2008-8#5)(2008-9#10)(2009-11#4)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#24)(2011-3#1)(2012-12#6)(2012-2#14)(2012-3#7)(2013-1#19)(2013-7#3)(2013-8#5)
course offerings##2##2##(1992-3#1)(1997-2#1)
course on##11##2##(1991-12#1)(1992-1#1)(1992-2#2)(1993-2#1)(2008-11#5)(2012-12#1)
course or##2##2##(1992-9#1)(2011-2#1)
course studies##3##2##(1993-8#1)(1995-12#1)(2008-11#1)
course that##2##2##(1991-3#1)(2010-10#1)
course through the##2##3##(2008-11#1)(2010-11#1)
course to the##2##3##(1996-6#1)(2009-8#1)
course to##12##2##(1994-12#1)(1995-2#1)(1996-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
course was uneventful and##4##4##(2008-10#1)(2008-12#1)(2009-5#1)(2012-3#1)
course was uneventful##14##3##(1996-8#1)(2006-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
course was##27##2##(1990-8#1)(1992-9#1)(1993-9#1)(1995-5#1)(1996-8#1)(2006-12#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
course which##2##2##(2007-5#1)(2008-7#1)
course with##5##2##(1991-11#1)(1991-4#1)(1995-2#1)(2007-4#1)(2008-7#1)
course work##2##2##(1997-3#1)(2008-12#1)
course##828##1##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#5)(1991-4#3)(1991-5#3)(1991-6#4)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#7)(1993-11#2)(1993-12#5)(1993-2#5)(1993-3#4)(1993-5#2)(1993-6#7)(1993-8#4)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-7#3)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#6)(1995-5#4)(1995-6#2)(1996-1#2)(1996-11#5)(1996-12#3)(1996-2#6)(1996-3#4)(1996-5#3)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#15)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2006-10#7)(2006-12#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#11)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#24)(2007-9#1)(2008-1#11)(2008-10#51)(2008-11#92)(2008-12#33)(2008-2#6)(2008-3#2)(2008-4#8)(2008-5#6)(2008-6#7)(2008-7#36)(2008-8#8)(2008-9#15)(2009-10#6)(2009-11#4)(2009-12#4)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#9)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#18)(2011-2#47)(2011-3#1)(2012-12#20)(2012-2#20)(2012-3#14)(2013-1#41)(2013-7#6)(2013-8#16)
course)##3##1##(1991-2#1)(2008-11#1)(2008-8#1)
course]##3##1##(1990-3#1)(1993-3#1)(2012-3#1)
courses and those who##2##4##(1995-1#1)(2008-12#1)
courses and##6##2##(1991-6#1)(1994-12#1)(1995-1#1)(2008-12#2)(2008-8#1)
courses at##2##2##(1990-12#1)(2010-9#1)
courses for##6##2##(1991-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2013-1#1)
courses in##18##2##(1991-2#2)(1992-1#1)(1994-1#2)(1996-1#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
courses is##2##2##(1994-12#1)(2008-12#1)
courses of antibiotics##2##3##(2007-11#1)(2011-2#1)
courses of chemotherapy##3##3##(2008-6#2)(2011-2#1)
courses of cisplatin##2##3##(1990-6#1)(1992-10#1)
courses of ifosfamide##3##3##(2008-6#3)
courses of the##3##3##(1992-11#1)(2008-11#1)(2008-8#1)
courses of these##2##3##(1995-6#1)(2008-11#1)
courses of##39##2##(1990-6#2)(1992-10#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-6#1)(1997-2#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-6#5)(2008-7#2)(2008-8#1)(2011-2#4)(2013-1#1)
courses on##2##2##(1992-12#1)(2011-2#1)
courses or##2##2##(1993-9#1)(1995-1#1)
courses to##2##2##(1991-2#1)(2010-3#1)
courses were##5##2##(1990-9#1)(1992-12#1)(1993-2#1)(2008-10#1)(2013-1#1)
courses with##2##2##(2007-4#1)(2008-6#1)
courses##147##1##(1990-12#8)(1990-6#2)(1990-9#1)(1991-2#6)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#8)(1994-2#1)(1994-3#1)(1995-1#5)(1995-6#1)(1996-1#4)(1997-2#1)(1997-3#1)(2007-11#5)(2007-4#3)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#13)(2008-12#11)(2008-3#3)(2008-5#1)(2008-6#6)(2008-7#3)(2008-8#3)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#3)(2013-1#11)(2013-2#1)(2013-8#1)
courses)##3##1##(1992-10#3)
coursing##2##1##(2007-8#1)(2013-1#1)
court affirmed##2##2##(1995-12#1)(1995-6#1)
court and##3##2##(2010-10#1)(2011-2#2)
court case##2##2##(1993-12#1)(1996-11#1)
court concluded that##2##3##(1990-11#1)(1990-2#1)
court files##2##2##(1992-9#2)
court found that##3##3##(1991-7#1)(1996-2#1)(1997-5#1)
court found##4##2##(1991-7#1)(1995-2#1)(1996-2#1)(1997-5#1)
court had##2##2##(1995-6#1)(1997-6#1)
court interpretations of the##2##4##(1993-1#1)(1993-2#1)
court order##2##2##(1992-12#1)(2008-11#1)
court rejected the##2##3##(1995-6#1)(1996-5#1)
court ruling##2##2##(1995-12#1)(1995-6#1)
court rulings##2##2##(1992-11#1)(1994-1#1)
court to##3##2##(1992-12#1)(1995-5#1)(2011-2#1)
court##87##1##(1990-11#6)(1990-2#2)(1991-1#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#8)(1995-2#3)(1995-5#1)(1995-6#8)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#6)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-8#1)(2009-8#1)(2010-10#2)(2011-2#4)(2012-1#1)
court's decision##2##2##(1993-12#1)(1995-6#1)
court's order##2##2##(1992-12#1)(1996-5#1)
court's##6##1##(1992-12#1)(1993-12#1)(1995-6#2)(1996-5#1)(1997-6#1)
courting##2##1##(1997-3#1)(2009-9#1)
courts have held that a##2##5##(1991-3#1)(1994-1#1)
courts have##4##2##(1991-3#1)(1993-12#2)(1994-1#1)
courts in##2##2##(1995-6#1)(2010-10#1)
courts of##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
courts##31##1##(1990-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(2007-2#1)(2007-3#1)(2008-10#5)(2008-6#2)(2008-9#1)(2010-10#3)(2010-6#1)(2011-2#2)(2012-2#1)
courtship behavior##4##2##(2008-6#2)(2008-8#1)(2013-8#1)
courtship##17##1##(1990-11#2)(2007-12#1)(2008-5#1)(2008-6#3)(2008-8#6)(2008-9#1)(2009-9#1)(2013-8#2)
cousins##3##1##(2011-2#2)(2012-3#1)
covalency##5##1##(1997-7#5)
covalent affinity chromatography with thiol-disulphide##2##5##(2008-10#2)
covalent affinity chromatography##3##3##(2008-10#3)
covalent attachment of##5##3##(1994-5#1)(1995-6#1)(2008-4#1)(2008-5#1)(2013-1#1)
covalent attachment##9##2##(1994-5#1)(1995-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
covalent binding of##10##3##(1990-7#1)(1994-5#1)(1995-3#1)(1995-6#2)(2008-10#3)(2008-3#1)(2012-12#1)
covalent binding to##3##3##(1991-9#1)(1995-6#2)
covalent binding##14##2##(1990-7#1)(1991-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#4)(2008-10#3)(2008-3#1)(2012-12#1)
covalent bond##4##2##(1990-8#1)(1992-9#1)(2008-10#1)(2010-12#1)
covalent bonding##2##2##(2008-10#1)(2009-9#1)
covalent bonds##2##2##(1995-12#1)(2008-10#1)
covalent chromatography##2##2##(1993-11#2)
covalent grafting##3##2##(2008-10#3)
covalent immobilization of DNA##2##4##(2008-10#2)
covalent immobilization of##7##3##(2008-10#6)(2013-8#1)
covalent immobilization on##2##3##(2008-10#2)
covalent immobilization##11##2##(2008-10#10)(2013-8#1)
covalent linkage between##2##3##(1995-6#1)(2008-10#1)
covalent linkage of##4##3##(1992-6#1)(1994-11#1)(1994-8#1)(2008-11#1)
covalent linkage##7##2##(1992-6#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#1)
covalent modification at the##2##4##(1990-8#1)(1994-5#1)
covalent modification of##4##3##(1990-7#1)(1991-12#1)(2008-2#1)(2008-4#1)
covalent modification##7##2##(1990-7#1)(1990-8#2)(1991-12#1)(1994-5#1)(2008-2#1)(2008-4#1)
covalent##98##1##(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#5)(1993-11#5)(1993-8#1)(1994-11#1)(1994-5#5)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#9)(1997-1#1)(1997-2#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-12#1)(2009-9#2)(2010-12#3)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
covalently attached to a##3##4##(1994-9#1)(2010-5#2)
covalently attached to##8##3##(1991-3#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(2008-10#1)(2010-5#2)
covalently attached##12##2##(1990-12#1)(1991-3#1)(1992-3#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(2008-10#2)(2008-4#1)(2010-5#2)
covalently binds to##2##3##(1992-8#1)(2008-10#1)
covalently binds##3##2##(1992-8#1)(1996-8#1)(2008-10#1)
covalently bond##2##2##(2008-10#2)
covalently bonded to the##2##4##(2008-10#1)(2008-7#1)
covalently bonded to##3##3##(2008-10#2)(2008-7#1)
covalently bonded##6##2##(2008-10#4)(2008-5#1)(2008-7#1)
covalently bound fatty acids##4##4##(1993-6#2)(2008-5#2)
covalently bound lipids on the##2##5##(2008-5#2)
covalently bound lipids##4##3##(2008-5#4)
covalently bound to a##2##4##(2008-10#2)
covalently bound to the##2##4##(1991-3#1)(2008-10#1)
covalently bound to##10##3##(1990-2#1)(1990-8#1)(1991-3#1)(1993-6#1)(2008-10#5)(2009-5#1)
covalently bound##29##2##(1990-2#1)(1990-8#1)(1991-3#2)(1993-6#3)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-10#10)(2008-5#7)(2009-5#1)
covalently closed circular##3##3##(1990-11#2)(2008-10#1)
covalently closed##6##2##(1990-11#2)(1995-3#1)(2008-10#1)(2010-2#2)
covalently conjugated##2##2##(2008-10#1)(2008-8#1)
covalently cross-linked by##2##3##(1993-11#1)(2009-12#1)
covalently cross-linked##4##2##(1993-11#2)(2008-9#1)(2009-12#1)
covalently crosslinked##2##2##(1992-8#1)(1995-2#1)
covalently immobilized on a##2##4##(2008-10#2)
covalently immobilized on##4##3##(1997-2#1)(2008-10#3)
covalently immobilized onto##3##3##(2008-10#3)
covalently immobilized##13##2##(1995-3#1)(1997-2#1)(2008-10#9)(2008-2#1)(2010-4#1)
covalently linked to the##2##4##(1992-8#1)(2008-10#1)
covalently linked to##10##3##(1991-12#1)(1992-8#1)(1993-11#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)
covalently linked##18##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)
covalently modifiable enzymes##3##3##(1990-7#3)
covalently modified##2##2##(1992-11#1)(1992-6#1)
covalently to##2##2##(1991-8#1)(2008-10#1)
covalently##128##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-7#5)(1990-8#2)(1991-12#1)(1991-3#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#44)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#9)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-2#2)(2010-4#1)(2010-5#2)(2013-1#3)
covalently-coated##2##1##(2013-1#2)
covariables##4##1##(1992-9#1)(1995-9#3)
covariance analysis##2##2##(2008-10#2)
covariance between##2##2##(1997-7#1)(2008-8#1)
covariance functions##2##2##(2008-2#2)
covariance matrices##6##2##(1995-2#1)(2008-6#1)(2009-4#1)(2013-1#3)
covariance matrix and then##2##4##(2008-2#1)(2009-9#1)
covariance matrix and##4##3##(2008-2#1)(2009-12#1)(2009-9#1)(2012-12#1)
covariance matrix of the errors##2##5##(1992-6#2)
covariance matrix of the##4##4##(1992-6#2)(2008-3#1)(2009-4#1)
covariance matrix##16##2##(1992-6#2)(1994-2#2)(1997-3#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-12#1)(2009-4#3)(2009-9#1)(2012-12#1)
covariance of##3##2##(1997-3#1)(2008-3#1)(2008-8#1)
covariance structure##2##2##(1992-9#1)(2013-1#1)
covariance##50##1##(1990-3#1)(1992-6#2)(1992-9#2)(1994-2#2)(1995-2#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#3)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#4)(2009-7#1)(2009-8#1)(2009-9#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
covariances and variances of post-treatment measurements##3##6##(2012-1#3)
covariances and##4##2##(2012-1#4)
covariances##8##1##(2008-8#4)(2012-1#4)
covariate effects##4##2##(1992-6#1)(1994-2#1)(1997-4#2)
covariate in##2##2##(1995-2#1)(2013-8#1)
covariate information##2##2##(1997-7#2)
covariate is##2##2##(2010-2#1)(2012-1#1)
covariate models##2##2##(1992-9#2)
covariate values##2##2##(1992-9#2)
covariate##26##1##(1992-6#4)(1992-9#4)(1994-2#3)(1994-8#1)(1995-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
covariates and##2##2##(2008-8#1)(2010-8#1)
covariates are##2##2##(1995-2#1)(2009-5#1)
covariates in##3##2##(2011-2#1)(2012-1#1)(2013-1#1)
covariates is##2##2##(2008-8#2)
covariates that##3##2##(1994-2#1)(1995-2#1)(2008-8#1)
covariates##49##1##(1990-8#1)(1993-5#1)(1994-11#1)(1994-2#3)(1995-12#1)(1995-2#2)(1997-4#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#7)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#6)(2011-2#3)(2012-1#3)(2012-12#1)(2013-1#6)
covariation between##2##2##(2008-10#1)(2008-8#1)
covariation in##3##2##(2008-10#1)(2008-8#2)
covariation##7##1##(2008-10#3)(2008-8#4)
covariations##3##1##(1993-5#3)
covary##3##1##(1991-12#1)(2008-8#1)(2012-3#1)
cover a broad##2##3##(2007-11#1)(2009-10#1)
cover a wide##2##3##(2008-1#1)(2008-3#1)
cover a wider##2##3##(2008-2#1)(2008-4#1)
cover a##11##2##(1996-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2011-2#1)
cover all##2##2##(1993-12#1)(2008-7#1)
cover and##8##2##(2007-5#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)
cover both##2##2##(1990-2#1)(2008-9#1)
cover by##3##2##(2008-10#2)(2008-3#1)
cover crop and##2##3##(2008-10#2)
cover crop on##2##3##(2008-10#2)
cover crop##10##2##(2008-10#8)(2008-6#2)
cover different##2##2##(1995-3#1)(2008-10#1)
cover for the##2##3##(2008-9#2)
cover has increased##2##3##(2008-5#2)
cover has##3##2##(2008-5#3)
cover in the##2##3##(2007-5#1)(2008-9#1)
cover in##6##2##(1990-3#1)(2007-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-9#1)
cover increased##2##2##(2008-9#1)(2011-2#1)
cover many##2##2##(1994-2#1)(2008-12#1)
cover more than##3##3##(1996-10#2)(2011-2#1)
cover of the##2##3##(2008-3#1)(2008-7#1)
cover of##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)
cover other##2##2##(1991-2#1)(2012-2#1)
cover the following##2##3##(1995-1#1)(1996-1#1)
cover the whole##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
cover the##32##2##(1990-2#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#2)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)
cover was##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
cover with##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
cover##168##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-12#3)(2007-5#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-12#8)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#14)(2009-10#1)(2009-5#1)(2009-8#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#15)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
cover)##4##1##(2007-5#1)(2012-3#3)
coverage among##3##2##(1992-2#2)(2013-1#1)
coverage and attitudes of primary care staff in Australia##2##9##(2011-2#2)
coverage and poorer##2##3##(2012-2#2)
coverage and##22##2##(1992-2#1)(1993-10#1)(1993-3#2)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#1)
coverage are still##2##3##(2011-1#1)(2013-1#1)
coverage are##4##2##(1991-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
coverage as##2##2##(1995-2#1)(2011-1#1)
coverage by##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
coverage data##3##2##(1996-12#2)(2008-10#1)
coverage determination##2##2##(2008-10#1)(2010-9#1)
coverage for all##2##3##(1993-3#1)(2012-2#1)
coverage for the##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
coverage for these##2##3##(1994-3#1)(2012-2#1)
coverage for##22##2##(1992-1#1)(1992-2#1)(1993-3#3)(1994-1#1)(1994-3#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-2#3)(2013-8#1)
coverage has increased##2##3##(1994-9#1)(2012-12#1)
coverage has##5##2##(1991-2#1)(1994-9#1)(2008-11#1)(2009-8#1)(2012-12#1)
coverage have##2##2##(1996-3#1)(2008-7#1)
coverage in the##2##3##(2008-10#1)(2008-12#1)
coverage in##16##2##(1993-1#1)(1996-12#3)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
coverage is##7##2##(1994-2#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-5#1)
coverage of a comprehensive##2##4##(1995-12#1)(2010-12#1)
coverage of a##3##3##(1995-12#1)(2010-12#1)(2010-8#1)
coverage of the poor##2##4##(1996-1#2)
coverage of the##22##3##(1991-1#1)(1992-2#1)(1993-9#1)(1995-2#1)(1996-1#2)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
coverage of##57##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1997-2#1)(2007-11#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
coverage on the##2##3##(1993-3#1)(2013-1#1)
coverage on##6##2##(1993-3#1)(1995-1#1)(2008-10#3)(2013-1#1)
coverage probability##9##2##(1995-2#1)(1995-9#1)(2008-10#6)(2012-1#1)
coverage rate##2##2##(2007-2#1)(2012-3#1)
coverage than##2##2##(2009-10#1)(2011-2#1)
coverage to##11##2##(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-9#1)
coverage was##7##2##(1996-12#1)(2008-10#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
coverage with##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
coverage##320##1##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-1#2)(1992-2#8)(1993-1#4)(1993-10#1)(1993-12#1)(1993-3#7)(1993-9#1)(1994-1#4)(1994-2#5)(1994-3#6)(1994-8#1)(1994-9#1)(1995-1#7)(1995-12#9)(1995-2#5)(1995-3#4)(1995-6#2)(1995-9#1)(1996-1#5)(1996-12#12)(1996-2#1)(1996-3#3)(1996-5#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#30)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#9)(2013-8#3)
covered a range of##2##4##(1994-12#1)(2008-10#1)
covered a wide range of topics##2##6##(2008-5#1)(2012-2#1)
covered a wide##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
covered a##9##2##(1994-12#1)(1997-2#3)(2008-10#3)(2008-5#1)(2012-2#1)
covered and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
covered are##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
covered by Apo B##2##4##(1994-3#2)
covered by Medicaid##4##3##(1992-2#1)(1993-12#1)(1994-3#1)(1996-2#1)
covered by a##8##3##(1990-2#1)(1992-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
covered by an##3##3##(1991-11#1)(2008-12#1)(2011-2#1)
covered by the##11##3##(1990-2#1)(1991-8#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
covered by##60##2##(1990-2#2)(1991-11#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#2)(1993-1#2)(1993-12#1)(1994-12#1)(1994-3#6)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-3#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-7#2)(2009-11#1)(2010-8#1)(2011-2#5)(2013-7#1)
covered in a##2##3##(1994-9#1)(2008-4#1)
covered in the##2##3##(2007-2#1)(2013-8#1)
covered in this article##2##4##(1995-1#1)(1996-2#1)
covered in this review include##2##5##(2008-10#1)(2012-12#1)
covered in this review##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
covered in this##8##3##(1995-1#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
covered in##17##2##(1994-9#1)(1995-1#1)(1996-2#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
covered include the##2##3##(2008-10#2)
covered include##5##2##(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
covered smut##5##2##(2008-10#5)
covered stent##4##2##(2007-8#1)(2008-12#1)(2010-5#2)
covered the entire##2##3##(2008-9#1)(2012-3#1)
covered the##12##2##(1995-2#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-8#1)
covered with a##14##3##(2007-12#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-7#1)
covered with an##5##3##(2008-10#2)(2008-11#1)(2008-3#2)
covered with##47##2##(1990-12#1)(1996-10#1)(1997-2#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#7)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
covered##218##1##(1990-12#1)(1990-2#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#3)(1993-1#3)(1993-12#1)(1994-12#3)(1994-3#6)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-10#2)(1996-12#2)(1996-2#4)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#4)(2008-1#2)(2008-10#54)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#14)(2008-4#3)(2008-5#14)(2008-6#2)(2008-7#5)(2008-9#6)(2009-11#1)(2010-11#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#4)
covering a period of##2##4##(1992-12#1)(2013-7#1)
covering a wide range of##2##5##(2008-10#1)(2009-10#1)
covering a wide##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2012-5#1)
covering a##16##2##(1991-6#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-5#1)(2013-7#1)
covering all##5##2##(1991-6#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-5#1)
covering almost##3##2##(2007-11#1)(2008-7#1)(2012-3#1)
covering an##2##2##(2007-12#1)(2008-2#1)
covering and##2##2##(2008-5#1)(2013-1#1)
covering approximately##2##2##(1995-1#1)(2012-12#1)
covering different##4##2##(2008-10#3)(2008-5#1)
covering expenditures for various types of medical services and products and their sources of funding from 1960 to##3##18##(1995-3#1)(1997-1#1)(1997-3#1)
covering more than##2##3##(2007-12#1)(2012-9#1)
covering most##3##2##(2008-10#1)(2009-4#1)(2010-8#1)
covering over##2##2##(2007-11#1)(2008-10#1)
covering the entire##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
covering the whole##3##3##(2007-5#1)(2008-1#1)(2013-8#1)
covering the##37##2##(1990-12#1)(1990-7#1)(1991-2#1)(1992-3#1)(1993-5#1)(1995-6#1)(1996-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2012-3#1)(2013-8#2)
covering##145##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-5#1)(1994-12#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#2)(1996-11#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#23)(2008-11#6)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#4)(2012-5#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#3)
covers a##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
covers about##2##2##(1993-2#1)(1995-6#1)
covers at##2##2##(2007-12#1)(2013-8#1)
covers both##3##2##(1994-3#1)(2008-9#1)(2010-8#1)
covers such##2##2##(2008-9#1)(2013-8#1)
covers the##30##2##(1995-12#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
covers those##2##2##(2008-2#1)(2008-5#1)
covers three##2##2##(2008-4#2)
covers##89##1##(1993-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#11)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#8)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
coverslips were sprayed with##3##4##(2008-10#3)
coverslips##8##1##(2008-10#6)(2008-11#2)
covert##8##1##(1994-3#1)(1995-12#1)(2008-11#1)(2010-5#1)(2012-1#4)
cow milk samples##2##3##(2008-10#2)
cow milk##10##2##(2008-10#6)(2013-1#4)
cow tracheal epithelium##2##3##(1995-11#2)
cow##29##1##(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-12#1)(1994-5#1)(1995-11#2)(1996-11#1)(1996-3#2)(2008-10#8)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-1#5)
cow's milk and##3##3##(2008-10#2)(2009-2#1)
cow's milk##9##2##(1991-6#1)(2007-8#1)(2008-10#3)(2009-2#2)(2010-6#1)(2013-8#1)
cow's##10##1##(1991-6#1)(2007-8#1)(2008-10#4)(2009-2#2)(2010-6#1)(2013-8#1)
cowpea (Vigna unguiculata)##2##3##(2008-10#2)
cowpea cultivars##4##2##(2008-12#4)
cowpea leaves##4##2##(2008-10#4)
cowpea mosaic virus##3##3##(1995-2#1)(2008-10#2)
cowpea##25##1##(1995-2#1)(2008-10#16)(2008-12#7)(2008-9#1)
cows and a calf##2##4##(1991-8#2)
cows and young bulls##2##4##(2013-1#2)
cows and##8##2##(1991-8#2)(1992-2#1)(2007-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
cows fed a trehalose-supplemented diet##3##5##(2013-1#3)
cows fed a##4##3##(2013-1#4)
cows fed##7##2##(2012-2#3)(2013-1#4)
cows in early##2##3##(1991-3#2)
cows in##7##2##(1990-6#2)(1991-3#2)(1995-9#1)(2008-12#1)(2012-3#1)
cows were used##4##3##(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
cows were##10##2##(1991-3#1)(1991-8#1)(1992-2#1)(1997-4#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
cows with suppurative##2##3##(1991-8#2)
cows##68##1##(1990-6#3)(1990-9#1)(1991-3#5)(1991-6#1)(1991-8#5)(1992-11#1)(1992-12#1)(1992-2#2)(1993-6#1)(1995-9#1)(1996-8#5)(1997-4#3)(2007-11#1)(2007-2#1)(2008-12#2)(2008-9#2)(2011-2#2)(2012-2#8)(2012-3#7)(2013-1#16)
cows'##2##1##(2008-10#1)(2013-1#1)
cox##4##1##(2008-10#4)
cox14 mutants##2##2##(1995-6#2)
coxI and II##2##3##(2008-10#2)
coxI and##3##2##(2008-10#3)
coxII##4##1##(2008-10#4)
coxa##4##1##(2007-12#3)(2008-5#1)
coxae are##2##2##(2007-12#2)
coxae##5##1##(2007-12#5)
coxal glands##2##2##(2007-12#2)
coxarthrosis##7##1##(1997-6#1)(2007-11#4)(2013-1#2)
coxibs##4##1##(2008-11#4)
coxo-trochanteral##2##1##(2007-12#2)
coxsackie B virus##2##3##(2011-3#2)
coxsackie##3##1##(1997-4#1)(2011-3#2)
coxsackievirus##6##1##(1991-5#4)(2013-8#2)
cpA and##2##2##(2008-10#2)
cpB##2##1##(2008-10#2)
cpDNA##8##1##(1996-4#3)(1997-2#5)
cpPKs and##5##2##(2009-5#5)
cpPPs##4##1##(2009-5#4)
cpSRP43##2##1##(2009-7#2)
cpe-positive##4##1##(2011-2#4)
cpxyl1##2##1##(2008-10#2)
cr##2##1##(1990-8#1)(2008-2#1)
cr(4+)##3##1##(2008-2#1)(2008-3#2)
crab Goniopsis cruentata##2##3##(2013-7#2)
crab apple blossoms##3##3##(2008-10#3)
crab apple flowers were##2##4##(2008-10#2)
crab apple flowers##3##3##(2008-10#3)
crab apple##8##2##(2008-10#8)
crab species##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2013-7#1)
crab##29##1##(1994-11#4)(2007-12#4)(2008-10#10)(2008-12#2)(2008-5#1)(2008-7#5)(2013-7#3)
crabgrass##4##1##(2008-10#3)(2013-8#1)
crabs are##2##2##(2008-5#1)(2013-7#1)
crabs##11##1##(2007-12#2)(2007-5#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2013-7#1)
crack arrest##2##2##(2008-3#2)
crack behaviour##2##2##(2009-7#2)
crack bridging##2##2##(2008-8#2)
crack cocaine##6##2##(2008-1#1)(2008-10#1)(2008-4#1)(2010-1#1)(2012-1#1)(2012-2#1)
crack deflection##2##2##(2008-8#2)
crack injection##2##2##(2008-1#2)
crack or##2##2##(2008-4#1)(2009-4#1)
crack patterns##2##2##(2009-7#2)
crack propagation in##2##3##(2008-3#1)(2009-7#1)
crack propagation##7##2##(1991-8#1)(2008-3#1)(2009-6#1)(2009-7#3)(2012-2#1)
crack use##2##2##(2008-10#1)(2008-7#1)
crack##55##1##(1991-12#1)(1991-8#1)(2008-1#3)(2008-10#4)(2008-2#6)(2008-3#4)(2008-4#3)(2008-7#1)(2008-8#6)(2008-9#1)(2009-4#1)(2009-6#4)(2009-7#12)(2010-1#1)(2010-4#3)(2012-1#1)(2012-2#3)
crackers##2##1##(2008-1#1)(2009-5#1)
cracking of##3##2##(2008-10#2)(2008-12#1)
cracking##8##1##(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)
cracks and##2##2##(2007-11#1)(2012-2#1)
cracks in##3##2##(1991-8#1)(2008-10#1)(2008-2#1)
cracks##12##1##(1991-8#2)(1996-4#2)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-5#1)(2012-2#1)
cradle##2##1##(2008-11#1)(2008-3#1)
cradling##4##1##(2007-12#4)
craft##3##1##(1996-1#1)(1996-3#1)(2013-1#1)
cramps##4##1##(2008-1#1)(2008-8#1)(2011-2#1)(2013-8#1)
crampy abdominal pain##2##3##(1993-9#1)(2013-8#1)
cranberry cultivars##2##2##(2008-10#2)
cranberry juice##4##2##(1997-4#3)(2012-12#1)
cranberry plants and##2##3##(2008-10#2)
cranberry plants##5##2##(2008-10#5)
cranberry stem gall and##2##4##(2008-10#2)
cranberry stem gall##5##3##(2008-10#5)
cranberry##24##1##(1997-4#4)(2008-10#18)(2011-1#1)(2012-12#1)
crane##2##1##(1997-6#2)
crania##3##1##(1996-3#1)(2011-2#2)
cranial MRI##3##2##(1996-11#1)(2007-10#1)(2010-12#1)
cranial and spinal##3##3##(1991-3#1)(2007-10#1)(2008-7#1)
cranial and##10##2##(1991-3#1)(1997-3#2)(2007-10#2)(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#1)
cranial base##8##2##(2007-12#5)(2011-2#3)
cranial blood vessels and##2##4##(1994-9#1)(2008-9#1)
cranial bones##2##2##(1997-3#1)(2009-6#1)
cranial chondrosarcoma##3##2##(2011-2#3)
cranial fossa##6##2##(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)
cranial irradiation##4##2##(1995-8#1)(1995-9#1)(2008-7#1)(2012-3#1)
cranial nerve palsies##9##3##(1996-9#2)(2007-10#1)(2008-7#4)(2011-2#2)
cranial nerve##18##2##(1990-9#1)(1996-12#1)(1996-8#1)(1996-9#3)(2007-10#1)(2007-12#1)(2008-7#6)(2011-2#3)(2012-3#1)
cranial nerves and##2##3##(2008-7#1)(2011-2#1)
cranial nerves are##2##3##(2008-1#1)(2012-3#1)
cranial nerves##16##2##(1991-3#1)(1993-9#1)(1996-12#1)(1996-8#1)(2008-1#5)(2008-7#2)(2011-2#3)(2012-3#1)(2013-1#1)
cranial neuropathies##2##2##(1993-9#1)(2008-11#1)
cranial surgery##6##2##(2008-9#1)(2011-2#2)(2012-3#3)
cranial tibial translation##2##3##(2012-3#2)
cranial tibial##3##2##(1996-6#1)(2012-3#2)
cranial trauma##2##2##(1996-8#1)(2007-10#1)
cranial vault##11##2##(2006-7#1)(2007-12#7)(2011-2#3)
cranial##121##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#2)(1993-9#2)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#4)(1996-9#3)(1997-3#3)(1997-4#1)(2006-12#1)(2006-7#1)(2007-10#7)(2007-12#18)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#12)(2008-8#1)(2008-9#4)(2009-6#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#20)(2012-2#2)(2012-3#9)(2013-1#1)(2013-8#1)
craniectomy for##2##2##(2006-7#1)(2011-2#1)
craniectomy##9##1##(2006-7#3)(2008-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
cranio-cerebral##2##1##(1992-6#1)(2007-11#1)
cranio-facial##2##1##(1995-6#2)
craniocaudal##3##1##(1995-4#1)(2011-1#1)(2012-3#1)
craniocervical junction##5##2##(2011-2#5)
craniocervical##7##1##(2011-2#5)(2012-12#1)(2013-1#1)
craniofacial anomalies##2##2##(2007-12#2)
craniofacial bones##2##2##(2008-6#1)(2008-8#1)
craniofacial deformities##6##2##(2007-12#5)(2011-2#1)
craniofacial development##2##2##(2007-12#1)(2013-1#1)
craniofacial features##2##2##(2010-8#1)(2013-1#1)
craniofacial hypertrophy##2##2##(2012-12#2)
craniofacial muscle##2##2##(2008-4#2)
craniofacial skeletal##2##2##(2007-12#1)(2010-6#1)
craniofacial superimposition##2##2##(1995-6#1)(2009-2#1)
craniofacial syndromes##2##2##(2007-12#2)
craniofacial team##3##2##(2007-12#3)
craniofacial##58##1##(1995-6#1)(1996-6#2)(2007-12#32)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-5#1)(2010-6#6)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
craniomaxillofacial##3##1##(2006-12#1)(2007-12#2)
craniopharyngioma##10##1##(1993-9#1)(1995-5#2)(2008-7#4)(2011-2#3)
craniopharyngiomas##6##1##(1995-9#1)(2008-7#4)(2011-2#1)
cranioplasty##4##1##(2011-2#4)
craniospinal irradiation##3##2##(1997-3#1)(2007-10#2)
craniospinal##6##1##(1997-3#1)(2007-10#4)(2007-4#1)
craniosynostosis and##3##2##(2011-1#3)
craniosynostosis##11##1##(2007-12#7)(2011-1#3)(2012-12#1)
craniotomies for##2##2##(2006-12#1)(2011-2#1)
craniotomies##4##1##(2006-12#1)(2008-7#2)(2011-2#1)
craniotomy and##5##2##(2008-7#2)(2011-2#1)(2012-3#2)
craniotomy approach##2##2##(2011-2#1)(2013-1#1)
craniotomy for##4##2##(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
craniotomy with##6##2##(1990-12#1)(1995-11#1)(2008-7#3)(2008-8#1)
craniotomy##37##1##(1990-12#4)(1995-11#1)(2006-12#4)(2008-1#1)(2008-7#12)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
craniovertebral junction##2##2##(2008-7#1)(2013-1#1)
cranwelli##3##1##(2013-7#3)
crash##6##1##(1995-2#1)(1996-11#2)(1997-5#1)(2007-2#1)(2011-1#1)
crashes of##2##2##(1995-2#1)(2008-9#1)
crashes##8##1##(1995-2#1)(1996-6#1)(1997-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)
crassa and##5##2##(2008-10#1)(2009-6#1)(2010-7#2)(2012-3#1)
crassa##28##1##(1992-3#2)(1992-8#2)(1993-12#1)(1995-2#3)(1996-6#1)(1997-4#4)(2008-10#3)(2008-6#2)(2008-8#2)(2009-6#1)(2010-7#3)(2012-3#4)
crassipes##3##1##(2008-10#1)(2012-2#1)(2012-3#1)
crassus##5##1##(1994-12#5)
crater lakes##6##2##(2013-1#6)
crater##15##1##(1990-11#1)(1997-5#5)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#6)
craters##6##1##(1991-2#1)(1997-5#4)(2008-10#1)
craving and##3##2##(1991-1#1)(2008-6#1)(2011-2#1)
craving##11##1##(1991-1#2)(1997-5#1)(1997-6#1)(2008-2#2)(2008-6#2)(2009-10#1)(2010-1#1)(2011-2#1)
crayfish Astacus leptodactylus##2##3##(2008-7#2)
crayfish##14##1##(1993-12#2)(2007-12#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#4)(2008-7#2)
cream BP##2##2##(2008-3#2)
cream and##7##2##(1990-9#1)(2008-5#6)
cream at##2##2##(2008-5#2)
cream base##3##2##(2008-5#3)
cream containing##5##2##(2008-10#1)(2008-5#4)
cream formulations##2##2##(2008-5#2)
cream in##5##2##(2007-11#1)(2008-10#1)(2008-5#3)
cream or##2##2##(2008-5#2)
cream was##5##2##(2007-11#1)(2008-5#3)(2011-2#1)
cream with a##2##3##(2008-5#2)
cream with##3##2##(2008-5#3)
cream##66##1##(1990-9#3)(2007-11#2)(2008-10#5)(2008-3#2)(2008-5#46)(2008-6#1)(2011-2#5)(2012-3#1)(2013-7#1)
creaminess##3##1##(2008-5#3)
creams and lotions##2##3##(2008-5#2)
creams and##3##2##(2008-5#3)
creams cause##2##2##(2008-5#2)
creams were##3##2##(2007-11#1)(2008-5#2)
creams##33##1##(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#25)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#1)
creams/lotions##2##1##(2008-5#2)
crease##8##1##(1997-3#1)(2008-9#1)(2010-8#6)
creases##2##1##(2008-5#2)
create &quot##2##2##(2011-2#2)
create a climate for##2##4##(1992-2#1)(1993-2#1)
create a common##2##3##(1996-1#1)(2011-2#1)
create a model##2##3##(1996-4#1)(1996-6#1)
create a more##2##3##(1994-12#1)(1996-1#1)
create a new##7##3##(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1996-3#1)(2008-11#1)(2008-5#1)
create a positive##2##3##(2008-7#1)(2010-10#1)
create a professional relationship between##2##5##(2008-3#2)
create a single##2##3##(1995-6#1)(2009-11#1)
create a##81##2##(1990-5#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-6#1)(1996-1#4)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#9)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#4)(2011-9#2)(2013-1#6)(2013-8#1)
create an##17##2##(1991-3#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
create any conditions that##2##4##(1990-2#2)
create genetic##2##2##(2008-11#1)(2008-9#1)
create health##2##2##(1996-12#1)(1996-2#1)
create new##8##2##(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)
create novel##2##2##(2007-7#1)(2010-7#1)
create spatial##2##2##(2008-8#1)(2008-9#1)
create special##2##2##(1996-12#1)(2008-9#1)
create the need for##2##4##(1993-2#1)(2008-8#1)
create the##19##2##(1991-2#1)(1993-2#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
create two##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
create##276##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1993-2#3)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#4)(1995-3#4)(1995-5#2)(1995-6#2)(1996-1#7)(1996-12#2)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#7)(2007-8#2)(2008-1#6)(2008-10#21)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#18)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#9)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#12)(2011-9#2)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#2)
created a &quot##2##3##(1992-1#1)(2008-1#1)
created a model##2##3##(1992-2#1)(2009-10#1)
created a new##4##3##(1993-8#1)(1994-12#1)(1997-2#1)(2012-2#1)
created a pressing need##2##4##(1995-1#1)(2010-12#1)
created a##34##2##(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
created an##10##2##(1995-3#1)(1996-2#1)(1996-9#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-8#1)
created and##14##2##(1991-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
created as a result of the##2##6##(2008-10#1)(2008-8#1)
created as a##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
created at the##3##3##(1996-2#1)(2008-1#1)(2008-8#1)
created between##2##2##(2008-2#1)(2008-4#1)
created by the##11##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-7#1)(2011-2#2)
created by##48##2##(1991-11#1)(1991-3#1)(1992-12#1)(1994-3#1)(1996-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#2)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#1)
created during##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
created equal?##2##2##(1991-12#1)(1996-3#1)
created for the##2##3##(2007-5#1)(2008-7#1)
created for this purpose##2##4##(2008-1#1)(2008-7#1)
created for##11##2##(1996-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2010-6#1)(2013-7#1)
created from##9##2##(1991-12#1)(1996-3#1)(2008-10#3)(2008-4#1)(2012-2#1)(2013-1#2)
created in a##2##3##(2008-5#1)(2013-1#1)
created in the##4##3##(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
created in##18##2##(1996-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
created is##2##2##(2008-11#1)(2010-4#1)
created on the##2##3##(2010-4#1)(2012-2#1)
created on##3##2##(2007-7#1)(2010-4#1)(2012-2#1)
created skill (adjusted OR 0##2##5##(2008-10#2)
created skill##3##2##(2008-10#3)
created that##6##2##(1994-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
created the##11##2##(1991-6#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-6#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
created through##3##2##(1997-3#1)(2008-9#2)
created to allow##2##3##(2008-10#1)(2008-7#1)
created to##14##2##(1992-2#1)(1993-9#1)(1994-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-6#1)(2013-1#1)
created uncertainty##2##2##(1990-6#1)(2011-2#1)
created using a##4##3##(1992-1#1)(2008-10#1)(2009-11#1)(2010-10#1)
created using##9##2##(1992-1#1)(2007-7#1)(2008-10#2)(2008-5#2)(2009-11#1)(2010-10#1)(2010-12#1)
created with##4##2##(2008-9#1)(2011-3#1)(2011-9#1)(2013-1#1)
created within##2##2##(1991-1#1)(1993-1#1)
created##286##1##(1990-11#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#1)(1992-2#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#5)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#4)(1996-2#4)(1996-3#3)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#3)(2008-1#5)(2008-10#30)(2008-11#14)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#5)(2008-7#17)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#4)(2010-12#2)(2010-2#1)(2010-4#6)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#16)(2011-3#2)(2011-9#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#3)
creates a model##2##3##(1996-2#1)(2009-5#1)
creates a new##3##3##(1990-8#1)(2010-12#1)(2012-12#1)
creates a##29##2##(1990-2#1)(1990-8#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
creates an##7##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#2)
creates new##3##2##(1995-6#1)(2011-2#2)
creates the##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
creates two##3##2##(1996-10#1)(2008-3#2)
creates##76##1##(1990-2#1)(1990-8#2)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#2)(1997-8#1)(2007-11#2)(2007-12#4)(2007-7#2)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#4)
creatinase##2##1##(1990-2#1)(2008-10#1)
creatine N-phosphotransferase##2##2##(1991-2#1)(1992-3#1)
creatine and creatinine##4##3##(1990-8#1)(2008-10#3)
creatine and##8##2##(1990-8#1)(2008-10#4)(2008-7#3)
creatine kinase (ATP##2##3##(1991-2#1)(1992-3#1)
creatine kinase (CK) and##2##4##(2011-2#1)(2013-8#1)
creatine kinase (CK)##7##3##(1990-11#1)(1990-2#1)(1994-12#2)(1997-2#1)(2011-2#1)(2013-8#1)
creatine kinase and##3##3##(1993-3#1)(2008-10#2)
creatine kinase in##2##3##(1990-2#1)(1995-8#1)
creatine kinase##31##2##(1990-11#1)(1990-2#2)(1991-2#2)(1991-6#2)(1992-3#1)(1993-11#4)(1993-3#1)(1994-12#2)(1994-8#3)(1995-8#2)(1997-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
creatine kinase-MB (CK-MB)##2##3##(2007-8#1)(2011-2#1)
creatine kinase-MB##5##2##(2007-8#1)(2008-3#3)(2011-2#1)
creatine phosphate##2##2##(2008-7#1)(2013-1#1)
creatine phosphokinase B##8##3##(1990-11#8)
creatine phosphokinase##13##2##(1990-11#8)(2006-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
creatine supplementation in humans##2##4##(2008-5#2)
creatine supplementation##6##2##(2008-5#6)
creatine transporter##4##2##(2008-5#4)
creatine##88##1##(1990-11#11)(1990-2#5)(1990-8#1)(1991-2#3)(1991-6#2)(1992-3#2)(1993-11#4)(1993-3#1)(1994-12#3)(1994-8#7)(1995-8#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#14)(2008-6#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#4)(2013-8#1)
creating a complex##2##3##(2008-8#1)(2010-5#1)
creating a new##2##3##(1992-4#1)(2007-2#1)
creating a##39##2##(1990-8#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-12#1)(1995-12#3)(1995-3#1)(2007-11#1)(2007-2#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
creating an integrated##2##3##(1995-3#1)(2008-7#1)
creating an##9##2##(1994-3#1)(1995-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#2)
creating and##6##2##(1992-3#1)(1997-2#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-3#1)
creating any##2##2##(2008-3#1)(2011-2#1)
creating both##2##2##(2008-10#1)(2011-2#1)
creating more##2##2##(1996-1#1)(2008-11#1)
creating new##6##2##(1992-11#1)(1996-1#1)(1997-2#1)(2008-2#1)(2010-4#1)(2012-12#1)
creating opportunities##2##2##(1993-6#1)(1997-3#1)
creating significant##2##2##(2007-7#1)(2012-3#1)
creating the##15##2##(1990-5#1)(1992-1#1)(1996-12#2)(1996-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
creating##145##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#8)(2008-11#2)(2008-12#7)(2008-2#4)(2008-3#9)(2008-4#4)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#3)
creatinine &gt##3##2##(2006-10#1)(2012-3#2)
creatinine (r = 0##3##4##(1995-11#1)(2008-1#1)(2011-2#1)
creatinine (r =##4##3##(1995-11#2)(2008-1#1)(2011-2#1)
creatinine and the##2##3##(1992-11#1)(2011-2#1)
creatinine and urea were##2##4##(2011-2#2)
creatinine and urea##4##3##(1995-3#1)(2008-10#1)(2011-2#2)
creatinine and##14##2##(1991-12#1)(1992-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(2008-10#3)(2008-4#1)(2009-5#1)(2011-2#3)(2013-8#1)
creatinine clearance##10##2##(2007-12#1)(2007-7#1)(2008-1#4)(2008-7#2)(2009-12#1)(2011-2#1)
creatinine concentration##2##2##(2008-10#2)
creatinine concentrations##2##2##(2008-10#2)
creatinine deiminase##5##2##(1991-12#2)(1995-3#1)(2008-10#2)
creatinine in protocol A and B##2##6##(2008-4#2)
creatinine in urine and##2##4##(1990-8#1)(1992-11#1)
creatinine in urine by##2##4##(1992-11#1)(2008-10#1)
creatinine in urine##7##3##(1990-8#1)(1992-11#2)(2008-10#4)
creatinine in##13##2##(1990-8#1)(1991-12#1)(1992-11#2)(2008-10#6)(2008-4#2)(2012-3#1)
creatinine level was##2##3##(2007-12#1)(2008-4#1)
creatinine level##6##2##(1994-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)
creatinine levels##9##2##(1992-3#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-4#1)(2012-3#1)
creatinine of 1##2##3##(2013-1#1)(2013-8#1)
creatinine of##3##2##(2012-3#1)(2013-1#1)(2013-8#1)
creatinine phosphokinase##2##2##(2008-1#1)(2011-2#1)
creatinine ratio##5##2##(1991-12#1)(2008-5#1)(2012-2#1)(2013-1#2)
creatinine sensitive##3##2##(2008-10#3)
creatinine sensor##3##2##(2008-10#3)
creatinine was##5##2##(1992-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
creatinine##161##1##(1990-12#1)(1990-3#1)(1990-8#2)(1991-12#6)(1992-11#6)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#4)(1995-3#6)(1997-2#1)(1997-8#1)(2006-10#2)(2007-12#3)(2007-7#2)(2008-1#13)(2008-10#44)(2008-3#1)(2008-4#9)(2008-5#2)(2008-7#7)(2008-8#4)(2009-12#2)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#13)(2012-2#2)(2012-3#6)(2013-1#8)(2013-8#2)
creatinine) was##2##2##(1990-3#1)(2008-1#1)
creatinine)##7##1##(1990-3#2)(1993-9#2)(1997-2#1)(2008-1#1)(2008-10#1)
creation and##8##2##(1992-1#1)(1997-3#1)(2007-7#1)(2008-9#2)(2011-1#1)(2012-3#1)(2013-1#1)
creation in##2##2##(2007-11#1)(2007-7#1)
creation of a##32##3##(1991-3#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1997-2#3)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
creation of an##6##3##(1994-7#1)(1996-12#1)(1996-3#1)(2007-7#1)(2007-8#2)
creation of broadband localized optical fields##2##6##(2007-11#2)
creation of new##8##3##(1991-7#1)(1991-8#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
creation of rare restriction sites##2##5##(1990-5#2)
creation of the##8##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-9#1)(2012-3#1)
creation of##115##2##(1990-5#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-6#2)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#16)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
creation##137##1##(1990-5#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#2)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-6#2)(2007-11#4)(2007-12#1)(2007-7#8)(2007-8#3)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
creative and##4##2##(1992-1#1)(1992-12#1)(2007-8#1)(2008-12#1)
creative approach##2##2##(1992-2#1)(2013-1#1)
creative financing##3##2##(1993-2#2)(1996-1#1)
creative ideas##2##2##(1996-1#1)(1997-2#1)
creative strategies to##2##3##(1993-12#1)(2008-1#1)
creative strategies##3##2##(1993-12#1)(1997-3#1)(2008-1#1)
creative thinking##3##2##(1994-2#1)(2008-11#1)(2008-12#1)
creative##45##1##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-2#1)(1995-1#6)(1995-6#1)(1996-1#2)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2009-3#1)(2010-10#1)(2010-5#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#4)
creativity and innovation##2##3##(1995-1#2)
creativity and##8##2##(1992-1#1)(1995-1#5)(2008-11#1)(2008-4#1)
creativity is a##3##3##(1995-1#3)
creativity##20##1##(1991-3#1)(1992-1#1)(1994-2#1)(1995-1#11)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
creator##3##1##(1992-2#1)(2008-4#1)(2013-1#1)
creators##2##1##(1996-9#1)(2009-10#1)
credence to the##2##3##(1992-3#1)(1996-1#1)
credence to##3##2##(1991-9#1)(1992-3#1)(1996-1#1)
credence##5##1##(1991-9#1)(1992-3#1)(1996-1#2)(2008-10#1)
credentialing and peer review##2##4##(1993-1#1)(1994-2#1)
credentialing and##5##2##(1992-2#1)(1993-1#1)(1993-3#1)(1994-2#1)(2008-8#1)
credentialing decisions##2##2##(1992-2#1)(1993-3#1)
credentialing for##2##2##(1991-2#1)(2012-2#1)
credentialing in##2##2##(1991-12#1)(1993-12#1)
credentialing##37##1##(1991-12#7)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#3)(1993-1#1)(1993-12#4)(1993-3#2)(1994-2#2)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#1)(2007-3#1)(2008-8#1)(2012-2#2)
credentials##4##1##(1992-3#3)(2012-12#1)
credibility and##4##2##(1990-2#1)(2007-10#1)(2008-11#2)
credibility interval##2##2##(2008-11#1)(2011-2#1)
credibility##20##1##(1990-2#1)(1993-12#1)(2007-10#1)(2008-11#7)(2008-12#1)(2009-11#1)(2011-2#4)(2012-1#1)(2013-1#3)
credible##15##1##(1992-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2012-1#1)(2013-1#2)
credit enhancement##2##2##(1991-9#2)
credit for##2##2##(1993-11#1)(1993-12#1)
credit##17##1##(1991-12#4)(1991-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)(2013-8#1)
credited##2##1##(1992-2#1)(1997-3#1)
credits##4##1##(1995-2#1)(1996-3#2)(1996-9#1)
creep and##2##2##(1996-4#1)(2008-5#1)
creep loading##2##2##(2009-7#2)
creep tests##3##2##(2009-4#3)
creep##18##1##(1996-4#4)(2007-11#1)(2008-5#2)(2009-4#4)(2009-7#4)(2009-9#3)
creeping bentgrass (Agrostis stolonifera)##3##4##(2008-10#3)
creeping bentgrass##12##2##(2008-10#12)
creeping thistle##2##2##(2008-10#2)
creeping##18##1##(1994-8#2)(1997-4#1)(2008-10#15)
crenata##3##1##(2008-10#3)
creosote##2##1##(2008-10#2)
crepitus##3##1##(2010-12#1)(2011-2#2)
crescentic glomerulonephritis##3##2##(1997-8#1)(2007-7#1)(2008-1#1)
crescentic##4##1##(1997-8#1)(2007-7#1)(2008-1#2)
crest autograft##2##2##(2008-7#1)(2012-3#1)
crest##23##1##(1991-6#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-7#2)(2009-10#3)(2009-9#3)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#3)(2012-3#1)
crestal##3##1##(2010-5#1)(2013-1#2)
crested##2##1##(1997-3#1)(2008-9#1)
crests##5##1##(2008-9#4)(2012-2#1)
cresyl violet##2##2##(1996-12#1)(2008-10#1)
cresyl##4##1##(1996-12#1)(2008-10#3)
cretinism and##2##2##(1996-11#1)(2007-11#1)
crevice spawning##2##2##(2010-8#2)
crevice##7##1##(1992-4#2)(1995-2#1)(2008-10#1)(2008-2#1)(2010-8#2)
crevices##5##1##(2008-10#3)(2010-8#1)(2011-2#1)
crew##6##1##(1992-6#1)(2008-1#1)(2009-10#1)(2011-2#3)
crewmembers##3##1##(1996-12#3)
cribriform plate##3##2##(2008-11#1)(2011-2#2)
cribriform##4##1##(2008-11#1)(2011-2#2)(2013-8#1)
cricket##7##1##(2007-12#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)
crickets##5##1##(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
cricopharyngeal##6##1##(1997-2#1)(2007-8#1)(2011-1#4)
crime and##3##2##(2008-11#1)(2009-9#1)(2012-1#1)
crime in hospitals##3##3##(1992-2#1)(1994-2#1)(1996-12#1)
crime in##8##2##(1992-2#1)(1994-2#1)(1996-11#1)(1996-12#3)(2011-2#2)
crime prevention##2##2##(1991-1#1)(1992-12#1)
crime scene##7##2##(1995-6#1)(2008-10#2)(2008-12#4)
crime scenes##4##2##(2008-10#4)
crime survey##2##2##(1994-12#1)(1997-2#1)
crime was##2##2##(2011-1#1)(2011-2#1)
crime##65##1##(1990-3#1)(1991-1#2)(1991-12#1)(1992-12#2)(1992-2#3)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#3)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#6)(1997-2#1)(1997-7#1)(2007-1#1)(2008-10#9)(2008-11#2)(2008-12#7)(2009-7#4)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)
crimes##13##1##(1991-2#1)(1991-6#1)(1993-2#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-9#1)(2011-2#3)
criminal investigations##2##2##(2008-12#1)(2009-5#1)
criminal justice supervision##2##3##(2008-6#2)
criminal justice system##8##3##(1996-1#2)(2008-11#3)(2009-11#1)(2009-9#1)(2012-2#1)
criminal justice##14##2##(1996-1#4)(2008-11#4)(2008-6#3)(2009-11#1)(2009-9#1)(2012-2#1)
criminal penalties##2##2##(1991-2#1)(1997-5#1)
criminal proceedings##3##2##(2011-2#3)
criminal transmission##2##2##(1996-5#2)
criminal##45##1##(1991-1#1)(1991-2#3)(1992-1#2)(1993-12#2)(1993-3#1)(1994-3#2)(1995-12#1)(1996-1#5)(1996-5#2)(1997-5#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#4)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-6#1)(2011-2#4)(2012-2#1)(2013-8#2)
criminality in##2##2##(2008-10#1)(2008-2#1)
criminality##3##1##(1996-6#1)(2008-10#1)(2008-2#1)
criminalization of##2##2##(1994-2#1)(1996-1#1)
criminalization##3##1##(1994-2#1)(1996-1#2)
criminals##3##1##(1991-6#1)(1995-8#1)(2008-10#1)
criminological theory##2##2##(2009-7#1)(2012-12#1)
criminology##2##1##(2008-1#1)(2009-7#1)
crinkle##2##1##(2008-10#2)
crinkling##2##1##(2008-10#1)(2008-5#1)
crippling##3##1##(1994-9#1)(2008-5#1)(2008-7#1)
crise convulsive##2##2##(2013-1#2)
crises and##5##2##(1997-5#1)(2008-12#2)(2013-1#2)
crises as##2##2##(2009-9#1)(2011-2#1)
crises convulsives##3##2##(2013-1#3)
crises in##2##2##(1991-6#1)(1993-3#1)
crises of##2##2##(1993-2#1)(2008-7#1)
crises##26##1##(1991-6#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-1#1)(1996-3#2)(1997-5#1)(2008-10#1)(2008-12#4)(2008-7#1)(2009-9#2)(2011-2#3)(2012-12#1)(2013-1#5)
crisis and the##3##3##(1993-12#1)(1996-8#1)(2012-12#1)
crisis and##9##2##(1993-12#1)(1996-8#1)(1997-3#1)(2008-6#1)(2009-6#2)(2012-12#1)(2013-1#2)
crisis as##2##2##(2008-10#1)(2013-8#1)
crisis centre for children##3##4##(1995-5#3)
crisis for##2##2##(1995-1#1)(1996-3#1)
crisis in##16##2##(1997-3#1)(1997-5#1)(2008-11#1)(2008-6#2)(2009-5#4)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
crisis intervention##2##2##(1992-3#1)(1993-3#1)
crisis management##3##2##(1992-1#1)(2008-12#1)(2008-7#1)
crisis of the##2##3##(2013-1#2)
crisis of##8##2##(1990-8#1)(1995-8#1)(2007-7#1)(2008-10#1)(2012-12#1)(2013-1#3)
crisis situations##2##2##(1995-3#1)(2009-6#1)
crisis that##2##2##(2011-2#1)(2013-1#1)
crisis##119##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#4)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-5#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#3)(2008-4#2)(2008-6#4)(2008-7#2)(2009-5#5)(2009-6#8)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#18)(2013-7#1)(2013-8#3)
crisis)##2##1##(2009-6#1)(2013-1#1)
crisis?##2##1##(2008-1#1)(2013-8#1)
crisis]##2##1##(2013-1#2)
crispa##3##1##(2008-10#2)(2008-5#1)
crispbread##2##1##(1991-6#2)
crisps##2##1##(2012-1#2)
crista##4##1##(2006-12#2)(2007-8#1)(2008-7#1)
cristae density##2##2##(2012-3#2)
cristae##9##1##(2008-12#2)(2008-7#3)(2012-3#4)
criteria (sensitivity##2##2##(1997-8#2)
criteria a##2##2##(1994-3#1)(2011-2#1)
criteria after##3##2##(1990-6#1)(2013-1#2)
criteria alone##2##2##(1997-2#1)(2008-5#1)
criteria and methods for##3##4##(2008-4#2)(2011-1#1)
criteria and standards##2##3##(1991-3#2)
criteria and the##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
criteria and were##2##3##(2007-11#1)(2013-1#1)
criteria and##53##2##(1991-3#2)(1992-3#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-12#1)(1997-8#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#6)(2011-7#1)(2012-12#5)(2012-2#3)(2013-1#3)(2013-7#1)
criteria are identified##2##3##(2008-2#1)(2008-7#1)
criteria are used##2##3##(2009-11#1)(2009-6#1)
criteria are##29##2##(1990-6#1)(1990-9#1)(1992-2#1)(1995-11#1)(1997-8#2)(2007-12#1)(2007-8#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
criteria as##3##2##(1995-3#1)(2007-10#1)(2011-2#1)
criteria by##4##2##(2009-8#1)(2010-7#1)(2012-3#1)(2013-1#1)
criteria can be##3##3##(1990-8#1)(2008-3#1)(2011-2#1)
criteria can##5##2##(1990-6#1)(1990-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
criteria defined by the##2##4##(1991-11#1)(2011-2#1)
criteria for &quot##2##3##(1997-8#1)(2011-2#1)
criteria for ASPD##2##3##(1994-2#2)
criteria for a##5##3##(1991-1#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
criteria for depression##3##3##(2013-1#3)
criteria for diagnosis##2##3##(1997-4#1)(2008-3#1)
criteria for distinguishing##2##3##(2008-9#1)(2010-5#1)
criteria for evaluating##3##3##(2007-8#1)(2008-8#1)(2008-9#1)
criteria for identifying##2##3##(2008-7#1)(2013-1#1)
criteria for inclusion##2##3##(2009-5#1)(2011-2#1)
criteria for major depressive disorder (MDD)##2##6##(2011-2#1)(2012-3#1)
criteria for major depressive disorder##4##5##(2011-2#3)(2012-3#1)
criteria for major depressive##5##4##(2010-2#1)(2011-2#3)(2012-3#1)
criteria for major##6##3##(2010-2#1)(2011-2#4)(2012-3#1)
criteria for selecting the##2##4##(1990-5#1)(2008-3#1)
criteria for selecting##4##3##(1990-5#1)(1996-12#1)(2008-3#1)(2010-11#1)
criteria for the diagnosis of##9##5##(1997-2#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2013-1#3)
criteria for the selection of##2##5##(1994-2#1)(2008-1#1)
criteria for the##24##3##(1990-6#1)(1994-2#2)(1997-2#1)(1997-5#2)(1997-8#2)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#2)(2013-1#3)
criteria for these##3##3##(2008-1#1)(2008-3#1)(2011-1#1)
criteria for this##2##3##(2008-7#1)(2009-6#1)
criteria for##185##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#4)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#6)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#12)(2013-8#2)
criteria from##2##2##(1996-2#1)(2010-2#1)
criteria had##3##2##(1997-8#1)(2011-2#1)(2012-2#1)
criteria have been##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
criteria have##7##2##(1994-2#1)(1997-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
criteria in the##5##3##(1991-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
criteria in##13##2##(1991-12#1)(1994-9#1)(1995-1#1)(1997-8#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#3)(2012-1#1)(2013-1#1)
criteria included##4##2##(1997-1#1)(2006-10#1)(2009-8#1)(2010-2#1)
criteria including##2##2##(1997-8#1)(2011-2#1)
criteria is##5##2##(1997-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
criteria must be##2##3##(1994-3#1)(2010-3#1)
criteria of choice##3##3##(1990-3#1)(1992-9#1)(2008-8#1)
criteria of the##6##3##(1990-6#1)(1991-2#1)(1994-5#1)(2008-7#1)(2010-4#1)(2011-3#1)
criteria of##48##2##(1990-3#1)(1990-6#3)(1991-2#2)(1991-3#1)(1991-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#3)(2013-7#1)
criteria on the##5##3##(2008-3#1)(2009-7#2)(2011-2#1)(2012-2#1)
criteria on##7##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-7#2)(2011-2#1)(2012-2#1)
criteria other than##2##3##(1991-12#1)(1995-8#1)
criteria proposed##4##2##(1997-8#1)(2007-7#1)(2008-3#1)(2013-1#1)
criteria regarding##2##2##(2008-11#1)(2012-3#1)
criteria set##2##2##(2011-2#2)
criteria should be used##2##4##(1991-2#1)(2010-3#1)
criteria should be##3##3##(1991-2#1)(1992-12#1)(2010-3#1)
criteria should##4##2##(1991-2#1)(1992-12#1)(2010-12#1)(2010-3#1)
criteria studied##2##2##(2008-5#1)(2013-1#1)
criteria such as##6##3##(1992-6#1)(2008-10#3)(2008-3#1)(2008-5#1)
criteria that have##2##3##(2008-10#1)(2011-2#1)
criteria that##8##2##(1992-2#1)(1993-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
criteria to define##3##3##(1991-12#1)(1992-12#1)(2010-1#1)
criteria to establish##2##3##(1992-3#1)(2012-2#1)
criteria to##16##2##(1991-12#1)(1992-12#1)(1992-3#1)(1995-3#1)(2007-7#1)(2008-10#4)(2008-4#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
criteria used for##4##3##(1992-2#1)(2008-1#1)(2010-5#1)(2013-1#1)
criteria used in##2##3##(2007-11#1)(2008-8#1)
criteria used to identify candidates for EPOF##2##7##(1993-12#2)
criteria used to##5##3##(1993-12#2)(1996-3#1)(1997-2#1)(2008-4#1)
criteria used##14##2##(1992-2#1)(1993-12#2)(1996-3#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
criteria was##2##2##(1996-6#1)(2012-2#1)
criteria were developed for##2##4##(2008-7#1)(2010-12#1)
criteria were developed##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
criteria were used##2##3##(2007-10#1)(2012-12#1)
criteria were##28##2##(1991-3#1)(1995-8#1)(1996-11#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
criteria which##2##2##(2008-6#1)(2013-7#1)
criteria will be##3##3##(1995-3#1)(2008-11#1)(2011-2#1)
criteria will##5##2##(1994-8#1)(1995-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
criteria with##3##2##(1991-3#1)(1992-2#1)(2011-2#1)
criteria##786##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#8)(1990-8#2)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#7)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#7)(1992-3#2)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#7)(1994-3#5)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#6)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#3)(1996-7#2)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#26)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#12)(2007-11#5)(2007-12#7)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#12)(2008-10#48)(2008-11#20)(2008-12#8)(2008-2#15)(2008-3#39)(2008-4#11)(2008-5#14)(2008-6#15)(2008-7#27)(2008-8#7)(2008-9#14)(2009-10#2)(2009-11#5)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#8)(2010-2#8)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#17)(2011-2#78)(2011-3#4)(2011-7#1)(2012-1#4)(2012-12#19)(2012-2#25)(2012-3#24)(2013-1#51)(2013-7#4)(2013-8#9)
criteria) and##3##2##(1996-7#1)(2008-3#1)(2013-1#1)
criteria)##11##1##(1991-3#1)(1994-6#2)(1996-5#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
criteriae##2##1##(2008-10#2)
criterion allows##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
criterion and the##2##3##(2008-3#1)(2012-3#1)
criterion and##8##2##(1993-3#1)(1995-3#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)(2012-3#1)
criterion are##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
criterion for the##7##3##(1996-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2009-8#1)
criterion for##28##2##(1991-9#1)(1994-12#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-7#1)
criterion in##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
criterion is based##2##3##(2008-3#1)(2008-8#1)
criterion is##9##2##(1992-12#1)(1996-6#1)(2008-10#1)(2008-3#2)(2008-6#2)(2008-8#1)(2012-3#1)
criterion lists##2##2##(2008-12#2)
criterion of##11##2##(1991-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#3)
criterion that##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
criterion to##6##2##(2008-10#3)(2008-6#1)(2009-5#1)(2011-2#1)
criterion was##7##2##(1991-2#1)(1991-6#1)(1995-11#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-8#1)
criterion were##3##2##(1991-6#1)(1991-9#1)(2011-2#1)
criterion##146##1##(1991-2#2)(1991-6#2)(1991-9#5)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-12#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#22)(2008-12#3)(2008-2#2)(2008-3#19)(2008-5#2)(2008-6#13)(2008-7#6)(2008-8#3)(2009-5#1)(2009-8#1)(2010-2#4)(2010-8#2)(2011-1#7)(2011-2#4)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#1)
criterion)##6##1##(1991-8#1)(2008-10#5)
criterium##2##1##(2008-10#1)(2009-12#1)
critical DGPS failure##2##3##(2009-10#2)
critical access hospital##2##3##(2008-11#1)(2012-2#1)
critical access##4##2##(2008-11#3)(2012-2#1)
critical action research##2##3##(2008-11#2)
critical age##2##2##(2011-2#1)(2012-3#1)
critical amino acid residues##2##4##(1997-8#1)(2008-9#1)
critical amino acid##4##3##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
critical analysis of the##6##4##(1992-1#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)
critical analysis of##11##3##(1991-6#1)(1992-1#1)(1995-1#1)(1997-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-12#1)
critical analysis##14##2##(1991-6#1)(1992-1#1)(1994-2#1)(1995-1#1)(1997-5#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-10#1)(2012-12#2)
critical and##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)
critical angle##13##2##(2008-2#2)(2008-3#11)
critical applications##2##2##(1993-2#1)(1996-12#1)
critical appraisal of##2##3##(1993-6#1)(2008-11#1)
critical appraisal skills##3##3##(2008-11#2)(2008-12#1)
critical appraisal##9##2##(1993-6#1)(1995-1#1)(2007-5#1)(2008-11#4)(2008-12#1)(2012-3#1)
critical aqueous##2##2##(1994-12#1)(1994-5#1)
critical area##3##2##(1991-3#2)(2008-12#1)
critical areas of##3##3##(1997-3#1)(2008-4#1)(2008-6#1)
critical areas##6##2##(1993-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)
critical aspects of##4##3##(1994-2#1)(2008-9#3)
critical aspects##5##2##(1994-2#1)(2008-9#3)(2012-2#1)
critical assessment##2##2##(2008-8#1)(2013-8#1)
critical care nurses##4##3##(2007-11#4)
critical care nursing practice##3##4##(2007-11#3)
critical care nursing##8##3##(2007-11#6)(2008-11#2)
critical care pathways##2##3##(2008-3#2)
critical care patients##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
critical care placements##2##3##(2008-11#2)
critical care population##2##3##(2012-12#2)
critical care setting##4##3##(1991-1#3)(1994-3#1)
critical care unit##2##3##(2007-12#1)(2013-1#1)
critical care##48##2##(1991-1#3)(1994-1#1)(1994-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(2007-11#10)(2007-12#2)(2007-6#1)(2008-11#5)(2008-3#4)(2008-9#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
critical colonization##2##2##(2008-5#1)(2011-2#1)
critical comparison of##4##3##(1992-3#1)(2008-10#3)
critical comparison##5##2##(1992-3#1)(2008-10#4)
critical component of##4##3##(2007-12#1)(2008-7#1)(2008-9#1)(2012-12#1)
critical component##7##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
critical components of##7##3##(1996-2#1)(2008-1#2)(2008-4#1)(2009-10#1)(2011-2#1)(2013-7#1)
critical components##9##2##(1996-2#1)(2008-1#2)(2008-4#1)(2009-10#1)(2010-11#1)(2011-2#2)(2013-7#1)
critical concentration of##3##3##(1994-5#1)(2008-6#1)(2008-7#1)
critical concentration##6##2##(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
critical control points##2##3##(1997-4#1)(2011-2#1)
critical control##3##2##(1996-3#1)(1997-4#1)(2011-2#1)
critical decision##2##2##(2008-11#1)(2008-8#1)
critical design##2##2##(1995-5#1)(2012-2#1)
critical determinant of##2##3##(1992-9#1)(2010-11#1)
critical developmental##4##2##(2009-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
critical differences in the##2##4##(1994-12#1)(2009-9#1)
critical differences##4##2##(1992-6#1)(1993-12#1)(1994-12#1)(2009-9#1)
critical dimension##3##2##(2008-2#1)(2008-7#1)(2010-4#1)
critical discussion on the##2##4##(2008-10#1)(2008-5#1)
critical discussion##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
critical distance##2##2##(2008-10#1)(2009-8#1)
critical element##3##2##(1992-6#1)(1995-2#1)(2008-4#1)
critical elements of##4##3##(1991-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
critical elements##5##2##(1991-12#1)(1993-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
critical evaluation of the##6##4##(1990-5#1)(1990-9#1)(1995-3#1)(2008-3#1)(2013-1#2)
critical evaluation of##12##3##(1990-5#1)(1990-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#2)(2013-8#2)
critical evaluation##13##2##(1990-5#1)(1990-9#1)(1992-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#2)(2013-8#2)
critical event##3##2##(1992-9#1)(2008-9#1)(2011-1#1)
critical examination of the##4##4##(1991-12#1)(2008-10#2)(2008-11#1)
critical examination of##6##3##(1991-12#1)(2008-10#3)(2008-11#1)(2009-4#1)
critical exposure dose##2##3##(2008-10#2)
critical exposure##3##2##(2008-10#2)(2011-2#1)
critical factor that affects##2##4##(2008-3#1)(2008-8#1)
critical factor##9##2##(1993-1#1)(1994-2#1)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)
critical factors in##2##3##(2008-12#1)(2010-10#1)
critical factors that##2##3##(2008-9#1)(2013-7#1)
critical factors##11##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
critical field##2##2##(2010-7#1)(2012-2#1)
critical flicker fusion##2##3##(1990-3#2)
critical flicker##5##2##(1990-3#2)(2012-1#3)
critical for achieving##3##3##(1991-12#1)(1997-4#1)(2008-2#1)
critical for its##4##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-9#1)
critical for survival##2##3##(2008-4#1)(2010-2#1)
critical for the activation##2##4##(2008-10#1)(2008-9#1)
critical for the induction of##2##5##(2008-11#1)(2008-12#1)
critical for the survival##2##4##(2009-8#1)(2013-7#1)
critical for the##24##3##(1990-3#1)(1992-2#1)(1992-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
critical for their##2##3##(2011-2#1)(2012-7#1)
critical for##108##2##(1990-3#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#4)(1993-12#1)(1993-8#2)(1994-1#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-2#2)(1996-7#1)(1997-4#1)(1997-7#1)(1997-9#1)(2007-12#3)(2008-10#10)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-4#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
critical function##2##2##(1993-12#1)(2013-1#1)
critical health##3##2##(1990-12#1)(1997-3#1)(2010-8#1)
critical if##3##2##(2008-10#2)(2008-2#1)
critical illness myopathy##2##3##(2010-11#1)(2012-3#1)
critical illness polyneuropathy##2##3##(2010-11#1)(2012-3#1)
critical illness##5##2##(2008-6#1)(2010-11#2)(2012-3#2)
critical importance##10##2##(1990-6#1)(1991-1#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
critical in helping##2##3##(1997-2#1)(2007-12#1)
critical in the##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
critical in##18##2##(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
critical incident##9##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#2)(2012-1#3)(2013-1#1)
critical incidents##6##2##(2008-11#4)(2012-1#1)(2012-3#1)
critical information##6##2##(1992-12#1)(1993-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
critical intermediates##2##2##(1992-3#1)(1996-5#1)
critical issue for##2##3##(2008-3#1)(2010-9#1)
critical issue##3##2##(2008-3#1)(2008-7#1)(2010-9#1)
critical issues in##3##3##(2008-4#2)(2010-8#1)
critical issues##13##2##(1994-2#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-3#1)(2010-8#1)(2013-1#2)(2013-8#2)
critical level of##2##3##(2008-7#1)(2013-8#1)
critical level##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
critical levels##2##2##(2008-10#1)(2008-11#1)
critical literature review##2##3##(2010-8#1)(2013-1#1)
critical micellar concentration##4##3##(1996-5#1)(2008-10#2)(2010-11#1)
critical micelle concentration (CMC)##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
critical micelle concentration##10##3##(1994-9#1)(2008-10#7)(2008-4#1)(2008-7#1)
critical need to##3##3##(1995-3#1)(2008-4#1)(2010-7#1)
critical need##8##2##(1992-1#1)(1995-1#1)(1995-3#1)(2008-4#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
critical number of##2##3##(2008-8#1)(2010-7#1)
critical of the##2##3##(1994-12#1)(2013-8#1)
critical parameters for##2##3##(1990-12#1)(2008-9#1)
critical parameters needed for##2##4##(2008-3#1)(2008-4#1)
critical parameters of##2##3##(2008-3#2)
critical parameters##13##2##(1990-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#2)(2012-3#1)
critical part of the##3##4##(2008-10#1)(2009-6#1)(2013-8#1)
critical part##4##2##(1991-12#1)(2008-10#1)(2009-6#1)(2013-8#1)
critical patch size effects##3##4##(2008-8#3)
critical patch size##4##3##(2008-8#4)
critical path efforts##2##3##(1995-12#2)
critical path##5##2##(1993-3#1)(1995-12#4)
critical paths can##2##3##(1995-12#2)
critical paths##9##2##(1993-3#2)(1995-12#7)
critical pathway for##2##3##(1995-12#1)(2008-3#1)
critical pathway implementation##2##3##(1995-12#1)(2008-3#1)
critical pathway##13##2##(1995-12#5)(2008-3#8)
critical pathways and order sets##2##5##(1996-12#2)
critical pathways and##3##3##(1996-12#3)
critical pathways for acute coronary syndrome##2##6##(2008-3#2)
critical pathways for##3##3##(2008-3#3)
critical pathways in##2##3##(1995-12#1)(2008-3#1)
critical pathways##15##2##(1995-12#2)(1996-12#5)(2008-3#8)
critical patients##2##2##(2011-2#1)(2012-3#1)
critical period##10##2##(1993-12#1)(1994-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2012-2#3)
critical periods of##2##3##(1996-5#1)(2010-7#1)
critical periods##4##2##(1996-5#1)(2008-1#1)(2008-10#1)(2010-7#1)
critical phenomena##2##2##(2008-3#1)(2008-8#1)
critical players##2##2##(1995-6#1)(2009-3#1)
critical point##2##2##(2008-3#1)(2009-6#1)
critical points of##4##3##(1997-2#2)(2007-11#1)(2008-2#1)
critical points##10##2##(1997-2#2)(2007-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-3#1)(2010-4#1)
critical process##4##2##(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
critical questions##2##2##(1991-9#1)(2012-3#1)
critical reactions##2##2##(2009-11#1)(2009-12#1)
critical region##3##2##(1996-12#1)(1997-2#1)(1997-3#1)
critical regions##2##2##(2008-11#1)(2013-8#1)
critical relationship##2##2##(2008-9#1)(2010-3#1)
critical review of the literature##4##5##(1996-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
critical review of the##7##4##(1993-3#1)(1996-12#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
critical review of##21##3##(1992-3#1)(1993-12#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
critical review##29##2##(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
critical role in the##20##4##(1990-11#1)(1990-5#1)(1992-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
critical role in##58##3##(1990-11#1)(1990-5#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#2)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)
critical role of##9##3##(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
critical role##77##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#3)(1995-6#1)(1996-12#2)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
critical roles in##7##3##(1991-1#1)(2008-1#2)(2008-10#1)(2009-4#1)(2009-9#1)(2011-1#1)
critical roles##9##2##(1991-1#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#1)
critical shortage##2##2##(2008-10#1)(2011-2#1)
critical situation##2##2##(2008-11#1)(2008-8#1)
critical size##3##2##(1994-5#1)(2008-7#2)
critical state##2##2##(2013-1#2)
critical stenosis of##2##3##(2013-8#2)
critical step for##2##3##(2008-11#1)(2011-2#1)
critical step in the##4##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
critical step in##10##3##(1993-9#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#2)(2013-1#1)
critical step to##2##3##(2009-6#1)(2013-1#1)
critical step##15##2##(1993-9#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#2)(2009-6#1)(2011-2#1)(2013-1#2)
critical steps and##2##3##(2008-4#1)(2008-9#1)
critical steps##5##2##(1996-5#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)
critical success factors##5##3##(1993-2#1)(1993-3#1)(1995-12#1)(2008-12#1)(2008-9#1)
critical success##6##2##(1993-2#1)(1993-3#1)(1995-12#1)(1997-1#1)(2008-12#1)(2008-9#1)
critical surface tension (gamma(c))##2##4##(2008-5#2)
critical surface tension##3##3##(2008-5#3)
critical target##2##2##(1994-5#1)(1995-2#1)
critical temperature##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
critical thinking and##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
critical thinking in nursing##3##4##(2008-12#3)
critical thinking in##5##3##(2008-11#1)(2008-12#4)
critical thinking skills in nurse prescribers##2##6##(2008-12#2)
critical thinking skills in##3##4##(2008-11#1)(2008-12#2)
critical thinking skills##5##3##(2008-11#3)(2008-12#2)
critical thinking##34##2##(2008-1#1)(2008-11#20)(2008-12#11)(2008-8#1)(2012-2#1)
critical threshold##7##2##(1997-4#1)(2008-4#1)(2008-8#2)(2010-10#3)
critical tilt##2##2##(2008-2#2)
critical time for##2##3##(2008-10#2)
critical to developing##2##3##(2007-12#1)(2011-1#1)
critical to the success of##7##5##(1994-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2011-2#3)
critical to the successful##2##4##(2008-3#1)(2011-2#1)
critical to the##26##3##(1990-7#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-8#1)
critical to##76##2##(1990-7#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-3#1)(2007-12#3)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-2#5)(2013-1#1)(2013-8#1)
critical value##6##2##(1997-8#1)(2008-1#2)(2008-3#1)(2008-7#1)(2012-2#1)
critical wavelength##6##2##(2008-5#6)
critical##1161##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#6)(1991-12#5)(1991-2#3)(1991-3#5)(1991-6#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#6)(1992-2#4)(1992-3#8)(1992-6#7)(1992-8#2)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#15)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-1#5)(1994-11#2)(1994-12#6)(1994-2#9)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#4)(1995-12#23)(1995-2#10)(1995-3#6)(1995-5#8)(1995-6#6)(1995-8#5)(1995-9#1)(1996-1#3)(1996-12#15)(1996-2#8)(1996-3#5)(1996-4#1)(1996-5#6)(1996-7#2)(1997-1#7)(1997-2#11)(1997-3#7)(1997-4#6)(1997-5#1)(1997-7#2)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#17)(2007-12#22)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#20)(2008-10#89)(2008-11#95)(2008-12#30)(2008-2#21)(2008-3#63)(2008-4#32)(2008-5#22)(2008-6#12)(2008-7#39)(2008-8#40)(2008-9#35)(2009-10#13)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#11)(2009-9#4)(2010-1#2)(2010-10#10)(2010-11#9)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#9)(2010-8#10)(2010-9#3)(2011-1#9)(2011-2#41)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#15)(2012-2#47)(2012-3#22)(2012-4#1)(2012-7#1)(2013-1#33)(2013-7#5)(2013-8#20)
critical&quot##3##1##(2008-11#2)(2009-7#1)
criticality##4##1##(1991-12#1)(1996-2#1)(2007-11#1)(2012-2#1)
critically analysed##3##2##(2008-10#1)(2008-11#2)
critically appraise the##2##3##(1991-2#1)(2008-12#1)
critically appraise##3##2##(1991-2#1)(2008-12#1)(2012-12#1)
critically appraised##5##2##(2008-1#1)(2008-10#2)(2008-11#2)
critically compared##3##2##(2008-10#3)
critically dependent on##4##3##(1990-8#1)(2007-11#1)(2008-7#1)(2013-8#1)
critically dependent##5##2##(1990-8#1)(2007-11#1)(2008-7#1)(2012-1#1)(2013-8#1)
critically depends on##3##3##(2008-2#1)(2010-7#1)(2011-2#1)
critically discuss##2##2##(2009-12#1)(2013-1#1)
critically discussed##4##2##(2008-10#3)(2008-9#1)
critically endangered##3##2##(2010-8#1)(2013-1#2)
critically evaluate and interpret##2##4##(2007-5#2)
critically evaluate##6##2##(1992-1#1)(2007-5#2)(2008-10#1)(2012-2#2)
critically evaluated##6##2##(1994-6#1)(2007-12#1)(2008-10#2)(2009-8#1)(2013-1#1)
critically examine##2##2##(1996-3#1)(2008-9#1)
critically examined##4##2##(2007-8#1)(2008-10#2)(2008-3#1)
critically examines##3##2##(1990-5#1)(2008-11#1)(2010-8#1)
critically ill patients and##3##4##(2008-11#1)(2010-8#1)(2013-1#1)
critically ill patients##20##3##(1991-3#1)(1992-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
critically ill##42##2##(1990-8#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-6#1)(1995-12#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
critically important for##3##3##(1996-4#1)(2008-9#1)(2013-1#1)
critically important##8##2##(1990-11#1)(1996-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2013-1#1)
critically influence##2##2##(1992-9#1)(2008-3#1)
critically investigated##2##2##(2007-5#1)(2008-10#1)
critically involved in the##2##4##(1990-7#1)(2008-8#1)
critically involved in##4##3##(1990-7#1)(1997-7#1)(2008-8#1)(2013-8#1)
critically on the##6##3##(1994-2#1)(2007-11#1)(2008-6#2)(2008-8#1)(2012-2#1)
critically on##8##2##(1994-2#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-2#1)
critically review the##4##3##(1996-9#1)(2008-10#1)(2008-11#1)(2009-7#1)
critically review##6##2##(1996-9#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-1#1)(2013-8#1)
critically reviewed in##2##3##(2008-10#1)(2012-3#1)
critically reviewed##7##2##(2007-10#1)(2007-12#1)(2008-10#3)(2011-1#1)(2012-3#1)
critically the##3##2##(2007-8#2)(2008-10#1)
critically##170##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-5#5)(2007-8#7)(2008-1#1)(2008-10#26)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#3)(2010-8#5)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#8)(2013-8#6)
criticised##3##1##(1993-7#1)(1997-8#1)(2013-8#1)
criticism and##2##2##(2008-10#1)(2008-5#1)
criticism of the##2##3##(2012-12#1)(2013-7#1)
criticism of##5##2##(1993-12#1)(1995-12#1)(2009-11#1)(2012-12#1)(2013-7#1)
criticism than##2##2##(1997-8#1)(2011-2#1)
criticism##22##1##(1990-11#1)(1990-3#1)(1991-6#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-11#3)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)
criticisms of##3##2##(2008-3#1)(2008-4#1)(2012-12#1)
criticisms##5##1##(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)
criticized by##3##2##(1996-1#1)(1996-12#1)(2008-3#1)
criticized for not##2##3##(1994-12#1)(1996-2#1)
criticized for##4##2##(1994-12#1)(1996-2#2)(2008-8#1)
criticized##13##1##(1991-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)(2013-1#2)
critics##5##1##(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
critique of the##2##3##(1994-12#1)(1995-1#1)
critique of##7##2##(1994-12#2)(1995-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
critique##13##1##(1992-1#1)(1993-6#1)(1994-12#3)(1995-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2011-2#1)
critiqued##3##1##(1993-3#1)(2010-9#1)(2012-12#1)
critiques of##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
critiques##4##1##(1996-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
critiquing##3##1##(1992-3#1)(2008-11#1)(2008-12#1)
critères de##2##2##(2013-1#2)
crk##2##1##(2012-12#2)
croaker##4##1##(2009-7#1)(2010-8#3)
crocea##2##1##(2008-5#2)
croceipes##3##1##(2010-2#3)
crocetin glycosides##2##2##(2008-11#1)(2013-1#1)
crocin and safranal##3##3##(2008-10#3)
crocin and##4##2##(2008-10#3)(2008-11#1)
crocin##7##1##(2008-10#4)(2008-11#3)
crocodile##4##1##(2010-3#4)
croissant##2##1##(2008-5#1)(2013-1#1)
cromakalim and##2##2##(1990-7#1)(1996-9#1)
cromakalim##6##1##(1990-7#1)(1992-9#3)(1996-9#1)(2008-5#1)
cromoglycate and##2##2##(1997-1#1)(1997-6#1)
cromoglycate##9##1##(1997-1#1)(1997-6#5)(2008-10#2)(2008-7#1)
cromolyn##3##1##(1995-12#1)(2008-11#1)(2011-1#1)
crop and##12##2##(2008-10#9)(2008-8#2)(2011-2#1)
crop anthesis##3##2##(2008-10#3)
crop at##2##2##(2007-8#1)(2008-10#1)
crop breeding and##2##3##(2008-7#1)(2008-9#1)
crop by##2##2##(2008-10#2)
crop edges##2##2##(2013-1#2)
crop growth stage##2##3##(2008-10#2)
crop growth##4##2##(2008-10#3)(2008-12#1)
crop health##4##2##(2008-10#4)
crop improvement##2##2##(2008-2#1)(2010-10#1)
crop in the field##2##4##(2008-10#2)
crop in the##5##3##(2008-10#4)(2010-10#1)
crop in##10##2##(2008-10#7)(2010-10#2)(2013-8#1)
crop is##3##2##(2008-10#3)
crop management practices such as##2##5##(2008-10#2)
crop management practices##3##3##(2008-10#3)
crop management##5##2##(2008-10#3)(2008-12#2)
crop of##4##2##(1991-11#1)(2007-5#1)(2008-10#1)(2008-7#1)
crop on##4##2##(2008-10#2)(2011-2#2)
crop or##3##2##(2008-10#3)
crop pathogens##2##2##(2008-10#2)
crop pests##2##2##(2008-8#1)(2009-8#1)
crop plant##2##2##(2008-11#1)(2011-2#1)
crop plants in##2##3##(2008-11#1)(2008-12#1)
crop plants##9##2##(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)
crop production systems##2##3##(2008-10#2)
crop production##7##2##(2008-10#5)(2008-12#1)(2012-2#1)
crop productivity of##2##3##(2010-10#2)
crop productivity##5##2##(2008-10#1)(2009-8#1)(2010-10#2)(2011-2#1)
crop protection decision making##2##4##(2008-10#2)
crop protection technologies based on##2##5##(2008-10#2)
crop protection##10##2##(2008-10#10)
crop rotation and##3##3##(2008-12#3)
crop rotation in##2##3##(2008-12#2)
crop rotation##17##2##(2008-10#7)(2008-12#10)
crop rotations##2##2##(2008-10#1)(2011-2#1)
crop seasons##2##2##(2008-10#2)
crop sequences##4##2##(2008-10#4)
crop species##5##2##(2008-10#3)(2012-2#2)
crop types##2##2##(2008-10#1)(2011-2#1)
crop was##3##2##(2008-10#3)
crop yield##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2012-1#1)
crop yields##5##2##(2008-12#3)(2010-10#1)(2010-7#1)
crop##230##1##(1991-11#1)(1992-3#1)(2007-5#1)(2007-8#1)(2008-10#137)(2008-11#5)(2008-12#24)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-8#2)(2010-10#10)(2010-7#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#3)(2013-8#2)
crop-host availability##2##2##(2008-10#2)
crop-production##2##1##(2008-10#2)
cropland##2##1##(2008-5#1)(2013-1#1)
cropped to##4##2##(2008-10#4)
cropped with##2##2##(2008-10#2)
cropped##7##1##(2008-10#7)
cropping areas##2##2##(2008-10#2)
cropping frequency##2##2##(2008-10#2)
cropping in the##2##3##(2008-10#1)(2013-8#1)
cropping period##2##2##(2008-10#2)
cropping periods##3##2##(2008-10#3)
cropping season##4##2##(2008-10#4)
cropping seasons##4##2##(2008-10#3)(2008-12#1)
cropping sequence##4##2##(2008-10#4)
cropping sequences##3##2##(2008-10#3)
cropping systems##9##2##(2008-10#8)(2008-5#1)
cropping##47##1##(2008-10#42)(2008-12#1)(2008-5#1)(2010-7#1)(2012-4#1)(2013-8#1)
crops and weeds##2##3##(2008-10#2)
crops and##16##2##(2008-10#10)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
crops are planted##2##3##(2008-10#2)
crops are##3##2##(2008-10#3)
crops by##2##2##(2008-10#1)(2008-6#1)
crops following##2##2##(2008-10#2)
crops for##2##2##(2008-10#1)(2009-6#1)
crops from##2##2##(2008-10#2)
crops grown##2##2##(2008-10#1)(2012-2#1)
crops in the##5##3##(2008-10#5)
crops in##18##2##(1997-6#1)(2008-10#14)(2008-6#1)(2012-2#1)(2013-1#1)
crops of winter wheat##2##4##(2008-10#2)
crops of##4##2##(2008-10#4)
crops such as##6##3##(2008-10#6)
crops to##2##2##(2008-10#1)(2008-7#1)
crops was##5##2##(2008-10#4)(2013-1#1)
crops were grown##2##3##(2008-10#2)
crops were##6##2##(2008-10#6)
crops with##5##2##(2008-10#4)(2008-6#1)
crops worldwide##4##2##(2008-10#4)
crops##182##1##(1997-6#2)(2008-10#138)(2008-12#2)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-10#4)(2011-2#13)(2012-2#3)(2013-1#3)(2013-8#4)
croscarmellose sodium and##2##3##(2010-3#2)
crospovidone and mixture of##2##4##(2010-3#2)
crospovidone##4##1##(2010-3#4)
cross LB x##2##3##(2008-10#2)
cross MiA##2##2##(2008-10#2)
cross between a##6##3##(2008-10#5)(2012-3#1)
cross between partially resistant##2##4##(2008-10#2)
cross between the resistant##4##4##(2008-10#4)
cross between the##12##3##(2008-10#12)
cross between two##4##3##(2008-10#3)(2008-5#1)
cross between##48##2##(1996-12#1)(2008-10#38)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#1)(2012-3#3)
cross clamp##4##2##(1996-9#3)(2007-9#1)
cross correlation between##2##3##(2007-12#1)(2008-3#1)
cross correlation of the##2##4##(2008-2#1)(2008-3#1)
cross correlation of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
cross correlation##14##2##(2007-12#5)(2008-2#3)(2008-3#4)(2010-8#2)
cross correlations##3##2##(2007-12#2)(2008-2#1)
cross country##2##2##(1992-6#2)
cross coupling##2##2##(2007-11#2)
cross court and down the line##2##6##(2011-2#2)
cross education may##2##3##(2013-8#2)
cross education##4##2##(2013-8#4)
cross grating##2##2##(2008-3#2)
cross gratings##3##2##(2008-3#3)
cross inoculated##2##2##(2008-10#2)
cross link##2##2##(2009-11#2)
cross linker##2##2##(2008-5#1)(2009-5#1)
cross linking##5##2##(1990-5#1)(1994-5#1)(2008-2#1)(2008-4#2)
cross links##3##2##(1990-7#1)(2008-2#2)
cross of the susceptible##2##4##(2008-10#2)
cross of the##3##3##(2008-10#3)
cross of two##2##3##(2008-10#2)
cross of##14##2##(2008-10#14)
cross pathogenicity of##2##3##(2008-10#2)
cross pathogenicity##3##2##(2008-10#3)
cross peaks##2##2##(1997-2#1)(2010-2#1)
cross polarization##2##2##(2008-10#2)
cross protection against##2##3##(2008-10#2)
cross protection##11##2##(2008-10#11)
cross react with the##2##4##(1990-8#1)(2008-4#1)
cross reaction was##2##3##(2008-5#1)(2010-4#1)
cross reaction##3##2##(1995-2#1)(2008-5#1)(2010-4#1)
cross reactions##3##2##(1996-11#1)(2008-10#1)(2008-5#1)
cross reactivity##7##2##(1992-9#2)(1995-5#1)(2008-10#2)(2008-8#1)(2009-5#1)
cross resistance##5##2##(1997-4#1)(2008-10#1)(2008-11#2)(2009-8#1)
cross section and the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
cross section and##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
cross section for##5##3##(2008-2#2)(2008-3#2)(2010-4#1)
cross section in##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
cross section is##2##3##(2008-2#1)(2008-3#1)
cross section of a##2##4##(2008-2#1)(2008-3#1)
cross section of the##6##4##(1997-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
cross section of##18##3##(1997-3#1)(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#7)(2008-7#1)
cross section##66##2##(1990-4#1)(1993-5#1)(1997-3#1)(2007-11#7)(2007-12#9)(2008-10#1)(2008-2#17)(2008-3#24)(2008-5#1)(2008-7#1)(2009-6#1)(2010-4#2)
cross sectional study of##2##4##(1997-5#1)(2008-8#1)
cross sectional study was##2##4##(2013-8#2)
cross sectional study##14##3##(1990-6#1)(1997-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
cross sectional##19##2##(1990-6#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#4)
cross sections and##2##3##(2008-3#2)
cross sections at##2##3##(2008-3#1)(2009-10#1)
cross sections for the##2##4##(2008-2#2)
cross sections for##3##3##(2008-2#3)
cross sections have##2##3##(2008-2#1)(2008-3#1)
cross sections of the##4##4##(2008-3#3)(2011-2#1)
cross sections of##8##3##(2008-2#2)(2008-3#4)(2009-7#1)(2011-2#1)
cross sections##39##2##(2007-11#1)(2007-12#3)(2008-2#13)(2008-3#18)(2008-5#1)(2009-10#1)(2009-7#1)(2011-2#1)
cross sensitivity of##3##3##(2008-10#1)(2008-3#2)
cross sensitivity##5##2##(2008-10#3)(2008-3#2)
cross studied##2##2##(2008-10#2)
cross talk and##3##3##(2008-2#2)(2008-3#1)
cross talk between##9##3##(2007-12#1)(2008-2#1)(2008-3#5)(2013-1#2)
cross talk due to##2##4##(2008-2#2)
cross talk in##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
cross talk of land and groove recording##2##7##(2008-3#2)
cross talk of less than##2##5##(2008-3#2)
cross talk of##7##3##(2008-2#2)(2008-3#5)
cross talk##47##2##(2007-11#5)(2007-12#3)(2008-2#14)(2008-3#21)(2009-12#1)(2011-2#1)(2013-1#2)
cross the blood-labyrinth barrier into endolymph##2##6##(2009-8#1)(2012-2#1)
cross the blood-labyrinth barrier##3##4##(2009-8#2)(2012-2#1)
cross the membrane##2##3##(1995-11#1)(2008-11#1)
cross the##17##2##(1993-12#1)(1995-11#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-8#3)(2011-2#1)(2012-2#1)(2013-8#1)
cross this barrier##2##3##(1992-12#1)(2009-8#1)
cross validation##9##2##(2007-11#1)(2008-10#6)(2008-3#1)(2010-8#1)
cross was made between##3##4##(2008-10#2)(2008-8#1)
cross was##4##2##(2008-10#3)(2008-8#1)
cross were##2##2##(2008-10#2)
cross##464##1##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-12#3)(1992-6#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#3)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#20)(2007-12#26)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#141)(2008-11#8)(2008-12#3)(2008-2#54)(2008-3#79)(2008-4#5)(2008-5#9)(2008-7#2)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#6)(2010-2#2)(2010-4#4)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#10)
cross-ambiguity function##2##2##(2008-2#2)
cross-ambiguity##3##1##(2008-2#3)
cross-boundary##2##1##(2008-12#1)(2008-8#1)
cross-bridge##3##1##(1992-3#1)(2008-8#1)(2009-6#1)
cross-clamp##2##1##(2007-8#2)
cross-clamping##3##1##(2007-8#1)(2012-3#2)
cross-connectors##2##1##(2012-3#2)
cross-contamination from##2##2##(2008-11#1)(2008-7#1)
cross-contamination of##2##2##(2008-10#2)
cross-contamination##14##1##(1991-12#1)(1994-11#1)(2008-10#3)(2008-11#8)(2008-7#1)
cross-correlation analysis##2##2##(1997-6#1)(2008-9#1)
cross-correlation dynamic light-scattering##3##3##(2008-3#3)
cross-correlation functions##2##2##(2008-2#1)(2008-3#1)
cross-correlation method##2##2##(2007-11#1)(2008-2#1)
cross-correlation spectroscopy##3##2##(2007-12#1)(2008-3#1)(2010-9#1)
cross-correlation system##2##2##(2008-2#2)
cross-correlation##27##1##(1994-11#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#10)(2008-9#1)(2010-9#1)(2012-2#1)
cross-correlations##2##1##(2008-11#1)(2009-9#1)
cross-coupling reactions of##2##3##(1996-5#1)(2010-8#1)
cross-coupling reactions##3##2##(1996-5#1)(2009-12#1)(2010-8#1)
cross-coupling##6##1##(1996-5#1)(2007-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#1)
cross-cultural adaptation##2##2##(2008-4#1)(2013-1#1)
cross-cultural and linguistic adaptation##2##4##(2007-8#2)
cross-cultural research##2##2##(2008-11#1)(2008-12#1)
cross-cultural study##3##2##(1996-12#1)(2007-12#2)
cross-cultural##24##1##(1991-1#1)(1991-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2007-12#2)(2007-8#2)(2008-1#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
cross-cutting##2##1##(1994-2#1)(2012-2#1)
cross-disciplinary##6##1##(2007-12#1)(2008-11#1)(2012-2#1)(2013-8#3)
cross-fertilization##2##1##(2008-7#1)(2012-2#1)
cross-flow##4##1##(1992-5#1)(2008-10#2)(2008-11#1)
cross-fostered##2##1##(2008-8#2)
cross-functional##2##1##(1994-1#1)(1997-1#1)
cross-gender violence perpetration##2##3##(2009-7#2)
cross-gender##5##1##(2009-7#3)(2010-5#2)
cross-hybridization##2##1##(2008-10#1)(2012-2#1)
cross-hybridize##2##1##(1991-6#1)(1997-6#1)
cross-infection##2##1##(2008-10#1)(2011-2#1)
cross-intolerance to##2##2##(2013-1#2)
cross-lagged##7##1##(2009-7#4)(2009-9#2)(2010-10#1)
cross-leg flap##2##2##(2012-12#2)
cross-link DNA at##2##3##(1993-11#2)
cross-link adduct##2##2##(1992-3#2)
cross-link the##2##2##(2008-2#1)(2008-4#1)
cross-link##20##1##(1992-3#3)(1993-11#7)(1995-12#1)(2008-11#3)(2008-2#3)(2008-4#1)(2010-4#1)(2013-8#1)
cross-link)##2##1##(1993-11#2)
cross-linkages##4##1##(2008-10#4)
cross-linked acrylic acid##2##3##(2008-5#2)
cross-linked agarose##2##2##(2008-10#1)(2008-7#1)
cross-linked by##6##2##(1990-5#1)(1993-11#1)(1994-2#1)(1995-3#1)(2008-10#1)(2009-12#1)
cross-linked chitosan##2##2##(2008-10#2)
cross-linked phyllosilicates##2##2##(2008-6#2)
cross-linked polyacrylic acid polymers##4##4##(2008-5#4)
cross-linked polymer##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
cross-linked products##3##2##(1992-2#1)(1995-6#1)(2008-4#1)
cross-linked to##5##2##(1991-8#1)(1993-11#2)(1995-11#1)(2013-8#1)
cross-linked with##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)
cross-linked##69##1##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#4)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#3)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#13)(2008-2#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#4)(2010-4#5)(2010-8#2)(2013-1#1)(2013-8#1)
cross-linker##9##1##(1990-8#1)(2008-10#4)(2010-4#4)
cross-linking activity##2##2##(2012-3#2)
cross-linking agent##4##2##(2008-10#4)
cross-linking amino acid##2##3##(1990-7#2)
cross-linking and##2##2##(1995-6#1)(2008-8#1)
cross-linking by##2##2##(1993-11#1)(2008-5#1)
cross-linking experiments##4##2##(1992-6#1)(1993-11#1)(1995-12#2)
cross-linking in##4##2##(1990-7#2)(2007-12#1)(2008-10#1)
cross-linking molecular weights##4##3##(2008-5#4)
cross-linking of the##3##3##(1995-2#1)(1995-6#1)(2010-4#1)
cross-linking of##13##2##(1990-5#1)(1991-2#2)(1992-9#1)(1993-11#1)(1995-2#1)(1995-6#2)(2007-12#1)(2008-10#1)(2008-5#2)(2010-4#1)
cross-linking process of the resist##2##5##(2007-12#2)
cross-linking process##4##2##(1993-11#1)(2007-12#2)(2009-12#1)
cross-linking reaction##5##2##(1992-3#1)(1994-5#4)
cross-linking reagent##3##2##(1992-3#1)(1995-6#1)(2008-6#1)
cross-linking studies##2##2##(1994-6#1)(1995-6#1)
cross-linking to##2##2##(1993-11#1)(1995-5#1)
cross-linking was##2##2##(1990-7#1)(1995-2#1)
cross-linking with glutaraldehyde##5##3##(2008-10#5)
cross-linking with##9##2##(1990-2#1)(1994-5#1)(2008-10#6)(2008-4#1)
cross-linking##106##1##(1990-2#1)(1990-5#2)(1990-7#5)(1991-2#3)(1991-5#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-11#9)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#5)(1994-6#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#5)(1997-2#1)(2007-12#4)(2008-10#18)(2008-11#3)(2008-2#4)(2008-4#4)(2008-5#10)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-4#3)(2012-2#1)(2012-3#2)(2013-1#2)
cross-links are##2##2##(2008-2#1)(2009-9#1)
cross-links between molecules that are in close proximity##2##8##(2008-2#2)
cross-links between##3##2##(2008-1#1)(2008-2#2)
cross-links of##2##2##(1992-6#1)(2013-7#1)
cross-links##27##1##(1990-8#1)(1992-3#1)(1992-6#2)(1993-11#4)(1994-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#6)(2008-7#1)(2009-12#1)(2009-9#1)(2010-4#1)(2013-7#1)
cross-match before##2##2##(1997-5#2)
cross-match##3##1##(1997-5#2)(2011-2#1)
cross-matched##2##1##(2008-11#1)(2011-2#1)
cross-matches) performed##2##2##(2011-1#2)
cross-matching##9##1##(1997-5#2)(2011-1#2)(2011-2#4)(2011-3#1)
cross-membrane potential##2##2##(2008-10#2)
cross-modal and delayed response&quot##2##4##(2008-8#2)
cross-modal##10##1##(1990-11#1)(2008-5#3)(2008-8#5)(2012-1#1)
cross-national##5##1##(1993-2#2)(1996-2#1)(2008-3#1)(2012-2#1)
cross-over design##2##2##(2007-12#1)(2008-2#1)
cross-over study##2##2##(1990-12#1)(2009-4#1)
cross-over##13##1##(1990-12#1)(1991-8#1)(1992-10#1)(1993-1#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)
cross-phase modulation##9##2##(2007-11#6)(2007-12#3)
cross-polarization and magic angle spinning nuclear magnetic resonance##2##8##(2008-10#1)(2013-8#1)
cross-polarization and##3##2##(1997-7#1)(2008-10#1)(2013-8#1)
cross-polarization##7##1##(1997-7#1)(2008-10#2)(2008-3#3)(2013-8#1)
cross-polarized four-wave mixing##2##3##(2008-2#2)
cross-polarized##9##1##(2007-12#1)(2008-2#3)(2008-3#5)
cross-protect##2##1##(2008-10#2)
cross-protection experiments##2##2##(2008-10#2)
cross-protection##11##1##(1991-8#1)(1997-3#2)(1997-6#1)(2008-10#2)(2008-8#3)(2011-2#2)
cross-react with the##2##3##(1995-11#1)(1997-1#1)
cross-react with##8##2##(1990-5#1)(1992-6#1)(1995-11#2)(1997-1#1)(2006-10#1)(2008-4#1)(2008-7#1)
cross-react##10##1##(1990-5#2)(1992-6#1)(1995-11#2)(1995-6#1)(1997-1#1)(2006-10#1)(2008-4#1)(2008-7#1)
cross-reacted with polyclonal##2##3##(1997-6#1)(2008-10#1)
cross-reacted with the##2##3##(1996-2#1)(1997-4#1)
cross-reacted with##13##2##(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-2#2)(1997-4#1)(1997-6#1)(2008-10#4)
cross-reacted##16##1##(1992-6#1)(1993-12#1)(1993-2#2)(1993-9#1)(1995-12#1)(1996-2#2)(1997-4#1)(1997-6#1)(2008-10#6)
cross-reacting##2##1##(1991-12#1)(1992-12#1)
cross-reaction of##3##2##(1991-12#1)(2008-11#2)
cross-reaction was observed##2##3##(2008-11#1)(2010-4#1)
cross-reaction with##3##2##(1995-8#1)(2008-10#1)(2013-8#1)
cross-reaction##12##1##(1990-5#1)(1991-12#1)(1995-8#1)(2008-10#2)(2008-11#5)(2010-4#1)(2013-8#1)
cross-reactions##4##1##(2008-10#3)(2008-7#1)
cross-reactive epitopes##2##2##(2008-5#2)
cross-reactive##12##1##(1991-2#1)(1992-3#1)(1992-6#1)(2008-10#2)(2008-11#1)(2008-5#4)(2011-2#1)(2012-2#1)
cross-reactivities##4##1##(1994-11#1)(2008-10#2)(2008-9#1)
cross-reactivity against##2##2##(2008-10#1)(2009-12#1)
cross-reactivity between##3##2##(1994-11#1)(2008-4#1)(2011-2#1)
cross-reactivity for##2##2##(2008-10#2)
cross-reactivity of##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
cross-reactivity to##3##2##(1995-11#1)(1997-2#1)(2008-10#1)
cross-reactivity was##2##2##(2008-10#2)
cross-reactivity with antibodies##2##3##(1991-9#1)(1993-11#1)
cross-reactivity with##6##2##(1990-11#1)(1991-9#1)(1992-3#1)(1993-11#1)(2008-10#1)(2008-9#1)
cross-reactivity##30##1##(1990-11#1)(1990-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#1)(1997-2#1)(2008-10#14)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)
cross-reactivity)##2##1##(2008-10#2)
cross-reacts with##3##2##(1992-12#1)(1993-9#1)(1997-1#1)
cross-resistance between##2##2##(2008-7#1)(2011-2#1)
cross-resistance to##4##2##(2008-5#1)(2011-2#1)(2013-1#2)
cross-resistance##13##1##(2008-10#3)(2008-5#2)(2008-7#1)(2011-2#4)(2013-1#3)
cross-resistant to camptothecin##2##3##(1994-8#2)
cross-resistant to##8##2##(1991-3#1)(1992-3#1)(1994-8#3)(2008-5#3)
cross-section of the##3##3##(1992-9#1)(2008-7#1)(2009-11#1)
cross-section of##4##2##(1992-9#1)(1997-3#1)(2008-7#1)(2009-11#1)
cross-section##14##1##(1992-9#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-7#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#1)
cross-sectional analysis##2##2##(1991-5#1)(1997-3#1)
cross-sectional and##2##2##(1995-2#1)(2012-3#1)
cross-sectional area of the##3##4##(2008-2#1)(2010-12#1)(2013-8#1)
cross-sectional area of##7##3##(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
cross-sectional area was##3##3##(2008-5#1)(2009-3#1)(2012-2#1)
cross-sectional area##17##2##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#2)(2010-12#1)(2012-2#1)(2013-3#1)(2013-8#1)
cross-sectional areas##2##2##(1995-5#1)(2012-2#1)
cross-sectional data##2##2##(2011-2#2)
cross-sectional descriptive study##2##3##(2011-1#1)(2011-2#1)
cross-sectional descriptive##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
cross-sectional design##4##2##(2008-4#1)(2010-2#1)(2012-5#1)(2013-8#1)
cross-sectional imaging of##4##3##(2007-11#1)(2007-12#1)(2012-2#1)(2013-1#1)
cross-sectional imaging##11##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#2)(2012-2#3)(2013-1#1)
cross-sectional mortality##2##2##(2011-2#2)
cross-sectional observational study##2##3##(2012-12#1)(2013-1#1)
cross-sectional sample##3##2##(1994-11#1)(2008-3#1)(2010-3#1)
cross-sectional shape##2##2##(2008-2#1)(2008-7#1)
cross-sectional studies##2##2##(1994-3#1)(2012-2#1)
cross-sectional study based on##2##4##(2011-1#1)(2011-2#1)
cross-sectional study of##7##3##(1996-1#1)(1996-2#1)(2007-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
cross-sectional study to##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
cross-sectional study was carried out in##3##6##(2011-1#1)(2011-2#1)(2013-8#1)
cross-sectional study was carried out##8##5##(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-8#1)
cross-sectional study was conducted with##2##5##(2008-10#1)(2011-2#1)
cross-sectional study was conducted##6##4##(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
cross-sectional study was performed##2##4##(2008-10#1)(2013-1#1)
cross-sectional study was##22##3##(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
cross-sectional study with##3##3##(2010-3#1)(2010-9#1)(2012-12#1)
cross-sectional study##79##2##(1993-11#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#2)(2010-10#5)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#14)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#6)
cross-sectional survey##13##2##(1994-11#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-7#1)(2008-9#2)(2011-1#2)(2011-2#2)(2013-1#1)
cross-sectional surveys##3##2##(1997-4#1)(2009-7#1)(2013-1#1)
cross-sectional##199##1##(1991-5#1)(1993-11#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#2)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#26)(2012-12#13)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#19)(2013-3#1)(2013-8#10)
cross-sections of the##2##3##(2007-11#1)(2008-11#1)
cross-sections of##4##2##(2007-11#1)(2008-11#2)(2011-2#1)
cross-sections##13##1##(1996-7#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#1)
cross-sensitivity##4##1##(1995-5#1)(2008-10#3)
cross-shaped grid bandpass##2##3##(2008-3#2)
cross-sibling influences##2##2##(2011-2#2)
cross-species amplification##2##2##(2008-10#1)(2008-5#1)
cross-species chromosome painting##2##3##(2010-3#2)
cross-species##12##1##(1993-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-3#2)(2012-2#1)(2013-1#2)
cross-spectrum##2##1##(2008-3#1)(2010-5#1)
cross-stimulation##3##1##(2008-9#3)
cross-talk between the##5##3##(1994-12#1)(1997-1#1)(2008-10#1)(2008-4#1)(2009-10#1)
cross-talk between##12##2##(1994-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-10#3)(2009-6#1)
cross-talk in##2##2##(2008-4#1)(2008-9#1)
cross-talk noise##2##2##(2008-2#1)(2008-3#1)
cross-talk performance##2##2##(2008-2#2)
cross-talk reduction##4##2##(2008-2#3)(2008-3#1)
cross-talk to the##2##3##(1995-5#2)
cross-talk with##2##2##(2008-2#1)(2012-2#1)
cross-talk##36##1##(1994-12#1)(1995-5#3)(1996-2#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-2#10)(2008-3#4)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-6#1)(2009-8#1)(2012-2#1)
cross-training##3##1##(1995-12#1)(1996-1#1)(2008-11#1)
cross-type&quot##3##1##(2010-8#3)
cross-validated correlation coefficient##2##3##(1995-3#1)(2009-3#1)
cross-validated##10##1##(1995-3#2)(1996-1#1)(2007-12#2)(2009-3#2)(2011-2#1)(2012-3#2)
cross-validation method##5##2##(2008-10#5)
cross-validation predictive densities##2##3##(2010-3#2)
cross-validation##24##1##(2007-11#2)(2008-10#12)(2008-12#1)(2008-3#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-8#1)
crossbar network##2##2##(2008-3#2)
crossbar switch##3##2##(2008-2#2)(2008-3#1)
crossbar switches##4##2##(2008-2#1)(2008-3#3)
crossbar##13##1##(2008-2#5)(2008-3#8)
crossbills##4##1##(2013-1#4)
crossbred##6##1##(2009-4#1)(2010-2#1)(2012-2#4)
crossbreeding##3##1##(1994-12#1)(2008-5#2)
crossbridges##4##1##(1995-2#4)
crossed by##2##2##(2008-3#1)(2009-7#1)
crossed focused##3##2##(2008-3#3)
crossed gratings##3##2##(2008-2#1)(2008-3#2)
crossed or##2##2##(2007-8#1)(2008-10#1)
crossed polarizers##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
crossed the##3##2##(1995-2#1)(2008-10#1)(2008-12#1)
crossed to##4##2##(2008-10#4)
crossed waveguide##2##2##(2007-12#1)(2007-9#1)
crossed with a##3##3##(2008-10#3)
crossed with two##2##3##(2008-10#1)(2008-9#1)
crossed with##19##2##(2008-10#14)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
crossed##61##1##(1991-8#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
crossed-over##2##1##(2008-3#1)(2011-2#1)
crosses and##3##2##(2008-10#2)(2011-2#1)
crosses between Columbia and##2##4##(2008-10#2)
crosses between resistant and susceptible##2##5##(2008-10#2)
crosses between resistant##4##3##(2008-10#4)
crosses between the resistant##3##4##(2008-10#3)
crosses between##23##2##(1995-8#1)(2008-10#17)(2008-5#2)(2008-8#1)(2009-12#1)(2012-3#1)
crosses in##4##2##(2008-12#1)(2009-10#1)(2009-12#1)(2012-3#1)
crosses indicated##2##2##(2008-10#2)
crosses involving##3##2##(2008-10#3)
crosses of##12##2##(2008-10#10)(2009-12#2)
crosses the##7##2##(1990-7#1)(1994-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)
crosses were made between##3##4##(2008-10#2)(2009-12#1)
crosses were made##4##3##(2008-10#3)(2009-12#1)
crosses were performed##2##3##(2008-10#2)
crosses were##12##2##(2008-10#11)(2009-12#1)
crosses with##5##2##(2008-10#5)
crosses##112##1##(1990-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(2008-10#77)(2008-12#4)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#7)(2011-2#1)(2012-2#1)(2012-3#4)
crosses)##3##1##(2008-10#2)(2008-8#1)
crossing HAI##2##2##(2011-1#2)
crossing an##2##2##(1994-1#1)(2007-11#1)
crossing for##4##2##(1994-3#2)(1995-12#1)(1997-3#1)
crossing method##2##2##(2008-10#2)
crossing of both##2##3##(1996-2#1)(2007-12#1)
crossing of##4##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)
crossing over##3##2##(1995-8#1)(2008-12#1)(2008-7#1)
crossing the##9##2##(1992-2#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-9#1)
crossing to##2##2##(1994-3#1)(2008-8#1)
crossing##56##1##(1990-3#1)(1992-2#1)(1993-8#1)(1994-1#1)(1994-3#6)(1995-12#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-4#1)(1997-3#2)(2007-11#4)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#2)
crossings##9##1##(1993-8#1)(2008-2#2)(2008-3#2)(2008-6#2)(2012-12#2)
crosslink formation in##2##3##(1991-9#1)(2008-10#1)
crosslink formation##4##2##(1991-9#1)(2008-10#3)
crosslink under##2##2##(1993-8#2)
crosslink##10##1##(1991-9#1)(1993-8#2)(2008-10#5)(2009-9#1)(2010-11#1)
crosslinked by##4##2##(1993-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
crosslinked fibers##3##2##(1995-2#3)
crosslinked knedel-like (SCK) nanoparticles##2##4##(2009-9#2)
crosslinked to##3##2##(1993-3#1)(1993-8#1)(1995-2#1)
crosslinked with glutaraldehyde##2##3##(2008-10#1)(2008-5#1)
crosslinked with##4##2##(2008-10#3)(2008-5#1)
crosslinked##33##1##(1992-8#1)(1993-3#2)(1993-8#1)(1995-2#5)(2008-10#12)(2008-11#1)(2008-5#4)(2009-9#2)(2010-12#1)(2010-2#1)(2010-6#1)(2013-1#2)
crosslinker##3##1##(1995-2#1)(2008-10#1)(2013-8#1)
crosslinking and##2##2##(2008-1#1)(2008-10#1)
crosslinking density##2##2##(2010-6#2)
crosslinking of##7##2##(1991-2#1)(1992-8#1)(1995-2#3)(2008-4#1)(2012-2#1)
crosslinking with##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
crosslinking##29##1##(1991-2#2)(1992-11#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-2#4)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#2)(2012-2#1)
crosslinks were##2##2##(1991-9#1)(1993-3#1)
crosslinks##9##1##(1990-8#1)(1991-9#1)(1993-3#4)(1995-8#1)(2008-1#1)(2008-10#1)
crossmatch by##3##2##(2011-2#3)
crossmatch indicates##2##2##(2011-2#2)
crossmatch##8##1##(2008-9#1)(2011-2#7)
crossover design##4##2##(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)
crossover from##2##2##(1996-2#1)(2008-3#1)
crossover of the##2##3##(2008-10#1)(2008-3#1)
crossover point at##2##3##(2008-2#2)
crossover point##4##2##(2008-2#2)(2008-9#2)
crossover study to##4##3##(1996-12#1)(2007-7#1)(2008-1#1)(2013-1#1)
crossover study##8##2##(1996-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
crossover trial##3##2##(1993-11#1)(2008-5#1)(2012-2#1)
crossover##36##1##(1993-11#1)(1994-3#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#3)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
crossovers##2##1##(1992-2#1)(2007-12#1)
crossreacted strongly with##2##3##(1993-6#2)
crossreacted##3##1##(1991-12#1)(1993-6#2)
crossreactivity with##2##2##(1995-3#2)
crossreactivity##4##1##(1995-12#1)(1995-3#2)(1996-3#1)
crossroad##2##1##(1995-2#1)(2008-11#1)
crossroads##4##1##(1996-1#1)(1996-3#1)(1997-6#1)(2013-1#1)
crosstalk between##6##2##(2008-4#1)(2011-2#1)(2012-2#3)(2013-7#1)
crosstalk from cAMP pathway##2##4##(2008-11#2)
crosstalk in##2##2##(2008-11#1)(2008-7#1)
crosstalk##16##1##(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-7#1)
crotalid##2##1##(1994-6#1)(2007-12#1)
crotoxyphos and chlorfenvinphos in##2##4##(2008-10#2)
croup##9##1##(1990-8#3)(2007-12#2)(2008-11#3)(2008-8#1)
crow's##2##1##(2008-5#2)
crowd membership##3##2##(2009-7#3)
crowd##9##1##(2009-7#9)
crowded and##2##2##(2009-6#1)(2011-2#1)
crowded conditions##2##2##(2012-2#2)
crowded plant populations are##2##4##(2008-8#2)
crowded plant populations##3##3##(2008-8#3)
crowded##23##1##(1991-12#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-8#3)(2008-9#2)(2009-6#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
crowding is##2##2##(2009-8#1)(2012-2#1)
crowding out##2##2##(1992-3#2)
crowding##13##1##(1992-3#2)(1993-2#1)(1994-2#1)(2008-9#1)(2009-8#2)(2012-12#1)(2012-2#4)(2013-8#1)
crowds##4##1##(2008-3#1)(2009-10#1)(2009-7#2)
crown and cervical##2##3##(2011-2#2)
crown and root rot of asparagus##3##6##(2008-10#3)
crown and root rot of poinsettia##2##6##(2008-10#2)
crown and root rot of tomato##2##6##(2008-10#2)
crown and root rot of##8##5##(2008-10#8)
crown and root rot##15##4##(2008-10#15)
crown and##21##2##(2008-10#17)(2008-11#1)(2011-2#2)(2013-7#1)
crown at##2##2##(2013-1#1)(2013-7#1)
crown ether ring##2##3##(2008-10#2)
crown ether was##2##3##(2008-10#2)
crown ether##16##2##(1996-5#1)(2008-10#15)
crown ethers##16##2##(2008-10#16)
crown gall##7##2##(2008-10#6)(2011-2#1)
crown of##7##2##(2008-10#1)(2008-5#1)(2008-6#2)(2009-8#1)(2013-1#2)
crown outline##3##2##(2011-2#3)
crown rot of strawberry##3##4##(2008-10#3)
crown rot##9##2##(2008-10#9)
crown rust resistance gene##3##4##(2008-10#3)
crown rust resistance genes##2##4##(2008-10#2)
crown rust resistance in##4##4##(2008-10#4)
crown rust resistance##15##3##(2008-10#15)
crown rust##21##2##(2008-10#21)
crown size##2##2##(2008-9#2)
crown##145##1##(1990-5#1)(1996-5#1)(2007-12#1)(2008-10#103)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#4)(2009-8#1)(2011-2#13)(2012-3#2)(2013-1#11)(2013-7#2)
crown-rump length (r = 0##2##5##(1995-8#2)
crown-rump length##4##2##(1993-12#2)(1995-8#2)
crown/implant failures##2##2##(2013-1#2)
crowns (fine spatial##2##3##(2013-7#2)
crowns and##2##2##(2008-10#1)(2009-8#1)
crowns were##6##2##(2008-10#2)(2008-12#1)(2008-6#1)(2013-1#2)
crowns##32##1##(1990-12#1)(1995-9#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-7#1)(2009-8#2)(2013-1#7)(2013-7#4)
crucial and##2##2##(1996-2#1)(2008-11#1)
crucial aspects##2##2##(2008-11#1)(2008-8#1)
crucial component of the##2##4##(2007-8#1)(2009-11#1)
crucial component of##3##3##(2007-8#1)(2009-11#1)(2009-9#1)
crucial component##4##2##(1994-3#1)(2007-8#1)(2009-11#1)(2009-9#1)
crucial determinants of##2##3##(1997-1#1)(2008-7#1)
crucial determinants##3##2##(1992-8#1)(1997-1#1)(2008-7#1)
crucial factor##7##2##(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2012-1#1)(2012-3#1)
crucial factors##2##2##(1996-5#1)(2008-7#1)
crucial for a##2##3##(2009-8#1)(2012-3#1)
crucial for its##2##3##(1992-5#1)(2008-10#1)
crucial for normal##2##3##(1994-8#1)(2008-11#1)
crucial for obtaining##4##3##(1995-2#1)(2007-12#1)(2008-2#1)(2008-4#1)
crucial for survival##3##3##(2008-12#1)(2009-6#1)(2010-3#1)
crucial for the formation of##2##5##(2009-8#1)(2012-2#1)
crucial for the##14##3##(1994-12#1)(1994-2#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
crucial for their##3##3##(1991-2#1)(2007-8#1)(2009-7#1)
crucial for this##2##3##(2010-3#1)(2011-2#1)
crucial for understanding the##2##4##(1995-1#1)(2009-12#1)
crucial for understanding##3##3##(1995-1#1)(2008-6#1)(2009-12#1)
crucial for##72##2##(1991-2#2)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-4#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-11#2)(2010-3#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
crucial in the##4##3##(2007-12#1)(2008-9#1)(2011-2#1)(2012-1#1)
crucial in##17##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
crucial issues##2##2##(2007-5#1)(2008-4#1)
crucial parameters##2##2##(2008-12#1)(2008-5#1)
crucial question##2##2##(1990-12#1)(2008-7#1)
crucial role in the development of##3##6##(2008-6#1)(2011-2#1)(2013-1#1)
crucial role in the##17##4##(1993-6#1)(1994-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#3)(2013-1#1)
crucial role in##44##3##(1993-6#1)(1993-8#1)(1994-10#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
crucial role of##11##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
crucial role##66##2##(1992-10#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
crucial roles in##7##3##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-8#1)(2012-2#1)
crucial step in##2##3##(2008-9#1)(2009-8#1)
crucial steps##2##2##(2008-1#1)(2012-3#1)
crucial to improving##2##3##(2007-12#1)(2008-6#1)
crucial to the development of##2##5##(2008-11#2)
crucial to the##14##3##(1990-6#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
crucial to##49##2##(1990-6#1)(1991-12#1)(1993-3#1)(1997-2#1)(1997-3#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#2)
crucial##344##1##(1990-12#1)(1990-6#1)(1991-12#2)(1991-2#2)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#21)(2008-11#16)(2008-12#7)(2008-2#5)(2008-3#9)(2008-4#13)(2008-5#7)(2008-6#6)(2008-7#28)(2008-8#10)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#3)(2010-5#6)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#14)(2012-3#9)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#7)
crucially on##3##2##(1990-12#1)(1994-8#1)(2008-10#1)
crucially##7##1##(1990-12#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-2#1)(2010-9#1)(2012-1#1)
crucian carp (Carassius##2##3##(2008-8#1)(2008-9#1)
crucian carp##12##2##(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#5)(2010-8#1)
crucian##13##1##(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-5#5)(2010-8#1)
cruciate ligament injuries##2##3##(1990-6#2)
cruciate ligament reconstruction surgery##2##4##(2008-12#1)(2012-2#1)
cruciate ligament reconstruction##10##3##(2008-11#3)(2008-12#1)(2012-2#2)(2013-1#4)
cruciate ligament##34##2##(1990-6#2)(1997-8#2)(2007-8#6)(2008-11#3)(2008-12#1)(2009-1#1)(2009-7#1)(2012-2#3)(2012-3#1)(2013-1#14)
crucible##2##1##(1995-3#1)(2008-10#1)
crucifer isolates##4##2##(2008-10#4)
crucifer##7##1##(2008-10#6)(2011-2#1)
cruciferous hosts##5##2##(2008-10#5)
cruciferous plants##3##2##(2008-10#3)
cruciferous##11##1##(2008-10#11)
crucifers##3##1##(2008-10#3)
crude and##2##2##(2008-10#1)(2012-2#1)
crude antigen##2##2##(1996-12#1)(2008-10#1)
crude cell##3##2##(1994-5#1)(2008-10#1)(2012-2#1)
crude cells##2##2##(2008-12#2)
crude culture filtrate and partially purified chlorosis toxin##2##8##(2008-10#2)
crude death##2##2##(1997-7#1)(2013-1#1)
crude enzyme##3##2##(1994-12#1)(2008-6#1)(2010-3#1)
crude ether##2##2##(2008-10#2)
crude extract and##3##3##(2008-11#3)
crude extract of sweet potato root (Ipomoea batatas (L##2##9##(2008-10#2)
crude extract of the##2##4##(2011-1#2)
crude extract of##8##3##(2008-10#4)(2008-11#1)(2008-12#1)(2011-1#2)
crude extract##17##2##(2008-10#9)(2008-11#5)(2008-12#1)(2011-1#2)
crude extracts from##3##3##(1994-6#1)(1997-3#1)(2008-8#1)
crude extracts of##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
crude extracts##16##2##(1992-3#1)(1994-12#1)(1994-6#1)(1995-2#2)(1997-3#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-8#1)(2010-3#1)
crude fiber##2##2##(1993-9#1)(2012-2#1)
crude glycerol##4##2##(2013-1#4)
crude lipid##2##2##(1990-2#1)(1992-8#1)
crude membranes##2##2##(1991-9#1)(1995-2#1)
crude methanol##2##2##(2008-12#2)
crude oil and##2##3##(2008-10#2)
crude oil refinery wastewater##2##4##(2008-10#2)
crude oil samples##2##3##(2008-10#2)
crude oil##25##2##(2008-10#23)(2008-3#1)(2008-6#1)
crude oils and##3##3##(2008-10#2)(2008-3#1)
crude oils##10##2##(2008-10#7)(2008-3#3)
crude per-subject risk##2##3##(2012-2#2)
crude preparation of##2##3##(2008-7#1)(2008-9#1)
crude preparations##2##2##(1992-8#1)(1996-12#1)
crude protein content##2##3##(1997-4#1)(2008-12#1)
crude protein contents##2##3##(2008-12#1)(2010-2#1)
crude protein##9##2##(1997-4#2)(2008-12#3)(2008-4#1)(2010-2#3)
crude sample##2##2##(2008-10#1)(2008-4#1)
crude soil extracts##2##3##(2008-10#2)
crude tissue##3##2##(1996-12#3)
crude##177##1##(1990-2#3)(1990-6#2)(1990-8#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#5)(1996-12#5)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#2)(2008-1#4)(2008-10#60)(2008-11#10)(2008-12#12)(2008-2#2)(2008-3#5)(2008-4#7)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#3)(2010-3#3)(2011-1#2)(2011-2#1)(2012-2#6)(2013-1#7)
crudes##2##1##(2008-10#2)
cruel##2##1##(1993-9#1)(1995-5#1)
cruelty##2##1##(1994-2#1)(2012-12#1)
cruentata##7##1##(2008-8#4)(2013-7#3)
cruise##3##1##(2008-10#2)(2008-3#1)
cruising##2##1##(2008-3#1)(2008-9#1)
crural##5##1##(1993-9#1)(1997-8#1)(2009-9#1)(2011-2#1)(2011-3#1)
cruris##5##1##(2007-7#4)(2008-5#1)
crush injury##4##2##(2007-7#1)(2008-1#1)(2008-9#2)
crush##11##1##(1990-4#1)(1991-11#2)(1992-6#1)(1993-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-9#2)(2012-7#1)
crushed##15##1##(1992-6#1)(1996-12#3)(1997-5#1)(2008-10#8)(2013-1#2)
crushing##6##1##(1990-6#1)(1991-11#1)(2008-10#1)(2008-12#2)(2010-5#1)
crust##17##1##(1996-4#12)(1997-5#1)(2008-10#2)(2013-8#2)
crustacean brain##3##2##(2007-12#3)
crustacean species##2##2##(1994-11#1)(2008-6#1)
crustacean##20##1##(1990-2#2)(1994-11#1)(1994-8#1)(1995-11#1)(2007-12#5)(2008-10#1)(2008-5#5)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
crustaceans and##2##2##(2007-12#1)(2010-8#1)
crustaceans##20##1##(2007-12#8)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#3)
crustal##4##1##(1996-4#3)(2008-11#1)
crusting##3##1##(2007-7#1)(2008-2#2)
crutches##4##1##(1991-6#1)(2007-11#3)
cruzi strain DS##2##3##(2012-12#2)
cruzi strain##4##2##(2012-12#4)
cruzi##19##1##(1992-9#2)(1994-12#3)(1996-12#3)(2007-12#4)(2012-12#7)
cry##5##1##(1992-1#1)(1993-6#2)(2008-8#1)(2012-2#1)
cry1Ab gene##5##2##(2008-9#5)
cry1Ab##7##1##(2008-10#1)(2008-9#6)
cry1Ac and##3##2##(2011-2#3)
cry1Ac##4##1##(2011-2#4)
cryIA(b)##2##1##(2008-10#2)
cryIVB transcription##2##2##(1993-12#2)
cryIVB##6##1##(1993-12#6)
crycoid cartilage##2##2##(2013-7#2)
crying##3##1##(1995-1#1)(2010-4#1)(2011-2#1)
cryo-electron microscopy##2##2##(1997-4#1)(2008-5#1)
cryo-electron##4##1##(1997-4#1)(2008-5#3)
cryo-transmission electron##2##2##(2008-5#2)
cryoablation##3##1##(2010-8#1)(2011-2#2)
cryoconcentration was##2##2##(2011-2#2)
cryoconcentration##5##1##(2011-2#5)
cryofocussing##3##1##(2008-10#3)
cryogel membrane##2##2##(2008-10#2)
cryogel##4##1##(2008-10#2)(2012-1#2)
cryogenic cooling##2##2##(2007-12#1)(2008-3#1)
cryogenic methods##2##2##(1990-8#2)
cryogenic trap##4##2##(2008-10#4)
cryogenic##21##1##(1990-8#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#4)
cryogenically##3##1##(2007-11#1)(2008-10#1)(2008-11#1)
cryoglobulinemia##4##1##(1993-8#1)(2013-1#3)
cryoglobulinemic##2##1##(2008-1#1)(2012-2#1)
cryoinjury##2##1##(2010-6#2)
cryopreservation and##2##2##(1997-7#1)(2008-8#1)
cryopreservation of##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
cryopreservation##16##1##(1996-3#1)(1996-8#2)(1997-7#1)(2008-11#4)(2008-8#2)(2008-9#4)(2011-2#1)(2012-3#1)
cryopreserved in tris-based egg yolk extender##2##6##(2012-3#2)
cryopreserved in##3##2##(2008-9#1)(2012-3#2)
cryopreserved samples##2##2##(2008-9#2)
cryopreserved##13##1##(1996-3#1)(2008-11#2)(2008-9#7)(2012-3#3)
cryoprobes##3##1##(2009-11#3)
cryoprotectant##2##1##(2008-9#2)
cryoprotection##2##1##(1992-3#1)(1996-3#1)
cryoprotective##3##1##(1992-3#2)(2012-3#1)
cryoresponsive##3##1##(2008-11#3)
cryosectioned##2##1##(2008-7#1)(2011-1#1)
cryosections##3##1##(1993-9#1)(2008-2#1)(2008-4#1)
cryostat sections##2##2##(2008-10#1)(2008-4#1)
cryostat##5##1##(2008-10#2)(2008-3#1)(2008-4#2)
cryosurgery in##2##2##(1996-8#1)(1996-9#1)
cryosurgery##8##1##(1992-1#2)(1996-8#1)(1996-9#1)(2007-7#2)(2009-11#2)
cryotherapy##3##1##(2007-12#1)(2012-3#2)
crypt cells##2##2##(2008-8#2)
crypt##4##1##(1990-12#1)(2008-8#2)(2011-2#1)
cryptands##2##1##(1992-6#1)(2008-10#1)
cryptic site##2##2##(1991-2#2)
cryptic species##8##2##(2008-10#5)(2008-9#1)(2010-1#1)(2012-3#1)
cryptic##23##1##(1991-2#3)(1994-2#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#3)
cryptica##5##1##(2008-10#1)(2010-11#4)
cryptitis##4##1##(2011-2#4)
cryptococcal meningitis##6##2##(1991-2#1)(2007-7#1)(2007-8#1)(2011-2#3)
cryptococcosis and##2##2##(2012-3#2)
cryptococcosis in##3##2##(2008-5#3)
cryptococcosis##11##1##(2008-10#1)(2008-5#8)(2012-3#2)
cryptogein-treated tobacco plants##2##3##(2008-10#2)
cryptogenic stroke##3##2##(2007-10#1)(2008-11#1)(2008-7#1)
cryptogenic##8##1##(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2013-1#1)
cryptographic##3##1##(2008-2#2)(2010-8#1)
cryptorchidism and inguinal hernia##2##4##(2008-10#2)
cryptorchidism##6##1##(2008-10#6)
cryptosporidiosis in##3##2##(1996-12#1)(2008-5#1)(2013-8#1)
cryptosporidiosis were##2##2##(1996-12#1)(2013-1#1)
cryptosporidiosis##12##1##(1992-2#1)(1996-11#1)(1996-12#4)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#2)
cryptosporidium##3##1##(2012-2#1)(2013-8#2)
cryptoviolin##2##1##(1994-5#2)
crypts##6##1##(1990-12#1)(1991-12#1)(2009-12#1)(2011-2#2)(2013-1#1)
crystal a##2##2##(2007-11#1)(2012-12#1)
crystal also##2##2##(2007-11#1)(2007-12#1)
crystal and a##3##3##(1992-8#1)(2007-11#1)(2008-2#1)
crystal and solution##2##3##(1992-8#1)(2012-2#1)
crystal and the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
crystal and##22##2##(1992-8#2)(1995-3#1)(2007-11#6)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
crystal are compared##2##3##(2008-2#1)(2008-3#1)
crystal are##8##2##(1992-4#1)(2008-2#3)(2008-3#4)
crystal as a saturable absorber##2##5##(2007-11#2)
crystal as a##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
crystal as the##2##3##(2008-3#2)
crystal as##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#3)
crystal at room temperature##2##4##(2007-12#1)(2013-1#1)
crystal at##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
crystal axis##2##2##(2007-11#1)(2008-3#1)
crystal by use of a##2##5##(2007-11#1)(2007-12#1)
crystal by use of##7##4##(2007-11#1)(2007-12#3)(2008-3#3)
crystal by##16##2##(2007-11#1)(2007-12#8)(2008-10#2)(2008-2#1)(2008-3#4)
crystal can be##3##3##(2007-11#1)(2008-3#2)
crystal can##4##2##(2007-11#2)(2008-3#2)
crystal cut as a##2##4##(2007-12#1)(2008-3#1)
crystal data##2##2##(1997-7#1)(2010-2#1)
crystal electrode##3##2##(2008-10#3)
crystal face##2##2##(2008-3#1)(2008-7#1)
crystal faces##2##2##(2008-2#1)(2008-7#1)
crystal fiber##6##2##(2007-11#1)(2007-12#5)
crystal films##2##2##(2008-10#1)(2009-5#1)
crystal for##9##2##(2007-12#5)(2008-10#1)(2008-3#3)
crystal form I##3##3##(2008-8#3)
crystal form II##2##3##(2008-8#2)
crystal form of##2##3##(1993-8#1)(2008-10#1)
crystal form##12##2##(1992-9#1)(1993-8#1)(2008-10#1)(2008-8#6)(2008-9#3)
crystal formation##2##2##(1993-3#1)(2008-11#1)
crystal forms of human recombinant##2##5##(1992-8#2)
crystal forms were##2##3##(2008-8#1)(2009-11#1)
crystal forms##9##2##(1992-8#3)(2008-8#3)(2009-11#3)
crystal generates##2##2##(2007-12#1)(2008-3#1)
crystal grown##2##2##(2007-12#1)(2008-3#1)
crystal growth was##2##3##(2008-10#1)(2009-11#1)
crystal growth##7##2##(2008-10#2)(2008-4#3)(2009-11#1)(2013-1#1)
crystal has a##2##3##(1996-5#1)(2008-2#1)
crystal has been developed##2##4##(2008-10#1)(2008-2#1)
crystal has been##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#2)
crystal has##9##2##(1996-5#1)(2008-10#2)(2008-2#3)(2008-3#1)(2013-1#2)
crystal have been##2##3##(2007-12#1)(2008-2#1)
crystal in a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
crystal in the##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
crystal in##11##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
crystal inside a##2##3##(2007-11#1)(2007-12#1)
crystal inside the##3##3##(2007-12#3)
crystal inside##5##2##(2007-11#1)(2007-12#4)
crystal is demonstrated##2##3##(2007-12#2)
crystal is described##2##3##(2007-11#1)(2008-3#1)
crystal is of##2##3##(2007-11#1)(2008-10#1)
crystal is placed##2##3##(2007-12#1)(2008-3#1)
crystal is proposed##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
crystal is used##2##3##(2007-12#2)
crystal is##30##2##(1996-5#1)(1997-7#1)(2007-11#6)(2007-12#7)(2008-10#2)(2008-2#3)(2008-3#9)(2013-1#1)
crystal lasers##2##2##(2007-12#1)(2008-3#1)
crystal length##3##2##(2007-12#1)(2008-2#2)
crystal lengths##2##2##(2007-11#1)(2008-3#1)
crystal materials##4##2##(2008-10#2)(2008-2#1)(2009-12#1)
crystal measured##2##2##(2007-11#1)(2008-3#1)
crystal methamphetamine use##2##3##(2013-1#2)
crystal microbalance##28##2##(2008-10#27)(2008-6#1)
crystal morphologies##2##2##(1995-6#1)(2008-5#1)
crystal nephropathy##2##2##(2008-8#2)
crystal of##12##2##(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#2)
crystal on the##2##3##(2007-11#1)(2008-3#1)
crystal on##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
crystal operating##2##2##(2007-11#1)(2007-12#1)
crystal orientation##4##2##(2007-11#1)(2008-3#3)
crystal packing##2##2##(1993-8#1)(2010-4#1)
crystal permits##2##2##(2007-11#2)
crystal phase##4##2##(2008-3#1)(2009-7#1)(2012-2#1)(2013-8#1)
crystal properties##2##2##(2008-3#2)
crystal protein-encoding##2##2##(1993-12#2)
crystal pumped by##2##3##(2007-12#1)(2008-3#1)
crystal pumped##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
crystal quality (bulk LIDT##2##4##(2007-11#2)
crystal quality and##2##3##(2007-11#1)(2008-2#1)
crystal quality##4##2##(2007-11#3)(2008-2#1)
crystal rotation##2##2##(2008-3#2)
crystal screening##2##2##(2008-11#2)
crystal sensor array##2##3##(2008-10#2)
crystal sensor##3##2##(2007-11#1)(2008-10#2)
crystal showed##2##2##(2007-12#1)(2008-2#1)
crystal size##5##2##(1995-6#1)(2008-2#1)(2008-3#1)(2013-8#2)
crystal standard##2##2##(2008-3#2)
crystal structure analysis##2##3##(1996-5#1)(2007-11#1)
crystal structure determined##3##3##(1991-3#1)(1995-11#1)(1997-7#1)
crystal structure for##2##3##(1994-5#1)(1997-9#1)
crystal structure of a##4##4##(1991-5#1)(2010-10#1)(2013-8#2)
crystal structure of allophycocyanin from red algaePorphyra yezoensis##2##8##(2008-8#2)
crystal structure of allophycocyanin from##3##5##(2008-8#3)
crystal structure of the trp##2##5##(1994-3#2)
crystal structure of the##13##4##(1990-7#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-8#2)(2012-2#1)(2013-8#1)
crystal structure of##45##3##(1990-7#1)(1991-11#2)(1991-5#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-7#1)(2007-11#2)(2008-8#5)(2008-9#1)(2009-11#1)(2010-10#4)(2011-1#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#3)
crystal structure was determined##2##4##(1996-5#1)(1997-7#1)
crystal structure was##4##3##(1992-12#1)(1996-5#1)(1997-7#1)(2008-8#1)
crystal structure##73##2##(1990-7#1)(1991-11#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-8#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#4)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-7#3)(1997-9#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#7)(2008-9#2)(2009-11#2)(2010-10#5)(2011-1#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#4)
crystal structures of homologous##2##4##(1994-5#2)
crystal structures of two##2##4##(1995-5#1)(1996-5#1)
crystal structures of##14##3##(1992-8#1)(1994-5#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-6#1)(2008-10#1)(2009-8#1)(2011-1#1)
crystal structures##21##2##(1992-8#2)(1994-5#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-5#1)(1997-7#2)(2007-11#2)(2007-6#1)(2008-10#1)(2009-11#1)(2009-8#1)(2011-1#1)
crystal substrates##2##2##(2008-3#2)
crystal surface##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
crystal temperature##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
crystal that is##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
crystal that##10##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)
crystal thickness##2##2##(2008-2#1)(2008-3#1)
crystal to##11##2##(1992-8#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#3)
crystal used##2##2##(2007-12#1)(2008-2#1)
crystal via an##2##3##(2007-11#1)(2008-10#1)
crystal violet (CV)##2##3##(2008-10#2)
crystal violet and##2##3##(2008-10#2)
crystal violet by##2##3##(2008-10#2)
crystal violet staining##2##3##(1990-12#1)(2008-8#1)
crystal violet##23##2##(1990-12#1)(1991-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
crystal was demonstrated##2##3##(2007-12#1)(2008-3#1)
crystal was obtained##2##3##(2007-12#1)(2008-3#1)
crystal was used##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
crystal was##11##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
crystal waveguides##7##2##(2007-11#4)(2007-12#3)
crystal were measured##2##3##(2008-2#1)(2008-3#1)
crystal were##3##2##(2008-2#1)(2008-3#2)
crystal with a##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
crystal with an absorption##2##4##(2007-12#1)(2008-2#1)
crystal with the##2##3##(2007-11#1)(2007-12#1)
crystal with##25##2##(2007-11#8)(2007-12#6)(2008-2#4)(2008-3#6)(2008-8#1)
crystal##881##1##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-8#3)(1992-12#2)(1992-3#3)(1992-4#3)(1992-8#13)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#8)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-2#6)(1996-5#5)(1997-7#12)(1997-9#1)(2006-4#2)(2007-11#142)(2007-12#172)(2007-6#1)(2008-1#1)(2008-10#107)(2008-11#5)(2008-12#1)(2008-2#86)(2008-3#162)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#21)(2008-9#7)(2009-11#9)(2009-12#3)(2009-5#4)(2009-7#1)(2009-8#1)(2010-10#5)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#11)(2013-7#2)(2013-8#10)
crystal's##2##1##(2007-11#2)
crystal)##2##1##(2007-12#1)(2008-10#1)
crystallin##5##1##(1991-6#1)(1992-8#3)(1993-6#1)
crystalline and amorphous##2##3##(2008-10#1)(2008-6#1)
crystalline and cross-linked glucose##2##4##(2008-10#2)
crystalline and##9##2##(1992-8#2)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)
crystalline arrays##2##2##(1992-9#1)(2007-12#1)
crystalline axes##2##2##(2008-3#2)
crystalline characteristics##2##2##(2008-2#1)(2008-5#1)
crystalline inclusions that##2##3##(2008-10#1)(2008-5#1)
crystalline inclusions##3##2##(2008-10#1)(2008-5#2)
crystalline lattice##2##2##(1993-11#1)(2008-10#1)
crystalline samples##2##2##(1992-8#1)(2008-4#1)
crystalline silica##3##2##(2008-10#1)(2009-12#2)
crystalline state##2##2##(2008-10#2)
crystalline structure##2##2##(2008-3#1)(2008-7#1)
crystalline structures##2##2##(2008-10#1)(2008-3#1)
crystalline##103##1##(1990-2#1)(1990-3#1)(1990-9#1)(1992-3#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-8#1)(1994-3#2)(1995-11#1)(1996-2#2)(1996-5#3)(1997-4#1)(2006-4#1)(2007-11#2)(2007-12#5)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#4)(2009-12#3)(2010-12#2)(2010-6#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
crystallinity and##3##2##(2007-11#2)(2013-8#1)
crystallinity of the##3##3##(2008-10#2)(2013-1#1)
crystallinity of##6##2##(1995-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#1)
crystallinity##17##1##(1995-11#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#2)
crystallins##2##1##(1990-12#1)(1992-8#1)
crystallisation of the##2##3##(2007-12#1)(2008-10#1)
crystallisation of##3##2##(1992-9#1)(2007-12#1)(2008-10#1)
crystallisation##6##1##(1992-9#1)(2007-12#1)(2008-10#4)
crystallite##3##1##(2008-10#1)(2009-11#1)(2010-4#1)
crystallites##5##1##(2007-12#2)(2008-10#2)(2008-3#1)
crystallization and preliminary##2##3##(2008-4#1)(2008-8#1)
crystallization and##4##2##(1990-8#1)(1995-8#1)(2008-4#1)(2008-8#1)
crystallization conditions##6##2##(2008-10#1)(2008-4#3)(2009-11#2)
crystallization in##2##2##(1993-3#1)(2008-3#1)
crystallization of the##3##3##(1996-2#1)(2008-4#1)(2008-5#1)
crystallization of##7##2##(1996-2#2)(2007-12#1)(2008-4#2)(2008-5#2)
crystallization trials##2##2##(2008-4#1)(2012-2#1)
crystallization##41##1##(1990-8#1)(1993-3#1)(1995-8#1)(1996-2#3)(2007-12#3)(2007-5#1)(2008-10#4)(2008-3#8)(2008-4#8)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#4)(2010-10#1)(2012-2#1)(2013-8#1)
crystallize in the monoclinic##2##4##(1997-7#2)
crystallize in the##3##3##(1997-7#2)(2008-5#1)
crystallize##4##1##(1997-7#2)(2008-4#1)(2008-5#1)
crystallized in##7##2##(1996-2#1)(2008-4#1)(2008-8#1)(2008-9#3)(2010-10#1)
crystallized##17##1##(1991-3#1)(1992-12#1)(1992-4#1)(1996-2#1)(1996-5#1)(2007-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-10#1)(2012-1#1)
crystallizes from n-hexane at##2##4##(1997-7#2)
crystallizes in the monoclinic space group C2/m##2##7##(1996-2#1)(1997-7#1)
crystallizes in the monoclinic space group P2(1)/c##3##7##(1996-2#2)(2007-11#1)
crystallizes in the monoclinic space group##7##6##(1996-2#3)(1997-7#3)(2007-11#1)
crystallizes in the monoclinic##8##4##(1996-2#3)(1997-7#3)(2007-11#1)(2013-1#1)
crystallizes in the orthorhombic space group##2##6##(1996-2#2)
crystallizes in the triclinic space group##3##6##(1996-2#1)(2007-11#2)
crystallizes in the triclinic##4##4##(1996-2#1)(1997-7#1)(2007-11#2)
crystallizes in the##16##3##(1996-2#8)(1997-7#4)(2007-11#3)(2013-1#1)
crystallizes in##17##2##(1993-8#1)(1996-2#8)(1997-7#4)(2007-11#3)(2013-1#1)
crystallizes##20##1##(1993-8#1)(1996-2#9)(1997-7#6)(2007-11#3)(2013-1#1)
crystallizing##2##1##(1994-8#1)(2008-5#1)
crystallographic R##2##2##(1995-5#1)(2008-9#1)
crystallographic analysis of##2##3##(1991-3#1)(2007-11#1)
crystallographic analysis##3##2##(1990-12#1)(1991-3#1)(2007-11#1)
crystallographic asymmetric unit##2##3##(1992-9#1)(2008-8#1)
crystallographic data##3##2##(1992-8#1)(1994-6#1)(2011-3#1)
crystallographic investigations of##3##3##(2008-8#1)(2010-2#2)
crystallographic phases##3##2##(2008-10#1)(2008-2#2)
crystallographic##41##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#3)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-2#2)(2011-2#1)(2011-3#1)
crystallographically##5##1##(1996-2#2)(2006-4#1)(2008-5#1)(2012-12#1)
crystallography and NMR##2##3##(2012-2#1)(2013-1#1)
crystallography and##5##2##(1993-11#1)(1996-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
crystallography has##3##2##(2008-4#3)
crystallography of##2##2##(1997-4#1)(2008-7#1)
crystallography##39##1##(1991-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1994-8#1)(1995-3#1)(1996-2#3)(1996-5#1)(1997-4#2)(1997-7#1)(2006-4#2)(2007-11#1)(2008-10#2)(2008-4#9)(2008-7#3)(2009-10#1)(2009-11#2)(2012-2#1)(2013-1#2)
crystals and a##2##3##(2007-11#1)(2008-2#1)
crystals and##17##2##(1992-8#1)(1992-9#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#5)(2009-12#1)(2012-2#1)
crystals are##9##2##(1992-9#1)(1995-6#1)(2007-12#2)(2008-2#2)(2008-3#2)(2012-2#1)
crystals as##5##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#2)
crystals at the##2##3##(2007-11#1)(2008-3#1)
crystals at##6##2##(1995-6#1)(2007-11#1)(2008-3#4)
crystals by the##2##3##(2007-11#1)(2008-3#1)
crystals by use of##2##4##(2007-11#1)(2008-3#1)
crystals by##10##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#4)(2009-12#1)
crystals can##3##2##(2007-12#2)(2008-3#1)
crystals diffract##2##2##(2008-8#2)
crystals doped with##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
crystals exhibit##2##2##(1992-8#1)(2010-12#1)
crystals for second-harmonic generation##2##4##(2007-12#1)(2008-3#1)
crystals for##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)
crystals formed##2##2##(1995-6#1)(2010-4#1)
crystals have been##3##3##(1992-9#1)(2007-11#1)(2008-3#1)
crystals have##6##2##(1992-9#2)(2007-11#1)(2008-3#2)(2008-9#1)
crystals in a##2##3##(2007-11#1)(2008-3#1)
crystals in the##5##3##(1995-6#1)(2006-10#1)(2008-2#1)(2008-3#2)
crystals in##12##2##(1995-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-12#1)
crystals is proposed for##2##4##(2007-11#1)(2008-3#1)
crystals is##8##2##(2007-11#4)(2007-12#1)(2008-3#3)
crystals of cubic##2##3##(2007-11#1)(2008-3#1)
crystals of potassium titanyl phosphate##2##5##(2008-10#2)
crystals of the##8##3##(1992-11#1)(1993-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
crystals of##28##2##(1992-11#1)(1992-9#1)(1993-8#1)(1996-2#3)(2006-4#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#2)
crystals pumped##2##2##(2008-2#2)
crystals that are##2##3##(2007-11#1)(2008-3#1)
crystals that have##2##3##(2008-2#2)
crystals that##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
crystals to##7##2##(1992-9#1)(2007-11#2)(2007-12#1)(2008-3#3)
crystals under##2##2##(1996-12#1)(2008-3#1)
crystals was##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
crystals were##10##2##(1990-7#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2013-1#1)
crystals with different##2##3##(2008-3#2)
crystals with high crystal quality##2##5##(2007-11#2)
crystals with two##2##3##(1996-2#1)(2007-12#1)
crystals with##15##2##(1996-2#1)(2007-11#5)(2007-12#2)(2008-2#2)(2008-3#4)(2009-8#1)
crystals##358##1##(1990-12#1)(1990-7#1)(1991-11#2)(1992-11#2)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#8)(1993-11#1)(1993-8#1)(1995-3#2)(1995-6#7)(1996-12#2)(1996-2#4)(1997-7#1)(2006-10#2)(2006-4#8)(2007-11#61)(2007-12#46)(2008-10#13)(2008-11#4)(2008-2#47)(2008-3#95)(2008-4#10)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#4)(2010-4#1)(2012-2#4)(2013-1#2)(2013-8#1)
crystals)##2##1##(2008-3#2)
cs##2##1##(2008-7#2)
ct##4##1##(2008-4#3)(2010-4#1)
ctDNA##8##1##(2008-10#7)(2008-8#1)
ctr-EGR-Xa was##2##2##(1994-5#2)
ctr-EGR-Xa##3##1##(1994-5#3)
cu-doped##3##1##(2013-8#3)
cuadrijuga is##2##2##(2013-7#2)
cuadrijuga##7##1##(2013-7#7)
cube for##2##2##(2008-3#2)
cube##15##1##(2008-10#1)(2008-2#2)(2008-3#11)(2010-2#1)
cube-corner##3##1##(2008-3#3)
cubense race four##2##3##(2008-10#2)
cubense suggests that##2##3##(2008-10#2)
cubense##14##1##(2008-10#14)
cubensis isolate##2##2##(2008-10#2)
cubensis##13##1##(2008-10#13)
cubes##6##1##(1996-2#1)(2008-3#4)(2008-6#1)
cubic and##2##2##(2007-12#1)(2008-3#1)
cubic crystals##2##2##(2007-11#1)(2008-3#1)
cubic dispersion##2##2##(2007-11#1)(2007-12#1)
cubic nonlinear optical##2##3##(2007-11#2)
cubic nonlinearities in##2##3##(2007-11#2)
cubic nonlinearities##4##2##(2007-11#2)(2007-12#2)
cubic nonlinearity induced by##2##4##(2007-11#1)(2007-12#1)
cubic nonlinearity##6##2##(2007-11#1)(2007-12#5)
cubic optical nonlinearity of##2##4##(2007-12#2)
cubic rod-packing##2##2##(2008-5#2)
cubic simplex##2##2##(2008-5#2)
cubic symmetry is##2##3##(2007-11#2)
cubic symmetry##3##2##(2007-11#2)(2008-2#1)
cubic##55##1##(1991-5#1)(1995-2#1)(1995-3#1)(2007-11#12)(2007-12#16)(2008-10#2)(2008-2#4)(2008-3#7)(2008-5#6)(2009-9#1)(2010-3#2)(2010-7#1)(2013-8#1)
cubic-like##2##1##(2008-5#2)
cubic-phase plate##2##2##(2007-12#2)
cubic-phase##3##1##(2007-12#3)
cubital tunnel syndrome##5##3##(2008-12#1)(2008-9#4)
cubital tunnel##7##2##(2008-12#1)(2008-9#6)
cubital##8##1##(2008-12#1)(2008-7#1)(2008-9#6)
cubitus varus##2##2##(2008-7#1)(2009-3#1)
cubitus##3##1##(2008-7#1)(2009-3#1)(2013-1#1)
cuboid##2##1##(2009-10#2)
cuboidal##4##1##(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
cucumber (Cucumis sativus L##2##4##(2008-10#1)(2009-12#1)
cucumber (Cucumis sativus)##5##3##(2008-10#5)
cucumber (Cucumis##7##2##(2008-10#6)(2009-12#1)
cucumber and##6##2##(2008-10#3)(2008-4#2)(2010-10#1)
cucumber crop##2##2##(2008-10#2)
cucumber fruit##2##2##(2008-10#2)
cucumber leaves##4##2##(2008-10#4)
cucumber mosaic cucumovirus (CMV)##2##4##(2008-10#2)
cucumber mosaic cucumovirus##3##3##(2008-10#3)
cucumber mosaic virus (CMV) was##2##5##(2008-10#2)
cucumber mosaic virus (CMV)##5##4##(1997-6#1)(2008-10#3)(2012-2#1)
cucumber mosaic virus RNA##2##4##(1997-6#1)(2008-10#1)
cucumber mosaic virus in##2##4##(2008-10#2)
cucumber mosaic virus##12##3##(1997-6#2)(2008-10#9)(2012-2#1)
cucumber mosaic##15##2##(1997-6#2)(2008-10#12)(2012-2#1)
cucumber pathogens##4##2##(2008-10#4)
cucumber plants##5##2##(2008-10#5)
cucumber seedlings##3##2##(2008-10#3)
cucumber seeds##2##2##(2008-10#2)
cucumber was##2##2##(2008-12#1)(2009-12#1)
cucumber##94##1##(1997-6#2)(2008-10#80)(2008-12#1)(2008-4#2)(2008-5#1)(2009-12#4)(2010-10#1)(2012-2#1)(2013-8#2)
cucumber)##2##1##(2008-10#1)(2011-2#1)
cucumbers##3##1##(2007-5#1)(2008-10#2)
cucumerinum##6##1##(2008-10#6)
cucumeris)##2##1##(2008-10#2)
cucumovirus##4##1##(2008-10#4)
cucurbit crops##2##2##(2013-8#2)
cucurbit hosts##5##2##(2008-10#5)
cucurbit or##2##2##(2008-10#2)
cucurbit wilt##2##2##(2008-10#2)
cucurbit yellow stunting disorder virus##3##5##(2008-10#3)
cucurbit yellow vine disease (CYVD)##2##5##(2008-10#2)
cucurbit yellow##5##2##(2008-10#5)
cucurbit##23##1##(2008-10#20)(2011-2#1)(2013-8#2)
cucurbit-infecting Tobamoviruses##2##2##(2008-10#2)
cucurbit-infecting tobamovirus##2##2##(2008-10#2)
cucurbit-infecting##6##1##(2008-10#6)
cucurbitae PG isozymes##2##3##(2008-10#2)
cucurbitae in##2##2##(2008-10#2)
cucurbitae##12##1##(2008-10#8)(2011-2#3)(2013-8#1)
cucurbits in##2##2##(2008-10#1)(2013-8#1)
cucurbits##18##1##(2008-10#16)(2013-8#2)
cue and##2##2##(1990-12#1)(2009-8#1)
cue for sequential integration##2##4##(2009-9#2)
cue for the##2##3##(1995-5#1)(2012-2#1)
cue for##8##2##(1994-8#1)(1995-5#2)(2008-10#1)(2009-3#1)(2009-9#2)(2012-2#1)
cue in##3##2##(1990-12#1)(2007-12#1)(2008-8#1)
cue learning##4##2##(1993-12#4)
cue levels##2##2##(2013-8#2)
cue than##3##2##(2008-1#2)(2013-8#1)
cue to##2##2##(2008-9#1)(2013-8#1)
cue was##4##2##(2008-11#1)(2008-2#2)(2013-8#1)
cue##55##1##(1990-12#4)(1993-12#4)(1993-5#1)(1993-9#1)(1994-8#1)(1995-5#2)(2007-12#1)(2008-1#5)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#5)(2008-8#5)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#7)
cue'##2##1##(2008-9#2)
cue-based parsing##2##2##(2007-12#1)(2008-1#1)
cue-based##5##1##(2007-12#3)(2008-1#1)(2008-8#1)
cue-dependent PM##2##2##(2008-1#2)
cue-dependent##3##1##(2008-1#3)
cue-paced foot##2##2##(2013-8#2)
cued word generation##2##3##(1996-2#2)
cued##13##1##(1994-8#3)(1996-2#2)(2008-11#2)(2008-3#1)(2010-5#4)(2010-8#1)
cueing##5##1##(2007-6#2)(2008-2#2)(2009-8#1)
cues and##6##2##(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
cues are##2##2##(1990-11#1)(2011-2#1)
cues available##2##2##(2008-1#1)(2008-9#1)
cues can be##3##3##(2008-6#1)(2008-9#1)(2009-9#1)
cues can##4##2##(2008-2#1)(2008-6#1)(2008-9#1)(2009-9#1)
cues for##2##2##(2008-5#1)(2008-6#1)
cues from the##2##3##(2008-5#1)(2009-3#1)
cues in##6##2##(1993-9#1)(1994-3#1)(2007-12#1)(2008-6#1)(2008-8#1)(2011-2#1)
cues may be##3##3##(2008-8#1)(2009-8#1)(2009-9#1)
cues of##3##2##(2009-9#1)(2010-8#2)
cues operate##2##2##(2013-8#2)
cues that##5##2##(1993-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
cues to##13##2##(2007-12#2)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-10#1)(2012-12#1)
cues were presented##2##3##(1995-11#1)(2008-11#1)
cues were##4##2##(1995-11#1)(2008-11#1)(2012-3#1)(2013-8#1)
cues when##2##2##(2009-5#1)(2010-8#1)
cues which##3##2##(1993-6#1)(1995-5#2)
cues##124##1##(1990-11#1)(1990-12#1)(1991-2#1)(1993-6#2)(1993-9#2)(1994-3#6)(1994-8#2)(1995-11#1)(1995-5#2)(1996-10#1)(1996-3#1)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#9)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#4)(2008-8#6)(2008-9#5)(2009-10#3)(2009-3#1)(2009-5#1)(2009-8#9)(2009-9#4)(2010-10#4)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#11)
cuff of the##3##3##(2008-2#2)(2011-2#1)
cuff of##5##2##(1993-1#1)(2007-8#1)(2008-2#2)(2011-2#1)
cuff tears##2##2##(1994-2#2)
cuff##38##1##(1991-12#5)(1993-1#1)(1994-2#5)(1995-1#1)(1996-6#1)(2007-11#11)(2007-8#1)(2008-12#2)(2008-2#2)(2009-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
cuisines##3##1##(2012-2#3)
culinary##6##1##(1994-3#1)(2008-10#1)(2008-12#1)(2012-2#3)
cull##3##1##(1996-3#1)(2008-10#2)
culled##3##1##(1997-2#1)(2008-10#1)(2012-3#1)
culling##5##1##(1995-12#1)(2007-6#1)(2011-3#2)(2012-2#1)
culminate in the##2##3##(1995-1#1)(2011-1#1)
culminate in##3##2##(1995-1#1)(2010-9#1)(2011-1#1)
culminate##4##1##(1995-1#1)(2008-8#1)(2010-9#1)(2011-1#1)
culminated in a##2##3##(2008-11#1)(2010-4#1)
culminated in##4##2##(1993-3#1)(2008-11#2)(2010-4#1)
culminates##2##1##(1994-2#1)(1996-5#1)
culminating in the##3##3##(1991-12#1)(1995-6#1)(2008-7#1)
culminating in##6##2##(1991-12#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-7#2)
culmorum##23##1##(2008-10#23)
culmorum-inoculated##2##1##(2008-10#2)
culprit##4##1##(1991-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
cultivable##3##1##(2008-9#1)(2013-7#2)
cultivar AB 136##3##3##(2008-10#3)
cultivar Aichi Asahi##2##3##(2008-10#2)
cultivar CPS 1##2##3##(2008-10#2)
cultivar also##2##2##(2008-10#2)
cultivar and geographical region##2##4##(2008-10#2)
cultivar and geographical##3##3##(2008-10#3)
cultivar and##13##2##(2008-10#12)(2011-10#1)
cultivar had##2##2##(2008-10#2)
cultivar in##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
cultivar mixtures##6##2##(2008-10#6)
cultivar of##8##2##(1997-2#1)(2008-10#7)
cultivar on##3##2##(2008-10#3)
cultivar resistance##3##2##(2008-10#2)(2011-10#1)
cultivar specificity##3##2##(2008-10#3)
cultivar susceptibility##3##2##(2008-10#3)
cultivar susceptible to both##2##4##(2008-10#2)
cultivar susceptible to##3##3##(2008-10#3)
cultivar that##3##2##(2008-10#3)
cultivar to##2##2##(2008-10#2)
cultivar was##10##2##(2008-10#10)
cultivar with##3##2##(2008-10#3)
cultivar##215##1##(1997-2#1)(2008-10#195)(2008-11#1)(2008-12#9)(2008-9#1)(2011-10#4)(2011-2#2)(2012-2#2)
cultivar-preferential infection by the two genotypes##2##6##(2008-10#2)
cultivars accumulated more mycotoxins##2##4##(2008-10#2)
cultivars after##2##2##(2008-10#2)
cultivars against##2##2##(2008-10#2)
cultivars also##2##2##(2008-10#2)
cultivars and in##4##3##(2008-10#4)
cultivars and isolates##2##3##(2008-10#2)
cultivars and one##2##3##(2008-10#2)
cultivars and selections##3##3##(2008-10#3)
cultivars and##33##2##(2008-10#31)(2011-2#1)(2013-8#1)
cultivars are##7##2##(2008-10#5)(2008-8#1)(2011-10#1)
cultivars as##2##2##(2008-10#2)
cultivars at##4##2##(2008-10#3)(2011-2#1)
cultivars based on##2##3##(2008-10#2)
cultivars by##4##2##(2008-10#3)(2011-2#1)
cultivars carrying##2##2##(2008-10#2)
cultivars containing##2##2##(2008-10#2)
cultivars differing in their##2##4##(2008-10#2)
cultivars differing in##4##3##(2008-10#3)(2008-12#1)
cultivars for##4##2##(2008-10#3)(2009-8#1)
cultivars from the##2##3##(2008-10#2)
cultivars from##5##2##(2008-10#5)
cultivars grown in##2##3##(2008-10#2)
cultivars grown##3##2##(2008-10#3)
cultivars had##4##2##(2008-10#4)
cultivars has##2##2##(2008-10#1)(2008-5#1)
cultivars have##3##2##(2008-10#3)
cultivars in the greenhouse##2##4##(2008-10#2)
cultivars in the##5##3##(2008-10#5)
cultivars in##18##2##(2008-10#17)(2008-12#1)
cultivars indicated that##2##3##(2008-10#2)
cultivars inoculated with two##2##4##(2008-10#2)
cultivars is##3##2##(2008-10#2)(2008-8#1)
cultivars like##2##2##(2008-10#2)
cultivars may##3##2##(2008-10#3)
cultivars of Brassica##2##3##(2008-10#1)(2011-1#1)
cultivars of both##3##3##(2008-10#3)
cultivars of rice##4##3##(2008-10#4)
cultivars of soybean with##2##4##(2008-10#2)
cultivars of soybean##3##3##(2008-10#3)
cultivars of wheat##4##3##(2008-10#4)
cultivars of##37##2##(2008-10#30)(2008-12#4)(2008-5#1)(2008-6#1)(2011-1#1)
cultivars or##2##2##(2008-10#2)
cultivars over##2##2##(2008-10#2)
cultivars representing##2##2##(2008-10#2)
cultivars resistant to##3##3##(2008-10#3)
cultivars showed##3##2##(2008-10#2)(2011-2#1)
cultivars such as##2##3##(2008-10#2)
cultivars tested were susceptible to##2##5##(2008-10#2)
cultivars tested##7##2##(2008-10#7)
cultivars than in##3##3##(2008-10#3)
cultivars that##6##2##(2008-10#5)(2009-10#1)
cultivars through##2##2##(2008-10#2)
cultivars to##5##2##(2008-10#5)
cultivars used##2##2##(2008-10#1)(2008-9#1)
cultivars using##3##2##(2008-10#2)(2008-5#1)
cultivars was##10##2##(2008-10#9)(2008-5#1)
cultivars were analyzed##2##3##(2008-10#2)
cultivars were crossed with##3##4##(2008-10#3)
cultivars were evaluated using race##2##5##(2008-10#2)
cultivars were grown##2##3##(2008-10#2)
cultivars were inoculated##2##3##(2008-10#1)(2011-10#1)
cultivars were resistant##2##3##(2008-10#2)
cultivars were used as##2##4##(2008-10#1)(2008-12#1)
cultivars were##41##2##(2008-10#36)(2008-12#3)(2011-10#1)(2012-4#1)
cultivars when##2##2##(2008-10#1)(2011-10#1)
cultivars while##2##2##(2008-10#2)
cultivars with different levels of##2##5##(2008-10#2)
cultivars with different##5##3##(2008-10#5)
cultivars with low susceptibility##2##4##(2008-10#2)
cultivars with lower##2##3##(2008-10#2)
cultivars with##23##2##(2008-10#21)(2011-10#1)(2012-4#1)
cultivars##514##1##(2007-1#1)(2008-10#435)(2008-12#27)(2008-5#6)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-10#11)(2011-2#12)(2012-1#2)(2012-2#3)(2012-4#3)(2013-8#1)
cultivars)##2##1##(2008-10#2)
cultivate##8##1##(1995-12#1)(2008-11#2)(2008-12#2)(2008-2#1)(2010-4#1)(2013-1#1)
cultivated and wild##3##3##(2008-10#2)(2012-3#1)
cultivated and##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)
cultivated areas##2##2##(2008-10#2)
cultivated durum##2##2##(2008-10#2)
cultivated for##3##2##(2008-11#1)(2008-2#1)(2011-3#1)
cultivated from##2##2##(1992-11#1)(2008-5#1)
cultivated in a##8##3##(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)
cultivated in continuous##2##3##(2008-11#1)(2008-12#1)
cultivated in the presence of##3##5##(2008-11#2)(2008-5#1)
cultivated in the##5##3##(2007-1#1)(2008-11#3)(2008-5#1)
cultivated in vitro##2##3##(2008-10#2)
cultivated in##31##2##(1994-5#1)(2007-1#1)(2008-10#8)(2008-11#12)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)
cultivated potatoes in the##2##4##(2008-10#2)
cultivated potatoes##5##2##(2008-10#5)
cultivated rice##5##2##(2009-10#5)
cultivated with##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
cultivated##120##1##(1990-12#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-1#1)(2007-1#1)(2008-1#1)(2008-10#49)(2008-11#21)(2008-12#6)(2008-2#1)(2008-5#5)(2008-6#7)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#5)(2010-10#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#4)
cultivates##2##1##(1995-3#1)(2013-7#1)
cultivating the##2##2##(2008-10#1)(2008-11#1)
cultivating##7##1##(1994-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#3)
cultivation and##10##2##(2008-10#2)(2008-11#6)(2008-7#1)(2010-7#1)
cultivation by##2##2##(1996-7#1)(2008-11#1)
cultivation conditions##7##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2013-1#1)
cultivation for##4##2##(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#1)
cultivation in the##2##3##(2008-10#1)(2008-11#1)
cultivation in##10##2##(1991-12#1)(1994-11#1)(2008-10#3)(2008-11#4)(2008-7#1)
cultivation method##2##2##(2008-10#1)(2008-6#1)
cultivation of a##7##3##(2008-11#5)(2008-6#1)(2008-7#1)
cultivation of recombinant##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
cultivation of##42##2##(1994-3#1)(1994-5#3)(1997-7#1)(2006-11#1)(2008-10#3)(2008-11#17)(2008-5#1)(2008-6#4)(2008-7#4)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
cultivation on##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
cultivation period##2##2##(2008-11#1)(2011-2#1)
cultivation system##2##2##(2008-11#2)
cultivation systems##2##2##(1994-11#1)(2010-11#1)
cultivation temperature##3##2##(2008-11#2)(2011-2#1)
cultivation time##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
cultivation under##2##2##(2008-11#2)
cultivation vessels##2##2##(2008-11#2)
cultivation was##4##2##(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)
cultivation were##2##2##(2008-10#1)(2008-7#1)
cultivation with##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
cultivation##184##1##(1990-5#1)(1991-12#1)(1994-11#3)(1994-3#3)(1994-5#9)(1995-12#1)(1995-6#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-11#1)(2008-1#1)(2008-10#27)(2008-11#79)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#16)(2008-7#11)(2008-9#2)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#3)
cultivation)##2##1##(2013-1#2)
cultivations in##2##2##(2008-10#1)(2008-11#1)
cultivations##19##1##(1993-6#1)(1994-3#3)(1997-2#1)(2008-10#2)(2008-11#4)(2008-7#7)(2011-2#1)
culturability##2##1##(2008-9#2)
culturable bacteria##6##2##(2008-10#5)(2012-3#1)
culturable##17##1##(2008-10#12)(2008-7#2)(2008-9#1)(2010-4#1)(2012-3#1)
culturable-bacterial groups##2##2##(2013-7#2)
culturable-bacterial##3##1##(2013-7#3)
cultural adaptation of##2##3##(2008-4#2)
cultural adaptation##4##2##(2008-4#2)(2013-1#2)
cultural and linguistic##4##3##(1997-2#1)(2010-5#1)(2013-1#2)
cultural and other##2##3##(2008-1#1)(2008-4#1)
cultural and political##3##3##(2008-1#1)(2008-11#1)(2008-9#1)
cultural and##19##2##(1997-1#1)(1997-2#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
cultural approach##2##2##(2008-1#2)
cultural appropriateness##2##2##(2010-4#2)
cultural aspects##3##2##(1993-11#1)(2011-2#1)(2012-12#1)
cultural awareness##2##2##(2008-11#2)
cultural background##2##2##(2008-5#1)(2012-2#1)
cultural barriers##2##2##(1991-3#1)(2010-4#1)
cultural beliefs##6##2##(2009-10#5)(2009-11#1)
cultural care##2##2##(2007-2#1)(2010-8#1)
cultural change process##2##3##(1994-1#2)
cultural change##4##2##(1993-2#1)(1994-1#2)(2008-11#1)
cultural characteristics##2##2##(2008-10#2)
cultural competence in##2##3##(2008-1#1)(2008-12#1)
cultural competence##6##2##(2008-1#2)(2008-11#1)(2008-12#2)(2012-3#1)
cultural competency##2##2##(1997-3#1)(2008-7#1)
cultural context of##2##3##(2008-4#1)(2012-12#1)
cultural context##6##2##(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-8#1)
cultural contexts##2##2##(2007-12#1)(2012-3#1)
cultural controls##2##2##(1991-12#1)(2008-10#1)
cultural differences in responses to##2##5##(2007-12#2)
cultural differences in##3##3##(1992-5#1)(2007-12#2)
cultural differences##7##2##(1992-5#1)(2007-10#1)(2007-12#2)(2008-1#2)(2012-12#1)
cultural dimensions of##2##3##(1995-12#1)(1997-3#1)
cultural dimensions##3##2##(1995-12#1)(1997-3#1)(2012-12#1)
cultural diversity and##2##3##(1994-12#1)(2012-12#1)
cultural diversity in maternity##2##4##(2012-3#2)
cultural diversity in the##2##4##(2008-11#1)(2008-8#1)
cultural diversity in##5##3##(2008-11#2)(2008-8#1)(2012-3#2)
cultural diversity issues##2##3##(1997-2#2)
cultural diversity##13##2##(1992-2#1)(1994-12#1)(1996-1#2)(1997-2#2)(2008-11#2)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
cultural factors##4##2##(1995-12#1)(2007-12#1)(2010-3#1)(2012-12#1)
cultural heritage##5##2##(2008-10#4)(2008-11#1)
cultural influences##2##2##(2008-1#2)
cultural issues##5##2##(1995-1#1)(2008-1#2)(2010-8#1)(2011-1#1)
cultural needs##2##2##(2008-1#1)(2008-11#1)
cultural norms##4##2##(2008-1#1)(2008-11#1)(2010-5#1)(2012-12#1)
cultural objects##2##2##(2008-10#2)
cultural orientations were##2##3##(2011-2#2)
cultural orientations##3##2##(2011-2#3)
cultural origin##4##2##(1991-11#1)(1991-12#1)(2011-2#1)(2012-2#1)
cultural perspectives##2##2##(2009-6#2)
cultural practices and values##2##4##(2009-7#2)
cultural practices have##2##3##(2008-10#2)
cultural practices##11##2##(2008-1#1)(2008-10#5)(2009-7#4)(2010-8#1)
cultural relevance##2##2##(2008-4#1)(2010-3#1)
cultural sensitivity##2##2##(2009-6#1)(2010-6#1)
cultural shift##2##2##(2007-2#1)(2009-3#1)
cultural values and##2##3##(2008-1#1)(2013-8#1)
cultural values##6##2##(2008-1#3)(2008-11#1)(2009-10#1)(2013-8#1)
cultural##238##1##(1990-3#1)(1991-11#1)(1991-12#4)(1991-3#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#3)(1995-5#1)(1996-1#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(2007-10#1)(2007-12#4)(2007-2#2)(2008-1#26)(2008-10#29)(2008-11#17)(2008-12#9)(2008-3#1)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#10)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#5)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#1)(2010-8#8)(2011-1#3)(2011-2#8)(2012-12#14)(2012-2#7)(2012-3#6)(2013-1#6)(2013-8#3)
culturally appropriate care##3##3##(2011-1#1)(2013-8#2)
culturally appropriate##7##2##(2008-6#1)(2010-9#1)(2011-1#3)(2013-8#2)
culturally competent##4##2##(1997-2#1)(2009-5#1)(2010-8#1)(2011-2#1)
culturally diverse##5##2##(1997-2#2)(2008-1#1)(2008-7#1)(2012-2#1)
culturally relevant##4##2##(1992-2#1)(2009-5#1)(2010-3#1)(2012-3#1)
culturally safe health##2##3##(2008-1#1)(2011-1#1)
culturally sensitive knowledge##2##3##(2010-9#1)(2011-2#1)
culturally sensitive##10##2##(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
culturally specific##2##2##(2008-8#1)(2009-5#1)
culturally##48##1##(1992-2#1)(1997-2#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#4)(2008-11#2)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#3)(2009-6#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
culturally-sensitive##2##1##(2008-1#1)(2008-4#1)
culture additive##2##2##(2008-11#2)
culture additives##2##2##(2008-11#1)(2012-12#1)
culture also##4##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
culture and from##2##3##(2008-11#1)(2012-2#1)
culture and gender##2##3##(2008-11#1)(2011-2#1)
culture and in##7##3##(1990-12#1)(1992-11#1)(1993-12#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-9#1)
culture and serology##2##3##(2007-2#2)
culture and the##9##3##(1997-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-2#1)(2012-2#1)
culture and were##2##3##(1993-9#1)(2008-5#1)
culture and##91##2##(1990-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#3)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#22)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#1)
culture are the##2##3##(1996-6#1)(2008-1#1)
culture are##10##2##(1991-12#1)(1992-5#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)
culture as a##2##3##(1993-12#1)(2008-7#1)
culture as the##2##3##(2008-11#1)(2008-5#1)
culture as##7##2##(1993-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
culture assay##4##2##(1995-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
culture assays##5##2##(1990-12#1)(2008-5#1)(2008-9#1)(2011-2#2)
culture at 37 degrees C##2##5##(1995-2#1)(2008-11#1)
culture at a##2##3##(2008-10#1)(2008-11#1)
culture at the##5##3##(1995-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
culture at##11##2##(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2010-8#1)
culture bacteria##2##2##(2008-9#1)(2011-1#1)
culture before##2##2##(2007-12#1)(2008-4#1)
culture broth of Hericium erinaceus##2##5##(2008-11#2)
culture broth of##3##3##(2008-11#2)(2008-12#1)
culture broth##5##2##(1997-2#1)(2008-11#2)(2008-12#1)(2008-6#1)
culture broths##2##2##(1991-12#1)(2008-10#1)
culture but##4##2##(1993-2#1)(1994-1#1)(1995-6#1)(2008-10#1)
culture by##7##2##(2008-10#1)(2008-11#5)(2008-12#1)
culture cell assays##2##3##(2008-9#2)
culture cells##9##2##(1993-3#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#3)
culture collections##4##2##(2008-10#4)
culture condition##6##2##(2008-11#5)(2008-5#1)
culture conditions and##5##3##(1991-5#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#1)
culture conditions for maintaining##2##4##(2008-11#2)
culture conditions for##6##3##(2008-11#6)
culture conditions that##2##3##(1996-12#1)(2008-11#1)
culture conditions to##2##3##(2008-11#2)
culture conditions were##2##3##(2008-11#1)(2010-5#1)
culture conditions##43##2##(1990-12#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-11#1)(1995-11#3)(1996-12#2)(2008-10#2)(2008-11#19)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#2)(2012-3#1)
culture confirmed##3##2##(2008-1#2)(2008-11#1)
culture could be maintained##2##4##(2008-6#1)(2008-7#1)
culture could be##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
culture could##5##2##(2008-11#3)(2008-6#1)(2008-7#1)
culture did not##4##3##(2008-10#1)(2008-11#2)(2008-6#1)
culture dish##5##2##(1995-12#1)(2008-11#4)
culture dishes##3##2##(1995-11#1)(2008-11#2)
culture engineering##3##2##(2008-11#3)
culture environment##2##2##(2008-11#1)(2008-5#1)
culture even##2##2##(1992-9#1)(2008-11#1)
culture exhibited##2##2##(2008-11#1)(2009-6#1)
culture experiment##3##2##(1996-2#1)(1996-8#1)(2008-8#1)
culture experiments##8##2##(1990-12#1)(2008-10#1)(2008-11#2)(2008-5#4)
culture express##3##2##(1991-5#1)(1992-3#1)(1993-3#1)
culture filtrate of RC-2##3##4##(2008-10#3)
culture filtrate of##7##3##(1991-5#1)(2008-10#6)
culture filtrate was##2##3##(2008-10#2)
culture filtrate##14##2##(1991-5#1)(2008-10#12)(2008-8#1)
culture filtrates of##7##3##(2008-10#6)(2008-11#1)
culture filtrates##14##2##(2008-10#12)(2008-11#1)(2008-6#1)
culture flasks##2##2##(2008-11#2)
culture fluid##2##2##(1995-2#1)(2008-10#1)
culture fluids of##2##3##(2008-10#1)(2008-9#1)
culture fluids##5##2##(1995-2#1)(2008-10#1)(2008-9#3)
culture for a##2##3##(2008-11#1)(2008-8#1)
culture for##22##2##(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#8)(2008-7#6)(2008-8#1)(2008-9#2)(2013-1#1)
culture from##4##2##(1992-2#1)(2008-8#2)(2013-1#1)
culture has been##2##3##(2008-11#1)(2008-9#1)
culture has##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
culture in a serum-free medium##2##5##(1993-6#1)(2008-11#1)
culture in a##4##3##(1993-6#1)(1995-2#1)(2008-11#1)(2008-5#1)
culture in the##8##3##(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)
culture in##38##2##(1992-2#1)(1993-6#1)(1994-11#1)(1995-2#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#12)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
culture induced##2##2##(2008-10#1)(2008-11#1)
culture is a##2##3##(2008-6#1)(2008-8#1)
culture is the##2##3##(2008-8#1)(2012-2#1)
culture is##21##2##(1993-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)(2008-8#4)(2010-6#1)(2012-2#3)(2013-1#2)
culture material##4##2##(2008-5#4)
culture matrix##4##2##(2008-11#1)(2008-7#1)(2011-2#2)
culture may be##4##3##(2008-11#2)(2008-4#2)
culture may##7##2##(1991-2#1)(1993-2#1)(2008-11#2)(2008-4#2)(2012-12#1)
culture media and##2##3##(2008-10#1)(2010-8#1)
culture media of##3##3##(1994-2#1)(1994-6#1)(2008-11#1)
culture media was##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
culture media##42##2##(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-12#2)(2008-10#10)(2008-11#10)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
culture medium and##8##3##(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-6#1)(2013-1#1)
culture medium composition##2##3##(2008-11#2)
culture medium for##4##3##(1997-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
culture medium in##2##3##(1992-8#1)(1994-5#1)
culture medium of##9##3##(1990-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-4#1)(2009-3#2)
culture medium on##2##3##(2008-7#1)(2011-2#1)
culture medium or##2##3##(1993-9#1)(1995-2#1)
culture medium was##7##3##(1994-5#1)(1994-6#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
culture medium##120##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-6#4)(1993-9#6)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#3)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#1)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#29)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-6#1)(2013-1#2)
culture method##9##2##(1991-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-3#1)(2012-2#3)
culture methodology##2##2##(2008-11#2)
culture methods##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2012-3#1)
culture mode##5##2##(2008-11#5)
culture model##11##2##(1994-9#1)(1995-9#2)(1996-12#1)(1997-4#1)(2007-12#1)(2008-5#3)(2008-7#1)(2009-3#1)
culture models##4##2##(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)
culture modes##2##2##(2008-11#2)
culture months##2##2##(2013-7#2)
culture negative##2##2##(2007-7#1)(2008-1#1)
culture of CHO##2##3##(2008-11#2)
culture of Chinese hamster ovary cells##2##6##(2008-11#2)
culture of Chinese hamster ovary##3##5##(2008-11#3)
culture of L##2##3##(2008-6#2)
culture of a##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
culture of human hematopoietic cells##3##5##(2008-11#3)
culture of human##7##3##(2008-11#4)(2008-2#1)(2008-9#1)(2013-1#1)
culture of mammalian cells##2##4##(2008-11#2)
culture of mouse##2##3##(1994-9#1)(1995-3#1)
culture of rat##4##3##(1992-3#2)(2008-11#1)(2008-9#1)
culture of recombinant##2##3##(2008-7#2)
culture of the##9##3##(1994-2#1)(1997-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)
culture of##110##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-3#2)(1993-8#2)(1994-1#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-6#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#40)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#3)(2009-12#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
culture on##10##2##(2008-11#3)(2008-3#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-8#1)(2013-8#2)
culture or##11##2##(2008-10#3)(2008-11#3)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
culture parameters##2##2##(2008-11#2)
culture period of##2##3##(1996-5#1)(2008-11#1)
culture period to##2##3##(2008-11#1)(2009-11#1)
culture period##15##2##(1990-11#1)(1993-3#1)(1996-5#1)(2008-11#10)(2009-11#2)
culture plate##6##2##(1994-6#1)(2008-10#2)(2008-8#2)(2010-11#1)
culture plates##6##2##(2008-10#1)(2008-11#4)(2011-2#1)
culture pond##5##2##(2008-5#5)
culture procedure##2##2##(2008-4#2)
culture process##9##2##(1997-2#1)(2008-11#5)(2008-7#2)(2008-9#1)
culture processes##9##2##(2008-11#9)
culture production##3##2##(2008-11#3)
culture redox potential##3##3##(2008-11#2)(2008-7#1)
culture results in##2##3##(2008-11#1)(2008-9#1)
culture results##5##2##(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)
culture revealed##2##2##(2008-1#1)(2009-7#1)
culture samples##5##2##(2008-11#3)(2008-9#1)(2010-6#1)
culture showed##2##2##(2008-11#2)
culture solution##4##2##(2010-3#4)
culture studies of##2##3##(2008-11#1)(2008-6#1)
culture studies##6##2##(2008-11#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
culture supernatant##10##2##(1990-8#1)(1992-12#1)(1993-11#1)(1993-9#1)(2008-10#2)(2008-11#3)(2008-6#1)
culture supernatants of##2##3##(1997-2#1)(2008-10#1)
culture supernatants##13##2##(1990-12#1)(1990-2#1)(1993-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2011-3#1)
culture supernates##2##2##(2008-7#2)
culture supplement for##2##3##(1994-2#2)
culture supplement##3##2##(1994-2#2)(2008-11#1)
culture surface##2##2##(2008-11#1)(2012-5#1)
culture system for##5##3##(2008-10#1)(2008-11#2)(2009-12#1)(2012-12#1)
culture system has##2##3##(2008-7#1)(2008-9#1)
culture system of##2##3##(2008-11#1)(2012-12#1)
culture system was##2##3##(2008-11#1)(2008-8#1)
culture system were##2##3##(1992-3#1)(2008-10#1)
culture system with##2##3##(2008-10#1)(2008-11#1)
culture system##42##2##(1990-10#1)(1990-9#1)(1991-5#1)(1992-3#2)(1993-12#1)(1993-9#1)(2008-10#5)(2008-11#16)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#4)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
culture systems##24##2##(1992-2#1)(1994-5#1)(1997-2#1)(2008-11#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#1)
culture technique##3##2##(2008-10#1)(2008-11#2)
culture techniques##4##2##(1993-2#1)(2008-11#2)(2008-7#1)
culture technologies##2##2##(2008-11#1)(2011-3#1)
culture technology##3##2##(2008-11#3)
culture temperature##7##2##(1995-11#2)(2008-11#3)(2008-6#1)(2008-7#1)
culture than##2##2##(2008-11#2)
culture that##6##2##(1993-1#1)(1994-8#1)(1995-1#1)(2008-9#1)(2010-2#1)(2012-3#1)
culture the##4##2##(1992-5#2)(2008-10#1)(2008-11#1)
culture through##2##2##(1997-1#1)(2008-10#1)
culture time##2##2##(1993-8#1)(2008-11#1)
culture to##11##2##(1993-2#1)(2008-10#2)(2008-11#5)(2008-6#1)(2011-2#1)(2012-2#1)
culture under##6##2##(2008-10#1)(2008-11#5)
culture using a##2##3##(2008-11#1)(2008-7#1)
culture using##8##2##(2008-11#6)(2008-7#2)
culture via##2##2##(1991-12#1)(2011-2#1)
culture viability##2##2##(2008-11#2)
culture volume##3##2##(2008-11#2)(2008-7#1)
culture was investigated##2##3##(1995-3#1)(1995-5#1)
culture was negative##3##3##(2007-7#2)(2008-1#1)
culture was not##3##3##(1993-2#1)(1994-11#1)(2008-7#1)
culture was performed##2##3##(1990-2#1)(2008-11#1)
culture was positive for##2##4##(2007-8#1)(2013-8#1)
culture was very##2##3##(1991-12#1)(2008-11#1)
culture was##44##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-2#2)(1994-11#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#14)(2008-6#3)(2008-7#6)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
culture wells##2##2##(1994-9#1)(2008-10#1)
culture were compared##2##3##(2008-11#2)
culture were studied##2##3##(1996-2#1)(2008-11#1)
culture were##10##2##(1994-2#1)(1994-8#1)(1996-2#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#4)
culture when##2##2##(1995-8#1)(2008-6#1)
culture where##2##2##(2008-11#1)(2008-7#1)
culture with the##2##3##(2008-11#1)(2008-4#1)
culture with##15##2##(1990-12#1)(1994-5#1)(1996-12#1)(1997-1#1)(2008-11#6)(2008-3#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
culture within##3##2##(2010-10#1)(2011-2#2)
culture without##4##2##(1992-9#1)(2008-11#2)(2008-7#1)
culture##1706##1##(1990-10#1)(1990-11#7)(1990-12#10)(1990-2#4)(1990-5#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#2)(1991-5#7)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#7)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#8)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#10)(1993-3#7)(1993-6#6)(1993-8#6)(1993-9#11)(1994-1#4)(1994-11#8)(1994-12#5)(1994-2#11)(1994-3#2)(1994-5#5)(1994-6#11)(1994-8#9)(1994-9#4)(1995-1#5)(1995-11#8)(1995-12#11)(1995-2#10)(1995-3#12)(1995-5#4)(1995-6#4)(1995-8#6)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#12)(1996-2#6)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#7)(1997-2#5)(1997-3#7)(1997-4#8)(1997-6#4)(1997-7#3)(2006-6#1)(2007-10#7)(2007-11#4)(2007-12#3)(2007-2#3)(2007-6#2)(2007-7#15)(2007-8#4)(2007-9#1)(2008-1#14)(2008-10#145)(2008-11#588)(2008-12#17)(2008-2#13)(2008-3#3)(2008-4#30)(2008-5#53)(2008-6#33)(2008-7#84)(2008-8#40)(2008-9#62)(2009-10#5)(2009-11#4)(2009-12#10)(2009-2#1)(2009-3#11)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#4)(2009-8#3)(2010-10#7)(2010-11#5)(2010-12#7)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#6)(2011-1#14)(2011-2#39)(2011-3#2)(2012-1#2)(2012-12#9)(2012-2#26)(2012-3#16)(2012-5#2)(2012-6#2)(2013-1#32)(2013-7#5)(2013-8#9)
culture)##3##1##(2008-5#1)(2008-9#2)
culture-based##3##1##(1991-9#1)(2008-10#1)(2011-2#1)
culture-bound syndrome##2##2##(1991-12#1)(2012-2#1)
culture-dependent##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
culture-derived##2##1##(2008-10#1)(2008-11#1)
culture-independent##4##1##(2008-10#2)(2011-2#1)(2012-2#1)
culture-negative endocarditis##3##2##(1993-2#1)(1996-11#1)(2008-4#1)
culture-negative##6##1##(1993-12#1)(1993-2#1)(1996-11#2)(2008-4#1)(2011-2#1)
culture-positive##6##1##(1991-11#1)(2007-7#1)(2008-10#1)(2010-6#3)
cultured and##6##2##(2007-10#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)
cultured animal cells and##2##4##(2008-1#1)(2008-4#1)
cultured animal cells##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
cultured astrocytes##7##2##(1993-12#1)(1995-5#6)
cultured at##8##2##(1990-11#2)(1990-12#1)(1991-12#1)(2008-10#1)(2008-8#1)(2010-2#1)(2013-1#1)
cultured bovine aortic endothelial cells##6##5##(1990-12#2)(1990-2#2)(1991-5#1)(1993-8#1)
cultured bovine##7##2##(1990-12#2)(1990-2#2)(1991-5#1)(1993-8#1)(1995-5#1)
cultured by##2##2##(2008-9#1)(2013-1#1)
cultured cancer cells##2##3##(1992-5#1)(2007-11#1)
cultured cell##4##2##(1993-8#1)(1995-6#1)(2008-8#1)(2011-2#1)
cultured cells and##2##3##(2008-11#1)(2008-2#1)
cultured cells are##2##3##(1994-11#1)(2008-11#1)
cultured cells for##2##3##(1995-12#1)(2008-4#1)
cultured cells in##4##3##(1991-9#1)(1992-12#1)(1994-12#1)(2008-11#1)
cultured cells is##2##3##(2008-1#1)(2008-11#1)
cultured cells of##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
cultured cells to##3##3##(1994-11#2)(2008-11#1)
cultured cells using##2##3##(1994-9#1)(2008-11#1)
cultured cells were##4##3##(2008-11#1)(2008-6#2)(2009-12#1)
cultured cells with##4##3##(1994-11#1)(1995-12#1)(2008-4#1)(2008-9#1)
cultured cells##75##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#7)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-5#1)(1997-6#1)(2008-1#4)(2008-10#4)(2008-11#19)(2008-2#4)(2008-4#4)(2008-6#2)(2008-7#1)(2008-9#5)(2009-12#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
cultured cerebral##2##2##(1993-12#1)(1996-2#1)
cultured chick##2##2##(1996-5#1)(1997-2#1)
cultured colonic##2##2##(1993-9#1)(1994-9#1)
cultured cumulus##2##2##(2008-9#2)
cultured dorsal root##2##3##(1993-5#2)
cultured endothelial cells##6##3##(1990-2#1)(1990-5#1)(1991-2#1)(1993-3#1)(1994-5#1)(1995-11#1)
cultured endothelial##7##2##(1990-2#1)(1990-5#1)(1991-2#1)(1993-3#1)(1994-5#1)(1995-11#1)(2008-1#1)
cultured fetal##2##2##(1996-5#1)(2008-4#1)
cultured fibroblasts##6##2##(1990-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(2008-4#1)(2008-5#1)
cultured for 6 days##2##4##(1995-8#2)
cultured for a##2##3##(2008-11#1)(2008-4#1)
cultured for up to##2##4##(1992-8#1)(1995-11#1)
cultured for##14##2##(1992-8#2)(1993-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
cultured from the##3##3##(1991-3#1)(1997-1#1)(2008-5#1)
cultured from##11##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-2#1)(1995-12#1)(1997-1#2)(2008-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
cultured guinea pig chief cells##2##5##(1995-8#2)
cultured hepatocytes##4##2##(1992-12#1)(1993-3#1)(1993-6#1)(1996-5#1)
cultured hippocampal neurons by##2##4##(1995-2#1)(1996-12#1)
cultured hippocampal neurons##4##3##(1995-2#1)(1996-12#1)(1997-7#2)
cultured hippocampal##5##2##(1990-7#1)(1995-2#1)(1996-12#1)(1997-7#2)
cultured human cells##3##3##(1994-3#1)(2008-11#1)(2008-2#1)
cultured human osteoblast-like cells##2##4##(2008-11#2)
cultured human skin fibroblasts were##2##5##(2008-5#2)
cultured human skin fibroblasts##7##4##(1991-12#1)(1994-6#1)(2008-5#5)
cultured human##36##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-3#2)(1994-6#1)(1995-11#1)(1996-2#3)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#8)
cultured in HG##3##3##(1992-8#3)
cultured in MS##2##3##(2008-12#2)
cultured in a##7##3##(1994-8#1)(2008-10#3)(2008-11#2)(2008-9#1)
cultured in an##2##3##(2008-11#1)(2008-4#1)
cultured in both suspension and monolayer##2##6##(2008-11#2)
cultured in media##2##3##(1992-12#1)(2008-5#1)
cultured in monolayer##4##3##(2008-11#3)(2008-5#1)
cultured in serum-free medium##5##4##(1992-12#1)(1992-2#1)(1995-11#1)(2008-11#2)
cultured in suspension##5##3##(2008-11#5)
cultured in the medium containing##2##5##(2008-11#2)
cultured in the presence of a##2##6##(2008-4#1)(2008-6#1)
cultured in the presence of##13##5##(1992-5#1)(1992-8#1)(1993-3#1)(1995-3#1)(2008-11#5)(2008-4#2)(2008-6#1)(2011-3#1)
cultured in the##19##3##(1992-5#1)(1992-8#1)(1993-3#1)(1995-3#1)(2008-11#10)(2008-4#2)(2008-6#1)(2011-3#1)(2012-2#1)
cultured in vitro##10##3##(1993-3#1)(1996-2#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)
cultured in##102##2##(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#6)(1993-12#1)(1993-3#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#39)(2008-12#3)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-4#2)(2013-1#1)
cultured lymphocytes##4##2##(1990-8#2)(2008-4#2)
cultured mammalian cells and##2##4##(2008-4#1)(2012-3#1)
cultured mammalian cells##8##3##(1991-12#1)(1991-5#1)(2008-1#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
cultured mouse##6##2##(1990-11#1)(1990-7#2)(1995-11#1)(1996-5#1)(2008-11#1)
cultured myoblasts##2##2##(1997-1#2)
cultured neonatal rat##3##3##(1993-3#1)(1995-11#2)
cultured neonatal##4##2##(1993-3#1)(1993-6#1)(1995-11#2)
cultured neuronal cells##2##3##(1994-8#1)(1997-2#1)
cultured neuronal##3##2##(1994-8#1)(1997-2#2)
cultured neurons of rat cerebral cortex##2##6##(1992-12#2)
cultured neurons##8##2##(1992-12#3)(1994-5#1)(1995-5#1)(2008-11#2)(2012-2#1)
cultured normal and##2##3##(1994-8#1)(2008-4#1)
cultured normal human##3##3##(1994-6#1)(2008-5#1)(2008-8#1)
cultured normal##5##2##(1994-6#1)(1994-8#1)(2008-4#1)(2008-5#1)(2008-8#1)
cultured on a##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
cultured on the##5##3##(1993-3#1)(2008-11#4)
cultured on##34##2##(1992-3#1)(1993-3#2)(1995-2#1)(2008-10#2)(2008-11#16)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#3)(2012-1#1)(2012-5#1)
cultured osteoblast##2##2##(2008-11#2)
cultured osteoblast-like cells##2##3##(1990-12#1)(2008-11#1)
cultured porcine aortic endothelial cells##2##5##(1990-2#1)(1993-3#1)
cultured porcine##3##2##(1990-2#1)(1993-3#1)(1995-12#1)
cultured primary##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
cultured rat hepatocytes##8##3##(1990-7#2)(1990-8#1)(1993-3#1)(1993-6#2)(1995-12#1)(2008-7#1)
cultured rat pheochromocytoma##2##3##(1990-2#1)(2008-10#1)
cultured rat##27##2##(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-7#2)
cultured shoot##2##2##(2008-8#2)
cultured skin fibroblasts from##4##4##(1991-5#1)(1995-8#1)(1996-7#2)
cultured skin fibroblasts##7##3##(1991-5#3)(1995-8#1)(1996-7#2)(2008-5#1)
cultured skin##8##2##(1991-5#3)(1995-8#1)(1996-7#2)(2008-5#2)
cultured spermatogenic cysts##2##3##(2012-2#2)
cultured together##2##2##(2006-6#1)(2008-10#1)
cultured trophoblast cells##2##3##(1995-11#1)(2011-2#1)
cultured under different##2##3##(1991-6#1)(2008-5#1)
cultured under##11##2##(1991-6#1)(1992-8#1)(2008-11#4)(2008-5#2)(2008-9#1)(2011-2#1)(2012-4#1)
cultured vascular endothelial cells##3##4##(1991-12#1)(1991-9#1)(1994-6#1)
cultured vascular##5##2##(1991-12#1)(1991-9#1)(1992-9#1)(1993-3#1)(1994-6#1)
cultured with or without##2##4##(1992-8#1)(2008-6#1)
cultured with the##4##3##(1994-2#1)(1997-2#1)(2008-11#1)(2011-3#1)
cultured with##22##2##(1992-8#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(2007-2#1)(2008-11#7)(2008-6#1)(2008-8#1)(2011-3#1)(2013-1#1)(2013-8#1)
cultured##594##1##(1990-11#5)(1990-12#10)(1990-2#9)(1990-5#2)(1990-6#2)(1990-7#7)(1990-8#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#9)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#9)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#4)(1992-8#10)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#17)(1993-5#4)(1993-6#9)(1993-8#5)(1993-9#1)(1994-10#1)(1994-11#12)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#8)(1994-8#7)(1994-9#4)(1995-11#12)(1995-12#9)(1995-2#2)(1995-3#3)(1995-5#10)(1995-6#3)(1995-8#6)(1996-12#4)(1996-2#8)(1996-5#7)(1996-7#2)(1997-1#7)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#11)(2008-10#22)(2008-11#117)(2008-12#3)(2008-2#7)(2008-4#19)(2008-5#30)(2008-6#5)(2008-7#12)(2008-8#12)(2008-9#19)(2009-12#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#14)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2012-4#3)(2012-5#2)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#2)
culturedin##2##1##(2008-11#1)(2008-8#1)
cultures -##2##2##(2008-11#1)(2012-2#1)
cultures and antibiotic sensitivity tests##2##5##(1996-6#1)(2007-7#1)
cultures and in##2##3##(2008-11#1)(2008-4#1)
cultures and organotypic slices##2##4##(2009-9#2)
cultures and the##3##3##(1990-12#1)(2008-11#1)(2008-4#1)
cultures and##36##2##(1990-12#1)(1991-6#2)(1994-5#2)(1996-6#1)(2007-7#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-9#2)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
cultures are##14##2##(1990-7#2)(1991-9#1)(1994-11#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
cultures as a##2##3##(1990-7#1)(2012-4#1)
cultures as well as##3##4##(1997-6#1)(2008-2#1)(2011-1#1)
cultures as##5##2##(1990-7#1)(1997-6#1)(2008-2#1)(2011-1#1)(2012-4#1)
cultures at 37 degrees C##2##5##(1995-12#1)(2008-5#1)
cultures at the##3##3##(2008-11#1)(2008-7#2)
cultures at##13##2##(1994-8#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#3)(2010-12#1)
cultures because of##2##3##(1994-3#1)(2008-11#1)
cultures but##4##2##(1992-3#1)(1995-5#1)(1997-2#1)(2008-11#1)
cultures by##9##2##(1994-11#1)(1995-8#1)(2008-10#1)(2008-11#5)(2010-8#1)
cultures can##3##2##(1994-11#1)(2008-11#2)
cultures carrying##2##2##(2008-7#2)
cultures clash##2##2##(2007-9#1)(2010-3#1)
cultures compared to control##2##4##(1995-12#1)(2008-6#1)
cultures compared to##4##3##(1995-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
cultures containing##4##2##(1993-9#1)(2008-11#1)(2008-8#1)(2008-9#1)
cultures derived from##6##3##(1992-11#1)(1992-2#3)(2008-10#1)(2008-11#1)
cultures did not##2##3##(1996-7#1)(2008-11#1)
cultures during##2##2##(2008-11#1)(2008-6#1)
cultures exposed to##3##3##(1994-8#1)(2008-7#2)
cultures exposed##4##2##(1994-8#1)(2008-7#3)
cultures for##12##2##(1993-11#1)(2008-11#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-1#1)(2011-2#1)(2012-3#1)
cultures from the##2##3##(2007-8#1)(2008-11#1)
cultures from##20##2##(1990-3#1)(1991-12#3)(1993-12#1)(1993-9#1)(1995-5#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#2)(2010-3#2)(2010-8#1)(2011-2#1)(2013-8#1)
cultures grown in the##2##4##(1994-12#1)(2008-7#1)
cultures grown in##6##3##(1994-12#1)(1996-5#1)(2008-11#1)(2008-7#3)
cultures grown##8##2##(1994-12#1)(1996-11#1)(1996-5#1)(2008-11#1)(2008-7#4)
cultures had##3##2##(1992-3#1)(1993-2#1)(2008-11#1)
cultures has##2##2##(2008-11#1)(2008-6#1)
cultures have been##2##3##(2008-11#2)
cultures have##3##2##(2008-11#2)(2008-4#1)
cultures in order to##2##4##(2008-11#1)(2008-7#1)
cultures in the##2##3##(2008-10#1)(2008-11#1)
cultures in which##2##3##(2008-10#1)(2008-11#1)
cultures in##21##2##(1990-12#1)(1993-2#1)(1993-6#1)(2007-11#1)(2008-10#2)(2008-11#10)(2008-5#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-2#1)
cultures incubated##3##2##(2008-11#3)
cultures indicate##2##2##(1996-5#1)(2008-6#1)
cultures infected##5##2##(1994-6#1)(1997-6#1)(2008-11#2)(2008-7#1)
cultures is##7##2##(1995-9#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)
cultures maintained##2##2##(2008-11#1)(2013-7#1)
cultures may##2##2##(2008-11#1)(2011-1#1)
cultures obtained from##4##3##(1990-8#1)(1995-11#1)(1997-2#1)(2010-6#1)
cultures of H##3##3##(2008-10#3)
cultures of a murine##2##4##(2008-11#1)(2008-7#1)
cultures of a##4##3##(2008-11#3)(2008-7#1)
cultures of cerebellar granule neurons##2##5##(1991-12#1)(2009-8#1)
cultures of each##2##3##(1992-9#1)(2008-12#1)
cultures of embryonic##3##3##(1996-2#1)(1996-5#2)
cultures of fetal##3##3##(1994-2#1)(1994-3#1)(1996-5#1)
cultures of human##15##3##(1991-5#1)(1992-9#1)(1993-3#2)(1994-9#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-11#3)(2008-4#1)(2010-11#2)(2012-2#1)
cultures of hybridoma##3##3##(1994-5#2)(2008-11#1)
cultures of mouse##5##3##(1990-5#1)(1994-2#2)(2008-1#1)(2008-11#1)
cultures of normal##3##3##(1992-6#1)(1994-6#1)(2008-4#1)
cultures of porcine##2##3##(1995-12#1)(2008-11#1)
cultures of rat hepatocytes##2##4##(1990-5#1)(2008-11#1)
cultures of rat##9##3##(1990-5#2)(1995-11#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
cultures of the##13##3##(1991-9#1)(1992-5#1)(1993-9#1)(1994-8#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2011-2#1)
cultures of##143##2##(1990-12#2)(1990-5#4)(1990-8#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-8#2)(1996-2#3)(1996-5#5)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#13)(2008-11#30)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#9)(2008-9#2)(2009-8#1)(2009-9#1)(2010-11#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
cultures on##6##2##(1995-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#1)
cultures or##4##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
cultures prepared from##4##3##(1995-5#1)(1996-5#1)(2008-7#1)(2009-3#1)
cultures remained##2##2##(2008-11#1)(2008-5#1)
cultures represent##2##2##(2008-11#2)
cultures screened for##3##3##(1995-8#1)(2008-6#1)(2012-2#1)
cultures showed a##5##3##(1993-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(2011-2#1)
cultures showed##9##2##(1993-8#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#2)(2008-11#1)(2010-12#1)(2011-2#1)
cultures stimulated with##2##3##(1994-8#1)(1995-12#1)
cultures stimulated##3##2##(1992-9#1)(1994-8#1)(1995-12#1)
cultures that do not##2##4##(1992-3#1)(2012-12#1)
cultures that were##2##3##(2007-12#1)(2008-10#1)
cultures that##7##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2012-12#1)
cultures to 1##2##3##(1990-11#1)(1994-3#1)
cultures to##9##2##(1990-11#1)(1994-3#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-4#2)(2010-6#1)(2013-1#1)
cultures treated with##4##3##(2008-10#1)(2008-4#1)(2008-7#2)
cultures under##2##2##(2008-10#1)(2008-11#1)
cultures using the##2##3##(1996-2#1)(2011-1#1)
cultures using##7##2##(1996-2#1)(2008-11#4)(2008-6#1)(2011-1#1)
cultures was more##2##3##(1995-12#1)(2008-10#1)
cultures was##15##2##(1992-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(2008-10#5)(2008-11#4)(2010-3#1)(2013-1#1)
cultures were analyzed##3##3##(1996-5#1)(2008-11#2)
cultures were maintained##2##3##(1996-5#1)(2008-11#1)
cultures were negative##2##3##(2007-12#1)(2008-5#1)
cultures were obtained from##2##4##(2008-7#1)(2011-2#1)
cultures were obtained##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
cultures were performed##2##3##(1992-6#1)(2013-1#1)
cultures were positive for##2##4##(2013-1#2)
cultures were positive##4##3##(2008-5#2)(2013-1#2)
cultures were prepared from##3##4##(1994-2#1)(1995-12#1)(2008-5#1)
cultures were##54##2##(1990-12#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#2)(1996-2#1)(1996-5#2)(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#14)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#4)
cultures which##2##2##(1995-11#1)(2008-11#1)
cultures with a##2##3##(2008-10#1)(2008-2#1)
cultures with elevated Fis##2##4##(2008-7#2)
cultures with##27##2##(1990-11#1)(1991-5#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#9)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
cultures without##2##2##(1992-8#1)(2008-11#1)
cultures##898##1##(1990-10#1)(1990-11#6)(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#7)(1990-7#3)(1990-8#3)(1991-12#7)(1991-5#7)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#6)(1992-5#2)(1992-6#2)(1992-8#7)(1992-9#5)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#4)(1993-8#5)(1993-9#3)(1994-11#11)(1994-12#2)(1994-2#8)(1994-3#6)(1994-5#11)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#8)(1995-12#13)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#5)(1995-9#2)(1996-11#1)(1996-12#5)(1996-2#14)(1996-5#12)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#6)(1997-7#4)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#73)(2008-11#270)(2008-12#3)(2008-2#10)(2008-3#2)(2008-4#31)(2008-5#33)(2008-6#18)(2008-7#45)(2008-8#5)(2008-9#15)(2009-1#1)(2009-12#3)(2009-3#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#4)(2010-3#5)(2010-4#3)(2010-6#5)(2010-8#10)(2010-9#1)(2011-1#6)(2011-2#15)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#6)(2012-4#4)(2013-1#21)(2013-7#1)(2013-8#8)
cultures)##5##1##(2008-10#2)(2008-11#3)
cultures]##2##1##(1991-11#1)(1995-11#1)
culturing and##2##2##(2008-11#1)(2008-9#1)
culturing of##6##2##(1992-5#1)(1996-12#1)(2008-11#3)(2012-1#1)
culturing porcine##2##2##(1992-8#1)(2008-11#1)
culturing the cells##2##3##(1993-8#1)(2008-11#1)
culturing the##3##2##(1993-8#1)(2008-11#1)(2008-8#1)
culturing with##3##2##(1993-6#1)(2008-9#1)(2012-1#1)
culturing##42##1##(1990-11#1)(1991-12#1)(1992-5#2)(1992-8#1)(1993-6#1)(1993-8#1)(1996-12#1)(2008-10#3)(2008-11#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#6)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#2)(2013-1#1)
cumana##3##1##(2008-10#3)
cumbersome and##3##2##(1991-3#1)(2008-12#1)(2009-3#1)
cumbersome to##2##2##(2008-11#1)(2008-8#1)
cumbersome##18##1##(1990-4#1)(1991-3#1)(1992-8#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#2)
cumene hydroperoxide##3##2##(1993-12#1)(1994-2#1)(1996-2#1)
cumulant##3##1##(2007-12#1)(2008-2#1)(2013-8#1)
cumulants##5##1##(2008-3#4)(2010-10#1)
cumulate##2##1##(1995-5#1)(2013-8#1)
cumulated##2##1##(1991-8#1)(2008-10#1)
cumulative and##2##2##(1996-7#1)(2012-3#1)
cumulative bleeding##2##2##(2008-7#2)
cumulative chill-hours##2##2##(2008-10#2)
cumulative daily mean##2##3##(2008-10#2)
cumulative disease incidence between##2##4##(2008-10#2)
cumulative dose of##5##3##(1991-4#1)(1991-6#1)(2011-2#2)(2013-1#1)
cumulative dose##6##2##(1990-10#1)(1991-4#1)(1991-6#1)(2011-2#2)(2013-1#1)
cumulative effect##4##2##(2007-10#1)(2008-10#1)(2010-10#1)(2012-12#1)
cumulative effects of##5##3##(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-5#1)
cumulative effects##8##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-5#1)
cumulative excretion##2##2##(2013-8#2)
cumulative genetic##2##2##(1995-12#1)(2010-10#1)
cumulative incidence of##5##3##(2008-11#1)(2008-7#3)(2013-1#1)
cumulative incidence##11##2##(1997-4#3)(2008-11#3)(2008-7#3)(2012-2#1)(2013-1#1)
cumulative mean##2##2##(2008-7#1)(2012-3#1)
cumulative mortality rate##2##3##(2008-10#1)(2012-2#1)
cumulative mortality##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
cumulative number of##5##3##(1994-5#1)(2008-10#3)(2013-1#1)
cumulative precipitation##2##2##(2008-10#2)
cumulative pregnancy##2##2##(1994-9#2)
cumulative risk of##4##3##(1993-9#3)(2012-12#1)
cumulative risk##7##2##(1992-2#1)(1993-9#3)(2009-10#1)(2012-12#2)
cumulative spore deposition##2##3##(2008-10#2)
cumulative time##3##2##(1994-5#1)(2012-2#2)
cumulative##170##1##(1990-10#2)(1990-12#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-11#3)(1993-9#3)(1994-5#2)(1994-9#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-7#2)(1997-4#4)(2007-10#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#8)(2008-12#7)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#3)(2008-7#14)(2008-8#2)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#4)(2011-1#1)(2011-2#6)(2011-3#3)(2012-12#4)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#7)(2013-8#3)
cumulatively##4##1##(1994-11#1)(1997-6#1)(2009-8#1)(2012-12#1)
cumulus cells at##2##3##(2013-1#2)
cumulus cells from##3##3##(1992-9#1)(2013-1#2)
cumulus cells##10##2##(1992-9#2)(2008-9#2)(2013-1#6)
cumulus##15##1##(1992-9#2)(2008-3#1)(2008-9#3)(2012-12#1)(2013-1#8)
cumulus-oocyte##2##1##(2012-3#1)(2013-1#1)
cuneate##3##1##(1993-12#1)(1996-5#2)
cuneiform##2##1##(2008-2#1)(2010-3#1)
cup##19##1##(1991-1#1)(1992-6#1)(2007-5#1)(2008-10#6)(2008-5#2)(2008-8#3)(2009-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
cupferron##4##1##(2008-10#4)
cupin##2##1##(2010-10#2)
cupping##13##1##(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#10)
cupric oxide##2##2##(2013-1#2)
cupric sulfate##2##2##(2008-10#1)(2009-7#1)
cupric##10##1##(1995-6#1)(2008-10#3)(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
cuprolinic##2##1##(1993-12#2)
cuprophane##4##1##(2007-7#2)(2008-1#2)
cuprorivaite (Egyptian blue)##2##3##(2008-10#2)
cuprous##2##1##(1996-12#1)(2008-10#1)
cups##12##1##(1996-3#1)(2007-10#1)(2008-10#7)(2008-5#3)
curable and##2##2##(2011-1#1)(2012-3#1)
curable##15##1##(1990-8#1)(1993-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
curated##2##1##(2008-4#1)(2009-10#1)
curation##8##1##(2008-4#1)(2008-7#5)(2011-2#1)(2012-1#1)
curative effect##2##2##(2013-1#2)
curative potential##2##2##(2010-5#1)(2010-8#1)
curative radiation therapy for nasopharyngeal carcinoma##2##6##(1991-2#2)
curative radiation therapy##4##3##(1991-2#2)(2008-6#1)(2008-7#1)
curative resection##3##2##(1993-9#1)(2011-2#2)
curative surgery##6##2##(1991-6#2)(1996-11#1)(1997-7#1)(1997-8#2)
curative therapeutic approach for##2##4##(1992-8#1)(2013-1#1)
curative therapies##2##2##(2008-5#1)(2013-1#1)
curative treatment for##2##3##(1997-8#1)(2012-3#1)
curative treatment of colorectal liver metastases##2##6##(2012-3#2)
curative treatment##8##2##(1996-11#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-6#1)(2012-3#3)
curative##67##1##(1990-11#1)(1991-2#2)(1991-6#2)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-9#2)(1994-2#1)(1995-1#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#4)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-5#3)(2008-6#5)(2008-7#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
curators##3##1##(2008-4#2)(2010-8#1)
curb##5##1##(1990-10#1)(1997-5#1)(2007-10#1)(2010-5#1)(2013-1#1)
curbed##3##1##(2007-11#1)(2007-6#1)(2008-11#1)
curbing##2##1##(1992-2#1)(2008-7#1)
curcas##2##1##(2009-3#1)(2010-9#1)
curcumin and##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
curcumin moiety##2##2##(2008-10#1)(2013-1#1)
curcumin or turmeric##3##3##(1994-8#3)
curcumin was##3##2##(2011-2#3)
curcumin were##2##2##(1992-9#1)(2013-1#1)
curcumin##34##1##(1992-9#2)(1994-8#4)(1995-9#1)(2008-10#3)(2008-11#5)(2008-7#1)(2010-3#1)(2011-2#7)(2012-3#4)(2013-1#6)
curcumin-induced##4##1##(2011-2#3)(2012-3#1)
curd formation##4##2##(2010-2#4)
curd##14##1##(2008-12#2)(2008-7#1)(2010-2#10)(2013-1#1)
cure and##3##2##(2008-3#1)(2012-3#1)(2013-8#1)
cure disease##2##2##(2006-10#1)(2008-10#1)
cure for AIDS##2##3##(1995-12#1)(1995-6#1)
cure for##10##2##(1991-1#1)(1991-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-7#1)(2008-10#1)(2010-11#1)(2012-8#2)
cure in about##2##3##(2010-12#1)(2011-2#1)
cure in##7##2##(2008-5#2)(2010-12#1)(2011-2#2)(2013-1#2)
cure is##2##2##(2008-7#2)
cure many##2##2##(2008-7#1)(2012-3#1)
cure may be achieved in##2##5##(1990-8#1)(1991-12#1)
cure may be##3##3##(1990-8#1)(1991-12#1)(2006-12#1)
cure more##2##2##(2008-11#1)(2011-2#1)
cure of desire##2##3##(2007-7#2)
cure of the##4##3##(1991-5#1)(2006-12#1)(2008-1#1)(2008-5#1)
cure of##14##2##(1991-1#1)(1991-5#1)(1992-12#1)(1996-3#1)(2006-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)
cure or##4##2##(1995-11#1)(2007-7#1)(2010-5#1)(2011-2#1)
cure patients with##2##3##(1993-2#1)(2008-11#1)
cure rate of##2##3##(2008-12#1)(2013-1#1)
cure rate was##2##3##(2010-3#1)(2012-3#1)
cure rate##8##2##(2008-1#1)(2008-12#1)(2008-7#2)(2010-3#2)(2012-3#1)(2013-1#1)
cure rates and##2##3##(2008-2#1)(2008-3#1)
cure rates##8##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-6#1)(2011-2#1)
cure the##3##2##(1995-8#1)(2011-2#1)(2012-3#1)
cure to##2##2##(2010-11#2)
cure with##4##2##(2006-12#1)(2007-12#1)(2007-7#1)(2011-1#1)
cure##125##1##(1990-8#2)(1991-1#2)(1991-12#2)(1991-5#1)(1992-12#2)(1992-6#2)(1993-2#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-6#2)(2006-10#1)(2006-12#3)(2007-12#2)(2007-7#5)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#2)(2009-12#3)(2009-5#2)(2010-11#3)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-3#5)(2012-8#2)(2013-1#4)(2013-7#2)(2013-8#1)
cure&quot##2##1##(2009-10#1)(2009-7#1)
cured after##2##2##(2008-10#1)(2013-1#1)
cured by##11##2##(1990-5#1)(1991-12#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-9#2)(1997-6#1)(2006-12#1)(2007-8#1)(2011-2#1)
cured ham##3##2##(2008-10#2)(2010-4#1)
cured in##2##2##(1994-9#1)(2010-8#1)
cured of the##2##3##(2008-10#2)
cured of##4##2##(2008-1#1)(2008-10#2)(2012-12#1)
cured or improved##2##3##(1994-9#1)(2008-5#1)
cured or##5##2##(1994-9#1)(2007-7#1)(2008-5#1)(2010-4#1)(2010-6#1)
cured the##2##2##(1996-9#1)(2007-7#1)
cured with##6##2##(1990-12#1)(1991-9#1)(2008-7#1)(2010-3#1)(2011-2#1)(2011-3#1)
cured##62##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-9#3)(1995-11#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-9#3)(1997-4#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#8)(2008-5#4)(2008-7#1)(2010-3#4)(2010-4#4)(2010-6#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#3)
cures##5##1##(1990-4#1)(1995-10#1)(1996-12#1)(2008-5#1)(2010-1#1)
curettage and##3##2##(2008-6#1)(2010-3#1)(2012-12#1)
curettage##17##1##(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-3#1)(1995-8#2)(2007-10#1)(2008-6#2)(2009-4#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
curette##7##1##(1991-12#1)(1992-12#3)(1992-2#1)(2008-12#2)
curettes##2##1##(1992-12#1)(2010-3#1)
curing light##2##2##(2008-12#1)(2013-1#1)
curing of##4##2##(2008-10#1)(2008-3#1)(2008-8#2)
curing or##2##2##(2011-2#1)(2013-1#1)
curing tip distance##2##3##(2008-12#2)
curing tip##3##2##(2008-12#3)
curing##32##1##(1991-9#1)(2007-12#1)(2008-10#6)(2008-12#9)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#2)
curiosity##5##1##(1996-11#1)(2008-5#1)(2009-10#1)(2009-5#1)(2013-1#1)
curious about##2##2##(2008-12#1)(2009-9#1)
curious##8##1##(1994-2#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)
curl virus##34##2##(2008-10#30)(2008-8#2)(2008-9#2)
curl##75##1##(2008-10#69)(2008-8#3)(2008-9#2)(2010-1#1)
curled##5##1##(2008-10#4)(2011-2#1)
curly top virus (BCTV)##2##4##(2008-10#2)
curly top virus##13##3##(2008-10#13)
curly top##14##2##(2008-10#14)
curly##17##1##(2008-10#16)(2013-8#1)
currency##5##1##(1992-3#1)(2008-11#2)(2008-8#1)(2008-9#1)
current &quot##4##2##(1994-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
current (Isc)##2##2##(2008-1#1)(2008-5#1)
current AR##2##2##(2012-2#2)
current HIV##2##2##(1997-6#1)(2008-4#1)
current HPLC##2##2##(2008-10#1)(2008-4#1)
current PCR##2##2##(1997-4#1)(2008-10#1)
current activities##9##2##(2008-10#1)(2013-8#8)
current algorithms##2##2##(1994-9#1)(2007-12#1)
current amplitude##2##2##(1990-7#1)(2008-8#1)
current analysis##2##2##(1994-6#1)(2010-12#1)
current analytical##2##2##(1990-2#1)(2010-11#1)
current and NO##2##3##(2008-10#1)(2013-8#1)
current and emerging##2##3##(2008-10#1)(2008-6#1)
current and former##3##3##(1995-12#2)(2010-8#1)
current and future directions##2##4##(2008-11#1)(2008-12#1)
current and future##15##3##(1994-2#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-3#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
current and past##2##3##(2007-12#1)(2008-10#1)
current and potential future##3##4##(2008-11#1)(2009-4#1)(2012-12#1)
current and potential##7##3##(1994-12#1)(1996-3#1)(1997-1#1)(2008-11#2)(2009-4#1)(2012-12#1)
current and the##5##3##(2008-10#4)(2008-3#1)
current and##75##2##(1992-11#1)(1992-12#1)(1993-12#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(2007-12#2)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
current antidepressants##2##2##(2008-6#2)
current antiretroviral##2##2##(2007-7#1)(2013-1#1)
current applications of##3##3##(1993-12#1)(2008-8#2)
current applications##8##2##(1993-12#2)(2007-7#1)(2008-11#1)(2008-3#2)(2008-8#2)
current approach##4##2##(2007-4#1)(2008-3#1)(2010-12#1)(2010-4#1)
current approaches to##4##3##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
current approaches##6##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
current article##5##2##(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
current as a function of##2##5##(2008-3#1)(2008-7#1)
current as a##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
current as##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
current assays##2##2##(2008-10#1)(2009-12#1)
current asthma##2##2##(2008-10#2)
current at##6##2##(1990-7#1)(2008-10#4)(2009-12#1)
current available##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
current body##5##2##(1991-6#1)(2007-12#2)(2008-12#1)(2009-8#1)
current by a##2##3##(1992-12#1)(2008-8#1)
current by##5##2##(1992-12#1)(1995-11#1)(2008-10#1)(2008-8#2)
current capabilities##2##2##(1993-2#1)(2010-11#1)
current care##2##2##(2008-5#1)(2013-1#1)
current case##3##2##(2008-12#1)(2010-10#1)(2013-1#1)
current challenge##3##2##(2007-6#1)(2008-10#1)(2012-3#1)
current challenges to##2##3##(1996-1#1)(2009-11#1)
current challenges##5##2##(1994-2#1)(1996-1#1)(2008-11#1)(2009-11#1)(2010-7#1)
current climate##2##2##(2008-11#1)(2008-8#1)
current clinical use##2##3##(2008-5#1)(2011-2#1)
current clinical##12##2##(1992-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
current coders##2##2##(2007-12#2)
current concept##2##2##(1995-5#1)(2008-10#1)
current concepts of##2##3##(2008-7#1)(2013-1#1)
current concepts##5##2##(1992-8#1)(1994-8#1)(1997-1#1)(2008-7#1)(2013-1#1)
current critical##2##2##(1995-12#1)(2008-3#1)
current data regarding##3##3##(1997-2#1)(2010-6#1)(2012-3#1)
current data suggest##2##3##(2008-9#1)(2012-12#1)
current data##16##2##(1990-11#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
current debate on##2##3##(1993-12#1)(2008-10#1)
current debate##5##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
current debates##3##2##(1997-2#1)(2010-4#1)(2010-8#1)
current definition of##2##3##(2008-7#1)(2009-10#1)
current demands##2##2##(1997-2#1)(2008-12#1)
current density and##2##3##(2008-10#1)(2009-2#1)
current density##14##2##(1995-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-2#1)(2012-12#1)(2013-1#3)
current development##2##2##(2008-1#1)(2012-2#1)
current developments in##3##3##(2010-5#1)(2010-6#2)
current developments##4##2##(1991-2#1)(2010-5#1)(2010-6#2)
current diagnostic and therapeutic##2##4##(1990-6#1)(2006-10#1)
current diagnostic##4##2##(1990-6#1)(1997-3#1)(2006-10#1)(2013-7#1)
current drop##2##2##(2008-10#2)
current drugs##2##2##(2008-3#1)(2011-3#1)
current efforts to##2##3##(2008-8#1)(2010-3#1)
current efforts##4##2##(1995-12#1)(2008-8#1)(2010-3#1)(2011-1#1)
current environment##2##2##(1996-2#1)(1996-3#1)
current environmental conditions##2##3##(2008-8#1)(2008-9#1)
current epidemiological##5##2##(1991-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
current events##3##2##(1995-1#1)(2011-2#2)
current evidence for##3##3##(2009-8#1)(2011-2#2)
current evidence on##3##3##(2007-5#2)(2013-1#1)
current evidence regarding##2##3##(2008-3#1)(2013-1#1)
current evidence suggests that##3##4##(2008-1#1)(2008-5#1)(2012-2#1)
current evidence that##2##3##(2007-8#1)(2012-3#1)
current evidence##24##2##(2007-5#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
current experiment##2##2##(1995-3#1)(2010-7#1)
current experimental##6##2##(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
current federal##2##2##(1991-2#1)(2010-9#1)
current field##2##2##(1990-2#1)(2007-1#1)
current findings##5##2##(1991-11#1)(2008-10#1)(2009-10#1)(2013-8#2)
current for the##2##3##(2008-10#2)
current for##5##2##(2008-10#5)
current formulations##2##2##(1992-3#1)(1996-1#1)
current framework##2##2##(1992-12#1)(2012-12#1)
current funding##2##2##(1993-3#1)(1994-7#1)
current global##2##2##(1994-2#1)(2013-1#1)
current government and professional##2##4##(2008-11#1)(2008-12#1)
current government##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
current guidelines##6##2##(2007-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2010-8#1)
current had##4##2##(2008-10#4)
current health care environment##2##4##(1996-3#1)(1997-3#1)
current health care##6##3##(1993-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#2)
current health##12##2##(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(2008-7#1)(2010-8#1)(2013-1#1)
current hospital##3##2##(1991-1#1)(1992-2#1)(1996-1#1)
current hypotheses##3##2##(2008-10#1)(2011-1#2)
current ideas##2##2##(1993-6#1)(2008-3#1)
current imaging##3##2##(2007-12#1)(2008-4#1)(2010-12#1)
current in human##2##3##(1991-9#1)(1992-11#1)
current in the##4##3##(1991-9#1)(2008-10#1)(2008-6#1)(2009-11#1)
current in##14##2##(1991-5#1)(1991-9#2)(1992-11#1)(1993-12#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-6#1)(2009-11#1)(2012-2#2)(2013-1#1)
current increased##4##2##(2008-10#3)(2009-11#1)
current increases##2##2##(2008-10#1)(2013-1#1)
current indicated##2##2##(1993-12#1)(2007-12#1)
current induced by##2##3##(1992-8#1)(1997-2#1)
current influenza##2##2##(2009-12#1)(2013-8#1)
current information##3##2##(1994-12#1)(2008-6#1)(2012-3#1)
current inhibition##6##2##(2008-8#5)(2013-8#1)
current insights##2##2##(2011-2#2)
current intensities##2##2##(1993-12#1)(2008-10#1)
current interest##5##2##(1995-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
current investigation##7##2##(1991-12#1)(1993-1#1)(1997-6#1)(2007-10#1)(2008-12#1)(2008-2#1)(2013-8#1)
current is observed##2##3##(2008-10#2)
current is##28##2##(1990-7#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-2#1)(2008-3#1)(2008-8#2)(2009-11#1)(2011-1#1)
current issues and##2##3##(1990-2#1)(2008-7#1)
current issues in##2##3##(1994-1#1)(1996-6#1)
current issues##9##2##(1990-2#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-6#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-2#1)
current job##3##2##(1993-12#1)(1993-3#2)
current knowledge about##7##3##(1996-5#1)(2008-11#2)(2008-4#2)(2010-3#1)(2012-2#1)
current knowledge and##3##3##(2008-1#1)(2009-4#1)(2010-12#1)
current knowledge in##3##3##(1995-3#1)(1996-3#1)(2008-1#1)
current knowledge of the##11##4##(1996-3#1)(1997-7#1)(2007-7#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
current knowledge of##19##3##(1996-3#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#4)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
current knowledge on the##9##4##(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-7#1)(2013-8#1)
current knowledge on##15##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-4#2)(2010-12#1)(2011-2#1)(2011-7#1)(2013-8#1)
current knowledge regarding the##2##4##(2008-11#1)(2008-4#1)
current knowledge regarding##4##3##(2008-11#1)(2008-4#2)(2012-2#1)
current knowledge##56##2##(1995-3#1)(1996-3#2)(1996-5#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-4#5)(2008-5#6)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#3)(2009-5#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
current lack of##2##3##(2010-5#1)(2012-2#1)
current laws and practices continue##2##5##(1993-3#1)(1996-2#1)
current laws and practices##3##4##(1992-3#1)(1993-3#1)(1996-2#1)
current legal##2##2##(2013-1#1)(2013-8#1)
current levels##3##2##(1994-12#1)(1997-2#1)(2008-9#1)
current limitations in the##2##4##(1993-3#1)(2010-5#1)
current limitations##4##2##(1993-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
current literature and##6##3##(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
current literature on the##4##4##(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
current literature on##5##3##(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#2)
current literature##32##2##(1992-12#1)(1994-1#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
current management of##2##3##(2008-1#1)(2013-1#1)
current management##9##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
current medical need and recent advances##2##6##(2008-5#2)
current medical##6##2##(1992-8#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#1)
current medication##2##2##(2010-1#1)(2011-1#1)
current members of##2##3##(1996-3#2)
current members##4##2##(1996-3#3)(2012-1#1)
current method of##2##3##(2008-4#1)(2009-6#1)
current method##7##2##(2008-10#2)(2008-4#1)(2008-5#2)(2009-6#1)(2010-5#1)
current methodology##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
current methods for##4##3##(2008-11#1)(2010-12#1)(2011-3#1)(2012-3#1)
current methods of evaluation of##2##5##(2007-8#1)(2008-3#1)
current methods of##6##3##(1997-7#1)(2007-8#1)(2008-11#2)(2008-3#1)(2013-1#1)
current methods used##3##3##(2008-11#1)(2009-10#1)(2013-1#1)
current methods##17##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#2)
current modalities##2##2##(2010-3#1)(2013-1#1)
current model for##3##3##(1994-8#1)(2007-11#1)(2008-3#1)
current model##6##2##(1994-8#1)(2007-11#1)(2008-3#1)(2008-4#2)(2011-2#1)
current models of##6##3##(1991-11#1)(1995-1#1)(2008-7#1)(2012-1#1)(2013-8#2)
current models##9##2##(1991-11#1)(1995-1#1)(1995-5#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-8#2)
current modulation##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2009-5#1)
current molecular##2##2##(2008-9#1)(2012-3#1)
current monitoring##2##2##(1995-3#1)(2008-10#1)
current national##3##2##(2009-4#1)(2012-3#2)
current noninvasive##2##2##(2010-11#1)(2013-1#1)
current nursing##4##2##(1991-2#1)(1993-2#1)(2008-12#2)
current obtained##4##2##(2008-10#4)
current of glucose##2##3##(2008-10#2)
current of the##6##3##(2008-10#5)(2012-3#1)
current of##30##2##(1990-7#1)(2007-11#1)(2008-10#21)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
current on##4##2##(2008-10#1)(2008-3#2)(2009-12#1)
current opinion##2##2##(2007-2#1)(2011-2#1)
current opinions##4##2##(2007-2#1)(2007-4#1)(2008-10#1)(2012-3#1)
current opportunities for##2##3##(1996-3#1)(2008-10#1)
current optical##2##2##(2007-12#1)(2008-2#1)
current or##5##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
current organizational structure##2##3##(1993-2#1)(2009-10#1)
current paper##11##2##(1993-12#1)(1993-6#1)(1997-3#1)(1997-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2012-2#2)(2013-1#1)
current peaks##2##2##(2008-10#2)
current performance##3##2##(1992-1#1)(2008-8#1)(2009-9#1)
current perspectives##4##2##(1991-2#1)(1996-12#1)(2008-11#1)(2010-8#1)
current plasma##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
current policy##8##2##(1995-6#1)(1996-2#3)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
current political##2##2##(2008-11#2)
current position##2##2##(1995-3#1)(1996-12#1)
current practice and##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
current practice in##2##3##(2008-10#1)(2008-7#1)
current practice is##3##3##(2008-12#1)(2008-8#1)(2009-4#1)
current practice of sedation and analgesia in intensive care units##2##10##(2008-8#2)
current practice of##6##3##(1991-6#1)(2008-10#1)(2008-8#2)(2012-3#1)(2013-1#1)
current practice patterns##2##3##(2011-2#1)(2012-1#1)
current practice##25##2##(1991-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
current practices in the##2##4##(2007-11#1)(2008-12#1)
current practices##9##2##(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-12#2)(2012-12#1)(2013-8#1)
current pregnancy##2##2##(2012-3#1)(2013-1#1)
current problem##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
current problems in##2##3##(1992-8#1)(2008-7#1)
current problems##5##2##(1991-2#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-7#1)
current programs##3##2##(1991-12#1)(1992-2#1)(1993-6#1)
current progress in the##2##4##(1996-6#1)(2011-3#1)
current progress##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2011-3#1)
current proposals##2##2##(2008-7#1)(2013-8#1)
current prospective##2##2##(2010-5#1)(2012-3#1)
current pulse##4##2##(2008-10#3)(2008-3#1)
current range##2##2##(2008-10#1)(2008-5#1)
current reality##2##2##(1992-12#1)(2013-1#1)
current recommendations for##2##3##(2008-11#1)(2008-3#1)
current recommendations##10##2##(1995-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2010-7#1)
current recommended##2##2##(1992-9#2)
current relationship##2##2##(1996-1#1)(2010-8#1)
current renal##2##2##(1997-4#1)(2008-11#1)
current report##8##2##(1992-3#1)(1996-3#1)(2008-10#3)(2008-7#1)(2012-2#1)(2012-3#1)
current reproduction##6##2##(2008-8#6)
current research is##2##3##(1996-11#1)(2012-2#1)
current research##19##2##(1990-11#1)(1994-9#1)(1995-8#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#2)
current response##10##2##(1992-12#1)(2008-10#8)(2009-10#1)
current responses##3##2##(1995-5#1)(1996-2#1)(2008-10#1)
current results##6##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-6#1)
current review##8##2##(2008-10#1)(2008-3#2)(2010-1#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
current risk##2##2##(1993-2#1)(2012-1#1)
current risk-reducing##2##2##(1993-12#2)
current role##2##2##(2009-10#1)(2012-3#1)
current sample##2##2##(2008-10#1)(2012-2#1)
current scientific evidence##2##3##(2011-2#1)(2013-1#1)
current scientific##5##2##(1994-6#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
current sensor##6##2##(2008-3#6)
current serologic##2##2##(2007-8#1)(2011-2#1)
current service##2##2##(1991-3#1)(1994-1#1)
current short acting beta agonist use##2##6##(2012-1#2)
current signal##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
current signals##4##2##(2008-10#4)
current situation in##3##3##(1991-11#1)(2007-5#1)(2009-5#1)
current situation##8##2##(1991-11#1)(1991-3#1)(2007-5#1)(2007-7#1)(2009-5#1)(2012-12#1)(2013-1#2)
current size##2##2##(2008-8#2)
current smokers##8##2##(1994-6#1)(1996-3#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#2)
current smoking##2##2##(1992-6#1)(2013-1#1)
current source density##2##3##(1993-12#2)
current source##3##2##(1993-12#2)(2008-10#1)
current species##2##2##(2008-10#1)(2012-3#1)
current standard methods##2##3##(2008-4#2)
current standard##6##2##(2008-11#1)(2008-4#2)(2010-8#1)(2011-2#2)
current state and future##2##4##(2007-4#1)(2010-3#1)
current state and##4##3##(2007-4#1)(2010-3#1)(2011-2#1)(2013-1#1)
current state of the art##3##5##(1994-8#1)(2008-10#1)(2008-8#1)
current state of the##8##4##(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#1)
current state of##32##3##(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
current state##41##2##(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
current state-of-the-art##4##2##(1991-1#1)(2008-3#1)(2008-4#1)(2011-7#1)
current status and future prospects##2##5##(2006-9#1)(2009-11#1)
current status and future##5##4##(1997-3#1)(2006-9#1)(2008-7#1)(2009-11#1)(2012-3#1)
current status and##9##3##(1990-6#1)(1995-1#1)(1997-3#1)(2006-9#1)(2008-7#1)(2009-11#1)(2011-7#1)(2012-12#1)(2012-3#1)
current status in##2##3##(1992-10#1)(2009-9#1)
current status of the##4##4##(1996-8#1)(1997-3#2)(2013-1#1)
current status of##33##3##(1991-1#1)(1994-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-7#1)(2012-12#2)(2013-1#4)(2013-8#1)
current status##54##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-10#1)(1994-12#1)(1995-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#5)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-7#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
current stimulation##8##2##(2008-11#1)(2010-7#3)(2011-1#2)(2012-2#2)
current strategies##2##2##(2010-3#1)(2012-12#1)
current studies##12##2##(1990-11#1)(1993-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)(2012-12#1)
current study aimed to##2##4##(2009-10#1)(2012-12#1)
current study evaluated##3##3##(2012-2#2)(2013-1#1)
current study examines how##2##4##(2009-11#1)(2009-7#1)
current study indicated that##2##4##(2008-10#1)(2008-12#1)
current study is##2##3##(2007-8#1)(2012-3#1)
current study was designed to##2##5##(2008-10#1)(2011-2#1)
current study was##17##3##(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
current study##114##2##(1994-6#1)(1995-2#3)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-2#1)(2010-3#2)(2010-6#3)(2010-8#1)(2011-2#10)(2012-12#6)(2012-2#5)(2012-3#10)(2013-1#8)(2013-8#5)
current supply##2##2##(1994-1#1)(2008-1#1)
current surgical techniques##2##3##(1997-8#1)(2009-5#1)
current surgical##4##2##(1997-8#1)(2007-12#1)(2008-11#1)(2009-5#1)
current symptoms##3##2##(2012-1#3)
current system of radiation protection##2##5##(2008-12#2)
current system##9##2##(1991-3#2)(1992-3#1)(1997-2#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-5#1)
current systems##2##2##(2007-5#1)(2008-11#1)
current taxonomy##2##2##(1996-6#1)(1997-4#1)
current technique##3##2##(1995-9#1)(2008-10#1)(2008-3#1)
current technologies##2##2##(2008-10#1)(2009-12#1)
current technology##4##2##(1993-12#1)(2008-11#1)(2008-2#1)(2011-1#1)
current that##3##2##(2007-12#1)(2008-8#1)(2010-8#1)
current theories of##4##3##(1997-6#1)(2008-10#1)(2008-4#1)(2010-9#1)
current theories##6##2##(1995-6#1)(1997-6#1)(2008-10#2)(2008-4#1)(2010-9#1)
current theory##4##2##(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
current therapies##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
current therapy##4##2##(2008-1#1)(2008-11#1)(2009-5#1)(2010-1#1)
current thinking##2##2##(2009-8#1)(2010-11#1)
current through the##3##3##(2008-8#2)(2009-5#1)
current through##7##2##(2008-10#1)(2008-8#3)(2008-9#2)(2009-5#1)
current to the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
current to##5##2##(1991-9#1)(2007-12#1)(2008-10#2)(2008-3#1)
current topics of##2##3##(2008-5#1)(2012-2#1)
current treatment strategies##2##3##(2008-11#1)(2010-12#1)
current treatment##7##2##(1995-12#1)(2008-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2013-8#1)
current treatments##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
current trend##2##2##(2008-10#1)(2012-2#1)
current trends in the##2##4##(1996-3#1)(2008-9#1)
current trends in##8##3##(1993-1#1)(1994-1#1)(1996-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-7#1)(2013-1#1)
current trends##10##2##(1993-1#1)(1994-1#1)(1995-1#1)(1996-3#1)(2007-11#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-7#1)(2013-1#1)
current trial##2##2##(1996-6#1)(2008-6#1)
current tuning##2##2##(2008-2#2)
current understanding of the role of##2##6##(2008-7#1)(2012-2#1)
current understanding of the##9##4##(1990-12#1)(2008-7#3)(2009-12#1)(2009-2#1)(2009-4#1)(2012-2#1)(2013-8#1)
current understanding of##24##3##(1990-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
current understanding on##2##3##(2009-12#1)(2012-12#1)
current understanding##26##2##(1990-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
current up to##2##3##(2008-3#2)
current usage and##2##3##(2008-11#1)(2012-2#1)
current usage##4##2##(1996-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
current use of##9##3##(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
current use##11##2##(2007-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
current users of##2##3##(1997-6#1)(2008-8#1)
current velocity##2##2##(2008-5#1)(2008-9#1)
current versus concentration##2##3##(2008-10#2)
current views on the##3##4##(2007-8#1)(2010-3#1)(2012-2#1)
current views on##5##3##(2007-11#2)(2007-8#1)(2010-3#1)(2012-2#1)
current views##6##2##(1995-5#1)(2007-11#2)(2007-8#1)(2010-3#1)(2012-2#1)
current was proportional to the concentration of##2##7##(2008-10#2)
current was the##2##3##(1993-12#1)(2008-8#1)
current was##24##2##(1990-5#1)(1992-11#1)(1992-8#1)(1993-12#3)(1993-3#1)(1994-3#1)(1995-11#1)(1995-12#2)(1997-6#1)(2008-10#8)(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#1)
current weight##2##2##(2007-12#2)
current were##2##2##(1993-3#1)(2010-9#1)
current with##8##2##(1991-5#1)(1991-9#1)(2008-10#4)(2008-7#1)(2012-2#1)
current work##12##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-10#2)(2010-5#1)(2010-8#1)(2013-1#1)
current##2040##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#4)(1990-6#4)(1990-7#5)(1990-8#1)(1991-1#4)(1991-11#4)(1991-12#6)(1991-2#7)(1991-3#5)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#9)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#12)(1992-2#4)(1992-3#9)(1992-5#1)(1992-6#3)(1992-8#9)(1992-9#2)(1993-1#3)(1993-12#27)(1993-2#7)(1993-3#12)(1993-6#4)(1994-1#8)(1994-11#3)(1994-12#7)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#7)(1995-11#6)(1995-12#20)(1995-2#7)(1995-3#10)(1995-5#6)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#12)(1996-11#1)(1996-12#11)(1996-2#13)(1996-3#16)(1996-4#3)(1996-5#9)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#13)(1997-3#15)(1997-4#7)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#3)(2006-10#3)(2006-12#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#53)(2007-2#8)(2007-4#6)(2007-5#7)(2007-6#1)(2007-7#7)(2007-8#10)(2008-1#22)(2008-10#325)(2008-11#94)(2008-12#36)(2008-2#40)(2008-3#85)(2008-4#34)(2008-5#37)(2008-6#21)(2008-7#50)(2008-8#74)(2008-9#29)(2009-1#2)(2009-10#13)(2009-11#11)(2009-12#17)(2009-2#7)(2009-3#4)(2009-4#15)(2009-5#16)(2009-6#3)(2009-7#9)(2009-8#8)(2009-9#4)(2010-1#8)(2010-10#11)(2010-11#10)(2010-12#19)(2010-2#8)(2010-3#18)(2010-4#12)(2010-5#21)(2010-6#14)(2010-7#10)(2010-8#25)(2010-9#7)(2011-1#20)(2011-2#73)(2011-3#7)(2011-7#4)(2012-1#20)(2012-12#32)(2012-2#62)(2012-3#49)(2012-7#1)(2012-8#1)(2013-1#73)(2013-7#6)(2013-8#50)
current)##5##1##(2008-10#3)(2008-8#1)(2013-1#1)
current-carrying capacity of##2##3##(1995-3#1)(2012-2#1)
current-carrying##3##1##(1995-3#1)(2007-12#1)(2012-2#1)
current-density anodic##2##2##(2008-10#2)
current-induced##2##1##(2008-3#1)(2008-7#1)
current-modulated##2##1##(2007-11#2)
current-potential response##2##2##(2008-10#2)
current-voltage (I-V)##2##2##(1993-12#1)(2010-7#1)
current-voltage relations##2##2##(1990-8#1)(2010-4#1)
current-voltage##5##1##(1990-8#1)(1993-12#1)(2008-7#1)(2010-4#1)(2010-7#1)
currently accepted##6##2##(1990-6#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
currently adopted##2##2##(1997-7#1)(2008-7#1)
currently approved##3##2##(1995-3#1)(2008-10#1)(2010-12#1)
currently are##3##2##(2008-9#1)(2010-3#1)(2011-2#1)
currently available clinical data##2##4##(2010-11#1)(2013-1#1)
currently available for the##5##4##(2008-11#1)(2008-5#1)(2009-1#1)(2011-2#1)(2013-7#1)
currently available for##8##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2010-3#1)(2011-2#2)(2013-7#1)
currently available in##4##3##(1992-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
currently available is##2##3##(1992-12#1)(1994-9#1)
currently available methods##4##3##(1991-8#1)(2008-10#1)(2008-4#1)(2011-3#1)
currently available on the##3##4##(2008-3#1)(2008-5#1)(2013-8#1)
currently available on##5##3##(1994-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
currently available therapies##2##3##(2008-11#1)(2010-3#1)
currently available to##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
currently available treatments##2##3##(2008-4#1)(2008-8#1)
currently available##86##2##(1991-8#1)(1992-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#1)
currently be##2##2##(2007-2#1)(2008-3#1)
currently being considered##2##3##(2008-3#1)(2013-1#1)
currently being developed for the treatment of##2##7##(2008-10#1)(2010-5#1)
currently being developed##5##3##(1996-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-5#1)
currently being evaluated##3##3##(1997-1#1)(2008-6#1)(2008-7#1)
currently being implemented##2##3##(2008-11#1)(2008-12#1)
currently being used for the##2##5##(2007-11#1)(2008-10#1)
currently being used for##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
currently being used##8##3##(1990-2#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-6#1)
currently being##47##2##(1990-2#2)(1992-2#1)(1992-3#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#1)
currently causing##2##2##(1993-12#1)(2008-10#1)
currently comprise##3##2##(1994-3#2)(2009-10#1)
currently considered as##3##3##(1991-12#1)(2007-11#1)(2011-2#1)
currently considered##9##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
currently depressed adolescents##2##3##(2008-11#2)
currently employed##9##2##(1991-12#2)(1995-12#1)(2008-10#4)(2008-11#1)(2012-2#1)
currently enrolled in##2##3##(1991-1#1)(2012-12#1)
currently exist##3##2##(2008-1#1)(2012-12#1)(2012-2#1)
currently existing##2##2##(2008-10#1)(2009-5#1)
currently facing##2##2##(2010-6#2)
currently found in##2##3##(1993-2#1)(2008-11#1)
currently found##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
currently have##2##2##(2008-7#1)(2012-2#1)
currently impede##2##2##(1994-12#1)(2010-10#1)
currently implemented##2##2##(2008-3#1)(2011-2#1)
currently in clinical trials##2##4##(1993-8#1)(2009-4#1)
currently in clinical use or in clinical trials##2##8##(2008-5#2)
currently in clinical##5##3##(1993-8#1)(2008-5#3)(2009-4#1)
currently in development##3##3##(2008-10#1)(2008-11#2)
currently in phase III##2##4##(2007-11#1)(2008-1#1)
currently in progress##4##3##(1994-9#1)(1997-4#1)(2008-5#1)(2011-2#1)
currently in use##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
currently in##32##2##(1993-8#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#2)
currently includes##3##2##(1996-1#1)(2008-7#1)(2009-11#1)
currently is##6##2##(1990-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
currently known about the##2##4##(2008-7#1)(2013-1#1)
currently known about##5##3##(2007-11#1)(2008-7#2)(2009-8#1)(2013-1#1)
currently known##11##2##(2007-11#1)(2007-12#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#2)(2010-10#1)(2012-2#1)(2013-1#1)
currently limited##5##2##(2007-12#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
currently limiting the##2##3##(2008-7#1)(2013-8#1)
currently marketed##2##2##(2008-1#1)(2010-4#1)
currently much##2##2##(2008-10#1)(2008-8#1)
currently no##7##2##(1996-1#1)(2008-11#1)(2011-2#3)(2012-12#1)(2012-2#1)
currently not##8##2##(1990-2#1)(1992-12#1)(2008-1#1)(2008-3#1)(2011-2#2)(2011-3#1)(2012-3#1)
currently of interest##2##3##(2008-3#1)(2008-5#1)
currently of##4##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
currently on the##2##3##(1997-2#1)(2009-6#1)
currently ongoing##2##2##(2008-5#1)(2010-12#1)
currently performed##4##2##(1992-12#1)(1996-1#1)(2008-2#1)(2010-8#1)
currently practiced in the field of##2##6##(1991-8#1)(2008-2#1)
currently receiving##5##2##(1994-2#2)(1994-3#1)(2008-5#1)(2008-8#1)
currently recognized##3##2##(2008-8#1)(2008-9#1)(2010-3#1)
currently recommended##4##2##(2007-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
currently reported##2##2##(2007-10#1)(2012-12#1)
currently the most##7##3##(1991-3#1)(1995-3#1)(1996-1#2)(2008-10#2)(2008-8#1)
currently the##20##2##(1991-3#1)(1995-3#1)(1996-1#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#3)(2013-1#2)
currently there are no##2##4##(2008-7#2)
currently thought to##2##3##(2008-6#1)(2013-1#1)
currently to##2##2##(1997-6#1)(2008-3#1)
currently uncertain##2##2##(1994-1#1)(2012-3#1)
currently under construction##2##3##(2007-11#1)(2007-12#1)
currently under development at##2##4##(2008-2#1)(2008-3#1)
currently under development##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
currently under investigation##3##3##(1991-9#1)(1994-5#1)(2007-12#1)
currently under way to##2##4##(2007-11#1)(2008-2#1)
currently under way##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
currently under##21##2##(1991-9#1)(1994-5#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-3#1)(2013-1#1)
currently undergoing##4##2##(1995-3#1)(1996-9#1)(2007-12#1)(2010-3#1)
currently underway in##3##3##(1992-1#1)(1996-4#1)(2008-2#1)
currently underway##4##2##(1992-1#1)(1996-4#1)(2008-2#1)(2008-4#1)
currently unknown##10##2##(1992-12#1)(1995-6#1)(1997-1#1)(2007-8#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-6#1)(2012-2#1)
currently use##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
currently used as##5##3##(1991-2#1)(1997-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
currently used drugs##2##3##(2010-12#1)(2013-8#1)
currently used for the##2##4##(1992-12#1)(2007-7#1)
currently used for##10##3##(1992-12#1)(2007-7#1)(2008-10#2)(2009-6#1)(2010-11#2)(2010-7#1)(2010-8#1)(2013-1#1)
currently used in clinical##2##4##(2008-4#1)(2008-7#1)
currently used in the##3##4##(1995-2#1)(2008-10#2)
currently used in##14##3##(1993-10#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-11#2)(2011-2#1)(2012-3#1)
currently used methods##2##3##(1997-8#1)(2008-10#1)
currently used to##7##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)
currently used toxicity##2##3##(2008-10#2)
currently used##65##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-10#1)(1994-1#1)(1994-8#1)(1995-2#2)(1997-3#1)(1997-8#1)(2007-4#1)(2007-7#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-11#4)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
currently well##2##2##(2008-10#1)(2011-2#1)
currently working##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
currently##626##1##(1990-2#4)(1990-3#1)(1990-6#3)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#3)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#6)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#1)(1996-1#9)(1996-12#2)(1996-2#7)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#8)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#10)(2007-12#12)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#10)(2008-10#66)(2008-11#30)(2008-12#5)(2008-2#15)(2008-3#24)(2008-4#12)(2008-5#25)(2008-6#9)(2008-7#40)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#6)(2010-12#10)(2010-3#9)(2010-4#4)(2010-5#4)(2010-6#9)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#30)(2011-3#7)(2012-12#9)(2012-2#16)(2012-3#10)(2013-1#19)(2013-7#5)(2013-8#5)
currents (&lt##2##2##(2008-2#2)
currents and the##2##3##(2008-10#1)(2008-8#1)
currents and##14##2##(1991-2#1)(1995-12#1)(2007-11#1)(2008-10#6)(2008-7#1)(2008-8#3)(2010-8#1)
currents are##7##2##(1992-11#1)(2008-10#5)(2008-11#1)
currents as well as##2##4##(1992-8#1)(2008-10#1)
currents as##3##2##(1992-8#1)(2008-10#1)(2008-3#1)
currents at##3##2##(1992-12#1)(1997-2#1)(2009-7#1)
currents by ATPgammaS##2##3##(1996-2#2)
currents by##5##2##(1992-8#1)(1996-2#2)(2008-8#1)(2013-1#1)
currents elicited by##3##3##(1995-5#1)(2008-4#1)(2008-8#1)
currents evoked by##3##3##(1995-11#2)(1995-12#1)
currents evoked##6##2##(1995-11#3)(1995-12#1)(1997-2#2)
currents had##2##2##(1995-2#1)(2008-10#1)
currents have been##2##3##(1995-11#1)(1996-5#1)
currents have##3##2##(1995-11#1)(1996-5#1)(2008-4#1)
currents in TG neurons##3##4##(2009-12#3)
currents in a##2##3##(1996-2#1)(2009-12#1)
currents in rat##2##3##(1993-12#1)(2009-12#1)
currents in the##2##3##(1992-12#1)(1997-2#1)
currents in##34##2##(1992-12#3)(1992-8#2)(1993-12#2)(1993-3#2)(1995-12#4)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#7)(2010-12#1)(2013-1#1)
currents measured at##2##3##(2008-10#2)
currents obtained##2##2##(2008-10#1)(2011-1#1)
currents of cardiac##2##3##(1994-9#1)(1996-2#1)
currents of the##2##3##(1994-9#1)(2012-2#1)
currents of##12##2##(1994-3#1)(1994-9#2)(1995-2#1)(1996-2#2)(2008-10#4)(2012-12#1)(2012-2#1)
currents on the##2##3##(2008-10#1)(2009-12#1)
currents on##4##2##(2007-11#2)(2008-10#1)(2009-12#1)
currents originating in##2##3##(2012-2#1)(2013-1#1)
currents similar to those##2##4##(2008-10#1)(2011-2#1)
currents than##3##2##(1991-2#1)(2008-10#2)
currents that##2##2##(1995-5#1)(2008-3#1)
currents through##3##2##(1995-11#1)(2008-7#1)(2013-1#1)
currents to##4##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-8#1)
currents was##3##2##(1993-12#2)(2008-8#1)
currents were observed##2##3##(1993-3#1)(2008-10#1)
currents were##18##2##(1993-3#1)(1994-11#1)(1995-12#3)(1995-5#1)(1996-5#1)(2008-10#6)(2008-8#5)
currents which##2##2##(1990-5#1)(1993-3#1)
currents with a##3##3##(1992-12#1)(2007-12#1)(2008-8#1)
currents with##6##2##(1992-12#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
currents##227##1##(1990-5#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-12#6)(1992-3#1)(1992-8#5)(1993-12#9)(1993-3#5)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#10)(1995-12#11)(1995-2#6)(1995-5#5)(1996-12#1)(1996-2#7)(1996-4#3)(1996-5#6)(1997-2#4)(2007-11#5)(2007-12#3)(2007-5#1)(2008-10#47)(2008-11#5)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#3)(2008-8#27)(2008-9#2)(2009-10#1)(2009-12#14)(2009-2#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)
curricula and##4##2##(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)
curricula in the##2##3##(1997-3#1)(2008-12#1)
curricula in##4##2##(1997-3#1)(2008-12#2)(2012-3#1)
curricula of##3##2##(1996-1#1)(2008-11#1)(2011-2#1)
curricula##45##1##(1991-1#1)(1993-12#4)(1994-1#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#10)(2008-12#10)(2010-3#1)(2011-2#4)(2012-1#2)(2012-3#3)
curricular content##2##2##(1997-3#1)(2008-10#1)
curricular##9##1##(1996-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#2)
curriculum and##8##2##(1996-1#1)(2007-4#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
curriculum as##2##2##(2008-12#1)(2012-3#1)
curriculum at the University of##3##5##(1992-6#1)(1993-1#1)(2012-1#1)
curriculum based on##2##3##(1992-1#1)(2008-12#1)
curriculum change##2##2##(1996-3#1)(2009-8#1)
curriculum content##3##2##(1994-12#1)(1996-3#2)
curriculum design##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2012-3#1)
curriculum development##4##2##(2008-11#2)(2009-8#1)(2011-2#1)
curriculum for##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
curriculum from##2##2##(1997-3#1)(2011-2#1)
curriculum has##5##2##(2007-12#1)(2008-11#3)(2013-1#1)
curriculum in##7##2##(1994-3#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#2)
curriculum inquiry and##2##3##(1993-2#2)
curriculum is a##2##3##(2008-11#1)(2011-2#1)
curriculum is##8##2##(1993-1#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)
curriculum of Greek medical schools##2##5##(2011-2#2)
curriculum of the##3##3##(1991-6#1)(1996-8#1)(2011-2#1)
curriculum of##10##2##(1991-6#1)(1996-8#1)(2007-11#1)(2007-5#1)(2009-6#1)(2011-2#5)
curriculum on##2##2##(2007-12#1)(2012-3#1)
curriculum planning##3##2##(2008-12#2)(2010-3#1)
curriculum to##2##2##(2011-2#1)(2012-3#1)
curriculum was##3##2##(2008-11#2)(2012-3#1)
curriculum##173##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#3)(1993-1#5)(1993-12#1)(1993-2#6)(1994-1#2)(1994-12#6)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-8#1)(1997-2#2)(1997-3#3)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#3)(2008-1#2)(2008-10#7)(2008-11#38)(2008-12#20)(2008-3#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-3#2)(2011-1#3)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#13)(2013-1#4)
curriculums##2##1##(2008-12#1)(2011-1#1)
curse of##3##2##(1991-9#1)(2008-7#1)(2013-1#1)
curse##4##1##(1991-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
cursorial##2##1##(2009-4#1)(2012-3#1)
cursory##2##1##(2008-1#1)(2012-1#1)
curtail##5##1##(1996-2#1)(1997-3#1)(2008-10#2)(2009-4#1)
curtailed##5##1##(1992-6#1)(1993-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
curtailing##4##1##(1992-8#1)(1997-1#1)(2008-2#1)(2008-8#1)
curtovirus##6##1##(2008-10#6)
curtoviruses##2##1##(2008-10#2)
curtula##3##1##(2007-12#3)
curvature and twist fringes##2##4##(2008-3#2)
curvature and twist##4##3##(2008-3#4)
curvature and##17##2##(1997-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#5)(2009-5#2)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#2)
curvature between##2##2##(2008-3#1)(2013-1#1)
curvature correction##2##2##(2008-2#1)(2010-2#1)
curvature in the##2##3##(2007-12#1)(2012-2#1)
curvature in##3##2##(1990-12#1)(2007-12#1)(2012-2#1)
curvature is##2##2##(2008-9#1)(2009-11#1)
curvature of rice root##2##4##(2008-9#2)
curvature of the##9##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2013-1#1)
curvature of##19##2##(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-9#3)(2009-11#2)(2013-1#1)
curvature values##4##2##(2008-3#1)(2009-6#3)
curvature##102##1##(1990-12#2)(1992-3#2)(1994-12#1)(1997-2#2)(2007-11#4)(2007-12#7)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#30)(2008-6#1)(2008-7#5)(2008-9#5)(2009-11#4)(2009-2#3)(2009-5#4)(2009-6#5)(2009-9#1)(2010-2#2)(2012-1#3)(2012-2#4)(2013-1#5)
curvatures##7##1##(2008-3#3)(2008-9#1)(2009-6#1)(2011-1#1)(2012-1#1)
curvatus##5##1##(1996-6#4)(2012-2#1)
curve (AUC) of##2##3##(2008-7#1)(2012-3#1)
curve (AUC)##12##2##(1994-12#1)(1996-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
curve (P &lt##2##3##(2008-10#1)(2009-11#1)
curve analyses##6##2##(2008-12#1)(2009-7#1)(2012-12#1)(2012-2#2)(2013-7#1)
curve analysis##6##2##(2008-10#5)(2009-11#1)
curve and the##3##3##(2008-10#2)(2008-3#1)
curve and##20##2##(1994-9#1)(2007-8#2)(2008-10#8)(2008-3#1)(2008-7#3)(2008-9#3)(2012-2#1)(2013-1#1)
curve are##2##2##(2008-10#1)(2008-8#1)
curve as##2##2##(1995-3#1)(2008-10#1)
curve based on##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
curve but##2##2##(1995-12#1)(2009-5#1)
curve by##7##2##(1997-2#1)(2008-10#5)(2008-9#1)
curve can be##2##3##(1991-5#1)(2008-10#1)
curve can##3##2##(1991-4#1)(1991-5#1)(2008-10#1)
curve could be##2##3##(2008-10#1)(2011-2#1)
curve covered##2##2##(2008-10#2)
curve fit##3##2##(2008-2#1)(2008-7#1)(2009-12#1)
curve fitting and##2##3##(1995-2#1)(2008-2#1)
curve fitting##11##2##(1993-12#1)(1995-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)
curve for the##4##3##(1993-12#1)(1995-8#1)(2008-10#1)(2008-2#1)
curve for##30##2##(1990-11#1)(1990-12#1)(1993-12#1)(1995-11#1)(1995-8#2)(1996-2#2)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2011-2#3)(2012-1#1)
curve from 1##2##3##(2008-10#2)
curve from##6##2##(1994-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)
curve had##2##2##(1996-2#1)(2010-5#1)
curve in the##9##3##(1992-3#1)(2008-10#7)(2009-10#1)
curve in##15##2##(1992-3#1)(1995-3#1)(2008-10#10)(2008-2#1)(2009-10#1)(2012-2#1)
curve is linear in the range##2##6##(2008-10#2)
curve is linear in the##4##5##(2008-10#4)
curve is linear over the concentration range##4##7##(2008-10#4)
curve is linear over the##5##5##(2008-10#5)
curve is linear over##9##4##(2008-10#9)
curve is linear##17##3##(2008-10#17)
curve is##42##2##(1990-8#1)(1995-9#1)(2008-10#27)(2008-11#2)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)
curve may##3##2##(1997-5#1)(2008-7#1)(2012-2#1)
curve method##2##2##(2008-10#2)
curve modeling##2##2##(2008-12#1)(2013-1#1)
curve obtained by##2##3##(2008-10#2)
curve obtained in the##2##4##(2007-8#1)(2008-10#1)
curve obtained##5##2##(2007-8#1)(2008-10#4)
curve of a##4##3##(1992-8#1)(2008-2#3)
curve of the##9##3##(1992-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-2#1)(2013-8#1)
curve of##37##2##(1992-8#1)(1992-9#1)(1993-1#1)(1994-11#1)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#2)(2009-4#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#3)
curve over the##3##3##(1997-4#1)(2008-10#2)
curve over##4##2##(1997-4#1)(2008-10#3)
curve resolution methods##2##3##(2008-10#2)
curve resolution##7##2##(2007-12#4)(2008-10#3)
curve shape##2##2##(1995-9#1)(2008-11#1)
curve showed##2##2##(1994-11#1)(2010-3#1)
curve shows##3##2##(2007-11#1)(2008-3#2)
curve techniques##2##2##(2008-10#1)(2013-1#1)
curve that##7##2##(2008-10#3)(2008-3#1)(2008-6#1)(2009-6#1)(2011-1#1)
curve to##7##2##(1990-12#1)(1992-3#1)(1994-11#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-2#1)
curve was 0##4##3##(2008-10#3)(2010-8#1)
curve was affected mainly by initial conditions##2##7##(2008-10#2)
curve was constructed##4##3##(2007-8#1)(2008-10#3)
curve was found##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
curve was linear from##3##4##(2008-10#3)
curve was linear in the concentration range of##2##8##(2008-10#2)
curve was linear in the concentration range##3##7##(2008-10#3)
curve was linear in the##6##5##(2008-10#6)
curve was linear##24##3##(2008-10#23)(2011-2#1)
curve was obtained in##3##4##(2008-10#2)(2008-5#1)
curve was obtained##9##3##(2008-10#7)(2008-3#1)(2008-5#1)
curve was##68##2##(1991-12#1)(2007-8#1)(2008-10#56)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
curve when##3##2##(2007-12#1)(2011-2#2)
curve with respect to##2##4##(2008-10#1)(2009-6#1)
curve with##7##2##(2008-10#6)(2009-6#1)
curve##513##1##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-3#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#3)(1994-11#4)(1994-12#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-8#3)(1995-9#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-8#12)(2008-1#1)(2008-10#251)(2008-11#9)(2008-12#3)(2008-2#14)(2008-3#23)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#14)(2008-8#10)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#13)(2012-1#5)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#7)
curve) of##2##2##(2008-10#1)(2010-8#1)
curve)##6##1##(2007-8#1)(2008-10#3)(2010-10#1)(2010-8#1)
curve-fitting procedure##2##2##(2008-2#1)(2008-3#1)
curve-fitting##7##1##(1990-8#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-11#1)
curved surface##4##2##(1994-9#1)(2008-2#1)(2008-3#2)
curved surfaces are##2##3##(2008-2#1)(2008-3#1)
curved surfaces##5##2##(2008-2#1)(2008-3#3)(2008-7#1)
curved##36##1##(1992-3#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#15)(2008-5#1)(2008-7#3)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
curves and the##2##3##(2008-10#1)(2013-8#1)
curves and##12##2##(1995-12#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2013-8#2)
curves are##15##2##(1994-11#1)(2008-10#7)(2008-3#4)(2008-5#1)(2009-5#1)(2009-7#1)
curves as##3##2##(2007-10#1)(2008-6#1)(2011-1#1)
curves at##3##2##(1990-5#1)(1995-1#1)(2009-6#1)
curves between##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
curves can##2##2##(1997-2#1)(2008-7#1)
curves corresponded##2##2##(2008-7#1)(2008-8#1)
curves corresponding to##2##3##(2008-10#1)(2008-4#1)
curves drawn with zero-to-peak values##2##5##(2008-10#2)
curves for a##2##3##(1995-5#1)(2008-3#1)
curves for the##7##3##(1993-6#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
curves for##34##2##(1990-8#2)(1992-2#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-5#2)(1997-2#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-7#5)(2012-2#1)(2013-8#1)
curves from##2##2##(1995-2#1)(1995-9#1)
curves generated##2##2##(1994-5#1)(1995-12#1)
curves have been##2##3##(2008-3#1)(2008-5#1)
curves in##7##2##(2008-10#4)(2010-11#2)(2013-7#1)
curves indicate that##2##3##(1994-8#1)(2008-10#1)
curves indicated that the##2##4##(1993-8#1)(2008-12#1)
curves obtained##7##2##(1990-6#1)(1996-2#1)(2008-10#2)(2008-5#1)(2011-2#2)
curves of the##4##3##(2008-10#1)(2008-3#2)(2012-3#1)
curves of##25##2##(1990-8#1)(1992-12#1)(1993-1#2)(1995-1#1)(1996-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2012-1#1)(2012-2#1)(2012-3#1)
curves show##2##2##(1995-6#1)(2008-2#1)
curves showed##6##2##(2008-10#4)(2011-1#1)(2011-2#1)
curves that##2##2##(2008-3#1)(2009-7#1)
curves to a##2##3##(2008-5#1)(2008-7#1)
curves to##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
curves using##2##2##(2008-10#2)
curves was##3##2##(1991-8#1)(1994-3#1)(2008-10#1)
curves were calculated##2##3##(2007-7#1)(2011-2#1)
curves were constructed by##2##4##(2008-10#1)(2008-6#1)
curves were constructed##4##3##(2008-10#3)(2008-6#1)
curves were determined##2##3##(1992-5#1)(2013-1#1)
curves were drawn##2##3##(2008-10#2)
curves were established##3##3##(2008-10#3)
curves were generated for##2##4##(2008-10#2)
curves were linear in##4##4##(2008-10#4)
curves were linear##9##3##(2008-10#9)
curves were obtained for##3##4##(2008-10#3)
curves were obtained in##2##4##(2008-10#1)(2008-7#1)
curves were obtained##8##3##(2008-10#6)(2008-7#1)(2013-1#1)
curves were recorded##3##3##(1993-11#1)(2008-10#1)(2008-5#1)
curves were used to##2##4##(2008-11#1)(2011-1#1)
curves were##56##2##(1992-5#1)(1993-11#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#34)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#3)
curves with a##2##3##(2008-10#1)(2008-11#1)
curves with the##3##3##(1995-12#1)(1995-3#1)(2008-7#1)
curves with##8##2##(1995-12#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-7#1)
curves##348##1##(1990-5#1)(1990-6#1)(1990-8#6)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#5)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#4)(2008-10#145)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#23)(2008-4#2)(2008-5#15)(2008-6#2)(2008-7#16)(2008-8#4)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#7)
curves)##4##1##(1990-8#1)(2008-10#2)(2008-7#1)
curvilinear relationship##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
curvilinear##7##1##(1991-5#1)(1991-7#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-6#1)
cushions##4##1##(1996-12#1)(2008-10#2)(2009-3#1)
cusp##8##1##(2009-7#1)(2011-2#1)(2012-2#6)
cusps and##2##2##(1990-11#1)(2009-11#1)
cusps##7##1##(1990-11#1)(1997-5#1)(2009-11#1)(2011-2#4)
custodial work##3##2##(1991-12#3)
custodial workers##2##2##(1991-12#2)
custodial##8##1##(1991-12#6)(2007-1#1)(2007-2#1)
custodians of the##2##3##(1991-12#1)(2010-4#1)
custodians##6##1##(1991-12#5)(2010-4#1)
custody##7##1##(2008-1#1)(2010-1#6)
custom made##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
custom software##3##2##(2008-10#1)(2009-10#1)(2012-2#1)
custom##39##1##(1992-3#1)(1993-9#1)(1996-3#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
custom-built##5##1##(2007-8#1)(2008-10#3)(2008-3#1)
custom-designed##6##1##(2008-3#3)(2009-9#1)(2010-5#1)(2012-2#1)
custom-made##6##1##(2007-11#1)(2008-10#3)(2008-4#1)(2008-8#1)
customarily##2##1##(2007-12#1)(2008-3#1)
customary charges##2##2##(1991-12#2)
customary##8##1##(1991-12#2)(1991-2#1)(1991-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
customer needs##7##2##(1992-1#1)(1994-2#3)(1996-2#2)(1996-3#1)
customer requirements##4##2##(1994-1#1)(1996-3#3)
customer satisfaction##14##2##(1991-2#1)(1992-1#1)(1994-3#1)(1995-3#2)(1996-1#2)(1996-2#3)(1996-3#1)(1997-3#1)(2007-4#1)(2008-10#1)
customer service and##2##3##(1991-1#1)(1996-2#1)
customer service##14##2##(1991-1#1)(1993-1#1)(1993-12#1)(1994-3#2)(1995-1#3)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(2011-2#1)
customer value##2##2##(1994-12#1)(2013-8#1)
customer##65##1##(1991-1#1)(1991-2#1)(1992-1#3)(1992-3#3)(1993-1#1)(1993-12#3)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#4)(1995-1#6)(1995-12#1)(1995-2#3)(1995-3#3)(1996-1#4)(1996-2#7)(1996-3#7)(1997-3#3)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
customer's##4##1##(1991-12#1)(1994-12#2)(2008-10#1)
customer-supplier dialogue##2##2##(1994-3#2)
customer-supplier##3##1##(1994-1#1)(1994-3#2)
customers and##7##2##(1993-2#1)(1994-12#2)(1994-3#1)(1996-2#2)(2009-3#1)
customers for##2##2##(1994-1#1)(1994-3#1)
customers who##2##2##(1992-3#1)(1996-1#1)
customers with special needs##2##4##(2012-3#2)
customers##42##1##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#2)(1994-1#4)(1994-12#4)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2009-3#1)(2012-3#2)
customers' needs##2##2##(1994-1#1)(1994-3#1)
customers'##9##1##(1992-1#4)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-3#1)
customisable##2##1##(2011-3#2)
customization##2##1##(2008-10#2)
customize the##2##2##(2007-12#1)(2008-10#1)
customize##5##1##(1993-11#1)(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#1)
customized##15##1##(1993-1#1)(1995-3#2)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-4#1)(2011-7#1)(2013-1#1)(2013-8#1)
customs##3##1##(2008-11#1)(2009-6#1)(2011-2#1)
cut across##3##2##(2008-3#1)(2010-12#1)(2010-8#1)
cut and##6##2##(1992-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
cut as##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
cut at the##5##3##(2007-12#1)(2008-3#1)(2008-9#3)
cut costs##7##2##(1990-4#2)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-9#1)
cut down##2##2##(2008-10#1)(2011-2#1)
cut from##5##2##(2006-12#1)(2009-7#1)(2010-4#2)(2011-2#1)
cut in##2##2##(2008-10#1)(2008-9#1)
cut into##2##2##(2008-5#1)(2008-7#1)
cut null##2##2##(2008-9#2)
cut off of##2##3##(2007-7#1)(2008-11#1)
cut off##11##2##(1993-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2012-3#1)
cut on##2##2##(1995-6#1)(2008-11#1)
cut out##4##2##(1992-12#1)(1992-8#1)(1996-8#1)(2009-4#1)
cut scores##5##2##(2008-12#2)(2012-2#3)
cut surface##2##2##(2012-3#1)(2013-1#1)
cut the##2##2##(1996-1#1)(2007-12#1)
cut to##3##2##(2008-11#1)(2010-2#1)(2011-3#1)
cut was##3##2##(2008-5#3)
cut##130##1##(1990-2#1)(1990-4#3)(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#2)(1996-1#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#11)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#4)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
cut-and-sew&quot##2##1##(2010-8#2)
cut-flower roses##3##2##(2008-10#3)
cut-flower##4##1##(2008-10#4)
cut-off level##2##2##(2007-12#1)(2008-6#1)
cut-off of##2##2##(2008-7#1)(2013-1#1)
cut-off point of##2##3##(1992-1#1)(2007-8#1)
cut-off point##3##2##(1992-1#1)(2007-8#1)(2013-1#1)
cut-off points##3##2##(1992-12#1)(1995-9#1)(2008-10#1)
cut-off value##9##2##(1992-11#1)(1996-12#1)(1997-3#4)(2010-4#1)(2010-5#1)(2012-3#1)
cut-off values for##3##3##(2009-3#1)(2011-1#2)
cut-off values in##2##3##(2010-8#1)(2011-2#1)
cut-off values which##2##3##(1997-7#1)(2011-1#1)
cut-off values##9##2##(1994-12#1)(1994-3#1)(1997-7#1)(2009-3#1)(2010-8#1)(2011-1#3)(2011-2#1)
cut-off##40##1##(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-12#2)(1997-3#4)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-3#2)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#4)
cut-offs##3##1##(1997-2#1)(2008-10#1)(2008-9#1)
cutaneous B cell lymphoma##2##4##(2007-7#2)
cutaneous B cell##3##3##(1993-9#1)(2007-7#2)
cutaneous SSc##3##2##(2008-8#3)
cutaneous adenoid cystic carcinoma (ACC)##2##5##(1991-6#1)(2013-8#1)
cutaneous adverse drug reaction##2##4##(2007-7#1)(2008-8#1)
cutaneous adverse drug reactions##2##4##(2007-7#2)
cutaneous adverse drug##4##3##(2007-7#3)(2008-8#1)
cutaneous adverse##5##2##(2007-7#3)(2008-8#2)
cutaneous ageing##4##2##(2008-5#4)
cutaneous allodynia##2##2##(2008-9#2)
cutaneous amyloidosis##5##2##(2007-7#3)(2007-8#2)
cutaneous anaphylaxis activated by##2##4##(2008-10#2)
cutaneous anaphylaxis##4##2##(1995-11#1)(2008-10#3)
cutaneous and##8##2##(1990-10#1)(1991-4#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
cutaneous angiomyolipoma##3##2##(2010-6#3)
cutaneous basal cell##2##3##(2007-12#1)(2007-4#1)
cutaneous blood flow##2##3##(1990-7#2)
cutaneous candidosis##3##2##(2008-5#3)
cutaneous disorders##2##2##(1992-8#1)(2008-5#1)
cutaneous dryness##2##2##(2008-5#2)
cutaneous flaps##2##2##(1990-6#1)(2008-9#1)
cutaneous homeostasis##2##2##(2008-5#1)(2012-2#1)
cutaneous infections##2##2##(2008-5#1)(2012-3#1)
cutaneous involvement##3##2##(1990-8#1)(1991-4#1)(2010-6#1)
cutaneous larva migrans##2##3##(2007-2#2)
cutaneous leishmaniasis in##2##3##(2007-7#1)(2013-1#1)
cutaneous leishmaniasis##11##2##(2007-7#4)(2008-12#2)(2009-10#1)(2012-12#3)(2013-1#1)
cutaneous lesion##3##2##(2007-8#1)(2008-5#1)(2012-2#1)
cutaneous lesions of##2##3##(2008-5#1)(2009-10#1)
cutaneous lesions were##2##3##(1997-6#1)(2013-8#1)
cutaneous lesions##14##2##(1997-6#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#5)(2009-10#1)(2011-1#1)(2012-3#2)(2013-8#1)
cutaneous lymphoma##3##2##(2008-5#3)
cutaneous malignant melanoma (CMM)##2##4##(2007-10#1)(2012-3#1)
cutaneous malignant melanoma##3##3##(2007-10#1)(2007-12#1)(2012-3#1)
cutaneous manifestation##2##2##(2010-6#1)(2013-1#1)
cutaneous manifestations were the##2##4##(2007-7#1)(2008-6#1)
cutaneous manifestations##7##2##(2006-10#2)(2007-7#2)(2008-6#1)(2011-2#1)(2012-3#1)
cutaneous mass##3##2##(2013-8#3)
cutaneous mast cell tumors##2##4##(2012-3#2)
cutaneous melanoma##9##2##(1996-6#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-6#1)(2011-1#1)(2011-2#1)
cutaneous melanomas##5##2##(1994-6#1)(2009-4#4)
cutaneous metastases from esophageal##2##4##(2009-4#1)(2010-6#1)
cutaneous metastases from##3##3##(1990-8#1)(2009-4#1)(2010-6#1)
cutaneous metastases##9##2##(1990-8#1)(2009-4#1)(2010-6#3)(2013-8#4)
cutaneous metastasis##5##2##(2007-7#3)(2010-11#1)(2010-6#1)
cutaneous nerve##4##2##(1997-3#1)(2008-9#3)
cutaneous or##2##2##(1997-3#1)(2012-3#1)
cutaneous pigmentation##2##2##(1995-2#2)
cutaneous sporotrichosis lasting for 10 years##2##6##(2007-7#2)
cutaneous tuberculosis##2##2##(2007-7#2)
cutaneous tumors##3##2##(2007-12#1)(2008-6#1)(2013-8#1)
cutaneous vascular##2##2##(2008-10#1)(2013-1#1)
cutaneous vasculitis##3##2##(1997-4#1)(2007-7#1)(2008-8#1)
cutaneous##263##1##(1990-10#1)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#4)(1992-8#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-11#2)(1996-6#3)(1997-3#6)(1997-4#1)(1997-6#1)(2006-10#5)(2007-10#1)(2007-12#5)(2007-2#3)(2007-4#2)(2007-7#30)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#46)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#2)(2009-4#7)(2009-8#2)(2010-11#1)(2010-6#15)(2010-8#4)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#7)(2012-3#14)(2013-1#8)(2013-7#2)(2013-8#14)
cutané##2##1##(2008-5#1)(2013-1#1)
cutanée##2##1##(2008-5#1)(2013-1#1)
cuticle Col##2##2##(1993-12#2)
cuticle and wax##2##3##(2008-10#2)
cuticle and##12##2##(2007-12#2)(2008-10#8)(2008-7#1)(2008-9#1)
cuticle cells are##2##3##(2008-5#2)
cuticle components##2##2##(2009-8#2)
cuticle degradation##2##2##(2008-10#1)(2008-7#1)
cuticle layers##2##2##(2008-5#1)(2008-7#1)
cuticle thickness##2##2##(2008-10#2)
cuticle was##2##2##(2008-10#2)
cuticle with##2##2##(2007-12#1)(2008-7#1)
cuticle##75##1##(1993-12#4)(1994-12#1)(2007-12#17)(2008-10#26)(2008-5#6)(2008-7#10)(2008-8#5)(2008-9#1)(2009-8#4)(2011-2#1)
cuticle-lined##2##1##(2007-12#2)
cuticles##2##1##(2007-12#2)
cuticular col##3##2##(1994-12#3)
cuticular fingers##2##2##(2008-7#2)
cuticular hydrocarbons##9##2##(2008-9#5)(2012-3#3)(2013-8#1)
cuticular wall##2##2##(2007-12#2)
cuticular wax##3##2##(2008-10#2)(2008-5#1)
cuticular##41##1##(1993-9#1)(1994-12#5)(2007-12#16)(2008-10#3)(2008-5#3)(2008-7#2)(2008-9#6)(2012-3#3)(2013-8#2)
cutinase family##2##2##(2009-6#2)
cutinase in##2##2##(2008-10#1)(2008-7#1)
cutinase##10##1##(1995-3#1)(2008-10#2)(2008-7#5)(2009-6#2)
cutis as the##2##3##(2010-6#2)
cutis is##4##2##(2010-6#4)
cutis laxa##2##2##(2008-5#1)(2008-7#1)
cutis##11##1##(2008-5#1)(2008-7#1)(2010-6#9)
cutoff filters##3##2##(2008-3#3)
cutoff for##2##2##(2006-10#1)(2008-2#1)
cutoff frequency##10##2##(2007-11#2)(2008-2#3)(2008-3#5)
cutoff in microstructured optical fibers##2##5##(2007-11#2)
cutoff of##5##2##(1992-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-3#1)
cutoff point of##4##3##(2008-3#1)(2012-12#1)(2012-2#2)
cutoff point##7##2##(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#3)
cutoff points##4##2##(2011-2#1)(2012-3#2)(2013-1#1)
cutoff score for depression was##2##5##(2006-10#2)
cutoff score##3##2##(2006-10#3)
cutoff size##2##2##(1992-6#2)
cutoff value##6##2##(1992-6#1)(1994-11#1)(1995-3#1)(2013-1#3)
cutoff values##2##2##(1994-7#1)(2008-10#1)
cutoff was##2##2##(2006-10#1)(2008-8#1)
cutoff wavelength##3##2##(2007-12#1)(2008-2#2)
cutoff##69##1##(1992-6#9)(1993-11#1)(1994-11#2)(1994-7#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#1)(2006-10#5)(2007-10#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#13)(2008-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
cutoffs for##2##2##(2012-3#2)
cutoffs##4##1##(2008-12#1)(2008-2#1)(2012-3#2)
cutpoint##2##1##(2008-10#2)
cuts and##2##2##(1996-3#1)(2008-11#1)
cuts in##7##2##(1992-5#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2013-8#1)
cuts is##2##2##(2008-3#2)
cuts of##2##2##(2008-12#1)(2009-4#1)
cuts to the##2##3##(1993-3#1)(2008-2#1)
cuts to##3##2##(1993-3#1)(2008-2#1)(2009-3#1)
cuts##46##1##(1990-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-5#2)(1996-3#2)(1996-5#2)(1997-2#1)(2007-11#1)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#8)(2008-5#2)(2009-3#1)(2009-4#5)(2011-2#1)(2013-1#2)(2013-8#1)
cutter##3##1##(1993-6#1)(1996-2#1)(2012-3#1)
cutthroat trout##2##2##(2010-8#2)
cutting and##3##2##(2008-10#1)(2010-6#1)(2010-8#1)
cutting balloon##2##2##(2008-1#1)(2011-2#1)
cutting edge##6##2##(1994-1#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
cutting instruments##3##2##(2008-11#1)(2012-12#2)
cutting of##2##2##(2008-2#1)(2013-1#1)
cutting or##2##2##(2008-10#1)(2008-2#1)
cutting restriction##2##2##(2008-10#1)(2008-5#1)
cutting the##4##2##(1992-3#1)(1993-12#1)(2008-5#1)(2013-1#1)
cutting##52##1##(1990-4#2)(1990-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-6#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
cutting-edge##4##1##(1993-3#1)(1997-1#1)(2008-7#1)(2012-2#1)
cuttings (physiological age##2##3##(2008-10#2)
cuttings of##2##2##(1990-8#1)(2008-10#1)
cuttings was##2##2##(2008-10#2)
cuttings were##2##2##(2008-10#2)
cuttings##14##1##(1990-8#1)(2008-10#12)(2012-4#1)
cuttlefish##2##1##(2013-7#2)
cuttlefishes##2##1##(2013-7#2)
cuvette and##2##2##(1992-11#1)(2008-3#1)
cuvette##14##1##(1992-11#1)(1993-3#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#4)(2010-2#1)
cuvettes##3##1##(2007-12#1)(2008-10#2)
cv##242##1##(1990-5#1)(1995-6#2)(1996-12#1)(1997-6#1)(2008-10#211)(2008-11#1)(2008-12#12)(2008-6#4)(2008-8#2)(2008-9#7)
cvs##51##1##(2008-10#50)(2008-6#1)
cw 244-nm##2##2##(2007-12#2)
cw CO(2) laser##2##3##(2008-3#2)
cw CO(2)##3##2##(2008-3#3)
cw Doppler lidar##3##3##(2008-3#3)
cw Nd##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
cw Raman laser in H(2) with##2##6##(2007-11#2)
cw Raman laser##5##3##(2007-11#3)(2007-12#2)
cw Ti##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
cw Tm##2##2##(2007-12#1)(2008-2#1)
cw and pulsed##4##3##(2008-2#1)(2008-3#3)
cw and##10##2##(1993-9#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)
cw argon laser##2##3##(2008-3#2)
cw diode laser at##2##4##(2007-12#1)(2008-2#1)
cw diode-pumped##3##2##(2007-12#3)
cw excitation##2##2##(2007-12#1)(2008-3#1)
cw laser beam##3##3##(2007-12#2)(2008-2#1)
cw laser to##2##3##(2008-2#2)
cw laser##23##2##(2007-11#2)(2007-12#7)(2008-2#6)(2008-3#8)
cw lasing##3##2##(2007-11#1)(2008-3#2)
cw light##2##2##(2007-11#1)(2007-12#1)
cw mode##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
cw mode-locked##3##2##(2007-11#3)
cw operation##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
cw optical parametric oscillator (OPO)##2##5##(2007-12#1)(2008-3#1)
cw optical parametric oscillator##4##4##(2007-12#3)(2008-3#1)
cw optical parametric##5##3##(2007-12#4)(2008-3#1)
cw optical##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
cw output power##3##3##(2007-12#1)(2008-2#2)
cw output##5##2##(2007-12#3)(2008-2#2)
cw photothermal##2##2##(2008-3#2)
cw power performance##2##3##(2008-2#2)
cw power##5##2##(2007-12#2)(2008-2#3)
cw probe laser##2##3##(2008-2#1)(2008-3#1)
cw radiation is##3##3##(2007-12#1)(2008-2#2)
cw radiation##4##2##(2007-12#1)(2008-2#3)
cw single-mode##2##2##(2008-2#1)(2008-3#1)
cw##171##1##(1993-9#2)(2007-11#25)(2007-12#59)(2008-2#43)(2008-3#42)
cw-laser##2##1##(2008-3#2)
cyan fluorescent proteins##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
cyan##5##1##(2008-10#2)(2008-3#1)(2008-9#2)
cyanate##4##1##(2008-10#2)(2010-2#2)
cyanelles##3##1##(1997-6#3)
cyanex##4##1##(2008-10#4)
cyanide activity in##2##3##(2008-10#2)
cyanide and##5##2##(1996-5#1)(2008-10#4)
cyanide by##2##2##(2008-10#2)
cyanide complexes##2##2##(1993-8#1)(2008-10#1)
cyanide concentration##2##2##(2008-10#2)
cyanide gas is##2##3##(2008-10#2)
cyanide gas##5##2##(2008-10#5)
cyanide in##3##2##(2008-10#3)
cyanide insensitive Acyl CoA oxidase##2##5##(1990-12#2)
cyanide ion##3##2##(2008-10#3)
cyanide is##3##2##(2008-10#3)
cyanide or##3##2##(1993-8#1)(1994-6#1)(2008-11#1)
cyanide solution##2##2##(2008-10#2)
cyanide using##3##2##(2008-10#3)
cyanide was##2##2##(2008-10#2)
cyanide with##4##2##(2008-10#4)
cyanide##87##1##(1990-12#2)(1991-5#1)(1991-9#2)(1992-12#2)(1993-11#1)(1993-8#4)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#4)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#59)(2008-11#1)(2008-7#1)(2009-2#1)
cyanides##3##1##(2008-10#3)
cyanine R##2##2##(2008-10#2)
cyanine dye films##3##3##(2008-3#3)
cyanine dye##7##2##(2008-10#3)(2008-3#3)(2008-7#1)
cyanine dyes##5##2##(2007-11#1)(2008-10#2)(2009-12#2)
cyanine##20##1##(2007-11#2)(2007-12#1)(2008-10#11)(2008-3#3)(2008-7#1)(2009-12#2)
cyano groups of the##2##4##(2007-11#1)(2008-10#1)
cyano propyl stationary phase##4##4##(2008-10#4)
cyano propyl stationary##5##3##(2008-10#5)
cyano##10##1##(1996-5#1)(2007-11#1)(2008-10#7)(2010-11#1)
cyanoacrylate skin surface##2##3##(2008-5#2)
cyanoacrylate##7##1##(2008-10#1)(2008-5#5)(2008-7#1)
cyanobacteria are##2##2##(2009-4#1)(2013-7#1)
cyanobacteria from##2##2##(2013-7#2)
cyanobacteria##22##1##(1990-11#2)(1992-12#1)(1992-3#2)(1993-11#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-2#2)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#5)
cyanobacterial biofilms##2##2##(2008-10#2)
cyanobacterial toxins##2##2##(1990-12#1)(2012-12#1)
cyanobacterial##19##1##(1990-11#3)(1990-12#1)(1992-3#1)(1994-6#2)(1995-6#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
cyanobacterium Anabaena sp##2##3##(2008-8#2)
cyanobacterium Anabaena##3##2##(2008-11#1)(2008-8#2)
cyanobacterium Calothrix##2##2##(1992-12#2)
cyanobacterium Synechococcus sp##3##3##(1992-3#1)(1996-6#2)
cyanobacterium Synechococcus##4##2##(1992-3#1)(1996-6#2)(2013-1#1)
cyanobacterium Synechocystis sp##5##3##(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)
cyanobacterium##21##1##(1992-12#2)(1992-3#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-6#4)(1997-6#1)(2008-11#1)(2008-6#1)(2008-8#3)(2013-1#1)
cyanocobalamin##2##1##(2008-10#1)(2013-1#1)
cyanocopolymer##3##1##(2008-10#3)
cyanogen bromide and chloromethylsilane##2##4##(2008-4#1)(2008-9#1)
cyanogen bromide peptide##2##3##(1990-8#1)(2008-10#1)
cyanogen bromide##11##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
cyanogen##12##1##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
cyanopropyl##2##1##(2008-10#2)
cyanosis and##2##2##(2007-8#1)(2010-5#1)
cyanosis are##2##2##(1990-11#1)(2009-9#1)
cyanosis##6##1##(1990-11#1)(2007-8#1)(2009-9#3)(2010-5#1)
cyanotic##2##1##(2008-3#1)(2009-9#1)
cyanthiwigin##4##1##(2009-12#4)
cyanthiwigins##2##1##(2009-12#2)
cyberspace##2##1##(1995-12#1)(2008-1#1)
cycad toxicity##2##2##(1994-11#2)
cycad##6##1##(1994-11#6)
cyclamate by an##2##3##(2008-10#2)
cyclamate in the##2##3##(2008-10#2)
cyclamate##7##1##(2008-10#5)(2011-1#2)
cyclamen leaves##2##2##(2008-10#2)
cyclamen##7##1##(2008-10#7)
cyclandelate##7##1##(1994-8#7)
cyclase activation##3##2##(1990-7#1)(1993-6#1)(1994-8#1)
cyclase activities##2##2##(1995-11#1)(1997-7#1)
cyclase activity as##2##3##(1994-11#1)(1995-12#1)
cyclase activity in##4##3##(1990-8#2)(1994-11#1)(1994-3#1)
cyclase activity##14##2##(1990-8#4)(1992-3#1)(1992-6#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-12#2)(2008-4#1)
cyclase and##5##2##(1990-12#1)(1992-8#1)(1994-8#1)(2008-4#2)
cyclase in##9##2##(1991-2#3)(1995-2#1)(1995-3#1)(1997-1#2)(2008-3#1)(2010-11#1)
cyclase inhibitor##2##2##(2008-4#1)(2008-5#1)
cyclase stimulating activity##3##3##(1990-7#1)(1992-9#2)
cyclase stimulation##3##2##(1990-7#1)(1995-11#1)(2008-4#1)
cyclase system##2##2##(1993-3#1)(1995-11#1)
cyclase##99##1##(1990-12#3)(1990-5#1)(1990-7#4)(1990-8#5)(1991-2#5)(1991-9#4)(1992-3#8)(1992-6#1)(1992-8#3)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#5)(1995-11#7)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-7#1)(2008-10#1)(2008-3#3)(2008-4#10)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)
cyclase-activating##3##1##(1992-3#1)(1995-11#2)
cyclases##7##1##(1992-3#2)(1992-8#3)(1994-8#1)(2008-9#1)
cycle -##2##2##(2008-12#2)
cycle 1##5##2##(2008-7#5)
cycle analysis of##3##3##(2008-9#2)(2011-1#1)
cycle analysis##15##2##(1997-1#1)(2008-11#5)(2008-2#1)(2008-9#7)(2011-1#1)
cycle and in##2##3##(2007-7#1)(2011-1#1)
cycle and mating behavior of Zygotylenchus guevarai##2##7##(2008-12#2)
cycle and the##5##3##(2008-10#2)(2008-5#1)(2011-1#1)(2011-3#1)
cycle and##39##2##(1990-9#1)(1991-9#1)(1992-9#1)(1994-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-5#2)(2008-9#2)(2010-1#2)(2010-4#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-1#3)(2012-12#1)(2012-3#1)
cycle are##6##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-3#1)
cycle arrest##32##2##(1991-5#1)(1991-9#1)(1994-11#1)(1995-2#3)(1997-1#1)(1997-3#2)(1997-7#5)(2008-11#4)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
cycle as##4##2##(1993-8#1)(1994-2#1)(2008-10#1)(2011-2#1)
cycle based on##2##3##(2009-9#1)(2010-7#1)
cycle between##2##2##(2008-10#1)(2008-3#1)
cycle by##6##2##(1994-3#1)(1997-1#1)(2007-9#1)(2009-11#1)(2012-2#1)(2013-1#1)
cycle caused##2##2##(2008-10#1)(2008-2#1)
cycle control##8##2##(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
cycle delay##3##2##(1993-12#1)(2008-10#1)(2010-2#1)
cycle disorders and##2##3##(1990-9#1)(2009-8#1)
cycle during##4##2##(2008-7#1)(2009-8#1)(2010-3#1)(2012-3#1)
cycle enzymes##6##2##(2008-7#3)(2009-10#2)(2012-6#1)
cycle for both##2##3##(2008-11#1)(2010-8#1)
cycle for##3##2##(1997-1#1)(2008-11#1)(2010-8#1)
cycle frequency##3##2##(2010-4#3)
cycle from##4##2##(1990-11#1)(1994-3#1)(2008-12#1)(2008-5#1)
cycle genes##4##2##(2008-10#3)(2010-7#1)
cycle has also been##2##4##(1990-7#1)(2012-2#1)
cycle has##5##2##(1990-7#1)(1995-2#1)(1996-2#1)(2012-2#1)(2013-1#1)
cycle in the##4##3##(1996-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
cycle in##24##2##(1990-5#1)(1993-11#1)(1993-8#1)(1996-3#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-4#2)(2008-9#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)
cycle is the##2##3##(1996-2#1)(2008-10#1)
cycle is##10##2##(1993-9#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
cycle lasted##2##2##(2008-10#1)(2008-5#1)
cycle length##2##2##(1995-12#1)(1995-9#1)
cycle may be##2##3##(1993-11#1)(2009-4#1)
cycle may##4##2##(1993-11#1)(2008-10#1)(2009-3#1)(2009-4#1)
cycle number##4##2##(1996-12#1)(2008-10#1)(2008-3#2)
cycle of Leishmania##2##3##(2012-2#1)(2013-1#1)
cycle of chemotherapy and##2##4##(2008-6#1)(2008-7#1)
cycle of chemotherapy##3##3##(2008-6#1)(2008-7#2)
cycle of the seminiferous epithelium##3##5##(2009-10#3)
cycle of the##19##3##(1991-9#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-6#2)(2009-10#3)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
cycle of this##3##3##(2007-6#1)(2008-10#1)(2008-9#1)
cycle of##76##2##(1991-9#1)(1992-3#2)(1992-6#1)(1994-11#1)(1994-2#2)(1995-6#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
cycle on the##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
cycle on##7##2##(1992-6#2)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#2)
cycle phase##9##2##(2008-11#7)(2008-5#1)(2008-9#1)
cycle plays##2##2##(2013-1#2)
cycle ratio##4##2##(2008-3#4)
cycle regulation##9##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)
cycle research##2##2##(1991-5#1)(2008-11#1)
cycle stage##2##2##(2008-6#1)(2008-9#1)
cycle studies##2##2##(2010-2#1)(2013-1#1)
cycle than##2##2##(1997-6#1)(2008-9#1)
cycle that##5##2##(1995-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)
cycle threshold##2##2##(2008-10#2)
cycle time of##3##3##(2008-10#1)(2008-11#2)
cycle time##7##2##(1993-12#1)(2008-10#4)(2008-11#2)
cycle to##2##2##(1994-7#1)(2012-2#1)
cycle transition##2##2##(2008-9#1)(2011-2#1)
cycle was##9##2##(1990-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
cycle were##7##2##(1990-12#1)(1993-12#2)(2007-10#1)(2008-7#2)(2011-1#1)
cycle with a##2##3##(1992-1#1)(2011-2#1)
cycle with##7##2##(1992-1#1)(1993-11#1)(1993-6#1)(2007-12#1)(2008-10#2)(2011-2#1)
cycle within##2##2##(2008-10#1)(2011-2#1)
cycle##770##1##(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#5)(1991-11#2)(1991-2#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#3)(1992-2#1)(1992-3#4)(1992-6#5)(1992-8#3)(1992-9#3)(1993-11#8)(1993-12#4)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#4)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#4)(1994-5#2)(1994-7#1)(1994-8#6)(1994-9#7)(1995-11#3)(1995-12#2)(1995-2#8)(1995-5#1)(1995-6#2)(1995-9#5)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-9#1)(1997-1#7)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#10)(1997-7#11)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-9#2)(2008-1#3)(2008-10#94)(2008-11#79)(2008-12#8)(2008-2#10)(2008-3#17)(2008-4#14)(2008-5#27)(2008-6#10)(2008-7#42)(2008-8#13)(2008-9#45)(2009-10#11)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#9)(2009-9#4)(2010-1#4)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#9)(2011-2#23)(2011-3#4)(2012-1#6)(2012-12#17)(2012-2#24)(2012-3#17)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#22)(2013-7#2)(2013-8#7)
cycle&quot##2##1##(2008-9#1)(2010-3#1)
cycle) and##2##2##(1991-4#1)(2008-11#1)
cycle)##8##1##(1991-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-8#1)
cycler##3##1##(2008-4#1)(2011-2#2)
cycles (range##2##2##(1992-8#1)(2008-6#1)
cycles and in##2##3##(2007-6#1)(2011-2#1)
cycles and##10##2##(1991-6#2)(1994-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
cycles are##2##2##(2008-10#2)
cycles as##2##2##(2008-2#1)(2012-12#1)
cycles before surgery##2##3##(2009-4#2)
cycles during##2##2##(1991-2#1)(2010-8#1)
cycles for##2##2##(2007-12#1)(2008-10#1)
cycles in##4##2##(1994-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
cycles of chemotherapy##7##3##(1991-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)
cycles of cisplatin##2##3##(2008-10#1)(2013-1#1)
cycles of doxorubicin and##2##4##(1991-8#1)(2013-1#1)
cycles of selection##3##3##(2008-10#3)
cycles of the##2##3##(2008-11#1)(2012-2#1)
cycles of therapy##2##3##(1992-10#1)(2009-12#1)
cycles of treatment##2##3##(1994-5#1)(2008-7#1)
cycles of wetting and drying of##2##6##(2008-10#2)
cycles of##84##2##(1990-6#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1994-5#2)(1996-9#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#4)(2008-2#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#2)(2009-8#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)
cycles over##2##2##(2008-10#2)
cycles per##4##2##(1994-11#1)(2007-10#1)(2008-2#1)(2008-6#1)
cycles showed##2##2##(2008-10#2)
cycles that were delivered##2##4##(2008-7#2)
cycles that##3##2##(2008-10#1)(2008-7#2)
cycles to##5##2##(1990-5#1)(1994-12#1)(1994-9#1)(2008-3#2)
cycles using##3##2##(2008-10#2)(2008-5#1)
cycles was##4##2##(1992-2#1)(1994-9#1)(2008-6#1)(2008-7#1)
cycles were##8##2##(2008-10#2)(2008-3#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-6#1)(2013-1#1)
cycles with##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2009-7#1)
cycles without##3##2##(2008-10#3)
cycles##247##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#6)(1991-8#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-2#3)(1993-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#3)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#2)(1995-5#1)(1996-4#1)(1996-9#1)(1997-3#1)(2007-10#2)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#69)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#3)(2009-4#8)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#2)(2010-8#5)(2011-1#4)(2011-2#12)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#1)
cycles)##7##1##(1990-6#1)(1991-11#1)(1997-7#1)(2008-10#3)(2011-2#1)
cycles/min##2##1##(1990-8#1)(2009-6#1)
cyclic ADP-ribose##2##2##(1994-11#1)(1995-3#1)
cyclic AMP (cAMP)##2##3##(1997-2#1)(2008-10#1)
cyclic AMP accumulation and##2##4##(1996-12#1)(2008-4#1)
cyclic AMP accumulation##6##3##(1993-3#1)(1994-2#2)(1996-12#2)(2008-4#1)
cyclic AMP and##5##3##(1991-9#1)(1993-6#1)(1995-11#1)(1996-5#1)(1997-7#1)
cyclic AMP as##2##3##(1992-3#1)(1995-11#1)
cyclic AMP content in##2##4##(1994-6#2)
cyclic AMP content##4##3##(1994-6#2)(1995-11#2)
cyclic AMP formation##2##3##(1990-5#1)(1995-12#1)
cyclic AMP generation##2##3##(1993-11#2)
cyclic AMP is##2##3##(1991-9#1)(1993-6#1)
cyclic AMP levels in##2##4##(1993-5#2)
cyclic AMP production##3##3##(1995-11#3)
cyclic AMP response element##2##4##(1991-2#1)(1997-2#1)
cyclic AMP response##3##3##(1991-2#1)(1995-8#1)(1997-2#1)
cyclic AMP##62##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-9#2)(1992-3#2)(1992-9#2)(1993-11#3)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#1)(1994-11#3)(1994-2#5)(1994-6#4)(1995-11#10)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-5#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(2008-10#2)(2008-4#2)
cyclic AMP-dependent protein kinase (protein kinase A)##2##7##(1993-8#1)(1994-9#1)
cyclic AMP-dependent protein kinase##7##4##(1990-12#1)(1991-2#1)(1993-8#2)(1994-9#2)(1995-11#1)
cyclic AMP-responsive element binding protein (CREB)##2##6##(1996-12#2)
cyclic GMP phosphodiesterase##2##3##(1992-12#2)
cyclic GMP##11##2##(1990-12#1)(1992-12#3)(1992-3#1)(1994-11#1)(1994-12#1)(1995-11#2)(2007-10#1)(2008-4#1)
cyclic adenosine monophosphate (cAMP)##2##4##(1994-8#1)(1995-8#1)
cyclic adenosine monophosphate##3##3##(1994-8#1)(1995-8#1)(2009-3#1)
cyclic adenosine##5##2##(1994-8#1)(1994-9#2)(1995-8#1)(2009-3#1)
cyclic alcohols##2##2##(1994-6#2)
cyclic and reciprocal##2##3##(2008-6#2)
cyclic and square wave voltammetry##2##5##(2008-10#2)
cyclic and square-wave voltammetry##3##4##(2008-10#3)
cyclic and##12##2##(2008-10#9)(2008-6#2)(2008-7#1)
cyclic batch operating mode##2##4##(2008-11#2)
cyclic depsipeptides##2##2##(2007-12#1)(2008-9#1)
cyclic derivative##2##2##(1991-12#1)(2008-10#1)
cyclic error##2##2##(2007-11#1)(2008-3#1)
cyclic food##2##2##(2008-4#1)(2009-8#1)
cyclic gas exchange##2##3##(2010-4#2)
cyclic guanosine monophosphate##3##3##(1991-9#2)(2007-10#1)
cyclic guanosine##4##2##(1991-9#2)(1995-2#1)(2007-10#1)
cyclic hypoxia##3##2##(2010-4#3)
cyclic ketals##2##2##(2008-5#2)
cyclic loading##6##2##(2008-5#1)(2009-3#2)(2009-7#2)(2012-7#1)
cyclic nucleotide phosphodiesterase isozyme##4##4##(1993-6#1)(1997-2#3)
cyclic nucleotide phosphodiesterase##9##3##(1992-3#1)(1993-6#1)(1997-2#7)
cyclic nucleotide##12##2##(1992-3#1)(1993-6#1)(1995-3#1)(1997-2#7)(2009-10#1)(2012-2#1)
cyclic pentapeptide##2##2##(1992-4#1)(2008-7#1)
cyclic peptide##4##2##(1990-12#1)(1992-3#1)(1993-5#1)(2008-10#1)
cyclic peptides##3##2##(1994-6#2)(2008-4#1)
cyclic process##2##2##(2008-10#1)(2009-10#1)
cyclic restriction##2##2##(2008-4#2)
cyclic strain and forskolin##2##4##(1993-3#2)
cyclic strain##9##2##(1993-3#4)(1994-11#5)
cyclic succession##3##2##(2008-9#3)
cyclic tensile loading##2##3##(2012-7#2)
cyclic tetrapeptide derivatives as neutral ionophores##2##6##(2008-10#2)
cyclic tetrapeptide##3##2##(2008-10#3)
cyclic tetrathioethers##2##2##(2008-10#2)
cyclic voltammetric studies##2##3##(2009-9#2)
cyclic voltammetric technique for##2##4##(2008-10#2)
cyclic voltammetric##11##2##(2008-10#9)(2009-9#2)
cyclic voltammetry (CV) and differential pulse voltammetry##2##7##(2008-10#2)
cyclic voltammetry (CV) and##8##4##(2008-10#8)
cyclic voltammetry (CV)##18##3##(2008-10#18)
cyclic voltammetry and differential pulse##3##5##(2008-10#3)
cyclic voltammetry and##16##3##(2008-10#13)(2013-1#3)
cyclic voltammetry as a function of##2##6##(2008-10#2)
cyclic voltammetry at a##4##4##(2008-10#4)
cyclic voltammetry at##5##3##(2008-10#5)
cyclic voltammetry with##2##3##(2008-4#1)(2009-9#1)
cyclic voltammetry##82##2##(2008-10#74)(2008-3#1)(2008-4#2)(2008-6#1)(2009-9#1)(2013-1#3)
cyclic voltammograms of##3##3##(1996-5#1)(2008-10#2)
cyclic voltammograms were##2##3##(2008-10#2)
cyclic voltammograms##10##2##(1996-5#1)(2008-10#9)
cyclic##372##1##(1990-11#1)(1990-12#4)(1990-5#5)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-9#7)(1992-12#4)(1992-3#5)(1992-4#2)(1992-9#2)(1993-11#3)(1993-3#5)(1993-5#3)(1993-6#7)(1993-8#5)(1994-11#13)(1994-12#2)(1994-2#5)(1994-6#8)(1994-8#2)(1994-9#4)(1995-11#15)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#2)(1995-9#1)(1996-12#4)(1996-2#2)(1996-5#6)(1997-1#1)(1997-2#10)(1997-4#1)(1997-6#2)(1997-7#2)(2007-10#2)(2007-11#4)(2007-12#2)(2008-10#133)(2008-11#6)(2008-3#2)(2008-4#10)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#5)(2009-8#6)(2009-9#4)(2010-4#6)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#3)(2013-1#3)(2013-7#2)
cyclical parthenogen##2##2##(2012-3#2)
cyclical sleep##2##2##(2008-7#2)
cyclical##17##1##(1992-1#1)(1992-2#2)(1994-8#2)(2008-11#4)(2008-7#2)(2008-9#2)(2012-2#2)(2012-3#2)
cyclically##2##1##(2008-9#1)(2012-7#1)
cyclicity##2##1##(1994-7#2)
cyclin A and cdk2##3##4##(1994-6#3)
cyclin A expression##2##3##(1993-6#1)(2013-7#1)
cyclin A##15##2##(1993-6#4)(1994-11#1)(1994-6#5)(1994-8#2)(2008-4#1)(2011-2#1)(2013-7#1)
cyclin A-activated G1 extract##2##4##(1994-8#2)
cyclin A-activated G1##3##3##(1994-8#3)
cyclin A/cdk2##2##2##(1994-6#2)
cyclin B1##2##2##(2008-5#1)(2012-3#1)
cyclin B2##2##2##(2008-5#2)
cyclin D##2##2##(2013-8#2)
cyclin D1##7##2##(2008-4#1)(2010-1#2)(2012-3#1)(2013-1#3)
cyclin D1-Cdk4 complexes##2##3##(1997-7#2)
cyclin D2 gene##2##3##(1997-8#2)
cyclin D2 mRNA##2##3##(1997-8#2)
cyclin D2##8##2##(1997-8#8)
cyclin D3 cDNA##3##3##(1997-4#3)
cyclin D3 pseudogene##3##3##(1997-4#3)
cyclin D3##10##2##(1997-4#10)
cyclin E##4##2##(1995-5#2)(2008-10#1)(2010-6#1)
cyclin dependent kinase##2##3##(1995-5#1)(2012-3#1)
cyclin dependent kinases##3##3##(1997-6#2)(2011-2#1)
cyclin dependent##5##2##(1995-5#1)(1997-6#2)(2011-2#1)(2012-3#1)
cyclin expression and##2##3##(1994-11#1)(2008-4#1)
cyclin expression##4##2##(1994-11#1)(2008-4#3)
cyclin##76##1##(1992-10#2)(1993-6#4)(1993-9#1)(1994-11#6)(1994-6#7)(1994-8#5)(1995-5#3)(1997-1#1)(1997-4#10)(1997-6#3)(1997-7#2)(1997-8#8)(2008-10#1)(2008-4#5)(2008-5#3)(2008-9#1)(2010-1#2)(2010-6#1)(2011-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
cyclin-dependent kinase 4##2##3##(1993-3#2)
cyclin-dependent kinase inhibitor##4##3##(2008-11#2)(2008-5#1)(2012-12#1)
cyclin-dependent kinase##13##2##(1993-3#2)(1994-11#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
cyclin-dependent protein##2##2##(1994-11#1)(2010-6#1)
cyclin-dependent##16##1##(1993-3#2)(1994-11#2)(1997-1#1)(1997-7#1)(2008-11#3)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
cycling (-55 degrees C-125 degrees C)##2##6##(2008-2#2)
cycling at##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
cycling cells from##2##3##(2008-11#2)
cycling cells##5##2##(2008-11#5)
cycling exercise bout##2##3##(2013-8#2)
cycling experiment##3##2##(2008-10#3)
cycling in##4##2##(2008-10#4)
cycling of P##2##3##(2008-10#2)
cycling of the##2##3##(2008-10#2)
cycling of##9##2##(1990-8#1)(2008-10#6)(2008-11#1)(2008-7#1)
cycling on continental margins##2##4##(2012-2#2)
cycling the##2##2##(2008-10#2)
cycling##75##1##(1990-5#1)(1990-8#1)(1992-6#1)(1992-8#2)(1995-12#1)(1995-5#1)(1997-1#1)(2008-10#22)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-4#1)(2009-9#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#3)(2013-8#5)
cyclins B1 and B2##3##4##(2008-5#3)
cyclins and CDKs##3##3##(1997-6#3)
cyclins and##4##2##(1997-6#3)(2012-2#1)
cyclins##20##1##(1993-9#1)(1997-6#9)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#2)(2012-12#1)(2012-2#1)
cyclisation##2##1##(2007-11#1)(2008-10#1)
cyclists##7##1##(1990-6#3)(1992-6#2)(2011-2#2)
cyclization of a##3##3##(1994-8#1)(2007-11#1)(2009-5#1)
cyclization of##6##2##(1994-8#1)(1995-5#1)(1996-5#1)(2007-11#2)(2009-5#1)
cyclization product##2##2##(1995-3#1)(2009-10#1)
cyclization step##2##2##(1996-5#1)(2008-4#1)
cyclization to##5##2##(2008-10#2)(2009-10#1)(2009-8#2)
cyclization##30##1##(1992-6#1)(1994-8#2)(1995-3#1)(1995-5#1)(1996-5#5)(1997-6#1)(2007-11#5)(2008-10#2)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#4)(2009-11#1)(2009-5#1)(2009-8#2)
cyclizations of##2##2##(2008-9#1)(2009-8#1)
cyclizations##4##1##(2007-11#1)(2008-9#1)(2009-5#1)(2009-8#1)
cyclized to the##2##3##(1996-5#2)
cyclized to##3##2##(1996-5#2)(2011-1#1)
cyclo-1##5##1##(2008-10#5)
cyclo-decapeptide##2##1##(2011-2#2)
cyclo-oxygenase##4##1##(1995-11#1)(1995-6#1)(2006-6#1)(2008-10#1)
cycloaddition of##5##2##(1996-5#4)(2007-11#1)
cycloaddition reaction with##2##3##(2007-11#2)
cycloaddition reaction##3##2##(2007-11#2)(2009-10#1)
cycloaddition reactions##3##2##(1997-4#2)(2012-3#1)
cycloaddition with##5##2##(1996-5#4)(2012-2#1)
cycloaddition##28##1##(1996-5#13)(1997-4#2)(2007-11#3)(2008-4#2)(2009-10#2)(2009-11#2)(2009-5#2)(2012-2#1)(2012-3#1)
cycloadditions##5##1##(1996-5#3)(1997-4#1)(2008-8#1)
cycloadduct was##2##2##(1996-5#2)
cycloadduct##7##1##(1996-5#6)(2009-12#1)
cycloadducts##8##1##(1996-5#4)(2009-12#1)(2010-2#2)(2012-3#1)
cycloartenol##2##1##(1991-5#1)(1992-8#1)
cyclobis(paraquat-p-phenylene)##2##1##(2010-12#2)
cyclobutane##3##1##(1992-8#1)(1994-8#2)
cyclocondensation of##2##2##(2012-2#1)(2012-3#1)
cyclocondensation##3##1##(2012-2#1)(2012-3#2)
cyclodeviation##2##1##(2011-1#2)
cyclodextrin complexes##2##2##(2008-10#2)
cyclodextrin##18##1##(1995-11#1)(2008-10#14)(2008-5#1)(2013-1#2)
cyclodextrin-mediated capillary##2##2##(2008-10#2)
cyclodextrins (CDs)##4##2##(1996-5#1)(2008-10#3)
cyclodextrins were##2##2##(2008-10#2)
cyclodextrins with##2##2##(2008-10#2)
cyclodextrins##26##1##(1996-5#2)(2008-10#22)(2008-6#2)
cyclohexane##15##1##(1994-8#1)(2008-10#12)(2008-2#1)(2009-12#1)
cyclohexanone and##2##2##(2008-10#2)
cyclohexanone##8##1##(2007-11#1)(2008-10#7)
cyclohexene##2##1##(2009-7#2)
cycloheximide (CHX)##2##2##(2008-11#2)
cycloheximide and actinomycin D##2##4##(1995-12#1)(2008-11#1)
cycloheximide and##6##2##(1991-5#1)(1994-9#1)(1995-12#1)(1997-7#1)(2008-11#1)(2011-3#1)
cycloheximide##35##1##(1991-12#3)(1991-5#3)(1992-8#5)(1993-12#2)(1993-3#2)(1993-8#1)(1994-12#2)(1994-9#3)(1995-12#1)(1995-6#1)(1997-1#2)(1997-7#1)(2008-10#3)(2008-11#4)(2009-8#1)(2011-3#1)
cycloheximide-sensitive##2##1##(1992-8#1)(1994-11#1)
cyclohexyl##5##1##(1995-11#2)(1997-7#1)(2008-10#1)(2010-12#1)
cyclohexyldiamine tetraacetic acid##2##3##(2008-10#2)
cyclohexyldiamine##3##1##(2008-10#2)(2010-11#1)
cyclohydrolase##6##1##(1990-7#1)(1992-8#3)(1993-8#2)
cyclone##2##1##(2008-1#1)(2008-7#1)
cyclooxygenase (COX)##2##2##(2011-2#1)(2012-2#1)
cyclooxygenase (COX)-2 inhibitors##2##3##(2008-11#1)(2008-7#1)
cyclooxygenase 2 (COX-2)##2##3##(2008-7#1)(2013-8#1)
cyclooxygenase 2##3##2##(1994-11#1)(2008-7#1)(2013-8#1)
cyclooxygenase activity##3##2##(1992-3#2)(2011-2#1)
cyclooxygenase and##2##2##(1994-5#1)(2006-10#1)
cyclooxygenase as##2##2##(1994-9#1)(2008-5#1)
cyclooxygenase in##3##2##(1993-11#1)(2008-11#2)
cyclooxygenase inhibitor##4##2##(1991-8#1)(1995-12#1)(1997-1#1)(2008-10#1)
cyclooxygenase or##3##2##(1995-11#1)(2008-11#1)(2008-4#1)
cyclooxygenase##41##1##(1990-12#1)(1991-8#2)(1992-3#2)(1993-11#1)(1993-8#2)(1994-11#1)(1994-5#3)(1994-9#4)(1995-11#1)(1995-12#1)(1996-12#2)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-8#1)
cyclooxygenase-2##9##1##(1997-1#2)(2006-10#1)(2008-10#3)(2008-8#1)(2012-2#1)(2013-1#1)
cyclopalladated amine complexes##2##3##(2008-10#2)
cyclopenta[b]benzopyran##2##1##(2008-8#2)
cyclopentadiene##2##1##(1996-5#2)
cyclopentadienylnickel(II) thiolato Schiff base##2##4##(2008-10#2)
cyclophellitol##2##1##(1991-5#2)
cyclophilin##3##1##(1991-9#2)(2010-12#1)
cyclophosphamide (CPA)##3##2##(1994-7#1)(1995-4#1)(1997-7#1)
cyclophosphamide and ifosphamide in##2##4##(2008-10#2)
cyclophosphamide and ifosphamide##3##3##(2008-10#3)
cyclophosphamide and##11##2##(1992-10#1)(1993-2#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)
cyclophosphamide are##3##2##(1993-2#1)(2006-10#1)(2012-3#1)
cyclophosphamide in##5##2##(1993-2#1)(1997-8#1)(2007-7#1)(2008-1#2)
cyclophosphamide or##4##2##(1995-5#1)(2008-1#1)(2008-10#2)
cyclophosphamide therapy##2##2##(2007-7#2)
cyclophosphamide treatment##4##2##(1993-2#1)(1994-5#2)(2008-7#1)
cyclophosphamide was##2##2##(1993-2#1)(2006-10#1)
cyclophosphamide##80##1##(1990-10#1)(1990-12#1)(1991-6#1)(1991-8#3)(1992-10#3)(1993-2#7)(1993-9#2)(1994-5#2)(1994-7#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-6#1)(1997-7#1)(1997-8#2)(2006-10#7)(2007-7#9)(2008-1#5)(2008-10#9)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-4#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#2)
cyclophosphamide-treated mice##2##2##(1994-5#1)(2008-10#1)
cyclophosphamide-treated patients##2##2##(1995-12#1)(2006-10#1)
cyclophosphamide-treated##4##1##(1994-5#1)(1995-12#1)(2006-10#1)(2008-10#1)
cyclophotocoagulation##2##1##(2008-2#2)
cycloplegic##2##1##(2010-1#1)(2013-7#1)
cyclopropanated quinolizine species were##2##4##(2008-11#2)
cyclopropanation of##2##2##(2008-10#1)(2009-6#1)
cyclopropanation##3##1##(2008-10#1)(2008-7#1)(2009-6#1)
cyclopropane##4##1##(2007-11#1)(2008-10#3)
cyclosporin A (CsA)##3##3##(1990-12#1)(1991-9#1)(1997-2#1)
cyclosporin A##12##2##(1990-12#2)(1991-5#2)(1991-9#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-11#1)(2011-2#1)(2011-3#1)
cyclosporin##32##1##(1990-12#2)(1990-3#1)(1991-3#2)(1991-5#3)(1991-9#2)(1992-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)
cyclosporine (Neoral)##2##2##(2008-10#2)
cyclosporine A and##3##3##(2008-10#3)
cyclosporine A##11##2##(1992-12#1)(1992-9#1)(1994-8#1)(1995-12#2)(2008-10#5)(2011-3#1)
cyclosporine A-induced##4##2##(1995-12#3)(1997-6#1)
cyclosporine and##2##2##(2006-10#1)(2010-12#1)
cyclosporine##40##1##(1992-12#1)(1992-3#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-12#5)(1997-6#1)(2006-10#2)(2007-7#1)(2008-1#6)(2008-10#11)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#3)
cyclosporine-treated rats##3##2##(1992-3#3)
cyclotron resonance##5##2##(1994-2#1)(2008-10#2)(2008-7#2)
cyclotron##10##1##(1990-12#1)(1990-6#1)(1991-6#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)
cyfluthrin##11##1##(2008-10#1)(2011-2#10)
cylinder and##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
cylinder as the##2##3##(2008-2#1)(2008-3#1)
cylinder can be##2##3##(2008-3#2)
cylinder coordinates##3##2##(2008-3#3)
cylinder is arbitrarily located and arbitrarily oriented##2##7##(2008-2#1)(2008-3#1)
cylinder is##4##2##(2008-2#2)(2008-3#2)
cylinder with a##4##3##(2007-12#2)(2008-2#2)
cylinder with##8##2##(2007-12#2)(2008-2#5)(2013-1#1)
cylinder##71##1##(1991-12#1)(2007-11#5)(2007-12#2)(2008-10#10)(2008-2#17)(2008-3#21)(2008-7#1)(2009-2#7)(2012-2#3)(2013-1#3)(2013-8#1)
cylinders and##5##2##(2007-11#1)(2008-2#3)(2013-8#1)
cylinders are##3##2##(2008-2#2)(2009-2#1)
cylinders at##3##2##(2008-2#3)
cylinders were##2##2##(2008-12#1)(2012-2#1)
cylinders with##2##2##(1996-2#1)(2008-2#1)
cylinders##45##1##(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#18)(2008-3#7)(2008-7#2)(2009-2#8)(2010-8#1)(2012-2#2)(2013-8#1)
cylindrical and##2##2##(2012-1#2)
cylindrical cavities in##2##3##(2007-11#1)(2008-3#1)
cylindrical cavity##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
cylindrical containers##2##2##(2008-11#1)(2011-2#1)
cylindrical fibers##2##2##(2008-2#2)
cylindrical impactor##3##2##(2008-10#3)
cylindrical jets##3##2##(2008-3#3)
cylindrical lens##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
cylindrical lenses##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
cylindrical modes##3##2##(2008-3#3)
cylindrical object##2##2##(2008-2#1)(2008-3#1)
cylindrical objects##4##2##(2008-3#4)
cylindrical optical##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
cylindrical particles##2##2##(2007-12#1)(2008-2#1)
cylindrical rough surfaces##3##3##(2008-3#3)
cylindrical taper as##2##3##(2008-3#2)
cylindrical waveguide##2##2##(2007-11#1)(2008-2#1)
cylindrical waveguides##2##2##(2008-2#2)
cylindrical##127##1##(1992-12#1)(1995-12#1)(1995-5#1)(2007-11#7)(2007-12#18)(2008-10#17)(2008-11#3)(2008-2#17)(2008-3#48)(2008-5#2)(2008-6#2)(2008-7#3)(2010-7#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-7#1)
cylindrically shaped microactuator##2##3##(2008-3#2)
cylindrically symmetrical systems##2##3##(2008-3#2)
cylindrically##7##1##(1995-3#1)(2007-11#1)(2008-3#4)(2009-4#1)
cylindroids were##2##2##(2008-11#2)
cylindroids##4##1##(2008-11#4)
cymbalariae##3##1##(2012-3#3)
cymbidium mosaic##4##2##(1997-2#3)(2008-10#1)
cymbidium##5##1##(1997-2#4)(2008-10#1)
cymiazole##2##1##(2008-10#2)
cymosum##2##1##(2008-11#2)
cymoxanil##4##1##(1991-5#2)(2008-10#2)
cynodontis##2##1##(2008-10#2)
cynomolgus monkey (Macaca fascicularis)##2##4##(2008-10#1)(2012-2#1)
cynomolgus monkey##8##2##(2008-10#4)(2009-6#1)(2012-2#3)
cynomolgus monkeys##3##2##(2008-10#3)
cynomolgus##13##1##(1997-8#1)(2008-10#8)(2009-6#1)(2012-2#3)
cyoE##4##1##(1992-12#4)
cypermethrin and##4##2##(2008-10#4)
cypermethrin in##2##2##(2008-12#2)
cypermethrin##11##1##(2007-10#2)(2008-10#4)(2008-12#5)
cyprinacea##3##1##(2008-12#3)
cyproterone##2##1##(2008-10#1)(2009-4#1)
cyromazine and abamectin##3##3##(2011-2#3)
cyromazine resistance##3##2##(2011-2#3)
cyromazine resistance-correlated oligonucleotides##3##3##(2011-2#3)
cyromazine##11##1##(2011-2#11)
cyromazine-resistant strain##3##2##(2011-2#3)
cyromazine-resistant##4##1##(2011-2#4)
cys-3##2##1##(1992-3#2)
cyst and egg##4##3##(2008-10#4)
cyst and the##2##3##(2006-10#1)(2008-12#1)
cyst and##17##2##(1991-11#1)(1991-8#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-12#2)(2009-10#2)(2011-2#1)(2013-1#1)
cyst associated with##5##3##(2009-5#4)(2013-1#1)
cyst attached to the##2##4##(2007-8#1)(2008-5#1)
cyst can##2##2##(1997-8#1)(2008-7#1)
cyst cavity##3##2##(1992-3#2)(1997-8#1)
cyst cells##5##2##(2012-2#5)
cyst disease##2##2##(2010-12#1)(2011-2#1)
cyst fluid##10##2##(1994-2#1)(1994-7#3)(2007-7#1)(2008-12#2)(2010-6#3)
cyst fluids##5##2##(1993-1#3)(2008-4#2)
cyst formation##3##2##(1995-2#2)(2006-10#1)
cyst growth and##2##3##(2013-1#2)
cyst growth##3##2##(2013-1#3)
cyst in a child##3##4##(2008-10#1)(2012-12#2)
cyst in a##7##3##(1995-12#1)(1997-8#1)(2008-10#3)(2012-12#2)
cyst in the##7##3##(2008-12#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
cyst in##17##2##(1995-12#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
cyst into the##2##3##(1991-8#1)(2008-12#1)
cyst invading##2##2##(2007-12#1)(2009-7#1)
cyst is a##2##3##(2008-5#1)(2008-7#1)
cyst is##6##2##(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
cyst may##2##2##(2008-12#1)(2013-8#1)
cyst nematode##11##2##(2008-10#8)(2008-12#3)
cyst nematodes##4##2##(2008-10#3)(2008-12#1)
cyst of small##2##3##(2013-1#2)
cyst of the left##2##4##(2007-7#1)(2008-7#1)
cyst of the liver##3##4##(1991-3#1)(1991-8#1)(1992-5#1)
cyst of the liver--a case report##2##6##(2008-12#2)
cyst of the third ventricle##4##5##(2008-7#4)
cyst of the##21##3##(1991-3#3)(1991-5#1)(1991-8#1)(1992-5#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-7#6)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
cyst of##26##2##(1991-3#4)(1991-5#1)(1991-8#1)(1992-5#1)(1997-3#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-7#6)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#1)(2013-1#3)
cyst populations##2##2##(2008-10#2)
cyst rupture##5##2##(1996-3#4)(2006-10#1)
cyst size##4##2##(2008-7#4)
cyst type##4##2##(1997-8#4)
cyst wall##4##2##(1992-3#1)(2008-12#1)(2008-5#1)(2008-7#1)
cyst was made##2##3##(1990-10#1)(2007-8#1)
cyst was##15##2##(1990-10#1)(1992-3#1)(1997-8#1)(2007-7#2)(2007-8#2)(2008-5#2)(2008-7#3)(2009-3#1)(2011-2#1)(2012-12#1)
cyst with##8##2##(1993-10#1)(1997-8#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
cyst##281##1##(1990-10#1)(1990-6#1)(1991-11#3)(1991-3#4)(1991-5#2)(1991-8#4)(1992-3#5)(1992-5#1)(1993-1#3)(1993-10#1)(1993-5#1)(1994-2#1)(1994-7#3)(1994-9#2)(1995-12#3)(1995-2#2)(1996-3#4)(1997-3#1)(1997-8#13)(2006-10#3)(2007-10#1)(2007-12#7)(2007-7#6)(2007-8#18)(2008-1#1)(2008-10#29)(2008-12#16)(2008-2#1)(2008-4#5)(2008-5#12)(2008-7#29)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#5)(2010-11#2)(2010-12#3)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#10)(2012-12#8)(2012-2#15)(2012-3#3)(2013-1#25)(2013-8#4)
cyst]##2##1##(2008-8#1)(2013-1#1)
cystadenocarcinoma of the##2##3##(1993-9#1)(2010-12#1)
cystadenocarcinoma of##3##2##(1993-9#1)(2010-12#2)
cystadenocarcinoma##8##1##(1990-6#3)(1993-9#1)(2010-12#3)(2011-2#1)
cystadenoma of boundary malignancy in a##2##6##(2008-11#2)
cystadenoma of the##5##3##(2012-2#3)(2013-7#2)
cystadenoma of##7##2##(2008-11#2)(2012-2#3)(2013-7#2)
cystadenoma##11##1##(2008-11#2)(2010-12#1)(2011-2#2)(2012-2#4)(2013-7#2)
cystamine and##3##2##(2011-2#3)
cystamine are##2##2##(2011-2#2)
cystamine as##2##2##(2011-2#2)
cystamine##15##1##(1992-8#1)(1995-8#1)(2011-2#13)
cystathionine beta-synthase##6##2##(1995-2#5)(2012-2#1)
cystathionine##14##1##(1990-8#1)(1995-12#5)(1995-2#6)(2008-10#1)(2012-2#1)
cystatin C and##3##3##(2010-12#1)(2010-4#1)(2010-8#1)
cystatin C concentration##3##3##(2010-4#3)
cystatin C##10##2##(2010-12#1)(2010-4#5)(2010-8#1)(2011-2#1)(2013-1#2)
cystatin##14##1##(1990-2#2)(1994-12#2)(2010-12#1)(2010-4#5)(2010-8#1)(2011-2#1)(2013-1#2)
cysteamine##4##1##(1992-8#1)(1994-12#1)(1995-8#2)
cysteamine-modified carbon paste electrodes##2##4##(2008-10#2)
cysteamine-modified##3##1##(2008-10#3)
cystectomies##2##1##(2011-2#1)(2013-1#1)
cystectomy and##2##2##(1996-3#1)(2008-10#1)
cystectomy or##2##2##(1996-3#1)(2011-2#1)
cystectomy was performed##2##3##(1992-3#1)(1996-3#1)
cystectomy with##2##2##(1991-8#1)(2011-2#1)
cystectomy##20##1##(1990-6#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1996-3#4)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#5)(2013-1#1)
cysteine (Cys)##5##2##(2008-10#4)(2008-4#1)
cysteine 419##4##2##(1995-2#4)
cysteine and cystine##5##3##(1991-5#3)(2008-10#2)
cysteine and penicillamine##3##3##(2008-10#3)
cysteine and##19##2##(1991-5#3)(1991-9#2)(1992-8#1)(2008-10#10)(2009-8#1)(2010-11#1)(2011-3#1)
cysteine are##2##2##(1991-5#1)(2008-10#1)
cysteine as##2##2##(1991-9#1)(2008-10#1)
cysteine at##3##2##(1994-11#1)(2008-10#1)(2008-4#1)
cysteine by##3##2##(1991-5#1)(2008-10#1)(2009-9#1)
cysteine derivatives##2##2##(1991-9#2)
cysteine dioxygenase##2##2##(2009-11#2)
cysteine in a##3##3##(1993-11#1)(2008-10#2)
cysteine in human plasma##2##4##(2008-10#2)
cysteine in human##4##3##(2008-10#4)
cysteine in the##2##3##(1992-8#1)(2008-10#1)
cysteine in##15##2##(1992-8#1)(1993-11#1)(1993-8#1)(2008-10#10)(2009-9#1)(2011-2#1)
cysteine is##3##2##(1991-5#1)(1992-3#1)(1992-8#1)
cysteine methyl ester##2##3##(2008-10#2)
cysteine mutants##2##2##(1994-11#1)(1995-5#1)
cysteine protease##4##2##(1990-2#1)(1991-2#1)(1995-11#1)(2012-3#1)
cysteine proteases##5##2##(1995-6#1)(2008-11#1)(2008-4#2)(2008-7#1)
cysteine proteinase cDNA##2##3##(1997-6#2)
cysteine proteinase##4##2##(1997-6#4)
cysteine proteinases##3##2##(1997-6#1)(2008-10#2)
cysteine residue at##2##3##(1990-2#1)(1990-5#1)
cysteine residue in the##2##4##(1993-11#1)(1993-8#1)
cysteine residue in##3##3##(1993-11#1)(1993-8#1)(1995-2#1)
cysteine residue##16##2##(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1991-9#1)(1993-11#2)(1993-8#1)(1995-2#4)(1995-6#2)
cysteine residues and##2##3##(1992-10#1)(2008-5#1)
cysteine residues at the##2##4##(1990-2#1)(1995-2#1)
cysteine residues in the extracellular domain##2##6##(1992-12#2)
cysteine residues in the##4##4##(1992-12#2)(1992-8#1)(1997-7#1)
cysteine residues in##6##3##(1992-12#2)(1992-8#1)(1993-8#1)(1997-7#1)(2008-10#1)
cysteine residues##31##2##(1990-11#1)(1990-2#1)(1991-12#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1995-2#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#1)
cysteine rich region##2##3##(1997-7#2)
cysteine rich##5##2##(1997-7#5)
cysteine scanning mutagenesis##2##3##(1990-12#2)
cysteine supply is##2##3##(1991-9#2)
cysteine to##4##2##(1991-9#1)(2008-10#1)(2008-9#1)(2009-11#1)
cysteine with##5##2##(2008-10#4)(2008-12#1)
cysteine##243##1##(1990-11#1)(1990-12#3)(1990-2#4)(1990-5#2)(1991-12#5)(1991-2#2)(1991-5#8)(1991-9#15)(1992-10#1)(1992-11#1)(1992-12#6)(1992-3#1)(1992-5#1)(1992-8#10)(1992-9#2)(1993-11#7)(1993-6#1)(1993-8#7)(1993-9#2)(1994-11#6)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#12)(1995-3#1)(1995-5#5)(1995-6#3)(1996-5#1)(1997-6#6)(1997-7#6)(2008-1#2)(2008-10#83)(2008-11#2)(2008-12#1)(2008-4#8)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#3)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
cysteine)##2##1##(1992-8#1)(2008-10#1)
cysteine-1##2##1##(1994-11#2)
cysteine-223##2##1##(1992-3#2)
cysteine-rich EGF##2##2##(1995-6#2)
cysteine-rich domain##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
cysteine-rich proteins##2##2##(2011-2#1)(2013-7#1)
cysteine-rich region##2##2##(1991-9#1)(1995-2#1)
cysteine-rich subdomains##3##2##(1992-11#3)
cysteine-rich##25##1##(1990-5#2)(1991-5#1)(1991-9#1)(1992-11#5)(1993-3#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-6#3)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
cysteines and##2##2##(1990-5#1)(1991-2#1)
cysteines are##2##2##(1990-5#1)(1992-5#1)
cysteines have##2##2##(1993-8#1)(1994-11#1)
cysteines in##3##2##(1991-12#1)(1992-3#1)(1992-8#1)
cysteines##19##1##(1990-5#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#5)(1997-2#1)(2008-4#1)
cysteinyl leukotrienes##4##2##(1993-6#1)(1993-9#2)(1994-12#1)
cysteinyl##7##1##(1991-5#2)(1993-6#1)(1993-9#3)(1994-12#1)
cysteinylglycine##2##1##(2008-10#2)
cystemustine##2##1##(2008-5#2)
cystic abdominal mass##2##3##(2008-7#2)
cystic adenomatoid malformation##2##3##(2007-10#2)
cystic and##3##2##(1992-12#1)(1997-8#1)(2013-1#1)
cystic breast##3##2##(2008-12#2)(2008-4#1)
cystic carcinoma##5##2##(1991-11#1)(1991-6#2)(2013-8#2)
cystic changes##2##2##(1997-3#1)(2008-4#1)
cystic craniopharyngiomas##4##2##(1995-9#1)(2008-7#3)
cystic disease##6##2##(1993-1#1)(1994-7#2)(1997-8#2)(2008-7#1)
cystic duct syndrome##2##3##(1992-9#1)(1993-9#1)
cystic duct##11##2##(1992-9#5)(1993-9#1)(2008-12#3)(2010-12#2)
cystic endosalpingiosis##3##2##(2008-11#3)
cystic fibrosis (CF) has recently been##2##6##(1990-8#1)(2007-12#1)
cystic fibrosis (CF)##8##3##(1990-3#1)(1990-8#1)(1997-1#1)(2007-12#1)(2008-5#1)(2011-3#2)(2013-1#1)
cystic fibrosis gene##3##3##(1990-2#1)(1991-3#1)(2007-6#1)
cystic fibrosis in##2##3##(1993-2#1)(1997-8#1)
cystic fibrosis patients##4##3##(1990-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
cystic fibrosis transmembrane conductance regulator##2##5##(1994-5#1)(2011-3#1)
cystic fibrosis was##2##3##(1994-2#2)
cystic fibrosis##67##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-5#3)(1995-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-6#3)(2007-8#3)(2008-10#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-5#1)(2010-5#2)(2011-1#1)(2011-3#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
cystic fibrosis]##4##2##(1990-3#1)(1991-2#1)(1994-2#1)(2007-6#1)
cystic hypoglossal schwannoma with##2##4##(2011-2#2)
cystic hypoglossal##3##2##(2011-2#3)
cystic kidney disease##5##3##(2007-7#2)(2011-2#3)
cystic kidneys##2##2##(1997-5#1)(2008-10#1)
cystic lesion of##2##3##(2008-10#1)(2008-7#1)
cystic lesion##12##2##(1992-2#1)(2006-10#2)(2008-1#3)(2008-10#2)(2008-5#2)(2008-7#1)(2013-1#1)
cystic lesions of##2##3##(2008-7#1)(2010-11#1)
cystic lesions##8##2##(2007-12#1)(2008-1#1)(2008-7#2)(2010-11#1)(2012-2#1)(2013-8#2)
cystic lymphangioma##4##2##(1990-6#1)(2007-8#2)(2008-10#1)
cystic mass in the##3##4##(2007-8#1)(2011-2#1)(2013-8#1)
cystic mass with##3##3##(1990-6#1)(2011-2#1)(2012-12#1)
cystic mass##9##2##(1990-6#1)(2007-8#1)(2008-9#1)(2011-2#2)(2012-12#2)(2013-8#2)
cystic neoplasm##2##2##(2010-12#1)(2012-2#1)
cystic neoplasms##2##2##(2008-12#1)(2013-8#1)
cystic ovarian endometriosis##2##3##(1994-9#2)
cystic ovarian##3##2##(1994-9#3)
cystic pulmonary lesions##2##3##(2007-10#1)(2012-1#1)
cystic pulmonary##3##2##(2007-10#1)(2012-1#2)
cystic schwannoma##2##2##(2008-7#1)(2011-2#1)
cystic teratoma (dermoid cyst)##2##4##(1994-9#1)(2013-8#1)
cystic teratoma (dermoid##3##3##(1994-9#1)(2013-8#2)
cystic teratoma##7##2##(1994-9#1)(2009-7#1)(2013-8#5)
cystic##218##1##(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-9#6)(1993-1#1)(1993-2#1)(1993-9#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-7#2)(1994-9#4)(1995-9#2)(1997-1#2)(1997-3#4)(1997-5#2)(1997-8#5)(2006-10#3)(2007-10#3)(2007-11#2)(2007-12#2)(2007-6#4)(2007-7#4)(2007-8#7)(2008-1#6)(2008-10#5)(2008-11#3)(2008-12#9)(2008-4#3)(2008-5#7)(2008-7#15)(2008-9#1)(2009-1#1)(2009-3#3)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#3)(2010-5#2)(2011-1#2)(2011-2#13)(2011-3#5)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#15)
cystica##3##1##(2011-2#3)
cysticercosis in##2##2##(1991-8#1)(2008-7#1)
cysticercosis is##2##2##(1991-8#2)
cysticercosis##8##1##(1991-8#5)(1993-1#1)(2008-7#2)
cystine and##5##2##(1991-5#1)(2007-7#1)(2008-10#2)(2008-11#1)
cystine was##2##2##(2008-10#2)
cystine##40##1##(1990-5#3)(1991-5#5)(1991-9#4)(1992-8#1)(1997-4#1)(2007-7#5)(2008-10#11)(2008-11#8)(2008-4#1)(2008-5#1)
cystine-rich##2##1##(1990-12#1)(1994-9#1)
cystinuria##9##1##(1991-5#1)(2007-7#7)(2008-10#1)
cystinuric patients##3##2##(2007-7#3)
cystitis and##2##2##(1993-2#1)(2008-10#1)
cystitis in women##2##3##(1993-2#2)
cystitis in##3##2##(1993-2#2)(2008-12#1)
cystitis##18##1##(1991-11#1)(1991-6#1)(1993-2#3)(2007-9#1)(2008-10#4)(2008-12#3)(2009-1#1)(2012-3#4)
cystoadenocarcinoma##2##1##(2008-12#2)
cystocarpic##2##1##(2007-5#2)
cystocele##4##1##(1994-3#1)(2007-10#1)(2010-11#1)(2011-2#1)
cystocoele##4##1##(2011-2#4)
cystography##2##1##(2008-10#1)(2013-1#1)
cystomas of intestinal type##3##4##(1990-2#3)
cystomas of intestinal##4##3##(1990-2#4)
cystomas of##5##2##(1990-2#5)
cystomas##11##1##(1990-2#11)
cystometric studies##2##2##(2008-7#2)
cystometric##4##1##(1993-2#1)(2008-3#1)(2008-7#2)
cystosarcoma phyllodes are##2##3##(2011-3#2)
cystosarcoma phyllodes##4##2##(2011-3#4)
cystosarcoma##5##1##(2008-10#1)(2011-3#4)
cystoscopy and##2##2##(2007-4#1)(2007-7#1)
cystoscopy##11##1##(2007-4#1)(2007-7#1)(2008-10#5)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
cystospores##6##1##(2008-10#6)
cystourethrogram##4##1##(2008-10#4)
cysts and##8##2##(1990-10#1)(1993-1#1)(2008-10#2)(2008-5#1)(2011-1#2)(2013-1#1)
cysts are discussed##2##3##(1991-6#1)(2008-7#1)
cysts are##11##2##(1991-6#1)(1993-1#1)(2008-10#2)(2008-7#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
cysts arising##2##2##(2010-12#1)(2013-1#1)
cysts associated with ectopic##2##4##(2013-1#2)
cysts associated with##5##3##(2007-8#2)(2008-7#1)(2013-1#2)
cysts can##2##2##(2013-1#2)
cysts each##2##2##(2012-12#1)(2012-2#1)
cysts have been##2##3##(2008-7#1)(2013-1#1)
cysts have##4##2##(1995-12#1)(2008-7#1)(2013-1#2)
cysts in the##5##3##(2007-8#1)(2010-6#1)(2011-2#2)(2013-7#1)
cysts in##15##2##(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-7#1)
cysts is##4##2##(1991-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
cysts isolated from##2##3##(2008-10#2)
cysts lined by##2##3##(2008-12#2)
cysts lined##3##2##(2008-12#2)(2013-1#1)
cysts may be##2##3##(1993-1#1)(2007-7#1)
cysts may##4##2##(1993-1#1)(2007-7#1)(2008-12#1)(2011-1#1)
cysts of the orbit##2##4##(2011-2#2)
cysts of the ovary##2##4##(1991-5#2)
cysts of the##7##3##(1991-5#2)(1992-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
cysts of##13##2##(1991-5#2)(1992-5#1)(1992-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
cysts on##2##2##(2008-7#1)(2012-2#1)
cysts per##2##2##(2008-10#1)(2008-5#1)
cysts that##2##2##(2008-10#1)(2012-2#1)
cysts usually##2##2##(2007-8#1)(2013-8#1)
cysts was##3##2##(2008-10#1)(2012-2#2)
cysts were found##2##3##(2008-8#1)(2013-1#1)
cysts were removed##2##3##(2010-11#1)(2011-2#1)
cysts were##16##2##(1990-6#1)(1995-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
cysts when compared to##2##4##(1993-1#1)(1995-12#1)
cysts with##4##2##(1993-1#1)(1993-8#1)(2007-8#1)(2008-7#1)
cysts##179##1##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-5#1)(1992-8#1)(1993-1#5)(1993-5#1)(1993-8#1)(1994-9#1)(1995-12#4)(1997-3#2)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#4)(2008-4#5)(2008-5#5)(2008-7#23)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#12)(2011-2#6)(2012-12#4)(2012-2#17)(2012-3#2)(2013-1#23)(2013-7#3)(2013-8#4)
cysts)##2##1##(1991-2#1)(1993-1#1)
cyt P450##3##2##(1991-5#3)
cyt c##3##2##(2011-2#3)
cyt##8##1##(1991-5#3)(2010-4#2)(2011-2#3)
cytarabine##4##1##(1990-2#2)(2008-5#2)
cytidine and##2##2##(1992-8#1)(1996-5#1)
cytidine deaminase##2##2##(1994-5#1)(1994-8#1)
cytidine##15##1##(1990-7#1)(1992-8#1)(1994-5#2)(1994-8#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-8#1)
cytidylyltransferase cDNA##5##2##(1997-2#5)
cytidylyltransferase was##2##2##(1991-11#2)
cytidylyltransferase##14##1##(1991-11#7)(1995-3#2)(1997-2#5)
cytisine administration##2##2##(2011-1#2)
cytisine##16##1##(2008-10#3)(2011-1#13)
cytoarchitectural##2##1##(1993-12#1)(2013-8#1)
cytoarchitecture and##2##2##(1994-3#1)(1994-9#1)
cytoarchitecture in the##3##3##(1992-9#2)(2013-8#1)
cytoarchitecture in##4##2##(1992-9#2)(2012-2#1)(2013-8#1)
cytoarchitecture##10##1##(1992-9#2)(1994-3#1)(1994-9#1)(2008-11#1)(2008-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
cytobrush##4##1##(1992-1#4)
cytochalasin B is observed to potentiate the rate of##2##9##(1990-8#2)
cytochalasin B is##3##3##(1990-8#3)
cytochalasin B##9##2##(1990-8#4)(1994-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
cytochalasin D##4##2##(1990-8#3)(2009-5#1)
cytochalasin##13##1##(1990-8#7)(1994-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)
cytochemical analysis and##2##3##(2008-3#1)(2008-9#1)
cytochemical analysis##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
cytochemical staining##3##2##(1993-12#1)(2008-4#2)
cytochemical techniques##2##2##(2007-12#1)(2008-7#1)
cytochemical##21##1##(1993-11#2)(1993-12#1)(2007-12#1)(2008-10#8)(2008-3#2)(2008-4#2)(2008-7#3)(2008-9#1)(2009-12#1)
cytochemically##2##1##(2008-10#2)
cytochemistry##7##1##(2007-12#1)(2008-10#3)(2008-8#2)(2009-12#1)
cytochrome B gene##2##3##(2008-5#1)(2008-6#1)
cytochrome C oxidase##2##3##(2008-10#1)(2008-9#1)
cytochrome C##4##2##(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)
cytochrome P-450 2D6 (CYP2D6)##2##4##(2008-3#1)(2008-4#1)
cytochrome P-450 monooxygenase##3##3##(1990-7#1)(1991-5#1)(1992-3#1)
cytochrome P-450 reductase##2##3##(1995-8#1)(2008-11#1)
cytochrome P-450##34##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#6)(1991-5#2)(1991-9#1)(1992-11#6)(1992-3#2)(1994-2#1)(1995-8#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
cytochrome P-450c##2##2##(1991-12#2)
cytochrome P-450cam##5##2##(1994-5#5)
cytochrome P450 (CYP)##4##3##(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
cytochrome P450 2B1##2##3##(1994-6#2)
cytochrome P450 3A4 activity##2##4##(2008-10#2)
cytochrome P450 3A4##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
cytochrome P450 IA2##2##3##(1990-5#2)
cytochrome P450 is##2##3##(1991-2#1)(1995-6#1)
cytochrome P450 monooxygenases##2##3##(1991-2#1)(2009-9#1)
cytochrome P450 reductase##3##3##(1994-9#1)(1995-6#2)
cytochrome P450##62##2##(1990-5#3)(1991-2#4)(1991-9#1)(1992-11#1)(1992-8#4)(1993-11#2)(1994-11#1)(1994-5#3)(1994-6#5)(1994-8#4)(1994-9#1)(1995-5#1)(1995-6#5)(1996-12#2)(1996-3#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-9#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
cytochrome P450-dependent monooxygenases##2##3##(2008-11#1)(2009-8#1)
cytochrome P450-dependent##4##2##(1991-8#1)(1992-8#1)(2008-11#1)(2009-8#1)
cytochrome P4501A1##3##2##(1994-6#1)(1994-8#1)(2008-11#1)
cytochrome P4502E1 (CYP2E1)##2##3##(1993-11#1)(2008-8#1)
cytochrome P4502E1##3##2##(1993-11#1)(2008-8#2)
cytochrome P450cam with##2##3##(1994-6#2)
cytochrome P450cam##7##2##(1992-11#2)(1994-6#5)
cytochrome P450s of subfamily 2C##2##5##(1993-6#2)
cytochrome P450s##5##2##(1991-2#1)(1993-6#2)(1997-7#1)(2008-9#1)
cytochrome P450sccK201E##2##2##(2008-10#2)
cytochrome b 561##2##3##(2009-9#2)
cytochrome b gene##11##3##(1995-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#2)
cytochrome b sequences##2##3##(1995-11#1)(2008-5#1)
cytochrome b##19##2##(1995-11#3)(2008-10#5)(2008-5#4)(2008-6#2)(2009-9#2)(2010-4#1)(2010-8#2)
cytochrome b(5)##5##2##(2008-7#1)(2011-2#4)
cytochrome b5##3##2##(1992-6#2)(1994-6#1)
cytochrome b558##7##2##(1991-2#2)(1993-8#5)
cytochrome b559##3##2##(1990-5#1)(1996-4#2)
cytochrome b561##2##2##(2009-9#2)
cytochrome bo##2##2##(1992-12#2)
cytochrome c (cyt c)##2##4##(2008-10#1)(2011-2#1)
cytochrome c and##4##3##(1994-8#1)(1995-2#2)(2008-10#1)
cytochrome c levels in vivo##2##5##(1995-5#2)
cytochrome c nitrite reductase##3##4##(1994-11#2)(2011-2#1)
cytochrome c oxidase (COX)##2##4##(1991-6#2)
cytochrome c oxidase subunit I##2##5##(2010-4#2)
cytochrome c oxidase subunit##4##4##(1991-6#1)(2008-10#1)(2010-4#2)
cytochrome c oxidase##19##3##(1990-12#1)(1991-6#4)(1992-12#2)(1995-2#4)(1997-7#3)(2008-10#2)(2008-6#1)(2010-4#2)
cytochrome c reductase activity##4##4##(1990-11#4)
cytochrome c reductase##8##3##(1990-11#6)(1995-2#1)(1997-3#1)
cytochrome c release##3##3##(2010-3#2)(2010-6#1)
cytochrome c to##3##3##(1994-8#1)(1995-2#1)(1997-2#1)
cytochrome c was##3##3##(1993-3#2)(1995-2#1)
cytochrome c##76##2##(1990-11#6)(1990-12#2)(1990-3#1)(1990-5#1)(1991-6#4)(1992-12#2)(1993-3#3)(1993-6#1)(1994-11#2)(1994-8#4)(1995-2#17)(1995-5#7)(1997-2#3)(1997-3#1)(1997-7#3)(2008-10#8)(2008-6#2)(2008-7#1)(2009-9#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-2#2)
cytochrome c3##5##2##(1994-5#5)
cytochrome o##4##2##(1990-11#4)
cytochrome oxidase I##5##3##(2007-12#1)(2008-6#1)(2011-2#3)
cytochrome oxidase II##4##3##(2008-10#2)(2008-8#2)
cytochrome oxidase activity##3##3##(1990-3#1)(1995-6#1)(2008-7#1)
cytochrome oxidase at##2##3##(1990-3#2)
cytochrome oxidase in##3##3##(1990-3#1)(1993-2#1)(1994-8#1)
cytochrome oxidase subunit I##2##4##(1993-2#1)(2011-2#1)
cytochrome oxidase subunit##3##3##(1990-5#1)(1993-2#1)(2011-2#1)
cytochrome oxidase##33##2##(1990-12#1)(1990-3#7)(1990-5#1)(1993-2#2)(1994-8#1)(1995-6#7)(1997-2#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#4)
cytochrome subunit##5##2##(1993-8#4)(1994-11#1)
cytochrome##334##1##(1990-11#15)(1990-12#3)(1990-2#1)(1990-3#9)(1990-5#10)(1990-7#6)(1991-12#4)(1991-2#7)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#5)(1992-11#9)(1992-12#4)(1992-3#2)(1992-6#2)(1992-8#6)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#9)(1994-11#5)(1994-2#1)(1994-5#17)(1994-6#14)(1994-8#10)(1994-9#2)(1995-11#3)(1995-2#18)(1995-5#8)(1995-6#12)(1995-8#3)(1996-12#2)(1996-3#1)(1996-4#2)(1997-2#7)(1997-3#1)(1997-7#4)(2007-11#1)(2007-12#1)(2008-10#29)(2008-11#7)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#7)(2008-7#5)(2008-8#9)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#7)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#1)(2012-3#1)(2013-1#1)
cytochrome-c reductase##3##2##(1995-11#1)(1995-8#2)
cytochromes c##2##2##(1994-5#1)(1995-5#1)
cytochromes c3##2##2##(1994-5#2)
cytochromes##13##1##(1990-7#1)(1993-6#1)(1994-5#4)(1994-8#2)(1995-5#2)(1995-6#1)(2008-3#1)(2008-7#1)
cytocompatibility of the##3##3##(2008-5#2)(2009-7#1)
cytocompatibility of##5##2##(2008-5#2)(2009-7#2)(2013-8#1)
cytocompatibility##7##1##(2008-5#3)(2009-7#3)(2013-8#1)
cytofluorimetric analysis of##3##3##(1992-9#1)(1993-11#2)
cytofluorimetric analysis##4##2##(1992-9#1)(1993-11#2)(1993-6#1)
cytofluorimetric##5##1##(1991-8#1)(1992-9#1)(1993-11#2)(1993-6#1)
cytogenetic analyses##2##2##(1996-2#1)(2013-1#1)
cytogenetic analysis of##5##3##(2008-4#1)(2008-5#2)(2008-9#2)
cytogenetic analysis##8##2##(2007-4#1)(2008-4#1)(2008-5#2)(2008-9#2)(2012-3#2)
cytogenetic and genomic##2##3##(2010-3#2)
cytogenetic and##7##2##(1992-8#1)(2010-1#1)(2010-3#3)(2010-4#1)(2010-5#1)
cytogenetic damage##2##2##(2008-9#1)(2013-8#1)
cytogenetic data on##2##3##(2008-12#2)
cytogenetic data##5##2##(2008-12#2)(2008-5#1)(2010-3#2)
cytogenetic diagnosis##7##2##(2008-11#4)(2012-3#3)
cytogenetic endpoints##2##2##(1992-8#1)(1996-2#1)
cytogenetic findings##2##2##(1997-5#2)
cytogenetic map##3##2##(2008-5#1)(2010-3#2)
cytogenetic results##2##2##(2008-4#2)
cytogenetic study##2##2##(2007-11#2)
cytogenetic techniques##2##2##(2008-7#1)(2010-3#1)
cytogenetic##70##1##(1990-8#1)(1991-4#1)(1992-8#3)(1993-8#2)(1993-9#1)(1994-12#2)(1996-11#1)(1996-2#3)(1997-4#1)(1997-5#2)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#1)(2008-9#3)(2010-1#2)(2010-3#12)(2010-4#2)(2010-5#1)(2012-3#7)(2013-1#1)(2013-8#2)
cytogenetical##4##1##(2008-10#2)(2008-5#1)(2009-12#1)
cytogenetically##4##1##(1993-9#1)(2008-7#1)(2009-8#1)(2010-4#1)
cytogenetics and##4##2##(2008-7#2)(2008-9#1)(2010-4#1)
cytogenetics laboratory##4##2##(1997-3#3)(2008-11#1)
cytogenetics##25##1##(1997-3#3)(2008-11#2)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#9)(2009-8#1)(2010-1#1)(2010-4#1)
cytoglobin##5##1##(2010-11#5)
cytokeratin and vimentin##2##3##(2012-1#1)(2013-1#1)
cytokeratin and##4##2##(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
cytokeratin##16##1##(1991-12#1)(1994-8#2)(2007-7#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
cytokeratins##5##1##(1993-9#1)(1994-8#2)(2010-12#1)(2011-2#1)
cytokine IL-8##2##2##(1990-5#1)(2009-10#1)
cytokine action##3##2##(1996-12#2)(1996-2#1)
cytokine and chemokine production##2##4##(2008-10#1)(2010-5#1)
cytokine and chemokine##3##3##(2008-10#1)(2009-3#1)(2010-5#1)
cytokine and##16##2##(1991-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#3)(2009-3#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
cytokine expression##4##2##(1994-8#1)(2008-10#2)(2009-8#1)
cytokine gene expression in the##2##5##(2012-2#2)
cytokine gene expression##3##3##(1997-4#1)(2012-2#2)
cytokine gene##6##2##(1997-4#2)(2008-1#1)(2008-11#1)(2012-2#2)
cytokine genes##4##2##(1994-5#1)(1997-2#1)(2008-4#1)(2008-9#1)
cytokine is##3##2##(1994-6#1)(1994-9#1)(2008-4#1)
cytokine levels in##5##3##(1996-12#2)(2008-10#1)(2008-6#1)(2008-7#1)
cytokine levels##11##2##(1996-12#4)(2008-10#1)(2008-6#3)(2008-7#1)(2009-9#1)(2010-12#1)
cytokine mRNA##2##2##(1994-8#1)(2008-4#1)
cytokine may##2##2##(1993-8#1)(1994-9#1)
cytokine network##4##2##(1991-2#1)(1995-12#1)(2007-8#1)(2008-7#1)
cytokine or##2##2##(2008-11#1)(2008-9#1)
cytokine patterns##3##2##(1994-8#1)(2007-2#2)
cytokine producing cells##4##3##(2008-11#4)
cytokine producing##5##2##(2008-11#5)
cytokine production and##4##3##(1991-8#2)(2008-10#2)
cytokine production in##6##3##(2008-10#3)(2008-4#2)(2010-12#1)
cytokine production##40##2##(1991-2#1)(1991-8#2)(1992-2#1)(1994-11#1)(1996-12#1)(2007-2#1)(2008-10#13)(2008-11#6)(2008-4#8)(2009-6#1)(2010-12#2)(2012-2#2)(2013-8#1)
cytokine receptors and##4##3##(2008-4#1)(2008-9#2)(2009-12#1)
cytokine receptors##8##2##(1994-2#2)(1996-2#1)(2008-4#2)(2008-9#2)(2009-12#1)
cytokine response##4##2##(1996-12#1)(2007-2#2)(2009-5#1)
cytokine responses in##3##3##(2008-11#2)(2008-9#1)
cytokine responses##5##2##(2008-11#3)(2008-4#1)(2008-9#1)
cytokine secretion from##2##3##(2008-11#2)
cytokine secretion patterns##2##3##(1997-8#1)(2008-10#1)
cytokine secretion##18##2##(1997-8#1)(2006-6#3)(2008-10#3)(2008-11#4)(2008-4#6)(2011-2#1)
cytokine that##4##2##(1993-8#1)(1995-6#1)(2008-8#1)(2009-7#1)
cytokine with multiple##2##3##(2008-4#1)(2008-9#1)
cytokine with##3##2##(1994-9#1)(2008-4#1)(2008-9#1)
cytokine##217##1##(1990-12#2)(1990-5#2)(1991-2#2)(1991-8#3)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#2)(1993-3#3)(1993-6#1)(1993-8#4)(1994-11#6)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#3)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#9)(1996-2#7)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#1)(2006-6#3)(2007-11#1)(2007-2#5)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#24)(2008-3#1)(2008-4#26)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#8)(2013-1#4)(2013-8#4)
cytokine-dependent##3##1##(1990-12#1)(2006-6#2)
cytokine-induced apoptosis##2##2##(2010-11#2)
cytokine-induced##7##1##(1995-11#2)(2010-11#2)(2011-1#1)(2012-1#1)(2013-1#1)
cytokine-like##2##1##(1990-12#1)(2009-3#1)
cytokine-secreting##3##1##(1997-4#2)(2008-9#1)
cytokines (e##3##2##(2008-11#1)(2008-4#1)(2010-3#1)
cytokines and chemokines##2##3##(2008-4#1)(2010-11#1)
cytokines and growth factors##6##4##(1992-2#1)(2007-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
cytokines and hormones##2##3##(1996-9#1)(2009-10#1)
cytokines and nuclear hormone receptors##2##5##(2008-5#2)
cytokines and their receptors in##2##5##(1997-2#1)(2008-4#1)
cytokines and their##3##3##(1992-2#1)(1997-2#1)(2008-4#1)
cytokines and##37##2##(1990-2#1)(1992-2#2)(1993-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
cytokines are##8##2##(1992-3#1)(1992-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)
cytokines as well as##3##4##(2008-4#2)(2008-7#1)
cytokines as##4##2##(2008-2#1)(2008-4#2)(2008-7#1)
cytokines by##2##2##(1994-8#1)(1995-5#1)
cytokines in the serum##2##4##(2008-10#1)(2009-6#1)
cytokines in the##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
cytokines in##14##2##(1994-11#1)(1994-9#1)(1996-12#4)(2007-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
cytokines including##4##2##(1996-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
cytokines induce##2##2##(1991-3#1)(1996-2#1)
cytokines interleukin##2##2##(1992-3#1)(1996-2#1)
cytokines involved in##2##3##(1994-9#1)(2012-3#1)
cytokines may##3##2##(1996-12#1)(2011-1#1)(2012-2#1)
cytokines on##4##2##(1990-2#2)(1994-6#1)(1994-9#1)
cytokines or glucose##2##3##(2010-11#2)
cytokines or##3##2##(2008-11#1)(2010-11#2)
cytokines produced by##3##3##(2008-11#1)(2008-9#2)
cytokines produced##4##2##(2006-10#1)(2008-11#1)(2008-9#2)
cytokines production##3##2##(1995-5#1)(2008-10#1)(2013-1#1)
cytokines released##3##2##(1996-2#1)(1997-1#1)(2008-7#1)
cytokines such as interferon gamma##2##5##(2008-11#1)(2008-8#1)
cytokines such as##9##3##(1992-8#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)
cytokines that##4##2##(1996-2#1)(2006-10#1)(2008-4#1)(2012-12#1)
cytokines to##4##2##(1996-12#1)(1996-2#1)(2008-11#1)(2012-3#1)
cytokines using##2##2##(1997-4#1)(2012-2#1)
cytokines was##2##2##(1997-1#1)(2011-2#1)
cytokines were##5##2##(1992-2#1)(1993-6#1)(1996-12#1)(2008-5#1)(2012-2#1)
cytokines##240##1##(1990-2#3)(1990-8#1)(1991-3#1)(1991-5#1)(1992-2#5)(1992-3#3)(1992-8#4)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#5)(1994-3#3)(1994-6#1)(1994-8#4)(1994-9#3)(1995-12#3)(1995-5#4)(1995-8#1)(1996-12#10)(1996-2#9)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#7)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#1)(2008-1#4)(2008-10#12)(2008-11#14)(2008-2#1)(2008-3#1)(2008-4#21)(2008-5#8)(2008-7#4)(2008-8#3)(2008-9#13)(2009-10#2)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#16)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#2)
cytokinesis in##5##2##(2009-10#5)
cytokinesis##25##1##(1994-11#1)(2008-11#3)(2008-7#1)(2009-10#9)(2009-12#1)(2009-8#5)(2009-9#1)(2011-1#2)(2013-1#2)
cytokinin and auxin##2##3##(2008-10#2)
cytokinin and##3##2##(2008-10#3)
cytokinin##12##1##(2008-10#3)(2008-12#1)(2008-7#4)(2009-8#4)
cytokinins##2##1##(2008-11#1)(2009-8#1)
cytologic diagnosis##2##2##(1991-2#1)(1992-8#1)
cytologic screening##2##2##(1992-1#1)(1992-10#1)
cytologic##19##1##(1990-10#1)(1990-5#1)(1991-2#3)(1992-1#1)(1992-10#3)(1992-12#1)(1992-8#4)(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)
cytological analysis##2##2##(1990-2#1)(2008-9#1)
cytological and biochemical parameters##2##4##(2011-10#2)
cytological and biochemical##3##3##(2011-10#3)
cytological and##6##2##(2008-10#1)(2008-9#1)(2011-10#3)(2011-2#1)
cytological characteristics##2##2##(2007-12#1)(2010-12#1)
cytological confirmation##2##2##(2008-2#1)(2010-9#1)
cytological criteria##2##2##(1997-2#1)(2013-7#1)
cytological diagnosis of##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
cytological diagnosis##5##2##(1997-2#2)(2008-10#1)(2011-2#1)(2013-1#1)
cytological diagnostics of##2##3##(2013-1#2)
cytological events##3##2##(2008-10#3)
cytological evidence##2##2##(2008-10#1)(2009-12#1)
cytological examination##2##2##(2007-7#1)(2012-12#1)
cytological features##2##2##(2008-7#1)(2009-10#1)
cytological grade##2##2##(2013-8#2)
cytological grading##4##2##(2013-8#4)
cytological observations##2##2##(2008-10#2)
cytological samples##2##2##(1993-11#1)(2011-2#1)
cytological study##2##2##(2008-10#1)(2008-6#1)
cytological test##2##2##(2011-1#2)
cytological##68##1##(1990-2#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-5#1)(1997-2#5)(2007-12#2)(2007-7#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-10#4)(2011-2#3)(2012-12#1)(2013-1#3)(2013-7#2)(2013-8#7)
cytologically positive##2##2##(1990-2#2)
cytologically##9##1##(1990-2#3)(1994-7#1)(2008-10#1)(2008-5#1)(2008-6#2)(2011-2#1)
cytologists##5##1##(2008-6#5)
cytology and##13##2##(1990-2#1)(1994-1#1)(2007-10#1)(2008-11#2)(2008-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
cytology findings##2##2##(2008-10#1)(2008-11#1)
cytology in the##4##3##(1990-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
cytology in##10##2##(1990-6#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#4)
cytology of the##3##3##(1993-12#1)(2013-1#2)
cytology of##7##2##(1993-12#1)(2007-5#1)(2008-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
cytology reports and##2##3##(2012-12#1)(2013-8#1)
cytology reports##3##2##(2012-12#2)(2013-8#1)
cytology screening##2##2##(1990-12#1)(2012-12#1)
cytology was##3##2##(1990-10#1)(1994-1#1)(2008-6#1)
cytology were##2##2##(1990-12#1)(1994-1#1)
cytology##92##1##(1990-10#2)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1992-8#1)(1993-12#1)(1994-1#5)(1994-12#1)(1994-7#2)(1996-12#2)(1996-6#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-5#3)(2008-10#5)(2008-11#5)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#11)
cytolysis##4##1##(1994-11#1)(1995-2#1)(1995-5#1)(2008-1#1)
cytolytic activity of##2##3##(1991-12#1)(1994-5#1)
cytolytic activity##5##2##(1991-12#1)(1993-9#1)(1994-5#1)(2008-10#2)
cytolytic##18##1##(1991-12#2)(1991-9#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-5#1)(1995-5#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)
cytomegalovirus (CMV) infection##2##3##(2007-7#1)(2012-12#1)
cytomegalovirus (CMV)##10##2##(1992-6#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
cytomegalovirus and hepatitis C##2##4##(2008-1#2)
cytomegalovirus and##3##2##(1990-9#1)(2008-1#2)
cytomegalovirus immediate early##2##3##(1993-8#1)(2008-11#1)
cytomegalovirus infection##6##2##(1991-8#1)(1997-3#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-2#1)
cytomegalovirus promoter##3##2##(2008-11#3)
cytomegalovirus##38##1##(1990-9#1)(1991-8#2)(1992-6#1)(1993-8#2)(1995-12#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-11#6)(2008-4#3)(2008-8#1)(2008-9#3)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
cytometer for##3##2##(2008-4#1)(2008-9#2)
cytometer is##3##2##(2008-3#1)(2008-9#2)
cytometer to##6##2##(1994-2#2)(2008-9#4)
cytometer##40##1##(1994-2#2)(2006-6#1)(2007-8#1)(2008-11#2)(2008-3#3)(2008-4#2)(2008-9#29)
cytometers##19##1##(2008-4#1)(2008-9#16)(2010-8#1)(2012-2#1)
cytometric analysis of##19##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#13)(2012-3#1)
cytometric analysis##35##2##(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#17)(2009-12#2)(2012-3#2)
cytometric approach##5##2##(1995-9#1)(2006-6#1)(2008-11#1)(2008-9#2)
cytometric assays##3##2##(2008-9#3)
cytometric data##2##2##(2008-10#1)(2008-11#1)
cytometric detection of##3##3##(2008-9#2)(2010-1#1)
cytometric detection##5##2##(2008-10#1)(2008-9#3)(2010-1#1)
cytometric determination of##3##3##(2008-9#3)
cytometric measurement of##3##3##(2008-9#3)
cytometric platelet cross-matching##2##3##(2011-2#2)
cytometric platelet##3##2##(2011-2#3)
cytometric screening##2##2##(2008-9#2)
cytometric##111##1##(1990-12#4)(1993-1#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-9#2)(1997-7#1)(2006-6#2)(2008-10#5)(2008-11#9)(2008-2#2)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#52)(2009-12#2)(2009-8#1)(2010-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
cytometry analysis of##2##3##(1997-7#1)(2012-2#1)
cytometry analysis##12##2##(1992-12#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-10#1)(2008-4#2)(2008-9#1)(2012-2#1)
cytometry and provides##2##3##(2008-9#2)
cytometry and##24##2##(1994-12#1)(1995-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#13)(2010-7#1)(2011-2#1)
cytometry can be##2##3##(2008-11#1)(2008-9#1)
cytometry can##4##2##(2008-11#1)(2008-9#3)
cytometry has##6##2##(2008-9#6)
cytometry have##5##2##(1992-8#1)(2008-9#4)
cytometry is##5##2##(1994-6#1)(2008-4#1)(2008-9#2)(2011-2#1)
cytometry of apoptosis##3##3##(2008-1#1)(2008-9#2)
cytometry of##7##2##(2008-1#1)(2008-9#5)(2012-1#1)
cytometry or##2##2##(2008-9#2)
cytometry provides##3##2##(2008-4#1)(2008-9#2)
cytometry revealed##2##2##(1994-8#1)(2008-11#1)
cytometry to##5##2##(1992-12#1)(2006-6#1)(2008-11#1)(2008-9#2)
cytometry using##4##2##(2008-4#1)(2008-9#3)
cytometry was##2##2##(1991-6#1)(2008-11#1)
cytometry with##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
cytometry##293##1##(1990-12#2)(1990-8#1)(1991-6#2)(1992-12#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2006-6#3)(2007-10#1)(2007-2#1)(2008-1#3)(2008-10#7)(2008-11#17)(2008-3#3)(2008-4#19)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#159)(2009-12#1)(2009-2#2)(2009-6#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
cytopathic effect and##2##3##(1994-6#2)
cytopathic effect of##2##3##(2008-11#2)
cytopathic effect##9##2##(1993-2#1)(1994-6#2)(2007-6#2)(2008-11#3)(2011-3#1)
cytopathic effects of##2##3##(1992-8#1)(2008-11#1)
cytopathic effects##4##2##(1992-8#1)(2008-11#2)(2008-5#1)
cytopathic##18##1##(1992-8#1)(1993-2#1)(1994-6#2)(2006-10#1)(2007-6#2)(2008-11#6)(2008-5#2)(2011-1#1)(2011-3#1)(2012-3#1)
cytopathological##4##1##(2008-10#3)(2009-2#1)
cytopenia##4##1##(2007-12#1)(2011-2#2)(2013-8#1)
cytopenias##2##1##(2008-11#2)
cytoplasm and nucleus##3##3##(1994-12#1)(2009-10#1)(2010-8#1)
cytoplasm and##22##2##(1994-12#1)(1994-6#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)
cytoplasm can##2##2##(1991-2#1)(2012-7#1)
cytoplasm disorganization and##2##3##(2008-10#2)
cytoplasm disorganization##3##2##(2008-10#3)
cytoplasm during##2##2##(2008-8#1)(2008-9#1)
cytoplasm in##2##2##(2006-6#1)(2008-10#1)
cytoplasm is##2##2##(1992-6#1)(2008-12#1)
cytoplasm leaves to##2##3##(2008-10#2)
cytoplasm of eukaryotic cells##2##4##(1994-8#1)(2008-11#1)
cytoplasm of infected cells##2##4##(2008-10#1)(2009-7#1)
cytoplasm of some##2##3##(1997-2#2)
cytoplasm of the##11##3##(1991-2#1)(1992-2#1)(1995-5#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
cytoplasm of##47##2##(1990-11#1)(1991-11#2)(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#2)(1997-2#2)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2012-2#1)(2013-1#2)
cytoplasm to##3##2##(1991-2#2)(2012-2#1)
cytoplasm was##9##2##(1994-6#1)(2008-10#5)(2008-8#2)(2008-9#1)
cytoplasm were##3##2##(2008-10#2)(2008-5#1)
cytoplasm with##4##2##(2008-5#1)(2008-7#2)(2012-2#1)
cytoplasm##210##1##(1990-11#1)(1990-5#1)(1991-11#5)(1991-2#5)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-12#12)(2008-1#1)(2008-10#43)(2008-11#12)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#11)(2008-9#9)(2009-10#2)(2009-2#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#8)(2012-7#2)(2013-1#3)(2013-8#2)
cytoplasmatic##2##1##(1994-5#1)(1994-6#1)
cytoplasmic Ca(2+)##2##2##(2006-6#1)(2013-1#1)
cytoplasmic Ca2+##4##2##(1992-6#1)(1994-11#2)(1995-11#1)
cytoplasmic RNA and##2##3##(1990-7#2)
cytoplasmic RNA from##2##3##(2008-2#2)
cytoplasmic RNA##6##2##(1990-7#2)(1991-2#1)(2008-11#1)(2008-2#2)
cytoplasmic and lumenal pH##2##4##(1994-8#2)
cytoplasmic and mitochondrial##3##3##(1992-10#2)(1993-2#1)
cytoplasmic and nuclear loci##3##4##(2008-9#3)
cytoplasmic and nuclear##4##3##(2008-11#1)(2008-9#3)
cytoplasmic and##10##2##(1992-10#2)(1993-2#1)(1994-8#2)(2008-11#1)(2008-8#1)(2008-9#3)
cytoplasmic antibodies##2##2##(2006-10#1)(2008-1#1)
cytoplasmic antibody##3##2##(1992-2#1)(2013-1#2)
cytoplasmic blebbing##2##2##(2008-11#1)(2009-12#1)
cytoplasmic calcium##3##2##(1990-7#1)(1991-5#1)(1991-9#1)
cytoplasmic domain of##6##3##(1991-6#1)(1993-12#2)(1994-9#1)(1995-2#1)(2008-5#1)
cytoplasmic domain##12##2##(1990-11#1)(1991-6#1)(1993-12#2)(1994-9#1)(1995-2#1)(1997-4#1)(2008-11#2)(2008-5#2)(2013-1#1)
cytoplasmic domains of##2##3##(1994-12#1)(2008-11#1)
cytoplasmic domains##4##2##(1992-12#1)(1994-12#1)(2008-11#1)(2008-8#1)
cytoplasmic droplets##2##2##(2011-1#2)
cytoplasmic enzymes were##2##3##(1990-5#1)(1993-2#1)
cytoplasmic enzymes##3##2##(1990-5#1)(1992-6#1)(1993-2#1)
cytoplasmic expression of##2##3##(1994-5#1)(2006-10#1)
cytoplasmic expression##3##2##(1994-5#1)(2006-10#1)(2013-7#1)
cytoplasmic extracts##2##2##(1990-7#1)(2008-2#1)
cytoplasmic free calcium concentration##2##4##(1991-12#1)(1993-3#1)
cytoplasmic free calcium##4##3##(1991-12#1)(1992-6#2)(1993-3#1)
cytoplasmic free##5##2##(1991-12#1)(1992-6#2)(1993-3#2)
cytoplasmic fumarase##2##2##(2008-6#2)
cytoplasmic inclusion bodies in##2##4##(1997-3#1)(2011-2#1)
cytoplasmic inclusion bodies##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
cytoplasmic inclusion##4##2##(1997-3#1)(2008-10#2)(2011-2#1)
cytoplasmic inclusions in##2##3##(1993-12#1)(2008-7#1)
cytoplasmic inclusions##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
cytoplasmic incompatibility (CI)##2##3##(2008-8#2)
cytoplasmic incompatibility##4##2##(2008-8#3)(2008-9#1)
cytoplasmic irradiation##4##2##(2008-8#4)
cytoplasmic kinases##2##2##(2008-4#1)(2009-10#1)
cytoplasmic localization of the##2##4##(1992-11#1)(1996-2#1)
cytoplasmic localization##3##2##(1992-11#1)(1993-6#1)(1996-2#1)
cytoplasmic location##2##2##(1991-2#1)(2008-7#1)
cytoplasmic loop##5##2##(1991-12#1)(1992-3#3)(2009-6#1)
cytoplasmic malate dehydrogenase##3##3##(1993-11#3)
cytoplasmic male sterile##2##3##(1996-10#1)(2008-8#1)
cytoplasmic male sterility (CMS)##2##4##(2008-9#1)(2011-2#1)
cytoplasmic male##4##2##(1996-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
cytoplasmic membrane and##4##3##(1991-10#2)(1997-8#1)(2011-2#1)
cytoplasmic membrane##21##2##(1990-11#5)(1990-8#2)(1991-10#2)(1991-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1997-4#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
cytoplasmic polyanions##2##2##(1991-11#2)
cytoplasmic probe##2##2##(1991-5#2)
cytoplasmic processes##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
cytoplasmic protein##4##2##(1992-9#1)(1993-8#1)(1994-11#1)(2008-2#1)
cytoplasmic receptor domain##3##3##(1997-7#3)
cytoplasmic receptor##4##2##(1997-7#3)(2008-4#1)
cytoplasmic region of human CD45##2##5##(1994-6#2)
cytoplasmic region of##3##3##(1994-6#3)
cytoplasmic side of the platelet membranes##3##6##(1992-6#3)
cytoplasmic side of the##4##4##(1990-8#1)(1992-6#3)
cytoplasmic side##5##2##(1990-8#1)(1992-6#4)
cytoplasmic streaming in##2##3##(1994-9#1)(2008-11#1)
cytoplasmic tail##4##2##(1992-12#1)(2008-9#3)
cytoplasmic vacuolization in##4##3##(2008-9#4)
cytoplasmic vacuolization of##3##3##(2008-8#1)(2008-9#2)
cytoplasmic vacuolization##10##2##(2008-10#1)(2008-8#1)(2008-9#8)
cytoplasmic vesicles##4##2##(2008-10#2)(2009-2#1)(2011-1#1)
cytoplasmic##270##1##(1990-11#6)(1990-2#1)(1990-5#1)(1990-7#6)(1990-8#5)(1991-10#2)(1991-11#8)(1991-12#4)(1991-2#3)(1991-5#8)(1991-6#1)(1991-9#1)(1992-10#5)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#9)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#5)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#4)(1995-5#2)(1995-6#3)(1996-10#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-7#5)(1997-8#1)(2006-10#2)(2006-6#2)(2007-12#3)(2008-1#3)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#6)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#14)(2008-8#13)(2008-9#23)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
cytoplasts##2##1##(1994-12#1)(1994-8#1)
cytoprotection##5##1##(1994-6#1)(1994-8#1)(2008-7#1)(2013-7#2)
cytoprotective action##2##2##(1996-2#1)(2013-7#1)
cytoprotective effect##4##2##(1993-12#1)(2008-11#1)(2008-7#1)(2009-6#1)
cytoprotective mechanisms##2##2##(1995-3#1)(1996-9#1)
cytoprotective properties of##2##3##(1993-12#1)(1994-6#1)
cytoprotective##16##1##(1993-12#2)(1994-6#1)(1995-3#1)(1996-2#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-10#2)(2012-2#1)(2013-7#2)
cytoreductive surgery##5##2##(1993-9#1)(2010-12#1)(2011-2#3)
cytosine and cytosine derivatives##3##4##(1992-8#3)
cytosine and##4##2##(1992-8#3)(2008-10#1)
cytosine methylation##3##2##(1997-4#1)(2009-10#1)(2011-2#1)
cytosine##24##1##(1991-12#1)(1991-2#1)(1992-8#7)(1993-11#2)(1993-9#1)(1994-12#1)(1997-2#2)(1997-4#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
cytosines of##2##2##(2009-10#2)
cytosines##3##1##(1990-8#1)(2009-10#2)
cytoskeletal architecture##2##2##(1994-8#1)(2011-2#1)
cytoskeletal components##2##2##(2008-11#1)(2009-8#1)
cytoskeletal dynamics##2##2##(2009-8#1)(2012-12#1)
cytoskeletal elements (actin filaments##2##4##(2007-12#2)
cytoskeletal elements##7##2##(1994-8#2)(1997-1#1)(2007-12#3)(2009-10#1)
cytoskeletal extracts##2##2##(1994-6#2)
cytoskeletal fraction##4##2##(1997-2#4)
cytoskeletal protein##8##2##(1991-9#1)(1992-2#1)(1995-12#2)(1996-10#1)(2008-7#1)(2008-8#1)(2010-5#1)
cytoskeletal proteins##3##2##(1996-12#1)(1996-2#1)(2009-8#1)
cytoskeletal structure##2##2##(2008-11#1)(2008-6#1)
cytoskeletal structures##2##2##(2008-11#1)(2008-7#1)
cytoskeletal##48##1##(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#3)(1994-8#4)(1995-11#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#4)(2007-12#3)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
cytoskeleton and also##2##3##(1996-2#1)(2011-2#1)
cytoskeleton and##7##2##(1990-5#1)(1992-11#1)(1996-2#1)(1997-3#1)(2008-11#1)(2009-5#1)(2011-2#1)
cytoskeleton by##2##2##(2009-8#1)(2012-12#1)
cytoskeleton in##5##2##(1996-5#1)(2008-10#1)(2008-11#2)(2009-10#1)
cytoskeleton is essential for##2##4##(2008-11#1)(2009-9#1)
cytoskeleton is##5##2##(2007-12#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-12#1)
cytoskeleton of##3##2##(1995-2#1)(2009-10#2)
cytoskeleton plays a##2##3##(2008-11#1)(2012-2#1)
cytoskeleton protein##2##2##(1996-5#1)(1997-2#1)
cytoskeleton##71##1##(1990-12#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#3)(1994-5#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#3)(1997-3#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#13)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)
cytoskeleton-associated##2##1##(1995-9#1)(2008-9#1)
cytosol and membrane fractions of##2##5##(1990-2#1)(2008-11#1)
cytosol and membrane fractions##3##4##(1990-2#1)(1991-2#1)(2008-11#1)
cytosol and membrane##5##3##(1990-2#1)(1991-2#1)(1993-8#1)(1993-9#1)(2008-11#1)
cytosol and##19##2##(1990-2#2)(1990-5#2)(1990-8#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#2)(1993-9#1)(2008-11#2)(2009-5#1)(2009-8#1)(2013-1#1)
cytosol by##4##2##(1995-11#1)(1996-2#1)(1996-5#1)(2008-10#1)
cytosol fraction##5##2##(1990-11#2)(1992-6#1)(2008-10#2)
cytosol or##2##2##(2010-10#1)(2013-1#1)
cytosol to nucleus##3##3##(2008-8#1)(2008-9#2)
cytosol to##11##2##(1990-7#1)(1991-2#1)(1992-12#1)(1992-6#1)(1995-11#2)(1997-1#1)(2008-8#1)(2008-9#2)(2011-2#1)
cytosol##112##1##(1990-11#4)(1990-2#4)(1990-5#5)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#8)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-9#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-7#2)(2008-1#4)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#3)(2013-1#4)
cytosolic 3##5##2##(1990-11#3)(1991-5#2)
cytosolic Ca(2+) concentration##2##3##(2008-11#1)(2008-7#1)
cytosolic Ca++##3##2##(1993-3#1)(1993-8#2)
cytosolic Ca2+ concentration##4##3##(1991-12#1)(1994-8#1)(1995-11#1)(1995-12#1)
cytosolic Ca2+ in##2##3##(1991-5#1)(1994-6#1)
cytosolic Ca2+##19##2##(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1994-6#4)(1994-8#1)(1995-11#2)(1995-12#2)(1996-2#5)(2008-8#1)
cytosolic NADH levels##3##3##(1994-8#2)(2009-9#1)
cytosolic NADH##6##2##(1994-8#4)(2009-9#2)
cytosolic PKC activity##2##3##(1997-6#2)
cytosolic PKC##3##2##(1997-6#3)
cytosolic activity##2##2##(1991-5#1)(1995-9#1)
cytosolic and membrane PKC##2##4##(1994-11#2)
cytosolic and membrane fractions##2##4##(1991-2#1)(1994-11#1)
cytosolic and membrane##5##3##(1991-2#1)(1993-8#1)(1994-11#3)
cytosolic and particulate fractions##3##4##(1996-5#3)
cytosolic and particulate##4##3##(1996-5#3)(1997-4#1)
cytosolic and perinuclear##2##3##(1993-11#2)
cytosolic and##18##2##(1990-8#1)(1991-2#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-11#3)(1995-11#2)(1996-5#3)(1997-4#1)(2008-11#1)(2009-10#1)
cytosolic calcium and##2##3##(1990-2#1)(1995-11#1)
cytosolic calcium concentration##3##3##(1990-5#1)(1993-11#1)(1994-11#1)
cytosolic calcium##12##2##(1990-2#1)(1990-5#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-11#3)(1995-12#1)(2008-9#1)(2009-12#1)
cytosolic components##2##2##(1991-5#1)(1993-8#1)
cytosolic dihydrofolate reductase##3##3##(1994-6#3)
cytosolic distribution##2##2##(1992-6#1)(2012-12#1)
cytosolic domain of the KDR##2##5##(1994-11#2)
cytosolic domain##3##2##(1994-11#2)(1996-2#1)
cytosolic estrogen receptor##3##3##(1990-11#1)(1993-8#2)
cytosolic estrogen##4##2##(1990-11#1)(1993-8#3)
cytosolic extracts##2##2##(1992-8#2)
cytosolic fraction##5##2##(1991-2#2)(1992-11#1)(1992-6#1)(2008-11#1)
cytosolic fractions of##2##3##(1990-5#1)(1990-7#1)
cytosolic fractions##5##2##(1990-5#1)(1990-7#1)(1996-2#2)(1996-5#1)
cytosolic free Ca(2+)##2##3##(2008-11#1)(2009-2#1)
cytosolic free Ca2+ concentration##4##4##(1990-12#1)(1990-7#1)(1995-11#1)(1995-5#1)
cytosolic free Ca2+##8##3##(1990-12#1)(1990-2#1)(1990-7#1)(1992-3#2)(1995-11#1)(1995-5#1)(1997-1#1)
cytosolic free Mg2+##2##3##(1990-7#2)
cytosolic free calcium concentration##2##4##(1992-6#2)
cytosolic free calcium levels##2##4##(1991-5#1)(1997-1#1)
cytosolic free calcium##7##3##(1991-5#1)(1992-6#2)(1993-12#1)(1994-9#2)(1997-1#1)
cytosolic free##21##2##(1990-12#1)(1990-2#1)(1990-7#3)(1991-5#1)(1992-3#2)(1992-6#2)(1993-12#1)(1994-9#2)(1995-11#1)(1995-5#2)(1997-1#2)(2008-11#1)(2009-2#1)(2013-1#1)
cytosolic or##2##2##(1996-11#1)(2008-11#1)
cytosolic peptides##3##2##(1996-2#3)
cytosolic phospholipase A2 (cPLA2)##5##4##(1993-11#1)(1993-6#1)(1994-11#3)
cytosolic phospholipase A2 activation in##3##5##(1994-11#1)(1995-11#2)
cytosolic phospholipase A2 gene##2##4##(1994-11#2)
cytosolic phospholipase A2##15##3##(1993-11#1)(1993-6#2)(1994-11#6)(1995-11#6)
cytosolic phosphoprotein that##2##3##(1991-9#1)(2013-1#1)
cytosolic protein tyrosine##2##3##(1992-3#1)(1995-11#1)
cytosolic protein##6##2##(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)
cytosolic proteins##4##2##(1992-12#3)(2009-12#1)
cytosolic purine 5'-nucleotidase##3##3##(1994-11#3)
cytosolic subfraction##2##2##(1995-2#2)
cytosolic to##2##2##(1993-8#1)(1997-4#1)
cytosolic transport##3##2##(1994-6#3)
cytosolic##223##1##(1990-11#6)(1990-12#3)(1990-2#2)(1990-5#6)(1990-7#6)(1990-8#1)(1991-12#1)(1991-2#5)(1991-5#9)(1991-8#2)(1991-9#1)(1992-11#6)(1992-12#4)(1992-3#4)(1992-4#1)(1992-6#4)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#6)(1993-3#1)(1993-6#2)(1993-8#12)(1994-11#17)(1994-12#2)(1994-2#1)(1994-6#12)(1994-8#6)(1994-9#3)(1995-11#16)(1995-12#5)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#11)(1996-3#2)(1996-5#5)(1997-1#2)(1997-4#2)(1997-6#4)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-9#3)(2010-5#2)(2011-2#1)(2012-12#2)(2013-1#4)
cytosols from##2##2##(1990-11#1)(2008-10#1)
cytosols metabolized [3H]DHT##2##3##(1990-11#2)
cytosols##14##1##(1990-11#6)(1995-11#6)(2008-10#2)
cytostatic drugs##2##2##(1991-8#2)
cytostatic effects##2##2##(1990-6#1)(2012-12#1)
cytostatic production phase is established##2##5##(2008-7#2)
cytostatic treatment##2##2##(1990-9#1)(1992-10#1)
cytostatic##24##1##(1990-6#1)(1990-9#2)(1991-8#4)(1992-10#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-8#2)(1996-5#2)(1997-4#1)(2008-7#6)(2009-12#1)(2012-12#1)
cytostatics##4##1##(1997-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
cytostructural##2##1##(2008-3#2)
cytotoxic T cell##2##3##(2008-4#1)(2013-1#1)
cytotoxic T cells (150 ppm)##2##5##(2008-10#2)
cytotoxic T cells##7##3##(1991-9#1)(1993-9#1)(1997-6#1)(2008-10#3)(2008-8#1)
cytotoxic T lymphocyte (CTL)##3##4##(1995-3#1)(2011-2#1)(2013-1#1)
cytotoxic T lymphocyte##6##3##(1995-3#2)(1997-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
cytotoxic T lymphocytes (CTL)##3##4##(2008-11#2)(2008-4#1)
cytotoxic T lymphocytes##8##3##(1992-2#1)(1995-5#1)(2008-11#4)(2008-4#2)
cytotoxic T##23##2##(1991-9#1)(1992-2#1)(1993-9#1)(1995-3#2)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-4#3)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
cytotoxic T-cell##4##2##(1993-6#2)(2010-1#1)(2012-12#1)
cytotoxic action##2##2##(1994-2#1)(2008-10#1)
cytotoxic activities against human##2##4##(2011-2#1)(2013-1#1)
cytotoxic activities of##2##3##(2008-11#1)(2013-1#1)
cytotoxic activities##5##2##(2008-11#2)(2011-2#1)(2013-1#2)
cytotoxic activity against##5##3##(1992-2#1)(1992-5#1)(2008-11#2)(2010-6#1)
cytotoxic activity of##8##3##(1990-12#4)(1992-9#1)(2008-10#1)(2008-4#2)
cytotoxic activity##24##2##(1990-12#5)(1992-2#1)(1992-5#1)(1992-9#2)(1993-9#1)(1994-2#3)(1996-12#1)(2008-10#2)(2008-11#3)(2008-4#3)(2010-6#1)(2011-2#1)
cytotoxic against##5##2##(1993-9#2)(1995-2#1)(1995-3#1)(2008-11#1)
cytotoxic agent##5##2##(2008-7#2)(2008-8#2)(2013-1#1)
cytotoxic agents##18##2##(1991-9#1)(1992-6#1)(1997-8#1)(2007-7#1)(2008-11#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
cytotoxic analogs of luteinizing hormone-releasing hormone##2##6##(1993-1#2)
cytotoxic and cytogenetic##2##3##(1993-8#2)
cytotoxic and##12##2##(1992-9#1)(1993-3#1)(1993-8#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
cytotoxic at##3##2##(1992-11#1)(1994-8#1)(2011-2#1)
cytotoxic challenges##3##2##(2008-7#3)
cytotoxic chemotherapy##11##2##(1993-12#1)(1997-5#1)(2008-11#1)(2008-6#3)(2008-7#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
cytotoxic drugs##14##2##(1990-9#1)(1991-8#2)(1995-4#1)(2007-5#2)(2008-1#1)(2008-11#2)(2009-1#1)(2009-12#1)(2010-8#1)(2013-1#2)
cytotoxic edema as the##2##4##(2007-10#2)
cytotoxic edema##5##2##(2007-10#3)(2008-8#1)(2009-9#1)
cytotoxic effect in vitro against##2##5##(1992-2#1)(2008-10#1)
cytotoxic effect of##8##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
cytotoxic effect on##2##3##(1992-8#1)(2008-11#1)
cytotoxic effect##19##2##(1990-2#1)(1992-2#1)(1992-8#1)(1995-8#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
cytotoxic effects of##9##3##(1990-2#1)(1990-5#1)(2008-11#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
cytotoxic effects on##2##3##(2008-11#1)(2009-12#1)
cytotoxic effects##16##2##(1990-2#1)(1990-5#1)(1990-7#1)(1997-4#1)(2008-10#1)(2008-11#4)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
cytotoxic for cells##2##3##(1990-8#1)(2013-8#1)
cytotoxic function##2##2##(2008-4#1)(2013-1#1)
cytotoxic in##2##2##(1993-8#1)(2013-1#1)
cytotoxic lymphocyte##2##2##(2008-1#1)(2011-2#1)
cytotoxic mechanisms##2##2##(2008-7#2)
cytotoxic potency##3##2##(1995-3#1)(2012-2#1)(2013-1#1)
cytotoxic potential##2##2##(2008-11#1)(2008-4#1)
cytotoxic property##2##2##(1994-3#1)(2008-11#1)
cytotoxic radicals##2##2##(1993-1#2)
cytotoxic response in##2##3##(1995-8#1)(2008-11#1)
cytotoxic response##3##2##(1992-10#1)(1995-8#1)(2008-11#1)
cytotoxic therapy##5##2##(1992-10#1)(2008-1#1)(2008-6#1)(2009-12#1)(2013-1#1)
cytotoxic to##5##2##(1993-9#1)(1995-12#1)(2008-9#1)(2010-1#1)(2012-3#1)
cytotoxic treatments##2##2##(1991-6#1)(2012-3#1)
cytotoxic##268##1##(1990-12#6)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-8#2)(1991-9#5)(1992-10#2)(1992-11#3)(1992-2#5)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#7)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#5)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#12)(2008-11#33)(2008-12#1)(2008-4#10)(2008-5#1)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#1)(2009-1#1)(2009-12#4)(2009-9#3)(2010-1#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#20)(2013-7#1)(2013-8#2)
cytotoxicities##3##1##(1995-3#1)(2008-8#1)(2013-1#1)
cytotoxicity (ADCC)##5##2##(1992-2#1)(1993-6#1)(2008-11#1)(2008-4#2)
cytotoxicity against K562##3##3##(1994-3#1)(2008-11#2)
cytotoxicity against##17##2##(1992-5#1)(1994-3#2)(1994-6#3)(1997-7#1)(2008-11#4)(2008-4#1)(2008-7#2)(2011-3#2)(2013-1#1)
cytotoxicity and the##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
cytotoxicity and##11##2##(1992-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)
cytotoxicity assay to##2##3##(2007-12#1)(2008-11#1)
cytotoxicity assay##5##2##(1990-12#2)(2007-12#1)(2008-11#1)(2008-9#1)
cytotoxicity assays using the##2##4##(1997-2#1)(2008-8#1)
cytotoxicity assays##6##2##(1995-3#2)(1997-2#1)(2008-5#1)(2008-8#1)(2009-12#1)
cytotoxicity at##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
cytotoxicity by##3##2##(1990-2#1)(1992-2#1)(2008-11#1)
cytotoxicity in murine##2##3##(1991-4#1)(2013-1#1)
cytotoxicity in##19##2##(1990-2#2)(1991-12#1)(1991-4#2)(1993-9#1)(1994-8#2)(1995-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
cytotoxicity induced by##2##3##(1994-12#1)(2012-12#1)
cytotoxicity is##3##2##(1992-8#1)(1993-3#1)(2008-9#1)
cytotoxicity of the##9##3##(2008-11#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-4#1)
cytotoxicity of##33##2##(1990-5#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-8#6)(2008-9#1)(2009-12#2)(2009-4#2)(2012-3#1)(2013-1#2)(2013-7#1)
cytotoxicity on##5##2##(1992-2#1)(1993-8#1)(1994-2#1)(2008-10#1)(2008-11#1)
cytotoxicity or##2##2##(1995-3#1)(1997-4#1)
cytotoxicity screening##2##2##(2008-5#1)(2008-9#1)
cytotoxicity studies##3##2##(1993-5#1)(2008-11#2)
cytotoxicity test##3##2##(2008-11#3)
cytotoxicity testing##2##2##(2008-11#2)
cytotoxicity tests##2##2##(2008-11#2)
cytotoxicity than##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
cytotoxicity to##6##2##(1992-3#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)
cytotoxicity toward##3##2##(1994-8#2)(2012-2#1)
cytotoxicity was##7##2##(1993-1#1)(1993-6#1)(1994-6#1)(1995-3#1)(1995-8#1)(2009-4#1)(2012-12#1)
cytotoxicity##217##1##(1990-12#2)(1990-2#3)(1990-5#2)(1991-12#1)(1991-4#5)(1991-5#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-5#2)(1992-7#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#11)(1995-12#2)(1995-3#8)(1995-8#4)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#38)(2008-4#10)(2008-5#3)(2008-7#7)(2008-8#11)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-3#1)(2011-1#3)(2011-2#6)(2011-3#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#3)
cytotoxin production by Serratia marcescens##2##5##(1996-12#2)
cytotoxin production##3##2##(1996-12#3)
cytotoxin##13##1##(1994-2#6)(1995-3#2)(1996-12#4)(2007-10#1)
cytotoxins##2##1##(2011-2#1)(2013-8#1)
cytotrophoblast##2##1##(1994-9#1)(1995-11#1)
d 1##4##2##(1992-12#3)(2008-8#1)
d = 0##2##3##(2007-11#1)(2013-1#1)
d =##3##2##(2007-11#1)(2008-5#1)(2013-1#1)
d after spraying##2##3##(2011-2#2)
d after the##3##3##(2010-12#1)(2013-1#2)
d after##13##2##(2006-11#1)(2008-8#5)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#2)
d and##5##2##(1990-7#1)(2008-10#2)(2008-9#1)(2012-2#1)
d at##3##2##(2008-11#1)(2011-2#2)
d deficiency##2##2##(2011-1#2)
d elivery of##2##3##(2008-11#2)
d for##2##2##(2008-11#1)(2008-3#1)
d from##2##2##(2007-11#1)(2011-2#1)
d in a##2##3##(2008-3#1)(2011-2#1)
d in##7##2##(2007-5#2)(2008-10#1)(2008-3#1)(2011-2#3)
d of##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
d on P##4##3##(2011-2#4)
d on##6##2##(2008-8#1)(2011-2#5)
d treatment##2##2##(2008-11#1)(2011-1#1)
d with##2##2##(2008-10#1)(2008-6#1)
d yielded##5##2##(1990-12#1)(2011-2#4)
d##213##1##(1990-11#2)(1990-12#2)(1990-7#2)(1991-2#2)(1992-12#5)(1992-6#10)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-8#1)(1996-2#4)(1997-7#1)(2006-11#1)(2007-11#4)(2007-5#3)(2008-10#51)(2008-11#6)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#9)(2008-7#4)(2008-8#15)(2008-9#7)(2009-3#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#6)(2011-1#3)(2011-2#34)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)
d&lt##3##1##(1995-3#1)(2008-10#2)
d'##6##1##(1991-2#3)(1992-11#1)(2012-1#2)
d'Anjou pear##2##2##(2008-10#2)
d'amino-acides##3##1##(2008-5#3)
d'autres##2##1##(2013-1#2)
d'hygiene personnelle##2##2##(2008-5#2)
d'hypertension##2##1##(2011-2#1)(2013-1#1)
d'origine##2##1##(2008-10#1)(2011-2#1)
d'un phéochromocytome##2##2##(2011-2#2)
d'un##18##1##(2008-2#2)(2008-5#2)(2011-2#5)(2013-1#9)
d'une##16##1##(2008-11#1)(2008-5#5)(2011-2#5)(2013-1#5)
d'évaluer##2##1##(2011-2#1)(2013-1#1)
d(-1) in##3##2##(2007-5#1)(2008-5#2)
d(-1)##11##1##(2007-5#5)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#2)
d(-1)) and the##2##3##(2008-5#1)(2008-9#1)
d(-1)) and##3##2##(2007-5#1)(2008-5#1)(2008-9#1)
d(-1))##6##1##(2007-5#2)(2008-5#2)(2008-9#1)(2009-8#1)
d(0)##2##1##(2008-3#2)
d(1)##3##1##(2008-12#1)(2008-3#2)
d(2)##2##1##(2008-12#1)(2008-2#1)
d(31)##2##1##(2007-11#1)(2007-12#1)
d(33)##3##1##(2007-11#2)(2009-5#1)
d(AG/CT)n##2##1##(1996-8#2)
d(CCG/CGG)n##2##1##(1996-8#2)
d(CGCAAATTTGCG)2 in##2##2##(1995-3#2)
d(CGTAATTACG)2##2##1##(1993-11#2)
d(CH2)5Tyr(Me)vasopressin##3##1##(1995-12#3)
d(CTGCAG)2 complex##2##2##(1990-7#2)
d(CTGCAG)2##4##1##(1990-7#4)
d(GpG)##3##1##(1992-3#3)
d(TACGTA)##3##1##(1991-5#3)
d(eff)##2##1##(2007-11#1)(2007-12#1)
d) and##2##2##(2008-10#1)(2011-2#1)
d) on##2##2##(2008-11#1)(2011-2#1)
d)##23##1##(1993-9#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2011-2#4)(2012-2#1)(2013-7#1)
d- and l-tryptophan##2##3##(2008-10#2)
d- and##4##2##(2008-10#3)(2010-5#1)
d-##5##1##(2008-10#4)(2010-5#1)
d-1##2##1##(2008-11#2)
d-LDH paste electrode##2##3##(2008-10#2)
d-LDH##3##1##(2008-10#3)
d-ROMs and PON1 activity##2##4##(2012-12#2)
d-Ser##2##1##(2008-10#2)
d-Tagatose##3##1##(2008-5#3)
d-amphetamine##9##1##(1990-9#1)(1991-1#1)(1992-7#1)(1994-8#6)
d-glucosamine##4##1##(2008-10#4)
d-glucose##2##1##(2008-10#1)(2008-5#1)
d-lactate##3##1##(2008-10#3)
d-lactic acid##7##2##(2008-10#5)(2008-11#2)
d-malate##4##1##(2008-10#4)
d-penicillamine in##2##2##(2008-10#2)
d-penicillamine##4##1##(2008-10#4)
d-ribose##2##1##(2011-1#2)
d-sorbitol##8##1##(2008-10#1)(2008-5#7)
d-tagatose was##2##2##(2008-5#2)
d-tagatose##14##1##(2008-5#14)
d-thyroxine##2##1##(2008-10#2)
d-tubocurarine chloride##2##2##(1996-12#2)
d-xylose and##2##2##(2013-1#2)
dA##2##1##(1994-8#1)(2008-4#1)
dA+5##2##1##(1992-6#2)
dA-dT or##2##2##(1992-6#2)
dA-dT##3##1##(1992-6#3)
dACT##3##1##(2008-9#3)
dAMP hydroxyl##2##2##(2008-8#2)
dAMP##5##1##(2008-8#4)(2008-9#1)
dAVS##5##1##(1996-9#5)
dAdo##2##1##(1995-6#2)
dB (A)##3##2##(2011-2#3)
dB (naftidrofuryl)##2##2##(1995-6#2)
dB (piracetam)##2##2##(1995-6#2)
dB +/- 1##2##3##(2008-4#2)
dB MHz(-1)##2##2##(2008-7#2)
dB MHz(-1))##2##2##(2008-7#2)
dB SNR##2##2##(2008-9#2)
dB after##2##2##(2007-11#2)
dB and a##3##3##(2007-11#2)(2008-3#1)
dB and##6##2##(2007-11#4)(2008-3#2)
dB are##2##2##(2008-3#2)
dB at a##2##3##(2007-12#1)(2008-2#1)
dB at##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
dB by##2##2##(2008-2#1)(2008-3#1)
dB for the##3##3##(2007-12#2)(2008-2#1)
dB for##11##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)
dB from the fiber input##2##5##(2008-2#2)
dB from the##3##3##(2007-12#1)(2008-2#2)
dB in the##2##3##(2007-12#1)(2008-3#1)
dB in##4##2##(2007-12#2)(2008-3#2)
dB is obtained##2##3##(2007-12#1)(2008-3#1)
dB is##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
dB of##4##2##(2007-12#3)(2008-3#1)
dB over##2##2##(2007-11#1)(2008-3#1)
dB to##2##2##(2008-3#1)(2009-5#1)
dB under##2##2##(2007-11#1)(2008-3#1)
dB was##4##2##(2007-11#2)(2007-9#1)(2008-2#1)
dB were measured##2##3##(2008-3#1)(2009-5#1)
dB were##4##2##(2008-2#1)(2008-3#2)(2009-5#1)
dB when##2##2##(2007-11#1)(2007-12#1)
dB with a##2##3##(2007-11#1)(2008-3#1)
dB with##4##2##(2007-11#2)(2008-3#2)
dB x##2##2##(2008-3#2)
dB##139##1##(1995-12#2)(1995-6#4)(2007-11#29)(2007-12#25)(2007-9#1)(2008-2#16)(2008-3#36)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#6)(2009-9#1)(2010-4#1)(2011-2#3)(2013-8#4)
dB) and low##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
dB) and##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
dB) at##2##2##(2007-9#1)(2008-3#1)
dB) by the##2##3##(2007-12#1)(2008-3#1)
dB)##15##1##(2007-12#3)(2007-9#2)(2008-2#2)(2008-3#8)
dB/0##4##1##(2010-8#4)
dB/Hz##2##1##(2007-11#1)(2007-12#1)
dB/cm at##2##2##(2008-2#2)
dB/cm##7##1##(2007-11#1)(2007-12#3)(2008-2#3)
dB/m##2##1##(2007-12#1)(2008-2#1)
dB/mm##2##1##(2007-11#1)(2008-2#1)
dBA##7##1##(2008-8#4)(2013-1#3)
dBm##3##1##(2007-12#2)(2008-3#1)
dC##3##1##(1994-8#1)(1997-2#1)(2008-4#1)
dG##3##1##(1994-11#1)(1994-8#1)(2008-4#1)
dLGN##3##1##(1992-10#3)
dNADPH##2##1##(1992-3#2)
dNTP##2##1##(1992-6#1)(1995-2#1)
dNTPs##2##1##(1995-2#2)
dP)##3##1##(2008-10#3)
dQTL##5##1##(2008-10#5)
dR)##2##1##(2008-12#2)
dRLh cells##2##2##(1991-5#2)
dRTA##5##1##(2008-1#5)
dRecQ5##4##1##(2011-1#4)
dS m(-1))##6##2##(2008-10#4)(2008-12#2)
dSMAD2##6##1##(2008-9#6)
dT-dA base pairs at positions -4/+4 and -5/+5##2##8##(1992-6#2)
dTMP synthase##3##2##(1992-8#3)
dTMP##4##1##(1992-8#4)
dThd and##2##2##(1995-6#2)
dUTP nick end labeling##2##4##(2008-10#1)(2008-8#1)
da Vinci##2##2##(1991-3#1)(2008-10#1)
da##10##1##(1991-3#1)(2008-10#1)(2009-10#7)(2010-1#1)
dabeicola##2##1##(2010-10#2)
dabigatran##2##1##(2012-12#1)(2013-1#1)
dabsyl chloride##2##2##(2008-10#2)
dacarbazine##2##1##(2007-5#1)(2008-6#1)
dacron##2##1##(1992-3#1)(2012-3#1)
dacryoadenitis##4##1##(2011-2#4)
dactylitis##5##1##(2006-10#3)(2010-12#1)(2012-12#1)
dactyloides and##2##2##(2008-10#2)
dactyloides##4##1##(2008-10#4)
dactylon##4##1##(2008-10#4)
dahlia violet##2##2##(2008-10#2)
dahlia##4##1##(2008-10#3)(2008-12#1)
dahliae and V##2##3##(2008-10#2)
dahliae and##7##2##(2008-10#5)(2008-12#1)(2011-1#1)
dahliae by##3##2##(2008-10#3)
dahliae from cruciferous##2##3##(2008-10#2)
dahliae from noncruciferous hosts##2##4##(2008-10#2)
dahliae from##4##2##(2008-10#4)
dahliae in the##4##3##(2008-10#3)(2008-12#1)
dahliae in##10##2##(2008-10#9)(2008-12#1)
dahliae inoculum and##3##3##(2008-10#3)
dahliae isolates from artichoke##3##4##(2008-10#3)
dahliae isolates from##6##3##(2008-10#6)
dahliae isolates was##2##3##(2008-10#2)
dahliae isolates within##2##3##(2008-10#2)
dahliae isolates##12##2##(2008-10#12)
dahliae on##3##2##(2008-10#2)(2011-1#1)
dahliae was##3##2##(2008-10#3)
dahliae##97##1##(2008-10#88)(2008-12#3)(2011-1#6)
dahliae-infested plots##3##2##(2008-10#3)
dahliae-infested##4##1##(2008-10#4)
daidzein and genistein##2##3##(1993-12#1)(2008-10#1)
daidzein and##5##2##(1993-12#1)(2008-10#4)
daidzein by##2##2##(2008-10#1)(2010-1#1)
daidzein in##2##2##(2008-10#2)
daidzein to equol##2##3##(2010-1#2)
daidzein to##3##2##(2010-1#2)(2012-2#1)
daidzein##26##1##(1993-12#1)(2008-10#14)(2010-1#6)(2012-2#5)
daidzin##7##1##(2008-11#6)(2010-12#1)
daikenchuto##2##1##(2010-12#1)(2011-2#1)
daily 1##2##2##(2008-6#1)(2008-7#1)
daily Internet use and low well-being##2##6##(2009-7#2)
daily Internet use was##2##4##(2009-7#2)
daily Internet use##4##3##(2009-7#4)
daily activities and##3##3##(2008-7#1)(2009-7#2)
daily activities##24##2##(1992-3#1)(2007-10#2)(2007-11#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
daily activity##3##2##(2008-8#1)(2010-3#1)(2012-1#1)
daily administration##2##2##(2007-11#1)(2011-2#1)
daily amount##2##2##(1997-4#1)(2008-9#1)
daily and##14##2##(1992-11#1)(1997-4#2)(2007-10#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)
daily application##3##2##(2007-11#1)(2007-7#1)(2008-5#1)
daily at bedtime##2##3##(2007-7#1)(2008-5#1)
daily at##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
daily care##3##2##(1991-1#1)(1996-3#1)(2007-12#1)
daily census##2##2##(1992-12#2)
daily clinical practice##5##3##(2011-2#4)(2013-8#1)
daily clinical##8##2##(1995-5#1)(2011-2#4)(2013-1#1)(2013-8#2)
daily death counts caused by cardiovascular disease##2##7##(2011-1#2)
daily death counts##3##3##(2011-1#3)
daily death##4##2##(2011-1#4)
daily diary method was used to##2##6##(2009-7#1)(2011-2#1)
daily diet##2##2##(2008-10#1)(2013-8#1)
daily dietary##4##2##(1991-6#1)(1997-4#2)(2008-10#1)
daily dosage was##2##3##(2011-2#2)
daily dosage##5##2##(1990-12#1)(2007-11#1)(2010-5#1)(2011-2#2)
daily dose of##13##3##(1990-11#3)(1990-12#1)(1990-2#1)(1992-2#1)(1994-6#4)(2008-10#1)(2011-2#1)(2013-1#1)
daily dose##20##2##(1990-11#4)(1990-12#1)(1990-2#1)(1991-11#1)(1992-10#1)(1992-2#1)(1994-6#4)(2008-10#1)(2008-11#2)(2011-2#2)(2013-1#2)
daily doses of##15##3##(1991-11#1)(2007-7#1)(2008-7#1)(2008-8#3)(2008-9#9)
daily doses##21##2##(1991-11#1)(1991-2#1)(2007-7#1)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#11)
daily dosing##2##2##(2008-9#1)(2012-2#1)
daily during the##2##3##(1993-3#1)(2008-5#1)
daily during##4##2##(1990-8#1)(1991-11#1)(1993-3#1)(2008-5#1)
daily energy##2##2##(1990-2#1)(2012-2#1)
daily exercises##2##2##(1990-6#1)(2013-8#1)
daily exposure##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
daily food##2##2##(1990-2#1)(2008-7#1)
daily for 10 days##3##4##(1991-8#1)(2007-10#1)(2008-7#1)
daily for 12##2##3##(1995-12#1)(2007-10#1)
daily for 14 days##2##4##(2009-5#1)(2011-2#1)
daily for 14##3##3##(1995-12#1)(2009-5#1)(2011-2#1)
daily for 15 days##2##4##(2012-3#1)(2013-8#1)
daily for 15##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
daily for 2##3##3##(2007-7#1)(2008-5#2)
daily for 3##4##3##(2007-7#1)(2008-10#1)(2008-5#2)
daily for 4 weeks##2##4##(2007-7#1)(2008-3#1)
daily for 4##3##3##(2007-7#1)(2008-3#1)(2013-1#1)
daily for 5 days##4##4##(1992-8#1)(2008-7#3)
daily for 5##5##3##(1992-8#1)(2008-12#1)(2008-7#3)
daily for 7 days##2##4##(1994-3#1)(2013-1#1)
daily for 7##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
daily for a period of##3##5##(2007-7#1)(2008-1#1)(2008-10#1)
daily for a##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
daily for##45##2##(1990-5#1)(1990-8#1)(1991-8#1)(1992-8#2)(1993-11#1)(1994-3#1)(1994-7#1)(1995-12#2)(1997-4#1)(2007-10#2)(2007-7#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#4)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
daily gain##4##2##(2008-12#2)(2010-2#1)(2013-1#1)
daily home hemodialysis##2##3##(2010-5#2)
daily in the morning##3##4##(2007-11#2)(2008-10#1)
daily in##12##2##(1990-2#1)(1991-11#1)(1992-8#1)(1993-2#1)(1996-1#1)(2007-11#2)(2008-10#1)(2008-3#1)(2009-11#1)(2012-1#1)(2013-1#1)
daily infection##2##2##(2008-10#2)
daily injection##2##2##(2008-10#1)(2009-11#1)
daily injections of##4##3##(1990-12#1)(1997-2#1)(2008-10#1)(2009-11#1)
daily injections##6##2##(1990-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-11#1)(2012-4#1)
daily intake of##13##3##(1991-11#1)(1992-9#1)(1994-2#1)(1994-9#1)(2008-10#4)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
daily intake##14##2##(1991-11#1)(1992-9#1)(1994-2#1)(1994-9#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
daily intakes##2##2##(2008-10#1)(2011-2#1)
daily is##3##2##(1996-11#1)(1997-8#1)(2007-12#1)
daily life##29##2##(1990-8#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
daily lives##6##2##(1993-3#1)(2008-2#2)(2008-9#1)(2012-2#1)(2013-1#1)
daily living##27##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-2#2)(1995-3#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-11#1)(2008-7#4)(2009-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#3)
daily maximum##2##2##(2010-5#1)(2011-1#1)
daily meals##2##2##(2008-10#2)
daily mean temperature##2##3##(2008-10#2)
daily mean##3##2##(2008-10#3)
daily minimum##3##2##(2012-2#1)(2013-1#2)
daily mortality##3##2##(1997-1#3)
daily number of##2##3##(2011-1#2)
daily nutrient##2##2##(2008-7#1)(2013-1#1)
daily or##2##2##(2007-10#1)(2007-11#1)
daily oral##5##2##(1990-7#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
daily pain##3##2##(2008-7#3)
daily physical activity##2##3##(2008-10#1)(2008-3#1)
daily practice of##2##3##(1993-3#1)(1997-3#1)
daily practice##16##2##(1993-11#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-11#3)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
daily restraint##2##2##(1994-2#2)
daily routine##4##2##(1993-12#1)(2008-11#1)(2010-4#1)(2011-1#1)
daily smokers##2##2##(1990-2#1)(1990-6#1)
daily smoking##3##2##(1991-11#1)(1991-6#1)(2013-1#1)
daily spawning##2##2##(2010-8#2)
daily sperm production##2##3##(1992-12#2)
daily spiritual experiences##2##3##(2009-11#2)
daily spiritual##4##2##(2009-11#4)
daily stressors##3##2##(2012-1#3)
daily supplementation##2##2##(2007-11#1)(2011-2#1)
daily tasks'##2##2##(2012-3#2)
daily temperature##2##2##(2008-10#2)
daily temperatures##2##2##(2008-10#1)(2012-2#1)
daily to##3##2##(1992-8#1)(2011-9#1)(2013-8#1)
daily treatment##2##2##(1991-1#1)(1995-3#1)
daily ultrasound##2##2##(1994-7#1)(2013-1#1)
daily use of##3##3##(2008-8#2)(2012-2#1)
daily use##7##2##(1991-9#1)(1992-4#1)(2008-3#1)(2008-8#2)(2012-2#1)(2013-1#1)
daily variations##3##2##(2008-5#3)
daily was##4##2##(1992-8#1)(1996-1#1)(2007-11#1)(2008-5#1)
daily weight gain##2##3##(2008-9#1)(2013-7#1)
daily weight##3##2##(2008-12#1)(2008-9#1)(2013-7#1)
daily were##2##2##(2007-11#1)(2013-1#1)
daily with##5##2##(2008-10#2)(2008-11#1)(2008-6#1)(2010-6#1)
daily work##6##2##(1994-1#1)(1997-3#1)(2008-1#1)(2010-10#1)(2013-1#2)
daily##639##1##(1990-10#1)(1990-11#8)(1990-12#4)(1990-2#6)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-1#2)(1991-11#8)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#6)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-6#5)(1994-7#4)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#3)(1996-1#4)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#8)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#10)(2007-11#14)(2007-12#7)(2007-5#3)(2007-7#12)(2007-8#4)(2008-1#5)(2008-10#60)(2008-11#24)(2008-12#13)(2008-2#5)(2008-3#20)(2008-4#1)(2008-5#19)(2008-6#6)(2008-7#29)(2008-8#13)(2008-9#28)(2009-1#1)(2009-10#1)(2009-11#11)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#11)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#8)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#13)(2011-2#37)(2011-9#1)(2012-1#11)(2012-12#8)(2012-2#15)(2012-3#7)(2012-4#1)(2013-1#35)(2013-7#1)(2013-8#9)
daily) for##2##2##(1997-6#1)(2006-10#1)
daily) is##2##2##(1992-11#1)(1992-8#1)
daily) or##3##2##(1993-5#1)(1996-2#1)(2013-1#1)
daily) was##2##2##(1992-10#1)(1995-3#1)
daily)##24##1##(1990-11#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-3#2)(1995-3#3)(1996-11#1)(1996-2#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-5#1)(2009-11#1)(2013-1#2)
dairies##2##1##(2008-10#1)(2010-4#1)
dairy and beef cattle##3##4##(2010-4#1)(2012-3#2)
dairy calves of the north-western zone of the Bogota##2##9##(2012-12#2)
dairy calves##3##2##(1997-5#1)(2012-12#2)
dairy cattle barns##2##3##(2010-4#2)
dairy cattle##3##2##(1996-3#1)(2010-4#2)
dairy cows fed a##2##4##(2013-1#2)
dairy cows##5##2##(1996-8#1)(2012-2#1)(2013-1#3)
dairy dessert##3##2##(2011-2#3)
dairy farms##4##2##(2008-6#1)(2012-12#2)(2012-3#1)
dairy goats were##2##3##(2008-12#1)(2010-2#1)
dairy goats##6##2##(1996-12#1)(2008-12#2)(2008-9#1)(2010-2#2)
dairy herds in the southern Netherlands##2##6##(1996-8#2)
dairy herds##6##2##(1990-6#1)(1992-2#1)(1995-9#1)(1996-8#2)(2012-3#1)
dairy products##9##2##(1990-8#1)(2008-10#3)(2011-2#1)(2012-1#1)(2012-2#3)
dairy streams##2##2##(2012-2#2)
dairy##69##1##(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-8#3)(1997-5#2)(2008-10#6)(2008-12#3)(2008-6#1)(2008-9#1)(2009-11#1)(2010-2#2)(2010-4#4)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#12)(2012-3#6)(2013-1#8)
daisy modes the##2##3##(2007-11#2)
daisy modes##3##2##(2007-11#3)
daisy##6##1##(2007-11#4)(2008-10#2)
dalton##3##1##(1991-12#1)(1992-9#1)(2008-10#1)
daltons were##2##2##(1990-11#1)(2008-10#1)
daltons##6##1##(1990-11#1)(1990-2#1)(1991-8#1)(1992-8#1)(1993-3#1)(2008-10#1)
dam water##2##2##(2008-10#2)
dam##10##1##(1990-5#3)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)
damage DNA##2##2##(1992-9#1)(1997-4#1)
damage among##2##2##(1997-4#1)(2012-2#1)
damage and a##3##3##(1996-3#1)(2012-3#1)(2013-1#1)
damage and apoptosis##2##3##(2012-12#1)(2013-7#1)
damage and cell##2##3##(2009-12#1)(2012-2#1)
damage and loss of##3##4##(1992-2#1)(2006-10#1)(2008-10#1)
damage and repair##3##3##(1995-3#1)(1996-12#1)(2008-7#1)
damage and the##5##3##(1994-8#1)(2007-8#1)(2008-11#2)(2009-6#1)
damage and##76##2##(1990-12#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
damage appears##2##2##(2008-10#1)(2008-3#1)
damage as##8##2##(1993-12#2)(1994-2#1)(1995-12#1)(1995-5#1)(2009-12#1)(2010-5#1)(2011-2#1)
damage associated with##2##3##(1994-2#1)(2012-2#1)
damage at the##6##3##(1990-3#1)(1997-4#1)(2007-8#1)(2008-6#1)(2008-8#1)(2012-2#1)
damage at##11##2##(1990-3#1)(1994-11#1)(1997-4#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
damage by##19##2##(1992-3#3)(1992-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
damage can be##6##3##(2008-11#2)(2008-3#2)(2008-4#1)(2013-8#1)
damage can##7##2##(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2013-8#1)
damage caused by the##2##4##(2008-10#1)(2008-5#1)
damage caused by##20##3##(1990-7#1)(1992-2#1)(1992-3#2)(1995-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
damage caused to##2##3##(2008-10#1)(2008-5#1)
damage caused##22##2##(1990-7#1)(1992-2#1)(1992-3#2)(1995-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
damage control##4##2##(2008-9#1)(2011-2#2)(2013-8#1)
damage could be##2##3##(2008-2#1)(2008-5#1)
damage due to##5##3##(1991-12#1)(1997-4#1)(2008-5#1)(2008-7#2)
damage during##15##2##(1991-9#1)(1992-5#1)(1994-6#1)(1995-12#1)(1996-9#2)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#1)
damage fluences of##2##3##(2007-11#1)(2008-3#1)
damage following##3##2##(1997-4#1)(2008-8#1)(2010-3#1)
damage from##5##2##(1992-9#1)(2008-1#1)(2008-10#2)(2012-3#1)
damage has##2##2##(2008-6#1)(2010-2#1)
damage have been##2##3##(1997-4#1)(2008-11#1)
damage have##3##2##(1997-4#1)(2008-11#1)(2009-10#1)
damage in a##4##3##(1995-6#1)(1996-5#1)(2008-4#1)(2012-2#1)
damage in adult##2##3##(2008-4#1)(2013-7#1)
damage in both##2##3##(2008-10#1)(2011-2#1)
damage in children##3##3##(2011-2#3)
damage in human##3##3##(1997-4#3)
damage in ischemic##2##3##(1996-2#1)(1996-9#1)
damage in mice##3##3##(1995-3#1)(2010-7#1)(2013-8#1)
damage in patients with##2##4##(2008-1#1)(2008-12#1)
damage in patients##3##3##(2007-10#1)(2008-1#1)(2008-12#1)
damage in rats##3##3##(2012-2#1)(2013-8#2)
damage in the##15##3##(1990-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1995-6#2)(1996-12#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-12#2)(2009-9#1)
damage in tumor cells##3##4##(2010-2#3)
damage in various##2##3##(2007-10#1)(2008-3#1)
damage in##99##2##(1990-12#1)(1990-7#2)(1991-11#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-6#4)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#12)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-12#4)(2009-5#2)(2009-7#1)(2009-9#1)(2010-2#4)(2010-5#1)(2010-7#1)(2011-2#9)(2012-2#2)(2012-4#2)(2013-1#2)(2013-7#1)(2013-8#3)
damage induced by perfusion of radical generating azo compound##2##9##(1995-6#2)
damage induced by##12##3##(1993-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
damage induced in##3##3##(1992-3#1)(1993-3#1)(1997-4#1)
damage induced##15##2##(1992-3#1)(1993-3#2)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
damage is caused by##2##4##(2011-2#1)(2012-12#1)
damage is limited to##2##4##(1991-9#1)(2013-1#1)
damage is the##2##3##(1992-8#1)(2008-3#1)
damage is##25##2##(1990-5#1)(1991-9#2)(1992-8#1)(1995-2#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
damage levels##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
damage mainly##2##2##(2008-5#1)(2009-8#1)
damage markers##2##2##(2009-8#1)(2012-3#1)
damage may##6##2##(1995-8#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-12#1)
damage measured##2##2##(2008-10#1)(2010-5#1)
damage mechanism##2##2##(2008-3#1)(2009-7#1)
damage mechanisms##3##2##(2008-3#3)
damage morphologies##2##2##(2008-3#2)
damage motor##2##2##(2008-7#2)
damage observed in##3##3##(1997-4#1)(2007-10#1)(2008-11#1)
damage observed##4##2##(1994-8#1)(1997-4#1)(2007-10#1)(2008-11#1)
damage occurred##2##2##(2008-10#1)(2008-3#1)
damage of DNA and lipids in normal##2##7##(2008-4#2)
damage of DNA and##3##4##(2008-10#1)(2008-4#2)
damage of DNA##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
damage of the##11##3##(1990-2#1)(1990-8#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-8#1)
damage of##26##2##(1990-2#1)(1990-8#1)(1992-9#1)(1994-5#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
damage on##8##2##(1993-3#1)(2007-11#1)(2008-10#2)(2008-8#2)(2011-2#1)(2013-8#1)
damage or##3##2##(1992-11#1)(2008-3#1)(2008-8#1)
damage pattern##2##2##(2008-3#2)
damage produced by##2##3##(1992-9#1)(2008-10#1)
damage produced##3##2##(1992-9#1)(2008-10#1)(2013-1#1)
damage rather than##2##3##(2008-5#1)(2011-2#1)
damage repair##2##2##(1994-8#1)(2012-12#1)
damage resulted in##2##3##(1991-9#1)(1993-3#1)
damage resulting from##3##3##(1997-8#1)(2010-2#1)(2012-2#1)
damage resulting in##2##3##(2008-4#1)(2008-5#1)
damage resulting##5##2##(1997-8#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)
damage than##4##2##(1996-5#1)(2008-11#1)(2008-2#1)(2008-6#1)
damage that can occur in##2##5##(2008-3#1)(2010-9#1)
damage that can##3##3##(2008-3#1)(2010-9#1)(2011-2#1)
damage that##8##2##(1991-9#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
damage the##9##2##(1990-11#1)(1990-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#2)(2011-2#1)
damage they##2##2##(2008-11#1)(2009-8#1)
damage threshold at##2##3##(2007-11#1)(2008-2#1)
damage threshold is##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
damage threshold of##4##3##(2008-3#4)
damage threshold##24##2##(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#5)(2008-3#8)(2013-8#1)
damage thresholds of##3##3##(2008-3#3)
damage thresholds##10##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)
damage to DNA##2##3##(2008-10#2)
damage to a##4##3##(1992-3#1)(1992-8#1)(2008-10#1)(2008-2#1)
damage to cells and##2##4##(2008-1#1)(2009-10#1)
damage to cells##3##3##(1992-11#1)(2008-1#1)(2009-10#1)
damage to cells)##2##3##(1997-4#1)(2008-10#1)
damage to the anterior cruciate ligament##4##6##(2007-8#4)
damage to the cells##2##4##(2008-11#1)(2008-6#1)
damage to the liver##2##4##(1997-4#1)(2013-1#1)
damage to the stratum corneum##2##5##(2008-5#2)
damage to the##41##3##(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#5)(2008-10#2)(2008-11#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
damage to##101##2##(1990-3#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-3#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(2007-11#2)(2007-12#2)(2007-8#6)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#6)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#3)
damage using##4##2##(1994-6#1)(1997-4#2)(2008-10#1)
damage was assessed by##2##4##(1994-6#2)
damage was induced by##2##4##(1995-12#1)(2008-6#1)
damage was most severe in the##2##6##(1996-5#2)
damage was most##3##3##(1994-11#1)(1996-5#2)
damage was observed in##2##4##(1995-8#1)(2008-10#1)
damage was observed##5##3##(1995-8#1)(1997-4#1)(2008-10#2)(2013-1#1)
damage was recorded##2##3##(2008-1#1)(2008-10#1)
damage was reduced##2##3##(2009-12#1)(2010-5#1)
damage was##34##2##(1994-11#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-4#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#3)
damage were also##2##3##(1997-4#1)(2008-4#1)
damage were##11##2##(1994-5#2)(1995-6#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-3#1)
damage when##4##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
damage with a##2##3##(1992-12#1)(1992-3#1)
damage with##9##2##(1992-12#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
damage##1011##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#15)(1992-10#2)(1992-11#6)(1992-12#3)(1992-2#3)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#10)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#1)(1994-1#1)(1994-11#7)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#13)(1994-6#7)(1994-8#9)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#8)(1995-5#5)(1995-6#17)(1995-8#4)(1995-9#2)(1996-1#2)(1996-12#6)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#8)(1996-9#7)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#39)(1997-6#1)(1997-8#2)(2006-10#6)(2006-4#1)(2007-10#7)(2007-11#15)(2007-12#17)(2007-8#11)(2008-1#9)(2008-10#96)(2008-11#40)(2008-12#5)(2008-2#20)(2008-3#61)(2008-4#21)(2008-5#43)(2008-6#14)(2008-7#39)(2008-8#21)(2008-9#22)(2009-1#5)(2009-10#5)(2009-11#2)(2009-12#12)(2009-2#2)(2009-5#12)(2009-6#7)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#9)(2010-3#3)(2010-4#2)(2010-5#10)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#63)(2011-3#2)(2011-7#2)(2012-1#3)(2012-12#11)(2012-2#24)(2012-3#8)(2012-4#3)(2013-1#38)(2013-7#2)(2013-8#23)
damage)##4##1##(1992-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
damage-free##2##1##(2008-3#1)(2010-3#1)
damage-induced##2##1##(2008-9#1)(2013-8#1)
damage?##2##1##(1995-3#1)(2008-11#1)
damage]##3##1##(1994-7#1)(1995-8#1)(2013-1#1)
damaged DNA##5##2##(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-8#1)
damaged and apoptotic cells##3##4##(1995-2#3)
damaged and undamaged plants had equal##2##6##(2008-8#2)
damaged and undamaged##3##3##(1995-2#1)(2008-8#2)
damaged and##9##2##(1995-2#4)(2007-10#1)(2008-10#1)(2008-8#2)(2013-8#1)
damaged areas##2##2##(1997-2#1)(2011-1#1)
damaged at##2##2##(2008-11#1)(2013-1#1)
damaged by an##2##3##(2008-2#1)(2012-2#1)
damaged by the##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
damaged by##14##2##(1990-5#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
damaged cells##8##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-10#1)(2013-7#1)
damaged hairs##2##2##(2008-5#2)
damaged in the##2##3##(2008-8#1)(2009-1#1)
damaged in##5##2##(2008-10#1)(2008-8#2)(2009-1#1)(2011-2#1)
damaged layer##2##2##(2008-3#2)
damaged neurons##2##2##(1997-2#1)(2008-7#1)
damaged or##4##2##(1997-2#1)(2008-8#1)(2010-8#1)(2012-1#1)
damaged plants##6##2##(2008-8#6)
damaged site##2##2##(2008-11#1)(2012-2#1)
damaged telomeres##2##2##(2010-2#2)
damaged tissues and##2##3##(2007-11#1)(2008-11#1)
damaged tissues##3##2##(2007-11#1)(2008-11#1)(2010-8#1)
damaged##130##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#1)(1995-6#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2008-10#12)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#16)(2008-9#4)(2009-1#1)(2009-2#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
damages and##2##2##(1991-1#1)(1996-5#1)
damages at a local##2##4##(2013-1#2)
damages at##3##2##(2008-3#1)(2013-1#2)
damages by##3##2##(1990-10#1)(1995-6#1)(2013-7#1)
damages for emotional distress to third parties##2##7##(1991-1#1)(1992-1#1)
damages for##5##2##(1991-1#1)(1992-1#1)(1995-12#1)(1996-5#1)(1997-4#1)
damages in##3##2##(1991-1#1)(1992-1#1)(2009-12#1)
damages induced by##2##3##(1990-6#1)(2009-8#1)
damages of##2##2##(2011-2#1)(2011-3#1)
damages the##2##2##(1991-4#1)(2012-3#1)
damages to the##2##3##(1990-11#1)(2008-2#1)
damages to##5##2##(1990-11#1)(2008-2#3)(2013-1#1)
damages were##2##2##(1990-10#1)(1995-6#1)
damages##77##1##(1990-10#2)(1990-11#1)(1990-6#1)(1991-1#6)(1991-12#1)(1991-4#1)(1992-1#4)(1992-11#1)(1992-2#5)(1992-3#5)(1993-12#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-12#6)(1995-6#4)(1995-8#1)(1996-5#2)(1997-4#2)(1997-5#2)(2008-10#5)(2008-2#3)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
damaging agents##9##2##(1994-10#1)(1994-5#1)(2008-10#1)(2008-7#6)
damaging effects of##7##3##(1992-8#1)(1994-6#1)(1996-5#2)(2008-8#1)(2010-5#1)(2013-8#1)
damaging effects##8##2##(1991-12#1)(1992-8#1)(1994-6#1)(1996-5#2)(2008-8#1)(2010-5#1)(2013-8#1)
damaging to##2##2##(2008-10#2)
damaging##49##1##(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-5#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-7#8)(2008-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
dammam##3##1##(2008-1#3)
damped response##2##2##(2008-10#2)
damped##6##1##(2008-10#2)(2008-3#1)(2009-10#3)
dampen##2##1##(1992-2#1)(2008-10#1)
damper system##2##2##(2008-11#2)
damper##3##1##(1997-3#1)(2008-11#2)
damping##5##1##(2007-11#2)(2008-3#1)(2012-2#2)
damping-off and##2##2##(2008-10#2)
damping-off caused by##3##3##(2008-10#3)
damping-off in##3##2##(2008-10#3)
damping-off of cucumber##3##3##(2008-10#3)
damping-off of radish##2##3##(2008-10#2)
damping-off of sugar beet##2##4##(2008-10#2)
damping-off of##14##2##(2008-10#14)
damping-off was not##2##3##(2008-10#2)
damping-off was##6##2##(2008-10#6)
damping-off##41##1##(2008-10#41)
dams##12##1##(2008-10#6)(2010-4#3)(2012-3#3)
damselfish##5##1##(2007-5#2)(2008-5#3)
damselfly##3##1##(2008-8#2)(2012-3#1)
dance##22##1##(1991-8#1)(2007-12#5)(2007-6#1)(2008-10#1)(2008-2#8)(2008-7#1)(2009-1#1)(2009-3#2)(2009-7#1)(2012-2#1)
dancers##3##1##(2009-7#2)(2012-3#1)
dances##5##1##(2008-11#1)(2010-6#4)
dander##2##1##(1994-9#2)
dandruff and##2##2##(2008-5#2)
dandruff##20##1##(2008-5#20)
danger for##2##2##(2007-11#1)(2008-4#1)
danger of a##2##3##(1996-11#1)(2007-8#1)
danger of losing##2##3##(1995-12#1)(2007-12#1)
danger of##18##2##(1990-11#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#2)(2013-1#1)
danger that##2##2##(1996-11#1)(2011-2#1)
danger to human##2##3##(2008-10#1)(2013-8#1)
danger to##3##2##(2007-2#1)(2008-10#1)(2013-8#1)
danger##45##1##(1990-11#2)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-11#3)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#5)(2012-12#2)(2013-1#1)(2013-8#1)
dangerous and##3##2##(1991-6#1)(1995-8#1)(2008-8#1)
dangerous due to its##2##4##(2011-2#1)(2012-2#1)
dangerous for##2##2##(1994-6#1)(2008-11#1)
dangerous goods##4##2##(2009-10#4)
dangerous to life##3##3##(1996-12#1)(2011-2#2)
dangerous to##4##2##(1996-12#1)(2011-2#2)(2013-1#1)
dangerous with##2##2##(2012-3#2)
dangerous##65##1##(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#4)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
dangerousness##2##1##(2008-6#1)(2010-6#1)
dangers that##2##2##(2007-2#1)(2010-12#1)
dangers##15##1##(1992-2#1)(1992-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-5#1)(2013-1#1)
danofloxacin##3##1##(1991-3#3)
dans la littérature médicale##2##4##(2011-2#1)(2013-1#1)
dans la##7##2##(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#3)
dans les produits de##2##4##(2008-5#2)
dans les##10##2##(2008-5#7)(2009-4#2)(2011-2#1)
dans une##4##2##(2008-5#3)(2013-1#1)
dans##28##1##(2008-11#1)(2008-5#13)(2009-4#4)(2011-2#3)(2013-1#7)
dansyl amino acids##2##3##(1994-9#1)(2008-10#1)
dansyl amino##3##2##(1994-9#1)(2008-10#2)
dansyl chloride##5##2##(1990-8#1)(1996-5#1)(2008-10#3)
dansyl fluorescence##4##2##(1992-3#1)(1994-5#1)(2008-10#2)
dansyl hydrazones##3##2##(1990-8#3)
dansyl peptides##2##2##(1994-5#2)
dansyl tetrapeptide is##2##3##(1994-5#2)
dansyl tripeptides##2##2##(1994-5#2)
dansyl##35##1##(1990-8#5)(1992-3#2)(1994-5#12)(1994-9#1)(1995-6#1)(1996-5#3)(2008-10#11)
dansyl-C6-choline##3##1##(1994-5#3)
dansyl-phenylalanine and -sarcosine##2##3##(2008-10#2)
dansyl-threonine##2##1##(2008-10#2)
dansylamino acids were##2##3##(1994-9#2)
dansylamino acids##4##2##(1994-9#4)
dansylated##3##1##(1994-9#1)(2008-10#1)(2009-12#1)
dapsone##3##1##(1990-11#1)(2007-7#1)(2008-11#1)
daptomycin##4##1##(2009-6#1)(2010-6#1)(2011-2#2)
darbepoetin alfa##6##2##(2008-7#6)
darbepoetin##7##1##(2008-7#7)
dark and light##2##3##(2008-10#1)(2008-5#1)
dark and##8##2##(1993-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
dark areas##2##2##(2008-10#1)(2008-5#1)
dark beams##2##2##(2007-12#2)
dark brown##9##2##(2008-1#1)(2008-10#5)(2008-5#1)(2010-6#1)(2013-8#1)
dark count##3##2##(2007-11#1)(2008-3#2)
dark cycle##2##2##(1994-8#1)(1995-11#1)
dark decay of##2##3##(2007-11#2)
dark decay##3##2##(2007-11#2)(2008-2#1)
dark fermentation##2##2##(2013-1#2)
dark for##3##2##(2008-10#3)
dark green##4##2##(2008-10#1)(2013-8#3)
dark laser spot##2##3##(2007-11#2)
dark matter##2##2##(2012-3#2)
dark modes##2##2##(2007-12#1)(2008-3#1)
dark or##2##2##(2007-12#1)(2008-10#1)
dark peat##2##2##(2008-10#1)(2008-2#1)
dark photoperiod##2##2##(2008-11#1)(2009-6#1)
dark respiration##2##2##(2008-10#2)
dark side##2##2##(1996-1#1)(2008-11#1)
dark skin##3##2##(2008-11#1)(2008-5#2)
dark spot##6##2##(2007-11#2)(2008-3#3)(2013-7#1)
dark to##3##2##(2008-10#1)(2008-6#1)(2009-10#1)
dark toxicity##2##2##(2008-11#2)
dark urine##2##2##(1994-12#1)(2012-12#1)
dark vegetation covered by atmospheric aerosols##2##6##(2008-3#2)
dark vegetation##3##2##(2008-3#3)
dark##171##1##(1990-7#1)(1991-12#2)(1991-5#4)(1992-5#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-6#2)(2006-11#2)(2007-11#11)(2007-12#15)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#23)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#2)(2009-9#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#5)
dark-adapted##2##1##(1991-12#1)(1997-1#1)
dark-eyed juncos (Junco hyemalis)##2##4##(2008-8#2)
dark-field illumination##2##2##(2008-3#2)
dark-field microscopy##3##2##(2007-12#1)(2008-6#2)
dark-field##7##1##(2007-11#1)(2007-12#1)(2008-3#2)(2008-6#2)(2010-12#1)
dark-grown seedlings##4##2##(1994-8#2)(1996-10#2)
dark-pulse train##2##2##(2007-11#2)
dark-skinned##5##1##(2008-11#3)(2008-5#1)(2011-2#1)
dark-spot##2##1##(2007-11#1)(2008-3#1)
dark/light adaptation in the##2##4##(2007-12#2)
darkened##3##1##(2008-10#2)(2012-3#1)
darkening##7##1##(2008-5#4)(2008-8#1)(2009-6#2)
darker skin##4##2##(2008-5#2)(2010-8#1)(2012-3#1)
darker##10##1##(1992-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-4#1)(2010-8#2)(2012-3#1)
darkness and##4##2##(1994-5#1)(2008-10#3)
darkness at##3##2##(2006-11#1)(2008-10#1)(2008-12#1)
darkness in##2##2##(2006-11#1)(2008-10#1)
darkness##31##1##(1991-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(2006-11#4)(2007-11#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2010-8#1)
darlingi from##2##2##(2012-12#2)
darlingi##8##1##(2012-12#8)
darwinii##3##1##(2010-3#3)
dasatinib##11##1##(2012-12#1)(2012-2#6)(2013-1#4)
dassonvillei##3##1##(2011-2#3)
data (Experiment##2##2##(2013-1#2)
data (a##3##2##(1992-12#1)(1993-12#1)(2013-1#1)
data (e##3##2##(2008-1#1)(2008-9#1)(2013-1#1)
data (i##2##2##(2013-1#2)
data (n =##2##3##(2010-6#1)(2013-1#1)
data -##2##2##(2010-10#1)(2012-3#1)
data a##4##2##(1997-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
data about a##2##3##(2007-9#1)(2008-9#1)
data about the##9##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-5#2)(2012-2#1)(2012-3#1)
data about##25##2##(1990-3#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
data access##2##2##(1997-3#1)(1997-7#1)
data according to##2##3##(1992-11#1)(2008-10#1)
data accuracy##2##2##(1994-3#1)(2008-3#1)
data acquired at##2##3##(2008-10#1)(2008-3#1)
data acquired by##2##3##(2008-2#1)(2012-7#1)
data acquired from##2##3##(2007-12#1)(2008-9#1)
data acquired in##3##3##(2008-3#2)(2008-5#1)
data acquired with an##2##4##(2008-3#2)
data acquired##13##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-9#1)(2012-7#1)
data acquisition and processing##5##4##(2008-10#2)(2008-3#2)(2009-6#1)
data acquisition and##10##3##(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2009-6#1)
data acquisition##33##2##(1996-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
data across##2##2##(2008-4#1)(2013-1#1)
data after##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
data agree well with##4##4##(1993-11#1)(2007-11#1)(2008-3#1)(2008-7#1)
data allow##3##2##(1990-5#1)(2008-2#1)(2009-4#1)
data allowed us to##2##4##(2008-3#1)(2008-8#1)
data allowed##4##2##(1995-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
data allowing##2##2##(2008-12#1)(2011-2#1)
data alone##2##2##(1997-6#1)(2008-11#1)
data along##2##2##(2008-12#1)(2010-8#1)
data also indicate that##3##4##(1993-6#1)(1994-5#1)(2008-8#1)
data also showed##4##3##(1992-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
data also suggest that the##4##5##(1991-12#1)(1992-9#1)(2007-12#1)(2008-9#1)
data also suggest that##8##4##(1991-12#1)(1992-9#2)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
data also suggest##9##3##(1991-12#1)(1992-9#2)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-5#1)
data also##37##2##(1991-12#1)(1992-3#2)(1992-9#3)(1993-6#1)(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
data analyses##2##2##(1995-3#1)(1996-12#1)
data analysis and interpretation##3##4##(1994-2#1)(1996-6#1)(2008-9#1)
data analysis and mining##2##4##(2008-7#2)
data analysis and##20##3##(1991-12#1)(1991-3#1)(1994-2#2)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
data analysis are##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
data analysis has##2##3##(2008-10#1)(2008-7#1)
data analysis in##5##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-12#1)
data analysis is##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
data analysis method##2##3##(2008-10#1)(2008-3#1)
data analysis methods##2##3##(2008-10#1)(2010-4#1)
data analysis of the Michelson Interferometer for Passive Atmospheric Sounding##2##10##(2008-3#2)
data analysis of##6##3##(1990-3#1)(2008-10#2)(2008-3#2)(2009-6#1)
data analysis procedures##2##3##(2008-10#1)(2008-4#1)
data analysis tools##3##3##(2008-10#2)(2010-12#1)
data analysis was##5##3##(2008-6#2)(2008-7#1)(2010-12#1)(2013-8#1)
data analysis##124##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#1)(1993-9#1)(1994-2#3)(1996-6#1)(1997-3#2)(2008-1#2)(2008-10#26)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#10)(2008-4#6)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
data analytic##2##2##(2008-7#1)(2009-8#1)
data and a##7##3##(1997-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
data and analysis of##2##4##(1995-2#1)(2012-12#1)
data and analysis##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
data and can##2##3##(1994-9#1)(2009-9#1)
data and clinical##2##3##(2007-10#1)(2008-5#1)
data and compare##3##3##(2008-3#1)(2008-7#1)(2009-8#1)
data and computer##3##3##(2007-11#1)(2008-10#2)
data and elemental##2##3##(2007-11#1)(2011-1#1)
data and for the##2##4##(2008-2#1)(2008-3#1)
data and for##3##3##(2008-2#1)(2008-3#1)(2010-3#1)
data and in##2##3##(1995-3#1)(2008-7#1)
data and information##3##3##(1994-12#1)(1996-2#1)(2008-12#1)
data and its##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
data and methods##3##3##(1992-3#1)(2006-6#1)(2008-2#1)
data and model##3##3##(2008-6#1)(2008-7#2)
data and multivariate##3##3##(1992-1#1)(2008-10#2)
data and other##2##3##(2008-11#1)(2008-7#1)
data and production of##2##4##(1996-9#1)(2008-10#1)
data and provides##2##3##(2008-4#1)(2012-12#1)
data and that the##2##4##(2008-2#1)(2008-8#1)
data and the##23##3##(1990-7#1)(1990-8#1)(1995-12#1)(1995-5#1)(1996-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#3)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
data and their##3##3##(2008-6#1)(2009-4#1)(2013-8#1)
data and to##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
data and trapping##2##3##(1996-5#1)(2008-10#1)
data and treatment##2##3##(1997-3#1)(2007-11#1)
data and were used to##2##5##(2008-7#1)(2013-1#1)
data and were##3##3##(1994-12#1)(2008-7#1)(2013-1#1)
data and will##2##3##(2007-7#1)(2008-7#1)
data and##254##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#34)(2008-11#5)(2008-12#4)(2008-2#10)(2008-3#16)(2008-4#3)(2008-5#3)(2008-6#7)(2008-7#19)(2008-8#12)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#6)
data are acquired##2##3##(2008-3#1)(2008-9#1)
data are also consistent with##2##5##(1990-5#1)(1993-11#1)
data are also presented for##3##5##(1991-2#1)(1994-12#1)(2008-5#1)
data are also presented##5##4##(1991-2#1)(1994-12#1)(2008-10#2)(2008-5#1)
data are also##9##3##(1990-5#1)(1991-2#1)(1993-11#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
data are analyzed to##2##4##(2008-2#2)
data are analyzed##5##3##(1992-11#1)(1994-2#1)(2008-10#1)(2008-2#2)
data are available about##2##4##(1992-10#1)(2009-3#1)
data are available for##2##4##(2008-11#1)(2008-7#1)
data are available from##3##4##(1990-3#1)(2008-3#1)(2011-2#1)
data are available in##2##4##(2008-10#1)(2008-4#1)
data are available on the##2##5##(1995-3#1)(2011-2#1)
data are available on##3##4##(1995-3#1)(2008-5#1)(2011-2#1)
data are available regarding the##2##5##(2007-10#1)(2013-1#1)
data are available to##2##4##(2007-12#1)(2008-8#1)
data are available via##2##4##(2008-7#2)
data are available##33##3##(1990-3#1)(1992-10#1)(1992-6#1)(1992-9#1)(1995-3#1)(1995-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
data are being##3##3##(1994-2#2)(2008-4#1)
data are collected##5##3##(1996-3#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-9#1)
data are combined##2##3##(1991-6#1)(2008-5#1)
data are compared with##5##4##(2008-3#5)
data are compared##6##3##(1996-1#1)(2008-3#5)
data are compatible with the##3##5##(1990-5#1)(2008-8#1)(2013-1#1)
data are compatible with##5##4##(1990-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
data are consistent with a##3##5##(1991-5#1)(1992-2#1)(2008-10#1)
data are consistent with the hypothesis that##4##7##(2008-10#1)(2008-8#2)(2013-1#1)
data are consistent with the##9##5##(1994-3#1)(1994-8#1)(1995-3#1)(1997-9#1)(2008-10#1)(2008-8#2)(2012-3#1)(2013-1#1)
data are consistent with##20##4##(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-7#1)(1997-9#1)(2008-10#3)(2008-2#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
data are consistent##22##3##(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-7#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
data are converted into##2##4##(2008-2#1)(2008-3#1)
data are critical##2##3##(1997-3#1)(2013-1#1)
data are currently available##2##4##(2010-3#1)(2013-7#1)
data are currently##3##3##(2010-3#1)(2012-12#1)(2013-7#1)
data are discussed##9##3##(1994-2#1)(1996-2#1)(2008-10#1)(2008-3#2)(2009-4#1)(2011-2#1)(2013-1#2)
data are fitted to##2##4##(2008-2#1)(2010-8#1)
data are frequently##2##3##(1995-12#1)(1997-7#1)
data are given for##3##4##(2008-10#1)(2008-3#2)
data are given##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
data are in##2##3##(2007-12#1)(2008-7#1)
data are lacking##5##3##(2008-8#2)(2010-5#1)(2012-2#2)
data are missing##2##3##(1995-12#1)(2009-12#1)
data are necessary to##2##4##(2008-10#1)(2008-3#1)
data are needed to##5##4##(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
data are needed##8##3##(1992-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
data are not##7##3##(1991-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-3#1)
data are presented for##2##4##(1997-7#1)(2008-3#1)
data are presented##14##3##(1991-3#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-2#3)(2008-3#2)(2010-10#1)(2011-2#2)
data are processed##4##3##(2008-10#2)(2008-3#2)
data are promising##2##3##(2007-12#1)(2012-2#1)
data are required##3##3##(2008-10#1)(2010-11#1)(2012-12#1)
data are reviewed##2##3##(1993-8#1)(2006-7#1)
data are scarce##2##3##(2007-12#1)(2008-9#1)
data are still##4##3##(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
data are subsequently##2##3##(2008-11#1)(2008-5#1)
data are the##3##3##(1992-12#1)(1997-3#1)(2009-2#1)
data are then##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
data are used to##6##4##(1995-2#1)(1996-3#1)(2008-3#1)(2009-11#1)(2010-3#1)(2013-1#1)
data are used##10##3##(1995-2#1)(1996-3#1)(2008-3#3)(2009-11#1)(2009-12#1)(2010-3#1)(2010-8#1)(2013-1#1)
data are usually##2##3##(2008-4#1)(2008-7#1)
data are##271##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#4)(1997-7#3)(1997-8#1)(1997-9#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#32)(2008-11#7)(2008-12#3)(2008-2#15)(2008-3#30)(2008-4#7)(2008-5#9)(2008-7#11)(2008-8#9)(2008-9#7)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#4)(2011-2#13)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
data argue against##2##3##(1996-5#1)(2008-9#1)
data argue##3##2##(1996-5#1)(2007-12#1)(2008-9#1)
data arrays##3##2##(2008-10#2)(2008-3#1)
data as a basis for##4##5##(1996-12#1)(2011-1#1)(2013-1#2)
data as a##7##3##(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#2)
data as well as the##4##5##(1992-12#1)(1994-6#1)(1996-3#1)(2009-8#1)
data as well as##9##4##(1991-3#1)(1992-12#1)(1994-2#1)(1994-6#1)(1996-3#1)(2008-3#1)(2009-8#1)(2010-5#1)(2013-8#1)
data as##24##2##(1991-3#1)(1992-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
data assessment##2##2##(1994-3#1)(2008-11#1)
data associated with##2##3##(2008-10#2)
data at a##2##3##(2008-11#1)(2008-3#1)
data at different##2##3##(1990-8#1)(2007-10#1)
data at the##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
data at##26##2##(1990-8#1)(1993-3#2)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#5)(2008-8#1)(2010-3#2)(2013-1#1)
data augmentation##2##2##(1997-3#1)(2008-8#1)
data available at##2##3##(2009-9#1)(2013-8#1)
data available for##2##3##(1990-12#1)(2011-1#1)
data available from the##4##4##(1993-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
data available from##5##3##(1993-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
data available in the literature##2##5##(1997-7#1)(2012-12#1)
data available in the##4##4##(1997-7#1)(2008-8#1)(2012-12#2)
data available in##5##3##(1997-7#1)(2007-11#1)(2008-8#1)(2012-12#2)
data available on the##2##4##(1994-12#1)(2008-12#1)
data available on##5##3##(1990-6#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
data available to date##2##4##(2008-11#1)(2008-7#1)
data available##29##2##(1990-12#1)(1990-6#1)(1990-9#1)(1993-8#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-8#1)
data bank##4##2##(1995-11#2)(2008-1#1)(2008-10#1)
data banks##7##2##(1995-2#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)
data base of##2##3##(1994-3#1)(2011-2#1)
data base to##2##3##(1991-2#1)(1993-2#1)
data base was##2##3##(1991-2#1)(1994-3#1)
data base##21##2##(1990-3#1)(1990-8#1)(1991-2#3)(1992-1#1)(1993-12#3)(1993-2#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
data based on both##2##4##(1996-4#1)(2007-12#1)
data based on the##3##4##(2008-10#1)(2008-9#1)(2012-12#1)
data based on##10##3##(1996-4#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
data bases##12##2##(1991-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-3#1)
data basis##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
data be##4##2##(1992-3#1)(1993-11#1)(1993-12#1)(2007-11#1)
data being##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-12#1)
data between##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-8#1)(2013-1#1)
data but##2##2##(2008-3#1)(2011-2#1)
data by the##3##3##(1995-5#1)(2008-3#1)(2008-7#1)
data by use of##3##4##(2008-3#2)(2013-1#1)
data by using##6##3##(1990-9#1)(2008-10#1)(2008-3#3)(2008-6#1)
data by##37##2##(1990-9#1)(1992-2#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-3#11)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2011-2#1)(2011-9#1)(2012-3#1)(2013-1#2)
data calculated using##3##3##(1990-12#1)(2008-10#1)(2013-8#1)
data can be obtained##4##4##(2007-12#2)(2008-10#2)
data can be recovered##2##4##(2008-3#2)
data can be used to determine the##2##7##(2008-1#1)(2008-2#1)
data can be used to improve##2##6##(1996-12#1)(2008-2#1)
data can be used to##8##5##(1996-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-9#1)(2010-6#1)(2012-1#1)
data can be used##12##4##(1996-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)
data can be##32##3##(1991-2#1)(1993-12#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#6)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)
data can##45##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-3#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#7)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
data cannot be##2##3##(2007-12#1)(2008-11#1)
data cannot##4##2##(1990-8#1)(1993-11#1)(2007-12#1)(2008-11#1)
data capture##8##2##(1996-3#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-8#3)
data captured##2##2##(2008-11#1)(2008-7#1)
data clearly##4##2##(1996-12#1)(2009-10#1)(2010-11#1)(2012-2#1)
data collected at##2##3##(2008-3#1)(2008-7#1)
data collected by the##2##4##(1992-2#1)(1994-6#1)
data collected during##3##3##(1994-11#1)(2008-7#1)(2012-1#1)
data collected from a random sample##2##6##(1993-12#1)(1996-2#1)
data collected from a##5##4##(1993-12#1)(1996-2#1)(2007-11#1)(2008-10#2)
data collected from research##2##4##(2008-10#1)(2013-1#1)
data collected from the##3##4##(1991-12#1)(2011-1#1)(2013-8#1)
data collected from##21##3##(1991-12#1)(1993-12#1)(1994-9#1)(1996-2#1)(2007-11#1)(2008-10#7)(2008-12#2)(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
data collected in a##2##4##(1997-4#1)(2009-8#1)
data collected in##11##3##(1997-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-5#1)(2009-8#1)(2010-3#1)(2012-3#1)(2013-8#1)
data collected over a##2##4##(2008-10#1)(2012-12#1)
data collected over##3##3##(1990-8#1)(2008-10#1)(2012-12#1)
data collected through##4##3##(1990-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
data collected using##2##3##(2008-10#1)(2008-9#1)
data collected##57##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-2#2)(1993-12#1)(1994-11#1)(1994-6#2)(1994-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
data collection and analysis##5##4##(1994-3#1)(1997-2#1)(2008-11#1)(2009-11#1)(2012-2#1)
data collection and reporting as well as identifies the issues that need to be addressed##2##15##(2013-8#2)
data collection and reporting as well as identifies the issues##3##10##(2013-8#3)
data collection and reporting as well as identifying the issues that need to be addressed##4##15##(2013-8#4)
data collection and reporting as well as##7##7##(2013-8#7)
data collection and##22##3##(1992-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#7)
data collection are##2##3##(1992-1#1)(2008-8#1)
data collection design##2##3##(1995-2#1)(1995-3#1)
data collection efforts##2##3##(1995-3#1)(2010-8#1)
data collection for##2##3##(2010-3#1)(2012-12#1)
data collection instruments##2##3##(1990-8#1)(2010-3#1)
data collection interface##2##3##(2010-8#2)
data collection is##4##3##(1993-3#1)(1994-12#1)(1995-12#1)(2008-4#1)
data collection methods##3##3##(1995-2#1)(2007-4#1)(2012-2#1)
data collection of##2##3##(2008-11#1)(2008-7#1)
data collection strategies for##2##4##(2010-5#2)
data collection system##2##3##(1991-8#1)(1993-3#1)
data collection time##2##3##(2008-3#2)
data collection was##4##3##(1990-12#1)(1994-3#1)(2008-11#1)(2011-2#1)
data collection##114##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-12#2)(1993-2#1)(1993-3#4)(1994-12#5)(1994-3#4)(1995-1#1)(1995-12#2)(1995-2#6)(1995-3#5)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#4)(2007-12#3)(2007-4#1)(2008-10#1)(2008-11#6)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-8#7)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#12)
data coming from##2##3##(2008-7#1)(2013-1#1)
data compared to the##2##4##(2008-7#1)(2013-1#1)
data compared with##3##3##(1997-8#1)(2007-11#1)(2008-10#1)
data compared##5##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
data compression and visualization##2##4##(2008-10#2)
data compression and##3##3##(2008-10#3)
data compression##4##2##(2008-10#3)(2013-8#1)
data concerning the##4##3##(1996-3#1)(2008-10#2)(2013-1#1)
data concerning##15##2##(1996-3#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
data confirm that the##4##4##(1990-6#1)(2008-3#1)(2008-5#1)(2009-8#1)
data confirm that##9##3##(1990-6#1)(1990-8#1)(1991-6#1)(1994-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
data confirm the##4##3##(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
data confirm##14##2##(1990-6#1)(1990-8#1)(1991-6#1)(1994-11#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
data confirmed that##2##3##(2008-12#1)(2008-9#1)
data confirmed##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
data consistency##2##2##(2008-10#1)(2010-2#1)
data consisting of##2##3##(2008-10#1)(2012-3#1)
data contain##2##2##(2008-9#1)(2011-1#1)
data contained##2##2##(1991-2#1)(2012-12#1)
data content##2##2##(1997-3#1)(2010-5#1)
data contributed to##2##3##(2008-10#1)(2013-1#1)
data correlate##2##2##(1992-9#1)(1994-6#1)
data corresponding to the##2##4##(2008-10#2)
data corresponding to##4##3##(2008-10#4)
data could be obtained##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
data could provide##2##3##(1997-3#1)(2013-7#1)
data could##9##2##(1994-9#1)(1997-3#1)(2008-10#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
data covering##2##2##(2008-10#1)(2009-10#1)
data currently being##2##3##(1997-2#1)(2009-12#1)
data currently##4##2##(1997-2#1)(2009-12#1)(2011-3#1)(2012-2#1)
data demonstrate a##3##3##(1992-7#1)(1997-2#1)(2009-10#1)
data demonstrate that the##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
data demonstrate that##40##3##(1991-12#2)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2007-11#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2011-1#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
data demonstrate the##8##3##(1990-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#3)
data demonstrate##57##2##(1990-11#1)(1991-12#2)(1991-5#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2007-11#2)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
data demonstrated that the##3##4##(2008-10#2)(2010-10#1)
data demonstrated that##9##3##(1996-12#1)(2006-4#1)(2008-10#3)(2008-5#1)(2010-10#1)(2011-2#1)(2011-3#1)
data demonstrated##10##2##(1996-12#1)(1996-6#1)(2006-4#1)(2008-10#3)(2008-5#1)(2010-10#1)(2011-2#1)(2011-3#1)
data demonstrates that##2##3##(2008-11#1)(2008-7#1)
data demonstrates##6##2##(1992-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-2#1)
data demonstrating that##2##3##(2008-3#1)(2009-2#1)
data demonstrating##6##2##(2008-3#1)(2009-2#1)(2010-5#2)(2011-2#2)
data depends on##2##3##(2008-2#1)(2008-7#1)
data derived from##12##3##(1993-12#1)(1994-12#1)(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)
data derived##13##2##(1993-12#1)(1994-12#1)(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)
data described in the##2##4##(2008-10#1)(2013-1#1)
data describing the##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
data describing##6##2##(2008-10#2)(2010-10#2)(2011-2#1)(2013-1#1)
data detection##2##2##(2008-3#1)(2012-3#1)
data directly##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
data display##2##2##(1993-9#1)(2008-9#1)
data distribution##2##2##(2009-9#1)(2010-8#1)
data do not support the##3##5##(1992-11#1)(1997-6#1)(2008-8#1)
data do not support##5##4##(1992-11#1)(1997-5#1)(1997-6#1)(2008-8#1)(2011-2#1)
data do not##16##3##(1992-11#1)(1993-6#1)(1995-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-4#1)(2011-2#2)(2013-1#1)
data do##17##2##(1992-11#1)(1993-6#1)(1995-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2011-2#2)(2013-1#1)
data elements##3##2##(1997-3#1)(2007-10#1)(2008-6#1)
data emphasize the##2##3##(2006-10#1)(2008-11#1)
data entry and##4##3##(1993-12#1)(2011-1#2)(2013-1#1)
data entry program##2##3##(1996-2#2)
data entry##7##2##(1993-12#1)(1994-2#1)(1996-2#2)(2011-1#2)(2013-1#1)
data evaluation##6##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
data exchange as swift and##2##5##(1995-12#1)(1996-1#1)
data exchange##6##2##(1995-12#1)(1996-1#1)(2008-11#1)(2008-7#3)
data exist on the##2##4##(2009-9#1)(2013-1#1)
data exist##6##2##(2007-10#1)(2007-12#1)(2009-9#1)(2011-2#1)(2013-1#2)
data exists##3##2##(2008-4#1)(2013-1#2)
data extracted from##3##3##(1993-12#1)(2007-12#1)(2009-7#1)
data extracted##5##2##(1991-2#1)(1993-12#1)(2007-12#1)(2009-7#1)(2013-1#1)
data extraction##3##2##(2007-7#1)(2008-12#1)(2008-7#1)
data fields##2##2##(2008-11#1)(2010-8#1)
data file##4##2##(2008-3#1)(2008-4#1)(2008-9#2)
data files##10##2##(1997-2#2)(2008-11#1)(2008-9#6)(2010-8#1)
data filtering##2##2##(2008-4#1)(2008-7#1)
data fit##2##2##(2008-10#1)(2013-8#1)
data flow##2##2##(1990-11#1)(2009-5#1)
data followed##4##2##(2007-8#1)(2008-10#3)
data for 2##2##3##(1997-7#2)
data for a##13##3##(1993-9#1)(1994-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
data for all##4##3##(1992-6#1)(1995-1#1)(1996-1#1)(2013-1#1)
data for analysis##2##3##(2008-4#1)(2012-12#1)
data for animal##2##3##(2008-7#1)(2008-9#1)
data for both species##2##4##(1993-11#1)(2008-9#1)
data for both##7##3##(1993-11#1)(2008-10#2)(2008-2#2)(2008-8#1)(2008-9#1)
data for different##2##3##(1994-5#1)(2008-3#1)
data for dioxins and##2##4##(2008-10#2)
data for each##4##3##(1992-9#1)(2008-11#1)(2008-2#1)(2009-11#1)
data for health##2##3##(2007-4#1)(2008-11#1)
data for improved##2##3##(1992-12#1)(2008-11#1)
data for many##2##3##(2007-12#1)(2008-7#1)
data for particle##2##3##(2008-3#2)
data for penile##2##3##(2011-1#2)
data for population##2##3##(1991-3#1)(2008-10#1)
data for populations of##2##4##(2008-10#1)(2008-8#1)
data for six##3##3##(1992-7#1)(1993-2#1)(2008-10#1)
data for some##3##3##(2008-10#3)
data for the calibration plots showed good linear relationship with r(2)=0##2##11##(2008-10#2)
data for the determination of the##2##6##(2008-10#2)
data for the determination of##4##5##(2008-10#4)
data for the first##2##4##(1991-10#1)(2010-6#1)
data for the##36##3##(1991-10#1)(1992-12#1)(1992-5#1)(1993-3#2)(1995-11#1)(1996-2#3)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
data for these##2##3##(1997-2#1)(2008-10#1)
data for this study##2##4##(1996-1#1)(2010-7#1)
data for this##3##3##(1996-1#1)(2007-2#1)(2010-7#1)
data for understanding##2##3##(2008-8#1)(2013-1#1)
data for use in##2##4##(2007-7#1)(2008-3#1)
data for##235##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#10)(1996-3#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#4)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#48)(2008-11#10)(2008-12#1)(2008-2#12)(2008-3#18)(2008-4#4)(2008-6#2)(2008-7#11)(2008-8#12)(2008-9#4)(2009-11#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
data found in the literature##5##5##(1990-12#1)(1990-9#1)(2008-3#2)(2008-7#1)
data found##8##2##(1990-12#1)(1990-9#1)(1994-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)
data from 1##2##3##(2008-8#1)(2010-5#1)
data from 1984 to##2##4##(1991-12#1)(1994-3#1)
data from British##2##3##(1997-8#1)(2008-8#1)
data from Monte Carlo simulations##2##5##(2008-3#1)(2013-1#1)
data from a cohort of##2##5##(1997-3#1)(1997-7#1)
data from a cohort##3##4##(1997-3#1)(1997-7#1)(2011-1#1)
data from a group of##3##5##(2008-10#1)(2010-12#1)(2010-8#1)
data from a longitudinal##2##4##(2012-12#1)(2013-1#1)
data from a number of##2##5##(2007-5#1)(2012-12#1)
data from a recent##2##4##(2006-12#1)(2008-8#1)
data from a sample of##3##5##(1995-2#1)(1997-4#1)(2008-12#1)
data from a study of##2##5##(1993-1#1)(1994-2#1)
data from a study##3##4##(1993-1#1)(1994-2#1)(1994-3#1)
data from a##61##3##(1991-8#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#1)(2006-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
data from all##6##3##(1997-1#1)(2008-10#3)(2008-11#2)
data from an experiment##2##4##(2008-1#1)(2008-4#1)
data from an##13##3##(1992-9#1)(1994-11#1)(1994-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)
data from both##4##3##(2008-10#1)(2008-3#2)(2010-1#1)
data from clinical trials##2##4##(1995-5#1)(2008-8#1)
data from clinical##3##3##(1995-5#1)(2008-8#1)(2013-8#1)
data from computer-based journals##2##4##(1994-6#2)
data from different##5##3##(1994-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
data from each##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
data from field experiments##2##4##(2008-10#1)(2008-9#1)
data from field##3##3##(2008-10#2)(2008-9#1)
data from five##2##3##(2008-10#1)(2009-2#1)
data from four##5##3##(1993-12#1)(2008-10#2)(2008-2#1)(2013-1#1)
data from interviews##2##3##(1993-1#1)(2007-12#1)
data from literature##2##3##(2008-10#1)(2012-12#1)
data from many##2##3##(1994-2#1)(2008-7#1)
data from more##3##3##(2008-10#1)(2008-6#1)(2009-11#1)
data from multiple surface densities##2##5##(1997-2#2)
data from multiple##4##3##(1997-2#2)(2010-10#1)(2010-4#1)
data from natural populations##2##4##(2008-9#1)(2012-3#1)
data from non-fused and non-pi-complexed pentafulvenes##2##6##(2008-10#2)
data from observational studies##2##4##(2008-11#1)(2010-6#1)
data from other##7##3##(1996-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-12#1)
data from our##2##3##(2008-7#1)(2009-8#1)
data from patients##2##3##(2010-11#1)(2011-2#1)
data from previous##3##3##(1992-2#1)(2008-10#1)(2011-2#1)
data from prospective##3##3##(2009-7#1)(2010-5#1)(2011-2#1)
data from randomized controlled trials##2##5##(2011-2#2)
data from randomized##4##3##(1993-12#1)(1997-3#1)(2011-2#2)
data from several laboratories##2##4##(1992-11#1)(2008-10#1)
data from six##3##3##(1991-6#1)(2008-11#1)(2008-3#1)
data from speakers who stammer##3##5##(2008-4#3)
data from studies of##2##4##(2008-7#2)
data from the Medicare Current Beneficiary Survey (MCBS)##3##8##(1995-12#2)(1997-2#1)
data from the Medicare##6##4##(1993-1#1)(1993-3#1)(1995-12#2)(1995-2#1)(1997-2#1)
data from the National Health Interview Survey##2##7##(1995-12#1)(1996-5#1)
data from the National Health##3##5##(1995-12#1)(1996-5#1)(2010-12#1)
data from the National Longitudinal Study of Adolescent Health##2##9##(2009-7#1)(2013-8#1)
data from the National Longitudinal##3##5##(2009-7#1)(2009-8#1)(2013-8#1)
data from the National##8##4##(1995-12#1)(1996-5#1)(1997-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
data from the first##3##4##(1992-6#1)(1994-1#1)(2008-10#1)
data from the literature##4##4##(1991-12#1)(1997-3#1)(2007-8#1)(2012-3#1)
data from the ongoing##2##4##(2008-5#1)(2012-2#1)
data from the two##2##4##(1990-3#1)(2010-5#1)
data from the##132##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-8#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#8)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
data from these##4##3##(2008-3#1)(2008-7#1)(2009-4#1)(2012-3#1)
data from this study##6##4##(2007-10#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
data from this##10##3##(1992-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
data from three different##2##4##(2008-10#1)(2008-7#1)
data from three##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
data from two##18##3##(1992-2#1)(1992-6#1)(1996-5#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#2)
data from various##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)
data from which##2##3##(2008-3#1)(2008-8#1)
data from##513##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-6#3)(1992-9#2)(1993-1#5)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#4)(1994-6#6)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#6)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#9)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#3)(2006-12#1)(2006-4#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#61)(2008-11#20)(2008-12#8)(2008-2#7)(2008-3#37)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#18)(2008-8#18)(2008-9#13)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#4)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#31)(2011-3#1)(2011-7#1)(2011-8#1)(2011-9#1)(2012-1#3)(2012-12#13)(2012-2#9)(2012-3#13)(2013-1#17)(2013-7#4)(2013-8#5)
data further##4##2##(1990-12#1)(1990-2#1)(1990-7#1)(2008-11#1)
data gathered in##2##3##(1994-3#1)(1997-4#1)
data gathered##5##2##(1990-12#1)(1994-3#1)(1997-4#1)(2008-3#1)(2009-9#1)
data generated by the##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
data generated by##6##3##(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)
data generated from##4##3##(1996-12#1)(2008-10#2)(2008-4#1)
data generated##18##2##(1996-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2010-12#1)(2011-2#1)
data had##5##2##(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-6#1)
data handling##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#2)
data has been##11##3##(1992-8#1)(1995-12#1)(1997-2#1)(2008-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-12#1)
data has grown##2##3##(2008-7#1)(2010-1#1)
data has indicated##2##3##(2008-5#1)(2013-1#1)
data has shown that##2##4##(1993-11#1)(2008-7#1)
data has##31##2##(1992-8#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#5)(2009-11#1)(2009-12#1)(2009-3#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
data have also##3##3##(2006-10#1)(2008-1#2)
data have been collected##2##4##(2008-8#1)(2011-2#1)
data have been investigated##2##4##(1994-6#1)(2008-10#1)
data have been obtained##2##4##(2008-10#1)(2008-7#1)
data have been presented##2##4##(1991-3#1)(2008-5#1)
data have been processed##4##4##(1997-5#1)(2008-10#2)(2008-2#1)
data have been##29##3##(1991-3#1)(1994-6#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
data have demonstrated##2##3##(1990-6#1)(1992-8#1)
data have implications##2##3##(2010-6#1)(2012-3#1)
data have important implications for##2##5##(1993-3#1)(1994-8#1)
data have revealed##2##3##(1993-11#1)(2011-2#1)
data have shown that the##2##5##(2008-8#2)
data have shown that##4##4##(2008-10#1)(2008-7#1)(2008-8#2)
data have suggested that##2##4##(1996-2#1)(2007-10#1)
data have suggested##3##3##(1993-9#1)(1996-2#1)(2007-10#1)
data have to##2##3##(2008-10#1)(2009-4#1)
data have##62##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)
data highlight a##2##3##(2008-10#1)(2012-2#1)
data highlight the##2##3##(2013-1#1)(2013-8#1)
data highlight##5##2##(1993-3#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
data highlighted##2##2##(2008-11#1)(2008-7#1)
data identified##5##2##(1992-8#1)(2008-10#3)(2012-2#1)
data illustrate##2##2##(1995-6#1)(2010-8#1)
data illustrated that##2##3##(2008-10#1)(2008-11#1)
data implicate##5##2##(1991-5#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-6#1)
data imply that##5##3##(1991-1#1)(1995-2#1)(2008-11#1)(2008-4#1)(2012-12#1)
data imply##7##2##(1991-1#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#1)
data in a##17##3##(1995-12#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-12#1)
data in an##4##3##(2008-9#2)(2011-2#1)(2012-12#1)
data in clinical trials##2##4##(1997-4#2)
data in clinical##3##3##(1997-4#2)(2010-8#1)
data in different##3##3##(2008-3#1)(2010-10#1)(2013-8#1)
data in multiple##2##3##(2008-2#1)(2008-4#1)
data in multiwavelength mode##2##4##(2008-10#2)
data in order to determine the##2##6##(2008-10#1)(2010-3#1)
data in order to##7##4##(2008-1#1)(2008-10#2)(2008-11#2)(2010-3#1)(2012-12#1)
data in our##2##3##(1997-8#1)(2008-11#1)
data in relation to##3##4##(2008-1#1)(2008-4#1)(2008-8#1)
data in terms of##2##4##(1991-2#1)(2008-3#1)
data in the context of##2##5##(2008-8#1)(2009-8#1)
data in the light of##2##5##(2007-12#1)(2011-1#1)
data in the literature##11##4##(1990-6#1)(1991-12#1)(1997-3#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-10#1)
data in the presence of##2##5##(2008-10#1)(2008-6#1)
data in the##35##3##(1990-6#1)(1991-12#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-3#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)
data in this##5##3##(1992-1#1)(2008-1#1)(2008-4#1)(2010-2#1)(2013-1#1)
data in type##2##3##(2008-8#2)
data in which##2##3##(1997-3#1)(2008-10#1)
data in##143##2##(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-8#1)(2007-12#4)(2007-4#1)(2008-1#4)(2008-10#21)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#7)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
data include the##2##3##(2007-10#2)
data include##3##2##(1991-12#1)(2007-10#2)
data included##5##2##(1997-3#1)(1997-8#1)(2008-7#1)(2010-3#1)(2012-5#1)
data indicate a##7##3##(1990-5#1)(1991-5#1)(1992-2#1)(1995-6#1)(2008-10#1)(2008-9#1)(2012-1#1)
data indicate that a##5##4##(1994-5#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
data indicate that each##2##4##(1994-8#1)(2008-10#1)
data indicate that even##2##4##(2007-7#1)(2010-4#1)
data indicate that in##3##4##(1990-5#1)(1995-12#1)(1997-2#1)
data indicate that inhibition of##2##5##(1991-1#1)(1992-12#1)
data indicate that plasma##2##4##(2008-4#1)(2008-7#1)
data indicate that the effects of##2##6##(1996-3#1)(2011-2#1)
data indicate that the##34##4##(1990-11#1)(1990-12#1)(1990-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-7#1)
data indicate that there is##3##5##(1995-11#1)(2008-11#1)(2008-3#1)
data indicate that there##4##4##(1990-11#1)(1995-11#1)(2008-11#1)(2008-3#1)
data indicate that this##2##4##(1993-8#1)(1995-11#1)
data indicate that##141##3##(1990-11#3)(1990-12#3)(1990-5#2)(1990-8#2)(1991-1#1)(1991-12#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#6)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
data indicate the##7##3##(1990-11#1)(1990-7#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)
data indicate##165##2##(1990-11#4)(1990-12#3)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#6)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
data indicated a##3##3##(1993-3#1)(2008-10#2)
data indicated that a##2##4##(1997-3#1)(2008-11#1)
data indicated that the##5##4##(1992-3#1)(1995-12#1)(2008-10#3)
data indicated that##19##3##(1990-2#1)(1990-7#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-3#1)(2008-10#7)(2008-11#2)(2010-8#1)
data indicated the presence of two##2##6##(1994-3#1)(2008-10#1)
data indicated the##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
data indicated##30##2##(1990-2#1)(1990-7#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-6#1)(2008-10#11)(2008-11#3)(2008-6#1)(2010-8#1)
data indicates that the##3##4##(1994-5#1)(2008-10#1)(2008-7#1)
data indicates that##7##3##(1994-2#1)(1994-5#1)(2008-10#2)(2008-5#1)(2008-7#2)
data indicates##9##2##(1990-12#1)(1994-2#1)(1994-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#1)
data indicating that##2##3##(1990-12#1)(2009-12#1)
data indicating##3##2##(1990-12#1)(2009-12#1)(2011-2#1)
data inputs##2##2##(2008-12#1)(2008-3#1)
data integration##4##2##(2008-3#1)(2008-7#1)(2011-3#1)(2012-3#1)
data interpretation##9##2##(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#2)(2011-2#2)(2012-3#1)
data into a##5##3##(1992-12#1)(2007-7#1)(2008-3#2)(2012-12#1)
data into##16##2##(1992-12#1)(1995-2#1)(1997-3#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-6#1)(2010-9#1)(2012-12#2)
data inversion##2##2##(2008-3#1)(2011-2#1)
data is a##5##3##(1993-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
data is available for##2##4##(1991-12#1)(2010-2#1)
data is available##7##3##(1991-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-2#1)(2012-12#1)
data is compared with##2##4##(2008-7#1)(2009-12#1)
data is compared##3##3##(2008-1#1)(2008-7#1)(2009-12#1)
data is described##2##3##(1995-12#1)(1997-1#1)
data is not##2##3##(1994-5#1)(2007-11#1)
data is often##2##3##(1995-2#1)(2007-12#1)
data is presented##3##3##(2008-10#3)
data is required##2##3##(1995-8#1)(2008-7#1)
data is studied##2##3##(1995-12#1)(2008-10#1)
data is that##2##3##(2008-6#1)(2008-8#1)
data is##78##2##(1990-2#1)(1990-3#1)(1991-12#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1997-1#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-8#1)(2012-12#3)(2013-1#1)(2013-8#1)
data it##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
data known before##2##3##(2007-8#2)
data leads to the##2##4##(2008-3#1)(2009-10#1)
data link##2##2##(2008-2#1)(2008-3#1)
data linking##3##2##(1994-8#1)(2008-10#1)(2009-8#1)
data links##5##2##(1996-1#1)(2008-3#4)
data management##17##2##(1990-3#1)(1991-5#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-11#1)(2010-5#2)(2010-8#1)(2012-12#1)
data matrices##4##2##(1995-5#1)(2008-10#2)(2012-2#1)
data matrix##6##2##(1992-11#1)(2008-10#4)(2008-5#1)
data may be used##2##4##(2008-12#1)(2009-12#1)
data may be##6##3##(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-8#1)
data may have##3##3##(1990-2#1)(2011-2#1)(2013-8#1)
data may##16##2##(1990-2#1)(1992-8#1)(1993-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
data mean##2##2##(2008-10#1)(2008-5#1)
data measured at##2##3##(2008-10#2)
data measured by##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
data measured in##3##3##(2008-3#2)(2008-5#1)
data measured##13##2##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-1#1)
data mining and##2##3##(2008-4#1)(2012-1#1)
data mining method##2##3##(2008-10#1)(2010-8#1)
data mining##17##2##(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-10#1)(2010-8#2)(2012-1#2)(2012-3#1)
data model##6##2##(1997-3#2)(2008-2#1)(2008-7#3)
data monitoring##4##2##(1996-6#2)(2011-2#1)(2012-3#1)
data must be##4##3##(2008-3#1)(2008-9#2)(2010-5#1)
data necessary for##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
data needs##2##2##(1991-2#1)(1994-2#1)
data normalization##2##2##(2008-7#2)
data not##2##2##(2008-7#1)(2008-9#1)
data obtained are##2##3##(2008-10#2)
data obtained at##5##3##(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
data obtained by the##5##4##(2008-10#4)(2012-12#1)
data obtained by##25##3##(1990-12#1)(1995-3#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-3#2)(2012-12#1)(2012-3#1)
data obtained during##2##3##(2008-3#1)(2011-1#1)
data obtained for the##2##4##(2008-2#1)(2011-2#1)
data obtained for##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
data obtained from a##3##4##(1994-2#1)(2008-10#1)(2012-2#1)
data obtained from both##2##4##(2008-10#1)(2008-2#1)
data obtained from the##2##4##(2006-7#1)(2008-10#1)
data obtained from this##3##4##(2008-10#2)(2011-1#1)
data obtained from##30##3##(1994-2#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-7#1)(2006-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
data obtained in a##4##4##(1991-9#1)(1993-12#1)(1996-5#1)(2008-2#1)
data obtained in##13##3##(1991-9#1)(1992-3#1)(1993-12#1)(1993-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-8#1)
data obtained indicate that##2##4##(2008-10#1)(2008-5#1)
data obtained on solutions containing##2##5##(2008-10#2)
data obtained on##4##3##(1993-8#1)(1995-2#1)(2008-10#2)
data obtained using the##4##4##(2008-10#4)
data obtained using##8##3##(1990-8#1)(2008-10#7)
data obtained with a##2##4##(2008-10#1)(2008-3#1)
data obtained with different##2##4##(2008-10#1)(2008-11#1)
data obtained with other##2##4##(2008-11#1)(2008-3#1)
data obtained with##14##3##(1990-7#1)(1993-3#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)
data obtained##125##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#49)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
data of 52##2##3##(2008-7#1)(2011-2#1)
data of a##10##3##(1991-3#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-6#1)(2012-1#1)
data of all##2##3##(2008-5#1)(2013-8#1)
data of both##2##3##(2008-10#1)(2008-2#1)
data of different##2##3##(2008-11#1)(2008-7#1)
data of five##2##3##(1996-5#1)(2008-12#1)
data of the##32##3##(1994-6#1)(1995-12#1)(1996-4#1)(1997-8#1)(2008-10#14)(2008-3#3)(2008-5#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-3#1)(2013-1#3)
data of these##2##3##(2008-11#1)(2011-2#1)
data of this##2##3##(1997-6#1)(2008-6#1)
data of##127##2##(1990-8#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#3)(1996-4#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#2)
data often##2##2##(2008-2#1)(2011-2#1)
data on 22##2##3##(1994-5#2)
data on T##2##3##(2007-5#1)(2008-7#1)
data on a##6##3##(1994-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
data on body##2##3##(2007-12#1)(2008-8#1)
data on community and##2##4##(1990-6#1)(1995-3#1)
data on drug##2##3##(1997-7#1)(2008-1#1)
data on health care##4##4##(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
data on health##5##3##(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-9#1)
data on how##2##3##(2010-11#1)(2013-8#1)
data on its##4##3##(1995-11#1)(1996-4#1)(2008-11#1)(2010-12#1)
data on mortality##2##3##(1991-3#1)(1991-6#1)
data on patient##2##3##(1996-2#1)(2007-10#1)
data on potential##2##3##(2008-9#1)(2010-3#1)
data on renal##2##3##(2008-1#2)
data on the diagnostic##2##4##(2008-12#2)
data on the distribution of##2##5##(1996-5#1)(2008-8#1)
data on the effect of##2##5##(2009-8#1)(2011-2#1)
data on the health##2##4##(1993-2#1)(1995-12#1)
data on the incidence##2##4##(1991-3#1)(2007-8#1)
data on the interaction of##2##5##(1992-12#1)(2008-10#1)
data on the quality of##2##5##(1995-12#1)(2012-3#1)
data on the relative##2##4##(2008-8#1)(2011-2#1)
data on the use of##3##5##(1991-3#1)(1995-1#1)(2012-1#1)
data on the##100##3##(1990-11#1)(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#4)(1995-2#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
data on their##7##3##(1995-11#1)(1996-3#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
data on this##2##3##(1992-3#1)(2008-12#1)
data on which##2##3##(2010-11#1)(2011-8#1)
data on##324##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#3)(1996-10#1)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#1)(2007-10#2)(2007-11#8)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#8)(2008-10#25)(2008-11#16)(2008-12#7)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#15)(2008-9#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#5)(2010-6#1)(2010-8#4)(2010-9#1)(2011-2#16)(2011-3#1)(2011-8#1)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#2)
data only##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
data or##11##2##(1990-8#1)(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
data over the##6##3##(1990-3#1)(1991-5#1)(2007-7#1)(2008-2#1)(2008-3#2)
data over##10##2##(1990-3#1)(1991-5#1)(1996-4#1)(2007-7#1)(2008-2#2)(2008-3#4)
data page##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
data pages##7##2##(2007-11#2)(2008-3#5)
data pattern##2##2##(2007-11#1)(2008-3#1)
data patterns and##2##3##(2008-10#1)(2012-2#1)
data patterns##5##2##(1994-9#1)(2008-10#2)(2012-2#2)
data pertaining to the##2##4##(2008-7#1)(2010-3#1)
data pertaining to##4##3##(2007-5#1)(2008-7#1)(2010-3#1)(2013-8#1)
data plots##2##2##(2008-10#1)(2008-7#1)
data point to the##2##4##(1991-6#1)(2008-7#1)
data point to##5##3##(1991-6#1)(1995-3#1)(2008-2#1)(2008-7#1)(2011-2#1)
data point##7##2##(1991-6#1)(1995-3#1)(2008-2#2)(2008-7#1)(2009-9#1)(2011-2#1)
data points##40##2##(1990-8#1)(1991-8#1)(2008-10#8)(2008-2#4)(2008-3#4)(2008-4#15)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2012-12#1)(2013-8#1)
data preprocessing##2##2##(2008-10#1)(2008-2#1)
data preprocessing/optimization scheme##2##3##(2008-3#2)
data present##2##2##(2008-10#1)(2010-10#1)
data presented in the##2##4##(1993-12#1)(2008-6#1)
data presented in this##2##4##(2008-12#1)(2008-7#1)
data presented in##5##3##(1993-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
data presented##20##2##(1993-12#1)(1994-12#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-8#1)(2012-12#1)(2012-3#2)
data presents##2##2##(1995-11#1)(2008-7#1)
data pretreatment##2##2##(2008-10#2)
data processed by##2##3##(2008-10#2)
data processing and##3##3##(1995-12#1)(2008-3#1)(2009-6#1)
data processing in##2##3##(1990-11#1)(2008-3#1)
data processing with##2##3##(2007-11#1)(2008-3#1)
data processing##32##2##(1990-11#1)(1993-3#1)(1995-12#1)(1995-5#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#14)(2008-8#1)(2008-9#1)(2009-6#1)
data produced##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
data products##2##2##(2008-3#2)
data proved##2##2##(2008-10#1)(2008-9#1)
data provide a##7##3##(1994-6#1)(1994-8#1)(2008-11#1)(2009-4#1)(2012-5#1)(2013-1#1)(2013-8#1)
data provide direct evidence##2##4##(2008-7#1)(2009-8#1)
data provide evidence for an##2##5##(2008-10#1)(2008-4#1)
data provide evidence for the##2##5##(1990-7#1)(2008-7#1)
data provide evidence for##6##4##(1990-7#1)(1993-12#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
data provide evidence that##3##4##(1995-8#1)(2008-10#1)(2008-9#1)
data provide evidence##11##3##(1990-7#1)(1993-12#1)(1995-11#1)(1995-8#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
data provide the first##6##4##(1994-5#1)(1997-4#1)(2007-7#1)(2008-10#2)(2010-11#1)
data provide the##7##3##(1994-5#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-11#1)
data provide##42##2##(1990-7#1)(1990-8#2)(1992-1#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
data provided a##2##3##(2008-10#1)(2008-11#1)
data provided by##3##3##(1991-5#1)(2008-2#1)(2010-3#1)
data provided##9##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-7#1)
data provides evidence##2##3##(1997-4#1)(2010-2#1)
data provides##7##2##(1995-5#1)(1997-4#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#2)
data providing evidence for##2##4##(2008-4#1)(2009-10#1)
data providing##3##2##(2008-4#1)(2009-10#1)(2012-3#1)
data published by##2##3##(2008-10#1)(2013-1#1)
data published##6##2##(2007-10#1)(2008-10#2)(2008-7#1)(2012-3#1)(2013-1#1)
data publishing##3##2##(1991-5#3)
data quality##12##2##(1997-1#1)(2007-12#1)(2008-10#3)(2008-3#2)(2010-1#3)(2010-7#1)(2012-12#1)
data rate##4##2##(2008-2#1)(2008-3#2)(2009-6#1)
data rates of##3##3##(2008-2#2)(2008-9#1)
data rates##4##2##(2008-2#3)(2008-9#1)
data received from##2##3##(2008-10#1)(2008-11#1)
data received##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
data recorded during##2##3##(2008-11#1)(2010-8#1)
data recorded from##2##3##(2008-3#1)(2013-8#1)
data recorded##8##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
data recording##2##2##(2007-12#1)(2011-1#1)
data reduction and analysis##2##4##(2008-2#1)(2008-3#1)
data reduction##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
data refer to##2##3##(2008-10#1)(2008-12#1)
data reflect##2##2##(1991-12#1)(2011-2#1)
data regarding the##16##3##(2007-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
data regarding##30##2##(1990-12#1)(1997-2#1)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#2)
data registered##2##2##(2008-3#1)(2010-4#1)
data related to the##2##4##(2008-10#1)(2011-2#1)
data related to##8##3##(1991-2#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-4#1)(2011-2#2)
data relating to##5##3##(1991-8#1)(1993-11#1)(2007-11#1)(2007-8#1)(2008-3#1)
data relevant##2##2##(2008-10#2)
data remain##2##2##(2008-1#1)(2013-1#1)
data reported here##3##3##(1993-9#1)(1995-6#1)(2007-12#1)
data reported in the literature##2##5##(1993-9#1)(2008-2#1)
data reported in##3##3##(1993-9#1)(2008-1#1)(2008-2#1)
data reported##11##2##(1992-9#1)(1993-9#2)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-4#1)(2012-12#1)
data reporting##4##2##(2008-8#1)(2011-2#3)
data repositories##3##2##(1995-12#1)(2008-11#1)(2008-7#1)
data repository##2##2##(2008-7#2)
data representation##3##2##(2008-7#2)(2010-8#1)
data represents a##2##3##(2008-10#1)(2008-11#1)
data require##6##2##(2008-10#1)(2008-3#1)(2008-9#2)(2013-1#1)(2013-8#1)
data required for the##2##4##(2008-10#1)(2008-6#1)
data required##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
data requirements##2##2##(2011-2#1)(2013-1#1)
data requires##6##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
data resulted in##3##3##(2008-1#1)(2008-5#1)(2012-1#1)
data results##2##2##(2008-2#1)(2010-2#1)
data retrieval##3##2##(2008-11#1)(2008-3#2)
data reveal that the##5##4##(1990-12#1)(2008-10#1)(2010-2#2)(2013-8#1)
data reveal that##13##3##(1990-11#1)(1990-12#1)(1994-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#2)(2013-1#1)(2013-8#2)
data reveal##20##2##(1990-11#1)(1990-12#1)(1994-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
data revealed a##5##3##(1994-12#1)(2008-10#2)(2009-8#1)(2012-2#1)
data revealed that##7##3##(2008-10#3)(2008-11#1)(2008-6#1)(2009-10#1)(2010-3#1)
data revealed three##2##3##(2008-10#1)(2008-5#1)
data revealed##21##2##(1991-9#1)(1994-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-2#1)
data reviewed##4##2##(1994-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
data sacrifice##2##2##(2008-2#2)
data seem to##2##3##(2008-4#1)(2013-1#1)
data seem##3##2##(1996-4#1)(2008-4#1)(2013-1#1)
data separated isolates##2##3##(2008-10#2)
data set and the##2##4##(1997-4#1)(2008-10#1)
data set and##3##3##(1997-4#1)(2008-10#2)
data set are##3##3##(1990-2#1)(2008-2#1)(2008-8#1)
data set clustered in three groups according to the three types of plants##2##13##(2008-10#2)
data set consisted of##2##4##(2008-3#1)(2009-9#1)
data set consisting of##2##4##(2007-12#1)(2008-10#1)
data set from##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2009-12#1)
data set in##3##3##(1997-3#1)(2007-12#1)(2008-1#1)
data set of the##3##4##(1995-12#1)(2008-10#2)
data set of##9##3##(1995-12#1)(1996-1#1)(2008-10#5)(2009-11#1)(2012-3#1)
data set showed##2##3##(2008-10#2)
data set that is##2##4##(1994-12#1)(2008-9#1)
data set that##3##3##(1994-12#1)(2008-9#1)(2012-12#1)
data set was##2##3##(1995-9#1)(2008-10#1)
data set with##2##3##(1997-4#1)(2008-3#1)
data set##100##2##(1990-2#1)(1994-12#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#37)(2008-11#3)(2008-2#4)(2008-3#13)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#3)(2009-7#1)(2009-9#3)(2010-6#1)(2012-12#4)(2012-3#4)
data sets and##6##3##(2008-10#3)(2008-7#1)(2008-9#1)(2012-2#1)
data sets are##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
data sets as##2##3##(2008-7#1)(2010-12#1)
data sets at the leaflet##2##5##(2008-10#2)
data sets at the##4##4##(2008-10#4)
data sets collected##2##3##(2008-10#1)(2009-9#1)
data sets describing##2##3##(1992-12#1)(2008-9#1)
data sets for##3##3##(1995-2#1)(1996-2#1)(2012-2#1)
data sets from##7##3##(2006-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)
data sets is##2##3##(2008-11#1)(2008-3#1)
data sets of##6##3##(1995-6#1)(2008-10#1)(2008-3#1)(2010-11#1)(2012-12#1)(2012-3#1)
data sets reveals##2##3##(2010-10#1)(2010-7#1)
data sets that##5##3##(1995-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-7#1)
data sets using##3##3##(2008-10#2)(2008-6#1)
data sets was##2##3##(2008-10#2)
data sets were collected##2##4##(1995-5#1)(2008-10#1)
data sets were##6##3##(1995-5#1)(2008-10#3)(2008-11#1)(2013-1#1)
data sets##142##2##(1992-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#50)(2008-11#6)(2008-2#3)(2008-3#14)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#5)(2009-11#1)(2009-5#1)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
data sharing##4##2##(1994-3#1)(1995-3#1)(1996-3#1)(2011-2#1)
data should be##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
data should##5##2##(1997-1#1)(1997-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
data show a significant overall decrease in length of stay##2##10##(1994-12#2)
data show a##6##3##(1994-12#2)(1994-6#1)(2008-11#1)(2008-7#1)(2010-5#1)
data show that a##2##4##(2008-3#1)(2008-7#1)
data show that the##12##4##(1991-2#1)(1993-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
data show that these##2##4##(1993-2#1)(2008-10#1)
data show that##66##3##(1990-12#1)(1990-5#2)(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#3)
data show the##3##3##(1991-9#1)(2011-2#1)(2013-7#1)
data show##87##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#1)(2007-11#2)(2007-8#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
data showed a##3##3##(1994-12#1)(2008-1#1)(2008-10#1)
data showed no##2##3##(1991-3#1)(2007-9#1)
data showed that several##2##4##(2008-3#1)(2009-10#1)
data showed that the##5##4##(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)
data showed that there was##2##5##(2011-1#1)(2012-2#1)
data showed that there##3##4##(2008-8#1)(2011-1#1)(2012-2#1)
data showed that##24##3##(1991-6#1)(1993-1#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
data showed##34##2##(1991-3#1)(1991-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1996-3#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
data showing that##2##3##(2007-5#1)(2009-8#1)
data showing##6##2##(1994-12#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)
data shows that the##2##4##(1991-8#1)(2008-11#1)
data shows that##8##3##(1991-8#2)(1996-9#1)(1997-2#1)(2008-11#2)(2008-3#1)(2008-4#1)
data shows##12##2##(1991-8#2)(1993-6#1)(1996-9#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
data significantly##2##2##(2008-2#1)(2013-8#1)
data simultaneously##2##2##(2008-2#1)(2010-8#1)
data so##4##2##(1997-1#1)(2008-10#2)(2008-9#1)
data source##5##2##(1995-6#1)(2008-1#1)(2008-9#1)(2010-5#1)(2012-12#1)
data sources to##2##3##(1991-3#1)(2009-10#1)
data sources were used##3##4##(1995-1#1)(1996-2#1)(2013-1#1)
data sources##16##2##(1991-2#2)(1991-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-11#1)(2012-12#1)(2013-1#1)
data spaces##2##2##(2009-9#2)
data standards##5##2##(1992-12#1)(1997-3#1)(2008-7#2)(2010-8#1)
data still##3##2##(1992-10#1)(2008-8#1)(2010-11#1)
data storage and##4##3##(2007-12#1)(2008-3#1)(2008-7#2)
data storage by use of##2##5##(2008-3#2)
data storage by##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
data storage in a##2##4##(2008-3#2)
data storage in##4##3##(2007-12#2)(2008-3#2)
data storage system##3##3##(2008-2#1)(2008-3#2)
data storage systems##4##3##(2008-2#2)(2008-3#2)
data storage with##2##3##(2007-11#1)(2008-3#1)
data storage##45##2##(2007-11#3)(2007-12#8)(2008-2#8)(2008-3#24)(2008-7#2)
data stored in##2##3##(2007-12#2)
data stream##2##2##(2007-12#1)(2008-2#1)
data streams##2##2##(2008-2#1)(2008-3#1)
data strongly suggest that##4##4##(1990-7#1)(1996-5#1)(1997-4#1)(2008-5#1)
data strongly support the##3##4##(1994-12#1)(1994-8#1)(1997-7#1)
data strongly support##4##3##(1994-12#1)(1994-8#1)(1997-5#1)(1997-7#1)
data strongly##9##2##(1990-7#1)(1994-12#1)(1994-8#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-5#1)(2010-5#1)
data structure and##2##3##(2008-6#1)(2010-5#1)
data structure n i##2##4##(2008-7#2)
data structure##13##2##(1995-5#1)(1997-4#1)(2008-10#4)(2008-6#3)(2008-7#3)(2010-5#1)
data structures##2##2##(2008-7#2)
data such as##7##3##(1992-8#1)(1994-10#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-12#1)(2013-7#1)
data such##8##2##(1992-8#1)(1994-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-12#1)(2013-7#1)
data suggest a role for##2##5##(1991-2#1)(1992-3#1)
data suggest a##13##3##(1991-2#1)(1992-3#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-2#2)(2012-7#1)
data suggest an##2##3##(1990-8#1)(1992-5#1)
data suggest that IGF-I##2##4##(1991-5#1)(2008-8#1)
data suggest that P##2##4##(2008-10#1)(2008-12#1)
data suggest that a##7##4##(1992-6#1)(1993-12#1)(1995-2#1)(1996-9#1)(2008-10#2)(2012-3#1)
data suggest that both##2##4##(1997-2#1)(2013-1#1)
data suggest that certain##2##4##(2008-10#1)(2008-11#1)
data suggest that exposure to##2##5##(1997-1#1)(2008-5#1)
data suggest that in##4##4##(1992-8#1)(1995-12#1)(2008-8#1)(2012-1#1)
data suggest that it##2##4##(2008-3#1)(2013-1#1)
data suggest that not##2##4##(1992-3#1)(2008-12#1)
data suggest that regulation of##2##5##(1995-12#1)(2008-8#1)
data suggest that respiratory##2##4##(1996-5#1)(2008-7#1)
data suggest that specific##2##4##(2008-10#1)(2008-8#1)
data suggest that the ability##2##5##(1992-10#1)(2008-10#1)
data suggest that the##63##4##(1990-11#1)(1990-2#2)(1990-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#3)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
data suggest that there is##3##5##(2008-11#1)(2008-3#1)(2011-2#1)
data suggest that there##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
data suggest that this##6##4##(1990-11#1)(1993-11#1)(1995-2#1)(1996-12#1)(2006-10#1)(2012-3#1)
data suggest that when##2##4##(1996-9#1)(2008-10#1)
data suggest that##248##3##(1990-11#3)(1990-12#1)(1990-2#5)(1990-5#3)(1990-7#3)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#8)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#4)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#30)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2011-10#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#2)
data suggest the##9##3##(1990-5#1)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
data suggest##287##2##(1990-11#3)(1990-12#1)(1990-2#5)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#6)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#2)(1994-11#8)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#7)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#5)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#33)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#11)(2008-9#6)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-10#1)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#5)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
data suggested that the##2##4##(2008-11#1)(2008-12#1)
data suggested that##11##3##(1990-6#1)(1991-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2011-2#1)(2012-12#2)
data suggested the##2##3##(2010-12#1)(2012-12#1)
data suggested##15##2##(1990-6#1)(1991-5#1)(1991-9#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#3)
data suggesting##3##2##(1993-12#1)(1996-12#1)(2008-8#1)
data suggests that the##2##4##(2008-5#1)(2011-1#1)
data suggests that##12##3##(1994-2#1)(2007-2#1)(2008-11#1)(2008-5#2)(2008-8#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)
data suggests##16##2##(1994-2#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
data support a role for##2##5##(2008-5#1)(2013-1#1)
data support a##5##3##(1991-12#1)(1993-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
data support the hypothesis that##8##5##(1991-1#1)(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#3)(2013-7#1)
data support the idea##2##4##(1992-9#1)(2008-11#1)
data support the notion that##2##5##(1995-3#1)(2012-12#1)
data support the view that the##2##6##(1997-6#1)(2009-9#1)
data support the view that##4##5##(1992-8#1)(1996-7#1)(1997-6#1)(2009-9#1)
data support the##32##3##(1990-2#1)(1991-1#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
data support##42##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
data supported##2##2##(2008-10#1)(2010-8#1)
data supporting the##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
data supporting##6##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
data supports the hypothesis that##2##5##(1991-1#1)(2012-2#1)
data supports the##3##3##(1991-1#1)(2012-2#1)(2013-1#1)
data supports##5##2##(1991-1#1)(2007-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
data surrounding the##2##3##(1997-6#1)(2008-7#1)
data synthesis and##2##3##(2007-5#2)
data system##7##2##(1994-2#1)(1994-3#1)(2013-8#5)
data systems and##2##3##(1994-3#1)(1996-3#1)
data systems to##2##3##(1997-2#1)(2013-8#1)
data systems##14##2##(1992-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)(2013-8#4)
data taken from the literature##2##5##(2008-10#1)(2008-2#1)
data taken from##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
data taken##6##2##(1990-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#2)
data than##2##2##(2008-10#1)(2008-2#1)
data that are##4##3##(1993-12#1)(1995-5#1)(2008-3#1)(2010-6#1)
data that can be obtained##2##5##(1995-6#1)(2011-2#1)
data that can be used##2##5##(1996-12#1)(1997-3#1)
data that can be##5##4##(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2011-2#1)
data that demonstrate##4##3##(1991-1#1)(2008-11#1)(2008-2#1)(2008-7#1)
data that have##2##3##(2008-3#1)(2009-9#1)
data that is collected##2##4##(2008-9#1)(2012-2#1)
data that is##5##3##(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
data that may##2##3##(1997-8#1)(2008-7#1)
data that suggest that##2##4##(2008-4#1)(2008-7#1)
data that suggest##4##3##(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)
data that the##5##3##(1990-5#1)(2008-1#1)(2008-10#1)(2008-11#2)
data that these##2##3##(1991-8#1)(2008-7#1)
data that were##2##3##(2008-2#1)(2008-3#1)
data that will##4##3##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
data that##78##2##(1990-5#1)(1991-1#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#7)(2008-2#4)(2008-3#13)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#1)
data the##7##2##(1990-7#1)(1997-4#1)(2008-2#1)(2008-3#1)(2010-11#1)(2012-2#1)(2012-3#1)
data there##3##2##(1995-5#1)(1997-7#1)(2008-7#1)
data they##2##2##(1994-12#1)(2012-2#1)
data through##8##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
data throughput##2##2##(2008-10#1)(2009-6#1)
data thus##5##2##(1990-5#1)(1991-8#1)(1994-9#1)(1997-6#1)(2008-10#1)
data to a##2##3##(1992-11#1)(2007-12#1)
data to an unstructured##3##4##(2013-1#3)
data to an##4##3##(2008-10#1)(2013-1#3)
data to assess the##2##4##(2008-3#1)(2011-2#1)
data to assess##3##3##(1993-12#1)(2008-3#1)(2011-2#1)
data to be##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-8#1)
data to calculate##2##3##(1993-2#1)(2012-12#1)
data to create##3##3##(1995-1#2)(2007-5#1)
data to determine the##2##4##(2008-2#1)(2008-3#1)
data to determine##4##3##(1991-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
data to develop##2##3##(1995-2#1)(1996-2#1)
data to estimate the##2##4##(1992-12#1)(2008-7#1)
data to estimate##5##3##(1992-12#1)(1992-5#1)(2008-10#2)(2008-7#1)
data to evaluate##3##3##(1993-1#1)(1996-3#1)(2010-6#1)
data to examine the##2##4##(1994-2#1)(1996-1#1)
data to examine##6##3##(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
data to general##3##3##(1992-9#1)(1995-9#2)
data to identify##3##3##(1997-3#1)(2008-12#1)(2010-1#1)
data to inform##4##3##(1997-3#1)(2008-11#1)(2008-12#1)(2010-10#1)
data to monitor##2##3##(1993-12#1)(1994-1#1)
data to obtain##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
data to pathotype 1##2##4##(2008-10#2)
data to predict##2##3##(2008-8#1)(2009-8#1)
data to produce##2##3##(2008-8#1)(2010-8#1)
data to support such##2##4##(2008-10#1)(2012-1#1)
data to support the##3##4##(2007-11#1)(2008-12#1)(2008-4#1)
data to support##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-1#1)
data to the model##2##4##(2008-3#1)(2009-2#1)
data to the##11##3##(2008-10#2)(2008-2#3)(2008-3#3)(2009-2#1)(2010-2#1)(2010-4#1)
data to those##2##3##(1994-12#1)(2008-7#1)
data to##145##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#3)(1997-3#3)(1997-8#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#21)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#5)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
data together with##4##3##(1990-2#1)(2007-11#1)(2008-7#1)(2013-1#1)
data tools##2##2##(1996-3#2)
data transfer##3##2##(2008-3#2)(2011-1#1)
data transformations have##2##3##(2008-10#2)
data transformations##3##2##(2008-10#3)
data transmission##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2010-8#1)
data treatment and##2##3##(2008-10#2)
data treatment##6##2##(2008-10#6)
data types##3##2##(1997-4#1)(2008-11#1)(2011-2#1)
data typically##2##2##(2008-1#1)(2008-8#1)
data under##2##2##(2009-5#1)(2012-2#1)
data unequivocally##2##2##(1993-6#1)(2008-10#1)
data used in this##2##4##(2008-10#2)
data used in##3##3##(1997-2#1)(2008-10#2)
data used to##2##3##(1996-12#1)(2008-10#1)
data used##9##2##(1994-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-8#2)
data using a##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
data using an##3##3##(1992-3#1)(2009-8#1)(2012-3#1)
data using principal component analysis (PCA)##2##6##(2008-10#2)
data using the##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
data using##29##2##(1992-2#1)(1992-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
data usually##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
data values##4##2##(1997-4#1)(2008-3#3)
data versus##2##2##(2013-1#1)(2013-7#1)
data via##5##2##(1992-4#1)(2008-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
data visualization##3##2##(2008-4#1)(2008-6#1)(2008-9#1)
data warehousing##2##2##(2008-4#1)(2008-7#1)
data was analysed##3##3##(2011-2#1)(2012-2#2)
data was analyzed using##3##4##(1997-5#1)(2011-1#1)(2013-1#1)
data was analyzed##8##3##(1997-5#1)(2008-10#1)(2008-12#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
data was collected by##3##4##(2010-8#1)(2011-2#2)
data was collected from##3##4##(1991-2#1)(2008-7#1)(2008-9#1)
data was collected##12##3##(1991-2#1)(2008-12#4)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
data was obtained##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
data was performed##2##3##(2008-10#1)(2008-12#1)
data was the##2##3##(1996-5#1)(2008-10#1)
data was used to##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
data was used##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
data was##74##2##(1991-2#2)(1993-6#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#7)(2008-2#1)(2008-7#4)(2008-9#2)(2009-11#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
data we##10##2##(1990-8#1)(1990-9#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-2#1)(2012-3#1)
data well##6##2##(1997-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
data were acquired using##2##4##(2008-10#1)(2012-3#1)
data were acquired##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
data were also##6##3##(1991-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)
data were analysed by##2##4##(2008-10#1)(2009-6#1)
data were analysed to##2##4##(2007-11#1)(2011-2#1)
data were analysed using##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
data were analysed##10##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#2)
data were analyzed by ANOVA and##2##6##(2009-8#1)(2013-1#1)
data were analyzed by##8##4##(1990-2#1)(1993-9#2)(1995-2#1)(2007-10#1)(2008-6#1)(2009-8#1)(2013-1#1)
data were analyzed for##2##4##(1994-11#1)(2010-11#1)
data were analyzed in terms of##2##6##(2008-10#2)
data were analyzed to##2##4##(2006-12#1)(2013-8#1)
data were analyzed using a##2##5##(2010-2#2)
data were analyzed using the##2##5##(2008-12#1)(2011-2#1)
data were analyzed using##5##4##(1994-11#1)(2008-12#1)(2010-2#2)(2011-2#1)
data were analyzed##24##3##(1990-2#1)(1990-6#1)(1993-9#2)(1994-11#2)(1995-12#1)(1995-2#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-6#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#2)(2011-2#1)(2013-1#2)(2013-8#1)
data were available for##3##4##(2007-2#1)(2008-12#1)(2008-3#1)
data were available from##2##4##(1996-7#1)(2012-3#1)
data were available##8##3##(1995-6#1)(1996-7#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-4#1)(2012-3#1)(2013-8#1)
data were collected at##3##4##(2008-5#1)(2010-1#1)(2011-2#1)
data were collected by##5##4##(1992-3#1)(2007-11#1)(2008-11#1)(2009-12#1)(2011-2#1)
data were collected for##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
data were collected from the##2##5##(1991-6#1)(2013-1#1)
data were collected from##12##4##(1991-6#1)(1993-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#2)
data were collected in the##2##5##(2008-3#1)(2013-1#1)
data were collected on##2##4##(1993-6#1)(2009-4#1)
data were collected to##2##4##(2008-7#1)(2008-8#1)
data were collected using##3##4##(2008-11#1)(2013-1#2)
data were collected with##3##4##(2008-2#1)(2009-5#1)(2011-2#1)
data were collected##47##3##(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
data were compared to##2##4##(1991-12#1)(2008-9#1)
data were compared with the##3##5##(1994-3#1)(2007-11#1)(2008-10#1)
data were compared with##6##4##(1994-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
data were compared##10##3##(1991-12#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
data were confirmed by##3##4##(1992-3#1)(2008-5#1)(2013-1#1)
data were confirmed##4##3##(1992-3#2)(2008-5#1)(2013-1#1)
data were consistent with##3##4##(1990-5#1)(1991-8#1)(2008-10#1)
data were evaluated by##2##4##(2008-10#2)
data were evaluated##3##3##(2008-10#2)(2008-6#1)
data were examined##3##3##(1991-6#1)(2011-1#1)(2013-1#1)
data were extracted##2##3##(2013-1#2)
data were fitted to the##2##5##(2008-10#1)(2008-2#1)
data were fitted to##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
data were fitted with##2##4##(2008-10#1)(2008-2#1)
data were fitted##8##3##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2010-5#1)
data were generated##2##3##(2008-10#1)(2008-3#1)
data were in##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
data were not##2##3##(2008-10#2)
data were obtained by##2##4##(2008-10#1)(2008-3#1)
data were obtained for##4##4##(1991-1#1)(1997-2#1)(2008-10#1)(2013-1#1)
data were obtained from the##3##5##(1991-6#1)(2011-1#2)
data were obtained from##7##4##(1990-2#1)(1990-8#1)(1991-6#1)(1995-12#1)(2008-7#1)(2011-1#2)
data were obtained##19##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-6#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#2)(2011-1#2)(2011-2#1)(2013-1#1)
data were performed##2##3##(1997-5#1)(2008-10#1)
data were processed by the##2##5##(2008-10#1)(2011-1#1)
data were processed by##3##4##(2008-10#2)(2011-1#1)
data were processed##4##3##(2008-10#3)(2011-1#1)
data were recorded##9##3##(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
data were statistically##2##3##(1990-8#1)(1995-6#1)
data were subjected to##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
data were taken from the##2##5##(2008-10#1)(2008-9#1)
data were taken from##4##4##(1996-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
data were taken##5##3##(1996-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
data were then##6##3##(2008-10#2)(2008-3#1)(2009-12#1)(2011-2#2)
data were used to estimate the##2##6##(2008-10#1)(2008-3#1)
data were used to##16##4##(1991-1#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-8#2)(2009-8#2)(2011-2#1)
data were used##18##3##(1991-1#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-8#2)(2009-8#2)(2010-10#1)(2011-2#1)(2012-3#1)
data were##259##2##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-3#3)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-3#1)(1995-12#3)(1995-2#1)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#53)(2008-11#5)(2008-12#8)(2008-2#6)(2008-3#19)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#13)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#18)(2013-7#3)(2013-8#4)
data when##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
data where##2##2##(1997-8#1)(2009-12#1)
data which##11##2##(1990-2#1)(1992-12#1)(1993-2#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
data while##2##2##(2007-7#1)(2013-1#1)
data will be##9##3##(1995-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2008-4#2)(2008-8#1)(2008-9#1)
data will##16##2##(1992-12#1)(1995-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-8#2)(2010-9#1)(2011-3#1)
data with a##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-6#1)
data with high##3##3##(2008-2#2)(2008-3#1)
data with other##2##3##(1991-12#1)(2008-12#1)
data with the##13##3##(1990-9#1)(1992-10#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(2008-11#2)(2008-2#3)(2008-3#1)(2013-8#1)
data with these##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
data with those from##3##4##(2008-10#2)(2009-8#1)
data with those##6##3##(2008-10#3)(2008-3#1)(2008-7#1)(2009-8#1)
data with##78##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-10#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
data within the##2##3##(1995-1#1)(2008-7#1)
data within##5##2##(1995-1#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-7#1)
data without##3##2##(2008-2#1)(2010-8#1)(2011-2#1)
data would##5##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
data yielded##2##2##(1997-7#1)(2013-1#1)
data yields the##2##3##(1997-7#1)(2008-3#1)
data##7433##1##(1990-10#2)(1990-11#16)(1990-12#21)(1990-2#20)(1990-3#13)(1990-4#1)(1990-5#20)(1990-6#10)(1990-7#20)(1990-8#34)(1990-9#15)(1991-1#11)(1991-10#1)(1991-11#6)(1991-12#43)(1991-2#22)(1991-3#22)(1991-4#1)(1991-5#20)(1991-6#14)(1991-7#1)(1991-8#12)(1991-9#13)(1992-1#12)(1992-10#6)(1992-11#14)(1992-12#32)(1992-2#21)(1992-3#30)(1992-4#4)(1992-5#10)(1992-6#21)(1992-7#5)(1992-8#16)(1992-9#17)(1993-1#15)(1993-11#16)(1993-12#39)(1993-2#18)(1993-3#31)(1993-5#1)(1993-6#12)(1993-8#18)(1993-9#17)(1994-1#15)(1994-10#1)(1994-11#18)(1994-12#32)(1994-2#45)(1994-3#45)(1994-5#19)(1994-6#25)(1994-7#2)(1994-8#15)(1994-9#26)(1995-1#14)(1995-11#17)(1995-12#75)(1995-2#53)(1995-3#36)(1995-5#36)(1995-6#24)(1995-8#15)(1995-9#24)(1996-1#25)(1996-10#1)(1996-11#8)(1996-12#31)(1996-2#52)(1996-3#41)(1996-4#7)(1996-5#18)(1996-6#10)(1996-7#7)(1996-8#1)(1996-9#4)(1997-1#30)(1997-2#65)(1997-3#78)(1997-4#36)(1997-5#18)(1997-6#15)(1997-7#37)(1997-8#25)(1997-9#1)(2006-10#6)(2006-12#2)(2006-4#8)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#32)(2007-11#77)(2007-12#115)(2007-2#9)(2007-4#4)(2007-5#17)(2007-6#3)(2007-7#15)(2007-8#23)(2007-9#3)(2008-1#63)(2008-10#1127)(2008-11#274)(2008-12#96)(2008-2#267)(2008-3#579)(2008-4#171)(2008-5#127)(2008-6#77)(2008-7#356)(2008-8#225)(2008-9#168)(2009-1#1)(2009-10#40)(2009-11#32)(2009-12#27)(2009-2#15)(2009-3#8)(2009-4#27)(2009-5#34)(2009-6#22)(2009-7#25)(2009-8#44)(2009-9#44)(2010-1#17)(2010-10#35)(2010-11#29)(2010-12#30)(2010-2#30)(2010-3#46)(2010-4#15)(2010-5#42)(2010-6#27)(2010-7#17)(2010-8#91)(2010-9#8)(2011-1#70)(2011-10#1)(2011-2#261)(2011-3#19)(2011-7#2)(2011-8#2)(2011-9#4)(2012-1#35)(2012-12#124)(2012-2#100)(2012-3#131)(2012-5#4)(2012-7#3)(2012-8#1)(2013-1#228)(2013-7#30)(2013-8#124)
data) to##2##2##(2007-11#1)(2008-10#1)
data)##15##1##(1990-5#1)(1993-11#2)(1993-12#1)(1995-9#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-9#1)(2010-11#1)(2013-8#1)
data-acquisition procedure is##2##3##(2007-11#1)(2008-3#1)
data-acquisition system##3##2##(2008-10#2)(2008-3#1)
data-acquisition##8##1##(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)
data-analysis##3##1##(2008-3#2)(2008-4#1)
data-based planning##4##2##(1996-2#1)(1997-1#3)
data-based##10##1##(1993-1#1)(1996-2#1)(1997-1#7)(2010-5#1)
data-dependent##4##1##(2008-3#3)(2011-2#1)
data-driven approach to##3##3##(1995-3#1)(1996-2#1)(2013-8#1)
data-driven##13##1##(1994-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-10#2)(2011-8#1)(2012-2#2)(2013-8#1)
data-inversion##2##1##(2008-3#2)
data-mining##2##1##(2008-7#1)(2008-9#1)
data-processing system##2##2##(2008-2#1)(2008-3#1)
data-processing##8##1##(2007-11#1)(2008-2#2)(2008-3#5)
data-reduction##4##1##(2008-3#4)
data-storage##9##1##(2008-2#3)(2008-3#6)
data?##6##1##(1994-2#1)(1995-8#1)(1997-1#1)(2007-9#1)(2008-4#1)(2008-7#1)
data]##4##1##(1990-3#1)(1997-5#1)(2008-4#1)(2008-8#1)
databanks##2##1##(1992-1#1)(1995-9#1)
database (http##3##2##(2008-7#1)(2011-2#2)
database and methods for##2##4##(2007-7#1)(2008-4#1)
database and the##2##3##(2010-12#1)(2010-5#1)
database and##24##2##(1991-12#1)(1994-12#1)(1996-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)
database application##2##2##(2008-11#2)
database are##3##2##(1991-3#1)(2008-3#1)(2010-5#1)
database at##2##2##(2008-12#1)(2013-1#1)
database by##2##2##(1995-6#1)(2008-7#1)
database consists of##2##3##(2008-4#1)(2009-2#1)
database designed to##2##3##(1991-12#1)(2008-4#1)
database designed##3##2##(1991-12#1)(2008-4#1)(2008-7#1)
database development##4##2##(1995-12#1)(2008-7#3)
database for the##6##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2012-12#1)
database for##23##2##(1991-11#1)(1992-4#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#2)(2010-5#1)(2010-6#1)(2012-12#1)
database from##2##2##(1994-12#1)(2008-10#1)
database has##3##2##(1995-3#1)(2008-2#1)(2010-8#1)
database homology search##2##3##(2008-10#1)(2008-5#1)
database in##3##2##(2008-11#1)(2010-5#2)
database is presented##2##3##(2008-4#1)(2008-7#1)
database is##11##2##(1991-12#1)(1991-3#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#2)(2012-3#1)
database management software##3##3##(1991-3#1)(1992-3#2)
database management system##4##3##(2008-2#1)(2008-7#2)(2008-9#1)
database management##11##2##(1991-3#2)(1992-3#3)(2008-2#1)(2008-7#2)(2008-9#2)(2010-8#1)
database matching##3##2##(1991-6#1)(2008-4#2)
database model for##2##3##(1996-2#2)
database of all##2##3##(2008-4#2)
database of natural##2##3##(2008-6#1)(2009-2#1)
database of nearly##2##3##(1997-5#1)(2008-6#1)
database of published##2##3##(1997-1#1)(2008-7#1)
database of the##4##3##(2008-7#2)(2011-2#1)(2012-2#1)
database of##34##2##(1992-3#1)(1993-8#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#5)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#2)
database on##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
database primitives##2##2##(2008-3#2)
database processing##2##2##(2008-3#2)
database provides##2##2##(2007-12#1)(2008-7#1)
database scanning##2##2##(2009-3#2)
database search program##2##3##(2008-4#2)
database search revealed that##2##4##(1992-3#1)(1996-10#1)
database search##6##2##(1992-3#1)(1996-10#1)(2008-4#2)(2008-7#1)(2013-1#1)
database searches##4##2##(2008-10#1)(2008-4#2)(2013-1#1)
database searching##3##2##(1995-1#1)(2008-11#1)(2008-4#1)
database skills##2##2##(2007-12#2)
database structure##2##2##(2008-7#1)(2012-1#1)
database system##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2011-3#2)
database systems##2##2##(2008-4#1)(2010-12#1)
database that provides##2##3##(2008-10#1)(2008-9#1)
database that##11##2##(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#2)(2012-3#1)
database to##10##2##(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
database using##2##2##(2008-1#1)(2008-10#1)
database was established##2##3##(2008-11#1)(2008-8#1)
database was retrospectively##2##3##(2012-1#1)(2012-3#1)
database was used to##2##4##(2008-9#1)(2012-12#1)
database was##12##2##(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
database were##3##2##(1996-10#1)(2008-7#1)(2012-12#1)
database##412##1##(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#7)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#2)(1993-1#4)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#5)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-10#2)(1996-2#3)(1996-3#7)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#25)(2008-11#18)(2008-12#11)(2008-2#4)(2008-3#18)(2008-4#43)(2008-5#2)(2008-6#6)(2008-7#56)(2008-8#10)(2008-9#19)(2009-10#6)(2009-2#5)(2009-3#2)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#11)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#2)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#7)(2013-1#12)(2013-7#1)
database) to##2##2##(2008-2#2)
database)##3##1##(2008-2#2)(2008-4#1)
databases and reference lists##4##4##(2008-10#1)(2012-12#3)
databases and the##2##3##(1997-1#1)(2011-4#1)
databases and to##2##3##(2008-10#1)(2010-5#1)
databases and##21##2##(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-4#1)(2012-12#3)(2013-8#1)
databases are##12##2##(1996-3#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#1)(2008-8#1)
databases available##2##2##(2008-7#1)(2013-8#1)
databases for biological##2##3##(2008-4#1)(2008-9#1)
databases for the##2##3##(1994-3#1)(2012-2#1)
databases for##11##2##(1994-3#1)(2008-1#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
databases has##2##2##(2008-7#1)(2009-6#1)
databases have become##3##3##(2008-2#1)(2008-4#1)(2008-7#1)
databases have##4##2##(2008-2#1)(2008-4#1)(2008-7#2)
databases in order to##2##4##(2008-11#1)(2008-4#1)
databases in##7##2##(1991-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)
databases indicated##4##2##(1995-8#1)(1996-10#1)(1996-2#1)(2008-5#1)
databases is##3##2##(2008-2#1)(2008-4#2)
databases of##8##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#2)
databases on the##4##3##(2008-2#2)(2008-4#2)
databases on##6##2##(1997-3#1)(2008-2#2)(2008-4#2)(2012-3#1)
databases revealed that##2##3##(1995-6#1)(2010-4#1)
databases such as##2##3##(2008-4#1)(2011-2#1)
databases that contain##2##3##(2008-3#1)(2009-10#1)
databases that##3##2##(2008-3#1)(2009-10#1)(2013-8#1)
databases to identify##3##3##(2007-12#1)(2009-3#1)(2012-12#1)
databases to improve the##2##4##(2008-4#1)(2010-8#1)
databases to##10##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)
databases using##2##2##(2008-4#1)(2013-1#1)
databases was##2##2##(2008-12#1)(2013-1#1)
databases were searched for##7##4##(1994-3#1)(2008-10#1)(2009-10#1)(2009-7#2)(2012-3#2)
databases were searched##8##3##(1994-3#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-7#2)(2012-3#2)
databases were##16##2##(1994-3#1)(1996-6#1)(2008-10#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-7#2)(2011-2#1)(2012-3#2)(2013-1#2)
databases with##2##2##(1991-12#1)(2008-9#1)
databases##260##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1993-2#1)(1994-3#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#7)(1996-6#3)(1996-8#1)(1997-1#5)(1997-2#1)(1997-3#6)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#13)(2008-11#9)(2008-12#2)(2008-2#12)(2008-3#5)(2008-4#37)(2008-5#3)(2008-6#4)(2008-7#27)(2008-8#3)(2008-9#8)(2009-10#9)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#9)(2011-4#1)(2012-12#10)(2012-2#2)(2012-3#5)(2013-1#11)(2013-8#8)
datafiles##3##1##(1995-12#3)
dataset and##3##2##(2008-4#1)(2008-7#1)(2010-7#1)
dataset containing##2##2##(2009-8#2)
dataset for##3##2##(2008-11#1)(2008-7#1)(2009-4#1)
dataset from##2##2##(2008-12#1)(2008-8#1)
dataset in##4##2##(2008-7#1)(2010-8#2)(2012-3#1)
dataset of##6##2##(1991-11#1)(1996-12#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
dataset to##2##2##(2008-4#1)(2012-3#1)
dataset was##3##2##(2008-3#1)(2010-5#1)(2010-8#1)
dataset with##2##2##(2010-11#1)(2012-2#1)
dataset##48##1##(1991-11#1)(1994-11#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#5)(2008-8#3)(2009-4#1)(2009-8#2)(2010-11#1)(2010-3#2)(2010-5#3)(2010-7#4)(2010-8#4)(2011-1#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
datasets are##3##2##(2008-7#2)(2012-12#1)
datasets from##4##2##(2008-6#2)(2008-8#1)(2010-5#1)
datasets that have##2##3##(2012-2#1)(2013-1#1)
datasets to##2##2##(2008-3#1)(2011-2#1)
datasets with##4##2##(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)
datasets##55##1##(1995-3#2)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#1)
date a##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
date and country of publication##12##5##(2007-8#12)
date and##20##2##(1991-6#1)(1994-6#1)(2007-8#12)(2008-10#2)(2008-7#2)(2008-9#1)(2009-6#1)
date back to the##2##4##(1993-3#1)(2008-5#1)
date back to##3##3##(1993-3#1)(2008-5#1)(2012-3#1)
date for the##36##3##(1996-1#1)(2011-1#15)(2011-2#10)(2012-1#10)
date for##41##2##(1996-1#1)(2007-11#1)(2008-10#1)(2009-12#1)(2010-8#1)(2011-1#15)(2011-2#10)(2012-1#10)(2012-12#1)
date from##7##2##(1993-11#1)(1997-5#1)(2008-10#3)(2008-2#2)
date in the##2##3##(2008-10#1)(2008-2#1)
date in##11##2##(1990-9#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
date most studies have##2##4##(2008-7#1)(2011-2#1)
date most##5##2##(1992-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
date no##3##2##(2008-12#1)(2008-5#1)(2009-2#1)
date of birth and##2##4##(1990-9#2)
date of first##4##3##(1990-8#1)(1991-11#1)(2008-12#1)(2008-7#1)
date of infection##2##3##(1992-9#1)(2008-10#1)
date of inoculation##2##3##(2008-10#2)
date of sowing##2##3##(2008-10#2)
date of the##5##3##(1990-9#1)(1997-5#1)(2008-10#1)(2013-1#2)
date of##38##2##(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1992-9#1)(1994-7#1)(1996-3#1)(1997-5#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#5)
date on##7##2##(2007-11#1)(2008-10#4)(2008-4#1)(2012-2#1)
date palm (Phoenix dactylifera L##2##5##(2008-10#1)(2013-1#1)
date palm (Phoenix##3##3##(2008-10#2)(2013-1#1)
date that##2##2##(1992-2#1)(2010-8#1)
date the##4##2##(2008-10#2)(2010-7#1)(2013-8#1)
date there has been##3##4##(1992-1#1)(2008-8#1)(2008-9#1)
date there have been no##3##5##(2007-8#1)(2008-7#1)(2010-12#1)
date there##8##2##(1992-1#1)(1992-2#1)(2007-8#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
date to##3##2##(1995-2#1)(1996-1#1)(2008-9#1)
date with##2##2##(2008-7#1)(2011-2#1)
date##415##1##(1990-11#3)(1990-12#1)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#4)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-6#2)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#2)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#5)(2007-7#2)(2007-8#16)(2008-1#8)(2008-10#78)(2008-11#9)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#21)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#18)(2011-2#30)(2011-7#1)(2012-1#13)(2012-12#6)(2012-2#8)(2012-3#10)(2012-8#1)(2013-1#13)(2013-7#2)(2013-8#2)
date)##3##1##(1993-9#1)(2013-1#2)
dated##8##1##(1992-3#1)(1994-12#1)(1997-5#1)(2007-6#1)(2008-10#2)(2010-8#1)(2013-8#1)
dates and##2##2##(1991-11#1)(2008-10#1)
dates back to the##4##4##(2006-12#1)(2008-6#1)(2009-7#1)(2011-2#1)
dates back to##6##3##(2006-12#1)(2008-12#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-8#1)
dates back##7##2##(2006-12#1)(2008-12#1)(2008-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
dates in##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
dates of##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)
dates was##2##2##(2008-10#2)
dates were##3##2##(2007-5#1)(2008-10#1)(2010-3#1)
dates##41##1##(1991-11#1)(1996-12#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#19)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#3)(2013-8#2)
dating back to the##3##4##(2008-10#1)(2009-10#1)(2009-8#1)
dating back to##4##3##(2008-10#1)(2009-10#1)(2009-8#1)(2010-5#1)
dating for##2##2##(2008-10#2)
dating of##2##2##(1994-9#1)(2008-10#1)
dating violence##2##2##(2009-7#2)
dating##22##1##(1994-9#1)(1997-3#1)(2007-5#1)(2008-10#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#1)
dauci and A##2##3##(2008-10#2)
dauci##7##1##(2008-10#7)
daughter and##2##2##(1991-12#1)(1995-9#1)
daughter cell##4##2##(1995-6#1)(1995-9#1)(2009-12#1)(2009-8#1)
daughter cells that##2##3##(1990-11#1)(2010-10#1)
daughter cells##11##2##(1990-11#2)(1995-9#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)
daughter chromosomes##2##2##(1994-6#2)
daughter##34##1##(1990-11#2)(1991-12#1)(1991-3#1)(1994-11#1)(1994-6#2)(1995-12#1)(1995-6#1)(1995-9#3)(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-8#1)(2010-10#1)
daughters##18##1##(1992-4#1)(1993-12#1)(1995-1#1)(1995-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#7)(2011-2#1)(2012-3#1)
daunomycin and##2##2##(2008-10#1)(2008-7#1)
daunomycin##17##1##(1990-2#2)(1994-12#2)(2008-10#8)(2008-11#1)(2008-7#4)
daunorubicin and##4##2##(1994-5#1)(2007-4#2)(2011-2#1)
daunorubicin##16##1##(1991-2#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-5#2)(1997-4#3)(2007-4#3)(2008-5#1)(2011-2#2)
daunorubicin-resistant AML-2 sublines##3##3##(1997-4#3)
daunorubicin-resistant##5##1##(1997-4#5)
daunting challenges##2##2##(2008-9#1)(2011-2#1)
daunting##9##1##(1995-1#1)(1995-3#1)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#3)
daw mutants##2##2##(2008-9#2)
dawn of a new era##3##5##(2008-7#1)(2009-5#1)(2011-2#1)
dawn of##8##2##(1991-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-7#1)
dawn##9##1##(1991-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-7#1)
day 0 to##3##3##(2008-10#1)(2010-7#2)
day 0##9##2##(1991-8#1)(1996-12#1)(2008-10#4)(2008-4#1)(2010-7#2)
day 1 and##3##3##(1991-5#1)(2007-10#1)(2010-6#1)
day 1##34##2##(1990-11#1)(1990-2#2)(1991-4#1)(1991-5#1)(1991-8#2)(1995-11#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#3)(2007-10#5)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#2)(2012-2#1)(2013-1#1)
day 10 to##2##3##(1993-6#2)
day 10##13##2##(1993-6#3)(1994-2#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-7#1)(2013-1#1)
day 100##4##2##(1991-5#1)(2008-10#2)(2010-2#1)
day 11##10##2##(1991-8#1)(1994-6#1)(1995-2#2)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2009-6#1)(2010-10#1)
day 12 of##2##3##(1992-5#1)(1994-12#1)
day 12##8##2##(1990-5#1)(1992-5#1)(1994-12#1)(1995-12#2)(2008-1#1)(2008-10#1)(2008-7#1)
day 125##3##2##(1990-5#1)(2008-10#2)
day 14 after##2##3##(2006-6#1)(2011-2#1)
day 14##12##2##(1991-8#1)(1993-12#1)(1996-5#1)(1997-3#1)(2006-6#2)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#2)(2011-2#1)
day 15 and##2##3##(1992-12#1)(2011-2#1)
day 15##8##2##(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-6#1)(2011-2#2)
day 16##7##2##(1993-12#1)(1993-6#2)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
day 17##6##2##(1995-12#1)(1996-5#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-2#1)
day 18##9##2##(1991-9#1)(1993-3#1)(1993-6#2)(2008-10#3)(2008-11#1)(2008-9#1)
day 2 and##3##3##(1992-3#1)(1994-8#1)(2012-12#1)
day 2 to day##3##4##(2008-7#1)(2008-8#1)(2010-7#1)
day 2##14##2##(1991-4#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#2)(2012-12#1)
day 20##10##2##(1993-12#1)(1995-12#3)(1996-12#2)(2008-10#1)(2010-4#1)(2011-1#1)(2012-3#1)
day 21 and##2##3##(1996-12#1)(2008-11#1)
day 21##9##2##(1995-11#1)(1996-12#2)(1996-5#2)(2006-6#1)(2008-11#1)(2008-5#1)(2012-3#1)
day 22##2##2##(2008-10#1)(2013-8#1)
day 28##7##2##(1996-5#1)(2008-5#1)(2008-7#4)(2013-1#1)
day 3 after##2##3##(2007-12#1)(2007-8#1)
day 3 to day##2##4##(1997-4#1)(2011-2#1)
day 3##24##2##(1991-5#1)(1992-3#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-8#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-10#2)(2011-2#2)
day 35##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
day 4 in##2##3##(1994-5#1)(2012-3#1)
day 4 of##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
day 4##16##2##(1992-6#1)(1993-9#1)(1994-5#2)(1995-11#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-9#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
day 40##4##2##(1993-12#1)(2008-10#1)(2008-7#2)
day 42##3##2##(1996-5#2)(2008-7#1)
day 5 after##2##3##(2008-11#1)(2008-7#1)
day 5 of##5##3##(1992-5#2)(1995-12#1)(1997-6#2)
day 5##16##2##(1992-5#2)(1994-2#2)(1995-12#1)(1995-2#2)(1997-6#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#1)
day 50##4##2##(1995-12#1)(2006-6#1)(2008-10#2)
day 6 of##4##3##(1993-8#1)(1994-6#1)(1995-2#1)(2008-11#1)
day 6##12##2##(1991-5#1)(1993-8#1)(1994-6#1)(1995-2#2)(1997-4#1)(2007-3#1)(2008-11#1)(2010-2#1)(2010-7#2)(2012-12#1)
day 7 and day##2##4##(1995-12#1)(2007-8#1)
day 7 and##4##3##(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#1)
day 7##20##2##(1992-11#1)(1994-5#2)(1994-8#1)(1995-12#1)(1996-12#2)(1996-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-8#1)
day 8 and##2##3##(2010-10#1)(2011-2#1)
day 8 of gestation##2##4##(1993-12#2)
day 8##11##2##(1993-12#2)(1995-2#1)(2008-12#2)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#2)
day 84##2##2##(2008-10#2)
day 9 bovine embryos##2##4##(1991-2#2)
day 9##3##2##(1991-2#2)(2013-1#1)
day 91 after sowing##2##4##(2008-12#2)
day after an##2##3##(1994-2#1)(2007-8#1)
day after surgery##2##3##(2007-8#2)
day after the operation##2##4##(2007-10#1)(2012-3#1)
day after the##5##3##(2007-10#1)(2007-12#1)(2008-10#1)(2012-3#2)
day after##28##2##(1990-12#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)
day and night sample##2##4##(2008-10#2)
day and night##9##3##(2008-10#4)(2008-2#2)(2010-2#1)(2011-2#2)
day and##39##2##(1990-12#1)(1990-8#1)(1991-1#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-8#1)(2007-10#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-2#4)(2013-8#1)
day are##2##2##(2008-10#1)(2008-3#1)
day as##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
day at##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
day before the##3##3##(1992-6#1)(2007-8#1)(2009-12#1)
day before##16##2##(1992-6#1)(1994-7#2)(1996-3#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-8#3)(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)
day by day##2##3##(1990-12#1)(2011-2#1)
day by##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
day can##2##2##(2008-11#1)(2008-7#1)
day care centers##2##3##(1992-1#1)(2011-1#1)
day care program##2##3##(1994-3#1)(2008-6#1)
day care##32##2##(1991-1#2)(1992-1#4)(1992-3#1)(1994-3#3)(1994-6#7)(1995-1#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-5#1)(2007-3#3)(2008-6#2)(2010-3#1)(2011-1#1)(2012-3#1)
day during##2##2##(2008-10#1)(2010-12#1)
day for 3 days##3##4##(1996-2#1)(2007-8#1)(2008-5#1)
day for 3##4##3##(1996-2#1)(2007-8#1)(2008-5#1)(2012-3#1)
day for 5 days##2##4##(2008-12#1)(2008-7#1)
day for 5##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
day for 7##2##3##(1995-3#1)(2008-5#1)
day for the##2##3##(1995-9#1)(2008-3#1)
day for two##3##3##(1994-12#1)(1994-6#1)(2008-7#1)
day for##33##2##(1990-2#1)(1990-9#2)(1992-3#2)(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#2)(1995-9#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#3)(2009-3#1)(2012-3#1)(2013-1#2)
day from##3##2##(1990-2#2)(1993-11#1)
day hospital for rehabilitation##2##4##(2008-7#2)
day hospital##8##2##(1993-2#2)(2008-7#6)
day in a##2##3##(1997-7#1)(2011-1#1)
day in the##4##3##(1997-6#1)(2008-10#1)(2009-10#1)(2013-8#1)
day in##18##2##(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-6#2)(2011-1#2)(2012-12#1)(2013-8#1)
day is##3##2##(1990-11#1)(2008-10#1)(2013-8#1)
day length##4##2##(2008-8#2)(2011-2#2)
day lengths##2##2##(2008-10#1)(2008-8#1)
day of admission##2##3##(1992-6#1)(2009-12#1)
day of hospitalization##3##3##(2008-12#1)(2013-1#2)
day of life##13##3##(1990-12#1)(1991-2#1)(1993-12#3)(2008-10#2)(2011-1#2)(2011-2#2)(2012-3#2)
day of pregnancy##2##3##(1990-5#1)(1992-5#1)
day of storage##2##3##(2008-10#2)
day of surgery##7##3##(1997-7#1)(2008-8#3)(2012-2#3)
day of the first##2##4##(2008-10#1)(2008-12#1)
day of the##12##3##(1994-7#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-1#2)
day of treatment##5##3##(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-4#1)
day of##96##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-12#7)(1994-3#2)(1994-6#1)(1994-7#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-7#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-8#2)(2008-10#13)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)
day old chicken##2##3##(1992-3#1)(2008-12#1)
day old##11##2##(1992-3#1)(1996-12#1)(1997-3#1)(2007-6#1)(2008-10#1)(2008-12#3)(2008-8#2)(2009-3#1)
day old)##2##2##(2011-2#2)
day on##5##2##(1992-3#1)(1993-12#1)(1995-3#1)(2008-10#1)(2013-8#1)
day or##4##2##(1991-9#1)(1995-12#1)(2008-10#1)(2008-12#1)
day period##2##2##(2008-10#1)(2008-12#1)
day post-infection##2##2##(2008-5#1)(2008-7#1)
day postinoculation##2##2##(2008-10#2)
day prior##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
day procedure##2##2##(1995-12#1)(2007-11#1)
day programs##4##2##(1993-2#2)(1995-1#1)(2013-1#1)
day resulted in##2##3##(2008-10#1)(2009-9#1)
day resulted##3##2##(2008-10#1)(2009-9#1)(2013-1#1)
day shift workers##2##3##(2011-2#2)
day shifts##5##2##(2010-6#4)(2011-2#1)
day surgery##12##2##(1990-2#2)(1995-1#3)(1995-2#1)(1996-3#1)(2007-9#1)(2009-2#1)(2009-3#2)(2012-3#1)
day ten##2##2##(1992-3#1)(2008-5#1)
day that##2##2##(1993-1#1)(2008-10#1)
day the##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
day three##2##2##(1997-3#1)(2007-9#1)
day to day##5##3##(1993-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
day to the##2##3##(2008-3#1)(2012-2#1)
day to##15##2##(1991-2#1)(1991-3#1)(1993-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)(2012-3#1)(2013-8#1)
day was##11##2##(1992-1#1)(1994-6#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
day were##5##2##(1990-2#1)(1991-11#1)(1992-5#1)(1997-2#1)(2008-10#1)
day when##2##2##(1997-1#1)(2012-2#1)
day with##6##2##(1990-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
day##1062##1##(1990-11#3)(1990-12#7)(1990-2#11)(1990-5#6)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#5)(1991-6#3)(1991-8#6)(1991-9#4)(1992-1#7)(1992-11#3)(1992-12#1)(1992-3#16)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#24)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#8)(1993-8#4)(1993-9#2)(1994-12#4)(1994-2#16)(1994-3#10)(1994-5#4)(1994-6#16)(1994-7#3)(1994-8#6)(1994-9#1)(1995-1#6)(1995-11#4)(1995-12#16)(1995-2#9)(1995-3#15)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#15)(1996-2#3)(1996-3#4)(1996-5#15)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#4)(1997-5#3)(1997-6#10)(1997-7#5)(2006-12#1)(2006-4#1)(2006-6#5)(2007-10#14)(2007-11#9)(2007-12#25)(2007-2#6)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#16)(2007-9#4)(2008-1#7)(2008-10#118)(2008-11#38)(2008-12#35)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#31)(2008-6#3)(2008-7#56)(2008-8#30)(2008-9#11)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#7)(2010-12#11)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#14)(2010-7#13)(2010-8#10)(2010-9#1)(2011-1#17)(2011-2#42)(2011-9#1)(2012-1#1)(2012-12#10)(2012-2#17)(2012-3#24)(2012-5#1)(2012-8#1)(2013-1#32)(2013-7#3)(2013-8#22)
day's##4##1##(2008-10#1)(2008-5#1)(2009-7#1)(2013-8#1)
day(-1) for##3##2##(2008-12#3)
day(-1)##22##1##(2008-10#3)(2008-11#11)(2008-12#3)(2010-8#4)(2013-8#1)
day(-1)) was##3##2##(2008-10#1)(2010-5#2)
day(-1))##10##1##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#2)(2010-7#1)(2012-2#1)(2013-8#1)
day) and the##2##3##(1993-12#1)(2011-1#1)
day) and##4##2##(1992-10#1)(1993-12#1)(2011-1#1)(2011-2#1)
day) as##2##2##(1992-12#1)(2011-2#1)
day) of##2##2##(1993-12#1)(1994-2#1)
day) to##2##2##(1992-12#1)(2008-12#1)
day) was##2##2##(1995-5#1)(2008-10#1)
day)##37##1##(1992-10#2)(1992-11#1)(1992-12#2)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#3)(1995-12#1)(1995-2#1)(1995-5#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#3)(2009-12#1)(2010-6#1)(2011-1#4)(2011-2#3)(2013-1#1)(2013-7#1)
day-1##4##1##(1995-12#1)(2008-5#3)
day-night changes##2##2##(1995-11#1)(2008-5#1)
day-night##4##1##(1990-7#2)(1995-11#1)(2008-5#1)
day-old##4##1##(1991-9#1)(1992-8#1)(1997-6#1)(2010-4#1)
day-time##2##1##(1990-7#2)
day-to-day care and##2##3##(1995-1#1)(2008-12#1)
day-to-day operations##3##2##(1997-1#2)(1997-2#1)
day-to-day work##2##2##(1994-3#1)(2007-10#1)
day-to-day##20##1##(1994-3#1)(1995-1#1)(1995-3#1)(1997-1#2)(1997-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
day/night care##2##2##(1995-12#2)
day]##2##1##(1990-11#1)(1993-3#1)
daycare centres##2##2##(2007-12#2)
daycare##5##1##(2007-12#3)(2008-11#1)(2010-6#1)
daylength##2##1##(2008-5#1)(2009-8#1)
daylight and skylight##3##3##(2008-3#3)
daylight and##5##2##(2008-3#5)
daylight spectral##2##2##(2008-2#2)
daylight##15##1##(1997-4#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#6)
days (7##2##2##(2008-12#1)(2011-2#1)
days (Group##2##2##(2010-12#2)
days (P &lt##2##3##(1994-3#1)(2009-11#1)
days (P##3##2##(1994-3#1)(2007-10#1)(2009-11#1)
days (P)##2##2##(1996-5#1)(2008-10#1)
days (P=##3##2##(2010-6#3)
days (median##2##2##(1994-2#2)
days (range##9##2##(1990-12#2)(2007-7#1)(2007-8#2)(2011-2#2)(2012-3#1)(2013-8#1)
days 0 and##3##3##(1997-6#1)(2008-10#2)
days 0##9##2##(1995-12#2)(1997-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)
days 1 and##6##3##(1990-2#1)(1993-12#1)(1994-7#1)(2008-10#1)(2009-11#1)(2010-6#1)
days 1##17##2##(1990-2#2)(1991-2#1)(1991-4#1)(1991-8#1)(1993-12#1)(1994-7#1)(2007-10#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-12#1)(2010-6#2)(2012-2#1)(2013-1#1)
days 1-2)##2##2##(1991-6#1)(2008-6#1)
days 1-3##3##2##(1990-2#2)(2008-6#1)
days 1-4)##2##2##(2008-6#2)
days 11-15##2##2##(1993-12#2)
days 12##3##2##(1990-5#1)(1995-12#1)(1996-12#1)
days 14 and 21##6##4##(2008-5#6)
days 14 and##7##3##(2008-10#1)(2008-5#6)
days 14##8##2##(1990-5#1)(2008-10#1)(2008-5#6)
days 15##3##2##(1993-11#1)(1993-12#2)
days 17##2##2##(1996-5#1)(2009-4#1)
days 4##4##2##(1994-5#1)(2008-11#1)(2008-5#1)(2010-7#1)
days 6##2##2##(2008-10#2)
days 7##4##2##(2006-6#1)(2008-7#2)(2011-2#1)
days a##7##2##(1995-2#1)(1995-5#1)(1997-2#1)(2007-8#1)(2008-9#2)(2013-1#1)
days across trials##2##3##(2008-10#2)
days after NGF gene transfection in##2##6##(1996-12#1)(1996-2#1)
days after a##4##3##(1996-5#1)(2008-8#2)(2010-12#1)
days after addition##2##3##(2008-10#1)(2008-11#1)
days after administration##2##3##(1995-3#1)(2008-10#1)
days after admission chest CT showed##2##6##(2013-1#2)
days after admission##5##3##(2008-6#1)(2009-3#1)(2013-1#2)(2013-8#1)
days after an##2##3##(1991-3#1)(2012-1#1)
days after anthesis##6##3##(2008-10#3)(2008-12#2)(2008-9#1)
days after birth##9##3##(1990-7#1)(1992-4#1)(1993-3#1)(1995-12#1)(1996-5#3)(2007-8#1)(2008-4#1)
days after birth)##3##3##(1992-2#1)(1995-12#2)
days after budbreak##2##3##(2008-10#2)
days after emergence##2##3##(2008-10#2)
days after implantation##2##3##(1990-8#1)(2008-10#1)
days after infection##2##3##(1992-8#1)(2008-10#1)
days after injection of##3##4##(1995-12#1)(1997-6#1)(2008-8#1)
days after injury##2##3##(2009-3#1)(2013-1#1)
days after inoculation and##2##4##(2008-10#2)
days after inoculation on##2##4##(2008-10#2)
days after inoculation with the pathogen##3##6##(2008-10#3)
days after inoculation with the##4##5##(2008-10#4)
days after inoculation with##6##4##(2008-10#6)
days after inoculation##47##3##(2008-10#45)(2008-5#1)(2008-8#1)
days after inoculation) were##2##4##(2008-10#2)
days after inoculation)##3##3##(2008-10#3)
days after onset##2##3##(1995-5#1)(2008-5#1)
days after operation##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
days after oviposition##4##3##(2007-12#4)
days after partial##2##3##(1990-12#1)(1996-2#1)
days after parturition##2##3##(2008-10#1)(2013-8#1)
days after placement##2##3##(2007-7#1)(2008-10#1)
days after planting##7##3##(2008-10#7)
days after pollination##4##3##(2008-10#4)
days after spraying##2##3##(2008-10#2)
days after surgery##9##3##(2007-8#3)(2010-10#1)(2011-2#3)(2012-1#1)(2012-12#1)
days after surgical##2##3##(1990-2#1)(1993-5#1)
days after the first##4##4##(1996-9#1)(2008-7#1)(2010-12#1)(2013-1#1)
days after the initial##2##4##(2009-3#1)(2013-7#1)
days after the last##6##4##(1990-7#1)(1991-9#1)(1993-12#1)(1995-12#1)(1996-12#1)(2010-12#1)
days after the onset of immunization##2##6##(2008-10#2)
days after the onset##3##4##(2008-10#2)(2010-4#1)
days after the operation##3##4##(1990-9#1)(2007-10#1)(2007-11#1)
days after the start of insulin therapy##2##7##(1993-12#2)
days after the start of##3##5##(1993-12#2)(2007-12#1)
days after the##45##3##(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#3)(1994-9#1)(1995-11#4)(1995-12#1)(1995-8#1)(1996-12#3)(1996-9#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
days after their##2##3##(1992-5#1)(2011-2#1)
days after transplantation##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
days after treatment##9##3##(1990-10#2)(1992-1#2)(2008-10#4)(2011-2#1)
days after##270##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#6)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#4)(1996-2#3)(1996-5#6)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#4)(2007-11#2)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#100)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-3#4)(2009-4#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#3)
days aged meat##2##3##(2010-4#2)
days aged##3##2##(2010-4#3)
days and 3##2##3##(1996-5#1)(2008-5#1)
days and a##2##3##(1993-9#1)(2011-2#1)
days and at##2##3##(1996-2#1)(2010-4#1)
days and in##2##3##(1992-5#1)(1994-7#1)
days and the##7##3##(1991-5#1)(1991-6#1)(1993-12#1)(1995-3#1)(2007-7#1)(2011-2#1)(2012-2#1)
days and then##8##3##(1991-2#1)(1996-5#1)(2008-10#3)(2008-11#2)(2010-3#1)
days and was##3##3##(1997-3#1)(2008-11#1)(2010-5#1)
days and when##2##3##(1992-2#1)(1994-3#1)
days and with##2##3##(2007-8#1)(2008-10#1)
days and##91##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#3)(1994-7#1)(1995-3#2)(1996-2#2)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#14)(2008-11#8)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
days as##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
days at 20 degrees C##3##5##(2008-10#2)(2008-12#1)
days at 5 degrees C##2##5##(2008-10#2)
days at a dose of##2##5##(1994-3#1)(2008-11#1)
days at a##3##3##(1994-3#1)(2008-11#2)
days at room temperature##3##4##(1992-9#1)(2008-10#1)(2008-6#1)
days at##33##2##(1992-3#2)(1992-9#1)(1994-3#1)(1995-8#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-5#4)(2008-6#1)(2012-2#1)
days before and after##2##4##(2008-10#1)(2013-8#1)
days before and##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
days before the onset of##2##5##(2007-12#2)
days before the##4##3##(1995-3#1)(2007-12#2)(2008-10#1)
days before##27##2##(1990-10#1)(1991-8#1)(1993-1#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-6#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-5#1)(2009-6#1)(2010-2#2)(2010-8#1)(2011-2#3)(2013-8#1)
days between##2##2##(2008-3#1)(2012-2#1)
days but##2##2##(2008-5#1)(2011-2#1)
days by##4##2##(1992-4#1)(2008-10#2)(2008-12#1)
days caused##2##2##(1992-9#1)(2008-3#1)
days compared##2##2##(2008-11#1)(2013-8#1)
days decreased##2##2##(1990-12#1)(1997-2#1)
days during the first 2 weeks##2##6##(2008-10#2)
days during the##3##3##(2007-11#1)(2008-10#2)
days during##7##2##(1990-12#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
days each week##2##3##(2011-2#1)(2012-12#1)
days every##4##2##(1991-11#1)(1992-8#1)(2007-7#1)(2008-6#1)
days exposure##2##2##(1991-12#1)(2008-12#1)
days followed by a##2##4##(1992-10#1)(2008-5#1)
days followed by##5##3##(1991-11#1)(1992-10#1)(1996-6#1)(2008-10#1)(2008-5#1)
days followed##6##2##(1991-11#1)(1992-10#1)(1996-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
days following inoculation##3##3##(2008-10#2)(2008-5#1)
days following sun exposure##2##4##(2008-5#2)
days following the##2##3##(1996-12#1)(2008-3#1)
days following treatment##2##3##(1992-5#1)(2012-2#1)
days following##16##2##(1991-9#1)(1992-5#1)(1993-12#1)(1996-12#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-2#1)
days for the period from##2##5##(2008-2#2)
days for the##4##3##(1997-4#1)(2008-2#2)(2008-4#1)
days for##26##2##(1991-3#1)(1991-5#1)(1997-4#2)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2011-1#1)(2013-1#2)
days from the##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
days from##8##2##(1990-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
days have##2##2##(2008-10#1)(2013-1#1)
days in a##3##3##(1994-6#1)(1995-3#1)(2013-1#1)
days in all models##2##4##(2007-10#2)
days in culture##4##3##(1995-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
days in the##14##3##(1995-2#1)(1995-5#1)(1995-8#1)(2007-10#3)(2008-10#3)(2008-11#1)(2008-5#2)(2013-1#1)(2013-8#1)
days in vitro##3##3##(1996-5#2)(2012-2#1)
days in vitro)##2##3##(1994-6#1)(2008-11#1)
days in##70##2##(1990-3#1)(1991-8#1)(1992-2#1)(1993-3#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-10#12)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-5#4)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
days increased##3##2##(1991-9#1)(1993-3#1)(1995-8#1)
days incubation##2##2##(2009-7#1)(2010-5#1)
days into the##2##3##(2008-10#1)(2008-6#1)
days is##2##2##(2008-10#1)(2010-12#1)
days later as##2##3##(2008-10#1)(2008-5#1)
days later##37##2##(1991-2#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-9#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#2)(2010-7#1)(2012-3#2)(2012-8#1)(2013-1#1)(2013-8#1)
days of administration of 1000 mg/kg per day##3##8##(1995-3#3)
days of administration of##4##4##(1995-3#4)
days of administration##6##3##(1995-3#5)(2006-10#1)
days of age and##2##4##(1997-6#1)(2012-2#1)
days of age in##2##4##(2007-6#2)
days of age##22##3##(1996-2#1)(1996-5#2)(1997-6#3)(2006-5#2)(2007-6#2)(2008-12#2)(2008-5#2)(2008-8#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-1#2)
days of age)##2##3##(2010-2#2)
days of care##2##3##(1991-1#1)(1992-3#1)
days of cell isolation##2##4##(2008-11#2)
days of cultivation##2##3##(2008-11#2)
days of culture##9##3##(1993-6#1)(1995-3#1)(2008-11#3)(2008-8#1)(2010-11#3)
days of discharge##2##3##(2007-10#1)(2012-12#1)
days of each##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
days of exposure at##2##4##(1997-4#1)(2008-12#1)
days of exposure to##4##4##(1992-11#1)(2008-10#2)(2010-8#1)
days of exposure##15##3##(1991-9#1)(1992-11#1)(1995-3#2)(1997-4#1)(2008-10#4)(2008-12#3)(2008-6#1)(2008-9#1)(2010-8#1)
days of gestation##4##3##(1991-3#1)(1995-5#1)(2010-2#1)(2013-1#1)
days of incubation##7##3##(2008-10#2)(2008-11#4)(2008-5#1)
days of inoculation##2##3##(2008-10#2)
days of life##4##3##(1992-5#1)(1997-3#1)(2008-7#1)(2011-2#1)
days of short acting beta agonist use##2##7##(2012-1#2)
days of storage in##2##4##(2008-10#1)(2008-5#1)
days of storage##5##3##(1997-4#1)(2008-10#1)(2008-5#1)(2012-2#2)
days of the##15##3##(1993-11#2)(1995-12#1)(1995-6#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-7#1)
days of therapy##3##3##(1991-2#1)(1994-6#1)(2008-5#1)
days of this##2##3##(1992-6#1)(1993-2#1)
days of treatment##14##3##(1990-6#1)(1990-9#1)(1992-10#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)
days of use##3##3##(2008-10#2)(2011-1#1)
days of##197##2##(1990-6#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#9)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#5)(2006-10#1)(2006-5#2)(2007-10#5)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#26)(2008-11#15)(2008-12#8)(2008-2#1)(2008-3#2)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#2)(2010-8#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
days old##10##2##(1992-11#1)(1996-2#1)(1997-6#3)(2008-10#3)(2008-12#2)
days old)##6##2##(1992-11#2)(2008-10#3)(2010-4#1)
days on a##2##3##(1993-3#2)
days on average)##2##3##(2011-2#2)
days on the surface of##2##5##(2007-6#1)(2008-10#1)
days on which##5##3##(2008-3#1)(2009-7#4)
days on##21##2##(1993-3#2)(1996-11#1)(2007-12#2)(2007-6#2)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#1)(2009-7#4)(2011-2#2)(2013-1#1)
days or less##2##3##(1995-8#1)(2008-10#1)
days or more##2##3##(2008-10#2)
days or weeks##4##3##(1992-5#1)(1995-2#1)(2008-5#1)(2013-1#1)
days or##18##2##(1991-3#1)(1992-5#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
days per month##2##3##(2008-10#1)(2012-12#1)
days per week for 28 weeks##3##6##(2008-9#3)
days per week for##26##4##(2008-9#24)(2013-1#2)
days per week##30##3##(2008-10#1)(2008-9#25)(2013-1#4)
days per week)##2##3##(2008-5#1)(2008-7#1)
days per##35##2##(1991-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#25)(2012-12#1)(2013-1#4)
days post inoculation##3##3##(2008-10#2)(2008-5#1)
days post##13##2##(1996-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#2)(2010-8#1)(2013-8#2)
days post-MCAO##3##2##(2007-10#3)
days post-challenge##2##2##(1997-3#1)(2009-6#1)
days post-hatch (dph)##2##3##(2008-7#1)(2010-8#1)
days post-hatch##4##2##(2008-12#1)(2008-7#1)(2010-8#2)
days post-implantation##3##2##(2008-5#3)
days post-infection##2##2##(2008-11#1)(2009-6#1)
days post-infestation##2##2##(1996-12#2)
days post-injection##2##2##(1994-5#1)(2008-10#1)
days post-inoculation##6##2##(2008-5#4)(2010-10#2)
days post-stroke##2##2##(2007-10#1)(2008-7#1)
days post-transfection##3##2##(2008-11#1)(2011-2#2)
days postinfection##4##2##(2008-10#1)(2008-5#1)(2012-3#2)
days postinoculation (dpi)##3##3##(2008-10#3)
days postinoculation##10##2##(2008-10#10)
days postlesion and##2##3##(1997-3#2)
days postlesion##10##2##(1993-6#1)(1997-3#9)
days postoperatively##5##2##(1991-5#1)(1993-1#1)(2008-12#1)(2011-2#2)
days postpartum##2##2##(2007-10#1)(2008-11#1)
days posttransfusion of##2##3##(1994-9#2)
days posttransplant##2##2##(2008-10#1)(2011-2#1)
days prior to inoculation##2##4##(2008-10#2)
days prior to the##2##4##(2008-10#2)
days prior to##20##3##(1995-12#1)(1996-12#5)(2008-10#8)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)
days produced a##2##3##(1995-12#1)(2012-12#1)
days produced##3##2##(1995-12#1)(2008-10#1)(2012-12#1)
days respectively##2##2##(1990-2#1)(1996-12#1)
days resulted in##4##3##(1995-3#1)(2008-10#2)(2008-12#1)
days resulted##5##2##(1995-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
days shorter##2##2##(2006-8#1)(2008-10#1)
days showed a##2##3##(2008-7#1)(2012-3#1)
days significantly reduced the##2##4##(1993-9#1)(2012-1#1)
days significantly##3##2##(1993-9#1)(2012-1#1)(2012-2#1)
days spent in##2##3##(1990-5#1)(2013-1#1)
days than##5##2##(1996-9#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
days that##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2009-12#1)
days the##8##2##(1994-6#1)(1994-9#1)(1995-12#1)(1997-2#1)(2008-1#1)(2010-12#1)(2012-2#1)(2012-3#1)
days to 5##2##3##(2008-10#1)(2013-1#1)
days to anthesis in##2##4##(2008-10#2)
days to anthesis##4##3##(2008-10#4)
days to assess##2##3##(1997-4#1)(2008-12#1)
days to be##3##3##(2008-11#2)(2008-7#1)
days to complete##4##3##(1992-7#1)(2008-10#1)(2008-5#1)(2009-12#1)
days to##41##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-5#1)(1992-7#1)(1993-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-4#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2013-1#2)
days total exposure) produced##2##4##(2008-10#2)
days total)##2##2##(2008-10#1)(2012-3#1)
days treatment with##2##3##(1994-3#1)(1995-12#1)
days treatment##6##2##(1991-12#1)(1994-3#1)(1995-12#1)(2008-4#1)(2008-5#2)
days under##5##2##(1995-11#1)(1997-2#1)(2008-10#3)
days until##3##2##(1995-3#1)(2008-10#1)(2009-12#1)
days using a##3##3##(2008-10#1)(2008-11#2)
days using##4##2##(1997-2#1)(2008-10#1)(2008-11#2)
days vs##4##2##(1994-6#2)(2008-1#1)(2013-1#1)
days was found##2##3##(2008-8#1)(2012-12#1)
days was observed##2##3##(2010-8#2)
days was##16##2##(1992-3#1)(1996-12#1)(1996-3#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#2)(2012-12#1)
days were also##2##3##(2010-6#1)(2011-1#1)
days were##11##2##(1990-9#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
days when##8##2##(1993-2#1)(2008-10#3)(2008-11#1)(2009-7#1)(2012-12#2)
days while##3##2##(2007-2#1)(2009-5#1)(2011-2#1)
days with a##2##3##(2008-12#1)(2009-5#1)
days with infection##2##3##(2008-10#2)
days with or without##2##4##(2008-10#1)(2008-12#1)
days with##25##2##(1993-2#2)(1994-3#1)(1997-3#1)(2007-10#2)(2008-10#9)(2008-12#3)(2008-2#1)(2008-3#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
days without any##2##3##(2011-2#1)(2013-1#1)
days without##5##2##(1990-11#1)(2008-10#2)(2011-2#1)(2013-1#1)
days##2011##1##(1990-10#3)(1990-11#5)(1990-12#20)(1990-2#13)(1990-3#6)(1990-5#9)(1990-6#3)(1990-7#6)(1990-8#5)(1990-9#6)(1991-1#2)(1991-11#4)(1991-12#13)(1991-2#9)(1991-3#8)(1991-4#3)(1991-5#11)(1991-6#6)(1991-8#7)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#11)(1992-12#10)(1992-2#5)(1992-3#13)(1992-4#2)(1992-5#9)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#25)(1993-2#8)(1993-3#8)(1993-5#1)(1993-6#9)(1993-8#5)(1993-9#3)(1994-1#1)(1994-12#3)(1994-2#10)(1994-3#12)(1994-5#5)(1994-6#13)(1994-7#5)(1994-8#2)(1994-9#9)(1995-1#1)(1995-11#10)(1995-12#26)(1995-2#15)(1995-3#25)(1995-5#7)(1995-6#2)(1995-8#10)(1996-1#2)(1996-11#1)(1996-12#24)(1996-2#11)(1996-3#9)(1996-5#25)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#8)(1997-3#20)(1997-4#25)(1997-5#3)(1997-6#15)(1997-8#2)(1997-9#1)(2006-10#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#42)(2007-11#10)(2007-12#21)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#13)(2007-7#13)(2007-8#20)(2007-9#3)(2008-1#10)(2008-10#436)(2008-11#88)(2008-12#64)(2008-2#6)(2008-3#14)(2008-4#9)(2008-5#87)(2008-6#26)(2008-7#53)(2008-8#18)(2008-9#47)(2009-10#1)(2009-11#5)(2009-12#9)(2009-3#7)(2009-4#7)(2009-5#2)(2009-6#3)(2009-7#8)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#8)(2010-12#14)(2010-2#6)(2010-3#5)(2010-4#16)(2010-5#11)(2010-6#13)(2010-7#2)(2010-8#12)(2011-1#23)(2011-2#72)(2011-3#1)(2012-1#9)(2012-12#22)(2012-2#32)(2012-3#28)(2012-8#1)(2013-1#79)(2013-7#4)(2013-8#21)
days'##10##1##(1991-5#1)(1993-2#1)(1996-12#1)(2007-12#1)(2008-11#2)(2008-5#3)(2011-2#1)
days) after##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
days) and##6##2##(1996-12#1)(1996-7#1)(2008-10#2)(2011-2#1)(2013-8#1)
days) and/or##2##2##(2008-7#1)(2009-12#1)
days) as well as##2##4##(1996-2#1)(2010-8#1)
days) in##2##2##(1995-2#1)(2008-10#1)
days) induced##2##2##(1990-12#1)(1996-2#1)
days) of##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
days) on##4##2##(1992-11#1)(2008-10#1)(2008-12#2)
days) or##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
days) to##2##2##(1992-9#1)(2009-11#1)
days) was##5##2##(1994-3#1)(1997-8#1)(2007-8#2)(2013-8#1)
days) were##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
days)##115##1##(1990-12#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-9#1)(1993-1#3)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-12#3)(1996-2#5)(1996-5#2)(1996-7#1)(1997-8#2)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-3#2)(2013-1#1)(2013-8#3)
days-old##5##1##(1990-7#4)(2011-2#1)
days/cm in the##2##3##(2009-3#2)
days/week##3##1##(1992-12#1)(2008-3#1)(2008-7#1)
daytime RH##2##2##(2008-10#2)
daytime and nighttime##3##3##(2008-2#1)(2008-3#2)
daytime and##6##2##(1991-6#1)(1997-5#1)(2008-2#1)(2008-3#3)
daytime functioning##3##2##(2010-7#3)
daytime levels##2##2##(1996-7#1)(2013-7#1)
daytime operation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
daytime sleepiness##2##2##(2008-7#1)(2010-7#1)
daytime temperature##5##2##(2012-7#5)
daytime temperatures##2##2##(2008-10#2)
daytime##54##1##(1991-6#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#5)(2008-3#9)(2008-6#1)(2008-7#2)(2008-8#1)(2010-7#5)(2010-8#1)(2012-5#2)(2012-6#1)(2012-7#5)(2013-1#5)(2013-7#1)(2013-8#1)
db/+ mice##3##2##(2012-3#3)
db/+##4##1##(2012-3#4)
db/db and##3##2##(1994-11#1)(2012-3#2)
db/db mice##8##2##(2012-12#1)(2012-3#6)(2013-1#1)
db/db##20##1##(1994-11#1)(2008-3#4)(2012-12#1)(2012-3#13)(2013-1#1)
db/db-mutants##2##1##(2008-3#2)
dbcGMP##2##1##(1995-8#2)
dc and##2##2##(2007-12#1)(2008-2#1)
dc component##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
dc data only##2##3##(2008-3#2)
dc electric field##2##3##(2007-11#2)
dc field##4##2##(1995-12#1)(2007-11#2)(2008-3#1)
dc voltage##3##2##(2007-11#1)(2007-12#2)
dc##31##1##(1995-12#1)(2007-11#7)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#10)
dcmB##2##1##(1993-9#2)
dcrB##4##1##(1993-9#4)
ddC##2##1##(1994-11#1)(2008-11#1)
ddI##3##1##(1994-11#1)(2008-11#2)
ddT##2##1##(1991-3#2)
ddTHF##3##1##(1995-2#3)
ddY mice##3##2##(2010-11#3)
de Arousa##4##2##(2008-10#2)(2010-5#2)
de Barquisimeto'##2##2##(2008-5#2)
de Broglie##3##2##(2008-5#2)(2008-7#1)
de Chile##4##2##(2013-1#4)
de Cuba Techo##4##3##(2007-10#4)
de Cuba##10##2##(2007-10#9)(2008-7#1)
de Hulst's##2##2##(2007-12#1)(2008-2#1)
de Kooning's dementia##2##3##(1996-6#2)
de LA##2##2##(2013-1#2)
de Los##3##2##(2008-5#3)
de Medicina##2##2##(2008-5#1)(2009-10#1)
de Montaigne##2##2##(2012-3#2)
de Montréal##2##2##(2008-2#2)
de Nó##2##2##(2009-5#2)
de Salud##3##2##(1993-3#1)(2012-12#2)
de Souza##4##2##(2008-10#1)(2009-10#3)
de Tracadie##2##2##(2009-4#2)
de Tramadol et de##2##4##(2013-1#2)
de Tramadol et##3##3##(2013-1#3)
de Tramadol##6##2##(2013-1#6)
de ble##2##2##(2008-5#2)
de ces##3##2##(2008-5#1)(2013-1#2)
de cette##2##2##(2008-5#1)(2011-2#1)
de décès##2##2##(2009-10#1)(2013-1#1)
de fabrication##2##2##(2008-5#2)
de facto##3##2##(2007-5#1)(2008-10#1)(2008-7#1)
de glissement&quot##4##2##(2010-6#4)
de kyste##2##2##(2011-2#1)(2013-1#1)
de l'ajout d'agents nacrants solides directement dans une formulation melangee##2##10##(2008-5#2)
de l'octyl##2##2##(2008-5#2)
de la grossesse##4##3##(2011-2#1)(2013-1#3)
de la leucémie aiguë##3##4##(2013-1#3)
de la maladie##3##3##(2009-4#2)(2013-1#1)
de la varicelle##3##3##(2013-1#3)
de la##57##2##(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#9)(2009-4#2)(2010-8#5)(2011-2#5)(2011-3#3)(2013-1#22)(2013-7#1)
de leurs##2##2##(2008-11#1)(2008-5#1)
de novo DNA##2##3##(1997-3#1)(2012-12#1)
de novo Parkinson's disease##2##4##(1995-12#2)
de novo adipogenesis##2##3##(2008-11#2)
de novo and##2##3##(2007-8#1)(2013-1#1)
de novo biosynthesis##2##3##(1993-11#1)(2008-5#1)
de novo designed##2##3##(1992-6#1)(1995-2#1)
de novo from##2##3##(1992-6#1)(1994-11#1)
de novo mutation##4##3##(1991-12#1)(1993-2#1)(1994-11#1)(2012-12#1)
de novo protein synthesis##2##4##(1995-12#1)(2008-11#1)
de novo purine synthesis##3##4##(1991-4#1)(1993-12#2)
de novo synthesis of cyclooxygenase##2##5##(1994-9#2)
de novo synthesis of##9##4##(1990-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(2011-1#1)(2012-1#1)
de novo synthesis##10##3##(1990-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
de novo##82##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-12#2)(1992-6#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#2)
de novo&quot##2##2##(1991-2#2)
de patients##2##2##(2011-2#1)(2013-1#1)
de pointes##6##2##(1991-8#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
de production##4##2##(2008-5#4)
de repeto##2##2##(2013-1#2)
de siècle##2##2##(1995-1#1)(2011-2#1)
de son##3##2##(2008-5#1)(2013-1#2)
de tensioactifs##2##2##(2008-5#2)
de traitement##2##2##(2011-2#1)(2013-1#1)
de zorgbehoefte##4##2##(2012-12#4)
de##553##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#6)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-3#3)(1997-5#2)(2007-10#11)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#45)(2008-11#17)(2008-12#3)(2008-2#10)(2008-3#12)(2008-4#5)(2008-5#98)(2008-6#8)(2008-7#13)(2008-9#4)(2009-10#21)(2009-12#1)(2009-4#9)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#2)(2010-5#3)(2010-6#4)(2010-8#6)(2011-1#1)(2011-2#40)(2011-3#3)(2012-1#1)(2012-12#20)(2012-2#2)(2012-3#6)(2013-1#107)(2013-7#3)(2013-8#4)
de)##3##1##(1990-6#1)(1995-12#2)
de-acylation##2##1##(2008-3#2)
de-ionized water##3##2##(2008-10#2)(2009-5#1)
deacetylase activity##3##2##(1997-3#2)(2012-12#1)
deacetylase from##2##2##(1997-3#1)(2011-1#1)
deacetylase inhibitors##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
deacetylase##27##1##(1991-5#4)(1997-3#5)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#1)
deacetylases##5##1##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
deacetylation in##2##2##(1991-5#1)(2008-7#1)
deacetylation##8##1##(1991-5#2)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
deactivate##3##1##(1995-6#1)(2009-8#1)(2010-1#1)
deactivated##5##1##(1992-11#1)(2007-11#2)(2008-10#1)(2013-8#1)
deactivates the##3##2##(1994-11#1)(2008-9#1)(2012-2#1)
deactivation by##3##2##(1992-11#1)(1994-8#2)
deactivation in##3##2##(1992-11#1)(2008-5#1)(2010-8#1)
deactivation kinetics of##2##3##(2008-8#2)
deactivation of the##2##3##(1996-4#1)(2008-2#1)
deactivation of##6##2##(1990-6#1)(1996-4#1)(2008-2#2)(2008-5#1)(2008-6#1)
deactivation was##2##2##(2008-6#1)(2009-2#1)
deactivation##23##1##(1990-6#1)(1992-11#2)(1993-11#1)(1994-8#2)(1995-6#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-2#3)(2008-5#2)(2008-6#2)(2008-8#2)(2009-2#1)(2010-8#1)(2013-1#2)
deacylated##2##1##(1990-5#1)(2008-10#1)
deacylation##2##1##(1990-8#1)(1995-2#1)
dead and##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
dead bodies##2##2##(2011-2#2)
dead cell##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
dead cells##8##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)
dead cyclamen leaf tissue##2##4##(2008-10#2)
dead end##4##2##(1991-12#1)(2007-12#1)(2008-9#1)(2010-5#1)
dead in##5##2##(1995-1#1)(1995-3#1)(1997-3#1)(2012-12#1)(2012-2#1)
dead leaves##2##2##(2008-10#2)
dead men##2##2##(1996-11#1)(1997-5#1)
dead or##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
dead space and##2##3##(1991-12#1)(2008-9#1)
dead space##10##2##(1991-12#5)(2008-10#2)(2008-9#2)(2012-2#1)
dead spot##3##2##(2008-10#3)
dead tits##2##2##(2008-5#2)
dead wood##3##2##(2008-10#3)
dead##111##1##(1990-9#1)(1991-11#1)(1991-12#6)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#7)(2009-6#3)(2010-10#1)(2010-3#1)(2010-5#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)
dead-in-shell turkey embryos##3##3##(2008-5#3)
deadline##3##1##(1991-11#1)(1996-1#1)(2008-11#1)
deadlines##2##1##(1994-2#1)(2008-12#1)
deadly disease##2##2##(2008-9#1)(2012-2#1)
deadly##18##1##(1990-6#1)(1992-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
deaf and hard of hearing students##3##6##(2011-2#3)
deaf and hard of hearing##6##5##(2011-2#6)
deaf children and##3##3##(2008-9#2)(2011-2#1)
deaf children##11##2##(2008-9#9)(2011-2#2)
deaf or hard of hearing##2##5##(2011-2#2)
deaf patients##3##2##(2008-2#1)(2008-9#2)
deaf signing##2##2##(2012-2#2)
deaf students##2##2##(2011-2#2)
deaf##48##1##(1996-3#1)(2008-2#2)(2008-9#21)(2011-2#17)(2012-2#5)(2012-3#2)
deafened adult##3##2##(2008-9#3)
deafened adults##6##2##(2008-9#6)
deafened children with##3##3##(2008-9#3)
deafened children##5##2##(2008-9#5)
deafened patients##3##2##(2008-9#3)
deafened users##2##2##(2008-9#2)
deafened##20##1##(2008-9#20)
deafferentation##4##1##(1993-5#1)(1996-12#1)(1996-2#1)(1996-6#1)
deafferented##4##1##(1991-2#2)(1992-10#1)(1997-3#1)
deafness and##5##2##(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)
deafness in##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
deafness were##2##2##(2008-9#2)
deafness##53##1##(1990-3#1)(1994-9#7)(1997-3#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#27)(2009-8#1)(2011-1#4)(2011-2#4)(2012-12#1)(2013-1#1)
deafness]##2##1##(1995-6#1)(2013-8#1)
deal also with##2##3##(1990-11#1)(2008-6#1)
deal of##34##2##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
deal with a##4##3##(2006-10#1)(2008-3#2)(2010-10#1)
deal with the problem##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
deal with the problems of##2##5##(1993-2#1)(1994-2#1)
deal with the situation##2##4##(2007-11#1)(2008-2#1)
deal with the##23##3##(1990-4#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-3#3)
deal with these##6##3##(1995-12#1)(1996-1#1)(2008-11#2)(2008-2#1)(2010-10#1)
deal with##94##2##(1990-4#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#2)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#1)
deal##152##1##(1990-11#1)(1990-4#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#12)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#1)
dealbata##5##1##(2008-5#4)(2011-2#1)
dealer##2##1##(1992-4#2)
dealing with a##6##3##(1995-2#1)(2008-12#1)(2008-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
dealing with an##5##3##(1991-6#1)(1992-1#1)(1994-3#1)(2008-10#1)(2010-3#1)
dealing with chronic##2##3##(1992-3#1)(1996-3#1)
dealing with plant##2##3##(2008-9#2)
dealing with the issue##2##4##(2008-1#1)(2011-2#1)
dealing with the problem##3##4##(1992-1#1)(1994-6#1)(2008-9#1)
dealing with the##24##3##(1992-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
dealing with them##2##3##(1992-2#1)(1996-6#1)
dealing with these##3##3##(1991-2#1)(1992-3#1)(2010-8#1)
dealing with this##4##3##(1993-6#1)(1996-9#2)(2008-2#1)
dealing with##118##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#2)(1992-3#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#14)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#7)(2009-10#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#6)(2013-8#3)
dealing##127##1##(1990-5#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#2)(1992-3#2)(1993-12#4)(1993-6#1)(1994-1#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#15)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#8)(2009-10#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#6)(2013-8#3)
dealloying##3##1##(2012-2#3)
deals in##2##2##(1990-11#1)(1990-8#1)
deals specifically with##2##3##(2008-10#1)(2008-2#1)
deals with a##6##3##(1995-12#1)(2008-10#3)(2008-9#1)(2012-3#1)
deals with the influence of##2##5##(1993-12#1)(2009-11#1)
deals with the##37##3##(1990-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#3)(2008-9#2)(2009-11#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
deals with##71##2##(1990-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#3)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
deals##79##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#4)(2009-11#1)(2009-6#1)(2009-7#3)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
dealt in##2##2##(2008-11#1)(2008-5#1)
dealt with a##2##3##(1996-3#1)(2009-7#1)
dealt with by##3##3##(1996-2#1)(1996-6#1)(2008-3#1)
dealt with in the##2##4##(2008-2#1)(2011-2#1)
dealt with in##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
dealt with the##6##3##(1990-3#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-5#2)
dealt with##36##2##(1990-3#1)(1991-3#1)(1992-1#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
dealt##39##1##(1990-3#1)(1991-3#1)(1992-1#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
deamidation##2##1##(1990-8#1)(2008-11#1)
deaminase activity##2##2##(1992-12#1)(1997-7#1)
deaminase adenosine activity##2##3##(2008-7#2)
deaminase adenosine##3##2##(2008-7#3)
deaminase and##2##2##(1990-12#1)(1997-7#1)
deaminase in acute##2##3##(1991-2#1)(1991-3#1)
deaminase##27##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#2)(1993-12#1)(1994-5#3)(1994-8#1)(1995-3#2)(1995-9#2)(1997-3#1)(1997-7#3)(2008-1#1)(2008-10#1)(2008-7#3)(2010-9#1)(2011-2#1)
deaminases##2##1##(1994-5#1)(1994-8#1)
deaminated##3##1##(1992-12#1)(2008-10#2)
deamination of##2##2##(1990-8#1)(1992-11#1)
deamination##3##1##(1990-8#1)(1992-11#1)(1992-8#1)
dean of##5##2##(1990-6#1)(2008-1#1)(2008-10#1)(2011-1#2)
dean##6##1##(1990-6#1)(2008-1#2)(2008-10#1)(2011-1#2)
deaneorum##2##1##(2007-12#2)
deans and##2##2##(2010-3#1)(2012-3#1)
deans##5##1##(2008-1#1)(2010-3#3)(2012-3#1)
deanships##2##1##(2010-3#2)
dearomatization##2##1##(2009-10#1)(2009-11#1)
dearth of evidence##2##3##(2010-12#1)(2012-2#1)
dearth of research##2##3##(2008-11#1)(2009-9#1)
dearth of##14##2##(1992-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
death after##5##2##(1991-11#1)(1994-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
death also##3##2##(1990-9#1)(2008-8#1)(2012-2#1)
death among##6##2##(1991-11#1)(1991-3#1)(1992-6#1)(2008-1#1)(2008-4#1)(2013-1#1)
death and differentiation##2##3##(1993-3#1)(1994-10#1)
death and disability##6##3##(1995-11#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
death and dying##5##3##(1994-1#3)(2011-2#2)
death and morbidity##3##3##(2008-5#1)(2010-12#1)(2011-2#1)
death and the##7##3##(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(2009-8#1)(2010-12#1)(2011-2#1)
death and##63##2##(1990-11#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#4)(1996-12#1)(2007-10#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
death anxiety##3##2##(2007-10#3)
death are##9##2##(1990-7#1)(1995-6#1)(2008-10#1)(2008-7#1)(2010-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
death as a result of##2##5##(2008-1#1)(2008-11#1)
death as a##7##3##(1991-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
death as##8##2##(1991-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)(2011-2#1)
death at##4##2##(2008-10#1)(2012-2#1)(2012-3#2)
death but##5##2##(1995-2#1)(1996-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
death by the##2##3##(1996-2#1)(1996-6#1)
death by##23##2##(1991-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
death caused by##7##3##(1991-9#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-7#1)
death certificates##5##2##(1991-2#1)(2007-10#1)(2010-4#1)(2012-12#1)(2013-8#1)
death counts##5##2##(1997-3#2)(2011-1#3)
death diagnosis##2##2##(1997-2#1)(2007-11#1)
death donors##2##2##(2011-3#2)
death due to##5##3##(1994-3#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-7#1)
death during the##5##3##(1994-2#1)(1995-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
death during##11##2##(1991-8#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
death followed by##2##3##(2008-11#1)(2013-8#1)
death following##6##2##(1990-7#1)(1996-12#1)(2008-7#2)(2010-12#1)(2010-8#1)
death for##3##2##(1991-3#1)(2008-11#1)(2012-12#1)
death from cardiovascular##5##3##(2008-11#1)(2010-12#1)(2011-1#2)(2011-2#1)
death from##16##2##(1995-12#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-11#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
death has been##2##3##(2011-1#1)(2012-2#1)
death has##3##2##(2008-9#1)(2011-1#1)(2012-2#1)
death if##2##2##(1997-3#1)(2010-5#1)
death in 0##2##3##(1990-3#1)(2013-1#1)
death in Norway]##2##3##(1990-6#1)(1992-4#1)
death in a##5##3##(1991-11#1)(1994-10#1)(2008-12#1)(2009-6#1)(2013-7#1)
death in different##2##3##(1994-8#1)(2012-7#1)
death in patients with##6##4##(1991-11#1)(1993-9#1)(1996-11#1)(2010-3#1)(2011-2#2)
death in patients##8##3##(1991-11#1)(1993-9#1)(1996-11#1)(2008-11#1)(2010-3#1)(2011-2#3)
death in the United States##2##5##(2010-10#1)(2011-2#1)
death in the developed##2##4##(2008-10#1)(2010-12#1)
death in the general##2##4##(2008-7#2)
death in the nervous system##2##5##(1994-11#1)(2008-4#1)
death in the##32##3##(1990-5#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#3)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#1)
death in vitro##2##3##(2008-9#1)(2013-1#1)
death in##141##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#4)(1991-12#1)(1991-3#1)(1992-11#1)(1992-4#2)(1992-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#10)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#1)
death incidence##4##2##(1997-3#3)(2011-2#1)
death induced by##6##3##(1994-10#1)(1995-5#1)(2008-11#2)(2008-7#1)(2012-2#1)
death induced##7##2##(1994-10#1)(1995-5#1)(2008-11#2)(2008-7#1)(2009-4#1)(2012-2#1)
death is a##2##3##(1996-6#1)(2008-10#1)
death is##19##2##(1992-6#1)(1992-9#1)(1995-1#1)(1995-5#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-12#1)
death issues##2##2##(2007-10#2)
death machinery##4##2##(2008-11#2)(2008-8#1)(2009-3#1)
death may be##2##3##(1993-9#1)(1996-11#1)
death may##4##2##(1990-6#1)(1993-9#1)(1996-11#1)(2008-9#1)
death mechanism##2##2##(2008-11#1)(2012-3#1)
death occurred##7##2##(1991-4#1)(1991-6#1)(1992-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
death occurs##2##2##(1996-11#1)(2010-1#1)
death of an##3##3##(1996-6#1)(2011-3#1)(2013-1#1)
death of homebound elderly persons##4##5##(1994-1#4)
death of patients##3##3##(2007-11#2)(2008-1#1)
death of plants##3##3##(2008-10#3)
death of the##12##3##(1992-10#1)(1992-4#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
death of##78##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-1#4)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
death on the##2##3##(2008-12#1)(2010-9#1)
death or##15##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-2#1)(1994-10#1)(1996-12#1)(2007-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)
death pathways##4##2##(2008-11#3)(2009-8#1)
death phase##4##2##(2008-11#3)(2008-7#1)
death programme##3##2##(2008-11#3)
death rate from breast cancer##2##5##(1997-7#1)(2010-9#1)
death rate in##2##3##(2008-11#1)(2010-9#1)
death rate increased##2##3##(1990-6#1)(2008-11#1)
death rate##22##2##(1990-11#1)(1990-6#3)(1990-9#1)(1992-5#1)(1994-3#1)(1997-1#1)(1997-7#2)(2007-12#1)(2008-11#4)(2008-7#1)(2008-8#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-8#1)
death rates are##2##3##(1990-2#1)(1996-3#1)
death rates from breast cancer##2##5##(1991-12#1)(1997-7#1)
death rates were##2##3##(1991-12#1)(2008-7#1)
death rates##15##2##(1990-2#1)(1991-12#3)(1993-1#1)(1996-3#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#1)
death receptors##2##2##(2008-4#2)
death signals##2##2##(2009-8#1)(2011-2#1)
death syndrome (SDS) of soybean##2##5##(2008-10#2)
death syndrome and##2##3##(1991-8#1)(2008-10#1)
death syndrome has##2##3##(1991-9#1)(2008-10#1)
death syndrome##26##2##(1991-11#5)(1991-8#1)(1991-9#3)(1992-11#3)(1992-4#1)(1993-12#2)(2007-12#1)(2008-10#6)(2009-8#1)(2011-1#1)(2013-1#2)
death than##2##2##(1991-12#1)(2008-11#1)
death that##4##2##(1992-6#1)(1995-6#1)(2008-4#1)(2013-1#1)
death throughout the##2##3##(2008-8#1)(2012-3#1)
death to##2##2##(1993-8#1)(2011-2#1)
death was caused##2##3##(1990-9#1)(2008-11#1)
death was determined##2##3##(1994-2#1)(1995-11#1)
death was due to##4##4##(1995-6#1)(2007-8#1)(2008-7#1)(2011-2#1)
death was observed in##2##4##(2008-10#1)(2011-2#1)
death was observed##3##3##(2008-10#2)(2011-2#1)
death was##31##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-11#2)(1994-2#1)(1995-11#2)(1995-3#1)(1995-6#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2011-1#3)(2011-2#3)(2012-12#2)
death were 1##2##3##(2011-1#2)
death were##13##2##(1990-8#1)(1991-12#1)(1991-8#1)(2008-1#2)(2008-10#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#3)
death which##3##2##(2007-11#1)(2008-5#1)(2013-8#1)
death with a##3##3##(2008-6#1)(2012-12#1)(2013-1#1)
death with##9##2##(1990-6#1)(1992-1#1)(1994-8#1)(1997-3#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
death within 2##2##3##(1997-3#1)(2009-12#1)
death within##3##2##(1997-3#1)(2009-12#1)(2012-3#1)
death##1136##1##(1990-11#7)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#10)(1990-7#5)(1990-8#1)(1990-9#4)(1991-11#14)(1991-12#15)(1991-2#7)(1991-3#4)(1991-4#1)(1991-6#4)(1991-8#5)(1991-9#10)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#8)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#8)(1994-10#6)(1994-11#8)(1994-12#2)(1994-2#8)(1994-3#6)(1994-5#5)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#7)(1995-12#12)(1995-2#12)(1995-3#12)(1995-5#8)(1995-6#15)(1995-8#5)(1995-9#1)(1996-11#4)(1996-12#17)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#9)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#12)(1997-4#2)(1997-6#1)(1997-7#7)(1997-8#3)(1997-9#1)(2006-10#5)(2006-7#1)(2007-10#15)(2007-11#14)(2007-12#7)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#9)(2008-1#20)(2008-10#78)(2008-11#74)(2008-12#14)(2008-2#1)(2008-3#7)(2008-4#17)(2008-5#8)(2008-6#9)(2008-7#64)(2008-8#37)(2008-9#18)(2009-10#14)(2009-12#9)(2009-2#4)(2009-3#4)(2009-4#11)(2009-5#5)(2009-6#9)(2009-7#7)(2009-8#19)(2009-9#3)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#9)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#11)(2010-9#7)(2011-1#20)(2011-2#61)(2011-3#6)(2011-9#2)(2012-1#4)(2012-12#29)(2012-2#20)(2012-3#22)(2012-7#1)(2013-1#37)(2013-7#6)(2013-8#20)
death'##3##1##(1995-3#1)(2010-10#2)
death) in##2##2##(1993-9#1)(2009-12#1)
death)##13##1##(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-2#1)
death-inducing##2##1##(2008-11#1)(2012-2#1)
death?##4##1##(1995-1#1)(2011-2#2)(2012-3#1)
death]##9##1##(1990-11#1)(1991-5#1)(1991-9#1)(1992-6#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-5#1)
deaths among the##2##3##(1990-5#1)(2008-7#1)
deaths among##7##2##(1990-5#1)(1991-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-1#1)
deaths and##16##2##(1996-12#1)(1997-7#1)(2007-2#7)(2007-8#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)
deaths are##2##2##(2008-11#1)(2010-8#1)
deaths at##5##2##(1991-3#1)(1992-6#2)(2013-8#2)
deaths caused by cardiovascular disease##2##5##(2011-1#2)
deaths caused by##5##3##(2011-1#2)(2011-2#1)(2012-12#2)
deaths due to##6##3##(1992-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
deaths during##2##2##(1995-6#1)(2008-3#1)
deaths each year##2##3##(1996-8#1)(2010-9#1)
deaths from cardiovascular##2##3##(2011-1#1)(2012-12#1)
deaths from other##2##3##(1992-6#1)(2008-6#1)
deaths from##18##2##(1991-11#1)(1992-6#2)(1995-3#1)(1997-3#1)(1997-6#1)(1997-7#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-12#2)
deaths have##3##2##(2008-4#1)(2008-6#1)(2008-8#1)
deaths in developed##2##3##(1992-6#1)(2011-3#1)
deaths in the##6##3##(1991-3#1)(1995-3#1)(1997-3#1)(2008-4#1)(2008-9#1)(2012-2#1)
deaths in this##2##3##(2008-1#1)(2008-7#1)
deaths in##31##2##(1991-12#1)(1991-3#2)(1991-9#1)(1992-6#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
deaths occur##2##2##(2010-8#1)(2011-2#1)
deaths occurred##3##2##(1991-3#1)(1997-8#1)(2013-1#1)
deaths of##3##2##(1992-8#1)(2010-12#1)(2011-2#1)
deaths or##2##2##(2007-10#1)(2009-10#1)
deaths per year##4##3##(1997-1#1)(2010-3#1)(2012-2#1)(2013-8#1)
deaths per##5##2##(1997-1#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
deaths related to##2##3##(2012-2#1)(2013-1#1)
deaths that##2##2##(2008-3#1)(2011-2#1)
deaths were due to##2##4##(2012-3#1)(2013-1#1)
deaths were observed in##2##4##(1991-12#1)(2013-1#1)
deaths were reported##2##3##(1993-2#1)(2007-2#1)
deaths were##11##2##(1991-12#1)(1992-6#1)(1993-2#1)(2007-2#2)(2008-9#1)(2012-3#2)(2013-1#3)
deaths worldwide##2##2##(2008-1#1)(2008-7#1)
deaths##232##1##(1990-2#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-3#5)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#9)(1992-8#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#2)(1996-11#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-6#3)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#10)(2007-7#1)(2007-8#9)(2008-1#4)(2008-10#2)(2008-11#10)(2008-12#2)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#4)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#13)(2011-3#4)(2012-12#13)(2012-2#6)(2012-3#3)(2013-1#13)(2013-8#4)
debaryanum##2##1##(2008-10#2)
debatable##7##1##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
debate about the##6##3##(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
debate about##15##2##(1990-6#1)(1992-2#1)(1994-12#1)(1995-2#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#2)
debate and##6##2##(1992-2#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-7#1)
debate between##2##2##(2008-12#1)(2008-2#1)
debate concerning##3##2##(1990-6#1)(1995-6#1)(2008-11#1)
debate for##2##2##(2008-11#1)(2008-9#1)
debate has##2##2##(2006-10#1)(2013-1#1)
debate in Russia and##2##4##(1997-1#2)
debate in the literature##2##4##(1995-11#1)(2008-11#1)
debate in the##5##3##(1995-11#1)(1995-2#1)(2008-11#1)(2009-10#1)(2013-8#1)
debate in##12##2##(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2013-8#1)
debate on how##2##3##(2008-11#1)(2010-11#1)
debate on the##7##3##(1993-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
debate on##23##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
debate over health care reform##2##5##(1993-12#1)(1994-3#1)
debate over health care##3##4##(1993-12#1)(1994-3#1)(1996-12#1)
debate over the##3##3##(1994-3#1)(1996-5#1)(2011-1#1)
debate over##13##2##(1993-12#1)(1994-3#3)(1995-2#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
debate regarding the##3##3##(1997-1#1)(2008-6#1)(2009-10#1)
debate surrounding##5##2##(1990-6#1)(1992-1#1)(2008-11#2)(2008-12#1)
debate##149##1##(1990-12#1)(1990-4#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#1)(1997-5#2)(1997-6#2)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#19)(2008-12#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
debated by##2##2##(1996-2#1)(1996-3#1)
debated in the##2##3##(2008-5#1)(2008-8#1)
debated##30##1##(1991-1#1)(1991-9#1)(1992-8#3)(1993-3#2)(1993-5#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#5)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-3#1)
debates concerning the##2##3##(2010-1#1)(2012-12#1)
debates in##2##2##(1994-3#1)(2012-3#1)
debates on##3##2##(2008-12#1)(2008-4#1)(2010-8#1)
debates over##3##2##(1994-8#1)(2012-2#2)
debates##24##1##(1994-3#1)(1994-8#2)(1995-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
debilitated elderly##2##2##(2008-7#2)
debilitated patients##2##2##(2008-7#1)(2013-8#1)
debilitated##7##1##(2008-7#4)(2009-9#1)(2013-8#2)
debilitating and##4##2##(2007-10#1)(2008-5#1)(2013-1#2)
debilitating condition that##2##3##(2008-1#1)(2011-2#1)
debilitating condition##5##2##(2008-1#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)
debilitating disease##5##2##(2007-7#1)(2008-9#2)(2009-3#1)(2013-1#1)
debilitating##29##1##(1994-3#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
deblurring##3##1##(2008-6#3)
debonding##4##1##(2008-8#1)(2009-11#1)(2009-7#2)
debranching enzyme##2##2##(1995-5#2)
debranching##3##1##(1995-5#2)(2008-4#1)
debrided##2##1##(2008-9#2)
debridement and##4##2##(2007-8#1)(2008-7#1)(2009-10#1)(2013-8#1)
debridement of all##2##3##(2011-2#1)(2012-2#1)
debridement of the##3##3##(1991-6#1)(2010-12#1)(2011-2#1)
debridement of##7##2##(1991-6#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
debridement##30##1##(1991-6#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-8#3)(2008-7#1)(2008-9#4)(2009-10#1)(2010-12#3)(2010-3#1)(2010-6#4)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
debriefing and##2##2##(2008-11#2)
debriefing##6##1##(2008-1#1)(2008-11#4)(2008-8#1)
debris and##5##2##(1992-12#1)(2007-8#1)(2008-10#3)
debris collected##2##2##(2008-10#2)
debris flow at the Mt##2##5##(2008-2#1)(2008-3#1)
debris flow with##2##3##(2008-2#1)(2008-3#1)
debris flow##7##2##(2008-2#4)(2008-3#3)
debris from##2##2##(1991-8#1)(2008-10#1)
debris in##2##2##(2008-10#1)(2008-8#1)
debris is the##2##3##(2008-8#2)
debris is##3##2##(2008-10#1)(2008-8#2)
debris of##4##2##(2008-10#1)(2013-8#3)
debris##65##1##(1991-8#1)(1992-12#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-5#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#23)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#11)(2008-9#1)(2009-10#1)(2012-12#2)(2012-3#1)(2013-8#3)
debrisoquine 4-hydroxylase##4##2##(1992-11#2)(1993-6#1)(2008-10#1)
debrisoquine##5##1##(1992-11#2)(1993-6#1)(2008-10#2)
debt and##3##2##(1994-2#3)
debt crisis##2##2##(1990-2#1)(1992-5#1)
debt financing##2##2##(2008-11#2)
debt is##2##2##(1992-5#1)(1994-2#1)
debt to##2##2##(1992-5#1)(2010-7#1)
debt##32##1##(1990-2#2)(1992-5#9)(1994-2#10)(1996-2#1)(1996-3#1)(2008-11#5)(2008-6#1)(2010-7#1)(2013-1#2)
debts##2##1##(2008-11#1)(2012-12#1)
debulking##4##1##(1992-10#1)(2006-12#1)(2008-6#1)(2013-1#1)
debut of##2##2##(1990-9#1)(2013-1#1)
debut##17##1##(1990-9#3)(2008-7#1)(2011-1#9)(2012-1#2)(2013-1#1)(2013-8#1)
debutants##2##1##(2010-1#2)
decade ago##7##2##(1992-3#1)(1993-2#1)(2008-10#1)(2009-3#1)(2010-7#1)(2012-2#2)
decade and##12##2##(1992-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
decade at##3##2##(2008-10#2)(2013-1#1)
decade due to the##3##4##(1990-12#1)(2008-10#1)(2013-1#1)
decade for##3##2##(1997-7#1)(2008-10#2)
decade has brought##2##3##(1993-1#1)(2012-3#1)
decade has##11##2##(1993-1#1)(1993-12#1)(1994-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)
decade in the##4##3##(2008-1#1)(2008-10#2)(2008-7#1)
decade in##8##2##(2008-1#1)(2008-10#4)(2008-7#2)(2011-3#1)
decade it has become##2##4##(1995-2#1)(2008-4#1)
decade it has##3##3##(1991-6#1)(1995-2#1)(2008-4#1)
decade it##4##2##(1991-6#1)(1995-2#1)(2008-4#1)(2008-5#1)
decade of change##2##3##(1992-3#1)(1993-1#1)
decade of life##6##3##(2007-5#1)(2007-7#2)(2008-1#1)(2009-12#1)(2013-1#1)
decade of research##4##3##(1990-11#1)(2007-12#1)(2009-10#1)(2013-1#1)
decade of the##2##3##(2011-1#2)
decade of##29##2##(1990-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-3#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
decade since the##4##3##(2008-4#1)(2008-5#1)(2010-4#1)(2012-12#1)
decade there has been a##2##5##(2007-12#1)(2009-7#1)
decade there has been##5##4##(1991-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-7#1)
decade to##2##2##(2008-11#1)(2012-12#1)
decade we##2##2##(1992-8#1)(2009-12#1)
decade##320##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-6#3)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#4)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#3)(2008-1#6)(2008-10#67)(2008-11#13)(2008-12#4)(2008-3#7)(2008-4#6)(2008-5#5)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#13)(2013-3#1)(2013-7#1)(2013-8#2)
decade)##6##1##(2008-10#6)
decades after the##2##3##(2008-7#2)
decades ago##9##2##(2008-1#2)(2008-10#1)(2008-2#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-8#1)
decades and the##2##3##(2008-10#1)(2008-7#1)
decades and##10##2##(1994-12#1)(2008-10#4)(2008-2#1)(2008-7#2)(2010-5#1)(2012-12#1)
decades are##3##2##(2008-2#1)(2008-4#1)(2012-2#1)
decades as##2##2##(2008-10#1)(2013-8#1)
decades has##4##2##(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
decades have seen a##2##4##(2010-11#1)(2012-2#1)
decades have seen##4##3##(2010-11#1)(2012-2#1)(2013-8#2)
decades have##10##2##(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#2)
decades in the##2##3##(1995-1#1)(2008-5#1)
decades in##6##2##(1995-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-3#1)(2012-2#1)
decades later##2##2##(2012-1#1)(2013-1#1)
decades new##2##2##(2009-9#1)(2010-5#1)
decades now##2##2##(2008-11#1)(2013-7#1)
decades of experience in##2##4##(2008-1#1)(2008-9#1)
decades of life##5##3##(1995-4#1)(2008-8#2)(2011-2#1)(2013-7#1)
decades of research##8##3##(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#2)
decades of the 20th century##2##5##(2008-10#1)(2011-7#1)
decades of the nineteenth century##2##5##(2009-10#1)(2011-2#1)
decades of the twentieth##2##4##(2010-1#1)(2011-2#1)
decades of the##8##3##(2008-10#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-2#2)(2011-7#1)(2013-7#1)
decades of##38##2##(1992-5#1)(1995-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
decades since##2##2##(2008-3#1)(2011-3#1)
decades there has been a##2##5##(1995-1#1)(2011-2#1)
decades there##3##2##(1994-2#1)(1995-1#1)(2011-2#1)
decades to##4##2##(1996-4#1)(2008-11#1)(2011-1#1)(2013-8#1)
decades with##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
decades##274##1##(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1995-1#2)(1995-12#1)(1995-4#1)(1996-2#2)(1996-3#2)(1996-4#1)(1997-1#2)(1997-3#1)(1997-7#2)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#7)(2008-10#25)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#18)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-5#5)(2010-6#1)(2010-8#5)(2011-1#5)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#8)(2012-2#13)(2012-3#8)(2013-1#12)(2013-7#3)(2013-8#8)
decalins##3##1##(2009-8#3)
decamer primers##3##2##(2008-10#1)(2008-5#2)
decamer##6##1##(1991-11#1)(1993-8#1)(2008-10#2)(2008-5#2)
decanethiol concentration##2##2##(2008-10#2)
decanethiol##12##1##(2008-10#12)
decanol##4##1##(1990-11#1)(2008-10#3)
decapeptide PS-SCL##2##2##(2008-4#2)
decapeptide sequence##3##2##(1992-11#3)
decapeptide##12##1##(1992-11#5)(1992-12#1)(1995-3#3)(2008-4#3)
decapeptides##2##1##(1992-12#1)(2008-11#1)
decapitated##4##1##(1991-12#1)(2007-12#1)(2008-7#1)(2013-8#1)
decapitating fly##2##2##(2007-12#2)
decapitation##3##1##(2008-10#2)(2013-8#1)
decapod crustaceans##5##2##(2007-12#4)(2008-7#1)
decapod##7##1##(2007-12#6)(2008-7#1)
decapods##9##1##(2007-12#9)
decarbamoyl##2##1##(1994-12#2)
decarbonylation##2##1##(2008-10#2)
decarboxylase (HDC)##3##2##(1990-12#1)(1997-1#1)(2008-11#1)
decarboxylase activity in##3##3##(1992-8#1)(1994-8#1)(2010-9#1)
decarboxylase activity##7##2##(1992-8#2)(1992-9#2)(1994-8#1)(2008-10#1)(2010-9#1)
decarboxylase and##6##2##(1991-12#2)(1992-9#1)(1995-8#1)(2008-10#1)(2011-2#1)
decarboxylase cDNA##3##2##(1990-12#2)(1992-11#1)
decarboxylase from##2##2##(1991-12#2)
decarboxylase gene expression##2##3##(1991-2#1)(1997-1#1)
decarboxylase gene##6##2##(1990-12#1)(1991-2#2)(1992-8#2)(1997-1#1)
decarboxylase in##2##2##(1994-12#1)(2008-10#1)
decarboxylase##69##1##(1990-12#6)(1991-12#7)(1991-2#2)(1991-5#3)(1992-11#2)(1992-8#7)(1992-9#6)(1993-8#2)(1994-12#2)(1994-8#3)(1995-6#1)(1995-8#2)(1996-12#3)(1996-5#2)(1997-1#2)(1997-3#1)(2006-4#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
decarboxylases##2##1##(1990-12#1)(2010-10#1)
decarboxylate##2##1##(1994-8#1)(2010-4#1)
decarboxylated S-adenosylmethionine##2##2##(1991-12#1)(2009-8#1)
decarboxylated dimer##2##2##(1994-11#2)
decarboxylated##6##1##(1991-12#1)(1994-11#2)(2008-10#1)(2009-8#1)(2013-8#1)
decarboxylation by##2##2##(1991-5#1)(2008-10#1)
decarboxylation in##3##2##(1991-5#2)(2008-6#1)
decarboxylation of the##2##3##(1993-11#1)(2007-11#1)
decarboxylation of##8##2##(1991-5#3)(1993-11#1)(1993-8#1)(2007-11#2)(2008-10#1)
decarboxylation##21##1##(1990-7#3)(1991-5#6)(1993-11#1)(1993-8#4)(1994-8#1)(2007-11#2)(2008-10#2)(2008-6#2)
decaurelia##2##1##(2008-12#2)
decavanadate##3##1##(1994-11#3)
decay after##2##2##(2007-12#2)
decay and##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
decay at##2##2##(2008-10#2)
decay constant##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
decay curves##4##2##(1993-11#1)(2008-10#1)(2008-2#1)(2009-5#1)
decay development##4##2##(2008-10#4)
decay in the##2##3##(2008-2#1)(2008-3#1)
decay in##11##2##(1994-8#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-6#3)
decay is##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
decay kinetics##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
decay law##2##2##(1993-11#1)(1996-4#1)
decay of the##12##3##(1990-7#1)(1992-12#1)(1996-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#3)(2009-12#1)(2011-2#1)
decay of##34##2##(1990-7#1)(1991-12#1)(1992-12#2)(1994-2#1)(1995-2#2)(1996-4#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#3)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
decay on##2##2##(1994-12#1)(2007-12#1)
decay rate##5##2##(1992-3#1)(2007-11#1)(2008-12#1)(2008-2#1)(2009-5#1)
decay symptoms##2##2##(2008-10#2)
decay time constant is##2##4##(2008-3#2)
decay time constant##5##3##(2008-2#1)(2008-3#4)
decay time##7##2##(2008-10#1)(2008-2#1)(2008-3#4)(2009-8#1)
decay transients##4##2##(2008-3#4)
decay was##2##2##(2008-10#2)
decay were##2##2##(2008-10#1)(2008-2#1)
decay##153##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-3#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#3)(1996-4#2)(1997-8#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#9)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#25)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#3)(2009-8#2)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)
decayed tissue and##2##3##(2008-10#2)
decayed##10##1##(2008-1#1)(2008-10#6)(2008-8#1)(2008-9#1)(2011-1#1)
decaying organic##2##2##(2007-12#1)(2011-2#1)
decaying##15##1##(2007-12#1)(2008-10#6)(2008-3#2)(2008-6#1)(2010-1#1)(2011-2#4)
decays exponentially##3##2##(2007-11#1)(2008-3#2)
decays faster##2##2##(1991-2#1)(2008-3#1)
decays of##5##2##(1990-4#1)(2008-10#2)(2008-3#2)
decays##28##1##(1990-12#1)(1990-4#1)(1991-2#2)(1991-5#1)(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#10)(2008-5#2)
deceased cancer patients##2##3##(1993-11#2)
deceased donor##3##2##(2011-2#2)(2013-8#1)
deceased##25##1##(1992-3#1)(1993-11#2)(1993-2#1)(1994-2#1)(1995-3#2)(1995-6#3)(1997-3#2)(2007-11#1)(2007-7#1)(2010-4#1)(2011-1#1)(2011-2#6)(2013-1#2)(2013-8#1)
decedent##2##1##(1995-11#1)(2012-12#1)
decedents##5##1##(1995-1#1)(2011-2#4)
deceit##3##1##(1995-5#1)(2008-12#1)(2008-9#1)
deceived by##2##2##(1993-11#1)(1995-5#1)
deceived##4##1##(1993-11#1)(1995-5#1)(1997-4#1)(2007-12#1)
decelerate the##2##2##(2008-2#1)(2012-3#1)
decelerated##4##1##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
deceleration##6##1##(1997-6#1)(2008-3#1)(2011-1#1)(2013-8#3)
decent##3##1##(2008-1#1)(2008-10#1)(2008-2#1)
decentered##2##1##(2007-12#1)(2008-3#1)
decentralised##2##1##(2007-12#1)(2008-7#1)
decentralization and##2##2##(1992-5#1)(2008-2#1)
decentralization in##4##2##(2008-7#1)(2012-3#3)
decentralization of the##2##3##(2008-1#1)(2012-12#1)
decentralization of##5##2##(1993-6#1)(1994-7#1)(2008-1#1)(2012-12#1)(2012-3#1)
decentralization process##2##2##(2008-7#2)
decentralization status of the##2##4##(2012-12#2)
decentralization##27##1##(1992-5#1)(1993-1#1)(1993-6#3)(1994-7#1)(2008-1#1)(2008-2#1)(2008-7#10)(2012-12#4)(2012-3#5)
decentralized management##2##2##(1992-12#1)(1995-12#1)
decentralized##18##1##(1992-1#1)(1992-12#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-7#1)(2013-1#1)
decentralizing the##2##2##(1994-1#2)
decentralizing##4##1##(1994-1#2)(1996-1#1)(2008-2#1)
deception##3##1##(1996-12#1)(1996-3#1)(2008-7#1)
deceptive plants##2##2##(2008-9#2)
deceptive pollination##2##2##(2008-9#2)
deceptive species##2##2##(2008-9#2)
deceptive##11##1##(2008-9#8)(2011-2#1)(2013-1#2)
decerebrate##2##1##(1993-12#1)(1997-2#1)
decerebrated##4##1##(1992-3#1)(1997-6#1)(2013-1#2)
dechlorinated##2##1##(2008-5#1)(2010-4#1)
dechlorination##5##1##(2008-10#2)(2009-2#1)(2011-1#2)
decide how##3##2##(1994-1#1)(2012-12#1)(2013-7#1)
decide on the##7##3##(1991-3#1)(1993-6#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-8#1)
decide on##10##2##(1991-3#1)(1993-6#1)(1995-2#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
decide the##6##2##(1992-4#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2013-7#1)
decide to##5##2##(1995-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-2#1)
decide upon##2##2##(1997-7#1)(2008-10#1)
decide whether to##4##3##(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
decide whether we##2##3##(1994-1#1)(2008-7#1)
decide whether##16##2##(1990-11#1)(1993-2#2)(1994-1#1)(1995-11#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
decide who##2##2##(2010-11#1)(2012-2#1)
decide##54##1##(1990-11#1)(1991-3#1)(1992-4#1)(1993-2#2)(1993-6#1)(1994-1#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)
decided a##2##2##(1996-11#1)(2013-8#1)
decided by the##3##3##(1994-2#1)(2007-11#1)(2008-8#1)
decided by##5##2##(1994-2#1)(2007-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
decided not to##3##3##(1990-9#1)(1996-3#1)(2010-11#1)
decided that the##7##3##(1991-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-11#1)
decided that##11##2##(1991-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-4#1)
decided to continue##2##3##(2008-5#1)(2010-5#1)
decided to study##2##3##(2008-12#1)(2013-7#1)
decided to##26##2##(1990-6#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
decided##63##1##(1990-6#1)(1990-9#1)(1991-6#3)(1992-5#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#2)(2011-4#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
decides##5##1##(1991-9#1)(1993-6#1)(1994-12#1)(2008-11#1)(2012-12#1)
deciding on##2##2##(1996-1#1)(2007-11#1)
deciding the##5##2##(1994-2#1)(1996-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
deciding to##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
deciding when##2##2##(2008-12#1)(2012-2#1)
deciding whether to##2##3##(2007-9#1)(2008-10#1)
deciding whether##6##2##(1991-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-4#1)
deciding which##2##2##(2008-10#1)(2008-4#1)
deciding##26##1##(1991-3#1)(1992-12#1)(1992-9#1)(1994-2#1)(1996-1#2)(1997-8#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#2)(2013-1#1)
decidua and##2##2##(1990-11#1)(2012-3#1)
decidua##9##1##(1990-11#1)(1994-9#2)(2008-10#2)(2012-3#1)(2013-7#3)
decidual cells##2##2##(1992-8#1)(1994-9#1)
decidual##3##1##(1992-8#1)(1994-9#1)(1997-6#1)
decidualization of##2##2##(1994-9#1)(2012-3#1)
decidualization##8##1##(1994-9#4)(1997-6#2)(2012-3#2)
decidualized uterine tissue##3##3##(1997-6#3)
decidualized##4##1##(1994-9#1)(1997-6#3)
deciduous oak##2##2##(2012-9#2)
deciduous teeth##2##2##(2008-12#2)
deciduous##9##1##(2008-11#1)(2008-12#2)(2008-9#1)(2012-9#2)(2013-1#1)(2013-7#1)(2013-8#1)
decim##2##1##(2008-9#2)
decimal##4##1##(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
decipher##8##1##(1997-9#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-8#1)
deciphering molecular##2##2##(2008-10#1)(2011-2#1)
deciphering of##2##2##(2008-7#1)(2009-5#1)
deciphering the##4##2##(1997-6#1)(2008-10#1)(2010-8#1)(2013-1#1)
deciphering##14##1##(1997-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
decision about whether to##2##4##(2008-10#1)(2008-8#1)
decision about##6##2##(1996-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-12#1)
decision aid##5##2##(2013-1#5)
decision analysis model##2##3##(2012-3#2)
decision analysis##6##2##(1994-6#1)(2007-12#2)(2009-4#1)(2012-3#2)
decision and detection limits are##2##5##(1995-9#2)
decision and detection limits##3##4##(1995-9#3)
decision and##6##2##(1995-9#3)(1997-3#1)(2010-8#1)(2013-1#1)
decision by the##2##3##(1992-9#1)(2012-3#1)
decision by##6##2##(1992-9#1)(1994-1#2)(1997-5#1)(2008-7#1)(2012-3#1)
decision can##3##2##(1993-3#1)(1994-3#1)(1995-6#1)
decision for the##3##3##(1991-12#1)(1992-9#1)(2008-10#1)
decision for##10##2##(1991-12#1)(1992-9#1)(1993-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
decision has##2##2##(1993-3#1)(2009-10#1)
decision in##6##2##(1991-12#1)(1993-12#1)(1994-3#1)(1995-6#1)(2008-9#1)(2013-1#1)
decision is##4##2##(1996-6#1)(2008-4#1)(2010-11#1)(2012-2#1)
decision limit##2##2##(2008-10#2)
decision makers and##3##3##(1993-1#1)(1997-1#1)(2008-10#1)
decision makers with##2##3##(2007-12#1)(2010-12#1)
decision makers##22##2##(1991-12#1)(1993-1#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-1#2)(2007-12#1)(2008-10#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
decision making about##3##3##(2008-9#1)(2011-1#1)(2012-3#1)
decision making and the##2##4##(1997-2#1)(2012-12#1)
decision making and##19##3##(1992-1#1)(1992-3#1)(1993-3#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-4#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)
decision making by##3##3##(1994-3#1)(2010-8#1)(2012-3#1)
decision making during##2##3##(2008-12#1)(2011-2#1)
decision making for outpatient chemotherapy in Japanese##2##7##(2010-2#2)
decision making for##6##3##(1992-3#1)(1993-12#1)(2007-10#1)(2010-2#2)(2011-2#1)
decision making in##12##3##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-10#2)(2010-11#1)(2012-1#1)(2013-7#1)
decision making is##2##3##(1993-3#1)(2008-11#1)
decision making process##4##3##(1992-3#1)(1996-6#2)(2011-2#1)
decision making processes##3##3##(2007-5#1)(2013-7#2)
decision making related to##2##4##(2008-11#1)(2010-11#1)
decision making##120##2##(1990-3#1)(1992-1#1)(1992-12#3)(1992-3#4)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-3#5)(1995-3#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#2)(2007-10#3)(2007-11#5)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#4)(2008-1#4)(2008-10#9)(2008-11#4)(2008-12#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-6#1)(2010-11#4)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#6)(2013-1#1)(2013-7#7)
decision may##2##2##(1992-1#1)(1997-5#1)
decision of the##2##3##(1993-1#1)(1997-8#1)
decision of##16##2##(1993-1#1)(1993-11#1)(1997-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
decision on##4##2##(2007-11#1)(2008-10#2)(2009-12#1)
decision point##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
decision points##2##2##(1992-2#1)(2012-12#1)
decision process##6##2##(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-6#1)
decision processes##4##2##(1995-1#1)(2009-3#1)(2009-7#1)(2012-3#1)
decision regarding##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
decision rules for##3##3##(2008-11#1)(2010-2#1)(2013-1#1)
decision rules that##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
decision rules##11##2##(1995-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#3)
decision support and##4##3##(1994-3#1)(2010-8#1)(2013-1#2)
decision support for##2##3##(2008-10#1)(2011-2#1)
decision support in##2##3##(1994-2#1)(2008-11#1)
decision support model##2##3##(2008-10#1)(2013-8#1)
decision support system for##4##4##(1993-2#1)(2008-10#1)(2010-8#2)
decision support system##6##3##(1993-2#1)(2008-10#2)(2010-8#3)
decision support systems##4##3##(1993-2#1)(1997-3#1)(2010-8#1)(2011-2#1)
decision support to##6##3##(1995-2#1)(1996-12#1)(1997-3#2)(2010-4#1)(2013-1#1)
decision support tool##3##3##(2008-10#1)(2009-6#1)(2010-8#1)
decision support##47##2##(1991-9#1)(1993-12#1)(1993-2#3)(1994-2#2)(1994-3#1)(1995-2#1)(1996-12#3)(1997-3#3)(2008-10#5)(2008-11#1)(2008-3#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#11)(2011-2#2)(2012-12#1)(2013-1#7)(2013-8#1)
decision that##2##2##(1991-1#1)(2011-2#1)
decision threshold##3##2##(2008-10#3)
decision to change##2##3##(1997-1#2)
decision to leave##2##3##(2008-9#2)
decision to operate##3##3##(1994-3#1)(1996-6#1)(2007-11#1)
decision to##41##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-6#2)(1997-1#3)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#5)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#3)(2013-1#1)
decision tree##7##2##(2008-10#3)(2010-8#3)(2012-3#1)
decision trees##2##2##(2008-6#2)
decision was made to##2##4##(2008-12#1)(2008-9#1)
decision was made##3##3##(2008-12#1)(2008-9#1)(2013-1#1)
decision was##5##2##(1995-3#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
decision when##3##2##(1992-9#1)(1997-8#1)(2008-9#1)
decision whether to##3##3##(2009-3#1)(2010-12#1)(2013-1#1)
decision##469##1##(1990-2#1)(1990-3#2)(1991-1#1)(1991-12#7)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#5)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#4)(1993-6#1)(1994-1#4)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#13)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#5)(1995-6#7)(1995-9#5)(1996-1#5)(1996-12#10)(1996-2#9)(1996-3#1)(1996-5#1)(1996-6#6)(1997-1#9)(1997-2#1)(1997-3#14)(1997-4#1)(1997-5#4)(1997-8#3)(2007-10#3)(2007-11#8)(2007-12#5)(2007-4#3)(2007-5#1)(2007-8#5)(2008-1#4)(2008-10#38)(2008-11#13)(2008-12#6)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#7)(2008-7#8)(2008-8#4)(2008-9#17)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-10#1)(2010-11#7)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#25)(2011-1#12)(2011-2#15)(2012-1#1)(2012-12#9)(2012-2#3)(2012-3#21)(2013-1#32)(2013-7#9)(2013-8#1)
decision-makers##10##1##(2008-10#1)(2008-11#1)(2009-3#2)(2010-5#1)(2011-2#4)(2012-1#1)
decision-making ability##2##2##(1992-2#1)(2008-9#1)
decision-making and##6##2##(1996-12#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
decision-making are discussed##2##3##(1993-12#1)(2009-11#1)
decision-making in the##5##3##(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)(2011-7#1)
decision-making in##6##2##(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2011-2#1)(2011-7#1)
decision-making is##2##2##(2008-10#1)(2008-4#1)
decision-making on##2##2##(1994-3#1)(2008-11#1)
decision-making power##2##2##(1995-1#1)(2013-8#1)
decision-making process##19##2##(1991-1#1)(1993-1#1)(1993-12#1)(1994-3#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#2)(2011-2#1)(2012-2#1)
decision-making processes##6##2##(1993-12#1)(1997-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
decision-making roles##2##2##(1996-1#1)(2010-8#1)
decision-making skills##5##2##(1992-2#1)(1993-2#1)(2008-11#1)(2010-3#1)(2012-2#1)
decision-making##139##1##(1991-1#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-12#5)(1993-2#2)(1994-1#1)(1994-12#5)(1994-3#3)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#4)(1996-3#1)(1997-1#6)(1997-2#1)(1997-3#1)(2007-10#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#17)(2008-12#7)(2008-4#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#2)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#6)(2011-1#3)(2011-10#1)(2011-2#9)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#4)
decisional capacity##3##2##(2009-4#3)
decisional##9##1##(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#4)(2011-1#1)
decisional-balance##3##1##(2010-2#3)
decisionmakers##3##1##(1992-12#3)
decisionmaking styles##2##2##(1997-3#2)
decisionmaking##8##1##(1990-4#1)(1992-2#1)(1997-3#6)
decisions about health##2##3##(1993-12#1)(2008-7#1)
decisions about the##2##3##(2008-12#1)(2011-3#1)
decisions about##22##2##(1992-12#1)(1992-3#1)(1993-12#4)(1994-11#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
decisions and the##4##3##(1991-1#1)(1994-12#1)(1995-2#1)(2008-7#1)
decisions and##12##2##(1991-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
decisions are based##2##3##(1997-3#1)(2008-8#1)
decisions are made##4##3##(2006-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
decisions are##13##2##(1992-5#1)(1993-1#1)(1995-1#1)(1997-3#1)(2006-10#1)(2008-8#1)(2009-12#2)(2010-3#1)(2011-2#2)(2012-12#2)
decisions associated with##2##3##(2007-10#1)(2007-12#1)
decisions based on##5##3##(1992-2#1)(1994-3#1)(2008-10#1)(2010-7#1)(2012-1#1)
decisions based##6##2##(1992-2#1)(1993-3#1)(1994-3#1)(2008-10#1)(2010-7#1)(2012-1#1)
decisions by##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
decisions concerning the##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
decisions concerning##6##2##(1991-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
decisions during##2##2##(1992-2#1)(2008-11#1)
decisions for patients with##3##4##(1993-12#1)(2008-10#1)(2009-4#1)
decisions for##11##2##(1992-3#1)(1993-12#1)(1995-12#2)(1996-1#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
decisions in the##6##3##(1995-3#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
decisions in##17##2##(1993-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-1#1)(2008-11#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
decisions is##4##2##(1991-1#1)(1991-3#1)(1997-3#1)(2008-11#1)
decisions made##4##2##(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
decisions on the##3##3##(1995-12#1)(1997-8#1)(2008-3#1)
decisions on##12##2##(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-3#2)(2009-6#3)(2010-8#1)(2011-2#1)(2012-12#1)
decisions regarding the##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
decisions regarding##9##2##(1992-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-2#1)
decisions such as##4##3##(1994-3#1)(2008-8#1)(2009-8#1)(2012-3#1)
decisions that##9##2##(1990-6#1)(1993-12#2)(1994-12#1)(1994-3#1)(1996-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
decisions they##2##2##(1994-12#1)(2010-9#1)
decisions to adopt##3##3##(1997-1#1)(2010-11#2)
decisions to##12##2##(1993-2#1)(1994-3#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-11#2)(2012-12#1)
decisions under risk conditions##2##4##(2009-10#2)
decisions under##4##2##(2009-10#4)
decisions was##2##2##(2008-10#1)(2008-11#1)
decisions were made##2##3##(1994-12#1)(2008-10#1)
decisions were##3##2##(1994-12#1)(2008-10#1)(2009-2#1)
decisions when##2##2##(1993-3#1)(1994-9#1)
decisions which##2##2##(1996-1#1)(2010-9#1)
decisions with the##2##3##(2011-1#2)
decisions with##5##2##(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#2)
decisions within##2##2##(1994-12#1)(2008-7#1)
decisions##288##1##(1990-6#1)(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-5#2)(1993-1#4)(1993-12#10)(1993-2#4)(1993-3#4)(1993-5#1)(1994-1#6)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#10)(1994-6#1)(1994-9#2)(1995-1#4)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#1)(1997-3#7)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#6)(2008-10#16)(2008-11#14)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#9)(2008-9#5)(2009-10#5)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#3)(2011-2#11)(2011-3#1)(2011-8#1)(2012-1#1)(2012-12#11)(2012-2#8)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
decisive for the##4##3##(2007-8#2)(2008-2#1)(2008-3#1)
decisive for##6##2##(1995-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)
decisive role in the##3##4##(2008-10#2)(2008-9#1)
decisive role in##5##3##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
decisive##28##1##(1990-11#1)(1992-11#1)(1993-1#1)(1993-9#1)(1995-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)
decisively##3##1##(1993-12#1)(2008-8#1)(2013-1#1)
decitabine##2##1##(2013-8#2)
deck##2##1##(2008-10#1)(2008-2#1)
declaration##4##1##(1990-3#1)(1993-2#1)(2009-10#1)(2009-4#1)
declarative##4##1##(2008-2#3)(2011-3#1)
declare the##2##2##(1991-12#1)(2008-10#1)
declare##4##1##(1991-12#1)(1992-3#1)(1995-9#1)(2008-10#1)
declared a##2##2##(1996-11#1)(2013-8#1)
declared an##2##2##(2007-2#1)(2011-2#1)
declared as##2##2##(1991-3#1)(2008-1#1)
declared by##2##2##(2008-10#2)
declared in##2##2##(2008-7#1)(2010-8#1)
declared##63##1##(1991-1#1)(1991-3#1)(1995-9#1)(1996-11#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#34)(2011-2#3)(2013-1#1)(2013-8#2)
declares Mr##2##2##(1992-1#1)(1992-2#1)
declares##6##1##(1992-1#1)(1992-2#1)(1995-12#1)(1996-11#1)(2008-9#1)(2009-4#1)
declaring##3##1##(1996-5#1)(2008-10#1)(2008-7#1)
decline and##10##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
decline began##2##2##(2008-6#1)(2008-8#1)
decline below the##2##3##(2008-8#1)(2011-2#1)
decline due##2##2##(1993-2#1)(2013-1#1)
decline during##2##2##(1990-3#1)(2008-7#1)
decline in bacterial##2##3##(2008-10#1)(2013-1#1)
decline in bone##2##3##(2007-7#1)(2008-1#1)
decline in cell##2##3##(2008-11#1)(2013-1#1)
decline in immune function##2##4##(1993-12#1)(2010-2#1)
decline in maternal##2##3##(2010-12#2)
decline in renal perfusion##2##4##(1992-8#2)
decline in the number of##3##5##(1991-3#1)(2007-2#1)(2008-10#1)
decline in the population between 2000 and 2010##2##8##(2013-8#2)
decline in the rate of##2##5##(2008-9#1)(2013-1#1)
decline in the total##2##4##(1996-12#1)(2013-8#1)
decline in the##24##3##(1990-6#1)(1991-3#1)(1991-7#1)(1994-11#1)(1996-12#1)(1997-2#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#2)(2013-8#3)
decline in their##2##3##(1992-12#1)(2008-9#1)
decline in##108##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#5)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#6)
decline is##4##2##(1994-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
decline occurring##2##2##(2008-10#2)
decline of cell##2##3##(2008-11#2)
decline of the##5##3##(1994-12#1)(2008-10#2)(2008-5#1)(2010-8#1)
decline of##36##2##(1990-7#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2009-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-7#3)(2013-1#1)
decline or##2##2##(2008-7#1)(2013-1#1)
decline over##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
decline phase##2##2##(2008-11#2)
decline syndrome##2##2##(2008-10#1)(2010-3#1)
decline to##3##2##(1990-7#1)(1991-2#1)(1994-6#1)
decline was##9##2##(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#4)(2013-1#1)
decline with age##3##3##(1991-8#1)(2008-10#1)(2008-9#1)
decline with increasing age##2##4##(1990-2#1)(2013-7#1)
decline with increasing##4##3##(1990-2#1)(2008-11#1)(2008-8#1)(2013-7#1)
decline with##12##2##(1990-2#1)(1991-1#1)(1991-8#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
decline##284##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-6#3)(1997-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#34)(2008-11#16)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#7)(2008-7#36)(2008-8#10)(2008-9#9)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#6)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2012-7#4)(2013-1#22)(2013-7#2)(2013-8#9)
decline]##2##1##(1991-6#1)(1997-8#1)
declined after##4##2##(1995-5#1)(2007-5#1)(2008-10#1)(2008-12#1)
declined and##2##2##(2010-8#1)(2011-2#1)
declined as##3##2##(2008-10#2)(2008-11#1)
declined at##2##2##(1992-8#1)(2008-10#1)
declined by##5##2##(1993-1#1)(2008-10#2)(2010-8#1)(2013-1#1)
declined dramatically##2##2##(1996-5#1)(2008-10#1)
declined during the course of##2##5##(2008-7#2)
declined during the##7##3##(1990-5#1)(1990-6#1)(1995-5#1)(2008-11#2)(2008-7#2)
declined during##9##2##(1990-5#1)(1990-6#1)(1995-5#1)(2008-11#2)(2008-7#2)(2010-2#1)(2013-1#1)
declined exponentially##2##2##(2008-10#2)
declined following##2##2##(1994-5#1)(2008-5#1)
declined from##17##2##(1991-2#3)(1992-3#1)(1993-3#1)(1995-9#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#3)
declined gradually##2##2##(2008-10#1)(2013-8#1)
declined in the##2##3##(2008-10#1)(2011-2#1)
declined in##14##2##(1991-11#1)(1993-3#1)(1993-8#1)(1995-5#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
declined linearly with##4##3##(1993-8#1)(2008-10#2)(2008-7#1)
declined markedly##2##2##(2008-10#1)(2011-2#1)
declined over successive spawnings##2##4##(2010-8#2)
declined over time##4##3##(2007-12#1)(2008-11#1)(2010-5#1)(2011-2#1)
declined over##7##2##(1990-6#1)(2007-12#1)(2008-11#1)(2010-5#1)(2010-8#2)(2011-2#1)
declined progressively##2##2##(1994-12#1)(2008-10#1)
declined rapidly after##2##3##(1996-1#1)(2008-10#1)
declined rapidly through##2##3##(1992-6#1)(2008-10#1)
declined rapidly##7##2##(1992-6#1)(1993-11#1)(1996-1#1)(2008-10#4)
declined significantly in##2##3##(2008-10#1)(2011-2#1)
declined significantly##6##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-5#1)
declined somewhat##2##2##(1991-3#1)(2008-10#1)
declined steadily during##2##3##(1990-5#1)(1993-12#1)
declined steadily##3##2##(1990-5#2)(1993-12#1)
declined surgery and##2##3##(2008-6#1)(2010-5#1)
declined to near zero as the pH##2##7##(2008-10#2)
declined to the##2##3##(2008-10#2)
declined to##13##2##(1990-5#1)(1996-9#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#1)
declined until##3##2##(2007-8#1)(2008-10#2)
declined with age##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2009-9#1)
declined with increasing##4##3##(2008-11#1)(2008-9#2)(2010-3#1)
declined with##10##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-3#1)
declined##170##1##(1990-5#4)(1990-6#4)(1991-11#2)(1991-2#4)(1991-3#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#41)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#6)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#5)
declines in cardiovascular##2##3##(2011-1#2)
declines in the##3##3##(1992-5#1)(1994-3#1)(2009-2#1)
declines in##25##2##(1992-5#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#3)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)
declines with age##3##3##(1990-3#1)(2008-1#1)(2008-7#1)
declines with increasing##2##3##(2008-8#2)
declines with##8##2##(1990-3#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-7#2)(2008-8#2)
declines##57##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#3)(2008-8#9)(2009-2#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#1)(2013-8#1)
declining by##2##2##(1995-12#1)(2010-3#1)
declining in##5##2##(1991-3#1)(1993-3#1)(1997-2#1)(2006-10#1)(2008-1#1)
declining land cover##2##3##(2011-2#2)
declining mobility##4##2##(2008-7#4)
declining or##2##2##(2010-3#1)(2010-7#1)
declining trend##2##2##(1990-3#1)(2012-3#1)
declining##60##1##(1990-3#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#2)(2010-3#3)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
declotting procedures##2##2##(2007-7#2)
decoction##11##1##(2008-10#4)(2012-3#2)(2013-8#5)
decoction]##2##1##(2012-3#2)
decode##6##1##(2007-12#1)(2008-2#1)(2008-3#3)(2012-3#1)
decoded##6##1##(2007-11#1)(2008-3#1)(2009-5#2)(2012-2#1)(2012-3#1)
decoders##6##1##(2008-2#1)(2008-3#5)
decoding the##2##2##(2009-10#1)(2013-8#1)
decoding##19##1##(2008-11#1)(2008-2#6)(2008-3#7)(2009-10#1)(2009-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
decoherence##3##1##(2008-5#1)(2012-2#2)
decoloration##4##1##(2008-10#2)(2008-11#2)
decolorization##2##1##(2008-10#2)
decolourization capacity##2##2##(2011-1#2)
decolourization##3##1##(2011-1#3)
decompensated cirrhosis##2##2##(2012-3#1)(2013-8#1)
decompensated heart failure##5##3##(2008-3#3)(2010-3#1)(2011-2#1)
decompensated##15##1##(2008-3#6)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#2)
decompensation##13##1##(1990-3#1)(1991-2#1)(1991-5#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#2)
decompensation]##2##1##(1990-3#1)(1992-5#1)
decomposable##8##1##(2008-1#1)(2008-11#1)(2009-12#1)(2010-2#5)
decompose the##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
decompose##16##1##(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
decomposed Sphagnum peat##2##3##(2008-10#2)
decomposed by##3##2##(2008-10#3)
decomposed in##2##2##(2008-3#1)(2008-6#1)
decomposed into a##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
decomposed into##11##2##(1992-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#1)(2013-1#1)
decomposed using##2##2##(2008-10#1)(2013-1#1)
decomposed##34##1##(1992-12#1)(1995-11#1)(2007-12#2)(2007-5#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
decomposes to yield##2##3##(1996-2#1)(2008-10#1)
decomposes##6##1##(1995-6#1)(1996-2#2)(2008-10#2)(2008-5#1)
decomposing the##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
decomposing##11##1##(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)
decomposition algorithm##2##2##(2008-10#1)(2008-7#1)
decomposition and##9##2##(2008-10#4)(2008-4#1)(2009-7#1)(2010-4#2)(2010-8#1)
decomposition as##2##2##(2008-10#1)(2008-3#1)
decomposition at##2##2##(2008-10#1)(2008-11#1)
decomposition in##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
decomposition is##5##2##(1994-8#1)(2008-10#3)(2008-11#1)
decomposition method for##2##3##(2008-10#2)
decomposition method##6##2##(2008-10#5)(2010-8#1)
decomposition methods##2##2##(2010-8#1)(2011-2#1)
decomposition of a##5##3##(2008-10#3)(2008-7#1)(2013-8#1)
decomposition of soil##3##3##(2008-10#2)(2013-8#1)
decomposition of the data##2##4##(2008-10#1)(2008-6#1)
decomposition of the organic matrix##2##5##(2008-10#1)(2013-8#1)
decomposition of the organic##3##4##(2008-10#2)(2013-8#1)
decomposition of the##23##3##(1990-11#1)(1992-12#1)(1993-11#1)(1994-8#1)(2008-10#10)(2008-2#3)(2008-3#2)(2008-6#1)(2009-11#1)(2009-7#1)(2013-8#1)
decomposition of##61##2##(1990-11#1)(1990-5#2)(1992-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-8#2)(1996-12#1)(2008-10#32)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#2)(2009-11#2)(2009-7#2)(2010-5#1)(2013-8#4)
decomposition to##2##2##(2008-10#2)
decomposition was##2##2##(2008-10#1)(2010-5#1)
decomposition##164##1##(1990-11#2)(1990-5#2)(1990-8#1)(1992-12#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-8#3)(1996-12#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-1#2)(2008-10#82)(2008-11#7)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-7#3)(2010-10#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#3)(2011-2#5)(2013-8#4)
decompositions##3##1##(2009-9#1)(2010-4#1)(2010-8#1)
decompressed##3##1##(2008-5#1)(2008-7#2)
decompression and extension of fusion##2##5##(2012-3#2)
decompression and neurolysis##2##3##(2013-1#2)
decompression and posterior##2##3##(2008-12#2)
decompression and stabilisation##3##3##(2007-11#2)(2011-2#1)
decompression and##18##2##(2007-11#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)
decompression for##5##2##(2008-7#2)(2011-2#2)(2013-1#1)
decompression is recommended##2##3##(2011-2#1)(2013-1#1)
decompression is##6##2##(2007-11#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
decompression of the spine##2##4##(2008-7#2)
decompression of the##7##3##(1991-8#1)(2007-8#1)(2008-12#1)(2008-7#4)
decompression of##11##2##(1991-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-7#4)(2009-3#2)(2013-8#1)
decompression sickness]##2##2##(1991-6#1)(2010-12#1)
decompression##79##1##(1991-6#3)(1991-8#1)(1994-3#1)(1996-11#2)(2007-11#6)(2007-8#5)(2008-1#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#2)(2008-7#16)(2008-9#1)(2009-3#3)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#2)
decompressive craniectomy##4##2##(2006-7#2)(2008-9#2)
decompressive hemicraniectomy##2##2##(2012-3#2)
decompressive surgery##2##2##(1991-9#1)(2012-12#1)
decompressive##11##1##(1991-9#1)(2006-7#2)(2008-10#1)(2008-9#2)(2009-3#1)(2010-11#1)(2012-12#1)(2012-3#2)
decondensation##2##1##(2008-7#1)(2008-9#1)
decondensed##3##1##(2008-4#1)(2008-9#2)
deconstruction##2##1##(2008-8#1)(2012-3#1)
decontaminated##3##1##(1997-4#1)(2008-4#1)(2008-9#1)
decontaminating##3##1##(2007-7#1)(2008-10#1)(2012-2#1)
decontamination of##5##2##(1991-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
decontamination##13##1##(1991-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#2)
deconvoluted##2##1##(1990-2#1)(2008-10#1)
deconvolution algorithm##3##2##(2008-3#3)
deconvolution for##2##2##(2008-10#1)(2011-2#1)
deconvolution method##5##2##(2008-10#2)(2008-3#3)
deconvolution methods##2##2##(2008-3#2)
deconvolution of the##2##3##(2008-10#1)(2008-4#1)
deconvolution of##5##2##(1997-3#1)(2008-10#3)(2008-4#1)
deconvolution process##2##2##(2008-3#2)
deconvolution was##3##2##(2008-10#2)(2008-2#1)
deconvolution##40##1##(1997-3#2)(2007-12#2)(2008-10#12)(2008-2#1)(2008-3#18)(2008-4#2)(2008-9#1)(2010-3#1)(2011-2#1)
deconvolved##4##1##(2008-10#2)(2008-3#2)
deconvolving##2##1##(2007-12#1)(2010-5#1)
decorated with##6##2##(1991-5#1)(1991-9#2)(1997-4#1)(2008-5#1)(2009-11#1)
decorated##9##1##(1991-5#1)(1991-9#2)(1992-3#2)(1997-4#1)(2008-10#1)(2008-5#1)(2009-11#1)
decoration##5##1##(1995-2#1)(2008-10#3)(2009-7#1)
decorative##2##1##(2008-10#1)(2008-5#1)
decorin##7##1##(1992-10#1)(2007-8#3)(2008-9#1)(2012-1#1)(2012-2#1)
decorrelation of the scattered##2##4##(2008-3#2)
decorrelation of the##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
decorrelation of##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
decorrelation##14##1##(2007-11#1)(2007-12#2)(2008-2#8)(2008-3#3)
decortication##5##1##(2007-12#1)(2007-8#3)(2012-3#1)
decouple the##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
decouple##4##1##(2008-10#1)(2008-6#1)(2010-4#1)(2011-1#1)
decoupled from the##3##3##(2008-3#2)(2008-9#1)
decoupled##7##1##(2008-2#1)(2008-3#4)(2008-9#1)(2010-10#1)
decoupling of##2##2##(2008-8#1)(2008-9#1)
decoupling##6##1##(1992-3#1)(1997-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
decoy##5##1##(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
decoys##7##1##(2008-9#7)
decrease (&quot##2##2##(2009-8#2)
decrease (increase) of##2##3##(2008-10#2)
decrease 2-hydroxylation##2##2##(1995-9#2)
decrease after##4##2##(1991-6#1)(2008-7#1)(2010-5#1)(2013-1#1)
decrease and the##2##3##(2008-10#1)(2008-11#1)
decrease and##7##2##(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)
decrease anxiety and##2##3##(1995-1#1)(2013-1#1)
decrease as a function of##2##5##(1990-3#1)(1990-5#1)
decrease as the##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
decrease as##11##2##(1990-3#1)(1990-5#1)(1994-3#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
decrease at##4##2##(1992-7#2)(2008-11#1)(2008-2#1)
decrease blood##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
decrease bone resorption and##2##4##(1993-11#2)
decrease bone##3##2##(1993-11#2)(2009-3#1)
decrease both##2##2##(1995-11#1)(2008-7#1)
decrease collagen synthesis##2##3##(2008-9#2)
decrease during the##2##3##(2008-5#1)(2013-1#1)
decrease during##7##2##(1994-5#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
decrease for the##2##3##(2008-10#1)(2008-3#1)
decrease for##5##2##(1990-5#1)(2008-10#3)(2008-3#1)
decrease from##5##2##(1997-4#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
decrease future##2##2##(1993-2#1)(2008-8#1)
decrease in HIV##2##3##(2006-10#1)(2013-8#1)
decrease in KmFru6P##2##3##(1995-2#2)
decrease in ST1##2##3##(2013-8#2)
decrease in absorbance of BG##2##5##(2008-10#2)
decrease in absorbance of the##2##5##(2008-10#2)
decrease in absorbance of##8##4##(2008-10#8)
decrease in absorbance##10##3##(2008-10#10)
decrease in activity of##2##4##(1993-11#1)(2008-5#1)
decrease in activity##9##3##(1992-6#1)(1993-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
decrease in alpha(1B)-AR mRNA##2##4##(2008-4#2)
decrease in an##3##3##(2008-10#2)(2011-2#1)
decrease in average##2##3##(1997-1#1)(2008-12#1)
decrease in bile flow##2##4##(1993-3#1)(2008-5#1)
decrease in binding##3##3##(1992-8#1)(1994-11#1)(1995-3#1)
decrease in blood pressure##4##4##(1990-2#1)(1994-11#1)(1995-11#1)(2008-7#1)
decrease in both##6##3##(1994-12#1)(1996-2#1)(1997-1#1)(2008-4#1)(2008-6#1)(2013-7#1)
decrease in cell multiplication##2##4##(2008-11#2)
decrease in cell numbers##2##4##(2008-11#1)(2011-2#1)
decrease in cell##10##3##(1993-8#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-11#4)(2009-7#1)(2011-2#1)
decrease in color intensity of##2##5##(2008-10#2)
decrease in colour intensity of##2##5##(2008-10#2)
decrease in colour##3##3##(1993-12#1)(2008-10#2)
decrease in either##2##3##(1993-9#1)(2010-3#1)
decrease in ethanol##2##3##(2008-6#1)(2012-12#1)
decrease in fluorescence##3##3##(1990-5#1)(1994-5#1)(2008-8#1)
decrease in growth rate##2##4##(2008-11#1)(2013-8#1)
decrease in in vitro##2##4##(1990-12#1)(1993-1#1)
decrease in incidence##2##3##(1995-9#1)(1996-11#1)
decrease in intensity of##2##4##(1990-5#1)(2011-1#1)
decrease in intracellular##2##3##(1991-5#1)(2008-11#1)
decrease in its##4##3##(1992-6#1)(1995-12#1)(1995-2#1)(2011-2#1)
decrease in length of stay##3##5##(1994-12#2)(1995-12#1)
decrease in length of##5##4##(1993-2#1)(1994-12#2)(1995-12#1)(2013-1#1)
decrease in levels##2##3##(1994-3#1)(2008-9#1)
decrease in lung##2##3##(2008-11#1)(2013-1#1)
decrease in mammary gland##2##4##(1991-12#1)(1995-11#1)
decrease in mean##2##3##(2008-7#1)(2008-9#1)
decrease in motor activity and an increase in the##2##9##(1991-2#2)
decrease in motor activity and an##3##6##(1991-2#3)
decrease in muscle##2##3##(1990-6#1)(2013-1#1)
decrease in number of##5##4##(1991-2#2)(2008-10#1)(2008-5#1)(2012-1#1)
decrease in number##6##3##(1991-2#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
decrease in platelet##5##3##(2006-6#1)(2008-10#1)(2011-2#3)
decrease in proliferative##2##3##(2008-6#1)(2012-1#1)
decrease in protein##4##3##(1992-12#1)(2008-8#1)(2011-2#2)
decrease in pulmonary##4##3##(1991-6#1)(2007-9#1)(2008-12#1)(2008-5#1)
decrease in range of motion##2##5##(2007-8#1)(2008-9#1)
decrease in resolution##2##3##(2008-10#2)
decrease in sensitivity##2##3##(1992-8#1)(2008-10#1)
decrease in serum##4##3##(1993-12#1)(1997-8#1)(2013-7#2)
decrease in spasticity##2##3##(2010-9#1)(2011-2#1)
decrease in species richness##2##4##(2008-8#2)
decrease in specific##2##3##(2008-11#1)(2008-7#1)
decrease in the ability of##2##5##(2008-10#1)(2008-5#1)
decrease in the absorbance of the##4##6##(2008-10#4)
decrease in the absorbance of##6##5##(2008-10#6)
decrease in the absorbance##7##4##(2008-10#7)
decrease in the activity of##2##5##(1990-12#1)(2008-10#1)
decrease in the amount of##5##5##(1990-7#1)(1993-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
decrease in the amount##6##4##(1990-7#1)(1993-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
decrease in the apparent affinity of##2##6##(1990-7#1)(1995-12#1)
decrease in the apparent##4##4##(1990-7#1)(1995-12#1)(1997-2#1)(2008-7#1)
decrease in the cell##2##4##(2008-11#2)
decrease in the concentration of##2##5##(2008-10#1)(2008-2#1)
decrease in the degree of##2##5##(1992-9#1)(1993-12#1)
decrease in the ethanol##2##4##(2008-6#2)
decrease in the extraction time of##2##6##(2008-10#2)
decrease in the first##2##4##(1990-11#1)(1991-2#1)
decrease in the fraction##2##4##(1997-7#1)(2008-11#1)
decrease in the frequency of##2##5##(2007-11#1)(2008-10#1)
decrease in the growth##2##4##(1990-3#1)(2009-6#1)
decrease in the level of##3##5##(1991-9#1)(2008-7#1)(2009-8#1)
decrease in the levels of##3##5##(1991-4#1)(2008-12#1)(2010-5#1)
decrease in the mean##5##4##(1996-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-5#1)
decrease in the number of##11##5##(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
decrease in the number##12##4##(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
decrease in the order##2##4##(1990-9#1)(2008-10#1)
decrease in the pH##2##4##(1995-5#1)(2008-10#1)
decrease in the percentage of##5##5##(1991-5#1)(2008-10#2)(2011-2#2)
decrease in the prevalence of##2##5##(1997-3#1)(2007-7#1)
decrease in the rate of protein##2##6##(1990-5#1)(1994-6#1)
decrease in the rate of##3##5##(1990-5#1)(1994-6#1)(1995-6#1)
decrease in the size of##3##5##(1994-8#1)(2007-10#1)(2008-10#1)
decrease in the steady-state##2##4##(1992-1#1)(2008-6#1)
decrease in the value##2##4##(2010-4#1)(2012-2#1)
decrease in the##215##3##(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-6#5)(1994-8#9)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-5#3)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#7)(2008-7#7)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#4)(2009-8#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
decrease in this##3##3##(1992-6#1)(2008-12#1)(2008-7#1)
decrease in total protein##2##4##(1992-12#1)(2008-11#1)
decrease in total##8##3##(1991-6#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-12#1)(2009-8#1)
decrease in unsaturation##2##3##(2008-10#2)
decrease in urine DPD##2##4##(2008-10#2)
decrease in viable##2##3##(2008-10#1)(2008-7#1)
decrease in##689##2##(1990-11#5)(1990-12#6)(1990-2#3)(1990-3#3)(1990-5#6)(1990-6#4)(1990-7#7)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#8)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#6)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-5#1)(1992-6#10)(1992-8#8)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#10)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#6)(1994-11#6)(1994-12#6)(1994-2#2)(1994-3#12)(1994-5#4)(1994-6#7)(1994-8#13)(1994-9#1)(1995-11#5)(1995-12#9)(1995-2#7)(1995-3#4)(1995-5#2)(1995-6#4)(1995-8#4)(1995-9#4)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#5)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#3)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#107)(2008-11#36)(2008-12#17)(2008-2#3)(2008-3#17)(2008-4#8)(2008-5#21)(2008-6#17)(2008-7#24)(2008-8#12)(2008-9#8)(2009-11#4)(2009-12#1)(2009-6#5)(2009-7#3)(2009-8#8)(2009-9#2)(2010-1#2)(2010-11#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#25)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#13)(2013-7#9)(2013-8#13)
decrease is##7##2##(2008-10#5)(2008-11#1)(2013-1#1)
decrease level of##2##3##(2008-8#1)(2012-3#1)
decrease markedly##2##2##(1990-2#1)(2008-8#1)
decrease monotonically##2##2##(2008-11#1)(2008-3#1)
decrease morbidity and mortality##2##4##(1996-9#1)(2008-7#1)
decrease morbidity and##3##3##(1996-9#1)(2008-10#1)(2008-7#1)
decrease morbidity##4##2##(1996-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
decrease more##2##2##(2008-3#1)(2008-9#1)
decrease occurred in##3##3##(2008-10#3)
decrease occurs##2##2##(1997-2#1)(2008-2#1)
decrease of its##2##3##(1995-12#1)(2011-2#1)
decrease of more than##3##4##(2008-7#2)(2008-8#1)
decrease of new##2##3##(2008-10#1)(2011-1#1)
decrease of pain##3##3##(2007-11#3)
decrease of peak current##2##4##(2008-10#2)
decrease of the diastolic##2##4##(1996-6#2)
decrease of the mean##3##4##(1993-12#2)(2008-1#1)
decrease of the peak current##2##5##(2008-10#2)
decrease of the specific##2##4##(1990-11#1)(1994-5#1)
decrease of the##53##3##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-12#4)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-8#1)(1996-6#3)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#3)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#2)(2013-8#1)
decrease of viability##3##3##(2008-11#3)
decrease of##186##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#8)(1993-8#1)(1994-11#1)(1994-2#2)(1994-5#5)(1994-8#4)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#3)(1997-4#2)(1997-5#1)(1997-7#1)(2007-11#6)(2008-1#5)(2008-10#49)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#7)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
decrease on##5##2##(2008-10#1)(2008-5#2)(2009-12#1)(2011-1#1)
decrease or absence of##2##4##(1991-9#1)(2008-10#1)
decrease or increase##2##3##(2008-10#1)(2012-12#1)
decrease or##9##2##(1991-9#1)(1995-5#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#1)
decrease over time##2##3##(2008-10#1)(2008-6#1)
decrease over##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
decrease patient##3##2##(1994-12#1)(1995-1#1)(2012-2#1)
decrease risk##2##2##(2011-2#1)(2013-1#1)
decrease sensitivity to##2##3##(2008-3#1)(2009-12#1)
decrease sensitivity##3##2##(2008-3#1)(2009-12#1)(2011-2#1)
decrease serum##2##2##(2010-11#1)(2011-2#1)
decrease sexual risk behaviors##2##4##(2008-4#1)(2010-7#1)
decrease significantly##5##2##(1996-1#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-3#1)
decrease that was##3##3##(2008-10#1)(2008-3#2)
decrease that##4##2##(1995-3#1)(2008-10#1)(2008-3#2)
decrease the duration of the##2##5##(2007-8#1)(2013-8#1)
decrease the efficiency of##2##4##(2008-8#1)(2008-9#1)
decrease the incidence of##4##4##(1993-3#1)(2011-2#2)(2013-1#1)
decrease the incidence##5##3##(1993-3#1)(2008-10#1)(2011-2#2)(2013-1#1)
decrease the number of##5##4##(2009-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
decrease the occurrence of##2##4##(1990-7#1)(2008-7#1)
decrease the rate of##6##4##(1993-11#1)(1995-5#1)(2007-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
decrease the relative##2##3##(2008-8#2)
decrease the risk of##12##4##(1990-6#1)(1991-2#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
decrease the sensitivity##2##3##(1997-4#1)(2007-12#1)
decrease the severity of##2##4##(2008-5#1)(2009-5#1)
decrease the severity##3##3##(2008-5#2)(2009-5#1)
decrease the specificity of the##2##5##(1990-7#1)(2013-8#1)
decrease the##110##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-5#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
decrease their##7##2##(1993-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2010-12#1)
decrease to##8##2##(1993-11#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
decrease was found##5##3##(1990-11#1)(1990-3#1)(1992-6#1)(2008-3#1)(2013-8#1)
decrease was observed in##2##4##(1993-12#1)(1995-9#1)
decrease was observed##4##3##(1993-12#1)(1995-2#1)(1995-9#1)(2008-12#1)
decrease was##27##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-2#2)(1995-9#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
decrease were##2##2##(2007-12#1)(2010-5#1)
decrease with advancing age##2##4##(1994-5#1)(2011-2#1)
decrease with age##2##3##(2008-5#1)(2011-2#1)
decrease with decreasing##2##3##(1990-8#1)(2008-5#1)
decrease with increasing##12##3##(1992-8#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-3#1)(2013-7#1)
decrease with the increase of##2##5##(2008-10#1)(2009-7#1)
decrease with the##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2009-7#1)
decrease with##30##2##(1990-8#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#4)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-7#1)
decrease##1369##1##(1990-11#8)(1990-12#10)(1990-2#7)(1990-3#7)(1990-5#15)(1990-6#5)(1990-7#10)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#12)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#9)(1991-8#6)(1991-9#4)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#17)(1992-7#2)(1992-8#11)(1992-9#2)(1993-1#6)(1993-10#1)(1993-11#10)(1993-12#22)(1993-2#4)(1993-3#4)(1993-5#2)(1993-6#5)(1993-8#4)(1993-9#7)(1994-11#7)(1994-12#7)(1994-2#9)(1994-3#16)(1994-5#13)(1994-6#9)(1994-8#18)(1994-9#1)(1995-1#2)(1995-11#7)(1995-12#11)(1995-2#11)(1995-3#7)(1995-5#9)(1995-6#4)(1995-8#5)(1995-9#7)(1996-1#2)(1996-11#3)(1996-12#10)(1996-2#8)(1996-3#5)(1996-5#5)(1996-6#4)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#3)(1997-4#7)(1997-5#1)(1997-7#8)(1997-8#3)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#3)(2007-11#15)(2007-12#14)(2007-2#1)(2007-7#3)(2007-8#14)(2007-9#3)(2008-1#12)(2008-10#222)(2008-11#65)(2008-12#27)(2008-2#15)(2008-3#43)(2008-4#16)(2008-5#40)(2008-6#25)(2008-7#52)(2008-8#40)(2008-9#19)(2009-10#2)(2009-11#6)(2009-12#3)(2009-3#3)(2009-5#3)(2009-6#7)(2009-7#6)(2009-8#12)(2009-9#5)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#8)(2010-5#5)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#64)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#21)(2012-3#19)(2012-5#1)(2013-1#35)(2013-7#12)(2013-8#29)
decrease) in##2##2##(2008-3#1)(2013-7#1)
decrease)##6##1##(1994-3#1)(1995-5#1)(2008-10#2)(2008-3#1)(2013-7#1)
decreased (P &lt##6##3##(1996-6#1)(2008-10#1)(2008-7#1)(2010-2#3)
decreased (P&lt##2##2##(2013-1#2)
decreased (approximately##2##2##(1995-11#1)(1995-12#1)
decreased (by##2##2##(1993-3#1)(1994-6#1)
decreased (p &lt##4##3##(2008-11#1)(2008-12#2)(2013-8#1)
decreased (p##6##2##(2008-11#1)(2008-12#2)(2011-2#1)(2013-8#2)
decreased 2##2##2##(2007-10#1)(2008-10#1)
decreased 4##2##2##(1994-6#1)(2008-11#1)
decreased 5##2##2##(1991-9#1)(2007-8#1)
decreased CL intensity was linear##2##5##(2008-10#2)
decreased CL intensity##3##3##(2008-10#3)
decreased TdR kinase activity in##2##5##(1992-8#2)
decreased about##2##2##(1990-3#1)(2008-11#1)
decreased activity##2##2##(1993-3#1)(1997-7#1)
decreased adherence to##2##3##(2008-1#2)
decreased affinity for##2##3##(1990-12#1)(2008-4#1)
decreased after exposure to##2##4##(1992-12#1)(1992-9#1)
decreased after the##4##3##(1996-2#1)(2008-10#1)(2011-1#1)(2013-1#1)
decreased after treatment##2##3##(1995-12#1)(2011-1#1)
decreased after##23##2##(1991-6#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-8#2)(1995-12#3)(1996-2#2)(2008-10#2)(2008-2#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
decreased again##3##2##(2008-8#2)(2013-8#1)
decreased along with##2##3##(2007-8#1)(2008-9#1)
decreased along##3##2##(2007-8#1)(2008-9#1)(2013-1#1)
decreased and a##2##3##(2008-11#1)(2009-8#1)
decreased and increased##2##3##(1994-6#1)(2008-5#1)
decreased and the##8##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2013-8#2)
decreased and##33##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#3)
decreased appetite and##2##3##(2011-1#1)(2011-2#1)
decreased appetite##4##2##(2007-12#1)(2011-1#1)(2011-2#2)
decreased as a function of##2##5##(1995-8#1)(2008-10#1)
decreased as a##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
decreased as compared##2##3##(1995-12#1)(2008-10#1)
decreased as temperature##2##3##(2008-10#2)
decreased as the concentration of##2##5##(2008-11#1)(2008-12#1)
decreased as the##12##3##(1993-3#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2011-3#1)(2012-2#1)
decreased as##27##2##(1993-3#2)(1995-12#1)(1995-3#1)(1995-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
decreased at all##2##3##(1995-12#1)(2008-10#1)
decreased at higher##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
decreased at the end of##2##5##(2008-10#1)(2008-12#1)
decreased at##21##2##(1993-11#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2013-1#1)
decreased attention in##2##3##(2008-11#2)
decreased attention##3##2##(2008-11#3)
decreased basal##2##2##(1995-3#1)(2008-4#1)
decreased binding##3##2##(1993-8#2)(1996-5#1)
decreased blood##2##2##(1994-12#1)(2011-1#1)
decreased body weight gain##2##4##(1996-12#1)(2010-4#1)
decreased body weight##3##3##(1996-12#1)(2010-4#1)(2011-2#1)
decreased bone##3##2##(2007-7#1)(2010-10#2)
decreased both##4##2##(1990-12#1)(1996-5#1)(2013-1#2)
decreased but##4##2##(1990-3#1)(1996-5#1)(2008-11#1)(2010-2#1)
decreased by 10%##2##3##(1991-6#1)(1996-11#1)
decreased by 11%##3##3##(2007-8#1)(2008-3#2)
decreased by 15%##2##3##(1995-3#1)(2008-7#1)
decreased by 20%##2##3##(1990-8#1)(2008-8#1)
decreased by 3##2##3##(1992-6#1)(2007-8#1)
decreased by 31##2##3##(2008-3#2)
decreased by 40%##2##3##(2008-10#1)(2008-11#1)
decreased by 55%##2##3##(2008-11#1)(2008-7#1)
decreased by BBR treatment##2##4##(2012-3#2)
decreased by a factor of##2##5##(1995-2#1)(2008-10#1)
decreased by a##5##3##(1995-2#2)(2008-10#2)(2008-7#1)
decreased by approximately##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
decreased by increasing##2##3##(2008-12#2)
decreased by only##2##3##(1996-5#1)(2008-10#1)
decreased by the##3##3##(1990-5#1)(1994-6#1)(2008-10#1)
decreased by##103##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#3)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#16)(2008-11#5)(2008-12#4)(2008-3#8)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#6)(2012-6#1)(2013-1#1)(2013-8#1)
decreased cardiac output##2##3##(2010-3#1)(2012-3#1)
decreased cardiac##4##2##(1991-10#1)(1994-5#1)(2010-3#1)(2012-3#1)
decreased catabolism of##2##3##(2008-6#2)
decreased cell##2##2##(2010-11#1)(2012-3#1)
decreased cellular DA levels##2##4##(1996-12#2)
decreased cellular##7##2##(1994-2#1)(1996-12#3)(2009-4#1)(2009-6#1)(2013-1#1)
decreased cognitive##2##2##(1993-11#1)(2008-1#1)
decreased compared with those##2##4##(1995-6#1)(2008-7#1)
decreased compared with##4##3##(1995-6#2)(2008-7#1)(2009-6#1)
decreased compared##5##2##(1993-1#1)(1995-6#2)(2008-7#1)(2009-6#1)
decreased compliance##2##2##(2012-3#1)(2013-1#1)
decreased concentration of##2##3##(2008-5#1)(2008-8#1)
decreased concomitantly##2##2##(1992-12#1)(1993-12#1)
decreased correspondingly##2##2##(1996-11#1)(2008-10#1)
decreased costs##3##2##(1992-2#1)(1996-2#1)(2010-11#1)
decreased disease##3##2##(2008-10#3)
decreased due to the##2##4##(2008-10#1)(2013-1#1)
decreased due to##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
decreased during the##10##3##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
decreased during##27##2##(1990-5#1)(1990-7#1)(1991-9#1)(1993-1#1)(1995-3#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#4)(2013-1#1)
decreased elastic##2##2##(2008-5#1)(2013-7#1)
decreased energy##2##2##(2008-10#1)(2008-7#1)
decreased epidermal##2##2##(2008-5#2)
decreased even##2##2##(2008-1#1)(2011-2#1)
decreased exercise tolerance##2##3##(2008-1#1)(2013-7#1)
decreased exponentially with increasing##2##4##(2008-10#2)
decreased exponentially with##3##3##(2008-10#3)
decreased expression of Na(+)/K(+)-ATPase##2##4##(2009-12#2)
decreased expression of the##3##4##(2008-10#1)(2012-12#2)
decreased expression of##11##3##(1995-11#1)(2008-10#2)(2009-12#2)(2009-5#1)(2011-2#2)(2012-1#1)(2012-12#2)
decreased following annuloplasty from##2##4##(2008-10#2)
decreased following##3##2##(2008-10#2)(2008-11#1)
decreased for##5##2##(1991-9#1)(2007-12#1)(2008-10#2)(2010-5#1)
decreased from 0##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
decreased from 1##4##3##(1990-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
decreased from 180##2##3##(1991-6#1)(2009-9#1)
decreased from 2##4##3##(2008-7#3)(2009-11#1)
decreased from 4##2##3##(2008-1#1)(2012-3#1)
decreased from 5##2##3##(1995-6#1)(2010-4#1)
decreased from 9##2##3##(2007-8#1)(2008-7#1)
decreased from a##2##3##(2008-1#1)(2008-7#1)
decreased from approximately##2##3##(2008-10#1)(2008-2#1)
decreased from the baseline of##2##5##(2008-7#2)
decreased from the##8##3##(1990-6#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
decreased from##67##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-6#2)(1992-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-11#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#9)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
decreased gradually as the##2##4##(2008-10#1)(2008-12#1)
decreased gradually from##2##3##(2011-2#1)(2012-3#1)
decreased gradually in##2##3##(1995-8#1)(2013-8#1)
decreased gradually with##2##3##(1995-8#1)(2008-9#1)
decreased gradually##15##2##(1993-11#1)(1993-6#1)(1995-8#2)(1997-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
decreased growth##4##2##(1990-7#1)(1992-3#1)(1995-2#1)(2012-12#1)
decreased hepatic##2##2##(1994-6#1)(2007-8#1)
decreased hospital##2##2##(2011-2#2)
decreased in FW##3##3##(2008-5#1)(2008-7#2)
decreased in a linear##2##4##(2008-10#1)(2008-7#1)
decreased in a##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
decreased in all##4##3##(1994-2#1)(1997-2#1)(2007-8#1)(2009-12#1)
decreased in both groups##3##4##(2009-3#1)(2013-1#1)(2013-8#1)
decreased in both##5##3##(1993-8#1)(2008-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
decreased in cells##2##3##(1993-3#1)(1995-6#1)
decreased in comparison to##2##4##(2008-10#1)(2008-8#1)
decreased in comparison##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
decreased in diabetic liver##2##4##(1993-3#2)
decreased in intensity##2##3##(2008-10#2)
decreased in midbrain and##2##4##(1997-2#2)
decreased in size##3##3##(1991-8#1)(2008-1#1)(2009-6#1)
decreased in the brain of##2##5##(1990-7#1)(2008-7#1)
decreased in the order##4##4##(2008-5#3)(2013-1#1)
decreased in the presence of##4##5##(1996-5#1)(2008-10#3)
decreased in the##33##3##(1990-12#1)(1990-7#2)(1992-3#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-2#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-5#3)(2008-7#3)(2008-9#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
decreased in this##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
decreased in##132##2##(1990-12#1)(1990-7#2)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-12#3)(1993-3#5)(1993-8#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#3)(1997-2#4)(1997-7#1)(2007-11#1)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#23)(2008-11#8)(2008-12#6)(2008-3#2)(2008-5#7)(2008-7#9)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#3)
decreased injury following ischemia-reperfusion##2##4##(1991-9#2)
decreased insulin##2##2##(1991-7#1)(1993-2#1)
decreased intensity##2##2##(2008-10#1)(2011-1#1)
decreased its##4##2##(1993-12#1)(1997-7#1)(2008-11#1)(2011-1#1)
decreased length of##2##3##(2008-10#1)(2013-1#1)
decreased level of##3##3##(1990-12#1)(1992-9#1)(1997-3#1)
decreased levels of##8##3##(1992-12#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-7#1)
decreased linearly with##3##3##(2008-3#1)(2008-6#1)(2009-11#1)
decreased linearly##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2009-11#1)
decreased lung##3##2##(2008-7#1)(2009-9#1)(2012-2#1)
decreased markedly##4##2##(1992-10#1)(1993-12#1)(2008-10#1)(2008-7#1)
decreased maternal age##5##3##(1997-3#5)
decreased mean##2##2##(1996-7#1)(2008-5#1)
decreased metabolic##2##2##(2008-11#1)(2011-1#1)
decreased monotonically##2##2##(2008-3#1)(2008-7#1)
decreased more##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
decreased need##2##2##(2008-10#1)(2011-2#1)
decreased number of##4##3##(1996-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
decreased on##7##2##(1993-12#1)(1994-2#1)(2008-10#2)(2008-8#1)(2010-5#1)(2013-1#1)
decreased only in the##2##4##(1994-2#1)(2011-2#1)
decreased only in##3##3##(1994-2#1)(2008-7#1)(2011-2#1)
decreased only##5##2##(1991-6#1)(1994-2#1)(2008-7#1)(2010-5#1)(2011-2#1)
decreased or##6##2##(1991-6#1)(1993-1#1)(1993-8#1)(1997-4#1)(1997-6#1)(2008-10#1)
decreased over the##2##3##(2010-10#1)(2012-3#1)
decreased over time##4##3##(2008-10#3)(2009-7#1)
decreased over##7##2##(2008-10#3)(2009-7#1)(2010-10#2)(2012-3#1)
decreased overall##2##2##(1992-11#2)
decreased pain##2##2##(2009-12#1)(2013-1#1)
decreased plasma##3##2##(2008-7#1)(2009-5#1)(2010-11#1)
decreased platelet##3##2##(1991-12#1)(2008-3#1)(2008-7#1)
decreased potency in the##2##4##(1991-1#2)
decreased potency##3##2##(1991-1#2)(1993-9#1)
decreased production of##2##3##(2008-7#1)(2012-3#1)
decreased progressively##5##2##(1993-3#1)(1996-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
decreased rapidly##8##2##(1991-2#1)(1992-8#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
decreased release##2##2##(1992-7#1)(1996-12#1)
decreased response to##5##3##(1990-11#1)(2008-11#3)(2008-4#1)
decreased risk of##9##3##(1992-9#1)(1996-9#1)(2007-8#1)(2009-11#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
decreased risk##12##2##(1992-9#1)(1993-12#1)(1996-9#1)(2007-4#1)(2007-8#1)(2009-11#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
decreased sensitivity to##2##3##(1990-7#1)(2008-9#1)
decreased sensitivity##3##2##(1990-7#1)(1991-10#1)(2008-9#1)
decreased serum leptin##2##3##(2008-9#1)(2013-8#1)
decreased serum##8##2##(1996-12#1)(1996-7#1)(2008-7#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
decreased sexual##2##2##(2008-8#1)(2011-2#1)
decreased sharply##4##2##(1996-5#1)(2008-10#3)
decreased sialylation##2##2##(2008-7#2)
decreased signal##2##2##(1991-11#1)(2008-10#1)
decreased significantly and##2##3##(2008-12#1)(2012-2#1)
decreased significantly at##3##3##(1995-2#1)(2010-5#1)(2011-2#1)
decreased significantly by##2##3##(2008-10#1)(2008-11#1)
decreased significantly compared##2##3##(2008-10#1)(2011-3#1)
decreased significantly during the##2##4##(1997-6#1)(2008-10#1)
decreased significantly during##4##3##(1995-3#1)(1997-6#1)(2008-10#1)(2012-3#1)
decreased significantly from##3##3##(2008-1#1)(2008-12#1)(2011-2#1)
decreased significantly in the##5##4##(1993-12#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-12#1)
decreased significantly in##10##3##(1993-12#1)(1993-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-2#1)
decreased significantly to##2##3##(2007-7#1)(2008-12#1)
decreased significantly with increasing##2##4##(1992-6#1)(2008-9#1)
decreased significantly with##6##3##(1990-3#2)(1992-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
decreased significantly##55##2##(1990-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)
decreased sleep##2##2##(1996-7#1)(2008-9#1)
decreased slightly##3##2##(1991-9#1)(2008-10#1)(2008-6#1)
decreased specific##3##2##(2008-11#2)(2008-3#1)
decreased specificity##2##2##(2012-2#1)(2013-1#1)
decreased strength##2##2##(2013-1#2)
decreased substantially##5##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
decreased survival##2##2##(2009-1#1)(2012-3#1)
decreased the ADP-ribosylation of##2##4##(1990-3#2)
decreased the activity of##3##4##(1991-5#1)(1994-8#1)(2013-1#1)
decreased the activity##5##3##(1991-5#1)(1994-8#1)(2009-2#1)(2009-9#1)(2013-1#1)
decreased the affinity of##2##4##(1990-5#1)(1993-6#1)
decreased the affinity##3##3##(1990-5#1)(1993-6#1)(1994-5#1)
decreased the amount of##3##4##(1993-8#1)(1995-6#1)(1996-12#1)
decreased the binding##3##3##(1990-5#1)(1996-2#1)(2008-10#1)
decreased the degree of##2##4##(2008-10#1)(2008-8#1)
decreased the duration of the##2##5##(1992-3#1)(1997-2#1)
decreased the duration of##3##4##(1992-3#1)(1997-2#1)(2008-5#1)
decreased the extent of##2##4##(1990-5#1)(1993-6#1)
decreased the formation of##3##4##(1992-2#1)(1993-3#1)(2008-11#1)
decreased the frequency of##5##4##(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-4#1)
decreased the gold concentration in the kidney and liver##2##9##(1994-5#1)(1995-3#1)
decreased the incidence of##2##4##(1997-4#1)(2008-10#1)
decreased the levels of##2##4##(2008-10#1)(2010-6#1)
decreased the number of##4##4##(1994-8#1)(1995-12#1)(2008-10#1)(2009-3#1)
decreased the number##5##3##(1994-8#1)(1995-12#1)(1996-2#1)(2008-10#1)(2009-3#1)
decreased the platelet deposition##2##4##(2006-6#2)
decreased the potency of##2##4##(1995-3#1)(2008-7#1)
decreased the production of ROS by mitochondria from##2##8##(1994-5#2)
decreased the rate of##2##4##(1994-8#1)(2008-11#1)
decreased the severity of##2##4##(2008-10#1)(2008-5#1)
decreased the##135##2##(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#3)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#5)(1994-6#1)(1994-8#6)(1995-11#2)(1995-12#3)(1995-3#4)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#4)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-10#15)(2008-11#9)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
decreased their##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
decreased thereafter##2##2##(1994-6#1)(2013-1#1)
decreased through##3##2##(1992-5#2)(2008-10#1)
decreased throughout the##3##3##(1990-7#1)(2008-5#1)(2011-1#1)
decreased throughout##4##2##(1990-7#1)(2008-12#1)(2008-5#1)(2011-1#1)
decreased to 0##2##3##(2007-12#1)(2011-1#1)
decreased to 25%##2##3##(2008-8#1)(2008-9#1)
decreased to a##3##3##(1993-11#1)(2007-12#1)(2008-7#1)
decreased to the##3##3##(1993-8#1)(1996-5#1)(2008-10#1)
decreased to##40##2##(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-2#1)(1995-3#1)(1996-5#2)(1997-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
decreased total##2##2##(1992-8#1)(2008-12#1)
decreased under##5##2##(1992-5#1)(1995-2#1)(2008-11#2)(2008-5#1)
decreased until##5##2##(1991-8#1)(1996-12#2)(2008-12#1)(2008-7#1)
decreased upon##5##2##(1993-9#1)(2008-10#2)(2008-11#2)
decreased uptake of##2##3##(1997-7#1)(2008-11#1)
decreased visual##2##2##(2011-1#1)(2011-2#1)
decreased water##2##2##(2008-9#1)(2010-8#1)
decreased when the##4##3##(1997-6#1)(2008-10#1)(2008-3#1)(2008-9#1)
decreased when##12##2##(1990-7#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
decreased whereas##5##2##(1991-12#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-6#1)
decreased while the##2##3##(1993-12#1)(2008-9#1)
decreased with age in##3##4##(1990-3#2)(2008-7#1)
decreased with age##8##3##(1990-12#1)(1990-3#2)(1995-8#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-3#1)
decreased with aging##2##3##(1994-6#1)(2008-7#1)
decreased with an increase in##3##5##(2008-10#1)(2008-11#1)(2008-6#1)
decreased with distance from the##2##5##(2008-10#2)
decreased with further##2##3##(2008-10#1)(2008-5#1)
decreased with increase in##4##4##(2008-10#3)(2008-6#1)
decreased with increased##5##3##(2008-10#2)(2010-4#1)(2013-1#1)(2013-8#1)
decreased with increasing age##3##4##(1992-6#2)(2008-7#1)
decreased with increasing concentrations##2##4##(1996-12#1)(2008-10#1)
decreased with increasing mu##2##4##(2008-10#2)
decreased with increasing soil temperature and##2##6##(2008-10#2)
decreased with increasing temperature and##2##5##(1997-4#1)(2008-9#1)
decreased with increasing temperature##4##4##(1997-4#1)(2008-10#2)(2008-9#1)
decreased with increasing##38##3##(1990-12#1)(1992-3#1)(1992-6#2)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2011-2#1)
decreased with the age##2##4##(2008-10#1)(2008-7#1)
decreased with the increase in##2##5##(2008-11#1)(2008-5#1)
decreased with the##9##3##(1994-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2013-7#1)
decreased with time##2##3##(1994-6#1)(2008-10#1)
decreased with##94##2##(1990-12#2)(1990-3#2)(1992-3#1)(1992-6#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-6#2)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#6)(2008-12#3)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#3)(2009-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-3#1)(2013-7#1)(2013-8#1)
decreased##1635##1##(1990-11#3)(1990-12#9)(1990-2#6)(1990-3#12)(1990-5#9)(1990-6#2)(1990-7#16)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#10)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#8)(1991-7#1)(1991-8#5)(1991-9#13)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#6)(1992-2#5)(1992-3#12)(1992-5#5)(1992-6#9)(1992-7#2)(1992-8#7)(1992-9#5)(1993-1#6)(1993-11#7)(1993-12#15)(1993-2#4)(1993-3#18)(1993-5#1)(1993-6#5)(1993-8#14)(1993-9#6)(1994-10#1)(1994-11#8)(1994-12#4)(1994-2#9)(1994-3#1)(1994-5#15)(1994-6#18)(1994-8#13)(1994-9#2)(1995-11#8)(1995-12#18)(1995-2#14)(1995-3#16)(1995-5#5)(1995-6#7)(1995-8#10)(1996-1#1)(1996-11#4)(1996-12#17)(1996-2#13)(1996-3#2)(1996-5#17)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#2)(1997-2#12)(1997-3#14)(1997-4#8)(1997-6#9)(1997-7#9)(1997-8#3)(2006-10#2)(2006-6#2)(2007-10#2)(2007-11#10)(2007-12#11)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#10)(2007-8#25)(2007-9#2)(2008-1#25)(2008-10#238)(2008-11#93)(2008-12#42)(2008-2#9)(2008-3#29)(2008-4#13)(2008-5#47)(2008-6#21)(2008-7#68)(2008-8#33)(2008-9#48)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#10)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#7)(2009-7#7)(2009-8#8)(2009-9#7)(2010-1#5)(2010-10#7)(2010-11#4)(2010-2#10)(2010-3#1)(2010-4#13)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#35)(2011-2#52)(2011-3#4)(2012-1#8)(2012-12#10)(2012-2#29)(2012-3#27)(2012-6#1)(2012-7#2)(2013-1#61)(2013-3#1)(2013-7#17)(2013-8#19)
decreasein##2##1##(2008-11#2)
decreases NGC-3'##2##2##(1993-12#2)
decreases a##2##2##(2008-10#1)(2012-2#1)
decreases after##4##2##(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
decreases and##2##2##(1992-2#1)(2008-5#1)
decreases as the##6##3##(1991-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-6#1)
decreases as##10##2##(1991-2#1)(1993-12#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)
decreases at##2##2##(1991-12#1)(2008-10#1)
decreases below##2##2##(2008-3#1)(2008-7#1)
decreases by##5##2##(1991-5#1)(2008-10#1)(2008-2#2)(2010-8#1)
decreases during##2##2##(2008-10#1)(2008-12#1)
decreases exponentially with increasing##2##4##(1990-7#1)(2008-10#1)
decreases exponentially with time##2##4##(2008-10#1)(2009-11#1)
decreases exponentially with##4##3##(1990-7#1)(2008-10#2)(2009-11#1)
decreases for##3##2##(2007-11#1)(2008-5#1)(2009-5#1)
decreases from 1##3##3##(1995-2#2)(2009-9#1)
decreases from##5##2##(1995-2#2)(1997-8#1)(2009-9#1)(2011-1#1)
decreases in 2-oxoglutarate levels##2##4##(1991-3#2)
decreases in TCa##2##3##(1997-4#2)
decreases in both##2##3##(1990-7#1)(1993-11#1)
decreases in morphine levels in##2##5##(1997-2#2)
decreases in morphine##3##3##(1997-2#3)
decreases in performance##2##3##(1993-12#1)(2010-8#1)
decreases in platelet counts##2##4##(2007-10#2)
decreases in platelet##3##3##(1997-7#1)(2007-10#2)
decreases in the levels of##2##5##(1993-6#1)(1996-12#1)
decreases in the local##2##4##(2008-8#2)
decreases in the##21##3##(1990-7#1)(1991-12#1)(1991-4#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2010-5#2)(2012-12#1)
decreases in their##2##3##(1995-2#1)(1995-3#1)
decreases in##102##2##(1990-7#2)(1990-8#1)(1991-12#2)(1991-3#2)(1991-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#2)(2007-10#3)(2007-11#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#4)(2009-3#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#1)
decreases linearly with increasing osmolarity##2##5##(1991-11#2)
decreases linearly##3##2##(1991-11#2)(2008-3#1)
decreases markedly##2##2##(1994-8#1)(2008-9#1)
decreases more##2##2##(2008-3#1)(2011-2#1)
decreases of##2##2##(1990-10#1)(2008-5#1)
decreases pain##2##2##(2009-12#1)(2013-1#1)
decreases rapidly##2##2##(1994-9#1)(2008-3#1)
decreases significantly##3##2##(1991-3#1)(2012-3#1)(2013-1#1)
decreases the Vmax##2##3##(1991-5#1)(1994-5#1)
decreases the activity of##2##4##(1997-7#1)(2008-5#1)
decreases the activity##3##3##(1994-2#1)(1997-7#1)(2008-5#1)
decreases the affinity of##2##4##(1990-5#1)(1993-6#1)
decreases the binding affinity of the##2##6##(1990-5#2)
decreases the number of##3##4##(1993-11#1)(1997-7#1)(2008-7#1)
decreases the risk of##8##4##(1990-5#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
decreases the##64##2##(1990-2#1)(1990-5#4)(1990-9#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-12#4)(2007-8#3)(2008-10#8)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#3)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
decreases their##3##2##(1992-12#1)(1997-1#1)(2013-1#1)
decreases to##2##2##(2008-10#1)(2008-8#1)
decreases upon##2##2##(1992-6#1)(2010-11#1)
decreases viral##2##2##(1995-5#1)(2010-12#1)
decreases when##2##2##(2007-11#1)(2008-10#1)
decreases with age##3##3##(1996-5#1)(2008-2#1)(2008-5#1)
decreases with an increase in##3##5##(1997-2#1)(2008-3#1)(2008-8#1)
decreases with increasing temperature##2##4##(1993-8#1)(2009-7#1)
decreases with increasing##13##3##(1990-7#1)(1991-11#1)(1993-8#2)(1997-6#1)(2008-10#3)(2008-2#1)(2009-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
decreases with temperature##3##3##(2008-10#2)(2008-3#1)
decreases with the increase##2##4##(2009-7#1)(2013-7#1)
decreases with the##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2013-7#1)
decreases with##36##2##(1990-7#1)(1991-11#1)(1991-9#1)(1993-8#2)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#3)(2009-12#1)(2009-7#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
decreases##389##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#5)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#2)(1993-6#7)(1993-8#2)(1994-12#3)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#6)(1996-7#3)(1997-1#6)(1997-2#6)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#1)(2007-10#3)(2007-11#8)(2007-12#9)(2007-5#1)(2007-8#5)(2008-1#3)(2008-10#45)(2008-11#7)(2008-12#7)(2008-2#9)(2008-3#18)(2008-4#1)(2008-5#20)(2008-7#13)(2008-8#18)(2008-9#9)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#5)
decreasing and##3##2##(2008-10#2)(2012-3#1)
decreasing at##5##2##(1992-3#1)(2007-11#1)(2008-3#1)(2008-8#2)
decreasing for##2##2##(1997-2#1)(2008-4#1)
decreasing frequency##3##2##(1993-9#2)(2008-1#1)
decreasing from##3##2##(2008-3#1)(2008-6#2)
decreasing gradient##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
decreasing in##12##2##(1990-3#1)(1992-2#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)
decreasing its##3##2##(1990-5#1)(2008-10#2)
decreasing levels of##2##3##(2008-10#1)(2009-8#1)
decreasing of the##5##3##(2008-10#3)(2008-7#1)(2008-9#1)
decreasing of##11##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#3)
decreasing on##2##2##(1994-3#1)(2008-7#1)
decreasing order of##3##3##(1992-12#1)(2008-10#1)(2010-4#1)
decreasing order##5##2##(1992-12#1)(1997-6#1)(2008-10#1)(2010-4#1)(2012-2#1)
decreasing pH##5##2##(1991-8#1)(1995-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
decreasing prevalence of##2##3##(1997-3#1)(2008-10#1)
decreasing relative##2##2##(1997-3#1)(2008-10#1)
decreasing risks of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
decreasing the chances##2##3##(1996-9#1)(2010-3#1)
decreasing the need for##2##4##(2011-2#1)(2012-2#1)
decreasing the pH##2##3##(2009-12#2)
decreasing the peak current obtained proportionally to the increase of its concentration##2##12##(2008-10#2)
decreasing the peak current obtained##3##5##(2008-10#3)
decreasing the peak##4##3##(2008-10#4)
decreasing the risk##4##3##(1992-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
decreasing the##52##2##(1990-5#1)(1990-8#2)(1992-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-9#1)(2007-12#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
decreasing with increasing##4##3##(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
decreasing with##8##2##(1993-8#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-9#1)
decreasing##253##1##(1990-3#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1993-12#3)(1993-2#1)(1993-8#3)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#50)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#11)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#2)
decree##2##1##(1990-3#1)(1995-12#1)
decrement in##2##2##(1994-3#1)(2008-5#1)
decrement of##4##2##(2008-10#3)(2012-3#1)
decrement##11##1##(1993-9#2)(1994-3#1)(1994-5#1)(2008-10#3)(2008-5#2)(2012-3#2)
decrements in##3##2##(2008-3#1)(2012-3#1)(2013-7#1)
decrements##4##1##(1997-6#1)(2008-3#1)(2012-3#1)(2013-7#1)
decrypt the##2##2##(2008-2#1)(2008-3#1)
decrypted data##2##2##(2008-3#2)
decrypted##6##1##(2008-3#6)
decrypting phase##3##2##(2008-3#3)
decrypting##4##1##(2008-2#1)(2008-3#3)
decryption of##5##2##(2007-12#1)(2008-3#4)
decryption##13##1##(2007-11#1)(2007-12#1)(2008-3#11)
decubitus ulcers##2##2##(2007-11#1)(2008-5#1)
decubitus##7##1##(1991-11#1)(1993-6#2)(2007-11#1)(2008-5#1)(2009-3#2)
decyclopropylated degradation product##3##3##(2008-10#3)
decyl polyglucoside##2##2##(2008-5#2)
decyl)##2##1##(2008-10#2)
dedicate##2##1##(1995-3#1)(2009-10#1)
dedicated for##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
dedicated neuronal##2##2##(2009-8#2)
dedicated optoelectronic##2##2##(2008-3#2)
dedicated software##2##2##(2008-2#1)(2012-2#1)
dedicated to health care##2##4##(2013-8#2)
dedicated to improving##2##3##(1993-2#1)(1996-1#1)
dedicated to research##2##3##(1997-3#1)(2008-7#1)
dedicated to the##9##3##(1990-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-9#2)(2011-1#1)(2011-2#1)
dedicated to##37##2##(1990-12#1)(1990-8#1)(1991-4#1)(1993-2#1)(1993-6#1)(1996-1#1)(1997-3#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-9#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
dedicated##80##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1996-1#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
dedication##2##1##(1993-12#1)(2012-3#1)
dedifferentiate##4##1##(2008-11#2)(2008-9#2)
dedifferentiated##6##1##(1995-4#1)(2008-11#1)(2010-3#2)(2011-2#2)
dedifferentiation of the##2##3##(2008-11#2)
dedifferentiation of##3##2##(2008-11#3)
dedifferentiation##12##1##(1994-10#1)(2008-11#8)(2008-5#2)(2011-2#1)
deduce that##2##2##(1993-11#1)(2008-9#1)
deduce the##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-7#1)
deduce##22##1##(1993-11#1)(1993-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)
deduced AA sequence##2##3##(1991-12#2)
deduced aa sequence##11##3##(1990-11#1)(1991-6#1)(1991-7#1)(1993-12#2)(1993-6#1)(1994-12#2)(1995-8#2)(1997-4#1)
deduced aa##13##2##(1990-11#1)(1991-6#1)(1991-7#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-12#2)(1995-8#2)(1997-4#1)
deduced amino acid (aa) sequence##6##5##(1991-6#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-12#2)
deduced amino acid (aa)##7##4##(1991-6#2)(1991-7#1)(1993-12#1)(1993-6#1)(1994-12#2)
deduced amino acid sequence and##2##5##(1991-6#1)(1997-2#1)
deduced amino acid sequence is##3##5##(1993-3#1)(1995-6#1)(1996-6#1)
deduced amino acid sequence of the##5##6##(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1997-4#1)
deduced amino acid sequence of##10##5##(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1997-4#2)(2008-11#1)(2008-8#1)
deduced amino acid sequence revealed##2##5##(1997-4#1)(1997-7#1)
deduced amino acid sequence shows a high##2##7##(1993-2#1)(1995-11#1)
deduced amino acid sequence shows a##3##6##(1993-2#1)(1994-8#1)(1995-11#1)
deduced amino acid sequence shows##4##5##(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)
deduced amino acid sequence was##3##5##(1992-3#1)(1996-12#1)(1997-2#1)
deduced amino acid sequence##37##4##(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#1)
deduced amino acid sequences are##2##5##(1992-10#1)(2008-8#1)
deduced amino acid sequences of the##3##6##(1993-12#1)(2008-10#2)
deduced amino acid sequences of##10##5##(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1996-10#1)(2008-10#2)(2008-7#1)
deduced amino acid sequences revealed##2##5##(1990-12#1)(1994-11#1)
deduced amino acid sequences##18##4##(1990-12#1)(1990-5#2)(1992-10#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1996-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)
deduced amino acid##64##3##(1990-12#1)(1990-5#3)(1991-12#1)(1991-6#3)(1991-7#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#2)
deduced amino##65##2##(1990-12#1)(1990-5#3)(1991-12#1)(1991-6#3)(1991-7#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#3)
deduced amino-acid sequence##4##3##(1994-12#2)(1996-12#1)(2008-8#1)
deduced amino-acid sequences##3##3##(1994-11#2)(1994-12#1)
deduced amino-acid##7##2##(1994-11#2)(1994-12#3)(1996-12#1)(2008-8#1)
deduced by analysis of cDNA clones from human cell line KG-1##3##11##(1995-8#1)(1996-2#2)
deduced by analysis of cDNA clones from##4##7##(1995-8#1)(1996-10#1)(1996-2#2)
deduced by##11##2##(1995-8#1)(1996-10#1)(1996-2#2)(2008-10#3)(2008-2#1)(2008-3#3)
deduced for##3##2##(1993-9#1)(2008-10#1)(2008-3#1)
deduced from the cDNA##2##4##(1991-5#1)(1992-10#1)
deduced from the known##2##4##(1993-6#1)(1993-8#1)
deduced from the nucleotide sequence data##2##6##(1992-3#1)(1997-6#1)
deduced from the nucleotide sequence of the##4##7##(1990-11#1)(1990-2#1)(1990-8#1)(1994-12#1)
deduced from the nucleotide sequence of##5##6##(1990-11#1)(1990-2#1)(1990-8#1)(1994-12#1)(1994-9#1)
deduced from the nucleotide sequence##9##5##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1992-3#1)(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#1)
deduced from the nucleotide##10##4##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-3#1)(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#1)
deduced from the sequence of##4##5##(1992-8#1)(1993-11#1)(1993-6#1)(1997-6#1)
deduced from the##40##3##(1990-11#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-5#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)
deduced from##57##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-5#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-8#2)(2009-8#1)(2010-5#1)(2012-2#2)(2013-1#1)
deduced molecular mass##2##3##(1992-9#1)(1996-10#1)
deduced primary structure of##2##4##(1991-6#1)(1992-3#1)
deduced primary structure##3##3##(1991-6#1)(1992-3#1)(1995-6#1)
deduced primary##4##2##(1991-6#1)(1992-3#1)(1993-9#1)(1995-6#1)
deduced protein exhibited##2##3##(1991-9#1)(1994-6#1)
deduced protein of##2##3##(1993-2#1)(2008-8#1)
deduced protein product##2##3##(1995-6#1)(1997-9#1)
deduced protein##12##2##(1991-9#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1997-9#1)(2008-8#5)(2013-1#1)
deduced sequence of the##2##4##(1993-3#1)(1995-6#1)
deduced sequence of##3##3##(1993-3#1)(1994-12#1)(1995-6#1)
deduced sequence##6##2##(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-6#1)
deduced structure of##2##3##(1993-2#1)(1997-2#1)
deduced that the##3##3##(2008-10#2)(2011-2#1)
deduced that##7##2##(1993-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
deduced the##3##2##(1991-9#1)(1995-8#1)(2008-10#1)
deduced to be##5##3##(1990-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)
deduced to##9##2##(1990-7#1)(1994-5#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-2#1)
deduced##240##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#5)(1990-7#2)(1990-8#1)(1991-12#3)(1991-2#3)(1991-5#2)(1991-6#5)(1991-7#2)(1991-9#3)(1992-10#2)(1992-12#2)(1992-3#4)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#6)(1993-2#10)(1993-3#2)(1993-6#8)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#15)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#7)(1995-8#6)(1996-10#4)(1996-12#3)(1996-2#4)(1996-6#1)(1996-8#1)(1997-2#5)(1997-4#5)(1997-6#3)(1997-7#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#3)(2008-2#6)(2008-3#17)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#15)(2008-9#3)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
deducing the##3##2##(2008-10#2)(2008-3#1)
deducing##4##1##(2008-10#3)(2008-3#1)
deductible##2##1##(1992-12#1)(1996-2#1)
deduction from##2##2##(1990-9#1)(2008-8#1)
deduction of##2##2##(2008-3#1)(2010-12#1)
deduction##6##1##(1990-9#1)(1993-1#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-12#1)
deductions##2##1##(1990-5#1)(2010-4#1)
deductive##6##1##(1994-5#1)(1997-9#1)(2009-8#2)(2010-10#1)(2013-1#1)
deed##2##1##(1994-1#1)(1996-12#1)
deemed a##2##2##(1995-11#1)(2008-10#1)
deemed clinically##2##2##(1996-11#1)(2013-1#1)
deemed necessary##3##2##(2008-2#1)(2008-5#1)(2013-1#1)
deemed prudent##2##2##(2011-1#1)(2012-2#1)
deemed to be##5##3##(1993-3#1)(2007-2#1)(2008-12#1)(2008-9#1)(2009-4#1)
deemed to##6##2##(1993-3#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-4#1)
deemed##33##1##(1993-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
deep LMS (p &lt##2##4##(2008-6#2)
deep LMS##4##2##(2008-6#4)
deep and cystic ovarian##2##4##(1994-9#2)
deep and superficial##2##3##(2008-6#2)
deep and##8##2##(1993-12#1)(1994-9#2)(2007-5#1)(2008-1#1)(2008-6#2)(2008-7#1)
deep brachial##2##2##(2008-7#2)
deep brain stimulation (DBS) in##2##5##(2008-1#1)(2012-3#1)
deep brain stimulation (DBS)##5##4##(2008-1#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
deep brain stimulation##10##3##(2008-1#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
deep breathing##9##2##(1994-3#1)(2012-2#8)
deep cortical layers of##3##4##(1993-12#3)
deep cortical layers##6##3##(1993-12#6)
deep dyslexia##2##2##(1996-2#2)
deep hypothermia##2##2##(2007-8#2)
deep hypothermic circulatory arrest##4##4##(2007-8#1)(2008-8#1)(2013-1#2)
deep hypothermic##5##2##(1995-3#1)(2007-8#1)(2008-8#1)(2013-1#2)
deep images##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
deep infection##2##2##(1991-9#2)
deep infections##3##2##(2007-11#3)
deep inferior epigastric perforator##2##4##(2013-1#2)
deep inferior epigastric##3##3##(2013-1#3)
deep inside the##2##3##(1995-3#1)(2007-12#1)
deep inside##3##2##(1995-3#1)(2007-12#1)(2011-1#1)
deep inspiration##2##2##(2009-11#1)(2011-2#1)
deep into the##3##3##(2007-8#1)(2008-5#1)(2008-6#1)
deep laminae##2##2##(1993-12#2)
deep layer##2##2##(2008-11#1)(2008-7#1)
deep layers of the##2##4##(1990-5#1)(2010-5#1)
deep layers of##3##3##(1990-5#1)(1993-12#1)(2010-5#1)
deep learning##3##2##(2008-11#2)(2011-1#1)
deep mycoses##3##2##(2008-5#3)
deep ocean##3##2##(1990-8#1)(2008-3#1)(2012-2#1)
deep regions##2##2##(2007-11#2)
deep sea##2##2##(2009-8#1)(2011-2#1)
deep seated##3##2##(2007-7#1)(2012-2#2)
deep squat##3##2##(2011-2#3)
deep sternal wound infection after##2##5##(2007-8#2)
deep tendon reflexes##2##3##(2008-6#1)(2008-7#1)
deep tillage was##2##3##(2008-12#2)
deep tillage##7##2##(2008-12#7)
deep tissues##3##2##(1995-12#1)(2008-6#1)(2012-3#1)
deep ultraviolet##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
deep vein thromboses##2##3##(2006-10#1)(2010-1#1)
deep vein thrombosis (DVT)##2##4##(1997-8#1)(2012-2#1)
deep vein thrombosis##9##3##(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2009-1#1)(2010-1#1)(2012-2#1)(2013-8#1)
deep vein##13##2##(1997-8#1)(2006-10#2)(2007-10#3)(2007-12#1)(2009-1#1)(2010-1#2)(2011-3#1)(2012-2#1)(2013-8#1)
deep venous thrombosis (DVT)##3##4##(1993-5#1)(2007-2#1)(2008-3#1)
deep venous thrombosis and pulmonary embolism##3##6##(1997-2#1)(2012-3#1)(2013-1#1)
deep venous thrombosis in##2##4##(1996-6#1)(2008-7#1)
deep venous thrombosis##19##3##(1990-6#1)(1993-5#1)(1993-9#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#2)(2008-3#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-3#2)(2013-1#1)
deep venous##21##2##(1990-6#1)(1993-5#1)(1993-9#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#2)(2007-8#2)(2008-3#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-3#2)(2013-1#1)
deep vibrissal##2##2##(2011-2#2)
deep waters##2##2##(2008-3#1)(2008-8#1)
deep white matter##2##3##(2007-10#1)(2009-10#1)
deep within##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
deep wounds##2##2##(2008-11#2)
deep zone##2##2##(2009-12#1)(2011-2#1)
deep##286##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#11)(1993-5#1)(1993-9#2)(1994-3#2)(1994-8#2)(1994-9#6)(1995-12#3)(1995-3#4)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#3)(2007-10#7)(2007-11#8)(2007-12#10)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#10)(2008-1#5)(2008-10#15)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#7)(2008-6#11)(2008-7#9)(2008-8#9)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-12#3)(2010-5#2)(2010-8#4)(2011-1#9)(2011-2#15)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#15)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#7)
deep)##2##1##(2008-10#2)
deep-UV laser system##2##3##(2008-3#2)
deep-UV##6##1##(2007-11#1)(2008-2#1)(2008-3#4)
deep-inspiration breath-hold##3##2##(2009-11#3)
deep-sea fish cells##4##3##(2008-11#4)
deep-sea fish##6##2##(2008-11#6)
deep-sea hydrothermal##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
deep-sea multicellular organisms under pressure##2##5##(2008-11#2)
deep-sea multicellular organisms##4##3##(2008-11#4)
deep-sea##19##1##(1995-3#1)(2008-10#1)(2008-11#12)(2008-5#1)(2011-2#1)(2012-2#3)
deep-seated##2##1##(2008-6#1)(2008-9#1)
deep-space##2##1##(2008-3#2)
deep-vein thrombosis##3##2##(1990-9#1)(1994-6#1)(2011-2#1)
deepen##6##1##(1994-12#1)(1997-5#1)(2008-10#1)(2009-10#1)(2010-12#1)(2013-7#1)
deepened##2##1##(1990-11#1)(2009-3#1)
deepening of##2##2##(1991-3#1)(2006-12#1)
deepening##3##1##(1991-3#1)(2006-12#1)(2008-10#1)
deeper insight into##2##3##(1993-8#1)(2008-4#1)
deeper insight##5##2##(1993-8#1)(2008-10#1)(2008-4#1)(2012-1#1)(2013-8#1)
deeper insights##2##2##(2009-8#1)(2012-2#1)
deeper layers##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
deeper parts##2##2##(1990-6#1)(2012-1#1)
deeper than##4##2##(1994-9#1)(2008-2#1)(2008-5#1)(2011-1#1)
deeper tissue layers##2##3##(1993-11#1)(2008-3#1)
deeper understanding of the##5##4##(2007-11#1)(2008-11#1)(2008-8#1)(2010-11#1)(2013-1#1)
deeper understanding of##11##3##(2007-11#1)(2008-11#2)(2008-5#1)(2008-8#2)(2010-11#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
deeper waters##2##2##(2008-5#2)
deeper##65##1##(1990-5#1)(1990-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#11)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
deeply embedded in the##2##4##(1990-5#1)(1993-11#1)
deeply embedded##3##2##(1990-5#1)(1991-5#1)(1993-11#1)
deeply infiltrating##2##2##(1992-8#1)(1994-9#1)
deeply rooted in the##2##4##(1997-1#1)(2008-10#1)
deeply rooted in##3##3##(1991-12#1)(1997-1#1)(2008-10#1)
deeply rooted##6##2##(1991-12#1)(1995-5#1)(1997-1#1)(2008-10#2)(2008-11#1)
deeply##34##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
deer (Cervus##3##2##(1993-2#2)(2008-5#1)
deer resistance is##2##3##(2008-8#2)
deer resistance##3##2##(2008-8#3)
deer##30##1##(1993-2#5)(1996-6#1)(2008-10#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#6)(2010-6#1)(2013-7#6)
defatted##10##1##(2007-11#1)(2008-10#5)(2008-11#1)(2008-6#1)(2013-1#2)
defatting##3##1##(2008-10#1)(2008-4#1)(2008-5#1)
default mode network##2##3##(2013-8#2)
default rate##2##2##(2009-5#1)(2013-8#1)
default##14##1##(1990-11#1)(1994-2#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-5#2)(2009-7#1)(2013-1#1)(2013-8#4)
defaulted##2##1##(2008-12#1)(2009-5#1)
defeat##4##1##(1997-1#1)(1997-6#1)(2008-10#2)
defeated##8##1##(1995-6#1)(1996-5#1)(2008-10#5)(2009-10#1)
defecation##3##1##(1993-5#1)(2009-3#1)(2013-1#1)
defect and a##2##3##(2008-3#1)(2008-7#1)
defect and##16##2##(1995-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)
defect associated with##2##3##(1996-2#1)(2012-3#1)
defect at##2##2##(1991-9#1)(2013-1#1)
defect by##4##2##(1997-1#1)(2007-11#1)(2008-11#1)(2012-1#1)
defect causing##2##2##(2008-2#1)(2008-7#1)
defect centers##2##2##(2008-3#2)
defect clusters in##2##3##(2007-12#2)
defect clusters##3##2##(2007-12#3)
defect finesse##2##2##(2008-3#2)
defect in CD28 expression##2##4##(2008-7#2)
defect in a##2##3##(2011-2#1)(2012-1#1)
defect in haematopoietic##2##3##(1990-5#1)(2010-8#1)
defect in platelet secretion##2##4##(2007-8#2)
defect in the##20##3##(1990-5#2)(1992-2#1)(1994-11#2)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
defect in##47##2##(1990-5#6)(1992-2#1)(1994-11#2)(1994-12#2)(1995-2#2)(1995-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
defect is##9##2##(1990-6#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
defect may##2##2##(1990-5#1)(2008-1#1)
defect of a##4##3##(1993-9#1)(1997-3#1)(2013-1#2)
defect of the posterior##2##4##(1997-3#1)(2008-9#1)
defect of the##5##3##(1995-6#1)(1997-3#1)(2008-9#1)(2009-8#1)(2013-1#1)
defect of##18##2##(1993-3#1)(1993-6#1)(1993-9#1)(1995-6#2)(1996-6#1)(1997-3#3)(1997-4#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#3)
defect on the##2##3##(2008-12#1)(2011-2#1)
defect on##3##2##(2008-12#1)(2008-9#1)(2011-2#1)
defect or##3##2##(1990-3#1)(1994-12#1)(1994-3#1)
defect repair##3##2##(2008-11#1)(2008-5#1)(2009-10#1)
defect site##2##2##(2007-12#1)(2010-6#1)
defect sites##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2010-6#1)
defect structures##2##2##(2007-11#2)
defect using##2##2##(2007-8#1)(2008-9#1)
defect was reconstructed##2##3##(2008-9#1)(2011-2#1)
defect was repaired with##2##4##(2007-8#1)(2008-12#1)
defect was repaired##4##3##(2007-8#1)(2008-12#2)(2012-3#1)
defect was##18##2##(1990-5#1)(1991-2#1)(1996-2#2)(1996-6#1)(2007-8#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
defect with a##2##3##(2007-8#1)(2008-6#1)
defect with##9##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
defect##284##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#10)(1990-6#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-3#2)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#4)(1996-2#3)(1996-6#5)(1996-9#1)(1997-1#2)(1997-3#5)(1997-4#1)(1997-7#2)(1997-8#2)(2007-11#21)(2007-12#15)(2007-5#1)(2007-7#1)(2007-8#22)(2008-1#6)(2008-10#7)(2008-11#13)(2008-12#6)(2008-2#1)(2008-3#12)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#11)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#2)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#19)(2012-1#4)(2012-12#9)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#8)
defect) in##2##2##(2007-12#1)(2008-3#1)
defect)##3##1##(2007-12#1)(2008-11#1)(2008-3#1)
defect-free##2##1##(1995-3#1)(2007-12#1)
defect-tolerance##5##1##(2012-2#5)
defective I element##3##3##(1995-8#3)
defective I##4##2##(1995-8#4)
defective RNAs in##2##3##(2008-10#2)
defective RNAs##3##2##(2008-10#3)
defective genes##2##2##(1991-11#1)(2008-11#1)
defective hearing##2##2##(1990-12#2)
defective herpes simplex virus##3##4##(1996-12#2)(2008-11#1)
defective in the##4##3##(1994-2#1)(1997-2#1)(2009-5#1)(2010-2#1)
defective in##23##2##(1990-11#1)(1990-5#1)(1991-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-3#3)(1997-2#2)(1997-7#1)(2008-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-2#2)(2011-1#1)(2011-2#1)
defective interfering (DI)##2##3##(2008-10#2)
defective interfering RNAs##2##3##(1994-8#2)
defective interfering##5##2##(1994-8#3)(2008-10#2)
defective replication##2##2##(2008-9#1)(2012-3#1)
defective##101##1##(1990-11#2)(1990-12#3)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-3#2)(1993-9#5)(1994-2#1)(1994-3#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-8#7)(1995-9#1)(1996-12#2)(1996-3#3)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
defectors##3##1##(2012-3#3)
defects and deformities##2##3##(2007-11#1)(2011-2#1)
defects and the##2##3##(2007-11#1)(2007-8#1)
defects and##28##2##(1994-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
defects are##12##2##(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#1)(2012-12#1)(2013-8#1)
defects associated with##4##3##(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)
defects associated##5##2##(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2013-8#1)
defects by##4##2##(1995-3#1)(2007-11#1)(2012-12#1)(2012-3#1)
defects can##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
defects caused by##3##3##(1990-5#1)(2008-5#1)(2012-3#1)
defects following oncological surgery##2##4##(2008-4#2)
defects following##3##2##(2008-4#2)(2013-1#1)
defects have been identified##2##4##(2007-10#1)(2008-4#1)
defects identified through##2##3##(2012-12#2)
defects identified##3##2##(2012-12#3)
defects in DNA##2##3##(1996-2#1)(2009-4#1)
defects in a##3##3##(2007-11#2)(2008-2#1)
defects in semiconductor crystals by##2##5##(2007-11#2)
defects in semiconductor crystals##3##4##(2007-11#3)
defects in the##26##3##(1991-7#1)(1994-12#2)(1995-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
defects in##97##2##(1990-5#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#3)(1994-6#1)(1995-2#3)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#1)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
defects inside##2##2##(2007-11#1)(2008-3#1)
defects is##3##2##(2007-8#1)(2012-2#1)(2013-1#1)
defects may##3##2##(2008-9#1)(2010-10#1)(2012-2#1)
defects of the anterior##2##4##(1991-5#1)(2010-3#1)
defects of the hand##2##4##(2008-9#1)(2011-2#1)
defects of the oral cavity##2##5##(2007-12#2)
defects of the oral##3##4##(2007-12#3)
defects of the##20##3##(1990-5#1)(1991-5#1)(1997-4#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#2)
defects of##34##2##(1990-5#1)(1991-5#1)(1993-3#1)(1993-9#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-6#2)(2011-2#3)(2012-2#2)(2012-3#1)
defects on the##2##3##(2007-11#1)(2009-11#1)
defects on##4##2##(2007-11#1)(2008-3#2)(2009-11#1)
defects or##2##2##(2007-8#1)(2007-9#1)
defects present in PCOS##2##4##(2008-4#2)
defects responsible for##3##3##(1995-8#1)(2009-5#1)(2011-1#1)
defects such as##4##3##(1997-3#1)(2008-10#1)(2008-3#2)
defects that##6##2##(1996-12#1)(2007-7#1)(2008-1#1)(2011-2#2)(2012-2#1)
defects to##2##2##(2007-12#1)(2008-3#1)
defects was found##3##3##(1993-8#1)(1996-5#1)(2008-11#1)
defects was##5##2##(1993-8#1)(1996-5#1)(2008-11#2)(2008-9#1)
defects were##6##2##(2007-10#1)(2007-11#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-3#1)
defects which##2##2##(1994-5#1)(2010-10#1)
defects with the##2##3##(2013-1#1)(2013-8#1)
defects with##4##2##(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
defects within the##2##3##(2007-12#1)(2010-12#1)
defects##409##1##(1990-11#1)(1990-2#1)(1990-5#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-5#3)(1992-6#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#6)(1994-3#2)(1994-5#1)(1994-6#3)(1995-1#1)(1995-2#3)(1995-3#4)(1995-8#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#7)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#9)(2006-12#1)(2007-10#4)(2007-11#28)(2007-12#16)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#9)(2008-10#18)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#22)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#17)(2008-8#4)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#11)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#25)(2011-3#1)(2012-1#4)(2012-12#19)(2012-2#22)(2012-3#14)(2013-1#8)(2013-8#8)
defects)##3##1##(1997-3#1)(2008-10#1)(2010-10#1)
defects]##3##1##(1990-11#1)(2009-5#1)(2013-1#1)
defence against##4##2##(1990-9#1)(1994-9#1)(1996-5#1)(2012-2#1)
defence and##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
defence mechanism##4##2##(1992-3#1)(1994-8#2)(2012-2#1)
defence mechanisms and##2##3##(1997-6#1)(2008-5#1)
defence mechanisms##4##2##(1997-6#1)(2008-10#1)(2008-5#1)(2011-10#1)
defence of the##2##3##(2008-10#1)(2008-7#1)
defence of##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
defence system##3##2##(2008-5#1)(2008-8#1)(2010-3#1)
defence##30##1##(1990-9#1)(1992-3#1)(1994-8#2)(1994-9#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-10#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#1)
defences##4##1##(2008-5#1)(2009-12#1)(2009-4#1)(2011-10#1)
defend against##4##2##(1997-5#1)(2008-2#1)(2008-6#2)
defend the##2##2##(2008-7#1)(2008-9#1)
defend themselves against##4##3##(1993-3#1)(1997-5#1)(2009-8#1)(2011-10#1)
defend themselves##6##2##(1993-3#1)(1997-5#2)(2008-10#1)(2009-8#1)(2011-10#1)
defend##16##1##(1992-1#1)(1993-3#1)(1997-5#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#1)(2011-10#1)
defendants##6##1##(1992-3#1)(1997-2#1)(1997-5#3)(2011-1#1)
defendants'##3##1##(1992-2#1)(1995-6#2)
defended##3##1##(1992-12#1)(1992-3#1)(2008-4#1)
defender##2##1##(1996-8#1)(1997-9#1)
defending the##3##2##(1995-6#1)(1996-8#1)(2008-8#1)
defending##8##1##(1991-1#1)(1995-6#1)(1996-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-2#1)
defends the##2##2##(1991-3#1)(2011-2#1)
defends##4##1##(1991-3#1)(1997-5#2)(2011-2#1)
defense against fungal pathogens##2##4##(2008-10#1)(2011-2#1)
defense against infection##2##3##(2008-10#1)(2008-9#1)
defense against##25##2##(1990-11#1)(1990-12#1)(1993-12#2)(2007-12#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-7#1)(2011-2#2)
defense and development##2##3##(2009-8#2)
defense and##13##2##(1992-12#1)(1997-5#1)(2008-8#4)(2008-9#1)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)
defense are##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
defense authorization bill##2##3##(1995-6#1)(1996-5#1)
defense bill##3##2##(1995-6#2)(1996-5#1)
defense by##2##2##(2008-10#2)
defense gene##5##2##(2008-10#3)(2008-8#2)
defense genes##4##2##(2008-10#4)
defense in##7##2##(1993-2#1)(1996-12#1)(1996-9#1)(2008-10#3)(2012-2#1)
defense is##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2009-12#1)
defense mechanism and form lung metastases##2##6##(2010-3#2)
defense mechanism of##3##3##(2008-10#3)
defense mechanism##12##2##(2008-10#5)(2008-12#1)(2008-9#1)(2010-3#3)(2012-12#1)(2012-3#1)
defense mechanisms to##2##3##(2008-10#1)(2009-6#1)
defense mechanisms##19##2##(1991-9#2)(1992-11#1)(2008-1#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-2#1)
defense of##8##2##(1991-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-9#1)(2008-11#1)(2010-4#1)
defense organs##2##2##(1995-8#1)(2008-9#1)
defense reaction##2##2##(1993-12#1)(2008-10#1)
defense reaction)##2##2##(2008-10#2)
defense reactions and##2##3##(2008-10#2)
defense reactions in##2##3##(2008-10#2)
defense reactions##12##2##(2008-10#12)
defense response##25##2##(1992-8#1)(2008-10#19)(2008-9#4)(2010-4#1)
defense responses against##3##3##(2008-10#2)(2008-9#1)
defense responses in##3##3##(2008-10#3)
defense responses to##2##3##(2008-10#2)
defense responses##20##2##(2008-10#17)(2008-4#1)(2008-9#1)(2009-6#1)
defense signaling pathways##2##3##(2008-10#1)(2009-8#1)
defense sprays##3##2##(2008-10#3)
defense strategies against##2##3##(2008-10#1)(2010-7#1)
defense strategies##4##2##(1991-3#1)(2008-10#1)(2009-8#1)(2010-7#1)
defense system##18##2##(1991-5#1)(1992-10#1)(1992-12#2)(1994-6#3)(1996-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#4)
defense systems##3##2##(2006-10#1)(2008-10#1)(2009-8#1)
defense to##2##2##(1994-3#1)(2008-10#1)
defense##283##1##(1990-11#1)(1990-12#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#9)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#2)(1994-3#2)(1994-6#3)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-5#4)(1996-9#3)(1997-2#2)(1997-5#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#110)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#19)(2008-9#23)(2009-10#3)(2009-12#1)(2009-6#6)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-7#3)(2011-1#8)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
defense)##2##1##(2008-7#1)(2008-8#1)
defense-associated##2##1##(2008-10#2)
defense-related genes##3##2##(2008-10#3)
defense-related##8##1##(2008-10#7)(2009-8#1)
defense-responsive genes##3##2##(2008-9#3)
defenses against##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
defenses and the##2##3##(1993-2#1)(2013-1#1)
defenses and##6##2##(1993-2#2)(2007-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
defenses of##3##2##(2009-8#2)(2013-1#1)
defenses##38##1##(1991-9#1)(1992-2#2)(1992-3#1)(1993-2#2)(1994-1#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#11)(2009-8#3)(2012-2#2)(2013-1#4)
defensible##2##1##(2008-2#1)(2008-7#1)
defensins##4##1##(2008-4#1)(2008-5#2)(2008-9#1)
defensive and##2##2##(2010-11#1)(2012-3#1)
defensive behavior##3##2##(1992-1#1)(2007-12#2)
defensive behaviors##3##2##(1992-1#1)(2008-4#2)
defensive behaviour##2##2##(1993-12#2)
defensive mechanisms##2##2##(2007-12#1)(2012-12#1)
defensive##34##1##(1991-12#1)(1992-1#2)(1992-12#2)(1993-12#3)(1993-3#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-3#1)(2007-12#7)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-3#2)
defensiveness##2##1##(2008-4#2)
deference to##2##2##(2009-11#2)
deferred##6##1##(1991-12#1)(1994-2#1)(2008-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
deferring##2##1##(2008-11#1)(2009-11#1)
defiance##4##1##(2008-12#4)
defibrillation##4##1##(1991-6#1)(2007-9#1)(2010-9#1)(2011-2#1)
defibrillator implantation##3##2##(2008-12#2)(2012-2#1)
defibrillator##11##1##(2008-12#4)(2008-3#1)(2009-10#1)(2010-9#2)(2011-2#1)(2012-2#2)
defibrillators have##2##2##(2009-10#1)(2010-8#1)
defibrillators##9##1##(1993-2#1)(2008-3#1)(2009-10#2)(2010-5#1)(2010-6#1)(2010-8#2)(2013-8#1)
defibrinogenating##2##1##(1994-9#1)(2008-5#1)
deficiencies and##5##2##(1996-2#1)(2007-11#1)(2011-1#2)(2013-1#1)
deficiencies are associated with##2##4##(1996-2#1)(2008-12#1)
deficiencies are##9##2##(1996-2#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-12#1)(2008-2#2)(2008-8#1)(2011-2#1)
deficiencies in the traditional##2##4##(1994-1#1)(2008-11#1)
deficiencies in the##7##3##(1992-9#1)(1994-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-1#1)
deficiencies in##26##2##(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-1#2)(2012-1#1)
deficiencies of##6##2##(1992-9#1)(2007-12#1)(2008-2#2)(2008-9#1)(2010-8#1)
deficiencies on##3##2##(1993-12#1)(1995-3#1)(2007-8#1)
deficiencies that##2##2##(2008-10#1)(2010-12#1)
deficiencies with##2##2##(2008-2#1)(2011-2#1)
deficiencies within##2##2##(2008-9#1)(2009-7#1)
deficiencies##84##1##(1990-6#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#4)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#6)(1996-2#3)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#4)
deficiency (GHD)##3##2##(2008-4#1)(2011-1#1)(2012-3#1)
deficiency among##6##2##(1991-8#2)(1997-3#1)(2008-9#1)(2012-3#2)
deficiency and for##2##3##(1996-12#1)(2009-10#1)
deficiency and its##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
deficiency and##32##2##(1990-3#1)(1991-11#2)(1991-2#1)(1992-9#1)(1994-8#2)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#2)(2007-2#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#2)(2012-3#2)(2013-8#1)
deficiency anemia##2##2##(1991-6#1)(1994-6#1)
deficiency are##6##2##(1990-8#1)(1997-8#1)(2007-11#1)(2011-1#2)(2012-2#1)
deficiency at##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
deficiency by##3##2##(1990-8#1)(2008-5#1)(2011-1#1)
deficiency can be##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
deficiency can cause##3##3##(2008-6#1)(2009-8#1)(2013-1#1)
deficiency can##7##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
deficiency developed##2##2##(1990-3#1)(2008-7#1)
deficiency disease##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
deficiency does not##2##3##(1991-2#1)(1992-11#1)
deficiency for##2##2##(2011-2#1)(2012-2#1)
deficiency has been associated with##3##5##(2013-1#2)(2013-8#1)
deficiency has been##6##3##(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
deficiency has##8##2##(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
deficiency have been##2##3##(2008-1#1)(2008-10#1)
deficiency have##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
deficiency in a##3##3##(2009-8#1)(2012-3#1)(2013-1#1)
deficiency in adulthood##2##3##(1997-8#1)(2008-10#1)
deficiency in the##15##3##(1990-5#1)(1992-12#1)(1992-9#1)(1993-3#1)(1996-8#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
deficiency in##51##2##(1990-5#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-8#1)(2007-12#4)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#2)(2009-8#1)(2010-2#1)(2011-1#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
deficiency induced##2##2##(2008-8#1)(2012-1#1)
deficiency is a##2##3##(2008-6#1)(2012-2#1)
deficiency is an autosomal recessive##2##5##(1991-8#1)(2008-2#1)
deficiency is an##3##3##(1991-8#1)(2008-2#1)(2009-8#1)
deficiency is associated with a##2##5##(2008-4#1)(2012-3#1)
deficiency is associated with##4##4##(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
deficiency is not##2##3##(1991-9#1)(2012-2#1)
deficiency is##21##2##(1990-8#1)(1991-8#1)(1991-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#2)
deficiency may be##4##3##(1992-9#1)(1994-5#1)(1996-2#1)(2007-12#1)
deficiency may##6##2##(1992-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2012-2#1)
deficiency of bone##2##3##(1990-9#1)(2007-11#1)
deficiency of complexes III and IV of the##2##8##(2011-2#2)
deficiency of the##10##3##(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#1)(1995-5#1)(1996-2#1)(2006-6#1)(2008-2#1)(2008-8#1)(2012-12#1)
deficiency of##40##2##(1990-3#1)(1990-8#2)(1990-9#1)(1991-7#2)(1991-9#2)(1992-12#2)(1992-9#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
deficiency on the##3##3##(1992-3#1)(2008-12#1)(2011-2#1)
deficiency on##4##2##(1992-3#1)(1993-6#1)(2008-12#1)(2011-2#1)
deficiency or##6##2##(1993-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
deficiency presenting##2##2##(1994-3#1)(2008-12#1)
deficiency reduces##2##2##(2013-1#2)
deficiency results in##2##3##(1995-11#1)(2008-12#1)
deficiency rickets##3##2##(2011-1#3)
deficiency syndrome and##2##3##(2010-11#1)(2013-1#1)
deficiency syndrome or##2##3##(1994-3#1)(2012-1#1)
deficiency syndrome##9##2##(1991-9#1)(1992-2#1)(1994-3#1)(1996-11#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
deficiency type##5##2##(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
deficiency was##8##2##(1993-3#1)(1994-11#1)(1997-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
deficiency with normal##2##3##(2008-8#1)(2011-1#1)
deficiency with##7##2##(1990-8#1)(1993-12#1)(1993-6#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
deficiency##463##1##(1990-11#3)(1990-2#2)(1990-3#6)(1990-5#1)(1990-6#1)(1990-8#10)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#11)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#8)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#4)(1993-6#7)(1993-8#1)(1994-11#3)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#4)(1996-2#5)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#3)(2006-6#2)(2007-11#6)(2007-12#12)(2007-2#3)(2007-7#1)(2007-9#1)(2008-1#19)(2008-10#24)(2008-11#5)(2008-12#7)(2008-2#6)(2008-3#5)(2008-4#15)(2008-5#6)(2008-6#3)(2008-7#14)(2008-8#10)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#4)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#30)(2011-2#24)(2012-1#5)(2012-12#7)(2012-2#29)(2012-3#20)(2013-1#23)(2013-7#2)(2013-8#10)
deficiency]##2##1##(1997-5#1)(2007-3#1)
deficient and##5##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-6#1)(2012-2#1)
deficient animals##2##2##(1992-11#1)(1993-6#1)
deficient by##2##2##(1994-5#1)(2009-4#1)
deficient diet##3##2##(1990-6#1)(1992-3#1)(1993-6#1)
deficient diets##2##2##(1994-5#2)
deficient for##6##2##(1992-3#1)(1995-8#1)(2008-11#1)(2012-2#2)(2012-3#1)
deficient in the##4##3##(1991-9#1)(1993-12#1)(2008-10#1)(2008-9#1)
deficient in##30##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#10)(2008-3#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
deficient medium##2##2##(2008-4#2)
deficient mice##10##2##(2008-6#2)(2008-7#2)(2008-8#5)(2010-3#1)
deficient mutants##2##2##(1997-7#1)(2008-7#1)
deficient or##3##2##(1993-12#1)(2008-6#1)(2012-2#1)
deficient rats##7##2##(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#3)
deficient transferrin (CDT)##2##3##(1993-8#1)(1997-2#1)
deficient transferrin##4##2##(1993-12#2)(1993-8#1)(1997-2#1)
deficient##135##1##(1990-11#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-9#1)(1992-11#1)(1992-3#4)(1993-12#4)(1993-2#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-5#7)(1994-8#7)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-8#2)(1996-11#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#3)(2006-6#1)(2007-12#3)(2007-2#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#10)(2012-3#5)(2013-1#1)
deficit and##9##2##(2007-10#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)
deficit by##2##2##(2007-10#1)(2013-1#1)
deficit disorder##2##2##(1995-1#1)(2008-11#1)
deficit for contralateral##2##3##(2009-10#2)
deficit hyperactivity disorder (ADHD) and##2##5##(2013-1#1)(2013-8#1)
deficit hyperactivity disorder (ADHD)##7##4##(1996-6#1)(2008-6#1)(2009-9#1)(2013-1#3)(2013-8#1)
deficit hyperactivity disorder in##2##4##(2008-7#1)(2009-9#1)
deficit hyperactivity disorder##16##3##(1996-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
deficit hyperactivity##17##2##(1996-6#1)(2008-11#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
deficit in a##2##3##(1993-2#1)(2009-8#1)
deficit in the##9##3##(1992-10#1)(1993-12#1)(1996-7#2)(1997-2#1)(2008-11#2)(2008-7#2)
deficit in##29##2##(1991-7#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-7#2)(1997-2#1)(1997-8#1)(2007-10#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-1#2)
deficit is##3##2##(1993-12#2)(1994-3#1)
deficit of##7##2##(1990-3#1)(1994-3#3)(2007-10#1)(2008-8#1)(2009-2#1)
deficit or##5##2##(1996-3#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
deficit regime##2##2##(2008-10#2)
deficit that##2##2##(2011-1#1)(2012-12#1)
deficit was greater##2##3##(1997-2#1)(2007-10#1)
deficit was##9##2##(1992-10#1)(1997-2#2)(2007-10#1)(2007-11#1)(2008-7#1)(2009-2#1)(2011-2#2)
deficit##179##1##(1990-12#1)(1990-3#2)(1990-9#1)(1991-7#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#11)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#6)(1994-5#4)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#10)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#3)(2008-2#1)(2008-4#4)(2008-6#2)(2008-7#12)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#3)
deficit/hyperactivity disorder in##2##3##(1997-8#2)
deficit/hyperactivity disorder##7##2##(1997-8#5)(2011-2#2)
deficit/hyperactivity##9##1##(1997-8#6)(2008-4#1)(2011-2#2)
deficits and##11##2##(1994-8#1)(1996-9#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2013-1#1)
deficits are being##2##3##(2008-7#1)(2012-2#1)
deficits are##12##2##(1991-2#1)(1993-12#2)(2007-7#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)
deficits associated with##2##3##(1994-8#1)(2011-2#1)
deficits caused by bilateral##3##4##(1993-3#1)(1995-5#2)
deficits caused by##4##3##(1993-3#1)(1995-5#2)(2013-1#1)
deficits due to##3##3##(1995-11#1)(2007-10#1)(2008-7#1)
deficits following##3##2##(1993-3#1)(1997-2#1)(2009-10#1)
deficits for##2##2##(2007-10#1)(2008-4#1)
deficits have been##2##3##(2008-7#1)(2011-1#1)
deficits in memory##3##3##(1993-12#1)(1994-8#1)(2013-8#1)
deficits in rats##3##3##(1994-3#1)(1994-8#1)(1997-6#1)
deficits in schizophrenia##2##3##(1996-7#1)(2011-1#1)
deficits in spatial##2##3##(1993-12#2)
deficits in the##5##3##(1993-12#1)(1994-3#1)(1996-7#1)(2008-4#1)(2013-1#1)
deficits in these##2##3##(1992-12#1)(1996-2#1)
deficits in##73##2##(1990-7#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-12#2)(1993-12#7)(1994-3#3)(1994-5#1)(1994-8#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#4)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#6)(2013-1#5)(2013-7#2)(2013-8#1)
deficits of##7##2##(1997-2#1)(1997-7#1)(2007-10#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
deficits on tests of##2##4##(1995-11#1)(2007-8#1)
deficits on this##3##3##(1992-11#1)(1993-3#2)
deficits on##9##2##(1992-11#2)(1993-3#2)(1995-11#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-2#1)
deficits that##2##2##(1996-3#1)(2007-8#1)
deficits to##2##2##(1991-3#1)(2012-3#1)
deficits were##7##2##(1992-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1997-2#1)(1997-6#1)(2007-10#1)
deficits with##4##2##(1993-12#1)(2007-10#1)(2010-3#1)(2012-3#1)
deficits##256##1##(1990-11#1)(1990-7#1)(1991-2#8)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#6)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#16)(1993-3#4)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#6)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#7)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#19)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#3)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#20)(2008-8#1)(2008-9#3)(2009-10#6)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#12)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#8)(2012-9#1)(2013-1#12)(2013-7#2)(2013-8#3)
defies##3##1##(1992-9#1)(2008-1#1)(2008-4#1)
definable##4##1##(1992-1#1)(2006-12#1)(2012-2#1)(2013-1#1)
define a new##2##3##(1992-12#1)(2013-1#1)
define a##22##2##(1990-8#1)(1992-12#1)(1994-6#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
define an##5##2##(1991-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2012-12#1)
define and##9##2##(1993-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)
define best##2##2##(2008-12#1)(2013-1#1)
define both##2##2##(1995-2#1)(2008-2#1)
define its role in##3##4##(1992-11#1)(1994-3#1)(2008-10#1)
define its role##4##3##(1992-11#1)(1994-3#1)(1996-12#1)(2008-10#1)
define its##6##2##(1992-11#1)(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#2)
define the clinical##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
define the effect of##2##4##(1995-2#1)(1997-7#1)
define the factors##2##3##(2008-10#1)(2010-2#1)
define the molecular##3##3##(1992-12#1)(2010-1#2)
define the risk##2##3##(2011-3#1)(2012-3#1)
define the role of the##3##5##(1993-3#1)(2008-10#1)(2008-7#1)
define the role of##11##4##(1990-12#1)(1993-11#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-5#1)
define the role##12##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-5#1)
define the specific##2##3##(2010-1#1)(2013-1#1)
define the term##3##3##(2012-12#1)(2013-1#2)
define the value##2##3##(2007-11#1)(2010-8#1)
define the##121##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-5#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-3#2)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#1)
define these##2##2##(2007-11#1)(2012-2#1)
define two##2##2##(2010-3#1)(2010-4#1)
define which##2##2##(1996-3#1)(2011-2#1)
define##275##1##(1990-11#1)(1990-12#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#4)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#5)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#5)(2007-12#4)(2007-7#2)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#22)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#7)(2012-2#8)(2012-3#8)(2013-1#16)(2013-7#3)(2013-8#3)
defined &quot##3##2##(1994-3#1)(2008-8#1)(2009-8#1)
defined a##5##2##(1991-11#1)(1992-9#1)(1993-1#1)(1997-7#1)(2012-2#1)
defined according to the##3##4##(2007-12#1)(2008-11#1)(2013-1#1)
defined and measured##2##3##(2008-3#1)(2009-11#1)
defined and reproducible##2##3##(2008-7#2)
defined and that##2##3##(1990-12#1)(1990-2#1)
defined and##29##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
defined area##2##2##(1992-1#1)(2008-8#1)
defined as &gt##2##3##(1992-9#1)(2008-1#1)
defined as &quot##6##3##(1991-3#1)(1993-5#1)(1994-6#1)(2008-4#1)(2010-3#1)(2012-3#1)
defined as a ratio##2##4##(2008-3#1)(2011-2#1)
defined as a##34##3##(1991-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-12#2)(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
defined as an##9##3##(1993-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
defined as benign##2##3##(2007-8#1)(2011-2#1)
defined as having##2##3##(1993-3#1)(2008-2#1)
defined as the ability##2##4##(2007-9#1)(2013-1#1)
defined as the concentration##2##4##(2008-10#2)
defined as the difference between##3##5##(1991-11#1)(2009-11#1)(2011-2#1)
defined as the number of##2##5##(2008-8#1)(2012-2#1)
defined as the ratio between##2##5##(2008-6#1)(2013-1#1)
defined as the ratio of the##3##6##(2008-10#1)(2008-11#1)(2008-3#1)
defined as the ratio of##5##5##(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
defined as the ratio##7##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)(2013-1#1)
defined as the##55##3##(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)
defined as those##2##3##(2008-8#1)(2012-12#1)
defined as three times the standard deviation of##2##8##(2008-10#2)
defined as##180##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-1#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#2)(2008-6#6)(2008-7#7)(2008-8#7)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#6)(2012-3#7)(2012-4#1)(2013-1#10)(2013-7#2)(2013-8#2)
defined at the##2##3##(2010-6#1)(2013-1#1)
defined at##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-6#1)(2013-1#1)
defined borders and subpleural locations##2##5##(2008-1#2)
defined brain##3##2##(1995-12#1)(2008-4#1)(2008-7#1)
defined by CT##2##3##(2012-12#2)
defined by RFLP analysis of phlD##2##6##(2008-10#2)
defined by a##9##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
defined by an##4##3##(1991-5#1)(2007-12#1)(2009-8#1)(2011-2#1)
defined by its##2##3##(2008-8#1)(2010-6#1)
defined by the National##2##4##(1995-6#1)(2008-3#1)
defined by the World Health Organization##2##6##(2008-3#1)(2011-2#1)
defined by the absence##2##4##(1995-6#1)(2008-9#1)
defined by the##33##3##(1991-11#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#2)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2013-1#1)
defined by their##7##3##(1992-6#1)(1994-2#1)(1995-8#1)(1997-1#1)(2008-7#1)(2010-9#1)(2012-2#1)
defined by##122##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1994-11#2)(1994-2#2)(1994-3#1)(1995-2#2)(1995-6#3)(1995-8#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-7#2)(2007-10#1)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#7)(2009-12#2)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#4)
defined changes in##2##3##(1993-11#1)(2013-8#1)
defined criteria##2##2##(2008-11#1)(2009-8#1)
defined culture conditions##2##3##(2008-2#1)(2008-8#1)
defined culture##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
defined daily##2##2##(2008-11#2)
defined for the##2##3##(2008-10#1)(2011-1#1)
defined for##10##2##(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
defined group of##2##3##(1990-9#1)(2009-5#1)
defined here as##3##3##(2008-6#1)(2009-5#1)(2013-1#1)
defined here##4##2##(2008-3#1)(2008-6#1)(2009-5#1)(2013-1#1)
defined in a##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
defined in terms of##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
defined in the##9##3##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
defined in this way##2##4##(1993-12#1)(2008-2#1)
defined in this##5##3##(1993-12#1)(2008-10#2)(2008-2#1)(2010-8#1)
defined in##34##2##(1991-3#1)(1993-12#1)(1993-3#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
defined kinetically##2##2##(1992-3#2)
defined media##4##2##(1994-9#1)(1997-4#2)(2008-9#1)
defined medium with##2##3##(1993-6#1)(2013-1#1)
defined medium##10##2##(1993-6#2)(1996-5#2)(1997-4#1)(2008-11#1)(2008-5#2)(2008-9#1)(2013-1#1)
defined mixtures of##4##3##(1996-12#1)(2008-12#2)(2008-9#1)
defined more##2##2##(1990-6#1)(2008-12#1)
defined on the##4##3##(1992-9#1)(1994-12#1)(2008-3#1)(2012-12#1)
defined pattern##2##2##(1994-9#1)(2008-10#1)
defined peak##2##2##(2008-10#1)(2013-8#1)
defined populations##5##2##(1995-12#1)(1996-3#1)(2006-10#1)(2008-10#1)(2013-1#1)
defined previously##2##2##(1997-5#1)(2008-10#1)
defined prognostic factors##2##3##(1997-8#2)
defined protein##2##2##(2008-2#2)
defined protein-free##5##2##(2008-11#5)
defined regions of##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
defined set of##2##3##(2008-10#1)(2012-2#1)
defined subgroups##2##2##(1991-3#1)(2011-2#1)
defined than##2##2##(2008-10#1)(2013-1#1)
defined that##3##2##(2008-3#1)(2008-6#1)(2010-10#1)
defined the##9##2##(1990-11#1)(1991-9#1)(1995-2#1)(1995-5#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)
defined time##4##2##(2012-2#2)(2012-3#1)(2013-1#1)
defined to be##2##3##(2008-11#1)(2009-3#1)
defined to##3##2##(1996-2#1)(2008-11#1)(2009-3#1)
defined using the##2##3##(1997-6#1)(2013-1#1)
defined using##3##2##(1997-6#1)(2010-11#1)(2013-1#1)
defined volume##2##2##(2008-10#2)
defined with##2##2##(2008-3#1)(2008-8#1)
defined##788##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#6)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#6)(1993-1#1)(1993-11#9)(1993-12#9)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#8)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#16)(1995-2#11)(1995-3#1)(1995-5#4)(1995-6#8)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#5)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#13)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#17)(2008-10#85)(2008-11#39)(2008-12#10)(2008-2#22)(2008-3#43)(2008-4#11)(2008-5#18)(2008-6#16)(2008-7#33)(2008-8#25)(2008-9#16)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#3)(2010-8#5)(2010-9#2)(2011-1#8)(2011-2#32)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#23)(2012-3#16)(2012-4#1)(2013-1#33)(2013-7#4)(2013-8#6)
defined--&quot##2##1##(1995-1#2)
defines a new##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
defines a##13##2##(1991-5#1)(1993-8#1)(1994-2#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
defines migraine##2##2##(2008-9#2)
defines the role of##2##4##(1996-2#1)(2007-5#1)
defines the##25##2##(1990-11#1)(1991-2#1)(1993-2#2)(1993-3#1)(1995-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-5#3)(2008-8#1)(2008-9#3)(2011-1#1)(2012-2#1)
defines##65##1##(1990-11#2)(1991-1#1)(1991-2#1)(1991-5#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#3)(1997-1#2)(1997-3#1)(1997-6#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#7)(2009-10#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#1)
defining a##7##2##(1991-7#1)(1993-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2012-2#1)
defining factors##2##2##(1995-6#1)(2008-7#1)
defining feature##2##2##(1996-1#1)(2008-7#1)
defining protein phosphorylation events##2##4##(2008-2#1)(2008-4#1)
defining quality##2##2##(1994-1#1)(2008-4#1)
defining the hospital's##2##3##(1991-1#1)(1991-12#1)
defining the role of##2##4##(2008-2#1)(2010-5#1)
defining the roles of##2##4##(1995-3#1)(2011-1#1)
defining the##38##2##(1991-1#1)(1991-12#1)(1991-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(2007-10#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
defining##111##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#4)(2008-7#7)(2008-8#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#6)(2013-1#3)
definite advantage##2##2##(1997-8#1)(2008-7#1)
definite and##3##2##(2006-10#2)(2011-2#1)
definite conclusion##2##2##(1997-6#1)(2008-1#1)
definite conclusions##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
definite effect on the##2##4##(1996-5#1)(2008-10#1)
definite effect on##3##3##(1996-5#1)(1997-6#1)(2008-10#1)
definite##48##1##(1990-10#2)(1990-12#1)(1990-9#1)(1991-6#2)(1994-10#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-6#2)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
definitely##17##1##(1990-6#1)(1991-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)
definition and measurement##3##3##(2008-2#1)(2013-1#2)
definition and practice##2##3##(1996-9#2)
definition and the##2##3##(1991-1#1)(2008-10#1)
definition and##24##2##(1991-1#2)(1991-12#1)(1995-12#1)(1996-9#2)(2007-4#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#4)
definition for##6##2##(1994-11#1)(2007-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
definition in##4##2##(1992-12#1)(1992-9#1)(1994-8#1)(2007-5#1)
definition is proposed##2##3##(1992-3#1)(2008-10#1)
definition is##9##2##(1992-3#1)(2008-10#1)(2008-3#2)(2012-3#1)(2013-1#4)
definition of &quot##2##3##(1996-6#1)(2008-7#1)
definition of CS##4##3##(2013-1#4)
definition of HC##2##3##(2008-10#2)
definition of MCI##2##3##(2008-6#1)(2013-8#1)
definition of a##5##3##(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)
definition of human##2##3##(1991-2#1)(2008-4#1)
definition of racial disparities##2##4##(2010-3#2)
definition of the##33##3##(1991-12#1)(1991-8#1)(1992-5#1)(1993-1#1)(1995-2#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
definition of this##2##3##(2008-5#1)(2012-1#1)
definition of##119##2##(1991-1#1)(1991-12#3)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-2#3)(1993-3#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#8)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
definition on##2##2##(1991-11#1)(2007-10#1)
definition##214##1##(1990-6#1)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-1#2)(1993-2#3)(1993-3#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-11#2)(1996-2#4)(1996-3#2)(1996-6#1)(1996-9#4)(1997-1#1)(1997-3#2)(1997-5#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#4)(2008-2#8)(2008-3#16)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#11)(2012-1#3)(2012-2#6)(2012-3#3)(2013-1#17)(2013-8#3)
definitional##2##1##(1991-12#1)(1995-1#1)
definitions and##10##2##(1992-12#1)(1992-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
definitions for##3##2##(1994-11#1)(2008-10#1)(2008-3#1)
definitions is##2##2##(2008-1#1)(2008-3#1)
definitions of &quot##2##3##(1991-12#1)(2010-12#1)
definitions of clinical##2##3##(2007-11#1)(2008-5#1)
definitions of the syndrome##2##4##(2008-1#1)(2008-3#1)
definitions of the##5##3##(1993-1#1)(2008-1#2)(2008-3#1)(2011-2#1)
definitions of##39##2##(1991-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#4)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
definitions require##2##2##(1997-4#1)(2011-1#1)
definitions were##2##2##(1997-5#1)(2008-7#1)
definitions with##2##2##(2007-12#1)(2008-2#1)
definitions##96##1##(1990-6#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-3#3)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-5#5)(2007-10#2)(2007-11#1)(2007-12#3)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
definitive EPC colony##2##3##(2012-12#2)
definitive changes in##2##3##(2008-9#1)(2013-1#1)
definitive clinical##2##2##(1990-3#1)(2012-12#1)
definitive conclusions##3##2##(1990-12#1)(1992-12#1)(2009-10#1)
definitive concurrent chemoradiotherapy##2##3##(2012-3#2)
definitive data are##2##3##(2008-8#1)(2012-2#1)
definitive diagnosis of##6##3##(1997-3#1)(1997-8#1)(2008-1#1)(2008-5#1)(2010-8#1)(2012-2#1)
definitive diagnosis was##3##3##(1993-6#1)(1994-7#1)(2011-2#1)
definitive diagnosis##19##2##(1993-6#1)(1993-8#1)(1994-7#1)(1997-3#1)(1997-8#3)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
definitive diagnostic##5##2##(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
definitive evidence of##2##3##(2008-10#1)(2010-12#1)
definitive evidence that##3##3##(1992-9#1)(1995-2#1)(1996-3#1)
definitive evidence##6##2##(1992-9#1)(1995-2#1)(1996-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
definitive host##2##2##(2007-7#1)(2011-2#1)
definitive irradiation##2##2##(1993-9#1)(1994-8#1)
definitive radiotherapy##2##2##(1991-4#2)
definitive studies##2##2##(1995-8#1)(2008-4#1)
definitive surgery was##2##3##(2008-6#2)
definitive surgery##4##2##(1991-3#1)(2008-10#1)(2008-6#2)
definitive therapy##2##2##(2008-10#1)(2010-6#1)
definitive treatment##10##2##(1991-6#1)(2007-8#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-3#1)(2011-2#2)
definitive trials##2##2##(2009-9#1)(2010-5#1)
definitive##136##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#4)(1992-12#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-8#3)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-2#13)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#2)
definitively the##2##2##(2007-8#1)(2008-10#1)
definitively##8##1##(1991-11#1)(1993-12#1)(1997-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)
definiton of the different classes of evidence is available on page##3##11##(2012-12#3)
deflated to##2##2##(1992-9#1)(1997-6#1)
deflating the lungs##2##3##(2007-8#2)
deflation##3##1##(1992-9#1)(2008-4#1)(2008-7#1)
deflect##2##1##(2008-2#1)(2009-6#1)
deflecting##2##1##(2008-3#2)
deflection angles##3##2##(2008-3#3)
deflection is##2##2##(2008-10#1)(2008-2#1)
deflection measurements##2##2##(2008-3#2)
deflection of a##2##3##(2008-10#1)(2008-3#1)
deflection of##4##2##(1995-5#1)(2008-10#1)(2008-3#2)
deflection signal##5##2##(2008-2#5)
deflection signals##2##2##(2008-3#2)
deflection##41##1##(1995-5#1)(2007-11#4)(2007-8#1)(2008-10#2)(2008-2#12)(2008-3#19)(2008-8#2)
deflections##5##1##(2008-2#2)(2008-3#3)
deflectograms##3##1##(2008-2#1)(2008-3#2)
deflector##8##1##(2007-12#2)(2008-2#1)(2008-3#5)
deflectors##3##1##(2008-2#3)
defocus aberration##2##2##(2008-3#2)
defocus blurs##2##2##(2008-3#2)
defocus is##2##2##(2008-2#1)(2008-3#1)
defocus##17##1##(2008-2#9)(2008-3#8)
defocused##10##1##(2008-2#4)(2008-3#6)
defocusing##10##1##(1992-12#1)(2007-12#4)(2008-2#3)(2008-3#2)
defoliating##3##1##(2008-10#2)(2008-5#1)
defoliation intensity##2##2##(2008-10#1)(2008-12#1)
defoliation severity##3##2##(2008-10#3)
defoliation##15##1##(2008-10#11)(2008-12#4)
defoliator##2##1##(2008-11#1)(2008-5#1)
deforestation##5##1##(1991-12#1)(2008-12#1)(2010-5#1)(2011-2#1)(2013-7#1)
deform##7##1##(2007-12#1)(2008-5#1)(2009-10#1)(2009-7#2)(2010-5#1)(2010-8#1)
deformability##4##1##(1991-9#1)(1997-6#1)(2009-11#2)
deformable mirror with a##2##4##(2007-11#2)
deformable mirror with##3##3##(2007-11#3)
deformable mirror##27##2##(2007-11#7)(2007-12#1)(2008-2#8)(2008-3#11)
deformable mirrors##3##2##(2007-11#2)(2008-3#1)
deformable model##3##2##(2009-12#1)(2010-4#1)(2012-3#1)
deformable##41##1##(1996-4#1)(2007-11#10)(2007-12#1)(2008-2#9)(2008-3#12)(2008-6#1)(2009-12#1)(2010-4#3)(2012-3#3)
deformans is##2##2##(2008-10#2)
deformans##8##1##(2008-10#8)
deformation along##2##2##(1994-3#1)(2008-3#1)
deformation and##7##2##(1997-5#1)(2008-3#3)(2008-6#1)(2009-6#1)(2009-7#1)
deformation are##3##2##(2008-2#1)(2009-5#1)(2010-8#1)
deformation disease##2##2##(2008-10#2)
deformation field##3##2##(2008-3#3)
deformation fields##3##2##(2008-3#3)
deformation for the##2##3##(2008-2#1)(2008-7#1)
deformation for##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
deformation fringes##2##2##(2008-3#2)
deformation in a##2##3##(2008-3#2)
deformation in##6##2##(2007-12#1)(2008-10#1)(2008-3#3)(2012-1#1)
deformation index##2##2##(2008-8#1)(2008-9#1)
deformation induced by##2##3##(1990-12#1)(2011-1#1)
deformation is calculated from the##2##5##(2008-2#1)(2010-5#1)
deformation is##7##2##(1990-12#1)(2008-2#2)(2008-3#3)(2010-5#1)
deformation measurement##3##2##(2008-2#1)(2008-3#2)
deformation measurements##3##2##(2008-3#3)
deformation of SWNTs##2##3##(2008-7#2)
deformation of a##5##3##(2008-2#1)(2008-3#3)(2008-7#1)
deformation of normal##2##3##(1992-6#2)
deformation of the##8##3##(2007-12#2)(2008-10#1)(2008-3#3)(2009-11#1)(2009-7#1)
deformation of##27##2##(1992-6#2)(1993-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#8)(2008-7#3)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#3)
deformation on##2##2##(2007-11#1)(2008-3#1)
deformation phase##2##2##(2008-3#2)
deformation rates larger than##2##4##(2009-7#2)
deformation rates##3##2##(2009-7#3)
deformation##152##1##(1990-12#2)(1992-6#3)(1993-11#1)(1994-3#1)(1996-5#1)(1997-5#1)(2007-11#5)(2007-12#7)(2008-10#7)(2008-11#1)(2008-2#11)(2008-3#52)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#13)(2010-5#5)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)
deformational loading##2##2##(2010-9#2)
deformations and##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
deformations are##3##2##(2008-3#3)
deformations as##2##2##(2008-3#2)
deformations between##2##2##(2008-3#1)(2010-5#1)
deformations by##2##2##(2009-10#2)
deformations in##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
deformations of a##2##3##(2008-3#1)(2008-7#1)
deformations of the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
deformations of##10##2##(2007-11#1)(2008-2#1)(2008-3#7)(2008-7#1)
deformations##51##1##(1996-4#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#22)(2008-6#2)(2008-7#1)(2009-10#3)(2009-7#4)(2009-9#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
deformed states##2##2##(1992-8#1)(2008-2#1)
deformed##26##1##(1992-8#1)(1993-11#1)(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
deforming and##2##2##(2008-3#1)(2010-4#1)
deforming##9##1##(1991-3#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-4#1)(2010-4#1)
deformities are##2##2##(2012-2#2)
deformities in children##2##3##(2007-11#1)(2012-2#1)
deformities in##9##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-2#2)
deformities or##2##2##(1997-6#1)(2011-2#1)
deformities##46##1##(1990-9#1)(1991-6#1)(1997-6#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#11)(2013-1#2)
deformity and##11##2##(1991-8#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2012-3#1)
deformity can be effectively##2##4##(2008-8#1)(2008-9#1)
deformity can be##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
deformity correction##3##2##(2007-11#1)(2008-12#1)(2012-12#1)
deformity following##2##2##(2007-11#1)(2008-7#1)
deformity for##2##2##(2008-9#1)(2009-3#1)
deformity in the thoracolumbar##2##4##(2008-8#2)
deformity in the##5##3##(1997-3#1)(2008-7#1)(2008-8#2)(2010-3#1)
deformity in##15##2##(1997-3#4)(2007-8#2)(2008-7#1)(2008-8#2)(2009-3#3)(2010-3#1)(2012-3#2)
deformity of the##2##3##(2007-11#1)(2008-9#1)
deformity of##3##2##(2007-11#1)(2008-9#1)(2010-3#1)
deformity with##3##2##(2012-2#2)(2013-8#1)
deformity##96##1##(1990-6#1)(1990-9#2)(1991-8#1)(1997-3#7)(2007-11#8)(2007-12#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#5)(2008-7#8)(2008-8#8)(2008-9#7)(2009-10#5)(2009-3#9)(2009-4#1)(2010-11#3)(2010-3#2)(2011-2#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#3)(2013-8#2)
deforms##3##1##(2007-12#1)(2008-11#1)(2011-2#1)
defrosting at room temperature##2##4##(2010-4#2)
defrosting at##4##2##(2010-4#4)
defrosting in the##2##3##(2010-4#2)
defrosting practices of ground beef##2##5##(2010-4#2)
defrosting practices##5##2##(2010-4#5)
defrosting##12##1##(2010-4#12)
defuse##2##1##(1993-12#1)(1996-2#1)
deg from the##2##3##(2008-3#2)
deg##21##1##(2008-2#2)(2008-3#19)
deg-1 gene##2##2##(1990-5#2)
degUh mutation##2##2##(1997-4#2)
degUh##5##1##(1997-4#5)
degeneracies##2##1##(1991-11#1)(2007-11#1)
degeneracy and##2##2##(2008-3#1)(2009-10#1)
degeneracy of##3##2##(1990-8#1)(2007-11#1)(2013-8#1)
degeneracy##14##1##(1990-8#1)(1995-5#1)(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#1)(2013-8#1)
degeneracy-split azimuthal modes##2##3##(2008-2#2)
degenerate discs##2##2##(2011-2#2)
degenerate four-wave mixing for##2##4##(2007-12#1)(2008-3#1)
degenerate four-wave mixing in a##2##5##(2007-12#2)
degenerate four-wave mixing in an##2##5##(2007-12#2)
degenerate four-wave mixing in##4##4##(2007-12#4)
degenerate four-wave mixing##11##3##(2007-12#8)(2008-3#3)
degenerate four-wave-mixing##2##2##(2007-12#2)
degenerate oligonucleotide primers##2##3##(1997-4#1)(1997-6#1)
degenerate oligonucleotide##3##2##(1992-8#1)(1997-4#1)(1997-6#1)
degenerate oligonucleotides##6##2##(1990-11#1)(1993-8#1)(1996-8#1)(2008-10#3)
degenerate optical parametric oscillator##2##4##(2007-12#2)
degenerate optical parametric##5##3##(2007-11#3)(2007-12#2)
degenerate or necrotic lymphoblasts##2##4##(2008-5#2)
degenerate parametric amplifier##2##3##(2007-11#1)(2007-12#1)
degenerate primer##2##2##(2008-10#1)(2008-5#1)
degenerate primers is##2##3##(2008-10#2)
degenerate primers that##2##3##(2008-10#2)
degenerate primers were##3##3##(1994-12#1)(2008-10#2)
degenerate primers##19##2##(1993-2#1)(1994-12#4)(1996-8#1)(1997-7#1)(2008-10#12)
degenerate##73##1##(1990-11#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-12#6)(1995-5#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#5)(2007-12#16)(2008-10#17)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#2)
degenerated##8##1##(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
degenerating##4##1##(1995-5#1)(2008-11#2)(2011-2#1)
degeneration -##2##2##(2008-11#2)
degeneration and##17##2##(1992-2#1)(1993-6#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
degeneration by##2##2##(1995-2#1)(2011-2#1)
degeneration followed by##2##3##(1992-9#1)(2008-5#1)
degeneration in Parkinson's disease##2##4##(1995-8#1)(2008-7#1)
degeneration in the liver##2##4##(2008-5#1)(2011-1#1)
degeneration in the##5##3##(1995-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
degeneration in##18##2##(1995-3#1)(1995-8#1)(2008-5#2)(2008-7#2)(2008-9#7)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
degeneration induced by##4##3##(1994-8#3)(2008-7#1)
degeneration is##5##2##(1991-11#1)(1997-3#1)(1997-8#1)(2010-12#1)(2012-12#1)
degeneration of hippocampal neurons##2##4##(2009-12#2)
degeneration of photoreceptor cells##2##4##(1990-11#1)(2008-7#1)
degeneration of the intervertebral disc##3##5##(2007-11#3)
degeneration of the##19##3##(1990-5#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-4#1)(2008-7#3)(2008-9#3)(2010-5#1)(2011-1#1)(2011-2#2)
degeneration of##36##2##(1990-11#1)(1990-5#4)(1990-9#1)(1992-12#1)(1996-6#1)(1997-5#1)(2007-10#1)(2007-11#4)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#4)(2009-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
degeneration or##3##2##(2009-10#1)(2011-2#2)
degeneration to##2##2##(1995-8#1)(2009-4#1)
degeneration##198##1##(1990-11#4)(1990-5#4)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-6#1)(1994-8#5)(1995-2#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-6#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#10)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-3#1)(2008-4#4)(2008-5#7)(2008-7#17)(2008-9#23)(2009-10#1)(2009-12#5)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#8)(2011-2#26)(2011-7#2)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#1)
degenerative and##4##2##(1993-2#1)(1994-5#2)(2008-7#1)
degenerative arthritis##4##2##(2007-8#1)(2008-8#1)(2013-1#2)
degenerative changes in the##9##4##(1993-5#1)(2006-6#1)(2007-8#5)(2011-2#1)(2012-12#1)
degenerative changes in##15##3##(1993-5#1)(1997-3#3)(2006-6#1)(2007-11#1)(2007-8#5)(2011-2#1)(2012-12#1)(2013-1#2)
degenerative changes of the##3##4##(2007-11#2)(2007-8#1)
degenerative changes of##4##3##(1990-3#1)(2007-11#2)(2007-8#1)
degenerative changes that##2##3##(1997-3#1)(2010-3#1)
degenerative changes##34##2##(1990-3#1)(1992-12#1)(1992-9#1)(1993-5#1)(1997-3#5)(1997-6#1)(2006-6#1)(2007-11#4)(2007-8#10)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#4)
degenerative dementias##2##2##(2008-7#2)
degenerative disc disease (DDD)##2##4##(2011-2#1)(2012-12#1)
degenerative disc disease and lumbar instability##2##6##(2011-2#2)
degenerative disc disease##12##3##(2008-11#2)(2008-7#1)(2011-2#4)(2012-12#2)(2012-3#3)
degenerative disc##14##2##(2008-11#2)(2008-7#1)(2011-2#5)(2012-12#3)(2012-3#3)
degenerative disease and##2##3##(1994-5#1)(2009-3#1)
degenerative disease of the##4##4##(2007-11#2)(2007-8#1)(2012-12#1)
degenerative disease of##5##3##(2007-11#2)(2007-8#1)(2008-9#1)(2012-12#1)
degenerative disease##9##2##(1994-5#1)(2007-11#2)(2007-8#1)(2008-9#1)(2009-3#1)(2012-12#2)(2013-8#1)
degenerative diseases of the##3##4##(2007-8#1)(2008-7#1)(2012-2#1)
degenerative diseases##16##2##(1992-9#1)(1994-11#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
degenerative disk##2##2##(2009-3#1)(2013-8#1)
degenerative disorders##2##2##(1995-12#1)(2013-7#1)
degenerative effects##2##2##(1991-11#1)(2011-2#1)
degenerative joint disease##4##3##(1992-4#1)(1996-6#1)(2007-11#1)(2011-2#1)
degenerative joint##5##2##(1992-4#1)(1996-6#1)(2007-11#1)(2011-2#2)
degenerative mitral regurgitation##2##3##(2009-4#2)
degenerative or##2##2##(1993-2#1)(2008-7#1)
degenerative process##2##2##(2008-9#1)(2013-1#1)
degenerative processes##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
degenerative spondylolisthesis##2##2##(2012-12#2)
degenerative##130##1##(1990-3#1)(1991-11#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-2#2)(1993-5#1)(1994-11#2)(1994-5#3)(1995-12#1)(1996-6#1)(1997-3#5)(1997-6#2)(2006-6#1)(2007-11#8)(2007-7#1)(2007-8#15)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#5)(2009-4#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#2)(2011-2#11)(2012-12#10)(2012-2#2)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
deglutition##2##1##(1990-3#1)(2011-1#1)
deglycosylase##2##1##(1994-5#2)
deglycosylated##3##1##(1990-8#1)(1991-12#1)(1997-2#1)
deglycosylation of##2##2##(1993-8#1)(1994-3#1)
deglycosylation##6##1##(1993-1#2)(1993-8#1)(1994-3#1)(1994-5#1)(2012-12#1)
degradability##3##1##(2008-7#1)(2010-10#1)(2010-3#1)
degradable##10##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-11#1)(2010-10#5)
degradant##2##1##(2008-10#1)(2008-11#1)
degradation -##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
degradation and can##2##3##(2008-11#1)(2012-2#1)
degradation and the##2##3##(1992-8#1)(2008-12#1)
degradation and##28##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-8#2)(1994-8#1)(1995-6#1)(1996-12#2)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#3)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
degradation are##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
degradation as well as##2##4##(1992-3#1)(2009-7#1)
degradation as well##3##3##(1992-3#1)(1994-11#1)(2009-7#1)
degradation at##3##2##(2008-10#2)(2008-7#1)
degradation behavior##3##2##(2010-10#1)(2012-2#2)
degradation by a##3##3##(2008-6#1)(2008-9#1)(2011-2#1)
degradation by the##4##3##(1990-2#1)(1995-12#1)(2008-10#1)(2008-5#1)
degradation by##23##2##(1990-2#1)(1991-7#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
degradation can##3##2##(2008-10#2)(2008-4#1)
degradation due to##2##3##(2008-11#1)(2008-2#1)
degradation during##5##2##(1997-2#1)(2008-10#1)(2008-7#1)(2011-10#1)(2011-2#1)
degradation effects##2##2##(2008-3#1)(2012-1#1)
degradation in either mirror image suppression performance or detectable velocity dynamic range##2##12##(2011-1#2)
degradation in the endoplasmic reticulum##2##5##(1993-11#1)(1995-2#1)
degradation in the##12##3##(1991-6#1)(1992-8#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-12#1)(2012-2#1)
degradation in##30##2##(1991-12#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#3)(2012-12#1)(2012-2#1)
degradation induced by##3##3##(1991-12#1)(1992-11#1)(1995-6#1)
degradation is##10##2##(1990-8#1)(1992-12#1)(1994-10#1)(2008-10#2)(2008-11#2)(2008-3#2)(2013-1#1)
degradation may##2##2##(2008-10#1)(2011-10#1)
degradation mechanism##2##2##(1994-9#1)(1995-2#1)
degradation occurs##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
degradation of 2##2##3##(2008-10#2)
degradation of IRS-1 in vitro##2##5##(1995-8#2)
degradation of LDL receptor##2##4##(1990-7#2)
degradation of LDL##3##3##(1990-7#2)(1991-5#1)
degradation of VHL##2##3##(2011-1#2)
degradation of a##4##3##(2008-11#2)(2008-3#1)(2013-1#1)
degradation of amyloid##2##3##(1992-12#1)(1994-9#1)
degradation of both##3##3##(2008-10#1)(2008-4#1)(2009-7#1)
degradation of host##2##3##(2008-10#2)
degradation of l-ascorbic acid##7##4##(2008-10#7)
degradation of normal##2##3##(2008-12#2)
degradation of short-lived##2##3##(1992-12#2)
degradation of specific##2##3##(2008-4#1)(2012-12#1)
degradation of the CD4##2##4##(1993-3#2)
degradation of the pesticides##2##4##(2008-11#2)
degradation of the##47##3##(1990-9#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#1)(2011-2#3)(2013-8#1)
degradation of these##4##3##(1995-8#1)(2008-5#2)(2008-7#1)
degradation of various##2##3##(1993-6#1)(2008-10#1)
degradation of##191##2##(1990-11#1)(1990-5#3)(1990-7#2)(1990-9#2)(1991-11#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-8#2)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-6#2)(1995-8#5)(1996-8#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#41)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#9)(2008-5#5)(2008-6#6)(2008-7#13)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#2)(2010-10#1)(2011-1#5)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#4)
degradation on##2##2##(2008-7#1)(2012-3#1)
degradation or##6##2##(1990-5#1)(1996-11#1)(1997-4#1)(2008-11#1)(2009-5#1)(2012-2#1)
degradation over time##2##3##(2008-3#2)
degradation pathway##8##2##(1992-12#1)(1994-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-4#2)(2012-1#1)
degradation process##3##2##(2008-10#2)(2009-11#1)
degradation processes of##2##3##(2008-10#2)
degradation processes##4##2##(2008-10#2)(2008-7#1)(2012-1#1)
degradation product in##4##3##(2008-10#4)
degradation product of##5##3##(1996-12#1)(2008-10#4)
degradation product were detected##2##4##(2008-10#2)
degradation product were##4##3##(2008-10#4)
degradation product##25##2##(1991-5#1)(1996-12#1)(2008-10#22)(2008-5#1)
degradation product)##3##2##(2007-5#1)(2008-10#2)
degradation products are##3##3##(1990-7#1)(2008-10#2)
degradation products have been##2##4##(2008-10#2)
degradation products have##3##3##(2008-10#3)
degradation products in##4##3##(2008-10#1)(2008-8#1)(2013-1#2)
degradation products of##4##3##(2008-10#2)(2010-11#1)(2010-5#1)
degradation products were##2##3##(2008-10#1)(2012-12#1)
degradation products##52##2##(1990-11#1)(1990-7#1)(1992-3#1)(1997-2#2)(2008-10#30)(2008-7#3)(2008-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)
degradation properties##2##2##(2011-2#1)(2012-2#1)
degradation rate of##4##3##(1991-5#1)(2008-10#1)(2009-8#2)
degradation rate was##2##3##(2007-5#1)(2008-6#1)
degradation rate##10##2##(1991-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-8#2)(2012-2#1)
degradation rates##6##2##(1994-9#1)(2007-5#1)(2008-10#1)(2008-11#2)(2010-10#1)
degradation reactions##2##2##(2008-11#1)(2010-4#1)
degradation study of##2##3##(1997-2#1)(2008-10#1)
degradation temperature##2##2##(2008-3#1)(2009-3#1)
degradation than##2##2##(1992-8#1)(2008-10#1)
degradation that##3##2##(2008-2#1)(2011-1#1)(2013-1#1)
degradation through##2##2##(2008-2#1)(2008-3#1)
degradation using##2##2##(2008-3#1)(2009-3#1)
degradation was found to be##2##5##(2008-10#1)(2008-8#1)
degradation was##9##2##(1990-8#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)
degradation were##3##2##(1997-1#1)(2011-2#1)(2011-3#1)
degradation with##2##2##(1994-5#1)(2009-12#1)
degradation##625##1##(1990-11#4)(1990-2#2)(1990-5#7)(1990-7#3)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#4)(1991-5#4)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#12)(1992-3#4)(1992-8#8)(1993-11#4)(1993-2#2)(1993-3#5)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#8)(1994-12#3)(1994-2#1)(1994-5#6)(1994-8#4)(1994-9#5)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#6)(1995-8#7)(1996-11#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-5#4)(2008-10#147)(2008-11#33)(2008-12#5)(2008-2#12)(2008-3#32)(2008-4#16)(2008-5#16)(2008-6#17)(2008-7#28)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#9)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#1)(2010-3#1)(2010-4#6)(2010-5#1)(2011-1#16)(2011-10#2)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#22)(2012-3#5)(2013-1#18)(2013-8#9)
degradation)##4##1##(2008-10#1)(2010-10#1)(2012-2#2)
degradations in##2##2##(2008-3#2)
degradations##7##1##(1995-11#1)(2008-10#1)(2008-3#4)(2011-1#1)
degradative actions##2##2##(2008-4#1)(2008-5#1)
degradative enzymes##2##2##(1992-2#1)(1992-9#1)
degradative pathway##3##2##(1992-12#2)(1994-9#1)
degradative##9##1##(1992-12#2)(1992-2#1)(1992-9#1)(1994-9#1)(1995-8#1)(2008-4#1)(2008-5#1)(2008-7#1)
degrade image quality##2##3##(2008-3#2)
degrade significantly##2##2##(2008-3#1)(2012-12#1)
degrade the##9##2##(1992-9#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#2)
degrade##48##1##(1990-2#1)(1990-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#5)(2008-7#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
degraded after##2##2##(2006-6#1)(2007-12#1)
degraded and##5##2##(1992-11#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
degraded by the##3##3##(1993-3#1)(2008-5#1)(2012-2#1)
degraded by##24##2##(1990-12#1)(1992-11#2)(1992-12#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
degraded images##2##2##(2008-3#2)
degraded in the presence of##2##5##(2007-11#1)(2008-10#1)
degraded in the##7##3##(1995-2#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
degraded in##13##2##(1992-12#1)(1994-9#1)(1995-2#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
degraded into##2##2##(1996-2#1)(2008-5#1)
degraded to##4##2##(1992-9#1)(2008-3#2)(2008-5#1)
degraded when##3##2##(2008-11#1)(2008-2#1)(2008-5#1)
degraded with##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
degraded within##3##2##(1995-2#1)(2007-7#1)(2008-10#1)
degraded##110##1##(1990-12#1)(1990-5#1)(1992-11#4)(1992-12#3)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#3)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-6#2)(1996-2#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#15)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#2)
degrades the##4##2##(1994-9#1)(2007-11#1)(2008-3#2)
degrades##13##1##(1992-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)
degrading enzyme##3##2##(1991-12#2)(1992-3#1)
degrading##20##1##(1991-12#2)(1992-12#1)(1992-3#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-2#1)
degranulation and##3##2##(1990-2#1)(2009-6#1)(2010-1#1)
degranulation of##3##2##(1994-11#2)(2008-4#1)
degranulation##19##1##(1990-2#1)(1992-12#2)(1992-3#1)(1993-6#1)(1994-11#3)(1994-2#1)(1995-12#2)(2008-11#1)(2008-4#3)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)
degree C##6##2##(1992-9#1)(1993-11#1)(1996-2#1)(2007-5#1)(2008-5#1)(2013-7#1)
degree and##10##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
degree as##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
degree at##3##2##(1992-2#1)(2008-12#1)(2008-9#1)
degree atrioventricular block##2##3##(1992-4#2)
degree by##3##2##(1993-8#1)(1996-5#1)(2008-4#1)
degree days##5##2##(2008-10#4)(2008-8#1)
degree days)##2##2##(2008-10#1)(2008-8#1)
degree distribution##2##2##(2008-2#1)(2008-4#1)
degree for##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
degree hours##4##2##(2008-10#4)
degree in the##2##3##(1995-6#1)(2008-10#1)
degree in##7##2##(1991-12#1)(1991-2#1)(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#2)
degree of accuracy in identifying##2##5##(1994-7#1)(2008-12#1)
degree of accuracy##8##3##(1994-7#1)(2008-12#1)(2008-2#2)(2008-3#3)(2013-1#1)
degree of activation##2##3##(1994-8#1)(1995-8#1)
degree of activity##3##3##(2008-4#1)(2010-3#1)(2010-5#1)
degree of aggregation of sclerotia##2##5##(2008-10#2)
degree of aggregation of##3##4##(2008-10#3)
degree of aggregation##6##3##(1992-9#1)(2008-10#3)(2008-11#1)(2008-8#1)
degree of agreement between##2##4##(1993-12#1)(2008-5#1)
degree of agreement##5##3##(1992-12#1)(1993-12#1)(1993-3#1)(1995-1#1)(2008-5#1)
degree of alteration of consciousness during##2##6##(2013-8#2)
degree of anisotropy##2##3##(2008-10#1)(2008-2#1)
degree of apoptosis##3##3##(1994-10#1)(1995-2#1)(2011-2#1)
degree of association##3##3##(1996-2#1)(2008-10#2)
degree of binding##2##3##(1991-12#1)(2008-10#1)
degree of bone##2##3##(2007-11#1)(2009-7#1)
degree of carotid artery narrowing##2##5##(2011-2#2)
degree of carotid artery##3##4##(2011-2#3)
degree of cellular##3##3##(1990-12#1)(2008-11#2)
degree of change##2##3##(2008-10#1)(2008-11#1)
degree of clustering##3##3##(1990-11#1)(2008-12#1)(2008-5#1)
degree of cognitive##2##3##(2008-2#1)(2008-6#1)
degree of coherence##4##3##(2008-2#1)(2008-3#3)
degree of conservation##3##3##(1990-2#1)(1991-6#1)(1993-12#1)
degree of conversion##3##3##(1992-11#1)(2013-1#2)
degree of correlation##3##3##(1996-3#1)(2008-3#1)(2008-7#1)
degree of coupling##6##3##(1994-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
degree of dependence##2##3##(2012-12#1)(2012-6#1)
degree of differentiation##3##3##(2008-11#1)(2011-2#2)
degree of disability##3##3##(2007-11#1)(2008-7#2)
degree of discrimination##2##3##(2008-2#1)(2008-7#1)
degree of disease control##3##4##(2008-10#3)
degree of disease##5##3##(1997-8#1)(2008-10#4)
degree of diversity##2##3##(2008-10#1)(2008-7#1)
degree of dominance##2##3##(2008-10#2)
degree of early##2##3##(1990-9#1)(2008-1#1)
degree of exposure to##2##4##(2007-10#1)(2008-4#1)
degree of freedom of##2##4##(2008-3#1)(2008-7#1)
degree of freedom##7##3##(1992-6#1)(1997-3#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
degree of functional##2##3##(1996-6#1)(2008-4#1)
degree of genetic diversity and##2##5##(2008-10#2)
degree of genetic diversity##6##4##(2008-10#6)
degree of genetic##10##3##(2008-10#9)(2008-8#1)
degree of heterogeneity of##2##4##(2008-10#2)
degree of heterogeneity##5##3##(2008-10#5)
degree of homogeneity##3##3##(1997-5#2)(2008-3#1)
degree of homology between##2##4##(1990-7#1)(1993-2#1)
degree of homology##11##3##(1990-2#1)(1990-7#1)(1992-8#1)(1993-11#1)(1993-2#3)(1994-11#1)(1996-3#1)(1997-1#1)(2008-10#1)
degree of host specificity##4##4##(2008-10#3)(2013-1#1)
degree of identity##3##3##(1991-2#1)(1994-12#1)(1996-2#1)
degree of immunodepression##2##3##(1991-5#2)
degree of impairment##4##3##(1991-1#1)(1991-2#1)(1995-3#1)(2008-7#1)
degree of independence##2##3##(1996-2#1)(2011-2#1)
degree of infection##3##3##(2008-10#3)
degree of isolation##2##3##(2008-9#1)(2011-2#1)
degree of malignancy##3##3##(2011-1#3)
degree of methylation##2##3##(2008-10#1)(2011-2#1)
degree of movement##2##3##(2007-10#2)
degree of nonlinearity##3##3##(1990-8#2)(2008-3#1)
degree of order of the##3##5##(2008-5#3)
degree of order of##4##4##(2008-5#4)
degree of order##5##3##(2008-5#5)
degree of overlap##2##3##(2007-12#2)
degree of oxidative##2##3##(1991-9#1)(2009-8#1)
degree of parental investment##2##4##(2008-9#2)
degree of polarization (DOP)##2##4##(2008-2#1)(2008-3#1)
degree of polarization to##2##4##(2008-3#2)
degree of polarization##15##3##(2007-12#2)(2008-2#5)(2008-3#8)
degree of polymerization (DP)##2##4##(2008-10#1)(2013-1#1)
degree of polymerization##5##3##(1990-6#1)(2008-10#3)(2013-1#1)
degree of polymorphism##2##3##(2008-10#1)(2008-4#1)
degree of proceeding of individual##2##5##(2008-10#2)
degree of protection against##2##4##(1991-9#1)(2008-10#1)
degree of protection##7##3##(1990-12#1)(1991-2#1)(1991-9#1)(2008-10#1)(2012-2#2)(2013-7#1)
degree of protonation of##3##4##(2008-10#3)
degree of pulmonary##2##3##(1997-3#1)(2012-3#1)
degree of recovery is##2##4##(2008-7#2)
degree of recovery##3##3##(2008-10#1)(2008-7#2)
degree of reduction##3##3##(2008-10#2)(2008-2#1)
degree of resistance##4##3##(1997-6#1)(2008-10#3)
degree of response to##2##4##(1990-12#1)(2010-8#1)
degree of response##3##3##(1990-12#1)(2008-5#1)(2010-8#1)
degree of rotational##2##3##(1991-5#1)(2008-4#1)
degree of selectivity##4##3##(1990-5#1)(2008-10#3)
degree of sensitivity##6##3##(2007-12#1)(2008-10#5)
degree of sequence##6##3##(1991-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(2008-10#1)
degree of sexual transmission##2##4##(2008-9#2)
degree of similarity##9##3##(1993-2#2)(1993-9#1)(2008-10#3)(2008-4#1)(2012-2#1)(2013-8#1)
degree of size##3##3##(2008-10#1)(2008-8#2)
degree of spatial##3##3##(1995-6#1)(2007-11#1)(2007-12#1)
degree of specialization##3##3##(2008-8#3)
degree of spectral overlap##2##4##(2008-10#2)
degree of stenosis##4##3##(1993-8#1)(2008-7#2)(2011-2#1)
degree of structural##4##3##(1991-6#1)(1992-6#1)(1997-2#1)(2013-1#1)
degree of substitution##4##3##(2007-11#1)(2008-10#1)(2011-2#2)
degree of survival##2##3##(1990-5#1)(2013-1#1)
degree of the##14##3##(1993-5#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
degree of this##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
degree of tolerance##3##3##(2008-10#3)
degree of uncertainty##2##3##(2008-10#1)(2009-11#1)
degree of variability in the##3##5##(2008-1#1)(2008-10#1)(2009-6#1)
degree of variability in##5##4##(2008-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-6#1)
degree of variability##7##3##(1991-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-6#1)
degree of##738##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#2)(1991-5#6)(1991-6#5)(1991-7#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#4)(1993-2#6)(1993-3#4)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#3)(1997-1#5)(1997-2#3)(1997-3#11)(1997-5#2)(1997-6#3)(1997-8#2)(2007-10#6)(2007-11#20)(2007-12#16)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#137)(2008-11#21)(2008-12#6)(2008-2#24)(2008-3#43)(2008-4#11)(2008-5#23)(2008-6#6)(2008-7#33)(2008-8#23)(2008-9#17)(2009-10#2)(2009-11#3)(2009-2#1)(2009-5#6)(2009-6#1)(2009-7#7)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#7)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#8)(2011-10#1)(2011-2#25)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#23)(2013-7#1)(2013-8#9)
degree on the##3##3##(1992-2#1)(1997-6#1)(2008-10#1)
degree on##6##2##(1992-2#1)(1997-6#1)(2008-10#3)(2008-11#1)
degree polynomial##2##2##(2008-6#1)(2013-8#1)
degree program##4##2##(1997-2#1)(2008-11#1)(2008-12#2)
degree relative##2##2##(1995-5#1)(2008-1#1)
degree relatives##5##2##(1994-12#1)(2007-5#1)(2007-7#3)
degree than##8##2##(1991-6#2)(1993-8#1)(1995-11#1)(2008-10#1)(2008-4#1)(2010-3#1)(2013-1#1)
degree the##2##2##(1993-12#1)(2008-2#1)
degree to which it##2##4##(1992-3#1)(2009-11#1)
degree to which the##7##4##(1992-6#1)(1993-5#1)(1996-3#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#1)
degree to which##28##3##(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
degree to##29##2##(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
degree were##2##2##(1990-2#1)(2012-3#1)
degree with a##2##3##(1994-12#2)
degree with##5##2##(1994-12#2)(1994-6#1)(1994-8#1)(2012-12#1)
degree##948##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#4)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#8)(1991-3#2)(1991-5#6)(1991-6#7)(1991-7#3)(1991-8#1)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#8)(1993-3#5)(1993-5#4)(1993-6#3)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#10)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#8)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#5)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#8)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#3)(1997-1#5)(1997-2#7)(1997-3#13)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#3)(2007-10#7)(2007-11#22)(2007-12#16)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#11)(2008-10#162)(2008-11#33)(2008-12#14)(2008-2#31)(2008-3#46)(2008-4#16)(2008-5#30)(2008-6#9)(2008-7#36)(2008-8#32)(2008-9#22)(2009-10#2)(2009-11#4)(2009-2#2)(2009-5#7)(2009-6#2)(2009-7#8)(2009-8#6)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#10)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#11)(2011-10#1)(2011-2#30)(2012-1#3)(2012-12#9)(2012-2#12)(2012-3#8)(2012-5#1)(2012-6#1)(2013-1#28)(2013-7#3)(2013-8#10)
degree)##3##1##(2008-2#1)(2012-2#1)(2013-7#1)
degree-day intervals##2##2##(2008-10#2)
degree-day##6##1##(2008-10#5)(2008-12#1)
degree-days (K)##2##2##(2008-6#2)
degree-days and##2##2##(2008-10#2)
degree-days##10##1##(2008-10#8)(2008-6#2)
degree-days)##3##1##(2008-10#3)
degree-hours##3##1##(2008-10#3)
degreeC##8##1##(2013-7#8)
degreeC)##2##1##(2013-7#2)
degrees &lt##5##2##(2008-2#2)(2008-3#3)
degrees '##4##2##(2008-10#3)(2008-6#1)
degrees (SD##3##2##(2008-12#2)(2008-8#1)
degrees (range##2##2##(2007-8#1)(2008-9#1)
degrees ) and D(21) (150 degrees )##2##7##(2008-2#2)
degrees ) and##5##3##(2008-10#1)(2008-2#3)(2008-9#1)
degrees ) for the##3##4##(2008-10#1)(2008-12#2)
degrees ) for##5##3##(2008-10#2)(2008-12#2)(2008-3#1)
degrees )##39##2##(1997-7#1)(2007-11#3)(2007-12#6)(2007-8#2)(2008-10#8)(2008-12#2)(2008-2#8)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)
degrees )C##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
degrees +/- 1##2##3##(1990-11#2)
degrees +/- 12 for##2##4##(1993-3#2)
degrees +/-##6##2##(1990-11#2)(1993-3#4)
degrees -cut##2##2##(2008-3#2)
degrees /mum##2##2##(2008-3#2)
degrees 0##3##2##(2008-2#3)
degrees 1##4##2##(2008-10#1)(2008-2#3)
degrees =##6##2##(1996-2#4)(1997-7#1)(2008-10#1)
degrees C (generally##2##3##(2008-10#2)
degrees C (n =##2##4##(2010-5#2)
degrees C +/- 0##3##4##(2010-5#3)
degrees C after##5##3##(1995-3#1)(2008-10#3)(2013-8#1)
degrees C all##2##3##(1996-3#1)(2008-10#1)
degrees C allowed##2##3##(2008-10#1)(2008-11#1)
degrees C also##3##3##(1991-2#1)(1991-8#1)(2008-4#1)
degrees C and 0##3##4##(2008-10#3)
degrees C and 100 degrees C##2##6##(2008-12#1)(2008-3#1)
degrees C and 15##2##4##(1997-4#1)(2008-10#1)
degrees C and 25##3##4##(2008-10#2)(2008-8#1)
degrees C and 28##2##4##(2008-11#1)(2008-5#1)
degrees C and 3##2##4##(1992-3#1)(1996-2#1)
degrees C and 30##2##4##(2008-10#1)(2010-4#1)
degrees C and 37 degrees C##3##6##(1994-3#1)(2008-5#2)
degrees C and 37 degrees##5##5##(1994-3#1)(2008-10#2)(2008-5#2)
degrees C and 4##2##4##(2008-10#1)(2008-7#1)
degrees C and 500##2##4##(2008-10#2)
degrees C and 90%##2##4##(2008-10#1)(2011-2#1)
degrees C and a##9##4##(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
degrees C and at##7##4##(1994-3#1)(1997-4#1)(2008-10#4)(2008-2#1)
degrees C and becoming##2##4##(1994-11#1)(2008-10#1)
degrees C and growth was##2##5##(2008-6#2)
degrees C and in##5##4##(2008-10#4)(2008-11#1)
degrees C and ionic strength##3##5##(2008-10#3)
degrees C and ionic##4##4##(1995-2#1)(2008-10#3)
degrees C and pH 1##2##5##(2008-10#1)(2013-8#1)
degrees C and pH 5##3##5##(1994-5#1)(2008-10#1)(2008-6#1)
degrees C and pH 7##2##5##(2008-10#1)(2008-5#1)
degrees C and pH##12##4##(1994-5#1)(1997-2#2)(2008-10#3)(2008-5#1)(2008-6#4)(2013-8#1)
degrees C and pressures##2##4##(2008-10#2)
degrees C and relative humidity##2##5##(2008-10#2)
degrees C and the##7##4##(1992-3#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)
degrees C and then##3##4##(2008-10#2)(2013-8#1)
degrees C and to##3##4##(1993-3#1)(2008-10#1)(2008-12#1)
degrees C and was##3##4##(2008-10#3)
degrees C and##182##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-5#2)(1991-8#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#2)(1997-4#2)(1997-7#1)(2007-12#2)(2008-10#90)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#5)(2008-5#9)(2008-6#8)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#5)(2011-1#3)(2011-2#4)(2013-1#1)(2013-8#2)
degrees C are##5##3##(2007-12#1)(2008-10#4)
degrees C at a##3##4##(1995-11#1)(2008-2#1)(2008-3#1)
degrees C at pH 5##2##5##(1997-2#1)(2008-10#1)
degrees C at pH##4##4##(1997-2#1)(2008-10#3)
degrees C at relative humidities &gt##2##6##(2008-10#2)
degrees C at##20##3##(1990-11#1)(1991-8#1)(1995-11#1)(1996-12#2)(1997-2#1)(2008-10#10)(2008-2#1)(2008-3#3)
degrees C before##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
degrees C but not at##7##5##(1991-2#1)(1992-9#1)(2008-10#5)
degrees C but only##2##4##(2008-10#1)(2008-12#1)
degrees C but##11##3##(1991-2#3)(1992-9#1)(2008-10#6)(2008-12#1)
degrees C by##6##3##(2007-11#1)(2008-10#5)
degrees C compared with that##2##5##(2008-10#1)(2008-7#1)
degrees C compared with##4##4##(2008-10#3)(2008-7#1)
degrees C compared##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
degrees C decreased##2##3##(2008-10#1)(2008-12#1)
degrees C degrees##2##3##(2007-12#2)
degrees C did not##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
degrees C during the##2##4##(2008-10#1)(2009-2#1)
degrees C during##7##3##(1990-3#1)(2007-12#1)(2008-10#4)(2009-2#1)
degrees C followed by##7##4##(1995-12#1)(1996-5#3)(2008-10#2)(2011-2#1)
degrees C for 1 h or after##2##7##(2008-2#2)
degrees C for 1 h##5##5##(2007-11#1)(2008-10#2)(2008-2#2)
degrees C for 1##8##4##(2007-11#1)(2008-10#4)(2008-2#2)(2008-5#1)
degrees C for 10 min##3##5##(1994-8#1)(1997-2#1)(2008-4#1)
degrees C for 10##5##4##(1994-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
degrees C for 12 h##2##5##(2008-10#1)(2009-11#1)
degrees C for 12##3##4##(2008-10#2)(2009-11#1)
degrees C for 15##3##4##(1994-8#1)(2008-6#1)(2010-2#1)
degrees C for 2 h##2##5##(2008-10#1)(2008-6#1)
degrees C for 2 weeks##2##5##(2008-10#1)(2008-5#1)
degrees C for 2##7##4##(1992-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)
degrees C for 20 h##2##5##(2007-11#1)(2008-10#1)
degrees C for 20 min##2##5##(1993-11#1)(2010-2#1)
degrees C for 20##5##4##(1993-11#1)(2007-11#1)(2008-10#2)(2010-2#1)
degrees C for 24 h##5##5##(2008-10#2)(2008-9#1)(2010-2#1)(2013-8#1)
degrees C for 24 hours##2##5##(2007-10#1)(2008-11#1)
degrees C for 24##7##4##(2007-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-2#1)(2013-8#1)
degrees C for 3 h##2##5##(2008-10#1)(2011-1#1)
degrees C for 3##4##4##(1991-12#1)(2008-10#2)(2011-1#1)
degrees C for 30 min in##2##6##(2008-10#2)
degrees C for 30 min##7##5##(1992-9#1)(2008-10#3)(2008-6#2)(2008-7#1)
degrees C for 30##10##4##(1990-12#1)(1992-9#1)(2008-10#4)(2008-12#1)(2008-6#2)(2008-7#1)
degrees C for 4##2##4##(1995-2#1)(2008-10#1)
degrees C for 48##2##4##(2008-10#1)(2008-11#1)
degrees C for 5 min##2##5##(1992-9#1)(1997-2#1)
degrees C for 5##3##4##(1992-9#1)(1997-2#1)(2008-10#1)
degrees C for 6 weeks##2##5##(2008-10#1)(2008-5#1)
degrees C for 6##3##4##(2008-10#2)(2008-5#1)
degrees C for 60 min##4##5##(2008-10#4)
degrees C for 7 days##2##5##(2008-10#1)(2009-8#1)
degrees C for 7##5##4##(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)
degrees C for 8 h##2##5##(2008-10#1)(2011-1#1)
degrees C for Cd##3##4##(2008-10#3)
degrees C for Pb##2##4##(2008-10#2)
degrees C for a##3##4##(2007-11#1)(2008-10#2)
degrees C for an##2##4##(2008-10#2)
degrees C for bands##2##4##(2008-3#2)
degrees C for both##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
degrees C for infection of##2##5##(2008-10#2)
degrees C for more than##3##5##(2008-2#2)(2008-9#1)
degrees C for one##2##4##(2008-11#1)(2008-5#1)
degrees C for over##2##4##(2008-11#1)(2008-2#1)
degrees C for the##4##4##(1992-8#2)(2008-10#2)
degrees C for two##2##4##(2006-11#1)(2008-10#1)
degrees C for up to##2##5##(1990-12#1)(1996-12#1)
degrees C for various##2##4##(1990-12#1)(1994-8#1)
degrees C for##158##3##(1990-12#3)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-8#1)(1994-8#3)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#4)(1997-4#1)(2006-11#2)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#72)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-2#3)(2010-3#1)(2010-4#4)(2011-1#3)(2011-2#2)(2013-8#1)
degrees C from##2##3##(2008-10#2)
degrees C gave the##2##4##(1996-5#1)(2008-10#1)
degrees C had been attained in the##2##7##(1995-6#2)
degrees C had##4##3##(1995-6#2)(1997-8#1)(2008-10#1)
degrees C has been##3##4##(1991-5#1)(2008-10#1)(2008-6#1)
degrees C have been##2##4##(2008-10#1)(2008-3#1)
degrees C in a##7##4##(1993-11#1)(2008-10#4)(2008-2#1)(2008-6#1)
degrees C in air##2##4##(2008-10#1)(2008-3#1)
degrees C in the dark##3##5##(2008-10#3)
degrees C in the presence##2##5##(1990-5#1)(1995-11#1)
degrees C in the range of##2##6##(2008-10#2)
degrees C in the##19##4##(1990-5#1)(1990-7#2)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2010-4#1)(2013-8#1)
degrees C in##54##3##(1990-5#1)(1990-7#2)(1991-5#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-9#1)(2010-3#1)(2010-4#3)(2013-8#1)
degrees C indicating##2##3##(2008-11#1)(2008-12#1)
degrees C is##14##3##(1991-3#1)(1992-8#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-8#1)
degrees C lower than the other##2##6##(2008-5#1)(2011-2#1)
degrees C lower than##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
degrees C night/day)##2##3##(2008-10#2)
degrees C on the##3##4##(2008-10#3)
degrees C on##5##3##(1993-12#1)(1994-3#1)(2008-10#3)
degrees C or for##2##4##(1994-3#1)(2008-10#1)
degrees C or##12##3##(1994-3#2)(1995-11#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-8#1)
degrees C over a##2##4##(2008-3#1)(2010-5#1)
degrees C over##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2010-5#1)
degrees C resulted in##4##4##(1995-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
degrees C s(-1))##2##3##(2008-3#2)
degrees C showed##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
degrees C temperature range##2##4##(2007-11#1)(2008-2#1)
degrees C temperature##4##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
degrees C than at##3##4##(1991-5#1)(1994-3#1)(2008-10#1)
degrees C than in##3##4##(2008-10#1)(2010-8#2)
degrees C than##7##3##(1990-2#1)(1991-5#1)(1994-3#1)(2008-10#2)(2010-8#2)
degrees C the##9##3##(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2010-4#1)
degrees C there is##2##4##(2008-11#1)(2008-12#1)
degrees C there##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
degrees C to##11##3##(2007-10#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)
degrees C under continuous wetness##2##5##(2008-10#2)
degrees C under the##2##4##(1991-2#1)(1994-8#1)
degrees C under##10##3##(1991-2#1)(1994-8#1)(2007-12#1)(2008-10#5)(2008-11#2)
degrees C using##4##3##(1990-7#1)(2008-10#2)(2008-12#1)
degrees C was the best##2##5##(2008-10#1)(2008-5#1)
degrees C was##25##3##(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#1)(2010-4#1)(2011-2#1)
degrees C were obtained##3##4##(2008-10#3)
degrees C were##21##3##(1992-3#1)(1992-6#1)(1993-8#1)(1996-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
degrees C when##2##3##(2008-11#2)
degrees C while##2##3##(2008-10#1)(2008-5#1)
degrees C with a##7##4##(2007-11#1)(2008-10#4)(2008-2#1)(2008-5#1)
degrees C with an##6##4##(1994-3#1)(2008-10#2)(2008-2#3)
degrees C with the##3##4##(2008-10#2)(2008-9#1)
degrees C with##25##3##(1990-8#1)(1994-3#3)(1996-5#1)(2007-11#1)(2008-10#10)(2008-2#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)
degrees C without any##3##4##(2008-10#2)(2008-11#1)
degrees C without##5##3##(2007-8#1)(2008-10#3)(2008-11#1)
degrees C yielded##3##3##(2008-10#2)(2011-2#1)
degrees C##1576##2##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#7)(1990-3#1)(1990-5#4)(1990-7#9)(1990-8#6)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#9)(1991-3#1)(1991-5#10)(1991-8#7)(1991-9#1)(1992-11#3)(1992-3#10)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#9)(1992-9#8)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#11)(1993-9#4)(1994-11#6)(1994-12#9)(1994-3#21)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#14)(1995-3#3)(1995-5#9)(1995-6#13)(1995-8#6)(1996-12#6)(1996-2#12)(1996-3#1)(1996-4#2)(1996-5#13)(1996-6#1)(1997-1#2)(1997-2#17)(1997-4#9)(1997-6#5)(1997-7#8)(1997-8#4)(2006-11#2)(2007-10#5)(2007-11#23)(2007-12#26)(2007-3#1)(2007-8#1)(2008-10#761)(2008-11#53)(2008-12#36)(2008-2#39)(2008-3#46)(2008-4#11)(2008-5#51)(2008-6#38)(2008-7#18)(2008-8#20)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#6)(2010-1#2)(2010-2#4)(2010-3#6)(2010-4#18)(2010-5#7)(2010-8#4)(2011-1#10)(2011-2#26)(2012-2#8)(2013-1#3)(2013-8#9)
degrees C) and high##3##4##(2008-10#1)(2008-12#2)
degrees C) and the##2##4##(2008-10#2)
degrees C) and##28##3##(1990-12#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-2#1)(2008-10#12)(2008-12#2)(2008-5#4)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
degrees C) by##2##3##(2008-10#2)
degrees C) during##4##3##(2007-10#1)(2008-10#2)(2008-8#1)
degrees C) for##10##3##(1994-12#1)(1995-12#1)(2007-10#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
degrees C) had##3##3##(2008-10#1)(2008-6#1)(2010-4#1)
degrees C) has been##2##4##(2008-10#2)
degrees C) in##3##3##(1997-7#1)(2008-10#2)
degrees C) is##3##3##(1992-8#1)(2007-11#2)
degrees C) of##4##3##(1992-3#1)(2008-10#2)(2008-12#1)
degrees C) or##2##3##(2008-10#2)
degrees C) to##2##3##(2008-10#2)
degrees C) was##2##3##(1995-3#1)(2008-10#1)
degrees C) were##3##3##(1990-7#1)(2008-10#1)(2008-12#1)
degrees C)##175##2##(1990-12#2)(1990-7#2)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#4)(2007-11#5)(2007-9#1)(2008-10#77)(2008-11#6)(2008-12#11)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#5)(2013-1#2)
degrees C-FM3A cells##2##3##(1995-11#2)
degrees C-FM3A##3##2##(1995-11#3)
degrees C-cells##5##2##(1995-11#5)
degrees C-cells)##2##2##(1995-11#2)
degrees C-grown C##5##3##(2008-5#5)
degrees C-grown cells##2##3##(2008-5#2)
degrees C-grown##7##2##(2008-5#7)
degrees C/10(-)(3) Torr)##2##3##(1997-7#2)
degrees Celsius for##2##3##(2008-8#2)
degrees Cmin(-1)##2##2##(2008-10#2)
degrees E)##2##2##(2008-3#2)
degrees N##7##2##(2008-10#2)(2008-2#1)(2008-3#4)
degrees N) from##2##3##(2008-2#1)(2010-8#1)
degrees N)##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)
degrees Parhelia##2##2##(2008-2#2)
degrees Parroid arc##2##3##(2008-2#2)
degrees W##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
degrees W)##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
degrees abduction##2##2##(2007-11#2)
degrees and 0##2##3##(2008-2#2)
degrees and 10##2##3##(2009-10#2)
degrees and 25##2##3##(2008-11#1)(2009-10#1)
degrees and 30 degrees##4##4##(2007-8#2)(2008-3#1)(2009-10#1)
degrees and 30+/-1 degrees##2##4##(2008-10#2)
degrees and 45 degrees##3##4##(2007-11#2)(2008-3#1)
degrees and a range of##2##5##(2008-2#2)
degrees and a##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
degrees and in##2##3##(2008-2#1)(2011-2#1)
degrees and that##2##3##(2008-2#1)(2008-3#1)
degrees and the##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
degrees and##51##2##(1991-12#1)(1993-8#1)(1994-12#1)(1995-5#2)(2007-11#3)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#8)(2008-8#2)(2009-10#4)(2009-3#1)(2011-2#3)(2012-3#1)
degrees angle##2##2##(2008-3#2)
degrees are##3##2##(1996-12#1)(2008-11#1)(2008-2#1)
degrees at##4##2##(2007-12#1)(2008-2#3)
degrees bend##2##2##(1993-8#1)(2007-11#1)
degrees between the##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
degrees compared with##2##3##(2013-1#2)
degrees external rotation##2##3##(2007-11#1)(2013-1#1)
degrees external##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
degrees for bond angles##3##4##(1992-4#1)(2008-8#1)(2008-9#1)
degrees for controls##2##3##(2013-1#2)
degrees for the##2##3##(1994-5#1)(2008-9#1)
degrees for##19##2##(1990-11#2)(1992-4#1)(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#2)(2013-1#2)
degrees from the##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
degrees from##8##2##(1993-11#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
degrees in a patient##2##4##(2008-11#2)
degrees in the##3##3##(1991-12#1)(1994-12#1)(2008-9#1)
degrees in##13##2##(1990-3#1)(1991-12#1)(1993-12#1)(1994-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-9#2)
degrees incident angle##3##3##(2008-3#3)
degrees is##5##2##(1993-1#1)(2008-2#2)(2008-3#2)
degrees of experience##2##3##(1997-2#1)(2008-11#1)
degrees of freedom and##2##4##(2007-12#1)(2008-5#1)
degrees of freedom for##2##4##(1992-8#1)(2008-3#1)
degrees of freedom of##2##4##(2008-2#1)(2008-6#1)
degrees of freedom##21##3##(1990-8#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)
degrees of freedom)##2##3##(2009-9#2)
degrees of homology##2##3##(1995-6#1)(2008-9#1)
degrees of knee flexion##2##4##(2009-3#1)(2013-1#1)
degrees of linear and circular polarization##2##6##(2007-12#2)
degrees of sequence##2##3##(1992-11#1)(2012-3#1)
degrees of severity##2##3##(1994-7#1)(2010-12#1)
degrees of similarity to##2##4##(1992-12#1)(1995-12#1)
degrees of similarity##5##3##(1992-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2010-5#1)
degrees of stigma##2##3##(2009-5#1)(2012-1#1)
degrees of##123##2##(1990-5#1)(1990-8#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-3#2)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-7#1)(2008-10#19)(2008-11#4)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#4)(2013-1#3)(2013-8#1)
degrees off the zenith##2##4##(2008-3#2)
degrees off##4##2##(2007-11#1)(2008-3#3)
degrees on##3##2##(1997-2#1)(2007-8#1)(2012-3#1)
degrees or 90 degrees##2##4##(2007-12#1)(2009-5#1)
degrees or##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
degrees over the##2##3##(2007-11#1)(2007-12#1)
degrees parhelion##2##2##(2008-2#2)
degrees range##2##2##(2008-2#1)(2008-3#1)
degrees relative to the##2##4##(2008-2#1)(2008-3#1)
degrees respectively##2##2##(2008-8#1)(2012-3#1)
degrees s##3##2##(2008-10#1)(2008-4#2)
degrees than at##2##3##(2008-11#2)
degrees that##2##2##(2007-11#1)(2008-2#1)
degrees to 0 degrees##2##4##(2009-3#1)(2009-9#1)
degrees to 0##3##3##(2008-2#1)(2009-3#1)(2009-9#1)
degrees to 180 degrees##3##4##(2007-12#2)(2008-3#1)
degrees to 50 degrees##2##4##(2008-2#1)(2008-7#1)
degrees to the##2##3##(1991-2#1)(2007-11#1)
degrees to##25##2##(1991-2#1)(1996-2#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-12#1)(2008-2#4)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2012-2#1)
degrees under##3##2##(2008-3#1)(2013-1#2)
degrees values##3##2##(1993-8#2)(2008-5#1)
degrees were##2##2##(1990-9#1)(2007-11#1)
degrees with respect to the##2##5##(2008-2#1)(2008-3#1)
degrees with##4##2##(1997-7#1)(2008-2#1)(2008-3#2)
degrees within##2##2##(2008-12#1)(2008-6#1)
degrees##2564##1##(1990-10#1)(1990-11#11)(1990-12#7)(1990-2#7)(1990-3#2)(1990-5#6)(1990-7#11)(1990-8#7)(1990-9#4)(1991-11#1)(1991-12#5)(1991-2#11)(1991-3#3)(1991-5#13)(1991-6#2)(1991-7#2)(1991-8#10)(1991-9#1)(1992-11#6)(1992-12#1)(1992-3#13)(1992-4#3)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#12)(1992-9#9)(1993-1#3)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#7)(1993-8#24)(1993-9#4)(1994-11#7)(1994-12#15)(1994-2#1)(1994-3#22)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#2)(1995-1#1)(1995-11#19)(1995-12#6)(1995-2#14)(1995-3#6)(1995-5#14)(1995-6#17)(1995-8#6)(1996-12#9)(1996-2#49)(1996-3#1)(1996-4#2)(1996-5#14)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#21)(1997-3#6)(1997-4#11)(1997-6#7)(1997-7#37)(1997-8#5)(2006-11#2)(2007-10#12)(2007-11#66)(2007-12#62)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#16)(2007-9#2)(2008-10#915)(2008-11#71)(2008-12#59)(2008-2#161)(2008-3#189)(2008-4#15)(2008-5#95)(2008-6#45)(2008-7#34)(2008-8#45)(2008-9#27)(2009-10#10)(2009-11#1)(2009-2#4)(2009-3#8)(2009-5#9)(2009-6#2)(2009-7#7)(2009-8#5)(2009-9#13)(2010-1#3)(2010-12#1)(2010-2#4)(2010-3#12)(2010-4#21)(2010-5#8)(2010-8#8)(2011-1#11)(2011-2#45)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#13)(2012-3#8)(2013-1#18)(2013-8#11)
degrees) and##2##2##(2008-3#1)(2013-1#1)
degrees)##9##1##(1991-3#1)(1993-3#1)(1995-5#1)(2008-3#4)(2008-8#1)(2013-1#1)
degrees-of-freedom##2##1##(2012-2#1)(2012-3#1)
degrees/s)##2##1##(2011-2#2)
deguelin with##2##2##(2011-1#2)
dehalogenase##8##1##(2009-3#1)(2011-1#7)
dehalogenases with##2##2##(2011-1#2)
dehalogenases##6##1##(2011-1#6)
dehalogenation##3##1##(2008-11#3)
dehiscence in##2##2##(2008-7#2)
dehiscence##9##1##(1991-2#2)(1992-9#1)(2008-7#5)(2011-2#1)
dehiscent##4##1##(2008-10#1)(2011-2#3)
dehumanization##2##1##(1995-2#1)(2013-1#1)
dehydratase was induced in##2##4##(1990-7#2)
dehydratase was##3##2##(1990-7#3)
dehydratase##8##1##(1990-7#5)(1993-12#1)(2008-10#2)
dehydrate##2##1##(2008-10#1)(2009-8#1)
dehydrated cowpea leaves##3##3##(2008-10#3)
dehydrated##9##1##(1990-8#1)(2008-10#5)(2008-9#2)(2012-1#1)
dehydration and##7##2##(1991-6#1)(1992-9#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
dehydration of the##2##3##(1994-2#1)(2013-7#1)
dehydration of##4##2##(1994-2#1)(2008-1#1)(2008-10#1)(2013-7#1)
dehydration##41##1##(1990-11#1)(1990-2#2)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-5#3)(2008-7#4)(2009-4#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-7#1)
dehydroalanine##4##1##(1992-6#1)(1994-5#3)
dehydroascorbate##3##1##(2008-11#1)(2009-9#2)
dehydroascorbic acid##7##2##(1993-3#2)(2008-10#5)
dehydrodimers of ferulic acid##3##4##(2008-10#3)
dehydroepiandrosterone##5##1##(1990-11#1)(1994-6#1)(1996-2#2)(2008-1#1)
dehydrogenase (EC 1##2##3##(1993-8#1)(1994-11#1)
dehydrogenase (G6PDH)##2##2##(1990-3#1)(1993-3#1)
dehydrogenase (GAPDH)##6##2##(1990-7#1)(1991-9#1)(1992-6#1)(1994-5#1)(1995-6#1)(2009-10#1)
dehydrogenase (GDH)##4##2##(1993-9#1)(1995-5#1)(2008-1#1)(2008-11#1)
dehydrogenase (LDH##2##2##(1993-11#1)(1993-12#1)
dehydrogenase (LDH) and##2##3##(1992-11#1)(2008-10#1)
dehydrogenase (LDH)##16##2##(1992-11#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#4)(2013-1#1)
dehydrogenase (SDH)##5##2##(1990-7#1)(1996-12#1)(2008-11#1)(2009-7#1)(2012-2#1)
dehydrogenase 1##2##2##(1991-10#1)(1994-6#1)
dehydrogenase 2##2##2##(2010-12#2)
dehydrogenase A##2##2##(2008-9#2)
dehydrogenase activities##3##2##(1996-2#1)(2008-11#2)
dehydrogenase activity and##4##3##(1990-11#1)(1993-3#1)(1995-6#1)(2008-8#1)
dehydrogenase activity in##3##3##(1992-11#1)(1993-3#1)(1996-12#1)
dehydrogenase activity was##3##3##(1990-11#1)(1996-12#1)(2012-2#1)
dehydrogenase activity##23##2##(1990-11#5)(1992-11#1)(1992-6#1)(1993-3#2)(1994-11#1)(1995-6#2)(1996-12#2)(2008-11#3)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#2)
dehydrogenase and the##3##3##(1991-5#1)(1996-12#1)(2008-10#1)
dehydrogenase and##26##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-5#2)(2009-11#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-7#2)
dehydrogenase as##2##2##(1995-11#1)(2010-9#1)
dehydrogenase assay##2##2##(1996-5#1)(2008-6#1)
dehydrogenase by##6##2##(1992-11#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)
dehydrogenase deficiency and##2##3##(1991-2#1)(1996-12#1)
dehydrogenase deficiency##9##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-8#1)(1996-12#2)(2007-12#1)(2008-4#1)(2008-8#1)
dehydrogenase expression##2##2##(2009-11#2)
dehydrogenase for the##2##3##(1995-2#1)(2008-10#1)
dehydrogenase from the##2##3##(1990-5#1)(1995-8#1)
dehydrogenase from##7##2##(1990-11#1)(1990-5#1)(1994-11#1)(1995-8#1)(2008-4#2)(2008-9#1)
dehydrogenase gene##6##2##(1991-8#1)(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-8#1)
dehydrogenase has been##2##3##(1990-7#1)(1992-1#1)
dehydrogenase in the##3##3##(1990-11#1)(1990-5#1)(2008-11#1)
dehydrogenase in##10##2##(1990-11#1)(1990-5#1)(1991-3#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-11#1)
dehydrogenase isoenzyme##3##2##(1992-6#2)(1993-12#1)
dehydrogenase levels##2##2##(1996-5#1)(2013-1#1)
dehydrogenase of##4##2##(1990-8#2)(1993-11#1)(1994-11#1)
dehydrogenase reactor##3##2##(1992-11#1)(2008-10#2)
dehydrogenase to##3##2##(1991-9#2)(2008-5#1)
dehydrogenase was determined##2##3##(1996-12#1)(1997-1#1)
dehydrogenase was purified to##2##4##(1990-11#1)(1992-11#1)
dehydrogenase was purified##3##3##(1990-11#2)(1992-11#1)
dehydrogenase was##10##2##(1990-11#3)(1992-11#1)(1994-8#2)(1996-12#1)(1997-1#1)(2008-10#2)
dehydrogenase with##2##2##(1990-7#1)(1995-5#1)
dehydrogenase##362##1##(1990-10#2)(1990-11#14)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#7)(1990-7#10)(1990-8#6)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-8#3)(1991-9#3)(1992-1#5)(1992-11#10)(1992-3#3)(1992-6#9)(1992-8#2)(1992-9#3)(1993-11#8)(1993-12#2)(1993-2#3)(1993-3#6)(1993-8#2)(1993-9#1)(1994-11#8)(1994-12#1)(1994-2#1)(1994-5#6)(1994-6#6)(1994-8#6)(1994-9#2)(1995-11#6)(1995-12#1)(1995-2#10)(1995-3#14)(1995-5#11)(1995-6#7)(1995-8#2)(1996-12#9)(1996-2#3)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#2)(2007-12#4)(2007-7#2)(2008-1#2)(2008-10#39)(2008-11#27)(2008-4#7)(2008-5#6)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#4)(2009-7#1)(2009-9#1)(2010-12#8)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#1)
dehydrogenase) and##2##2##(1995-6#1)(2008-10#1)
dehydrogenase)##4##1##(1994-8#1)(1995-6#1)(2008-10#1)(2008-8#1)
dehydrogenase-encoding gene from##2##3##(1993-6#1)(1995-8#1)
dehydrogenase-encoding gene##6##2##(1991-6#1)(1993-6#2)(1993-9#1)(1995-8#2)
dehydrogenases in##2##2##(1991-12#1)(1995-8#1)
dehydrogenases##19##1##(1990-7#2)(1991-12#3)(1991-3#2)(1991-5#3)(1993-3#1)(1994-11#1)(1994-12#2)(1995-5#1)(1995-8#1)(2008-10#1)(2008-4#1)(2012-5#1)
dehydrogenation##2##1##(1994-2#1)(1994-6#1)
dehydroxylation##2##1##(2008-1#1)(2013-1#1)
dei##2##1##(2010-1#2)
deiminase was##2##2##(1991-12#2)
deiminase##9##1##(1991-12#5)(1995-3#1)(2008-10#3)
deinstitutionalization##2##1##(1993-1#1)(2008-2#1)
deiodinase activity##2##2##(2009-12#1)(2011-1#1)
deiodinase##7##1##(1990-12#1)(1992-12#2)(1995-12#2)(2009-12#1)(2011-1#1)
deionised water##7##2##(2008-10#6)(2012-2#1)
deionized water and##2##3##(2008-10#2)
deionized water##17##2##(1994-3#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-6#1)(2009-7#1)(2010-3#2)(2013-1#1)
deionized##20##1##(1994-3#1)(2007-12#1)(2008-10#11)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-3#2)(2013-1#1)
del##16##1##(1991-4#1)(1991-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-12#2)
del/del##2##1##(2013-8#2)
delamination##6##1##(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)
delay (time from##2##3##(1990-12#2)
delay CS##4##2##(2008-5#4)
delay and diffusion##4##3##(2013-8#4)
delay and##18##2##(1990-11#1)(1990-12#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#5)
delay at the##2##3##(2008-2#1)(2012-7#1)
delay between the##2##3##(2008-3#2)
delay between two##2##3##(2007-11#2)
delay between##12##2##(1991-2#1)(1991-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-11#1)(2011-2#1)
delay by##3##2##(1991-11#1)(1997-2#1)(2008-3#1)
delay device##2##2##(2008-2#2)
delay for the##2##3##(1997-2#1)(2013-8#1)
delay for##6##2##(1997-2#1)(2007-12#1)(2008-3#1)(2010-11#1)(2012-1#1)(2013-8#1)
delay in children##2##3##(2011-1#1)(2012-1#1)
delay in diagnosis##6##3##(1990-12#1)(1992-8#1)(2006-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
delay in reaching##2##3##(2008-10#1)(2008-6#1)
delay in the##12##3##(1991-2#1)(1993-11#1)(1994-6#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-11#1)(2013-1#2)(2013-8#2)
delay in##61##2##(1990-12#4)(1991-2#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
delay introduced##3##2##(2008-3#1)(2013-8#2)
delay is##6##2##(1996-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
delay line for##3##3##(2008-3#3)
delay line is demonstrated##3##4##(2008-2#2)(2008-3#1)
delay line is##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
delay line with##2##3##(2008-2#1)(2008-3#1)
delay line##20##2##(2007-11#5)(2007-12#1)(2008-2#3)(2008-3#11)
delay lines based on##2##4##(2007-11#2)
delay lines##5##2##(2007-11#3)(2008-2#1)(2008-3#1)
delay may##4##2##(1990-12#1)(1992-10#1)(1996-3#1)(2007-12#1)
delay measurements##2##2##(2008-3#2)
delay of 1##2##3##(1993-6#1)(2008-6#1)
delay of 2##2##3##(2008-3#1)(2010-6#1)
delay of 3##2##3##(2008-4#1)(2012-6#1)
delay of a##3##3##(2007-11#2)(2008-2#1)
delay of the##3##3##(2007-12#2)(2008-11#1)
delay of##37##2##(1991-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-6#1)
delay on##2##2##(2008-2#2)
delay or##8##2##(1990-5#1)(1994-5#1)(1996-6#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
delay ratios##2##2##(2009-5#2)
delay the development of##2##4##(1991-9#1)(2010-12#1)
delay the onset and##2##4##(2007-11#1)(2011-2#1)
delay the onset of##3##4##(1990-3#1)(2008-5#1)(2013-1#1)
delay the onset##5##3##(1990-3#1)(2007-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
delay the##18##2##(1990-3#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-6#2)(1996-3#1)(2007-11#1)(2008-10#3)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
delay time and##4##3##(2008-10#4)
delay time between##2##3##(2007-12#1)(2011-1#1)
delay time##20##2##(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)(2010-9#1)(2011-1#2)(2013-8#5)
delay times##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
delay to##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
delay values##5##2##(2011-2#5)
delay was##13##2##(1990-12#4)(1991-2#1)(1992-10#1)(1994-3#1)(1997-2#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
delay##401##1##(1990-11#1)(1990-12#15)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#26)(2007-12#18)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#5)(2008-12#5)(2008-2#23)(2008-3#46)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#3)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#22)(2012-1#2)(2012-12#10)(2012-2#2)(2012-3#3)(2012-6#1)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#22)
delay)##3##1##(2008-3#1)(2008-7#1)(2009-5#1)
delay-line##3##1##(2008-2#1)(2008-3#2)
delay-time##3##1##(2008-3#3)
delayed Wallerian degeneration##3##3##(1997-3#3)
delayed alternation in##2##3##(1994-8#2)
delayed alternation##7##2##(1991-2#2)(1994-8#4)(2008-8#1)
delayed and prolonged##3##3##(1995-12#1)(1997-3#1)(2013-8#1)
delayed and##8##2##(1990-2#1)(1995-12#1)(1997-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
delayed apoptosis##2##2##(2008-11#2)
delayed as##2##2##(1991-2#1)(2009-8#1)
delayed because##2##2##(1992-2#1)(1997-8#1)
delayed complications##2##2##(1994-12#1)(1996-1#1)
delayed diagnosis of##2##3##(2008-11#1)(2009-3#1)
delayed diagnosis##7##2##(1996-3#1)(2007-5#1)(2008-11#1)(2009-3#1)(2010-12#2)(2012-3#1)
delayed disease onset##2##3##(2008-10#2)
delayed dispersal##6##2##(2008-8#6)
delayed feedback##7##2##(2007-11#2)(2008-10#1)(2009-8#4)
delayed for##8##2##(1990-12#1)(1991-6#1)(1992-12#1)(1994-3#1)(2008-10#2)(2010-11#1)(2013-8#1)
delayed four-wave Raman mixing in##2##5##(2007-11#2)
delayed gastric emptying##4##3##(1990-12#1)(1994-2#1)(1997-4#1)(2008-3#1)
delayed graft function##2##3##(2008-8#1)(2013-1#1)
delayed growth##2##2##(2008-1#1)(2008-11#1)
delayed hypersensitivity##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
delayed in the##2##3##(1997-3#1)(2012-12#1)
delayed in vitro closure##2##4##(2011-1#2)
delayed in##17##2##(1990-2#1)(1991-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
delayed increase##2##2##(2008-11#1)(2012-2#1)
delayed loading##3##2##(2013-1#3)
delayed matching to sample##2##4##(1995-5#2)
delayed migration##2##2##(2008-12#2)
delayed model)##2##2##(2013-8#2)
delayed neuronal cell death##3##4##(1995-5#2)(2008-2#1)
delayed neuronal death following##2##4##(1990-7#1)(1996-12#1)
delayed neuronal death##4##3##(1990-7#2)(1996-12#2)
delayed neuronal##7##2##(1990-7#2)(1995-5#2)(1996-12#2)(2008-2#1)
delayed non-matching to position##4##4##(1992-11#2)(1994-3#2)
delayed non-matching-to-sample task##2##3##(1992-11#1)(1993-3#1)
delayed non-matching-to-sample##4##2##(1992-11#1)(1993-3#3)
delayed onset##2##2##(1997-2#1)(2011-2#1)
delayed operation##2##2##(1997-8#1)(2008-7#1)
delayed or##3##2##(2008-1#1)(2008-10#1)(2009-5#1)
delayed phase##2##2##(1997-8#1)(2013-1#1)
delayed postoperative##2##2##(2008-7#2)
delayed progression##2##2##(2010-1#2)
delayed rectifier K(+) current##2##4##(2008-8#1)(2009-12#1)
delayed rectifier##4##2##(1993-3#1)(1996-5#1)(2008-8#1)(2009-12#1)
delayed referral##2##2##(2008-1#1)(2008-11#1)
delayed stimulation wave##2##3##(2008-7#2)
delayed surgery##2##2##(1990-12#1)(2008-9#1)
delayed symptom##2##2##(2008-10#1)(2012-12#1)
delayed the onset of##2##4##(2008-4#1)(2008-5#1)
delayed the time##2##3##(2008-10#2)
delayed the##13##2##(1995-12#2)(1996-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#2)
delayed to##2##2##(1996-5#1)(2008-10#1)
delayed treatment##3##2##(1991-6#1)(1992-8#1)(2008-9#1)
delayed ulcer healing##2##3##(2008-12#1)(2012-2#1)
delayed union##4##2##(2012-2#2)(2013-1#2)
delayed with##3##2##(1997-4#1)(2007-12#1)(2012-3#1)
delayed word recall##2##3##(2008-7#2)
delayed wound healing##2##3##(2008-8#1)(2011-2#1)
delayed##340##1##(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#4)(1991-6#2)(1991-9#4)(1992-11#4)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#6)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#5)(1994-9#1)(1995-12#4)(1995-5#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#7)(1997-4#2)(1997-6#1)(1997-8#6)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#35)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#22)(2008-8#18)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#16)(2012-12#5)(2012-2#11)(2012-3#8)(2012-7#3)(2013-1#18)(2013-7#2)(2013-8#10)
delayed-fungicide program##2##2##(2008-10#2)
delayed-onset##2##1##(2008-7#1)(2012-12#1)
delayed-type hypersensitivity##3##2##(1995-12#1)(2008-10#2)
delayed-type##4##1##(1995-12#2)(2008-10#2)
delaying disease##3##2##(2008-10#2)(2010-11#1)
delaying or##2##2##(2008-4#1)(2010-9#1)
delaying the##8##2##(1996-12#2)(2008-10#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-8#1)
delaying their##2##2##(1991-9#1)(2008-10#1)
delaying##29##1##(1991-9#1)(1992-9#1)(1995-1#1)(1996-12#2)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-11#2)(2010-12#2)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-8#1)
delays among##3##2##(2008-3#1)(2008-4#2)
delays and##4##2##(1993-3#1)(2008-2#1)(2009-5#1)(2013-8#1)
delays are##5##2##(1992-12#1)(2008-2#1)(2008-3#3)
delays associated with##2##3##(1997-2#1)(2007-7#1)
delays between##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
delays can be##2##3##(1993-12#1)(2007-12#1)
delays for##3##2##(2008-2#2)(2013-1#1)
delays in the##4##3##(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
delays in##14##2##(1991-6#1)(1996-2#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
delays of##4##2##(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#1)
delays or##3##2##(1991-9#1)(2007-2#1)(2008-7#1)
delays that##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
delays the##9##2##(1993-11#1)(1994-8#2)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
delays##97##1##(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#4)(1993-3#3)(1994-8#2)(1995-1#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-2#3)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#9)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
delbrueckii##7##1##(1994-12#2)(1995-8#3)(2008-11#2)
delegate##3##1##(1994-3#2)(2008-6#1)
delegates##8##1##(1994-3#2)(1994-9#1)(2007-5#1)(2008-11#1)(2008-5#2)(2008-7#1)
delegations##2##1##(1992-11#1)(1995-6#1)
deletants and chimeras##3##3##(2008-8#3)
deletants##5##1##(2008-8#5)
delete##4##1##(2008-10#1)(2008-4#1)(2008-8#2)
deleted and##5##2##(1994-11#1)(1995-8#1)(1996-6#1)(2008-1#1)(2009-8#1)
deleted at a 5' region##2##5##(1990-12#2)
deleted at##3##2##(1990-12#2)(1991-10#1)
deleted for##5##2##(1991-7#1)(1997-3#2)(2008-10#1)(2008-7#1)
deleted in the##2##3##(1991-2#1)(2008-8#1)
deleted in##7##2##(1991-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
deleted regions##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
deleted##60##1##(1990-12#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-2#5)(1995-8#2)(1996-6#1)(1997-2#2)(1997-3#5)(1997-6#3)(1997-7#5)(2008-1#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
deleterious StoThresh##2##2##(2008-7#2)
deleterious at the##2##3##(2008-8#2)
deleterious effect of##5##3##(1995-12#1)(1996-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
deleterious effect on the##3##4##(1997-5#1)(2008-8#1)(2010-3#1)
deleterious effect on##5##3##(1995-12#1)(1997-5#1)(2008-11#1)(2008-8#1)(2010-3#1)
deleterious effect##12##2##(1995-12#2)(1996-11#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-3#1)
deleterious effects of##12##3##(1991-6#1)(1994-11#2)(1995-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)
deleterious effects on##9##3##(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)
deleterious effects upon crop and wine quality##2##7##(2008-10#2)
deleterious effects##26##2##(1991-6#1)(1994-11#2)(1994-2#1)(1995-2#1)(1995-3#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2010-4#1)
deleterious mutations in the##2##4##(2008-4#1)(2013-1#1)
deleterious mutations in##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
deleterious mutations##8##2##(1997-7#2)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#2)
deleterious sequelae##2##2##(2011-2#1)(2012-12#1)
deleterious to the##2##3##(1991-9#1)(2007-12#1)
deleterious to##4##2##(1991-9#1)(2007-12#1)(2008-5#1)(2008-8#1)
deleterious##78##1##(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#2)(1997-4#1)(1997-5#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-3#2)(2010-4#1)(2011-2#6)(2012-12#1)(2013-1#4)(2013-8#1)
deleting the##2##2##(1992-12#1)(1995-2#1)
deleting##9##1##(1992-12#1)(1993-2#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-7#3)
deletion alleles##2##2##(2008-7#2)
deletion analysis of##5##3##(1992-12#1)(1995-6#1)(1997-6#1)(2008-7#1)(2008-8#1)
deletion analysis##7##2##(1990-11#1)(1992-12#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-7#1)(2008-8#1)
deletion and duplication##2##3##(2008-4#1)(2008-7#1)
deletion and##12##2##(1993-6#2)(1994-11#2)(1994-6#1)(1997-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)
deletion at##4##2##(1996-12#2)(1997-3#1)(2008-2#1)
deletion derivatives##3##2##(1991-9#2)(1997-3#1)
deletion experiments##2##2##(1997-3#1)(2008-7#1)
deletion homozygotes##2##2##(1992-8#2)
deletion in a##2##3##(1991-2#1)(1997-2#1)
deletion in the coding##2##4##(1992-8#1)(1993-2#1)
deletion in the##7##3##(1990-12#1)(1992-8#1)(1993-2#2)(1994-12#1)(2008-10#2)
deletion in##15##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2012-12#1)
deletion is##4##2##(1990-5#1)(1996-2#1)(2008-12#1)(2012-12#1)
deletion lines were##3##3##(2008-10#3)
deletion mutant of heterogeneous nuclear ribonucleoprotein##2##6##(2008-8#2)
deletion mutant of##3##3##(1994-5#1)(2008-8#2)
deletion mutant was##2##3##(1991-9#1)(2008-8#1)
deletion mutant##18##2##(1991-9#1)(1993-8#1)(1994-5#1)(1995-8#2)(1997-1#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#2)
deletion mutants and##3##3##(1992-12#1)(1993-8#1)(2012-2#1)
deletion mutants in##2##3##(2008-7#1)(2012-3#1)
deletion mutants of##3##3##(1992-6#1)(1994-8#1)(2008-10#1)
deletion mutants that##2##3##(2008-7#1)(2012-3#1)
deletion mutants were##2##3##(1997-3#1)(2008-10#1)
deletion mutants##30##2##(1990-12#2)(1991-2#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#2)(1995-6#1)(1995-8#1)(1997-3#3)(1997-7#1)(2008-10#3)(2008-4#1)(2008-7#7)(2012-2#1)(2012-3#2)
deletion mutation##3##2##(1997-3#2)(2008-10#1)
deletion mutations##2##2##(2008-7#2)
deletion of 6q21-q23##2##3##(1997-3#2)
deletion of a##4##3##(1993-6#1)(1996-12#1)(2011-1#1)(2012-12#1)
deletion of the BK channel##2##5##(2009-2#2)
deletion of the RGD sequence##2##5##(1995-6#2)
deletion of the region##2##4##(1996-12#1)(1997-2#1)
deletion of the##20##3##(1991-9#1)(1994-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-7#1)(2008-10#3)(2008-9#1)(2009-2#2)
deletion of##63##2##(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-6#3)(1995-8#2)(1996-12#3)(1996-6#1)(1997-2#2)(1997-3#9)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#3)(2011-1#2)(2012-12#1)(2012-2#1)
deletion on the##2##3##(2010-2#1)(2012-12#1)
deletion on##3##2##(2009-5#1)(2010-2#1)(2012-12#1)
deletion or##5##2##(1994-12#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
deletion resulting in##3##3##(1993-6#2)(2012-2#1)
deletion syndrome##4##2##(1997-3#2)(2011-2#1)(2012-12#1)
deletion that##2##2##(2008-4#2)
deletion was##4##2##(1994-11#1)(1995-12#1)(1996-12#1)(1996-9#1)
deletion within##3##2##(1990-7#2)(1995-8#1)
deletion##279##1##(1990-11#1)(1990-12#4)(1990-5#4)(1990-7#9)(1991-2#2)(1991-6#1)(1991-9#4)(1992-12#3)(1992-6#3)(1992-8#9)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#6)(1993-8#5)(1993-9#1)(1994-11#7)(1994-12#5)(1994-5#3)(1994-6#2)(1994-8#4)(1995-12#4)(1995-2#2)(1995-6#5)(1995-8#13)(1996-12#9)(1996-2#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#30)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-12#5)(2008-2#2)(2008-4#8)(2008-7#19)(2008-8#8)(2008-9#11)(2009-2#3)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#5)(2012-12#7)(2012-2#4)(2012-3#6)(2013-8#4)
deletions and duplications##3##3##(2008-4#3)
deletions and##11##2##(1990-11#1)(1993-2#2)(1995-2#1)(2008-1#1)(2008-11#1)(2008-4#3)(2011-1#1)(2012-3#1)
deletions are##4##2##(1993-2#1)(1997-3#1)(2008-1#1)(2011-1#1)
deletions at##2##2##(1992-8#1)(1993-12#1)
deletions by##2##2##(1994-12#1)(1997-3#1)
deletions did##2##2##(1991-9#1)(2009-8#1)
deletions from a##2##3##(1993-9#1)(1996-12#1)
deletions from the##4##3##(1992-3#1)(1996-12#2)(1997-3#1)
deletions from##7##2##(1992-3#1)(1993-9#1)(1994-12#1)(1996-12#3)(1997-3#1)
deletions in the##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
deletions in##15##2##(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1995-6#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#2)(2011-2#1)
deletions is##3##2##(1997-3#2)(1997-7#1)
deletions of the mitochondrial DNA in##2##6##(1994-11#2)
deletions of the##7##3##(1991-11#1)(1992-3#1)(1994-11#2)(1997-4#1)(2008-10#1)(2009-8#1)
deletions of##18##2##(1991-11#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-12#1)(1994-11#2)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-9#2)(2009-8#1)
deletions or##4##2##(1992-6#1)(2008-11#1)(2008-4#1)(2012-3#1)
deletions were##4##2##(1993-6#1)(1997-2#1)(1997-3#1)(2008-9#1)
deletions within the##2##3##(2008-10#1)(2011-2#1)
deletions##121##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#5)(1993-6#2)(1993-9#1)(1994-11#4)(1994-12#3)(1995-2#1)(1995-6#1)(1995-8#3)(1996-12#6)(1996-9#1)(1997-2#3)(1997-3#15)(1997-4#2)(1997-7#3)(2008-1#4)(2008-10#4)(2008-11#3)(2008-4#7)(2008-7#4)(2008-9#4)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-1#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-3#5)
deleyianum is a##2##3##(1994-11#1)(2011-2#1)
deleyianum##5##1##(1994-11#2)(2011-2#3)
delhi##2##1##(2009-10#1)(2010-5#1)
deliberate posterior hysterotomy##2##3##(2011-2#2)
deliberate self-harm##2##2##(2009-7#1)(2012-12#1)
deliberate self-persuasion##4##2##(2008-5#4)
deliberate##26##1##(1992-3#2)(1992-5#2)(1993-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-7#2)(2009-3#1)(2009-7#1)(2010-3#4)(2011-2#2)(2012-12#1)(2013-8#1)
deliberately introduced##2##2##(2007-12#1)(2008-10#1)
deliberately##17##1##(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#2)(2012-2#1)
deliberation##2##1##(2008-11#1)(2011-1#1)
deliberations##7##1##(1994-12#1)(2007-12#3)(2008-11#1)(2008-9#1)(2012-2#1)
deliberative process##3##2##(2008-7#3)
deliberative##6##1##(1993-2#1)(2008-7#4)(2011-1#1)
delicate##9##1##(1993-2#2)(1996-2#1)(2007-12#1)(2008-9#3)(2010-8#1)(2013-1#1)
delicisoa cells under osmotic stress##2##5##(2008-9#2)
delicisoa##3##1##(2008-9#3)
delignificated##2##1##(2013-1#2)
delimit the##3##2##(1993-12#1)(2008-10#1)(2012-12#1)
delimit##7##1##(1993-12#1)(1994-2#1)(2008-10#2)(2008-4#1)(2010-9#1)(2012-12#1)
delimitation##5##1##(2009-6#1)(2012-3#3)(2013-7#1)
delimited by##2##2##(2008-10#2)
delimited##12##1##(1991-6#1)(1992-1#1)(1993-9#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)
delimiting##3##1##(2008-3#1)(2008-7#1)(2012-3#1)
delineate the##11##2##(1990-6#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-1#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
delineate##23##1##(1990-3#1)(1990-6#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-1#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
delineated and##3##2##(1991-12#1)(1994-12#1)(2011-2#1)
delineated by the##2##3##(2008-5#1)(2009-11#1)
delineated by##3##2##(2008-4#1)(2008-5#1)(2009-11#1)
delineated in##2##2##(2012-1#2)
delineated on the##2##3##(1993-6#1)(1996-2#1)
delineated##31##1##(1991-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-2#1)(2007-10#1)(2008-10#8)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
delineates the##6##2##(1995-1#1)(1997-1#1)(1997-3#1)(2008-2#1)(2008-4#1)(2009-5#1)
delineates##8##1##(1994-2#1)(1995-1#1)(1997-1#1)(1997-3#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)
delineating the##5##2##(2008-7#1)(2009-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
delineating##9##1##(2008-10#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
delineation and##2##2##(2008-7#1)(2010-5#1)
delineation of the##5##3##(1992-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
delineation of##13##2##(1992-6#1)(1994-11#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-11#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
delineation##28##1##(1992-6#1)(1994-11#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#5)(2009-11#6)(2009-2#1)(2010-5#2)(2010-6#1)(2012-12#3)(2012-2#2)(2012-3#1)
delinquency and crime##2##3##(2009-7#2)
delinquency##15##1##(1990-12#2)(1994-2#2)(2009-7#7)(2012-12#4)
delinquent behavior for##2##3##(2009-7#2)
delinquent behavior is##2##3##(1990-12#2)
delinquent behavior##12##2##(1990-12#2)(2008-11#1)(2009-7#5)(2009-8#4)
delinquent group showed##2##3##(1990-12#2)
delinquent group##3##2##(1990-12#3)
delinquent##27##1##(1990-10#1)(1990-12#9)(2007-9#1)(2008-11#1)(2009-7#8)(2009-8#6)(2010-5#1)
delinquents##2##1##(1990-12#1)(2009-7#1)
delipidated protein##3##2##(1990-5#1)(1993-11#1)(1994-11#1)
delipidated##8##1##(1990-5#1)(1992-12#1)(1993-11#1)(1994-11#1)(1995-8#4)
delipidation method##2##2##(1990-5#2)
delipidation##4##1##(1990-5#3)(1995-8#1)
delirious##4##1##(2009-7#1)(2011-2#2)(2012-3#1)
delirium during##2##2##(2010-10#1)(2013-1#1)
delirium in##4##2##(2010-10#2)(2012-12#1)(2013-1#1)
delirium is##2##2##(2012-2#1)(2013-1#1)
delirium prevention##2##2##(2010-10#2)
delirium protocol was##2##3##(2010-10#2)
delirium protocol##3##2##(2010-10#3)
delirium therapy##2##2##(2011-2#2)
delirium was##3##2##(2011-2#1)(2013-1#2)
delirium##54##1##(1991-11#1)(2007-7#1)(2008-7#5)(2009-5#1)(2010-1#3)(2010-10#16)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#17)
deliver DNA and##2##3##(2008-7#2)
deliver DNA##3##2##(2008-11#1)(2008-7#2)
deliver a wider range of##2##5##(1994-12#1)(2008-10#1)
deliver a##13##2##(1994-12#1)(1996-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-2#2)
deliver an##2##2##(2007-11#1)(2012-2#1)
deliver and##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
deliver culturally##2##2##(2010-8#1)(2011-1#1)
deliver high quality##3##3##(1993-12#1)(1994-3#1)(1997-1#1)
deliver high##4##2##(1993-12#1)(1994-3#1)(1997-1#2)
deliver patient##2##2##(2008-10#1)(2008-11#1)
deliver primary care##2##3##(1996-9#1)(1997-3#1)
deliver quality##2##2##(1994-3#1)(2008-11#1)
deliver results##2##2##(2008-1#1)(2009-10#1)
deliver the##15##2##(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-12#1)
deliver##138##1##(1990-3#1)(1991-1#2)(1992-1#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2008-1#3)(2008-10#4)(2008-11#11)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#15)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#2)(2009-2#2)(2009-9#1)(2010-10#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#7)(2012-12#3)(2012-2#5)(2013-1#3)(2013-8#1)
deliverables##2##1##(1997-3#1)(2011-1#1)
delivered a viable infant##2##4##(1991-2#1)(2013-1#1)
delivered a##4##2##(1991-2#1)(1994-12#1)(2007-11#1)(2013-1#1)
delivered and targeted to the brain##2##6##(2010-5#2)
delivered and##4##2##(2010-5#2)(2011-2#1)(2013-1#1)
delivered as much as##2##4##(2007-12#1)(2008-3#1)
delivered as##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
delivered at low##2##3##(2008-7#1)(2013-1#1)
delivered at the##3##3##(1994-1#1)(1997-2#1)(2008-3#1)
delivered at##15##2##(1990-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#3)(2011-2#1)(2012-12#1)(2013-1#1)
delivered beam##2##2##(2008-3#2)
delivered by a##8##3##(1991-2#1)(1992-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2011-3#1)
delivered by cesarean section##3##4##(1994-9#1)(2008-9#1)(2011-2#1)
delivered by dental hygienists as part of a patient's regularly scheduled cleaning visit##2##13##(2008-4#2)
delivered by the##3##3##(2006-4#1)(2007-12#1)(2013-1#1)
delivered by##38##2##(1991-2#1)(1992-3#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#3)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
delivered directly into the##2##4##(1993-12#1)(2008-5#1)
delivered dose intensity##2##3##(2008-6#1)(2008-7#1)
delivered dose of##2##3##(1996-2#1)(1997-1#1)
delivered dose##5##2##(1996-2#2)(1997-1#1)(2008-6#1)(2008-7#1)
delivered during##3##2##(1990-3#1)(1994-2#1)(2013-1#1)
delivered either##2##2##(1994-7#1)(1997-2#1)
delivered from a##2##3##(2007-11#1)(2008-5#1)
delivered from the Diskus##2##4##(1996-2#2)
delivered from the##4##3##(1995-3#1)(1996-2#2)(1997-2#1)
delivered from##6##2##(1995-3#1)(1996-2#2)(1997-2#1)(2007-11#1)(2008-5#1)
delivered in a##5##3##(1990-12#1)(1995-5#1)(1996-3#1)(2011-1#1)(2012-2#1)
delivered in the##4##3##(1996-2#1)(2006-10#1)(2007-8#1)(2010-8#1)
delivered in##15##2##(1990-12#1)(1992-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
delivered into the##3##3##(1997-1#1)(2008-10#1)(2012-12#1)
delivered into##8##2##(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-8#1)(2012-12#1)
delivered this##2##2##(1994-1#1)(2013-8#1)
delivered through the##3##3##(2008-4#2)(2009-8#1)
delivered through##5##2##(2008-4#2)(2008-8#1)(2009-8#1)(2011-2#1)
delivered to a##2##3##(1993-9#1)(2013-1#1)
delivered to patients##3##3##(1995-2#1)(2010-7#1)(2013-8#1)
delivered to the respiratory tract##2##5##(1994-12#1)(1996-3#1)
delivered to the##16##3##(1994-12#3)(1996-3#1)(1997-2#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2011-2#1)(2012-2#1)
delivered to##31##2##(1993-9#1)(1994-12#3)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
delivered via##5##2##(1996-3#1)(1997-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
delivered with##2##2##(2008-11#1)(2008-7#1)
delivered##224##1##(1990-12#5)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#3)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#7)(1996-3#3)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#7)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#13)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#13)(2013-8#5)
deliveries and##3##2##(1995-12#1)(2008-7#1)(2011-1#1)
deliveries in##2##2##(1995-12#1)(2011-2#1)
deliveries were##3##2##(1995-12#1)(2007-11#1)(2008-5#1)
deliveries##33##1##(1990-3#3)(1991-3#1)(1992-2#1)(1993-3#1)(1994-3#3)(1995-12#4)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
delivering CFTR gene##2##3##(2011-3#2)
delivering a##8##2##(1992-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(2008-5#3)(2013-8#1)
delivering energy##2##2##(2008-9#2)
delivering optimal##2##2##(2008-6#1)(2013-1#1)
delivering quality care##2##3##(1996-1#1)(1996-2#1)
delivering services##2##2##(1996-2#1)(2007-4#1)
delivering the##4##2##(1991-12#1)(2008-11#1)(2008-4#1)(2010-11#1)
delivering##66##1##(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-2#6)(1997-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#1)(2013-1#3)(2013-8#1)
delivers an##4##2##(1996-11#1)(2007-11#1)(2007-7#1)(2012-3#1)
delivers the##6##2##(1991-12#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#1)
delivers##30##1##(1991-12#1)(1992-3#1)(1996-11#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#3)(2012-2#3)(2012-3#2)
delivery agents##2##2##(1994-3#1)(2009-10#1)
delivery allow##2##2##(2008-1#1)(2008-11#1)
delivery and evaluation of##3##4##(2008-12#2)(2012-12#1)
delivery and financing##4##3##(1992-3#1)(1993-2#1)(1995-1#1)(1996-3#1)
delivery and may##2##3##(1995-11#1)(1996-3#1)
delivery and stability of ODNs##2##5##(1994-12#2)
delivery and the##3##3##(2010-11#1)(2010-4#1)(2010-5#1)
delivery and utilization##2##3##(1995-5#1)(2010-11#1)
delivery and##63##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#2)(1994-12#3)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#4)(2007-10#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
delivery approach##3##2##(1995-1#1)(1995-3#1)(2010-5#1)
delivery are##5##2##(1992-3#2)(1992-5#1)(1993-3#1)(2008-5#1)
delivery as##3##2##(2008-12#1)(2008-2#1)(2012-2#1)
delivery at term##4##3##(1995-8#1)(2013-1#3)
delivery at the##2##3##(2012-2#1)(2013-1#1)
delivery at##7##2##(1992-2#1)(1995-8#1)(2012-2#1)(2013-1#4)
delivery by##7##2##(1995-3#1)(1996-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
delivery can be##2##3##(1994-2#1)(2008-8#1)
delivery can##4##2##(1994-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
delivery depends on the##2##4##(1996-2#1)(2008-5#1)
delivery devices##4##2##(2008-3#2)(2010-6#1)(2012-2#1)
delivery during the##2##3##(1996-9#1)(2008-5#1)
delivery efficiency##5##2##(1994-2#1)(1997-3#1)(2008-10#2)(2013-1#1)
delivery for##5##2##(1995-12#1)(1997-1#1)(2009-11#1)(2010-10#1)(2012-2#1)
delivery from##3##2##(1997-1#1)(2007-10#1)(2011-2#1)
delivery has##3##2##(1997-1#1)(2008-11#1)(2010-2#1)
delivery have been##2##3##(2008-3#1)(2010-6#1)
delivery have##3##2##(2008-3#1)(2008-7#1)(2010-6#1)
delivery in the##5##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
delivery in##18##2##(1993-1#1)(1995-10#1)(1996-3#1)(1997-1#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#3)
delivery into the##2##3##(2010-6#1)(2011-1#1)
delivery into##8##2##(2007-12#1)(2008-11#3)(2008-2#1)(2008-4#1)(2010-6#1)(2011-1#1)
delivery is##5##2##(1993-12#2)(1996-2#1)(2008-11#1)(2012-1#1)
delivery issues##2##2##(1995-2#1)(2012-3#1)
delivery method##2##2##(2008-12#1)(2008-8#1)
delivery methods##7##2##(1994-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
delivery model##3##2##(1997-3#1)(2008-1#1)(2008-3#1)
delivery more##2##2##(1992-4#1)(1996-3#1)
delivery of DNA##4##3##(1994-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
delivery of TNF-alpha##4##3##(2013-1#4)
delivery of a healthy##2##4##(2008-11#1)(2011-1#1)
delivery of a##12##3##(2007-7#1)(2008-11#3)(2008-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
delivery of an##5##3##(2008-12#1)(2008-3#1)(2008-5#2)(2010-8#1)
delivery of care##5##3##(1992-2#1)(2007-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
delivery of clinical##2##3##(1992-3#1)(1996-2#1)
delivery of drug##2##3##(1992-8#1)(1996-1#1)
delivery of drugs##2##3##(2008-11#1)(2008-8#1)
delivery of femtosecond pulses##3##4##(2007-11#1)(2007-12#2)
delivery of genes##2##3##(2008-4#1)(2008-5#1)
delivery of health care in##2##5##(1997-1#1)(2013-1#1)
delivery of health care services##6##5##(1994-12#1)(1994-3#1)(1995-3#2)(1996-2#1)(2010-3#1)
delivery of health care##12##4##(1992-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1996-2#1)(1997-1#1)(2010-3#1)(2010-8#1)(2013-1#1)
delivery of health services##6##4##(1993-2#1)(1993-6#1)(1996-1#1)(2008-1#1)(2009-3#1)(2011-1#1)
delivery of health##19##3##(1992-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(2008-1#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
delivery of insulin##5##3##(2008-5#1)(2011-1#4)
delivery of laser##2##3##(2007-12#1)(2007-8#1)
delivery of lipophilic##2##3##(1992-6#1)(2008-5#1)
delivery of nebulized insulin##2##4##(1996-3#2)
delivery of nucleic acids##2##4##(2008-5#1)(2010-10#1)
delivery of oxygen##2##3##(2008-9#1)(2011-2#1)
delivery of proteins##2##3##(1996-1#1)(2008-7#1)
delivery of safe##2##3##(1995-1#1)(2008-3#1)
delivery of services to##3##4##(1991-3#1)(2008-11#1)(2009-6#1)
delivery of services##6##3##(1991-3#1)(1994-12#1)(1997-2#2)(2008-11#1)(2009-6#1)
delivery of small##2##3##(1993-6#1)(2010-2#1)
delivery of the active##2##4##(2008-5#2)
delivery of the most##2##4##(1990-6#1)(2007-5#1)
delivery of the##15##3##(1990-6#1)(1993-6#1)(1994-3#1)(1995-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#2)(2013-1#1)
delivery of these##4##3##(1995-11#1)(2010-10#1)(2010-3#1)(2010-6#1)
delivery of this##2##3##(2008-12#1)(2008-6#1)
delivery of transgenes##2##3##(2008-11#1)(2008-4#1)
delivery of##225##2##(1990-6#1)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1994-1#3)(1994-12#5)(1994-3#4)(1994-5#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#6)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#5)(1996-3#3)(1996-9#1)(1997-1#3)(1997-2#4)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#8)(2008-5#19)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#3)(2010-6#4)(2010-8#8)(2011-1#10)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#1)
delivery or##3##2##(1994-2#1)(2008-7#1)(2011-1#1)
delivery practices##3##2##(1994-2#1)(2008-7#1)(2012-12#1)
delivery procedures##2##2##(2008-9#1)(2012-12#1)
delivery process##3##2##(1995-12#1)(2007-9#1)(2008-5#1)
delivery room##2##2##(1996-6#1)(2012-2#1)
delivery service##2##2##(1996-1#1)(2011-2#1)
delivery should be##2##3##(1994-12#1)(1995-12#1)
delivery should##3##2##(1992-4#1)(1994-12#1)(1995-12#1)
delivery showed##2##2##(1992-8#1)(1995-12#1)
delivery structures##3##2##(1994-1#1)(1995-3#1)(1996-1#1)
delivery system and##3##3##(1995-12#1)(2008-5#1)(2008-7#1)
delivery system by##2##3##(2008-3#1)(2011-2#1)
delivery system for##8##3##(1992-3#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2012-2#1)
delivery system in the##2##4##(1991-12#1)(1993-1#1)
delivery system in##4##3##(1991-12#1)(1993-1#1)(1995-2#1)(1995-3#1)
delivery system is##3##3##(2008-5#1)(2010-10#1)(2010-12#1)
delivery system that##4##3##(1995-3#1)(2008-5#1)(2013-1#2)
delivery system to##2##3##(1992-3#1)(1996-1#1)
delivery system using##2##3##(2008-11#1)(2008-8#1)
delivery system##98##2##(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#4)(1996-1#9)(1996-12#1)(1996-2#3)(1996-3#5)(1997-1#1)(1997-2#2)(1997-3#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-6#2)(2013-1#2)(2013-8#2)
delivery systems are##3##3##(1994-2#1)(1994-5#1)(2008-7#1)
delivery systems for##9##3##(1991-3#1)(1992-3#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
delivery systems of##3##3##(1993-2#1)(1996-1#2)
delivery systems provide##2##3##(1997-1#1)(2008-5#1)
delivery systems that are##2##4##(1994-2#1)(2010-5#1)
delivery systems that##4##3##(1993-12#1)(1994-2#1)(1995-12#1)(2010-5#1)
delivery systems to##2##3##(1992-3#1)(1993-12#1)
delivery systems##74##2##(1991-3#1)(1992-3#2)(1993-12#3)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#9)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#6)(1997-3#1)(2008-1#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-5#3)(2012-2#4)(2012-3#1)(2013-1#2)
delivery systems?##2##2##(1996-1#2)
delivery techniques##2##2##(1992-2#1)(2008-11#1)
delivery that##2##2##(1993-1#1)(1995-3#1)
delivery through##2##2##(1994-1#1)(2011-2#1)
delivery to a##2##3##(2008-1#1)(2008-2#1)
delivery to the##13##3##(1996-3#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
delivery to##37##2##(1991-6#1)(1994-5#2)(1995-2#1)(1996-3#3)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
delivery units##4##2##(1995-6#4)
delivery using##2##2##(2008-4#1)(2009-11#1)
delivery vector for##2##3##(2008-9#1)(2011-2#1)
delivery vectors##2##2##(1994-11#1)(1994-12#1)
delivery vehicle##4##2##(1995-5#1)(2008-12#1)(2009-11#1)(2009-7#1)
delivery vehicles##5##2##(2010-10#2)(2010-8#1)(2012-12#1)(2013-1#1)
delivery was##6##2##(1994-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)
delivery were##5##2##(1993-1#1)(1995-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
delivery will be##2##3##(1995-2#1)(2013-7#1)
delivery with##4##2##(1995-2#1)(2008-11#1)(2008-2#1)(2008-3#1)
delivery within##2##2##(1994-3#1)(1995-1#1)
delivery##959##1##(1990-6#2)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#7)(1991-6#2)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#3)(1992-2#9)(1992-3#14)(1992-4#4)(1992-5#1)(1992-6#2)(1992-8#3)(1993-1#5)(1993-10#2)(1993-11#1)(1993-12#10)(1993-2#6)(1993-3#8)(1993-6#6)(1994-1#11)(1994-11#1)(1994-12#15)(1994-2#10)(1994-3#13)(1994-5#8)(1994-6#1)(1994-7#2)(1994-9#1)(1995-1#12)(1995-10#1)(1995-11#3)(1995-12#15)(1995-2#10)(1995-3#21)(1995-5#6)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#28)(1996-11#3)(1996-12#11)(1996-2#20)(1996-3#23)(1996-6#1)(1996-9#2)(1997-1#23)(1997-2#13)(1997-3#10)(2006-7#1)(2007-10#4)(2007-11#5)(2007-12#15)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#18)(2008-10#22)(2008-11#50)(2008-12#14)(2008-2#13)(2008-3#22)(2008-4#24)(2008-5#36)(2008-6#8)(2008-7#25)(2008-8#20)(2008-9#10)(2009-10#4)(2009-11#8)(2009-12#5)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#13)(2010-11#3)(2010-12#6)(2010-2#6)(2010-3#8)(2010-4#3)(2010-5#14)(2010-6#9)(2010-7#2)(2010-8#13)(2010-9#1)(2011-1#31)(2011-2#33)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#25)(2012-3#21)(2012-6#3)(2013-1#38)(2013-7#2)(2013-8#16)
delivery)##2##1##(2008-10#1)(2008-5#1)
delocalization##12##1##(1996-2#2)(2007-11#5)(2007-12#1)(2008-11#1)(2009-10#1)(2010-7#2)
delocalized##6##1##(1990-5#1)(1990-8#1)(1994-5#2)(2007-12#1)(2008-10#1)
delta 1-4##2##2##(1993-11#2)
delta 1-opioid receptor agonist##2##4##(1996-2#2)
delta 12-PGJ2 and HS##2##4##(1991-9#2)
delta 12-PGJ2 induced##2##3##(1991-9#2)
delta 12-PGJ2##5##2##(1991-9#5)
delta 14##3##2##(1993-8#3)
delta 14)##2##2##(1993-8#2)
delta 171-215##2##2##(1993-11#2)
delta 181-215##2##2##(1993-11#2)
delta 194-215##2##2##(1993-11#2)
delta 2-opioid receptor##2##3##(1996-2#2)
delta 209-215##2##2##(1993-11#2)
delta 4##2##2##(1991-12#1)(1994-11#1)
delta 5##3##2##(1991-12#1)(1994-11#2)
delta 56-60)##2##2##(1994-12#2)
delta 6##3##2##(1991-12#1)(1994-11#2)
delta 9##3##2##(1991-12#2)(1996-5#1)
delta 9-tetrahydrocannabinol##4##2##(1991-10#1)(1991-4#2)(1996-2#1)
delta C0fold##2##2##(1992-5#2)
delta Cp##4##2##(1993-8#1)(1997-2#3)
delta G degrees 37 of##2##5##(1991-8#2)
delta G degrees 37##4##4##(1991-8#3)(1992-3#1)
delta G degrees values##2##4##(1993-8#2)
delta G degrees##8##3##(1991-8#3)(1992-3#1)(1993-8#4)
delta G##11##2##(1990-8#1)(1991-8#3)(1992-3#1)(1993-8#5)(2011-3#1)
delta GH2O##2##2##(1992-6#2)
delta Gc can##2##3##(1990-8#2)
delta Gc values##2##3##(1990-8#2)
delta Gc##4##2##(1990-8#4)
delta H of##2##3##(1990-8#1)(1994-3#1)
delta H##9##2##(1990-7#2)(1990-8#3)(1993-8#1)(1994-3#1)(1994-5#1)(1995-5#1)
delta H0fold##2##2##(1992-5#2)
delta Ka values##2##3##(1995-2#2)
delta Ka##5##2##(1995-2#5)
delta Vo##2##2##(1993-12#2)
delta and epsilon##4##3##(1993-3#1)(2008-8#3)
delta and gamma##2##3##(2008-8#2)
delta and kappa##2##3##(1993-12#1)(1995-6#1)
delta and##12##2##(1993-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-8#5)(2010-1#1)(2013-8#2)
delta antigens##2##2##(1994-11#2)
delta binding##2##2##(1995-3#2)
delta delta##4##2##(1990-8#1)(1992-6#2)(1995-5#1)
delta kappa = kappa##2##4##(1990-5#2)
delta kappa##5##2##(1990-5#5)
delta mutant##3##2##(1995-8#2)(1996-6#1)
delta of##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
delta opioid receptor##3##3##(1992-3#1)(1995-6#1)(2008-11#1)
delta opioid##7##2##(1992-3#1)(1995-3#1)(1995-6#1)(2008-11#1)(2009-7#3)
delta psi Na+##2##3##(1990-11#2)
delta receptor##4##2##(1992-3#1)(1995-3#2)(1995-6#1)
delta rule##2##2##(2008-10#1)(2008-2#1)
delta sleep-inducing##2##2##(1990-5#2)
delta virus##4##2##(1991-8#1)(1994-11#2)(2009-8#1)
delta was##2##2##(1995-2#1)(2007-12#1)
delta with respect to the##2##5##(1996-2#1)(2008-3#1)
delta##258##1##(1990-11#4)(1990-5#8)(1990-7#7)(1990-8#12)(1990-9#2)(1991-1#3)(1991-10#1)(1991-12#5)(1991-4#3)(1991-5#3)(1991-8#4)(1991-9#6)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#4)(1992-6#7)(1992-8#2)(1992-9#9)(1993-11#12)(1993-12#5)(1993-3#3)(1993-6#2)(1993-8#19)(1993-9#1)(1994-11#11)(1994-12#7)(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#12)(1995-3#8)(1995-5#5)(1995-6#3)(1995-8#2)(1996-12#3)(1996-2#7)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#5)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#8)(2008-8#9)(2009-11#1)(2009-12#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-3#1)(2012-3#3)(2013-8#4)
delta(11)##2##1##(1997-7#2)
delta(18)O =##2##2##(2008-2#2)
delta(22)##2##1##(1997-7#2)
delta- and kappa-opioid receptors were 4##2##6##(1995-11#2)
delta- and kappa-opioid receptors##5##4##(1995-11#5)
delta-##6##1##(1995-11#5)(1995-12#1)
delta-9 desaturase##2##2##(1996-6#2)
delta-9 fatty acid desaturase##2##4##(1996-6#2)
delta-9##4##1##(1996-6#4)
delta-opioid receptors##4##2##(1993-3#1)(1995-12#1)(1996-2#2)
delta-opioid##6##1##(1992-3#1)(1993-3#1)(1995-12#1)(1996-2#2)(2009-7#1)
delta-selective opioid##2##2##(1991-1#1)(1995-12#1)
delta-selective##3##1##(1991-1#1)(1995-12#1)(1995-3#1)
delta-tocopherol##2##1##(2008-10#1)(2008-5#1)
deltaT##5##1##(2008-3#5)
deltam was 0##2##3##(2008-3#2)
deltam##5##1##(2008-3#5)
deltamethrin in##3##2##(2008-10#3)
deltamethrin on##3##2##(2008-10#2)(2013-1#1)
deltamethrin##25##1##(2007-10#2)(2008-10#13)(2011-2#3)(2012-12#1)(2013-1#6)
deltamethrin-induced [Ca²⁺]i rise##2##3##(2013-1#2)
deltaproteobacterium##2##1##(2012-3#2)
deltoid group##2##2##(2010-4#2)
deltoid ligament##2##2##(2009-3#2)
deltoid muscle and the##2##4##(2010-4#1)(2010-6#1)
deltoid muscle##8##2##(2009-3#1)(2009-9#3)(2010-4#2)(2010-6#1)(2013-8#1)
deltoid##17##1##(1997-6#1)(2008-12#1)(2009-3#4)(2009-9#3)(2010-4#4)(2010-6#1)(2011-2#1)(2013-8#2)
deltoidae##3##1##(2008-10#3)
deltoides and##4##2##(2008-10#4)
deltoides##22##1##(2008-10#18)(2011-2#4)
deltorphin##3##1##(1995-3#2)(1995-6#1)
deluge##2##1##(2008-10#1)(2008-7#1)
delusion##2##1##(1996-11#1)(2008-1#1)
delusional##9##1##(1996-11#1)(2008-4#2)(2008-6#4)(2011-2#2)
delusions and hallucinations##5##3##(1995-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
delusions and##6##2##(1995-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2012-2#1)
delusions##15##1##(1995-11#1)(1995-8#1)(2008-2#1)(2008-4#2)(2008-6#2)(2009-10#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-8#1)
demand a more##2##3##(1996-3#1)(2010-10#1)
demand a##5##2##(1992-2#1)(1993-12#1)(1996-3#1)(2010-10#1)(2011-2#1)
demand and##7##2##(1992-9#1)(1994-12#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-6#1)(2013-7#1)
demand are##3##2##(1992-1#1)(1995-2#1)(2008-11#1)
demand for a##2##3##(1994-12#1)(2008-10#1)
demand for an##2##3##(2008-5#1)(2013-1#1)
demand for health care services##3##5##(1992-2#1)(1995-12#1)(1995-2#1)
demand for health care##5##4##(1992-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)
demand for health##7##3##(1992-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2012-3#1)
demand for physicians##2##3##(1991-1#2)
demand for this##2##3##(1995-3#1)(1997-1#1)
demand for waste collecting services##2##5##(2008-12#2)
demand for##77##2##(1990-2#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#2)(1992-1#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
demand from the##2##3##(1990-8#1)(2013-8#1)
demand from##3##2##(1990-8#1)(2011-2#1)(2013-8#1)
demand in##4##2##(1994-2#1)(2007-11#1)(2008-5#1)(2008-7#1)
demand is##2##2##(1994-1#1)(2013-7#1)
demand of##10##2##(1990-2#1)(1991-1#1)(1992-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-3#1)
demand on##5##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-6#1)
demand that##5##2##(1997-1#1)(2007-11#1)(2007-7#1)(2008-3#1)(2013-1#1)
demand the##3##2##(1994-3#1)(2009-12#1)(2009-4#1)
demand##202##1##(1990-2#3)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-6#2)(1992-1#4)(1992-12#1)(1992-2#5)(1992-3#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#8)(1995-3#3)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#4)(1997-1#3)(1997-3#2)(1997-6#1)(1997-8#3)(2006-6#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#11)(2008-12#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#3)(2013-8#2)
demand]##2##1##(1993-5#1)(1996-3#1)
demanded by##3##2##(1990-11#1)(1991-3#1)(2008-3#1)
demanded from##2##2##(1993-12#1)(2008-12#1)
demanded##15##1##(1990-11#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
demanding and##4##2##(1996-9#1)(2008-12#1)(2008-9#1)(2009-11#1)
demanding tasks##2##2##(2007-8#1)(2008-12#1)
demanding##42##1##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#3)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
demands a##3##2##(1994-2#1)(2008-1#1)(2009-11#1)
demands and##11##2##(1991-1#1)(1991-12#1)(1994-12#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-9#1)(2013-1#1)
demands are##4##2##(1991-1#1)(1995-2#1)(1996-2#1)(2008-6#1)
demands for##14##2##(1993-11#1)(1993-2#1)(1995-2#1)(1996-2#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#2)
demands from##2##2##(1996-8#1)(2010-12#1)
demands in the##2##3##(1997-3#1)(2012-12#1)
demands in##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-12#1)
demands lower##2##2##(1994-12#1)(1995-12#1)
demands of the##7##3##(1993-12#1)(1994-2#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-3#1)
demands of##27##2##(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#4)(2013-1#1)
demands on the##3##3##(1992-2#1)(2008-1#1)(2008-10#1)
demands on##17##2##(1991-2#1)(1992-2#1)(1992-3#1)(1994-12#1)(1996-1#1)(2006-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2012-1#1)
demands placed on##2##3##(1994-1#1)(2008-10#1)
demands that##8##2##(1992-3#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-8#1)(2011-1#1)
demands the##3##2##(2010-8#1)(2011-1#1)(2013-1#1)
demands to##2##2##(1994-2#1)(1995-3#1)
demands##161##1##(1990-12#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#7)(1994-2#5)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#17)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#7)(2012-1#3)(2012-12#1)(2012-3#5)(2013-1#6)
demarcated##4##1##(1993-9#1)(2008-10#1)(2010-6#1)(2012-12#1)
demarcation of##2##2##(2009-10#1)(2013-8#1)
demarcation##5##1##(2006-10#1)(2008-1#1)(2009-10#1)(2009-4#1)(2013-8#1)
dematiaceous hyphomycetes##3##2##(2008-10#3)
dematiaceous##7##1##(2008-10#3)(2008-5#4)
deme##7##1##(2008-10#1)(2008-9#6)
demembranated Orychophragmus violaceus sperm##2##4##(2008-9#2)
demembranated##3##1##(2008-9#3)
demembraned sperms##2##2##(2008-8#2)
demented PD patients##3##3##(2008-7#3)
demented PD##5##2##(2008-7#5)
demented and non-demented##3##3##(2008-7#3)
demented and##4##2##(2008-7#4)
demented patients##6##2##(2008-7#6)
demented##24##1##(1990-9#1)(2008-7#23)
dementerende patiënt en zijn mantelzorger##2##5##(2012-12#2)
dementerende##3##1##(2012-12#3)
dementia (FTD)##5##2##(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)
dementia and##18##2##(1990-3#1)(1994-5#1)(1994-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-9#1)(2010-10#1)(2010-11#1)(2013-8#1)
dementia are##3##2##(1990-3#1)(1992-3#1)(2008-5#1)
dementia can##2##2##(2008-7#1)(2013-8#1)
dementia care##4##2##(2008-6#1)(2011-1#1)(2013-8#2)
dementia group##2##2##(2008-7#2)
dementia have##2##2##(2008-6#1)(2008-7#1)
dementia in PD##2##3##(2008-7#2)
dementia in Parkinson's disease##2##4##(2008-7#2)
dementia in the elderly##2##4##(2008-7#2)
dementia in the##6##3##(1991-9#1)(2008-6#1)(2008-7#2)(2013-1#1)(2013-8#1)
dementia in which##2##3##(2007-10#1)(2008-6#1)
dementia in##20##2##(1991-9#2)(1995-12#1)(2007-10#1)(2008-6#2)(2008-7#8)(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
dementia is##3##2##(1996-11#1)(2008-7#1)(2013-8#1)
dementia of Alzheimer's type##3##4##(1994-6#2)(2008-6#1)
dementia of the Alzheimer type##4##5##(1994-5#2)(1996-11#1)(2008-7#1)
dementia of the Alzheimer##5##4##(1994-5#3)(1996-11#1)(2008-7#1)
dementia of the##6##3##(1994-5#3)(1996-11#1)(2008-6#1)(2008-7#1)
dementia of##11##2##(1991-9#1)(1994-5#3)(1994-6#2)(1996-11#1)(2008-6#2)(2008-7#2)
dementia or##3##2##(2008-7#2)(2012-12#1)
dementia patients##11##2##(1990-3#2)(2008-6#5)(2008-8#1)(2013-1#3)
dementia severity##5##2##(2008-6#3)(2013-1#2)
dementia that is##2##3##(2008-7#1)(2011-1#1)
dementia was##6##2##(1991-9#1)(2008-6#1)(2008-7#4)
dementia were##3##2##(1991-1#1)(1994-6#1)(2013-1#1)
dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies##2##10##(2008-7#2)
dementia with Lewy bodies and multiple system atrophy##3##8##(2008-7#3)
dementia with Lewy bodies##4##4##(2008-7#4)
dementia with##6##2##(2008-7#4)(2009-8#1)(2013-1#1)
dementia##243##1##(1990-11#2)(1990-3#5)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1994-5#4)(1994-6#4)(1995-11#1)(1995-12#3)(1995-3#1)(1996-11#12)(1996-2#1)(1996-5#2)(1996-6#2)(1996-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#24)(2008-7#73)(2008-8#2)(2008-9#7)(2009-12#2)(2009-2#4)(2009-8#1)(2009-9#4)(2010-10#3)(2010-11#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#15)(2013-8#11)
dementias##3##1##(1993-2#1)(2008-7#2)
demerits of the##2##3##(2008-10#2)
demerits of##3##2##(2008-10#3)
demes of high mean fitness##2##5##(2008-9#2)
demes of high##3##3##(2008-9#3)
demes of lower mean fitness##2##5##(2008-9#2)
demes of##5##2##(2008-9#5)
demes##10##1##(2008-10#1)(2008-9#9)
demetalation##2##1##(2010-5#2)
demetalization##3##1##(2008-10#3)
demethylase##6##1##(1991-5#3)(2008-10#1)(2008-8#1)(2009-7#1)
demethylated##4##1##(1991-5#2)(1995-2#2)
demethylating##3##1##(2007-11#2)(2013-1#1)
demethylation and##2##2##(1992-3#1)(1995-2#1)
demethylation inhibitor fungicides##3##3##(2008-10#3)
demethylation inhibitor##4##2##(2008-10#4)
demethylation of the##3##3##(1993-8#1)(1995-2#1)(2011-2#1)
demethylation of##5##2##(1992-3#1)(1993-8#2)(1995-2#1)(2011-2#1)
demethylation##21##1##(1992-11#1)(1992-3#3)(1993-8#2)(1994-9#1)(1995-2#4)(2008-10#7)(2008-3#1)(2008-9#1)(2011-2#1)
demineralization##8##1##(1997-4#3)(2007-11#1)(2007-8#1)(2008-6#1)(2012-2#1)(2013-1#1)
demineralized bone matrices##3##3##(2008-8#3)
demineralized bone matrix##2##3##(1991-5#2)
demineralized bone##5##2##(1991-5#2)(2008-8#3)
demineralized##9##1##(1991-5#2)(2008-11#1)(2008-12#1)(2008-8#3)(2011-2#1)(2012-12#1)
demise in##2##2##(1996-2#1)(2010-8#1)
demise##13##1##(1993-2#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
demissum##3##1##(2008-10#3)
demixed##2##1##(2008-10#2)
democracy##4##1##(1994-2#1)(1995-5#1)(1997-7#1)(2008-7#1)
democratic##5##1##(1996-8#1)(2008-7#2)(2013-7#2)
democratic-involved parenting style##2##3##(2009-7#2)
democratic-involved parenting##5##2##(2009-7#5)
demodulate##5##1##(2008-3#5)
demodulated##9##1##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)
demodulating##3##1##(2008-3#2)(2013-8#1)
demodulation of fiber##2##3##(2008-3#2)
demodulation of the##3##3##(2007-12#1)(2008-3#2)
demodulation of##10##2##(2007-12#3)(2008-2#1)(2008-3#6)
demodulation process##4##2##(2008-2#1)(2008-3#3)
demodulation system for low-coherence interferometric sensors based on highly birefringent fibers##2##11##(2008-3#2)
demodulation system##3##2##(2008-2#1)(2008-3#2)
demodulation technique##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
demodulation with##3##2##(2008-3#3)
demodulation##46##1##(2007-11#2)(2007-12#11)(2008-2#6)(2008-3#25)(2013-8#2)
demographic and clinical##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
demographic and health surveys##2##4##(2011-1#1)(2012-12#1)
demographic and medical factors##2##4##(1994-12#2)
demographic and medical##3##3##(1994-12#2)(2007-12#1)
demographic and##25##2##(1993-9#1)(1994-12#2)(1995-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#3)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
demographic basis of population regulation##2##5##(2008-8#2)
demographic basis of##4##3##(2008-8#4)
demographic changes##3##2##(1994-1#1)(1996-3#1)(2008-3#1)
demographic characteristics and##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
demographic characteristics of##4##3##(1992-1#1)(1992-12#1)(1992-8#1)(2010-3#1)
demographic characteristics such as##2##4##(1993-12#1)(1997-1#1)
demographic characteristics were##2##3##(2008-7#1)(2011-2#1)
demographic characteristics##27##2##(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
demographic context##3##2##(1997-5#1)(1997-6#1)(2008-8#1)
demographic data and##2##3##(2007-10#1)(2013-1#1)
demographic data##9##2##(1992-3#1)(2007-10#1)(2007-12#1)(2008-9#1)(2010-1#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
demographic differences between##2##3##(1993-1#1)(2008-12#1)
demographic differences##3##2##(1993-1#1)(2008-12#1)(2010-8#1)
demographic factors and##2##3##(1997-1#1)(2008-7#1)
demographic factors##14##2##(1992-6#1)(1993-2#1)(1997-1#1)(2007-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#6)
demographic features##3##2##(1992-8#1)(2008-5#1)(2011-2#1)
demographic groups##2##2##(2013-1#2)
demographic history##2##2##(2010-5#1)(2010-8#1)
demographic influences##2##2##(1993-12#1)(2008-8#1)
demographic information##4##2##(1994-3#1)(1995-3#1)(2008-9#1)(2011-2#1)
demographic mechanisms##2##2##(2008-8#2)
demographic or clinical features##2##4##(2007-10#1)(2008-6#1)
demographic or##4##2##(1994-12#1)(2007-10#1)(2008-6#1)(2008-8#1)
demographic parameters##4##2##(2008-8#2)(2010-7#1)(2011-2#1)
demographic profile of##3##3##(1993-1#2)(1995-2#1)
demographic profile##5##2##(1991-1#1)(1993-1#2)(1995-2#1)(2008-9#1)
demographic questionnaire##2##2##(2010-8#1)(2010-9#1)
demographic risk was##2##3##(2009-10#2)
demographic risk##5##2##(2009-10#4)(2010-2#1)
demographic variables and##2##3##(1996-9#1)(2008-7#1)
demographic variables were not##2##4##(1995-1#1)(2013-1#1)
demographic variables were##4##3##(1995-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
demographic variables##20##2##(1995-1#2)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
demographic variance##2##2##(2008-9#2)
demographic##207##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#2)(1993-1#3)(1993-12#2)(1993-2#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#3)(1997-5#1)(1997-6#1)(2007-10#6)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#6)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#24)(2008-9#14)(2009-10#4)(2009-11#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#3)
demographically##2##1##(2008-5#1)(2009-10#1)
demographics and##7##2##(1992-1#1)(1992-12#1)(1997-2#1)(2010-8#1)(2011-1#1)(2011-2#2)
demographics of##4##2##(1992-2#1)(2008-4#1)(2010-3#1)(2013-1#1)
demographics##43##1##(1992-1#2)(1992-12#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#3)(2012-2#2)(2013-1#2)(2013-8#2)
demography and genetics##2##3##(2008-8#2)
demography and##4##2##(2008-6#1)(2008-8#2)(2010-8#1)
demography of the##2##3##(2008-5#1)(2010-8#1)
demography of##6##2##(1991-12#1)(2008-5#1)(2008-8#1)(2010-8#3)
demography##18##1##(1991-12#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-8#6)(2009-5#1)(2010-8#6)(2011-2#1)
demolitor##4##1##(2010-2#4)
demonstrable in the##2##3##(1992-3#1)(1992-9#1)
demonstrable in##4##2##(1992-3#1)(1992-9#1)(2008-5#1)(2013-1#1)
demonstrable##20##1##(1990-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#4)(2013-1#1)
demonstrably##3##1##(2008-10#1)(2008-3#1)(2009-2#1)
demonstrate a direct##3##3##(1996-5#1)(2007-11#2)
demonstrate a greater##3##3##(1991-6#1)(2008-10#1)(2012-12#1)
demonstrate a large##2##3##(2008-3#1)(2011-1#1)
demonstrate a method for##2##4##(1991-8#1)(2007-11#1)
demonstrate a method##5##3##(1991-8#1)(2007-11#2)(2008-2#1)(2011-2#1)
demonstrate a new technique##2##4##(2007-11#1)(2007-12#1)
demonstrate a new##21##3##(1991-12#1)(2007-11#5)(2007-12#6)(2008-2#6)(2008-3#3)
demonstrate a novel method of##2##5##(2007-12#2)
demonstrate a novel method##3##4##(2007-12#2)(2012-2#1)
demonstrate a novel##18##3##(2007-11#1)(2007-12#9)(2008-11#1)(2008-2#2)(2008-3#2)(2012-2#3)
demonstrate a number of##2##4##(2008-7#2)
demonstrate a passively##3##3##(2007-11#2)(2007-12#1)
demonstrate a relationship between##2##4##(1990-12#1)(1993-11#1)
demonstrate a significant increase##2##4##(2007-7#1)(2008-3#1)
demonstrate a significant##5##3##(1994-2#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)
demonstrate a simple##8##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#4)
demonstrate a strong##3##3##(1993-12#1)(2008-3#1)(2009-7#1)
demonstrate a##157##2##(1990-12#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#1)(2007-11#32)(2007-12#37)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#12)(2008-3#25)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)
demonstrate an accuracy##2##3##(2008-2#2)
demonstrate an age-dependent##2##3##(2008-7#1)(2011-2#1)
demonstrate an association between##3##4##(2008-3#1)(2008-8#1)(2012-3#1)
demonstrate an automated##2##3##(1997-4#1)(2008-2#1)
demonstrate an##33##2##(1992-11#1)(1994-6#1)(1995-6#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
demonstrate and characterize the##2##4##(2007-11#1)(2008-3#1)
demonstrate and characterize##4##3##(2007-11#1)(2008-3#3)
demonstrate and##6##2##(1990-11#1)(2007-11#1)(2008-2#1)(2008-3#3)
demonstrate any##6##2##(1990-10#1)(1990-12#1)(2009-10#1)(2009-4#2)(2011-1#1)
demonstrate both##2##2##(1995-2#1)(2008-3#1)
demonstrate by##5##2##(1991-7#1)(1997-3#1)(1997-7#1)(2008-3#1)(2010-11#1)
demonstrate changes##2##2##(2008-7#1)(2010-12#1)
demonstrate different effects of##2##4##(2008-10#1)(2008-11#1)
demonstrate different##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
demonstrate direct##2##2##(1990-11#1)(2007-11#1)
demonstrate efficient frequency##2##3##(2007-12#2)
demonstrate efficient##5##2##(2007-11#1)(2007-12#3)(2008-11#1)
demonstrate enhanced##2##2##(2012-12#1)(2013-1#1)
demonstrate experimentally that##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
demonstrate experimentally##10##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#2)
demonstrate for the first time that##2##6##(2008-10#1)(2013-8#1)
demonstrate for the first time the##4##6##(1992-3#1)(1994-6#1)(2012-2#1)(2013-1#1)
demonstrate for the first time##8##5##(1992-3#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrate for##10##2##(1992-3#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrate good##2##2##(2008-10#1)(2009-4#1)
demonstrate here that the##2##4##(2008-8#1)(2012-12#1)
demonstrate here that##11##3##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-8#1)(2012-12#1)
demonstrate here the##2##3##(2008-10#1)(2012-2#1)
demonstrate here##17##2##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
demonstrate high##7##2##(1990-11#1)(1994-9#1)(2008-3#1)(2008-6#2)(2008-9#1)(2013-1#1)
demonstrate how a##2##3##(2008-3#1)(2010-3#1)
demonstrate how such##2##3##(2008-7#1)(2012-12#1)
demonstrate how the##2##3##(2008-3#1)(2008-8#1)
demonstrate how to##4##3##(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
demonstrate how##33##2##(1991-2#1)(1992-2#1)(1995-2#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
demonstrate image##2##2##(2007-11#1)(2008-3#1)
demonstrate improved##3##2##(2007-11#1)(2008-3#1)(2009-5#1)
demonstrate improvement##2##2##(2008-3#1)(2008-7#1)
demonstrate in##4##2##(2007-11#1)(2007-12#1)(2008-12#1)(2009-7#1)
demonstrate its effect##2##3##(1996-12#1)(2007-12#1)
demonstrate its potential##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
demonstrate its##16##2##(1995-3#1)(1996-12#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
demonstrate long-term##2##2##(1995-12#1)(2010-1#1)
demonstrate novel##2##2##(1992-11#1)(2007-11#1)
demonstrate our##5##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
demonstrate positive##3##2##(1990-3#1)(2012-12#1)(2012-3#1)
demonstrate potential##2##2##(2008-10#1)(2008-7#1)
demonstrate real-time##3##2##(2007-11#2)(2008-3#1)
demonstrate several##2##2##(2007-11#1)(2008-9#1)
demonstrate significant changes##2##3##(2008-7#1)(2012-2#1)
demonstrate significant##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
demonstrate some##3##2##(1993-3#1)(1995-12#1)(2009-3#1)
demonstrate spectral##2##2##(2007-11#1)(2007-12#1)
demonstrate successful##2##2##(2008-11#1)(2008-3#1)
demonstrate such##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
demonstrate that a large##2##4##(2007-12#1)(2009-6#1)
demonstrate that a##24##3##(1990-5#1)(1990-8#1)(1991-9#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)(2009-5#1)(2009-6#2)(2011-2#1)(2013-8#1)
demonstrate that activation of##2##4##(1995-8#1)(1997-7#1)
demonstrate that an##8##3##(1991-9#1)(1993-11#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
demonstrate that both##12##3##(1991-12#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#2)
demonstrate that different##2##3##(1995-11#1)(2009-8#1)
demonstrate that differentiation of##2##4##(1991-12#1)(1992-9#1)
demonstrate that even##3##3##(1991-12#1)(2008-7#1)(2010-4#1)
demonstrate that existing##2##3##(2008-3#1)(2010-10#1)
demonstrate that exposure to##4##4##(2008-10#3)(2013-1#1)
demonstrate that exposure##5##3##(1992-8#1)(2008-10#3)(2013-1#1)
demonstrate that expression of##2##4##(2008-8#1)(2012-12#1)
demonstrate that human##2##3##(2012-2#1)(2013-1#1)
demonstrate that in the absence of##2##6##(1991-5#1)(1992-3#1)
demonstrate that in the##3##4##(1991-5#1)(1992-3#1)(2008-7#1)
demonstrate that in##4##3##(1990-5#1)(1991-5#1)(1992-3#1)(2008-7#1)
demonstrate that it is not##2##5##(1995-6#1)(2008-3#1)
demonstrate that it is possible to##5##6##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
demonstrate that it is##9##4##(1995-6#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#1)
demonstrate that it may##2##4##(1994-10#1)(2008-9#1)
demonstrate that it##11##3##(1994-10#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
demonstrate that multiple##3##3##(1992-5#1)(2008-3#1)(2008-7#1)
demonstrate that one can##3##4##(2007-11#1)(2007-12#2)
demonstrate that our##3##3##(2008-3#1)(2010-2#1)(2012-3#1)
demonstrate that rapid##3##3##(1990-8#1)(1992-6#1)(2011-1#1)
demonstrate that recombinant##2##3##(1992-11#1)(1995-2#1)
demonstrate that simultaneous##2##3##(2007-12#1)(2008-3#1)
demonstrate that some##3##3##(1991-3#1)(2008-5#1)(2008-8#1)
demonstrate that specific##2##3##(1991-12#1)(2008-11#1)
demonstrate that such a##2##4##(2008-3#1)(2008-8#1)
demonstrate that such##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
demonstrate that the effects of##2##5##(1994-6#1)(2008-10#1)
demonstrate that the new##2##4##(2008-2#1)(2012-2#1)
demonstrate that the two##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
demonstrate that the##144##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-11#3)(1993-12#2)(1993-6#2)(1993-8#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(2007-11#3)(2007-12#6)(2008-10#16)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
demonstrate that there is##3##4##(1992-3#1)(2008-8#1)(2010-8#1)
demonstrate that there##5##3##(1991-2#1)(1992-3#1)(2008-3#1)(2008-8#1)(2010-8#1)
demonstrate that these##10##3##(1994-6#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2010-2#1)(2010-7#1)
demonstrate that this##18##3##(1990-8#1)(1992-12#2)(1995-8#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrate that vitamin##2##3##(1993-6#1)(1994-3#1)
demonstrate that##604##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#5)(1990-7#1)(1990-8#5)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#3)(1991-5#4)(1991-9#7)(1992-11#2)(1992-12#4)(1992-3#6)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#4)(1993-5#1)(1993-6#8)(1993-8#5)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#8)(1995-11#5)(1995-12#7)(1995-2#13)(1995-3#5)(1995-5#7)(1995-6#6)(1995-8#4)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#6)(1997-9#1)(2007-10#1)(2007-11#20)(2007-12#26)(2008-1#1)(2008-10#65)(2008-11#29)(2008-12#4)(2008-2#17)(2008-3#41)(2008-4#5)(2008-5#19)(2008-6#1)(2008-7#23)(2008-8#18)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#10)(2012-3#9)(2012-5#1)(2013-1#21)(2013-8#7)
demonstrate the ability of##5##4##(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
demonstrate the ability to##5##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
demonstrate the ability##10##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
demonstrate the accuracy and##2##4##(2007-12#1)(2008-10#1)
demonstrate the accuracy##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
demonstrate the advantage of##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
demonstrate the advantages of##3##4##(1995-12#1)(2008-3#1)(2012-12#1)
demonstrate the applicability of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
demonstrate the applicability##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
demonstrate the application of the##2##5##(2007-11#1)(2011-1#1)
demonstrate the application of##4##4##(2007-11#1)(2008-2#1)(2008-4#1)(2011-1#1)
demonstrate the application##5##3##(2007-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)
demonstrate the benefits of##2##4##(2007-12#1)(2008-3#1)
demonstrate the capabilities of the##3##5##(2007-12#1)(2008-2#2)
demonstrate the capabilities of this##2##5##(2008-3#1)(2008-6#1)
demonstrate the capabilities of##5##4##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
demonstrate the capability of the##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
demonstrate the capability of##6##4##(2008-10#2)(2008-2#1)(2008-3#3)
demonstrate the capability##7##3##(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)
demonstrate the concept##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
demonstrate the effect of##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
demonstrate the effect##4##3##(2008-3#1)(2008-7#1)(2012-2#2)
demonstrate the effectiveness of our##2##5##(2008-3#1)(2008-6#1)
demonstrate the effectiveness of the proposed##2##6##(2007-12#1)(2008-3#1)
demonstrate the effectiveness of the##3##5##(2007-12#1)(2008-3#1)(2008-6#1)
demonstrate the effectiveness of##5##4##(2007-12#1)(2008-3#2)(2008-6#2)
demonstrate the effectiveness##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#2)
demonstrate the effects of##4##4##(1990-8#1)(1995-5#1)(2008-3#1)(2011-2#1)
demonstrate the efficacy of##4##4##(2008-3#1)(2008-8#2)(2013-1#1)
demonstrate the efficiency of##2##4##(2007-12#1)(2008-10#1)
demonstrate the efficiency##3##3##(2007-12#2)(2008-10#1)
demonstrate the essential role of##2##5##(1995-2#1)(2011-2#1)
demonstrate the existence of a##3##5##(1990-8#1)(1992-6#1)(1995-2#1)
demonstrate the existence of##4##4##(1990-8#1)(1992-6#1)(1995-2#1)(2007-12#1)
demonstrate the fabrication##2##3##(2008-2#1)(2012-2#1)
demonstrate the feasibility of detecting##2##5##(2008-10#1)(2012-1#1)
demonstrate the feasibility of the##8##5##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
demonstrate the feasibility of this##2##5##(2007-11#1)(2008-10#1)
demonstrate the feasibility of##23##4##(2007-11#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#6)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
demonstrate the feasibility##24##3##(2007-11#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#6)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
demonstrate the first use##2##4##(2008-3#2)
demonstrate the first##3##3##(2008-3#2)(2010-5#1)
demonstrate the generation of##8##4##(2007-11#6)(2007-12#2)
demonstrate the great##2##3##(2008-10#1)(2008-2#1)
demonstrate the high##4##3##(2008-10#2)(2008-2#2)
demonstrate the importance of the##2##5##(1993-3#1)(2008-12#1)
demonstrate the importance of##7##4##(1993-3#1)(1995-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)
demonstrate the important role of##3##5##(1995-8#1)(2011-2#1)(2012-1#1)
demonstrate the improvement of##2##4##(1990-5#1)(2010-12#1)
demonstrate the method##2##3##(2008-3#1)(2008-6#1)
demonstrate the method's##2##3##(2008-5#1)(2009-12#1)
demonstrate the need for##2##4##(1997-1#1)(2013-1#1)
demonstrate the need##3##3##(1997-1#1)(2008-11#1)(2013-1#1)
demonstrate the performance of the method##2##6##(2008-10#1)(2012-1#1)
demonstrate the performance of the system##2##6##(2008-10#1)(2008-3#1)
demonstrate the performance of the##5##5##(2008-10#3)(2008-3#1)(2012-1#1)
demonstrate the performance of this##2##5##(2007-12#1)(2008-3#1)
demonstrate the performance of##7##4##(2007-12#1)(2008-10#3)(2008-3#2)(2012-1#1)
demonstrate the performance##8##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2012-1#1)
demonstrate the positive##2##3##(2008-11#2)
demonstrate the possibility of##10##4##(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
demonstrate the possibility##11##3##(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
demonstrate the potential application of##2##5##(2008-10#1)(2008-8#1)
demonstrate the potential for##3##4##(2008-1#1)(2008-8#1)(2012-12#1)
demonstrate the potential of the##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
demonstrate the potential of this##2##5##(1995-8#1)(2008-3#1)
demonstrate the potential of##9##4##(1995-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)(2012-2#1)
demonstrate the potential##17##3##(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
demonstrate the presence of##6##4##(1990-11#1)(1990-12#1)(1991-8#1)(1996-2#1)(2007-12#1)(2013-8#1)
demonstrate the presence##7##3##(1990-11#1)(1990-12#1)(1991-8#1)(1993-6#1)(1996-2#1)(2007-12#1)(2013-8#1)
demonstrate the proposed##5##3##(2007-11#1)(2008-3#4)
demonstrate the reliability of##2##4##(1990-9#1)(2008-10#1)
demonstrate the reliability##3##3##(1990-9#1)(2008-10#1)(2012-3#1)
demonstrate the role of##2##4##(2008-1#1)(2008-11#1)
demonstrate the simplicity##2##3##(2008-1#1)(2008-6#1)
demonstrate the suitability of the##3##5##(2007-11#1)(2008-10#2)
demonstrate the suitability of##5##4##(2007-11#2)(2008-10#2)(2010-8#1)
demonstrate the technique##3##3##(1992-12#1)(2007-12#1)(2008-3#1)
demonstrate the theory##2##3##(2008-3#2)
demonstrate the three-dimensional##2##3##(2007-11#1)(2008-3#1)
demonstrate the use of a##7##5##(2007-11#1)(2007-12#3)(2008-3#2)(2010-5#1)
demonstrate the use of the##2##5##(2007-12#1)(2008-11#1)
demonstrate the use of this##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
demonstrate the use of##22##4##(1995-2#1)(2007-11#1)(2007-12#7)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-8#1)(2010-5#1)
demonstrate the usefulness of this technique##2##6##(2008-10#1)(2008-5#1)
demonstrate the usefulness of this##3##5##(2008-10#1)(2008-5#1)(2011-1#1)
demonstrate the usefulness of##6##4##(1993-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
demonstrate the utility of the##4##5##(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
demonstrate the utility of##14##4##(1990-5#1)(1991-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#2)
demonstrate the validity and##2##4##(2007-12#1)(2008-10#1)
demonstrate the validity of the proposed##2##6##(2008-3#2)
demonstrate the validity of the##5##5##(2008-2#1)(2008-3#4)
demonstrate the validity of##7##4##(2007-11#1)(2008-2#1)(2008-3#5)
demonstrate the validity##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
demonstrate the value of##2##4##(1996-2#1)(2011-2#1)
demonstrate the versatility of##2##4##(2007-12#1)(2008-10#1)
demonstrate the##384##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-8#2)(1995-9#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-6#2)(2006-12#1)(2007-11#24)(2007-12#35)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#51)(2008-11#11)(2008-12#2)(2008-2#40)(2008-3#67)(2008-4#4)(2008-5#11)(2008-6#7)(2008-7#11)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#10)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#1)(2013-1#7)(2013-8#2)
demonstrate their##5##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
demonstrate to##2##2##(1994-12#1)(2012-3#1)
demonstrate unique##2##2##(1996-3#1)(2012-12#1)
demonstrate what is##6##3##(2007-11#4)(2007-12#2)
demonstrate what we believe##3##4##(2007-12#1)(2008-3#2)
demonstrate what##10##2##(2007-11#4)(2007-12#3)(2008-3#3)
demonstrate##1576##1##(1990-10#1)(1990-11#6)(1990-12#9)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#10)(1990-7#1)(1990-8#9)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#13)(1991-2#6)(1991-3#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#8)(1992-11#6)(1992-12#5)(1992-2#1)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#6)(1993-12#6)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#9)(1993-8#5)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#6)(1994-8#9)(1994-9#2)(1995-11#6)(1995-12#15)(1995-2#23)(1995-3#6)(1995-5#11)(1995-6#8)(1995-8#6)(1995-9#1)(1996-12#9)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#8)(1997-8#1)(1997-9#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#126)(2007-12#151)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#148)(2008-11#55)(2008-12#11)(2008-2#89)(2008-3#184)(2008-4#14)(2008-5#35)(2008-6#14)(2008-7#56)(2008-8#39)(2008-9#23)(2009-10#7)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#12)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#6)(2010-2#3)(2010-3#8)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#18)(2011-2#26)(2011-3#1)(2012-1#6)(2012-12#22)(2012-2#34)(2012-3#18)(2012-5#1)(2013-1#37)(2013-8#12)
demonstrated a 3##2##3##(1994-9#1)(2008-12#1)
demonstrated a broad##2##3##(1997-6#1)(2008-5#1)
demonstrated a deletion##2##3##(1997-3#1)(2008-10#1)
demonstrated a direct##2##3##(1996-5#1)(2013-1#1)
demonstrated a good##2##3##(2008-10#1)(2009-3#1)
demonstrated a high degree of##2##5##(2008-10#1)(2010-3#1)
demonstrated a high##10##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
demonstrated a higher##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
demonstrated a large##3##3##(2011-2#2)(2013-8#1)
demonstrated a linear##2##3##(1991-11#1)(2007-12#1)
demonstrated a low##2##3##(1992-3#1)(2008-5#1)
demonstrated a new##2##3##(2007-10#1)(2007-11#1)
demonstrated a novel##2##3##(2007-11#1)(2008-8#1)
demonstrated a reduction in##3##4##(2008-7#1)(2008-8#1)(2009-6#1)
demonstrated a selective##2##3##(1994-6#1)(1997-7#1)
demonstrated a significant reduction in##2##5##(2008-11#1)(2013-1#1)
demonstrated a significant##10##3##(1990-2#1)(1994-7#1)(1997-3#1)(2006-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#3)
demonstrated a statistically significant##3##4##(1992-11#1)(2008-12#1)(2013-1#1)
demonstrated a strong association##2##4##(2008-8#1)(2011-2#1)
demonstrated a strong##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
demonstrated a weak##2##3##(1994-2#1)(2007-12#1)
demonstrated a wide##2##3##(1996-12#1)(2009-4#1)
demonstrated a wider##2##3##(2008-5#1)(2012-12#1)
demonstrated a##167##2##(1990-12#1)(1990-2#3)(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#3)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#11)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#3)
demonstrated activity in##2##3##(1992-8#1)(2007-7#1)
demonstrated adequate##3##2##(2009-9#1)(2012-12#1)(2013-1#1)
demonstrated after##5##2##(1995-12#1)(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
demonstrated an##9##2##(1992-3#1)(1992-9#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-3#1)
demonstrated and the results##2##4##(2008-10#2)
demonstrated and the##3##3##(1996-6#1)(2008-10#2)
demonstrated and##17##2##(1992-12#1)(1996-6#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-3#1)
demonstrated as a method##2##4##(2008-10#1)(2008-3#1)
demonstrated as a##5##3##(2008-10#4)(2008-3#1)
demonstrated as##14##2##(1990-8#1)(2007-11#3)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)
demonstrated at a##4##3##(1993-11#1)(2008-2#1)(2008-3#2)
demonstrated at##17##2##(1992-4#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-6#1)(2009-2#1)(2012-3#1)
demonstrated attenuated##2##2##(2008-10#1)(2009-2#1)
demonstrated based on##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
demonstrated better##3##2##(2007-10#1)(2008-10#1)(2008-5#1)
demonstrated between the##5##3##(1993-2#1)(1994-5#1)(2007-11#1)(2011-3#2)
demonstrated between##10##2##(1993-2#1)(1994-5#1)(1994-9#1)(1996-7#1)(2007-10#1)(2007-11#1)(2008-9#1)(2009-8#1)(2011-3#2)
demonstrated both##8##2##(1991-6#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
demonstrated by a##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
demonstrated by affinity##2##3##(1995-5#1)(2008-6#1)
demonstrated by an##2##3##(2008-3#1)(2011-2#1)
demonstrated by application##3##3##(2008-10#2)(2008-3#1)
demonstrated by detecting##4##3##(2007-12#1)(2008-11#2)(2013-1#1)
demonstrated by detection of##2##4##(2007-12#1)(2008-10#1)
demonstrated by determining##2##3##(2008-10#2)
demonstrated by direct##2##3##(1994-5#1)(2007-11#1)
demonstrated by electron microscopy##2##4##(1993-2#1)(1994-11#1)
demonstrated by experiment##2##3##(2008-3#2)
demonstrated by increased##2##3##(2009-12#1)(2010-9#1)
demonstrated by its##2##3##(1994-5#1)(1996-7#1)
demonstrated by means of##6##4##(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
demonstrated by recording of##2##4##(2007-11#2)
demonstrated by recording##3##3##(2007-11#2)(2008-3#1)
demonstrated by the determination of##3##5##(2008-10#3)
demonstrated by the expression of##2##5##(1991-5#1)(1993-6#1)
demonstrated by the recovery##2##4##(2008-10#2)
demonstrated by the results of##2##5##(2008-10#1)(2008-8#1)
demonstrated by the##27##3##(1990-11#1)(1991-5#1)(1992-2#1)(1993-6#1)(2007-11#1)(2007-12#4)(2008-10#10)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
demonstrated by their##4##3##(1994-6#1)(1995-5#1)(2008-10#1)(2010-3#1)
demonstrated by these##2##3##(2008-10#1)(2008-7#1)
demonstrated by use of a##5##5##(2007-11#2)(2008-3#3)
demonstrated by use of an##2##5##(2007-11#2)
demonstrated by use of the##2##5##(2007-12#1)(2008-3#1)
demonstrated by use of##18##4##(2007-11#6)(2007-12#2)(2008-2#1)(2008-3#9)
demonstrated by##207##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-2#2)(1992-3#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#2)(1995-8#1)(1996-12#2)(1996-5#2)(1996-7#1)(1997-1#2)(1997-3#2)(1997-6#1)(2007-10#1)(2007-11#14)(2007-12#12)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#54)(2008-11#4)(2008-2#5)(2008-3#29)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
demonstrated changes##2##2##(1995-3#1)(2011-2#1)
demonstrated clinical##3##2##(1991-2#1)(1996-3#1)(2007-11#1)
demonstrated clinically##3##2##(2008-12#1)(2008-5#1)(2009-3#1)
demonstrated complete resolution of##2##4##(2009-6#1)(2010-5#1)
demonstrated complete##3##2##(2008-7#1)(2009-6#1)(2010-5#1)
demonstrated consistent##2##2##(1992-8#1)(2008-11#1)
demonstrated deletions##2##2##(1997-3#2)
demonstrated distinct differences##2##3##(2007-12#1)(2008-10#1)
demonstrated effects on##2##3##(2008-10#1)(2008-9#1)
demonstrated efficacy of##2##3##(2008-6#1)(2012-3#1)
demonstrated efficacy##4##2##(2008-3#1)(2008-6#1)(2009-10#1)(2012-3#1)
demonstrated enhanced##3##2##(1996-12#1)(2008-11#1)(2009-11#1)
demonstrated excellent##8##2##(1995-3#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)
demonstrated experimentally in##2##3##(2007-11#1)(2008-3#1)
demonstrated experimentally that##2##3##(2008-2#1)(2008-3#1)
demonstrated experimentally##22##2##(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#9)(2011-1#1)(2012-2#1)
demonstrated first##2##2##(1990-2#1)(2007-12#1)
demonstrated for a##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
demonstrated for each##2##3##(2008-10#1)(2008-5#1)
demonstrated for the analysis of##2##5##(1994-12#1)(2008-10#1)
demonstrated for the first time that the##2##7##(2008-10#1)(2012-2#1)
demonstrated for the first time that##5##6##(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
demonstrated for the first time the##2##6##(1993-3#1)(2013-8#1)
demonstrated for the first time to the authors' knowledge##3##9##(2007-11#2)(2008-2#1)
demonstrated for the first time to the##4##7##(2007-11#2)(2008-2#2)
demonstrated for the first time to##5##6##(2007-11#3)(2008-2#2)
demonstrated for the first time##15##5##(1993-3#1)(2007-11#3)(2008-10#4)(2008-2#4)(2008-9#1)(2012-2#1)(2013-8#1)
demonstrated for the##30##3##(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#2)(2007-11#3)(2008-10#12)(2008-2#5)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
demonstrated for what is##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
demonstrated for##78##2##(1991-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#2)(1995-3#1)(1997-2#1)(1997-5#2)(2006-12#1)(2007-11#7)(2007-12#12)(2008-10#22)(2008-2#13)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
demonstrated from a##2##3##(2007-12#2)
demonstrated from##7##2##(1991-1#1)(2007-11#2)(2007-12#3)(2008-10#1)
demonstrated general statistical differences in##2##5##(2013-1#2)
demonstrated good accuracy##2##3##(2008-10#2)
demonstrated good##9##2##(2008-10#5)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
demonstrated greater##2##2##(2008-3#1)(2013-1#1)
demonstrated here for##2##3##(1993-2#1)(2012-2#1)
demonstrated here that##2##3##(1997-4#1)(2007-12#1)
demonstrated here##6##2##(1990-11#1)(1993-2#1)(1997-4#1)(2007-12#1)(2008-3#1)(2012-2#1)
demonstrated high accuracy##2##3##(2010-9#1)(2013-8#1)
demonstrated high levels of##3##4##(1990-11#1)(1991-2#1)(2008-10#1)
demonstrated high##14##2##(1990-11#1)(1991-2#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-5#2)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
demonstrated higher##2##2##(1992-6#1)(2006-10#1)
demonstrated how##6##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
demonstrated improved speech perception##2##4##(2008-9#1)(2012-2#1)
demonstrated improved##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
demonstrated improvement##2##2##(2007-10#1)(2010-9#1)
demonstrated in 12##2##3##(2007-12#1)(2008-5#1)
demonstrated in a turbulent##2##4##(2008-3#2)
demonstrated in a##19##3##(1990-11#1)(1995-11#1)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#3)(2008-4#1)(2009-6#1)(2009-9#1)
demonstrated in all##3##3##(1990-12#1)(1990-7#1)(1995-3#1)
demonstrated in an##4##3##(2007-12#2)(2008-3#1)(2010-6#1)
demonstrated in both##3##3##(1993-11#1)(1997-6#1)(2007-8#1)
demonstrated in numerous##3##3##(1992-5#1)(2008-3#1)(2010-8#1)
demonstrated in patients##3##3##(1994-11#1)(2008-5#1)(2008-6#1)
demonstrated in rats##2##3##(1992-6#1)(1994-6#1)
demonstrated in several##4##3##(1992-11#1)(1992-12#1)(2008-2#1)(2010-5#1)
demonstrated in the presence of a##2##6##(1991-5#2)
demonstrated in the##34##3##(1991-10#2)(1991-12#1)(1991-5#2)(1992-11#1)(1993-11#1)(1994-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-6#1)(2011-1#1)(2013-1#1)
demonstrated in this study##4##4##(2008-10#2)(2008-5#1)(2008-9#1)
demonstrated in this work##2##4##(1992-12#1)(2008-10#1)
demonstrated in this##13##3##(1990-11#1)(1992-12#1)(1992-9#1)(1995-3#1)(2007-10#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
demonstrated in two##2##3##(1992-6#1)(2008-4#1)
demonstrated in vivo##2##3##(1994-2#1)(1994-8#1)
demonstrated in##157##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-5#2)(1992-11#2)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(1997-8#3)(2007-10#2)(2007-11#4)(2007-12#10)(2007-8#1)(2008-10#25)(2008-11#5)(2008-2#7)(2008-3#10)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
demonstrated increased lipid peroxidation##2##4##(1994-6#2)
demonstrated increased##5##2##(1994-6#2)(1996-12#1)(2008-9#1)(2009-11#1)
demonstrated inhibitory##2##2##(1996-2#1)(2010-8#1)
demonstrated its##3##2##(2008-3#1)(2008-5#1)(2010-5#1)
demonstrated lesions##2##2##(2011-2#1)(2013-1#1)
demonstrated less##2##2##(1995-1#1)(2008-9#1)
demonstrated light##2##2##(1991-9#1)(2007-12#1)
demonstrated long-term stability and reproducibility with relative standard deviations of less than##2##12##(2008-10#2)
demonstrated low##2##2##(2012-12#1)(2012-2#1)
demonstrated lower##3##2##(2008-5#2)(2008-7#1)
demonstrated marked##2##2##(2007-12#1)(2012-3#1)
demonstrated modest##2##2##(2012-3#1)(2013-1#1)
demonstrated more##2##2##(2008-5#1)(2009-3#1)
demonstrated no significant differences##2##4##(1991-3#1)(2012-2#1)
demonstrated no significant##4##3##(1991-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrated no##7##2##(1991-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrated on a##5##3##(2007-11#1)(2007-8#1)(2008-3#3)
demonstrated on the basis of##2##5##(1990-12#1)(2008-2#1)
demonstrated on the##5##3##(1990-12#1)(1996-3#1)(2008-10#2)(2008-2#1)
demonstrated on##20##2##(1990-12#1)(1993-1#1)(1995-2#1)(1996-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-7#1)(2010-2#1)
demonstrated only##3##2##(1990-11#1)(1993-12#1)(1996-12#1)
demonstrated over##4##2##(2008-10#2)(2008-2#1)(2009-8#1)
demonstrated poorer##2##2##(2008-7#1)(2013-1#1)
demonstrated potent##2##2##(2010-2#1)(2012-3#1)
demonstrated potential##3##2##(1996-3#1)(2010-6#1)(2013-1#1)
demonstrated previously that##4##3##(1990-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
demonstrated previously##6##2##(1990-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
demonstrated rapid##3##2##(2006-10#1)(2008-10#1)(2008-6#1)
demonstrated remarkable##2##2##(2008-10#1)(2010-4#1)
demonstrated robust##2##2##(2008-10#1)(2011-2#1)
demonstrated severe##2##2##(1996-5#1)(2010-10#1)
demonstrated significant genetic##2##3##(1994-2#1)(2008-12#1)
demonstrated significant##23##2##(1991-2#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
demonstrated significantly##4##2##(1995-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
demonstrated some##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)
demonstrated stable##2##2##(1994-9#1)(2009-3#1)
demonstrated statistically significant##2##3##(1993-1#1)(2011-2#1)
demonstrated statistically##3##2##(1993-1#1)(2008-5#1)(2011-2#1)
demonstrated strong##3##2##(1992-8#1)(2009-9#1)(2010-7#1)
demonstrated stronger##2##2##(2008-12#1)(2008-5#1)
demonstrated superior##4##2##(2008-10#2)(2008-3#1)(2008-6#1)
demonstrated superiority##2##2##(2007-5#1)(2008-5#1)
demonstrated that A##2##3##(2008-10#2)
demonstrated that LAIV##2##3##(2011-2#2)
demonstrated that Tid1##2##3##(2011-2#2)
demonstrated that a number of##2##5##(2008-1#1)(2008-5#1)
demonstrated that a##20##3##(1992-11#1)(1992-9#1)(1993-8#1)(1995-2#1)(1995-4#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2009-2#1)(2009-5#1)(2011-1#1)(2013-8#1)
demonstrated that acute##2##3##(1993-12#1)(2008-10#1)
demonstrated that all of the##2##5##(2009-8#1)(2011-1#1)
demonstrated that all##8##3##(1991-9#1)(1993-8#1)(2008-10#2)(2008-3#1)(2009-8#1)(2011-1#1)(2013-1#1)
demonstrated that an##7##3##(1993-11#1)(1995-5#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-3#1)
demonstrated that at least##2##4##(2008-10#1)(2009-5#1)
demonstrated that at##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
demonstrated that both##11##3##(1991-12#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)
demonstrated that ethanol##2##3##(1990-12#1)(2012-2#1)
demonstrated that even##2##3##(2008-10#1)(2011-2#1)
demonstrated that exogenous##2##3##(2008-9#1)(2010-8#1)
demonstrated that expression of##2##4##(1996-12#1)(2009-8#1)
demonstrated that for##2##3##(2008-10#1)(2012-2#1)
demonstrated that health##2##3##(2008-10#1)(2012-12#1)
demonstrated that high##2##3##(2008-1#1)(2009-8#1)
demonstrated that human##4##3##(1990-12#1)(1991-12#1)(1992-8#1)(2011-2#1)
demonstrated that in##8##3##(1994-11#2)(1997-2#1)(2007-12#1)(2008-5#2)(2009-3#1)(2010-1#1)
demonstrated that induction of the##2##5##(2008-10#2)
demonstrated that intrahippocampal##2##3##(1993-12#1)(2009-12#1)
demonstrated that is##2##3##(2007-12#1)(2013-1#1)
demonstrated that it is##6##4##(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2012-2#1)
demonstrated that it was##2##4##(2008-10#1)(2008-7#1)
demonstrated that it##9##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
demonstrated that most##2##3##(2008-10#2)
demonstrated that only the##3##4##(2008-10#2)(2008-7#1)
demonstrated that only##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
demonstrated that our##2##3##(2008-10#1)(2012-2#1)
demonstrated that patients##2##3##(1996-7#1)(2008-7#1)
demonstrated that patterns of##2##4##(1994-3#1)(2009-8#1)
demonstrated that plasma##3##3##(1994-6#1)(1997-7#1)(2013-1#1)
demonstrated that protein##3##3##(2008-10#1)(2008-9#1)(2011-3#1)
demonstrated that several##2##3##(1993-8#1)(2009-3#1)
demonstrated that some##3##3##(2007-12#1)(2009-8#1)(2011-1#1)
demonstrated that such##3##3##(1992-3#1)(2008-3#1)(2008-7#1)
demonstrated that the combination of##2##5##(2010-10#1)(2012-12#1)
demonstrated that the expression of##4##5##(1993-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
demonstrated that the expression##5##4##(1993-6#1)(2008-8#2)(2013-1#1)(2013-8#1)
demonstrated that the factors##2##4##(2008-10#2)
demonstrated that the level of##2##5##(2008-10#1)(2013-8#1)
demonstrated that the proposed##4##4##(2008-10#3)(2008-5#1)
demonstrated that the response of##2##5##(1990-7#1)(2008-10#1)
demonstrated that the set of##2##5##(2008-11#1)(2013-1#1)
demonstrated that the visual##2##4##(1991-2#1)(2008-8#1)
demonstrated that the##183##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#5)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#42)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#9)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
demonstrated that there are##2##4##(1995-2#1)(2010-1#1)
demonstrated that there is##2##4##(2008-2#1)(2008-8#1)
demonstrated that there was##2##4##(2008-11#1)(2010-8#1)
demonstrated that there##7##3##(1990-5#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-1#1)(2010-8#1)
demonstrated that these##9##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
demonstrated that they##5##3##(1990-12#1)(1991-3#1)(2008-1#1)(2008-11#1)(2010-3#1)
demonstrated that this laser##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
demonstrated that this##25##3##(1991-11#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
demonstrated that treatment with##2##4##(2008-7#1)(2011-2#1)
demonstrated that tumor##2##3##(2011-1#1)(2013-8#1)
demonstrated that two##5##3##(1990-5#1)(1994-2#1)(1995-6#1)(2008-2#1)(2011-2#1)
demonstrated that vitamin##2##3##(2008-5#1)(2013-1#1)
demonstrated that wild##2##3##(1991-8#1)(2008-5#1)
demonstrated that with the##2##4##(2008-10#2)
demonstrated that with##3##3##(2008-10#2)(2008-5#1)
demonstrated that##676##2##(1990-12#8)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#6)(1992-3#3)(1992-6#3)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#7)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1996-1#2)(1996-12#7)(1996-2#4)(1996-4#1)(1996-5#3)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2006-4#1)(2006-6#1)(2007-11#7)(2007-12#15)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#116)(2008-11#39)(2008-12#7)(2008-2#9)(2008-3#22)(2008-4#3)(2008-5#28)(2008-6#5)(2008-7#23)(2008-8#32)(2008-9#24)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#12)(2010-1#5)(2010-10#1)(2010-11#7)(2010-12#4)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#30)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#7)(2013-1#21)(2013-7#1)(2013-8#8)
demonstrated the ability of##2##4##(2008-10#1)(2008-5#1)
demonstrated the ability##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
demonstrated the benefits##2##3##(1991-6#1)(2009-4#1)
demonstrated the best##3##3##(1995-3#1)(2012-2#1)(2013-1#1)
demonstrated the characteristic##2##3##(1992-12#1)(1995-12#1)
demonstrated the detection of##2##4##(2008-2#1)(2008-5#1)
demonstrated the effectiveness of##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
demonstrated the efficacy of##6##4##(1992-1#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
demonstrated the existence of##3##4##(2008-11#1)(2009-1#1)(2009-3#1)
demonstrated the expression of##4##4##(1992-3#1)(1995-8#1)(1996-5#1)(2011-2#1)
demonstrated the feasibility of##8##4##(1990-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#2)
demonstrated the feasibility##9##3##(1990-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
demonstrated the importance of##7##4##(1996-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2009-6#1)(2010-11#1)(2013-7#1)
demonstrated the importance##8##3##(1993-11#1)(1996-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2009-6#1)(2010-11#1)(2013-7#1)
demonstrated the induction of##2##4##(1990-2#1)(2008-5#1)
demonstrated the need for##2##4##(1997-6#1)(2008-10#1)
demonstrated the potential use of treating##2##6##(2008-9#2)
demonstrated the potential##5##3##(2008-2#1)(2008-9#2)(2010-12#1)(2010-8#1)
demonstrated the presence of a##5##5##(1993-6#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-8#1)
demonstrated the presence of##16##4##(1990-2#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
demonstrated the presence##17##3##(1990-2#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
demonstrated the same##2##3##(1991-12#1)(2008-9#1)
demonstrated the specificity of##2##4##(1992-8#1)(1993-11#1)
demonstrated the suitability of the##2##5##(1997-6#1)(2008-10#1)
demonstrated the utility of##4##4##(2007-12#2)(2008-10#1)(2010-12#1)
demonstrated the##153##2##(1990-11#1)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#5)(2009-1#1)(2009-3#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
demonstrated theoretically##2##2##(2008-2#1)(2008-3#1)
demonstrated this##4##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-12#1)
demonstrated through##8##2##(1996-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2011-1#1)
demonstrated to be a useful##2##5##(2011-2#1)(2012-2#1)
demonstrated to be a##8##4##(1992-11#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
demonstrated to be able to##2##5##(2008-8#1)(2012-1#1)
demonstrated to be an essential component of##2##7##(1991-6#1)(1992-1#1)
demonstrated to be an##3##4##(1991-6#1)(1992-1#1)(2008-10#1)
demonstrated to be effective##3##4##(2008-7#1)(2010-5#1)(2012-2#1)
demonstrated to be suitable for##2##5##(1994-12#1)(2008-11#1)
demonstrated to be##53##3##(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-3#1)(1997-7#2)(2007-11#3)(2007-12#2)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
demonstrated to date##2##3##(2007-11#1)(2008-11#1)
demonstrated to have a##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
demonstrated to have the##2##4##(1993-6#1)(2008-2#1)
demonstrated to have##12##3##(1993-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2009-3#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-7#1)
demonstrated to promote the##3##4##(2008-10#2)(2012-2#1)
demonstrated to##100##2##(1990-12#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-3#1)(1997-7#2)(2007-11#6)(2007-12#4)(2007-8#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#5)(2013-1#3)(2013-7#1)
demonstrated tuning##2##2##(2007-11#1)(2008-2#1)
demonstrated two##3##2##(1993-3#1)(2008-10#1)(2008-3#1)
demonstrated under##2##2##(1992-2#1)(1994-8#1)
demonstrated using a##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
demonstrated using the##3##3##(1990-5#1)(2008-7#2)
demonstrated using##23##2##(1990-5#1)(1994-9#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-11#1)(2012-2#1)
demonstrated weak##2##2##(2012-12#1)(2013-1#1)
demonstrated when##6##2##(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2013-1#1)
demonstrated with a##12##3##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#3)
demonstrated with an##5##3##(1995-2#1)(2007-12#1)(2008-3#2)(2010-4#1)
demonstrated with good##2##3##(2008-2#1)(2010-2#1)
demonstrated with the##7##3##(1990-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
demonstrated with##56##2##(1990-8#1)(1995-2#1)(1997-4#2)(2007-11#5)(2007-12#8)(2008-10#5)(2008-2#7)(2008-3#17)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)
demonstrated##2586##1##(1990-11#13)(1990-12#14)(1990-2#9)(1990-3#3)(1990-4#2)(1990-5#6)(1990-6#5)(1990-7#5)(1990-8#7)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#3)(1991-12#11)(1991-2#7)(1991-3#5)(1991-5#13)(1991-6#5)(1991-8#7)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#11)(1992-12#16)(1992-2#3)(1992-3#13)(1992-4#1)(1992-5#4)(1992-6#9)(1992-8#13)(1992-9#10)(1993-1#6)(1993-11#10)(1993-12#9)(1993-2#4)(1993-3#10)(1993-5#1)(1993-6#8)(1993-8#10)(1993-9#4)(1994-1#2)(1994-11#13)(1994-12#10)(1994-2#10)(1994-3#9)(1994-5#7)(1994-6#12)(1994-7#2)(1994-8#14)(1994-9#9)(1995-1#2)(1995-11#10)(1995-12#12)(1995-2#15)(1995-3#10)(1995-4#1)(1995-5#7)(1995-6#6)(1995-8#6)(1996-1#5)(1996-11#4)(1996-12#18)(1996-2#8)(1996-3#7)(1996-4#1)(1996-5#12)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#10)(1997-3#16)(1997-4#7)(1997-5#2)(1997-6#8)(1997-7#8)(1997-8#3)(2006-10#4)(2006-12#2)(2006-4#1)(2006-6#2)(2007-10#10)(2007-11#122)(2007-12#150)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#14)(2008-1#12)(2008-10#408)(2008-11#91)(2008-12#20)(2008-2#104)(2008-3#229)(2008-4#19)(2008-5#89)(2008-6#24)(2008-7#82)(2008-8#57)(2008-9#53)(2009-1#2)(2009-10#3)(2009-11#9)(2009-12#7)(2009-2#5)(2009-3#17)(2009-4#5)(2009-5#14)(2009-6#7)(2009-7#2)(2009-8#17)(2009-9#9)(2010-1#8)(2010-10#3)(2010-11#11)(2010-12#13)(2010-2#7)(2010-3#10)(2010-4#6)(2010-5#11)(2010-6#8)(2010-7#4)(2010-8#15)(2010-9#5)(2011-1#29)(2011-2#80)(2011-3#4)(2012-1#7)(2012-12#27)(2012-2#50)(2012-3#28)(2013-1#77)(2013-7#5)(2013-8#19)
demonstrates a direct##2##3##(1990-11#1)(1995-2#1)
demonstrates a significant##2##3##(1997-7#1)(2008-8#1)
demonstrates a##28##2##(1990-11#1)(1990-2#1)(1991-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
demonstrates an##5##2##(1994-6#1)(2007-11#1)(2008-8#1)(2010-10#1)(2012-2#1)
demonstrates both the##2##3##(1992-2#1)(2008-5#1)
demonstrates good performance##2##3##(2008-3#2)
demonstrates good##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
demonstrates high##2##2##(2008-10#1)(2008-3#1)
demonstrates how the##3##3##(1995-1#2)(2008-11#1)
demonstrates how to##2##3##(2008-4#2)
demonstrates how##12##2##(1991-1#1)(1995-1#2)(1995-12#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#2)(2010-5#1)(2013-1#1)
demonstrates its##3##2##(2007-12#1)(2008-3#1)(2009-7#1)
demonstrates that a##5##3##(1993-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
demonstrates that an##4##3##(1993-12#1)(1995-2#1)(2008-7#1)(2010-12#1)
demonstrates that even##3##3##(1992-6#1)(2008-7#1)(2008-8#1)
demonstrates that in##2##3##(1992-9#1)(2009-4#1)
demonstrates that it is##3##4##(2008-10#2)(2012-3#1)
demonstrates that it##4##3##(1994-8#1)(2008-10#2)(2012-3#1)
demonstrates that the##29##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
demonstrates that there is##2##4##(2008-9#1)(2013-1#1)
demonstrates that there##5##3##(2008-1#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
demonstrates that these##4##3##(2008-1#1)(2008-10#1)(2010-10#1)(2012-2#1)
demonstrates that this##5##3##(1990-8#1)(1992-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
demonstrates that three##2##3##(1992-12#1)(1995-2#1)
demonstrates that##146##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#5)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#5)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#9)(2008-8#6)(2008-9#5)(2009-3#1)(2009-4#3)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
demonstrates the existence of a##2##5##(1995-11#1)(2008-8#1)
demonstrates the feasibility of using##2##5##(2007-11#1)(2008-2#1)
demonstrates the feasibility of##6##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-3#1)
demonstrates the importance of##6##4##(1994-12#1)(2008-6#2)(2008-7#1)(2009-5#1)(2012-2#1)
demonstrates the importance##7##3##(1994-12#1)(1995-1#1)(2008-6#2)(2008-7#1)(2009-5#1)(2012-2#1)
demonstrates the possibility of##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
demonstrates the potential for##3##4##(1990-8#1)(1992-1#1)(2007-11#1)
demonstrates the potential of##4##4##(2008-11#1)(2010-5#1)(2011-1#1)(2012-1#1)
demonstrates the potential##9##3##(1990-8#1)(1992-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-1#1)
demonstrates the presence of##2##4##(1990-11#1)(1991-6#1)
demonstrates the use of##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2009-12#1)
demonstrates the utility of##4##4##(2008-9#2)(2009-8#1)(2011-2#1)
demonstrates the value of##3##4##(2008-1#1)(2008-11#1)(2008-12#1)
demonstrates the##87##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
demonstrates##327##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#4)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#4)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(2006-12#1)(2007-11#7)(2007-12#5)(2007-5#1)(2007-8#3)(2008-1#9)(2008-10#40)(2008-11#13)(2008-12#5)(2008-2#3)(2008-3#19)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#14)(2008-8#11)(2008-9#9)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#2)
demonstrating a functional##2##3##(1994-12#1)(1995-6#1)
demonstrating a##17##2##(1990-8#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)(2012-7#1)
demonstrating an effect##2##3##(2007-11#1)(2008-8#1)
demonstrating an##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
demonstrating both##2##2##(2007-11#1)(2008-3#1)
demonstrating equivalence##2##2##(2008-10#2)
demonstrating functional##2##2##(1996-2#1)(2009-5#1)
demonstrating that a##2##3##(1990-11#1)(1995-2#1)
demonstrating that it is##3##4##(1993-9#1)(1995-6#1)(2008-2#1)
demonstrating that it##6##3##(1993-9#1)(1995-2#1)(1995-6#1)(2008-2#1)(2008-3#1)(2009-10#1)
demonstrating that neither##2##3##(1994-11#1)(1994-8#1)
demonstrating that the##18##3##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
demonstrating that this##3##3##(1992-8#1)(1993-6#1)(2009-2#1)
demonstrating that treatment##2##3##(2008-5#1)(2010-9#1)
demonstrating that##92##2##(1990-11#3)(1990-5#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-8#1)(1995-12#1)(1995-2#4)(1995-6#2)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
demonstrating the applicability of##2##4##(2009-12#2)
demonstrating the effectiveness of##2##4##(2008-10#1)(2008-3#1)
demonstrating the efficiency of the method##2##6##(2008-2#2)
demonstrating the efficiency of the##3##5##(2008-10#1)(2008-2#2)
demonstrating the efficiency##5##3##(1995-1#1)(1995-3#1)(2008-10#1)(2008-2#2)
demonstrating the feasibility of##6##4##(1990-5#1)(1992-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)
demonstrating the potential##4##3##(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
demonstrating the presence of##4##4##(1996-8#1)(2007-7#1)(2008-10#1)(2012-12#1)
demonstrating the utility of the##2##5##(2008-11#1)(2010-3#1)
demonstrating the utility of##3##4##(2008-11#1)(2010-3#1)(2012-2#1)
demonstrating the validity of##2##4##(2008-10#1)(2008-3#1)
demonstrating the##69##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
demonstrating##235##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-5#2)(1991-6#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#3)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-7#2)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#12)(2008-12#5)(2008-2#7)(2008-3#15)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#4)(2012-7#1)(2013-1#7)(2013-8#2)
demonstration and##3##2##(1992-12#1)(2008-3#1)(2008-8#1)
demonstration in##3##2##(1995-3#1)(2008-3#1)(2013-1#1)
demonstration is given##2##3##(2006-4#1)(2008-3#1)
demonstration is##8##2##(2006-4#1)(2007-11#2)(2008-3#3)(2008-8#1)(2012-12#1)
demonstration model##2##2##(1996-1#1)(2008-10#1)
demonstration of M protein in bone marrow aspirate##2##8##(2008-7#2)
demonstration of a##17##3##(1990-12#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)(2008-7#1)(2012-2#1)
demonstration of an##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2013-1#1)
demonstration of increased##2##3##(2008-9#1)(2012-2#1)
demonstration of the##19##3##(1994-12#1)(1996-1#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
demonstration of their##2##3##(2011-2#1)(2013-8#1)
demonstration of these##2##3##(2008-10#1)(2008-3#1)
demonstration of this##4##3##(2008-10#1)(2008-2#2)(2008-7#1)
demonstration of##116##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-6#1)(2007-11#13)(2007-12#19)(2007-7#4)(2008-1#3)(2008-10#6)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#4)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
demonstration program##2##2##(1996-3#1)(2008-6#1)
demonstration project##5##2##(1992-1#1)(1993-12#1)(1995-3#1)(1996-2#1)(2013-1#1)
demonstration projects##4##2##(1996-1#1)(1996-12#1)(2008-10#1)(2010-10#1)
demonstration system##2##2##(2008-3#2)
demonstration that##11##2##(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-5#1)(2012-1#1)
demonstration with##4##2##(2007-11#1)(2008-3#2)(2012-2#1)
demonstration##195##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#4)(1996-1#6)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(2006-4#1)(2007-11#20)(2007-12#20)(2007-7#4)(2008-1#3)(2008-10#16)(2008-11#1)(2008-2#10)(2008-3#22)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
demonstrations and##3##2##(1994-12#1)(2013-1#1)(2013-8#1)
demonstrations of the##3##3##(2008-3#2)(2008-9#1)
demonstrations of##8##2##(2007-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2012-3#1)
demonstrations##26##1##(1991-2#2)(1992-1#1)(1993-12#2)(1994-12#1)(1994-2#1)(1996-1#2)(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
demonstrator that##2##2##(2008-2#1)(2008-3#1)
demonstrator##9##1##(2008-2#3)(2008-3#6)
demonstrators##3##1##(1996-2#2)(2008-12#1)
demosponges##2##1##(2011-2#1)(2012-2#1)
demultiplexer with##2##2##(2008-3#2)
demultiplexer##9##1##(2007-12#3)(2008-3#6)
demultiplexing##12##1##(2007-11#4)(2007-12#1)(2008-3#7)
demyelinated##3##1##(2008-12#2)(2008-7#1)
demyelinating disease of the central nervous system##3##7##(2011-2#1)(2012-2#1)(2012-3#1)
demyelinating disease of the##4##4##(1995-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
demyelinating disease##6##2##(1995-12#1)(1995-2#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
demyelinating diseases##2##2##(1995-12#1)(2008-12#1)
demyelinating phase##2##2##(2008-7#2)
demyelinating polyneuropathy##7##2##(1995-5#1)(2008-1#1)(2008-7#2)(2012-3#2)(2013-1#1)
demyelinating##30##1##(1995-12#5)(1995-2#1)(1995-5#3)(2007-8#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-7#8)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
demyelination and##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
demyelination in##2##2##(2008-7#1)(2012-2#1)
demyelination of the##3##3##(2008-11#1)(2008-7#2)
demyelination##22##1##(1995-12#1)(2007-10#1)(2008-11#1)(2008-7#12)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
den##3##1##(1992-6#1)(2011-1#1)(2013-8#1)
denaturant and##3##2##(1990-7#1)(1995-2#1)(2008-10#1)
denaturant m##2##2##(1997-2#2)
denaturant##11##1##(1990-7#1)(1992-8#1)(1995-2#2)(1997-2#4)(2008-10#3)
denaturants##5##1##(1997-2#2)(2008-10#1)(2008-7#1)(2009-9#1)
denaturation and##4##2##(1995-5#1)(1997-4#1)(1997-7#1)(2008-8#1)
denaturation in##2##2##(1990-5#1)(1992-8#1)
denaturation is##4##2##(1992-6#1)(1995-2#1)(1997-2#1)(1997-3#1)
denaturation of the##4##3##(1990-8#1)(1992-6#1)(1994-11#1)(1995-5#1)
denaturation of##14##2##(1990-12#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-5#1)(1997-7#1)(2008-7#2)(2013-1#1)
denaturation or##3##2##(1990-5#1)(2008-9#1)(2013-1#1)
denaturation procedures##2##2##(2008-10#2)
denaturation process##2##2##(2008-10#1)(2008-3#1)
denaturation step##2##2##(2008-10#1)(2008-9#1)
denaturation##89##1##(1990-12#3)(1990-5#5)(1990-8#1)(1991-5#3)(1992-10#1)(1992-3#1)(1992-6#3)(1992-8#4)(1993-11#5)(1993-8#2)(1994-11#1)(1994-5#2)(1995-2#5)(1995-5#5)(1995-6#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-7#4)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#8)(2011-2#2)(2013-1#2)
denaturational##2##1##(1990-8#2)
denature##2##1##(1995-2#1)(2008-8#1)
denatured DNA##6##2##(1994-8#1)(2008-10#5)
denatured and##2##2##(2008-10#1)(2008-4#1)
denatured in##3##2##(1992-8#1)(1995-3#1)(1996-5#1)
denatured protein##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
denatured proteins##5##2##(1990-5#1)(2008-10#3)(2009-7#1)
denatured when##2##2##(1995-2#1)(2008-8#1)
denatured##50##1##(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-6#3)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#18)(2008-4#1)(2008-8#2)(2009-4#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)
denaturing agent##3##2##(1997-4#1)(2008-1#1)(2008-10#1)
denaturing conditions##10##2##(1990-11#1)(1994-5#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-11#1)
denaturing gradient gel electrophoresis (DGGE)##4##5##(2008-10#1)(2008-9#2)(2010-6#1)
denaturing gradient gel electrophoresis##6##4##(1994-8#1)(2008-10#2)(2008-9#2)(2010-6#1)
denaturing polyacrylamide gel##2##3##(2008-11#1)(2008-4#1)
denaturing polyacrylamide gels##2##3##(1994-8#1)(2008-2#1)
denaturing polyacrylamide##4##2##(1994-8#1)(2008-11#1)(2008-2#1)(2008-4#1)
denaturing##34##1##(1990-11#1)(1992-6#1)(1994-5#1)(1994-8#2)(1995-5#1)(1997-4#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#3)(2010-11#2)(2010-6#1)
dende##2##1##(2008-10#2)
dendrimer##16##1##(2007-12#3)(2008-10#7)(2008-12#1)(2010-5#1)(2010-8#4)
dendrimer-like polyamidoamine##2##2##(2008-10#2)
dendrimeric structure##2##2##(2008-4#2)
dendrimers##12##1##(1996-5#6)(2008-10#1)(2008-4#1)(2010-8#4)
dendrite growth##3##2##(1996-5#3)
dendrite of the##2##3##(1997-7#1)(2008-7#1)
dendrite##18##1##(1993-12#1)(1994-2#1)(1995-8#1)(1996-5#3)(1996-6#2)(1997-7#1)(2007-12#3)(2008-11#3)(2008-7#1)(2010-11#1)(2012-2#1)
dendrites and dendritic spines##2##4##(1995-8#1)(1996-2#1)
dendrites and somata##2##3##(1992-11#1)(1997-3#1)
dendrites and##5##2##(1992-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-11#1)
dendrites of##7##2##(1993-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#1)
dendrites that##2##2##(1994-2#1)(2008-4#1)
dendrites##42##1##(1990-4#1)(1992-11#1)(1992-12#1)(1993-12#2)(1994-2#3)(1995-12#1)(1995-8#1)(1996-2#3)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#2)(2007-12#6)(2007-8#4)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-11#2)(2012-2#2)
dendritic and##2##2##(2008-4#1)(2012-3#1)
dendritic arbors##3##2##(1994-2#3)
dendritic cell and##2##3##(2008-10#1)(2013-1#1)
dendritic cell function##2##3##(2006-10#1)(2008-11#1)
dendritic cell##15##2##(2006-10#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2013-1#2)
dendritic cells (DC)##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
dendritic cells (DCs) in the##2##5##(2008-11#2)
dendritic cells (DCs)##7##3##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)(2012-3#1)
dendritic cells and##7##3##(2008-10#1)(2008-4#1)(2008-9#3)(2011-1#1)(2012-1#1)
dendritic cells are##2##3##(2006-10#1)(2008-9#1)
dendritic cells from mice##3##4##(2008-11#3)
dendritic cells from##5##3##(2008-11#4)(2012-2#1)
dendritic cells in the##2##4##(2006-10#1)(2008-11#1)
dendritic cells in##3##3##(2006-10#1)(2008-11#1)(2009-4#1)
dendritic cells to##2##3##(2006-10#1)(2008-4#1)
dendritic cells##57##2##(1997-2#1)(2006-10#4)(2008-10#3)(2008-11#12)(2008-4#10)(2008-6#1)(2008-8#6)(2008-9#7)(2009-12#1)(2009-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)
dendritic cells'##2##2##(2006-10#1)(2008-4#1)
dendritic injury##5##2##(1996-6#2)(2008-7#3)
dendritic morphology of##2##3##(2008-10#1)(2008-8#1)
dendritic morphology##5##2##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
dendritic nanoboxes##2##2##(2007-11#2)
dendritic processes##2##2##(2008-4#2)
dendritic segment##3##2##(2007-12#1)(2010-11#2)
dendritic segments of##2##3##(2007-12#1)(2008-7#1)
dendritic segments##4##2##(2007-12#1)(2008-7#2)(2012-2#1)
dendritic spine##2##2##(1995-8#1)(2009-9#1)
dendritic spines of##3##3##(1995-8#1)(1996-2#1)(2012-2#1)
dendritic spines##11##2##(1995-12#1)(1995-8#2)(1996-2#3)(1996-6#1)(2008-11#1)(2012-2#3)
dendritic structure##2##2##(1996-6#1)(2013-1#1)
dendritic transport of β-actin mRNA##2##5##(2012-2#2)
dendritic tree##3##2##(1994-2#2)(2008-11#1)
dendritic trees##4##2##(1996-2#1)(2012-2#3)
dendritic##170##1##(1990-11#1)(1990-5#1)(1991-5#1)(1994-2#5)(1995-12#1)(1995-3#1)(1995-8#3)(1996-2#5)(1996-5#2)(1996-6#6)(1997-2#4)(2006-10#7)(2007-11#2)(2007-12#7)(2008-10#12)(2008-11#16)(2008-4#20)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#7)(2009-12#1)(2009-4#2)(2009-8#3)(2009-9#1)(2010-11#4)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#4)(2012-2#17)(2012-3#2)(2013-1#7)(2013-7#1)
dendritogenesis##3##1##(1996-5#3)
dendrogram constructed from##2##3##(2008-10#2)
dendrogram##10##1##(2008-10#8)(2008-12#1)(2008-5#1)
denervated muscle##2##2##(2008-8#1)(2011-2#1)
denervated neuropil##8##2##(1997-3#8)
denervated##18##1##(1995-11#1)(1997-3#12)(2007-8#2)(2008-8#1)(2008-9#1)(2011-2#1)
denervation of the muscles##3##4##(2008-9#2)(2011-2#1)
denervation of the##4##3##(2008-3#1)(2008-9#2)(2011-2#1)
denervation on##2##2##(1990-5#1)(2008-8#1)
denervation##19##1##(1990-5#1)(1991-12#1)(2007-8#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-1#1)(2011-2#3)(2013-1#1)(2013-8#2)
dengue 1 strains##2##3##(2007-10#2)
dengue 1 virus##2##3##(2009-7#2)
dengue 1##4##2##(2007-10#2)(2009-7#2)
dengue and##2##2##(2012-12#2)
dengue assay##2##2##(2012-3#2)
dengue fever##3##2##(2011-1#2)(2011-2#1)
dengue haemorrhagic fever##3##3##(1992-6#2)(2007-2#1)
dengue hemorrhagic##2##2##(2008-5#1)(2011-2#1)
dengue in##5##2##(2007-10#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
dengue infection##2##2##(2011-2#1)(2012-3#1)
dengue prevention##2##2##(2011-1#1)(2011-2#1)
dengue to##2##2##(2011-1#1)(2012-12#1)
dengue transmission##3##2##(2011-1#1)(2011-2#2)
dengue virus##4##2##(1992-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
dengue##53##1##(1992-6#3)(2007-10#3)(2007-2#5)(2008-5#4)(2009-7#2)(2011-1#6)(2011-2#16)(2011-3#3)(2012-12#4)(2012-2#2)(2012-3#3)(2013-8#2)
dengue-III virus D9964##2##3##(2013-8#2)
denial and##5##2##(1990-10#1)(2008-4#3)(2010-11#1)
denial of access##2##3##(1992-3#2)
denial of the##4##3##(2008-4#1)(2010-12#1)(2011-2#2)
denial of##10##2##(1990-6#1)(1991-12#1)(1992-3#2)(2008-4#3)(2010-12#1)(2011-2#2)
denial##18##1##(1990-10#2)(1990-6#1)(1991-12#1)(1992-3#2)(2008-4#7)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#2)
denials of payment##2##3##(1991-3#2)
denials of##3##2##(1991-3#2)(2009-6#1)
denials##5##1##(1991-3#4)(2009-6#1)
denied that##2##2##(1993-3#1)(1995-6#1)
denied##21##1##(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-12#4)(1995-6#3)(1996-5#1)(1997-5#2)(2007-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
denies the##2##2##(1996-5#1)(2013-1#1)
denies##5##1##(1991-3#1)(1991-9#1)(1996-5#1)(1997-7#1)(2013-1#1)
denitration##2##1##(1991-9#2)
denitrificans##4##1##(1992-3#2)(1994-8#1)(2008-6#1)
denitrifying##2##1##(1990-7#1)(2012-3#1)
denoised##2##1##(2008-10#1)(2013-8#1)
denoising##2##1##(2008-10#1)(2009-8#1)
denominated##3##1##(1991-2#1)(2008-9#1)(2013-8#1)
denomination of##2##2##(2008-10#1)(2011-2#1)
denomination##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
denominator in##4##2##(1993-6#1)(2007-4#1)(2008-11#1)(2011-2#1)
denominator##13##1##(1990-8#1)(1991-9#1)(1992-12#1)(1993-6#1)(1995-3#1)(1996-2#2)(2007-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
denosumab##4##1##(2008-7#2)(2010-7#1)(2013-7#1)
denote the##3##2##(2008-10#2)(2010-4#1)
denote##9##1##(1990-7#1)(1990-8#1)(1996-8#1)(2008-10#3)(2008-3#1)(2010-4#1)(2010-8#1)
denoted as##5##2##(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
denoted##11##1##(1992-11#1)(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
denotes the##3##2##(2008-10#2)(2008-3#1)
denotes##7##1##(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-7#1)
dense aggregates of##2##3##(2007-12#1)(2008-10#1)
dense aggregates##3##2##(2007-12#2)(2008-10#1)
dense and##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
dense array of##2##3##(2008-7#2)
dense bodies##2##2##(1996-5#1)(2008-7#1)
dense breasts##2##2##(1990-10#1)(2012-2#1)
dense cytoplasm##2##2##(2008-10#1)(2008-5#1)
dense granules##3##2##(1990-5#1)(2007-12#1)(2008-5#1)
dense image deformation##3##3##(2010-5#3)
dense in##3##2##(1992-3#1)(1993-12#1)(2007-12#1)
dense infiltration##2##2##(2008-1#1)(2010-6#1)
dense layer of##2##3##(2008-4#1)(2012-2#1)
dense network of##2##3##(1997-1#1)(2008-1#1)
dense network##4##2##(1997-1#1)(2008-1#1)(2008-9#1)(2011-1#1)
dense periodic fiber##2##3##(2007-12#2)
dense periodic##3##2##(2007-12#3)
dense population of##2##3##(2008-11#1)(2008-5#1)
dense stands##2##2##(2008-10#1)(2008-9#1)
dense suspensions##3##2##(2007-12#2)(2008-10#1)
dense wavelength-division multiplexed##2##3##(2007-11#1)(2008-2#1)
dense wavelength-division multiplexing##2##3##(2007-11#1)(2008-2#1)
dense wavelength-division##4##2##(2007-11#2)(2008-2#2)
dense##138##1##(1990-10#1)(1990-5#1)(1991-2#1)(1992-3#2)(1993-12#1)(1994-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(2007-11#6)(2007-12#19)(2008-1#5)(2008-10#16)(2008-11#2)(2008-2#9)(2008-3#15)(2008-4#3)(2008-5#10)(2008-7#11)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#1)
dense-core secretory granules##2##3##(1992-2#1)(1997-7#1)
densely packed##10##2##(1992-6#1)(2007-12#3)(2008-7#3)(2008-8#1)(2009-7#1)(2011-1#1)
densely populated pig##2##3##(2011-2#2)
densely populated##6##2##(2007-7#1)(2008-2#1)(2008-5#1)(2011-2#2)(2013-1#1)
densely##27##1##(1991-12#1)(1992-6#1)(1994-2#1)(1994-9#1)(1996-5#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
denser##7##1##(1990-5#1)(1993-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2011-2#1)
densification rate##3##2##(2007-12#3)
densification##7##1##(2007-12#6)(2008-2#1)
densities above##2##2##(1996-12#1)(2008-10#1)
densities and coverage##2##3##(2011-2#2)
densities and the##3##3##(1994-2#1)(1995-11#1)(2008-8#1)
densities and##28##2##(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#3)
densities are##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
densities as##3##2##(2008-2#3)
densities at the site of##2##5##(1992-12#1)(2008-10#1)
densities at the##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
densities at##7##2##(1992-12#1)(1994-2#1)(2008-10#3)(2008-5#2)
densities below##2##2##(2008-10#1)(2008-5#1)
densities between the two##2##4##(2008-8#1)(2010-8#1)
densities between the##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
densities between##6##2##(1994-5#2)(2008-10#2)(2008-8#1)(2010-8#1)
densities by##3##2##(2008-3#2)(2008-7#1)
densities for##8##2##(1993-9#1)(1996-5#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-1#2)
densities from##4##2##(1994-2#1)(2006-4#1)(2008-11#1)(2013-7#1)
densities in a##3##3##(2008-2#1)(2008-3#2)
densities in the field##2##4##(2008-10#1)(2008-9#1)
densities in the##7##3##(1996-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2013-1#1)
densities in##14##2##(1996-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
densities increased##2##2##(1993-3#1)(2008-9#1)
densities observed##2##2##(2008-10#1)(2011-2#1)
densities of 2##2##3##(2008-10#2)
densities of 4 and##2##4##(2008-11#1)(2008-12#1)
densities of H##7##3##(2008-10#7)
densities of fluorescent pseudomonads##2##4##(2008-10#2)
densities of four##2##3##(2008-10#2)
densities of indigenous 2##2##4##(2008-10#2)
densities of the pathogen##3##4##(2008-10#3)
densities of the##8##3##(1997-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)
densities of##72##2##(1993-12#1)(1994-2#2)(1994-5#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
densities on##4##2##(2008-10#3)(2010-10#1)
densities revealed##2##2##(2008-10#1)(2010-7#1)
densities than##3##2##(2007-12#1)(2008-10#2)
densities that##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
densities was observed##2##3##(2008-10#2)
densities were also##2##3##(2008-10#1)(2008-3#1)
densities were determined by##2##4##(2008-3#1)(2008-5#1)
densities were determined##3##3##(2008-3#1)(2008-5#2)
densities were found in##2##4##(2008-10#1)(2008-5#1)
densities were lower##2##3##(2008-10#2)
densities were##19##2##(1997-2#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#5)(2008-7#1)(2008-9#1)
densities##300##1##(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#10)(1994-3#1)(1994-5#4)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#4)(1996-5#1)(1996-7#1)(1997-2#5)(1997-3#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-5#3)(2007-6#2)(2008-10#108)(2008-11#16)(2008-12#2)(2008-2#11)(2008-3#24)(2008-5#12)(2008-7#17)(2008-8#18)(2008-9#12)(2009-10#3)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
densities)##2##1##(2008-2#1)(2008-9#1)
densitometer##5##1##(1993-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
densitometric analysis##2##2##(2007-11#1)(2008-9#1)
densitometric measurement of##2##3##(2007-8#1)(2008-10#1)
densitometric##13##1##(1997-2#1)(2007-11#3)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)
densitometry and##3##2##(1994-9#1)(2009-3#1)(2011-2#1)
densitometry##18##1##(1990-5#2)(1990-6#1)(1992-3#1)(1994-7#1)(1994-9#1)(1996-2#1)(1996-9#1)(1997-6#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-2#1)
density (Bmax) was##2##3##(1995-12#1)(1996-7#1)
density (Bmax)##4##2##(1993-6#1)(1995-12#1)(1996-7#1)(2008-6#1)
density (MVD)##3##2##(2011-2#2)(2012-2#1)
density (PSD)##5##2##(1996-12#2)(2008-11#1)(2008-3#1)(2010-8#1)
density (number##2##2##(2008-10#1)(2008-8#1)
density also##4##2##(1991-5#1)(1997-6#1)(2008-10#1)(2008-4#1)
density and a##2##3##(2008-6#1)(2008-9#1)
density and distribution of##3##4##(1995-12#1)(2008-12#1)(2013-8#1)
density and distribution##4##3##(1995-12#1)(2008-12#1)(2009-6#1)(2013-8#1)
density and increased##2##3##(2007-8#1)(2009-2#1)
density and obesity in young##2##5##(2011-2#2)
density and temperature##3##3##(2008-10#1)(2008-2#2)
density and the##14##3##(1991-11#1)(1995-11#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#2)(2010-8#1)
density and to##2##3##(2008-9#2)
density and total##3##3##(1994-3#1)(2008-10#1)(2008-9#1)
density and##134##2##(1991-11#2)(1992-11#1)(1992-5#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#32)(2008-11#15)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#6)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#2)(2010-8#2)(2011-1#6)(2011-2#5)(2012-1#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
density are solved##2##3##(2008-3#2)
density are##9##2##(1994-5#1)(1997-3#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
density as a result of##3##5##(2008-10#1)(2008-9#2)
density as a##4##3##(2008-10#2)(2008-9#2)
density as##7##2##(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-8#1)
density associated with##2##3##(2008-12#1)(2008-3#1)
density at least##2##3##(2008-10#1)(2008-11#1)
density at the##10##3##(1992-12#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)
density at which##2##3##(2008-9#2)
density at##22##2##(1992-12#2)(1995-2#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-12#1)
density being##2##2##(1993-8#1)(2012-2#1)
density between##4##2##(1993-9#1)(1996-7#1)(2008-10#1)(2012-12#1)
density but the##2##3##(2008-10#2)
density but##7##2##(1995-6#1)(2008-10#4)(2008-11#1)(2008-9#1)
density by##6##2##(1991-11#1)(1994-5#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-8#1)
density can##2##2##(1991-11#1)(2008-8#1)
density caused by##3##3##(1996-7#1)(2007-11#1)(2008-10#1)
density changes in##2##3##(1993-12#1)(2007-8#1)
density compared to##2##3##(1990-7#1)(2008-11#1)
density compared with##2##3##(2008-3#1)(2008-9#1)
density compared##4##2##(1990-7#1)(2008-11#1)(2008-3#1)(2008-9#1)
density could be##2##3##(2008-10#1)(2008-11#1)
density could##4##2##(1993-12#1)(2008-10#2)(2008-11#1)
density cultivation##2##2##(1994-5#2)
density culture##3##2##(2008-11#3)
density decreased##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
density dependence in##5##3##(2008-8#4)(2008-9#1)
density dependence##16##2##(2008-10#1)(2008-8#12)(2008-9#3)
density dependent for##2##3##(2008-9#2)
density dependent##5##2##(2008-10#1)(2008-8#1)(2008-9#3)
density determinations##2##2##(2008-8#2)
density did not affect##2##4##(2008-10#1)(2011-2#1)
density did not##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
density distribution of##2##3##(2008-10#1)(2008-3#1)
density distribution##7##2##(1992-3#1)(2008-10#1)(2008-2#2)(2008-3#3)
density distributions##2##2##(2008-3#1)(2008-7#1)
density drops##2##2##(2008-8#1)(2011-1#1)
density during##2##2##(2008-10#2)
density effects##5##2##(2008-11#1)(2008-9#4)
density fluctuations##2##2##(2008-3#2)
density for the##2##3##(1994-5#1)(2008-9#1)
density for##7##2##(1993-9#1)(1994-5#1)(2008-3#2)(2008-5#1)(2008-9#2)
density fractionation##2##2##(2008-11#2)
density from##4##2##(1991-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
density function##9##2##(2008-10#1)(2008-2#2)(2008-3#5)(2008-8#1)
density functional method##2##3##(2008-10#1)(2013-1#1)
density functional theory (DFT)##2##4##(2013-8#2)
density functional theory##6##3##(1996-2#1)(2008-10#2)(2012-2#1)(2013-8#2)
density functional##14##2##(1996-2#1)(2008-10#4)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#2)
density functionals have MUEs##4##4##(2012-12#4)
density functions##7##2##(2008-10#2)(2008-2#2)(2008-3#2)(2012-3#1)
density gradient centrifugation##15##3##(1991-11#1)(1993-8#2)(1994-8#2)(1995-12#1)(1997-3#1)(2008-1#2)(2008-4#2)(2008-9#3)(2011-2#1)
density gradient##27##2##(1990-7#1)(1990-8#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#4)(2010-12#1)(2011-2#1)
density gradients or by##2##4##(2008-2#1)(2008-4#1)
density gradients##8##2##(1991-11#1)(1992-12#1)(1995-6#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)
density has##2##2##(2008-9#1)(2009-9#1)
density have been##2##3##(2008-3#2)
density in a##5##3##(1992-12#1)(1993-3#1)(2008-2#2)(2012-1#1)
density in all##2##3##(1995-3#1)(1996-2#1)
density in an##2##3##(2008-2#2)
density in layer IV##2##4##(1993-12#2)
density in patients with##2##4##(2007-7#1)(2008-8#1)
density in the##29##3##(1990-11#1)(1991-3#1)(1992-5#3)(1995-8#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
density in##78##2##(1990-11#1)(1991-11#2)(1991-3#1)(1992-12#1)(1992-5#3)(1993-12#2)(1993-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#8)(2008-11#4)(2008-2#7)(2008-3#5)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#2)(2010-10#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
density increased##5##2##(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
density increases##2##2##(2008-8#1)(2012-2#1)
density inside##2##2##(2007-11#1)(2007-12#1)
density is calculated from the##2##5##(2007-12#1)(2008-3#1)
density is made##2##3##(2008-2#1)(2008-3#1)
density is##18##2##(1993-8#1)(1994-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
density lipoprotein (LDL)##13##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-8#3)(2008-10#1)(2010-12#1)
density lipoprotein cholesterol##7##3##(1991-3#1)(1993-12#2)(2008-1#2)(2010-8#1)(2013-1#1)
density lipoprotein from##2##3##(1993-8#1)(1995-6#1)
density lipoprotein in##2##3##(1991-5#1)(2010-5#1)
density lipoprotein ligated cholesterol##3##4##(1991-11#3)
density lipoprotein receptor##13##3##(1990-11#1)(1991-2#2)(1993-3#2)(1994-9#1)(1995-2#2)(1995-6#1)(2007-8#1)(2008-8#2)(2013-1#1)
density lipoprotein##67##2##(1990-11#2)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1992-5#1)(1993-12#4)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-2#3)(1995-6#3)(1995-8#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#2)
density lipoprotein-cholesterol##6##2##(1997-8#1)(2010-5#5)
density lipoproteins and##3##3##(1991-12#1)(1993-12#1)(1994-8#1)
density lipoproteins##31##2##(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-3#3)(1994-8#4)(1995-2#1)(1995-5#4)(2008-10#1)(2013-1#1)
density map##2##2##(1991-3#1)(2010-2#1)
density mapping of##2##3##(2006-4#1)(2007-12#1)
density maps##2##2##(2006-4#1)(2008-4#1)
density matrix##3##2##(2007-12#2)(2008-3#1)
density may##4##2##(1991-5#1)(1995-12#1)(2008-2#1)(2008-8#1)
density measurement and##2##3##(2007-8#1)(2008-10#1)
density measurement in##2##3##(1994-12#1)(2007-8#1)
density measurement##5##2##(1994-12#1)(2007-8#2)(2008-10#1)(2008-4#1)
density measurements##9##2##(2008-10#4)(2008-3#4)(2008-8#1)
density measures##3##2##(2009-5#1)(2009-9#2)
density more##2##2##(1993-12#1)(2008-9#1)
density of 0##4##3##(1994-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
density of 1##4##3##(1994-8#1)(2008-10#1)(2008-11#2)
density of 250##2##3##(2007-11#1)(2008-10#1)
density of 3##2##3##(2008-11#1)(2008-2#1)
density of 5##2##3##(2008-7#1)(2013-1#1)
density of CD95L receptors on##2##5##(2012-1#2)
density of I2-imidazoline receptors in##2##5##(1996-5#2)
density of a##4##3##(2007-12#1)(2008-11#1)(2008-7#2)
density of both##3##3##(1990-5#1)(1993-12#1)(2008-3#1)
density of each aerosol component##2##5##(2008-3#2)
density of hares was##2##4##(2013-1#2)
density of infectious##3##3##(2008-10#1)(2008-8#2)
density of nematode-trapping fungi##2##4##(2008-10#2)
density of nerve cell profiles##2##5##(1994-6#2)
density of nerve##3##3##(1994-6#2)(1995-8#1)
density of shift-multiplexed holographic memory##2##5##(2008-3#2)
density of states in##2##4##(1995-3#1)(2009-11#1)
density of states##6##3##(1995-3#1)(2008-2#1)(2009-11#4)
density of strain##3##3##(2008-10#3)
density of the pathogen##3##4##(2008-10#3)
density of the##44##3##(1990-5#1)(1991-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-7#1)(2013-8#1)
density of zinc##2##3##(2008-10#2)
density of##236##2##(1990-11#1)(1990-12#1)(1990-5#4)(1990-7#1)(1991-12#2)(1991-5#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#3)(1994-2#3)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#6)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#59)(2008-11#16)(2008-12#4)(2008-2#5)(2008-3#20)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#5)(2009-11#6)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#4)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#2)
density on infection by##2##4##(1997-6#1)(2008-10#1)
density on infection##3##3##(1997-6#2)(2008-10#1)
density on offspring##3##3##(2008-9#3)
density on the metal##2##4##(1994-5#1)(1996-2#1)
density on the##12##3##(1992-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)
density on##28##2##(1992-12#2)(1994-5#1)(1995-2#1)(1996-2#1)(1997-6#2)(2008-10#10)(2008-11#6)(2008-2#1)(2008-5#1)(2008-9#3)
density only##2##2##(2008-8#1)(2013-1#1)
density or##15##2##(1991-5#1)(1993-9#1)(1995-3#1)(1995-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
density per##3##2##(2008-10#2)(2008-5#1)
density perfusion cultures of##2##4##(2008-11#2)
density perfusion##6##2##(2008-11#6)
density polyethylene##5##2##(2008-10#2)(2009-3#2)(2011-2#1)
density produced by##2##3##(1995-2#1)(2007-12#1)
density profile##3##2##(1992-9#1)(1996-12#1)(2008-3#1)
density profiles##5##2##(1992-9#1)(1996-12#1)(2008-10#1)(2008-3#2)
density registered##2##2##(2008-5#1)(2008-6#1)
density regulation##8##2##(2008-8#5)(2008-9#3)
density relationships##2##2##(2008-10#2)
density required##2##2##(2008-10#1)(2008-11#1)
density than##4##2##(1995-2#1)(2007-12#1)(2008-11#1)(2011-2#1)
density that##2##2##(2008-3#1)(2009-9#1)
density to the##3##3##(2008-10#1)(2008-3#2)
density to##9##2##(1992-12#1)(1996-8#2)(2008-10#3)(2008-2#1)(2008-3#2)
density under##2##2##(2008-2#1)(2008-5#1)
density value##2##2##(1997-4#1)(2011-2#1)
density values##4##2##(1991-11#1)(1997-4#1)(2008-11#1)(2008-5#1)
density varied##2##2##(2008-5#1)(2008-8#1)
density was determined##2##3##(1992-12#1)(2008-7#1)
density was found to be##2##5##(1994-2#1)(2008-11#1)
density was high##2##3##(1996-2#1)(2008-10#1)
density was measured##2##3##(1991-11#1)(1992-5#1)
density was more##2##3##(2008-10#1)(2008-12#1)
density was over 10(7)##2##4##(2008-11#2)
density was positively correlated with##2##5##(1996-6#1)(2013-1#1)
density was significantly higher in##2##5##(1994-3#1)(2008-10#1)
density was significantly higher##3##4##(1992-5#1)(1994-3#1)(2008-10#1)
density was significantly##4##3##(1992-5#1)(1994-3#1)(2008-10#1)(2008-9#1)
density was##44##2##(1991-11#2)(1992-12#2)(1992-5#4)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#11)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2013-1#1)(2013-7#1)
density were##10##2##(1993-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
density when##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
density with an##2##3##(2008-10#2)
density with##7##2##(1996-5#1)(2008-10#3)(2008-12#1)(2011-1#1)(2012-12#1)
density within a##3##3##(2007-12#2)(2008-11#1)
density within##5##2##(2007-12#2)(2008-11#1)(2008-9#1)(2013-8#1)
density##1477##1##(1990-11#4)(1990-12#2)(1990-3#1)(1990-5#6)(1990-7#5)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#19)(1991-12#6)(1991-2#3)(1991-3#4)(1991-5#9)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#11)(1992-3#4)(1992-5#9)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#16)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#10)(1993-9#13)(1994-11#6)(1994-12#6)(1994-2#6)(1994-3#6)(1994-5#11)(1994-6#3)(1994-8#13)(1994-9#7)(1995-11#1)(1995-12#8)(1995-2#13)(1995-3#4)(1995-5#6)(1995-6#12)(1995-8#11)(1995-9#1)(1996-10#1)(1996-12#8)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#5)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#3)(2006-4#4)(2007-11#21)(2007-12#28)(2007-5#4)(2007-7#2)(2007-8#12)(2008-1#13)(2008-10#276)(2008-11#108)(2008-12#22)(2008-2#40)(2008-3#133)(2008-4#17)(2008-5#43)(2008-6#5)(2008-7#38)(2008-8#77)(2008-9#59)(2009-10#9)(2009-11#8)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#7)(2010-4#4)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#8)(2011-1#19)(2011-2#41)(2012-1#8)(2012-12#18)(2012-2#21)(2012-3#10)(2012-5#2)(2013-1#26)(2013-7#8)(2013-8#15)
density) and##3##2##(2008-10#2)(2008-9#1)
density)##10##1##(1991-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#2)(2012-12#1)
density-dependent manner##4##2##(1993-8#1)(1995-2#1)(2008-10#1)(2008-9#1)
density-dependent##19##1##(1990-6#1)(1993-8#3)(1995-2#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-6#1)(2011-2#1)
density-gradient centrifugation##2##2##(1991-2#1)(2008-11#1)
density-gradient##4##1##(1991-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
density-independent mortality##3##2##(2008-8#3)
density-independent##4##1##(2008-8#4)
density-mediated indirect##2##2##(2008-9#2)
density-mediated##3##1##(2008-9#3)
density-viscosity##2##1##(2008-10#2)
dent##3##1##(2007-7#1)(2008-10#2)
dental abnormalities##2##2##(1995-9#1)(2011-1#1)
dental amalgam##7##2##(1993-8#4)(1995-3#2)(2008-10#1)
dental amalgams##2##2##(2008-10#2)
dental and midfacial##2##3##(2011-2#2)
dental and##7##2##(2008-12#1)(2011-2#3)(2012-1#1)(2013-1#2)
dental anomaly##3##2##(2008-12#1)(2010-3#2)
dental anxiety##2##2##(2008-1#2)
dental applications##3##2##(2008-7#1)(2010-10#1)(2012-4#1)
dental arch##4##2##(2008-11#2)(2011-2#2)
dental arches##2##2##(1990-5#1)(2012-12#1)
dental biofilms of##3##3##(2013-1#3)
dental care is##2##3##(1993-12#1)(2007-12#1)
dental care##16##2##(1993-12#1)(1994-3#1)(1995-6#1)(1996-2#2)(2007-12#2)(2008-12#1)(2008-5#1)(2008-9#4)(2012-3#2)(2013-1#1)
dental caries and##6##3##(1991-6#1)(2008-9#1)(2010-3#1)(2011-1#2)(2012-2#1)
dental caries##33##2##(1991-6#3)(2007-7#3)(2008-1#1)(2008-12#1)(2008-7#3)(2008-9#2)(2010-3#2)(2011-1#8)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#5)
dental clinic##3##2##(2008-7#1)(2012-1#1)(2012-3#1)
dental clinics##4##2##(1991-6#1)(2008-1#3)
dental deformities##2##2##(2007-10#1)(2010-8#1)
dental disease##2##2##(2008-1#2)
dental education in##2##3##(2013-1#2)
dental education##19##2##(1993-1#1)(2008-8#4)(2012-1#3)(2013-1#11)
dental educational##4##2##(2013-1#4)
dental educators##2##2##(2012-1#1)(2013-1#1)
dental enamel##2##2##(1993-11#1)(2009-7#1)
dental extraction##2##2##(1990-5#1)(2007-12#1)
dental fear##3##2##(1993-1#3)
dental hard-tissue##2##2##(2008-7#2)
dental health##5##2##(1994-6#1)(1996-9#2)(2008-7#1)(2011-1#1)
dental home##3##2##(2011-2#3)
dental hygiene students##4##3##(2009-5#4)
dental hygiene##6##2##(2009-5#6)
dental hygienists who reported that they##2##6##(1993-1#2)
dental hygienists##7##2##(1993-1#4)(2008-4#2)(2009-5#1)
dental implant removal torque##2##4##(2009-7#2)
dental implant surgery##3##3##(2013-1#3)
dental implant##11##2##(1996-3#1)(2007-12#1)(2009-7#4)(2011-7#1)(2013-1#4)
dental implants and##2##3##(2009-7#1)(2010-5#1)
dental implants in##2##3##(2013-1#2)
dental implants using##2##3##(2012-12#1)(2013-1#1)
dental implants##20##2##(2007-12#3)(2008-12#1)(2009-7#3)(2009-8#1)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#9)
dental journals##3##2##(2013-1#3)
dental materials##2##2##(2008-3#1)(2008-5#1)
dental nanocomposites##4##2##(2008-8#4)
dental office##4##2##(1994-12#1)(2008-1#2)(2008-4#1)
dental patient##2##2##(1993-1#1)(2008-1#1)
dental patients##11##2##(1993-1#1)(1994-12#1)(1996-3#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-3#1)(2012-3#1)
dental plaque##4##2##(2008-1#1)(2008-5#1)(2011-2#1)(2012-3#1)
dental practice##3##2##(1990-9#1)(1993-12#1)(2008-1#1)
dental practices##2##2##(1993-12#1)(2013-1#1)
dental practitioner##4##2##(2008-1#3)(2011-2#1)
dental practitioners##5##2##(1993-12#1)(2008-1#3)(2011-2#1)
dental problems##2##2##(2011-1#1)(2013-1#1)
dental procedures##2##2##(2008-11#1)(2012-12#1)
dental pulp in human upper first premolar teeth##2##8##(2013-8#2)
dental pulp##6##2##(2011-2#1)(2012-12#2)(2013-8#3)
dental restorations##2##2##(2008-8#1)(2011-2#1)
dental restorative materials##5##3##(2009-7#1)(2011-2#4)
dental school##2##2##(2008-11#1)(2013-8#1)
dental schools##3##2##(2009-2#3)
dental services##9##2##(1993-12#2)(1994-3#2)(1995-12#1)(1996-2#1)(1996-3#2)(2008-11#1)
dental students##7##2##(2009-2#1)(2013-1#6)
dental therapy##2##2##(1990-12#1)(2013-1#1)
dental tissue engineering and##2##4##(2013-1#2)
dental tissue##4##2##(1990-9#1)(2011-1#1)(2013-1#2)
dental tissues##2##2##(1991-2#1)(1994-3#1)
dental trauma was##2##3##(2008-12#1)(2010-7#1)
dental trauma##3##2##(2008-12#1)(2010-7#2)
dental treatment and##2##3##(2008-1#1)(2011-2#1)
dental treatment##12##2##(1991-8#1)(2008-1#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
dental work##2##2##(1993-1#2)
dental##405##1##(1990-12#2)(1990-2#1)(1990-5#4)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#5)(1991-8#1)(1993-1#17)(1993-11#1)(1993-12#6)(1993-8#4)(1994-12#2)(1994-3#5)(1994-6#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#4)(1996-3#6)(1996-9#3)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-12#9)(2007-7#3)(2008-1#28)(2008-10#8)(2008-11#8)(2008-12#13)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#19)(2008-8#10)(2008-9#10)(2009-2#5)(2009-5#7)(2009-7#10)(2009-8#3)(2010-10#1)(2010-3#6)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#20)(2011-2#24)(2011-7#3)(2012-1#11)(2012-12#8)(2012-2#12)(2012-3#9)(2012-4#1)(2013-1#73)(2013-7#1)(2013-8#9)
dentate fast waves##2##3##(1994-8#2)
dentate fast##3##2##(1994-8#3)
dentate granule cells##3##3##(1990-5#2)(1996-12#1)
dentate granule##4##2##(1990-5#2)(1990-7#1)(1996-12#1)
dentate gyrus and##6##3##(1991-2#1)(1994-8#1)(1996-12#2)(2008-11#1)(2009-8#1)
dentate gyrus granule cells##4##4##(1990-7#2)(1997-2#1)(1997-6#1)
dentate gyrus granule##6##3##(1990-7#3)(1997-2#1)(1997-6#1)(2008-11#1)
dentate gyrus is##2##3##(1995-12#2)
dentate gyrus of the##2##4##(1995-12#1)(2008-11#1)
dentate gyrus of##6##3##(1994-8#2)(1995-12#2)(2008-11#1)(2011-2#1)
dentate gyrus was##2##3##(1990-5#1)(1995-12#1)
dentate gyrus##52##2##(1990-5#2)(1990-7#5)(1991-2#2)(1991-5#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-12#13)(1996-12#6)(1996-2#2)(1997-2#1)(1997-6#3)(2008-11#4)(2008-7#1)(2009-8#3)(2011-2#1)(2013-8#1)
dentate##69##1##(1990-5#4)(1990-7#6)(1991-10#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#6)(1995-12#14)(1996-12#7)(1996-2#2)(1997-2#1)(1997-6#3)(2008-1#2)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#2)(2009-8#3)(2010-11#1)(2011-2#1)(2013-7#1)(2013-8#1)
dentate)##3##1##(2008-5#3)
denticola##8##1##(2008-9#7)(2010-11#1)
dentifrice containing##4##2##(2011-2#3)(2013-1#1)
dentifrice##8##1##(2011-2#5)(2013-1#3)
dentigerous cyst##2##2##(2013-1#2)
dentigerous##6##1##(2010-3#1)(2011-1#1)(2013-1#4)
dentin and enamel##4##3##(1991-2#1)(2008-3#3)
dentin and##6##2##(1991-2#1)(2008-3#3)(2008-7#1)(2009-8#1)
dentin hypersensitivity##6##2##(2011-2#6)
dentin is##2##2##(1991-2#1)(2008-7#1)
dentin regeneration##2##2##(2013-1#2)
dentin##48##1##(1990-2#2)(1990-5#1)(1991-2#2)(1991-5#1)(2008-11#4)(2008-12#7)(2008-3#3)(2008-7#4)(2008-8#1)(2009-8#2)(2010-10#2)(2011-2#10)(2012-12#3)(2013-1#6)
dentinal tubules##2##2##(2008-3#1)(2008-7#1)
dentinal##3##1##(2008-3#1)(2008-7#1)(2013-1#1)
dentine##4##1##(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
dentinogenesis##2##1##(2008-7#2)
dentist should##2##2##(2011-1#1)(2012-2#1)
dentist to##2##2##(2008-7#1)(2011-2#1)
dentist##20##1##(1990-10#1)(1990-12#1)(1992-5#1)(1993-12#1)(1995-6#3)(1996-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
dentistry and##6##2##(1992-5#1)(1995-6#1)(2007-12#1)(2009-7#1)(2009-8#1)(2012-1#1)
dentistry as##2##2##(2012-2#1)(2013-1#1)
dentistry has been##2##3##(1990-6#1)(2012-2#1)
dentistry in##9##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1993-3#1)(2009-2#1)(2012-1#1)
dentistry##55##1##(1990-10#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-9#2)(1991-2#1)(1992-5#1)(1993-1#1)(1993-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
dentistry]##2##1##(1990-5#1)(1990-9#1)
dentists and##6##2##(1994-12#1)(2008-1#1)(2008-12#3)(2011-1#1)
dentists are##3##2##(1994-12#2)(2008-11#1)
dentists in Fiji##2##3##(2008-1#2)
dentists in##6##2##(1993-12#2)(2008-1#2)(2013-1#2)
dentists should##3##2##(1990-5#1)(2008-7#1)(2012-12#1)
dentists to##3##2##(2008-11#1)(2008-12#1)(2012-1#1)
dentists##45##1##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1993-1#1)(1993-12#3)(1994-12#3)(1995-6#1)(1997-2#1)(2007-10#2)(2008-1#6)(2008-11#4)(2008-12#6)(2008-7#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#2)(2013-1#3)
dentition and##2##2##(2008-7#1)(2012-3#1)
dentition examinations##2##2##(2012-2#2)
dentition is##2##2##(2007-12#1)(2011-2#1)
dentition##19##1##(2007-12#3)(2008-12#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)
dentoalveolar surgery##4##2##(2007-12#4)
dentoalveolar##5##1##(2007-12#5)
denture base##2##2##(2008-12#1)(2013-1#1)
denture cleansing##2##2##(2013-1#2)
denture wearers##2##2##(2008-7#1)(2013-1#1)
denture##29##1##(1991-2#1)(2007-12#1)(2008-12#2)(2008-7#1)(2009-4#3)(2012-1#1)(2013-1#20)
dentures and##2##2##(2011-2#1)(2013-1#1)
dentures##10##1##(1990-5#1)(2008-7#1)(2011-2#2)(2011-7#1)(2013-1#5)
denudation and##2##2##(1994-12#1)(2007-8#1)
denuded oocytes##2##2##(2013-1#2)
denuded##5##1##(1994-11#1)(2008-1#1)(2013-1#3)
denuder is##2##2##(2008-10#2)
denuder##7##1##(2008-10#7)
denuder-based##3##1##(2008-10#3)
denutrition##2##1##(2008-7#2)
deny the##2##2##(1997-2#1)(2008-12#1)
deny##9##1##(1991-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1997-2#1)(2006-10#1)(2008-12#1)(2009-11#1)(2012-3#1)
denying the##2##2##(1995-6#1)(2009-10#1)
denying##7##1##(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-5#1)(2009-10#1)
deodorancy benefits over and above##2##5##(2008-5#2)
deodorancy##4##1##(2008-5#4)
deodorant products##2##2##(2008-5#2)
deodorant systems##4##2##(2008-5#4)
deodorant##16##1##(2008-5#15)(2012-3#1)
deodorants##2##1##(2008-5#2)
deodorization##2##1##(2008-5#1)(2008-6#1)
deoxy Hb A##3##3##(1992-3#3)
deoxy Hb##4##2##(1992-3#4)
deoxy##8##1##(1990-8#3)(1992-3#4)(1994-8#1)
deoxy-##2##1##(1990-8#1)(2007-10#1)
deoxyadenosine##3##1##(1990-2#1)(1995-5#1)(2008-4#1)
deoxycholate or##2##2##(1990-7#1)(2008-10#1)
deoxycholate##19##1##(1990-12#1)(1990-7#1)(1992-6#1)(1992-9#1)(1993-8#1)(2008-1#1)(2008-10#8)(2011-2#3)(2012-1#2)
deoxycholic acid##4##2##(1990-8#1)(2008-10#3)
deoxycholic amides/cholanes##2##2##(2008-10#2)
deoxycholic##8##1##(1990-8#1)(2008-10#7)
deoxycorticosterone##3##1##(1990-11#1)(2013-8#2)
deoxycytidine analogs##4##2##(1994-8#4)
deoxycytidine##5##1##(1994-8#5)
deoxygenated##6##1##(1990-8#1)(1992-3#1)(2008-10#2)(2008-2#1)(2011-1#1)
deoxygenation of the##4##3##(2008-10#4)
deoxygenation##11##1##(1992-12#1)(1996-5#2)(2008-10#8)
deoxyglucose##2##1##(1992-11#1)(1993-8#1)
deoxyguanosine (dG)##2##2##(1994-8#1)(2008-4#1)
deoxyhemoglobin##3##1##(1990-8#3)
deoxynivalenol (DON)##10##2##(2008-10#10)
deoxynivalenol accumulation in##2##3##(2008-10#2)
deoxynivalenol accumulation##3##2##(2008-10#3)
deoxynivalenol##21##1##(2008-10#21)
deoxynucleosides##2##1##(1990-11#1)(2008-4#1)
deoxynucleotide radical cations##4##3##(2008-9#4)
deoxynucleotide##6##1##(2008-8#1)(2008-9#5)
deoxyribonuclease##4##1##(1991-9#1)(1994-2#1)(1994-8#1)(2008-2#1)
deoxyribonucleic acid (DNA) repair##2##4##(1991-9#1)(1994-8#1)
deoxyribonucleic acid (DNA)##4##3##(1991-9#1)(1994-8#1)(2008-10#1)(2013-7#1)
deoxyribonucleic acid##9##2##(1990-12#1)(1991-9#1)(1994-8#1)(2008-10#3)(2009-8#1)(2012-2#1)(2013-7#1)
deoxyribonucleoside phosphoramidites##3##2##(2008-4#3)
deoxyribonucleoside triphosphates (dNTPs)##2##3##(2008-2#1)(2008-9#1)
deoxyribonucleoside##6##1##(2008-2#1)(2008-4#4)(2008-9#1)
deoxyribonucleosides##3##1##(2008-4#3)
deoxyribonucleotides##2##1##(1990-2#1)(1993-11#1)
deoxyribose oxidation##4##2##(1995-6#4)
deoxyribose##8##1##(1991-3#1)(1995-6#5)(2008-10#1)(2008-9#1)
deoxyribozymes that##4##2##(2012-12#4)
deoxyribozymes##6##1##(2012-12#6)
deoxyuridine##2##1##(1990-7#1)(1992-5#1)
depart##2##1##(2008-3#1)(2012-3#1)
departed from##2##2##(2008-10#1)(2010-8#1)
departed##3##1##(2008-10#1)(2010-8#1)(2013-8#1)
department (ED)##12##2##(2007-5#3)(2008-11#2)(2008-3#2)(2009-6#2)(2010-8#1)(2011-9#1)(2012-2#1)
department and##7##2##(1992-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-3#1)(2011-2#1)
department at##5##2##(1995-4#1)(1996-1#1)(1996-2#1)(2011-1#1)(2011-2#1)
department can be##2##3##(1992-1#1)(2009-11#1)
department can##4##2##(1992-1#1)(1993-1#1)(1997-2#1)(2009-11#1)
department completed##2##2##(2007-12#1)(2008-9#1)
department during##2##2##(1990-9#1)(2007-10#1)
department for the##2##3##(2013-7#2)
department for##8##2##(1990-11#1)(1995-2#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
department from##3##2##(2007-8#1)(2012-3#1)(2013-1#1)
department has##5##2##(1993-12#1)(1993-2#1)(1996-1#1)(2007-5#1)(2008-3#1)
department in a##2##3##(1992-2#1)(1994-3#1)
department in the##3##3##(1990-10#1)(1991-11#1)(2012-2#1)
department in##15##2##(1990-10#1)(1991-11#1)(1992-2#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
department is##3##2##(1993-3#1)(1994-12#1)(1996-3#1)
department managers##2##2##(1991-2#1)(1994-2#1)
department must##2##2##(1994-12#1)(1995-1#1)
department observation unit##4##3##(2008-3#4)
department of a##4##3##(1992-5#1)(1995-1#1)(1997-3#1)(2008-10#1)
department of the national teaching hospital of##2##7##(2009-10#2)
department of the##6##3##(1991-1#1)(1996-12#2)(2009-10#2)(2011-2#1)
department of##36##2##(1990-10#1)(1991-1#1)(1991-11#2)(1991-3#2)(1992-11#1)(1992-5#1)(1993-3#1)(1995-1#1)(1995-2#2)(1996-12#3)(1996-2#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2009-10#2)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
department or##2##2##(2008-12#1)(2010-12#1)
department should##2##2##(1990-12#1)(1992-6#1)
department to##3##2##(1996-1#1)(1997-1#1)(2008-11#1)
department was##3##2##(1991-11#1)(2008-1#1)(2012-2#1)
department will##2##2##(1991-2#1)(1993-12#1)
department with a##5##3##(2007-10#1)(2008-12#1)(2011-2#2)(2013-1#1)
department with the##2##3##(2008-7#1)(2012-3#1)
department with##21##2##(2007-10#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#7)(2008-7#1)(2009-9#2)(2011-2#3)(2012-3#1)(2013-1#1)
department within the##2##3##(1993-2#1)(2008-7#1)
department within##3##2##(1993-2#1)(2007-10#1)(2008-7#1)
department##321##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-9#2)(1991-1#2)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#6)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#6)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1996-1#6)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-8#2)(2006-5#2)(2007-10#4)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#12)(2007-7#2)(2007-8#4)(2008-1#7)(2008-10#7)(2008-11#20)(2008-12#8)(2008-3#24)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#5)(2011-2#14)(2011-9#2)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#12)(2013-7#5)(2013-8#4)
department's##5##1##(1992-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-11#1)
department]##5##1##(1991-11#1)(1992-5#1)(2009-1#2)(2009-5#1)
departmental managers##2##2##(1992-3#1)(1993-12#1)
departmental portfolio##5##2##(2008-12#5)
departmental##20##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-3#1)(1997-2#1)(2007-4#1)(2008-12#5)(2011-2#1)(2012-3#1)
departments a##3##2##(1995-12#1)(1996-1#1)(1997-1#1)
departments and##14##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
departments are##2##2##(1994-12#1)(2007-4#1)
departments at##5##2##(1991-11#1)(1993-6#1)(1997-2#1)(2008-10#1)(2013-8#1)
departments by##2##2##(1991-12#1)(1997-2#1)
departments can##2##2##(1993-12#1)(1996-12#1)
departments have##6##2##(1996-1#2)(1997-3#1)(2007-4#1)(2012-12#1)(2012-3#1)
departments in##7##2##(1991-11#1)(1992-12#1)(1995-3#3)(1996-3#1)(2011-2#1)
departments include##2##2##(1996-1#1)(2007-4#1)
departments is##3##2##(1991-11#1)(1997-8#1)(2007-4#1)
departments must##3##2##(1993-2#1)(1994-3#1)(1995-12#1)
departments of general##2##3##(1993-11#1)(2013-8#1)
departments of health##3##3##(1993-1#1)(1993-2#1)(1997-3#1)
departments of public health and insurance##2##6##(1996-12#1)(1997-2#1)
departments of public health##3##4##(1996-12#1)(1997-2#2)
departments of##16##2##(1990-6#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-12#1)(1997-2#2)(1997-3#1)(2008-7#2)(2012-12#1)(2012-3#1)(2013-8#1)
departments to##7##2##(1990-10#1)(1996-1#1)(1996-12#1)(2008-10#2)(2012-2#1)(2013-8#1)
departments were##3##2##(1996-1#1)(2008-8#1)(2011-1#1)
departments with##2##2##(1991-3#1)(2009-9#1)
departments##167##1##(1990-10#1)(1990-3#2)(1990-6#2)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#4)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-10#4)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1994-1#6)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#7)(1995-3#4)(1996-1#9)(1996-12#5)(1996-2#6)(1996-3#4)(1996-9#1)(1997-1#5)(1997-2#9)(1997-3#4)(1997-8#2)(2007-11#1)(2007-12#1)(2007-4#11)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-7#5)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-9#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#4)
departments'##3##1##(1991-11#1)(1993-2#1)(1994-1#1)
departments)##2##1##(1991-6#1)(1992-1#1)
departments?]##2##1##(1991-11#1)(2012-3#1)
departments]##2##1##(1991-3#1)(2007-1#1)
departs from##2##2##(2008-10#1)(2008-5#1)
departs##4##1##(1991-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
departure from the##4##3##(1992-8#1)(2008-10#2)(2012-2#1)
departure from##10##2##(1992-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2012-2#1)
departure##21##1##(1991-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(2007-2#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#5)(2008-7#1)(2008-9#1)(2012-2#2)
departures from the##4##3##(1997-3#1)(1997-7#1)(2008-10#1)(2008-2#1)
departures from##6##2##(1997-3#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
departures of##2##2##(1990-8#1)(2008-2#1)
departures##9##1##(1990-8#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#2)
depend both on the##2##4##(1994-2#1)(2008-10#1)
depend critically on the##3##4##(1994-2#1)(2007-11#1)(2008-8#1)
depend critically on##4##3##(1994-2#1)(2007-11#1)(2008-2#1)(2008-8#1)
depend largely on##2##3##(2008-3#1)(2009-7#1)
depend mainly on the size##2##5##(1997-7#1)(2008-2#1)
depend mainly on the##3##4##(1997-7#1)(2008-2#1)(2008-3#1)
depend mainly##4##2##(1991-12#1)(1997-7#1)(2008-2#1)(2008-3#1)
depend more##2##2##(1996-3#1)(2009-7#1)
depend on a##6##3##(1994-2#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-3#1)
depend on an##2##3##(1994-8#1)(2009-11#1)
depend on body mass##2##4##(2008-9#1)(2012-2#1)
depend on both the##3##4##(1990-7#1)(2008-2#1)(2011-2#1)
depend on both##4##3##(1990-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
depend on dose##2##3##(1997-7#1)(2008-7#1)
depend on family physicians##2##4##(2008-10#2)
depend on how##2##3##(2008-7#1)(2011-1#1)
depend on its##4##3##(2008-4#1)(2008-8#1)(2009-7#1)(2013-1#1)
depend on many factors##2##4##(2008-3#1)(2013-8#1)
depend on sex##2##3##(2008-9#1)(2012-3#1)
depend on the ability of##2##5##(1994-12#1)(2008-10#1)
depend on the absolute##2##4##(2007-11#1)(2008-3#1)
depend on the anion##2##4##(2008-10#1)(2011-1#1)
depend on the availability of##3##5##(1991-1#1)(2008-10#1)(2008-9#1)
depend on the characteristics of the##2##6##(1997-7#1)(2008-7#1)
depend on the chemical##2##4##(1996-12#1)(2008-11#1)
depend on the clinical##2##4##(1990-2#1)(2008-9#1)
depend on the degree of##3##5##(1993-11#1)(2008-2#1)(2008-7#1)
depend on the existence##2##4##(1994-2#1)(2008-8#1)
depend on the laser's##2##4##(2008-2#1)(2008-3#1)
depend on the nature of the##2##6##(1994-11#1)(2013-1#1)
depend on the nature##3##4##(1994-11#1)(2008-10#1)(2013-1#1)
depend on the presence of##2##5##(1994-11#1)(2008-12#1)
depend on the size of##2##5##(2008-2#1)(2010-8#1)
depend on the size##3##4##(2007-11#1)(2008-2#1)(2010-8#1)
depend on the##106##3##(1990-2#1)(1991-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-12#1)(1996-4#2)(1997-1#2)(1997-4#1)(1997-7#2)(2006-4#2)(2007-11#5)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#9)(2008-5#3)(2008-7#6)(2008-8#7)(2008-9#5)(2009-12#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
depend on their##4##3##(1996-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
depend on two##3##3##(1992-3#1)(2008-9#1)(2012-12#1)
depend on whether the##2##4##(2008-1#1)(2012-2#1)
depend on whether##5##3##(1996-2#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
depend on##233##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#4)(2006-4#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#25)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#23)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#19)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
depend only##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
depend primarily on the##2##4##(2007-10#1)(2007-7#1)
depend strongly on the##9##4##(1992-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
depend strongly on##12##3##(1992-8#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#3)
depend upon the##8##3##(1991-2#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-9#1)(2008-2#1)(2008-7#2)
depend upon##16##2##(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-3#1)(1994-9#1)(1995-12#1)(1996-6#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2012-2#1)
depend##301##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#6)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#5)(2006-4#2)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#28)(2008-11#7)(2008-12#1)(2008-2#19)(2008-3#31)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#14)(2008-8#23)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#2)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
dependable##4##1##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
dependant on the##3##3##(1997-3#1)(2008-1#1)(2008-10#1)
dependant##7##1##(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)
dependants##2##1##(2010-8#1)(2011-2#1)
depended on both the##3##4##(1995-5#1)(2008-8#1)(2011-2#1)
depended on both##5##3##(1991-6#1)(1992-7#1)(1995-5#1)(2008-8#1)(2011-2#1)
depended on soil##2##3##(2008-10#1)(2012-6#1)
depended on the applied##2##4##(2008-10#2)
depended on the concentration of decanethiol##2##6##(2008-10#2)
depended on the concentration of##3##5##(2008-10#3)
depended on the culture##2##4##(2009-6#1)(2013-1#1)
depended on the degree of##2##5##(1993-6#1)(2013-1#1)
depended on the location of the##2##6##(1992-8#1)(2007-11#1)
depended on the presence of##2##5##(2008-6#1)(2008-9#1)
depended on the strain##2##4##(2008-11#1)(2008-5#1)
depended on the type of##4##5##(2007-11#2)(2010-3#1)(2012-12#1)
depended on the##55##3##(1991-2#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-9#2)(1996-2#1)(1997-1#1)(1997-4#1)(2007-11#4)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-1#2)
depended on##83##2##(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#4)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-6#3)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-9#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#2)
depended primarily on##2##3##(2008-10#1)(2008-2#1)
depended primarily##3##2##(2008-10#2)(2008-2#1)
depended upon the##4##3##(1992-3#2)(1993-11#1)(2008-10#1)
depended##98##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#3)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-11#5)(2007-9#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#2)
dependence among##2##2##(2008-10#1)(2008-9#1)
dependence and its##2##3##(1993-10#1)(2009-10#1)
dependence and substrate##2##3##(1992-8#1)(1996-5#1)
dependence and the##6##3##(1992-6#1)(2008-2#2)(2008-3#1)(2009-2#1)(2012-12#1)
dependence and withdrawal##3##3##(1991-1#1)(1995-11#2)
dependence and##34##2##(1990-6#1)(1991-1#2)(1992-6#1)(1992-8#1)(1993-10#1)(1994-8#1)(1995-11#2)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2012-12#2)(2012-2#1)
dependence are discussed##3##3##(1991-12#2)(2008-2#1)
dependence between the absorbance##2##4##(2008-10#2)
dependence between the##5##3##(1997-4#1)(2007-11#1)(2008-10#3)
dependence between##9##2##(1997-4#1)(2007-11#1)(2008-10#6)(2009-7#1)
dependence can be##2##3##(2008-2#1)(2008-3#1)
dependence in ADLs##2##3##(2008-7#2)
dependence in a##3##3##(2008-3#1)(2008-8#1)(2009-2#1)
dependence in rats##2##3##(2008-4#2)
dependence in the##5##3##(1992-1#1)(2008-3#2)(2008-8#1)(2012-2#1)
dependence in##33##2##(1991-1#4)(1992-1#1)(1993-9#1)(1996-4#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-4#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-2#2)
dependence is discussed##2##3##(1990-6#1)(1991-12#1)
dependence is##11##2##(1990-6#1)(1991-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2012-2#1)(2013-8#1)
dependence of absorption and##2##4##(2008-1#1)(2008-3#1)
dependence of absorption##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
dependence of chromatic dispersion##2##4##(2007-12#2)
dependence of fluorescence on##2##4##(2008-2#1)(2008-3#1)
dependence of fluorescence##3##3##(2008-2#1)(2008-3#2)
dependence of its##2##3##(2007-11#1)(2009-9#1)
dependence of lidar##2##3##(2008-2#2)
dependence of quantized kinoform reconstruction##2##5##(2008-3#2)
dependence of second-harmonic##2##3##(2007-12#2)
dependence of soliton##2##3##(2007-11#1)(2007-12#1)
dependence of the Bragg wavelength##2##5##(2007-11#1)(2007-12#1)
dependence of the Raman##2##4##(2007-11#1)(2008-2#1)
dependence of the beat frequency##2##5##(2007-11#1)(2008-3#1)
dependence of the degree of##2##5##(2007-11#2)
dependence of the diffraction##2##4##(2007-12#2)
dependence of the efficiency##3##4##(2007-12#2)(2008-3#1)
dependence of the enzyme##2##4##(1990-5#1)(1997-6#1)
dependence of the fluorescence##4##4##(1995-6#1)(2008-2#2)(2008-3#1)
dependence of the initial rate##2##5##(1990-12#1)(2008-10#1)
dependence of the initial##3##4##(1990-12#1)(1990-2#1)(2008-10#1)
dependence of the intensity##3##4##(2007-12#1)(2008-2#2)
dependence of the maximum##2##4##(1994-12#1)(2008-2#1)
dependence of the measured##2##4##(2007-12#2)
dependence of the mixing efficiency##2##5##(2008-2#2)
dependence of the mixing##3##4##(2007-10#1)(2008-2#2)
dependence of the optimum##2##4##(2008-2#1)(2008-3#1)
dependence of the output##3##4##(2008-3#3)
dependence of the population##2##4##(2008-2#2)
dependence of the rate##3##4##(1993-8#1)(1996-12#1)(2008-10#1)
dependence of the refractive index##3##5##(2008-2#1)(2008-3#2)
dependence of the scattering##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
dependence of the##169##3##(1990-12#3)(1990-2#1)(1990-5#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-8#4)(1994-12#2)(1994-6#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#18)(2007-12#20)(2008-10#19)(2008-2#28)(2008-3#40)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-2#1)
dependence of their##2##3##(2008-10#1)(2008-11#1)
dependence of these##2##3##(1992-7#1)(2008-3#1)
dependence of this##6##3##(1990-5#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
dependence of total##2##3##(2008-10#1)(2008-7#1)
dependence of two-photon##2##3##(2008-2#1)(2008-3#1)
dependence of uptake rate in##2##5##(2008-10#2)
dependence of##312##2##(1990-12#3)(1990-2#2)(1990-5#4)(1990-7#1)(1990-8#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-8#5)(1994-12#2)(1994-6#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-5#3)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#27)(2007-12#34)(2008-1#2)(2008-10#42)(2008-11#1)(2008-2#42)(2008-3#65)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-4#1)(2011-2#1)(2012-2#3)(2012-6#1)(2013-7#3)
dependence on intracavity##2##3##(2007-11#1)(2008-3#1)
dependence on temperature##5##3##(2007-11#3)(2008-10#1)(2008-3#1)
dependence on the concentration##3##4##(1993-12#1)(2008-10#1)(2009-12#1)
dependence on the optical##2##4##(2008-3#1)(2011-1#1)
dependence on the##38##3##(1992-3#1)(1993-12#1)(1993-8#1)(1996-5#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-2#7)(2008-3#10)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2011-1#1)
dependence on##93##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-5#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#7)(2008-1#3)(2008-10#15)(2008-11#1)(2008-2#9)(2008-3#23)(2008-5#2)(2008-6#2)(2008-7#4)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
dependence or##3##2##(1991-1#1)(2008-2#1)(2008-8#1)
dependence similar to##2##3##(2008-2#2)
dependence to##2##2##(2008-10#1)(2013-8#1)
dependence was linear##3##3##(1992-3#1)(2008-10#2)
dependence was##6##2##(1992-3#1)(2008-10#3)(2008-3#2)
dependence with the##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
dependence with##4##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-3#1)
dependence##650##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#5)(1991-1#14)(1991-10#1)(1991-12#9)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-3#6)(1992-4#1)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#7)(1993-9#2)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#6)(1995-12#1)(1995-2#5)(1995-5#4)(1995-6#2)(1995-9#1)(1996-12#3)(1996-3#1)(1996-4#2)(1996-5#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(2007-10#1)(2007-11#39)(2007-12#37)(2008-1#7)(2008-10#88)(2008-11#5)(2008-12#1)(2008-2#73)(2008-3#119)(2008-4#7)(2008-5#6)(2008-6#9)(2008-7#14)(2008-8#26)(2008-9#7)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-6#2)(2009-7#7)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#14)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#4)(2013-8#5)
dependence)##3##1##(2008-10#2)(2008-11#1)
dependence]##2##1##(1996-3#1)(2007-1#1)
dependences of the##5##3##(1992-5#1)(2007-11#1)(2008-10#1)(2008-3#2)
dependences of##6##2##(1992-5#1)(2007-11#1)(2008-10#2)(2008-3#2)
dependences##12##1##(1992-5#2)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-7#1)(2012-12#1)
dependencies in##2##2##(2008-2#1)(2008-3#1)
dependencies of the##5##3##(1993-8#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-6#1)
dependencies of##8##2##(1993-8#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
dependencies were##2##2##(2008-10#1)(2008-6#1)
dependencies##25##1##(1991-1#1)(1993-8#1)(1995-5#1)(1996-4#1)(1996-5#2)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)
dependency and##5##2##(1992-3#1)(1994-3#1)(2007-10#1)(2008-10#1)(2013-1#1)
dependency for##2##2##(2008-10#1)(2012-12#1)
dependency is##3##2##(1997-7#1)(2008-9#1)(2013-8#1)
dependency of malaria##2##3##(2008-8#2)
dependency of the##7##3##(1990-8#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)
dependency of##18##2##(1990-2#1)(1990-8#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#1)
dependency on##2##2##(2008-11#1)(2008-7#1)
dependency was##3##2##(1995-5#1)(2007-10#1)(2012-12#1)
dependency##66##1##(1990-2#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-5#2)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#5)(2013-1#1)(2013-8#1)
dependent (BOLD)##2##2##(2008-11#1)(2009-6#1)
dependent (i##2##2##(2008-8#1)(2009-6#1)
dependent and independent##3##3##(1993-12#1)(2007-11#1)(2008-7#1)
dependent and occurs##2##3##(1994-8#1)(2008-7#1)
dependent and##21##2##(1990-12#1)(1992-1#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-8#2)(2007-11#2)(2008-10#5)(2008-11#1)(2008-7#3)(2009-8#1)(2011-1#1)(2012-3#1)
dependent calcium channel##2##3##(1997-4#2)
dependent cellular growth##3##3##(1993-6#3)
dependent changes in##3##3##(1993-3#1)(2008-11#2)
dependent diabetes mellitus##15##3##(1992-11#1)(1992-5#1)(1994-12#2)(1997-5#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2012-12#1)(2013-8#1)
dependent diabetes##21##2##(1990-9#1)(1992-11#1)(1992-5#1)(1994-12#2)(1996-8#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2012-12#1)(2013-8#1)
dependent effect##2##2##(2008-12#1)(2009-7#1)
dependent for##3##2##(1994-8#1)(2008-9#2)
dependent growth##2##2##(2008-1#1)(2008-7#1)
dependent in##2##2##(2007-10#1)(2008-8#1)
dependent inactivation##2##2##(1991-5#1)(1991-9#1)
dependent inhibition of##3##3##(1990-11#1)(1991-4#1)(1997-2#1)
dependent investigation of##2##3##(2008-10#2)
dependent manner and##3##3##(1990-11#1)(1990-8#1)(1991-2#1)
dependent manner##24##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-5#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
dependent measure##2##2##(2011-2#1)(2012-3#1)
dependent mechanism##3##2##(1990-11#1)(2011-2#1)(2012-12#1)
dependent mechanisms##2##2##(2008-11#1)(2012-2#1)
dependent not only on the presence of light but also on its direction of incidence##2##15##(1991-2#2)
dependent not only on##3##4##(1991-2#2)(1997-8#1)
dependent observations##2##2##(1992-9#1)(1994-11#1)
dependent on Ca2+##2##3##(1990-7#1)(1992-9#1)
dependent on PI3-kinase##2##3##(2008-8#2)
dependent on a##8##3##(1990-5#1)(1994-6#1)(1994-8#1)(1996-6#1)(1996-7#1)(1997-2#1)(2008-8#1)(2010-8#1)
dependent on activation of the##2##5##(1997-2#1)(2008-4#1)
dependent on activation of##4##4##(1990-12#1)(1997-2#1)(2008-4#2)
dependent on age##3##3##(1992-2#1)(1994-9#1)(2011-3#1)
dependent on an##2##3##(2008-11#1)(2008-4#1)
dependent on both the##3##4##(1990-11#1)(1995-5#1)(2008-5#1)
dependent on both##10##3##(1990-11#1)(1995-3#1)(1995-5#1)(1996-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
dependent on concentration##2##3##(1990-12#1)(2008-9#1)
dependent on de novo##2##4##(1994-9#1)(1995-12#1)
dependent on divalent cations##2##4##(1992-9#1)(1993-8#1)
dependent on extracellular##2##3##(1990-12#1)(1995-12#1)
dependent on high##2##3##(2008-10#1)(2008-2#1)
dependent on others for their##2##5##(2007-8#1)(2012-12#1)
dependent on others for##3##4##(2007-8#1)(2012-1#1)(2012-12#1)
dependent on pH##4##3##(1990-7#1)(1990-8#1)(2008-10#2)
dependent on protein kinase C##2##5##(1991-5#1)(1995-12#1)
dependent on protein synthesis##2##4##(1990-11#1)(1995-12#1)
dependent on protein##4##3##(1990-11#1)(1991-5#1)(1995-12#2)
dependent on solution##2##3##(2008-10#2)
dependent on the UGT2B17 genotype##2##5##(2013-8#2)
dependent on the activity of##2##5##(2008-11#1)(2008-8#1)
dependent on the amount of##8##5##(1990-2#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)
dependent on the applied##2##4##(2008-10#1)(2013-1#1)
dependent on the availability of##3##5##(2007-10#1)(2008-7#1)(2008-9#1)
dependent on the bacterial##2##4##(2008-10#1)(2011-2#1)
dependent on the chemical##3##4##(1994-12#1)(2008-6#1)(2009-10#1)
dependent on the concentration of the##2##6##(1991-8#1)(1992-12#1)
dependent on the concentration of##9##5##(1991-8#1)(1992-12#1)(2008-10#3)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
dependent on the concentrations of##2##5##(2012-1#1)(2013-8#1)
dependent on the densities##2##4##(2008-10#1)(2008-9#1)
dependent on the fraction of##2##5##(1994-5#1)(2008-10#1)
dependent on the level of##3##5##(1991-8#1)(2008-10#1)(2008-11#1)
dependent on the nature of the##4##6##(1990-8#1)(1994-5#1)(2008-10#2)
dependent on the nature of##6##5##(1990-8#1)(1993-3#1)(1994-5#1)(2008-10#2)(2008-3#1)
dependent on the nature##7##4##(1990-8#1)(1993-3#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-3#1)
dependent on the pH of the##2##6##(1991-5#1)(1995-6#1)
dependent on the pH##3##4##(1991-5#1)(1995-6#1)(2008-10#1)
dependent on the presence of an##2##6##(1994-9#1)(1995-6#1)
dependent on the presence of calcium##2##6##(1993-6#1)(1995-3#1)
dependent on the presence of the##2##6##(1991-3#1)(1995-2#1)
dependent on the presence of##16##5##(1990-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
dependent on the size of the##4##6##(1993-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
dependent on the state of##2##5##(1993-5#1)(2008-3#1)
dependent on the thickness of the##2##6##(2007-11#1)(2009-5#1)
dependent on the thickness##3##4##(2007-11#1)(2008-3#1)(2009-5#1)
dependent on the time of day##2##6##(2009-8#2)
dependent on the time##4##4##(1994-10#1)(2007-8#1)(2009-8#2)
dependent on the type of##3##5##(1991-12#1)(1994-7#1)(2008-10#1)
dependent on the use of##2##5##(2008-10#2)
dependent on the##204##3##(1990-11#2)(1990-2#5)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#3)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#4)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-8#2)(2008-10#40)(2008-11#11)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#3)
dependent on wind##2##3##(2008-10#1)(2008-5#1)
dependent on##398##2##(1990-11#7)(1990-12#3)(1990-2#6)(1990-3#1)(1990-5#4)(1990-7#4)(1990-8#5)(1990-9#1)(1991-12#3)(1991-3#1)(1991-5#4)(1991-6#2)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#4)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#5)(1996-2#4)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#65)(2008-11#18)(2008-12#2)(2008-2#4)(2008-3#18)(2008-4#10)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#2)(2012-9#1)(2013-1#8)(2013-8#6)
dependent pathway##3##2##(1990-12#1)(1992-8#1)(2013-1#1)
dependent patients##6##2##(1992-12#2)(1994-2#1)(2009-10#1)(2009-7#1)(2011-2#1)
dependent pattern##2##2##(1993-3#1)(2013-1#1)
dependent plasticity##2##2##(2008-11#1)(2009-8#1)
dependent process##2##2##(1992-9#1)(1993-9#1)
dependent protein kinase##2##3##(1997-2#2)
dependent protein##4##2##(1991-2#1)(1997-2#2)(2012-2#1)
dependent response##2##2##(2008-10#1)(2009-9#1)
dependent signaling##2##2##(1997-2#1)(1997-7#1)
dependent transcription##2##2##(2009-8#1)(2012-12#1)
dependent upon a##6##3##(1990-5#1)(1993-6#1)(2008-8#2)(2011-1#1)(2012-2#1)
dependent upon the presence of##5##5##(1992-9#1)(1993-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
dependent upon the presence##6##4##(1992-9#1)(1993-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
dependent upon the##46##3##(1990-11#1)(1990-3#1)(1990-5#2)(1992-9#3)(1993-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#2)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-11#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
dependent upon##87##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-12#2)(1991-5#1)(1992-12#1)(1992-9#4)(1993-12#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-1#2)(2007-11#2)(2007-2#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)
dependent variable##8##2##(1992-1#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-1#1)(2010-2#1)
dependent variables in##2##3##(2008-10#1)(2008-11#1)
dependent variables##12##2##(1990-3#1)(1992-6#1)(1995-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2010-4#1)(2012-2#1)
dependent virus##5##2##(2008-10#5)
dependent##858##1##(1990-11#14)(1990-12#11)(1990-2#7)(1990-3#3)(1990-5#9)(1990-7#7)(1990-8#8)(1990-9#2)(1991-1#1)(1991-12#10)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#2)(1991-8#3)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#13)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#8)(1993-5#3)(1993-6#9)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#2)(1994-11#6)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#11)(1994-9#5)(1995-1#1)(1995-11#6)(1995-12#8)(1995-2#9)(1995-3#5)(1995-5#8)(1995-6#8)(1995-8#5)(1995-9#1)(1996-11#2)(1996-12#6)(1996-2#6)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#5)(2006-6#1)(2007-10#4)(2007-11#16)(2007-12#5)(2007-2#3)(2007-6#1)(2007-7#5)(2007-8#6)(2008-1#8)(2008-10#125)(2008-11#44)(2008-12#6)(2008-2#8)(2008-3#27)(2008-4#14)(2008-5#26)(2008-6#4)(2008-7#29)(2008-8#26)(2008-9#11)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#6)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#18)(2011-3#1)(2012-1#4)(2012-12#13)(2012-2#14)(2012-3#5)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#13)
dependently on##2##2##(2008-10#1)(2008-12#1)
dependently##14##1##(1990-5#1)(1992-5#1)(1994-2#1)(1995-11#1)(1995-12#6)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
dependents##2##1##(1994-3#2)
depending mainly on the##2##4##(1997-5#1)(2008-11#1)
depending mainly on##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
depending not only on the##3##5##(2008-2#1)(2008-3#1)(2008-8#1)
depending not##4##2##(1991-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
depending of the##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
depending on a##2##3##(1990-7#1)(2013-8#1)
depending on age##2##3##(2008-4#1)(2008-6#1)
depending on cell##2##3##(2008-11#1)(2009-8#1)
depending on clinical##2##3##(1991-3#1)(2013-1#1)
depending on different##2##3##(2008-10#1)(2011-2#1)
depending on how##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
depending on its protonation##2##4##(1990-8#1)(2008-10#1)
depending on its##7##3##(1990-8#1)(1996-3#1)(2008-10#3)(2008-5#1)(2010-11#1)
depending on location##2##3##(2008-10#1)(2008-7#1)
depending on pH and##2##4##(2008-10#1)(2008-6#1)
depending on pH##4##3##(1990-7#1)(2008-10#2)(2008-6#1)
depending on patient and##2##4##(2008-11#1)(2011-2#1)
depending on patient##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
depending on species and retinal location)##2##6##(2007-5#2)
depending on species##3##3##(2007-5#2)(2008-8#1)
depending on specific##2##3##(2011-1#1)(2013-8#1)
depending on the actual##3##4##(2006-6#1)(2007-12#1)(2008-10#1)
depending on the assay##2##4##(1993-8#1)(2008-1#1)
depending on the cell type##2##5##(1993-8#2)
depending on the cell##8##4##(1991-6#1)(1993-8#2)(1995-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)
depending on the characteristics of the##3##6##(2008-10#1)(2008-2#1)(2011-2#1)
depending on the concentration of##3##5##(1997-4#2)(2012-6#1)
depending on the conditions of##2##5##(1990-8#1)(1996-2#1)
depending on the context##2##4##(2010-8#1)(2012-2#1)
depending on the degree of##4##5##(2008-7#1)(2009-5#2)(2013-1#1)
depending on the experimental conditions##2##5##(1996-6#1)(2010-11#1)
depending on the experimental##3##4##(1996-6#1)(2008-10#1)(2010-11#1)
depending on the grating##2##4##(2007-12#1)(2008-2#1)
depending on the laser##2##4##(2008-2#1)(2011-1#1)
depending on the level of##2##5##(1993-12#1)(2011-1#1)
depending on the location##2##4##(2012-12#1)(2013-1#1)
depending on the matrix##2##4##(2008-10#1)(2008-5#1)
depending on the medium##2##4##(2008-10#2)
depending on the metal##3##4##(2008-10#2)(2010-11#1)
depending on the method used to##2##6##(2007-11#1)(2008-10#1)
depending on the method used##3##5##(2007-11#1)(2008-10#2)
depending on the nature and##2##5##(2008-5#1)(2012-12#1)
depending on the nature of the##3##6##(2008-10#1)(2008-3#1)(2008-8#1)
depending on the nature of##4##5##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
depending on the nature##6##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
depending on the number of##3##5##(1990-12#1)(2008-7#1)(2008-8#1)
depending on the orientation of the particles##2##7##(2008-3#2)
depending on the outcome##2##4##(2010-12#1)(2013-1#1)
depending on the pH##2##4##(1993-8#1)(2008-3#1)
depending on the parameters##2##4##(1993-3#1)(2009-5#1)
depending on the polarization##2##4##(2008-3#2)
depending on the population##2##4##(2008-1#1)(2013-1#1)
depending on the presence of##5##5##(1991-9#1)(1994-12#1)(2008-5#1)(2010-5#1)(2011-2#1)
depending on the reaction##2##4##(1996-5#1)(2008-10#1)
depending on the sample##2##4##(2008-10#2)
depending on the severity of##2##5##(2011-2#1)(2013-1#1)
depending on the sex##2##4##(1994-6#1)(2013-1#1)
depending on the shape of##2##5##(2008-11#1)(2010-8#1)
depending on the shape##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
depending on the size of##2##5##(2008-10#1)(2008-7#1)
depending on the size##3##4##(1993-2#1)(2008-10#1)(2008-7#1)
depending on the solution##2##4##(1997-2#1)(2008-10#1)
depending on the specific##2##4##(2007-12#1)(2011-2#1)
depending on the stage of##2##5##(1991-6#1)(2008-10#1)
depending on the structure##2##4##(2007-11#1)(2013-1#1)
depending on the timing##2##4##(2008-7#1)(2010-5#1)
depending on the training##2##4##(2008-10#1)(2011-1#1)
depending on the tumor##2##4##(2012-12#1)(2013-8#1)
depending on the type of the##2##6##(2007-11#1)(2008-11#1)
depending on the type of##7##5##(1997-2#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)
depending on the type##8##4##(1997-2#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)
depending on the##266##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#2)(1991-9#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#5)(1994-12#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-8#1)(2006-6#1)(2007-11#9)(2007-12#8)(2007-8#2)(2008-1#3)(2008-10#67)(2008-11#10)(2008-12#2)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#11)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#7)(2009-11#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#13)(2013-8#4)
depending on their##12##3##(1990-6#1)(1995-1#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#2)
depending on when##2##3##(1994-5#1)(1995-5#1)
depending on whether the##3##4##(1990-8#1)(1991-12#1)(1996-5#1)
depending on whether they##2##4##(2008-3#1)(2008-5#1)
depending on whether##9##3##(1990-8#1)(1991-12#1)(1992-9#1)(1994-3#1)(1996-5#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
depending on which of the two##2##6##(2008-2#1)(2008-4#1)
depending on which##6##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
depending on##387##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-12#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#5)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#11)(2007-12#10)(2007-5#2)(2007-8#3)(2008-1#3)(2008-10#91)(2008-11#17)(2008-12#4)(2008-2#8)(2008-3#15)(2008-4#6)(2008-5#16)(2008-6#6)(2008-7#9)(2008-8#8)(2008-9#11)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#4)(2010-8#2)(2011-1#5)(2011-2#18)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#2)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#8)
depending upon the cell type##2##5##(1992-6#1)(2008-7#1)
depending upon the nature##2##4##(1991-3#1)(2008-11#1)
depending upon the##15##3##(1991-3#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-7#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-7#1)
depending upon##20##2##(1991-3#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-7#1)(1995-5#1)(1997-5#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-7#1)
depending##425##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-12#2)(1991-3#2)(1991-6#2)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#6)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#12)(2007-12#10)(2007-5#2)(2007-8#3)(2008-1#3)(2008-10#97)(2008-11#22)(2008-12#4)(2008-2#10)(2008-3#17)(2008-4#6)(2008-5#17)(2008-6#6)(2008-7#10)(2008-8#9)(2008-9#11)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#19)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#2)(2012-6#1)(2013-1#18)(2013-7#1)(2013-8#8)
depends both on the##3##4##(1991-6#1)(2008-10#1)(2013-1#1)
depends both on##5##3##(1991-6#1)(1992-6#1)(1994-12#1)(2008-10#1)(2013-1#1)
depends critically on##2##3##(2008-6#1)(2011-2#1)
depends crucially on##2##3##(1990-12#1)(2008-10#1)
depends directly on the##2##4##(2008-5#2)
depends directly on##3##3##(2008-4#1)(2008-5#2)
depends extremely on the##2##4##(2007-4#1)(2008-10#1)
depends greatly on the##2##4##(2008-2#2)
depends in part on##2##4##(1995-12#1)(2012-12#1)
depends in part##3##3##(1993-10#1)(1995-12#1)(2012-12#1)
depends in##4##2##(1993-10#1)(1995-12#1)(2008-5#1)(2012-12#1)
depends largely on##2##3##(1990-5#1)(2008-7#1)
depends mainly on the##3##4##(2008-10#1)(2008-3#2)
depends mainly on##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#2)
depends not only on the##2##5##(2008-2#1)(2012-3#1)
depends not only on##5##4##(1997-6#1)(2007-7#1)(2008-2#1)(2012-3#1)(2013-1#1)
depends on Ca(2+)##2##3##(2008-7#1)(2012-2#1)
depends on a##9##3##(1990-11#1)(1990-3#1)(1993-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-10#1)(2012-3#1)
depends on an##2##3##(1995-2#1)(2008-10#1)
depends on both the##5##4##(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#1)
depends on both##10##3##(1991-12#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
depends on different##2##3##(2009-3#1)(2011-3#1)
depends on early##2##3##(1994-1#1)(2009-1#1)
depends on effective##2##3##(2006-6#1)(2011-2#1)
depends on how##3##3##(1993-3#1)(2008-4#1)(2009-5#1)
depends on its##2##3##(1993-2#1)(2008-8#1)
depends on many##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
depends on our##2##3##(1993-3#1)(2010-4#1)
depends on patient##2##3##(1992-8#1)(2007-12#1)
depends on patient's##2##3##(2008-10#1)(2013-1#1)
depends on stressor controllability and##2##5##(2008-11#2)
depends on the ability of##2##5##(2008-7#1)(2011-2#1)
depends on the ability to##2##5##(2008-11#1)(2012-12#1)
depends on the ability##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
depends on the activity##2##4##(2007-11#1)(2013-1#1)
depends on the amount and##2##5##(2008-10#1)(2008-5#1)
depends on the amount##3##4##(2008-10#2)(2008-5#1)
depends on the chemical##2##4##(2008-10#1)(2008-3#1)
depends on the concentration and##3##5##(2008-10#3)
depends on the concentration##4##4##(2008-10#4)
depends on the degree of##8##5##(1990-9#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
depends on the degree##9##4##(1990-9#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
depends on the diameter of the##2##6##(2008-3#1)(2008-7#1)
depends on the distance between the##2##6##(2008-2#1)(2008-3#1)
depends on the establishment of##2##5##(2008-7#1)(2008-8#1)
depends on the genetic##2##4##(1996-5#1)(2008-12#1)
depends on the initial##2##4##(1997-4#1)(2007-12#1)
depends on the level of##2##5##(2008-11#1)(2011-2#1)
depends on the magnitude of the##2##6##(2008-10#1)(2008-8#1)
depends on the mutual##2##4##(2007-11#1)(2008-10#1)
depends on the nature##2##4##(1990-5#1)(2008-10#1)
depends on the optical##2##4##(2008-3#2)
depends on the polarization##2##4##(2008-3#2)
depends on the presence of##4##5##(1991-2#1)(1991-8#1)(1994-6#1)(2011-2#1)
depends on the presence##7##4##(1991-2#1)(1991-8#1)(1993-8#1)(1994-6#1)(1997-8#1)(2008-8#1)(2011-2#1)
depends on the production##2##4##(2008-10#1)(2008-5#1)
depends on the proper identification##2##5##(1991-3#1)(2007-11#1)
depends on the ratio##2##4##(2008-3#1)(2008-5#1)
depends on the regression##2##4##(2008-10#1)(2008-2#1)
depends on the severity##2##4##(2007-11#1)(2013-1#1)
depends on the size and##2##5##(2010-2#1)(2012-2#1)
depends on the size of the##2##6##(1996-3#1)(2007-12#1)
depends on the size of##5##5##(1996-3#1)(2007-12#1)(2008-3#1)(2010-5#1)(2011-2#1)
depends on the size##7##4##(1996-3#1)(2007-12#1)(2008-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
depends on the specific##3##4##(1996-2#1)(2008-11#1)(2008-7#1)
depends on the stage of##3##5##(1993-2#1)(2008-7#1)(2008-8#1)
depends on the state of##2##5##(1994-5#1)(2008-8#1)
depends on the surface##2##4##(2008-10#1)(2008-3#1)
depends on the suspected##2##4##(2007-12#1)(2012-2#1)
depends on the type of##3##5##(1991-11#1)(1997-2#1)(2008-5#1)
depends on the type##4##4##(1991-11#1)(1997-2#1)(2008-5#1)(2008-8#1)
depends on the##205##3##(1990-11#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-2#4)(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2007-11#8)(2007-12#9)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#30)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#17)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#2)
depends on their##5##3##(1990-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)
depends on two##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
depends on whether##3##3##(2008-11#1)(2008-8#1)(2009-7#1)
depends on which##3##3##(1992-12#1)(1997-1#1)(2010-12#1)
depends on##377##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1997-1#3)(1997-2#2)(1997-4#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#19)(2007-12#15)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#54)(2008-11#11)(2008-12#5)(2008-2#15)(2008-3#38)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#18)(2008-8#28)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#5)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#8)(2013-8#5)
depends only on the##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)
depends only on##7##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)
depends only##9##2##(1990-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)
depends predominantly on##2##3##(2008-10#1)(2012-2#1)
depends primarily on the##3##4##(2007-2#1)(2008-7#1)(2012-12#1)
depends sensitively on the##2##4##(2008-10#1)(2008-3#1)
depends significantly on##2##3##(2008-12#1)(2008-3#1)
depends significantly##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)
depends strongly on the##6##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)
depends strongly on##7##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2013-1#1)
depends upon a##3##3##(1996-12#1)(2008-11#1)(2011-1#1)
depends upon its##2##3##(1994-12#1)(2008-10#1)
depends upon the presence of##2##5##(1992-12#1)(2008-8#1)
depends upon the##19##3##(1990-2#2)(1992-12#1)(1994-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)
depends upon##33##2##(1990-2#2)(1990-7#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#2)(2012-1#1)
depends##489##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#7)(1995-3#5)(1995-5#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#1)(1997-1#3)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#21)(2007-12#18)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#79)(2008-11#15)(2008-12#6)(2008-2#22)(2008-3#44)(2008-4#8)(2008-5#14)(2008-6#5)(2008-7#20)(2008-8#31)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#2)(2009-3#5)(2009-5#3)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#19)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#3)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#12)(2013-8#5)
depersonalization##3##1##(2008-10#1)(2008-11#1)(2012-1#1)
dephasing##8##1##(1992-8#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
dephosphorylate##5##1##(1995-3#3)(2008-4#1)(2012-2#1)
dephosphorylated by MBP##2##3##(1993-6#2)
dephosphorylated##15##1##(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#3)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#4)(2013-1#1)
dephosphorylation in the##2##3##(1995-11#1)(2008-4#1)
dephosphorylation in##3##2##(1995-11#1)(1997-6#1)(2008-4#1)
dephosphorylation of MLC20 in##2##4##(1994-11#2)
dephosphorylation of MLC20##3##3##(1994-11#3)
dephosphorylation of Rb##2##3##(1995-2#2)
dephosphorylation of the##3##3##(1992-12#1)(1994-11#1)(1996-2#1)
dephosphorylation of##22##2##(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#6)(1994-6#1)(1995-2#2)(1996-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
dephosphorylation##37##1##(1992-12#2)(1992-9#1)(1993-3#1)(1993-6#2)(1994-11#6)(1994-6#3)(1994-9#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#6)(1997-6#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#2)(2013-8#1)
depict a##2##2##(2008-1#1)(2009-3#1)
depict the##9##2##(1991-1#1)(2008-3#1)(2010-10#1)(2010-12#3)(2012-1#1)(2012-2#1)(2012-3#1)
depict##16##1##(1991-1#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)
depicted a##2##2##(2011-2#1)(2013-1#1)
depicted by##5##2##(2007-10#1)(2008-12#1)(2010-1#1)(2010-12#1)(2012-2#1)
depicted##19##1##(1995-1#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#4)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
depicting the##5##2##(1993-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
depicting##13##1##(1992-6#1)(1993-2#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
depiction of the##3##3##(2008-7#1)(2012-2#2)
depiction of##8##2##(2008-12#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#2)
depictions of##3##2##(2008-4#1)(2012-12#1)(2012-2#1)
depicts summarily##2##2##(1996-4#2)
depicts the##3##2##(1990-11#1)(2008-12#1)(2008-7#1)
depicts##9##1##(1990-11#1)(1993-12#1)(1996-4#2)(2008-12#1)(2008-7#2)(2009-3#1)(2012-2#1)
depigmentation on the##2##3##(2010-6#1)(2013-1#1)
depigmentation##12##1##(1994-12#1)(2007-7#2)(2008-7#1)(2010-6#4)(2011-2#1)(2012-3#2)(2013-1#1)
depigmenting activity##2##2##(2008-5#2)
depigmenting agent##2##2##(2008-5#2)
depigmenting##5##1##(2008-5#5)
depilatory##4##1##(2008-5#4)
deplete the##4##2##(1991-12#1)(1992-12#1)(2008-5#1)(2008-9#1)
deplete##10##1##(1991-12#1)(1992-12#1)(1992-8#1)(1993-12#1)(1995-12#1)(1997-6#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#1)
depleted cells##2##2##(1992-3#1)(2012-12#1)
depleted during##2##2##(2008-4#1)(2010-5#1)
depleted from the##2##3##(2007-12#1)(2008-11#1)
depleted in##5##2##(1990-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)
depleted of##9##2##(1992-10#1)(1993-6#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-4#1)
depleted##50##1##(1990-5#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-3#2)(2010-5#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
depleters##2##1##(2008-10#1)(2010-5#1)
depletes##5##1##(1991-9#1)(1993-12#1)(1997-1#1)(2008-12#1)(2008-8#1)
depleting##7##1##(1992-3#1)(1993-12#1)(1994-11#1)(1996-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
depletion and##12##2##(1990-7#1)(1991-6#1)(1992-11#1)(1992-9#1)(1994-8#2)(1996-1#1)(2007-7#1)(2008-8#2)(2011-1#1)(2011-2#1)
depletion by##4##2##(1993-12#1)(1997-6#1)(2008-7#2)
depletion in the##4##3##(1991-5#1)(2008-10#2)(2008-7#1)
depletion in##12##2##(1990-11#1)(1991-5#1)(1991-9#1)(2008-10#2)(2008-12#1)(2008-7#3)(2008-9#1)(2010-3#1)(2012-2#1)
depletion is##2##2##(1991-6#1)(1996-2#1)
depletion may##2##2##(2009-6#1)(2010-5#1)
depletion of Ca2+ stores##2##4##(2008-8#2)
depletion of cellular##3##3##(1990-11#1)(1992-11#1)(2008-5#1)
depletion of intracellular##2##3##(1992-8#1)(2009-6#1)
depletion of protein##3##3##(1990-12#2)(1992-11#1)
depletion of the##10##3##(1991-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(2007-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-8#1)
depletion of##54##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-8#2)(1993-2#1)(1994-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2009-11#1)(2009-6#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
depletion on the viability of human##2##6##(2008-7#2)
depletion on##6##2##(1997-2#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#1)
depletion or##3##2##(1991-9#1)(1997-7#1)(2008-11#1)
depletion was##2##2##(1991-9#1)(2008-10#1)
depletion##156##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-9#5)(1992-11#4)(1992-3#1)(1992-8#4)(1992-9#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#9)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#22)(2008-8#7)(2008-9#2)(2009-11#2)(2009-6#4)(2009-8#5)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
depletions of##3##2##(1993-12#1)(1994-2#1)(2007-12#1)
depletions##4##1##(1993-12#1)(1994-2#2)(2007-12#1)
deploy##8##1##(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#1)
deployed at the##2##3##(2008-3#2)
deployed at##4##2##(2007-5#1)(2008-11#1)(2008-3#2)
deployed for##2##2##(2007-5#1)(2008-10#1)
deployed in a##3##3##(2008-10#1)(2008-3#2)
deployed in##6##2##(2008-10#3)(2008-3#2)(2009-3#1)
deployed to detect##2##3##(2011-2#1)(2011-3#1)
deployed to##5##2##(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
deployed##33##1##(1995-6#1)(1997-2#1)(2007-5#3)(2008-10#11)(2008-11#3)(2008-3#4)(2008-7#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
deploying##4##1##(1994-2#1)(2008-10#2)(2010-11#1)
deployment and##5##2##(2008-10#2)(2008-7#2)(2012-1#1)
deployment has##2##2##(1994-11#1)(2008-10#1)
deployment in##5##2##(2007-8#1)(2008-10#2)(2011-2#1)(2013-7#1)
deployment of a##2##3##(2008-3#1)(2011-2#1)
deployment of resistance##2##3##(2008-10#1)(2011-2#1)
deployment of resistant cultivars##3##4##(2008-10#3)
deployment of resistant##5##3##(2008-10#5)
deployment of##21##2##(1994-11#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#3)(2013-1#1)
deployment##49##1##(1994-11#2)(1996-3#1)(1997-8#1)(2007-8#2)(2008-10#20)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
deployments in##3##2##(2008-10#2)(2008-7#1)
deployments##6##1##(2008-10#5)(2008-7#1)
depolarisation##4##1##(2008-11#3)(2010-8#1)
depolarization and##5##2##(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)
depolarization in##4##2##(1997-2#1)(2007-11#1)(2008-3#1)(2009-10#1)
depolarization is##3##2##(1993-12#1)(2008-2#1)(2008-3#1)
depolarization lidar##2##2##(2008-3#2)
depolarization loss##3##2##(2007-12#2)(2008-2#1)
depolarization of the##2##3##(1993-11#1)(2008-3#1)
depolarization of##10##2##(1992-6#1)(1993-11#1)(1996-5#1)(2007-11#2)(2008-11#1)(2008-3#4)
depolarization on##2##2##(1997-1#1)(2008-3#1)
depolarization ratio##7##2##(2008-2#2)(2008-3#5)
depolarization spectrum##3##2##(2008-3#3)
depolarization was##2##2##(1994-2#1)(2008-10#1)
depolarization##106##1##(1990-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1994-2#3)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#7)(2007-12#4)(2008-10#6)(2008-11#1)(2008-2#15)(2008-3#34)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#2)
depolarization-induced##4##1##(1991-2#2)(1996-5#2)
depolarizations in##2##2##(1990-5#1)(2008-4#1)
depolarizations were##2##2##(1990-5#1)(1995-12#1)
depolarizations##8##1##(1990-5#2)(1995-12#2)(2008-10#1)(2008-3#1)(2008-4#2)
depolarized DLS##2##2##(2008-2#2)
depolarized light scattering from##2##4##(2008-6#2)
depolarized light##3##2##(2008-2#1)(2008-6#2)
depolarized##14##1##(1990-8#2)(1992-11#1)(1992-6#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-2#4)(2008-6#2)(2008-8#1)
depolarizer##8##1##(2008-10#3)(2008-2#3)(2008-3#2)
depolarizes##2##1##(1990-7#1)(1993-11#1)
depolarizing pulse##2##2##(1991-9#2)
depolarizing##20##1##(1990-7#1)(1991-9#3)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)
depolymerase##3##1##(2008-10#3)
depolymerisation of##2##2##(1993-6#1)(2008-10#1)
depolymerisation##4##1##(1993-6#2)(2008-10#2)
depolymerization of##3##2##(1994-11#1)(2008-11#2)
depolymerization##17##1##(1994-11#1)(1994-6#1)(1997-6#2)(2008-11#3)(2008-6#3)(2009-7#1)(2011-1#1)(2012-12#5)
depolymerized##2##1##(1990-11#1)(2009-12#1)
depolymerizing##2##1##(2008-11#1)(2008-6#1)
depopulated##2##1##(1997-8#2)
depopulation##4##1##(1990-9#1)(2007-6#3)
deported to##2##2##(1993-6#2)
deposit in the##2##3##(1997-1#1)(2007-7#1)
deposit in##4##2##(1997-1#1)(2007-7#1)(2013-1#1)(2013-8#1)
deposit morphology##2##2##(2008-10#2)
deposit of##3##2##(1995-12#1)(2008-10#2)
deposit##27##1##(1994-12#1)(1995-12#2)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#13)(2008-4#1)(2008-5#4)(2008-7#1)(2013-1#1)(2013-8#1)
deposited as a thin##2##4##(2007-12#1)(2008-10#1)
deposited as##6##2##(1992-9#1)(2007-12#1)(2008-10#4)
deposited at the##2##3##(2007-5#1)(2008-10#1)
deposited at##5##2##(2007-5#1)(2008-10#3)(2008-3#1)
deposited by ion##2##3##(2008-3#2)
deposited by the##3##3##(2007-11#1)(2008-12#1)(2008-3#1)
deposited by##19##2##(1992-3#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#10)
deposited directly##2##2##(2008-10#1)(2011-2#1)
deposited in the airways##2##4##(1994-2#1)(1997-1#1)
deposited in the alveolar region##2##5##(1992-12#1)(1995-12#1)
deposited in the##17##3##(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
deposited in##25##2##(1992-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2010-5#1)(2011-2#1)(2013-8#1)
deposited on Si##2##3##(2007-12#1)(2008-2#1)
deposited on a##9##3##(2007-11#1)(2008-10#3)(2008-3#4)(2012-1#1)
deposited on glass##4##3##(2008-10#3)(2008-2#1)
deposited on microscope##2##3##(2008-10#1)(2008-2#1)
deposited on silica##3##3##(2007-11#2)(2008-2#1)
deposited on the electrode##2##4##(2008-10#2)
deposited on the surface of a##2##6##(2008-10#1)(2008-3#1)
deposited on the##16##3##(2008-10#13)(2008-3#2)(2009-5#1)
deposited on top##2##3##(2008-10#1)(2008-3#1)
deposited on transparent##2##3##(2007-12#1)(2008-2#1)
deposited on##59##2##(1996-3#1)(2007-11#3)(2007-12#4)(2008-10#28)(2008-11#1)(2008-2#8)(2008-3#9)(2008-8#1)(2009-11#2)(2009-5#1)(2012-1#1)
deposited onto a##2##3##(2007-12#1)(2008-7#1)
deposited onto glassy carbon##3##4##(2008-10#3)
deposited onto the##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
deposited onto##15##2##(2007-12#1)(2008-10#4)(2008-3#5)(2008-5#1)(2008-7#2)(2009-12#1)(2010-4#1)
deposited to##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
deposited upon glass##2##3##(2007-12#1)(2008-3#1)
deposited upon##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
deposited with##4##2##(1996-9#1)(1997-1#1)(2008-10#2)
deposited within the##2##3##(1997-5#1)(2009-8#1)
deposited##189##1##(1990-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#2)(1996-3#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-5#1)(2007-11#11)(2007-12#9)(2007-5#2)(2008-1#1)(2008-10#71)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#32)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
depositing a##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
depositing##7##1##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)
deposition (CVD)##4##2##(2008-2#1)(2008-3#1)(2008-7#2)
deposition and the##2##3##(2008-7#1)(2009-8#1)
deposition and##16##2##(1993-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-2#2)(2013-8#1)
deposition are##2##2##(1992-3#1)(2008-11#1)
deposition at a##2##3##(2008-10#2)
deposition at##4##2##(2006-6#1)(2008-10#3)
deposition by##2##2##(2008-10#1)(2008-2#1)
deposition chamber##2##2##(2008-3#1)(2008-7#1)
deposition conditions##2##2##(2007-12#1)(2008-3#1)
deposition during##3##2##(2008-10#1)(2008-11#2)
deposition events##2##2##(2008-10#1)(2013-1#1)
deposition in Alzheimer's disease##2##4##(1994-5#1)(1995-12#1)
deposition in the##10##3##(1991-11#1)(1992-2#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)(2011-1#1)
deposition in##22##2##(1991-1#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-5#2)(1995-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)
deposition is##10##2##(1992-3#1)(1997-1#2)(2008-11#1)(2008-3#1)(2010-4#1)(2012-2#2)(2013-1#2)
deposition may##2##2##(1994-6#1)(1997-1#1)
deposition mode##2##2##(1994-12#2)
deposition of Cd##5##3##(1995-3#5)
deposition of CdTe##2##3##(2008-2#2)
deposition of a##4##3##(2008-10#3)(2008-9#1)
deposition of amyloid##4##3##(1991-9#1)(1994-5#1)(1996-5#1)(2008-11#1)
deposition of an##2##3##(2007-12#1)(2008-10#1)
deposition of cadmium##2##3##(2008-10#2)
deposition of copper##2##3##(2008-10#2)
deposition of gold on the##2##5##(2008-10#2)
deposition of hygroscopic##2##3##(1994-12#1)(2013-1#1)
deposition of inhaled##2##3##(1992-3#1)(1994-12#1)
deposition of lignin##2##3##(2008-10#2)
deposition of the##7##3##(1996-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2010-5#1)
deposition of two layers of##2##5##(2008-10#2)
deposition of##91##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#2)(1994-12#3)(1994-5#3)(1995-12#1)(1995-3#6)(1996-12#1)(1996-5#2)(1997-8#1)(2007-12#2)(2007-7#1)(2008-10#36)(2008-11#2)(2008-2#3)(2008-3#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
deposition on a##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
deposition on glass##2##3##(2007-11#1)(2008-10#1)
deposition on the mercury##2##4##(2008-10#2)
deposition on the##4##3##(2008-10#3)(2008-11#1)
deposition on##12##2##(2007-11#1)(2008-10#7)(2008-11#1)(2010-4#2)(2012-2#1)
deposition patterns##5##2##(1994-2#1)(1996-12#1)(2008-10#3)
deposition potential##2##2##(2008-10#2)
deposition process##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#1)
deposition rate##6##2##(2008-10#2)(2008-3#1)(2009-7#2)(2010-4#1)
deposition solutions##3##2##(2008-10#3)
deposition studies##2##2##(1997-1#2)
deposition technique##7##2##(2007-12#2)(2008-10#2)(2008-3#3)
deposition techniques##2##2##(2008-3#2)
deposition temperature##2##2##(2009-11#2)
deposition than##2##2##(1996-12#1)(2008-11#1)
deposition time##7##2##(2008-10#7)
deposition was##5##2##(1994-9#1)(2008-10#3)(2008-2#1)
deposition were##6##2##(1993-2#1)(2008-10#3)(2008-11#1)(2010-4#1)
deposition with##5##2##(2008-11#2)(2008-3#2)(2010-3#1)
deposition within the##2##3##(1996-2#1)(2008-10#1)
deposition##368##1##(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#7)(1992-9#2)(1993-2#3)(1993-8#1)(1994-12#7)(1994-2#1)(1994-3#3)(1994-5#5)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#7)(1996-1#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#6)(1997-8#1)(2006-6#3)(2007-11#5)(2007-12#6)(2007-7#3)(2008-1#1)(2008-10#111)(2008-11#27)(2008-2#16)(2008-3#33)(2008-4#1)(2008-5#3)(2008-7#12)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#7)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2010-3#1)(2010-4#12)(2010-5#6)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)(2013-8#4)
deposition)##4##1##(2008-10#4)
depositions of##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
depositions##11##1##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#4)
depository##3##1##(2010-12#1)(2011-2#1)(2011-3#1)
deposits and##6##2##(1992-6#1)(1996-5#1)(1996-6#1)(2008-10#2)(2012-12#1)
deposits are##2##2##(1994-5#1)(1996-5#1)
deposits in the##3##3##(2008-10#1)(2012-12#2)
deposits in##8##2##(1992-12#1)(1994-11#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-6#1)(2012-12#2)
deposits of Alzheimer's disease##2##4##(1994-11#1)(1996-5#1)
deposits of##8##2##(1994-11#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-7#1)
deposits on the##3##3##(1990-2#1)(2008-10#2)
deposits on##4##2##(1990-2#1)(2008-1#1)(2008-10#2)
deposits were##9##2##(1994-5#2)(1996-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)
deposits##88##1##(1990-2#1)(1991-11#2)(1992-12#1)(1992-6#3)(1994-11#4)(1994-5#8)(1994-6#1)(1994-8#1)(1995-3#3)(1996-5#8)(1996-6#3)(1997-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#1)
depot##6##1##(1990-6#1)(1994-9#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
depots have##2##2##(2012-2#1)(2012-3#1)
depots##5##1##(2008-3#1)(2010-10#1)(2012-2#2)(2012-3#1)
deprenyl##9##1##(1990-12#1)(1994-6#3)(2009-12#5)
depress##3##1##(2008-11#1)(2008-9#1)(2013-8#1)
depressant##5##1##(1995-12#1)(1997-2#2)(2008-12#1)(2008-8#1)
depressed PD patients##2##3##(2008-7#2)
depressed adolescents##9##2##(1993-2#2)(2008-11#5)(2010-2#2)
depressed and##9##2##(1993-3#1)(1993-5#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-2#1)(2010-4#1)
depressed as##2##2##(2008-12#1)(2009-11#1)
depressed by a##2##3##(1993-8#1)(1995-12#1)
depressed by##4##2##(1992-12#1)(1993-8#1)(1995-12#2)
depressed cancer patients##3##3##(2009-11#3)
depressed children and adolescents##2##4##(1991-2#2)
depressed compared with##2##3##(1991-9#1)(2011-2#1)
depressed in patients with##2##4##(1990-11#1)(2007-11#1)
depressed in##6##2##(1990-11#1)(1993-3#1)(1994-5#1)(1996-5#1)(2007-11#1)(2011-1#1)
depressed individuals##2##2##(2008-6#1)(2012-12#1)
depressed mood##4##2##(2008-12#3)(2009-11#1)
depressed patients and healthy##2##4##(1996-7#1)(2011-2#1)
depressed patients are##2##3##(1995-5#1)(2008-11#1)
depressed patients##18##2##(1995-5#1)(1996-5#3)(1996-7#5)(1997-6#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-7#2)(2011-2#1)(2012-3#1)
depressed risers##2##2##(2010-4#2)
depressed stables##2##2##(2010-4#2)
depressed the##5##2##(1992-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-9#1)
depressed women##2##2##(2008-12#1)(2011-2#1)
depressed##133##1##(1990-11#2)(1990-12#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#4)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#9)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#8)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#1)(2009-11#5)(2009-7#2)(2010-2#5)(2010-4#8)(2010-7#2)(2011-1#2)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#2)
depresses##4##1##(1990-3#1)(1992-3#1)(1995-12#1)(2008-8#1)
depression (PPD)##2##2##(2007-2#1)(2013-1#1)
depression after##3##2##(1992-5#1)(2007-10#1)(2009-5#1)
depression also##2##2##(1997-7#1)(2006-10#1)
depression among the elderly##2##4##(2006-10#1)(2012-1#1)
depression among##8##2##(2006-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
depression and anxiety##7##3##(2007-6#1)(2008-11#2)(2008-7#1)(2009-5#1)(2010-8#1)(2013-7#1)
depression and bipolar##3##3##(2008-6#1)(2008-7#2)
depression and delinquency##2##3##(2012-12#2)
depression and emotional##2##3##(2008-11#1)(2013-1#1)
depression and hostility##3##3##(2008-4#3)
depression and should be considered##2##5##(1993-1#1)(2008-11#1)
depression and the##7##3##(1990-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-7#1)
depression and##72##2##(1990-3#1)(1991-1#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-6#2)(1996-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#8)(2008-12#4)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2011-3#2)(2012-12#4)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#1)
depression are also##2##3##(2007-10#1)(2008-2#1)
depression are##6##2##(1992-8#1)(2007-10#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
depression as a##2##3##(2008-8#1)(2011-10#1)
depression as##4##2##(1994-8#1)(2008-1#1)(2008-8#1)(2011-10#1)
depression at##5##2##(1997-7#2)(2007-10#1)(2007-11#1)(2008-8#1)
depression both##2##2##(1996-5#1)(2006-10#1)
depression but##4##2##(2006-10#1)(2009-8#1)(2010-10#1)(2010-2#1)
depression care##5##2##(2012-2#5)
depression criteria##2##2##(2013-1#2)
depression for patients##2##3##(2009-3#1)(2013-1#1)
depression for##4##2##(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
depression group##4##2##(2010-5#1)(2011-2#3)
depression has##3##2##(2009-12#1)(2010-10#1)(2013-1#1)
depression in Parkinson's disease##3##4##(2008-6#1)(2008-7#1)(2012-12#1)
depression in both##2##3##(2008-12#1)(2008-7#1)
depression in mothers##4##3##(2011-2#4)
depression in the##4##3##(2008-10#1)(2008-4#1)(2009-8#1)(2012-1#1)
depression in##36##2##(1992-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
depression increases##2##2##(2008-8#1)(2013-1#1)
depression is a##2##3##(2008-10#1)(2008-7#1)
depression is associated with increased##3##5##(2008-11#1)(2010-12#1)(2012-12#1)
depression is associated with##4##4##(2008-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
depression is##15##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#3)(2010-12#1)(2012-12#2)(2013-1#1)
depression may be##2##3##(1996-7#1)(2007-10#1)
depression may##5##2##(1996-7#1)(2007-10#1)(2008-4#1)(2008-6#1)(2010-12#1)
depression model##4##2##(1995-5#1)(2013-1#2)(2013-8#1)
depression of cardiac contractility induced by##2##6##(2008-9#2)
depression of synaptic transmission##4##4##(1995-12#3)(2008-5#1)
depression of the field##2##4##(1991-12#1)(1995-12#1)
depression of the##10##3##(1991-12#1)(1992-8#1)(1995-12#3)(2007-12#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
depression of##30##2##(1991-12#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#6)(1996-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
depression on##5##2##(2008-1#2)(2008-10#2)(2008-9#1)
depression or##6##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-3#1)(2010-7#1)
depression over##2##2##(2008-9#1)(2010-1#1)
depression scale##3##2##(2008-7#1)(2010-1#1)(2013-1#1)
depression scores and##2##3##(2008-4#1)(2011-2#1)
depression scores##8##2##(1996-7#1)(2008-12#2)(2008-4#1)(2010-7#1)(2011-2#2)(2012-12#1)
depression to##3##2##(1997-7#2)(2012-12#1)
depression was##9##2##(2006-10#3)(2008-10#2)(2010-2#1)(2010-7#1)(2013-1#2)
depression were observed##2##3##(1991-1#1)(2008-8#1)
depression were##8##2##(1991-1#1)(1993-12#1)(1996-2#1)(2007-7#1)(2008-12#1)(2008-8#1)(2012-1#2)
depression with##7##2##(1992-9#1)(2008-7#2)(2008-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
depression##564##1##(1990-3#2)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#6)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#11)(1995-2#3)(1995-3#1)(1995-5#5)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#20)(1997-3#1)(1997-6#2)(1997-7#7)(1997-8#1)(2006-10#7)(2007-1#1)(2007-10#16)(2007-11#1)(2007-12#7)(2007-2#2)(2007-5#1)(2007-6#3)(2007-7#2)(2008-1#15)(2008-10#9)(2008-11#23)(2008-12#16)(2008-2#10)(2008-3#2)(2008-4#19)(2008-5#5)(2008-6#22)(2008-7#39)(2008-8#17)(2008-9#11)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#6)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#8)(2010-10#2)(2010-12#3)(2010-2#9)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#10)(2010-8#5)(2011-1#4)(2011-10#2)(2011-2#28)(2011-3#2)(2012-1#7)(2012-12#21)(2012-2#22)(2012-3#6)(2013-1#45)(2013-7#3)(2013-8#16)
depression)##3##1##(2008-4#1)(2008-7#1)(2009-5#1)
depression?##2##1##(2008-6#1)(2013-8#1)
depression]##9##1##(1992-11#1)(1997-3#2)(1997-8#1)(2011-3#2)(2012-12#1)(2013-1#1)(2013-8#1)
depressions##6##1##(1991-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-3#1)(2013-8#1)
depressive and anxious state##3##4##(2007-6#3)
depressive and anxious##4##3##(1992-2#1)(2007-6#3)
depressive and##6##2##(1992-2#1)(2007-6#3)(2008-7#1)(2009-10#1)
depressive disorder##24##2##(1994-2#1)(1995-6#1)(1996-7#3)(2008-4#2)(2009-8#1)(2009-9#2)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
depressive disorders and##2##3##(2009-10#1)(2012-12#1)
depressive disorders##6##2##(2008-10#1)(2009-10#3)(2010-5#1)(2012-12#1)
depressive episodes##4##2##(1995-5#1)(2010-6#2)(2012-12#1)
depressive illness##4##2##(2006-10#1)(2008-1#1)(2008-7#1)(2010-12#1)
depressive mood##4##2##(1995-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
depressive or##2##2##(1992-2#1)(2010-5#1)
depressive phenomena##2##2##(2010-4#2)
depressive state##2##2##(2008-9#1)(2013-1#1)
depressive symptomatology##7##2##(2008-7#2)(2009-5#1)(2010-4#3)(2013-8#1)
depressive symptoms and risky##2##4##(2009-7#1)(2013-1#1)
depressive symptoms and well-being##3##4##(2009-11#3)
depressive symptoms and##13##3##(2009-11#3)(2009-5#2)(2009-7#4)(2010-10#1)(2010-4#1)(2013-1#2)
depressive symptoms in##9##3##(2008-8#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#5)
depressive symptoms than##2##3##(2009-7#1)(2011-2#1)
depressive symptoms were present in##2##5##(2013-1#2)
depressive symptoms were##4##3##(2009-10#1)(2009-9#1)(2013-1#2)
depressive symptoms##79##2##(1994-2#3)(2007-12#2)(2008-11#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#3)(2009-5#8)(2009-7#9)(2009-9#8)(2010-1#2)(2010-10#4)(2010-4#7)(2010-8#4)(2011-1#1)(2011-2#1)(2013-1#10)(2013-8#9)
depressive syndrome##2##2##(1991-11#1)(2013-8#1)
depressive temperament##2##2##(2013-8#2)
depressive##170##1##(1991-11#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-12#1)(1994-2#4)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-5#1)(1996-7#3)(1997-5#1)(2006-10#1)(2007-12#2)(2007-6#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#6)(2009-11#3)(2009-5#9)(2009-7#11)(2009-8#1)(2009-9#10)(2010-1#2)(2010-10#4)(2010-12#1)(2010-2#1)(2010-4#12)(2010-5#3)(2010-6#4)(2010-8#4)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#18)
depressive-like##3##1##(2013-1#2)(2013-8#1)
depressor response##2##2##(1991-5#1)(2008-11#1)
depressor##6##1##(1991-5#2)(1996-5#2)(2008-11#1)(2008-9#1)
deprivation and##9##2##(1994-1#1)(1994-2#2)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2013-8#1)
deprivation for##2##2##(2008-1#1)(2008-7#1)
deprivation is##2##2##(1991-1#1)(1995-12#1)
deprivation of##12##2##(1992-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)
deprivation on##3##2##(1991-1#1)(2011-2#1)(2012-2#1)
deprivation or##3##2##(1996-6#2)(2011-1#1)
deprivation resulted in##2##3##(1990-12#1)(1997-2#1)
deprivation therapy##4##2##(2008-7#3)(2012-3#1)
deprivation##82##1##(1990-12#2)(1991-1#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-8#2)(1995-12#2)(1995-5#1)(1996-6#2)(1997-2#5)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-4#2)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-6#1)(2010-9#3)(2011-1#8)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
deprived of L-arginine or##2##4##(1990-12#2)
deprived of L-arginine##4##3##(1990-12#4)
deprived of##12##2##(1990-12#6)(1992-3#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2010-4#1)
deprived##20##1##(1990-12#6)(1992-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#2)
deprotection and##4##2##(1996-5#1)(2007-11#1)(2008-4#1)(2009-9#1)
deprotection of the##3##3##(1992-12#1)(2008-2#1)(2009-12#1)
deprotection of##4##2##(1992-12#1)(2008-2#1)(2008-4#1)(2009-12#1)
deprotection##19##1##(1992-12#1)(1996-5#4)(2007-11#1)(2008-2#2)(2008-4#8)(2008-8#1)(2009-12#1)(2009-9#1)
deproteinized##5##1##(1990-8#1)(2008-10#3)(2008-12#1)
deprotonated##9##1##(1990-5#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-7#1)(2008-10#2)(2008-4#1)
deprotonation of the##6##3##(1990-5#1)(1995-5#1)(2008-10#3)(2011-1#1)
deprotonation of##7##2##(1990-5#1)(1995-5#1)(2008-10#4)(2011-1#1)
deprotonation##12##1##(1990-5#2)(1995-5#1)(2008-10#7)(2009-8#1)(2011-1#1)
depth (6##2##2##(2011-2#2)
depth (PD)##4##2##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
depth analysis and partial least square regression##2##7##(2013-8#2)
depth analysis and##5##3##(2013-8#5)
depth analysis##7##2##(2008-5#1)(2013-8#6)
depth and a##2##3##(2008-10#1)(2008-3#1)
depth and##25##2##(1993-1#1)(1993-12#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
depth are##2##2##(2008-1#1)(2008-2#1)
depth as##4##2##(2008-3#3)(2009-5#1)
depth at which the##2##4##(2008-3#2)
depth at##3##2##(2008-3#2)(2013-1#1)
depth between##2##2##(2008-3#2)
depth can be##2##3##(2008-2#1)(2008-3#1)
depth can##3##2##(2008-2#2)(2008-3#1)
depth compensation##3##2##(2011-1#3)
depth discrimination##3##2##(1990-8#1)(2007-12#1)(2008-3#1)
depth distribution##2##2##(2008-10#1)(2013-8#1)
depth dose curves##2##3##(2008-3#2)
depth dose##4##2##(2008-3#2)(2009-11#1)(2010-11#1)
depth for the##3##3##(2008-3#2)(2011-1#1)
depth for##7##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-1#1)
depth gradient##3##2##(2011-2#3)
depth imaging optical coherence tomography##3##5##(2011-7#2)(2013-1#1)
depth in a##2##3##(2008-3#1)(2008-7#1)
depth in the##2##3##(2008-2#1)(2008-3#1)
depth in##8##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)
depth information##4##2##(1990-8#1)(2007-11#1)(2008-3#1)(2013-8#1)
depth into the##2##3##(2007-12#1)(2008-10#1)
depth is limited by the##2##5##(2008-2#2)
depth is##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
depth localization and quantitative recovery##2##5##(2011-1#2)
depth localization and##4##3##(2011-1#4)
depth localization##5##2##(2011-1#5)
depth measurements##2##2##(2007-12#1)(2011-2#1)
depth of anesthesia##3##3##(2010-8#2)(2011-1#1)
depth of field and##2##4##(2008-3#1)(2012-2#1)
depth of field##9##3##(2007-11#1)(2008-10#1)(2008-3#6)(2012-2#1)
depth of focus of##2##4##(2008-3#2)
depth of focus##8##3##(2008-2#1)(2008-3#7)
depth of insertion##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
depth of invasion##3##3##(1990-9#1)(1994-9#1)(2008-5#1)
depth of myometrial##2##3##(1993-1#1)(1994-9#1)
depth of penetration##3##3##(2007-4#1)(2008-1#1)(2013-1#1)
depth of polishing##2##3##(2008-2#2)
depth of the groove##2##4##(2008-3#1)(2008-8#1)
depth of the##26##3##(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#11)(2008-5#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
depth of wear##3##3##(2008-8#3)
depth of##112##2##(1990-11#1)(1990-9#2)(1992-8#1)(1992-9#1)(1993-1#3)(1994-9#3)(1995-2#1)(1996-2#2)(1996-4#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#35)(2008-5#4)(2008-8#4)(2008-9#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#3)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#2)
depth profile##7##2##(2007-12#1)(2008-3#5)(2009-10#1)
depth profiles of##4##3##(2008-10#2)(2008-2#2)
depth profiles##9##2##(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2009-10#1)
depth profiling##3##2##(2008-10#1)(2009-10#1)(2009-2#1)
depth range of##2##3##(2008-3#2)
depth range##7##2##(2007-11#2)(2008-3#4)(2008-5#1)
depth relief##2##2##(2008-10#2)
depth resolution and##2##3##(2007-11#1)(2007-12#1)
depth resolution is##2##3##(2008-3#2)
depth resolution of 0##3##4##(2007-12#1)(2008-3#2)
depth resolution of a##2##4##(2007-11#1)(2008-3#1)
depth resolution of##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
depth resolution##17##2##(2007-11#3)(2007-12#7)(2008-3#7)
depth scanning##3##2##(2007-12#1)(2008-3#2)
depth steps##3##2##(2008-3#3)
depth than##2##2##(2008-3#1)(2012-2#1)
depth to##3##2##(2008-12#2)(2008-3#1)
depth values##3##2##(2008-3#3)
depth was##5##2##(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
depth were##2##2##(2008-10#1)(2010-8#1)
depth where##2##2##(2008-10#1)(2008-3#1)
depth with the##2##3##(2008-2#1)(2008-5#1)
depth with##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)
depth##455##1##(1990-11#1)(1990-8#2)(1990-9#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#2)(1994-2#1)(1994-9#3)(1995-2#1)(1996-2#5)(1996-4#1)(2007-11#13)(2007-12#31)(2007-4#1)(2007-5#3)(2008-1#3)(2008-10#42)(2008-11#11)(2008-12#12)(2008-2#50)(2008-3#129)(2008-5#19)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#2)(2009-5#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#4)(2011-1#17)(2011-2#16)(2011-7#2)(2012-12#2)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#13)(2013-7#4)(2013-8#14)
depth)##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
depth-compensated reconstruction##2##2##(2011-1#2)
depth-dependent##3##1##(2007-11#1)(2009-12#2)
depth-graded##2##1##(2008-2#1)(2008-3#1)
depth-resolved birefringence measurements of the human retinal nerve fiber layer##2##10##(2007-11#2)
depth-resolved##7##1##(2007-11#2)(2007-12#1)(2008-3#1)(2011-1#3)
depth-selected Raman measurements of epithelial tissue##3##6##(2011-1#3)
depth-selected##4##1##(2011-1#4)
depths and##8##2##(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2010-8#1)
depths at which the##2##4##(2008-3#2)
depths at##3##2##(2008-2#1)(2008-3#2)
depths from##2##2##(2008-3#2)
depths in##2##2##(2008-2#1)(2008-3#1)
depths of 0 to 60 cm than##2##7##(2008-10#2)
depths of 0 to##3##4##(2008-10#3)
depths of 3##2##3##(2007-11#1)(2007-5#1)
depths of 60 to 120 cm##2##6##(2008-10#2)
depths of the##2##3##(2008-10#1)(2008-3#1)
depths of##19##2##(1990-8#1)(1995-6#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#5)(2012-2#1)(2013-8#1)
depths ranging from##3##3##(2007-5#1)(2008-3#2)
depths were##2##2##(2008-10#1)(2008-3#1)
depths##78##1##(1990-8#1)(1992-3#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-10#18)(2008-12#2)(2008-2#11)(2008-3#29)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
depuis##4##1##(2008-5#3)(2013-1#1)
depurinating##2##1##(1992-3#1)(2008-10#1)
depurination of##3##2##(2008-10#3)
depurination##5##1##(1994-5#1)(2008-10#4)
dequalinium chloride##2##2##(2008-10#2)
dequalinium##3##1##(2008-10#3)
dequeened colony##3##2##(2008-6#3)
der Waals forces and##2##4##(2007-11#1)(2009-11#1)
der Waals##26##2##(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(2007-11#6)(2008-10#4)(2008-3#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#3)
der##33##1##(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-3#1)(2007-11#6)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2013-1#3)
deranged##4##1##(1994-11#1)(2010-11#1)(2012-1#1)(2013-1#1)
derangement of##2##2##(2007-7#1)(2008-10#1)
derangement##3##1##(2007-7#1)(2008-10#1)(2008-6#1)
derangements in##2##2##(2008-11#1)(2011-2#1)
derangements##10##1##(1990-2#1)(1990-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2010-8#1)(2011-2#1)(2012-12#1)
deregulated expression of##3##3##(1991-12#1)(1994-11#1)(2011-2#1)
deregulated##9##1##(1991-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-2#1)
deregulation of##6##2##(2008-8#1)(2009-4#1)(2009-5#1)(2011-2#2)(2012-12#1)
deregulation##10##1##(2008-7#1)(2008-8#2)(2009-4#3)(2009-5#1)(2011-2#2)(2012-12#1)
derepressed##6##1##(1990-5#1)(1995-8#1)(1996-10#1)(1997-2#1)(2008-6#2)
derepression of##2##2##(2011-2#2)
derepression##8##1##(1995-8#1)(1996-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#3)
derivate##2##1##(2007-11#1)(2011-2#1)
derivates##4##1##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
derivation and##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
derivation for##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
derivation from##2##2##(2007-12#1)(2008-9#1)
derivation is##2##2##(2008-3#2)
derivation of a##4##3##(1995-9#1)(2008-11#1)(2008-3#2)
derivation of the##12##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)
derivation of this##2##3##(2008-3#2)
derivation of##32##2##(1995-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2012-4#1)
derivation##61##1##(1990-9#2)(1992-9#1)(1995-9#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#4)(2012-4#1)
derivations for##3##2##(1990-6#1)(2008-2#2)
derivations##5##1##(1990-6#1)(1990-9#1)(2008-2#2)(2008-3#1)
derivatisation of##2##2##(1996-5#1)(2008-10#1)
derivatisation reaction##3##2##(2008-10#3)
derivatisation##16##1##(1990-12#1)(1994-9#1)(1996-5#1)(2008-10#12)(2013-1#1)
derivatised carbon##2##2##(2008-10#2)
derivatised##3##1##(2008-10#3)
derivatising##2##1##(2008-10#2)
derivative (HpD)##2##2##(1990-6#1)(2008-7#1)
derivative and##10##2##(1993-11#1)(1994-8#1)(2008-10#5)(2008-2#1)(2012-3#1)(2013-8#1)
derivative as well as##2##4##(1992-9#1)(2007-1#1)
derivative as##3##2##(1992-9#1)(2007-1#1)(2009-2#1)
derivative at##3##2##(1992-8#1)(2008-10#2)
derivative by##3##2##(1990-12#1)(2008-10#1)(2010-7#1)
derivative can##2##2##(2006-12#1)(2008-10#1)
derivative containing the##2##3##(1991-9#1)(1992-12#1)
derivative containing##4##2##(1991-9#1)(1992-12#1)(2008-10#1)(2008-6#1)
derivative could be##2##3##(2008-10#1)(2011-1#1)
derivative fluorescence##3##2##(2008-10#3)
derivative for##4##2##(2008-10#3)(2008-2#1)
derivative formed##3##2##(1991-3#1)(2008-10#1)(2008-11#1)
derivative from##6##2##(1992-6#1)(2008-10#3)(2008-5#1)(2011-3#1)
derivative has##2##2##(1995-6#1)(2008-10#1)
derivative in the##2##3##(1991-12#1)(2008-10#1)
derivative in##4##2##(1991-12#1)(2008-10#2)(2008-8#1)
derivative information##2##2##(2007-12#2)
derivative is##6##2##(1992-4#1)(1993-6#1)(2007-11#1)(2008-10#2)(2011-2#1)
derivative linear##2##2##(2008-10#2)
derivative of a##5##3##(1996-2#1)(1997-2#1)(2008-11#1)(2009-2#1)(2011-1#1)
derivative of heparin##2##3##(1997-1#2)
derivative of the##14##3##(1990-11#1)(1991-5#1)(1992-6#1)(1996-9#1)(2008-10#5)(2008-2#1)(2008-3#4)
derivative of##60##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-6#4)(1992-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2013-1#1)
derivative or##2##2##(1992-12#1)(2008-10#1)
derivative ratio methods##2##3##(2008-10#2)
derivative ratio##3##2##(2008-10#3)
derivative reduction##2##2##(2008-10#2)
derivative signals##2##2##(2008-10#2)
derivative spectra is##2##3##(2008-10#2)
derivative spectra of##4##3##(2008-10#4)
derivative spectra were##2##3##(2008-10#2)
derivative spectra##15##2##(2008-10#13)(2008-12#2)
derivative spectral##2##2##(2008-10#2)
derivative spectrophotometric determination of##6##4##(2008-10#6)
derivative spectrophotometric method for##2##4##(2008-10#2)
derivative spectrophotometric method using##2##4##(2008-10#2)
derivative spectrophotometric method##8##3##(2008-10#8)
derivative spectrophotometric##19##2##(2008-10#19)
derivative spectrophotometry has##2##3##(2008-10#2)
derivative spectrophotometry in##3##3##(2008-10#3)
derivative spectrophotometry using##2##3##(2008-10#2)
derivative spectrophotometry##27##2##(2008-10#27)
derivative spectroscopy##5##2##(2007-12#1)(2008-10#3)(2010-5#1)
derivative synchronous##2##2##(2008-10#2)
derivative that##4##2##(1993-12#1)(2008-10#2)(2008-3#1)
derivative to be##2##3##(2008-3#1)(2010-2#1)
derivative to the##2##3##(2008-10#2)
derivative to##7##2##(2008-10#4)(2008-3#1)(2009-5#1)(2010-2#1)
derivative was then##2##3##(1997-2#1)(2008-10#1)
derivative was##12##2##(1990-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#6)(2009-9#1)(2011-1#1)
derivative were##3##2##(2007-1#1)(2008-10#1)(2008-5#1)
derivative which##3##2##(1996-5#1)(2008-10#2)
derivative with##7##2##(1992-8#1)(1995-5#1)(2008-10#3)(2008-7#1)(2010-12#1)
derivative##417##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-12#9)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#8)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#3)(1993-5#2)(1993-6#3)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#4)(1996-5#6)(1996-9#1)(1997-1#3)(1997-2#3)(1997-7#2)(2006-12#1)(2007-1#2)(2007-11#8)(2007-12#6)(2008-10#223)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#6)(2013-8#1)
derivative)##4##1##(1993-6#1)(2008-10#1)(2009-11#2)
derivatives (e##2##2##(2008-10#1)(2008-11#1)
derivatives against##2##2##(2011-2#1)(2013-8#1)
derivatives and evaluation of##2##4##(2008-10#1)(2011-2#1)
derivatives and reaction##2##3##(1996-5#1)(2013-1#1)
derivatives and the##3##3##(1997-2#1)(2008-10#2)
derivatives and##14##2##(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-5#2)(2011-2#1)(2013-1#1)
derivatives are also##2##3##(1993-11#1)(2012-12#1)
derivatives are potent inhibitors of##2##5##(1992-12#1)(1994-11#1)
derivatives are##25##2##(1991-11#1)(1991-12#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-9#2)(1995-5#1)(1996-5#1)(2007-11#2)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
derivatives as neutral ionophores##3##4##(2008-10#3)
derivatives as potent##2##3##(1995-3#1)(2012-3#1)
derivatives as##21##2##(1992-12#1)(1993-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#1)
derivatives at the##2##3##(2008-10#1)(2008-4#1)
derivatives based on##2##3##(2008-10#1)(2008-4#1)
derivatives bearing##2##2##(2007-11#1)(2008-4#1)
derivatives by a##2##3##(2008-10#2)
derivatives by high-performance liquid chromatography##2##5##(2008-10#2)
derivatives by##13##2##(1990-8#1)(1994-9#1)(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)
derivatives can be##3##3##(1994-12#1)(2008-10#2)
derivatives can##6##2##(1992-9#1)(1994-12#1)(2008-10#3)(2008-11#1)
derivatives exhibited##2##2##(2008-10#1)(2010-3#1)
derivatives for the##2##3##(2008-10#1)(2012-2#1)
derivatives for##5##2##(1992-4#1)(2008-10#2)(2008-11#1)(2012-2#1)
derivatives from the##2##3##(1992-8#1)(2008-11#1)
derivatives from##8##2##(1992-12#1)(1992-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)
derivatives have been##6##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
derivatives in pharmaceutical preparations##3##4##(2008-10#3)
derivatives in pharmaceutical##4##3##(2008-10#4)
derivatives in the presence of##2##5##(2008-10#2)
derivatives in the##4##3##(1992-10#1)(2008-10#2)(2012-3#1)
derivatives in##32##2##(1992-10#2)(1994-9#1)(2007-11#2)(2008-10#22)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
derivatives involving##2##2##(1997-4#1)(1997-7#1)
derivatives is described##2##3##(1997-3#1)(2008-4#1)
derivatives is##9##2##(1991-9#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)
derivatives obtained##2##2##(2007-11#1)(2008-10#1)
derivatives of 1##2##3##(1995-3#1)(2012-2#1)
derivatives of a##3##3##(1995-3#1)(1995-6#1)(2012-3#1)
derivatives of all##2##3##(1991-5#1)(2008-11#1)
derivatives of amino##2##3##(1997-3#1)(2008-10#1)
derivatives of caffeic acid##2##4##(2013-1#2)
derivatives of fatty acids##2##4##(1990-8#1)(2008-10#1)
derivatives of quercetin and##2##4##(2008-10#1)(2008-5#1)
derivatives of the three##2##4##(2008-12#1)(2008-9#1)
derivatives of the##18##3##(1990-2#1)(1990-8#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-8#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
derivatives of this##2##3##(1995-2#1)(2012-3#1)
derivatives of##88##2##(1990-11#1)(1990-2#1)(1990-8#3)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#4)(1992-6#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#5)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#3)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#2)
derivatives on human##2##3##(2008-11#1)(2012-2#1)
derivatives on the##4##3##(1993-8#1)(1996-5#1)(2008-10#1)(2011-2#1)
derivatives on##12##2##(1993-6#1)(1993-8#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
derivatives showed##5##2##(1990-8#1)(2007-11#1)(2008-10#2)(2008-4#1)
derivatives structurally related to 1-methyl-4-phenyl-1##2##5##(1995-5#2)
derivatives substituted##2##2##(2008-10#1)(2008-4#1)
derivatives such as##5##3##(1990-11#1)(1991-12#1)(2008-11#1)(2008-5#1)(2012-3#1)
derivatives that##4##2##(1995-3#1)(2008-3#1)(2008-4#2)
derivatives to be used##2##4##(1993-12#1)(2008-10#1)
derivatives to##3##2##(1993-12#1)(2008-10#2)
derivatives using##7##2##(2007-11#1)(2008-10#4)(2009-8#1)(2010-5#1)
derivatives via##2##2##(1990-2#1)(2009-12#1)
derivatives was synthesized##2##3##(1992-8#1)(2008-12#1)
derivatives was##10##2##(1992-10#1)(1992-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-3#2)
derivatives were constructed##2##3##(1990-5#1)(2008-11#1)
derivatives were designed and synthesized##2##5##(2008-10#1)(2011-3#1)
derivatives were designed and##3##4##(2008-10#1)(2011-3#1)(2012-1#1)
derivatives were determined##2##3##(1997-2#1)(2008-10#1)
derivatives were not##2##3##(2008-10#1)(2011-2#1)
derivatives were prepared##4##3##(1992-12#1)(1995-3#1)(2008-10#1)(2008-9#1)
derivatives were synthesized and evaluated##2##5##(1993-1#1)(2007-11#1)
derivatives were synthesized and##3##4##(1993-1#1)(2007-11#1)(2011-1#1)
derivatives were synthesized##6##3##(1993-1#1)(1993-8#1)(2007-11#1)(2008-5#1)(2011-1#2)
derivatives were##43##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#2)(1994-5#1)(1995-3#1)(1997-2#2)(2007-11#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-1#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
derivatives which##2##2##(1991-12#1)(1995-3#1)
derivatives with the##2##3##(1995-11#2)
derivatives with##16##2##(1993-11#1)(1994-5#1)(1994-9#2)(1995-11#2)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2011-3#1)
derivatives##621##1##(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#7)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#4)(1992-10#3)(1992-12#15)(1992-4#1)(1992-6#2)(1992-8#8)(1992-9#3)(1993-1#4)(1993-11#7)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#8)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#6)(1994-8#2)(1994-9#8)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#11)(1995-5#11)(1995-6#4)(1995-8#2)(1996-2#4)(1996-5#11)(1996-7#1)(1997-2#5)(1997-3#6)(1997-4#1)(1997-7#3)(2006-6#1)(2007-11#42)(2007-12#13)(2007-5#1)(2008-1#2)(2008-10#182)(2008-11#36)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#19)(2008-5#29)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#9)(2009-10#2)(2009-12#3)(2009-3#3)(2009-5#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#6)(2011-2#12)(2011-3#5)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#12)(2013-1#8)(2013-8#2)
derivatives)##2##1##(1996-5#1)(2008-7#1)
derivatives]##3##1##(1993-11#1)(2011-3#2)
derivatization after reduction of##2##4##(2008-10#2)
derivatization and##8##2##(1993-9#1)(1995-2#1)(2008-10#5)(2008-5#1)
derivatization by##5##2##(1991-5#1)(2008-10#4)
derivatization conditions##2##2##(2008-10#2)
derivatization coupled##2##2##(2008-10#2)
derivatization has been##2##3##(2008-10#2)
derivatization is##2##2##(2008-10#2)
derivatization method##5##2##(2008-10#4)(2011-1#1)
derivatization methods##3##2##(2008-10#3)
derivatization of the##3##3##(2008-10#3)
derivatization of##19##2##(1990-8#1)(1997-2#1)(2008-10#16)(2008-4#1)
derivatization procedure##5##2##(1991-5#1)(2008-10#4)
derivatization procedures##3##2##(2008-10#3)
derivatization processes##2##2##(2008-10#2)
derivatization reaction##8##2##(2008-10#8)
derivatization reactions##2##2##(2008-10#2)
derivatization reagent##8##2##(2008-10#7)(2011-1#1)
derivatization reagents for##2##3##(2008-10#1)(2008-11#1)
derivatization reagents##5##2##(2008-10#4)(2008-11#1)
derivatization step##2##2##(1993-9#1)(2008-10#1)
derivatization was##3##2##(1995-2#1)(2008-10#2)
derivatization with (S)-(-)-alpha-methylbenzyl isocyanate##2##4##(2008-11#2)
derivatization with monodansylcadaverine##2##3##(1990-8#2)
derivatization with thiols##2##3##(2008-11#2)
derivatization with##25##2##(1990-8#3)(1991-12#2)(1991-5#1)(1993-2#1)(1994-9#1)(1996-5#1)(2008-10#9)(2008-11#5)(2008-5#1)(2011-1#1)
derivatization##159##1##(1990-8#9)(1991-12#2)(1991-5#4)(1993-2#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-2#2)(1996-5#1)(1997-2#1)(2008-10#123)(2008-11#6)(2008-4#1)(2008-5#2)(2011-1#3)
derivatizations##3##1##(1990-8#2)(1995-2#1)
derivatized denatured proteins##2##3##(2008-10#2)
derivatized with##16##2##(1990-2#1)(1990-8#4)(1993-9#1)(1995-2#1)(1997-2#1)(2008-10#7)(2008-11#1)
derivatized##39##1##(1990-2#1)(1990-5#1)(1990-8#6)(1992-6#1)(1992-8#2)(1993-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-3#1)(2012-1#1)
derivatizing agent##3##2##(2008-10#3)
derivatizing reagent##8##2##(1995-6#1)(2008-10#7)
derivatizing##13##1##(1995-6#1)(2008-10#11)(2008-4#1)
derive a general##2##3##(2008-2#1)(2008-3#1)
derive a method##2##3##(2008-10#1)(2008-3#1)
derive a model##2##3##(2007-11#1)(2008-9#1)
derive a reciprocity##2##3##(2007-12#1)(2008-3#1)
derive a set of##2##4##(2008-3#2)
derive a simple##2##3##(2008-10#1)(2008-8#1)
derive a##35##2##(1992-12#1)(1992-3#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-2#3)(2008-3#8)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2011-3#1)
derive an##8##2##(2007-11#2)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-3#1)
derive analytical expressions for the##2##5##(2008-2#1)(2008-8#1)
derive and##2##2##(2008-2#2)
derive explicit##3##2##(1995-5#1)(1997-7#1)(2008-3#1)
derive from the##4##3##(1992-3#1)(1993-12#1)(2012-12#1)(2013-1#1)
derive from##13##2##(1990-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
derive general##3##2##(2007-11#1)(2008-5#1)(2008-9#1)
derive its##2##2##(2008-2#1)(2010-3#1)
derive the maximum##2##3##(1992-9#1)(2012-1#1)
derive the##37##2##(1992-9#1)(1995-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-8#2)
derive##162##1##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-11#7)(2007-12#11)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#22)(2008-3#33)(2008-5#3)(2008-7#4)(2008-8#12)(2008-9#4)(2009-3#1)(2009-5#3)(2009-9#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
derived a##5##2##(1995-8#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
derived alleles##2##2##(2012-3#2)
derived amino acid sequence##4##4##(1990-8#1)(1993-3#1)(1994-8#1)(1996-3#1)
derived amino acid##5##3##(1990-8#1)(1991-9#1)(1993-3#1)(1994-8#1)(1996-3#1)
derived analytically##3##2##(2008-2#1)(2008-3#2)
derived and verified##2##3##(2007-12#1)(2008-3#1)
derived and##14##2##(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#6)(2010-7#1)
derived as##3##2##(1995-9#1)(2008-2#2)
derived based on##2##3##(1997-5#1)(2013-1#1)
derived by means of##2##4##(2007-12#1)(2008-3#1)
derived by proteolytic##2##3##(1992-12#1)(1994-12#1)
derived by the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
derived by use of a##2##5##(2007-11#1)(2008-2#1)
derived by use of the##2##5##(2008-3#2)
derived by use of##7##4##(2007-11#1)(2008-2#1)(2008-3#5)
derived by##45##2##(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1994-12#2)(1997-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#11)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
derived cell line##2##3##(1991-9#1)(2008-11#1)
derived cell##3##2##(1991-9#1)(2008-11#1)(2013-1#1)
derived cells##7##2##(1991-9#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-9#2)(2011-1#1)
derived compounds##2##2##(2008-10#1)(2008-11#1)
derived data##2##2##(1995-5#1)(2013-1#1)
derived deletions is##2##3##(1997-3#2)
derived deletions##7##2##(1997-3#7)
derived directly from##2##3##(2007-12#1)(2008-2#1)
derived directly##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
derived empirically from##2##3##(2008-7#1)(2008-9#1)
derived esters##2##2##(2008-5#2)
derived factors##2##2##(1993-6#1)(2013-7#1)
derived for a##3##3##(2008-2#2)(2008-3#1)
derived for both isotropic and anisotropic##2##6##(2008-2#1)(2008-3#1)
derived for the##21##3##(1990-8#1)(1993-2#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#7)(2013-8#2)
derived for these##2##3##(2008-11#1)(2008-9#1)
derived for##43##2##(1990-8#1)(1993-2#1)(1994-9#1)(2007-11#4)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#14)(2008-8#1)(2008-9#1)(2011-2#2)(2013-8#2)
derived from 1##2##3##(1996-8#1)(2008-10#1)
derived from 5##2##3##(2008-5#1)(2008-9#1)
derived from A##2##3##(2008-10#2)
derived from BALB/c##2##3##(2008-11#1)(2008-8#1)
derived from Chinese##3##3##(2008-5#2)(2008-7#1)
derived from FRET##2##3##(2008-10#2)
derived from Langmuir isotherm##2##4##(2008-10#2)
derived from Quillaja saponaria##2##4##(1997-4#2)
derived from R##2##3##(1995-12#2)
derived from a common##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
derived from a cross between a##2##6##(2008-10#2)
derived from a cross between the##3##6##(2008-10#3)
derived from a cross between##10##5##(2008-10#8)(2008-5#2)
derived from a cross of##3##5##(2008-10#3)
derived from a cross##14##4##(2008-10#12)(2008-5#2)
derived from a human##2##4##(1993-9#2)
derived from a novel##3##4##(1990-8#1)(1996-5#1)(2008-4#1)
derived from a single##5##4##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
derived from a subgroup##2##4##(2008-10#2)
derived from a##64##3##(1990-8#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
derived from all##3##3##(2008-10#3)
derived from amplified##2##3##(2008-10#1)(2012-3#1)
derived from an adult##2##4##(2008-9#2)
derived from an##10##3##(1993-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2011-1#1)(2013-8#1)
derived from bacterial##2##3##(2008-10#1)(2010-7#1)
derived from both##5##3##(1990-8#1)(1997-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
derived from cDNA clones##2##4##(2008-10#2)
derived from cDNA##3##3##(1995-2#1)(2008-10#2)
derived from cloned##3##3##(2008-10#2)(2008-8#1)
derived from conserved##2##3##(1994-12#1)(1997-6#1)
derived from contaminating##2##3##(2008-10#1)(2011-2#1)
derived from coupled-mode theory##2##4##(2007-11#1)(2008-3#1)
derived from crosses between the resistant##2##6##(2008-10#2)
derived from crosses between##4##4##(2008-10#4)
derived from crosses##5##3##(2008-10#5)
derived from crossing##2##3##(2008-10#2)
derived from different##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
derived from each##4##3##(1994-6#1)(2008-10#2)(2011-2#1)
derived from eight##2##3##(2008-1#1)(2008-10#1)
derived from either##3##3##(1994-8#1)(2008-10#2)
derived from existing##2##3##(2008-3#1)(2009-10#1)
derived from experimental##4##3##(2007-4#1)(2008-2#1)(2008-4#2)
derived from fertilized##2##3##(2008-10#1)(2008-11#1)
derived from human##8##3##(1990-11#1)(1992-2#1)(2008-4#2)(2008-7#2)(2009-5#1)(2012-3#1)
derived from imaging##2##3##(2007-4#1)(2013-1#1)
derived from individual##2##3##(1995-12#1)(2010-7#1)
derived from intracellular##2##3##(1994-6#1)(1994-8#1)
derived from it##2##3##(1992-12#1)(2009-10#1)
derived from its##4##3##(1995-12#1)(1996-1#1)(2008-10#1)(2008-12#1)
derived from mouse##2##3##(2008-11#1)(2010-3#1)
derived from natural##4##3##(2007-11#1)(2008-11#1)(2008-5#2)
derived from neural##2##3##(1997-4#1)(2011-2#1)
derived from one##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
derived from other##3##3##(1992-2#1)(1994-11#1)(1994-3#1)
derived from our##2##3##(2008-8#1)(2010-10#1)
derived from parent##3##3##(2008-10#3)
derived from patients with primary##2##5##(1993-8#1)(2008-10#1)
derived from patients with##3##4##(1993-8#1)(1993-9#1)(2008-10#1)
derived from patients##4##3##(1993-8#1)(1993-9#1)(2008-10#2)
derived from plants##3##3##(2008-10#1)(2008-11#2)
derived from porcine##2##3##(1994-11#2)
derived from rat##7##3##(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-11#2)(2008-6#1)
derived from secondary##2##3##(1996-5#1)(2007-11#1)
derived from sheep##2##3##(1996-11#1)(1997-5#1)
derived from small-scale##2##3##(2008-12#1)(2010-10#1)
derived from specific##2##3##(2008-11#1)(2008-2#1)
derived from strain AT##2##4##(2008-10#2)
derived from strain##4##3##(2008-10#4)
derived from structural##2##3##(2010-2#1)(2010-7#1)
derived from studies of the##2##5##(1993-11#1)(2009-11#1)
derived from studies##3##3##(1993-11#1)(2009-11#1)(2009-8#1)
derived from such##2##3##(1992-12#1)(2008-10#1)
derived from the cell##2##4##(1992-8#1)(2008-4#1)
derived from the cross between##5##5##(2008-10#4)(2012-3#1)
derived from the cross##15##4##(2007-12#1)(2008-10#13)(2012-3#1)
derived from the human immunodeficiency##2##5##(1994-8#1)(2009-6#1)
derived from the in situ##2##5##(2007-5#1)(2008-10#1)
derived from the logistic##2##4##(1994-11#1)(2008-10#1)
derived from the measured##2##4##(2008-2#1)(2008-3#1)
derived from the model##2##4##(1990-8#1)(2008-10#1)
derived from the protein##2##4##(1990-5#1)(1994-8#1)
derived from the purified protein##2##5##(1994-6#1)(1995-2#1)
derived from the purified##3##4##(1994-6#1)(1995-2#1)(2008-8#1)
derived from the radiative transfer equation##2##6##(2008-2#2)
derived from the rat##2##4##(1991-9#1)(1993-6#1)
derived from the same##4##4##(2008-10#2)(2009-1#1)(2012-2#1)
derived from the sequence of##2##5##(1991-9#1)(2008-10#1)
derived from the##198##3##(1990-11#1)(1990-12#1)(1990-5#5)(1990-8#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#3)(2007-12#4)(2007-5#2)(2008-1#1)(2008-10#46)(2008-11#9)(2008-12#2)(2008-2#11)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#1)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#2)
derived from them##2##3##(1991-9#1)(2008-10#1)
derived from these##10##3##(1995-2#1)(1996-1#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#1)(2012-3#1)
derived from this region of##2##5##(1995-6#1)(2008-10#1)
derived from this region##3##4##(1993-3#1)(1995-6#1)(2008-10#1)
derived from this##10##3##(1991-8#1)(1992-11#1)(1993-3#1)(1994-11#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)
derived from three##3##3##(2008-10#2)(2010-3#1)
derived from two##6##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
derived from various##3##3##(1993-8#1)(2008-9#1)(2010-10#1)
derived from wild-type##3##3##(2008-1#1)(2008-10#2)
derived from##818##2##(1990-11#2)(1990-12#1)(1990-5#7)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#5)(1992-11#3)(1992-12#5)(1992-2#7)(1992-3#2)(1992-5#3)(1992-6#5)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#5)(1993-6#4)(1993-8#5)(1993-9#4)(1994-11#14)(1994-12#8)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#5)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#7)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2006-4#1)(2007-11#10)(2007-12#10)(2007-4#2)(2007-5#3)(2007-8#1)(2008-1#7)(2008-10#196)(2008-11#60)(2008-12#8)(2008-2#30)(2008-3#39)(2008-4#18)(2008-5#22)(2008-6#8)(2008-7#20)(2008-8#25)(2008-9#16)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#5)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#6)(2010-4#4)(2010-7#5)(2010-8#2)(2011-1#4)(2011-2#12)(2011-3#3)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#15)(2012-4#1)(2012-7#1)(2013-1#11)(2013-8#6)
derived growth##3##2##(1991-12#1)(2008-9#1)(2013-1#1)
derived here##2##2##(2007-11#1)(2008-2#1)
derived in a##4##3##(1996-5#1)(2008-3#3)
derived in the##5##3##(2007-11#1)(2008-10#1)(2008-11#2)(2009-3#1)
derived in##16##2##(1992-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#4)(2009-3#1)(2012-1#1)(2013-1#1)
derived indices##3##2##(2008-7#3)
derived is##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
derived lineages##2##2##(2007-12#1)(2008-8#1)
derived neurotrophic factor (BDNF)##2##4##(2009-8#1)(2013-1#1)
derived neurotrophic factor##3##3##(2009-8#1)(2013-1#2)
derived on the basis of##2##5##(1995-9#1)(1996-3#1)
derived ozone abundances##2##3##(2008-2#2)
derived peptide##2##2##(2008-10#1)(2008-5#1)
derived products##3##2##(2008-11#1)(2008-8#1)(2010-2#1)
derived results##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
derived simultaneously##2##2##(2008-3#2)
derived solely from##2##3##(2008-10#2)
derived stem cells##2##3##(2008-11#1)(2008-9#1)
derived that##8##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-8#1)
derived the##6##2##(2008-2#1)(2008-3#4)(2012-2#1)
derived theoretical##2##2##(2008-3#2)
derived through##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
derived to##11##2##(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#5)(2013-1#1)
derived total ozone##3##3##(2008-2#3)
derived treatment##2##2##(2008-6#2)
derived using##4##2##(1993-11#1)(2008-10#2)(2008-5#1)
derived values##5##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
derived with the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
derived with##8##2##(2008-10#2)(2008-2#2)(2008-3#3)(2010-4#1)
derived##1329##1##(1990-11#3)(1990-12#3)(1990-3#1)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#12)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#10)(1992-11#3)(1992-12#8)(1992-2#8)(1992-3#5)(1992-5#4)(1992-6#6)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#5)(1993-2#4)(1993-3#9)(1993-5#1)(1993-6#5)(1993-8#6)(1993-9#4)(1994-11#14)(1994-12#14)(1994-2#3)(1994-3#5)(1994-5#7)(1994-6#5)(1994-8#6)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#4)(1995-5#7)(1995-6#5)(1995-8#2)(1995-9#4)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#7)(1997-3#13)(1997-4#6)(1997-5#5)(1997-6#4)(1997-7#5)(1997-8#4)(1997-9#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#30)(2007-12#31)(2007-4#2)(2007-5#4)(2007-7#2)(2007-8#3)(2008-1#7)(2008-10#261)(2008-11#81)(2008-12#9)(2008-2#89)(2008-3#138)(2008-4#22)(2008-5#31)(2008-6#12)(2008-7#34)(2008-8#35)(2008-9#27)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#4)(2009-5#5)(2009-6#6)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#7)(2010-4#9)(2010-6#2)(2010-7#7)(2010-8#4)(2011-1#8)(2011-2#22)(2011-3#5)(2012-1#4)(2012-12#3)(2012-2#14)(2012-3#24)(2012-4#1)(2012-7#1)(2013-1#22)(2013-7#1)(2013-8#11)
derived)##3##1##(1992-2#1)(1994-9#1)(2008-10#1)
derivedfrom##3##1##(2008-11#2)(2008-2#1)
derives amphoteres##2##2##(2008-5#2)
derives from a##4##3##(1991-5#1)(1992-8#1)(2008-3#1)(2013-8#1)
derives from the##2##3##(1992-12#1)(2010-10#1)
derives from##8##2##(1991-5#1)(1992-12#2)(1992-8#1)(2008-3#1)(2010-10#1)(2010-3#1)(2013-8#1)
derives its##2##2##(2008-10#1)(2008-3#1)
derives the##3##2##(2007-12#1)(2009-5#1)(2009-8#1)
derives##19##1##(1991-5#1)(1992-12#2)(1992-8#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2013-8#1)
deriving from the##5##3##(1994-6#1)(2008-10#3)(2008-7#1)
deriving from##10##2##(1990-2#1)(1994-6#1)(2008-10#5)(2008-7#2)(2012-3#1)
deriving##24##1##(1990-2#1)(1994-6#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#2)(2012-3#1)
dermal absorption##2##2##(2008-5#2)
dermal and epidermal##2##3##(2008-5#2)
dermal and skin##2##3##(2008-5#2)
dermal and subcutaneous##2##3##(2013-8#2)
dermal and##8##2##(2008-5#5)(2008-9#1)(2013-8#2)
dermal application for 26 weeks##2##5##(2008-9#2)
dermal application for 26##4##4##(2008-9#4)
dermal application##10##2##(2008-9#10)
dermal applications##6##2##(2008-9#6)
dermal changes##2##2##(2008-10#1)(2008-5#1)
dermal equivalent model##2##3##(2008-5#2)
dermal equivalent##3##2##(2008-5#3)
dermal exposure##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
dermal fibroblasts##6##2##(1990-5#2)(1990-9#1)(1993-8#1)(2008-5#2)
dermal matrix##2##2##(2008-5#2)
dermal plates##2##2##(2008-7#2)
dermal skin##2##2##(2008-5#2)
dermal studies##2##2##(2008-9#2)
dermal thickness##2##2##(2008-5#2)
dermal##97##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1996-6#1)(2007-12#1)(2007-7#3)(2007-9#2)(2008-10#4)(2008-12#1)(2008-5#33)(2008-7#3)(2008-9#25)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#7)
dermally for 20 or 27 weeks##2##6##(2008-9#2)
dermally for##5##2##(2008-9#5)
dermally##18##1##(2008-9#18)
dermaseptin b and##3##3##(1994-5#3)
dermaseptin b##6##2##(1994-5#6)
dermaseptin##7##1##(1994-5#7)
dermaseptins##2##1##(1993-3#2)
dermatan sulfate proteoglycan-II##2##3##(1992-10#2)
dermatan sulfate##3##2##(1992-10#2)(1992-12#1)
dermatitidis was##2##2##(2008-5#1)(2013-8#1)
dermatitidis##4##1##(2008-5#3)(2013-8#1)
dermatitis (AD)##3##2##(2011-1#1)(2012-1#1)(2012-2#1)
dermatitis and##5##2##(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
dermatitis in fattening pigs##2##4##(1990-3#2)
dermatitis in the##2##3##(2013-1#1)(2013-8#1)
dermatitis in##10##2##(1990-3#2)(1994-7#1)(1996-6#1)(2007-11#1)(2011-1#2)(2013-1#2)(2013-8#1)
dermatitis is##3##2##(1992-9#1)(2008-5#1)(2011-1#1)
dermatitis of##2##2##(1991-2#1)(2008-5#1)
dermatitis seborrhoeica##5##2##(2008-5#5)
dermatitis was##2##2##(1990-3#1)(2013-1#1)
dermatitis were##4##2##(1990-3#2)(1992-9#1)(2007-7#1)
dermatitis##99##1##(1990-10#1)(1990-3#5)(1991-11#1)(1991-2#5)(1991-3#1)(1992-9#4)(1994-11#1)(1994-7#1)(1996-6#2)(1997-2#2)(2007-11#3)(2007-7#10)(2008-11#1)(2008-3#1)(2008-5#20)(2008-8#1)(2008-9#4)(2010-5#1)(2010-8#2)(2011-1#11)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#2)
dermatofibrosarcoma protuberans of the##2##4##(1992-2#1)(2008-6#1)
dermatofibrosarcoma protuberans##4##2##(1992-2#1)(2008-6#3)
dermatofibrosarcoma##5##1##(1992-2#2)(2008-6#3)
dermatologic##13##1##(2006-10#2)(2007-7#1)(2008-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#3)(2013-7#1)
dermatological##18##1##(1991-12#2)(1992-6#1)(2007-7#2)(2008-5#7)(2008-8#3)(2010-8#2)(2012-1#1)
dermatologist##2##1##(1991-6#1)(2008-5#1)
dermatologists and##2##2##(2007-7#1)(2013-1#1)
dermatologists##14##1##(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-5#4)(2008-6#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
dermatology and##2##2##(1991-6#1)(2008-5#1)
dermatology##18##1##(1991-6#1)(1993-2#1)(2007-12#1)(2007-7#8)(2008-3#1)(2008-5#2)(2009-10#1)(2009-6#1)(2010-12#1)(2012-3#1)
dermatome##4##1##(1994-12#2)(2007-7#1)(2012-1#1)
dermatomyositis##22##1##(1994-7#2)(1995-5#1)(2006-10#12)(2007-7#2)(2009-3#1)(2009-6#1)(2011-2#2)(2012-2#1)
dermatophyte infections##2##2##(2007-7#1)(2008-5#1)
dermatophyte##5##1##(2007-7#1)(2008-5#4)
dermatophytes##7##1##(2007-7#1)(2008-3#2)(2008-5#3)(2012-3#1)
dermatophytic##2##1##(2008-8#2)
dermatophytosis##5##1##(2007-7#2)(2008-5#3)
dermatoses##11##1##(1993-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#5)(2013-1#1)
dermatosis##2##1##(2007-7#1)(2012-1#1)
dermis and epidermis##3##3##(1996-12#1)(2008-5#2)
dermis and##9##2##(1996-12#1)(2008-5#6)(2008-9#1)(2010-6#1)
dermis is##2##2##(1994-12#1)(2008-9#1)
dermis or##2##2##(2008-5#1)(2010-6#1)
dermis##57##1##(1994-12#1)(1996-12#7)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#21)(2008-6#1)(2008-9#11)(2010-6#7)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
dermoid cyst##4##2##(1994-9#1)(2009-7#1)(2011-2#2)
dermoid cysts of##2##3##(2011-2#1)(2013-8#1)
dermoid##12##1##(1994-9#1)(2009-7#7)(2011-2#3)(2013-8#1)
dermoids##2##1##(2009-7#1)(2011-2#1)
dermopathy##2##1##(2008-1#1)(2011-2#1)
derotation of the##2##3##(2007-11#1)(2011-2#1)
derotator##3##1##(2008-3#3)
des cas##3##2##(2011-2#2)(2013-1#1)
des cheveux##3##2##(2008-5#3)
des complications##2##2##(2013-1#2)
des crises convulsives##2##3##(2013-1#2)
des difficultés##2##2##(2011-2#1)(2013-1#1)
des enfants##2##2##(2008-11#2)
des malformations##2##2##(2011-2#2)
des melanges##2##2##(2008-5#2)
des produits##3##2##(2008-5#3)
des tensioactifs##2##2##(2008-5#2)
des##75##1##(1996-11#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-11#7)(2008-5#21)(2009-10#2)(2009-4#2)(2009-7#1)(2011-1#1)(2011-2#15)(2013-1#18)
des-acyl ghrelin##2##2##(2008-3#2)
desacetyl-alpha-MSH##5##1##(2008-6#5)
desalting##3##1##(1997-2#1)(2008-4#1)(2012-3#1)
desaturase activity##2##2##(1991-12#1)(1996-7#1)
desaturase gene##3##2##(1996-6#2)(2010-4#1)
desaturase##16##1##(1990-7#2)(1991-12#3)(1993-6#1)(1995-2#1)(1996-6#4)(1996-7#1)(2010-10#2)(2010-4#1)(2013-1#1)
desaturation in##2##2##(1990-7#1)(1993-1#1)
desaturation##14##1##(1990-11#1)(1990-7#2)(1991-12#1)(1993-1#5)(1994-11#2)(2007-12#1)(2008-7#1)(2009-4#1)
desaturations##2##1##(1994-11#2)
descend##3##1##(2008-10#1)(2008-8#1)(2013-1#1)
descendants and##2##2##(2007-12#2)
descendants##9##1##(1995-6#1)(2007-12#3)(2008-10#2)(2008-5#1)(2009-3#1)(2012-12#1)
descended##2##1##(2008-10#2)
descendents##3##1##(1994-1#1)(2008-10#1)(2012-2#1)
descending aorta and##2##3##(2007-8#1)(2012-3#1)
descending aorta##12##2##(1997-8#1)(2007-7#1)(2007-8#4)(2008-11#1)(2010-8#1)(2012-2#2)(2012-3#2)
descending colon##5##2##(1993-9#3)(2008-11#1)(2011-2#1)
descending mediastinitis##3##2##(2013-1#3)
descending necrotizing mediastinitis (DNM)##2##4##(2007-8#1)(2008-12#1)
descending necrotizing mediastinitis##4##3##(2007-8#2)(2008-12#2)
descending order##3##2##(1992-2#1)(1992-8#1)(2011-2#1)
descending thoracic aorta and##2##4##(1997-8#1)(2013-3#1)
descending thoracic aorta##7##3##(1997-8#2)(2007-8#2)(2010-8#2)(2013-3#1)
descending thoracic##12##2##(1997-8#3)(2007-8#3)(2008-10#1)(2010-8#2)(2013-3#3)
descending##65##1##(1991-1#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-9#3)(1994-11#1)(1995-12#1)(1996-5#1)(1997-8#4)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#13)(2008-10#2)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#3)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-3#3)(2013-7#1)
descent and##6##2##(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
descent from a cross between##2##5##(2008-10#2)
descent from##3##2##(2008-10#3)
descent is##2##2##(2010-8#1)(2013-1#1)
descent##35##1##(1992-6#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-8#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
describe 2 patients##4##3##(1997-3#1)(2006-10#1)(2007-10#1)(2011-2#1)
describe 2##5##2##(1997-3#1)(2006-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
describe a case of a##9##5##(1991-2#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
describe a case of an##3##5##(2010-6#1)(2011-2#1)(2013-7#1)
describe a case of primary##4##5##(1990-2#1)(1991-6#1)(1992-8#1)(1992-9#1)
describe a case of##39##4##(1990-2#2)(1991-2#1)(1991-5#1)(1991-6#3)(1992-4#1)(1992-8#1)(1992-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
describe a case##44##3##(1990-2#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
describe a detailed##2##3##(1996-12#1)(2008-3#1)
describe a device##3##3##(1994-6#1)(2008-2#1)(2008-3#1)
describe a general##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
describe a hypothetical##2##3##(2009-10#1)(2012-2#1)
describe a method for##11##4##(1991-11#1)(1993-8#1)(2007-11#2)(2008-2#3)(2008-3#3)(2011-2#1)
describe a method of##2##4##(2008-12#1)(2011-7#1)
describe a method##23##3##(1990-12#1)(1991-11#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#8)(2011-2#1)(2011-7#1)(2012-2#1)
describe a minimally invasive##2##4##(2011-2#1)(2012-2#1)
describe a modified##5##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)
describe a new method for##3##5##(1996-12#1)(2007-12#1)(2008-7#1)
describe a new method##6##4##(1996-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
describe a new species##2##4##(2008-5#2)
describe a new technique##2##4##(1990-3#1)(2008-1#1)
describe a new##30##3##(1990-3#1)(1992-8#1)(1994-10#1)(1994-8#1)(1996-12#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
describe a novel approach##2##4##(2007-11#1)(2012-2#1)
describe a novel##24##3##(2007-11#4)(2007-12#6)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#4)(2008-7#1)(2009-12#1)(2010-11#1)(2012-2#1)
describe a patient who##4##4##(2006-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
describe a patient with a##4##5##(1996-5#1)(1997-2#1)(2008-7#1)(2012-3#1)
describe a patient with##13##4##(1990-9#1)(1992-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
describe a patient##18##3##(1990-9#1)(1992-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-10#2)(2007-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
describe a procedure##2##3##(1997-6#1)(2008-12#1)
describe a protocol##2##3##(2008-1#2)
describe a rare case of##5##5##(1991-3#1)(1992-9#1)(1993-5#1)(2011-2#1)(2012-12#1)
describe a rare case##6##4##(1991-3#1)(1992-9#1)(1993-5#1)(2007-7#1)(2011-2#1)(2012-12#1)
describe a rare##7##3##(1991-3#1)(1992-9#1)(1993-5#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
describe a safe##2##3##(2008-9#1)(2010-5#1)
describe a series of##3##4##(2008-1#1)(2008-8#1)(2010-6#1)
describe a set of##3##4##(2008-4#1)(2010-11#1)(2012-2#1)
describe a simple##16##3##(1990-11#1)(1990-12#1)(1990-8#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-5#1)(2010-7#1)(2012-2#1)
describe a study##3##3##(2008-7#1)(2010-4#1)(2012-2#1)
describe a system##3##3##(1991-12#1)(1994-12#1)(2008-3#1)
describe a technique of##2##4##(2007-8#1)(2013-1#1)
describe a technique##7##3##(1992-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2013-1#1)
describe a variety of##2##4##(1994-1#1)(2012-1#1)
describe a##352##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-11#2)(1992-12#2)(1992-4#2)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#3)(2007-10#1)(2007-11#15)(2007-12#23)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#9)(2008-10#8)(2008-11#6)(2008-12#4)(2008-2#26)(2008-3#55)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#18)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#3)
describe advances##2##2##(2007-12#1)(2008-7#1)
describe alternative##2##2##(1992-6#1)(2010-8#1)
describe an algorithm##2##3##(2008-3#2)
describe an alternative technique##2##4##(2007-8#1)(2008-3#1)
describe an alternative##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
describe an approach to##2##4##(2008-3#1)(2008-7#1)
describe an approach##4##3##(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)
describe an automated##3##3##(2008-10#2)(2009-9#1)
describe an experimental##2##3##(1991-6#1)(2008-2#1)
describe an improved##2##3##(2008-2#1)(2012-3#1)
describe an##49##2##(1990-6#1)(1991-6#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#10)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)
describe and compare the##2##4##(2008-10#1)(2011-2#1)
describe and compare##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-7#1)
describe and discuss the##3##4##(2007-8#1)(2009-5#1)(2010-8#1)
describe and discuss##4##3##(1996-3#1)(2007-8#1)(2009-5#1)(2010-8#1)
describe and##20##2##(1992-12#2)(1996-2#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2009-5#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
describe both##2##2##(2008-7#1)(2010-5#1)
describe clinical##2##2##(1993-3#1)(2006-10#1)
describe current##3##2##(2007-7#1)(2008-1#1)(2010-7#1)
describe design##2##2##(2008-10#1)(2008-2#1)
describe diseases##3##2##(2008-10#1)(2013-1#2)
describe experimental results##2##3##(2008-3#1)(2013-1#1)
describe for the first time##3##5##(2008-10#1)(2008-6#1)(2012-2#1)
describe gene delivery to normal##2##5##(2008-4#2)
describe his##2##2##(2009-10#1)(2010-7#1)
describe how an##2##3##(1992-9#1)(2008-8#1)
describe how the##7##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#2)
describe how this##2##3##(2008-9#1)(2009-3#1)
describe how to use##3##4##(2008-4#3)
describe how to##11##3##(2008-10#1)(2008-4#6)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
describe how we##2##3##(2008-6#1)(2009-11#1)
describe how##48##2##(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-3#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#3)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
describe in##8##2##(1994-12#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
describe its##5##2##(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
describe methods for preparing##3##4##(2008-4#3)
describe methods for##6##3##(2008-4#5)(2008-9#1)
describe methods##7##2##(2008-4#5)(2008-9#2)
describe new##3##2##(1997-3#1)(2007-11#1)(2011-2#1)
describe one such##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
describe one##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)
describe our experience with##2##4##(2007-8#1)(2010-11#1)
describe our experience##3##3##(1997-3#1)(2007-8#1)(2010-11#1)
describe our##17##2##(1994-11#1)(1997-3#1)(1997-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
describe patterns##2##2##(2008-11#1)(2010-4#1)
describe preparation of##4##3##(2008-4#3)(2008-9#1)
describe recent advances in##3##4##(1993-12#1)(2010-11#1)(2012-1#1)
describe recent##5##2##(1993-12#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
describe research##2##2##(1993-2#1)(2008-2#1)
describe results from##2##3##(1997-3#1)(2012-3#1)
describe several##4##2##(1990-5#1)(2008-3#1)(2009-9#1)(2011-2#1)
describe simple##2##2##(2008-2#1)(2008-4#1)
describe some of the##5##4##(1996-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-7#1)
describe some of##6##3##(1991-3#1)(1996-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-7#1)
describe some##9##2##(1991-3#1)(1996-2#1)(2008-3#2)(2008-5#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
describe strategies used##2##3##(1990-5#1)(2010-11#1)
describe that##4##2##(2008-10#1)(2008-12#1)(2011-2#2)
describe the CT##2##3##(2012-12#1)(2012-2#1)
describe the analysis of##3##4##(1994-11#1)(2008-3#1)(2008-9#1)
describe the analysis##4##3##(1993-2#1)(1994-11#1)(2008-3#1)(2008-9#1)
describe the application of##8##4##(2008-10#1)(2008-3#2)(2008-7#1)(2012-3#1)(2013-1#3)
describe the application##9##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-3#1)(2013-1#3)
describe the approaches##2##3##(1997-2#1)(2013-1#1)
describe the architecture##2##3##(2008-3#1)(2009-6#1)
describe the aspects of##2##4##(2007-11#1)(2013-7#1)
describe the basic features of##3##5##(2008-3#1)(2011-2#2)
describe the basic principles of##2##5##(2007-12#1)(2009-5#1)
describe the basic##9##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#3)
describe the benefits##2##3##(2011-2#1)(2012-2#1)
describe the binding##2##3##(1993-8#1)(2008-12#1)
describe the case of a patient##3##6##(1993-6#1)(1993-8#1)(2008-5#1)
describe the case of a##11##5##(1990-8#1)(1993-6#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#2)
describe the case of an##3##5##(1994-9#1)(2008-7#1)(2011-2#1)
describe the case of##16##4##(1990-8#1)(1993-6#1)(1993-8#1)(1994-9#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#1)(2011-2#4)(2013-7#1)
describe the case##17##3##(1990-8#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-9#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#1)(2011-2#4)(2013-7#1)
describe the characteristics of##5##4##(2007-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
describe the characteristics##6##3##(2007-11#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
describe the clinical and##3##4##(1991-8#1)(2006-10#1)(2007-12#1)
describe the clinical features##2##4##(2007-10#1)(2010-5#1)
describe the clinical##17##3##(1991-8#1)(1993-12#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
describe the cloning##2##3##(1994-12#1)(2008-7#1)
describe the construction of a##5##5##(1990-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
describe the construction of##6##4##(1990-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
describe the construction##7##3##(1990-8#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
describe the design and##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
describe the design of a##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
describe the design of##8##4##(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)
describe the design##18##3##(1995-3#1)(2008-10#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-7#2)(2009-9#1)
describe the development of a##4##5##(1997-4#1)(2008-2#2)(2008-3#1)
describe the development of an##2##5##(1996-12#1)(2009-5#1)
describe the development of the##2##5##(1996-11#1)(1996-2#1)
describe the development of##9##4##(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)
describe the development##13##3##(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)
describe the effect of##2##4##(2008-2#1)(2008-3#1)
describe the effects of##2##4##(1995-2#1)(2011-1#1)
describe the evolution of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
describe the existence of##2##4##(1993-12#1)(2008-10#1)
describe the experience of##2##4##(2010-3#1)(2013-1#1)
describe the experience##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
describe the experiences##2##3##(2008-11#1)(2010-3#1)
describe the experimental##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
describe the features of##24##4##(2011-2#23)(2013-1#1)
describe the first##7##3##(1996-8#1)(1997-6#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)
describe the genetic##2##3##(2012-3#1)(2013-8#1)
describe the history of##2##4##(1992-4#1)(2010-3#1)
describe the implementation of##3##4##(2008-10#1)(2008-3#2)
describe the implementation##5##3##(2008-10#1)(2008-3#2)(2013-1#2)
describe the importance of##2##4##(1993-2#1)(2009-6#1)
describe the in vitro##2##4##(2008-11#2)
describe the in##3##3##(2008-11#2)(2012-12#1)
describe the integration of##2##4##(2009-6#1)(2009-9#1)
describe the magnetic resonance##2##4##(1995-4#1)(2008-7#1)
describe the main##5##3##(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
describe the methods##2##3##(2008-10#1)(2008-9#1)
describe the need##2##3##(1992-2#1)(2008-9#1)
describe the organization##2##3##(2008-11#1)(2013-8#1)
describe the origin and##2##4##(1993-6#1)(2008-5#1)
describe the pH##2##3##(2008-10#2)
describe the physical##2##3##(2008-2#1)(2008-5#1)
describe the practical implementation##2##4##(2007-12#1)(2008-3#1)
describe the preparation of##4##4##(2008-4#2)(2008-9#1)(2010-12#1)
describe the prevalence##2##3##(2012-12#1)(2012-2#1)
describe the process of##2##4##(2008-3#1)(2013-1#1)
describe the process##4##3##(1994-3#1)(2008-3#1)(2010-3#1)(2013-1#1)
describe the rationale for##2##4##(1996-9#1)(2008-3#1)
describe the relationship between##6##4##(2008-10#1)(2008-6#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)
describe the results of##6##4##(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-8#1)
describe the role of##5##4##(1992-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
describe the role##6##3##(1992-1#1)(2008-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
describe the screening##2##3##(2008-10#1)(2012-3#1)
describe the severity of the##2##5##(1997-2#2)
describe the steps##3##3##(1993-1#1)(2011-2#1)(2012-12#1)
describe the structure of##2##4##(2008-12#1)(2008-3#1)
describe the structure##3##3##(1994-1#1)(2008-12#1)(2008-3#1)
describe the successful##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
describe the synthesis of##2##4##(2008-4#1)(2009-10#1)
describe the synthesis##3##3##(2008-4#1)(2009-10#1)(2010-12#1)
describe the theoretical##2##3##(1997-2#1)(2008-2#1)
describe the type of##2##4##(2008-10#1)(2011-2#1)
describe the type##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
describe the unique##2##3##(2012-2#1)(2013-8#1)
describe the use of a##5##5##(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
describe the use of##22##4##(1995-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
describe the usefulness##2##3##(2007-8#1)(2012-12#1)
describe the##563##2##(1990-11#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#8)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#3)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#14)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#39)(2008-11#20)(2008-12#4)(2008-2#35)(2008-3#56)(2008-4#11)(2008-5#10)(2008-6#13)(2008-7#23)(2008-8#7)(2008-9#16)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-3#7)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#11)(2011-2#50)(2011-3#1)(2012-1#2)(2012-12#16)(2012-2#13)(2012-3#8)(2012-4#1)(2013-1#27)(2013-7#5)(2013-8#8)
describe their##16##2##(1990-8#1)(1991-2#1)(1991-3#1)(1993-1#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-5#1)(2012-2#1)(2012-3#2)
describe these##4##2##(2007-12#1)(2009-12#1)(2009-6#1)(2010-10#1)
describe this##9##2##(1993-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)
describe three##3##2##(2007-12#1)(2007-7#1)(2008-3#1)
describe treatment of##2##3##(2012-2#1)(2013-1#1)
describe two cases of##8##4##(1990-10#2)(1993-6#1)(1997-6#1)(2007-8#1)(2008-3#1)(2009-3#1)(2013-1#1)
describe two cases##11##3##(1990-10#2)(1993-6#1)(1995-8#1)(1997-6#1)(2007-8#1)(2008-3#1)(2009-3#1)(2011-2#1)(2013-1#2)
describe two methods##2##3##(2008-3#1)(2010-10#1)
describe two##27##2##(1990-10#2)(1991-11#1)(1992-11#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-1#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
describe various##3##2##(1997-2#1)(2008-3#1)(2008-7#1)
describe what is##3##3##(2007-11#1)(2013-1#2)
describe what##5##2##(2007-11#2)(2007-12#1)(2013-1#2)
describe##1454##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#8)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#4)(1991-2#5)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#2)(1992-4#3)(1992-6#5)(1992-8#3)(1992-9#10)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#12)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#7)(1993-8#3)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#5)(1994-12#11)(1994-2#4)(1994-3#8)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#13)(1997-3#9)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#2)(1997-9#1)(2006-10#9)(2006-12#1)(2006-8#1)(2007-10#9)(2007-11#41)(2007-12#54)(2007-2#3)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#18)(2008-1#15)(2008-10#91)(2008-11#44)(2008-12#13)(2008-2#90)(2008-3#150)(2008-4#47)(2008-5#18)(2008-6#26)(2008-7#58)(2008-8#13)(2008-9#36)(2009-10#5)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#12)(2009-6#6)(2009-7#3)(2009-8#3)(2009-9#8)(2010-1#1)(2010-10#8)(2010-11#13)(2010-12#11)(2010-3#10)(2010-4#6)(2010-5#11)(2010-6#4)(2010-7#12)(2010-8#7)(2010-9#4)(2011-1#19)(2011-2#87)(2011-3#3)(2011-7#2)(2012-1#5)(2012-12#32)(2012-2#48)(2012-3#22)(2012-4#1)(2013-1#60)(2013-7#7)(2013-8#15)
described PCR assay##2##3##(2008-10#2)
described PCR##3##2##(2008-10#3)
described a new##2##3##(1997-3#1)(2013-7#1)
described a syndrome##2##3##(1997-6#1)(2008-7#1)
described a##17##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-5#1)(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-5#1)(2013-1#1)(2013-7#1)
described about##2##2##(2008-10#1)(2008-5#1)
described above and##2##3##(1994-2#1)(2008-3#1)
described above##13##2##(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)
described according to##4##3##(1990-8#1)(1995-3#1)(2008-3#1)(2009-1#1)
described along with their##2##4##(2008-2#1)(2009-12#1)
described along with##10##3##(1996-12#1)(2008-2#4)(2008-4#2)(2008-9#2)(2009-12#1)
described an##7##2##(1990-8#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
described and analyzed##2##3##(2008-2#1)(2008-3#1)
described and characterized##2##3##(2008-3#2)
described and discussed in##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
described and discussed on the##2##5##(2008-5#1)(2008-8#1)
described and discussed##9##3##(1990-9#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
described and evaluated##5##3##(2008-10#4)(2008-3#1)
described and illustrated with##2##4##(1996-12#1)(2011-7#1)
described and illustrated##8##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-5#3)(2011-7#1)
described and is##2##3##(2007-7#1)(2008-3#1)
described and the##10##3##(1990-9#1)(1994-2#1)(1995-9#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)
described and their##6##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-12#1)
described and used for determination of##2##6##(2008-10#1)(2008-3#1)
described and used for##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
described and used##5##3##(1996-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
described and##87##2##(1990-12#1)(1990-9#3)(1991-3#1)(1992-4#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-6#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
described are the##2##3##(2008-2#1)(2008-4#1)
described are##7##2##(1991-1#1)(1994-3#1)(2008-2#2)(2008-4#2)(2008-9#1)
described as &quot##5##3##(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2012-12#1)
described as a new##2##4##(2008-10#1)(2011-1#1)
described as a##34##3##(1991-3#1)(1991-5#1)(1992-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
described as an##10##3##(1996-12#1)(2006-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2009-8#1)(2013-8#1)
described as being##3##3##(1997-7#1)(2008-1#2)
described as the##8##3##(1994-11#1)(1996-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2013-1#1)
described as well as the##4##5##(1992-3#1)(1995-3#1)(2008-10#1)(2013-1#1)
described as well as##7##4##(1992-3#1)(1995-3#1)(2008-10#3)(2008-3#1)(2013-1#1)
described as well##10##3##(1992-3#1)(1995-3#1)(2008-10#5)(2008-3#2)(2013-1#1)
described as##108##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-5#1)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-3#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
described based on the adsorption of the##2##7##(2008-10#2)
described based on the use of##2##6##(2008-10#2)
described based on the##6##4##(2008-10#6)
described based on##8##3##(2008-10#8)
described based##9##2##(1997-8#1)(2008-10#8)
described before##3##2##(2008-10#2)(2008-11#1)
described below##2##2##(2008-10#1)(2008-5#1)
described but##2##2##(1994-6#1)(2011-2#1)
described by A##2##3##(1993-11#1)(2012-3#1)
described by a Langmuir##2##4##(2008-10#2)
described by a set of##2##5##(1994-3#1)(2008-3#1)
described by a simple##5##4##(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
described by a single##2##4##(1990-7#1)(2007-12#1)
described by a transfer##2##4##(1993-11#1)(2007-12#1)
described by a two-state model##2##5##(1990-7#1)(1995-5#1)
described by a##42##3##(1990-7#2)(1991-5#2)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-5#2)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2012-2#1)(2013-1#1)
described by an##2##3##(2008-2#1)(2013-1#1)
described by our##2##3##(2008-11#1)(2010-12#1)
described by the Gompertz model##2##5##(2008-10#2)
described by the same##2##4##(1996-5#1)(2008-2#1)
described by the##35##3##(1990-5#1)(1990-8#1)(1991-5#1)(1992-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
described by two##3##3##(2007-11#1)(2008-3#2)
described by using##3##3##(2008-10#3)
described by##161##2##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-5#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-8#1)(2008-1#4)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
described can be applied##2##4##(2008-9#2)
described can be##4##3##(2008-4#1)(2008-5#1)(2008-9#2)
described case##2##2##(1990-9#1)(2008-10#1)
described could##2##2##(2008-10#1)(2008-5#1)
described direct##2##2##(2007-8#1)(2008-10#1)
described earlier##6##2##(1995-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
described elsewhere##7##2##(1995-2#1)(2008-10#1)(2008-4#5)
described for a##5##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#2)
described for determination of##3##4##(2008-10#3)
described for each##2##3##(2010-6#1)(2013-1#1)
described for other##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
described for preparation of##2##4##(2008-4#1)(2008-9#1)
described for rat##2##3##(2008-11#2)
described for the analysis of##3##5##(2008-10#3)
described for the assay of##3##5##(2008-10#2)(2008-4#1)
described for the determination of fluoride##2##6##(2008-10#2)
described for the determination of##53##5##(1991-5#1)(2008-10#52)
described for the direct##5##4##(2008-10#5)
described for the first time in##3##6##(2008-10#1)(2010-1#1)(2011-2#1)
described for the first time##9##5##(2008-10#6)(2010-1#1)(2011-2#1)(2013-1#1)
described for the first##10##4##(2008-10#6)(2010-1#1)(2011-2#2)(2013-1#1)
described for the rapid##2##4##(2008-10#2)
described for the simultaneous##4##4##(2008-10#4)
described for the##121##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-5#1)(2007-12#1)(2008-10#94)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#2)(2010-1#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
described for this##6##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2013-1#1)
described for##230##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-7#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#114)(2008-11#6)(2008-2#9)(2008-3#9)(2008-4#20)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#1)
described from the##5##3##(1990-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
described from##8##2##(1990-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
described here also##2##3##(2008-11#1)(2008-4#1)
described here are##3##3##(2008-3#1)(2008-4#2)
described here as##2##3##(2008-10#1)(2010-3#1)
described here has##2##3##(2008-2#1)(2008-5#1)
described here is a##2##4##(2010-10#1)(2011-2#1)
described here is##9##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)
described here provide##2##3##(2008-4#1)(2013-8#1)
described here requires##2##3##(1991-12#1)(1994-2#1)
described here should##2##3##(1994-6#1)(2008-11#1)
described here to##2##3##(2008-3#1)(2010-4#1)
described here uses a##2##4##(2008-2#1)(2013-8#1)
described here using##2##3##(2007-8#1)(2010-6#1)
described here was##3##3##(1995-2#1)(2008-10#1)(2009-7#1)
described here##90##2##(1991-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#19)(2008-5#3)(2008-9#4)(2009-11#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
described herein##15##2##(1994-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#1)(2009-11#1)(2011-1#1)
described how the##3##3##(1995-12#1)(2009-12#1)(2011-2#1)
described how##4##2##(1995-12#1)(2008-12#1)(2009-12#1)(2011-2#1)
described in 1970##2##3##(1990-12#1)(1997-5#1)
described in Dr##2##3##(1997-1#1)(2008-3#1)
described in Japan##3##3##(2008-10#2)(2010-10#1)
described in UNIT##2##3##(2008-4#2)
described in a support protocol##3##5##(2008-2#1)(2008-4#2)
described in a##21##3##(1990-8#1)(1992-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)
described in any##2##3##(1995-6#1)(1995-8#1)
described in association with##2##4##(1997-8#1)(2008-7#1)
described in both##2##3##(2007-12#1)(2012-3#1)
described in children##2##3##(2008-10#1)(2009-12#1)
described in detail and##3##4##(2007-8#1)(2008-3#1)(2008-6#1)
described in detail in this##2##5##(2011-1#1)(2011-2#1)
described in detail in##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
described in detail##27##3##(1994-12#1)(1997-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
described in greater detail##2##4##(2008-11#1)(2008-2#1)
described in human##3##3##(1992-8#1)(1992-9#1)(2008-12#1)
described in literature##3##3##(1992-9#1)(1996-3#1)(2008-10#1)
described in mammalian##2##3##(1990-5#1)(2009-8#1)
described in many##2##3##(1995-12#1)(1997-3#1)
described in most##2##3##(1996-7#1)(2008-7#1)
described in other studies of##2##5##(1990-5#1)(2011-2#1)
described in other##9##3##(1990-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#2)(2011-2#2)(2013-7#1)
described in patients with##5##4##(1994-5#1)(2008-1#1)(2008-4#1)(2009-5#1)(2012-3#1)
described in patients##7##3##(1994-5#1)(1997-5#1)(2008-1#1)(2008-4#1)(2009-5#1)(2010-12#1)(2012-3#1)
described in relation to##3##4##(1993-9#1)(2007-7#1)(2008-9#1)
described in terms of a##2##5##(2008-3#2)
described in terms of##4##4##(2008-3#3)(2012-4#1)
described in the following##2##4##(1995-5#1)(2008-4#1)
described in the literature and##2##5##(2007-12#1)(2008-8#1)
described in the literature##32##4##(1992-12#1)(1992-5#1)(1994-11#1)(1994-9#1)(1995-11#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
described in the present##2##4##(2008-10#1)(2008-11#1)
described in the second##3##4##(1997-6#1)(2008-4#1)(2010-11#1)
described in the##75##3##(1991-11#1)(1991-4#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
described in these##2##3##(2008-12#1)(2008-7#1)
described in this article##11##4##(1991-12#1)(1991-2#1)(1992-1#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
described in this chapter##2##4##(2008-4#2)
described in this paper are##2##5##(1992-9#1)(1997-2#1)
described in this paper is##2##5##(2008-10#1)(2011-1#1)
described in this paper was##2##5##(1991-9#1)(1994-9#1)
described in this paper##26##4##(1990-2#1)(1991-9#1)(1992-9#1)(1994-9#1)(1996-12#1)(1997-2#2)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
described in this report##6##4##(1991-6#1)(1993-6#1)(1995-2#1)(2008-11#1)(2010-4#1)(2011-2#1)
described in this review##2##4##(2008-8#1)(2009-11#1)
described in this study was##4##5##(2007-12#1)(2011-2#3)
described in this study##9##4##(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#4)
described in this unit are##2##5##(2008-4#2)
described in this unit can be used##3##7##(2008-4#3)
described in this unit is##4##5##(2008-2#1)(2008-4#3)
described in this unit##46##4##(2008-1#2)(2008-2#5)(2008-4#34)(2008-9#5)
described in this work##3##4##(2008-10#2)(2013-1#1)
described in this##116##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#10)(2008-4#36)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-7#1)
described in which##11##3##(1991-9#1)(1994-12#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-3#1)
described in##390##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#4)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#55)(2008-11#11)(2008-12#5)(2008-2#18)(2008-3#19)(2008-4#60)(2008-5#6)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#10)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#5)(2012-4#1)(2013-1#7)(2013-7#2)(2013-8#2)
described include##2##2##(2008-3#1)(2010-11#1)
described is a##4##3##(1996-5#1)(2008-4#2)(2008-9#1)
described is the##2##3##(1996-3#1)(2008-11#1)
described is##15##2##(1990-2#1)(1996-3#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#3)(2008-9#1)
described method##6##2##(1990-9#1)(2007-8#1)(2008-10#2)(2009-8#1)(2013-8#1)
described more than##2##3##(2007-6#1)(2008-3#1)
described of##7##2##(1991-3#1)(1992-12#2)(2008-2#1)(2008-4#1)(2009-10#1)(2012-12#1)
described on the basis of##3##5##(1990-6#1)(2007-8#1)(2008-10#1)
described on the##7##3##(1990-6#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-12#3)
described on##11##2##(1990-6#1)(1992-10#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-6#1)(2012-2#1)
described one##2##2##(2009-6#1)(2012-2#1)
described only in##2##3##(1990-9#1)(2008-10#1)
described only##4##2##(1990-9#1)(2008-10#1)(2008-3#1)(2012-12#1)
described over##2##2##(2008-10#1)(2013-1#1)
described previously in##3##3##(1992-12#1)(1995-12#2)
described previously##18##2##(1990-11#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-12#2)(1995-6#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)
described procedures##3##2##(2008-10#2)(2008-9#1)
described quantitatively##2##2##(1991-8#1)(2008-7#1)
described recently##3##2##(2008-3#1)(2008-7#2)
described so far in the##3##5##(2008-10#1)(2008-5#1)(2013-1#1)
described so far##6##3##(1991-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
described some##2##2##(1990-7#1)(2008-6#1)
described species##5##2##(2008-10#3)(2010-10#1)(2013-8#1)
described specific##2##2##(1996-1#1)(2010-9#1)
described technique##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)
described that can##3##3##(2008-3#1)(2008-4#1)(2012-2#1)
described that##39##2##(1994-5#1)(1994-9#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#7)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
described the association##2##3##(2008-7#1)(2013-1#1)
described the disease##3##3##(2008-10#3)
described the surgical##2##3##(1990-3#1)(2012-12#1)
described the##47##2##(1990-3#3)(1990-6#1)(1991-3#1)(1992-8#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#2)
described their##5##2##(1994-12#1)(1996-1#1)(2008-9#1)(2010-1#1)(2012-12#1)
described theoretically##2##2##(2007-12#1)(2008-10#1)
described through##2##2##(2007-12#1)(2010-10#1)
described to be##4##3##(1993-6#1)(1997-7#1)(2010-5#1)(2013-8#1)
described to confirm##2##3##(2007-8#1)(2010-8#1)
described to date##3##3##(2007-12#1)(2008-10#1)(2010-5#1)
described to##22##2##(1990-8#1)(1993-6#1)(1994-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-11#1)(2010-5#2)(2010-8#2)(2011-2#1)(2013-8#2)
described together with##2##3##(2008-10#1)(2008-4#1)
described two##2##2##(1993-3#1)(2011-2#1)
described using a##2##3##(2008-10#2)
described using the##2##3##(1991-9#1)(1996-2#1)
described using##10##2##(1991-9#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-7#1)(2012-12#1)
described well by the##3##4##(2008-10#2)(2008-3#1)
described well by##5##3##(1991-3#1)(2008-10#3)(2008-3#1)
described well##6##2##(1991-3#1)(1997-2#1)(2008-10#3)(2008-3#1)
described were##4##2##(2008-10#2)(2008-7#1)(2010-4#1)
described where##3##2##(1990-2#1)(2008-10#2)
described whereby##2##2##(1995-12#1)(2007-11#1)
described which##15##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-2#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
described with a##3##3##(1997-3#1)(2008-2#1)(2008-8#1)
described with the##3##3##(2008-3#1)(2013-1#2)
described with##23##2##(1990-7#1)(1991-6#1)(1992-5#1)(1995-5#1)(1997-2#1)(1997-3#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
described within the##2##3##(2008-1#1)(2008-11#1)
described within##4##2##(2008-1#1)(2008-11#1)(2009-3#1)(2011-1#1)
described##2789##1##(1990-10#1)(1990-11#10)(1990-12#13)(1990-2#7)(1990-3#5)(1990-5#9)(1990-6#5)(1990-7#5)(1990-8#17)(1990-9#10)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#9)(1991-3#8)(1991-4#1)(1991-5#18)(1991-6#7)(1991-7#1)(1991-8#5)(1991-9#7)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#15)(1992-2#8)(1992-3#8)(1992-4#4)(1992-5#6)(1992-6#7)(1992-8#14)(1992-9#9)(1993-11#9)(1993-12#6)(1993-2#5)(1993-3#5)(1993-6#10)(1993-8#5)(1993-9#5)(1994-1#3)(1994-11#6)(1994-12#8)(1994-2#13)(1994-3#10)(1994-5#13)(1994-6#5)(1994-8#3)(1994-9#6)(1995-1#4)(1995-11#6)(1995-12#20)(1995-2#10)(1995-3#10)(1995-5#4)(1995-6#13)(1995-8#5)(1995-9#4)(1996-1#8)(1996-11#3)(1996-12#11)(1996-2#15)(1996-3#9)(1996-4#2)(1996-5#13)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#8)(1997-3#18)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#10)(2006-10#5)(2006-12#4)(2006-5#2)(2007-10#8)(2007-11#45)(2007-12#72)(2007-2#3)(2007-5#4)(2007-6#3)(2007-7#9)(2007-8#26)(2008-1#30)(2008-10#763)(2008-11#78)(2008-12#33)(2008-2#135)(2008-3#189)(2008-4#198)(2008-5#54)(2008-6#18)(2008-7#58)(2008-8#25)(2008-9#64)(2009-1#1)(2009-10#8)(2009-11#8)(2009-12#9)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#8)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#6)(2010-1#5)(2010-10#9)(2010-11#10)(2010-12#9)(2010-2#3)(2010-3#11)(2010-4#9)(2010-5#9)(2010-6#11)(2010-7#3)(2010-8#13)(2010-9#3)(2011-1#24)(2011-10#2)(2011-2#66)(2011-3#5)(2011-7#3)(2012-1#5)(2012-12#23)(2012-2#25)(2012-3#23)(2012-4#1)(2013-1#44)(2013-7#15)(2013-8#19)
described)##2##1##(1993-12#1)(2008-4#1)
describes a case of a##3##5##(1994-12#1)(1996-2#1)(2008-11#1)
describes a case of##16##4##(1990-9#1)(1994-12#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
describes a case##18##3##(1990-9#1)(1994-12#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#2)(2013-1#2)
describes a fast and sensitive##2##5##(2008-10#1)(2008-9#1)
describes a fast and##3##4##(2008-10#2)(2008-9#1)
describes a general method for##2##5##(2008-4#1)(2008-9#1)
describes a method for the##6##5##(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)
describes a method for##22##4##(1994-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#9)(2008-9#6)
describes a method of##2##4##(2008-4#2)
describes a method##28##3##(1994-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#14)(2008-9#7)
describes a model for##2##4##(1996-1#1)(2008-9#1)
describes a model##5##3##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-9#1)
describes a new##10##3##(1994-12#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)
describes a newly developed##4##4##(2008-10#4)
describes a novel method for##2##5##(1990-11#1)(2008-10#1)
describes a novel##7##3##(1990-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-7#1)
describes a number of##4##4##(1992-1#1)(1994-2#1)(2008-1#1)(2008-9#1)
describes a patient##3##3##(2006-10#1)(2008-7#1)(2011-1#1)
describes a pregnant patient##2##4##(2009-6#1)(2013-1#1)
describes a procedure for##5##4##(2008-10#1)(2008-4#3)(2008-9#1)
describes a procedure##8##3##(2008-10#4)(2008-4#3)(2008-9#1)
describes a set of##2##4##(2008-1#1)(2008-9#1)
describes a simple and##4##4##(2008-10#2)(2008-4#1)(2008-9#1)
describes a staining##2##3##(2008-4#1)(2008-9#1)
describes a study##3##3##(1996-3#2)(2008-10#1)
describes a successful##2##3##(1996-2#1)(2007-8#1)
describes a system##4##3##(1992-3#1)(1997-1#1)(2008-9#2)
describes a technique##3##3##(1992-6#1)(2008-4#1)(2010-7#1)
describes a##223##2##(1990-11#1)(1990-12#1)(1990-9#2)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-7#1)(1995-2#3)(1996-1#1)(1996-2#4)(1996-3#3)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#9)(2008-10#32)(2008-11#12)(2008-12#3)(2008-2#3)(2008-4#38)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#25)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#1)
describes actions##2##2##(2008-7#1)(2013-1#1)
describes airway hyper-reactivity##2##3##(2010-5#2)
describes an alternative##2##3##(2008-10#1)(2008-5#1)
describes an analytical method for the determination of##2##8##(2008-10#2)
describes an analytical method for##3##5##(2008-10#3)
describes an analytical##4##3##(2008-10#4)
describes an animal model##2##4##(1994-6#1)(2008-4#1)
describes an assay for##2##4##(2008-4#2)
describes an assay##4##3##(2008-4#4)
describes an evaluation##2##3##(2008-11#2)
describes an experimental##2##3##(2007-10#1)(2012-2#1)
describes an in##2##3##(1991-12#1)(2008-1#1)
describes an innovative##4##3##(1992-1#1)(2008-11#1)(2008-12#2)
describes an##48##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-6#1)(1996-12#1)(2006-10#1)(2007-10#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-4#10)(2008-5#2)(2008-9#2)(2010-5#1)(2012-2#2)(2013-1#3)
describes and##2##2##(1992-12#1)(2007-8#1)
describes both##2##2##(1993-2#1)(2008-8#1)
describes considerations##2##2##(2008-4#1)(2010-7#1)
describes development##2##2##(2008-10#2)
describes different##2##2##(2008-4#1)(2013-1#1)
describes experimental##2##2##(2008-10#1)(2008-4#1)
describes for the first time##2##5##(2008-10#1)(2008-6#1)
describes four##3##2##(1995-6#1)(2013-7#1)(2013-8#1)
describes how a new##2##4##(1997-2#1)(2008-12#1)
describes how a##6##3##(1994-1#1)(1996-3#1)(1997-2#1)(2008-12#1)(2010-10#1)(2011-1#1)
describes how an##3##3##(1997-2#1)(1997-3#1)(2008-11#1)
describes how hospitals##3##3##(1992-1#1)(1995-1#1)(1995-3#1)
describes how it##2##3##(1996-1#1)(2008-11#1)
describes how one##2##3##(2008-1#1)(2008-12#1)
describes how the##7##3##(1991-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2009-8#1)(2010-3#1)
describes how to use##4##4##(2008-4#4)
describes how to##18##3##(1991-12#1)(1994-12#1)(2008-1#1)(2008-2#2)(2008-4#13)
describes how##59##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-6#1)(2008-1#2)(2008-11#5)(2008-12#2)(2008-2#4)(2008-4#16)(2009-12#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2013-8#1)
describes immunocytochemical##2##2##(2007-12#1)(2008-9#1)
describes in detail the##5##4##(1996-6#1)(1997-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
describes in detail##7##3##(1996-6#1)(1997-3#1)(2008-4#2)(2008-9#2)(2013-1#1)
describes in##11##2##(1994-3#1)(1996-6#1)(1997-3#1)(2008-4#2)(2008-9#3)(2009-7#1)(2013-1#2)
describes its##6##2##(1992-1#1)(1995-3#1)(1996-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
describes many##2##2##(1993-12#1)(2010-3#1)
describes methods for the##5##4##(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)
describes methods for##16##3##(2008-1#2)(2008-2#3)(2008-4#9)(2008-7#1)(2008-9#1)
describes methods to##3##3##(2008-2#1)(2008-9#1)(2010-5#1)
describes methods##21##2##(2008-1#2)(2008-2#4)(2008-4#10)(2008-7#1)(2008-9#3)(2010-5#1)
describes novel##2##2##(2008-10#1)(2008-11#1)
describes one of##2##3##(2007-8#1)(2008-4#1)
describes one such##2##3##(1997-3#1)(2008-10#1)
describes one##12##2##(1992-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)
describes our##5##2##(1990-11#1)(2007-5#1)(2008-10#1)(2010-8#2)
describes procedures##12##2##(2008-11#1)(2008-4#8)(2008-9#3)
describes protocols for##11##3##(2008-1#2)(2008-2#2)(2008-4#6)(2008-9#1)
describes protocols##14##2##(2008-1#2)(2008-2#2)(2008-4#7)(2008-9#3)
describes recent progress##2##3##(2007-8#1)(2011-2#1)
describes recent##8##2##(1993-3#1)(2007-8#1)(2008-10#4)(2008-8#1)(2011-2#1)
describes screening for##2##3##(2008-2#1)(2008-9#1)
describes several##6##2##(1991-1#1)(1997-3#1)(2008-4#3)(2008-9#1)
describes simple##2##2##(2008-4#1)(2008-9#1)
describes some characteristics##2##3##(1997-3#1)(2011-2#1)
describes some of the key##2##5##(1992-1#1)(2013-1#1)
describes some of the##10##4##(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-1#1)(2008-1#1)(2008-4#1)(2013-1#1)
describes some of##11##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-1#1)(2008-1#1)(2008-4#1)(2010-9#1)(2013-1#1)
describes some##18##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-1#1)(1994-12#1)(1995-1#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
describes staining##2##2##(2008-4#1)(2008-9#1)
describes strategies##5##2##(2008-2#1)(2008-4#2)(2008-5#1)(2011-1#1)
describes such##2##2##(2007-12#1)(2008-10#1)
describes testing##2##2##(2008-4#1)(2008-5#1)
describes the activation of##2##4##(2008-4#2)
describes the advantages##2##3##(1996-3#1)(2012-2#1)
describes the analysis of##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
describes the application of##3##4##(1993-2#1)(2008-10#2)
describes the assessment of##2##4##(1995-12#1)(2008-4#1)
describes the basic principles of the##2##6##(2008-9#2)
describes the basic##5##3##(2008-4#2)(2008-9#3)
describes the binding##2##3##(1996-2#1)(2008-10#1)
describes the clinical and##2##4##(1990-2#1)(1992-5#1)
describes the clinical##5##3##(1990-2#1)(1992-5#1)(2007-11#1)(2011-1#1)(2012-2#1)
describes the components of##2##4##(1993-3#1)(2008-4#1)
describes the construction and##2##4##(2008-10#1)(2008-4#1)
describes the construction##3##3##(2008-10#2)(2008-4#1)
describes the current state of##2##5##(2008-8#1)(2010-2#1)
describes the current##6##3##(1997-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-2#1)
describes the data collection process##2##5##(1997-2#1)(2008-11#1)
describes the data##5##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
describes the design##5##3##(2008-10#4)(2008-9#1)
describes the determination of##5##4##(2008-10#3)(2008-4#1)(2008-9#1)
describes the development and application of##2##6##(2008-10#2)
describes the development and##3##4##(2008-10#3)
describes the development of a##7##5##(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-2#1)
describes the development of##16##4##(1994-12#1)(1996-3#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
describes the development##22##3##(1994-12#1)(1996-3#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-6#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
describes the discovery of##2##4##(2008-10#1)(2008-6#1)
describes the distribution of##3##4##(1997-2#1)(2008-1#1)(2008-2#1)
describes the dynamics of##2##4##(2008-8#2)
describes the effect of##2##4##(1990-2#1)(2008-9#1)
describes the effect##3##3##(1990-2#1)(2008-1#1)(2008-9#1)
describes the effects of##4##4##(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
describes the electroporation of mammalian cells and an##2##8##(2008-1#1)(2008-2#1)
describes the experimental##3##3##(2008-10#3)
describes the first##5##3##(1990-6#1)(1991-5#1)(1992-4#1)(1996-3#1)(2008-11#1)
describes the impact##3##3##(1994-12#1)(2007-8#1)(2008-11#1)
describes the implementation of##2##4##(2008-9#1)(2012-1#1)
describes the implementation##3##3##(1992-2#1)(2008-9#1)(2012-1#1)
describes the isolation of##6##4##(1994-11#1)(2008-10#1)(2008-4#3)(2008-9#1)
describes the isolation##7##3##(1994-11#1)(2008-10#1)(2008-4#4)(2008-9#1)
describes the measurement of##2##4##(2008-4#2)
describes the methods##3##3##(1995-3#1)(2008-1#1)(2008-9#1)
describes the most common##2##4##(2008-1#1)(2008-4#1)
describes the most##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
describes the natural##2##3##(2006-10#1)(2008-2#1)
describes the new##2##3##(2008-10#1)(2008-8#1)
describes the potential##3##3##(1991-3#1)(2008-7#1)(2011-2#1)
describes the preparation of##10##4##(2008-2#1)(2008-4#7)(2008-9#2)
describes the preparation##11##3##(2008-10#1)(2008-2#1)(2008-4#7)(2008-9#2)
describes the principles##2##3##(1996-2#1)(2010-3#1)
describes the problems##2##3##(2008-11#1)(2008-9#1)
describes the procedure##2##3##(2008-11#1)(2008-4#1)
describes the procedures##3##3##(2008-2#1)(2008-3#1)(2009-9#1)
describes the process and##2##4##(2008-1#1)(2012-12#1)
describes the process followed##2##4##(1994-3#1)(2010-5#1)
describes the process of##3##4##(1995-2#1)(2008-11#1)(2010-6#1)
describes the process##9##3##(1994-1#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-11#2)(2010-5#1)(2010-6#1)(2012-12#1)
describes the quantitative##2##3##(2008-5#1)(2009-5#1)
describes the recent##3##3##(1991-1#1)(2008-11#2)
describes the relation between##2##4##(1991-6#1)(2010-10#1)
describes the results of a##5##5##(1991-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2008-10#1)
describes the results##6##3##(1991-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-5#1)
describes the role of##2##4##(2008-11#2)
describes the role##3##3##(2008-11#2)(2009-8#1)
describes the scope##2##3##(2008-1#1)(2008-6#1)
describes the significant##2##3##(2008-8#1)(2013-1#1)
describes the strategic planning process used##2##6##(1991-2#1)(1994-2#1)
describes the structure##2##3##(1997-2#1)(2008-12#1)
describes the successful##2##3##(2008-10#2)
describes the surgical##3##3##(1992-1#1)(1997-2#1)(2008-4#1)
describes the synthesis of##2##4##(2008-4#2)
describes the synthesis##4##3##(2008-4#4)
describes the technical aspects of##2##5##(1997-8#1)(2013-8#1)
describes the techniques for##2##4##(2008-4#1)(2008-9#1)
describes the techniques##3##3##(2008-4#1)(2008-9#2)
describes the technology##2##3##(2008-1#1)(2008-4#1)
describes the total##2##3##(1994-2#1)(2007-8#1)
describes the types of##4##4##(1992-12#1)(1993-1#1)(1995-12#1)(2008-4#1)
describes the use of a##7##5##(1992-1#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
describes the use of the##7##5##(1996-3#1)(1996-9#1)(2008-4#5)
describes the use of##37##4##(1990-6#1)(1992-1#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2012-12#1)(2013-8#1)
describes the various##2##3##(2011-2#1)(2012-12#1)
describes the##513##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#1)(1992-1#3)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#2)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#3)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#9)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#4)(1997-4#1)(1997-7#3)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-7#1)(2007-8#6)(2008-1#15)(2008-10#62)(2008-11#23)(2008-12#11)(2008-2#22)(2008-3#10)(2008-4#75)(2008-5#9)(2008-6#9)(2008-7#11)(2008-8#10)(2008-9#33)(2009-10#3)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#2)(2010-5#4)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#8)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#16)
describes these##6##2##(2007-10#1)(2007-3#1)(2008-11#1)(2008-9#1)(2010-1#1)(2011-3#1)
describes this##5##2##(1997-2#1)(2007-12#1)(2008-11#2)(2008-7#1)
describes three cases of##2##4##(2008-10#1)(2013-1#1)
describes three##9##2##(1993-11#1)(1995-12#1)(2008-10#1)(2008-9#2)(2010-2#1)(2010-3#1)(2013-1#2)
describes tissue##2##2##(2008-4#1)(2008-9#1)
describes two basic##2##3##(2008-9#2)
describes two##16##2##(1994-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#6)(2008-7#1)(2008-9#3)(2010-1#1)(2010-6#1)
describes various##4##2##(1991-1#1)(1995-2#1)(2008-11#1)(2008-4#1)
describes what##2##2##(1992-11#1)(2010-4#1)
describes why##2##2##(1996-12#1)(2007-7#1)
describes##1217##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-9#3)(1991-1#7)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#3)(1991-5#5)(1991-6#1)(1992-1#8)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#9)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#7)(1994-1#7)(1994-11#2)(1994-12#13)(1994-2#8)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#8)(1995-11#1)(1995-12#7)(1995-2#5)(1995-3#10)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#12)(1996-2#11)(1996-3#14)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#17)(1997-3#14)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#6)(2007-10#6)(2007-11#7)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#5)(2007-8#11)(2008-1#39)(2008-10#124)(2008-11#59)(2008-12#25)(2008-2#42)(2008-3#13)(2008-4#229)(2008-5#18)(2008-6#16)(2008-7#23)(2008-8#14)(2008-9#99)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#2)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#9)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#9)(2011-2#25)(2011-3#2)(2012-1#2)(2012-12#14)(2012-2#8)(2012-3#10)(2012-8#1)(2013-1#31)(2013-7#3)(2013-8#19)
describing a##9##2##(1992-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#2)(2011-2#1)(2013-1#1)
describing brain activations##2##3##(2012-12#2)
describing brain##3##2##(2012-12#2)(2012-2#1)
describing chemical##2##2##(2008-2#1)(2009-9#1)
describing how##3##2##(2008-10#1)(2008-7#1)(2009-9#1)
describing proton##3##2##(1990-8#1)(2012-12#2)
describing the characteristics##2##3##(2011-1#1)(2013-1#1)
describing the effect of##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
describing the effects of##2##4##(2008-3#1)(2013-7#1)
describing the relationship##2##3##(2008-10#1)(2008-7#1)
describing the spatial##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
describing the##85##2##(1990-6#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#3)
describing their##5##2##(2008-10#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-2#1)
describing these##4##2##(2008-5#1)(2012-3#1)(2013-1#2)
describing this##2##2##(2008-10#1)(2008-3#1)
describing##200##1##(1990-10#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1995-6#1)(1996-2#3)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#11)(2008-8#8)(2008-9#13)(2009-10#3)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#5)
description and analysis of##2##4##(1996-2#1)(2013-1#1)
description and##10##2##(1992-12#1)(1996-2#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#3)
description based on##2##3##(2008-3#1)(2012-2#1)
description by##2##2##(2008-6#1)(2010-1#1)
description can##2##2##(2008-10#1)(2009-3#1)
description for the##3##3##(1992-1#1)(2008-3#1)(2008-7#1)
description in##3##2##(2007-11#1)(2011-2#2)
description is provided##2##3##(2007-12#1)(2010-10#1)
description is##6##2##(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-10#1)
description of a##13##3##(1991-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2013-1#1)
description of all##2##3##(2008-10#1)(2008-9#1)
description of each##2##3##(2008-5#1)(2010-3#1)
description of how##2##3##(2007-10#1)(2008-9#1)
description of its##2##3##(1992-1#1)(2012-2#1)
description of one##2##3##(2008-12#1)(2008-4#1)
description of sequence variants in##2##5##(2008-4#2)
description of the electrode response##2##5##(2008-10#2)
description of the experimental##2##4##(2008-3#1)(2010-10#1)
description of the last##2##4##(1996-1#1)(2008-6#1)
description of the main##2##4##(2007-12#1)(2008-11#1)
description of the new##2##4##(2008-11#1)(2008-3#1)
description of the system##3##4##(2007-11#1)(2010-12#1)(2012-3#1)
description of the##124##3##(1990-12#1)(1990-5#1)(1991-11#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#7)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
description of their##3##3##(2008-10#1)(2008-4#1)(2011-7#1)
description of this##6##3##(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-3#1)
description of traditional##2##3##(1997-3#1)(2013-1#1)
description of##256##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1992-1#6)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#13)(2007-12#5)(2007-5#1)(2007-8#3)(2008-1#4)(2008-10#23)(2008-11#8)(2008-12#6)(2008-2#6)(2008-3#21)(2008-4#9)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#13)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-10#4)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#8)(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#4)
description##321##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1992-1#7)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#16)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#25)(2008-11#8)(2008-12#7)(2008-2#9)(2008-3#31)(2008-4#9)(2008-5#9)(2008-6#7)(2008-7#13)(2008-8#4)(2008-9#13)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-9#2)(2010-1#1)(2010-10#6)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#3)(2011-2#12)(2011-7#2)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#14)(2013-7#3)(2013-8#5)
descriptions and##3##2##(1994-1#1)(2008-2#1)(2013-1#1)
descriptions for the##2##3##(2008-12#1)(2008-4#1)
descriptions for##4##2##(1994-3#1)(2008-12#1)(2008-4#1)(2008-9#1)
descriptions of a##2##3##(2008-7#1)(2009-11#1)
descriptions of each##2##3##(2008-9#1)(2013-8#1)
descriptions of how##2##3##(2008-11#2)
descriptions of the##11##3##(1994-2#1)(1995-1#1)(1996-3#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)
descriptions of##41##2##(1993-2#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-3#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
descriptions with##2##2##(1997-3#1)(2008-7#1)
descriptions##64##1##(1992-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#2)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
descriptive analysis of the##2##4##(2012-12#1)(2012-2#1)
descriptive analysis of##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
descriptive analysis##11##2##(1991-12#1)(1992-1#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
descriptive and explorative##2##3##(2009-12#1)(2011-2#1)
descriptive and##15##2##(1993-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-8#2)(2009-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
descriptive correlational study##2##3##(2007-2#1)(2010-10#1)
descriptive correlational##3##2##(2007-2#1)(2010-10#1)(2012-3#1)
descriptive cross-sectional study was##2##4##(2011-2#1)(2013-1#1)
descriptive cross-sectional study with##2##4##(2010-9#1)(2012-12#1)
descriptive cross-sectional study##5##3##(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
descriptive cross-sectional##6##2##(2008-4#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
descriptive data##3##2##(1993-3#1)(2008-11#1)(2008-7#1)
descriptive design was##2##3##(2007-11#1)(2010-3#1)
descriptive epidemiological##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
descriptive information on##2##3##(1994-2#1)(1997-2#1)
descriptive information##4##2##(1993-12#1)(1994-2#1)(1995-3#1)(1997-2#1)
descriptive methods##2##2##(2008-10#1)(2010-1#1)
descriptive overview of##2##3##(2013-1#2)
descriptive pain##2##2##(2009-3#2)
descriptive phenomenological study##2##3##(2008-11#1)(2010-11#1)
descriptive qualitative study##2##3##(2010-10#1)(2013-1#1)
descriptive qualitative##3##2##(2010-10#1)(2010-3#1)(2013-1#1)
descriptive statistical##2##2##(2008-9#1)(2012-3#1)
descriptive statistics and##2##3##(2008-4#1)(2011-1#1)
descriptive statistics##7##2##(1993-12#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
descriptive study of##7##3##(1994-6#1)(2007-12#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
descriptive study to##2##3##(2010-6#1)(2012-12#1)
descriptive study was conducted##3##4##(2008-1#1)(2010-11#1)(2011-1#1)
descriptive study was##8##3##(2007-11#1)(2008-1#1)(2010-11#1)(2010-3#1)(2011-1#3)(2012-3#1)
descriptive study which##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
descriptive study##37##2##(1994-6#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-12#8)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
descriptive survey##6##2##(1992-1#1)(2008-12#1)(2010-10#1)(2010-3#1)(2010-8#1)(2013-8#1)
descriptive##168##1##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#4)(2008-2#2)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#2)(2009-8#3)(2010-1#2)(2010-10#7)(2010-11#3)(2010-3#6)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#11)(2012-12#20)(2012-2#5)(2012-3#10)(2013-1#14)(2013-8#3)
descriptor##6##1##(2008-1#1)(2008-10#3)(2011-2#2)
descriptors and##2##2##(2008-10#1)(2009-3#1)
descriptors as##2##2##(2008-10#1)(2009-8#1)
descriptors in##3##2##(2007-11#2)(2008-10#1)
descriptors of dyspnea##4##3##(2008-10#4)
descriptors of##11##2##(1992-6#1)(2007-11#2)(2008-10#7)(2012-2#1)
descriptors to##3##2##(2008-10#2)(2012-1#1)
descriptors was##3##2##(2007-11#1)(2008-10#2)
descriptors were used##2##3##(2007-11#1)(2008-12#1)
descriptors were##6##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)
descriptors which##2##2##(2009-3#1)(2012-2#1)
descriptors##70##1##(1992-6#1)(1996-3#1)(1997-2#1)(2007-11#18)(2008-1#3)(2008-10#29)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-7#1)
desensitization and##2##2##(2008-5#1)(2008-8#1)
desensitization of the angiotensin receptors##2##5##(1994-2#2)
desensitization of the##7##3##(1992-3#1)(1993-9#1)(1994-2#2)(1994-5#1)(2008-10#1)(2008-2#1)
desensitization of##16##2##(1992-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#3)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-7#1)(2012-3#1)
desensitization to chemotherapy drug protocols in##2##6##(2011-1#2)
desensitization to chemotherapy##3##3##(2011-1#3)
desensitization to##8##2##(1991-12#1)(1992-2#1)(1997-2#1)(2008-3#1)(2011-1#4)
desensitization##56##1##(1990-2#1)(1991-12#2)(1992-2#2)(1992-3#5)(1993-9#2)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#5)(1995-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#9)(2009-7#1)(2011-1#5)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
desensitizations##4##1##(2008-8#4)
desensitize##2##1##(1995-5#1)(2008-4#1)
desensitized to##2##2##(1991-12#1)(2008-8#1)
desensitized##7##1##(1991-12#1)(1995-12#1)(1995-8#1)(1997-1#1)(2008-2#1)(2008-8#2)
desensitizing dentifrice##4##2##(2011-2#4)
desensitizing effect##2##2##(1992-3#1)(2008-3#1)
desensitizing toothpastes##2##2##(2011-2#2)
desensitizing##10##1##(1992-3#1)(2008-3#1)(2011-2#8)
desert locust Schistocerca gregaria##2##4##(2007-12#1)(2012-12#1)
desert##17##1##(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-8#2)(2009-4#1)(2009-6#1)(2012-12#1)(2013-1#1)
deserted ducklings##2##2##(2008-9#2)
deserted##3##1##(2008-9#3)
desertion##6##1##(2008-8#3)(2008-9#3)
deserve further##2##2##(2007-10#1)(2008-6#1)
deserve##17##1##(1991-11#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#2)(2007-10#1)(2007-5#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
deserves a##2##2##(2007-10#1)(2008-7#1)
deserves further##5##2##(1991-6#1)(1997-5#1)(2008-7#1)(2012-3#2)
deserves to be##2##3##(2009-10#1)(2011-2#1)
deserves##19##1##(1990-12#2)(1991-6#1)(1996-11#2)(1996-4#1)(1997-5#1)(2007-10#1)(2008-7#3)(2009-10#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#1)
deserving particular attention##2##3##(1993-5#1)(2013-1#1)
deserving##4##1##(1993-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
desethylamiodarone##5##1##(1990-5#5)
desethylatrazine (DEA)##2##2##(2008-10#2)
desethylatrazine##3##1##(2008-10#3)
desferrioxamine and##2##2##(2008-10#1)(2008-11#1)
desferrioxamine mesylate and lisinopril##2##4##(2008-10#2)
desferrioxamine##16##1##(1990-12#1)(1990-9#1)(1991-3#1)(1992-11#2)(1993-2#2)(2008-10#5)(2008-11#1)(2008-12#3)
desialylation of##2##2##(2008-11#1)(2008-7#1)
desialylation##5##1##(2008-11#3)(2008-7#2)
desiccated seeds##2##2##(2013-7#2)
desiccated##5##1##(2008-10#1)(2008-3#2)(2013-7#2)
desiccation of##3##2##(2008-10#2)(2008-11#1)
desiccation resistance##3##2##(2008-10#3)
desiccation to##2##2##(2013-7#2)
desiccation##17##1##(1992-12#2)(2008-10#8)(2008-11#1)(2008-8#2)(2013-7#4)
design a##13##2##(1992-3#2)(1993-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)
design algorithm##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
design allowed us to##2##4##(2008-3#1)(2008-5#1)
design allows##2##2##(2007-12#1)(2008-3#1)
design also##2##2##(2008-10#1)(2012-3#1)
design an##6##2##(1994-2#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
design and a central composite design##2##6##(2008-10#2)
design and a##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
design and analysis in##2##4##(1995-5#1)(2008-3#1)
design and analysis of a##2##5##(1996-6#1)(2008-3#1)
design and analysis of##5##4##(1992-6#1)(1996-6#1)(2008-2#1)(2008-3#2)
design and analysis##9##3##(1992-6#1)(1994-2#1)(1995-5#1)(1996-6#1)(2008-2#2)(2008-3#3)
design and application of##2##4##(2008-10#1)(2008-3#1)
design and application to##3##4##(2008-3#3)
design and application##5##3##(2008-10#1)(2008-3#4)
design and business##2##3##(2012-3#2)
design and characterization of a##2##5##(2007-12#1)(2008-3#1)
design and characterization of##3##4##(2007-12#1)(2008-3#2)
design and construction of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
design and construction##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
design and control##2##3##(1994-5#1)(2012-2#1)
design and data##2##3##(2008-7#1)(2011-2#1)
design and delivery##3##3##(1995-5#1)(2009-4#1)(2013-8#1)
design and development of##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
design and development##4##3##(1995-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
design and ease of##2##4##(2008-10#1)(2008-3#1)
design and evaluation of##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
design and evaluation##4##3##(1997-3#1)(2008-2#1)(2008-3#1)(2013-8#1)
design and fabrication of a##2##5##(2007-11#1)(2009-9#1)
design and fabrication of##8##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-9#1)
design and fabrication##10##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-9#1)
design and implementation##10##3##(1991-1#1)(1995-1#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#2)(2012-2#1)
design and initial##2##3##(2008-11#1)(2008-3#1)
design and its##2##3##(2008-2#1)(2008-3#1)
design and jumping technique##2##4##(1995-2#2)
design and management of##3##4##(1995-12#1)(2010-4#1)(2013-1#1)
design and manufacture##2##3##(2008-2#1)(2008-3#1)
design and manufacturing##2##3##(2010-10#1)(2010-3#1)
design and methodology##2##3##(1993-6#1)(2008-8#1)
design and operation##7##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)
design and optimization of##2##4##(2008-2#1)(2013-7#1)
design and performance of a##2##5##(2008-3#2)
design and performance of##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
design and performance##9##3##(2008-10#1)(2008-2#2)(2008-3#5)(2010-8#1)
design and process##2##3##(1996-3#1)(2008-3#1)
design and production of##2##4##(2008-7#1)(2012-2#1)
design and recording##2##3##(2008-2#2)
design and renovation of##2##4##(2012-3#2)
design and testing of##3##4##(2008-2#1)(2008-3#1)(2009-4#1)
design and the fabrication##3##4##(2008-2#1)(2008-3#2)
design and the##23##3##(1993-1#1)(1994-9#1)(1995-2#1)(1996-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
design and##220##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#4)(1997-2#2)(1997-3#2)(2007-11#6)(2007-12#8)(2007-7#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#20)(2008-3#41)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#4)
design applied to##2##3##(2008-5#1)(2011-1#1)
design applied##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
design approach was##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
design approach##11##2##(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#2)(2009-7#1)
design approaches##2##2##(2008-2#1)(2008-3#1)
design appropriate##2##2##(1994-10#1)(2009-10#1)
design are discussed##4##3##(1993-12#1)(2008-2#2)(2008-3#1)
design are##7##2##(1993-12#1)(2008-2#2)(2008-3#3)(2009-8#1)
design as##2##2##(2008-10#1)(2011-2#1)
design aspects##2##2##(2008-3#2)
design at##4##2##(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
design by##4##2##(1995-2#1)(2008-2#1)(2008-3#2)
design can be##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)
design can##10##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)(2012-2#2)
design characteristics and##2##3##(2008-12#1)(2010-1#1)
design concept##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
design considerations for##2##3##(2008-11#1)(2008-3#1)
design considerations##5##2##(2008-10#1)(2008-11#2)(2008-3#2)
design constraints and##3##3##(2008-3#1)(2010-10#2)
design criteria for##3##3##(2008-10#1)(2008-2#1)(2010-10#1)
design criteria##6##2##(2007-12#1)(2008-10#1)(2008-2#3)(2010-10#1)
design criterion##3##2##(2008-6#1)(2008-7#2)
design described##2##2##(1995-1#1)(2008-2#1)
design elements##2##2##(1997-2#1)(2013-1#1)
design eliminates##2##2##(2007-12#1)(2008-2#1)
design encompasses##2##2##(2008-10#1)(2008-2#1)
design examples are##2##3##(2008-2#1)(2008-3#1)
design examples##4##2##(2008-2#2)(2008-3#2)
design features of##2##3##(2008-3#1)(2012-3#1)
design features##4##2##(1996-12#1)(1997-4#1)(2008-3#1)(2012-3#1)
design firms##2##2##(1992-2#1)(1997-3#1)
design for a##21##3##(1995-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#5)(2008-3#9)(2011-2#1)(2013-1#1)
design for an##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
design for imaging##2##3##(2008-3#1)(2012-2#1)
design for optimization##3##3##(2008-10#3)
design for the##8##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2013-1#2)
design for two component mixtures##2##5##(2008-10#2)
design for##67##2##(1992-9#1)(1995-2#3)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#9)(2008-3#24)(2008-5#1)(2008-7#2)(2009-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
design guidelines##2##2##(2007-12#1)(2012-2#1)
design has several advantages over##2##5##(2008-2#1)(2011-2#1)
design has##7##2##(1994-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
design have##6##2##(1992-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
design in the##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
design in##19##2##(1994-12#1)(1995-12#1)(1996-3#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
design includes##3##2##(2008-3#1)(2010-3#2)
design including##2##2##(2008-10#1)(2009-5#1)
design incorporates##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
design incorporating##2##2##(2008-10#1)(2012-3#1)
design interventions##2##2##(2011-2#1)(2013-8#1)
design involving##2##2##(1993-8#1)(2008-10#1)
design is applied to##2##4##(2008-10#1)(2008-3#1)
design is based on##3##4##(1994-1#1)(1994-3#1)(2011-2#1)
design is presented##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-8#1)
design is proposed##2##3##(2007-12#1)(2008-3#1)
design is the##2##3##(2007-6#1)(2008-3#1)
design is used for the##3##5##(2008-10#3)
design is used##4##3##(2008-10#3)(2008-11#1)
design is##43##2##(1993-3#1)(1994-1#1)(1994-3#1)(1995-9#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-2#6)(2008-3#11)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
design issues and##2##3##(2007-10#1)(2009-11#1)
design issues##6##2##(1991-1#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
design may##4##2##(2007-9#1)(2008-8#1)(2011-2#2)
design method is presented that##2##5##(2008-2#1)(2008-3#1)
design method##12##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#3)(2010-10#1)(2010-8#1)(2012-3#1)
design methodologies##3##2##(2008-10#2)(2008-3#1)
design methodology##4##2##(1997-4#1)(2008-10#2)(2010-10#1)
design methods##4##2##(1993-3#1)(2008-3#3)
design more##2##2##(2011-2#1)(2013-1#1)
design of a digital##2##4##(2008-2#1)(2010-8#1)
design of a nonperiodic grating-assisted directional coupler##2##7##(2008-3#2)
design of a polarization converter##2##5##(2008-3#2)
design of a simple##2##4##(2008-10#1)(2008-3#1)
design of a##47##3##(1994-11#1)(1994-3#2)(1996-6#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#5)(2008-3#26)(2008-7#1)(2008-8#2)(2010-8#1)
design of an##11##3##(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)
design of clinical trials of##2##5##(1995-5#1)(2008-8#1)
design of clinical trials##3##4##(1995-5#1)(2008-8#1)(2010-11#1)
design of diffractive optical elements (DOE's)##2##6##(2008-3#2)
design of diffractive optical elements##4##5##(2007-12#1)(2008-3#3)
design of diffractive optical##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
design of diffractive##10##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#5)
design of effective##3##3##(2011-2#3)
design of experiments&quot##2##3##(2008-10#2)
design of imaging##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
design of low noise##2##4##(2010-8#2)
design of modified Wollaston prisms##2##5##(2008-3#2)
design of new##10##3##(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
design of novel##5##3##(2008-1#1)(2008-3#2)(2008-5#1)(2009-3#1)
design of optical##3##3##(2008-2#2)(2008-3#1)
design of our##2##3##(2008-4#1)(2008-7#1)
design of such##6##3##(1994-9#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
design of the experiment##2##4##(2008-12#1)(2008-7#1)
design of the probes##2##4##(2010-5#2)
design of the study##2##4##(2008-11#1)(2010-3#1)
design of the system and##2##5##(2008-10#1)(2008-2#1)
design of the system##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2012-3#1)
design of the##47##3##(1990-2#1)(1992-2#1)(2007-11#4)(2007-12#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
design of these##2##3##(2008-10#1)(2011-2#1)
design of this##6##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
design of##324##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#2)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#3)(1997-6#1)(2006-10#1)(2007-11#18)(2007-12#10)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#31)(2008-11#6)(2008-12#5)(2008-2#28)(2008-3#84)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#2)(2010-5#3)(2010-8#4)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#10)(2012-3#6)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#4)
design offers a##2##3##(2008-2#1)(2009-10#1)
design on the##2##3##(2007-12#1)(2008-10#1)
design on##6##2##(2007-12#1)(2008-10#3)(2008-9#1)(2011-1#1)
design optimization and##2##3##(2008-2#2)
design optimization of the##2##4##(2008-10#1)(2008-2#1)
design optimization##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
design or##2##2##(2008-10#1)(2011-1#1)
design parameters for##4##3##(1995-5#1)(2007-12#1)(2008-2#2)
design parameters of the##2##4##(2008-3#2)
design parameters of##4##3##(2008-3#4)
design parameters##19##2##(1993-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#8)(2009-11#1)
design permits##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
design principles##9##2##(1994-3#1)(2007-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-12#1)
design problem##2##2##(2008-3#1)(2012-1#1)
design procedure for##2##3##(2008-2#1)(2008-3#1)
design procedure##5##2##(2008-2#1)(2008-3#4)
design process##6##2##(1996-1#1)(2008-2#2)(2008-3#2)(2010-10#1)
design provides##2##2##(2008-3#2)
design rationale##2##2##(2008-3#1)(2009-7#1)
design relies on the##2##4##(2008-3#2)
design requirements for##2##3##(2007-12#1)(2008-2#1)
design requirements##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
design rules for the##2##4##(2007-11#1)(2008-3#1)
design rules##3##2##(2007-11#1)(2008-3#2)
design strategies##2##2##(2011-3#1)(2013-1#1)
design strategy##3##2##(1994-2#1)(2009-9#1)(2012-2#1)
design structures##2##2##(1996-7#1)(2009-12#1)
design study##4##2##(2008-10#2)(2010-7#2)
design systems##2##2##(1990-4#1)(1997-2#1)
design techniques##3##2##(1994-12#1)(2007-12#1)(2008-2#1)
design that uses##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
design that##19##2##(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#2)
design the trial to##2##4##(1995-5#2)
design the##15##2##(1995-5#2)(1996-1#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#1)
design their own##2##3##(1995-1#1)(2008-4#1)
design to detect##2##3##(2008-10#2)
design to determine##2##3##(1996-3#1)(2010-3#1)
design to##26##2##(1995-2#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
design tool for##2##3##(2008-2#1)(2008-3#1)
design tool##3##2##(2008-2#1)(2008-3#2)
design two##2##2##(1996-2#1)(2008-10#1)
design using##2##2##(2008-5#1)(2013-1#1)
design utilizes##2##2##(2008-3#1)(2009-10#1)
design variables##3##2##(2007-9#2)(2013-1#1)
design was a##2##3##(2007-12#1)(2008-12#1)
design was applied##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
design was employed to evaluate the##2##6##(2008-12#1)(2008-6#1)
design was employed to##4##4##(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#1)
design was employed##7##3##(2008-10#2)(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#2)
design was proposed##2##3##(2008-10#2)
design was run##2##3##(2008-10#2)
design was used for##4##4##(2008-10#4)
design was used in##2##4##(1996-1#1)(2008-10#1)
design was used to determine the##2##6##(2008-10#1)(2011-2#1)
design was used to determine##3##5##(2008-10#2)(2011-2#1)
design was used to##14##4##(2007-10#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2010-5#1)(2011-1#2)(2011-2#2)
design was used with##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
design was used##30##3##(1996-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-8#1)
design was##67##2##(1994-3#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#5)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#2)(2010-5#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
design were used##2##3##(2008-10#2)
design were##5##2##(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)
design with a##10##3##(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-8#1)
design with four##2##3##(2008-12#1)(2008-6#1)
design with three##2##3##(2008-10#2)
design with##31##2##(1995-1#1)(2007-12#2)(2008-10#7)(2008-12#3)(2008-2#2)(2008-3#6)(2008-6#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
design##1698##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#3)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#8)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#7)(1993-6#1)(1993-8#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#10)(1994-3#10)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#6)(1995-12#8)(1995-2#14)(1995-3#10)(1995-5#8)(1995-6#2)(1995-9#1)(1996-1#6)(1996-12#7)(1996-2#6)(1996-3#7)(1996-6#5)(1996-7#1)(1997-1#3)(1997-2#7)(1997-3#9)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#46)(2007-12#50)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#8)(2008-10#262)(2008-11#40)(2008-12#28)(2008-2#145)(2008-3#315)(2008-4#15)(2008-5#34)(2008-6#16)(2008-7#56)(2008-8#17)(2008-9#19)(2009-10#5)(2009-11#5)(2009-12#6)(2009-2#3)(2009-3#1)(2009-4#8)(2009-5#6)(2009-6#1)(2009-7#11)(2009-8#3)(2009-9#9)(2010-1#2)(2010-10#12)(2010-11#9)(2010-12#4)(2010-2#6)(2010-3#11)(2010-4#7)(2010-5#8)(2010-6#2)(2010-7#5)(2010-8#21)(2010-9#2)(2011-1#24)(2011-2#47)(2011-3#4)(2011-9#1)(2012-1#10)(2012-12#33)(2012-2#36)(2012-3#36)(2012-5#1)(2013-1#55)(2013-7#9)(2013-8#21)
design)##5##1##(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-8#1)
design-orientated##2##1##(2009-12#2)
designate##5##1##(1991-3#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-9#1)
designated &quot##4##2##(1992-1#1)(1993-11#1)(2008-1#1)(2010-3#1)
designated as &quot##3##3##(2008-1#3)
designated as Lr46##2##3##(2008-10#2)
designated as the##3##3##(1992-3#1)(2008-10#2)
designated as##65##2##(1990-11#1)(1991-8#1)(1992-3#2)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#3)(1995-11#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-8#1)(2007-5#1)(2008-1#3)(2008-10#25)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#7)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)
designated beet##2##2##(2008-10#2)
designated species##2##2##(2008-10#2)
designated the##2##2##(1995-6#1)(2008-10#1)
designated this gene##2##3##(1994-12#1)(1995-6#1)
designated this##5##2##(1990-5#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)
designated##224##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-5#4)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#3)(1995-6#4)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#3)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#5)(2008-10#93)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#12)(2009-10#1)(2009-2#1)(2009-8#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
designates##2##1##(2012-12#2)
designation from the##2##3##(2008-5#1)(2008-7#1)
designation in##2##2##(2008-10#1)(2008-9#1)
designation of##4##2##(2007-7#1)(2008-10#1)(2008-6#1)(2013-8#1)
designation##13##1##(1992-5#1)(2007-7#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
designations##3##1##(2008-10#2)(2010-6#1)
designed a new##4##3##(1990-12#1)(2008-2#1)(2008-5#1)(2010-2#1)
designed a##20##2##(1990-12#1)(1992-1#1)(1995-3#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
designed according to the##4##4##(2008-10#1)(2008-3#1)(2008-8#2)
designed according to##6##3##(1993-6#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)
designed an##3##2##(2008-12#1)(2010-8#1)(2011-2#1)
designed and built a##5##4##(2008-3#3)(2009-6#1)(2009-8#1)
designed and built##10##3##(2008-11#1)(2008-2#1)(2008-3#6)(2009-6#1)(2009-8#1)
designed and constructed##7##3##(1997-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-4#1)
designed and developed in##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
designed and developed to##2##4##(2009-12#1)(2010-8#1)
designed and developed##8##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-8#1)
designed and evaluated##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
designed and fabricated to##2##4##(2008-10#1)(2010-2#1)
designed and fabricated##13##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-5#1)(2010-2#1)
designed and implemented##8##3##(1991-12#1)(2008-3#2)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
designed and manufactured##2##3##(2007-11#1)(2008-3#1)
designed and optimized##2##3##(2008-10#1)(2008-2#1)
designed and prepared##4##3##(2007-11#1)(2008-3#1)(2008-9#1)(2012-1#1)
designed and realized##2##3##(2007-12#1)(2012-3#1)
designed and synthesized as##3##4##(2008-11#1)(2008-8#1)(2010-5#1)
designed and synthesized for##2##4##(2008-10#1)(2012-12#1)
designed and synthesized##14##3##(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-6#1)(2011-3#3)(2012-12#1)
designed and tested##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
designed and used to##3##4##(2008-10#2)(2008-3#1)
designed and##102##2##(1991-12#2)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#25)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)
designed around##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
designed as a##9##3##(1992-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
designed as##13##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#2)
designed based on the##5##4##(1993-8#1)(2008-10#3)(2011-2#1)
designed based on##8##3##(1993-8#1)(2008-10#5)(2011-2#1)(2012-12#1)
designed by an##2##3##(2008-11#1)(2010-10#1)
designed by inverse spectral theory##3##5##(2008-2#1)(2008-3#2)
designed by the##2##3##(1993-12#1)(2008-10#1)
designed by use of the##2##5##(2008-3#2)
designed by use of##6##4##(2008-3#6)
designed by##22##2##(1991-12#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#10)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-3#1)
designed experiments##2##2##(2008-5#1)(2010-8#1)
designed for a##4##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
designed for both##2##3##(2008-10#2)
designed for measurement of##2##4##(2008-10#1)(2008-3#1)
designed for spark##2##3##(2008-10#2)
designed for specific##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)
designed for the diagnosis##2##4##(1991-1#1)(2008-7#1)
designed for the purpose of##2##5##(2008-10#1)(2008-2#1)
designed for the##21##3##(1991-1#2)(1992-1#1)(1992-3#1)(1995-3#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-5#1)
designed for this purpose##2##4##(1992-3#1)(2008-9#1)
designed for this study##2##4##(1992-2#1)(2008-5#1)
designed for this##6##3##(1992-2#1)(1992-3#1)(1993-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
designed for use in##4##4##(2008-3#1)(2009-7#1)(2010-11#1)(2011-2#1)
designed for use with##3##4##(2008-2#2)(2008-4#1)
designed for use##9##3##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#1)
designed for##118##2##(1991-1#2)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#17)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#3)
designed from conserved##3##3##(1994-12#1)(2008-10#2)
designed from the##9##3##(1993-6#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-2#1)
designed from##18##2##(1993-12#1)(1993-6#1)(1994-12#2)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)
designed in##12##2##(1990-12#1)(1994-2#1)(2008-10#3)(2010-10#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
designed lens##2##2##(2008-3#2)
designed on the basis of##3##5##(1991-9#1)(1992-9#1)(1993-8#1)
designed on the##4##3##(1991-9#1)(1992-9#1)(1993-8#1)(2010-4#1)
designed on##5##2##(1991-9#1)(1992-9#1)(1993-8#1)(2008-8#1)(2010-4#1)
designed so##3##2##(2008-5#1)(2008-9#1)(2010-8#1)
designed specifically for the##2##4##(2007-6#1)(2008-3#1)
designed specifically for##7##3##(1992-1#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-3#1)
designed specifically to##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
designed specifically##10##2##(1992-1#1)(2007-6#2)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2012-2#1)
designed such that##3##3##(2008-10#1)(2008-3#2)
designed system##4##2##(1990-3#1)(1997-2#1)(2008-11#1)(2008-3#1)
designed that##6##2##(1990-7#1)(2008-10#3)(2008-3#2)
designed the##4##2##(2008-2#1)(2008-7#2)(2010-11#1)
designed this study to##3##4##(1996-2#1)(2007-10#1)(2013-7#1)
designed to achieve##2##3##(1996-7#1)(2008-3#1)
designed to address the##2##4##(1992-11#1)(1996-2#1)
designed to address##3##3##(1992-11#1)(1993-12#1)(1996-2#1)
designed to allow##5##3##(1997-6#1)(2008-2#1)(2008-3#1)(2008-4#2)
designed to amplify##6##3##(2008-10#5)(2013-1#1)
designed to assess the##6##4##(1994-6#1)(2008-11#1)(2009-4#1)(2010-10#1)(2011-2#2)
designed to assess##13##3##(1994-3#1)(1994-6#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#3)
designed to assist##2##3##(1995-3#1)(1997-3#1)
designed to be##13##3##(1995-2#1)(1996-2#1)(1997-4#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-9#1)
designed to better##2##3##(2008-10#1)(2012-3#1)
designed to bind##2##3##(1992-12#1)(2012-12#1)
designed to capture the##2##4##(2008-7#1)(2009-8#1)
designed to change the##3##4##(1993-11#1)(1994-1#1)(2008-10#1)
designed to characterize the##2##4##(1996-2#1)(2008-2#1)
designed to characterize##3##3##(1996-2#1)(2008-2#1)(2008-7#1)
designed to clarify##3##3##(1994-12#1)(2008-5#2)
designed to collect##2##3##(1993-2#1)(1996-2#1)
designed to compare the##7##4##(1991-12#1)(1994-12#1)(1996-3#1)(2007-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
designed to compare##11##3##(1991-12#1)(1992-11#1)(1994-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
designed to control##2##3##(2008-5#2)
designed to decrease##2##3##(1996-1#1)(2008-4#1)
designed to describe##2##3##(1993-12#1)(2010-5#1)
designed to detect the##2##4##(2008-10#1)(2008-9#1)
designed to detect##10##3##(1992-2#1)(1994-2#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#1)
designed to determine the##9##4##(1990-5#1)(1993-3#1)(2008-10#1)(2008-3#3)(2008-6#1)(2012-3#2)
designed to determine whether##5##4##(1990-11#1)(1992-11#1)(2007-12#1)(2008-8#1)(2011-1#1)
designed to determine##18##3##(1990-11#1)(1990-5#1)(1992-11#1)(1993-3#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#2)
designed to discriminate##2##3##(1997-6#1)(2008-9#1)
designed to elicit##3##3##(1994-8#1)(2008-11#1)(2009-10#1)
designed to enable the##2##4##(1994-2#1)(2008-7#1)
designed to enable##3##3##(1994-2#1)(2008-7#1)(2010-12#1)
designed to encourage##3##3##(2008-11#2)(2012-1#1)
designed to enhance##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
designed to ensure that the##2##5##(2008-2#1)(2008-3#1)
designed to ensure that##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
designed to ensure##5##3##(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
designed to estimate##4##3##(1997-4#1)(2008-12#1)(2010-3#1)(2013-1#1)
designed to evaluate a##3##4##(1996-1#1)(2008-11#1)(2010-3#1)
designed to evaluate the effects of##3##6##(2008-5#1)(2011-1#1)(2011-2#1)
designed to evaluate the efficacy##2##5##(2007-10#1)(2007-7#1)
designed to evaluate the##20##4##(1990-12#1)(1995-8#1)(2007-10#1)(2007-7#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
designed to evaluate##29##3##(1990-12#1)(1995-8#1)(1996-1#1)(2007-10#1)(2007-7#3)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
designed to examine the effects of##2##6##(2008-10#1)(2008-4#1)
designed to examine the##9##4##(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
designed to examine##11##3##(1992-2#1)(1992-8#1)(1993-12#2)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
designed to explore the##4##4##(2006-10#1)(2008-3#1)(2009-11#1)(2011-2#1)
designed to explore##5##3##(2006-10#1)(2008-3#1)(2009-11#1)(2010-8#1)(2011-2#1)
designed to facilitate the##3##4##(2008-11#1)(2008-3#1)(2008-4#1)
designed to facilitate##7##3##(1992-2#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
designed to form a##2##4##(1993-11#2)
designed to form##3##3##(1993-11#3)
designed to further##2##3##(1993-3#1)(2008-12#1)
designed to generate##3##3##(1993-12#2)(2008-11#1)
designed to give##2##3##(2008-10#1)(2008-2#1)
designed to have a##2##4##(2008-2#1)(2008-3#1)
designed to have##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
designed to help##7##3##(1994-3#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
designed to identify##9##3##(1991-12#1)(1993-12#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-9#1)(2012-12#1)
designed to improve the##3##4##(1993-3#1)(1996-12#1)(2013-1#1)
designed to improve##16##3##(1991-12#1)(1993-3#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
designed to increase##7##3##(1993-3#1)(1996-1#2)(2008-9#1)(2009-11#1)(2010-4#1)(2012-2#1)
designed to investigate the influence of##4##6##(2008-11#2)(2011-2#2)
designed to investigate the##16##4##(1993-12#1)(1993-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-12#1)
designed to investigate##19##3##(1993-12#1)(1993-3#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#5)(2012-12#1)
designed to limit##3##3##(1994-2#1)(2011-1#1)(2013-1#1)
designed to maintain##2##3##(2008-9#2)
designed to make##3##3##(2008-3#2)(2008-4#1)
designed to match##2##3##(1995-11#1)(2009-2#1)
designed to maximize##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
designed to measure the##7##4##(1995-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-3#2)(2008-5#1)
designed to measure##17##3##(1993-2#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
designed to meet the needs of##3##6##(1992-2#1)(1996-2#1)(1997-1#1)
designed to meet the##5##4##(1991-12#1)(1992-2#1)(1996-2#1)(1997-1#1)(2008-10#1)
designed to mimic##2##3##(2008-10#1)(2008-5#1)
designed to minimize##2##3##(1993-3#1)(2011-2#1)
designed to operate in##2##4##(2008-2#1)(2008-3#1)
designed to operate##3##3##(2008-2#1)(2008-3#2)
designed to optimize##2##3##(1993-5#1)(2008-3#1)
designed to overcome##2##3##(2008-11#1)(2008-7#1)
designed to perform the##2##4##(2008-10#1)(2008-11#1)
designed to perform##7##3##(2008-10#5)(2008-11#1)(2008-3#1)
designed to permit##2##3##(1993-12#1)(2008-4#1)
designed to place##2##3##(2008-11#1)(2008-8#1)
designed to prevent##2##3##(2008-9#1)(2012-2#1)
designed to produce a##2##4##(2008-3#1)(2008-6#1)
designed to produce##7##3##(1993-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)
designed to promote##5##3##(2007-10#1)(2008-11#1)(2008-12#2)(2013-1#1)
designed to protect##2##3##(2008-11#1)(2008-4#1)
designed to provide a##2##4##(2008-7#1)(2012-2#1)
designed to provide##11##3##(1993-2#1)(1994-1#1)(1995-1#1)(2007-5#2)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
designed to record##2##3##(2008-2#1)(2008-3#1)
designed to reduce the incidence of##2##6##(1991-12#1)(2011-2#1)
designed to reduce the##3##4##(1991-12#1)(2008-9#1)(2011-2#1)
designed to reduce##6##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
designed to respond to##2##4##(1994-12#1)(1997-4#1)
designed to see##2##3##(2008-11#1)(2012-3#1)
designed to set up##2##4##(1997-4#1)(2013-8#1)
designed to simulate the##4##4##(1996-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
designed to stimulate##4##3##(1991-12#1)(2008-9#1)(2010-1#1)(2012-3#1)
designed to study the##2##4##(2008-11#1)(2008-4#1)
designed to study##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
designed to support##5##3##(1994-3#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-7#1)
designed to systematically##3##3##(1996-2#1)(2008-4#2)
designed to take##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
designed to target##4##3##(2008-10#2)(2008-8#1)(2010-5#1)
designed to test the effects of the##2##7##(1992-1#1)(2008-10#1)
designed to test the##6##4##(1992-1#1)(1992-12#1)(1997-8#1)(2008-10#2)(2008-3#1)
designed to test##9##3##(1991-12#1)(1992-1#1)(1992-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
designed to understand##2##3##(1992-3#1)(1996-12#1)
designed to yield an##2##4##(2008-2#1)(2012-1#1)
designed to##505##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#8)(1991-3#2)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#7)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#4)(1996-12#4)(1996-2#7)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#6)(1997-6#3)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#10)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#5)(2007-9#1)(2008-1#6)(2008-10#52)(2008-11#29)(2008-12#9)(2008-2#14)(2008-3#41)(2008-4#23)(2008-5#12)(2008-6#7)(2008-7#17)(2008-8#6)(2008-9#20)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#22)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#10)(2013-1#14)(2013-8#2)
designed two types of##2##4##(2008-10#1)(2013-1#1)
designed two##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
designed using##9##2##(2007-11#1)(2008-10#5)(2008-2#1)(2013-1#1)(2013-8#1)
designed with a##6##3##(1992-1#1)(2008-11#1)(2008-3#2)(2009-9#1)(2010-3#1)
designed with an##3##3##(2008-3#3)
designed with the##8##3##(1992-12#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#1)
designed with##28##2##(1992-1#1)(1992-12#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#1)
designed within the##2##3##(2008-10#1)(2008-3#1)
designed##1099##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#3)(1991-12#14)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#4)(1992-1#7)(1992-11#3)(1992-12#5)(1992-2#8)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#13)(1993-2#5)(1993-3#6)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#10)(1994-2#6)(1994-3#6)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#5)(1996-12#5)(1996-2#11)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#6)(1997-6#5)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#6)(2007-11#23)(2007-12#26)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#10)(2008-10#175)(2008-11#45)(2008-12#13)(2008-2#55)(2008-3#149)(2008-4#29)(2008-5#25)(2008-6#8)(2008-7#33)(2008-8#18)(2008-9#38)(2009-10#4)(2009-11#7)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#2)(2010-2#4)(2010-3#7)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#13)(2010-9#3)(2011-1#10)(2011-2#32)(2011-3#4)(2012-1#5)(2012-12#12)(2012-2#13)(2012-3#19)(2013-1#30)(2013-7#2)(2013-8#8)
designer and##2##2##(1992-12#1)(2008-2#1)
designer drinks##2##2##(1997-5#2)
designer drugs##2##2##(1991-1#1)(2010-11#1)
designer steroids##3##2##(2010-11#2)(2010-7#1)
designer##16##1##(1991-1#1)(1992-12#1)(1992-4#2)(1997-4#1)(1997-5#2)(2008-2#2)(2008-3#1)(2010-11#3)(2010-7#1)(2012-3#2)
designers and##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
designers##8##1##(1995-2#2)(1996-12#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-3#1)
designing a##24##2##(1991-12#1)(1994-3#2)(1995-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)
designing an##9##2##(1996-12#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
designing and implementing##2##3##(2008-12#1)(2010-8#1)
designing and##13##2##(1993-3#1)(1994-3#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-8#1)
designing decision##2##2##(2008-10#1)(2010-8#1)
designing effective##4##2##(2008-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
designing interventions to##2##3##(1996-1#1)(2012-12#1)
designing novel##4##2##(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
designing optimal##2##2##(2007-4#1)(2008-2#1)
designing successful##2##2##(2008-10#2)
designing the##16##2##(1991-3#2)(1994-2#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2010-11#1)(2010-12#1)
designing these##4##2##(1997-3#1)(2008-2#2)(2008-6#1)
designing##149##1##(1990-5#1)(1991-12#1)(1991-3#2)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#15)(2008-3#21)(2008-4#8)(2008-6#2)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#6)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
designs and some##2##3##(2007-12#1)(2011-2#1)
designs and##10##2##(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
designs are described##2##3##(2008-10#1)(2008-2#1)
designs are discussed##2##3##(2008-10#1)(2009-9#1)
designs are presented##3##3##(2008-2#2)(2008-4#1)
designs are proposed##2##3##(2008-3#1)(2011-2#1)
designs are##21##2##(1992-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#3)(2009-9#1)(2011-2#1)
designs can##2##2##(1997-4#1)(2009-9#1)
designs for randomized clinical trials##2##5##(1995-2#2)
designs for the##4##3##(2007-12#1)(2008-3#3)
designs for##22##2##(1995-2#3)(1997-8#1)(2007-12#3)(2008-10#2)(2008-3#6)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
designs have been##5##3##(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#1)
designs have##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)
designs in the##2##3##(1995-2#1)(2008-10#1)
designs in##6##2##(1995-2#1)(2008-10#2)(2008-3#2)(2008-9#1)
designs may be##2##3##(2008-10#1)(2008-11#1)
designs may##5##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
designs of##4##2##(2008-10#1)(2008-2#1)(2009-12#1)(2012-12#1)
designs over a##2##3##(2009-9#2)
designs that were##2##3##(2009-12#1)(2011-2#1)
designs that##5##2##(1994-12#1)(1996-3#1)(2008-3#1)(2009-12#1)(2011-2#1)
designs to##6##2##(1993-2#1)(2008-3#1)(2009-10#1)(2012-2#2)(2013-1#1)
designs using##2##2##(2008-10#2)
designs were##6##2##(2008-10#2)(2008-12#1)(2008-6#1)(2012-2#2)
designs which##2##2##(2009-12#2)
designs with##6##2##(2008-10#1)(2008-2#3)(2008-8#1)(2012-2#1)
designs##208##1##(1992-9#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-2#7)(1995-9#1)(1996-3#2)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#4)(2007-12#11)(2007-7#2)(2008-10#49)(2008-11#4)(2008-12#3)(2008-2#14)(2008-3#38)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#4)(2009-7#3)(2009-8#2)(2009-9#4)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#9)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#5)
designs)##2##1##(2008-10#1)(2008-3#1)
desipramine in the##2##3##(1990-5#1)(1991-1#1)
desipramine in##4##2##(1990-5#2)(1991-1#2)
desipramine treatment##2##2##(1995-12#2)
desipramine##19##1##(1990-5#3)(1991-1#4)(1995-12#7)(2008-10#5)
desirability function##5##2##(2008-10#5)
desirability of##7##2##(1992-2#2)(1994-1#1)(2008-3#1)(2008-9#1)(2009-3#2)
desirability##16##1##(1990-6#1)(1992-2#2)(1994-1#2)(2008-10#5)(2008-3#1)(2008-9#1)(2009-11#1)(2009-3#2)(2013-1#1)
desirable and##4##2##(1993-1#1)(1995-2#1)(1996-3#1)(1996-6#1)
desirable characteristics##3##2##(2008-10#1)(2008-12#1)(2009-7#1)
desirable for##7##2##(1995-11#1)(2008-10#3)(2008-2#2)(2011-1#1)
desirable inverse growth associated production behavior##2##6##(2008-11#2)
desirable level##2##2##(2008-11#1)(2012-2#1)
desirable or##2##2##(2008-10#1)(2008-2#1)
desirable outcomes##2##2##(1993-3#1)(1995-2#1)
desirable properties##8##2##(1997-4#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-12#1)(2013-1#2)
desirable spectral##3##2##(2007-12#2)(2008-10#1)
desirable to utilize##2##3##(1997-4#1)(2011-2#1)
desirable to##25##2##(1991-5#1)(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
desirable##123##1##(1990-2#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#4)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#12)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)
desire a##3##2##(1994-7#1)(2008-9#2)
desire and##2##2##(2009-10#1)(2013-1#1)
desire for##10##2##(1993-1#1)(1993-12#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
desire of a##2##3##(2008-10#1)(2008-11#1)
desire of##5##2##(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#1)
desire to be##2##3##(1993-12#1)(2011-1#1)
desire to understand##2##3##(2009-6#1)(2010-5#1)
desire to##23##2##(1993-12#1)(1994-12#1)(1996-8#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
desire##51##1##(1992-9#1)(1993-1#1)(1993-12#3)(1994-12#1)(1994-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#4)(2013-8#2)
desired and controllable##2##3##(2009-11#2)
desired and##3##2##(2008-3#1)(2009-11#2)
desired by##3##2##(1994-3#1)(1996-6#1)(2008-5#1)
desired characteristics and uses##2##4##(1993-2#2)
desired characteristics and##3##3##(1993-2#3)
desired characteristics##4##2##(1990-8#1)(1993-2#3)
desired family size##2##3##(1992-4#2)
desired family##3##2##(1992-4#3)
desired for##2##2##(1995-5#1)(2008-10#1)
desired friends##3##2##(2009-7#3)
desired image##7##2##(2008-2#3)(2008-3#4)
desired in health care graduates##2##5##(1994-12#2)
desired in##4##2##(1994-12#2)(2008-5#1)(2013-8#1)
desired level of##4##3##(1992-9#1)(2008-10#1)(2009-6#1)(2010-5#1)
desired levels of##2##3##(2008-10#2)
desired number##2##2##(1992-4#1)(2008-9#1)
desired outcomes##3##2##(1992-3#1)(1993-2#1)(2008-1#1)
desired phase##2##2##(2007-11#1)(2008-2#1)
desired product##5##2##(1994-11#1)(2008-10#2)(2010-4#1)(2012-3#1)
desired products##3##2##(2008-10#1)(2008-4#1)(2009-12#1)
desired protein##2##2##(2008-11#1)(2008-2#1)
desired quality##2##2##(2008-10#1)(2012-2#1)
desired spatial##3##2##(2007-11#1)(2008-3#2)
desired spatial-frequency component of##2##4##(2007-12#2)
desired to##3##2##(1995-2#1)(2008-10#1)(2008-2#1)
desired wavelength##2##2##(2007-12#1)(2008-3#1)
desired##206##1##(1990-8#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-4#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-8#1)(1995-2#2)(1995-3#4)(1995-5#2)(1996-12#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#6)(2007-12#12)(2008-1#3)(2008-10#25)(2008-11#4)(2008-2#15)(2008-3#27)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#4)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-7#2)(2013-8#1)
desires and condom use##2##4##(2011-1#2)
desires and##4##2##(1992-3#1)(2011-1#2)(2011-2#1)
desires of##3##2##(1997-1#1)(1997-3#1)(2010-10#1)
desires to##2##2##(1993-12#1)(2012-3#1)
desires##16##1##(1991-6#1)(1992-3#1)(1993-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2010-10#2)(2010-12#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-1#1)
desiring to##2##2##(1994-12#1)(1994-2#1)
desiring##3##1##(1994-12#1)(1994-2#1)(2008-9#1)
desisobutyryl-ciclesonide##3##1##(2008-8#3)
desisopropylatrazine (DIA)##2##2##(2008-10#2)
desisters##2##1##(2007-9#2)
desk##4##1##(1992-1#1)(1995-1#1)(2010-7#1)(2011-1#1)
desktop##3##1##(2008-10#1)(2008-11#1)(2008-6#1)
desmetryne at##2##2##(2008-10#2)
desmetryne in##2##2##(2008-10#2)
desmetryne##6##1##(2008-10#6)
desmin##7##1##(1991-6#1)(1992-8#1)(2008-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)
desmoid tumors##4##2##(1997-8#2)(2011-2#1)(2012-3#1)
desmoid##8##1##(1990-6#1)(1997-8#2)(2007-5#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
desmoids have a##2##3##(1997-8#2)
desmoids##7##1##(1997-8#6)(2007-5#1)
desmoplastic medulloblastomas##2##2##(1991-2#2)
desmoplastic small round cell tumor##2##5##(2008-10#1)(2008-6#1)
desmoplastic##8##1##(1991-2#3)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#2)
desmopressin##6##1##(1992-11#3)(2010-7#1)(2013-8#2)
desmosine##2##1##(1990-7#1)(1990-8#1)
desmosome##3##1##(2012-2#3)
desmosome-like junctions##2##2##(2009-10#2)
desmosome-like##3##1##(2009-10#3)
desmosomes and##5##2##(1994-6#1)(2008-12#1)(2008-7#2)(2012-2#1)
desmosomes##6##1##(1994-6#1)(2008-12#1)(2008-7#2)(2012-1#1)(2012-2#1)
desmosterol##2##1##(1992-6#2)
desnonapeptide##2##1##(1991-8#2)
desogestrel (EE+D)##2##2##(1994-5#2)
desolvation##5##1##(2008-10#5)
desorb the analyte##2##3##(2008-10#2)
desorb##6##1##(2008-10#5)(2008-2#1)
desorbed by##3##2##(2008-10#2)(2008-4#1)
desorbed in the##4##3##(2008-10#2)(2008-7#2)
desorbed in##5##2##(2008-10#3)(2008-7#2)
desorbed quantitatively with##2##3##(2008-10#2)
desorbed with##7##2##(2008-10#6)(2008-6#1)
desorbed##26##1##(2008-10#19)(2008-4#1)(2008-6#1)(2008-7#2)(2010-5#2)(2011-2#1)
desorbing##2##1##(2008-10#2)
desorption and##3##2##(2008-10#2)(2010-5#1)
desorption curves##2##2##(2008-5#2)
desorption from##3##2##(1994-2#1)(2008-10#2)
desorption into a##2##3##(2008-10#2)
desorption mass spectrometry##4##3##(1990-8#1)(1992-3#2)(2008-10#1)
desorption of a##2##3##(2008-10#1)(2009-12#1)
desorption of analytes##2##3##(2008-10#2)
desorption of the##7##3##(2008-10#6)(2008-4#1)
desorption of##21##2##(1991-9#1)(1994-3#1)(2007-12#1)(2008-10#14)(2008-2#1)(2008-4#1)(2009-12#1)(2010-4#1)
desorption peak##2##2##(2008-10#2)
desorption procedure##3##2##(2008-10#3)
desorption temperature##2##2##(2008-10#2)
desorption time##3##2##(2008-10#3)
desorption was##4##2##(2008-10#4)
desorption##94##1##(1990-8#1)(1991-9#2)(1992-3#2)(1994-2#1)(1994-3#2)(2007-12#3)(2008-10#70)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-4#1)(2010-5#4)(2012-3#2)
despair##2##1##(1991-12#2)
desperately needed##3##2##(2008-1#1)(2008-4#1)(2012-3#1)
desperately##4##1##(1995-1#1)(2008-1#1)(2008-4#1)(2012-3#1)
despite a##23##2##(1995-12#1)(1996-11#2)(1996-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#3)
despite an##4##2##(1992-8#1)(1993-1#1)(2007-12#1)(2012-3#1)
despite appropriate##2##2##(2009-6#1)(2012-2#1)
despite being on##2##3##(2008-11#1)(2013-1#1)
despite being##11##2##(1992-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
despite changes##2##2##(2012-2#1)(2013-1#1)
despite considerable##2##2##(2013-1#1)(2013-8#1)
despite current##2##2##(1994-8#1)(2008-10#1)
despite differences in##2##3##(2008-11#1)(2008-3#1)
despite evidence that##2##3##(2008-11#2)
despite extensive investigation##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
despite extensive##6##2##(2008-10#2)(2008-7#2)(2008-9#1)(2012-12#1)
despite having a##2##3##(2008-5#1)(2010-8#1)
despite having higher##2##3##(1995-8#1)(2011-2#1)
despite having##6##2##(1995-8#1)(2008-1#1)(2008-5#2)(2010-8#1)(2011-2#1)
despite high##3##2##(2008-12#1)(2008-8#1)(2010-10#1)
despite improvements in##2##3##(1996-8#1)(2013-1#1)
despite intensive##3##2##(2008-10#2)(2013-8#1)
despite its##13##2##(1994-12#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-5#2)(2009-1#2)(2011-1#1)
despite more than##2##3##(2009-8#1)(2012-12#1)
despite multiple##2##2##(2007-12#1)(2013-8#1)
despite negative##2##2##(1992-2#1)(2012-3#1)
despite no##2##2##(2010-7#1)(2012-3#1)
despite normal levels of##2##4##(2012-3#2)
despite numerous##2##2##(1994-9#1)(1997-8#1)
despite of##5##2##(1997-3#1)(2007-11#1)(2009-6#1)(2011-1#1)(2011-3#1)
despite prolonged vancomycin##2##3##(2007-12#2)
despite prolonged##4##2##(2007-10#1)(2007-12#2)(2008-9#1)
despite repeated##2##2##(2010-5#1)(2012-2#1)
despite significant##3##2##(1993-3#1)(2007-8#1)(2012-2#1)
despite similar##2##2##(2009-5#1)(2011-2#1)
despite some##3##2##(1994-5#1)(2008-7#1)(2010-2#1)
despite the absence of##2##4##(1997-8#1)(2012-3#1)
despite the abundance of##2##4##(2008-10#1)(2009-6#1)
despite the clear##2##3##(1995-12#1)(2008-8#1)
despite the current##2##3##(2012-2#1)(2013-1#1)
despite the fact that the##6##5##(1996-8#1)(1997-2#1)(2008-10#1)(2010-2#2)(2010-6#1)
despite the fact that they##3##5##(2008-10#2)(2012-3#1)
despite the fact that##20##4##(1992-3#1)(1995-11#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
despite the fact##21##3##(1992-12#1)(1992-3#1)(1995-11#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
despite the high##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
despite the lack of evidence##2##5##(2008-11#1)(2008-12#1)
despite the lack of##6##4##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
despite the large##3##3##(2007-12#1)(2008-8#1)(2010-8#1)
despite the many##2##3##(2008-7#1)(2009-8#1)
despite the presence of##10##4##(1990-5#1)(1994-12#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
despite the risks associated with##2##5##(2008-7#1)(2010-8#1)
despite the significant##2##3##(1997-5#1)(2010-8#1)
despite the use of##2##4##(1995-2#1)(2008-8#1)
despite the##119##2##(1990-3#1)(1990-5#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
despite their apparent##2##3##(1996-12#1)(2009-10#1)
despite their importance##2##3##(2008-7#1)(2010-6#1)
despite their large##2##3##(2008-8#1)(2012-3#1)
despite their##21##2##(1994-9#1)(1996-12#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
despite therapy##3##2##(1992-2#1)(2008-1#1)(2010-5#1)
despite these##3##2##(2009-10#1)(2011-2#1)(2013-1#1)
despite this##3##2##(1997-5#1)(2009-5#1)(2011-2#1)
despite widespread##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
despite##392##1##(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#6)(2007-11#5)(2007-12#8)(2007-2#1)(2007-7#5)(2007-8#2)(2008-1#8)(2008-10#35)(2008-11#27)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#18)(2008-8#10)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#4)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#6)(2011-1#12)(2011-2#16)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#15)(2012-3#13)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#11)
desquamation of##2##2##(2008-7#1)(2012-3#1)
desquamation process is##2##3##(2008-5#2)
desquamation process##6##2##(2008-5#6)
desquamation##24##1##(1994-12#1)(2008-5#21)(2008-7#1)(2012-3#1)
desquamatory##3##1##(2008-5#3)
desserts##2##1##(2008-8#1)(2010-4#1)
destabilisation##4##1##(2007-11#2)(2008-10#1)(2009-5#1)
destabilization of the##3##3##(1992-3#1)(1997-6#1)(2008-5#1)
destabilization of##5##2##(1990-8#1)(1992-3#1)(1997-6#1)(2007-11#1)(2008-5#1)
destabilization##14##1##(1990-8#3)(1992-3#1)(1995-2#1)(1997-3#2)(1997-6#1)(2007-11#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
destabilize##3##1##(1991-8#1)(1991-9#1)(2012-2#1)
destabilized by##6##2##(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
destabilized the##2##2##(1993-8#2)
destabilized##13##1##(1990-8#1)(1993-8#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
destabilizes the##2##2##(1996-4#1)(1997-2#1)
destabilizes##4##1##(1996-4#1)(1997-2#1)(2008-8#1)(2008-9#1)
destabilizing effect##3##2##(1993-8#1)(1995-5#1)(2008-8#1)
destabilizing##19##1##(1990-5#1)(1991-1#1)(1992-3#1)(1993-8#2)(1995-5#4)(1997-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#3)(2008-9#2)(2012-3#1)
destination therapy##3##2##(2010-6#1)(2011-2#1)(2012-3#1)
destination##12##1##(2007-10#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#3)(2012-3#1)
destinations and##2##2##(2008-2#1)(2011-2#1)
destinations##6##1##(1995-2#1)(1996-5#1)(2007-2#2)(2008-2#1)(2011-2#1)
destined for##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#1)
destined to adults at the Pavillon Albert-Prévost##3##7##(2008-2#3)
destined to##5##2##(2008-2#4)(2009-4#1)
destined##11##1##(2008-10#3)(2008-11#1)(2008-2#4)(2008-5#1)(2009-4#1)(2012-2#1)
destiny##3##1##(1995-12#1)(2008-10#1)(2011-1#1)
destratification efficiency##4##2##(2008-6#4)
destratification number##2##2##(2008-6#2)
destratification##6##1##(2008-6#6)
destroy the##10##2##(1992-2#1)(1994-9#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-1#1)(2010-3#1)(2010-4#1)
destroy##25##1##(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-3#2)(2010-4#1)(2011-1#1)
destroyed after##2##2##(1992-9#1)(2010-3#1)
destroyed by the##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
destroyed by##7##2##(1992-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-2#2)
destroyed in##3##2##(1990-5#1)(1993-1#1)(2013-1#1)
destroyed the##6##2##(1990-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2013-8#1)
destroyed##38##1##(1990-2#1)(1990-5#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-8#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-12#3)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
destroying the##4##2##(1990-2#1)(1994-3#1)(2007-10#1)(2010-4#1)
destroying##11##1##(1990-2#1)(1990-5#1)(1994-3#1)(1995-12#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-7#1)(2010-4#2)(2011-2#1)
destroys the##5##2##(1991-12#1)(1997-4#1)(1997-5#1)(2008-11#1)(2012-3#1)
destroys##11##1##(1991-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
destructans isolates##3##2##(2008-10#3)
destructans were##2##2##(2008-10#2)
destructans##18##1##(2008-10#18)
destruction and##10##2##(2007-11#1)(2008-12#1)(2009-7#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#2)
destruction by##4##2##(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
destruction in##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
destruction is##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
destruction of either the##2##4##(1993-3#1)(1994-3#1)
destruction of malignant cells by##2##5##(2008-5#1)(2008-7#1)
destruction of the articular##2##4##(2007-11#1)(2008-8#1)
destruction of the##25##3##(1990-12#1)(1990-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#3)(1994-5#1)(1995-6#1)(1997-2#1)(1997-5#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-8#1)(2009-8#2)(2010-11#1)(2011-2#2)(2013-8#1)
destruction of##64##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1992-9#2)(1993-3#2)(1993-5#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-5#1)(2007-11#4)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#1)
destruction was##2##2##(2007-11#1)(2008-10#1)
destruction##146##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#2)(1997-5#3)(2006-12#1)(2007-11#12)(2007-6#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#6)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#2)(2013-8#1)
destructiva##2##1##(2008-10#2)
destructive disease of##8##3##(2008-10#8)
destructive disease##10##2##(2008-10#10)
destructive interference##8##2##(1994-6#1)(2007-11#4)(2008-3#3)
destructive nature##2##2##(2008-10#1)(2008-7#1)
destructive pathogen##2##2##(2008-10#2)
destructive to##2##2##(2007-5#1)(2008-10#1)
destructive##67##1##(1990-6#1)(1991-2#2)(1994-6#1)(1995-2#1)(1996-3#1)(2006-10#2)(2007-11#5)(2007-5#1)(2008-1#1)(2008-10#27)(2008-11#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
destructively to##2##2##(2007-12#1)(2008-3#1)
destructively##5##1##(2007-12#2)(2008-10#1)(2008-3#2)
destructor##11##1##(1994-12#1)(2008-6#4)(2011-2#4)(2013-1#2)
destruxin E2 chlorohydrin##2##3##(2008-9#2)
destruxin in##2##2##(1991-5#2)
destruxin is##2##2##(1991-5#2)
destruxin##8##1##(1991-5#5)(2008-9#3)
destruxins##2##1##(1991-5#2)
desufflation##3##1##(2012-3#3)
deswelling##2##1##(2010-2#2)
desynchronization##2##1##(2008-5#1)(2013-8#1)
desynchronized##2##1##(1993-12#1)(2009-8#1)
detach from##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
detach the##2##2##(2008-11#2)
detach##9##1##(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#3)
detachable balloon##3##2##(1996-9#1)(1997-3#1)(2006-12#1)
detachable coil##3##2##(1996-9#1)(1997-3#1)(1997-6#1)
detachable coils##4##2##(1995-11#1)(1997-3#1)(2006-12#1)(2008-7#1)
detachable##14##1##(1995-11#1)(1996-9#2)(1997-3#3)(1997-6#1)(2006-12#3)(2008-10#1)(2008-7#2)(2011-2#1)
detached by exposure to##2##4##(2008-11#2)
detached by##4##2##(2008-11#3)(2008-7#1)
detached crab apple##3##3##(2008-10#3)
detached flowers##5##2##(2008-10#5)
detached from the##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
detached from##8##2##(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2011-2#1)
detached leaf##5##2##(2008-10#3)(2008-8#2)
detached leaflets and##2##3##(2008-10#2)
detached leaflets of##3##3##(2008-10#3)
detached leaflets##6##2##(2008-10#6)
detached leaves of##2##3##(2008-10#2)
detached leaves##8##2##(2008-10#8)
detached retinas##2##2##(2008-4#2)
detached##61##1##(1994-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#38)(2008-11#7)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#2)(2013-1#1)
detached-leaf##2##1##(2008-10#2)
detachers##2##1##(2012-1#2)
detaches##2##1##(2007-12#1)(2008-5#1)
detachment and##4##2##(1990-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
detachment associated with##3##3##(2013-1#2)(2013-8#1)
detachment from##2##2##(1990-8#1)(1995-12#1)
detachment in##3##2##(1991-9#1)(2008-1#1)(2013-8#1)
detachment of##6##2##(1990-9#1)(1991-3#1)(1991-9#1)(2007-12#1)(2008-11#2)
detachment to##2##2##(1996-9#1)(2013-8#1)
detachment##41##1##(1990-10#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-6#1)(1995-12#1)(1996-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#3)
detail a simple##2##3##(2008-3#1)(2008-4#1)
detail a##5##2##(1995-8#1)(2008-10#2)(2008-3#1)(2008-4#1)
detail about##2##2##(2007-8#1)(2008-10#1)
detail and the##2##3##(2008-10#1)(2008-3#1)
detail and##24##2##(1993-12#1)(1995-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-3#4)(2008-6#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#2)
detail as##2##2##(1992-6#1)(2008-9#1)
detail for the##2##3##(1997-2#1)(2011-2#1)
detail for##5##2##(1992-12#1)(1993-11#1)(1997-2#1)(2008-9#1)(2011-2#1)
detail in a##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
detail in the##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
detail in this##4##3##(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
detail in##16##2##(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
detail of##4##2##(2008-7#1)(2009-2#1)(2009-5#1)(2011-2#1)
detail on##4##2##(2008-12#1)(2008-6#1)(2008-9#2)
detail regarding##2##2##(1996-12#1)(2007-8#1)
detail the use of##2##4##(2008-4#1)(2012-2#1)
detail the##34##2##(1990-10#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-6#1)(1997-3#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
detail through##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
detail to##12##2##(1994-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)
detail using##2##2##(2008-10#2)
detail with##2##2##(1990-8#1)(2009-12#1)
detail##351##1##(1990-10#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#105)(2008-11#9)(2008-12#2)(2008-2#16)(2008-3#40)(2008-4#16)(2008-5#6)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#17)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#13)(2012-1#3)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
detailed analyses of the##2##4##(1996-7#1)(2008-2#1)
detailed analysis of its##2##4##(2007-6#1)(2008-3#1)
detailed analysis of the##13##4##(1992-6#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-3#7)(2008-7#1)(2009-10#1)
detailed analysis of##26##3##(1992-6#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#10)(2008-4#2)(2008-7#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
detailed analysis##28##2##(1991-9#1)(1992-6#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#10)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
detailed and##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
detailed assessment##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
detailed biochemical##2##2##(1992-6#1)(2012-2#1)
detailed characterization of##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
detailed chemical##2##2##(1995-5#1)(2008-3#1)
detailed comparison between##3##3##(1994-5#1)(2008-10#1)(2008-2#1)
detailed comparison of##3##3##(1990-11#1)(2007-12#1)(2008-10#1)
detailed comparison##8##2##(1990-11#1)(1991-6#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-2#1)
detailed cost##3##2##(1996-2#1)(1996-3#1)(2008-9#1)
detailed data on##2##3##(1996-3#1)(2011-3#1)
detailed data##5##2##(1990-3#1)(1995-1#1)(1996-3#1)(2009-3#1)(2011-3#1)
detailed description of the system##2##5##(2007-11#1)(2010-12#1)
detailed description of the##10##4##(1994-11#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)
detailed description of##19##3##(1994-11#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)
detailed description##20##2##(1994-11#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)
detailed descriptions of the##2##4##(1995-1#1)(2008-11#1)
detailed descriptions of##3##3##(1993-3#1)(1995-1#1)(2008-11#1)
detailed descriptions##4##2##(1993-3#1)(1995-1#1)(2008-11#1)(2008-9#1)
detailed design##6##2##(1996-1#1)(1996-3#1)(2008-2#1)(2012-2#2)(2013-1#1)
detailed discussion of how##2##4##(1996-3#1)(2008-2#1)
detailed discussion of##3##3##(1996-3#1)(2008-2#1)(2008-9#1)
detailed discussion##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
detailed evaluation of the##3##4##(1995-6#1)(2008-3#1)(2008-5#1)
detailed evaluation of##4##3##(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
detailed evaluation##6##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
detailed evaluations of##2##3##(1991-1#1)(2008-3#1)
detailed examination of the##4##4##(1992-12#1)(1994-2#1)(1997-3#1)(1997-8#1)
detailed examination of##6##3##(1992-12#1)(1994-2#1)(1997-3#1)(1997-8#1)(2008-7#1)(2009-8#1)
detailed experimental investigation of the##2##5##(2008-2#1)(2008-3#1)
detailed experimental investigation##3##3##(2008-2#2)(2008-3#1)
detailed experimental##8##2##(2007-11#1)(2008-2#3)(2008-3#3)(2008-8#1)
detailed exploration##2##2##(2009-12#1)(2012-2#1)
detailed for##4##2##(2007-12#1)(2008-4#2)(2008-9#1)
detailed formulas##2##2##(2008-2#1)(2008-3#1)
detailed functional##3##2##(1990-11#1)(2008-8#1)(2011-2#1)
detailed history and##3##3##(2009-12#1)(2012-12#1)(2012-3#1)
detailed history of##2##3##(1994-2#1)(2008-4#1)
detailed history##7##2##(1994-2#1)(2007-7#1)(2008-4#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
detailed images of##2##3##(2011-1#1)(2011-7#1)
detailed images##3##2##(2011-1#1)(2011-7#1)(2013-1#1)
detailed in this manual##3##4##(2008-4#1)(2008-9#2)
detailed in this##4##3##(1992-3#1)(2008-4#1)(2008-9#2)
detailed in##9##2##(1992-1#1)(1992-3#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#2)(2012-3#1)
detailed information about the##3##4##(2008-2#1)(2010-10#1)(2011-2#1)
detailed information about##5##3##(2008-2#1)(2010-10#1)(2011-2#2)(2013-1#1)
detailed information on##5##3##(1991-8#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
detailed information##18##2##(1991-8#1)(1993-2#1)(1996-1#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#3)(2011-3#1)(2013-1#1)
detailed instructions on##2##3##(1992-12#1)(2008-4#1)
detailed instructions##4##2##(1992-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
detailed investigation of the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
detailed investigation of##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
detailed investigation##6##2##(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-3#1)
detailed kinetic##3##2##(1991-8#1)(1992-8#1)(1994-5#1)
detailed knowledge of the##4##4##(1992-9#1)(1997-3#1)(2008-3#1)(2012-2#1)
detailed knowledge of##7##3##(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
detailed knowledge##9##2##(1992-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
detailed measurement##2##2##(2008-3#1)(2012-2#1)
detailed mechanism##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
detailed medical##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
detailed method for##3##3##(2008-4#1)(2008-9#2)
detailed method##5##2##(2008-4#3)(2008-9#2)
detailed molecular genetic analysis##2##4##(1997-6#1)(2008-5#1)
detailed molecular##4##2##(1997-6#1)(2008-5#1)(2010-12#2)
detailed phylogenetic analysis##2##3##(1995-3#1)(2008-10#1)
detailed phylogenetic##3##2##(1995-3#1)(2008-10#1)(2008-9#1)
detailed picture of the##4##4##(1992-2#1)(1992-6#1)(2008-10#1)(2012-12#1)
detailed picture of##5##3##(1992-2#1)(1992-6#1)(2007-12#1)(2008-10#1)(2012-12#1)
detailed procedures for##2##3##(2008-4#2)
detailed processes##2##2##(2008-4#1)(2013-1#1)
detailed protocols for##5##3##(2008-4#1)(2008-9#4)
detailed protocols##8##2##(2008-2#1)(2008-4#2)(2008-9#5)
detailed questionnaire##2##2##(1992-8#1)(2008-1#1)
detailed review##5##2##(1995-12#1)(2007-11#1)(2008-9#1)(2010-5#1)(2010-8#1)
detailed reviews##2##2##(1993-12#1)(2008-6#1)
detailed structure##2##2##(1994-3#1)(1995-5#1)
detailed studies of##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
detailed studies##8##2##(1992-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)
detailed study of the##4##4##(1991-5#1)(2008-10#1)(2008-3#2)
detailed study of##19##3##(1991-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2009-12#1)(2011-2#1)
detailed study##26##2##(1991-12#1)(1991-5#1)(1992-3#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2009-12#1)(2010-4#1)(2011-2#1)
detailed surface##2##2##(2008-3#2)
detailed the##2##2##(2008-5#1)(2008-9#1)
detailed theory and##2##3##(2008-2#2)
detailed theory##3##2##(2007-11#1)(2008-2#2)
detailed understanding of the##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2010-12#1)
detailed understanding of##9##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)
detailed unit##4##2##(2008-9#4)
detailed##485##1##(1990-11#2)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#3)(1994-11#2)(1994-2#5)(1994-3#4)(1994-5#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#4)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#7)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#3)(2007-11#10)(2007-12#14)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#8)(2008-10#34)(2008-11#16)(2008-12#1)(2008-2#24)(2008-3#55)(2008-4#32)(2008-5#12)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#40)(2009-10#1)(2009-11#1)(2009-12#7)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#11)(2011-3#3)(2011-7#2)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#9)(2013-8#7)
detailing the##3##2##(1990-2#1)(2008-1#1)(2011-2#1)
detailing##13##1##(1990-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-2#3)(2012-2#1)
details a protocol##2##3##(2008-2#1)(2008-4#1)
details a##6##2##(2008-2#1)(2008-4#3)(2010-12#1)(2012-12#1)
details about the##2##3##(1992-3#1)(2008-1#1)
details about##4##2##(1992-3#1)(2008-1#1)(2008-4#1)(2009-10#1)
details and##5##2##(1991-6#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-9#1)
details are##9##2##(1994-1#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
details for##5##2##(2008-4#3)(2008-9#1)(2011-1#1)
details how##2##2##(2008-9#1)(2010-5#1)
details in the##2##3##(1994-12#1)(2009-9#1)
details in##4##2##(1992-2#1)(1994-12#1)(2008-9#1)(2009-9#1)
details of the##30##3##(1990-11#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)
details of these##2##3##(2008-11#1)(2010-11#1)
details of this##3##3##(1991-9#1)(2008-3#2)
details of##68##2##(1990-11#1)(1991-9#2)(1992-2#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-3#3)(2013-8#3)
details on the##5##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
details on##8##2##(1990-8#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
details some of##2##3##(1995-1#1)(2008-4#1)
details such as##2##3##(2008-3#1)(2008-7#1)
details that##2##2##(2007-12#1)(2008-11#1)
details the use of##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
details the##25##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1994-2#1)(1994-3#3)(1995-3#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#6)(2008-9#2)(2010-7#1)(2012-12#1)
details to##2##2##(2008-10#1)(2011-1#1)
details##199##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#10)(2008-12#5)(2008-2#6)(2008-3#9)(2008-4#25)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#3)
detainees in police custody in London##2##6##(2010-1#2)
detainees in police custody##4##4##(2010-1#4)
detainees##5##1##(2010-1#5)
detect IgG##2##2##(1991-11#2)
detect P##5##2##(2008-10#4)(2008-12#1)
detect a##26##2##(1990-2#1)(1990-3#1)(1992-6#2)(1992-9#1)(1995-12#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)
detect all##5##2##(1996-12#1)(2008-10#2)(2009-11#1)(2012-2#1)
detect and identify##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
detect and quantify##16##3##(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
detect and##47##2##(1991-6#1)(1992-11#1)(1993-2#1)(1994-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
detect any changes##2##3##(2008-7#1)(2008-9#1)
detect any of##2##3##(2008-10#2)
detect any##18##2##(1993-2#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
detect as little as##5##4##(1991-2#1)(2008-10#3)(2013-1#1)
detect as##6##2##(1991-2#1)(2008-10#4)(2013-1#1)
detect both##4##2##(2008-10#3)(2008-4#1)
detect breast##4##2##(2008-10#1)(2008-4#1)(2010-6#1)(2012-2#1)
detect certain##3##2##(2006-10#1)(2007-5#1)(2011-2#1)
detect changes##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
detect differences in the##2##4##(1996-2#1)(2008-10#1)
detect differences in##3##3##(1992-11#1)(1996-2#1)(2008-10#1)
detect differences##4##2##(1992-11#1)(1996-2#1)(2008-10#2)
detect different##2##2##(2008-3#1)(2008-6#1)
detect dopamine in##2##3##(2008-10#2)
detect early##3##2##(1995-11#1)(2008-10#1)(2010-6#1)
detect effects##2##2##(2008-10#1)(2008-3#1)
detect familial coaggregation##2##3##(1997-5#2)
detect gene##2##2##(2008-9#1)(2012-3#1)
detect human##2##2##(1990-5#1)(1995-2#1)
detect its##2##2##(2008-5#1)(2011-1#1)
detect less than##2##3##(1996-12#1)(1996-5#1)
detect low##2##2##(1991-3#1)(1997-4#1)
detect malignant##2##2##(1997-7#1)(2010-12#1)
detect microbial##4##2##(2008-11#2)(2012-2#2)
detect possible##2##2##(1992-6#1)(2008-9#1)
detect potential##4##2##(2008-11#2)(2012-1#1)(2013-1#1)
detect resistance to##2##3##(2008-10#1)(2011-2#1)
detect target##3##2##(1996-5#1)(2008-10#1)(2008-4#1)
detect the association of##2##4##(2008-2#1)(2012-3#1)
detect the onset##2##3##(2008-2#1)(2011-2#1)
detect the pathogen##3##3##(2008-10#3)
detect the presence##13##3##(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
detect the##111##2##(1991-12#2)(1991-4#1)(1991-5#1)(1992-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-4#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-10#34)(2008-11#3)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#4)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
detect these##6##2##(1994-6#1)(1995-10#1)(2007-12#1)(2008-10#2)(2010-9#1)
detect this kind of##2##4##(1993-3#1)(2008-10#1)
detect this##3##2##(1993-3#1)(2008-10#1)(2008-6#1)
detect those##2##2##(2006-10#1)(2011-2#1)
detect three##2##2##(2007-6#1)(2008-10#1)
detect very##3##2##(1994-2#1)(2008-7#1)(2011-2#1)
detect virus in##2##3##(2007-6#1)(2008-5#1)
detect##723##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#7)(1992-8#1)(1992-9#5)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#4)(1994-11#3)(1994-2#5)(1994-3#1)(1994-6#2)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1997-2#1)(1997-3#8)(1997-4#5)(1997-5#6)(1997-6#3)(1997-7#1)(1997-8#4)(2006-10#4)(2007-10#4)(2007-11#9)(2007-12#14)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#4)(2008-1#8)(2008-10#186)(2008-11#19)(2008-12#6)(2008-2#14)(2008-3#32)(2008-4#33)(2008-5#18)(2008-6#5)(2008-7#14)(2008-8#10)(2008-9#24)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#4)(2010-8#6)(2010-9#2)(2011-1#16)(2011-2#24)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#20)(2012-3#25)(2013-1#16)(2013-7#3)(2013-8#9)
detect-to-protect##2##1##(2010-7#2)
detectability of##7##2##(2008-10#4)(2008-3#1)(2010-9#2)
detectability was##2##2##(2008-10#1)(2012-1#1)
detectability##24##1##(1990-12#1)(1996-4#1)(2008-10#11)(2008-3#3)(2008-5#1)(2010-9#2)(2012-1#5)
detectable activity##3##2##(1994-8#1)(2009-6#2)
detectable after##2##2##(1990-2#1)(1991-2#1)
detectable amount of##4##3##(1992-6#1)(1996-5#2)(2007-12#1)
detectable amount##5##2##(1992-6#1)(1992-9#1)(1996-5#2)(2007-12#1)
detectable amounts of##2##3##(1990-11#1)(2011-2#1)
detectable amounts##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
detectable and##5##2##(2008-10#3)(2009-5#2)
detectable at 0##2##3##(1992-11#1)(2008-10#1)
detectable at a##2##3##(1991-12#1)(2008-10#1)
detectable at##7##2##(1991-12#1)(1992-11#1)(1997-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
detectable but##2##2##(2008-9#2)
detectable by ESR##2##3##(1990-5#1)(2007-11#1)
detectable by the##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2009-9#1)
detectable by##21##2##(1990-5#2)(1991-5#1)(1992-6#1)(1994-11#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-9#1)(2012-3#1)
detectable cellular##3##2##(1991-12#1)(1992-12#1)(2008-9#1)
detectable change##5##2##(1991-5#1)(1994-3#1)(2008-8#1)(2008-9#1)(2013-7#1)
detectable changes in##2##3##(1995-2#1)(1997-7#1)
detectable concentration was##2##3##(2008-10#2)
detectable depurination##2##2##(2008-10#2)
detectable drug##2##2##(1997-4#1)(2010-11#1)
detectable during##4##2##(1996-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
detectable for##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
detectable in the sera##2##4##(1991-5#1)(1994-3#1)
detectable in the##12##3##(1991-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-1#1)
detectable in##35##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-8#1)(1992-9#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#3)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
detectable levels of##9##3##(1992-10#1)(1992-11#1)(1993-9#2)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)
detectable levels##13##2##(1992-10#1)(1992-11#1)(1993-12#1)(1993-9#2)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-5#1)
detectable on##4##2##(1997-4#1)(2008-10#1)(2008-4#1)(2011-2#1)
detectable only by nonstandard##2##4##(1994-12#2)
detectable only##3##2##(1994-12#2)(2008-5#1)
detectable orientation##2##2##(1993-8#1)(2012-2#1)
detectable populations##7##2##(2008-10#7)
detectable sequence similarity to##2##4##(2008-7#1)(2010-10#1)
detectable signal in##2##3##(2008-10#1)(2008-2#1)
detectable signal is##3##3##(2008-2#1)(2008-9#2)
detectable signal##7##2##(1996-12#1)(2008-10#1)(2008-2#3)(2008-9#2)
detectable with##3##2##(1990-2#1)(1996-5#1)(2008-10#1)
detectable##277##1##(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#4)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#5)(1994-6#2)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#3)(1995-9#1)(1996-12#7)(1996-4#1)(1996-5#5)(1997-2#1)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#62)(2008-11#7)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#8)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#5)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)
detectably##5##1##(1991-12#1)(1991-9#1)(1992-11#1)(1993-11#1)(2008-9#1)
detected 2##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
detected 30##2##2##(1996-12#1)(2008-10#1)
detected 4##2##2##(1993-8#1)(2008-10#1)
detected 92##2##2##(1991-11#1)(2008-10#1)
detected DNA##2##2##(2008-10#2)
detected PLRV##2##2##(2008-10#2)
detected a homozygous##3##3##(1997-2#1)(2008-7#1)(2013-1#1)
detected a##30##2##(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
detected after##16##2##(1992-11#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-8#1)(2008-10#6)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
detected all##3##2##(1992-9#1)(2008-7#1)(2013-8#1)
detected among all##3##3##(2008-10#3)
detected among isolates##3##3##(2008-10#3)
detected among the##7##3##(1995-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
detected among##23##2##(1991-6#1)(1995-12#1)(2008-10#17)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
detected amount##2##2##(2008-10#1)(2013-1#1)
detected amperometrically##2##2##(2008-10#2)
detected an##3##2##(1992-9#1)(1994-6#1)(2008-5#1)
detected and identified##2##3##(1994-6#1)(2008-10#1)
detected and quantified##3##3##(2008-10#2)(2008-2#1)
detected and quantitated##2##3##(1991-2#1)(2008-10#1)
detected and the number of##2##5##(1990-2#1)(2008-9#1)
detected and the##5##3##(1990-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
detected and##38##2##(1990-11#2)(1990-2#1)(1991-12#1)(1991-2#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
detected are##3##2##(2008-10#2)(2013-1#1)
detected as a##5##3##(1990-8#1)(1993-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
detected as an##2##3##(1992-2#1)(2008-6#1)
detected as early as##4##4##(1993-3#1)(2008-10#2)(2009-7#1)
detected as nitrite##2##3##(2008-10#2)
detected as##32##2##(1990-8#2)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-7#1)(2013-1#1)
detected at a level##2##4##(2008-10#2)
detected at a##5##3##(1995-8#1)(2008-10#2)(2009-5#1)(2010-5#1)
detected at all##4##3##(1990-9#1)(1995-11#1)(2008-10#2)
detected at any##2##3##(2008-5#1)(2008-6#1)
detected at baseline##2##3##(2013-1#2)
detected at low##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
detected at pH##2##3##(2008-10#1)(2008-5#1)
detected at the end of##2##5##(1996-6#1)(2007-3#1)
detected at the##18##3##(1990-8#1)(1991-12#1)(1992-3#2)(1994-12#1)(1994-9#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2012-12#1)
detected at##89##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#35)(2008-2#3)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
detected before the##3##3##(2008-10#2)(2012-1#1)
detected before##5##2##(2008-10#3)(2008-5#1)(2012-1#1)
detected between the two##2##4##(2008-1#1)(2008-8#1)
detected between the##5##3##(1996-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
detected between##19##2##(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-8#2)(2008-9#1)(2009-5#2)(2012-12#1)(2012-2#1)(2013-7#1)
detected both##5##2##(1990-5#1)(1991-5#1)(1995-6#1)(2008-10#1)(2011-2#1)
detected but##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
detected by ELISA##3##3##(1997-6#2)(2008-4#1)
detected by HPLC##2##3##(1994-11#1)(2008-10#1)
detected by NBI-ME##2##3##(2012-2#2)
detected by Northern##2##3##(1993-12#1)(1993-9#1)
detected by PCR##4##3##(1992-3#1)(2008-10#1)(2010-1#1)(2013-1#1)
detected by RT-PCR##2##3##(2008-10#1)(2008-6#1)
detected by Southern blot hybridization##2##5##(1992-3#1)(2008-10#1)
detected by Southern##4##3##(1992-3#1)(1992-9#1)(2008-10#1)(2008-9#1)
detected by UV##3##3##(2008-10#3)
detected by Western blot##5##4##(2008-8#2)(2008-9#2)(2012-2#1)
detected by Western blotting##2##4##(1996-5#1)(2012-3#1)
detected by Western##7##3##(1996-5#1)(2008-8#2)(2008-9#2)(2012-2#1)(2012-3#1)
detected by a combination of##2##5##(2008-10#1)(2008-3#1)
detected by a##19##3##(1992-2#1)(1994-12#1)(2007-11#1)(2008-10#6)(2008-3#5)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
detected by abdominal##2##3##(2008-1#1)(2011-1#1)
detected by absorbance##2##3##(1995-2#1)(2008-10#1)
detected by an##5##3##(1995-3#1)(2008-10#4)
detected by analysis##2##3##(1996-5#1)(2008-1#1)
detected by both##3##3##(2008-10#3)
detected by conventional##4##3##(1995-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
detected by direct##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
detected by fluorescence##2##3##(2008-10#1)(2011-1#1)
detected by imaging##2##3##(2008-1#1)(2013-1#1)
detected by immunoblotting##2##3##(1992-12#1)(2008-10#1)
detected by immunohistochemistry##2##3##(2007-8#1)(2013-8#1)
detected by in situ hybridization##2##5##(1995-12#1)(1996-12#1)
detected by in##4##3##(1995-12#1)(1996-12#1)(1997-3#1)(2011-1#1)
detected by means of##2##4##(2008-2#1)(2008-9#1)
detected by measuring the##4##4##(1991-5#1)(2008-10#1)(2008-4#1)(2010-2#1)
detected by phosphorylation##2##3##(1992-9#1)(1995-5#1)
detected by protein##2##3##(1990-12#1)(2008-10#1)
detected by radioimmunoassay##2##3##(1995-12#1)(1996-12#1)
detected by real-time##2##3##(2008-10#1)(2012-2#1)
detected by scintigraphy and##3##4##(2007-11#2)(2008-7#1)
detected by screening##2##3##(1990-2#1)(1995-12#1)
detected by sequence analysis##2##4##(2008-10#1)(2009-6#1)
detected by the method##4##4##(2008-10#4)
detected by the sensor##2##4##(2008-10#1)(2008-3#1)
detected by the##37##3##(1990-5#1)(1991-3#1)(1993-8#1)(1994-3#2)(1995-8#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#2)
detected by these##3##3##(1991-3#1)(2008-10#1)(2012-12#1)
detected by this##2##3##(2008-10#1)(2008-3#1)
detected by ultrasonic##2##3##(1990-2#1)(1994-9#1)
detected by ultrasound##2##3##(2008-7#1)(2012-3#1)
detected by use of a##3##5##(1995-3#1)(2007-12#1)(2008-3#1)
detected by using the##2##4##(1993-2#1)(2008-9#1)
detected by using##7##3##(1993-2#1)(2008-10#2)(2008-12#1)(2008-9#2)(2011-1#1)
detected by virtue of##2##4##(2008-10#1)(2008-9#1)
detected by##303##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-8#1)(1996-12#3)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-11#6)(2007-12#3)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#85)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#11)(2008-4#8)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#21)(2009-10#1)(2009-2#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-2#7)(2012-12#3)(2012-2#10)(2012-3#8)(2013-1#4)(2013-8#3)
detected compared to##2##3##(2008-10#1)(2013-8#1)
detected compounds##2##2##(2008-10#2)
detected consistently in##2##3##(2008-10#2)
detected consistently##3##2##(2008-10#3)
detected differences##2##2##(2008-10#2)
detected down to##2##3##(2008-10#1)(2013-8#1)
detected during the##5##3##(1997-2#1)(2008-10#4)
detected during##9##2##(1991-12#2)(1996-3#1)(1997-2#1)(2007-7#1)(2008-10#4)
detected early##6##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
detected either by##4##3##(1990-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
detected either##8##2##(1990-11#1)(1991-2#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-4#1)
detected even in##2##3##(2008-10#2)
detected even##5##2##(1996-11#1)(2008-10#3)(2010-3#1)
detected fluorescence##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
detected following##2##2##(1996-12#1)(2008-10#1)
detected for a##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
detected for all##2##3##(1990-7#1)(1991-2#1)
detected for the first time##2##5##(1993-12#1)(2008-10#1)
detected for the##8##3##(1991-1#1)(1993-12#1)(1995-5#1)(2008-10#3)(2011-2#2)
detected for##33##2##(1990-7#1)(1991-1#1)(1991-2#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-5#2)(1997-6#1)(1997-8#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
detected from the##6##3##(1997-4#1)(2008-10#4)(2008-6#1)
detected from##25##2##(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-7#2)(2008-10#11)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#2)(2013-1#1)
detected if##3##2##(1996-4#1)(2008-10#1)(2008-4#1)
detected in 1##3##3##(2007-7#1)(2008-10#1)(2012-3#1)
detected in 10 of the##2##5##(2008-10#1)(2008-5#1)
detected in 10##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
detected in 14##2##3##(2007-10#1)(2008-10#1)
detected in 18##3##3##(1996-6#1)(2008-12#1)(2009-8#1)
detected in 21##2##3##(2009-8#1)(2013-1#1)
detected in 3##3##3##(2011-2#2)(2012-3#1)
detected in 51##2##3##(1993-2#1)(2008-12#1)
detected in 8##3##3##(1993-3#1)(1995-4#1)(2008-1#1)
detected in CSF##3##3##(1994-8#1)(2007-8#1)(2012-3#1)
detected in HeLa cells##2##4##(1990-5#1)(1996-5#1)
detected in a wide##2##4##(1997-8#1)(2008-2#1)
detected in a##19##3##(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
detected in all of the##2##5##(1991-2#1)(2008-10#1)
detected in all the##3##4##(1997-6#1)(2008-11#1)(2008-8#1)
detected in all##13##3##(1990-12#1)(1990-2#1)(1991-2#1)(1993-12#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-8#1)
detected in an##4##3##(1991-9#1)(1995-11#1)(2008-10#2)
detected in both years##2##4##(2008-4#2)
detected in both##13##3##(1991-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-4#2)(2008-9#1)(2010-6#1)(2013-1#1)
detected in brain##2##3##(2008-8#1)(2011-2#1)
detected in cell##2##3##(1995-2#1)(2008-11#1)
detected in cells##2##3##(1995-6#1)(1995-8#1)
detected in culture##2##3##(2008-10#2)
detected in differentiating##2##3##(2008-8#2)
detected in each of##2##4##(2008-10#1)(2012-12#1)
detected in environmental##2##3##(2008-10#2)
detected in experimental##2##3##(2008-5#1)(2013-1#1)
detected in follicular##2##3##(1991-12#1)(2008-11#1)
detected in four##2##3##(2008-10#1)(2008-5#1)
detected in guttation fluid from systemically infected##2##7##(2008-10#2)
detected in human##9##3##(1990-2#1)(1992-12#2)(1992-8#1)(1993-6#1)(1994-8#1)(1996-12#1)(2008-10#1)(2013-1#1)
detected in individual##2##3##(2008-10#1)(2012-2#1)
detected in infected##2##3##(2008-10#2)
detected in islets##2##3##(1995-11#2)
detected in kidney##2##3##(1990-11#1)(1994-11#1)
detected in leaf##2##3##(2008-10#2)
detected in leukemic cells##2##4##(1995-2#1)(2008-9#1)
detected in most##2##3##(1993-3#1)(1996-12#1)
detected in mouse##3##3##(1990-11#1)(2008-10#1)(2013-1#1)
detected in nerve##2##3##(1990-5#1)(2008-6#1)
detected in nine##2##3##(2008-10#1)(2008-7#1)
detected in one##5##3##(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
detected in only one##2##4##(2007-10#1)(2008-11#1)
detected in only##4##3##(2007-10#1)(2008-11#1)(2011-2#2)
detected in other##5##3##(1994-6#1)(2008-10#2)(2008-8#1)(2010-11#1)
detected in patients with##4##4##(1992-3#1)(2008-6#2)(2009-8#1)
detected in patients##8##3##(1991-2#1)(1992-3#1)(1994-5#1)(1994-9#1)(2008-6#2)(2009-3#1)(2009-8#1)
detected in plasma##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
detected in progeny tubers##2##4##(2008-10#2)
detected in roots of##2##4##(2008-10#2)
detected in samples from##2##4##(2008-10#1)(2011-2#1)
detected in samples of##2##4##(2008-10#1)(2013-1#1)
detected in samples##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
detected in seed##2##3##(2008-10#2)
detected in serum##3##3##(1994-8#1)(2008-7#2)
detected in situ##2##3##(1992-10#1)(1993-12#1)
detected in six##2##3##(1990-8#1)(1996-12#1)
detected in some##6##3##(1996-12#2)(2008-10#3)(2008-7#1)
detected in stage##2##3##(1997-7#1)(2012-2#1)
detected in susceptible##2##3##(2008-10#2)
detected in the brain##3##4##(1994-2#1)(1996-12#1)(2009-7#1)
detected in the cytoplasm of##2##5##(1990-11#1)(2008-6#1)
detected in the cytosol##2##4##(1990-2#1)(1995-11#1)
detected in the first##2##4##(1990-5#1)(2008-10#1)
detected in the gut##2##4##(2008-10#2)
detected in the hemolymph##4##4##(2008-10#4)
detected in the leaves##2##4##(2008-10#1)(2008-12#1)
detected in the liver##3##4##(2008-10#1)(2008-7#1)(2011-3#1)
detected in the majority of##2##5##(2008-10#1)(2011-2#1)
detected in the patients##2##4##(1996-7#1)(2013-7#1)
detected in the plasma##3##4##(1994-11#1)(1994-8#1)(2008-11#1)
detected in the same##2##4##(1990-8#1)(2008-10#1)
detected in the serum##2##4##(1995-2#1)(2008-5#1)
detected in the tumor##2##4##(1992-9#1)(1993-9#1)
detected in the upper##2##4##(1994-7#1)(2008-10#1)
detected in the##181##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#1)(1995-11#6)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#57)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#2)(2009-1#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
detected in their##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
detected in these##7##3##(1995-11#1)(1997-4#1)(2008-10#4)(2008-5#1)
detected in this study##4##4##(1991-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
detected in this##11##3##(1991-12#1)(1993-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-8#1)(2013-1#1)
detected in three##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
detected in tissue##2##3##(2008-10#2)
detected in total##2##3##(1992-11#1)(2008-10#1)
detected in various biological##2##4##(1994-8#1)(1996-2#1)
detected in various##6##3##(1991-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-10#1)
detected in vitro##2##3##(1994-8#1)(2008-10#1)
detected in##692##2##(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#5)(1990-9#1)(1991-12#4)(1991-2#6)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#6)(1994-11#6)(1994-12#3)(1994-2#7)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#1)(1995-11#14)(1995-12#6)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#7)(1995-8#4)(1996-12#20)(1996-2#2)(1996-5#5)(1996-6#2)(1996-7#1)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#1)(1997-8#2)(2006-4#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-5#2)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#220)(2008-11#17)(2008-12#11)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#21)(2008-6#5)(2008-7#13)(2008-8#24)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#6)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#21)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#8)(2013-1#22)(2013-7#3)(2013-8#6)
detected incidentally during routine##2##4##(1997-3#1)(2008-11#1)
detected incidentally during##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
detected incidentally##4##2##(1997-3#1)(2008-11#2)(2008-7#1)
detected indirectly##2##2##(2008-10#1)(2008-4#1)
detected intracellularly##2##2##(1992-12#1)(2009-5#1)
detected is##2##2##(2008-11#1)(2009-5#1)
detected more frequently##2##3##(2008-10#1)(2008-5#1)
detected more##4##2##(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
detected most##2##2##(1997-4#1)(2008-10#1)
detected nine##2##2##(2008-10#1)(2009-2#1)
detected no##2##2##(2009-9#1)(2013-1#1)
detected on a##4##3##(1991-2#1)(1991-7#1)(2008-10#1)(2008-9#1)
detected on day##2##3##(1997-6#1)(2008-8#1)
detected on glassy carbon electrode surface at##2##7##(2008-10#2)
detected on glassy carbon electrode##3##5##(2008-10#3)
detected on the##8##3##(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
detected on##46##2##(1991-12#1)(1991-2#1)(1991-7#1)(1994-11#2)(1994-12#1)(1994-6#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
detected only by##2##3##(1994-12#1)(2012-3#1)
detected only in the liver##2##5##(1990-11#2)
detected only in the##4##4##(1990-11#2)(2008-10#1)(2012-1#1)
detected only in##9##3##(1990-11#2)(1996-12#1)(1997-8#1)(2008-10#3)(2012-1#1)(2012-12#1)
detected only##16##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-11#1)(1994-12#1)(1996-12#1)(1997-8#1)(2008-10#5)(2012-1#1)(2012-12#1)(2012-3#1)
detected over the##3##3##(1995-11#2)(2008-10#1)
detected over##6##2##(1990-12#1)(1995-11#2)(2008-10#3)
detected phase##3##2##(2008-3#3)
detected photons##5##2##(2008-2#3)(2008-3#1)(2010-2#1)
detected polymorphisms in##2##3##(2008-10#2)
detected powers##2##2##(2008-3#2)
detected prior to##2##3##(1991-9#1)(2012-3#1)
detected sensitively##2##2##(2007-12#1)(2008-3#1)
detected several##2##2##(1993-6#1)(2008-3#1)
detected signal is##3##3##(2008-2#2)(2008-3#1)
detected signal##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
detected significant##3##2##(1996-12#1)(2008-10#2)
detected significantly##2##2##(2008-10#1)(2008-12#1)
detected simultaneously##3##2##(2008-10#1)(2008-2#2)
detected spectrophotometrically at##3##3##(2008-10#3)
detected spectrophotometrically##6##2##(2008-10#6)
detected such##2##2##(2011-1#1)(2012-2#1)
detected the DNA##2##3##(2008-10#1)(2008-11#1)
detected the presence of##4##4##(1993-2#1)(2008-10#2)(2013-7#1)
detected the virus in##2##4##(2008-10#2)
detected the virus##3##3##(2008-10#3)
detected the##31##2##(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1995-8#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
detected through##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
detected throughout the year##2##4##(2008-10#1)(2013-8#1)
detected throughout the##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
detected throughout##4##2##(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
detected to##5##2##(1994-12#1)(2008-10#1)(2008-9#1)(2013-1#2)
detected up to##2##3##(2008-10#1)(2012-3#1)
detected using a##10##3##(1995-6#1)(1997-8#1)(2008-10#8)
detected using all three##2##4##(2008-10#2)
detected using the##5##3##(1993-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
detected using##37##2##(1991-12#1)(1993-12#1)(1995-6#2)(1997-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
detected was##2##2##(2008-10#1)(2013-7#1)
detected were##4##2##(1992-2#1)(2008-10#2)(2013-1#1)
detected when the##5##3##(1992-9#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-9#1)
detected when##18##2##(1991-3#1)(1992-9#1)(1993-12#1)(1995-12#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-9#1)(2010-10#1)(2010-5#1)
detected with PCR##2##3##(1997-8#1)(2008-10#1)
detected with a sensitivity##2##4##(1997-8#1)(2008-10#1)
detected with a##9##3##(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)
detected with an##3##3##(1990-5#1)(1991-5#1)(1992-9#1)
detected with immunohistochemistry##2##3##(2007-8#1)(2011-2#1)
detected with negative##2##3##(2008-10#1)(2011-1#1)
detected with the recovery of 90##2##6##(2008-10#2)
detected with the##13##3##(1991-3#1)(1992-6#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#8)
detected with this##2##3##(2008-10#1)(2008-5#1)
detected with##74##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#2)(2013-7#1)
detected within the##4##3##(2008-10#3)(2008-7#1)
detected within##15##2##(1992-3#1)(1993-3#1)(1995-2#1)(1997-3#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
detected##2188##1##(1990-11#17)(1990-12#10)(1990-2#11)(1990-3#2)(1990-5#9)(1990-6#1)(1990-7#6)(1990-8#13)(1990-9#4)(1991-1#1)(1991-11#4)(1991-12#19)(1991-2#10)(1991-3#5)(1991-5#11)(1991-6#3)(1991-7#4)(1991-8#2)(1991-9#5)(1992-10#3)(1992-11#7)(1992-12#8)(1992-2#5)(1992-3#9)(1992-5#2)(1992-6#6)(1992-8#7)(1992-9#9)(1993-11#7)(1993-12#10)(1993-2#8)(1993-3#13)(1993-5#1)(1993-6#9)(1993-8#12)(1993-9#13)(1994-1#1)(1994-10#1)(1994-11#18)(1994-12#12)(1994-2#13)(1994-3#4)(1994-5#3)(1994-6#10)(1994-7#2)(1994-8#12)(1994-9#6)(1995-11#25)(1995-12#16)(1995-2#12)(1995-3#4)(1995-4#3)(1995-5#8)(1995-6#11)(1995-8#8)(1995-9#2)(1996-11#2)(1996-12#38)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#9)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#14)(1997-3#17)(1997-4#6)(1997-5#2)(1997-6#15)(1997-7#6)(1997-8#16)(1997-9#2)(2006-10#2)(2006-4#2)(2006-6#2)(2007-10#6)(2007-11#16)(2007-12#21)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#11)(2007-8#12)(2007-9#2)(2008-1#17)(2008-10#720)(2008-11#48)(2008-12#31)(2008-2#37)(2008-3#59)(2008-4#30)(2008-5#59)(2008-6#18)(2008-7#43)(2008-8#49)(2008-9#53)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#4)(2009-3#3)(2009-5#12)(2009-6#5)(2009-7#4)(2009-8#8)(2009-9#1)(2010-1#6)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#9)(2010-6#3)(2010-8#3)(2011-1#26)(2011-2#57)(2011-3#5)(2012-1#6)(2012-12#22)(2012-2#36)(2012-3#38)(2012-6#1)(2012-7#1)(2013-1#47)(2013-7#11)(2013-8#24)
detecting DNA##3##2##(2008-10#3)
detecting a variety of##2##4##(2008-10#1)(2008-4#1)
detecting a weak##2##3##(1995-2#1)(2007-11#1)
detecting a##13##2##(1995-2#2)(1997-7#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-9#1)
detecting acute##2##2##(2008-3#1)(2013-1#1)
detecting and characterizing##2##3##(2008-10#1)(2008-4#1)
detecting and##11##2##(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-8#2)(2013-1#1)
detecting as little as##2##4##(2008-10#2)
detecting bleeding##2##2##(1991-6#1)(2010-12#1)
detecting early##3##2##(1991-3#1)(2007-9#1)(2011-1#1)
detecting high##2##2##(2008-7#1)(2011-2#1)
detecting hydroxyl radicals##2##3##(2008-10#2)
detecting it##2##2##(1996-4#1)(2008-10#1)
detecting low##2##2##(1990-12#1)(1991-3#1)
detecting malignancies##2##2##(1995-12#1)(2008-4#1)
detecting the early##2##3##(2009-12#1)(2010-8#1)
detecting the presence of##3##4##(1995-12#1)(2008-2#1)(2009-1#1)
detecting the presence##4##3##(1995-12#1)(2008-2#1)(2008-3#1)(2009-1#1)
detecting the##32##2##(1994-2#1)(1994-7#1)(1995-12#1)(2007-11#2)(2008-10#8)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
detecting trace##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
detecting variation##2##2##(2008-12#1)(2008-2#1)
detecting##281##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#3)(1994-2#2)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#2)(2007-10#3)(2007-11#7)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#77)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#19)(2008-4#13)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#9)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#5)(2013-8#2)
detection (2##2##2##(2008-10#2)
detection (AD) system##2##3##(2008-10#2)
detection (AD)##3##2##(2008-10#3)
detection (ECD)##4##2##(2008-10#4)
detection (GC-EAD)##2##2##(2008-10#2)
detection (GC-MS)##3##2##(1997-6#1)(2008-10#2)
detection (HPLC-ECD)##2##2##(2008-10#1)(2008-5#1)
detection (LOD) and quantification (LOQ)##3##5##(2008-10#3)
detection (LOD) and##9##3##(2008-10#9)
detection (LOD)##52##2##(2008-10#50)(2010-5#1)(2012-1#1)
detection 1##2##2##(2007-12#1)(2008-10#1)
detection accuracy of##2##3##(2008-2#1)(2008-3#1)
detection accuracy##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
detection after##3##2##(1993-12#1)(2008-10#2)
detection algorithm##2##2##(2008-2#1)(2008-3#1)
detection allows##2##2##(2007-11#1)(2008-10#1)
detection and analysis of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
detection and by##2##3##(1997-2#1)(2012-3#1)
detection and characterization of##11##4##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)
detection and characterization##15##3##(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)
detection and classification of##2##4##(2009-5#1)(2010-12#1)
detection and determination##4##3##(2008-10#2)(2008-11#2)
detection and differentiation of##3##4##(2008-10#2)(2012-2#1)
detection and discrimination##2##3##(2008-10#2)
detection and enumeration##2##3##(2008-9#1)(2010-1#1)
detection and identification of##10##4##(2007-12#1)(2008-10#8)(2008-3#1)
detection and identification##11##3##(2007-12#1)(2008-10#9)(2008-3#1)
detection and intervention##7##3##(2007-8#1)(2008-11#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-2#1)
detection and isolation##2##3##(1996-12#1)(2008-4#1)
detection and measurement of##2##4##(2008-3#2)
detection and monitoring##3##3##(2007-7#1)(2008-2#1)(2011-2#1)
detection and optical##2##3##(2008-10#1)(2009-4#1)
detection and quantification limits were##3##5##(2008-10#3)
detection and quantification limits##10##4##(2008-10#10)
detection and quantification of##11##4##(2008-10#9)(2008-3#1)(2010-7#1)
detection and quantification were##2##4##(2008-10#2)
detection and quantification##28##3##(2008-10#25)(2008-3#1)(2009-7#1)(2010-7#1)
detection and quantitation of##5##4##(1990-12#1)(1992-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
detection and quantitation##11##3##(1990-12#1)(1992-8#1)(2008-1#1)(2008-10#6)(2008-4#1)(2013-8#1)
detection and quantitative##2##3##(2008-10#1)(2008-9#1)
detection and relative quantitation of##2##5##(2008-10#2)
detection and relative##5##3##(2008-10#5)
detection and removal of##2##4##(2008-6#1)(2010-5#1)
detection and spectrophotometric##2##3##(2008-10#2)
detection and staging of pancreatic##2##5##(2008-1#2)
detection and the##8##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)
detection and treatment of##6##4##(2007-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2012-2#2)
detection and treatment##12##3##(1995-12#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-7#2)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#2)
detection and##228##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#103)(2008-11#5)(2008-2#11)(2008-3#14)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#1)
detection antibodies##2##2##(2008-9#1)(2010-5#1)
detection applications##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
detection approach##2##2##(2008-10#1)(2008-2#1)
detection are discussed##2##3##(2008-10#1)(2010-11#1)
detection are the##2##3##(2010-7#1)(2010-8#1)
detection are##17##2##(1997-2#1)(2007-12#1)(2008-10#10)(2008-2#1)(2009-5#1)(2010-11#1)(2010-7#1)(2010-8#1)
detection area##4##2##(2007-12#1)(2008-10#2)(2009-6#1)
detection as well as##3##4##(2008-10#2)(2008-3#1)
detection as##8##2##(2008-10#6)(2008-3#1)(2011-2#1)
detection at 254 nm##3##4##(1996-5#1)(2008-10#1)(2009-8#1)
detection at 310 nm##3##4##(2008-10#1)(2008-5#2)
detection at a##6##3##(2008-10#6)
detection at anodized boron-doped diamond##2##5##(2008-10#2)
detection at anodized##3##3##(2008-10#3)
detection at the##7##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)
detection at##64##2##(1996-5#2)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#49)(2008-11#1)(2008-3#2)(2008-5#3)(2009-8#1)(2010-3#1)(2013-1#1)
detection bandwidth##4##2##(2008-3#3)(2009-5#1)
detection based on a##3##4##(2008-10#2)(2008-3#1)
detection based on##8##3##(2008-10#4)(2008-2#2)(2008-3#1)(2009-5#1)
detection beam##2##2##(2008-2#1)(2008-3#1)
detection being##3##2##(2008-10#2)(2012-2#1)
detection by ELISA##3##3##(2008-10#1)(2013-8#2)
detection by PCR in##2##4##(2008-10#2)
detection by UV##2##3##(1996-5#1)(2008-10#1)
detection by a##2##3##(2008-3#1)(2012-2#1)
detection by an##2##3##(2008-10#2)
detection by inductively coupled plasma mass spectrometry##4##7##(2008-10#4)
detection by use of##2##4##(2008-2#1)(2008-3#1)
detection by##44##2##(1993-8#1)(1995-12#1)(1996-5#1)(1997-4#2)(1997-5#2)(2008-10#23)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
detection can be##4##3##(1990-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
detection capabilities##3##2##(2008-10#2)(2010-4#1)
detection capability##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
detection cell##12##2##(2008-10#12)
detection channels##5##2##(2007-11#1)(2008-3#4)
detection combined with##3##3##(2008-10#3)
detection conditions were##2##3##(2008-10#2)
detection could##2##2##(2008-10#2)
detection current##2##2##(2008-10#2)
detection data##2##2##(2008-10#2)
detection device##2##2##(1992-11#1)(2008-10#1)
detection efficiency and the##2##4##(2007-11#1)(2008-3#1)
detection efficiency and##3##3##(2007-11#1)(2008-3#1)(2010-8#1)
detection efficiency of##3##3##(2007-11#2)(2011-1#1)
detection efficiency##12##2##(2007-11#5)(2008-10#1)(2008-3#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
detection electrode##3##2##(2008-10#3)
detection for each##3##3##(2008-10#3)
detection for ethanol##2##3##(2008-10#2)
detection for liquid##2##3##(2008-10#2)
detection for several##2##3##(2008-10#2)
detection for the analysis of chelerythrine and sanguinarine##2##8##(2008-10#2)
detection for the determination of##5##5##(1990-8#1)(1991-5#1)(2008-10#3)
detection for the##15##3##(1990-8#1)(1991-5#1)(1997-2#1)(2008-10#11)(2010-11#1)
detection for##84##2##(1990-8#4)(1991-5#1)(1991-7#2)(1995-2#1)(1997-2#2)(2008-10#62)(2008-12#1)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)
detection frequency of P##4##4##(2008-10#4)
detection frequency##6##2##(2008-10#6)
detection from##6##2##(2008-10#4)(2012-2#2)
detection geometry##3##2##(2008-2#1)(2008-3#2)
detection has been developed for the determination of##3##8##(2008-10#3)
detection has been developed for the##5##6##(2008-10#5)
detection has been developed##9##4##(2008-10#9)
detection has been##16##3##(2008-10#14)(2008-2#2)
detection has the##2##3##(2008-10#1)(2008-3#1)
detection has##21##2##(1997-6#1)(2008-10#17)(2008-2#2)(2008-3#1)
detection have been developed##2##4##(2008-10#1)(2010-5#1)
detection have been##8##3##(2008-10#7)(2010-5#1)
detection have##10##2##(1991-5#1)(2008-10#8)(2010-5#1)
detection in a##7##3##(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#1)
detection in an##2##3##(2007-11#1)(2008-10#1)
detection in flow analysis systems##2##5##(2008-10#2)
detection in flow analysis##3##4##(2008-10#3)
detection in flow##4##3##(2008-10#4)
detection in the presence of##4##5##(2008-10#2)(2008-3#1)(2008-9#1)
detection in the##30##3##(1995-3#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
detection in urine##3##3##(2008-10#3)
detection in##102##2##(1991-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#3)(2008-10#47)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-11#2)(2010-7#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#3)
detection is 0##8##3##(2008-10#8)
detection is 2##5##3##(2008-10#5)
detection is a##3##3##(2007-7#1)(2008-10#1)(2008-4#1)
detection is an##2##3##(2007-12#1)(2008-10#1)
detection is demonstrated##2##3##(1997-2#1)(2007-12#1)
detection is described for the##2##5##(2008-10#2)
detection is described##6##3##(2008-10#6)
detection is important##2##3##(2008-3#1)(2011-1#1)
detection is presented##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
detection is proposed##6##3##(2007-11#1)(2008-10#5)
detection is##70##2##(1990-8#1)(1992-11#1)(1993-2#1)(1997-2#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#44)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#2)(2009-1#1)(2010-7#1)(2011-1#2)(2013-1#2)
detection kit##2##2##(2008-11#1)(2008-12#1)
detection level##2##2##(2008-10#2)
detection limit (0##5##3##(2008-10#5)
detection limit (1##2##3##(2008-10#2)
detection limit (3 s)##2##4##(2008-10#2)
detection limit (3##8##3##(1991-12#1)(2008-10#7)
detection limit (3s) of 0##2##5##(2008-10#2)
detection limit (3s) of##3##4##(2008-10#3)
detection limit (3s)##4##3##(2008-10#4)
detection limit (3sigma criterion)##2##4##(2008-10#2)
detection limit (3sigma##3##3##(2008-10#3)
detection limit (3sigma) in##3##4##(2008-10#3)
detection limit (3sigma) is##2##4##(2008-10#2)
detection limit (3sigma) of 0##8##5##(2008-10#8)
detection limit (3sigma) of##14##4##(2008-10#14)
detection limit (3sigma) was##4##4##(2008-10#4)
detection limit (3sigma)##25##3##(2008-10#25)
detection limit (DL)##4##3##(2008-10#4)
detection limit (S/N=3) of##5##4##(2008-10#5)
detection limit (S/N=3)##12##3##(2008-10#12)
detection limit (as##2##3##(2008-10#2)
detection limit (defined as##2##4##(2008-10#2)
detection limit (log##3##3##(2008-10#3)
detection limit (signal-to-noise ratio##2##4##(2008-10#1)(2008-3#1)
detection limit (signal-to-noise##3##3##(2008-10#2)(2008-3#1)
detection limit (signal/noise##2##3##(2008-10#2)
detection limit 0##6##3##(2008-10#6)
detection limit 1##4##3##(2008-10#4)
detection limit achieved##2##3##(2008-10#2)
detection limit and precision##2##4##(2008-10#2)
detection limit and the##8##4##(2008-10#8)
detection limit and##23##3##(2008-10#22)(2012-3#1)
detection limit are##2##3##(2008-10#2)
detection limit between##2##3##(1995-2#1)(2008-10#1)
detection limit could##2##3##(2008-10#2)
detection limit down to##4##4##(2008-10#4)
detection limit for the##6##4##(2008-10#6)
detection limit for trichlorfon##2##4##(2008-10#2)
detection limit for##45##3##(1990-8#2)(2008-10#39)(2008-12#1)(2008-2#2)(2012-3#1)
detection limit in the##2##4##(2007-12#1)(2008-3#1)
detection limit in##6##3##(2007-12#1)(2008-10#4)(2008-3#1)
detection limit is 0##25##4##(2008-10#25)
detection limit is 1##6##4##(2008-10#6)
detection limit is 2##6##4##(2008-10#6)
detection limit is 5##5##4##(2008-10#5)
detection limit is 6##2##4##(2008-10#2)
detection limit is down to##2##5##(2008-10#1)(2013-1#1)
detection limit is##73##3##(1996-5#1)(2008-10#70)(2008-2#1)(2013-1#1)
detection limit obtained was 4##2##5##(2008-10#2)
detection limit obtained##4##3##(2008-10#3)(2008-3#1)
detection limit of 0##108##4##(1992-11#1)(2007-12#1)(2008-10#100)(2008-11#3)(2008-2#1)(2010-4#1)(2013-1#1)
detection limit of 1 muM##3##5##(2008-10#3)
detection limit of 1##54##4##(1991-5#1)(1996-5#1)(2008-10#48)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
detection limit of 10##4##4##(2008-10#3)(2008-11#1)
detection limit of 12 mug l(-1)##2##6##(2008-10#2)
detection limit of 2##20##4##(2007-12#1)(2008-10#19)
detection limit of 20 ng ml(-1)##2##6##(2008-10#2)
detection limit of 20##5##4##(2008-10#5)
detection limit of 3##12##4##(2007-12#1)(2008-10#11)
detection limit of 32##2##4##(2008-10#2)
detection limit of 4##15##4##(2008-10#15)
detection limit of 5 x##2##5##(2008-10#2)
detection limit of 5##10##4##(2008-10#10)
detection limit of 6##12##4##(2008-10#10)(2010-5#2)
detection limit of 7##3##4##(2008-10#3)
detection limit of 8##8##4##(2008-10#8)
detection limit of Cu(II)##2##4##(2008-10#2)
detection limit of about##3##4##(2008-10#3)
detection limit of the method was##2##6##(1995-6#1)(2008-10#1)
detection limit of the method##11##5##(1995-6#1)(2008-10#10)
detection limit of the##29##4##(1995-6#1)(1997-2#1)(2008-10#23)(2008-12#1)(2008-2#2)(2013-8#1)
detection limit of this method was##4##6##(1990-2#1)(2008-10#2)(2008-11#1)
detection limit of this method##7##5##(1990-2#1)(2008-10#5)(2008-11#1)
detection limit of this##10##4##(1990-2#1)(1991-2#1)(1995-11#1)(2008-10#6)(2008-11#1)
detection limit of##394##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-11#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-12#6)(2008-10#354)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2010-4#1)(2010-5#2)(2011-1#1)(2013-1#2)(2013-8#3)
detection limit to##2##3##(2008-10#2)
detection limit using##2##3##(2008-10#2)
detection limit was 0##29##4##(1994-9#1)(2008-10#28)
detection limit was 1##8##4##(2008-10#8)
detection limit was 10##2##4##(2008-10#2)
detection limit was 2##8##4##(2008-10#8)
detection limit was 20##2##4##(2008-10#2)
detection limit was 3##4##4##(2008-10#4)
detection limit was 4##3##4##(1990-12#1)(2008-10#2)
detection limit was 5##3##4##(2008-10#3)
detection limit was 9##2##4##(2008-10#1)(2013-8#1)
detection limit was calculated##2##4##(2008-10#2)
detection limit was determined##4##4##(2008-10#4)
detection limit was estimated as 0##3##6##(2008-10#3)
detection limit was estimated##6##4##(2008-10#5)(2008-3#1)
detection limit was found to##4##5##(2008-10#4)
detection limit was improved to##2##5##(2008-10#2)
detection limit was lower##3##4##(2008-10#3)
detection limit was##115##3##(1990-12#1)(1990-8#1)(1991-5#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#107)(2008-3#1)(2013-8#1)
detection limit were##5##3##(2008-10#5)
detection limit##897##2##(1990-12#2)(1990-2#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#2)(1992-11#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#3)(1997-2#1)(2007-11#1)(2007-12#8)(2008-10#820)(2008-11#7)(2008-12#2)(2008-2#11)(2008-3#10)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#3)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#4)
detection limit) and##2##3##(2008-10#1)(2008-2#1)
detection limit)##3##2##(2008-10#2)(2008-2#1)
detection limits (0##5##3##(2008-10#4)(2013-1#1)
detection limits (3sigma) of##3##4##(2008-10#3)
detection limits (3sigma) were##3##4##(2008-10#3)
detection limits (3sigma)##10##3##(2008-10#10)
detection limits (DL) were##2##4##(2008-10#1)(2013-8#1)
detection limits (DL)##5##3##(2008-10#4)(2013-8#1)
detection limits (LOD)##3##3##(2008-10#3)
detection limits (LODs)##2##3##(2008-10#2)
detection limits (MDLs)##2##3##(2008-10#2)
detection limits (S/N=3) are##4##4##(2008-10#4)
detection limits (S/N=3) of##4##4##(2008-10#4)
detection limits (S/N=3) ranged from 0##2##6##(2008-10#2)
detection limits (S/N=3)##15##3##(2008-10#15)
detection limits achieved were##2##4##(2008-10#2)
detection limits achieved##5##3##(2008-10#5)
detection limits and the##2##4##(2008-10#2)
detection limits and##12##3##(2008-10#11)(2008-3#1)
detection limits are 0##8##4##(2008-10#8)
detection limits are 1##3##4##(2008-10#3)
detection limits are 3##2##4##(2008-10#2)
detection limits are##22##3##(1995-9#2)(2008-10#20)
detection limits being##2##3##(2008-10#2)
detection limits for the##4##4##(2008-10#4)
detection limits for##40##3##(1990-8#1)(1995-9#2)(1997-2#1)(2008-10#33)(2008-2#1)(2008-3#1)(2011-1#1)
detection limits in the range##2##5##(2008-10#2)
detection limits in the##4##4##(2008-10#3)(2008-3#1)
detection limits in##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
detection limits obtained were##2##4##(2008-10#2)
detection limits obtained##6##3##(2008-10#6)
detection limits of 0##20##4##(1997-4#1)(2008-10#19)
detection limits of 1##3##4##(1997-4#1)(2008-10#2)
detection limits of 2##2##4##(2008-10#2)
detection limits of 7##3##4##(2008-10#3)
detection limits of about##2##4##(2008-10#2)
detection limits of the method##5##5##(2008-10#3)(2008-5#1)(2012-1#1)
detection limits of the##16##4##(2008-10#13)(2008-5#1)(2012-1#1)(2013-8#1)
detection limits of this##2##4##(2008-10#2)
detection limits of##85##3##(1997-2#1)(1997-4#2)(2008-10#78)(2008-3#1)(2008-5#1)(2012-1#1)(2013-8#1)
detection limits on##2##3##(2008-10#2)
detection limits range##2##3##(2008-10#1)(2012-2#1)
detection limits ranged from##2##4##(2008-10#2)
detection limits ranging from 0##3##5##(2008-10#3)
detection limits ranging from 2##2##5##(2008-10#2)
detection limits ranging from##6##4##(2008-10#6)
detection limits that##2##3##(2008-10#1)(2008-3#1)
detection limits under##2##3##(2008-10#2)
detection limits was##2##3##(2008-10#2)
detection limits were 0##13##4##(2008-10#12)(2011-1#1)
detection limits were 10##2##4##(2008-10#2)
detection limits were 7##2##4##(2008-10#2)
detection limits were found to be##6##6##(2008-10#6)
detection limits were in the##2##5##(2008-10#2)
detection limits were##55##3##(2008-10#53)(2011-1#1)(2011-2#1)
detection limits##381##2##(1990-8#2)(1995-9#4)(1997-2#2)(1997-4#3)(2008-10#349)(2008-2#4)(2008-3#5)(2008-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
detection mechanism is##2##3##(1993-9#1)(2008-10#1)
detection mechanism##3##2##(1993-9#1)(2008-10#2)
detection method for capillary electrophoresis##2##5##(2008-10#2)
detection method for the##2##4##(2008-10#1)(2008-3#1)
detection method for##11##3##(2008-10#8)(2008-11#1)(2008-3#1)(2012-2#1)
detection method is##2##3##(2008-11#1)(2008-9#1)
detection method of##2##3##(2008-10#2)
detection method provides##2##3##(1993-1#1)(2008-10#1)
detection method##35##2##(1993-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#2)(2012-2#1)
detection methods and##4##3##(2008-10#2)(2008-11#1)(2010-3#1)
detection methods are##2##3##(2008-10#1)(2008-4#1)
detection methods for##2##3##(1997-4#1)(2008-3#1)
detection methods##31##2##(1997-4#3)(2008-10#14)(2008-11#3)(2008-3#3)(2008-4#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2013-1#2)
detection mode##3##2##(2008-10#3)
detection modes##5##2##(2008-10#5)
detection occurs##2##2##(1990-12#1)(2008-3#1)
detection of 0##17##3##(2008-10#17)
detection of 1##5##3##(2008-10#5)
detection of 2##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
detection of ASPV##2##3##(2008-10#2)
detection of Al##2##3##(2008-10#1)(2008-3#1)
detection of B##2##3##(2008-3#1)(2011-2#1)
detection of BrdU##2##3##(2008-9#2)
detection of CO##2##3##(2008-2#1)(2009-5#1)
detection of Cu(2+)##2##3##(2008-10#2)
detection of DNA fragmentation##3##4##(1995-12#1)(2008-1#1)(2008-10#1)
detection of DNA hybridization##3##4##(2008-10#3)
detection of DNA strand##3##4##(2008-10#2)(2008-9#1)
detection of DNA##14##3##(1995-12#1)(2008-1#1)(2008-10#11)(2008-9#1)
detection of E##5##3##(2008-10#4)(2008-9#1)
detection of Escherichia coli O157##3##5##(2008-10#3)
detection of Escherichia coliform##2##4##(2008-10#2)
detection of Escherichia##5##3##(2008-10#5)
detection of HBV DNA##2##4##(1990-8#1)(1997-4#1)
detection of HIV##2##3##(2007-7#2)
detection of HRP##2##3##(2008-10#2)
detection of M##2##3##(2008-10#1)(2008-5#1)
detection of NADH##5##3##(1992-9#1)(2008-10#3)(2010-5#1)
detection of NO##7##3##(2008-10#3)(2008-3#3)(2010-7#1)
detection of P##13##3##(1991-2#1)(2007-7#1)(2008-10#11)
detection of Phytophthora##4##3##(2008-10#4)
detection of Pseudomonas##2##3##(2008-10#2)
detection of RNA##2##3##(2008-10#1)(2008-4#1)
detection of Renibacterium salmoninarum##2##4##(2009-6#2)
detection of SNPs##2##3##(2011-2#1)(2013-1#1)
detection of Salmonella##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
detection of TNF##2##3##(1990-12#1)(1994-2#1)
detection of V##3##3##(2008-10#2)(2008-9#1)
detection of a single##2##4##(1991-2#1)(2008-10#1)
detection of a single-base##2##4##(2008-10#2)
detection of a virus##2##4##(2008-10#2)
detection of a##32##3##(1991-2#1)(1991-9#1)(1992-8#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#3)(2009-3#1)(2009-8#1)(2010-11#2)(2010-7#1)(2011-2#2)
detection of alkaline phosphatase activity##2##5##(2008-10#2)
detection of alkaline phosphatase##4##4##(2008-10#3)(2008-7#1)
detection of all##3##3##(2008-10#3)
detection of alleles##2##3##(2008-10#2)
detection of an##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2011-2#1)
detection of anions##2##3##(2008-10#2)
detection of antibodies class G##2##5##(2013-1#2)
detection of antibodies##9##3##(1990-12#3)(1991-3#2)(1992-6#1)(1997-6#1)(2013-1#2)
detection of antibody##2##3##(1996-12#1)(2008-5#1)
detection of any##2##3##(2008-5#1)(2013-1#1)
detection of arsenic using flow-injection hydride generation following sorbent extraction preconcentration##2##11##(2008-10#2)
detection of arsenic##3##3##(2008-10#3)
detection of as##2##3##(2008-9#1)(2010-4#1)
detection of ascorbate##2##3##(2008-10#2)
detection of avian leukosis/sarcoma virus##2##5##(1997-3#2)
detection of avian##3##3##(1997-3#2)(2011-2#1)
detection of bacterial##2##3##(2007-10#1)(2011-2#1)
detection of begomoviruses##3##3##(2008-10#3)
detection of beryllium##2##3##(2008-10#2)
detection of biological##5##3##(2008-10#1)(2008-3#2)(2009-6#1)(2010-2#1)
detection of both##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
detection of cancer cells##3##4##(2008-11#2)(2013-8#1)
detection of cancer##7##3##(1990-10#1)(1990-6#1)(1992-9#1)(2008-11#2)(2008-4#1)(2013-8#1)
detection of carbohydrates##2##3##(2008-10#2)
detection of carbon##2##3##(2007-12#1)(2008-2#1)
detection of changes in##3##4##(2006-6#1)(2008-7#1)(2008-9#1)
detection of circulating##2##3##(1995-11#1)(2010-1#1)
detection of codeine##2##3##(1990-8#1)(2008-3#1)
detection of colorectal##2##3##(1995-12#1)(2008-1#1)
detection of common##2##3##(2008-10#1)(2013-8#1)
detection of congenital##2##3##(1993-12#1)(1994-9#1)
detection of coronary artery disease##2##5##(2008-3#1)(2009-4#1)
detection of coronary##3##3##(1991-2#1)(2008-3#1)(2009-4#1)
detection of cryptosporidium##2##3##(2012-2#1)(2013-8#1)
detection of deletions and duplications##2##5##(2008-4#2)
detection of different##4##3##(2008-10#4)
detection of dipeptides##2##3##(1990-8#1)(1995-6#1)
detection of disease##3##3##(2008-6#1)(2012-2#1)(2012-3#1)
detection of dye labelled DNA##2##5##(2008-10#2)
detection of dystrophin##2##3##(1991-12#2)
detection of early##6##3##(1991-12#1)(2007-10#1)(2008-3#2)(2010-3#1)(2011-1#1)
detection of explosives##6##3##(2008-10#5)(2008-3#1)
detection of fluorescence##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-12#2)
detection of four##2##3##(2008-10#2)
detection of gas##2##3##(2008-10#1)(2008-3#1)
detection of gene##4##3##(2008-10#1)(2008-7#2)(2011-1#1)
detection of hantavirus antibodies##2##4##(2008-10#2)
detection of hantavirus##3##3##(2008-10#3)
detection of hazardous##2##3##(2008-10#1)(2008-2#1)
detection of heavy##2##3##(2008-10#1)(2011-2#1)
detection of homologous##2##3##(2008-10#1)(2008-11#1)
detection of human heart fatty-acid binding protein##2##7##(2008-10#2)
detection of human##7##3##(1990-8#1)(1992-6#1)(1995-2#2)(2008-10#2)(2008-2#1)
detection of hydrazine##5##3##(2008-10#4)(2013-1#1)
detection of hydrogen peroxide in##2##5##(2008-10#2)
detection of hydrogen peroxide##5##4##(2008-10#5)
detection of hydrogen##6##3##(2008-10#6)
detection of influenza##2##3##(2011-2#2)
detection of irregular antibodies##2##4##(2011-1#2)
detection of kidney##2##3##(1990-2#1)(2007-7#1)
detection of lipids##4##3##(2008-10#1)(2009-7#2)(2012-12#1)
detection of low levels of##3##5##(2008-10#2)(2008-5#1)
detection of low##5##3##(2008-10#4)(2008-5#1)
detection of lung##2##3##(1993-12#1)(1997-2#1)
detection of magnetic resonance##3##4##(1993-11#2)(1993-5#1)
detection of melatonin##2##3##(2008-10#2)
detection of metal##2##3##(2008-10#1)(2010-11#1)
detection of metastatic##3##3##(1994-12#1)(2008-7#1)(2010-3#1)
detection of microbial##2##3##(2008-11#1)(2008-4#1)
detection of microorganisms in##3##4##(2011-2#2)(2012-2#1)
detection of monovalent##2##3##(2008-10#2)
detection of multiple##7##3##(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
detection of new##2##3##(2010-11#1)(2011-2#1)
detection of nine grapevine viruses##2##5##(2008-10#2)
detection of nitric oxide##5##4##(2008-10#4)(2008-3#1)
detection of nitrogen##2##3##(2008-10#1)(2008-2#1)
detection of nucleic acid##2##4##(2008-9#1)(2012-3#1)
detection of objects in##2##4##(2008-3#2)
detection of occult fecal blood loss##2##6##(1991-6#1)(1993-3#1)
detection of only##2##3##(2008-10#1)(2008-2#1)
detection of organic##2##3##(2008-10#2)
detection of organophosphorus##2##3##(2008-10#2)
detection of other##3##3##(2008-10#2)(2012-2#1)
detection of paraoxon##4##3##(2008-10#4)
detection of pathogens##2##3##(2008-10#1)(2011-2#1)
detection of phosphate##2##3##(2008-10#2)
detection of phosphorylated##3##3##(2008-9#3)
detection of phytoplasma in##2##4##(2008-10#2)
detection of plant viruses##4##4##(2008-10#3)(2008-9#1)
detection of plant##6##3##(2007-12#1)(2008-10#4)(2008-9#1)
detection of proteins and##2##4##(2008-2#1)(2009-3#1)
detection of proteins##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)
detection of recurrence##2##3##(1991-4#1)(2010-3#1)
detection of reduced##2##3##(1995-2#1)(2008-10#1)
detection of resistivity for antibiotics##2##5##(2010-8#2)
detection of rhizomania##2##3##(2008-10#2)
detection of several##4##3##(2008-10#2)(2008-2#1)(2009-3#1)
detection of significant##2##3##(2010-5#1)(2012-2#1)
detection of single##6##3##(1997-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
detection of small##5##3##(1990-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)
detection of some organic##2##4##(2008-10#2)
detection of some##3##3##(2008-10#3)
detection of such##2##3##(1996-4#1)(2008-10#1)
detection of sulfide##2##3##(2008-10#2)
detection of surface and intracellular antigens##2##6##(1990-12#2)
detection of surface##5##3##(1990-12#2)(2008-3#2)(2011-1#1)
detection of surface-bound##2##3##(2008-2#1)(2008-3#1)
detection of synthetic pyrethroids containing##2##5##(2008-10#2)
detection of the Chikungunya##2##4##(2013-8#2)
detection of the DNA##2##4##(2008-10#1)(2013-1#1)
detection of the early##2##4##(1994-7#1)(2009-12#1)
detection of the effects of##2##5##(2008-5#1)(2009-12#1)
detection of the hybridization##2##4##(2008-10#2)
detection of the pathogen##4##4##(2008-10#4)
detection of the product##2##4##(1991-7#1)(2008-6#1)
detection of the three##3##4##(2008-10#3)
detection of the virus in##2##5##(2008-10#2)
detection of the##142##3##(1990-12#2)(1990-5#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#69)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#8)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
detection of their##2##3##(1993-9#1)(2010-11#1)
detection of these chemicals##2##4##(2008-10#1)(2008-2#1)
detection of these##7##3##(2008-10#6)(2008-2#1)
detection of thiols##2##3##(2008-10#2)
detection of this##4##3##(1997-6#1)(2008-10#2)(2008-11#1)
detection of three##3##3##(1990-5#1)(2008-10#2)
detection of toxic compounds##2##4##(2008-10#1)(2008-11#1)
detection of trace##9##3##(2008-10#9)
detection of trinitrotoluene##2##3##(2008-10#2)
detection of tumor##2##3##(1990-12#1)(1991-4#1)
detection of two##5##3##(2007-12#1)(2008-10#3)(2013-8#1)
detection of uric acid##2##4##(2008-10#2)
detection of various##2##3##(2008-10#1)(2010-5#1)
detection of very##2##3##(2008-10#1)(2008-9#1)
detection of water##2##3##(2008-3#1)(2013-8#1)
detection of weak analytical##2##4##(2008-10#2)
detection of whole##2##3##(2008-10#1)(2008-5#1)
detection of##1278##2##(1990-10#1)(1990-12#16)(1990-2#2)(1990-5#4)(1990-6#1)(1990-8#7)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-12#10)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-3#7)(1997-4#3)(1997-6#6)(1997-7#5)(1997-8#2)(2006-6#1)(2007-10#5)(2007-11#22)(2007-12#22)(2007-2#2)(2007-7#12)(2007-8#3)(2008-1#17)(2008-10#563)(2008-11#18)(2008-12#6)(2008-2#41)(2008-3#68)(2008-4#21)(2008-5#16)(2008-6#6)(2008-7#28)(2008-8#4)(2008-9#35)(2009-1#1)(2009-11#1)(2009-12#5)(2009-3#4)(2009-4#4)(2009-5#4)(2009-6#6)(2009-7#5)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#7)(2010-12#8)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#15)(2010-6#6)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#20)(2011-2#36)(2011-7#2)(2012-1#1)(2012-12#2)(2012-2#17)(2012-3#14)(2013-1#17)(2013-7#3)(2013-8#15)
detection on the##2##3##(2008-10#1)(2013-8#1)
detection on##5##2##(2008-10#3)(2009-9#1)(2013-8#1)
detection or exclusion of##2##4##(1993-2#1)(2012-2#1)
detection or##6##2##(1991-5#1)(1993-2#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
detection performance##2##2##(2008-10#1)(2008-3#1)
detection platform##2##2##(2010-5#1)(2012-2#1)
detection potential was##2##3##(2008-10#2)
detection potential##8##2##(2008-10#8)
detection power##3##2##(2008-10#2)(2012-3#1)
detection probes##2##2##(2010-11#1)(2013-8#1)
detection procedures##2##2##(2008-10#2)
detection processes##6##2##(2008-10#5)(2008-3#1)
detection provided by##3##3##(2008-10#3)
detection provided##5##2##(2008-10#5)
detection range of##3##3##(1992-12#1)(2008-10#2)
detection range##7##2##(1992-12#1)(2008-10#5)(2008-3#1)
detection rate of##11##3##(1991-12#1)(1992-10#1)(1994-1#1)(1994-7#1)(1995-4#2)(2007-8#1)(2008-1#1)(2010-12#1)(2012-2#1)(2013-8#1)
detection rate was##2##3##(2008-10#1)(2012-12#1)
detection rate##17##2##(1991-12#3)(1992-10#1)(1994-1#1)(1994-7#1)(1995-4#2)(1997-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
detection rates of##3##3##(2008-2#1)(2011-7#1)(2013-8#1)
detection rates##6##2##(1990-12#1)(2008-2#1)(2010-12#1)(2011-7#1)(2012-2#1)(2013-8#1)
detection reagent##2##2##(2008-10#1)(2008-4#1)
detection reagents##2##2##(2008-10#2)
detection scheme are##2##3##(2007-12#1)(2008-2#1)
detection scheme for##6##3##(1995-6#1)(2008-10#4)(2008-3#1)
detection scheme is##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
detection scheme that##2##3##(2007-12#1)(2008-10#1)
detection scheme with##2##3##(2007-11#1)(2008-3#1)
detection scheme##31##2##(1995-6#2)(2007-11#2)(2007-12#5)(2008-10#8)(2008-2#7)(2008-3#5)(2012-2#2)
detection schemes##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
detection selectivity##2##2##(1997-6#1)(2008-10#1)
detection sensitivity and##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
detection sensitivity for##3##3##(2007-12#1)(2008-3#2)
detection sensitivity is##3##3##(2008-10#2)(2008-3#1)
detection sensitivity of##8##3##(2008-10#2)(2008-3#5)(2008-7#1)
detection sensitivity##25##2##(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#9)(2008-7#2)(2010-2#1)(2012-12#1)
detection statistics##2##2##(2008-3#2)
detection step##3##2##(1995-6#1)(2008-10#2)
detection strategies is##2##3##(2008-10#2)
detection strategies##4##2##(2008-10#4)
detection strategy##2##2##(2008-2#1)(2008-3#1)
detection system based on##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
detection system for the##2##4##(2008-10#1)(2008-3#1)
detection system for##5##3##(1997-2#1)(2008-10#2)(2008-3#1)(2010-7#1)
detection system is##2##3##(2008-10#2)
detection system of##2##3##(2008-10#1)(2008-9#1)
detection system to##2##3##(2008-10#1)(2008-7#1)
detection system using##2##3##(2008-10#1)(2008-9#1)
detection system was##4##3##(2008-10#3)(2008-3#1)
detection system with##2##3##(2008-10#2)
detection system##52##2##(1997-2#1)(2007-12#1)(2008-10#30)(2008-2#3)(2008-3#9)(2008-7#1)(2008-9#3)(2010-7#1)(2011-1#2)(2013-8#1)
detection systems based on##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
detection systems##23##2##(2006-10#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#3)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)
detection task##3##2##(1995-12#1)(2008-11#1)(2008-9#1)
detection teams##3##2##(2011-1#3)
detection technique for##2##3##(2007-12#1)(2008-10#1)
detection technique is##2##3##(2008-10#2)
detection technique was##2##3##(2007-11#1)(2008-10#1)
detection technique##18##2##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-2#1)(2008-3#2)
detection techniques##11##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-3#1)(2012-3#1)
detection technology##2##2##(2008-10#2)
detection test##7##2##(2008-10#5)(2008-9#1)(2013-8#1)
detection tests and##2##3##(2007-2#1)(2008-9#1)
detection tests##4##2##(1991-3#1)(2007-2#2)(2008-9#1)
detection than##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
detection that##2##2##(2008-10#1)(2008-7#1)
detection threshold##4##2##(1996-5#1)(2008-3#1)(2008-5#1)(2008-7#1)
detection thresholds##3##2##(2008-3#2)(2011-1#1)
detection time##3##2##(2008-10#2)(2008-2#1)
detection to determine##2##3##(1991-5#1)(2008-10#1)
detection to measure##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
detection to record the##2##4##(2007-12#2)
detection to the##2##3##(1996-2#1)(2008-10#1)
detection to##19##2##(1991-5#1)(1996-2#1)(2007-11#3)(2007-12#4)(2008-10#6)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)
detection tools##2##2##(2007-12#1)(2008-7#1)
detection using a##7##3##(2008-10#4)(2008-9#1)(2012-2#2)
detection using different##2##3##(2008-10#2)
detection using the##3##3##(2008-10#2)(2012-2#1)
detection using##28##2##(2007-5#1)(2008-10#16)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#3)
detection via##3##2##(2008-10#3)
detection volume##2##2##(2008-10#1)(2008-7#1)
detection was 0##12##3##(2008-10#12)
detection was 7##3##3##(2008-10#2)(2008-5#1)
detection was accomplished by##2##4##(2008-10#2)
detection was achieved at##2##4##(2008-10#2)
detection was achieved##3##3##(2008-10#3)
detection was also studied##2##4##(2008-10#2)
detection was applied to the determination of##2##7##(2008-10#2)
detection was applied##3##3##(2008-10#3)
detection was at##4##3##(2008-10#4)
detection was based on the##3##5##(2008-10#3)
detection was based on##4##4##(2008-10#3)(2011-2#1)
detection was carried out at##3##5##(2008-10#2)(2008-5#1)
detection was carried out using##2##5##(2008-10#1)(2011-2#1)
detection was carried out##6##4##(2008-10#4)(2008-5#1)(2011-2#1)
detection was described##2##3##(2008-10#2)
detection was developed for the rapid separation and##2##8##(2008-10#2)
detection was developed for the##4##5##(1996-5#1)(2008-10#3)
detection was developed##10##3##(1996-5#1)(2008-10#9)
detection was employed##2##3##(2008-10#2)
detection was established##2##3##(2008-10#2)
detection was evaluated##4##3##(1994-9#1)(2008-10#3)
detection was fabricated##2##3##(2008-10#2)
detection was investigated##2##3##(2008-10#2)
detection was obtained##2##3##(2008-10#2)
detection was performed##8##3##(2008-10#8)
detection was used##2##3##(1996-5#1)(2008-10#1)
detection was##116##2##(1991-5#1)(1994-9#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#98)(2008-5#2)(2009-5#1)(2010-11#1)(2010-5#2)(2011-1#2)(2011-2#2)(2011-3#1)
detection wavelength was set at##3##5##(2011-1#2)(2011-2#1)
detection wavelength was##5##3##(2008-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
detection wavelength##10##2##(2008-10#4)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)
detection were 0##4##3##(2008-10#4)
detection were investigated##5##3##(2008-10#5)
detection were##39##2##(2008-10#34)(2008-2#2)(2009-6#1)(2011-1#1)(2013-1#1)
detection when##3##2##(2008-3#2)(2009-6#1)
detection will be##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
detection will##6##2##(2007-7#1)(2008-10#2)(2008-3#2)(2009-8#1)
detection window of##2##3##(2008-3#2)
detection with a single##2##4##(2007-12#1)(2008-10#1)
detection with a small##2##4##(2007-12#1)(2008-3#1)
detection with a##18##3##(1994-10#1)(2007-12#5)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#2)(2008-9#1)
detection with an##4##3##(1995-2#1)(1997-2#1)(2008-10#2)
detection with##43##2##(1990-8#1)(1994-10#1)(1995-2#1)(1997-2#1)(2007-12#5)(2008-10#17)(2008-2#1)(2008-3#7)(2008-5#2)(2008-9#3)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
detection without the##2##3##(2008-10#1)(2008-5#1)
detection without##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
detection##4922##1##(1990-10#1)(1990-11#1)(1990-12#23)(1990-2#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#26)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#10)(1991-2#5)(1991-3#7)(1991-4#2)(1991-5#16)(1991-6#2)(1991-7#6)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#5)(1994-6#5)(1994-7#3)(1994-8#2)(1994-9#7)(1995-11#4)(1995-12#7)(1995-2#9)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#11)(1995-9#5)(1996-11#1)(1996-12#14)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#20)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#23)(1997-3#7)(1997-4#16)(1997-5#2)(1997-6#11)(1997-7#6)(1997-8#7)(2006-10#2)(2006-6#1)(2006-8#2)(2007-10#6)(2007-11#58)(2007-12#79)(2007-2#4)(2007-5#1)(2007-7#25)(2007-8#5)(2008-1#30)(2008-10#3092)(2008-11#50)(2008-12#14)(2008-2#145)(2008-3#266)(2008-4#49)(2008-5#44)(2008-6#9)(2008-7#60)(2008-8#9)(2008-9#75)(2009-1#3)(2009-10#2)(2009-11#3)(2009-12#8)(2009-3#5)(2009-4#7)(2009-5#12)(2009-6#10)(2009-7#7)(2009-8#14)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#19)(2010-12#23)(2010-2#3)(2010-3#11)(2010-4#10)(2010-5#34)(2010-6#9)(2010-7#15)(2010-8#14)(2010-9#3)(2011-1#50)(2011-2#68)(2011-3#1)(2011-7#4)(2012-1#7)(2012-12#10)(2012-2#49)(2012-3#29)(2012-8#1)(2013-1#48)(2013-7#3)(2013-8#40)
detection)##10##1##(1993-8#1)(1994-8#2)(2008-10#5)(2008-4#1)(2013-8#1)
detection/identification##2##1##(2008-10#1)(2008-9#1)
detections of##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
detections##13##1##(2008-10#11)(2008-3#1)(2010-7#1)
detectivity of##2##2##(2008-3#2)
detectivity##5##1##(2008-2#1)(2008-3#4)
detector (FPD)##2##2##(2011-1#2)
detector A##4##2##(2008-2#1)(2008-3#3)
detector and a##8##3##(2008-10#6)(2008-2#1)(2008-3#1)
detector and the##2##3##(2008-10#1)(2008-2#1)
detector and##21##2##(1990-8#1)(2008-10#12)(2008-2#3)(2008-3#3)(2009-6#1)(2011-3#1)
detector are##5##2##(2008-10#4)(2008-3#1)
detector array##16##2##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#8)
detector as a##3##3##(2008-10#3)
detector as##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
detector at a##3##3##(2008-10#3)
detector at the##2##3##(2008-10#1)(2008-3#1)
detector at##9##2##(2008-10#7)(2008-3#1)(2010-5#1)
detector based on##6##3##(2007-12#1)(2008-10#5)
detector but##2##2##(2008-3#2)
detector by use of##2##4##(2008-2#1)(2008-3#1)
detector cell##3##2##(2008-10#3)
detector combined with##2##3##(2008-10#1)(2013-1#1)
detector dogs##4##2##(2008-10#4)
detector due to the##2##4##(2008-10#2)
detector electrode##2##2##(2008-10#2)
detector element##2##2##(2008-2#1)(2008-3#1)
detector elements##2##2##(2008-2#1)(2008-3#1)
detector equipped with a##2##4##(2008-10#1)(2009-8#1)
detector fibers##3##2##(2008-3#3)
detector for a##2##3##(2008-10#2)
detector for capillary electrophoresis##5##4##(2008-10#5)
detector for flow##4##3##(2008-10#4)
detector for liquid chromatography##2##4##(2008-10#2)
detector for the analysis of##2##5##(2008-10#2)
detector for the determination of##8##5##(2008-10#7)(2009-8#1)
detector for the##19##3##(2008-10#16)(2008-2#1)(2008-3#1)(2009-8#1)
detector for time-resolved##2##3##(2008-11#2)
detector for##52##2##(2007-11#1)(2008-10#43)(2008-11#2)(2008-2#1)(2008-3#3)(2009-8#1)(2013-1#1)
detector geometry##2##2##(2008-2#1)(2008-3#1)
detector has been developed##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
detector has been##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
detector has##7##2##(2007-12#2)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
detector have been##2##3##(2007-12#1)(2008-10#1)
detector in a sequential injection analysis system##2##7##(2008-10#2)
detector in a##6##3##(2007-12#1)(2008-10#3)(2008-3#2)
detector in flow##3##3##(2008-10#3)
detector in the##2##3##(2007-12#1)(2008-10#1)
detector in##17##2##(2007-12#2)(2008-10#12)(2008-3#2)(2011-1#1)
detector is described##3##3##(2008-10#2)(2008-3#1)
detector is developed##2##3##(2008-10#2)
detector is used##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
detector is##24##2##(2008-10#14)(2008-2#2)(2008-3#8)
detector noise##2##2##(2008-3#2)
detector nonlinearity##2##2##(2008-2#2)
detector of##5##2##(1990-11#1)(2008-10#2)(2008-7#1)(2012-12#1)
detector on##2##2##(2008-10#2)
detector outputs are##2##3##(2008-2#1)(2008-3#1)
detector pixel##2##2##(2007-11#1)(2010-2#1)
detector plane##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
detector port##3##2##(2008-10#1)(2008-3#2)
detector position##2##2##(2007-12#1)(2008-10#1)
detector provides##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
detector response at##2##3##(2008-10#2)
detector response is##3##3##(2008-10#2)(2008-3#1)
detector response##14##2##(2008-10#9)(2008-3#3)(2010-3#2)
detector showed good sensitivity##2##4##(2008-10#2)
detector showed##4##2##(2008-10#4)
detector signals##3##2##(2008-10#1)(2008-3#2)
detector such##2##2##(2008-2#2)
detector surface##3##2##(2008-3#3)
detector system##7##2##(2008-2#2)(2008-3#5)
detector that is##3##3##(2007-12#1)(2008-3#2)
detector that##7##2##(1990-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
detector to##7##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-1#1)
detector was developed for##3##4##(2008-10#3)
detector was developed##4##3##(1990-8#1)(2008-10#3)
detector was used for##2##4##(2008-10#2)
detector was used to##2##4##(1995-3#1)(2008-10#1)
detector was used##6##3##(1995-3#1)(2008-10#4)(2008-2#1)
detector was##15##2##(1990-8#1)(1995-3#1)(2008-10#12)(2008-2#1)
detector were##4##2##(2008-10#4)
detector which##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
detector with a##8##3##(1991-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-1#1)
detector with an##4##3##(2008-10#4)
detector with##15##2##(1991-5#1)(2008-10#9)(2008-2#2)(2008-3#2)(2011-1#1)
detector##635##1##(1990-11#1)(1990-12#1)(1990-8#5)(1991-5#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-11#16)(2007-12#29)(2008-10#351)(2008-11#5)(2008-2#63)(2008-3#113)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-2#1)(2010-3#3)(2010-5#1)(2011-1#13)(2011-2#1)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#1)(2013-1#3)
detector)##7##1##(1996-5#1)(2008-10#2)(2008-3#3)(2008-5#1)
detectors A and B##2##4##(2008-3#2)
detectors and##9##2##(1992-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#1)(2012-2#1)
detectors are##10##2##(2008-10#2)(2008-2#4)(2008-3#3)(2010-3#1)
detectors at##3##2##(2007-11#1)(2008-3#2)
detectors by##2##2##(2007-11#2)
detectors can be##3##3##(2008-3#2)(2012-12#1)
detectors connected in series##2##4##(1990-8#1)(2008-10#1)
detectors for flow##2##3##(2008-10#2)
detectors for##14##2##(2008-10#11)(2008-2#2)(2010-11#1)
detectors have##2##2##(2008-10#1)(2008-3#1)
detectors in the##2##3##(2008-2#2)
detectors in##8##2##(2008-10#2)(2008-2#3)(2008-3#3)
detectors is##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
detectors proved to##2##3##(2008-10#2)
detectors that are##2##3##(2007-11#1)(2008-2#1)
detectors that##5##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)
detectors was##2##2##(2007-11#1)(2008-3#1)
detectors were used##2##3##(2008-10#2)
detectors with##13##2##(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#6)
detectors##153##1##(1990-8#2)(1992-11#1)(2007-11#10)(2007-12#8)(2008-10#35)(2008-11#1)(2008-2#33)(2008-3#47)(2008-4#3)(2008-9#2)(2009-5#1)(2010-11#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#1)
detects a##4##2##(1993-11#1)(2009-7#1)(2010-11#1)(2011-2#1)
detects the##9##2##(1993-2#1)(2008-10#6)(2008-4#1)(2010-8#1)
detects##37##1##(1993-11#1)(1993-2#1)(1993-8#1)(1994-9#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
deter##5##1##(1993-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
detergent (Triton##2##2##(2008-7#1)(2008-8#1)
detergent Triton X-100##2##3##(1994-11#1)(2008-4#1)
detergent and##4##2##(1994-9#1)(2008-4#2)(2011-2#1)
detergent extracts of##2##3##(1990-12#1)(1993-6#1)
detergent extracts##3##2##(1990-12#1)(1990-5#1)(1993-6#1)
detergent fiber##2##2##(2010-2#2)
detergent fraction in##2##3##(1994-12#2)
detergent octyl##2##2##(1994-11#1)(2008-4#1)
detergent##67##1##(1990-11#1)(1990-12#6)(1990-2#3)(1990-5#1)(1991-10#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#3)(1994-12#5)(1994-6#1)(1994-8#2)(1994-9#4)(1997-7#1)(2008-1#1)(2008-10#3)(2008-4#12)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-2#2)(2011-2#2)(2012-2#6)(2013-1#1)
detergent-based##3##1##(2008-5#2)(2008-9#1)
detergent-extracted##2##1##(1994-6#1)(2008-6#1)
detergent-lipid##2##1##(1992-12#1)(1994-12#1)
detergent-solubilized##4##1##(1990-12#1)(1993-11#1)(1994-11#1)(1994-12#1)
detergents and##5##2##(1990-2#1)(1995-2#1)(2008-10#2)(2008-5#1)
detergents for##2##2##(1994-9#2)
detergents with##2##2##(1990-2#1)(1994-12#1)
detergents##42##1##(1990-11#1)(1990-12#2)(1990-2#5)(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-11#2)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#3)(1994-8#1)(1994-9#2)(1995-2#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
deteriorate in##2##2##(1995-12#1)(2008-10#1)
deteriorate##12##1##(1992-9#1)(1993-3#1)(1995-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-3#1)(2012-2#1)
deteriorated by##2##2##(1994-3#1)(2007-12#1)
deteriorated despite##2##2##(2007-2#1)(2007-7#1)
deteriorated from##2##2##(1995-12#1)(2008-7#1)
deteriorated in##3##2##(2008-1#1)(2008-7#2)
deteriorated on##2##2##(2009-2#1)(2012-12#1)
deteriorated##27##1##(1990-6#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-5#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-2#1)(2011-2#2)(2012-12#1)(2013-7#1)
deteriorates##5##1##(2007-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2013-1#1)
deteriorating environmental conditions over##2##4##(2008-8#2)
deteriorating the##2##2##(2008-10#2)
deteriorating##13##1##(1995-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
deterioration and##7##2##(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
deterioration in the##8##3##(1990-3#2)(1990-6#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
deterioration in##18##2##(1990-3#2)(1990-6#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
deterioration of motor##2##3##(2008-7#2)
deterioration of renal function##2##4##(1995-11#1)(2008-7#1)
deterioration of the##6##3##(1992-6#1)(1993-2#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
deterioration of##29##2##(1991-2#1)(1991-8#2)(1992-6#1)(1993-2#1)(1994-5#1)(1995-11#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#3)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#2)
deterioration was observed in the##2##5##(2008-10#1)(2010-3#1)
deterioration was##3##2##(2008-1#1)(2008-10#1)(2010-3#1)
deterioration with##3##2##(2007-10#2)(2013-8#1)
deterioration##102##1##(1990-3#3)(1990-6#1)(1991-2#1)(1991-8#2)(1992-6#1)(1993-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-9#1)(1997-8#1)(2006-7#1)(2007-10#5)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#2)
deteriorative##2##1##(2011-1#1)(2013-1#1)
determinability range##2##2##(2008-10#2)
determinable ranges##2##2##(2008-10#2)
determinable##5##1##(1992-5#1)(2008-10#4)
determinant factors of##2##3##(1991-6#1)(2008-10#1)
determinant for the##4##3##(1994-11#1)(1994-9#1)(1995-12#1)(2008-10#1)
determinant for##6##2##(1990-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(2008-10#2)
determinant in the##3##3##(2008-1#1)(2008-10#2)
determinant in##5##2##(2008-1#1)(2008-10#4)
determinant of HIV##2##3##(1995-5#1)(2011-1#1)
determinant of the durability of resistance##2##6##(2008-10#2)
determinant of the number##2##4##(1993-3#1)(2007-12#1)
determinant of the rate of##2##5##(1993-11#2)
determinant of the##19##3##(1990-2#1)(1992-2#1)(1993-11#2)(1993-3#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)(2013-7#1)
determinant of##71##2##(1990-12#1)(1990-2#2)(1990-8#1)(1992-2#2)(1992-9#1)(1993-11#2)(1993-3#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-6#1)(2008-10#6)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)
determinant##106##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-8#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-5#2)(2009-7#4)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#6)(2013-7#2)
determinants and##3##2##(1992-2#1)(2008-10#1)(2008-8#1)
determinants for##10##2##(1993-5#1)(1994-6#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-8#2)(2013-1#3)
determinants in the##5##3##(1992-8#1)(1993-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
determinants in##12##2##(1992-8#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
determinants of health##8##3##(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
determinants of the##15##3##(1992-3#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#1)(2011-3#1)(2013-8#1)
determinants of##102##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#2)(1997-1#2)(1997-4#1)(1997-9#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#3)
determinants other than##2##3##(2008-10#1)(2008-7#1)
determinants were##4##2##(1993-12#1)(2008-10#2)(2013-8#1)
determinants##178##1##(1990-12#2)(1990-2#1)(1990-7#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#7)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-3#3)(1997-1#2)(1997-4#2)(1997-9#1)(2007-10#3)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#13)(2008-9#2)(2009-10#4)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#8)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#8)(2013-8#4)
determinate##6##1##(1996-2#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
determinated by##2##2##(1995-2#1)(2008-10#1)
determinated##4##1##(1995-2#1)(1997-7#1)(2008-10#1)(2008-7#1)
determination (0##2##2##(2008-10#2)
determination (accuracy##2##2##(2008-10#2)
determination after##4##2##(2008-10#4)
determination and monitoring of##2##4##(2008-10#2)
determination and speciation of##4##4##(2008-10#4)
determination and speciation##5##3##(2008-10#5)
determination and the##4##3##(2008-10#4)
determination and##40##2##(1990-8#1)(1993-2#1)(1993-8#1)(1994-1#1)(2007-12#2)(2008-10#31)(2009-10#1)(2010-11#1)(2010-5#1)
determination are discussed##2##3##(2008-10#1)(2008-3#1)
determination are##7##2##(2008-10#5)(2008-3#1)(2010-3#1)
determination as well##2##3##(2008-10#2)
determination as##5##2##(2008-10#4)(2010-3#1)
determination at a##2##3##(2008-10#2)
determination at low##2##3##(2008-10#2)
determination at pH##2##3##(2008-10#2)
determination at the##3##3##(2008-10#3)
determination at trace##2##3##(2008-10#2)
determination at##18##2##(2008-10#17)(2009-11#1)
determination based on the##3##4##(2008-10#3)
determination based on##6##3##(2008-10#5)(2008-2#1)
determination between##3##2##(2008-10#3)
determination by FAAS in##2##4##(2008-10#2)
determination by FAAS##5##3##(2008-10#5)
determination by X-ray##2##3##(2008-10#1)(2008-4#1)
determination by atomic absorption spectrometry##2##5##(2008-10#2)
determination by atomic absorption##3##4##(2008-10#3)
determination by atomic##4##3##(2008-10#4)
determination by cold vapour atomic absorption spectrometry##3##7##(2008-10#3)
determination by cold##4##3##(2008-10#4)
determination by differential pulse##2##4##(2008-10#2)
determination by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
determination by electrothermal##3##3##(2008-10#3)
determination by energy dispersive X-ray fluorescence##2##6##(2008-10#2)
determination by flame atomic absorption spectrometry (FAAS)##5##7##(2008-10#5)
determination by flame atomic absorption spectrometry##19##6##(2008-10#19)
determination by flame atomic##21##4##(2008-10#21)
determination by flow injection##3##4##(2008-10#3)
determination by flow##4##3##(2008-10#4)
determination by flow-injection##2##3##(2008-10#2)
determination by graphite furnace atomic absorption spectrometry##4##7##(2008-10#4)
determination by inductively coupled plasma atomic emission spectrometry##6##8##(2008-10#6)
determination by inductively coupled plasma atomic emission##7##7##(2008-10#7)
determination by inductively coupled plasma optical emission spectrometry##4##8##(2008-10#4)
determination by inductively coupled plasma##12##5##(2008-10#12)
determination by inductively coupled plasma-atomic emission spectrometry##2##7##(2008-10#2)
determination by inductively coupled##14##4##(2008-10#14)
determination by solid##2##3##(2008-10#2)
determination by spectrophotometry##2##3##(2008-10#2)
determination by the proposed method##3##5##(2008-10#3)
determination by the##6##3##(1990-7#1)(2008-10#4)(2008-11#1)
determination by using##2##3##(2008-10#2)
determination by##120##2##(1990-7#1)(1990-8#1)(1993-8#1)(2008-10#113)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)
determination can be performed in the range of 0##2##9##(2008-10#2)
determination can be##5##3##(2008-10#5)
determination could be##2##3##(2008-10#1)(2008-5#1)
determination directly##2##2##(2008-10#2)
determination for##15##2##(1992-5#2)(1994-2#1)(2008-10#9)(2008-11#1)(2010-7#1)(2013-8#1)
determination from in-water##2##3##(2008-3#2)
determination from##9##2##(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#3)
determination gene##2##2##(1992-5#1)(2008-4#1)
determination has been##5##3##(2008-10#5)
determination has##8##2##(2008-10#6)(2008-4#1)(2010-3#1)
determination in a FIA system##2##5##(2008-10#2)
determination in a##10##3##(2008-10#10)
determination in air##2##3##(2008-10#2)
determination in alloys##2##3##(2008-10#2)
determination in animal##3##3##(2008-10#3)
determination in aqueous##4##3##(2008-10#4)
determination in biological samples##3##4##(2008-10#3)
determination in biological##4##3##(2008-10#4)
determination in blood##4##3##(2008-10#4)
determination in certified reference materials##2##5##(2008-10#2)
determination in complex##3##3##(2008-10#3)
determination in different##3##3##(2008-10#2)(2008-5#1)
determination in drinks##3##3##(2008-10#3)
determination in drugs##2##3##(2008-10#2)
determination in edible seaweed##2##4##(2008-10#2)
determination in edible##3##3##(2008-10#3)
determination in environmental samples by##2##5##(2008-10#2)
determination in environmental samples##4##4##(2008-10#4)
determination in environmental##7##3##(2008-10#7)
determination in food##3##3##(2008-10#3)
determination in geological samples by##2##5##(2008-10#2)
determination in honey##2##3##(2008-10#2)
determination in human urine##3##4##(2008-10#3)
determination in human##4##3##(2008-10#4)
determination in milk samples##2##4##(2008-10#2)
determination in mouth##2##3##(2008-10#1)(2013-1#1)
determination in natural water samples##2##5##(2008-10#2)
determination in natural water##3##4##(2008-10#3)
determination in natural waters##5##4##(2008-10#5)
determination in natural##12##3##(2008-10#12)
determination in pharmaceutical preparations and##2##5##(2008-10#2)
determination in pharmaceutical preparations##3##4##(2008-10#3)
determination in pharmaceutical samples##2##4##(2008-10#2)
determination in pharmaceutical##7##3##(2008-10#7)
determination in pharmaceuticals##2##3##(2008-10#2)
determination in plant##2##3##(2008-10#2)
determination in real samples##3##4##(2008-10#3)
determination in river##2##3##(2008-10#2)
determination in sediment##2##3##(2008-10#2)
determination in sediments##2##3##(2008-10#2)
determination in serum##2##3##(2008-10#2)
determination in standard##2##3##(2008-10#2)
determination in the concentration range##2##5##(2008-10#2)
determination in the concentration##3##4##(2008-10#3)
determination in the presence of##6##5##(2008-10#6)
determination in the range##3##4##(2008-10#3)
determination in the##26##3##(1990-6#1)(1991-11#1)(2008-10#23)(2008-2#1)
determination in urine by##2##4##(2008-10#2)
determination in urine samples##2##4##(2008-10#2)
determination in urine##10##3##(1990-12#1)(2008-10#9)
determination in various samples##2##4##(2008-10#2)
determination in various##5##3##(2008-10#5)
determination in water samples##5##4##(2008-10#5)
determination in water##8##3##(2008-10#8)
determination in waters##2##3##(2008-10#2)
determination in wines##2##3##(2008-10#2)
determination in##252##2##(1990-12#1)(1990-6#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1995-9#1)(1996-7#1)(2007-11#1)(2008-10#231)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
determination is 2##2##3##(2008-10#2)
determination is based on a##2##5##(2008-10#2)
determination is based on the##9##5##(2008-10#9)
determination is based on##14##4##(2008-10#13)(2010-6#1)
determination is developed##2##3##(2008-10#2)
determination is not##2##3##(1993-2#1)(2008-10#1)
determination is performed##2##3##(2008-10#2)
determination is presented##2##3##(2008-10#2)
determination is##44##2##(1991-4#1)(1993-2#1)(1994-7#1)(2008-10#37)(2008-2#1)(2008-5#1)(2009-4#1)(2010-6#1)
determination limit of##3##3##(2008-10#3)
determination limit was##6##3##(2008-10#6)
determination limit##13##2##(2008-10#13)
determination limits##6##2##(2008-10#6)
determination may be##2##3##(2008-10#1)(2010-3#1)
determination method for##9##3##(2008-10#9)
determination method of##4##3##(2008-10#4)
determination method##19##2##(2008-10#19)
determination methods of##2##3##(2008-10#2)
determination methods##4##2##(1991-11#1)(2008-10#3)
determination of 0##11##3##(2008-10#11)
determination of 1##4##3##(2008-10#4)
determination of 1-naphthylacetic acid##2##4##(2008-10#2)
determination of 10##3##3##(2008-10#2)(2011-1#1)
determination of 19##3##3##(2008-10#3)
determination of 2##3##3##(2008-10#3)
determination of 2-(thiocyanomethylthiol)benzothiazole##2##3##(2008-10#2)
determination of 2-mercaptopyrimidines##2##3##(2008-10#2)
determination of 3##2##3##(2008-10#2)
determination of 4-aminophenol##3##3##(2008-10#3)
determination of 5##2##3##(1990-8#1)(2008-10#1)
determination of 5-hydroxymethylfurfural##2##3##(2008-10#2)
determination of 50##4##3##(2008-10#4)
determination of 6-mercaptopurine##3##3##(2008-10#3)
determination of 7 nucleosides in Asterias rollestoni##2##7##(2011-1#2)
determination of AA##2##3##(2008-10#2)
determination of Ag##5##3##(2008-10#5)
determination of Ag(I)##3##3##(2008-10#3)
determination of Al in##2##4##(2008-10#2)
determination of Al##6##3##(2008-10#6)
determination of Al(3+)##2##3##(2008-10#2)
determination of Al(III) and Fe(III) in post-hemodialysis fluids##2##8##(2008-10#2)
determination of Al(III) and Fe(III) in##3##6##(2008-10#3)
determination of As##14##3##(2008-10#14)
determination of As(III) and As(V) in##2##6##(2008-10#2)
determination of As(III) and As(V)##3##5##(2008-10#3)
determination of As(III) in##5##4##(2008-10#5)
determination of As(III)##12##3##(2008-10#12)
determination of AsA##2##3##(2008-10#2)
determination of BPA##3##3##(2008-10#2)(2009-8#1)
determination of Ba##2##3##(2008-10#2)
determination of Bi##5##3##(2008-10#5)
determination of Bragg resonances##2##4##(2008-3#2)
determination of COD##3##3##(2008-10#3)
determination of Captopril in##3##4##(2008-10#3)
determination of Captopril##5##3##(2008-10#5)
determination of Cd and##4##4##(2008-10#4)
determination of Cd##13##3##(2008-10#13)
determination of Cd(2+)##2##3##(2008-10#2)
determination of Cd(II)##4##3##(2008-10#4)
determination of Ce##2##3##(2008-10#2)
determination of Co##4##3##(2008-10#4)
determination of Co(II)##6##3##(2008-10#6)
determination of Cr(III) and Cr(VI) in##4##6##(2008-10#4)
determination of Cr(III) and##5##4##(2008-10#5)
determination of Cr(III)##11##3##(2008-10#11)
determination of Cr(VI) and Cr(III)##2##5##(2008-10#2)
determination of Cr(VI) in##2##4##(2008-10#2)
determination of Cr(VI)##5##3##(2008-10#5)
determination of Cu and Mn in##2##6##(2008-10#2)
determination of Cu and##5##4##(2008-10#5)
determination of Cu##13##3##(2008-10#12)(2012-2#1)
determination of Cu(II) in##6##4##(2008-10#6)
determination of Cu(II)##10##3##(2008-10#10)
determination of Cypermethrin and Chlorpyrifos##2##5##(2008-10#2)
determination of DES##2##3##(2008-10#2)
determination of DNA content##2##4##(2008-9#2)
determination of DNA##5##3##(2008-10#2)(2008-9#3)
determination of Eu##2##3##(2008-10#2)
determination of Fe and V in##2##6##(2008-10#2)
determination of Fe and##6##4##(2008-10#5)(2013-8#1)
determination of Fe##10##3##(2008-10#9)(2013-8#1)
determination of Fe(3+)##2##3##(2008-10#2)
determination of Fe(II) and Fe(III) in pharmaceutical products##2##8##(2008-10#2)
determination of Fe(II) and Fe(III) in##3##6##(2008-10#3)
determination of Fe(II) and Fe(III)##7##5##(2008-10#7)
determination of Fe(II) and##8##4##(2008-10#8)
determination of Fe(II)##13##3##(2008-10#13)
determination of Fe(III) and Fe(II)##3##5##(2008-10#3)
determination of Fe(III) and##4##4##(2008-10#4)
determination of Fe(III) in the presence of Fe(II)##3##8##(2008-10#3)
determination of Fe(III) in the##4##5##(2008-10#4)
determination of Fe(III)##8##3##(2008-10#8)
determination of GSH in##2##4##(2008-10#2)
determination of GSH##3##3##(2008-10#3)
determination of H(2)O(2) in##4##4##(2008-10#4)
determination of H(2)O(2)##9##3##(2008-10#9)
determination of Hexythiazox in pesticide formulations##2##6##(2008-10#2)
determination of Hg in water##2##5##(2008-10#2)
determination of Hg in##5##4##(2008-10#5)
determination of Hg##6##3##(2008-10#6)
determination of Hg(II) in water samples##2##6##(2008-10#2)
determination of Hg(II) in##6##4##(2008-10#6)
determination of Hg(II)##10##3##(2008-10#10)
determination of Imatinib##2##3##(2008-10#2)
determination of L-dopa##2##3##(2008-10#2)
determination of Losartan and Valsartan in##2##6##(2008-10#2)
determination of MT in##2##4##(2008-10#2)
determination of Mancozeb in##2##4##(2008-10#2)
determination of Mn##2##3##(2008-10#2)
determination of Mo in##2##4##(2008-10#2)
determination of Mo##5##3##(2008-10#5)
determination of Mo(VI)##2##3##(2008-10#2)
determination of N-nitrosoamines##2##3##(2008-10#2)
determination of NO##3##3##(2008-10#3)
determination of Ni and Cr##2##5##(2008-10#2)
determination of Ni in##2##4##(2008-10#2)
determination of Ni##6##3##(2008-10#6)
determination of Ni(II) and Co(II)##3##5##(2008-10#3)
determination of P(+III)##2##3##(2008-10#2)
determination of PAHs##2##3##(2008-10#1)(2008-11#1)
determination of PCP##2##3##(2008-10#2)
determination of Pb##7##3##(2008-1#1)(2008-10#6)
determination of Pb(2+) and Cd(2+)##3##5##(2008-10#3)
determination of Pb(2+)##5##3##(2008-10#5)
determination of R-timolol in S-timolol maleate##2##6##(2008-10#2)
determination of Ru (III)##2##4##(2008-10#2)
determination of Sb(III) and Bi(III)##3##5##(2008-10#3)
determination of Sb(III) and Sb(V)##2##5##(2008-10#2)
determination of Sb(III) and##5##4##(2008-10#5)
determination of Sb(III) in Sb(III)/Sb(V) binary mixtures##2##7##(2008-10#2)
determination of Sb(III) in##4##4##(2008-10#4)
determination of Sb(III)##9##3##(2008-10#9)
determination of Se##10##3##(2008-10#10)
determination of Se(IV) and Se(VI)##2##5##(2008-10#2)
determination of Se(IV)##7##3##(2008-10#7)
determination of TAM in##2##4##(2008-10#2)
determination of Tween 80##2##4##(2008-10#2)
determination of V(V) and Al(III)##2##5##(2008-10#2)
determination of V(V) and##4##4##(2008-10#4)
determination of V(V) in##2##4##(2008-10#2)
determination of V(V)##7##3##(2008-10#7)
determination of VOCs in##2##4##(2008-10#2)
determination of Vitamin D(3) and 25-OH-D(3) in##2##7##(2008-10#2)
determination of Vitamin D(3) and##4##5##(2008-10#4)
determination of Vitamin##5##3##(2008-10#5)
determination of W(VI)##3##3##(2008-10#3)
determination of Ziram and Zineb in##3##6##(2008-10#3)
determination of Ziram##5##3##(2008-10#5)
determination of Zn(2+) and Pb(2+)##2##5##(2008-10#2)
determination of Zn(2+)##3##3##(2008-10#3)
determination of Zr##2##3##(2008-10#2)
determination of Zr(IV) and Hf(IV)##2##5##(2008-10#2)
determination of a##20##3##(1994-11#1)(1994-3#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)
determination of acetaminophen##3##3##(2008-10#3)
determination of acetylsalicylic acid (ASA)##2##5##(2008-10#2)
determination of acetylsalicylic acid##4##4##(2008-10#4)
determination of acid dissociation constants##3##5##(2008-10#3)
determination of acid numbers##2##4##(2008-10#2)
determination of acid values in oilseeds without titration##2##8##(2008-10#2)
determination of acid volatile sulfide in river sediments##2##8##(2008-10#2)
determination of acid volatile sulfide##3##5##(2008-10#3)
determination of acid volatile##4##4##(2008-10#4)
determination of acid##11##3##(2008-10#11)
determination of acidity constants##3##4##(2008-10#3)
determination of acrivastine in capsules##2##5##(2008-10#2)
determination of acrivastine in##3##4##(2008-10#3)
determination of acrivastine##4##3##(2008-10#4)
determination of active##3##3##(2008-10#3)
determination of acylglycerols##2##3##(2009-8#2)
determination of adenine in##2##4##(2008-10#2)
determination of aflatoxins##2##3##(1992-11#2)
determination of airborne carbamates in##2##5##(2008-10#2)
determination of airborne##3##3##(2008-10#3)
determination of albumin and immunoglobulin G##2##6##(2008-10#2)
determination of albumin and##3##4##(2008-10#3)
determination of aldehydes##2##3##(2008-10#2)
determination of aliphatic amines in##3##5##(2008-10#3)
determination of aliphatic amines##6##4##(2008-10#6)
determination of aliphatic##7##3##(2008-10#7)
determination of alkaline phosphatase##2##4##(2008-10#2)
determination of alkaline##3##3##(2008-10#3)
determination of all three##2##4##(2008-10#2)
determination of all##7##3##(2008-10#7)
determination of alpha-amylase##2##3##(1991-5#2)
determination of alpha-glycerophosphate##2##3##(2008-10#2)
determination of aluminium##9##3##(2008-10#9)
determination of aluminum in drinking water##2##6##(2008-10#2)
determination of aluminum in##4##4##(2008-10#4)
determination of aluminum##6##3##(2008-10#6)
determination of ambroxol hydrochloride and doxycycline in pharmaceutical preparations##2##9##(2008-10#2)
determination of amiloride##2##3##(2008-10#2)
determination of amines in##2##4##(2008-10#2)
determination of amines##3##3##(2008-10#3)
determination of amino acids##4##4##(2008-10#4)
determination of aminocaproic acid in pharmaceutical formulations##2##7##(2008-10#2)
determination of aminomethylbenzoic acid and aminophylline##2##6##(2008-10#2)
determination of aminomethylbenzoic acid##3##4##(2008-10#3)
determination of ammonia in##4##4##(2008-10#4)
determination of ammonia##7##3##(1995-3#2)(2008-10#5)
determination of ammonium and##4##4##(2008-10#4)
determination of ammonium in##2##4##(2008-10#2)
determination of ammonium##13##3##(2008-10#13)
determination of amphetamine##3##3##(2008-10#3)
determination of ampicillin and tetracycline in milk by##2##8##(2008-10#2)
determination of analyte ions##2##4##(2008-10#2)
determination of analytes in##3##4##(2008-10#3)
determination of analytes##4##3##(2008-10#4)
determination of andrographolide##2##3##(2008-10#2)
determination of anionic surfactants in##4##5##(2008-10#4)
determination of anionic surfactants##5##4##(2008-10#5)
determination of anionic##7##3##(2008-10#7)
determination of anions##4##3##(2008-10#4)
determination of antimony in pharmaceuticals##3##5##(2008-10#3)
determination of antimony in##7##4##(2008-10#7)
determination of antimony##15##3##(2008-10#15)
determination of antimony(III) and antimony(V)##2##5##(2008-10#2)
determination of antimony(III) in##2##4##(2008-10#2)
determination of antimony(III)##4##3##(2008-10#4)
determination of arsenic (As)##2##4##(2008-10#2)
determination of arsenic in essential##2##5##(2008-10#2)
determination of arsenic in##10##4##(2008-10#10)
determination of arsenic species in##2##5##(2008-10#2)
determination of arsenic##22##3##(2008-10#22)
determination of ascorbic acid (AA)##3##5##(2008-10#3)
determination of ascorbic acid (AsA)##2##5##(2008-10#2)
determination of ascorbic acid and##2##5##(2008-10#2)
determination of ascorbic acid by the##2##6##(2008-10#2)
determination of ascorbic acid in pharmaceutical##2##6##(2008-10#2)
determination of ascorbic acid in##7##5##(2008-10#7)
determination of ascorbic acid using##3##5##(2008-10#3)
determination of ascorbic acid was##2##5##(2008-10#2)
determination of ascorbic acid with##2##5##(2008-10#2)
determination of ascorbic acid##32##4##(2008-10#32)
determination of astemizole##2##3##(2008-10#2)
determination of atrazine in##5##4##(2008-10#5)
determination of atrazine##7##3##(2008-10#7)
determination of azithromycin##2##3##(2008-10#2)
determination of barbituric acid##2##4##(2008-10#2)
determination of benzo[a]pyrene in##3##4##(2008-10#3)
determination of benzo[a]pyrene##5##3##(2008-10#5)
determination of benzoyl peroxide##3##4##(2008-10#3)
determination of beryllium##3##3##(2008-10#3)
determination of binary mixtures##2##4##(2008-10#2)
determination of binary##3##3##(2008-10#3)
determination of biochemical oxygen demand##2##5##(2008-10#2)
determination of biochemical##3##3##(2008-10#3)
determination of biogenic amines##3##4##(2008-10#3)
determination of bismuth in water##2##5##(2008-10#2)
determination of bismuth in##9##4##(2008-10#9)
determination of bismuth##13##3##(2008-10#13)
determination of bismuth(III)##2##3##(2008-10#2)
determination of bisphenol A##2##4##(2008-10#1)(2009-8#1)
determination of blood##2##3##(1992-3#1)(2008-12#1)
determination of bone##2##3##(1991-11#2)
determination of boron in ceramic materials##2##6##(2008-10#2)
determination of boron in plants##3##5##(2008-10#3)
determination of boron in soil##2##5##(2008-10#2)
determination of boron in##7##4##(2008-10#7)
determination of boron##13##3##(2008-10#13)
determination of both analytes in##3##5##(2008-10#3)
determination of both analytes##5##4##(2008-10#5)
determination of both metals##2##4##(2008-10#2)
determination of both##19##3##(1991-2#1)(1992-11#1)(2008-10#17)
determination of bound##2##3##(2008-10#1)(2008-9#1)
determination of bromate##3##3##(2008-10#2)(2010-5#1)
determination of bromide in seawater samples##3##6##(2008-10#3)
determination of bromide in seawater##5##5##(2008-10#5)
determination of bromide in##7##4##(2008-10#7)
determination of bromide ion in a developer##2##7##(2008-10#2)
determination of bromide##14##3##(2008-10#14)
determination of cadmium and copper##2##5##(2008-10#2)
determination of cadmium and lead in table salt samples##2##9##(2008-10#2)
determination of cadmium and lead in##5##6##(2008-10#5)
determination of cadmium and lead##8##5##(2008-10#8)
determination of cadmium and zinc##2##5##(2008-10#2)
determination of cadmium and##12##4##(2008-10#12)
determination of cadmium in mussels##2##5##(2008-10#2)
determination of cadmium in urine##2##5##(2008-10#2)
determination of cadmium in##13##4##(2008-10#13)
determination of cadmium using##2##4##(2008-10#2)
determination of cadmium##34##3##(2008-10#34)
determination of caffeine##4##3##(2008-10#4)
determination of calcium and magnesium in natural waters##2##8##(2008-10#2)
determination of calcium and magnesium in##3##6##(2008-10#3)
determination of calcium and magnesium##5##5##(2008-10#5)
determination of calcium and##8##4##(2008-10#8)
determination of calcium in##2##4##(2008-10#2)
determination of calcium##17##3##(2008-10#17)
determination of captopril##3##3##(2008-10#3)
determination of carbaryl in##2##4##(2008-10#2)
determination of carbaryl##6##3##(2008-10#6)
determination of carbofuran##3##3##(2008-10#3)
determination of carbon in uranium carbide##2##6##(2008-10#2)
determination of carbon in##3##4##(2008-10#2)(2008-3#1)
determination of carbon##6##3##(2008-10#5)(2008-3#1)
determination of carp vitellogenin (Vg)##2##5##(2008-10#2)
determination of carp vitellogenin##3##4##(2008-10#3)
determination of carvedilol##2##3##(2008-10#2)
determination of catecholamines in##2##4##(2008-10#2)
determination of catecholamines##3##3##(2008-10#3)
determination of cationic surfactants##2##4##(2008-10#2)
determination of cationic##4##3##(2008-10#4)
determination of cefixime##3##3##(2008-10#3)
determination of cefminox in##2##4##(2008-10#2)
determination of cell##2##3##(2008-11#2)
determination of certain##3##3##(2008-10#3)
determination of cetylpyridinium##3##3##(2008-10#3)
determination of chemical oxygen demand##3##5##(2008-10#3)
determination of chlorate##3##3##(2008-10#3)
determination of chloride in##5##4##(2008-10#5)
determination of chloride##13##3##(2008-10#13)
determination of chlorine dioxide in##2##5##(2008-10#2)
determination of chlorine##3##3##(2008-10#3)
determination of chlorophylls##2##3##(2008-10#2)
determination of chloroquine##2##3##(2008-10#2)
determination of chlorpromazine##2##3##(2008-10#2)
determination of chlortetracycline##2##3##(2008-10#2)
determination of cholesterol##3##3##(2008-10#3)
determination of chromium (VI)##3##4##(2008-10#3)
determination of chromium in##7##4##(2008-10#7)
determination of chromium naphthenate in gasoline by flame##2##8##(2008-10#2)
determination of chromium species##2##4##(2008-10#2)
determination of chromium##21##3##(2008-10#21)
determination of chromium(VI) and##2##4##(2008-10#2)
determination of chromium(VI) in##7##4##(2008-10#7)
determination of chromium(VI)##11##3##(2008-10#11)
determination of cis-platin##2##3##(2008-10#2)
determination of cisatracurium##2##3##(2008-10#2)
determination of citric acid##2##4##(2008-10#2)
determination of cobalt and##3##4##(2008-10#3)
determination of cobalt in water samples##2##6##(2008-10#2)
determination of cobalt in##10##4##(2008-10#10)
determination of cobalt##29##3##(2008-10#29)
determination of cobalt(II) and##2##4##(2008-10#2)
determination of cobalt(II)##4##3##(2008-10#4)
determination of compounds##2##3##(2008-10#2)
determination of concentrations of##2##4##(2008-10#1)(2008-12#1)
determination of copper and cadmium##2##5##(2008-10#2)
determination of copper and iron in##3##6##(2008-10#3)
determination of copper and iron##6##5##(2008-10#6)
determination of copper and lead in seawater##2##7##(2008-10#2)
determination of copper and##15##4##(2008-10#15)
determination of copper at##4##4##(2008-10#4)
determination of copper by##6##4##(2008-10#6)
determination of copper in blood##2##5##(2008-10#2)
determination of copper in natural waters##2##6##(2008-10#2)
determination of copper in soft drink##2##6##(2008-10#2)
determination of copper in the presence of##2##7##(2008-10#2)
determination of copper in the##4##5##(2008-10#4)
determination of copper in water samples##4##6##(2008-10#4)
determination of copper in##26##4##(2008-10#26)
determination of copper with detection##2##5##(2008-10#2)
determination of copper##72##3##(2008-10#72)
determination of copper(II) based on its##2##6##(2008-10#2)
determination of copper(II) based on##3##5##(2008-10#3)
determination of copper(II) by##3##4##(2008-10#3)
determination of copper(II) in##3##4##(2008-10#3)
determination of copper(II)##19##3##(2008-10#19)
determination of creatine and creatinine##3##5##(1990-8#1)(2008-10#2)
determination of creatinine in urine##2##5##(2008-10#2)
determination of creatinine##3##3##(2008-10#3)
determination of cyanide as contaminant in pralidoxime mesylate##2##8##(2008-10#2)
determination of cyanide##10##3##(2008-10#10)
determination of cyclamate##2##3##(2008-10#2)
determination of cyclophosphamide and ifosphamide##2##5##(2008-10#2)
determination of cypermethrin and deltamethrin in emulsifiable concentrate formulations##2##9##(2008-10#2)
determination of cysteine (Cys)##2##4##(2008-10#2)
determination of cysteine and penicillamine##2##5##(2008-10#2)
determination of cysteine and##3##4##(2008-10#3)
determination of cysteine on flow injection system##2##7##(2008-10#2)
determination of cysteine##12##3##(2008-10#12)
determination of deltamethrin##2##3##(2008-10#2)
determination of desferrioxamine##2##3##(2008-10#2)
determination of dichlorvos pesticide##2##4##(2008-10#2)
determination of diclofenac in##2##4##(2008-10#2)
determination of different##10##3##(1993-8#2)(2008-10#8)
determination of dihydralazine sulfate##2##4##(2008-10#2)
determination of dioxins in##2##4##(2008-10#2)
determination of diphenhydramine##2##3##(2008-10#2)
determination of dipyridamole##2##3##(2008-10#2)
determination of dissolved chromium species##2##5##(2008-10#2)
determination of dissolved organic phosphorus##2##5##(2008-10#2)
determination of dissolved oxygen in##2##5##(2008-10#2)
determination of dissolved oxygen##3##4##(2008-10#3)
determination of dissolved reactive##2##4##(2008-10#2)
determination of dissolved##13##3##(2008-10#13)
determination of dopamine in injection and urine##2##7##(2008-10#2)
determination of dopamine in injection##3##5##(2008-10#3)
determination of dopamine in##4##4##(2008-10#4)
determination of dopamine##10##3##(2008-10#10)
determination of doxycycline##4##3##(2008-10#4)
determination of doxylamine succinate in pharmaceuticals##2##6##(2008-10#2)
determination of doxylamine succinate##3##4##(2008-10#3)
determination of drug##4##3##(2008-10#3)(2011-2#1)
determination of each##2##3##(2008-10#2)
determination of eight##6##3##(2008-10#6)
determination of environmental##3##3##(1994-9#1)(2008-10#2)
determination of enzymatically generated hydrogen peroxide##2##6##(2008-10#2)
determination of ephedrine##3##3##(1995-2#1)(2008-10#2)
determination of epinephrine in pharmaceutical##2##5##(2008-10#2)
determination of epinephrine in##3##4##(2008-10#3)
determination of epinephrine##7##3##(2008-10#7)
determination of ethanol and glycerol in wines##2##7##(2008-10#2)
determination of ethanol and##3##4##(1991-5#1)(2008-10#2)
determination of ethanol##8##3##(1991-5#1)(2008-10#7)
determination of europium##3##3##(2008-10#3)
determination of famotidine in urine##2##5##(2008-10#2)
determination of famotidine##3##3##(2008-10#3)
determination of fatigue development##2##4##(2008-5#2)
determination of fatigue##3##3##(2008-5#2)(2010-8#1)
determination of ferbam##3##3##(2008-10#3)
determination of five##7##3##(2008-10#3)(2008-5#2)(2011-1#1)(2011-2#1)
determination of flavonoids in##2##4##(2008-10#2)
determination of flow##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
determination of fluoride in plant samples##2##6##(2008-10#2)
determination of fluoride in##5##4##(2008-10#5)
determination of fluoride ion##5##4##(2008-10#5)
determination of fluoride with ion-selective electrode##2##6##(2008-10#2)
determination of fluoride##14##3##(2008-10#14)
determination of fluoxetine in pharmaceuticals and biological fluids##2##8##(2008-10#2)
determination of fluoxetine##4##3##(2008-10#4)
determination of fluphenazine##2##3##(2008-10#2)
determination of formaldehyde in##3##4##(2008-10#3)
determination of formaldehyde##4##3##(2008-10#4)
determination of four anti-dandruff agents##2##5##(2008-5#2)
determination of four##12##3##(2008-10#8)(2008-5#3)(2012-3#1)
determination of free and##2##4##(1993-2#1)(2008-10#1)
determination of free cyanide##2##4##(2008-10#2)
determination of free##15##3##(1990-8#2)(1993-2#1)(2008-10#12)
determination of furosemide and triamterene##2##5##(2008-10#2)
determination of gallium by##2##4##(2008-10#2)
determination of gallium##4##3##(2008-10#4)
determination of gallium(III) and indium(III)##2##5##(2008-10#2)
determination of garenoxacin in##2##4##(2008-10#2)
determination of gentamycin is##2##4##(2008-10#2)
determination of gentamycin##3##3##(2008-10#3)
determination of gestodene##2##3##(2011-3#2)
determination of glucose and fructosamine##2##5##(2009-3#2)
determination of glucose and##3##4##(2008-10#1)(2009-3#2)
determination of glucose in human serum##2##6##(2008-10#2)
determination of glucose in human##3##5##(2008-10#2)(2010-5#1)
determination of glucose in soluble coffee##2##6##(2008-10#2)
determination of glucose in##12##4##(2008-10#11)(2010-5#1)
determination of glucose was##2##4##(2008-10#2)
determination of glucose##23##3##(2008-10#19)(2009-3#2)(2010-5#2)
determination of glutamine in biological samples##2##6##(1993-9#2)
determination of glutamine in##3##4##(1993-9#3)
determination of glutathione##3##3##(2008-10#3)
determination of glycerol##2##3##(2008-10#2)
determination of gold##4##3##(2007-12#2)(2008-10#2)
determination of heavy metals in##3##5##(2008-10#3)
determination of hemoglobin##4##3##(2008-10#4)
determination of hexachlorobenzene##2##3##(2008-10#2)
determination of histamine##2##3##(2008-10#2)
determination of histidine##2##3##(1995-3#1)(2008-10#1)
determination of homocysteine##4##3##(1992-9#1)(2008-10#3)
determination of human skin##2##4##(2008-5#2)
determination of human##3##3##(2008-10#1)(2008-5#2)
determination of hydrazine and phenylhydrazine##3##5##(2008-10#3)
determination of hydrazine##14##3##(2008-10#14)
determination of hydrogen peroxide was##2##5##(2008-10#2)
determination of hydrogen peroxide##20##4##(1992-11#2)(2008-10#18)
determination of hydrogen##22##3##(1992-11#2)(2008-1#1)(2008-10#19)
determination of hydroquinone in##4##4##(2008-10#4)
determination of hydroquinone##7##3##(2008-10#7)
determination of hydroxyl radical##2##4##(2008-10#2)
determination of hydroxyl##3##3##(2008-10#3)
determination of ibuprofen in the presence of beta-CD##2##8##(2008-10#2)
determination of ibuprofen in##3##4##(2008-10#3)
determination of imidacloprid##2##3##(2008-10#2)
determination of in##2##3##(1990-12#1)(2010-8#1)
determination of indium##3##3##(2008-10#3)
determination of individual##4##3##(2008-10#4)
determination of indomethacin and acemethacin by differential pulse adsorptive stripping voltammetry##2##11##(2008-10#2)
determination of indomethacin##3##3##(2008-10#3)
determination of inorganic and##2##4##(2008-10#2)
determination of inorganic arsenic##3##4##(2008-10#3)
determination of inorganic cations##2##4##(2008-10#2)
determination of inorganic##16##3##(1993-12#1)(2008-10#15)
determination of inosine nucleoside in nucleotides##2##6##(2008-10#2)
determination of inosine##3##3##(2008-10#3)
determination of iodate and iodide in table##2##7##(2008-10#2)
determination of iodate and iodide##3##5##(2008-10#3)
determination of iodate and##5##4##(2008-10#5)
determination of iodate in iodized##2##5##(2008-10#2)
determination of iodate##10##3##(2008-10#10)
determination of iodide ion in##2##5##(2008-10#2)
determination of iodide##9##3##(2008-10#9)
determination of iodine##3##3##(2008-10#3)
determination of iridium##3##3##(2008-10#3)
determination of iridium(IV)##3##3##(2008-10#3)
determination of iron and chromium in steel alloys##3##8##(2008-10#3)
determination of iron and vanadium##2##5##(2008-10#2)
determination of iron and zinc in##2##6##(2008-10#2)
determination of iron and zinc##3##5##(2008-10#3)
determination of iron and##11##4##(2008-10#11)
determination of iron in##10##4##(2008-10#10)
determination of iron with##2##4##(2008-10#2)
determination of iron##35##3##(2008-10#35)
determination of iron(III) and##4##4##(2008-10#4)
determination of iron(III) in the##2##5##(2008-10#2)
determination of iron(III) in##3##4##(2008-10#3)
determination of iron(III)##8##3##(2008-10#8)
determination of iron(III)-dimethyldithiocarbamate (ferbam)##2##4##(2008-10#2)
determination of isoniazid##3##3##(2008-10#3)
determination of isoproterenol##2##3##(2008-10#2)
determination of isoproturon##3##3##(2008-10#3)
determination of its##3##3##(1990-7#1)(2008-10#1)(2010-4#1)
determination of l-ascorbic acid##4##4##(2008-10#4)
determination of l-cysteine and l-cystine##2##5##(2008-10#2)
determination of l-phenylalanine##2##3##(2008-10#2)
determination of lactic acid in##4##5##(2008-10#4)
determination of lanthanide##2##3##(2008-10#2)
determination of lanthanides##2##3##(2008-10#2)
determination of lead and copper##2##5##(2008-10#2)
determination of lead and tin##2##5##(2008-10#2)
determination of lead and##6##4##(2008-10#6)
determination of lead by##2##4##(2008-10#2)
determination of lead extracted by acetic acid from glazed ceramic surfaces by flow injection##2##14##(2008-10#2)
determination of lead in foods with##2##6##(2008-10#2)
determination of lead in natural##2##5##(2008-10#2)
determination of lead in soil and water samples##2##8##(2008-10#2)
determination of lead in vegetables with##2##6##(2008-10#2)
determination of lead in water samples##2##6##(2008-10#2)
determination of lead in water##3##5##(2008-10#3)
determination of lead in##34##4##(2008-10#34)
determination of lead using##2##4##(2008-10#2)
determination of lead with Arsenazo III##2##6##(2008-10#2)
determination of lead with##3##4##(2008-10#3)
determination of lead##60##3##(1993-9#1)(2008-1#1)(2008-10#58)
determination of lead(II) and cadmium(II)##2##5##(2008-10#2)
determination of lead(II) in##2##4##(2008-10#2)
determination of lead(II) with a 1##2##6##(2008-10#2)
determination of lead(II)##10##3##(2008-10#10)
determination of levofloxacin in##2##4##(2008-10#2)
determination of linoleate hydroperoxide##2##4##(2008-10#2)
determination of lithium ion##3##4##(2008-10#3)
determination of lithium##7##3##(2008-10#7)
determination of low concentrations of##2##5##(2008-10#2)
determination of low##12##3##(2008-10#11)(2012-1#1)
determination of magnesium in urine and##2##6##(2008-10#2)
determination of magnesium in##4##4##(2008-10#4)
determination of magnesium##8##3##(2008-10#8)
determination of maleic hydrazide##2##4##(2008-10#2)
determination of maltol in beverages##3##5##(2008-10#3)
determination of manganese and selenium in serum by##2##8##(2008-10#2)
determination of manganese and zinc in##3##6##(2008-10#3)
determination of manganese and##5##4##(2008-10#5)
determination of manganese in##8##4##(2008-10#8)
determination of manganese oxide content of Portland cement and cement raw meal##2##12##(2008-10#2)
determination of manganese##19##3##(2008-10#19)
determination of manganese(II) in##2##4##(2008-10#2)
determination of manganese(II)##8##3##(2008-10#8)
determination of mebendazole and pyrantel pamoate from tablets##2##8##(2008-10#2)
determination of mequitazine in human plasma##2##6##(2008-10#2)
determination of mercury in##5##4##(2008-10#5)
determination of mercury##13##3##(2008-10#13)
determination of mercury(II) and##2##4##(2008-10#2)
determination of mercury(II)##8##3##(2008-10#8)
determination of mesna##2##3##(2008-10#2)
determination of metal ions in water##2##6##(2008-10#2)
determination of metal ions##6##4##(2008-10#6)
determination of metal##9##3##(2008-10#8)(2010-11#1)
determination of metallothionein##2##3##(2008-10#2)
determination of metals in##7##4##(2008-10#7)
determination of metals##8##3##(2008-10#8)
determination of metformin##2##3##(2008-10#1)(2010-5#1)
determination of methamidophos using##2##4##(2008-10#2)
determination of methanol##2##3##(2008-10#2)
determination of methyldopa and dopamine in pharmaceutical formulations##2##8##(2008-10#2)
determination of methyldopa##3##3##(2008-10#3)
determination of metoclopramide and tetracaine hydrochloride##2##6##(2008-10#2)
determination of metoclopramide hydrochloride##4##4##(2008-10#4)
determination of metoclopramide in##2##4##(2008-10#2)
determination of metoclopramide##10##3##(2008-10#10)
determination of metrifonate in##2##4##(2008-10#2)
determination of metrifonate##3##3##(2008-10#3)
determination of metronidazole at a##2##5##(2008-10#2)
determination of metronidazole##5##3##(2008-10#5)
determination of minoxidil##3##3##(2008-10#3)
determination of mixtures of##2##4##(2008-10#2)
determination of mixtures##3##3##(2008-10#3)
determination of molybdenum and copper##3##5##(2008-10#3)
determination of molybdenum and##4##4##(2008-10#4)
determination of molybdenum in##8##4##(2008-10#8)
determination of molybdenum with Alizarin Red S##2##7##(2008-10#2)
determination of molybdenum##20##3##(2008-10#20)
determination of molybdenum(VI) and tungsten(VI)##2##5##(2008-10#2)
determination of molybdenum(VI)##4##3##(2008-10#4)
determination of morphine##3##3##(2008-10#3)
determination of mug l(-1)##2##4##(2008-10#2)
determination of n##3##3##(2008-3#3)
determination of nalidixic acid and##2##5##(2008-10#2)
determination of nalidixic acid##3##4##(2008-10#3)
determination of nanogram##4##3##(2008-10#4)
determination of naphazoline nitrate and methylparaben##2##6##(2008-10#2)
determination of naproxen##6##3##(2008-10#6)
determination of natural##3##3##(2008-10#3)
determination of neostigmine in##2##4##(2008-10#2)
determination of neostigmine##3##3##(2008-10#3)
determination of nickel and##3##4##(2008-10#3)
determination of nickel has been##2##5##(2008-10#2)
determination of nickel in natural water samples##2##7##(2008-10#2)
determination of nickel in natural##3##5##(2008-10#3)
determination of nickel in the##2##5##(2008-10#2)
determination of nickel in##18##4##(2008-10#18)
determination of nickel##31##3##(2008-10#31)
determination of nicotine##2##3##(1993-8#1)(2008-10#1)
determination of nitrate and nitrite##2##5##(2008-10#2)
determination of nitrate and##4##4##(2008-10#4)
determination of nitrate in vegetables##2##5##(2008-10#2)
determination of nitrate in##8##4##(2008-10#8)
determination of nitrate##14##3##(2008-10#14)
determination of nitric oxide##3##4##(2008-10#3)
determination of nitrite and nitrate in dew##2##7##(2008-10#2)
determination of nitrite and nitrate in water##3##7##(2008-10#3)
determination of nitrite and nitrate in##9##6##(2008-10#9)
determination of nitrite and nitrate##15##5##(2008-10#15)
determination of nitrite based on its catalytic effect on the##2##10##(2008-10#2)
determination of nitrite in##11##4##(2008-10#11)
determination of nitrite ion in##2##5##(2008-10#2)
determination of nitrite ion using##2##5##(2008-10#2)
determination of nitrite ion##4##4##(2008-10#4)
determination of nitrite using##2##4##(2008-10#2)
determination of nitrite##42##3##(2008-10#41)(2008-11#1)
determination of nitroaniline isomers by##2##5##(2008-10#2)
determination of nitroaniline isomers##3##4##(2008-10#3)
determination of nitroaniline##5##3##(2008-10#5)
determination of nitrogen oxides in the air##2##7##(2008-10#2)
determination of nitrogen oxides##3##4##(2008-10#3)
determination of nitrogen##4##3##(2008-10#4)
determination of non-ionic surfactants##2##4##(2008-10#2)
determination of noradrenaline and##2##4##(2008-10#2)
determination of novalgin##2##3##(2008-10#2)
determination of nucleic acids##5##4##(2008-10#5)
determination of nucleic##6##3##(2008-10#6)
determination of nucleotides##2##3##(2008-2#2)
determination of numerous##2##3##(2008-10#2)
determination of ochratoxin A in##3##5##(2008-10#3)
determination of ochratoxin A##4##4##(2008-10#4)
determination of ofloxacin in##3##4##(2008-10#3)
determination of ofloxacin##4##3##(2008-10#4)
determination of optical constants of##3##5##(2008-2#2)(2008-3#1)
determination of optical##4##3##(2008-2#2)(2008-3#2)
determination of organic acids in##2##5##(1994-9#2)
determination of organic acids##3##4##(1994-9#2)(2008-10#1)
determination of organic dye mixtures by using##2##7##(2008-10#2)
determination of organic mercury##2##4##(2008-10#2)
determination of organic##8##3##(1994-9#2)(2008-10#6)
determination of organophosphorus pesticides in water and fruit juice with##2##10##(2008-10#2)
determination of organophosphorus pesticides##3##4##(2008-10#3)
determination of organophosphorus##4##3##(2008-10#4)
determination of organotin##2##3##(2008-10#2)
determination of orthophosphate and total inorganic phosphates in detergents##2##9##(2008-10#2)
determination of orthophosphate and total##3##5##(2008-10#3)
determination of orthophosphate in##3##4##(2008-10#3)
determination of orthophosphate##6##3##(2008-10#6)
determination of other##3##3##(2008-10#3)
determination of oxalate in urine##3##5##(1990-12#1)(2008-10#2)
determination of oxalate##6##3##(1990-12#1)(2008-10#5)
determination of oxidizable##4##3##(2008-10#4)
determination of oxychlorine species##2##4##(2008-10#2)
determination of p-aminobenzoic acid##2##4##(2008-10#2)
determination of palladium in airborne particulate matter##2##7##(2008-10#2)
determination of palladium in##5##4##(2008-10#5)
determination of palladium##7##3##(2008-10#7)
determination of palladium(II)##7##3##(2008-10#7)
determination of panaxynol in a##2##5##(2008-10#2)
determination of panaxynol in##3##4##(2008-10#3)
determination of paracetamol in pharmaceutical formulations##2##6##(2008-10#2)
determination of paracetamol in pharmaceuticals##3##5##(2008-10#3)
determination of paracetamol in##9##4##(2008-10#9)
determination of paracetamol##13##3##(2008-10#13)
determination of paraquat in##5##4##(2008-10#5)
determination of paraquat##11##3##(2008-10#11)
determination of particle##2##3##(2008-10#1)(2008-3#1)
determination of partition coefficients of##3##5##(2008-10#3)
determination of partition coefficients##4##4##(2008-10#4)
determination of perchlorate in complex##2##5##(2008-10#2)
determination of perchlorate in##4##4##(2008-10#4)
determination of perchlorate##8##3##(2008-10#8)
determination of periodate and iodate##3##5##(2008-10#3)
determination of periodate##4##3##(2008-10#4)
determination of periodate-bromate and iodate-bromate mixtures##2##6##(2008-10#2)
determination of periodate-bromate and iodate-bromate##3##5##(2008-10#3)
determination of pesticides in##2##4##(2008-10#2)
determination of pharmaceuticals in##2##4##(2008-10#2)
determination of phenol##4##3##(2008-10#4)
determination of phenolic compounds and##2##5##(2008-10#2)
determination of phenolic compounds##3##4##(2008-10#3)
determination of phenolic##4##3##(2008-10#4)
determination of phenols in##2##4##(2008-10#2)
determination of phenols##7##3##(2008-10#7)
determination of phenothiazines##2##3##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical dosage forms##2##8##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical preparations##2##7##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical##4##6##(2008-10#4)
determination of phenylmercury##2##3##(2008-10#2)
determination of phenytoin in capsules and plasma##2##7##(2008-10#2)
determination of phosphate and silicate##2##5##(2008-10#2)
determination of phosphate and##4##4##(2008-10#4)
determination of phosphate in##3##4##(2008-10#3)
determination of phosphate##12##3##(2008-10#12)
determination of phosphorus by##3##4##(2008-10#3)
determination of phosphorus in##2##4##(2008-10#2)
determination of phosphorus species in environmental matrices##2##7##(2008-10#2)
determination of phosphorus species in##3##5##(2008-10#3)
determination of phosphorus species##4##4##(2008-10#4)
determination of phosphorus##13##3##(2008-10#13)
determination of piroxicam in##2##4##(2008-10#2)
determination of piroxicam##4##3##(2008-10#4)
determination of plaque##2##3##(2008-7#1)(2010-9#1)
determination of platinum##8##3##(2008-10#8)
determination of pollutants in##2##4##(2008-10#2)
determination of polycyclic aromatic hydrocarbons (PAHs)##3##6##(2008-10#3)
determination of polycyclic aromatic hydrocarbons##6##5##(2008-10#6)
determination of polynuclear aromatic hydrocarbons##2##5##(2008-10#2)
determination of polyphenols in##2##4##(2008-10#2)
determination of potassium ions##2##4##(2008-10#2)
determination of potassium##4##3##(2008-10#4)
determination of praseodymium in##3##4##(2008-10#3)
determination of primary##3##3##(2008-10#3)
determination of procaine hydrochloride##4##4##(2008-10#4)
determination of propacetamol##2##3##(2008-10#2)
determination of propiverine and##2##4##(2008-10#2)
determination of propranolol and pindolol##3##5##(2008-10#3)
determination of protein concentration##3##4##(2008-1#1)(2008-4#2)
determination of protein##13##3##(1990-12#1)(1991-11#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-4#3)(2009-12#1)
determination of proteins in human serum##2##6##(2008-10#2)
determination of proteins in##4##4##(2008-10#3)(2009-12#1)
determination of proteins##10##3##(2008-10#9)(2009-12#1)
determination of protolytic constants##2##4##(2008-10#2)
determination of pseudoephedrine hydrochloride and diphenhydramine hydrochloride in cough syrup##2##10##(2008-10#2)
determination of pseudoephedrine##3##3##(2008-10#3)
determination of psilocybin##2##3##(2008-10#2)
determination of pyridoxine hydrochloride in##2##5##(2008-10#2)
determination of pyridoxine hydrochloride##3##4##(2008-10#3)
determination of pyrogallol compounds##2##4##(2008-10#2)
determination of pyrogallol##3##3##(2008-10#3)
determination of quinalphos in##2##4##(2008-10#2)
determination of quinine##3##3##(2008-10#3)
determination of rare##3##3##(2008-10#3)
determination of rates of##2##4##(1994-3#1)(2007-12#1)
determination of recombinant##2##3##(2008-10#1)(2010-6#1)
determination of reduced glutathione##2##4##(2008-10#2)
determination of reducing sugars##2##4##(2008-10#2)
determination of relative##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
determination of residual##2##3##(2008-10#1)(2008-9#1)
determination of rifampicin and isoniazid in##2##6##(2008-10#2)
determination of rifampicin##3##3##(2007-7#1)(2008-10#2)
determination of rubidate##3##3##(2008-10#3)
determination of ruthenium##6##3##(2008-10#6)
determination of rutin in##3##4##(2008-10#3)
determination of rutin##4##3##(2008-10#4)
determination of salbutamol##3##3##(2008-10#3)
determination of salicylamide##2##3##(2008-10#2)
determination of salicylate in##2##4##(2008-10#2)
determination of salicylic acid##2##4##(2008-10#2)
determination of salsalate in##3##4##(2008-10#3)
determination of salsalate##4##3##(2008-10#4)
determination of seawater##2##3##(2008-10#2)
determination of selected##2##3##(1996-5#1)(2008-10#1)
determination of selenium (IV)##2##4##(2008-10#2)
determination of selenium in##5##4##(2008-10#5)
determination of selenium##13##3##(2008-10#13)
determination of selenium(IV) and (VI)##2##5##(2008-10#2)
determination of selenium(IV) and##5##4##(2008-10#5)
determination of selenium(IV)##7##3##(2008-10#7)
determination of semicarbazide and hydrazine##3##5##(2008-10#3)
determination of semicarbazide##5##3##(2008-10#5)
determination of serum cholesterol##2##4##(1991-6#1)(2008-10#1)
determination of serum##4##3##(1991-12#1)(1991-6#1)(1993-12#1)(2008-10#1)
determination of seven##5##3##(2008-10#3)(2012-3#2)
determination of several##9##3##(1992-5#1)(2008-10#8)
determination of silicon##3##3##(2008-10#3)
determination of silver in##6##4##(2008-10#6)
determination of silver##11##3##(2008-10#11)
determination of silver(I)##5##3##(2008-10#5)
determination of small amounts of##3##5##(2008-10#3)
determination of small##4##3##(2008-10#4)
determination of sodium cyclamate##2##4##(2008-10#2)
determination of sodium impurities in##2##5##(2008-10#2)
determination of sodium percarbonate##2##4##(2008-10#2)
determination of sodium##10##3##(2008-10#10)
determination of some anions##2##4##(2008-10#2)
determination of some metals##3##4##(2008-10#3)
determination of some phenothiazine##2##4##(2008-10#2)
determination of some##23##3##(2008-10#22)(2008-2#1)
determination of specific##2##3##(1990-12#1)(2008-10#1)
determination of spironolactone and canrenone in urine##2##7##(2008-10#2)
determination of stability constants of##3##5##(2008-10#3)
determination of stability constants##6##4##(2008-10#6)
determination of stachyose##2##3##(2008-10#2)
determination of starch in food##2##5##(2008-10#2)
determination of stoichiometry and association##2##5##(2008-10#2)
determination of sub-nanogram##2##3##(2008-10#2)
determination of sucrose in beet root##2##6##(2008-10#2)
determination of sucrose in##4##4##(2008-10#4)
determination of sucrose##5##3##(2008-10#5)
determination of sulfamonomethoxine##2##3##(2008-10#2)
determination of sulfate ion##2##4##(2008-10#2)
determination of sulfate##3##3##(2008-10#3)
determination of sulfide in##6##4##(2008-10#6)
determination of sulfide##11##3##(2008-10#11)
determination of sulfite and sulfide##2##5##(2008-10#2)
determination of sulfite in food##2##5##(2008-10#2)
determination of sulfite in sugar and sulfur dioxide in air##2##10##(2008-10#2)
determination of sulfite in##5##4##(2008-10#5)
determination of sulfite##10##3##(2008-10#10)
determination of sulfonamide##2##3##(2008-10#1)(2009-8#1)
determination of sulfonamides in##3##4##(2008-10#3)
determination of sulfur dioxide##2##4##(2008-10#2)
determination of sulfur##3##3##(2008-10#3)
determination of sulphate in soil solutions##2##6##(2008-10#2)
determination of sulphate in##3##4##(2008-10#3)
determination of sulphide##2##3##(2008-10#2)
determination of tannic acid##2##4##(2008-10#2)
determination of taurine in##2##4##(2008-10#2)
determination of terbinafine and##2##4##(2008-10#2)
determination of terbinafine##3##3##(2008-10#3)
determination of ternary mixtures##2##4##(2008-10#2)
determination of tetracycline##2##3##(2008-10#2)
determination of tetracyclines##2##3##(2008-10#2)
determination of thallium in##2##4##(1991-12#1)(2008-10#1)
determination of thallium##8##3##(1991-12#3)(2008-10#5)
determination of thallium(I)##2##3##(2008-10#2)
determination of the absolute##2##4##(2008-10#1)(2008-2#1)
determination of the active##4##4##(2008-10#2)(2008-8#1)(2010-9#1)
determination of the aerosol##2##4##(2008-2#2)
determination of the amount of##2##5##(2008-10#2)
determination of the colorants tartrazine##2##5##(2008-10#2)
determination of the colorants##3##4##(2008-10#3)
determination of the complex index of refraction and##2##8##(2008-2#2)
determination of the complex index of refraction##4##7##(2008-2#4)
determination of the complex##5##4##(2007-12#1)(2008-2#4)
determination of the components of##2##5##(2008-10#2)
determination of the composition##2##4##(2008-10#2)
determination of the concentration of##6##5##(2008-10#5)(2008-11#1)
determination of the concentration##8##4##(2008-10#6)(2008-11#1)(2008-3#1)
determination of the content of##3##5##(2008-10#2)(2012-2#1)
determination of the drug in##8##5##(2008-10#8)
determination of the drug##10##4##(2008-10#10)
determination of the entire genome##3##5##(1996-6#3)
determination of the free##2##4##(1991-5#1)(2008-10#1)
determination of the growth##2##4##(2008-11#2)
determination of the levels of##3##5##(2008-10#2)(2011-2#1)
determination of the molecular masses of##2##6##(1990-12#1)(1996-5#1)
determination of the optical constants##4##5##(2008-2#2)(2008-3#2)
determination of the optical##5##4##(2008-2#3)(2008-3#2)
determination of the optimum##2##4##(2008-10#1)(2008-3#1)
determination of the pesticide##4##4##(2008-10#4)
determination of the radiative forcing of##2##6##(2008-2#2)
determination of the rare##2##4##(2008-10#2)
determination of the real##2##4##(2008-10#2)
determination of the refractive index##3##5##(2008-3#3)
determination of the refractive##4##4##(2008-3#4)
determination of the relative##2##4##(2008-3#1)(2008-5#1)
determination of the stability constants##2##5##(2008-10#2)
determination of the stability##4##4##(2008-10#4)
determination of the synthetic antioxidant butylated hydroxyanisole##2##7##(2008-10#2)
determination of the target##3##4##(2008-10#2)(2008-7#1)
determination of the three-dimensional orientation of##2##6##(2007-11#2)
determination of the time##2##4##(1995-12#1)(2008-10#1)
determination of the total amount of##3##6##(2008-10#3)
determination of the total##11##4##(1996-4#1)(2008-10#9)(2008-11#1)
determination of the two##5##4##(2008-10#5)
determination of the upconversion##2##4##(2008-3#2)
determination of the##363##3##(1990-12#3)(1990-3#1)(1990-7#3)(1990-8#6)(1991-11#2)(1991-12#1)(1991-5#3)(1991-7#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#3)(1993-8#1)(1994-11#1)(1994-5#1)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#1)(2006-4#1)(2007-11#8)(2007-12#2)(2008-1#1)(2008-10#201)(2008-11#6)(2008-12#4)(2008-2#27)(2008-3#33)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
determination of their##9##3##(1990-12#1)(1995-3#1)(1995-6#1)(2007-5#1)(2008-10#2)(2008-12#1)(2009-5#1)(2013-1#1)
determination of these compounds##8##4##(2008-10#8)
determination of these metal ions in##4##6##(2008-10#4)
determination of these metal ions##5##5##(2008-10#5)
determination of these metals##3##4##(2008-10#3)
determination of these parameters##3##4##(2008-10#2)(2008-3#1)
determination of these pesticides in##2##5##(2008-10#2)
determination of these two##3##4##(2008-10#3)
determination of these##47##3##(1990-8#1)(2008-10#45)(2008-3#1)
determination of thiamine in pharmaceutical formulations##2##6##(2008-10#2)
determination of thiamine in pharmaceutical##3##5##(2008-10#3)
determination of thiamine##6##3##(2008-10#6)
determination of thiocyanate##2##3##(2008-10#2)
determination of this compound##3##4##(2008-10#3)
determination of this element##4##4##(2008-10#4)
determination of this metal##2##4##(2008-10#2)
determination of this##14##3##(2008-10#13)(2011-2#1)
determination of thorium and rare earth##2##6##(2008-10#2)
determination of thorium and##3##4##(2008-10#3)
determination of thorium##6##3##(2008-10#6)
determination of three##14##3##(2008-10#14)
determination of tin and nickel in##2##6##(2008-10#2)
determination of tin in##4##4##(2008-10#4)
determination of tin##11##3##(2008-10#11)
determination of tissue optical properties##3##5##(2008-3#3)
determination of tolnaftate##2##3##(2008-10#2)
determination of toluene##2##3##(2008-10#2)
determination of total As##2##4##(2008-10#2)
determination of total amount of nitrite and nitrate##2##8##(2008-10#2)
determination of total and##3##4##(2008-10#3)
determination of total arsenic in##2##5##(2008-10#2)
determination of total arsenic##4##4##(2008-10#4)
determination of total chromium in##3##5##(2008-10#3)
determination of total inorganic carbon##2##5##(2008-10#2)
determination of total inorganic##4##4##(2008-10#4)
determination of total iron##3##4##(2008-10#3)
determination of total mercury in##2##5##(2008-10#2)
determination of total mercury##6##4##(2008-10#6)
determination of total phosphorus##3##4##(2008-10#3)
determination of total polyphenol##2##4##(2008-10#2)
determination of total protein in human serum##2##7##(2008-10#2)
determination of total proteins##2##4##(2008-10#2)
determination of total sulfur##4##4##(2008-10#4)
determination of total##60##3##(1991-11#1)(1995-2#1)(2008-10#58)
determination of toxic metals in##2##5##(2008-10#2)
determination of toxic##5##3##(2008-10#5)
determination of toxicologically relevant arsenic##2##5##(2008-10#2)
determination of trace aluminum##3##4##(2008-10#3)
determination of trace amount of cobalt in##2##7##(2008-10#2)
determination of trace amount of##19##5##(2008-10#19)
determination of trace amount##20##4##(2008-10#20)
determination of trace amounts of Se(IV) in##2##7##(2008-10#2)
determination of trace amounts of cadmium in##2##7##(2008-10#2)
determination of trace amounts of cadmium##3##6##(2008-10#3)
determination of trace amounts of cobalt##2##6##(2008-10#2)
determination of trace amounts of copper and iron##2##8##(2008-10#2)
determination of trace amounts of copper##4##6##(2008-10#4)
determination of trace amounts of iodide##2##6##(2008-10#2)
determination of trace amounts of iron##2##6##(2008-10#2)
determination of trace amounts of lead##3##6##(2008-10#3)
determination of trace amounts of nitrite##3##6##(2008-10#3)
determination of trace amounts of selenium##2##6##(2008-10#2)
determination of trace amounts of vanadium and molybdenum in##2##9##(2008-10#2)
determination of trace amounts of vanadium##3##6##(2008-10#3)
determination of trace amounts of zinc##2##6##(2008-10#2)
determination of trace amounts of##76##5##(2008-10#76)
determination of trace arsenic##2##4##(2008-10#2)
determination of trace copper##2##4##(2008-10#2)
determination of trace elements in##9##5##(2008-10#7)(2011-2#1)(2013-8#1)
determination of trace elements##15##4##(2008-10#13)(2011-2#1)(2013-8#1)
determination of trace lead in water after##2##7##(2008-10#2)
determination of trace lead##5##4##(2008-10#3)(2013-8#2)
determination of trace level of##2##5##(2008-10#2)
determination of trace levels of germanium##2##6##(2008-10#2)
determination of trace levels of##17##5##(1990-8#1)(2008-10#16)
determination of trace manganese in##2##5##(2008-10#2)
determination of trace manganese##6##4##(2008-10#6)
determination of trace mercury##8##4##(2008-10#8)
determination of trace metals by##3##5##(2008-10#3)
determination of trace metals in##6##5##(2008-10#6)
determination of trace metals##11##4##(2008-10#11)
determination of trace molybdenum##3##4##(2008-10#3)
determination of trace nitrite in food products with##2##8##(2008-10#2)
determination of trace nitrite in##3##5##(2008-10#3)
determination of trace or##2##4##(2008-10#2)
determination of trace oxyhalides and haloacetic acids##2##7##(2008-10#2)
determination of trace sulfur dioxide##2##5##(2008-10#2)
determination of trace water in organic solvents##2##7##(2008-10#2)
determination of trace##222##3##(1990-8#1)(2008-10#216)(2011-2#2)(2013-8#3)
determination of traces of##12##4##(2008-10#12)
determination of tramadol##2##3##(1996-5#2)
determination of trans-beta-carotene in##2##4##(2008-10#2)
determination of triiodide##2##3##(2008-10#2)
determination of tungsten based on##2##5##(2008-10#2)
determination of tungsten in##5##4##(2008-10#5)
determination of tungsten##11##3##(2008-10#11)
determination of two##9##3##(2008-10#9)
determination of type B trichothecenes##2##5##(2008-10#2)
determination of ultra trace amounts of##6##6##(2008-10#6)
determination of ultra trace##8##4##(2008-10#8)
determination of ultra-trace levels of##2##5##(2008-10#2)
determination of ultra-trace##7##3##(2008-10#7)
determination of uranium in##6##4##(2008-10#6)
determination of uranium##11##3##(2008-10#11)
determination of urea in##3##4##(2008-10#3)
determination of urea##7##3##(2008-10#7)
determination of uric acid (UA)##2##5##(2008-10#2)
determination of uric acid and creatinine in urine##2##8##(2008-10#2)
determination of uric acid in##6##5##(2008-10#6)
determination of uric acid##14##4##(2008-10#14)
determination of uric##15##3##(2008-10#15)
determination of urinary##7##3##(1990-8#2)(1991-5#1)(1992-11#1)(1992-3#1)(2008-10#2)
determination of vanadium and its application to##2##7##(2008-10#2)
determination of vanadium and##3##4##(2008-10#3)
determination of vanadium in high saline##2##6##(2008-10#2)
determination of vanadium in natural waters##2##6##(2008-10#2)
determination of vanadium in petroleum oils and mineral ore samples##2##10##(2008-10#2)
determination of vanadium in##15##4##(2008-10#15)
determination of vanadium##26##3##(2008-10#26)
determination of vanadium(IV) and total vanadium##2##6##(2008-10#2)
determination of vanadium(V)##3##3##(2008-10#3)
determination of vancomycin and##2##4##(2008-10#2)
determination of vanillin and##2##4##(2008-10#2)
determination of vanillin##4##3##(2008-10#4)
determination of various##3##3##(2008-10#3)
determination of very##3##3##(1990-12#1)(2008-10#2)
determination of vitamin C in pharmaceutical preparations##2##7##(2008-10#2)
determination of vitamin C##3##4##(2008-10#3)
determination of vitamin K(1)##2##4##(2008-10#2)
determination of vitamin##7##3##(2008-10#7)
determination of volatile chlorination by-products in drinking water##2##8##(2008-10#2)
determination of volatile compounds in##2##5##(2008-10#2)
determination of volatile##8##3##(2008-10#8)
determination of water##4##3##(2008-10#2)(2009-12#1)(2012-1#1)
determination of water-leaving##2##3##(2008-2#2)
determination of water-soluble##3##3##(2008-10#3)
determination of wear metals in used##2##6##(2008-10#2)
determination of whether##2##3##(2008-3#1)(2008-9#1)
determination of withanolide##2##3##(2012-2#2)
determination of zinc and nickel in aqueous##2##7##(2008-10#2)
determination of zinc and nickel##3##5##(2008-10#3)
determination of zinc and##5##4##(2008-10#5)
determination of zinc in standard alloys##2##6##(2008-10#2)
determination of zinc in##9##4##(2008-10#9)
determination of zinc##23##3##(1992-3#1)(2008-10#22)
determination of zirconium##2##3##(2008-10#2)
determination of zirconium(IV)##3##3##(2008-10#3)
determination of##4289##2##(1990-12#14)(1990-2#5)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#28)(1991-11#6)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#13)(1991-6#2)(1991-7#1)(1992-11#9)(1992-12#1)(1992-3#7)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-5#3)(1993-8#5)(1993-9#5)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-7#2)(1994-8#1)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#14)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#8)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#11)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#9)(2008-10#3693)(2008-11#22)(2008-12#8)(2008-2#47)(2008-3#77)(2008-4#16)(2008-5#33)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#12)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#11)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#9)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#19)(2011-2#13)(2011-3#3)(2012-1#7)(2012-12#4)(2012-2#9)(2012-3#4)(2012-4#1)(2012-8#1)(2013-1#6)(2013-8#9)
determination on the##2##3##(2008-10#1)(2009-8#1)
determination on##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
determination or##4##2##(2008-10#3)(2010-5#1)
determination per hour##3##3##(2008-10#3)
determination range of##3##3##(2008-10#3)
determination range##7##2##(2008-10#7)
determination results##3##2##(2008-10#3)
determination since##2##2##(2008-10#2)
determination system##3##2##(2008-10#3)
determination that##2##2##(2008-10#1)(2008-8#1)
determination the##3##2##(2008-10#1)(2010-8#2)
determination to##3##2##(2008-10#2)(2010-10#1)
determination using the##2##3##(2008-10#2)
determination using##15##2##(2008-10#12)(2008-9#1)(2009-7#1)(2009-8#1)
determination via##2##2##(2008-10#1)(2008-8#1)
determination was also##2##3##(2008-10#2)
determination was based on the##3##5##(2008-10#3)
determination was carried out by##2##5##(2008-10#2)
determination was carried out##4##4##(2008-10#4)
determination was found to be##2##5##(2008-10#2)
determination was investigated##4##3##(1992-5#1)(2008-10#3)
determination was performed by##2##4##(1991-5#1)(2008-10#1)
determination was performed##5##3##(1991-5#1)(2008-10#4)
determination was proposed##2##3##(2008-10#2)
determination was##55##2##(1991-5#1)(1992-5#1)(1994-2#1)(2008-10#49)(2008-11#1)(2008-5#2)
determination were studied##2##3##(2008-10#2)
determination were##21##2##(1995-11#1)(2008-10#17)(2008-5#2)(2013-7#1)
determination with a##2##3##(2008-10#2)
determination with atomic absorption spectrometry##2##5##(2008-10#2)
determination with the##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
determination with##17##2##(1993-8#1)(2008-10#14)(2008-11#1)(2009-3#1)
determination within##2##2##(2008-10#2)
determination without titration##2##3##(2008-10#2)
determination without##4##2##(2008-10#4)
determination##5345##1##(1990-11#1)(1990-12#15)(1990-2#5)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#6)(1990-8#31)(1991-11#9)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#14)(1991-6#2)(1991-7#1)(1992-11#9)(1992-12#1)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#7)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#8)(1993-5#3)(1993-8#8)(1993-9#5)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#2)(1994-7#3)(1994-8#1)(1994-9#5)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#5)(1995-4#1)(1995-6#4)(1995-9#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#14)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#10)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2006-4#2)(2006-6#1)(2007-11#13)(2007-12#10)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#9)(2008-10#4571)(2008-11#30)(2008-12#11)(2008-2#52)(2008-3#88)(2008-4#21)(2008-5#49)(2008-6#1)(2008-7#13)(2008-8#11)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#7)(2009-8#13)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#16)(2010-4#5)(2010-5#12)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#21)(2011-2#18)(2011-3#3)(2012-1#8)(2012-12#7)(2012-2#10)(2012-3#7)(2012-4#1)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#11)
determination) and##2##2##(2008-10#1)(2008-3#1)
determination)##8##1##(1991-5#1)(2008-10#5)(2008-3#2)
determination]##2##1##(1991-3#1)(1996-11#1)
determinations and##3##2##(1991-11#1)(2008-10#2)
determinations are##4##2##(1990-9#1)(2008-10#3)
determinations as##2##2##(1990-2#1)(2008-10#1)
determinations at the##5##3##(2008-10#5)
determinations at trace levels##2##4##(2008-10#2)
determinations at##10##2##(2008-10#10)
determinations by##7##2##(2008-10#5)(2008-4#1)(2008-8#1)
determinations can be##3##3##(1991-5#1)(1993-3#1)(2008-10#1)
determinations during##2##2##(1990-9#1)(1997-7#1)
determinations for##4##2##(2008-10#3)(2008-5#1)
determinations h(-1)##2##2##(2008-10#2)
determinations have##4##2##(2008-10#4)
determinations in environmental samples##2##4##(2008-10#2)
determinations in the##6##3##(1995-3#1)(2008-10#5)
determinations in water##3##3##(2008-10#3)
determinations in##20##2##(1993-2#1)(1995-3#1)(2008-10#18)
determinations is##3##2##(1990-8#1)(2008-10#2)
determinations of 0##6##3##(2008-10#6)
determinations of 1##5##3##(2008-10#5)
determinations of 2 and##2##4##(1997-7#1)(2008-10#1)
determinations of 2##5##3##(1997-7#1)(2008-10#4)
determinations of 5##3##3##(2008-10#3)
determinations of 60##2##3##(2008-10#1)(2010-4#1)
determinations of As(III)##2##3##(2008-10#2)
determinations of a##3##3##(2008-10#3)
determinations of cobalt(II) and hydrogen peroxide##2##6##(2008-10#2)
determinations of metal binding##2##4##(2010-11#2)
determinations of oxygen##2##3##(2008-10#1)(2008-11#1)
determinations of the##5##3##(1997-2#1)(2008-1#1)(2008-10#2)(2008-2#1)
determinations of trace##3##3##(2008-10#3)
determinations of##101##2##(1990-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#85)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#3)(2010-4#1)
determinations on##4##2##(2008-10#4)
determinations per h were##2##4##(2008-10#2)
determinations per h##3##3##(2008-10#3)
determinations per hour and##2##4##(2008-10#2)
determinations per hour##13##3##(2008-10#13)
determinations per##17##2##(2008-10#17)
determinations using##3##2##(2008-10#3)
determinations was##4##2##(2008-10#3)(2008-8#1)
determinations were carried out##2##4##(1990-5#1)(2008-10#1)
determinations were performed##2##3##(2008-10#2)
determinations were##15##2##(1990-5#1)(2008-10#13)(2008-5#1)
determinations with##3##2##(2008-10#3)
determinations##270##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#2)(2008-1#3)(2008-10#217)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#4)(2009-8#1)(2010-11#3)(2010-4#1)(2011-2#2)
determinations)##3##1##(2008-10#2)(2008-5#1)
determine BPA##2##2##(2008-10#1)(2009-8#1)
determine a##18##2##(1993-12#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#2)
determine all the##4##3##(1993-11#1)(2008-10#2)(2008-3#1)
determine all##5##2##(1993-11#1)(2008-10#2)(2008-3#2)
determine and##6##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)
determine changes in the##2##4##(1993-12#1)(2008-3#1)
determine changes in##5##3##(1991-2#1)(1993-12#1)(2008-10#1)(2008-3#2)
determine cysteine##2##2##(2008-10#2)
determine dopamine##2##2##(2008-10#2)
determine how these##3##3##(1990-5#1)(2008-10#1)(2013-1#1)
determine how to##4##3##(1991-12#2)(2008-10#1)(2012-2#1)
determine how##45##2##(1990-3#1)(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-7#1)(1993-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-12#3)(2008-10#10)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
determine if a##8##3##(1992-3#1)(1996-6#1)(1997-3#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals##2##24##(2008-11#2)
determine if the##30##3##(1990-2#1)(1990-8#1)(1991-2#2)(1992-2#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
determine if there is##3##4##(2010-1#1)(2012-12#1)(2012-3#1)
determine if there##6##3##(1994-12#1)(2008-10#2)(2010-1#1)(2012-12#1)(2012-3#1)
determine if this##6##3##(1992-12#1)(1994-8#1)(1997-2#1)(2008-10#1)(2009-9#1)(2012-7#1)
determine if##129##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#2)(1994-2#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#3)(1997-5#1)(2007-11#2)(2007-12#1)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
determine in##5##2##(2007-5#1)(2008-4#2)(2009-8#1)(2011-1#1)
determine inheritance##2##2##(2008-10#2)
determine insensitivity##2##2##(2008-10#2)
determine it##2##2##(1990-8#1)(2008-10#1)
determine its effect on##4##4##(1993-6#1)(1995-3#1)(2008-10#1)(2013-7#1)
determine its##15##2##(1993-6#1)(1994-11#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-3#1)(2011-1#1)(2012-3#2)(2013-7#1)
determine levels of##3##3##(1997-4#1)(2008-10#1)(2013-1#1)
determine numerically##2##2##(2008-3#1)(2010-2#1)
determine optical##2##2##(2008-3#2)
determine optimal##4##2##(1997-7#1)(2008-11#1)(2008-12#1)(2008-5#1)
determine potential##4##2##(1997-4#1)(2007-5#1)(2008-10#2)
determine prevalence of##2##3##(2008-3#1)(2013-8#1)
determine primary##2##2##(2007-7#1)(2008-7#1)
determine quantitatively the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
determine resistance##2##2##(2008-12#1)(2011-2#1)
determine risk##2##2##(2009-10#1)(2012-2#1)
determine stroke##2##2##(2007-10#2)
determine that the##5##3##(1992-12#1)(1994-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
determine that##8##2##(1992-12#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
determine the ability of##5##4##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
determine the accuracy of the##2##5##(2007-5#1)(2012-2#1)
determine the accuracy of##5##4##(1990-9#1)(1994-3#1)(2007-5#1)(2012-1#1)(2012-2#1)
determine the active##3##3##(1995-2#1)(2008-10#2)
determine the amount of##6##4##(2008-10#6)
determine the apparent##4##3##(2008-10#4)
determine the appropriate##8##3##(1993-2#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-5#2)(2011-2#1)
determine the association of##2##4##(2008-1#1)(2012-3#1)
determine the association##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
determine the average##2##3##(2008-2#1)(2009-7#1)
determine the cellular##3##3##(1994-10#1)(1995-11#1)(2008-10#1)
determine the changes in##4##4##(2008-3#2)(2011-1#1)(2012-2#1)
determine the changes##5##3##(2008-3#2)(2008-7#1)(2011-1#1)(2012-2#1)
determine the chromosomal##3##3##(2008-10#2)(2008-4#1)
determine the clinical##2##3##(2007-10#1)(2008-7#1)
determine the complex##2##3##(2008-3#2)
determine the concentration of free##2##5##(2008-10#1)(2008-2#1)
determine the concentration of##13##4##(1991-12#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-9#1)
determine the concentration##14##3##(1991-12#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)
determine the concentrations of##3##4##(2008-10#2)(2008-3#1)
determine the content of##5##4##(2008-10#4)(2008-2#1)
determine the content##6##3##(1996-1#1)(2008-10#4)(2008-2#1)
determine the contribution of##5##4##(1992-1#1)(2008-3#2)(2008-8#1)(2009-10#1)
determine the correlation between##3##4##(2008-1#1)(2013-8#2)
determine the correlation##4##3##(1992-3#1)(2008-1#1)(2013-8#2)
determine the degree of##6##4##(1996-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)
determine the degree##7##3##(1996-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)
determine the development of##2##4##(2011-2#1)(2013-1#1)
determine the distribution of##3##4##(1995-9#1)(2008-10#1)(2011-2#1)
determine the effect of different##4##5##(1996-2#1)(2008-12#2)(2013-1#1)
determine the effect of mismatches on##2##6##(1995-12#2)
determine the effect of the##3##5##(1997-1#1)(2008-8#1)(2013-1#1)
determine the effect of##37##4##(1990-5#1)(1991-8#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-2#2)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#7)(2008-8#2)(2009-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)
determine the effect##40##3##(1990-5#1)(1991-8#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-12#7)(2008-8#2)(2009-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)
determine the effectiveness of##5##4##(1990-10#1)(1990-6#1)(1996-3#1)(2012-12#1)(2012-3#1)
determine the effectiveness##6##3##(1990-10#1)(1990-6#1)(1996-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
determine the effects of##34##4##(1990-5#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
determine the efficacy of##5##4##(1994-3#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
determine the efficacy##6##3##(1994-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
determine the efficiency of##3##4##(2008-10#1)(2008-2#1)(2010-7#1)
determine the equilibrium##2##3##(1992-6#1)(2008-2#1)
determine the evolution of##2##4##(2007-10#1)(2008-8#1)
determine the exact##5##3##(1994-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2009-9#1)
determine the extent of##5##4##(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
determine the extent##9##3##(1992-6#1)(1996-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-12#1)
determine the feasibility of##2##4##(2007-8#1)(2010-10#1)
determine the feasibility##4##3##(2007-8#1)(2008-6#1)(2010-10#1)(2011-2#1)
determine the four##2##3##(2007-11#1)(2010-11#1)
determine the frequency of##8##4##(1991-11#1)(1995-1#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)
determine the genetic structure of##3##5##(2008-10#3)
determine the genetic##8##3##(2008-10#7)(2011-1#1)
determine the genotypes##2##3##(2008-12#1)(2008-4#1)
determine the identity and##3##4##(2008-10#1)(2012-2#2)
determine the identity##4##3##(1992-9#1)(2008-10#1)(2012-2#2)
determine the impact of##7##4##(1993-2#1)(1994-3#1)(1995-1#1)(2008-9#1)(2011-2#2)(2013-1#1)
determine the impact##9##3##(1993-2#1)(1994-3#1)(1995-1#1)(1996-7#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
determine the importance of##4##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
determine the incidence and##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
determine the incidence of##7##4##(1991-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
determine the incidence##10##3##(1991-11#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
determine the influence of##15##4##(1996-5#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#4)
determine the kinetic parameters for##2##5##(1994-5#1)(2013-1#1)
determine the kinetic parameters##3##4##(1994-5#1)(2008-10#1)(2013-1#1)
determine the knowledge and##2##4##(2009-10#1)(2009-5#1)
determine the level of##9##4##(1990-8#1)(1993-3#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-8#1)
determine the location##2##3##(2008-10#1)(2010-12#1)
determine the locations of##2##4##(1990-9#1)(2008-11#1)
determine the long-term##4##3##(1996-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
determine the magnitude of##3##4##(1997-3#1)(2007-11#1)(2008-8#1)
determine the magnitude##4##3##(1997-3#1)(2007-11#1)(2008-8#1)(2010-8#1)
determine the maximum##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
determine the mechanism by which##3##5##(2008-6#1)(2011-1#1)(2013-1#1)
determine the mechanism of##5##4##(1991-9#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-5#1)
determine the mechanism##8##3##(1991-9#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
determine the molecular##2##3##(2008-10#1)(2008-11#1)
determine the optical properties of the##2##6##(2007-12#1)(2008-3#1)
determine the optical properties of##5##5##(2007-12#1)(2008-2#1)(2008-3#3)
determine the optical##8##3##(2007-12#1)(2008-2#3)(2008-3#4)
determine the optimal##9##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2011-2#1)(2012-3#1)
determine the optimum##9##3##(1994-3#1)(2008-10#5)(2008-12#2)(2008-3#1)
determine the origin of##2##4##(1992-12#1)(2012-3#1)
determine the outcome of##2##4##(2008-8#1)(2011-1#1)
determine the overall##6##3##(2008-10#4)(2008-12#1)(2009-5#1)
determine the parameters##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
determine the phase##3##3##(1990-6#1)(2008-3#1)(2012-2#1)
determine the plasma##2##3##(2008-3#1)(2011-2#1)
determine the possible##5##3##(1994-3#1)(1997-4#1)(2008-4#2)(2011-2#1)
determine the potential##3##3##(1994-5#1)(2008-7#1)(2013-8#1)
determine the prevalence and##3##4##(2011-1#3)
determine the prevalence of##26##4##(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
determine the prevalence##31##3##(1996-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
determine the range of##3##4##(2007-8#1)(2008-7#1)(2012-2#1)
determine the rate of##4##4##(1991-3#1)(1996-12#1)(2013-8#2)
determine the rate##7##3##(1991-3#1)(1996-12#1)(2008-10#2)(2013-1#1)(2013-8#2)
determine the regions##2##3##(1993-12#1)(1993-3#1)
determine the relationship between##11##4##(2008-10#4)(2008-12#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
determine the relationship##13##3##(2008-10#4)(2008-12#3)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
determine the relative##10##3##(1992-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)
determine the results##2##3##(2008-9#2)
determine the risk of transmission##2##5##(1992-6#2)
determine the risk of##3##4##(1992-6#2)(2011-2#1)
determine the risk##4##3##(1992-6#2)(2011-1#1)(2011-2#1)
determine the role of##9##4##(1994-11#1)(1994-8#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2013-1#1)
determine the role##13##3##(1993-1#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2013-1#1)
determine the sensitivity of##3##4##(1997-4#1)(2008-10#1)(2012-6#1)
determine the sensitivity##4##3##(1993-3#1)(1997-4#1)(2008-10#1)(2012-6#1)
determine the size of##2##4##(1997-2#1)(2013-1#1)
determine the size##4##3##(1995-2#1)(1997-2#1)(2008-3#1)(2013-1#1)
determine the specific##3##3##(1992-9#1)(1995-5#1)(2011-1#1)
determine the spectral##2##3##(2008-10#2)
determine the structural##3##3##(1993-2#1)(1995-2#1)(2008-9#1)
determine the success of##2##4##(2012-3#1)(2013-8#1)
determine the susceptibility to##2##4##(1997-8#1)(2013-8#1)
determine the susceptibility##3##3##(1997-8#1)(2012-12#1)(2013-8#1)
determine the temperature##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
determine the time of##3##4##(1994-2#1)(1995-6#1)(2008-11#1)
determine the time##5##3##(1994-2#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-6#1)
determine the true##2##3##(2008-3#1)(2012-3#1)
determine the types of##2##4##(1995-3#1)(1997-5#1)
determine the values of##2##4##(2008-10#1)(2008-12#1)
determine the##998##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#7)(1993-3#7)(1993-8#3)(1994-1#3)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#6)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#7)(1995-12#6)(1995-2#9)(1995-3#6)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#8)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#5)(2007-11#8)(2007-12#13)(2007-2#2)(2007-5#3)(2007-7#5)(2007-8#4)(2008-1#13)(2008-10#219)(2008-11#21)(2008-12#30)(2008-2#49)(2008-3#73)(2008-4#21)(2008-5#24)(2008-6#13)(2008-7#20)(2008-8#22)(2008-9#21)(2009-10#6)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#12)(2010-9#1)(2011-1#20)(2011-2#33)(2012-1#3)(2012-12#12)(2012-2#21)(2012-3#17)(2012-6#1)(2013-1#41)(2013-3#1)(2013-7#2)(2013-8#20)
determine their##40##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1994-1#1)(1995-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
determine these metal ions##2##4##(2008-10#2)
determine these##7##2##(2008-10#4)(2008-2#1)(2008-7#1)(2012-2#1)
determine this##5##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
determine to what extent##3##4##(1997-8#1)(2008-10#1)(2011-1#1)
determine total##7##2##(1994-2#1)(2007-2#1)(2008-10#4)(2009-4#1)
determine trace elements##2##3##(2008-10#2)
determine trace##7##2##(2008-10#7)
determine treatment##2##2##(2008-4#1)(2013-1#1)
determine trends##2##2##(1994-12#1)(2012-2#1)
determine unambiguously##2##2##(1995-12#1)(2008-4#1)
determine what to##2##3##(1997-1#1)(2010-5#1)
determine what##16##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-12#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
determine when##6##2##(1992-12#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-8#1)
determine whether Bcl-2 antagonists##2##4##(2009-12#2)
determine whether a##11##3##(1996-12#1)(1996-5#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
determine whether any##3##3##(1991-8#1)(1993-11#1)(2010-3#1)
determine whether the##40##3##(1990-5#1)(1990-8#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-9#1)(2011-2#2)(2013-8#1)
determine whether there are differences##2##5##(2010-7#1)(2013-1#1)
determine whether there are##3##4##(2008-7#1)(2010-7#1)(2013-1#1)
determine whether there##7##3##(1995-12#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-12#1)(2010-7#1)(2013-1#1)
determine whether they##5##3##(2007-12#1)(2007-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
determine whether this##8##3##(1991-12#1)(1991-8#1)(1993-11#1)(1995-11#1)(1995-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
determine whether##218##2##(1990-10#1)(1990-11#1)(1990-5#5)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#11)(2013-8#3)
determine which of##3##3##(1994-3#1)(1995-5#1)(1996-1#1)
determine which##33##2##(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-5#2)(1996-1#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
determine who##2##2##(1997-3#1)(2012-12#1)
determine why##2##2##(1994-5#1)(2008-10#1)
determine with##5##2##(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)
determine##2109##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#12)(1990-6#3)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#9)(1991-2#8)(1991-3#6)(1991-5#4)(1991-6#1)(1991-8#5)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#8)(1992-12#11)(1992-2#5)(1992-3#6)(1992-5#2)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#3)(1993-11#10)(1993-12#11)(1993-2#12)(1993-3#9)(1993-5#1)(1993-6#6)(1993-8#8)(1993-9#6)(1994-1#6)(1994-10#3)(1994-11#9)(1994-12#10)(1994-2#10)(1994-3#11)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#11)(1995-12#11)(1995-2#14)(1995-3#11)(1995-5#9)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#6)(1996-12#13)(1996-2#7)(1996-3#6)(1996-4#3)(1996-5#6)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#5)(1997-2#8)(1997-3#9)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#7)(2006-10#2)(2006-12#1)(2006-4#2)(2007-10#19)(2007-11#22)(2007-12#30)(2007-2#4)(2007-5#11)(2007-7#11)(2007-8#7)(2007-9#2)(2008-1#22)(2008-10#566)(2008-11#53)(2008-12#42)(2008-2#67)(2008-3#112)(2008-4#44)(2008-5#51)(2008-6#19)(2008-7#46)(2008-8#38)(2008-9#37)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#8)(2009-2#1)(2009-3#1)(2009-4#10)(2009-5#8)(2009-6#1)(2009-7#9)(2009-8#8)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#7)(2010-12#7)(2010-2#5)(2010-3#10)(2010-4#10)(2010-5#7)(2010-6#8)(2010-7#4)(2010-8#20)(2010-9#2)(2011-1#35)(2011-2#70)(2012-1#5)(2012-12#20)(2012-2#42)(2012-3#29)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#75)(2013-3#1)(2013-7#9)(2013-8#30)
determined 'off line'##2##3##(2008-10#2)
determined N-terminal##2##2##(1994-12#1)(1997-7#1)
determined a##7##2##(1990-3#1)(1993-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-2#1)
determined according to a##2##4##(1997-6#1)(2008-10#1)
determined according to the##6##4##(1997-8#1)(2008-10#2)(2008-5#2)(2009-7#1)
determined according to##12##3##(1997-6#1)(1997-8#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-7#1)(2013-7#1)
determined across##2##2##(2008-10#2)
determined after a##2##3##(2008-10#2)
determined after incubation##2##3##(1990-8#1)(2013-8#1)
determined after##15##2##(1990-2#1)(1990-8#1)(1995-6#1)(2008-10#11)(2013-8#1)
determined also##2##2##(2008-10#2)
determined analytically##3##2##(2008-2#1)(2008-3#2)
determined and analysed##2##3##(1996-3#1)(2008-8#1)
determined and analyzed##6##3##(1994-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)
determined and are##3##3##(1995-11#1)(2008-8#1)(2009-9#1)
determined and compared with those of##3##6##(1997-6#1)(2008-10#1)(2011-2#1)
determined and compared with those##5##5##(1990-9#1)(1997-6#1)(2008-10#2)(2011-2#1)
determined and compared with##6##4##(1990-9#1)(1997-6#1)(2008-10#3)(2011-2#1)
determined and compared##13##3##(1990-9#1)(1991-12#1)(1994-12#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2011-2#1)
determined and its##3##3##(1992-8#1)(2008-10#1)(2009-5#1)
determined and the##10##3##(1990-2#1)(1990-7#1)(1991-7#1)(2008-10#5)(2008-5#1)(2010-8#1)
determined and their##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
determined and will be##2##4##(2008-10#1)(2008-8#1)
determined and##79##2##(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-8#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)
determined as a function of the##5##6##(1991-11#1)(1991-9#1)(1994-12#1)(2008-3#1)(2008-5#1)
determined as a function of##10##5##(1990-8#1)(1991-11#1)(1991-9#1)(1994-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)
determined as a##12##3##(1990-8#1)(1991-11#1)(1991-9#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)
determined as the ratio##2##4##(1996-1#1)(2008-10#1)
determined as the##5##3##(1992-12#1)(1996-1#1)(2008-10#2)(2009-8#1)
determined as##53##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(2008-10#23)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-7#1)
determined at 1##2##3##(1991-3#1)(2008-3#1)
determined at 2##8##3##(1993-8#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-8#1)
determined at 25 degrees C and##2##6##(2008-10#2)
determined at 25 degrees C by##2##6##(2008-10#2)
determined at 25 degrees C##9##5##(2008-10#9)
determined at different##4##3##(1997-4#1)(2008-10#3)
determined at high##2##3##(2008-2#1)(2008-4#1)
determined at room temperature##2##4##(1990-3#1)(2008-2#1)
determined at the##3##3##(2008-10#2)(2008-7#1)
determined at##55##2##(1990-3#1)(1990-6#2)(1991-3#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-8#2)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-4#1)
determined based on the##4##4##(2008-10#3)(2013-8#1)
determined based on triple-resonance experiments with##2##6##(2009-7#2)
determined based on##12##3##(2008-10#8)(2009-3#1)(2009-7#2)(2013-8#1)
determined before and after##2##4##(2008-1#1)(2008-12#1)
determined before and##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
determined before##7##2##(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#1)(2012-12#1)
determined between##5##2##(2008-10#2)(2008-12#2)(2008-5#1)
determined blood##2##2##(2008-9#1)(2011-1#1)
determined but##2##2##(1995-9#1)(2012-3#1)
determined by 1H##2##3##(1991-11#1)(1992-3#1)
determined by AAS##2##3##(2008-10#2)
determined by DNA##2##3##(1995-4#1)(2008-10#1)
determined by FAAS##3##3##(2008-10#3)
determined by HPLC##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
determined by ICP-AES##2##3##(2008-10#2)
determined by ICP-MS##2##3##(2008-10#2)
determined by NMR##2##3##(1991-5#1)(2006-12#1)
determined by Northern##2##3##(1993-3#1)(2008-6#1)
determined by PCR##2##3##(1997-4#1)(2012-12#1)
determined by RIA##2##3##(2008-7#1)(2008-9#1)
determined by RP-HPLC##2##3##(2008-10#1)(2012-2#1)
determined by RT-PCR##2##3##(2008-12#1)(2013-1#1)
determined by S1##2##3##(1991-9#1)(1994-11#1)
determined by SDS-PAGE##5##3##(1990-5#1)(1994-9#1)(1995-11#1)(1997-4#1)(2008-11#1)
determined by TCA and by##2##5##(2008-10#2)
determined by X-ray crystallography##4##4##(1992-4#1)(1992-8#1)(1997-7#1)(2008-10#1)
determined by X-ray diffraction##2##4##(1996-2#2)
determined by X-ray##7##3##(1992-4#1)(1992-8#1)(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#1)
determined by a combination of##2##5##(2008-10#1)(2008-3#1)
determined by a##45##3##(1990-2#1)(1990-5#1)(1990-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)
determined by adding##2##3##(1993-12#1)(2008-10#1)
determined by agarose gel electrophoresis##2##5##(1993-8#1)(2013-1#1)
determined by amino acid analysis##2##5##(1992-6#1)(1995-3#1)
determined by an##9##3##(1993-9#1)(1996-7#1)(1997-7#1)(2008-10#4)(2008-5#2)
determined by analysis of the##2##5##(1992-8#1)(2012-12#1)
determined by analysis of##4##4##(1992-8#1)(2008-10#1)(2008-9#1)(2012-12#1)
determined by analyzing##4##3##(1996-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
determined by anodic stripping##2##4##(2008-10#2)
determined by anodic##3##3##(2008-10#3)
determined by applying##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
determined by atomic absorption##7##4##(1994-11#1)(1997-4#1)(2008-10#5)
determined by atomic##8##3##(1994-11#1)(1997-4#1)(2008-10#6)
determined by automated Edman degradation##3##5##(1991-12#1)(1992-3#1)(1994-11#1)
determined by both the##2##4##(1993-11#1)(2008-10#1)
determined by both##8##3##(1990-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-2#1)(2008-10#3)
determined by capillary##4##3##(1994-9#1)(2008-10#3)
determined by chemical##3##3##(1993-8#1)(2010-4#1)(2013-1#1)
determined by circular dichroism##3##4##(1990-5#1)(1992-6#1)(1993-11#1)
determined by clinical##2##3##(2007-10#1)(2007-12#1)
determined by comparison of##2##4##(2008-2#1)(2008-3#1)
determined by comparison##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
determined by computer simulations##2##4##(2008-2#2)
determined by counting##3##3##(1990-3#1)(1996-12#1)(2008-6#1)
determined by densitometry##2##3##(1990-6#1)(1996-9#1)
determined by differential pulse polarography##3##5##(2008-10#3)
determined by differential##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
determined by direct##8##3##(1994-12#1)(1997-2#1)(2008-10#5)(2008-3#1)
determined by electrothermal atomic absorption spectrometry (ETAAS)##4##7##(2008-10#4)
determined by electrothermal atomic absorption spectrometry##7##6##(2008-10#7)
determined by enzymatic##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
determined by enzyme-linked immunosorbent assay##3##5##(1990-5#1)(2008-10#1)(2010-4#1)
determined by external##2##3##(1996-1#1)(2008-10#1)
determined by fitting the data##2##5##(1990-8#1)(2010-4#1)
determined by fitting the##3##4##(1990-8#1)(2008-10#1)(2010-4#1)
determined by flame atomic absorption spectrometry (FAAS)##6##7##(2008-10#6)
determined by flame atomic absorption spectrometry##8##6##(2008-10#8)
determined by flame atomic absorption##11##5##(2008-10#11)
determined by flame atomic##12##4##(2008-10#12)
determined by flame##13##3##(2008-10#13)
determined by flow##3##3##(2008-10#2)(2008-9#1)
determined by fluorescence##2##3##(1997-8#1)(2008-10#1)
determined by gas chromatography##6##4##(1993-12#1)(1997-6#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
determined by gas chromatography-mass spectrometry##3##5##(1990-8#1)(1992-3#1)(1992-5#1)
determined by gas##10##3##(1990-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1997-6#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
determined by graphite furnace atomic absorption spectrometry (GFAAS)##3##8##(2008-10#3)
determined by graphite furnace atomic absorption spectrometry##6##7##(1995-6#1)(2008-10#5)
determined by graphite furnace##7##4##(1992-3#1)(1995-6#1)(2008-10#5)
determined by high performance liquid chromatography##2##6##(2008-10#1)(2013-1#1)
determined by high##3##3##(2008-10#2)(2013-1#1)
determined by high-performance liquid chromatography (HPLC)##3##6##(1996-2#1)(1997-2#1)(2008-10#1)
determined by high-resolution##2##3##(1994-5#1)(2008-10#1)
determined by hydride##2##3##(2008-10#2)
determined by in vitro##2##4##(1995-6#1)(2008-7#1)
determined by in##3##3##(1995-6#1)(1997-6#1)(2008-7#1)
determined by inductively coupled plasma atomic emission spectrometry##2##8##(2008-10#2)
determined by inductively coupled plasma##6##5##(2008-10#4)(2013-8#2)
determined by inductively coupled plasma-atomic emission##2##6##(1995-2#1)(2008-10#1)
determined by inductively coupled##9##4##(1995-2#1)(2008-10#6)(2013-8#2)
determined by inductively##10##3##(1995-2#1)(2008-10#7)(2013-8#2)
determined by isocratic##2##3##(1991-5#1)(2009-8#1)
determined by its##2##3##(2008-4#1)(2008-5#1)
determined by local##2##3##(2008-3#1)(2010-6#1)
determined by mass spectrometry##3##4##(1991-2#1)(1993-8#1)(2008-4#1)
determined by mass##4##3##(1991-2#1)(1993-8#2)(2008-4#1)
determined by matrix-assisted laser desorption/ionization time of flight mass spectrometry##2##10##(2008-11#2)
determined by matrix-assisted laser desorption/ionization##4##5##(2008-11#4)
determined by matrix-assisted##5##3##(2008-11#5)
determined by means of the##2##5##(2008-3#1)(2008-8#1)
determined by means of##12##4##(2008-10#3)(2008-3#3)(2008-5#1)(2008-8#2)(2012-1#1)(2012-2#1)(2013-1#1)
determined by measuring the##11##4##(1990-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)
determined by measuring##17##3##(1990-12#1)(1990-7#1)(1990-8#2)(1992-3#1)(1993-3#1)(1994-3#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)
determined by monitoring##2##3##(2008-11#1)(2008-4#1)
determined by nuclear magnetic resonance##2##5##(1994-5#1)(2008-10#1)
determined by one root##2##4##(2008-3#2)
determined by polymerase chain reaction##2##5##(1990-12#1)(2010-6#1)
determined by protein##2##3##(1994-8#1)(1995-6#1)
determined by sequencing##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
determined by single##2##3##(2007-11#1)(2008-10#1)
determined by size exclusion chromatography##2##5##(2008-10#1)(2011-2#1)
determined by sodium dodecyl sulfate gel electrophoresis##2##7##(1990-7#1)(2008-10#1)
determined by sodium dodecyl sulfate##3##5##(1990-7#1)(2008-10#1)(2008-11#1)
determined by sodium dodecyl##7##4##(1990-7#1)(2008-10#5)(2008-11#1)
determined by sodium##8##3##(1990-7#1)(1991-5#1)(2008-10#5)(2008-11#1)
determined by solution calorimetry in##2##5##(2008-10#2)
determined by solution##3##3##(1995-8#1)(2008-10#2)
determined by spectrophotometry##3##3##(2008-10#3)
determined by spiking##2##3##(2008-10#2)
determined by standard##3##3##(1994-5#1)(2008-10#2)
determined by studying the##2##4##(1997-6#1)(2008-10#1)
determined by the HPLC method##2##5##(1990-8#1)(2009-8#1)
determined by the HPLC##3##4##(1990-8#2)(2009-8#1)
determined by the Kjedahl method##2##5##(1997-4#2)
determined by the difference##2##4##(2008-10#1)(2008-8#1)
determined by the distribution##2##4##(1991-5#1)(2008-10#1)
determined by the first##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
determined by the interaction##2##4##(2008-8#2)
determined by the matched potential method (MPM)##2##7##(2008-10#2)
determined by the measurement of##2##5##(2008-10#1)(2008-3#1)
determined by the method of##2##5##(1992-6#1)(2011-2#1)
determined by the method##5##4##(1992-6#1)(2008-10#2)(2011-2#1)(2012-12#1)
determined by the peak##2##4##(1990-8#1)(2008-2#1)
determined by the phase##2##4##(2008-2#2)
determined by the presence##2##4##(1994-8#1)(1995-11#1)
determined by the proposed method##3##5##(2008-10#3)
determined by the proposed##4##4##(2008-10#4)
determined by the quality of##2##5##(2010-5#1)(2013-1#1)
determined by the spectrophotometric method##3##5##(2008-10#2)(2013-8#1)
determined by the underlying##2##4##(2007-12#1)(2008-1#1)
determined by the use of##2##5##(1992-12#1)(2008-10#1)
determined by the##181##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#6)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#3)(1995-11#3)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#3)(2007-10#2)(2007-11#4)(2007-12#8)(2008-1#2)(2008-10#54)(2008-11#2)(2008-2#7)(2008-3#16)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#5)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
determined by their##6##3##(1990-7#1)(1992-9#1)(1995-8#1)(2008-7#1)(2008-8#1)(2009-7#1)
determined by thermal##2##3##(1992-3#1)(2008-10#1)
determined by this method##3##4##(2008-10#3)
determined by this technique##2##4##(2008-10#2)
determined by this##6##3##(2008-10#6)
determined by two##2##3##(2008-3#2)
determined by use of a##3##5##(2007-11#1)(2008-3#2)
determined by use of##9##4##(1991-8#1)(2007-11#1)(2008-3#6)(2013-1#1)
determined by using the##6##4##(1991-9#1)(2008-10#4)(2010-11#1)
determined by using##18##3##(1991-9#1)(2006-4#1)(2008-10#12)(2008-2#1)(2008-9#1)(2010-11#1)(2011-1#1)
determined by various##2##3##(1993-12#1)(2010-12#1)
determined by##891##2##(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#7)(1990-6#1)(1990-7#8)(1990-8#18)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#5)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#4)(1993-3#6)(1993-6#5)(1993-8#4)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#4)(1994-7#1)(1994-8#7)(1994-9#2)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#5)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#9)(1997-6#6)(1997-7#4)(1997-8#2)(2006-12#2)(2006-4#2)(2007-10#5)(2007-11#11)(2007-12#13)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#324)(2008-11#20)(2008-12#4)(2008-2#19)(2008-3#47)(2008-4#10)(2008-5#23)(2008-6#9)(2008-7#11)(2008-8#25)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-5#4)(2009-7#2)(2009-8#8)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#4)(2010-4#11)(2010-5#2)(2010-6#5)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#14)(2013-7#3)(2013-8#6)
determined directly from the##2##4##(2008-10#1)(2008-11#1)
determined directly from##3##3##(2008-10#1)(2008-11#2)
determined directly in##4##3##(2008-10#4)
determined directly##14##2##(1995-2#1)(2008-10#11)(2008-11#2)
determined disease##3##2##(2008-10#2)(2012-3#1)
determined during a##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
determined during the##2##3##(1995-6#1)(2008-3#1)
determined during##7##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)
determined either by##3##3##(1992-6#1)(2008-6#1)(2012-3#1)
determined every##3##2##(2008-12#1)(2008-5#2)
determined exclusively by##2##3##(2008-10#2)
determined experimentally for the##2##4##(1994-8#1)(2008-7#1)
determined experimentally##4##2##(1994-8#1)(2008-3#1)(2008-7#1)(2013-1#1)
determined fluorimetrically by##2##3##(1990-8#1)(2008-10#1)
determined fluorimetrically##3##2##(1990-8#1)(2008-10#2)
determined following##3##2##(2008-11#1)(2008-5#1)(2009-11#1)
determined for a##2##3##(1995-1#1)(2008-3#1)
determined for all##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)
determined for another##2##3##(1990-7#1)(2008-10#1)
determined for both##4##3##(2008-10#1)(2008-12#1)(2010-1#1)(2012-12#1)
determined for each##13##3##(1992-12#1)(1993-12#1)(2007-8#1)(2008-10#7)(2011-2#1)(2012-12#1)(2012-3#1)
determined for seven##2##3##(1994-9#1)(2008-10#1)
determined for the first time##2##5##(1990-5#1)(2008-3#1)
determined for the##17##3##(1990-5#2)(1992-9#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)
determined for##87##2##(1990-5#2)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#25)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
determined from a##4##3##(1993-12#1)(2008-3#3)
determined from an##2##3##(2008-10#1)(2008-3#1)
determined from cDNA clones##2##4##(2008-10#2)
determined from each of##2##4##(2008-10#2)
determined from lordosis angles##2##4##(2012-1#2)
determined from the measured##3##4##(2007-11#2)(2008-3#1)
determined from the##39##3##(1990-11#1)(1990-7#1)(1991-11#1)(1995-2#1)(1996-5#1)(1997-2#2)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#9)(2009-8#1)(2009-9#1)(2011-2#2)
determined from their##2##3##(2008-10#2)
determined from these##2##3##(2008-3#1)(2008-5#1)
determined from##105##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#1)(2008-10#37)(2008-11#1)(2008-2#7)(2008-3#19)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)
determined if the##2##3##(2007-12#1)(2013-1#1)
determined if##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
determined in 0##2##3##(2008-10#1)(2008-7#1)
determined in Australia##2##3##(2007-11#1)(2008-10#1)
determined in a single##3##4##(1990-8#1)(2008-10#2)
determined in a##14##3##(1990-8#1)(1992-5#1)(1994-9#1)(2007-10#1)(2008-10#8)(2008-3#1)(2012-12#1)
determined in adult rats##2##4##(1992-12#1)(1994-2#1)
determined in all##4##3##(1995-3#1)(1997-7#1)(2008-10#2)
determined in an##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
determined in aqueous##4##3##(2008-10#4)
determined in batch##2##3##(1994-5#1)(2008-10#1)
determined in different ionic media##2##5##(2008-10#2)
determined in different##5##3##(2008-10#4)(2013-1#1)
determined in each##2##3##(1991-12#1)(1997-3#1)
determined in four##2##3##(2008-10#1)(2013-3#1)
determined in human##3##3##(1996-5#1)(2008-10#2)
determined in large##2##3##(2008-1#1)(2008-10#1)
determined in one##2##3##(1993-6#1)(2008-10#1)
determined in order to##6##4##(2008-10#2)(2008-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
determined in pharmaceutical##2##3##(2008-10#2)
determined in relation to the##2##5##(1992-3#1)(1996-3#1)
determined in relation to##3##4##(1992-3#1)(1992-6#1)(1996-3#1)
determined in river##2##3##(2008-10#2)
determined in samples##4##3##(1991-2#1)(1992-3#1)(2008-10#1)(2008-12#1)
determined in serum##4##3##(1995-3#1)(2008-10#2)(2008-7#1)
determined in six##2##3##(1992-3#1)(2008-10#1)
determined in solutions##2##3##(2008-10#2)
determined in spiked##2##3##(2008-10#2)
determined in standard and environmental samples##2##6##(2008-10#2)
determined in standard and##3##4##(2008-10#3)
determined in standard##4##3##(2008-10#4)
determined in the concentration range of##2##6##(2008-10#2)
determined in the concentration range##4##5##(2008-10#4)
determined in the concentration##5##4##(2008-10#5)
determined in the field##2##4##(2008-10#2)
determined in the linear range##2##5##(2008-10#2)
determined in the presence of##10##5##(1994-5#1)(1995-12#1)(2008-10#8)
determined in the range from##2##5##(2007-11#1)(2008-10#1)
determined in the range of 0##4##6##(2008-10#4)
determined in the range of##5##5##(2008-10#4)(2008-11#1)
determined in the range##10##4##(2007-11#1)(2008-10#8)(2008-11#1)
determined in the same##2##4##(1994-11#1)(2008-10#1)
determined in the##60##3##(1990-11#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#36)(2008-11#2)(2008-3#5)(2008-5#2)(2008-7#2)(2009-8#1)(2011-2#1)
determined in this##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
determined in urine##2##3##(1995-2#1)(2008-10#1)
determined in vitro##2##3##(1991-12#1)(2008-10#1)
determined in vivo##3##3##(1990-6#1)(2006-6#1)(2008-5#1)
determined in water##3##3##(2008-10#3)
determined in whole##2##3##(1991-3#1)(2009-4#1)
determined in##269##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#130)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-4#1)(2013-1#2)(2013-3#1)
determined independently##5##2##(2008-10#2)(2008-3#2)(2011-2#1)
determined its##4##2##(1993-3#1)(1994-11#1)(1996-7#1)(1997-7#1)
determined mainly by##4##3##(1995-8#1)(2008-10#3)
determined measuring the absorbance at##3##5##(2008-10#3)
determined more by##2##3##(2009-6#1)(2009-8#1)
determined not##2##2##(2008-8#1)(2012-3#1)
determined nucleotide sequences of the##2##5##(1997-7#1)(2008-6#1)
determined number of##2##3##(1994-11#1)(2009-5#1)
determined on a##4##3##(1996-5#2)(2008-10#2)
determined on the basis of##2##5##(2008-10#1)(2009-3#1)
determined on the##8##3##(1994-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)
determined on##23##2##(1990-6#1)(1992-10#1)(1994-12#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
determined on-line##2##2##(2008-10#2)
determined only by the##2##4##(1991-12#1)(2008-9#1)
determined only##5##2##(1990-12#1)(1991-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
determined over the##3##3##(2008-10#3)
determined over##10##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
determined potentiometrically##4##2##(2008-10#4)
determined previously##2##2##(2008-10#1)(2008-8#1)
determined primarily by##3##3##(2008-10#1)(2008-8#2)
determined satisfactorily##4##2##(2008-10#4)
determined separately##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
determined similarly##7##2##(2008-10#7)
determined simultaneously by##2##3##(2008-10#2)
determined simultaneously with##7##3##(2008-10#7)
determined simultaneously##17##2##(2008-10#15)(2008-3#2)
determined solely##3##2##(1993-2#1)(2008-2#1)(2008-3#1)
determined spectrophotometrically as##3##3##(2008-10#3)
determined spectrophotometrically at##3##3##(2008-10#3)
determined spectrophotometrically by the##2##4##(2008-10#2)
determined spectrophotometrically by##3##3##(2008-10#3)
determined spectrophotometrically using##3##3##(2008-10#2)(2012-2#1)
determined spectrophotometrically##15##2##(1992-3#1)(2008-10#13)(2012-2#1)
determined structure##2##2##(2008-4#1)(2008-8#1)
determined successfully##2##2##(2008-10#2)
determined that the##16##3##(1991-4#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#3)(2010-11#1)(2013-8#1)
determined that##49##2##(1990-11#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-10#10)(2008-2#1)(2008-3#6)(2008-5#1)(2008-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
determined the absolute##2##3##(2008-3#2)
determined the complete nucleotide sequence of a##2##7##(1995-9#1)(1997-4#1)
determined the complete nucleotide sequence of##3##6##(1994-12#1)(1995-9#1)(1997-4#1)
determined the complete nucleotide sequence##4##5##(1994-12#1)(1995-8#1)(1995-9#1)(1997-4#1)
determined the complete##6##3##(1993-2#1)(1994-12#1)(1995-8#1)(1995-9#1)(1997-4#1)(1997-6#1)
determined the concentrations of##2##4##(1993-1#1)(1993-12#1)
determined the critical##2##3##(1993-8#1)(2008-10#1)
determined the effect of##2##4##(1994-6#1)(2008-10#1)
determined the effects of##3##4##(1992-2#1)(2012-5#1)(2013-7#1)
determined the expression of##2##4##(2008-11#1)(2013-7#1)
determined the expression##4##3##(2008-11#1)(2010-12#1)(2013-7#1)(2013-8#1)
determined the nucleotide sequence of the##2##6##(1990-5#1)(1993-8#1)
determined the nucleotide sequence of##3##5##(1990-5#1)(1993-8#1)(1997-3#1)
determined the nucleotide sequences of##2##5##(1990-8#1)(1993-12#1)
determined the nucleotide##5##3##(1990-5#1)(1990-8#1)(1993-12#1)(1993-8#1)(1997-3#1)
determined the onset of##2##4##(2008-10#2)
determined the optimal##2##3##(2008-7#1)(2012-3#1)
determined the relative##3##3##(1991-12#1)(1994-8#1)(2008-10#1)
determined the##103##2##(1990-5#1)(1990-8#2)(1991-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-5#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#1)
determined their##7##2##(1991-12#1)(1991-9#1)(1993-6#1)(1995-5#1)(2007-10#2)(2008-10#1)
determined through a##3##3##(2008-10#1)(2008-3#2)
determined through##10##2##(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)
determined throughout##2##2##(1994-3#1)(2008-2#1)
determined to 2##2##3##(1995-5#1)(2010-10#1)
determined to be 0##12##4##(2008-10#7)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)
determined to be 1##2##4##(2008-10#1)(2008-11#1)
determined to be 15##2##4##(2008-10#1)(2008-6#1)
determined to be 4##3##4##(1995-2#1)(1997-8#1)(2008-10#1)
determined to be 5##2##4##(1997-2#1)(2008-10#1)
determined to be Pd(MQ)(2)##2##4##(2008-10#2)
determined to be approximately##2##4##(2008-10#1)(2008-2#1)
determined to be at##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2009-2#1)
determined to be##109##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1995-2#2)(1996-2#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#51)(2008-11#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-11#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
determined to contain##2##3##(2008-10#1)(2008-9#1)
determined to describe the##2##4##(1997-2#1)(2008-6#1)
determined to have##3##3##(1990-7#1)(1991-11#1)(2008-10#1)
determined to obtain a##2##4##(2008-4#2)
determined to##144##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#2)(1995-5#1)(1996-2#2)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#61)(2008-11#6)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-5#2)(2010-6#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
determined together with##3##3##(1992-12#1)(2008-10#2)
determined under controlled conditions##2##4##(2008-10#2)
determined under the same##2##4##(1992-11#1)(2008-10#1)
determined under the##3##3##(1992-11#1)(1994-1#1)(2008-10#1)
determined under##11##2##(1990-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-1#1)(2008-10#4)(2008-3#1)(2008-5#1)
determined uniquely by##2##3##(1992-4#1)(2008-3#1)
determined uniquely##3##2##(1992-4#1)(2007-11#1)(2008-3#1)
determined using a##12##3##(1991-2#1)(1992-5#1)(2007-6#1)(2008-10#5)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
determined using an##4##3##(1993-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
determined using flow##2##3##(1993-8#1)(2008-10#1)
determined using gas##2##3##(2008-10#1)(2011-1#1)
determined using inductively coupled##2##4##(2008-10#2)
determined using the samples collected by##2##6##(2008-10#2)
determined using the##21##3##(1992-2#1)(1994-11#1)(2008-10#15)(2008-12#1)(2008-9#1)(2013-1#1)(2013-7#1)
determined using this##3##3##(2008-10#3)
determined using two##2##3##(1991-8#1)(2008-3#1)
determined using##118##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#2)(1995-3#1)(2007-10#1)(2007-6#1)(2008-10#52)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
determined values##8##2##(2008-1#1)(2008-10#6)(2008-3#1)
determined via##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
determined was##3##2##(1991-2#1)(2008-10#2)
determined were##4##2##(1993-2#1)(2008-10#3)
determined when##2##2##(1992-3#1)(2008-3#1)
determined whether the##7##3##(1994-8#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)
determined whether this##3##3##(1995-8#1)(2006-10#1)(2010-8#1)
determined whether##20##2##(1992-9#1)(1993-3#1)(1994-8#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
determined which##6##2##(1991-2#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#2)
determined with a relative error##2##5##(2008-10#2)
determined with a relative##3##4##(2008-10#3)
determined with a##17##3##(1990-11#2)(2007-11#1)(2008-10#9)(2008-3#4)(2010-3#1)
determined with an##6##3##(1990-8#1)(1992-7#1)(2008-10#2)(2008-3#2)
determined with high accuracy##4##4##(2007-12#1)(2008-10#3)
determined with numerical##2##3##(2008-10#1)(2008-3#1)
determined with recovery##2##3##(2008-10#2)
determined with satisfactory results##5##4##(2008-10#5)
determined with satisfactory##6##3##(2008-10#6)
determined with the relative##2##4##(2008-10#2)
determined with the use of##2##5##(2008-10#2)
determined with the##13##3##(2008-10#8)(2008-3#2)(2008-8#1)(2009-8#1)(2013-8#1)
determined with this method##2##4##(2008-10#2)
determined with this##3##3##(1990-8#1)(2008-10#2)
determined with##95##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1992-12#1)(1992-7#1)(1993-8#1)(1996-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#52)(2008-11#2)(2008-2#4)(2008-3#13)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-8#1)
determined within##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
determined without##7##2##(1992-4#1)(2008-10#6)
determined##3068##1##(1990-11#10)(1990-12#11)(1990-2#7)(1990-3#5)(1990-5#19)(1990-6#5)(1990-7#16)(1990-8#35)(1990-9#7)(1991-11#5)(1991-12#12)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#14)(1991-6#5)(1991-7#2)(1991-8#7)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#6)(1992-12#13)(1992-2#3)(1992-3#21)(1992-4#4)(1992-5#7)(1992-6#10)(1992-7#2)(1992-8#11)(1992-9#11)(1993-1#3)(1993-11#5)(1993-12#18)(1993-2#13)(1993-3#11)(1993-6#9)(1993-8#15)(1993-9#8)(1994-1#1)(1994-11#9)(1994-12#19)(1994-2#7)(1994-3#6)(1994-5#20)(1994-6#3)(1994-7#2)(1994-8#19)(1994-9#7)(1995-1#3)(1995-11#14)(1995-12#13)(1995-2#19)(1995-3#12)(1995-4#1)(1995-5#5)(1995-6#8)(1995-8#13)(1995-9#3)(1996-1#3)(1996-10#3)(1996-12#11)(1996-2#17)(1996-3#7)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#3)(1996-8#7)(1996-9#1)(1997-1#2)(1997-2#31)(1997-3#12)(1997-4#18)(1997-5#1)(1997-6#13)(1997-7#17)(1997-8#10)(2006-10#1)(2006-12#2)(2006-4#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#15)(2007-11#36)(2007-12#28)(2007-5#2)(2007-6#2)(2007-8#7)(2007-9#1)(2008-1#14)(2008-10#1166)(2008-11#80)(2008-12#40)(2008-2#75)(2008-3#202)(2008-4#26)(2008-5#85)(2008-6#25)(2008-7#58)(2008-8#74)(2008-9#30)(2009-10#4)(2009-11#7)(2009-12#6)(2009-2#4)(2009-3#6)(2009-4#3)(2009-5#9)(2009-6#2)(2009-7#8)(2009-8#18)(2009-9#8)(2010-1#4)(2010-10#6)(2010-11#4)(2010-12#6)(2010-2#7)(2010-3#5)(2010-4#19)(2010-5#7)(2010-6#10)(2010-8#8)(2010-9#3)(2011-1#18)(2011-2#57)(2011-3#2)(2012-1#8)(2012-12#16)(2012-2#29)(2012-3#25)(2012-4#1)(2012-5#1)(2012-7#2)(2012-9#1)(2013-1#44)(2013-3#1)(2013-7#10)(2013-8#18)
determinedin##2##1##(2008-11#2)
determines a##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
determines how##2##2##(1994-1#1)(2008-10#1)
determines its##6##2##(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
determines the level of##2##4##(1993-11#1)(2008-10#1)
determines the need for##2##4##(2008-11#1)(2011-2#1)
determines the number of##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
determines the optimum##2##3##(2008-2#1)(2008-3#1)
determines the resolution##2##3##(2008-3#1)(2012-12#1)
determines the strength##2##3##(2008-2#1)(2013-8#1)
determines the##56##2##(1990-11#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-8#1)(1993-11#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#7)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-8#1)
determines whether a##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
determines whether##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
determines which##2##2##(2008-2#1)(2008-3#1)
determines##101##1##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#1)(2007-11#3)(2008-10#15)(2008-11#2)(2008-2#10)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#3)
determining Cu(2+)##2##2##(2008-10#2)
determining NO() in##2##3##(2008-10#2)
determining a##4##2##(1996-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
determining an##3##2##(1992-12#1)(2008-9#1)(2011-2#1)
determining cell##5##2##(1993-6#1)(2008-11#2)(2008-8#1)(2008-9#1)
determining factor##2##2##(2008-7#1)(2012-2#1)
determining factors##3##2##(2008-9#1)(2010-4#1)(2011-2#1)
determining future##3##2##(1995-3#1)(2008-10#1)(2010-8#1)
determining gene##2##2##(1994-11#1)(2008-11#1)
determining growth##2##2##(2008-10#1)(2008-9#1)
determining how##5##2##(1993-2#2)(2008-3#1)(2010-5#1)(2012-3#1)
determining if##8##2##(1992-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-9#1)(2010-8#2)
determining individual##2##2##(2007-8#1)(2008-10#1)
determining mechanisms##2##2##(2008-11#1)(2010-3#1)
determining mercury##2##2##(2008-10#2)
determining optimal##3##2##(1996-3#1)(2007-12#1)(2008-3#1)
determining particle size##2##3##(2008-3#2)
determining patients'##2##2##(1991-3#1)(1996-3#1)
determining phosphate ion##2##3##(2008-10#2)
determining protein##2##2##(2008-4#1)(2009-12#1)
determining risk for##2##3##(2008-11#1)(2008-4#1)
determining the ability of##2##4##(1995-8#1)(2008-5#1)
determining the absorption##2##3##(2008-3#2)
determining the activity##2##3##(2008-10#1)(2008-11#1)
determining the amount of##2##4##(2008-10#2)
determining the carrier-envelope##2##3##(2007-11#1)(2007-12#1)
determining the change in the##2##5##(1994-3#1)(2008-3#1)
determining the clinical##2##3##(1994-9#1)(2010-11#1)
determining the cost of##2##4##(1994-3#1)(2008-8#1)
determining the diagnosis##2##3##(1990-2#1)(2008-12#1)
determining the extraction##2##3##(2008-10#2)
determining the genetic structure of##2##5##(2008-10#2)
determining the material##2##3##(2008-3#1)(2009-4#1)
determining the most##2##3##(2008-8#1)(2013-1#1)
determining the optical constants##3##4##(2008-2#1)(2008-3#2)
determining the optical properties of a two-layer##2##7##(2008-2#2)
determining the optical properties of a##3##6##(2008-2#2)(2008-3#1)
determining the optical properties of##6##5##(2007-11#1)(2008-2#2)(2008-3#2)(2009-2#1)
determining the optical##9##3##(2007-11#1)(2008-2#3)(2008-3#4)(2009-2#1)
determining the optimal##3##3##(2007-8#1)(2008-11#1)(2008-4#1)
determining the oxidation state##2##4##(1997-7#1)(2008-10#1)
determining the presence of##2##4##(2008-10#1)(2008-5#1)
determining the prevalence of##3##4##(1991-12#1)(2011-1#1)(2013-8#1)
determining the quality of##3##4##(2007-8#1)(2008-9#1)(2009-1#1)
determining the relative##4##3##(2008-10#3)(2008-8#1)
determining the titers of##2##4##(2008-4#2)
determining the value of##3##4##(1996-11#1)(2007-8#1)(2008-8#1)
determining the##252##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#2)(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-8#1)(1996-11#2)(1996-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-4#1)(2007-11#5)(2007-12#3)(2007-8#4)(2008-1#3)(2008-10#49)(2008-11#10)(2008-12#2)(2008-2#15)(2008-3#42)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#15)(2008-9#5)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-11#3)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#3)
determining their##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)
determining what##3##2##(2008-4#1)(2010-8#1)(2012-1#1)
determining whether a##2##3##(1993-1#1)(2008-8#1)
determining whether or not##4##4##(1991-1#1)(1995-2#1)(2008-5#1)(2008-7#1)
determining whether the##3##3##(1993-1#1)(2008-4#1)(2008-8#1)
determining whether##19##2##(1991-1#1)(1993-1#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-10#1)(2012-12#1)
determining which patients##2##3##(1993-12#1)(2008-11#1)
determining which##11##2##(1990-5#1)(1993-12#1)(1994-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
determining##571##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-4#2)(2007-10#1)(2007-11#8)(2007-12#5)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#158)(2008-11#25)(2008-12#4)(2008-2#20)(2008-3#57)(2008-4#20)(2008-5#12)(2008-6#3)(2008-7#19)(2008-8#26)(2008-9#18)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#7)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#14)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#6)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#7)
determinism and##2##2##(2008-12#1)(2008-8#1)
determinism was##2##2##(1991-6#1)(2012-2#1)
determinism##10##1##(1991-6#1)(2008-1#1)(2008-12#4)(2008-8#1)(2012-2#3)
deterministic dynamics##2##2##(2009-8#2)
deterministic effects are##2##3##(1996-6#1)(2008-7#1)
deterministic effects##7##2##(1996-6#4)(2008-7#2)(2012-2#1)
deterministic model##3##2##(2008-10#1)(2008-8#2)
deterministic models##3##2##(1990-9#1)(1996-3#1)(2008-8#1)
deterministic##46##1##(1990-9#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-3#2)(1996-6#4)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#4)(2008-7#4)(2008-8#6)(2008-9#4)(2009-12#1)(2009-8#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
deterrence##2##1##(2010-7#1)(2013-7#1)
deterrent##3##1##(1991-12#1)(1994-5#1)(2008-10#1)
deterrents##3##1##(2008-8#3)
detonation##2##1##(2009-10#1)(2010-3#1)
detour phase##2##2##(2008-2#2)
detoxification enzymes##3##2##(1994-2#1)(2008-8#2)
detoxification of##15##2##(1992-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)
detoxification pathway##2##2##(1994-2#1)(2013-1#1)
detoxification system##2##2##(2008-12#1)(2008-7#1)
detoxification##44##1##(1990-3#1)(1991-1#1)(1991-12#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-3#1)(2008-10#6)(2008-11#8)(2008-12#1)(2008-5#2)(2008-7#6)(2008-8#4)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
detoxified by##3##2##(1991-9#1)(1997-7#1)(2008-11#1)
detoxified##8##1##(1991-9#1)(1996-2#1)(1996-7#2)(1997-7#1)(2008-11#1)(2011-1#1)(2012-2#1)
detoxify the##2##2##(2008-10#1)(2013-8#1)
detoxify##7##1##(1994-11#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-8#1)
detoxifying##2##1##(1991-12#1)(2008-8#1)
detriment in##2##2##(2008-3#1)(2008-4#1)
detriment##4##1##(2008-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
detrimental consequences##3##2##(2008-1#1)(2010-5#1)(2013-1#1)
detrimental effect of##6##3##(1995-5#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-7#1)
detrimental effect on##11##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#4)
detrimental effect##18##2##(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#4)(2012-7#1)
detrimental effects of##10##3##(1990-10#1)(1993-12#1)(1994-3#1)(1996-12#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)
detrimental effects on the##4##4##(1991-3#1)(2008-10#1)(2013-1#2)
detrimental effects on##8##3##(1991-3#3)(2008-10#2)(2009-10#1)(2013-1#2)
detrimental effects##24##2##(1990-10#1)(1991-3#3)(1993-1#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-7#1)(2013-1#2)
detrimental for##2##2##(2008-11#1)(2008-7#1)
detrimental impact on##3##3##(1996-3#1)(1997-3#1)(2013-8#1)
detrimental or beneficial##2##3##(2008-10#1)(2012-3#1)
detrimental side##2##2##(2008-12#1)(2011-1#1)
detrimental to the##6##3##(1995-6#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-8#1)
detrimental to##13##2##(1992-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#3)(2012-1#1)(2013-8#1)
detrimental##85##1##(1990-10#1)(1991-3#3)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#2)(1996-6#3)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#2)(2010-5#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-3#2)(2012-7#2)(2013-1#3)(2013-8#2)
detritus##4##1##(2008-11#2)(2008-3#1)(2008-5#1)
detrusor muscle##5##2##(2008-3#1)(2009-2#3)(2009-7#1)
detrusor##11##1##(2008-10#3)(2008-3#1)(2008-7#2)(2009-2#3)(2009-5#1)(2009-7#1)
detubularization##2##1##(1996-3#2)
detumescence##2##1##(2008-10#1)(2013-8#1)
detuned from##2##2##(2007-12#2)
detuning from##2##2##(2007-11#1)(2008-2#1)
detuning of the##2##3##(2007-12#2)
detuning of##5##2##(2007-11#2)(2007-12#3)
detuning the##3##2##(2007-12#1)(2008-3#2)
detuning##27##1##(2007-11#9)(2007-12#9)(2008-2#2)(2008-3#7)
deuterated and fluorinated methacrylate polymer waveguides##2##6##(2008-2#2)
deuterated##10##1##(1993-11#1)(1996-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
deuteration##2##1##(2008-4#1)(2012-1#1)
deuterium NMR spectroscopy##2##3##(1990-12#2)
deuterium NMR##3##2##(1990-12#2)(1990-7#1)
deuterium isotope effect##2##3##(1992-6#1)(1993-8#1)
deuterium oxide##3##2##(1992-6#1)(2008-4#1)(2008-7#1)
deuterium##29##1##(1990-12#2)(1990-7#3)(1991-3#2)(1992-4#1)(1992-6#4)(1993-8#2)(1996-5#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#1)(2009-11#1)(2010-2#1)
deuterons##2##1##(1993-11#1)(2008-4#1)
deuterostomes##7##1##(2007-12#4)(2008-7#2)(2010-4#1)
deutocerebral##2##1##(2007-12#2)
deutocerebrum##4##1##(2007-12#4)
deux cas##2##2##(2011-2#1)(2013-1#1)
deux##6##1##(2008-7#1)(2011-2#1)(2013-1#4)
devascularization##4##1##(1997-6#1)(2006-12#1)(2008-9#1)(2013-8#1)
devastated##2##1##(2008-1#1)(2008-10#1)
devastating complication following##2##3##(2008-8#1)(2009-3#1)
devastating complication##5##2##(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)
devastating consequences##2##2##(2009-2#1)(2011-2#1)
devastating disease##10##2##(2008-10#6)(2008-11#2)(2008-7#1)(2012-2#1)
devastating diseases##4##2##(1997-7#1)(2008-10#2)(2011-2#1)
devastating effects##3##2##(2007-11#1)(2008-8#1)(2013-1#1)
devastating for##2##2##(2007-2#1)(2011-2#1)
devastating impact##2##2##(2008-7#1)(2010-5#1)
devastating injuries##2##2##(2008-9#1)(2011-2#1)
devastating injury##3##2##(2008-9#3)
devastating##59##1##(1993-6#1)(1995-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
devazepide##3##1##(1993-6#2)(1996-2#1)
develop &quot##2##2##(1995-3#1)(2008-7#1)
develop AIDS##2##2##(1995-12#1)(1996-5#1)
develop a culture##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
develop a database##2##3##(2009-10#1)(2010-7#1)
develop a framework##2##3##(1994-3#1)(2012-12#1)
develop a fully automated##3##4##(1994-1#1)(2008-10#2)
develop a fully##5##3##(1994-1#1)(2008-10#2)(2008-8#1)(2008-9#1)
develop a general model of##2##5##(2008-3#1)(2013-1#1)
develop a general##4##3##(1996-3#1)(2008-3#2)(2013-1#1)
develop a method for##4##4##(2008-10#1)(2008-3#1)(2009-8#1)(2012-4#1)
develop a method##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2012-4#1)
develop a model##8##3##(1993-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#2)
develop a new approach to##2##5##(2008-8#1)(2009-9#1)
develop a new##15##3##(1992-11#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
develop a novel##7##3##(2007-12#1)(2008-10#2)(2009-12#1)(2010-11#1)(2010-2#1)(2012-3#1)
develop a practical##2##3##(2008-7#1)(2012-3#1)
develop a recombinant##2##3##(2008-11#1)(2008-5#1)
develop a simple and##3##4##(1997-8#1)(2008-10#1)(2008-5#1)
develop a simple##11##3##(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2013-1#1)
develop a specific##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
develop a strategic##2##3##(1997-2#1)(1997-3#1)
develop a technique##2##3##(2008-2#1)(2008-3#1)
develop a type##2##3##(1990-2#1)(2007-7#1)
develop a##238##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#4)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2008-1#6)(2008-10#32)(2008-11#16)(2008-12#3)(2008-2#6)(2008-3#17)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#5)(2008-8#11)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#11)(2013-8#5)
develop after##4##2##(1992-1#1)(2008-6#1)(2010-11#1)(2012-2#1)
develop alternative##2##2##(1996-2#1)(2008-11#1)
develop amphetamine##2##2##(1993-6#2)
develop an action plan for##2##5##(2007-4#1)(2011-2#1)
develop an action plan##4##4##(1995-12#1)(1995-3#1)(2007-4#1)(2011-2#1)
develop an analytical expression for the##2##6##(2008-2#2)
develop an approach for##2##4##(1997-2#1)(2008-8#1)
develop an effective##2##3##(1992-1#1)(2008-6#1)
develop an##65##2##(1990-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#4)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
develop and analyze a##2##4##(2008-9#2)
develop and apply##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
develop and implement a new##2##5##(1996-1#1)(2012-3#1)
develop and implement a##8##4##(1991-12#1)(1993-1#1)(1995-2#1)(1996-1#1)(2007-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
develop and implement##13##3##(1991-12#1)(1992-2#1)(1993-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
develop and monitor##2##3##(1997-1#1)(2008-10#1)
develop and##55##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#2)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
develop appropriate##2##2##(1990-10#1)(2008-1#1)
develop as a##2##3##(2008-6#1)(2012-1#1)
develop as##4##2##(2008-6#1)(2009-12#1)(2011-2#1)(2012-1#1)
develop at##3##2##(1993-2#1)(1996-9#1)(2011-1#1)
develop both##2##2##(2008-12#1)(2008-8#1)
develop clinical##4##2##(1993-12#1)(2007-7#1)(2008-12#1)(2010-12#1)
develop disease##2##2##(2008-10#2)
develop during##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
develop effective##10##2##(1990-10#1)(1992-2#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
develop from##6##2##(1990-12#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
develop general##2##2##(2008-8#1)(2012-3#1)
develop in a##2##3##(2008-11#1)(2010-12#1)
develop in order to##2##4##(2008-11#1)(2009-4#1)
develop in the##4##3##(2007-11#1)(2008-10#2)(2011-2#1)
develop in##31##2##(1992-2#1)(1996-12#1)(1997-1#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
develop independently##2##2##(1993-2#1)(2008-11#1)
develop infections##2##2##(2008-10#1)(2013-1#1)
develop into a##3##3##(1992-9#1)(2008-3#2)
develop into##4##2##(1992-9#1)(2008-3#2)(2008-4#1)
develop knowledge##2##2##(2007-12#1)(2009-12#1)
develop local##2##2##(1997-8#1)(2012-2#1)
develop long-term##2##2##(1994-12#1)(2008-12#1)
develop metastases##2##2##(1997-5#1)(2009-10#1)
develop models that##2##3##(2008-9#1)(2010-5#1)
develop models##5##2##(2008-10#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)
develop more effective therapeutic strategies##2##5##(2009-5#1)(2011-2#1)
develop more effective##5##3##(2008-10#1)(2008-12#1)(2009-5#1)(2010-8#1)(2011-2#1)
develop more##13##2##(1993-2#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#3)
develop multiple##3##2##(2007-7#1)(2008-8#1)(2012-3#1)
develop new##15##2##(1990-3#1)(1992-3#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)
develop normally##2##2##(1993-12#1)(2008-11#1)
develop novel therapies for##2##4##(2008-5#1)(2008-9#1)
develop novel##9##2##(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2013-1#1)
develop nurses##2##2##(2008-11#1)(2008-12#1)
develop of##2##2##(2008-11#1)(2011-2#1)
develop on the##2##3##(2008-10#2)
develop on##4##2##(2008-10#3)(2012-2#1)
develop preventive measures##2##3##(2008-10#1)(2013-1#1)
develop preventive##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
develop processes##2##2##(1995-3#1)(1997-1#1)
develop protocols##3##2##(1995-3#1)(2006-6#1)(2008-9#1)
develop quantitative##2##2##(2008-1#1)(2008-9#1)
develop regional##2##2##(2008-10#1)(2008-7#1)
develop resistance to##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
develop resistance##4##2##(2008-10#1)(2011-2#2)(2012-1#1)
develop secondary##5##2##(2008-10#2)(2009-8#1)(2010-5#1)(2011-2#1)
develop severe dwarfism##2##3##(2008-1#2)
develop severe##7##2##(1990-6#1)(1991-6#1)(1993-11#1)(1995-12#1)(2008-1#2)(2013-1#1)
develop strategies for##4##3##(2008-10#1)(2008-11#1)(2010-11#1)(2011-1#1)
develop strategies##5##2##(2008-10#2)(2008-11#1)(2010-11#1)(2011-1#1)
develop such##5##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
develop symptoms##3##2##(1997-6#1)(2008-10#2)
develop the disease##2##3##(1993-3#1)(2010-6#1)
develop the##36##2##(1991-1#1)(1993-3#2)(1995-12#1)(1995-6#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
develop their##10##2##(1994-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
develop them##2##2##(1993-1#1)(2007-2#1)
develop two##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
develop very##3##2##(2008-10#2)(2008-7#1)
develop when##2##2##(1997-8#1)(2008-11#1)
develop with##2##2##(2008-3#1)(2010-6#1)
develop within##2##2##(2007-8#1)(2008-5#1)
develop##992##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#6)(1992-11#2)(1992-2#7)(1992-3#3)(1992-6#2)(1992-9#4)(1993-1#5)(1993-11#3)(1993-12#6)(1993-2#6)(1993-3#10)(1993-6#4)(1993-7#1)(1994-1#6)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#9)(1994-5#4)(1994-9#3)(1995-1#2)(1995-12#7)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#5)(1996-12#5)(1996-2#10)(1996-3#10)(1996-4#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#10)(1997-2#10)(1997-3#9)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#7)(2006-10#2)(2006-6#1)(2007-10#4)(2007-11#11)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#26)(2008-10#141)(2008-11#59)(2008-12#28)(2008-2#15)(2008-3#38)(2008-4#12)(2008-5#26)(2008-6#11)(2008-7#34)(2008-8#32)(2008-9#21)(2009-10#5)(2009-11#5)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#7)(2010-12#9)(2010-2#6)(2010-3#9)(2010-4#1)(2010-5#12)(2010-6#6)(2010-7#6)(2010-8#8)(2010-9#4)(2011-1#9)(2011-10#1)(2011-2#37)(2011-3#1)(2012-1#9)(2012-12#13)(2012-2#28)(2012-3#13)(2012-4#1)(2013-1#38)(2013-7#1)(2013-8#16)
developed ELISA##2##2##(1994-11#1)(2008-10#1)
developed EPS##3##2##(2011-2#3)
developed HPLC##2##2##(2008-10#1)(2010-5#1)
developed MWP##2##2##(2008-10#2)
developed PCR##3##2##(2008-10#2)(2013-1#1)
developed Paget's disease##2##3##(2007-11#1)(2011-2#1)
developed STR##2##2##(1995-11#1)(2008-12#1)
developed a compact##2##3##(2008-3#2)
developed a comprehensive##2##3##(1995-3#1)(2013-1#1)
developed a computational model##3##4##(2010-7#1)(2012-2#1)(2013-8#1)
developed a computer##2##3##(1997-6#1)(2009-9#1)
developed a concept of##2##4##(2008-7#1)(2012-2#1)
developed a concept##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
developed a dense##2##3##(2008-10#1)(2008-7#1)
developed a fast##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
developed a follicular##3##3##(1992-11#1)(2007-10#1)(2012-3#1)
developed a framework##2##3##(1992-3#1)(1993-2#1)
developed a fulminant##2##3##(2007-7#1)(2009-4#1)
developed a high-resolution##2##3##(2007-11#1)(2012-3#1)
developed a high-throughput##3##3##(2009-10#1)(2010-2#1)(2012-3#1)
developed a highly##3##3##(2008-10#1)(2013-1#2)
developed a large##2##3##(2008-7#1)(2010-3#1)
developed a method for inducing##2##5##(1991-12#1)(2008-10#1)
developed a method for##3##4##(1991-12#1)(2008-10#1)(2008-5#1)
developed a method of##2##4##(1995-9#1)(2012-1#1)
developed a method to##7##4##(1992-11#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)
developed a method##15##3##(1991-12#1)(1992-11#1)(1993-8#1)(1995-9#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-1#1)
developed a model for##2##4##(2008-2#1)(2008-3#1)
developed a model of##2##4##(1995-1#1)(2008-3#1)
developed a model to##2##4##(2008-7#1)(2013-1#1)
developed a model##9##3##(1995-1#1)(1996-5#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
developed a modified##3##3##(1997-1#1)(2007-12#1)(2010-6#1)
developed a new method for the determination of##2##8##(2008-10#2)
developed a new method for##4##5##(2008-10#3)(2008-2#1)
developed a new method##6##4##(1992-3#1)(2008-10#3)(2008-2#1)(2008-3#1)
developed a new##27##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
developed a novel##19##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
developed a procedure to##2##4##(2008-10#1)(2012-2#1)
developed a process##3##3##(1993-1#1)(2008-5#1)(2008-6#1)
developed a program##2##3##(1991-12#1)(1994-12#1)
developed a rapid and##2##4##(2008-10#1)(2008-11#1)
developed a rapid##6##3##(1990-12#1)(2008-10#2)(2008-11#2)(2008-9#1)
developed a real-time##2##3##(2008-10#1)(2008-8#1)
developed a right##2##3##(2007-6#1)(2008-7#1)
developed a sensitive##6##3##(1992-9#1)(1993-12#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-5#1)
developed a set of##2##4##(2009-8#1)(2010-8#1)
developed a simple and##2##4##(1995-12#1)(2008-11#1)
developed a simple##11##3##(1993-12#1)(1994-11#1)(1995-12#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)
developed a sudden##2##3##(2007-12#1)(2011-2#1)
developed a systemic##2##3##(1997-8#1)(2013-1#1)
developed a technique for##2##4##(1990-8#1)(2008-3#1)
developed a technique##3##3##(1990-8#1)(2008-11#1)(2008-3#1)
developed a test##2##3##(1991-11#1)(2013-1#1)
developed a unique##4##3##(1991-3#1)(1994-1#1)(1996-3#1)(2008-9#1)
developed a##327##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#10)(2007-12#9)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-10#39)(2008-11#15)(2008-12#2)(2008-2#11)(2008-3#25)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#16)(2013-8#3)
developed across##2##2##(2007-11#1)(2011-2#1)
developed acute##10##2##(1992-10#1)(1992-4#1)(1996-3#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-4#1)(2012-12#1)
developed after##7##2##(1991-3#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
developed against##2##2##(2008-11#1)(2008-9#1)
developed allows##3##2##(2008-10#3)
developed also##2##2##(1995-5#1)(2009-10#1)
developed an acute##6##3##(1992-12#1)(1995-11#1)(2007-10#1)(2008-3#1)(2009-3#1)(2010-3#1)
developed an approach to##2##4##(1994-2#1)(2008-10#1)
developed an improved##3##3##(1990-12#1)(2008-11#1)(2008-5#1)
developed an in vitro assay##2##5##(1994-12#1)(2013-1#1)
developed an in vitro##4##4##(1994-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
developed an in##5##3##(1990-8#1)(1994-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
developed an infection##2##3##(2008-10#2)
developed an##65##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#3)
developed analytical##4##2##(2008-10#3)(2010-5#1)
developed and a##2##3##(1992-1#1)(2008-10#1)
developed and applied to the##3##5##(1994-12#1)(2008-10#1)(2008-2#1)
developed and applied to##7##4##(1994-12#1)(2008-10#3)(2008-2#2)(2008-3#1)
developed and applied##13##3##(1994-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2012-3#1)
developed and characterized##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
developed and compared##2##3##(1997-1#1)(2008-10#1)
developed and conducted##2##3##(2010-10#1)(2013-1#1)
developed and demonstrated for##2##4##(2007-12#1)(2008-3#1)
developed and developing countries##4##4##(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#1)
developed and developing##5##3##(1997-7#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#1)
developed and evaluated##6##3##(2007-12#2)(2008-10#2)(2008-3#1)(2009-6#1)
developed and implemented a##3##4##(2009-6#1)(2010-5#1)(2011-1#1)
developed and implemented at Lawrence Berkeley National Laboratory to##2##9##(2008-3#2)
developed and implemented in a##2##5##(1993-3#1)(1996-12#1)
developed and implemented in##4##4##(1993-3#1)(1996-12#1)(2008-10#1)(2011-1#1)
developed and implemented##22##3##(1993-3#1)(1996-12#2)(1997-3#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#4)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#3)(2013-1#3)
developed and improved##2##3##(2008-11#1)(2008-2#1)
developed and introduced##3##3##(1996-1#1)(2007-8#1)(2010-8#1)
developed and investigated##2##3##(2008-10#1)(2008-5#1)
developed and is##2##3##(1990-5#1)(2007-12#1)
developed and maintained##2##3##(2008-7#1)(2009-12#1)
developed and optimized##6##3##(1997-2#1)(2008-10#5)
developed and published##2##3##(2008-3#1)(2008-8#1)
developed and successfully##2##3##(1991-1#1)(2008-10#1)
developed and tested a##2##4##(2008-10#1)(2008-3#1)
developed and tested for the##2##5##(2008-10#2)
developed and tested for##3##4##(2008-10#3)
developed and tested in##2##4##(1993-3#1)(2009-11#1)
developed and tested##19##3##(1993-3#1)(1996-1#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#2)(2009-11#1)
developed and the##4##3##(1994-3#1)(2008-10#3)
developed and used for the##3##5##(2008-10#2)(2008-7#1)
developed and used for##5##4##(2008-10#4)(2008-7#1)
developed and used to identify the##2##6##(1991-5#1)(2008-10#1)
developed and used to##11##4##(1991-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
developed and used##23##3##(1991-5#1)(1993-12#1)(1993-2#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-8#1)
developed and utilized##3##3##(2008-10#2)(2008-12#1)
developed and validated in##3##4##(2008-10#3)
developed and validated##23##3##(1995-12#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
developed and##206##2##(1990-5#1)(1991-1#1)(1991-2#2)(1991-5#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#1)(1994-3#5)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-12#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#8)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#70)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#16)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#3)(2010-8#4)(2011-1#6)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#6)(2013-8#1)
developed antibodies##2##2##(1995-9#1)(1996-2#1)
developed approach##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
developed around##2##2##(2008-10#1)(2010-7#1)
developed as a means to##2##5##(2007-12#1)(2009-11#1)
developed as a result of##2##5##(1990-3#1)(2008-12#1)
developed as a##24##3##(1990-3#1)(1992-1#1)(1994-3#1)(1996-5#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-5#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
developed as an alternative to##5##5##(1997-2#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
developed as an alternative##6##4##(1997-2#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-12#1)
developed as an##12##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-12#1)
developed as well##3##3##(2008-5#1)(2008-6#1)(2010-8#1)
developed as##46##2##(1990-3#1)(1992-1#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
developed assay##3##2##(1990-2#1)(1994-11#1)(2008-10#1)
developed at a##4##3##(1996-5#1)(2008-10#1)(2008-12#1)(2013-8#1)
developed at the##7##3##(1991-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
developed at##25##2##(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-5#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
developed based on a##5##4##(2007-11#1)(2008-10#4)
developed based on the##12##4##(2007-11#1)(2008-10#9)(2008-8#1)(2011-1#1)
developed based on##38##3##(1993-3#2)(1995-12#1)(2007-11#3)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
developed based upon##2##3##(1992-3#1)(2008-10#1)
developed based##41##2##(1992-3#1)(1993-3#2)(1995-12#1)(2007-11#3)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
developed between##6##2##(1991-6#1)(1996-1#1)(2008-2#1)(2008-6#1)(2008-7#2)
developed bilateral##4##2##(2007-10#1)(2007-2#1)(2008-10#1)(2011-1#1)
developed biosensor##2##2##(2008-10#2)
developed both##2##2##(2011-2#1)(2013-1#1)
developed breast##2##2##(2008-5#2)
developed by C##2##3##(2008-10#2)
developed by a##9##3##(1995-2#1)(1997-3#1)(2008-10#4)(2008-3#1)(2010-12#1)(2012-3#1)
developed by the Ministry of##2##5##(2008-10#1)(2008-8#1)
developed by the authors##3##4##(1994-2#1)(2008-10#1)(2008-6#1)
developed by the use of a##3##6##(2008-10#3)
developed by the##44##3##(1990-12#1)(1991-2#1)(1991-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
developed by use of##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
developed by using a##3##4##(2008-10#3)
developed by using the##2##4##(1993-11#1)(2007-12#1)
developed by using##10##3##(1993-11#1)(2007-12#2)(2008-10#7)
developed by##166##2##(1990-12#2)(1990-8#3)(1991-2#2)(1991-9#1)(1993-11#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-7#1)(1995-12#2)(1995-2#3)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#56)(2008-11#5)(2008-2#3)(2008-3#14)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)
developed can be##3##3##(2008-10#2)(2008-3#1)
developed can##4##2##(2008-10#2)(2008-3#2)
developed capsular##2##2##(2011-2#1)(2013-1#1)
developed chelating matrix##2##3##(2008-10#2)
developed chronic##3##2##(1992-5#1)(2008-1#1)(2008-6#1)
developed clinical##3##2##(2010-10#1)(2010-5#1)(2011-2#1)
developed countries and##3##3##(1997-7#1)(2007-2#1)(2011-1#1)
developed countries in the##2##4##(2009-4#1)(2012-12#1)
developed countries in##3##3##(2009-4#2)(2012-12#1)
developed countries##69##2##(1990-9#1)(1991-6#1)(1992-6#7)(1996-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-2#4)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#3)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)
developed de novo##2##3##(2007-10#1)(2008-10#1)
developed delayed##2##2##(1996-1#1)(2013-8#1)
developed device##2##2##(2010-8#2)
developed diabetes##2##2##(1994-12#1)(2008-7#1)
developed distant##2##2##(1994-12#1)(2008-6#1)
developed drug##2##2##(1997-7#1)(2011-2#1)
developed due to the##2##4##(2008-12#1)(2009-6#1)
developed due to##4##3##(2008-12#1)(2008-6#1)(2009-6#1)(2013-1#1)
developed during the##5##3##(1996-6#1)(2007-7#1)(2008-10#2)(2008-8#1)
developed during##7##2##(1993-2#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-8#1)(2012-12#1)
developed electrode##2##2##(2008-10#2)
developed employing three##2##3##(1991-2#1)(2012-2#1)
developed encephalopathy##2##2##(2007-7#1)(2012-12#1)
developed experimental##2##2##(2008-2#1)(2010-8#1)
developed extensively##2##2##(2010-5#1)(2010-7#1)
developed flow injection##2##3##(2008-10#2)
developed flow##4##2##(2008-10#4)
developed following##4##2##(1994-2#1)(1996-5#1)(2008-10#1)(2012-2#1)
developed for a new##2##4##(2008-10#1)(2008-11#1)
developed for a##12##3##(1993-12#2)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-9#1)(2012-3#1)
developed for analysis of##5##4##(2008-10#3)(2008-3#1)(2012-12#1)
developed for application##2##3##(2008-10#2)
developed for both##3##3##(2008-10#2)(2008-3#1)
developed for breast##2##3##(1991-12#1)(1995-2#1)
developed for calculating the##2##4##(2008-3#2)
developed for detecting##5##3##(1995-11#1)(2008-10#3)(2008-9#1)
developed for detection##3##3##(2008-10#3)
developed for determination of the##2##5##(2008-10#1)(2008-2#1)
developed for determination of trace amounts of##2##7##(2008-10#2)
developed for determination of trace##3##5##(2008-10#3)
developed for determination of##18##4##(2008-10#17)(2008-2#1)
developed for determining##3##3##(2008-10#1)(2008-2#2)
developed for direct##2##3##(1994-11#1)(2008-3#1)
developed for easy##2##3##(2008-10#2)
developed for in situ measurements##2##5##(2008-2#1)(2008-3#1)
developed for isolating##2##3##(1990-5#1)(1997-2#1)
developed for measuring##5##3##(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
developed for mercury speciation##2##4##(2008-10#2)
developed for monitoring##3##3##(2008-10#3)
developed for one##2##3##(2008-10#1)(2008-3#1)
developed for optical##2##3##(2008-2#1)(2008-3#1)
developed for precise measurement of the##2##6##(2007-12#1)(2008-3#1)
developed for quantitative determination of##3##5##(2008-10#3)
developed for quantitative##8##3##(2007-11#1)(2008-10#4)(2008-3#1)(2010-5#2)
developed for rapid and##2##4##(2008-10#2)
developed for simultaneous determination of##7##5##(2008-10#7)
developed for simultaneous##12##3##(2008-10#11)(2008-4#1)
developed for the analysis of##10##5##(1996-5#1)(2008-10#8)(2008-3#1)
developed for the construction of##2##5##(2008-11#1)(2009-5#1)
developed for the detection of##8##5##(1990-12#1)(2008-10#7)
developed for the detection##9##4##(1990-12#1)(2008-10#8)
developed for the determination of carbon##2##6##(2008-10#2)
developed for the determination of copper##2##6##(2008-10#2)
developed for the determination of dissolved##2##6##(2008-10#2)
developed for the determination of free##2##6##(1990-8#1)(2008-10#1)
developed for the determination of hydrogen##2##6##(2008-10#2)
developed for the determination of proteins##3##6##(2008-10#3)
developed for the determination of some##2##6##(2008-10#2)
developed for the determination of the##6##6##(1991-5#1)(2008-10#5)
developed for the determination of trace amounts of##4##8##(2008-10#4)
developed for the determination of trace##12##6##(2008-10#12)
developed for the determination of tungsten##2##6##(2008-10#2)
developed for the determination of##102##5##(1990-8#1)(1991-5#1)(1996-5#2)(2008-10#90)(2008-11#1)(2008-3#1)(2011-1#4)(2011-3#1)(2012-1#1)
developed for the determination##103##4##(1990-8#1)(1991-5#1)(1996-5#2)(2008-10#91)(2008-11#1)(2008-3#1)(2011-1#4)(2011-3#1)(2012-1#1)
developed for the direct determination of##6##6##(2008-10#6)
developed for the direct##9##4##(2008-10#9)
developed for the extraction of##3##5##(2008-10#3)
developed for the first time##3##5##(2008-10#1)(2008-7#1)(2010-4#1)
developed for the identification and determination##2##6##(2008-10#1)(2013-1#1)
developed for the identification and##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
developed for the identification##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
developed for the isolation of##2##5##(2008-11#1)(2009-12#1)
developed for the on-line determination of##3##6##(2008-10#3)
developed for the on-line##4##4##(2008-10#4)
developed for the preconcentration##2##4##(2008-10#2)
developed for the prediction of##3##5##(1996-12#1)(2007-11#1)(2008-10#1)
developed for the production of##2##5##(2008-11#1)(2008-6#1)
developed for the quantification of##2##5##(2008-10#2)
developed for the quantitative determination of##6##6##(2008-10#5)(2012-12#1)
developed for the rapid and sensitive determination of##2##8##(2008-10#2)
developed for the rapid and##3##5##(2008-10#3)
developed for the rapid##6##4##(2008-10#6)
developed for the sensitive##2##4##(2008-10#2)
developed for the separation and determination of##4##7##(2008-10#4)
developed for the separation and##6##5##(2008-10#6)
developed for the separation of##4##5##(2008-10#4)
developed for the separation##10##4##(2008-10#10)
developed for the shot-noise-limited measurement precision of Doppler wind lidars based on the##2##13##(2008-2#2)
developed for the simultaneous detection##2##5##(2008-10#2)
developed for the simultaneous determination of the##2##7##(2008-10#1)(2008-2#1)
developed for the simultaneous determination of##15##6##(1990-8#1)(2008-10#13)(2008-2#1)
developed for the simultaneous estimation of##2##6##(2008-10#1)(2010-3#1)
developed for the simultaneous##23##4##(1990-8#1)(2008-10#19)(2008-2#1)(2008-5#1)(2010-3#1)
developed for the spectrophotometric##4##4##(2008-10#4)
developed for the treatment of##5##5##(1992-8#1)(2008-10#2)(2010-5#1)(2010-6#1)
developed for the##285##3##(1990-12#1)(1990-8#3)(1991-5#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-2#2)(1996-12#1)(1996-5#4)(2007-10#1)(2007-11#1)(2008-10#217)(2008-11#9)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-12#2)(2009-5#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#5)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#2)
developed for this purpose##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
developed for this##6##3##(1994-5#1)(1996-2#1)(2008-10#1)(2008-3#2)(2008-5#1)
developed for trace##4##3##(2008-10#4)
developed for use in the##2##5##(1997-1#1)(2008-9#1)
developed for use in##7##4##(1994-9#1)(1997-1#1)(2008-10#1)(2008-9#2)(2009-10#1)(2011-1#1)
developed for use##8##3##(1994-9#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-10#1)(2011-1#1)
developed for##570##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#5)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2008-10#343)(2008-11#16)(2008-12#2)(2008-2#16)(2008-3#43)(2008-4#7)(2008-5#6)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#2)(2011-1#7)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#2)
developed formulation was found to be 16##2##7##(2012-2#2)
developed formulation##3##2##(2012-2#3)
developed four##2##2##(2008-1#1)(2008-3#1)
developed from a cross between the resistant##2##7##(2008-10#2)
developed from a cross between the##3##6##(2008-10#3)
developed from a cross between##5##5##(2008-10#4)(2008-9#1)
developed from a##14##3##(1990-8#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)
developed from the cross##2##4##(2008-10#1)(2008-5#1)
developed from the##9##3##(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2011-2#1)
developed from this##2##3##(2008-10#1)(2008-5#1)
developed from##51##2##(1990-8#1)(1991-2#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#1)(1997-8#2)(2007-12#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
developed has##2##2##(2008-10#1)(2008-5#1)
developed have been##2##3##(2008-10#1)(2008-11#1)
developed here##6##2##(2008-10#3)(2008-3#1)(2008-8#2)
developed high##2##2##(1995-2#1)(2008-10#1)
developed his##2##2##(2008-10#1)(2011-2#1)
developed host##2##2##(2008-10#1)(2010-4#1)
developed if##2##2##(2008-6#1)(2010-11#1)
developed in 1##3##3##(1991-8#1)(2012-3#2)
developed in a##10##3##(1991-11#2)(1994-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)
developed in an##4##3##(1993-6#1)(2008-1#1)(2008-3#1)(2008-5#1)
developed in combination with##2##4##(2008-10#2)
developed in order to##18##4##(1990-2#1)(1991-3#1)(1993-11#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2010-7#1)
developed in order##19##3##(1990-2#1)(1991-3#1)(1993-11#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2010-7#1)(2011-2#1)
developed in our laboratory##10##4##(1993-1#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)
developed in our##14##3##(1993-1#1)(1993-12#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#2)(2012-12#2)
developed in previous##2##3##(2008-10#2)
developed in the last##2##4##(2008-3#1)(2008-8#1)
developed in the present##2##4##(2008-10#2)
developed in the range##2##4##(2008-10#2)
developed in the##35##3##(1991-6#1)(1992-11#1)(1992-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-11#1)(2012-3#1)(2012-7#1)
developed in this laboratory##2##4##(2008-10#1)(2008-7#1)
developed in this paper##6##4##(2007-12#1)(2008-10#5)
developed in this study have##2##5##(2008-10#1)(2009-8#1)
developed in this study to determine##2##6##(2008-10#2)
developed in this study##11##4##(2008-10#10)(2009-8#1)
developed in this work##10##4##(2008-10#9)(2011-2#1)
developed in this##32##3##(1993-1#1)(2007-12#1)(2007-7#1)(2008-10#25)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
developed in which##7##3##(1992-3#1)(2008-10#2)(2008-11#2)(2008-3#2)
developed in##191##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#77)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#4)(2012-7#1)(2013-1#1)
developed inflammatory##3##2##(1990-11#1)(1991-8#1)(2006-10#1)
developed instrument##2##2##(2010-3#1)(2012-3#1)
developed instruments##2##2##(2008-10#1)(2008-9#1)
developed into a##5##3##(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)
developed into##7##2##(1994-12#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)
developed is based on##2##4##(2008-10#2)
developed is##10##2##(2007-11#1)(2008-10#8)(2008-3#1)
developed leaf curling##2##3##(2008-10#2)
developed local recurrence##3##3##(1994-12#1)(2008-6#1)(2012-1#1)
developed local##5##2##(1991-6#1)(1994-12#1)(2008-1#1)(2008-6#1)(2012-1#1)
developed low##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
developed may##3##2##(2008-10#2)(2010-4#1)
developed method for the##2##4##(2008-10#2)
developed method for##7##3##(2008-10#7)
developed method has been##5##4##(2008-10#5)
developed method is sensitive##2##4##(2008-10#1)(2011-1#1)
developed method is##11##3##(2008-10#9)(2008-3#1)(2011-1#1)
developed method of##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
developed method provides##2##3##(2008-10#1)(2012-12#1)
developed method was successfully applied to##5##6##(2008-10#3)(2008-11#1)(2011-2#1)
developed method was##37##3##(2008-10#34)(2008-11#1)(2011-2#1)(2012-12#1)
developed method##102##2##(1997-4#1)(2008-10#90)(2008-11#2)(2008-3#4)(2011-1#1)(2011-2#2)(2012-12#2)
developed methodology was##4##3##(2008-10#4)
developed methodology##13##2##(2008-10#11)(2011-2#2)
developed methods of##3##3##(2008-10#2)(2010-1#1)
developed methods were##6##3##(2008-10#6)
developed methods##13##2##(1994-6#1)(2008-10#8)(2008-4#1)(2008-7#1)(2010-1#1)(2012-3#1)
developed model##7##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-3#1)(2013-1#1)
developed models##2##2##(2008-5#1)(2008-8#1)
developed more slowly##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
developed more##11##2##(1991-8#1)(1993-12#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)
developed multiple##6##2##(1992-12#1)(2007-6#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
developed multiplex##3##2##(1995-11#1)(2008-10#2)
developed negative##2##2##(2007-12#2)
developed new##7##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)
developed novel##4##2##(2008-10#3)(2011-1#1)
developed of##2##2##(2008-10#1)(2010-10#1)
developed on a##2##3##(2008-10#1)(2008-8#1)
developed on day##2##3##(2008-11#1)(2008-7#1)
developed on the basis of the##3##6##(2007-11#1)(2008-3#2)
developed on the basis of##7##5##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)
developed on the##13##3##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2010-6#1)(2011-1#2)
developed on##23##2##(2006-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#2)
developed only in##2##3##(1997-8#1)(2008-10#1)
developed only##3##2##(1997-8#1)(2008-10#2)
developed optical##2##2##(2008-2#1)(2008-3#1)
developed or##2##2##(1994-9#1)(2010-10#1)
developed over the last##2##4##(1992-1#1)(2012-2#1)
developed over the past##2##4##(1992-3#1)(2008-4#1)
developed over the period of##2##5##(1993-2#1)(1996-12#1)
developed over the##7##3##(1992-1#1)(1992-3#1)(1993-2#1)(1996-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
developed over##14##2##(1992-1#1)(1992-3#1)(1993-2#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
developed partial##2##2##(2008-9#1)(2011-2#1)
developed per##2##2##(2008-10#1)(2013-1#1)
developed pleural##2##2##(1991-12#1)(2007-8#1)
developed postoperative##2##2##(2008-7#1)(2009-4#1)
developed previously##5##2##(1990-12#1)(2008-10#4)
developed procedure has been successfully##3##5##(2008-10#3)
developed procedure is##2##3##(2008-10#2)
developed procedure was##5##3##(2008-10#5)
developed procedure##20##2##(2008-10#20)
developed progressive pain##2##3##(2006-10#1)(2008-9#1)
developed progressive##4##2##(1997-8#1)(2006-10#2)(2008-9#1)
developed provides a##2##3##(2007-10#1)(2008-10#1)
developed pulmonary##4##2##(2008-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
developed questionnaire##3##2##(2007-10#1)(2009-11#1)(2009-7#1)
developed rapid##5##2##(2007-7#1)(2008-10#4)
developed rapidly##4##2##(2008-10#1)(2009-7#1)(2010-6#1)(2010-8#1)
developed recently##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
developed renal##3##2##(1994-5#1)(2008-4#1)(2013-1#1)
developed represents a##2##3##(2008-10#1)(2008-3#1)
developed resin matrix##2##3##(2008-10#2)
developed resin##4##2##(2008-10#4)
developed resistance to##3##3##(2008-11#1)(2008-8#1)(2010-8#1)
developed respiratory##3##2##(2010-12#1)(2010-7#1)(2013-1#1)
developed several##4##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
developed severe powdery mildew##2##4##(2008-10#2)
developed severe##16##2##(1990-3#1)(1991-8#1)(1992-11#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-10#3)(2011-1#1)(2013-1#1)
developed significantly less##2##3##(1993-12#1)(2008-10#1)
developed significantly##3##2##(1993-12#1)(2008-10#2)
developed signs##2##2##(2008-7#1)(2013-1#1)
developed skeletal metastases##2##3##(2008-6#2)
developed skin##2##2##(1990-8#1)(2008-10#1)
developed slowly##2##2##(2009-12#1)(2010-8#1)
developed so far##2##3##(1996-12#1)(2008-10#1)
developed so that##2##3##(1996-1#1)(2008-3#1)
developed so##5##2##(1996-1#1)(1996-12#1)(2008-10#2)(2008-3#1)
developed solid phase##2##3##(2008-10#2)
developed specifically to##2##3##(2008-10#1)(2008-11#1)
developed specifically##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
developed spectrophotometric method##2##3##(2008-10#2)
developed symptoms of##3##3##(2008-4#1)(2009-3#1)(2011-1#1)
developed symptoms##6##2##(1993-10#1)(2008-10#2)(2008-4#1)(2009-3#1)(2011-1#1)
developed system##10##2##(2008-10#7)(2008-3#1)(2010-10#1)(2010-8#1)
developed systemic resistance to##2##4##(2008-10#2)
developed systemic##4##2##(2008-10#3)(2013-8#1)
developed technique##6##2##(1997-4#1)(2007-12#2)(2008-10#2)(2008-9#1)
developed than##2##2##(2008-10#1)(2008-5#1)
developed that can##3##3##(2008-10#1)(2008-2#2)
developed that included##3##3##(1997-1#1)(2010-7#1)(2012-12#1)
developed that includes##3##3##(1990-8#1)(2007-11#1)(2008-9#1)
developed that required##2##3##(2008-10#1)(2010-4#1)
developed that specifically##2##3##(1996-5#1)(2012-2#1)
developed that##55##2##(1990-8#1)(1994-12#2)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#12)(2008-2#7)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#3)
developed the ability to##2##4##(1997-6#1)(2008-9#1)
developed the plan##2##3##(1992-1#1)(1996-3#1)
developed the##28##2##(1992-1#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
developed these##2##2##(2008-7#1)(2011-2#1)
developed three##2##2##(1991-2#1)(2009-4#1)
developed through a##2##3##(2007-8#1)(2008-11#1)
developed through##9##2##(1991-1#1)(1993-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
developed to account for##2##4##(1992-3#1)(2008-10#1)
developed to achieve##3##3##(1993-12#1)(2008-7#1)(2009-10#1)
developed to acquire##2##3##(2008-10#1)(2008-11#1)
developed to address##5##3##(2008-12#2)(2008-3#1)(2008-7#1)(2010-8#1)
developed to allow##5##3##(1992-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
developed to analyze the##2##4##(2008-3#1)(2008-7#1)
developed to analyze##4##3##(1997-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
developed to approximate the##2##4##(1997-4#1)(2008-3#1)
developed to assess the##2##4##(2008-2#1)(2010-9#1)
developed to assess##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-9#1)
developed to be used##2##4##(1994-3#1)(2008-2#1)
developed to be##4##3##(1994-3#1)(2008-11#1)(2008-12#1)(2008-2#1)
developed to calculate the##2##4##(2008-10#1)(2008-2#1)
developed to control##2##3##(2008-10#1)(2011-1#1)
developed to date##4##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)
developed to describe the##6##4##(1992-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-5#1)
developed to detect the##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
developed to detect##13##3##(1991-12#1)(1995-11#1)(1997-4#1)(2008-10#6)(2008-11#1)(2009-5#1)(2010-11#1)(2013-1#1)
developed to determine the concentration of##2##6##(2008-10#2)
developed to determine the##8##4##(2008-10#6)(2008-5#1)(2011-2#1)
developed to determine##24##3##(2008-10#22)(2008-5#1)(2011-2#1)
developed to ensure##4##3##(2008-3#1)(2009-5#1)(2010-5#1)(2012-2#1)
developed to estimate##3##3##(1994-9#1)(2008-10#2)
developed to evaluate the##2##4##(2009-11#1)(2012-1#1)
developed to evaluate##7##3##(1996-7#1)(1997-2#1)(2008-10#2)(2009-11#1)(2012-1#1)(2013-1#1)
developed to examine the##2##4##(1992-1#1)(2010-7#1)
developed to examine##5##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)
developed to explain the##2##4##(2008-3#1)(2012-2#1)
developed to explain##3##3##(2008-3#1)(2010-3#1)(2012-2#1)
developed to extract##2##3##(2008-10#1)(2008-9#1)
developed to facilitate##6##3##(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
developed to guide the##2##4##(2008-10#1)(2010-7#1)
developed to guide##5##3##(1994-3#1)(2008-10#1)(2010-6#1)(2010-7#1)(2012-2#1)
developed to identify and##2##4##(2008-10#1)(2010-4#1)
developed to identify##5##3##(1992-12#1)(1994-2#1)(2008-10#1)(2010-4#1)(2012-1#1)
developed to improve the##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
developed to increase the##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
developed to isolate##2##3##(1990-7#1)(2008-10#1)
developed to limit##2##3##(2008-3#1)(2011-2#1)
developed to measure in situ the thermoelastic##2##7##(2007-12#1)(2008-3#1)
developed to measure##9##3##(1993-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#3)(2011-1#1)
developed to meet the##2##4##(2008-11#1)(2008-3#1)
developed to meet##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
developed to model##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
developed to modify##2##3##(2008-2#1)(2008-3#1)
developed to monitor##4##3##(2008-10#3)(2008-3#1)
developed to overcome the##3##4##(2008-3#2)(2013-1#1)
developed to overcome##6##3##(1994-6#1)(2008-1#1)(2008-3#2)(2013-1#1)(2013-7#1)
developed to permit##2##3##(2008-3#1)(2008-9#1)
developed to predict the##6##4##(1991-12#1)(2008-10#3)(2008-6#1)(2010-4#1)
developed to predict##8##3##(1991-12#1)(1992-3#1)(2008-10#4)(2008-6#1)(2010-4#1)
developed to provide a##4##4##(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
developed to provide##10##3##(1996-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)(2013-1#1)
developed to quantify the##4##4##(2007-12#1)(2008-10#3)
developed to quantify##7##3##(2007-12#1)(2008-10#6)
developed to quantitate the##2##4##(1991-9#1)(1992-12#1)
developed to quantitate##3##3##(1991-9#1)(1992-12#1)(1995-2#1)
developed to rapidly##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
developed to replace##3##3##(2008-10#1)(2009-10#1)(2010-8#1)
developed to reproduce##2##3##(1992-9#1)(2008-2#1)
developed to restore##2##3##(2008-3#1)(2009-12#1)
developed to separate##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
developed to simulate the##6##4##(2007-11#1)(2008-10#1)(2008-3#4)
developed to simulate##10##3##(2007-11#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-6#1)
developed to simultaneously##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
developed to solve the##3##4##(2008-10#1)(2008-3#2)
developed to solve this problem##3##5##(1997-1#1)(2008-3#1)(2010-2#1)
developed to solve##6##3##(1997-1#1)(2008-10#1)(2008-3#3)(2010-2#1)
developed to study the##10##4##(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2011-2#1)
developed to study##13##3##(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-7#2)(2011-2#1)
developed to target##2##3##(2010-4#1)(2012-3#1)
developed to test the##2##4##(2008-3#1)(2011-1#1)
developed to the##2##3##(1992-3#1)(1995-8#1)
developed to##340##2##(1990-7#1)(1991-12#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#104)(2008-11#16)(2008-12#10)(2008-2#17)(2008-3#43)(2008-4#3)(2008-5#4)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
developed transfection##2##2##(2008-11#2)
developed transient##3##2##(1990-6#1)(1991-8#1)(2010-3#1)
developed tumors##2##2##(2008-10#2)
developed two##8##2##(1993-6#1)(1997-1#1)(2008-10#3)(2008-8#2)(2012-2#1)
developed under the##2##3##(1994-11#1)(2012-2#1)
developed under##5##2##(1994-11#1)(1996-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
developed using Merrifield chloromethylated resin anchored with##3##7##(2008-10#3)
developed using a##7##3##(2007-8#2)(2008-10#5)
developed using an##3##3##(2007-11#1)(2008-10#2)
developed using the##4##3##(1990-2#1)(1996-2#1)(2008-10#2)
developed using##56##2##(1990-2#2)(1992-6#1)(1996-2#2)(2007-11#1)(2007-8#2)(2008-10#42)(2008-11#1)(2009-10#1)(2010-10#1)(2011-1#2)(2013-1#1)
developed via##2##2##(1992-2#1)(2008-10#1)
developed was used##2##3##(2008-10#2)
developed was##10##2##(1990-12#1)(1994-2#1)(2008-10#8)
developed were##5##2##(1994-12#1)(2008-10#4)
developed when##3##2##(1996-6#1)(2008-10#2)
developed which allows the##2##4##(1991-5#1)(2008-10#1)
developed which requires##2##3##(2008-10#2)
developed which was##2##3##(1991-2#1)(2008-10#1)
developed which##16##2##(1991-2#1)(1991-5#1)(1993-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2009-10#1)(2009-12#1)
developed while##2##2##(2007-5#1)(2012-12#1)
developed with a##7##3##(2008-10#2)(2008-11#3)(2008-2#1)(2009-7#1)
developed with the aim of##2##5##(1994-12#1)(2008-10#1)
developed with the aim##3##4##(1994-12#1)(2008-10#2)
developed with the##11##3##(1990-2#1)(1994-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)
developed with##44##2##(1990-2#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-5#1)(2007-11#3)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
developed within a##2##3##(2008-8#1)(2012-5#1)
developed within the##4##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)
developed within##9##2##(1991-12#1)(1992-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-5#1)
developed world and##3##3##(1994-9#1)(2008-8#1)(2013-1#1)
developed world##9##2##(1994-9#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
developed##4040##1##(1990-11#2)(1990-12#8)(1990-2#8)(1990-3#4)(1990-5#2)(1990-6#5)(1990-7#2)(1990-8#18)(1990-9#7)(1991-1#4)(1991-11#4)(1991-12#12)(1991-2#12)(1991-3#6)(1991-5#5)(1991-6#7)(1991-8#9)(1991-9#9)(1992-1#6)(1992-10#2)(1992-11#9)(1992-12#12)(1992-2#7)(1992-3#16)(1992-4#2)(1992-5#5)(1992-6#12)(1992-8#3)(1992-9#2)(1993-1#7)(1993-10#2)(1993-11#3)(1993-12#16)(1993-2#9)(1993-3#8)(1993-6#4)(1993-8#7)(1994-1#2)(1994-11#8)(1994-12#33)(1994-2#9)(1994-3#23)(1994-5#5)(1994-6#5)(1994-7#4)(1994-8#1)(1994-9#8)(1995-1#5)(1995-11#6)(1995-12#19)(1995-2#19)(1995-3#7)(1995-4#1)(1995-5#4)(1995-6#6)(1995-8#3)(1995-9#2)(1996-1#14)(1996-11#5)(1996-12#20)(1996-2#15)(1996-3#13)(1996-4#1)(1996-5#15)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#10)(1997-2#15)(1997-3#17)(1997-4#10)(1997-5#7)(1997-6#10)(1997-7#6)(1997-8#10)(2006-10#14)(2006-12#4)(2006-4#3)(2006-7#1)(2007-10#18)(2007-11#54)(2007-12#67)(2007-2#6)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#22)(2007-8#23)(2007-9#2)(2008-1#30)(2008-10#1529)(2008-11#133)(2008-12#45)(2008-2#105)(2008-3#267)(2008-4#36)(2008-5#81)(2008-6#36)(2008-7#114)(2008-8#53)(2008-9#52)(2009-10#12)(2009-11#13)(2009-12#15)(2009-2#4)(2009-3#11)(2009-4#11)(2009-5#11)(2009-6#13)(2009-7#9)(2009-8#14)(2009-9#5)(2010-1#6)(2010-10#13)(2010-11#11)(2010-12#16)(2010-2#3)(2010-3#14)(2010-4#21)(2010-5#22)(2010-6#10)(2010-7#18)(2010-8#28)(2010-9#5)(2011-1#68)(2011-2#93)(2011-3#10)(2011-7#1)(2012-1#13)(2012-12#44)(2012-2#55)(2012-3#46)(2012-5#2)(2012-6#2)(2012-7#1)(2013-1#87)(2013-7#3)(2013-8#22)
developement and##2##2##(1997-2#1)(2006-8#1)
developer sample##2##2##(2008-10#2)
developer##12##1##(1994-1#1)(2008-10#9)(2008-2#2)
developers and##3##2##(1995-3#1)(2007-5#1)(2008-7#1)
developers of##6##2##(1994-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-11#1)
developers##15##1##(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-7#3)(2009-11#1)
developing CRC##2##2##(2012-2#2)
developing Drosophila##4##2##(1993-12#1)(1993-8#1)(2008-9#2)
developing T2D##3##2##(2009-3#3)
developing a forecasting system##2##4##(2008-10#2)
developing a health##2##3##(1997-1#1)(2011-2#1)
developing a more##4##3##(2008-11#1)(2008-5#1)(2010-5#1)(2010-8#1)
developing a national##2##3##(1994-12#1)(2008-1#1)
developing a new##3##3##(1990-12#1)(1992-8#1)(1996-5#1)
developing a strategic##2##3##(1992-3#1)(2008-11#1)
developing a##81##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#2)(1995-1#2)(1995-12#2)(1995-2#3)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#3)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-8#1)(2012-2#2)(2013-1#3)(2013-8#2)
developing after##5##2##(1992-11#1)(2008-10#2)(2008-12#1)(2013-8#1)
developing an effective##4##3##(1995-1#1)(1995-9#1)(2009-12#1)(2011-2#1)
developing an##22##2##(1993-9#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#2)(2011-2#1)(2012-12#4)(2012-2#1)
developing and developed countries##3##4##(1990-9#1)(2010-10#1)(2011-2#1)
developing and implementing a##3##4##(1992-2#1)(1995-12#2)
developing and implementing##9##3##(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#2)(2007-11#1)(2008-11#2)(2011-1#1)
developing and mature##3##3##(1991-7#1)(1996-2#1)(2008-4#1)
developing and monitoring##2##3##(1997-2#1)(2008-11#1)
developing and##39##2##(1990-9#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
developing approach to##2##3##(2008-8#1)(2009-10#1)
developing better##2##2##(2008-4#1)(2012-12#1)
developing bolls##3##2##(2008-10#3)
developing brain##6##2##(1994-2#1)(1995-12#2)(1996-2#1)(2007-12#1)(2008-7#1)
developing breast cancer than##2##4##(1993-1#1)(2008-12#1)
developing breast cancer##8##3##(1991-2#1)(1993-1#1)(1995-9#1)(2008-12#2)(2008-4#1)(2012-3#2)
developing cardiovascular##2##2##(2008-10#1)(2012-2#1)
developing clinical##6##2##(1993-12#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)
developing clinically##2##2##(2008-11#1)(2013-1#1)
developing colorectal carcinoma##2##3##(1992-9#2)
developing comprehensive##2##2##(1992-12#1)(1995-1#1)
developing computerized##2##2##(1994-3#1)(1997-1#1)
developing cotton##2##2##(1993-3#1)(2008-9#1)
developing countries and##5##3##(2007-7#1)(2009-4#1)(2010-6#1)(2011-2#2)
developing countries in##2##3##(2009-4#1)(2010-12#1)
developing countries like##2##3##(2011-2#1)(2012-2#1)
developing countries must##2##3##(1993-3#1)(2010-12#1)
developing countries of Asia and the##2##6##(2008-1#1)(2012-12#1)
developing countries of Asia##3##4##(2007-12#1)(2008-1#1)(2012-12#1)
developing countries of##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
developing countries where##2##3##(1993-3#1)(1997-8#1)
developing countries##113##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-2#2)(1992-5#1)(1993-3#3)(1994-12#1)(1994-9#3)(1995-9#2)(1996-12#3)(1996-3#1)(1997-7#3)(1997-8#1)(2007-10#2)(2007-12#3)(2007-7#6)(2008-1#4)(2008-10#5)(2008-11#5)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-4#8)(2009-5#1)(2009-6#2)(2009-9#2)(2010-12#5)(2010-4#1)(2010-6#1)(2010-8#5)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)
developing countries]##2##2##(1991-6#1)(2011-2#1)
developing country##12##2##(1993-9#1)(1994-9#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
developing diabetes##3##2##(2008-1#2)(2012-5#1)
developing drug-induced##2##2##(2008-8#1)(2010-8#1)
developing early##2##2##(1994-3#1)(2012-2#1)
developing educational##3##2##(1996-1#1)(2008-11#1)(2010-3#1)
developing effective##3##2##(1997-3#1)(2008-10#2)
developing embryos##2##2##(1994-8#1)(2012-1#1)
developing field of##2##3##(2008-10#1)(2009-4#1)
developing field##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
developing follicles##2##2##(2008-12#1)(2008-8#1)
developing from infected##2##3##(2008-10#2)
developing from##7##2##(2008-10#4)(2008-8#1)(2013-1#2)
developing germ cells must##2##4##(2009-10#2)
developing germ cells##5##3##(2009-10#3)(2012-2#2)
developing germ tubes##3##3##(2008-10#3)
developing germ##8##2##(2008-10#3)(2009-10#3)(2012-2#2)
developing improved##3##2##(1995-2#1)(1996-12#1)(2008-9#1)
developing in a patient##2##4##(2007-8#1)(2011-2#1)
developing in a##3##3##(2007-8#1)(2008-9#1)(2011-2#1)
developing in situ##2##3##(1993-5#1)(2008-8#1)
developing in vitro##2##3##(2009-12#2)
developing in##16##2##(1993-5#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#3)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#3)
developing kidney##2##2##(2010-11#1)(2013-1#1)
developing limb##6##2##(2008-11#4)(2009-3#1)(2010-3#1)
developing linguistic##2##2##(2010-8#2)
developing malignant##2##2##(1996-9#1)(2012-3#1)
developing management##3##2##(1990-4#1)(1994-2#1)(2011-2#1)
developing models##2##2##(1992-2#1)(1992-3#1)
developing mouse##2##2##(1994-2#1)(2008-5#1)
developing nations##3##2##(2007-12#1)(2009-4#1)(2011-2#1)
developing new##15##2##(1997-3#2)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-2#1)(2012-3#1)
developing novel##4##2##(2008-11#1)(2009-1#1)(2012-2#1)(2013-1#1)
developing nutrition##2##2##(1992-12#1)(1995-3#1)
developing on##2##2##(1990-8#1)(2008-8#1)
developing oocyte##2##2##(2007-12#1)(2008-10#1)
developing oocytes of##2##3##(2008-7#2)
developing over##2##2##(2008-11#1)(2008-3#1)
developing premature##2##2##(1992-9#1)(2011-2#1)
developing processes##2##2##(1993-3#1)(2008-3#1)
developing professional##3##2##(1996-12#1)(2008-11#2)
developing rat brains##2##3##(1991-7#1)(2008-1#1)
developing rat cerebellum##2##3##(1993-11#2)
developing rat stomach mucosa##2##4##(1993-11#2)
developing rat##10##2##(1991-7#1)(1993-11#5)(1996-12#1)(1996-5#2)(2008-1#1)
developing rats##2##2##(1991-12#1)(1994-5#1)
developing reflective##2##2##(2008-9#1)(2012-12#1)
developing regional##2##2##(1992-12#1)(2008-10#1)
developing resistance##2##2##(2008-10#1)(2013-8#1)
developing sample##2##2##(2008-1#1)(2008-10#1)
developing skin##3##2##(1991-6#1)(2008-5#1)(2012-3#1)
developing solution##7##2##(2008-10#7)
developing spontaneous##2##2##(2008-4#1)(2012-12#1)
developing staff##2##2##(2008-6#1)(2013-8#1)
developing strategies##4##2##(1992-3#1)(1997-6#1)(2009-12#1)(2010-10#1)
developing such##3##2##(1993-3#1)(2008-4#1)(2009-6#1)
developing sustainable##2##2##(1997-7#1)(2011-1#1)
developing systemic##2##2##(1994-9#1)(1997-6#1)
developing systems##2##2##(2008-10#1)(2008-3#1)
developing the##28##2##(1990-11#1)(1992-9#2)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#1)
developing their##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
developing tranilast##2##2##(2008-5#2)
developing tumors##2##2##(2012-12#1)(2012-3#1)
developing two##2##2##(2008-8#1)(2011-2#1)
developing ways to##2##3##(1994-12#1)(1996-9#1)
developing within##2##2##(1992-1#1)(2008-6#1)
developing world##21##2##(1997-7#4)(2007-2#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#2)
developing##922##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#3)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#8)(1993-1#2)(1993-11#8)(1993-12#4)(1993-2#1)(1993-3#7)(1993-5#5)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#8)(1994-3#9)(1994-5#1)(1994-8#4)(1994-9#8)(1995-1#4)(1995-12#11)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-9#4)(1996-1#2)(1996-12#11)(1996-2#8)(1996-3#6)(1996-5#11)(1996-6#1)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#12)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#1)(1997-9#2)(2007-10#3)(2007-11#4)(2007-12#20)(2007-2#1)(2007-5#1)(2007-7#8)(2007-8#2)(2008-1#16)(2008-10#104)(2008-11#58)(2008-12#29)(2008-2#3)(2008-3#9)(2008-4#19)(2008-5#23)(2008-6#10)(2008-7#28)(2008-8#21)(2008-9#17)(2009-1#2)(2009-10#9)(2009-11#4)(2009-12#8)(2009-3#7)(2009-4#12)(2009-5#6)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#3)(2010-10#5)(2010-11#4)(2010-12#15)(2010-2#2)(2010-3#4)(2010-4#9)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#11)(2010-9#2)(2011-1#11)(2011-2#35)(2011-3#4)(2011-8#1)(2012-1#4)(2012-12#20)(2012-2#25)(2012-3#20)(2012-5#1)(2013-1#29)(2013-7#1)(2013-8#14)
development -##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
development a##2##2##(1992-5#1)(2009-8#1)
development activities##5##2##(1996-3#1)(2007-5#1)(2008-11#1)(2012-1#2)
development after##3##2##(1996-9#2)(2010-5#1)
development also##2##2##(2009-8#1)(2011-2#1)
development among the##2##3##(2008-10#1)(2013-1#1)
development among##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
development and a##5##3##(1992-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
development and aging##4##3##(2008-7#3)(2008-9#1)
development and application##10##3##(1994-3#1)(1996-3#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
development and are##3##3##(1993-6#1)(1993-8#1)(2008-10#1)
development and characterization of##4##4##(2008-10#1)(2008-3#2)(2013-1#1)
development and clinical##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
development and current##2##3##(2007-11#1)(2008-12#1)
development and delivery of##2##4##(2008-12#2)
development and delivery##3##3##(2008-12#3)
development and differentiation of##2##4##(1995-8#1)(2008-7#1)
development and differentiation##4##3##(1995-8#1)(2008-7#2)(2008-8#1)
development and expansion##2##3##(2008-10#1)(2009-4#1)
development and for##4##3##(1997-7#1)(2008-5#1)(2009-3#1)(2009-8#1)
development and function of##3##4##(2007-5#1)(2008-4#1)(2009-4#1)
development and function##11##3##(2007-5#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-4#1)(2010-11#1)(2010-7#1)(2013-1#1)
development and functional##2##3##(2008-8#2)
development and germination##2##3##(1995-6#1)(2008-10#1)
development and growth of##4##4##(2008-10#4)
development and growth##7##3##(2008-10#4)(2008-9#1)(2011-1#1)(2013-7#1)
development and implementation of a##4##5##(1993-3#3)(2012-2#1)
development and implementation of an##2##5##(1992-3#1)(2008-11#1)
development and implementation of##17##4##(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-2#2)(2008-11#3)(2008-2#1)(2009-12#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
development and implementation##22##3##(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#3)(1995-2#1)(2008-11#4)(2008-2#1)(2009-12#1)(2009-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
development and in adults##2##4##(1997-6#1)(2008-7#1)
development and in##6##3##(1994-2#1)(1994-3#1)(1997-6#1)(2008-7#1)(2009-11#1)(2009-8#1)
development and initial##2##3##(1996-3#1)(1997-1#1)
development and innovation##2##3##(2008-1#1)(2008-11#1)
development and integrity##2##3##(2012-12#2)
development and its##3##3##(1994-5#1)(2008-10#1)(2013-8#1)
development and learning##3##3##(2007-8#1)(2008-11#2)
development and maintenance of##8##4##(1993-8#1)(1996-5#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-2#1)
development and maintenance##9##3##(1993-8#1)(1996-5#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-2#2)
development and maturation of##2##4##(1992-12#1)(2008-10#1)
development and optimization of##3##4##(2008-10#3)
development and organization##2##3##(2008-4#1)(2009-11#1)
development and physiology##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
development and plant##2##3##(2008-10#1)(2008-9#1)
development and preliminary##2##3##(2008-10#1)(2010-6#1)
development and production of##2##4##(1995-5#1)(2008-12#1)
development and production##4##3##(1992-12#1)(1995-5#1)(2008-12#1)(2008-5#1)
development and progression of##15##4##(1993-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
development and progression##18##3##(1993-9#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#2)
development and regulation of##2##4##(2012-3#1)(2013-1#1)
development and regulation##4##3##(2012-3#3)(2013-1#1)
development and remodeling##2##3##(2009-9#1)(2013-1#1)
development and repair##2##3##(1994-3#1)(2007-8#1)
development and reproduction##3##3##(2008-10#1)(2010-3#1)(2010-5#1)
development and research##2##3##(1992-8#1)(2007-12#1)
development and spermatogenesis##2##3##(2009-10#1)(2012-2#1)
development and stress responses##2##4##(2009-10#1)(2009-6#1)
development and stress##5##3##(2009-10#3)(2009-6#1)(2009-8#1)
development and survival of##3##4##(1993-3#1)(2010-10#1)(2011-2#1)
development and testing of a##3##5##(1996-2#1)(2007-11#1)(2008-10#1)
development and testing of##4##4##(1992-2#1)(1996-2#1)(2007-11#1)(2008-10#1)
development and testing##5##3##(1992-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
development and the##11##3##(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
development and to##5##3##(1993-12#1)(1994-1#1)(1994-3#1)(1996-12#1)(2012-2#1)
development and treatment##2##3##(2008-3#1)(2012-12#1)
development and use of##10##4##(1992-1#1)(1992-12#1)(1993-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
development and use##12##3##(1992-1#1)(1992-12#1)(1993-12#1)(1997-3#1)(2008-10#3)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
development and validation of a##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
development and validation of##5##4##(2008-10#1)(2008-5#2)(2008-7#2)
development and validation##10##3##(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#3)(2010-11#1)
development and##423##2##(1990-3#2)(1991-1#2)(1991-12#3)(1991-3#1)(1992-1#3)(1992-12#5)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-8#3)(2008-1#7)(2008-10#62)(2008-11#24)(2008-12#15)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#16)(2008-6#3)(2008-7#25)(2008-8#15)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-8#6)(2009-9#3)(2010-10#3)(2010-11#6)(2010-12#2)(2010-2#1)(2010-3#4)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#16)(2011-8#1)(2012-1#1)(2012-12#11)(2012-2#14)(2012-3#10)(2012-4#1)(2012-5#1)(2013-1#17)(2013-7#1)(2013-8#4)
development and/or##3##2##(1995-6#1)(2008-6#1)(2013-8#1)
development are discussed##5##3##(1993-12#1)(1993-3#1)(2008-10#1)(2009-8#1)(2012-3#1)
development are##20##2##(1993-12#1)(1993-3#1)(1993-9#3)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-8#3)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
development as a teacher##3##4##(2012-1#3)
development as a##11##3##(2008-1#2)(2008-11#2)(2009-11#1)(2009-9#1)(2010-5#1)(2012-1#4)
development as well as##5##4##(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#2)
development as##23##2##(1995-11#1)(1996-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-3#1)
development at the##2##3##(2008-2#1)(2008-5#1)
development at work##3##3##(2011-1#3)
development at##16##2##(1990-6#1)(1992-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2011-1#3)(2012-3#1)
development based on##3##3##(1994-2#1)(2008-10#1)(2010-11#1)
development based##4##2##(1994-2#1)(2008-10#2)(2010-11#1)
development because##2##2##(1993-9#1)(2008-10#1)
development between##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2009-7#1)
development by the##2##3##(2008-10#1)(2012-2#1)
development by##31##2##(1992-3#1)(1996-5#1)(1997-4#1)(2008-10#7)(2008-5#16)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)
development can be##3##3##(1995-6#1)(2008-4#1)(2008-8#1)
development can##7##2##(1994-2#1)(1995-6#1)(2008-10#1)(2008-4#2)(2008-8#1)(2012-2#1)
development caused by##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
development course##2##2##(2008-1#1)(2008-11#1)
development depends on##2##3##(1995-2#1)(2009-7#1)
development during adolescence##3##3##(2008-11#3)
development during the##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
development during##16##2##(1992-3#2)(2008-10#2)(2008-11#5)(2008-8#1)(2008-9#1)(2011-1#2)(2013-1#2)(2013-8#1)
development efforts##6##2##(1992-12#1)(1994-1#1)(2008-11#2)(2008-8#1)(2011-2#1)
development environment##2##2##(2008-10#2)
development following##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
development for health##2##3##(1994-1#1)(1995-3#1)
development for medical##2##3##(2009-10#1)(2009-12#1)
development for the##9##3##(1991-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
development for##39##2##(1991-3#1)(1991-5#1)(1992-1#1)(1994-1#1)(1994-9#1)(1995-3#1)(1997-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
development from##7##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
development goals##4##2##(2011-1#3)(2012-12#1)
development has been##3##3##(1994-11#1)(2008-11#1)(2013-1#1)
development has##14##2##(1994-11#1)(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-11#2)(2009-5#1)(2010-8#1)(2013-1#1)
development have been##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
development have##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
development in Arabidopsis##2##3##(2010-9#1)(2011-1#1)
development in Drosophila##2##3##(2009-7#1)(2012-2#1)
development in New##2##3##(1991-2#1)(2008-10#1)
development in a##10##3##(1990-11#1)(1992-12#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-3#1)
development in boys##2##3##(2008-4#1)(2013-1#1)
development in children with##4##4##(2006-8#1)(2008-9#2)(2010-10#1)
development in children##5##3##(2006-8#1)(2008-9#2)(2010-10#1)(2013-1#1)
development in humans##3##3##(2008-10#1)(2008-4#2)
development in insects##2##3##(2007-12#1)(2008-7#1)
development in relation to the##2##5##(2008-11#2)
development in the field of##3##5##(2008-3#1)(2008-9#1)(2010-8#1)
development in the field##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
development in the##36##3##(1991-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
development in this area##4##4##(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
development in this##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)
development in vitro##2##3##(2008-10#1)(2008-9#1)
development in vivo##2##3##(2008-10#1)(2008-11#1)
development in##170##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#12)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#4)(2012-2#3)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#2)
development include##4##2##(1994-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
development included##2##2##(2008-10#1)(2008-7#1)
development increased##2##2##(2008-10#2)
development initiatives##4##2##(1992-1#1)(2008-10#1)(2010-12#2)
development instrument##3##2##(2008-11#2)(2013-8#1)
development into##3##2##(1992-1#1)(1994-6#1)(2010-9#1)
development involves the##2##3##(2007-5#1)(2008-11#1)
development involves##3##2##(1995-12#1)(2007-5#1)(2008-11#1)
development is a##3##3##(1993-2#1)(2008-10#1)(2010-12#1)
development is an##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
development is difficult##2##3##(1995-2#1)(2010-9#1)
development is normal##2##3##(1997-8#1)(2010-2#1)
development is often##2##3##(1997-2#1)(2009-9#1)
development is one##2##3##(2007-12#1)(2008-11#1)
development is presented##2##3##(2008-10#1)(2012-12#1)
development is still##2##3##(2007-12#1)(2008-11#1)
development is the##2##3##(2007-12#1)(2009-5#1)
development is##54##2##(1992-2#2)(1993-2#1)(1993-5#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#6)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
development may contribute to the##2##5##(1995-12#1)(1996-5#1)
development may##9##2##(1992-12#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-1#1)
development module##2##2##(2008-12#1)(2010-5#1)
development needs of##3##3##(1995-12#1)(2012-2#1)(2012-3#1)
development needs##4##2##(1994-1#1)(1995-12#1)(2012-2#1)(2012-3#1)
development of ARM##2##3##(2011-2#2)
development of ASD##2##3##(2012-12#1)(2012-3#1)
development of B##3##3##(1991-5#1)(1994-3#1)(2008-10#1)
development of Drosophila melanogaster##2##4##(1997-8#2)
development of IABP##2##3##(2010-8#2)
development of P##2##3##(2008-10#2)
development of S##2##3##(2008-10#1)(2010-8#1)
development of Tabebuia rosea##2##4##(2008-5#2)
development of a catalytic##2##4##(2008-10#1)(2010-6#1)
development of a comprehensive##3##4##(1995-3#1)(1997-3#1)(1997-8#1)
development of a continuous##2##4##(2008-10#1)(2011-1#1)
development of a highly sensitive##2##5##(2008-10#2)
development of a highly##3##4##(2008-10#2)(2008-3#1)
development of a hybrid artificial liver##2##6##(2008-11#2)
development of a method for the determination of##2##8##(2008-10#2)
development of a method##3##4##(2008-10#2)(2008-4#1)
development of a national##2##4##(2008-10#1)(2008-3#1)
development of a new class of##2##6##(2008-5#1)(2013-1#1)
development of a new##18##4##(1995-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
development of a novel##3##4##(2008-10#2)(2010-12#1)
development of a number of##2##5##(2008-4#2)
development of a process##2##4##(2008-10#1)(2008-11#1)
development of a sensitive##2##4##(1990-2#1)(2008-10#1)
development of a single##4##4##(1996-5#1)(2008-10#1)(2011-1#1)(2013-1#1)
development of a solid##2##4##(2008-10#2)
development of a##219##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-3#1)(1991-9#3)(1992-1#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#7)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#56)(2008-11#14)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#5)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#8)(2011-7#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)
development of accurate##2##3##(2008-10#2)
development of additional##3##3##(2007-12#1)(2011-1#2)
development of adequate##2##3##(1997-1#1)(2011-2#1)
development of an artificial##2##4##(2009-11#1)(2009-4#1)
development of an automated##2##4##(2008-10#1)(2010-8#1)
development of an integrated##5##4##(1992-3#1)(2006-9#1)(2008-10#2)(2008-6#1)
development of an optical biosensor based on##2##7##(2008-10#2)
development of an##51##3##(1990-12#1)(1990-2#1)(1991-1#2)(1992-3#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-3#6)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
development of analytical methods for##3##5##(2008-10#3)
development of analytical##5##3##(2008-10#4)(2011-2#1)
development of animal models of##2##5##(1992-9#1)(2008-4#1)
development of animal##4##3##(1992-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
development of anthracnose lesions##2##4##(1997-6#2)
development of anti-HIV-1 drugs##2##4##(2011-2#2)
development of anti-nuclear##2##3##(2008-10#2)
development of appropriate##4##3##(1995-12#1)(2007-10#1)(2008-1#1)(2011-2#1)
development of artificial##3##3##(2009-11#1)(2011-1#1)(2013-1#1)
development of asthma##3##3##(2008-12#1)(2010-5#1)(2012-3#1)
development of atherosclerosis and##2##4##(1995-8#1)(2012-2#1)
development of atherosclerosis##4##3##(1995-8#1)(2008-1#1)(2012-2#1)(2012-3#1)
development of autoimmunity##4##3##(2008-10#2)(2010-5#2)
development of baccalaureate##2##3##(1991-1#1)(1994-2#1)
development of bacterial resistance##2##4##(1997-3#1)(2009-5#1)
development of bacterial##3##3##(1997-3#1)(2008-10#1)(2009-5#1)
development of better##3##3##(1996-4#1)(2008-7#1)(2011-1#1)
development of biological##2##3##(1990-2#1)(2013-1#1)
development of both##7##3##(1991-8#1)(1992-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-10#1)
development of brown rot##3##4##(2008-10#3)
development of brown##4##3##(2008-10#4)
development of cancer##4##3##(1990-12#1)(2008-11#1)(2009-5#1)(2011-3#1)
development of cardiac##3##3##(2008-12#1)(2010-6#1)(2010-8#1)
development of cardiovascular disease##7##4##(1997-8#1)(2008-1#2)(2008-3#1)(2008-7#2)(2011-1#1)
development of cardiovascular##9##3##(1997-8#1)(2008-1#2)(2008-3#1)(2008-7#3)(2011-1#1)(2013-7#1)
development of cerebral##4##3##(1995-5#1)(1995-6#1)(2008-7#1)(2008-9#1)
development of children with a##2##5##(1993-1#1)(2010-10#1)
development of children with##4##4##(1993-1#2)(2010-10#1)(2012-3#1)
development of children##9##3##(1993-1#3)(2008-11#2)(2010-1#1)(2010-10#1)(2012-3#1)(2013-1#1)
development of chronic kidney disease (CKD)##2##6##(2009-1#1)(2010-10#1)
development of chronic kidney disease##3##5##(2008-8#1)(2009-1#1)(2010-10#1)
development of chronic##9##3##(1994-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-1#1)(2010-10#1)(2011-2#1)(2013-1#2)
development of cirrhosis##2##3##(1996-11#1)(2013-8#1)
development of clinical placements##2##4##(2008-11#1)(2008-12#1)
development of clinical##17##3##(1992-6#1)(1993-12#1)(1996-1#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#2)
development of colonies##2##3##(1997-6#1)(2010-2#1)
development of colorectal##3##3##(1993-8#1)(1994-2#1)(2011-2#1)
development of combination##2##3##(1995-5#1)(2007-10#1)
development of community##2##3##(1996-4#1)(2011-2#1)
development of coronary heart##2##4##(1996-3#1)(2008-3#1)
development of coronary##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
development of dementia##2##3##(1995-12#1)(2013-1#1)
development of diabetes mellitus##2##4##(2010-11#1)(2011-2#1)
development of diabetes##4##3##(2008-1#1)(2010-11#1)(2011-2#1)(2013-7#1)
development of diabetic##4##3##(2008-1#1)(2009-11#1)(2011-1#1)(2012-2#1)
development of different##3##3##(2008-10#1)(2010-8#2)
development of disease##4##3##(2008-1#1)(2008-10#2)(2008-8#1)
development of drug##5##3##(1990-8#1)(1997-6#1)(2007-11#1)(2010-7#1)(2012-2#1)
development of drugs##4##3##(2008-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
development of early##7##3##(1990-2#1)(1992-12#1)(1994-2#1)(2007-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
development of effective##7##3##(1993-12#1)(1995-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
development of efficient##3##3##(2008-10#1)(2012-2#1)(2013-7#1)
development of entomology##2##3##(2010-1#2)
development of fusarium##2##3##(2008-10#2)
development of gene##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
development of genetic##2##3##(2008-10#1)(2008-4#1)
development of guidelines and##2##4##(1992-2#1)(2009-4#1)
development of guidelines##3##3##(1992-2#1)(2009-4#1)(2013-1#1)
development of health##2##3##(1992-1#1)(2008-11#1)
development of heart##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
development of high##2##3##(2008-10#1)(2010-4#1)
development of high-throughput##2##3##(2008-7#1)(2009-8#1)
development of hip##2##3##(2007-11#2)
development of human##9##3##(1991-3#1)(1994-12#1)(1994-5#1)(1995-3#2)(2007-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
development of hyperalgesia##4##3##(1993-12#3)(1996-5#1)
development of hypertension was##2##4##(1997-6#2)
development of hypertension##7##3##(1997-6#4)(2008-1#1)(2010-2#1)(2011-2#1)
development of hypertrophic##2##3##(1991-2#1)(2008-9#1)
development of improved##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
development of individual##2##3##(2008-9#1)(2010-8#1)
development of infants##2##3##(1992-12#1)(1994-6#1)
development of infection##2##3##(2008-10#2)
development of inflammation##2##3##(1991-2#1)(2013-8#1)
development of inhibitors##2##3##(2008-4#1)(2012-12#1)
development of insulin resistance and##2##5##(2010-12#1)(2012-2#1)
development of insulin resistance##9##4##(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#3)(2012-2#1)(2012-5#1)(2013-1#1)
development of insulin##10##3##(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#3)(2012-2#1)(2012-5#1)(2013-1#1)
development of integrated##3##3##(1996-3#1)(1997-3#1)(2011-2#1)
development of latent##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
development of lung##2##3##(1991-2#1)(1994-6#1)
development of macular degeneration##2##4##(2011-2#2)
development of malignant##3##3##(1992-2#1)(2007-8#1)(2011-2#1)
development of many##5##3##(2007-12#1)(2008-6#2)(2010-12#1)(2013-8#1)
development of media##2##3##(2008-11#1)(2008-12#1)
development of medical##6##3##(1993-2#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#2)
development of methods##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-7#1)
development of minimally invasive##4##4##(2007-8#1)(2008-11#1)(2009-4#1)(2011-2#1)
development of modern##3##3##(1991-11#1)(2007-8#1)(2012-3#1)
development of molecular##5##3##(2008-10#3)(2008-2#1)(2011-1#1)
development of more effective##3##4##(1993-12#1)(2007-7#1)(2009-12#1)
development of more specific##2##4##(2010-11#1)(2012-2#1)
development of more##19##3##(1993-12#1)(1994-5#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#2)
development of mouse##2##3##(2008-11#2)
development of multiple##7##3##(1996-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
development of neurodegenerative##2##3##(1994-11#1)(2008-11#1)
development of new and##3##4##(1994-9#1)(1997-4#1)(2010-11#1)
development of new drugs##2##4##(2007-2#1)(2008-8#1)
development of new materials##2##4##(2009-8#1)(2010-10#1)
development of new treatment##2##4##(2008-9#1)(2010-12#1)
development of new##78##3##(1991-12#1)(1991-8#2)(1991-9#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#3)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
development of next generation##2##4##(2012-2#2)
development of non-Hodgkin's lymphoma##2##4##(2007-10#2)
development of novel anti-HIV-1##2##4##(2011-2#1)(2011-3#1)
development of novel deodorant systems##3##5##(2008-5#3)
development of novel##26##3##(1994-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
development of nursing##5##3##(1997-7#1)(2008-1#1)(2008-12#2)(2012-3#1)
development of obesity##2##3##(1991-6#1)(1995-5#1)
development of one##3##3##(1992-1#1)(2008-10#2)
development of ontogenic resistance##3##4##(2008-10#3)
development of osteoarthritis##2##3##(2007-11#1)(2009-3#1)
development of our##3##3##(1997-8#1)(2008-9#1)(2012-2#1)
development of periodontal disease##2##4##(1997-4#1)(2012-12#1)
development of pharmaceutical products##2##4##(1997-2#1)(2008-10#1)
development of pharmaceutical##3##3##(1997-2#1)(2008-10#2)
development of phasic and tonic inhibition##2##6##(2011-2#2)
development of physical therapy##2##4##(1991-3#1)(1996-1#1)
development of physical##4##3##(1991-3#1)(1996-1#1)(2008-12#1)(2008-7#1)
development of piezoelectric##2##3##(2008-10#2)
development of policies##3##3##(1996-1#1)(2007-5#1)(2010-7#1)
development of polish##2##3##(2007-8#2)
development of populations##2##3##(2008-10#2)
development of potential##2##3##(2008-10#1)(2008-7#1)
development of powdery mildew on##2##5##(2008-10#2)
development of primary##4##3##(1993-10#1)(1996-1#1)(2008-8#1)(2009-9#1)
development of products##2##3##(2008-11#1)(2008-5#1)
development of pulmonary edema##2##4##(1994-8#1)(2008-11#1)
development of pulmonary##3##3##(1994-8#1)(2008-11#1)(2009-5#1)
development of quality measures##2##4##(1996-2#1)(1997-2#1)
development of quality##4##3##(1995-2#1)(1996-2#1)(1997-2#1)(2012-12#1)
development of quantitative##2##3##(2008-9#1)(2009-5#1)
development of rapid##5##3##(2008-10#3)(2008-7#1)(2008-8#1)
development of rat##2##3##(1996-2#1)(2008-11#1)
development of reflective skills##2##4##(2008-11#1)(2008-12#1)
development of reflective##3##3##(2008-11#1)(2008-12#2)
development of regional##3##3##(1992-12#1)(1996-2#1)(2012-12#1)
development of reliable##3##3##(1993-6#1)(2008-7#1)(2010-11#1)
development of renal##2##3##(2010-11#1)(2013-1#1)
development of research priorities for##2##5##(2007-11#2)
development of research##3##3##(2007-11#2)(2008-11#1)
development of resistance to##3##4##(2012-1#1)(2012-3#2)
development of resistance##8##3##(1994-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-1#1)(2012-3#2)
development of rust##2##3##(2008-10#2)
development of second-generation##2##3##(2010-12#1)(2012-2#1)
development of selective##3##3##(2008-4#1)(2009-5#1)(2009-7#1)
development of several##6##3##(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
development of severe dengue##2##4##(2011-2#2)
development of sexually##2##3##(1993-5#1)(2008-4#1)
development of skin cancer##2##4##(1991-6#1)(2011-2#1)
development of skin##3##3##(1991-6#1)(2011-2#2)
development of social##2##3##(2008-11#1)(2008-12#1)
development of some##2##3##(1997-7#1)(2008-5#1)
development of specific##10##3##(1991-12#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
development of speech##2##3##(2008-9#1)(2012-1#1)
development of spontaneous head movements##2##5##(1993-12#2)
development of spontaneous##3##3##(1993-12#2)(2008-6#1)
development of standardized##2##3##(2008-10#1)(2012-3#1)
development of stem##2##3##(2008-10#1)(2008-11#1)
development of strategies for##3##4##(1994-3#1)(2013-1#2)
development of strategies##6##3##(1994-3#1)(2007-8#1)(2010-11#1)(2012-3#1)(2013-1#2)
development of successful##2##3##(1996-11#1)(2008-10#1)
development of such##8##3##(1994-1#1)(1995-3#1)(1996-11#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-3#1)(2012-2#1)
development of symptoms##3##3##(2008-10#3)
development of synthetic##2##3##(2008-7#1)(2009-5#1)
development of targeted##2##3##(2008-5#1)(2011-3#1)
development of technologies##2##3##(1995-5#1)(2010-7#1)
development of the brain##2##4##(1993-3#1)(2007-12#1)
development of the concept##2##4##(1996-3#1)(2009-5#1)
development of the cultivation of a bone marrow stromal cell line##2##11##(2008-11#2)
development of the disease##3##4##(1990-6#1)(2010-10#1)(2013-1#1)
development of the diseases##2##4##(1993-11#1)(2008-3#1)
development of the facial##2##4##(1996-5#1)(2007-12#1)
development of the first##2##4##(2008-8#1)(2012-2#1)
development of the hip##2##4##(2007-11#2)
development of the immune system##2##5##(1995-12#1)(2008-10#1)
development of the immune##3##4##(1993-12#1)(1995-12#1)(2008-10#1)
development of the mouse##3##4##(1992-12#1)(1993-3#1)(1997-4#1)
development of the nervous system##5##5##(1994-11#1)(2007-12#2)(2008-7#1)(2009-3#1)
development of the pancreas##2##4##(2010-11#1)(2013-1#1)
development of the pathogen##2##4##(2008-10#2)
development of the polycystic ovary syndrome##2##6##(2008-4#2)
development of the role##2##4##(2008-11#1)(2008-12#1)
development of the skill of reflection##2##6##(2008-11#2)
development of the vesico-ureteric junction##2##5##(2008-10#2)
development of the##198##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-3#2)(1991-6#2)(1991-9#3)(1992-1#1)(1992-12#2)(1992-6#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#4)(2007-12#13)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#10)(2008-12#10)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#3)
development of therapeutic resistance##2##4##(2008-7#1)(2012-12#1)
development of therapeutic##8##3##(1990-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-2#1)
development of these devices##2##4##(2008-12#1)(2008-7#1)
development of these##18##3##(1990-11#1)(1992-9#1)(1995-12#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#2)(2011-2#1)(2011-7#1)(2013-8#1)
development of this##28##3##(1992-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
development of transgenic##2##3##(2008-11#1)(2008-7#1)
development of two##4##3##(1994-12#1)(2008-10#2)(2008-5#1)
development of type##4##3##(1996-11#1)(2007-5#1)(2008-1#1)(2008-11#1)
development of user-friendly##2##3##(1991-3#1)(2008-10#1)
development of various##5##3##(2008-2#1)(2009-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
development of visual##2##3##(1991-12#1)(2008-10#1)
development of young##3##3##(1997-2#1)(2009-9#1)(2010-10#1)
development of##2095##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#6)(1990-3#4)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#3)(1991-1#7)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#7)(1991-5#2)(1991-6#8)(1991-8#4)(1991-9#12)(1992-1#8)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#5)(1993-10#1)(1993-11#6)(1993-12#20)(1993-2#3)(1993-3#9)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#5)(1994-11#6)(1994-12#20)(1994-2#8)(1994-3#14)(1994-5#6)(1994-6#7)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#11)(1995-2#8)(1995-3#9)(1995-4#1)(1995-5#10)(1995-6#4)(1995-8#7)(1995-9#1)(1996-1#8)(1996-11#7)(1996-12#10)(1996-2#13)(1996-3#16)(1996-4#6)(1996-5#14)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#18)(1997-3#20)(1997-4#7)(1997-5#1)(1997-6#12)(1997-7#7)(1997-8#13)(2006-10#3)(2006-6#2)(2006-9#1)(2007-10#12)(2007-11#29)(2007-12#30)(2007-2#5)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#22)(2008-1#31)(2008-10#318)(2008-11#115)(2008-12#50)(2008-2#26)(2008-3#40)(2008-4#45)(2008-5#44)(2008-6#18)(2008-7#79)(2008-8#38)(2008-9#44)(2009-1#5)(2009-10#6)(2009-11#14)(2009-12#12)(2009-2#3)(2009-3#5)(2009-4#9)(2009-5#13)(2009-6#10)(2009-7#12)(2009-8#12)(2009-9#6)(2010-1#11)(2010-10#13)(2010-11#19)(2010-12#25)(2010-2#4)(2010-3#9)(2010-4#8)(2010-5#14)(2010-6#6)(2010-7#12)(2010-8#25)(2010-9#6)(2011-1#37)(2011-10#3)(2011-2#94)(2011-3#11)(2011-7#5)(2012-1#8)(2012-12#38)(2012-2#51)(2012-3#51)(2012-4#1)(2012-5#2)(2013-1#56)(2013-7#9)(2013-8#30)
development officer##2##2##(1991-1#1)(1993-1#1)
development on grape##2##3##(2008-10#2)
development on the##2##3##(2008-10#1)(2009-5#1)
development on##23##2##(1996-5#1)(2008-10#16)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#2)(2012-2#1)
development or in##2##3##(2008-6#1)(2008-9#1)
development or##7##2##(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)(2011-8#1)
development over time##3##3##(2008-10#3)
development over##6##2##(2007-8#1)(2008-10#4)(2008-11#1)
development partners##2##2##(2011-1#1)(2012-12#1)
development period##2##2##(2008-7#1)(2010-8#1)
development perspective##2##2##(1993-12#1)(2008-11#1)
development plan##2##2##(2008-1#1)(2010-7#1)
development plans##3##2##(1994-1#1)(2008-11#1)(2008-8#1)
development process##12##2##(1994-3#2)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2012-12#1)
development processes##3##2##(2008-10#1)(2010-3#1)(2012-3#1)
development program##5##2##(1994-3#1)(2007-11#1)(2012-3#2)(2013-1#1)
development programmes##2##2##(2007-7#1)(2012-3#1)
development programs are##2##3##(2008-7#1)(2010-5#1)
development programs##18##2##(1992-1#1)(1994-1#2)(1995-1#2)(1995-3#2)(1995-5#1)(1996-3#1)(2008-12#1)(2008-7#3)(2010-12#1)(2010-5#3)(2011-2#1)
development project##3##2##(2008-10#1)(2008-11#2)
development projects##2##2##(1991-12#1)(2008-11#1)
development rate of##2##3##(2008-10#1)(2008-9#1)
development rate##3##2##(2008-10#2)(2008-9#1)
development requires##2##2##(2008-11#1)(2008-4#1)
development should##2##2##(1991-3#1)(2008-8#1)
development since##2##2##(2010-10#1)(2011-2#1)
development stage##3##2##(1995-3#1)(2008-10#2)
development stages##4##2##(1993-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
development strategy##3##2##(2008-8#1)(2010-10#2)
development than##4##2##(1990-11#1)(2009-7#1)(2010-10#1)(2011-1#1)
development that can##2##3##(1994-12#1)(2008-10#1)
development that has##2##3##(1994-8#1)(2008-11#1)
development that##10##2##(1991-1#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#1)(2010-3#1)(2010-6#1)
development the##3##2##(1996-5#1)(1997-4#1)(2008-3#1)
development through a##2##3##(2009-7#1)(2012-2#1)
development through##6##2##(1993-6#1)(1994-3#1)(2008-10#1)(2009-7#1)(2009-9#1)(2012-2#1)
development throughout##2##2##(2008-12#1)(2008-7#1)
development time in##2##3##(2008-9#1)(2010-2#1)
development time##8##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-10#1)(2010-2#2)
development times for##3##3##(2008-10#3)
development times##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
development to improve##2##3##(1996-12#1)(2008-8#1)
development to##11##2##(1990-10#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
development toward##2##2##(2008-3#1)(2010-9#1)
development under##2##2##(2008-10#1)(2009-10#1)
development until adulthood##2##3##(1993-12#1)(2008-10#1)
development using##6##2##(1997-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2012-2#1)
development was greater at##2##4##(2008-10#2)
development was positively##2##3##(2008-10#2)
development was related##2##3##(2008-10#1)(2009-8#1)
development was similar to##2##4##(1997-6#1)(2008-10#1)
development was similar##3##3##(1997-6#1)(2008-10#2)
development was##32##2##(1990-5#1)(1992-3#1)(1996-1#1)(1996-5#2)(1997-6#1)(2008-10#16)(2008-2#2)(2008-5#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
development we##2##2##(1996-2#1)(2013-8#1)
development were also##2##3##(2008-3#1)(2011-2#1)
development were evaluated##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
development were investigated using##2##4##(2008-10#2)
development were more sensitive to##2##5##(2008-11#1)(2008-12#1)
development were##21##2##(1991-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)
development when##6##2##(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
development whilst##2##2##(2008-11#1)(2008-5#1)
development will##7##2##(1993-2#1)(1994-3#1)(1996-3#1)(2007-7#2)(2008-8#1)(2009-11#1)
development with the##2##3##(2008-10#1)(2012-9#1)
development with##7##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-9#1)
development within the##2##3##(2008-12#1)(2010-10#1)
development within##5##2##(1990-2#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-9#1)
development work##4##2##(2008-7#1)(2010-9#3)
development##4307##1##(1990-10#3)(1990-11#9)(1990-12#6)(1990-2#9)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#4)(1990-8#4)(1991-1#14)(1991-11#1)(1991-12#16)(1991-2#10)(1991-3#10)(1991-5#8)(1991-6#8)(1991-7#1)(1991-8#4)(1991-9#14)(1992-1#16)(1992-10#2)(1992-11#4)(1992-12#22)(1992-2#13)(1992-3#12)(1992-4#1)(1992-5#6)(1992-6#7)(1992-8#6)(1992-9#5)(1993-1#10)(1993-10#1)(1993-11#8)(1993-12#33)(1993-2#14)(1993-3#18)(1993-5#3)(1993-6#9)(1993-8#3)(1993-9#10)(1994-1#23)(1994-11#10)(1994-12#33)(1994-2#24)(1994-3#34)(1994-5#9)(1994-6#11)(1994-7#1)(1994-8#12)(1994-9#11)(1995-1#8)(1995-11#4)(1995-12#23)(1995-2#22)(1995-3#19)(1995-4#1)(1995-5#14)(1995-6#8)(1995-8#15)(1995-9#3)(1996-1#14)(1996-11#8)(1996-12#22)(1996-2#27)(1996-3#26)(1996-4#6)(1996-5#36)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#12)(1997-2#26)(1997-3#28)(1997-4#18)(1997-5#1)(1997-6#20)(1997-7#17)(1997-8#18)(2006-10#4)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#15)(2007-11#37)(2007-12#93)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#7)(2007-6#1)(2007-7#14)(2007-8#31)(2008-1#58)(2008-10#700)(2008-11#274)(2008-12#97)(2008-2#43)(2008-3#61)(2008-4#77)(2008-5#119)(2008-6#36)(2008-7#155)(2008-8#111)(2008-9#119)(2009-1#6)(2009-10#22)(2009-11#22)(2009-12#21)(2009-2#5)(2009-3#18)(2009-4#14)(2009-5#24)(2009-6#16)(2009-7#24)(2009-8#51)(2009-9#17)(2010-1#13)(2010-10#29)(2010-11#40)(2010-12#44)(2010-2#11)(2010-3#23)(2010-4#12)(2010-5#32)(2010-6#14)(2010-7#22)(2010-8#41)(2010-9#17)(2011-1#84)(2011-10#3)(2011-2#162)(2011-3#12)(2011-7#5)(2011-8#2)(2012-1#25)(2012-12#85)(2012-2#111)(2012-3#98)(2012-4#2)(2012-5#3)(2012-9#1)(2013-1#117)(2013-7#18)(2013-8#54)
development'##2##1##(2007-12#1)(2008-10#1)
development)##4##1##(1994-12#1)(2007-12#1)(2008-10#1)(2013-8#1)
development?##6##1##(1991-3#1)(1992-3#1)(1995-3#1)(2008-11#2)(2011-2#1)
development]##4##1##(1991-6#1)(1992-5#1)(1993-11#1)(2013-1#1)
developmental abnormalities##2##2##(2007-10#1)(2012-12#1)
developmental ages##2##2##(1991-9#1)(1995-12#1)
developmental and adult##2##3##(2012-2#1)(2013-1#1)
developmental and##15##2##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
developmental anomaly##3##2##(1991-6#1)(2008-12#1)(2013-1#1)
developmental biology to##3##3##(2008-8#1)(2009-3#2)
developmental biology##14##2##(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#2)(2012-12#2)(2012-2#1)
developmental change##2##2##(2010-8#1)(2010-9#1)
developmental changes in the##3##4##(1996-5#1)(1997-2#1)(2008-11#1)
developmental changes in##9##3##(1996-5#1)(1997-2#1)(2007-12#1)(2008-11#3)(2008-7#1)(2009-7#1)(2012-1#1)
developmental changes##11##2##(1992-10#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-11#3)(2008-7#1)(2009-7#1)(2012-1#1)
developmental competence##3##2##(2007-5#2)(2013-1#1)
developmental contexts##2##2##(2007-12#1)(2008-7#1)
developmental control##2##2##(1996-12#1)(2010-2#1)
developmental data##2##2##(2008-3#1)(2011-2#1)
developmental decisions##2##2##(2009-8#2)
developmental defects##3##2##(1994-12#1)(2008-12#1)(2012-3#1)
developmental delay and##2##3##(2008-11#1)(2012-12#1)
developmental delay##16##2##(1991-5#1)(1992-12#1)(1994-6#1)(1996-5#1)(1996-9#1)(1997-3#4)(2008-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
developmental delays##3##2##(1992-12#1)(2007-2#1)(2012-3#1)
developmental differences between##2##3##(2008-10#1)(2008-11#1)
developmental differences##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
developmental disabilities##7##2##(1991-12#1)(1993-1#1)(1993-3#2)(1997-2#1)(2010-10#1)(2010-12#1)
developmental dislocation of the hip##4##5##(2007-11#1)(2007-8#3)
developmental dislocation##6##2##(2007-11#2)(2007-8#4)
developmental disorder##3##2##(2007-8#1)(2008-3#1)(2009-4#1)
developmental disorders##9##2##(1995-1#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
developmental disturbances##2##2##(1995-8#1)(1997-3#1)
developmental dynamics##3##2##(2007-12#1)(2011-2#2)
developmental dyslexia##3##2##(2012-2#2)(2013-8#1)
developmental dysplasia of hip##2##4##(2013-7#2)
developmental dysplasia of the hip##13##5##(2007-11#4)(2007-8#8)(2012-12#1)
developmental dysplasia of##15##3##(2007-11#4)(2007-8#8)(2012-12#1)(2013-7#2)
developmental events##6##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
developmental exposure to##2##3##(2008-10#2)
developmental exposure##3##2##(2008-10#2)(2012-3#1)
developmental expression and##2##3##(1993-6#1)(2008-4#1)
developmental expression of##3##3##(1993-3#1)(2008-8#2)
developmental expression##8##2##(1993-12#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-4#1)(2008-8#2)(2008-9#1)
developmental fate##2##2##(2008-8#1)(2010-4#1)
developmental genes##2##2##(1991-9#1)(2013-1#1)
developmental hip dislocation##6##3##(2007-11#2)(2007-8#3)(2009-4#1)
developmental history##2##2##(1997-8#1)(2008-6#1)
developmental immunotoxicity##4##2##(2008-10#4)
developmental immunotoxicology##3##2##(2008-10#3)
developmental in##2##2##(1990-3#1)(1991-12#1)
developmental increase##2##2##(2011-2#2)
developmental instability##4##2##(2008-7#1)(2008-8#2)(2008-9#1)
developmental issues##2##2##(1992-3#1)(1993-12#1)
developmental mechanisms##2##2##(2007-12#1)(2013-1#1)
developmental needs##3##2##(1991-12#1)(2007-2#1)(2008-11#1)
developmental or##2##2##(1992-12#1)(2011-2#1)
developmental origins of##2##3##(2012-2#2)
developmental outcomes##3##2##(1995-1#1)(2009-11#1)(2010-1#1)
developmental pathways##7##2##(1994-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)
developmental pattern##4##2##(1993-12#1)(2008-11#2)(2008-7#1)
developmental patterning##2##2##(2009-8#2)
developmental patterns of the##2##4##(2008-5#1)(2008-8#1)
developmental patterns##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
developmental period##6##2##(1992-12#1)(2007-12#1)(2009-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
developmental periods##4##2##(2009-11#2)(2009-7#1)(2011-2#1)
developmental phase##3##2##(2008-10#1)(2008-9#1)(2012-1#1)
developmental phases of##3##3##(1990-6#1)(1993-9#1)(2008-7#1)
developmental plasticity in##2##3##(2008-7#1)(2010-12#1)
developmental potential of##2##3##(2008-9#2)
developmental potential##6##2##(2008-11#1)(2008-8#1)(2008-9#4)
developmental problems##2##2##(1994-1#1)(2012-12#1)
developmental process##6##2##(1992-2#1)(1993-12#1)(1997-1#1)(2008-8#2)(2009-3#1)
developmental processes of##3##3##(2008-8#2)(2011-2#1)
developmental processes that##2##3##(2010-2#1)(2012-1#1)
developmental processes##16##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#1)
developmental program##7##2##(1991-9#2)(2007-12#2)(2008-11#1)(2008-8#1)(2013-8#1)
developmental programs##5##2##(2008-4#1)(2008-9#1)(2009-8#1)(2013-1#2)
developmental prosopagnosics##3##2##(2008-11#3)
developmental regulators of##2##3##(2012-12#2)
developmental risk##2##2##(1991-12#1)(1992-12#1)
developmental role##2##2##(1995-2#1)(2009-8#1)
developmental sequence##2##2##(2007-12#1)(2008-9#1)
developmental sequences##3##2##(2008-9#3)
developmental signals##2##2##(2007-12#1)(2008-7#1)
developmental stage and##3##3##(1994-9#1)(1995-2#1)(1997-6#1)
developmental stage of the##3##4##(2008-10#2)(2008-9#1)
developmental stage of##4##3##(2008-10#2)(2008-9#1)(2010-4#1)
developmental stage##14##2##(1991-9#1)(1993-9#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)
developmental stages and##2##3##(2008-10#2)
developmental stages in##2##3##(1994-9#1)(2008-11#1)
developmental stages of the##2##4##(2008-10#2)
developmental stages of##9##3##(1997-6#2)(2008-10#5)(2010-10#1)(2011-2#1)
developmental stages##44##2##(1992-8#1)(1993-3#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-6#2)(1997-7#1)(2007-12#2)(2008-10#16)(2008-11#5)(2008-7#1)(2008-8#4)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
developmental status##2##2##(1994-1#1)(1996-9#1)
developmental thresholds##3##2##(2008-8#3)
developmental time at##2##3##(2008-8#1)(2011-2#1)
developmental time##6##2##(1990-5#1)(2008-12#1)(2008-8#3)(2011-2#1)
developmental toxicity of citrinin##2##4##(1993-12#2)
developmental toxicity##8##2##(1993-12#2)(1995-3#1)(1997-4#1)(2010-1#3)(2011-2#1)
developmental toxin##2##2##(1993-12#2)
developmental trajectories##3##2##(2008-11#2)(2012-12#1)
developmental##493##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-8#1)(1993-1#1)(1993-12#13)(1993-3#4)(1993-6#3)(1993-9#2)(1994-1#3)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#6)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#4)(1997-9#1)(2007-10#1)(2007-11#10)(2007-12#21)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#20)(2008-1#1)(2008-10#36)(2008-11#35)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#17)(2008-8#31)(2008-9#24)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#6)(2009-4#2)(2009-5#3)(2009-7#6)(2009-8#10)(2010-1#6)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#18)(2012-1#6)(2012-12#20)(2012-2#14)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#6)
developmental-biological##2##1##(2007-12#1)(2009-2#1)
developmentally appropriate##5##2##(2008-9#1)(2010-5#3)(2011-1#1)
developmentally disabled##4##2##(1997-6#1)(2008-12#2)(2010-3#1)
developmentally important##2##2##(1993-6#1)(2013-1#1)
developmentally regulated##19##2##(1990-11#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#1)(1995-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2012-3#1)
developmentally##48##1##(1990-11#2)(1991-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#2)(1995-2#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
developments and applications##2##3##(2007-11#1)(2008-10#1)
developments and future directions##2##4##(1991-2#1)(2013-8#1)
developments and future##3##3##(1991-2#1)(2006-9#1)(2013-8#1)
developments and##19##2##(1990-2#1)(1991-2#1)(1994-2#1)(2006-9#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#2)
developments are##5##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
developments as##2##2##(1997-3#1)(2007-3#1)
developments concerning##2##2##(1995-3#1)(2008-11#1)
developments for##3##2##(1991-2#1)(2009-6#1)(2012-1#1)
developments have been made in##2##5##(2010-10#1)(2012-12#1)
developments have##7##2##(1992-1#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-12#1)
developments in both##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
developments in clinical##2##3##(2008-11#1)(2008-12#1)
developments in molecular##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
developments in oncology##2##3##(1991-3#1)(2008-2#1)
developments in the application of##4##5##(1995-3#1)(2008-1#1)(2008-10#2)
developments in the field of##8##5##(1991-6#1)(1994-9#1)(2008-10#2)(2008-12#1)(2010-11#1)(2010-9#1)(2013-8#1)
developments in the field##10##4##(1991-6#1)(1994-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-11#1)(2010-7#1)(2010-9#1)(2013-8#1)
developments in the law##2##4##(1992-12#2)
developments in the treatment of##5##5##(2008-2#1)(2008-6#1)(2009-7#1)(2010-6#1)(2013-8#1)
developments in the treatment##6##4##(2007-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-6#1)(2013-8#1)
developments in the##48##3##(1990-6#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-9#1)(1995-3#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2013-8#3)
developments in these##2##3##(2008-11#2)
developments in this field##2##4##(2008-10#1)(2010-7#1)
developments in this##5##3##(1995-2#1)(2008-10#1)(2008-7#1)(2010-7#1)(2013-8#1)
developments in##129##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-1#4)(2008-10#21)(2008-11#12)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#7)(2008-9#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-2#3)(2012-7#1)(2013-8#5)
developments of nonlinear##2##3##(2012-1#1)(2012-2#1)
developments of the##2##3##(1992-12#1)(2008-7#1)
developments of##14##2##(1992-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-2#2)(2013-8#1)
developments on##5##2##(2008-10#2)(2009-10#1)(2009-8#1)(2010-12#1)
developments regarding##3##2##(2009-10#1)(2011-2#1)(2011-7#1)
developments that have taken place in##2##6##(2008-2#1)(2011-1#1)
developments that have##3##3##(2008-2#1)(2009-6#1)(2011-1#1)
developments that##6##2##(2008-11#1)(2008-2#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
developments will##2##2##(2007-5#1)(2008-8#1)
developments with##4##2##(1997-4#1)(2008-10#1)(2010-7#1)(2012-2#1)
developments##250##1##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#5)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#2)(1997-4#3)(1997-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#3)(2008-1#5)(2008-10#42)(2008-11#20)(2008-12#5)(2008-2#6)(2008-3#2)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#14)(2008-8#3)(2008-9#5)(2009-10#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#5)(2010-9#1)(2011-1#6)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2012-7#1)(2013-8#8)
developped##2##1##(2007-8#1)(2008-10#1)
develops a conceptual##2##3##(2007-12#1)(2010-5#1)
develops a##11##2##(1991-1#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#1)
develops as a result of##2##5##(2009-10#1)(2012-2#1)
develops as##3##2##(2009-10#1)(2012-2#1)(2012-3#1)
develops both##2##2##(1996-8#1)(2008-5#1)
develops by##3##2##(2011-2#2)(2012-3#1)
develops from##2##2##(2007-12#1)(2013-1#1)
develops gene-for-gene interactions with##2##4##(2008-10#2)
develops in the##6##3##(1995-11#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
develops in##15##2##(1991-12#1)(1991-2#1)(1995-11#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
develops into##3##2##(1993-9#1)(1994-9#1)(2008-7#1)
develops later##2##2##(2010-8#1)(2011-1#1)
develops on##4##2##(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)
develops the##3##2##(1995-2#1)(2009-10#1)(2012-12#1)
develops when##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
develops##91##1##(1991-1#1)(1991-12#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-12#4)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#3)(2009-10#2)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#2)
deviance information##2##2##(2009-12#1)(2011-1#1)
deviance##10##1##(1994-9#2)(1995-8#1)(1996-3#1)(2009-12#1)(2009-2#2)(2009-7#1)(2011-1#2)
deviant stimuli##3##2##(2008-8#2)(2013-8#1)
deviant##17##1##(1994-12#1)(1995-5#3)(1995-8#1)(2007-11#1)(2008-12#1)(2008-8#3)(2009-2#1)(2010-1#1)(2012-2#1)(2013-7#2)(2013-8#2)
deviants in##2##2##(2009-2#2)
deviants##4##1##(2009-2#4)
deviate from the##2##3##(2008-2#1)(2010-3#1)
deviate from##5##2##(1991-11#1)(2007-8#1)(2008-2#1)(2009-6#1)(2010-3#1)
deviate##11##1##(1991-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-6#1)(2010-3#1)
deviated from the##3##3##(1997-8#1)(2008-10#2)
deviated from##5##2##(1997-8#1)(2008-10#3)(2008-8#1)
deviated##9##1##(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
deviates from a##2##3##(1994-1#1)(2008-7#1)
deviates from##4##2##(1994-1#1)(2008-5#1)(2008-7#1)(2012-2#1)
deviates more##2##2##(2008-10#1)(2008-8#1)
deviates##10##1##(1990-7#1)(1994-1#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
deviating##2##1##(2008-8#1)(2013-1#1)
deviation (S##6##2##(2008-10#6)
deviation 2##2##2##(2007-12#1)(2008-10#1)
deviation [SD]##2##2##(2010-3#1)(2013-1#1)
deviation about the##3##3##(1994-5#1)(1995-5#1)(2008-2#1)
deviation about##4##2##(1994-5#1)(1995-5#1)(2008-10#1)(2008-2#1)
deviation between##7##2##(1995-3#1)(2008-10#4)(2008-3#1)(2013-8#1)
deviation from a##2##3##(1994-1#1)(2012-2#1)
deviation from additivity##2##3##(1992-12#1)(2008-10#1)
deviation from the##8##3##(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
deviation from##25##2##(1992-12#1)(1992-4#2)(1994-1#1)(1995-6#1)(1997-2#1)(2008-10#5)(2008-2#4)(2008-3#5)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
deviation in the##9##3##(2008-10#3)(2008-3#5)(2008-7#1)
deviation in##18##2##(2007-10#1)(2008-10#9)(2008-3#5)(2008-7#1)(2010-5#1)(2013-1#1)
deviation is 0##3##3##(2008-10#2)(2008-9#1)
deviation is##24##2##(2008-10#22)(2008-2#1)(2008-9#1)
deviation less than##3##3##(2008-10#3)
deviation lower than##3##3##(2008-10#3)
deviation observed##2##2##(2009-2#2)
deviation of 0##12##3##(2008-10#10)(2008-3#1)(2009-2#1)
deviation of 1##20##3##(2008-10#19)(2008-2#1)
deviation of 2##16##3##(2007-12#1)(2008-10#15)
deviation of the##53##3##(1994-11#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#32)(2008-2#5)(2008-3#11)(2009-11#1)
deviation of##183##2##(1994-11#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#147)(2008-2#9)(2008-3#13)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-1#1)
deviation on##2##2##(2008-3#1)(2013-1#1)
deviation that##2##2##(2008-10#1)(2008-2#1)
deviation was##45##2##(1990-8#1)(2008-10#43)(2008-2#1)
deviation within##2##2##(2008-10#1)(2008-3#1)
deviation##625##1##(1990-8#1)(1992-12#1)(1992-4#2)(1993-12#1)(1994-1#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-4#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#485)(2008-11#1)(2008-2#18)(2008-3#34)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#2)(2009-2#4)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#8)
deviation) of##3##2##(1996-12#1)(2008-10#2)
deviation)##14##1##(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
deviations and##3##2##(1990-8#1)(2007-8#1)(2008-10#1)
deviations are##5##2##(1991-11#1)(2008-10#2)(2008-3#1)(2013-8#1)
deviations being##2##2##(1993-8#1)(2008-1#1)
deviations between##7##2##(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)
deviations from ideal##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
deviations from the##8##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
deviations from##23##2##(1990-8#1)(1992-12#1)(1993-8#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
deviations in the##4##3##(2008-11#1)(2008-3#2)(2008-8#1)
deviations in##8##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
deviations lower than##2##3##(2008-10#2)
deviations obtained for##3##3##(2008-10#3)
deviations obtained##4##2##(2008-10#3)(2008-5#1)
deviations of 0##4##3##(1997-4#1)(2008-10#2)(2008-9#1)
deviations of 1##2##3##(1994-5#1)(2008-10#1)
deviations of the##17##3##(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)
deviations of##48##2##(1992-1#1)(1993-9#1)(1994-5#1)(1994-6#1)(1997-4#1)(2007-11#1)(2008-10#34)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)
deviations were lower than 3##2##5##(2008-10#2)
deviations were lower than##4##4##(2008-10#4)
deviations were##31##2##(2008-10#26)(2011-1#2)(2011-2#3)
deviations##231##1##(1990-8#3)(1991-11#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#144)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#10)(2008-5#6)(2008-7#3)(2008-8#5)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#10)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#2)
device a##2##2##(2008-3#1)(2013-1#1)
device after##2##2##(2012-2#1)(2012-3#1)
device allows##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
device and its##3##3##(2008-10#2)(2008-2#1)
device and the##2##3##(1997-2#1)(2012-3#1)
device and##33##2##(1993-12#1)(1995-1#1)(1997-2#1)(2007-12#3)(2007-8#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
device applications##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
device are analyzed##2##3##(2008-2#1)(2008-3#1)
device are##8##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#1)
device arrays for increased interconnection density##2##6##(2008-3#2)
device as a##2##3##(2008-2#1)(2008-7#1)
device as the##2##3##(2008-10#1)(2008-3#1)
device as well as##2##4##(2008-3#1)(2008-8#1)
device as##7##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)
device at##2##2##(2008-3#1)(2011-7#1)
device available##2##2##(1996-1#1)(2008-10#1)
device based on a##2##4##(2008-10#1)(2008-3#1)
device based on plastic optical fibers##2##6##(2008-3#2)
device based on##12##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2012-2#1)
device by##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
device can also##2##3##(1993-2#1)(2008-10#1)
device can be easily##2##4##(2007-12#1)(2008-10#1)
device can be##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
device can##14##2##(1993-2#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#2)(2010-1#1)
device capable of##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
device closure##6##2##(2007-8#1)(2008-11#5)
device concept##2##2##(2007-11#1)(2008-3#1)
device consisted of a##2##4##(2008-10#1)(2008-7#1)
device consisting of a##2##4##(2008-10#1)(2012-2#1)
device consists of a##5##4##(1991-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
device consists of##9##3##(1991-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
device could##2##2##(1994-9#1)(2008-3#1)
device designs##2##2##(2008-12#1)(2008-2#1)
device developed##2##2##(2008-10#1)(2008-3#1)
device embolization##2##2##(2008-11#2)
device exhibited##2##2##(2007-11#1)(2007-12#1)
device failure##4##2##(2008-9#2)(2010-9#1)(2012-12#1)
device failures##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
device for measuring phase retardance##2##5##(2008-3#2)
device for measuring##3##3##(2008-3#3)
device for optical##2##3##(2008-10#1)(2008-2#1)
device for the##5##3##(2008-10#3)(2009-3#1)(2010-8#1)
device for which##2##3##(2008-2#1)(2008-3#1)
device for##56##2##(1991-3#1)(1994-1#1)(1994-6#1)(1996-1#1)(1996-12#2)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#12)(2008-11#3)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-8#3)(2011-2#2)(2013-1#2)
device from##2##2##(2007-11#1)(2012-3#1)
device generation##2##2##(2011-1#2)
device has a##9##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#4)
device has been developed##3##4##(2008-10#2)(2008-3#1)
device has been##9##3##(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)
device has##24##2##(2007-11#3)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-8#1)
device implantation##5##2##(2009-10#1)(2009-11#1)(2010-6#1)(2011-2#2)
device in a##8##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-6#2)(2013-1#1)
device in the treatment of##2##5##(1996-1#1)(2011-2#1)
device in the##7##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)
device in##23##2##(1996-1#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
device is a##4##3##(2007-8#1)(2008-2#1)(2008-9#1)(2012-3#1)
device is an##3##3##(2007-12#1)(2010-1#1)(2010-8#1)
device is based on##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
device is described##3##3##(2008-10#1)(2008-2#2)
device is presented##3##3##(1995-1#1)(2008-3#2)
device is proposed##2##3##(2008-10#1)(2008-3#1)
device is simple##2##3##(2007-11#1)(2008-1#1)
device is used as a##2##5##(2007-11#1)(2007-12#1)
device is used##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2010-1#1)
device is##56##2##(1991-6#1)(1992-11#1)(1994-6#1)(1995-1#1)(2007-11#7)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#12)(2008-5#2)(2008-9#1)(2010-1#2)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#1)(2012-1#1)(2012-3#1)
device made##2##2##(2008-3#2)
device manufacture##3##2##(2007-11#2)(2008-10#1)
device may##2##2##(1990-6#1)(2010-1#1)
device must be##3##3##(1996-2#2)(2012-3#1)
device of##2##2##(2008-10#1)(2009-10#1)
device on##2##2##(2008-9#1)(2012-3#1)
device operates by##2##3##(2007-12#1)(2008-3#1)
device operates##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
device performance##2##2##(2007-12#1)(2008-2#1)
device performed##2##2##(2010-6#1)(2011-2#1)
device prepared##3##2##(2008-10#3)
device reporting##2##2##(1993-3#2)
device shows##2##2##(2007-12#1)(2008-3#1)
device structure##4##2##(2007-11#1)(2008-2#1)(2009-5#1)(2012-2#1)
device technique##2##2##(2008-3#2)
device technology and##2##3##(2008-3#1)(2009-11#1)
device technology##5##2##(2008-2#1)(2008-3#2)(2009-11#1)(2010-8#1)
device that exhibits##2##3##(2007-12#1)(2008-3#1)
device that is##2##3##(2008-2#1)(2008-3#1)
device that uses##2##3##(2007-12#1)(2008-3#1)
device that was##2##3##(2008-10#1)(2008-11#1)
device that##19##2##(2007-11#4)(2007-12#5)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#5)(2009-10#1)
device the##2##2##(2008-3#2)
device therapy for##2##3##(2009-10#1)(2010-6#1)
device therapy##4##2##(2009-10#2)(2010-3#1)(2010-6#1)
device to the##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
device to##21##2##(1994-3#1)(1994-8#1)(1997-2#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
device use##5##2##(2008-9#1)(2009-11#2)(2012-2#2)
device used##4##2##(1990-6#1)(1997-2#1)(2008-7#1)(2009-5#1)
device uses##2##2##(2007-12#1)(2008-3#1)
device using##5##2##(2007-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
device was designed to##2##4##(2008-8#1)(2010-1#1)
device was developed##3##3##(2008-10#1)(2008-3#2)
device was used to##2##4##(2008-11#1)(2008-2#1)
device was used##4##3##(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
device was##31##2##(1994-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#4)(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
device were measured and##2##4##(1991-3#1)(2008-3#1)
device were##6##2##(1991-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
device which##4##2##(2008-10#1)(2008-5#2)(2009-7#1)
device will be##2##3##(1992-3#1)(2008-5#1)
device with a##5##3##(2007-11#2)(2008-12#1)(2008-3#2)
device with an##3##3##(2008-3#1)(2010-7#1)(2012-3#1)
device with##16##2##(2007-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
device##831##1##(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#2)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#2)(1995-3#3)(1996-1#4)(1996-12#2)(1996-2#8)(1996-6#1)(1996-9#1)(1997-2#5)(1997-4#1)(2006-6#1)(2007-11#58)(2007-12#55)(2007-7#4)(2007-8#21)(2008-1#3)(2008-10#108)(2008-11#46)(2008-12#4)(2008-2#66)(2008-3#128)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#21)(2008-8#6)(2008-9#25)(2009-10#7)(2009-11#6)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#8)(2009-6#5)(2009-7#5)(2009-9#1)(2010-1#11)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#9)(2010-7#10)(2010-8#17)(2010-9#2)(2011-1#8)(2011-2#21)(2011-7#1)(2012-1#3)(2012-12#9)(2012-2#21)(2012-3#16)(2013-1#22)(2013-8#4)
device)##4##1##(2008-3#1)(2009-11#1)(2011-1#1)(2012-2#1)
device-level##2##1##(2008-7#2)
device-related##4##1##(1993-3#1)(2008-10#1)(2010-12#1)(2010-8#1)
device-specific##2##1##(2009-12#1)(2011-2#1)
device]##6##1##(1990-8#1)(1996-6#1)(2010-8#3)(2012-3#1)
devices and a##2##3##(2008-10#1)(2008-2#1)
devices and implants##2##3##(2009-11#1)(2009-7#1)
devices and the##3##3##(2008-3#1)(2009-11#1)(2013-8#1)
devices and to##2##3##(2008-10#1)(2012-3#1)
devices and##41##2##(1992-8#1)(1993-12#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-7#2)(2009-11#4)(2009-12#1)(2009-6#1)(2009-7#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
devices are discussed##3##3##(2007-12#1)(2009-11#1)(2010-11#1)
devices are in##2##3##(2008-11#1)(2009-5#1)
devices are##35##2##(1991-3#1)(1993-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#6)(2008-6#2)(2008-7#3)(2009-11#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#3)(2012-2#1)(2013-1#1)
devices as well as##2##4##(2007-11#1)(2008-10#1)
devices as##8##2##(2007-11#2)(2007-12#1)(2008-10#2)(2009-12#1)(2009-7#1)(2012-12#1)
devices at the##2##3##(2007-7#1)(2010-8#1)
devices available for##2##3##(2008-9#1)(2011-2#1)
devices available##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
devices based on the##2##4##(2008-2#1)(2012-3#1)
devices based on##13##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#4)(2012-3#2)
devices but also##3##3##(2008-2#1)(2008-6#1)(2012-2#1)
devices but##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)
devices by##6##2##(1997-1#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)
devices can be##3##3##(1992-3#1)(2008-7#1)(2008-8#1)
devices can##5##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
devices could##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
devices designed##2##2##(2008-10#1)(2008-2#1)
devices during##2##2##(1992-3#1)(2012-3#1)
devices explanted from##2##3##(2012-12#2)
devices for the##5##3##(2007-11#1)(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
devices for##33##2##(1992-2#1)(1992-3#1)(1997-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
devices from##2##2##(2008-7#1)(2011-2#1)
devices has been##2##3##(2008-10#1)(2010-7#1)
devices have been developed##4##4##(1996-8#1)(2008-9#1)(2009-12#1)(2010-8#1)
devices have been##8##3##(1994-2#1)(1996-8#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-8#1)
devices have the potential to##2##5##(2008-2#1)(2009-2#1)
devices have the##3##3##(2008-11#1)(2008-2#1)(2009-2#1)
devices have##16##2##(1991-12#1)(1994-2#1)(1996-8#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2012-3#1)
devices in a##2##3##(2008-2#2)
devices in the##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2009-12#1)
devices in##26##2##(2007-11#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-11#1)(2010-8#5)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
devices into##3##2##(2009-12#1)(2009-6#1)(2010-8#1)
devices is discussed##2##3##(2007-12#1)(2008-2#1)
devices is often##2##3##(2009-11#1)(2010-6#1)
devices is##16##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-11#2)(2010-5#1)(2010-6#2)(2010-8#1)(2012-3#1)
devices made##2##2##(2008-10#1)(2011-2#1)
devices may##3##2##(2008-6#1)(2008-9#1)(2010-8#1)
devices need##2##2##(2010-10#1)(2011-2#1)
devices of this type##2##4##(1994-5#1)(1994-6#1)
devices of##4##2##(1994-5#1)(1994-6#1)(2008-2#1)(2008-7#1)
devices on the##2##3##(1994-8#1)(2008-10#1)
devices on##5##2##(1994-8#1)(2008-10#1)(2009-12#1)(2013-1#2)
devices operating in the##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
devices or##2##2##(2010-6#1)(2012-3#1)
devices such as##14##3##(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#1)
devices that are##3##3##(2010-6#1)(2010-7#1)(2012-2#1)
devices that can be##2##4##(2008-10#1)(2008-7#1)
devices that can##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
devices that combine##2##3##(2008-2#1)(2008-7#1)
devices that use##5##3##(2007-11#1)(2008-3#1)(2008-7#2)(2012-2#1)
devices that will##2##3##(2007-11#1)(2011-2#1)
devices that##33##2##(2007-11#5)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#4)(2008-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#2)
devices to##12##2##(1992-3#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)
devices used##4##2##(2006-10#1)(2008-10#1)(2008-4#1)(2013-7#1)
devices was##4##2##(2007-12#1)(2008-12#1)(2008-2#2)
devices were developed##2##3##(1996-2#1)(2009-12#1)
devices were fabricated##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
devices were##14##2##(1993-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)(2010-8#1)
devices which can##2##3##(1995-1#1)(2008-10#1)
devices will##2##2##(1997-1#2)
devices with different##2##3##(2008-10#2)
devices with##20##2##(1993-12#1)(1997-1#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#6)(2009-12#1)(2010-10#1)(2010-7#1)(2010-8#1)
devices##640##1##(1991-12#1)(1991-3#4)(1992-2#2)(1992-3#6)(1992-8#1)(1993-12#5)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-3#2)(1996-2#6)(1996-8#1)(1997-1#8)(1997-2#2)(1997-4#1)(2006-10#4)(2007-11#30)(2007-12#37)(2007-2#1)(2007-7#7)(2007-8#4)(2008-1#1)(2008-10#70)(2008-11#20)(2008-12#7)(2008-2#56)(2008-3#72)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#37)(2008-8#8)(2008-9#13)(2009-10#1)(2009-11#20)(2009-12#12)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#17)(2010-7#7)(2010-8#24)(2010-9#3)(2011-1#3)(2011-2#29)(2011-7#1)(2012-12#9)(2012-2#15)(2012-3#12)(2013-1#14)(2013-7#2)(2013-8#3)
devices)##6##1##(2007-10#1)(2010-1#2)(2011-2#1)(2013-7#2)
devices?##2##1##(2008-11#1)(2012-1#1)
deviennent##2##1##(2008-11#2)
devil##2##1##(2008-2#1)(2009-10#1)
devise a##6##2##(1994-2#1)(2007-7#1)(2008-10#2)(2012-2#1)(2013-1#1)
devise and implement##2##3##(1993-2#1)(1994-1#1)
devise##18##1##(1993-2#1)(1994-1#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#4)
devised a##9##2##(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2012-2#1)
devised an##4##2##(1994-2#1)(1997-4#1)(2008-10#1)(2008-5#1)
devised and##3##2##(1996-8#1)(2008-10#2)
devised by##4##2##(1990-8#1)(2007-7#1)(2008-10#1)(2008-4#1)
devised for the##3##3##(1990-8#1)(1991-8#1)(2007-12#1)
devised for##7##2##(1990-8#1)(1991-8#1)(1992-6#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-10#1)
devised to measure##2##3##(1991-5#1)(2008-3#1)
devised to##9##2##(1991-5#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
devised##66##1##(1990-8#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)
devising a##2##2##(1996-5#1)(2008-10#1)
devising the##2##2##(1992-2#1)(1995-3#1)
devising##9##1##(1991-1#1)(1992-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#1)(2010-9#1)(2013-1#1)(2013-8#1)
devoid of activity##3##3##(1991-9#1)(1992-12#1)(1996-5#1)
devoid of any##3##3##(1993-8#1)(2008-1#1)(2008-6#1)
devoid of catalytic activity##2##4##(1992-3#1)(1994-5#1)
devoid of functional##2##3##(1995-8#1)(2008-6#1)
devoid of the##7##3##(1992-6#1)(1993-11#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
devoid of##45##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#2)(1994-5#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
devolution of responsibilities##2##3##(2008-7#1)(2012-3#1)
devolution of##4##2##(1992-1#1)(1997-2#1)(2008-7#1)(2012-3#1)
devolution##7##1##(1992-1#1)(1997-2#4)(2008-7#1)(2012-3#1)
devolved##3##1##(1997-5#1)(2008-11#1)(2011-1#1)
devote##8##1##(1990-4#1)(1991-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
devoted to the study of##3##5##(2010-11#1)(2010-5#1)(2011-1#1)
devoted to the##15##3##(1991-2#1)(1996-3#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#1)
devoted to this##2##3##(2008-12#1)(2008-4#1)
devoted to understanding##2##3##(2007-12#1)(2010-6#1)
devoted to##48##2##(1990-8#1)(1991-2#2)(1993-3#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
devoted##54##1##(1990-8#1)(1991-12#1)(1991-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
devoured by##2##2##(2008-9#1)(2009-10#1)
dew period##7##2##(2008-10#7)
dew##22##1##(2008-10#22)
dewatered sewage sludge##2##3##(2008-12#2)
dewatered sludge##2##2##(2008-12#2)
dewatered##5##1##(2008-12#4)(2008-6#1)
dex-mediated apoptosis##2##2##(2009-4#2)
dexamethasone (DEX)##4##2##(1994-9#1)(2008-10#1)(2008-11#2)
dexamethasone administration##2##2##(1992-12#1)(1993-5#1)
dexamethasone and aspirin##2##3##(1993-3#2)
dexamethasone and##10##2##(1990-3#1)(1991-12#1)(1993-3#2)(1994-3#1)(1995-12#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)
dexamethasone for##2##2##(2008-11#1)(2012-2#1)
dexamethasone in##2##2##(1990-3#1)(2008-5#1)
dexamethasone induced ulcer model##2##4##(2012-2#2)
dexamethasone induced##3##2##(1991-5#1)(2012-2#2)
dexamethasone may##2##2##(1994-3#1)(2008-5#1)
dexamethasone on##6##2##(1994-3#1)(1994-8#1)(1996-5#1)(2008-5#1)(2010-12#1)(2012-12#1)
dexamethasone or##4##2##(1994-3#1)(1995-8#1)(1997-1#1)(2008-5#1)
dexamethasone promoted##2##2##(2008-5#2)
dexamethasone suppression test##6##3##(1990-3#2)(1995-11#2)(2011-2#2)
dexamethasone treatment##4##2##(1992-12#1)(1995-12#1)(1996-5#1)(2008-10#1)
dexamethasone was##3##2##(1993-5#1)(1994-6#1)(2008-5#1)
dexamethasone##109##1##(1990-11#2)(1990-3#4)(1990-5#4)(1990-6#1)(1990-7#3)(1991-12#3)(1991-5#3)(1992-11#2)(1992-12#4)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#2)(1994-10#2)(1994-11#1)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#9)(1995-3#1)(1995-8#2)(1996-5#3)(1997-1#3)(1997-4#1)(2007-7#2)(2008-10#7)(2008-11#10)(2008-5#7)(2009-11#3)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
dexamethasone-dependent##2##1##(1991-5#1)(1994-3#1)
dexamethasone-induced##3##1##(1992-9#1)(2012-2#2)
dexmedetomidine and ketamine were##2##4##(2011-2#2)
dexmedetomidine and ketamine##4##3##(2011-2#4)
dexmedetomidine##6##1##(2011-2#6)
dexrazoxane##7##1##(2008-11#7)
dexterity##3##1##(1993-12#1)(2007-10#1)(2007-11#1)
dextra##2##1##(2008-11#1)(2011-3#1)
dextran amines##3##2##(1996-5#1)(1997-3#1)(2008-4#1)
dextran sulphate##3##2##(1990-12#1)(1990-5#1)(2006-6#1)
dextran##22##1##(1990-12#1)(1990-5#2)(1992-9#2)(1995-12#1)(1995-5#1)(1996-5#2)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
dextran-based##2##1##(2008-11#1)(2008-2#1)
dextran-coated##2##1##(1992-10#1)(2008-10#1)
dextranicum##2##1##(2012-2#2)
dextransulphate##3##1##(2008-11#3)
dextrin##2##1##(1995-5#1)(2008-10#1)
dextrocardia with##2##2##(2008-7#2)
dextrocardia##8##1##(2007-8#2)(2008-7#4)(2010-8#2)
dextromethorphan##6##1##(1991-1#1)(1996-2#4)(2010-9#1)
dextrose agar##15##2##(2007-7#1)(2008-10#13)(2008-5#1)
dextrose broth##5##2##(2008-10#4)(2008-5#1)
dextrose side##2##2##(2008-9#2)
dextrose solution##3##2##(2008-9#2)(2011-2#1)
dextrose##37##1##(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#19)(2008-5#4)(2008-9#4)(2011-2#6)
df = 1##2##3##(2008-6#2)
df =##4##2##(2008-3#1)(2008-6#2)(2012-3#1)
dga gene##2##2##(1995-2#2)
dga##3##1##(1995-2#3)
dhfr##2##1##(2008-11#2)
dhn1##2##1##(2008-9#2)
dhod##4##1##(1993-2#4)
di##4##1##(2007-12#1)(2008-10#1)(2008-4#2)
di- and tri-)##2##3##(2008-10#2)
di- and tri-methylation##3##3##(2009-10#3)
di- and tri-nucleotides##2##3##(2012-3#2)
di- and triphosphates##2##3##(1996-5#2)
di- and trivalent##2##3##(1990-2#1)(2008-10#1)
di- and##18##2##(1990-2#1)(1995-6#1)(1996-5#3)(2008-10#6)(2008-4#1)(2009-10#3)(2009-6#1)(2012-3#2)
di-##25##1##(1990-2#1)(1993-8#2)(1995-6#1)(1996-5#3)(2008-10#8)(2008-11#1)(2008-4#2)(2009-10#3)(2009-12#1)(2009-6#1)(2012-3#2)
di-(2-ethylhexyl) phosphoric acid##2##3##(2008-10#2)
di-(2-ethylhexyl)##4##1##(2008-10#3)(2012-1#1)
di-2-pyridyl ketone##2##2##(2008-10#2)
di-2-thienyl ketone p-nitrophenylhydrazone (DSKNPH)##2##4##(2008-10#2)
di-2-thienyl ketone##3##2##(2008-10#3)
di-estrus II##4##2##(1992-9#4)
di-estrus##5##1##(1992-9#5)
di-hydroxylated##2##1##(2011-1#2)
di-n-butyl##2##1##(1993-12#1)(2008-5#1)
di-n-butyltin compounds##2##2##(1993-12#2)
di-n-butyltin##3##1##(1993-12#3)
di-substituted##4##1##(2008-10#2)(2010-12#1)(2011-1#1)
diS-C3(3)##5##1##(1994-12#5)
diabesity##2##1##(2013-8#2)
diabetes (type##2##2##(1993-2#1)(2008-1#1)
diabetes among##5##2##(1994-12#1)(2008-1#1)(2008-7#1)(2012-2#1)(2013-8#1)
diabetes and a##3##3##(2007-7#1)(2008-1#1)(2009-9#1)
diabetes and cardiovascular disease##2##4##(2008-11#1)(2009-6#1)
diabetes and cardiovascular diseases##3##4##(2008-5#1)(2010-10#1)(2012-2#1)
diabetes and cardiovascular##5##3##(2008-11#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-2#1)
diabetes and coronary heart disease##2##5##(2008-11#1)(2012-2#1)
diabetes and heart##2##3##(2012-3#1)(2013-8#1)
diabetes and hypertension##2##3##(2007-7#1)(2012-3#1)
diabetes and impaired glucose tolerance##2##5##(2008-7#2)
diabetes and its##7##3##(2008-1#3)(2010-9#2)(2011-1#2)
diabetes and obesity##3##3##(2008-1#2)(2013-8#1)
diabetes and other NCDs##3##4##(2013-8#3)
diabetes and other##8##3##(2007-10#1)(2008-1#2)(2013-8#5)
diabetes and the##3##3##(2008-1#3)
diabetes and##78##2##(1990-5#1)(1990-9#1)(1991-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#2)(1997-4#1)(2007-10#1)(2007-7#2)(2008-1#19)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-10#3)(2010-9#3)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#5)(2013-8#9)
diabetes are##9##2##(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2011-2#1)
diabetes as well as##2##4##(2011-2#1)(2013-1#1)
diabetes as well##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
diabetes as##5##2##(2008-1#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
diabetes be##2##2##(1992-9#1)(1996-11#1)
diabetes but##2##2##(2008-1#1)(2011-1#1)
diabetes by##4##2##(2008-1#2)(2011-2#1)(2012-3#1)
diabetes can be##2##3##(2008-10#1)(2008-3#1)
diabetes can##4##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
diabetes care in##2##3##(2008-7#1)(2009-6#1)
diabetes care##16##2##(1994-12#1)(2008-1#1)(2008-7#9)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
diabetes children and##2##3##(2013-1#2)
diabetes control##5##2##(1993-9#1)(2008-8#1)(2011-2#3)
diabetes dataset##2##2##(2010-7#2)
diabetes development##3##2##(2010-11#2)(2013-1#1)
diabetes diagnosed##2##2##(2011-2#2)
diabetes diagnosis##4##2##(2008-1#1)(2012-3#3)
diabetes disease##3##2##(2010-7#3)
diabetes duration##2##2##(1995-2#1)(1997-8#1)
diabetes for more than 16 years##2##6##(2013-1#2)
diabetes from##5##2##(2007-12#1)(2008-6#1)(2009-11#1)(2010-4#1)(2011-2#1)
diabetes group##3##2##(1996-11#2)(2008-12#1)
diabetes groups##2##2##(1996-11#1)(2008-12#1)
diabetes has been##4##3##(2008-1#2)(2008-4#1)(2012-5#1)
diabetes has##11##2##(1990-11#1)(1996-11#1)(2008-1#2)(2008-3#3)(2008-4#1)(2010-8#1)(2012-5#1)(2013-7#1)
diabetes have increased##2##3##(2008-7#1)(2009-4#1)
diabetes have##9##2##(1994-12#1)(1996-11#1)(2008-1#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2012-3#1)
diabetes in China##2##3##(2010-10#2)
diabetes in Indian population##2##4##(2012-2#2)
diabetes in Kin-Hu##2##3##(1994-12#2)
diabetes in Zucker diabetic fatty##2##5##(2008-4#2)
diabetes in children##2##3##(2008-11#1)(2009-12#1)
diabetes in the##10##3##(1994-12#1)(2008-12#1)(2008-4#3)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
diabetes in##56##2##(1994-12#7)(1996-11#1)(1997-4#1)(1997-8#1)(2007-5#1)(2008-1#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#6)(2008-7#7)(2008-8#1)(2009-12#2)(2009-5#2)(2009-7#1)(2010-10#3)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
diabetes including##2##2##(1996-12#1)(2008-1#1)
diabetes insipidus##20##2##(1993-6#2)(1994-11#2)(1994-8#3)(1997-3#2)(1997-8#2)(2007-10#1)(2008-4#2)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#2)
diabetes insipidus)##2##2##(2013-1#2)
diabetes is associated with##4##4##(2008-1#1)(2010-10#1)(2011-1#1)(2013-1#1)
diabetes is##23##2##(1996-11#1)(2008-1#6)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-11#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
diabetes management##3##2##(2008-4#1)(2008-7#1)(2009-11#1)
diabetes may##5##2##(1990-12#1)(1993-3#1)(2008-1#1)(2010-10#1)(2010-9#1)
diabetes medications##2##2##(2008-1#1)(2012-5#1)
diabetes mellitus (DM)##13##3##(2007-7#2)(2008-1#1)(2008-3#3)(2008-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-5#1)
diabetes mellitus (GDM)##5##3##(2008-1#2)(2009-3#1)(2010-8#1)(2011-2#1)
diabetes mellitus (IDDM)##4##3##(1995-3#1)(2007-5#1)(2008-11#1)(2011-2#1)
diabetes mellitus (NIDDM)##8##3##(1991-12#1)(1991-7#1)(1992-9#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#2)
diabetes mellitus (PTDM)##2##3##(2008-1#2)
diabetes mellitus (T1DM)##2##3##(2010-11#1)(2011-1#1)
diabetes mellitus (type##2##3##(2008-1#1)(2008-3#1)
diabetes mellitus 2##2##3##(2011-1#2)
diabetes mellitus and an##2##4##(2007-12#1)(2008-7#1)
diabetes mellitus and its complications##2##5##(2007-5#1)(2011-2#1)
diabetes mellitus and##33##3##(1990-11#1)(1992-12#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#6)
diabetes mellitus are##4##3##(2008-1#1)(2008-3#1)(2013-1#2)
diabetes mellitus as##2##3##(2008-3#1)(2010-11#1)
diabetes mellitus had##2##3##(2008-11#1)(2009-3#1)
diabetes mellitus in a##2##4##(2008-7#1)(2008-8#1)
diabetes mellitus in the##2##4##(2008-3#1)(2011-2#1)
diabetes mellitus in##17##3##(1994-6#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-1#1)
diabetes mellitus is##10##3##(1992-5#1)(1996-11#1)(2008-1#1)(2008-3#4)(2008-7#1)(2010-12#1)(2011-2#1)
diabetes mellitus or##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)
diabetes mellitus patients##2##3##(1991-12#1)(2010-11#1)
diabetes mellitus represent a##2##4##(2008-1#2)
diabetes mellitus type 2##4##4##(1993-11#1)(1993-2#1)(2011-2#1)(2012-2#1)
diabetes mellitus type##5##3##(1993-11#1)(1993-2#1)(2011-2#2)(2012-2#1)
diabetes mellitus was##5##3##(1992-12#1)(1992-5#1)(1994-6#1)(2008-1#1)(2008-10#1)
diabetes mellitus were##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
diabetes mellitus##332##2##(1990-11#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#2)(1992-11#1)(1992-12#5)(1992-5#4)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#4)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-6#3)(1994-8#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#5)(1996-3#1)(1996-8#1)(1997-3#2)(1997-5#2)(1997-8#4)(2007-10#4)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#7)(2007-8#2)(2008-1#37)(2008-10#8)(2008-11#13)(2008-12#2)(2008-3#29)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#14)(2008-8#4)(2009-11#8)(2009-3#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#9)(2010-12#2)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#12)(2011-2#18)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#9)(2012-3#6)(2012-5#2)(2013-1#25)(2013-7#1)(2013-8#5)
diabetes mellitus]##4##2##(1990-2#1)(1994-2#1)(1994-6#1)(2013-1#1)
diabetes of the young##2##4##(2008-1#2)
diabetes of the##3##3##(2008-1#3)
diabetes of##7##2##(2008-1#3)(2008-10#1)(2008-7#2)(2010-4#1)
diabetes on rat liver and heart tissues##2##7##(2008-10#2)
diabetes on rat##3##3##(1994-11#1)(2008-10#2)
diabetes on##16##2##(1993-9#1)(1994-11#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
diabetes or##7##2##(1995-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
diabetes patient##4##2##(1992-6#1)(2009-11#2)(2013-1#1)
diabetes patients attending government health clinics##2##6##(2008-8#2)
diabetes patients##21##2##(1995-11#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-11#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#4)
diabetes prevalence##3##2##(2008-7#1)(2010-4#2)
diabetes prevention and control##2##4##(2008-1#2)
diabetes prevention and##3##3##(2008-1#2)(2008-11#1)
diabetes program##2##2##(1993-3#1)(1996-12#1)
diabetes research##5##2##(2010-10#1)(2010-11#2)(2012-12#2)
diabetes risk in##2##3##(2010-11#1)(2010-5#1)
diabetes risk##4##2##(2008-1#1)(2010-10#1)(2010-11#1)(2010-5#1)
diabetes should be##3##3##(1996-11#1)(2008-1#1)(2010-4#1)
diabetes should##5##2##(1996-11#2)(2008-1#1)(2010-4#1)(2011-1#1)
diabetes than##2##2##(1994-12#1)(2008-3#1)
diabetes that##2##2##(2009-11#1)(2010-10#1)
diabetes therapy systems##2##3##(2009-11#2)
diabetes therapy##3##2##(2009-11#3)
diabetes to##2##2##(2008-3#2)
diabetes treatment##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
diabetes type##2##2##(2008-3#2)
diabetes using an##2##3##(1995-8#1)(2007-10#1)
diabetes was the most##2##4##(2007-10#1)(2012-3#1)
diabetes was the##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
diabetes was##11##2##(2007-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#2)
diabetes were##4##2##(2007-7#1)(2008-7#1)(2011-2#1)(2013-1#1)
diabetes with##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
diabetes##1230##1##(1990-11#2)(1990-12#2)(1990-2#4)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#4)(1991-12#4)(1991-2#1)(1991-3#1)(1991-7#2)(1991-8#2)(1992-11#3)(1992-12#5)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#3)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#23)(1994-2#2)(1994-6#7)(1994-8#7)(1995-11#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-11#20)(1996-12#4)(1996-2#5)(1996-3#1)(1996-8#2)(1997-3#4)(1997-4#3)(1997-5#2)(1997-8#14)(2006-10#1)(2007-10#10)(2007-11#2)(2007-12#5)(2007-5#9)(2007-7#14)(2007-8#6)(2008-1#167)(2008-10#27)(2008-11#27)(2008-12#7)(2008-3#77)(2008-4#30)(2008-5#13)(2008-6#4)(2008-7#72)(2008-8#21)(2008-9#7)(2009-1#3)(2009-10#1)(2009-11#39)(2009-12#7)(2009-3#12)(2009-4#3)(2009-5#8)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#5)(2010-1#4)(2010-10#36)(2010-11#22)(2010-12#8)(2010-3#1)(2010-4#14)(2010-5#8)(2010-7#6)(2010-8#11)(2010-9#6)(2011-1#40)(2011-2#59)(2011-3#7)(2012-1#4)(2012-12#17)(2012-2#31)(2012-3#37)(2012-4#6)(2012-5#10)(2012-6#2)(2012-7#1)(2013-1#64)(2013-7#6)(2013-8#60)
diabetes&quot##2##1##(1990-11#1)(2009-11#1)
diabetes)##5##1##(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-4#1)
diabetes-associated T-cell##2##2##(1995-2#2)
diabetes-associated##4##1##(1995-2#2)(2013-1#2)
diabetes-extract group##3##2##(2008-12#3)
diabetes-obesity##2##1##(2008-3#2)
diabetes-related##2##1##(2008-10#1)(2013-8#1)
diabetes?##5##1##(1992-12#1)(2008-1#1)(2009-5#1)(2010-12#1)(2012-5#1)
diabetes]##6##1##(1993-6#1)(1994-6#1)(1995-11#1)(1996-11#1)(2008-4#1)(2009-5#1)
diabetic (NOD)##3##2##(1995-2#1)(2008-10#1)(2010-11#1)
diabetic ESRD patients##2##3##(2008-1#2)
diabetic and control##4##3##(1994-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
diabetic and##11##2##(1994-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
diabetic by##2##2##(2008-10#2)
diabetic cardiomyopathy##2##2##(1994-12#2)
diabetic class##2##2##(2007-10#2)
diabetic complications and##2##3##(2008-3#1)(2013-1#1)
diabetic complications##20##2##(1991-5#1)(1996-2#1)(2008-1#6)(2008-3#3)(2008-7#2)(2009-11#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
diabetic conditions##3##2##(1993-8#1)(1994-8#1)(2008-1#1)
diabetic control##3##2##(1996-11#1)(2012-5#1)(2013-1#1)
diabetic decompensation##2##2##(1990-3#1)(1994-12#1)
diabetic education##2##2##(2007-10#2)
diabetic elderly##3##2##(2008-12#2)(2008-7#1)
diabetic emergencies##3##2##(1994-12#3)
diabetic fatty rats##2##3##(2008-4#1)(2011-1#1)
diabetic fatty##4##2##(2008-4#2)(2011-1#1)(2012-1#1)
diabetic foot syndrome##3##3##(2011-1#1)(2012-12#2)
diabetic foot ulcers##4##3##(2008-5#2)(2010-10#1)(2012-2#1)
diabetic foot##18##2##(2007-11#5)(2008-5#2)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
diabetic glomerulopathy##2##2##(1992-6#1)(2011-2#1)
diabetic glomerulosclerosis##2##2##(2008-1#2)
diabetic hepatocytes##3##2##(1994-8#3)
diabetic individuals##2##2##(2011-2#1)(2012-3#1)
diabetic ketoacidosis and##2##3##(1993-6#1)(2011-1#1)
diabetic ketoacidosis##7##2##(1993-6#1)(2011-1#3)(2011-2#3)
diabetic kidney disease##3##3##(2008-1#2)(2012-1#1)
diabetic liver##4##2##(1993-3#3)(2008-10#1)
diabetic macular##4##2##(2011-2#2)(2011-7#2)
diabetic male##2##2##(1996-12#1)(2012-12#1)
diabetic men and##2##3##(2008-7#1)(2011-2#1)
diabetic men were##2##3##(2008-7#2)
diabetic men##8##2##(2008-7#7)(2011-2#1)
diabetic mice##5##2##(1994-11#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-12#1)
diabetic mouse model##2##3##(1994-11#1)(2012-12#1)
diabetic nephropathy and##5##3##(1997-5#1)(1997-8#1)(2008-1#1)(2008-8#1)(2011-2#1)
diabetic nephropathy##34##2##(1991-11#1)(1994-3#3)(1997-5#1)(1997-8#3)(2007-12#1)(2007-7#1)(2008-1#12)(2008-3#1)(2008-8#2)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
diabetic nephropathy]##2##2##(1997-8#1)(2013-8#1)
diabetic neuropathy and##2##3##(2008-4#1)(2012-2#1)
diabetic neuropathy##14##2##(1995-5#1)(2008-1#7)(2008-4#2)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
diabetic patient and##2##3##(2008-1#1)(2012-3#1)
diabetic patient is##2##3##(2008-7#1)(2013-7#1)
diabetic patient who##2##3##(2008-7#1)(2013-1#1)
diabetic patient with##2##3##(2008-8#1)(2013-1#1)
diabetic patient##17##2##(1993-11#1)(1994-3#1)(2007-9#1)(2008-1#4)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
diabetic patients and identify##3##4##(2012-12#1)(2012-3#1)(2012-4#1)
diabetic patients and the##3##4##(2008-1#1)(2008-10#1)(2008-9#1)
diabetic patients and##14##3##(1990-11#1)(1993-12#1)(1993-2#1)(2008-1#4)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-4#1)
diabetic patients are##2##3##(1993-8#1)(2008-10#1)
diabetic patients in##3##3##(2008-7#1)(2011-2#1)(2012-4#1)
diabetic patients is##2##3##(1993-11#1)(2007-8#1)
diabetic patients over##2##3##(1991-5#1)(2008-8#1)
diabetic patients than##2##3##(1993-2#1)(2008-1#1)
diabetic patients to##2##3##(1993-12#1)(2012-2#1)
diabetic patients was##4##3##(1993-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
diabetic patients who have##2##4##(1991-8#1)(2013-1#1)
diabetic patients who##4##3##(1991-8#1)(2007-10#1)(2007-7#1)(2013-1#1)
diabetic patients with end-stage##2##4##(2008-1#1)(2013-1#1)
diabetic patients with high##2##4##(2008-7#1)(2013-1#1)
diabetic patients with##16##3##(1991-12#1)(1993-12#1)(1993-2#1)(1995-2#1)(1997-8#1)(2007-2#1)(2008-1#3)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
diabetic patients without overt##2##4##(2011-2#2)
diabetic patients##128##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-6#2)(1991-8#1)(1993-11#2)(1993-12#3)(1993-2#6)(1993-8#3)(1994-12#1)(1994-8#2)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#21)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#1)(2010-10#2)(2010-12#1)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2012-4#3)(2012-8#1)(2013-1#5)(2013-8#1)
diabetic patients]##4##2##(1990-6#1)(1991-6#1)(1996-10#1)(2012-12#1)
diabetic peripheral neuropathy##4##3##(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)
diabetic peripheral##5##2##(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#2)
diabetic population##5##2##(2008-1#1)(2008-8#3)(2012-2#1)
diabetic rat is##2##3##(2008-4#1)(2011-1#1)
diabetic rat##8##2##(1993-8#1)(2008-4#1)(2011-1#5)(2012-3#1)
diabetic rats for##2##3##(2008-10#1)(2012-2#1)
diabetic rats received##2##3##(2008-12#1)(2012-3#1)
diabetic rats to##2##3##(2008-10#1)(2012-1#1)
diabetic rats were##3##3##(1991-12#1)(2011-1#1)(2012-2#1)
diabetic rats##35##2##(1991-12#3)(1994-11#1)(1994-12#2)(1994-8#2)(1996-9#1)(2008-10#2)(2008-12#5)(2010-11#1)(2011-1#4)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-8#1)
diabetic rats]##3##2##(2010-12#1)(2011-3#1)(2013-8#1)
diabetic retinopathy in##4##3##(2008-7#1)(2011-1#1)(2013-1#2)
diabetic retinopathy##27##2##(1991-12#1)(1991-9#1)(1995-9#3)(1996-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#6)(2010-8#2)(2011-1#2)(2011-2#3)(2013-1#5)
diabetic sensorimotor polyneuropathy##3##3##(2008-1#3)
diabetic subjects and##2##3##(2012-12#2)
diabetic subjects##12##2##(1994-12#3)(2007-11#1)(2008-1#2)(2012-12#5)(2013-7#1)
diabetic tissues##2##2##(1993-3#1)(2008-10#1)
diabetic using##2##2##(1991-12#1)(2013-1#1)
diabetic vascular complications##2##3##(2008-1#2)
diabetic vascular##5##2##(2008-1#5)
diabetic##515##1##(1990-11#1)(1990-3#3)(1990-5#3)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#4)(1993-12#3)(1993-2#6)(1993-3#4)(1993-6#2)(1993-8#8)(1994-11#4)(1994-12#17)(1994-3#4)(1994-8#9)(1995-2#3)(1995-3#1)(1995-5#2)(1995-9#5)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#5)(2007-10#8)(2007-11#7)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#80)(2008-10#16)(2008-11#2)(2008-12#10)(2008-3#8)(2008-4#8)(2008-5#5)(2008-7#21)(2008-8#12)(2008-9#5)(2009-11#3)(2009-3#3)(2009-6#1)(2010-10#9)(2010-11#3)(2010-12#3)(2010-8#2)(2011-1#22)(2011-2#50)(2011-3#6)(2011-7#2)(2012-1#5)(2012-12#19)(2012-2#22)(2012-3#14)(2012-4#5)(2012-5#2)(2012-8#1)(2013-1#22)(2013-7#4)(2013-8#6)
diabetics at##2##2##(2008-1#1)(2008-9#1)
diabetics in##6##2##(1990-11#1)(1991-12#1)(1992-11#1)(2007-2#1)(2008-4#1)(2012-3#1)
diabetics suffer from##2##3##(2008-3#1)(2012-2#1)
diabetics who fast during Ramadan##2##5##(2011-1#2)
diabetics with##3##2##(2008-3#1)(2012-3#1)(2013-8#1)
diabetics##56##1##(1990-11#4)(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-8#1)(1995-2#1)(1996-9#1)(1997-4#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-3#6)(2008-4#2)(2008-7#5)(2008-9#5)(2009-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#5)(2012-3#2)(2013-8#1)
diabetogenic##7##1##(1995-2#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#2)
diabetological care##2##2##(1990-11#2)
diabetological##3##1##(1990-11#3)
diabetology##2##1##(1990-11#2)
diacetate##11##1##(1993-12#2)(2008-10#2)(2008-11#2)(2008-5#3)(2008-9#1)(2013-1#1)
diacetyl##4##1##(2008-6#4)
diacetylactis##3##1##(2008-6#2)(2008-7#1)
diacetyldioxime modified carbon paste electrode##2##5##(2008-10#2)
diacetyldioxime##4##1##(2008-10#4)
diacrylate##2##1##(1994-11#1)(2009-10#1)
diacyl##2##1##(1990-12#1)(1996-5#1)
diacylated compounds##2##2##(1996-5#2)
diacylglycerol (DAG)##3##2##(1991-12#1)(1992-9#1)(1995-11#1)
diacylglycerol (DG)##2##2##(1993-8#1)(1994-3#1)
diacylglycerol acyltransferase##2##2##(1990-5#2)
diacylglycerol and phorbol##2##3##(1994-8#2)
diacylglycerol and phosphocholine##2##3##(1990-12#2)
diacylglycerol and##8##2##(1990-12#2)(1991-3#2)(1992-8#1)(1994-8#2)(2008-11#1)
diacylglycerol formation##2##2##(1990-12#1)(1991-5#1)
diacylglycerol kinase##2##2##(1992-8#1)(1997-7#1)
diacylglycerol or##2##2##(1990-5#1)(1994-5#1)
diacylglycerol production##2##2##(1990-12#2)
diacylglycerol which##2##2##(1991-9#1)(1994-3#1)
diacylglycerol##44##1##(1990-12#8)(1990-5#3)(1991-12#2)(1991-3#2)(1991-5#1)(1991-9#2)(1992-8#3)(1992-9#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#6)(1994-8#4)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
diacylglycerol-containing membranes##2##2##(1994-5#2)
diadducts in##2##2##(1997-7#2)
diadducts##5##1##(1997-7#5)
diadenosine polyphosphate analogs##2##3##(2009-2#2)
diadenosine##3##1##(1997-7#1)(2009-2#2)
diadromous##2##1##(2010-8#2)
diafiltration were##2##2##(2008-6#2)
diafiltration##10##1##(2008-10#2)(2008-6#2)(2011-2#6)
diagenesis##2##1##(2013-8#2)
diagnosable##6##1##(1991-11#2)(2008-1#1)(2008-11#1)(2012-2#2)
diagnose a##2##2##(1991-12#1)(2008-10#1)
diagnose and manage the##2##4##(2008-1#1)(2011-2#1)
diagnose and treat this##2##4##(1995-5#1)(2006-10#1)
diagnose and treat##7##3##(1995-5#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
diagnose and##17##2##(1992-5#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
diagnose in##2##2##(2009-10#1)(2010-10#1)
diagnose the##8##2##(1993-6#1)(1996-3#1)(2007-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
diagnose##103##1##(1990-6#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#14)(2008-3#2)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#2)
diagnosed HIV infection##2##3##(2009-10#1)(2011-2#1)
diagnosed according to the##2##4##(1997-8#1)(2008-3#1)
diagnosed according to##3##3##(1997-8#1)(2008-3#1)(2008-7#1)
diagnosed acute##3##2##(2008-11#1)(2009-1#1)(2013-1#1)
diagnosed after an##2##3##(1992-10#1)(2007-8#1)
diagnosed after birth##2##3##(1990-2#1)(2008-11#1)
diagnosed after##10##2##(1990-2#1)(1992-10#1)(1993-2#1)(2007-12#1)(2007-8#3)(2008-11#1)(2008-7#1)(2013-1#1)
diagnosed among##3##2##(2007-7#1)(2008-11#1)(2013-1#1)
diagnosed and treated in##2##4##(1993-2#1)(2010-10#1)
diagnosed and treated##8##3##(1993-2#1)(2008-1#2)(2008-8#1)(2010-10#1)(2012-3#1)(2013-8#2)
diagnosed and##22##2##(1990-6#1)(1991-2#2)(1993-2#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
diagnosed as a##8##3##(1995-4#1)(2007-8#2)(2008-11#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-2#1)
diagnosed as an##2##3##(2011-2#1)(2012-3#1)
diagnosed as having a##3##4##(1996-9#1)(2008-7#1)(2011-2#1)
diagnosed as having##19##3##(1991-11#1)(1991-4#1)(1995-11#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-7#2)(2009-2#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#1)
diagnosed as##70##2##(1990-6#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-9#2)(2011-1#4)(2011-2#3)(2012-1#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
diagnosed at an early##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
diagnosed at an##5##3##(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
diagnosed at##19##2##(1990-9#2)(1993-2#1)(1994-12#1)(1996-3#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-3#1)(2010-7#1)(2012-3#4)(2013-1#1)
diagnosed based on##3##3##(1994-12#1)(2012-2#1)(2013-1#1)
diagnosed before the##2##3##(1997-5#1)(2009-8#1)
diagnosed before##5##2##(1994-3#1)(1996-11#1)(1997-5#1)(2007-8#1)(2009-8#1)
diagnosed between 1980 and##3##4##(1993-2#1)(1993-9#1)(2010-3#1)
diagnosed between January##2##3##(2008-1#1)(2011-2#1)
diagnosed between##6##2##(1993-2#1)(1993-9#1)(2008-1#1)(2010-3#1)(2011-2#2)
diagnosed by the##2##3##(2010-6#1)(2013-8#1)
diagnosed by ultrasound in##2##4##(1997-3#1)(2012-3#1)
diagnosed by ultrasound##6##3##(1994-5#1)(1996-11#1)(1997-3#1)(2009-4#1)(2012-3#2)
diagnosed by##31##2##(1991-6#1)(1994-3#1)(1994-5#1)(1996-11#1)(1997-3#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
diagnosed cancer##4##2##(1993-1#2)(2012-12#1)(2013-1#1)
diagnosed cases of##3##3##(2007-8#1)(2012-2#2)
diagnosed clinically as##2##3##(1991-8#1)(2011-1#1)
diagnosed clinically##6##2##(1991-8#1)(2006-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
diagnosed diabetes mellitus##2##3##(2013-1#2)
diagnosed diabetes##3##2##(2012-3#1)(2013-1#2)
diagnosed disease##2##2##(1993-6#1)(2013-1#1)
diagnosed due to##3##3##(1993-3#1)(2007-8#2)
diagnosed during##5##2##(1994-12#1)(1997-8#1)(2007-8#1)(2009-1#1)(2013-1#1)
diagnosed finally##2##2##(2011-2#1)(2013-7#1)
diagnosed for##3##2##(1990-3#1)(1994-2#1)(2009-1#1)
diagnosed from##4##2##(1992-10#1)(1992-9#1)(2011-2#1)(2013-8#1)
diagnosed in 13##2##3##(1991-8#1)(2012-3#1)
diagnosed in a##6##3##(1990-2#1)(1991-3#1)(1991-5#1)(1995-11#1)(1997-5#1)(2007-10#1)
diagnosed in childhood##2##3##(1995-6#1)(2008-10#1)
diagnosed in four patients##2##4##(1997-8#1)(2008-1#1)
diagnosed in the last##2##4##(2012-3#1)(2013-1#1)
diagnosed in the##12##3##(1990-2#1)(1990-9#1)(1995-12#1)(2007-5#1)(2008-1#2)(2008-5#1)(2010-12#1)(2012-3#3)(2013-1#1)
diagnosed in##61##2##(1990-2#2)(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-9#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#2)
diagnosed initially as##2##3##(2006-10#1)(2013-7#1)
diagnosed more##5##2##(1992-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
diagnosed of##4##2##(2009-8#1)(2011-2#1)(2013-1#2)
diagnosed on fine needle aspiration##2##5##(2008-7#1)(2010-11#1)
diagnosed on the basis of##7##5##(1990-12#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-3#1)
diagnosed on the##8##3##(1990-12#1)(1990-9#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-3#1)
diagnosed on##14##2##(1990-12#1)(1990-9#1)(1995-12#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#1)(2012-2#1)(2012-3#1)
diagnosed only##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
diagnosed or##2##2##(2008-4#1)(2013-1#1)
diagnosed patients with##2##3##(2008-1#1)(2013-1#1)
diagnosed patients##5##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
diagnosed pre-operatively##2##2##(2008-11#1)(2012-2#1)
diagnosed preoperatively##3##2##(1991-5#1)(2009-9#1)(2013-7#1)
diagnosed than##2##2##(1991-2#1)(2009-10#1)
diagnosed this##5##2##(2007-8#1)(2009-1#1)(2010-6#2)(2011-2#1)
diagnosed to be a##2##4##(2008-10#1)(2012-2#1)
diagnosed to be##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
diagnosed to have##14##3##(1991-2#1)(1997-8#1)(2007-2#1)(2007-7#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#2)(2013-1#1)
diagnosed to##17##2##(1991-2#1)(1997-8#1)(2007-2#1)(2007-7#4)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#3)(2013-1#1)
diagnosed type 2 diabetes##2##4##(2011-2#1)(2012-3#1)
diagnosed type##6##2##(2009-8#1)(2011-1#3)(2011-2#1)(2012-3#1)
diagnosed using##5##2##(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#2)
diagnosed when##4##2##(2008-1#1)(2008-11#1)(2010-3#2)
diagnosed with AIDS##2##3##(1995-2#1)(1997-5#1)
diagnosed with CRPS I##2##4##(2008-12#2)
diagnosed with a##12##3##(1995-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#3)
diagnosed with acute##2##3##(2007-4#1)(2011-2#1)
diagnosed with cancer##4##3##(1993-1#1)(2008-4#1)(2012-3#1)(2013-1#1)
diagnosed with diabetes##4##3##(2008-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
diagnosed with glioblastoma##3##3##(2012-3#3)
diagnosed with prostate cancer##2##4##(2008-4#1)(2012-3#1)
diagnosed with prostate##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
diagnosed with severe##3##3##(2006-8#1)(2010-10#1)(2012-3#1)
diagnosed with the##5##3##(2008-10#1)(2009-10#1)(2013-1#2)(2013-8#1)
diagnosed with##141##2##(1991-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-3#3)(1997-5#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#3)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#19)(2012-1#2)(2012-12#8)(2012-2#1)(2012-3#10)(2013-1#14)(2013-8#7)
diagnosed##648##1##(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#4)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#7)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#6)(1994-2#4)(1994-3#2)(1994-5#1)(1994-7#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#1)(1996-1#1)(1996-11#5)(1996-12#3)(1996-3#3)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-3#9)(1997-5#6)(1997-8#11)(2006-10#4)(2006-8#2)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#13)(2007-8#24)(2008-1#19)(2008-10#19)(2008-11#16)(2008-12#11)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#10)(2008-6#6)(2008-7#24)(2008-8#6)(2008-9#8)(2009-1#4)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#9)(2010-4#2)(2010-5#1)(2010-6#8)(2010-7#1)(2010-8#8)(2010-9#3)(2011-1#20)(2011-2#65)(2011-3#1)(2011-5#1)(2012-1#9)(2012-12#15)(2012-2#21)(2012-3#33)(2013-1#46)(2013-7#5)(2013-8#21)
diagnoses ICD##2##2##(1990-12#2)
diagnoses and drugs##2##3##(2008-11#2)
diagnoses and the##2##3##(2008-9#1)(2012-12#1)
diagnoses and treatment are##2##4##(1990-12#1)(1994-9#1)
diagnoses and##15##2##(1990-12#1)(1994-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-11#3)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#3)
diagnoses are possible in##2##4##(2008-6#1)(2011-2#1)
diagnoses are##5##2##(1990-9#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
diagnoses as##2##2##(1993-12#1)(1997-5#1)
diagnoses based on##2##3##(1997-3#1)(2009-9#1)
diagnoses for##4##2##(1991-1#1)(2007-12#1)(2008-7#1)(2012-3#1)
diagnoses from##3##2##(1990-6#1)(1994-6#2)
diagnoses have been##2##3##(2008-6#1)(2008-9#1)
diagnoses in the##4##3##(1993-12#1)(1994-2#1)(1995-12#1)(2008-11#1)
diagnoses in##8##2##(1993-12#1)(1994-2#2)(1995-12#1)(2008-11#1)(2012-3#1)(2013-1#2)
diagnoses included##2##2##(1997-5#1)(2008-9#1)
diagnoses is##2##2##(2011-2#1)(2012-3#1)
diagnoses like##3##2##(1997-6#1)(2008-4#1)(2011-2#1)
diagnoses made##2##2##(1993-3#1)(1994-6#1)
diagnoses of##19##2##(1990-6#1)(1992-8#1)(1993-12#1)(1994-2#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#3)
diagnoses on##2##2##(1991-2#1)(2013-8#1)
diagnoses or##2##2##(2008-11#1)(2009-10#1)
diagnoses were made##3##3##(1991-2#1)(1993-8#1)(2012-3#1)
diagnoses were used##2##3##(1997-1#1)(1997-5#1)
diagnoses were##24##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#2)(1992-4#1)(1993-12#1)(1993-8#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-5#1)(2007-12#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#1)
diagnoses with##2##2##(1997-3#1)(2007-12#1)
diagnoses##186##1##(1990-12#5)(1990-2#1)(1990-6#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#6)(1993-3#1)(1993-8#2)(1994-2#4)(1994-3#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-2#2)(1997-1#4)(1997-2#1)(1997-3#4)(1997-5#3)(1997-6#5)(1997-8#4)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#11)(2008-12#1)(2008-4#4)(2008-6#3)(2008-7#2)(2008-9#6)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#11)(2012-12#4)(2012-2#6)(2012-3#9)(2013-1#17)(2013-8#6)
diagnosing and##3##2##(1996-2#1)(2011-2#1)(2012-2#1)
diagnosing the##10##2##(2007-2#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
diagnosing this##2##2##(2008-9#1)(2013-7#1)
diagnosing##68##1##(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-5#1)(1992-9#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-7#1)(1996-2#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-2#7)(2012-3#3)(2013-7#1)(2013-8#2)
diagnosis &quot##3##2##(1990-6#1)(1997-7#1)(2009-8#1)
diagnosis ICD##2##2##(1990-12#2)
diagnosis a##2##2##(2007-8#1)(2008-12#1)
diagnosis among##2##2##(1990-2#1)(2008-12#1)
diagnosis and a##2##3##(1991-11#1)(2011-2#1)
diagnosis and adequate##3##3##(1990-9#1)(2009-1#1)(2010-11#1)
diagnosis and allows##2##3##(1993-11#1)(2008-12#1)
diagnosis and appropriate##5##3##(1991-8#1)(2007-12#1)(2007-7#1)(2010-1#1)(2013-1#1)
diagnosis and at##3##3##(1990-10#1)(2011-2#2)
diagnosis and classification of##2##4##(2008-10#1)(2012-2#1)
diagnosis and clinical management##2##4##(2008-4#1)(2012-12#1)
diagnosis and clinical##3##3##(2008-12#1)(2008-4#1)(2012-12#1)
diagnosis and early##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
diagnosis and evaluation of##5##4##(1992-5#1)(2007-8#2)(2008-1#1)(2013-1#1)
diagnosis and evaluation##6##3##(1992-5#1)(1996-8#1)(2007-8#2)(2008-1#1)(2013-1#1)
diagnosis and follow-up of##8##4##(2008-1#1)(2008-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)
diagnosis and help##2##3##(2008-12#1)(2013-1#1)
diagnosis and immediate treatment##2##4##(1996-9#1)(2010-12#1)
diagnosis and immediate##4##3##(1996-9#1)(2007-8#1)(2010-12#1)(2011-2#1)
diagnosis and in the##2##4##(1997-3#1)(2013-1#1)
diagnosis and initial management##2##4##(2007-12#1)(2011-2#1)
diagnosis and intervention##2##3##(2008-11#1)(2011-1#1)
diagnosis and management are crucial##2##5##(2007-12#1)(2008-7#1)
diagnosis and management of obstructive airway diseases##2##7##(2008-3#2)
diagnosis and management of patients with##3##6##(2007-11#1)(2011-2#2)
diagnosis and management of this##3##5##(2008-10#1)(2008-12#1)(2010-3#1)
diagnosis and management of##49##4##(1992-5#1)(1993-11#1)(1993-6#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#4)(2010-3#1)(2011-2#5)(2011-7#5)(2012-2#2)(2013-1#1)(2013-8#1)
diagnosis and management##65##3##(1991-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#4)(2010-3#1)(2010-9#1)(2011-2#9)(2011-7#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
diagnosis and monitoring of##8##4##(1990-6#1)(1992-3#1)(1992-5#1)(1997-7#1)(2007-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
diagnosis and more effective treatment##2##5##(2010-6#1)(2013-1#1)
diagnosis and more effective##3##4##(2008-3#1)(2010-6#1)(2013-1#1)
diagnosis and prognosis of##6##4##(1995-9#1)(2007-7#1)(2008-11#1)(2008-4#2)(2012-2#1)
diagnosis and prompt treatment##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
diagnosis and prompt##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
diagnosis and proper treatment##2##4##(2013-8#2)
diagnosis and proper##3##3##(2010-11#1)(2013-8#2)
diagnosis and recommendations##3##3##(1995-1#3)
diagnosis and risk##2##3##(2007-7#1)(2008-3#1)
diagnosis and subsequent##3##3##(1990-8#1)(2006-10#1)(2008-12#1)
diagnosis and surgical intervention##2##4##(1995-5#1)(2008-7#1)
diagnosis and surgical planning##2##4##(2008-7#1)(2011-2#1)
diagnosis and surgical treatment##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
diagnosis and surgical##7##3##(1995-5#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-8#1)
diagnosis and the need for##3##5##(1992-8#1)(2007-2#1)(2009-5#1)
diagnosis and the start of treatment##2##6##(2012-12#2)
diagnosis and the subsequent treatment##2##5##(2008-8#1)(2010-12#1)
diagnosis and the surgical##2##4##(1990-6#1)(2007-8#1)
diagnosis and the##20##3##(1990-6#2)(1991-3#1)(1991-5#1)(1992-8#1)(1993-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
diagnosis and therapeutic##6##3##(1997-4#1)(2008-1#1)(2008-12#2)(2011-2#1)(2012-2#1)
diagnosis and therapy of this##2##5##(1990-2#1)(2012-3#1)
diagnosis and therapy of##8##4##(1990-2#1)(1990-6#1)(1992-5#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-3#2)
diagnosis and therapy##25##3##(1990-2#1)(1990-6#1)(1990-9#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)
diagnosis and therapy]##3##3##(1990-3#1)(1990-6#1)(1995-5#1)
diagnosis and to##4##3##(1997-3#1)(2007-11#1)(2008-12#1)(2009-10#1)
diagnosis and treatment in the##2##5##(2011-1#1)(2012-12#1)
diagnosis and treatment in##7##4##(1990-3#1)(1996-8#1)(2008-12#2)(2011-1#1)(2012-12#2)
diagnosis and treatment is essential##2##5##(2011-1#1)(2011-2#1)
diagnosis and treatment is##7##4##(2008-12#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#2)
diagnosis and treatment of ADHF##2##5##(2008-3#2)
diagnosis and treatment of breast cancer##3##6##(1997-3#1)(2009-5#1)(2010-8#1)
diagnosis and treatment of the##3##5##(1993-2#1)(1996-3#1)(2008-4#1)
diagnosis and treatment of these##2##5##(2010-5#1)(2012-3#1)
diagnosis and treatment of##51##4##(1990-9#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#1)(1996-3#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#3)(2011-7#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
diagnosis and treatment##110##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-2#1)(1994-9#1)(1995-8#1)(1996-3#2)(1996-8#1)(1997-3#2)(1997-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#5)(2011-2#10)(2011-7#2)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
diagnosis and treatment]##5##3##(1992-5#1)(1993-2#1)(1996-3#1)(1996-6#1)(2013-1#1)
diagnosis and treatments##2##3##(2008-9#1)(2012-2#1)
diagnosis and tumor##2##3##(1990-12#1)(2011-2#1)
diagnosis and with##2##3##(1992-12#1)(2013-1#1)
diagnosis and##440##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#8)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#4)(1993-6#4)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#8)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#2)(2007-5#3)(2007-7#8)(2007-8#7)(2008-1#9)(2008-10#10)(2008-11#8)(2008-12#19)(2008-2#1)(2008-3#12)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#4)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#11)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#9)(2011-2#43)(2011-7#7)(2012-1#1)(2012-12#17)(2012-2#18)(2012-3#10)(2013-1#26)(2013-7#3)(2013-8#12)
diagnosis and/or##2##2##(2012-3#2)
diagnosis are based##2##3##(2008-9#1)(2013-1#1)
diagnosis are discussed##3##3##(1997-8#1)(2008-11#1)(2012-3#1)
diagnosis are examined##2##3##(1990-9#1)(2008-3#1)
diagnosis are##25##2##(1990-2#2)(1990-9#2)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#3)
diagnosis as the##2##3##(1991-12#1)(2012-3#1)
diagnosis as##12##2##(1991-12#1)(1991-6#1)(2007-2#1)(2007-8#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
diagnosis at the##3##3##(1991-9#1)(2010-12#1)(2012-12#1)
diagnosis at##8##2##(1991-9#1)(1996-9#1)(1997-6#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
diagnosis based on##3##3##(1990-10#1)(1996-12#1)(2008-10#1)
diagnosis based##4##2##(1990-10#1)(1996-12#1)(2008-10#1)(2008-7#1)
diagnosis between##8##2##(1990-10#1)(2009-8#1)(2010-12#4)(2012-3#1)(2013-1#1)
diagnosis but##4##2##(1990-5#1)(1997-3#1)(2008-6#1)(2008-7#1)
diagnosis by the##2##3##(2007-8#2)
diagnosis by##9##2##(2006-10#1)(2007-2#1)(2007-8#2)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
diagnosis can be##4##3##(1992-5#1)(2008-5#1)(2010-7#1)(2012-12#1)
diagnosis can##7##2##(1992-5#1)(1994-12#1)(2007-8#1)(2008-5#1)(2010-7#1)(2010-8#1)(2012-12#1)
diagnosis codes##2##2##(1991-3#1)(1993-12#1)
diagnosis could be##3##3##(1991-9#1)(1992-12#1)(2008-5#1)
diagnosis could not be##3##4##(2008-12#2)(2011-1#1)
diagnosis could##8##2##(1991-9#1)(1992-12#1)(1996-12#1)(1997-6#1)(2008-12#2)(2008-5#1)(2011-1#1)
diagnosis difficult##2##2##(1991-8#1)(2009-1#1)
diagnosis followed##2##2##(1993-9#1)(2008-7#1)
diagnosis for an##2##3##(2008-8#1)(2012-2#1)
diagnosis for##24##2##(1992-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-8#1)
diagnosis from##3##2##(1991-12#1)(2008-5#1)(2012-12#1)
diagnosis has been##8##3##(1990-9#1)(1993-2#1)(2007-4#1)(2007-8#1)(2008-6#1)(2013-1#3)
diagnosis has to be##2##4##(2008-7#1)(2009-12#1)
diagnosis has##18##2##(1990-9#1)(1991-11#1)(1993-2#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-3#2)(2013-1#4)
diagnosis heading##2##2##(2007-12#2)
diagnosis if##2##2##(1995-8#1)(2010-3#1)
diagnosis in a##6##3##(1992-6#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-6#1)(2012-3#1)
diagnosis in mind##2##3##(1992-4#1)(2011-2#1)
diagnosis in most cases##3##4##(2012-2#2)(2012-3#1)
diagnosis in order to##2##4##(2009-4#1)(2012-12#1)
diagnosis in patients with##2##4##(2008-7#1)(2012-3#1)
diagnosis in the identification of the numerical chromosomal abnormalities##2##9##(2012-3#2)
diagnosis in the##8##3##(1990-10#1)(1997-2#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-12#1)(2012-3#2)
diagnosis in this##2##3##(2008-7#1)(2011-2#1)
diagnosis in##70##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-2#2)(1991-6#1)(1992-1#2)(1992-4#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-11#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#7)(2013-7#1)(2013-8#1)
diagnosis is a##2##3##(1992-11#1)(2011-3#1)
diagnosis is available##2##3##(1990-6#1)(2011-2#1)
diagnosis is based mainly on##2##5##(2011-2#1)(2013-1#1)
diagnosis is based on##3##4##(1993-2#1)(2011-1#1)(2013-1#1)
diagnosis is based##6##3##(1993-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
diagnosis is crucial##2##3##(2008-12#1)(2011-2#1)
diagnosis is difficult##4##3##(1993-6#1)(1996-6#1)(1996-9#1)(2012-12#1)
diagnosis is discussed##2##3##(1990-12#2)
diagnosis is essential for##4##4##(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
diagnosis is essential##6##3##(1993-6#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
diagnosis is established##2##3##(1990-12#1)(2013-1#1)
diagnosis is important##2##3##(2010-8#1)(2013-8#1)
diagnosis is made with##2##4##(2013-1#2)
diagnosis is made##10##3##(1990-3#1)(1992-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)(2013-1#3)
diagnosis is more##2##3##(1993-2#1)(2008-5#1)
diagnosis is not##3##3##(1991-2#1)(2011-2#1)(2013-8#1)
diagnosis is often difficult##2##4##(1993-2#1)(2008-5#1)
diagnosis is very important##3##4##(1992-11#1)(2010-11#1)(2012-1#1)
diagnosis is very##4##3##(1990-2#1)(1992-11#1)(2010-11#1)(2012-1#1)
diagnosis is##78##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#3)(1992-9#1)(1993-2#3)(1993-5#1)(1993-6#2)(1996-6#1)(1996-9#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#2)
diagnosis made##2##2##(2008-7#1)(2012-3#1)
diagnosis may be difficult##4##4##(2007-8#1)(2008-7#1)(2010-11#1)(2011-1#1)
diagnosis may be##9##3##(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
diagnosis may##15##2##(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
diagnosis method##2##2##(2008-10#2)
diagnosis methods##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
diagnosis must be##3##3##(1994-8#1)(1997-8#1)(2012-12#1)
diagnosis of &quot##3##3##(1991-12#1)(2008-12#1)(2013-7#1)
diagnosis of AD##3##3##(2008-7#1)(2012-2#2)
diagnosis of ADHD were##2##4##(2011-2#1)(2013-7#1)
diagnosis of ADHD##5##3##(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#2)
diagnosis of AIDS##2##3##(1990-9#1)(1993-3#1)
diagnosis of AMI##2##3##(2008-3#2)
diagnosis of AS##2##3##(2007-7#2)
diagnosis of ASD##2##3##(2012-3#2)
diagnosis of Alzheimer's##2##3##(1996-11#1)(2013-1#1)
diagnosis of CNS##2##3##(1994-9#1)(2008-7#1)
diagnosis of CTEPH##3##3##(2010-6#3)
diagnosis of Cushing's syndrome##2##4##(1990-3#1)(1991-10#1)
diagnosis of Cushing's##5##3##(1990-3#2)(1991-10#1)(2011-2#2)
diagnosis of DDH##2##3##(2007-8#2)
diagnosis of DR-ILD##2##3##(2011-2#2)
diagnosis of EPTB##2##3##(2013-8#2)
diagnosis of FA##2##3##(2008-4#2)
diagnosis of HIT##2##3##(2010-3#1)(2013-1#1)
diagnosis of HS##2##3##(2011-2#2)
diagnosis of LVNC##2##3##(2010-4#2)
diagnosis of Lyme##2##3##(1997-3#1)(2008-10#1)
diagnosis of M##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
diagnosis of NE##2##3##(1991-11#2)
diagnosis of NETs##2##3##(2011-2#2)
diagnosis of NPC##2##3##(1990-8#1)(1992-6#1)
diagnosis of Newcastle disease##2##4##(2008-5#2)
diagnosis of P##3##3##(2008-10#1)(2011-2#2)
diagnosis of Plasmodium##2##3##(2011-2#1)(2012-12#1)
diagnosis of Schönlein-Henoch##2##3##(1997-8#2)
diagnosis of Steinert's dystrophy##2##4##(2013-1#2)
diagnosis of TA##2##3##(1997-8#2)
diagnosis of TB##3##3##(2008-1#1)(2010-5#2)
diagnosis of TBP##3##3##(2008-1#3)
diagnosis of Takayasu arteritis##2##4##(1997-8#2)
diagnosis of a patient##2##4##(2007-12#1)(2012-3#1)
diagnosis of a##32##3##(1990-10#1)(1991-11#1)(1992-2#1)(1994-7#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
diagnosis of abdominal##2##3##(1991-2#1)(1992-5#1)
diagnosis of acute appendicitis##2##4##(2009-7#1)(2013-1#1)
diagnosis of acute##14##3##(1994-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-3#3)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
diagnosis of an##11##3##(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
diagnosis of appendiceal Crohn's disease##2##5##(2011-2#2)
diagnosis of aspergillosis##2##3##(1997-3#2)
diagnosis of autism in##2##4##(2012-12#2)
diagnosis of autism##3##3##(2010-12#1)(2012-12#2)
diagnosis of autoimmune hepatitis##3##4##(1996-11#2)(2011-1#1)
diagnosis of bacterial vaginosis##2##4##(2007-12#1)(2008-10#1)
diagnosis of bacterial##4##3##(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)
diagnosis of bipolar##2##3##(2011-1#2)
diagnosis of bone##2##3##(1994-12#1)(2010-11#1)
diagnosis of brain##2##3##(2009-11#2)
diagnosis of breast cancer##5##4##(1991-12#2)(1996-3#2)(2008-4#1)
diagnosis of breast cancer]##2##4##(1992-2#1)(1996-3#1)
diagnosis of breast lumps##2##4##(1991-12#1)(2008-7#1)
diagnosis of breast##12##3##(1990-6#1)(1991-12#3)(1992-2#1)(1996-3#3)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
diagnosis of bullous##2##3##(2007-7#1)(2008-12#1)
diagnosis of cancer##3##3##(1991-12#1)(1996-11#1)(2012-3#1)
diagnosis of cerebrovascular accidents##2##4##(2008-1#1)(2012-12#1)
diagnosis of cerebrovascular##3##3##(2007-10#1)(2008-1#1)(2012-12#1)
diagnosis of certain##2##3##(2008-9#1)(2011-2#1)
diagnosis of cervical##4##3##(1994-9#1)(2008-11#2)(2013-1#1)
diagnosis of chronic##9##3##(1992-5#2)(1992-9#1)(1993-5#1)(1994-11#1)(2008-1#1)(2008-12#1)(2010-10#1)(2010-6#1)
diagnosis of colorectal##3##3##(1990-11#1)(1993-3#1)(1993-9#1)
diagnosis of congenital##2##3##(2007-11#1)(2008-4#1)
diagnosis of coronary##4##3##(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
diagnosis of cutaneous##2##3##(2007-7#1)(2008-5#1)
diagnosis of cystic##3##3##(1994-2#1)(2012-2#1)(2013-1#1)
diagnosis of dementia##6##3##(1996-11#3)(2008-7#2)(2012-12#1)
diagnosis of diabetes##4##3##(2007-7#1)(2008-1#2)(2011-2#1)
diagnosis of disease##2##3##(2008-7#1)(2012-1#1)
diagnosis of disorders##2##3##(2008-7#1)(2011-7#1)
diagnosis of disseminated superficial porokeratosis##2##5##(2007-7#2)
diagnosis of disseminated##3##3##(2007-7#2)(2008-5#1)
diagnosis of drug-induced liver injury##3##5##(2008-8#3)
diagnosis of drug-induced liver##4##4##(2008-8#4)
diagnosis of dyslexia##2##3##(2008-11#2)
diagnosis of early##3##3##(1990-9#1)(1991-12#1)(2008-5#1)
diagnosis of echinococcosis##2##3##(2012-3#2)
diagnosis of either##2##3##(1994-2#1)(1997-2#1)
diagnosis of endobronchial metastasis was##2##5##(1992-8#2)
diagnosis of endobronchial##3##3##(1992-8#2)(2013-7#1)
diagnosis of endometrial##2##3##(1995-3#1)(2013-1#1)
diagnosis of eosinophilic##2##3##(1990-11#1)(2013-8#1)
diagnosis of femoral##2##3##(1992-11#1)(2009-3#1)
diagnosis of gastric##3##3##(1992-9#2)(2008-12#1)
diagnosis of genetic##2##3##(1994-2#1)(2008-10#1)
diagnosis of genital herpes##2##4##(2008-10#2)
diagnosis of giant##2##3##(2006-12#1)(2013-1#1)
diagnosis of heart failure##2##4##(2008-3#2)
diagnosis of hepatoblastoma##2##3##(2011-1#2)
diagnosis of hepatocellular carcinoma##2##4##(2008-2#1)(2010-7#1)
diagnosis of hereditary##2##3##(2008-1#1)(2011-2#1)
diagnosis of hypertension##2##3##(1997-3#1)(2008-7#1)
diagnosis of infection in##2##4##(2008-10#2)
diagnosis of inflammatory##2##3##(2008-7#1)(2013-1#1)
diagnosis of intestinal obstruction##2##4##(2013-1#2)
diagnosis of invasive##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
diagnosis of ischemic##2##3##(1990-6#1)(2011-2#1)
diagnosis of left##3##3##(2008-1#1)(2012-2#1)(2013-1#1)
diagnosis of leukemia##2##3##(2008-11#1)(2011-2#1)
diagnosis of lipoma##2##3##(2008-6#1)(2013-1#1)
diagnosis of lung##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
diagnosis of malaria in##2##4##(2007-2#1)(2012-3#1)
diagnosis of malaria##4##3##(2007-2#1)(2007-7#2)(2012-3#1)
diagnosis of malignancy##4##3##(1990-3#2)(1991-3#1)(2008-4#1)
diagnosis of many##4##3##(1990-9#1)(2008-5#1)(2011-7#1)(2013-8#1)
diagnosis of mild##3##3##(2012-2#1)(2013-8#2)
diagnosis of oesophageal##2##3##(2008-1#1)(2008-11#1)
diagnosis of oral##3##3##(2012-2#1)(2013-1#2)
diagnosis of osteosarcoma##2##3##(2010-3#2)
diagnosis of ovarian cancer##2##4##(1996-11#1)(2012-2#1)
diagnosis of parasites##2##3##(1997-7#1)(2011-2#1)
diagnosis of parathyroid##2##3##(2009-7#1)(2011-1#1)
diagnosis of patients##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
diagnosis of pelvic-peritoneal tuberculosis##2##4##(2008-10#2)
diagnosis of pleural##2##3##(2008-1#1)(2008-7#1)
diagnosis of potato##2##3##(2008-10#2)
diagnosis of primary hyperoxaluria type I##2##6##(1995-12#2)
diagnosis of primary hyperparathyroidism was##2##5##(2008-12#1)(2011-1#1)
diagnosis of primary##8##3##(1995-12#2)(2008-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
diagnosis of prostate cancer##2##4##(2009-12#1)(2011-2#1)
diagnosis of prostatic cancer##2##4##(1991-7#1)(2009-5#1)
diagnosis of prostatic##4##3##(1991-2#2)(1991-7#1)(2009-5#1)
diagnosis of pulmonary embolism##3##4##(1991-11#3)
diagnosis of pulmonary##6##3##(1991-11#3)(1997-3#1)(2008-1#1)(2008-10#1)
diagnosis of rectal##2##3##(2013-1#1)(2013-8#1)
diagnosis of relapse##2##3##(1997-8#1)(2007-7#1)
diagnosis of renal disease##2##4##(2007-7#1)(2008-1#1)
diagnosis of renal tumor##2##4##(2008-10#2)
diagnosis of renal##10##3##(1990-9#1)(1992-8#1)(2007-7#1)(2008-1#3)(2008-10#3)(2011-2#1)
diagnosis of sarcoidosis##3##3##(1997-5#1)(2008-1#1)(2013-7#1)
diagnosis of sarcoma##2##3##(2008-6#2)
diagnosis of schistosomiasis##2##3##(1996-12#1)(1996-8#1)
diagnosis of schizophrenia or##2##4##(2008-3#1)(2008-6#1)
diagnosis of significant##2##3##(1991-3#1)(2008-11#1)
diagnosis of spindle cell##2##4##(1991-8#1)(2008-6#1)
diagnosis of stroke##3##3##(2007-10#3)
diagnosis of subarachnoid haemorrhage##2##4##(1995-9#1)(2008-7#1)
diagnosis of such##3##3##(2008-1#1)(2013-1#1)(2013-8#1)
diagnosis of superficial##2##3##(1993-9#1)(2008-5#1)
diagnosis of systemic lupus erythematosus##2##5##(2006-10#1)(2011-2#1)
diagnosis of the Brugada syndrome##2##5##(2008-12#2)
diagnosis of the disease##2##4##(1991-2#1)(2011-2#1)
diagnosis of the lesions##2##4##(2013-1#1)(2013-8#1)
diagnosis of the underlying cause##2##5##(2010-10#2)
diagnosis of the##38##3##(1990-3#1)(1990-6#1)(1991-2#1)(1997-3#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-10#3)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
diagnosis of these##7##3##(1990-5#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#2)
diagnosis of this disease##2##4##(1997-8#1)(2007-7#1)
diagnosis of this disorder##2##4##(2008-8#1)(2011-2#1)
diagnosis of this pathology##3##4##(1991-3#1)(1992-8#1)(2009-3#1)
diagnosis of this##14##3##(1991-3#1)(1992-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnosis of trypanosomiasis##2##3##(2013-1#2)
diagnosis of tuberculosis##5##3##(1990-6#1)(1990-9#1)(2007-7#1)(2008-12#1)(2013-1#1)
diagnosis of type##2##3##(1992-6#1)(2007-8#1)
diagnosis of upper##2##3##(2007-2#1)(2011-2#1)
diagnosis of urinary##2##3##(1997-2#1)(2008-10#1)
diagnosis of vascular##2##3##(2008-1#1)(2008-7#1)
diagnosis of viral##2##3##(2008-11#1)(2013-8#1)
diagnosis of##908##2##(1990-10#4)(1990-11#5)(1990-2#2)(1990-3#8)(1990-5#1)(1990-6#8)(1990-8#6)(1990-9#9)(1991-10#1)(1991-11#10)(1991-12#8)(1991-2#6)(1991-3#8)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#9)(1992-6#4)(1992-8#4)(1992-9#4)(1993-12#1)(1993-2#4)(1993-3#3)(1993-5#3)(1993-6#1)(1993-9#5)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#4)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#11)(1996-12#7)(1996-2#1)(1996-3#5)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#5)(1997-3#15)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#11)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#13)(2007-11#12)(2007-12#8)(2007-2#6)(2007-5#3)(2007-7#25)(2007-8#13)(2008-1#29)(2008-10#43)(2008-11#18)(2008-12#16)(2008-2#4)(2008-3#16)(2008-4#10)(2008-5#16)(2008-6#12)(2008-7#30)(2008-8#9)(2008-9#11)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#10)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#9)(2010-4#3)(2010-5#5)(2010-6#11)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#21)(2011-2#76)(2011-3#1)(2011-7#2)(2012-1#3)(2012-12#23)(2012-2#34)(2012-3#32)(2013-1#62)(2013-7#9)(2013-8#27)
diagnosis on##3##2##(1997-2#1)(2007-11#1)(2013-1#1)
diagnosis or differential diagnosis##3##4##(2010-12#3)
diagnosis or##18##2##(1991-1#1)(1992-3#1)(1993-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-2#1)
diagnosis requires##3##2##(1992-2#1)(2008-3#1)(2011-2#1)
diagnosis revealed##2##2##(2010-11#1)(2011-2#1)
diagnosis should be considered##2##4##(2008-4#1)(2008-9#1)
diagnosis should be##3##3##(2007-5#1)(2008-4#1)(2008-9#1)
diagnosis should##6##2##(1990-3#1)(2007-5#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
diagnosis such as##2##3##(2008-8#1)(2012-12#1)
diagnosis suggestive of##2##3##(2013-1#2)
diagnosis taking##2##2##(2009-9#1)(2013-1#1)
diagnosis than##2##2##(1993-2#1)(2008-6#1)
diagnosis that##4##2##(1995-6#1)(2007-11#1)(2008-3#1)(2008-6#1)
diagnosis through the##2##3##(2008-7#1)(2013-8#1)
diagnosis through##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
diagnosis to be made##2##4##(1991-5#1)(1992-9#1)
diagnosis to be##4##3##(1991-5#1)(1992-9#1)(2008-10#1)(2013-1#1)
diagnosis to##18##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-9#1)(1993-3#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
diagnosis today##2##2##(1997-8#2)
diagnosis was 3##2##3##(2008-6#1)(2011-2#1)
diagnosis was a##2##3##(2008-7#1)(2009-5#1)
diagnosis was based on##4##4##(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
diagnosis was based##5##3##(1993-5#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
diagnosis was confirmed by the##2##5##(1997-8#1)(2007-8#1)
diagnosis was confirmed by##12##4##(1990-2#1)(1990-3#1)(1990-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-12#1)
diagnosis was confirmed##18##3##(1990-2#1)(1990-3#1)(1990-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-12#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
diagnosis was delayed##3##3##(1990-9#1)(2009-4#1)(2010-11#1)
diagnosis was made by##2##4##(1993-9#1)(2007-10#1)
diagnosis was made in##2##4##(1990-6#1)(1997-2#1)
diagnosis was made##15##3##(1990-6#1)(1993-12#1)(1993-9#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-1#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-8#1)
diagnosis was not##5##3##(1990-12#1)(1992-5#1)(2007-8#1)(2008-7#1)(2008-9#1)
diagnosis was obtained in##2##4##(1991-6#1)(2013-8#1)
diagnosis was obtained##4##3##(1990-10#1)(1991-6#1)(2009-1#1)(2013-8#1)
diagnosis was subsequently##2##3##(1994-7#1)(2011-2#1)
diagnosis was##117##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#2)(1990-9#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-7#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#4)(2007-8#6)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#5)(2008-7#8)(2008-9#2)(2009-1#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#7)(2012-12#5)(2012-2#1)(2012-3#7)(2013-1#4)(2013-8#4)
diagnosis were##3##2##(1996-7#1)(2011-2#1)(2013-1#1)
diagnosis when##7##2##(1992-6#1)(1995-11#1)(1996-12#1)(2008-1#1)(2012-3#2)(2013-8#1)
diagnosis will be##2##3##(1990-3#1)(2012-12#1)
diagnosis with##10##2##(1990-8#1)(1993-8#1)(1993-9#1)(2008-11#1)(2008-9#2)(2011-2#2)(2013-7#1)(2013-8#1)
diagnosis within the##2##3##(1995-12#1)(2010-3#1)
diagnosis would##3##2##(1992-5#2)(2008-9#1)
diagnosis##2521##1##(1990-10#13)(1990-11#7)(1990-12#19)(1990-2#16)(1990-3#21)(1990-5#5)(1990-6#25)(1990-8#11)(1990-9#19)(1991-1#3)(1991-10#1)(1991-11#17)(1991-12#18)(1991-2#13)(1991-3#12)(1991-4#2)(1991-5#7)(1991-6#13)(1991-7#2)(1991-8#10)(1991-9#4)(1992-1#2)(1992-10#4)(1992-11#6)(1992-12#7)(1992-2#8)(1992-3#4)(1992-4#4)(1992-5#30)(1992-6#10)(1992-8#9)(1992-9#10)(1993-1#3)(1993-11#4)(1993-12#7)(1993-2#15)(1993-3#6)(1993-5#5)(1993-6#8)(1993-8#3)(1993-9#12)(1994-1#2)(1994-10#2)(1994-11#6)(1994-12#4)(1994-2#11)(1994-3#3)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#1)(1994-9#7)(1995-1#7)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#5)(1995-5#4)(1995-6#4)(1995-8#5)(1995-9#2)(1996-11#18)(1996-12#14)(1996-2#5)(1996-3#12)(1996-6#5)(1996-7#3)(1996-8#8)(1996-9#6)(1997-1#2)(1997-2#13)(1997-3#33)(1997-4#9)(1997-5#6)(1997-6#6)(1997-7#8)(1997-8#26)(2006-10#11)(2006-12#7)(2006-8#3)(2007-10#23)(2007-11#42)(2007-12#29)(2007-2#17)(2007-4#2)(2007-5#13)(2007-7#44)(2007-8#48)(2008-1#54)(2008-10#92)(2008-11#45)(2008-12#53)(2008-2#9)(2008-3#38)(2008-4#30)(2008-5#46)(2008-6#41)(2008-7#88)(2008-8#23)(2008-9#30)(2009-1#7)(2009-10#10)(2009-11#8)(2009-12#4)(2009-2#3)(2009-3#15)(2009-4#10)(2009-5#12)(2009-6#3)(2009-7#5)(2009-8#14)(2009-9#10)(2010-1#6)(2010-10#11)(2010-11#14)(2010-12#61)(2010-2#2)(2010-3#29)(2010-4#6)(2010-5#17)(2010-6#26)(2010-7#10)(2010-8#25)(2010-9#5)(2011-1#51)(2011-2#200)(2011-3#3)(2011-7#10)(2012-1#8)(2012-12#83)(2012-2#84)(2012-3#93)(2013-1#148)(2013-7#16)(2013-8#67)
diagnosis)##4##1##(1991-11#2)(1993-9#1)(2008-9#1)
diagnosis-related group (DRG)##3##3##(1991-3#1)(1992-12#1)(1995-2#1)
diagnosis-related group weights##2##3##(1991-1#1)(1993-1#1)
diagnosis-related group##9##2##(1991-1#3)(1991-3#2)(1992-12#1)(1992-2#1)(1993-1#1)(1995-2#1)
diagnosis-related groups (DRGs)##8##3##(1991-12#1)(1992-12#1)(1992-2#2)(1994-12#3)(1995-3#1)
diagnosis-related groups to##2##3##(1991-12#1)(1994-12#1)
diagnosis-related groups##19##2##(1991-1#2)(1991-12#2)(1991-3#2)(1992-12#1)(1992-2#3)(1993-1#1)(1993-12#2)(1994-12#5)(1995-3#1)
diagnosis-related##28##1##(1991-1#5)(1991-12#2)(1991-3#4)(1992-12#2)(1992-2#4)(1993-1#2)(1993-12#2)(1994-12#5)(1995-2#1)(1995-3#1)
diagnosis?##10##1##(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(2007-12#3)(2007-2#2)(2010-10#1)
diagnosis?]##4##1##(1992-2#1)(1995-8#1)(1997-3#1)(1997-7#1)
diagnosis]##16##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-4#1)(1992-2#1)(1995-6#1)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
diagnosisof##2##1##(2009-8#2)
diagnostic PCR##2##2##(2008-10#1)(2013-1#1)
diagnostic accuracy and therapeutic##2##4##(2007-8#1)(2011-2#1)
diagnostic accuracy and##4##3##(1991-3#1)(2007-8#1)(2011-2#1)(2012-3#1)
diagnostic accuracy of the technique##2##5##(1995-11#1)(2010-12#1)
diagnostic accuracy of the##3##4##(1995-11#1)(2010-12#1)(2012-2#1)
diagnostic accuracy of##12##3##(1995-11#1)(1995-4#1)(2008-12#2)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#2)(2013-1#1)
diagnostic accuracy##35##2##(1991-3#1)(1995-11#2)(1995-4#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-12#5)(2008-7#4)(2009-11#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#4)
diagnostic activity##2##2##(2010-12#2)
diagnostic agreement##2##2##(1995-12#1)(2011-2#1)
diagnostic algorithm for##3##3##(2008-10#2)(2008-4#1)
diagnostic algorithm##5##2##(2008-10#2)(2008-3#2)(2008-4#1)
diagnostic algorithms##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
diagnostic and clinical##2##3##(2012-3#1)(2013-8#1)
diagnostic and curative##2##3##(1993-3#1)(2008-2#1)
diagnostic and interventional procedures##3##4##(2006-10#1)(2011-2#2)
diagnostic and management##6##3##(1990-6#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#2)
diagnostic and nondiagnostic##2##3##(2008-11#2)
diagnostic and prognostic significance##2##4##(2008-4#1)(2010-4#1)
diagnostic and prognostic##17##3##(1991-2#1)(1991-6#1)(1994-11#1)(1995-5#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-12#1)
diagnostic and therapeutic approach##2##4##(1993-5#1)(2008-7#1)
diagnostic and therapeutic approaches##2##4##(2006-10#1)(2008-10#1)
diagnostic and therapeutic challenge##2##4##(2007-2#1)(2012-2#1)
diagnostic and therapeutic challenges##3##4##(2007-7#1)(2008-12#1)(2013-1#1)
diagnostic and therapeutic dilemmas##2##4##(2008-6#1)(2011-2#1)
diagnostic and therapeutic options for##2##5##(2010-8#1)(2011-1#1)
diagnostic and therapeutic procedures are##2##5##(1996-3#2)
diagnostic and therapeutic procedures##4##4##(1996-3#3)(2013-7#1)
diagnostic and therapeutic strategies##3##4##(2010-11#1)(2011-2#1)(2013-8#1)
diagnostic and therapeutic##51##3##(1990-12#1)(1990-6#1)(1992-6#1)(1993-1#1)(1993-5#3)(1996-3#3)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
diagnostic and treatment issues##2##4##(1993-9#1)(2011-2#1)
diagnostic and treatment options##2##4##(2011-2#1)(2013-1#1)
diagnostic and treatment##11##3##(1993-9#1)(1994-2#1)(2007-11#1)(2008-2#1)(2011-2#4)(2013-1#3)
diagnostic and##109##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-5#3)(1993-9#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-3#3)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#3)
diagnostic angiography##3##2##(1997-6#1)(2008-11#1)(2009-8#1)
diagnostic antigen##2##2##(2011-1#1)(2012-3#1)
diagnostic application##2##2##(1997-8#1)(2008-10#1)
diagnostic applications in##2##3##(2008-10#2)
diagnostic applications##7##2##(1990-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-8#1)
diagnostic approach and##3##3##(1994-6#1)(2010-8#1)(2012-2#1)
diagnostic approach for##2##3##(2008-3#1)(2012-3#1)
diagnostic approach to##5##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
diagnostic approach##14##2##(1992-9#1)(1994-6#2)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
diagnostic approaches for##2##3##(2012-2#2)
diagnostic approaches##5##2##(1996-9#1)(2011-2#1)(2012-2#3)
diagnostic as well as##3##4##(1990-9#1)(2012-2#1)(2013-1#1)
diagnostic assays to##2##3##(2008-10#2)
diagnostic assays##4##2##(2008-10#3)(2011-2#1)
diagnostic assessment in##2##3##(2008-7#1)(2011-2#1)
diagnostic assessment##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
diagnostic biomarker##2##2##(2012-3#2)
diagnostic biomarkers##2##2##(2010-12#1)(2011-2#1)
diagnostic capabilities##2##2##(2008-1#1)(2010-8#1)
diagnostic categories that##2##3##(1997-1#1)(2010-1#1)
diagnostic categories##6##2##(1994-2#1)(1997-1#2)(2008-11#2)(2010-1#1)
diagnostic category##3##2##(2009-8#1)(2011-2#1)(2012-2#1)
diagnostic certainty##2##2##(1996-3#1)(2008-10#1)
diagnostic challenge of##2##3##(2008-6#1)(2009-8#1)
diagnostic challenge##9##2##(2007-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
diagnostic challenges##2##2##(2011-2#1)(2013-1#1)
diagnostic characteristics##6##2##(1993-2#1)(1995-5#1)(2008-5#1)(2012-12#2)(2013-7#1)
diagnostic characters##2##2##(1996-6#1)(2008-10#1)
diagnostic classification##2##2##(2013-1#2)
diagnostic clue##2##2##(2007-2#1)(2008-12#1)
diagnostic clues##2##2##(2008-11#1)(2011-1#1)
diagnostic considerations##3##2##(1997-2#1)(1997-4#1)(2007-8#1)
diagnostic coronary angiography##2##3##(2008-7#1)(2011-2#1)
diagnostic coverage##2##2##(2012-12#2)
diagnostic criteria and##4##3##(1997-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
diagnostic criteria are presented##2##4##(1990-9#1)(1995-11#1)
diagnostic criteria are##3##3##(1990-9#1)(1995-11#1)(2011-2#1)
diagnostic criteria for TS##2##4##(2008-7#2)
diagnostic criteria for##16##3##(1991-3#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
diagnostic criteria of##5##3##(1991-8#1)(1995-8#1)(2006-10#1)(2011-2#1)(2013-7#1)
diagnostic criteria were##2##3##(1991-3#1)(1995-8#1)
diagnostic criteria##54##2##(1990-6#1)(1990-9#1)(1991-3#2)(1991-8#1)(1991-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#2)(1997-2#1)(1997-8#2)(2006-10#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#13)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#3)
diagnostic data##3##2##(1991-12#1)(1993-2#1)(2011-2#1)
diagnostic de##4##2##(2013-1#4)
diagnostic delay##5##2##(1990-12#4)(2008-10#1)
diagnostic difficulties##10##2##(1992-5#1)(2007-11#4)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
diagnostic difficulty##2##2##(2007-7#1)(2011-2#1)
diagnostic dilemma##10##2##(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
diagnostic errors##3##2##(2007-11#1)(2008-4#1)(2013-1#1)
diagnostic evaluation and##3##3##(2007-9#1)(2010-5#1)(2013-8#1)
diagnostic evaluation of##4##3##(1991-12#1)(1992-12#1)(2011-2#1)(2012-1#1)
diagnostic evaluation##15##2##(1990-10#1)(1991-11#1)(1991-12#1)(1992-12#1)(2007-9#2)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
diagnostic examination##3##2##(1990-6#1)(1997-8#1)(2008-8#1)
diagnostic examinations##2##2##(1997-2#1)(1997-8#1)
diagnostic feature in##2##3##(2008-9#1)(2009-9#1)
diagnostic features of##3##3##(2008-3#1)(2011-2#2)
diagnostic features##7##2##(2008-3#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-7#1)
diagnostic findings##3##2##(2008-12#1)(2010-10#1)(2013-1#1)
diagnostic follow-up##2##2##(1990-9#1)(2008-4#1)
diagnostic for##12##2##(1996-2#1)(1996-8#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#2)(2011-1#1)
diagnostic groups##8##2##(1991-11#2)(1993-9#1)(2009-3#1)(2010-5#4)
diagnostic imaging department##2##3##(1992-2#1)(1994-2#1)
diagnostic imaging modalities in##2##4##(2008-7#1)(2009-4#1)
diagnostic imaging modalities##3##3##(2008-7#1)(2008-8#1)(2009-4#1)
diagnostic imaging##26##2##(1990-2#1)(1991-1#2)(1992-1#1)(1992-2#2)(1994-1#3)(1994-2#1)(1995-3#1)(1997-6#1)(2007-11#4)(2007-4#1)(2008-7#1)(2008-8#3)(2009-4#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
diagnostic importance##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
diagnostic information and##2##3##(2008-2#1)(2008-8#1)
diagnostic information is##2##3##(1995-11#1)(2008-6#1)
diagnostic information##13##2##(1992-4#1)(1995-11#1)(1995-12#1)(1997-1#2)(2007-12#1)(2007-4#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)
diagnostic injections##2##2##(2008-9#2)
diagnostic interval##3##2##(1991-8#3)
diagnostic interview##2##2##(2010-8#1)(2011-2#1)
diagnostic investigations##2##2##(1991-3#1)(2008-7#1)
diagnostic kits##2##2##(2008-5#1)(2010-11#1)
diagnostic labels##2##2##(1995-1#1)(1997-4#1)
diagnostic laboratories are##2##3##(2008-10#2)
diagnostic laboratories in##2##3##(1997-8#1)(2011-1#1)
diagnostic laboratories##7##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
diagnostic laboratory##6##2##(2008-4#3)(2011-1#1)(2011-2#2)
diagnostic laparoscopy##4##2##(1993-1#1)(1994-3#1)(2007-7#1)(2013-1#1)
diagnostic marker of##2##3##(2008-10#1)(2013-7#1)
diagnostic marker##5##2##(2008-10#1)(2009-3#1)(2010-11#1)(2013-7#1)(2013-8#1)
diagnostic markers for##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
diagnostic markers##6##2##(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#1)(2013-8#2)
diagnostic means##3##2##(1992-12#1)(1993-3#1)(2007-11#1)
diagnostic measures##2##2##(1991-6#1)(1992-11#1)
diagnostic method for##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
diagnostic method##19##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-5#1)(1996-11#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)
diagnostic method]##2##2##(1990-10#1)(1990-6#1)
diagnostic methods and##4##3##(1990-9#1)(2007-11#1)(2008-11#1)(2012-2#1)
diagnostic methods for##3##3##(1990-9#1)(2010-5#1)(2011-1#1)
diagnostic methods in##3##3##(1994-9#1)(2007-11#1)(2011-2#1)
diagnostic methods that they##2##4##(1992-9#1)(2008-10#1)
diagnostic methods that##3##3##(1992-9#1)(2007-8#1)(2008-10#1)
diagnostic methods used##2##3##(2008-4#1)(2011-2#1)
diagnostic methods were##2##3##(1997-3#1)(2013-8#1)
diagnostic methods##31##2##(1990-9#3)(1992-6#1)(1992-9#1)(1994-6#1)(1994-9#1)(1997-3#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
diagnostic microarray for##2##3##(2011-1#2)
diagnostic modalities##2##2##(1993-9#1)(2011-1#1)
diagnostic network##3##2##(2012-12#3)
diagnostic of the##3##3##(2007-11#2)(2011-2#1)
diagnostic of##11##2##(1992-3#1)(1994-2#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#2)
diagnostic or therapeutic##4##3##(1990-12#1)(1991-9#1)(2008-7#1)(2010-6#1)
diagnostic or##8##2##(1990-12#1)(1990-2#1)(1991-9#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)
diagnostic orientation##2##2##(1990-5#1)(1990-6#1)
diagnostic parameters for##2##3##(1997-4#1)(2007-2#1)
diagnostic parameters##4##2##(1997-4#1)(2007-2#1)(2008-7#1)(2010-3#1)
diagnostic pathology##3##2##(2006-10#1)(2008-9#1)(2012-3#1)
diagnostic performance##3##2##(1990-6#1)(2009-3#1)(2010-4#1)
diagnostic pitfalls##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
diagnostic possibilities of##2##3##(2007-11#1)(2012-2#1)
diagnostic possibilities##5##2##(1990-11#1)(1990-6#1)(2007-11#1)(2011-2#1)(2012-2#1)
diagnostic potential of##6##3##(1993-8#1)(1994-2#1)(1997-6#2)(2008-2#1)(2013-8#1)
diagnostic potential##8##2##(1993-8#1)(1994-2#1)(1997-6#2)(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
diagnostic problem##4##2##(1992-4#1)(2008-4#1)(2008-7#1)(2010-3#1)
diagnostic problems and##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
diagnostic problems##12##2##(1992-5#1)(1992-6#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
diagnostic procedure in##3##3##(1992-11#1)(1993-9#1)(1995-11#1)
diagnostic procedure was##2##3##(1996-12#1)(2007-12#1)
diagnostic procedure##15##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-11#1)(1993-9#1)(1995-11#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2012-12#1)(2013-8#1)
diagnostic procedures and##4##3##(1996-3#1)(1997-5#1)(2008-1#1)(2008-12#1)
diagnostic procedures are##3##3##(1990-9#1)(1991-11#1)(1996-3#1)
diagnostic procedures have##2##3##(1991-11#1)(1997-1#1)
diagnostic procedures is##2##3##(1995-12#1)(1996-3#1)
diagnostic procedures##41##2##(1990-12#1)(1990-9#3)(1991-11#2)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#5)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-8#1)(2011-2#1)
diagnostic process##11##2##(1990-9#1)(1996-11#1)(2007-4#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-6#1)(2013-1#1)(2013-7#2)
diagnostic purposes##4##2##(1996-12#1)(2008-1#1)(2008-9#1)(2013-7#1)
diagnostic radiology as##2##3##(2007-4#2)
diagnostic radiology##10##2##(1993-12#1)(1994-1#1)(1996-2#1)(2007-4#7)
diagnostic relevance##2##2##(1993-2#1)(2010-8#1)
diagnostic resources##2##2##(2008-11#1)(2008-12#1)
diagnostic sensitivity##5##2##(1993-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
diagnostic specificity##6##2##(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)
diagnostic strategy##5##2##(1991-5#1)(2008-3#3)(2011-2#1)
diagnostic studies##2##2##(2010-8#1)(2012-3#1)
diagnostic study##3##2##(2007-10#1)(2008-7#1)(2009-3#1)
diagnostic suspicion##2##2##(1990-3#1)(1993-2#1)
diagnostic system##8##2##(2006-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-6#1)(2010-8#1)(2011-1#1)
diagnostic systems##2##2##(1997-8#1)(2012-2#1)
diagnostic technique based on##2##4##(2008-2#2)
diagnostic technique for##2##3##(2008-10#1)(2008-2#1)
diagnostic technique##9##2##(2008-10#3)(2008-2#3)(2008-3#1)(2009-9#1)(2012-12#1)
diagnostic techniques##19##2##(1991-2#1)(1992-9#1)(1996-9#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
diagnostic technologies and##2##3##(1993-12#1)(2012-1#1)
diagnostic technologies##3##2##(1993-12#2)(2012-1#1)
diagnostic test characteristics##2##3##(2012-12#2)
diagnostic test for##5##3##(1995-3#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
diagnostic test##17##2##(1995-3#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#2)(2012-12#2)(2013-1#2)
diagnostic testing##4##2##(1997-3#1)(2008-11#1)(2008-4#2)
diagnostic tests and##2##3##(2012-3#1)(2013-8#1)
diagnostic tests are##2##3##(1990-6#1)(2013-8#1)
diagnostic tests for##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
diagnostic tests in##2##3##(2012-3#1)(2013-1#1)
diagnostic tests to##2##3##(2009-9#1)(2013-1#1)
diagnostic tests##28##2##(1990-6#1)(1991-2#1)(1993-1#1)(1993-3#2)(2007-6#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#6)(2013-1#3)(2013-8#2)
diagnostic thresholds##3##2##(1997-5#2)(2012-12#1)
diagnostic tool for##9##3##(1994-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
diagnostic tool in the evaluation of##3##6##(2008-12#1)(2008-8#1)(2008-9#1)
diagnostic tool in the##6##4##(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2011-1#1)
diagnostic tool in##15##3##(1991-12#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#1)
diagnostic tool to##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
diagnostic tool with##2##3##(2009-12#1)(2010-8#1)
diagnostic tool##40##2##(1991-12#1)(1994-7#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#8)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-9#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
diagnostic tools and##5##3##(2006-12#1)(2008-12#1)(2011-1#1)(2011-2#2)
diagnostic tools are##2##3##(1991-3#1)(2013-8#1)
diagnostic tools for##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
diagnostic tools in##2##3##(2008-1#1)(2011-1#1)
diagnostic tools##27##2##(1990-3#1)(1991-3#1)(1992-9#1)(1994-3#1)(1996-6#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#2)
diagnostic ultrasound##3##2##(1994-6#1)(1996-3#1)(2013-1#1)
diagnostic uncertainty##5##2##(1996-3#1)(2007-11#1)(2008-12#2)(2013-1#1)
diagnostic use of##2##3##(1993-11#1)(2010-8#1)
diagnostic use##3##2##(1993-11#1)(2008-11#1)(2010-8#1)
diagnostic usefulness of##2##3##(2007-10#1)(2013-1#1)
diagnostic utility of the##2##4##(2008-12#1)(2013-1#1)
diagnostic utility of##8##3##(2008-12#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnostic utility##10##2##(2007-8#1)(2008-12#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
diagnostic value of a##2##4##(1991-6#1)(1994-7#1)
diagnostic value of##14##3##(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1994-7#1)(1995-4#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-1#3)
diagnostic value##20##2##(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1994-7#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
diagnostic work up of##2##4##(1992-6#1)(2008-10#1)
diagnostic work up##3##3##(1992-6#1)(2008-10#2)
diagnostic work##5##2##(1992-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
diagnostic work-up##6##2##(1992-5#1)(1997-3#1)(2010-10#3)(2012-2#1)
diagnostic workup##6##2##(1992-1#1)(1994-9#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
diagnostic yield and##3##3##(1990-3#1)(2011-2#1)(2012-2#1)
diagnostic yield of##4##3##(1992-11#1)(2010-12#1)(2011-2#2)
diagnostic yield was##2##3##(2011-2#2)
diagnostic yield##16##2##(1990-3#2)(1992-11#1)(1997-8#1)(2008-3#1)(2010-12#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
diagnostic##1169##1##(1990-10#2)(1990-11#1)(1990-12#8)(1990-2#4)(1990-3#8)(1990-5#3)(1990-6#10)(1990-9#13)(1991-1#2)(1991-11#6)(1991-12#8)(1991-2#6)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#6)(1991-8#7)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#6)(1992-4#2)(1992-5#6)(1992-6#5)(1992-8#2)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#8)(1993-3#6)(1993-5#4)(1993-8#2)(1993-9#4)(1994-1#7)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#4)(1994-7#2)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#4)(1996-12#9)(1996-2#4)(1996-3#13)(1996-5#1)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#7)(1997-4#7)(1997-5#5)(1997-6#5)(1997-8#15)(2006-10#10)(2006-12#1)(2006-9#1)(2007-10#7)(2007-11#33)(2007-12#11)(2007-2#6)(2007-4#13)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#12)(2007-9#2)(2008-1#15)(2008-10#90)(2008-11#26)(2008-12#23)(2008-2#12)(2008-3#29)(2008-4#19)(2008-5#12)(2008-6#14)(2008-7#48)(2008-8#11)(2008-9#20)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#5)(2009-4#3)(2009-5#2)(2009-8#9)(2009-9#7)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#18)(2010-3#3)(2010-4#4)(2010-5#13)(2010-6#8)(2010-7#1)(2010-8#20)(2011-1#24)(2011-2#86)(2011-3#6)(2011-7#1)(2012-1#4)(2012-12#26)(2012-2#37)(2012-3#28)(2013-1#68)(2013-7#14)(2013-8#26)
diagnostic/therapeutic##2##1##(2008-10#2)
diagnostically superior##2##2##(1996-12#1)(2008-1#1)
diagnostically useful##2##2##(2008-5#1)(2008-7#1)
diagnostically##12##1##(1992-5#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
diagnosticity##3##1##(2008-11#1)(2008-8#2)
diagnostics and management##2##3##(2007-11#1)(2013-1#1)
diagnostics and therapy##5##3##(1994-3#2)(1997-7#1)(2007-11#1)(2008-5#1)
diagnostics and##16##2##(1994-3#2)(1996-6#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-5#1)(2013-1#2)(2013-8#1)
diagnostics are discussed##2##3##(2008-2#1)(2008-3#1)
diagnostics are##6##2##(1995-5#1)(1995-9#1)(2008-2#2)(2008-3#2)
diagnostics at##2##2##(1997-4#1)(2007-12#1)
diagnostics for the##2##3##(2008-10#1)(2012-12#1)
diagnostics in##2##2##(2008-3#1)(2009-4#1)
diagnostics is##5##2##(1995-6#1)(2007-11#2)(2008-10#1)(2008-3#1)
diagnostics of malignant##2##3##(2013-1#2)
diagnostics of the##5##3##(1990-5#1)(2007-8#2)(2008-2#1)(2013-1#1)
diagnostics of##22##2##(1990-5#1)(1993-2#1)(2007-11#2)(2007-8#3)(2008-2#2)(2008-3#3)(2011-2#2)(2011-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
diagnostics or##2##2##(2007-12#1)(2008-10#1)
diagnostics with##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
diagnostics##121##1##(1990-5#1)(1993-2#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-4#2)(1997-7#2)(2007-11#16)(2007-12#4)(2007-8#4)(2008-10#12)(2008-11#2)(2008-2#10)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#9)(2011-3#1)(2012-12#2)(2013-1#7)(2013-7#1)(2013-8#5)
diagnostique##2##1##(2011-2#1)(2013-1#1)
diagnostiquées##3##1##(2011-2#2)(2013-1#1)
diagonal and##2##2##(2007-12#1)(2008-8#1)
diagonal band of Broca (DBB)##2##5##(1995-12#1)(2008-9#1)
diagonal band of Broca##3##4##(1994-3#1)(1995-12#1)(2008-9#1)
diagonal band of##4##3##(1994-3#2)(1995-12#1)(2008-9#1)
diagonal of the##2##3##(1997-7#1)(2007-12#1)
diagonal##21##1##(1994-3#2)(1995-12#1)(1997-7#1)(2007-12#5)(2008-3#6)(2008-4#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-8#1)
diagram and##2##2##(2008-5#2)
diagram for##2##2##(2008-3#1)(2013-8#1)
diagram of the##2##3##(2008-3#1)(2012-2#1)
diagram of##6##2##(2008-10#2)(2008-3#2)(2012-2#2)
diagram##33##1##(1994-3#1)(2008-10#9)(2008-2#2)(2008-3#5)(2008-5#4)(2012-2#3)(2013-1#7)(2013-8#2)
diagrams and##5##2##(1996-1#1)(2008-10#3)(2008-2#1)
diagrams are##2##2##(2008-2#1)(2008-3#1)
diagrams for##4##2##(1991-9#1)(2008-10#2)(2010-8#1)
diagrams from##2##2##(2007-12#1)(2012-7#1)
diagrams of the##3##3##(1995-5#1)(2008-10#2)
diagrams of##10##2##(1993-8#1)(1995-5#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-4#1)(2010-8#1)
diagrams show that##2##3##(2008-2#2)
diagrams were##3##2##(2008-10#1)(2008-5#2)
diagrams##40##1##(1991-9#1)(1993-2#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-1#4)(2007-12#1)(2008-10#14)(2008-2#6)(2008-3#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#2)(2012-7#1)
dial of treatment##2##3##(2010-6#2)
dial##4##1##(2008-10#1)(2010-6#2)(2013-1#1)
dialdehyde##5##1##(1991-5#1)(1993-8#1)(2008-10#2)(2013-1#1)
dialect##5##1##(2009-9#5)
dialectical##2##1##(2010-10#1)(2012-3#1)
dialects##9##1##(2009-9#7)(2013-8#2)
diallelic##2##1##(2008-10#1)(2008-5#1)
dialog##2##1##(2009-11#1)(2012-2#1)
dialogue between##4##2##(1994-1#1)(1997-3#1)(2008-5#1)(2011-1#1)
dialogue in the##2##3##(2011-2#1)(2012-3#1)
dialogue with##5##2##(1996-11#1)(2008-10#1)(2008-12#2)(2013-8#1)
dialogue##19##1##(1991-1#1)(1994-1#1)(1994-3#2)(1996-11#1)(1997-3#2)(2008-10#1)(2008-12#3)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
dialogues##2##1##(2012-3#1)(2013-1#1)
dialysate from the##3##3##(2007-7#1)(2008-10#2)
dialysate purity##2##2##(2008-1#2)
dialysate volume##2##2##(2011-2#2)
dialysate##36##1##(1995-12#2)(2007-12#2)(2007-7#1)(2008-1#15)(2008-10#8)(2011-1#1)(2011-2#5)(2013-1#2)
dialysate-to-plasma ratio of creatinine##2##4##(2011-2#2)
dialysates##2##1##(1995-5#1)(1997-2#1)
dialysed patients##3##2##(1994-5#1)(1997-8#1)(2007-8#1)
dialysed##7##1##(1994-5#1)(1994-8#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-10#1)
dialyser reprocessing##2##2##(2008-1#2)
dialyser##10##1##(2008-1#6)(2008-10#4)
dialyses##2##1##(1991-9#1)(2007-7#1)
dialysis (PD)##18##2##(2007-12#4)(2008-1#2)(2008-4#1)(2011-2#11)
dialysis ESR##2##2##(2007-7#2)
dialysis adequacy##3##2##(2007-12#2)(2008-1#1)
dialysis and is##2##3##(2007-7#1)(2010-7#1)
dialysis and the##2##3##(2007-7#1)(2008-10#1)
dialysis and##23##2##(1990-5#1)(1993-12#1)(1994-6#1)(2007-12#2)(2007-7#5)(2008-1#6)(2008-10#2)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#2)
dialysis assay##3##2##(1993-12#1)(2008-4#2)
dialysis catheter##3##2##(2007-7#3)
dialysis catheters##5##2##(2007-12#1)(2008-10#1)(2010-3#3)
dialysis centers in##5##3##(2007-7#3)(2008-1#2)
dialysis centers##9##2##(2007-7#4)(2008-1#5)
dialysis concentrate##3##2##(2008-10#3)
dialysis concentrates##4##2##(2008-10#4)
dialysis delivery##3##2##(2008-1#3)
dialysis dose##6##2##(2007-12#3)(2008-1#2)(2011-2#1)
dialysis during##2##2##(2008-10#2)
dialysis fluids##2##2##(2007-8#1)(2008-10#1)
dialysis for the##2##3##(2008-10#2)
dialysis for##5##2##(1996-2#1)(2008-1#1)(2008-10#2)(2013-8#1)
dialysis in patients with##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
dialysis in the##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
dialysis in##15##2##(1992-5#1)(1992-7#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-9#1)(2011-2#1)
dialysis is##7##2##(1997-5#1)(2008-10#4)(2008-4#1)(2011-2#1)
dialysis membrane##8##2##(1992-3#1)(1993-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)
dialysis membrane)##2##2##(2008-10#2)
dialysis membranes##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
dialysis method##5##2##(1994-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
dialysis of##4##2##(1990-12#1)(2007-12#1)(2008-1#1)(2008-10#1)
dialysis or##5##2##(1997-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)
dialysis patient##4##2##(1993-9#1)(2007-12#1)(2007-7#1)(2011-2#1)
dialysis patients and##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
dialysis patients in##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
dialysis patients##44##2##(1990-2#1)(1994-5#1)(1995-1#1)(2007-12#13)(2007-7#3)(2007-8#2)(2008-1#8)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#9)(2013-1#3)
dialysis population##5##2##(2007-12#1)(2007-7#1)(2008-1#2)(2011-2#1)
dialysis probe##3##2##(1992-3#1)(1997-2#2)
dialysis procedure##2##2##(1993-12#1)(2008-10#1)
dialysis process##2##2##(2008-10#1)(2008-12#1)
dialysis program##2##2##(1994-5#1)(2007-12#1)
dialysis services##2##2##(1995-12#1)(2008-1#1)
dialysis sessions##4##2##(2007-7#4)
dialysis should be##2##3##(2007-8#1)(2008-10#1)
dialysis solution in##2##3##(2008-10#1)(2011-2#1)
dialysis solution##5##2##(2008-10#1)(2011-2#4)
dialysis solutions##7##2##(2008-10#2)(2011-2#5)
dialysis system##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
dialysis technique that##2##3##(1993-8#1)(2008-10#1)
dialysis technique##4##2##(1993-12#1)(1993-8#1)(2008-10#1)(2011-2#1)
dialysis therapy##9##2##(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-12#2)
dialysis treatment for##2##3##(2008-1#1)(2011-1#1)
dialysis treatment in##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
dialysis treatment##13##2##(1991-6#1)(1994-5#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-4#3)(2011-1#1)(2011-2#1)
dialysis unit was##2##3##(2007-7#1)(2008-10#1)
dialysis unit##8##2##(1996-12#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-4#1)
dialysis units##3##2##(2007-7#1)(2008-1#1)(2013-1#1)
dialysis versus##2##2##(2008-1#2)
dialysis vintage##2##2##(2011-2#2)
dialysis was##5##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
dialysis with##4##2##(1994-8#1)(2007-12#1)(2008-4#1)(2011-2#1)
dialysis##459##1##(1990-12#5)(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-5#2)(1992-7#1)(1993-12#6)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#7)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#8)(1995-2#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#2)(2007-12#61)(2007-7#49)(2007-8#11)(2008-1#67)(2008-10#63)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#23)(2008-5#12)(2008-7#8)(2008-8#1)(2008-9#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#65)(2012-12#2)(2013-1#6)(2013-8#1)
dialysis)##4##1##(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
dialysis-induced hypotension##2##2##(2008-1#2)
dialytic age##2##2##(2007-7#1)(2008-1#1)
dialytic##5##1##(2007-7#3)(2008-1#1)(2008-11#1)
dialyzates##3##1##(2008-10#3)
dialyzed blood volume##2##3##(2008-4#2)
dialyzed for##2##2##(1990-11#1)(1990-12#1)
dialyzed patients##2##2##(1990-11#1)(2008-10#1)
dialyzed through##4##2##(2007-7#4)
dialyzed##18##1##(1990-11#2)(1990-12#1)(1990-5#1)(1994-8#1)(1995-2#1)(2006-10#1)(2007-7#5)(2008-10#3)(2008-4#2)(2011-2#1)
dialyzer reuse##2##2##(2008-1#2)
dialyzer##14##1##(2007-12#4)(2007-7#3)(2008-1#6)(2008-10#1)
dialyzers##10##1##(2007-7#4)(2008-1#5)(2008-10#1)
dialyzing##2##1##(2007-7#1)(2008-10#1)
diamagnetic##5##1##(1994-5#1)(1997-7#1)(2007-11#1)(2008-9#1)(2012-2#1)
diameter &lt##3##2##(1997-1#1)(2008-3#1)(2011-2#1)
diameter (HPD)##2##2##(2008-3#1)(2013-1#1)
diameter -##2##2##(2011-1#1)(2013-1#1)
diameter 0##2##2##(2007-12#1)(2007-8#1)
diameter 10##3##2##(2009-8#3)
diameter 2##2##2##(2008-5#1)(2010-8#1)
diameter D/r(0)##2##2##(2008-2#1)(2008-3#1)
diameter and 20##2##3##(2008-10#1)(2008-8#1)
diameter and a##4##3##(2008-11#1)(2008-2#1)(2008-3#2)
diameter and length of##2##4##(1990-2#1)(2008-11#1)
diameter and number of involved structures/organs##3##6##(2007-8#3)
diameter and the##5##3##(2008-3#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)
diameter and##54##2##(1990-2#2)(1991-12#1)(1995-11#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-8#5)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2009-7#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
diameter approximately##2##2##(1995-11#1)(2008-5#1)
diameter are##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
diameter as well as##2##4##(2008-10#1)(2009-4#1)
diameter as##4##2##(2008-10#1)(2008-3#1)(2009-4#1)(2013-1#1)
diameter at##3##2##(2008-2#1)(2008-5#1)(2011-2#1)
diameter between##3##2##(1997-3#1)(2008-3#1)(2013-1#1)
diameter by##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2009-1#1)(2010-12#1)
diameter can be##2##3##(1990-7#1)(1997-5#1)
diameter carbon disc electrode positioned opposite the outlet of capillary##2##10##(2008-10#2)
diameter carbon disc electrode##3##4##(2008-10#3)
diameter during the##2##3##(2008-11#2)
diameter for##2##2##(2008-2#2)
diameter gold##2##2##(2008-10#2)
diameter in the##2##3##(2008-10#1)(2012-2#1)
diameter in##12##2##(1990-2#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
diameter is##9##2##(1995-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)
diameter measurement##2##2##(2008-2#1)(2010-5#1)
diameter of 0##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
diameter of 1##2##3##(2008-2#1)(2008-3#1)
diameter of 3##2##3##(2012-2#1)(2013-1#1)
diameter of a##4##3##(2008-10#1)(2008-3#2)(2012-1#1)
diameter of about##4##3##(1990-2#1)(1996-3#1)(2007-12#1)(2008-1#1)
diameter of both##2##3##(2008-3#1)(2008-5#1)
diameter of from##2##3##(2008-2#2)
diameter of less than##3##4##(1990-9#1)(2008-3#1)(2010-5#1)
diameter of the##31##3##(1994-9#1)(1995-6#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2011-1#2)(2012-2#2)(2013-1#2)
diameter of##112##2##(1990-2#1)(1990-8#2)(1990-9#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-5#1)(2007-11#4)(2007-12#5)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#5)(2013-1#9)(2013-7#1)(2013-8#2)
diameter range##2##2##(2012-1#1)(2013-8#1)
diameter ranged from##2##3##(2008-11#1)(2009-7#1)
diameter size##2##2##(2008-10#1)(2008-5#1)
diameter stems##2##2##(2008-10#2)
diameter that maximizes the##2##4##(2008-3#2)
diameter that##4##2##(2008-3#2)(2009-10#1)(2013-1#1)
diameter using##2##2##(2008-5#1)(2010-5#1)
diameter was##10##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
diameter were formed##2##3##(2009-11#1)(2012-2#1)
diameter were##12##2##(1992-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#2)(2010-4#1)(2012-2#1)(2013-1#1)
diameter with a##4##3##(1993-6#1)(2008-11#1)(2008-3#1)(2013-1#1)
diameter with##10##2##(1993-6#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-1#1)
diameter##507##1##(1990-11#1)(1990-2#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-2#5)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#8)(1997-8#2)(2007-10#1)(2007-11#18)(2007-12#15)(2007-7#3)(2007-8#21)(2007-9#1)(2008-1#3)(2008-10#83)(2008-11#14)(2008-12#7)(2008-2#35)(2008-3#55)(2008-4#3)(2008-5#27)(2008-6#3)(2008-7#17)(2008-8#7)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#8)(2009-8#6)(2010-12#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#13)(2012-1#5)(2012-2#12)(2012-3#5)(2013-1#26)(2013-7#5)(2013-8#10)
diameter) in##2##2##(2008-10#1)(2008-11#1)
diameter) was##2##2##(1991-2#1)(2008-10#1)
diameter) were##3##2##(2008-10#2)(2013-1#1)
diameter)##33##1##(1990-10#1)(1991-2#1)(1991-6#1)(1996-1#1)(1996-6#1)(2007-12#1)(2007-5#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
diameters and##6##2##(1990-8#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-7#1)
diameters are##2##2##(2007-12#1)(2008-3#1)
diameters between##2##2##(2008-10#1)(2008-2#1)
diameters in the range##2##4##(2007-11#1)(2008-2#1)
diameters of the##11##3##(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#1)(2011-2#1)
diameters of##28##2##(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#4)(2008-3#7)(2008-5#3)(2008-7#1)(2011-1#1)(2011-2#1)
diameters on##2##2##(2008-3#1)(2010-9#1)
diameters ranging from##2##3##(2008-3#2)
diameters ranging##3##2##(2008-3#3)
diameters smaller than##2##3##(2007-11#1)(2008-3#1)
diameters to##2##2##(2008-10#1)(2008-3#1)
diameters were measured by##2##4##(2009-9#2)
diameters were##5##2##(2008-7#2)(2009-2#1)(2009-9#2)
diameters##96##1##(1990-6#1)(1990-8#1)(1993-12#2)(1993-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-4#2)(2007-11#3)(2007-12#7)(2008-10#9)(2008-12#1)(2008-2#12)(2008-3#24)(2008-5#5)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#3)(2013-1#1)
diameters)##3##1##(2008-11#1)(2010-2#1)(2011-2#1)
diametral tensile strength##2##3##(2009-7#2)
diamide##3##1##(2008-10#2)(2011-2#1)
diamide-substituted##2##1##(2008-10#2)
diamides##8##1##(2008-10#8)
diamidoaluminum##2##1##(1996-2#2)
diamine (MSOPD)##2##2##(2008-10#2)
diamine hydrochloride in##2##3##(2008-10#2)
diamine oxidase was##2##3##(1992-11#1)(1992-8#1)
diamine oxidase##13##2##(1991-12#1)(1992-11#3)(1992-8#6)(2008-10#3)
diamine substrates##2##2##(1992-11#2)
diamine##36##1##(1991-12#1)(1992-11#5)(1992-8#6)(1996-2#3)(2008-10#15)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
diamines##5##1##(1992-11#1)(1996-2#1)(2008-10#3)
diamino##5##1##(1996-5#1)(2008-10#1)(2009-11#2)(2009-9#1)
diaminobenzidine (DAB)##2##2##(2008-10#1)(2011-2#1)
diaminobenzidine##7##1##(1990-12#1)(1992-3#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)
diamond (BDD) electrode##3##3##(2008-10#3)
diamond (BDD)##5##2##(2008-10#5)
diamond 1mum##2##2##(2008-10#2)
diamond based Fresnel zone plates##2##5##(2012-2#2)
diamond electrode##9##2##(2008-10#9)
diamond films##4##2##(2008-10#4)
diamond surfaces for 200-ps CO(2) laser pulses##2##7##(2007-11#2)
diamond##65##1##(1991-5#1)(2007-11#7)(2007-12#7)(2008-10#40)(2008-2#2)(2008-3#4)(2010-8#1)(2012-2#2)(2013-1#1)
diamondback moth##4##2##(2010-4#1)(2011-2#3)
diamondback rattlesnake##4##2##(1992-8#2)(1994-6#1)(1994-8#1)
diamondback##8##1##(1992-8#2)(1994-6#1)(1994-8#1)(2010-4#1)(2011-2#3)
diamonds##4##1##(1990-11#3)(2009-11#1)
dianionic##2##1##(1992-6#1)(1994-11#1)
dianions##2##1##(1996-5#1)(2009-5#1)
dianthi in##2##2##(2008-10#2)
dianthi##12##1##(2008-10#12)
diapause and postdiapause##2##3##(2013-1#2)
diapause eggs and non-diapause eggs##3##5##(2008-5#3)
diapause eggs##4##2##(2008-5#4)
diapause embryos##2##2##(2013-1#2)
diapause hormone##2##2##(2008-8#2)
diapause nature##2##2##(2008-8#2)
diapause of##3##2##(2008-8#3)
diapause##25##1##(1995-11#1)(2008-5#4)(2008-8#11)(2013-1#9)
diaperinus##2##1##(2011-2#2)
diaphorase##10##1##(1992-3#5)(1992-6#1)(1992-8#1)(1995-11#1)(1995-8#1)(2008-11#1)
diaphorase)##2##1##(1994-8#2)
diaphragm and##6##2##(1990-2#1)(1995-8#1)(1996-12#1)(2008-3#1)(2010-9#1)(2012-2#1)
diaphragm is##5##2##(2007-7#1)(2007-8#1)(2010-5#2)(2012-3#1)
diaphragm was##2##2##(1996-12#1)(2007-8#1)
diaphragm##42##1##(1990-2#2)(1990-5#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-8#1)(1995-8#3)(1996-12#2)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-5#4)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
diaphragm-free##3##1##(2008-10#3)
diaphragma##3##1##(1990-7#1)(2011-2#2)
diaphragmatic defect##2##2##(2011-1#1)(2013-8#1)
diaphragmatic hernia in a pregnant##2##5##(2011-1#2)
diaphragmatic hernia in##3##3##(2008-11#1)(2011-1#2)
diaphragmatic hernia is a##2##4##(2012-2#1)(2012-3#1)
diaphragmatic hernia is##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
diaphragmatic hernia##12##2##(1990-5#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-1#3)(2012-2#2)(2012-3#2)
diaphragmatic##24##1##(1990-5#1)(2007-8#2)(2008-11#2)(2008-7#3)(2009-4#1)(2010-5#1)(2011-1#5)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
diaphragms##2##1##(2008-3#2)
diaphyseal fractures##2##2##(2007-11#1)(2007-2#1)
diaphyseal shapes##2##2##(2009-10#2)
diaphyseal##12##1##(1996-3#1)(2007-11#2)(2007-2#1)(2009-10#5)(2009-4#1)(2009-7#1)(2011-2#1)
diaphysis##5##1##(2007-11#3)(2009-10#1)(2010-11#1)
diaries and##2##2##(2008-2#1)(2012-12#1)
diaries##10##1##(1997-2#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-12#2)
diarrhea and##8##2##(1990-2#1)(1996-3#1)(2007-12#1)(2008-4#1)(2010-4#1)(2011-2#2)(2012-1#1)
diarrhea from##2##2##(1991-3#1)(1992-12#1)
diarrhea in the##2##3##(2007-12#1)(2013-1#1)
diarrhea in##12##2##(1991-3#1)(1992-12#1)(2007-10#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#3)
diarrhea was##2##2##(1993-3#1)(2013-1#1)
diarrhea with##2##2##(1993-3#1)(2008-7#1)
diarrhea##85##1##(1990-12#1)(1990-2#1)(1991-3#3)(1991-6#1)(1991-8#8)(1991-9#1)(1992-10#1)(1992-12#3)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#3)(1993-8#1)(1996-3#2)(1997-3#3)(2007-10#1)(2007-12#9)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#8)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
diarrhea]##2##1##(1992-6#1)(2013-1#1)
diarrheagenic##2##1##(2009-9#1)(2011-1#1)
diarrheal illness##2##2##(2008-7#1)(2012-3#1)
diarrheal##7##1##(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#2)
diarrhetic shellfish poisoning##2##3##(1997-4#2)
diarrhoea and##8##2##(1995-10#1)(1996-12#1)(2007-7#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
diarrhoea in AIDS##2##3##(2007-7#1)(2008-8#1)
diarrhoea in children##2##3##(2009-2#1)(2009-5#1)
diarrhoea in##9##2##(1992-2#1)(1997-8#1)(2007-7#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)
diarrhoea of rabbits##2##3##(1991-8#2)
diarrhoea were##2##2##(1990-9#1)(1993-2#1)
diarrhoea with##2##2##(2008-5#1)(2013-1#1)
diarrhoea##50##1##(1990-3#1)(1990-9#4)(1991-3#2)(1991-8#3)(1992-2#2)(1993-2#2)(1993-7#1)(1995-10#1)(1996-12#1)(1997-3#2)(1997-5#2)(1997-8#1)(2007-2#1)(2007-7#7)(2008-1#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
diarrhoeal##6##1##(1991-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
diarrhoeic type##3##2##(1997-6#3)
diarrhoeic##5##1##(1996-12#1)(1997-6#3)(2013-1#1)
diary##12##1##(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
diarylamines##2##1##(1996-5#2)
diarylazobisphenol modified##2##2##(2008-10#2)
diastasis##7##1##(2011-2#5)(2012-1#2)
diastereoisomers##4##1##(1995-6#3)(2012-1#1)
diastereomer##4##1##(1993-8#2)(1996-2#1)(1996-5#1)
diastereomeric glucuronides##2##2##(1990-8#2)
diastereomeric##11##1##(1990-8#2)(1991-5#1)(1995-3#1)(1996-5#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-9#1)(2012-12#1)
diastereomers##7##1##(1993-8#3)(1996-2#2)(2009-9#1)(2012-12#1)
diastereoselective##6##1##(1996-5#3)(2007-12#1)(2009-7#1)(2009-9#1)
diastereoselectivity##3##1##(1996-5#3)
diastole##4##1##(1992-9#1)(2009-12#1)(2013-1#2)
diastolic BP##5##2##(1991-3#1)(1992-6#1)(2008-5#1)(2010-7#2)
diastolic arterial blood pressure##3##4##(2007-8#1)(2011-2#1)(2012-3#1)
diastolic blood pressure (DBP)##4##4##(1990-3#1)(1991-10#1)(1992-12#1)(2008-10#1)
diastolic blood pressure and##4##4##(1997-8#1)(2008-1#1)(2011-1#1)(2013-1#1)
diastolic blood pressure##38##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-6#1)(1992-8#4)(1993-2#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-7#4)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
diastolic blood##42##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-6#1)(1992-8#4)(1993-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#4)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
diastolic dysfunction##5##2##(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)
diastolic frequency##2##2##(1991-12#2)
diastolic function##7##2##(1991-2#1)(1992-9#1)(2006-10#2)(2010-4#1)(2013-1#1)(2013-8#1)
diastolic heart failure##2##3##(2008-7#2)
diastolic pressure##5##2##(1990-8#1)(1994-6#1)(1996-3#2)(2008-1#1)
diastolic pressures##3##2##(1990-8#1)(2009-12#1)(2010-4#1)
diastolic velocities##2##2##(1996-6#2)
diastolic velocity##4##2##(1996-6#2)(2008-7#1)(2013-8#1)
diastolic ventricular##2##2##(1992-5#1)(1992-9#1)
diastolic##105##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1996-3#4)(1996-6#4)(1997-5#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-8#3)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#6)(2008-5#1)(2008-7#7)(2008-8#1)(2009-12#2)(2010-4#3)(2010-5#1)(2010-7#3)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#4)
diathermic##2##1##(2008-5#2)
diathesis##3##1##(2008-7#3)
diatom Cyclotella cryptica##2##3##(2010-11#2)
diatom##6##1##(1994-8#1)(2008-5#1)(2010-11#2)(2011-2#2)
diatomaceous##2##1##(2007-12#1)(2008-12#1)
diatomic##4##1##(2008-2#1)(2008-3#1)(2009-2#2)
diatoms##10##1##(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#3)
diaza-18-crown-6 ligands##2##2##(2008-10#2)
diaza-18-crown-6##4##1##(2008-10#4)
diazacrown##3##1##(2008-10#3)
diazadibenzocrown##2##1##(2008-10#2)
diazepam (0##2##2##(2008-11#1)(2012-3#1)
diazepam and prazepam##4##3##(2008-10#4)
diazepam and##9##2##(1990-8#1)(1991-1#1)(1992-3#1)(1993-5#1)(2008-10#5)
diazepam in##3##2##(1991-12#2)(2011-2#1)
diazepam on the##2##3##(2008-6#1)(2013-1#1)
diazepam on##5##2##(2008-6#2)(2012-3#1)(2013-1#2)
diazepam or##2##2##(1991-12#1)(2011-2#1)
diazepam treatment##2##2##(1994-6#1)(2011-2#1)
diazepam was##2##2##(2008-6#1)(2013-1#1)
diazepam##43##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#3)(1992-3#1)(1993-12#2)(1993-5#1)(1994-6#2)(1995-11#1)(2008-10#6)(2008-11#2)(2008-6#7)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
diazepam-insensitive##10##1##(1992-3#5)(1995-11#5)
diazinon in##2##2##(2008-10#2)
diazinon##12##1##(2008-10#12)
diazo coupling reaction##2##3##(2008-10#2)
diazo-2##2##1##(1991-12#2)
diazoamino p-azobenzene##2##2##(2008-10#2)
diazomethane and##2##2##(2008-10#2)
diazomethane##5##1##(2008-10#5)
diazonium salt##3##2##(1992-9#1)(2008-10#2)
diazonium salts##2##2##(2012-3#2)
diazonium##8##1##(1992-9#1)(2008-10#4)(2008-5#1)(2012-3#2)
diazotisation of##2##2##(2008-10#2)
diazotisation##4##1##(2008-10#4)
diazotization and##2##2##(1990-2#1)(2008-10#1)
diazotization##3##1##(1990-2#1)(2008-10#2)
diazotization-coupling reaction##2##2##(2008-10#2)
diazotized##4##1##(2008-10#4)
diazoxide##4##1##(1990-7#1)(1997-1#1)(2008-1#1)(2008-8#1)
dibasic##5##1##(1994-11#1)(2007-7#1)(2008-10#2)(2009-8#1)
dibenzo 18 crown 6##2##4##(2008-10#2)
dibenzo##3##1##(2008-10#3)
dibenzo-18-crown-6 incorporated##2##2##(2008-10#2)
dibenzo-18-crown-6 or##2##2##(2008-10#2)
dibenzo-18-crown-6##11##1##(2008-10#11)
dibenzo-p-dioxins and polychlorinated dibenzofurans##2##4##(2008-10#1)(2008-7#1)
dibenzo-p-dioxins and##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
dibenzo-p-dioxins##9##1##(2008-10#7)(2008-11#1)(2008-7#1)
dibenzo[3n+2]crown-n##2##1##(2008-10#2)
dibenzofuran##2##1##(1993-12#1)(2008-10#1)
dibenzofurans##7##1##(1994-3#1)(2008-10#4)(2008-11#1)(2008-7#1)
dibenzothiophene##2##1##(1993-12#1)(2008-10#1)
diblock copolymer films prepared by the Langmuir-Blodgett##2##7##(2008-11#2)
diblock copolymer##5##2##(2008-10#2)(2008-11#2)(2008-12#1)
diblock copolymers##3##2##(2008-10#2)(2008-3#1)
diblock##10##1##(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)
dibromo-##2##1##(2008-10#2)
dibromo-p-methyl-bromosulfonazo##2##1##(2008-10#2)
dibromo-p-methyl-carboxysulfonazo##2##1##(2008-10#2)
dibromo-p-methyl-methylsulfonazo##2##1##(2008-10#2)
dibromodicyanobutane##3##1##(2008-5#3)
dibutyl phthalate (DBP)##4##3##(2008-10#3)(2010-5#1)
dibutyl phthalate as##2##3##(2008-10#2)
dibutyl phthalate##7##2##(2008-10#6)(2010-5#1)
dibutyl##10##1##(2007-11#1)(2008-10#8)(2010-5#1)
dibutylamine##2##1##(2008-10#2)
dibutylphthalate (DBP)##2##2##(2008-10#2)
dibutylphthalate##5##1##(2008-10#5)
dibutyltin dichloride (DBTC)##2##3##(2008-10#2)
dibutyltin dichloride##3##2##(2008-10#3)
dibutyltin##4##1##(2008-10#3)(2008-4#1)
dibutyrate##5##1##(1990-11#2)(1990-2#1)(1994-8#1)(1995-8#1)
dibutyryl cAMP##7##2##(1991-12#1)(1991-3#1)(1991-9#1)(1993-8#1)(1995-11#1)(1996-2#1)(1996-5#1)
dibutyryl cyclic AMP##3##3##(1994-11#1)(1997-7#2)
dibutyryl cyclic##4##2##(1994-11#1)(1995-11#1)(1997-7#2)
dibutyryl##14##1##(1991-12#1)(1991-3#1)(1991-9#2)(1993-8#1)(1994-11#1)(1995-11#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-7#2)
dicarboximide##3##1##(2008-10#3)
dicarboximide-resistant##2##1##(2008-10#2)
dicarboximides##2##1##(2008-10#2)
dicarboxylate ligands##3##2##(2008-10#3)
dicarboxylic acid##5##2##(1995-11#1)(2008-10#2)(2008-4#1)(2012-2#1)
dicarboxylic acids##2##2##(2008-10#1)(2008-4#1)
dicarboxylic##10##1##(1995-11#1)(2008-10#5)(2008-4#2)(2012-2#1)(2013-1#1)
dicationic##3##1##(2007-11#2)(2010-12#1)
diced##2##1##(2009-4#1)(2010-8#1)
dichlobenil##3##1##(1996-5#1)(2008-10#2)
dichloride (DBTC)##3##2##(1993-12#1)(2008-10#2)
dichloride was##2##2##(1992-1#1)(2008-11#1)
dichloride##14##1##(1992-1#2)(1993-12#1)(1997-7#1)(2008-10#5)(2008-11#4)(2008-4#1)
dichloroacetate##3##1##(1991-3#1)(1995-3#1)(2008-4#1)
dichloroacetic acid (DCA)##2##3##(1995-3#1)(2008-10#1)
dichloroacetic acid exposure##2##3##(2008-9#2)
dichloroacetic acid for 26##4##4##(2008-9#4)
dichloroacetic acid for##5##3##(2008-9#5)
dichloroacetic acid in##8##3##(2008-10#1)(2008-9#7)
dichloroacetic acid##22##2##(1995-3#1)(2008-10#3)(2008-9#18)
dichloroacetic##25##1##(1995-3#1)(2008-10#4)(2008-9#20)
dichlorobromomethane##2##1##(2008-10#2)
dichlorodiphenyltrichloroethane##2##1##(2008-7#2)
dichloroethane##2##1##(2008-10#2)
dichlorofluorescein (DCF)##2##2##(2008-10#1)(2008-11#1)
dichlorofluorescein##4##1##(2008-10#3)(2008-11#1)
dichloroisocyanurate##3##1##(2008-10#3)
dichloromethane and chloroform##2##3##(2008-10#2)
dichloromethane and##10##2##(2008-10#9)(2008-5#1)
dichloromethane as##2##2##(2008-10#2)
dichloromethane has been studied##2##4##(2008-10#2)
dichloromethane in##3##2##(1996-2#1)(2008-10#2)
dichloromethane to##2##2##(2007-11#1)(2008-10#1)
dichloromethane was##2##2##(2008-10#2)
dichloromethane were##4##2##(2008-10#3)(2008-11#1)
dichloromethane##52##1##(1996-2#1)(2007-11#1)(2008-10#42)(2008-11#5)(2008-5#2)(2013-1#1)
dichlorprop##2##1##(2008-11#2)
dichlorvos was##2##2##(1997-5#1)(2008-10#1)
dichlorvos##19##1##(1997-5#2)(2007-5#1)(2008-10#16)
dichotomizing##2##1##(2008-9#1)(2009-6#1)
dichotomous and quantitative traits in##2##5##(2012-3#2)
dichotomous##14##1##(1996-2#1)(1997-8#1)(2008-10#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2012-3#6)
dichotomy between##2##2##(2008-6#1)(2009-8#1)
dichotomy in the##2##3##(1992-10#1)(2008-11#1)
dichotomy##10##1##(1990-9#1)(1991-6#1)(1992-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)
dichroic filters##2##2##(2008-3#2)
dichroic##12##1##(1992-8#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#7)(2009-2#1)
dichroism (CD) spectra##2##3##(1992-6#1)(1994-12#1)
dichroism (CD) spectroscopy##2##3##(1994-5#1)(1995-2#1)
dichroism (CD) studies##2##3##(1990-8#1)(1997-4#1)
dichroism (CD)##16##2##(1990-5#2)(1990-8#1)(1992-6#3)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-7#1)
dichroism and##10##2##(1990-5#3)(1991-12#1)(1993-11#2)(1994-5#1)(2006-4#1)(2008-10#1)(2009-10#1)
dichroism in##4##2##(1992-8#1)(1993-5#1)(1993-8#1)(2006-4#1)
dichroism of the##2##3##(1991-9#1)(2008-3#1)
dichroism spectroscopy##5##2##(1990-7#1)(1992-3#1)(1995-2#1)(1995-5#1)(2010-5#1)
dichroism to##2##2##(1995-5#1)(2008-3#1)
dichroism##87##1##(1990-5#5)(1990-7#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#4)(1992-6#5)(1992-8#4)(1993-11#6)(1993-5#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#4)(1994-8#2)(1995-2#4)(1995-5#5)(1997-2#1)(1997-4#1)(1997-6#1)(2006-4#4)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-5#2)(2012-2#2)(2013-1#1)
dichromate concentration##2##2##(2008-3#2)
dichromate##10##1##(2008-10#6)(2008-2#1)(2008-3#3)
dichromated gelatin (DCG)##2##3##(2008-3#2)
dichromated gelatin##13##2##(2007-12#1)(2008-2#5)(2008-3#7)
dichromated##15##1##(2007-12#1)(2008-2#5)(2008-3#9)
dichromated-gelatin gratings##3##2##(2008-3#3)
dichromated-gelatin##5##1##(2008-2#1)(2008-3#4)
dicistronic configuration##2##2##(2008-11#2)
dicistronic expression plasmids##2##3##(1993-6#2)
dicistronic expression##4##2##(1993-6#2)(2008-7#2)
dicistronic##9##1##(1993-6#2)(1994-6#1)(1997-8#2)(2008-11#2)(2008-7#2)
diclazuril (2/4)##2##2##(2007-6#2)
diclazuril##3##1##(2007-6#3)
diclofenac and##4##2##(1995-3#1)(2008-10#2)(2011-2#1)
diclofenac at##3##2##(1990-9#1)(2008-12#1)(2008-7#1)
diclofenac in pharmaceutical preparations by##3##5##(2008-10#3)
diclofenac in pharmaceutical preparations##4##4##(2008-10#4)
diclofenac in pharmaceutical##5##3##(2008-10#5)
diclofenac in the presence of##3##5##(2008-10#3)
diclofenac in the##4##3##(2008-10#4)
diclofenac in##12##2##(2008-10#12)
diclofenac sodium 3% gel##3##4##(2010-8#3)
diclofenac sodium 3%##4##3##(2010-8#4)
diclofenac sodium and##2##3##(2008-10#2)
diclofenac sodium##10##2##(1991-3#1)(2008-10#4)(2010-8#4)(2011-1#1)
diclofenac##43##1##(1990-9#3)(1991-3#1)(1995-3#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-7#2)(2009-5#1)(2010-8#4)(2011-1#1)(2011-2#4)
dicoccoides##5##1##(2008-10#5)
dicot##4##1##(1991-6#1)(2008-10#2)(2013-8#1)
dicot-infecting##2##1##(2008-10#2)
dicots (Arabidopsis##2##2##(2008-9#1)(2009-10#1)
dicots and##2##2##(2008-10#1)(2008-9#1)
dicots##7##1##(1991-6#1)(2008-10#2)(2008-9#2)(2009-10#1)(2010-5#1)
dicotyledenous##2##1##(2008-9#2)
dicotyledon##2##1##(2008-10#1)(2008-7#1)
dicotyledonous plants##3##2##(1997-2#1)(2008-10#1)(2011-1#1)
dicrotophos##2##1##(2008-10#2)
dictate the##2##2##(1995-1#1)(2012-12#1)
dictate##10##1##(1993-2#1)(1994-2#1)(1995-1#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2012-12#1)
dictated by the##4##3##(1996-12#1)(2007-12#1)(2008-2#2)
dictated by##6##2##(1992-2#1)(1996-12#1)(2007-12#1)(2008-2#2)(2011-1#1)
dictated##13##1##(1992-2#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
dictates that##2##2##(1992-1#1)(2008-5#1)
dictates the##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
dictates##11##1##(1992-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#1)
dictating##2##1##(2007-12#1)(2012-3#1)
dictionary##10##1##(2008-11#1)(2008-4#5)(2012-12#4)
dicyano complex##3##2##(2008-10#3)
dicyclohexano-18-crown-6##5##1##(2008-10#5)
dicyclohexylcarbodiimide##15##1##(2008-9#15)
did a##9##2##(1992-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-7#1)
did affect the##3##3##(2008-10#2)(2008-11#1)
did affect##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#1)
did appear##2##2##(2008-11#1)(2008-12#1)
did cause##4##2##(1993-6#1)(1997-8#1)(2008-10#1)(2011-2#1)
did consent to##2##3##(2009-6#2)
did controls##2##2##(1992-2#1)(1993-8#1)
did correlate with##2##3##(2008-9#2)
did correlate##3##2##(2008-9#2)(2012-12#1)
did develop##3##2##(1997-3#1)(2008-10#2)
did differ##2##2##(1995-5#1)(2008-8#1)
did find##2##2##(2008-9#1)(2009-7#1)
did have a##2##3##(1993-8#1)(1994-7#1)
did have##5##2##(1992-12#1)(1993-8#1)(1994-7#1)(2008-11#1)(2008-9#1)
did improve##3##2##(2008-9#2)(2013-1#1)
did in##5##2##(1993-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)
did increase##2##2##(2008-10#1)(2010-6#1)
did induce##2##2##(1997-4#1)(2008-10#1)
did it##7##2##(1991-8#1)(1992-8#1)(1996-12#1)(2007-9#1)(2008-10#3)
did lead to##2##3##(2011-1#1)(2013-8#1)
did males##2##2##(2008-10#1)(2008-4#1)
did nature##2##2##(2012-2#2)
did not accept##2##3##(2008-12#1)(2008-5#1)
did not account for the##3##5##(1996-12#1)(2008-6#1)(2013-8#1)
did not account for##5##4##(1996-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
did not accumulate##2##3##(1995-6#1)(2008-10#1)
did not accurately##2##3##(1997-4#1)(2008-8#1)
did not achieve a##2##4##(2007-11#1)(2008-6#1)
did not achieve statistical significance##2##5##(2008-7#2)
did not achieve##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#2)
did not act##3##3##(2008-10#1)(2008-8#2)
did not activate##2##3##(1997-6#1)(2008-10#1)
did not affect any##2##4##(1996-5#1)(2008-11#1)
did not affect bacterial##2##4##(2008-10#1)(2012-2#1)
did not affect cell##2##4##(1994-11#1)(2008-11#1)
did not affect either##3##4##(1991-5#1)(1997-4#1)(2008-10#1)
did not affect kernel##2##4##(2011-2#2)
did not affect outcome##2##4##(2007-8#1)(2013-1#1)
did not affect root##2##4##(2008-10#2)
did not affect the ability of##2##6##(1990-5#1)(2008-10#1)
did not affect the contractile##2##5##(1997-4#1)(2008-2#1)
did not affect the efficacy of##3##6##(2008-10#2)(2011-2#1)
did not affect the expression##3##5##(2008-6#1)(2008-8#2)
did not affect the life span of##2##7##(1993-8#1)(2008-7#1)
did not affect the striatal##2##5##(1993-9#1)(1996-2#1)
did not affect the survival of##2##6##(2008-10#1)(2009-10#1)
did not affect the##86##4##(1990-5#2)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#1)
did not affect this##3##4##(1994-8#1)(2008-11#1)(2008-4#1)
did not affect total##2##4##(1990-11#1)(1997-1#1)
did not affect##173##3##(1990-11#2)(1990-12#1)(1990-5#4)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#6)(1997-1#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#37)(2008-11#10)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-2#3)(2012-5#1)(2013-1#3)
did not allow the##2##4##(2008-10#2)
did not allow us to##3##5##(2008-10#2)(2008-7#1)
did not allow##7##3##(2007-10#1)(2008-10#5)(2008-7#1)
did not alter the##23##4##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1992-3#1)(1992-7#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2009-9#1)
did not alter##43##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
did not always##5##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
did not amount to##2##4##(1995-12#1)(2008-1#1)
did not amplify DNA from##2##5##(2008-10#2)
did not amplify DNA##3##4##(2008-10#2)(2009-6#1)
did not amplify##6##3##(2008-10#4)(2008-11#1)(2009-6#1)
did not anastomose with##2##4##(2008-10#1)(2008-12#1)
did not and##2##3##(2007-7#1)(2009-3#1)
did not antagonize the##3##4##(1994-11#2)(1997-2#1)
did not appear to be##4##5##(1994-7#1)(1994-8#1)(1995-12#1)(2008-7#1)
did not appear to influence##2##5##(2008-6#1)(2012-12#1)
did not appear to##28##4##(1990-7#2)(1994-7#1)(1994-8#1)(1995-12#1)(1997-4#1)(2007-10#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
did not appear##32##3##(1990-7#2)(1991-12#1)(1994-7#1)(1994-8#1)(1995-12#1)(1997-4#1)(1997-8#1)(2007-10#2)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
did not apply to##3##4##(1995-2#2)(1996-5#1)
did not apply##4##3##(1995-2#2)(1996-5#1)(2013-1#1)
did not attain statistical significance##2##5##(2007-7#1)(2008-7#1)
did not attend##2##3##(1990-6#1)(2007-10#1)
did not attenuate the##2##4##(1990-2#1)(2008-4#1)
did not become##5##3##(1993-12#1)(2007-2#2)(2008-10#2)
did not believe##2##3##(1993-6#1)(2007-7#1)
did not bind to the##2##5##(1992-8#1)(1995-11#1)
did not bind##8##3##(1990-5#1)(1992-11#1)(1992-8#1)(1995-11#2)(1995-2#2)(2008-8#1)
did not block the##2##4##(1994-8#1)(1995-12#1)
did not block##4##3##(1994-12#1)(1994-8#2)(1995-12#1)
did not capture##2##3##(1996-2#1)(2013-1#1)
did not catalyze##3##3##(1994-8#1)(1996-2#1)(2008-10#1)
did not cause any##7##4##(1990-2#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-12#1)(2008-10#1)(2013-1#1)
did not cause cell death##2##5##(2008-10#1)(2013-1#1)
did not cause disease##2##4##(2008-10#2)
did not cause##27##3##(1990-2#1)(1991-2#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-6#1)(1995-12#2)(1996-6#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#2)(2013-8#1)
did not change after##5##4##(1991-6#1)(2007-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
did not change during##4##4##(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
did not change following##3##4##(1991-12#1)(2008-10#1)(2009-9#1)
did not change in the control##2##6##(2008-10#1)(2011-2#1)
did not change in the##6##5##(1992-5#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
did not change in##11##4##(1991-12#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-10#1)(2011-2#2)(2013-1#1)
did not change over##2##4##(1996-3#1)(2008-11#1)
did not change significantly after##2##5##(2009-4#1)(2011-1#1)
did not change significantly during the##2##6##(1997-2#1)(2011-1#1)
did not change significantly during##3##5##(1997-2#1)(2008-7#1)(2011-1#1)
did not change significantly in either##2##6##(1994-2#1)(2008-3#1)
did not change significantly in##3##5##(1994-2#1)(2008-3#1)(2013-7#1)
did not change significantly##15##4##(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
did not change the basal##2##5##(1995-5#1)(1996-2#1)
did not change the##18##4##(1990-11#1)(1991-12#1)(1992-4#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
did not change with age##3##5##(1990-3#2)(1994-5#1)
did not change with##4##4##(1990-3#2)(1994-5#1)(2008-10#1)
did not change##86##3##(1990-11#1)(1990-3#2)(1991-12#4)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-1#5)(2011-10#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
did not colonize##2##3##(2008-10#2)
did not compete with##2##4##(1990-8#1)(2008-6#1)
did not compete##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
did not completely##3##3##(1991-5#1)(1994-9#1)(2008-10#1)
did not comply with the##2##5##(1991-8#1)(2011-2#1)
did not confirm##2##3##(1992-8#1)(2008-12#1)
did not consent##3##3##(1995-12#1)(2008-4#1)(2012-3#1)
did not consider##4##3##(1996-1#1)(1997-2#1)(2007-7#1)(2008-10#1)
did not consistently affect##3##4##(2008-10#3)
did not consistently suppress##3##4##(2008-10#3)
did not consistently##9##3##(2008-10#8)(2008-8#1)
did not contain the##4##4##(1996-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
did not contain##7##3##(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
did not continue##2##3##(1993-11#1)(2008-11#1)
did not contribute to##3##4##(1995-12#1)(1995-2#1)(2008-8#1)
did not contribute##5##3##(1995-12#1)(1995-2#1)(2007-8#1)(2008-8#1)(2013-8#1)
did not control##2##3##(2008-10#2)
did not correlate well with##3##5##(2008-1#1)(2008-10#1)(2010-10#1)
did not correlate with the##11##5##(1990-11#1)(1991-12#2)(1991-5#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)(2013-8#1)
did not correlate with##27##4##(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
did not correlate##36##3##(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
did not correspond to the##4##5##(2008-10#3)(2008-5#1)
did not correspond to##5##4##(2008-10#4)(2008-5#1)
did not cross-react with##2##4##(1992-6#1)(1995-11#1)
did not decline with age##2##5##(1991-8#1)(2008-10#1)
did not decline##4##3##(1991-8#1)(1992-5#1)(2008-10#2)
did not decrease GR##2##4##(1994-2#2)
did not decrease significantly##2##4##(1996-1#1)(2011-2#1)
did not decrease the##4##4##(1990-7#1)(1995-5#1)(1997-4#1)(2008-5#1)
did not decrease##16##3##(1990-7#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-5#1)
did not demonstrate any##3##4##(1990-10#1)(2009-10#1)(2009-4#1)
did not demonstrate##13##3##(1990-10#1)(1991-3#1)(1992-11#1)(1995-2#1)(2007-12#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
did not depend on##3##4##(1996-8#1)(2008-1#1)(2012-2#1)
did not detect any##5##4##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
did not detect differences##2##4##(2008-10#2)
did not detect##11##3##(1990-5#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
did not determine##2##3##(1992-1#1)(2007-7#1)
did not develop in##3##4##(1996-12#1)(2008-10#2)
did not develop##10##3##(1990-11#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2012-2#1)
did not differ among##5##4##(1995-12#1)(2008-10#3)(2008-5#1)
did not differ between groups##2##5##(2009-12#1)(2010-1#1)
did not differ between the 2##2##6##(2007-10#1)(2013-1#1)
did not differ between the two##2##6##(1991-12#1)(2008-3#1)
did not differ between the##10##5##(1991-12#1)(1992-2#1)(1993-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
did not differ between##26##4##(1990-2#1)(1991-12#2)(1992-2#1)(1993-12#2)(1993-3#1)(1994-3#1)(1996-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
did not differ by##4##4##(1997-2#1)(2007-7#1)(2008-10#1)(2012-2#1)
did not differ from control##3##5##(1993-6#1)(1995-12#1)(2008-10#1)
did not differ from that of##2##6##(1991-3#1)(2008-10#1)
did not differ from that##5##5##(1991-3#1)(1996-9#1)(2007-5#1)(2008-10#1)(2012-2#1)
did not differ from the##4##5##(1991-6#1)(2008-11#1)(2009-5#1)(2010-1#1)
did not differ from their##2##5##(1996-5#1)(2013-1#1)
did not differ from those of##2##6##(1995-1#1)(2008-7#1)
did not differ from those##4##5##(1995-1#1)(1995-11#1)(2008-10#1)(2008-7#1)
did not differ from##23##4##(1991-3#1)(1991-6#1)(1993-5#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-9#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#1)
did not differ in the##2##5##(2008-9#1)(2009-4#1)
did not differ in their##2##5##(1997-4#1)(2010-8#1)
did not differ in##17##4##(1991-3#1)(1991-7#1)(1993-12#1)(1993-2#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#1)(2013-8#1)
did not differ over##2##4##(2008-10#1)(2012-3#1)
did not differ significantly (P##2##5##(2008-10#2)
did not differ significantly across the##2##6##(1996-7#1)(2008-9#1)
did not differ significantly between the three groups##2##8##(2009-10#2)
did not differ significantly between the three##4##7##(2008-5#1)(2009-10#3)
did not differ significantly between the two groups##2##8##(1993-12#1)(2011-2#1)
did not differ significantly between the two##3##7##(1993-12#1)(2008-6#1)(2011-2#1)
did not differ significantly between the##10##6##(1993-12#1)(2008-5#1)(2008-6#2)(2009-10#3)(2011-2#2)(2013-7#1)
did not differ significantly between##18##5##(1993-12#1)(1994-2#1)(2007-1#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#3)(2011-1#1)(2011-2#2)(2013-7#1)
did not differ significantly for##4##5##(2008-10#2)(2008-12#1)(2009-12#1)
did not differ significantly from that of##2##7##(1994-2#1)(2008-10#1)
did not differ significantly from the##3##6##(2008-10#3)
did not differ significantly from those in##2##7##(1995-11#1)(1996-3#1)
did not differ significantly from##12##5##(1994-2#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(2008-10#5)(2010-12#1)
did not differ significantly in##4##5##(1994-2#1)(2007-11#1)(2008-7#1)(2013-1#1)
did not differ significantly##53##4##(1993-12#1)(1993-2#1)(1994-2#3)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-6#1)(2007-1#1)(2007-11#1)(2008-10#16)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
did not differ with##3##4##(1993-9#1)(2007-8#1)(2008-7#1)
did not differ##148##3##(1990-2#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-2#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#4)(2009-10#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
did not differentiate##3##3##(2008-10#2)(2008-8#1)
did not diminish##3##3##(1991-2#1)(2008-9#1)(2012-2#1)
did not directly##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
did not disclose##2##3##(2006-12#1)(2007-12#1)
did not discriminate##2##3##(1994-8#1)(2011-10#1)
did not display##5##3##(1993-3#1)(1994-11#1)(1996-12#1)(2009-3#1)(2013-8#1)
did not distinguish##2##3##(2008-10#1)(2008-6#1)
did not disturb##2##3##(2008-6#1)(2012-3#1)
did not do##2##3##(1995-3#1)(2009-7#1)
did not elicit##6##3##(1991-4#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
did not enhance the##2##4##(1992-3#1)(2008-7#1)
did not enhance##11##3##(1992-3#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)
did not evolve##2##3##(2008-10#1)(2011-1#1)
did not exceed 1##2##4##(2008-10#1)(2008-7#1)
did not exceed##16##3##(1990-11#1)(1994-12#1)(2008-10#9)(2008-2#2)(2008-7#1)(2011-1#1)(2013-1#1)
did not exert any##2##4##(1995-6#1)(2011-1#1)
did not exert##4##3##(1995-6#1)(2008-10#1)(2011-1#1)(2013-1#1)
did not exhibit any##3##4##(1997-3#1)(2008-1#1)(2011-2#1)
did not exhibit the##2##4##(1993-11#1)(2008-10#1)
did not exhibit this##2##4##(2008-7#2)
did not exhibit##17##3##(1991-3#1)(1993-11#1)(1993-8#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#4)(2011-2#1)
did not exist##2##3##(1990-3#1)(2008-10#1)
did not experience##3##3##(1991-12#1)(1995-6#1)(2008-7#1)
did not explain##2##3##(2008-8#2)
did not express GM1##2##4##(1996-5#2)
did not express the##3##4##(1991-2#1)(2008-11#1)(2009-12#1)
did not express##10##3##(1991-2#1)(1996-5#2)(2008-11#3)(2009-12#1)(2010-11#1)(2012-12#1)(2013-1#1)
did not extend to##2##4##(2008-10#1)(2010-8#1)
did not extend##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
did not feel##3##3##(2008-5#2)(2013-7#1)
did not find a##5##4##(1990-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
did not find any##4##4##(2008-12#1)(2008-5#1)(2009-10#2)
did not find##19##3##(1990-3#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
did not fit a##2##4##(1990-7#1)(2008-10#1)
did not fit the##2##4##(2009-8#1)(2013-1#1)
did not fit##5##3##(1990-7#1)(2008-10#2)(2009-8#1)(2013-1#1)
did not follow the##4##4##(1991-12#1)(2008-7#1)(2010-11#1)(2013-1#1)
did not follow##6##3##(1991-12#1)(2008-7#2)(2009-6#1)(2010-11#1)(2013-1#1)
did not form##11##3##(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-2#1)
did not fulfil##2##3##(1992-11#1)(1994-7#1)
did not fulfill##2##3##(1993-8#1)(2009-4#1)
did not function##2##3##(1996-5#1)(1997-2#1)
did not further##5##3##(1996-2#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
did not germinate##2##3##(2008-10#1)(2010-10#1)
did not give##3##3##(2006-12#1)(2008-10#2)
did not greatly##2##3##(2008-10#1)(2008-11#1)
did not grow in##2##4##(1994-5#1)(2008-5#1)
did not grow##4##3##(1994-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
did not guarantee##2##3##(2009-5#1)(2012-12#1)
did not harbor##2##3##(1991-12#1)(2009-7#1)
did not hatch##2##3##(2008-5#1)(2008-6#1)
did not have a significant effect on##2##7##(1991-8#1)(1992-9#1)
did not have a significant effect##3##6##(1991-8#1)(1992-9#1)(2008-11#1)
did not have a significant##5##5##(1991-8#1)(1992-9#1)(1994-12#1)(2008-11#1)(2013-1#1)
did not have a statistically##2##5##(1994-9#1)(2007-7#1)
did not have a##16##4##(1991-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
did not have an##5##4##(1995-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)
did not have any effect on the##2##7##(1994-5#1)(2008-10#1)
did not have any effect on##3##6##(1992-9#1)(1994-5#1)(2008-10#1)
did not have any significant effect on the##3##8##(1995-3#1)(2008-10#1)(2008-12#1)
did not have any significant effect on##4##7##(1995-3#1)(2008-10#1)(2008-12#2)
did not have any##17##4##(1990-12#1)(1991-9#1)(1992-9#1)(1994-5#1)(1995-3#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-7#2)(2010-12#1)(2012-2#1)
did not have significant effect on##2##6##(2008-10#1)(2013-1#1)
did not have significant effects on##2##6##(2008-10#1)(2008-9#1)
did not have significant##5##4##(2007-5#1)(2008-10#2)(2008-9#1)(2013-1#1)
did not have##75##3##(1990-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1997-5#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#6)
did not hybridize to##2##4##(1992-11#1)(2008-10#1)
did not hybridize with any##2##5##(2008-10#2)
did not hybridize with##4##4##(2008-10#4)
did not hybridize##7##3##(1992-11#1)(2008-10#6)
did not hydrolyze##2##3##(1990-2#1)(1995-6#1)
did not identify##5##3##(1990-6#1)(1991-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
did not impair##3##3##(1992-10#1)(1995-2#1)(2008-7#1)
did not improve and##2##4##(2008-5#1)(2011-2#1)
did not improve significantly##3##4##(2008-10#2)(2008-7#1)
did not improve survival##2##4##(2012-3#1)(2013-1#1)
did not improve the##6##4##(1991-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)
did not improve##24##3##(1990-2#1)(1991-6#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)
did not include##3##3##(1997-5#1)(2008-11#1)(2013-8#1)
did not increase in##3##4##(1992-3#1)(2008-7#1)(2008-8#1)
did not increase the level of##2##6##(1995-3#1)(2008-11#1)
did not increase the##16##4##(1990-11#1)(1991-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
did not increase with##2##4##(1995-2#1)(2010-8#1)
did not increase##45##3##(1990-11#1)(1991-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#2)(2007-10#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)
did not induce a significant change in##2##7##(1993-8#1)(2008-6#1)
did not induce a##4##4##(1993-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
did not induce apoptosis##3##4##(1993-9#1)(2008-11#1)(2008-8#1)
did not induce significant##2##4##(1996-12#1)(2008-10#1)
did not induce the##2##4##(1990-5#1)(2008-10#1)
did not induce##32##3##(1990-5#2)(1991-12#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-6#1)(2008-8#3)
did not influence the##19##4##(1990-8#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2010-4#1)(2012-1#1)(2013-1#1)
did not influence##31##3##(1990-8#1)(1991-4#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#3)
did not infringe##2##3##(1993-9#1)(1995-6#1)
did not inhibit germination##2##4##(2008-10#2)
did not inhibit the##5##4##(1994-6#1)(1994-8#1)(2008-10#2)(2009-2#1)
did not inhibit##24##3##(1990-11#1)(1990-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1997-3#1)(2006-6#1)(2008-10#6)(2008-6#1)(2009-2#1)(2010-4#1)
did not interfere in the##2##5##(2008-10#1)(2008-5#1)
did not interfere in##4##4##(2008-10#2)(2008-5#1)(2010-5#1)
did not interfere the##3##4##(2008-10#3)
did not interfere with the assay##2##6##(2008-10#2)
did not interfere with the response##2##6##(2008-10#2)
did not interfere with the##14##5##(1990-12#1)(1997-2#1)(2008-10#11)(2008-8#1)
did not interfere with##23##4##(1990-12#1)(1991-5#1)(1992-3#1)(1997-2#1)(2008-10#15)(2008-8#1)(2010-8#1)(2012-12#1)(2013-8#1)
did not interfere##33##3##(1990-12#1)(1991-5#1)(1992-3#1)(1997-2#1)(2008-10#23)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
did not know whether##3##4##(1995-1#1)(2008-10#1)(2008-12#1)
did not know##7##3##(1995-1#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
did not lead to an increase##2##6##(2007-2#1)(2008-11#1)
did not lead to the##2##5##(2008-11#1)(2008-7#1)
did not lead to##9##4##(2007-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-5#1)(2012-12#1)(2013-8#1)
did not lead##10##3##(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-5#1)(2012-12#1)(2013-8#1)
did not lose##2##3##(2008-10#2)
did not make##3##3##(1992-11#1)(1994-9#1)(2012-12#1)
did not match the##3##4##(2011-1#1)(2012-12#1)(2013-1#1)
did not match##4##3##(2008-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
did not mediate the relationship between##2##6##(2010-11#1)(2012-1#1)
did not mediate the##3##4##(1990-7#1)(2010-11#1)(2012-1#1)
did not mediate##4##3##(1990-7#1)(2010-11#1)(2011-1#1)(2012-1#1)
did not meet##4##3##(1991-8#1)(1997-7#1)(2006-10#1)(2008-7#1)
did not modify the##6##4##(1994-3#1)(1995-12#1)(2008-10#2)(2008-3#1)(2009-7#1)
did not modify##13##3##(1990-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-3#2)(2009-7#1)(2013-7#1)
did not necessarily##2##3##(2008-4#1)(2009-7#1)
did not need##5##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
did not normalize the##2##4##(2007-10#1)(2008-7#1)
did not observe##3##3##(2009-9#1)(2012-12#1)(2013-1#1)
did not obtain##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
did not occur after the##2##5##(1994-8#1)(2013-8#1)
did not occur after##3##4##(1994-8#1)(1995-8#1)(2013-8#1)
did not occur at##2##4##(2008-10#2)
did not occur during##2##4##(2007-10#1)(2007-5#1)
did not occur in##6##4##(1990-3#1)(1990-9#1)(1991-8#1)(2008-2#1)(2008-6#1)(2011-1#1)
did not occur##27##3##(1990-3#1)(1990-9#1)(1991-8#2)(1992-12#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(2007-10#1)(2007-5#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-8#3)
did not offer##4##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-9#1)
did not overlap##2##3##(2007-12#1)(2011-2#1)
did not participate in##2##4##(1995-6#1)(1997-2#1)
did not pass##2##3##(1991-1#1)(2008-10#1)
did not perform any##3##4##(2008-2#1)(2009-1#1)(2009-3#1)
did not perform##5##3##(2008-10#1)(2008-2#1)(2009-1#1)(2009-3#1)(2009-9#1)
did not permit##2##3##(1991-2#1)(2008-10#1)
did not play a role in##4##6##(1990-7#1)(2008-10#2)(2010-8#1)
did not possess##3##3##(2008-10#2)(2008-8#1)
did not potentiate the##3##4##(1992-3#1)(1996-2#1)(2008-5#1)
did not predict skew##2##4##(2008-9#2)
did not predict the##2##4##(2007-7#1)(2008-11#1)
did not predict##15##3##(1994-12#1)(1995-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#3)(2013-1#1)
did not present any##2##4##(1992-10#1)(2008-10#1)
did not present with##2##4##(2010-6#1)(2011-2#1)
did not present##14##3##(1992-10#1)(1992-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
did not prevent the##4##4##(1992-9#1)(1994-5#1)(2007-12#1)(2008-10#1)
did not prevent##12##3##(1992-9#1)(1993-3#1)(1994-5#2)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)
did not produce any##4##4##(1995-12#2)(2008-10#1)(2013-1#1)
did not produce the##2##4##(2008-10#2)
did not produce##25##3##(1991-3#2)(1991-7#1)(1993-6#1)(1994-3#1)(1995-12#2)(1997-6#1)(2008-10#12)(2008-4#1)(2008-5#1)(2009-8#1)(2013-1#2)
did not promote the##2##4##(2008-10#1)(2008-11#1)
did not promote##7##3##(2008-10#1)(2008-11#4)(2008-5#1)(2013-1#1)
did not protect##2##3##(1991-12#1)(1993-6#1)
did not prove as effective##2##5##(2007-6#1)(2008-10#1)
did not prove##4##3##(1996-3#1)(2007-6#1)(2008-10#1)(2008-4#1)
did not provide adequate##2##4##(1991-6#1)(2008-10#1)
did not provide any##4##4##(2008-10#1)(2008-12#1)(2009-4#1)(2013-1#1)
did not provide##17##3##(1991-6#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-1#1)
did not reach significance##2##4##(1995-12#1)(2012-3#1)
did not reach statistical significance##5##5##(1991-2#1)(1994-12#1)(1994-5#1)(2008-6#1)(2008-7#1)
did not reach##12##3##(1991-2#1)(1992-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
did not react with other##2##5##(1996-12#1)(2008-11#1)
did not react with##17##4##(1993-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2010-4#1)
did not react##19##3##(1990-8#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2010-4#1)
did not realize##2##3##(1997-8#1)(2013-1#1)
did not receive any treatment##3##5##(2008-5#1)(2008-7#1)(2012-3#1)
did not receive any##7##4##(1995-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
did not receive reperfusion therapy##2##5##(2008-3#2)
did not receive this intervention##2##5##(1995-1#2)
did not receive##22##3##(1993-1#1)(1994-6#1)(1995-1#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
did not recognize the##2##4##(1992-3#1)(2008-3#1)
did not recover##5##3##(1991-9#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-8#1)
did not reduce disease##2##4##(2008-10#2)
did not reduce the severity of##2##6##(2008-10#2)
did not reduce the##6##4##(1994-8#1)(1997-4#1)(2008-10#3)(2010-1#1)
did not reduce##23##3##(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-8#1)
did not reflect##2##3##(1997-2#1)(2007-2#1)
did not report##6##3##(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
did not reproduce##2##3##(2008-10#1)(2013-1#1)
did not require a##2##4##(2008-10#1)(2011-2#1)
did not require any##5##4##(1991-2#1)(2008-10#4)
did not require##18##3##(1990-2#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-9#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2010-8#1)(2011-2#1)(2013-1#1)
did not rescue##2##3##(1994-8#1)(2010-6#1)
did not respond to the conventional##2##6##(2007-7#1)(2012-12#1)
did not respond to the##5##5##(2007-7#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
did not respond to##20##4##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-11#1)(1994-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-8#1)
did not respond##21##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-11#1)(1994-12#1)(1997-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-8#1)
did not result in any##2##5##(1991-9#1)(1994-8#1)
did not result in global changes##2##6##(2008-4#2)
did not result in the##5##5##(1991-3#1)(1991-9#1)(1995-6#1)(2009-2#1)(2009-4#1)
did not result in##25##4##(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#7)(2008-4#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#1)
did not result##26##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#7)(2008-4#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#1)
did not return for a##2##5##(1993-2#1)(2008-4#1)
did not return##4##3##(1993-2#1)(2008-4#1)(2011-2#2)
did not reveal a close correlation between##2##7##(2008-10#1)(2008-12#1)
did not reveal an##2##4##(1997-8#1)(2007-10#1)
did not reveal any increase in##2##6##(1997-7#1)(2008-6#1)
did not reveal any##12##4##(1993-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
did not reveal##28##3##(1992-5#1)(1993-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(1997-9#2)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
did not routinely##2##3##(2007-2#1)(2010-12#1)
did not seem to affect the##2##6##(1990-2#1)(2013-1#1)
did not seem to affect##3##5##(1990-2#1)(2008-11#1)(2013-1#1)
did not seem to be influenced by##2##7##(1990-9#1)(1995-5#1)
did not seem to be##4##5##(1990-10#1)(1990-9#1)(1995-5#1)(2008-3#1)
did not seem to##12##4##(1990-10#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-8#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
did not separate##2##3##(1995-6#1)(2008-10#1)
did not shift##2##3##(1994-6#1)(1995-5#1)
did not show a significant similarity to any other gene##2##10##(1996-12#2)
did not show a significant##3##5##(1996-12#2)(2007-7#1)
did not show a##10##4##(1992-9#1)(1996-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#2)
did not show any alteration##2##5##(2008-11#1)(2009-10#1)
did not show any change##2##5##(2011-2#1)(2013-8#1)
did not show any significant differences##2##6##(1994-5#1)(2008-10#1)
did not show any significant##11##5##(1994-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
did not show any##38##4##(1990-2#2)(1992-6#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
did not show significant differences##4##5##(1995-12#1)(2007-10#1)(2011-2#1)(2013-7#1)
did not show significant##12##4##(1991-12#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
did not show similar##2##4##(2008-5#1)(2012-8#1)
did not show statistical##2##4##(2008-10#1)(2011-1#1)
did not show the##3##4##(2008-11#1)(2008-7#1)(2012-12#1)
did not show##98##3##(1990-2#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#2)(1993-8#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#2)
did not significantly affect the##3##5##(1997-7#1)(2010-4#1)(2010-8#1)
did not significantly affect##7##4##(1993-5#1)(1997-7#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
did not significantly alter either##2##5##(1993-6#1)(1997-4#1)
did not significantly alter the##3##5##(1992-3#1)(1995-11#1)(2008-10#1)
did not significantly alter##8##4##(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-11#2)(1997-4#1)(2008-10#1)
did not significantly change after##2##5##(2008-2#1)(2010-8#1)
did not significantly change the##2##5##(1994-5#1)(1995-12#1)
did not significantly change##5##4##(1994-5#1)(1995-12#1)(2008-2#2)(2010-8#1)
did not significantly differ between##4##5##(2008-10#1)(2008-8#1)(2010-2#1)(2012-12#1)
did not significantly differ from##2##5##(2008-10#1)(2008-7#1)
did not significantly differ##8##4##(1995-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)
did not significantly eliminate##2##4##(1994-6#1)(1997-2#1)
did not significantly improve##2##4##(2013-1#2)
did not significantly influence the##2##5##(1995-12#1)(2008-9#1)
did not significantly influence##5##4##(1991-2#1)(1995-12#1)(1997-2#1)(2008-9#1)(2010-7#1)
did not significantly inhibit##2##4##(1991-11#1)(2012-2#1)
did not significantly##53##3##(1990-12#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-6#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
did not simply##2##3##(1991-12#1)(2008-7#1)
did not spread##3##3##(2008-10#2)(2010-8#1)
did not stimulate##7##3##(1990-12#1)(1992-6#1)(1994-6#1)(1994-9#1)(1995-3#1)(2008-10#2)
did not suffer##2##3##(2008-10#1)(2008-7#1)
did not support the##5##4##(1990-2#1)(1994-6#1)(2008-10#2)(2008-9#1)
did not support##11##3##(1990-2#1)(1992-6#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-9#1)
did not suppress the##3##4##(1993-12#1)(1995-2#1)(2008-11#1)
did not suppress##9##3##(1992-8#2)(1993-12#1)(1995-2#1)(1996-5#1)(2008-10#3)(2008-11#1)
did not survive##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
did not take into account##2##5##(2008-10#1)(2009-2#1)
did not take place##2##4##(2008-10#1)(2009-6#1)
did not take##5##3##(2008-10#2)(2009-2#1)(2009-6#1)(2012-2#1)
did not translate##2##3##(2009-4#1)(2013-8#1)
did not undergo##4##3##(2008-10#1)(2009-5#1)(2012-12#1)(2012-3#1)
did not use any##3##4##(1997-2#1)(2013-1#2)
did not use##10##3##(1991-6#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#2)
did not vary by age##2##5##(1997-2#1)(2010-11#1)
did not vary by##5##4##(1997-2#1)(2008-1#2)(2008-10#1)(2010-11#1)
did not vary from##2##4##(1996-7#1)(1997-3#1)
did not vary significantly between##2##5##(2008-8#1)(2013-7#1)
did not vary significantly##5##4##(1996-1#1)(2008-10#1)(2008-8#2)(2013-7#1)
did not vary with##2##4##(2008-5#1)(2008-8#1)
did not vary##16##3##(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2009-4#1)(2010-11#1)(2013-7#1)
did not violate the##2##4##(1996-5#1)(1996-9#1)
did not wear##2##3##(2008-9#1)(2012-2#1)
did not wish to##2##4##(1991-3#1)(2010-4#1)
did not yield##5##3##(1992-3#1)(1997-5#1)(2006-12#1)(2008-10#1)(2013-1#1)
did not##2123##2##(1990-10#2)(1990-11#11)(1990-12#12)(1990-2#14)(1990-3#7)(1990-5#13)(1990-6#3)(1990-7#9)(1990-8#7)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#24)(1991-2#11)(1991-3#9)(1991-4#2)(1991-5#9)(1991-6#7)(1991-7#2)(1991-8#11)(1991-9#9)(1992-1#3)(1992-10#3)(1992-11#10)(1992-12#7)(1992-2#2)(1992-3#20)(1992-4#1)(1992-5#6)(1992-6#8)(1992-7#1)(1992-8#7)(1992-9#8)(1993-1#1)(1993-11#6)(1993-12#12)(1993-2#3)(1993-3#11)(1993-5#4)(1993-6#14)(1993-8#13)(1993-9#7)(1994-1#1)(1994-11#8)(1994-12#10)(1994-2#12)(1994-3#7)(1994-5#13)(1994-6#12)(1994-7#2)(1994-8#20)(1994-9#9)(1995-1#5)(1995-11#21)(1995-12#41)(1995-2#19)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#14)(1995-8#6)(1996-1#4)(1996-12#13)(1996-2#17)(1996-3#4)(1996-5#16)(1996-6#3)(1996-7#6)(1996-8#6)(1996-9#2)(1997-1#5)(1997-2#18)(1997-3#10)(1997-4#13)(1997-5#6)(1997-6#7)(1997-7#8)(1997-8#10)(1997-9#2)(2006-10#3)(2006-12#3)(2006-6#4)(2007-1#1)(2007-10#21)(2007-11#11)(2007-12#16)(2007-2#8)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#15)(2007-8#14)(2008-1#22)(2008-10#450)(2008-11#86)(2008-12#41)(2008-2#12)(2008-3#15)(2008-4#19)(2008-5#69)(2008-6#29)(2008-7#71)(2008-8#39)(2008-9#31)(2009-1#2)(2009-10#11)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#7)(2009-4#12)(2009-5#5)(2009-6#9)(2009-7#6)(2009-8#6)(2009-9#6)(2010-1#6)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#7)(2010-3#7)(2010-4#10)(2010-5#4)(2010-6#6)(2010-7#6)(2010-8#19)(2010-9#1)(2011-1#22)(2011-10#3)(2011-2#70)(2012-1#9)(2012-12#26)(2012-2#38)(2012-3#23)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#78)(2013-7#6)(2013-8#27)
did occur##3##2##(1992-2#1)(1992-8#1)(2007-7#1)
did provide##4##2##(1996-2#1)(2008-10#2)(2008-12#1)
did react with##4##3##(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)
did result in##2##3##(1995-3#1)(2009-9#1)
did reveal##2##2##(1997-2#1)(2008-10#1)
did show some##2##3##(1990-8#1)(2008-6#1)
did show##7##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-9#1)(2012-2#1)
did so in##2##3##(2010-1#1)(2012-12#1)
did so##6##2##(1995-12#1)(2008-11#1)(2010-1#1)(2012-12#2)(2012-2#1)
did some##2##2##(1997-3#1)(2012-12#1)
did suppress##2##2##(2008-10#1)(2008-5#1)
did the##43##2##(1990-5#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-8#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-3#1)(1997-4#2)(1997-8#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#3)(2010-4#1)(2011-2#1)(2013-1#1)
did their##4##2##(1993-12#1)(1997-3#1)(2008-10#1)(2008-9#1)
did they develop##2##3##(1996-1#1)(2008-8#1)
did they##6##2##(1995-8#1)(1996-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
did to##2##2##(1991-6#1)(1994-12#1)
did well##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
did##2473##1##(1990-10#2)(1990-11#12)(1990-12#12)(1990-2#14)(1990-3#7)(1990-5#17)(1990-6#4)(1990-7#9)(1990-8#8)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#27)(1991-2#13)(1991-3#10)(1991-4#2)(1991-5#9)(1991-6#8)(1991-7#2)(1991-8#13)(1991-9#9)(1992-1#4)(1992-10#3)(1992-11#10)(1992-12#9)(1992-2#8)(1992-3#22)(1992-4#2)(1992-5#7)(1992-6#11)(1992-7#1)(1992-8#10)(1992-9#8)(1993-1#4)(1993-11#7)(1993-12#15)(1993-2#3)(1993-3#15)(1993-5#4)(1993-6#15)(1993-8#15)(1993-9#7)(1994-1#2)(1994-11#9)(1994-12#11)(1994-2#14)(1994-3#9)(1994-5#13)(1994-6#13)(1994-7#3)(1994-8#21)(1994-9#10)(1995-1#5)(1995-11#24)(1995-12#44)(1995-2#26)(1995-3#10)(1995-4#2)(1995-5#6)(1995-6#15)(1995-8#8)(1996-1#5)(1996-11#1)(1996-12#17)(1996-2#20)(1996-3#6)(1996-5#16)(1996-6#8)(1996-7#6)(1996-8#6)(1996-9#2)(1997-1#6)(1997-2#19)(1997-3#15)(1997-4#17)(1997-5#6)(1997-6#12)(1997-7#9)(1997-8#13)(1997-9#2)(2006-10#4)(2006-12#3)(2006-6#6)(2007-1#1)(2007-10#23)(2007-11#13)(2007-12#17)(2007-2#8)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#16)(2007-8#15)(2007-9#2)(2008-1#22)(2008-10#527)(2008-11#105)(2008-12#46)(2008-2#16)(2008-3#18)(2008-4#21)(2008-5#79)(2008-6#36)(2008-7#77)(2008-8#49)(2008-9#48)(2009-1#3)(2009-10#12)(2009-11#5)(2009-12#4)(2009-2#5)(2009-3#7)(2009-4#15)(2009-5#6)(2009-6#11)(2009-7#11)(2009-8#7)(2009-9#9)(2010-1#7)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#7)(2010-3#7)(2010-4#11)(2010-5#5)(2010-6#7)(2010-7#6)(2010-8#19)(2010-9#2)(2011-1#28)(2011-10#3)(2011-2#76)(2012-1#10)(2012-12#31)(2012-2#44)(2012-3#23)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#84)(2013-7#7)(2013-8#29)
didactic and##3##2##(1991-2#1)(1996-2#1)(2008-1#1)
didactic##10##1##(1991-2#1)(1993-12#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-7#1)
didactics##2##1##(2011-2#1)(2011-7#1)
didanosine##2##1##(1995-3#1)(1997-8#1)
dideoxy##3##1##(2008-2#3)
didn't have##2##2##(2008-12#1)(2013-8#1)
didn't##9##1##(1990-12#1)(1993-12#1)(1996-2#1)(2008-11#1)(2008-12#2)(2009-8#1)(2013-1#1)(2013-8#1)
didodecyldimethylammonium bromide (DDAB)##2##3##(2008-10#2)
didodecyldimethylammonium bromide##3##2##(2008-10#3)
die at##3##2##(1993-3#1)(2009-12#1)(2010-8#1)
die before##3##2##(2008-10#2)(2008-8#1)
die by apoptosis##3##3##(1993-3#1)(2008-7#1)(2009-8#1)
die by##6##2##(1993-3#1)(1994-8#2)(2008-11#1)(2008-7#1)(2009-8#1)
die for##2##2##(1996-12#1)(2008-8#1)
die from##5##2##(1993-3#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-5#1)
die in acute care##3##4##(2010-8#1)(2011-2#2)
die in##9##2##(1990-6#2)(1991-8#1)(1994-7#1)(2007-7#1)(2008-11#1)(2010-8#1)(2011-2#2)
die of a##2##3##(2008-7#1)(2013-7#1)
die of their disease##2##4##(2007-11#1)(2008-6#1)
die of##6##2##(1993-6#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-7#1)
die or##2##2##(1995-5#1)(2007-7#1)
die within##2##2##(1990-11#1)(2008-10#1)
die##76##1##(1990-11#1)(1990-2#4)(1990-6#2)(1991-8#1)(1993-3#3)(1993-6#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-12#1)(2013-7#1)
die)##2##1##(2007-9#1)(2008-8#1)
dieback in##2##2##(2008-10#2)
dieback is##3##2##(2008-10#3)
dieback symptoms##3##2##(2008-10#3)
dieback##17##1##(2008-10#17)
died 3##2##2##(2009-3#1)(2010-3#1)
died 4##2##2##(2007-6#1)(2008-7#1)
died 8 months##2##3##(1990-8#1)(1994-6#1)
died 8##3##2##(1990-8#1)(1994-6#1)(2008-10#1)
died a few##4##3##(1991-4#1)(2008-1#1)(2008-11#1)(2013-1#1)
died after##9##2##(1991-8#1)(1995-9#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
died and##2##2##(1991-12#1)(1992-6#1)
died as a result of##3##5##(1990-8#1)(1996-6#1)(2008-7#1)
died at the age of##3##5##(1997-3#1)(2008-7#1)(2013-1#1)
died at the##5##3##(1997-3#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
died at##11##2##(1991-8#1)(1997-3#2)(2007-6#2)(2007-7#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
died because of##6##3##(2010-3#1)(2011-2#5)
died before the end of the study##2##7##(2008-9#2)
died before the##3##3##(2008-9#2)(2012-2#1)
died before##7##2##(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#3)(2012-2#1)
died due to##5##3##(2007-11#1)(2011-2#3)(2011-3#1)
died during the##7##3##(1993-2#1)(1997-3#1)(1997-4#2)(2008-11#1)(2011-3#1)(2013-1#1)
died during##13##2##(1991-7#1)(1993-2#1)(1994-7#1)(1997-3#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-1#1)
died for##2##2##(1992-12#1)(1992-6#1)
died from cardiac##2##3##(1996-9#1)(2012-2#1)
died from their##2##3##(1997-4#1)(2010-12#1)
died from##20##2##(1991-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#2)(2007-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
died in the##3##3##(1996-8#1)(2011-2#1)(2012-3#1)
died in##14##2##(1991-12#1)(1991-8#1)(1996-8#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)
died of AIDS##2##3##(1993-6#1)(1993-8#1)
died of disease##4##3##(1991-6#1)(2007-10#1)(2008-6#1)(2010-3#1)
died of progressive disease##2##4##(1992-12#1)(1995-5#1)
died of the disease##4##4##(1991-6#2)(2007-7#1)(2008-6#1)
died of the##5##3##(1990-6#1)(1991-6#2)(2007-7#1)(2008-6#1)
died of##45##2##(1990-12#2)(1990-2#1)(1990-6#3)(1991-12#1)(1991-4#1)(1991-6#3)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-5#1)(1997-3#3)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-6#5)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#4)
died on the##5##3##(2007-4#1)(2008-10#2)(2011-2#1)(2012-3#1)
died on##8##2##(1992-3#1)(2007-4#1)(2008-10#2)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
died or were found moribund and sacrificed prior to day##2##10##(2008-9#2)
died or were##6##3##(1996-6#1)(2008-9#5)
died or##8##2##(1996-6#1)(2007-10#1)(2008-9#5)(2011-3#1)
died prematurely##3##2##(2007-2#1)(2008-10#1)(2008-9#1)
died soon after##2##3##(1993-12#1)(2008-6#1)
died soon##3##2##(1992-6#1)(1993-12#1)(2008-6#1)
died suddenly##3##2##(1991-8#1)(1991-9#1)(2012-12#1)
died within 24 h##2##4##(1994-5#1)(2008-6#1)
died within 5##2##3##(1995-2#2)
died within##12##2##(1990-9#1)(1994-12#1)(1994-5#1)(1995-2#4)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
died##281##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#4)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#3)(1991-4#3)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#8)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#3)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#7)(1997-4#4)(1997-5#2)(1997-6#2)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#13)(2008-11#7)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#10)(2008-7#14)(2008-9#10)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#5)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#22)(2011-3#3)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#10)(2013-8#2)
dieffenbachiae##4##1##(2008-10#4)
diel##2##1##(2008-8#1)(2009-9#1)
dieldrin and##2##2##(2008-10#2)
dieldrin##6##1##(2008-10#6)
dielectric and metallic##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
dielectric and##7##2##(2007-11#2)(2007-12#3)(2008-3#1)(2013-1#1)
dielectric barrier discharge##3##3##(2012-1#1)(2013-8#2)
dielectric bispheres##3##2##(2007-11#3)
dielectric coatings and##3##3##(2008-3#3)
dielectric coatings##8##2##(2007-12#3)(2008-3#5)
dielectric constant of the##2##4##(2008-10#2)
dielectric constant##11##2##(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
dielectric constants##9##2##(2008-10#6)(2008-3#2)(2008-4#1)
dielectric cylinder##4##2##(2007-11#1)(2008-2#3)
dielectric cylindrical##2##2##(2008-3#2)
dielectric film##2##2##(2007-11#1)(2008-2#1)
dielectric function of a##2##4##(2008-3#2)
dielectric function of##3##3##(2007-12#1)(2008-3#2)
dielectric function##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
dielectric grating##3##2##(2007-11#2)(2008-3#1)
dielectric gratings##3##2##(2007-11#2)(2008-3#1)
dielectric interface##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
dielectric layer##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
dielectric material##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
dielectric materials##2##2##(2008-3#1)(2008-7#1)
dielectric media##2##2##(2007-11#1)(2008-3#1)
dielectric mirror##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
dielectric mirrors##3##2##(2007-12#1)(2008-2#2)
dielectric of##2##2##(2007-12#1)(2008-2#1)
dielectric particles##7##2##(2007-11#1)(2008-3#5)(2008-6#1)
dielectric permittivities##2##2##(2008-3#2)
dielectric properties of##2##3##(2008-3#1)(2010-12#1)
dielectric properties##4##2##(2008-10#1)(2008-3#1)(2009-9#1)(2010-12#1)
dielectric spectroscopy##6##2##(2008-10#1)(2008-5#5)
dielectric stack##5##2##(2007-12#2)(2008-2#3)
dielectric structures with cylindrical symmetry##2##5##(2007-12#2)
dielectric structures##4##2##(2007-12#2)(2008-3#2)
dielectric surfaces##3##2##(2008-3#1)(2013-8#2)
dielectric thin##2##2##(2007-11#1)(2008-3#1)
dielectric##218##1##(1993-5#1)(1994-8#2)(1997-2#6)(2007-11#27)(2007-12#41)(2008-10#18)(2008-11#1)(2008-2#30)(2008-3#63)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2009-5#2)(2009-9#1)(2010-12#2)(2011-1#1)(2012-1#1)(2013-1#5)(2013-8#5)
dielectric-modulated##2##1##(2008-7#2)
dielectrically##2##1##(2008-10#2)
dielectrics##12##1##(1997-2#3)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
diencephalic##6##1##(1991-10#1)(1991-5#1)(1993-8#1)(1994-8#1)(2008-7#2)
diencephalon##5##1##(1993-8#1)(1995-12#1)(1996-5#1)(2008-6#1)(2012-3#1)
diene formation##2##2##(1991-5#1)(1994-9#1)
diene##14##1##(1990-5#1)(1991-5#2)(1994-5#1)(1994-9#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#5)(2008-4#1)
dienes##11##1##(1992-3#3)(1996-5#1)(2008-5#1)(2008-8#1)(2009-8#5)
dienophile##2##1##(1996-5#2)
dienophiles##4##1##(1996-5#4)
diepoxybutane##4##1##(1997-3#1)(2008-4#1)(2008-7#2)
dies##8##1##(1993-3#1)(1995-6#1)(1996-11#1)(1997-5#1)(2007-2#1)(2008-10#1)(2009-3#1)(2009-9#1)
diesel exhaust particles##4##3##(2008-10#4)
diesel fuel##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
diesel fuels##5##2##(2008-10#3)(2008-11#2)
diesel oil and white oil##2##5##(2008-10#2)
diesel oil##5##2##(2008-10#2)(2009-8#2)(2011-1#1)
diesel##28##1##(2008-10#18)(2008-11#4)(2008-3#2)(2008-6#1)(2009-8#2)(2011-1#1)
diester substituted calix[4]arene##2##3##(2008-10#2)
diester##4##1##(2008-10#2)(2008-4#2)
diesters##3##1##(2008-4#3)
diet (&lt##2##2##(2008-3#2)
diet (0##3##2##(1992-8#1)(2011-2#2)
diet (P &lt##4##2##(2012-2#4)
diet +##4##2##(2008-3#3)(2013-1#1)
diet alone##2##2##(1991-2#1)(1992-9#1)
diet also##2##2##(1997-3#1)(1997-4#1)
diet and T-2 toxin##2##4##(2011-2#2)
diet and a##2##3##(2008-3#2)
diet and body weight##2##4##(2011-2#1)(2013-1#1)
diet and cancer##2##3##(1990-8#2)
diet and exercise##2##3##(1994-5#1)(2008-3#1)
diet and gemfibrosil##2##3##(1992-10#2)
diet and lifestyle##2##3##(2009-5#1)(2012-12#1)
diet and oral##2##3##(1993-12#1)(1997-6#1)
diet and other##2##3##(1994-3#1)(2009-5#1)
diet and physical activity##2##4##(2008-3#1)(2013-8#1)
diet and physical##4##3##(2008-1#1)(2008-3#1)(2013-8#2)
diet and##61##2##(1990-12#1)(1990-6#3)(1990-8#5)(1991-12#2)(1991-8#1)(1992-10#2)(1992-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-5#1)(1997-6#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-3#6)(2008-5#3)(2009-5#2)(2009-8#1)(2010-12#2)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
diet are##2##2##(1994-9#1)(2008-5#1)
diet as##3##2##(2008-3#2)(2011-2#1)
diet at##2##2##(1994-9#1)(2010-6#1)
diet based on##4##3##(2008-12#4)
diet breadth##6##2##(2008-9#4)(2012-3#1)(2013-7#1)
diet can##2##2##(1992-8#1)(2008-4#1)
diet changes##2##2##(2008-9#1)(2010-8#1)
diet compared##3##2##(2008-12#1)(2010-2#2)
diet comprised foods rich in##2##5##(2010-6#2)
diet containing heat-killed##2##3##(2011-1#2)
diet containing##24##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-12#1)(1997-4#3)(2008-10#2)(2008-11#1)(2009-12#1)(2010-10#1)(2010-2#5)(2010-4#3)(2011-1#2)
diet control group##2##3##(2013-1#2)
diet control##3##2##(2013-1#3)
diet for the##2##3##(2007-5#1)(2008-3#1)
diet for##15##2##(1991-2#1)(1992-11#1)(1992-3#1)(1994-6#1)(2007-5#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
diet from day 1##2##4##(1997-3#1)(1997-6#1)
diet from##4##2##(1997-3#1)(1997-6#1)(2012-2#1)(2013-1#1)
diet group##9##2##(2008-7#6)(2011-1#2)(2012-2#1)
diet had a##4##3##(1996-12#1)(2008-3#1)(2010-2#1)(2012-2#1)
diet had##5##2##(1995-3#1)(1996-12#1)(2008-3#1)(2010-2#1)(2012-2#1)
diet has##2##2##(2008-3#1)(2009-11#1)
diet have##2##2##(1990-8#1)(2008-3#1)
diet improved the##2##3##(2008-10#1)(2010-4#1)
diet in the##2##3##(1990-8#1)(2008-10#1)
diet in##11##2##(1990-8#1)(1991-2#2)(1991-6#1)(1993-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
diet induced##3##2##(2008-10#1)(2013-1#2)
diet is##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
diet lacking##2##2##(1995-11#1)(2008-11#1)
diet may be##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
diet may##6##2##(1990-9#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)
diet of the##4##3##(2008-5#2)(2012-2#1)(2013-7#1)
diet of##16##2##(1990-3#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#5)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
diet on performance##2##3##(2013-8#2)
diet on the##5##3##(2008-2#1)(2008-3#2)(2010-4#2)
diet on##16##2##(1990-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
diet only##2##2##(1994-12#1)(2013-1#1)
diet or the##2##3##(2009-12#1)(2010-10#1)
diet or##6##2##(1993-12#2)(2009-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
diet plus##2##2##(2008-3#1)(2013-1#1)
diet quality of##2##3##(2011-2#2)
diet quality##6##2##(2011-2#5)(2013-1#1)
diet resulted in a##2##4##(2008-5#1)(2010-2#1)
diet resulted in##3##3##(2008-5#1)(2010-2#2)
diet rich in##3##3##(1995-2#1)(2008-7#1)(2013-1#1)
diet significantly##3##2##(1996-12#1)(2010-6#1)(2013-1#1)
diet supplemented with##2##3##(1991-2#1)(2013-1#1)
diet that##5##2##(1992-8#1)(1997-1#1)(2008-3#2)(2011-2#1)
diet to##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
diet was##15##2##(1990-2#1)(1990-6#1)(1993-9#1)(1997-3#1)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-8#5)
diet were##5##2##(1992-3#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-5#1)
diet which##2##2##(1990-6#1)(2010-4#1)
diet with a##2##3##(2008-3#1)(2008-5#1)
diet with or without##2##4##(1992-11#1)(1997-3#1)
diet with##10##2##(1990-3#1)(1992-11#2)(1997-3#1)(2008-12#1)(2008-3#1)(2008-5#3)(2010-2#1)
diet without##3##2##(1993-12#1)(2008-3#1)(2010-2#1)
diet##560##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#7)(1990-7#2)(1990-8#12)(1990-9#3)(1991-11#2)(1991-12#3)(1991-2#11)(1991-5#1)(1991-6#4)(1991-8#1)(1992-10#2)(1992-11#4)(1992-3#5)(1992-8#5)(1992-9#4)(1993-11#1)(1993-12#6)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#5)(1995-8#1)(1995-9#1)(1996-12#3)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#14)(1997-5#1)(1997-6#6)(2007-12#1)(2007-2#1)(2007-5#4)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#28)(2008-11#6)(2008-12#12)(2008-2#1)(2008-3#60)(2008-4#3)(2008-5#24)(2008-7#17)(2008-8#1)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#6)(2009-5#2)(2009-8#2)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#28)(2010-4#11)(2010-6#9)(2010-7#1)(2010-8#6)(2011-1#10)(2011-2#40)(2012-1#2)(2012-12#7)(2012-2#35)(2012-3#3)(2013-1#33)(2013-7#4)(2013-8#26)
diet)##11##1##(2008-11#2)(2008-2#1)(2008-3#4)(2011-1#1)(2012-2#1)(2013-1#2)
diet-induced hypercholesterolemia##3##2##(1990-11#1)(1995-2#2)
diet-induced##7##1##(1990-11#1)(1995-2#2)(2008-1#1)(2008-4#1)(2009-12#1)(2012-2#1)
dietary Cd##5##2##(1997-4#5)
dietary Se##2##2##(1991-12#1)(2012-2#1)
dietary adherence##2##2##(2008-4#2)
dietary advice##2##2##(2008-10#1)(2008-7#1)
dietary and pharmacological##2##3##(1991-2#2)
dietary and physical activity##2##4##(2012-2#1)(2013-8#1)
dietary and##9##2##(1991-2#2)(1992-9#1)(1995-9#1)(1997-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
dietary assessment##2##2##(2010-1#1)(2012-2#1)
dietary behaviors##3##2##(1997-1#1)(2010-4#1)(2012-2#1)
dietary biomarkers##2##2##(2008-7#2)
dietary boron##3##2##(1990-3#3)
dietary carbohydrate##2##2##(2008-3#1)(2012-1#1)
dietary change##3##2##(1991-12#1)(1997-1#1)(2010-4#1)
dietary changes##6##2##(1990-6#3)(2008-1#1)(2010-8#1)(2012-2#1)
dietary components##2##2##(1990-8#1)(2008-5#1)
dietary compound##2##2##(2008-5#1)(2009-8#1)
dietary compounds##2##2##(2008-10#2)
dietary conditions##4##2##(1992-3#1)(2008-10#2)(2011-1#1)
dietary constituents##2##2##(1995-6#1)(1995-9#1)
dietary counselling##2##2##(1996-11#1)(2011-2#1)
dietary deoxynivalenol##2##2##(2008-10#2)
dietary ellagic acid##2##3##(1994-6#2)
dietary energy##2##2##(2013-1#2)
dietary factors that##2##3##(2008-10#1)(2008-2#1)
dietary factors##10##2##(1992-10#1)(1993-9#1)(1994-2#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
dietary fat absorption##2##3##(2008-12#2)
dietary fat and##3##3##(1990-7#1)(1994-2#1)(2013-1#1)
dietary fat intake##3##3##(1994-12#1)(2008-4#1)(2010-3#1)
dietary fat restriction##2##3##(2008-4#2)
dietary fat##14##2##(1990-7#1)(1991-8#1)(1994-12#1)(1994-2#2)(2008-12#2)(2008-4#4)(2010-3#1)(2010-4#1)(2013-1#1)
dietary fiber and##4##3##(2011-2#2)(2012-2#2)
dietary fiber from##3##3##(1993-11#3)
dietary fiber##12##2##(1993-11#5)(2010-1#1)(2010-8#2)(2011-2#2)(2012-2#2)
dietary glucose##2##2##(2010-2#2)
dietary gluten##4##2##(2007-5#4)
dietary groups##3##2##(1991-12#1)(1993-11#1)(2010-2#1)
dietary guidelines##4##2##(2009-5#2)(2012-2#2)
dietary habits are##2##3##(2010-6#1)(2013-7#1)
dietary habits of##2##3##(1990-8#1)(2011-2#1)
dietary habits##16##2##(1990-8#2)(1992-8#2)(1993-11#1)(1993-9#1)(2008-1#1)(2008-3#1)(2010-1#1)(2010-6#3)(2011-2#2)(2012-12#1)(2013-7#1)
dietary history##3##2##(1997-3#1)(2008-2#1)(2011-2#1)
dietary indexes##3##2##(2012-2#3)
dietary intake and##2##3##(2008-3#1)(2011-1#1)
dietary intake of##4##3##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#1)
dietary intake##15##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
dietary intakes##2##2##(2012-2#1)(2013-1#1)
dietary intervention##5##2##(1996-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)
dietary iron##2##2##(1992-8#1)(1997-7#1)
dietary isoflavones##4##2##(1993-12#4)
dietary level##3##2##(1993-12#1)(2008-11#1)(2013-7#1)
dietary lipids##4##2##(1990-8#1)(2008-10#2)(2012-2#1)
dietary lysine levels on##2##4##(2012-2#2)
dietary lysine levels##3##3##(2012-2#3)
dietary lysine##4##2##(2012-2#4)
dietary macronutrients##2##2##(1996-12#1)(2008-3#1)
dietary management##2##2##(1991-8#1)(2008-10#1)
dietary modification##2##2##(2009-5#1)(2010-1#1)
dietary nitrogen##2##2##(2008-8#2)
dietary nucleotides##4##2##(2008-11#4)
dietary oxalate##2##2##(2012-2#2)
dietary patterns in the##2##4##(1992-12#1)(2010-6#1)
dietary patterns in##3##3##(1992-12#1)(2010-6#1)(2012-2#1)
dietary patterns##7##2##(1990-8#1)(1992-12#1)(2008-1#1)(2010-6#3)(2012-2#1)
dietary phosphorus##7##2##(2008-10#7)
dietary phytase##2##2##(2010-2#2)
dietary potassium loading##2##3##(1991-5#2)
dietary protein and resistance training##2##5##(2008-5#2)
dietary protein and##5##3##(2007-12#1)(2008-3#2)(2008-5#2)
dietary protein intake and##2##4##(2008-1#1)(2008-5#1)
dietary protein intake##5##3##(2008-1#2)(2008-5#3)
dietary protein##14##2##(1994-3#2)(2007-12#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#1)
dietary protocols##2##2##(2008-3#2)
dietary recommendations##4##2##(2008-1#1)(2008-4#1)(2010-1#1)(2012-2#1)
dietary restricted##2##2##(1991-12#2)
dietary restriction##7##2##(1991-12#2)(1992-2#1)(2008-7#4)
dietary selenium##2##2##(2012-2#2)
dietary sources##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
dietary sphingomyelin##2##2##(2012-2#2)
dietary strategies##2##2##(2008-5#1)(2010-1#1)
dietary supplement##5##2##(1991-6#1)(1992-9#1)(2007-12#1)(2008-10#2)
dietary supplementation##3##2##(1991-6#1)(2011-2#1)(2013-1#1)
dietary supplements and##2##3##(2008-10#1)(2010-3#1)
dietary supplements##16##2##(2007-12#1)(2008-10#1)(2008-5#8)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
dietary survey##2##2##(1997-8#1)(2008-7#1)
dietary threonine##3##2##(1997-8#3)
dietary treatment and insulin##2##4##(1996-11#2)
dietary treatment##6##2##(1992-11#1)(1996-11#2)(2010-10#1)(2010-2#1)(2012-2#1)
dietary treatments##3##2##(2008-12#1)(2008-5#1)(2010-2#1)
dietary variables##2##2##(2011-2#2)
dietary variety##2##2##(2008-5#1)(2011-2#1)
dietary vitamin C##2##3##(1997-3#1)(2010-7#1)
dietary##393##1##(1990-3#3)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#7)(1991-11#1)(1991-12#11)(1991-2#3)(1991-5#2)(1991-6#3)(1991-8#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#4)(1993-11#8)(1993-12#8)(1993-9#6)(1994-12#1)(1994-2#5)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-11#4)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#3)(1997-4#9)(1997-6#3)(1997-7#1)(1997-8#4)(2007-12#5)(2007-5#4)(2007-7#1)(2008-1#9)(2008-10#29)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#12)(2008-4#9)(2008-5#28)(2008-6#1)(2008-7#16)(2008-8#3)(2009-11#2)(2009-4#1)(2009-5#6)(2009-6#3)(2009-8#3)(2010-1#7)(2010-10#2)(2010-2#8)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#8)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#16)(2012-1#3)(2012-12#2)(2012-2#43)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#4)
dietary-induced##2##1##(1990-3#1)(2011-2#1)
dietetic intern##2##2##(1992-2#2)
dietetic internship##4##2##(1992-2#2)(1993-3#2)
dietetic practice##3##2##(1992-2#1)(1994-2#2)
dietetic##15##1##(1992-2#6)(1993-3#2)(1993-5#1)(1994-2#3)(1995-2#1)(1995-3#2)
dietetics graduates##2##2##(1993-3#2)
dietetics##11##1##(1992-2#4)(1993-3#2)(1994-2#3)(1995-12#1)(2013-1#1)
diethanolamine##2##1##(2008-10#1)(2008-11#1)
diethanolamine-typed dendrimer##4##2##(2008-10#4)
diethyl 2##2##2##(2012-3#2)
diethyl dithiophosphate##4##2##(2008-10#4)
diethyl ether##9##2##(1990-8#1)(1997-2#1)(2008-10#5)(2008-11#2)
diethyl pyrocarbonate##3##2##(1990-12#1)(1992-6#1)(2008-4#1)
diethyl##28##1##(1990-12#1)(1990-8#2)(1992-6#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-10#10)(2008-11#3)(2008-4#1)(2008-5#2)(2010-5#1)(2012-3#4)
diethylacetal##6##1##(1990-12#6)
diethylamine##3##1##(2008-10#3)
diethylaminoethyl##5##1##(2008-1#1)(2008-10#3)(2013-1#1)
diethylaminoethyldextran##2##1##(2008-11#2)
diethyldithiocarbamate (DDTC)##3##2##(2008-10#3)
diethyldithiocarbamate##18##1##(1997-2#1)(2008-10#16)(2010-11#1)
diethylenetriamine with##2##2##(2008-10#2)
diethylenetriamine##10##1##(2008-10#10)
diethylenetriaminepentaacetic acid (DTPA)##3##3##(1990-8#1)(2008-10#1)(2008-5#1)
diethylenetriaminepentaacetic acid##4##2##(1990-8#1)(1996-12#1)(2008-10#1)(2008-5#1)
diethylnitrosamine-induced##2##1##(1990-7#2)
diethylstilbestrol (DES) and##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
diethylstilbestrol (DES)##5##2##(1990-7#1)(2008-10#2)(2008-4#1)(2008-5#1)
diethylstilbestrol##12##1##(1990-7#2)(1992-9#1)(1995-12#2)(2008-10#4)(2008-4#1)(2008-5#1)(2010-9#1)
diethylstilboestrol and vinblastine##2##3##(2011-1#2)
dieting##5##1##(1997-7#1)(2008-4#2)(2011-1#1)(2012-2#1)
dietitian and##2##2##(1993-12#1)(1994-2#1)
dietitian in##5##2##(1993-12#3)(1993-3#2)
dietitian##16##1##(1992-12#1)(1993-12#5)(1993-3#3)(1994-2#2)(1995-2#1)(1995-3#3)(2010-9#1)
dietitians are##2##2##(1994-2#1)(1995-12#1)
dietitians were##2##2##(1994-2#2)
dietitians##20##1##(1992-12#1)(1993-12#4)(1993-2#1)(1994-2#6)(1994-3#1)(1995-12#3)(1995-3#4)
dietitians/dietetic interns##3##2##(1995-2#3)
diets (P &lt##2##3##(2010-2#2)
diets and##6##2##(1994-9#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#2)
diets are##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
diets as##2##2##(1993-3#1)(2009-4#1)
diets containing##14##2##(1995-8#1)(1997-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-4#1)(2013-1#1)
diets for##6##2##(1993-11#1)(1994-5#1)(1996-12#1)(2008-10#1)(2010-2#2)
diets formulated on##2##3##(2008-12#2)
diets had##3##2##(1994-5#1)(2008-4#1)(2010-2#1)
diets in the##3##3##(2008-10#1)(2008-3#2)
diets in##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
diets is##2##2##(1991-12#1)(2008-3#1)
diets of##6##2##(1991-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)
diets on##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
diets rich in##2##3##(2011-1#1)(2013-1#1)
diets showed##2##2##(1993-11#1)(2010-2#1)
diets that##2##2##(1993-11#1)(2008-9#1)
diets was##2##2##(1994-2#1)(1995-2#1)
diets were fed##2##3##(2008-12#1)(2010-2#1)
diets were formulated##2##3##(2008-10#1)(2008-12#1)
diets were##6##2##(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)(2012-2#1)
diets##150##1##(1990-11#1)(1991-12#4)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#2)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#2)(1997-4#3)(1997-6#1)(2007-10#1)(2008-10#12)(2008-11#2)(2008-12#12)(2008-3#20)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-4#4)(2009-9#3)(2010-2#16)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#2)
dif##5##1##(1995-2#5)
difenoconazole##3##1##(2008-10#3)
diferric transferrin##4##2##(1992-6#1)(1994-3#3)
diferulic acid##2##2##(2008-10#2)
differ according to the##3##4##(1997-1#1)(2008-11#1)(2011-2#1)
differ according to##4##3##(1997-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
differ across##5##2##(1994-1#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-8#1)
differ among plant##2##3##(2008-10#2)
differ among the##2##3##(2008-5#1)(2008-9#1)
differ among##11##2##(1995-12#1)(1996-5#1)(2008-10#4)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)
differ as##3##2##(1991-3#1)(1991-6#1)(1994-8#1)
differ at##3##2##(1995-12#1)(2008-5#1)(2010-10#1)
differ based on##2##3##(2009-9#1)(2012-12#1)
differ between groups##3##3##(2009-12#1)(2010-1#1)(2012-1#1)
differ between patients##2##3##(1993-12#1)(2008-8#1)
differ between the##13##3##(1991-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
differ between##52##2##(1990-2#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-8#1)(2007-10#2)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#3)
differ by the##2##3##(1991-12#1)(2011-2#1)
differ by their##2##3##(2008-8#1)(2013-8#1)
differ by two##2##3##(1993-11#1)(2008-10#1)
differ by##17##2##(1991-12#1)(1991-2#1)(1993-11#1)(1993-3#1)(1997-2#1)(1997-9#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
differ considerably from those##2##4##(2008-4#1)(2010-3#1)
differ considerably from##5##3##(1992-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)
differ considerably in their##2##4##(2008-10#2)
differ considerably##9##2##(1992-4#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
differ for##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
differ from each other in##4##5##(1997-7#1)(2008-10#1)(2009-8#1)(2013-1#1)
differ from other##4##3##(1993-6#1)(2007-4#1)(2008-12#1)(2009-5#1)
differ from that for##3##4##(2011-2#1)(2012-1#1)(2012-2#1)
differ from that of a##2##5##(1991-3#1)(2008-3#1)
differ from that of the##2##5##(2008-10#1)(2008-3#1)
differ from that of##5##4##(1991-3#1)(2008-10#2)(2008-3#2)
differ from that##12##3##(1991-3#1)(1994-3#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-3#2)(2011-2#2)(2012-1#1)(2012-2#1)
differ from the##15##3##(1991-5#1)(1991-6#1)(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)
differ from their##4##3##(1995-6#1)(1996-5#1)(1997-4#1)(2013-1#1)
differ from those of the##3##5##(1997-6#1)(2008-7#1)(2008-8#1)
differ from those of##8##4##(1995-1#1)(1996-3#1)(1997-6#1)(2008-7#2)(2008-8#2)(2011-2#1)
differ from those##12##3##(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#1)
differ from##88##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-3#1)(1993-5#1)(1993-6#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#2)(2012-2#1)(2013-1#2)
differ fundamentally from##2##3##(1997-2#1)(2010-8#1)
differ fundamentally##3##2##(1997-2#1)(2008-5#1)(2010-8#1)
differ greatly in their##2##4##(1997-3#1)(2008-8#1)
differ greatly##3##2##(1997-3#1)(2008-8#1)(2012-3#1)
differ in a##2##3##(1995-2#1)(2008-10#1)
differ in both##3##3##(1995-5#1)(2008-11#1)(2008-4#1)
differ in host##2##3##(2008-10#1)(2008-8#1)
differ in pathogenicity##2##3##(2008-10#2)
differ in several##2##3##(1996-6#1)(2009-9#1)
differ in terms of##2##4##(2011-1#1)(2012-2#1)
differ in the##16##3##(1990-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)
differ in their abilities to##3##5##(1996-12#1)(1996-2#1)(2009-12#1)
differ in their ability to##2##5##(1990-5#1)(1995-12#1)
differ in their##38##3##(1990-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#2)(2010-8#1)(2013-1#2)(2013-8#1)
differ in two##2##3##(2008-3#1)(2009-6#1)
differ in virulence##2##3##(2008-10#2)
differ in##116##2##(1990-11#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#4)(1996-2#1)(1996-6#1)(1997-4#2)(1997-8#1)(2007-12#4)(2007-7#2)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#8)(2008-9#8)(2009-1#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-9#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#5)
differ markedly##3##2##(2008-11#2)(2008-2#1)
differ on several autosomal genes##2##5##(1996-5#2)
differ on##4##2##(1995-11#1)(1996-5#2)(2010-4#1)
differ only at##3##3##(1991-11#1)(1994-8#1)(2008-9#1)
differ only by their##2##4##(2008-3#1)(2009-5#1)
differ only in##2##3##(1994-9#1)(2008-5#1)
differ only##9##2##(1991-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(1996-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)
differ primarily##2##2##(1996-5#1)(2008-9#1)
differ significantly between##21##3##(1993-12#1)(1994-2#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#3)(2010-3#1)(2011-1#1)(2011-2#2)(2013-7#1)
differ significantly for##5##3##(1991-12#1)(2008-10#2)(2008-12#1)(2009-12#1)
differ significantly from that##3##4##(1993-11#1)(1994-2#1)(2008-10#1)
differ significantly from the##7##4##(1997-2#1)(2008-10#4)(2008-5#1)(2008-7#1)
differ significantly from those of##2##5##(2008-8#1)(2013-1#1)
differ significantly from those##6##4##(1995-11#1)(1996-3#1)(2008-7#1)(2008-8#2)(2013-1#1)
differ significantly from##23##3##(1993-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-12#1)(2012-3#1)(2013-1#1)
differ significantly in the##2##4##(2010-3#1)(2013-1#1)
differ significantly in##9##3##(1993-11#1)(1994-2#1)(2007-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
differ significantly with respect to##2##5##(2008-7#1)(2013-1#1)
differ significantly with##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
differ significantly##79##2##(1991-12#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-2#3)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-2#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
differ somewhat from##2##3##(1995-12#1)(2008-3#1)
differ substantially from##6##3##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#2)
differ substantially##8##2##(1994-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
differ widely in their##2##4##(2008-10#1)(2008-5#1)
differ widely in##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
differ widely##6##2##(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
differ with regard to##2##4##(1993-9#1)(2008-10#1)
differ with respect to their##2##5##(1995-12#1)(2007-11#1)
differ with respect to##4##4##(1995-12#1)(2007-11#1)(2007-8#1)(2008-7#1)
differ with##8##2##(1993-9#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
differ##480##1##(1990-11#2)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#7)(1996-2#4)(1996-3#4)(1996-5#5)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#76)(2008-11#9)(2008-12#7)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#13)(2008-6#3)(2008-7#20)(2008-8#23)(2008-9#17)(2009-1#1)(2009-10#4)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#5)(2009-6#3)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#7)(2011-1#4)(2011-2#17)(2012-1#4)(2012-12#8)(2012-2#5)(2012-3#5)(2012-6#1)(2013-1#13)(2013-7#1)(2013-8#10)
differed about##2##2##(2012-3#2)
differed according to the##2##4##(2008-10#2)
differed according to##3##3##(2008-10#2)(2011-2#1)
differed among plant parts##2##4##(2008-5#2)
differed among the##4##3##(1992-3#1)(2008-10#2)(2012-3#1)
differed among##13##2##(1992-3#1)(2008-10#4)(2008-5#2)(2008-8#2)(2010-8#1)(2012-12#1)(2012-3#1)(2012-6#1)
differed at##2##2##(2008-10#2)
differed between the two##3##4##(1991-11#1)(1992-12#1)(2008-11#1)
differed between the##7##3##(1991-11#1)(1992-12#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#1)
differed between##17##2##(1991-11#1)(1992-12#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-8#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
differed by a factor of##2##5##(1996-5#1)(2008-10#1)
differed by##12##2##(1990-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-12#1)
differed clearly from##2##3##(2008-10#1)(2008-7#1)
differed clearly##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
differed considerably among##2##3##(2008-10#2)
differed considerably from##2##3##(1995-12#1)(2008-7#1)
differed considerably##7##2##(1991-12#1)(1995-12#1)(2008-10#2)(2008-7#2)(2013-1#1)
differed for##2##2##(2008-10#1)(2009-11#1)
differed from each other##2##4##(1990-12#1)(2008-8#1)
differed from that of##3##4##(1997-3#1)(1997-4#1)(2008-11#1)
differed from that##7##3##(1992-8#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
differed from the##13##3##(1992-12#1)(1993-8#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-4#1)(2012-3#1)
differed from those of##4##4##(1993-11#1)(2008-10#3)
differed from those##6##3##(1991-2#1)(1993-11#1)(2008-10#3)(2008-7#1)
differed from##41##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#3)(2008-8#3)(2009-4#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#2)
differed greatly##3##2##(1994-6#1)(2011-2#1)(2012-3#1)
differed in quantity between##2##4##(2008-8#2)
differed in the number of##2##5##(2008-10#1)(2010-1#1)
differed in the two##3##4##(1996-7#1)(2008-10#1)(2010-2#1)
differed in the##10##3##(1996-7#1)(2008-10#5)(2008-9#1)(2010-1#1)(2010-2#1)(2010-4#1)
differed in their ability to##5##5##(2008-10#5)
differed in their##18##3##(2008-10#9)(2008-11#3)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)
differed in##53##2##(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)(1996-7#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#6)(2008-9#3)(2009-10#1)(2010-1#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
differed markedly in##2##3##(1993-6#1)(2009-12#1)
differed markedly##4##2##(1993-6#1)(1994-8#1)(2009-12#1)(2012-3#1)
differed more##2##2##(1997-6#1)(2012-1#1)
differed significantly (P##4##3##(1990-11#1)(2008-10#2)(2013-1#1)
differed significantly (p &lt##2##4##(2009-9#1)(2012-2#1)
differed significantly between the three##2##5##(1996-12#1)(2011-1#1)
differed significantly between the##7##4##(1996-12#1)(1997-7#2)(2007-10#1)(2008-8#1)(2009-10#1)(2011-1#1)
differed significantly between##10##3##(1996-12#1)(1997-7#2)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-7#1)
differed significantly depending on##2##4##(2008-10#1)(2008-2#1)
differed significantly for##3##3##(2008-10#3)
differed significantly from that##2##4##(1994-5#1)(1996-7#1)
differed significantly from those##2##4##(2009-8#1)(2013-8#1)
differed significantly from##7##3##(1994-5#1)(1996-7#1)(2008-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2013-8#1)
differed significantly in the##2##4##(1995-11#1)(2009-9#1)
differed significantly in##4##3##(1995-11#1)(2008-10#2)(2009-9#1)
differed significantly##41##2##(1990-11#1)(1991-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-7#2)(2007-10#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
differed slightly in##2##3##(2008-10#1)(2008-5#1)
differed slightly##3##2##(2008-10#2)(2008-5#1)
differed somewhat##2##2##(1990-12#1)(2011-2#1)
differed substantially##2##2##(1994-1#1)(2008-7#1)
differed widely in##2##3##(2008-9#1)(2013-8#1)
differed with respect to##2##4##(1994-2#1)(2008-12#1)
differed with##4##2##(1994-2#1)(1995-5#1)(2008-10#1)(2008-12#1)
differed##246##1##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-2#3)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-7#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#67)(2008-11#12)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#14)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-2#5)(2010-4#2)(2010-5#4)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#8)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#3)
difference (OPD)##3##2##(2008-3#3)
difference (P &lt##5##3##(2011-1#1)(2011-2#1)(2013-1#3)
difference (P##8##2##(2008-10#1)(2011-1#2)(2011-2#1)(2013-1#4)
difference (p &gt##2##3##(2011-1#1)(2012-2#1)
difference (p &lt##4##3##(2008-5#2)(2012-2#1)(2013-1#1)
difference (p##8##2##(2007-2#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
difference (p&lt##2##2##(2008-12#1)(2012-12#1)
difference -0##2##2##(2013-1#2)
difference Fourier##3##2##(1991-3#1)(2008-8#1)(2008-9#1)
difference among the##7##3##(1991-9#1)(1994-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-12#1)
difference among##11##2##(1991-1#1)(1991-9#1)(1994-3#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2011-2#1)(2013-1#1)
difference and the##6##3##(1990-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
difference and##11##2##(1990-6#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)
difference as##3##2##(1992-12#1)(2008-11#1)(2008-3#1)
difference at the 95%##4##4##(2008-10#4)
difference at##10##2##(2008-10#9)(2008-9#1)
difference being##5##2##(1991-11#1)(1994-2#1)(1996-6#1)(2008-10#1)(2008-3#1)
difference between a##3##3##(1997-6#1)(2008-3#2)
difference between control##3##3##(1995-8#1)(1996-5#1)(2008-12#1)
difference between groups##5##3##(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#2)
difference between levels##2##3##(1991-11#1)(1994-3#1)
difference between light##2##3##(2007-12#1)(2008-10#1)
difference between men and women##2##5##(1991-11#1)(2009-10#1)
difference between normal##2##3##(1990-12#1)(2012-2#1)
difference between plasma##2##3##(1992-12#1)(1994-7#1)
difference between the control and##2##5##(1990-3#1)(2011-3#1)
difference between the groups in the##2##6##(1990-5#1)(2008-7#1)
difference between the groups##6##4##(1990-5#1)(1991-2#1)(2008-3#1)(2008-7#2)(2012-3#1)
difference between the latter two##2##5##(1996-7#1)(2009-7#1)
difference between the mean##2##4##(1991-4#1)(1993-9#1)
difference between the measured##3##4##(2008-2#1)(2008-3#1)(2012-1#1)
difference between the mutant and##2##5##(2008-10#2)
difference between the performance of##2##5##(1993-8#1)(2008-9#1)
difference between the reference and the##2##6##(2008-3#2)
difference between the results##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
difference between the two groups##8##5##(1990-6#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
difference between the two laser##2##5##(2007-11#2)
difference between the two##36##4##(1990-6#1)(1990-7#2)(1991-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
difference between the##162##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-8#3)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#17)(2008-4#2)(2008-5#5)(2008-7#8)(2008-8#5)(2008-9#8)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
difference between these two groups##2##5##(1992-11#1)(2008-8#1)
difference between these##3##3##(1992-11#1)(2008-8#1)(2011-2#1)
difference between those##2##3##(2007-10#1)(2008-10#1)
difference between transgenic##2##3##(2008-10#1)(2008-12#1)
difference between treatments##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2013-7#1)
difference between two groups##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
difference between two treatments##2##4##(1995-9#2)
difference between two##13##3##(1994-9#2)(1995-9#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2011-2#1)(2013-1#1)
difference between##322##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#2)(1991-11#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#3)(1997-9#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#53)(2008-11#6)(2008-12#10)(2008-2#16)(2008-3#28)(2008-4#2)(2008-5#6)(2008-7#10)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#7)(2011-2#16)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#4)
difference can be##4##3##(1992-11#1)(2008-3#2)(2011-2#1)
difference can##6##2##(1992-11#1)(2008-3#2)(2010-2#1)(2011-2#1)(2012-3#1)
difference could be detected##2##4##(1996-5#1)(2008-8#1)
difference could be found between##2##5##(1995-8#1)(2008-10#1)
difference could be found##3##4##(1993-2#1)(1995-8#1)(2008-10#1)
difference could be##5##3##(1993-2#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-8#1)
difference did not##3##3##(2008-1#1)(2008-7#1)(2009-4#1)
difference did##4##2##(1995-2#1)(2008-1#1)(2008-7#1)(2009-4#1)
difference disappeared##4##2##(2008-3#2)(2012-2#1)(2013-1#1)
difference emerged in##2##3##(1990-8#2)
difference equations##4##2##(2008-3#2)(2008-8#1)(2009-8#1)
difference existed##3##2##(1993-12#1)(1993-2#1)(2008-1#1)
difference exists between##2##3##(1995-11#1)(2009-9#1)
difference exists##3##2##(1993-1#1)(1995-11#1)(2009-9#1)
difference for the##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
difference for##18##2##(1992-10#1)(2008-10#4)(2008-12#2)(2008-7#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
difference found##2##2##(2008-10#1)(2011-1#1)
difference frequency generation in a##2##5##(2007-11#1)(2008-2#1)
difference frequency generation in##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
difference frequency generation##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
difference frequency##10##2##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#1)
difference from the##2##3##(1990-3#1)(2008-8#1)
difference from##6##2##(1990-3#1)(1992-3#1)(2008-10#1)(2008-8#1)(2010-3#1)(2013-8#1)
difference function##2##2##(2008-2#1)(2013-8#1)
difference gel electrophoresis##3##3##(2008-4#2)(2008-7#1)
difference has##2##2##(1990-6#1)(2008-5#1)
difference in H##2##3##(2008-10#1)(2008-12#1)
difference in HR##3##3##(2013-8#3)
difference in a##3##3##(1995-6#1)(2007-11#1)(2012-3#1)
difference in activity##3##3##(1991-12#1)(1997-6#1)(2008-8#1)
difference in age##2##3##(2008-1#1)(2009-12#1)
difference in average##3##3##(2008-9#1)(2010-10#1)(2012-3#1)
difference in binding##2##3##(1990-11#1)(2009-7#1)
difference in body weight##2##4##(2008-5#1)(2010-4#1)
difference in both##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2013-7#1)
difference in clinical##4##3##(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
difference in complication rates##2##4##(1996-2#1)(2012-2#1)
difference in concentrations##2##3##(1990-8#1)(1992-12#1)
difference in density between##2##4##(1993-9#1)(2008-10#1)
difference in drug##2##3##(1994-2#1)(1997-4#1)
difference in effect##2##3##(2008-11#1)(2010-4#1)
difference in how##2##3##(1992-1#1)(1997-3#1)
difference in length of##2##4##(1997-4#2)
difference in log K(ex) for two cations (one of each type) with the same number of carbon atoms was about##2##20##(2008-10#2)
difference in log K(ex)##3##4##(2008-10#3)
difference in mean##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
difference in morphology##2##3##(2012-2#1)(2013-1#1)
difference in outcome##3##3##(1995-11#1)(2010-3#1)(2012-3#1)
difference in packing##2##3##(1990-12#1)(1994-5#1)
difference in patients with##3##4##(1995-6#1)(2008-7#1)(2010-10#1)
difference in plasma##2##3##(1990-8#1)(1993-2#1)
difference in prevalence of##2##4##(1990-2#1)(2011-2#1)
difference in production of##2##4##(2008-10#1)(2008-12#1)
difference in proportions##2##3##(1992-9#1)(2013-1#1)
difference in reproductive success##2##4##(2009-12#2)
difference in resistance to##2##4##(2008-10#1)(2011-2#1)
difference in response##3##3##(1994-7#1)(1995-4#1)(2013-8#1)
difference in selectivity##2##3##(1995-3#1)(2008-10#1)
difference in sensitivity to##2##4##(2008-7#1)(2012-6#1)
difference in sensitivity was##2##4##(1997-8#1)(2008-10#1)
difference in sensitivity##4##3##(1997-8#1)(2008-10#1)(2008-7#1)(2012-6#1)
difference in smoking prevalence##2##4##(1994-6#1)(2011-2#1)
difference in survival##6##3##(1990-6#1)(1990-8#1)(1991-8#1)(1992-12#1)(2008-6#1)(2010-3#1)
difference in terms of##2##4##(2008-11#1)(2011-2#1)
difference in the amount of##3##5##(2007-2#1)(2009-11#1)(2009-2#1)
difference in the clinical##2##4##(1997-3#1)(2013-1#1)
difference in the degree of##2##5##(1990-6#1)(1995-2#1)
difference in the density##2##4##(1990-7#1)(2008-5#1)
difference in the frequency of##2##5##(2011-2#1)(2013-1#1)
difference in the growth##2##4##(1994-12#1)(2008-11#1)
difference in the incidence of##2##5##(2011-2#1)(2013-1#1)
difference in the level of##2##5##(1997-4#1)(2008-8#1)
difference in the nucleotide##2##4##(2013-8#2)
difference in the number of##3##5##(1997-6#1)(2008-11#1)(2011-2#1)
difference in the pattern of##2##5##(2008-10#1)(2008-11#1)
difference in the pattern##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
difference in the prevalence of##3##5##(1996-12#1)(2008-1#1)(2008-7#1)
difference in the rate of##5##5##(1990-11#1)(2008-10#3)(2013-1#1)
difference in the rates##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
difference in the relative##3##4##(1991-2#1)(1992-9#1)(2008-6#1)
difference in the size of##2##5##(2008-9#1)(2012-3#1)
difference in the two##2##4##(2008-11#1)(2008-7#1)
difference in the##137##3##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#21)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#5)
difference in their##6##3##(1993-12#1)(1996-6#1)(1997-6#1)(2008-5#1)(2009-7#1)(2012-3#1)
difference in this##2##3##(1994-3#1)(1995-5#1)
difference in today's##2##3##(1990-11#1)(2008-1#1)
difference in total##2##3##(2008-2#1)(2008-5#1)
difference in##440##2##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#4)(1990-7#1)(1990-8#5)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#6)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#3)(1995-9#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#6)(1997-6#3)(1997-7#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#2)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#58)(2008-11#21)(2008-12#9)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#12)(2008-6#10)(2008-7#13)(2008-8#10)(2008-9#11)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#26)(2012-12#2)(2012-2#7)(2012-3#12)(2012-6#1)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#13)
difference is the presence of##2##5##(2008-5#1)(2012-3#1)
difference is the##3##3##(2008-5#1)(2010-12#1)(2012-3#1)
difference is##24##2##(1991-11#1)(1991-8#1)(1993-5#1)(1993-8#1)(1995-5#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
difference may be##2##3##(1993-12#1)(2008-9#1)
difference may##6##2##(1993-12#1)(1994-12#2)(2008-11#1)(2008-2#1)(2008-9#1)
difference measurements##4##2##(2008-3#4)
difference observed between##2##3##(2008-12#1)(2008-8#1)
difference observed was##2##3##(1996-12#1)(2013-1#1)
difference observed##6##2##(1996-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
difference of 1##2##3##(2007-10#1)(2008-11#1)
difference of the chemical##2##4##(2008-10#2)
difference of the##16##3##(2007-11#1)(2007-12#2)(2008-10#6)(2008-3#3)(2008-7#2)(2008-9#1)(2012-3#1)
difference of two##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
difference of##70##2##(1990-12#1)(1990-7#1)(1990-8#1)(1995-5#1)(1996-12#3)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-7#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#12)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
difference on##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
difference or ratio##2##3##(1995-5#2)
difference or##5##2##(1995-5#3)(2008-1#1)(2008-6#1)
difference regarding the##2##3##(1995-12#1)(1997-3#1)
difference regarding##3##2##(1995-12#1)(1997-3#1)(2010-1#1)
difference spectra of##2##3##(1992-6#1)(1994-5#1)
difference spectra##4##2##(1990-8#1)(1992-6#1)(1994-5#1)(2008-10#1)
difference spectroscopy##5##2##(1991-3#1)(1992-11#1)(1992-3#1)(2011-1#2)
difference spectrum##5##2##(1993-11#1)(1993-8#1)(1994-5#1)(2007-12#1)(2008-3#1)
difference that##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
difference to a##2##3##(2008-2#1)(2011-1#1)
difference to the##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
difference to##10##2##(1995-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2011-1#2)(2013-8#1)
difference under##2##2##(2008-10#1)(2009-10#1)
difference was detected between##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
difference was detected##4##3##(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)
difference was found between the two##2##6##(1994-11#1)(2010-12#1)
difference was found between the##9##5##(1992-2#1)(1993-2#1)(1994-11#1)(1994-5#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-2#2)
difference was found between##17##4##(1990-3#1)(1990-8#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-5#1)(2008-10#3)(2008-12#2)(2010-12#1)(2010-8#1)(2011-2#4)
difference was found in the##6##5##(1994-7#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
difference was found in##7##4##(1994-7#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
difference was found when##2##4##(1994-3#1)(2008-10#1)
difference was found##35##3##(1990-3#1)(1990-8#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1996-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#2)
difference was more pronounced in##2##5##(1993-2#1)(1995-5#1)
difference was more##3##3##(1993-2#1)(1995-5#1)(2007-2#1)
difference was not significant##6##4##(1992-11#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#1)
difference was not statistically significant##5##5##(1991-6#1)(1996-12#1)(2008-5#1)(2009-3#2)
difference was not##14##3##(1991-6#1)(1992-11#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
difference was noted##2##3##(1996-12#1)(2008-7#1)
difference was observed between the##2##5##(1996-12#1)(2008-12#1)
difference was observed between##6##4##(1992-12#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
difference was observed in the##5##5##(1990-5#1)(1992-3#1)(2008-3#1)(2009-11#1)(2011-2#1)
difference was observed in##8##4##(1990-12#1)(1990-5#1)(1992-3#1)(1996-9#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
difference was observed##20##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
difference was seen between##2##4##(2008-5#2)
difference was seen##4##3##(1991-2#1)(1991-6#1)(2008-5#2)
difference was significant##3##3##(2008-8#1)(2008-9#2)
difference was statistically significant (P##2##5##(1990-3#1)(1996-12#1)
difference was statistically significant (p##2##5##(2011-2#1)(2013-1#1)
difference was statistically significant##12##4##(1990-3#1)(1996-12#1)(2009-3#2)(2009-6#1)(2011-2#4)(2013-1#3)
difference was##111##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#4)(2009-6#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
difference were##2##2##(2007-12#1)(2008-12#1)
difference when##2##2##(2008-11#1)(2008-9#1)
difference with##3##2##(1993-3#1)(2008-12#1)(2009-12#1)
difference within##3##2##(1990-12#1)(2008-10#1)(2013-8#1)
difference##1362##1##(1990-10#2)(1990-11#6)(1990-12#9)(1990-2#4)(1990-3#5)(1990-5#3)(1990-6#7)(1990-7#7)(1990-8#13)(1991-1#1)(1991-11#5)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#4)(1991-8#10)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#5)(1993-12#7)(1993-2#8)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#6)(1993-9#5)(1994-1#2)(1994-11#3)(1994-12#7)(1994-2#8)(1994-3#11)(1994-5#8)(1994-6#4)(1994-7#3)(1994-8#1)(1994-9#6)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#12)(1995-6#6)(1995-8#3)(1995-9#4)(1996-1#1)(1996-12#14)(1996-2#5)(1996-3#2)(1996-5#5)(1996-6#5)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#8)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#5)(1997-9#1)(2006-6#1)(2006-8#1)(2007-10#8)(2007-11#19)(2007-12#34)(2007-2#5)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#12)(2008-10#188)(2008-11#48)(2008-12#35)(2008-2#46)(2008-3#102)(2008-4#12)(2008-5#30)(2008-6#15)(2008-7#38)(2008-8#39)(2008-9#38)(2009-10#4)(2009-11#3)(2009-12#7)(2009-2#2)(2009-3#6)(2009-4#6)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#9)(2010-5#1)(2010-6#2)(2010-7#7)(2010-8#8)(2010-9#2)(2011-1#27)(2011-2#66)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#26)(2012-3#25)(2012-6#1)(2012-7#1)(2013-1#47)(2013-7#5)(2013-8#33)
difference)##7##1##(1991-4#1)(1995-2#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-2#1)
difference-frequency generation in##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
difference-frequency generation##9##2##(2007-12#2)(2008-2#4)(2008-3#3)
difference-frequency laser##2##2##(2008-3#2)
difference-frequency mixing in##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
difference-frequency mixing of##2##3##(2007-12#1)(2008-3#1)
difference-frequency mixing##9##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#1)
difference-frequency radiation##2##2##(2007-11#1)(2007-12#1)
difference-frequency##27##1##(2007-11#2)(2007-12#9)(2008-2#10)(2008-3#6)
difference?##5##1##(1991-12#1)(1991-2#1)(1997-3#1)(2008-2#1)(2013-1#1)
differences (P &lt##4##3##(2008-10#2)(2008-5#2)
differences (P##5##2##(1995-12#1)(2008-10#2)(2008-5#2)
differences (corresponding to the##2##4##(2008-6#2)
differences (p &lt##3##3##(2008-5#1)(2011-2#2)
differences (p##4##2##(2008-5#2)(2011-2#2)
differences (p&lt##3##2##(2008-12#1)(2010-4#1)(2013-7#1)
differences account for some of the##2##6##(2007-3#1)(2012-12#1)
differences across##7##2##(1994-12#1)(1995-3#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
differences among any of the##2##5##(1993-3#1)(2011-2#1)
differences among different##2##3##(2008-10#1)(2008-5#1)
differences among groups##3##3##(2008-5#1)(2009-1#1)(2011-2#1)
differences among individuals within##2##4##(2008-10#1)(2012-7#1)
differences among isolates##4##3##(2008-10#4)
differences among populations##3##3##(2008-10#2)(2009-5#1)
differences among the four##2##4##(1994-2#1)(2008-10#1)
differences among the three groups##3##5##(1993-1#1)(2008-9#1)(2013-8#1)
differences among the various##2##4##(1993-11#1)(2011-2#1)
differences among the##18##3##(1990-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
differences among##70##2##(1990-3#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-8#1)
differences and also##2##3##(1992-11#1)(2012-2#1)
differences and similarities##4##3##(2008-7#2)(2009-12#1)(2009-7#1)
differences and##34##2##(1991-2#1)(1992-11#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2012-2#3)(2013-1#1)
differences are due to##3##4##(1994-12#1)(2008-3#1)(2012-2#1)
differences are established##2##3##(1991-6#1)(2010-9#1)
differences are observed between the##2##5##(1992-4#1)(2008-10#1)
differences are observed##3##3##(1992-4#1)(2008-10#1)(2008-3#1)
differences are##41##2##(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#2)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
differences as##4##2##(1996-5#1)(2007-10#1)(2010-12#1)(2011-1#1)
differences associated with##4##3##(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
differences at the##2##3##(2008-10#1)(2008-5#1)
differences at##9##2##(1993-12#1)(1993-6#1)(1994-6#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
differences between boys##2##3##(2009-5#1)(2010-3#1)
differences between children and adults##2##5##(1992-4#1)(2007-12#1)
differences between children and##3##4##(1992-4#1)(2007-11#1)(2007-12#1)
differences between different##2##3##(2007-11#1)(2008-10#1)
differences between groups were found in##2##6##(2008-12#1)(2011-2#1)
differences between groups were##4##4##(1991-3#1)(1994-3#1)(2008-12#1)(2011-2#1)
differences between groups##13##3##(1991-3#1)(1994-3#1)(1994-5#1)(2008-12#1)(2009-3#1)(2009-7#1)(2011-2#2)(2013-1#4)(2013-8#1)
differences between healthy##2##3##(2008-10#1)(2009-8#1)
differences between high##2##3##(2008-4#1)(2013-1#1)
differences between isolates##2##3##(2008-10#1)(2010-10#1)
differences between measured##2##3##(2008-3#1)(2008-7#1)
differences between men and women##3##5##(1991-6#1)(1993-2#2)
differences between normal##2##3##(2008-7#1)(2013-1#1)
differences between our##3##3##(2008-7#1)(2011-1#2)
differences between paediatric and adult sleep medicine##2##7##(2008-9#2)
differences between patients and##4##4##(1995-2#1)(1997-5#1)(2012-1#1)(2013-1#1)
differences between patients##5##3##(1995-2#1)(1996-1#1)(1997-5#1)(2012-1#1)(2013-1#1)
differences between plants##2##3##(1997-4#1)(2008-10#1)
differences between populations##2##3##(2008-9#1)(2011-2#1)
differences between practising and non-practising##2##5##(1993-1#2)
differences between species##2##3##(2008-10#1)(2008-4#1)
differences between the clinical##3##4##(1994-6#1)(1995-5#1)(2008-1#1)
differences between the effects of##3##5##(1993-6#1)(1995-5#1)(2007-11#1)
differences between the groups##4##4##(1995-1#1)(2008-5#1)(2008-6#1)(2009-12#1)
differences between the methods##2##4##(2008-10#2)
differences between the semi-deep and deep tillage##2##7##(2008-12#2)
differences between the sexes##5##4##(1997-6#1)(2008-10#1)(2008-9#3)
differences between the t(2g) and e(g) orbitals##2##7##(1997-7#2)
differences between the three##3##4##(1990-6#1)(2008-6#1)(2013-7#1)
differences between the two groups in the##2##7##(1995-4#1)(2007-11#1)
differences between the two groups were observed##2##7##(1992-12#1)(2013-1#1)
differences between the two groups##11##5##(1992-12#1)(1995-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
differences between the two species##2##5##(1994-11#1)(2008-8#1)
differences between the two##35##4##(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-4#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
differences between the##136##3##(1990-11#1)(1990-6#1)(1991-3#1)(1991-6#2)(1991-9#2)(1992-12#2)(1992-6#2)(1993-11#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#26)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-1#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
differences between their##2##3##(2009-7#1)(2010-10#1)
differences between them##4##3##(1995-1#1)(2008-10#1)(2008-5#1)(2009-11#1)
differences between these two##4##4##(2008-10#2)(2008-5#1)(2012-12#1)
differences between these##13##3##(1991-2#1)(1993-1#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
differences between those who##2##4##(1992-2#1)(1993-3#1)
differences between those##4##3##(1992-2#1)(1993-3#1)(1994-2#1)(2012-12#1)
differences between treatment groups in##2##5##(2008-7#1)(2012-2#1)
differences between treatments##2##3##(2008-10#1)(2008-12#1)
differences between two##3##3##(2007-11#1)(2008-2#1)(2009-5#1)
differences between van't Hoff and calorimetric enthalpy estimates##2##8##(1997-2#2)
differences between##395##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#4)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#3)(1995-8#1)(1996-1#2)(1996-12#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#1)(2007-10#3)(2007-11#8)(2007-12#7)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#58)(2008-11#10)(2008-12#12)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#11)(2008-6#5)(2008-7#19)(2008-8#11)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#20)(2013-7#6)(2013-8#4)
differences both##2##2##(1993-8#1)(2007-12#1)
differences by race##3##3##(1995-2#2)(2009-5#1)
differences by sex##3##3##(1991-6#2)(2011-2#1)
differences by##11##2##(1991-6#2)(1993-11#1)(1994-2#2)(1995-2#2)(2008-12#1)(2009-5#1)(2009-7#1)(2011-2#1)
differences can be##5##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-1#1)
differences can##8##2##(1991-12#1)(1991-6#1)(2007-11#2)(2008-10#1)(2008-8#1)(2010-8#1)(2012-1#1)
differences compared to##2##3##(2008-5#1)(2012-2#1)
differences compared with##2##3##(2008-3#1)(2008-6#1)
differences compared##4##2##(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
differences correlate with##2##3##(1997-2#1)(2013-8#1)
differences could be observed##2##4##(1993-1#1)(2008-10#1)
differences could be##7##3##(1993-1#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#2)(2013-7#1)
differences could##10##2##(1992-8#1)(1993-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#2)(2013-7#1)
differences did not##2##3##(1993-8#1)(2008-5#1)
differences do##2##2##(1992-2#1)(2010-10#1)
differences due to##2##3##(2008-12#1)(2010-4#1)
differences emerged for##2##3##(2008-12#1)(2009-11#1)
differences emerged##4##2##(2008-12#1)(2008-9#2)(2009-11#1)
differences exist between the##2##4##(1996-2#1)(2008-5#1)
differences exist between##6##3##(1992-8#1)(1996-2#1)(2008-5#1)(2012-3#2)(2013-8#1)
differences exist in the##3##4##(1994-5#1)(2007-12#1)(2008-11#1)
differences exist in##4##3##(1994-5#1)(1996-12#1)(2007-12#1)(2008-11#1)
differences exist##12##2##(1992-8#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#2)(2013-8#1)
differences existed##3##2##(1992-5#1)(2009-7#1)(2012-3#1)
differences for the##4##3##(1996-2#1)(1996-5#1)(2011-2#1)(2013-1#1)
differences for##14##2##(1994-8#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
differences found among##3##3##(2008-12#2)(2013-1#1)
differences found between the##2##4##(2007-6#1)(2008-3#1)
differences found between##3##3##(2007-6#1)(2008-3#1)(2008-9#1)
differences found in##2##3##(2008-10#1)(2013-1#1)
differences found##11##2##(1996-9#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#2)
differences from the##4##3##(1991-9#1)(1997-3#1)(2007-11#1)(2008-10#1)
differences from##13##2##(1991-8#1)(1991-9#1)(1992-12#1)(1995-5#1)(1997-2#2)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
differences have been demonstrated##2##4##(1997-4#1)(2008-5#1)
differences have been##6##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)
differences have##8##2##(1997-4#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#2)
differences in CVD##2##3##(2010-12#1)(2011-1#1)
differences in DNA##4##3##(1995-5#1)(2008-10#2)(2008-11#1)
differences in RGR##2##3##(2008-8#2)
differences in a##4##3##(1994-5#1)(1996-3#1)(2008-10#1)(2013-1#1)
differences in activity were##3##4##(1995-8#1)(2008-8#1)(2013-1#1)
differences in age##3##3##(1995-3#1)(2012-5#1)(2013-1#1)
differences in aggressiveness on##2##4##(2008-10#2)
differences in aggressiveness##5##3##(2008-10#5)
differences in allele frequencies##4##4##(2008-10#2)(2008-8#1)(2009-5#1)
differences in allele##5##3##(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)
differences in allelic##2##3##(2008-10#1)(2012-3#1)
differences in amino##2##3##(2008-5#1)(2012-8#1)
differences in average##2##3##(2008-10#1)(2008-5#1)
differences in basal##2##3##(2008-11#2)
differences in bleeding##2##3##(2009-3#2)
differences in blood pressure##3##4##(1990-3#1)(1993-1#1)(2011-2#1)
differences in both##5##3##(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
differences in cardiovascular##3##3##(2008-7#1)(2010-6#1)(2011-1#1)
differences in charge##2##3##(2008-10#1)(2010-5#1)
differences in community##2##3##(2008-8#1)(2008-9#1)
differences in complex##2##3##(2008-10#1)(2008-11#1)
differences in composition of##2##4##(2008-10#1)(2012-8#1)
differences in composition##3##3##(2008-10#2)(2012-8#1)
differences in depressive symptoms##3##4##(2009-7#2)(2010-4#1)
differences in detection##2##3##(1990-12#1)(2012-3#1)
differences in development in##2##4##(2008-9#2)
differences in diagnostic##3##3##(1991-8#1)(2007-4#1)(2012-2#1)
differences in disease severity##3##4##(2008-10#3)
differences in disease##5##3##(1997-5#1)(2008-10#4)
differences in disease-induced root##2##4##(2008-10#2)
differences in distribution of##2##4##(1993-2#1)(2012-12#1)
differences in distribution##3##3##(1993-2#1)(2010-6#1)(2012-12#1)
differences in diversity##2##3##(2008-10#1)(2008-8#1)
differences in drug##2##3##(1994-2#1)(2008-9#1)
differences in eccrine sweat and skin surface pH##2##8##(2008-5#2)
differences in energy##2##3##(2010-8#1)(2013-1#1)
differences in expression##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
differences in facial morphology##2##4##(2010-8#2)
differences in facial##4##3##(2008-5#1)(2010-8#3)
differences in fat##2##3##(2008-5#1)(2009-4#1)
differences in flower##2##3##(2009-12#1)(2009-8#1)
differences in food##2##3##(2008-5#1)(2010-6#1)
differences in frequencies##2##3##(2008-10#1)(2008-8#1)
differences in frequency##2##3##(1997-5#1)(2008-10#1)
differences in functional##2##3##(2008-10#1)(2010-12#1)
differences in gender##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
differences in gene expression##3##4##(1993-6#1)(2008-7#1)(2013-1#1)
differences in genetic##2##3##(2008-12#1)(2011-2#1)
differences in growth were observed##2##5##(2008-5#1)(2010-8#1)
differences in growth##5##3##(1997-3#1)(2008-10#1)(2008-5#1)(2010-8#2)
differences in hand##2##3##(2007-12#1)(2011-2#1)
differences in health care##2##4##(1993-2#1)(1996-2#1)
differences in health##10##3##(1993-2#1)(1996-2#1)(2008-7#3)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
differences in host##2##3##(2008-10#1)(2011-2#1)
differences in how##3##3##(1994-3#1)(2008-8#1)(2012-2#1)
differences in immune function##2##4##(2008-9#2)
differences in immune##5##3##(2008-8#1)(2008-9#4)
differences in immunotoxic##2##3##(2008-10#2)
differences in incidence##2##3##(1995-5#1)(2011-2#1)
differences in infection##2##3##(2008-10#2)
differences in isolates##3##3##(2008-10#3)
differences in leaf##2##3##(2008-10#1)(2008-5#1)
differences in life histories##2##4##(2008-10#1)(2008-8#1)
differences in liver##5##3##(1995-11#1)(1995-12#3)(2013-1#1)
differences in major depressive disorder##2##5##(2008-4#2)
differences in major##4##3##(1992-4#1)(2008-4#3)
differences in management##2##3##(2008-3#1)(2011-2#1)
differences in mean##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
differences in measurement##2##3##(2008-11#1)(2010-8#1)
differences in morphology##2##3##(2007-11#1)(2008-10#1)
differences in mortality rates##2##4##(1993-12#1)(2008-9#1)
differences in mortality##3##3##(1993-12#1)(2008-9#1)(2013-8#1)
differences in nitrogen content##2##4##(2008-8#2)
differences in numbers of##2##4##(1996-5#1)(2007-8#1)
differences in outcome##3##3##(1990-2#1)(1997-3#1)(2007-7#1)
differences in parasitism##2##3##(2008-9#2)
differences in pathogenicity##4##3##(2008-10#4)
differences in patient##3##3##(1995-12#1)(2007-8#1)(2008-7#1)
differences in physical##2##3##(1992-5#1)(2010-11#1)
differences in plasma##2##3##(1991-8#1)(2008-7#1)
differences in platelet##2##3##(1991-12#1)(2010-3#1)
differences in potential##2##3##(1994-12#1)(2008-10#1)
differences in preferences##2##3##(1993-12#1)(2007-12#1)
differences in prevalence##6##3##(1990-3#1)(1996-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
differences in protein##2##3##(1995-5#1)(2008-7#1)
differences in relative##2##3##(2008-10#1)(2008-11#1)
differences in reported##2##3##(1994-1#1)(2008-4#1)
differences in response to##2##4##(1994-5#1)(2011-2#1)
differences in responses##3##3##(2007-12#2)(2008-10#1)
differences in root##2##3##(2007-8#1)(2008-10#1)
differences in sampling##2##3##(2008-10#1)(2013-8#1)
differences in sensitivity##4##3##(2008-10#3)(2011-2#1)
differences in serum##3##3##(1993-9#1)(1997-7#1)(2013-8#1)
differences in service##2##3##(1993-3#1)(1995-3#1)
differences in severity of##3##4##(1993-12#1)(2008-10#1)(2008-12#1)
differences in severity##4##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-12#1)
differences in size##3##3##(1996-12#1)(2008-4#1)(2008-8#1)
differences in skin structure and##2##5##(2008-5#2)
differences in skin##4##3##(2008-5#4)
differences in smoking abstinence##2##4##(2010-11#2)
differences in social##2##3##(1994-3#1)(2008-11#1)
differences in spatial ability##2##4##(2008-11#2)
differences in spore##2##3##(2008-10#2)
differences in stress##3##3##(2009-7#1)(2012-1#1)(2013-1#1)
differences in stroke##3##3##(2007-10#2)(2008-8#1)
differences in survival rates##2##4##(1990-8#1)(2008-9#1)
differences in survival##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
differences in susceptibility of##2##4##(1996-12#1)(2008-10#1)
differences in susceptibility to##3##4##(2007-12#2)(2008-10#1)
differences in susceptibility##6##3##(1996-12#1)(2007-12#2)(2008-10#2)(2011-3#1)
differences in temperature##2##3##(2009-9#1)(2010-8#1)
differences in terms of##7##4##(2008-10#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
differences in the absorption spectra##2##5##(2008-10#1)(2008-8#1)
differences in the age##2##4##(1991-12#1)(1996-1#1)
differences in the behavior of##2##5##(2008-11#1)(2012-2#1)
differences in the capacity of##2##5##(1993-5#1)(1995-3#1)
differences in the chemical##2##4##(1991-5#1)(1997-2#1)
differences in the degree of##2##5##(1995-5#1)(2008-5#1)
differences in the distribution of##5##5##(1993-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
differences in the effects of##2##5##(1997-2#1)(1997-7#1)
differences in the expression of##5##5##(1996-12#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-1#1)
differences in the extent of##3##5##(2008-10#2)(2008-5#1)
differences in the fibre type composition between the left and right muscle##2##12##(2011-2#2)
differences in the frequencies of mtDNA haplotypes##2##7##(2008-10#2)
differences in the frequency of##6##5##(1991-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
differences in the gene##2##4##(2012-1#2)
differences in the growth##2##4##(1991-12#1)(2008-8#1)
differences in the incidence of##4##5##(1990-6#1)(1991-11#1)(2008-10#1)(2010-6#1)
differences in the level of##2##5##(1996-12#1)(2012-3#1)
differences in the magnitude##2##4##(2008-10#1)(2013-1#1)
differences in the mean##2##4##(2011-2#1)(2012-2#1)
differences in the number##2##4##(1993-3#1)(2008-10#1)
differences in the overall##2##4##(1996-7#1)(2011-10#1)
differences in the percentage of##2##5##(2008-10#1)(2008-9#1)
differences in the rate and##2##5##(1992-8#1)(2008-10#1)
differences in the rate##3##4##(1992-8#1)(2008-10#1)(2013-1#1)
differences in the rates of##5##5##(1994-2#1)(1996-2#1)(2008-10#2)(2013-1#1)
differences in the relationship between body##2##6##(2007-12#1)(2010-7#1)
differences in the relationship between##4##5##(2007-12#1)(2008-10#1)(2010-1#1)(2010-7#1)
differences in the relationship##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-7#1)
differences in the response##2##4##(1990-6#1)(1996-12#1)
differences in the structure of##2##5##(1990-5#1)(1993-2#1)
differences in the three groups##2##5##(1994-12#1)(2008-10#1)
differences in the timing of##3##5##(1993-12#1)(2008-11#2)
differences in the total##2##4##(1992-12#1)(1997-6#1)
differences in the two##2##4##(2008-8#1)(2008-9#1)
differences in the type of##3##5##(1997-6#1)(2008-10#1)(2010-5#1)
differences in the way##2##4##(2008-5#1)(2011-2#1)
differences in the##283##3##(1990-2#2)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2008-1#3)(2008-10#40)(2008-11#14)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#6)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#11)(2012-1#4)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#4)
differences in their##17##3##(1995-11#1)(1996-5#1)(2007-7#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2013-8#1)
differences in these##6##3##(2008-10#1)(2008-8#2)(2010-7#1)(2012-1#1)(2012-12#1)
differences in this##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
differences in tissue##3##3##(1992-9#1)(1996-5#1)(2008-5#1)
differences in treatment##3##3##(1991-1#1)(1997-2#1)(2008-4#1)
differences in use##2##3##(1994-2#1)(2008-12#1)
differences in virulence and##2##4##(2008-10#2)
differences in virulence were##2##4##(2008-10#2)
differences in virulence##6##3##(2008-10#6)
differences in weight##4##3##(1991-2#1)(1996-8#1)(2008-12#1)(2013-8#1)
differences in yield##2##3##(2008-10#2)
differences in##1001##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#10)(1993-2#6)(1993-3#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#14)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#6)(1995-12#11)(1995-2#5)(1995-3#5)(1995-5#7)(1995-6#2)(1995-8#1)(1996-1#4)(1996-12#13)(1996-2#5)(1996-3#6)(1996-5#7)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#3)(1997-9#1)(2006-10#2)(2007-10#6)(2007-11#6)(2007-12#17)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#175)(2008-11#43)(2008-12#23)(2008-2#8)(2008-3#16)(2008-4#17)(2008-5#46)(2008-6#7)(2008-7#27)(2008-8#42)(2008-9#32)(2009-10#2)(2009-11#5)(2009-12#5)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#12)(2009-8#8)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#16)(2010-9#3)(2011-1#12)(2011-10#2)(2011-2#29)(2011-3#1)(2012-1#8)(2012-12#7)(2012-2#18)(2012-3#20)(2012-5#4)(2012-8#2)(2013-1#41)(2013-7#3)(2013-8#17)
differences is##4##2##(1993-11#1)(1997-3#1)(2008-10#1)(2008-3#1)
differences may be related to the##3##6##(1997-7#1)(2008-7#1)(2011-2#1)
differences may be##8##3##(1997-7#2)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
differences may##14##2##(1993-11#1)(1993-2#1)(1994-2#1)(1995-5#1)(1997-7#2)(2007-10#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
differences might##3##2##(1991-5#1)(1993-3#1)(2012-3#1)
differences observable in##2##3##(2008-5#2)
differences observed between##5##3##(1993-8#1)(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
differences observed in the##2##4##(2008-10#2)
differences observed in##5##3##(1997-9#1)(2008-10#2)(2011-2#1)(2013-8#1)
differences observed on##2##3##(2008-10#1)(2012-3#1)
differences observed were##2##3##(1991-2#1)(2011-3#1)
differences observed##17##2##(1991-2#1)(1993-8#1)(1997-4#1)(1997-9#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-8#1)
differences occur##2##2##(2008-2#1)(2008-7#1)
differences occurred##5##2##(1997-8#1)(2007-7#1)(2008-10#3)
differences of 0##2##3##(2007-12#1)(2008-8#1)
differences of less than##2##4##(2007-12#1)(2008-3#1)
differences of opinion##2##3##(1990-9#1)(2008-5#1)
differences of the spine trauma in##2##6##(2007-11#2)
differences of the##14##3##(1993-6#1)(1994-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-6#1)(2008-9#1)(2012-3#1)(2012-7#1)(2013-1#1)
differences of these##2##3##(2008-2#1)(2008-5#1)
differences of##52##2##(1990-7#1)(1990-9#1)(1992-11#1)(1993-6#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#1)
differences on the##4##3##(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
differences on##12##2##(1992-8#1)(1994-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
differences over##4##2##(1992-6#1)(1995-2#1)(1997-2#1)(2008-5#1)
differences reflect##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
differences related to##3##3##(1995-11#1)(2008-1#1)(2013-1#1)
differences seem to be##2##4##(1993-11#1)(2008-10#1)
differences that are##3##3##(2007-11#1)(2007-12#1)(2008-8#1)
differences that could##2##3##(1993-2#1)(2008-6#1)
differences that exist##2##3##(2008-8#2)
differences that##12##2##(1993-2#1)(2007-11#2)(2007-12#2)(2008-3#2)(2008-6#1)(2008-8#3)(2010-8#1)
differences to be##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
differences to##10##2##(1992-7#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)
differences was##2##2##(1990-11#1)(2007-12#1)
differences were also found between##2##5##(1995-2#1)(2010-1#1)
differences were also##6##3##(1993-1#1)(1995-2#1)(2008-2#1)(2008-9#1)(2009-12#1)(2010-1#1)
differences were detected##4##3##(2008-12#1)(2009-5#1)(2013-7#1)(2013-8#1)
differences were determined between the##2##5##(2008-10#1)(2008-5#1)
differences were determined##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
differences were found among the##2##5##(1993-2#1)(2008-10#1)
differences were found among##8##4##(1993-2#1)(1997-4#1)(2008-10#4)(2010-3#1)(2012-3#1)
differences were found between the##6##5##(1992-3#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
differences were found between##20##4##(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-12#1)(2013-1#1)
differences were found for##3##4##(1996-3#1)(2008-12#1)(2012-12#1)
differences were found in the##6##5##(1990-5#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
differences were found in##19##4##(1990-5#1)(1992-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2011-2#1)(2013-1#1)
differences were found##60##3##(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-9#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2012-4#1)(2013-1#2)
differences were not found##2##4##(2008-10#1)(2008-8#1)
differences were not significant##6##4##(1992-2#1)(1995-6#1)(2008-5#3)(2012-1#1)
differences were not statistically significant##4##5##(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
differences were not##14##3##(1992-2#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
differences were noted in the##2##5##(1997-7#1)(2013-1#1)
differences were noted in##3##4##(1996-7#1)(1997-7#1)(2013-1#1)
differences were noted##8##3##(1994-1#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
differences were noticed##2##3##(1994-2#1)(2008-8#1)
differences were observed between the two##2##6##(1995-5#1)(2011-2#1)
differences were observed between the##6##5##(1994-2#1)(1995-5#1)(2008-10#2)(2008-7#1)(2011-2#1)
differences were observed between##13##4##(1990-7#1)(1994-2#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
differences were observed for##2##4##(2008-10#2)
differences were observed in the##7##5##(1992-6#1)(1995-11#2)(1997-4#1)(2008-10#1)(2008-5#1)(2012-3#1)
differences were observed in##24##4##(1992-3#1)(1992-6#1)(1994-5#1)(1995-11#2)(1995-5#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-5#3)(2008-6#2)(2008-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
differences were observed##49##3##(1990-3#1)(1990-7#1)(1992-3#1)(1992-6#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-5#2)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#2)(2008-7#3)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
differences were obtained in##2##4##(1994-8#1)(2008-8#1)
differences were revealed##2##3##(1990-5#1)(2012-2#1)
differences were seen in the##4##5##(1991-12#1)(1997-6#1)(2008-5#2)
differences were seen in##11##4##(1991-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#3)(2012-12#1)(2013-1#2)
differences were seen##15##3##(1991-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#4)(2012-12#1)(2013-1#2)
differences were small##2##3##(1994-2#1)(2008-10#1)
differences were statistically significant##2##4##(2008-7#1)(2011-2#1)
differences were##199##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#2)(1994-1#2)(1994-2#5)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#46)(2008-11#3)(2008-12#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#17)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#9)(2013-7#1)(2013-8#2)
differences when##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
differences which##2##2##(1992-6#1)(1993-2#1)
differences with regard to##4##4##(1992-12#1)(1994-6#1)(1997-7#1)(2011-1#1)
differences with respect to##3##4##(1991-6#1)(1995-12#1)(2008-12#1)
differences with the##2##3##(1990-6#1)(1991-6#1)
differences with##14##2##(1990-6#1)(1991-6#3)(1992-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-7#1)(2008-12#1)(2008-8#1)(2011-1#2)
differences within the##6##3##(1991-12#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-4#1)
differences within##10##2##(1991-12#1)(1992-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)
differences##2314##1##(1990-11#7)(1990-12#2)(1990-2#5)(1990-3#5)(1990-5#4)(1990-6#6)(1990-7#3)(1990-8#7)(1990-9#4)(1991-1#4)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#4)(1991-6#15)(1991-7#1)(1991-8#8)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#9)(1992-3#9)(1992-4#3)(1992-5#4)(1992-6#12)(1992-7#1)(1992-8#7)(1992-9#2)(1993-1#8)(1993-11#11)(1993-12#16)(1993-2#16)(1993-3#10)(1993-5#3)(1993-6#10)(1993-8#5)(1993-9#3)(1994-1#5)(1994-11#4)(1994-12#12)(1994-2#26)(1994-3#8)(1994-5#13)(1994-6#8)(1994-8#9)(1994-9#6)(1995-1#7)(1995-11#12)(1995-12#18)(1995-2#19)(1995-3#14)(1995-4#1)(1995-5#16)(1995-6#9)(1995-8#3)(1995-9#1)(1996-1#10)(1996-12#18)(1996-2#10)(1996-3#7)(1996-5#9)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#16)(1997-3#17)(1997-4#8)(1997-5#4)(1997-6#6)(1997-7#18)(1997-8#7)(1997-9#2)(2006-10#5)(2006-11#1)(2007-10#13)(2007-11#29)(2007-12#44)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#22)(2008-10#382)(2008-11#73)(2008-12#55)(2008-2#27)(2008-3#52)(2008-4#28)(2008-5#113)(2008-6#27)(2008-7#77)(2008-8#84)(2008-9#58)(2009-1#2)(2009-10#5)(2009-11#12)(2009-12#10)(2009-2#4)(2009-3#6)(2009-4#8)(2009-5#14)(2009-6#3)(2009-7#18)(2009-8#13)(2009-9#11)(2010-1#7)(2010-10#8)(2010-11#7)(2010-12#12)(2010-2#4)(2010-3#11)(2010-4#14)(2010-5#9)(2010-6#7)(2010-7#5)(2010-8#26)(2010-9#4)(2011-1#28)(2011-10#2)(2011-2#80)(2011-3#4)(2012-1#13)(2012-12#26)(2012-2#43)(2012-3#46)(2012-4#1)(2012-5#6)(2012-7#2)(2012-8#2)(2013-1#90)(2013-7#15)(2013-8#39)
differences)##4##1##(1991-1#1)(1997-5#1)(2008-11#1)(2008-5#1)
different (P = 0##3##4##(2008-10#3)
different (P##7##2##(2008-10#5)(2011-1#2)
different 3-year cropping systems##2##4##(2008-10#2)
different 5'##2##2##(1993-8#1)(1995-8#1)
different 5-HT##2##2##(1990-5#1)(2008-5#1)
different AGs##2##2##(2008-10#1)(2008-12#1)
different AR##3##2##(2008-2#1)(2012-2#2)
different CL##2##2##(2008-10#2)
different DNA##6##2##(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
different European##2##2##(2008-10#2)
different G##2##2##(1995-6#1)(2008-4#1)
different Gaussian-weighted beams and##2##4##(2008-3#2)
different German##2##2##(2008-12#2)
different HIV##2##2##(2008-5#2)
different HIV-1 subtypes##2##3##(2013-1#2)
different HNF1-like##2##2##(1990-12#2)
different IBV##2##2##(1997-3#1)(2008-5#1)
different IGS types##2##3##(2008-10#2)
different MBRs was##2##3##(2013-1#2)
different P##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
different PCB congeners##2##3##(2008-10#2)
different VCGs##4##2##(2008-10#4)
different absorption##3##2##(1992-8#1)(2008-3#2)
different access##2##2##(2009-10#1)(2009-3#1)
different accessibility to the##2##4##(1997-2#1)(2008-7#1)
different acoustic##2##2##(2008-3#1)(2013-1#1)
different across##4##2##(2008-10#2)(2010-4#1)(2011-2#1)
different activated##2##2##(1994-11#1)(1997-7#1)
different additives##2##2##(2008-6#1)(2012-3#1)
different aerosol##2##2##(2008-11#1)(2008-3#1)
different aetiology##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
different affective##2##2##(2013-8#2)
different affinities for##3##3##(1990-11#1)(1990-12#1)(1991-11#1)
different affinities##4##2##(1990-11#1)(1990-12#1)(1991-11#1)(2008-7#1)
different age groups of##2##4##(1993-9#1)(2008-9#1)
different age groups##11##3##(1993-12#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
different age##17##2##(1990-2#1)(1990-6#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
different ages##23##2##(1990-5#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-6#2)(1997-6#1)(1997-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2013-8#1)
different agonists##2##2##(1995-12#1)(2009-12#1)
different aims##2##2##(2008-12#1)(2012-1#1)
different air##2##2##(2008-10#1)(2008-12#1)
different alpha##2##2##(1994-8#1)(2008-3#1)
different alternatives##3##2##(2008-10#2)(2013-1#1)
different altitudes##3##2##(2008-2#1)(2008-3#1)(2013-7#1)
different amino acid substitutions##2##4##(1995-3#1)(2011-1#1)
different amino acid##3##3##(1995-3#1)(2008-10#1)(2011-1#1)
different amino acids##3##3##(1994-6#1)(2008-10#1)(2008-4#1)
different amino##7##2##(1994-6#1)(1995-3#1)(2008-10#3)(2008-4#1)(2011-1#1)
different among the##10##3##(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
different among##21##2##(1995-6#1)(1996-1#1)(2008-10#5)(2008-12#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-4#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#2)
different amount##2##2##(2008-10#2)
different amounts of these##2##4##(2008-10#2)
different amounts of##23##3##(1994-5#1)(1997-7#1)(2007-8#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#2)(2012-8#1)
different amounts##26##2##(1994-5#1)(1997-7#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)(2012-8#1)
different analgesic##2##2##(1993-1#1)(2009-3#1)
different analysis##2##2##(2008-11#1)(2008-8#1)
different analytes##7##2##(2008-10#6)(2008-3#1)
different analytical methods for##2##4##(2008-10#2)
different analytical methods##7##3##(2008-10#6)(2008-11#1)
different analytical##14##2##(1991-9#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-6#1)(2012-12#1)
different and##13##2##(1992-8#1)(1994-11#1)(1995-3#1)(1996-8#1)(2008-10#3)(2008-4#2)(2008-7#1)(2010-6#1)(2013-7#2)
different angles of incidence##2##4##(2007-11#1)(2008-3#1)
different angles##7##2##(1995-6#2)(2007-11#1)(2008-2#2)(2008-3#1)(2010-10#1)
different animal##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
different animals##2##2##(1993-12#1)(2009-5#1)
different anions##5##2##(1993-12#2)(2008-10#3)
different antibiotics##4##2##(1991-1#1)(1996-11#1)(2007-7#1)(2012-3#1)
different antibodies##3##2##(1990-7#1)(1994-12#1)(2009-3#1)
different anticancer##2##2##(2008-11#1)(2010-11#1)
different antisera##2##2##(1990-5#1)(1992-3#1)
different apo(a) isoforms##2##3##(1993-3#1)(1995-2#1)
different apple##2##2##(2008-10#2)
different applications##8##2##(1997-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-9#1)(2013-8#1)
different approaches for##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
different approaches to the##2##4##(2010-3#1)(2011-1#1)
different approaches to##10##3##(1991-6#1)(1994-2#1)(1995-6#1)(1996-9#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
different approaches used##2##3##(2010-8#1)(2013-1#1)
different approaches##31##2##(1991-6#2)(1993-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-9#1)(1997-7#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
different are##2##2##(1996-9#1)(2009-3#1)
different areas of the##8##4##(1994-5#2)(2008-1#1)(2008-10#1)(2008-2#1)(2010-9#1)(2011-1#1)(2012-12#1)
different areas of##19##3##(1994-5#2)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
different areas##25##2##(1992-12#1)(1994-5#2)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
different arrays##2##2##(2008-10#1)(2008-2#1)
different arsenic##3##2##(2008-10#2)(2008-11#1)
different artificial##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
different aspect##3##2##(1997-4#1)(2007-11#1)(2008-2#1)
different aspects of the##7##4##(1990-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
different aspects of##31##3##(1990-6#1)(1992-11#1)(1994-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#3)(2012-2#3)(2013-1#2)
different aspects related to##2##4##(1991-9#1)(2008-11#1)
different aspects##36##2##(1990-6#1)(1991-9#1)(1992-11#1)(1994-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#2)
different assay##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
different assays##5##2##(2008-10#2)(2011-1#1)(2013-1#2)
different at##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2012-1#1)
different atmospheric##2##2##(2008-2#1)(2008-3#1)
different atomic##5##2##(2008-10#1)(2008-2#2)(2008-7#2)
different auxin##2##2##(2008-12#2)
different average##2##2##(2008-10#2)
different axes##2##2##(1997-7#1)(2013-8#1)
different axial##2##2##(2008-2#1)(2009-4#1)
different bands##2##2##(2013-7#1)(2013-8#1)
different batches of##3##3##(2008-10#2)(2008-11#1)
different batches##6##2##(2008-10#2)(2008-11#2)(2011-2#1)(2013-8#1)
different beam##2##2##(2007-11#1)(2008-3#1)
different behavior##2##2##(2007-11#1)(2008-10#1)
different behavioral##4##2##(1991-2#1)(2008-5#2)(2008-8#1)
different behaviors in terms of##2##5##(2008-3#1)(2013-1#1)
different behaviors in##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
different behaviors##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
different behaviour of##2##3##(1992-2#1)(2008-10#1)
different behaviour##4##2##(1992-2#1)(2008-10#3)
different behavioural##2##2##(1995-12#1)(1997-3#1)
different between males and females##2##5##(1990-3#1)(2008-7#1)
different between men and##2##4##(2008-7#1)(2013-8#1)
different between the 2 groups##2##5##(1991-11#1)(2012-3#1)
different between the two groups##4##5##(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#1)
different between the two##7##4##(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
different between the##19##3##(1990-7#1)(1991-11#1)(1995-12#1)(1995-4#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
different between##51##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-8#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#15)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
different binding##7##2##(1993-8#1)(1995-11#2)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)
different biochemical##3##2##(1994-5#1)(2008-11#1)(2008-5#1)
different biological behavior##2##3##(2010-3#1)(2013-1#1)
different biological samples##2##3##(2008-10#2)
different biological##14##2##(2007-10#1)(2007-5#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
different bioluminescence inhibition##2##3##(2008-10#2)
different blood##2##2##(2008-10#2)
different bloom##2##2##(2008-10#2)
different body##6##2##(2008-12#2)(2008-4#1)(2008-6#2)(2010-12#1)
different botanical origins##2##3##(2008-10#2)
different botanical##3##2##(2008-10#2)(2013-8#1)
different brain areas were##2##4##(1996-2#1)(2012-12#1)
different brain areas##8##3##(1995-11#1)(1996-2#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-12#2)
different brain regions##3##3##(1990-5#1)(2008-1#1)(2008-9#1)
different brain##16##2##(1990-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)
different branches of the##2##4##(1996-5#1)(1997-5#1)
different branches of##3##3##(1996-5#1)(1997-5#1)(2013-1#1)
different branches##5##2##(1996-5#1)(1997-5#1)(2008-10#1)(2013-1#2)
different brands of##3##3##(2008-10#3)
different brands##5##2##(2008-10#5)
different buccolingual##2##2##(2010-3#2)
different buffer media##3##3##(2008-10#3)
different buffer##6##2##(2008-10#6)
different buffers##3##2##(1993-11#1)(2008-10#2)
different but##5##2##(1994-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
different cadmium##2##2##(2008-10#1)(2013-1#1)
different calcium channels##2##3##(2008-8#2)
different calcium##3##2##(2008-12#1)(2008-8#2)
different calibration##4##2##(2008-10#4)
different cancers##4##2##(1997-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
different carbon sources##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
different carbon##5##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-5#1)
different carrier frequencies##2##3##(2008-2#2)
different carrier##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
different cases##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
different categories##6##2##(1990-9#1)(1991-6#1)(1992-11#1)(2012-12#2)(2012-2#1)
different cationic##2##2##(2008-10#1)(2008-5#1)
different cations and anions##3##4##(2008-10#3)
different causes of##3##3##(1993-11#1)(2007-12#1)(2008-10#1)
different causes##4##2##(1993-11#1)(2007-12#1)(2008-10#1)(2012-1#1)
different cell cultures##2##3##(1996-5#1)(2008-4#1)
different cell lines and##2##4##(1991-9#1)(2008-11#1)
different cell lines##6##3##(1991-9#1)(2008-11#4)(2008-7#1)
different cell populations##2##3##(1992-8#1)(2009-4#1)
different cell types in##4##4##(2008-2#1)(2008-4#2)(2009-8#1)
different cell types##23##3##(1991-2#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2012-12#1)
different cell##48##2##(1991-2#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#8)(2008-2#3)(2008-4#7)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-3#1)
different cells##8##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2013-8#1)
different cellular functions##2##3##(1993-8#1)(2009-7#1)
different cellular##7##2##(1993-8#1)(2008-11#1)(2008-9#1)(2009-7#1)(2009-8#2)(2012-2#1)
different centers##7##2##(1990-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-3#2)
different central##2##2##(2008-2#1)(2008-7#1)
different centres##2##2##(1992-11#1)(2013-1#1)
different changes in##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
different changes##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
different channels##3##2##(2008-2#1)(2008-3#2)
different characteristics of##2##3##(2008-1#1)(2013-8#1)
different characteristics##4##2##(1992-3#1)(2008-1#1)(2010-8#1)(2013-8#1)
different characters##2##2##(2008-10#1)(2008-11#1)
different chemical structure##2##3##(1997-4#1)(2008-10#1)
different chemical structures##4##3##(1992-3#1)(1995-11#1)(2008-10#2)
different chemical##18##2##(1992-3#1)(1993-8#1)(1995-11#1)(1997-4#2)(2008-10#11)(2008-11#1)(2008-6#1)
different chromatographic##2##2##(2008-10#1)(2010-11#1)
different chromosomal regions are##2##4##(2007-11#1)(2008-7#1)
different chromosomal##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)
different chromosomes##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
different chronic diseases##3##3##(1997-1#1)(2013-1#2)
different classes of chemotherapeutic##2##4##(1997-7#2)
different classes of##25##3##(1990-8#1)(1992-3#1)(1994-8#1)(1997-3#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#2)(2010-3#2)(2012-12#3)(2012-2#1)
different classes##30##2##(1990-8#1)(1992-3#1)(1994-8#1)(1997-3#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-3#2)(2012-12#3)(2012-2#1)
different classrooms##2##2##(2008-12#2)
different cleavage##2##2##(2008-8#1)(2011-1#1)
different climatic##2##2##(2008-10#1)(2012-9#1)
different clinical manifestations##2##3##(1997-8#1)(2008-7#1)
different clinical##21##2##(1996-3#1)(1997-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)
different clusters##4##2##(1993-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
different coding##2##2##(1994-2#1)(2008-9#1)
different colloidal##2##2##(1997-1#1)(2008-5#1)
different colors##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
different coloured charge-transfer complexes and radicals were developed##2##8##(2008-10#2)
different combinations of the##2##4##(2008-3#1)(2008-9#1)
different combinations of three##2##4##(2008-10#1)(2008-12#1)
different combinations of##13##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2012-2#1)(2012-4#1)(2013-1#1)
different combinations##16##2##(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
different commercial devices##4##3##(2008-10#4)
different commercial formulations##2##3##(2008-10#2)
different commercial##13##2##(1997-6#1)(2008-10#12)
different commercially available##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
different communities##4##2##(1994-3#1)(2009-6#1)(2011-2#1)(2013-7#1)
different community##2##2##(2008-10#1)(2008-9#1)
different companies##3##2##(1995-2#2)(1997-3#1)
different compartments of the##2##4##(2008-10#1)(2008-7#1)
different complex##3##2##(2008-10#3)
different complexation##2##2##(1994-3#1)(2008-10#1)
different components of cow milk##3##5##(2008-10#3)
different components of the##3##4##(1993-3#1)(2008-10#1)(2008-8#1)
different components of##10##3##(1991-1#1)(1993-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)
different components##16##2##(1991-1#1)(1993-3#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-6#1)
different compositions of##2##3##(2008-10#1)(2008-3#1)
different compositions##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
different compound##2##2##(2008-10#2)
different compounds that##2##3##(2010-12#1)(2011-2#1)
different compounds##7##2##(1994-5#1)(2008-10#3)(2010-10#1)(2010-12#1)(2011-2#1)
different computational##3##2##(2008-8#1)(2011-1#1)(2011-2#1)
different concentration levels##4##3##(2008-10#3)(2011-2#1)
different concentration of##4##3##(2008-10#4)
different concentration ranges##2##3##(1995-8#1)(2008-10#1)
different concentration ratios of##4##4##(2008-10#3)(2008-6#1)
different concentration##15##2##(1995-8#1)(2008-10#12)(2008-6#1)(2011-2#1)
different concentrations and##5##3##(2008-10#4)(2013-1#1)
different concentrations of aflatoxin##4##4##(2008-12#4)
different concentrations of aluminum tetrasulfophthalocyanines##2##5##(2012-3#2)
different concentrations of the##4##4##(1997-2#1)(2008-10#3)
different concentrations of##41##3##(1993-12#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#14)(2008-11#1)(2008-12#7)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-3#1)(2012-2#1)(2012-3#3)(2013-1#3)
different concentrations on##2##3##(2008-10#1)(2012-2#1)
different concentrations was##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
different concentrations##65##2##(1993-12#1)(1993-8#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#25)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-3#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)
different conclusions##4##2##(1991-2#1)(2008-10#1)(2008-3#1)(2009-7#1)
different conditions and##2##3##(1993-12#1)(2007-8#1)
different conditions##27##2##(1992-8#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#4)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
different configurations of##2##3##(2007-11#1)(2008-10#1)
different configurations##5##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-9#1)
different constitutive models##2##3##(2013-1#2)
different contents##2##2##(2008-10#2)
different continents##8##2##(2008-10#4)(2008-12#1)(2009-5#1)(2012-3#1)(2013-8#1)
different control##4##2##(1997-3#1)(2007-6#1)(2008-10#1)(2008-8#1)
different coping orientations&quot##2##3##(2013-1#2)
different correction##2##2##(2008-10#1)(2008-9#1)
different cortical regions##3##3##(2007-8#2)(2008-11#1)
different cosmetic##2##2##(2008-5#2)
different cost##3##2##(1992-12#1)(2008-12#1)(2013-8#1)
different countries and##2##3##(2008-11#1)(2008-8#1)
different countries to##4##3##(1991-11#1)(2008-11#2)(2008-3#1)
different countries##19##2##(1990-11#1)(1991-11#1)(1992-3#1)(1995-5#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
different criteria##6##2##(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#3)
different crops##2##2##(2008-10#2)
different crude##2##2##(2008-10#1)(2008-3#1)
different crystal##2##2##(2008-10#1)(2008-3#1)
different cultivars##4##2##(2008-10#3)(2011-1#1)
different cultivation conditions##2##3##(1995-6#1)(2008-7#1)
different cultural##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2010-2#1)
different culture##6##2##(1996-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2013-1#1)
different cultures##7##2##(2008-11#1)(2008-6#1)(2010-4#1)(2010-8#3)(2012-2#1)
different cytokines##3##2##(2006-6#1)(2008-10#1)(2012-3#1)
different cytopathological##2##2##(2008-10#1)(2009-2#1)
different damage mechanisms##2##3##(2008-3#2)
different damage##3##2##(2008-3#2)(2008-8#1)
different data##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
different days of##4##3##(1993-11#2)(2008-10#2)
different days##8##2##(1990-12#1)(1993-11#2)(2008-1#1)(2008-10#3)(2008-6#1)
different definitions of##5##3##(1996-3#1)(1997-5#3)(2008-8#1)
different definitions##7##2##(1996-3#1)(1997-5#3)(2008-1#1)(2008-8#1)(2012-2#1)
different degree##2##2##(1991-2#1)(2007-11#1)
different degrees of##19##3##(1990-5#1)(1991-5#2)(1991-7#1)(1994-11#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-3#1)
different degrees##26##2##(1990-5#1)(1991-5#2)(1991-7#1)(1994-11#1)(1994-5#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#2)(2011-2#1)(2011-3#1)(2012-3#1)
different delay times##2##3##(2008-10#1)(2008-3#1)
different delay##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
different demographic histories##2##3##(2012-3#2)
different demographic##4##2##(1995-1#1)(2008-8#1)(2012-3#2)
different densities and##2##3##(2008-10#1)(2008-3#1)
different densities##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2013-1#1)
different density##2##2##(1995-8#1)(2013-8#1)
different depending##2##2##(2008-7#1)(2010-5#1)
different depths of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
different depths##7##2##(2008-10#2)(2008-2#2)(2008-3#3)
different design##2##2##(1992-9#1)(2008-2#1)
different designs##2##2##(2007-12#1)(2008-3#1)
different detection modes##2##3##(2008-10#2)
different detection techniques##2##3##(1994-12#1)(2008-4#1)
different detection##8##2##(1994-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-5#1)
different determinants##2##2##(2007-10#1)(2008-10#1)
different developmental stages of Schistosoma mansoni##2##6##(1997-6#2)
different developmental stages of##3##4##(1997-6#2)(2011-2#1)
different developmental stages##10##3##(1993-3#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
different developmental##12##2##(1993-12#1)(1993-3#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
different devices##5##2##(1997-1#1)(2008-10#2)(2008-3#2)
different diagnoses##3##2##(1990-6#1)(1992-12#1)(2008-6#1)
different diagnostic##6##2##(1990-12#1)(2006-12#1)(2007-10#1)(2009-9#1)(2012-3#1)(2013-8#1)
different dialysis##2##2##(2008-7#2)
different dicarboxylate ligands##2##3##(2008-10#2)
different dietary##7##2##(1992-8#1)(1993-11#1)(2008-10#3)(2008-3#1)(2012-2#1)
different diets##4##2##(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)
different diffraction##2##2##(2008-2#1)(2008-3#1)
different digestion##3##2##(2008-10#3)
different dimensions##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
different directions##8##2##(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)
different disease##2##2##(2008-10#1)(2008-6#1)
different diseases by the same##5##5##(2013-8#5)
different diseases in##2##3##(1990-6#1)(2011-2#1)
different diseases##20##2##(1990-6#1)(1991-12#1)(1994-5#1)(1996-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#7)
different disk##2##2##(2008-2#1)(2008-3#1)
different distances##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)
different distribution##3##2##(2008-10#2)(2013-1#1)
different distributions of##3##3##(2008-3#1)(2008-5#1)(2008-8#1)
different distributions##7##2##(1993-12#1)(1995-11#1)(1995-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
different districts of##2##3##(1997-3#1)(2008-10#1)
different districts##3##2##(1994-2#1)(1997-3#1)(2008-10#1)
different doctors##2##2##(1994-6#1)(1996-6#1)
different domains##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
different doping##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
different dosages of##3##3##(2010-8#1)(2011-1#1)(2012-12#1)
different dosages##4##2##(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
different dose levels##2##3##(2010-5#1)(2012-1#1)
different dose##5##2##(1994-3#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-1#1)
different doses and##3##3##(1992-2#1)(2008-10#1)(2012-2#1)
different doses of##9##3##(1992-8#1)(1993-9#1)(1994-9#1)(2007-10#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
different doses##15##2##(1992-2#1)(1992-8#1)(1993-9#1)(1994-9#1)(2007-10#1)(2008-10#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#3)
different droplet sizes##2##3##(1994-12#1)(2008-2#1)
different drug##7##2##(1990-12#1)(1992-2#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#1)
different drugs##4##2##(1997-7#1)(2008-11#1)(2009-6#1)(2013-8#1)
different dye##2##2##(1991-5#1)(2008-5#1)
different dynamic##3##2##(1995-3#1)(2006-6#1)(2008-10#1)
different dynamics##4##2##(2008-8#1)(2011-2#1)(2012-3#2)
different ecological##2##2##(2008-10#1)(2012-2#1)
different ecotypes##2##2##(2008-10#2)
different effectors##3##2##(1990-3#2)(2012-2#1)
different effects of##4##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
different effects on the##3##4##(1997-7#1)(2008-10#2)
different effects on##6##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
different effects##14##2##(1990-5#1)(1992-11#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)
different efficiency##2##2##(1992-2#1)(2008-11#1)
different egg##2##2##(1991-8#1)(2011-2#1)
different electroanalytical techniques##2##3##(2008-10#2)
different electrode##2##2##(2008-10#1)(2008-9#1)
different electrodes##5##2##(2008-10#5)
different electron##3##2##(1993-11#1)(2008-10#1)(2008-12#1)
different elements of##2##3##(1994-3#1)(1995-5#1)
different elements##4##2##(1994-3#1)(1995-5#1)(2008-2#1)(2009-7#1)
different elevation levels##2##3##(2008-10#2)
different elevation##3##2##(2008-10#2)(2012-7#1)
different elevations##2##2##(2012-7#2)
different elution##3##2##(2008-10#3)
different emission##2##2##(2008-10#2)
different endometrial##2##2##(1994-9#1)(1995-12#1)
different endpoints##2##2##(2008-10#1)(2008-5#1)
different energy##2##2##(1990-8#1)(2008-11#1)
different entities##2##2##(1990-7#1)(1997-8#1)
different environmental conditions##11##3##(2008-10#6)(2008-8#1)(2010-10#2)(2011-2#1)(2013-8#1)
different environmental settings##4##3##(2008-8#4)
different environmental##18##2##(2008-10#8)(2008-5#1)(2008-8#5)(2010-10#2)(2011-2#1)(2013-8#1)
different environments and##2##3##(2011-1#1)(2011-2#1)
different environments##23##2##(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
different enzymatic##5##2##(2008-10#1)(2010-4#1)(2010-5#1)(2013-1#2)
different enzymes##5##2##(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
different epigenetic##2##2##(2008-8#1)(2012-2#1)
different epitopes on the##2##4##(1993-1#1)(1994-8#1)
different epitopes##3##2##(1993-1#1)(1994-8#1)(2008-11#1)
different ethnic groups##6##3##(2008-1#1)(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#1)
different ethnic##8##2##(2008-1#1)(2008-5#4)(2008-8#1)(2008-9#1)(2012-12#1)
different etiologies##3##2##(1991-8#1)(2012-3#1)(2013-7#1)
different events##2##2##(2008-10#1)(2008-9#1)
different evolutionary histories##2##3##(2008-10#1)(2012-2#1)
different evolutionary##6##2##(1997-2#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
different experimental conditions##11##3##(1991-6#2)(1997-2#2)(2008-1#1)(2008-10#5)(2008-11#1)
different experimental designs##2##3##(2008-10#2)
different experimental methods##2##3##(2008-10#1)(2012-3#1)
different experimental models##3##3##(2008-7#1)(2009-7#1)(2012-1#1)
different experimental##33##2##(1990-7#1)(1991-5#1)(1991-6#2)(1995-3#1)(1997-2#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-4#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
different experiments##3##2##(1994-6#1)(2008-10#2)
different expression##5##2##(1993-8#1)(2008-11#1)(2008-7#2)(2011-2#1)
different extent##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
different external##2##2##(2008-5#1)(2011-2#1)
different extraction conditions##2##3##(2008-10#2)
different extraction methods##3##3##(2008-10#3)
different extraction##8##2##(2008-10#6)(2008-4#1)(2012-3#1)
different facets of##2##3##(1992-2#1)(2008-11#1)
different facial##2##2##(2008-11#1)(2008-5#1)
different factors##16##2##(2007-11#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)
different families##5##2##(2008-10#2)(2008-12#1)(2011-2#1)(2013-8#1)
different fashion##2##2##(1992-6#1)(2008-10#1)
different features of##3##3##(2007-11#1)(2007-8#1)(2010-8#1)
different features##8##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-8#1)(2013-1#2)
different feeding habits##2##3##(2008-8#2)
different fiber##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
different fibre##2##2##(2009-7#1)(2011-2#1)
different field experiments##2##3##(2008-10#2)
different field##4##2##(2008-10#3)(2009-11#1)
different fields in the##2##4##(2008-10#2)
different fields in##4##3##(2008-10#3)(2008-12#1)
different fields of##4##3##(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
different fields##14##2##(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-4#1)(2012-2#1)
different floral##2##2##(2008-10#1)(2008-8#1)
different flow rates##2##3##(1996-2#1)(2008-10#1)
different flow##7##2##(1996-2#1)(2008-10#6)
different fluorescence##2##2##(2008-1#1)(2012-2#1)
different fluorescent##4##2##(1991-6#1)(1993-6#1)(2008-10#2)
different fluorophores##2##2##(2008-1#1)(2008-9#1)
different flux burdens##3##3##(2008-7#3)
different flux##4##2##(2008-7#4)
different folding##2##2##(2008-9#1)(2010-5#1)
different food##3##2##(2008-10#3)
different foodstuffs##2##2##(2008-10#2)
different for different##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#2)
different for each##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
different for the two##2##4##(2008-10#1)(2008-7#1)
different for the various##2##4##(1991-5#1)(2008-2#1)
different for the##5##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
different for##24##2##(1991-5#1)(1992-12#1)(1992-3#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#2)(2013-1#2)
different forest##2##2##(2008-10#1)(2012-2#1)
different form of the##2##4##(2007-12#1)(2010-10#1)
different form##3##2##(2007-12#1)(2008-3#1)(2010-10#1)
different formats##5##2##(2008-10#2)(2008-4#1)(2010-10#2)
different forms of memory##2##4##(1994-8#2)
different forms of the##2##4##(1993-2#1)(1994-11#1)
different forms of treatment##2##4##(1994-9#1)(2013-1#1)
different forms of##31##3##(1990-12#1)(1990-9#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#3)(1994-9#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
different forms##40##2##(1990-12#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#3)(1994-9#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
different formulations##2##2##(2008-10#1)(2010-4#1)
different fractions of##5##3##(1997-1#1)(2008-10#3)(2012-3#1)
different fractions##8##2##(1993-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2012-3#1)
different fragments##3##2##(1997-1#1)(2008-10#1)(2010-6#1)
different frequencies##12##2##(1996-12#4)(1997-7#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
different frequency and##2##3##(2008-2#1)(2008-8#1)
different frequency##5##2##(2007-12#1)(2007-9#1)(2008-2#1)(2008-8#1)(2009-8#1)
different from 1##3##3##(1997-4#1)(2008-10#2)
different from a##3##3##(2008-10#2)(2008-3#1)
different from all##6##3##(1993-12#1)(2008-10#2)(2008-2#1)(2011-2#2)
different from and##2##3##(1995-5#1)(2009-7#1)
different from controls##4##3##(1991-12#1)(1993-12#1)(1995-8#1)(2008-7#1)
different from conventional##2##3##(2007-12#1)(2010-3#1)
different from each other##4##4##(1990-11#1)(1993-3#1)(2008-10#2)
different from each##5##3##(1990-11#1)(1993-3#1)(2008-10#3)
different from observed disease severity##2##5##(2008-10#2)
different from other##11##3##(1991-2#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-8#1)(2010-10#1)(2012-3#1)
different from that for##2##4##(2008-11#1)(2008-8#1)
different from that in the##4##5##(1994-5#1)(1995-2#1)(2008-5#1)(2013-1#1)
different from that in##8##4##(1992-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
different from that induced by##2##5##(1993-3#1)(2008-11#1)
different from that observed for##2##5##(1993-6#1)(2008-10#1)
different from that of a##2##5##(2007-11#1)(2008-3#1)
different from that of other##2##5##(1993-2#1)(2008-9#1)
different from that of the##13##5##(1993-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
different from that of##38##4##(1990-8#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-10#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
different from that##64##3##(1990-8#2)(1992-4#1)(1992-5#3)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2010-12#1)(2011-10#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
different from the control##3##4##(1993-1#1)(1993-12#1)(2008-4#1)
different from the ones##2##4##(2010-8#1)(2011-2#1)
different from the other##2##4##(2010-11#1)(2010-3#1)
different from the##68##3##(1990-8#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-12#1)(1995-3#1)(1996-9#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
different from their##2##3##(1990-11#1)(2008-10#1)
different from those for##3##4##(1995-6#2)(2010-3#1)
different from those in the##3##5##(1997-8#1)(2007-7#1)(2008-5#1)
different from those in##6##4##(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
different from those of a##3##5##(1990-12#1)(2008-10#2)
different from those of endothelin##2##5##(1992-12#2)
different from those of the##4##5##(1997-6#1)(2008-10#2)(2008-9#1)
different from those of##15##4##(1990-12#1)(1992-1#1)(1992-12#2)(1993-8#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
different from those reported##2##4##(1993-8#1)(2012-2#1)
different from those##38##3##(1990-12#2)(1992-1#1)(1992-12#2)(1993-2#1)(1993-8#2)(1995-6#2)(1996-2#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)
different from what##2##3##(2008-1#1)(2008-10#1)
different from zero##8##3##(2008-10#6)(2008-2#1)(2011-2#1)
different from##284##2##(1990-11#2)(1990-12#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#7)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#3)(2008-1#4)(2008-10#70)(2008-11#8)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#11)(2008-9#9)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
different fruit##3##2##(2008-10#3)
different function##2##2##(2008-8#1)(2011-2#1)
different functional and##2##3##(1990-8#1)(2007-12#1)
different functional groups##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
different functional properties##2##3##(1992-3#1)(2010-8#1)
different functional##15##2##(1990-8#1)(1992-3#1)(1993-12#1)(2007-12#2)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#3)(2010-8#1)(2012-2#1)
different functions for different##2##4##(2008-3#1)(2010-10#1)
different functions for##3##3##(1995-12#1)(2008-3#1)(2010-10#1)
different functions##6##2##(1990-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
different fungal species##2##3##(2009-8#1)(2012-2#1)
different fungal##5##2##(1997-4#1)(2008-10#2)(2009-8#1)(2012-2#1)
different gas-liquid##2##2##(2008-10#2)
different gelling##2##2##(2011-1#1)(2011-2#1)
different gene##3##2##(1990-11#1)(1992-8#1)(2010-4#1)
different genera of##3##3##(2008-11#2)(2013-1#1)
different genes##8##2##(1991-12#1)(1992-3#1)(1997-7#1)(2008-10#2)(2009-5#1)(2012-3#1)(2013-1#1)
different genetic backgrounds##3##3##(2008-10#1)(2012-3#2)
different genetic##11##2##(1997-5#1)(2008-1#1)(2008-10#4)(2009-10#1)(2011-1#1)(2012-3#2)(2013-1#1)
different genomes##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
different genotypes at##2##3##(1997-7#1)(2008-12#1)
different genotypes were found##2##4##(2008-10#2)
different genotypes were##5##3##(2008-10#5)
different genotypes##15##2##(1997-7#1)(2008-10#11)(2008-12#1)(2011-2#1)(2013-8#1)
different geographic areas##2##3##(2008-10#1)(2011-2#1)
different geographic locations##4##3##(2008-10#2)(2008-9#1)(2009-2#1)
different geographic regions##4##3##(1993-12#1)(2008-10#1)(2013-8#2)
different geographic##12##2##(1993-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-8#2)
different geographical areas##2##3##(2008-10#1)(2013-1#1)
different geographical regions##4##3##(2008-1#1)(2008-10#3)
different geographical##10##2##(2008-1#1)(2008-10#6)(2008-12#1)(2011-2#1)(2013-1#1)
different geometric##2##2##(2008-3#1)(2010-2#1)
different glucose##3##2##(2008-5#1)(2008-7#1)(2010-10#1)
different grades of##2##3##(2011-2#1)(2012-3#1)
different grain##2##2##(1996-2#1)(2008-10#1)
different group##2##2##(1994-9#1)(2008-10#1)
different groups and##2##3##(1992-2#1)(1994-9#1)
different groups have##2##3##(1994-11#1)(2006-6#1)
different groups of##7##3##(1993-8#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-11#1)
different groups##36##2##(1992-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
different growing areas was##2##4##(2008-10#2)
different growing media##3##3##(2008-12#3)
different growing##6##2##(2008-10#3)(2008-12#3)
different growth phases##2##3##(1996-7#1)(2012-3#1)
different growth rates##4##3##(1993-12#1)(2010-12#1)(2012-2#2)
different growth regulator##2##3##(2008-12#1)(2013-1#1)
different growth##14##2##(1991-12#1)(1993-12#1)(1996-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
different habitats##5##2##(2008-6#1)(2008-8#2)(2013-7#1)(2013-8#1)
different hair##2##2##(2008-5#2)
different haplotypes##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
different health care##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
different health##7##2##(1992-3#1)(1992-4#1)(2008-11#2)(2008-12#1)(2008-4#1)(2011-2#1)
different heating##3##2##(2008-10#1)(2008-2#2)
different hepatic##2##2##(1992-8#1)(2008-10#1)
different heterologous##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
different homozygous##2##2##(2008-10#1)(2008-4#1)
different hospitals##8##2##(1991-11#2)(1991-2#1)(1992-2#1)(1994-2#1)(1995-6#1)(2008-1#1)(2010-8#1)
different host genotypes##2##3##(2008-10#2)
different host plant species##3##4##(2008-10#3)
different host plants##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
different host species##2##3##(2008-9#2)
different host##17##2##(2008-10#10)(2008-3#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)
different hosts and##4##3##(2008-10#3)(2012-2#1)
different hosts##17##2##(2008-10#15)(2011-2#1)(2012-2#1)
different human##4##2##(1991-6#1)(1996-10#1)(2008-1#1)(2008-12#1)
different humic##3##2##(2008-10#3)
different hybridization##2##2##(2008-10#2)
different hybridoma cell##3##3##(1994-5#2)(2008-11#1)
different hydrolysis##2##2##(2008-10#2)
different hydrophilic##2##2##(2008-10#2)
different ideas##2##2##(2008-11#1)(2011-1#1)
different images##4##2##(2007-11#1)(2008-2#2)(2008-6#1)
different imaging modalities##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
different imaging techniques##3##3##(2011-2#1)(2012-2#2)
different imaging##6##2##(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
different impact on the##2##4##(2009-9#1)(2012-2#1)
different implements##2##2##(2008-10#2)
different in both##2##3##(2008-11#1)(2013-7#1)
different in control##2##3##(1990-8#1)(2008-12#1)
different in each##2##3##(2010-12#1)(2013-7#1)
different in many##2##3##(2008-10#1)(2008-8#1)
different in the two##4##4##(1992-3#1)(1996-5#1)(2008-10#1)(2009-12#1)
different in the##15##3##(1992-3#1)(1993-11#1)(1993-5#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#2)
different in their##2##3##(2007-7#1)(2008-3#1)
different in vitro##7##3##(1992-2#1)(2008-5#4)(2008-9#1)(2011-1#1)
different in vivo##2##3##(1990-8#1)(2008-8#1)
different in young and##2##4##(1991-12#1)(2008-11#1)
different in##67##2##(1990-2#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-5#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-4#1)(2007-7#2)(2008-10#10)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#6)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
different incident##4##2##(2008-2#2)(2008-3#2)
different incubation temperatures##2##3##(2008-10#1)(2011-2#1)
different incubation##4##2##(1994-6#1)(2008-10#1)(2011-2#2)
different indications##2##2##(1990-9#1)(2011-2#1)
different indicators of##2##3##(1995-12#1)(2010-11#1)
different individual##3##2##(2008-5#1)(2009-3#1)(2011-2#1)
different individuals##10##2##(1993-12#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)
different industrial##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
different influenza##2##2##(2011-2#1)(2012-2#1)
different information##3##2##(1995-12#1)(2010-8#1)(2013-1#1)
different inhibitors##2##2##(1995-11#1)(2008-7#1)
different initial##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
different injection##2##2##(2008-10#1)(2010-4#1)
different inoculation##3##2##(2008-10#3)
different inoculum##3##2##(2008-10#3)
different inorganic##2##2##(2008-10#2)
different insect species##2##3##(2007-12#2)
different inspiratory##2##2##(1995-3#1)(2011-2#1)
different instrumental##2##2##(2008-10#1)(2008-5#1)
different instruments are##2##3##(2008-3#1)(2008-5#1)
different instruments##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-1#1)
different intensities along##2##3##(2008-2#2)
different intensities of heat##2##4##(1992-3#2)
different intensities of##5##3##(1992-3#3)(2008-5#1)(2008-8#1)
different intensities##11##2##(1992-3#3)(1996-2#1)(2007-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
different intensity##2##2##(2007-11#1)(2008-3#1)
different interventions##5##2##(1994-12#1)(2008-10#2)(2011-2#2)
different intracellular##6##2##(1991-12#1)(1991-5#1)(1993-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
different investigators##3##2##(2008-1#1)(2008-2#2)
different ion sources##2##3##(2008-3#2)
different ion##3##2##(2008-3#3)
different ionic##11##2##(1992-5#1)(1994-5#1)(1997-2#1)(2008-10#8)
different islands##2##2##(2008-10#1)(2008-8#1)
different isoforms of PKC##3##4##(1995-11#3)
different isoforms of##5##3##(1993-8#1)(1995-11#4)
different isoforms##6##2##(1993-8#2)(1995-11#4)
different isolates of##5##3##(2008-10#4)(2008-9#1)
different isolates##8##2##(2008-10#6)(2008-9#1)(2012-3#1)
different kidney##2##2##(2008-1#1)(2008-7#1)
different kind of samples##2##4##(2008-10#2)
different kind of##6##3##(1993-11#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-7#1)
different kinds and##2##3##(2008-12#1)(2008-7#1)
different kinds of milk##2##4##(2008-10#2)
different kinds of water##2##4##(2008-11#2)
different kinds of##33##3##(1991-11#2)(1992-3#1)(1996-6#2)(1997-4#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-3#1)(2013-1#2)
different kinds##35##2##(1991-11#2)(1992-3#1)(1996-6#2)(1997-4#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-3#1)(2013-1#2)
different labeling##2##2##(2008-9#1)(2009-5#1)
different laboratories##8##2##(2008-10#5)(2008-5#1)(2011-2#1)(2012-3#1)
different laboratory##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
different language##2##2##(2010-5#1)(2011-2#1)
different laser##4##2##(2007-12#1)(2008-3#3)
different lateral##2##2##(2008-10#1)(2008-3#1)
different layers##4##2##(1990-9#1)(2008-12#1)(2008-3#1)(2008-9#1)
different leaf##4##2##(2008-10#2)(2008-12#1)(2010-3#1)
different leaves of##2##3##(2008-10#2)
different leg##2##2##(2007-12#2)
different length##5##2##(1990-2#1)(1996-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
different lengths of the##2##4##(1997-2#1)(2008-10#1)
different lengths of##5##3##(1991-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
different lengths##9##2##(1991-7#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#1)(2013-7#1)
different lesions##2##2##(2008-10#1)(2008-11#1)
different level of##2##3##(2008-3#1)(2008-7#1)
different level##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
different levels of energy##2##4##(2008-12#2)
different levels of resistance to Aphanomyces root rot and##2##9##(2008-10#2)
different levels of resistance##4##4##(2008-10#4)
different levels of the##3##4##(2008-7#1)(2009-10#1)(2009-7#1)
different levels of virulence##2##4##(2008-10#1)(2008-8#1)
different levels of##52##3##(1990-11#1)(1990-2#1)(1992-9#1)(1994-3#1)(1997-3#1)(2008-10#20)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
different levels to##2##3##(2008-10#1)(2013-8#1)
different levels##70##2##(1990-11#1)(1990-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#23)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-11#1)(2009-7#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
different lidar##2##2##(2008-3#2)
different life##2##2##(1994-5#1)(2008-8#1)
different ligands##2##2##(1990-8#1)(2008-10#1)
different light##3##2##(1992-8#1)(1993-5#1)(1997-8#1)
different linear##2##2##(2008-10#2)
different lines##2##2##(1994-8#1)(2008-10#1)
different lipid classes##2##3##(2008-11#1)(2008-5#1)
different lipid compositions##2##3##(1994-3#1)(2008-11#1)
different lipid##7##2##(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)
different load##3##2##(2011-1#1)(2013-1#2)
different loading##2##2##(2007-11#1)(2009-7#1)
different local##4##2##(1993-1#1)(1994-9#1)(2008-3#1)(2010-8#1)
different localities##4##2##(2008-10#1)(2008-5#1)(2013-1#2)
different localization##2##2##(1994-6#1)(2013-1#1)
different localizations##2##2##(2007-11#1)(2011-2#1)
different locations and##2##3##(2008-10#2)
different locations in the##2##4##(2008-10#1)(2008-5#1)
different locations in##10##3##(1992-6#1)(2008-10#8)(2008-5#1)
different locations of##2##3##(2012-3#2)
different locations on the##3##4##(2008-10#1)(2008-3#1)(2009-7#1)
different locations##34##2##(1992-6#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#2)(2012-3#5)
different loci##7##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)
different locking##2##2##(2008-3#1)(2008-8#1)
different loop##2##2##(2008-3#1)(2008-8#1)
different mRNAs##2##2##(2007-12#1)(2008-4#1)
different magnitude##2##2##(2008-10#1)(2011-1#1)
different magnitudes of##2##3##(2008-10#1)(2008-7#1)
different main##2##2##(2013-8#2)
different mammalian species##2##3##(1994-11#1)(1995-2#1)
different mammalian##5##2##(1993-9#1)(1994-11#1)(1995-2#1)(2008-7#1)(2013-1#1)
different manners##4##2##(2008-10#2)(2008-2#1)(2011-1#1)
different manufacture##2##2##(2008-10#2)
different manufacturers##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
different materials##4##2##(2008-10#4)
different mathematical##2##2##(1994-5#1)(2013-8#1)
different mating types##2##3##(2008-10#2)
different mating##4##2##(2008-10#4)
different matrices such as##2##4##(2008-10#2)
different matrices##13##2##(2008-10#12)(2008-2#1)
different matrix##3##2##(1992-3#1)(2008-10#2)
different mats##2##2##(2011-2#2)
different maximum luminance settings##3##4##(2010-9#3)
different mean##2##2##(2007-12#1)(2008-5#1)
different measurement##3##2##(2008-10#2)(2008-2#1)
different measures of##3##3##(1991-11#1)(2007-12#1)(2010-7#1)
different measures##7##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-2#2)
different mechanical properties##2##3##(2008-5#1)(2009-6#1)
different mechanical##3##2##(2008-2#1)(2008-5#1)(2009-6#1)
different mechanism of action##2##4##(2008-10#1)(2008-7#1)
different mechanism of##4##3##(1997-6#1)(2008-10#2)(2008-7#1)
different mechanism##9##2##(1991-5#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-7#1)(2008-8#1)
different mechanisms for##2##3##(1995-11#1)(2008-10#1)
different mechanisms of action##2##4##(2007-11#1)(2011-2#1)
different mechanisms of##8##3##(1992-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
different mechanisms##29##2##(1991-1#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#4)
different media and##2##3##(2008-10#1)(2008-11#1)
different media##6##2##(1991-8#2)(2008-10#2)(2008-11#2)
different medical##5##2##(1991-11#1)(1992-3#1)(1994-9#1)(2012-2#1)(2013-8#1)
different memory##3##2##(2007-8#1)(2008-3#1)(2009-8#1)
different metabolic##3##2##(1995-12#1)(2008-7#1)(2011-1#1)
different metal ions##3##3##(2008-10#2)(2008-7#1)
different metal oxides##3##3##(2008-10#3)
different metal##6##2##(2008-10#5)(2008-7#1)
different metals##2##2##(2008-10#2)
different meteorological##2##2##(2008-2#2)
different method##2##2##(2007-12#1)(2010-8#1)
different methodologies##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
different methods for the##4##4##(2008-10#2)(2008-4#1)(2009-8#1)
different methods for##11##3##(2007-12#1)(2007-6#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
different methods have been##2##4##(2008-11#1)(2008-9#1)
different methods of##8##3##(1990-2#1)(1990-7#1)(1994-5#1)(2007-10#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-8#1)
different methods to##3##3##(2008-10#2)(2008-11#1)
different methods used##2##3##(2008-11#1)(2008-2#1)
different methods were used to##2##5##(2008-10#1)(2008-12#1)
different methods##56##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-3#2)(1994-5#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#3)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
different microbes##2##2##(2011-2#1)(2012-2#1)
different microbial##2##2##(2008-10#1)(2011-2#1)
different microenvironments##2##2##(1990-5#1)(2007-12#1)
different microorganisms##3##2##(1990-12#1)(2007-11#1)(2010-5#1)
different migration##2##2##(1992-8#1)(2008-5#1)
different milk##2##2##(2008-10#1)(2010-12#1)
different mitogenic agents##2##3##(1992-5#2)
different mixed##2##2##(2008-10#2)
different mixtures of##5##3##(2008-10#5)
different mixtures##6##2##(2008-10#6)
different mobility species##3##3##(1991-7#3)
different mobility##4##2##(1991-7#3)(1994-9#1)
different modalities of treatment##2##4##(2007-7#1)(2008-7#1)
different modalities##5##2##(2007-7#3)(2008-7#1)(2013-1#1)
different mode##4##2##(1995-5#1)(2007-11#1)(2008-3#1)(2010-11#1)
different model##4##2##(1997-2#1)(2008-10#1)(2009-11#1)(2010-4#1)
different models and##4##3##(1993-3#1)(1997-5#1)(2008-10#1)(2008-5#1)
different models for##4##3##(1992-6#1)(2008-3#1)(2008-8#1)(2012-1#1)
different models of##11##3##(1992-3#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-10#3)(2009-1#1)(2010-12#1)(2012-2#2)
different models##26##2##(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-10#3)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-1#1)(2012-2#2)
different modes of cytokinesis##2##4##(2009-10#2)
different modes of##5##3##(1995-2#1)(2008-10#1)(2009-10#2)(2010-11#1)
different modes##8##2##(1995-2#1)(2008-10#1)(2008-3#2)(2009-10#2)(2010-11#1)(2010-9#1)
different moisture##4##2##(2008-10#3)(2008-12#1)
different molar ratios of##4##4##(1995-5#1)(2008-10#2)(2008-8#1)
different molar ratios##6##3##(1995-5#1)(2008-10#4)(2008-8#1)
different molar##8##2##(1995-5#1)(1996-2#1)(2008-10#4)(2008-8#1)(2013-1#1)
different molecular descriptors##3##3##(2008-10#2)(2009-3#1)
different molecular techniques##2##3##(2008-5#2)
different molecular weight AFGPs##2##4##(1990-12#2)
different molecular weight##6##3##(1990-12#3)(1996-2#1)(2008-10#2)
different molecular weights##3##3##(2008-10#2)(2008-11#1)
different molecular##28##2##(1990-12#3)(1991-7#1)(1992-9#1)(1995-12#1)(1996-2#2)(2008-10#8)(2008-11#1)(2008-5#3)(2009-12#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
different molecules##2##2##(1994-5#1)(2007-12#1)
different monomers##2##2##(2008-4#1)(2008-6#1)
different months##2##2##(2013-7#1)(2013-8#1)
different morphologic##2##2##(1991-12#1)(1994-8#1)
different morphological pattern##2##3##(2011-2#1)(2013-7#1)
different morphological##4##2##(1991-12#1)(2008-5#1)(2011-2#1)(2013-7#1)
different mouse models##2##3##(2008-11#1)(2011-2#1)
different mouse##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
different mutant##2##2##(2008-10#1)(2011-1#1)
different mutants of##3##3##(1990-11#1)(1997-2#1)(2013-7#1)
different mutations in##2##3##(1997-4#1)(2007-7#1)
different nationalities##2##2##(1992-5#1)(1995-6#1)
different natural##3##2##(2008-10#2)(2012-3#1)
different nebulizers##2##2##(1994-12#1)(1995-3#1)
different nerve##2##2##(1996-2#1)(2008-10#1)
different neural mechanisms##2##3##(1992-3#1)(2008-8#1)
different neurons##2##2##(2007-12#1)(2009-10#1)
different nitrogen##2##2##(2008-10#1)(2008-12#1)
different noise##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
different nominal##3##2##(1995-3#1)(2008-10#2)
different nuclear##2##2##(1997-7#1)(2008-10#1)
different null models##2##3##(2008-8#2)
different number of##5##3##(1990-11#1)(1990-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
different numbers of layers of##2##5##(2008-12#2)
different numbers of##11##3##(1990-12#1)(2008-10#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-11#1)
different numerical apertures and##2##4##(2008-2#1)(2008-3#1)
different numerical##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
different nursing##3##2##(2008-8#1)(2010-10#2)
different nutritional##2##2##(2008-10#1)(2008-6#1)
different object##2##2##(2008-2#1)(2008-3#1)
different objective##2##2##(2007-11#1)(2008-3#1)
different objects##3##2##(1996-2#1)(2007-12#1)(2008-12#1)
different observation##2##2##(2007-11#1)(2008-3#1)
different occasions##2##2##(1996-5#1)(2008-11#1)
different of##2##2##(2008-8#1)(2011-2#1)
different off-line methods##2##3##(2008-11#2)
different oil##2##2##(2008-10#1)(2008-11#1)
different oils##2##2##(2008-5#1)(2013-1#1)
different open reading frames##2##4##(1997-7#1)(2008-10#1)
different operating##4##2##(1992-12#1)(2008-2#3)
different operational##3##2##(1997-2#1)(2007-10#1)(2010-5#1)
different operative methods##2##3##(1991-5#1)(1996-12#1)
different operative##3##2##(1991-5#1)(1996-12#1)(2008-10#1)
different operators##3##2##(2008-10#2)(2010-7#1)
different optical##9##2##(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#3)(2009-5#1)(2011-1#1)
different or##5##2##(1992-9#1)(1996-5#1)(2008-2#1)(2010-12#1)(2013-1#1)
different order of##2##3##(1996-5#1)(2013-8#1)
different order##5##2##(1993-12#1)(1996-5#1)(2007-12#1)(2008-3#1)(2013-8#1)
different orders##2##2##(2008-2#1)(2008-9#1)
different organic solvents##2##3##(2008-10#2)
different organic##8##2##(1995-11#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2013-8#1)
different organism##2##2##(2008-4#1)(2011-2#1)
different organisms##9##2##(1993-2#2)(1993-6#1)(1997-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2011-2#1)
different organization##4##2##(1990-11#1)(1992-5#1)(2008-10#1)(2009-3#1)
different organs of##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
different organs or##2##3##(2008-10#1)(2008-4#1)
different organs##13##2##(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
different orientations of the##2##4##(1992-6#1)(2012-2#1)
different orientations of##3##3##(1992-6#1)(2007-11#1)(2012-2#1)
different orientations##5##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
different origins##12##2##(2008-10#10)(2008-2#1)(2008-3#1)
different outcome##2##2##(2007-7#1)(2008-5#1)
different oxidant##2##2##(2008-10#2)
different oxidation states with##2##4##(2008-10#2)
different oxidation states##7##3##(2007-11#1)(2008-10#6)
different oxygen##3##2##(1990-8#2)(2011-1#1)
different pH conditions##3##3##(2008-10#1)(2009-11#1)(2010-11#1)
different pH values##13##3##(1992-8#3)(1993-11#1)(1994-11#2)(2008-10#6)(2008-5#1)
different pH##28##2##(1992-8#3)(1993-11#1)(1994-11#2)(2008-10#15)(2008-5#2)(2009-11#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-6#1)
different pK(app)##2##2##(2008-10#2)
different packing##2##2##(2008-10#1)(2008-12#1)
different pairs of##2##3##(1991-6#1)(2008-10#1)
different parameters and##2##3##(2008-10#1)(2008-3#1)
different parameters of##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
different parameters such as##3##4##(2008-10#2)(2011-3#1)
different parameters##23##2##(1990-9#1)(1997-2#1)(2007-11#1)(2008-10#10)(2008-3#5)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-8#1)
different particle##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
different parts of the plant##2##5##(2008-10#2)
different parts of the##22##4##(1990-12#1)(1993-12#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
different parts of##28##3##(1990-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
different pathogenic##2##2##(2008-10#2)
different pathogenicity##3##2##(2008-10#2)(2013-8#1)
different pathogens##6##2##(2006-5#1)(2008-10#4)(2012-3#1)
different pathological conditions##2##3##(2008-7#1)(2012-2#1)
different pathologies##2##2##(2008-3#1)(2012-2#1)
different pathophysiology##2##2##(2008-9#1)(2013-7#1)
different pathotypes of##2##3##(2008-10#2)
different pathotypes##4##2##(2008-10#4)
different paths##3##2##(1996-1#1)(2008-3#1)(2009-8#1)
different pathways and##2##3##(2008-10#1)(2010-8#1)
different pathways in liver cells##2##5##(1994-6#1)(1995-6#1)
different pathways##8##2##(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
different patient populations##3##3##(1992-3#2)(2009-10#1)
different patient##5##2##(1992-3#2)(2009-10#1)(2010-10#1)(2010-11#1)
different pattern of##2##3##(1994-3#1)(2008-11#1)
different pattern##6##2##(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2009-5#1)
different patterns of DNA##2##4##(1992-11#1)(2008-10#1)
different patterns of distribution##2##4##(1994-6#1)(1995-11#1)
different patterns of recruitment and follow-up##2##6##(1994-2#2)
different patterns of##17##3##(1992-11#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2009-11#1)(2009-8#2)(2010-2#2)(2011-1#1)(2012-2#1)
different patterns##23##2##(1992-11#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2009-11#1)(2009-8#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
different people##4##2##(1994-12#1)(2008-11#1)(2009-5#1)(2010-2#1)
different peptide##2##2##(1997-6#1)(2008-11#1)
different peptides##6##2##(1991-12#1)(1991-2#1)(1992-5#1)(1995-6#1)(2008-4#1)(2008-5#1)
different percentages of##4##3##(2008-10#4)
different perceptions##3##2##(2008-8#1)(2010-11#1)(2011-1#1)
different periods of##11##3##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
different periods##17##2##(1992-8#1)(1996-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
different permanent modifiers##4##3##(2008-10#4)
different personality##3##2##(1994-2#1)(2008-1#1)(2011-1#1)
different perspectives and##2##3##(2008-11#1)(2008-3#1)
different perspectives of the##2##4##(2008-12#1)(2013-1#1)
different perspectives on##2##3##(1995-2#1)(2012-3#1)
different perspectives##10##2##(1995-2#1)(2008-11#2)(2008-12#4)(2008-3#1)(2012-3#1)(2013-1#1)
different phantoms##2##2##(1997-8#1)(2008-3#1)
different pharmaceutical formulations##2##3##(2008-10#1)(2010-5#1)
different pharmaceutical samples##2##3##(2008-10#2)
different pharmaceutical##4##2##(2008-10#3)(2010-5#1)
different pharmacologic##2##2##(2008-10#1)(2012-12#1)
different pharmacological##4##2##(1990-3#1)(1995-12#1)(1997-5#1)(2008-10#1)
different phases are##2##3##(1990-5#1)(2008-3#1)
different phases in the##2##4##(2008-5#1)(2008-8#1)
different phases of menstrual cycle##2##5##(2012-2#2)
different phases of the cell cycle##4##6##(2008-11#2)(2008-4#1)(2008-7#1)
different phases of##9##3##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#3)(2013-1#1)
different phases##17##2##(1990-5#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#3)(2013-1#1)
different phenolic##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
different phenotypes##6##2##(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
different phenotypic characters##2##3##(2008-10#2)
different phenotypic##4##2##(2008-10#4)
different photochemical##2##2##(1996-5#1)(2007-11#1)
different phylogenetic##4##2##(1995-12#1)(2008-10#2)(2008-8#1)
different physical and chemical properties##2##5##(2008-4#1)(2012-1#1)
different physical##6##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-1#1)
different physiological roles##3##3##(1997-7#1)(2010-2#2)
different physiological stages##2##3##(1996-12#1)(2010-12#1)
different physiological states##3##3##(1994-12#1)(2008-3#2)
different physiological##16##2##(1994-12#1)(1996-12#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-2#1)
different phytoplasmas##2##2##(2008-10#2)
different pitches##2##2##(1993-9#1)(2008-3#1)
different places##5##2##(2008-10#4)(2008-2#1)
different plant spacing##3##3##(2008-12#3)
different plant species was##2##4##(2008-10#2)
different plant species##4##3##(2008-10#3)(2008-8#1)
different plant##15##2##(2008-10#6)(2008-12#3)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-7#1)
different plants##6##2##(1997-4#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
different plasmids##3##2##(1995-8#1)(1997-3#1)(2008-11#1)
different plasticizers##2##2##(2008-10#2)
different point of view##2##4##(1995-2#1)(2010-10#1)
different point of##3##3##(1995-2#1)(2008-10#1)(2010-10#1)
different points of the##4##4##(2008-10#3)(2009-3#1)
different points of##5##3##(2008-10#3)(2008-3#1)(2009-3#1)
different points##8##2##(2008-10#3)(2008-3#2)(2009-3#1)(2010-2#1)(2013-8#1)
different polar##2##2##(2008-10#1)(2008-5#1)
different polarity##5##2##(2008-10#5)
different polarization configurations##2##3##(2008-3#1)(2013-8#1)
different polarization states in##2##4##(2007-11#1)(2008-3#1)
different polarization states##3##3##(2007-11#1)(2008-3#2)
different polarization##6##2##(2007-11#1)(2008-3#4)(2013-8#1)
different polarizations of the##2##4##(2007-12#1)(2008-3#1)
different polarizations of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
different polarizations##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
different policy##2##2##(2008-11#1)(2010-8#1)
different polyadenylation##3##2##(1990-2#2)(2008-8#1)
different polyamines##4##2##(2008-12#4)
different polymer##2##2##(2008-7#1)(2010-5#1)
different polymeric##2##2##(2008-10#2)
different polymers##5##2##(2008-10#1)(2008-5#2)(2012-2#2)
different population##2##2##(2008-10#1)(2008-8#1)
different populations of cells##2##4##(1995-2#1)(2012-3#1)
different populations of neurons##2##4##(1993-12#1)(1993-6#1)
different populations of##8##3##(1990-5#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-3#1)(2009-2#1)(2012-3#1)
different populations to##2##3##(1997-8#1)(2008-8#1)
different populations##23##2##(1990-5#1)(1993-12#1)(1993-6#1)(1995-2#1)(1997-8#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
different portions of the##4##4##(1994-6#1)(1995-2#1)(2008-5#2)
different portions of##5##3##(1994-6#1)(1995-2#1)(2008-10#1)(2008-5#2)
different position in##2##3##(1991-8#1)(2007-11#1)
different positions in##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
different positions of the##4##4##(1990-2#1)(1995-3#1)(2008-2#1)(2008-3#1)
different positions##12##2##(1990-2#1)(1994-1#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
different potencies##2##2##(1995-2#1)(2008-5#1)
different potential##3##2##(2006-10#1)(2008-10#1)(2010-6#1)
different preparations of##2##3##(2008-10#1)(2011-1#1)
different preparations##8##2##(1993-12#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-1#1)
different problems##3##2##(2007-5#1)(2008-7#1)(2009-10#1)
different procedures for##2##3##(2007-7#1)(2008-10#1)
different procedures##10##2##(1995-8#1)(2007-7#1)(2008-10#7)(2008-9#1)
different processes of##2##3##(2008-10#1)(2008-9#1)
different processes##9##2##(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-7#1)
different processing conditions##2##3##(2008-5#1)(2010-4#1)
different processing##5##2##(1995-5#1)(2008-4#1)(2008-5#1)(2010-4#1)(2013-8#1)
different product##2##2##(1994-12#1)(2008-5#1)
different production##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
different products##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
different profile of##2##3##(1993-1#1)(1995-5#1)
different profile##4##2##(1993-1#1)(1995-5#1)(2008-10#2)
different profiles##4##2##(1997-2#1)(1997-3#1)(2008-3#1)(2012-12#1)
different programs##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
different promoters##5##2##(1990-11#1)(1992-3#1)(1994-12#1)(2008-7#1)(2010-5#1)
different properties of##2##3##(1994-12#1)(2008-3#1)
different properties##11##2##(1993-6#1)(1994-12#1)(1996-2#2)(2007-11#1)(2008-3#2)(2009-5#1)(2010-5#1)(2010-8#1)(2012-2#1)
different proportions##5##2##(2008-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
different protein kinases and##2##4##(1990-8#1)(1997-2#1)
different protein kinases##3##3##(1990-8#2)(1997-2#1)
different protein##13##2##(1990-8#2)(1992-12#1)(1997-2#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)
different proteins at##2##3##(1995-8#1)(2008-10#1)
different proteins##8##2##(1994-11#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2013-8#1)
different protocols##8##2##(1990-10#1)(2007-8#1)(2008-2#1)(2008-4#3)(2012-1#1)(2013-8#1)
different provinces##2##2##(2008-1#1)(2008-8#1)
different psychiatric##3##2##(1996-7#1)(2009-11#1)(2009-9#1)
different pulse##7##2##(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
different pump light distributions##2##4##(2008-2#2)
different purification procedures##2##3##(2008-10#2)
different purposes##4##2##(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
different races of##2##3##(2008-10#2)
different races##4##2##(2008-10#3)(2011-1#1)
different racial groups##3##3##(2008-5#3)
different racial##4##2##(2008-5#4)
different radii##2##2##(2008-3#2)
different radiographic methods##2##3##(2007-11#2)
different random number##2##3##(2008-3#1)(2008-7#1)
different random##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
different ranges of##2##3##(1995-2#1)(2008-10#1)
different ranges##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
different raters##2##2##(2008-9#1)(2012-2#1)
different rates##7##2##(1994-3#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-7#1)
different ratios of##2##3##(1996-5#1)(2009-4#1)
different ratios##11##2##(1991-5#1)(1996-5#1)(2008-10#4)(2008-5#2)(2009-4#1)(2010-3#1)(2012-2#1)
different reaction##7##2##(1996-5#1)(1997-7#1)(2008-10#3)(2010-10#2)
different reactions with##2##3##(1997-6#1)(2011-1#1)
different reactors##2##2##(2008-10#1)(2008-6#1)
different rearing systems##2##3##(2010-4#2)
different rearing##3##2##(2007-12#1)(2010-4#2)
different reasons##7##2##(1991-9#1)(1994-5#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#2)
different rec mutants##2##3##(1990-11#2)
different receptor##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
different reference materials##3##3##(2008-10#3)
different reference##5##2##(2008-10#4)(2012-2#1)
different refractive index##2##3##(2007-11#1)(2008-10#1)
different refractive indices##3##3##(2008-2#3)
different refractive##6##2##(2007-11#1)(2008-10#1)(2008-2#4)
different regimens##4##2##(1993-1#1)(2008-10#1)(2008-6#1)(2009-8#1)
different regional##2##2##(1994-12#1)(2008-1#1)
different regions in the##3##4##(1991-11#1)(2008-4#1)(2010-5#1)
different regions in##4##3##(1991-11#1)(2008-4#1)(2010-5#1)(2011-1#1)
different regions of interest##2##4##(2007-10#1)(2008-6#1)
different regions of the##14##4##(1990-11#1)(1990-3#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-2#1)(2011-1#1)(2012-3#1)
different regions of##30##3##(1990-11#1)(1990-3#2)(1990-8#1)(1993-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
different regions##44##2##(1990-11#1)(1990-3#2)(1990-8#1)(1991-11#2)(1993-12#2)(1995-3#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
different regulation##2##2##(1991-5#1)(2008-7#1)
different regulatory##5##2##(1993-8#1)(1997-7#1)(2008-7#1)(2012-2#1)(2012-3#1)
different relative##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
different relaxation##2##2##(1995-3#1)(2009-6#1)
different reproductive##3##2##(2007-5#1)(2008-4#1)(2008-9#1)
different requirements for##2##3##(2008-8#1)(2010-8#1)
different requirements##3##2##(2008-8#1)(2010-12#1)(2010-8#1)
different research methods##2##3##(2008-10#1)(2008-12#1)
different research##4##2##(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
different residues##2##2##(1992-3#1)(2008-7#1)
different resin##2##2##(2008-10#1)(2009-8#1)
different resistance genes##3##3##(2008-10#3)
different resistance##6##2##(2007-6#1)(2008-10#5)
different responses to##9##3##(1991-2#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-9#2)(2013-1#1)
different responses##16##2##(1991-2#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-6#1)(2013-1#2)
different rest##2##2##(2007-10#2)
different restriction enzymes##3##3##(1996-2#1)(2008-10#2)
different restriction##5##2##(1996-2#1)(2008-10#4)
different results##5##2##(1992-12#1)(2007-12#1)(2008-10#2)(2009-5#1)
different retention times##3##3##(2008-10#1)(2008-11#2)
different retention##5##2##(1996-5#1)(2008-10#2)(2008-11#2)
different rice##5##2##(2008-10#2)(2008-9#3)
different risk factors##2##3##(1990-6#1)(2007-2#1)
different risk##7##2##(1990-6#1)(2007-2#1)(2008-10#3)(2012-2#2)
different rivers##2##2##(2008-10#1)(2008-9#1)
different role in##2##3##(2010-2#1)(2013-1#1)
different roles##5##2##(1995-11#1)(2008-11#2)(2008-7#1)(2012-2#1)
different rotational##4##2##(1995-5#1)(1997-2#1)(2008-3#2)
different routes##2##2##(1996-1#1)(2008-7#1)
different rules##3##2##(1993-2#1)(1997-3#1)(2008-8#1)
different salt##3##2##(2008-10#1)(2010-4#1)(2012-12#1)
different sample extraction##2##3##(2008-10#2)
different sample preparation##2##3##(2008-10#1)(2012-12#1)
different sample##13##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-11#1)(2012-12#1)
different samples of##9##3##(1995-11#1)(2008-10#7)(2009-7#1)
different samples##26##2##(1991-5#1)(1993-11#1)(1995-11#1)(1997-5#1)(2007-11#1)(2008-10#16)(2008-4#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#1)
different sampling##6##2##(1997-4#1)(2008-10#4)(2008-11#1)
different scFv##2##2##(2008-10#2)
different scales and##2##3##(2008-10#1)(2008-8#1)
different scales##9##2##(2008-10#2)(2008-8#4)(2008-9#1)(2010-7#1)(2013-1#1)
different scattering##2##2##(2008-2#1)(2008-3#1)
different schedules of##2##3##(2008-8#1)(2011-2#1)
different scores##2##2##(2008-9#1)(2012-2#1)
different seasons##6##2##(2008-10#2)(2008-8#2)(2012-2#2)
different sections of##3##3##(2007-11#1)(2008-10#1)(2009-12#1)
different sectors of##2##3##(1991-3#1)(1992-4#1)
different sectors##5##2##(1991-3#1)(1992-4#1)(2008-11#1)(2010-12#1)(2012-3#1)
different segments of##2##3##(1993-9#1)(2010-1#1)
different segments##4##2##(1993-9#1)(1994-3#1)(2008-3#1)(2010-1#1)
different selenium##2##2##(2008-10#2)
different sensitivities to##2##3##(1990-11#1)(1992-12#1)
different sensitivities##3##2##(1990-11#1)(1992-12#1)(2008-3#1)
different sensitivity to##2##3##(1990-5#1)(2008-9#1)
different sensitivity##4##2##(1990-5#1)(1995-11#1)(2008-9#1)(2011-2#1)
different sensitization##2##2##(2008-10#1)(2013-1#1)
different separation##2##2##(1996-5#1)(2008-10#1)
different sequences of##2##3##(1993-1#1)(2008-4#1)
different sequences##5##2##(1992-6#2)(1993-1#1)(2008-4#1)(2008-8#1)
different series##2##2##(1995-3#1)(2008-11#1)
different serogroups##2##2##(2008-10#1)(2008-5#1)
different serotypes##5##2##(1993-2#1)(1995-5#1)(1997-3#1)(2008-8#1)(2013-8#1)
different set of##7##3##(1992-2#1)(1995-8#1)(2008-2#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
different set##8##2##(1992-2#1)(1995-8#1)(2008-2#2)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
different sets of conditions##3##4##(2008-10#1)(2008-4#1)(2010-12#1)
different sets of##15##3##(1992-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-8#1)
different settings##7##2##(2008-11#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-12#2)(2012-3#1)
different shape##2##2##(2007-12#2)
different shapes of##3##3##(1994-8#1)(2008-2#1)(2013-1#1)
different shapes##8##2##(1994-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
different shoulder##2##2##(2010-7#1)(2011-2#1)
different side##4##2##(1990-8#1)(2008-10#1)(2008-7#2)
different sides of the##2##4##(2009-10#1)(2013-8#1)
different sides of##3##3##(2009-10#2)(2013-8#1)
different signaling pathways##5##3##(2008-4#1)(2008-8#3)(2008-9#1)
different signaling##7##2##(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)
different signals##6##2##(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)
different significantly from that of##2##5##(2008-8#1)(2009-10#1)
different sites in##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
different sites of the##3##4##(1992-3#1)(2008-5#1)(2008-6#1)
different sites of##5##3##(1992-3#1)(1997-2#1)(2006-4#1)(2008-5#1)(2008-6#1)
different sites on##2##3##(1990-5#1)(1992-3#1)
different sites##21##2##(1990-5#1)(1991-12#1)(1992-3#2)(1993-11#1)(1997-2#1)(1997-8#1)(2006-4#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-7#1)
different situations##6##2##(1990-9#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-3#1)(2009-11#1)
different size##6##2##(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-7#2)
different sized supernumerary segments##2##4##(2008-5#2)
different sized##7##2##(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)
different sizes and shapes##2##4##(2008-10#2)
different sizes and##7##3##(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
different sizes of the##2##4##(2008-10#1)(2011-2#1)
different sizes of##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
different sizes##29##2##(1990-2#1)(1995-8#1)(1996-4#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#4)(2011-2#1)(2012-2#4)
different snow##3##2##(2008-3#3)
different social##4##2##(2007-12#1)(2008-11#1)(2010-2#1)(2012-2#1)
different socioeconomic##2##2##(2008-10#1)(2012-2#1)
different sodium##2##2##(1994-5#1)(2010-3#1)
different soft##3##2##(2008-12#2)(2011-2#1)
different soil##5##2##(2008-10#5)
different soils and##2##3##(2008-10#2)
different soils##7##2##(2008-10#5)(2008-2#1)(2008-6#1)
different solar##2##2##(2008-3#1)(2013-8#1)
different solid##4##2##(2008-10#3)(2008-3#1)
different solutions to the##2##4##(2008-3#1)(2008-9#1)
different solutions##6##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
different solvent##4##2##(1997-2#1)(2007-11#1)(2008-10#2)
different solvents##7##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
different somatic##2##2##(2008-10#1)(2008-5#1)
different sorbents##2##2##(2008-10#2)
different sorption rates##2##3##(2008-10#2)
different sorption##3##2##(2008-10#3)
different source and##2##3##(2008-2#1)(2008-6#1)
different source##4##2##(2008-10#2)(2008-2#1)(2008-6#1)
different sources of##3##3##(2008-3#1)(2012-2#2)
different sources##17##2##(1990-5#1)(1992-12#1)(1992-3#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
different space##2##2##(1993-8#1)(2009-11#1)
different spaces##3##2##(2008-12#1)(2008-5#1)(2012-1#1)
different spatial and##2##3##(2008-3#1)(2013-1#1)
different spatial frequencies##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
different spatial patterns##2##3##(1996-12#1)(2007-12#1)
different spatial scales##7##3##(2008-10#1)(2008-8#3)(2009-2#1)(2012-12#1)(2013-7#1)
different spatial##17##2##(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#3)(2009-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
different specialties##4##2##(1991-6#1)(2007-11#1)(2013-1#2)
different species and##4##3##(2008-10#3)(2008-8#1)
different species in##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
different species of##13##3##(1994-11#1)(1994-6#1)(1994-9#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#1)
different species with##2##3##(1990-5#1)(1997-3#1)
different species##60##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1997-3#1)(1997-6#1)(2007-12#3)(2008-10#22)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#5)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
different specific##4##2##(1991-2#1)(1994-11#1)(2008-11#1)(2008-7#1)
different specificity##3##2##(1996-12#1)(2008-11#1)(2008-4#1)
different spectral##8##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
different spectroscopic##2##2##(2008-10#2)
different spectrum of##3##3##(2008-6#1)(2009-9#1)(2011-2#1)
different spike##2##2##(1993-12#1)(2008-10#1)
different stage of##4##3##(1996-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
different stage##5##2##(1996-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
different stages of germ cell development##2##6##(2009-10#1)(2009-3#1)
different stages of life##2##4##(1997-7#1)(2008-10#1)
different stages of pregnancy##2##4##(1995-12#1)(2008-9#1)
different stages of the disease##2##5##(2008-5#1)(2008-8#1)
different stages of the##10##4##(1990-12#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)
different stages of##47##3##(1990-12#1)(1990-5#1)(1993-1#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)
different stages##59##2##(1990-12#1)(1990-5#1)(1993-1#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)
different standard##2##2##(1994-3#1)(2013-8#1)
different starting##4##2##(1992-11#1)(1994-5#1)(2008-10#1)(2008-3#1)
different states of##3##3##(1992-6#1)(2007-11#1)(2013-8#1)
different states##8##2##(1990-11#1)(1992-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-8#1)
different steps of the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
different steps of##5##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-2#1)(2011-2#1)
different steps##8##2##(1994-2#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-2#1)(2011-2#1)
different steric##2##2##(1996-2#1)(2010-12#1)
different stimuli##4##2##(1990-12#1)(1993-12#1)(1994-3#1)(2013-1#1)
different stimulus conditions##2##3##(1996-2#1)(2008-11#1)
different stimulus##5##2##(1994-3#3)(1996-2#1)(2008-11#1)
different storage##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
different strains and##2##3##(2008-10#1)(2008-5#1)
different strains of mice##2##4##(1996-5#1)(2008-10#1)
different strains of the##6##4##(2008-10#3)(2008-5#1)(2010-12#1)(2012-2#1)
different strains of##17##3##(1992-8#1)(1996-5#1)(1997-7#1)(2008-10#6)(2008-12#2)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
different strains##30##2##(1992-8#1)(1996-5#1)(1997-7#2)(2007-6#1)(2008-10#9)(2008-12#2)(2008-5#4)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-8#1)
different strategies and##2##3##(2008-10#1)(2013-1#1)
different strategies for##4##3##(1994-12#1)(1995-3#1)(2008-10#2)
different strategies to##3##3##(2008-7#1)(2008-8#1)(2010-10#1)
different strategies##18##2##(1994-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
different strategy##2##2##(2009-6#1)(2010-8#1)
different strengths##2##2##(2008-5#1)(2013-1#1)
different stress##2##2##(2008-11#1)(2008-7#1)
different stresses##4##2##(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
different structural##10##2##(1992-6#1)(1993-2#1)(1995-5#2)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-7#1)
different structures and##2##3##(2010-7#1)(2011-3#1)
different structures##8##2##(1993-12#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-3#1)
different studies##14##2##(1990-3#1)(2008-1#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
different study designs and##2##4##(2007-7#1)(2013-1#1)
different study##3##2##(1995-2#1)(2007-7#1)(2013-1#1)
different subcellular##3##2##(1990-5#1)(1996-2#1)(1997-7#1)
different subjects##3##2##(1991-12#1)(2008-5#1)(2010-8#1)
different subpopulations##4##2##(1995-12#1)(2007-6#1)(2008-10#2)
different subregions##2##2##(2008-8#2)
different subsets of##2##3##(1994-3#1)(2010-5#1)
different subsets##3##2##(1994-3#1)(2008-6#1)(2010-5#1)
different substances##2##2##(2008-10#1)(2008-11#1)
different substituted##2##2##(2008-10#1)(2011-1#1)
different substitutions##2##2##(2008-4#1)(2010-4#1)
different substrate##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
different substrates##8##2##(1991-5#1)(1993-11#1)(2008-10#3)(2008-3#2)(2010-3#1)
different subtypes of##6##3##(2008-12#2)(2010-12#1)(2010-2#1)(2012-12#2)
different subtypes##7##2##(2008-12#2)(2010-12#1)(2010-2#1)(2012-12#3)
different subunits in##2##3##(1991-10#1)(2008-9#1)
different subunits of##2##3##(2008-4#1)(2008-7#1)
different subunits##5##2##(1991-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
different sunscreen##2##2##(2008-5#2)
different surface treatments##2##3##(2008-12#2)
different surface##6##2##(1994-5#1)(1997-2#1)(2008-10#1)(2008-12#2)(2013-1#1)
different surgical##2##2##(1990-6#1)(2013-1#1)
different susceptibility to##2##3##(1992-12#1)(2008-10#1)
different synaptic##3##2##(1996-12#1)(2008-7#1)(2009-3#1)
different synthetic##4##2##(2008-11#2)(2008-8#1)(2012-3#1)
different systems##6##2##(1993-2#1)(1993-3#1)(1995-1#1)(2007-4#1)(2008-10#2)
different target tissues##2##3##(2008-4#1)(2010-3#1)
different target##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)
different targets##2##2##(2008-10#1)(2010-7#1)
different tasks##5##2##(1994-8#1)(1996-3#1)(2008-11#1)(2009-8#1)(2013-8#1)
different taste substances##3##3##(2008-10#3)
different tastes##4##2##(2008-10#3)(2013-1#1)
different techniques and##2##3##(2008-10#2)
different techniques for##6##3##(1991-3#1)(1994-11#1)(1995-12#1)(2007-12#1)(2008-4#1)(2013-1#1)
different techniques of##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
different techniques to##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
different techniques##31##2##(1991-3#1)(1994-11#1)(1995-12#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
different temperature and##6##3##(2008-10#2)(2008-2#2)(2008-7#1)(2011-2#1)
different temperature regimes##2##3##(2008-10#1)(2008-12#1)
different temperature##13##2##(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
different temperatures (ranging from 30 to##3##6##(2008-10#3)
different temperatures and##11##3##(1996-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
different temperatures were##2##3##(2008-10#2)
different temperatures##42##2##(1994-3#1)(1995-5#1)(1996-12#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#1)(2010-3#1)(2011-2#1)(2012-8#1)(2013-1#2)
different test##6##2##(2008-10#1)(2008-2#1)(2008-5#2)(2009-5#1)(2009-9#1)
different tests based on the same principle##3##7##(2008-10#3)
different textures##2##2##(2007-12#1)(2008-10#1)
different than that##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
different than the##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
different than those##2##3##(2007-10#1)(2008-7#1)
different than##14##2##(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#2)
different theoretical##2##2##(2008-10#1)(2009-12#1)
different theories##2##2##(2008-3#1)(2010-10#1)
different therapeutic agents##2##3##(2008-8#1)(2008-9#1)
different therapeutic procedures##2##3##(1993-9#1)(2007-8#1)
different therapeutic##9##2##(1993-11#1)(1993-9#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
different thermal##2##2##(2008-3#1)(2012-2#1)
different thicknesses##2##2##(2008-12#1)(2008-3#1)
different threshold##2##2##(2008-3#1)(2013-8#1)
different thyroid##2##2##(2013-1#1)(2013-8#1)
different tillage systems##3##3##(2008-10#3)
different tillage##4##2##(2008-10#4)
different time courses##2##3##(1991-2#1)(2008-11#1)
different time intervals##4##3##(2007-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
different time of##2##3##(2008-7#1)(2012-5#1)
different time periods##5##3##(1995-6#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
different time points##3##3##(1990-7#1)(2008-3#1)(2011-3#1)
different time##21##2##(1990-7#1)(1991-2#1)(1995-6#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
different times after##3##3##(1994-5#1)(2008-10#2)
different times##23##2##(1994-5#2)(1994-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-3#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
different tissue origins##2##3##(2008-8#1)(2009-9#1)
different tissue##10##2##(1995-11#1)(1997-7#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
different tissues by##2##3##(1993-11#1)(2009-8#1)
different tissues or##2##3##(2008-4#1)(2008-7#1)
different tissues##21##2##(1991-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2013-8#1)
different to that for##2##4##(2008-10#1)(2011-1#1)
different to that of the##2##5##(1994-6#1)(1994-8#1)
different to that##6##3##(1994-6#1)(1994-8#1)(2008-10#3)(2011-1#1)
different to the##3##3##(1996-12#1)(2008-7#1)(2013-1#1)
different to those##2##3##(2007-5#1)(2012-12#1)
different to##15##2##(1994-6#1)(1994-8#1)(1996-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-1#2)(2012-12#1)(2013-1#2)
different tomato cultivars##2##3##(2008-10#2)
different total##2##2##(2008-10#1)(2008-4#1)
different toxicity##6##2##(2007-11#1)(2008-10#4)(2008-5#1)
different traffic intensities##2##3##(2008-10#2)
different training##2##2##(1994-12#1)(2013-1#1)
different transcripts##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
different transferrin isoforms##2##3##(1993-8#2)
different transitions##6##2##(2007-12#5)(2008-3#1)
different transmission##2##2##(2008-10#1)(2008-7#1)
different transplant##2##2##(2010-8#1)(2011-2#1)
different treatment modalities##7##3##(1992-9#1)(1993-8#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-7#1)(2012-3#1)
different treatment options##3##3##(2009-6#1)(2009-8#1)(2011-2#1)
different treatment##18##2##(1990-2#1)(1992-2#1)(1992-9#1)(1993-8#1)(1995-5#1)(1996-9#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
different treatments are##2##3##(2008-6#1)(2011-2#1)
different treatments##15##2##(1991-6#1)(1992-9#1)(1994-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2010-5#1)(2011-2#1)(2012-2#1)
different tumor##4##2##(1993-11#1)(1997-7#1)(2008-6#1)(2011-2#1)
different type II##2##3##(1992-5#1)(2012-3#1)
different type of##7##3##(1995-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
different type##13##2##(1992-5#1)(1993-9#1)(1995-6#1)(2008-1#1)(2008-10#4)(2009-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
different types and##2##3##(2010-7#2)
different types of B##2##4##(2008-12#1)(2008-7#1)
different types of cancer##2##4##(1992-8#1)(2008-1#1)
different types of commercial##2##4##(2008-10#2)
different types of data##2##4##(2008-4#1)(2011-2#1)
different types of disturbances##2##4##(1997-2#1)(2007-11#1)
different types of exercise##3##4##(2013-1#3)
different types of laboratory##2##4##(2008-11#1)(2010-6#1)
different types of resistance##2##4##(2008-10#2)
different types of sampling##2##4##(2008-10#2)
different types of solid##2##4##(2008-10#1)(2011-2#1)
different types of tobacco##2##4##(2008-10#2)
different types of water##2##4##(2008-10#1)(2008-2#1)
different types of waters##3##4##(2008-10#3)
different types of wrinkles##2##4##(2008-5#2)
different types of##162##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#3)(1994-1#1)(1995-1#1)(1996-2#3)(1996-4#1)(1996-9#1)(1997-2#2)(1997-4#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-7#4)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#5)
different types##182##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#3)(1996-4#1)(1996-9#1)(1997-2#3)(1997-4#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#45)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#5)(2013-8#1)
different underlying##4##2##(1994-11#1)(1996-3#1)(2008-7#1)(2011-2#1)
different units of##2##3##(1995-3#1)(2008-1#1)
different units##3##2##(1995-3#1)(2008-1#1)(2008-12#1)
different universities##2##2##(1990-12#1)(1991-6#1)
different values obtained##2##3##(1992-3#1)(2008-10#1)
different values of##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)
different values##8##2##(1992-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)
different variables were##3##3##(2008-10#3)
different variables##11##2##(2008-10#11)
different variants##2##2##(1990-11#1)(2008-10#1)
different varieties of##5##3##(1991-8#1)(2008-10#3)(2011-1#1)
different varieties##7##2##(1991-8#1)(2008-10#5)(2011-1#1)
different vehicles##2##2##(2008-5#2)
different velocities##3##2##(2008-6#1)(2012-3#2)
different versions of the##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
different versions of##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
different viewing##2##2##(2007-8#1)(2008-3#1)
different views of##2##3##(2008-3#1)(2013-8#1)
different views##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
different viral##4##2##(2008-10#2)(2008-4#1)(2013-8#1)
different virulence##2##2##(1995-2#1)(2008-10#1)
different viruses##2##2##(2008-10#1)(2008-11#1)
different voltammetric##2##2##(2008-10#2)
different volumes of##2##3##(2008-10#2)
different water samples##9##3##(2008-10#9)
different water##13##2##(2007-10#1)(2008-10#12)
different wavelength##4##2##(2008-10#1)(2008-3#2)(2010-5#1)
different wavelengths are##3##3##(2008-3#2)(2011-1#1)
different wavelengths is##3##3##(2007-11#1)(2008-2#1)(2013-8#1)
different wavelengths##32##2##(1990-8#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2011-1#1)(2013-8#1)
different ways of##4##3##(1991-2#1)(1993-2#1)(2008-10#1)(2012-1#1)
different ways to##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
different ways##34##2##(1990-3#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
different weight##2##2##(2007-11#1)(2012-3#1)
different weights##2##2##(2007-11#1)(2012-12#1)
different wetness##2##2##(2008-10#2)
different wheat cultivars##2##3##(2008-10#2)
different wheat##3##2##(2008-10#3)
different when compared with##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
different when compared##4##3##(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
different when##6##2##(1996-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
different wine##2##2##(2008-10#2)
different with respect to##2##4##(1991-6#1)(2008-10#1)
different with the##2##3##(2008-3#1)(2011-1#1)
different with##5##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)
different within##2##2##(1990-8#1)(2008-3#1)
different xenobiotics##2##2##(2008-10#1)(2008-5#1)
different years##7##2##(1993-2#1)(2008-10#5)(2008-12#1)
different zenith angles##2##3##(2008-2#1)(2008-3#1)
different zones of the##2##4##(2008-5#1)(2011-2#1)
different zones of##3##3##(2008-5#2)(2011-2#1)
different##7174##1##(1990-10#1)(1990-11#21)(1990-12#33)(1990-2#17)(1990-3#10)(1990-5#29)(1990-6#9)(1990-7#13)(1990-8#24)(1990-9#11)(1991-1#8)(1991-10#2)(1991-11#18)(1991-12#18)(1991-2#16)(1991-3#8)(1991-5#19)(1991-6#18)(1991-7#6)(1991-8#11)(1991-9#10)(1992-1#2)(1992-10#1)(1992-11#10)(1992-12#21)(1992-2#14)(1992-3#42)(1992-4#3)(1992-5#12)(1992-6#19)(1992-8#25)(1992-9#13)(1993-1#9)(1993-11#20)(1993-12#41)(1993-2#20)(1993-3#16)(1993-5#6)(1993-6#17)(1993-8#32)(1993-9#12)(1994-1#3)(1994-11#22)(1994-12#33)(1994-2#19)(1994-3#26)(1994-5#31)(1994-6#19)(1994-8#22)(1994-9#13)(1995-1#6)(1995-10#1)(1995-11#24)(1995-12#37)(1995-2#34)(1995-3#21)(1995-4#1)(1995-5#26)(1995-6#27)(1995-8#14)(1995-9#1)(1996-1#9)(1996-10#3)(1996-11#3)(1996-12#28)(1996-2#38)(1996-3#12)(1996-4#3)(1996-5#23)(1996-6#8)(1996-7#5)(1996-8#1)(1996-9#6)(1997-1#8)(1997-2#44)(1997-3#31)(1997-4#28)(1997-5#10)(1997-6#24)(1997-7#38)(1997-8#21)(1997-9#3)(2006-10#3)(2006-12#4)(2006-4#2)(2006-5#1)(2006-6#6)(2007-1#1)(2007-10#24)(2007-11#80)(2007-12#109)(2007-2#3)(2007-4#7)(2007-5#11)(2007-6#5)(2007-7#24)(2007-8#25)(2007-9#3)(2008-1#61)(2008-10#1911)(2008-11#234)(2008-12#156)(2008-2#195)(2008-3#348)(2008-4#109)(2008-5#233)(2008-6#69)(2008-7#208)(2008-8#223)(2008-9#156)(2009-1#4)(2009-10#34)(2009-11#15)(2009-12#22)(2009-2#16)(2009-3#19)(2009-4#7)(2009-5#23)(2009-6#12)(2009-7#33)(2009-8#44)(2009-9#13)(2010-1#5)(2010-10#32)(2010-11#23)(2010-12#30)(2010-2#20)(2010-3#36)(2010-4#33)(2010-5#31)(2010-6#9)(2010-7#13)(2010-8#51)(2010-9#12)(2011-1#92)(2011-10#1)(2011-2#206)(2011-3#11)(2011-4#1)(2011-7#1)(2012-1#36)(2012-12#57)(2012-2#140)(2012-3#114)(2012-4#2)(2012-5#3)(2012-6#3)(2012-7#6)(2012-8#6)(2012-9#2)(2013-1#230)(2013-7#40)(2013-8#112)
different)##2##1##(1994-8#1)(2008-1#1)
different-ethnic##3##1##(2009-7#3)
different-sized##6##1##(1992-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
different?##5##1##(1995-11#1)(1995-3#1)(2008-4#1)(2008-5#1)(2009-7#1)
differentiable##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
differential JFTC##2##2##(2008-3#2)
differential absorption Mueller matrix##2##4##(2008-3#2)
differential absorption coefficient##4##3##(2008-2#4)
differential absorption lidar (DIAL) measurements##2##5##(2008-3#2)
differential absorption lidar (DIAL) system##5##5##(2007-12#1)(2008-2#2)(2008-3#2)
differential absorption lidar (DIAL) technique##2##5##(2008-3#2)
differential absorption lidar (DIAL)##16##4##(2007-12#1)(2008-2#6)(2008-3#9)
differential absorption lidar application##2##4##(2007-11#1)(2008-2#1)
differential absorption lidar for##4##4##(2008-2#3)(2008-3#1)
differential absorption lidar measurements##3##4##(2008-2#1)(2008-3#2)
differential absorption lidar ozone##2##4##(2008-2#1)(2008-3#1)
differential absorption lidar system for##2##5##(2008-2#1)(2008-3#1)
differential absorption lidar system##5##4##(2008-2#1)(2008-3#4)
differential absorption lidar##47##3##(2007-11#1)(2007-12#2)(2008-2#17)(2008-3#27)
differential absorption spectroscopy##3##3##(2008-2#1)(2008-3#2)
differential absorption##59##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#22)(2008-3#32)
differential activation in##2##3##(2008-11#1)(2008-7#1)
differential activation##3##2##(2008-11#1)(2008-7#1)(2013-7#1)
differential and##6##2##(1990-11#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#1)
differential cell counts in##2##4##(1991-11#2)
differential cell##6##2##(1991-11#2)(1991-9#1)(1993-11#1)(2008-11#2)
differential centrifugation##6##2##(1991-7#1)(1993-8#1)(2008-1#2)(2008-10#1)(2008-4#1)
differential clinical##3##2##(1991-8#1)(2007-10#1)(2009-4#1)
differential confocal microscopy##2##3##(2007-12#2)
differential control##2##2##(1993-3#1)(2008-5#1)
differential count##2##2##(1991-11#1)(2008-10#1)
differential counts##3##2##(2008-10#2)(2008-7#1)
differential cultivars##10##2##(2008-10#10)
differential detection##3##2##(2008-2#2)(2008-3#1)
differential determination of##3##3##(2008-10#3)
differential diagnoses are##2##3##(1990-9#1)(2011-2#1)
differential diagnoses##12##2##(1990-9#1)(1993-8#1)(1995-6#1)(2007-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#3)(2012-3#1)
differential diagnosis and also##2##4##(2008-9#1)(2013-1#1)
differential diagnosis and##8##3##(1990-6#1)(1993-8#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-9#1)(2012-1#1)(2013-1#1)
differential diagnosis are discussed##2##4##(2008-11#1)(2012-3#1)
differential diagnosis are##4##3##(1992-11#1)(2008-11#1)(2012-3#2)
differential diagnosis between##3##3##(1990-10#1)(2012-3#1)(2013-1#1)
differential diagnosis for a##2##4##(2007-7#1)(2012-12#1)
differential diagnosis for##9##3##(2007-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
differential diagnosis has##2##3##(1993-2#2)
differential diagnosis in##7##3##(1990-12#1)(1990-6#1)(1991-2#1)(1996-11#1)(1997-4#1)(2006-10#1)(2010-6#1)
differential diagnosis includes##4##3##(2006-12#1)(2008-7#1)(2010-3#1)(2011-2#1)
differential diagnosis is##4##3##(1990-12#1)(1991-8#1)(1992-10#1)(2008-6#1)
differential diagnosis may##2##3##(2007-8#1)(2011-2#1)
differential diagnosis of a##6##4##(1992-2#1)(1994-7#1)(2007-12#1)(2007-8#1)(2009-1#1)(2010-12#1)
differential diagnosis of dementia##3##4##(1996-11#2)(2008-7#1)
differential diagnosis of the##4##4##(2008-12#1)(2008-7#1)(2013-1#2)
differential diagnosis of##82##3##(1990-11#1)(1990-2#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-5#1)(1994-7#1)(1996-11#3)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#5)(2009-1#1)(2009-3#4)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
differential diagnosis when##2##3##(1995-11#1)(2013-8#1)
differential diagnosis with##3##3##(1990-8#1)(1993-8#1)(2008-9#1)
differential diagnosis##177##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-2#4)(1993-8#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1996-11#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-12#2)(2007-10#2)(2007-12#3)(2007-5#3)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#5)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#13)(2012-1#2)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#5)
differential diagnosis]##3##2##(1991-4#1)(1996-11#1)(1996-6#1)
differential diagnostic##6##2##(1992-3#1)(1993-2#1)(1995-5#1)(1997-2#1)(2008-7#1)(2011-2#1)
differential display (RMDD)##2##3##(2008-2#2)
differential display method##2##3##(1997-7#1)(2008-9#1)
differential display##21##2##(1994-6#1)(1997-7#1)(2008-1#1)(2008-2#7)(2008-8#4)(2008-9#5)(2010-12#2)
differential effect of##8##3##(1992-3#1)(1994-5#1)(2008-10#2)(2010-1#1)(2012-8#1)(2013-1#2)
differential effect##10##2##(1991-5#1)(1992-3#1)(1994-5#1)(2008-10#2)(2010-1#1)(2012-8#2)(2013-1#2)
differential effects of##6##3##(1992-12#1)(1996-2#1)(1997-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
differential effects on##6##3##(1992-12#1)(1993-12#1)(1996-12#1)(2007-12#1)(2009-10#1)(2012-3#1)
differential effects##14##2##(1992-12#2)(1993-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-4#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
differential electrolytic##2##2##(2008-10#2)
differential equation for##2##3##(2008-2#1)(2008-3#1)
differential equation model##5##3##(2008-10#1)(2008-8#1)(2009-10#1)(2013-8#2)
differential equation modeling##2##3##(2009-10#2)
differential equation##19##2##(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#4)(2013-8#2)
differential equations and##2##3##(1993-5#1)(2008-9#1)
differential equations for##2##3##(2008-10#1)(2013-8#1)
differential equations that##2##3##(2007-12#1)(2008-8#1)
differential equations were##3##3##(2008-10#2)(2013-1#1)
differential equations with##2##3##(2008-10#1)(2010-11#1)
differential equations##24##2##(1993-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2013-1#1)(2013-8#5)
differential exposure##2##2##(1994-2#1)(2008-2#1)
differential expression in##2##3##(1991-2#1)(2008-10#1)
differential expression of the##4##4##(1991-9#1)(1993-11#1)(1993-12#1)(1997-7#1)
differential expression of various##2##4##(1992-10#1)(2008-2#1)
differential expression of##9##3##(1991-9#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-2#1)(1997-7#1)(2008-2#1)
differential expression patterns##2##3##(1992-6#1)(2010-12#1)
differential expression##28##2##(1991-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-7#6)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
differential function##2##2##(2008-10#1)(2008-4#1)
differential gene expression##5##3##(1994-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
differential geometric form factor##2##4##(2008-3#2)
differential global positioning##2##3##(2008-10#1)(2009-10#1)
differential glycosylation##3##2##(1990-12#2)(1992-9#1)
differential group delay (DGD)##2##4##(2007-11#1)(2007-12#1)
differential group delay in##2##4##(2007-11#1)(2007-12#1)
differential group delay of##3##4##(2007-11#2)(2007-12#1)
differential group delay##12##3##(2007-11#5)(2007-12#5)(2008-3#2)
differential growth##3##2##(2007-5#1)(2009-8#1)(2013-7#1)
differential hosts composing the scale##2##5##(2008-10#2)
differential hosts##8##2##(2008-10#8)
differential hybridization##2##2##(1991-9#1)(1993-6#1)
differential in##4##2##(1993-11#1)(1995-2#1)(2007-12#2)
differential interactions##2##2##(2008-10#2)
differential interference contrast##5##3##(2007-12#1)(2008-3#1)(2008-4#2)(2008-9#1)
differential interferometer##3##2##(2008-3#3)
differential involvement of##2##3##(2007-7#1)(2009-9#1)
differential isolates of##3##3##(2008-10#3)
differential kinetic method##3##3##(2008-10#3)
differential kinetic##5##2##(2008-10#5)
differential length##2##2##(2008-3#2)
differential medication of##2##3##(1993-12#2)
differential method is##3##3##(2008-10#1)(2008-3#2)
differential method##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
differential of##3##2##(2007-12#1)(2008-3#2)
differential optical absorption spectroscopy##5##4##(2008-2#1)(2008-3#4)
differential optical##7##2##(2008-2#3)(2008-3#4)
differential optical-fiber displacement sensor##2##4##(2008-2#1)(2008-3#1)
differential pathogenicity##3##2##(2008-10#3)
differential phase measurement##3##3##(2007-11#1)(2007-12#2)
differential phase optical interferometer##2##4##(2007-11#1)(2008-2#1)
differential phase tracking##2##3##(2008-2#2)
differential phase##11##2##(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#1)
differential phase-contrast##2##2##(2007-11#2)
differential phosphorylation##2##2##(2008-8#2)
differential polarization##2##2##(2008-2#1)(2008-3#1)
differential processing of##2##3##(1994-11#1)(1995-5#1)
differential prognostic##2##2##(2007-8#2)
differential protein##2##2##(2010-12#2)
differential proteomic##2##2##(2008-4#1)(2010-12#1)
differential pulse (DPV) and square wave##2##6##(2008-10#2)
differential pulse (DPV)##3##3##(2008-10#3)
differential pulse adsorption cathodic stripping voltammetry##2##6##(2008-10#2)
differential pulse adsorption##3##3##(2008-10#3)
differential pulse adsorptive##5##3##(2008-10#5)
differential pulse and square wave voltammetric techniques##3##7##(2008-10#3)
differential pulse and square wave voltammetry using##2##7##(2008-10#2)
differential pulse and square wave voltammetry##3##6##(2008-10#3)
differential pulse and square wave##6##5##(2008-10#6)
differential pulse anodic stripping voltammetric##3##5##(2008-10#3)
differential pulse anodic stripping voltammetry (DPASV)##4##6##(2008-10#4)
differential pulse anodic stripping voltammetry##18##5##(2008-10#17)(2010-2#1)
differential pulse anodic stripping##21##4##(2008-10#20)(2010-2#1)
differential pulse cathodic stripping voltammetry (DPCSV)##2##6##(2008-10#2)
differential pulse cathodic stripping voltammetry##4##5##(2008-10#4)
differential pulse cathodic stripping##6##4##(2008-10#6)
differential pulse cathodic##7##3##(2008-10#7)
differential pulse polarographic (DPP)##2##4##(2008-10#2)
differential pulse polarographic method has been developed for the determination of trace amount of##3##14##(2008-10#3)
differential pulse polarographic method has been developed for the##4##9##(2008-10#4)
differential pulse polarographic##8##3##(2008-10#8)
differential pulse polarography (DPP)##6##4##(2008-10#6)
differential pulse polarography##20##3##(2008-10#20)
differential pulse stripping method##2##4##(2008-10#2)
differential pulse stripping##5##3##(2008-10#5)
differential pulse voltammetric (DPV)##2##4##(2008-10#2)
differential pulse voltammetric determination##2##4##(2008-10#2)
differential pulse voltammetric method##2##4##(2008-10#2)
differential pulse voltammetric##9##3##(2008-10#9)
differential pulse voltammetry (DPV) technique##2##5##(2008-10#2)
differential pulse voltammetry (DPV)##10##4##(2008-10#10)
differential pulse voltammetry at##2##4##(1995-5#1)(2008-10#1)
differential pulse voltammetry##23##3##(1995-5#1)(2008-10#22)
differential pulse##121##2##(1995-5#1)(2008-10#119)(2010-2#1)
differential reaction to##2##3##(2008-10#2)
differential reactions##2##2##(2008-10#2)
differential regulation by##2##3##(1991-12#1)(2008-11#1)
differential regulation of##3##3##(1992-3#1)(1996-12#1)(2008-11#1)
differential regulation##5##2##(1991-12#1)(1992-3#1)(1996-12#1)(2008-11#2)
differential resistance##2##2##(2008-10#2)
differential response to##4##3##(2008-10#2)(2008-11#1)(2009-5#1)
differential response##5##2##(2008-10#3)(2008-11#1)(2009-5#1)
differential responses##2##2##(1995-2#1)(2009-7#1)
differential results##2##2##(2008-10#2)
differential scanning calorimetric##3##3##(1990-7#2)(1995-8#1)
differential scanning calorimetry (DSC)##7##4##(1992-10#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#1)
differential scanning calorimetry and X-ray##2##5##(2008-10#1)(2011-1#1)
differential scanning calorimetry and##4##4##(1990-2#1)(1997-7#1)(2008-10#1)(2011-1#1)
differential scanning calorimetry##23##3##(1990-2#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-8#3)(1994-3#1)(1995-5#1)(1997-2#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)
differential scanning potentiometry (DSP)##2##4##(2008-10#2)
differential scanning##28##2##(1990-2#1)(1990-7#2)(1991-5#1)(1992-10#1)(1992-8#1)(1993-8#3)(1994-3#1)(1995-5#1)(1995-8#1)(1997-2#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)
differential scattering cross##3##3##(2008-2#1)(2008-3#2)
differential scattering##4##2##(1990-12#1)(2008-2#1)(2008-3#2)
differential selection at a##2##4##(2008-8#2)
differential sensitivity of the##2##4##(2008-10#1)(2008-11#1)
differential sensitivity of##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
differential series##3##2##(2008-10#3)
differential set##4##2##(2008-10#4)
differential staining of##2##3##(2008-9#2)
differential staining##7##2##(1997-8#1)(2008-1#1)(2008-5#1)(2008-9#4)
differential survival of##2##3##(2008-9#1)(2010-8#1)
differential susceptibility to##2##3##(1994-2#1)(2011-2#1)
differential susceptibility##4##2##(1994-2#1)(2011-2#3)
differential technique##2##2##(2008-10#2)
differential thermal expansion##2##3##(2008-2#2)
differential thermal##4##2##(2008-10#2)(2008-2#2)
differential time##2##2##(2008-2#1)(2012-1#1)
differential varieties##2##2##(2008-10#2)
differential##972##1##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#2)(1990-5#1)(1990-6#6)(1990-7#3)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#3)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#4)(1993-11#3)(1993-12#6)(1993-2#6)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#8)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-5#5)(1995-6#2)(1995-8#1)(1996-11#5)(1996-12#3)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#8)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#7)(1997-8#1)(2006-10#3)(2006-12#3)(2006-4#1)(2007-10#4)(2007-11#26)(2007-12#27)(2007-5#4)(2007-7#5)(2007-8#5)(2008-1#6)(2008-10#268)(2008-11#17)(2008-12#10)(2008-2#57)(2008-3#81)(2008-4#13)(2008-5#12)(2008-6#13)(2008-7#27)(2008-8#24)(2008-9#21)(2009-1#1)(2009-10#7)(2009-11#1)(2009-3#8)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#15)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#8)(2011-2#28)(2012-1#4)(2012-12#13)(2012-2#6)(2012-3#8)(2012-8#2)(2013-1#16)(2013-7#4)(2013-8#14)
differential-absorption lidar##2##2##(2008-3#2)
differential-heterodyne interferometer##2##2##(2008-3#2)
differential-interference contrast##3##2##(2008-3#3)
differential-piston##2##1##(2007-11#2)
differential-pulse polarography##2##2##(2008-10#2)
differential-pulse##3##1##(2008-10#3)
differentially activated##2##2##(1995-2#1)(2012-12#1)
differentially affected##2##2##(2008-7#1)(2009-8#1)
differentially affects##2##2##(2008-10#1)(2012-2#1)
differentially associated with##2##3##(1994-12#1)(1995-2#1)
differentially determine##2##2##(2008-8#1)(2013-1#1)
differentially expressed between##3##3##(2008-9#2)(2012-3#1)
differentially expressed by##2##3##(1992-2#1)(2010-1#1)
differentially expressed genes were##2##4##(2008-9#2)
differentially expressed genes##14##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#2)(2011-1#1)
differentially expressed in the##3##4##(2008-11#1)(2008-5#1)(2009-10#1)
differentially expressed in##11##3##(1991-2#2)(1994-12#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-5#1)
differentially expressed miRNAs##2##3##(2013-8#2)
differentially expressed probesets##2##3##(2012-3#2)
differentially expressed protein##2##3##(2011-3#2)
differentially expressed proteins in##2##4##(2010-12#2)
differentially expressed proteins##9##3##(2010-12#5)(2011-3#4)
differentially expressed species##2##3##(2008-7#2)
differentially expressed##61##2##(1991-2#2)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#10)(2010-4#2)(2010-5#1)(2011-1#1)(2011-3#6)(2012-3#3)(2013-8#2)
differentially influence##2##2##(2008-10#1)(2008-7#1)
differentially mediate##3##2##(1993-6#1)(1994-2#2)
differentially methylated##2##2##(1991-6#1)(2008-10#1)
differentially modulates##2##2##(1993-8#1)(2012-12#1)
differentially processed##2##2##(1993-6#1)(2008-11#1)
differentially regulated by##5##3##(1993-3#1)(1993-5#1)(1994-6#1)(1996-12#1)(2008-8#1)
differentially regulated##11##2##(1990-7#1)(1991-9#1)(1993-3#1)(1993-5#1)(1994-6#1)(1996-12#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#1)
differentially susceptible##3##2##(2008-10#2)(2008-12#1)
differentially to the##2##3##(2008-10#2)
differentially to##5##2##(1990-2#1)(2008-10#2)(2008-8#1)(2012-2#1)
differentially up-regulated##2##2##(2011-2#1)(2013-1#1)
differentially with##2##2##(1996-2#1)(2007-12#1)
differentially##149##1##(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1995-2#3)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#3)(2008-4#5)(2008-5#3)(2008-7#9)(2008-8#9)(2008-9#9)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#10)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#6)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
differentials and##2##2##(2008-10#2)
differentials between##2##2##(1993-9#1)(1995-6#1)
differentials by religious affiliation of the mother##2##7##(2009-6#1)(2009-7#1)
differentials by##3##2##(2008-9#1)(2009-6#1)(2009-7#1)
differentials in##2##2##(1994-2#1)(2008-10#1)
differentials was##2##2##(2008-10#2)
differentials were##4##2##(2008-10#4)
differentials with Pc genes##4##4##(2008-10#4)
differentials with##6##2##(2008-10#4)(2008-3#2)
differentials##49##1##(1993-9#1)(1994-2#1)(1995-6#1)(2008-10#39)(2008-3#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)
differentiate abnormally and##2##3##(2008-9#2)
differentiate among##5##2##(1994-1#1)(2008-10#4)
differentiate at the##2##3##(2007-12#1)(2008-5#1)
differentiate between groups##3##3##(1994-9#1)(2013-1#1)(2013-7#1)
differentiate between the##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
differentiate between##30##2##(1993-6#1)(1994-2#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
differentiate during##2##2##(1995-12#1)(2007-12#1)
differentiate each##2##2##(2008-10#2)
differentiate in##5##2##(1995-2#1)(2008-11#2)(2012-2#1)(2013-1#1)
differentiate into neurons##3##3##(1994-11#1)(2008-7#1)(2012-12#1)
differentiate into the##2##3##(2008-4#1)(2009-5#1)
differentiate into##34##2##(1992-12#1)(1994-11#1)(1994-8#1)(2007-12#1)(2008-11#10)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-11#1)(2012-12#5)(2012-4#1)
differentiate isolates##2##2##(2008-10#2)
differentiate species##2##2##(2007-12#1)(2010-3#1)
differentiate the two##3##3##(2008-10#1)(2010-10#1)(2012-1#1)
differentiate the##18##2##(1993-12#1)(1995-12#1)(2007-12#1)(2008-10#6)(2008-12#2)(2009-10#1)(2010-10#1)(2010-4#1)(2012-1#2)(2012-5#1)(2013-1#1)
differentiate them from##2##3##(2008-10#1)(2008-2#1)
differentiate them##3##2##(1990-8#1)(2008-10#1)(2008-2#1)
differentiate these cells##2##3##(2008-11#1)(2008-9#1)
differentiate these##5##2##(2008-10#2)(2008-11#2)(2008-9#1)
differentiate those##2##2##(2009-4#1)(2011-1#1)
differentiate to##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
differentiate##184##1##(1990-5#2)(1990-8#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#8)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#3)(2012-4#1)(2012-5#2)(2013-1#4)(2013-7#1)
differentiated F9 cells##2##3##(1992-9#2)
differentiated KU812F cells##2##3##(2008-11#2)
differentiated SNPs##3##2##(2013-1#3)
differentiated according to##3##3##(2008-10#3)
differentiated and##6##2##(1990-9#1)(1991-2#1)(1993-8#2)(2006-8#1)(2008-5#1)
differentiated approach##2##2##(1997-3#1)(2008-8#1)
differentiated at the##2##3##(2008-10#2)
differentiated at##4##2##(2008-10#2)(2008-4#1)(2010-8#1)
differentiated based##2##2##(2008-10#2)
differentiated between##2##2##(2007-11#1)(2008-10#1)
differentiated by##15##2##(1991-11#1)(1996-1#1)(1996-2#1)(2008-10#6)(2008-7#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
differentiated carcinomas##3##2##(1993-9#1)(1994-11#2)
differentiated cell##5##2##(1992-2#1)(1997-2#1)(2008-11#1)(2008-8#2)
differentiated cells are##2##3##(1992-3#1)(2008-11#1)
differentiated cells##8##2##(1992-3#1)(1992-9#3)(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
differentiated for##2##2##(2008-10#2)
differentiated from each other##2##4##(2008-10#2)
differentiated from each##3##3##(2008-10#2)(2008-5#1)
differentiated from other##5##3##(2008-10#1)(2008-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
differentiated from the##3##3##(2008-10#3)
differentiated from##21##2##(1995-8#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-1#2)
differentiated hepatocytes##2##2##(2008-11#1)(2012-2#1)
differentiated human##3##2##(1994-9#1)(2008-11#2)
differentiated in terms of##2##4##(2008-10#1)(2012-2#1)
differentiated in##4##2##(2008-10#2)(2008-8#1)(2012-2#1)
differentiated into several##2##3##(2008-5#1)(2008-8#1)
differentiated into the##2##3##(2008-8#1)(2009-10#1)
differentiated into##16##2##(1994-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2012-12#1)
differentiated macrophages##2##2##(1995-6#2)
differentiated myeloid##2##2##(1992-3#1)(1994-6#1)
differentiated neurons##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
differentiated only by##2##3##(2009-11#1)(2012-2#1)
differentiated phenotype in##3##3##(1990-11#1)(1995-11#2)
differentiated phenotype##7##2##(1990-11#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-11#3)
differentiated populations##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
differentiated progeny##2##2##(1995-11#1)(2008-10#1)
differentiated state##2##2##(2008-5#1)(2008-9#1)
differentiated them from##2##3##(2008-10#2)
differentiated thyroid cancer##2##3##(2011-2#1)(2013-1#1)
differentiated thyroid carcinoma##3##3##(2012-3#1)(2013-1#2)
differentiated thyroid##6##2##(1994-11#1)(2011-2#1)(2012-3#1)(2013-1#3)
differentiated tissues##2##2##(1994-11#1)(2008-11#1)
differentiated tumours##2##2##(1994-10#1)(2006-8#1)
differentiated##262##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#6)(1993-6#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#7)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#4)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-8#3)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#55)(2008-11#20)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#1)
differentiates the##3##2##(1996-2#1)(2008-10#1)(2010-10#1)
differentiates##10##1##(1992-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
differentiating and##3##2##(1990-5#1)(2008-4#1)(2012-2#1)
differentiating between##7##2##(1990-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#3)
differentiating cells of the##2##4##(2008-9#1)(2009-10#1)
differentiating cells##4##2##(2007-12#1)(2008-9#2)(2009-10#1)
differentiating into##5##2##(2008-11#1)(2008-9#2)(2012-12#1)(2012-2#1)
differentiating neurons##3##2##(1990-11#1)(2007-12#1)(2008-9#1)
differentiating the##12##2##(1992-5#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-5#1)
differentiating##102##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#3)(1992-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2007-12#3)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#5)
differentiation (G(ST) = 0##3##4##(2008-10#3)
differentiation across##2##2##(2010-8#1)(2012-3#1)
differentiation among isolates##2##3##(2008-10#2)
differentiation among populations##6##3##(2008-10#2)(2008-8#2)(2012-2#1)(2013-8#1)
differentiation among provinces##2##3##(2008-10#2)
differentiation among##27##2##(1996-3#1)(2007-11#1)(2008-10#19)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
differentiation and activation##4##3##(1990-9#1)(1995-6#2)(2011-2#1)
differentiation and apoptosis##5##3##(1993-3#2)(2008-10#1)(2011-2#2)
differentiation and function##2##3##(1993-11#1)(2013-1#1)
differentiation and growth of##2##4##(2009-10#1)(2011-2#1)
differentiation and growth##3##3##(2008-11#1)(2009-10#1)(2011-2#1)
differentiation and in##2##3##(2012-3#1)(2013-1#1)
differentiation and maturation##5##3##(2008-8#1)(2009-12#1)(2010-12#2)(2013-7#1)
differentiation and mitogenesis##3##3##(1997-7#3)
differentiation and proliferation##4##3##(1993-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
differentiation and regeneration##3##3##(2008-2#1)(2008-4#1)(2010-11#1)
differentiation and survival##3##3##(1996-2#1)(2008-12#1)(2009-8#1)
differentiation and the##5##3##(2008-4#2)(2008-7#1)(2011-2#1)(2012-3#1)
differentiation and##84##2##(1990-4#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-3#2)(1997-7#3)(2007-12#1)(2008-10#7)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)(2013-7#1)
differentiation antigen##2##2##(1992-5#1)(2008-8#1)
differentiation are also##2##3##(2008-9#1)(2012-12#1)
differentiation are##10##2##(2007-5#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-12#1)(2012-12#1)
differentiation as##6##2##(1992-9#1)(1996-5#1)(2008-11#2)(2008-6#1)(2008-9#1)
differentiation assays##2##2##(2008-11#1)(2008-4#1)
differentiation associated tyrosine protein kinase activity##2##6##(1992-3#2)
differentiation at neutral##2##3##(2012-3#1)(2013-1#1)
differentiation at the##4##3##(2009-8#2)(2012-3#2)
differentiation at##9##2##(1997-6#1)(2008-10#1)(2009-8#2)(2012-3#4)(2013-1#1)
differentiation based on##2##3##(2011-2#1)(2012-2#1)
differentiation between the##7##3##(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
differentiation between##36##2##(1991-3#1)(1993-9#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
differentiation but##4##2##(1991-5#1)(1992-6#1)(1994-11#1)(2008-11#1)
differentiation by a##2##3##(1994-11#1)(2008-10#1)
differentiation by##12##2##(1990-5#1)(1994-11#1)(1994-9#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)
differentiation capacities##2##2##(2008-5#1)(2012-12#1)
differentiation capacity##3##2##(2008-11#1)(2010-6#1)(2012-12#1)
differentiation could be##2##3##(2008-10#2)
differentiation culture##2##2##(2008-11#1)(2008-4#1)
differentiation cultures##3##2##(2008-11#1)(2008-4#2)
differentiation during##6##2##(1994-9#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#1)
differentiation enhancing factor##3##3##(1990-11#2)(1993-6#1)
differentiation enhancing##4##2##(1990-11#2)(1993-6#2)
differentiation even##2##2##(2008-11#1)(2012-3#1)
differentiation factor##3##2##(1991-12#2)(2009-3#1)
differentiation factors for##2##3##(1995-12#1)(1996-5#1)
differentiation factors##6##2##(1994-12#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-4#1)(2011-2#1)
differentiation for##2##2##(1990-11#1)(2010-7#1)
differentiation from other##2##3##(2008-10#1)(2010-12#1)
differentiation from##12##2##(1991-6#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
differentiation have been##2##3##(2008-11#1)(2010-5#1)
differentiation have##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2010-5#1)
differentiation in B##2##3##(1991-9#1)(2008-5#1)
differentiation in P19##2##3##(1994-11#2)
differentiation in SFME cells##2##4##(2008-11#2)
differentiation in a##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
differentiation in human##2##3##(1992-12#1)(1993-11#1)
differentiation in sensitivity to male body##2##6##(2008-5#2)
differentiation in the##14##3##(1993-12#1)(1997-6#2)(2007-7#2)(2008-10#2)(2008-11#3)(2008-5#3)(2008-7#1)
differentiation in vitro and##2##4##(1997-2#1)(2008-9#1)
differentiation in vitro##6##3##(1993-8#1)(1997-2#1)(2008-11#2)(2008-9#1)(2009-10#1)
differentiation in vivo##2##3##(2008-4#1)(2012-12#1)
differentiation in##69##2##(1990-11#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-10#1)(1994-11#2)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#3)(1997-7#1)(2007-12#1)(2007-7#3)(2008-10#7)(2008-11#16)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#2)(2012-12#2)(2013-7#1)
differentiation index##2##2##(2008-10#1)(2008-8#1)
differentiation induced by##4##3##(1990-11#1)(1991-9#1)(1994-11#1)(2008-11#1)
differentiation induced##5##2##(1990-11#1)(1991-9#1)(1994-11#1)(2008-11#2)
differentiation into an osteoblastic##2##4##(2008-11#1)(2010-3#1)
differentiation into an##3##3##(2008-11#1)(2009-8#1)(2010-3#1)
differentiation into astrocytes##2##3##(2008-11#2)
differentiation into multiple lineages##2##4##(2008-11#1)(2010-6#1)
differentiation into##21##2##(1991-5#1)(1992-8#1)(1994-8#2)(1995-12#1)(2007-7#1)(2008-11#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-7#1)(2013-1#1)
differentiation is accompanied by##2##4##(1993-8#1)(1994-11#1)
differentiation is not##2##3##(1996-6#1)(2007-5#1)
differentiation is##13##2##(1990-5#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-5#1)(2008-9#2)(2012-3#2)
differentiation markers##6##2##(1992-8#1)(1996-2#1)(1997-7#1)(2008-5#1)(2008-7#1)(2010-11#1)
differentiation may##2##2##(1992-6#1)(2011-2#1)
differentiation observed##2##2##(2008-10#2)
differentiation occurred##2##2##(2008-10#1)(2008-6#1)
differentiation occurring##2##2##(1994-3#1)(2009-1#1)
differentiation occurs##2##2##(2008-11#1)(2009-5#1)
differentiation of 3T3-L1 preadipocytes is##2##5##(2008-3#2)
differentiation of 3T3-L1##3##3##(2008-3#3)
differentiation of ES cells##3##4##(2008-8#2)(2008-9#1)
differentiation of PC12 cells##2##4##(2008-10#1)(2008-11#1)
differentiation of SKT6 cells##2##4##(1991-12#2)
differentiation of a##2##3##(1993-9#1)(2008-9#1)
differentiation of cells##3##3##(1993-5#1)(2008-5#1)(2008-8#1)
differentiation of cultured##2##3##(1990-11#1)(1994-12#1)
differentiation of erythroid##2##3##(2008-11#1)(2008-9#1)
differentiation of human##12##3##(1991-9#1)(1993-9#1)(1994-6#1)(2008-11#3)(2008-7#1)(2009-10#2)(2012-1#2)(2012-7#1)
differentiation of limb mesenchymal cells##2##5##(1994-11#2)
differentiation of limb##3##3##(1991-11#1)(1994-11#2)
differentiation of male and female##2##5##(2008-12#2)
differentiation of many cell types##2##5##(1993-6#1)(2008-11#1)
differentiation of many##3##3##(1993-6#2)(2008-11#1)
differentiation of mesenchymal##2##3##(2008-11#1)(2008-5#1)
differentiation of modern##2##3##(2011-2#2)
differentiation of mouse##2##3##(1992-8#1)(2008-9#1)
differentiation of murine##5##3##(1991-2#2)(2008-11#1)(2008-4#1)(2008-8#1)
differentiation of oligodendrocytes##2##3##(1991-5#1)(2008-7#1)
differentiation of the human##2##4##(1991-12#1)(1991-7#1)
differentiation of the target##2##4##(1990-11#1)(2008-10#1)
differentiation of the##37##3##(1990-11#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
differentiation of these cells##2##4##(1993-3#1)(2008-11#1)
differentiation of this##2##3##(1990-5#1)(2008-7#1)
differentiation of various human myeloid leukemia cell lines##2##8##(1993-3#2)
differentiation of various##4##3##(1990-11#1)(1993-3#3)
differentiation of##239##2##(1990-11#7)(1990-12#1)(1990-5#2)(1991-11#1)(1991-12#6)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-3#2)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#3)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#3)(2006-8#2)(2007-12#5)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#33)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#9)(2009-10#3)(2009-11#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#6)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#3)(2012-6#1)(2012-7#1)(2013-1#3)(2013-8#2)
differentiation on##2##2##(1996-6#1)(2009-3#1)
differentiation pathway##2##2##(2008-4#1)(2008-7#1)
differentiation potential of##3##3##(2008-11#2)(2008-7#1)
differentiation potential##6##2##(1994-5#1)(2008-11#4)(2008-7#1)
differentiation process of##2##3##(1991-11#1)(2008-7#1)
differentiation process##13##2##(1991-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1997-6#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
differentiation processes##3##2##(1992-8#1)(2008-11#1)(2012-3#1)
differentiation programs of##2##3##(1995-2#1)(1995-6#1)
differentiation programs##3##2##(1995-2#1)(1995-6#1)(2008-8#1)
differentiation regulator##2##2##(2008-8#1)(2010-7#1)
differentiation resulted in##2##3##(1991-9#1)(1995-6#1)
differentiation signal##3##2##(1991-12#2)(2013-1#1)
differentiation that##3##2##(2007-5#1)(2008-6#1)(2011-2#1)
differentiation therapy##2##2##(1993-3#1)(2011-2#1)
differentiation through##3##2##(1995-8#1)(2008-11#1)(2012-7#1)
differentiation to##6##2##(1994-12#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-11#1)(2012-4#1)
differentiation toward##2##2##(2012-12#1)(2013-7#1)
differentiation was detected##3##3##(2008-10#3)
differentiation was found##2##3##(2008-10#2)
differentiation was observed##3##3##(2008-10#1)(2008-11#2)
differentiation was significantly##2##3##(2008-10#1)(2008-11#1)
differentiation was##24##2##(1992-3#1)(1992-5#1)(1992-9#1)(1994-11#1)(2008-10#9)(2008-11#6)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
differentiation were observed##2##3##(1992-2#1)(2008-10#1)
differentiation were##9##2##(1992-2#1)(1992-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
differentiation will be##2##3##(2010-3#1)(2011-2#1)
differentiation within##2##2##(2008-10#1)(2008-11#1)
differentiation without##2##2##(1993-3#1)(2008-10#1)
differentiation##1069##1##(1990-11#17)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#15)(1991-2#6)(1991-3#1)(1991-5#9)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#9)(1992-12#11)(1992-2#6)(1992-3#9)(1992-5#6)(1992-6#10)(1992-8#7)(1992-9#9)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#13)(1993-5#1)(1993-6#8)(1993-8#6)(1993-9#6)(1994-1#2)(1994-10#1)(1994-11#13)(1994-12#10)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#7)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#4)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#8)(1996-6#2)(1997-2#8)(1997-3#3)(1997-4#2)(1997-6#8)(1997-7#15)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#15)(2007-4#1)(2007-5#4)(2007-7#8)(2007-8#2)(2008-1#7)(2008-10#133)(2008-11#132)(2008-12#9)(2008-2#2)(2008-3#16)(2008-4#31)(2008-5#34)(2008-6#10)(2008-7#33)(2008-8#40)(2008-9#42)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#14)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#9)(2009-9#2)(2010-10#2)(2010-11#10)(2010-12#9)(2010-3#8)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#36)(2012-1#4)(2012-12#19)(2012-2#21)(2012-3#18)(2012-4#2)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#20)(2013-7#6)(2013-8#3)
differentiation)##2##1##(2006-10#1)(2008-4#1)
differentiation-dependent##2##1##(1990-4#1)(1992-9#1)
differentiation-inducing##2##1##(1992-2#1)(1993-3#1)
differentiation-specific##3##1##(1993-6#1)(2008-5#1)(2008-6#1)
differentiations in the size of a group alone may have predisposed a group to either favorable or unfavorable comparisons to national standards##2##22##(1994-3#2)
differentiations on survival##2##3##(2007-5#2)
differentiations on##3##2##(2007-5#2)(2008-3#1)
differentiations##9##1##(1992-10#1)(1994-3#2)(2007-5#3)(2008-3#1)(2010-8#2)
differentiative##3##1##(1992-6#1)(2008-10#2)
differently affected by the##2##4##(1991-12#1)(2008-7#1)
differently affected##3##2##(1991-12#1)(2008-7#1)(2012-5#1)
differently and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
differently by##4##2##(1994-2#1)(1995-5#1)(1996-12#1)(2008-5#1)
differently depending on##3##3##(1996-2#1)(2008-10#1)(2010-11#1)
differently expressed##2##2##(2007-11#1)(2013-8#1)
differently from other##2##3##(2007-12#1)(2008-7#1)
differently from##10##2##(1990-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
differently in the##2##3##(2007-11#1)(2008-10#1)
differently in##10##2##(1991-1#1)(1992-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2010-9#1)
differently on the##2##3##(2008-9#1)(2011-2#1)
differently on##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
differently substituted##2##2##(2007-11#1)(2008-10#1)
differently than##5##2##(1990-2#1)(2008-4#2)(2010-12#1)(2013-8#1)
differently to##8##2##(1992-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-5#1)(2013-7#1)
differently with the##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
differently with##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2009-12#1)
differently##96##1##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#2)
differently?##2##1##(1994-1#1)(2009-10#1)
differing by##3##2##(1996-7#1)(2007-11#1)(2008-10#1)
differing degrees##2##2##(1997-3#1)(2008-10#1)
differing effects between##2##3##(2007-6#2)
differing electrophoretic##2##2##(1990-12#1)(1994-9#1)
differing from other##2##3##(1991-5#1)(2013-7#1)
differing from that of##2##4##(2008-10#1)(2009-12#1)
differing from the##2##3##(1997-4#1)(2008-10#1)
differing from##7##2##(1991-5#1)(1997-4#1)(2008-10#2)(2008-8#1)(2009-12#1)(2013-7#1)
differing impacts##2##2##(1992-3#1)(1996-2#1)
differing in susceptibility to##2##4##(2008-10#2)
differing in the##4##3##(1993-11#2)(1994-11#1)(2008-10#1)
differing in their##5##3##(1996-5#1)(2008-10#3)(2010-3#1)
differing in##31##2##(1990-8#1)(1993-11#2)(1994-11#1)(1994-3#1)(1995-12#2)(1996-5#1)(1997-6#1)(2008-10#11)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-6#1)(2013-1#1)
differing only##2##2##(1997-8#1)(2007-8#1)
differing potencies##2##2##(1991-3#1)(2008-12#1)
differing widely##2##2##(1994-6#1)(2008-12#1)
differing##118##1##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#5)(1995-2#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-12#2)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-6#1)(2013-1#2)(2013-7#2)
differs among##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
differs and##2##2##(2008-7#2)
differs between##5##2##(1993-3#1)(2008-11#1)(2008-8#1)(2013-1#2)
differs by##3##2##(2008-3#1)(2009-2#1)(2011-2#1)
differs depending on##2##3##(2008-12#1)(2010-4#1)
differs for##2##2##(1995-6#1)(2008-3#1)
differs from H##3##3##(2013-7#3)
differs from other##8##3##(1991-9#1)(1994-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
differs from others##2##3##(2008-11#1)(2008-2#1)
differs from previously##2##3##(1990-12#1)(2011-2#1)
differs from that for##2##4##(1997-4#1)(2008-10#1)
differs from that in##3##4##(1997-5#1)(2008-7#1)(2012-2#1)
differs from that of##5##4##(1991-8#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-2#1)
differs from that##12##3##(1991-8#1)(1995-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2012-2#1)
differs from the Caucasian##2##4##(2010-5#1)(2010-8#1)
differs from the other##2##4##(1994-5#1)(2008-6#1)
differs from the previously##3##4##(2007-11#1)(2008-10#2)
differs from the##25##3##(1991-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)
differs from##74##2##(1990-12#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)
differs in the acute and subacute stages##2##7##(2008-3#2)
differs in the##4##3##(1997-7#1)(2008-3#2)(2008-7#1)
differs in##14##2##(1991-2#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#2)
differs significantly between##2##3##(1994-8#1)(2008-6#1)
differs significantly from that of##2##5##(2008-3#1)(2009-3#1)
differs significantly from that##3##4##(2008-3#2)(2009-3#1)
differs significantly from the##2##4##(1990-5#1)(2008-10#1)
differs significantly from##5##3##(1990-5#1)(2008-10#1)(2008-3#2)(2009-3#1)
differs significantly##9##2##(1990-5#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-3#1)
differs strongly from##2##3##(2007-12#2)
differs##139##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-7#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
difficile toxin##3##2##(2007-12#3)
difficile##20##1##(2007-12#8)(2007-7#1)(2008-11#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#4)(2013-1#2)
difficult a##2##2##(2007-12#1)(2013-1#1)
difficult airway##2##2##(1996-11#1)(2011-2#1)
difficult and costly##3##3##(1994-5#1)(2007-7#1)(2008-10#1)
difficult and it is##2##4##(2007-7#1)(2012-1#1)
difficult and the##3##3##(1996-12#1)(2010-11#1)(2012-2#1)
difficult and##38##2##(1990-12#1)(1990-5#1)(1991-3#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
difficult as##5##2##(1992-11#1)(1992-9#1)(2008-10#1)(2008-12#2)
difficult because it##2##3##(2008-2#1)(2009-1#1)
difficult because of low##2##4##(2008-10#1)(2011-1#1)
difficult because of the##9##4##(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-7#1)(2010-12#1)
difficult because of##17##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
difficult because the##4##3##(2008-10#2)(2008-3#2)
difficult because##33##2##(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)
difficult cases and##2##3##(2008-9#1)(2012-3#1)
difficult cases##7##2##(1995-5#1)(1995-6#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
difficult challenge##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
difficult challenges##4##2##(2007-7#1)(2008-10#1)(2008-8#1)(2009-3#1)
difficult childhood##2##2##(1994-2#1)(2008-10#1)
difficult clinical##3##2##(1994-11#1)(2007-11#1)(2012-12#1)
difficult conditions##3##2##(1991-3#1)(2008-2#1)(2008-6#1)
difficult decisions in the##2##4##(1995-3#1)(2011-2#1)
difficult diagnosis##3##2##(1990-9#1)(1992-5#1)(2008-10#1)
difficult diagnostic##2##2##(1992-4#1)(2011-2#1)
difficult due to a##2##4##(2008-10#1)(2008-5#1)
difficult due to##3##3##(2008-10#1)(2008-5#1)(2009-2#1)
difficult for##15##2##(1993-11#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-8#1)
difficult if##4##2##(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)
difficult in the##2##3##(2008-1#1)(2008-10#1)
difficult in##12##2##(1996-2#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)
difficult on##2##2##(1992-5#1)(2008-4#1)
difficult or impossible to##4##4##(1997-3#1)(1997-8#1)(2008-4#1)(2008-8#1)
difficult or##7##2##(1997-3#2)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-7#1)
difficult problem in##5##3##(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)
difficult problem##10##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-6#1)
difficult situations##3##2##(1996-3#1)(2011-2#1)(2012-3#1)
difficult task and##2##3##(2007-7#1)(2008-11#1)
difficult task##11##2##(1990-9#1)(1991-12#1)(1993-12#1)(1996-3#1)(1996-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
difficult tasks##2##2##(2008-10#2)
difficult to achieve##8##3##(1992-3#1)(1994-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
difficult to analyse##2##3##(2008-10#1)(2010-4#1)
difficult to analyze##3##3##(1991-12#1)(2008-4#1)(2008-8#1)
difficult to apply##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
difficult to assess##4##3##(2008-11#2)(2008-8#1)(2012-3#1)
difficult to be##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
difficult to characterize##2##3##(2009-10#1)(2009-5#1)
difficult to control##6##3##(2007-10#1)(2007-6#1)(2008-10#1)(2009-4#1)(2009-9#1)(2011-2#1)
difficult to define##4##3##(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
difficult to describe##2##3##(2007-12#1)(2008-3#1)
difficult to detect##11##3##(1994-11#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#1)
difficult to determine##11##3##(1990-8#1)(1993-2#1)(1995-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2013-1#1)
difficult to diagnose and##2##4##(2012-12#1)(2013-8#1)
difficult to diagnose because##2##4##(2008-10#1)(2011-2#1)
difficult to diagnose##14##3##(1994-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
difficult to differentiate##6##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#2)(2012-2#1)
difficult to distinguish##8##3##(1990-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
difficult to eradicate##2##3##(1997-7#1)(2012-12#1)
difficult to establish##3##3##(1996-9#1)(2008-11#1)(2008-7#1)
difficult to estimate##4##3##(1990-9#1)(2008-11#1)(2011-2#1)(2013-1#1)
difficult to evaluate for##2##4##(2008-10#1)(2009-6#1)
difficult to evaluate the##2##4##(1990-2#1)(2008-11#1)
difficult to evaluate##6##3##(1990-2#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-6#1)(2013-8#1)
difficult to explain##5##3##(1992-5#1)(1992-6#1)(1993-12#1)(2008-9#2)
difficult to guarantee the##2##4##(2008-3#2)
difficult to identify the##3##4##(1990-10#1)(2008-4#1)(2012-3#1)
difficult to identify##9##3##(1990-10#2)(1997-2#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-3#1)
difficult to implement##4##3##(2008-8#1)(2012-2#2)(2012-3#1)
difficult to interpret and##2##4##(2007-10#1)(2008-10#1)
difficult to interpret##9##3##(1991-11#1)(1993-2#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
difficult to isolate##2##3##(2008-10#2)
difficult to make##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
difficult to manage##4##3##(1996-2#1)(2008-10#1)(2012-3#1)(2013-7#1)
difficult to measure##5##3##(1990-3#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
difficult to model##2##3##(2010-4#2)
difficult to observe##2##3##(2007-11#1)(2008-3#1)
difficult to obtain by##2##4##(1991-2#1)(2008-10#1)
difficult to obtain in##2##4##(2008-10#1)(2008-9#1)
difficult to obtain##15##3##(1991-2#1)(1992-9#1)(2006-12#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)
difficult to perform##5##3##(2008-11#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-7#1)
difficult to predict how##2##4##(2011-2#1)(2012-2#1)
difficult to predict##5##3##(1996-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
difficult to preserve##2##3##(2008-5#1)(2012-2#1)
difficult to prove##2##3##(2008-10#1)(2008-7#1)
difficult to quantify##2##3##(1994-6#1)(2008-11#1)
difficult to reach##2##3##(1991-2#1)(1997-3#1)
difficult to remove##2##3##(2010-12#1)(2011-1#1)
difficult to resolve##3##3##(2008-11#1)(2008-9#1)(2010-12#1)
difficult to separate##5##3##(1994-9#1)(1995-5#1)(2007-6#1)(2008-10#1)(2008-7#1)
difficult to set##2##3##(2008-4#1)(2008-9#1)
difficult to study because##2##4##(2008-10#1)(2008-9#1)
difficult to study##5##3##(2008-10#2)(2008-9#1)(2009-9#1)(2010-12#1)
difficult to test##2##3##(1996-4#1)(2008-8#1)
difficult to treat and##2##4##(2010-8#1)(2011-2#1)
difficult to treat##9##3##(2008-10#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
difficult to understand##2##3##(1990-2#1)(2008-8#1)
difficult to##301##2##(1990-10#2)(1990-2#3)(1990-3#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#3)(1996-4#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-9#1)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#36)(2008-11#14)(2008-12#4)(2008-2#2)(2008-3#17)(2008-4#6)(2008-5#5)(2008-6#6)(2008-7#12)(2008-8#13)(2008-9#14)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#5)(2010-8#1)(2011-1#2)(2011-2#16)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#5)(2012-8#1)(2012-9#1)(2013-1#12)(2013-7#3)(2013-8#5)
difficult when##6##2##(1992-9#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-12#1)
difficult##679##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-7#1)(1991-8#2)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#2)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-4#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(1997-9#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#7)(2007-12#7)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#7)(2008-1#7)(2008-10#71)(2008-11#25)(2008-12#14)(2008-2#8)(2008-3#32)(2008-4#14)(2008-5#11)(2008-6#12)(2008-7#23)(2008-8#19)(2008-9#31)(2009-1#3)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#1)(2010-3#8)(2010-4#8)(2010-5#4)(2010-6#7)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#11)(2011-2#29)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#16)(2012-2#19)(2012-3#15)(2012-8#1)(2012-9#1)(2013-1#23)(2013-7#7)(2013-8#11)
difficult-to-control asthma##5##2##(2009-6#5)
difficult-to-treat##2##1##(2008-12#1)(2009-11#1)
difficulties after the##2##3##(1994-3#1)(2008-12#1)
difficulties and barriers##2##3##(2011-2#2)
difficulties and the##2##3##(1993-2#1)(2012-3#1)
difficulties and their##2##3##(2010-1#1)(2012-3#1)
difficulties and##26##2##(1993-2#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
difficulties are##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
difficulties associated with##6##3##(1992-3#1)(1995-2#1)(1996-1#1)(2008-11#1)(2008-8#1)(2013-1#1)
difficulties associated##7##2##(1992-3#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
difficulties caused by the##2##4##(1995-6#1)(2008-11#1)
difficulties caused by##3##3##(1995-6#1)(2008-11#1)(2008-12#1)
difficulties due to##2##3##(2008-7#1)(2010-12#1)
difficulties encountered in##4##3##(1995-11#1)(1997-3#1)(2008-11#1)(2012-2#1)
difficulties encountered with##2##3##(1996-12#1)(2008-10#1)
difficulties encountered##8##2##(1995-11#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
difficulties faced by##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
difficulties for the##3##3##(2007-5#1)(2008-2#1)(2012-3#1)
difficulties for##6##2##(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-3#1)
difficulties have been##2##3##(2008-10#1)(2008-4#1)
difficulties have##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
difficulties in applying##3##3##(2007-6#1)(2008-1#1)(2010-11#1)
difficulties in interpretation##2##3##(2010-8#1)(2013-1#1)
difficulties in interpreting##2##3##(1996-3#1)(2013-1#1)
difficulties in mobility##3##3##(2008-7#3)
difficulties in nursing practice##2##4##(2008-11#2)
difficulties in obtaining##3##3##(2008-11#1)(2008-2#1)(2012-12#1)
difficulties in taking treatment##3##4##(2010-4#3)
difficulties in the interpretation of##2##5##(2007-11#1)(2008-5#1)
difficulties in the##12##3##(1992-11#1)(1993-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
difficulties in walking##2##3##(2008-7#2)
difficulties in##70##2##(1992-11#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#1)
difficulties involved in##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
difficulties of establishing##2##3##(1995-3#1)(2007-6#1)
difficulties of##21##2##(1990-6#1)(1991-6#1)(1992-5#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
difficulties or##2##2##(2007-11#1)(2010-9#1)
difficulties that##6##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
difficulties they##2##2##(1996-1#1)(2008-12#1)
difficulties to##5##2##(2007-4#1)(2008-10#1)(2009-10#1)(2011-2#2)
difficulties with written##2##3##(2008-12#1)(2012-1#1)
difficulties with##11##2##(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-5#1)(2010-4#1)(2012-1#1)(2013-1#1)
difficulties##279##1##(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#4)(1996-7#1)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#5)(2008-1#1)(2008-10#14)(2008-11#27)(2008-12#9)(2008-2#8)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#7)(2009-10#6)(2009-11#2)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#6)(2011-2#16)(2012-1#4)(2012-12#7)(2012-2#10)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#5)
difficulties]##2##1##(2009-5#1)(2013-8#1)
difficulty and##6##2##(1992-1#1)(1996-3#1)(2008-11#3)(2012-12#1)
difficulty by##3##2##(2007-7#1)(2012-2#1)(2012-3#1)
difficulty communicating##2##2##(2010-4#1)(2011-1#1)
difficulty finding##2##2##(2008-12#1)(2012-3#1)
difficulty in accessing##2##3##(2008-11#1)(2008-12#1)
difficulty in attracting##2##3##(1996-8#1)(2008-11#1)
difficulty in diagnosis and##2##4##(2008-10#1)(2010-3#1)
difficulty in diagnosis##3##3##(2008-10#1)(2010-12#1)(2010-3#1)
difficulty in disengaging##2##3##(2008-2#1)(2010-7#1)
difficulty in estimating##2##3##(2008-10#1)(2008-3#1)
difficulty in eye opening##2##4##(2007-10#2)
difficulty in getting##2##3##(1993-6#1)(2008-10#1)
difficulty in obtaining##4##3##(2008-10#1)(2008-3#1)(2008-9#2)
difficulty in the##2##3##(1991-3#1)(2007-11#1)
difficulty in using##2##3##(2007-11#1)(2011-2#1)
difficulty in##78##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-5#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#4)(2011-7#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)
difficulty is##4##2##(1992-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
difficulty of the##5##3##(1997-2#1)(2008-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
difficulty of using##2##3##(1992-3#1)(2012-1#1)
difficulty of##33##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-2#2)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
difficulty to##6##2##(1993-6#1)(1997-7#1)(2008-12#1)(2008-5#2)(2011-2#1)
difficulty was##3##2##(1995-12#1)(2007-9#1)(2012-3#1)
difficulty with##10##2##(1993-10#1)(1994-11#1)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-12#2)(2012-3#2)
difficulty##193##1##(1990-12#1)(1990-3#2)(1990-6#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-6#2)(1994-11#2)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-1#4)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#13)(2013-1#10)(2013-8#1)
diffirence in##2##2##(2006-8#2)
diffract to##2##2##(1992-11#1)(1992-8#1)
diffract##5##1##(1992-11#1)(1992-8#1)(2008-3#1)(2008-8#2)
diffracted at##2##2##(2007-11#1)(2008-3#1)
diffracted beam##5##2##(2008-3#5)
diffracted beams##2##2##(2007-11#1)(2008-3#1)
diffracted by a##4##3##(2008-2#1)(2008-3#3)
diffracted by##7##2##(2008-2#2)(2008-3#5)
diffracted components##2##2##(2008-2#1)(2008-3#1)
diffracted field##3##2##(2007-11#1)(2008-3#2)
diffracted from the##2##3##(2007-11#1)(2008-3#1)
diffracted light##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
diffracted order##2##2##(2008-2#1)(2008-3#1)
diffracted orders##4##2##(2008-2#1)(2008-3#3)
diffracted wave##3##2##(2008-3#3)
diffracted##48##1##(2007-11#8)(2007-12#1)(2008-2#8)(2008-3#31)
diffracting##8##1##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)
diffraction (XRD) analysis##2##3##(2009-7#1)(2010-4#1)
diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR)##2##8##(2008-10#2)
diffraction (XRD) and Fourier transform infrared spectroscopy##3##7##(2008-10#2)(2012-2#1)
diffraction (XRD) and##7##3##(2008-10#6)(2012-2#1)
diffraction (XRD)##18##2##(2008-10#12)(2008-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
diffraction analysis of##4##3##(1992-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
diffraction analysis##13##2##(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
diffraction and optical##2##3##(2010-12#1)(2010-5#1)
diffraction and##27##2##(1994-5#1)(1995-3#1)(1997-4#1)(2007-11#3)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2010-12#1)(2010-5#1)
diffraction angle##4##2##(2007-12#2)(2008-3#2)
diffraction are##2##2##(2007-11#1)(2008-2#1)
diffraction at a##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
diffraction at the##2##3##(2008-2#1)(2013-1#1)
diffraction at##7##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-5#1)(2013-1#1)
diffraction by##3##2##(2007-12#1)(2008-3#2)
diffraction calculation##2##2##(2007-12#1)(2008-3#1)
diffraction can be##2##3##(2007-12#1)(2008-3#1)
diffraction data of##2##3##(1991-5#1)(2008-4#1)
diffraction data##9##2##(1990-12#1)(1991-5#1)(1992-8#1)(1992-9#1)(1997-7#1)(2006-4#1)(2008-4#1)(2008-6#1)(2008-8#1)
diffraction effect##3##2##(2007-12#2)(2008-2#1)
diffraction effects##3##2##(2008-3#3)
diffraction efficiencies of the##2##4##(2007-12#1)(2008-3#1)
diffraction efficiencies of##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
diffraction efficiencies##10##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#5)
diffraction efficiency and the signal-to-noise ratio##2##6##(2008-3#2)
diffraction efficiency and the##5##4##(2008-3#5)
diffraction efficiency and##12##3##(2007-11#1)(2008-2#1)(2008-3#10)
diffraction efficiency as##2##3##(2008-3#2)
diffraction efficiency can be##2##4##(2007-12#1)(2008-3#1)
diffraction efficiency depends on##2##4##(2007-11#1)(2008-2#1)
diffraction efficiency from a##2##4##(2008-3#2)
diffraction efficiency from##3##3##(2008-3#3)
diffraction efficiency have been determined##2##5##(2008-3#2)
diffraction efficiency in the##2##4##(2007-12#1)(2008-3#1)
diffraction efficiency is##2##3##(2008-2#2)
diffraction efficiency of a##4##4##(2007-11#3)(2008-3#1)
diffraction efficiency of as much as##2##6##(2007-12#1)(2008-2#1)
diffraction efficiency of gratings##2##4##(2007-12#1)(2008-3#1)
diffraction efficiency of the##7##4##(2007-11#2)(2007-12#1)(2008-3#4)
diffraction efficiency of##30##3##(2007-11#6)(2007-12#8)(2008-2#4)(2008-3#12)
diffraction efficiency upper bound##2##4##(2007-12#2)
diffraction efficiency upper##3##3##(2007-12#3)
diffraction efficiency was##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
diffraction efficiency##96##2##(2007-11#11)(2007-12#20)(2008-2#20)(2008-3#45)
diffraction for the##3##3##(1996-2#1)(1996-5#1)(2008-3#1)
diffraction for##5##2##(1996-2#1)(1996-5#1)(2008-3#1)(2008-5#1)(2008-7#1)
diffraction from the##3##3##(2007-11#2)(2008-3#1)
diffraction from##7##2##(1992-11#1)(2007-11#2)(2008-2#1)(2008-3#3)
diffraction grating and an original scanning system##2##7##(2008-3#2)
diffraction grating and##3##3##(2007-12#1)(2008-3#2)
diffraction grating in the##2##4##(2007-11#1)(2008-2#1)
diffraction grating in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
diffraction grating to##3##3##(2007-11#2)(2008-3#1)
diffraction grating##30##2##(2007-11#8)(2007-12#4)(2008-2#5)(2008-3#13)
diffraction gratings are##2##3##(2008-3#2)
diffraction gratings for##2##3##(2008-3#2)
diffraction gratings in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction gratings is##2##3##(2008-3#2)
diffraction gratings##24##2##(2007-12#6)(2008-2#1)(2008-3#17)
diffraction in a##2##3##(2008-3#2)
diffraction in the##3##3##(2008-10#1)(2008-3#2)
diffraction in##5##2##(2008-10#1)(2008-3#4)
diffraction integral for##2##3##(2008-2#1)(2008-3#1)
diffraction integral is##2##3##(2008-3#2)
diffraction integral##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
diffraction is##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2009-12#1)
diffraction limit in##3##3##(2007-11#1)(2008-3#1)(2009-5#1)
diffraction limit##15##2##(2007-11#3)(2007-12#1)(2008-3#7)(2009-5#3)(2012-2#1)
diffraction limited in the##2##4##(2007-11#1)(2007-12#1)
diffraction limited##7##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
diffraction losses##4##2##(2008-2#1)(2008-3#3)
diffraction maxima##2##2##(2007-12#2)
diffraction measurements##3##2##(1995-6#1)(2008-2#1)(2008-3#1)
diffraction method for##2##3##(2008-3#2)
diffraction method##5##2##(2008-3#4)(2013-8#1)
diffraction model##2##2##(2008-2#1)(2008-3#1)
diffraction of a##5##3##(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
diffraction of the probe beam##2##5##(2007-11#1)(2007-12#1)
diffraction of the##6##3##(2007-11#3)(2007-12#1)(2009-5#1)(2010-4#1)
diffraction of##19##2##(1992-8#1)(1993-11#1)(2006-4#1)(2007-11#4)(2007-12#3)(2008-2#3)(2008-3#4)(2009-5#1)(2010-4#1)
diffraction on the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction on##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
diffraction order and##2##3##(2008-2#1)(2008-3#1)
diffraction order near##2##3##(2008-3#2)
diffraction order##11##2##(2007-11#1)(2008-2#2)(2008-3#8)
diffraction orders of##2##3##(2008-3#2)
diffraction orders##16##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#9)
diffraction pattern in##2##3##(2007-11#1)(2008-2#1)
diffraction pattern is##2##3##(2008-3#2)
diffraction pattern of a##3##4##(2008-2#1)(2008-3#2)
diffraction pattern of##4##3##(2008-2#2)(2008-3#2)
diffraction pattern##26##2##(2007-11#4)(2008-2#5)(2008-3#16)(2009-8#1)
diffraction patterns from##2##3##(1992-9#1)(2008-2#1)
diffraction patterns of##2##3##(1993-11#1)(2008-3#1)
diffraction patterns##13##2##(1992-9#1)(1993-11#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#5)
diffraction phase##2##2##(2007-12#1)(2008-9#1)
diffraction phenomena that##2##3##(2007-11#1)(2008-3#1)
diffraction phenomena##5##2##(2007-11#2)(2008-3#3)
diffraction point-spread##2##2##(2008-2#2)
diffraction problems##2##2##(2007-12#2)
diffraction profiles##2##2##(1991-5#1)(1996-2#1)
diffraction properties##2##2##(2007-12#1)(2008-2#1)
diffraction showed that##3##3##(2008-6#1)(2008-8#2)
diffraction spectrometry##3##2##(2008-10#2)(2008-3#1)
diffraction studies and##2##3##(2007-11#1)(2010-5#1)
diffraction studies##6##2##(1991-5#1)(2007-11#1)(2008-5#1)(2009-8#1)(2010-5#2)
diffraction study of##2##3##(1997-7#1)(2006-4#1)
diffraction study##3##2##(1997-7#1)(2006-4#1)(2010-5#1)
diffraction system##3##2##(2008-3#3)
diffraction theory and##2##3##(2007-11#1)(2007-12#1)
diffraction theory for##3##3##(2008-2#2)(2008-3#1)
diffraction theory is extended to##2##5##(2008-2#1)(2008-3#1)
diffraction theory is##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
diffraction theory##32##2##(2007-11#3)(2007-12#2)(2008-2#10)(2008-3#17)
diffraction to##4##2##(1993-11#1)(2007-12#1)(2009-11#1)(2009-5#1)
diffraction tomography based on the##2##5##(2008-2#1)(2008-3#1)
diffraction tomography with##2##3##(2007-12#1)(2008-3#1)
diffraction tomography##10##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
diffraction topography##2##2##(2006-4#2)
diffraction with##2##2##(2007-11#1)(2008-3#1)
diffraction##601##1##(1990-12#1)(1991-5#4)(1991-6#1)(1992-11#2)(1992-4#1)(1992-8#2)(1992-9#2)(1993-11#4)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#5)(1996-5#1)(1997-4#1)(1997-7#5)(2006-4#9)(2007-11#64)(2007-12#77)(2008-10#30)(2008-11#4)(2008-2#95)(2008-3#229)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#1)(2009-5#5)(2009-7#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#4)(2013-8#4)
diffraction-free##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
diffraction-limited beam##2##2##(2007-12#1)(2008-3#1)
diffraction-limited image##2##2##(2008-2#1)(2008-3#1)
diffraction-limited imaging##2##2##(2008-2#1)(2008-3#1)
diffraction-limited laser##2##2##(2007-12#1)(2008-2#1)
diffraction-limited operation##2##2##(2007-11#1)(2008-3#1)
diffraction-limited optical systems##2##3##(2008-2#2)
diffraction-limited performance##4##2##(2008-2#2)(2008-3#2)
diffraction-limited resolution##2##2##(2007-11#1)(2007-12#1)
diffraction-limited spot size##3##3##(2007-11#1)(2008-3#2)
diffraction-limited spot##4##2##(2007-11#1)(2008-3#3)
diffraction-limited##48##1##(2007-11#9)(2007-12#8)(2008-2#12)(2008-3#19)
diffraction-order##3##1##(2008-3#3)
diffractive and##3##2##(2007-12#1)(2008-3#2)
diffractive element that##2##3##(2008-3#2)
diffractive element##6##2##(2008-3#6)
diffractive elements##16##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#8)
diffractive gratings##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
diffractive lens doublet##2##3##(2008-2#2)
diffractive lens##11##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#4)
diffractive lenses##3##2##(2008-3#3)
diffractive microlens##2##2##(2008-2#1)(2008-3#1)
diffractive microlenses##2##2##(2008-2#2)
diffractive micromachined chopper##2##3##(2008-2#2)
diffractive mirrors##2##2##(2008-3#2)
diffractive optic##3##2##(2008-2#2)(2008-3#1)
diffractive optical element (DOE)##2##4##(2007-12#1)(2008-3#1)
diffractive optical element##19##3##(2007-11#1)(2007-12#2)(2008-3#16)
diffractive optical elements (DOE's)##6##4##(2008-2#1)(2008-3#5)
diffractive optical elements (DOEs)##3##4##(2008-3#3)
diffractive optical elements and##3##4##(2008-3#3)
diffractive optical elements for##5##4##(2007-12#1)(2008-2#4)
diffractive optical elements is presented##2##5##(2008-3#2)
diffractive optical elements is##4##4##(2008-2#2)(2008-3#2)
diffractive optical elements on##2##4##(2008-3#2)
diffractive optical elements with##3##4##(2008-2#1)(2008-3#2)
diffractive optical elements##49##3##(2007-11#1)(2007-12#1)(2008-2#16)(2008-3#31)
diffractive optical encoder##2##3##(2008-3#2)
diffractive optical filter##3##3##(2008-3#3)
diffractive optical##79##2##(2007-11#2)(2007-12#3)(2008-2#17)(2008-3#57)
diffractive optics##11##2##(2007-11#1)(2008-2#2)(2008-3#8)
diffractive phase elements (DPE's)##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
diffractive phase elements for laser beam shaping##2##7##(2007-11#2)
diffractive phase elements for##3##4##(2007-11#2)(2008-3#1)
diffractive phase elements##18##3##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#10)
diffractive phase##19##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#11)
diffractive structures##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
diffractive##205##1##(2007-11#15)(2007-12#14)(2008-2#45)(2008-3#131)
diffractive-refractive##2##1##(2008-3#2)
diffractometer (XRD)##2##2##(2009-11#1)(2013-8#1)
diffractometry##3##1##(2008-10#2)(2011-1#1)
diffus aux deux##2##3##(2013-1#2)
diffuse PVNS##2##2##(2013-1#2)
diffuse and##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
diffuse atmospheric##2##2##(2008-11#2)
diffuse attenuation coefficient##7##3##(2008-2#2)(2008-3#5)
diffuse attenuation coefficients##4##3##(2008-2#4)
diffuse attenuation##11##2##(2008-2#6)(2008-3#5)
diffuse bronchoconstriction##2##2##(1996-3#2)
diffuse correlation spectroscopy (DCS)##2##4##(2011-1#2)
diffuse correlation spectroscopy##4##3##(2011-1#4)
diffuse disease##2##2##(2008-3#1)(2013-1#1)
diffuse form##3##2##(1995-11#1)(2013-1#2)
diffuse illumination##3##2##(2008-3#3)
diffuse inflammation##2##2##(1992-3#1)(2008-5#1)
diffuse inflammatory##2##2##(1995-12#1)(2012-2#1)
diffuse into the##2##3##(1993-2#1)(2008-5#1)
diffuse into##3##2##(1993-2#1)(2008-10#1)(2008-5#1)
diffuse involvement##2##2##(1990-6#1)(2008-9#1)
diffuse irradiance##3##2##(2008-2#2)(2008-3#1)
diffuse large B-cell lymphoma (DLBCL)##3##5##(2009-8#2)(2013-1#1)
diffuse large B-cell lymphoma##4##4##(2009-8#2)(2013-1#1)(2013-8#1)
diffuse large B-cell##7##3##(2009-8#5)(2013-1#1)(2013-8#1)
diffuse large##9##2##(2009-8#5)(2013-1#3)(2013-8#1)
diffuse light##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
diffuse linear light##2##3##(2008-3#2)
diffuse marine reflectance##5##3##(2008-3#5)
diffuse media##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
diffuse medium##2##2##(2008-3#2)
diffuse metastases##2##2##(1994-12#1)(1994-6#1)
diffuse noxious inhibitory controls##3##4##(1995-12#2)(2008-10#1)
diffuse optical tomography (DOT)##2##4##(2011-1#2)
diffuse optical tomography##9##3##(2007-11#1)(2007-12#2)(2008-3#2)(2011-1#3)(2012-12#1)
diffuse optical##10##2##(2007-11#1)(2007-12#2)(2008-3#3)(2011-1#3)(2012-12#1)
diffuse or##4##2##(1993-9#1)(1997-1#1)(2008-1#1)(2008-8#1)
diffuse panbronchiolitis##2##2##(1995-8#2)
diffuse photon##2##2##(2007-12#1)(2008-3#1)
diffuse powdery mildew colonies##2##4##(2008-10#2)
diffuse powdery mildew##3##3##(2008-10#3)
diffuse pulmonary##2##2##(1991-12#1)(2011-2#1)
diffuse radiation##2##2##(2008-2#2)
diffuse reflectance and##2##3##(2008-10#1)(2008-2#1)
diffuse reflectance infrared Fourier transform (DRIFT)##2##6##(2008-1#1)(2008-10#1)
diffuse reflectance infrared Fourier transform spectroscopy##2##6##(2008-10#2)
diffuse reflectance infrared Fourier transform##4##5##(2008-1#1)(2008-10#3)
diffuse reflectance infrared Fourier##5##4##(2008-1#1)(2008-10#4)
diffuse reflectance infrared fourier##2##4##(2008-1#1)(2008-10#1)
diffuse reflectance infrared##7##3##(2008-1#2)(2008-10#5)
diffuse reflectance spectra and their first derivative spectra##2##8##(2008-10#2)
diffuse reflectance spectra##3##3##(2008-10#3)
diffuse reflectance spectroscopy##6##3##(2008-10#5)(2008-3#1)
diffuse reflectance##37##2##(2008-1#2)(2008-10#23)(2008-2#4)(2008-3#7)(2011-1#1)
diffuse reflection##3##2##(2008-2#2)(2013-8#1)
diffuse solar##2##2##(2008-2#2)
diffuse subarachnoid hemorrhage on##2##4##(2012-3#2)
diffuse subarachnoid hemorrhage##3##3##(2012-3#3)
diffuse systemic sclerosis##6##3##(2006-10#1)(2009-8#4)(2009-9#1)
diffuse through##2##2##(1990-11#1)(2007-12#1)
diffuse transmittance##4##2##(2008-2#3)(2008-3#1)
diffuse traumatic brain injury##2##4##(2008-7#2)
diffuse type##2##2##(2012-2#1)(2012-3#1)
diffuse##318##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#10)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#3)(1995-8#3)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#1)(2007-11#4)(2007-12#10)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#32)(2008-3#63)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#10)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-1#9)(2011-2#5)(2012-12#7)(2012-2#4)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#4)
diffuse&quot##2##1##(1997-6#2)
diffuse-reflectance##5##1##(2008-10#1)(2008-2#3)(2010-4#1)
diffused into##2##2##(1991-5#1)(2008-10#1)
diffused through the##2##3##(2008-10#2)
diffused through##3##2##(2008-10#3)
diffused##19##1##(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-9#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
diffusely distributed in the##3##4##(1992-9#1)(2007-12#1)(2008-7#1)
diffusely distributed##4##2##(1992-9#1)(1994-2#1)(2007-12#1)(2008-7#1)
diffusely positive##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
diffusely reflected##4##2##(2008-3#4)
diffusely##21##1##(1992-9#1)(1993-12#1)(1994-2#1)(1997-1#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
diffuser##12##1##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#5)
diffusers##2##1##(2008-3#1)(2008-6#1)
diffuses##3##1##(2008-3#1)(2008-5#1)(2008-9#1)
diffusible##13##1##(1990-7#1)(1992-8#2)(1993-11#1)(1994-12#3)(2008-10#5)(2013-8#1)
diffusing capacity##3##2##(2007-12#3)
diffusing into##2##2##(1991-5#1)(2008-10#1)
diffusing plate##2##2##(2008-3#2)
diffusing##28##1##(1991-5#1)(1997-6#1)(2007-12#12)(2008-10#3)(2008-2#4)(2008-3#5)(2009-6#1)(2011-1#1)
diffusion across the skin##2##4##(2008-11#2)
diffusion across the##6##3##(1991-5#2)(2008-10#1)(2008-11#2)(2010-11#1)
diffusion analysis##2##2##(2009-7#1)(2012-2#1)
diffusion and reaction##2##3##(2008-7#2)
diffusion and the##4##3##(1992-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
diffusion and##28##2##(1990-6#1)(1992-12#3)(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-9#2)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
diffusion approximation in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffusion approximation##20##2##(2007-11#1)(2007-12#2)(2008-2#9)(2008-3#8)
diffusion as##2##2##(2008-1#1)(2013-1#1)
diffusion barrier##2##2##(2007-12#2)
diffusion capacity##2##2##(1991-9#1)(1992-6#1)
diffusion cells##5##2##(2008-3#1)(2008-5#3)(2011-3#1)
diffusion coefficient and##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2009-11#1)
diffusion coefficient in##2##3##(2008-10#1)(2008-5#1)
diffusion coefficient is found to be##2##6##(2007-11#2)
diffusion coefficient is##4##3##(2007-11#3)(2007-12#1)
diffusion coefficient of##7##3##(1990-7#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
diffusion coefficient values of In(III) in potassium chloride and##2##9##(2008-10#2)
diffusion coefficient##42##2##(1990-7#3)(1996-5#1)(2007-10#1)(2007-11#5)(2007-12#3)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#2)(2010-12#2)(2012-2#1)
diffusion coefficients for##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
diffusion coefficients of##3##3##(2008-10#2)(2008-7#1)
diffusion coefficients were##3##3##(2008-10#2)(2008-7#1)
diffusion coefficients##20##2##(1990-2#1)(1991-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#3)(2010-4#1)(2012-2#1)
diffusion coefficients)##2##2##(2008-10#2)
diffusion controlled##6##2##(2008-10#4)(2008-9#1)(2012-2#1)
diffusion controlling##2##2##(2008-10#2)
diffusion deposition##2##2##(2008-11#2)
diffusion equation##14##2##(2007-11#2)(2008-2#5)(2008-3#6)(2008-7#1)
diffusion flame##9##2##(2008-2#5)(2008-3#4)
diffusion flames are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffusion flames##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
diffusion from skin##3##3##(2008-5#3)
diffusion from the##2##3##(1993-6#1)(1997-1#1)
diffusion from##6##2##(1993-6#1)(1997-1#1)(2008-10#1)(2008-5#3)
diffusion has been##2##3##(2008-10#1)(2010-10#1)
diffusion in a##2##3##(1993-11#2)
diffusion in the##4##3##(1993-6#1)(2008-10#2)(2008-6#1)
diffusion in##17##2##(1990-6#1)(1992-8#1)(1993-11#3)(1993-6#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#1)
diffusion into##3##2##(2008-10#1)(2008-7#1)(2009-2#1)
diffusion is##8##2##(1993-12#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-8#2)(2013-8#1)
diffusion kinetics##2##2##(2008-10#1)(2012-2#1)
diffusion layer##4##2##(1990-12#1)(2008-10#3)
diffusion mechanism##2##2##(2008-10#1)(2008-11#1)
diffusion method against##3##3##(2008-8#1)(2011-1#1)(2013-1#1)
diffusion method##17##2##(2007-7#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-8#2)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
diffusion model for##2##3##(1995-5#1)(2008-3#1)
diffusion model##15##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#9)(2009-12#1)(2009-9#1)
diffusion models##4##2##(2007-12#1)(2008-3#3)
diffusion of ions##2##3##(2008-10#1)(2008-8#1)
diffusion of the##9##3##(1990-9#1)(1994-5#1)(2007-12#2)(2008-10#5)
diffusion of##52##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-5#1)(1991-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#6)(2007-3#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
diffusion on##2##2##(2008-2#1)(2009-11#1)
diffusion optical##3##2##(2007-12#1)(2008-3#2)
diffusion phenomena##2##2##(2008-10#1)(2008-7#1)
diffusion process##4##2##(1992-3#1)(2008-2#1)(2008-5#1)(2008-6#1)
diffusion properties##2##2##(2012-2#2)
diffusion rate of##3##3##(1992-9#1)(2008-5#1)(2013-8#1)
diffusion rate##8##2##(1992-9#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2013-8#2)
diffusion rates##4##2##(2008-10#1)(2008-8#1)(2013-8#2)
diffusion reflectance spectroscopic detection was evaluated##2##6##(2008-10#2)
diffusion sequential injection system for##2##5##(2008-10#2)
diffusion solution##2##2##(2008-2#1)(2008-3#1)
diffusion studies##3##2##(1997-6#1)(2008-3#1)(2011-2#1)
diffusion technique##2##2##(1992-11#1)(2008-7#1)
diffusion tensor imaging##3##3##(2008-9#1)(2010-7#1)(2011-2#1)
diffusion tensor##8##2##(2008-11#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
diffusion theory and##3##3##(2008-3#2)(2010-10#1)
diffusion theory##10##2##(2007-11#1)(2008-2#1)(2008-3#7)(2010-10#1)
diffusion through the##2##3##(1991-5#1)(1992-5#1)
diffusion through##6##2##(1990-2#1)(1991-5#1)(1992-5#1)(1993-11#1)(2008-10#1)(2011-2#1)
diffusion to the##2##3##(2008-10#2)
diffusion to##5##2##(2008-10#4)(2008-5#1)
diffusion with##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
diffusion within the##3##3##(1991-5#1)(2008-10#1)(2009-2#1)
diffusion##509##1##(1990-12#3)(1990-2#3)(1990-6#3)(1990-7#3)(1990-9#1)(1991-5#6)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#9)(1993-12#3)(1993-3#1)(1993-6#3)(1993-8#2)(1994-12#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#4)(1997-1#1)(1997-6#6)(1997-7#1)(2007-10#4)(2007-11#14)(2007-12#20)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#92)(2008-11#16)(2008-12#4)(2008-2#34)(2008-3#67)(2008-5#26)(2008-6#4)(2008-7#26)(2008-8#10)(2008-9#12)(2009-11#5)(2009-12#2)(2009-2#4)(2009-7#2)(2009-9#3)(2010-10#8)(2010-11#1)(2010-12#8)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#17)(2012-3#5)(2013-1#8)(2013-8#14)
diffusion- and perfusion-weighted##2##3##(2007-10#2)
diffusion-based##3##1##(2008-3#3)
diffusion-controlled process##2##2##(2008-10#2)
diffusion-controlled with limited adsorption properties##2##5##(2008-10#2)
diffusion-controlled##12##1##(2008-10#10)(2008-5#2)
diffusion-flow injection##5##2##(2008-10#5)
diffusion-limited##2##1##(2008-3#1)(2008-8#1)
diffusion-weighted imaging (DWI)##2##3##(2007-10#1)(2010-12#1)
diffusion-weighted imaging##4##2##(2007-10#1)(2010-12#2)(2012-2#1)
diffusion-weighted magnetic resonance imaging##2##4##(2009-11#1)(2013-8#1)
diffusion-weighted##13##1##(1996-5#2)(2007-10#2)(2008-11#1)(2008-7#1)(2009-11#2)(2010-12#2)(2012-2#1)(2013-8#2)
diffusional limitations##2##2##(2008-11#1)(2008-7#1)
diffusional##6##1##(1997-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
diffusive gradient in thin films##2##5##(2008-10#2)
diffusive media##2##2##(2008-3#2)
diffusive sampler##2##2##(2010-5#2)
diffusive samplers##4##2##(2008-10#2)(2010-5#2)
diffusive sampling##2##2##(2008-10#1)(2010-5#1)
diffusive##43##1##(1991-9#1)(1992-9#1)(1994-9#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-2#4)(2008-3#12)(2008-7#1)(2008-8#1)(2010-5#6)(2011-2#1)(2013-8#1)
diffusive-wave##2##1##(2008-3#2)
diffusivity in##2##2##(2008-3#1)(2008-7#1)
diffusivity is##2##2##(2008-3#2)
diffusivity##14##1##(2008-3#10)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
difluoride (PVDF)##2##2##(2008-11#1)(2008-7#1)
difluoride##4##1##(1992-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
difunctional##3##1##(2008-2#3)
digalactosyldiacylglycerol##2##1##(1990-2#2)
digastric EMG##3##2##(1990-9#3)
digastric##6##1##(1990-9#6)
digenic epistatic interactions##2##3##(2008-10#2)
digenic##6##1##(2008-10#5)(2008-4#1)
digest of##7##2##(1990-8#1)(1992-12#1)(1993-9#1)(1997-2#1)(2008-8#1)(2010-2#1)(2013-1#1)
digest##23##1##(1990-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#2)(1996-5#1)(1997-2#2)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-1#1)
digestates##3##1##(2008-10#3)
digested and the##2##3##(1990-12#1)(1992-6#1)
digested and##6##2##(1990-12#1)(1992-6#1)(2008-10#4)
digested by a suitably##2##4##(2008-10#2)
digested by a##3##3##(1995-8#1)(2008-10#2)
digested by##12##2##(1993-8#2)(1995-8#1)(2008-10#6)(2009-3#1)(2013-8#2)
digested in a##2##3##(2008-10#2)
digested in##4##2##(2008-10#4)
digested sample##5##2##(2008-10#5)
digested samples of##2##3##(2008-10#2)
digested samples##8##2##(2008-10#8)
digested solutions##3##2##(2008-10#3)
digested with EcoRI##2##3##(1993-2#1)(2008-10#1)
digested with a##2##3##(2008-4#1)(2008-9#1)
digested with nitric acid##2##4##(2008-10#2)
digested with trypsin and##3##4##(1994-11#1)(1997-2#1)(2008-4#1)
digested with trypsin##4##3##(1990-2#1)(1994-11#1)(1997-2#1)(2008-4#1)
digested with##30##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-6#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#2)(2006-8#1)(2008-10#10)(2008-4#2)(2008-8#3)(2008-9#1)
digested##95##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-6#1)(1992-6#3)(1993-11#2)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-8#2)(1996-12#1)(1997-2#2)(2006-8#1)(2008-1#1)(2008-10#53)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#3)(2008-9#2)(2009-3#1)(2012-1#1)(2013-1#1)(2013-8#2)
digester failure##2##2##(2008-6#1)(2008-7#1)
digester overloading##2##2##(2008-7#2)
digester##16##1##(2008-6#8)(2008-7#7)(2013-1#1)
digesters##5##1##(2008-6#2)(2008-7#3)
digestibility and fecal characteristics##2##4##(2009-4#2)
digestibility and##5##2##(2008-12#1)(2009-4#2)(2010-2#1)(2012-2#1)
digestibility of##7##2##(2008-10#2)(2008-12#2)(2010-2#1)(2013-1#2)
digestibility##29##1##(2008-10#2)(2008-12#4)(2009-4#5)(2010-2#8)(2011-2#1)(2012-2#4)(2013-1#5)
digestible##11##1##(1990-5#1)(1993-12#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-8#1)(2009-4#2)(2011-2#1)
digesting##6##1##(1993-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
digestion analysis##2##2##(2008-10#1)(2008-8#1)
digestion and UV##2##3##(2008-10#2)
digestion and absorption##2##3##(2012-1#1)(2012-2#1)
digestion and##25##2##(1990-5#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(2008-10#14)(2012-1#1)(2012-2#1)(2012-3#1)
digestion by##7##2##(1991-9#2)(1994-5#1)(2008-10#2)(2008-11#1)(2010-11#1)
digestion conditions##2##2##(2008-10#2)
digestion efficiency##2##2##(2008-10#2)
digestion followed by##2##3##(2008-10#1)(2008-4#1)
digestion for the##2##3##(2008-10#2)
digestion for##11##2##(2008-10#11)
digestion has been developed##2##4##(2008-10#1)(2011-2#1)
digestion in##6##2##(1993-11#1)(1994-12#1)(2008-10#4)
digestion is##3##2##(2008-10#2)(2012-3#1)
digestion method were##2##3##(2008-10#2)
digestion method##9##2##(2008-10#9)
digestion methods##11##2##(2008-10#11)
digestion of DNA##2##3##(1996-12#1)(1997-3#1)
digestion of bovine##2##3##(2008-10#2)
digestion of genomic DNA##3##4##(1993-2#1)(2008-4#2)
digestion of purified##2##3##(1994-8#1)(2008-4#1)
digestion of samples##6##3##(2008-10#6)
digestion of the samples in##3##5##(2008-10#3)
digestion of the samples##6##4##(1995-6#1)(2008-10#5)
digestion of the##26##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#12)(2008-2#2)(2008-9#1)
digestion of##76##2##(1990-12#1)(1990-2#1)(1990-5#3)(1991-5#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-12#2)(1997-3#1)(2007-10#1)(2008-10#29)(2008-2#3)(2008-4#9)(2008-5#1)(2008-6#2)(2008-9#2)(2010-8#1)
digestion patterns##3##2##(2008-10#2)(2012-3#1)
digestion procedure and##2##3##(2008-10#2)
digestion procedure by##2##3##(2008-10#2)
digestion procedure for##2##3##(2008-10#2)
digestion procedure was##3##3##(2008-10#2)(2010-5#1)
digestion procedure##18##2##(2008-10#17)(2010-5#1)
digestion procedures for##3##3##(2008-10#3)
digestion procedures were##2##3##(2008-10#2)
digestion procedures##9##2##(2008-10#9)
digestion showed##2##2##(2008-10#1)(2008-11#1)
digestion solution##3##2##(2008-10#2)(2008-11#1)
digestion system##7##2##(2008-10#7)
digestion the##3##2##(1995-6#1)(2008-10#2)
digestion time##3##2##(2008-10#3)
digestion to##2##2##(1994-8#1)(2008-10#1)
digestion under##3##2##(1993-6#1)(2008-10#2)
digestion using##4##2##(2008-10#4)
digestion vessel##2##2##(2008-10#2)
digestion was used to##2##4##(2008-10#1)(2008-8#1)
digestion was used##3##3##(2008-10#2)(2008-8#1)
digestion was##8##2##(2008-10#7)(2008-8#1)
digestion were##2##2##(1994-12#1)(2008-10#1)
digestion with AluI##2##3##(2008-10#2)
digestion with HNO(3)##2##3##(2008-10#2)
digestion with a##2##3##(2008-10#2)
digestion with four##2##3##(2008-10#2)
digestion with nitric acid and##2##5##(2008-10#1)(2008-5#1)
digestion with nitric acid##3##4##(2008-10#2)(2008-5#1)
digestion with the##2##3##(1992-8#1)(2012-1#1)
digestion with##35##2##(1990-2#1)(1990-5#2)(1991-12#1)(1992-6#2)(1992-8#2)(1993-11#1)(1996-5#1)(2008-1#2)(2008-10#16)(2008-4#2)(2008-5#2)(2008-8#1)(2012-1#1)(2013-8#1)
digestion without##2##2##(2008-10#2)
digestion##365##1##(1990-12#4)(1990-2#3)(1990-5#7)(1991-12#2)(1991-5#3)(1991-9#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#5)(1992-8#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#7)(1994-11#2)(1994-12#7)(1994-5#2)(1994-8#5)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-10#211)(2008-11#6)(2008-2#3)(2008-4#22)(2008-5#6)(2008-6#5)(2008-7#1)(2008-8#4)(2008-9#5)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#3)
digestion-hydride##4##1##(2008-10#4)
digestions of##2##2##(1992-4#1)(2008-10#1)
digestions with##3##2##(1992-8#1)(2008-4#2)
digestions##15##1##(1992-4#1)(1992-8#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-4#3)(2008-7#1)(2008-8#2)
digestive disorders##4##2##(1995-2#1)(2008-10#1)(2009-10#1)(2013-7#1)
digestive endoscopy##2##2##(1992-9#1)(2013-1#1)
digestive enzyme activity##2##3##(2012-12#1)(2012-2#1)
digestive enzyme##3##2##(1992-9#1)(2012-12#1)(2012-2#1)
digestive enzymes in##2##3##(1990-12#1)(2013-1#1)
digestive enzymes##3##2##(1990-12#1)(2012-12#1)(2013-1#1)
digestive gland##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
digestive hemorrhage##4##2##(1991-11#2)(1992-5#2)
digestive system and##2##3##(2007-8#1)(2011-1#1)
digestive system##11##2##(1992-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
digestive tract of##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
digestive tract##33##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-6#1)(1993-9#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-5#4)(2008-7#1)(2009-5#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)
digestive tracts##2##2##(2008-5#1)(2013-1#1)
digestive##97##1##(1990-12#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-11#1)(1993-9#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-12#5)(2007-8#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-5#8)(2008-7#2)(2008-8#1)(2009-10#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)
digests and##3##2##(2008-10#3)
digests of##13##2##(1990-8#2)(1992-8#1)(1997-3#1)(1997-6#1)(2008-10#8)
digests##32##1##(1990-8#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1997-3#2)(1997-6#1)(2008-10#20)(2008-7#1)(2013-8#1)
digging##3##1##(1993-3#1)(2007-12#1)(2011-2#1)
digit is##2##2##(2008-3#1)(2008-9#1)
digit preference##2##2##(1992-6#2)
digit##17##1##(1992-6#2)(1994-6#1)(2007-10#1)(2008-3#1)(2008-9#8)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
digit-set-restricted modified signed-digit##2##3##(2008-3#2)
digital Pacinian corpuscle hyperplasia##2##4##(2008-12#2)
digital abnormalities##2##2##(1997-3#2)
digital analysis of the##2##4##(2008-1#1)(2008-3#1)
digital and##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
digital camera##9##2##(2007-11#2)(2008-3#4)(2008-9#1)(2010-8#1)(2012-6#1)
digital capture and##2##3##(2007-12#1)(2008-1#1)
digital capture##3##2##(2007-12#1)(2008-1#1)(2008-4#1)
digital communication##2##2##(2007-11#1)(2008-3#1)
digital data##14##2##(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#8)(2011-1#1)
digital filtering##2##2##(2008-3#2)
digital hologram##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
digital holograms##7##2##(2007-11#3)(2008-3#4)
digital holographic interferometry##4##3##(2008-2#1)(2008-3#3)
digital holographic##11##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2011-1#3)
digital holography and##3##3##(2007-11#1)(2008-3#2)
digital holography for##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
digital holography is presented##2##4##(2008-3#2)
digital holography is##4##3##(2007-12#1)(2008-3#3)
digital holography with a##2##4##(2008-2#1)(2008-3#1)
digital holography with##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
digital holography##38##2##(2007-11#7)(2007-12#8)(2008-2#2)(2008-3#21)
digital image analysis technique##2##4##(2008-10#2)
digital image analysis##12##3##(1992-3#1)(2008-10#8)(2008-4#1)(2008-9#1)(2012-2#1)
digital image processing##3##3##(2008-11#1)(2008-2#2)
digital image##22##2##(1992-3#1)(1996-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-9#1)(2010-8#1)(2012-2#1)
digital images are##2##3##(2007-12#1)(2008-3#1)
digital images of the##3##4##(2008-1#1)(2008-5#1)(2008-6#1)
digital images of##4##3##(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)
digital images##9##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#1)
digital imaging##11##2##(1992-6#1)(1993-11#2)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
digital message##2##2##(2007-11#2)
digital method for##2##3##(2008-3#2)
digital method##3##2##(2008-3#2)(2013-8#1)
digital micromirror device##3##3##(2008-2#1)(2008-3#2)
digital micromirror##5##2##(2008-2#2)(2008-3#3)
digital microscope##2##2##(2008-10#1)(2008-2#1)
digital microscopic holography##2##3##(2008-3#2)
digital microscopic##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
digital microscopy##4##2##(2008-3#2)(2008-9#1)(2011-2#1)
digital nerves##2##2##(2008-9#2)
digital optical computing##4##3##(2008-3#4)
digital or##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
digital phase demodulation##2##3##(2007-12#2)
digital phase##3##2##(2007-12#3)
digital radio##2##2##(2009-3#2)
digital radiography##4##2##(1991-12#1)(2008-7#1)(2009-9#1)(2011-1#1)
digital readout##2##2##(2008-1#1)(2011-1#1)
digital reconstruction##3##2##(2007-11#1)(2008-2#1)(2009-11#1)
digital rectal examination##3##3##(1991-7#1)(2008-7#1)(2012-12#1)
digital rectal examinations##4##3##(1991-7#2)(1994-12#1)(2008-4#1)
digital rectal##8##2##(1991-7#3)(1994-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)
digital revascularization##3##2##(2008-9#3)
digital signal processing##6##3##(1994-12#2)(2008-2#2)(2008-3#1)(2010-8#1)
digital signal processor##3##3##(2008-3#3)
digital signal##11##2##(1994-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2010-8#1)
digital simulation##2##2##(2008-10#1)(2009-5#1)
digital speckle photography (DSP)##2##4##(2008-3#2)
digital speckle photography##11##3##(2008-3#11)
digital speckle##12##2##(2008-3#12)
digital speckle-pattern interferometry (DSPI)##3##4##(2008-2#2)(2008-3#1)
digital speckle-pattern interferometry##4##3##(2008-2#3)(2008-3#1)
digital subtraction angiography (DSA)##4##4##(1993-8#1)(2008-7#2)(2012-2#1)
digital subtraction angiography##10##3##(1993-8#2)(2008-7#5)(2011-2#2)(2012-2#1)
digital subtraction##11##2##(1993-8#2)(2008-7#6)(2011-2#2)(2012-2#1)
digital versatile disc##2##3##(2008-3#2)
digital versatile disk (DVD)##2##4##(2008-3#2)
digital versatile disk##5##3##(2008-2#1)(2008-3#4)
digital versatile##9##2##(2008-2#1)(2008-3#8)
digital video##3##2##(2008-3#3)
digital##362##1##(1991-12#1)(1991-7#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-7#1)(1995-11#1)(1995-5#1)(1996-2#2)(1997-3#3)(1997-8#1)(2006-10#1)(2007-11#22)(2007-12#20)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#22)(2008-11#3)(2008-12#7)(2008-2#28)(2008-3#128)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#10)(2011-1#7)(2011-2#6)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#5)(2013-7#2)(2013-8#2)
digitalis intoxication##2##2##(1992-7#1)(1993-8#1)
digitalis##9##1##(1992-5#1)(1992-6#2)(1992-7#1)(1993-8#1)(1994-6#2)(1994-7#2)
digitalis-like factor##2##2##(1990-12#2)
digitalis-like##3##1##(1990-12#2)(1994-2#1)
digitalized##2##1##(1994-11#1)(2012-3#1)
digitally##11##1##(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#5)(2009-2#1)
digitata##5##1##(1991-5#2)(1994-11#3)
digitatum were##3##2##(2008-10#3)
digitatum##15##1##(2008-10#15)
digitization errors##2##2##(2008-3#2)
digitization of##2##2##(2008-10#1)(2008-7#1)
digitization##7##1##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-12#2)
digitize##2##1##(2008-7#1)(2008-9#1)
digitized at##2##2##(2008-3#1)(2012-12#1)
digitized##24##1##(1990-11#1)(1991-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#6)(2008-2#1)(2008-3#7)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
digitizers##2##1##(2008-2#1)(2008-7#1)
digitonin##4##1##(1990-2#2)(1992-6#1)(2008-4#1)
digitonin-permeabilized##2##1##(1991-6#1)(1994-9#1)
digitorum longus##4##2##(2008-12#1)(2008-9#2)(2010-3#1)
digitorum##14##1##(2008-12#1)(2008-5#2)(2008-9#4)(2009-5#3)(2010-3#1)(2010-5#2)(2012-2#1)
digits and##4##2##(2008-6#1)(2008-9#3)
digits are##2##2##(2008-10#1)(2008-3#1)
digits on##2##2##(2010-4#2)
digits##22##1##(1996-2#1)(2008-10#1)(2008-3#5)(2008-6#2)(2008-9#8)(2009-5#1)(2010-4#2)(2012-12#1)(2012-2#1)
diglucoside##3##1##(2008-11#1)(2011-1#2)
diglyceride##2##1##(1990-8#1)(1992-6#1)
diglycerides##3##1##(1990-2#1)(1992-9#2)
dignity and##3##2##(1990-6#1)(2010-3#1)(2011-2#1)
dignity in##2##2##(2010-10#2)
dignity is presented in the main theme##2##7##(2010-10#2)
dignity##22##1##(1990-6#1)(1991-8#1)(1993-1#1)(1996-1#1)(2007-10#1)(2007-6#1)(2008-7#1)(2009-12#1)(2010-10#6)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
digoxigenin##5##1##(2008-10#3)(2008-12#1)(2008-4#1)
digoxigenin-dUTP##2##1##(2008-10#2)
digoxigenin-labeled##5##1##(1996-12#1)(1997-6#1)(2008-10#3)
digoxin in##2##2##(1990-12#1)(2009-10#1)
digoxin##21##1##(1990-12#3)(1993-8#1)(1994-6#8)(1995-11#1)(2006-8#1)(2008-10#2)(2008-7#1)(2009-10#2)(2010-8#1)(2013-8#1)
digoxin-like immunoreactive factors##2##3##(1991-8#2)
digoxin-like immunoreactivity##2##2##(1990-12#1)(1991-8#1)
digoxin-like##4##1##(1990-12#1)(1991-8#3)
digraphs##2##1##(1996-1#1)(2008-3#1)
dihaloacetonitriles and halophenols##2##3##(2008-10#2)
dihedral angle of##5##3##(1993-8#2)(1996-2#2)(2013-8#1)
dihedral angle##10##2##(1993-8#3)(1996-2#2)(1997-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
dihedral angles##3##2##(1993-11#1)(2008-3#1)(2011-2#1)
dihedral##15##1##(1993-11#1)(1993-8#3)(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
diheptanoyl-PI##2##1##(1993-8#2)
dihydralazine##3##1##(2008-10#3)
dihydrate##5##1##(2008-10#1)(2013-1#4)
dihydroberberine##3##1##(2008-11#3)
dihydrochloride (DAPI)##2##2##(1995-6#1)(2008-2#1)
dihydrochloride##12##1##(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-10#6)(2008-2#1)(2008-5#1)
dihydrodiol##2##1##(1990-11#2)
dihydroergotoxine##3##1##(1990-6#3)
dihydroetorphine##6##1##(1995-11#6)
dihydrofolate reductase (DHFR)##4##3##(1992-6#1)(1994-9#1)(2008-11#1)(2008-2#1)
dihydrofolate reductase inhibitors##3##3##(2007-11#2)(2008-5#1)
dihydrofolate reductase##20##2##(1990-8#1)(1992-6#2)(1992-8#1)(1994-6#4)(1994-9#1)(1995-2#2)(2007-11#2)(2008-11#4)(2008-2#1)(2008-5#1)(2011-1#1)
dihydrofolate##22##1##(1990-8#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-6#4)(1994-9#1)(1995-2#2)(2007-11#2)(2008-11#5)(2008-2#1)(2008-5#1)(2011-1#1)
dihydrogen phosphate##10##2##(1996-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-12#1)
dihydrogen##18##1##(1996-2#2)(1996-5#1)(1997-7#3)(2008-10#4)(2008-3#2)(2008-5#1)(2009-10#2)(2010-3#1)(2011-1#1)(2012-12#1)
dihydrokainic acid##2##2##(2008-7#1)(2008-8#1)
dihydrolipoamide dehydrogenase##4##2##(1995-6#4)
dihydrolipoamide##5##1##(1992-3#1)(1995-6#4)
dihydroorotate dehydrogenase##2##2##(1993-2#2)
dihydroorotate##3##1##(1993-2#2)(1995-5#1)
dihydropyridine calcium antagonists##2##3##(1996-5#2)
dihydropyridine calcium##3##2##(1990-7#1)(1996-5#2)
dihydropyridine##9##1##(1990-7#2)(1995-11#2)(1995-3#1)(1996-5#3)(2012-12#1)
dihydropyridine-sensitive##3##1##(1993-3#2)(1997-1#1)
dihydropyridines##6##1##(1990-7#1)(1991-2#2)(1993-11#1)(1993-3#1)(2012-3#1)
dihydrotestosterone and##2##2##(1990-11#1)(1996-5#1)
dihydrotestosterone##13##1##(1990-11#4)(1991-9#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-5#1)(2008-2#1)(2008-5#2)
dihydroxyacetone##4##1##(1995-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
dihydroxyacid##2##1##(1993-12#2)
dihydroxybenzene##2##1##(2008-10#2)
dihydroxybenzenes##2##1##(2008-10#2)
dihystera##2##1##(2008-10#2)
diimine##3##1##(2008-10#3)
diiodosalicylate (LIS)##2##2##(1996-12#1)(2008-8#1)
diiron site##6##2##(1991-12#5)(1992-8#1)
diiron##10##1##(1991-12#6)(1991-8#1)(1992-8#2)(2009-9#1)
diiron(II) complexes##2##2##(2009-11#2)
diiron(II)##3##1##(2009-11#3)
diisopropyl ether##2##2##(2008-10#1)(2008-7#1)
diisopropyl##3##1##(2008-10#1)(2008-4#1)(2008-7#1)
diisopropylcarbodiimide in##2##2##(2008-9#2)
diisopropylcarbodiimide##7##1##(2008-4#1)(2008-9#6)
diketo functionality##2##2##(2010-5#2)
dilaceration in permanent##2##3##(2013-1#2)
dilaceration##3##1##(2013-1#3)
dilatation and curettage##5##3##(1991-12#1)(1992-12#1)(1993-12#1)(1995-3#1)(2011-1#1)
dilatation and##9##2##(1991-12#1)(1992-12#1)(1993-12#2)(1995-3#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-1#1)
dilatation in##4##2##(2008-9#3)(2013-1#1)
dilatation is##2##2##(1990-12#1)(2011-2#1)
dilatation may##2##2##(2008-10#1)(2011-2#1)
dilatation of the##9##3##(1990-9#1)(1991-5#1)(2008-12#1)(2008-7#2)(2010-10#1)(2012-1#1)(2012-2#2)
dilatation of##21##2##(1990-9#2)(1991-5#1)(1992-9#1)(1994-9#1)(1995-3#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-10#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-2#4)
dilatation with##2##2##(1995-10#1)(2008-7#1)
dilatation##74##1##(1990-12#3)(1990-9#2)(1991-12#1)(1991-3#4)(1991-5#1)(1992-12#1)(1992-9#4)(1993-12#2)(1994-9#1)(1995-10#1)(1995-3#3)(1996-3#1)(1997-3#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#5)
dilatation)##2##1##(1990-9#1)(1996-3#1)
dilatational tracheostomy##4##2##(2012-12#4)
dilatational##6##1##(1994-3#2)(2012-12#4)
dilated blood vessels##2##3##(2010-6#1)(2011-1#1)
dilated cardiomyopathy and##3##3##(1992-6#1)(2010-8#1)(2011-2#1)
dilated cardiomyopathy in##5##3##(2007-8#1)(2008-10#1)(2008-7#2)(2013-8#1)
dilated cardiomyopathy##22##2##(1992-6#1)(1993-2#3)(2007-8#1)(2008-10#2)(2008-7#2)(2009-10#1)(2009-5#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
dilated using##2##2##(2010-12#1)(2013-7#1)
dilated##57##1##(1990-6#1)(1992-6#1)(1993-2#3)(1993-6#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#6)(2009-10#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
dilation and##7##2##(1993-6#2)(2008-10#1)(2010-12#1)(2011-1#2)(2013-1#1)
dilation in##2##2##(2008-7#1)(2012-12#1)
dilation of the##6##3##(1990-6#1)(1997-8#1)(2008-10#1)(2010-10#2)(2010-11#1)
dilation of##8##2##(1990-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2010-10#2)(2010-11#1)(2012-3#1)
dilation##35##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-9#1)(1993-6#5)(1997-8#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#5)(2011-1#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
dilational surface##2##2##(2008-10#2)
dilational##4##1##(2008-10#3)(2008-7#1)
dilatometry##2##1##(2008-10#2)
dilator##2##1##(1990-12#1)(2007-7#1)
dilaurate##3##1##(1993-12#3)
dilauroylphosphatidylethanolamine##2##1##(1992-9#2)
dilazep and dipyridamole##2##3##(1995-8#2)
dilemma and##4##2##(1996-2#1)(2006-10#1)(2008-8#1)(2011-1#1)
dilemma in##5##2##(1994-12#1)(1994-8#1)(1997-8#1)(2009-5#1)(2012-3#1)
dilemma of##12##2##(1991-8#1)(1992-1#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#3)
dilemma theory##3##2##(2008-8#3)
dilemma to a##2##3##(2008-8#1)(2011-2#1)
dilemma with##2##2##(2008-11#1)(2008-7#1)
dilemma##57##1##(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#1)(2009-11#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
dilemma?##2##1##(1996-12#1)(2011-1#1)
dilemmas and##5##2##(1991-1#1)(2007-12#1)(2008-11#1)(2012-12#1)(2013-1#1)
dilemmas are##4##2##(1995-5#1)(2009-6#1)(2009-8#1)(2010-4#1)
dilemmas associated with##2##3##(2007-12#1)(2013-8#1)
dilemmas in##6##2##(1993-2#1)(1993-3#1)(1995-3#1)(2008-12#1)(2009-5#1)(2012-3#1)
dilemmas of##3##2##(1991-1#1)(1991-9#1)(2010-10#1)
dilemmas that##2##2##(1997-3#1)(2013-8#1)
dilemmas##46##1##(1991-1#2)(1991-3#1)(1991-9#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#3)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
diligence and##2##2##(1993-12#1)(2007-9#1)
diligence##8##1##(1993-12#2)(2007-9#1)(2008-10#1)(2008-11#4)
diligent##3##1##(2008-4#1)(2011-1#2)
dill##6##1##(2008-10#6)
dilocus allozyme##2##2##(2008-10#2)
diltiazem hydrochloride##3##2##(1990-8#2)(1992-8#1)
diltiazem in##3##2##(1992-8#1)(2008-7#2)
diltiazem##25##1##(1990-12#1)(1990-7#1)(1990-8#3)(1992-8#9)(1993-3#1)(1994-9#2)(2007-8#1)(2008-10#1)(2008-7#5)(2012-2#1)
diluent and##2##2##(2008-10#2)
diluent solution##2##2##(2008-10#2)
diluent with##3##2##(2008-10#3)
diluent##17##1##(1995-2#1)(2008-10#16)
diluents of low dielectric constants##2##5##(2008-10#2)
diluents of low dielectric##3##4##(2008-10#3)
diluents were##2##2##(1995-2#1)(2008-10#1)
diluents##14##1##(1995-2#1)(2008-10#13)
dilute acid##4##2##(2008-10#3)(2008-6#1)
dilute aqueous solution##2##3##(2008-10#1)(2008-6#1)
dilute aqueous solutions##5##3##(2008-10#5)
dilute aqueous##11##2##(2008-10#10)(2008-6#1)
dilute hydrochloric acid##4##3##(2008-10#3)(2013-1#1)
dilute nitric acid##5##3##(2008-10#5)
dilute nitric##6##2##(2008-10#6)
dilute solute##2##2##(2008-10#2)
dilute solution of##2##3##(2007-12#1)(2008-10#1)
dilute solution##4##2##(1995-6#1)(2007-12#1)(2008-10#2)
dilute solutions of##2##3##(2008-3#1)(2009-5#1)
dilute solutions##6##2##(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)
dilute sulfuric##2##2##(2008-10#1)(2013-1#1)
dilute suspensions of##2##3##(2007-12#2)
dilute##66##1##(1990-5#1)(1991-3#1)(1992-3#1)(1993-12#1)(1995-6#1)(2007-12#4)(2008-1#1)(2008-10#38)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#2)(2008-7#3)(2009-5#1)(2009-8#1)(2013-1#3)
diluted 1##2##2##(2010-4#1)(2011-2#1)
diluted H(2)SO(4)##2##2##(2008-10#2)
diluted blood##2##2##(1991-12#1)(2008-2#1)
diluted by##2##2##(2008-10#2)
diluted five-fold with 0##3##4##(2008-10#3)
diluted in##5##2##(1992-6#1)(1994-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
diluted milk##2##2##(2007-11#2)
diluted samples##3##2##(2008-10#3)
diluted solution of the alcohol sample and quantitatively determined measuring the absorbance at##2##13##(2008-10#2)
diluted solutions##2##2##(2008-10#2)
diluted to##6##2##(1997-4#1)(2008-10#4)(2009-6#1)
diluted up to##2##3##(2008-10#1)(2011-2#1)
diluted urine sample##2##3##(1990-8#2)
diluted urine samples##3##3##(2008-10#3)
diluted urine##6##2##(1990-8#2)(2008-10#4)
diluted with##12##2##(1990-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2011-3#1)
diluted##101##1##(1990-12#1)(1990-8#3)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-9#2)(1995-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-1#1)(2013-1#4)
diluting the sample##2##3##(2008-10#1)(2009-6#1)
diluting the##4##2##(1994-12#1)(2008-10#1)(2009-11#1)(2009-6#1)
diluting##9##1##(1990-3#1)(1994-12#1)(2008-10#4)(2008-5#1)(2009-11#1)(2009-6#1)
dilution analysis##2##2##(2008-10#1)(2008-4#1)
dilution and##11##2##(2008-10#7)(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
dilution assay##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
dilution calibration##2##2##(2008-10#2)
dilution effect##4##2##(1995-3#1)(2008-10#2)(2010-5#1)
dilution for##3##2##(2008-10#3)
dilution in##6##2##(2008-10#6)
dilution method for##2##3##(2008-10#2)
dilution method##16##2##(1991-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#2)
dilution of 1##2##3##(2008-10#1)(2008-2#1)
dilution of a##2##3##(2008-10#2)
dilution of sample##2##3##(2008-10#2)
dilution of serum##2##3##(1992-3#1)(1993-12#1)
dilution of the sample##3##4##(2008-10#3)
dilution of the##15##3##(1992-8#1)(2008-10#11)(2008-5#2)(2013-1#1)
dilution of##35##2##(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-3#1)(1997-5#1)(2008-10#21)(2008-2#1)(2008-5#3)(2013-1#1)
dilution on##2##2##(2008-10#1)(2008-11#1)
dilution plating##4##2##(2008-10#4)
dilution procedure##2##2##(2008-10#2)
dilution rate (D)##2##3##(2008-6#1)(2008-7#1)
dilution rate of 0##5##4##(2008-6#4)(2008-7#1)
dilution rate of##6##3##(2008-6#4)(2008-7#2)
dilution rate##15##2##(1997-2#1)(2008-11#1)(2008-6#9)(2008-7#4)
dilution rate)##2##2##(2008-11#2)
dilution rates##8##2##(2008-11#3)(2008-6#3)(2008-7#2)
dilution series##4##2##(2008-10#4)
dilution step##2##2##(2008-10#2)
dilution to##2##2##(2008-10#1)(2008-9#1)
dilution with##3##2##(1990-2#1)(2008-10#2)
dilution##199##1##(1990-11#3)(1990-2#1)(1990-3#2)(1990-8#1)(1991-5#2)(1991-8#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#3)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#116)(2008-11#13)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#13)(2008-7#8)(2008-8#1)(2008-9#2)(2010-11#1)(2010-5#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
dilution&quot##3##1##(1990-3#1)(1991-8#1)(2008-10#1)
dilution)##3##1##(1990-12#1)(2008-10#2)
dilution-thermal ionisation mass spectrometry##2##4##(2008-10#2)
dilutions of the##2##3##(1994-3#1)(2008-10#1)
dilutions of##9##2##(1994-3#2)(1996-12#1)(2008-10#4)(2008-5#1)(2013-8#1)
dilutions##25##1##(1990-12#1)(1994-3#2)(1995-11#1)(1996-12#1)(2008-10#14)(2008-2#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
dilysine-tagged##3##1##(1994-12#3)
dim##5##1##(1995-12#1)(2008-2#1)(2008-9#1)(2010-1#1)(2013-1#1)
dimedone##3##1##(1997-7#1)(2008-10#2)
dimeglumine##6##1##(2008-7#6)
dimenhydrinate##2##1##(2008-10#2)
dimension and a##2##3##(2008-3#1)(2012-12#1)
dimension and##11##2##(1990-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-12#1)
dimension correlation##2##2##(2013-8#2)
dimension for##2##2##(2007-8#1)(2010-4#1)
dimension has##2##2##(2010-3#1)(2011-2#1)
dimension in##4##2##(1991-5#1)(2008-4#1)(2008-6#1)(2011-2#1)
dimension increased##2##2##(2011-2#2)
dimension is##4##2##(2007-12#2)(2008-11#1)(2011-2#1)
dimension of BI##2##3##(2007-12#2)
dimension of a##2##3##(2008-10#1)(2011-2#1)
dimension of pancreas##2##3##(2012-3#2)
dimension of the##11##3##(2007-10#1)(2008-10#2)(2008-5#2)(2008-7#2)(2009-8#1)(2009-9#1)(2012-1#1)(2012-2#1)
dimension of##48##2##(1991-2#1)(1991-6#1)(1993-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#4)(2008-7#3)(2009-1#1)(2009-11#5)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-8#1)
dimension reduction techniques##2##3##(2008-6#1)(2008-7#1)
dimension reduction##4##2##(2008-6#2)(2008-7#1)(2012-12#1)
dimension to the##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
dimension to##6##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
dimension was##3##2##(2011-2#3)
dimension##151##1##(1990-2#1)(1990-3#1)(1991-2#2)(1991-5#1)(1991-6#1)(1993-5#1)(1993-8#1)(1995-2#1)(1996-2#2)(1996-3#1)(1996-4#2)(1997-2#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-8#4)(2008-1#1)(2008-10#16)(2008-11#10)(2008-12#3)(2008-2#8)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#7)(2009-12#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
dimensional changes##3##2##(2012-2#3)
dimensional stability of##2##3##(1990-9#1)(2007-12#1)
dimensional stability##3##2##(1990-9#1)(2007-12#1)(2012-12#1)
dimensional##58##1##(1990-7#1)(1990-9#1)(1991-8#1)(1995-8#1)(1997-6#2)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#4)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-8#2)
dimensionality is##3##2##(2008-10#1)(2010-7#2)
dimensionality of##8##2##(1994-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-7#1)(2012-2#1)(2012-3#2)
dimensionality reduction##5##2##(2008-2#1)(2008-6#2)(2012-3#1)(2013-8#1)
dimensionality##24##1##(1993-12#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#3)(2008-7#2)(2009-11#2)(2010-10#1)(2010-7#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
dimensionally##6##1##(2007-12#2)(2008-10#1)(2008-3#3)
dimensionless parameters##2##2##(2008-2#1)(2008-3#1)
dimensionless##8##1##(1995-2#2)(2007-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
dimensions and function##2##3##(2008-12#2)
dimensions and##21##2##(1991-12#1)(1994-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
dimensions are##3##2##(2008-10#2)(2008-3#1)
dimensions as##4##2##(2007-8#1)(2008-2#1)(2008-9#1)(2011-2#1)
dimensions concerning##2##2##(2012-12#2)
dimensions for##3##2##(2008-11#2)(2008-3#1)
dimensions in##5##2##(1992-3#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)
dimensions is##3##2##(2008-3#2)(2008-7#1)
dimensions of an##2##3##(1996-2#1)(2008-10#1)
dimensions of child well-being##2##4##(2008-2#1)(2010-3#1)
dimensions of mental health##2##4##(2013-1#2)
dimensions of personality##2##3##(1994-2#1)(2007-8#1)
dimensions of quality##6##3##(1995-12#1)(1996-1#1)(1996-2#2)(1997-2#1)(2012-12#1)
dimensions of the##21##3##(1991-6#1)(1991-9#1)(1992-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2009-11#2)(2010-4#1)(2012-2#1)
dimensions of##94##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#1)(1994-2#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#5)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#3)(2009-12#2)(2009-5#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#3)
dimensions required for##2##3##(2007-11#1)(2008-3#1)
dimensions such as##2##3##(1994-2#1)(1995-6#1)
dimensions that##4##2##(1994-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
dimensions the##2##2##(2008-3#2)
dimensions to##3##2##(1992-3#1)(2008-1#1)(2008-11#1)
dimensions was##3##2##(2012-12#1)(2012-3#1)(2013-1#1)
dimensions were##6##2##(1993-5#1)(1995-6#1)(2008-10#1)(2009-1#1)(2009-7#1)(2011-2#1)
dimensions with##4##2##(1991-3#1)(1994-2#1)(1997-6#1)(2008-7#1)
dimensions##281##1##(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#4)(1993-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#9)(1996-3#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#7)(2007-12#13)(2007-8#5)(2008-1#1)(2008-10#21)(2008-11#11)(2008-12#6)(2008-2#13)(2008-3#34)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#1)(2009-5#5)(2009-7#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#12)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#15)(2013-8#9)
dimer also##2##2##(1993-9#1)(2009-9#1)
dimer and##3##2##(1990-7#1)(1995-2#1)(2008-10#1)
dimer assembly##2##2##(1995-8#2)
dimer containing##2##2##(1993-8#2)
dimer cooperativity##2##2##(1990-8#2)
dimer formation as##2##3##(1992-3#1)(2008-10#1)
dimer formation##9##2##(1992-3#2)(1993-11#1)(1995-5#1)(2008-10#4)(2012-2#1)
dimer fraction##2##2##(1994-11#1)(2008-6#1)
dimer in the##3##3##(1992-3#1)(1994-8#1)(1997-7#1)
dimer in##5##2##(1992-3#1)(1994-8#1)(1995-5#1)(1997-7#1)(2008-8#1)
dimer interface##5##2##(1995-5#1)(2008-8#1)(2012-2#3)
dimer is##3##2##(1993-3#1)(1994-11#1)(2008-10#1)
dimer of the##3##3##(1991-12#1)(1994-8#1)(1997-2#1)
dimer of##8##2##(1991-12#1)(1991-7#1)(1992-3#1)(1994-11#1)(1994-8#1)(1997-2#1)(2008-10#1)(2013-1#1)
dimer or##2##2##(2008-8#1)(2008-9#1)
dimer species##2##2##(2008-10#1)(2010-10#1)
dimer to##2##2##(1995-11#1)(2008-8#1)
dimer was##2##2##(1995-5#1)(1995-6#1)
dimer##111##1##(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#3)(1991-12#2)(1991-6#1)(1991-7#2)(1992-3#5)(1993-11#1)(1993-3#1)(1993-8#7)(1993-9#2)(1994-11#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#6)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#7)(1995-6#1)(1995-8#2)(1996-2#2)(1997-2#3)(1997-7#3)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#3)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2012-2#4)(2013-1#2)
dimer-tetramer assembly##6##2##(1990-8#4)(1997-2#2)
dimer-tetramer##8##1##(1990-8#6)(1997-2#2)
dimer-to-tetramer##2##1##(1997-2#2)
dimeric Lac repressor##2##3##(1995-3#2)
dimeric aluminate species##2##3##(2008-10#2)
dimeric and##3##2##(1990-8#1)(2008-10#2)
dimeric complexes##2##2##(2010-2#2)
dimeric enzyme##2##2##(1992-3#2)
dimeric form##3##2##(1993-3#1)(2008-9#1)(2011-1#1)
dimeric forms of##2##3##(2008-10#1)(2013-1#1)
dimeric forms##3##2##(2008-10#2)(2013-1#1)
dimeric hydrogenase##2##2##(1992-3#2)
dimeric interleukin-5##3##2##(1994-6#3)
dimeric protein##4##2##(1990-7#1)(1994-11#1)(1995-5#1)(2008-8#1)
dimeric##63##1##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-9#1)(1992-3#6)(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#3)(1995-3#3)(1995-5#1)(1995-6#1)(1996-2#4)(1997-2#1)(2008-10#11)(2008-8#3)(2008-9#2)(2009-7#1)(2010-10#1)(2010-2#8)(2011-1#1)(2012-2#1)(2013-1#1)
dimerisation##2##1##(2010-10#2)
dimerization and##3##2##(1993-8#1)(2011-1#1)(2012-2#1)
dimerization constant##2##2##(2008-10#2)
dimerization domains##2##2##(1997-6#1)(2008-10#1)
dimerization equilibrium##3##2##(1996-2#1)(2008-10#2)
dimerization of##7##2##(1992-3#1)(1993-11#1)(1993-8#1)(1996-2#2)(2008-9#1)(2009-9#1)
dimerization or##2##2##(1996-5#1)(2008-10#1)
dimerization##31##1##(1992-3#1)(1993-11#1)(1993-8#4)(1994-10#1)(1996-2#3)(1996-5#1)(1997-6#1)(2008-10#10)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-2#2)(2013-8#1)
dimerize##3##1##(2008-10#2)(2010-12#1)
dimerized##2##1##(2008-8#1)(2011-2#1)
dimerizing domains##2##2##(1995-6#2)
dimerizing##3##1##(1995-6#3)
dimers and monomers##3##3##(1997-2#3)
dimers and##4##2##(1997-2#3)(2008-8#1)
dimers in##4##2##(1996-2#1)(2008-10#1)(2010-7#2)
dimers of##2##2##(1992-8#1)(2010-7#1)
dimers##53##1##(1990-12#1)(1990-2#1)(1990-8#6)(1991-7#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-8#3)(1996-2#2)(1997-2#7)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-9#4)(2010-12#1)(2010-2#1)(2010-7#4)
dimethacrylate (EDMA)##3##2##(2008-10#3)
dimethacrylate##12##1##(2008-10#8)(2009-7#1)(2013-1#3)
dimethicone and cyclotetrasiloxane##5##3##(2008-5#5)
dimethicone##6##1##(2008-5#6)
dimethoate##2##1##(1990-9#1)(2008-10#1)
dimethomorph##3##1##(2008-10#3)
dimethyl PABA##4##2##(2008-5#4)
dimethyl carbonate##3##2##(2011-2#3)
dimethyl ester##4##2##(1990-5#2)(1996-5#2)
dimethyl formamide (DMF)##2##3##(2008-10#2)
dimethyl formamide##3##2##(2008-10#2)(2008-5#1)
dimethyl sulfate##6##2##(1991-7#1)(2008-10#4)(2008-4#1)
dimethyl sulfide##3##2##(1996-5#3)
dimethyl sulfoxide (DMSO)##5##3##(1994-8#1)(2008-10#4)
dimethyl sulfoxide and##4##3##(1993-3#2)(2008-10#1)(2009-5#1)
dimethyl sulfoxide as a##2##4##(1995-5#1)(2008-10#1)
dimethyl sulfoxide##17##2##(1993-3#2)(1994-8#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#7)(2008-5#1)(2008-9#1)(2009-5#1)(2010-1#1)
dimethyl trisulphide##2##2##(2008-10#2)
dimethyl##72##1##(1990-5#3)(1990-7#1)(1991-12#1)(1991-7#1)(1993-3#2)(1994-8#3)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#8)(1996-9#1)(2007-11#2)(2008-10#22)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#4)(2013-8#1)
dimethylamine##3##1##(2008-10#3)
dimethylaminopyridinium##2##1##(1990-8#2)
dimethylarginine##3##1##(2009-4#2)(2011-2#1)
dimethylarsenic##2##1##(1993-3#1)(2008-10#1)
dimethylarsinate##3##1##(2008-10#3)
dimethylarsine##2##1##(2008-10#1)(2009-6#1)
dimethylarsinic acid (DMA) and##2##4##(2008-10#2)
dimethylarsinic acid (DMA)##6##3##(2008-10#6)
dimethylarsinic acid (DMAA)##4##3##(1993-3#2)(2008-10#2)
dimethylarsinic acid and##2##3##(2008-10#2)
dimethylarsinic acid##19##2##(1993-3#4)(2008-10#15)
dimethylarsinic##22##1##(1993-3#4)(2008-10#18)
dimethylated arsenic##2##2##(2008-10#2)
dimethylated##4##1##(1995-11#1)(2008-10#3)
dimethylation of arginine##2##3##(2009-7#2)
dimethyldioxirane##5##1##(1990-5#3)(2007-11#2)
dimethyldithiocarbamate##2##1##(2008-10#2)
dimethylethylamine alane##2##2##(2008-3#1)(2010-4#1)
dimethylformamide (DMF) and##5##3##(2008-10#5)
dimethylformamide (DMF)##6##2##(2008-10#6)
dimethylformamide or##2##2##(1992-2#1)(2008-10#1)
dimethylformamide solution##3##2##(2008-10#3)
dimethylformamide##13##1##(1992-2#2)(2008-10#11)
dimethylglyoxime##6##1##(2008-10#6)
dimethylsuberimidate##2##1##(1993-8#1)(2008-10#1)
dimethylsulfoxide (DMSO)##2##2##(2008-10#2)
dimethylsulfoxide and##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
dimethylsulfoxide##13##1##(1993-8#1)(1994-11#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)
dimethylsulphonazo(III)##2##1##(2008-10#2)
dimethylsulphoxide##4##1##(2008-10#2)(2008-5#1)(2010-5#1)
dimethyltin hydride##2##2##(2008-10#2)
dimethyltin##7##1##(2008-10#7)
dimetridazole##3##1##(1992-2#1)(1997-4#2)
dimidiata##3##1##(2008-8#3)
diminish its##2##2##(1993-6#1)(1995-3#1)
diminish the##7##2##(1991-8#1)(2007-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)
diminish##25##1##(1990-11#1)(1991-2#1)(1991-8#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-11#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
diminished after##4##2##(1995-8#1)(2007-9#1)(2008-8#1)(2008-9#1)
diminished and##3##2##(1991-9#1)(1994-9#1)(2008-10#1)
diminished as the##2##3##(1997-3#1)(2008-3#1)
diminished as##4##2##(1992-9#1)(1997-3#1)(2008-11#1)(2008-3#1)
diminished by##12##2##(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-9#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
diminished in the presence of##3##5##(1995-2#1)(2007-11#1)(2008-10#1)
diminished in the##5##3##(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2009-12#1)
diminished in##12##2##(1993-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)
diminished or##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
diminished renal function##2##3##(2010-8#1)(2011-2#1)
diminished the##8##2##(1994-6#1)(1994-8#1)(1995-3#2)(1996-3#1)(2008-10#1)(2008-7#1)(2010-4#1)
diminished their stimulatory actions##2##4##(2008-11#2)
diminished to##2##2##(2007-12#1)(2007-8#1)
diminished when##3##2##(1990-12#1)(1992-3#1)(2008-10#1)
diminished with##5##2##(1991-12#2)(1996-1#1)(2008-10#1)(2013-1#1)
diminished##160##1##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#5)(1991-2#2)(1991-4#1)(1991-9#4)(1992-12#1)(1992-3#6)(1992-4#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#14)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
diminishes the##9##2##(1991-9#1)(1993-11#1)(1995-11#1)(2007-11#3)(2008-10#2)(2008-9#1)
diminishes##25##1##(1991-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-2#1)(1997-6#1)(2007-11#4)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
diminishing of##2##2##(2007-11#1)(2008-4#1)
diminishing the##5##2##(1993-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
diminishing##20##1##(1992-6#1)(1993-12#2)(1993-3#1)(1996-1#2)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
diminuta##2##1##(2008-12#1)(2012-2#1)
diminution in the##2##3##(1994-6#1)(2008-10#1)
diminution in##3##2##(1994-6#1)(2008-10#2)
diminution of the##2##3##(2008-5#1)(2013-7#1)
diminution of##8##2##(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-7#1)
diminution##12##1##(1990-5#1)(1994-6#1)(2008-10#4)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-7#1)
dimly fluorescent##2##2##(2008-9#2)
dimly##3##1##(2008-11#1)(2008-9#2)
dimmer##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
dimming##2##1##(2008-11#1)(2008-3#1)
dimorphic DNA demethylation##2##3##(1995-2#2)
dimorphic##20##1##(1991-9#2)(1992-3#4)(1993-5#1)(1993-8#1)(1995-2#2)(1995-6#2)(1996-6#1)(2008-5#1)(2008-8#3)(2008-9#1)(2013-7#2)
dimorphism in##11##2##(1995-6#4)(2008-8#2)(2008-9#1)(2010-6#2)(2010-8#1)(2012-3#1)
dimorphism was found##3##3##(1995-6#1)(2007-12#1)(2012-3#1)
dimorphism##27##1##(1995-6#7)(1996-6#1)(2007-12#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-12#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
dimorphisms##4##1##(1994-2#1)(1997-3#2)(2008-9#1)
dimpled##3##1##(1997-3#1)(2008-5#2)
dimyristoylphosphatidylcholine (DMPC)##2##2##(1993-11#1)(1994-3#1)
dining##4##1##(1993-3#1)(2008-1#1)(2011-2#2)
dinitrate##5##1##(1996-9#1)(2008-10#3)(2008-3#1)
dinitrogen##2##1##(1997-7#2)
dinitrosalicylic##2##1##(2008-6#2)
dinoflagellate##4##1##(1992-8#3)(2008-5#1)
dinoflagellates associated with ciguatera##2##4##(2008-5#2)
dinoflagellates##5##1##(1997-4#1)(2008-5#4)
dinuclear##11##1##(1991-8#2)(1996-2#2)(1997-7#5)(2007-11#1)(2008-10#1)
dinucleoside phosphate##2##2##(1992-3#1)(2008-4#1)
dinucleoside##5##1##(1992-3#1)(2008-4#4)
dinucleotide (NADH)##3##2##(2008-10#2)(2013-1#1)
dinucleotide repeat##2##2##(1997-7#1)(2010-8#1)
dinucleotide##42##1##(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1993-11#3)(1994-11#1)(1994-12#1)(1995-3#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#1)(2008-10#5)(2008-4#6)(2008-5#2)(2010-8#1)(2011-2#3)(2013-1#1)
dinucleotides are##3##2##(2008-4#2)(2013-8#1)
dinucleotides##21##1##(1990-8#2)(1991-6#1)(1993-2#2)(1995-3#1)(1996-2#1)(2007-11#2)(2008-4#10)(2013-8#2)
diocese##2##1##(1991-2#2)
dioctyl phthalate (DOP)##5##3##(2008-10#5)
dioctyl##7##1##(2008-10#7)
dioctylphthalate (DOP)##3##2##(2008-10#3)
dioctylphthalate##4##1##(2008-10#4)
diode (LED) as##2##3##(2008-10#2)
diode (LED)##7##2##(2008-10#6)(2008-11#1)
diode and the##2##3##(2008-2#1)(2008-3#1)
diode and##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
diode array and##4##3##(2008-10#1)(2008-2#2)(2012-1#1)
diode array detection##8##3##(2008-10#8)
diode array detector (DAD)##3##4##(2008-10#3)
diode array detector##9##3##(2008-10#8)(2010-5#1)
diode array spectrophotometer##6##3##(2008-10#6)
diode array##36##2##(1991-2#1)(2008-10#27)(2008-2#4)(2008-3#1)(2010-5#1)(2012-1#1)(2012-3#1)
diode arrays##3##2##(2007-12#1)(2008-2#2)
diode as a##2##3##(2007-12#1)(2008-10#1)
diode as the##4##3##(2008-2#3)(2008-7#1)
diode as##7##2##(2007-12#1)(2008-10#1)(2008-2#4)(2008-7#1)
diode bar##2##2##(2007-11#1)(2008-3#1)
diode bars##3##2##(2007-11#3)
diode by##2##2##(2007-12#1)(2008-3#1)
diode can be##3##3##(2008-3#3)
diode curing##2##2##(2008-12#1)(2013-1#1)
diode emitting##2##2##(2008-10#1)(2008-3#1)
diode facet##2##2##(2008-3#2)
diode for##5##2##(2008-2#1)(2008-3#4)
diode has##2##2##(2008-2#1)(2008-3#1)
diode is used##2##3##(2008-2#1)(2008-3#1)
diode is##12##2##(2007-12#2)(2008-2#5)(2008-3#5)
diode laser absorption##5##3##(2008-2#1)(2008-3#4)
diode laser and##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
diode laser array##2##3##(2007-12#2)
diode laser as the##2##4##(2007-11#1)(2008-3#1)
diode laser at##8##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#2)
diode laser bar##6##3##(2007-12#1)(2011-1#5)
diode laser bars##2##3##(2008-2#1)(2011-1#1)
diode laser beam##2##3##(2007-12#1)(2008-2#1)
diode laser for##2##3##(2008-2#1)(2008-3#1)
diode laser has been##2##4##(2008-10#1)(2008-2#1)
diode laser in an external##2##5##(2007-12#1)(2008-3#1)
diode laser in the##2##4##(2008-2#1)(2013-1#1)
diode laser in##8##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2013-1#1)
diode laser into##2##3##(2008-3#2)
diode laser is##5##3##(2007-12#1)(2008-10#1)(2008-2#3)
diode laser light##2##3##(2007-11#1)(2008-3#1)
diode laser operating in the##2##5##(2008-3#2)
diode laser operating near##2##4##(2008-2#1)(2008-3#1)
diode laser operating##4##3##(2008-2#1)(2008-3#3)
diode laser side##2##3##(2008-2#2)
diode laser source##2##3##(1992-6#1)(2008-3#1)
diode laser spectrometer##3##3##(2008-2#1)(2008-3#2)
diode laser was##4##3##(2008-2#4)
diode laser with##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diode laser##128##2##(1992-6#1)(2007-11#14)(2007-12#26)(2007-8#1)(2008-10#5)(2008-2#35)(2008-3#38)(2011-1#7)(2013-1#1)
diode lasers emitting##2##3##(2007-11#1)(2008-3#1)
diode lasers for##2##3##(2008-3#2)
diode lasers operating near##2##4##(2008-3#2)
diode lasers that##2##3##(2007-12#2)
diode lasers used##2##3##(2008-2#1)(2008-3#1)
diode lasers was##2##3##(2007-12#1)(2008-3#1)
diode lasers with##3##3##(2007-11#2)(2008-3#1)
diode lasers##47##2##(2007-11#7)(2007-12#6)(2008-2#10)(2008-3#24)
diode light source##2##3##(2007-12#1)(2008-2#1)
diode oscillator##2##2##(2007-11#1)(2007-12#1)
diode power##3##2##(2007-11#1)(2008-2#2)
diode pumped##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
diode pumping at##2##3##(2007-11#1)(2007-12#1)
diode pumping##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
diode side-pumped Nd##3##3##(2008-2#3)
diode side-pumped solid-state##2##3##(2008-3#2)
diode side-pumped##5##2##(2008-2#3)(2008-3#2)
diode with a##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
diode with##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
diode##415##1##(1991-2#1)(1992-6#1)(2007-11#48)(2007-12#69)(2007-8#1)(2008-10#54)(2008-11#1)(2008-12#1)(2008-2#98)(2008-3#123)(2008-7#2)(2009-11#3)(2010-11#1)(2010-5#1)(2011-1#7)(2012-1#1)(2012-3#1)(2013-1#2)
diode-array detection##2##2##(2008-10#1)(2010-11#1)
diode-array detector##2##2##(2008-10#2)
diode-array##9##1##(2007-12#3)(2008-10#4)(2010-11#1)(2012-1#1)
diode-end-pumped##6##1##(2007-11#1)(2008-2#5)
diode-induced fluorescence detector for capillary electrophoresis##2##6##(2008-10#2)
diode-laser absorption technique##2##3##(2008-2#2)
diode-laser absorption##6##2##(2008-2#2)(2008-3#4)
diode-laser light is##2##3##(2008-3#2)
diode-laser light##3##2##(2008-3#3)
diode-laser sensor system##2##3##(2008-2#2)
diode-laser sensor##6##2##(2008-2#4)(2008-3#2)
diode-laser sensors##2##2##(2008-2#1)(2008-3#1)
diode-laser system##2##2##(2007-12#1)(2008-3#1)
diode-laser##30##1##(2007-11#1)(2007-12#4)(2008-2#8)(2008-3#17)
diode-laser-based sensor##2##2##(2008-3#2)
diode-laser-based##3##1##(2007-12#1)(2008-3#2)
diode-laser-pumped##3##1##(2008-2#2)(2008-3#1)
diode-pump##2##1##(2008-2#1)(2008-3#1)
diode-pumped Nd##31##2##(2007-11#2)(2007-12#11)(2008-2#5)(2008-3#13)
diode-pumped Tm##3##2##(2007-12#2)(2008-2#1)
diode-pumped Yb##9##2##(2007-11#2)(2007-12#4)(2008-3#3)
diode-pumped Yb(3+)##2##2##(2007-11#1)(2007-12#1)
diode-pumped continuous-wave##2##2##(2007-11#2)
diode-pumped cw##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
diode-pumped laser##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
diode-pumped lasers##2##2##(2007-11#1)(2008-2#1)
diode-pumped passively mode-locked##2##3##(2007-11#1)(2007-12#1)
diode-pumped passively##3##2##(2007-11#2)(2007-12#1)
diode-pumped solid-state##3##2##(2007-12#2)(2008-2#1)
diode-pumped tunable##2##2##(2007-12#2)
diode-pumped##110##1##(2007-11#22)(2007-12#39)(2008-2#21)(2008-3#28)
diode-seeded##2##1##(2008-2#2)
diodes (LEDs)##3##2##(1995-3#1)(2008-10#2)
diodes and##4##2##(2007-11#1)(2008-3#3)
diodes at##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
diodes by##2##2##(2008-3#2)
diodes have##2##2##(2007-12#1)(2008-3#1)
diodes is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
diodes that##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
diodes to##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
diodes were##3##2##(1993-9#1)(2007-11#1)(2009-11#1)
diodes with##3##2##(2007-11#2)(2007-12#1)
diodes##63##1##(1993-9#1)(1995-3#1)(2007-11#11)(2007-12#12)(2008-10#2)(2008-2#10)(2008-3#23)(2008-7#1)(2009-11#1)(2011-1#1)
dioestrous##2##1##(1994-7#2)
dioica##11##1##(1990-11#2)(1992-3#3)(2008-10#1)(2008-12#5)
diol lactone##2##2##(2008-7#2)
diol##11##1##(1991-5#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)
diolein##4##1##(1990-8#2)(1992-6#2)
dioleoyl PC##2##2##(1995-8#2)
dioleoylphosphatidylcholine##4##1##(1990-11#1)(1990-2#2)(1992-6#1)
dioleoylphosphatidylethanolamine##2##1##(1994-12#1)(2008-10#1)
diopters##2##1##(2008-3#2)
dioptric power##3##2##(2008-2#1)(2009-7#2)
dioptric##4##1##(2007-12#1)(2008-2#1)(2009-7#2)
diospyrin##4##1##(2008-10#4)
dioxane##2##1##(2007-11#1)(2008-2#1)
dioxane-water##2##1##(2008-10#2)
dioxide (SO(2)) in##2##3##(2008-10#2)
dioxide and oxygen##2##3##(1997-4#1)(2008-10#1)
dioxide and##9##2##(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-2#1)
dioxide by##4##2##(2008-10#2)(2008-3#2)
dioxide in air##5##3##(2008-10#5)
dioxide in gaseous samples##3##4##(2008-10#3)
dioxide in the##4##3##(2008-10#3)(2008-3#1)
dioxide in water##4##3##(2008-10#4)
dioxide in##27##2##(1993-12#1)(2008-10#25)(2008-3#1)
dioxide is##2##2##(2008-10#1)(2013-8#1)
dioxide laser in##2##3##(1992-1#1)(1992-3#1)
dioxide laser##8##2##(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-8#1)(2008-3#1)
dioxide laser-assisted poling##2##3##(2007-12#2)
dioxide thin films##3##3##(2007-12#1)(2008-3#2)
dioxide using##3##2##(2008-10#3)
dioxide was##6##2##(2008-10#6)
dioxide were determined by##2##4##(2008-10#1)(2008-2#1)
dioxide were##5##2##(2008-10#4)(2008-2#1)
dioxide##223##1##(1990-11#2)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#2)(1992-3#2)(1992-7#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1995-6#1)(1995-8#2)(1996-12#9)(1997-4#1)(1997-7#2)(2007-11#3)(2007-12#4)(2008-10#123)(2008-11#11)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
dioxide)##4##1##(2008-10#2)(2008-3#1)(2008-7#1)
dioxin TEQ##2##2##(2008-10#2)
dioxin and furan##2##3##(1997-4#1)(2008-10#1)
dioxin and##5##2##(1997-4#1)(2008-10#2)(2008-7#2)
dioxin contamination##2##2##(2008-10#1)(2008-11#1)
dioxin exposure##3##2##(2008-7#3)
dioxin fraction##2##2##(2008-10#2)
dioxin levels in##2##3##(2008-10#2)
dioxin levels##4##2##(2008-10#4)
dioxin precursor##2##2##(2008-10#2)
dioxin responsive##2##2##(1993-11#2)
dioxin##44##1##(1991-11#2)(1991-5#1)(1993-11#2)(1997-4#1)(2008-10#29)(2008-11#4)(2008-7#5)
dioxin)##2##1##(1993-11#1)(2008-10#1)
dioxin-like PCB##2##2##(2008-10#1)(2008-7#1)
dioxin-like PCBs##6##2##(2008-10#6)
dioxin-like compounds##5##2##(2008-10#5)
dioxin-like##19##1##(2008-10#18)(2008-7#1)
dioxin-responsive##4##1##(1992-8#1)(2008-11#3)
dioxins and dioxin-like##4##3##(2008-10#4)
dioxins and related compounds##2##4##(2008-10#1)(2008-7#1)
dioxins and related##3##3##(2008-10#2)(2008-7#1)
dioxins and##11##2##(1994-3#1)(2008-10#9)(2008-7#1)
dioxins in feed##2##3##(2008-10#2)
dioxins in##9##2##(2008-10#9)
dioxins##33##1##(1994-3#1)(2008-10#23)(2008-11#4)(2008-7#5)
dioxolanone##4##1##(2007-11#4)
dioxouranium(VI)/copper(II)##2##1##(2008-10#2)
dioxygen binding##2##2##(1997-7#2)
dioxygen by##2##2##(2008-10#2)
dioxygen to##2##2##(2008-10#2)
dioxygen##17##1##(1991-3#1)(1997-7#3)(2008-10#12)(2009-9#1)
dioxygenase##7##1##(1993-12#1)(1995-8#1)(2009-11#5)
dioxygenation product##2##2##(1992-12#2)
dioxygenation##3##1##(1992-12#3)
dioxynaphthalene##2##1##(2010-12#2)
dip bioassays##3##2##(2011-2#3)
dip coating##4##2##(2007-12#1)(2008-2#3)
dip coats##2##2##(2008-3#2)
dip in##3##2##(1990-6#1)(2008-3#2)
dip stick urine chemistry analyser##2##5##(2007-10#2)
dip stick urine##3##3##(2007-10#3)
dip stick##5##2##(2007-10#3)(2010-8#2)
dip##40##1##(1990-6#5)(1992-2#1)(1994-11#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#8)(2008-2#4)(2008-3#8)(2010-8#2)(2011-2#4)
dip-coating##2##1##(2008-10#2)
dipalmitoyl PC##2##2##(1995-8#2)
dipalmitoyl##4##1##(1995-8#2)(2008-10#2)
dipalmitoylphosphatidylcholine (DPPC)##3##2##(1990-2#1)(1991-5#1)(1992-3#1)
dipalmitoylphosphatidylcholine##4##1##(1990-2#1)(1991-5#1)(1992-3#1)(1994-12#1)
dipeptide amides##4##2##(1990-8#4)
dipeptide##15##1##(1990-8#6)(1992-8#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#1)
dipeptides and beta-lactam antibiotics##5##4##(1990-11#5)
dipeptides and##7##2##(1990-11#5)(1990-8#1)(2008-10#1)
dipeptides are##5##2##(1990-8#3)(1994-8#1)(2008-5#1)
dipeptides##26##1##(1990-11#7)(1990-8#4)(1994-8#2)(1995-6#5)(2008-10#4)(2008-11#1)(2008-5#1)(2009-2#1)(2009-8#1)
dipeptidyl peptidase IV##6##3##(1992-3#1)(1993-8#2)(2012-2#2)(2012-3#1)
dipeptidyl##8##1##(1992-3#1)(1993-12#1)(1993-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
diphenadione and chlorophacinone##2##3##(2008-10#2)
diphenhydramine hydrochloride##5##2##(2008-10#3)(2010-5#2)
diphenhydramine##13##1##(2008-10#10)(2010-5#2)(2010-9#1)
diphenolic compounds##2##2##(2007-7#1)(2008-10#1)
diphenols##2##1##(1993-12#1)(2008-10#1)
diphenyl ethers##8##2##(1993-12#1)(2008-10#6)(2008-7#1)
diphenyl##9##1##(1993-12#1)(2008-10#7)(2008-7#1)
diphenylamido##3##1##(2008-11#3)
diphenylamine (DPA)##2##2##(2008-10#2)
diphenylamine##6##1##(1996-5#1)(2008-10#5)
diphenylcarbazide##5##1##(2008-10#5)
diphenyleneiodonium##3##1##(1993-6#1)(1994-6#1)(2008-10#1)
diphosphate (ADP) and##2##3##(1997-7#1)(2006-6#1)
diphosphate (ADP)##4##2##(1997-7#1)(2006-6#2)(2011-1#1)
diphosphate and##3##2##(1997-6#2)(2008-8#1)
diphosphate as##2##2##(2008-10#2)
diphosphate kinase##3##2##(1994-8#1)(1996-2#2)
diphosphate kinases##2##2##(1997-7#2)
diphosphate##38##1##(1990-2#1)(1992-6#2)(1992-8#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-8#2)(1995-2#7)(1995-8#2)(1996-2#2)(1996-7#1)(1997-6#2)(1997-7#3)(2006-6#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2011-1#1)
diphosphates##7##1##(1994-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-4#2)(2008-7#1)
diphosphatidylglycerol##2##1##(1990-5#1)(1992-10#1)
diphthamide##4##1##(1993-3#1)(1993-9#3)
diphtheria and tetanus toxoids and pertussis vaccine##2##7##(1995-3#1)(1995-5#1)
diphtheria and tetanus##3##3##(1992-2#1)(1995-3#1)(1995-5#1)
diphtheria and##4##2##(1992-2#2)(1995-3#1)(1995-5#1)
diphtheria##20##1##(1992-2#5)(1993-3#2)(1994-8#1)(1995-3#4)(1995-5#3)(1996-11#1)(1996-8#1)(2007-11#1)(2009-5#1)(2013-1#1)
diphtheriae##3##1##(1991-8#1)(1996-11#1)(2008-5#1)
dipicolinate##2##1##(2008-2#2)
diplegia##5##1##(1995-11#1)(1995-6#1)(1997-5#1)(2007-11#2)
diploid and##2##2##(2008-11#1)(2008-8#1)
diploid cells##3##2##(1991-2#1)(1995-6#1)(1997-3#1)
diploid chromosome number##2##3##(2008-12#1)(2009-12#1)
diploid chromosome numbers##2##3##(2008-10#1)(2008-12#1)
diploid chromosome##4##2##(2008-10#1)(2008-12#2)(2009-12#1)
diploid clones##2##2##(2008-11#2)
diploid endosperm formation##2##3##(2009-12#2)
diploid fibroblasts##4##2##(1990-3#1)(1997-1#1)(2008-11#1)(2009-4#1)
diploid host##3##2##(1995-5#1)(1997-4#1)(2008-10#1)
diploid in##2##2##(2008-2#1)(2009-12#1)
diploid number of##3##3##(2008-12#2)(2010-3#1)
diploid number##5##2##(2008-12#3)(2010-3#2)
diploid populations##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
diploid progenitors##3##2##(2008-10#1)(2013-1#2)
diploid species##2##2##(2008-12#1)(2009-9#1)
diploid tumors##2##2##(1994-12#1)(2008-6#1)
diploid##81##1##(1990-3#1)(1991-2#1)(1993-3#2)(1994-12#3)(1995-5#1)(1995-6#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-4#1)(2008-10#8)(2008-11#5)(2008-12#7)(2008-2#1)(2008-4#2)(2008-5#8)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#11)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#4)(2010-3#4)(2010-8#1)(2012-3#1)(2013-1#3)
diploid-triploid##2##1##(2010-3#2)
diploidization##3##1##(1993-3#2)(2009-10#1)
diploids and##3##2##(2008-5#2)(2010-3#1)
diploids are##2##2##(1995-9#1)(2010-3#1)
diploids of##2##2##(1997-4#1)(2008-5#1)
diploids##14##1##(1995-9#3)(1997-4#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-9#1)(2010-3#4)
diploma in nursing##4##3##(2008-11#3)(2008-12#1)
diploma in##5##2##(2008-11#4)(2008-12#1)
diploma nursing##2##2##(2008-11#1)(2008-12#1)
diploma students##3##2##(2008-11#2)(2008-12#1)
diploma##16##1##(2008-1#1)(2008-11#8)(2008-12#7)
diplopia and##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
diplopia##14##1##(1996-9#1)(2008-7#8)(2011-1#1)(2011-2#3)(2012-3#1)
diplopods##3##1##(2007-12#2)(2008-11#1)
diplotene##2##1##(2007-12#1)(2008-5#1)
diplotype##2##1##(2009-7#2)
dipolar couplings##2##2##(2012-8#2)
dipolar interaction##2##2##(1994-3#1)(2012-2#1)
dipolar interactions##4##2##(2009-11#2)(2010-4#2)
dipolar##16##1##(1993-8#2)(1994-3#1)(1994-5#1)(1997-7#1)(2007-12#2)(2008-10#1)(2009-11#3)(2010-4#2)(2012-2#1)(2012-8#2)
dipolar-coupled magnetic disks##2##3##(2012-2#2)
dipole antenna##4##2##(2007-12#3)(2008-3#1)
dipole antennas##3##2##(2007-12#3)
dipole layer##3##2##(1992-6#1)(2008-3#2)
dipole locations##2##2##(1990-5#2)
dipole method##2##2##(2007-11#2)
dipole moment##6##2##(2007-11#3)(2008-10#2)(2008-3#1)
dipole moments of##4##3##(1997-6#3)(2007-11#1)
dipole moments##11##2##(1996-5#1)(1997-6#6)(2007-11#4)
dipole source analysis##2##3##(2008-11#2)
dipole tracing method##2##3##(1990-5#2)
dipole##69##1##(1990-5#4)(1992-12#2)(1992-6#1)(1992-8#2)(1996-5#1)(1997-6#8)(2007-11#12)(2007-12#14)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#10)(2008-9#1)(2009-5#1)(2010-8#1)
dipole-dipole interaction##2##2##(2008-10#2)
dipole-dipole##4##1##(1991-5#1)(2008-10#3)
dipole-mode##3##1##(2007-11#3)
dipolelike##2##1##(2007-11#2)
dipoles##15##1##(1990-5#2)(1991-5#1)(1992-4#1)(1992-8#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
dipped in##7##2##(1990-6#2)(1993-12#1)(2007-3#2)(2008-10#1)(2011-2#1)
dipped##10##1##(1990-6#2)(1993-12#2)(2007-3#2)(2008-10#3)(2011-2#1)
dipping animals in##2##3##(2010-1#2)
dipping##16##1##(1990-6#1)(2007-3#2)(2008-10#4)(2008-12#1)(2008-3#1)(2010-1#5)(2013-1#1)(2013-8#1)
dipropionate##7##1##(1990-9#2)(1996-1#1)(2007-11#1)(2008-1#2)(2008-10#1)
diprotic acids##2##2##(2008-10#2)
dips##4##1##(1994-7#1)(2007-11#1)(2008-10#1)(2010-1#1)
dipsaci sensu stricto##2##3##(2008-10#2)
dipsaci##9##1##(2008-10#9)
dipstick##5##1##(1991-3#1)(2007-2#3)(2010-8#1)
diptera in##2##2##(2007-10#1)(2010-1#1)
dipteran##3##1##(1993-12#1)(2008-11#1)(2010-1#1)
dipterophagy##2##1##(2012-3#2)
dipyridamole is##2##2##(1992-5#1)(2008-8#1)
dipyridamole##17##1##(1992-5#3)(1994-5#5)(1995-8#2)(1997-8#1)(2008-10#3)(2008-8#3)
dipyrone##5##1##(2008-10#5)
diquat and paraquat##2##3##(2008-10#2)
diradical species##2##2##(2009-10#2)
diradical##5##1##(2009-10#3)(2010-12#2)
dire##6##1##(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
direct (T/A)##2##2##(1997-4#2)
direct DNA sequencing##2##3##(1994-8#1)(2012-1#1)
direct DNA##5##2##(1993-3#1)(1994-8#1)(1996-5#1)(2010-2#1)(2012-1#1)
direct ELISA##5##2##(1997-3#2)(2008-10#2)(2008-11#1)
direct ETAAS##3##2##(2008-10#3)
direct UV detection##4##3##(2008-10#4)
direct UV##5##2##(2008-10#5)
direct absorption##2##2##(2008-3#2)
direct access##2##2##(1996-5#1)(2013-1#1)
direct acting mutagens##2##3##(1992-8#1)(1996-2#1)
direct acting##3##2##(1992-8#1)(1996-2#1)(2012-12#1)
direct action of##5##3##(1990-11#1)(1991-12#1)(1994-2#1)(1994-8#1)(1996-5#1)
direct action on the##2##4##(1992-6#1)(2008-7#1)
direct action on##4##3##(1992-6#1)(1992-8#1)(1997-7#1)(2008-7#1)
direct action##11##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-7#1)
direct activation of##5##3##(1990-5#1)(1995-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
direct addition of##2##3##(1992-12#1)(2010-4#1)
direct addition##3##2##(1992-12#1)(2008-11#1)(2010-4#1)
direct adsorption of##2##3##(2008-10#2)
direct adsorption##3##2##(2008-10#2)(2008-6#1)
direct agglutination test (DAT)##2##4##(1996-12#1)(2012-2#1)
direct agglutination test##3##3##(1996-12#2)(2012-2#1)
direct analysis of solid##2##4##(2008-10#2)
direct analysis of the##5##4##(2008-10#2)(2008-3#2)(2008-9#1)
direct analysis of##16##3##(1993-3#1)(1997-2#2)(2008-10#10)(2008-3#2)(2008-9#1)
direct analysis##20##2##(1993-3#1)(1997-2#2)(2008-10#14)(2008-3#2)(2008-9#1)
direct and competitive##2##3##(2008-10#2)
direct and fast##2##3##(2007-11#1)(2008-10#1)
direct and indirect PAD##2##4##(2008-10#2)
direct and indirect costs##2##4##(2008-11#1)(2009-6#1)
direct and indirect effects of##5##5##(1997-1#1)(2008-7#1)(2010-8#2)(2011-1#1)
direct and indirect effects##9##4##(1991-12#1)(1997-1#1)(2008-7#2)(2008-8#1)(2010-8#2)(2011-1#1)(2012-2#1)
direct and indirect health##3##4##(1991-6#1)(2010-1#1)(2013-8#1)
direct and indirect in situ##2##5##(2008-9#2)
direct and indirect organogenesis of Memordica charantia##2##7##(2008-12#2)
direct and indirect##41##3##(1990-12#1)(1990-5#1)(1991-12#2)(1991-6#1)(1992-3#1)(1996-2#1)(1997-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#3)(2012-2#2)(2013-1#1)(2013-8#1)
direct and simple##2##3##(1994-3#1)(2008-10#1)
direct and##75##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-6#1)(1992-3#2)(1994-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#2)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
direct animal contact##2##3##(2008-12#2)
direct antiglobulin test and##2##4##(1992-3#1)(1992-6#1)
direct antiglobulin test was##3##4##(1992-9#1)(1994-12#1)(1994-9#1)
direct antiglobulin test##11##3##(1992-3#1)(1992-6#1)(1992-9#2)(1994-12#3)(1994-3#2)(1994-9#2)
direct antiglobulin tests##2##3##(1994-6#2)
direct antiglobulin##13##2##(1992-3#1)(1992-6#1)(1992-9#2)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#2)
direct application of the##4##4##(1996-2#1)(2008-10#2)(2008-3#1)
direct application of##5##3##(1996-2#1)(2008-10#2)(2008-3#1)(2010-4#1)
direct approach for##3##3##(1990-5#1)(1994-11#1)(2008-4#1)
direct aspiration of the##2##4##(2008-10#2)
direct assay of##2##3##(1990-5#1)(2008-10#1)
direct assay##3##2##(1990-5#1)(2008-10#2)
direct assessment of##2##3##(2008-6#1)(2009-10#1)
direct bilirubin##2##2##(2010-8#1)(2013-1#1)
direct binding of##6##3##(1994-11#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-4#1)(2008-9#1)
direct binding to##2##3##(1995-2#1)(2008-11#1)
direct binding##9##2##(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
direct bonding between the##2##4##(2008-3#1)(2008-7#1)
direct bonding##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
direct cDNA##2##2##(1996-2#1)(1997-8#1)
direct capture##2##2##(2008-10#1)(2008-5#1)
direct care##4##2##(1993-1#1)(1995-3#2)(2008-11#1)
direct cell-cell contacts between the hepatic endoderm and##2##8##(2008-6#2)
direct cell-cell contacts##3##3##(2008-6#3)
direct channel inhibition##2##3##(2010-8#2)
direct chemiluminescence##4##2##(2008-10#4)
direct chemiluminescent##2##2##(2008-10#2)
direct cloning##4##2##(1991-7#1)(1997-4#1)(2008-2#2)
direct colorimetric method##2##3##(2008-10#2)
direct communication between##2##3##(1993-9#1)(2008-7#1)
direct comparison of##9##3##(1991-11#1)(1992-3#1)(1995-3#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
direct comparison##13##2##(1991-11#1)(1992-3#1)(1995-3#1)(1996-12#1)(1996-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
direct comparisons of##2##3##(1996-7#1)(2008-10#1)
direct comparisons##4##2##(1996-7#1)(2008-10#2)(2008-5#1)
direct competition##2##2##(2008-11#1)(2009-10#1)
direct competitive##2##2##(1990-5#1)(2008-10#1)
direct confirmation##2##2##(2007-12#1)(2008-4#1)
direct connection between##2##3##(2008-10#1)(2011-2#1)
direct consequence of##4##3##(1994-5#1)(1997-7#1)(2008-11#1)(2012-3#1)
direct consequence##6##2##(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
direct contact between##2##3##(1997-5#1)(2008-10#1)
direct contact with the##6##4##(2007-12#2)(2008-10#3)(2008-12#1)
direct contact with##11##3##(1995-11#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-12#1)(2011-2#1)
direct contact##16##2##(1990-8#1)(1995-11#1)(1997-5#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-12#1)(2010-8#1)(2011-2#1)
direct control##2##2##(2008-10#1)(2008-3#1)
direct conversion of##2##3##(2008-10#1)(2008-6#1)
direct correlation between##7##3##(1994-11#1)(1994-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
direct correlation was observed between##2##5##(1995-5#1)(2008-7#1)
direct correlation was##3##3##(1995-5#1)(2007-7#1)(2008-7#1)
direct correlation##12##2##(1994-11#1)(1994-5#1)(1995-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-7#2)(2011-1#1)
direct costs##5##2##(1996-1#3)(2008-8#2)
direct current plasma##2##3##(2008-5#1)(2008-7#1)
direct current##16##2##(1995-6#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#4)(2011-1#2)(2012-2#2)(2013-8#2)
direct cytosolic dihydrofolate reductase into mitochondria##2##6##(1994-6#2)
direct delivery of##2##3##(2008-10#1)(2008-4#1)
direct detection Doppler wind lidar##3##5##(2008-2#1)(2008-3#2)
direct detection and##3##3##(2008-10#2)(2008-2#1)
direct detection of the##3##4##(1990-5#1)(1997-4#1)(2008-10#1)
direct detection of##15##3##(1990-5#2)(1997-4#1)(2008-10#7)(2008-3#2)(2008-4#2)(2012-3#1)
direct detection optical##2##3##(2008-3#2)
direct detection##38##2##(1990-5#2)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-2#5)(2008-3#10)(2008-4#2)(2008-9#1)(2012-3#1)
direct determination of Cu and##2##5##(2008-10#2)
direct determination of free##2##4##(2008-10#2)
direct determination of lead in##3##5##(2008-10#3)
direct determination of the##16##4##(1992-12#1)(2007-12#1)(2008-10#10)(2008-2#2)(2008-3#2)
direct determination of total##2##4##(2008-10#2)
direct determination of trace##5##4##(2008-10#5)
direct determination of##80##3##(1991-12#1)(1992-12#1)(2007-12#1)(2008-10#69)(2008-2#2)(2008-3#6)
direct determination##87##2##(1991-12#1)(1992-12#1)(2007-12#1)(2008-10#76)(2008-2#2)(2008-3#6)
direct determinations##3##2##(2008-10#3)
direct dissolution##2##2##(2008-10#1)(2010-5#1)
direct effect of##11##3##(1991-12#1)(1991-3#1)(1995-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-9#2)(2011-2#1)(2012-2#1)
direct effect on##7##3##(1992-6#1)(1994-2#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-5#1)(2008-8#1)
direct effect##19##2##(1991-12#1)(1991-3#1)(1992-6#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-9#2)(2011-2#1)(2012-2#1)
direct effects of##10##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-1#1)
direct effects on the##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
direct effects on##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#3)(2011-2#1)
direct effects##19##2##(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2011-2#1)(2013-1#1)
direct electrochemical synthesis##2##3##(2013-1#2)
direct electrochemical##5##2##(1995-5#1)(2008-10#2)(2013-1#2)
direct electrochemistry##3##2##(2008-10#3)
direct electron transfer##2##3##(2008-10#2)
direct electronic##3##2##(1994-5#2)(2008-8#1)
direct emissions##2##2##(2008-11#2)
direct estimates of##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
direct evidence for the##5##4##(1990-7#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
direct evidence for##9##3##(1990-7#1)(1993-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-8#1)
direct evidence of##3##3##(1993-11#1)(2008-5#1)(2008-7#1)
direct evidence that the##2##4##(2008-10#1)(2009-8#1)
direct evidence that##11##3##(1994-8#1)(1995-2#2)(1996-12#2)(2007-7#1)(2008-10#3)(2009-8#1)(2013-8#1)
direct evidence##29##2##(1990-7#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-2#2)(1996-12#2)(2007-7#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
direct examination##5##2##(2007-10#2)(2008-5#3)
direct excitation of the upper lasing level##2##7##(2008-3#2)
direct experience##3##2##(1994-1#2)(2011-1#1)
direct experimental evidence of##2##4##(2007-11#1)(2007-12#1)
direct experimental##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2012-3#1)
direct exposure##2##2##(2008-11#1)(2013-8#1)
direct expression##2##2##(1990-11#1)(1991-6#1)
direct extension of##2##3##(2007-11#1)(2008-3#1)
direct extraction of the##2##4##(2008-10#1)(2008-6#1)
direct extraction of##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
direct extraction##6##2##(2007-8#1)(2008-10#3)(2008-6#1)(2011-2#1)
direct federal##2##2##(1995-2#1)(2009-7#1)
direct fitness##3##2##(2008-8#3)
direct functional##2##2##(1992-10#1)(2008-2#1)
direct funding##2##2##(1991-2#1)(2009-4#1)
direct gene transfer into##2##4##(1991-9#1)(1994-5#1)
direct gene transfer##7##3##(1991-9#1)(1994-5#5)(1996-5#1)
direct genetic evidence##2##3##(2008-1#1)(2010-11#1)
direct genetic##3##2##(2008-1#1)(2010-11#1)(2011-1#1)
direct government regulation##2##3##(1995-3#2)
direct identification of##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
direct identification##4##2##(1996-2#1)(2008-10#2)(2011-2#1)
direct imaging of the##2##4##(2007-12#1)(2010-12#1)
direct imaging of##3##3##(2007-12#1)(2008-7#1)(2010-12#1)
direct immunoassay##3##2##(2008-10#2)(2008-4#1)
direct immunofluorescence##6##2##(2007-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
direct infection##2##2##(2011-2#2)
direct influence on the##3##4##(1992-11#1)(2011-2#1)(2012-2#1)
direct information on##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
direct inhibition of##6##3##(1990-5#1)(1994-8#2)(2008-4#1)(2008-5#1)(2012-2#1)
direct inhibition##7##2##(1990-5#1)(1994-6#1)(1994-8#2)(2008-4#1)(2008-5#1)(2012-2#1)
direct inhibitory effect of##2##4##(1990-11#1)(1992-8#1)
direct injection of the##2##4##(1991-5#1)(2009-8#1)
direct injection of urine##2##4##(1990-8#2)
direct injection of##11##3##(1990-8#3)(1991-5#1)(1992-11#1)(2008-10#3)(2008-9#1)(2009-8#1)(2012-12#1)
direct injection##21##2##(1990-8#3)(1991-5#1)(1992-11#1)(2008-10#9)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-12#1)
direct injury##3##2##(2008-4#1)(2008-9#1)(2010-4#1)
direct interaction between##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
direct interaction of##5##3##(1992-3#1)(1994-8#1)(1995-5#1)(2010-11#1)(2011-2#1)
direct interaction with the##3##4##(1994-11#1)(1997-2#1)(2008-10#1)
direct interaction with##6##3##(1991-6#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-2#1)(2008-10#1)
direct interaction##18##2##(1990-8#1)(1991-6#1)(1992-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
direct interactions between##3##3##(1990-5#1)(2008-10#1)(2008-2#1)
direct interactions##5##2##(1990-5#1)(2008-10#2)(2008-2#1)(2008-8#1)
direct intramuscular injection of##2##4##(2008-8#2)
direct introduction into the##2##4##(1991-11#1)(2008-10#1)
direct introduction into##3##3##(1991-11#1)(2008-10#1)(2008-8#1)
direct introduction of##3##3##(2008-10#3)
direct introduction##6##2##(1991-11#1)(2008-10#4)(2008-8#1)
direct invasion##2##2##(2007-8#1)(2011-2#1)
direct involvement of the##2##4##(1990-11#1)(2008-4#1)
direct involvement of##10##3##(1990-11#2)(1992-11#1)(1992-6#1)(1995-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)
direct irradiance##4##2##(2008-2#3)(2008-3#1)
direct irradiation with ultraviolet light##3##5##(1991-8#1)(2008-10#2)
direct irradiation##5##2##(1991-8#1)(2008-10#2)(2008-2#1)(2008-7#1)
direct isolation of##2##3##(2008-10#1)(2008-5#1)
direct isolation##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
direct laser interference patterning##2##4##(2010-4#2)
direct laser##3##2##(2008-3#1)(2010-4#2)
direct link between##6##3##(1994-8#1)(1995-3#1)(1996-2#1)(2009-7#1)(2009-8#1)(2013-1#1)
direct links##2##2##(1994-1#1)(2008-7#1)
direct liquid##2##2##(2008-10#2)
direct losses##2##2##(2008-10#1)(2011-2#1)
direct mapping##2##2##(2007-12#1)(2012-3#1)
direct means##2##2##(2008-3#1)(2008-5#1)
direct measure of the##5##4##(1992-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
direct measure of##9##3##(1992-2#1)(2007-12#1)(2008-10#4)(2008-3#2)(2013-1#1)
direct measurement by##2##3##(2008-10#2)
direct measurement method and##2##4##(2008-3#2)
direct measurement of the##14##4##(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#4)(2008-7#1)
direct measurement of##28##3##(1992-3#1)(1994-2#1)(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
direct measurement##36##2##(1992-3#1)(1994-2#1)(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#12)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
direct measurements of the##2##4##(2008-3#2)
direct measurements of##5##3##(1992-12#1)(1995-9#1)(2008-10#1)(2008-3#2)
direct measurements##9##2##(1992-12#1)(1995-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2013-1#1)
direct measures of##5##3##(1994-3#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
direct method for##4##3##(1990-5#1)(1995-12#2)(2008-10#1)
direct method##10##2##(1990-5#1)(1992-12#1)(1995-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)
direct methods##5##2##(2006-4#1)(2008-3#2)(2010-10#1)(2012-3#1)
direct microscopic##2##2##(2008-5#1)(2010-6#1)
direct microscopy##3##2##(2007-7#1)(2008-12#1)(2008-5#1)
direct mutation analysis##2##3##(2008-4#2)
direct mutation##3##2##(2008-1#1)(2008-4#2)
direct numerical simulation of the full system##2##7##(2007-11#1)(2007-12#1)
direct numerical simulation##6##3##(2007-11#4)(2007-12#1)(2008-3#1)
direct numerical simulations##2##3##(2007-12#2)
direct numerical##10##2##(2007-11#5)(2007-12#3)(2008-3#1)(2008-9#1)
direct observation of##9##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-1#1)(2012-12#1)
direct observation##11##2##(1990-8#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-1#1)(2012-12#1)
direct one##2##2##(1994-8#1)(2008-10#1)
direct optical##3##2##(1997-7#1)(2007-12#1)(2009-5#1)
direct optimization##2##2##(2008-2#2)
direct or indirect##8##3##(1992-9#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-9#1)(2012-2#1)
direct or##14##2##(1992-9#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#1)
direct osmotic stimulation of the##2##5##(1994-8#2)
direct patient care##5##3##(1992-1#1)(1995-3#2)(2007-10#1)(2008-11#1)
direct patient##8##2##(1992-1#1)(1995-3#2)(2007-10#1)(2008-11#2)(2011-2#1)(2012-3#1)
direct penetration by##2##3##(2008-10#2)
direct penetration##4##2##(2008-10#3)(2011-10#1)
direct phase##2##2##(2008-2#1)(2008-5#1)
direct phosphorylation##3##2##(1993-6#1)(2008-8#1)(2012-12#1)
direct physical##2##2##(2008-12#1)(2010-7#1)
direct potentiometric determination of##2##4##(2008-10#2)
direct potentiometric method in the##2##5##(2008-10#2)
direct potentiometric method##4##3##(2008-10#4)
direct potentiometric##7##2##(2008-10#7)
direct product of##2##3##(1993-11#1)(1994-8#1)
direct proof for##2##3##(1990-7#1)(2009-12#1)
direct proof of the##2##4##(2007-11#1)(2009-10#1)
direct proof##6##2##(1990-7#1)(1993-8#1)(2007-11#1)(2009-10#1)(2009-12#2)
direct reduction##2##2##(2008-10#1)(2009-9#1)
direct regulation of##2##3##(1993-6#1)(2012-12#1)
direct regulatory##3##2##(1994-1#1)(2008-10#1)(2008-7#1)
direct relation##6##2##(1993-9#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#2)
direct relationship between##11##3##(1994-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
direct relationship with##2##3##(1990-6#1)(2008-9#1)
direct relationship##15##2##(1990-12#1)(1990-6#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
direct repeats##5##2##(1995-6#1)(1995-8#2)(2008-10#2)
direct result of##7##3##(1990-11#1)(1991-9#1)(1994-6#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#1)
direct role##5##2##(1992-3#1)(1992-9#1)(1993-6#1)(1996-8#1)(2009-8#1)
direct sample injection##4##3##(1990-8#2)(2008-10#2)
direct sample##7##2##(1990-8#2)(2008-10#5)
direct sampling##3##2##(2008-10#2)(2008-3#1)
direct screening of##2##3##(1991-9#1)(1996-8#1)
direct selection of mutations##2##4##(1990-5#2)
direct selection##3##2##(1990-5#2)(2008-8#1)
direct sequencing of the##2##4##(1996-2#1)(1996-8#1)
direct sequencing of##3##3##(1994-12#1)(1996-2#1)(1996-8#1)
direct sequencing##10##2##(1992-2#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-8#1)(2008-2#1)(2008-4#2)(2011-2#1)(2013-1#1)
direct service volunteer##2##3##(1994-2#2)
direct service##3##2##(1994-2#2)(2012-2#1)
direct sinus packing##2##3##(2008-7#2)
direct solar irradiance##2##3##(2008-2#1)(2008-3#1)
direct solar radiation##3##3##(2008-2#3)
direct solar##5##2##(2008-2#4)(2008-3#1)
direct solid##4##2##(2008-10#4)
direct space-to-time pulse shaper##4##4##(2007-11#2)(2007-12#2)
direct speciation of##3##3##(2008-10#3)
direct spectrophotometric determination of##3##4##(2008-10#3)
direct spectrophotometric method##3##3##(2008-10#3)
direct spectrophotometric##9##2##(2008-10#9)
direct spectroscopic##2##2##(1991-5#1)(1995-5#1)
direct stimulation of##5##3##(1990-8#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#1)
direct structural##2##2##(2010-12#1)(2011-2#1)
direct sunlight##3##2##(1994-1#1)(2008-10#1)(2008-2#1)
direct surgery##2##2##(2008-7#2)
direct switching##2##2##(2008-11#2)
direct technique##2##2##(1997-4#1)(2008-10#1)
direct the formation of##2##4##(1997-4#1)(2008-7#1)
direct the synthesis of##5##4##(1991-5#1)(1991-9#2)(1997-2#1)(2008-7#1)
direct the##18##2##(1991-5#1)(1991-9#2)(1994-8#1)(1997-2#2)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
direct thrombin inhibitor##2##3##(2012-12#1)(2013-1#1)
direct thrombin##3##2##(2012-12#1)(2013-1#2)
direct toxic effects on##2##4##(2011-1#1)(2013-1#1)
direct transfer of##2##3##(2008-3#1)(2013-1#1)
direct trauma##2##2##(2007-5#1)(2012-12#1)
direct treatment of##3##3##(2008-7#1)(2009-6#1)(2010-6#1)
direct treatment##6##2##(2008-7#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-6#1)
direct tumor##3##2##(2007-4#1)(2007-7#1)(2008-8#1)
direct use of##3##3##(2008-10#1)(2008-3#2)
direct use##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
direct view##2##2##(2008-4#1)(2011-2#1)
direct vision##4##2##(1991-12#1)(2007-7#1)(2007-8#2)
direct visual##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
direct visualisation##2##2##(2008-10#1)(2008-7#1)
direct visualization catheter##3##3##(2010-6#3)
direct visualization of the##5##4##(1992-9#1)(1996-1#1)(2008-1#1)(2008-3#1)(2008-7#1)
direct visualization of##7##3##(1992-9#1)(1995-2#1)(1996-1#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
direct visualization##13##2##(1992-9#1)(1995-2#1)(1996-1#1)(2006-12#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-6#3)
direct way to##2##3##(2009-6#1)(2013-1#1)
direct way##4##2##(2007-12#1)(2008-3#1)(2009-6#1)(2013-1#1)
direct##1549##1##(1990-11#10)(1990-12#4)(1990-2#2)(1990-5#13)(1990-6#3)(1990-7#2)(1990-8#9)(1990-9#1)(1991-11#4)(1991-12#9)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#3)(1992-3#13)(1992-5#1)(1992-6#6)(1992-8#8)(1992-9#6)(1993-1#1)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#5)(1993-8#3)(1993-9#3)(1994-1#5)(1994-11#7)(1994-12#6)(1994-2#10)(1994-3#6)(1994-5#12)(1994-6#6)(1994-8#17)(1994-9#6)(1995-1#2)(1995-11#7)(1995-12#3)(1995-2#14)(1995-3#12)(1995-5#6)(1995-6#6)(1995-8#8)(1995-9#1)(1996-1#4)(1996-12#13)(1996-2#11)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#10)(1997-3#6)(1997-4#13)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#2)(2006-12#2)(2006-4#1)(2007-10#9)(2007-11#30)(2007-12#38)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#14)(2008-1#12)(2008-10#395)(2008-11#42)(2008-12#16)(2008-2#44)(2008-3#92)(2008-4#27)(2008-5#37)(2008-6#13)(2008-7#48)(2008-8#43)(2008-9#36)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#5)(2009-7#3)(2009-8#10)(2009-9#10)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#8)(2010-8#10)(2011-1#14)(2011-10#1)(2011-2#40)(2011-3#1)(2012-1#3)(2012-12#14)(2012-2#20)(2012-3#20)(2012-7#1)(2013-1#30)(2013-7#2)(2013-8#11)
direct-acting##3##1##(1991-9#1)(1997-4#1)(2009-5#1)
direct-binding##2##1##(2008-10#2)
direct-current##3##1##(2008-2#1)(2008-3#2)
direct-detection Doppler lidar systems##2##4##(2008-3#2)
direct-detection Doppler lidar##3##3##(2008-3#3)
direct-detection Doppler##4##2##(2008-3#4)
direct-detection##8##1##(2007-12#1)(2008-3#7)
direct-injection##6##1##(1990-8#1)(2008-10#1)(2008-2#4)
direct-search method##2##2##(2008-3#2)
direct-search##3##1##(2008-3#3)
direct-to-consumer##3##1##(1996-1#1)(2008-12#2)
direct-view display##2##2##(2007-12#2)
direct-write electron-beam lithography##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
direct-write gray-level##2##2##(2008-2#2)
direct-write##6##1##(2007-12#1)(2008-2#3)(2008-3#1)(2008-7#1)
directed against mouse##2##3##(1993-8#1)(2008-11#1)
directed against the catalytic##3##4##(1992-3#1)(1994-8#1)(1995-3#1)
directed against the heavy chain of the cofactor##2##8##(1994-5#2)
directed against the##24##3##(1990-5#1)(1990-8#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-3#1)(1996-5#2)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)
directed against##52##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#4)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-3#1)(1995-9#1)(1996-5#2)(1997-3#1)(1997-5#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#3)(2013-8#1)
directed assembly##2##2##(2008-7#2)
directed at SSB consumption##2##4##(2012-2#2)
directed at a##3##3##(1994-11#1)(1997-8#1)(2008-2#1)
directed at the##7##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-12#1)(2012-2#1)
directed at##28##2##(1992-2#1)(1993-1#1)(1994-11#1)(1994-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2009-12#4)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#4)(2013-8#1)
directed biopsy for##2##3##(1992-10#1)(2008-11#1)
directed biopsy##6##2##(1991-2#1)(1992-10#1)(2008-11#4)
directed by a##2##3##(1990-11#1)(2009-8#1)
directed by the##3##3##(1990-11#1)(1992-12#1)(2008-9#1)
directed by##15##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
directed drug##2##2##(1995-11#1)(2012-2#1)
directed evolution of##2##3##(2011-1#2)
directed evolution##6##2##(2008-9#2)(2010-4#1)(2011-1#3)
directed growth##2##2##(1997-3#2)
directed into the##2##3##(2008-10#1)(2008-3#1)
directed into##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
directed mainly##2##2##(2008-7#1)(2008-9#1)
directed migration##3##2##(1990-12#1)(1994-11#1)(2010-9#1)
directed mutagenesis##6##2##(1992-12#1)(1992-8#1)(1992-9#1)(1994-6#1)(2008-1#1)(2008-8#1)
directed secretion##2##2##(1994-9#1)(2012-2#1)
directed through a##2##3##(2007-11#1)(2013-1#1)
directed through##4##2##(1995-3#1)(2007-11#1)(2008-3#1)(2013-1#1)
directed to a##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
directed to an##2##3##(2008-11#1)(2008-4#1)
directed to specific##2##3##(2008-1#1)(2008-11#1)
directed to the GPIIIa##2##4##(2006-6#2)
directed to the##13##3##(1992-12#2)(1993-1#1)(1994-12#1)(2006-6#4)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2010-12#1)
directed to##42##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-6#5)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
directed toward the##5##3##(1992-3#1)(1993-1#1)(1993-2#1)(1996-12#1)(2011-2#1)
directed toward##18##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#3)(2011-7#1)
directed towards the##3##3##(2008-6#2)(2011-2#1)
directed towards##16##2##(1991-6#1)(1992-9#1)(1994-11#1)(1995-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)(2011-2#2)
directed##270##1##(1990-11#2)(1990-12#4)(1990-5#3)(1990-8#2)(1991-12#1)(1991-2#2)(1991-6#2)(1992-10#2)(1992-12#8)(1992-2#2)(1992-3#4)(1992-5#2)(1992-8#2)(1992-9#3)(1993-1#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#3)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-5#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#5)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#7)(2008-10#15)(2008-11#18)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#11)(2009-12#5)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#14)(2011-7#1)(2012-12#2)(2012-2#9)(2013-1#3)(2013-8#3)
directing the##10##2##(1992-1#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
directing##27##1##(1991-9#1)(1992-1#1)(1992-3#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2013-1#1)
direction a##2##2##(1997-3#1)(2009-7#1)
direction and the##2##3##(2008-2#1)(2008-3#1)
direction and velocity##2##3##(2008-5#1)(2008-7#1)
direction and##27##2##(1990-8#1)(1992-2#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
direction as the##5##3##(1994-12#1)(2007-12#1)(2008-2#2)(2008-4#1)
direction as##6##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-4#1)
direction at the##2##3##(2008-3#1)(2008-5#1)
direction at##5##2##(2008-3#1)(2008-5#3)(2008-8#1)
direction by##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
direction changes##2##2##(1990-11#1)(2008-7#1)
direction could be##2##3##(2008-10#2)
direction for##8##2##(1994-2#1)(1994-3#1)(2008-2#2)(2008-7#1)(2009-6#1)(2011-1#1)(2013-8#1)
direction from##2##2##(2008-10#1)(2008-4#1)
direction has been##2##3##(2008-3#1)(2008-8#1)
direction in a##2##3##(2007-12#1)(2008-3#1)
direction in the##4##3##(2008-3#3)(2008-9#1)
direction in this##2##3##(2011-7#1)(2013-8#1)
direction in##20##2##(1990-7#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-8#1)(2008-9#1)(2011-7#1)(2012-2#2)(2013-8#2)
direction is##7##2##(2007-11#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-4#1)
direction of a##2##3##(2009-6#1)(2011-2#1)
direction of effect of gestational stress##2##6##(2008-11#2)
direction of effect##3##3##(1990-3#1)(2008-11#2)
direction of effects##2##3##(2008-10#1)(2010-4#1)
direction of evolution##3##3##(2008-8#2)(2008-9#1)
direction of gaze##2##3##(2008-11#1)(2010-10#1)
direction of laterality##2##3##(1994-8#2)
direction of motion and##2##4##(2008-2#1)(2008-8#1)
direction of motion##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
direction of rotation##3##3##(2008-2#1)(2009-6#1)(2012-2#1)
direction of selection##2##3##(2008-10#1)(2008-8#1)
direction of spread##2##3##(2009-2#2)
direction of the first saccade##2##5##(2009-2#2)
direction of the grating##4##4##(2007-12#1)(2008-3#3)
direction of the##45##3##(1990-11#1)(1992-11#1)(1993-12#1)(1995-1#2)(1995-11#1)(1996-2#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#15)(2008-6#4)(2009-2#2)(2009-7#2)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
direction of time##2##3##(2007-12#2)
direction of##143##2##(1990-11#3)(1990-3#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-8#4)(1995-1#2)(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-11#3)(2007-12#7)(2007-4#1)(2007-8#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#26)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-6#2)(2009-7#4)(2010-10#1)(2010-4#3)(2010-5#1)(2010-8#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
direction or##2##2##(1993-12#1)(2008-10#1)
direction parallel to the##2##4##(2008-10#1)(2008-3#1)
direction perpendicular to the##6##4##(2007-11#1)(2008-10#1)(2008-3#4)
direction selectivity and##3##3##(2008-8#3)
direction selectivity##6##2##(2008-8#5)(2008-9#1)
direction that##2##2##(2007-12#1)(2008-3#1)
direction thereby##2##2##(1994-11#1)(2011-2#1)
direction to the##5##3##(1997-6#1)(2008-2#1)(2008-3#2)(2008-9#1)
direction to##10##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-12#1)
direction was##6##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
direction were##2##2##(1994-8#1)(2012-3#1)
direction when the##2##3##(2007-11#1)(2009-10#1)
direction when##3##2##(2007-11#1)(2008-5#1)(2009-10#1)
direction with respect to the##2##5##(2007-11#1)(2009-11#1)
direction with respect to##3##4##(2007-11#1)(2008-11#1)(2009-11#1)
direction with##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)
direction##449##1##(1990-11#5)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#5)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(2007-11#20)(2007-12#22)(2007-4#2)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#45)(2008-11#12)(2008-12#3)(2008-2#33)(2008-3#90)(2008-4#4)(2008-5#6)(2008-6#8)(2008-7#9)(2008-8#21)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#6)(2009-12#2)(2009-2#4)(2009-4#1)(2009-6#4)(2009-7#12)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#7)(2013-8#8)
direction)##7##1##(1991-5#1)(1992-12#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)
directional and##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
directional coupler##10##2##(2007-12#1)(2007-9#2)(2008-3#7)
directional couplers##3##2##(2007-11#3)
directional effects##3##2##(2008-3#2)(2008-5#1)
directional emission from##2##3##(2007-11#1)(2008-3#1)
directional emission##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
directional hemispherical reflectance (DHR) and bidirectional reflectance distribution function (BRDF) measurements of##2##12##(2008-3#2)
directional hemispherical reflectance (DHR)##3##4##(2008-3#3)
directional selection##4##2##(2008-10#1)(2008-8#2)(2009-2#1)
directional tuning of##2##3##(2008-8#2)
directional##72##1##(1995-12#1)(1997-8#1)(2007-11#4)(2007-12#6)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#22)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-2#1)(2009-9#2)(2010-7#1)(2012-1#1)(2012-2#2)(2013-1#1)
directional-hemispherical reflectance is##2##3##(2008-2#2)
directionality of##2##2##(2008-3#1)(2008-8#1)
directionality##4##1##(2008-3#1)(2008-8#1)(2009-12#1)(2010-2#1)
directionally selective cells##2##3##(2008-8#2)
directionally##8##1##(1996-12#1)(2008-2#2)(2008-8#3)(2010-12#2)
directions and the##2##3##(1993-3#1)(2008-3#1)
directions and##8##2##(1993-3#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-8#1)
directions are discussed##6##3##(2007-12#1)(2008-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2012-1#1)
directions are##12##2##(1994-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2012-1#1)
directions at##2##2##(2008-3#1)(2013-8#1)
directions by##2##2##(2007-11#1)(2007-12#1)
directions during##2##2##(2008-10#1)(2008-4#1)
directions for development##2##3##(1996-1#1)(2010-9#1)
directions for further research##2##4##(1995-12#1)(2013-1#1)
directions for future research are discussed##2##6##(2007-12#1)(2012-12#1)
directions for future research are##5##5##(1995-2#1)(1996-2#1)(2007-12#1)(2008-12#1)(2012-12#1)
directions for future research##13##4##(1995-2#1)(1996-2#1)(1996-3#1)(2007-12#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-12#2)(2012-3#1)
directions for future##18##3##(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-12#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)
directions for research into##2##4##(2009-7#1)(2013-1#1)
directions for research##3##3##(2009-5#1)(2009-7#1)(2013-1#1)
directions for the##5##3##(1992-11#1)(1995-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
directions for##49##2##(1991-2#2)(1992-11#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-3#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#5)(2009-5#1)(2009-7#2)(2010-12#1)(2010-9#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)
directions from##2##2##(2008-10#1)(2008-2#1)
directions in a##2##3##(2008-2#1)(2008-3#1)
directions in the##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)
directions in##20##2##(1992-2#1)(1994-2#1)(1996-12#1)(1996-9#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-1#2)(2012-2#1)
directions of future##2##3##(2008-10#1)(2008-9#1)
directions of the##7##3##(1992-9#1)(1994-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2013-1#1)
directions of##30##2##(1990-12#1)(1990-5#1)(1992-9#1)(1994-1#1)(1994-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-9#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)
directions out of the plane of incidence##2##7##(2008-3#2)
directions that are##2##3##(2008-11#1)(2009-3#1)
directions that##5##2##(1995-1#1)(2008-11#1)(2009-3#1)(2010-9#1)(2011-2#1)
directions through##2##2##(2008-3#1)(2011-2#1)
directions to##2##2##(2008-6#2)
directions were##3##2##(2008-1#1)(2008-11#2)
directions when##2##2##(2008-2#1)(2008-8#1)
directions with##2##2##(2008-3#1)(2008-9#1)
directions##257##1##(1990-10#1)(1990-12#1)(1990-5#2)(1991-2#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-9#1)(1997-2#1)(1997-3#3)(2007-10#2)(2007-11#7)(2007-12#5)(2008-1#2)(2008-10#17)(2008-11#11)(2008-12#5)(2008-2#17)(2008-3#40)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#6)(2008-8#6)(2008-9#11)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-7#4)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#11)(2012-1#6)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
directive##15##1##(1992-12#1)(1993-12#1)(1994-1#1)(1996-8#2)(1997-8#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-12#2)(2010-5#1)
directives and##2##2##(1992-12#2)
directives for##3##2##(1992-11#1)(1992-3#1)(2008-1#1)
directives provide##2##2##(1993-2#1)(1996-3#1)
directives##20##1##(1990-3#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1993-2#4)(1994-1#2)(1996-3#2)(2008-1#1)(2008-12#2)(2009-6#1)(2010-8#1)
directivity##2##1##(2008-2#1)(2008-3#1)
directly about their##2##3##(1995-2#2)
directly activate##2##2##(1990-2#1)(2006-6#1)
directly address this##2##3##(1994-11#1)(2013-1#1)
directly address##3##2##(1994-11#1)(2013-1#2)
directly addressed##2##2##(2007-8#1)(2008-5#1)
directly affect the##2##3##(1990-7#1)(1994-2#1)
directly affect##8##2##(1990-7#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
directly affected by##2##3##(2008-3#1)(2011-2#1)
directly affected##5##2##(2008-3#2)(2011-2#2)(2012-2#1)
directly affects the##2##3##(1993-6#1)(1995-3#1)
directly affects##3##2##(1993-6#1)(1995-3#1)(1996-5#1)
directly after##10##2##(1990-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
directly amplified##2##2##(1996-6#1)(2008-10#1)
directly and indirectly##7##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
directly and##17##2##(1993-12#1)(1993-3#1)(1996-5#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
directly applicable to##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
directly applicable##6##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
directly applied to##2##3##(2008-10#1)(2009-9#1)
directly applied##5##2##(2008-10#4)(2009-9#1)
directly as##6##2##(1991-5#1)(1996-5#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
directly assess the##2##3##(2008-3#1)(2010-4#1)
directly assess##3##2##(1997-2#1)(2008-3#1)(2010-4#1)
directly associated with##4##3##(2008-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
directly at the##4##3##(1991-2#1)(2007-8#1)(2008-11#1)(2011-2#1)
directly at##8##2##(1991-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2011-3#1)
directly attributable to the##2##4##(2008-7#2)
directly attributable to##5##3##(2008-10#1)(2008-4#1)(2008-7#3)
directly be##3##2##(2008-10#2)(2012-2#1)
directly by the##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
directly by use of##3##4##(2007-11#1)(2008-3#1)(2008-8#1)
directly by##36##2##(1992-3#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-11#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
directly compare##2##2##(2008-10#1)(2008-8#1)
directly compared##6##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
directly compares##2##2##(2008-3#1)(2008-6#1)
directly comparing##2##2##(1995-2#1)(2008-10#1)
directly compressible##2##2##(2010-3#1)(2010-5#1)
directly contribute to##3##3##(2009-8#1)(2013-1#2)
directly correlate with the##2##4##(2008-7#1)(2008-9#1)
directly correlated with the##4##4##(1996-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
directly correlated with##11##3##(1993-11#1)(1996-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#2)(2013-8#1)
directly correlates with##2##3##(2009-3#1)(2013-1#1)
directly coupled to##2##3##(1994-6#1)(2008-4#1)
directly coupled with fluorimetric detection in a##2##7##(2008-10#2)
directly coupled with##3##3##(2008-10#3)
directly coupled##5##2##(1994-6#1)(2008-10#3)(2008-4#1)
directly demonstrated by##2##3##(2007-12#1)(2012-2#1)
directly demonstrated##4##2##(1994-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
directly dependent on the##2##4##(2008-10#1)(2008-8#1)
directly dependent on##4##3##(1990-8#1)(2007-7#1)(2008-10#1)(2008-8#1)
directly dependent##5##2##(1990-12#1)(1990-8#1)(2007-7#1)(2008-10#1)(2008-8#1)
directly deposited##2##2##(2008-10#1)(2008-2#1)
directly detect##2##2##(2007-11#1)(2008-10#1)
directly detected##2##2##(2008-10#2)
directly determined by the##2##4##(1993-6#1)(1995-11#1)
directly determined by##3##3##(1993-6#1)(1995-11#1)(2008-10#1)
directly determined##6##2##(1993-6#1)(1995-11#1)(2007-12#1)(2008-10#3)
directly diode-pumped##2##2##(2007-11#1)(2007-12#1)
directly examined the##2##3##(1994-3#1)(1995-6#1)
directly examined##4##2##(1990-11#1)(1994-3#2)(1995-6#1)
directly exploiting##2##2##(2008-9#2)
directly exposed to the##2##4##(2008-10#1)(2008-5#1)
directly exposed to##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
directly for##4##2##(1995-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
directly from a femtosecond laser resonator without##2##7##(2007-11#1)(2007-12#1)
directly from a##9##3##(1990-5#1)(2007-11#4)(2007-12#3)(2008-5#1)
directly from crude##2##3##(2008-10#1)(2008-4#1)
directly from the crude##2##4##(2008-11#2)
directly from the##32##3##(1993-12#1)(1994-12#1)(1994-7#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
directly from their##2##3##(1994-12#1)(2008-10#1)
directly from##79##2##(1990-12#1)(1990-5#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-6#1)(1996-2#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#15)(2008-11#4)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
directly if##2##2##(1994-2#1)(2008-8#1)
directly impact on##2##3##(2013-8#2)
directly impact the##3##3##(1994-3#1)(2010-10#1)(2010-12#1)
directly impact##7##2##(1992-1#1)(1994-3#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-8#2)
directly in soil##3##3##(2008-10#3)
directly in the##18##3##(1991-1#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-2#1)
directly in##35##2##(1991-1#1)(1995-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
directly influence the##3##3##(1995-9#1)(2008-7#1)(2013-1#1)
directly influence##9##2##(1995-11#1)(1995-9#1)(1996-2#1)(2008-7#2)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
directly influences the##2##3##(2008-10#2)
directly influences##3##2##(2008-10#2)(2008-3#1)
directly inhibit##5##2##(1993-11#1)(1994-6#1)(2008-5#1)(2008-9#1)(2009-2#1)
directly inhibited##2##2##(1994-6#1)(2008-10#1)
directly inhibits##2##2##(2008-11#1)(2011-2#1)
directly injected into##2##3##(2008-10#2)
directly injected##5##2##(1997-4#1)(2008-10#4)
directly inserted in the plasma for ICP-AES measurement##2##8##(2008-10#2)
directly inserted##3##2##(2008-10#3)
directly inside##2##2##(2008-11#1)(2008-8#1)
directly interact##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
directly interfaced##2##2##(2008-1#1)(2008-10#1)
directly into a##7##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)
directly into the##27##3##(1990-8#2)(1992-11#1)(1992-3#1)(1993-12#2)(2006-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-2#1)
directly into##46##2##(1990-8#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-12#2)(2006-12#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-2#1)
directly introduced in the##2##4##(1995-2#1)(2008-10#1)
directly introduced into a##2##4##(2008-10#2)
directly introduced into the flame##2##5##(2008-10#2)
directly introduced into the##5##4##(2008-10#5)
directly introduced into##8##3##(2008-10#7)(2008-6#1)
directly introduced to the##2##4##(2008-10#1)(2008-9#1)
directly introduced##14##2##(1995-2#2)(2008-10#10)(2008-6#1)(2008-9#1)
directly involved in the control of##2##6##(2008-4#2)
directly involved in the regulation of##3##6##(1992-11#1)(1993-5#1)(1995-12#1)
directly involved in the##9##4##(1990-11#1)(1992-11#1)(1993-5#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-4#2)(2012-3#1)
directly involved in##19##3##(1990-11#1)(1992-11#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2012-3#1)
directly involved##21##2##(1990-11#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-3#1)
directly linked to##7##3##(1994-11#1)(1994-9#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-3#1)
directly linked##9##2##(1994-11#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#2)(2012-3#1)
directly measure##5##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
directly measured by##2##3##(1995-11#1)(2007-12#1)
directly measured##13##2##(1992-3#1)(1995-11#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2013-8#1)
directly measuring the##3##3##(1991-3#1)(2007-11#1)(2008-10#1)
directly measuring##4##2##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#1)
directly modulate##2##2##(2008-7#1)(2009-9#1)
directly modulated##2##2##(2008-2#1)(2013-1#1)
directly observed preventive therapy (DOPT)##2##5##(1996-3#1)(1997-2#1)
directly observed preventive therapy##3##4##(1996-3#1)(1997-2#2)
directly observed therapy (DOT)##6##4##(1996-11#1)(1996-3#4)(2010-4#1)
directly observed therapy in##2##4##(1996-3#2)
directly observed therapy##16##3##(1996-11#1)(1996-3#14)(2010-4#1)
directly observed##25##2##(1996-11#1)(1996-3#15)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-4#1)(2013-8#1)
directly on a##2##3##(2008-10#1)(2008-2#1)
directly on blood agar plates##2##5##(1996-11#2)
directly on the surface of the##2##6##(2008-10#1)(2012-2#1)
directly on the##20##3##(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#1)(2009-12#1)(2012-2#1)
directly on##43##2##(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-11#2)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
directly onto a##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)
directly onto one##2##3##(2008-10#1)(2008-2#1)
directly onto the##2##3##(1990-8#1)(2008-2#1)
directly onto##11##2##(1990-8#1)(2008-10#3)(2008-2#4)(2008-3#2)(2009-5#1)
directly or after##2##3##(2008-10#2)
directly or indirectly##18##3##(1991-1#1)(1991-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)
directly or##27##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(1996-2#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)
directly patterned##2##2##(2008-10#1)(2009-11#1)
directly performed##3##2##(2008-10#3)
directly proportional to the concentration of##5##6##(2008-10#5)
directly proportional to the##17##4##(1994-12#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
directly proportional to##20##3##(1994-12#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
directly provides the##2##3##(1992-6#1)(2008-3#1)
directly regulate##2##2##(2007-12#1)(2008-10#1)
directly related to the##20##4##(1990-5#1)(1995-12#1)(1996-2#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-12#1)
directly related to##41##3##(1990-5#2)(1993-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
directly related with##2##3##(2008-10#1)(2011-2#1)
directly related##45##2##(1990-5#2)(1993-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
directly relates##2##2##(2007-11#1)(2008-10#1)
directly relevant to##3##3##(2008-8#1)(2012-12#1)(2013-8#1)
directly repeated sequences##2##3##(1990-11#1)(1996-6#1)
directly repeated##5##2##(1990-11#1)(1993-2#1)(1995-8#2)(1996-6#1)
directly sequenced##2##2##(2008-10#1)(2008-4#1)
directly shows##2##2##(2008-3#2)
directly stimulate uterine contractions##2##4##(2010-3#2)
directly stimulate##9##2##(1991-5#1)(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#2)
directly support##3##2##(1996-1#1)(1997-4#1)(2008-9#1)
directly targeted##2##2##(2008-5#1)(2012-2#1)
directly the##10##2##(1991-5#1)(1992-6#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-2#3)(2011-1#1)
directly through the##5##3##(2008-10#4)(2008-3#1)
directly through##9##2##(2008-10#5)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
directly to a##4##3##(1992-8#2)(2008-5#1)(2008-9#1)
directly to an##3##3##(2007-12#2)(2008-10#1)
directly to the nebulizer-burner system of the##2##7##(2008-10#2)
directly to the surface of##2##5##(1994-11#1)(2008-10#1)
directly to the##28##3##(1990-7#1)(1990-8#2)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#2)(2008-7#3)
directly to##62##2##(1990-7#1)(1990-8#2)(1990-9#1)(1992-8#2)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#2)(1995-12#2)(1995-6#1)(1996-1#1)(1997-1#1)(2007-12#3)(2007-8#1)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
directly under##2##2##(2008-2#1)(2011-2#1)
directly using##2##2##(1991-12#1)(2008-10#1)
directly via##2##2##(1997-6#1)(2007-12#1)
directly weighed##3##2##(2008-10#3)
directly with an##2##3##(1996-12#1)(2008-10#1)
directly with the##11##3##(1992-11#2)(1993-2#1)(1993-6#1)(1995-6#2)(1996-2#2)(2008-2#1)(2008-3#1)(2012-2#1)
directly with##28##2##(1992-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)
directly within the##3##3##(2008-11#2)(2008-9#1)
directly within##4##2##(1990-7#1)(2008-11#2)(2008-9#1)
directly without the##3##3##(1995-8#1)(2008-10#1)(2008-12#1)
directly without##4##2##(1995-8#1)(2008-10#2)(2008-12#1)
directly##1087##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-5#4)(1990-7#4)(1990-8#9)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#5)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#5)(1992-2#1)(1992-3#6)(1992-6#2)(1992-8#5)(1992-9#3)(1993-11#6)(1993-12#8)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#6)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#8)(1994-3#7)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#7)(1995-2#10)(1995-3#5)(1995-5#2)(1995-6#9)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#10)(1996-3#15)(1996-5#6)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#7)(1997-4#7)(1997-6#2)(1997-7#3)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#21)(2007-12#36)(2007-5#1)(2007-7#1)(2007-8#10)(2008-1#7)(2008-10#271)(2008-11#44)(2008-12#6)(2008-2#38)(2008-3#56)(2008-4#27)(2008-5#24)(2008-6#12)(2008-7#34)(2008-8#28)(2008-9#27)(2009-10#1)(2009-11#6)(2009-12#4)(2009-2#3)(2009-3#4)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#14)(2011-2#33)(2011-3#2)(2012-1#4)(2012-12#3)(2012-2#20)(2012-3#8)(2012-6#1)(2013-1#25)(2013-2#1)(2013-7#1)(2013-8#10)
director and##3##2##(1993-12#2)(1994-3#1)
director at##2##2##(1996-1#1)(2008-9#1)
director axis##2##2##(2007-11#1)(2007-12#1)
director field##2##2##(2007-12#1)(2008-3#1)
director of the International AIDS Center##2##6##(1990-11#2)
director of the##7##3##(1990-11#2)(1992-3#1)(1992-8#1)(1997-5#1)(1997-6#1)(2007-5#1)
director of##13##2##(1990-11#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-5#1)(2008-3#1)(2013-8#1)
director##36##1##(1990-11#2)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#3)(1993-2#1)(1994-1#1)(1994-3#2)(1995-1#2)(1996-1#1)(1996-2#2)(1997-2#1)(1997-5#1)(1997-6#2)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2010-8#1)(2013-8#1)
director's##4##1##(1994-2#1)(1994-3#2)(1995-3#1)
directories##3##1##(1994-3#1)(1995-3#1)(2008-9#1)
directors and##7##2##(1992-12#1)(1994-1#2)(1994-12#1)(1995-12#1)(1995-3#1)(2007-4#1)
directors are##2##2##(1991-3#1)(1994-3#1)
directors in##3##2##(1992-2#1)(2007-12#1)(2009-8#1)
directors of##8##2##(1991-5#1)(1993-1#1)(1994-1#1)(1995-2#1)(1995-3#3)(1995-6#1)
directors to##3##2##(2009-8#1)(2012-12#2)
directors##58##1##(1991-3#2)(1991-5#1)(1992-12#4)(1992-2#4)(1993-1#4)(1993-3#1)(1994-1#3)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-4#1)(2009-8#3)(2011-2#2)(2012-12#4)(2012-3#1)(2013-8#1)
directory##4##1##(1991-3#1)(1994-1#1)(1995-9#1)(1996-12#1)
directs its##2##2##(2007-12#1)(2011-1#1)
directs the##7##2##(1994-2#1)(1994-5#1)(1994-8#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-1#1)
directs##19##1##(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-12#1)(1996-5#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-2#1)
dirhodium(II)##2##1##(2008-10#1)(2008-7#1)
dirhodum##2##1##(2008-10#2)
dirhodum)##2##1##(2008-10#2)
dirithromycin components##2##2##(2008-10#2)
dirithromycin##5##1##(2008-10#5)
dirofilariasis##2##1##(2007-7#1)(2012-2#1)
dirt and##2##2##(1997-2#1)(2008-5#1)
dirty##6##1##(1991-3#1)(1993-1#1)(1996-2#1)(1997-5#1)(2008-2#1)(2013-7#1)
disabilities and##7##2##(1994-2#1)(1995-1#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)
disabilities as##2##2##(1995-12#1)(2008-7#1)
disabilities have##2##2##(1993-1#1)(1997-2#1)
disabilities in the##2##3##(2009-2#1)(2010-8#1)
disabilities in##10##2##(1991-12#1)(1995-6#1)(1996-1#2)(1997-1#2)(1997-2#2)(2009-2#1)(2010-8#1)
disabilities of##2##2##(1995-2#1)(2008-9#1)
disabilities or##4##2##(1993-3#1)(2010-11#3)
disabilities were##2##2##(1995-1#1)(1996-1#1)
disabilities who##2##2##(1996-1#1)(1997-1#1)
disabilities##99##1##(1991-12#2)(1993-1#2)(1993-3#5)(1993-9#1)(1994-1#2)(1994-2#1)(1995-1#4)(1995-12#5)(1995-2#1)(1995-6#3)(1996-1#10)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#4)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#3)(2008-7#2)(2008-9#2)(2009-2#1)(2009-6#7)(2010-10#2)(2010-11#3)(2010-12#6)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
disability among##4##2##(1995-2#1)(2007-10#1)(2010-12#1)(2012-12#1)
disability and outcome##3##3##(2007-10#1)(2007-11#2)
disability and##22##2##(1991-11#1)(1991-12#1)(1995-12#1)(1995-6#1)(1997-1#2)(2007-10#2)(2007-11#2)(2008-10#1)(2008-11#2)(2008-7#3)(2009-12#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
disability are##2##2##(2008-11#1)(2008-8#1)
disability as##4##2##(1995-1#1)(2008-12#1)(2008-7#1)(2012-12#1)
disability associated with##2##3##(2007-10#1)(2008-7#1)
disability at 3 months##2##4##(2007-10#1)(2008-7#1)
disability at##5##2##(2007-10#1)(2008-7#2)(2008-9#2)
disability benefit##2##2##(1995-5#2)
disability benefits##4##2##(1997-5#3)(1997-8#1)
disability caused by##2##3##(2008-3#1)(2008-7#1)
disability following##2##2##(2007-10#1)(2012-12#1)
disability from##2##2##(2007-10#2)
disability in young##2##3##(2012-12#1)(2013-1#1)
disability in##15##2##(1990-3#1)(1993-3#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#2)
disability management program##2##3##(1997-2#2)
disability management##3##2##(1992-2#1)(1997-2#2)
disability measurement##2##2##(1996-1#1)(2007-11#1)
disability of the##2##3##(1990-6#1)(2007-8#1)
disability of##4##2##(1990-6#1)(2007-11#1)(2007-8#1)(2012-2#1)
disability pension##11##2##(1991-11#2)(1993-6#1)(1995-5#4)(1997-6#4)
disability pensions##3##2##(1993-6#2)(1995-5#1)
disability policy##4##2##(1992-3#2)(1996-1#2)
disability prevention##2##2##(1995-12#1)(1997-3#1)
disability were determined##2##3##(2011-2#1)(2012-12#1)
disability were##6##2##(1995-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
disability##246##1##(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#6)(1991-12#2)(1991-3#1)(1992-12#2)(1992-2#3)(1992-3#3)(1993-3#2)(1993-6#4)(1994-1#2)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#10)(1995-6#1)(1996-1#7)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-5#4)(1997-6#6)(1997-8#1)(2006-10#1)(2007-10#12)(2007-11#9)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#13)(2008-12#7)(2008-3#2)(2008-4#2)(2008-6#5)(2008-7#21)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#13)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#15)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#2)
disability)##3##1##(1991-12#1)(2010-4#1)(2011-1#1)
disability-based distinctions##2##2##(1995-12#1)(1996-5#1)
disability-based##3##1##(1995-12#1)(1996-5#2)
disable##2##1##(2011-2#2)
disabled Medicare beneficiaries##3##3##(1991-1#1)(1991-2#1)(1991-3#1)
disabled Medicare enrollees##4##3##(1992-2#3)(1997-1#1)
disabled Medicare##9##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#3)(1995-12#2)(1997-1#1)
disabled after##2##2##(1995-2#1)(2013-8#1)
disabled and elderly subjects##2##4##(2008-7#2)
disabled and##7##2##(1991-12#1)(1994-2#1)(2008-7#4)(2013-8#1)
disabled at##2##2##(2007-10#1)(2008-7#1)
disabled children##3##2##(2008-8#2)(2010-3#1)
disabled in##4##2##(2007-10#1)(2008-7#2)(2009-1#1)
disabled patients##3##2##(1995-1#1)(1995-11#1)(2008-8#1)
disabled people##5##2##(1993-1#1)(1995-12#1)(1996-11#1)(2008-11#1)(2012-12#1)
disabled persons##2##2##(1992-3#1)(1995-3#1)
disabled population##2##2##(1997-2#2)
disabled state in##2##3##(1997-3#2)
disabled workers##3##2##(1994-1#1)(1995-2#2)
disabled##72##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#4)(1992-3#2)(1993-1#1)(1993-3#1)(1994-1#3)(1994-2#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#2)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-7#9)(2008-8#3)(2009-1#1)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#4)
disabling and##5##2##(1992-5#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
disabling chronic conditions##2##3##(2011-2#2)
disabling conditions##6##2##(1994-1#1)(1994-3#1)(1997-2#3)(2010-12#1)
disabling disease##2##2##(1990-6#1)(1997-3#1)
disabling or##2##2##(2006-10#1)(2008-5#1)
disabling tinnitus##2##2##(2010-7#2)
disabling##39##1##(1990-6#1)(1991-11#1)(1992-5#1)(1994-1#1)(1994-3#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#3)(2013-1#2)
disaccharidase activity##2##2##(2013-1#2)
disaccharide analogues##3##2##(1995-11#3)
disaccharide derivatives##2##2##(1995-6#2)
disaccharide units##2##2##(1992-12#2)
disaccharide##21##1##(1990-12#1)(1990-2#1)(1992-12#5)(1992-6#1)(1993-11#2)(1994-8#1)(1995-11#4)(1995-6#3)(2009-6#1)(2010-11#2)
disaccharides and##3##2##(1995-11#1)(2008-10#1)(2008-7#1)
disaccharides##14##1##(1992-6#1)(1994-5#2)(1995-11#1)(1995-6#2)(1997-4#1)(2008-10#2)(2008-6#1)(2008-7#4)
disadvantage and##2##2##(2010-12#1)(2010-9#1)
disadvantage for##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
disadvantage is##2##2##(2008-8#1)(2008-9#1)
disadvantage of##8##2##(1995-5#1)(1997-2#2)(2008-1#2)(2008-11#1)(2009-8#1)(2012-2#1)
disadvantage was##2##2##(2008-10#1)(2009-7#1)
disadvantage##45##1##(1990-2#1)(1992-3#2)(1995-2#1)(1995-5#1)(1997-2#2)(2007-10#3)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#5)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
disadvantaged community##3##2##(2010-3#2)(2010-9#1)
disadvantaged families##2##2##(2008-11#1)(2008-12#1)
disadvantaged groups##2##2##(1992-3#1)(1995-2#1)
disadvantaged populations##3##2##(2008-8#1)(2011-2#2)
disadvantaged##20##1##(1992-1#1)(1992-3#1)(1995-2#1)(1995-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-8#4)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
disadvantageous##3##1##(2008-11#1)(2008-5#1)(2009-10#1)
disadvantages and##4##2##(1996-1#1)(1996-3#1)(1997-7#1)(2011-2#1)
disadvantages associated with##2##3##(2008-5#1)(2012-2#1)
disadvantages for##2##2##(1992-3#1)(2008-5#1)
disadvantages in##3##2##(2008-10#1)(2009-2#1)(2010-2#1)
disadvantages of the developed##2##4##(2008-10#1)(2010-8#1)
disadvantages of the##12##3##(1992-3#1)(1992-8#1)(2007-5#1)(2008-10#4)(2008-3#2)(2009-5#1)(2010-8#1)(2013-7#1)
disadvantages of these##2##3##(2011-2#1)(2012-3#1)
disadvantages of##53##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-3#1)(1996-1#1)(1996-3#3)(1997-2#1)(2007-10#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#3)(2008-4#3)(2008-9#3)(2009-5#2)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
disadvantages to##4##2##(1997-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
disadvantages with##2##2##(2008-7#1)(2010-11#1)
disadvantages##101##1##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#2)(1992-2#1)(1992-3#3)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-1#2)(1996-3#4)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#4)(2009-2#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
disaggregated by##2##2##(2008-8#1)(2009-9#1)
disaggregated##10##1##(1992-3#1)(1992-9#4)(1996-3#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-2#1)
disaggregates##2##1##(1996-1#1)(2009-7#1)
disaggregation of##2##2##(2008-8#1)(2011-2#1)
disaggregation##5##1##(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
disagree with##2##2##(1990-8#1)(2008-3#1)
disagree##5##1##(1990-8#1)(1993-3#1)(2008-3#1)(2008-5#1)(2009-4#1)
disagreed with##2##2##(1995-6#1)(2008-10#1)
disagreed##6##1##(1995-6#1)(1996-5#2)(1997-5#1)(2008-10#1)(2011-1#1)
disagreement about the##2##3##(1997-7#1)(2011-10#1)
disagreement between##2##2##(1991-6#1)(2013-1#1)
disagreement in##2##2##(1990-12#1)(2009-3#1)
disagreement is##2##2##(2008-8#1)(2012-3#1)
disagreement with the##2##3##(1991-2#1)(2008-8#1)
disagreement with##4##2##(1991-2#1)(2008-2#1)(2008-8#1)(2010-10#1)
disagreement##25##1##(1990-12#1)(1991-2#1)(1991-6#1)(1996-11#1)(1997-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-10#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)
disagreements##8##1##(1994-9#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#3)
disagrees with the##2##3##(1995-3#1)(2008-10#1)
disagrees with##3##2##(1995-3#1)(1996-3#1)(2008-10#1)
disalicylic##2##1##(2008-10#2)
disappear due to##2##3##(2007-8#1)(2010-11#1)
disappear in##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
disappear spontaneously##2##2##(1995-11#1)(2008-10#1)
disappear with##2##2##(2008-11#1)(2012-12#1)
disappear##21##1##(1990-11#1)(1990-6#1)(1993-2#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2010-11#1)(2012-12#1)
disappearance of pain##2##3##(1994-9#1)(2009-4#1)
disappearance of the##13##3##(1990-5#1)(1990-8#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-3#2)(2007-8#1)(2008-10#2)(2008-3#1)(2009-2#1)(2009-9#1)
disappearance of##38##2##(1990-5#3)(1990-8#1)(1992-12#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-5#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-9#1)(2011-2#3)(2013-8#1)
disappearance##42##1##(1990-11#1)(1990-5#3)(1990-8#1)(1992-12#1)(1992-6#1)(1993-8#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-5#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
disappeared after the##4##3##(1991-11#1)(1991-2#1)(1994-3#1)(2008-5#1)
disappeared after##14##2##(1991-11#1)(1991-2#1)(1991-8#1)(1994-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2013-1#1)
disappeared and##7##2##(1995-2#1)(1996-9#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
disappeared as##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
disappeared by##3##2##(1995-11#1)(1995-12#1)(1995-2#1)
disappeared completely##5##2##(1991-8#1)(1996-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
disappeared during##2##2##(1993-12#1)(2008-5#1)
disappeared from the##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
disappeared from##7##2##(1990-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2010-8#1)
disappeared in the##3##3##(1992-6#1)(1997-8#1)(2008-7#1)
disappeared in##14##2##(1990-8#1)(1992-5#1)(1992-6#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#5)(2012-2#1)
disappeared or##4##2##(1991-2#1)(1991-5#1)(1993-3#1)(2008-10#1)
disappeared when the##2##3##(1991-2#1)(2008-9#1)
disappeared when##5##2##(1991-2#1)(1991-9#1)(2008-3#1)(2008-9#1)(2011-2#1)
disappeared with##5##2##(2008-1#1)(2008-5#1)(2009-2#1)(2010-4#1)(2013-1#1)
disappeared within 1 month##2##4##(2006-12#1)(2007-8#1)
disappeared within##6##2##(1991-12#1)(2006-12#1)(2007-8#1)(2011-2#1)(2012-12#2)
disappeared##110##1##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#6)(1991-5#1)(1991-8#2)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#7)(2008-7#6)(2008-8#3)(2008-9#8)(2009-2#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#1)
disappearing##6##1##(1991-3#1)(1994-9#1)(1997-5#1)(2007-7#1)(2010-3#1)(2011-2#1)
disappears when##2##2##(1992-6#1)(2007-12#1)
disappears##10##1##(1992-6#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
disappointing results in##2##3##(1992-6#1)(2011-1#1)
disappointing results##6##2##(1990-12#1)(1990-6#1)(1992-6#1)(1997-3#1)(2008-8#1)(2011-1#1)
disappointing##26##1##(1990-10#1)(1990-12#1)(1990-6#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-11#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-3#1)
disappointment##2##1##(2007-4#1)(2010-1#1)
disassemble##3##1##(2008-10#1)(2008-9#1)(2011-2#1)
disassembly and##2##2##(1994-5#1)(2011-2#1)
disassembly of the nuclear##2##4##(2011-2#2)
disassembly of the##4##3##(2009-11#1)(2011-2#3)
disassembly of##6##2##(1994-12#1)(2009-11#1)(2011-2#4)
disassembly##10##1##(1994-12#1)(1994-5#1)(2008-11#1)(2008-8#1)(2009-11#1)(2011-2#5)
disaster and##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
disaster management in##2##3##(2008-10#1)(2008-11#1)
disaster management##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
disaster medicine##2##2##(2008-9#1)(2013-8#1)
disaster mental health research##2##4##(2012-12#2)
disaster mental health##5##3##(2012-12#4)(2012-2#1)
disaster nursing##3##2##(2008-11#3)
disaster plan##2##2##(1995-2#1)(1996-2#1)
disaster preparedness##2##2##(2013-1#2)
disaster relief nurses##2##3##(2012-1#2)
disaster response##3##2##(1992-12#1)(2008-1#1)(2012-12#1)
disaster strikes##2##2##(2010-8#1)(2012-3#1)
disaster to##2##2##(2010-8#2)
disaster##68##1##(1991-2#4)(1991-3#1)(1992-12#4)(1993-1#1)(1995-11#5)(1995-2#1)(1996-2#1)(1997-3#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#7)(2008-9#2)(2009-12#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#1)
disaster-impacted##2##1##(2012-2#2)
disasters and suicide##2##3##(2013-1#2)
disasters and##4##2##(1997-5#1)(2012-3#1)(2013-1#2)
disasters in##3##2##(1991-2#1)(2008-2#1)(2010-8#1)
disasters on##3##2##(2013-1#3)
disasters##41##1##(1990-9#1)(1991-11#1)(1991-2#3)(1993-1#1)(1997-5#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-7#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#16)(2013-8#1)
disastrous consequences for##2##3##(2008-9#1)(2010-5#1)
disastrous consequences##6##2##(2008-1#1)(2008-11#1)(2008-9#2)(2010-5#1)(2010-7#1)
disastrous##9##1##(2008-1#1)(2008-11#1)(2008-9#3)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)
disc and a##2##3##(2008-2#1)(2008-3#1)
disc and for a##2##4##(2008-3#1)(2009-4#1)
disc and##10##2##(1994-11#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#2)
disc arthroplasty##5##2##(2011-2#3)(2012-12#2)
disc as##2##2##(2007-8#1)(2012-3#1)
disc at##2##2##(2008-3#1)(2012-2#1)
disc cells##3##2##(1997-6#2)(2008-9#1)
disc decompression##2##2##(2007-8#2)
disc degeneration and##4##3##(2007-11#2)(2010-6#1)(2013-8#1)
disc degeneration##10##2##(2007-11#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
disc diffusion and##2##3##(2012-3#2)
disc diffusion method and##2##4##(2008-12#1)(2012-3#1)
disc diffusion method##8##3##(2008-12#3)(2008-5#1)(2010-3#1)(2012-2#1)(2012-3#2)
disc diffusion susceptibility##2##3##(2008-7#2)
disc diffusion##15##2##(2008-12#4)(2008-5#2)(2008-7#3)(2010-3#1)(2012-2#1)(2012-3#4)
disc disease of the##3##4##(2011-2#2)(2012-12#1)
disc disease##24##2##(2007-11#4)(2007-8#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#8)(2012-12#2)(2012-3#3)(2013-1#1)
disc electrode##8##2##(2008-10#8)
disc fragment##2##2##(2011-2#2)
disc harrow##3##2##(2008-10#3)
disc height##5##2##(2007-11#1)(2008-11#2)(2011-2#2)
disc herniation at##2##3##(2011-2#2)
disc herniation during pregnancy##2##4##(2008-12#2)
disc herniation##17##2##(1997-2#1)(1997-3#2)(2007-11#1)(2008-12#5)(2009-12#1)(2011-2#3)(2012-2#3)(2013-1#1)
disc hernitation##2##2##(2007-11#2)
disc implants##2##2##(2012-12#2)
disc in##4##2##(1996-6#1)(2007-11#2)(2009-4#1)
disc is##2##2##(2008-9#1)(2012-2#1)
disc model##2##2##(2008-9#1)(2011-2#1)
disc on##3##2##(2007-11#1)(2008-12#1)(2009-4#1)
disc prolapse##2##2##(2007-11#1)(2013-1#1)
disc protrusion##4##2##(2008-7#3)(2012-2#1)
disc replacement in adolescents##2##4##(2012-12#2)
disc replacement in##5##3##(2012-12#5)
disc replacement versus fusion##3##4##(2008-11#1)(2012-12#2)
disc replacement##18##2##(2008-11#1)(2012-12#17)
disc was##2##2##(2007-11#1)(2011-2#1)
disc with a##2##3##(1994-11#1)(1995-12#1)
disc with##5##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-3#2)
disc##236##1##(1994-11#5)(1995-12#2)(1996-6#4)(1997-2#1)(1997-3#2)(1997-6#2)(2006-12#1)(2007-11#23)(2007-8#11)(2008-10#18)(2008-11#6)(2008-12#13)(2008-2#1)(2008-3#13)(2008-5#2)(2008-7#11)(2008-9#4)(2009-12#1)(2009-4#11)(2009-5#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#34)(2012-12#31)(2012-2#11)(2012-3#15)(2013-1#4)(2013-7#1)(2013-8#1)
disc-recordable##2##1##(2008-3#2)
discarded as##2##2##(2008-11#1)(2008-3#1)
discarded from##4##2##(2007-7#1)(2008-10#3)
discarded in favor of the##2##5##(1995-6#1)(2008-1#1)
discarded##21##1##(1995-6#1)(1996-9#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#1)(2013-1#1)
discarding##4##1##(1993-2#1)(2008-10#2)(2011-2#1)
discectomy##20##1##(1996-3#3)(2007-11#3)(2007-8#2)(2008-12#3)(2008-7#2)(2012-12#5)(2012-3#2)
discern the##5##2##(1996-2#1)(2007-12#1)(2008-3#2)(2008-9#1)
discern##14##1##(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-7#1)(2013-1#3)
discernable##7##1##(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-3#1)
discerned##7##1##(1991-5#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
discernible##14##1##(1991-5#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2013-7#1)
discerning##4##1##(1997-1#1)(2008-11#1)(2008-3#2)
discharge and the##2##3##(2008-10#1)(2013-1#1)
discharge and##15##2##(1990-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
discharge between##3##2##(2008-2#1)(2008-3#2)
discharge by##2##2##(1994-2#1)(2013-8#1)
discharge device##3##2##(2007-11#2)(2013-8#1)
discharge diagnosis and level of service among the different##2##9##(2012-3#2)
discharge disposition##2##2##(2008-8#1)(2011-2#1)
discharge for##2##2##(1991-2#1)(2013-1#1)
discharge forms##3##2##(2007-12#1)(2008-3#2)
discharge from hospital##3##3##(1990-2#1)(1992-5#1)(1994-9#1)
discharge from the##11##3##(1992-3#1)(1994-2#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-10#1)(2012-12#1)(2013-8#1)
discharge from##23##2##(1990-2#1)(1992-3#1)(1992-5#1)(1994-2#1)(1994-9#1)(1995-1#1)(2006-8#1)(2007-10#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-10#1)(2012-12#1)(2013-8#1)
discharge in##3##2##(2008-3#2)(2008-7#1)
discharge is##4##2##(1996-12#1)(2007-12#1)(2007-9#1)(2008-3#1)
discharge letter##3##2##(2007-12#3)
discharge letters##2##2##(2007-12#2)
discharge of ascospores##4##3##(2008-10#4)
discharge of the##5##3##(1993-12#1)(1995-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
discharge of##16##2##(1991-6#1)(1993-12#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2011-2#1)
discharge on the##2##3##(2012-12#1)(2013-1#1)
discharge on##3##2##(1994-6#1)(2012-12#1)(2013-1#1)
discharge or##5##2##(1991-12#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-12#1)
discharge pattern of##2##3##(1991-5#1)(1997-7#1)
discharge pattern##3##2##(1991-5#1)(1997-7#1)(2008-10#1)
discharge patterns##2##2##(1996-1#1)(2008-10#1)
discharge planning and##5##3##(1997-3#1)(2008-11#1)(2010-11#1)(2012-2#2)
discharge planning##8##2##(1997-3#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-11#2)(2012-2#2)
discharge plans##3##2##(1991-3#1)(1995-1#1)(1997-3#1)
discharge plasma##3##2##(2007-12#1)(2013-7#1)(2013-8#1)
discharge rate in##2##3##(1993-12#1)(1995-12#1)
discharge rate##6##2##(1990-12#1)(1993-12#1)(1995-12#1)(1996-2#2)(1997-7#1)
discharge records##3##2##(1993-12#2)(2008-8#1)
discharge summary##3##2##(1991-12#1)(2008-11#1)(2012-12#1)
discharge teaching##2##2##(1994-2#2)
discharge the##2##2##(2008-1#1)(2008-10#1)
discharge to##2##2##(1994-3#1)(2010-8#1)
discharge was##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
discharge were##3##2##(1990-11#1)(2007-11#1)(2008-11#1)
discharge with##3##2##(2007-7#1)(2008-12#1)(2012-3#1)
discharge##292##1##(1990-11#2)(1990-12#1)(1990-2#2)(1991-1#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#4)(1992-2#2)(1992-3#2)(1992-5#1)(1993-12#11)(1993-2#2)(1994-2#6)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-3#3)(1997-7#2)(2006-8#2)(2007-1#2)(2007-10#9)(2007-11#10)(2007-12#12)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#34)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#19)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#4)(2009-11#1)(2009-3#4)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#19)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#8)
discharged and dead##2##3##(2008-7#2)
discharged and##4##2##(2008-3#1)(2008-7#3)
discharged from a##3##3##(1992-11#1)(2008-9#2)
discharged from hospital##2##3##(2007-11#1)(2008-11#1)
discharged from the hospital##5##4##(1994-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
discharged from##19##2##(1992-11#1)(1994-6#1)(1995-3#1)(2006-8#3)(2007-11#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
discharged home with##3##3##(1995-3#1)(2010-7#1)(2012-12#1)
discharged home##8##2##(1995-3#2)(2007-10#2)(2007-8#1)(2008-12#1)(2010-7#1)(2012-12#1)
discharged in##2##2##(2007-8#1)(2011-1#1)
discharged into##4##2##(2007-5#1)(2008-10#1)(2008-5#2)
discharged on##9##2##(2007-8#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
discharged patients##2##2##(1993-1#1)(1996-1#1)
discharged to##6##2##(1990-12#2)(1995-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
discharged with home oxygen##2##4##(2012-12#2)
discharged with##3##2##(2008-10#1)(2012-12#2)
discharged without##3##2##(1996-9#1)(2010-10#1)(2013-1#1)
discharged##86##1##(1990-12#4)(1991-12#1)(1991-5#1)(1992-11#1)(1993-1#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#5)(1995-6#1)(1996-1#1)(1996-9#1)(1997-8#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-5#1)(2007-8#4)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#6)(2012-2#1)(2013-1#3)(2013-8#4)
discharges and##3##2##(1992-2#1)(2013-1#1)(2013-8#1)
discharges by##2##2##(1993-12#1)(2007-11#1)
discharges from##3##2##(1992-2#1)(1993-12#1)(1996-3#1)
discharges in##4##2##(1992-2#1)(1993-12#1)(1995-8#1)(2007-12#1)
discharges may##2##2##(2008-11#1)(2008-9#1)
discharges of##3##2##(1993-12#1)(2007-12#1)(2008-11#1)
discharges that##2##2##(1992-3#1)(2008-1#1)
discharges to home##2##3##(1991-2#2)
discharges to##3##2##(1991-2#3)
discharges were##3##2##(1995-8#1)(2008-1#1)(2008-9#1)
discharges##64##1##(1990-12#3)(1991-1#1)(1991-2#4)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#1)(1993-12#9)(1993-5#1)(1995-2#1)(1995-8#2)(1996-3#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#4)(2009-8#3)(2010-11#1)(2013-1#4)(2013-8#2)
discharging the##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
discharging##6##1##(2008-10#3)(2008-11#1)(2009-3#1)(2012-2#1)
disciplinary##9##1##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-1#1)(2013-1#1)
discipline and##4##2##(2008-1#1)(2008-12#1)(2009-9#1)(2010-11#1)
discipline gap##2##2##(2008-12#2)
discipline in Poland##2##3##(2007-8#1)(2013-1#1)
discipline in##6##2##(1991-6#1)(2007-8#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
discipline is##4##2##(1996-4#1)(2007-4#1)(2011-1#1)(2012-3#1)
discipline of##6##2##(1994-3#2)(2008-12#1)(2008-2#1)(2008-4#1)(2010-1#1)
discipline strategies##2##2##(1995-2#1)(2010-11#1)
discipline with##2##2##(2008-11#1)(2008-12#1)
discipline##66##1##(1991-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#5)(1994-2#2)(1994-3#2)(1995-2#1)(1996-1#1)(1996-4#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#3)(2009-9#2)(2010-1#2)(2010-11#5)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
discipline)##2##1##(2009-9#1)(2010-11#1)
disciplined approach to##3##3##(1995-1#1)(2010-3#1)(2010-8#1)
disciplined##5##1##(1995-1#1)(1995-2#1)(2008-11#1)(2010-3#1)(2010-8#1)
disciplines and##6##2##(1995-2#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)
disciplines are##4##2##(1991-2#1)(1996-12#1)(2008-7#1)(2011-2#1)
disciplines in##3##2##(1994-12#1)(2007-12#1)(2011-2#1)
disciplines involved in##2##3##(1997-3#1)(2008-5#1)
disciplines involved##3##2##(1991-12#1)(1997-3#1)(2008-5#1)
disciplines of##2##2##(1994-12#1)(2008-10#1)
disciplines that##2##2##(1996-1#1)(2009-11#1)
disciplines to##5##2##(1996-3#1)(2008-10#2)(2008-11#2)
disciplines##68##1##(1991-12#2)(1991-2#1)(1992-2#1)(1993-3#2)(1994-12#3)(1994-2#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#4)(2008-11#10)(2008-12#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
disclose a##2##2##(2007-11#1)(2008-9#1)
disclose the##8##2##(1990-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)
disclose their##2##2##(2007-12#1)(2010-4#1)
disclose##24##1##(1990-12#1)(1991-12#1)(1995-11#1)(1995-2#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#1)(2012-2#1)
disclosed a##3##2##(1990-3#1)(2007-10#1)(2008-3#1)
disclosed by##4##2##(1992-5#1)(1996-6#1)(2008-1#1)(2008-10#1)
disclosed that##7##2##(1990-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
disclosed to##4##2##(2008-9#1)(2009-4#3)
disclosed##39##1##(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-3#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#6)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#3)(2012-3#1)(2013-1#1)
discloses the use of##2##4##(2008-5#2)
discloses##5##1##(1997-8#1)(2008-5#3)(2009-7#1)
disclosing the##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
disclosing##12##1##(1991-6#1)(1995-11#1)(1996-3#2)(1997-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-1#1)
disclosure in##7##2##(1995-3#1)(1996-12#1)(2008-7#1)(2009-4#3)(2013-1#1)
disclosure is##2##2##(2008-12#1)(2008-7#1)
disclosure of HIV status##2##4##(2008-10#1)(2012-12#1)
disclosure of TTM##3##3##(2007-12#3)
disclosure of mental health records##2##5##(1992-3#2)
disclosure of the##2##3##(1995-12#1)(2008-2#1)
disclosure of##14##2##(1992-3#3)(1995-12#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#1)
disclosure to##2##2##(2008-10#1)(2009-4#1)
disclosure was##2##2##(2008-10#1)(2009-4#1)
disclosure##57##1##(1991-12#3)(1991-3#1)(1992-2#1)(1992-3#5)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-5#1)(1997-3#1)(2007-12#7)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#6)(2009-4#10)(2009-7#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
discogenic##4##1##(2010-9#1)(2012-12#3)
discographies##2##1##(2012-12#2)
discography in patients with##3##4##(2012-12#3)
discography##12##1##(2012-12#12)
discoid lupus##3##2##(2008-1#1)(2008-8#1)(2011-2#1)
discoid##8##1##(1992-6#1)(2008-1#1)(2008-8#1)(2011-2#2)(2013-1#3)
discoidectomy##3##1##(2007-8#3)
discoideum##14##1##(1991-2#2)(1991-9#1)(1993-6#2)(1994-12#1)(1995-6#3)(1995-8#1)(1997-3#2)(2008-9#1)(2009-8#1)
discoloration and##2##2##(2008-10#1)(2010-4#1)
discoloration of the skin##2##4##(1995-11#1)(2008-1#1)
discoloration of the##3##3##(1995-11#1)(1995-3#1)(2008-1#1)
discoloration of##8##2##(1990-11#1)(1995-11#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-6#1)(2013-1#1)
discoloration##24##1##(1990-11#1)(1995-11#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-5#1)(2010-4#1)(2012-6#1)(2013-1#1)
discolored backgrounds##3##2##(2009-8#3)
discolored##14##1##(1995-11#3)(2008-10#3)(2008-12#1)(2009-8#4)(2011-2#3)
discolouration##5##1##(2008-10#5)
discomfort and##7##2##(1991-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-1#1)
discomfort are the##2##3##(1990-3#1)(2013-8#1)
discomfort during##2##2##(1996-9#1)(2010-6#1)
discomfort in the##3##3##(1996-9#2)(2008-12#1)
discomfort in##5##2##(1996-3#1)(1996-9#2)(2008-12#2)
discomfort to##2##2##(1996-9#1)(2008-12#1)
discomfort was reported##2##3##(1996-9#1)(2008-12#1)
discomfort was##4##2##(1996-9#3)(2008-12#1)
discomfort with##2##2##(2008-6#1)(2011-2#1)
discomfort##53##1##(1990-3#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#11)(1997-4#1)(2007-7#1)(2008-1#1)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
disconnect between##2##2##(2012-12#1)(2012-2#1)
disconnect##3##1##(2007-12#1)(2012-12#1)(2012-2#1)
disconnected##4##1##(1994-2#1)(1995-12#1)(1996-3#1)(2011-3#1)
disconnection of a central venous catheter##2##6##(2008-7#2)
disconnection of##3##2##(2007-8#1)(2008-7#2)
disconnection##8##1##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#4)(2010-2#1)
disconnects##2##1##(2008-11#1)(2011-2#1)
discontinuation and##2##2##(1996-5#1)(2008-11#1)
discontinuation of the##5##3##(1992-2#1)(1996-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
discontinuation of therapy##4##3##(1993-11#1)(2007-7#1)(2008-3#1)(2009-5#1)
discontinuation of treatment##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
discontinuation of##26##2##(1991-2#2)(1992-2#1)(1993-11#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#4)(2012-3#1)
discontinuation or continuation of##2##4##(2011-1#2)
discontinuation was##2##2##(2008-7#1)(2013-1#1)
discontinuation##43##1##(1991-12#2)(1991-2#2)(1992-2#1)(1992-3#1)(1993-11#1)(1996-3#1)(1996-5#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#7)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-1#3)(2011-2#5)(2012-3#1)(2013-1#2)
discontinue treatment##5##2##(1991-3#1)(2008-6#1)(2011-1#3)
discontinue##15##1##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-6#1)(1995-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#3)(2012-2#1)(2013-8#1)
discontinued and##3##2##(1992-1#1)(2008-1#1)(2013-1#1)
discontinued because of##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
discontinued##32##1##(1990-2#1)(1992-1#1)(1992-6#1)(1994-3#2)(1994-6#1)(1997-2#1)(2006-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#3)(2008-9#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
discontinuers##2##1##(2008-11#1)(2011-1#1)
discontinuing##12##1##(2007-12#1)(2008-1#4)(2008-7#2)(2010-9#1)(2011-1#2)(2013-1#1)(2013-8#1)
discontinuities in##3##2##(1996-2#1)(2008-2#1)(2012-2#1)
discontinuities##14##1##(1991-8#2)(1995-11#2)(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#6)(2012-2#1)
discontinuity sensing##2##2##(2008-2#2)
discontinuity##10##1##(1995-11#1)(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)
discontinuous height steps and##2##4##(2008-2#1)(2008-3#1)
discontinuous sucrose##2##2##(2008-1#1)(2008-8#1)
discontinuous##37##1##(1990-12#1)(1993-11#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)
discopathy of the lumbar spine##2##5##(2007-11#2)
discopathy##6##1##(2007-11#2)(2007-8#4)
discordance in a pair of monozygotic twins##2##7##(2008-7#2)
discordance in##4##2##(2008-7#2)(2009-5#1)(2011-1#1)
discordance##5##1##(2008-7#2)(2009-5#1)(2009-9#1)(2011-1#1)
discordancy rate of##2##3##(2009-8#2)
discordant findings##2##2##(2010-12#1)(2010-8#1)
discordant for##2##2##(2008-10#1)(2008-11#1)
discordant results##3##2##(2007-10#1)(2007-7#1)(2011-2#1)
discordant##12##1##(1990-12#1)(1997-3#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
discount the##5##2##(2007-2#1)(2008-10#2)(2009-7#1)(2009-9#1)
discount##13##1##(1993-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(2007-2#1)(2008-10#2)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#3)
discounted##9##1##(1990-6#1)(1990-9#1)(1996-12#1)(1997-1#3)(2008-8#1)(2013-1#2)
discounting and collection policies for uninsured and underinsured patients##2##9##(2008-11#2)
discounting and##6##2##(2008-11#2)(2008-9#4)
discounting##10##1##(2008-11#2)(2008-9#6)(2009-4#1)(2012-3#1)
discounts##4##1##(1993-12#1)(1997-1#2)(1997-6#1)
discourage##3##1##(1991-7#1)(2008-9#1)(2009-7#1)
discouraged##15##1##(1991-6#1)(1992-3#2)(1992-6#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-8#1)
discourages##2##1##(1993-1#1)(1996-11#1)
discouraging##2##1##(2008-11#1)(2008-3#1)
discourse about##3##2##(2010-10#2)(2012-12#1)
discourse analysis##3##2##(2010-10#1)(2010-2#1)(2012-3#1)
discourse and##2##2##(2008-9#1)(2011-2#1)
discourse comprehension##3##2##(2011-1#1)(2012-3#2)
discourse of##4##2##(2008-7#2)(2010-10#1)(2013-8#1)
discourse##35##1##(2007-12#1)(2008-12#1)(2008-7#6)(2008-9#2)(2009-7#2)(2010-10#4)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#3)(2013-1#4)(2013-8#2)
discourses and##3##2##(2008-11#1)(2010-9#1)(2011-2#1)
discourses##11##1##(1994-1#1)(2008-11#2)(2009-7#1)(2010-10#3)(2010-9#3)(2011-2#1)
discover new##3##2##(2008-3#1)(2008-4#1)(2012-3#1)
discover that##2##2##(2012-2#1)(2012-3#1)
discover##41##1##(1991-7#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1994-12#1)(1995-2#2)(1995-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-9#3)(2010-12#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#5)(2013-8#2)
discovered a##8##2##(1995-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
discovered about##4##2##(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)
discovered and##6##2##(2008-10#2)(2008-8#2)(2011-2#1)(2012-12#1)
discovered as a##4##3##(1991-11#1)(2008-10#1)(2009-4#1)(2011-2#1)
discovered as##7##2##(1991-11#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
discovered at##2##2##(1990-2#1)(1997-3#1)
discovered by magnetic resonance imaging##2##5##(2008-7#1)(2009-5#1)
discovered by##9##2##(1990-5#1)(1993-8#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
discovered during the##2##3##(2008-5#1)(2012-2#1)
discovered during##6##2##(2008-5#3)(2009-8#1)(2011-2#1)(2012-2#1)
discovered for its##2##3##(2007-11#1)(2008-3#1)
discovered in a##6##3##(1990-11#1)(1990-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
discovered in the##13##3##(1990-3#1)(1991-12#1)(1991-7#1)(1991-8#1)(1995-1#1)(1996-11#1)(2007-8#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-7#1)(2012-3#1)
discovered in##44##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
discovered incidentally##2##2##(1991-5#1)(2011-2#1)
discovered on##5##2##(2008-7#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
discovered protein##2##2##(2007-8#1)(2008-4#1)
discovered several##2##2##(2008-10#1)(2013-1#1)
discovered so far##2##3##(2008-9#1)(2013-8#1)
discovered that the##7##3##(1991-3#1)(1991-7#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
discovered that##24##2##(1991-3#1)(1991-7#1)(1996-1#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
discovered the##5##2##(1990-3#1)(1990-5#1)(1992-5#1)(1993-6#1)(1997-5#1)
discovered to have##4##3##(1997-5#1)(2008-10#2)(2008-3#1)
discovered to##6##2##(1997-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-7#1)
discovered##224##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#4)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#2)(2007-11#5)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#18)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#9)(2008-7#9)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#4)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#5)
discoveries and##4##2##(1996-12#1)(2009-10#1)(2012-2#1)(2013-1#1)
discoveries in the##4##3##(1991-5#1)(1997-3#1)(2008-10#1)(2010-3#1)
discoveries in##6##2##(1991-5#1)(1997-1#1)(1997-3#1)(2008-10#1)(2010-3#1)(2012-2#1)
discoveries of##6##2##(1994-3#1)(2008-10#2)(2008-4#1)(2010-1#1)(2011-2#1)
discoveries that##3##2##(2008-11#1)(2009-5#1)(2012-12#1)
discoveries to##2##2##(2010-1#1)(2010-10#1)
discoveries##44##1##(1991-5#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#1)
discovering and##3##2##(2008-4#1)(2009-3#1)(2012-3#1)
discovering new##3##2##(2008-8#1)(2009-6#1)(2012-3#1)
discovering the##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
discovering##22##1##(1991-1#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)
discovers##2##1##(2008-9#1)(2010-8#1)
discovery and biological##2##3##(2008-4#1)(2011-3#1)
discovery and characterization of novel##2##5##(2008-10#1)(2008-9#1)
discovery and characterization of##3##4##(1997-1#1)(2008-10#1)(2008-9#1)
discovery and development of DAPY derivatives as next-generation##2##8##(2011-3#2)
discovery and development of##4##4##(2007-2#1)(2010-8#1)(2011-3#2)
discovery and validation##2##3##(2008-10#1)(2010-11#1)
discovery and##30##2##(1997-1#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#5)(2012-12#2)(2012-3#1)(2013-8#1)
discovery from##2##2##(2008-10#1)(2008-7#1)
discovery in the##6##3##(2008-2#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
discovery in##15##2##(1990-5#1)(1991-7#1)(1994-9#1)(1995-12#1)(2008-2#2)(2008-7#2)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
discovery is##3##2##(2010-5#1)(2010-7#1)(2012-2#1)
discovery of a##12##3##(1990-12#1)(1991-7#1)(1992-6#1)(1993-3#1)(1996-4#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
discovery of conserved##2##3##(2008-4#2)
discovery of genes##2##3##(2008-7#1)(2011-1#1)
discovery of multiple##4##3##(1991-2#1)(2008-10#1)(2009-5#1)(2012-3#1)
discovery of new##5##3##(2008-10#2)(2009-12#1)(2011-2#1)(2011-3#1)
discovery of novel##8##3##(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
discovery of numerous##2##3##(2008-7#1)(2008-8#1)
discovery of potent and##2##4##(2008-11#1)(2008-5#1)
discovery of the##29##3##(1991-8#1)(1993-5#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
discovery of two##2##3##(1995-8#1)(2007-8#1)
discovery of##145##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-5#2)(1994-11#2)(1994-2#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#6)(2009-6#2)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#3)(2011-1#4)(2011-2#7)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#3)(2013-8#1)
discovery process##5##2##(1995-12#1)(2008-10#2)(2008-7#1)(2010-5#1)
discovery that##10##2##(1994-11#1)(1994-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-4#1)(2009-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
discovery to##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
discovery was##2##2##(1994-11#1)(2010-12#1)
discovery with##2##2##(2009-9#1)(2013-8#1)
discovery##320##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-7#4)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-5#2)(1994-11#4)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#5)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#13)(2008-5#4)(2008-6#4)(2008-7#23)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-5#6)(2009-6#4)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#5)(2010-4#2)(2010-5#11)(2010-6#3)(2010-7#9)(2010-8#1)(2011-1#8)(2011-2#10)(2011-3#12)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#10)(2013-1#6)(2013-8#6)
discreet##7##1##(1996-1#1)(2008-10#3)(2009-3#2)(2011-2#1)
discrepancies between the##5##3##(1994-12#1)(1995-3#1)(2008-1#1)(2008-3#1)(2011-2#1)
discrepancies between##20##2##(1990-6#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-9#2)(2011-2#1)(2012-1#1)
discrepancies from##3##2##(2008-3#2)(2008-8#1)
discrepancies in the##2##3##(2008-7#1)(2012-1#1)
discrepancies in##7##2##(2008-10#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)
discrepancies##47##1##(1990-6#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#2)(1997-2#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#9)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-7#1)(2013-8#1)
discrepancy between the##9##3##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-3#2)
discrepancy between##18##2##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1995-1#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-6#1)
discrepancy in the##3##3##(2007-11#1)(2008-3#1)(2010-6#1)
discrepancy in##10##2##(1993-3#1)(1993-9#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-6#1)
discrepancy is probably##2##3##(2008-3#1)(2008-8#1)
discrepancy is##8##2##(1993-11#1)(1993-9#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
discrepancy of the##2##3##(2008-3#2)
discrepancy of##4##2##(2008-3#2)(2011-2#2)
discrepancy principle##2##2##(2008-2#2)
discrepancy##64##1##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#3)(1993-3#1)(1993-9#3)(1994-2#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-4#2)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#2)(2008-8#3)(2009-2#1)(2009-3#3)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
discrepant analysis##3##2##(1996-8#2)(2011-2#1)
discrepant results##4##2##(1992-6#1)(1996-8#1)(2010-5#1)(2011-2#1)
discrepant##11##1##(1992-6#1)(1994-2#1)(1996-8#3)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)
discrete Fourier transform##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)
discrete Fourier##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)
discrete and##3##2##(1995-12#1)(2007-11#1)(2008-4#1)
discrete bands##2##2##(1991-9#1)(2008-4#1)
discrete bottle##2##2##(2008-3#2)
discrete brain regions##3##3##(1991-1#1)(1995-2#1)(1996-12#1)
discrete classes of##2##3##(1997-4#1)(2008-8#1)
discrete clusters##2##2##(1996-12#1)(2008-10#1)
discrete data##2##2##(2008-10#1)(2009-9#1)
discrete density##2##2##(1995-3#1)(2008-3#1)
discrete foci##2##2##(2008-10#1)(2008-3#1)
discrete hierarchy of##2##3##(1996-4#2)
discrete injections##2##2##(1992-10#1)(2008-10#1)
discrete mortality pockets##2##3##(2008-10#2)
discrete or continuous##2##3##(1994-11#1)(2008-10#1)
discrete ordinates##5##2##(2008-2#4)(2008-3#1)
discrete parameter variations##2##3##(2008-3#2)
discrete phase##2##2##(2007-11#1)(2008-3#1)
discrete points in##2##3##(1997-3#1)(2008-10#1)
discrete regions of the##2##4##(1992-10#1)(1995-6#1)
discrete sample##2##2##(2008-10#2)
discrete sampling##2##2##(2008-10#1)(2008-3#1)
discrete scatterers##2##2##(2008-3#2)
discrete steps##3##2##(2007-11#1)(2008-11#1)(2008-5#1)
discrete##197##1##(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#3)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#3)(1996-4#5)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(2006-4#1)(2007-11#14)(2007-12#8)(2007-8#1)(2008-1#4)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#30)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#7)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
discrete-event##2##1##(2008-8#2)
discrete-time##6##1##(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2011-2#1)
discretely##2##1##(2008-3#1)(2008-5#1)
discretion in##2##2##(1992-2#1)(2010-9#1)
discretion to##2##2##(1997-6#1)(2011-2#1)
discretion##8##1##(1992-2#1)(1995-9#1)(1996-9#1)(1997-6#1)(2010-9#1)(2011-2#3)
discretionary##3##1##(1994-3#1)(2008-11#1)(2008-12#1)
discretization##9##1##(2007-12#1)(2008-2#2)(2008-3#5)(2013-8#1)
discriminability##5##1##(1992-11#1)(2008-3#1)(2011-2#3)
discriminant analyses in##2##3##(1991-12#2)
discriminant analyses##3##2##(1991-12#2)(2008-10#1)
discriminant analysis and artificial neural networks##3##6##(2008-10#3)
discriminant analysis and##8##3##(2007-11#1)(2008-10#5)(2008-5#2)
discriminant analysis identified##2##3##(1991-12#1)(2008-10#1)
discriminant analysis was performed##2##4##(2008-7#1)(2009-4#1)
discriminant analysis were##2##3##(2008-10#2)
discriminant analysis##47##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1995-8#1)(2007-11#1)(2008-10#31)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-4#1)(2010-8#1)
discriminant equation 'J##2##3##(2008-10#2)
discriminant equation##3##2##(2008-10#3)
discriminant factorial analysis##2##3##(2008-10#2)
discriminant function analysis##7##3##(1992-11#2)(1994-2#1)(1995-6#3)(2008-10#1)
discriminant function##15##2##(1992-11#2)(1993-5#1)(1994-2#1)(1995-6#5)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
discriminant functions were##2##3##(2008-10#2)
discriminant functions##7##2##(2008-10#3)(2008-3#2)(2008-5#2)
discriminant partial least squares##2##4##(2008-10#2)
discriminant test##2##2##(1991-12#2)
discriminant validity##4##2##(2007-12#1)(2008-10#2)(2009-11#1)
discriminant##97##1##(1991-12#7)(1991-2#2)(1992-1#1)(1992-11#3)(1992-2#1)(1993-5#1)(1994-2#1)(1995-6#5)(1995-8#1)(2007-11#3)(2007-12#1)(2008-10#50)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#1)
discriminate against foreign songs recorded at##3##6##(2008-8#3)
discriminate against foreign songs##4##4##(2008-8#4)
discriminate against##8##2##(1990-2#1)(1994-2#1)(1994-3#1)(2008-8#4)(2013-1#1)
discriminate among##2##2##(2009-11#1)(2011-2#1)
discriminate between a##2##3##(1992-10#1)(2010-2#1)
discriminate between tastants##3##3##(2008-11#3)
discriminate between the##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
discriminate between them##2##3##(1990-11#1)(1994-8#1)
discriminate between##46##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#2)(1996-12#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-10#6)(2008-11#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#1)(2011-2#1)
discriminate different##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
discriminate the##5##2##(1993-8#1)(2007-12#1)(2008-7#2)(2011-1#1)
discriminate##113##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-10#2)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-2#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#9)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
discriminated against##4##2##(1995-5#1)(1997-5#2)(2008-10#1)
discriminated between survivors and nonsurvivors##2##5##(1991-6#2)
discriminated between##6##2##(1991-6#2)(1992-10#1)(2008-10#1)(2008-6#1)(2011-10#1)
discriminated by##5##2##(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
discriminated from##5##2##(2008-3#1)(2008-7#2)(2009-6#1)(2012-2#1)
discriminated on the##2##3##(1990-2#1)(2008-10#1)
discriminated##38##1##(1990-2#1)(1990-3#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-5#1)(1995-5#1)(1997-5#2)(1997-6#1)(2008-10#15)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2011-10#1)(2012-2#1)(2013-7#1)
discriminates between##2##2##(2008-4#1)(2010-3#1)
discriminates different##2##2##(1994-8#1)(2009-11#1)
discriminates##8##1##(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-3#1)(2010-3#1)
discriminating ability of lacustrine sockeye##2##5##(2008-5#2)
discriminating ability towards##6##3##(2008-10#6)
discriminating ability##9##2##(2008-10#7)(2008-5#2)
discriminating between##10##2##(1994-5#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)
discriminating concentration of##2##3##(2011-2#2)
discriminating concentration##3##2##(2011-2#3)
discriminating different##2##2##(1990-11#1)(2011-2#1)
discriminating factors##3##2##(2008-10#1)(2010-5#2)
discriminating power##2##2##(2008-10#1)(2011-2#1)
discriminating the##3##2##(2008-10#2)(2009-8#1)
discriminating##57##1##(1990-11#2)(1994-5#1)(1995-11#1)(1995-6#2)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-5#2)(2011-2#6)(2012-1#2)(2013-1#1)
discrimination ability##4##2##(2008-8#1)(2008-9#3)
discrimination against people with##2##4##(1995-12#1)(1995-6#1)
discrimination against women##2##3##(1995-12#1)(2012-12#1)
discrimination against##10##2##(1994-7#1)(1995-12#2)(1995-6#1)(1996-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-12#1)
discrimination algorithm##2##2##(2008-7#2)
discrimination and identification##3##3##(1996-2#1)(2008-9#2)
discrimination and##18##2##(1992-10#1)(1992-12#1)(1993-6#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2010-4#1)
discrimination are##4##2##(1996-3#1)(2007-10#1)(2008-3#1)(2010-4#1)
discrimination at the##2##3##(2011-2#2)
discrimination based on##3##3##(1990-2#1)(2008-2#1)(2008-3#1)
discrimination between different models##2##4##(2008-10#2)
discrimination between different##3##3##(2008-10#3)
discrimination between one component##2##4##(2008-10#2)
discrimination between the##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)
discrimination between##35##2##(1991-12#1)(1991-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-2#1)(2011-2#1)
discrimination but##3##2##(1993-12#1)(2008-12#1)(2008-7#1)
discrimination by##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
discrimination can be##3##3##(2008-10#2)(2008-2#1)
discrimination capability##4##2##(2007-11#1)(2008-3#3)
discrimination from##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
discrimination in a##2##3##(1996-2#1)(2007-11#1)
discrimination in the##4##3##(1990-8#1)(1992-10#1)(1997-5#1)(2008-9#1)
discrimination in##16##2##(1990-8#1)(1991-1#1)(1992-10#2)(1994-8#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#3)(2011-2#1)
discrimination index##2##2##(2011-2#1)(2012-1#1)
discrimination is##6##2##(1993-5#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
discrimination learning in##3##3##(1992-10#1)(1992-12#1)(1993-5#1)
discrimination learning##5##2##(1992-10#1)(1992-12#3)(1993-5#1)
discrimination of a##2##3##(1992-10#1)(2008-2#1)
discrimination of coatings on##2##4##(2008-10#2)
discrimination of the##7##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)
discrimination of##45##2##(1992-10#2)(1993-6#1)(2007-11#1)(2008-10#19)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2010-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
discrimination on##3##2##(1994-1#1)(2008-12#1)(2008-2#1)
discrimination power##11##2##(1995-11#1)(2008-10#2)(2008-12#2)(2011-2#4)(2013-1#2)
discrimination procedure##4##2##(1991-12#1)(1997-7#1)(2008-2#1)(2011-2#1)
discrimination ratio##2##2##(2008-2#2)
discrimination task##5##2##(1992-11#1)(1993-3#1)(1994-3#1)(1995-12#1)(2008-9#1)
discrimination technique##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
discrimination test##3##2##(2008-9#3)
discrimination tests##2##2##(2008-9#2)
discrimination than##2##2##(2008-12#1)(2008-5#1)
discrimination that##2##2##(2007-11#1)(2012-1#1)
discrimination to##2##2##(2008-10#2)
discrimination using##4##2##(2008-12#1)(2008-4#2)(2008-9#1)
discrimination with##2##2##(2007-12#1)(2008-10#1)
discrimination##295##1##(1990-2#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-10#6)(1992-11#1)(1992-12#5)(1993-12#1)(1993-3#1)(1993-5#5)(1993-6#2)(1994-1#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#6)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#2)(1997-5#4)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-5#2)(2007-8#2)(2008-10#53)(2008-11#3)(2008-12#13)(2008-2#16)(2008-3#26)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#27)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#4)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
discriminations during##2##2##(1993-12#2)
discriminations in##2##2##(1992-10#1)(1994-8#1)
discriminations were##2##2##(1993-12#1)(1993-6#1)
discriminations##12##1##(1992-10#2)(1992-11#1)(1993-12#7)(1993-6#1)(1994-8#1)
discriminative accuracy##8##2##(1992-11#8)
discriminative stimuli##2##2##(1992-10#1)(1997-7#1)
discriminative stimulus effects of##2##4##(1991-1#1)(1997-7#1)
discriminative stimulus effects##4##3##(1991-1#1)(1991-12#2)(1997-7#1)
discriminative stimulus properties##2##3##(1997-7#2)
discriminative stimulus##7##2##(1991-1#1)(1991-12#2)(1997-7#3)(2009-11#1)
discriminative##25##1##(1990-6#1)(1990-7#2)(1991-1#1)(1991-12#2)(1992-10#1)(1992-11#8)(1992-6#1)(1993-12#1)(1997-7#4)(2009-11#1)(2010-4#1)(2010-8#1)(2012-12#1)
discriminator##10##1##(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-8#1)
discriminators##2##1##(1996-3#1)(2008-2#1)
discriminatory ability##2##2##(2008-10#1)(2012-1#1)
discriminatory power of##2##3##(2008-11#1)(2008-12#1)
discriminatory power##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)
discriminatory##18##1##(1993-12#1)(1996-12#1)(1997-5#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2012-1#1)(2012-2#2)(2013-1#1)
discs and##2##2##(2007-11#1)(2012-12#1)
discs containing##2##2##(1997-4#1)(1997-5#1)
discs of##7##2##(2008-10#4)(2008-11#1)(2008-7#1)(2009-4#1)
discs taken from##3##3##(2008-10#3)
discs were##6##2##(2008-10#1)(2008-3#1)(2009-4#2)(2012-3#2)
discs with##5##2##(2008-3#1)(2008-9#1)(2009-7#1)(2012-12#2)
discs##68##1##(1993-2#1)(1994-11#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-11#3)(2007-8#7)(2008-10#14)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#3)(2009-4#8)(2009-7#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-3#7)(2013-8#1)
discs'##2##1##(2007-11#1)(2009-4#1)
discursive##2##1##(2008-7#1)(2009-5#1)
discus##2##1##(2007-8#1)(2008-11#1)
discuss a case##2##3##(1993-9#1)(2013-8#1)
discuss a new##2##3##(2008-2#1)(2011-2#1)
discuss a##21##2##(1990-9#1)(1993-9#1)(1995-2#1)(1997-2#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-8#2)
discuss about the##3##3##(2008-12#1)(2012-2#1)(2012-3#1)
discuss about##5##2##(1993-3#1)(2008-12#1)(2012-2#1)(2012-3#2)
discuss alternative##2##2##(2008-5#1)(2008-8#1)
discuss an##5##2##(2008-2#2)(2008-3#1)(2008-9#1)(2013-8#1)
discuss and##3##2##(2006-10#1)(2008-10#2)
discuss aspects##2##2##(2008-11#1)(2013-1#1)
discuss briefly the##2##3##(2012-1#1)(2012-2#1)
discuss briefly##3##2##(1992-6#1)(2012-1#1)(2012-2#1)
discuss clinical##3##2##(2008-11#1)(2013-1#2)
discuss current issues##2##3##(2008-7#1)(2012-2#1)
discuss current##7##2##(2008-3#2)(2008-7#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-2#1)
discuss design##2##2##(2007-12#1)(2008-3#1)
discuss different aspects##2##3##(1997-3#1)(2008-11#1)
discuss different##4##2##(1991-11#1)(1992-9#1)(1997-3#1)(2008-11#1)
discuss each##2##2##(2012-12#1)(2013-8#1)
discuss factors##2##2##(1993-2#1)(2008-2#1)
discuss future##3##2##(2008-7#1)(2009-3#1)(2011-2#1)
discuss here the##2##3##(2008-10#1)(2011-1#1)
discuss here##3##2##(2008-10#1)(2010-11#1)(2011-1#1)
discuss how advances in##2##4##(2008-7#1)(2008-8#1)
discuss how errors##2##3##(2008-3#1)(2009-3#1)
discuss how the##8##3##(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)(2013-8#1)
discuss how these##4##3##(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
discuss how to##5##3##(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
discuss how##39##2##(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-8#2)
discuss in detail the##2##4##(2008-2#1)(2012-2#1)
discuss in##6##2##(1994-12#1)(2007-8#1)(2008-2#1)(2009-8#1)(2012-2#2)
discuss indications##2##2##(1992-9#1)(1994-6#1)
discuss issues relevant to##2##4##(1992-12#1)(2010-8#1)
discuss issues##5##2##(1992-12#1)(2007-11#1)(2010-11#1)(2010-8#1)(2011-2#1)
discuss its##9##2##(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-7#1)
discuss many##2##2##(2011-2#1)(2012-2#1)
discuss new##5##2##(1996-12#1)(2008-7#1)(2011-2#1)(2012-2#2)
discuss on##2##2##(2011-2#1)(2013-1#1)
discuss our current understanding of##2##5##(2012-1#1)(2012-12#1)
discuss our findings##2##3##(2008-9#1)(2009-11#1)
discuss our##14##2##(1992-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#2)(2012-1#1)(2012-12#1)(2012-3#1)
discuss possible explanations##2##3##(1991-11#1)(1993-11#1)
discuss possible##11##2##(1991-11#1)(1993-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#2)(2010-3#1)(2012-1#1)
discuss potential##7##2##(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
discuss practical##2##2##(2007-11#1)(2009-9#1)
discuss problems##2##2##(1991-3#1)(2008-2#1)
discuss recent advances in the##3##5##(2008-9#1)(2009-12#1)(2012-12#1)
discuss recent advances in##5##4##(1994-3#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-12#1)
discuss recent advances##6##3##(1994-3#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
discuss recent studies##2##3##(2009-6#1)(2011-2#1)
discuss recent##14##2##(1994-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
discuss results##3##2##(1996-9#1)(2008-3#1)(2008-8#1)
discuss several factors##2##3##(2008-2#1)(2008-7#1)
discuss several##11##2##(1994-2#2)(1995-9#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#3)
discuss some of the##9##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)
discuss some of##12##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)
discuss some##20##2##(1991-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)
discuss specific##3##2##(2008-10#1)(2009-5#1)(2012-3#1)
discuss spinal##2##2##(2007-5#1)(2012-12#1)
discuss that##3##2##(1991-6#1)(2008-7#1)(2009-6#1)
discuss the advantages and limitations of##3##6##(2008-1#1)(2008-9#1)(2012-3#1)
discuss the advantages and##4##4##(2008-1#1)(2008-9#1)(2011-2#1)(2012-3#1)
discuss the advantages##5##3##(2008-1#1)(2008-9#1)(2011-2#2)(2012-3#1)
discuss the application of##4##4##(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
discuss the association of##3##4##(2008-8#1)(2010-10#1)(2011-1#1)
discuss the benefits and##2##4##(1993-1#1)(2011-2#1)
discuss the benefits##3##3##(1993-1#1)(2008-9#1)(2011-2#1)
discuss the case of a##3##5##(1992-12#1)(2008-9#1)(2011-2#1)
discuss the case of##4##4##(1991-2#1)(1992-12#1)(2008-9#1)(2011-2#1)
discuss the case##5##3##(1991-2#1)(1992-12#1)(2008-9#1)(2011-2#2)
discuss the cause##2##3##(1996-6#1)(2007-10#1)
discuss the characteristics of##3##4##(2008-11#1)(2008-2#1)(2011-1#1)
discuss the choice of##2##4##(2008-3#1)(2012-2#1)
discuss the clinical##3##3##(2007-5#1)(2008-8#1)(2009-8#1)
discuss the conditions##2##3##(2007-12#1)(2008-2#1)
discuss the current knowledge##2##4##(2008-11#1)(2008-5#1)
discuss the current##5##3##(1996-2#1)(2008-11#2)(2008-5#1)(2012-3#1)
discuss the data##2##3##(1990-11#1)(2008-1#1)
discuss the design##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
discuss the development of the##2##5##(2008-11#1)(2010-5#1)
discuss the development of##5##4##(2008-10#1)(2008-11#2)(2008-2#1)(2010-5#1)
discuss the diagnosis##3##3##(1990-9#1)(1995-8#1)(2008-10#1)
discuss the diagnostic##4##3##(1990-9#1)(2008-6#1)(2010-8#1)(2013-1#1)
discuss the distribution##2##3##(1996-2#1)(2012-2#1)
discuss the effect of##4##4##(1995-5#1)(2007-11#1)(2008-3#2)
discuss the effects of##3##4##(2008-10#1)(2008-3#2)
discuss the epidemiology##3##3##(2008-9#1)(2009-4#1)(2011-2#1)
discuss the evidence##2##3##(2008-1#1)(2010-2#1)
discuss the evolution of##3##4##(2008-2#2)(2009-8#1)
discuss the findings of##2##4##(2008-12#1)(2013-1#1)
discuss the functional significance of##2##5##(2008-7#1)(2009-5#1)
discuss the impact of##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
discuss the impact##4##3##(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
discuss the implications for##2##4##(2008-9#1)(2010-5#1)
discuss the implications of the##2##5##(2007-11#1)(2008-8#1)
discuss the implications of##10##4##(1994-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-2#1)
discuss the implications##12##3##(1994-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)
discuss the importance of##6##4##(2008-11#2)(2010-4#1)(2011-2#2)(2012-12#1)
discuss the importance##7##3##(1991-6#1)(2008-11#2)(2010-4#1)(2011-2#2)(2012-12#1)
discuss the influence##2##3##(2008-11#1)(2008-2#1)
discuss the key##2##3##(1994-12#1)(2008-11#1)
discuss the late##2##3##(2008-7#1)(2011-1#1)
discuss the latest##2##3##(2008-5#1)(2009-9#1)
discuss the main##2##3##(1996-12#1)(2008-10#1)
discuss the major##5##3##(1991-12#1)(2008-5#3)(2010-9#1)
discuss the manner in which the##2##6##(1994-2#1)(2008-2#1)
discuss the mechanisms##2##3##(2010-8#1)(2012-12#1)
discuss the methodological##2##3##(2008-10#1)(2008-8#1)
discuss the molecular mechanisms of##2##5##(2008-1#1)(2008-9#1)
discuss the most##4##3##(1997-3#1)(2008-8#1)(2009-10#1)(2010-7#1)
discuss the need for##2##4##(1993-12#1)(2011-1#1)
discuss the need##3##3##(1993-12#1)(2009-8#1)(2011-1#1)
discuss the pathology##2##3##(1997-3#1)(2011-2#1)
discuss the possibility of##4##4##(2008-2#1)(2009-5#1)(2011-1#1)(2013-8#1)
discuss the possibility that##5##4##(1991-4#1)(1991-5#1)(1993-12#1)(2009-8#1)(2011-2#1)
discuss the possibility##9##3##(1991-4#1)(1991-5#1)(1993-12#1)(2008-2#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
discuss the possible role of##3##5##(1992-5#1)(1992-8#1)(2008-7#1)
discuss the possible##15##3##(1992-5#1)(1992-8#1)(1994-11#1)(1995-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
discuss the potential of##2##4##(2008-3#1)(2011-1#1)
discuss the potential role of##2##5##(2008-7#1)(2012-3#1)
discuss the potential##10##3##(2008-3#1)(2008-7#2)(2009-5#1)(2009-8#2)(2011-1#2)(2012-3#1)(2013-8#1)
discuss the principles and##2##4##(2007-11#1)(2007-12#1)
discuss the problem of##5##4##(1993-5#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
discuss the relationship between the##3##5##(2007-11#1)(2010-12#1)(2011-2#1)
discuss the relationship between##4##4##(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
discuss the relationship##5##3##(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
discuss the relevance of##2##4##(2009-6#1)(2010-2#1)
discuss the results in terms of the##2##7##(1994-2#1)(2007-12#1)
discuss the results in##3##4##(1994-2#1)(2007-12#1)(2008-10#1)
discuss the results of##2##4##(1995-2#1)(2013-8#1)
discuss the results##6##3##(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
discuss the role of##12##4##(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#4)
discuss the role##13##3##(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
discuss the roles of##2##4##(2008-7#1)(2009-3#1)
discuss the significance of##3##4##(2008-3#1)(2009-1#1)(2013-8#1)
discuss the specific##2##3##(1994-1#1)(2007-12#1)
discuss the strengths and##2##4##(2009-4#1)(2012-2#1)
discuss the underlying##2##3##(2008-3#1)(2012-2#1)
discuss the use of##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
discuss the utility of this##2##5##(2008-3#1)(2010-5#1)
discuss the various##3##3##(2008-10#1)(2009-12#1)(2011-7#1)
discuss the##393##2##(1990-11#1)(1990-2#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#2)(2007-10#1)(2007-11#9)(2007-12#12)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#17)(2008-11#16)(2008-12#5)(2008-2#25)(2008-3#32)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#20)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#4)(2009-8#13)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#12)(2011-2#27)(2011-7#1)(2012-1#1)(2012-12#11)(2012-2#9)(2012-3#8)(2013-1#12)(2013-7#2)(2013-8#11)
discuss their potential##2##3##(2008-7#1)(2009-8#1)
discuss their##19##2##(1991-6#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
discuss these findings in##2##4##(2008-8#1)(2009-8#1)
discuss these findings##3##3##(2008-3#1)(2008-8#1)(2009-8#1)
discuss these issues and##2##4##(2009-9#1)(2010-11#1)
discuss these issues##3##3##(2008-10#1)(2009-9#1)(2010-11#1)
discuss these results in the context of##2##7##(2008-7#1)(2008-8#1)
discuss these##17##2##(1995-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)
discuss this##9##2##(1990-9#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2012-3#1)
discuss to what##2##3##(2007-5#1)(2009-8#1)
discuss two cases##2##3##(1996-3#1)(2007-11#1)
discuss two##7##2##(1996-3#1)(2007-11#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)
discuss various aspects of##3##4##(2007-7#1)(2010-8#2)
discuss various##9##2##(1991-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2010-8#2)
discuss ways of##2##3##(2008-11#1)(2008-3#1)
discuss ways to##3##3##(1991-2#1)(2007-4#1)(2008-2#1)
discuss ways##5##2##(1991-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
discuss why##3##2##(1992-12#1)(2008-12#1)(2012-3#1)
discuss##815##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#4)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#4)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#3)(2007-11#17)(2007-12#25)(2007-4#3)(2007-5#6)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#8)(2008-10#37)(2008-11#39)(2008-12#10)(2008-2#40)(2008-3#59)(2008-4#12)(2008-5#9)(2008-6#8)(2008-7#47)(2008-8#27)(2008-9#28)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#12)(2009-6#11)(2009-7#1)(2009-8#26)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#7)(2010-12#5)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#7)(2010-8#9)(2010-9#5)(2011-1#16)(2011-2#49)(2011-7#1)(2012-1#5)(2012-12#16)(2012-2#23)(2012-3#19)(2012-8#1)(2013-1#22)(2013-7#3)(2013-8#19)
discussed according to the##2##4##(1997-4#1)(2012-1#1)
discussed according to##3##3##(1997-4#1)(2010-3#1)(2012-1#1)
discussed along with literature##2##4##(1992-3#1)(2007-11#1)
discussed along with the##3##4##(1993-3#1)(2008-8#1)(2012-2#1)
discussed along with##11##3##(1992-3#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#1)
discussed and a##3##3##(1997-1#1)(2008-10#1)(2011-7#1)
discussed and compared with the##3##5##(1993-12#1)(1994-11#1)(2008-2#1)
discussed and compared with those##4##5##(1993-11#1)(2008-10#2)(2008-3#1)
discussed and compared with##9##4##(1993-11#1)(1993-12#1)(1994-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
discussed and compared##13##3##(1993-11#1)(1993-12#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-9#1)(2010-3#1)
discussed and demonstrated experimentally##2##4##(2007-11#1)(2008-3#1)
discussed and demonstrated##3##3##(2007-11#1)(2008-3#2)
discussed and illustrated with##2##4##(2008-10#1)(2012-2#1)
discussed and illustrated##3##3##(2008-10#1)(2012-2#2)
discussed and the##15##3##(1991-5#1)(1993-5#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#6)(2008-7#3)(2012-12#1)
discussed and##75##2##(1990-3#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#15)(2008-12#3)(2008-2#5)(2008-3#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
discussed are##12##2##(1990-8#1)(1992-12#1)(1994-1#2)(1994-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
discussed as a##5##3##(1995-3#1)(2007-11#1)(2008-10#1)(2009-6#1)(2013-8#1)
discussed as the##2##3##(1996-6#1)(2009-8#1)
discussed as well as##6##4##(1991-1#1)(2007-11#1)(2008-10#3)(2008-5#1)
discussed as well##9##3##(1991-1#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)
discussed as##30##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1995-3#1)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
discussed at the##2##3##(2008-5#1)(2013-8#1)
discussed at##6##2##(1994-12#1)(1995-6#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-8#1)
discussed based on the##3##4##(2008-10#2)(2010-3#1)
discussed based on##4##3##(1995-5#1)(2008-10#2)(2010-3#1)
discussed both in##2##3##(1991-3#1)(1996-1#1)
discussed both##3##2##(1991-3#1)(1996-1#1)(2008-3#1)
discussed briefly##8##2##(1991-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)
discussed by comparing the##2##4##(2008-5#1)(2010-4#1)
discussed by comparing##3##3##(2008-5#2)(2010-4#1)
discussed by##8##2##(1991-3#1)(1992-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-4#1)
discussed for##13##2##(1991-9#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#4)(2013-1#1)
discussed from a##2##3##(2008-7#1)(2010-11#1)
discussed from the##3##3##(2008-10#1)(2008-3#2)
discussed from##6##2##(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-11#1)
discussed group##2##2##(2007-11#2)
discussed here in##2##3##(1994-5#1)(1997-6#1)
discussed here##14##2##(1993-8#1)(1994-12#1)(1994-5#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-5#1)(2012-12#1)
discussed herein##4##2##(1992-3#1)(1993-2#1)(2008-3#1)(2011-2#1)
discussed how the##2##3##(1995-5#1)(2008-10#1)
discussed how##5##2##(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#1)
discussed in Part I##2##4##(1992-3#1)(2007-5#1)
discussed in Part##3##3##(1992-3#1)(2007-5#1)(2008-7#1)
discussed in a##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
discussed in connection with##7##4##(1990-8#1)(1994-6#2)(2008-10#1)(2008-11#1)(2008-3#2)
discussed in detail and##2##4##(2007-2#1)(2008-3#1)
discussed in detail##40##3##(1990-2#1)(1991-4#1)(1992-6#1)(1993-2#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#16)(2008-2#2)(2008-3#9)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)
discussed in details##3##3##(2008-10#2)(2008-8#1)
discussed in light of recent##2##5##(2011-2#1)(2012-12#1)
discussed in light of the##8##5##(1993-11#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-5#1)(2010-7#1)(2013-1#2)
discussed in light of##17##4##(1993-11#1)(1994-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
discussed in order to##5##4##(1990-8#1)(1994-11#1)(2008-4#1)(2008-8#1)(2013-7#1)
discussed in regard to##2##4##(1991-12#1)(1992-12#1)
discussed in relation to other##2##5##(1993-11#1)(2008-10#1)
discussed in relation to the##19##5##(1990-12#2)(1992-12#1)(1994-2#1)(1995-12#1)(1996-4#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2012-2#1)
discussed in relation to##38##4##(1990-12#2)(1990-7#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)
discussed in relation##39##3##(1990-12#2)(1990-7#1)(1990-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)
discussed in some detail##4##4##(1992-4#1)(1994-11#1)(2008-5#1)(2012-1#1)
discussed in terms of protein##2##5##(1991-3#1)(2009-8#1)
discussed in terms of the##22##5##(1990-11#1)(1990-7#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-1#1)
discussed in terms of##56##4##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-6#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#1)
discussed in the article##3##4##(1994-12#1)(1997-6#1)(2011-3#1)
discussed in the context of the##4##6##(2007-11#1)(2007-12#1)(2008-6#1)(2010-1#1)
discussed in the context of##25##5##(1990-11#1)(1990-7#1)(1992-6#1)(1993-11#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
discussed in the light of the##6##6##(1990-8#1)(1993-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
discussed in the light of##16##5##(1990-12#1)(1990-8#1)(1990-9#1)(1991-4#1)(1993-3#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-5#1)(2012-2#1)(2012-3#1)
discussed in the literature##6##4##(2008-10#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#1)
discussed in the present paper##2##5##(2008-10#2)
discussed in the present##5##4##(1993-11#1)(1995-8#1)(2008-10#2)(2008-8#1)
discussed in the##67##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-4#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#10)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#1)
discussed in this article##12##4##(1994-3#1)(1997-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#2)(2013-1#1)
discussed in this overview##3##4##(2008-4#3)
discussed in this paper##14##4##(1990-11#1)(1992-1#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2012-2#2)
discussed in this review##9##4##(2008-10#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-5#2)(2010-7#1)(2010-8#1)(2012-1#1)
discussed in this##50##3##(1990-11#1)(1992-1#1)(1993-6#1)(1994-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#4)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#3)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
discussed in turn##2##3##(2006-4#1)(2013-1#1)
discussed in view of the##2##5##(1994-6#1)(1996-4#1)
discussed in view of##3##4##(1994-6#1)(1996-4#1)(2008-5#1)
discussed in which##2##3##(2008-10#1)(2008-4#1)
discussed in##325##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-4#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#6)(2008-10#60)(2008-11#11)(2008-12#8)(2008-2#11)(2008-3#22)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#12)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#3)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
discussed include##8##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)
discussed including the##2##3##(2008-10#1)(2008-3#1)
discussed including##4##2##(2008-10#2)(2008-3#1)(2010-6#1)
discussed on the basis of the##4##6##(1994-6#1)(2008-10#1)(2008-5#1)(2009-6#1)
discussed on the basis of##8##5##(1993-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-6#1)
discussed on the##9##3##(1993-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#1)
discussed problems##2##2##(2007-11#1)(2011-2#1)
discussed regarding the##3##3##(2009-7#2)(2010-8#1)
discussed that##7##2##(1994-8#1)(1996-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-1#1)
discussed the potential##2##3##(2008-6#1)(2009-5#1)
discussed the##25##2##(1990-9#1)(1992-3#1)(1994-7#1)(1995-8#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-3#1)(2010-9#1)(2012-3#2)(2013-1#1)
discussed theoretically##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
discussed through##2##2##(2008-11#1)(2008-12#1)
discussed throughout##2##2##(1992-12#1)(1997-1#1)
discussed to illustrate the##2##4##(2008-10#1)(2012-2#1)
discussed to##14##2##(1990-12#1)(1995-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)(2009-2#2)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
discussed using##2##2##(1997-7#1)(2008-10#1)
discussed when##2##2##(2008-3#1)(2010-8#1)
discussed with a##4##3##(1995-11#1)(1995-12#1)(2008-4#1)(2008-8#1)
discussed with an emphasis on##2##5##(2008-11#1)(2010-3#1)
discussed with an##3##3##(1993-3#1)(2008-11#1)(2010-3#1)
discussed with emphasis##3##3##(1997-2#1)(2008-2#1)(2008-5#1)
discussed with reference to##2##4##(2008-12#1)(2011-1#1)
discussed with regard to##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
discussed with respect to the##6##5##(1992-6#1)(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-8#1)
discussed with respect to##15##4##(1992-3#1)(1992-6#1)(1993-8#1)(1994-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-8#1)
discussed with respect##16##3##(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-8#1)
discussed with the##2##3##(1997-5#1)(2007-10#1)
discussed with##45##2##(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
discussed within the##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
discussed within##5##2##(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
discussed##2165##1##(1990-11#4)(1990-12#8)(1990-2#5)(1990-3#2)(1990-5#6)(1990-6#10)(1990-7#5)(1990-8#11)(1990-9#11)(1991-1#4)(1991-11#4)(1991-12#15)(1991-2#9)(1991-3#8)(1991-4#3)(1991-5#6)(1991-6#4)(1991-8#6)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#8)(1992-3#12)(1992-4#1)(1992-5#6)(1992-6#9)(1992-8#5)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#10)(1993-12#17)(1993-2#4)(1993-3#11)(1993-5#1)(1993-6#12)(1993-8#10)(1993-9#5)(1994-1#10)(1994-10#1)(1994-11#8)(1994-12#7)(1994-2#12)(1994-3#8)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#5)(1995-11#9)(1995-12#11)(1995-2#8)(1995-3#11)(1995-5#6)(1995-6#6)(1995-8#4)(1995-9#2)(1996-1#8)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#16)(1996-3#9)(1996-4#3)(1996-5#6)(1996-6#4)(1996-8#2)(1996-9#2)(1997-1#13)(1997-2#10)(1997-3#12)(1997-4#7)(1997-5#3)(1997-6#8)(1997-7#8)(1997-8#4)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#50)(2007-12#69)(2007-2#3)(2007-4#3)(2007-5#5)(2007-6#5)(2007-7#7)(2007-8#13)(2008-1#25)(2008-10#415)(2008-11#71)(2008-12#40)(2008-2#96)(2008-3#186)(2008-4#57)(2008-5#47)(2008-6#21)(2008-7#74)(2008-8#49)(2008-9#32)(2009-1#1)(2009-10#5)(2009-11#12)(2009-12#12)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#10)(2009-6#5)(2009-7#10)(2009-8#18)(2009-9#15)(2010-1#3)(2010-10#6)(2010-11#11)(2010-12#9)(2010-2#9)(2010-3#12)(2010-4#5)(2010-5#7)(2010-6#2)(2010-7#8)(2010-8#11)(2010-9#6)(2011-1#11)(2011-2#38)(2011-3#6)(2011-7#5)(2012-1#11)(2012-12#14)(2012-2#28)(2012-3#8)(2012-4#1)(2013-1#47)(2013-7#5)(2013-8#18)
discusses a##10##2##(1994-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)
discusses an##2##2##(2008-4#1)(2010-12#1)
discusses and##2##2##(1997-2#1)(2012-12#1)
discusses current##2##2##(2007-8#1)(2008-7#1)
discusses four##2##2##(1992-3#1)(2008-4#1)
discusses how the use of##2##5##(1993-2#1)(2010-3#1)
discusses how the##7##3##(1992-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(2008-4#1)(2010-3#1)
discusses how to##5##3##(1991-3#1)(2008-4#4)
discusses how##28##2##(1991-3#2)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-4#6)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#1)
discusses in##2##2##(2008-9#1)(2010-7#1)
discusses indications##2##2##(2007-12#1)(2011-2#1)
discusses issues##2##2##(2008-1#1)(2008-9#1)
discusses mass spectral##2##3##(2011-2#2)
discusses new##2##2##(2006-10#1)(2008-1#1)
discusses one##2##2##(2008-12#1)(2010-7#1)
discusses possible mechanisms of##2##4##(1997-4#1)(2007-11#1)
discusses possible##6##2##(1997-4#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-8#1)
discusses practical##2##2##(1991-11#1)(2008-10#1)
discusses recent advances in the field##2##6##(2008-9#1)(2010-12#1)
discusses recent advances in##3##4##(2008-9#1)(2010-10#1)(2010-12#1)
discusses recent##10##2##(1992-12#1)(1996-1#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
discusses several##4##2##(1992-3#1)(2008-1#1)(2008-10#1)(2012-2#1)
discusses some of the legal##2##5##(1991-12#1)(1992-3#1)
discusses some of the major##2##5##(2008-12#1)(2011-2#1)
discusses some of the##17##4##(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
discusses some of##18##3##(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
discusses some##19##2##(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
discusses techniques##2##2##(2008-10#1)(2008-9#1)
discusses the advantages and disadvantages of the##2##7##(2008-10#2)
discusses the advantages and disadvantages of##3##6##(2008-10#2)(2008-4#1)
discusses the application of##4##4##(1995-9#1)(1996-12#1)(2008-10#1)(2008-11#1)
discusses the aspects of##2##4##(2008-11#1)(2011-2#1)
discusses the background##2##3##(1994-3#1)(2011-1#1)
discusses the clinical and##2##4##(2007-8#1)(2008-11#1)
discusses the conceptual##2##3##(1993-3#1)(1997-2#1)
discusses the contribution##2##3##(2007-7#1)(2013-1#1)
discusses the current status of##2##5##(2008-10#1)(2008-11#1)
discusses the current##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)
discusses the development and##3##4##(1996-3#1)(2008-10#1)(2012-2#1)
discusses the development of a##2##5##(1997-3#1)(2009-7#1)
discusses the development of##4##4##(1991-3#1)(1997-3#1)(2009-10#1)(2009-7#1)
discusses the development##8##3##(1991-3#1)(1996-3#1)(1997-3#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#1)
discusses the effect of##2##4##(1993-1#1)(2008-7#1)
discusses the general##5##3##(1996-8#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
discusses the history of##2##4##(2008-12#1)(2013-1#1)
discusses the importance of##6##4##(1994-2#1)(1997-2#1)(2008-11#3)(2011-2#1)
discusses the indications for##3##4##(1990-11#1)(1990-9#1)(2008-7#1)
discusses the issue of##2##4##(2006-10#1)(2008-4#1)
discusses the issues##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
discusses the life##2##3##(2008-2#1)(2008-9#1)
discusses the literature##2##3##(2008-11#1)(2011-2#1)
discusses the medical##2##3##(1993-11#1)(2013-1#1)
discusses the need for##2##4##(1993-3#1)(1997-3#1)
discusses the potential##6##3##(1992-1#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
discusses the principles##3##3##(2008-10#1)(2008-9#2)
discusses the process##2##3##(1996-2#1)(2008-7#1)
discusses the rationale for##2##4##(1993-1#1)(2008-9#1)
discusses the reasons why##2##4##(2008-6#1)(2010-4#1)
discusses the receptors##2##3##(2008-4#2)
discusses the requirements##2##3##(1993-1#1)(1993-3#1)
discusses the role of the##2##5##(1990-12#1)(1991-9#1)
discusses the role of##10##4##(1990-12#1)(1991-9#1)(1994-11#1)(1995-6#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
discusses the role##11##3##(1990-12#1)(1991-9#1)(1994-11#1)(1995-6#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
discusses the use of##7##4##(1994-2#1)(1995-2#1)(1996-1#2)(2009-11#1)(2011-2#1)(2013-1#1)
discusses the##241##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#5)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#4)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#2)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#18)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#16)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#17)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#2)
discusses their##7##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
discusses these##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
discusses this##4##2##(1996-3#1)(2008-12#1)(2010-10#1)(2012-1#1)
discusses two##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
discusses various##3##2##(1991-12#1)(1994-6#1)(2011-2#1)
discusses what##2##2##(1996-2#1)(2010-12#1)
discusses why##5##2##(1992-12#1)(1992-2#1)(1993-2#1)(1996-12#1)(1996-2#1)
discusses##474##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#8)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-12#5)(1992-2#7)(1992-3#4)(1992-6#2)(1993-1#5)(1993-11#1)(1993-12#6)(1993-2#7)(1993-3#10)(1993-6#2)(1994-1#5)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#4)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-6#4)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#8)(1996-3#9)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#1)(2006-10#3)(2007-10#4)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#11)(2008-10#18)(2008-11#23)(2008-12#10)(2008-2#3)(2008-3#5)(2008-4#40)(2008-5#5)(2008-6#6)(2008-7#13)(2008-8#3)(2008-9#43)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#13)(2013-8#5)
discussing how to##2##3##(1991-1#1)(1994-1#1)
discussing how##3##2##(1991-1#1)(1994-1#1)(2008-8#1)
discussing its##2##2##(2010-4#1)(2012-2#1)
discussing recent##2##2##(2008-4#1)(2008-7#1)
discussing some of##2##3##(1995-3#1)(1996-2#1)
discussing some##3##2##(1995-3#1)(1996-2#1)(2010-8#1)
discussing the case##2##3##(1994-7#1)(2008-6#1)
discussing the results##2##3##(2008-10#1)(2008-3#1)
discussing the##23##2##(1990-9#1)(1993-2#1)(1994-7#1)(1995-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-3#1)
discussing##59##1##(1990-9#1)(1991-1#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-7#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
discussion about the##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
discussion about##6##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
discussion among##2##2##(1996-1#1)(2013-1#1)
discussion and##11##2##(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
discussion are##2##2##(1995-5#1)(2008-11#1)
discussion as a##2##3##(1992-11#1)(2013-1#1)
discussion as to whether##2##4##(1992-4#1)(2008-2#1)
discussion as to##3##3##(1992-4#1)(2008-2#1)(2008-7#1)
discussion as##5##2##(1992-11#1)(1992-4#1)(2008-2#1)(2008-7#1)(2013-1#1)
discussion at##2##2##(2008-10#1)(2008-8#1)
discussion between##2##2##(2008-11#1)(2013-8#1)
discussion concerning##3##2##(2010-1#1)(2010-11#2)
discussion focuses on##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
discussion focuses##4##2##(1993-9#1)(2008-10#1)(2008-3#1)(2010-10#1)
discussion groups in##2##3##(1996-11#1)(2008-11#1)
discussion groups##8##2##(1994-12#1)(1996-1#1)(1996-11#1)(2008-11#4)(2012-2#1)
discussion has been##2##3##(1994-2#1)(2007-11#1)
discussion in the##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
discussion in##9##2##(1995-11#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
discussion includes##4##2##(1996-12#1)(2008-4#1)(2010-11#1)(2013-8#1)
discussion is based on##4##4##(1991-6#1)(2008-12#1)(2008-8#1)(2013-1#1)
discussion is##12##2##(1991-3#1)(1991-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2013-1#1)
discussion of a##2##3##(1992-1#1)(2008-4#1)
discussion of data##3##3##(2008-4#1)(2009-8#1)(2009-9#1)
discussion of findings##2##3##(1992-3#1)(2011-2#1)
discussion of future directions##2##4##(2008-9#1)(2013-8#1)
discussion of how##8##3##(1996-3#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-10#1)(2012-1#1)
discussion of its##4##3##(1992-1#1)(1994-2#1)(2009-7#1)(2013-1#1)
discussion of methods for##2##4##(2008-4#1)(2008-9#1)
discussion of our##2##3##(2009-8#1)(2012-12#1)
discussion of possible##4##3##(1991-2#1)(1995-12#1)(2008-3#1)(2012-2#1)
discussion of some of the##5##5##(1993-2#1)(1996-2#1)(1997-3#1)(2008-4#1)(2008-8#1)
discussion of some of##6##4##(1993-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-4#1)(2008-8#1)
discussion of the development of##2##5##(2008-11#1)(2009-9#1)
discussion of the importance of##2##5##(2010-12#1)(2012-1#1)
discussion of the principles of##2##5##(1997-3#1)(2008-9#1)
discussion of the##63##3##(1990-5#1)(1991-1#2)(1992-3#2)(1992-9#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#6)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
discussion of their##8##3##(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2010-6#1)(2012-3#1)(2013-1#1)
discussion of these##2##3##(2008-9#1)(2009-9#1)
discussion of##171##2##(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-6#1)(1992-1#3)(1992-2#1)(1992-3#5)(1992-9#1)(1993-2#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#14)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#18)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#4)
discussion on how##4##3##(1992-12#1)(2008-10#1)(2008-6#1)(2012-2#1)
discussion on the##16##3##(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
discussion on##35##2##(1992-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
discussion paper##3##2##(2007-5#1)(2008-11#1)(2009-12#1)
discussion to##2##2##(2006-10#1)(2008-3#1)
discussion will explore##2##3##(2008-11#2)
discussion will##7##2##(1992-2#1)(2008-10#2)(2008-11#4)
discussion with the##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
discussion with##7##2##(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
discussion##373##1##(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#4)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#5)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-7#2)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#26)(2008-11#33)(2008-12#12)(2008-2#7)(2008-3#13)(2008-4#17)(2008-5#6)(2008-6#6)(2008-7#5)(2008-8#11)(2008-9#24)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#7)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#18)(2013-8#8)
discussion]##2##1##(2012-2#1)(2013-1#1)
discussions about the##5##3##(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)
discussions about##7##2##(1996-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)
discussions among##2##2##(1994-6#1)(2013-1#1)
discussions and##5##2##(1992-3#1)(1996-3#1)(2009-10#1)(2010-11#1)(2010-3#1)
discussions are##2##2##(1993-8#1)(2008-3#1)
discussions in the field##2##4##(2008-11#1)(2008-9#1)
discussions in##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
discussions of##10##2##(1994-3#1)(1996-2#1)(1996-9#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2012-2#1)
discussions on the##4##3##(1992-12#1)(2008-12#1)(2008-4#1)(2008-9#1)
discussions on##5##2##(1992-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)
discussions were##4##2##(1995-1#1)(2008-7#1)(2010-3#1)(2010-7#1)
discussions with##9##2##(1993-2#1)(2007-7#1)(2008-11#2)(2009-5#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
discussions##83##1##(1992-12#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-5#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-2#1)(2007-7#3)(2008-10#4)(2008-11#12)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
disease (AD) is a##3##4##(2008-7#1)(2012-12#1)(2013-1#1)
disease (AD) is##7##3##(1992-12#1)(1992-9#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
disease (AD)##56##2##(1991-1#1)(1991-11#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#2)(1997-2#2)(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#12)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
disease (ASD)##4##2##(2011-2#1)(2012-12#1)(2012-3#2)
disease (CD) is##2##3##(2011-2#1)(2013-8#1)
disease (CD)##11##2##(1996-2#1)(2008-10#2)(2009-12#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#2)
disease (CLD)##3##2##(1992-2#1)(2008-10#2)
disease (COPD)##27##2##(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-7#1)(2008-1#1)(2008-7#2)(2010-10#1)(2010-5#2)(2011-2#8)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
disease (CVD)##24##2##(2008-1#1)(2008-3#5)(2008-6#1)(2008-7#2)(2009-4#2)(2010-12#2)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
disease (FMD)##2##2##(2009-2#1)(2013-1#1)
disease (HD) gene##2##3##(1996-8#1)(2011-8#1)
disease (HD)##9##2##(1993-9#1)(1995-12#1)(1995-5#1)(1996-8#1)(2008-7#1)(2011-10#1)(2011-2#2)(2011-8#1)
disease (HFMD)##2##2##(2011-1#1)(2013-8#1)
disease (IBD)##9##2##(1997-6#1)(2008-11#1)(2009-12#1)(2010-12#3)(2011-1#1)(2011-2#1)(2013-8#1)
disease (LSD)##2##2##(2007-7#1)(2008-10#1)
disease (MD)##3##2##(1997-6#1)(2008-5#1)(2011-1#1)
disease (OR 2##2##3##(2007-10#1)(2011-1#1)
disease (OR##4##2##(2007-10#2)(2008-3#1)(2011-1#1)
disease (PAD)##3##2##(2008-8#2)(2012-2#1)
disease (PD) and##6##3##(2008-5#1)(2008-6#1)(2008-7#3)(2013-1#1)
disease (PD) is##11##3##(2008-12#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-8#1)(2013-8#1)
disease (PD)##61##2##(1990-2#1)(1990-6#1)(1995-12#1)(1995-5#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#33)(2008-8#1)(2009-10#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
disease (n = 30)##2##4##(1990-8#1)(1993-1#1)
disease (n =##8##3##(1990-8#1)(1992-8#1)(1993-1#1)(2008-11#2)(2008-7#2)(2012-12#1)
disease -##7##2##(2007-12#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
disease 4##2##2##(1991-2#1)(2012-3#1)
disease a##3##2##(1993-3#1)(2008-1#1)(2008-7#1)
disease according to##3##3##(2008-4#1)(2008-6#1)(2012-3#1)
disease accounted for##2##3##(2007-7#1)(2011-2#1)
disease activity and flexibility##3##4##(2008-10#3)
disease activity and##9##3##(2006-10#1)(2008-10#3)(2008-7#1)(2012-1#3)(2012-2#1)
disease activity in##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
disease activity index##3##3##(2010-5#1)(2011-3#1)(2013-8#1)
disease activity indices##2##3##(2011-2#2)
disease activity was##3##3##(2012-1#3)
disease activity##35##2##(1992-3#1)(1997-8#3)(2006-10#2)(2008-10#5)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-1#9)(2012-2#2)(2013-8#2)
disease affecting the##3##3##(1991-11#1)(2008-7#1)(2012-2#1)
disease affecting##10##2##(1991-11#1)(2008-10#6)(2008-7#1)(2009-5#1)(2012-2#1)
disease affects the central nervous system##2##6##(2008-9#2)
disease affects the##3##3##(1994-9#1)(2008-9#2)
disease affects##4##2##(1994-9#1)(1996-5#1)(2008-9#2)
disease after##17##2##(1990-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1993-1#1)(1994-3#1)(1994-5#1)(1996-11#1)(1997-4#1)(1997-7#1)(2007-5#1)(2008-10#4)(2008-7#1)(2008-8#1)
disease also##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
disease among##12##2##(1991-12#1)(1992-2#2)(1993-2#1)(1994-9#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-5#1)(2010-8#1)(2012-12#1)
disease and DON levels from##2##5##(2008-10#2)
disease and DON levels##3##4##(2008-10#3)
disease and a##10##3##(1994-9#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-11#1)(2013-1#1)
disease and acute##4##3##(2007-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
disease and all##2##3##(1990-2#1)(2008-6#1)
disease and are##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
disease and associated##3##3##(2008-5#1)(2009-10#1)(2013-8#1)
disease and can##2##3##(2008-1#1)(2008-10#1)
disease and cancer##4##3##(1996-11#1)(2008-11#1)(2011-2#1)(2013-8#1)
disease and cerebrovascular disease##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
disease and cerebrovascular##4##3##(2008-10#1)(2008-8#1)(2011-1#2)
disease and chronic##3##3##(1995-12#1)(2008-3#1)(2009-3#1)
disease and complications##2##3##(2010-3#1)(2011-3#1)
disease and death##4##3##(1992-6#1)(1997-7#1)(2008-3#1)(2012-2#1)
disease and development##2##3##(2008-9#1)(2011-2#1)
disease and diabetes##3##3##(2007-10#1)(2008-7#1)(2012-12#1)
disease and electrical disorders##2##4##(2009-5#1)(2012-3#1)
disease and environmental##2##3##(1991-12#1)(2008-12#1)
disease and for##4##3##(1992-12#1)(1995-9#1)(2008-10#1)(2013-7#1)
disease and has##2##3##(1997-8#1)(2007-8#1)
disease and heart##2##3##(1993-2#1)(2010-11#1)
disease and hypertension##2##3##(1996-11#1)(2008-8#1)
disease and in##9##3##(1990-2#1)(1990-3#1)(1990-8#1)(1994-11#1)(2008-1#2)(2008-10#2)(2008-7#1)
disease and injury##2##3##(1995-6#1)(2013-1#1)
disease and is##6##3##(1993-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
disease and it##2##3##(2008-7#1)(2010-7#1)
disease and its treatment##3##4##(1990-6#1)(1991-2#1)(1996-3#1)
disease and its##17##3##(1990-6#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-6#1)(1993-9#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
disease and metabolic##2##3##(2007-5#1)(2012-2#1)
disease and not##2##3##(2007-12#1)(2008-10#1)
disease and novel##2##3##(1993-12#1)(2011-2#1)
disease and of##3##3##(1990-3#1)(2008-7#1)(2012-3#1)
disease and one##3##3##(2008-5#1)(2008-7#1)(2010-3#1)
disease and other##7##3##(1991-12#1)(1995-12#1)(1995-3#1)(1996-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
disease and present##2##3##(1993-3#1)(2007-8#1)
disease and public health##2##4##(2007-12#1)(2011-2#1)
disease and pulmonary##2##3##(1992-5#1)(2007-7#1)
disease and risk factors##2##4##(2007-8#1)(2008-1#1)
disease and some##2##3##(2009-5#1)(2012-2#1)
disease and systemic##2##3##(2008-5#2)
disease and that##4##3##(1992-12#1)(1993-11#1)(1997-8#1)(2008-10#1)
disease and the##42##3##(1991-6#1)(1992-3#1)(1992-9#1)(1993-6#1)(1995-2#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
disease and to evaluate##2##4##(1997-2#1)(2010-9#1)
disease and to##9##3##(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-1#1)(2010-11#1)(2010-9#1)(2013-7#1)
disease and treatment##2##3##(2008-7#1)(2013-8#1)
disease and type##2##3##(2008-3#1)(2012-4#1)
disease and ulcerative##6##3##(1993-2#1)(2010-12#4)(2013-1#1)
disease and with##3##3##(1996-2#1)(2010-12#1)(2012-3#1)
disease and##439##2##(1990-11#2)(1990-2#2)(1990-3#7)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#4)(1991-6#3)(1991-8#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-9#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#8)(2006-10#1)(2006-5#1)(2007-10#3)(2007-11#8)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#9)(2007-8#12)(2007-9#2)(2008-1#18)(2008-10#57)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#10)(2008-6#4)(2008-7#23)(2008-8#10)(2008-9#4)(2009-1#1)(2009-10#3)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#9)(2010-3#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#24)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#7)(2012-4#1)(2013-1#17)(2013-7#6)(2013-8#10)
disease and/or##4##2##(1990-2#1)(2008-1#1)(2009-11#1)(2012-3#1)
disease apparently##2##2##(1990-8#1)(2008-10#1)
disease appears to be##5##4##(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#1)
disease appears to##6##3##(1992-3#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#1)
disease are a##3##3##(1992-2#1)(2008-7#1)(2012-2#1)
disease are at##2##3##(2008-11#1)(2013-1#1)
disease are discussed##7##3##(1990-6#1)(1991-9#1)(1993-8#1)(1995-6#1)(2008-10#1)(2010-11#1)(2013-8#1)
disease are not##4##3##(1990-12#1)(1996-11#1)(2008-7#1)(2013-1#1)
disease are presented##3##3##(1994-11#1)(2008-11#1)(2009-9#1)
disease are reviewed##3##3##(1995-5#1)(2009-10#1)(2010-9#1)
disease are the##2##3##(2010-4#1)(2013-1#1)
disease are##53##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-2#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#4)(2009-10#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
disease as a##3##3##(2007-7#1)(2008-11#1)(2010-6#1)
disease as compared to##2##4##(2008-7#1)(2011-1#1)
disease as compared with##2##4##(2008-10#1)(2008-7#1)
disease as compared##4##3##(2008-10#1)(2008-7#2)(2011-1#1)
disease as effectively as##2##4##(2008-10#2)
disease as the##2##3##(1997-1#1)(2008-3#1)
disease as well as##4##4##(1991-8#1)(2008-8#1)(2009-8#1)(2012-2#1)
disease as well##5##3##(1991-8#1)(1995-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
disease as##26##2##(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1995-11#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
disease assessment and##2##3##(2008-10#2)
disease assessment##5##2##(2008-10#3)(2008-6#1)(2010-4#1)
disease associated with##15##3##(1991-11#1)(1992-9#1)(1995-12#1)(2008-1#2)(2008-7#3)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
disease associated##17##2##(1991-11#1)(1992-9#1)(1995-12#1)(2008-1#3)(2008-7#3)(2008-9#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
disease associations##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
disease at all##2##3##(2008-10#2)
disease at an##2##3##(1994-7#1)(2012-3#1)
disease at diagnosis##3##3##(1990-12#1)(1995-8#1)(2010-3#1)
disease at the##5##3##(1991-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-6#1)
disease at##27##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-11#2)(1993-2#1)(1994-7#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
disease awareness##2##2##(2008-1#1)(2012-3#1)
disease based on##2##3##(2008-3#1)(2010-5#1)
disease be treated with##2##4##(1996-9#1)(2011-2#1)
disease be##5##2##(1994-8#1)(1996-9#1)(1997-8#1)(2008-12#1)(2011-2#1)
disease because##2##2##(1995-2#1)(2008-10#1)
disease begins##2##2##(2008-9#1)(2013-1#1)
disease between##3##2##(2008-10#2)(2008-6#1)
disease biomarkers##2##2##(2008-7#1)(2012-3#1)
disease burden among##2##3##(2008-1#1)(2008-12#1)
disease burden##9##2##(2008-1#2)(2008-12#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
disease but does##2##3##(1995-12#1)(2013-1#1)
disease but not##2##3##(2008-10#1)(2008-6#1)
disease but the##2##3##(1996-12#1)(2008-7#1)
disease but##11##2##(1990-6#1)(1995-12#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
disease by comparing##2##3##(2008-4#1)(2013-8#1)
disease by the##3##3##(1993-11#1)(1994-9#1)(2008-10#1)
disease by##32##2##(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-4#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
disease can be treated##2##4##(2007-7#1)(2007-8#1)
disease can be##13##3##(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
disease can##19##2##(1996-3#1)(1997-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
disease care##2##2##(1997-1#1)(2007-7#1)
disease cases##4##2##(1997-3#2)(2007-12#1)(2009-5#1)
disease category in##2##3##(2008-11#2)
disease caused by a##3##4##(2008-10#2)(2009-3#1)
disease caused by both##2##4##(2008-10#2)
disease caused by mutations in the##2##6##(1997-1#1)(2013-8#1)
disease caused by the##8##4##(2007-2#1)(2008-10#5)(2008-6#1)(2012-3#1)
disease caused by##47##3##(1991-5#1)(1994-8#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#1)(2010-11#1)(2010-8#2)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
disease caused##48##2##(1991-5#1)(1994-8#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
disease causing##2##2##(2008-7#1)(2011-2#1)
disease characterized by a##2##4##(2008-8#1)(2013-8#1)
disease characterized by the##2##4##(1990-5#1)(2012-12#1)
disease characterized by##14##3##(1990-5#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-5#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
disease compared with the##2##4##(1997-8#1)(2008-10#1)
disease compared with##3##3##(1994-5#1)(1997-8#1)(2008-10#1)
disease complex of banana##2##4##(2008-10#2)
disease complex of##3##3##(2008-10#3)
disease complex##7##2##(2008-10#7)
disease complicated by##2##3##(2012-12#1)(2013-1#1)
disease complicated##3##2##(1993-5#1)(2012-12#1)(2013-1#1)
disease complications##2##2##(2007-12#1)(2010-5#1)
disease conditions##4##2##(2008-1#1)(2008-3#1)(2011-2#2)
disease confined to the##2##4##(2007-8#1)(2013-8#1)
disease confined to##3##3##(1990-3#1)(2007-8#1)(2013-8#1)
disease continues to##2##3##(2010-6#1)(2010-8#1)
disease control by##2##3##(2008-10#2)
disease control efficacy##2##3##(2008-10#2)
disease control in the##2##4##(2008-10#2)
disease control in##5##3##(1997-7#1)(2008-10#2)(2008-7#1)(2011-1#1)
disease control measures##2##3##(1997-7#1)(2008-10#1)
disease control provided by##2##4##(2008-10#2)
disease control strategies##3##3##(2008-10#3)
disease control was##2##3##(2008-10#2)
disease control##73##2##(1990-12#1)(1991-8#1)(1993-6#1)(1997-7#4)(2007-2#1)(2008-10#56)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2011-1#1)(2012-3#3)
disease could be##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
disease could##6##2##(1994-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
disease course of##2##3##(2011-1#1)(2012-2#1)
disease course##7##2##(2006-10#1)(2007-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
disease currently##3##2##(1994-9#1)(2008-10#2)
disease cycle##6##2##(2008-10#6)
disease data##4##2##(2007-12#1)(2008-10#3)
disease death##3##2##(2011-1#3)
disease despite##2##2##(2009-3#1)(2013-1#1)
disease detection##3##2##(2007-12#1)(2008-10#1)(2009-6#1)
disease developed##4##2##(2008-10#4)
disease development and##3##3##(2008-10#3)
disease development in the##2##4##(2008-10#2)
disease development in##6##3##(2008-10#6)
disease development of##2##3##(2008-10#2)
disease development on##4##3##(2008-10#3)(2012-12#1)
disease development was##5##3##(2008-10#5)
disease development##53##2##(2008-10#52)(2012-12#1)
disease develops##3##2##(2009-10#1)(2010-6#1)(2010-7#1)
disease diagnosed##2##2##(2010-8#1)(2013-1#1)
disease diagnosis##9##2##(2007-11#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-7#2)
disease did##2##2##(2008-10#1)(2008-7#1)
disease diversity##2##2##(2008-10#2)
disease does not##2##3##(1991-6#1)(2008-2#1)
disease does##3##2##(1991-6#1)(2008-2#1)(2010-9#1)
disease due to##5##3##(2008-1#2)(2008-10#1)(2008-11#1)(2009-5#1)
disease duration and##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
disease duration##11##2##(1995-2#1)(2006-10#1)(2010-12#1)(2011-2#6)(2013-1#1)(2013-8#1)
disease during treatment##2##3##(1991-2#1)(1991-6#1)
disease during##15##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-9#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-8#2)(2010-3#1)(2011-2#2)(2013-1#1)
disease dynamics##2##2##(2008-10#1)(2008-9#1)
disease entities##4##2##(1991-2#1)(2007-7#1)(2009-7#1)(2011-2#1)
disease entity##4##2##(1991-2#1)(1996-12#1)(2008-7#2)
disease epidemics##11##2##(2008-10#11)
disease epidemiology##6##2##(2007-12#1)(2008-10#4)(2009-4#1)
disease episodes##3##2##(1994-9#1)(2007-7#1)(2008-8#1)
disease estimated##2##2##(2008-10#1)(2012-12#1)
disease events##3##2##(2008-10#1)(2008-12#2)
disease experience##2##2##(1995-3#1)(2007-11#1)
disease expression##7##2##(2006-10#1)(2008-10#5)(2009-8#1)
disease extension##3##2##(1992-9#1)(2008-1#2)
disease foci##5##2##(2008-10#5)
disease following##2##2##(1997-7#1)(2012-3#1)
disease for men##2##3##(2008-10#2)
disease for the##2##3##(1990-9#1)(2007-8#1)
disease for##20##2##(1990-9#1)(1992-5#1)(1993-11#1)(1994-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-7#2)(2010-11#1)(2012-12#3)(2013-8#1)
disease forecasting##3##2##(2008-10#3)
disease found in##2##3##(2008-10#1)(2008-3#1)
disease free at##4##3##(1990-6#1)(1991-8#1)(1992-5#1)(2011-2#1)
disease free survival (DFS)##3##4##(2008-7#1)(2009-4#1)(2011-2#1)
disease free survival##4##3##(2007-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
disease free##14##2##(1990-6#1)(1991-2#1)(1991-8#1)(1992-5#1)(2007-11#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-4#1)(2011-2#2)(2013-1#2)
disease frequently##3##2##(1994-11#1)(2006-10#1)(2008-7#1)
disease from a##2##3##(2008-10#1)(2010-4#1)
disease from other##2##3##(2007-10#1)(2010-12#1)
disease from the##4##3##(1993-6#1)(2008-8#1)(2010-3#1)(2011-2#1)
disease from##18##2##(1993-6#1)(2007-10#1)(2008-10#5)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
disease gene##12##2##(1992-3#1)(1993-1#1)(1993-11#1)(1995-5#3)(1997-8#2)(2008-1#1)(2008-4#2)(2008-7#1)
disease genes##8##2##(1994-9#1)(1997-8#1)(2007-7#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
disease gradient##2##2##(2008-10#2)
disease gradients of wheat stripe rust##2##6##(2008-10#2)
disease gradients of##3##3##(2008-10#3)
disease gradients were##2##3##(2008-10#2)
disease gradients##11##2##(2008-10#11)
disease greater than 15 mm in diameter##2##7##(1995-12#2)
disease group##4##2##(1993-3#1)(1996-12#1)(2008-7#1)(2011-2#1)
disease had been##5##3##(1994-9#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#1)
disease had##8##2##(1992-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)
disease has a##4##3##(1991-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
disease has been##20##3##(1990-3#1)(1992-8#1)(1995-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
disease has not been##4##4##(2007-7#1)(2008-4#1)(2009-9#1)(2010-6#1)
disease has not##5##3##(2007-7#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-6#1)
disease has##43##2##(1990-3#1)(1991-2#1)(1992-8#1)(1995-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
disease have a##2##3##(1996-2#1)(2008-7#1)
disease have been reported##2##4##(1991-11#1)(2009-5#1)
disease have been##8##3##(1990-9#1)(1991-11#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-5#1)
disease have##20##2##(1990-9#1)(1991-11#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
disease having##2##2##(2007-7#1)(2008-7#1)
disease if##3##2##(1993-1#1)(1993-2#1)(2010-12#1)
disease in 2 patients##2##4##(1990-6#1)(1992-6#1)
disease in 2##3##3##(1990-6#1)(1991-8#1)(1992-6#1)
disease in 25##2##3##(2007-8#1)(2008-1#1)
disease in 3##2##3##(1990-3#1)(1992-12#1)
disease in 30##2##3##(2007-7#2)
disease in 36##2##3##(1991-4#1)(2007-7#1)
disease in British Columbia##2##4##(2007-12#2)
disease in British##3##3##(1990-6#1)(2007-12#2)
disease in Canada##3##3##(2007-12#2)(2008-11#1)
disease in Chile##4##3##(2011-2#3)(2013-8#1)
disease in Europe##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
disease in Japan##2##3##(1993-12#1)(2008-1#1)
disease in North America##3##4##(2008-10#2)(2008-11#1)
disease in Switzerland##2##3##(1990-3#1)(1996-6#1)
disease in Washington state##2##4##(2008-10#2)
disease in a tertiary care##3##5##(2010-4#1)(2011-2#1)(2013-8#1)
disease in a##23##3##(1990-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#2)
disease in addition to##2##4##(1994-6#1)(2006-10#1)
disease in adults##3##3##(1991-4#1)(2008-7#1)(2008-9#1)
disease in an##8##3##(1997-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#3)(2012-3#1)
disease in cases##2##3##(2012-3#1)(2013-1#1)
disease in childhood##4##3##(1991-8#1)(2008-12#1)(2009-11#1)(2012-2#1)
disease in children and##2##4##(2007-11#1)(2007-12#1)
disease in children##9##3##(1991-8#1)(2007-11#2)(2007-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)
disease in developing##2##3##(1991-8#1)(2008-12#1)
disease in elderly##2##3##(2007-12#1)(2008-7#1)
disease in general and##2##4##(2007-12#1)(2008-8#1)
disease in grapevine##2##3##(2008-10#2)
disease in humans##4##3##(1995-2#1)(2008-10#1)(2009-5#1)(2012-12#1)
disease in infants##2##3##(2011-1#1)(2011-2#1)
disease in many##2##3##(2009-8#1)(2011-1#1)
disease in men##2##3##(1995-11#1)(1996-3#1)
disease in north##2##3##(2008-10#1)(2008-12#1)
disease in northern##2##3##(1993-12#1)(2011-2#1)
disease in older##3##3##(2007-12#1)(2008-7#1)(2012-12#1)
disease in our##5##3##(1993-5#1)(1996-8#1)(1997-8#1)(2007-7#1)(2008-8#1)
disease in patients with##10##4##(1993-12#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#2)(2013-8#2)
disease in patients##12##3##(1993-12#1)(1993-3#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#2)(2013-8#2)
disease in primary##3##3##(1996-3#1)(1996-8#1)(1996-9#1)
disease in recent##2##3##(2008-7#1)(2010-12#1)
disease in sugar##2##3##(2008-10#1)(2012-3#1)
disease in terms of##2##4##(2010-5#1)(2013-1#1)
disease in the United States##2##5##(2008-10#1)(2008-9#1)
disease in the United##3##4##(2008-1#1)(2008-10#1)(2008-9#1)
disease in the absence of##3##5##(1995-5#1)(2006-10#1)(2008-3#1)
disease in the field##5##4##(2008-10#5)
disease in the##62##3##(1990-9#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#2)(2010-1#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#2)
disease in these##2##3##(1995-2#1)(2011-1#1)
disease in this##3##3##(1997-3#1)(2007-2#1)(2008-10#1)
disease in tomato##2##3##(2008-10#2)
disease in transgenic##2##3##(1990-11#1)(2008-8#1)
disease in tropical##3##3##(1996-11#2)(2010-4#1)
disease in two##3##3##(2008-10#2)(2010-2#1)
disease in type 1 diabetes patients##2##6##(2013-1#2)
disease in type 1 diabetes##3##5##(2013-1#3)
disease in type 2##2##4##(2011-2#1)(2012-3#1)
disease in type##6##3##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
disease in which the##2##4##(1991-12#2)
disease in which##5##3##(1991-12#2)(1997-8#1)(2011-2#1)(2013-1#1)
disease in women##5##3##(1996-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
disease in young##2##3##(1996-3#1)(1997-1#1)
disease in##413##2##(1990-11#3)(1990-3#3)(1990-6#2)(1990-9#2)(1991-11#5)(1991-12#8)(1991-3#1)(1991-4#3)(1991-8#6)(1992-1#1)(1992-12#5)(1992-2#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-5#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#5)(1996-6#1)(1996-8#7)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#2)(1997-6#2)(1997-8#6)(2006-10#3)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#15)(2007-2#4)(2007-7#8)(2007-8#3)(2008-1#9)(2008-10#68)(2008-11#5)(2008-12#12)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#16)(2008-8#6)(2008-9#12)(2009-1#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#7)(2011-2#26)(2012-12#11)(2012-2#11)(2012-3#9)(2013-1#12)(2013-7#1)(2013-8#11)
disease incidence among sampling units##2##5##(2008-10#2)
disease incidence among##4##3##(2008-10#4)
disease incidence and disease severity##2##5##(1994-9#1)(2008-10#1)
disease incidence and severity##11##4##(2008-10#11)
disease incidence and##21##3##(1994-9#1)(2008-10#20)
disease incidence are##2##3##(2008-10#2)
disease incidence at the##2##4##(2008-10#2)
disease incidence at##6##3##(2008-10#6)
disease incidence between##3##3##(2008-10#3)
disease incidence from##3##3##(2008-10#3)
disease incidence in a spatial hierarchy##2##6##(2008-10#2)
disease incidence in a##4##4##(2008-10#4)
disease incidence in the greenhouse##2##5##(2008-10#2)
disease incidence in the##5##4##(1997-3#1)(2008-10#4)
disease incidence in##11##3##(1994-9#1)(1997-3#1)(2008-10#9)
disease incidence of##2##3##(2008-10#2)
disease incidence was not##2##4##(2008-10#2)
disease incidence was##15##3##(1997-6#1)(2008-10#14)
disease incidence were##2##3##(2008-10#2)
disease incidence##140##2##(1990-3#1)(1994-9#2)(1997-3#2)(1997-6#1)(2008-10#134)
disease incidence)##3##2##(2008-10#2)(2010-3#1)
disease incidences##4##2##(2008-10#3)(2011-2#1)
disease incited by##3##3##(2008-10#3)
disease include##2##2##(1993-3#1)(1995-3#1)
disease included##2##2##(2007-7#1)(2008-11#1)
disease including##5##2##(2008-7#1)(2009-8#1)(2011-2#3)
disease increased##3##2##(2008-10#2)(2012-2#1)
disease increases##2##2##(2008-10#1)(2008-5#1)
disease induced by##3##3##(1996-11#1)(2008-4#1)(2013-7#1)
disease induced##5##2##(1996-11#1)(2008-10#1)(2008-4#1)(2012-1#1)(2013-7#1)
disease induction is##3##3##(1991-12#1)(2008-10#2)
disease initiation and progression##2##4##(2008-10#1)(2011-2#1)
disease initiation and##3##3##(2008-10#2)(2011-2#1)
disease intensity index (DII)##2##4##(2008-10#2)
disease intensity##16##2##(2008-10#16)
disease involving the##2##3##(1990-11#1)(2011-2#1)
disease involving##6##2##(1990-11#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
disease is a benign##2##4##(2008-4#1)(2012-12#1)
disease is a chronic##2##4##(2010-12#1)(2012-3#1)
disease is a leading cause of##2##6##(1993-3#1)(2008-10#1)
disease is a multisystem disorder##2##5##(2008-9#1)(2012-3#1)
disease is a rare##2##4##(2010-12#1)(2013-1#1)
disease is a significant##2##4##(2008-8#1)(2011-2#1)
disease is a##27##3##(1993-3#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#3)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
disease is an autosomal##2##4##(1991-9#1)(2010-9#1)
disease is an important##3##4##(2007-12#1)(2008-4#1)(2008-8#1)
disease is an##12##3##(1991-1#1)(1991-9#1)(1994-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2013-1#1)
disease is caused by a##2##5##(1994-8#1)(2008-10#1)
disease is caused by##6##4##(1994-8#1)(2008-10#3)(2011-2#1)(2012-1#1)
disease is caused##7##3##(1994-8#1)(2008-10#4)(2011-2#1)(2012-1#1)
disease is characterised by##2##4##(1996-6#1)(2007-8#1)
disease is characterized by increased##2##5##(2010-5#1)(2010-6#1)
disease is characterized by##7##4##(1991-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-1#1)
disease is common in##2##4##(2008-1#1)(2008-7#1)
disease is common##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
disease is commonly##2##3##(2008-10#1)(2008-2#1)
disease is currently##2##3##(2010-8#1)(2011-3#1)
disease is derived##2##3##(1992-12#1)(1992-5#1)
disease is difficult to##2##4##(1991-2#1)(2011-2#1)
disease is discussed##6##3##(1991-4#1)(1996-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
disease is due##2##3##(2007-12#1)(2008-4#1)
disease is extremely rare##2##4##(1991-9#1)(2010-12#1)
disease is found##2##3##(2008-5#1)(2013-1#1)
disease is not associated with##2##5##(1996-12#1)(2008-10#1)
disease is not##7##3##(1996-12#1)(2007-7#1)(2008-10#3)(2010-1#1)(2013-8#1)
disease is often##2##3##(1990-9#1)(1996-6#1)
disease is one of the##3##5##(1995-3#1)(1997-3#1)(2012-12#1)
disease is one of##4##4##(1995-3#1)(1997-3#1)(2008-11#1)(2012-12#1)
disease is possible##2##3##(1991-6#1)(1995-5#1)
disease is presented##2##3##(2008-6#1)(2011-1#1)
disease is rare and##2##4##(1992-8#1)(2010-8#1)
disease is rare in##2##4##(2006-10#1)(2012-3#1)
disease is rare##5##3##(1992-8#1)(1995-9#1)(2006-10#1)(2010-8#1)(2012-3#1)
disease is rarely##2##3##(2011-2#1)(2012-12#1)
disease is responsible for##2##4##(1997-2#1)(2012-2#1)
disease is significantly##2##3##(2009-11#1)(2010-11#1)
disease is still a##3##4##(1993-6#1)(2008-10#1)(2010-12#1)
disease is still##5##3##(1993-6#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
disease is the leading cause of death##2##7##(2011-2#1)(2012-2#1)
disease is the leading##3##4##(2010-9#1)(2011-2#1)(2012-2#1)
disease is the most common##3##5##(1993-1#1)(2007-11#1)(2008-10#1)
disease is the most##6##4##(1993-1#1)(2007-11#1)(2008-10#1)(2009-2#1)(2013-1#1)(2013-8#1)
disease is the##19##3##(1991-9#1)(1993-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
disease is transmitted##2##3##(1997-6#1)(2008-9#1)
disease is unknown##2##3##(1991-11#1)(2008-10#1)
disease is usually##6##3##(1990-12#1)(1991-4#1)(2008-1#1)(2008-12#1)(2011-2#2)
disease is very rare##2##4##(2007-11#1)(2012-12#1)
disease is very##5##3##(1990-8#1)(1992-5#1)(2007-11#2)(2012-12#1)
disease is##224##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#25)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#3)(2008-9#5)(2009-11#2)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#4)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#7)(2013-8#6)
disease it##2##2##(1990-8#1)(2010-8#1)
disease known as##4##3##(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)
disease known##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)
disease later in life##2##4##(2008-10#1)(2013-1#1)
disease led to##2##3##(1990-8#1)(1996-11#1)
disease lesions##2##2##(2008-10#2)
disease level at##2##3##(2008-10#2)
disease level##7##2##(2008-10#7)
disease levels##6##2##(2008-10#5)(2008-4#1)
disease like##2##2##(2010-4#1)(2012-12#1)
disease locus##4##2##(1993-11#1)(1996-8#1)(1997-5#1)(2008-4#1)
disease managed##2##2##(1996-12#1)(2007-8#1)
disease management and##2##3##(2007-7#1)(2008-10#1)
disease management decisions##2##3##(2008-10#2)
disease management in##2##3##(2008-10#1)(2010-12#1)
disease management program##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
disease management programs##3##3##(2008-10#1)(2008-11#2)
disease management strategies##4##3##(2008-10#4)
disease management strategy for##2##4##(2008-10#1)(2013-1#1)
disease management strategy##5##3##(2008-10#4)(2013-1#1)
disease management than##2##3##(1995-3#1)(2011-2#1)
disease management tools##2##3##(2008-10#2)
disease management was##2##3##(2008-10#2)
disease management##54##2##(1995-3#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#35)(2008-11#3)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
disease manifestation##2##2##(2011-2#1)(2012-2#1)
disease mapping##2##2##(2008-8#2)
disease markers##8##2##(1996-12#4)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
disease may be##7##3##(1993-6#1)(1994-7#1)(2010-6#2)(2011-2#1)(2013-8#2)
disease may have##2##3##(1991-7#1)(1996-12#1)
disease may result in##2##4##(1991-4#1)(1994-8#1)
disease may##22##2##(1990-12#1)(1991-11#1)(1991-4#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-1#2)(2008-7#2)(2008-9#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
disease measures##3##2##(1997-2#1)(1997-3#1)(2008-10#1)
disease mechanisms##4##2##(2008-2#1)(2009-2#2)(2011-7#1)
disease might be##4##3##(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#1)
disease might##6##2##(1991-12#1)(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2010-12#1)
disease model##6##2##(2007-5#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-8#1)
disease models##2##2##(2008-10#1)(2008-8#1)
disease modifying##2##2##(2008-5#1)(2012-3#1)
disease monitoring##5##2##(2009-6#1)(2010-11#1)(2010-8#1)(2011-3#1)(2013-8#1)
disease morbidity and mortality##3##4##(1993-12#2)(1997-1#1)
disease more##2##2##(1994-9#1)(2008-7#1)
disease mortality of##2##3##(2010-2#2)
disease mortality##10##2##(1991-6#1)(1992-6#1)(1997-2#2)(2010-2#5)(2013-8#1)
disease most##2##2##(1992-4#1)(2010-8#1)
disease much##2##2##(1991-11#1)(1993-3#1)
disease nurseries##2##2##(2008-10#2)
disease observed##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
disease occurred##2##2##(2008-10#2)
disease occurrence##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
disease occurring##2##2##(1991-4#1)(2010-3#1)
disease occurs##3##2##(2007-8#1)(2008-10#1)(2009-4#1)
disease of apple##2##3##(2008-10#2)
disease of banana##2##3##(2008-10#2)
disease of barley in many##4##5##(2008-10#4)
disease of barley##7##3##(2008-10#5)(2008-8#2)
disease of bone##3##3##(1990-6#1)(1997-6#1)(2008-7#1)
disease of cattle##2##3##(2007-2#1)(2008-10#1)
disease of cherry##2##3##(2008-10#2)
disease of citrus in##2##4##(2008-10#2)
disease of citrus##3##3##(2008-10#3)
disease of groundnut##2##3##(2008-10#2)
disease of lettuce##2##3##(2008-10#2)
disease of maize##2##3##(2008-10#2)
disease of pear and apple##2##5##(2008-10#2)
disease of perennial ryegrass (Lolium##2##5##(2008-10#2)
disease of perennial ryegrass##3##4##(2008-10#3)
disease of pines##2##3##(2008-10#2)
disease of rice worldwide##2##4##(2008-10#2)
disease of rice##3##3##(2008-10#2)(2012-2#1)
disease of several##2##3##(2008-10#2)
disease of small##3##3##(1995-12#1)(2008-10#1)(2010-1#1)
disease of the breast##3##4##(1997-8#2)(2012-1#1)
disease of the central nervous system##4##6##(1995-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
disease of the cervical spine##2##5##(2012-12#2)
disease of the fetus##2##4##(2010-11#2)
disease of the gastrointestinal tract##2##5##(2013-8#2)
disease of the lower##2##4##(1991-6#1)(2007-8#1)
disease of the newborn##6##4##(1992-12#1)(1993-12#1)(1994-12#2)(1994-3#1)(2012-2#1)
disease of the spine##3##4##(2007-11#2)(2008-8#1)
disease of the##59##3##(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#3)
disease of tomato under##2##4##(2008-10#2)
disease of tomato##3##3##(2008-10#3)
disease of unknown etiology##6##4##(1991-2#1)(1995-6#1)(2008-10#2)(2012-3#1)(2013-1#1)
disease of unknown##7##3##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#2)(2012-3#1)(2013-1#1)
disease of wheat worldwide##2##4##(2008-10#2)
disease of wheat##7##3##(2008-10#7)
disease of young##2##3##(2008-10#1)(2013-8#1)
disease of##204##2##(1990-12#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#4)(2007-10#2)(2007-11#5)(2007-2#1)(2007-7#6)(2007-8#3)(2008-10#93)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
disease often##4##2##(1992-3#1)(2008-10#1)(2008-8#1)(2009-5#1)
disease on St##2##3##(2008-10#2)
disease on chromosome##2##3##(1990-3#1)(1996-2#1)
disease on lettuce##2##3##(2008-10#2)
disease on the##7##3##(2007-2#1)(2008-10#3)(2008-11#1)(2010-6#1)(2012-12#1)
disease on tomato and##2##4##(2008-10#2)
disease on##51##2##(1990-3#1)(1994-7#1)(1996-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#35)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-6#1)(2012-12#2)(2012-2#1)
disease only in##2##3##(2008-10#1)(2012-12#1)
disease only##7##2##(1991-12#1)(1997-8#1)(2008-10#3)(2011-3#1)(2012-12#1)
disease onset and##4##3##(2008-10#4)
disease onset but##2##3##(2008-10#1)(2012-3#1)
disease onset was##2##3##(2008-10#1)(2012-12#1)
disease onset##19##2##(1993-6#1)(1997-5#2)(2008-10#12)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
disease or condition##2##3##(1997-2#1)(2008-4#1)
disease or diabetes and##2##4##(2008-7#1)(2013-1#1)
disease or its##2##3##(2008-6#1)(2010-5#1)
disease or to##2##3##(2006-10#1)(2010-6#1)
disease or##44##2##(1990-3#3)(1991-8#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
disease outbreak##3##2##(1990-3#1)(1996-2#1)(2008-12#1)
disease outbreaks in##2##3##(2009-2#1)(2010-2#1)
disease outbreaks##8##2##(1996-12#1)(2007-12#1)(2008-10#2)(2009-2#1)(2010-2#1)(2010-5#1)(2011-2#1)
disease outcome##4##2##(2008-1#1)(2011-2#2)(2012-12#1)
disease outcomes##2##2##(2013-1#2)
disease over the last decade##2##5##(2008-1#1)(2008-12#1)
disease over the##3##3##(2008-1#1)(2008-12#1)(2010-8#1)
disease over##6##2##(1994-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-8#1)(2013-7#1)
disease pathogenesis and##2##3##(2008-4#1)(2013-8#1)
disease pathogenesis is##2##3##(1994-8#1)(2013-1#1)
disease pathogenesis##9##2##(1992-12#1)(1994-8#1)(1995-3#1)(1997-5#1)(2007-7#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
disease pathology and##2##3##(2007-12#1)(2008-7#1)
disease pathology##4##2##(1995-5#1)(1996-12#1)(2007-12#1)(2008-7#1)
disease patient##2##2##(2008-12#1)(2013-8#1)
disease patients and##5##3##(2008-5#3)(2010-5#1)(2011-2#1)
disease patients in##3##3##(2007-10#1)(2007-7#1)(2010-4#1)
disease patients is##3##3##(2008-7#2)(2010-12#1)
disease patients undergoing##3##3##(1991-9#1)(2008-7#1)(2010-5#1)
disease patients who are##2##4##(2010-8#1)(2013-8#1)
disease patients with##4##3##(1995-8#1)(2008-5#1)(2008-7#1)(2009-8#1)
disease patients without##2##3##(2008-7#1)(2010-12#1)
disease patients##41##2##(1990-6#1)(1991-11#2)(1991-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#4)(2008-7#7)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
disease patients'##3##2##(2008-7#1)(2009-8#1)(2013-1#1)
disease pattern##2##2##(2008-3#1)(2009-3#1)
disease patterns##4##2##(1997-3#1)(2008-10#2)(2011-1#1)
disease phenotype##5##2##(1997-5#1)(2007-7#1)(2008-10#3)
disease phenotypes##3##2##(2008-10#2)(2008-9#1)
disease population##3##2##(1991-3#1)(2007-10#2)
disease potential##2##2##(1991-12#1)(2008-10#1)
disease prediction model##2##3##(2008-10#2)
disease prediction##3##2##(2008-10#3)
disease presentations##2##2##(2010-6#1)(2012-2#1)
disease presented with##2##3##(2007-8#2)
disease presenting with##3##3##(2010-12#1)(2012-12#1)(2012-3#1)
disease presenting##5##2##(1991-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
disease pressure##11##2##(2008-10#11)
disease prevalence and##2##3##(2011-2#1)(2012-2#1)
disease prevalence in##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
disease prevalence##12##2##(1991-12#1)(1997-3#1)(2008-10#4)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
disease prevention and control##2##4##(1997-1#1)(2007-12#1)
disease prevention and##5##3##(1996-3#1)(1997-1#1)(2007-12#1)(2009-6#1)(2010-12#1)
disease prevention##21##2##(1991-2#1)(1994-12#2)(1995-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
disease problems in##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
disease problems##6##2##(1997-7#1)(2008-10#4)(2008-11#1)
disease process and##4##3##(2008-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
disease process##28##2##(1991-9#1)(1995-5#1)(1995-9#1)(1997-4#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#4)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
disease processes in##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
disease processes##13##2##(2006-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2012-2#1)
disease prognosis and##3##3##(2010-11#1)(2010-8#1)(2013-1#1)
disease prognosis##4##2##(2008-10#1)(2010-11#1)(2010-8#1)(2013-1#1)
disease progress and##3##3##(2007-11#1)(2008-10#2)
disease progress curve##29##3##(2008-10#29)
disease progress curves were##2##4##(2008-10#2)
disease progress curves##6##3##(2008-10#6)
disease progress on##2##3##(2008-10#2)
disease progress were##2##3##(2008-10#2)
disease progress##53##2##(2007-11#1)(2008-10#52)
disease progressed##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
disease progression and complications##2##4##(2009-8#1)(2013-1#1)
disease progression and survival##2##4##(1995-2#1)(2008-7#1)
disease progression and##11##3##(1995-2#1)(2008-10#1)(2008-7#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
disease progression as well as##2##5##(2008-9#1)(2013-8#1)
disease progression in##7##3##(2008-10#2)(2008-2#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#1)
disease progression or##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
disease progression##64##2##(1991-4#1)(1991-6#1)(1992-8#1)(1994-8#1)(1995-2#3)(1997-5#1)(1997-8#1)(2008-10#13)(2008-2#4)(2008-3#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
disease protection##2##2##(2008-10#2)
disease ranged##2##2##(2008-10#2)
disease rare in##2##3##(1990-9#1)(1996-11#1)
disease rates##5##2##(1990-3#1)(1991-8#1)(1996-3#1)(2008-1#1)(2011-1#1)
disease rating##6##2##(2008-10#5)(2008-7#1)
disease ratings in##2##3##(2008-10#2)
disease ratings were##2##3##(2008-10#2)
disease ratings##10##2##(2008-10#10)
disease reaction##6##2##(2008-10#6)
disease reactions##3##2##(2008-10#3)
disease receiving##3##2##(1990-8#1)(2013-1#2)
disease recurred##2##2##(2008-6#2)
disease recurrence at##2##3##(2012-2#1)(2012-3#1)
disease recurrence##12##2##(2007-5#1)(2008-6#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
disease reduction##7##2##(2008-10#7)
disease regardless of##2##3##(2008-10#1)(2011-1#1)
disease regardless##3##2##(1990-11#1)(2008-10#1)(2011-1#1)
disease relapse##2##2##(2008-10#1)(2012-2#1)
disease relationships##2##2##(2008-10#1)(2010-5#1)
disease remains a##2##3##(2006-10#1)(2012-3#1)
disease remains the##2##3##(2010-8#1)(2013-7#1)
disease remains##6##2##(1995-5#1)(2006-10#2)(2010-8#1)(2012-3#1)(2013-7#1)
disease reporting##3##2##(2006-5#1)(2011-2#2)
disease requires##3##2##(2008-6#1)(2010-8#1)(2013-1#1)
disease requiring##3##2##(2007-8#1)(2012-1#1)(2012-12#1)
disease research##4##2##(2007-12#1)(2008-12#1)(2009-10#1)(2013-1#1)
disease resembling##2##2##(1991-11#1)(2008-7#1)
disease resistance QTLs##2##3##(2009-10#2)
disease resistance and##4##3##(2008-10#3)(2009-8#1)
disease resistance genes##2##3##(2008-10#2)
disease resistance in plants##2##4##(2008-10#2)
disease resistance in rice##2##4##(2008-9#1)(2009-10#1)
disease resistance in##8##3##(1992-9#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)
disease resistance is##2##3##(2008-10#2)
disease resistance to bacterial pathogens##2##5##(2008-10#2)
disease resistance##47##2##(1992-9#1)(1997-6#1)(2008-10#32)(2008-8#4)(2008-9#3)(2009-10#4)(2009-8#1)(2010-10#1)
disease resistant##2##2##(2006-10#1)(2008-8#1)
disease response##3##2##(2008-10#3)
disease resulting from##5##3##(1991-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
disease resulting in##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
disease resulting##9##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
disease results##2##2##(1995-2#1)(2011-2#1)
disease revealed##2##2##(1997-8#1)(2008-7#1)
disease risk and##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
disease risk assessment##4##3##(2008-10#3)(2009-4#1)
disease risk factors and##2##4##(2008-7#1)(2011-2#1)
disease risk factors in##2##4##(2008-10#1)(2012-2#1)
disease risk factors##10##3##(1991-6#2)(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#3)(2011-2#1)(2012-2#1)
disease risk in##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
disease risk##41##2##(1991-6#4)(1993-3#1)(1995-2#1)(2007-12#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#5)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#5)
disease scores##3##2##(2008-10#3)
disease secondary to##3##3##(1990-12#1)(1992-11#1)(2007-7#1)
disease seen in##2##3##(2008-5#1)(2011-1#1)
disease seen##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
disease severities were##2##3##(2008-10#1)(2008-12#1)
disease severities##3##2##(2008-10#2)(2008-12#1)
disease severity and pathogen population##2##5##(2008-10#2)
disease severity and pathogen##3##4##(2008-10#3)
disease severity and##17##3##(1990-3#1)(1994-11#1)(2008-10#11)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)
disease severity as##2##3##(2008-10#1)(2012-2#1)
disease severity at##4##3##(2008-10#4)
disease severity between##2##3##(2008-10#2)
disease severity by##4##3##(2008-10#3)(2012-1#1)
disease severity compared with##2##4##(2008-10#2)
disease severity in PEI##2##4##(2008-10#2)
disease severity in##15##3##(2008-10#12)(2008-5#1)(2008-9#1)(2009-2#1)
disease severity of##3##3##(2008-10#3)
disease severity on##6##3##(2008-10#5)(2008-12#1)
disease severity than##3##3##(2008-10#3)
disease severity values##2##3##(2008-10#2)
disease severity was##9##3##(2008-10#9)
disease severity were##4##3##(2008-10#4)
disease severity##169##2##(1990-3#1)(1994-11#1)(1994-9#1)(1996-1#2)(1997-5#1)(2006-10#1)(2008-10#126)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-2#6)(2009-4#3)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
disease severity)##5##2##(2008-10#5)
disease should be considered in##3##5##(2007-8#1)(2008-10#1)(2011-2#1)
disease should be considered##4##4##(1990-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
disease should be##16##3##(1990-9#1)(1991-8#1)(1993-11#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
disease should##20##2##(1990-9#1)(1991-8#1)(1993-11#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
disease shows that##2##3##(1993-2#1)(2008-8#1)
disease significantly##2##2##(2008-7#1)(2009-6#1)
disease since##3##2##(2008-7#1)(2008-9#1)(2010-3#1)
disease site##2##2##(2007-12#1)(2008-7#1)
disease sites##3##2##(2008-10#2)(2012-2#1)
disease spread within the##2##4##(2008-1#1)(2008-10#1)
disease spread##14##2##(1990-8#1)(2008-1#2)(2008-10#8)(2008-2#1)(2010-1#1)(2011-2#1)
disease stage and##3##3##(1990-12#1)(1992-6#1)(2013-1#1)
disease stage##7##2##(1990-12#1)(1991-8#1)(1992-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
disease stages##3##2##(1995-9#1)(2009-8#1)(2010-7#1)
disease state management##2##3##(2008-1#2)
disease state##4##2##(2008-1#3)(2008-10#1)
disease states and##3##3##(1992-12#1)(2008-4#1)(2009-8#1)
disease states##27##2##(1992-12#1)(1995-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-3#1)
disease status of##9##3##(1992-3#2)(1994-11#1)(2008-10#5)(2008-9#1)
disease status##14##2##(1991-4#1)(1992-3#2)(1994-11#1)(2008-10#6)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)
disease subjects##2##2##(1994-11#1)(2008-7#1)
disease successfully##2##2##(2008-2#1)(2010-12#1)
disease such as##5##3##(1990-2#1)(1992-12#1)(2007-8#1)(2011-2#1)(2011-3#1)
disease suppression by the##2##4##(2008-10#2)
disease suppression by##7##3##(2008-10#7)
disease suppression in##2##3##(2008-10#2)
disease suppression was##5##3##(2008-10#5)
disease suppression with##2##3##(2008-10#2)
disease suppression##41##2##(2008-10#41)
disease suppressive##2##2##(2008-10#2)
disease suppressiveness of soils##3##4##(2008-10#3)
disease suppressiveness of##4##3##(2008-10#4)
disease suppressiveness##9##2##(2008-10#9)
disease surveillance system##3##3##(1994-9#1)(1997-3#2)
disease surveillance##15##2##(1994-9#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-3#6)(2008-1#2)(2009-6#1)(2010-4#1)(2011-2#1)
disease susceptibility##6##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
disease symptom##5##2##(2008-10#2)(2008-12#1)(2008-7#2)
disease symptoms and##5##3##(2008-10#1)(2008-5#1)(2008-7#3)
disease symptoms in##2##3##(2008-10#2)
disease symptoms of##2##3##(2008-10#2)
disease symptoms on##5##3##(2008-10#5)
disease symptoms were##4##3##(2008-10#4)
disease symptoms##40##2##(2007-11#1)(2008-10#32)(2008-5#2)(2008-7#3)(2011-1#1)(2013-8#1)
disease syndromes##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
disease synergism##2##2##(2008-10#2)
disease systems##2##2##(2008-10#2)
disease than in those##3##4##(1992-12#1)(2012-3#1)(2013-1#1)
disease than in##4##3##(1992-12#1)(1996-9#1)(2012-3#1)(2013-1#1)
disease than other##2##3##(2009-5#1)(2011-2#1)
disease than the##2##3##(2008-10#2)
disease than##19##2##(1992-12#1)(1996-9#1)(2008-10#9)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease that affects##5##3##(2008-10#2)(2008-6#1)(2009-9#1)(2010-4#1)
disease that can##3##3##(1996-11#1)(2009-1#1)(2011-2#1)
disease that causes##2##3##(2008-10#1)(2011-1#1)
disease that has##3##3##(1994-12#1)(2007-12#1)(2010-12#1)
disease that is a##2##4##(2008-10#1)(2011-2#1)
disease that is##9##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
disease that occurred in##2##4##(2010-4#1)(2012-3#1)
disease that originated##2##3##(2008-10#2)
disease that##49##2##(1992-9#1)(1994-12#1)(1994-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
disease the method##2##3##(1990-11#1)(1994-11#1)
disease the##5##2##(1990-11#1)(1994-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
disease therapy##2##2##(2008-7#1)(2013-1#1)
disease there##2##2##(2013-1#1)(2013-8#1)
disease threats##2##2##(2007-12#1)(2010-12#1)
disease through their##2##3##(1996-3#1)(2008-10#1)
disease through##7##2##(1993-8#1)(1996-3#1)(2006-6#1)(2007-12#1)(2008-10#2)(2011-2#1)
disease to be##5##3##(1990-9#1)(1997-3#1)(2007-7#1)(2008-11#1)(2010-6#1)
disease to date##2##3##(2007-11#1)(2012-12#1)
disease to the##7##3##(1990-12#1)(1991-8#1)(2008-1#2)(2008-10#1)(2011-2#2)
disease to##29##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#2)(2010-1#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
disease tolerance##2##2##(2008-10#2)
disease transmission to the##2##4##(2011-2#2)
disease transmission##15##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#5)(2008-9#2)(2010-5#1)(2011-2#2)
disease transmitted##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
disease treated##4##2##(1993-2#1)(2011-2#3)
disease type 1A##2##3##(1997-3#1)(2008-7#1)
disease type 4C##2##3##(2013-1#2)
disease type##10##2##(1990-2#1)(1992-6#2)(1995-8#1)(1997-2#2)(1997-3#1)(2008-7#1)(2013-1#2)
disease under##5##2##(1996-7#1)(2008-10#3)(2008-4#1)
disease undergoing##3##2##(2006-10#1)(2007-8#1)(2008-10#1)
disease underwent##3##2##(1991-2#1)(1994-3#1)(2009-10#1)
disease using measurements of dysphonia##2##5##(2010-8#2)
disease using##11##2##(2008-10#2)(2008-7#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
disease usually##2##2##(2007-12#1)(2012-2#1)
disease vaccine##2##2##(2007-12#1)(2011-2#1)
disease vectors##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
disease virus (NDV)##5##3##(1997-6#1)(2007-6#1)(2008-11#1)(2008-9#1)(2013-8#1)
disease virus in##2##3##(1997-6#1)(2008-5#1)
disease virus##28##2##(1990-11#1)(1994-6#1)(1994-8#2)(1997-6#2)(2007-6#4)(2008-11#4)(2008-5#7)(2008-9#2)(2011-1#2)(2011-2#2)(2013-8#1)
disease warning system##2##3##(2008-10#2)
disease was detected##2##3##(1996-6#1)(2008-10#1)
disease was diagnosed##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
disease was established##2##3##(1992-2#1)(1997-8#1)
disease was first##3##3##(2008-10#3)
disease was found in##2##4##(2007-10#1)(2011-2#1)
disease was found to be##3##5##(2008-1#2)(2008-10#1)
disease was found to##4##4##(2008-1#2)(2008-10#1)(2008-7#1)
disease was found##7##3##(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-7#1)(2011-2#1)
disease was highest in##2##4##(1994-5#1)(2008-10#1)
disease was investigated##2##3##(2008-10#2)
disease was less##2##3##(2012-12#1)(2013-1#1)
disease was made##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
disease was most##2##3##(2008-10#2)
disease was not##3##3##(1991-8#1)(2008-10#1)(2008-7#1)
disease was observed##7##3##(1991-8#1)(2008-10#3)(2008-7#1)(2010-11#2)
disease was present in##2##4##(1990-3#1)(2008-10#1)
disease was the most common##2##5##(2008-1#1)(2011-2#1)
disease was the##4##3##(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)
disease was##104##2##(1990-3#1)(1991-3#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-3#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#41)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2010-11#2)(2010-3#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
disease week##2##2##(2009-9#2)
disease were described##2##3##(2008-10#1)(2011-2#1)
disease were diagnosed##2##3##(1996-3#1)(2008-10#1)
disease were examined##2##3##(1992-11#1)(2007-11#1)
disease were studied##5##3##(1991-11#1)(1991-5#1)(2007-10#1)(2008-5#1)(2008-7#1)
disease were treated##2##3##(2007-8#1)(2008-7#1)
disease were##44##2##(1990-10#1)(1990-2#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(1994-2#2)(1994-7#1)(1996-3#1)(1997-3#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
disease when used alone##2##4##(2008-10#2)
disease when used##3##3##(2008-10#3)
disease when##7##2##(1991-12#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-10#3)
disease where##2##2##(2008-1#1)(2008-10#1)
disease which affects##3##3##(1997-8#1)(2008-10#1)(2012-12#1)
disease which is##2##3##(1992-9#1)(1993-6#1)
disease which was##2##3##(1996-3#1)(2011-3#1)
disease which##18##2##(1992-5#1)(1992-9#1)(1993-6#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-8#3)(2008-1#2)(2008-10#1)(2008-5#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
disease while##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
disease who are##4##3##(2006-10#1)(2008-1#2)(2009-2#1)
disease who was##4##3##(1996-6#1)(1997-5#1)(2008-1#1)(2010-12#1)
disease who were##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
disease who##19##2##(1991-9#1)(1992-11#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#2)(2011-2#1)(2013-8#1)
disease will be##3##3##(1990-6#1)(1997-8#1)(2012-2#1)
disease will##10##2##(1990-6#1)(1995-6#1)(1997-8#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)(2013-8#1)
disease with a major##2##4##(1994-9#1)(2007-2#1)
disease with a poor prognosis##3##5##(1997-5#1)(2008-11#1)(2008-6#1)
disease with a very##2##4##(1996-3#1)(2010-6#1)
disease with a##15##3##(1990-2#1)(1993-2#1)(1994-9#2)(1996-3#1)(1997-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease with an##2##3##(1991-11#1)(1993-9#1)
disease with higher##2##3##(1997-8#1)(2013-8#1)
disease with no##2##3##(2006-10#1)(2008-10#1)
disease with onset##2##3##(1990-3#1)(2007-7#1)
disease with the use of##2##5##(2006-10#1)(2007-11#1)
disease with the##3##3##(2006-10#1)(2007-11#1)(2010-3#1)
disease with unknown##2##3##(1992-11#1)(2008-10#1)
disease with varied##2##3##(2009-5#1)(2013-8#1)
disease with##83##2##(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-11#2)(1991-4#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-11#1)(1996-3#1)(1997-5#1)(1997-8#2)(2006-10#4)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
disease within##5##2##(1995-2#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
disease without##5##2##(1992-3#1)(2008-1#2)(2008-6#1)(2009-11#1)
disease would##3##2##(2007-10#1)(2012-3#1)(2013-1#1)
disease##7235##1##(1990-10#5)(1990-11#16)(1990-12#16)(1990-2#19)(1990-3#44)(1990-5#9)(1990-6#31)(1990-7#3)(1990-8#16)(1990-9#18)(1991-1#3)(1991-10#2)(1991-11#39)(1991-12#40)(1991-2#25)(1991-3#11)(1991-4#18)(1991-5#9)(1991-6#28)(1991-7#3)(1991-8#34)(1991-9#13)(1992-1#3)(1992-10#2)(1992-11#11)(1992-12#36)(1992-2#23)(1992-3#16)(1992-4#6)(1992-5#20)(1992-6#26)(1992-8#27)(1992-9#31)(1993-1#12)(1993-11#30)(1993-12#35)(1993-2#22)(1993-3#18)(1993-5#7)(1993-6#18)(1993-8#7)(1993-9#10)(1994-11#29)(1994-12#16)(1994-2#14)(1994-3#14)(1994-5#23)(1994-6#15)(1994-7#9)(1994-8#20)(1994-9#39)(1995-1#5)(1995-10#1)(1995-11#11)(1995-12#42)(1995-2#20)(1995-3#17)(1995-4#2)(1995-5#26)(1995-6#9)(1995-8#12)(1995-9#7)(1996-1#9)(1996-11#17)(1996-12#30)(1996-2#20)(1996-3#29)(1996-5#12)(1996-6#19)(1996-7#3)(1996-8#17)(1996-9#14)(1997-1#17)(1997-2#22)(1997-3#53)(1997-4#24)(1997-5#19)(1997-6#29)(1997-7#25)(1997-8#79)(2006-10#72)(2006-12#2)(2006-5#3)(2006-6#4)(2007-1#1)(2007-10#48)(2007-11#65)(2007-12#77)(2007-2#25)(2007-4#2)(2007-5#8)(2007-6#16)(2007-7#110)(2007-8#72)(2007-9#5)(2008-1#173)(2008-10#1669)(2008-11#97)(2008-12#75)(2008-2#26)(2008-3#91)(2008-4#76)(2008-5#122)(2008-6#98)(2008-7#404)(2008-8#114)(2008-9#90)(2009-1#10)(2009-10#50)(2009-11#11)(2009-12#21)(2009-2#14)(2009-3#22)(2009-4#26)(2009-5#42)(2009-6#19)(2009-7#15)(2009-8#28)(2009-9#15)(2010-1#23)(2010-10#22)(2010-11#37)(2010-12#139)(2010-2#15)(2010-3#39)(2010-4#27)(2010-5#41)(2010-6#55)(2010-7#14)(2010-8#65)(2010-9#15)(2011-1#88)(2011-10#2)(2011-2#373)(2011-3#13)(2011-7#4)(2011-8#1)(2012-1#34)(2012-12#131)(2012-2#186)(2012-3#120)(2012-4#1)(2013-1#252)(2013-3#1)(2013-7#33)(2013-8#155)
disease&quot##6##1##(1995-5#1)(1997-6#1)(2008-10#1)(2010-4#1)(2013-1#2)
disease's##4##1##(1992-2#1)(2007-10#1)(2009-1#1)(2012-12#1)
disease) and##4##2##(2008-4#1)(2012-2#1)(2013-8#2)
disease) in##4##2##(1996-3#1)(1996-8#1)(2011-2#1)(2012-3#1)
disease) is##2##2##(1990-5#1)(2008-10#1)
disease) or##2##2##(2008-1#1)(2012-3#1)
disease) that##2##2##(1990-9#1)(2008-3#1)
disease) with##2##2##(1995-3#1)(2011-2#1)
disease)##49##1##(1990-5#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#1)(1995-3#1)(1996-3#2)(1996-8#2)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-3#4)(2011-2#3)(2012-2#2)(2012-3#4)(2013-8#9)
disease- and##4##2##(1997-8#1)(2008-10#3)
disease-##6##1##(1997-8#1)(2008-10#4)(2011-2#1)
disease--current##2##1##(2008-4#1)(2009-8#1)
disease-associated##9##1##(1996-12#1)(1997-8#1)(2008-10#3)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)
disease-causing mutations##2##2##(2008-8#1)(2009-5#1)
disease-causing##6##1##(2008-10#1)(2008-4#1)(2008-8#2)(2009-5#1)(2012-3#1)
disease-centric##2##1##(2011-2#1)(2013-8#1)
disease-free and overall survival##2##4##(1990-12#1)(1995-4#1)
disease-free and##3##2##(1990-12#2)(1995-4#1)
disease-free for##2##2##(1991-2#1)(2010-3#1)
disease-free interval of##3##3##(1992-10#1)(2008-6#1)(2011-2#1)
disease-free interval##9##2##(1992-10#1)(1993-11#1)(2008-6#2)(2010-3#3)(2011-2#2)
disease-free intervals##2##2##(1994-2#1)(2010-7#1)
disease-free rates##2##2##(1991-8#1)(2008-1#1)
disease-free survival (DFS)##3##3##(2007-10#1)(2008-10#1)(2010-3#1)
disease-free survival rate was##3##4##(1997-7#2)(2011-2#1)
disease-free survival rate##6##3##(1994-7#1)(1997-7#4)(2011-2#1)
disease-free survival##26##2##(1990-12#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#2)(1997-3#1)(1997-7#4)(2007-10#1)(2007-12#1)(2008-10#3)(2008-6#1)(2010-3#1)(2011-2#3)(2013-7#1)
disease-free##58##1##(1990-12#3)(1991-2#1)(1991-8#3)(1992-10#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#2)(1995-4#1)(1997-3#1)(1997-7#5)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#6)(2008-6#6)(2010-3#5)(2010-7#1)(2011-2#7)(2013-7#1)(2013-8#1)
disease-induced root growth##5##3##(2008-10#5)
disease-induced root production##3##3##(2008-10#3)
disease-induced root##8##2##(2008-10#8)
disease-induced##10##1##(2008-10#10)
disease-modifying antirheumatic drugs (DMARDs)##2##4##(1990-6#1)(2010-5#1)
disease-modifying antirheumatic drugs##5##3##(1990-6#1)(2006-10#1)(2008-8#1)(2010-5#1)(2011-2#1)
disease-modifying##8##1##(1990-6#1)(2006-10#1)(2008-1#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-2#1)
disease-related##11##1##(1994-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
disease-resistant##5##1##(2008-10#3)(2008-8#1)(2011-10#1)
disease-specific survival was##2##3##(2008-6#2)
disease-specific survival##9##2##(2008-6#6)(2011-2#2)(2013-1#1)
disease-specific##19##1##(1991-5#1)(1994-12#1)(1996-1#2)(2008-1#1)(2008-11#1)(2008-6#6)(2008-7#1)(2009-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
disease-suppressive mechanisms##2##2##(2008-10#2)
disease-suppressive soils##2##2##(2008-10#2)
disease-suppressive##7##1##(2008-10#7)
disease/rare variant##4##2##(2012-3#4)
disease?##15##1##(1994-1#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-7#1)(2013-8#2)
disease?]##6##1##(1991-3#1)(1991-6#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
disease]##60##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-11#1)(1996-11#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-9#2)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#7)
diseased and##6##2##(1994-1#1)(2008-10#5)
diseased area##2##2##(2008-10#2)
diseased bean leaves##2##3##(2008-10#2)
diseased bean##3##2##(2008-10#3)
diseased cucumber##2##2##(2008-10#2)
diseased cultivar##2##2##(2008-10#2)
diseased from##2##2##(2008-10#1)(2011-2#1)
diseased fruit##2##2##(2008-10#2)
diseased individuals at##2##3##(2008-10#2)
diseased individuals##3##2##(2008-10#3)
diseased leaf area##4##3##(2008-10#4)
diseased leaves was significantly higher##2##5##(2008-10#2)
diseased leaves##8##2##(2008-10#8)
diseased lettuce##4##2##(2008-10#4)
diseased orchards##2##2##(2008-10#2)
diseased plant units##2##3##(2008-10#2)
diseased plant##4##2##(2008-10#4)
diseased plants and##2##3##(2008-10#2)
diseased plants is##2##3##(2008-10#2)
diseased plants##17##2##(2008-10#17)
diseased plants)##2##2##(2008-10#2)
diseased roots##6##2##(2008-10#6)
diseased seedlings##4##2##(2008-10#4)
diseased strawberry##3##2##(2008-10#3)
diseased than##3##2##(2008-10#3)
diseased tissue##7##2##(1995-12#1)(2008-10#5)(2013-1#1)
diseased tissues is##2##3##(2010-6#1)(2010-8#1)
diseased tissues##4##2##(2008-10#2)(2010-6#1)(2010-8#1)
diseased trees##5##2##(2008-10#5)
diseased##166##1##(1992-3#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1995-12#1)(2007-7#1)(2008-10#138)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
diseased)##2##1##(2008-10#2)
diseases (CVD)##4##2##(2009-9#2)(2011-1#1)(2011-2#1)
diseases affecting##4##2##(1992-8#1)(1997-8#1)(2008-7#1)(2011-10#1)
diseases among##7##2##(1993-11#1)(1994-6#1)(1996-6#1)(2007-2#1)(2008-10#1)(2011-1#1)(2012-12#1)
diseases and a##3##3##(1997-1#1)(2011-1#1)(2011-2#1)
diseases and are##2##3##(1992-3#1)(2010-5#1)
diseases and health##2##3##(1996-1#1)(2012-12#1)
diseases and in##5##3##(1990-3#1)(1993-2#1)(2008-11#1)(2008-5#1)(2010-11#1)
diseases and injuries##4##3##(1990-6#1)(2007-8#1)(2008-10#1)(2012-12#1)
diseases and may##2##3##(2007-10#1)(2008-10#1)
diseases and medical##3##3##(1991-11#1)(1991-6#1)(2008-11#1)
diseases and pathogens##2##3##(2008-10#1)(2012-2#1)
diseases and the##10##3##(1991-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
diseases and their##2##3##(2007-11#1)(2013-1#1)
diseases and to the development of##2##6##(1993-2#1)(2010-5#1)
diseases and to##3##3##(1992-5#1)(1993-2#1)(2010-5#1)
diseases and total##2##3##(2008-10#1)(2013-8#1)
diseases and##121##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#5)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2009-10#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2011-1#9)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
diseases and/or pathology##2##3##(2010-1#2)
diseases and/or##3##2##(2009-9#1)(2010-1#2)
diseases are a##2##3##(2008-7#1)(2009-4#1)
diseases are also##2##3##(2008-1#1)(2011-2#1)
diseases are among the##3##4##(2013-1#2)(2013-8#1)
diseases are associated with##2##4##(1991-9#1)(1995-3#1)
diseases are at##2##3##(2008-1#1)(2008-10#1)
diseases are considered##2##3##(2008-10#1)(2008-9#1)
diseases are influenced by##2##4##(2008-3#1)(2008-4#1)
diseases are not##2##3##(2008-10#1)(2012-2#1)
diseases are reviewed##2##3##(2008-7#1)(2010-9#1)
diseases are still##2##3##(2007-7#1)(2008-2#1)
diseases are the##5##3##(1991-6#1)(1996-11#1)(1996-2#1)(2008-10#1)(2013-1#1)
diseases are transmitted##2##3##(2007-2#1)(2008-10#1)
diseases are##58##2##(1990-2#2)(1991-2#1)(1991-6#1)(1991-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#2)(2010-9#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
diseases as well as##2##4##(2007-11#1)(2008-7#1)
diseases as well##3##3##(2007-11#1)(2008-7#1)(2010-8#1)
diseases as##12##2##(1994-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
diseases associated with the##2##4##(2009-12#1)(2010-5#1)
diseases associated with##14##3##(1992-6#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#2)
diseases at the##2##3##(1995-5#1)(2008-10#1)
diseases at##5##2##(1994-5#1)(1995-5#1)(2008-10#2)(2011-1#1)
diseases between##2##2##(2011-1#1)(2013-1#1)
diseases but##3##2##(1991-11#1)(1993-8#1)(2013-8#1)
diseases by##10##2##(1993-9#1)(2013-1#1)(2013-8#8)
diseases can be##8##3##(1990-6#1)(1993-6#1)(1996-9#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)
diseases can##10##2##(1990-6#1)(1992-6#1)(1993-6#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)
diseases caused by soilborne##3##4##(2008-10#3)
diseases caused by##16##3##(1994-9#1)(1995-2#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
diseases causing##6##2##(1997-6#1)(2008-7#1)(2010-12#3)(2012-12#1)
diseases characterised by##2##3##(2012-2#2)
diseases characterized by##3##3##(2009-8#1)(2011-1#1)(2011-2#1)
diseases diagnosed##3##2##(1993-2#1)(1994-2#2)
diseases during the##2##3##(2008-10#1)(2011-1#1)
diseases during##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
diseases for which##4##3##(1997-2#1)(1997-3#1)(2008-10#1)(2010-10#1)
diseases for##8##2##(1997-2#1)(1997-3#1)(2008-10#3)(2008-4#1)(2009-12#1)(2010-10#1)
diseases from##2##2##(2008-10#2)
diseases has been##3##3##(1997-3#1)(2008-11#1)(2012-3#1)
diseases has##7##2##(1997-3#2)(2008-11#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
diseases have been associated with##2##5##(2011-2#1)(2012-2#1)
diseases have been##8##3##(1991-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
diseases have##15##2##(1991-12#1)(1991-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#3)(2012-2#1)(2013-8#2)
diseases in Canadian##2##3##(2007-12#2)
diseases in North##2##3##(2008-10#1)(2010-1#1)
diseases in South Africa##2##4##(2010-1#2)
diseases in a##3##3##(2008-1#1)(2008-7#2)
diseases in adulthood##2##3##(2012-2#2)
diseases in children in##2##4##(2007-7#1)(2008-7#1)
diseases in children##8##3##(1997-2#1)(1997-8#2)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
diseases in humans##6##3##(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
diseases in order to##2##4##(2011-2#1)(2011-7#1)
diseases in other##2##3##(2008-10#1)(2008-7#1)
diseases in the elderly##3##4##(1991-3#1)(1994-5#1)(1997-8#1)
diseases in the world##2##4##(2008-1#1)(2013-8#1)
diseases in the##35##3##(1990-6#2)(1991-3#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-5#2)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
diseases in this##2##3##(2008-10#1)(2013-8#1)
diseases in travelers##3##3##(2007-2#1)(2011-2#2)
diseases in which##3##3##(1997-8#1)(2006-6#1)(2008-10#1)
diseases in##139##2##(1990-12#1)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#5)(2006-5#2)(2006-6#1)(2007-12#3)(2007-2#2)(2007-7#6)(2008-1#6)(2008-10#17)(2008-11#3)(2008-12#2)(2008-4#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-1#3)(2010-10#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
diseases include##3##2##(2007-7#1)(2008-11#1)(2011-7#1)
diseases included##2##2##(2007-6#1)(2007-7#1)
diseases including HIV/AIDS##2##3##(1996-12#1)(2012-2#1)
diseases including atherosclerosis##2##3##(1993-3#1)(2012-3#1)
diseases including cancer##2##3##(2009-4#1)(2010-2#1)
diseases including##21##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
diseases involving##2##2##(1996-12#1)(2008-10#1)
diseases is one of the##2##5##(2008-10#1)(2010-12#1)
diseases is the##6##3##(1994-5#1)(1994-8#1)(1996-5#1)(2008-9#1)(2009-5#1)(2012-2#1)
diseases is##16##2##(1994-5#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#1)
diseases like##11##2##(1993-2#1)(1993-5#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2013-1#1)
diseases linked to##2##3##(2008-10#1)(2009-8#1)
diseases may##7##2##(1991-12#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-4#1)(2013-1#2)
diseases might##2##2##(2007-5#1)(2012-2#1)
diseases must##2##2##(1994-9#1)(2007-12#1)
diseases occurring##2##2##(1996-3#1)(2008-7#1)
diseases of barley in the##3##5##(2008-10#3)
diseases of childhood##4##3##(1991-2#1)(1997-8#1)(2008-10#1)(2011-2#1)
diseases of citrus##2##3##(2008-10#1)(2011-2#1)
diseases of potato##2##3##(2008-10#2)
diseases of rice##2##3##(2008-10#2)
diseases of strawberry##2##3##(2008-10#2)
diseases of the brain##2##4##(2010-12#1)(2012-2#1)
diseases of the nervous system##2##5##(1992-9#1)(2008-4#1)
diseases of the urinary tract##2##5##(2007-5#2)
diseases of the##37##3##(1990-5#1)(1990-6#1)(1992-4#2)(1992-9#1)(1994-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1997-1#1)(1997-6#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-9#1)(2010-12#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
diseases of tropical##2##3##(2008-10#2)
diseases of wheat##6##3##(2008-10#5)(2011-10#1)
diseases of##101##2##(1990-5#1)(1990-6#1)(1991-2#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-6#1)(1994-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-9#2)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
diseases often##4##2##(1990-11#1)(1992-4#1)(2008-8#1)(2008-9#1)
diseases on a##2##3##(2008-10#2)
diseases on##10##2##(2008-10#4)(2011-2#3)(2012-12#1)(2013-1#2)
diseases or##9##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-12#1)
diseases related to##6##3##(1995-9#1)(2008-10#2)(2010-8#1)(2011-1#1)(2012-3#1)
diseases remain##3##2##(1996-2#1)(2008-11#1)(2010-8#1)
diseases should be##3##3##(1992-8#1)(2008-5#1)(2011-1#1)
diseases such as Alzheimer's disease##3##5##(1994-9#1)(2008-11#1)(2009-8#1)
diseases such as allergic rhinitis##2##5##(2008-3#1)(2012-12#1)
diseases such as arthritis##2##4##(2008-4#1)(2008-7#1)
diseases such as asthma##3##4##(1994-11#1)(2008-10#1)(2008-3#1)
diseases such as atherosclerosis##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
diseases such as malaria##2##4##(2010-8#1)(2012-12#1)
diseases such as multiple sclerosis##2##5##(2011-2#1)(2012-3#1)
diseases such as##45##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-9#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)
diseases suggest that##2##3##(2010-12#1)(2011-1#1)
diseases than##3##2##(1992-6#1)(2008-7#1)(2009-5#1)
diseases that are##3##3##(1997-3#1)(2008-4#1)(2010-4#1)
diseases that##20##2##(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
diseases they cause##2##3##(2008-10#2)
diseases through##4##2##(2008-5#1)(2011-2#1)(2013-1#2)
diseases to##7##2##(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1995-12#1)(1996-1#1)(2008-10#1)
diseases treated with##2##3##(2010-8#1)(2011-2#1)
diseases treated##3##2##(2010-8#1)(2011-2#1)(2012-12#1)
diseases under##2##2##(2008-10#1)(2008-8#1)
diseases was##8##2##(1994-3#1)(2008-10#5)(2008-7#1)(2013-8#1)
diseases were considered##2##3##(2007-7#1)(2008-10#1)
diseases were excluded##2##3##(2011-2#1)(2013-8#1)
diseases were the##3##3##(1995-6#1)(2007-7#1)(2008-3#1)
diseases were##19##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-6#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-8#1)
diseases when##2##2##(1996-9#1)(2008-10#1)
diseases where##3##2##(1994-2#1)(1994-8#1)(2011-2#1)
diseases which are not##2##4##(1995-2#1)(2010-4#1)
diseases which are##7##3##(1991-11#1)(1991-12#1)(1995-2#1)(2008-11#1)(2009-5#1)(2010-4#1)(2013-8#1)
diseases which##14##2##(1991-11#1)(1991-12#1)(1994-5#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-4#1)(2013-1#4)(2013-8#1)
diseases will##5##2##(1992-9#1)(1993-12#1)(1994-2#1)(2009-9#1)(2012-2#1)
diseases with a##4##3##(1993-8#1)(1997-5#1)(2008-10#1)(2008-4#1)
diseases with similar##2##3##(1993-8#1)(2013-8#1)
diseases with##25##2##(1992-3#1)(1992-6#1)(1993-8#2)(1996-6#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
diseases worldwide##2##2##(2012-3#1)(2013-8#1)
diseases##1752##1##(1990-11#5)(1990-12#5)(1990-2#8)(1990-3#7)(1990-5#5)(1990-6#16)(1990-8#3)(1990-9#3)(1991-11#8)(1991-12#8)(1991-2#10)(1991-3#4)(1991-5#6)(1991-6#11)(1991-8#1)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#5)(1992-4#4)(1992-5#5)(1992-6#6)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#10)(1993-3#4)(1993-5#2)(1993-6#4)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#12)(1994-6#9)(1994-8#4)(1994-9#9)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#3)(1995-5#6)(1995-6#3)(1995-8#3)(1995-9#9)(1996-1#3)(1996-11#6)(1996-12#6)(1996-2#6)(1996-3#11)(1996-5#3)(1996-6#8)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#8)(1997-2#7)(1997-3#22)(1997-4#1)(1997-5#5)(1997-6#5)(1997-7#14)(1997-8#13)(2006-10#6)(2006-5#2)(2006-6#1)(2007-10#3)(2007-11#15)(2007-12#11)(2007-2#11)(2007-4#2)(2007-5#10)(2007-6#2)(2007-7#24)(2007-8#9)(2008-1#46)(2008-10#243)(2008-11#36)(2008-12#13)(2008-2#7)(2008-3#15)(2008-4#38)(2008-5#29)(2008-6#3)(2008-7#68)(2008-8#34)(2008-9#17)(2009-1#4)(2009-10#7)(2009-12#11)(2009-2#6)(2009-3#2)(2009-4#7)(2009-5#15)(2009-6#8)(2009-7#2)(2009-8#7)(2009-9#9)(2010-1#11)(2010-10#7)(2010-11#3)(2010-12#31)(2010-2#2)(2010-3#10)(2010-4#9)(2010-5#21)(2010-6#5)(2010-7#2)(2010-8#17)(2010-9#3)(2011-1#58)(2011-10#3)(2011-2#103)(2011-3#7)(2011-7#6)(2011-9#1)(2012-1#13)(2012-12#38)(2012-2#69)(2012-3#44)(2013-1#80)(2013-7#10)(2013-8#70)
diseases&quot##3##1##(1995-6#1)(2008-9#1)(2011-7#1)
diseases'##2##1##(2010-4#1)(2013-8#1)
diseases) and##2##2##(1990-9#1)(2008-10#1)
diseases)##8##1##(1990-9#1)(1993-2#1)(1995-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
diseases?##3##1##(2008-7#2)(2010-12#1)
diseases]##38##1##(1990-3#2)(1990-8#1)(1991-2#2)(1992-4#1)(1992-9#1)(1993-11#3)(1993-2#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
diselenide##2##1##(1992-12#1)(2008-10#1)
disenfranchised##2##1##(1996-12#1)(2008-8#1)
disengaged##2##1##(1992-4#1)(2011-2#1)
disengagement and re-engagement##3##3##(2010-2#3)
disengagement and##5##2##(2010-2#5)
disengagement##16##1##(2008-11#1)(2008-9#1)(2009-9#6)(2010-2#6)(2010-7#2)
disengaging from##2##2##(2008-2#1)(2012-12#1)
disengaging##3##1##(2008-2#1)(2010-7#1)(2012-12#1)
disenrollment##3##1##(1993-12#1)(1996-3#1)(1997-3#1)
disentangle the##5##2##(1991-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
disentangle##6##1##(1991-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
disequilibria between##3##2##(2008-10#2)(2008-8#1)
disequilibrium between##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
disequilibrium of##2##2##(1997-8#1)(2008-9#1)
disequilibrium was##2##2##(2008-10#1)(2012-3#1)
disequilibrium##38##1##(1995-6#1)(1997-5#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-2#2)(2012-3#8)(2012-5#1)
disfavor##2##1##(1991-5#1)(1995-6#1)
disfiguring##4##1##(1991-11#1)(1997-8#2)(2008-9#1)
disfluency##11##1##(2008-2#11)
disguise##2##1##(1995-2#1)(2008-10#1)
disguising##2##1##(2008-5#1)(2011-1#1)
disgust and##3##2##(2010-7#2)(2013-8#1)
disgust attentional biases##2##3##(2010-7#2)
disgust in##2##2##(2012-2#2)
disgust prone individuals##3##3##(2010-7#3)
disgust targets impaired attention##2##4##(2010-7#2)
disgust targets##3##2##(2010-7#3)
disgust##36##1##(2008-11#4)(2009-8#3)(2010-7#15)(2012-2#11)(2013-8#3)
dish after##2##2##(2008-11#2)
dish that had a##2##4##(2008-11#2)
dish##35##1##(1995-12#1)(2008-10#4)(2008-11#20)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#7)
dishabituation##4##1##(1994-3#1)(2008-6#3)
dishes and##4##2##(1994-3#1)(1995-8#1)(2008-11#2)
dishes containing##2##2##(2008-10#1)(2008-11#1)
dishes in##2##2##(2008-11#2)
dishes is##2##2##(2008-11#1)(2011-2#1)
dishes of##2##2##(2008-10#1)(2008-2#1)
dishes tested for##2##3##(1997-4#2)
dishes under##2##2##(1993-3#1)(2008-5#1)
dishes were##2##2##(1993-3#1)(2008-11#1)
dishes with a##2##3##(1995-8#1)(2008-11#1)
dishes with##6##2##(1995-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
dishes without##2##2##(2008-11#1)(2013-1#1)
dishes##51##1##(1993-3#2)(1994-3#1)(1995-11#1)(1995-8#2)(1997-3#1)(1997-4#5)(2008-10#7)(2008-11#24)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#3)(2013-1#2)
dishing##3##1##(2008-3#3)
dishonesty##5##1##(2008-1#1)(2008-12#4)
disialoganglioside##2##1##(1993-11#2)
disilicate##2##1##(2009-7#2)
disincentive to##2##2##(1996-1#1)(2008-8#1)
disincentive##3##1##(1996-1#1)(2008-12#1)(2008-8#1)
disinfectant##3##1##(1992-2#1)(2008-10#1)(2012-2#1)
disinfectants##8##1##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
disinfected with##2##2##(2008-10#1)(2013-1#1)
disinfected##4##1##(2007-7#1)(2008-10#1)(2008-12#1)(2013-1#1)
disinfecting##3##1##(2007-7#1)(2008-10#2)
disinfection and##3##2##(2008-10#1)(2009-5#1)(2013-8#1)
disinfection by-product##2##2##(2008-9#1)(2010-5#1)
disinfection by-products##4##2##(2008-10#1)(2008-9#3)
disinfection of the##2##3##(1994-11#1)(2007-7#1)
disinfection of##8##2##(1994-11#3)(2007-7#3)(2008-3#1)(2013-1#1)
disinfection rates##3##2##(2013-1#3)
disinfection with##3##2##(2007-7#1)(2013-1#1)(2013-8#1)
disinfection##39##1##(1992-2#1)(1994-11#3)(1997-3#2)(2007-12#1)(2007-7#6)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#5)(2009-5#1)(2010-5#1)(2012-2#1)(2013-1#7)(2013-8#4)
disinfection)##2##1##(2007-7#1)(2013-8#1)
disinfested##3##1##(2008-10#3)
disinhibition##12##1##(1994-3#1)(1996-5#1)(1997-2#1)(2009-2#1)(2010-3#3)(2012-12#1)(2013-1#3)(2013-8#1)
disintegrants alone##2##2##(2012-2#2)
disintegrants##3##1##(2010-3#1)(2012-2#2)
disintegrate##2##1##(1994-5#1)(2008-7#1)
disintegrated##4##1##(2007-12#1)(2008-10#2)(2008-7#1)
disintegration of the##2##3##(2008-7#2)
disintegration of##6##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#1)
disintegration##13##1##(1991-2#1)(1996-12#1)(1997-3#3)(2008-10#3)(2008-11#1)(2008-7#2)(2010-4#1)(2011-2#1)
disjoining##3##1##(2008-10#3)
disjoint##4##1##(2007-12#1)(2008-2#2)(2008-6#1)
disjointed##2##1##(1995-1#1)(1996-12#1)
disjunct##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
disk and##5##2##(2008-10#2)(2008-12#1)(2008-3#2)
disk assays##2##2##(2008-10#2)
disk by##2##2##(2008-10#2)
disk defocus##3##2##(2008-2#3)
disk diffusion method##2##3##(2007-7#1)(2013-8#1)
disk diffusion##5##2##(2007-7#2)(2008-5#1)(2011-2#1)(2013-8#1)
disk drive##5##2##(2008-2#2)(2008-3#3)
disk electrode with##2##3##(1990-12#1)(2008-10#1)
disk electrode##14##2##(1990-12#1)(1992-11#1)(2008-10#11)(2008-5#1)
disk hernias##2##2##(1990-9#2)
disk herniation##2##2##(2007-10#2)
disk in##2##2##(1990-12#1)(2008-3#1)
disk is##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
disk microelectrode##3##2##(2008-10#3)
disk prolapse##4##2##(1992-5#1)(1997-2#2)(1997-3#1)
disk readout signals##2##3##(2008-3#2)
disk readout##7##2##(2008-2#2)(2008-3#5)
disk resonator##3##2##(2008-3#3)
disk structure##2##2##(2008-2#1)(2008-3#1)
disk that##3##2##(2008-10#1)(2008-2#2)
disk tilt##8##2##(2008-2#8)
disk to##5##2##(2008-10#4)(2012-2#1)
disk under##2##2##(2008-3#1)(2009-3#1)
disk was##2##2##(2008-10#1)(2008-2#1)
disk were##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
disk with a##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
disk with##9##2##(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)
disk##201##1##(1990-11#1)(1990-12#2)(1990-9#2)(1992-11#1)(1992-5#2)(1993-11#2)(1993-8#1)(1995-11#3)(1996-3#2)(1997-2#2)(1997-3#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#48)(2008-11#2)(2008-12#1)(2008-2#49)(2008-3#54)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#5)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
disk-shaped##3##1##(2007-12#2)(2009-6#1)
disk]##2##1##(1990-9#1)(1996-8#1)
diskectomy##2##1##(2009-3#1)(2012-12#1)
disks and##5##2##(2008-10#3)(2008-3#1)(2010-8#1)
disks are##3##2##(2008-3#2)(2008-5#1)
disks at##2##2##(2008-2#2)
disks by##2##2##(2008-2#1)(2012-2#1)
disks have been##2##3##(2008-10#2)
disks in##3##2##(2008-10#3)
disks is##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
disks of the##2##3##(2008-11#1)(2008-3#1)
disks of##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
disks the##3##2##(2008-2#3)
disks to##2##2##(2008-10#1)(2008-8#1)
disks was##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
disks were inoculated with##2##4##(2008-10#2)
disks were##7##2##(2008-10#5)(2008-3#2)
disks with##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
disks##108##1##(1992-6#1)(1994-11#1)(2008-10#56)(2008-11#2)(2008-12#1)(2008-2#19)(2008-3#18)(2008-5#1)(2008-8#3)(2009-8#2)(2010-8#1)(2012-2#3)
disks)##2##1##(2009-3#2)
dislike##2##1##(1991-6#1)(1995-12#1)
dislipidemia##2##1##(2011-1#2)
dislocated hips##2##2##(2007-11#1)(2007-8#1)
dislocated##14##1##(1997-6#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-8#1)(2009-3#2)(2009-4#4)(2010-5#1)(2012-12#1)
dislocation depends##2##2##(2007-11#1)(2007-8#1)
dislocation for the##2##3##(2008-4#1)(2008-8#1)
dislocation in##6##2##(2007-8#2)(2008-8#1)(2009-3#2)(2011-2#1)
dislocation is the##2##3##(2007-8#1)(2008-12#1)
dislocation loops##2##2##(2012-2#2)
dislocation of a##3##3##(2008-9#1)(2009-3#2)
dislocation of the hip##7##4##(2007-11#4)(2007-8#3)
dislocation of the##23##3##(2007-11#4)(2007-8#5)(2008-10#1)(2008-12#1)(2008-8#2)(2009-1#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
dislocation of##29##2##(2007-11#4)(2007-8#5)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#2)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#1)
dislocation with##2##2##(2008-12#1)(2008-8#1)
dislocation##87##1##(2007-11#10)(2007-12#1)(2007-8#14)(2008-10#1)(2008-11#2)(2008-12#8)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-1#1)(2009-3#9)(2009-4#2)(2010-3#3)(2011-2#10)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#1)
dislocations are##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
dislocations of a##2##3##(2008-2#1)(2009-3#1)
dislocations of##3##2##(2007-12#1)(2008-2#1)(2009-3#1)
dislocations##26##1##(2007-11#15)(2007-12#4)(2008-12#2)(2008-2#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)
dislodged into the subclavian vein##2##5##(2012-2#2)
dislodged##6##1##(1997-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
dislodgement##3##1##(2009-4#1)(2011-2#1)(2012-2#1)
dismal prognosis##2##2##(1993-11#1)(2008-6#1)
dismal##4##1##(1993-11#1)(2008-6#1)(2008-8#1)(2010-12#1)
dismiss##4##1##(1995-12#2)(1995-6#1)(1996-5#1)
dismissal of##2##2##(1995-12#1)(1995-6#1)
dismissal##3##1##(1991-2#1)(1995-12#1)(1995-6#1)
dismissed##10##1##(1993-5#1)(1993-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
dismutase (SOD)##33##2##(1990-11#1)(1991-9#2)(1992-9#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)
dismutase activity##5##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(2008-7#1)
dismutase in##3##2##(1992-11#1)(1994-6#1)(2008-10#1)
dismutase##114##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#5)(1990-5#2)(1991-12#5)(1991-5#1)(1991-9#3)(1992-11#3)(1992-12#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#8)(1995-3#2)(1995-6#4)(1995-8#1)(1996-2#2)(1996-5#2)(1996-6#2)(1997-2#2)(1997-4#4)(1997-8#2)(2007-11#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#4)(2009-12#1)(2009-2#2)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#1)
dismutation activity##2##2##(1997-2#2)
dismutation and##2##2##(1997-2#2)
dismutation##5##1##(1997-2#5)
disodium 1-nitroso-2-naphthol-3##2##2##(2008-10#2)
disodium cromoglycate##5##2##(1997-6#4)(2008-7#1)
disodium##13##1##(1996-5#1)(1997-6#4)(2008-10#7)(2008-7#1)
disomic substitution line##2##3##(2008-10#1)(2008-8#1)
disomic substitution##3##2##(2008-10#2)(2008-8#1)
disomic##10##1##(2008-10#6)(2008-8#3)(2012-2#1)
disorder (ADHD) in##2##3##(2008-6#1)(2011-2#1)
disorder (ADHD) is a##4##4##(1996-6#1)(2008-2#3)
disorder (ADHD)##15##2##(1996-6#1)(2008-2#6)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
disorder (ASD)##2##2##(2011-2#1)(2013-1#1)
disorder (BD)##2##2##(2013-8#2)
disorder (BPD)##4##2##(1997-5#1)(2008-4#1)(2009-8#2)
disorder (MDD)##5##2##(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
disorder (OCD)##6##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-9#1)
disorder (SAD)##3##2##(1995-11#1)(1997-6#1)(2008-6#1)
disorder (n =##3##3##(1994-2#2)(2007-8#1)
disorder affecting##4##2##(2008-5#1)(2008-7#2)(2012-3#1)
disorder among women##2##3##(1994-2#1)(2013-8#1)
disorder among##3##2##(1994-2#1)(1995-5#1)(2013-8#1)
disorder and control##2##3##(2011-2#1)(2013-8#1)
disorder and major depression##2##4##(2009-9#1)(2011-2#1)
disorder and the##6##3##(1991-2#1)(1994-2#1)(1997-5#1)(2008-7#2)(2010-12#1)
disorder and war##2##3##(2007-7#2)
disorder and##55##2##(1990-11#1)(1991-2#1)(1993-8#1)(1994-2#3)(1996-7#1)(1997-5#2)(1997-6#1)(2006-10#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#6)
disorder are also##2##3##(2008-1#1)(2012-3#1)
disorder are##10##2##(1997-2#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-7#1)(2012-3#1)(2013-7#1)
disorder as##3##2##(1992-5#1)(2010-1#1)(2012-2#1)
disorder associated with##4##3##(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
disorder but##2##2##(2011-2#1)(2012-3#1)
disorder can##5##2##(2008-10#2)(2008-4#1)(2008-9#2)
disorder cases as compared##2##4##(2012-2#2)
disorder caused by a deficiency##2##5##(1996-8#1)(2011-2#1)
disorder caused by a##3##4##(1996-8#1)(2011-2#1)(2013-1#1)
disorder caused by the##2##4##(2011-2#1)(2013-8#1)
disorder caused by##11##3##(1990-5#1)(1991-9#1)(1996-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
disorder characterized by a##2##4##(2007-7#1)(2010-3#1)
disorder characterized by the##3##4##(2008-4#1)(2009-10#1)(2012-12#1)
disorder characterized by##27##3##(1991-5#1)(1995-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
disorder diagnoses##3##2##(1993-12#3)
disorder diagnostic##2##2##(2006-10#1)(2012-2#1)
disorder due to##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
disorder group##2##2##(2007-8#1)(2010-5#1)
disorder had##2##2##(1996-7#1)(1997-5#1)
disorder has a##2##3##(2008-11#1)(2008-6#1)
disorder has been##5##3##(1990-5#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-6#1)
disorder has##12##2##(1990-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-6#1)(2010-7#1)(2011-1#1)
disorder in a##2##3##(1990-8#1)(2013-8#1)
disorder in adults##3##3##(1997-8#2)(2008-7#1)
disorder in children and adolescents##3##5##(2008-11#1)(2008-8#2)
disorder in the elderly##2##4##(2008-1#1)(2008-8#1)
disorder in the##9##3##(1997-5#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-11#2)(2011-1#1)(2013-1#1)
disorder in this##3##3##(1997-5#1)(2009-3#2)
disorder in which a##2##4##(2008-9#1)(2013-8#1)
disorder in which##6##3##(1990-8#1)(1994-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-8#1)
disorder in##45##2##(1990-8#2)(1990-9#1)(1992-1#1)(1994-5#1)(1995-2#1)(1997-5#2)(1997-8#3)(2006-9#1)(2007-5#1)(2008-1#2)(2008-11#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
disorder involving##3##2##(2008-3#1)(2008-6#1)(2009-11#1)
disorder is characterized by##2##4##(2008-7#2)
disorder is still##2##3##(1992-5#1)(2008-8#1)
disorder is##28##2##(1992-5#1)(1994-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-3#1)
disorder linked to##2##3##(1997-3#1)(2011-1#1)
disorder may be##2##3##(2010-6#1)(2011-1#1)
disorder may##3##2##(2008-7#1)(2010-6#1)(2011-1#1)
disorder not otherwise##2##3##(2011-2#2)
disorder not##3##2##(2008-12#1)(2011-2#2)
disorder of social##2##3##(2008-4#1)(2009-9#1)
disorder of the peripheral nervous system##2##6##(2007-10#1)(2013-1#1)
disorder of the##16##3##(1991-8#1)(1994-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
disorder of##37##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-8#1)(1992-5#1)(1994-2#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
disorder on##3##2##(1997-5#2)(2013-8#1)
disorder or##2##2##(2008-2#1)(2008-4#1)
disorder patients##5##2##(1996-5#2)(1997-5#1)(2008-6#1)(2012-2#1)
disorder resulting from##3##3##(2006-6#1)(2008-7#1)(2011-2#1)
disorder resulting##4##2##(2006-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
disorder such as##2##3##(2009-1#1)(2010-8#1)
disorder symptoms##2##2##(2007-11#1)(2010-11#1)
disorder that affects##3##3##(2008-2#1)(2011-2#1)(2012-12#1)
disorder that can##2##3##(2007-10#1)(2013-8#1)
disorder that causes##3##3##(2007-10#1)(2008-5#1)(2013-1#1)
disorder that has been##2##4##(1991-8#1)(2008-1#1)
disorder that has##4##3##(1991-8#1)(2008-1#1)(2008-7#1)(2009-9#1)
disorder that is characterized by##2##5##(2008-12#1)(2008-4#1)
disorder that is often##2##4##(1996-7#1)(2008-4#1)
disorder that is##5##3##(1996-7#1)(2008-10#1)(2008-12#1)(2008-4#2)
disorder that presents with##2##4##(2007-8#1)(2008-2#1)
disorder that##27##2##(1991-8#1)(1996-7#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
disorder to##4##2##(1996-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
disorder was found in##2##4##(1993-12#1)(2008-7#1)
disorder was##7##2##(1993-12#1)(2008-4#2)(2008-7#1)(2009-2#1)(2013-8#2)
disorder were##5##2##(2011-2#4)(2013-8#1)
disorder which##4##2##(1992-5#1)(1993-3#1)(2012-2#1)(2013-7#1)
disorder whose##2##2##(2009-6#1)(2013-8#1)
disorder with a high##4##4##(1991-6#1)(1995-5#1)(2008-4#1)(2012-3#1)
disorder with a##8##3##(1991-6#1)(1995-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
disorder with##21##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-1#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
disorder##818##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-3#2)(1992-5#4)(1992-8#1)(1993-12#9)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#10)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#16)(1996-8#2)(1997-2#3)(1997-3#3)(1997-5#18)(1997-6#2)(1997-7#4)(1997-8#7)(2006-10#4)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#6)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#12)(2007-8#5)(2008-1#22)(2008-10#18)(2008-11#22)(2008-12#7)(2008-2#25)(2008-3#8)(2008-4#31)(2008-5#13)(2008-6#29)(2008-7#47)(2008-8#13)(2008-9#20)(2009-1#1)(2009-10#11)(2009-11#10)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#5)(2009-9#14)(2010-1#9)(2010-10#1)(2010-11#5)(2010-12#8)(2010-2#5)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#11)(2010-7#8)(2010-8#5)(2010-9#2)(2011-1#16)(2011-2#55)(2011-3#1)(2012-1#6)(2012-12#24)(2012-2#34)(2012-3#27)(2013-1#38)(2013-7#9)(2013-8#48)
disorder&quot##6##1##(1993-6#2)(1995-6#1)(2011-2#2)(2012-2#1)
disorder'##2##1##(1993-2#1)(2012-12#1)
disorder) and##2##2##(1996-7#1)(2008-4#1)
disorder)##5##1##(1996-7#1)(2008-4#1)(2010-4#1)(2012-12#1)(2013-8#1)
disorder?##3##1##(2007-8#1)(2012-12#1)(2012-2#1)
disorder]##6##1##(1996-11#1)(2009-10#2)(2012-3#1)(2013-7#1)(2013-8#1)
disordered eating and##2##3##(2007-12#1)(2012-2#1)
disordered eating##12##2##(2007-12#3)(2008-11#1)(2010-1#2)(2011-2#1)(2012-2#5)
disordered##45##1##(1990-12#1)(1991-12#1)(1993-1#1)(1993-12#4)(1993-5#1)(1994-1#2)(1994-5#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-9#2)(1997-2#3)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#2)(2010-8#2)(2011-2#1)(2012-2#7)
disordering effect on the##2##4##(2008-10#1)(2008-11#1)
disordering effect##3##2##(2008-10#2)(2008-11#1)
disordering##5##1##(2008-10#3)(2008-11#1)(2012-2#1)
disorderly##2##1##(2010-6#1)(2012-2#1)
disorders (4##2##2##(1990-8#1)(2008-8#1)
disorders (e##2##2##(2010-4#2)
disorders [OR =##2##3##(2009-7#2)
disorders affecting##3##2##(1992-8#1)(2008-4#1)(2012-3#1)
disorders after controlling##2##3##(2011-1#1)(2013-1#1)
disorders among children##2##3##(2010-12#1)(2013-8#1)
disorders among male##2##3##(2008-8#1)(2012-2#1)
disorders among##12##2##(2007-7#1)(2008-11#4)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
disorders and have##2##3##(1995-1#1)(2006-10#1)
disorders and is##2##3##(1995-3#1)(2012-12#1)
disorders and may##2##3##(1994-11#1)(2013-8#1)
disorders and other##3##3##(2008-7#1)(2009-8#1)(2012-3#1)
disorders and substance use##2##4##(2008-4#1)(2008-6#1)
disorders and the##8##3##(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-1#1)
disorders and##83##2##(1990-10#1)(1990-3#1)(1990-9#1)(1992-1#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-3#2)(2006-10#1)(2007-11#1)(2007-7#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#2)
disorders are a##4##3##(2008-5#1)(2008-7#1)(2009-5#1)(2013-7#1)
disorders are common in##2##4##(2009-12#1)(2013-7#1)
disorders are common##3##3##(2009-11#1)(2009-12#1)(2013-7#1)
disorders are discussed##2##3##(2008-11#1)(2013-1#1)
disorders are##44##2##(1990-2#1)(1992-5#1)(1993-2#2)(1995-6#1)(1997-7#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#4)(2013-8#1)
disorders as a result of##2##5##(2008-11#1)(2012-3#1)
disorders as a##3##3##(2008-11#1)(2010-3#1)(2012-3#1)
disorders as well as##5##4##(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
disorders as##11##2##(1990-10#1)(1992-9#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disorders associated with##9##3##(1990-3#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2011-2#1)(2013-7#1)
disorders by##4##2##(1990-2#1)(2008-11#1)(2008-4#1)(2013-8#1)
disorders can be##4##3##(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
disorders can##7##2##(1991-3#1)(2006-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
disorders caused by##3##3##(1990-3#1)(1997-6#1)(2008-9#1)
disorders caused##5##2##(1990-3#1)(1990-6#1)(1993-3#1)(1997-6#1)(2008-9#1)
disorders causing##3##2##(2008-7#2)(2009-12#1)
disorders characterized by accumulation of##2##5##(2007-7#1)(2010-10#1)
disorders characterized by##7##3##(1991-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#2)
disorders differ##2##2##(1996-7#1)(2012-3#1)
disorders during##3##2##(2008-4#2)(2010-8#1)
disorders encountered##2##2##(1992-1#1)(2013-8#1)
disorders especially##2##2##(2008-1#1)(2011-1#1)
disorders following##2##2##(1990-6#1)(2009-10#1)
disorders for##3##2##(2007-10#1)(2008-11#2)
disorders from##3##2##(1997-3#1)(2008-10#1)(2008-6#1)
disorders had##3##2##(1993-12#1)(2013-1#2)
disorders has been##2##3##(2010-6#1)(2013-8#1)
disorders has##7##2##(1992-1#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-8#1)
disorders have been##5##3##(1994-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-8#1)
disorders have##10##2##(1994-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#2)
disorders in Iran##2##3##(2008-12#1)(2013-1#1)
disorders in a##2##3##(2009-10#1)(2011-2#1)
disorders in cancer patients##4##4##(1991-3#1)(2013-1#3)
disorders in cerebral##2##3##(1997-3#2)
disorders in childhood##2##3##(2008-11#1)(2011-2#1)
disorders in children##5##3##(2008-2#2)(2009-6#1)(2013-8#2)
disorders in diabetes mellitus##2##4##(2009-11#2)
disorders in elderly##2##3##(1992-5#1)(2007-1#1)
disorders in humans##3##3##(2008-11#1)(2012-3#2)
disorders in patients with##4##4##(1996-7#1)(2007-2#1)(2008-7#1)(2013-1#1)
disorders in renal##2##3##(2008-4#1)(2011-1#1)
disorders in the##12##3##(1997-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#3)
disorders in urban##2##3##(2012-12#2)
disorders in which##5##3##(1993-12#1)(2008-1#2)(2008-4#1)(2012-2#1)
disorders in women##2##3##(1991-1#1)(2008-4#1)
disorders in##95##2##(1990-6#1)(1991-1#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-7#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-6#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#7)
disorders including##13##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#5)(2011-1#1)(2012-3#3)(2013-7#1)
disorders increased##2##2##(1990-9#1)(1995-2#1)
disorders involving##2##2##(2008-7#1)(2011-2#1)
disorders is discussed##3##3##(1991-11#1)(1995-9#1)(2008-1#1)
disorders is##21##2##(1991-11#1)(1991-3#1)(1992-2#1)(1995-9#1)(1997-7#1)(1997-8#1)(2007-7#2)(2008-1#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
disorders it##2##2##(1996-3#1)(1997-7#1)
disorders like##3##2##(2008-11#1)(2009-12#1)(2011-2#1)
disorders mapped to the##2##4##(1997-2#2)
disorders mapped##3##2##(1997-2#3)
disorders may be##4##3##(1991-3#1)(1997-6#1)(2007-12#1)(2008-7#1)
disorders may##9##2##(1991-3#1)(1997-6#2)(2007-12#1)(2008-1#2)(2008-6#1)(2008-7#1)(2011-2#1)
disorders must be##2##3##(1992-8#1)(2008-4#1)
disorders must##3##2##(1992-8#1)(1997-5#1)(2008-4#1)
disorders observed##2##2##(1996-12#1)(2008-9#1)
disorders of cerebral##2##3##(1990-6#1)(2008-8#1)
disorders of lipid metabolism##2##4##(2008-9#1)(2013-1#1)
disorders of lipid##3##3##(1990-2#1)(2008-9#1)(2013-1#1)
disorders of platelet alpha-granules##2##4##(1997-7#2)
disorders of propionyl-CoA metabolism##2##4##(1991-12#2)
disorders of pyruvate metabolism##3##4##(1991-5#3)
disorders of the CNS##3##4##(1994-9#1)(2008-7#1)(2010-12#1)
disorders of the cardiac rhythm##3##5##(2011-1#3)
disorders of the nervous system##2##5##(2008-7#1)(2012-3#1)
disorders of the skin##2##4##(2008-5#1)(2008-9#1)
disorders of the##19##3##(1990-12#1)(1992-9#1)(1994-9#1)(1995-6#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)
disorders of##72##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-7#3)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#6)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#5)
disorders on##4##2##(1996-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
disorders or##14##2##(1992-5#1)(1993-12#2)(1994-6#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
disorders remain underdiagnosed and undertreated##2##5##(2013-8#2)
disorders represents##2##2##(2009-5#1)(2011-2#1)
disorders seen in##2##3##(1995-6#1)(2008-12#1)
disorders should be##2##3##(2009-7#1)(2012-2#1)
disorders since##2##2##(1997-5#1)(2012-2#1)
disorders such as##21##3##(1991-2#1)(1992-8#1)(1995-1#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
disorders that are##5##3##(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
disorders that##13##2##(1992-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
disorders the##2##2##(2008-10#1)(2009-12#1)
disorders to##4##2##(1990-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
disorders was evaluated##2##3##(1991-2#1)(2007-11#1)
disorders was##6##2##(1991-2#1)(1994-2#1)(2007-11#1)(2008-6#1)(2009-12#1)(2011-1#1)
disorders were##13##2##(1993-12#1)(1993-2#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
disorders which##2##2##(1994-3#1)(2008-7#1)
disorders who##2##2##(1992-2#1)(1992-3#1)
disorders with##6##2##(1997-5#2)(2008-4#1)(2008-6#1)(2010-5#1)(2012-2#1)
disorders##1176##1##(1990-10#3)(1990-11#6)(1990-12#2)(1990-2#6)(1990-3#6)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#4)(1990-9#6)(1991-1#7)(1991-11#7)(1991-12#3)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#8)(1992-6#5)(1992-8#7)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#8)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-11#6)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#6)(1996-7#6)(1996-8#4)(1997-2#5)(1997-3#10)(1997-4#2)(1997-5#12)(1997-6#8)(1997-7#13)(1997-8#10)(2006-10#10)(2006-12#1)(2007-1#1)(2007-10#9)(2007-11#6)(2007-12#8)(2007-2#5)(2007-7#15)(2007-8#11)(2008-1#24)(2008-10#30)(2008-11#50)(2008-12#20)(2008-2#9)(2008-3#17)(2008-4#39)(2008-5#24)(2008-6#27)(2008-7#64)(2008-8#19)(2008-9#31)(2009-10#17)(2009-11#6)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#12)(2009-6#8)(2009-7#9)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#9)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#7)(2010-5#9)(2010-6#6)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#27)(2011-2#60)(2011-3#3)(2011-7#1)(2012-1#8)(2012-12#30)(2012-2#61)(2012-3#45)(2013-1#47)(2013-7#15)(2013-8#52)
disorders)##6##1##(1992-8#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-3#1)(2012-3#1)
disorders?##3##1##(2008-11#1)(2008-7#1)(2012-1#1)
disorders]##17##1##(1990-6#2)(1991-3#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-3#1)(1996-11#1)(1997-3#2)(1997-6#2)(2008-11#1)(2010-6#1)(2012-12#1)(2013-7#2)
disorganization and##3##2##(2008-10#3)
disorganization in##2##2##(1996-7#1)(2008-10#1)
disorganization of the##5##3##(2008-10#3)(2008-7#1)(2009-10#1)
disorganization of##8##2##(1992-9#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-10#1)
disorganization##21##1##(1992-9#1)(1996-7#1)(2008-10#10)(2008-2#2)(2008-6#2)(2008-7#2)(2009-10#1)(2010-6#2)
disorganized##6##1##(1996-7#1)(2008-10#1)(2009-10#1)(2009-9#1)(2012-2#1)(2013-1#1)
disorientation##2##1##(2008-7#1)(2009-10#1)
dispar##10##1##(2008-12#4)(2008-5#1)(2009-10#3)(2010-11#2)
disparage##2##1##(1993-1#1)(2009-11#1)
disparate sources##3##2##(2008-7#1)(2011-1#2)
disparate##26##1##(1990-5#1)(1992-6#1)(1997-9#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
disparities and##4##2##(2009-5#1)(2010-3#1)(2012-2#2)
disparities between##3##2##(2008-1#1)(2008-10#1)(2010-4#1)
disparities in a##2##3##(1992-12#1)(2008-4#1)
disparities in health##5##3##(2008-1#1)(2008-11#2)(2009-5#2)
disparities in the##4##3##(2008-1#1)(2008-11#1)(2010-2#1)(2013-1#1)
disparities in##33##2##(1992-12#1)(1993-12#1)(1995-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2009-5#2)(2010-2#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
disparities##73##1##(1992-12#1)(1993-12#1)(1994-12#1)(1995-3#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-4#4)(2009-5#6)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#12)(2013-8#1)
disparity among##2##2##(2008-1#1)(2011-1#1)
disparity between##4##2##(1991-6#1)(1992-6#1)(2008-1#1)(2009-5#1)
disparity detector##4##2##(1990-8#4)
disparity in cancer##2##3##(1997-1#1)(2008-1#1)
disparity in leprosy##2##3##(2007-7#2)
disparity in##8##2##(1997-1#1)(2007-7#3)(2008-1#2)(2008-8#2)
disparity##33##1##(1990-6#1)(1990-8#5)(1991-6#1)(1992-6#1)(1997-1#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-12#1)(2008-4#1)(2008-8#4)(2008-9#2)(2009-5#1)(2010-3#2)(2010-8#1)(2011-1#2)(2012-3#1)(2012-7#1)
dispel##3##1##(1993-3#1)(2008-7#1)(2010-4#1)
dispelling the##2##2##(1997-1#1)(2007-6#1)
dispensable for##6##2##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2011-2#1)
dispensable##7##1##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#2)(2011-2#1)
dispense with the need for##2##5##(1997-7#1)(2008-3#1)
dispense##8##1##(1995-1#2)(1995-2#2)(1996-1#1)(1997-7#1)(2008-10#1)(2008-3#1)
dispensed into##2##2##(2008-10#2)
dispensed over##2##2##(2008-10#1)(2013-8#1)
dispensed prescribing##2##2##(2008-11#2)
dispensed to##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
dispensed with##2##2##(2008-10#2)
dispensed##17##1##(1995-11#1)(2008-10#8)(2008-11#5)(2010-10#1)(2010-3#1)(2013-8#1)
dispensing costs##4##2##(1995-1#4)
dispensing##17##1##(1990-9#1)(1995-1#5)(2007-11#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-3#2)(2010-5#3)(2013-8#1)
dispensing-based##2##1##(2010-9#2)
dispersal ability##7##2##(2008-6#1)(2008-8#1)(2008-9#5)
dispersal and the##3##3##(2008-10#2)(2008-9#1)
dispersal and##21##2##(2008-10#4)(2008-8#10)(2008-9#3)(2009-6#1)(2010-8#1)(2013-1#1)(2013-7#1)
dispersal as a##2##3##(2008-10#1)(2008-8#1)
dispersal as##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
dispersal at large distances##2##4##(2008-10#2)
dispersal between##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
dispersal can##2##2##(2008-8#1)(2008-9#1)
dispersal corridors##2##2##(2008-9#2)
dispersal data##2##2##(2008-8#1)(2008-9#1)
dispersal distance##3##2##(2008-10#2)(2008-8#1)
dispersal distances##5##2##(2008-10#1)(2008-8#2)(2008-9#1)(2013-1#1)
dispersal from##3##2##(2008-10#2)(2008-5#1)
dispersal gradient##10##2##(2008-10#10)
dispersal gradients##3##2##(2008-10#3)
dispersal in marine species##2##4##(2013-1#2)
dispersal in##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#2)
dispersal is##8##2##(2008-10#3)(2008-8#3)(2008-9#1)(2013-1#1)
dispersal models##3##2##(2008-10#2)(2008-8#1)
dispersal of B##2##3##(2008-10#1)(2010-6#1)
dispersal of ascospores##2##3##(2008-10#2)
dispersal of conidia from##2##4##(2008-10#2)
dispersal of spores##4##3##(2008-10#4)
dispersal of this##2##3##(2010-6#1)(2011-2#1)
dispersal of##34##2##(2008-10#27)(2008-8#1)(2010-3#1)(2010-6#2)(2011-2#2)(2012-3#1)
dispersal or##3##2##(2008-8#2)(2010-4#1)
dispersal rates can##2##3##(2008-8#2)
dispersal rates in##2##3##(2008-8#2)
dispersal rates##9##2##(2008-8#9)
dispersal strategies##2##2##(2008-8#2)
dispersal using##2##2##(2008-10#1)(2008-9#1)
dispersal was##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
dispersal were##4##2##(2008-10#4)
dispersal with##3##2##(2008-10#2)(2008-9#1)
dispersal within the##2##3##(2008-10#2)
dispersal within##3##2##(2008-10#3)
dispersal##227##1##(2007-5#1)(2008-10#93)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#68)(2008-9#29)(2009-6#1)(2009-8#2)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#1)
disperse in the##2##3##(2008-10#1)(2008-7#1)
disperse in##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
disperse the##2##2##(2008-2#2)
disperse##18##1##(1992-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-2#1)
dispersed and##2##2##(2008-10#2)
dispersed as a##2##3##(1997-2#1)(2008-9#1)
dispersed by##7##2##(2008-10#2)(2008-8#2)(2008-9#2)(2013-1#1)
dispersed chicken kidney cells##2##4##(1991-3#2)
dispersed chicken##3##2##(1991-3#3)
dispersed in a##6##3##(2008-10#3)(2008-3#2)(2008-7#1)
dispersed in water##4##3##(2008-10#2)(2008-3#1)(2010-2#1)
dispersed in##14##2##(2007-11#1)(2008-10#5)(2008-3#3)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2013-1#1)
dispersed into##4##2##(1994-12#1)(2008-10#2)(2008-6#1)
dispersed on a##2##3##(2008-10#1)(2009-11#1)
dispersed on##4##2##(2008-10#2)(2008-3#1)(2009-11#1)
dispersed organic silicon sol##2##4##(2008-10#2)
dispersed over##2##2##(2008-10#1)(2008-7#1)
dispersed phase##3##2##(2008-10#1)(2008-7#2)
dispersed repetitive##2##2##(1995-12#1)(2008-5#1)
dispersed throughout the##2##3##(1992-9#1)(2008-12#1)
dispersed to##4##2##(1997-2#1)(2008-10#2)(2008-8#1)
dispersed well in the##2##4##(2008-10#1)(2013-8#1)
dispersed within a##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
dispersed##114##1##(1990-2#1)(1991-12#1)(1991-3#4)(1992-8#1)(1992-9#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-3#2)(1996-3#1)(1997-2#2)(1997-3#1)(2007-11#4)(2007-12#1)(2008-10#44)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
disperser##7##1##(2007-11#3)(2008-5#3)(2008-8#1)
dispersers##7##1##(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)
dispersible##2##1##(2008-10#1)(2008-5#1)
dispersing D##3##2##(2011-2#3)
dispersing the##2##2##(2008-10#1)(2008-3#1)
dispersing##16##1##(1991-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#3)(2011-2#4)
dispersion (PMD)##10##2##(2007-11#7)(2007-12#2)(2008-3#1)
dispersion and high##2##3##(2007-11#1)(2007-12#1)
dispersion and the##3##3##(2007-11#1)(2008-3#1)(2012-1#1)
dispersion and##25##2##(1997-2#1)(2007-11#6)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2012-1#1)(2013-1#1)
dispersion as##2##2##(2007-11#1)(2008-2#1)
dispersion at the##2##3##(2008-10#1)(2008-3#1)
dispersion at##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
dispersion by##2##2##(2007-11#1)(2008-3#1)
dispersion can be##2##3##(2007-12#1)(2008-10#1)
dispersion caused by##2##3##(2008-3#1)(2008-8#1)
dispersion causes##2##2##(2007-12#1)(2008-3#1)
dispersion coefficient##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
dispersion coefficients##2##2##(2008-2#1)(2008-3#1)
dispersion compensation in##2##3##(2007-11#1)(2008-3#1)
dispersion compensation##13##2##(2007-11#9)(2007-12#2)(2008-3#2)
dispersion control##2##2##(2007-11#1)(2008-10#1)
dispersion for##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
dispersion formula##2##2##(2008-3#2)
dispersion function##5##2##(2008-2#4)(2008-3#1)
dispersion in a##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
dispersion in optical fiber##2##4##(2007-12#2)
dispersion in patients##2##3##(2010-5#1)(2011-1#1)
dispersion in the##8##3##(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
dispersion in##26##2##(1992-4#1)(2007-11#9)(2007-12#7)(2008-10#3)(2008-2#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-1#1)
dispersion into the##2##3##(2008-11#1)(2011-2#1)
dispersion is##19##2##(1991-12#1)(1997-2#1)(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)(2012-2#1)
dispersion management and##2##3##(2007-12#2)
dispersion management##14##2##(2007-11#5)(2007-12#9)
dispersion map##5##2##(2007-11#1)(2007-12#4)
dispersion measurements##2##2##(2008-2#1)(2008-3#1)
dispersion medium##2##2##(2008-2#1)(2008-3#1)
dispersion of a##2##3##(2007-11#1)(2007-12#1)
dispersion of an##2##3##(2007-12#2)
dispersion of optical##2##3##(2007-11#2)
dispersion of the fiber##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
dispersion of the refractive index##3##5##(2008-2#2)(2008-3#1)
dispersion of the transmission fiber##2##5##(2007-11#2)
dispersion of the##32##3##(1990-3#2)(2007-11#6)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#7)(2008-3#9)(2010-4#1)
dispersion of##75##2##(1990-3#2)(1995-11#1)(1997-2#1)(2007-11#17)(2007-12#11)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#8)(2008-3#13)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2013-1#1)
dispersion on the##3##3##(2008-2#1)(2008-3#2)
dispersion on##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
dispersion or##2##2##(2008-5#1)(2008-6#1)
dispersion over a##2##3##(2007-12#1)(2008-2#1)
dispersion over##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
dispersion parameters##3##2##(2007-11#1)(2008-3#2)
dispersion phase##2##2##(2011-1#2)
dispersion properties of##2##3##(2007-11#2)
dispersion properties##3##2##(2007-11#3)
dispersion regime##2##2##(2007-11#2)
dispersion safety factor##2##3##(2013-1#2)
dispersion slope##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
dispersion techniques can##2##3##(2006-4#2)
dispersion techniques##4##2##(2006-4#4)
dispersion than##2##2##(2008-5#2)
dispersion that is##2##3##(2007-11#1)(2007-12#1)
dispersion to the##2##3##(2008-10#1)(2008-3#1)
dispersion to##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
dispersion turning##4##2##(2007-12#4)
dispersion was##6##2##(2007-11#1)(2008-10#2)(2008-8#2)(2011-2#1)
dispersion with##2##2##(2007-11#1)(2008-5#1)
dispersion within the##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
dispersion within##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
dispersion zero##2##2##(2007-11#2)
dispersion##451##1##(1990-3#2)(1991-12#1)(1992-4#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#7)(2006-4#4)(2007-11#122)(2007-12#80)(2007-5#1)(2008-1#1)(2008-10#51)(2008-11#7)(2008-2#46)(2008-3#74)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#6)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#1)
dispersion)##2##1##(2008-3#2)
dispersion-compensated##3##1##(2007-11#2)(2007-12#1)
dispersion-compensating fiber##5##2##(2007-12#5)
dispersion-compensating##8##1##(2007-11#3)(2007-12#5)
dispersion-decreasing fiber##3##2##(2007-11#3)
dispersion-free##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
dispersion-imbalanced nonlinear optical loop mirror##2##5##(2007-11#2)
dispersion-induced##2##1##(2007-11#1)(2008-3#1)
dispersion-managed fiber##3##2##(2007-12#3)
dispersion-managed optical##3##2##(2007-11#2)(2007-12#1)
dispersion-managed soliton communication systems##2##4##(2007-11#2)
dispersion-managed soliton transmission##2##3##(2007-11#1)(2007-12#1)
dispersion-managed soliton##14##2##(2007-11#8)(2007-12#6)
dispersion-managed solitons in##2##3##(2007-11#2)
dispersion-managed solitons##14##2##(2007-11#5)(2007-12#9)
dispersion-managed system##2##2##(2007-11#1)(2007-12#1)
dispersion-managed transmission systems##4##3##(2007-11#3)(2007-12#1)
dispersion-managed transmission##5##2##(2007-11#3)(2007-12#2)
dispersion-managed wavelength-division-multiplexed optical fiber systems##2##5##(2007-11#2)
dispersion-managed##54##1##(2007-11#24)(2007-12#30)
dispersion-management##2##1##(2007-12#2)
dispersion-shifted fiber##9##2##(2007-11#5)(2007-12#1)(2008-3#3)
dispersion-shifted##10##1##(2007-11#5)(2007-12#1)(2008-2#1)(2008-3#3)
dispersions at pH##2##3##(2008-10#1)(2008-5#1)
dispersions containing##3##2##(1994-12#1)(1994-5#1)(2008-10#1)
dispersions in##3##2##(2008-3#2)(2012-2#1)
dispersions of the fifth- and seventh-order nonlinear optical susceptibilities##2##9##(2007-12#2)
dispersions of the##4##3##(2007-12#3)(2008-3#1)
dispersions of##10##2##(1990-7#2)(1994-5#1)(2007-12#3)(2008-3#1)(2012-2#3)
dispersions were evaluated##2##3##(2012-2#2)
dispersions were##3##2##(2008-5#1)(2012-2#2)
dispersions##43##1##(1990-7#5)(1994-12#1)(1994-5#4)(2007-12#4)(2008-10#7)(2008-2#2)(2008-3#6)(2008-5#3)(2008-9#1)(2010-4#2)(2012-2#7)(2013-1#1)
dispersity##3##1##(2010-8#2)(2011-1#1)
dispersive X-ray fluorescence spectroscopy##3##4##(2008-10#3)
dispersive X-ray fluorescence##10##3##(2008-10#10)
dispersive X-ray spectrometry##2##3##(2008-10#2)
dispersive X-ray##18##2##(2008-10#14)(2008-5#1)(2008-9#1)(2012-2#2)
dispersive and nonlinear##2##3##(2007-12#2)
dispersive and##4##2##(2007-12#4)
dispersive effects##2##2##(2007-12#2)
dispersive elements##4##2##(2007-11#3)(2007-12#1)
dispersive fibers with##2##3##(2007-11#1)(2008-2#1)
dispersive fibers##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
dispersive media##4##2##(2007-11#2)(2007-12#2)
dispersive medium##2##2##(2007-11#1)(2007-12#1)
dispersive mirror##2##2##(2008-3#2)
dispersive properties of##2##3##(2007-11#2)
dispersive solid-state dye-laser oscillator##2##4##(2008-2#2)
dispersive spectroscopy##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
dispersive wave##3##2##(2008-10#2)(2008-3#1)
dispersive##75##1##(2007-11#15)(2007-12#17)(2008-10#21)(2008-11#2)(2008-2#5)(2008-3#9)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
disphosphonates##2##1##(2008-7#2)
displace the##3##2##(1992-3#1)(2007-12#1)(2008-8#1)
displace##12##1##(1992-3#3)(1994-12#1)(2007-12#1)(2008-10#1)(2008-8#4)(2009-8#1)(2011-1#1)
displaced along##2##2##(1995-2#1)(2008-3#1)
displaced by##9##2##(1990-8#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(2008-10#1)(2010-10#1)(2011-2#1)
displaced communities##2##2##(2013-1#2)
displaced femoral##2##2##(1991-9#1)(2008-12#1)
displaced fractures##3##2##(1991-9#1)(2013-1#2)
displaced intra-articular calcaneal fracture##2##4##(2012-2#2)
displaced persons##5##2##(1994-9#3)(2008-7#2)
displaced relative to##2##3##(1995-3#1)(2008-3#1)
displaced with##2##2##(1993-9#1)(2008-3#1)
displaced women##3##2##(2013-1#3)
displaced##80##1##(1990-5#2)(1990-8#1)(1991-8#1)(1991-9#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#4)(1995-2#1)(1995-3#3)(1995-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#5)(2013-1#15)
displacement amplification##2##2##(2008-12#1)(2012-2#1)
displacement amplitude##2##2##(2008-11#1)(2008-2#1)
displacement and temperature##2##3##(2007-12#2)
displacement and##9##2##(1997-5#1)(2007-11#2)(2007-12#2)(2008-9#2)(2009-3#1)(2013-1#1)
displacement assay##2##2##(1994-8#1)(2008-4#1)
displacement at##4##2##(1992-6#1)(1994-6#1)(2008-2#1)(2008-9#1)
displacement by##9##2##(1990-11#1)(1991-1#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
displacement chromatography##6##2##(2008-11#4)(2008-7#2)
displacement equilibrium##3##2##(2008-10#3)
displacement field##5##2##(1990-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
displacement fields##2##2##(2008-3#2)
displacement from the##2##3##(2008-10#1)(2008-2#1)
displacement from##3##2##(2008-10#2)(2008-2#1)
displacement in a##2##3##(2007-12#1)(2008-9#1)
displacement in##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
displacement is##4##2##(2007-11#1)(2008-6#1)(2008-9#1)(2010-3#1)
displacement measurement##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2012-2#1)
displacement measurements##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
displacement of a##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)
displacement of the##29##3##(1990-12#1)(1991-8#1)(1996-2#2)(2007-11#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#4)
displacement of this##2##3##(1992-9#1)(2009-9#1)
displacement of##70##2##(1990-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-2#2)(1997-1#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#9)(2008-2#7)(2008-3#9)(2008-5#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#4)(2013-1#9)
displacement or##2##2##(2007-11#1)(2013-1#1)
displacement process##3##2##(1997-2#1)(2008-7#2)
displacement reaction##2##2##(1997-3#1)(2008-10#1)
displacement resolution of##2##3##(2008-3#2)
displacement sensing##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
displacement sensitivity of##2##3##(2007-12#2)
displacement sensor is proposed and demonstrated##2##6##(2008-2#1)(2008-3#1)
displacement sensor##7##2##(2008-2#4)(2008-3#3)
displacement vector##2##2##(2008-3#1)(2010-8#1)
displacement with a##2##3##(2007-11#1)(2008-3#1)
displacement with##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
displacement##252##1##(1990-11#3)(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#2)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#14)(2007-12#15)(2007-8#2)(2008-10#23)(2008-11#6)(2008-12#1)(2008-2#27)(2008-3#39)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#11)(2009-10#2)(2009-12#1)(2009-3#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#3)(2010-7#1)(2010-8#2)(2011-2#4)(2012-2#10)(2013-1#18)(2013-8#1)
displacements in the##4##3##(1990-11#1)(2008-3#2)(2009-4#1)
displacements of the##2##3##(2008-2#1)(2013-1#1)
displacements of##7##2##(1997-6#1)(2008-2#3)(2013-1#3)
displacements on##2##2##(2008-3#1)(2009-7#1)
displacements##37##1##(1990-11#2)(1997-6#1)(2007-11#3)(2008-2#7)(2008-3#10)(2008-7#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#5)
displacer##5##1##(2007-11#1)(2008-7#4)
displacers##2##1##(2008-7#2)
displaces the##5##2##(1991-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-7#1)
displaces##8##1##(1991-12#1)(2007-11#2)(2008-11#2)(2008-7#1)(2010-7#1)(2012-1#1)
displacing the##6##2##(1990-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
displacing##10##1##(1990-2#1)(1993-1#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
display a response to##2##4##(2008-10#1)(2009-11#1)
display a##29##2##(1990-12#2)(1990-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#1)
display an##4##2##(1994-8#1)(1995-6#1)(2008-10#1)(2011-2#1)
display and##7##2##(1993-8#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)
display applications##4##2##(2008-3#4)
display based on a##2##4##(2008-3#2)
display based on##3##3##(2007-12#1)(2008-3#2)
display by use of a##3##5##(2007-11#2)(2008-2#1)
display by use of##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
display can be##3##3##(1994-12#1)(2007-11#1)(2008-3#1)
display devices##4##2##(2008-3#3)(2008-7#1)
display differences in##2##3##(2008-1#1)(2010-6#1)
display different##3##2##(1992-12#1)(2008-10#1)(2008-5#1)
display dramatic##2##2##(1995-11#1)(2008-11#1)
display elevated##2##2##(2008-11#1)(2010-8#1)
display enhanced##5##2##(1992-9#1)(1993-3#1)(2008-10#3)
display for##2##2##(2007-12#1)(2008-2#1)
display in##7##2##(1993-9#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-4#1)(2012-3#2)
display is##4##2##(2008-3#2)(2008-4#1)(2008-7#1)
display libraries##10##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#1)
display library##5##2##(2008-10#2)(2008-7#2)(2012-2#1)
display method##5##2##(1997-7#1)(2008-11#2)(2008-9#1)(2010-12#1)
display methods##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
display no##2##2##(2006-12#1)(2012-3#1)
display of a##3##3##(1991-2#1)(1994-12#1)(2008-3#1)
display of the##9##3##(1995-11#1)(1997-8#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-6#1)
display of##26##2##(1991-2#2)(1994-12#1)(1995-11#1)(1995-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-7#1)(2008-9#2)(2009-6#1)(2012-3#2)(2013-1#1)
display potent##2##2##(1995-3#1)(2011-3#1)
display resolution##2##2##(2008-3#2)
display several##2##2##(1992-9#1)(1994-5#1)
display significant##2##2##(1994-11#1)(2008-10#1)
display similar##4##2##(1996-2#1)(2012-12#1)(2013-1#2)
display system based on##2##4##(2007-11#1)(2008-2#1)
display system##5##2##(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
display systems##2##2##(1995-2#1)(2008-6#1)
display technologies##2##2##(2008-2#1)(2008-7#1)
display that##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
display the ability to##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
display the##21##2##(1994-8#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#6)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
display their##2##2##(2008-10#1)(2008-7#1)
display to##5##2##(2008-3#2)(2008-8#2)(2008-9#1)
display two##2##2##(2008-2#1)(2009-10#1)
display was##5##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
display when##2##2##(1993-12#1)(2008-9#1)
display with a micromirror array##2##5##(2007-12#2)
display with a##5##3##(1993-12#1)(2007-12#3)(2008-2#1)
display with##7##2##(1993-12#1)(2007-12#3)(2008-2#3)
display##419##1##(1990-11#1)(1990-12#5)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#6)(1995-2#5)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#4)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#12)(2007-12#15)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#35)(2008-11#13)(2008-12#2)(2008-2#28)(2008-3#67)(2008-4#16)(2008-5#2)(2008-6#11)(2008-7#22)(2008-8#14)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#9)(2013-1#8)(2013-8#4)
displayed a Ki value of##4##5##(1995-3#4)
displayed a broad##2##3##(1994-8#1)(2008-10#1)
displayed a greater##4##3##(1991-5#1)(2007-11#1)(2008-5#1)(2009-10#1)
displayed a high##2##3##(2008-11#1)(2011-3#1)
displayed a higher##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
displayed a low##2##3##(1995-2#1)(2007-12#1)
displayed a satisfactory##2##3##(2011-2#2)
displayed a similar##2##3##(2008-2#1)(2013-1#1)
displayed a##66##2##(1990-11#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#6)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-7#1)
displayed an##9##2##(1991-12#1)(1991-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
displayed any##3##2##(1994-5#1)(2008-4#1)(2011-2#1)
displayed as##2##2##(1997-4#1)(2008-3#1)
displayed at the##2##3##(1994-11#1)(1994-3#1)
displayed at##3##2##(1994-11#1)(1994-3#1)(2012-2#1)
displayed both##2##2##(1995-12#1)(2008-7#1)
displayed by the##3##3##(2008-10#3)
displayed by this##2##3##(1992-11#1)(1993-3#1)
displayed by##21##2##(1990-8#1)(1992-11#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-3#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
displayed comparable##2##2##(1993-3#1)(2012-2#1)
displayed different##3##2##(1995-2#1)(2013-1#2)
displayed excellent##2##2##(2008-10#1)(2008-4#1)
displayed for##2##2##(2008-5#1)(2009-10#1)
displayed good##4##2##(1993-12#1)(2008-10#2)(2008-6#1)
displayed greater##2##2##(1995-1#1)(1996-7#1)
displayed higher##3##2##(1995-12#1)(1995-2#1)(2011-2#1)
displayed improved##2##2##(2008-10#1)(2010-7#1)
displayed in the##3##3##(1996-2#1)(2008-3#1)(2008-8#1)
displayed in##7##2##(1992-9#1)(1996-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-1#1)
displayed increased##2##2##(1997-5#1)(2008-7#1)
displayed inhibitory##2##2##(2007-8#1)(2010-12#1)
displayed low##2##2##(1994-5#1)(2008-1#1)
displayed more##2##2##(2008-11#2)
displayed much##2##2##(2008-10#1)(2008-5#1)
displayed no##3##2##(1993-8#1)(1994-3#1)(2008-10#1)
displayed normal##2##2##(1993-6#1)(1995-9#1)
displayed on a liquid-crystal##2##4##(2008-3#1)(2010-9#1)
displayed on a##7##3##(1996-2#1)(2008-12#1)(2008-3#3)(2010-9#2)
displayed on the surface of##3##5##(2008-8#2)(2013-1#1)
displayed on the##5##3##(2008-2#1)(2008-8#2)(2013-1#2)
displayed on##22##2##(1995-5#1)(1996-10#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#1)(2010-9#2)(2013-1#3)(2013-8#1)
displayed only a##2##3##(1995-2#1)(2008-9#1)
displayed only##4##2##(1995-2#1)(1997-3#1)(2008-7#1)(2008-9#1)
displayed reduced##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
displayed remarkable##3##2##(1994-12#1)(1996-2#1)(2008-10#1)
displayed significant##6##2##(1992-11#1)(1993-1#1)(2008-10#2)(2008-8#1)(2012-3#1)
displayed significantly##5##2##(1994-2#1)(2007-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
displayed similar##4##2##(1994-5#1)(2008-8#2)(2009-12#1)
displayed strong synergistic##2##3##(2008-10#1)(2012-12#1)
displayed strong##3##2##(2008-10#2)(2012-12#1)
displayed substantially##2##2##(1994-6#1)(2008-4#1)
displayed that the##2##3##(2008-10#1)(2008-9#1)
displayed that##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
displayed the highest##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
displayed the maximum##2##3##(2008-10#1)(2008-6#1)
displayed the same##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
displayed the##24##2##(1990-2#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)
displayed two##2##2##(1997-7#1)(2008-5#1)
displayed various##2##2##(2007-8#1)(2012-3#1)
displayed weaker##2##2##(1990-7#1)(2012-2#1)
displayed##333##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-6#2)(1991-8#1)(1992-11#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#9)(1995-3#9)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-5#4)(1996-7#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#63)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#12)(2008-6#5)(2008-7#13)(2008-8#10)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#6)(2011-2#6)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#4)(2012-7#2)(2013-1#16)(2013-7#1)(2013-8#3)
displaying a##10##2##(1990-2#1)(1994-11#1)(1995-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
displaying significantly##2##2##(1994-3#1)(2008-10#1)
displaying the##5##2##(1993-9#1)(2008-10#3)(2008-2#1)
displaying##61##1##(1990-2#1)(1991-9#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-8#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
displays a high degree of##2##5##(1995-12#1)(2008-10#1)
displays a high##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
displays a remarkable##2##3##(1995-6#1)(2008-10#1)
displays a similar##2##3##(1991-5#1)(1995-2#1)
displays a##29##2##(1991-5#1)(1992-2#1)(1992-3#1)(1993-11#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)
displays an##7##2##(1990-12#1)(1990-8#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
displays and##5##2##(2008-3#2)(2008-9#1)(2012-2#1)(2013-1#1)
displays are##3##2##(2008-6#2)(2013-1#1)
displays considerable##2##2##(1993-2#1)(1995-11#1)
displays enhanced##2##2##(2007-12#1)(2011-1#1)
displays gender-specific##2##2##(2008-11#2)
displays in##2##2##(2008-3#2)
displays many##2##2##(2008-10#1)(2008-6#1)
displays the##6##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#3)
displays##136##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-7#3)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#19)(2008-4#1)(2008-6#6)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#6)
disposable nebulizer##2##2##(1994-12#1)(1995-12#1)
disposable screen-printed##4##2##(2008-10#4)
disposable sensing##2##2##(2008-10#2)
disposable sensors##3##2##(2008-10#3)
disposable syringe##2##2##(2007-7#1)(2008-10#1)
disposable##46##1##(1992-12#1)(1992-8#1)(1994-12#2)(1994-2#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#24)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#5)(2011-1#1)
disposables##2##1##(1995-2#1)(2007-12#1)
disposal and##4##2##(2008-3#2)(2008-4#1)(2008-9#1)
disposal of biohazards##2##3##(2008-4#1)(2008-9#1)
disposal of##9##2##(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-9#1)
disposal##40##1##(1991-11#1)(1992-6#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-11#1)(1997-4#3)(1997-5#2)(2008-1#2)(2008-10#5)(2008-12#3)(2008-3#3)(2008-4#2)(2008-6#5)(2008-7#1)(2008-9#3)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
dispose##3##1##(2008-10#1)(2008-11#1)(2008-12#1)
disposed of##4##2##(1996-12#1)(1997-4#1)(2008-4#1)(2008-5#1)
disposed##7##1##(1996-12#1)(1997-4#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#1)
disposition and##3##2##(1991-2#1)(2008-5#1)(2012-3#1)
disposition in##4##2##(1994-5#1)(2008-3#1)(2011-1#1)(2013-1#1)
disposition index##2##2##(2008-1#1)(2012-7#1)
disposition of##7##2##(1996-12#1)(1996-3#1)(2008-10#1)(2008-8#1)(2010-10#2)(2013-1#1)
disposition##25##1##(1991-2#2)(1994-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-10#2)(2011-1#1)(2011-2#2)(2012-3#2)(2012-7#1)(2013-1#2)
dispositional##2##1##(1994-2#1)(2007-12#1)
dispositions##3##1##(2008-11#3)
disproportion##3##1##(1991-9#1)(2010-2#1)(2010-8#1)
disproportional to surgical trauma##2##4##(2012-12#2)
disproportionally##2##1##(1996-12#1)(2013-1#1)
disproportionate effects on##2##3##(1990-11#1)(2008-8#1)
disproportionate share hospital##2##3##(1996-1#1)(2008-11#1)
disproportionate share##5##2##(1996-1#2)(1997-2#1)(2008-11#1)(2008-8#1)
disproportionate##12##1##(1990-11#1)(1991-12#1)(1995-1#1)(1996-1#2)(1997-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)
disproportionate-share##2##1##(1991-1#1)(1992-12#1)
disproportionately high##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
disproportionately more##2##2##(2008-9#1)(2010-8#1)
disproportionately represented in##2##3##(2008-1#1)(2010-11#1)
disproportionately represented##4##2##(2007-2#1)(2008-1#2)(2010-11#1)
disproportionately##26##1##(1995-6#1)(1996-5#1)(2007-2#2)(2008-1#3)(2008-11#1)(2008-7#1)(2008-9#4)(2010-11#3)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
disproportionation##3##1##(1996-2#2)(2008-7#1)
dispute resolution##3##2##(1994-1#2)(2007-4#1)
dispute##10##1##(1990-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#2)(1997-3#1)(2007-4#1)(2009-7#2)
disputed##6##1##(1990-9#1)(1992-8#1)(1997-7#1)(2010-1#1)(2011-2#2)
disputes##6##1##(1990-6#1)(1991-12#1)(1994-1#1)(1996-1#1)(2008-11#1)(2008-3#1)
disregard##4##1##(1990-6#1)(1996-5#1)(1997-6#1)(2010-5#1)
disregarded##5##1##(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)
disrupt both##2##2##(1990-8#1)(1993-12#1)
disrupt normal##2##2##(2008-5#1)(2012-2#1)
disrupt the##13##2##(1990-7#1)(1991-3#1)(1994-11#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
disrupt##38##1##(1990-11#2)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-7#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
disruptant##2##1##(1997-4#1)(2009-12#1)
disrupted and##2##2##(1997-4#1)(2008-10#1)
disrupted by lesions##2##3##(1992-10#1)(1996-5#1)
disrupted by the##4##3##(1994-12#1)(2008-10#2)(2010-5#1)
disrupted by##14##2##(1992-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-5#1)(2012-3#1)
disrupted gene##2##2##(1994-8#1)(2008-10#1)
disrupted in##8##2##(1993-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-9#1)
disrupted or##3##2##(1993-6#1)(2010-11#1)(2011-2#1)
disrupted the##4##2##(2008-2#1)(2011-3#1)(2012-12#1)(2012-7#1)
disrupted##70##1##(1992-10#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-8#1)
disrupting the##6##2##(2008-10#2)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#1)
disrupting##21##1##(1990-2#1)(1992-3#1)(1995-2#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#3)
disruption and##4##2##(2008-4#2)(2008-7#1)(2008-8#1)
disruption by##5##2##(2008-10#1)(2008-4#2)(2010-5#1)(2012-2#1)
disruption did not##2##3##(2008-10#1)(2008-5#1)
disruption even##2##2##(1995-2#1)(2009-10#1)
disruption experiment##2##2##(2008-8#1)(2008-9#1)
disruption in the##3##3##(1995-3#1)(1995-8#1)(2008-8#1)
disruption in##6##2##(1995-3#1)(1995-6#1)(1995-8#1)(2008-8#1)(2010-11#1)(2010-6#1)
disruption may be a##2##4##(1997-3#1)(2008-7#1)
disruption mutants##3##2##(1990-5#1)(1995-8#1)(2008-7#1)
disruption of microtubules##2##3##(2008-10#1)(2009-7#1)
disruption of the##30##3##(1991-12#1)(1994-11#2)(1994-12#2)(1994-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2011-1#1)(2011-2#1)(2013-8#1)
disruption of##78##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-3#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-2#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#5)(2013-1#1)(2013-8#1)
disruption to the##2##3##(2008-10#1)(2008-11#1)
disruption was##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
disruption##155##1##(1990-5#2)(1991-12#2)(1991-2#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#5)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#19)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#12)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#5)
disruptions in##5##2##(1993-8#1)(2008-10#1)(2012-3#1)(2013-1#2)
disruptions##20##1##(1992-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1997-3#4)(2008-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
disruptive behavior##2##2##(1992-3#1)(2008-12#1)
disruptive behaviour##2##2##(2012-2#1)(2013-1#1)
disruptive passenger behaviour##5##3##(2007-2#5)
disruptive selection on genetic diversity##2##5##(2009-2#2)
disruptive selection on##3##3##(2008-8#1)(2009-2#2)
disruptive selection##6##2##(2008-8#4)(2009-2#2)
disruptive to the##2##3##(1994-1#1)(2010-11#1)
disruptive##30##1##(1992-3#1)(1994-1#1)(1996-1#1)(1996-12#1)(2007-2#5)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-2#2)(2009-5#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#3)
disruptive/violent##2##1##(1991-12#2)
disruptor##3##1##(2008-10#2)(2011-2#1)
disruptors have##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
disruptors##13##1##(2008-10#5)(2008-11#3)(2010-5#2)(2011-2#2)(2012-2#1)
disrupts cognition##2##2##(2012-1#2)
disrupts the##11##2##(1991-7#1)(1993-9#1)(1994-12#1)(2008-7#1)(2008-8#1)(2010-4#2)(2012-3#1)(2013-1#3)
disrupts##22##1##(1990-5#1)(1991-12#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
dissatisfaction and disordered eating##3##4##(2012-2#3)
dissatisfaction and##10##2##(2007-12#5)(2012-2#3)(2012-3#1)(2013-8#1)
dissatisfaction in##3##2##(2007-12#2)(2008-7#1)
dissatisfaction was##2##2##(2007-12#2)
dissatisfaction with body##2##3##(2007-7#2)
dissatisfaction with the##3##3##(2008-11#1)(2008-9#1)(2009-5#1)
dissatisfaction with##10##2##(1994-12#1)(1995-1#1)(1996-3#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-9#1)(2009-5#1)(2011-2#1)
dissatisfaction##66##1##(1993-6#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#39)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-4#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
dissatisfied with their##4##3##(2007-12#1)(2008-9#2)(2012-2#1)
dissatisfied with##6##2##(2007-11#1)(2007-12#1)(2008-9#2)(2012-2#1)(2013-1#1)
dissatisfied##11##1##(1992-5#1)(2007-11#1)(2007-12#2)(2008-7#2)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#1)
dissecans (OCD)##3##2##(2008-8#1)(2013-1#2)
dissecans##5##1##(1992-4#1)(2008-8#2)(2013-1#2)
dissect the##7##2##(2008-8#2)(2009-3#1)(2009-8#2)(2010-11#1)(2011-2#1)
dissect##11##1##(1997-9#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-12#1)
dissected and##3##2##(2007-11#1)(2007-8#1)(2011-1#1)
dissected from the##2##3##(2008-10#1)(2008-12#1)
dissected from##7##2##(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)
dissected lymph nodes##4##3##(2009-5#1)(2011-2#3)
dissected the##3##2##(1991-6#1)(1994-9#1)(2008-12#1)
dissected##37##1##(1991-6#1)(1992-3#1)(1994-5#1)(1994-9#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#1)
dissecting aneurysm of the##2##4##(2008-7#2)
dissecting aneurysm##7##2##(1997-5#1)(2008-12#1)(2008-7#5)
dissecting aneurysms of##2##3##(2008-7#2)
dissecting the##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2009-12#1)
dissecting##23##1##(1994-3#1)(1997-5#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#7)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
dissection and the##2##3##(2011-2#1)(2013-1#1)
dissection and##11##2##(1991-8#2)(1994-2#1)(2007-10#1)(2007-8#3)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
dissection are##4##2##(2007-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
dissection associated with##2##3##(2013-8#2)
dissection for##4##2##(2007-5#1)(2008-10#1)(2009-3#1)(2013-1#1)
dissection has##3##2##(1994-7#1)(2008-9#1)(2011-2#1)
dissection in a##2##3##(2013-1#2)
dissection in the##2##3##(2013-1#1)(2013-8#1)
dissection in##7##2##(2008-10#1)(2013-1#5)(2013-8#1)
dissection intimal##2##2##(2011-2#2)
dissection is a##3##3##(2008-7#1)(2010-10#1)(2012-1#1)
dissection is performed##2##3##(2008-10#1)(2008-8#1)
dissection is##12##2##(1991-8#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#3)(2012-1#1)(2013-8#1)
dissection may##3##2##(2007-7#1)(2010-10#2)
dissection of complex traits##2##4##(1994-9#2)
dissection of complex##3##3##(1994-9#3)
dissection of the nidus##2##4##(2008-7#2)
dissection of the superior mesenteric artery##3##6##(2013-1#3)
dissection of the##21##3##(1992-10#1)(1993-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-3#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#3)
dissection of##44##2##(1990-3#1)(1992-10#1)(1993-12#1)(1994-9#3)(1995-2#1)(1995-6#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-3#1)(2010-10#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)
dissection ofthe right##2##3##(2013-8#2)
dissection should be##2##3##(1990-8#1)(2010-10#1)
dissection to##2##2##(1994-3#1)(2008-10#1)
dissection was##2##2##(2008-7#1)(2013-1#1)
dissection were##3##2##(2007-10#2)(2013-1#1)
dissection with##4##2##(2008-11#2)(2013-1#2)
dissection##196##1##(1990-3#1)(1990-8#3)(1991-2#3)(1991-8#4)(1992-10#1)(1993-12#2)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-7#1)(1994-9#3)(1995-2#1)(1995-5#1)(1995-6#1)(2006-12#1)(2007-10#7)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#13)(2008-10#15)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#14)(2008-8#3)(2008-9#7)(2009-2#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-10#7)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#18)(2012-1#7)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#19)(2013-8#9)
dissections were##2##2##(2008-10#1)(2011-2#1)
dissections##12##1##(1991-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#3)(2011-2#1)(2012-1#2)(2012-12#1)
dissector##3##1##(1991-3#1)(2009-7#1)(2012-2#1)
disseminate information##2##2##(1996-1#1)(2008-11#1)
disseminate the results##2##3##(1991-1#1)(1993-12#1)
disseminate##11##1##(1991-1#1)(1993-12#1)(1996-1#1)(1997-3#2)(2006-9#1)(2008-11#2)(2010-8#1)(2011-1#1)(2013-1#1)
disseminated Trichosporon asahii infection in a child##2##7##(2009-4#2)
disseminated by##5##2##(2008-10#2)(2008-5#1)(2010-1#1)(2013-8#1)
disseminated encephalomyelitis##3##2##(2012-12#3)
disseminated for##2##2##(2008-11#2)
disseminated form of##2##3##(2007-8#1)(2011-2#1)
disseminated histoplasmosis##3##2##(1990-9#1)(2006-10#2)
disseminated intravascular coagulation (DIC)##3##4##(2008-7#1)(2010-3#1)(2012-3#1)
disseminated intravascular coagulation##8##3##(1992-9#1)(2006-10#1)(2007-10#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-3#1)
disseminated intravascular##9##2##(1992-9#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-3#1)
disseminated neoplasm (mean##2##3##(1996-12#2)
disseminated neoplasm##5##2##(1996-12#5)
disseminated pulmonary##2##2##(2008-10#2)
disseminated superficial porokeratosis##3##3##(2007-7#2)(2010-6#1)
disseminated superficial##4##2##(2007-7#3)(2010-6#1)
disseminated to##6##2##(1996-1#1)(1996-2#1)(2008-10#2)(2011-2#1)(2012-3#1)
disseminated##83##1##(1990-8#2)(1990-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-1#1)(1996-12#5)(1996-2#1)(1997-3#2)(1997-7#1)(2006-10#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#5)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-3#3)(2010-5#2)(2010-6#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
disseminates##3##1##(1994-3#1)(2012-2#1)(2013-8#1)
disseminating research##2##2##(2008-12#1)(2010-4#1)
disseminating structures##3##2##(2007-12#3)
disseminating the##3##2##(1996-3#1)(2008-10#1)(2009-10#1)
disseminating##22##1##(1993-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2007-12#4)(2007-7#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
dissemination activities##2##2##(1990-3#1)(1993-12#1)
dissemination and use##2##3##(1997-1#1)(2012-12#1)
dissemination and##7##2##(1992-2#1)(1993-12#1)(1996-12#1)(1997-1#1)(2012-12#2)(2013-1#1)
dissemination in##5##2##(1997-5#1)(2008-10#2)(2010-10#1)(2013-1#1)
dissemination is##3##2##(1990-2#1)(2008-7#2)
dissemination of conidia from##2##4##(2008-10#2)
dissemination of conidia##3##3##(2008-10#3)
dissemination of information##3##3##(1992-9#1)(1996-11#1)(1996-4#1)
dissemination of knowledge##2##3##(1993-6#1)(2008-11#1)
dissemination of research##2##3##(2010-2#1)(2011-2#1)
dissemination of the tumor##2##4##(1993-9#1)(2013-1#1)
dissemination of the##4##3##(1993-9#1)(2008-5#1)(2008-9#1)(2013-1#1)
dissemination of##27##2##(1991-12#1)(1992-9#1)(1993-6#2)(1993-9#1)(1996-11#1)(1996-4#1)(2007-10#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
dissemination to##3##2##(2008-10#1)(2009-4#1)(2013-8#1)
dissemination##89##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-4#3)(1992-12#1)(1992-2#1)(1992-9#2)(1993-12#5)(1993-6#2)(1993-9#1)(1994-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-5#1)(2007-10#2)(2007-11#4)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#5)(2008-9#3)(2009-1#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
dissertation##8##1##(2008-11#5)(2008-2#1)(2008-3#1)(2013-8#1)
dissimilar from##3##2##(1990-8#1)(1994-2#1)(2008-10#1)
dissimilar##33##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1992-12#1)(1993-11#1)(1993-2#2)(1994-2#2)(1994-9#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#5)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2010-10#1)(2012-2#1)(2013-1#1)
dissimilarities##3##1##(1996-5#1)(2008-10#1)(2010-6#1)
dissimilarity between two##2##3##(2008-4#1)(2013-1#1)
dissimilarity data##2##2##(1995-5#1)(2008-10#1)
dissimilarity##12##1##(1990-4#1)(1995-5#2)(2008-10#4)(2008-4#1)(2009-2#1)(2010-6#1)(2013-1#1)(2013-7#1)
dissipate##6##1##(1994-12#1)(1994-6#1)(2008-10#1)(2009-12#1)(2010-7#1)(2012-12#1)
dissipated##6##1##(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)
dissipation and##3##2##(2008-10#1)(2008-11#2)
dissipation in##2##2##(2008-7#1)(2012-2#1)
dissipation of the##4##3##(1990-2#1)(1994-9#1)(2008-1#1)(2010-8#1)
dissipation of##7##2##(1990-2#1)(1994-9#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
dissipation was##2##2##(2008-5#1)(2011-1#1)
dissipation##33##1##(1990-2#1)(1992-8#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#12)(2008-9#1)(2009-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-6#1)
dissipative processes in##2##3##(2008-2#1)(2010-7#1)
dissipative structures##3##2##(2008-1#1)(2012-2#2)
dissipative##12##1##(1992-8#1)(2007-11#1)(2008-1#3)(2008-2#1)(2008-3#2)(2009-5#1)(2010-7#1)(2012-2#2)
dissociable##5##1##(1996-2#1)(2008-11#2)(2008-4#1)(2011-1#1)
dissociate from##2##2##(1992-3#1)(1995-8#1)
dissociate the##2##2##(1995-2#1)(1996-2#1)
dissociate##15##1##(1992-3#1)(1992-6#1)(1994-6#1)(1995-2#2)(1995-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-8#1)
dissociated and##2##2##(1995-5#1)(2008-10#1)
dissociated cell culture##4##3##(1993-12#1)(1996-2#1)(1997-6#2)
dissociated cultures##4##2##(1996-2#1)(1997-6#1)(2009-8#1)(2009-9#1)
dissociated from the##6##3##(1990-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-5#1)(2008-8#1)
dissociated from##10##2##(1990-12#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
dissociated into##5##2##(1990-5#1)(1993-6#1)(2008-10#1)(2008-11#1)(2010-7#1)
dissociated neuronal##2##2##(1997-6#1)(2009-9#1)
dissociated##57##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-6#4)(2008-10#11)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-7#1)(2013-8#1)
dissociates from the##3##3##(1993-8#1)(1993-9#1)(1994-8#1)
dissociates into##2##2##(1990-11#1)(2008-9#1)
dissociates##7##1##(1990-11#1)(1991-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-2#1)(2008-9#1)
dissociating the##2##2##(2008-2#1)(2008-4#1)
dissociating##6##1##(1990-12#1)(1990-5#1)(1995-6#1)(2008-2#1)(2008-4#1)(2008-9#1)
dissociation (CID) of the##2##4##(2008-10#2)
dissociation (CID)##3##2##(2008-10#3)
dissociation and somatization disorders##2##4##(2012-12#2)
dissociation and somatization##3##3##(2012-12#3)
dissociation and##9##2##(1993-8#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-12#3)
dissociation between the##4##3##(1993-6#1)(1994-8#1)(2010-8#1)(2013-8#1)
dissociation between##6##2##(1993-12#1)(1993-6#1)(1994-8#1)(1996-2#1)(2010-8#1)(2013-8#1)
dissociation by##2##2##(1994-6#1)(2010-4#1)
dissociation constant (Kd) of##2##4##(1990-12#1)(1993-6#1)
dissociation constant (Kd)##3##3##(1990-11#1)(1990-12#1)(1993-6#1)
dissociation constant at##2##3##(1993-3#1)(1993-8#1)
dissociation constant for the##4##4##(1990-5#1)(1992-5#2)(1995-2#1)
dissociation constant is##2##3##(1993-8#1)(1995-5#1)
dissociation constant of the##3##4##(1993-8#1)(1996-3#1)(2008-11#1)
dissociation constant of##11##3##(1990-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
dissociation constant##42##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-5#2)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-5#1)(1995-2#3)(1995-5#1)(1996-3#1)(1997-2#2)(2008-10#14)(2008-11#1)(2008-6#1)(2008-9#1)
dissociation constants and##2##3##(2008-10#2)
dissociation constants for##3##3##(1995-2#1)(1995-6#1)(2008-10#1)
dissociation constants in##2##3##(2007-11#1)(2008-10#1)
dissociation constants of##15##3##(1992-8#1)(1993-8#1)(1995-11#1)(2008-10#12)
dissociation constants were##3##3##(1991-5#1)(2008-10#2)
dissociation constants##45##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#32)
dissociation equilibria##2##2##(2008-10#2)
dissociation equilibrium##3##2##(2007-11#1)(2008-10#2)
dissociation from##2##2##(1995-11#1)(1995-2#1)
dissociation in the##2##3##(1990-12#1)(1996-7#1)
dissociation in##4##2##(1990-12#1)(1996-7#1)(1997-5#1)(2010-9#1)
dissociation intermediates##2##2##(2008-10#2)
dissociation of function##2##3##(2008-11#1)(2008-6#1)
dissociation of protonated##3##3##(2008-10#2)(2012-12#1)
dissociation of the##10##3##(1990-12#1)(1993-11#1)(1993-6#1)(1995-11#1)(1996-2#1)(2009-10#1)(2010-12#1)(2012-12#2)(2012-3#1)
dissociation of##45##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#3)(2012-3#1)
dissociation on##2##2##(1993-8#1)(2008-2#1)
dissociation products##3##2##(1994-6#1)(1996-7#2)
dissociation rate of##2##3##(1991-5#1)(1993-8#1)
dissociation rate##5##2##(1991-5#1)(1992-6#1)(1993-8#2)(2008-10#1)
dissociation rates##2##2##(1991-5#1)(2008-10#1)
dissociation reactions of##3##3##(2008-10#3)
dissociation was##2##2##(1992-6#1)(2008-10#1)
dissociation##236##1##(1990-11#2)(1990-12#4)(1990-5#1)(1990-8#4)(1990-9#1)(1991-2#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-3#4)(1992-5#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-6#7)(1993-8#11)(1993-9#3)(1994-2#1)(1994-5#3)(1994-6#4)(1994-8#3)(1995-11#4)(1995-12#1)(1995-2#9)(1995-5#3)(1995-6#3)(1996-10#2)(1996-2#5)(1996-3#1)(1996-7#8)(1997-2#3)(1997-5#1)(1997-6#1)(2007-11#5)(2007-4#1)(2007-8#1)(2008-10#81)(2008-11#2)(2008-2#6)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#8)(2012-3#1)(2013-8#1)
dissociations##4##1##(1990-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
dissociative##12##1##(1992-8#1)(1996-7#2)(2008-9#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-1#4)
dissolution and##11##2##(2008-10#4)(2008-3#2)(2008-7#1)(2009-7#2)(2013-1#2)
dissolution in a##2##3##(2008-10#2)
dissolution in##8##2##(2008-10#8)
dissolution media##2##2##(2008-10#1)(2010-3#1)
dissolution medium was##4##3##(2008-10#1)(2010-3#3)
dissolution medium##6##2##(2008-10#1)(2010-3#5)
dissolution mixtures##2##2##(2008-10#2)
dissolution of a##3##3##(2008-10#2)(2010-5#1)
dissolution of the sample in##3##5##(2008-10#3)
dissolution of the##19##3##(1991-1#1)(1995-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2009-7#1)(2013-1#1)
dissolution of##46##2##(1991-1#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-5#1)(2013-1#1)
dissolution procedure##2##2##(2008-10#2)
dissolution profiles of isoniazid##3##4##(2008-10#3)
dissolution profiles of##4##3##(2008-10#4)
dissolution profiles##6##2##(2008-10#5)(2012-2#1)
dissolution rate and dissolution efficiency##2##5##(2012-2#2)
dissolution rate of##4##3##(2008-10#1)(2012-2#3)
dissolution rate##8##2##(2008-10#2)(2008-5#1)(2012-2#5)
dissolution rates of ceramic##2##4##(2008-5#2)
dissolution rates of##3##3##(2008-5#2)(2009-7#1)
dissolution rates##5##2##(2008-5#3)(2009-7#2)
dissolution studies of##2##3##(2008-10#2)
dissolution studies##4##2##(2008-10#4)
dissolution study##3##2##(2010-3#1)(2010-5#1)(2012-2#1)
dissolution system##2##2##(2008-10#2)
dissolution testing is described##2##4##(2008-10#2)
dissolution testing##4##2##(2008-10#4)
dissolution tests##4##2##(2008-10#3)(2011-1#1)
dissolution than##2##2##(2008-10#1)(2012-2#1)
dissolution was##2##2##(2008-10#2)
dissolution with##2##2##(2008-10#2)
dissolution##176##1##(1991-1#1)(1991-3#2)(1995-3#1)(1995-8#1)(2007-12#4)(2008-1#1)(2008-10#114)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#5)(2009-9#1)(2010-3#8)(2010-5#2)(2011-1#1)(2012-2#13)(2013-1#3)
dissolution-reaction##2##1##(2008-7#2)
dissolvable##2##1##(2008-10#1)(2008-5#1)
dissolve in##2##2##(1992-8#1)(2008-5#1)
dissolve##12##1##(1992-8#1)(1994-8#1)(1995-2#4)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)
dissolved Cr(III) and Cr(VI)##2##4##(2008-10#2)
dissolved O(2) level##2##3##(2011-2#2)
dissolved O(2) levels##3##3##(2011-2#3)
dissolved O(2)##6##2##(2011-2#6)
dissolved and##4##2##(2008-10#3)(2008-3#1)
dissolved by##2##2##(2008-10#2)
dissolved fractions##2##2##(2008-10#2)
dissolved humic##3##2##(2008-10#3)
dissolved hydrogen##5##2##(2008-11#1)(2008-7#4)
dissolved in 0##2##3##(2008-10#2)
dissolved in 1 ml of##2##5##(2008-10#2)
dissolved in 1##3##3##(1990-8#1)(2008-10#2)
dissolved in 5 ml##2##4##(1996-12#1)(2008-10#1)
dissolved in 90% ethanol##2##4##(2008-10#2)
dissolved in a##11##3##(2007-11#1)(2008-10#8)(2008-7#1)(2009-3#1)
dissolved in acetone##2##3##(2008-10#2)
dissolved in aqueous##3##3##(2008-10#2)(2008-3#1)
dissolved in kerosene##2##3##(2008-10#2)
dissolved in normal##2##3##(2008-10#1)(2008-12#1)
dissolved in organic solvents##3##4##(1995-2#1)(2008-10#1)(2008-7#1)
dissolved in several##2##3##(2008-10#1)(2008-7#1)
dissolved in the##6##3##(1990-5#1)(1991-5#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
dissolved in water and##2##4##(2008-10#2)
dissolved in water##3##3##(2008-10#3)
dissolved in##93##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#2)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#58)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2009-3#1)(2012-7#1)(2013-1#1)
dissolved inorganic##2##2##(2008-10#1)(2013-1#1)
dissolved iron##3##2##(2008-10#3)
dissolved metal##4##2##(2008-10#4)
dissolved molecular hydrogen##2##3##(2008-3#2)
dissolved organic matter (DOM)##4##4##(2008-10#4)
dissolved organic matter are##2##4##(2008-2#1)(2008-3#1)
dissolved organic matter on##2##4##(2008-10#1)(2008-2#1)
dissolved organic matter##15##3##(2008-10#8)(2008-2#4)(2008-3#3)
dissolved organic phosphorus (DOP) in##2##5##(2008-10#2)
dissolved organic phosphorus##4##3##(2008-10#4)
dissolved organic##23##2##(2008-10#16)(2008-2#4)(2008-3#3)
dissolved oxygen (DO) probe##2##4##(2008-10#2)
dissolved oxygen (DO)##8##3##(2008-10#5)(2008-11#3)
dissolved oxygen and##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
dissolved oxygen concentration##2##3##(2008-10#1)(2008-7#1)
dissolved oxygen probe##4##3##(2008-10#4)
dissolved oxygen##41##2##(1994-3#2)(2008-10#26)(2008-11#7)(2008-7#4)(2010-8#1)(2011-2#1)
dissolved silica##2##2##(2008-10#2)
dissolved silicon##3##2##(2008-10#2)(2012-2#1)
dissolved solids##2##2##(2008-10#1)(2013-7#1)
dissolved substances in river water##2##5##(2008-10#2)
dissolved substances in##3##3##(2008-10#2)(2008-2#1)
dissolved with 5 ml of dimethylformamide (DMF) and the metal determined by##2##12##(2008-10#2)
dissolved with 5 ml of dimethylformamide (DMF) and the metal##3##10##(2008-10#3)
dissolved with 5 ml of##4##5##(2008-10#4)
dissolved with water##2##3##(2008-10#2)
dissolved with##16##2##(2008-10#15)(2011-2#1)
dissolved##278##1##(1990-5#2)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#2)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#188)(2008-11#15)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#14)(2009-12#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#8)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
dissolves in##2##2##(1994-12#1)(2008-5#1)
dissolves##6##1##(1994-12#1)(2008-10#2)(2008-5#2)(2010-5#1)
dissolving agent for the##3##4##(2008-10#3)
dissolving drug##2##2##(2010-5#1)(2012-2#1)
dissolving tablets##2##2##(2010-3#1)(2010-5#1)
dissolving the##5##2##(2008-10#4)(2008-2#1)
dissolving them in##2##3##(2008-10#2)
dissolving##27##1##(2008-10#16)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2012-2#2)
dissonance-induction##2##1##(2007-12#2)
dissorophoid amphibians##3##2##(2010-6#3)
dissorophoids##3##1##(2010-6#3)
dissotocum##2##1##(2008-10#2)
distal and proximal##2##3##(1991-9#1)(2010-4#1)
distal aortic arch##3##3##(2007-8#3)
distal aortic##4##2##(2007-8#4)
distal arm monoparesis##2##3##(2007-10#2)
distal basilar##2##2##(1997-3#1)(2007-10#1)
distal chromosome##2##2##(2008-2#1)(2008-7#1)
distal clearance##2##2##(1991-12#2)
distal components of the insulin exocytotic##2##6##(2010-11#2)
distal coronary##3##2##(1994-11#1)(1996-9#1)(2007-8#1)
distal cues##2##2##(1993-6#1)(1994-8#1)
distal dendrite##2##2##(2007-12#1)(2010-11#1)
distal dendrites##2##2##(2007-12#1)(2010-11#1)
distal embolic protection##2##3##(2008-11#1)(2009-5#1)
distal end of##13##3##(1991-7#1)(1992-12#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-2#1)
distal end##19##2##(1991-7#1)(1992-12#1)(1997-5#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
distal endothelial##3##2##(2007-8#3)
distal ends of the long arms##2##6##(2008-5#2)
distal ends of the##3##4##(2008-2#1)(2008-5#2)
distal ends of##5##3##(1995-6#1)(2008-2#1)(2008-5#2)(2013-1#1)
distal ends##6##2##(1995-6#1)(2008-2#1)(2008-5#2)(2008-8#1)(2013-1#1)
distal epiphyseal breadth##3##3##(1995-6#3)
distal extremities##3##2##(2008-7#3)
distal femoral##5##2##(1993-8#1)(2007-11#2)(2013-1#2)
distal femur##6##2##(2009-3#1)(2010-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
distal from##2##2##(1990-7#1)(2008-10#1)
distal half##3##2##(2007-12#1)(2007-8#1)(2008-7#1)
distal humerus##3##2##(2012-2#3)
distal hypospadias repair##3##3##(2008-10#2)(2009-5#1)
distal hypospadias##6##2##(2008-10#2)(2009-5#4)
distal leg##2##2##(2007-12#1)(2010-11#1)
distal limb##3##2##(1997-3#2)(2008-1#1)
distal lung epithelial phenotype##2##4##(2008-9#2)
distal lung epithelial##3##3##(2008-9#3)
distal lung##6##2##(1991-12#1)(2008-9#5)
distal metaphyseal##3##2##(2011-2#1)(2013-1#2)
distal obstruction##2##2##(1993-1#1)(2010-6#1)
distal of##2##2##(1995-6#1)(2008-10#1)
distal pancreatectomy with splenectomy##2##4##(2010-1#1)(2010-12#1)
distal pancreatectomy##4##2##(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
distal part of femur##2##4##(2007-11#2)
distal part of the##12##4##(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-1#1)(2013-1#2)
distal part of##14##3##(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-1#1)(2013-1#2)
distal part##15##2##(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-4#1)(2012-1#1)(2013-1#2)
distal parts of the##2##4##(1996-3#1)(2008-9#1)
distal portion##8##2##(1991-5#1)(1996-8#1)(1997-4#1)(2007-12#2)(2008-7#1)(2011-2#2)
distal promoter##2##2##(1990-11#1)(2008-9#1)
distal radial##4##2##(2007-8#1)(2008-9#1)(2013-8#2)
distal radius and##2##3##(2008-9#1)(2012-1#1)
distal radius fractures with##2##4##(2008-9#2)
distal radius fractures##9##3##(2008-9#8)(2011-2#1)
distal radius##27##2##(2007-11#3)(2008-9#17)(2009-3#3)(2011-2#2)(2012-1#1)(2013-1#1)
distal region of##2##3##(1991-9#1)(2012-3#1)
distal region##3##2##(1991-9#1)(1997-8#1)(2012-3#1)
distal renal tubular acidosis##2##4##(2008-1#2)
distal segment##3##2##(2007-12#1)(2013-8#2)
distal site##3##2##(1995-3#2)(1996-5#1)
distal symmetric##2##2##(2011-1#2)
distal third##4##2##(2008-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
distal tibia##4##2##(2007-11#1)(2007-8#2)(2011-2#1)
distal tip of the##2##4##(2007-12#1)(2008-10#1)
distal tip##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
distal to the occlusion##3##4##(1993-3#1)(1997-6#1)(2008-4#1)
distal to the##22##3##(1991-6#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-3#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2009-1#1)(2010-6#1)(2013-1#2)
distal to##27##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2009-1#1)(2010-6#1)(2012-2#1)(2013-1#2)
distal tubal##3##2##(1991-12#1)(1993-1#2)
distal tubule##2##2##(1994-9#1)(1997-8#1)
distal ulnar##2##2##(2008-6#1)(2008-9#1)
distal ureteral##2##2##(2013-8#2)
distal ureteric##2##2##(2008-10#1)(2009-5#1)
distal urethral##2##2##(2008-10#2)
distal##376##1##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-5#1)(1993-1#6)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#3)(1995-3#3)(1995-6#6)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#7)(2007-10#3)(2007-11#8)(2007-12#17)(2007-7#3)(2007-8#22)(2008-1#4)(2008-10#27)(2008-11#6)(2008-12#6)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#17)(2008-8#4)(2008-9#37)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#10)(2009-4#1)(2009-5#6)(2009-8#1)(2010-1#1)(2010-11#9)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#15)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#6)(2013-1#19)(2013-3#1)(2013-8#8)
distally located##2##2##(1996-5#1)(1997-3#1)
distally to##2##2##(1992-6#1)(2009-4#1)
distally valved catheter##2##3##(2007-7#2)
distally valved##3##2##(2007-7#3)
distally##16##1##(1992-6#1)(1996-5#1)(1997-3#1)(2007-7#3)(2008-10#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
distamycin##3##1##(1995-3#3)
distance D##2##2##(2008-3#2)
distance alone##2##2##(2008-8#1)(2009-8#1)
distance among##5##2##(2008-10#3)(2009-2#2)
distance and coping##2##3##(1996-1#2)
distance and the##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2010-4#1)
distance and##19##2##(1990-3#1)(1995-2#1)(1996-1#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
distance as##2##2##(2007-11#1)(2008-11#1)
distance at which##2##3##(2008-10#1)(2013-1#1)
distance at##3##2##(2008-10#2)(2013-1#1)
distance between populations##2##3##(2008-10#1)(2012-3#1)
distance between the two##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
distance between the##39##3##(1991-5#1)(1993-12#1)(1994-5#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#10)(2008-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
distance between their##2##3##(1997-6#1)(2013-1#1)
distance between two##2##3##(2008-10#1)(2008-11#1)
distance between##68##2##(1991-5#1)(1992-4#1)(1993-12#1)(1993-8#2)(1994-5#2)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#3)
distance class##2##2##(2008-10#2)
distance constraint##2##2##(2009-9#1)(2010-5#1)
distance constraints##5##2##(1994-5#2)(2008-8#1)(2009-9#2)
distance d##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
distance distribution measurements between##2##4##(1995-6#2)
distance education##4##2##(2012-3#4)
distance for##4##2##(1993-3#1)(1995-5#1)(1996-4#1)(2008-10#1)
distance from plants##2##3##(2008-10#2)
distance from the aperture to the##4##6##(2008-3#4)
distance from the focus##2##4##(2008-10#2)
distance from the needle##2##4##(1996-6#1)(2008-9#1)
distance from the source##4##4##(2008-10#3)(2008-2#1)
distance from the##42##3##(1995-6#2)(1996-1#1)(1996-5#1)(1996-6#2)(1997-5#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#12)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
distance from##54##2##(1994-9#1)(1995-6#2)(1996-1#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#15)(2008-12#2)(2008-2#2)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
distance geometry and molecular dynamics##2##5##(1991-8#2)
distance geometry##3##2##(1991-8#2)(2008-8#1)
distance in the##5##3##(1995-2#1)(1996-1#1)(2007-11#1)(2008-3#1)(2010-8#1)
distance in##13##2##(1995-2#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-4#1)(2010-8#1)
distance indices##11##2##(2007-11#6)(2008-10#5)
distance is kept fixed##2##4##(2008-3#2)
distance is##8##2##(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-8#1)
distance learning approaches##2##3##(2008-11#2)
distance learning##9##2##(2008-11#6)(2010-10#2)(2012-12#1)
distance less than##2##3##(2008-10#1)(2008-3#1)
distance limitations##3##2##(2009-8#3)
distance matrix##4##2##(2007-11#4)
distance measurements##6##2##(2008-10#1)(2008-3#5)
distance methods##4##2##(1995-3#1)(2008-4#2)(2008-8#1)
distance of 0##3##3##(2008-10#2)(2008-3#1)
distance of 1##7##3##(1997-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
distance of 10##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
distance of 100##2##3##(1993-6#1)(2008-10#1)
distance of 2##3##3##(2008-10#2)(2008-9#1)
distance of 4##2##3##(2008-10#1)(2011-2#1)
distance of a##2##3##(1993-11#1)(2008-10#1)
distance of approximately##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
distance of more##2##3##(2008-7#1)(2012-1#1)
distance of the##11##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-10#1)
distance of##82##2##(1991-2#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-6#1)(1997-7#2)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#22)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
distance on##2##2##(1997-3#1)(2008-10#1)
distance or##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
distance over##2##2##(2008-10#1)(2010-6#1)
distance should##2##2##(2008-12#1)(2008-8#1)
distance that##4##2##(2008-10#3)(2008-4#1)
distance the##2##2##(2007-10#1)(2008-2#1)
distance to regularity for##2##4##(2008-10#2)
distance to regularity##3##3##(2008-10#3)
distance to the##6##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)
distance to##16##2##(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-1#1)
distance transform##3##2##(2008-3#3)
distance transforms##3##2##(2008-3#3)
distance walked##2##2##(2013-1#2)
distance was 0##2##3##(2008-10#1)(2013-1#1)
distance was found##3##3##(2008-10#3)
distance was##14##2##(1996-6#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
distance were##2##2##(2008-8#1)(2012-3#1)
distance when the##2##3##(2008-3#2)
distance with##2##2##(2011-2#1)(2012-2#1)
distance without##2##2##(2010-10#1)(2013-1#1)
distance##536##1##(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-2#2)(1994-5#5)(1994-9#2)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#6)(1996-1#5)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#23)(2007-12#16)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#125)(2008-11#15)(2008-12#15)(2008-2#34)(2008-3#71)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#22)(2008-9#12)(2009-11#2)(2009-2#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#4)(2010-10#7)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#13)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#15)(2013-7#2)(2013-8#11)
distance)##5##1##(2008-10#4)(2008-5#1)
distance-based methods##2##2##(2008-4#2)
distance-based##4##1##(2008-10#1)(2008-4#3)
distance-dependent##2##1##(2008-8#1)(2011-2#1)
distance-multiplying##2##1##(2008-2#2)
distances among populations##2##3##(2008-10#1)(2013-1#1)
distances among##7##2##(2008-10#4)(2008-5#1)(2008-8#1)(2013-1#1)
distances and##12##2##(1995-6#1)(1996-2#2)(2007-4#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-8#1)(2010-8#1)(2012-2#1)
distances are##2##2##(1993-8#1)(2008-10#1)
distances as small as 0##2##5##(2008-3#2)
distances as##3##2##(1996-7#1)(2008-3#2)
distances based on##2##3##(2008-10#1)(2010-7#1)
distances based##3##2##(2008-10#1)(2009-9#1)(2010-7#1)
distances between each##2##3##(2008-10#1)(2008-3#1)
distances between the##3##3##(2008-5#1)(2008-6#1)(2008-9#1)
distances between##19##2##(1994-5#1)(1996-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
distances by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
distances for##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
distances from the##9##3##(1991-5#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2009-11#1)
distances from##19##2##(1991-5#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-11#1)(2011-2#1)
distances in the##5##3##(1991-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)
distances in##12##2##(1991-11#1)(1996-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)
distances observed in##2##3##(2008-8#1)(2010-12#1)
distances observed##3##2##(2008-8#1)(2010-12#1)(2013-1#1)
distances of 2##3##3##(1996-2#2)(2008-10#1)
distances of spread##2##3##(2008-10#2)
distances of##18##2##(1990-7#1)(1992-11#1)(1995-2#1)(1996-2#2)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2010-10#1)(2012-2#1)
distances on##3##2##(2008-10#1)(2008-12#2)
distances over which##2##3##(1990-8#1)(2009-8#1)
distances than##2##2##(1995-6#1)(2008-4#1)
distances that##2##2##(1996-2#1)(2008-8#1)
distances to##6##2##(1992-11#1)(2008-10#1)(2008-3#3)(2011-2#1)
distances was##2##2##(2008-12#1)(2013-1#1)
distances were not##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
distances were##15##2##(1997-7#1)(2008-10#5)(2008-12#2)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#2)(2013-1#1)
distances without##2##2##(2007-12#1)(2011-2#1)
distances##223##1##(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-1#1)(1996-2#11)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#8)(2007-4#1)(2008-10#53)(2008-11#2)(2008-12#15)(2008-2#8)(2008-3#24)(2008-4#6)(2008-5#4)(2008-6#6)(2008-7#1)(2008-8#14)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-12#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#3)(2013-1#7)(2013-8#2)
distancing##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
distant and##2##2##(1993-12#1)(2011-2#1)
distant failure##2##2##(2008-10#1)(2008-6#1)
distant from PWCs##2##3##(2012-2#2)
distant from the##7##3##(1991-6#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
distant from this##2##3##(1994-9#1)(2008-10#1)
distant from##17##2##(1991-6#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(2008-10#6)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
distant metastases##23##2##(1990-6#1)(1991-8#1)(1992-12#1)(1993-1#2)(1994-8#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#7)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
distant metastasis##8##2##(1993-8#1)(1993-9#1)(1994-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2010-3#2)
distant organ##2##2##(2009-10#1)(2011-2#1)
distant organs##2##2##(2008-10#1)(2011-1#1)
distant recurrence##2##2##(1990-6#1)(1995-4#1)
distant sites##5##2##(1995-4#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-3#1)
distant visual##2##2##(1994-8#1)(2013-1#1)
distant##127##1##(1990-12#1)(1990-6#2)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-1#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-4#2)(1996-10#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#4)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#1)
distantly related to##7##3##(2007-12#1)(2008-10#5)(2008-5#1)
distantly related##17##2##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)
distasonis and B##3##3##(1997-2#3)
distasonis##4##1##(1997-2#4)
distended##4##1##(1993-6#1)(1997-6#1)(2013-1#2)
distensibility and##3##2##(2007-8#2)(2013-3#1)
distensibility##12##1##(2007-8#5)(2008-3#2)(2013-3#5)
distension and##4##2##(2008-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
distension of##2##2##(2008-1#1)(2013-1#1)
distension##15##1##(1997-8#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#3)(2012-3#2)(2013-1#3)
distention##6##1##(1992-9#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-3#1)
distichum chromosome##3##2##(2008-5#3)
distichum chromosomes##4##2##(2008-5#4)
distichum##8##1##(2008-5#8)
distillate##3##1##(2008-5#1)(2008-6#2)
distillation in##4##2##(2008-10#3)(2008-6#1)
distillation##23##1##(1992-8#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#6)
distilled drinks##3##2##(2008-10#3)
distilled water (DW)##2##3##(2008-10#1)(2013-1#1)
distilled water and##7##3##(2008-10#3)(2008-12#1)(2008-2#1)(2012-3#1)(2013-1#1)
distilled water as##2##3##(2008-10#1)(2012-2#1)
distilled water at##2##3##(2009-8#1)(2010-3#1)
distilled water containing##2##3##(2008-10#1)(2008-5#1)
distilled water lavage##2##3##(2010-3#2)
distilled water was##2##3##(2007-12#1)(2009-11#1)
distilled water##49##2##(1992-8#1)(1996-12#1)(1996-5#2)(2007-12#2)(2007-3#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-3#5)(2010-5#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
distilled water)##2##2##(1994-9#1)(2012-3#1)
distilled##68##1##(1992-8#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-5#2)(2007-12#2)(2007-3#1)(2008-10#23)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#4)(2009-11#1)(2009-6#1)(2009-8#1)(2010-3#5)(2010-5#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
distiller's grains##2##2##(2011-2#2)
distilling##2##1##(2008-10#1)(2009-3#1)
distills##2##1##(2008-9#1)(2010-3#1)
distinct North##2##2##(2008-10#1)(2010-10#1)
distinct advantages over the##2##4##(1993-3#1)(1994-1#1)
distinct advantages over##3##3##(1993-3#1)(1994-1#1)(2009-9#1)
distinct advantages##6##2##(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(2008-3#1)(2009-9#1)
distinct anatomical##2##2##(2012-2#2)
distinct and##13##2##(1991-1#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-12#2)(2008-5#1)(2011-2#2)(2012-2#1)
distinct approaches##3##2##(2007-7#1)(2008-2#1)(2012-2#1)
distinct areas in##2##3##(2007-12#1)(2011-1#1)
distinct areas##5##2##(1994-3#1)(2007-12#1)(2008-6#1)(2010-6#1)(2011-1#1)
distinct bands##4##2##(1995-12#2)(2008-10#1)(2008-9#1)
distinct barcode clusters##2##3##(2008-9#2)
distinct binding##2##2##(1990-7#1)(1993-3#1)
distinct biological##4##2##(1995-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
distinct cell##4##2##(1993-3#1)(1993-8#1)(1995-6#1)(2008-5#1)
distinct cellular##2##2##(1996-9#1)(2011-2#1)
distinct changes##2##2##(2008-9#1)(2009-12#1)
distinct characteristics##4##2##(1995-3#1)(2007-5#1)(2008-11#1)(2008-8#1)
distinct clades##5##2##(2008-10#3)(2009-8#1)(2010-4#1)
distinct classes of##4##3##(2008-7#2)(2009-12#1)(2009-3#1)
distinct clinical features##2##3##(2007-10#1)(2009-12#1)
distinct clinical##5##2##(2007-10#1)(2008-7#1)(2009-12#1)(2010-4#1)(2012-2#1)
distinct clonal##2##2##(2008-10#1)(2009-2#1)
distinct cluster##2##2##(2008-10#2)
distinct clusters of isolates were##2##5##(2008-10#2)
distinct clusters of isolates##3##4##(2008-10#3)
distinct clusters of##4##3##(2008-10#4)
distinct clusters##10##2##(2008-10#10)
distinct components##3##2##(1994-5#1)(2008-2#1)(2008-8#1)
distinct constructs##3##2##(2008-11#1)(2009-9#1)(2010-7#1)
distinct contributions##2##2##(2008-10#1)(2008-5#1)
distinct cortical##2##2##(2007-8#1)(2008-11#1)
distinct differences among##2##3##(1994-9#1)(2008-10#1)
distinct differences in##2##3##(2008-10#1)(2011-2#1)
distinct differences##5##2##(1994-9#1)(2007-12#1)(2008-10#2)(2011-2#1)
distinct disease##2##2##(2007-7#1)(2008-10#1)
distinct diseases##2##2##(1991-11#1)(2008-10#1)
distinct domains of##3##3##(1993-8#1)(1996-2#2)
distinct domains##6##2##(1990-12#1)(1993-8#1)(1996-2#2)(1997-4#1)(2011-2#1)
distinct ecological##2##2##(1996-4#2)
distinct effects on##3##3##(1995-3#1)(1996-12#1)(2012-12#1)
distinct effects##5##2##(1994-2#1)(1995-3#1)(1996-12#1)(2008-9#1)(2012-12#1)
distinct elements##2##2##(2009-7#1)(2010-6#1)
distinct entities##3##2##(1991-8#1)(1994-9#1)(2008-8#1)
distinct expression##4##2##(1993-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
distinct factors##2##2##(2010-6#1)(2013-7#1)
distinct feature of this##2##4##(2008-10#1)(2008-8#1)
distinct features##2##2##(2008-7#1)(2009-8#1)
distinct for##3##2##(2008-10#2)(2012-12#1)
distinct forms of the##2##4##(1992-3#1)(1995-6#1)
distinct forms of##4##3##(1990-5#1)(1992-3#1)(1995-6#1)(2010-5#1)
distinct forms##6##2##(1990-5#1)(1992-3#1)(1995-6#1)(2007-7#1)(2008-10#1)(2010-5#1)
distinct from a##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
distinct from all other##2##4##(2008-10#2)
distinct from all the##2##4##(2007-12#1)(2008-10#1)
distinct from all##7##3##(2007-12#1)(2008-10#6)
distinct from any##3##3##(1990-5#1)(2007-7#1)(2008-10#1)
distinct from other##14##3##(1990-12#1)(1990-8#1)(1995-2#1)(2008-1#1)(2008-10#9)(2008-11#1)
distinct from that in##2##4##(1990-2#1)(1995-12#1)
distinct from that of the##3##5##(1992-6#1)(1995-12#1)(2008-10#1)
distinct from that of##12##4##(1992-10#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-10#1)
distinct from that##18##3##(1990-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)
distinct from the other##2##4##(2008-10#2)
distinct from the##25##3##(1990-8#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2010-1#1)(2010-3#2)(2013-8#1)
distinct from these##2##3##(2008-10#2)
distinct from those in##3##4##(1994-2#1)(2007-12#1)(2012-2#1)
distinct from those of##2##4##(2008-10#1)(2008-11#1)
distinct from those##12##3##(1993-6#1)(1994-2#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-2#2)
distinct from##134##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-5#2)(1996-5#2)(1997-2#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#49)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
distinct function##2##2##(1995-5#1)(2008-11#1)
distinct functional##4##2##(1994-8#1)(1994-9#1)(2008-10#1)(2008-4#1)
distinct functions##4##2##(1993-3#1)(1994-3#1)(2007-12#1)(2009-10#1)
distinct genetic groups##3##3##(2008-10#2)(2010-10#1)
distinct genetic##8##2##(1994-6#1)(2007-12#1)(2008-10#2)(2010-10#2)(2011-2#2)
distinct genotypes##5##2##(2008-10#4)(2008-9#1)
distinct geographic##3##2##(2008-10#3)
distinct group##3##2##(1994-9#1)(2010-10#1)(2010-11#1)
distinct groups corresponding to##2##4##(2008-10#1)(2008-9#1)
distinct groups in##2##3##(2008-10#2)
distinct groups of##9##3##(1991-2#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)
distinct groups that##2##3##(2008-10#2)
distinct groups##26##2##(1991-2#1)(1996-2#1)(2008-10#15)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#2)(2011-2#1)(2013-1#1)
distinct growth##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
distinct habitat##2##2##(2008-8#1)(2009-2#1)
distinct haplotypes##2##2##(2008-10#2)
distinct histologic##2##2##(2009-12#1)(2010-11#1)
distinct host##3##2##(2008-10#2)(2008-5#1)
distinct in##5##2##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
distinct isolates##3##2##(2008-10#3)
distinct levels##2##2##(1990-5#1)(2009-9#1)
distinct lineages##2##2##(2008-10#2)
distinct mechanisms for##2##3##(1996-2#1)(2008-10#1)
distinct mechanisms##9##2##(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#3)(2008-10#2)(2008-7#1)
distinct modes of##2##3##(1992-6#1)(2007-9#1)
distinct modes##3##2##(1992-6#1)(2007-11#1)(2007-9#1)
distinct molecular##3##2##(1992-3#1)(2009-10#1)(2012-12#1)
distinct molecules##3##2##(1990-5#1)(1990-8#1)(2008-8#1)
distinct monophyletic groups in a phylogenetic tree##2##7##(2008-10#2)
distinct neural circuits##2##3##(1990-5#2)
distinct neurochemical##2##2##(2008-4#1)(2008-6#1)
distinct nuclear##2##2##(2009-12#1)(2013-8#1)
distinct optical##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
distinct pathotypes##2##2##(2008-10#2)
distinct pathways##4##2##(1990-5#1)(1991-2#1)(1992-3#1)(2009-10#1)
distinct pattern of##4##3##(1990-12#1)(1991-9#1)(2008-10#1)(2008-4#1)
distinct patterns of##6##3##(1990-5#1)(1992-2#1)(1995-5#1)(2008-5#1)(2009-10#1)(2013-8#1)
distinct patterns##8##2##(1990-5#1)(1990-8#1)(1992-2#1)(1995-5#1)(1997-6#1)(2008-5#1)(2009-10#1)(2013-8#1)
distinct phases##5##2##(1996-3#1)(2007-8#1)(2008-5#1)(2008-7#2)
distinct phylogenetic##3##2##(2008-10#3)
distinct populations##9##2##(1991-8#1)(2007-12#2)(2008-10#4)(2009-2#1)(2010-8#1)
distinct preferences for##2##3##(2008-8#1)(2013-1#1)
distinct processes##3##2##(1992-9#1)(2009-10#1)(2012-2#1)
distinct properties##2##2##(1995-12#1)(2008-11#1)
distinct proteins##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
distinct races were##2##3##(2008-10#2)
distinct races##4##2##(2008-10#4)
distinct receptors##2##2##(1991-2#1)(2008-5#1)
distinct regions of##4##3##(1994-9#1)(2008-10#2)(2008-11#1)
distinct regions##7##2##(1991-5#1)(1994-9#1)(2007-12#2)(2008-10#2)(2008-11#1)
distinct replicons##2##2##(2011-2#2)
distinct roles in the##2##4##(1992-9#1)(1997-2#1)
distinct roles in##6##3##(1992-9#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-5#1)(2013-8#1)
distinct roles##7##2##(1992-9#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-5#1)(2013-8#1)
distinct sampling##2##2##(2008-8#1)(2013-7#1)
distinct secondary##2##2##(2008-10#1)(2008-11#1)
distinct sets of##4##3##(1991-3#1)(1993-8#1)(1994-12#1)(2010-11#1)
distinct sites##4##2##(1992-4#1)(2008-3#1)(2008-8#1)(2012-1#1)
distinct small##2##2##(2008-10#1)(2009-3#1)
distinct spatial##2##2##(2008-10#1)(2008-5#1)
distinct species of##4##3##(1991-12#1)(2008-10#3)
distinct species##20##2##(1991-12#1)(2008-10#15)(2008-5#3)(2010-10#1)
distinct spectral##2##2##(2008-4#1)(2009-9#1)
distinct stages of##2##3##(1994-12#1)(1997-6#1)
distinct stages##4##2##(1994-11#1)(1994-12#1)(1997-6#1)(2008-11#1)
distinct strain##2##2##(2008-10#2)
distinct strains##4##2##(2008-10#4)
distinct subgroup##3##2##(2007-12#1)(2008-10#2)
distinct subgroups##4##2##(2008-10#4)
distinct subtypes of##2##3##(1993-11#1)(2008-12#1)
distinct subtypes##4##2##(1993-11#1)(2007-6#1)(2008-1#1)(2008-12#1)
distinct taxa##2##2##(2008-10#2)
distinct to##2##2##(1996-2#1)(2008-3#1)
distinct trajectories##2##2##(2008-7#1)(2009-8#1)
distinct type of##2##3##(1990-12#1)(2008-2#1)
distinct types of##5##3##(1997-2#1)(2008-10#1)(2009-5#1)(2010-1#1)(2012-12#1)
distinct types##7##2##(1997-2#1)(2008-10#2)(2009-5#1)(2010-1#1)(2012-12#2)
distinct viruses##2##2##(2008-10#2)
distinct ways##2##2##(1994-2#1)(2008-8#1)
distinct##969##1##(1990-11#4)(1990-12#5)(1990-2#2)(1990-5#9)(1990-7#1)(1990-8#7)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#6)(1991-3#3)(1991-5#6)(1991-8#2)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-4#1)(1992-6#6)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#6)(1993-12#1)(1993-3#9)(1993-6#2)(1993-8#7)(1994-1#2)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#8)(1995-11#3)(1995-12#7)(1995-2#13)(1995-3#3)(1995-5#5)(1995-6#4)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#10)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#5)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#21)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#9)(2008-10#284)(2008-11#30)(2008-12#7)(2008-2#14)(2008-3#12)(2008-4#16)(2008-5#28)(2008-6#11)(2008-7#22)(2008-8#22)(2008-9#20)(2009-10#7)(2009-12#7)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#5)(2009-9#8)(2010-1#4)(2010-10#10)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#7)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#6)(2011-2#34)(2012-1#3)(2012-12#9)(2012-2#25)(2012-3#5)(2012-5#1)(2013-1#17)(2013-7#2)(2013-8#12)
distinction between the##6##3##(2007-12#2)(2008-10#2)(2008-3#1)(2010-5#1)
distinction between##44##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
distinction by##2##2##(2008-10#1)(2008-11#1)
distinction can be##2##3##(1995-8#1)(2013-7#1)
distinction in##2##2##(2008-10#1)(2011-2#1)
distinction is##7##2##(1991-1#1)(1992-9#1)(1996-4#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)
distinction of the##3##3##(1990-7#1)(1997-3#1)(2013-7#1)
distinction of##6##2##(1990-7#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-6#1)(2013-7#1)
distinction was##3##2##(2008-10#2)(2010-1#1)
distinction##82##1##(1990-12#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-4#2)(1997-3#2)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#3)
distinctions between the##2##3##(1996-2#1)(2008-12#1)
distinctions between##7##2##(1990-8#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
distinctions in##3##2##(1995-12#1)(2008-4#1)(2008-9#1)
distinctions##24##1##(1990-11#1)(1990-8#3)(1991-2#3)(1991-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#2)(2013-8#1)
distinctive effects##2##2##(2008-10#1)(2009-8#1)
distinctive feature of##4##3##(1993-1#1)(1995-2#1)(2008-10#1)(2008-2#1)
distinctive features of##2##3##(1996-12#1)(2008-12#1)
distinctive features##5##2##(1996-12#1)(2007-12#1)(2008-12#1)(2008-6#1)(2011-2#1)
distinctive from##2##2##(1993-2#1)(2008-10#1)
distinctive mechanisms##2##2##(1996-5#1)(2011-1#1)
distinctive regions##2##2##(1993-12#1)(1997-2#1)
distinctive##79##1##(1990-5#1)(1991-12#1)(1991-7#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-8#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#2)(2013-1#2)(2013-8#1)
distinctively##3##1##(2008-10#1)(2008-8#1)(2012-12#1)
distinctiveness of##3##2##(1996-6#1)(2008-6#1)(2009-8#1)
distinctiveness##5##1##(1996-6#1)(2008-6#2)(2009-8#1)(2010-10#1)
distinctly different from those##2##4##(2008-10#1)(2008-9#1)
distinctly different from##5##3##(1990-11#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
distinctly different##20##2##(1990-11#1)(1994-2#1)(1994-9#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-2#2)(2012-2#1)(2012-7#1)
distinctly higher in##2##3##(1993-12#2)
distinctly##36##1##(1990-11#1)(1990-8#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-2#2)(2012-7#1)
distinguish a##5##2##(2006-12#1)(2008-3#2)(2008-5#2)
distinguish among these##2##3##(2008-11#1)(2008-8#1)
distinguish among##11##2##(1993-12#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)(2012-2#1)
distinguish areas of##2##3##(2007-5#1)(2011-2#1)
distinguish between different##2##3##(2008-10#2)
distinguish between normal##2##3##(2011-1#1)(2012-3#1)
distinguish between the##9##3##(1994-2#1)(1996-5#1)(2008-10#3)(2008-4#1)(2009-12#1)(2010-11#1)(2012-2#1)
distinguish between##55##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-4#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#3)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
distinguish cells that##2##3##(1994-3#1)(2009-5#1)
distinguish normal and##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
distinguish the two##5##3##(2008-10#3)(2008-11#1)(2010-3#1)
distinguish the##25##2##(1990-11#1)(1993-11#1)(1995-1#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#2)(2011-1#1)
distinguish their##2##2##(2008-3#1)(2012-1#1)
distinguish them from other##2##4##(2008-11#1)(2008-9#1)
distinguish them from##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
distinguish them##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
distinguish these##4##2##(1996-2#1)(2008-1#1)(2008-10#1)(2008-4#1)
distinguish this##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
distinguish three##2##2##(1991-11#1)(2008-8#1)
distinguish with##2##2##(2008-10#1)(2011-2#1)
distinguish##213##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#3)(2006-12#1)(2006-4#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#54)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#9)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-3#6)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#7)
distinguishable by the##2##3##(2008-10#2)
distinguishable by their##2##3##(1990-11#1)(1992-8#1)
distinguishable by##5##2##(1990-11#1)(1992-8#1)(2008-10#3)
distinguishable from the##2##3##(2008-10#1)(2008-5#1)
distinguishable from##7##2##(1990-7#1)(2008-10#4)(2008-5#1)(2012-2#1)
distinguishable##29##1##(1990-11#1)(1990-7#2)(1992-8#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-5#4)(2008-7#1)(2010-10#1)(2012-2#1)(2012-3#2)
distinguished as##4##2##(1993-12#1)(2008-10#1)(2008-7#2)
distinguished based on##3##3##(2008-10#2)(2008-9#1)
distinguished between##5##2##(1992-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
distinguished by the##2##3##(2008-5#1)(2013-8#1)
distinguished by their##5##3##(1991-11#1)(2007-8#1)(2008-11#1)(2011-2#2)
distinguished by these##2##3##(1991-11#1)(1993-12#1)
distinguished by##21##2##(1990-7#1)(1991-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2011-2#2)(2012-3#1)(2013-8#1)
distinguished experts from##3##3##(2010-12#3)
distinguished from each other by##3##5##(2008-10#2)(2008-4#1)
distinguished from each other##7##4##(2008-10#4)(2008-4#1)(2009-12#1)(2009-5#1)
distinguished from other##4##3##(2008-10#2)(2009-3#1)(2010-12#1)
distinguished from the##7##3##(1990-10#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-7#1)
distinguished from##45##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-12#1)(1997-6#1)(2007-6#1)(2007-9#2)(2008-10#12)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
distinguished in##6##2##(1995-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)
distinguished into##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
distinguished the##7##2##(1990-7#1)(1997-8#2)(2008-10#3)(2008-6#1)
distinguished them from##2##3##(1997-7#1)(2008-5#1)
distinguished##162##1##(1990-10#1)(1990-7#2)(1991-11#2)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#44)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#3)
distinguishes between##3##2##(1993-12#1)(1994-12#1)(1994-2#1)
distinguishes##15##1##(1990-12#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
distinguishing between##13##2##(1990-2#1)(1991-1#1)(1996-12#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-7#1)
distinguishing feature of##2##3##(2008-3#1)(2008-9#1)
distinguishing feature##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
distinguishing features##4##2##(2007-5#1)(2008-5#1)(2008-8#1)(2013-1#1)
distinguishing isolates of##2##3##(2008-10#2)
distinguishing isolates##3##2##(2008-10#3)
distinguishing it##2##2##(1992-5#1)(2011-2#1)
distinguishing the##2##2##(1991-1#1)(2007-8#1)
distinguishing them from##2##3##(2008-10#1)(2008-2#1)
distinguishing##68##1##(1990-2#1)(1991-1#2)(1991-12#1)(1992-5#1)(1994-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#5)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
distonic##2##1##(2008-10#2)
distort the##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
distort##5##1##(2008-10#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
distorted and##4##2##(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
distorted by##2##2##(2008-10#1)(2008-2#1)
distorted from##2##2##(1996-2#1)(2012-2#1)
distorted octahedron##2##2##(1996-2#1)(1997-7#1)
distorted##49##1##(1990-12#1)(1993-8#1)(1995-8#1)(1996-2#3)(1997-7#5)(2007-11#1)(2008-1#2)(2008-10#7)(2008-2#5)(2008-3#15)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#2)
distorters##2##1##(2012-3#2)
distorting factors##2##2##(1993-9#1)(2010-11#1)
distorting##6##1##(1993-9#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-3#1)(2011-2#1)
distortion and##8##2##(1992-12#1)(2007-11#3)(2007-12#3)(2008-4#1)
distortion in lettuce##2##3##(2008-10#2)
distortion in the##2##3##(2008-2#2)
distortion in##9##2##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-4#1)(2011-1#1)
distortion of the##21##3##(1996-2#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2012-2#2)
distortion of##30##2##(1993-11#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#2)
distortion on the##2##3##(2008-11#1)(2008-2#1)
distortion on##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
distortion or##2##2##(1992-12#1)(2008-10#1)
distortion product otoacoustic emissions##2##4##(2008-1#1)(2008-4#1)
distortion that##2##2##(2007-11#1)(2008-3#1)
distortion was##2##2##(2008-10#1)(2008-3#1)
distortion##121##1##(1990-9#1)(1991-8#1)(1992-12#2)(1993-11#2)(1995-6#1)(1996-2#1)(1997-7#3)(2006-12#1)(2007-11#16)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#21)(2008-3#17)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#4)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-8#2)
distortion-invariant##5##1##(2008-2#4)(2008-3#1)
distortion-product otoacoustic emissions##2##3##(2008-1#1)(2008-4#1)
distortions and##4##2##(1994-1#1)(2007-11#1)(2007-12#1)(2008-2#1)
distortions are##3##2##(2007-12#1)(2008-3#2)
distortions can##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
distortions caused by##2##3##(2008-3#2)
distortions in glomerulonephritis##2##3##(1993-2#2)
distortions in the##4##3##(1997-3#1)(2008-10#2)(2008-3#1)
distortions in##11##2##(1993-2#2)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
distortions of the##5##3##(2008-2#3)(2008-3#1)(2011-1#1)
distortions of##9##2##(2008-2#4)(2008-3#2)(2008-4#1)(2011-1#1)(2013-1#1)
distortions on the##2##3##(2008-2#1)(2008-3#1)
distortions produced during the##2##4##(2007-11#2)
distortions##66##1##(1993-2#3)(1994-1#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-3#1)(2007-11#4)(2007-12#5)(2008-10#6)(2008-2#11)(2008-3#23)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
distorts the##4##2##(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
distracted##3##1##(2007-12#1)(2013-8#2)
distracters##6##1##(2009-2#6)
distraction by motion##2##3##(2012-3#2)
distraction by##3##2##(2012-3#3)
distraction condition##2##2##(2008-6#1)(2009-11#1)
distraction device##3##2##(2007-12#1)(2011-2#2)
distraction in##2##2##(2007-12#1)(2008-6#1)
distraction may##2##2##(2007-12#1)(2010-4#1)
distraction of##5##2##(2007-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
distraction on##2##2##(2008-12#1)(2009-11#1)
distraction osteogenesis can##2##3##(2007-12#2)
distraction osteogenesis for##3##3##(2007-12#1)(2009-3#1)(2011-2#1)
distraction osteogenesis in the##2##4##(2007-12#2)
distraction osteogenesis in##4##3##(2007-12#4)
distraction osteogenesis##19##2##(2007-12#12)(2007-8#5)(2009-3#1)(2011-2#1)
distraction within##2##2##(2011-2#1)(2012-3#1)
distraction##70##1##(1993-12#1)(1996-2#1)(2007-12#22)(2007-8#5)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#4)(2009-3#2)(2010-10#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#10)(2012-2#2)(2012-3#8)(2013-1#1)(2013-8#2)
distractor##3##1##(2007-12#1)(2008-5#1)(2012-3#1)
distractors##2##1##(2011-2#1)(2013-8#1)
distress among##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
distress and parenting##2##3##(1995-2#1)(2009-12#1)
distress and##25##2##(1990-12#1)(1990-3#1)(1995-2#1)(1996-2#3)(1997-3#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
distress associated with##4##3##(1995-12#2)(2009-9#1)(2013-1#1)
distress during##6##2##(1992-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(2008-5#1)
distress experienced by##2##3##(2008-11#1)(2008-2#1)
distress from##2##2##(2007-8#1)(2008-11#1)
distress in the##2##3##(1996-2#1)(2008-7#1)
distress in##10##2##(1996-2#2)(2008-7#1)(2008-9#1)(2010-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
distress may##2##2##(1991-9#1)(2012-1#1)
distress or##3##2##(1992-10#1)(1996-2#1)(1997-5#1)
distress than##2##2##(1995-1#1)(2008-9#1)
distress that##2##2##(1995-9#1)(2008-11#1)
distress tolerance##4##2##(2013-8#4)
distress was##3##2##(1992-2#1)(2007-11#1)(2007-8#1)
distress were##2##2##(1995-12#1)(1995-2#1)
distress with##3##2##(1996-2#1)(2007-12#1)(2008-3#1)
distress##199##1##(1990-11#2)(1990-12#4)(1990-3#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-2#7)(1992-3#3)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#5)(1995-2#5)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#11)(1996-5#2)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#2)(2006-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-2#4)(2012-1#13)(2012-12#4)(2012-2#4)(2012-3#15)(2013-1#10)(2013-7#1)(2013-8#12)
distressed couples##2##2##(2012-2#2)
distressed##8##1##(1995-12#1)(1996-8#1)(2008-3#2)(2010-3#1)(2012-2#2)(2013-8#1)
distressful##2##1##(2010-12#1)(2013-8#1)
distressing##7##1##(1991-6#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-11#1)
distribute the##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
distribute##12##1##(1995-2#1)(1996-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-9#1)
distributed Bragg reflector##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
distributed Bragg##7##2##(2007-11#1)(2007-12#2)(2008-3#4)
distributed Raman##2##2##(2007-11#2)
distributed absorbers##2##2##(2007-11#2)
distributed across the##3##3##(2008-10#2)(2008-9#1)
distributed across##6##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
distributed along the##11##3##(1990-5#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2013-7#4)
distributed along##12##2##(1990-5#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#2)(2013-7#4)
distributed among the##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)
distributed among##21##2##(1997-2#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
distributed amongst the##2##3##(2009-7#1)(2012-12#1)
distributed amongst##3##2##(2007-12#1)(2009-7#1)(2012-12#1)
distributed and##5##2##(1992-11#1)(1992-8#1)(2008-7#1)(2010-8#1)(2012-3#1)
distributed around the##2##3##(2008-7#1)(2012-2#1)
distributed as##4##2##(1992-6#1)(1993-6#1)(2008-12#1)(2013-8#1)
distributed at##2##2##(2007-12#1)(2008-8#1)
distributed beacons##2##2##(2008-3#2)
distributed between the##3##3##(2008-10#2)(2009-7#1)
distributed between##7##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#1)
distributed by##5##2##(1995-2#3)(1997-3#1)(2009-2#1)
distributed data management##2##3##(2010-5#2)
distributed data##8##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#2)(2010-8#1)(2013-1#1)
distributed environments##3##2##(2010-8#3)
distributed feedback (DFB)##2##3##(2008-3#2)
distributed feedback diode lasers##2##4##(2008-2#1)(2008-3#1)
distributed feedback laser##3##3##(2008-2#1)(2008-3#2)
distributed feedback##13##2##(2007-11#1)(2008-2#3)(2008-3#8)(2008-7#1)
distributed fiber temperature##2##3##(2007-11#2)
distributed fiber##4##2##(2007-11#3)(2008-2#1)
distributed forces##2##2##(2012-2#2)
distributed in a##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
distributed in the cell##2##4##(1990-5#1)(2007-12#1)
distributed in the##21##3##(1990-5#1)(1992-9#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-7#2)(2008-9#2)(2009-12#3)(2010-6#1)(2011-1#1)(2013-8#1)
distributed in various##2##3##(1993-3#1)(2008-12#1)
distributed in##49##2##(1990-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#3)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2013-7#1)(2013-8#2)
distributed information##3##2##(2008-11#1)(2010-8#2)
distributed into##3##2##(1994-9#1)(2008-10#1)(2008-12#1)
distributed mainly in##2##3##(2008-7#1)(2011-2#1)
distributed mainly##4##2##(1993-6#1)(2007-11#1)(2008-7#1)(2011-2#1)
distributed on all##2##3##(2008-9#1)(2009-10#1)
distributed on the##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
distributed on##9##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)
distributed optical##4##2##(2007-12#3)(2008-3#1)
distributed over a##4##3##(1993-11#1)(1993-12#1)(2008-3#1)(2008-9#1)
distributed over all##4##3##(2008-1#1)(2008-10#3)
distributed over##16##2##(1990-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1996-10#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-9#1)(2011-2#1)
distributed species##3##2##(2008-12#1)(2012-3#1)(2013-7#1)
distributed strain and temperature##2##4##(2007-12#1)(2008-3#1)
distributed throughout the##11##3##(1993-12#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-8#2)
distributed throughout##14##2##(1993-12#1)(1995-11#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-8#2)
distributed to all##3##3##(2007-11#1)(2007-12#1)(2010-8#1)
distributed to##14##2##(1990-2#3)(1992-6#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
distributed unevenly##2##2##(2008-10#2)
distributed uniformly##3##2##(1994-8#1)(2008-10#2)
distributed widely##2##2##(1994-12#1)(2011-3#1)
distributed with##4##2##(1993-9#1)(2008-10#1)(2008-8#2)
distributed within a##2##3##(2008-10#2)
distributed within the##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
distributed within##11##2##(2008-10#9)(2008-7#1)(2008-9#1)
distributed##391##1##(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(2007-11#15)(2007-12#20)(2008-1#1)(2008-10#77)(2008-11#8)(2008-12#6)(2008-2#10)(2008-3#36)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#16)(2008-8#13)(2008-9#11)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#4)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#17)(2011-1#4)(2011-2#8)(2011-3#1)(2011-9#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#8)(2013-8#5)
distributed-feedback (DFB) laser##2##3##(2008-3#2)
distributed-feedback (DFB)##3##2##(2008-3#3)
distributed-feedback InGaAs laser##2##3##(2008-3#2)
distributed-feedback diode laser##3##3##(2008-2#2)(2008-3#1)
distributed-feedback diode##4##2##(2008-2#2)(2008-3#2)
distributed-feedback dye laser##2##3##(2007-11#1)(2008-3#1)
distributed-feedback laser##14##2##(2007-11#5)(2007-12#3)(2008-3#6)
distributed-feedback lasers with##2##3##(2007-12#1)(2008-3#1)
distributed-feedback lasers##10##2##(2007-11#3)(2007-12#4)(2008-3#3)
distributed-feedback##46##1##(2007-11#10)(2007-12#12)(2008-2#2)(2008-3#22)
distributes##5##1##(1997-4#1)(2006-10#1)(2011-3#1)(2012-3#1)(2013-1#1)
distributing##5##1##(1991-1#1)(1992-3#1)(1996-12#1)(2008-12#1)(2010-5#1)
distribution (PSD)##2##2##(2008-3#2)
distribution across the##2##3##(2008-5#1)(2008-8#1)
distribution along a##2##3##(2008-5#1)(2011-2#1)
distribution along the##3##3##(2007-11#1)(2007-12#1)(2009-7#1)
distribution along##6##2##(2007-11#1)(2007-12#1)(2008-5#1)(2009-7#1)(2011-2#2)
distribution among##6##2##(1992-12#1)(1997-2#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
distribution analysis##6##2##(1994-3#1)(2008-10#4)(2011-2#1)
distribution and a##3##3##(2008-3#1)(2010-3#1)(2012-3#1)
distribution and abundance##3##3##(2008-8#3)
distribution and composition##2##3##(2008-10#1)(2008-5#1)
distribution and even##2##3##(2008-5#1)(2008-6#1)
distribution and exchange##2##3##(1995-12#1)(2008-7#1)
distribution and frequency of##2##4##(2008-10#2)
distribution and molecular##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
distribution and particle size##2##4##(1993-2#1)(2008-3#1)
distribution and temporal development of##2##5##(2008-10#2)
distribution and the refractive index##2##5##(2008-2#1)(2008-3#1)
distribution and the##13##3##(1992-3#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-8#1)(2009-10#1)
distribution and type##2##3##(2008-5#1)(2009-12#1)
distribution and##135##2##(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#11)(2008-3#16)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#9)(2009-10#1)(2009-11#1)(2009-12#1)(2010-3#2)(2010-6#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#4)(2013-8#2)
distribution are obtained with##2##4##(1996-12#1)(2008-2#1)
distribution are##7##2##(1996-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2013-1#1)
distribution around a##2##3##(2007-11#1)(2009-4#1)
distribution around##3##2##(2007-11#1)(2007-12#1)(2009-4#1)
distribution as a function of##2##5##(2007-12#1)(2008-7#1)
distribution as a##4##3##(1997-4#1)(2007-12#1)(2008-7#2)
distribution as the##3##3##(2007-5#1)(2008-3#1)(2008-4#1)
distribution as##11##2##(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)
distribution at the##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-2#1)
distribution at##14##2##(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
distribution between the two##2##4##(2008-3#1)(2011-1#1)
distribution between the##4##3##(1992-9#1)(2008-3#1)(2011-1#1)(2012-2#1)
distribution between##11##2##(1992-9#1)(1997-3#1)(2008-3#2)(2008-5#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
distribution by##9##2##(1992-10#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-12#1)
distribution can be determined##2##4##(2008-2#1)(2008-3#1)
distribution can be##9##3##(1991-5#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)
distribution can##12##2##(1991-5#1)(1995-11#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)
distribution changes##2##2##(2008-3#1)(2009-5#1)
distribution characteristics of##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
distribution characteristics##4##2##(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
distribution coefficient and##2##3##(2008-10#2)
distribution coefficient of##2##3##(2008-10#2)
distribution coefficient##10##2##(2008-10#10)
distribution coefficients for##2##3##(2008-10#2)
distribution coefficients##5##2##(2008-10#5)
distribution constant of##2##3##(2008-10#2)
distribution constant##5##2##(2008-10#5)
distribution constants of##7##3##(2008-10#7)
distribution constants##10##2##(2008-10#10)
distribution could##2##2##(2008-3#1)(2008-7#1)
distribution curve##3##2##(2007-12#1)(2008-3#1)(2009-11#1)
distribution curves##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
distribution data of##2##3##(2008-10#1)(2008-6#1)
distribution data##4##2##(2008-10#3)(2008-6#1)
distribution demonstrated##2##2##(2008-8#1)(2013-1#1)
distribution diagrams of##2##3##(2008-10#2)
distribution diagrams##4##2##(2008-10#4)
distribution during the##2##3##(2008-10#1)(2008-3#1)
distribution during##7##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
distribution equilibria of##2##3##(2008-10#2)
distribution equilibrium##2##2##(2008-10#2)
distribution for a##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
distribution for each##3##3##(1992-9#1)(2008-3#1)(2008-6#1)
distribution for the##8##3##(2008-10#3)(2008-3#3)(2008-6#1)(2010-8#1)
distribution for##32##2##(1992-8#1)(1992-9#1)(2007-12#1)(2008-10#7)(2008-2#5)(2008-3#9)(2008-6#2)(2009-11#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
distribution from##10##2##(1991-5#1)(2008-2#3)(2008-3#5)(2013-7#1)
distribution function of##3##3##(2007-12#1)(2008-3#2)
distribution function was##2##3##(2008-2#2)
distribution function##29##2##(2007-12#1)(2008-2#11)(2008-3#14)(2012-2#2)(2013-8#1)
distribution functions of##2##3##(2008-10#1)(2008-3#1)
distribution functions##7##2##(1990-7#1)(1992-9#2)(2008-10#1)(2008-3#2)(2010-8#1)
distribution generated by a##2##4##(2007-12#1)(2008-2#1)
distribution generated by##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
distribution has##4##2##(1996-2#1)(2008-2#2)(2008-7#1)
distribution have been##2##3##(1996-2#1)(2008-5#1)
distribution in a single##2##4##(2008-3#2)
distribution in a##14##3##(1995-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#7)(2008-7#1)(2009-9#1)
distribution in an##2##3##(2007-11#1)(2008-2#1)
distribution in any##2##3##(2007-12#1)(2008-2#1)
distribution in brain##2##3##(1997-2#1)(2009-7#1)
distribution in human##3##3##(1994-12#1)(1994-6#1)(2010-12#1)
distribution in rat##2##3##(1991-2#2)
distribution in the focal plane##2##5##(2008-2#2)
distribution in the focal##3##4##(2008-2#2)(2008-3#1)
distribution in the two##2##4##(1996-5#1)(2007-12#1)
distribution in the##33##3##(1990-12#2)(1995-9#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#10)(2008-5#3)(2008-9#1)(2013-8#1)
distribution in various human tissues##2##5##(1993-6#1)(2008-8#1)
distribution in##112##2##(1990-12#2)(1991-2#2)(1991-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#5)(2008-10#13)(2008-11#2)(2008-2#10)(2008-3#28)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#3)
distribution induced by the##2##4##(2007-12#1)(2008-3#1)
distribution induced##3##2##(2007-12#1)(2008-3#2)
distribution into##4##2##(1992-8#1)(1996-2#1)(2007-11#1)(2013-1#1)
distribution is in##3##3##(1994-9#1)(2008-12#1)(2008-3#1)
distribution is not##2##3##(2008-10#1)(2008-9#1)
distribution is##49##2##(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-5#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#5)(2008-3#8)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-5#1)(2013-1#2)(2013-8#2)
distribution made##2##2##(2007-11#1)(2007-12#1)
distribution may##2##2##(1997-2#1)(2012-2#1)
distribution measurements##3##2##(1995-6#2)(2011-1#1)
distribution model##4##2##(2008-10#2)(2009-5#1)(2013-7#1)
distribution must##2##2##(1996-4#1)(2007-12#1)
distribution obtained by##2##3##(2008-3#1)(2010-5#1)
distribution of CaM##2##3##(2008-8#2)
distribution of DNA##2##3##(1995-2#1)(1997-4#1)
distribution of P##2##3##(2008-10#2)
distribution of PSA-NCAM##2##3##(2009-8#2)
distribution of RAPD markers##2##4##(2008-5#2)
distribution of RAPD##3##3##(2008-5#3)
distribution of Snails and##2##4##(2011-1#2)
distribution of Snails##3##3##(2011-1#3)
distribution of TiO _ 2##2##5##(2008-5#2)
distribution of V##2##3##(2008-10#1)(2010-3#1)
distribution of [125I]thyroxine##2##3##(1993-12#2)
distribution of a##16##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)
distribution of aerosol in##2##4##(1996-3#1)(2008-2#1)
distribution of aerosol##3##3##(1996-3#2)(2008-2#1)
distribution of airborne##2##3##(2008-10#1)(2008-11#1)
distribution of all##2##3##(2008-5#1)(2008-7#1)
distribution of an##5##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-1#1)
distribution of any##2##3##(2008-10#1)(2012-1#1)
distribution of bcl-2 protein##2##4##(1994-10#2)
distribution of benthic meiofauna##2##4##(2008-5#2)
distribution of blood##3##3##(1997-1#1)(2007-11#1)(2010-7#1)
distribution of both##3##3##(2008-10#2)(2010-8#1)
distribution of cadmium##2##3##(1995-3#1)(2011-2#1)
distribution of calmodulin##2##3##(2008-8#2)
distribution of cases##2##3##(1992-12#1)(2008-10#1)
distribution of cell##2##3##(2008-11#1)(2009-10#1)
distribution of cells##3##3##(1997-1#1)(2008-11#1)(2012-1#1)
distribution of data##2##3##(2008-10#1)(2008-2#1)
distribution of deaths##2##3##(2008-3#1)(2008-7#1)
distribution of different##4##3##(1992-11#1)(1995-11#1)(2008-8#1)(2013-1#1)
distribution of diseased##2##3##(2008-10#2)
distribution of doxorubicin##2##3##(2008-11#2)
distribution of each##4##3##(2007-11#2)(2008-10#1)(2013-8#1)
distribution of errors##2##3##(2008-12#1)(2009-9#1)
distribution of fluorescent##2##3##(2010-4#1)(2012-3#1)
distribution of food##2##3##(2008-10#1)(2008-8#1)
distribution of forward-scattered light##2##4##(2008-2#2)
distribution of four##2##3##(2008-10#2)
distribution of functional##2##3##(1994-9#1)(2009-12#1)
distribution of genotypes##2##3##(2008-10#1)(2011-1#1)
distribution of health##2##3##(1992-3#1)(1994-2#1)
distribution of histopathologic types##2##4##(2011-2#2)
distribution of identical##2##3##(2008-10#2)
distribution of intensity##2##3##(1992-9#1)(2007-12#1)
distribution of internal##2##3##(2009-10#1)(2012-3#1)
distribution of iron in the brain##2##6##(1996-5#2)
distribution of iron##5##3##(1996-5#3)(2008-10#1)(2013-8#1)
distribution of its##2##3##(1991-5#1)(2008-11#1)
distribution of laser##2##3##(2008-3#2)
distribution of lifetimes##2##3##(1991-12#1)(1995-5#1)
distribution of light scattered##2##4##(2007-11#1)(2008-3#1)
distribution of light##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
distribution of mating types##2##4##(2008-10#2)
distribution of mating##3##3##(2008-10#3)
distribution of optical##2##3##(2008-3#2)
distribution of our##2##3##(2008-10#1)(2010-8#1)
distribution of phospholipids##2##3##(1992-6#1)(2012-12#1)
distribution of photons##2##3##(2008-2#2)
distribution of potential##2##3##(2008-2#1)(2008-8#1)
distribution of power##2##3##(2008-2#1)(2011-1#1)
distribution of protein kinase C##4##5##(1990-2#2)(1994-3#1)(1996-5#1)
distribution of resources##2##3##(1990-12#1)(2007-7#1)
distribution of scatterers##2##3##(2008-2#1)(2008-3#1)
distribution of sex##2##3##(1993-2#1)(2010-3#1)
distribution of shorebirds##2##3##(2013-7#2)
distribution of skin##2##3##(1994-12#1)(2010-6#1)
distribution of species##3##3##(1991-8#1)(2008-8#2)
distribution of survival##3##3##(2007-8#3)
distribution of the different##3##4##(2007-10#1)(2008-8#1)(2010-8#1)
distribution of the electromagnetic field##2##5##(2007-12#1)(2008-3#1)
distribution of the final equilibria##2##5##(2008-10#2)
distribution of the incidence of seed infection##2##7##(2008-10#2)
distribution of the light##2##4##(2007-11#2)
distribution of the mortality##2##4##(1997-7#1)(2008-9#1)
distribution of the optical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
distribution of the pathogen##2##4##(2008-10#2)
distribution of the patients##2##4##(1997-8#1)(2012-3#1)
distribution of the population##2##4##(1994-6#1)(2008-10#1)
distribution of the primary##2##4##(1991-6#1)(2008-3#1)
distribution of the proteins##2##4##(1996-5#1)(2008-10#1)
distribution of the scattering##3##4##(2008-2#1)(2008-3#2)
distribution of the species##2##4##(2008-5#1)(2008-8#1)
distribution of the spontaneous emission##2##5##(2007-11#1)(2008-2#1)
distribution of the two##4##4##(1992-6#1)(1995-12#1)(2008-10#2)
distribution of the##175##3##(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-5#2)(1997-1#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#10)(2007-12#9)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-2#15)(2008-3#22)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#3)
distribution of their##3##3##(2008-3#1)(2008-4#1)(2009-8#1)
distribution of these##11##3##(1990-12#1)(1990-7#1)(1992-6#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
distribution of this##7##3##(1994-2#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2013-7#1)
distribution of time to##2##4##(1995-9#1)(2012-3#1)
distribution of two##3##3##(1994-11#1)(2007-12#1)(2008-10#1)
distribution of values##4##3##(2008-7#1)(2012-3#1)(2013-1#2)
distribution of vanadium##2##3##(1990-5#1)(2008-10#1)
distribution of various##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
distribution of virus##3##3##(1997-4#1)(2008-10#2)
distribution of which##2##3##(1997-7#1)(2008-3#1)
distribution of##807##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#7)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#9)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#7)(1992-3#3)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#4)(1993-11#3)(1993-12#11)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#10)(1996-8#1)(1997-1#4)(1997-2#9)(1997-3#2)(1997-4#8)(1997-6#2)(1997-7#3)(1997-8#4)(2006-8#1)(2007-10#3)(2007-11#22)(2007-12#21)(2007-5#6)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#141)(2008-11#24)(2008-12#6)(2008-2#39)(2008-3#68)(2008-4#11)(2008-5#22)(2008-6#7)(2008-7#18)(2008-8#38)(2008-9#10)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#10)(2011-1#13)(2011-2#16)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#8)(2013-1#13)(2013-7#6)(2013-8#9)
distribution on the##8##3##(1991-2#1)(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-7#1)
distribution on##15##2##(1991-2#1)(1995-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-7#1)(2010-7#1)(2013-1#1)
distribution or##2##2##(1991-12#1)(2008-10#1)
distribution over the##3##3##(1992-3#1)(2008-8#1)(2013-1#1)
distribution over##5##2##(1992-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
distribution pattern in##2##3##(1993-5#1)(2012-3#1)
distribution pattern of the##3##4##(1996-12#1)(2008-5#1)(2012-3#1)
distribution pattern of##12##3##(1996-12#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
distribution pattern with##2##3##(1992-12#1)(2008-10#1)
distribution pattern##25##2##(1990-11#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-4#2)(2007-10#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
distribution patterns of##6##3##(1992-3#1)(1997-2#1)(2008-10#3)(2011-2#1)
distribution patterns##12##2##(1992-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-1#1)(2011-2#1)
distribution profile##4##2##(1990-7#1)(1997-1#1)(2010-5#1)(2013-1#1)
distribution profiles of pseudosclerotia##2##4##(2008-10#2)
distribution profiles of##3##3##(2008-10#2)(2008-3#1)
distribution profiles##5##2##(2008-10#3)(2008-3#2)
distribution programs##3##2##(1995-12#1)(1997-5#1)(2007-11#1)
distribution ratio of##2##3##(2008-10#2)
distribution ratio##7##2##(2008-10#7)
distribution ratios##3##2##(2008-10#3)
distribution showed##2##2##(1990-9#1)(1995-6#1)
distribution shows that##2##3##(2008-10#1)(2008-7#1)
distribution shows##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
distribution similar to##2##3##(1992-6#1)(2008-10#1)
distribution system##2##2##(1992-3#1)(1996-12#1)
distribution systems##2##2##(1995-12#1)(2008-10#1)
distribution tended to##2##3##(2008-10#1)(2008-5#1)
distribution that can##2##3##(2008-10#1)(2012-2#1)
distribution that is##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
distribution that##10##2##(1996-5#1)(2007-12#4)(2008-10#2)(2008-3#1)(2009-10#1)(2012-2#1)
distribution throughout the##3##3##(2008-10#2)(2009-8#1)
distribution to multiple##2##3##(2008-10#2)
distribution to the##4##3##(2008-10#1)(2008-3#1)(2009-10#1)(2013-1#1)
distribution to##13##2##(1997-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-8#2)(2009-10#1)(2013-1#1)
distribution under##5##2##(1993-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
distribution volume##2##2##(1996-5#1)(2012-3#1)
distribution was found##2##3##(1994-2#1)(2011-2#1)
distribution was highly##2##3##(2008-10#1)(2009-10#1)
distribution was not##4##3##(1993-9#2)(2008-10#1)(2013-8#1)
distribution was observed##3##3##(2009-12#2)(2011-2#1)
distribution was##27##2##(1990-9#1)(1993-12#1)(1993-9#2)(1994-2#1)(1996-12#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2011-2#2)(2013-1#2)(2013-8#1)
distribution were assessed##2##3##(1992-2#1)(1995-1#1)
distribution were##12##2##(1992-2#1)(1993-12#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2013-1#1)
distribution which##2##2##(1990-12#1)(2008-5#1)
distribution width##4##2##(1995-5#1)(2008-10#3)
distribution with a##6##3##(1996-3#1)(2008-10#1)(2008-2#2)(2008-3#2)
distribution with##16##2##(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#6)(2008-2#2)(2008-3#2)(2009-2#1)(2009-7#1)
distribution within the##7##3##(1993-11#1)(1994-1#1)(2008-10#1)(2008-3#4)
distribution within##10##2##(1993-11#1)(1994-1#1)(2008-10#2)(2008-3#5)(2010-7#1)
distribution##1960##1##(1990-11#3)(1990-12#8)(1990-2#3)(1990-3#2)(1990-5#10)(1990-6#2)(1990-7#6)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#12)(1991-2#5)(1991-3#3)(1991-5#6)(1991-6#4)(1991-8#3)(1991-9#2)(1992-10#3)(1992-11#5)(1992-12#11)(1992-2#8)(1992-3#9)(1992-5#1)(1992-6#8)(1992-8#4)(1992-9#12)(1993-11#5)(1993-12#16)(1993-2#5)(1993-3#2)(1993-5#2)(1993-6#4)(1993-8#4)(1993-9#9)(1994-1#2)(1994-10#2)(1994-11#2)(1994-12#6)(1994-2#11)(1994-3#4)(1994-5#11)(1994-6#7)(1994-7#2)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#5)(1995-12#11)(1995-2#6)(1995-3#6)(1995-5#4)(1995-6#10)(1995-8#1)(1995-9#7)(1996-1#3)(1996-10#1)(1996-12#15)(1996-2#7)(1996-3#8)(1996-4#8)(1996-5#16)(1996-8#1)(1997-1#5)(1997-2#16)(1997-3#9)(1997-4#13)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#4)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#5)(2007-11#46)(2007-12#60)(2007-5#10)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#373)(2008-11#45)(2008-12#12)(2008-2#131)(2008-3#247)(2008-4#20)(2008-5#59)(2008-6#17)(2008-7#57)(2008-8#78)(2008-9#28)(2009-10#13)(2009-11#8)(2009-12#6)(2009-2#3)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#9)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#9)(2010-4#3)(2010-5#7)(2010-6#8)(2010-7#4)(2010-8#16)(2010-9#1)(2011-1#27)(2011-2#41)(2011-7#1)(2012-1#6)(2012-12#15)(2012-2#22)(2012-3#22)(2012-5#1)(2013-1#44)(2013-7#22)(2013-8#24)
distribution)##5##1##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
distribution-free##5##1##(1992-6#4)(1997-3#1)
distributional assumptions##4##2##(1994-2#1)(1996-3#1)(2008-8#1)(2012-3#1)
distributional##10##1##(1994-2#3)(1996-12#1)(1996-3#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-3#1)
distributions (Brethaire##2##2##(1992-2#2)
distributions across##2##2##(2009-7#2)
distributions and the##3##3##(2008-3#1)(2009-5#1)(2010-8#1)
distributions and thermal deformations of mirror substrates in laser resonators##2##10##(2008-3#2)
distributions and thermal deformations##3##4##(2008-3#3)
distributions and##25##2##(1992-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-5#1)(2008-11#3)(2008-2#1)(2008-3#9)(2008-8#2)(2008-9#2)(2009-5#1)(2010-8#1)
distributions are skewed##2##3##(2013-1#2)
distributions are##17##2##(1990-8#1)(1991-8#1)(1992-3#1)(1994-12#1)(1995-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#2)
distributions at the##2##3##(2008-3#1)(2012-12#1)
distributions at##3##2##(2008-3#1)(2009-7#1)(2012-12#1)
distributions between the##2##3##(2008-12#1)(2013-1#1)
distributions by##2##2##(2007-11#1)(2008-8#1)
distributions can be##2##3##(2008-3#2)
distributions can##4##2##(2008-3#3)(2008-8#1)
distributions during##2##2##(2008-3#1)(2013-1#1)
distributions for the different##2##4##(2008-10#1)(2013-1#1)
distributions for the##6##3##(1994-9#1)(2008-10#2)(2008-3#1)(2010-9#1)(2013-1#1)
distributions for##21##2##(1994-3#3)(1994-9#1)(2007-12#1)(2008-10#4)(2008-3#6)(2008-7#1)(2009-2#2)(2010-9#1)(2011-2#1)(2013-1#1)
distributions from##3##2##(1992-2#1)(2008-2#1)(2008-3#1)
distributions have been##2##3##(2008-2#1)(2008-7#1)
distributions in a##4##3##(2008-3#3)(2008-7#1)
distributions in biochemical networks using##2##5##(2008-7#2)
distributions in the##7##3##(1990-7#1)(2008-3#4)(2008-4#1)(2013-1#1)
distributions in##26##2##(1990-7#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-11#2)(2011-2#1)(2012-3#2)(2013-1#1)
distributions is explained##2##3##(2007-11#1)(2008-10#1)
distributions is##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
distributions obtained from##2##3##(2008-10#1)(2012-12#1)
distributions of a##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
distributions of apparent##2##3##(1990-8#1)(1997-2#1)
distributions of both##3##3##(1992-2#1)(1993-12#1)(2008-2#1)
distributions of the##15##3##(1996-4#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)
distributions of##86##2##(1990-8#2)(1991-10#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#2)(1996-4#2)(1996-7#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-8#1)
distributions on the parameters##2##4##(2008-10#1)(2009-10#1)
distributions on the##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
distributions on##4##2##(2008-10#1)(2008-2#1)(2009-10#1)(2009-4#1)
distributions that##4##2##(1996-4#1)(2008-3#2)(2012-2#1)
distributions to##5##2##(1990-12#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
distributions was developed##2##3##(2008-3#2)
distributions was##4##2##(2008-2#1)(2008-3#3)
distributions were##13##2##(1992-2#2)(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-1#1)
distributions with##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
distributions within##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
distributions##358##1##(1990-12#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-2#7)(1992-3#3)(1993-12#3)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-7#1)(1997-2#3)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#13)(2007-5#1)(2008-10#31)(2008-11#10)(2008-12#3)(2008-2#38)(2008-3#78)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#14)(2008-8#23)(2008-9#9)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#5)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
distributive justice##2##2##(1994-1#1)(2011-2#1)
distributive##3##1##(1994-1#1)(2010-8#1)(2011-2#1)
distributors and##2##2##(1993-3#1)(2010-4#1)
distributors##4##1##(1993-3#1)(2010-4#2)(2010-8#1)
district and local##2##3##(2008-9#2)
district and##5##2##(1994-6#1)(2007-7#1)(2008-9#2)(2010-8#1)
district general hospital##4##3##(1990-3#1)(1997-7#1)(2007-2#1)(2008-7#1)
district general##5##2##(1990-3#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-7#1)
district health##2##2##(1990-3#1)(2008-1#1)
district hospital##3##2##(1996-12#1)(1996-8#1)(2008-10#1)
district in##5##2##(1995-9#1)(2008-12#1)(2009-8#1)(2010-8#1)(2013-8#1)
district of##8##2##(1993-3#1)(1996-6#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-8#1)
district##82##1##(1990-3#3)(1990-6#1)(1991-12#1)(1992-11#1)(1993-11#3)(1993-3#2)(1994-6#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-6#1)(1996-8#1)(1997-5#2)(1997-6#3)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#3)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#6)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#8)
district]##2##1##(1997-3#1)(1997-5#1)
districts and##2##2##(1997-5#1)(2008-11#1)
districts in##2##2##(2008-12#1)(2010-8#1)
districts of Bangladesh##2##3##(2008-10#2)
districts of Uganda##2##3##(2008-10#2)
districts of the##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
districts of##16##2##(1991-2#1)(1994-6#1)(1997-3#1)(2008-10#6)(2008-3#1)(2010-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
districts were##2##2##(2008-10#1)(2010-4#1)
districts##39##1##(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-8#7)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
distrust of science##2##3##(1995-11#2)
distrust of##3##2##(1995-11#2)(2009-5#1)
distrust##4##1##(1995-1#1)(1995-11#2)(2009-5#1)
disturb the##9##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2012-3#1)
disturb##13##1##(1994-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
disturbance and##5##2##(1990-6#1)(1996-11#1)(2008-9#2)(2013-7#1)
disturbance in the##4##3##(1990-11#1)(1991-12#1)(2012-12#1)(2013-1#1)
disturbance in##11##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-6#1)(1995-8#1)(1996-7#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-1#1)
disturbance is##2##2##(2008-7#1)(2008-9#1)
disturbance of circumnutation##2##3##(2009-6#2)
disturbance of the##6##3##(1990-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
disturbance of##22##2##(1990-2#1)(1991-11#1)(1992-6#1)(1994-5#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#2)(2011-1#2)(2012-3#1)
disturbance often##2##2##(1994-9#1)(2008-5#1)
disturbance remained##2##2##(2008-7#1)(2009-3#1)
disturbance was##2##2##(1991-11#1)(2007-8#1)
disturbance##106##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#3)(1991-12#1)(1992-6#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-8#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#14)(2008-9#14)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
disturbance)##2##1##(2008-8#2)
disturbances and##11##2##(1990-9#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
disturbances are##6##2##(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
disturbances associated with##3##3##(2008-3#2)(2009-12#1)
disturbances can##4##2##(2008-2#1)(2008-4#1)(2009-5#1)(2012-2#1)
disturbances have##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
disturbances in Parkinson's disease##2##4##(2008-7#2)
disturbances in a##2##3##(2008-2#1)(2008-3#1)
disturbances in children##3##3##(2011-1#2)(2013-7#1)
disturbances in the##5##3##(2008-2#1)(2011-1#2)(2012-3#1)(2013-8#1)
disturbances in various##2##3##(2008-3#1)(2012-2#1)
disturbances in##38##2##(1991-2#1)(1992-10#1)(1992-12#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-9#1)(2011-1#5)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
disturbances is##2##2##(2008-2#1)(2008-5#1)
disturbances of the##5##3##(1995-6#1)(2007-11#3)(2009-6#1)
disturbances of##17##2##(1991-2#1)(1995-6#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#2)(2009-6#1)(2011-2#2)(2013-8#1)
disturbances on##3##2##(2008-10#2)(2008-9#1)
disturbances or##2##2##(2008-7#2)
disturbances that##2##2##(2007-7#1)(2008-5#1)
disturbances were found##2##3##(1994-6#1)(1997-8#1)
disturbances were##6##2##(1994-6#1)(1997-8#1)(2007-11#1)(2007-8#2)(2011-2#1)
disturbances which##3##2##(1995-8#1)(2007-11#1)(2008-7#1)
disturbances with##2##2##(2008-8#2)
disturbances##175##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-2#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-6#2)(1995-6#1)(1995-8#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-7#4)(2007-8#10)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#10)(2012-1#2)(2012-2#4)(2012-3#7)(2013-1#4)(2013-7#2)(2013-8#4)
disturbed and##2##2##(2008-5#2)
disturbed by##4##2##(1994-5#1)(2008-11#1)(2008-3#1)(2011-1#1)
disturbed eating##4##2##(1997-7#1)(2007-7#3)
disturbed flow##3##2##(2007-7#1)(2010-12#1)(2012-3#1)
disturbed grasslands##2##2##(2013-7#2)
disturbed habitats##4##2##(2008-8#3)(2008-9#1)
disturbed in##2##2##(2008-3#1)(2008-7#1)
disturbed norepinephrine and dopamine##2##4##(2008-3#2)
disturbed the##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
disturbed##58##1##(1991-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-2#2)(1994-5#3)(1994-8#2)(1997-4#1)(1997-7#1)(2007-7#4)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-10#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#4)
disturbing areas in the interferogram##2##5##(2008-3#2)
disturbing##20##1##(1991-1#1)(1995-12#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#8)(2008-4#2)
disturbs the##2##2##(2007-11#1)(2008-2#1)
disturbs##3##1##(2007-11#1)(2008-2#1)(2012-12#1)
disulfide bond##8##2##(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-9#1)
disulfide bonding##3##2##(2008-12#1)(2012-1#2)
disulfide bonds and the glycosylation site in a lectin of the acorn barnacle Megabalanus rosa##2##15##(1990-5#2)
disulfide bonds are##2##3##(1990-5#1)(1994-11#1)
disulfide bonds in##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
disulfide bonds into##2##3##(2008-4#1)(2010-10#1)
disulfide bonds were##3##3##(1990-5#2)(1994-9#1)
disulfide bonds##27##2##(1990-5#7)(1992-11#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-4#5)(2010-10#2)(2012-1#2)
disulfide bridge between residues##2##4##(1990-12#2)
disulfide bridge##7##2##(1990-12#5)(1992-6#1)(1994-8#1)
disulfide bridges in the##2##4##(1992-12#1)(1992-9#1)
disulfide bridges##3##2##(1992-12#1)(1992-9#1)(2008-8#1)
disulfide exchange##5##2##(1990-2#2)(1993-11#3)
disulfide in##5##2##(1990-12#1)(1995-3#1)(2008-10#3)
disulfide is##2##2##(1992-1#1)(1993-11#1)
disulfide isomerase##14##2##(1990-7#3)(1993-6#6)(1995-3#2)(2008-7#1)(2013-1#2)
disulfide isomerases##2##2##(2009-8#1)(2011-2#1)
disulfide linkage##3##2##(1993-11#1)(1995-3#1)(2008-4#1)
disulfide##118##1##(1990-12#6)(1990-2#2)(1990-5#7)(1990-7#3)(1990-8#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#3)(1993-11#7)(1993-6#8)(1993-8#5)(1994-11#7)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#4)(1995-5#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#10)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2011-2#1)(2012-1#4)(2012-2#1)(2013-1#2)
disulfide-based carrier systems##2##3##(2010-10#2)
disulfide-containing proteins##2##2##(1995-5#1)(2011-2#1)
disulfide-linked##3##1##(1992-11#1)(2008-4#2)
disulfides##13##1##(1991-9#1)(1995-3#1)(2008-10#5)(2008-9#4)(2010-10#1)(2012-1#1)
disulfiram##5##1##(1994-5#2)(2010-11#2)(2011-2#1)
disulfonic acid##3##2##(1992-12#1)(2008-10#2)
disulfoton##2##1##(2008-10#2)
disulphide bond##2##2##(1993-9#2)
disulphide compounds##3##2##(2008-10#3)
disulphide##12##1##(1993-2#1)(1993-9#3)(2008-10#8)
disulphine blue##2##2##(2008-10#2)
disuse and misuse##3##3##(2013-1#3)
disuse##7##1##(1993-11#2)(2008-7#2)(2013-1#3)
ditch##2##1##(2008-10#1)(2011-2#1)
diterpenoid##3##1##(2007-1#1)(2008-10#2)
dither modulation from##2##3##(2007-12#2)
dither modulation##3##2##(2007-12#3)
dither##4##1##(2007-12#3)(2008-3#1)
dithered##2##1##(2007-12#2)
dithering##3##1##(2007-12#2)(2008-3#1)
dithiadiazolyl radical##2##2##(2007-11#2)
dithiane##2##1##(2010-7#2)
dithioacetal derivatives##2##2##(2008-10#2)
dithioacetal##3##1##(2008-10#3)
dithiocarbamate (APDC) was##2##3##(2008-10#2)
dithiocarbamate (APDC)##10##2##(2008-10#10)
dithiocarbamate and##2##2##(2008-10#2)
dithiocarbamate fungicides##2##2##(2008-10#2)
dithiocarbamate##26##1##(1993-3#2)(1994-5#1)(2008-10#23)
dithiocarbamates##5##1##(2008-10#5)
dithiocarbamoyl moieties##2##2##(2008-10#2)
dithiocarbamoyl##5##1##(2008-10#5)
dithiocarboxylate as a##2##3##(2008-10#2)
dithiol##4##1##(1993-6#1)(2008-11#1)(2010-4#2)
dithiols##3##1##(2008-11#2)(2010-4#1)
dithionite##5##1##(1991-2#1)(1992-8#1)(1993-11#2)(2008-8#1)
dithiophosphoric acid##2##2##(2008-10#2)
dithiothreitol (DTT)##7##2##(1990-11#1)(1990-12#1)(1992-12#1)(1994-12#1)(1995-8#1)(2010-11#1)(2012-2#1)
dithiothreitol##20##1##(1990-11#2)(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-6#2)(1993-6#2)(1994-12#1)(1995-11#1)(1995-8#1)(2008-5#1)(2008-6#1)(2010-11#1)(2012-2#1)
dithioxamide##3##1##(2008-10#3)
dithizonate##5##1##(2008-10#5)
dithizone and##4##2##(2008-10#4)
dithizone sorbent##2##2##(2008-10#2)
dithizone##17##1##(2008-10#17)
dithizone-anchored microbeads##2##2##(2008-10#2)
dithizone-anchored poly (EGDMA-HEMA) microbeads##2##4##(2008-10#2)
dithizone-anchored##4##1##(2008-10#4)
dityrosine##5##1##(2008-1#1)(2009-8#4)
diuresis and natriuresis##2##3##(1991-6#1)(2008-3#1)
diuresis and##3##2##(1991-6#1)(2008-1#1)(2008-3#1)
diuresis##6##1##(1990-9#1)(1991-6#1)(2008-1#1)(2008-3#2)(2011-2#1)
diuretic activity##3##2##(1991-12#1)(2012-2#2)
diuretic peptide##3##2##(1991-12#3)
diuretic##23##1##(1991-12#4)(1992-11#1)(1992-3#1)(1992-6#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#4)(2010-1#1)(2012-2#2)
diuretics (1##2##2##(2008-8#2)
diuretics and beta-blockers##3##3##(1992-6#1)(1993-2#1)(1994-12#1)
diuretics and##8##2##(1992-11#1)(1992-6#2)(1993-2#1)(1994-12#1)(2007-8#1)(2010-10#2)
diuretics in##4##2##(2008-10#4)
diuretics##38##1##(1992-11#4)(1992-6#2)(1993-2#2)(1994-12#2)(1994-7#1)(1994-8#4)(2006-8#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-5#1)(2008-8#3)(2009-9#2)(2010-10#3)(2010-6#1)(2013-1#1)
diurnal fluctuation##3##2##(2008-7#3)
diurnal foragers##2##2##(2007-12#2)
diurnal pattern of##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
diurnal pattern##4##2##(1997-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
diurnal rhythm##2##2##(2008-10#1)(2012-2#1)
diurnal rhythms##2##2##(1990-3#1)(2008-10#1)
diurnal variability##2##2##(2008-2#1)(2008-3#1)
diurnal variation in##2##3##(1992-3#1)(2008-5#1)
diurnal variation##4##2##(1990-3#1)(1992-3#1)(1994-6#1)(2008-5#1)
diurnal##35##1##(1990-3#2)(1992-11#1)(1992-3#1)(1994-6#1)(1997-8#2)(2007-12#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#5)(2008-7#3)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
diuron##11##1##(2008-10#11)
divalent and##2##2##(2008-10#2)
divalent cation##11##2##(1990-2#5)(1991-8#1)(1992-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-6#1)
divalent cations Ca2+ and Mg2+##2##5##(1990-7#1)(1995-11#1)
divalent cations on the##3##4##(1991-2#1)(1994-5#2)
divalent cations was##2##3##(1995-11#1)(2008-10#1)
divalent cations were##2##3##(1990-7#1)(1995-5#1)
divalent cations##31##2##(1990-12#1)(1990-5#2)(1990-7#3)(1991-2#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-5#4)(1994-6#2)(1995-11#2)(1995-2#2)(1995-5#2)(2008-10#6)(2008-6#1)
divalent ions##8##2##(1995-11#1)(2008-10#6)(2011-2#1)
divalent metal cations##4##3##(2008-10#4)
divalent metal ions##3##3##(1991-5#1)(2008-10#2)
divalent metal##8##2##(1991-5#1)(1995-2#1)(2008-10#6)
divalent##83##1##(1990-12#1)(1990-2#5)(1990-5#4)(1990-7#3)(1991-2#1)(1991-5#1)(1991-8#3)(1992-5#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-5#4)(1994-6#2)(1995-11#3)(1995-2#3)(1995-5#2)(1997-3#1)(2006-6#1)(2008-10#35)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-11#1)(2011-2#2)
divaricata##4##1##(2008-10#4)
diverge from the##2##3##(2008-8#1)(2010-12#1)
diverge##7##1##(1992-8#1)(1993-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
diverged from a common##2##4##(2008-10#1)(2008-5#1)
diverged from the ancestor of##2##5##(2008-9#1)(2009-10#1)
diverged from the##4##3##(1991-6#1)(2008-9#1)(2009-10#1)(2009-8#1)
diverged from##9##2##(1991-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#2)(2013-7#1)
diverged##22##1##(1991-5#2)(1991-6#2)(1991-9#1)(1994-6#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-9#2)(2009-10#1)(2009-8#3)(2012-3#1)(2013-1#2)(2013-7#1)
divergence among##3##2##(2008-10#2)(2010-10#1)
divergence and the##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
divergence and##10##2##(1997-8#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-8#1)(2013-1#3)
divergence angle##5##2##(2008-10#2)(2008-3#2)(2009-8#1)
divergence between low- and high-altitude populations of##2##7##(2013-1#2)
divergence between populations##3##3##(2008-8#2)(2012-3#1)
divergence between the##3##3##(1993-12#1)(2007-10#1)(2013-1#1)
divergence between##11##2##(1993-12#1)(2007-10#1)(2008-10#1)(2008-8#3)(2009-2#1)(2012-3#1)(2013-1#3)
divergence from##3##2##(1997-1#1)(2008-12#1)(2012-3#1)
divergence in potential##5##3##(2008-10#5)
divergence in potentials##5##3##(2008-10#5)
divergence in the##4##3##(2007-12#2)(2008-10#1)(2008-7#1)
divergence in##26##2##(2007-12#2)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
divergence is##6##2##(1994-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-3#1)
divergence matching##2##2##(2007-10#2)
divergence of the##12##3##(1993-2#1)(1993-6#1)(1997-6#1)(2008-2#1)(2008-3#5)(2009-2#1)(2010-3#1)(2011-1#1)
divergence of these##2##3##(1991-6#1)(2012-3#1)
divergence of##27##2##(1991-6#2)(1993-2#1)(1993-6#1)(1994-11#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-3#2)
divergence or convergence##2##3##(1996-4#1)(2008-10#1)
divergence that is##2##3##(2008-10#1)(2008-3#1)
divergence times##5##2##(2008-6#1)(2009-2#1)(2010-3#1)(2010-6#2)
divergence timing information##3##3##(2008-1#3)
divergence to##2##2##(2008-10#2)
divergence was##3##2##(2007-10#1)(2008-3#1)(2012-3#1)
divergence##161##1##(1991-5#1)(1991-6#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#4)(2007-12#5)(2008-1#3)(2008-10#33)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#23)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#11)(2008-9#1)(2009-12#1)(2009-2#7)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#16)(2013-1#13)(2013-7#2)
divergence)##3##1##(2008-7#1)(2008-8#1)(2013-7#1)
divergences##5##1##(2008-10#2)(2008-3#1)(2009-10#1)(2009-2#1)
divergent 5'##2##2##(1990-8#1)(2008-10#1)
divergent and##3##2##(2008-7#1)(2009-9#1)(2011-2#1)
divergent from that of##2##4##(1990-11#1)(2008-11#1)
divergent from##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
divergent lineages##2##2##(2008-10#1)(2010-8#1)
divergent natural selection##2##3##(2008-8#1)(2012-3#1)
divergent residues##2##2##(1997-9#1)(2008-8#1)
divergent responses##2##2##(1994-6#2)
divergent results##3##2##(1990-6#1)(1993-12#1)(2008-10#1)
divergent##87##1##(1990-11#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#3)(1993-2#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-9#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
diverging beams##3##2##(2007-12#1)(2008-3#2)
diverging laser beam##2##3##(2008-2#1)(2008-3#1)
diverging##19##1##(1993-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#4)(2009-2#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-3#1)
divers with primary affection of the##2##6##(1991-6#2)
divers##9##1##(1991-6#6)(1996-11#2)(2010-2#1)
diverse P##2##2##(2008-10#2)
diverse and that##2##3##(2008-10#1)(2008-8#1)
diverse and##13##2##(1990-4#1)(1994-5#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#1)(2011-2#2)(2013-1#2)
diverse bacterial species##2##3##(2008-10#1)(2008-9#1)
diverse bacterial##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
diverse biological##5##2##(2008-4#2)(2009-7#1)(2011-1#1)(2013-7#1)
diverse cell types##3##3##(1995-12#1)(2008-9#1)(2010-2#1)
diverse cell##5##2##(1995-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2013-1#1)
diverse cellular functions##2##3##(2012-12#1)(2013-8#1)
diverse cellular processes##3##3##(1995-2#1)(2008-4#2)
diverse cellular##5##2##(1995-2#1)(2008-4#2)(2012-12#1)(2013-8#1)
diverse clade of##2##3##(2010-3#1)(2010-6#1)
diverse clade##3##2##(2008-10#1)(2010-3#1)(2010-6#1)
diverse collection of##3##3##(1990-8#1)(2008-10#1)(2011-1#1)
diverse communities##2##2##(2009-6#1)(2010-8#1)
diverse community##3##2##(1994-3#1)(2008-12#1)(2012-2#1)
diverse conditions##2##2##(2008-10#1)(2008-7#1)
diverse cultures##3##2##(2010-1#1)(2010-8#1)(2013-8#1)
diverse developmental##2##2##(2007-12#1)(2011-1#1)
diverse environments##3##2##(2008-9#1)(2011-2#2)
diverse ethnic##2##2##(2009-5#1)(2010-10#1)
diverse field##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
diverse functions##7##2##(1993-5#1)(1996-5#1)(2008-10#2)(2009-10#2)(2011-1#1)
diverse genes##2##2##(2007-11#1)(2009-8#1)
diverse geographic##3##2##(2008-10#3)
diverse geographical regions##2##3##(2008-10#1)(2012-3#1)
diverse group of patients##2##4##(2006-10#1)(2008-3#1)
diverse group of##12##3##(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#3)(2012-12#2)
diverse group##14##2##(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-2#3)(2012-12#2)
diverse groups of##2##3##(2008-1#1)(2012-3#1)
diverse groups##3##2##(2008-1#1)(2008-4#1)(2012-3#1)
diverse in##6##2##(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
diverse ions on the##5##4##(2008-10#5)
diverse ions##9##2##(2008-10#9)
diverse locations##3##2##(2007-8#1)(2008-10#2)
diverse needs##2##2##(1995-3#1)(1997-1#1)
diverse organisms##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
diverse pathways##2##2##(2008-10#1)(2008-8#1)
diverse physiological##2##2##(2009-6#1)(2013-8#1)
diverse population of##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
diverse population##8##2##(2007-12#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
diverse populations of##4##3##(2008-10#2)(2008-11#1)(2012-1#1)
diverse populations##12##2##(2008-10#2)(2008-11#1)(2008-6#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
diverse range of##18##3##(1994-8#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
diverse repertoire of##2##3##(2008-10#1)(2008-11#1)
diverse roles of##4##3##(1990-11#1)(1996-12#1)(2010-10#1)(2011-2#1)
diverse sample of##5##3##(2008-10#1)(2009-7#2)(2010-1#2)
diverse sample##6##2##(2008-10#1)(2008-5#1)(2009-7#2)(2010-1#2)
diverse set of##8##3##(1991-3#1)(2007-11#1)(2008-10#3)(2008-9#1)(2012-4#1)(2013-1#1)
diverse settings##2##2##(1997-1#1)(2009-9#1)
diverse signaling pathways##2##3##(2008-4#1)(2012-12#1)
diverse signaling##3##2##(1993-5#1)(2008-4#1)(2012-12#1)
diverse socioeconomic backgrounds##2##3##(2009-5#1)(2010-8#1)
diverse species and##2##3##(2008-11#1)(2008-7#1)
diverse species##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)
diverse symptoms##2##2##(2008-11#1)(2013-8#1)
diverse than previously##2##3##(2008-11#1)(2012-2#1)
diverse than##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
diverse types of##3##3##(1994-9#1)(2008-4#1)(2011-1#1)
diverse uses##2##2##(2008-10#1)(2008-2#1)
diverse work force##2##3##(1997-2#2)
diverse##457##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#5)(1992-11#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-3#3)(1993-5#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#3)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-7#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#8)(2007-5#1)(2007-8#3)(2008-1#5)(2008-10#103)(2008-11#19)(2008-12#8)(2008-2#3)(2008-3#3)(2008-4#18)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#10)(2009-10#7)(2009-11#1)(2009-12#4)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#3)(2009-9#2)(2010-1#6)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#5)(2011-1#12)(2011-2#22)(2011-3#2)(2011-9#1)(2012-1#2)(2012-12#9)(2012-2#21)(2012-3#11)(2012-4#2)(2013-1#16)(2013-7#7)(2013-8#10)
diversicaudatum##2##1##(2008-10#2)
diversicaudatum)##2##1##(2008-10#2)
diversification among##2##2##(1997-4#1)(2008-9#1)
diversification and speciation##2##3##(1996-6#1)(2008-8#1)
diversification and##5##2##(1996-6#1)(2008-11#2)(2008-8#1)(2012-3#1)
diversification in##4##2##(2008-10#1)(2010-3#2)(2012-3#1)
diversification is##2##2##(2008-11#1)(2009-10#1)
diversification of the##2##3##(2009-10#1)(2010-6#1)
diversification of##11##2##(1993-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-7#1)
diversification##45##1##(1991-1#1)(1991-3#2)(1993-3#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-8#5)(2008-9#6)(2009-10#2)(2009-5#1)(2009-8#1)(2010-3#6)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#4)(2013-7#1)
diversified##15##1##(1990-8#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
diversifolia##5##1##(2008-10#3)(2008-5#2)
diversify##6##1##(2008-11#3)(2008-8#1)(2012-2#2)
diversifying##2##1##(2008-8#1)(2008-9#1)
diversion and##3##2##(1993-3#1)(2010-8#1)(2011-2#1)
diversion control program##2##3##(1996-12#2)
diversion of##4##2##(1992-1#1)(1992-5#1)(1993-9#1)(2008-9#1)
diversion with##2##2##(2008-10#1)(2012-3#1)
diversion##28##1##(1990-6#1)(1991-11#1)(1992-1#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-9#1)(1996-12#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
diversities##11##1##(1994-8#3)(2008-10#5)(2008-4#1)(2008-8#1)(2011-2#1)
diversity (H)##3##2##(2008-10#2)(2008-5#1)
diversity across##3##2##(2008-10#2)(2012-3#1)
diversity among X##4##3##(2008-10#4)
diversity among isolates from the##2##5##(2008-10#2)
diversity among isolates##4##3##(2008-10#4)
diversity among populations##2##3##(2008-1#1)(2013-1#1)
diversity among strains of##2##4##(2008-10#2)
diversity among strains##3##3##(2008-10#3)
diversity among##26##2##(1994-9#1)(2008-1#1)(2008-10#20)(2008-6#1)(2008-8#1)(2013-1#1)(2013-7#1)
diversity analyses##2##2##(2008-10#2)
diversity analysis##4##2##(2008-10#3)(2008-5#1)
diversity and distribution##3##3##(2013-7#3)
diversity and its##3##3##(1994-12#1)(2012-2#1)(2013-7#1)
diversity and pathogenic##2##3##(2008-10#2)
diversity and population differentiation at the innate##2##7##(2012-3#2)
diversity and population differentiation##4##4##(2008-10#2)(2012-3#2)
diversity and population structure of##3##5##(2011-2#2)(2013-8#1)
diversity and population structure##4##4##(2008-10#1)(2011-2#2)(2013-8#1)
diversity and population##8##3##(2008-10#3)(2011-2#2)(2012-3#2)(2013-8#1)
diversity and the distribution##2##4##(2008-10#1)(2013-7#1)
diversity and the##4##3##(2008-10#2)(2009-2#1)(2013-7#1)
diversity and##68##2##(1994-12#1)(1995-3#1)(1997-6#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-7#5)(2013-8#1)
diversity are discussed##2##3##(2008-10#1)(2008-8#1)
diversity are##4##2##(1994-2#1)(2008-10#2)(2008-8#1)
diversity as well as##2##4##(2008-9#1)(2012-3#1)
diversity as##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
diversity at the##3##3##(2008-10#3)
diversity at##7##2##(2008-10#4)(2008-8#2)(2009-2#1)
diversity because##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
diversity between populations##2##3##(2008-10#2)
diversity between##6##2##(1995-2#1)(2008-10#3)(2008-7#1)(2011-2#1)
diversity by##2##2##(2008-2#1)(2010-2#1)
diversity can##4##2##(1994-12#1)(2008-10#1)(2009-8#1)(2012-3#1)
diversity compared to##3##3##(2008-5#1)(2013-1#1)(2013-7#1)
diversity compared##4##2##(2008-10#1)(2008-5#1)(2013-1#1)(2013-7#1)
diversity data##2##2##(2008-10#2)
diversity during the##2##3##(2011-2#1)(2013-1#1)
diversity during##3##2##(1997-9#1)(2011-2#1)(2013-1#1)
diversity for aggressiveness##3##3##(2008-10#3)
diversity for the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
diversity for##16##2##(1991-2#1)(1996-1#1)(2008-10#8)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
diversity found in the##2##4##(2008-10#2)
diversity found##3##2##(2008-10#3)
diversity in a##4##3##(2008-10#1)(2008-5#2)(2009-2#1)
diversity in nature##2##3##(1994-11#1)(2008-10#1)
diversity in populations##2##3##(2008-10#1)(2008-7#1)
diversity in the pathogen population##2##5##(2008-10#2)
diversity in the##25##3##(1993-2#1)(1994-11#1)(1997-3#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
diversity in this##8##3##(2008-10#7)(2012-3#1)
diversity in##83##2##(1990-8#1)(1992-8#1)(1993-2#1)(1994-11#3)(1994-12#1)(1996-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-5#1)(2008-1#2)(2008-10#28)(2008-11#4)(2008-5#4)(2008-7#4)(2008-8#5)(2009-2#4)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2012-2#2)(2012-3#8)(2013-1#1)(2013-7#2)
diversity index##2##2##(2013-7#2)
diversity indexes##2##2##(2008-10#1)(2013-7#1)
diversity indicated##2##2##(2008-10#2)
diversity indices were##2##3##(2008-10#1)(2008-5#1)
diversity indices##11##2##(2008-10#4)(2008-5#3)(2008-8#3)(2013-7#1)
diversity is##8##2##(1993-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
diversity management##3##2##(1994-12#3)
diversity may be##2##3##(2008-10#2)
diversity may##7##2##(2008-10#4)(2008-7#1)(2012-3#1)(2013-1#1)
diversity measures##2##2##(2008-8#1)(2008-9#1)
diversity observed in##2##3##(2008-10#2)
diversity of a##3##3##(2008-5#1)(2008-9#2)
diversity of hepatitis B virus##2##5##(2009-3#1)(2013-1#1)
diversity of insect##2##3##(2008-8#1)(2013-7#1)
diversity of other##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
diversity of parasites##2##3##(2008-9#1)(2012-3#1)
diversity of plant pathogens##2##4##(2008-10#2)
diversity of plant##3##3##(2008-10#3)
diversity of populations##2##3##(2008-10#1)(2012-1#1)
diversity of prolactin's actions##2##4##(2008-4#2)
diversity of the isolates##2##4##(2008-10#2)
diversity of the pathogen##2##4##(2008-10#2)
diversity of the population##2##4##(2008-10#1)(2008-6#1)
diversity of the##32##3##(1992-6#1)(1997-5#1)(1997-9#2)(2008-10#16)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#3)(2013-8#2)
diversity of these##4##3##(2008-10#1)(2010-7#1)(2013-7#2)
diversity of this##4##3##(1992-3#1)(2008-10#3)
diversity of##175##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-9#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#60)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-3#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#6)(2012-3#7)(2013-1#3)(2013-7#4)(2013-8#5)
diversity on plant diversity##2##4##(2008-9#2)
diversity on##7##2##(2008-10#5)(2008-9#2)
diversity ranged from##2##3##(2008-12#1)(2008-5#1)
diversity ranged##3##2##(2008-12#1)(2008-5#1)(2013-7#1)
diversity revealed by##2##3##(2008-10#2)
diversity revealed##3##2##(2008-10#3)
diversity should be##2##3##(2008-8#1)(2008-9#1)
diversity should##3##2##(2008-8#1)(2008-9#1)(2013-7#1)
diversity than##4##2##(2008-10#1)(2008-9#1)(2010-3#1)(2013-8#1)
diversity that exists within##2##4##(2008-12#1)(2012-12#1)
diversity that exists##4##3##(2008-10#1)(2008-12#2)(2012-12#1)
diversity that##7##2##(2008-10#3)(2008-12#2)(2012-12#1)(2013-1#1)
diversity to##4##2##(1996-1#1)(2008-9#1)(2010-3#1)(2013-7#1)
diversity was assessed using##2##4##(2008-10#2)
diversity was found within##2##4##(2008-10#2)
diversity was found##3##3##(2008-10#2)(2012-2#1)
diversity was greatest##2##3##(2008-10#2)
diversity was high##4##3##(2008-10#4)
diversity was studied in##2##4##(2008-10#1)(2013-7#1)
diversity was very##2##3##(2008-10#1)(2012-3#1)
diversity was##45##2##(2008-10#35)(2008-12#1)(2008-9#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
diversity were##2##2##(2008-10#1)(2012-5#1)
diversity with##3##2##(1997-8#1)(2008-12#1)(2008-5#1)
diversity within a field##2##4##(2008-10#2)
diversity within a##5##3##(2008-10#4)(2011-2#1)
diversity within and between##2##4##(2008-10#2)
diversity within populations##5##3##(2008-10#5)
diversity within the##12##3##(1997-2#1)(2008-10#8)(2008-8#1)(2009-2#1)(2009-5#1)
diversity within##36##2##(1997-2#1)(2008-10#28)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-2#1)
diversity##769##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#9)(1994-2#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-6#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(1997-9#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#325)(2008-11#9)(2008-12#15)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#35)(2008-6#4)(2008-7#20)(2008-8#49)(2008-9#36)(2009-10#3)(2009-12#1)(2009-2#12)(2009-3#2)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#7)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#10)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#8)(2011-2#19)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#29)(2012-5#2)(2013-1#12)(2013-7#28)(2013-8#11)
diversus##3##1##(2011-2#3)
divert##4##1##(1991-1#1)(1997-1#1)(2008-11#1)(2012-3#1)
diverted to##3##2##(1990-2#1)(1990-5#1)(2008-9#1)
diverted##9##1##(1990-2#1)(1990-5#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-11#1)(2012-1#2)
diverticula##9##1##(1990-12#1)(1991-6#2)(1992-1#1)(1993-9#1)(2007-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
diverticular disease is##3##3##(2010-8#3)
diverticular disease##13##2##(2008-6#3)(2010-8#10)
diverticular##17##1##(2008-6#3)(2009-8#1)(2010-8#13)
diverticulatis##2##1##(2009-1#2)
diverticulitis in##2##2##(2009-8#1)(2010-8#1)
diverticulitis or##2##2##(1993-2#1)(2010-8#1)
diverticulitis##20##1##(1991-8#1)(1993-2#1)(2008-10#1)(2008-7#1)(2009-8#3)(2010-8#10)(2011-2#1)(2012-2#2)
diverticulosis is##2##2##(2010-8#2)
diverticulosis##5##1##(1990-11#1)(2008-6#1)(2010-8#2)(2011-2#1)
diverticulum in a female child##2##5##(2008-10#2)
diverticulum in a female##3##4##(2008-10#3)
diverticulum in a##5##3##(2008-10#3)(2011-2#2)
diverticulum in##8##2##(1991-5#1)(2008-10#4)(2009-8#1)(2011-2#2)
diverticulum of the##2##3##(1991-6#1)(2007-8#1)
diverticulum##32##1##(1990-6#2)(1991-5#2)(1991-6#3)(1992-1#1)(1996-3#1)(1997-2#2)(2007-8#1)(2008-10#7)(2008-3#1)(2009-8#4)(2010-7#1)(2011-2#3)(2013-1#3)(2013-7#1)
divested##3##1##(1993-2#1)(2008-9#2)
divide again##2##2##(2007-12#2)
divide in##2##2##(1995-11#1)(2008-7#1)
divide the##5##2##(1996-2#1)(2007-11#1)(2008-2#2)(2008-3#1)
divide##25##1##(1995-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-3#1)
divided and##2##2##(1997-3#1)(2007-8#1)
divided attention##3##2##(1991-1#1)(1996-5#1)(2008-4#1)
divided between##3##2##(1994-6#1)(1996-8#1)(2008-10#1)
divided by that##2##3##(2008-10#1)(2008-2#1)
divided by the slope of the calibration##2##7##(2008-10#2)
divided by the##11##3##(1992-12#1)(1995-8#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)
divided by##21##2##(1990-11#1)(1992-12#1)(1995-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#4)
divided doses##2##2##(2007-7#1)(2012-2#1)
divided evenly##2##2##(2008-3#1)(2008-9#1)
divided in three groups according to the##2##7##(2007-6#1)(2011-2#1)
divided in three groups according##3##5##(2007-6#1)(2011-2#1)(2013-1#1)
divided in three groups##4##4##(2007-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
divided in three##8##3##(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#1)
divided in to##2##3##(2008-12#2)
divided in two subgroups##2##4##(2007-8#1)(2013-1#1)
divided in two##4##3##(1996-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
divided in##20##2##(1996-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-9#1)(2013-1#3)
divided into 2 groups##4##4##(1990-2#1)(1994-6#1)(2007-10#1)(2009-7#1)
divided into 3 groups##7##4##(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2012-4#1)(2013-1#1)
divided into 4##7##3##(1992-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
divided into 6 groups##2##4##(2013-1#1)(2013-7#1)
divided into 6##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
divided into a##4##3##(1995-5#1)(2007-8#1)(2008-11#1)(2011-2#1)
divided into an experimental group##2##5##(1993-12#1)(2010-6#1)
divided into control##2##3##(1995-12#1)(2008-12#1)
divided into discrete##2##3##(1993-12#1)(2008-1#1)
divided into either##2##3##(2008-10#1)(2008-3#1)
divided into five groups##6##4##(1990-12#1)(2008-10#1)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)
divided into five##13##3##(1990-12#1)(1995-12#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)
divided into four areas##2##4##(2008-10#1)(2013-7#1)
divided into four groups##16##4##(1991-2#1)(1992-1#1)(1993-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#3)
divided into four subgroups##2##4##(2008-10#1)(2009-8#1)
divided into four##28##3##(1991-2#1)(1992-1#1)(1993-5#1)(1997-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#3)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-7#1)
divided into groups##4##3##(1993-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
divided into one control##2##4##(1997-6#1)(2011-2#1)
divided into several##2##3##(2008-3#1)(2010-3#1)
divided into six equal##2##4##(2008-3#2)
divided into six##6##3##(2008-10#2)(2008-3#2)(2009-6#1)(2011-2#1)
divided into the following##3##4##(2007-10#1)(2010-6#1)(2012-12#1)
divided into the primordial##2##4##(2007-12#2)
divided into the##10##3##(1990-5#1)(1993-2#1)(2007-10#1)(2007-12#2)(2008-10#3)(2010-6#1)(2012-12#1)
divided into three different##2##4##(1997-8#1)(2008-10#1)
divided into three groups##17##4##(1994-6#1)(1995-1#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
divided into three phases##2##4##(2008-10#1)(2010-8#1)
divided into three stages##3##4##(2008-10#1)(2008-4#2)
divided into three##37##3##(1994-6#1)(1995-1#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
divided into two categories##2##4##(2008-11#1)(2008-9#1)
divided into two distinct##5##4##(2007-12#1)(2008-10#3)(2008-7#1)
divided into two equal groups of##3##6##(2007-7#1)(2007-9#1)(2008-1#1)
divided into two equal groups##5##5##(2007-7#2)(2007-9#1)(2008-1#1)(2012-2#1)
divided into two groups according to the##2##7##(1997-7#1)(2008-10#1)
divided into two groups according to##4##6##(1997-7#1)(2008-10#1)(2008-3#2)
divided into two groups and##2##5##(1993-2#1)(2012-3#1)
divided into two groups of##7##5##(1991-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#1)
divided into two groups##45##4##(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-8#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
divided into two phases##3##4##(2008-4#1)(2008-5#2)
divided into two subfamilies##2##4##(2008-4#1)(2008-8#1)
divided into two subgroups##4##4##(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
divided into two types##2##4##(2008-10#2)
divided into two##88##3##(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1997-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
divided into##279##2##(1990-12#3)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-5#1)(1993-9#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#6)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#47)(2008-11#10)(2008-12#8)(2008-2#1)(2008-3#15)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#16)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#15)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#16)(2013-7#2)(2013-8#4)
divided on the##2##3##(2008-6#1)(2008-8#1)
divided on two groups##2##4##(2008-12#1)(2013-1#1)
divided on##5##2##(1996-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2013-1#1)
divided the##6##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2011-2#2)
divided this##2##2##(2008-6#1)(2011-2#1)
divided to##3##2##(2008-12#2)(2011-2#1)
divided##372##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-5#1)(1993-9#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#6)(2007-12#7)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#66)(2008-11#11)(2008-12#14)(2008-2#4)(2008-3#21)(2008-4#8)(2008-5#13)(2008-6#5)(2008-7#18)(2008-8#10)(2008-9#10)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#23)(2011-3#3)(2012-12#2)(2012-2#3)(2012-3#2)(2012-4#1)(2012-9#1)(2013-1#20)(2013-7#2)(2013-8#4)
dividends##3##1##(1993-2#1)(1994-2#1)(1997-2#1)
divides the##4##2##(1993-12#1)(2007-12#1)(2008-2#1)(2012-2#1)
divides##9##1##(1990-3#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)(2010-8#1)(2012-2#2)
dividing cells to##3##3##(1990-5#1)(2008-4#1)(2008-6#1)
dividing cells##16##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-9#3)(2009-8#1)(2012-12#2)
dividing spermatogonia##2##2##(2012-2#2)
dividing the##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)
dividing##40##1##(1990-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-3#2)(1995-2#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-8#1)(2012-12#3)(2012-2#2)
divine##5##1##(1992-5#1)(1996-1#1)(2009-7#1)(2013-1#2)
diving is##2##2##(1991-6#1)(2010-3#1)
diving to##2##2##(1991-6#1)(2008-5#1)
diving##14##1##(1991-6#6)(1996-2#2)(1997-1#1)(2008-5#2)(2010-3#2)(2013-7#1)
divinorum##4##1##(2008-12#3)(2009-12#1)
divinyl benzene##3##2##(2008-10#3)
divinylbenzene##2##1##(2008-10#1)(2008-11#1)
divinylbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS)##2##2##(2008-10#2)
divinylsulphone##4##1##(2008-10#4)
divisible space##4##2##(2008-8#4)
division and##8##2##(1990-5#1)(1991-5#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
division as##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
division between the##2##3##(1992-5#1)(2009-6#1)
division between##3##2##(1992-5#1)(2009-6#1)(2010-4#1)
division by##3##2##(1994-11#1)(2007-12#1)(2008-9#1)
division cycle##4##2##(1994-3#1)(1994-5#1)(1995-2#1)(1997-6#1)
division during##3##2##(1995-11#1)(2008-10#1)(2008-7#1)
division in##10##2##(1990-11#2)(1993-8#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#1)
division is##4##2##(1990-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
division meeting##42##2##(2008-11#42)
division of labor in honeybee colonies##2##6##(2008-8#2)
division of labor in##4##4##(2008-8#3)(2008-9#1)
division of labor##11##3##(1991-6#2)(1995-1#1)(1996-1#1)(2008-8#6)(2008-9#1)
division of labour##2##3##(2007-10#1)(2008-7#1)
division of the##10##3##(1993-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)
division of##44##2##(1991-2#1)(1991-6#2)(1992-8#1)(1993-12#1)(1993-6#1)(1995-1#1)(1996-1#1)(1996-3#3)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#2)(2012-2#1)(2013-8#1)
division site##2##2##(2009-10#1)(2009-2#1)
division##224##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-2#2)(1991-5#1)(1991-6#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#4)(1996-6#1)(1997-1#1)(1997-4#2)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-8#4)(2008-1#4)(2008-10#11)(2008-11#51)(2008-12#1)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#8)(2008-9#11)(2009-10#5)(2009-12#6)(2009-2#4)(2009-3#1)(2009-5#6)(2009-6#2)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
division)##2##1##(2008-10#1)(2008-7#1)
division-of-amplitude photopolarimeter##3##2##(2008-3#3)
division-of-amplitude##4##1##(2008-3#4)
divisions are##2##2##(2008-10#1)(2008-7#1)
divisions in##2##2##(2009-8#1)(2012-2#1)
divisions meeting##3##2##(2008-11#3)
divisions of the##3##3##(2008-5#1)(2008-7#1)(2010-1#1)
divisions of##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-1#1)
divisions that##2##2##(2012-2#2)
divisions were##2##2##(1991-4#1)(2013-7#1)
divisions##39##1##(1990-11#1)(1991-4#1)(1994-1#1)(1994-12#1)(1996-3#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2012-2#5)(2013-7#1)
divisor-ratio spectra derivative##4##3##(2008-10#4)
divisum##2##1##(1991-9#2)
divorce in##2##2##(2008-12#1)(2011-2#1)
divorce##17##1##(2008-11#1)(2008-12#2)(2008-2#1)(2009-11#2)(2011-2#11)
divorced##5##1##(1994-6#2)(1996-12#1)(2008-9#1)(2011-1#1)
divulge##2##1##(1996-3#1)(2008-6#1)
dizocilpine maleate##4##2##(1996-12#4)
dizocilpine##7##1##(1994-8#1)(1995-12#1)(1996-12#4)(2007-10#1)
dizygotic twins##4##2##(1997-8#1)(2008-11#1)(2008-7#1)(2010-8#1)
dizygotic##7##1##(1997-5#1)(1997-8#1)(2008-11#2)(2008-7#1)(2010-8#1)(2013-1#1)
dizziness and##6##2##(1991-2#1)(1992-9#1)(1997-6#1)(2008-11#1)(2008-8#1)(2013-1#1)
dizziness##14##1##(1991-2#1)(1992-9#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
dl(-1)##2##1##(2008-10#2)
dl-alanine or dl-leucine##2##3##(2008-10#2)
dl-dithiothreitol##3##1##(2008-10#3)
dlt operon is##2##3##(1995-6#2)
dlt operon##5##2##(1995-6#5)
dlt##6##1##(1995-6#6)
dltB and dltD##2##3##(1995-6#2)
dm(-3) with##5##2##(2008-10#5)
dm(-3)##69##1##(1996-5#2)(2008-10#67)
dm(-3))##13##1##(2008-10#13)
dm(3) mol(-1) cm(-1)##2##3##(2008-10#2)
dm(3) mol(-1)##4##2##(2008-10#4)
dm(3)##11##1##(2008-10#10)(2008-8#1)
dn/dT##3##1##(2008-3#3)
dnaA##6##1##(1994-12#2)(1996-12#4)
dnaCts gene##2##2##(1991-12#2)
dnaG##2##1##(1994-12#2)
dnaK##2##1##(1994-12#1)(2008-10#1)
dnaN##2##1##(1994-12#1)(1996-12#1)
dnl4 mutants are##2##3##(1997-7#2)
do = OMe##2##3##(1997-7#2)
do =##3##2##(1997-7#3)
do African American men##2##4##(2009-5#2)
do I##9##2##(1991-6#1)(1994-12#1)(1995-12#1)(1997-1#3)(1997-2#1)(2007-7#1)(2013-1#1)
do Rio##3##2##(2008-6#1)(2008-9#2)
do Sul##11##2##(1993-6#3)(2008-5#1)(2009-7#1)(2011-2#4)(2013-7#2)
do a##5##2##(1994-3#1)(1996-4#1)(2007-4#1)(2008-8#1)(2013-8#1)
do about##3##2##(1996-3#1)(2008-1#1)(2008-11#1)
do all##2##2##(2008-9#1)(2011-2#1)
do and do not##2##4##(1993-3#1)(2009-5#1)
do and##5##2##(1992-12#1)(1993-3#1)(1996-2#1)(2009-5#1)(2009-9#1)
do better##4##2##(1995-2#1)(1997-1#1)(2008-8#2)
do business##4##2##(1991-3#1)(1992-12#1)(1995-3#1)(1996-2#1)
do dental##2##2##(2013-1#2)
do exist for##2##3##(2007-10#1)(2011-2#1)
do exist##4##2##(2007-10#1)(2008-7#1)(2010-10#1)(2011-2#1)
do females##2##2##(2008-6#1)(2008-8#1)
do for##2##2##(1997-1#1)(2012-12#1)
do have the##2##3##(1995-2#1)(1997-3#1)
do have##6##2##(1995-2#1)(1997-3#1)(2008-5#1)(2008-9#2)(2009-10#1)
do improve##2##2##(2008-5#2)
do in##4##2##(1993-12#1)(1994-9#1)(1995-1#1)(2010-12#1)
do influence##2##2##(1991-12#1)(2010-3#1)
do is##3##2##(1991-1#1)(1992-2#1)(2008-10#1)
do it right##2##3##(1993-1#1)(1997-1#1)
do it##15##2##(1993-1#1)(1994-1#1)(1995-1#1)(1995-12#1)(1997-1#1)(2008-6#1)(2008-9#8)(2009-8#1)
do it?##2##2##(1997-6#1)(2008-4#1)
do it]##2##2##(1995-6#1)(1997-5#1)
do justice to##2##3##(2008-11#1)(2008-7#1)
do know##3##2##(1990-9#1)(1991-2#1)(1994-2#1)
do large##2##2##(2008-8#1)(2008-9#1)
do medical##2##2##(1993-6#1)(1995-3#1)
do more##4##2##(1992-8#1)(1993-3#1)(2008-11#1)(2013-8#1)
do no##5##2##(1996-10#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
do not account for##3##4##(1994-6#1)(2008-10#1)(2008-3#1)
do not achieve##2##3##(1997-7#1)(2008-7#1)
do not acknowledge##2##3##(1995-1#1)(2010-11#1)
do not address##2##3##(2008-3#1)(2011-2#1)
do not adequately describe the##2##5##(2008-9#1)(2013-1#1)
do not adequately##7##3##(1993-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
do not adjust##2##3##(2009-12#1)(2009-4#1)
do not adopt##2##3##(1997-6#1)(2008-12#1)
do not affect the##8##4##(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
do not affect##15##3##(1993-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2009-8#1)
do not agree##2##3##(2008-8#1)(2013-1#1)
do not allow##6##3##(1997-3#1)(2008-10#1)(2012-1#1)(2012-2#2)(2013-1#1)
do not alter##4##3##(1993-6#1)(1994-3#1)(1995-5#1)(2012-2#1)
do not always##8##3##(1991-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
do not appear to be a##2##6##(1993-12#1)(1995-1#1)
do not appear to be involved in##2##7##(2008-10#2)
do not appear to be irreversibly altered by chronic exposure to##2##11##(1991-4#2)
do not appear to be##13##5##(1991-2#1)(1991-4#2)(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
do not appear to have a##2##6##(2006-8#1)(2008-12#1)
do not appear to##20##4##(1991-2#1)(1991-4#2)(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)
do not appear##22##3##(1991-2#1)(1991-4#2)(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)
do not bear##2##3##(2008-1#1)(2009-4#1)
do not become##2##3##(2008-11#1)(2008-7#1)
do not believe##2##3##(2008-12#1)(2010-8#1)
do not bind##3##3##(1995-2#1)(1995-5#1)(2008-10#1)
do not carry the##2##4##(1991-3#1)(2008-7#1)
do not carry##4##3##(1991-3#1)(1994-8#1)(2008-5#1)(2008-7#1)
do not cause##4##3##(1990-11#1)(2007-11#1)(2008-10#2)
do not change##7##3##(1993-11#1)(1994-8#1)(1995-2#2)(2007-12#1)(2008-5#2)
do not clearly##2##3##(1996-1#1)(2013-8#1)
do not completely##2##3##(1992-4#1)(2010-4#1)
do not comply with##2##4##(1996-3#1)(2008-7#1)
do not confirm##3##3##(1991-8#1)(2008-6#1)(2008-7#1)
do not conform to##2##4##(2008-3#1)(2011-2#1)
do not consider##3##3##(1990-10#1)(2008-10#1)(2008-8#1)
do not consistently##2##3##(2008-10#1)(2013-1#1)
do not constitute##2##3##(2008-10#1)(2011-2#1)
do not contain any##2##4##(1993-12#1)(2008-11#1)
do not contain the##2##4##(1992-3#1)(2008-10#1)
do not contain##12##3##(1990-8#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
do not contribute to##5##4##(1994-12#1)(1994-6#1)(1995-11#1)(2008-3#1)(2009-8#1)
do not contribute##6##3##(1994-12#1)(1994-6#1)(1995-11#1)(2008-11#1)(2008-3#1)(2009-8#1)
do not correlate##2##3##(1994-2#1)(1995-11#1)
do not correspond to##3##4##(1997-3#1)(2008-10#1)(2008-9#1)
do not correspond##4##3##(1997-3#1)(2008-10#1)(2008-9#1)(2010-8#1)
do not cover##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
do not cross-react with##2##4##(1995-11#1)(2008-4#1)
do not depend on the##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
do not depend on##4##4##(1993-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
do not depend##5##3##(1993-12#1)(2008-2#1)(2008-3#1)(2008-7#2)
do not differ between##4##4##(1991-11#1)(1992-1#1)(2008-8#1)(2012-12#1)
do not differ in##2##4##(2008-10#1)(2013-8#1)
do not differ significantly##3##4##(1992-8#1)(2008-8#1)(2010-3#1)
do not differ##10##3##(1991-11#1)(1992-1#1)(1992-8#1)(2008-10#1)(2008-8#2)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
do not directly##3##3##(1997-2#1)(1997-4#1)(2008-7#1)
do not discriminate##2##3##(1990-12#1)(2008-8#1)
do not distinguish between##2##4##(2008-11#1)(2011-2#1)
do not do##2##3##(1995-11#1)(2013-8#1)
do not engage in##2##4##(2007-6#1)(2008-11#1)
do not engage##3##3##(2007-6#1)(2008-11#1)(2013-8#1)
do not enter the##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
do not establish##2##3##(1993-12#1)(2013-1#1)
do not exceed##4##3##(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
do not exhibit##8##3##(1990-8#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)
do not exist in the##2##5##(1997-3#1)(2007-12#1)
do not exist in##6##4##(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
do not exist##11##3##(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
do not explain the##2##4##(1996-12#1)(2009-7#1)
do not explicitly##2##3##(1996-1#1)(2011-2#1)
do not express##3##3##(1994-2#1)(2008-8#2)
do not facilitate##2##3##(1995-12#1)(2007-10#1)
do not fit the##3##4##(1991-3#1)(2008-10#1)(2008-3#1)
do not fit##4##3##(1991-3#1)(1993-6#1)(2008-10#1)(2008-3#1)
do not follow##5##3##(1992-5#1)(1994-9#1)(1997-4#1)(2009-11#1)(2009-4#1)
do not form a##3##4##(2008-10#2)(2010-3#1)
do not form complexes##2##4##(2008-10#2)
do not form##8##3##(1995-8#1)(2008-10#5)(2008-9#1)(2010-3#1)
do not fully##4##3##(1991-5#1)(2008-10#1)(2010-9#1)(2011-3#1)
do not function##2##3##(2011-2#1)(2012-12#1)
do not get##2##3##(2008-12#1)(2013-1#1)
do not give##5##3##(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
do not have a##10##4##(1993-8#1)(2008-11#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
do not have an##5##4##(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
do not have such##2##4##(2009-2#1)(2012-2#1)
do not have the same##2##5##(1992-12#1)(1992-9#1)
do not have the##7##4##(1992-12#1)(1992-9#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)
do not have to##2##4##(2008-10#1)(2008-5#1)
do not have##42##3##(1991-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)
do not help##2##3##(1996-12#1)(2008-8#1)
do not hold##2##3##(1990-8#1)(2008-11#1)
do not impair the##2##4##(1991-8#1)(2011-2#1)
do not include##4##3##(1995-1#1)(2007-12#1)(2008-2#1)(2010-10#1)
do not increase##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
do not indicate##3##3##(1992-3#1)(1997-3#1)(2008-4#1)
do not induce##4##3##(1996-2#1)(1997-4#1)(2008-10#1)(2008-8#1)
do not influence the##3##4##(1994-2#1)(2009-10#1)(2012-2#1)
do not influence##5##3##(1994-2#1)(2008-10#2)(2009-10#1)(2012-2#1)
do not inhibit##2##3##(1992-9#1)(1994-11#1)
do not interact##5##3##(1992-6#1)(1994-11#1)(1994-5#1)(1996-2#1)(2010-12#1)
do not interfere in the determination##2##6##(2008-10#2)
do not interfere in the proposed##3##6##(2008-10#3)
do not interfere in the working of the electrode##2##9##(2008-10#2)
do not interfere in the##8##5##(2008-10#8)
do not interfere in##9##4##(2008-10#9)
do not interfere the##2##4##(2008-10#2)
do not interfere with the determination of##2##7##(2008-10#2)
do not interfere with the determination##5##6##(2008-10#5)
do not interfere with the##7##5##(1993-2#1)(2008-10#6)
do not interfere with##11##4##(1993-2#1)(1996-6#1)(2008-10#8)(2008-11#1)
do not interfere##31##3##(1993-2#1)(1996-6#1)(2008-10#28)(2008-11#1)
do not involve##8##3##(1992-4#1)(1992-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
do not know if##2##4##(1991-3#1)(2008-10#1)
do not know##10##3##(1990-6#1)(1991-3#2)(1993-3#1)(1994-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)
do not lie##2##3##(1995-6#1)(2008-7#1)
do not make full use of the##2##7##(2008-8#1)(2013-8#1)
do not make##3##3##(1996-5#1)(2008-8#1)(2013-8#1)
do not match with##2##4##(1990-2#1)(1993-11#1)
do not meet##3##3##(1996-12#1)(1996-9#1)(2008-3#1)
do not necessarily##9##3##(1991-9#1)(1996-2#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
do not need glucocorticoid##2##4##(2008-1#2)
do not need to be##5##5##(1991-11#1)(1996-11#1)(2008-10#2)(2008-11#1)
do not need to##7##4##(1991-11#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-7#2)
do not need##15##3##(1991-11#1)(1994-3#1)(1996-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2013-7#1)
do not normally##3##3##(2008-1#1)(2008-11#1)(2008-9#1)
do not occur in##3##4##(2007-12#1)(2013-1#2)
do not occur##6##3##(1992-4#1)(1996-4#1)(1996-5#1)(2007-12#1)(2013-1#2)
do not or##2##3##(2008-10#1)(2011-2#1)
do not overlap##4##3##(1993-11#1)(2008-3#1)(2008-6#2)
do not place##2##3##(2008-11#1)(2009-7#1)
do not play a major role in##3##7##(2008-4#1)(2008-7#1)(2009-8#1)
do not play##4##3##(1992-3#1)(2008-4#1)(2008-7#1)(2009-8#1)
do not predict##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
do not produce any detectable##2##5##(1992-9#1)(1995-2#1)
do not produce##6##3##(1990-12#1)(1992-9#1)(1995-2#2)(2007-11#1)(2008-10#1)
do not prolong the##2##4##(2007-11#1)(2008-1#1)
do not provide a resolution##2##5##(1997-2#2)
do not provide a##3##4##(1990-3#1)(1997-2#2)
do not provide information##2##4##(1995-2#1)(2008-4#1)
do not provide long-term##2##4##(2008-3#2)
do not provide##16##3##(1990-11#1)(1990-3#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-2#1)(1997-2#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)
do not react##2##3##(1996-2#1)(2008-10#1)
do not receive##3##3##(2008-6#1)(2008-7#1)(2009-6#1)
do not recommend##2##3##(1996-6#1)(2012-3#1)
do not reduce##3##3##(1990-2#1)(1991-12#1)(2008-10#1)
do not reflect the##2##4##(2008-5#1)(2008-7#1)
do not reflect##4##3##(1996-6#1)(2008-5#1)(2008-7#1)(2009-8#1)
do not relate to##2##4##(1992-9#1)(2008-7#1)
do not release##2##3##(1990-11#2)
do not represent a##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
do not represent an##2##4##(2008-2#1)(2010-11#1)
do not represent the##2##4##(2008-10#1)(2008-2#1)
do not represent##11##3##(1992-5#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#1)(2010-11#1)(2010-3#1)
do not require any separation step##2##6##(2008-10#2)
do not require any##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
do not require the##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
do not require##25##3##(1991-9#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
do not resolve##2##3##(2007-11#1)(2011-1#1)
do not respond to##11##4##(1991-11#1)(1992-3#1)(1993-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)
do not respond##12##3##(1991-11#1)(1992-3#1)(1993-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)
do not result in##4##4##(1992-3#1)(2008-10#2)(2008-4#1)
do not result##5##3##(1992-3#1)(1996-5#1)(2008-10#2)(2008-4#1)
do not rule out the##2##5##(1990-10#1)(2011-2#1)
do not rule out##3##4##(1990-10#1)(2008-10#1)(2011-2#1)
do not see##2##3##(1990-6#1)(2008-12#1)
do not seem to be##7##5##(1991-6#1)(1994-9#1)(1995-2#1)(2007-4#1)(2009-11#1)(2011-2#1)(2012-3#1)
do not seem to have##3##5##(1992-6#1)(2008-10#1)(2009-6#1)
do not seem to##13##4##(1991-6#1)(1992-6#1)(1994-9#1)(1995-2#1)(2007-4#1)(2008-10#2)(2009-11#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
do not share the##2##4##(1994-2#1)(2013-8#1)
do not share##4##3##(1994-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
do not show any##4##4##(1990-6#1)(1997-4#1)(2008-10#2)
do not show significant##3##4##(1997-3#1)(2008-10#2)
do not show##17##3##(1990-6#1)(1992-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
do not significantly##2##3##(1991-2#1)(2008-3#1)
do not suggest##3##3##(1990-12#1)(1990-6#1)(2009-4#1)
do not support a##3##4##(1991-6#1)(2007-12#1)(2012-2#1)
do not support an association##2##5##(2008-11#1)(2011-2#1)
do not support an##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
do not support the hypothesis##2##5##(1991-12#1)(2008-7#1)
do not support the##12##4##(1990-2#1)(1991-12#1)(1992-11#1)(1993-11#1)(1997-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2013-8#1)
do not support##23##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-11#1)(1997-5#2)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
do not survive##2##3##(2009-5#1)(2011-2#1)
do not take into account##2##5##(2009-4#1)(2011-2#1)
do not take into##3##4##(2009-3#1)(2009-4#1)(2011-2#1)
do not take##4##3##(2008-10#1)(2009-3#1)(2009-4#1)(2011-2#1)
do not undergo##2##3##(1992-8#1)(1996-12#1)
do not use##4##3##(1992-9#1)(1996-1#1)(2008-11#1)(2010-8#1)
do not usually##3##3##(1992-9#1)(1993-1#1)(2008-9#1)
do not vary with##3##4##(1995-2#1)(2008-11#1)(2008-9#1)
do not vary##7##3##(1995-2#1)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)
do not want to##3##4##(1994-7#1)(1996-8#1)(2012-3#1)
do not work##2##3##(2007-11#1)(2008-5#1)
do not yet exist##2##4##(1995-2#1)(2008-11#1)
do not yet##4##3##(1994-2#1)(1995-2#1)(2008-11#1)(2008-8#1)
do not yield the##2##4##(2008-10#2)
do not##787##2##(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#5)(1990-8#4)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#8)(1993-1#1)(1993-11#5)(1993-12#10)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#10)(1994-3#7)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-11#7)(1995-12#2)(1995-2#16)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#2)(1996-1#5)(1996-11#1)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#10)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#9)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#3)(2006-10#2)(2006-8#1)(2007-10#3)(2007-11#9)(2007-12#14)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#11)(2008-10#120)(2008-11#21)(2008-12#9)(2008-2#6)(2008-3#19)(2008-4#17)(2008-5#18)(2008-6#7)(2008-7#35)(2008-8#22)(2008-9#22)(2009-10#3)(2009-11#5)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#3)(2009-6#3)(2009-7#6)(2009-8#6)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#25)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#15)(2012-3#9)(2013-1#20)(2013-7#2)(2013-8#11)
do occur##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
do or do not##2##4##(1996-5#1)(2008-11#1)
do other##2##2##(2008-10#1)(2008-7#1)
do our beneficiaries##2##3##(1997-3#2)
do parents##3##2##(1996-1#1)(2008-11#1)(2013-1#1)
do patients##3##2##(1991-11#1)(2007-9#1)(2012-12#1)
do people##4##2##(1991-9#1)(1993-2#1)(2008-8#1)(2009-6#1)
do poorly##2##2##(2008-5#1)(2012-3#1)
do possess##2##2##(1992-3#1)(1994-8#1)
do provide##2##2##(1993-11#1)(2010-11#1)
do respond##2##2##(1995-3#1)(1997-6#1)
do show a##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
do show##7##2##(1996-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#2)
do so at##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
do so by##3##3##(1991-7#1)(2008-11#1)(2008-3#1)
do so in##3##3##(1997-1#1)(2008-10#1)(2008-7#1)
do so##34##2##(1991-12#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
do some##2##2##(1991-12#1)(1997-6#1)
do that##2##2##(1991-1#1)(1994-3#1)
do the right##2##3##(1991-2#1)(2009-11#1)
do the##25##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-3#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
do their##4##2##(1997-3#1)(2008-11#1)(2012-12#1)(2013-8#1)
do these##4##2##(1991-12#1)(1996-9#1)(1997-2#1)(2012-12#1)
do they work?##2##3##(1994-3#1)(1997-3#1)
do they##13##2##(1990-3#1)(1994-12#1)(1994-3#3)(1997-3#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-11#1)
do things##4##2##(1994-1#1)(1994-12#1)(1996-3#2)
do this##10##2##(1992-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
do those of##2##3##(1995-8#1)(2008-10#1)
do those##3##2##(1994-3#1)(1995-8#1)(2008-10#1)
do to##9##2##(1990-11#1)(1991-3#2)(2007-12#1)(2008-11#1)(2008-12#2)(2008-6#1)(2012-12#1)
do we go from here?##2##5##(2008-11#1)(2008-8#1)
do we have##2##3##(1993-2#1)(2008-10#1)
do we know about##2##4##(1995-5#1)(2008-12#1)
do we know##3##3##(1995-5#1)(2008-12#1)(2013-1#1)
do we know?##2##3##(2007-12#1)(2008-1#1)
do we stand?##2##3##(2008-7#1)(2012-12#1)
do we##21##2##(1991-6#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
do well##4##2##(1991-11#1)(1996-1#1)(2008-8#1)(2013-8#1)
do what##2##2##(1991-9#1)(1995-2#1)
do with the##4##3##(1997-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
do with##13##2##(1991-1#1)(1994-3#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-12#1)
do you know##2##3##(2008-12#1)(2008-9#1)
do you want to be?##2##5##(1994-3#1)(2012-3#1)
do you##18##2##(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-12#1)(2008-4#2)(2008-9#1)(2012-3#1)(2013-1#2)
do young##3##2##(2010-2#1)(2011-2#1)(2012-1#1)
do##1301##1##(1990-10#3)(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#3)(1990-5#2)(1990-6#5)(1990-8#5)(1990-9#3)(1991-1#4)(1991-11#6)(1991-12#16)(1991-2#5)(1991-3#9)(1991-4#2)(1991-5#1)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#7)(1992-2#2)(1992-3#14)(1992-4#3)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#11)(1993-1#3)(1993-11#6)(1993-12#14)(1993-2#5)(1993-3#6)(1993-6#10)(1993-8#4)(1994-1#6)(1994-11#2)(1994-12#7)(1994-2#14)(1994-3#23)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#9)(1995-11#8)(1995-12#6)(1995-2#21)(1995-3#6)(1995-5#9)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#8)(1996-10#1)(1996-11#1)(1996-12#11)(1996-2#9)(1996-3#15)(1996-4#4)(1996-5#11)(1996-6#5)(1996-8#1)(1996-9#4)(1997-1#10)(1997-2#11)(1997-3#16)(1997-4#6)(1997-5#7)(1997-6#6)(1997-7#5)(1997-8#4)(2006-10#3)(2006-8#1)(2007-10#7)(2007-11#16)(2007-12#26)(2007-2#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#16)(2008-10#141)(2008-11#42)(2008-12#18)(2008-2#9)(2008-3#27)(2008-4#27)(2008-5#29)(2008-6#13)(2008-7#53)(2008-8#44)(2008-9#45)(2009-10#6)(2009-11#8)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#6)(2009-5#8)(2009-6#6)(2009-7#12)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#8)(2010-12#9)(2010-2#3)(2010-3#8)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#9)(2010-9#4)(2011-1#4)(2011-2#43)(2011-3#1)(2012-1#3)(2012-12#18)(2012-2#23)(2012-3#13)(2012-6#1)(2013-1#37)(2013-7#10)(2013-8#17)
do?##8##1##(1994-12#1)(1994-5#1)(1997-6#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
dobesilate##3##1##(1990-3#3)
dobutamine echocardiography##2##2##(2008-11#1)(2009-4#1)
dobutamine stress##2##2##(1994-11#1)(2009-10#1)
dobutamine##12##1##(1994-11#3)(1996-2#4)(2007-7#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-4#1)
docetaxel and cisplatin with##2##4##(2008-10#2)
docetaxel and cisplatin##4##3##(2008-10#4)
docetaxel in##3##2##(2008-10#1)(2008-6#2)
docetaxel##17##1##(2008-10#8)(2008-6#5)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
docked##9##1##(1992-9#2)(1997-7#5)(2012-2#2)
docking and fusion##2##3##(1997-1#1)(2008-11#1)
docking and##4##2##(1997-1#1)(1997-7#1)(2008-11#1)(2012-2#1)
docking approach##2##2##(2013-7#1)(2013-8#1)
docking of##3##2##(1995-2#2)(2013-7#1)
docking sites for##2##3##(1995-6#1)(1996-2#1)
docking sites##3##2##(1995-6#1)(1996-2#1)(1997-7#1)
docking studies of##2##3##(2012-3#1)(2013-7#1)
docking studies##4##2##(2012-3#1)(2013-1#1)(2013-7#2)
docking study of##2##3##(2012-2#2)
docking study##3##2##(2012-12#1)(2012-2#2)
docking##39##1##(1990-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1995-2#7)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#5)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#1)
docks##2##1##(2009-7#1)(2012-12#1)
docosahexaenoic acid (DHA) in##2##4##(2010-1#1)(2012-1#1)
docosahexaenoic acid (DHA)##5##3##(2008-3#1)(2010-1#1)(2010-2#1)(2012-1#1)(2013-1#1)
docosahexaenoic acid##9##2##(1996-7#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2012-1#1)(2013-1#2)
docosahexaenoic##12##1##(1990-5#1)(1996-7#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
docs##4##1##(1992-8#1)(1997-3#2)(2010-9#1)
doctor and a##3##3##(1992-5#1)(2010-12#1)(2013-8#1)
doctor and##13##2##(1992-5#1)(1993-11#1)(1993-12#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-12#1)(2010-12#1)(2011-1#3)(2013-1#1)(2013-8#1)
doctor dispensing##2##2##(2010-5#2)
doctor has##4##2##(1996-8#1)(2008-10#1)(2008-4#1)(2010-12#1)
doctor in the##4##3##(1990-6#1)(2009-3#2)(2011-2#1)
doctor in##7##2##(1990-6#1)(1997-4#1)(2008-2#1)(2009-3#2)(2011-2#2)
doctor or##4##2##(1997-2#1)(2009-5#2)(2013-1#1)
doctor visits##2##2##(2008-11#1)(2013-1#1)
doctor##81##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2010-12#5)(2010-5#3)(2010-9#3)(2011-1#4)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
doctor's office##3##2##(1996-11#1)(2009-5#2)
doctor's role##5##2##(1992-6#4)(1993-12#1)
doctor's##14##1##(1992-6#4)(1993-10#1)(1993-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(2007-2#1)(2008-7#1)(2009-5#2)(2013-1#1)
doctor-diagnosed asthma##2##2##(2010-6#1)(2012-1#1)
doctor-patient##7##1##(1992-12#2)(1997-6#3)(2011-2#2)
doctoral##3##1##(1994-12#1)(2008-8#1)(2009-4#1)
doctorates in##2##2##(2013-8#2)
doctorates##5##1##(1993-6#1)(2013-8#4)
doctors and nurses##3##3##(1995-3#1)(1997-1#1)(2008-12#1)
doctors and patients##4##3##(1996-11#1)(2008-8#2)(2013-1#1)
doctors and##19##2##(1994-7#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
doctors are not##2##3##(1995-6#1)(1997-5#1)
doctors are##8##2##(1995-6#2)(1996-8#1)(1997-5#2)(2009-6#1)(2010-12#2)
doctors did##2##2##(1997-4#1)(2010-12#1)
doctors for##3##2##(1990-12#1)(1990-6#1)(1995-6#1)
doctors from##5##2##(1992-2#2)(1992-5#1)(1994-12#1)(1996-3#1)
doctors had##4##2##(1991-8#1)(1993-11#1)(1994-12#1)(1996-6#1)
doctors have##3##2##(1991-4#1)(1993-6#1)(2008-11#1)
doctors in the##4##3##(1991-8#2)(1997-8#1)(2008-5#1)
doctors in##17##2##(1991-4#1)(1991-8#5)(1993-3#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
doctors is##2##2##(1991-2#1)(1996-11#1)
doctors of##2##2##(1990-3#1)(1991-2#1)
doctors on##3##2##(1995-2#1)(1996-3#1)(2008-11#1)
doctors seemed##2##2##(1995-5#1)(2011-2#1)
doctors to##6##2##(1993-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2009-10#1)(2012-2#1)
doctors towards##2##2##(1990-6#1)(1996-6#1)
doctors were##2##2##(1990-9#1)(2008-10#1)
doctors who were##2##3##(2008-10#1)(2011-2#1)
doctors who##7##2##(1992-11#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
doctors with##2##2##(1992-4#1)(2008-8#1)
doctors##201##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-6#3)(1990-9#4)(1991-2#5)(1991-4#2)(1991-6#3)(1991-8#8)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#4)(1994-12#3)(1994-6#3)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#7)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#3)(1996-6#5)(1996-8#5)(1997-1#2)(1997-3#2)(1997-4#2)(1997-5#7)(1997-6#4)(1997-8#6)(2007-10#2)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#10)(2008-8#5)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#7)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#1)
doctors'##17##1##(1990-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-6#1)(1997-5#1)(1997-6#1)(1997-8#4)(2006-10#1)(2008-7#1)(2010-12#1)(2011-2#2)
doctrine of double effect##3##4##(2012-2#3)
doctrine of##6##2##(1991-3#2)(1994-3#1)(2012-2#3)
doctrine##12##1##(1991-12#1)(1991-2#1)(1991-3#2)(1993-1#2)(1994-3#3)(2012-2#3)
document a##5##2##(1994-8#1)(2007-9#1)(2008-2#1)(2010-12#1)(2012-3#1)
document analysis##3##2##(2008-11#1)(2010-3#1)(2011-2#1)
document and##3##2##(1995-3#1)(2008-10#2)
document for the##2##3##(2012-12#1)(2013-8#1)
document for##5##2##(1992-2#1)(2007-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
document is##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
document levels of##2##3##(1991-2#1)(1997-1#1)
document that##3##2##(2008-10#2)(2008-11#1)
document the##23##2##(1994-3#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-7#1)
document their##2##2##(1995-2#1)(2007-8#1)
document to##2##2##(2007-12#1)(2008-10#1)
document was##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
document##107##1##(1991-2#1)(1992-12#2)(1992-2#2)(1992-3#2)(1993-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#16)(2008-11#9)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
documental##2##1##(2009-10#2)
documentary##4##1##(2008-7#2)(2010-3#1)(2011-2#1)
documentation and##11##2##(1991-1#1)(1992-12#1)(1994-12#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)
documentation for##3##2##(1992-4#1)(2007-2#1)(2008-12#1)
documentation in##2##2##(1995-5#1)(2007-2#1)
documentation of a##4##3##(1995-12#1)(2007-11#1)(2010-12#1)(2013-1#1)
documentation of an##2##3##(1997-3#1)(1997-4#1)
documentation of quality##2##3##(1993-12#1)(1994-2#1)
documentation of the##6##3##(1991-12#1)(1997-3#2)(2008-3#1)(2008-7#1)(2008-8#1)
documentation of this##2##3##(2008-10#1)(2013-1#1)
documentation of##29##2##(1990-8#1)(1991-12#2)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)
documentation on##2##2##(1993-6#1)(2008-3#1)
documentation that##2##2##(1995-12#1)(1995-6#1)
documentation to##2##2##(1992-11#1)(2010-8#1)
documentation##93##1##(1990-8#1)(1991-1#2)(1991-12#3)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#3)(1997-8#1)(2007-10#3)(2007-11#2)(2007-2#3)(2007-4#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#4)(2008-7#4)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#6)
documentations##3##1##(2007-11#2)(2012-2#1)
documented a##3##2##(2007-12#1)(2008-6#1)(2013-1#1)
documented ability##2##2##(1993-11#1)(1994-11#1)
documented according##2##2##(1991-12#1)(1991-3#1)
documented and the##2##3##(1990-7#1)(2008-11#1)
documented and##12##2##(1990-7#1)(1994-12#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2009-12#1)(2009-6#1)(2011-2#1)
documented as##6##2##(1996-8#1)(2008-11#1)(2008-12#2)(2011-7#1)(2012-12#1)
documented by a##3##3##(1996-11#1)(1996-2#1)(2008-7#1)
documented by the##2##3##(2007-11#1)(2008-11#1)
documented by##18##2##(1991-11#1)(1993-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2011-1#1)(2012-2#1)(2013-1#2)
documented case in##2##3##(2008-9#1)(2010-1#1)
documented case##5##2##(2008-9#1)(2009-4#1)(2010-1#1)(2012-2#1)(2013-1#1)
documented cases of##4##3##(1996-5#1)(2008-5#1)(2009-7#1)(2013-1#1)
documented cases##8##2##(1992-11#1)(1996-5#2)(2008-5#1)(2008-6#1)(2009-7#1)(2013-1#2)
documented coronary artery disease##2##4##(1993-12#1)(2008-11#1)
documented during##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
documented effect on##2##3##(1993-2#1)(1995-5#1)
documented effect##3##2##(1993-2#1)(1995-5#1)(1997-6#1)
documented for the##2##3##(2007-12#1)(2008-6#1)
documented for##6##2##(1996-5#1)(2007-12#1)(2008-6#1)(2010-11#1)(2010-3#1)(2013-1#1)
documented from##2##2##(2007-7#1)(2008-10#1)
documented here##2##2##(1993-2#1)(2013-1#1)
documented in adults##2##3##(2008-12#1)(2012-2#1)
documented in several##2##3##(1996-6#1)(2013-1#1)
documented in the##5##3##(1994-8#1)(1997-8#1)(2008-12#1)(2008-6#1)(2010-3#1)
documented in this##4##3##(1994-1#2)(1997-4#1)(2012-2#1)
documented in two##2##3##(2008-5#1)(2008-8#1)
documented in##42##2##(1991-4#1)(1991-7#1)(1992-3#1)(1994-1#2)(1994-8#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#6)(2013-1#3)
documented myocardial##2##2##(1990-3#1)(2008-11#1)
documented or##2##2##(1995-6#1)(2008-9#1)
documented that the##3##3##(1990-12#1)(1992-1#1)(1995-6#1)
documented that##13##2##(1990-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#2)
documented the##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2013-1#1)
documented to be##2##3##(1992-3#1)(2013-8#1)
documented to##4##2##(1992-3#1)(2008-10#1)(2013-7#1)(2013-8#1)
documented##285##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-11#2)(1993-12#2)(1993-2#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#3)(1997-4#4)(1997-6#3)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#19)(2008-12#11)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#14)(2008-8#5)(2008-9#9)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#14)(2012-3#3)(2013-1#17)(2013-7#3)(2013-8#4)
documenting the##4##2##(1991-8#1)(2008-9#1)(2009-11#1)(2009-5#1)
documenting##21##1##(1991-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
documents and##6##2##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
documents how##2##2##(2008-4#1)(2011-2#1)
documents in##2##2##(2010-8#1)(2012-2#1)
documents that can be##3##4##(1994-3#2)(2012-12#1)
documents that##6##2##(1994-3#2)(1996-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
documents the need##2##3##(1996-12#1)(2008-11#1)
documents the##8##2##(1994-2#1)(1996-12#1)(2007-5#1)(2008-11#2)(2008-6#1)(2012-12#1)(2012-3#1)
documents##67##1##(1990-5#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-3#4)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#1)(2007-5#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
dodecamer##6##1##(1990-7#1)(1995-3#2)(2008-7#2)(2010-8#1)
dodecamers##2##1##(1994-11#1)(2010-8#1)
dodecane##4##1##(1997-2#1)(2008-10#3)
dodecapeptide##5##1##(1992-12#1)(1994-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
dodecaurelia##4##1##(2008-12#4)
dodecyl benzene sulfonate##3##3##(2008-10#3)
dodecyl sulfate (SDS)##23##3##(1990-11#1)(1994-9#2)(1995-5#1)(1996-5#1)(2008-10#15)(2008-2#1)(2008-4#1)(2012-2#1)
dodecyl sulfate and##5##3##(1990-11#2)(1995-5#1)(1996-12#1)(2008-10#1)
dodecyl sulfate##62##2##(1990-10#1)(1990-11#8)(1990-5#1)(1990-7#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#1)(1994-9#2)(1995-5#2)(1996-12#1)(1996-5#3)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#2)(2008-4#2)(2010-11#1)(2012-2#2)
dodecyl sulfate-polyacrylamide gel electrophoresis analysis##3##5##(2008-10#3)
dodecyl sulfate-polyacrylamide gel electrophoresis of##5##5##(2008-10#5)
dodecyl sulfate-polyacrylamide gel electrophoresis##23##4##(1990-10#1)(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(2008-10#15)(2008-11#1)(2010-2#1)
dodecyl sulfate-polyacrylamide gel##24##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#2)(2008-10#15)(2008-11#1)(2010-2#1)
dodecyl sulphate (SDS)##5##3##(1994-9#1)(2008-10#3)(2008-5#1)
dodecyl sulphate##10##2##(1993-3#1)(1994-9#1)(2008-10#6)(2008-5#2)
dodecyl##118##1##(1990-10#2)(1990-11#9)(1990-5#3)(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-9#3)(1995-5#2)(1996-12#1)(1996-5#4)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#60)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#2)
dodecylamine-N##2##1##(2008-10#2)
dodecylbenzenesulfonate##2##1##(2008-10#2)
dodecylbenzenesulfonic acid##2##2##(2008-10#2)
dodecylpyridinium chloride##2##2##(2008-10#2)
dodecylpyridinium##3##1##(2008-10#3)
dodecylsulfate and##2##2##(1991-12#1)(2008-10#1)
dodecylsulfate##17##1##(1991-12#1)(2008-10#14)(2008-5#1)(2013-8#1)
dodecylsulphate##2##1##(2008-10#2)
dodecyltrimethylammonium##2##1##(2008-10#2)
dodine##4##1##(2008-10#4)
does a##6##2##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)
does affect the##2##3##(1991-12#1)(1992-3#1)
does affect##3##2##(1991-12#1)(1992-3#1)(2008-2#1)
does an##2##2##(2012-3#1)(2013-1#1)
does appear to be##2##4##(1995-6#1)(2012-3#1)
does appear##3##2##(1995-6#1)(2012-1#1)(2012-3#1)
does contain##2##2##(1993-6#1)(2008-9#1)
does exist in##2##3##(2008-3#1)(2008-9#1)
does exist##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
does for##3##2##(2008-3#2)(2008-8#1)
does have##2##2##(1995-12#1)(2007-2#1)
does human##2##2##(1992-6#1)(2012-2#1)
does in fact##3##3##(1990-5#1)(2009-4#1)(2010-11#1)
does in##6##2##(1990-5#1)(1991-12#1)(1991-2#1)(2009-4#1)(2010-10#1)(2010-11#1)
does indeed##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
does it affect##3##3##(1993-2#1)(1994-9#1)(1995-12#1)
does it appear to##2##4##(1994-12#1)(2008-10#1)
does it change##2##3##(2008-11#1)(2011-2#1)
does it take to##2##4##(1997-3#1)(2008-8#1)
does it##29##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#4)(2013-8#1)
does not account for##2##4##(1994-3#1)(2013-1#1)
does not act as an##2##5##(1995-6#1)(2008-2#1)
does not act as##3##4##(1993-8#1)(1995-6#1)(2008-2#1)
does not act##5##3##(1990-7#2)(1993-8#1)(1995-6#1)(2008-2#1)
does not address##2##3##(2008-10#1)(2009-5#1)
does not adversely affect##2##4##(1991-1#1)(2010-11#1)
does not affect the activity of##2##6##(1990-2#1)(1992-3#1)
does not affect the##20##4##(1990-2#1)(1991-12#2)(1992-3#1)(1993-11#3)(1994-5#2)(1995-8#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
does not affect##37##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#1)(1992-3#1)(1993-11#4)(1993-3#1)(1994-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
does not allow for##4##4##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
does not allow us to##2##5##(2008-6#1)(2008-8#1)
does not allow##13##3##(1990-9#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-5#1)(2013-1#1)
does not alter the##11##4##(1991-8#1)(1991-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-7#1)(2008-2#1)(2008-3#1)(2010-9#1)(2011-2#2)
does not alter##14##3##(1991-8#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)(2011-2#2)
does not always correlate##2##4##(2008-1#1)(2008-10#1)
does not always follow##2##4##(1995-2#1)(1997-3#1)
does not always provide##2##4##(2008-12#1)(2011-1#1)
does not always##14##3##(1990-11#1)(1995-2#1)(1995-4#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-8#1)(2011-1#1)
does not appear to affect##2##5##(1994-3#1)(2008-7#1)
does not appear to be a##3##6##(2008-10#1)(2008-3#2)
does not appear to be affected##2##6##(1996-3#1)(2013-1#1)
does not appear to be involved##2##6##(1992-3#1)(2008-10#1)
does not appear to be##19##5##(1991-6#1)(1992-3#1)(1994-3#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-1#3)
does not appear to influence##2##5##(1996-2#1)(2008-11#1)
does not appear to preferentially##2##5##(1997-1#1)(2013-1#1)
does not appear to##33##4##(1991-6#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2012-2#1)(2013-1#4)
does not appear##35##3##(1991-6#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2010-10#1)(2012-2#1)(2013-1#4)
does not apply to##4##4##(1995-12#2)(1997-5#1)(2008-2#1)
does not apply##7##3##(1994-12#1)(1995-12#2)(1997-5#1)(2008-2#1)(2008-3#1)(2009-12#1)
does not become##2##3##(1997-2#1)(2008-10#1)
does not bind##8##3##(1990-8#1)(1994-11#2)(1994-12#1)(1996-2#1)(1996-5#1)(1997-3#2)
does not block##3##3##(1994-2#1)(1995-6#1)(1996-2#1)
does not carry##2##3##(1995-12#1)(1997-6#1)
does not cause symptoms##2##4##(2008-10#2)
does not cause##12##3##(1991-5#1)(1994-5#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#1)
does not change the##8##4##(1993-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
does not change with##3##4##(1994-2#1)(2008-10#1)(2008-8#1)
does not change##16##3##(1991-12#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#2)(2010-4#1)
does not combine##2##3##(1992-3#1)(2007-8#1)
does not come##2##3##(1996-2#1)(2012-12#1)
does not completely##2##3##(1994-2#1)(2012-3#1)
does not confer##2##3##(1994-9#1)(2009-6#1)
does not conform to##2##4##(1995-8#1)(2008-10#1)
does not constitute##2##3##(1997-5#1)(2010-10#1)
does not contain any##2##4##(1992-6#1)(2011-1#1)
does not contain##12##3##(1991-6#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
does not contribute##3##3##(1991-12#1)(1997-7#1)(2008-2#1)
does not correlate with##2##4##(1991-5#1)(1996-5#1)
does not correlate##3##3##(1991-5#1)(1993-3#1)(1996-5#1)
does not correspond to##2##4##(2008-3#2)
does not decrease##2##3##(1990-12#1)(2008-8#1)
does not depend on the##4##5##(1992-12#1)(1993-3#1)(2008-3#1)(2008-8#1)
does not depend on##13##4##(1992-12#1)(1993-3#1)(1995-2#2)(1995-3#1)(1995-6#1)(2008-11#1)(2008-3#4)(2008-8#1)(2008-9#1)
does not depend##17##3##(1991-12#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#2)(1995-3#1)(1995-6#1)(2008-11#1)(2008-3#4)(2008-8#2)(2008-9#1)
does not differ from that##2##5##(1994-3#1)(2011-2#1)
does not differ##5##3##(1994-3#1)(2008-10#2)(2011-2#1)(2012-2#1)
does not differentiate##2##3##(1995-12#1)(2008-11#1)
does not diminish##3##3##(1993-6#1)(1994-3#1)(2008-8#1)
does not disturb##2##3##(2007-12#1)(2008-10#1)
does not enhance##2##3##(1990-6#1)(1993-8#1)
does not ensure##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
does not entail##2##3##(1993-6#1)(2008-6#1)
does not enter the##2##4##(2008-3#1)(2008-5#1)
does not equal##2##3##(2007-11#1)(2008-8#1)
does not exceed##6##3##(1996-12#1)(1996-3#1)(2008-10#3)(2008-5#1)
does not exclude the possibility of##2##6##(2008-4#1)(2011-1#1)
does not exclude##3##3##(1997-3#1)(2008-4#1)(2011-1#1)
does not exist##4##3##(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
does not explain the##2##4##(1990-6#1)(1997-8#1)
does not express##2##3##(1996-5#1)(2008-10#1)
does not find##2##3##(2007-11#1)(2011-2#1)
does not fit##2##3##(1997-4#1)(2007-12#1)
does not follow##2##3##(1992-3#1)(2008-3#1)
does not form a##3##4##(1994-8#1)(2008-2#1)(2008-5#1)
does not form##6##3##(1990-5#1)(1991-2#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-5#1)
does not fully##2##3##(2012-2#1)(2013-8#1)
does not generate##2##3##(2007-12#1)(2008-11#1)
does not give a##2##4##(1995-12#1)(2008-10#1)
does not give##3##3##(1994-6#1)(1995-12#1)(2008-10#1)
does not grow##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
does not happen##2##3##(1997-2#1)(2008-9#1)
does not have a##9##4##(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1995-6#1)(1996-5#1)(1997-8#1)(2008-10#1)(2010-8#1)
does not have any##2##4##(2011-1#1)(2011-3#1)
does not have the##5##4##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
does not have##24##3##(1990-2#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-6#1)(1995-6#1)(1996-5#2)(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)
does not hold##2##3##(1997-8#1)(2008-5#1)
does not impair##2##3##(1993-1#1)(1997-7#1)
does not impede##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
does not imply##3##3##(1990-11#1)(1991-6#1)(2009-6#1)
does not impose##3##3##(1990-8#1)(2012-12#1)(2013-1#1)
does not improve the##2##4##(1990-3#1)(2008-10#1)
does not improve##7##3##(1990-3#1)(1992-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
does not in##2##3##(1993-6#1)(2008-9#1)
does not include##5##3##(1993-3#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
does not increase the##2##4##(2008-3#1)(2011-2#1)
does not increase##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
does not induce##5##3##(1993-12#1)(1993-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
does not inhibit the##3##4##(1993-9#1)(1994-9#1)(1995-2#1)
does not inhibit##8##3##(1990-2#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
does not interact with##4##4##(1992-3#1)(1993-8#1)(1994-5#1)(1995-2#1)
does not interfere with the anticoagulant activity of warfarin##2##9##(1990-12#2)
does not interfere with the##4##5##(1990-12#2)(2008-4#2)
does not interfere with##8##4##(1990-12#2)(1995-2#2)(2008-10#1)(2008-4#2)(2013-1#1)
does not interfere##10##3##(1990-12#2)(1995-2#2)(2008-10#3)(2008-4#2)(2013-1#1)
does not involve any##3##4##(1995-8#1)(2008-3#2)
does not involve##12##3##(1994-8#1)(1995-3#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)
does not lead to##5##4##(1992-6#1)(1994-11#1)(2008-10#2)(2008-8#1)
does not lead##6##3##(1992-6#1)(1994-11#1)(2008-10#2)(2008-2#1)(2008-8#1)
does not limit the##2##4##(2008-2#1)(2008-3#1)
does not limit##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
does not look##2##3##(2010-10#1)(2011-2#1)
does not make it##2##4##(2008-8#1)(2008-9#1)
does not make##7##3##(1995-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
does not match##3##3##(1997-7#1)(2007-11#1)(2012-2#1)
does not matter##3##3##(1997-6#1)(2011-2#1)(2013-1#1)
does not mean that##2##4##(2008-4#1)(2008-7#1)
does not mean##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-7#1)
does not mediate##3##3##(1993-9#1)(1995-8#1)(2008-4#1)
does not necessarily follow##2##4##(1992-1#1)(2008-4#1)
does not necessarily imply##5##4##(1991-2#2)(1997-8#1)(2008-10#1)(2009-5#1)
does not necessarily indicate##2##4##(1994-11#1)(2010-5#1)
does not necessarily##21##3##(1991-11#1)(1991-2#2)(1992-1#1)(1994-11#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
does not need any##3##4##(2008-10#1)(2008-3#2)
does not need to##2##4##(1996-3#1)(2008-2#1)
does not need##11##3##(1996-12#1)(1996-3#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)
does not occur in##6##4##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)
does not occur##18##3##(1990-12#1)(1990-7#1)(1991-9#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)
does not offer##2##3##(1996-12#1)(2008-9#1)
does not permit##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
does not play a major role in##2##7##(2009-8#1)(2013-1#1)
does not play a role in the##3##7##(1993-3#1)(1996-5#1)(2008-11#1)
does not play a role in##4##6##(1993-3#1)(1996-5#1)(2008-11#1)(2008-7#1)
does not play a significant role in##2##7##(2008-10#2)
does not play a##8##4##(1993-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
does not play##9##3##(1993-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
does not pose any##3##4##(2008-7#1)(2012-12#1)(2012-3#1)
does not preclude##2##3##(2011-2#2)
does not predict##3##3##(2007-12#1)(2008-11#1)(2013-8#1)
does not present a##3##4##(1991-6#1)(2008-10#1)(2008-5#1)
does not present any##2##4##(2008-10#2)
does not present##5##3##(1991-6#1)(2008-10#3)(2008-5#1)
does not prevent##6##3##(1992-9#1)(1993-3#1)(1994-10#1)(1994-6#1)(2008-11#1)(2012-3#1)
does not produce##14##3##(1991-1#1)(1997-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#2)(2013-1#1)
does not promote##4##3##(2007-5#1)(2008-5#2)(2008-9#1)
does not protect##3##3##(1992-9#1)(1994-10#1)(1996-12#1)
does not prove##2##3##(1991-3#1)(1995-5#1)
does not provide a sufficiently##2##5##(1995-12#1)(2008-2#1)
does not provide a##5##4##(1995-12#1)(1996-3#1)(2008-2#2)(2013-1#1)
does not provide an##3##4##(1993-12#1)(2008-3#1)(2008-8#1)
does not provide##13##3##(1991-12#2)(1991-2#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-3#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
does not read##2##3##(1994-2#1)(2012-2#1)
does not really##2##3##(1990-8#1)(1994-12#1)
does not recognize##3##3##(1995-6#1)(2008-4#1)(2008-8#1)
does not reduce the##3##4##(1997-1#1)(2008-6#1)(2008-7#1)
does not reduce##10##3##(1990-11#1)(1993-6#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
does not rely on a##2##5##(2007-12#1)(2008-8#1)
does not rely on the##2##5##(1990-12#1)(2008-2#1)
does not rely on##6##4##(1990-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)
does not remove the##3##4##(1994-8#1)(2007-11#1)(2009-12#1)
does not render##2##3##(1997-3#1)(2008-3#1)
does not replace conventional##2##4##(1991-4#1)(2007-12#1)
does not replace##3##3##(1991-4#1)(2007-11#1)(2007-12#1)
does not represent a##2##4##(2008-1#1)(2008-5#1)
does not represent##4##3##(2008-1#1)(2008-5#2)(2010-9#1)
does not require a##9##4##(1992-3#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-6#1)(2011-2#1)
does not require any sample pre-treatment##2##6##(2008-10#2)
does not require any sample##3##5##(2008-10#3)
does not require any##11##4##(2008-10#7)(2008-3#2)(2012-2#1)(2013-8#1)
does not require heating##2##4##(2008-10#2)
does not require knowledge of the##2##6##(2008-2#1)(2008-3#1)
does not require special##2##4##(1996-12#1)(2008-3#1)
does not require the use of##2##6##(2008-3#1)(2008-4#1)
does not require the##10##4##(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-6#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
does not require##73##3##(1990-5#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(2007-11#3)(2007-12#4)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
does not resemble##2##3##(1990-5#1)(1994-12#1)
does not result in a##3##5##(1997-3#1)(2008-5#1)(2008-6#1)
does not result in##8##4##(1992-8#1)(1993-6#1)(1995-6#1)(1997-3#1)(2007-8#1)(2008-5#1)(2008-6#1)(2012-3#1)
does not reveal##4##3##(1991-6#1)(1992-1#1)(1996-12#1)(2008-10#1)
does not seem to be a##2##6##(1994-11#1)(1995-12#1)
does not seem to be##8##5##(1990-8#1)(1992-12#1)(1994-11#1)(1995-12#1)(1996-9#1)(2008-2#1)(2010-1#1)(2013-1#1)
does not seem to##20##4##(1990-6#1)(1990-8#2)(1991-2#2)(1992-12#1)(1993-11#1)(1994-11#1)(1995-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2013-1#1)
does not seem##23##3##(1990-6#1)(1990-8#2)(1991-2#2)(1991-9#1)(1992-12#1)(1993-11#1)(1994-11#1)(1995-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2013-1#1)
does not separate##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
does not serve##2##3##(1992-9#1)(1996-3#1)
does not shift##2##3##(2007-12#1)(2008-10#1)
does not show a##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
does not show any##2##4##(1997-3#1)(2008-8#1)
does not show the##2##4##(1992-9#1)(1996-2#1)
does not show##11##3##(1990-8#1)(1991-9#1)(1992-9#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
does not significantly affect the##2##5##(2007-12#1)(2008-2#1)
does not significantly change the##2##5##(1995-1#1)(2008-10#1)
does not significantly increase the##2##5##(2008-2#1)(2008-3#1)
does not significantly##14##3##(1990-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)
does not stimulate##4##3##(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#1)
does not suffer from##2##4##(2007-12#1)(2008-10#1)
does not suffer##4##3##(2007-12#1)(2008-10#3)
does not support the hypothesis##2##5##(1992-5#1)(2008-8#1)
does not support the##8##4##(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1997-1#1)(2007-11#1)(2008-8#1)(2008-9#1)
does not support##15##3##(1991-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-5#1)(2012-3#1)
does not treat##2##3##(2008-7#2)
does not undergo##6##3##(1993-6#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-11#1)(2011-2#1)
does not use##5##3##(2008-10#2)(2008-6#1)(2010-8#1)(2011-2#1)
does not vary##7##3##(1990-3#1)(1990-5#1)(1991-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)
does not work at##2##4##(1997-6#1)(2008-4#1)
does not work for##2##4##(2011-2#1)(2013-8#1)
does not work##7##3##(1992-12#1)(1997-6#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-8#1)
does not##936##2##(1990-11#6)(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#5)(1990-7#3)(1990-8#7)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#7)(1991-2#9)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#6)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#9)(1992-5#2)(1992-6#12)(1992-8#4)(1992-9#10)(1993-1#3)(1993-11#8)(1993-12#4)(1993-2#1)(1993-3#10)(1993-6#9)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#8)(1994-3#8)(1994-5#7)(1994-6#7)(1994-8#10)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#10)(1995-2#17)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#14)(1995-8#5)(1996-11#1)(1996-12#12)(1996-2#11)(1996-3#8)(1996-5#10)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#4)(1997-3#10)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#4)(2007-10#1)(2007-11#14)(2007-12#17)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#4)(2008-10#123)(2008-11#22)(2008-12#7)(2008-2#30)(2008-3#60)(2008-4#18)(2008-5#32)(2008-6#12)(2008-7#16)(2008-8#37)(2008-9#15)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#3)(2010-8#5)(2010-9#2)(2011-1#9)(2011-2#26)(2011-3#1)(2012-12#3)(2012-2#16)(2012-3#8)(2012-5#1)(2013-1#20)(2013-7#2)(2013-8#7)
does occur in##3##3##(1996-4#1)(2008-7#1)(2012-2#1)
does occur##7##2##(1990-7#1)(1991-6#1)(1992-2#1)(1996-4#1)(2008-7#1)(2009-9#1)(2012-2#1)
does provide##2##2##(1996-12#1)(2008-1#1)
does restriction of privileges without due process violate medical staff##2##10##(1993-1#1)(1993-3#1)
does show##2##2##(2008-10#1)(2008-4#1)
does so##4##2##(1990-2#1)(1994-6#1)(1995-9#1)(2012-2#1)
does take place##2##3##(2008-10#1)(2011-2#1)
does the##43##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-12#1)(1993-1#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
does this##3##2##(1991-6#1)(2008-9#1)(2011-1#1)
does your##3##2##(1994-2#1)(1995-2#1)(2008-4#1)
does##1178##1##(1990-10#1)(1990-11#6)(1990-12#7)(1990-2#6)(1990-3#2)(1990-5#9)(1990-6#5)(1990-7#4)(1990-8#7)(1990-9#2)(1991-1#3)(1991-11#3)(1991-12#12)(1991-2#11)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#8)(1991-8#3)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#11)(1992-5#2)(1992-6#14)(1992-8#5)(1992-9#10)(1993-1#6)(1993-11#9)(1993-12#4)(1993-2#3)(1993-3#12)(1993-6#11)(1993-7#1)(1993-8#7)(1993-9#2)(1994-1#2)(1994-10#2)(1994-11#5)(1994-12#8)(1994-2#10)(1994-3#9)(1994-5#9)(1994-6#10)(1994-8#12)(1994-9#4)(1995-1#3)(1995-11#4)(1995-12#14)(1995-2#19)(1995-3#8)(1995-4#2)(1995-5#4)(1995-6#16)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#14)(1996-2#12)(1996-3#9)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#7)(1997-2#6)(1997-3#15)(1997-4#8)(1997-5#2)(1997-6#7)(1997-7#7)(1997-8#4)(2007-10#1)(2007-11#15)(2007-12#18)(2007-2#4)(2007-5#1)(2007-7#4)(2007-8#11)(2008-1#9)(2008-10#133)(2008-11#32)(2008-12#10)(2008-2#35)(2008-3#74)(2008-4#25)(2008-5#36)(2008-6#13)(2008-7#25)(2008-8#44)(2008-9#24)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#8)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#4)(2010-8#6)(2010-9#3)(2011-1#10)(2011-2#32)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#20)(2012-3#14)(2012-5#1)(2013-1#24)(2013-7#2)(2013-8#10)
doesn't necessarily##2##2##(1992-11#1)(2010-9#1)
doesn't##19##1##(1991-5#2)(1992-11#3)(1993-2#2)(1994-1#2)(1994-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(2009-9#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
dog and cat##2##3##(1990-6#1)(2007-12#1)
dog and rat liver microsomes##2##5##(2011-3#2)
dog and##7##2##(1990-6#1)(1992-8#1)(2007-12#1)(2008-8#1)(2011-3#3)
dog bite##3##2##(2008-12#3)
dog bites##5##2##(2013-8#5)
dog is##3##2##(1995-2#1)(1996-11#1)(2008-10#1)
dog kidney##4##2##(1993-3#2)(1995-11#2)
dog liver##4##2##(1993-3#1)(1995-11#2)(2008-9#1)
dog model##2##2##(2006-6#1)(2008-8#1)
dog owner/dog walkers##2##3##(2013-1#2)
dog owners##2##2##(2013-1#2)
dog saliva samples##2##3##(2012-3#2)
dog was##2##2##(2008-5#1)(2013-8#1)
dog with a##2##3##(2008-10#1)(2012-3#1)
dog with##3##2##(2008-10#1)(2012-3#2)
dog##95##1##(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-10#1)(1992-5#1)(1992-8#2)(1993-2#1)(1993-3#3)(1994-6#1)(1994-9#1)(1995-11#5)(1995-12#2)(1995-2#2)(1995-9#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-3#3)(2012-2#1)(2012-3#8)(2013-1#7)(2013-8#8)
dogfish liver##2##2##(2008-10#2)
dogfish muscle##2##2##(2008-10#2)
dogfish##7##1##(2008-10#6)(2008-11#1)
dogma that##2##2##(2008-11#1)(2010-5#1)
dogma##10##1##(2007-5#2)(2008-11#1)(2008-12#3)(2010-5#2)(2010-8#1)(2012-2#1)
dogmatic##2##1##(2008-8#1)(2013-1#1)
dogs (6##2##2##(1996-12#2)
dogs (class##2##2##(1992-3#2)
dogs and cats##6##3##(1995-11#2)(2008-3#1)(2012-3#1)(2013-1#2)
dogs and rabbits##4##3##(1994-8#1)(1996-9#2)(2008-5#1)
dogs and##18##2##(1991-11#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-6#1)(1996-9#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#3)(2013-1#2)
dogs are##2##2##(2008-12#1)(2011-2#1)
dogs demonstrated##3##2##(1994-2#1)(2008-5#1)(2008-6#1)
dogs exposed##2##2##(1996-1#1)(2008-10#1)
dogs for##3##2##(1993-2#1)(1994-9#1)(2013-1#1)
dogs from##2##2##(2008-12#1)(2008-7#1)
dogs had##2##2##(2008-5#1)(2012-3#1)
dogs has##2##2##(1992-5#1)(2008-10#1)
dogs have##2##2##(1990-7#1)(2008-10#1)
dogs in the Northern Cape Province##2##6##(2011-1#2)
dogs in the##5##3##(2008-10#1)(2008-12#1)(2011-1#3)
dogs in##10##2##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-1#5)
dogs is##2##2##(1992-3#1)(2011-2#1)
dogs may##2##2##(1995-2#1)(2011-1#1)
dogs of##2##2##(2008-5#1)(2012-3#1)
dogs pretreated##2##2##(1994-8#1)(1996-9#1)
dogs than in##2##3##(2012-3#2)
dogs treated with surgery##2##4##(2012-3#2)
dogs treated with##3##3##(2011-2#1)(2012-3#2)
dogs was##2##2##(1991-11#1)(2008-12#1)
dogs were treated with##2##4##(2012-1#1)(2012-3#1)
dogs were##16##2##(1991-6#1)(1992-3#1)(1995-12#1)(1996-6#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
dogs with GM1 gangliosidosis##4##4##(2012-3#4)
dogs with chronic##2##3##(1991-3#1)(2008-10#1)
dogs with##24##2##(1991-3#1)(1992-5#1)(1993-2#2)(1995-12#1)(1997-8#1)(2008-10#2)(2008-6#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-3#5)(2013-1#1)
dogs##223##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#3)(1991-12#1)(1991-3#2)(1991-6#3)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#5)(1992-5#8)(1992-6#2)(1993-2#4)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#5)(1995-2#1)(1996-1#1)(1996-11#2)(1996-12#11)(1996-6#4)(1996-9#4)(1997-1#1)(1997-3#1)(1997-5#2)(1997-8#1)(2008-10#21)(2008-11#2)(2008-12#14)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#6)(2008-7#3)(2008-8#1)(2009-4#2)(2009-8#1)(2010-12#3)(2011-1#12)(2011-2#15)(2012-1#9)(2012-12#1)(2012-3#29)(2013-1#12)(2013-8#2)
dogs)##2##1##(1996-12#2)
dogwood in the##2##3##(2008-10#2)
dogwood##4##1##(2008-10#4)
doi##22##1##(2008-11#6)(2008-7#1)(2009-12#5)(2010-4#1)(2012-3#3)(2013-7#1)(2013-8#5)
doing a##4##2##(2007-11#1)(2008-2#2)(2012-2#1)
doing and##2##2##(2008-12#1)(2012-12#1)
doing in##3##2##(1996-2#2)(2008-1#1)
doing it##2##2##(1994-1#1)(1995-2#1)
doing so##21##2##(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2013-1#2)
doing the##3##2##(1994-1#1)(2007-2#1)(2008-2#1)
doing this##6##2##(1992-12#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-3#1)
doing well##9##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2013-1#1)(2013-7#1)
doing##88##1##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-1#2)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-7#2)
doing? A##2##2##(1991-3#1)(2008-12#1)
doing?##7##1##(1991-3#1)(1996-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
dolasetron##2##1##(2008-7#1)(2010-8#1)
dolichol concentration##2##2##(1991-12#2)
dolichol##5##1##(1991-12#4)(1996-6#1)
dolichyl phosphoryl mannose synthase##3##4##(1996-6#3)
dolichyl##5##1##(1990-5#2)(1996-6#3)
doll##5##1##(1992-3#1)(2013-8#4)
dollar spent##2##2##(1993-3#1)(1997-2#1)
dollar spot disease##2##3##(2008-10#2)
dollar spot of turfgrass##2##4##(2008-10#2)
dollar spot of##3##3##(2008-10#3)
dollar spot resistance in creeping bentgrass##2##6##(2008-10#2)
dollar spot resistance in##3##4##(2008-10#3)
dollar spot resistance##4##3##(2008-10#4)
dollar spot##16##2##(2008-10#16)
dollar value of##2##3##(1995-3#1)(1996-1#1)
dollar value##3##2##(1995-3#2)(1996-1#1)
dollar##36##1##(1991-1#2)(1992-2#1)(1993-3#2)(1994-1#4)(1995-12#2)(1995-3#2)(1996-1#1)(1997-2#1)(2007-5#1)(2008-10#16)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
dollars and##2##2##(1996-12#1)(2008-11#1)
dollars are##3##2##(1991-2#1)(1993-12#1)(1996-2#1)
dollars in##3##2##(2008-6#2)(2008-7#1)
dollars##27##1##(1990-12#1)(1991-2#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
dollars)##3##1##(1991-2#1)(1992-12#1)(1994-2#1)
dolls##4##1##(1992-3#3)(2013-8#1)
domain (CBD) from##2##3##(1995-5#1)(2008-7#1)
domain (CBD)##3##2##(1995-5#1)(2008-7#1)(2009-7#1)
domain (CTD)##2##2##(2009-7#1)(2012-2#1)
domain (ECD) of##2##3##(1995-12#1)(2008-11#1)
domain (domain##3##2##(1997-4#3)
domain 2##3##2##(1995-6#1)(2008-7#1)(2008-8#1)
domain C##2##2##(1990-12#2)
domain and a##4##3##(1990-5#1)(1993-2#1)(1994-12#1)(2009-3#1)
domain and an##3##3##(1993-3#1)(2008-11#1)(2012-12#1)
domain and the##3##3##(1993-6#1)(1997-2#1)(2008-10#1)
domain and##34##2##(1990-5#1)(1992-12#3)(1992-6#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2012-1#1)(2012-12#1)
domain are##7##2##(1995-2#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2011-1#1)
domain as##3##2##(2008-2#1)(2008-7#1)(2013-1#1)
domain at its C-terminus##2##4##(1997-6#1)(2011-2#1)
domain at its##4##3##(1997-6#2)(2007-12#1)(2011-2#1)
domain at the##4##3##(1992-8#1)(1997-8#2)(2010-10#1)
domain at their##2##3##(1994-11#2)
domain at##10##2##(1992-8#1)(1994-11#2)(1997-6#2)(1997-8#2)(2007-12#1)(2010-10#1)(2011-2#1)
domain binding##3##2##(1994-6#1)(2008-4#1)(2012-2#1)
domain bound##2##2##(1995-8#1)(2010-5#1)
domain boundary##2##2##(1995-2#1)(2008-2#1)
domain but lack the##2##4##(2008-8#1)(2009-10#1)
domain by##12##2##(1991-9#1)(1995-2#1)(1995-5#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)
domain can be##4##3##(1994-9#1)(2007-11#1)(2008-6#1)(2009-5#1)
domain can##7##2##(1994-9#1)(2007-11#1)(2008-5#2)(2008-6#1)(2009-5#1)(2012-12#1)
domain composed##2##2##(1995-6#2)
domain consisting of##3##3##(1990-12#1)(1995-6#1)(2009-2#1)
domain containing protein##2##3##(2009-8#1)(2013-8#1)
domain containing the##2##3##(1994-8#1)(1995-2#1)
domain containing##11##2##(1991-12#1)(1991-7#1)(1994-8#1)(1995-2#1)(1995-6#2)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
domain contains two##2##3##(1992-6#1)(1997-4#1)
domain contains##4##2##(1990-11#1)(1992-11#1)(1992-6#1)(1997-4#1)
domain evolution##3##2##(2011-2#3)
domain experts##2##2##(2008-7#1)(2010-12#1)
domain folds##2##2##(2008-4#1)(2012-2#1)
domain followed by##2##3##(1993-2#1)(1995-6#1)
domain for a##2##3##(2007-11#1)(2008-2#1)
domain for##10##2##(1990-12#1)(1996-3#1)(2007-11#2)(2008-2#1)(2008-7#1)(2010-8#3)(2011-2#1)
domain forms a##2##3##(1995-6#1)(2010-10#1)
domain from the human JARID1C##2##5##(2009-7#2)
domain from the human##3##4##(1995-2#1)(2009-7#2)
domain from the##5##3##(1995-2#1)(1996-2#1)(1997-4#1)(2009-7#2)
domain from##10##2##(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-4#1)(2009-7#3)(2013-1#1)
domain has##6##2##(1990-7#1)(1994-6#1)(1996-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
domain in both##2##3##(1993-11#1)(2011-2#1)
domain in the middle##2##4##(1997-2#1)(1997-6#1)
domain in the##8##3##(1997-2#2)(1997-6#1)(2007-12#3)(2008-12#1)(2010-6#1)
domain in##21##2##(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#1)(1997-2#2)(1997-6#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
domain interactions##2##2##(1993-8#1)(2012-12#1)
domain inversion in##2##3##(2007-12#2)
domain inversion##5##2##(2007-12#3)(2008-3#2)
domain is used to##4##4##(2007-11#1)(2008-3#2)(2008-9#1)
domain is##28##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2013-1#1)
domain knowledge##2##2##(2008-6#1)(2008-7#1)
domain may##5##2##(1992-4#1)(1995-2#2)(2009-10#1)(2010-5#1)
domain of AC2##2##3##(2008-9#2)
domain of APP##2##3##(1992-12#2)
domain of NF-L##2##3##(2008-8#2)
domain of PKD##3##3##(1994-8#3)
domain of Shc##2##3##(1997-7#1)(2012-2#1)
domain of cTR##2##3##(1991-6#2)
domain of fibronectin##2##3##(1992-3#1)(1995-5#1)
domain of human PTPN7##2##4##(2009-7#2)
domain of human##9##3##(1995-5#1)(1995-6#1)(1997-2#1)(2008-11#1)(2008-8#1)(2009-7#3)(2011-2#1)
domain of intact##2##3##(1995-5#2)
domain of protein##4##3##(1990-5#1)(1994-8#1)(1995-5#1)(1997-4#1)
domain of the TSH receptor##3##5##(1992-12#2)(1996-5#1)
domain of the alpha-subunit##2##4##(1990-11#2)
domain of the aspartate receptor##3##5##(1992-8#2)(1992-9#1)
domain of the human glucocorticoid receptor##2##6##(1990-11#1)(1995-2#1)
domain of the human##7##4##(1990-11#1)(1991-5#1)(1992-8#1)(1993-3#1)(1995-2#1)(1997-2#1)(2006-6#1)
domain of the receptor##4##4##(1992-12#2)(1994-8#1)(2008-5#1)
domain of the##68##3##(1990-11#3)(1990-12#1)(1990-7#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#3)(1996-5#1)(1997-2#1)(1997-4#1)(2006-6#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#2)(2012-2#1)(2013-1#1)
domain of unknown function##3##4##(2008-9#1)(2010-10#2)
domain of##205##2##(1990-11#6)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1992-11#2)(1992-12#9)(1992-3#6)(1992-4#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#3)(1994-5#2)(1994-6#4)(1994-8#7)(1994-9#2)(1995-11#1)(1995-2#3)(1995-5#7)(1995-6#11)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#5)(1997-7#2)(1997-8#2)(2006-6#4)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#9)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#15)(2009-8#2)(2009-9#3)(2010-10#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)
domain on##4##2##(1993-8#1)(1997-2#1)(1997-4#1)(2011-2#1)
domain optical coherence tomography##5##4##(2009-3#1)(2011-1#3)(2012-12#1)
domain or##5##2##(1994-11#1)(2008-4#1)(2008-8#1)(2009-2#2)
domain organization##2##2##(1991-6#1)(2008-11#1)
domain protein##5##2##(1990-11#1)(2007-12#1)(2008-9#1)(2009-5#1)(2012-2#1)
domain proteins##2##2##(2008-9#2)
domain region##2##2##(1995-6#1)(1997-2#1)
domain revealed##2##2##(2008-10#1)(2013-1#1)
domain structure and##2##3##(1995-6#1)(2009-10#1)
domain structure of##2##3##(1991-1#1)(1995-2#1)
domain structure##7##2##(1991-1#1)(1995-2#1)(1995-6#2)(2008-10#1)(2009-10#1)(2012-12#1)
domain that is##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
domain that##12##2##(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-10#1)(2009-2#1)(2010-10#1)(2012-12#1)(2013-1#1)
domain to the##4##3##(1991-10#1)(1995-6#1)(1997-4#1)(2009-6#1)
domain to##10##2##(1991-10#1)(1992-9#1)(1993-8#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-2#2)(2009-6#1)(2011-1#1)
domain wall##4##2##(2008-2#1)(2009-6#3)
domain walls##2##2##(1991-9#1)(2009-6#1)
domain was##9##2##(1991-2#1)(1991-9#1)(1992-9#1)(1995-6#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-8#1)
domain were##11##2##(1990-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-4#1)(2011-2#1)(2011-3#1)
domain where##2##2##(2008-2#1)(2008-4#1)
domain which was##2##3##(2008-11#1)(2008-9#1)
domain which##7##2##(1993-6#1)(1993-9#1)(2008-11#3)(2008-7#1)(2008-9#1)
domain with##8##2##(1992-6#1)(1993-3#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2013-7#1)
domain within##3##2##(1991-6#1)(1993-8#1)(2013-1#1)
domain##962##1##(1990-11#13)(1990-12#9)(1990-2#2)(1990-5#8)(1990-7#10)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#16)(1991-2#5)(1991-3#2)(1991-5#6)(1991-6#9)(1991-7#1)(1991-8#2)(1991-9#9)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#18)(1992-3#7)(1992-4#3)(1992-6#6)(1992-8#7)(1992-9#12)(1993-1#2)(1993-11#4)(1993-12#11)(1993-2#4)(1993-3#7)(1993-6#10)(1993-8#20)(1993-9#2)(1994-11#9)(1994-12#12)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#10)(1994-8#12)(1994-9#5)(1995-11#6)(1995-12#1)(1995-2#23)(1995-5#15)(1995-6#40)(1995-8#6)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1997-2#15)(1997-3#2)(1997-4#25)(1997-6#4)(1997-7#10)(1997-8#6)(1997-9#1)(2006-6#4)(2007-11#17)(2007-12#31)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#17)(2008-12#1)(2008-2#27)(2008-3#38)(2008-4#24)(2008-5#5)(2008-6#5)(2008-7#24)(2008-8#44)(2008-9#30)(2009-10#11)(2009-11#1)(2009-12#3)(2009-2#7)(2009-3#4)(2009-5#5)(2009-6#13)(2009-7#34)(2009-8#12)(2009-9#4)(2010-10#11)(2010-12#4)(2010-2#1)(2010-5#4)(2010-6#1)(2010-8#6)(2011-1#14)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#17)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#5)
domain&quot##3##1##(2008-11#1)(2011-1#1)(2012-2#1)
domain'##2##1##(1994-3#2)
domain)##4##1##(1995-5#1)(1997-4#1)(2010-10#1)(2012-3#1)
domain-containing proteins##3##2##(2008-7#2)(2009-2#1)
domain-containing##7##1##(1992-9#1)(2008-10#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-7#1)
domain-general##5##1##(2008-11#1)(2012-1#2)(2012-12#2)
domain-inverted structure##2##2##(2007-12#2)
domain-inverted##4##1##(2007-12#2)(2008-2#2)
domain-specific##4##1##(1993-12#1)(1993-8#1)(2012-12#2)
domain-wall##2##1##(2007-12#2)
domains along the##2##3##(1992-4#1)(2008-3#1)
domains and is##2##3##(1997-7#1)(2008-10#1)
domains and the##2##3##(1994-8#1)(2011-1#1)
domains and##22##2##(1992-12#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
domains are##14##2##(1991-2#1)(1993-6#1)(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
domains as well as##2##4##(2008-10#1)(2011-1#1)
domains as##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
domains at##3##2##(1994-5#1)(2008-7#2)
domains can be##2##3##(1991-2#1)(1994-9#1)
domains can##3##2##(1991-2#1)(1994-9#1)(2007-12#1)
domains characteristic of##2##3##(1992-12#1)(1994-12#1)
domains for##6##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
domains from the##2##3##(1992-6#1)(1997-6#1)
domains from##4##2##(1992-6#1)(1997-2#1)(1997-6#1)(2012-3#1)
domains have##2##2##(1995-2#1)(1997-6#1)
domains in a##2##3##(1995-12#1)(2012-2#1)
domains in the##8##3##(1993-11#1)(1994-5#1)(1994-8#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-2#1)
domains in##24##2##(1990-12#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2012-2#3)
domains including##2##2##(2008-10#1)(2011-3#1)
domains into##2##2##(2008-11#1)(2009-9#1)
domains is##7##2##(1992-4#1)(1995-5#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)
domains may##3##2##(2008-10#1)(2008-6#1)(2009-12#1)
domains of NF-L##2##3##(2008-8#2)
domains of a##3##3##(1995-6#1)(1996-12#1)(2008-3#1)
domains of both##2##3##(1995-11#1)(2008-6#1)
domains of human##5##3##(1991-9#2)(1992-9#1)(1993-8#1)(1994-8#1)
domains of several##2##3##(1995-3#1)(1997-3#1)
domains of the human##3##4##(1992-9#1)(1993-11#1)(2012-2#1)
domains of the##21##3##(1990-8#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-11#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
domains of various##2##3##(1993-2#1)(2008-3#1)
domains of##103##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#3)(1991-9#3)(1992-3#2)(1992-4#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#4)(1994-8#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#8)(1996-12#3)(1996-2#4)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
domains on the##3##3##(1993-3#2)(2011-2#1)
domains on##4##2##(1993-3#2)(2008-9#1)(2011-2#1)
domains or##2##2##(1992-3#1)(2008-4#1)
domains responsible for##2##3##(1991-9#1)(2008-9#1)
domains that##7##2##(1997-3#1)(2008-1#1)(2008-9#1)(2009-7#1)(2011-1#1)(2013-1#2)
domains through the##2##3##(1995-11#1)(2008-3#1)
domains to##8##2##(1993-6#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#1)
domains was##3##2##(1990-7#1)(2008-10#1)(2008-7#1)
domains were identified##2##3##(1996-10#1)(2007-12#1)
domains were##15##2##(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-12#1)(1996-10#1)(2007-11#1)(2007-12#2)(2008-4#1)
domains which##2##2##(1994-11#1)(1994-6#1)
domains with lower##2##3##(1996-2#2)
domains with the##2##3##(2008-3#1)(2008-4#1)
domains with##12##2##(1994-12#1)(1995-3#1)(1996-2#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)
domains within the##2##3##(2008-3#1)(2011-1#1)
domains within##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
domains##472##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-12#1)(1991-2#5)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#7)(1992-12#5)(1992-3#4)(1992-4#7)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#9)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#4)(1993-6#6)(1993-8#14)(1994-11#3)(1994-12#10)(1994-5#4)(1994-6#1)(1994-8#8)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#13)(1995-8#3)(1996-10#1)(1996-12#5)(1996-2#12)(1996-5#1)(1997-2#4)(1997-3#7)(1997-4#4)(1997-6#4)(1997-7#3)(1997-8#2)(2006-4#1)(2007-10#1)(2007-11#9)(2007-12#7)(2008-1#4)(2008-10#16)(2008-11#15)(2008-12#3)(2008-2#10)(2008-3#19)(2008-4#20)(2008-5#7)(2008-6#4)(2008-7#21)(2008-8#17)(2008-9#9)(2009-1#3)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#8)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2011-1#8)(2011-2#13)(2011-3#1)(2011-8#1)(2012-1#5)(2012-12#7)(2012-2#18)(2012-3#5)(2013-1#8)(2013-8#2)
domains)##5##1##(1997-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)
domains/dimensions##2##1##(2008-4#2)
dome chondral and osteochondral lesions##2##5##(2011-2#2)
dome points##2##2##(2009-2#2)
dome##19##1##(1991-6#1)(1995-10#2)(1995-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#3)(2009-2#2)(2009-7#2)(2010-5#1)(2011-2#2)
domestic and foreign##2##3##(2009-8#1)(2012-3#1)
domestic and international##2##3##(2008-10#1)(2010-8#1)
domestic and##7##2##(2008-10#2)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
domestic animals and##3##3##(1996-12#1)(2008-12#1)(2012-2#1)
domestic animals are##2##3##(1994-9#1)(2010-2#1)
domestic animals in##3##3##(1990-3#1)(2007-12#1)(2008-12#1)
domestic animals##19##2##(1990-3#1)(1994-9#1)(1995-8#2)(1996-12#1)(1996-3#1)(2007-12#1)(2008-12#3)(2008-8#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
domestic dogs in the##2##4##(2011-1#2)
domestic food##2##2##(2007-12#1)(2012-2#1)
domestic golden hamster##2##3##(1995-3#2)
domestic homicide cases##4##3##(2011-2#4)
domestic homicide##8##2##(2011-2#8)
domestic microwave oven##7##3##(2007-11#1)(2008-10#6)
domestic or public setting##3##4##(2013-1#3)
domestic or##4##2##(1994-3#1)(2013-1#3)
domestic pigs##2##2##(2010-4#1)(2013-7#1)
domestic rabbits##2##2##(1996-3#2)
domestic violence##13##2##(1993-12#2)(1995-12#1)(2007-2#1)(2008-7#1)(2009-11#1)(2009-4#1)(2012-12#3)(2012-3#1)(2013-1#2)
domestic wastes##2##2##(2008-10#2)
domestic wastewater##3##2##(2008-10#1)(2013-1#2)
domestic water##2##2##(2007-7#1)(2008-7#1)
domestic work##3##2##(2011-2#3)
domestic workers##3##2##(2011-2#3)
domestic##132##1##(1990-3#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-12#3)(1993-3#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-12#5)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#1)(2008-10#15)(2008-11#1)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#5)(2011-2#19)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#2)
domestic-family work##2##2##(2011-2#2)
domestica##16##1##(1996-9#1)(2007-11#2)(2008-10#4)(2008-12#2)(2008-8#1)(2008-9#2)(2013-1#4)
domestica)##6##1##(2008-10#5)(2009-8#1)
domestically##3##1##(2011-2#2)(2012-1#1)
domesticated##10##1##(1996-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-1#1)(2010-4#2)(2012-3#1)
domestication##3##1##(2009-10#1)(2010-4#2)
domesticus)##5##1##(2008-12#2)(2008-5#3)
dominance and##3##2##(1995-6#1)(2008-4#1)(2008-8#1)
dominance columns##5##2##(2008-11#5)
dominance for##4##2##(1990-3#1)(1996-2#1)(2008-10#1)(2009-5#1)
dominance hierarchies##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
dominance hierarchy##2##2##(2008-11#1)(2009-8#1)
dominance in##11##2##(1991-6#1)(2008-10#1)(2008-8#3)(2008-9#4)(2011-2#2)
dominance is##5##2##(2008-8#4)(2011-2#1)
dominance of the##4##3##(1991-12#1)(2008-3#1)(2010-5#1)(2010-8#1)
dominance of##17##2##(1991-12#1)(1991-6#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#2)(2009-7#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
dominance was##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
dominance##99##1##(1990-3#1)(1991-12#1)(1991-6#2)(1992-11#2)(1994-8#6)(1995-11#3)(1995-6#1)(1996-2#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#9)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#20)(2008-9#7)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#6)(2013-1#1)(2013-7#2)(2013-8#1)
dominant allele##3##2##(2008-10#3)
dominant and subordinate O##2##4##(2010-8#2)
dominant and subordinate##4##3##(2008-8#1)(2010-8#3)
dominant and##16##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2009-8#1)(2010-8#3)(2012-3#1)
dominant but##2##2##(2007-12#1)(2008-5#1)
dominant disorder characterized by##4##4##(2008-8#1)(2010-3#1)(2010-9#1)(2013-1#1)
dominant disorder##13##2##(1992-3#1)(1997-3#1)(2007-10#1)(2007-4#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#3)
dominant factor##4##2##(1993-1#1)(2008-10#2)(2009-11#1)
dominant factors##2##2##(2008-2#1)(2011-2#1)
dominant flocculation genes##4##3##(1995-6#4)
dominant for avirulence##3##3##(2008-10#3)
dominant for##6##2##(1997-7#1)(2008-10#3)(2008-11#2)
dominant form of##2##3##(1997-2#1)(2012-12#1)
dominant gene action##2##3##(2008-10#2)
dominant gene and##3##3##(2008-10#3)
dominant gene for resistance to##4##5##(2008-10#3)(2008-5#1)
dominant gene for##6##3##(2008-10#5)(2008-5#1)
dominant gene in##2##3##(2008-10#2)
dominant gene was##3##3##(2008-10#3)
dominant gene##38##2##(2008-10#35)(2008-4#1)(2008-5#1)(2013-8#1)
dominant genes##2##2##(2008-10#2)
dominant genotype##3##2##(2008-10#1)(2008-8#2)
dominant hemisphere##2##2##(1990-11#1)(1990-3#1)
dominant in the##9##3##(1992-3#3)(1995-11#1)(2008-10#3)(2009-12#1)(2010-8#1)
dominant in##15##2##(1990-6#1)(1992-3#3)(1995-11#1)(2008-10#7)(2009-12#1)(2010-4#1)(2010-8#1)
dominant inheritance pattern##3##3##(1994-8#2)(2008-7#1)
dominant inheritance##6##2##(1994-8#2)(2007-7#1)(2008-7#3)
dominant loci##2##2##(2008-10#2)
dominant markers##2##2##(2008-5#1)(2008-9#1)
dominant masculinity##2##2##(2008-11#2)
dominant mechanism##3##2##(2008-3#2)(2012-12#1)
dominant mode of inheritance##2##4##(1994-8#1)(2008-1#1)
dominant mode of##3##3##(1994-8#1)(1997-2#1)(2008-1#1)
dominant model##3##2##(1997-5#1)(2008-8#1)(2010-5#1)
dominant multisystem disorder##2##3##(1993-12#1)(2012-3#1)
dominant mutations##2##2##(1990-5#1)(2008-1#1)
dominant negative Ras##2##3##(1995-11#1)(2013-7#1)
dominant negative##12##2##(1991-5#1)(1991-9#1)(1993-11#1)(1995-11#2)(1995-8#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#2)
dominant or symptomatic cavernoma##2##4##(1996-6#2)
dominant or##6##2##(1992-1#1)(1996-6#2)(2008-10#1)(2008-11#1)(2008-5#1)
dominant over##2##2##(2008-10#1)(2008-8#1)
dominant pattern##2##2##(1992-3#1)(1997-6#1)
dominant phase##2##2##(2008-7#2)
dominant polycystic kidney disease##7##4##(1997-1#2)(2007-7#1)(2008-1#1)(2010-6#1)(2013-1#2)
dominant polycystic kidney##8##3##(1997-1#2)(2007-7#1)(2008-1#1)(2010-6#1)(2013-1#3)
dominant resistance gene##5##3##(2008-10#5)
dominant resistance##7##2##(2008-10#7)
dominant role in the##2##4##(1992-1#1)(2011-3#1)
dominant role in##7##3##(1992-1#1)(2008-1#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
dominant role##10##2##(1992-1#1)(2008-1#1)(2008-2#1)(2010-11#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
dominant species##11##2##(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#3)(2013-7#2)
dominant to##2##2##(1994-12#1)(2008-10#1)
dominant trait##3##2##(2007-7#1)(2008-10#1)(2010-6#1)
dominant under##3##2##(2008-3#1)(2008-8#2)
dominant##432##1##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-3#6)(1992-5#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1997-1#3)(1997-2#3)(1997-3#5)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#5)(2007-10#5)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#1)(2008-1#8)(2008-10#116)(2008-11#14)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#9)(2008-5#15)(2008-6#4)(2008-7#18)(2008-8#26)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#5)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#13)(2013-1#12)(2013-7#6)(2013-8#5)
dominant-negative##8##1##(1994-12#1)(1994-8#1)(1997-4#1)(2008-6#2)(2008-8#1)(2012-12#2)
dominantly dual##2##2##(2009-8#2)
dominantly inherited##6##2##(1990-12#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-6#1)(2013-1#1)
dominantly##12##1##(1990-12#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
dominants but##2##2##(2008-8#2)
dominants in##2##2##(2008-8#1)(2010-8#1)
dominants##15##1##(1992-1#4)(2008-8#5)(2008-9#1)(2010-8#5)
dominate in##2##2##(2008-9#1)(2012-1#1)
dominate the##7##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-7#1)
dominate##23##1##(1990-6#1)(1991-12#1)(1995-9#1)(1996-1#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-1#1)
dominated as##2##2##(1992-6#1)(2008-7#1)
dominated by a single##3##4##(1990-8#1)(2008-10#2)
dominated by a##8##3##(1990-7#1)(1990-8#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)
dominated by different##2##3##(1990-5#1)(2008-3#1)
dominated by either##2##3##(2008-5#1)(2008-9#1)
dominated by one##2##3##(2008-10#1)(2009-9#1)
dominated by strains##2##3##(2013-8#2)
dominated by the##18##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#3)
dominated by##84##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1992-12#1)(1992-9#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#4)(2007-5#3)(2008-1#2)(2008-10#12)(2008-11#1)(2008-3#15)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#6)(2012-2#1)(2013-8#2)
dominated cluster##2##2##(2010-4#2)
dominated the population##2##3##(2008-10#2)
dominated the##13##2##(1993-12#2)(1995-2#1)(2008-10#5)(2008-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
dominated##126##1##(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#2)(1995-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#4)(2007-5#5)(2007-8#1)(2008-1#4)(2008-10#28)(2008-11#2)(2008-3#16)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
dominates for##2##2##(2008-10#1)(2008-2#1)
dominates in the##2##3##(2007-11#1)(2008-9#1)
dominates in##4##2##(2007-11#1)(2008-11#2)(2008-9#1)
dominates the##8##2##(2008-10#1)(2008-3#3)(2008-5#1)(2009-5#1)(2009-7#1)(2010-4#1)
dominates##18##1##(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-12#1)
dominating the##2##2##(2008-10#1)(2012-2#1)
dominating##14##1##(1992-3#1)(1996-6#2)(1996-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
domination by##2##2##(1991-3#1)(2008-8#1)
domination of the community by##2##5##(2008-8#2)
domination of the##3##3##(2008-1#1)(2008-8#2)
domination of##4##2##(2008-1#1)(2008-11#1)(2008-8#2)
domination##7##1##(1991-3#1)(1991-6#1)(2008-1#1)(2008-11#1)(2008-8#3)
domino accidents##3##2##(2009-10#3)
domino##9##1##(2007-11#1)(2009-10#7)(2010-2#1)
domoic acid##2##2##(1992-8#2)
domperidone and##3##2##(2011-2#3)
domperidone cover##2##2##(2008-7#2)
domperidone in the##2##3##(2008-10#1)(2008-7#1)
domperidone in##3##2##(2008-10#2)(2008-7#1)
domperidone##24##1##(2008-10#4)(2008-7#10)(2011-2#10)
don't have a##3##3##(1994-12#1)(2008-1#1)(2008-4#1)
don't know about##2##3##(1994-2#1)(1995-1#1)
don't know##3##2##(1991-2#1)(1994-2#1)(1995-1#1)
don't##34##1##(1990-12#1)(1991-2#1)(1991-3#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2009-5#1)(2011-1#2)(2011-2#2)(2013-8#4)
donate blood##2##2##(1994-3#1)(1996-1#1)
donate##8##1##(1991-5#1)(1992-8#1)(1994-3#1)(1996-1#1)(2007-10#2)(2009-3#1)(2012-12#1)
donated blood##4##2##(1994-2#2)(1996-9#2)
donated##18##1##(1992-1#1)(1992-3#1)(1994-2#2)(1995-12#1)(1996-11#1)(1996-9#3)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-5#1)
donating blood##2##2##(1994-3#1)(1996-1#1)
donating##11##1##(1994-3#1)(1996-1#1)(2008-10#4)(2009-9#3)(2010-5#2)
donation after##2##2##(2010-6#1)(2011-2#1)
donation and##4##2##(1991-3#1)(2008-1#1)(2009-3#1)(2011-2#1)
donation as##2##2##(2008-10#1)(2008-12#1)
donation from##2##2##(2008-1#1)(2008-4#1)
donation in##4##2##(1994-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
donation is##2##2##(1996-9#1)(2008-12#1)
donation of an organ##2##4##(1993-2#1)(2011-2#1)
donation of##3##2##(1993-2#2)(2011-2#1)
donation or##2##2##(2007-9#1)(2011-2#1)
donation##68##1##(1990-6#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#3)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-1#2)(1996-9#5)(2007-10#1)(2007-7#1)(2007-9#4)(2008-1#2)(2008-10#1)(2008-12#7)(2008-4#4)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#17)(2012-12#1)(2012-2#2)
donations##15##1##(1991-12#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-7#1)(1994-9#1)(1995-3#2)(2008-12#2)(2008-4#1)(2008-7#1)(2011-2#2)
done a##2##2##(1991-11#1)(2008-10#1)
done after##5##2##(2007-7#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
done and the##3##3##(2008-7#1)(2008-8#1)(2009-12#1)
done and##16##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
done as an##2##3##(2008-6#2)
done as##4##2##(1994-5#1)(1997-3#1)(2008-6#2)
done at a##2##3##(2008-10#1)(2013-8#1)
done at the##3##3##(1990-3#2)(2008-3#1)
done at##20##2##(1990-3#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-12#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#2)(2013-8#1)
done because##3##2##(1995-2#1)(2007-7#1)(2008-10#1)
done before and after##2##4##(2008-10#1)(2012-2#1)
done before and##3##3##(2008-10#2)(2012-2#1)
done before##4##2##(1996-11#1)(2008-10#2)(2012-2#1)
done by a##5##3##(2008-6#1)(2010-1#1)(2013-1#3)
done by means of##3##4##(1991-2#1)(1991-5#1)(2008-10#1)
done by the##6##3##(1990-3#1)(1994-6#1)(2008-10#2)(2013-8#2)
done by use of##2##4##(2008-2#1)(2008-3#1)
done by using##7##3##(2008-10#4)(2008-11#1)(2013-8#2)
done by##75##2##(1990-3#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#8)
done during##4##2##(1994-8#1)(2008-8#1)(2008-9#1)(2010-6#1)
done for a##2##3##(2008-10#1)(2011-2#1)
done for the##4##3##(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
done for##12##2##(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
done from band 2 and band 3##2##7##(2013-8#2)
done from band 2##3##4##(2013-8#3)
done from##6##2##(1994-3#1)(1996-3#1)(2011-2#1)(2013-8#3)
done in a##8##3##(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#2)
done in one##3##3##(1994-8#2)(2007-11#1)
done in only##2##3##(1991-3#1)(2013-1#1)
done in our##2##3##(1995-1#1)(2008-11#1)
done in the absence##2##4##(1995-2#1)(2008-4#1)
done in the field##2##4##(2008-10#2)
done in the##14##3##(1991-4#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)
done in##85##2##(1990-10#2)(1991-3#1)(1991-4#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-2#1)(2009-7#1)(2011-1#3)(2011-2#5)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
done laparoscopically##2##2##(2011-2#2)
done on a##3##3##(1990-6#1)(1996-5#1)(2012-2#1)
done on the##7##3##(1991-3#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
done on##25##2##(1990-6#1)(1991-11#1)(1991-3#1)(1993-12#1)(1993-6#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#3)
done only##2##2##(1993-12#1)(2010-8#1)
done over##2##2##(1990-12#1)(2011-2#1)
done simultaneously##2##2##(1991-2#1)(2011-2#1)
done so##3##2##(1991-11#1)(1996-2#1)(2012-1#1)
done through a##2##3##(1994-3#1)(2008-3#1)
done through the##5##3##(2008-10#2)(2012-12#2)(2012-2#1)
done through##8##2##(1994-1#1)(1994-3#1)(2008-10#2)(2008-3#1)(2012-12#2)(2012-2#1)
done to assess the##2##4##(2008-10#1)(2013-8#1)
done to compare the##5##4##(2007-7#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
done to determine the##2##4##(2008-10#1)(2008-11#1)
done to determine##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
done to ensure##3##3##(1991-1#1)(1992-11#1)(2008-5#1)
done to evaluate##2##3##(2008-12#1)(2008-6#1)
done to get##2##3##(2007-8#1)(2008-10#1)
done to reduce##2##3##(2011-1#1)(2013-1#1)
done to##52##2##(1990-5#1)(1991-1#1)(1992-11#2)(1992-8#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-8#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#4)
done under##5##2##(1992-12#1)(2008-4#1)(2008-5#1)(2011-1#2)
done using a##4##3##(2007-10#1)(2008-10#1)(2008-6#1)(2011-1#1)
done using the##2##3##(1997-8#2)
done using##16##2##(1996-5#1)(1997-8#2)(2007-10#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
done with a##2##3##(2007-11#1)(2007-8#1)
done with the##8##3##(1990-8#1)(2007-7#1)(2008-10#3)(2008-7#2)(2012-12#1)
done with two##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
done with##34##2##(1990-12#1)(1990-8#2)(1992-6#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#3)(2008-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
done within 72 hours##3##4##(2013-1#3)
done within##5##2##(2007-11#1)(2012-3#1)(2013-1#3)
done without##4##2##(2007-8#1)(2008-10#2)(2010-10#1)
done##519##1##(1990-10#2)(1990-12#2)(1990-3#4)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#4)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2007-10#2)(2007-11#10)(2007-12#5)(2007-5#1)(2007-7#14)(2007-8#14)(2008-1#7)(2008-10#87)(2008-11#15)(2008-12#14)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#21)(2008-6#6)(2008-7#15)(2008-8#9)(2008-9#5)(2009-1#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-6#2)(2010-7#4)(2010-8#8)(2011-1#13)(2011-2#26)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#16)(2012-3#3)(2013-1#31)(2013-7#3)(2013-8#27)
done?##4##1##(1991-3#1)(2008-6#1)(2012-12#2)
donkey leukocyte##3##2##(2008-9#3)
donkey meat from##2##3##(2010-4#2)
donkey##10##1##(1990-3#2)(2008-9#3)(2010-4#5)
donnan##2##1##(2008-10#1)(2011-2#1)
donnees##2##1##(2008-5#2)
données##5##1##(2011-2#1)(2013-1#4)
donor DNA##2##2##(2008-4#1)(2008-8#1)
donor ability##2##2##(2008-10#2)
donor agencies##2##2##(1994-3#1)(2012-12#1)
donor and acceptor##7##3##(1996-12#1)(2007-12#1)(2008-10#4)(2011-2#1)
donor and recipient##6##3##(2008-4#2)(2011-2#3)(2012-2#1)
donor and the##2##3##(1995-5#1)(2007-11#1)
donor and##25##2##(1990-7#1)(1995-11#2)(1995-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-4#2)(2009-8#1)(2011-2#6)(2012-2#1)(2013-7#1)
donor are##2##2##(2011-2#2)
donor atoms of##2##3##(1996-2#1)(2008-10#1)
donor atoms##5##2##(1996-2#2)(1997-7#1)(2008-10#2)
donor blood##3##2##(1990-8#2)(1993-6#1)
donor can##2##2##(1993-8#1)(2011-2#1)
donor cells were transferred and##2##5##(2008-9#2)
donor cells##10##2##(2008-11#1)(2008-9#9)
donor embryos##2##2##(1994-9#1)(2008-11#1)
donor ester##2##2##(1997-2#1)(2008-7#1)
donor evaluation##2##2##(2011-2#2)
donor for##4##2##(1995-6#1)(2007-9#1)(2008-10#1)(2008-9#1)
donor groups##2##2##(2008-10#2)
donor has##2##2##(1994-12#1)(2011-2#1)
donor heart##2##2##(2010-12#2)
donor in##3##2##(1994-5#1)(2008-10#1)(2013-1#1)
donor is##10##2##(1992-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#3)(2010-7#1)(2011-2#2)
donor kidney transplantation is##4##4##(2011-2#4)
donor kidney transplantation##10##3##(2007-10#1)(2011-2#9)
donor kidney##14##2##(2007-10#1)(2011-2#13)
donor knowledge##3##2##(1994-3#3)
donor liver##3##2##(2010-6#1)(2011-2#1)(2013-8#1)
donor livers##2##2##(2008-11#1)(2011-2#1)
donor lungs##2##2##(2007-8#1)(2011-3#1)
donor must be##2##3##(2011-2#2)
donor must##4##2##(2011-2#4)
donor nephrectomy is##4##3##(2007-7#1)(2009-3#1)(2011-2#2)
donor nephrectomy##8##2##(2007-7#2)(2009-3#1)(2011-2#5)
donor of##3##2##(2008-10#2)(2012-2#1)
donor oocyte##3##2##(1994-9#3)
donor oocytes##2##2##(1994-9#2)
donor or##3##2##(1991-11#1)(2007-12#1)(2008-1#1)
donor organs##3##2##(2009-3#1)(2010-6#1)(2011-2#1)
donor pancreata##2##2##(2010-11#1)(2010-12#1)
donor pool##3##2##(1992-12#1)(2008-10#1)(2010-11#1)
donor scars##2##2##(2008-9#2)
donor selection##3##2##(2011-2#1)(2011-3#1)(2012-12#1)
donor shortage##3##2##(2009-9#1)(2010-10#2)
donor site closure and##2##4##(2011-2#2)
donor site is a##2##4##(2008-6#1)(2008-7#1)
donor site morbidity and##2##4##(2011-2#2)
donor site morbidity##7##3##(2007-12#1)(2009-10#1)(2011-2#3)(2012-3#2)
donor site##26##2##(2007-12#2)(2008-6#3)(2008-7#2)(2009-10#1)(2011-1#1)(2011-2#11)(2012-2#1)(2012-3#2)(2013-1#3)
donor sites##2##2##(1994-11#1)(2011-2#1)
donor solution##2##2##(2008-10#2)
donor stream##5##2##(2008-10#5)
donor testing##2##2##(1994-2#2)
donor that##2##2##(2008-4#1)(2012-12#1)
donor to a##2##3##(2008-10#1)(2012-12#1)
donor to##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
donor transplant##4##2##(2011-2#4)
donor transplantation##2##2##(2011-2#2)
donor vesicles to##2##3##(1992-3#1)(1994-5#1)
donor vesicles##5##2##(1992-3#4)(1994-5#1)
donor wall##2##2##(1991-1#1)(1994-1#1)
donor was##4##2##(1991-7#2)(1995-11#1)(2013-8#1)
donor were##2##2##(1992-12#1)(2008-9#1)
donor with##2##2##(1991-9#1)(2009-2#1)
donor##370##1##(1990-10#1)(1990-11#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#2)(1991-3#3)(1991-5#4)(1991-7#4)(1991-9#1)(1992-10#2)(1992-12#5)(1992-3#4)(1992-6#5)(1992-8#1)(1993-11#5)(1993-12#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#3)(1994-6#1)(1994-9#7)(1995-11#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#13)(2008-12#1)(2008-3#1)(2008-4#12)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#23)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#83)(2011-3#4)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#4)
donor's##7##1##(1990-3#2)(1991-7#1)(1994-9#1)(2008-10#1)(2011-2#2)
donor)##4##1##(1991-7#1)(2008-10#2)(2011-2#1)
donor-acceptor##10##1##(1992-6#1)(2007-11#2)(2008-10#2)(2009-11#1)(2009-3#3)(2010-5#1)
donors and the##2##3##(1995-5#1)(2011-2#1)
donors and##21##2##(1990-6#1)(1991-3#1)(1994-5#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-12#1)(2009-3#1)(2010-7#2)(2011-2#3)(2012-12#1)
donors are##3##2##(2008-12#1)(2011-2#2)
donors as##3##2##(2008-5#2)(2012-2#1)
donors for the##2##3##(1991-9#1)(2012-12#1)
donors for their non-medical expenses##2##5##(2008-12#2)
donors for##9##2##(1990-12#1)(1991-9#1)(2008-12#3)(2011-2#2)(2012-12#2)
donors from##5##2##(1991-11#2)(1994-3#1)(1994-9#1)(2012-12#1)
donors in##12##2##(1992-12#1)(1992-6#1)(1996-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
donors is##4##2##(1997-7#3)(2011-2#1)
donors of age##2##3##(2011-2#2)
donors of##6##2##(1994-2#1)(1997-7#1)(2007-12#1)(2010-12#1)(2011-2#2)
donors or##2##2##(1990-7#1)(1994-3#1)
donors recruitment##2##2##(2008-10#2)
donors showed##3##2##(1990-6#1)(2008-11#1)(2008-7#1)
donors to##4##2##(1994-3#1)(1995-6#1)(2008-10#1)(2009-12#1)
donors using##2##2##(1997-7#1)(2008-10#1)
donors was##4##2##(1994-9#2)(2008-10#1)(2012-2#1)
donors were##11##2##(1990-11#2)(1994-12#1)(1995-3#1)(2008-1#1)(2008-11#3)(2010-12#1)(2011-2#1)(2012-2#1)
donors who##5##2##(1997-1#1)(2008-10#1)(2008-12#1)(2012-2#2)
donors with##7##2##(1993-12#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-7#2)
donors##231##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-6#3)(1990-7#1)(1991-11#3)(1991-3#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-9#5)(1995-3#2)(1995-5#5)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#7)(1997-8#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#20)(2008-11#15)(2008-12#20)(2008-4#2)(2008-5#4)(2008-7#9)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#33)(2011-3#2)(2012-12#8)(2012-2#13)(2013-1#4)(2013-7#1)
donors'##2##1##(2008-3#1)(2011-2#1)
donovani##3##1##(1990-7#1)(1997-7#1)(2008-7#1)
dont la##2##2##(2013-1#2)
dont##5##1##(2013-1#5)
doogh##3##1##(2013-7#3)
door to##3##2##(2007-11#1)(2008-4#1)(2011-2#1)
door##15##1##(1993-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-5#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#2)
doors of##2##2##(2009-5#1)(2012-2#1)
doors##7##1##(1993-12#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-2#1)(2012-3#1)
dopa##3##1##(1990-12#2)(1993-2#1)
dopamine (3-hydroxytyramine)##2##2##(2008-10#1)(2008-7#1)
dopamine (DA) and##2##3##(1994-2#1)(2008-10#1)
dopamine (DA)##26##2##(1992-12#1)(1992-7#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-12#3)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-6#2)(2008-7#1)(2009-7#1)(2013-1#1)
dopamine D(2) receptor##2##3##(2008-10#2)
dopamine D1 and##2##3##(1996-5#2)
dopamine D1 receptor##6##3##(1992-3#1)(1993-3#2)(1995-12#1)(1996-2#2)
dopamine D1##8##2##(1992-3#1)(1993-3#2)(1995-12#1)(1996-2#2)(1996-5#2)
dopamine D2 or##2##3##(1993-9#1)(1995-12#1)
dopamine D2 receptor gene##2##4##(1997-5#1)(2008-9#1)
dopamine D2 receptor loss##2##4##(1996-5#2)
dopamine D2 receptor##10##3##(1995-12#3)(1996-5#3)(1996-7#2)(1997-5#1)(2008-9#1)
dopamine D2 receptors and##3##4##(1992-12#1)(1995-12#2)
dopamine D2 receptors by##2##4##(1995-11#1)(1995-12#1)
dopamine D2 receptors in##3##4##(1993-5#1)(1993-9#1)(1995-12#1)
dopamine D2 receptors##12##3##(1992-12#1)(1993-5#1)(1993-9#1)(1995-11#1)(1995-12#6)(1996-5#2)
dopamine D2##26##2##(1992-12#1)(1993-5#1)(1993-9#2)(1995-11#3)(1995-12#10)(1996-5#5)(1996-7#2)(1997-5#1)(2008-9#1)
dopamine D3##4##2##(1995-2#2)(1997-5#1)(2008-9#1)
dopamine D4 receptor gene##2##4##(1993-9#1)(2008-9#1)
dopamine D4##3##2##(1993-9#2)(2008-9#1)
dopamine agonist quinpirole##2##3##(1993-3#2)
dopamine agonist##11##2##(1991-9#1)(1993-3#2)(2006-10#1)(2008-7#5)(2008-8#1)(2012-2#1)
dopamine agonists##9##2##(1993-12#1)(1994-3#1)(1996-3#1)(2008-4#1)(2008-7#5)
dopamine and norepinephrine##2##3##(1995-11#1)(2012-3#1)
dopamine and serotonin systems##2##4##(1993-1#1)(2008-9#1)
dopamine and serotonin##5##3##(1993-1#1)(1996-12#1)(1997-7#2)(2008-9#1)
dopamine and##24##2##(1990-8#1)(1991-1#1)(1993-1#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-10#8)(2008-7#3)(2008-9#1)(2012-3#1)
dopamine beta-hydroxylase (DBH)##2##3##(1995-12#1)(1997-3#1)
dopamine beta-hydroxylase##4##2##(1991-5#1)(1995-12#2)(1997-3#1)
dopamine biosynthesis and##2##3##(2008-10#1)(2008-11#1)
dopamine biosynthesis in PC12 cells##2##5##(2008-11#2)
dopamine biosynthesis##4##2##(2008-10#1)(2008-11#3)
dopamine cell firing rate##2##4##(1994-2#2)
dopamine cell##4##2##(1992-10#1)(1994-2#2)(1995-2#1)
dopamine cells##7##2##(1994-2#1)(1995-12#5)(2008-7#1)
dopamine conjugated to##2##3##(1993-8#2)
dopamine content in##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
dopamine from##4##2##(1992-3#1)(1997-7#1)(2008-10#1)(2008-4#1)
dopamine function##2##2##(1993-11#1)(2008-3#1)
dopamine has been developed##2##4##(2008-10#2)
dopamine hydrochloride##4##2##(2008-10#4)
dopamine in rat##2##3##(1992-7#1)(2008-10#1)
dopamine in the nigrostriatal system##2##5##(2008-7#2)
dopamine in the presence of ascorbic acid and uric acid##2##10##(2008-10#2)
dopamine in the presence of ascorbic acid##4##7##(2008-10#4)
dopamine in the##16##3##(1993-6#3)(1995-8#1)(2007-8#3)(2008-10#7)(2008-7#2)
dopamine in##32##2##(1990-8#1)(1992-7#1)(1993-6#4)(1993-8#1)(1994-3#1)(1995-8#1)(2007-8#4)(2008-10#17)(2008-7#2)
dopamine innervation##2##2##(1994-3#1)(2013-8#1)
dopamine lesion##2##2##(1996-12#1)(2008-7#1)
dopamine level##5##2##(1995-5#2)(1997-2#1)(2008-10#2)
dopamine levels in the##2##4##(1994-2#1)(2009-8#1)
dopamine levels##4##2##(1994-2#1)(1997-6#1)(2008-5#1)(2009-8#1)
dopamine ligand binding##2##3##(1996-12#2)
dopamine membrane transporter##2##3##(1996-12#2)
dopamine metabolism in the nucleus accumbens and striatum##2##8##(1993-12#1)(1997-7#1)
dopamine metabolism##3##2##(1993-12#1)(1997-7#1)(2009-8#1)
dopamine nerve##2##2##(1996-2#1)(1997-7#1)
dopamine neuron##2##2##(1995-2#2)
dopamine neurons in the##2##4##(1995-3#1)(1996-2#1)
dopamine neurons in##4##3##(1992-11#1)(1995-3#1)(1996-2#1)(2008-7#1)
dopamine neurons to##2##3##(1992-11#1)(2008-7#1)
dopamine neurons##12##2##(1992-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(2008-7#5)
dopamine on##5##2##(1993-5#2)(2008-10#3)
dopamine or##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
dopamine re-uptake site##2##3##(1995-12#2)
dopamine re-uptake##3##2##(1995-12#3)
dopamine receptor antagonist##4##3##(1995-12#1)(1995-2#1)(1996-2#2)
dopamine receptor binding##3##3##(1996-12#3)
dopamine receptor mRNA##2##3##(1993-5#2)
dopamine receptor stimulation##2##3##(1995-2#1)(2010-12#1)
dopamine receptor##17##2##(1992-12#1)(1993-5#2)(1994-5#1)(1995-12#1)(1995-2#3)(1996-12#3)(1996-2#2)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
dopamine receptors and##2##3##(1994-5#1)(2013-1#1)
dopamine receptors in the striatum##2##5##(1994-2#1)(1995-12#1)
dopamine receptors in the substantia nigra##2##6##(1995-2#2)
dopamine receptors in the##5##4##(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#2)
dopamine receptors##18##2##(1992-11#2)(1992-3#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#5)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
dopamine release in##2##3##(1993-6#1)(2008-4#1)
dopamine release##10##2##(1993-6#2)(1995-12#3)(1996-12#1)(1997-2#1)(2008-2#1)(2008-4#1)(2013-8#1)
dopamine reuptake##3##2##(1991-1#2)(1995-12#1)
dopamine sensing##5##2##(2008-10#5)
dopamine system##2##2##(1992-10#1)(1994-5#1)
dopamine systems##3##2##(1991-5#2)(1996-2#1)
dopamine to the##2##3##(1993-12#1)(1995-8#1)
dopamine to##4##2##(1993-12#1)(1993-8#1)(1995-8#1)(2007-8#1)
dopamine transporter##7##2##(1991-12#1)(1995-11#1)(1996-2#5)
dopamine uptake system##4##3##(1995-11#4)
dopamine were##5##2##(1990-7#1)(1990-8#2)(1993-8#2)
dopamine##409##1##(1990-7#1)(1990-8#6)(1991-1#5)(1991-12#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#6)(1992-12#3)(1992-3#3)(1992-7#2)(1993-1#2)(1993-11#1)(1993-12#8)(1993-3#5)(1993-5#6)(1993-6#8)(1993-8#6)(1993-9#5)(1994-2#7)(1994-3#4)(1994-5#5)(1994-8#3)(1995-11#11)(1995-12#30)(1995-2#15)(1995-3#3)(1995-5#4)(1995-8#5)(1996-12#15)(1996-2#17)(1996-3#1)(1996-5#8)(1996-7#4)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#9)(2006-10#1)(2007-8#5)(2008-10#85)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#35)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
dopamine)##2##1##(1995-8#1)(2008-1#1)
dopamine- and##2##2##(1991-10#1)(1995-11#1)
dopamine-##5##1##(1991-10#1)(1993-12#1)(1995-11#3)
dopamine-beta-hydroxylase (DBH)##3##2##(1995-11#1)(1995-5#1)(2013-1#1)
dopamine-beta-hydroxylase##5##1##(1995-11#2)(1995-5#2)(2013-1#1)
dopamine-containing neurons##2##2##(1996-2#1)(2009-10#1)
dopamine-dependent##2##1##(1993-6#1)(1996-5#1)
dopamine-depleted rats##2##2##(1994-3#1)(1996-2#1)
dopamine-mediated##2##1##(1994-2#1)(1996-2#1)
dopamine-producing##2##1##(1995-8#1)(2010-12#1)
dopaminergic (DA)##3##2##(1992-10#1)(1996-2#1)(1996-5#1)
dopaminergic activity in##3##3##(1995-5#1)(1997-8#1)(2008-7#1)
dopaminergic activity##5##2##(1992-12#1)(1995-5#1)(1997-8#1)(2008-7#2)
dopaminergic agents##3##2##(1997-4#1)(2008-7#1)(2012-12#1)
dopaminergic agonist##3##2##(1993-2#1)(2007-10#1)(2012-12#1)
dopaminergic and serotonergic##2##3##(1993-1#1)(2009-10#1)
dopaminergic and##7##2##(1993-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)
dopaminergic areas##3##2##(2008-10#3)
dopaminergic cell##2##2##(1996-12#1)(2008-7#1)
dopaminergic cells of##2##3##(1996-12#2)
dopaminergic drug withdrawal##3##3##(2009-11#3)
dopaminergic drug##4##2##(1995-12#1)(2009-11#3)
dopaminergic drugs##2##2##(2008-7#1)(2009-11#1)
dopaminergic function in##4##3##(2008-7#4)
dopaminergic function##6##2##(1994-5#1)(2008-7#4)(2012-2#1)
dopaminergic mechanism##2##2##(1991-1#1)(2013-1#1)
dopaminergic medication##3##2##(2010-12#1)(2013-1#1)(2013-8#1)
dopaminergic nerve##4##2##(1995-12#2)(1996-12#1)(1997-2#1)
dopaminergic neurons from##2##3##(1990-7#1)(1997-3#1)
dopaminergic neurons in the##6##4##(1996-12#1)(1997-3#2)(1997-6#1)(2008-7#2)
dopaminergic neurons in##10##3##(1996-12#2)(1996-5#1)(1997-3#2)(1997-6#1)(2008-7#4)
dopaminergic neurons of the substantia nigra##2##6##(1996-12#2)
dopaminergic neurons of the##4##4##(1996-12#2)(2008-7#2)
dopaminergic neurons##40##2##(1990-7#4)(1992-11#1)(1992-7#1)(1995-11#1)(1995-2#1)(1996-12#6)(1996-5#3)(1997-2#1)(1997-3#4)(1997-6#1)(2008-7#17)
dopaminergic neurotransmission##4##2##(1995-12#1)(1996-2#1)(2013-8#2)
dopaminergic reward##2##2##(2009-6#1)(2009-8#1)
dopaminergic stimulation##2##2##(2008-7#2)
dopaminergic system##10##2##(1994-5#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-1#2)(2012-12#1)
dopaminergic systems##3##2##(1993-5#1)(2008-10#1)(2008-5#1)
dopaminergic therapy##4##2##(2008-7#1)(2010-12#1)(2013-1#2)
dopaminergic transmission##3##2##(1994-2#1)(1995-2#1)(2008-7#1)
dopaminergic##165##1##(1990-7#7)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#4)(1993-6#1)(1994-2#2)(1994-3#2)(1994-5#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-5#5)(1996-12#14)(1996-2#5)(1996-5#5)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#38)(2009-10#1)(2009-11#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#3)(2012-1#2)(2012-12#6)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#3)
dopant levels##2##2##(2008-10#1)(2008-3#1)
dopant##6##1##(2008-10#1)(2008-2#2)(2008-3#2)(2010-11#1)
dope##5##1##(1990-11#1)(2007-11#1)(2008-3#2)(2008-7#1)
doped compounds##2##2##(2008-10#2)
doped fiber##2##2##(2008-10#1)(2008-2#1)
doped into##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
doped polymer##3##2##(2008-2#2)(2008-3#1)
doped samples##3##2##(2008-10#3)
doped with Rhodamine 6G##2##4##(2008-3#2)
doped with Rhodamine##3##3##(2007-11#1)(2008-3#2)
doped with Ru(bpy)(3)(2+)##2##3##(2008-10#2)
doped with a##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)
doped with praseodymium##2##3##(2007-12#1)(2008-2#1)
doped with silver##2##3##(2007-12#1)(2008-2#1)
doped with##47##2##(2007-11#8)(2007-12#7)(2008-10#17)(2008-11#1)(2008-2#5)(2008-3#7)(2009-2#2)
doped##98##1##(1991-9#1)(2007-11#11)(2007-12#15)(2008-10#40)(2008-11#1)(2008-2#11)(2008-3#12)(2008-7#1)(2009-2#3)(2012-2#1)(2013-8#2)
doping and##2##2##(2007-12#1)(2008-10#1)
doping behaviors in##2##3##(2009-11#2)
doping behaviors##3##2##(2009-11#3)
doping concentration##3##2##(2007-12#2)(2013-8#1)
doping concentrations##2##2##(2008-2#1)(2008-3#1)
doping control in##2##3##(1993-3#1)(2010-11#1)
doping control##7##2##(1993-3#1)(2008-10#1)(2010-11#5)
doping in##3##2##(1990-12#1)(1993-3#1)(2008-10#1)
doping of##3##2##(2008-10#2)(2008-3#1)
doping the##3##2##(2007-11#1)(2008-10#2)
doping##59##1##(1990-12#1)(1990-8#1)(1993-3#6)(1995-6#1)(2007-11#1)(2007-12#4)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-11#6)(2009-2#1)(2009-7#1)(2010-11#6)(2010-7#1)(2012-2#1)(2013-8#2)
doppler##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
doramectin and ivermectin##2##3##(1996-11#1)(1997-3#1)
dormancy progression in##3##3##(2012-8#3)
dormancy release in##3##3##(2012-8#3)
dormancy##22##1##(1992-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#4)(2009-10#1)(2012-8#10)
dormant D##2##2##(2008-8#2)
dormant buds##2##2##(2008-10#2)
dormant cell types##2##3##(2008-10#1)(2011-2#1)
dormant or##2##2##(1993-6#1)(2008-10#1)
dormant spores##2##2##(2011-2#2)
dormant##21##1##(1993-6#1)(2008-10#11)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#4)(2012-8#1)
dorsal and ventral##6##3##(1990-5#1)(1996-12#2)(2007-12#1)(2008-11#1)(2011-2#1)
dorsal and##10##2##(1990-5#1)(1991-12#1)(1991-2#1)(1996-12#3)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
dorsal augmentation##2##2##(2010-8#2)
dorsal caudate-putamen injections of##2##4##(1993-6#2)
dorsal caudate-putamen##5##2##(1993-6#5)
dorsal fin##7##2##(2008-5#1)(2010-8#1)(2013-7#5)
dorsal hippocampal afferent and##2##4##(1993-5#2)
dorsal hippocampus##7##2##(1991-2#2)(1992-3#1)(1995-12#1)(2008-11#2)(2013-8#1)
dorsal horn following##3##3##(1990-7#1)(1992-6#1)(1997-3#1)
dorsal horn of##5##3##(1993-12#1)(1994-2#1)(1995-12#1)(2008-7#1)(2011-2#1)
dorsal horn that##2##3##(1994-2#1)(1997-3#1)
dorsal horn##36##2##(1990-5#1)(1990-7#6)(1992-6#1)(1993-12#3)(1994-2#3)(1994-8#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#8)(2008-4#3)(2008-7#1)(2011-2#1)
dorsal lateral##3##2##(1992-10#1)(1997-7#1)(2008-10#1)
dorsal lips##5##2##(2011-2#5)
dorsal noradrenergic bundle##2##3##(1993-3#2)
dorsal nucleus of the##7##4##(1993-12#1)(1997-3#5)(2012-12#1)
dorsal nucleus of##8##3##(1991-7#1)(1993-12#1)(1997-3#5)(2012-12#1)
dorsal or##2##2##(1996-2#1)(2008-9#1)
dorsal pancreatic artery##2##3##(2008-7#2)
dorsal part of##2##3##(1996-5#2)
dorsal premotor cortex##2##3##(2010-7#1)(2013-1#1)
dorsal premotor##3##2##(1995-5#1)(2010-7#1)(2013-1#1)
dorsal radiolar##2##2##(2011-2#2)
dorsal raphe nucleus##5##3##(1992-3#2)(1993-12#1)(1993-3#1)(1995-5#1)
dorsal raphe of##3##3##(1994-2#2)(1997-6#1)
dorsal raphe##12##2##(1991-2#1)(1992-3#2)(1993-12#1)(1993-3#2)(1994-2#3)(1995-5#1)(1996-12#1)(1997-6#1)
dorsal region##2##2##(2007-12#1)(2009-3#1)
dorsal rhizotomy##2##2##(1995-12#1)(1996-5#1)
dorsal rim area##2##3##(2007-12#2)
dorsal root ganglia (DRG)##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
dorsal root ganglia##12##3##(1992-12#1)(1993-5#1)(1995-5#1)(1997-3#1)(1997-6#1)(2008-4#1)(2008-7#3)(2008-9#3)
dorsal root ganglion (DRG) neurons##4##5##(1993-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
dorsal root ganglion (DRG)##5##4##(1993-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
dorsal root ganglion neurons##3##4##(1992-9#1)(2008-5#1)(2013-8#1)
dorsal root ganglion##16##3##(1991-7#1)(1992-9#1)(1993-12#1)(1993-5#1)(1995-12#1)(1997-2#2)(2008-4#1)(2008-5#1)(2008-8#3)(2011-2#1)(2013-1#2)(2013-8#1)
dorsal root ganglionic##2##3##(1996-5#2)
dorsal root##33##2##(1990-5#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-5#2)(1995-12#1)(1995-5#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-6#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2011-2#1)(2013-1#2)(2013-8#1)
dorsal roots##2##2##(1994-8#1)(2013-1#1)
dorsal skin layers##5##3##(2008-11#5)
dorsal skin##7##2##(1996-6#1)(2008-10#1)(2008-11#5)
dorsal spinocerebellar##2##2##(1996-5#2)
dorsal striatum##5##2##(1993-6#1)(1996-2#1)(2010-2#1)(2013-8#2)
dorsal to the##2##3##(1993-12#1)(1996-5#1)
dorsal to##4##2##(1993-12#1)(1993-3#1)(1996-5#1)(2007-12#1)
dorsal##266##1##(1990-2#1)(1990-5#3)(1990-7#7)(1990-9#2)(1991-12#3)(1991-2#6)(1991-5#1)(1991-7#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#13)(1993-3#7)(1993-5#4)(1993-6#6)(1994-12#1)(1994-2#7)(1994-8#4)(1995-12#6)(1995-5#4)(1996-12#5)(1996-2#3)(1996-5#13)(1996-6#1)(1997-2#5)(1997-3#14)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#20)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#10)(2008-4#6)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#22)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#2)(2010-7#1)(2010-8#5)(2011-2#14)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#5)(2013-8#7)
dorsal-ventral patterning##2##2##(1994-12#1)(2012-12#1)
dorsal-ventral##3##1##(1994-12#1)(1997-3#1)(2012-12#1)
dorsalis (Hendel) and##2##3##(2011-2#1)(2013-8#1)
dorsalis (Hendel)##3##2##(2011-2#2)(2013-8#1)
dorsalis##13##1##(1991-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2010-7#2)(2011-2#3)(2013-8#1)
dorsally##3##1##(1994-12#1)(2007-12#1)(2013-1#1)
dorsi free##3##2##(2008-10#1)(2008-9#2)
dorsi muscle##4##2##(2008-7#1)(2010-2#1)(2010-4#1)(2013-1#1)
dorsi myocutaneous flap##2##3##(1990-9#1)(1993-11#1)
dorsi myocutaneous##3##2##(1990-9#1)(1993-11#1)(1994-12#1)
dorsi##27##1##(1990-9#2)(1991-5#1)(1992-9#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#3)
dorsiflexion range of motion were##2##5##(2007-11#2)
dorsiflexion range of motion##3##4##(2007-11#3)
dorsiflexion##7##1##(2007-11#4)(2009-11#1)(2011-2#2)
dorso-lateral##2##1##(2008-7#1)(2011-2#1)
dorso-medial##2##1##(2007-12#2)
dorso-ventral##2##1##(1993-5#1)(2008-6#1)
dorsolateral AVM##2##2##(2008-7#2)
dorsolateral and##2##2##(1996-5#1)(2007-12#1)
dorsolateral prefrontal cortex##3##3##(1996-2#1)(2010-7#2)
dorsolateral prefrontal##4##2##(1996-2#1)(2010-7#2)(2011-2#1)
dorsolateral##19##1##(1991-2#1)(1993-9#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-7#4)(2010-7#2)(2011-2#1)(2012-12#1)
dorsolumbar spinal injury##2##3##(2012-2#2)
dorsomedial##8##1##(1993-12#2)(1994-8#1)(1996-5#1)(1997-3#2)(2008-6#1)(2008-9#1)
dorsoventral axis##4##2##(1991-5#3)(2010-4#1)
dorsoventral pattern##3##2##(1991-5#3)
dorsoventral patterning##2##2##(1994-12#1)(1994-9#1)
dorsoventral##15##1##(1990-3#1)(1991-5#6)(1994-12#1)(1994-9#1)(1997-3#3)(2007-12#2)(2010-4#1)
dorsum of##7##2##(1997-4#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-3#1)
dorsum##8##1##(1997-4#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-3#1)
dorée phytoplasma##3##2##(2008-10#3)
dosage adjustments##2##2##(2008-1#2)
dosage and the##2##3##(2007-11#1)(2008-8#1)
dosage and##14##2##(1992-9#1)(1995-11#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#3)
dosage calculations##2##2##(2008-11#2)
dosage compensation are##2##3##(2007-12#2)
dosage compensation complex##3##3##(2007-12#3)
dosage compensation##8##2##(2007-12#8)
dosage effect##2##2##(1994-12#1)(2008-10#1)
dosage for##3##2##(1994-5#1)(2008-3#1)(2008-7#1)
dosage form and##3##3##(2008-10#2)(2010-5#1)
dosage form of##3##3##(2010-5#1)(2011-1#1)(2012-2#1)
dosage form##26##2##(2008-10#10)(2010-3#1)(2010-5#10)(2011-1#1)(2012-12#1)(2012-2#3)
dosage forms and biological fluids##5##5##(2008-10#5)
dosage forms and##6##3##(2008-10#6)
dosage forms as well##2##4##(2010-5#1)(2011-1#1)
dosage forms by##2##3##(2008-10#2)
dosage forms##42##2##(2008-10#33)(2010-5#3)(2011-1#3)(2012-2#3)
dosage in the##2##3##(1994-6#1)(2007-11#1)
dosage in##4##2##(1994-6#1)(1994-8#1)(2007-11#1)(2008-8#1)
dosage is##4##2##(1994-2#1)(2008-1#1)(2008-11#1)(2012-12#1)
dosage of 0##2##3##(1994-2#1)(2007-8#1)
dosage of 75##2##3##(1991-2#1)(1994-2#1)
dosage of levodopa##2##3##(2008-7#2)
dosage of the##2##3##(2007-8#1)(2011-2#1)
dosage of warfarin##2##3##(1990-12#1)(2011-1#1)
dosage of##38##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#1)(1996-3#2)(2006-10#2)(2007-8#2)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
dosage regimens##3##2##(1991-9#1)(2008-11#1)(2011-2#1)
dosage schedule##3##2##(2007-11#2)(2011-2#1)
dosage to##4##2##(1993-9#1)(1994-6#1)(2008-10#1)(2013-1#1)
dosage was reduced##2##3##(1996-7#1)(2013-1#1)
dosage was then##2##3##(2007-7#1)(2011-2#1)
dosage was##9##2##(1991-2#1)(1996-7#1)(1997-6#1)(2007-11#1)(2007-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
dosage##223##1##(1990-12#1)(1990-5#1)(1990-9#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#5)(1994-5#1)(1994-6#4)(1994-8#4)(1995-11#2)(1996-3#4)(1996-7#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#6)(2007-11#10)(2007-12#8)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#51)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#1)(2009-11#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#14)(2010-9#1)(2011-1#6)(2011-2#11)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#6)(2013-8#1)
dosage-dependent##4##1##(1993-9#1)(1995-5#1)(2008-10#1)(2008-3#1)
dosage</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##2##4##(1996-11#2)
dosages and##2##2##(2008-10#1)(2010-8#1)
dosages in##2##2##(1995-11#1)(2013-1#1)
dosages of these drugs##2##4##(1991-9#1)(1992-12#1)
dosages of##9##2##(1991-9#1)(1992-12#1)(1992-8#1)(1994-3#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
dosages that##2##2##(2009-5#1)(2010-2#1)
dosages##33##1##(1991-9#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-12#4)(1994-3#1)(1995-1#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#2)
dose (0##4##2##(1995-12#1)(1995-3#1)(2006-6#1)(2008-5#1)
dose (1##2##2##(2008-5#1)(2012-2#1)
dose (5##2##2##(2008-7#1)(2012-3#1)
dose (ED(50))##3##2##(2008-10#3)
dose (ID50)##2##2##(1992-2#1)(1995-3#1)
dose (renal dose) dopamine in the critically ill patient##2##9##(2007-8#2)
dose =##2##2##(1996-5#2)
dose DAC##2##2##(2013-8#2)
dose X-rays##2##2##(2008-10#1)(2008-7#1)
dose adjustment##3##2##(1997-8#1)(2008-3#1)(2013-1#1)
dose adjustments##2##2##(2006-10#1)(2010-6#1)
dose and duration##2##3##(2008-11#1)(2011-2#1)
dose and study duration##2##4##(2012-3#2)
dose and the##4##3##(2008-2#1)(2008-7#1)(2010-2#1)(2013-8#1)
dose and time dependent##2##4##(1992-3#2)
dose and time##4##3##(1992-12#1)(1992-3#2)(2008-10#1)
dose and##41##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
dose applied##4##2##(1994-7#1)(2008-10#3)
dose as##4##2##(1994-8#1)(1996-2#1)(2008-10#1)(2008-7#1)
dose at the##2##3##(2008-10#1)(2011-2#1)
dose at##5##2##(2007-10#2)(2008-10#2)(2011-2#1)
dose below the threshold##2##4##(2008-10#1)(2008-7#1)
dose below##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
dose but not##3##3##(1991-5#1)(2008-11#1)(2008-5#1)
dose but the##2##3##(1996-6#1)(2008-7#1)
dose but##6##2##(1991-5#1)(1996-6#1)(2008-11#1)(2008-5#1)(2008-7#2)
dose calculation##2##2##(2009-11#2)
dose characteristics of##2##3##(2008-3#1)(2010-11#1)
dose chemotherapy##3##2##(1997-3#1)(2008-8#2)
dose coefficients##2##2##(2008-2#2)
dose components##2##2##(1994-3#2)
dose concentration##2##2##(2008-7#2)
dose curves##3##2##(2008-3#2)(2008-7#1)
dose delivered##3##2##(1995-3#1)(1997-2#1)(2013-8#1)
dose dependency##2##2##(1994-3#1)(2008-5#1)
dose dependent and##2##3##(1992-5#1)(2007-11#1)
dose dependent manner##7##3##(1991-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-7#1)(2007-10#1)(2007-11#1)
dose dependent##24##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-12#1)(2008-5#2)(2012-12#1)
dose dependently##9##2##(1990-5#1)(1992-5#1)(1994-2#1)(1995-12#4)(2012-2#1)(2012-3#1)
dose distribution##6##2##(1994-3#1)(1995-9#1)(2008-3#2)(2009-2#2)
dose distributions and##2##3##(1994-8#1)(2007-5#1)
dose distributions for##5##3##(1994-3#2)(2009-2#2)(2010-9#1)
dose distributions of##2##3##(2009-2#1)(2010-9#1)
dose distributions##13##2##(1994-3#2)(1994-8#1)(2007-5#1)(2009-2#5)(2010-9#2)(2012-1#1)(2013-1#1)
dose due to##2##3##(2008-5#1)(2013-1#1)
dose during##2##2##(1995-8#1)(2007-7#1)
dose effect##4##2##(1993-6#1)(1995-5#1)(2008-6#1)(2008-7#1)
dose escalation##2##2##(2008-10#1)(2008-7#1)
dose exposures##5##2##(2008-7#5)
dose for a##2##3##(1997-8#1)(2013-1#1)
dose for##16##2##(1990-11#1)(1992-11#1)(1994-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#2)(2009-2#1)(2009-6#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
dose from##3##2##(1992-12#1)(1994-9#1)(2007-10#1)
dose group##5##2##(1993-12#1)(2008-5#1)(2010-1#2)(2010-11#1)
dose groups##3##2##(2008-9#1)(2010-5#1)(2012-2#1)
dose has been##2##3##(2011-2#1)(2013-1#1)
dose in a##2##3##(1994-3#1)(1997-2#1)
dose in the##2##3##(1994-8#1)(2009-11#1)
dose in##15##2##(1992-10#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-7#2)(2009-11#1)(2010-6#1)(2011-2#1)
dose increased##2##2##(2007-9#1)(2008-3#1)
dose inhaled##2##2##(1992-5#1)(1997-1#1)
dose inhalers (MDI)##3##3##(1992-3#2)(1996-1#1)
dose inhalers (MDIs)##8##3##(1992-3#1)(1996-1#5)(1997-1#1)(2008-3#1)
dose inhalers##20##2##(1992-2#3)(1992-3#6)(1993-2#1)(1996-1#8)(1997-1#1)(2008-3#1)
dose intensity was##2##3##(1992-10#1)(2008-6#1)
dose intensity##19##2##(1991-6#1)(1992-10#2)(1992-2#1)(1993-11#1)(1994-12#1)(2008-5#1)(2008-6#3)(2008-7#7)(2010-4#1)(2011-2#1)
dose is##13##2##(1995-3#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
dose level of##2##3##(1992-3#1)(2008-8#1)
dose level##7##2##(1992-3#1)(1994-5#2)(2008-8#2)(2013-1#2)
dose levels of##3##3##(1994-5#1)(2010-1#1)(2010-5#1)
dose levels##9##2##(1991-3#1)(1992-6#1)(1994-5#2)(1996-6#1)(2008-10#1)(2010-1#1)(2010-5#1)(2012-1#1)
dose limits##2##2##(1993-12#1)(2008-7#1)
dose may be##2##3##(1997-1#1)(2008-11#1)
dose may##6##2##(1993-11#1)(1993-9#1)(1997-1#1)(2008-11#1)(2008-6#1)(2012-1#1)
dose methotrexate##2##2##(1990-12#1)(2010-3#1)
dose model##2##2##(1996-12#1)(1996-3#1)
dose not##2##2##(1995-8#1)(2008-12#1)
dose of 0##14##3##(1990-9#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-12#1)(2008-12#1)(2008-7#1)(2011-1#2)(2013-1#1)(2013-8#1)
dose of 1##11##3##(1990-7#3)(1994-6#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
dose of 10 mg/kg##2##4##(1994-6#1)(2013-1#1)
dose of 10##7##3##(1991-6#1)(1994-6#1)(1994-8#1)(2007-10#1)(2008-6#1)(2012-3#1)(2013-1#1)
dose of 10(9)##2##3##(1997-1#1)(2008-9#1)
dose of 100##5##3##(1992-2#1)(1995-12#1)(2011-2#1)(2012-2#2)
dose of 1000##2##3##(1994-6#1)(2013-1#1)
dose of 15##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
dose of 2##10##3##(1992-12#1)(1992-3#1)(1995-5#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
dose of 20 mg##2##4##(1990-2#1)(1991-8#1)
dose of 20##5##3##(1990-2#1)(1991-8#1)(1994-8#1)(2008-1#1)(2008-6#1)
dose of 200##3##3##(2008-5#1)(2010-3#2)
dose of 3##3##3##(1990-12#1)(1995-12#1)(2012-2#1)
dose of 4##5##3##(1990-7#1)(1990-9#1)(2012-3#3)
dose of 40 Gy##3##4##(1992-11#1)(2008-6#1)(2009-11#1)
dose of 40 mg##2##4##(1995-5#1)(2007-7#1)
dose of 40##9##3##(1991-2#1)(1992-11#1)(1995-5#1)(1996-12#1)(2007-7#1)(2008-6#2)(2008-8#1)(2009-11#1)
dose of 5##4##3##(1994-6#1)(1996-12#1)(2008-3#1)(2012-3#1)
dose of 50 mg##2##4##(1990-11#1)(1994-8#1)
dose of 50##3##3##(1990-11#1)(1992-3#1)(1994-8#1)
dose of 500 mg kg(-1) bw##2##6##(2008-10#2)
dose of 500##4##3##(2008-10#2)(2013-1#2)
dose of 6 Gy##2##4##(2009-2#2)
dose of 6##6##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-2#2)
dose of 60##2##3##(2007-7#1)(2008-7#1)
dose of 75##2##3##(2008-6#2)
dose of 8##2##3##(1991-6#1)(2007-11#1)
dose of AdsiRNA-survivin##2##3##(2010-1#2)
dose of DPE in##2##4##(2013-1#2)
dose of EMR##2##3##(2008-12#2)
dose of IFN##2##3##(2009-8#2)
dose of KLH##2##3##(2008-10#2)
dose of PMA##2##3##(1994-8#2)
dose of TBTO##2##3##(2008-10#2)
dose of [14C] III##2##4##(1991-12#2)
dose of a##2##3##(1992-3#1)(1994-9#1)
dose of allergen##2##3##(2008-10#1)(2008-8#1)
dose of anesthetic##2##3##(2012-3#2)
dose of approximately##2##3##(2011-2#1)(2012-1#1)
dose of aspirin##2##3##(1993-2#1)(2011-2#1)
dose of atorvastatin##2##3##(2008-5#1)(2011-2#1)
dose of drug##3##3##(1993-12#1)(1997-1#1)(1997-4#1)
dose of hepatitis##2##3##(1995-3#1)(2007-2#1)
dose of insulin##2##3##(1994-6#1)(2008-3#1)
dose of intravenous##2##3##(1993-1#1)(2012-2#1)
dose of levodopa##2##3##(2008-7#2)
dose of medication##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
dose of methotrexate##2##3##(1995-8#2)
dose of misoprostol##2##3##(1995-8#2)
dose of morphine##2##3##(2008-12#2)
dose of pSinCMV-Vac-MEG990##2##3##(2013-1#2)
dose of prednisolone##2##3##(1995-5#1)(2008-1#1)
dose of radiation##6##3##(2008-6#1)(2008-7#3)(2009-11#1)(2013-1#1)
dose of the compound##2##4##(1994-6#2)
dose of the##13##3##(1990-11#1)(1990-6#1)(1994-6#2)(1997-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-3#2)(2010-11#1)(2013-1#1)
dose of##379##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-6#3)(1990-7#4)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#5)(1991-4#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#6)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#9)(1994-7#4)(1994-8#9)(1994-9#1)(1995-11#2)(1995-12#8)(1995-2#2)(1995-3#11)(1995-5#3)(1995-8#4)(1995-9#1)(1996-12#6)(1996-2#3)(1996-5#2)(1997-1#2)(1997-3#2)(1997-4#7)(1997-5#1)(1997-8#2)(2006-6#1)(2007-10#3)(2007-11#8)(2007-12#6)(2007-2#1)(2007-7#8)(2007-9#2)(2008-1#6)(2008-10#17)(2008-11#6)(2008-12#9)(2008-3#7)(2008-5#10)(2008-6#12)(2008-7#29)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#3)(2009-2#2)(2009-3#1)(2009-5#2)(2009-8#2)(2010-1#4)(2010-11#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#16)(2013-1#20)(2013-8#3)
dose on##4##2##(2007-11#2)(2008-10#1)(2008-5#1)
dose optimization points##3##3##(2009-2#3)
dose optimization##4##2##(2009-2#4)
dose or##2##2##(2008-10#1)(2008-11#1)
dose oral##8##2##(1994-5#1)(2007-11#1)(2008-11#3)(2011-1#1)(2013-1#2)
dose per fraction##2##3##(1993-9#1)(2008-6#1)
dose per##6##2##(1993-9#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
dose protected##3##2##(2008-7#3)
dose radiation (LDR)##2##3##(2008-7#1)(2013-1#1)
dose radiation##11##2##(1994-8#1)(2007-10#1)(2008-7#6)(2010-4#1)(2013-1#2)
dose range of##10##3##(1992-6#1)(1994-5#1)(1994-8#3)(1996-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
dose range##15##2##(1992-5#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-8#3)(1996-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)
dose ranged from 0##2##4##(2011-2#2)
dose ranged from##3##3##(2008-7#1)(2011-2#2)
dose ranged##4##2##(1991-8#1)(2008-7#1)(2011-2#2)
dose rate and fractionation##2##4##(2007-4#2)
dose rate and##4##3##(2007-4#2)(2008-7#1)(2013-1#1)
dose rate brachytherapy##3##3##(1994-3#1)(1995-8#1)(2009-11#1)
dose rate in air##2##4##(2012-2#2)
dose rate##25##2##(1990-6#1)(1994-3#1)(1994-8#1)(1995-8#1)(2007-11#1)(2007-4#4)(2008-2#1)(2008-6#1)(2008-7#5)(2009-11#3)(2011-2#2)(2012-2#3)(2013-1#1)
dose rates of##2##3##(2008-12#1)(2008-7#1)
dose rates##10##2##(1996-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-7#5)(2009-7#1)
dose received##4##2##(2008-6#1)(2009-10#1)(2009-11#2)
dose reduction##9##2##(1990-8#1)(1990-9#1)(1991-8#1)(1997-8#1)(2009-11#1)(2012-1#2)(2013-1#2)
dose reductions and##2##3##(2007-7#1)(2008-7#1)
dose reductions##6##2##(2007-7#1)(2008-7#4)(2012-1#1)
dose regimen##3##2##(1994-2#2)(2008-7#1)
dose regions##2##2##(1993-9#1)(2012-1#1)
dose related##7##2##(1991-11#1)(1993-8#1)(1994-11#1)(2008-10#3)(2013-1#1)
dose required##2##2##(1995-3#1)(2008-10#1)
dose response curves##3##3##(2008-11#1)(2008-7#2)
dose response relationships##3##3##(2008-7#3)
dose response##16##2##(1992-10#1)(1992-9#1)(1994-11#1)(2008-11#2)(2008-5#1)(2008-7#8)(2008-9#1)(2009-12#1)
dose responses##2##2##(2008-5#1)(2008-7#1)
dose responsive##2##2##(1992-5#1)(2008-11#1)
dose schedules##2##2##(1993-9#1)(2008-6#1)
dose selection##2##2##(2011-2#2)
dose should be##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
dose studies which##2##3##(2008-7#2)
dose studies##4##2##(2008-7#4)
dose tested##2##2##(1992-9#1)(2008-10#1)
dose than##3##2##(1997-2#1)(1997-7#1)(2012-12#1)
dose that##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2012-1#1)
dose to the##5##3##(1997-8#1)(2008-2#1)(2009-2#2)(2013-1#1)
dose to##20##2##(1991-12#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-2#1)(2009-2#4)(2012-1#3)(2013-1#2)(2013-8#1)
dose used##2##2##(2008-10#1)(2013-1#1)
dose variation##2##2##(1995-9#1)(2007-10#1)
dose versus##2##2##(1993-9#1)(2012-3#1)
dose was calculated for##2##4##(2007-8#1)(2012-2#1)
dose was increased to##2##4##(2006-10#1)(2011-1#1)
dose was increased##3##3##(1992-10#1)(2006-10#1)(2011-1#1)
dose was reduced##3##3##(1990-11#1)(1991-2#1)(1994-3#1)
dose was##31##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-2#2)(1992-10#3)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
dose while##2##2##(2011-3#1)(2012-3#1)
dose will##2##2##(2008-7#2)
dose with##4##2##(1993-9#1)(2008-10#1)(2008-7#1)(2010-10#1)
dose would be##2##3##(1990-6#1)(2008-7#1)
dose would##3##2##(1990-6#1)(2008-10#1)(2008-7#1)
dose##1300##1##(1990-10#1)(1990-11#7)(1990-12#7)(1990-2#4)(1990-5#2)(1990-6#6)(1990-7#5)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#7)(1991-12#9)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#7)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#12)(1992-11#3)(1992-12#9)(1992-2#9)(1992-3#19)(1992-5#8)(1992-6#3)(1992-8#7)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#5)(1993-6#6)(1993-8#5)(1993-9#13)(1994-11#4)(1994-12#2)(1994-2#6)(1994-3#14)(1994-5#9)(1994-6#14)(1994-7#10)(1994-8#17)(1994-9#5)(1995-11#5)(1995-12#21)(1995-2#4)(1995-3#20)(1995-5#5)(1995-8#8)(1995-9#4)(1996-1#9)(1996-12#13)(1996-2#8)(1996-3#1)(1996-5#9)(1996-6#9)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#7)(1997-3#5)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#9)(2006-10#3)(2006-6#2)(2007-10#21)(2007-11#25)(2007-12#15)(2007-2#1)(2007-4#10)(2007-5#2)(2007-7#15)(2007-8#3)(2007-9#3)(2008-1#16)(2008-10#96)(2008-11#27)(2008-12#21)(2008-2#8)(2008-3#27)(2008-4#3)(2008-5#35)(2008-6#30)(2008-7#159)(2008-8#14)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#16)(2009-12#1)(2009-2#18)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#3)(2010-1#7)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#4)(2010-3#7)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#46)(2011-3#1)(2012-1#22)(2012-12#15)(2012-2#29)(2012-3#32)(2013-1#60)(2013-8#10)
dose)##10##1##(1992-10#1)(1992-11#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2011-2#1)
dose- and time-dependent##17##3##(1990-5#1)(1991-5#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2011-2#4)(2013-1#1)
dose- and##19##2##(1990-5#1)(1991-5#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#4)(2013-1#1)
dose-##21##1##(1990-5#1)(1991-5#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2011-2#4)(2013-1#2)
dose-dependant##2##1##(2008-10#1)(2011-1#1)
dose-dependent and##4##2##(1992-9#1)(2008-5#1)(2008-8#1)(2008-9#1)
dose-dependent decrease of licking##2##4##(2013-7#2)
dose-dependent decrease of##4##3##(1995-12#1)(2013-1#1)(2013-7#2)
dose-dependent decrease##6##2##(1993-11#1)(1994-8#1)(1995-12#1)(2013-1#1)(2013-7#2)
dose-dependent depression of##2##3##(1992-3#1)(1995-12#1)
dose-dependent depression##3##2##(1992-3#1)(1995-12#2)
dose-dependent effect##3##2##(2008-2#1)(2011-2#1)(2012-12#1)
dose-dependent effects##2##2##(1993-12#1)(2010-11#1)
dose-dependent fashion in##4##3##(1991-5#1)(1992-12#1)(1992-8#1)(2007-10#1)
dose-dependent fashion##14##2##(1991-5#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-5#1)
dose-dependent in##2##2##(1996-12#1)(2008-11#1)
dose-dependent increase in the##3##4##(1991-12#1)(1993-12#1)(2012-2#1)
dose-dependent increase in##16##3##(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#2)(1995-12#1)(1996-12#1)(1997-4#1)(2006-6#1)(2008-10#3)(2008-5#2)(2012-2#1)
dose-dependent increase of##2##3##(1994-9#1)(2009-12#1)
dose-dependent increase##19##2##(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-9#1)(1995-12#1)(1996-12#1)(1997-4#1)(2006-6#1)(2008-10#3)(2008-5#2)(2009-12#1)(2011-2#1)(2012-2#1)
dose-dependent increases in##2##3##(1990-7#1)(1996-2#1)
dose-dependent increases##3##2##(1990-7#1)(1996-2#1)(1997-7#1)
dose-dependent inhibition of##9##3##(1990-12#2)(1992-12#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-5#1)
dose-dependent manner and##4##3##(1993-11#1)(1993-6#1)(1994-8#1)(2008-11#1)
dose-dependent manner in##7##3##(1991-10#2)(1992-8#1)(1993-11#1)(1994-6#1)(1995-8#1)(2008-11#1)
dose-dependent manner##86##2##(1990-12#1)(1990-2#1)(1990-8#3)(1991-10#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#4)(1995-6#1)(1995-8#5)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#2)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
dose-dependent reduction in##7##3##(1991-12#1)(1992-12#1)(1993-11#1)(1994-9#1)(1997-2#1)(2008-7#2)
dose-dependent reduction##10##2##(1991-12#1)(1992-12#2)(1993-11#1)(1994-9#1)(1995-12#2)(1997-2#1)(2008-7#2)
dose-dependent response was##2##3##(1993-9#1)(2010-3#1)
dose-dependent toxicity##2##2##(2008-7#2)
dose-dependent##230##1##(1990-12#4)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#2)(1991-12#3)(1991-2#2)(1991-5#2)(1991-9#1)(1992-11#2)(1992-12#6)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#1)(1993-11#5)(1993-12#3)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#6)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#4)(1995-11#4)(1995-12#16)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#5)(1996-12#4)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#3)(1997-7#5)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#12)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#11)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#3)(2010-1#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)
dose-dependently decreased##3##2##(1990-12#1)(2011-2#1)(2012-3#1)
dose-dependently inhibited by##2##3##(1995-6#1)(2008-5#1)
dose-dependently inhibited the##4##3##(1990-2#1)(1990-7#1)(1991-12#1)(2008-11#1)
dose-dependently inhibited##11##2##(1990-2#1)(1990-7#2)(1991-12#2)(1993-6#1)(1994-3#1)(1995-6#1)(2008-11#2)(2008-5#1)
dose-dependently suppressed##2##2##(1991-9#1)(2011-2#1)
dose-dependently##30##1##(1990-12#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-12#3)(1991-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-3#2)(1995-6#1)(2008-11#5)(2008-5#2)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
dose-effect##6##1##(1991-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(2008-7#1)(2011-1#1)
dose-intense##2##1##(2008-6#2)
dose-limiting toxicity##4##2##(1994-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
dose-limiting##8##1##(1994-8#1)(2008-3#1)(2008-5#2)(2008-7#3)(2013-1#1)
dose-ranging##3##1##(1992-8#1)(1994-9#1)(2008-8#1)
dose-rate##7##1##(1994-8#2)(2008-6#1)(2013-1#4)
dose-rates of##3##2##(2013-1#3)
dose-rates##7##1##(2008-7#1)(2013-1#6)
dose-related and##2##2##(2008-10#1)(2013-1#1)
dose-related decreases in##2##3##(1994-2#2)
dose-related effects of##2##3##(1997-4#1)(2011-2#1)
dose-related effects##3##2##(1991-1#1)(1997-4#1)(2011-2#1)
dose-related increase##2##2##(2008-10#1)(2008-9#1)
dose-related##36##1##(1990-10#1)(1991-1#2)(1991-12#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#3)(1994-8#1)(1995-11#1)(1996-1#1)(1997-2#2)(1997-4#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-9#4)(2011-2#1)(2013-1#1)
dose-response assessment##2##2##(1993-12#1)(2008-5#1)
dose-response characteristics##2##2##(2008-10#1)(2008-7#1)
dose-response curve for##3##3##(1993-12#1)(1995-8#1)(1996-2#1)
dose-response curve##14##2##(1993-12#2)(1994-11#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-7#2)
dose-response curves##10##2##(1993-6#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-12#1)(2008-7#5)
dose-response experiments##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
dose-response model##2##2##(2008-10#1)(2008-7#1)
dose-response nonlinearities##3##2##(2008-7#3)
dose-response of##2##2##(1990-7#1)(1996-2#1)
dose-response relation##2##2##(1994-8#1)(2013-1#1)
dose-response relations##2##2##(2008-7#2)
dose-response relationship and##2##3##(2008-7#1)(2011-2#1)
dose-response relationship between##3##3##(2008-10#1)(2011-1#2)
dose-response relationship for##2##3##(1990-8#1)(1994-8#1)
dose-response relationship##19##2##(1990-6#1)(1990-8#2)(1992-9#1)(1993-9#1)(1994-8#1)(1996-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
dose-response relationships for##4##3##(1995-8#1)(2008-7#3)
dose-response relationships in##3##3##(2008-10#1)(2008-7#2)
dose-response relationships##18##2##(1991-12#1)(1994-5#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-7#9)(2013-8#1)
dose-response study##4##2##(1994-8#2)(2008-5#1)(2012-2#1)
dose-response##104##1##(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-10#1)(1992-9#1)(1993-12#6)(1993-6#1)(1993-9#1)(1994-11#4)(1994-5#1)(1994-8#5)(1995-12#2)(1995-3#2)(1995-8#2)(1996-12#1)(1996-2#4)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#31)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
dose-responses##5##1##(1995-3#4)(2008-7#1)
dose-volume histogram##2##2##(1995-8#1)(1995-9#1)
dose-volume##3##1##(1995-8#1)(1995-9#1)(2008-11#1)
dose/response##3##1##(1993-8#1)(2008-10#2)
dosed at##2##2##(2008-10#2)
dosed groups of mice##4##4##(2008-9#4)
dosed groups of##10##3##(2008-9#10)
dosed groups##21##2##(1996-12#1)(2008-9#20)
dosed males##8##2##(2008-9#8)
dosed with F3TdR##2##3##(1994-8#2)
dosed with##10##2##(1994-8#2)(2008-10#1)(2008-5#2)(2008-9#5)
dosed##57##1##(1994-8#2)(1995-11#1)(1995-12#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#40)(2011-3#1)(2013-1#3)
doses &lt##2##2##(2008-7#2)
doses (&gt##2##2##(1993-11#1)(2008-6#1)
doses (0##2##2##(1994-8#1)(1997-7#1)
doses (2##2##2##(2010-6#1)(2011-2#1)
doses above##2##2##(2008-7#2)
doses and concentrations##2##3##(2008-10#2)
doses and dose rates##2##4##(2008-7#2)
doses and the##3##3##(1994-9#1)(2008-7#1)(2009-11#1)
doses and##26##2##(1992-2#1)(1993-9#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
doses and/or##2##2##(1992-9#1)(2009-12#1)
doses are##7##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-9#1)(1996-6#1)(2012-2#1)
doses as low as##3##4##(1990-4#1)(2008-10#1)(2008-5#1)
doses as##5##2##(1990-4#1)(1992-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
doses at the gonads##2##4##(2009-11#2)
doses at##4##2##(2008-10#1)(2009-11#2)(2013-7#1)
doses below##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
doses between##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
doses by##6##2##(1995-12#2)(2007-10#1)(2007-7#1)(2008-8#2)
doses could##2##2##(1990-5#1)(2008-8#1)
doses decreased##2##2##(1991-10#1)(2008-3#1)
doses for##10##2##(1993-9#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
doses from##5##2##(1992-11#1)(1995-12#2)(2013-1#2)
doses greater than##2##3##(1992-8#1)(2008-7#1)
doses have##3##2##(2008-12#1)(2008-7#1)(2009-11#1)
doses i##3##2##(1992-5#2)(2013-1#1)
doses in##9##2##(1990-11#1)(1990-8#1)(1992-2#1)(1997-2#1)(2008-12#1)(2008-7#3)(2009-11#1)
doses increased##2##2##(2007-10#1)(2008-7#1)
doses is##3##2##(1995-12#1)(2007-11#1)(2013-8#1)
doses may##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
doses of 0##5##3##(1995-11#2)(2008-10#1)(2010-11#1)(2013-8#1)
doses of 1##8##3##(1990-7#1)(1993-6#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
doses of 2##4##3##(1991-8#1)(2008-7#2)(2012-3#1)
doses of 250##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
doses of 5##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
doses of 50 and##2##4##(2008-12#1)(2008-5#1)
doses of 50##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
doses of DNA damaging agents##3##5##(2008-7#3)
doses of E##3##3##(1994-7#2)(2008-5#1)
doses of EP-IPV##2##3##(1995-5#2)
doses of IV##2##3##(2006-10#1)(2008-1#1)
doses of O(3)##2##3##(2008-5#2)
doses of antigen##5##3##(1995-5#1)(2008-11#4)
doses of apomorphine##2##3##(1992-11#1)(1997-2#1)
doses of approximately##13##3##(2007-6#1)(2008-8#3)(2008-9#9)
doses of aspirin##3##3##(1991-11#1)(1992-5#1)(2006-10#1)
doses of corticosteroids##2##3##(2006-10#2)
doses of drug##2##3##(1996-2#2)
doses of each##2##3##(1993-6#1)(2008-5#1)
doses of inhaled corticosteroids##2##4##(2007-11#2)
doses of ionizing##7##3##(2008-7#3)(2011-1#2)(2013-1#2)
doses of medication##3##3##(1992-3#1)(1994-7#1)(1997-4#1)
doses of methotrexate##3##3##(1990-12#1)(1992-6#1)(2010-3#1)
doses of oral polio##2##4##(1994-9#1)(2007-10#1)
doses of oral##4##3##(1994-9#1)(1995-3#1)(2007-10#1)(2007-7#1)
doses of radiation can##2##4##(2008-7#2)
doses of radiation##12##3##(1993-9#2)(2008-7#9)(2010-4#1)
doses of the##7##3##(1992-11#1)(1993-1#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-12#1)
doses of these##2##3##(2008-11#1)(2009-7#1)
doses of##308##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#1)(1993-6#2)(1993-9#4)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#3)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-7#5)(2006-10#4)(2007-10#4)(2007-11#5)(2007-2#3)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#11)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#14)(2008-6#2)(2008-7#43)(2008-8#6)(2008-9#9)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-3#3)(2010-4#1)(2011-1#6)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#13)(2013-8#2)
doses relative to##2##3##(1993-1#1)(1997-4#1)
doses tested##3##2##(1993-6#1)(1994-11#1)(2010-1#1)
doses that##7##2##(1992-6#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-3#1)
doses the##2##2##(1996-6#1)(2013-1#1)
doses to the##2##3##(2008-7#1)(2009-2#1)
doses to##7##2##(1997-8#2)(2008-10#1)(2008-7#3)(2009-2#1)
doses up to##3##3##(1994-8#1)(1997-7#1)(2008-7#1)
doses used##2##2##(1992-11#1)(2013-1#1)
doses was significantly##2##3##(1994-2#1)(2012-2#1)
doses was##4##2##(1994-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
doses were##14##2##(1992-8#1)(1995-12#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-3#1)(2012-12#1)
doses when##2##2##(2008-12#1)(2009-11#1)
doses which##3##2##(1991-9#1)(1996-2#1)(2008-7#1)
doses with##6##2##(1992-5#1)(1994-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2012-2#1)
doses without##2##2##(1991-11#1)(2009-11#1)
doses##639##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-11#9)(1992-12#1)(1992-2#4)(1992-3#8)(1992-5#5)(1992-6#4)(1992-8#4)(1992-9#4)(1993-1#4)(1993-11#2)(1993-12#1)(1993-6#3)(1993-9#12)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#3)(1994-8#5)(1994-9#6)(1995-11#2)(1995-12#12)(1995-2#5)(1995-3#6)(1995-5#6)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#5)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#2)(2006-10#5)(2007-10#11)(2007-11#9)(2007-12#1)(2007-2#4)(2007-6#3)(2007-7#9)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#47)(2008-11#22)(2008-12#13)(2008-2#1)(2008-3#10)(2008-5#28)(2008-6#7)(2008-7#90)(2008-8#16)(2008-9#17)(2009-11#11)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#9)(2012-2#17)(2012-3#3)(2013-1#27)(2013-7#1)(2013-8#5)
doses)##2##1##(2008-4#1)(2008-5#1)
dosimeter##9##1##(1991-5#4)(1993-1#3)(2009-11#1)(2013-1#1)
dosimeters and##2##2##(1993-9#1)(2008-3#1)
dosimeters##11##1##(1993-1#2)(1993-11#1)(1993-9#1)(1995-9#1)(2007-10#2)(2008-3#4)
dosimetric data##2##2##(2009-11#1)(2012-1#1)
dosimetric##9##1##(1994-3#1)(1995-12#1)(1995-8#1)(2007-4#1)(2007-5#1)(2009-11#1)(2012-1#1)(2013-1#2)
dosimetries##2##1##(2013-1#2)
dosimetry and##4##2##(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)
dosimetry has##2##2##(2007-4#1)(2008-7#1)
dosimetry of##2##2##(1993-1#1)(2008-10#1)
dosimetry protocol##2##2##(2012-1#2)
dosimetry##21##1##(1992-3#1)(1993-1#1)(1994-3#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-3#3)(2008-7#4)(2009-12#2)(2009-2#1)(2009-4#1)(2012-1#2)(2013-7#1)(2013-8#1)
dosing and##7##2##(2008-10#1)(2008-11#1)(2011-10#1)(2012-1#1)(2012-12#3)
dosing characteristics##2##2##(1995-12#1)(1997-2#1)
dosing errors##2##2##(2010-8#2)
dosing for##4##2##(2008-7#3)(2013-1#1)
dosing in##3##2##(1991-8#1)(2008-9#1)(2010-5#1)
dosing interval##2##2##(1992-8#1)(2009-11#1)
dosing is##2##2##(2008-1#1)(2008-7#1)
dosing of##9##2##(1997-4#1)(2006-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
dosing on##2##2##(1996-3#1)(2008-7#1)
dosing phase##2##2##(2008-7#2)
dosing regimen##5##2##(1994-2#1)(1996-5#1)(2008-5#2)(2008-7#1)
dosing regimens##3##2##(2008-5#1)(2008-7#1)(2010-11#1)
dosing schedule##2##2##(1996-3#1)(2008-5#1)
dosing schedules##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
dosing time##3##2##(2008-5#1)(2008-8#2)
dosing was##2##2##(2008-5#1)(2008-7#1)
dosing##100##1##(1991-8#2)(1992-3#1)(1992-8#5)(1994-2#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-3#6)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#3)(2006-10#3)(2008-1#4)(2008-10#3)(2008-11#5)(2008-3#1)(2008-5#10)(2008-7#19)(2008-8#4)(2008-9#3)(2009-11#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#5)
dot blot hybridization technique##2##4##(1994-1#1)(2008-10#1)
dot blot hybridization##5##3##(1994-1#2)(2008-10#3)
dot blot##14##2##(1993-12#1)(1994-1#2)(2008-10#10)(2008-9#1)
dot##44##1##(1990-12#1)(1990-5#2)(1992-11#1)(1993-12#1)(1994-1#2)(1994-8#1)(1995-2#2)(1997-4#1)(2007-11#2)(2008-10#15)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#4)(2010-12#1)(2012-2#3)
dot-blot##3##1##(1990-8#1)(1991-2#1)(2008-10#1)
dot-embedded##2##1##(2009-6#2)
dothidea conidia##3##2##(2008-10#3)
dothidea from##4##2##(2008-10#4)
dothidea hyphae##2##2##(2008-10#2)
dothidea isolates##2##2##(2008-10#2)
dothidea##25##1##(2008-10#25)
dots and a##2##3##(2007-11#1)(2008-3#1)
dots and##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
dots are grown by##2##4##(2008-7#1)(2009-11#1)
dots are##5##2##(2008-10#1)(2008-7#2)(2009-11#1)(2012-2#1)
dots in the##2##3##(2007-11#1)(2008-8#1)
dots in##6##2##(2007-11#3)(2008-10#1)(2008-5#1)(2008-8#1)
dots of##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
dots on the##2##3##(2009-11#1)(2013-8#1)
dots on##3##2##(2008-10#1)(2009-11#1)(2013-8#1)
dots to##2##2##(2008-10#1)(2008-7#1)
dots with##3##2##(2007-12#1)(2008-10#1)(2009-11#1)
dots##81##1##(1995-12#1)(1995-3#3)(1996-8#1)(2007-11#13)(2007-12#4)(2008-10#24)(2008-3#5)(2008-5#1)(2008-7#9)(2008-8#2)(2009-10#1)(2009-11#10)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#4)
dotted##3##1##(2008-3#1)(2008-9#1)(2009-8#1)
double Suzuki##2##2##(2008-11#2)
double and triple##2##3##(1991-9#1)(1992-8#1)
double and##4##2##(1991-9#1)(1992-8#1)(1995-6#1)(2008-10#1)
double antibody##3##2##(1990-12#1)(1993-8#1)(2008-10#1)
double beam UV-vis spectrophotometer##2##4##(2008-10#2)
double blind and##2##3##(2008-5#1)(2011-2#1)
double blind clinical##3##3##(1991-5#1)(1996-9#1)(2008-11#1)
double blind randomized##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
double blind study##3##3##(1994-11#1)(2008-7#1)(2010-7#1)
double blind trial##3##3##(1990-5#1)(1997-1#1)(2008-10#1)
double blind##23##2##(1990-5#1)(1991-5#1)(1994-11#2)(1996-9#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#2)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)
double bond in the##2##4##(1992-3#1)(2007-11#1)
double bond in##3##3##(1992-3#1)(1996-5#1)(2007-11#1)
double bond##12##2##(1992-3#1)(1992-6#1)(1995-8#1)(1996-5#2)(2007-11#2)(2008-10#2)(2009-8#1)(2009-9#1)(2011-2#1)
double bonds of##2##3##(1991-5#1)(1996-5#1)
double bonds##7##2##(1991-5#1)(1994-11#1)(1996-5#1)(2009-7#2)(2010-2#2)
double cell quartz crystal##2##4##(2008-10#2)
double centering##2##2##(2008-10#2)
double chamber bulk acoustic wave##2##5##(2008-10#2)
double dispersion##2##2##(2008-2#2)
double dissociation of##2##3##(2008-2#1)(2008-6#1)
double divisor-ratio spectra derivative and ratio spectra-zero crossing methods##2##9##(2008-10#2)
double divisor-ratio spectra derivative##3##4##(2008-10#3)
double dose##2##2##(1992-12#1)(1997-6#1)
double emulsion##4##2##(1994-12#4)
double fertilization##3##2##(2009-12#2)(2009-8#1)
double helical##3##2##(2008-10#3)
double helix DNA##3##3##(2008-10#3)
double helix##11##2##(1995-8#2)(2008-10#6)(2008-11#1)(2008-7#2)
double in##2##2##(1995-8#1)(2008-5#1)
double infection##2##2##(1990-8#1)(2008-10#1)
double jeopardy##2##2##(1992-1#1)(2008-11#1)
double knockout##7##2##(2007-8#1)(2008-8#5)(2009-10#1)
double labelled##2##2##(1994-10#1)(1995-5#1)
double labelling##2##2##(1994-10#1)(1995-5#1)
double layer of##3##3##(2008-10#1)(2008-5#2)
double layer##5##2##(2008-10#3)(2008-5#2)
double layers##2##2##(2008-10#1)(2008-3#1)
double localization##2##2##(2007-8#1)(2009-10#1)
double lumen##3##2##(1997-6#1)(2007-7#1)(2010-7#1)
double membrane phase separator##2##4##(2008-10#2)
double membrane##3##2##(2008-10#2)(2008-9#1)
double monochromator##2##2##(2008-2#1)(2008-3#1)
double mutant strain##2##3##(1994-12#1)(2008-7#1)
double mutant##12##2##(1990-11#1)(1993-9#1)(1994-12#1)(1995-6#4)(1997-1#1)(2008-7#1)(2009-10#1)(2012-2#2)
double mutants##5##2##(1994-11#1)(1997-4#1)(2008-9#1)(2009-10#1)(2009-8#1)
double negative##5##2##(2008-10#2)(2008-12#1)(2008-5#2)
double or triple##2##3##(2008-10#1)(2012-3#1)
double or##3##2##(1991-4#1)(2008-10#1)(2012-3#1)
double pass##2##2##(2007-12#1)(2008-3#1)
double peak##3##2##(1992-11#1)(2008-10#1)(2010-11#1)
double positive##2##2##(1997-7#1)(2008-10#1)
double presence##2##2##(2011-2#2)
double product##2##2##(2008-7#2)
double quantum dot##2##3##(2012-2#2)
double resistance to##2##3##(1993-8#1)(2008-10#1)
double resistance##3##2##(1993-8#1)(2008-10#2)
double staining##3##2##(1990-12#1)(2008-9#1)(2013-7#1)
double strand break##3##3##(1996-2#2)(2011-1#1)
double strand breaks (DSB)##2##4##(1995-6#1)(2008-11#1)
double strand breaks##6##3##(1994-11#2)(1995-6#1)(2008-11#1)(2011-1#1)(2012-3#1)
double strand##11##2##(1994-11#2)(1995-6#1)(1996-2#2)(2008-11#1)(2008-9#1)(2011-1#3)(2012-3#1)
double stranded (ds)##2##3##(2008-10#2)
double stranded DNA (dsDNA)##2##4##(2008-10#2)
double stranded DNA##5##3##(1990-12#1)(2007-11#1)(2008-10#2)(2013-8#1)
double stranded##15##2##(1990-12#1)(1990-5#1)(1994-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2013-8#1)
double that##4##2##(1994-6#1)(2008-1#1)(2008-10#2)
double the##10##2##(1991-3#1)(1992-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-12#1)(2013-1#1)
double their##3##2##(2007-8#1)(2008-4#1)(2009-10#1)
double vision##4##2##(1996-9#1)(2011-2#3)
double##368##1##(1990-11#1)(1990-12#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#6)(1993-9#1)(1994-10#2)(1994-11#6)(1994-12#5)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-6#7)(1995-8#5)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#7)(1996-6#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#7)(2007-12#8)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#72)(2008-11#15)(2008-12#1)(2008-2#10)(2008-3#19)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#9)(2009-10#7)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-11#2)(2010-2#4)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#4)
double- and##4##2##(1991-5#1)(1992-6#1)(1993-3#1)(2009-7#1)
double-##7##1##(1991-5#1)(1992-6#1)(1993-3#1)(2007-12#1)(2008-3#1)(2009-7#1)(2013-8#1)
double-L system##2##2##(2007-12#2)
double-antibody sandwich enzyme-linked immunosorbent assay##4##5##(2008-10#4)
double-antibody sandwich##7##2##(2008-10#6)(2010-12#1)
double-antibody##8##1##(2008-10#7)(2010-12#1)
double-balloon endoscopy##3##2##(2008-3#1)(2010-12#2)
double-balloon enteroscopy##2##2##(2012-2#1)(2013-1#1)
double-balloon##5##1##(2008-3#1)(2010-12#2)(2012-2#1)(2013-1#1)
double-blind clinical trials##2##3##(2008-2#1)(2012-2#1)
double-blind clinical##3##2##(1990-5#1)(2008-2#1)(2012-2#1)
double-blind fashion##2##2##(2008-5#2)
double-blind placebo-controlled clinical##2##3##(2008-5#1)(2008-7#1)
double-blind placebo-controlled study##2##3##(2008-5#1)(2010-8#1)
double-blind placebo-controlled##5##2##(2008-5#2)(2008-7#1)(2009-5#1)(2010-8#1)
double-blind randomized study##2##3##(1994-8#1)(2012-12#1)
double-blind randomized##6##2##(1991-3#1)(1994-6#1)(1994-8#1)(2008-5#2)(2012-12#1)
double-blind studies##3##2##(1992-5#1)(2008-12#1)(2008-3#1)
double-blind study on##2##3##(1996-1#1)(2008-5#1)
double-blind study##10##2##(1991-2#1)(1992-5#1)(1993-3#1)(1996-1#2)(2008-5#4)(2008-7#1)
double-blind treatment##2##2##(1992-8#1)(2008-3#1)
double-blind trial to evaluate##2##4##(2008-5#1)(2008-7#1)
double-blind trial##6##2##(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
double-blind trials##2##2##(2008-10#1)(2008-2#1)
double-blind##88##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-3#2)(1994-12#1)(1994-6#2)(1994-8#1)(1996-1#3)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#26)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
double-blinded##5##1##(2007-9#1)(2008-10#2)(2012-12#1)(2013-8#1)
double-bond stretch vibrations of the##2##5##(2007-11#2)
double-chamber flow##2##2##(2008-4#2)
double-chamber##4##1##(1991-9#1)(2008-4#2)(2011-2#1)
double-charged ions##2##2##(2008-10#2)
double-charged##3##1##(2008-10#3)
double-chirped mirrors##4##2##(2007-11#3)(2007-12#1)
double-chirped##5##1##(2007-11#4)(2007-12#1)
double-clad fiber amplifier##2##3##(2007-11#1)(2007-12#1)
double-clad fiber laser##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
double-clad fiber##8##2##(2007-11#2)(2007-12#5)(2008-2#1)
double-clad thulium-doped fiber laser##2##4##(2008-3#2)
double-clad##18##1##(2007-11#8)(2007-12#7)(2008-2#1)(2008-3#2)
double-contrast##2##1##(1997-8#2)
double-controlled and double-blinded clinical trial##2##5##(2008-10#2)
double-crossover events##2##2##(1990-11#2)
double-deficient mice##2##2##(2008-7#2)
double-difference pair##2##2##(2008-3#2)
double-digit##2##1##(1994-12#1)(2008-11#1)
double-edged sword##3##2##(1994-2#1)(2010-5#1)(2011-2#1)
double-edged swords##2##2##(1995-12#1)(2009-8#1)
double-edged##5##1##(1994-2#1)(1995-12#1)(2009-8#1)(2010-5#1)(2011-2#1)
double-exposure holographic interferometry##2##3##(2007-11#1)(2008-2#1)
double-exposure holography##2##2##(2008-2#1)(2008-3#1)
double-exposure stroboscopic television holography##2##4##(2008-3#2)
double-exposure##8##1##(2007-11#2)(2008-2#2)(2008-3#4)
double-focusing sector field ICP-MS##4##4##(2008-10#4)
double-focusing##8##1##(2008-10#7)(2008-4#1)
double-frequency##2##1##(2008-3#2)
double-labeled##2##1##(1993-11#1)(2008-9#1)
double-labeling immunofluorescence##3##2##(1993-12#2)(1997-2#1)
double-labeling##7##1##(1993-12#2)(1997-2#2)(2008-7#2)(2008-9#1)
double-labelled##3##1##(1995-5#1)(1996-5#1)(2008-11#1)
double-labelling##2##1##(1996-5#1)(1997-3#1)
double-layer##10##1##(1990-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-10#2)(2009-7#1)
double-linker##2##1##(2008-10#2)
double-major scoliosis##2##2##(2007-8#2)
double-modulation##2##1##(2008-2#1)(2008-3#1)
double-origin vectors##2##2##(1994-12#2)
double-pass##14##1##(2007-11#3)(2007-12#3)(2008-2#5)(2008-3#3)
double-pass-pumped##2##1##(2008-2#2)
double-peaked##2##1##(2008-10#1)(2008-8#1)
double-phase##2##1##(2007-11#2)
double-pulse excitation##2##2##(2007-11#1)(2008-2#1)
double-pulse##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
double-pulsed holographic interferometry##2##3##(2008-2#2)
double-pulsed ruby laser##4##3##(2008-2#1)(2008-3#3)
double-pulsed##6##1##(2008-2#3)(2008-3#3)
double-random phase encoding##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
double-random phase encryption##2##3##(2007-11#1)(2008-3#1)
double-random phase##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
double-random##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
double-sided##5##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
double-site mutation of the##2##4##(2008-8#2)
double-slit##2##1##(2007-11#1)(2007-12#1)
double-staining##2##1##(1994-8#1)(2008-9#1)
double-strand breaks##10##2##(1995-2#1)(1995-8#1)(1997-7#1)(2008-9#3)(2010-2#1)(2011-2#1)(2013-1#2)
double-strand##19##1##(1995-2#1)(1995-8#1)(1997-7#3)(2008-7#1)(2008-9#4)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#4)
double-stranded (ds) DNA##2##3##(2008-10#1)(2008-2#1)
double-stranded (ds)##4##2##(2008-10#3)(2008-2#1)
double-stranded DNA (dsDNA)##2##3##(1995-2#1)(2008-10#1)
double-stranded DNA breaks##2##3##(2008-11#1)(2008-7#1)
double-stranded DNA in the##2##4##(2008-10#2)
double-stranded DNA in##4##3##(2008-10#4)
double-stranded DNA probes##5##3##(2010-5#5)
double-stranded DNA through##2##3##(1995-3#1)(2008-2#1)
double-stranded DNA##32##2##(1990-11#1)(1992-3#1)(1994-12#2)(1995-2#1)(1995-3#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#4)(2010-5#6)(2012-2#1)
double-stranded DNAs##2##2##(2008-10#2)
double-stranded RNA (dsRNA)##11##3##(2008-10#8)(2008-2#1)(2008-9#1)(2013-1#1)
double-stranded RNA##24##2##(1993-12#1)(1997-4#1)(2008-10#12)(2008-2#1)(2008-8#1)(2008-9#4)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
double-stranded and single-stranded##2##3##(1990-11#1)(1994-8#1)
double-stranded cDNA##3##2##(2008-2#3)
double-stranded oligodeoxynucleotide##2##2##(2008-9#2)
double-stranded structure##2##2##(2008-10#1)(2011-2#1)
double-stranded##90##1##(1990-11#3)(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-10#35)(2008-11#1)(2008-2#7)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#13)(2009-5#1)(2010-4#1)(2010-5#6)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
double-walled wall-pore sensilla##2##3##(2008-7#2)
double-walled wall-pore##3##2##(2007-12#1)(2008-7#2)
double-walled##6##1##(2007-12#1)(2008-7#4)(2012-2#1)
double-well##3##1##(2007-12#2)(2009-9#1)
doubled haploid (DH) population##4##4##(2008-10#2)(2008-4#1)(2008-9#1)
doubled haploid line##2##3##(2008-10#2)
doubled haploid population##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
doubled haploid##11##2##(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
doubled in the##2##3##(1996-7#1)(2008-12#1)
doubled in##9##2##(1991-9#1)(1992-3#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)
doubled the##3##2##(1995-11#1)(2007-12#1)(2008-10#1)
doubled to##4##2##(2008-11#2)(2008-2#1)(2008-3#1)
doubled##52##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-6#1)(1995-11#1)(1996-12#1)(1996-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
doubled-haploid (DH)##2##2##(2008-10#1)(2008-5#1)
doubled-haploid lines##2##2##(2008-5#2)
doubled-haploid##6##1##(2008-10#3)(2008-5#3)
doubler##2##1##(2007-12#1)(2008-2#1)
doubles the##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
doubles##5##1##(2008-2#2)(2008-3#1)(2012-2#1)(2013-1#1)
doublesex##4##1##(2007-12#4)
doublet is not##2##3##(1995-12#2)
doublet is##3##2##(1995-12#2)(2008-3#1)
doublet##14##1##(1991-2#2)(1995-12#3)(2008-2#4)(2008-3#5)
doublets with##4##2##(2008-3#4)
doublets##10##1##(2008-12#1)(2008-2#2)(2008-3#7)
doubling crystal##4##2##(2008-2#1)(2008-3#3)
doubling in##5##2##(1993-6#1)(2007-11#2)(2007-12#2)
doubling of the##7##3##(2007-11#2)(2007-12#4)(2008-10#1)
doubling of##28##2##(1996-12#1)(2007-11#4)(2007-12#17)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
doubling their##2##2##(2013-1#2)
doubling time (DT)##2##3##(2011-2#2)
doubling time of##6##3##(2008-11#5)(2008-5#1)
doubling time##15##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#8)(2008-5#1)(2008-9#1)(2011-2#2)
doubling times##2##2##(1996-12#1)(2008-3#1)
doubling##92##1##(1990-5#1)(1991-6#1)(1993-5#1)(1993-6#1)(1994-6#1)(1996-12#3)(2007-10#1)(2007-11#12)(2007-12#24)(2008-10#2)(2008-11#13)(2008-2#8)(2008-3#13)(2008-5#2)(2008-9#1)(2011-1#2)(2011-2#4)(2013-1#2)
doubly covalently bound##2##3##(1991-3#2)
doubly distilled water##2##3##(2008-10#2)
doubly doped LiNbO(3)##3##3##(2007-12#2)(2008-3#1)
doubly doped##5##2##(2007-12#4)(2008-3#1)
doubly infected with##2##3##(2008-10#2)
doubly infected##3##2##(2008-10#3)
doubly protonated##4##2##(1996-7#4)
doubly resonant optical parametric oscillator (OPO)##2##6##(2007-12#2)
doubly resonant optical parametric oscillator that##2##6##(2007-11#2)
doubly resonant optical parametric oscillator##7##5##(2007-11#3)(2007-12#4)
doubly resonant optical parametric##8##4##(2007-11#4)(2007-12#4)
doubly resonant sum-frequency mixing in an external resonator##2##8##(2008-2#2)
doubly resonant##17##2##(2007-11#4)(2007-12#8)(2008-2#4)(2008-3#1)
doubly##49##1##(1990-8#2)(1991-3#3)(1992-3#1)(1996-7#4)(1997-2#1)(1997-7#2)(2007-11#4)(2007-12#13)(2008-10#7)(2008-2#4)(2008-3#5)(2010-11#1)(2010-2#1)(2012-2#1)
doubly-doped##3##1##(2008-3#3)
doubt about##3##2##(1993-3#1)(2008-1#1)(2011-1#1)
doubt on the##5##3##(1993-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
doubt on this##2##3##(2008-11#1)(2008-9#1)
doubt on##7##2##(1993-11#1)(2008-11#2)(2008-8#1)(2008-9#2)(2013-1#1)
doubt that##11##2##(1992-6#1)(1995-4#1)(1995-9#1)(2008-3#1)(2008-4#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
doubt##42##1##(1992-1#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
doubtful##13##1##(1990-6#1)(1992-6#1)(1994-7#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-12#3)(2009-5#1)(2012-2#1)(2013-1#1)
doubts about##2##2##(2008-8#1)(2009-9#1)
doubts on##2##2##(1994-2#1)(2013-8#1)
doubts regarding the##2##3##(1991-6#1)(2009-10#1)
doubts##13##1##(1990-3#1)(1991-11#1)(1991-6#1)(1994-2#2)(1995-2#1)(1997-3#1)(2008-8#1)(2009-10#1)(2009-9#1)(2013-7#2)(2013-8#1)
dough stage##5##2##(2008-10#5)
dough##11##1##(2008-10#7)(2010-7#2)(2011-1#1)(2011-2#1)
doughnut laser##2##2##(2007-11#2)
doughnut mode##2##2##(2007-11#1)(2008-2#1)
doughnut##4##1##(2007-11#3)(2008-2#1)
douglasii##3##1##(1993-2#3)
douleur##2##1##(2013-1#2)
doves or##2##2##(2008-5#2)
doves##11##1##(1991-5#1)(2008-5#10)
down a##4##2##(1996-5#1)(2007-11#1)(2010-12#2)
down and##4##2##(1997-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
down as##2##2##(2008-10#1)(2008-6#1)
down at##2##2##(2008-10#1)(2008-11#1)
down barriers##3##2##(1994-3#1)(1997-6#1)(2012-12#1)
down by the##2##3##(2008-9#1)(2012-2#1)
down by##6##2##(1990-8#1)(1997-8#1)(2008-9#1)(2012-2#3)
down continuously##2##2##(1997-4#1)(2008-6#1)
down for##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
down from##4##2##(1991-4#1)(1994-9#1)(2007-12#1)(2008-10#1)
down in the##3##3##(1997-5#1)(2008-11#1)(2010-8#1)
down in##10##2##(1991-11#1)(1995-11#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-8#1)(2012-12#1)
down into the##2##3##(1995-5#1)(2010-9#1)
down into##5##2##(1992-1#1)(1995-3#1)(1995-5#1)(2010-9#1)(2011-2#1)
down its##3##2##(2009-9#1)(2011-2#1)(2012-2#1)
down of##8##2##(1991-12#1)(1993-6#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
down on the farm##2##4##(2008-10#1)(2008-4#1)
down on the##4##3##(1997-2#1)(2008-10#2)(2008-4#1)
down on##6##2##(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-4#1)
down regulated##8##2##(1993-3#1)(1995-2#1)(2008-8#1)(2008-9#2)(2009-9#1)(2013-1#2)
down regulation of the##2##4##(1994-8#1)(2013-1#1)
down regulation of##7##3##(1990-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-3#1)(2008-11#1)(2013-1#1)
down regulation##9##2##(1990-3#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-11#1)(2013-1#1)
down state##2##2##(2008-11#2)
down the root##2##3##(2008-10#2)
down the##36##2##(1992-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)
down their##2##2##(2008-11#1)(2008-8#1)
down to 0##11##3##(2008-10#8)(2008-11#1)(2008-3#1)(2013-1#1)
down to 1##4##3##(2008-10#2)(2008-11#1)(2010-2#1)
down to 2##4##3##(2008-10#3)(2008-11#1)
down to 5##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
down to 50##2##3##(2008-10#1)(2008-7#1)
down to a few##2##4##(2008-10#1)(2010-12#1)
down to a##7##3##(1990-12#1)(1991-12#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-12#1)
down to about (M -##2##5##(1996-4#2)
down to about##3##3##(1996-4#2)(2008-10#1)
down to ca##2##3##(2008-10#1)(2008-11#1)
down to the##19##3##(1990-11#1)(1991-5#1)(1993-6#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
down to zero##2##3##(2007-11#1)(2012-2#1)
down to##96##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#2)(1996-4#3)(1997-4#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#33)(2008-11#4)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#3)(2013-8#2)
down with##2##2##(2008-10#1)(2011-2#1)
down##296##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#3)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#3)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#54)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#9)(2009-10#2)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#13)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#4)
down-regulate##5##1##(1995-2#1)(2006-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
down-regulated and##3##2##(2008-8#1)(2010-4#1)(2013-8#1)
down-regulated at##2##2##(2010-4#1)(2010-6#1)
down-regulated by##5##2##(1995-8#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
down-regulated cells##2##2##(1991-5#2)
down-regulated in response to##2##4##(1995-12#1)(2010-4#1)
down-regulated in##8##2##(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#1)(2009-5#2)(2010-4#2)
down-regulated##40##1##(1991-5#2)(1992-9#1)(1993-8#1)(1993-9#2)(1994-6#1)(1995-11#2)(1995-12#2)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-5#2)(2010-4#8)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
down-regulates the##3##2##(1994-11#1)(2008-11#1)(2008-8#1)
down-regulates##7##1##(1992-1#1)(1994-11#1)(1995-12#1)(2008-11#2)(2008-8#1)(2011-1#1)
down-regulating##7##1##(1992-8#1)(1993-9#1)(1995-12#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
down-regulation and desensitization##2##3##(1993-9#2)
down-regulation and##4##2##(1993-9#2)(2012-12#1)(2013-1#1)
down-regulation by the phorbol ester##2##5##(1992-9#2)
down-regulation by##4##2##(1992-9#3)(1995-12#1)
down-regulation in##3##2##(1992-8#1)(1994-2#1)(1996-12#1)
down-regulation of AR##2##3##(1995-12#2)
down-regulation of PKC##3##3##(1992-8#1)(1992-9#1)(1997-1#1)
down-regulation of Sp1##2##3##(2013-1#2)
down-regulation of VEGF##2##3##(2008-3#1)(2008-9#1)
down-regulation of c-myc##3##3##(1991-9#1)(1992-2#1)(2008-11#1)
down-regulation of the##7##3##(1993-6#1)(1994-11#1)(1995-11#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
down-regulation of##50##2##(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#4)(1996-2#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-3#2)(2009-9#1)(2010-4#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-6#1)(2012-7#1)(2013-1#5)
down-regulation was##2##2##(1997-4#1)(2008-7#1)
down-regulation##75##1##(1990-11#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-2#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#2)(2009-3#2)(2009-9#2)(2010-4#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-6#1)(2012-7#1)(2013-1#7)
down-stream##2##1##(2008-8#1)(2009-8#1)
down?##2##1##(1991-12#1)(2007-9#1)
downconversion in##3##2##(2007-12#1)(2008-3#2)
downconversion of##2##2##(2007-12#2)
downconversion##14##1##(2007-11#3)(2007-12#6)(2008-2#2)(2008-3#3)
downgrading of##2##2##(1990-9#1)(2012-12#1)
downgrading##4##1##(1990-9#2)(2007-7#1)(2012-12#1)
downhill##2##1##(2008-3#1)(2013-1#1)
download and##2##2##(2008-4#1)(2008-9#1)
download##7##1##(2008-4#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)
downloadable##3##1##(2007-2#1)(2008-5#1)(2012-3#1)
downloaded from GenBank##2##3##(2008-12#1)(2011-1#1)
downloaded from##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
downloaded##7##1##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
downloading##3##1##(2008-3#1)(2008-4#1)(2008-7#1)
downregulate the##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
downregulate##8##1##(1993-12#1)(1994-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-5#1)
downregulated by the##2##3##(1994-9#1)(2008-4#1)
downregulated by##3##2##(1994-9#1)(2008-4#1)(2012-12#1)
downregulated genes##2##2##(2010-11#1)(2012-12#1)
downregulated in##11##2##(2009-8#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
downregulated upon##2##2##(1997-2#1)(2009-4#1)
downregulated##33##1##(1994-9#2)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#5)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
downregulates##4##1##(1995-9#1)(2008-4#2)(2009-8#1)
downregulating##7##1##(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
downregulation of the##2##3##(2008-8#2)
downregulation of##18##2##(1992-2#2)(1994-6#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
downregulation##24##1##(1992-12#1)(1992-2#2)(1994-6#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
downs##3##1##(1995-3#1)(1996-3#1)(2013-7#1)
downsampling##4##1##(2008-2#3)(2008-3#1)
downshift of##2##2##(1995-5#1)(2008-10#1)
downsized flow set up##2##4##(2008-10#2)
downsized##3##1##(2008-10#3)
downsizing process##4##2##(1993-1#1)(1994-3#2)(1996-12#1)
downsizing##19##1##(1993-1#3)(1994-3#6)(1996-12#4)(1997-2#1)(2008-1#3)(2008-10#1)(2012-3#1)
downstaging##4##1##(1993-11#1)(2007-8#1)(2010-12#1)(2010-6#1)
downstream DNA##2##2##(1995-6#1)(1997-7#1)
downstream activation of##2##3##(2013-1#2)
downstream activation##3##2##(1994-8#1)(2013-1#2)
downstream analyses##2##2##(2008-4#1)(2008-7#1)
downstream applications##2##2##(2008-2#1)(2008-9#1)
downstream component of oriLyt##3##4##(1997-3#3)
downstream component of##5##3##(1997-3#4)(2012-12#1)
downstream component##9##2##(1997-3#8)(2012-12#1)
downstream effector molecules##2##3##(1997-4#1)(2012-2#1)
downstream effector of##4##3##(1997-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
downstream effector##7##2##(1997-2#1)(1997-4#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
downstream effectors##5##2##(2008-9#1)(2010-11#1)(2012-12#3)
downstream events of##2##3##(2008-4#1)(2008-9#1)
downstream events##3##2##(2008-4#1)(2008-9#1)(2009-6#1)
downstream from a##2##3##(1994-12#1)(1997-4#1)
downstream from the##11##3##(1993-12#2)(1993-9#1)(1994-12#2)(1996-12#1)(1997-4#2)(1997-6#1)(2008-10#1)(2008-11#1)
downstream from##19##2##(1990-5#1)(1990-8#1)(1993-12#2)(1993-2#2)(1993-9#1)(1994-12#4)(1996-12#1)(1997-4#3)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
downstream genes##6##2##(1994-8#1)(2007-12#1)(2009-8#2)(2011-2#1)(2012-12#1)
downstream in the##2##3##(1995-8#1)(2008-11#1)
downstream occlusion##2##2##(2011-2#2)
downstream of its##2##3##(1992-11#1)(1995-2#1)
downstream of the alcohol dehydrogenase##2##5##(1994-6#1)(1997-8#1)
downstream of the promoter##3##4##(2008-11#1)(2008-8#2)
downstream of the##21##3##(1990-11#1)(1990-12#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-8#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-11#1)(2013-1#1)
downstream of this##3##3##(1992-3#1)(2008-3#1)(2008-4#1)
downstream of##46##2##(1990-11#1)(1990-12#1)(1991-7#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-2#2)(1997-8#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#6)(2009-11#1)(2009-6#1)(2012-12#2)(2012-2#1)(2013-1#2)
downstream pressure##2##2##(1991-3#1)(1997-1#1)
downstream processing##4##2##(2008-11#1)(2008-4#1)(2008-7#2)
downstream region of##3##3##(1991-9#1)(1997-2#1)(2008-9#1)
downstream sequence +1-+125nt##2##3##(2008-9#2)
downstream sequence##3##2##(2008-9#3)
downstream sequences##2##2##(1997-2#1)(2008-8#1)
downstream signaling pathways##5##3##(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-7#1)
downstream signaling##8##2##(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
downstream target##6##2##(1992-12#2)(1995-2#2)(2011-2#1)(2012-2#1)
downstream targets of##2##3##(2008-7#1)(2011-2#1)
downstream targets##5##2##(1994-8#1)(1996-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
downstream to##3##2##(2008-10#2)(2012-2#1)
downstream##211##1##(1990-11#3)(1990-12#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-6#1)(1994-8#3)(1995-2#5)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-6#3)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#2)(1997-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#11)(2008-9#8)(2009-10#4)(2009-11#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#1)
downtime##4##1##(1992-2#1)(1996-2#1)(1996-3#1)(2008-7#1)
downward and##3##2##(2008-2#2)(2008-7#1)
downward gaze palsy##2##3##(2007-10#2)
downward gaze##3##2##(2007-10#3)
downward in##2##2##(2009-5#1)(2010-9#1)
downward irradiance##5##2##(2008-2#1)(2008-3#4)
downward trend in##2##3##(1996-11#1)(2008-11#1)
downward trend was observed##2##4##(2007-7#1)(2012-12#1)
downward trend was##3##3##(2007-7#1)(2012-12#2)
downward trend##6##2##(1996-11#1)(2007-7#1)(2008-11#1)(2010-5#1)(2012-12#2)
downward##44##1##(1990-5#1)(1996-11#1)(1997-5#1)(2007-10#3)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#7)(2008-7#3)(2009-11#2)(2009-12#1)(2009-5#2)(2010-5#1)(2010-9#1)(2012-12#3)(2012-2#1)(2013-8#1)
downward)##2##1##(2008-3#1)(2009-5#1)
downwardly##2##1##(2008-11#2)
downwards##4##1##(2007-12#1)(2007-8#1)(2009-12#1)(2011-2#1)
downwelling irradiance##7##2##(2008-2#6)(2008-3#1)
downwelling##12##1##(2008-2#7)(2008-3#5)
downwind from the##2##3##(2008-10#2)
downwind##5##1##(2008-10#5)
downy mildew (Pseudoperonospora cubensis)##2##4##(2008-10#2)
downy mildew development##4##3##(2008-10#4)
downy mildew incidence##3##3##(2008-10#3)
downy mildew of##4##3##(2008-10#4)
downy mildew resistance locus Pp523##2##5##(2012-3#2)
downy mildew##41##2##(2008-10#39)(2012-3#2)
downy##42##1##(2008-10#39)(2008-12#1)(2012-3#2)
dowsers##3##1##(1997-6#3)
dox in the treatment of##2##5##(2008-6#2)
dox##6##1##(2008-6#6)
doxazosin and terazosin##2##3##(1995-12#2)
doxazosin##8##1##(1993-2#3)(1995-12#5)
doxepin##4##1##(2008-10#4)
doxifluridine and##2##2##(1992-8#1)(1997-7#1)
doxifluridine##5##1##(1992-8#3)(1993-8#1)(1997-7#1)
doxorubicin (18 mg/kg)##2##3##(2011-2#2)
doxorubicin and cisplatin##2##3##(1990-10#1)(1995-12#1)
doxorubicin and vincristine##2##3##(2008-11#1)(2009-11#1)
doxorubicin and##11##2##(1990-10#1)(1991-11#1)(1991-8#1)(1995-12#1)(2008-11#3)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
doxorubicin by##2##2##(2010-4#1)(2012-1#1)
doxorubicin chemotherapy##2##2##(1992-10#2)
doxorubicin in##2##2##(2008-10#1)(2008-7#1)
doxorubicin to##2##2##(1995-2#1)(2011-2#1)
doxorubicin##81##1##(1990-10#3)(1990-2#2)(1991-11#1)(1991-6#2)(1991-8#1)(1992-10#3)(1992-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#3)(1997-7#1)(2007-7#1)(2008-10#4)(2008-11#11)(2008-12#1)(2008-6#8)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-2#15)(2012-1#4)(2013-1#5)(2013-8#1)
doxorubicin-based combination##2##2##(2008-6#2)
doxorubicin-based##3##1##(2008-6#3)
doxorubicin-induced mutagenicity##2##2##(2011-2#2)
doxorubicin-induced##3##1##(2011-2#3)
doxorubicin-loaded##3##1##(2008-10#3)
doxorubicin-treated##2##1##(2011-2#1)(2012-1#1)
doxycycline hydrochloride and chlortetracycline hydrochloride##3##5##(2008-10#3)
doxycycline hydrochloride and##4##3##(2008-10#4)
doxycycline hydrochloride##6##2##(2008-10#6)
doxycycline in##4##2##(2007-7#1)(2008-10#3)
doxycycline were##2##2##(2008-10#2)
doxycycline##26##1##(1994-11#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#17)(2011-2#2)
dozen##12##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
dozens of##5##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
dozens##6##1##(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
dp##2##1##(1992-12#1)(1995-11#1)
dph to 25 dph during larval development##2##7##(2008-7#2)
dph##9##1##(2008-7#6)(2010-5#1)(2010-8#2)
dpi and##3##2##(2008-10#2)(2008-12#1)
dpi when##2##2##(2008-10#2)
dpi##13##1##(2008-10#12)(2008-12#1)
dpi)##2##1##(2008-10#2)
dpo##2##1##(2008-7#2)
dppe##3##1##(1996-2#2)(2009-9#1)
dppm##2##1##(2009-9#2)
dppp##2##1##(1996-2#2)
dps genes##3##2##(1994-12#3)
dr##2##1##(2008-12#1)(2009-10#1)
draft genome sequence of##2##4##(2008-9#1)(2011-2#1)
draft standard##4##2##(2008-3#4)
draft##16##1##(1991-9#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)
drafted##3##1##(2007-6#1)(2008-5#1)(2010-5#1)
drafting##3##1##(1997-2#1)(2010-4#1)(2011-2#1)
drafts##3##1##(2008-9#1)(2012-3#1)(2013-1#1)
drag##3##1##(1997-1#1)(2008-3#1)(2010-8#1)
dragline silk##3##2##(2008-7#2)(2012-2#1)
dragon##2##1##(2008-10#1)(2008-3#1)
dragonfly##2##1##(2008-8#2)
drain flow##3##2##(2011-2#3)
drain group##2##2##(2008-8#2)
drain in##2##2##(2011-2#1)(2012-2#1)
drain parameters##2##2##(2011-2#2)
drain time##2##2##(2011-2#2)
drain was##2##2##(2010-3#1)(2013-8#1)
drain##37##1##(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#3)(2009-5#2)(2010-3#1)(2011-2#15)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
drainage after##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
drainage alone##3##2##(1997-8#1)(2012-2#2)
drainage and antibiotic therapy##2##4##(2007-6#1)(2007-7#1)
drainage and##16##2##(1991-2#1)(1992-9#1)(1996-9#1)(1997-8#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2011-2#1)
drainage are##2##2##(1991-6#1)(2010-8#1)
drainage basin##2##2##(2009-12#1)(2013-7#1)
drainage but##2##2##(2009-6#1)(2011-2#1)
drainage for##2##2##(2011-2#1)(2013-1#1)
drainage from the##3##3##(2008-6#1)(2011-2#1)(2012-3#1)
drainage in the##3##3##(1992-3#1)(1993-9#1)(2008-7#1)
drainage in##4##2##(1992-3#1)(1993-9#1)(2008-7#1)(2011-1#1)
drainage is##5##2##(1996-9#1)(2008-10#1)(2008-4#1)(2010-8#1)(2013-8#1)
drainage of the bile##2##4##(1991-3#2)
drainage of the##12##3##(1991-3#2)(1991-9#1)(1996-9#2)(2008-12#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
drainage of##23##2##(1991-3#2)(1991-9#1)(1996-9#2)(2008-1#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
drainage procedure##2##2##(2009-9#2)
drainage site##2##2##(2007-8#1)(2008-6#1)
drainage techniques##2##2##(1997-5#1)(2006-10#1)
drainage through##4##2##(2007-8#1)(2008-7#1)(2009-3#1)(2012-8#1)
drainage was performed##2##3##(2008-5#1)(2013-8#1)
drainage was##11##2##(1991-3#1)(1995-2#1)(1996-9#2)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2013-8#1)
drainage with##3##2##(2007-8#2)(2008-8#1)
drainage##149##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-2#2)(1991-3#5)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-9#3)(1995-2#1)(1996-9#8)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#8)(2011-1#2)(2011-2#12)(2012-12#4)(2012-2#4)(2012-3#2)(2012-8#2)(2013-1#5)(2013-7#4)(2013-8#5)
drainages##9##1##(1991-3#5)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
drained directly into the##2##4##(2011-2#1)(2013-2#1)
drained into the##5##3##(1990-5#1)(1996-9#1)(2007-8#1)(2008-10#2)
drained into##6##2##(1990-5#1)(1996-9#1)(2007-8#1)(2008-10#3)
drained the##2##2##(2011-2#1)(2012-3#1)
drained##21##1##(1990-11#1)(1990-2#1)(1990-5#1)(1993-12#1)(1996-9#2)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-2#1)
drainer clipping##2##2##(1996-9#2)
drainer##3##1##(1996-9#3)
draining into the##2##3##(2011-2#1)(2013-2#1)
draining vein##4##2##(2008-1#1)(2008-7#3)
draining veins of##2##3##(2008-7#1)(2012-3#1)
draining veins##5##2##(1997-3#1)(2008-7#3)(2012-3#1)
draining##19##1##(1990-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#6)(2009-6#1)(2011-2#2)(2012-3#1)(2013-2#1)(2013-8#1)
drains after thoracic##2##3##(2007-8#2)
drains after##3##2##(2007-8#2)(2008-8#1)
drains and##2##2##(2007-5#1)(2008-8#1)
drains in##2##2##(1991-3#1)(1993-9#1)
drains into the right##2##4##(1997-1#1)(2012-2#1)
drains into the##3##3##(1996-9#1)(1997-1#1)(2012-2#1)
drains##19##1##(1991-3#1)(1993-9#1)(1996-9#1)(1997-1#2)(2007-12#1)(2007-5#2)(2007-8#4)(2008-10#2)(2008-8#4)(2012-2#1)
drama##2##1##(1994-3#1)(2008-6#1)
dramatic change in##2##3##(1997-2#1)(2007-11#1)
dramatic change##6##2##(1995-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)
dramatic changes in the##2##4##(1991-3#1)(2008-7#1)
dramatic changes in##6##3##(1991-3#1)(1993-12#2)(1995-12#1)(2008-7#1)(2008-8#1)
dramatic changes##12##2##(1991-3#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)
dramatic clinical improvement##2##3##(2008-8#1)(2010-7#1)
dramatic clinical##4##2##(2008-8#2)(2010-7#1)(2010-8#1)
dramatic decrease##14##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-1#1)(1995-3#1)(1995-5#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2012-3#1)
dramatic differences in the##2##4##(1993-5#1)(2008-10#1)
dramatic differences in##3##3##(1993-5#1)(1995-11#1)(2008-10#1)
dramatic differences##6##2##(1992-12#1)(1993-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-4#1)
dramatic effect##4##2##(1991-2#1)(1991-3#1)(2008-10#1)(2008-3#1)
dramatic effects on the##2##4##(2008-10#1)(2008-11#1)
dramatic effects on##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
dramatic enhancement in##2##3##(2008-10#2)
dramatic growth##4##2##(1994-1#1)(1994-10#1)(1996-3#1)(2009-8#1)
dramatic improvement in the quality of care##2##7##(1997-1#1)(2008-7#1)
dramatic improvement in##8##3##(1991-4#1)(1992-11#1)(1993-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-7#2)
dramatic improvement##13##2##(1991-4#1)(1992-11#1)(1993-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-9#1)(2013-1#1)
dramatic improvements in##2##3##(1993-12#1)(2012-3#1)
dramatic in the##2##3##(2008-10#1)(2008-12#1)
dramatic increase in##15##3##(1994-12#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#4)
dramatic increase of##5##3##(1990-12#1)(1996-11#1)(1997-4#1)(2008-10#1)(2011-3#1)
dramatic increase##23##2##(1990-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#4)(2013-8#1)
dramatic induction of##3##3##(1990-5#1)(1992-8#1)(2013-1#1)
dramatic reduction in##5##3##(1994-8#1)(1995-11#1)(1997-7#1)(2010-10#1)(2013-1#1)
dramatic reduction of##2##3##(1996-6#1)(2011-1#1)
dramatic reduction##8##2##(1994-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
dramatic response##2##2##(2012-1#1)(2012-12#1)
dramatic symptoms##2##2##(1995-5#1)(2008-10#1)
dramatic##163##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#5)(2007-5#1)(2008-10#20)(2008-11#5)(2008-12#6)(2008-3#3)(2008-4#2)(2008-7#6)(2008-8#10)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#11)(2013-8#1)
dramatically altered##2##2##(1993-12#1)(2012-2#1)
dramatically and##2##2##(1992-9#1)(2008-8#1)
dramatically change##2##2##(1997-3#1)(2011-2#1)
dramatically changed##3##2##(2007-11#1)(2010-4#1)(2013-8#1)
dramatically changing##2##2##(1994-12#1)(2008-11#1)
dramatically decreases the##4##3##(1994-2#1)(2007-12#2)(2008-10#1)
dramatically decreases##5##2##(1994-2#1)(2007-12#2)(2008-10#1)(2008-2#1)
dramatically different##8##2##(1992-3#1)(1997-2#1)(2008-1#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-3#1)
dramatically improve the##3##3##(1992-12#1)(2008-3#1)(2008-9#1)
dramatically improved the outcome##2##4##(2010-3#2)
dramatically improved the##5##3##(2008-3#1)(2010-12#1)(2010-3#2)(2011-2#1)
dramatically improved##8##2##(2008-1#1)(2008-3#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-1#1)
dramatically in the##5##3##(1996-3#1)(2007-7#1)(2008-7#1)(2009-7#1)(2013-1#1)
dramatically in##12##2##(1993-8#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-11#2)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
dramatically increase the##2##3##(1993-12#1)(1994-12#1)
dramatically increase##5##2##(1993-12#1)(1994-12#1)(2007-11#1)(2010-12#1)(2012-2#1)
dramatically increased as the##2##4##(2007-11#1)(2013-1#1)
dramatically increased in the##3##4##(1993-3#1)(2008-3#1)(2008-8#1)
dramatically increased in##4##3##(1993-3#1)(2008-3#1)(2008-6#1)(2008-8#1)
dramatically increased the##2##3##(2008-11#1)(2009-11#1)
dramatically increased##14##2##(1993-3#1)(1994-9#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-6#1)(2013-1#1)
dramatically influence the##3##3##(1996-7#1)(1997-1#1)(1997-2#1)
dramatically lower the##3##3##(2007-11#2)(2008-11#1)
dramatically lower##5##2##(1995-3#1)(1997-2#1)(2007-11#2)(2008-11#1)
dramatically modified##2##2##(2008-3#1)(2008-7#1)
dramatically over the past three decades##2##6##(2008-1#1)(2008-11#1)
dramatically reduce the##4##3##(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
dramatically reduce##5##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
dramatically reduced the##2##3##(2008-10#1)(2011-2#1)
dramatically reduced to##2##3##(2008-10#1)(2008-7#1)
dramatically reduced##9##2##(1994-11#1)(1994-2#1)(2007-12#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-12#1)
dramatically reduces##2##2##(2007-8#1)(2011-1#1)
dramatically shorten##2##2##(2007-12#1)(2012-3#1)
dramatically shortened##2##2##(2007-11#1)(2008-10#1)
dramatically to##3##2##(1992-4#1)(1996-5#1)(2008-1#1)
dramatically with##5##2##(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#1)
dramatically##189##1##(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#2)(1995-6#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-7#2)(2007-11#8)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#6)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#4)
drank kava##5##2##(2008-1#5)
drank more##2##2##(1993-11#1)(2008-1#1)
drank##9##1##(1993-11#1)(2008-1#6)(2008-9#1)(2013-8#1)
drastic change in the##2##4##(2008-10#2)
drastic changes##2##2##(1995-12#1)(2012-2#1)
drastic differences in##2##3##(2009-9#1)(2010-8#1)
drastic improvement of##2##3##(2008-3#2)
drastic increase##3##2##(1992-8#1)(2008-10#1)(2011-1#1)
drastic reduction in##7##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-5#2)(2008-8#1)(2011-1#1)
drastic reduction of##2##3##(2008-10#1)(2012-3#1)
drastic reduction##9##2##(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-3#1)
drastic##38##1##(1990-11#1)(1990-5#1)(1992-8#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
drastically change##4##2##(2007-12#2)(2008-11#1)(2013-1#1)
drastically decreased##2##2##(1992-8#1)(1993-8#1)
drastically different##2##2##(2009-7#1)(2010-5#1)
drastically improve the##2##3##(1994-1#1)(2010-4#1)
drastically reduce##2##2##(1991-1#1)(2011-1#1)
drastically reduced in##2##3##(1990-5#1)(2008-5#1)
drastically reduced##13##2##(1990-5#1)(1991-3#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
drastically reduces the##3##3##(1990-5#1)(1992-6#1)(2008-3#1)
drastically reduces##4##2##(1990-5#1)(1992-6#1)(2007-11#1)(2008-3#1)
drastically reducing##2##2##(2008-10#1)(2008-3#1)
drastically the##6##2##(1990-5#1)(2007-12#1)(2008-10#3)(2008-3#1)
drastically##63##1##(1990-5#3)(1991-1#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#4)(2008-10#15)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-1#2)
draught##2##1##(2008-11#1)(2011-2#1)
draw attention to the##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
draw attention to these##2##4##(1991-11#1)(2011-1#1)
draw attention to##10##3##(1990-9#1)(1991-11#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
draw conclusions##6##2##(1990-3#1)(1991-1#1)(2007-7#1)(2008-6#1)(2010-12#1)(2010-3#1)
draw on##5##2##(1996-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2010-8#1)
draw the##9##2##(1991-6#1)(1994-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-12#1)(2010-3#1)
draw upon our##2##3##(1997-1#1)(2011-2#1)
draw upon##5##2##(1994-2#1)(1995-1#1)(1997-1#1)(2006-10#1)(2011-2#1)
draw##63##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
drawback in##2##2##(1991-4#1)(2010-3#1)
drawback of##7##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-2#1)
drawback##23##1##(1991-4#1)(1992-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#6)(2009-12#1)(2009-2#1)(2010-3#1)(2013-1#1)
drawbacks and##5##2##(1996-12#1)(2010-8#1)(2012-2#2)(2013-1#1)
drawbacks are##3##2##(2008-10#2)(2009-12#1)
drawbacks in##3##2##(1996-3#1)(2008-8#1)(2012-3#1)
drawbacks of the##6##3##(2007-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
drawbacks of using##2##3##(1995-3#1)(2008-3#1)
drawbacks of##17##2##(1995-3#1)(2007-12#2)(2008-10#6)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
drawbacks##50##1##(1990-2#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
drawing a##3##2##(1995-8#1)(2006-10#1)(2008-2#1)
drawing and discharging##3##3##(2008-10#3)
drawing and transportation##2##3##(2013-1#2)
drawing and##5##2##(2008-10#3)(2013-1#2)
drawing attention to the##2##4##(1996-2#1)(2009-8#1)
drawing from##3##2##(2007-12#1)(2008-1#1)(2008-12#1)
drawing on the##2##3##(2008-12#1)(2008-7#1)
drawing on##7##2##(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
drawing##42##1##(1991-12#2)(1992-12#1)(1994-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#2)(2009-8#2)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
drawings and##3##2##(1992-3#1)(2007-12#2)
drawings are##2##2##(1992-3#1)(2007-11#1)
drawings is##2##2##(1992-3#1)(2008-6#1)
drawings of##5##2##(1992-3#1)(1996-2#1)(2007-12#2)(2008-10#1)
drawings##20##1##(1992-3#4)(1996-2#2)(2007-11#2)(2007-12#8)(2008-10#1)(2008-11#1)(2008-6#2)
drawn at baseline##3##3##(2007-10#1)(2012-3#1)(2013-8#1)
drawn at the##2##3##(1994-11#1)(1994-9#1)
drawn at##6##2##(1994-11#1)(1994-9#1)(2007-10#1)(2007-11#1)(2012-3#1)(2013-8#1)
drawn between##5##2##(1991-1#1)(1995-1#1)(1995-11#1)(1996-3#1)(2008-10#1)
drawn by the##2##3##(1992-12#1)(2008-10#1)
drawn by##4##2##(1992-12#1)(2008-10#1)(2008-3#2)
drawn for##3##2##(1992-3#1)(1993-12#1)(2010-10#1)
drawn from a##10##3##(1993-12#1)(1995-11#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-7#1)
drawn from clinical##2##3##(2008-12#1)(2013-8#1)
drawn from the literature##2##4##(2008-11#1)(2008-7#1)
drawn from the study##2##4##(2008-12#1)(2010-3#1)
drawn from the##20##3##(1991-12#1)(1993-12#1)(1996-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#2)(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
drawn from three##2##3##(1993-12#1)(2008-11#1)
drawn from##62##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#3)(1993-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#4)(2008-2#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
drawn in##2##2##(2007-12#1)(2008-6#1)
drawn into the##4##3##(1994-3#1)(2008-10#3)
drawn into##5##2##(1994-3#1)(2008-10#3)(2008-7#1)
drawn on##5##2##(1992-6#1)(2007-11#1)(2008-11#1)(2008-3#2)
drawn through##2##2##(2007-11#1)(2008-10#1)
drawn to the fact that##2##5##(2007-11#1)(2008-5#1)
drawn to the##4##3##(1996-8#1)(2007-11#1)(2008-5#1)(2009-7#1)
drawn to##7##2##(1990-9#1)(1994-3#1)(1996-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
drawn up a##2##3##(1996-6#1)(1997-3#1)
drawn up##4##2##(1996-6#1)(1997-3#1)(2008-11#2)
drawn with##4##2##(2008-10#2)(2008-2#2)
drawn##143##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-12#4)(1993-2#1)(1994-11#2)(1994-3#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#6)(2007-12#4)(2008-1#3)(2008-10#21)(2008-11#6)(2008-12#5)(2008-2#7)(2008-3#7)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
draws attention to the##4##4##(1997-8#1)(2008-10#1)(2008-6#1)(2010-4#1)
draws attention to##7##3##(1993-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-4#1)
draws on the##2##3##(2008-12#1)(2012-12#1)
draws on##12##2##(1993-12#1)(1994-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
draws##31##1##(1993-1#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
dread##4##1##(2008-11#2)(2009-10#1)(2010-8#1)
dreaded complication##2##2##(1994-8#1)(2009-9#1)
dreaded##7##1##(1990-11#1)(1993-2#1)(1994-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-9#1)
dream for##2##2##(1992-3#1)(2012-2#1)
dream##18##1##(1991-3#1)(1992-3#1)(1993-6#1)(1994-9#1)(2007-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
dreaming and##2##2##(2013-8#2)
dreaming##6##1##(2013-8#6)
dreams in##2##2##(2008-12#2)
dreams##8##1##(2008-12#4)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
dreamy states##4##2##(2008-7#4)
dreamy##5##1##(2008-7#5)
drebrin E and Arp3##2##4##(2012-2#2)
drebrin E and##3##3##(2012-2#3)
drebrin E is##3##3##(2012-2#3)
drebrin E may be acting as a##2##7##(2012-2#2)
drebrin E was found to##2##5##(2012-2#2)
drebrin E was##3##3##(2012-2#3)
drebrin E##16##2##(2012-2#16)
dredge##2##1##(2007-5#1)(2008-5#1)
dredging##2##1##(2007-5#1)(2010-5#1)
drench##5##1##(2008-10#4)(2008-9#1)
dressed##4##1##(1997-5#2)(2008-11#1)(2011-1#1)
dressing changes##2##2##(2007-7#1)(2008-9#1)
dressing percentage##3##2##(2008-12#2)(2012-2#1)
dressing was##2##2##(2012-2#1)(2013-1#1)
dressing##27##1##(1992-6#2)(1997-5#1)(1997-7#1)(2007-7#4)(2008-10#1)(2008-12#3)(2008-5#2)(2008-9#1)(2009-5#2)(2011-2#5)(2012-2#2)(2013-1#2)(2013-7#1)
dressings and##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
dressings##5##1##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)
drew attention to the##3##4##(1995-11#1)(2008-12#1)(2008-5#1)
drew attention to##4##3##(1993-12#1)(1995-11#1)(2008-12#1)(2008-5#1)
drew on##2##2##(2010-8#1)(2012-1#1)
drew##9##1##(1993-12#1)(1995-11#1)(1996-5#1)(2008-12#1)(2008-5#2)(2010-8#1)(2012-1#1)(2013-1#1)
dried and##6##2##(2008-10#4)(2008-5#2)
dried at room temperature##2##4##(1995-2#1)(2013-7#1)
dried at##3##2##(1995-2#1)(2008-10#1)(2013-7#1)
dried blood spots##6##3##(1991-2#2)(1991-8#1)(1992-12#1)(2010-11#2)
dried blood##7##2##(1991-2#2)(1991-8#1)(1992-12#1)(2010-11#2)(2013-1#1)
dried chloroform##2##2##(2008-10#2)
dried in##2##2##(2008-10#2)
dried leaves##3##2##(2008-10#2)(2012-2#1)
dried material##2##2##(2008-10#2)
dried plant##3##2##(2008-10#2)(2012-2#1)
dried plum##3##2##(2010-4#3)
dried product##2##2##(2008-10#2)
dried products##2##2##(2008-10#2)
dried with##2##2##(2008-7#1)(2013-1#1)
dried##79##1##(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1994-6#1)(1995-2#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#41)(2008-12#6)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#2)(2010-4#4)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
drier##8##1##(2008-10#3)(2008-5#1)(2008-8#1)(2012-7#1)(2012-9#2)
drift algae##3##2##(2007-5#3)
drift and##4##2##(2008-10#2)(2012-7#1)(2013-1#1)
drift from##2##2##(2008-11#1)(2008-5#1)
drift in the##4##3##(2008-10#3)(2008-2#1)
drift in##9##2##(2008-10#5)(2008-2#2)(2013-8#2)
drift is discussed##2##3##(2008-10#1)(2013-1#1)
drift is##6##2##(2007-12#2)(2008-10#3)(2013-1#1)
drift noise in Fourier transform spectroscopy##2##6##(2008-2#2)
drift noise##5##2##(2008-2#5)
drift of a##2##3##(2007-12#1)(2012-2#1)
drift of the##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
drift of##13##2##(1990-12#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-3#2)(2010-4#1)(2012-2#1)
drift on##2##2##(2008-3#1)(2013-8#1)
drift that##3##2##(1996-6#1)(2008-2#1)(2008-3#1)
drift tube##2##2##(2008-10#2)
drift was##4##2##(2007-5#1)(2008-10#1)(2008-8#2)
drift with##4##2##(2007-5#1)(2008-10#2)(2013-1#1)
drift##108##1##(1990-12#1)(1995-5#1)(1996-12#1)(1996-6#4)(2007-11#2)(2007-12#6)(2007-5#6)(2008-10#40)(2008-11#2)(2008-2#9)(2008-3#9)(2008-5#1)(2008-8#3)(2009-12#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#5)
drifted##3##1##(2008-2#1)(2008-3#1)(2010-4#1)
drifting##6##1##(2008-10#3)(2008-3#3)
drifts##6##1##(2007-11#1)(2008-10#1)(2008-3#3)(2012-2#1)
drill##9##1##(1992-11#1)(1993-12#2)(1995-3#1)(1996-2#1)(2007-12#1)(2008-7#2)(2011-2#1)
drilled for the##2##3##(2012-2#2)
drilled into the##2##3##(2008-10#1)(2011-2#1)
drilled##6##1##(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#3)
drilling a##2##2##(2007-12#1)(2012-2#1)
drilling of the##3##3##(2008-3#1)(2009-1#1)(2009-4#1)
drilling of##6##2##(2007-12#1)(2008-3#2)(2008-9#1)(2009-1#1)(2009-4#1)
drilling units in the North Sea##2##6##(2009-10#2)
drilling units##4##2##(2009-10#4)
drilling##25##1##(1991-3#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-9#2)(2009-1#1)(2009-10#4)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
drink and##2##2##(2008-10#1)(2009-7#1)
drink kava##2##2##(2008-1#2)
drink sizes##5##2##(2009-7#5)
drink##41##1##(1992-3#1)(1993-12#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#10)(2011-2#4)(2012-1#2)(2012-2#2)
drinkers and##4##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
drinkers##12##1##(1993-11#1)(1994-2#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#3)(2013-8#1)
drinkers'##2##1##(1997-2#1)(2013-1#1)
drinking 'benifuuki' green tea##2##4##(2008-11#2)
drinking alcohol##3##2##(1991-9#1)(2007-12#1)(2008-10#1)
drinking and##10##2##(1994-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)(2010-9#1)(2011-2#1)
drinking behavior##5##2##(1994-2#3)(2009-4#2)
drinking behaviors##2##2##(2010-7#2)
drinking behaviour##5##2##(1990-2#1)(2008-10#1)(2009-7#2)(2011-2#1)
drinking contexts##3##2##(2008-12#3)
drinking habits##3##2##(1990-2#1)(2008-11#1)(2009-7#1)
drinking in##6##2##(1994-2#2)(2008-1#1)(2008-12#2)(2008-8#1)
drinking is##4##2##(2008-1#1)(2008-4#1)(2010-7#1)(2011-2#1)
drinking levels##2##2##(2008-11#1)(2009-7#1)
drinking of##2##2##(1991-11#1)(2008-11#1)
drinking or##2##2##(2010-7#1)(2010-9#1)
drinking patterns and drinking contexts##2##5##(2008-12#2)
drinking patterns##3##2##(2008-12#2)(2010-7#1)
drinking tap water##2##3##(2008-10#2)
drinking water and the##2##4##(2007-2#1)(2008-10#1)
drinking water and##17##3##(1990-6#1)(2007-2#1)(2007-7#1)(2008-10#10)(2008-5#1)(2008-9#2)(2013-1#1)
drinking water as##3##3##(2008-10#2)(2008-9#1)
drinking water by##7##3##(2008-10#7)
drinking water containing 0##12##4##(2008-10#2)(2008-9#10)
drinking water containing##14##3##(2008-10#3)(2008-4#1)(2008-9#10)
drinking water did not##2##4##(1993-8#1)(2008-10#1)
drinking water for 26##3##4##(2008-9#3)
drinking water for 4##2##4##(2008-10#1)(2008-5#1)
drinking water for##15##3##(1995-12#1)(2008-10#3)(2008-5#2)(2008-9#8)(2013-1#1)
drinking water is##9##3##(2008-10#8)(2008-11#1)
drinking water of##2##3##(2008-10#2)
drinking water samples##9##3##(2008-10#9)
drinking water studies##4##3##(2008-9#4)
drinking water supplies##2##3##(2008-10#1)(2008-9#1)
drinking water treatment##4##3##(1992-5#1)(2008-10#1)(2013-1#2)
drinking water##165##2##(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)(1992-5#2)(1993-8#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-6#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#85)(2008-11#2)(2008-4#1)(2008-5#5)(2008-9#40)(2009-7#1)(2011-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
drinking water)##3##2##(1995-12#1)(1996-2#1)(2008-10#1)
drinking##291##1##(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-2#2)(1992-3#1)(1992-5#2)(1993-6#2)(1993-8#1)(1994-2#20)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#105)(2008-11#10)(2008-12#13)(2008-2#2)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#40)(2009-4#2)(2009-5#3)(2009-7#7)(2010-5#1)(2010-7#12)(2010-9#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#4)
drinking-water##4##1##(2008-10#3)(2013-1#1)
drinks and##7##2##(1996-11#2)(2008-10#4)(2009-7#1)
drinks are##2##2##(1995-8#1)(1997-5#1)
drinks for##2##2##(2008-10#1)(2012-12#1)
drinks is##2##2##(2008-10#2)
drinks on##2##2##(2010-3#1)(2012-6#1)
drinks per day##4##3##(1993-9#1)(1994-2#2)(2008-2#1)
drinks per##6##2##(1993-9#1)(1994-2#3)(2008-2#1)(2013-1#1)
drinks were##2##2##(2008-10#1)(2012-2#1)
drinks##59##1##(1993-9#1)(1994-2#5)(1995-8#1)(1996-11#2)(1997-5#3)(2008-10#29)(2008-2#1)(2008-5#1)(2009-5#1)(2009-7#6)(2010-3#1)(2010-8#2)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#1)
drip irrigation and associated##2##4##(2008-10#2)
drip irrigation and##3##3##(2008-10#3)
drip irrigation was##2##3##(2008-10#2)
drip irrigation##18##2##(2008-10#18)
drip loss and##2##3##(2010-2#1)(2010-4#1)
drip loss##3##2##(2010-2#1)(2010-4#1)(2013-1#1)
drip##30##1##(1997-8#1)(2008-10#24)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
dripping##3##1##(2011-2#1)(2012-2#2)
drippy bud##2##2##(2008-10#2)
drippy nut##2##2##(2008-10#2)
drippy##4##1##(2008-10#4)
drive and##4##2##(1996-12#1)(1996-5#1)(2011-2#1)(2012-3#1)
drive control system##2##3##(2013-8#2)
drive differentiation##2##2##(2008-11#1)(2008-9#1)
drive in##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
drive laser##3##2##(2008-2#3)
drive the evolution of##2##4##(2008-9#1)(2010-5#1)
drive the##24##2##(1994-6#1)(1994-8#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
drive to##5##2##(1995-12#2)(1996-5#1)(2008-1#1)(2010-12#1)
drive voltage##3##2##(2007-12#2)(2013-8#1)
drive##113##1##(1990-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#6)(2008-2#8)(2008-3#7)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#4)
driven by a femtosecond##2##4##(2007-11#2)
driven by a##16##3##(1994-12#1)(1994-6#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2013-1#1)
driven by an##3##3##(2008-11#2)(2008-8#1)
driven by concerns##2##3##(1992-1#1)(2009-11#1)
driven by the fact that##2##5##(2008-10#1)(2011-1#1)
driven by the##36##3##(1990-2#1)(1991-9#3)(1993-9#2)(1994-11#1)(1994-5#1)(1995-1#1)(1996-12#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
driven by##119##2##(1990-2#1)(1991-9#3)(1992-1#1)(1992-7#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2006-12#2)(2007-11#5)(2007-12#6)(2008-10#8)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#9)(2008-9#9)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
driven into the##2##3##(1994-9#1)(2007-12#1)
driven primarily by##2##3##(2010-6#1)(2012-12#1)
driven the##4##2##(2008-10#1)(2008-8#1)(2009-2#1)(2011-2#1)
driven to the quartz flow cell and measured with##2##9##(2008-10#2)
driven to the##3##3##(2008-10#3)
driven to##8##2##(1993-8#1)(2007-11#1)(2008-10#5)(2008-7#1)
driven with##3##2##(2008-3#2)(2008-7#1)
driven##188##1##(1990-12#1)(1990-2#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-12#2)(1993-5#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2006-12#2)(2007-11#7)(2007-12#11)(2008-10#20)(2008-11#14)(2008-12#3)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#8)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#2)
driver of##2##2##(2012-12#1)(2013-1#1)
driver with##2##2##(1995-12#1)(2010-11#1)
driver##26##1##(1992-6#1)(1995-12#1)(1995-3#2)(1997-6#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
driver's##3##1##(1992-6#1)(1996-5#1)(2008-4#1)
drivers and##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
drivers for##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
drivers of hybridization##2##3##(2012-3#2)
drivers of##7##2##(1997-6#1)(2008-11#1)(2012-12#2)(2012-2#1)(2012-3#2)
drivers##25##1##(1992-6#2)(1997-6#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)
drives the evolution of##2##4##(2008-8#1)(2010-7#1)
drives the##11##2##(1991-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
drives##34##1##(1991-5#1)(1993-12#1)(1995-2#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-7#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
driving a##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
driving force behind##3##3##(1995-3#1)(2010-5#1)(2012-3#1)
driving force for the##4##4##(2008-10#2)(2008-5#1)(2013-8#1)
driving force for##9##3##(2008-10#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2013-8#2)
driving force in the##2##4##(1994-5#1)(2008-9#1)
driving force of##3##3##(1991-12#1)(2010-2#2)
driving force##23##2##(1991-12#1)(1994-5#1)(1995-3#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-5#1)(2012-3#1)(2013-8#2)
driving forces##2##2##(2007-11#1)(2008-11#1)
driving simulators##2##2##(2011-2#2)
driving the##15##2##(1991-3#1)(1993-12#1)(1995-1#1)(1996-1#1)(2007-12#4)(2008-11#2)(2008-3#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#1)
driving this##2##2##(2010-10#1)(2013-1#1)
driving##98##1##(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-6#1)(2007-11#3)(2007-12#7)(2007-2#1)(2008-10#9)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#4)
droebachiensis##3##1##(2009-2#3)
drones##3##1##(2008-10#3)
drop and the##2##3##(2008-10#1)(2008-3#1)
drop and##4##2##(2008-10#2)(2008-3#1)(2009-11#1)
drop detachment##2##2##(2008-10#2)
drop formation##2##2##(2008-10#2)
drop growth##3##2##(2008-10#3)
drop in egg production##2##4##(1997-6#1)(2013-1#1)
drop in plasma##2##3##(1994-11#1)(2008-12#1)
drop in the##7##3##(1992-5#1)(1994-11#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-3#1)
drop in##26##2##(1990-11#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-3#2)(2010-6#1)(2011-2#1)(2013-1#1)
drop incidence was##3##3##(2008-10#3)
drop incidence##7##2##(2008-10#7)
drop interface##2##2##(2008-10#2)
drop into##2##2##(1991-5#1)(2008-10#1)
drop is##3##2##(1991-5#1)(1996-4#1)(2009-11#1)
drop metastasis##2##2##(2008-12#2)
drop method##2##2##(2008-10#2)
drop of a##3##3##(2008-10#2)(2008-3#1)
drop of liquid##2##3##(2008-10#1)(2008-3#1)
drop of the##5##3##(1991-3#1)(2008-10#3)(2009-10#1)
drop of##23##2##(1990-11#2)(1991-3#1)(1993-3#2)(2007-8#1)(2008-10#10)(2008-3#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
drop or##2##2##(2008-10#1)(2008-2#1)
drop out##2##2##(2007-6#1)(2008-7#1)
drop port##3##2##(2007-11#1)(2007-12#1)(2011-1#1)
drop pressure##2##2##(2008-10#2)
drop radius##2##2##(2008-10#2)
drop shape##2##2##(2008-10#2)
drop size##2##2##(2008-10#1)(2008-5#1)
drop test##3##2##(2008-7#2)(2011-2#1)
drop the##2##2##(1992-2#1)(2012-3#1)
drop to##2##2##(2008-9#1)(2011-2#1)
drop volume##4##2##(2008-10#4)
drop was##5##2##(2007-12#1)(2008-10#3)(2008-6#1)
drop##237##1##(1990-11#3)(1991-3#1)(1991-5#4)(1992-11#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#3)(1994-11#2)(1994-12#1)(1994-2#3)(1995-3#1)(1996-2#1)(1996-4#6)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#138)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#3)(2009-6#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
drop-based##4##1##(2008-10#4)
drop-out from##2##2##(1993-1#1)(2007-12#1)
drop-out##10##1##(1990-2#1)(1992-5#1)(1993-1#1)(1996-12#1)(1997-7#2)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
drop-outs##2##1##(1993-12#1)(2008-7#1)
droperidol and fentanyl##2##3##(1996-6#2)
droperidol and##3##2##(1996-6#2)(2010-8#1)
droperidol##5##1##(1996-6#2)(2008-10#2)(2010-8#1)
droplet and##5##2##(1995-3#1)(2008-10#2)(2008-12#2)
droplet can##2##2##(2007-11#1)(2008-7#1)
droplet deformation##2##2##(2008-3#2)
droplet diameter##4##2##(2008-10#2)(2008-5#2)
droplet generation and##2##3##(1995-3#2)
droplet manipulation##2##2##(2009-5#2)
droplet of##3##2##(2007-12#1)(2008-10#2)
droplet size and##2##3##(1994-12#1)(2008-3#1)
droplet size distribution##4##3##(1996-3#1)(2008-5#2)(2008-7#1)
droplet size##15##2##(1994-12#1)(1995-3#1)(1996-3#2)(2008-3#3)(2008-5#6)(2008-7#2)
droplet sizes##4##2##(1994-12#1)(1995-3#1)(2008-2#1)(2008-5#1)
droplet##86##1##(1992-3#1)(1994-12#2)(1994-9#3)(1995-3#7)(1996-3#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#13)(2008-3#16)(2008-5#9)(2008-7#3)(2009-5#3)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#1)
droplets and droplets with inclusions##3##5##(2008-3#3)
droplets and the##2##3##(1995-3#1)(2012-1#1)
droplets and vapor distributions in a##3##6##(2008-3#3)
droplets and##23##2##(1995-3#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-9#1)(2012-1#2)
droplets are##7##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
droplets containing##2##2##(2008-2#1)(2008-3#1)
droplets from##2##2##(2008-2#1)(2008-3#1)
droplets have##3##2##(2007-12#1)(2007-5#1)(2008-3#1)
droplets in liquid-liquid systems##2##4##(2008-2#2)
droplets in the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
droplets in##7##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)
droplets is##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
droplets may##2##2##(2008-10#1)(2008-2#1)
droplets of##6##2##(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2013-1#1)
droplets that##3##2##(1995-3#1)(2008-2#2)
droplets were##4##2##(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)
droplets with a##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
droplets with inclusions##4##3##(2008-3#4)
droplets with##9##2##(1994-12#1)(1995-3#1)(2007-11#1)(2008-2#1)(2008-3#5)
droplets##144##1##(1992-9#1)(1994-12#2)(1995-2#1)(1995-3#9)(1996-3#1)(2007-10#3)(2007-11#3)(2007-12#16)(2007-5#5)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#28)(2008-3#32)(2008-5#6)(2008-7#4)(2008-9#2)(2009-3#1)(2009-5#1)(2011-1#2)(2011-3#1)(2012-1#3)(2012-2#1)(2013-1#1)
droplets)##3##1##(2008-7#2)(2010-4#1)
dropout rate##3##2##(2008-12#1)(2008-5#1)(2011-1#1)
dropout##12##1##(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-1#1)
dropouts in the##2##3##(2011-1#1)(2012-2#1)
dropouts##4##1##(2007-12#1)(2011-1#2)(2012-2#1)
dropped below the##2##3##(2008-10#1)(2012-2#1)
dropped below##4##2##(2008-10#3)(2012-2#1)
dropped from##10##2##(1990-7#1)(1994-3#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
dropped fruit##4##2##(2008-10#4)
dropped on##2##2##(2008-10#1)(2008-12#1)
dropped out##5##2##(1992-11#1)(2008-6#1)(2010-11#1)(2013-1#2)
dropped to 2##2##3##(1990-11#1)(2008-1#1)
dropped to##13##2##(1990-11#1)(1990-6#1)(1990-7#1)(1993-6#1)(1994-6#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
dropped##63##1##(1990-11#1)(1990-6#1)(1990-7#2)(1992-11#1)(1992-2#1)(1992-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
dropping a##2##2##(2008-7#1)(2009-12#1)
dropping mercury electrode##6##3##(2008-10#6)
dropping##19##1##(1991-12#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)
droppings##7##1##(1990-3#1)(1994-8#1)(1995-9#3)(2008-5#2)
drops and##4##2##(1990-9#1)(2008-10#1)(2008-2#1)(2013-8#1)
drops at##2##2##(1996-4#1)(2008-10#1)
drops below##2##2##(2007-11#1)(2008-8#1)
drops in##4##2##(1990-7#1)(2008-10#2)(2008-5#1)
drops that##2##2##(2008-10#2)
drops to##2##2##(1991-6#1)(2008-3#1)
drops were##2##2##(2008-10#2)
drops##48##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-6#1)(1993-9#1)(1994-2#2)(1996-4#1)(2007-11#1)(2008-10#19)(2008-2#6)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-8#1)
drosophila##2##1##(2009-5#2)
drosophila&quot##3##1##(2008-10#3)
drotrecogin alfa##2##2##(2009-5#1)(2009-9#1)
drought and air warming##3##4##(2012-6#3)
drought and air##4##3##(2012-6#3)(2012-9#1)
drought and elevated##2##3##(2012-6#1)(2012-7#1)
drought and##15##2##(2008-11#1)(2008-12#1)(2012-2#1)(2012-5#2)(2012-6#5)(2012-7#2)(2012-8#1)(2012-9#2)
drought and/or air warming##2##4##(2012-5#1)(2012-9#1)
drought resistance##2##2##(2008-12#1)(2008-6#1)
drought resistant##3##2##(2008-12#2)(2012-6#1)
drought stress##13##2##(2008-12#7)(2008-7#2)(2011-2#3)(2012-6#1)
drought tolerance##3##2##(2008-8#1)(2012-5#1)(2012-9#1)
drought treatment##2##2##(2008-8#1)(2012-7#1)
drought##84##1##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#13)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2011-2#5)(2012-2#5)(2012-5#7)(2012-6#14)(2012-7#8)(2012-8#6)(2012-9#10)(2013-7#1)
drought- and##2##2##(2012-6#1)(2012-7#1)
drought-induced##2##1##(2012-7#2)
drought-mediated changes in##2##3##(2012-8#2)
drought-mediated##3##1##(2012-8#3)
drove##2##1##(1997-3#1)(2009-9#1)
drovers##2##1##(2011-2#2)
drowning##6##1##(1995-3#5)(2013-1#1)
drowsiness and##2##2##(2008-10#1)(2008-12#1)
drowsiness##5##1##(1991-5#1)(2008-10#2)(2008-12#1)(2008-7#1)
drowsy##2##1##(2008-7#1)(2012-2#1)
drug (NSAID) use##2##3##(2006-10#1)(2008-10#1)
drug (NSAID)##5##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
drug absorption##4##2##(1991-8#1)(1994-2#1)(2008-10#1)(2012-2#1)
drug abuse and##3##3##(1996-4#1)(2008-4#1)(2011-1#1)
drug abuse prevention##2##3##(2008-6#1)(2009-7#1)
drug abuse treatment programs##2##4##(2008-6#2)
drug abuse treatment##8##3##(1991-1#1)(2008-6#6)(2010-4#1)
drug abuse##38##2##(1990-2#1)(1991-1#3)(1992-2#1)(1992-3#2)(1993-6#1)(1994-2#1)(1994-8#2)(1995-5#1)(1996-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#1)(2009-6#1)(2009-7#4)(2010-4#1)(2011-1#1)
drug abuser##3##2##(1991-1#1)(2008-12#1)(2012-2#1)
drug abusers and##4##3##(1990-3#1)(2007-7#1)(2008-12#1)(2008-6#1)
drug abusers##10##2##(1990-3#1)(1991-1#4)(1994-2#1)(2007-7#1)(2008-12#1)(2008-6#2)
drug accumulation and##4##3##(2008-10#2)(2008-11#2)
drug accumulation##8##2##(2007-2#1)(2008-10#2)(2008-11#5)
drug action##3##2##(1995-12#1)(2008-4#2)
drug activity##3##2##(1992-2#1)(2008-5#1)(2008-8#1)
drug addict##3##2##(1990-9#1)(1994-3#1)(2012-2#1)
drug addiction and##2##3##(1991-6#1)(2007-7#1)
drug addiction in adolescents##2##4##(2011-1#2)
drug addiction in##3##3##(2011-1#2)(2012-3#1)
drug addiction##14##2##(1991-6#1)(1996-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#3)(2011-1#3)(2012-3#2)
drug addicts in##3##3##(1991-5#1)(1993-2#1)(1996-11#1)
drug addicts##11##2##(1991-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-11#1)(2007-7#3)(2011-1#1)(2012-2#1)(2012-3#1)
drug administration##22##2##(1991-3#1)(1992-6#1)(1994-6#2)(1994-9#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
drug after##2##2##(1990-6#1)(2008-7#1)
drug alone##3##2##(1993-8#1)(2011-10#1)(2012-12#1)
drug amantadine##2##2##(1992-3#2)
drug analysis and##2##3##(2008-10#1)(2010-7#1)
drug analysis##8##2##(1990-8#1)(2008-10#6)(2010-7#1)
drug and alcohol abuse##2##4##(1996-6#1)(2013-1#1)
drug and alcohol##7##3##(1993-12#1)(1993-3#1)(1996-6#1)(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
drug and in##4##3##(2008-10#3)(2010-5#1)
drug and its##6##3##(1990-8#1)(1995-11#1)(2008-10#3)(2008-8#1)
drug and placebo compliance##2##4##(1994-11#2)
drug and protein##3##3##(2008-10#1)(2010-10#1)(2012-2#1)
drug and the##4##3##(1994-5#1)(2008-10#2)(2011-3#1)
drug and vaccine##2##3##(2008-4#1)(2010-12#1)
drug and##55##2##(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-5#1)(1995-11#1)(1996-3#1)(1996-6#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
drug application##2##2##(1994-2#1)(2008-8#1)
drug are##2##2##(2008-10#2)
drug as##3##2##(1990-8#1)(2008-10#1)(2008-11#1)
drug at the##2##3##(2008-10#1)(2008-11#1)
drug at##8##2##(1991-10#1)(1992-3#1)(1995-2#1)(2008-10#4)(2008-11#1)
drug benefit##10##2##(1995-1#4)(2007-9#2)(2008-11#2)(2008-4#2)
drug binding site##2##3##(1995-5#1)(2009-9#1)
drug binding##4##2##(1995-5#1)(2008-10#1)(2008-9#1)(2009-9#1)
drug bioavailability##2##2##(2008-8#1)(2010-5#1)
drug by##5##2##(1990-2#1)(2008-10#2)(2008-7#1)(2010-8#1)
drug calculation skills##2##3##(2008-11#2)
drug calculation##3##2##(2008-11#2)(2008-12#1)
drug calculations##3##2##(2008-11#2)(2008-12#1)
drug can##3##2##(1993-6#1)(2008-10#1)(2012-2#1)
drug candidate##6##2##(2008-10#2)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
drug candidates on##2##3##(2007-11#1)(2009-12#1)
drug candidates##6##2##(2007-11#2)(2009-12#1)(2011-3#2)(2013-1#1)
drug carriers##4##2##(1997-1#2)(2008-7#1)(2008-8#1)
drug category##2##2##(2010-5#2)
drug choice##2##2##(2007-2#1)(2010-4#1)
drug cisplatin##2##2##(1991-9#1)(2012-2#1)
drug combination##3##2##(2008-3#1)(2010-3#1)(2012-12#1)
drug companies##5##2##(1994-7#1)(1996-5#1)(1997-5#1)(2008-7#1)(2010-4#1)
drug company##2##2##(1994-3#1)(2011-2#1)
drug concentration in##3##3##(1993-12#1)(1996-3#1)(2010-11#1)
drug concentration monitoring##3##3##(2007-11#3)
drug concentration##13##2##(1990-2#1)(1993-12#1)(1994-8#1)(1996-3#3)(2007-11#3)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
drug concentrations (microgram/g)##4##3##(1995-2#4)
drug concentrations are##2##3##(2008-8#1)(2010-11#1)
drug concentrations in the##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
drug concentrations in##6##3##(1992-9#1)(1995-2#1)(2008-10#1)(2008-8#2)(2011-3#1)
drug concentrations##20##2##(1990-12#1)(1991-8#1)(1992-9#1)(1994-8#1)(1995-2#7)(2008-10#1)(2008-8#3)(2010-11#1)(2010-5#1)(2011-3#2)(2013-1#1)
drug consumption##3##2##(1993-3#1)(2012-3#2)
drug content and in vitro dispersion time##2##7##(2010-3#2)
drug content uniformity and in vitro dispersion time##2##8##(2010-3#2)
drug content##7##2##(2010-3#5)(2011-1#1)(2012-2#1)
drug contents##2##2##(2008-10#1)(2010-5#1)
drug control##3##2##(1995-11#1)(2008-7#1)(2012-1#1)
drug coverage##4##2##(1992-1#1)(1995-1#1)(2009-3#2)
drug cross resistance##2##3##(2008-11#2)
drug delivered##2##2##(1992-3#1)(1996-3#1)
drug delivery and##5##3##(1995-11#1)(1996-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
drug delivery by##2##3##(1996-2#1)(2011-1#1)
drug delivery devices##2##3##(2010-6#1)(2012-2#1)
drug delivery in##3##3##(1995-10#1)(1997-1#1)(2012-3#1)
drug delivery of##2##3##(1992-6#1)(1992-8#1)
drug delivery system##11##3##(1991-12#1)(1991-3#1)(1997-1#1)(2008-11#2)(2008-5#1)(2009-12#1)(2010-5#1)(2012-2#1)(2013-1#2)
drug delivery systems for##2##4##(2008-7#1)(2012-2#1)
drug delivery systems using##2##4##(1996-2#1)(2012-2#1)
drug delivery systems##14##3##(1992-3#1)(1996-2#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-5#3)(2012-2#3)(2013-1#2)
drug delivery vehicle##3##3##(2008-12#1)(2009-11#1)(2009-7#1)
drug delivery##76##2##(1991-12#1)(1991-3#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1995-10#1)(1995-11#2)(1996-2#5)(1997-1#4)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#5)(2008-7#5)(2008-8#1)(2009-11#3)(2009-12#4)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#6)(2010-6#3)(2011-1#3)(2012-2#7)(2012-3#2)(2013-1#8)
drug dependence##5##2##(1991-1#1)(1994-2#1)(2008-6#2)(2012-1#1)
drug deposition in##2##3##(1992-2#1)(2010-5#1)
drug design##16##2##(1992-5#1)(1992-9#1)(2007-11#1)(2008-5#4)(2008-7#3)(2009-7#1)(2011-3#3)(2012-12#1)(2012-3#1)
drug development and the##2##4##(2008-8#1)(2010-11#1)
drug development and##5##3##(2008-5#2)(2008-8#1)(2010-11#2)
drug development for##3##3##(1991-3#1)(2008-10#1)(2011-1#1)
drug development##48##2##(1991-3#2)(1992-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#9)(2009-9#1)(2010-10#1)(2010-11#4)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#2)
drug did not##2##3##(2008-9#1)(2012-3#1)
drug discovery and##4##3##(2008-4#1)(2008-8#1)(2011-3#2)
drug discovery bioanalysis##3##3##(2008-10#3)
drug discovery in##2##3##(2009-6#1)(2013-1#1)
drug discovery##48##2##(1997-1#1)(1997-4#3)(2008-10#14)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-3#5)(2012-2#1)(2013-1#1)
drug disorder##3##2##(1993-12#3)
drug disorders##2##2##(1993-12#1)(2013-1#1)
drug dissolution testing##2##3##(2008-10#2)
drug distribution##3##2##(2008-11#3)
drug dosage##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
drug dose and##2##3##(2008-6#1)(2008-7#1)
drug doses were##2##3##(1995-12#1)(2012-12#1)
drug doses##4##2##(1994-6#1)(1995-12#1)(2008-11#1)(2012-12#1)
drug dosing histories##2##3##(1997-7#2)
drug dosing##3##2##(1997-7#2)(2011-10#1)
drug during the##3##3##(2008-11#1)(2008-5#1)(2012-12#1)
drug effect##2##2##(1992-8#1)(2011-2#1)
drug effects on##3##3##(1994-6#1)(2008-3#1)(2010-8#1)
drug effects##9##2##(1991-11#1)(1993-1#1)(1994-6#1)(1995-2#1)(2008-3#3)(2009-12#1)(2010-8#1)
drug efficacy and##3##3##(1997-4#1)(2008-11#1)(2009-12#1)
drug efficacy##6##2##(1990-3#1)(1997-4#1)(2008-11#1)(2008-8#2)(2009-12#1)
drug efflux##2##2##(2008-11#2)
drug eluting##2##2##(2008-1#1)(2008-12#1)
drug elution##2##2##(2008-7#2)
drug encapsulation/release##2##2##(2009-11#2)
drug epidemics##3##2##(2013-8#3)
drug events##4##2##(1993-12#1)(2007-9#1)(2011-2#1)(2011-3#1)
drug existed##2##2##(2008-10#1)(2010-1#1)
drug exposure was##2##3##(1997-4#1)(2013-1#1)
drug exposure##15##2##(1994-8#1)(1996-12#2)(1997-4#4)(2008-10#1)(2008-7#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
drug following##2##2##(1996-12#1)(2008-4#1)
drug for the##3##3##(1990-2#1)(2012-3#2)
drug for##22##2##(1990-2#1)(1990-3#1)(1990-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1995-1#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
drug forms##2##2##(2008-10#1)(2011-3#1)
drug formulary##2##2##(2011-1#1)(2011-2#1)
drug formulation using##2##3##(2008-10#2)
drug formulation##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
drug formulations was##2##3##(1997-4#1)(2008-10#1)
drug formulations##9##2##(1997-4#1)(2008-10#8)
drug from##7##2##(1996-1#1)(2008-10#3)(2009-11#1)(2010-5#2)
drug has been##4##3##(1990-3#1)(1994-5#1)(1994-6#1)(2008-10#1)
drug has##8##2##(1990-10#1)(1990-3#1)(1990-6#1)(1993-12#1)(1994-5#1)(1994-6#1)(2008-10#2)
drug have been##2##3##(2008-5#1)(2010-11#1)
drug have##3##2##(1991-5#1)(2008-5#1)(2010-11#1)
drug history##2##2##(1992-9#1)(2013-1#1)
drug hypersensitivity##2##2##(2008-10#1)(2008-8#1)
drug in human##4##3##(2008-10#4)
drug in patients##3##3##(1990-12#1)(2008-1#1)(2008-10#1)
drug in pharmaceutical preparations##3##4##(2008-10#3)
drug in pharmaceutical##4##3##(2008-10#4)
drug in tablets##2##3##(2008-10#2)
drug in the##11##3##(1990-11#1)(1990-6#1)(1991-12#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-6#1)(2013-1#1)
drug in##47##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1993-11#1)(1996-2#1)(2007-11#1)(2008-1#3)(2008-10#25)(2008-11#2)(2008-6#2)(2008-7#2)(2008-8#3)(2010-5#1)(2012-2#1)(2013-1#1)
drug induced a##2##3##(1992-11#1)(2008-11#1)
drug induced##8##2##(1991-8#1)(1992-11#1)(2008-11#2)(2008-7#2)(2008-8#2)
drug industry##2##2##(1997-1#1)(2008-5#1)
drug information##6##2##(2008-11#2)(2008-7#1)(2011-1#3)
drug infusion##2##2##(1992-5#1)(1997-3#1)
drug inhibits##2##2##(2007-11#1)(2011-2#1)
drug injection##7##2##(1994-2#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
drug instrumentalization##3##2##(2012-3#3)
drug insurance##3##2##(2010-5#3)
drug intake##4##2##(2007-7#1)(2008-7#2)(2008-8#1)
drug interaction of glimepride##3##4##(2011-1#3)
drug interaction##6##2##(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#3)
drug interactions and##2##3##(2008-3#1)(2011-3#1)
drug interactions##14##2##(1991-8#1)(1992-8#1)(1994-5#2)(1997-2#1)(2007-11#2)(2008-11#2)(2008-3#3)(2008-8#1)(2011-3#1)
drug is taken##2##3##(2007-10#1)(2008-3#1)
drug is##21##2##(1990-3#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2010-2#1)(2011-1#1)
drug levels##6##2##(1992-3#1)(1992-8#1)(1994-2#1)(1997-4#1)(2008-7#1)(2010-6#1)
drug lords##2##2##(2013-8#2)
drug may##4##2##(2007-5#1)(2007-9#1)(2008-3#1)(2008-8#1)
drug memory##2##2##(2012-3#2)
drug metabolic functions##3##3##(2008-11#3)
drug metabolising enzymes##2##3##(2008-11#2)
drug metabolism and##2##3##(1993-12#1)(2008-8#1)
drug metabolism##9##2##(1993-12#1)(1994-5#1)(2008-3#1)(2008-8#2)(2011-2#3)(2012-2#1)
drug metabolizing enzymes##3##3##(1996-12#2)(2010-12#1)
drug metabolizing##4##2##(1996-12#2)(2008-10#1)(2010-12#1)
drug misuse##4##2##(1992-5#1)(2013-8#3)
drug molecules##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
drug monitoring in##2##3##(2008-8#1)(2010-7#1)
drug monitoring of##2##3##(2008-6#1)(2010-11#1)
drug monitoring##11##2##(1991-3#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-11#5)(2010-7#1)
drug of choice for##2##4##(1991-10#1)(2010-2#1)
drug of choice##4##3##(1991-10#1)(2010-2#1)(2010-8#1)(2011-2#1)
drug of##7##2##(1991-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
drug on##9##2##(1994-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
drug onto##2##2##(2008-10#2)
drug or alcohol abuse##2##4##(2009-7#1)(2011-2#1)
drug or alcohol##3##3##(1992-12#1)(2009-7#1)(2011-2#1)
drug or gene##2##3##(2008-11#1)(2010-12#1)
drug or##9##2##(1992-12#1)(1992-9#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)
drug particles##4##2##(1992-2#1)(1996-12#1)(1996-2#1)(2009-11#1)
drug penetration##2##2##(2008-5#2)
drug pharmacokinetics##2##2##(1994-2#1)(2008-8#1)
drug plan##4##2##(1995-6#2)(2008-11#1)(2008-8#1)
drug plasma concentration##2##3##(2008-1#1)(2010-11#1)
drug policies##4##2##(1991-1#1)(1995-1#2)(2012-12#1)
drug policy##3##2##(1995-1#1)(1995-8#1)(2007-7#1)
drug precursor##2##2##(2013-8#2)
drug prescribing and##2##3##(2008-7#1)(2009-3#1)
drug prescribing##3##2##(2008-7#1)(2009-3#1)(2010-5#1)
drug price##2##2##(1993-1#1)(1993-3#1)
drug problem##2##2##(1992-12#1)(2008-6#1)
drug product##2##2##(2008-10#1)(2010-4#1)
drug products##4##2##(1993-12#1)(1997-6#1)(2008-10#1)(2010-11#1)
drug properties##3##2##(1992-3#1)(2008-4#1)(2012-3#1)
drug racemates##3##2##(2008-10#3)
drug reaction##6##2##(1993-1#1)(2007-7#1)(2008-3#1)(2008-8#2)(2010-5#1)
drug reactions (ADRs)##4##3##(2008-11#1)(2008-3#1)(2011-2#2)
drug reactions##53##2##(1994-6#2)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#2)(2007-12#1)(2007-7#3)(2008-10#2)(2008-11#4)(2008-3#2)(2008-8#6)(2010-5#8)(2010-6#2)(2011-2#13)(2013-8#5)
drug receptors##2##2##(1994-2#1)(1997-7#1)
drug regimen for##2##3##(1994-6#1)(2007-12#1)
drug regimen##6##2##(1994-6#1)(1997-7#1)(2007-12#1)(2008-11#3)
drug regimens##5##2##(1995-1#1)(2007-11#1)(2008-1#1)(2008-11#2)
drug rehabilitation##2##2##(1996-5#1)(2013-1#1)
drug reinforcement##3##2##(2007-8#1)(2008-4#1)(2012-3#1)
drug release and##4##3##(2008-5#1)(2010-5#2)(2012-2#1)
drug release##24##2##(2008-5#1)(2010-10#1)(2010-3#4)(2010-5#7)(2011-1#3)(2012-2#8)
drug repurposing##2##2##(2012-1#2)
drug research##3##2##(1991-3#1)(2008-5#1)(2009-12#1)
drug resistance and##7##3##(1992-2#1)(2007-11#1)(2008-11#2)(2009-8#1)(2009-9#1)(2010-11#1)
drug resistance in##9##3##(1993-8#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-3#1)
drug resistance mutations##2##3##(2013-1#2)
drug resistance of##2##3##(1994-2#1)(2008-8#1)
drug resistance will##2##3##(1997-7#1)(2008-11#1)
drug resistance##68##2##(1990-2#1)(1991-2#1)(1992-2#2)(1993-8#1)(1994-2#3)(1994-5#3)(1996-11#2)(1996-8#1)(1997-6#2)(1997-7#4)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#20)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
drug resistant cells##2##3##(2008-11#2)
drug resistant strain##2##3##(2011-2#2)
drug resistant##14##2##(1990-2#2)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#1)(2010-7#1)(2011-2#3)(2012-2#1)
drug response##4##2##(1990-2#1)(1992-2#1)(2008-8#1)(2008-9#1)
drug restored##2##2##(1993-6#1)(2008-5#1)
drug reward##2##2##(1992-7#1)(2008-4#1)
drug safety during##2##3##(2010-12#2)
drug safety##10##2##(2008-10#1)(2008-11#3)(2008-8#1)(2010-11#2)(2010-12#2)(2013-1#1)
drug samples##8##2##(2008-10#8)
drug screening##7##2##(1992-1#1)(2008-10#2)(2008-6#1)(2010-3#1)(2011-3#1)(2013-1#1)
drug seizures and##2##3##(2008-1#1)(2008-10#1)
drug seizures##4##2##(2008-1#1)(2008-10#3)
drug selection and##2##3##(2010-4#1)(2013-1#1)
drug selection##4##2##(1993-2#1)(2010-4#1)(2011-10#1)(2013-1#1)
drug self-administration##6##2##(1993-6#1)(2008-4#4)(2012-3#1)
drug sensitive cells##2##3##(1990-2#2)
drug sensitive##3##2##(1990-2#2)(1991-4#1)
drug sensitivity##9##2##(1990-12#1)(1992-2#4)(1994-5#1)(1995-2#1)(1997-4#1)(1997-7#1)
drug should be##2##3##(2008-10#1)(2013-1#1)
drug showed##3##2##(1991-1#2)(2008-5#1)
drug solubilization##2##2##(2012-2#2)
drug solution##3##2##(2008-10#3)
drug solutions##2##2##(1995-3#1)(2008-10#1)
drug spending##4##2##(1994-2#1)(1995-1#2)(2008-11#1)
drug substance##12##2##(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#3)
drug substances##3##2##(1997-6#1)(2008-10#2)
drug supply##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
drug susceptibility##7##2##(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#2)
drug target for the treatment of##2##6##(2012-2#2)
drug target for##5##3##(2008-1#1)(2009-12#1)(2012-2#3)
drug target##11##2##(1995-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#3)
drug targeting##5##2##(1992-3#1)(2009-11#1)(2009-12#2)(2011-1#1)
drug targets and##4##3##(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
drug targets for##2##3##(2012-2#2)
drug targets##14##2##(2008-5#1)(2008-7#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2012-1#1)(2012-2#3)(2013-1#1)
drug testing##6##2##(1991-1#1)(2010-4#3)(2012-2#1)(2013-1#1)
drug tests##2##2##(2008-10#1)(2008-7#1)
drug than##2##2##(1997-1#1)(2008-8#1)
drug that is##3##3##(1991-6#1)(1997-2#1)(2010-11#1)
drug that##6##2##(1991-6#1)(1997-2#1)(2006-12#1)(2008-6#1)(2010-11#2)
drug therapies and##2##3##(2008-10#1)(2008-11#1)
drug therapies##9##2##(1994-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2013-7#1)
drug therapy in##7##3##(1990-11#1)(1991-5#1)(1997-1#1)(1997-8#1)(2009-7#2)(2013-1#1)
drug therapy is the##2##4##(2008-4#1)(2010-12#1)
drug therapy is##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
drug therapy to##3##3##(1991-3#1)(2010-11#1)(2010-12#1)
drug therapy##41##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-6#1)(1995-12#1)(1996-9#1)(1997-1#2)(1997-8#1)(2007-1#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
drug therapy?]##2##2##(1990-9#1)(1994-3#1)
drug to the##2##3##(1997-1#1)(2008-5#1)
drug to##14##2##(1990-3#1)(1990-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
drug tolerance to intrathecal baclofen##3##5##(2011-2#3)
drug tolerance##4##2##(1990-8#1)(2011-2#3)
drug toxicity##5##2##(1991-1#1)(2008-10#1)(2008-7#3)
drug trade##2##2##(1997-6#1)(2008-11#1)
drug transport in##2##3##(1990-2#1)(2008-11#1)
drug transport##4##2##(1990-2#1)(2008-11#2)(2008-7#1)
drug transporter##2##2##(2008-11#2)
drug treatment and##2##3##(2008-11#1)(2009-9#1)
drug treatment of##2##3##(1990-6#1)(1992-9#1)
drug treatment##42##2##(1990-11#1)(1990-3#2)(1990-6#2)(1991-1#1)(1992-12#1)(1992-9#3)(1993-6#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-4#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-10#2)(2011-2#1)(2013-8#1)
drug treatments##7##2##(1995-12#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
drug trials##5##2##(1991-3#1)(1994-2#2)(2006-10#1)(2008-6#1)
drug trimethoprim##2##2##(2008-10#2)
drug uptake##3##2##(1997-1#1)(2008-11#1)(2008-8#1)
drug usage##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
drug use among##4##3##(1992-1#1)(1996-6#1)(2010-4#1)(2013-8#1)
drug use and##13##3##(1991-1#2)(1995-1#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-5#1)(2012-1#1)(2013-8#1)
drug use are##2##3##(2012-12#1)(2013-8#1)
drug use behaviors of##2##4##(1996-1#2)
drug use behaviors##4##3##(1996-1#4)
drug use in middle adulthood##4##5##(2009-7#4)
drug use in the##3##4##(2009-12#1)(2009-3#1)(2009-9#1)
drug use in##11##3##(1996-2#1)(2008-11#1)(2009-12#1)(2009-3#1)(2009-7#4)(2009-9#1)(2011-2#1)(2012-1#1)
drug use were##2##3##(2009-7#1)(2011-1#1)
drug use##92##2##(1991-1#3)(1992-1#1)(1992-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#4)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#2)(1997-5#1)(1997-6#1)(2007-12#2)(2007-4#2)(2007-7#1)(2008-1#5)(2008-11#5)(2008-6#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#10)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#5)(2012-12#2)(2012-3#3)(2013-1#8)(2013-8#7)
drug use)##3##2##(2009-9#1)(2010-1#1)(2010-9#1)
drug used in the treatment of##2##6##(1990-3#1)(1995-11#1)
drug used in##3##3##(1990-3#1)(1995-11#1)(2013-7#1)
drug used to##2##3##(1996-3#1)(2010-4#1)
drug used##11##2##(1990-3#1)(1994-11#1)(1995-11#1)(1996-3#1)(2006-10#1)(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-7#1)
drug user##4##2##(2008-1#1)(2009-6#2)(2013-1#1)
drug users and##5##3##(1992-9#1)(1996-4#1)(1997-6#1)(2012-1#2)
drug users in##5##3##(1991-12#1)(1996-11#2)(2007-7#1)(2008-4#1)
drug users##36##2##(1991-1#2)(1991-12#4)(1992-9#3)(1996-11#3)(1996-3#1)(1996-4#2)(1997-5#1)(1997-6#4)(2007-4#1)(2007-7#3)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2012-1#3)(2013-8#3)
drug users]##2##2##(2009-10#1)(2013-8#1)
drug using##2##2##(1996-2#1)(2008-10#1)
drug utilization in##2##3##(2008-11#1)(2008-3#1)
drug utilization is##2##3##(2008-11#2)
drug utilization studies##2##3##(1997-2#1)(2008-11#1)
drug utilization##8##2##(1992-1#1)(1995-1#1)(1997-2#1)(2008-11#4)(2008-3#1)
drug was evaluated in##2##4##(1991-3#1)(2008-5#1)
drug was not##2##3##(1994-11#1)(1996-7#1)
drug was##40##2##(1990-2#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-4#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-5#3)(2008-7#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
drug were##9##2##(1990-9#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2013-8#1)
drug when##3##2##(2008-10#1)(2010-11#1)(2011-10#1)
drug which has##2##3##(1990-12#1)(1994-11#1)
drug which is##2##3##(1994-2#1)(2010-8#1)
drug which##5##2##(1990-12#1)(1994-11#1)(1994-2#1)(2008-7#1)(2010-8#1)
drug whose##2##2##(1994-11#1)(1995-3#1)
drug with a##2##3##(1991-2#1)(2009-10#1)
drug with significantly different R(f) values##2##6##(2008-10#2)
drug with##19##2##(1991-2#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-8#2)(2009-10#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
drug withdrawal##5##2##(1991-1#1)(2008-7#1)(2009-11#3)
drug within##3##2##(1992-2#1)(2007-11#1)(2008-10#1)
drug##2153##1##(1990-10#1)(1990-11#6)(1990-12#6)(1990-2#22)(1990-3#11)(1990-5#2)(1990-6#9)(1990-7#3)(1990-8#5)(1990-9#7)(1991-1#25)(1991-10#2)(1991-11#1)(1991-12#7)(1991-2#5)(1991-3#15)(1991-4#1)(1991-5#4)(1991-6#6)(1991-8#5)(1991-9#2)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#17)(1992-3#19)(1992-5#9)(1992-6#3)(1992-7#2)(1992-8#8)(1992-9#15)(1993-1#3)(1993-11#6)(1993-12#15)(1993-2#5)(1993-3#7)(1993-6#11)(1993-8#8)(1993-9#1)(1994-11#8)(1994-12#1)(1994-2#19)(1994-3#5)(1994-5#11)(1994-6#13)(1994-7#1)(1994-8#15)(1994-9#3)(1995-1#24)(1995-10#1)(1995-11#6)(1995-12#15)(1995-2#16)(1995-3#7)(1995-5#4)(1995-6#6)(1995-8#2)(1996-1#9)(1996-10#1)(1996-11#10)(1996-12#6)(1996-2#18)(1996-3#14)(1996-4#4)(1996-5#10)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#20)(1997-2#17)(1997-3#4)(1997-4#19)(1997-5#3)(1997-6#13)(1997-7#11)(1997-8#4)(2006-10#9)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#22)(2007-12#5)(2007-2#3)(2007-4#6)(2007-5#2)(2007-7#25)(2007-8#4)(2007-9#5)(2008-1#29)(2008-10#265)(2008-11#149)(2008-12#17)(2008-2#5)(2008-3#29)(2008-4#36)(2008-5#63)(2008-6#31)(2008-7#71)(2008-8#87)(2008-9#16)(2009-10#8)(2009-11#19)(2009-12#17)(2009-3#6)(2009-4#1)(2009-5#4)(2009-6#7)(2009-7#22)(2009-8#6)(2009-9#14)(2010-1#2)(2010-10#4)(2010-11#30)(2010-12#13)(2010-2#8)(2010-3#16)(2010-4#18)(2010-5#51)(2010-6#9)(2010-7#5)(2010-8#8)(2010-9#4)(2011-1#43)(2011-10#9)(2011-2#66)(2011-3#31)(2012-1#16)(2012-12#14)(2012-2#62)(2012-3#35)(2013-1#59)(2013-7#2)(2013-8#41)
drug's##11##1##(1991-2#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
drug) and##2##2##(2008-10#2)
drug)##6##1##(1990-10#1)(1995-2#1)(2008-10#3)(2011-2#1)
drug- and##3##2##(2008-11#2)(2012-2#1)
drug-##4##1##(2008-11#2)(2012-2#2)
drug-delivery systems##3##2##(1992-8#3)
drug-dependent##3##1##(1991-9#1)(1993-6#1)(1996-12#1)
drug-drug interactions##8##2##(2007-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
drug-eluting stent##3##2##(2008-11#1)(2009-5#1)(2013-7#1)
drug-eluting stents in##3##3##(2008-11#2)(2008-12#1)
drug-eluting stents##22##2##(2008-11#7)(2008-12#3)(2009-12#7)(2009-5#3)(2011-2#1)(2013-8#1)
drug-eluting##32##1##(2008-11#10)(2008-12#3)(2008-5#1)(2009-11#2)(2009-12#8)(2009-5#4)(2011-2#2)(2013-7#1)(2013-8#1)
drug-free patients##3##2##(1996-7#3)
drug-free##10##1##(1995-2#1)(1996-3#1)(1996-7#6)(1997-2#2)
drug-induced hepatotoxicity##3##2##(2008-7#1)(2008-8#1)(2009-8#1)
drug-induced hypothermia in##2##3##(2007-10#2)
drug-induced hypothermia##3##2##(2007-10#3)
drug-induced liver injury##5##3##(1996-11#1)(2008-8#4)
drug-induced liver##9##2##(1996-11#2)(2006-10#2)(2008-8#5)
drug-induced lung##2##2##(2008-1#1)(2011-2#1)
drug-induced##60##1##(1990-11#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-9#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-11#2)(1997-1#1)(1997-2#1)(2006-10#4)(2007-10#4)(2007-11#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-7#1)
drug-like##2##1##(2009-4#1)(2012-2#1)
drug-loading##2##1##(2008-5#1)(2013-1#1)
drug-naive##4##1##(1994-2#1)(1996-2#1)(1996-7#1)(2013-7#1)
drug-refractory##3##1##(1993-2#1)(2011-2#2)
drug-related##14##1##(1994-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
drug-resistance##3##1##(2007-2#1)(2007-7#1)(2012-2#1)
drug-resistant TB##6##2##(2008-10#2)(2010-5#4)
drug-resistant cells in##2##3##(1992-2#1)(1997-4#1)
drug-resistant cells##3##2##(1991-4#1)(1992-2#1)(1997-4#1)
drug-resistant strains##2##2##(2012-12#1)(2013-1#1)
drug-resistant##27##1##(1991-4#2)(1992-2#2)(1997-4#1)(2007-12#1)(2008-10#3)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#5)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#3)(2013-1#2)
drug-screening of##2##2##(2008-10#2)
drug-seeking##2##1##(1993-6#1)(2007-8#1)
drug-sensitive##2##1##(1991-4#1)(1995-11#1)
drug-specific##3##1##(1990-12#1)(1997-7#1)(2008-10#1)
drug-taking behavior##4##2##(2008-4#2)(2012-3#2)
drug-taking##5##1##(2008-4#2)(2012-3#2)(2013-8#1)
drug-target##2##1##(2012-2#2)
drug-testing##2##1##(2010-11#1)(2010-4#1)
drug-treated##7##1##(1992-12#2)(1992-9#2)(2008-10#1)(2008-11#1)(2008-4#1)
drug-treating##2##1##(2008-10#1)(2008-8#1)
drug?##2##1##(2007-5#1)(2013-7#1)
drugs (2##2##2##(1997-2#1)(2008-3#1)
drugs (AEDs)##3##2##(2008-8#1)(2013-1#2)
drugs (NSAIDS)##2##2##(2006-10#1)(2013-8#1)
drugs (NSAIDs) and##2##3##(2008-3#1)(2012-2#1)
drugs (NSAIDs)##12##2##(1993-2#1)(1995-5#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-3#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
drugs (a##2##2##(1991-1#1)(2010-3#1)
drugs +/-##2##2##(1991-8#1)(2008-10#1)
drugs after##2##2##(2007-7#1)(2008-10#1)
drugs against##6##2##(1993-8#1)(1994-6#1)(1995-11#1)(2009-12#1)(2010-5#1)(2013-7#1)
drugs also##3##2##(1995-12#1)(1995-5#1)(2008-8#1)
drugs among##2##2##(2008-11#1)(2013-8#1)
drugs and alcohol##3##3##(1992-12#1)(2008-11#1)(2009-12#1)
drugs and biomolecules##3##3##(2008-5#2)(2010-11#1)
drugs and can be##2##4##(2010-4#1)(2010-5#1)
drugs and duration##2##3##(2008-8#1)(2010-6#1)
drugs and hormones##2##3##(1992-8#1)(2008-10#1)
drugs and new##2##3##(1993-6#1)(2008-3#1)
drugs and the##9##3##(1990-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
drugs and their##2##3##(1995-5#1)(2008-10#1)
drugs and urine analytes##2##4##(2008-10#2)
drugs and urine##3##3##(2008-10#3)
drugs and##123##2##(1990-3#1)(1990-5#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#2)(2007-11#6)(2007-7#1)(2008-1#4)(2008-10#17)(2008-11#6)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#4)(2011-1#3)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
drugs and/or##2##2##(1991-12#1)(2011-2#1)
drugs approved##2##2##(2011-3#2)
drugs are available##2##3##(1997-5#1)(2008-7#1)
drugs are currently##2##3##(2008-5#1)(2011-2#1)
drugs are not##3##3##(1995-8#1)(2012-1#1)(2012-3#1)
drugs are now##2##3##(1993-2#1)(2011-2#1)
drugs are of##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
drugs are often##2##3##(1996-11#1)(2006-10#1)
drugs are used##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
drugs are usually##2##3##(2008-10#1)(2010-4#1)
drugs are well##2##3##(1997-1#1)(2013-8#1)
drugs are widely used##2##4##(1997-6#1)(2008-5#1)
drugs are##63##2##(1990-2#2)(1990-6#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
drugs as well as##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
drugs as##10##2##(1990-3#1)(1992-11#1)(1995-1#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-12#1)
drugs at high##2##3##(2008-10#1)(2009-6#1)
drugs at##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#2)
drugs because##2##2##(2008-7#1)(2010-5#1)
drugs by capillary##2##3##(2008-10#2)
drugs by##13##2##(1991-1#1)(1992-3#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#1)
drugs can be##8##3##(1993-3#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2013-1#1)
drugs can##15##2##(1993-3#1)(1995-1#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
drugs caused##3##2##(1990-7#1)(1995-12#2)
drugs come##2##2##(1995-1#1)(2012-12#1)
drugs commonly used##4##3##(1992-3#1)(1994-12#1)(2006-10#1)(2008-2#1)
drugs compared##3##2##(1997-7#1)(2008-12#1)(2013-1#1)
drugs could be##2##3##(1995-2#1)(2008-10#1)
drugs could##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2013-8#1)
drugs currently used##2##3##(2008-8#1)(2009-11#1)
drugs directed##2##2##(2009-12#1)(2011-2#1)
drugs do not##2##3##(1995-1#1)(2008-10#1)
drugs due to##3##3##(2008-9#1)(2011-2#1)(2011-3#1)
drugs during the##2##3##(1991-3#1)(2012-12#1)
drugs during##7##2##(1990-5#1)(1991-3#1)(2008-11#2)(2008-7#1)(2012-12#1)(2012-2#1)
drugs effective against##2##3##(2008-4#1)(2008-8#1)
drugs either##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
drugs employed##2##2##(1991-2#1)(2008-10#1)
drugs for Alzheimer's##2##3##(1993-12#1)(2008-5#1)
drugs for the treatment of##7##5##(1991-6#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)
drugs for the##9##3##(1991-6#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)
drugs for their##2##3##(1990-9#1)(2011-2#1)
drugs for treating##4##3##(1994-12#1)(1997-6#1)(2007-2#1)(2011-2#1)
drugs for treatment##3##3##(2007-2#1)(2008-10#1)(2008-6#1)
drugs for##49##2##(1990-9#2)(1991-6#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(2006-10#2)(2007-2#2)(2007-7#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-10#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
drugs from spiked##2##3##(2008-10#2)
drugs from##6##2##(1992-5#1)(2008-10#4)(2012-1#1)
drugs fulfilling##2##2##(1996-11#1)(2012-12#1)
drugs given##2##2##(1991-8#1)(2010-3#1)
drugs had##2##2##(1990-8#1)(2008-11#1)
drugs has been##5##3##(1991-8#1)(1992-9#1)(1994-8#1)(2008-10#1)(2010-10#1)
drugs has##11##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-8#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)
drugs have been developed##3##4##(2008-10#1)(2009-12#1)(2010-6#1)
drugs have been used##2##4##(1996-11#1)(2008-4#1)
drugs have been##10##3##(1996-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-6#1)
drugs have not been##2##4##(2006-10#1)(2013-1#1)
drugs have##26##2##(1993-12#1)(1994-5#1)(1996-11#1)(1997-3#1)(2006-10#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
drugs in a##7##3##(1992-8#1)(1994-9#1)(1996-3#1)(2008-10#2)(2010-3#2)
drugs in patients with##5##4##(1991-3#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#1)
drugs in patients##6##3##(1991-3#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
drugs in pharmaceutical##2##3##(2008-10#2)
drugs in pregnancy##2##3##(2008-7#2)
drugs in real##2##3##(2008-10#1)(2008-3#1)
drugs in serum##2##3##(1990-8#2)
drugs in sport##2##3##(2010-4#1)(2010-7#1)
drugs in the treatment of##7##5##(1996-3#1)(2007-11#2)(2008-2#1)(2008-6#1)(2011-2#1)(2012-3#1)
drugs in the##22##3##(1995-3#1)(1996-3#1)(1996-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
drugs in this##2##3##(1994-6#1)(2009-10#1)
drugs in urine##3##3##(2008-10#3)
drugs in various##2##3##(2008-8#1)(2012-1#1)
drugs in##109##2##(1990-8#3)(1991-12#2)(1991-3#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#8)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
drugs including##3##2##(1997-4#1)(2007-7#1)(2008-3#1)
drugs into##4##2##(1997-1#1)(2008-1#1)(2008-7#1)(2011-2#1)
drugs is not##2##3##(2008-10#1)(2010-11#1)
drugs is presented##2##3##(2008-10#1)(2010-11#1)
drugs is##17##2##(1990-2#1)(1991-8#1)(1991-9#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2010-11#2)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#1)
drugs known to##2##3##(1995-12#1)(2008-1#1)
drugs led to##2##3##(2008-10#1)(2013-7#1)
drugs like##5##2##(1990-11#1)(2008-11#1)(2008-7#2)(2011-1#1)
drugs may be##5##3##(1990-12#1)(2008-8#2)(2010-5#1)(2012-12#1)
drugs may improve##2##3##(2009-4#1)(2013-1#1)
drugs may induce##3##3##(2008-10#2)(2009-12#1)
drugs may##18##2##(1990-11#1)(1990-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
drugs must##2##2##(2006-10#1)(2009-7#1)
drugs namely##2##2##(2008-1#2)
drugs of abuse##12##3##(1991-1#2)(1995-12#1)(2007-8#1)(2008-10#5)(2009-7#1)(2013-8#2)
drugs of##21##2##(1991-1#3)(1994-2#1)(1995-12#1)(1996-5#2)(2007-6#1)(2007-8#1)(2008-10#8)(2009-7#1)(2013-1#1)(2013-8#2)
drugs on the##6##3##(1992-11#1)(1993-12#1)(1995-6#1)(2008-10#2)(2010-7#1)
drugs on##32##2##(1990-2#2)(1990-5#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-5#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
drugs or##16##2##(1990-2#1)(1991-8#1)(1994-2#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
drugs other than##2##3##(1991-3#1)(2008-3#1)
drugs per##2##2##(2008-10#1)(2008-11#1)
drugs prescribed##4##2##(1991-2#1)(2008-11#1)(2010-5#2)
drugs produced##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
drugs remain##2##2##(1997-7#1)(2012-12#1)
drugs seem to##2##3##(1995-5#1)(2012-3#1)
drugs seem##3##2##(1991-11#1)(1995-5#1)(2012-3#1)
drugs serve as##2##3##(1992-10#1)(2012-12#1)
drugs should be##4##3##(1996-6#1)(2008-7#1)(2010-5#1)(2012-3#1)
drugs should##6##2##(1990-11#1)(1992-5#1)(1996-6#1)(2008-7#1)(2010-5#1)(2012-3#1)
drugs showed##4##2##(1991-1#3)(2008-10#1)
drugs showing##2##2##(2008-10#1)(2008-6#1)
drugs such as##15##3##(1990-11#1)(1992-3#1)(1994-8#2)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
drugs targeting TSPO##2##3##(2012-2#2)
drugs targeting##3##2##(2008-9#1)(2012-2#2)
drugs than among##2##3##(1995-1#2)
drugs than##4##2##(1995-1#2)(1996-6#1)(2013-1#1)
drugs that act##2##3##(1993-11#1)(2008-8#1)
drugs that are##4##3##(1993-11#1)(1997-6#1)(2008-3#1)(2008-4#1)
drugs that may##2##3##(2008-4#1)(2013-8#1)
drugs that target##3##3##(2009-4#1)(2009-7#1)(2013-1#1)
drugs that##26##2##(1990-5#1)(1991-8#1)(1993-11#2)(1995-2#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
drugs the##4##2##(1991-1#2)(1995-6#1)(2008-8#1)
drugs themselves##2##2##(1991-8#1)(2010-11#1)
drugs through the##2##3##(1997-2#1)(2010-5#1)
drugs to relieve##2##3##(1992-5#1)(2008-10#1)
drugs to the##2##3##(1995-12#1)(1997-1#1)
drugs to treat##2##3##(1994-8#1)(2012-3#1)
drugs to##17##2##(1992-5#1)(1994-8#1)(1995-12#1)(1997-1#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-9#1)(2010-8#1)(2012-1#1)(2012-3#1)
drugs use were##2##3##(2008-5#1)(2013-1#1)
drugs use##6##2##(1996-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)
drugs used for##3##3##(2006-10#1)(2007-8#1)(2010-4#1)
drugs used in the treatment of##4##6##(1996-3#1)(1997-1#1)(2010-11#1)(2011-2#1)
drugs used in the##5##4##(1993-3#1)(1996-3#1)(1997-1#1)(2010-11#1)(2011-2#1)
drugs used in##7##3##(1993-3#1)(1994-11#1)(1996-3#1)(1997-1#1)(2008-5#1)(2010-11#1)(2011-2#1)
drugs used to treat##2##4##(2008-8#1)(2011-1#1)
drugs used to##3##3##(1996-3#1)(2008-8#1)(2011-1#1)
drugs used##23##2##(1990-6#1)(1992-6#1)(1993-3#2)(1994-11#2)(1996-1#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-8#3)(2010-11#1)(2010-4#2)(2011-1#2)(2011-2#1)(2011-3#1)
drugs using##5##2##(1995-6#1)(2008-10#2)(2008-3#1)(2012-2#1)
drugs was 0##2##3##(1995-2#1)(2008-11#1)
drugs was also##3##3##(2008-10#2)(2009-7#1)
drugs was##12##2##(1991-8#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#1)
drugs were not##2##3##(2007-8#1)(2008-12#1)
drugs were used##4##3##(1994-12#1)(2008-1#1)(2010-3#1)(2011-2#1)
drugs were##26##2##(1990-3#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2011-3#1)
drugs which are##2##3##(2008-11#2)
drugs which have been##2##4##(2007-11#1)(2009-12#1)
drugs which##9##2##(1991-6#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-12#2)
drugs whose##2##2##(2007-11#1)(2008-11#1)
drugs will##2##2##(2008-5#1)(2011-2#1)
drugs with a##6##3##(1990-9#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
drugs with different##3##3##(2007-11#1)(2008-11#2)
drugs with respect to their##2##5##(2008-8#2)
drugs with##43##2##(1990-9#2)(1993-11#1)(1994-9#2)(1995-5#1)(1996-4#1)(1996-6#2)(1997-5#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
drugs within the##2##3##(1997-1#1)(2010-11#1)
drugs##1480##1##(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#14)(1990-3#6)(1990-5#10)(1990-6#4)(1990-7#3)(1990-8#7)(1990-9#10)(1991-1#14)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#14)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#6)(1992-5#4)(1992-6#3)(1992-8#2)(1992-9#7)(1993-1#4)(1993-10#1)(1993-11#13)(1993-12#3)(1993-2#5)(1993-3#6)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#10)(1994-12#6)(1994-2#8)(1994-3#3)(1994-5#8)(1994-6#8)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#11)(1995-11#6)(1995-12#10)(1995-2#11)(1995-3#8)(1995-4#1)(1995-5#7)(1995-6#6)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#7)(1996-12#2)(1996-3#13)(1996-4#1)(1996-5#13)(1996-6#11)(1996-7#2)(1996-9#2)(1997-1#18)(1997-2#7)(1997-3#5)(1997-4#9)(1997-5#3)(1997-6#10)(1997-7#10)(1997-8#3)(2006-10#20)(2006-6#1)(2007-10#2)(2007-11#18)(2007-12#2)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#7)(2007-9#1)(2008-1#21)(2008-10#191)(2008-11#89)(2008-12#8)(2008-2#4)(2008-3#34)(2008-4#20)(2008-5#35)(2008-6#9)(2008-7#57)(2008-8#61)(2008-9#9)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#15)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#8)(2009-7#7)(2009-8#1)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#25)(2010-12#9)(2010-2#5)(2010-3#10)(2010-4#14)(2010-5#17)(2010-6#9)(2010-7#3)(2010-8#9)(2010-9#7)(2011-1#23)(2011-10#1)(2011-2#57)(2011-3#18)(2012-1#13)(2012-12#19)(2012-2#33)(2012-3#26)(2013-1#49)(2013-7#5)(2013-8#23)
drugs)##4##1##(1997-2#1)(2008-11#1)(2009-11#1)(2012-12#1)
drugs-of-abuse##4##1##(2010-5#4)
drugs?##2##1##(1996-8#1)(2008-11#1)
drugs]##11##1##(1990-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2011-3#1)
drum##5##1##(2008-11#1)(2008-4#3)(2008-9#1)
drunk##3##1##(1990-5#1)(1995-8#1)(1996-1#1)
drunkenness##3##1##(1996-11#2)(2012-2#1)
dry acetonitrile##2##2##(2008-10#2)
dry air##4##2##(2007-12#1)(2008-10#1)(2012-3#2)
dry and rainy seasons##2##4##(2008-5#1)(2013-7#1)
dry and wet##2##3##(2008-10#1)(2008-3#1)
dry and##12##2##(1997-5#1)(2008-10#4)(2008-3#1)(2008-5#5)(2013-7#1)
dry ashing method##3##3##(2008-10#2)(2013-8#1)
dry ashing procedure##2##3##(2008-10#2)
dry ashing##9##2##(2008-10#8)(2013-8#1)
dry bean##5##2##(2008-10#5)
dry biomass##2##2##(2008-12#1)(2008-7#1)
dry conditions##5##2##(2008-10#4)(2008-5#1)
dry conidia##2##2##(2008-6#2)
dry cough##6##2##(1997-7#1)(2008-1#3)(2010-2#1)(2011-2#1)
dry cupping##2##2##(2013-1#2)
dry cured ham volatile compounds##2##5##(2008-10#2)
dry environment##2##2##(2008-10#1)(2008-5#1)
dry etching##2##2##(2007-12#2)
dry eye##2##2##(2006-10#2)
dry fermented sausages##4##3##(2010-4#2)(2013-1#2)
dry fermented##6##2##(2010-4#2)(2013-1#4)
dry film##2##2##(2008-2#2)
dry forest##6##2##(2008-5#4)(2013-7#2)
dry forests##2##2##(2008-5#1)(2013-7#1)
dry g m(-2) d(-1) in##2##5##(2008-5#2)
dry g m(-2) in##2##4##(2008-5#2)
dry g m(-2)##4##3##(2008-5#4)
dry heat##4##2##(2008-10#4)
dry heating##3##2##(2008-10#3)
dry ice##2##2##(1993-6#1)(2008-10#1)
dry inoculum##2##2##(2008-10#1)(2008-5#1)
dry inoculums##2##2##(2008-5#2)
dry mass##8##2##(2008-10#3)(2008-12#2)(2008-7#1)(2010-8#1)(2011-1#1)
dry matter (DM)##3##3##(1997-4#1)(2010-2#1)(2012-2#1)
dry matter accumulation##2##3##(2008-10#1)(2008-9#1)
dry matter and##3##3##(2008-12#3)
dry matter production##3##3##(2008-9#3)
dry matter##24##2##(1997-4#3)(2008-10#7)(2008-11#2)(2008-12#3)(2008-9#4)(2009-4#1)(2009-6#1)(2010-2#1)(2012-2#2)
dry mopping##2##2##(1997-2#2)
dry mouth and##2##3##(2006-10#1)(2008-3#1)
dry mouth symptoms##2##3##(2006-10#2)
dry mouth##7##2##(2006-10#5)(2008-3#1)(2008-8#1)
dry period##6##2##(2008-10#3)(2008-5#1)(2013-7#2)
dry periods##4##2##(2008-10#4)
dry powder budesonide 200##2##4##(2007-11#2)
dry powder inhaler (DPI)##2##4##(1997-2#2)
dry powder##8##2##(1992-3#1)(1997-1#1)(1997-2#2)(2007-11#4)
dry residue##2##2##(2008-11#1)(2008-6#1)
dry residues##2##2##(2008-10#1)(2008-11#1)
dry rot##3##2##(2008-10#3)
dry season##20##2##(2007-2#1)(2007-5#4)(2008-5#8)(2008-6#1)(2008-8#1)(2012-2#2)(2013-7#3)
dry sediment##4##2##(1992-3#1)(2008-10#3)
dry seed##2##2##(2008-10#1)(2009-6#1)
dry skin and##2##3##(2008-5#2)
dry skin conditions##2##3##(2008-5#2)
dry skin improvement potential##2##4##(2008-5#2)
dry skin improvement##3##3##(2008-5#3)
dry skin##28##2##(2008-5#27)(2012-3#1)
dry sodium chloride aerosol##2##4##(1996-3#2)
dry soil##4##2##(2008-10#2)(2008-11#2)
dry tissue##2##2##(1991-12#1)(2008-10#1)
dry to##2##2##(2008-10#1)(2013-7#1)
dry tomato peel##2##3##(2010-4#2)
dry weight for##2##3##(2008-10#1)(2012-12#1)
dry weight of the##2##4##(2008-5#1)(2011-2#1)
dry weight of##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
dry weight was##2##3##(2008-10#1)(2012-12#1)
dry weight##36##2##(1991-11#3)(1992-3#1)(1992-9#1)(1996-6#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-5#1)
dry weight)##2##2##(1993-6#1)(2008-9#1)
dry weights of##4##3##(2008-10#3)(2008-12#1)
dry weights##7##2##(2008-10#6)(2008-12#1)
dry wines##3##2##(2008-10#3)
dry wt##8##2##(2007-5#7)(2008-6#1)
dry wt)##3##2##(1991-11#1)(1996-9#2)
dry##397##1##(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#4)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#3)(1992-9#1)(1993-6#2)(1994-12#1)(1995-3#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#4)(1997-5#1)(1997-7#1)(2006-10#8)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#11)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#132)(2008-11#10)(2008-12#18)(2008-2#4)(2008-3#7)(2008-5#67)(2008-6#12)(2008-7#6)(2008-8#5)(2008-9#7)(2009-11#1)(2009-4#1)(2009-6#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#4)(2012-5#2)(2012-6#1)(2013-1#8)(2013-7#14)(2013-8#4)
dry-air##2##1##(2008-3#1)(2008-5#1)
dryer##3##1##(2008-6#1)(2011-2#2)
drying and oxidation##2##3##(2008-10#2)
drying and##6##2##(2008-10#5)(2008-3#1)
drying experiments were conducted##2##4##(2011-2#2)
drying in##2##2##(2008-5#1)(2012-12#1)
drying models##2##2##(2011-2#2)
drying of##6##2##(1990-12#1)(2008-10#5)
drying oils##5##2##(2008-10#5)
drying on##2##2##(2008-10#1)(2008-6#1)
drying process##8##2##(2008-10#2)(2008-2#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
drying step##3##2##(2008-10#3)
drying surface layers##2##3##(2012-2#2)
drying temperature##4##2##(2008-10#1)(2011-2#3)
drying the##2##2##(2008-10#1)(2008-6#1)
drying time##2##2##(2007-7#1)(2008-10#1)
drying##85##1##(1990-12#1)(1997-1#1)(2007-7#1)(2008-10#44)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#6)(2008-7#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#3)(2012-7#1)
drylot systems##2##2##(2010-4#2)
drylot##4##1##(2010-4#4)
dryness in##2##2##(2007-11#1)(2008-10#1)
dryness##29##1##(1990-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(2007-10#1)(2007-11#2)(2008-10#13)(2008-5#7)(2009-12#1)(2013-7#1)
ds-DNA amplified by PCR##2##4##(2008-2#2)
ds-DNA##6##1##(2008-10#1)(2008-2#5)
dsDNA could be##2##3##(1995-2#1)(2008-10#1)
dsDNA immobilized##2##2##(2008-10#2)
dsDNA in##2##2##(2008-10#1)(2008-8#1)
dsDNA##23##1##(1995-2#3)(2008-1#1)(2008-10#14)(2008-2#1)(2008-4#2)(2008-8#2)
dsDNA-modified##2##1##(2008-10#2)
dsRNA and##5##2##(2008-10#4)(2008-2#1)
dsRNA from isolate##2##3##(2008-10#2)
dsRNA from##6##2##(2008-10#6)
dsRNA in##3##2##(2008-10#3)
dsRNA isolated from a plant infected with##2##7##(2008-10#2)
dsRNA isolated from##5##3##(2008-10#5)
dsRNA pattern##2##2##(2008-10#2)
dsRNA segments##3##2##(2008-10#3)
dsRNA targeting##2##2##(2008-9#2)
dsRNA virus##5##2##(1997-3#3)(2008-10#2)
dsRNA was##3##2##(2008-10#3)
dsRNA##73##1##(1997-3#4)(2008-10#56)(2008-2#4)(2008-9#6)(2010-2#1)(2013-1#2)
dsRNA-free##2##1##(2008-10#2)
dsRNAs from Anhui##2##3##(2008-10#2)
dsRNAs from##6##2##(2008-10#6)
dsRNAs hybridized to##3##3##(2008-10#3)
dsRNAs of##3##2##(2008-10#3)
dsRNAs sampled##2##2##(2008-10#2)
dsRNAs were##6##2##(2008-10#6)
dsRNAs##38##1##(2008-10#36)(2008-2#2)
du Tramadol seul##2##3##(2013-1#2)
du Tramadol##3##2##(2013-1#3)
du##43##1##(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#8)(2009-4#2)(2010-1#1)(2011-2#8)(2013-1#16)(2013-8#1)
dual CO(2)##2##2##(2008-2#2)
dual HBV/HCV##2##2##(2009-8#2)
dual action reagents##2##3##(2012-2#2)
dual action##6##2##(2008-10#1)(2008-8#2)(2012-2#3)
dual antiplatelet therapy after##3##4##(2008-11#1)(2009-12#2)
dual antiplatelet therapy##4##3##(2008-11#1)(2008-8#1)(2009-12#2)
dual antiplatelet##5##2##(2008-11#1)(2008-8#2)(2009-12#2)
dual bait system##2##3##(2008-2#2)
dual blood supply##3##3##(2010-12#1)(2011-2#2)
dual chamber pacing##2##3##(1992-5#2)
dual chamber##3##2##(1992-5#2)(1994-11#1)
dual column system##3##3##(2008-10#3)
dual column##4##2##(1997-2#1)(2008-10#3)
dual culture##2##2##(2008-10#2)
dual detector##3##2##(2008-10#2)(2009-4#1)
dual diode laser bar configurations##2##5##(2011-1#2)
dual diode laser bar##3##4##(2011-1#3)
dual effect on##2##3##(1993-8#1)(1995-6#1)
dual effect##6##2##(1990-2#1)(1993-8#1)(1995-6#1)(2008-4#1)(2010-4#1)(2011-2#1)
dual electrochemical detector##2##3##(2008-10#2)
dual electrode##2##2##(1990-8#1)(2008-10#1)
dual energy X-ray absorptiometry##2##4##(2008-5#1)(2011-1#1)
dual energy##4##2##(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#1)
dual enzyme electrode##3##3##(2008-10#3)
dual infection##2##2##(1996-3#1)(2012-3#1)
dual inhibitors##2##2##(2012-12#2)
dual integrin alpha(v)beta(3) and GRPR##2##5##(2010-6#2)
dual integrin##3##2##(2010-6#3)
dual length plane-wave-based QM/MM method to study both the associative and dissociative mechanisms of ATP hydrolysis##2##16##(2013-1#2)
dual length scale method for combined plane-wave and Eular exponential spline-based QM/MM simulations##2##13##(2013-1#2)
dual length##4##2##(2013-1#4)
dual luminophors##2##2##(2008-10#2)
dual mechanism bifunctional##2##3##(2008-10#2)
dual mechanism##3##2##(2008-10#2)(2012-2#1)
dual or##2##2##(2008-1#1)(2008-10#1)
dual parameter##2##2##(1990-12#1)(2007-11#1)
dual photon##3##2##(1991-11#2)(2008-3#1)
dual regulation of##2##3##(1991-5#1)(2008-7#1)
dual signal-wave##2##2##(2007-12#2)
dual source CT##2##3##(2008-7#1)(2012-1#1)
dual source##4##2##(2008-7#1)(2012-1#1)(2012-12#2)
dual stage##2##2##(2008-10#1)(2011-1#1)
dual staining##3##2##(2008-11#3)
dual tachykinin NK1 and NK2 receptor##2##6##(1995-12#2)
dual task##4##2##(2012-2#3)(2013-1#1)
dual therapy##2##2##(2013-8#2)
dual viral infection##2##3##(2009-8#2)
dual wavelength modulation##3##3##(2008-10#3)
dual wavelength##5##2##(2007-12#2)(2008-10#3)
dual##213##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-8#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-5#3)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#2)(1997-8#3)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#3)(2008-10#36)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#2)(2011-1#9)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#12)(2013-8#7)
dual-acting##2##1##(2008-10#1)(2012-3#1)
dual-antibiotic-resistant colonies##2##2##(2008-10#2)
dual-axis joint##3##2##(2008-2#3)
dual-band electrochemical cell##3##3##(2008-10#3)
dual-band##6##1##(2008-10#3)(2008-3#3)
dual-beam detector is##2##3##(2008-3#2)
dual-beam detector##3##2##(2008-3#3)
dual-beam##6##1##(2008-10#1)(2008-2#1)(2008-3#4)
dual-broadband rotational CARS##3##3##(2007-12#1)(2008-2#2)
dual-cavity##4##1##(2007-11#1)(2007-12#2)(2012-3#1)
dual-chamber##3##1##(2008-12#1)(2010-4#1)(2011-2#1)
dual-channel imaging##2##2##(2010-5#2)
dual-channel optical low-coherence reflectometer##2##4##(2007-12#2)
dual-channel##7##1##(2007-11#1)(2007-12#2)(2008-3#1)(2010-5#3)
dual-color##2##1##(1997-6#1)(2008-9#1)
dual-detector##2##1##(2008-10#1)(2009-8#1)
dual-emitting luminescent##2##2##(2008-10#2)
dual-energy X-ray absorptiometry (DXA)##4##4##(2008-10#1)(2008-7#2)(2011-2#1)
dual-energy X-ray absorptiometry##9##3##(2008-10#2)(2008-7#3)(2008-8#1)(2009-11#1)(2011-2#2)
dual-energy x-ray absorptiometry##2##3##(2008-12#1)(2008-8#1)
dual-energy##11##1##(2008-10#2)(2008-12#1)(2008-7#3)(2008-8#2)(2009-11#1)(2011-2#2)
dual-fiber probe##2##2##(2008-3#2)
dual-fiber probes##2##2##(2008-3#2)
dual-fiber##6##1##(2008-3#6)
dual-field-of-view##2##1##(2008-2#2)
dual-frequency beat signal##2##3##(2007-11#2)
dual-frequency##5##1##(2007-11#4)(2008-3#1)
dual-grating dielectric resonant grating reflection filters##2##6##(2007-12#2)
dual-grating sensor##2##2##(2007-11#1)(2008-2#1)
dual-grating##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
dual-labeled##2##1##(2008-10#1)(2012-2#1)
dual-mode##2##1##(2008-10#1)(2008-3#1)
dual-order##2##1##(2008-3#2)
dual-parameter##2##1##(2007-11#1)(2008-8#1)
dual-phase gas-permeation##2##2##(2008-10#2)
dual-process theory##2##2##(2008-6#1)(2013-1#1)
dual-process##4##1##(2008-6#2)(2013-1#2)
dual-pump coherent##2##2##(2008-2#2)
dual-source computed tomography##2##3##(2008-12#1)(2009-4#1)
dual-use##2##1##(2008-10#1)(2008-3#1)
dual-vector##2##1##(2011-3#2)
dual-wavelength Ti##2##2##(2007-11#2)
dual-wavelength laser##3##2##(2007-11#1)(2008-3#2)
dual-wavelength method##2##2##(2008-2#2)
dual-wavelength multichannel##2##2##(2008-3#2)
dual-wavelength optical##2##2##(2008-3#2)
dual-wavelength resonance light scattering##2##4##(2008-10#2)
dual-wavelength resonance##3##2##(2008-10#3)
dual-wavelength spectrophotometry##2##2##(2008-10#2)
dual-wavelength##33##1##(2007-11#8)(2007-12#4)(2008-10#6)(2008-2#5)(2008-3#7)(2009-12#1)(2011-1#2)
duality of##3##2##(2008-5#1)(2009-8#1)(2013-8#1)
duality##5##1##(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2013-8#1)
dually entitled##5##2##(1995-3#5)
dually infected chicks##3##3##(2008-5#3)
dually##12##1##(1995-3#5)(2008-10#1)(2008-5#3)(2009-9#1)(2012-2#1)(2012-3#1)
dub##2##1##(2008-6#1)(2009-12#1)
dubbed &quot##2##2##(2012-2#1)(2012-3#1)
dubbed the &quot##2##3##(2008-12#1)(2008-9#1)
dubbed the##3##2##(2008-12#1)(2008-9#1)(2011-1#1)
dubbed##6##1##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
dubia##3##1##(2008-11#3)
dubious##4##1##(1990-6#1)(1992-2#1)(2007-8#1)(2013-1#1)
dubliniensis##12##1##(2008-5#11)(2013-1#1)
duck pineal gland##2##3##(1995-12#2)
duck pineal##3##2##(1995-12#3)
duck##10##1##(1991-6#1)(1995-12#3)(1996-8#1)(1997-7#1)(2006-10#1)(2008-5#2)(2011-2#1)
duckling##6##1##(1997-1#3)(2008-10#3)
ducklings##9##1##(1992-9#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-9#4)
ducks##6##1##(1992-2#1)(2008-5#3)(2008-9#1)(2009-9#1)
duckweed##3##1##(2008-10#3)
duct and##4##2##(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
duct carcinoma arising from##2##4##(2008-10#2)
duct cyst##2##2##(2008-10#1)(2008-7#1)
duct cysts##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
duct disruption##2##2##(2010-1#1)(2013-8#1)
duct in the##3##3##(1996-11#1)(2007-12#2)
duct in##5##2##(1996-11#1)(2007-12#2)(2008-12#1)(2011-2#1)
duct involvement##2##2##(2008-2#1)(2010-1#1)
duct ligation##4##2##(1995-11#1)(2008-8#1)(2010-11#1)(2013-8#1)
duct obstruction##3##2##(1997-8#1)(2010-11#1)(2011-1#1)
duct of##2##2##(1991-9#1)(2007-12#1)
duct or##2##2##(1995-11#1)(1995-9#1)
duct syndrome##4##2##(1992-9#1)(1993-9#1)(2007-2#1)(2008-10#1)
duct which##2##2##(1993-3#1)(2008-12#1)
duct##127##1##(1990-12#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#4)(1991-3#4)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#5)(1993-12#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-7#1)(1995-11#2)(1995-4#1)(1995-9#1)(1996-11#1)(1997-8#4)(2007-12#16)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#2)(2009-7#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#6)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
duct-mucosa pancreaticojejunostomy##4##2##(2008-10#4)
ductal adenocarcinoma##3##2##(1994-3#1)(2007-2#1)(2013-1#1)
ductal breast##2##2##(2008-4#1)(2012-12#1)
ductal carcinoma in situ##3##4##(1994-8#2)(1995-4#1)
ductal carcinoma in##4##3##(1994-7#1)(1994-8#2)(1995-4#1)
ductal carcinoma of##3##3##(1994-12#1)(2007-5#2)
ductal carcinoma##11##2##(1990-12#1)(1994-12#1)(1994-7#2)(1994-8#2)(1995-4#2)(2007-5#2)(2008-10#1)
ductal invasive##3##2##(1997-7#2)(2013-1#1)
ductal structures##2##2##(1990-6#2)
ductal##38##1##(1990-12#1)(1990-6#2)(1992-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#2)(1995-11#1)(1995-4#2)(1997-7#2)(1997-8#1)(2007-2#1)(2007-5#2)(2008-10#2)(2008-4#1)(2008-5#2)(2009-4#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
ductile##3##1##(1996-4#2)(2009-7#1)
ductility##3##1##(2009-11#1)(2009-7#2)
ducting##2##1##(2008-3#2)
ducts and##13##2##(1997-6#5)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
ducts were##2##2##(1990-6#1)(1994-9#1)
ducts with##3##2##(1994-9#1)(2008-1#1)(2013-1#1)
ducts##61##1##(1990-6#2)(1993-9#1)(1994-11#2)(1994-7#1)(1994-9#2)(1997-6#5)(1997-8#5)(2007-12#13)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-12#2)(2010-7#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
ductular##4##1##(1990-12#3)(2009-8#1)
ductules that##2##2##(1995-11#1)(2007-12#1)
ductules##4##1##(1995-11#1)(2007-12#2)(2008-11#1)
ductus arteriosus##14##2##(1994-3#1)(1996-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#3)(2010-10#2)(2012-3#1)(2013-1#1)
ductus arteriosus]##2##2##(1994-9#1)(1997-8#1)
ductus##16##1##(1994-3#1)(1994-9#1)(1996-3#1)(1997-8#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#3)(2010-10#2)(2012-3#1)(2013-1#1)
due care##2##2##(1992-2#2)
due consideration in##2##3##(1991-12#1)(2012-12#1)
due consideration##3##2##(1991-12#1)(2008-9#1)(2012-12#1)
due diligence##6##2##(1993-12#2)(2008-11#4)
due either to##2##3##(1997-6#1)(2008-11#1)
due for##2##2##(1997-2#1)(2008-10#1)
due in large part to##2##5##(2008-9#1)(2009-12#1)
due in part to the##7##5##(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)
due in part to##15##4##(1990-2#1)(1990-8#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
due in##20##2##(1990-2#1)(1990-8#1)(1993-11#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
due largely to the##2##4##(2008-10#1)(2008-4#1)
due largely to##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
due mainly to the##3##4##(1992-8#1)(1992-9#1)(1994-8#1)
due mainly to##11##3##(1992-8#1)(1992-9#1)(1993-2#1)(1994-8#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
due only to##4##3##(1995-11#1)(1997-2#1)(2008-10#1)(2012-3#1)
due primarily to the##2##4##(2008-10#1)(2008-8#1)
due primarily to##8##3##(1990-12#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-10#1)
due process##8##2##(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-7#1)
due solely to##3##3##(1995-8#1)(2007-12#1)(2008-7#1)
due the##2##2##(2011-1#2)
due to &quot##3##3##(1990-9#1)(2008-1#1)(2012-12#1)
due to 21-hydroxylase deficiency##2##4##(2008-1#1)(2010-2#1)
due to AIDS##2##3##(1997-6#1)(2009-7#1)
due to C##2##3##(2007-12#1)(2008-5#1)
due to CC##2##3##(2008-11#2)
due to Clostridium##2##3##(2007-8#1)(2011-2#1)
due to DCM##2##3##(2011-2#2)
due to DNA##2##3##(1993-8#1)(1994-3#1)
due to Doppler-broadened Rayleigh##2##4##(2008-2#2)
due to Exserohilum rostratum##2##4##(2007-7#1)(2008-10#1)
due to Fusobacterium necrophorum##2##4##(1990-3#2)
due to KCl##3##3##(1995-12#3)
due to Musca domestica##2##4##(2013-1#2)
due to Mycobacterium fortuitum##3##4##(2007-12#2)(2007-7#1)
due to Mycobacterium##5##3##(1991-11#1)(1996-11#1)(2007-12#2)(2007-7#1)
due to Pseudomonas stutzeri##2##4##(2007-12#2)
due to Salmonella##5##3##(1990-3#1)(2007-6#1)(2007-7#2)(2007-8#1)
due to Schistosoma##2##3##(1996-12#2)
due to Trichomonas##3##3##(2007-6#1)(2008-10#2)
due to a change##2##4##(1992-3#1)(2008-11#1)
due to a combination of##5##5##(1991-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)
due to a decrease in the##2##6##(1993-8#1)(1997-2#1)
due to a decrease in##5##5##(1993-8#1)(1994-3#1)(1997-2#1)(2008-5#1)(2012-2#1)
due to a decreased##4##4##(1990-11#1)(1990-7#1)(1994-5#1)(1996-5#1)
due to a defective##2##4##(2008-10#1)(2008-7#1)
due to a deficiency##2##4##(1990-8#1)(1994-11#1)
due to a difference in##2##5##(1994-5#1)(1995-6#1)
due to a direct##3##4##(1990-5#1)(1991-3#1)(1991-6#1)
due to a failure to##2##5##(1994-12#1)(2008-5#1)
due to a failure##3##4##(1994-12#1)(1995-2#1)(2008-5#1)
due to a high##4##4##(2008-10#2)(2008-7#1)(2010-11#1)
due to a higher##4##4##(1993-8#1)(2008-10#1)(2008-3#1)(2009-7#1)
due to a lack of##7##5##(2008-1#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
due to a large##2##4##(2011-2#1)(2013-8#1)
due to a loss of##2##5##(1990-5#1)(1992-12#1)
due to a mutation in the##2##6##(2008-10#2)
due to a noninfectious disease##2##5##(2009-5#2)
due to a number of##5##5##(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-11#1)
due to a possible##2##4##(1990-8#1)(2010-3#1)
due to a reduced##3##4##(1995-12#2)(2008-7#1)
due to a reduction in##3##5##(1991-12#1)(1991-7#1)(2008-11#1)
due to a reduction##4##4##(1991-12#1)(1991-7#1)(2008-11#1)(2010-4#1)
due to a short##2##4##(2008-5#1)(2008-7#1)
due to a single##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
due to a small##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
due to a temperature##2##4##(2007-11#1)(2008-10#1)
due to a##187##3##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#4)
due to absorption##2##3##(2008-3#2)
due to accidental##4##3##(1995-11#2)(2007-7#1)(2008-7#1)
due to accumulation of##3##4##(1992-4#1)(2008-11#1)(2013-1#1)
due to activation of the##2##5##(1992-12#1)(2008-4#1)
due to activation of##4##4##(1992-12#1)(1993-3#1)(1994-11#1)(2008-4#1)
due to acute##4##3##(1996-8#1)(2011-2#2)(2012-1#1)
due to advances in##2##4##(2008-10#1)(2008-4#1)
due to advantages##2##3##(2008-10#1)(2011-2#1)
due to aerosols##2##3##(2008-2#2)
due to age##2##3##(2011-2#1)(2013-1#1)
due to alterations in##3##4##(1997-2#1)(2008-7#1)(2009-12#1)
due to alterations##4##3##(1997-2#1)(2008-7#1)(2008-8#1)(2009-12#1)
due to altered##5##3##(1990-5#1)(1995-2#1)(2008-8#1)(2012-7#1)(2013-8#1)
due to an enhancement of the##2##6##(1992-9#1)(1993-12#1)
due to an inadequate##2##4##(2008-4#1)(2013-1#1)
due to an increase in the##3##6##(1990-5#1)(2008-10#1)(2012-2#1)
due to an increase in##8##5##(1990-5#1)(1994-6#1)(1997-1#1)(1997-7#3)(2008-10#1)(2012-2#1)
due to an increased##3##4##(1996-2#1)(1997-3#1)(2008-7#1)
due to an interaction##3##4##(1992-5#1)(1997-7#1)(2008-10#1)
due to an##52##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#4)(2007-5#1)(2008-10#8)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
due to anatomical##2##3##(2009-9#1)(2011-2#1)
due to any##3##3##(1995-11#1)(2008-10#1)(2008-6#1)
due to asbestos used in##2##5##(1991-12#2)
due to associated##2##3##(2008-1#1)(2008-10#1)
due to asymmetric##2##3##(2008-5#1)(2008-8#1)
due to attenuated##2##3##(2008-11#1)(2008-7#1)
due to better control of##3##5##(1992-8#1)(2008-11#1)(2008-7#1)
due to better##7##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-7#1)(2013-1#1)
due to binding##2##3##(1990-12#1)(2012-2#1)
due to blunt##2##3##(2009-2#1)(2012-12#1)
due to bone metastases in##2##5##(2007-11#2)
due to bone metastases##7##4##(2007-11#7)
due to bone##9##3##(1997-7#1)(2007-11#7)(2010-3#1)
due to both the##3##4##(1992-3#1)(2008-1#1)(2008-3#1)
due to both##9##3##(1990-6#1)(1992-3#1)(1994-12#1)(1994-6#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-9#1)
due to brain##2##3##(1991-11#1)(2011-2#1)
due to cancer##2##3##(1990-9#1)(1992-2#1)
due to cardiac##4##3##(1992-3#1)(2007-7#1)(2011-2#2)
due to cardiovascular diseases##2##4##(2013-1#1)(2013-7#1)
due to cardiovascular##7##3##(1994-5#1)(2008-12#1)(2008-3#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
due to cell##3##3##(2008-11#2)(2008-7#1)
due to cellular##2##3##(1995-4#1)(2009-12#1)
due to cervical##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
due to changes in the##2##5##(1993-6#1)(1994-12#1)
due to changes in##9##4##(1991-10#1)(1993-6#1)(1994-11#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
due to chemical##2##3##(2008-10#1)(2008-11#1)
due to chronic obstructive pulmonary disease##2##6##(1992-11#1)(2008-8#1)
due to chronic##4##3##(1992-11#1)(1996-2#1)(2008-5#1)(2008-8#1)
due to clinical##2##3##(2007-10#1)(2011-2#1)
due to competition##2##3##(2008-10#1)(2012-2#1)
due to complications##4##3##(2008-7#1)(2011-2#1)(2012-2#2)
due to compression of the##2##5##(1992-9#1)(2008-7#1)
due to compression of##3##4##(1992-9#1)(2008-7#1)(2012-12#1)
due to compression##5##3##(1992-9#1)(1993-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
due to conformational differences between##2##5##(1995-3#2)
due to conformational##4##3##(1995-3#2)(2008-7#1)(2012-2#1)
due to contact##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
due to contaminated##2##3##(2007-7#1)(2008-10#1)
due to contamination##2##3##(2008-10#1)(2012-2#1)
due to critical##2##3##(2008-7#1)(2010-11#1)
due to decreased cellular##3##4##(1996-12#2)(2009-6#1)
due to decreased##7##3##(1991-10#1)(1996-12#2)(1997-7#1)(2008-6#1)(2009-6#1)(2013-1#1)
due to defects in##2##4##(2007-10#1)(2008-1#1)
due to deletions##2##3##(2008-10#1)(2012-3#1)
due to diabetic##2##3##(1997-8#1)(2008-1#1)
due to differences in the##3##5##(1997-2#1)(2007-12#1)(2009-12#1)
due to differences in##12##4##(1994-2#2)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2009-12#1)(2012-3#1)
due to differences##14##3##(1994-2#2)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-6#1)(2009-12#1)(2012-3#2)
due to different reasons##3##4##(2008-10#1)(2012-3#2)
due to different##9##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#4)
due to differential##2##3##(1992-9#1)(2008-9#1)
due to difficulties in##2##4##(2008-11#1)(2012-2#1)
due to direct##5##3##(1997-7#2)(2007-7#1)(2008-10#1)(2008-8#1)
due to disease##2##3##(2008-10#1)(2011-1#1)
due to effects##2##3##(1992-5#1)(2008-8#1)
due to either##3##3##(1993-12#1)(1997-3#1)(2008-7#1)
due to electronic##2##3##(2008-3#1)(2010-1#1)
due to emotional problems##2##4##(2007-11#1)(2011-2#1)
due to emotional##4##3##(2007-11#2)(2011-2#1)(2012-12#1)
due to enhanced##3##3##(1992-8#1)(2008-10#1)(2012-5#1)
due to errors##2##3##(2008-2#1)(2012-2#1)
due to ethanol##2##3##(2011-2#1)(2013-8#1)
due to excessive throat pack##2##5##(2008-2#1)(2012-12#1)
due to excessive##5##3##(1992-5#1)(2008-2#2)(2012-12#1)(2013-1#1)
due to exercise##3##3##(1992-3#1)(2008-7#1)(2011-2#1)
due to exposure to##4##4##(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
due to external##2##3##(2010-5#1)(2012-12#1)
due to failure##2##3##(2008-7#1)(2011-2#1)
due to foreign body##2##4##(1990-3#1)(2013-1#1)
due to gastric##2##3##(1993-5#1)(2007-11#1)
due to generation of active oxygen radicals##2##7##(1996-2#2)
due to genetic and environmental##2##5##(2008-10#1)(2008-9#1)
due to genetic##7##3##(1993-5#1)(2007-2#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
due to genotype##2##3##(2008-10#1)(2008-2#1)
due to good##2##3##(2007-2#1)(2011-2#1)
due to graft##2##3##(2008-1#1)(2009-5#1)
due to growth##2##3##(2009-7#1)(2013-1#1)
due to habitat##2##3##(2008-8#1)(2013-7#1)
due to hepatic##2##3##(2011-1#1)(2012-3#1)
due to high##10##3##(1991-9#1)(2008-10#2)(2008-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)
due to higher absorption##2##4##(2008-10#1)(2008-12#1)
due to higher##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
due to his##2##3##(1995-12#1)(1997-5#1)
due to histologically##2##3##(1992-10#1)(2012-3#1)
due to host##2##3##(2008-10#2)
due to human##2##3##(2008-8#1)(2012-12#1)
due to iatrogenic##2##3##(1990-3#1)(1995-8#1)
due to impaired##2##3##(2008-10#1)(2008-3#1)
due to impairment of##2##4##(1996-12#1)(2012-1#1)
due to improved##4##3##(1991-12#1)(1994-5#1)(2008-7#1)(2013-1#1)
due to inadequate##7##3##(1993-11#1)(1993-9#1)(2007-11#1)(2008-10#3)(2012-3#1)
due to inappropriate##2##3##(1994-9#1)(2008-3#1)
due to incomplete##5##3##(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-2#1)
due to inconsistent findings##3##4##(2009-10#1)(2012-12#2)
due to increase##2##3##(2007-7#1)(2011-1#1)
due to increased secretion##2##4##(1990-12#1)(2009-5#1)
due to increased##17##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1992-9#1)(1994-3#1)(2007-7#1)(2008-10#4)(2009-11#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
due to increases##2##3##(1991-2#1)(1995-12#1)
due to infection##5##3##(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
due to information##2##3##(2008-2#1)(2013-8#1)
due to inherent##2##3##(2008-10#2)
due to inhibition of##5##4##(1993-6#1)(2007-10#1)(2008-10#1)(2011-1#2)
due to insufficient##7##3##(1990-5#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
due to interaction##2##3##(2012-6#2)
due to interactions##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
due to internal##2##3##(1993-9#1)(1995-8#1)
due to intravenous##2##3##(1992-2#1)(2009-3#1)
due to involvement of##2##4##(2012-3#2)
due to ischemia##2##3##(1990-6#1)(2008-4#1)
due to its ability to##4##5##(1991-12#1)(1993-3#1)(2011-2#1)(2012-2#1)
due to its anatomical##2##4##(2011-2#1)(2012-2#1)
due to its high##6##4##(1993-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
due to its low##2##4##(2008-10#1)(2009-5#1)
due to its simplicity##2##4##(2007-10#1)(2008-10#1)
due to its specific##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
due to its versatility##2##4##(2009-10#1)(2011-2#1)
due to its wide##2##4##(2008-10#1)(2009-1#1)
due to its##97##3##(1990-12#1)(1990-5#2)(1991-12#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-5#1)(1995-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-12#2)(2011-1#3)(2011-10#1)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#7)(2013-1#4)(2013-7#1)(2013-8#3)
due to lack of##18##4##(1993-12#1)(1993-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#2)(2012-12#1)(2013-1#2)(2013-8#1)
due to less##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
due to light##2##3##(2007-12#1)(2008-3#1)
due to limitation of##3##4##(1991-9#1)(2008-10#2)
due to limitation##4##3##(1991-9#1)(1994-8#1)(2008-10#2)
due to limitations##2##3##(2008-11#1)(2012-2#1)
due to limited##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
due to local##4##3##(2008-6#1)(2008-8#1)(2009-11#1)(2013-1#1)
due to long-distance dispersal##2##4##(2008-10#1)(2011-2#1)
due to longstanding AS##2##4##(2012-3#2)
due to loss of##4##4##(1991-12#1)(1993-9#1)(2007-8#1)(2009-8#1)
due to low##3##3##(1997-4#1)(2008-7#1)(2010-8#1)
due to lower##3##3##(2007-2#1)(2011-1#1)(2012-2#1)
due to macular##2##3##(2011-2#1)(2013-1#1)
due to malnutrition##2##3##(1991-12#1)(1996-3#1)
due to massive##2##3##(1995-10#1)(1997-4#1)
due to material##2##3##(2008-3#2)
due to mechanical##3##3##(1992-5#1)(2007-11#1)(2009-10#1)
due to metastasis##2##3##(2007-11#1)(2008-1#1)
due to metastatic##2##3##(2007-11#1)(2009-5#1)
due to methodological##2##3##(2008-10#1)(2012-1#1)
due to metoclopramide##2##3##(2012-12#2)
due to misuse of##2##4##(1994-2#1)(2007-11#1)
due to movement##2##3##(2008-8#1)(2011-2#1)
due to multiple##8##3##(1996-2#1)(2007-11#2)(2008-10#2)(2008-3#2)(2011-2#1)
due to muscle##2##3##(2008-6#1)(2008-7#1)
due to mutation of the CIAS1 gene##2##7##(2012-2#2)
due to mutations in##5##4##(2008-11#2)(2008-7#1)(2009-8#1)(2013-1#1)
due to natural##2##3##(2008-10#2)
due to numerous##2##3##(2008-10#1)(2009-4#1)
due to obstruction of##2##4##(2008-1#1)(2012-12#1)
due to obstruction##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
due to occlusion of the##2##5##(2009-11#1)(2013-1#1)
due to one##2##3##(2008-2#1)(2013-1#1)
due to opening of##2##4##(2007-10#1)(2008-11#1)
due to optical##2##3##(2007-11#1)(2007-12#1)
due to other##5##3##(1993-6#1)(2007-2#2)(2010-8#1)(2013-1#1)
due to overlapping##2##3##(2008-10#1)(2008-3#1)
due to oxygen##2##3##(1995-11#1)(2010-7#1)
due to pain or##2##4##(1996-12#1)(2011-2#1)
due to pain##6##3##(1996-12#1)(2010-3#1)(2011-2#1)(2013-1#3)
due to pancreatic hypoplasia##2##4##(2011-1#2)
due to pancreatic##3##3##(2011-1#2)(2013-1#1)
due to pathological##2##3##(2007-11#2)
due to patient##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
due to phase##2##3##(2008-3#1)(2008-9#1)
due to physical problems##3##4##(2007-11#2)(2011-2#1)
due to physical##4##3##(2007-11#2)(2011-1#1)(2011-2#1)
due to poor##5##3##(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-3#1)
due to possible##2##3##(2007-7#1)(2008-7#1)
due to posttranscriptional##2##3##(1995-2#1)(1996-12#1)
due to premature death##2##4##(2012-12#2)
due to previous##2##3##(2008-1#1)(2008-12#1)
due to primary angiosarcoma##2##4##(2008-11#2)
due to primary##3##3##(1996-9#1)(2008-11#2)
due to problems of##3##4##(1991-6#1)(2008-8#1)(2010-8#1)
due to problems##5##3##(1991-6#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
due to prolonged##2##3##(1991-4#1)(1993-8#1)
due to properties of the##2##5##(2007-12#1)(2009-8#1)
due to pulmonary##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
due to recent##2##3##(2008-10#2)
due to reduced##7##3##(1991-9#1)(1992-9#1)(1997-3#1)(2008-10#2)(2008-3#1)(2013-1#1)
due to reduction##2##3##(2008-1#1)(2008-2#1)
due to repeated##3##3##(2008-4#1)(2008-7#2)
due to residual##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
due to resistance##2##3##(2008-10#2)
due to respiratory failure##2##4##(2008-7#1)(2013-1#1)
due to respiratory##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
due to retinol per se##2##5##(2008-5#2)
due to right##3##3##(1996-2#1)(2007-8#1)(2012-2#1)
due to road##2##3##(2007-2#1)(2013-7#1)
due to root##2##3##(2008-10#1)(2010-5#1)
due to rupture of an##2##5##(1995-5#1)(1996-3#1)
due to rupture of##4##4##(1995-5#2)(1996-3#1)(2008-10#1)
due to sample##7##3##(2008-1#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
due to secondary##2##3##(2008-11#1)(2012-3#1)
due to selected NCD (diabetes##4##5##(2013-8#4)
due to selected##5##3##(2013-8#5)
due to selection by##2##4##(2008-10#2)
due to sepsis and##2##4##(2008-4#1)(2013-1#1)
due to several##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
due to severe##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
due to short##3##3##(1996-2#1)(2007-11#1)(2011-2#1)
due to shortage of##2##4##(1990-3#1)(2008-1#1)
due to side-effects##2##3##(2008-5#2)
due to significant##3##3##(2008-10#2)(2008-3#1)
due to small##2##3##(1992-5#1)(1994-12#1)
due to some##4##3##(1990-2#1)(1992-6#1)(1996-6#1)(2012-3#1)
due to spatial##2##3##(2008-8#2)
due to specific##2##3##(1992-6#1)(2012-2#1)
due to spectral interferences##2##4##(2008-10#2)
due to stent##2##3##(2011-2#1)(2013-1#1)
due to steric hindrance##2##4##(2008-10#2)
due to steric##3##3##(2008-10#3)
due to stimulation of##4##4##(1991-2#1)(1995-11#1)(2008-11#2)
due to stimulation##5##3##(1991-2#1)(1993-11#1)(1995-11#1)(2008-11#2)
due to strong##3##3##(2008-10#2)(2008-7#1)
due to such##2##3##(2008-10#1)(2010-8#1)
due to surface##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
due to systemic##2##3##(1990-8#1)(2008-10#1)
due to technical##2##3##(1991-12#1)(2012-2#1)
due to temperature##2##3##(2008-3#1)(2011-1#1)
due to the ability of##2##5##(2008-10#1)(2008-11#1)
due to the ability##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
due to the absence of the##3##6##(1995-5#1)(1997-3#1)(2011-2#1)
due to the absence of##9##5##(1990-12#1)(1991-6#1)(1995-5#1)(1997-3#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
due to the accumulation of##4##5##(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#1)
due to the action of##3##5##(1995-12#1)(2008-10#1)(2011-2#1)
due to the activity of##2##5##(1992-12#1)(1994-8#1)
due to the administration of##2##5##(1994-6#1)(2007-5#1)
due to the aging of##2##5##(1992-1#1)(2013-1#1)
due to the aging##3##4##(1991-12#1)(1992-1#1)(2013-1#1)
due to the amount of##2##5##(2007-6#1)(2008-11#1)
due to the amount##3##4##(2007-6#1)(2008-11#1)(2012-2#1)
due to the change in##2##5##(2008-8#1)(2011-2#1)
due to the changes##3##4##(1994-6#1)(2008-10#1)(2011-1#1)
due to the close similarity of their chemical properties##2##9##(2008-10#2)
due to the combined effect of##2##6##(1990-2#1)(2008-3#1)
due to the combined##4##4##(1990-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
due to the complex##2##4##(2010-1#1)(2010-12#1)
due to the complexation##2##4##(2008-10#2)
due to the complexity of the##2##6##(1997-3#1)(2011-2#1)
due to the complexity##3##4##(1997-3#1)(2011-2#2)
due to the cost##2##4##(2008-10#1)(2013-1#1)
due to the costs##2##4##(2007-2#1)(2008-7#1)
due to the decrease in##2##5##(2007-8#1)(2008-3#1)
due to the development of##7##5##(2008-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2010-8#1)(2011-3#1)
due to the difference in##3##5##(1990-8#1)(2007-11#1)(2008-3#1)
due to the different##3##4##(1997-2#1)(2008-10#2)
due to the differing##2##4##(1996-2#1)(2011-2#1)
due to the difficulties##3##4##(2007-12#1)(2007-6#1)(2008-11#1)
due to the difficulty##2##4##(2008-10#1)(2008-8#1)
due to the disease##2##4##(2008-12#1)(2009-10#1)
due to the diverse##2##4##(2008-10#1)(2010-5#1)
due to the effects of##2##5##(1996-12#1)(2008-10#1)
due to the electrostatic##2##4##(2008-10#1)(2008-5#1)
due to the emergence of##2##5##(2011-3#1)(2013-8#1)
due to the fact that in##2##6##(1991-6#1)(2008-7#1)
due to the fact that the##2##6##(1991-11#1)(1991-2#1)
due to the fact that##13##5##(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-2#1)
due to the fact##14##4##(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-2#1)
due to the formation of a##4##6##(1991-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
due to the formation of##18##5##(1991-9#1)(1994-11#1)(1994-2#2)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#2)
due to the formation##19##4##(1991-9#1)(1994-11#1)(1994-2#2)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)
due to the frequent occurrence of##2##6##(2008-6#1)(2012-3#1)
due to the greater##3##4##(1994-5#1)(2008-6#1)(2012-2#1)
due to the growing##2##4##(2008-10#1)(2010-4#1)
due to the heterogeneous##2##4##(1993-8#1)(2008-7#1)
due to the high frequency##2##5##(2008-10#1)(2012-3#1)
due to the high##22##4##(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
due to the higher##2##4##(1992-8#1)(2008-10#1)
due to the highly##3##4##(2008-11#1)(2012-12#1)(2013-1#1)
due to the improved##3##4##(2008-10#1)(2008-11#2)
due to the inability to##2##5##(2008-1#1)(2008-10#1)
due to the inability##3##4##(2008-1#1)(2008-10#1)(2012-3#1)
due to the inclusion of##2##5##(2008-10#1)(2011-1#1)
due to the increase##3##4##(2008-10#2)(2013-1#1)
due to the increased number of##4##6##(1991-12#1)(1991-2#1)(1991-3#1)(1994-6#1)
due to the increased##10##4##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-6#1)(1997-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
due to the increasing##4##4##(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
due to the induced##2##4##(1993-2#1)(2007-11#1)
due to the induction of##2##5##(1994-10#1)(2008-10#1)
due to the influence of##5##5##(1991-12#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
due to the inherent##3##4##(2007-11#1)(2008-12#1)(2008-2#1)
due to the inhibition of the##3##6##(1992-9#1)(1993-8#1)(1997-4#1)
due to the inhibition of##6##5##(1990-5#1)(1992-9#1)(1993-8#1)(1994-8#1)(1997-4#1)(2008-11#1)
due to the insertion of##2##5##(2008-11#1)(2008-9#1)
due to the interaction of##4##5##(2008-10#4)
due to the interaction##5##4##(2008-10#5)
due to the interference of##2##5##(2008-10#1)(2008-5#1)
due to the interference##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
due to the lack of##14##5##(1991-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-1#1)
due to the large##4##4##(1995-5#1)(2008-11#1)(2008-8#1)(2009-11#1)
due to the larger##2##4##(2008-9#1)(2012-5#1)
due to the limited number##2##5##(2012-12#1)(2012-2#1)
due to the limited##4##4##(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
due to the long##2##4##(1991-3#1)(2008-9#1)
due to the low##6##4##(2008-10#4)(2008-8#1)(2010-8#1)
due to the matrix##2##4##(2008-10#2)
due to the nature of##3##5##(1996-4#1)(2008-10#1)(2011-1#1)
due to the new##2##4##(1997-2#1)(2008-9#1)
due to the number of##2##5##(1994-12#1)(2008-10#1)
due to the onset of##2##5##(1996-2#1)(2008-12#1)
due to the opening of##2##5##(1993-12#1)(1995-2#1)
due to the overall##2##4##(2008-3#1)(2008-5#1)
due to the polymerization process##2##5##(2008-3#1)(2010-10#1)
due to the poor##2##4##(2008-10#2)
due to the presence of a##5##6##(1997-6#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
due to the presence of the##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
due to the presence of##37##5##(1990-12#2)(1992-3#1)(1993-11#1)(1994-8#2)(1995-12#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#2)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-7#1)
due to the production of##3##5##(2008-10#1)(2008-4#1)(2013-8#1)
due to the rapid##4##4##(2008-10#2)(2009-3#1)(2009-4#1)
due to the rarity of##2##5##(2011-2#1)(2013-1#1)
due to the reduction of##3##5##(2008-10#2)(2012-2#1)
due to the reduction##4##4##(1992-9#1)(2008-10#2)(2012-2#1)
due to the requirement of##2##5##(2008-10#1)(2008-3#1)
due to the risk of##2##5##(1995-11#1)(2013-1#1)
due to the same##4##4##(1995-8#1)(2008-10#2)(2012-3#1)
due to the selective##2##4##(1994-8#1)(2013-1#1)
due to the severe##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
due to the slow##2##4##(2008-10#1)(2008-5#1)
due to the small number of##2##6##(1991-5#1)(2008-10#1)
due to the small sample size##2##6##(2008-7#1)(2011-2#1)
due to the small size##2##5##(2008-10#1)(2008-12#1)
due to the small##10##4##(1991-12#1)(1991-5#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)
due to the spatial##2##4##(2008-2#1)(2008-9#1)
due to the strong##5##4##(1993-8#1)(1996-5#1)(2008-10#1)(2008-2#1)(2009-5#1)
due to the unique##2##4##(2008-8#1)(2013-8#1)
due to the use of##5##5##(1990-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
due to the##664##3##(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#8)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#3)(1997-2#2)(1997-3#4)(1997-4#4)(1997-6#4)(1997-7#5)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#13)(2007-12#12)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#6)(2008-1#7)(2008-10#164)(2008-11#32)(2008-12#10)(2008-2#15)(2008-3#35)(2008-4#5)(2008-5#15)(2008-6#6)(2008-7#25)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#3)(2009-3#2)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#5)(2010-8#5)(2011-1#12)(2011-2#18)(2011-3#3)(2012-1#1)(2012-12#11)(2012-2#16)(2012-3#10)(2012-5#1)(2013-1#21)(2013-7#2)(2013-8#6)
due to their ability to##2##5##(2008-10#1)(2008-11#1)
due to their copper##2##4##(2008-10#1)(2012-2#1)
due to their high##2##4##(2008-10#2)
due to their inherent##2##4##(2008-10#1)(2008-4#1)
due to their potential##2##4##(2007-11#1)(2008-10#1)
due to their small size##2##5##(2008-1#1)(2008-10#1)
due to their unique##3##4##(2010-10#1)(2010-5#1)(2012-2#1)
due to their##59##3##(1990-3#1)(1991-2#1)(1991-9#1)(1993-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#13)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#3)
due to these##5##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
due to this##6##3##(1996-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#2)
due to thrombosis and##2##4##(2009-11#1)(2011-3#1)
due to thrombosis##3##3##(2008-7#1)(2009-11#1)(2011-3#1)
due to tissue##2##3##(2008-4#1)(2010-8#1)
due to tobacco##3##3##(1991-12#1)(1992-6#1)(2008-6#1)
due to toxicity##2##3##(2008-5#1)(2012-12#1)
due to trauma##4##3##(2008-5#1)(2012-3#1)(2013-1#2)
due to two##3##3##(1991-9#1)(2008-4#1)(2010-4#1)
due to type##2##3##(1991-3#1)(2011-1#1)
due to unsafe abortions##2##4##(2008-11#2)
due to uptake##2##3##(1993-9#1)(2008-10#1)
due to uterine##3##3##(1994-9#1)(2011-2#2)
due to variation in##2##4##(2008-9#1)(2011-2#1)
due to variations in##2##4##(2008-8#1)(2011-1#1)
due to various reasons##3##4##(2007-10#1)(2010-11#1)(2010-3#1)
due to various##5##3##(1996-1#1)(2007-10#1)(2010-11#1)(2010-3#1)(2013-1#1)
due to violence##2##3##(1995-8#1)(2008-9#1)
due to viral##2##3##(2007-11#1)(2013-1#1)
due to virus##2##3##(1997-1#1)(2008-11#1)
due to##2658##2##(1990-11#3)(1990-12#9)(1990-2#5)(1990-3#12)(1990-5#15)(1990-6#11)(1990-7#3)(1990-8#12)(1990-9#5)(1991-10#3)(1991-11#8)(1991-12#25)(1991-2#11)(1991-3#10)(1991-4#2)(1991-5#3)(1991-6#12)(1991-7#2)(1991-8#7)(1991-9#11)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#12)(1992-4#2)(1992-5#7)(1992-6#15)(1992-8#10)(1992-9#11)(1993-1#2)(1993-11#8)(1993-12#13)(1993-2#5)(1993-3#7)(1993-5#4)(1993-6#12)(1993-8#8)(1993-9#7)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#10)(1994-2#13)(1994-3#9)(1994-5#11)(1994-6#6)(1994-7#1)(1994-8#10)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#11)(1995-12#19)(1995-2#12)(1995-3#12)(1995-4#1)(1995-5#11)(1995-6#4)(1995-8#12)(1996-1#3)(1996-11#2)(1996-12#14)(1996-2#15)(1996-3#10)(1996-4#4)(1996-5#9)(1996-6#5)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#12)(1997-3#16)(1997-4#9)(1997-5#7)(1997-6#8)(1997-7#19)(1997-8#7)(2006-10#3)(2006-6#1)(2007-10#13)(2007-11#63)(2007-12#39)(2007-2#14)(2007-5#4)(2007-6#5)(2007-7#33)(2007-8#29)(2008-1#43)(2008-10#437)(2008-11#93)(2008-12#35)(2008-2#53)(2008-3#113)(2008-4#26)(2008-5#63)(2008-6#21)(2008-7#105)(2008-8#48)(2008-9#31)(2009-1#2)(2009-10#10)(2009-11#13)(2009-12#11)(2009-2#4)(2009-3#9)(2009-4#11)(2009-5#20)(2009-6#6)(2009-7#15)(2009-8#9)(2009-9#8)(2010-1#7)(2010-10#4)(2010-11#9)(2010-12#9)(2010-2#6)(2010-3#13)(2010-4#6)(2010-5#14)(2010-6#5)(2010-7#3)(2010-8#24)(2010-9#1)(2011-1#46)(2011-10#1)(2011-2#115)(2011-3#6)(2012-1#6)(2012-12#46)(2012-2#71)(2012-3#58)(2012-5#3)(2012-6#4)(2012-7#2)(2012-8#1)(2013-1#127)(2013-7#12)(2013-8#49)
due##2760##1##(1990-11#3)(1990-12#10)(1990-2#7)(1990-3#12)(1990-5#15)(1990-6#12)(1990-7#3)(1990-8#15)(1990-9#5)(1991-10#3)(1991-11#8)(1991-12#27)(1991-2#12)(1991-3#10)(1991-4#2)(1991-5#3)(1991-6#12)(1991-7#2)(1991-8#7)(1991-9#11)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#7)(1992-3#13)(1992-4#2)(1992-5#7)(1992-6#15)(1992-8#11)(1992-9#12)(1993-1#3)(1993-11#9)(1993-12#16)(1993-2#6)(1993-3#8)(1993-5#4)(1993-6#12)(1993-8#9)(1993-9#8)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#10)(1994-2#13)(1994-3#10)(1994-5#11)(1994-6#6)(1994-7#1)(1994-8#12)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#12)(1995-12#19)(1995-2#13)(1995-3#12)(1995-4#2)(1995-5#11)(1995-6#4)(1995-8#13)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#14)(1996-2#15)(1996-3#10)(1996-4#4)(1996-5#9)(1996-6#5)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#14)(1997-3#17)(1997-4#9)(1997-5#7)(1997-6#9)(1997-7#22)(1997-8#7)(2006-10#3)(2006-6#1)(2007-10#14)(2007-11#64)(2007-12#42)(2007-2#14)(2007-5#4)(2007-6#5)(2007-7#34)(2007-8#30)(2008-1#43)(2008-10#450)(2008-11#99)(2008-12#36)(2008-2#55)(2008-3#117)(2008-4#29)(2008-5#63)(2008-6#22)(2008-7#107)(2008-8#50)(2008-9#34)(2009-1#3)(2009-10#12)(2009-11#13)(2009-12#12)(2009-2#4)(2009-3#9)(2009-4#11)(2009-5#20)(2009-6#6)(2009-7#15)(2009-8#9)(2009-9#8)(2010-1#8)(2010-10#4)(2010-11#9)(2010-12#9)(2010-2#6)(2010-3#13)(2010-4#6)(2010-5#14)(2010-6#5)(2010-7#3)(2010-8#24)(2010-9#1)(2011-1#48)(2011-10#1)(2011-2#116)(2011-3#6)(2012-1#6)(2012-12#50)(2012-2#71)(2012-3#59)(2012-5#3)(2012-6#4)(2012-7#2)(2012-8#1)(2013-1#128)(2013-7#13)(2013-8#49)
duels and##2##2##(2012-3#2)
duels##3##1##(2012-3#3)
dueto##3##1##(2008-11#2)(2008-2#1)
dullness##2##1##(2007-12#1)(2008-5#1)
duloxetine##12##1##(2008-10#2)(2008-3#5)(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#1)
duly##2##1##(2008-10#1)(2008-5#1)
dumbbell##5##1##(1997-8#2)(2007-8#1)(2008-6#1)(2010-12#1)
dumbbell-shaped##2##1##(1990-5#1)(2011-2#1)
dumeril##3##1##(2008-5#3)
dumerilii##5##1##(1990-5#2)(1996-2#3)
dummy area##3##2##(2008-2#1)(2008-3#2)
dummy material##2##2##(2009-11#2)
dummy##6##1##(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#2)
dump##4##1##(2008-3#1)(2011-2#3)
dumping of##2##2##(2008-10#1)(2008-3#1)
dumping##10##1##(1992-8#1)(1993-2#1)(1994-3#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)
dune##2##1##(2008-3#1)(2011-2#1)
dung beetles##4##2##(2008-5#2)(2013-7#2)
dung##8##1##(1995-2#1)(2008-5#2)(2013-1#1)(2013-7#4)
duodenal and gastric ulcer and##2##5##(1992-11#2)
duodenal and gastric ulcer##4##4##(1992-11#2)(2008-12#1)(2008-5#1)
duodenal and gastric##5##3##(1992-11#3)(2008-12#1)(2008-5#1)
duodenal and jejunal##2##3##(2008-5#1)(2013-1#1)
duodenal and##7##2##(1992-11#3)(2008-12#1)(2008-5#2)(2013-1#1)
duodenal atresia##2##2##(1997-3#2)
duodenal perforation##3##2##(2008-12#2)(2013-1#1)
duodenal ulcer after laparoscopic cholecystectomy##2##5##(2008-12#2)
duodenal ulcer disease##2##3##(1997-1#1)(2009-8#1)
duodenal ulcer patients##2##3##(1997-1#2)
duodenal ulcer##17##2##(1990-6#1)(1992-11#1)(1992-6#2)(1997-1#3)(2007-8#1)(2008-10#1)(2008-12#4)(2009-8#1)(2010-4#2)(2012-12#1)
duodenal ulcers##7##2##(1995-2#1)(1997-1#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-12#1)
duodenal varices with##2##3##(2011-2#2)
duodenal varices##5##2##(2011-2#5)
duodenal##63##1##(1990-10#1)(1990-12#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-11#4)(1992-5#2)(1992-6#3)(1992-9#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-5#2)(1997-1#5)(1997-3#3)(2006-10#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#8)(2008-5#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#2)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#3)
duodenopancreatectomies##2##1##(1991-3#1)(1994-3#1)
duodenopancreatic resection##2##2##(2008-10#2)
duodenoscope##3##1##(2008-5#1)(2013-1#2)
duodenum and##5##2##(1997-8#1)(2008-7#1)(2013-1#1)(2013-7#2)
duodenum in##2##2##(1995-11#1)(2008-3#1)
duodenum to##3##2##(1994-12#1)(1996-5#1)(2013-1#1)
duodenum##33##1##(1990-10#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#2)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-7#2)
duplex DNA fragments##2##3##(2008-9#2)
duplex DNA##10##2##(1991-3#1)(1994-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(2008-11#1)(2008-9#2)
duplex DNAs##2##2##(1990-5#1)(1997-4#1)
duplex Doppler ultrasound##3##3##(2008-12#3)
duplex Doppler##4##2##(2008-12#3)(2011-5#1)
duplex TaqMan##3##2##(2012-3#3)
duplex collecting system##2##3##(2008-7#2)
duplex containing an##2##3##(1995-5#2)
duplex fluorescent quantitative one-step RT-PCR assay##3##6##(2013-8#3)
duplex fluorescent quantitative one-step RT-PCR##4##5##(2013-8#4)
duplex oligomers containing a##2##4##(2008-11#2)
duplex oligomers containing##4##3##(2008-11#4)
duplex oligonucleotides##3##2##(1991-3#1)(1993-11#1)(1993-8#1)
duplex scanning##4##2##(2008-7#2)(2012-3#2)
duplex sonography##3##2##(2006-10#1)(2007-10#2)
duplex ultrasound##3##2##(1997-8#1)(2007-7#2)
duplex with a##2##3##(1993-11#1)(1993-8#1)
duplex with##3##2##(1993-11#1)(1993-8#2)
duplex##82##1##(1990-12#1)(1990-5#2)(1990-7#2)(1991-3#2)(1991-8#1)(1992-6#1)(1993-11#7)(1993-8#4)(1994-12#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#5)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-7#2)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#2)(2011-5#1)(2012-3#7)(2013-1#1)(2013-8#4)
duplexes and##2##2##(1991-8#2)
duplexes with##3##2##(1991-8#2)(2008-4#1)
duplexes##20##1##(1991-8#4)(1995-5#4)(2008-10#2)(2008-4#7)(2008-7#1)(2009-6#1)(2013-7#1)
duplicate anterior inferior cerebellar artery feeding an associated dural arteriovenous malformation##2##11##(2008-7#2)
duplicate urethra##4##2##(2008-10#4)
duplicate##31##1##(1994-12#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#1)(2012-3#1)
duplicated genes##4##2##(1990-12#1)(1993-3#1)(2007-11#2)
duplicated in##3##2##(1993-12#1)(1997-4#1)(2008-3#1)
duplicated region##2##2##(2008-11#1)(2009-10#1)
duplicated##30##1##(1990-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-8#3)(1997-3#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#3)(2009-10#5)(2010-5#1)(2012-3#1)
duplicates of the##2##3##(2008-1#1)(2008-5#1)
duplicates##10##1##(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#4)
duplicating the##2##2##(1994-6#1)(2011-1#1)
duplicating##3##1##(1994-6#1)(2011-1#1)(2012-2#1)
duplication and##12##2##(1992-3#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-6#1)(2010-4#1)(2011-1#1)(2012-3#1)
duplication early&quot##2##2##(2008-1#2)
duplication event##3##2##(1997-8#1)(2008-1#1)(2009-8#1)
duplication in the##2##3##(2008-10#1)(2009-10#1)
duplication in##3##2##(1996-3#1)(2008-10#1)(2009-10#1)
duplication is##2##2##(1997-3#1)(2009-10#1)
duplication of a##5##3##(1997-3#1)(2007-11#1)(2009-10#1)(2009-5#1)(2011-2#1)
duplication of services##2##3##(1996-1#1)(2007-12#1)
duplication of the##6##3##(1995-6#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)
duplication of##30##2##(1993-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-3#2)
duplication or##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
duplication upon insertion##2##3##(1995-8#1)(2012-3#1)
duplication with##5##2##(2008-10#3)(2012-3#1)(2013-1#1)
duplication##90##1##(1990-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-3#6)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#10)(2013-1#2)
duplications and deletions##2##3##(1997-3#1)(2009-5#1)
duplications and##7##2##(1997-3#2)(1997-7#1)(2007-11#1)(2008-7#2)(2009-5#1)
duplications in the##4##3##(2008-4#1)(2008-9#1)(2011-1#2)
duplications in##6##2##(2008-4#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#2)
duplications that##2##2##(2007-11#1)(2010-3#1)
duplications##37##1##(1993-12#2)(1993-6#1)(1995-11#1)(1995-8#1)(1997-3#4)(1997-7#1)(2007-11#4)(2008-1#1)(2008-4#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#5)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#1)(2011-3#1)
duplicative##3##1##(1995-2#1)(1995-3#1)(2010-8#1)
duplicitous##2##1##(2009-10#1)(2013-8#1)
dura around the##3##3##(1996-9#1)(2011-2#2)
dura mater##4##2##(2006-12#1)(2007-11#1)(2009-8#1)(2013-1#1)
dura##21##1##(1993-10#1)(1996-9#1)(2006-12#2)(2007-11#1)(2008-7#4)(2008-9#2)(2009-8#3)(2011-2#4)(2012-2#2)(2013-1#1)
durability and##4##2##(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)
durability of resistance against##2##4##(2008-10#2)
durability of resistance##7##3##(2008-10#7)
durability of##22##2##(2007-11#2)(2008-10#14)(2008-11#1)(2008-3#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
durability##42##1##(2007-11#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#2)(2010-6#2)(2010-8#2)(2012-12#3)(2012-2#1)(2013-1#2)
durable and##3##2##(2008-10#2)(2012-3#1)
durable complete remission##2##3##(1997-3#2)
durable disease resistance##2##3##(2008-10#1)(2009-10#1)
durable resistance to stripe rust##2##5##(2008-10#2)
durable resistance to##7##3##(2008-10#6)(2008-8#1)
durable resistance##12##2##(2008-10#11)(2008-8#1)
durable##42##1##(1992-1#1)(1997-3#2)(2007-7#1)(2008-10#22)(2008-3#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
dural AVF##5##2##(1996-9#4)(2006-12#1)
dural and##2##2##(2008-7#1)(2011-2#1)
dural arteriovenous fistula##3##3##(2008-7#2)(2013-8#1)
dural arteriovenous fistulae (AVF)##2##4##(1996-9#2)
dural arteriovenous fistulae##3##3##(1996-9#3)
dural arteriovenous malformation##3##3##(2008-7#3)
dural arteriovenous malformations##6##3##(2006-12#2)(2008-7#4)
dural arteriovenous shunts##3##3##(1996-9#3)
dural arteriovenous##20##2##(1996-9#7)(2006-12#2)(2008-7#10)(2013-8#1)
dural closure##6##2##(2012-3#5)(2013-8#1)
dural defect##3##2##(2008-12#1)(2011-2#1)(2013-8#1)
dural puncture##4##2##(1993-10#3)(2009-7#1)
dural sealing techniques##4##3##(2012-3#4)
dural sealing##5##2##(2012-3#5)
dural sinus thrombosis##3##3##(2008-7#3)
dural sinus##7##2##(1996-9#1)(2006-12#1)(2008-7#5)
dural sinuses##3##2##(2008-7#3)
dural venous sinus##2##3##(1996-9#2)
dural venous##3##2##(1996-9#3)
dural##87##1##(1991-3#1)(1993-10#5)(1996-9#16)(1997-3#2)(2006-12#4)(2007-8#1)(2008-12#1)(2008-7#28)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#14)(2013-8#5)
durant##2##1##(2013-1#2)
duration (h) that temperature was between 15 and 30 degrees C##2##11##(2008-10#2)
duration (h)##3##2##(2008-10#3)
duration (p##2##2##(2008-7#1)(2011-2#1)
duration after##2##2##(1990-5#1)(2008-2#1)
duration and temperature##2##3##(2008-10#2)
duration and the##8##3##(1992-12#1)(1993-1#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-2#2)(2011-2#1)
duration and timing of##2##4##(2008-11#1)(2012-3#1)
duration and wavelength effects on the optical limiting behavior of##2##10##(2007-11#2)
duration and wavelength##4##3##(2007-11#4)
duration and##74##2##(1990-3#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-1#1)(1994-12#1)(1996-5#1)(1996-7#2)(1997-8#1)(2006-10#1)(2007-11#10)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#3)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
duration are##2##2##(2012-1#1)(2013-8#1)
duration as a##2##3##(2011-2#1)(2013-8#1)
duration as##5##2##(1997-6#1)(2008-10#2)(2011-2#1)(2013-8#1)
duration at##10##2##(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)(2011-2#1)
duration between##2##2##(2007-8#1)(2012-2#1)
duration but##2##2##(2008-1#1)(2008-3#1)
duration by use of a##2##5##(2007-11#1)(2007-12#1)
duration by##4##2##(2007-11#2)(2007-12#1)(2008-1#1)
duration each##2##2##(2007-7#1)(2008-10#1)
duration following##2##2##(1995-12#1)(2011-2#1)
duration for##2##2##(2008-10#1)(2008-8#1)
duration from##3##2##(2007-12#2)(2011-2#1)
duration in a##2##3##(2008-3#1)(2009-9#1)
duration in the##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
duration in##21##2##(1991-12#1)(1992-3#2)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-9#2)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#1)
duration increased##2##2##(2008-10#1)(2011-2#1)
duration is##11##2##(1991-2#1)(1992-9#1)(2007-11#1)(2007-12#2)(2008-3#3)(2008-6#1)(2012-2#1)(2013-8#1)
duration obtained from an ytterbium laser with a crystalline host##2##10##(2007-11#1)(2007-12#1)
duration of 30##2##3##(1993-1#1)(2011-2#1)
duration of 4##2##3##(2008-1#1)(2008-10#1)
duration of PD##2##3##(2008-7#2)
duration of TI##2##3##(1991-12#2)
duration of a##5##3##(1993-1#1)(2008-7#1)(2009-9#2)(2013-1#1)
duration of action and##2##4##(2008-7#1)(2012-2#1)
duration of action in##2##4##(1992-12#1)(1996-2#1)
duration of action of##2##4##(2010-7#1)(2012-12#1)
duration of action##9##3##(1991-5#1)(1992-12#1)(1996-2#1)(2008-11#2)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)
duration of analysis##2##3##(2008-10#2)
duration of breastfeeding was##2##4##(1990-12#1)(2007-2#1)
duration of breastfeeding##3##3##(1990-12#1)(2007-2#1)(2009-4#1)
duration of deafness##3##3##(2008-9#3)
duration of diabetes and##2##4##(1994-6#1)(2012-5#1)
duration of diabetes mellitus##2##4##(2007-7#1)(2008-8#1)
duration of diabetes##12##3##(1994-12#1)(1994-6#2)(2007-7#1)(2008-8#2)(2012-2#2)(2012-5#2)(2013-1#2)
duration of dialysis##3##3##(2007-7#2)(2008-7#1)
duration of disease##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
duration of drug##2##3##(1994-6#1)(1997-4#1)
duration of each##3##3##(2007-6#1)(2010-2#2)
duration of exponential##2##3##(2008-11#2)
duration of exposure##5##3##(2008-10#2)(2008-11#1)(2011-2#2)
duration of follow-up was##3##4##(1991-11#1)(2011-2#1)(2013-8#1)
duration of follow-up##6##3##(1991-11#1)(2008-1#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
duration of general anesthesia##2##4##(1990-11#2)
duration of high relative humidity##2##5##(2008-10#2)
duration of hospital##2##3##(2012-2#1)(2013-1#1)
duration of hospitalization##5##3##(1991-12#1)(1992-3#1)(2007-8#1)(2011-2#2)
duration of individual calls##2##4##(1994-8#2)
duration of infection and precancerous lesions##2##6##(2011-3#2)
duration of leaf wetness##5##4##(2008-10#5)
duration of motility##5##3##(2008-7#5)
duration of neutropenia##2##3##(2008-7#2)
duration of pain##3##3##(1997-2#1)(2007-11#2)
duration of pregnancy##3##3##(1991-9#1)(1993-3#1)(2012-3#1)
duration of protection##2##3##(2007-2#1)(2011-2#1)
duration of remission was 7 months (range##2##7##(1990-2#1)(1992-2#1)
duration of remission##3##3##(1990-2#1)(1991-4#1)(1992-2#1)
duration of response was##6##4##(1990-2#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-8#1)
duration of response##7##3##(1990-2#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-8#1)(2008-6#1)
duration of stay##3##3##(1992-12#1)(2009-8#1)(2012-3#1)
duration of surgery and##2##4##(2007-8#1)(2012-3#1)
duration of surgery##8##3##(2007-8#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-3#3)(2013-1#1)
duration of survival##3##3##(1993-1#1)(2008-10#2)
duration of symptoms##8##3##(1997-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#3)
duration of the IAI##2##4##(2008-12#2)
duration of the disease##5##4##(1994-12#1)(1997-8#2)(2011-2#1)(2013-1#1)
duration of the inhibition period and##2##6##(1991-12#2)
duration of the inhibition##3##4##(1991-12#2)(1996-2#1)
duration of the surgical procedure##3##5##(2008-8#3)
duration of the treatment was##2##5##(1994-7#1)(2007-7#1)
duration of the treatment##3##4##(1994-7#1)(2007-7#1)(2008-8#1)
duration of the##91##3##(1990-12#1)(1991-11#1)(1991-12#3)(1992-12#1)(1992-3#3)(1992-6#2)(1994-11#1)(1994-12#1)(1994-7#1)(1995-5#1)(1996-2#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-8#3)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-6#1)(2010-4#2)(2010-8#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
duration of therapy##2##3##(2007-7#1)(2008-7#1)
duration of time##2##3##(2007-2#1)(2008-8#1)
duration of transplantation##2##3##(2008-1#2)
duration of treatment was##2##4##(1991-2#1)(1995-5#1)
duration of treatment##12##3##(1991-2#1)(1993-11#2)(1995-2#1)(1995-5#1)(2007-8#3)(2008-7#2)(2011-1#1)(2013-8#1)
duration of use##2##3##(1991-12#1)(2013-1#1)
duration of wetness##3##3##(2008-10#3)
duration of##412##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#10)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#5)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-6#4)(1994-7#1)(1994-8#4)(1995-12#1)(1995-2#1)(1995-5#5)(1995-6#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#10)(2007-12#2)(2007-2#5)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#9)(2008-1#10)(2008-10#41)(2008-11#16)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#38)(2008-8#12)(2008-9#9)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#19)(2011-3#2)(2012-12#2)(2012-2#14)(2012-3#8)(2012-5#2)(2013-1#15)(2013-8#8)
duration on dialysis and##3##4##(2007-7#2)(2008-1#1)
duration on dialysis##5##3##(2007-7#3)(2008-1#2)
duration on the##3##3##(2007-7#1)(2008-10#1)(2011-3#1)
duration on##12##2##(1991-2#1)(2007-7#4)(2008-1#2)(2008-10#3)(2011-2#1)(2011-3#1)
duration recorded##2##2##(2008-10#1)(2012-3#1)
duration than##4##2##(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#1)
duration that##4##2##(1993-1#1)(2008-7#1)(2009-9#1)(2013-1#1)
duration time of##2##3##(2008-10#1)(2008-7#1)
duration time##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
duration to##3##2##(1994-2#1)(2007-2#1)(2013-8#1)
duration was 10##2##3##(2008-3#1)(2008-6#1)
duration was##29##2##(1991-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-7#1)(1997-4#1)(2007-5#1)(2007-8#3)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2009-9#1)(2011-2#5)(2013-8#3)
duration were##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
duration which##4##2##(2008-7#1)(2010-11#1)(2012-12#2)
duration with an average power of##2##6##(2007-11#1)(2007-12#1)
duration with##6##2##(2007-11#3)(2007-12#1)(2008-2#1)(2012-2#1)
duration without##3##2##(1990-2#1)(2007-7#1)(2008-5#1)
duration##831##1##(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#11)(1991-2#7)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#8)(1992-2#3)(1992-3#8)(1992-6#4)(1992-8#4)(1992-9#3)(1993-1#6)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#8)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#7)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#3)(2007-10#2)(2007-11#33)(2007-12#17)(2007-2#6)(2007-5#2)(2007-6#2)(2007-7#19)(2007-8#13)(2008-1#14)(2008-10#100)(2008-11#26)(2008-12#9)(2008-2#16)(2008-3#31)(2008-4#2)(2008-5#19)(2008-6#11)(2008-7#59)(2008-8#20)(2008-9#12)(2009-10#1)(2009-11#1)(2009-2#8)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#9)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#57)(2011-3#3)(2012-1#1)(2012-12#6)(2012-2#22)(2012-3#17)(2012-5#2)(2012-8#1)(2013-1#28)(2013-7#5)(2013-8#21)
duration)##7##1##(1992-8#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
duration-were used##2##2##(2008-10#2)
durations as short as##3##4##(2007-11#2)(2007-12#1)
durations as##4##2##(2007-11#3)(2007-12#1)
durations from##2##2##(2007-11#1)(2008-3#1)
durations of##18##2##(2007-11#1)(2007-12#5)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#3)(2010-6#1)(2012-3#1)
durations were correlated with##2##4##(2008-10#1)(2008-5#1)
durations were##4##2##(2008-10#2)(2008-5#1)(2009-9#1)
durations##57##1##(1996-11#1)(1997-6#1)(2007-10#1)(2007-11#10)(2007-12#9)(2008-10#11)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2009-3#1)(2009-9#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-3#1)(2013-1#1)
during 0600 to 1000##2##4##(2008-10#2)
during 1 month##2##3##(2008-10#2)
during 1 week##2##3##(2008-10#1)(2008-7#1)
during 1##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-11#1)
during 10##5##2##(1992-12#1)(2008-10#3)(2011-1#1)
during 12 months##2##3##(2011-1#1)(2013-1#1)
during 12##4##2##(1994-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
during 16##2##2##(2008-10#1)(2012-2#1)
during 1986##3##2##(1990-12#1)(1990-2#1)(1992-3#1)
during 1987 to##2##3##(2008-10#2)
during 1990##2##2##(1997-4#1)(2008-5#1)
during 1991 to##2##3##(1997-6#1)(2008-10#1)
during 1992##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
during 1993 to##4##3##(2008-10#4)
during 1993##6##2##(1995-12#1)(2008-10#5)
during 1994 and##2##3##(1995-6#1)(2008-10#1)
during 1994 through 1996##2##4##(2008-10#2)
during 1994##10##2##(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#7)
during 1995 to 1996##2##4##(2008-10#1)(2011-1#1)
during 1995 to##3##3##(2008-10#1)(2011-1#2)
during 1996 and 1997##2##4##(1996-1#1)(2008-11#1)
during 1996##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
during 1997 to##2##3##(2008-10#1)(2011-1#1)
during 1997##5##2##(2008-10#3)(2008-11#1)(2011-1#1)
during 1998 to##2##3##(2008-10#2)
during 1998##3##2##(2008-10#2)(2008-5#1)
during 1999##4##2##(2008-10#3)(2008-5#1)
during 1999-2002##2##2##(2008-10#2)
during 2 weeks##2##3##(1996-12#1)(2010-7#1)
during 2##5##2##(1993-1#1)(1996-12#1)(2009-10#1)(2010-7#1)(2012-3#1)
during 20##3##2##(1993-12#1)(2008-7#1)(2013-8#1)
during 2000 and 2001##2##4##(2008-10#1)(2008-5#1)
during 2000##6##2##(2007-11#1)(2008-10#3)(2008-5#2)
during 2000-2002##2##2##(2007-2#1)(2009-7#1)
during 2001##2##2##(2008-12#1)(2008-3#1)
during 2003-2004##2##2##(2008-10#2)
during 2004 and 2005##2##4##(2008-12#2)
during 2004-2006##2##2##(2008-12#1)(2011-2#1)
during 2005 and##2##3##(2012-12#1)(2013-1#1)
during 2005##3##2##(2009-6#1)(2012-12#1)(2013-1#1)
during 2005-2007##2##2##(2010-4#1)(2011-2#1)
during 2006##3##2##(2009-5#1)(2009-6#1)(2011-2#1)
during 2007##2##2##(2013-1#1)(2013-7#1)
during 2008##5##2##(2011-1#2)(2011-2#2)(2013-1#1)
during 2011##3##2##(2013-1#1)(2013-8#2)
during 2011]##2##2##(2013-8#2)
during 22 months##2##3##(1991-11#1)(2011-2#1)
during 24 h##2##3##(2008-10#2)
during 24##3##2##(2007-10#1)(2008-10#2)
during 3##4##2##(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
during 30##2##2##(2008-2#1)(2008-7#1)
during 4 weeks##2##3##(1990-8#1)(2008-10#1)
during 4##5##2##(1990-8#1)(2008-10#2)(2009-4#1)(2013-1#1)
during 4h##3##2##(2008-10#3)
during 5 h##2##3##(2008-2#1)(2008-3#1)
during 5##10##2##(1990-12#1)(1991-2#1)(1996-6#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)(2011-2#1)
during 6##2##2##(2008-10#1)(2013-1#1)
during 7 days##2##3##(2008-10#2)
during 7##4##2##(1990-12#1)(2008-10#2)(2008-7#1)
during AMI##2##2##(2010-12#2)
during ANP infusion##3##3##(2008-5#3)
during April##2##2##(2008-5#1)(2013-8#1)
during August and September##2##4##(2008-10#1)(2008-3#1)
during August##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
during C##3##2##(1990-11#2)(1995-3#1)
during CABG##2##2##(2007-8#2)
during CO##2##2##(1990-5#1)(2008-7#1)
during CPB##4##2##(2007-8#3)(2008-10#1)
during CoQ10 treatment (P = 0##2##6##(2013-1#2)
during CoQ10 treatment##5##3##(2013-1#5)
during DBS##2##2##(2009-8#2)
during DNA##3##2##(1992-3#1)(2009-7#1)(2011-2#1)
during December##2##2##(1994-9#1)(1996-6#1)
during Drosophila##2##2##(2008-9#1)(2012-12#1)
during EO versus EC##2##4##(2013-8#2)
during EO##3##2##(2013-8#3)
during ESWL##2##2##(2009-5#2)
during G1 phase##2##3##(1993-8#1)(2008-8#1)
during G1##4##2##(1992-10#1)(1993-8#1)(1994-6#1)(2008-8#1)
during HD##4##2##(2007-12#1)(2008-1#3)
during HIV infection##3##3##(2013-8#3)
during HK##2##2##(2011-2#2)
during HL-60 cell differentiation##2##4##(1991-12#1)(1994-9#1)
during Hemodialysis##2##2##(2008-1#2)
during I/R##2##2##(2008-10#2)
during IL-2##2##2##(1990-12#1)(1993-8#1)
during IVM##2##2##(2013-1#2)
during January##2##2##(2011-2#1)(2012-3#1)
during July 1996##2##3##(2007-7#1)(2008-10#1)
during July##5##2##(1994-9#1)(2007-7#1)(2008-10#2)(2008-3#1)
during June and July##2##4##(2010-10#1)(2011-2#1)
during June and##3##3##(2010-10#1)(2011-2#2)
during June##8##2##(1990-2#1)(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#4)
during KB##4##2##(1991-10#4)
during MRI##2##2##(1992-3#2)
during May##4##2##(2008-10#2)(2008-12#1)(2012-2#1)
during November and December##2##4##(1991-8#1)(1995-3#1)
during November##5##2##(1991-8#1)(1995-3#2)(2008-5#1)(2008-7#1)
during PPS##2##2##(1992-12#1)(1992-2#1)
during REM sleep##3##3##(1991-5#1)(1994-8#1)(2008-11#1)
during Ramadan Fasting##3##3##(2012-3#3)
during Ramadan##8##2##(2010-11#1)(2011-1#3)(2012-3#4)
during Recovery##2##2##(1994-2#1)(2013-1#1)
during S phase##3##3##(1994-6#2)(2009-3#1)
during SD##3##2##(1993-12#3)
during SDS-PAGE##2##2##(1992-10#2)
during TEd suppression##3##3##(1993-12#3)
during WW I##2##3##(2008-11#2)
during World War II##4##4##(1990-11#1)(1990-6#2)(2007-5#1)
during World War##5##3##(1990-11#1)(1990-6#2)(1991-11#1)(2007-5#1)
during a 1-year period##2##4##(2008-11#2)
during a 10-year##2##3##(1991-9#1)(2007-2#1)
during a 12-month period##2##4##(1994-9#1)(2010-4#1)
during a 2-year period##2##4##(2007-10#1)(2008-10#1)
during a 3##2##3##(2007-2#1)(2008-5#1)
during a 3-year##2##3##(2008-11#1)(2008-9#1)
during a 30-day##2##3##(1990-8#1)(2008-5#1)
during a 5-year period##2##4##(1991-2#1)(2009-8#1)
during a 6-month##2##3##(2008-1#1)(2013-1#1)
during a child's cancer treatment##3##5##(2009-9#3)
during a child's##4##3##(1991-8#1)(2009-9#3)
during a clinical examination##2##4##(2008-12#1)(2008-7#1)
during a continuous tone##2##4##(1996-5#2)
during a continuous##3##3##(1996-5#2)(2008-10#1)
during a course##2##3##(2008-12#1)(2011-2#1)
during a cycle of##2##4##(1992-3#1)(2008-7#1)
during a five year period##2##5##(2011-1#1)(2011-2#1)
during a follow-up##3##3##(2007-8#1)(2008-4#2)
during a growing season##2##4##(2008-10#2)
during a long-term##2##3##(1994-2#1)(2012-3#1)
during a medical##2##3##(1992-2#1)(2011-2#1)
during a one year period##2##5##(1997-4#1)(2011-2#1)
during a one year##3##4##(1991-2#1)(1997-4#1)(2011-2#1)
during a pandemic##2##3##(2010-8#1)(2011-2#1)
during a period of##9##4##(1990-6#1)(1991-2#2)(1996-3#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)
during a period##10##3##(1990-6#1)(1991-2#2)(1996-3#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
during a physical##2##3##(1992-3#1)(2012-12#1)
during a re-exacerbation phase##2##4##(2011-2#2)
during a recent##4##3##(1993-2#1)(2008-1#2)(2008-10#1)
during a routine##7##3##(1993-2#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-1#1)(2011-1#1)(2012-12#1)
during a second##3##3##(1991-3#1)(1992-3#1)(2008-11#1)
during a single##6##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2013-1#1)
during a standard##2##3##(2011-2#1)(2013-1#1)
during a stay##2##3##(1990-8#1)(1992-12#1)
during a three##3##3##(1992-6#2)(2008-5#1)
during a time##2##3##(2008-11#1)(2008-8#1)
during a total##2##3##(1994-2#1)(2007-11#1)
during a typical##4##3##(2007-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
during a variety of##2##4##(1992-6#1)(2008-4#1)
during a year##2##3##(2008-5#1)(2013-8#1)
during a##243##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#3)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-8#2)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#4)(2007-7#2)(2007-8#6)(2008-1#8)(2008-10#30)(2008-11#13)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#15)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#5)
during acarbose##2##2##(1994-12#2)
during acid##2##2##(2008-10#1)(2011-1#1)
during acquisition##3##2##(1994-6#1)(2008-11#1)(2008-5#1)
during active##3##2##(1993-10#1)(2008-7#1)(2012-3#1)
during actual##2##2##(1992-12#1)(1992-3#1)
during acute hospitalization##2##3##(2011-2#2)
during acute illness in children with classic##2##7##(2010-2#2)
during acute##20##2##(1991-1#2)(1994-11#3)(1994-8#1)(1995-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
during adipocyte differentiation##3##3##(1990-4#1)(1994-12#1)(2008-3#1)
during adjuvant##3##2##(2007-10#2)(2008-10#1)
during administration of##3##3##(1990-9#1)(1993-1#1)(1995-12#1)
during administration##4##2##(1990-9#1)(1993-1#2)(1995-12#1)
during adolescence and##2##3##(2008-11#1)(2010-3#1)
during adolescence##26##2##(2007-12#1)(2007-7#1)(2008-11#7)(2008-9#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
during adult##2##2##(2008-12#1)(2009-6#1)
during adulthood##7##2##(1995-12#1)(1996-5#2)(2009-10#1)(2009-7#1)(2010-3#1)(2013-1#1)
during ageing##3##2##(1990-5#2)(2008-10#1)
during aggressive interactions##2##3##(2008-8#2)
during aggressive##4##2##(1993-3#1)(2008-8#2)(2009-9#1)
during aging and in##2##4##(1993-12#1)(1995-6#1)
during aging and##3##3##(1993-12#1)(1995-6#1)(2010-12#1)
during aging##25##2##(1990-3#1)(1991-12#4)(1993-12#2)(1994-5#4)(1994-6#1)(1995-6#1)(1997-2#1)(2008-3#2)(2008-7#3)(2010-12#1)(2011-2#2)(2012-1#2)(2013-7#1)
during air travel##2##3##(2010-5#2)
during air##3##2##(2008-10#1)(2010-5#2)
during all phases##2##3##(2007-12#1)(2008-2#1)
during all the##2##3##(2008-10#1)(2011-2#1)
during all##15##2##(1993-1#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2011-2#1)(2013-8#1)
during ambulatory##2##2##(2008-7#1)(2013-1#1)
during an 8-month period##2##4##(1991-9#2)
during an annual cycle##2##4##(2008-5#2)
during an episode of##2##4##(1992-9#1)(1994-3#1)
during an extraction##2##3##(1990-5#2)
during an outbreak of##2##4##(1991-11#1)(2008-11#1)
during an outbreak##4##3##(1991-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
during an##52##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#6)(2008-6#1)(2008-9#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
during anaesthesia##2##2##(2010-11#1)(2010-8#1)
during anal sex##2##3##(2010-7#2)
during analysis##2##2##(2008-10#2)
during and after a##4##4##(1995-5#1)(1996-5#1)(2008-10#1)(2010-8#1)
during and after surgery##2##4##(2008-10#1)(2008-12#1)
during and after the##6##4##(1991-2#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
during and after##28##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
during and following##3##3##(1994-2#1)(2008-3#1)(2012-2#1)
during and##37##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1994-2#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#2)
during animal##2##2##(1991-8#1)(1993-9#1)
during anoscopy##5##2##(2013-1#5)
during anoxia##2##2##(1990-7#2)
during antiviral##2##2##(2009-7#1)(2009-8#1)
during any##6##2##(1995-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
during aortocoronary bypass surgery on beating##2##6##(2012-3#2)
during apoptosis##6##2##(1994-10#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)
during application of##5##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
during asexual reproduction##3##3##(2008-10#3)
during assessment##2##2##(1992-9#1)(2008-12#1)
during at least##2##3##(2008-10#2)
during autopsy##2##2##(2009-1#1)(2009-8#1)
during autumn##2##2##(2008-10#1)(2010-8#1)
during bacterial##2##2##(1994-2#1)(2012-12#1)
during batch culture##2##3##(2008-11#2)
during batch growth##2##3##(2008-7#2)
during batch##7##2##(2008-11#4)(2008-7#2)(2011-2#1)
during behavior##3##2##(2007-8#2)(2008-11#1)
during behavioral##2##2##(2008-4#1)(2008-8#1)
during bench##2##2##(2009-1#1)(2009-10#1)
during bloom##8##2##(2008-10#8)
during both seasons##2##3##(2008-10#2)
during both the##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
during both##17##2##(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
during brain development##4##3##(1995-2#1)(1996-5#2)(2008-1#1)
during brain##6##2##(1993-3#1)(1994-3#1)(1995-2#1)(1996-5#2)(2008-1#1)
during breastfeeding##2##2##(2010-12#2)
during caesarean section##2##3##(2011-2#1)(2012-12#1)
during cancer progression##2##3##(2008-1#1)(2011-1#1)
during cancer##9##2##(1991-12#1)(1993-6#1)(1995-2#1)(2008-1#1)(2011-1#1)(2011-2#2)(2012-2#2)
during cardiac arrest##2##3##(1990-9#1)(1995-3#1)
during cardiac development##2##3##(1997-6#2)
during cardiac surgery##2##3##(1991-3#1)(2012-3#1)
during cardiac##8##2##(1990-9#1)(1991-3#1)(1995-3#1)(1997-6#2)(2007-8#2)(2012-3#1)
during cardiopulmonary bypass##7##3##(2006-10#1)(2007-8#4)(2007-9#1)(2008-10#1)
during cardiopulmonary##8##2##(2006-10#1)(2007-8#4)(2007-9#1)(2008-10#1)(2011-2#1)
during carotid##3##2##(2011-2#2)(2013-8#1)
during catalysis##4##2##(1990-11#1)(1992-12#1)(1995-6#1)(2008-8#1)
during cell competition##3##3##(2008-10#3)
during cell cycle##2##3##(1995-9#1)(2008-11#1)
during cell death##2##3##(2008-1#1)(2008-10#1)
during cell differentiation##2##3##(1990-11#1)(2008-8#1)
during cell division##2##3##(1993-12#1)(2012-12#1)
during cell growth##3##3##(2008-11#2)(2008-7#1)
during cell proliferation or after##2##5##(1992-5#2)
during cell##20##2##(1990-11#1)(1992-5#2)(1993-12#1)(1994-2#1)(1995-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)
during cellular aging##2##3##(1990-3#2)
during cellular##4##2##(1990-3#2)(1991-2#1)(2012-12#1)
during central##3##2##(2008-2#1)(2008-5#1)(2010-11#1)
during cerebral##2##2##(2008-7#1)(2008-8#1)
during certain decisions##2##3##(2008-11#2)
during certain##5##2##(2008-11#2)(2008-8#1)(2009-12#1)(2009-9#1)
during chemical##6##2##(1990-7#1)(2008-10#2)(2008-7#1)(2010-7#1)(2012-3#1)
during chemotherapy##2##2##(1994-7#1)(2008-7#1)
during chick embryogenesis##2##3##(1997-4#2)
during chick##4##2##(1997-4#4)
during childhood and adolescence##2##4##(2008-9#1)(2011-2#1)
during childhood and##4##3##(2008-2#1)(2008-9#2)(2011-2#1)
during childhood##15##2##(1990-5#1)(1993-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
during chronic infection##2##3##(2008-7#1)(2013-1#1)
during chronic##6##2##(1992-3#1)(2007-8#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
during clinical magnetic resonance diagnostic procedures##2##6##(1992-3#2)
during clinical placement##4##3##(2008-11#1)(2008-12#3)
during clinical placements##2##3##(2010-3#1)(2012-12#1)
during clinical##14##2##(1992-3#2)(1995-9#1)(2008-11#1)(2008-12#4)(2008-2#1)(2010-1#1)(2010-3#1)(2010-9#1)(2012-12#1)(2013-7#1)
during cold##2##2##(1995-3#1)(2008-10#1)
during colonization##2##2##(2008-10#1)(2009-8#1)
during combination##2##2##(1992-2#1)(2008-10#1)
during combined##2##2##(1996-7#1)(2012-3#1)
during concurrent##2##2##(2007-7#1)(2008-10#1)
during conscious perception##3##3##(2007-9#3)
during conscious##4##2##(2007-9#4)
during construction of##2##3##(2007-12#1)(2008-10#1)
during contact##2##2##(1991-9#1)(1995-12#1)
during continuing##2##2##(1996-3#1)(1996-8#1)
during continuous contact brachiation##2##4##(2012-12#2)
during continuous##10##2##(1990-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#2)
during contraction##3##2##(1994-8#1)(2008-7#1)(2011-1#1)
during control##2##2##(1997-1#2)
during convalescence##2##2##(2007-2#1)(2013-1#1)
during conventional##3##2##(1990-10#1)(2008-1#1)(2008-10#1)
during conversion##2##2##(2008-6#1)(2010-10#1)
during cooling##2##2##(1995-3#2)
during coronary artery bypass grafting##6##5##(2007-8#6)
during coronary artery##7##3##(2007-8#6)(2008-12#1)
during coronary##14##2##(1995-12#1)(2007-8#8)(2008-12#1)(2009-12#1)(2011-2#2)(2012-3#1)
during courtship##2##2##(1990-11#1)(2008-5#1)
during critical##3##2##(2008-6#1)(2009-7#1)(2010-7#1)
during cultivation##5##2##(2008-11#3)(2008-7#1)(2011-1#1)
during culture##3##2##(1994-9#1)(2011-1#1)(2013-1#1)
during cycle-exercise##2##2##(2008-10#2)
during cytokinesis##4##2##(2009-10#2)(2009-12#1)(2009-8#1)
during daily##3##2##(1990-8#1)(2010-8#1)(2011-2#1)
during darkness and##2##3##(1994-5#1)(2008-10#1)
during darkness##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
during data analysis##2##3##(2008-4#1)(2008-9#1)
during data##3##2##(2008-4#1)(2008-9#2)
during day##2##2##(1995-1#1)(2008-12#1)
during daytime##4##2##(1991-6#1)(2008-3#2)(2010-8#1)
during deep##3##2##(2007-8#1)(2009-8#2)
during denaturation##4##2##(1990-5#4)
during depolarization##2##2##(1994-2#2)
during deposition##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
during development and ageing##2##4##(1990-3#2)
during development and aging##3##4##(2008-7#3)
during development and in##3##4##(1994-2#1)(2008-7#1)(2009-8#1)
during development and regeneration##2##4##(1993-5#1)(2008-7#1)
during development and stress##2##4##(2009-10#2)
during development and##18##3##(1990-3#2)(1993-5#1)(1994-2#1)(1994-5#1)(1995-2#1)(2008-7#5)(2009-10#2)(2009-8#2)(2012-2#2)(2013-7#1)
during development from##2##3##(2008-10#1)(2011-2#1)
during development in##2##3##(1996-5#1)(2012-3#1)
during development of the##2##4##(1994-11#1)(2008-5#1)
during development of##5##3##(1994-11#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)
during development##68##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#3)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2009-10#2)(2009-5#1)(2009-8#4)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-7#1)
during device##2##2##(2008-3#1)(2011-2#1)
during di-estrus##2##2##(1992-9#2)
during diabetes##2##2##(2008-1#1)(2013-1#1)
during diagnostic##4##2##(1993-12#1)(1996-2#1)(2008-5#1)(2013-7#1)
during dialysis##3##2##(1990-5#1)(2008-10#1)(2012-12#1)
during diapause##5##2##(2013-1#5)
during different physiological states##2##4##(2008-3#2)
during different seasons##2##3##(2008-10#1)(2012-2#1)
during different stages of waking and sleep##2##7##(2007-8#2)
during different stages of##7##4##(1993-1#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-9#1)
during different##16##2##(1993-1#1)(1996-7#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
during differentiation of##3##3##(1990-5#1)(1995-6#1)(1997-2#1)
during differentiation##10##2##(1990-5#1)(1992-6#4)(1995-6#1)(1997-2#1)(2008-11#2)(2012-2#1)
during disease##2##2##(1996-2#1)(2008-8#1)
during drought##2##2##(2008-5#2)
during drug##3##2##(2008-3#1)(2010-4#1)(2012-3#1)
during dry##2##2##(2008-10#2)
during drying and##2##3##(2008-10#1)(2008-3#1)
during drying##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
during dynamic##2##2##(2008-3#1)(2011-1#1)
during each of##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
during each phase of the##2##5##(1991-2#1)(2007-8#1)
during each##16##2##(1991-2#1)(1994-9#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
during early childhood##2##3##(1997-7#1)(2008-11#1)
during early development and##3##4##(1995-12#1)(1995-3#1)(2009-11#1)
during early development in##2##4##(1996-5#1)(2009-3#1)
during early development##12##3##(1992-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2013-1#1)
during early embryogenesis##5##3##(1997-4#1)(2008-5#2)(2008-8#1)(2009-3#1)
during early life##2##3##(2012-12#1)(2012-2#1)
during early pregnancy##3##3##(1990-8#1)(1996-12#1)(2012-3#1)
during early stages of##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
during early##46##2##(1990-8#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-8#4)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
during egg fertilization and##2##4##(1994-11#1)(2008-8#1)
during egg##4##2##(1994-11#1)(2007-12#1)(2008-8#1)(2008-9#1)
during either##5##2##(1993-1#1)(1993-2#1)(1994-6#1)(2008-10#1)(2010-4#1)
during electrical stimulation##2##3##(1990-5#1)(1993-12#1)
during electrophoresis##5##2##(1990-12#1)(1995-5#1)(2008-10#2)(2008-4#1)
during elution##3##2##(2008-10#3)
during embryogenesis and##2##3##(1996-2#1)(2008-7#1)
during embryogenesis##17##2##(1991-5#1)(1993-6#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-1#1)
during embryonic development##8##3##(1993-12#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-7#2)(2010-9#1)(2012-2#1)
during embryonic##12##2##(1993-12#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-12#1)(2008-11#1)(2008-7#2)(2010-9#1)(2012-2#1)
during endoscopic sinus##2##3##(2008-9#1)(2012-1#1)
during endoscopic##3##2##(2008-9#1)(2012-1#1)(2013-1#1)
during endovascular##3##2##(1994-9#1)(1997-6#1)(2011-1#1)
during ensiling##2##2##(2013-1#2)
during epidemics##2##2##(2008-10#2)
during epidural and electromagnetic stimulation##2##5##(2013-1#2)
during epidural##3##2##(2013-1#3)
during episodes of##2##3##(2008-10#1)(2008-5#1)
during evaporation##8##2##(2008-3#2)(2008-5#6)
during evening hours##3##3##(2008-10#2)(2008-5#1)
during evening##4##2##(2008-10#2)(2008-5#1)(2010-10#1)
during evolution##6##2##(1995-9#1)(1997-2#1)(2007-12#1)(2010-1#1)(2011-2#1)(2012-3#1)
during exercise in##2##3##(2008-3#1)(2013-8#1)
during exercise testing##2##3##(1996-6#1)(2008-7#1)
during exercise##21##2##(1991-2#1)(1996-6#1)(2007-6#1)(2008-3#2)(2008-7#4)(2011-1#3)(2013-1#1)(2013-7#1)(2013-8#7)
during exhaustive exercise##2##3##(2011-2#1)(2012-1#1)
during exhaustive##3##2##(2009-1#1)(2011-2#1)(2012-1#1)
during experimental##3##2##(1991-2#1)(2011-2#1)(2013-1#1)
during exponential growth phase##2##4##(2008-11#2)
during exponential growth##4##3##(1994-11#1)(2008-11#2)(2008-7#1)
during exposure to##4##3##(1990-5#1)(1994-2#1)(2008-7#1)(2009-12#1)
during exposure##7##2##(1990-5#1)(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-2#1)
during extracorporeal shock wave lithotripsy##2##5##(2009-5#2)
during extracorporeal##3##2##(2009-5#2)(2010-8#1)
during extraction##3##2##(1991-3#1)(2008-10#2)
during fall##2##2##(2008-10#2)
during fermentation##8##2##(1995-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#3)
during fertilization##6##2##(2008-11#3)(2008-7#1)(2008-9#1)(2012-12#1)
during fetal life##2##3##(2008-10#1)(2012-2#1)
during fetal lung development##2##4##(1995-8#2)
during fetal##7##2##(1994-2#1)(1995-12#1)(1995-8#2)(2008-10#2)(2012-2#1)
during fibrogenesis##3##2##(2008-9#3)
during first##5##2##(1992-2#1)(2007-11#1)(2007-12#1)(2009-7#1)(2012-2#1)
during fiscal years##2##3##(1992-12#1)(2012-2#1)
during five##4##2##(1997-6#1)(2008-10#1)(2008-3#1)(2013-7#1)
during flashbacks were significantly higher than##2##6##(1996-7#2)
during flight##3##2##(1996-12#1)(2008-2#1)(2008-9#1)
during fluid reasoning##2##3##(2008-11#2)
during follow-up##14##2##(1991-4#1)(1996-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
during followup##2##2##(1997-6#1)(2013-1#1)
during food##2##2##(2011-2#1)(2012-2#1)
during forensic##2##2##(2008-10#1)(2008-12#1)
during formation of the##2##4##(1995-12#1)(2008-12#1)
during formation##3##2##(1993-11#1)(1995-12#1)(2008-12#1)
during four##5##2##(1995-4#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)
during freezing##2##2##(2008-10#1)(2011-2#1)
during fruit development##2##3##(2008-10#1)(2008-9#1)
during fruit ripening##3##3##(2008-12#1)(2011-2#2)
during fruit##6##2##(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#2)
during functional magnetic resonance imaging##2##5##(2008-11#1)(2008-6#1)
during functional##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
during fungal infection##2##3##(2008-10#1)(2011-10#1)
during fungal##4##2##(2008-10#2)(2008-6#1)(2011-10#1)
during gait##4##2##(2007-10#1)(2008-12#1)(2008-7#1)(2013-7#1)
during gastrulation##2##2##(2008-7#2)
during general anaesthesia##2##3##(2008-2#1)(2008-7#1)
during general anesthesia##6##3##(1993-1#4)(2010-5#1)(2012-12#1)
during general##8##2##(1993-1#4)(2008-2#1)(2008-7#1)(2010-5#1)(2012-12#1)
during germination and##2##3##(2008-10#1)(2009-8#1)
during germination##8##2##(2008-10#2)(2008-12#3)(2009-8#3)
during gestation##12##2##(1990-5#4)(1990-9#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#2)
during global##3##2##(2008-7#1)(2010-1#1)(2012-6#1)
during goal-directed##2##2##(2007-8#1)(2008-11#1)
during growth and##2##3##(1994-3#1)(2008-7#1)
during growth in##2##3##(1995-11#1)(2008-10#1)
during growth of cells on##3##5##(1995-9#2)(2008-10#1)
during growth of the##2##4##(1992-4#1)(2007-11#1)
during growth of##6##3##(1992-4#1)(1995-9#2)(2007-11#1)(2008-10#1)(2008-7#1)
during growth on##3##3##(2008-6#1)(2008-7#2)
during growth##22##2##(1992-4#1)(1994-3#1)(1995-11#1)(1995-9#3)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#5)(2011-2#1)(2012-1#1)
during hardening##2##2##(2008-10#2)
during head##2##2##(2009-4#1)(2012-2#1)
during heat shock##2##3##(2008-7#2)
during heat##7##2##(1995-6#1)(2008-10#1)(2008-7#2)(2010-4#1)(2011-2#1)(2013-8#1)
during heavy##2##2##(2008-5#2)
during hepatic##3##2##(1992-12#1)(2008-11#1)(2008-9#1)
during hibernation##2##2##(1995-12#2)
during his##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
during holographic##2##2##(2007-12#1)(2008-2#1)
during hospital admission##2##3##(2011-2#2)
during hospital stay##2##3##(2011-2#1)(2013-1#1)
during hospital##4##2##(2011-2#3)(2013-1#1)
during hospitalization##4##2##(1992-3#1)(1994-2#1)(2007-10#1)(2008-11#1)
during human evolution##2##3##(2008-12#1)(2012-2#1)
during human##5##2##(1990-11#1)(2008-12#1)(2009-11#1)(2012-12#1)(2012-2#1)
during humidity detection##2##3##(2009-5#2)
during hypoxia##4##2##(1990-3#1)(1990-7#1)(2008-5#1)(2010-8#1)
during image##2##2##(2008-10#1)(2008-6#1)
during imbibition##3##2##(2008-10#2)(2008-12#1)
during immune##2##2##(1995-2#1)(2010-3#1)
during implantation##2##2##(2008-9#1)(2009-11#1)
during in vitro aging of##2##5##(1990-3#2)
during in vitro culture##4##4##(1995-3#1)(2006-6#1)(2008-2#1)(2009-6#1)
during in vitro differentiation of##2##5##(1995-6#1)(2008-11#1)
during in vitro##13##3##(1990-3#3)(1993-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(2006-6#1)(2008-11#2)(2008-2#1)(2009-6#1)(2011-1#1)
during in##14##2##(1990-3#3)(1993-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(2006-6#1)(2008-11#2)(2008-2#1)(2009-6#1)(2010-1#1)(2011-1#1)
during incubation at##2##3##(1995-3#1)(2008-10#1)
during incubation##11##2##(1990-2#3)(1995-3#1)(2006-6#1)(2008-10#5)(2008-8#1)
during individual sample periods##2##4##(2008-10#2)
during individual##3##2##(2008-10#2)(2010-3#1)
during induced##3##2##(1991-2#1)(2008-10#1)(2008-8#1)
during induction treatment of##2##4##(2011-2#2)
during induction##7##2##(2008-10#3)(2011-2#4)
during infancy##6##2##(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)
during infection by##2##3##(1991-9#1)(2008-10#1)
during infection of susceptible crops such as maize (Zea##2##9##(2008-10#2)
during infection of susceptible crops such as maize##4##8##(2008-10#4)
during infection of##5##3##(1995-12#1)(2008-10#4)
during infection with##2##3##(2008-10#1)(2008-5#1)
during infection##19##2##(1991-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(2008-10#10)(2008-5#1)(2008-9#1)(2013-1#3)
during inflammation##8##2##(1992-6#1)(2008-10#1)(2008-4#3)(2010-8#1)(2011-2#1)(2013-8#1)
during influenza seasons##2##3##(2012-12#2)
during influenza##3##2##(2012-12#3)
during initial##8##2##(1992-3#1)(1993-3#1)(1994-3#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-6#1)
during initiation##3##2##(1992-5#1)(1994-6#1)(2011-1#1)
during injection of##2##3##(1990-3#1)(2013-8#1)
during insertion##2##2##(2008-9#1)(2013-1#1)
during integration##2##2##(2008-3#1)(2008-6#1)
during interferon-alpha therapy##2##3##(1992-10#1)(2008-6#1)
during intermittent exercise##2##3##(2013-8#2)
during internal##2##2##(2012-2#1)(2012-3#1)
during intervention##3##2##(2007-8#1)(2011-1#1)(2012-2#1)
during intravenous##2##2##(1993-1#1)(2008-7#1)
during invasion##2##2##(1994-9#1)(2013-1#1)
during invasive##3##2##(1990-3#1)(1995-2#1)(2013-8#1)
during ischaemia##5##2##(1993-9#3)(2008-3#1)(2008-7#1)
during ischemia##5##2##(1994-11#1)(1995-12#1)(1996-9#2)(2010-3#1)
during isometric##2##2##(2010-9#1)(2013-1#1)
during its evolution##2##3##(1991-8#1)(1992-9#1)
during its first##2##3##(1997-2#1)(2008-7#1)
during its growth##2##3##(2008-10#2)
during its implementation##2##3##(2007-11#1)(2012-2#1)
during its reaction with##3##4##(2008-10#3)
during its use##2##3##(2008-11#1)(2009-2#1)
during its##25##2##(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
during judgment##2##2##(2009-9#1)(2013-1#1)
during labor##4##2##(1994-3#1)(2007-2#1)(2008-8#1)(2011-2#1)
during labour##17##2##(1992-5#2)(1993-10#1)(1994-3#2)(1994-5#3)(2010-3#4)(2012-1#2)(2013-1#3)
during lactation##7##2##(1991-12#1)(1992-5#1)(2008-9#1)(2010-2#1)(2012-12#2)(2013-8#1)
during landing##4##2##(2011-2#4)
during laparoscopic##3##2##(2008-12#2)(2012-12#1)
during larval and postlarval development of gilthead sea bream Sparus auratus##2##11##(2010-8#2)
during larval development##3##3##(2008-5#1)(2008-7#2)
during larval##6##2##(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#2)
during laser##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
during last##4##2##(2007-11#2)(2008-7#1)(2013-8#1)
during late gestation##2##3##(2010-2#1)(2013-8#1)
during late##7##2##(1994-6#1)(2008-10#2)(2009-10#1)(2010-2#1)(2012-3#1)(2013-8#1)
during lateral bending##3##3##(2013-1#3)
during learning##2##2##(2008-11#1)(2013-1#1)
during leisure time##2##3##(2010-11#1)(2012-1#1)
during leisure##3##2##(2008-5#1)(2010-11#1)(2012-1#1)
during life##6##2##(1990-6#1)(2008-12#1)(2008-7#4)
during liver resection##2##3##(2011-2#2)
during liver transplantation##4##3##(1991-8#2)(1992-3#1)(2013-1#1)
during liver##11##2##(1991-8#2)(1992-3#1)(1994-6#1)(1995-6#1)(1997-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
during loaded isometric shoulder flexion##2##5##(2010-9#2)
during loaded shoulder flexion##2##4##(2010-9#2)
during loaded##4##2##(2010-9#4)
during loading##2##2##(2007-7#1)(2008-7#1)
during locomotion##3##2##(2008-5#1)(2009-10#1)(2012-2#1)
during long term memory##2##4##(2013-1#2)
during long##6##2##(2008-10#2)(2008-11#1)(2010-5#1)(2013-1#2)
during long-term culture##2##3##(2008-11#2)
during long-term follow-up##2##3##(2013-1#2)
during long-term interferon-alpha##2##3##(1992-10#2)
during long-term maintenance of##2##4##(2008-11#2)
during long-term##17##2##(1992-10#2)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#6)(2008-2#1)(2008-6#1)(2008-7#1)(2013-1#2)
during low##2##2##(2008-10#1)(2013-1#1)
during luteal##3##2##(2008-9#1)(2012-2#2)
during magnetic resonance imaging##2##4##(1992-3#1)(1995-12#1)
during magnitude estimation of##2##4##(2012-12#2)
during maize##3##2##(2008-10#2)(2009-8#1)
during major##2##2##(1992-8#1)(2011-2#1)
during male##2##2##(2009-10#1)(2009-3#1)
during mammalian##3##2##(1991-9#1)(1992-12#1)(2008-9#1)
during management##2##2##(2008-7#2)
during mandible occlusion without clenching##2##5##(2010-6#2)
during mania##2##2##(2013-8#2)
during manic##2##2##(1996-7#1)(2013-8#1)
during manufacturing##2##2##(2007-11#1)(2011-1#1)
during many##2##2##(1993-3#1)(1994-5#1)
during maturation and##2##3##(1991-7#1)(2008-7#1)
during maturation of##2##3##(2013-1#2)
during maturation##8##2##(1991-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#2)
during maximal occlusion##2##3##(2013-1#2)
during maximal##4##2##(2008-7#1)(2012-2#1)(2013-1#2)
during measurement##2##2##(2008-10#1)(2008-3#1)
during mechanical##3##2##(1994-2#1)(2010-5#1)(2013-1#1)
during meditation##2##2##(2008-10#2)
during meiosis in##2##3##(2009-12#2)
during meiosis##9##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#2)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
during meiotic maturation##4##3##(2013-1#4)
during meiotic prophase I##3##4##(2011-2#3)
during meiotic##7##2##(2011-2#3)(2013-1#4)
during migration##3##2##(1990-12#1)(2008-8#2)
during military##2##2##(1992-6#1)(1993-8#1)
during mitosis is##2##3##(1992-12#1)(2009-5#1)
during mitosis##4##2##(1992-12#2)(2009-5#1)(2011-2#1)
during mixed##2##2##(2008-10#2)
during moderate and severe grades of##2##6##(2011-2#2)
during moderate and severe##3##4##(2011-2#3)
during moderate##4##2##(2006-7#1)(2011-2#3)
during molecular##2##2##(2008-10#1)(2012-3#1)
during more than##2##3##(2008-10#2)
during most of the year##2##5##(2008-3#2)
during most of the##7##4##(2008-10#1)(2008-3#2)(2008-9#3)(2009-8#1)
during most##8##2##(2008-10#1)(2008-3#2)(2008-9#4)(2009-8#1)
during mouth opening##2##3##(1991-2#2)
during movement##3##2##(1991-5#2)(2013-8#1)
during murine##2##2##(1992-9#1)(2008-11#1)
during natural##3##2##(1997-2#1)(2008-9#1)(2012-3#1)
during neonatal##5##2##(1991-8#1)(1992-3#1)(1997-6#1)(2010-8#1)(2012-3#1)
during neuronal##3##2##(1995-3#1)(2010-1#1)(2011-2#1)
during nine##2##2##(2008-3#1)(2008-5#1)
during non-loaded breathing##2##3##(1996-5#2)
during normal aging##3##3##(1991-12#1)(2008-7#1)(2010-11#1)
during normal development##2##3##(1996-5#1)(2008-9#1)
during normal pregnancy##3##3##(1993-2#1)(1996-11#1)(2013-1#1)
during normal##16##2##(1991-12#1)(1991-3#1)(1993-2#1)(1993-6#1)(1996-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-9#1)(2013-1#1)
during ocular fixation##3##3##(2008-7#3)
during off road driving]##2##4##(1990-6#2)
during off road##3##3##(1990-6#3)
during off-pump coronary artery bypass grafting##2##6##(2007-8#2)
during off-pump coronary artery bypass##4##5##(2007-8#4)
during one season##2##3##(2008-10#2)
during one year##5##3##(1991-6#1)(2007-12#1)(2007-8#1)(2008-6#1)(2013-8#1)
during one##16##2##(1990-2#1)(1991-11#1)(1991-6#1)(1995-2#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2013-8#1)
during ongoing##2##2##(2008-7#1)(2009-8#1)
during only one##2##3##(2007-5#1)(2008-5#1)
during ontogenesis##3##2##(1991-12#3)
during ontogeny and##2##3##(1992-6#1)(1993-3#1)
during oocyte maturation and egg activation##2##6##(2008-9#2)
during oocyte maturation##3##3##(2008-5#1)(2008-9#2)
during oocyte##5##2##(2008-5#1)(2008-9#2)(2010-3#1)(2010-5#1)
during oogenesis##6##2##(1994-12#1)(2007-12#1)(2008-9#1)(2009-3#2)(2010-5#1)
during open heart surgery##2##4##(1996-9#1)(2007-8#1)
during open##3##2##(1996-9#1)(1997-8#1)(2007-8#1)
during operation##4##2##(1991-6#1)(1994-12#1)(2008-11#1)(2008-12#1)
during operative##2##2##(2007-11#1)(2011-2#1)
during or after##6##3##(1995-6#1)(2007-10#1)(2008-5#1)(2010-3#1)(2010-8#1)(2012-12#1)
during or before##2##3##(2008-10#1)(2008-11#1)
during or following##2##3##(1996-12#1)(2009-5#1)
during or##12##2##(1993-1#1)(1995-6#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-12#1)
during oral corticosteroid##2##3##(2008-11#2)
during oral##4##2##(1993-1#1)(2008-11#3)
during orthodontic##2##2##(1990-10#1)(2009-7#1)
during overshoot##2##2##(2008-11#1)(2008-7#1)
during oviposition##2##2##(2010-8#2)
during painful##2##2##(1995-12#1)(2013-8#1)
during particular##2##2##(2008-7#1)(2009-10#1)
during passage through##2##3##(2008-10#1)(2011-1#1)
during passage##4##2##(2008-10#3)(2011-1#1)
during passive##5##2##(1990-8#1)(1991-5#1)(1995-5#1)(1996-5#1)(2012-3#1)
during pathogen##3##2##(2008-10#3)
during patient##3##2##(1994-3#2)(2007-8#1)
during peak differentiation##2##3##(2007-12#2)
during peak##5##2##(1992-8#1)(2007-12#2)(2008-10#1)(2012-12#1)
during pediatric hospitalization##2##3##(1992-2#2)
during periods of##12##3##(1995-3#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
during periods when##2##3##(2008-10#1)(2008-11#1)
during periods##14##2##(1995-3#1)(1996-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
during physical activities##2##3##(2010-8#2)
during physical##5##2##(2009-1#1)(2010-10#1)(2010-2#1)(2010-8#2)
during placebo treatment##3##3##(2013-1#3)
during planning##3##2##(2007-7#1)(2009-8#1)(2012-12#1)
during platelet##3##2##(1992-6#2)(2006-6#1)
during pollen##3##2##(2008-8#2)(2009-10#1)
during polymer##2##2##(2008-11#1)(2012-12#1)
during polymerization##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
during postembryonic development##2##3##(2007-12#2)
during posterior##2##2##(2008-9#1)(2012-3#1)
during postnatal development##2##3##(1992-6#1)(1994-5#1)
during postnatal##3##2##(1992-6#1)(1994-5#1)(1994-6#1)
during postoperative##2##2##(2013-1#2)
during practice##2##2##(2008-11#2)
during pre-ecdysis##2##2##(2008-7#2)
during precipitation events##2##3##(2008-10#2)
during pregnancy and lactation##3##4##(2008-4#3)
during pregnancy and postpartum##2##4##(2008-9#2)
during pregnancy and the##3##4##(1993-10#1)(2007-2#1)(2012-2#1)
during pregnancy and##25##3##(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-7#2)(2007-2#1)(2007-7#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
during pregnancy can##4##3##(1992-5#1)(2008-4#1)(2009-1#1)(2009-3#1)
during pregnancy in a##3##4##(1992-12#1)(2010-6#1)(2013-8#1)
during pregnancy in##6##3##(1992-12#1)(2007-7#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
during pregnancy is a##2##4##(2008-4#1)(2011-1#1)
during pregnancy is##5##3##(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#1)(2011-1#1)
during pregnancy may##3##3##(1992-4#1)(1994-8#1)(2013-1#1)
during pregnancy on birth##2##4##(1997-7#2)
during pregnancy on##3##3##(1995-12#1)(1997-7#2)
during pregnancy or##3##3##(2009-3#1)(2010-12#2)
during pregnancy to##2##3##(1996-11#1)(2013-1#1)
during pregnancy##131##2##(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#3)(1992-5#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-12#5)(1995-6#4)(1996-11#1)(1997-7#5)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#6)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#10)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#3)(2009-12#1)(2009-3#5)(2009-9#1)(2010-11#1)(2010-12#3)(2010-6#4)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#11)(2013-8#2)
during pregnancy?##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
during pregnancy]##5##2##(1990-2#1)(1991-11#1)(1992-5#1)(1997-8#1)(2013-1#1)
during preimplantation##2##2##(1995-2#1)(2013-1#1)
during prenatal life##2##3##(1993-12#1)(2008-10#1)
during preparation##2##2##(2008-10#1)(2008-8#1)
during pretreatment##2##2##(2008-6#1)(2013-1#1)
during primary##4##2##(1990-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
during processing of##5##3##(1993-12#1)(1995-2#1)(2008-11#1)(2008-3#1)(2010-4#1)
during processing##7##2##(1993-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
during product development##2##3##(2008-5#2)
during production##3##2##(2008-11#1)(2008-3#1)(2010-4#1)
during progression##3##2##(2008-7#1)(2011-1#1)(2012-12#1)
during prolonged##6##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-1#1)(2011-1#1)
during protein##2##2##(2008-9#1)(2012-2#1)
during puberty##4##2##(1993-2#1)(2008-10#1)(2009-12#1)(2011-2#1)
during pulse##2##2##(2007-11#1)(2008-3#1)
during purification##2##2##(1990-5#1)(2008-11#1)
during rHGH treatment##2##3##(2007-11#2)
during radiation##2##2##(1991-2#1)(1993-2#1)
during radical##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
during radiological##2##2##(2011-2#1)(2012-2#1)
during radiotherapy##6##2##(1990-8#1)(1992-12#1)(1993-8#1)(1995-9#2)(2008-7#1)
during rapid##4##2##(1990-7#1)(1992-3#1)(2008-7#2)
during rat development##2##3##(1990-7#2)
during rat##3##2##(1990-7#2)(1995-12#1)
during reaching movements##2##3##(2008-6#2)
during reaching##3##2##(2008-6#2)(2010-7#1)
during reading##2##2##(2008-9#1)(2013-8#1)
during recent years##2##3##(1992-11#1)(1996-1#1)
during recent##5##2##(1992-11#1)(1996-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
during reconstruction##2##2##(2008-2#1)(2012-12#1)
during recording of##2##3##(2008-2#1)(2013-1#1)
during recording##4##2##(2007-12#1)(2008-2#2)(2013-1#1)
during recovery from##7##3##(1990-5#1)(1996-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#2)
during recovery##9##2##(1990-2#1)(1990-5#1)(1992-3#1)(1996-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#2)
during regeneration##4##2##(2008-5#1)(2012-2#3)
during rehabilitation##4##2##(2007-8#2)(2008-7#1)(2010-4#1)
during removal of##3##3##(1991-2#1)(2009-4#1)(2011-2#1)
during repeated exposure to##2##4##(2012-2#2)
during repeated exposure##3##3##(2012-2#3)
during repeated##8##2##(1996-4#1)(2007-7#1)(2008-5#1)(2008-7#2)(2012-2#3)
during reperfusion##5##2##(1991-9#1)(1996-9#2)(2007-8#1)(2008-4#1)
during replication##2##2##(2008-10#1)(2009-2#1)
during resection of##3##3##(2008-7#2)(2009-3#1)
during rest and##2##3##(2007-12#1)(2009-3#1)
during rest or sleep##2##4##(1994-8#1)(2008-8#1)
during rest##5##2##(1994-8#2)(2007-12#1)(2008-8#1)(2009-3#1)
during resting and##3##3##(1994-3#1)(2008-7#2)
during resting##4##2##(1994-3#1)(2008-7#2)(2013-8#1)
during resuscitation##2##2##(1995-5#1)(2012-2#1)
during reversed flow##2##3##(1991-3#2)
during reversible electroporation##2##3##(2009-11#2)
during reversible##3##2##(1991-5#1)(2009-11#2)
during riding##2##2##(2012-12#2)
during root##3##2##(2008-10#1)(2010-5#2)
during routine analysis##2##3##(2008-10#2)
during routine clinical practice##2##4##(2010-4#1)(2011-2#1)
during routine##16##2##(1991-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
during sampling##2##2##(2008-10#1)(2011-1#1)
during scoliosis repair surgery with##2##5##(2011-2#2)
during seasonal##4##2##(1990-2#1)(2008-10#1)(2010-4#1)(2011-2#1)
during second mating##2##3##(2008-5#2)
during second##3##2##(2008-5#2)(2012-3#1)
during secondary metabolism##2##3##(1990-12#1)(2008-7#1)
during secondary##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
during senescence##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
during sepsis##3##2##(1997-1#1)(2013-8#2)
during sequential finger##2##3##(1996-2#2)
during sequential##3##2##(1996-2#2)(2011-2#1)
during several##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
during severe##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
during sexual contacts##2##3##(2011-1#2)
during sexual reproduction##2##3##(1990-7#1)(2008-7#1)
during sexual##7##2##(1990-7#1)(1992-12#1)(2007-8#1)(2008-7#1)(2011-1#3)
during short##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
during short-term##2##2##(2008-10#1)(2013-1#1)
during single-lung ventilation##2##3##(2006-10#2)
during single-mode operation##2##3##(2007-12#2)
during sinus rhythm##3##3##(1990-3#1)(1995-12#1)(2009-10#1)
during sitting##2##2##(1995-8#1)(2013-1#1)
during six years of##2##4##(2008-1#1)(2008-2#1)
during six##3##2##(2008-1#1)(2008-2#1)(2008-6#1)
during skeletal development##2##3##(2008-11#1)(2012-12#1)
during sleep in##2##3##(1992-8#1)(1993-12#1)
during sleep##11##2##(1992-11#1)(1992-8#1)(1993-12#1)(1997-4#1)(2007-8#1)(2009-8#2)(2012-3#2)(2013-8#2)
during solar##2##2##(2008-3#1)(2008-5#1)
during space##2##2##(1996-12#1)(2008-3#1)
during specific##4##2##(1996-5#2)(2007-12#1)(2012-1#1)
during speech##2##2##(2008-9#1)(2012-12#1)
during sperm##2##2##(2008-4#1)(2009-10#1)
during spermatogenesis##5##2##(2008-5#1)(2009-10#1)(2012-2#3)
during spermiogenesis##3##2##(2008-7#1)(2012-2#2)
during spreading depression (SD)##2##4##(1993-12#2)
during spreading depression##3##3##(1993-12#2)(1996-5#1)
during spring and##2##3##(2008-10#1)(2012-3#1)
during spring##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
during stabilization##2##2##(2008-10#1)(2009-2#1)
during stair##2##2##(2013-1#2)
during standard##2##2##(2013-1#1)(2013-8#1)
during standing##2##2##(2010-3#1)(2010-9#1)
during starvation##3##2##(1990-11#1)(2008-4#1)(2008-7#1)
during steady exercise##2##3##(2008-7#2)
during steady##3##2##(2008-7#2)(2010-8#1)
during steady-state growth at 23 degrees C##2##7##(1993-9#2)
during steady-state growth##3##3##(1993-9#2)(2008-7#1)
during sternal re-entry##2##3##(2007-8#2)
during stimulation of##2##3##(1995-5#1)(2012-1#1)
during stimulation##5##2##(1993-12#1)(1995-12#1)(1995-5#1)(2008-9#1)(2012-1#1)
during storage at##4##3##(1993-12#1)(1997-4#1)(2008-10#1)(2013-1#1)
during storage of##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
during storage##16##2##(1993-12#1)(1997-4#1)(1997-6#1)(2008-10#9)(2010-4#1)(2011-2#2)(2013-1#1)
during stress##6##2##(1997-4#2)(2008-10#1)(2008-3#2)(2008-4#1)
during studies of##2##3##(1997-6#1)(2008-10#1)
during studies##3##2##(1997-6#1)(2008-10#2)
during subacute##2##2##(1990-6#1)(1997-3#1)
during subcellular fractionation##2##3##(1990-5#2)
during subsequent##2##2##(2009-4#1)(2012-12#1)
during successive##2##2##(2008-2#1)(2008-9#1)
during such##6##2##(1992-8#1)(1993-5#1)(2007-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
during summer##3##2##(1991-8#1)(2008-10#2)
during sun exposure##2##3##(2008-5#2)
during supramaximal exercise##3##3##(2013-8#3)
during surgery for##2##3##(2008-10#1)(2009-1#1)
during surgery##19##2##(1990-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#4)(2009-1#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
during surgical procedures##2##3##(1993-1#1)(2009-12#1)
during surgical treatment##2##3##(1990-5#1)(2008-1#1)
during surgical##9##2##(1990-5#1)(1992-11#1)(1993-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
during swallowing##3##2##(1993-12#1)(2011-2#1)(2012-3#1)
during synthesis of##2##3##(1990-8#1)(2011-2#1)
during synthesis##3##2##(1990-8#1)(1993-8#1)(2011-2#1)
during systemic##2##2##(1990-6#1)(2008-10#1)
during task##2##2##(1995-12#1)(2011-2#1)
during terminal differentiation##2##3##(1994-3#1)(2008-9#1)
during testing##6##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)
during that##5##2##(1992-8#1)(1994-7#1)(1996-3#1)(2010-4#1)(2013-8#1)
during the &quot##2##3##(2008-5#1)(2008-7#1)
during the 1940s##2##3##(1993-6#1)(2011-2#1)
during the 1970s##3##3##(1993-12#1)(1996-1#1)(1997-4#1)
during the 1980s and##2##4##(1997-1#1)(2008-10#1)
during the 1980s##4##3##(1994-9#1)(1997-1#1)(1997-4#1)(2008-10#1)
during the 1990s##4##3##(1992-3#1)(1992-6#1)(1997-6#1)(2008-10#1)
during the 1999##2##3##(2008-10#2)
during the 1st##2##3##(1994-3#1)(2008-12#1)
during the 2-week##2##3##(1993-5#1)(2008-10#1)
during the 2002##2##3##(2008-10#2)
during the 20th century##2##4##(2008-4#1)(2008-8#1)
during the 20th##3##3##(1992-6#1)(2008-4#1)(2008-8#1)
during the 24 h##2##4##(1996-5#1)(2008-10#1)
during the 3 years##2##4##(1995-12#1)(2008-10#1)
during the 3##4##3##(1995-12#1)(2007-7#1)(2008-10#1)(2008-3#1)
during the 4##3##3##(1993-3#1)(2010-10#1)(2012-2#1)
during the 4-year##2##3##(2008-10#2)
during the 48-h inoculation period##2##5##(2008-10#2)
during the 4th week##2##4##(1990-12#1)(2008-10#1)
during the Breeding##2##3##(2008-5#1)(2008-6#1)
during the First World War##2##5##(2008-10#1)(2009-7#1)
during the Reagan years##2##4##(1993-2#2)
during the S##3##3##(1993-6#1)(2008-11#1)(2010-8#1)
during the active period##2##4##(2008-7#2)
during the active study##2##4##(2010-11#2)
during the active##6##3##(2008-7#3)(2010-11#2)(2011-2#1)
during the acute phase of##5##5##(2008-12#1)(2008-7#1)(2013-1#3)
during the acute phase##7##4##(1994-6#1)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#3)
during the acute##12##3##(1994-6#1)(1997-6#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#2)(2013-1#4)
during the acute-phase##2##3##(1990-2#1)(1993-8#1)
during the administration of##5##4##(1991-12#1)(2007-10#1)(2008-1#2)(2009-8#1)
during the adsorption##2##3##(2008-10#1)(2008-7#1)
during the adult##2##3##(1990-3#1)(2008-6#1)
during the aging process##5##4##(1997-2#2)(2008-10#2)(2008-9#1)
during the biological##2##3##(2010-7#2)
during the breeding season##3##4##(2008-6#1)(2008-9#1)(2013-7#1)
during the breeding##4##3##(2008-6#2)(2008-9#1)(2013-7#1)
during the calendar period##2##4##(1993-9#2)
during the cell cycle##5##4##(1990-2#1)(1997-3#1)(2011-2#2)(2012-2#1)
during the cell##6##3##(1990-2#1)(1997-3#1)(1997-6#1)(2011-2#2)(2012-2#1)
during the characterization of##2##4##(1995-8#1)(2008-5#1)
during the cholera epidemic in Bergen in##2##7##(1993-3#2)
during the clinical##3##3##(1992-6#2)(2010-8#1)
during the competition##4##3##(2008-5#3)(2013-8#1)
during the concentration##2##3##(2011-2#2)
during the conditioning##2##3##(2008-10#2)
during the course of an##2##5##(2008-10#1)(2008-11#1)
during the course of natural##2##5##(2008-11#1)(2013-8#1)
during the course of the disease##5##6##(1990-6#1)(1993-12#1)(2007-7#1)(2008-7#1)(2011-1#1)
during the course of the##14##5##(1990-6#1)(1991-5#1)(1993-12#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#1)
during the course of treatment##3##5##(1991-12#1)(1996-9#1)(2013-8#1)
during the course of ulcerative colitis##2##6##(2007-10#2)
during the course of##52##4##(1990-6#1)(1991-12#1)(1991-5#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-5#1)(1994-9#1)(1996-9#1)(1997-4#1)(1997-9#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
during the critical period##2##4##(2012-2#2)
during the cropping##2##3##(2008-10#2)
during the cultivation##3##3##(2008-11#2)(2008-12#1)
during the culture##2##3##(2008-11#1)(2008-7#1)
during the current##2##3##(2010-10#1)(2012-3#1)
during the dark period##3##4##(1990-7#1)(1995-11#1)(2008-11#1)
during the dark##6##3##(1990-7#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
during the day##6##3##(1996-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
during the deposition##2##3##(2008-10#2)
during the development of the##4##5##(1992-6#1)(1995-3#1)(2008-10#1)(2013-1#1)
during the development of##10##4##(1992-6#1)(1993-12#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#2)
during the developmental##3##3##(1992-12#1)(1994-9#1)(2013-1#1)
during the different stages of##2##5##(1990-12#1)(2011-2#1)
during the different##3##3##(1990-12#1)(2008-5#1)(2011-2#1)
during the differentiation##3##3##(1991-11#1)(1992-12#1)(2010-12#1)
during the driest and coldest periods of the year##2##9##(2008-5#2)
during the dry season##9##4##(2007-5#1)(2008-5#5)(2008-6#1)(2008-8#1)(2013-7#1)
during the dry##10##3##(2007-5#1)(2008-10#1)(2008-5#5)(2008-6#1)(2008-8#1)(2013-7#1)
during the early events of##2##5##(2008-10#1)(2008-7#1)
during the early phase of##3##5##(1993-9#1)(1996-2#1)(2012-2#1)
during the early phase##4##4##(1993-9#1)(1996-2#1)(2012-2#2)
during the early postnatal period##4##5##(1991-1#1)(1997-2#1)(2008-11#1)(2010-1#1)
during the early postoperative period##2##5##(1991-2#1)(1995-4#1)
during the early stages of##9##5##(1993-3#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
during the early stages##10##4##(1993-3#1)(1994-3#1)(1996-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
during the early years##2##4##(1993-12#1)(2008-11#1)
during the early##38##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
during the earthquake##3##3##(2012-1#2)(2013-1#1)
during the entire experiment##2##4##(2008-10#2)
during the entire##10##3##(1993-1#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)
during the enzymatic reaction of##2##5##(2008-10#2)
during the enzymatic reaction##3##4##(2008-10#3)
during the enzymatic##6##3##(1994-12#1)(2008-10#5)
during the epidemic##2##3##(2008-1#1)(2008-10#1)
during the epidemics##3##3##(2007-10#1)(2012-3#2)
during the epithelial cycle##2##4##(2009-10#1)(2012-2#1)
during the establishment##2##3##(1996-11#1)(2008-11#1)
during the evaluation##2##3##(2008-10#2)
during the evening and morning hours##2##6##(2012-5#2)
during the event##3##3##(1997-3#1)(2009-2#1)(2012-12#1)
during the evolution of##4##4##(2008-2#1)(2012-2#1)(2013-1#2)
during the evolution##6##3##(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#2)
during the experiment##7##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#2)(2013-1#1)
during the experimental periods##2##4##(2008-10#1)(2013-1#1)
during the experimental##5##3##(2008-10#1)(2012-5#2)(2013-1#2)
during the experiments##2##3##(2008-10#2)
during the exponential growth phase##2##5##(2008-11#1)(2008-7#1)
during the exponential phase##3##4##(2008-11#3)
during the exponential##5##3##(2008-11#4)(2008-7#1)
during the exposure##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
during the extraction##3##3##(1990-5#1)(2008-10#2)
during the fabrication process##2##4##(2008-10#1)(2008-3#1)
during the fall of##2##4##(2007-2#1)(2008-10#1)
during the fall##4##3##(2007-2#1)(2008-10#2)(2008-3#1)
during the fed-batch##2##3##(2008-7#2)
during the fermentation of##2##4##(2008-6#1)(2008-8#1)
during the fetal##2##3##(1993-3#1)(2008-10#1)
during the fiber##2##3##(2008-3#1)(2008-8#1)
during the field##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
during the final years##2##4##(1990-6#1)(2011-2#1)
during the final##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
during the first 10##3##4##(1991-12#1)(2008-10#2)
during the first 2##5##4##(1995-1#1)(2008-10#3)(2008-9#1)
during the first 24 h##4##5##(1994-8#2)(1995-12#1)(2008-11#1)
during the first 24##6##4##(1994-8#2)(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
during the first 3 days##2##5##(1995-3#1)(2008-11#1)
during the first 3 months##2##5##(2008-10#1)(2013-1#1)
during the first 3 weeks of##2##6##(2008-11#1)(2008-5#1)
during the first 3##8##4##(1992-12#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
during the first 4 days of the differentiation process##2##9##(2008-3#2)
during the first 4 days##3##5##(1995-11#1)(2008-3#2)
during the first 4##5##4##(1994-8#1)(1995-11#1)(2008-3#2)(2008-7#1)
during the first 5 years##2##5##(1994-12#1)(2008-9#1)
during the first 5##3##4##(1994-12#1)(2008-5#1)(2008-9#1)
during the first 6 h##2##5##(2008-10#1)(2008-11#1)
during the first 6##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
during the first 60 days of##2##6##(1992-3#2)
during the first 60 days##5##5##(1992-3#3)(1993-3#2)
during the first 60##6##4##(1991-9#1)(1992-3#3)(1993-3#2)
during the first 7##2##4##(2007-10#1)(2008-8#1)
during the first and##3##4##(1991-9#1)(2008-10#1)(2011-2#1)
during the first days of treatment##2##6##(1990-6#1)(1990-9#1)
during the first days##3##4##(1990-6#1)(1990-9#1)(2012-3#1)
during the first few##2##4##(2008-10#1)(2008-8#1)
during the first four##2##4##(2008-6#1)(2011-2#1)
during the first half of the##2##6##(2009-8#1)(2011-2#1)
during the first half of##3##5##(2007-12#1)(2009-8#1)(2011-2#1)
during the first half##4##4##(1992-6#1)(2007-12#1)(2009-8#1)(2011-2#1)
during the first minutes of##2##5##(1994-3#1)(1996-9#1)
during the first month of##4##5##(1990-8#1)(1993-2#1)(2008-9#2)
during the first month##5##4##(1990-8#1)(1993-2#2)(2008-9#2)
during the first part of the##2##6##(1992-6#1)(2008-5#1)
during the first step of##2##5##(1992-8#1)(2008-10#1)
during the first step##3##4##(1992-8#1)(2008-10#2)
during the first three months##3##5##(1990-6#1)(2008-6#1)(2010-8#1)
during the first three weeks##2##5##(2008-12#1)(2008-5#1)
during the first three##7##4##(1990-11#1)(1990-6#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)
during the first trimester##6##4##(1990-9#1)(1992-2#2)(2011-2#1)(2013-1#2)
during the first two weeks of##2##6##(1994-6#1)(2010-3#1)
during the first two weeks##3##5##(1994-6#1)(2007-5#1)(2010-3#1)
during the first two##6##4##(1994-6#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#1)
during the first week##5##4##(1991-2#1)(1996-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
during the first year of life##6##6##(1994-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(2008-12#1)
during the first year of the##3##6##(1993-11#1)(2008-2#1)(2011-2#1)
during the first year of treatment##2##6##(2008-5#1)(2013-1#1)
during the first year of##16##5##(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
during the first year##20##4##(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#2)
during the first years of##4##5##(1995-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
during the first years##5##4##(1995-6#1)(2008-11#1)(2008-5#1)(2011-2#2)
during the first##155##3##(1990-10#2)(1990-11#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-3#2)(2013-1#8)
during the folding process##2##4##(1991-6#2)
during the folding##3##3##(1991-6#3)
during the follow up##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
during the follow-up period##4##4##(1997-8#1)(2008-6#1)(2011-1#1)(2011-2#1)
during the follow-up##6##3##(1990-9#1)(1997-8#1)(2008-6#1)(2011-1#1)(2011-2#1)(2011-3#1)
during the following days##2##4##(1991-6#1)(1991-9#1)
during the following months##2##4##(1997-3#1)(2008-7#1)
during the following##10##3##(1991-6#1)(1991-9#1)(1994-6#2)(1997-3#1)(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
during the formation##2##3##(2007-12#1)(2008-8#1)
during the four##2##3##(2007-5#1)(2010-5#1)
during the fourth##6##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
during the fruit development##4##4##(2008-9#4)
during the fruiting##2##3##(2008-6#2)
during the grazing season##2##4##(2010-2#2)
during the growing season##14##4##(2008-10#10)(2009-2#3)(2010-8#1)
during the growing##16##3##(2008-10#11)(2009-2#3)(2010-8#1)(2012-5#1)
during the growth cycle##2##4##(1991-9#1)(2008-5#1)
during the growth of##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
during the growth##7##3##(1991-9#1)(1992-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
during the heat wave##2##4##(2011-1#2)
during the high##2##3##(1990-3#1)(2008-5#1)
during the host-free period##2##4##(2008-10#2)
during the hot##4##3##(2008-10#2)(2008-8#1)(2009-12#1)
during the hours following acquisition##2##5##(1993-5#2)
during the hydrolysis process##2##4##(2008-10#2)
during the incubation period##2##4##(1991-12#1)(2008-10#1)
during the induction of##2##4##(2008-9#1)(2009-8#1)
during the induction therapy##2##4##(2008-1#1)(2011-2#1)
during the induction##4##3##(2008-1#1)(2008-9#1)(2009-8#1)(2011-2#1)
during the industrial##2##3##(1993-2#1)(2012-2#1)
during the infection##2##3##(2008-10#2)
during the initial phase of##2##5##(2007-7#1)(2013-8#1)
during the initial phase##3##4##(2007-7#1)(2008-11#1)(2013-8#1)
during the initial preconditioning period##2##5##(1996-9#2)
during the initial stage of##2##5##(2008-10#1)(2008-7#1)
during the initial stages of##3##5##(2008-3#1)(2009-8#1)(2009-9#1)
during the initial treatment period##2##5##(1992-3#1)(2007-10#1)
during the initial##23##3##(1990-11#1)(1991-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-9#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
during the initiation of##2##4##(1994-6#1)(2013-1#1)
during the initiation##3##3##(1994-6#1)(2008-8#1)(2013-1#1)
during the inoculation period##2##4##(2008-10#2)
during the interaction of##2##4##(1993-8#1)(2008-10#1)
during the interaction##5##3##(1993-8#1)(2008-10#3)(2009-11#1)
during the intervention##2##3##(2011-1#1)(2013-1#1)
during the intraoperative period##2##4##(2010-5#1)(2011-3#1)
during the intraoperative##3##3##(2010-5#1)(2011-3#1)(2013-1#1)
during the jump##2##3##(2007-12#1)(2008-9#1)
during the larval##4##3##(1990-3#1)(2007-12#1)(2008-7#1)(2008-8#1)
during the last 10 years##2##5##(2008-11#1)(2013-1#1)
during the last 12 years##2##5##(1997-3#1)(2008-10#1)
during the last 12##3##4##(1996-9#1)(1997-3#1)(2008-10#1)
during the last 15 years##2##5##(1991-9#1)(1993-11#1)
during the last 20##3##4##(1992-4#1)(1994-12#2)
during the last 3##2##4##(2007-8#1)(2008-9#1)
during the last 50 years##3##5##(1995-2#1)(2008-10#2)
during the last decade##8##4##(1996-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#1)
during the last decades##4##4##(2008-11#1)(2009-12#1)(2009-4#1)(2011-2#1)
during the last few decades##2##5##(1993-9#1)(2013-1#1)
during the last few##3##4##(1990-3#1)(1993-9#1)(2013-1#1)
during the last three##4##4##(1995-6#1)(2008-9#1)(2011-2#2)
during the last two decades and##2##6##(2008-7#1)(2012-12#1)
during the last two##4##4##(2008-4#1)(2008-7#1)(2010-2#1)(2012-12#1)
during the last years##2##4##(2008-10#1)(2011-2#1)
during the last##67##3##(1990-3#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-12#3)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
during the late 1980s##2##4##(1995-12#1)(2008-10#1)
during the late nineteenth and early twentieth centuries##2##8##(2010-1#2)
during the late##12##3##(1993-12#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-1#2)(2010-12#1)(2012-3#1)
during the later stages of##4##5##(1990-5#1)(2008-10#1)(2009-5#1)(2012-3#1)
during the later stages##5##4##(1990-5#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)
during the latter##7##3##(1991-12#1)(1994-2#1)(1995-8#1)(1996-1#1)(2008-10#1)(2009-3#1)(2011-2#1)
during the life cycle##2##4##(2009-2#1)(2009-3#1)
during the light period of##2##5##(1994-8#1)(1995-11#1)
during the light##5##3##(1991-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)
during the luteal phase##2##4##(1994-9#1)(2012-2#1)
during the luteal##3##3##(1994-9#1)(2012-2#2)
during the main breeding season##2##5##(2008-5#2)
during the maturation of##2##4##(1993-6#1)(2008-8#1)
during the measurement##4##3##(2008-10#2)(2008-3#2)
during the medical##3##3##(1992-12#1)(1995-2#1)(2007-11#1)
during the mission##2##3##(2008-3#2)
during the molt cycle##2##4##(2008-6#2)
during the molt##3##3##(2008-6#2)(2008-7#1)
during the months of##2##4##(2007-7#1)(2012-3#1)
during the morning##3##3##(2008-12#1)(2008-3#1)(2010-5#1)
during the natural##2##3##(1995-5#1)(2013-8#1)
during the neonatal period##2##4##(1992-2#1)(2011-1#1)
during the next decade##2##4##(1991-12#1)(1996-2#1)
during the next##10##3##(1990-2#1)(1991-11#1)(1991-12#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
during the night##5##3##(2008-10#2)(2010-8#1)(2011-1#1)(2012-12#1)
during the observation period##4##4##(1992-9#1)(1997-4#1)(2008-11#1)(2011-1#1)
during the observation##5##3##(1992-9#1)(1997-4#1)(2008-11#2)(2011-1#1)
during the operation##2##3##(1993-1#1)(1997-3#1)
during the oxidation##2##3##(2008-10#2)
during the past 3##2##4##(2008-10#1)(2010-7#1)
during the past 6##2##4##(1991-3#2)
during the past century##2##4##(2008-10#1)(2011-2#1)
during the past decade##8##4##(1991-12#1)(1993-12#1)(1996-4#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-5#1)
during the past few years##3##5##(2008-10#1)(2008-9#2)
during the past few##4##4##(2008-10#1)(2008-9#2)(2012-2#1)
during the past five##2##4##(1994-12#1)(1994-2#1)
during the past several years##2##5##(1992-3#2)
during the past two decades##2##5##(2007-11#1)(2008-10#1)
during the past year##2##4##(2006-10#1)(2008-12#1)
during the past##42##3##(1991-12#1)(1991-3#2)(1992-3#2)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
during the peak##2##3##(2008-10#1)(2008-2#1)
during the performance of a##2##5##(2008-4#1)(2013-1#1)
during the performance of##3##4##(1995-2#1)(2008-4#1)(2013-1#1)
during the period January##3##4##(2007-12#1)(2011-2#1)(2013-1#1)
during the period June##2##4##(1995-2#1)(2006-10#1)
during the period from January##2##5##(2007-8#1)(2008-5#1)
during the period from##8##4##(1992-1#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
during the period of##21##4##(1991-5#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
during the period when##3##4##(1996-5#1)(2008-6#1)(2008-8#1)
during the period##79##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
during the perioperative period##2##4##(1992-3#1)(2011-1#1)
during the planning and##2##4##(2008-7#1)(2009-8#1)
during the planning##3##3##(2008-6#1)(2008-7#1)(2009-8#1)
during the postpandemic##2##3##(2013-1#2)
during the pre-monsoon season##3##4##(2008-7#2)(2013-7#1)
during the preceding##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
during the preconcentration##2##3##(2008-10#2)
during the pregnancy##6##3##(2008-2#4)(2011-2#1)(2012-3#1)
during the prenatal period##3##4##(1996-5#1)(2007-2#1)(2012-2#1)
during the preoperative##4##3##(2011-2#1)(2012-3#2)(2013-8#1)
during the preparation of##2##4##(2008-10#1)(2008-5#1)
during the previous##2##3##(2008-12#1)(2011-2#1)
during the primary##3##3##(2008-8#1)(2010-11#1)(2012-12#1)
during the prior##2##3##(2013-1#2)
during the procedure and##3##4##(1992-12#1)(1994-11#1)(2012-2#1)
during the procedure in three cases##2##6##(1997-3#2)
during the procedure##14##3##(1991-2#1)(1992-12#2)(1994-11#1)(1997-3#2)(2008-5#2)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
during the process of assembly##2##5##(1995-2#2)
during the process of##12##4##(1991-2#1)(1995-2#2)(2008-10#2)(2008-11#2)(2008-2#2)(2011-1#1)(2011-2#1)(2012-2#1)
during the process##16##3##(1991-2#1)(1995-2#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
during the processing of the##2##5##(2008-7#1)(2013-8#1)
during the processing##3##3##(2008-7#1)(2010-8#1)(2013-8#1)
during the production of##3##4##(2008-11#2)(2008-7#1)
during the production##7##3##(2008-10#1)(2008-11#4)(2008-7#1)(2012-2#1)
during the programme##3##3##(2008-11#1)(2008-12#2)
during the progress of##2##4##(2008-10#1)(2008-11#1)
during the pupal stage##2##4##(2007-12#2)
during the purification of##2##4##(1990-5#1)(1990-7#1)
during the purification##3##3##(1990-5#1)(1990-7#1)(2008-10#1)
during the quinolinic acid##2##4##(1995-5#2)
during the rainy season##5##4##(1994-9#1)(2008-10#1)(2008-5#2)(2008-8#1)
during the rainy##6##3##(1994-9#1)(2008-10#1)(2008-5#2)(2008-8#2)
during the reaction##8##3##(1990-7#1)(1995-6#1)(2008-10#6)
during the recent##2##3##(2008-3#1)(2011-2#1)
during the recording of##2##4##(2007-12#1)(2008-2#1)
during the recovery phase from acute##2##6##(1996-2#2)
during the recovery process##2##4##(2012-2#2)
during the recovery##7##3##(1992-3#1)(1996-2#2)(2008-5#1)(2012-2#2)(2013-1#1)
during the repair of##2##4##(2007-8#2)
during the repair##3##3##(1995-3#1)(2007-8#2)
during the reproductive cycle##2##4##(1990-12#1)(2012-12#1)
during the reproductive period##4##4##(1997-4#4)
during the reproductive##8##3##(1990-12#1)(1997-4#4)(2012-12#1)(2012-2#1)(2013-1#1)
during the retrieval##2##3##(2008-2#1)(2008-3#1)
during the ripening of##2##4##(2008-12#2)
during the ripening##3##3##(2008-12#3)
during the role plays##2##4##(2009-11#2)
during the run##2##3##(1997-2#1)(2008-7#1)
during the same period in##2##5##(1995-11#1)(1996-3#1)
during the same period of time##4##6##(1991-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
during the same period##11##4##(1990-6#1)(1991-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)(2012-2#2)
during the same time##2##4##(2008-1#2)
during the same##20##3##(1990-6#1)(1991-8#1)(1993-5#1)(1995-1#2)(1995-11#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#2)
during the sample##2##3##(2008-10#2)
during the sampling##3##3##(2008-10#2)(2011-3#1)
during the school##2##3##(2008-11#1)(2008-12#1)
during the screening process##2##4##(2007-11#1)(2010-11#1)
during the season##6##3##(2008-10#5)(2008-8#1)
during the second and third trimester##2##6##(1992-10#1)(1995-8#1)
during the second infestation##2##4##(1996-12#2)
during the second year##2##4##(2008-10#1)(2010-3#1)
during the second##19##3##(1992-10#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-12#2)(1997-6#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
during the selection and##2##4##(1992-12#1)(2011-2#1)
during the seminiferous epithelial cycle of spermatogenesis##3##7##(2012-2#3)
during the separation##2##3##(2008-10#2)
during the spawning season##2##4##(2008-7#1)(2010-8#1)
during the spawning##3##3##(2008-7#1)(2010-8#2)
during the spring and fall seasons##2##6##(2008-10#2)
during the spring and##3##4##(2008-10#2)(2012-3#1)
during the spring##7##3##(2008-10#4)(2011-2#1)(2012-3#2)
during the stationary phase##2##4##(2008-11#1)(2008-7#1)
during the storage##5##3##(2008-10#1)(2008-3#1)(2012-2#3)
during the stress##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
during the study of##2##4##(2008-4#1)(2011-1#1)
during the study period##20##4##(1994-12#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
during the study##35##3##(1993-9#1)(1994-12#1)(1996-12#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#2)
during the subjective night##2##4##(1994-2#1)(1995-12#1)
during the subjective##3##3##(1994-2#1)(1995-12#2)
during the subsequent##5##3##(1991-9#1)(2007-12#1)(2008-12#1)(2011-2#2)
during the summer months##2##4##(2008-11#1)(2011-1#1)
during the summer of##4##4##(1990-9#1)(1995-11#1)(2008-10#1)(2010-1#1)
during the summer##10##3##(1990-9#1)(1995-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#1)
during the surgery##3##3##(2009-4#2)(2010-8#1)
during the synthesis##2##3##(2008-10#1)(2008-5#1)
during the test period##2##4##(1996-4#1)(2011-1#1)
during the test##4##3##(1996-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
during the testing##2##3##(2008-3#1)(2013-8#1)
during the thawing process##2##4##(2008-10#2)
during the therapeutic##2##3##(1991-12#1)(2008-5#1)
during the third trimester##2##4##(1990-6#1)(2007-2#1)
during the third##7##3##(1990-6#1)(1996-6#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-5#1)
during the three-month##2##3##(2008-5#1)(2013-1#1)
during the three-year period##2##4##(1997-3#1)(2011-2#1)
during the time of##3##4##(2008-1#2)(2008-5#1)
during the time##6##3##(2007-2#1)(2008-1#3)(2008-3#1)(2008-5#1)
during the titration##3##3##(1996-12#1)(2008-10#2)
during the total##2##3##(2008-10#1)(2013-1#1)
during the transit of##2##4##(2008-7#1)(2012-2#1)
during the transition from hospital to##2##6##(2011-2#1)(2012-12#1)
during the transition from##5##4##(1997-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
during the transition state##2##4##(1990-5#1)(2010-4#1)
during the transition to##2##4##(2007-2#1)(2008-11#1)
during the transition##10##3##(1990-5#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
during the treatment of##2##4##(1991-8#1)(2009-5#1)
during the treatment period##3##4##(1992-11#1)(2008-7#1)(2013-1#1)
during the treatment##10##3##(1991-8#1)(1992-11#1)(1992-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
during the trial##2##3##(1992-3#1)(2007-7#1)
during the two##3##3##(1993-3#1)(2008-5#1)(2013-7#1)
during the validation##2##3##(2008-10#1)(2008-9#1)
during the various##2##3##(2008-11#1)(2012-2#1)
during the viral##2##3##(1991-5#1)(1994-8#1)
during the washing##2##3##(1997-2#1)(2008-7#1)
during the week of##2##4##(1995-6#1)(1996-5#1)
during the week##4##3##(1990-12#1)(1995-6#1)(1996-5#1)(2013-8#1)
during the wet period##2##4##(2008-10#1)(2008-5#1)
during the wet season of 1996 and##2##7##(2007-5#2)
during the wet season##3##4##(2007-5#2)(2008-5#1)
during the wet##5##3##(2007-5#2)(2008-10#1)(2008-5#2)
during the whole experiment##2##4##(2008-5#1)(2012-2#1)
during the whole pregnancy##2##4##(2013-1#2)
during the whole process of##3##5##(1995-12#1)(2008-11#1)(2013-8#1)
during the whole##15##3##(1992-5#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
during the winter months and##2##5##(1991-8#1)(2011-1#1)
during the winter months##4##4##(1991-8#1)(2008-10#1)(2009-11#1)(2011-1#1)
during the winter##14##3##(1991-8#1)(1995-11#3)(1996-9#1)(1997-3#1)(2008-10#2)(2008-5#2)(2009-11#1)(2011-1#1)(2013-7#1)(2013-8#1)
during the winter/spring of 2008##2##5##(2011-2#2)
during the workday and##2##4##(2012-12#2)
during the workday##4##3##(2012-12#4)
during the year##5##3##(1996-1#1)(2008-12#1)(2011-2#1)(2013-8#2)
during the years##8##3##(1990-2#1)(1991-11#1)(1995-6#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
during the##1840##2##(1990-10#2)(1990-11#6)(1990-12#5)(1990-2#5)(1990-3#6)(1990-5#7)(1990-6#11)(1990-7#5)(1990-8#3)(1990-9#8)(1991-1#2)(1991-11#5)(1991-12#13)(1991-2#6)(1991-3#4)(1991-5#5)(1991-6#10)(1991-8#4)(1991-9#9)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#13)(1992-2#7)(1992-3#11)(1992-4#1)(1992-5#3)(1992-6#12)(1992-8#7)(1992-9#6)(1993-1#6)(1993-10#1)(1993-11#5)(1993-12#14)(1993-2#6)(1993-3#12)(1993-5#4)(1993-6#5)(1993-8#4)(1993-9#7)(1994-1#3)(1994-11#2)(1994-12#13)(1994-2#10)(1994-3#11)(1994-5#3)(1994-6#7)(1994-7#3)(1994-8#7)(1994-9#11)(1995-1#5)(1995-11#11)(1995-12#8)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#14)(1995-8#6)(1995-9#1)(1996-1#5)(1996-11#5)(1996-12#12)(1996-2#5)(1996-3#6)(1996-4#3)(1996-5#7)(1996-6#8)(1996-7#3)(1996-9#9)(1997-1#2)(1997-2#14)(1997-3#14)(1997-4#14)(1997-6#8)(1997-7#3)(1997-8#3)(1997-9#1)(2006-10#3)(2006-8#2)(2007-10#12)(2007-11#9)(2007-12#21)(2007-2#8)(2007-4#1)(2007-5#7)(2007-6#1)(2007-7#13)(2007-8#14)(2008-1#22)(2008-10#299)(2008-11#75)(2008-12#31)(2008-2#30)(2008-3#49)(2008-4#19)(2008-5#81)(2008-6#33)(2008-7#71)(2008-8#31)(2008-9#44)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#6)(2009-3#5)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#6)(2010-10#5)(2010-11#8)(2010-12#7)(2010-2#6)(2010-3#8)(2010-4#8)(2010-5#8)(2010-7#4)(2010-8#18)(2010-9#2)(2011-1#29)(2011-10#1)(2011-2#77)(2011-3#4)(2012-1#6)(2012-12#26)(2012-2#48)(2012-3#29)(2012-5#7)(2012-7#1)(2012-8#1)(2013-1#70)(2013-7#9)(2013-8#24)
during their clinical##4##3##(1995-3#1)(2007-10#1)(2008-12#1)(2010-3#1)
during their first year of##3##5##(2007-10#1)(2011-1#1)(2013-1#1)
during their first year##4##4##(2007-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
during their first##12##3##(1992-5#1)(2007-10#1)(2008-11#3)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#3)
during their growth##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
during their life##3##3##(1994-11#1)(2008-12#1)(2010-8#1)
during their migration##2##3##(2007-12#1)(2010-8#1)
during their stay##2##3##(2013-1#2)
during their training##3##3##(1992-12#1)(2008-11#1)(2013-1#1)
during their##74##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#8)
during therapeutic##2##2##(2011-2#1)(2012-1#1)
during therapy with##3##3##(1990-5#2)(1995-11#1)
during therapy##9##2##(1990-5#2)(1992-11#1)(1992-12#1)(1992-9#1)(1995-11#1)(2008-10#1)(2010-4#1)(2011-2#1)
during thermal##4##2##(1996-12#1)(2008-10#2)(2011-2#1)
during these##18##2##(1990-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
during this emergency##3##3##(2013-1#3)
during this period of##2##4##(1994-3#1)(1995-3#1)
during this period was##3##4##(1992-12#1)(2007-8#1)(2008-9#1)
during this period##25##3##(1990-5#1)(1992-12#1)(1992-4#1)(1994-3#1)(1995-3#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#5)(2012-3#1)
during this process##2##3##(1991-9#1)(2010-5#1)
during this short##2##3##(1992-6#1)(1994-12#1)
during this study##4##3##(2008-11#2)(2011-2#1)(2012-2#1)
during this time##4##3##(1990-3#1)(1994-6#1)(1996-9#1)(2008-5#1)
during this transition##2##3##(2007-2#1)(2008-11#1)
during this##58##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#2)(1996-2#1)(1996-9#1)(1997-3#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#8)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
during thoracic aortic##2##3##(2010-8#2)
during thoracic surgery##2##3##(2006-10#1)(2011-2#1)
during thoracic##5##2##(2006-10#1)(2008-12#1)(2010-8#2)(2011-2#1)
during three##7##2##(1991-10#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-3#1)
during time##2##2##(2008-10#1)(2008-12#1)
during times of##4##3##(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
during times##5##2##(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
during tissue##4##2##(2007-7#1)(2010-10#1)(2010-9#2)
during titration##2##2##(1995-5#1)(2008-10#1)
during titrations##2##2##(1991-5#1)(2008-10#1)
during total knee arthroplasty##2##4##(2008-8#2)
during total knee replacement##2##4##(2007-8#1)(2013-1#1)
during total knee##4##3##(2007-8#1)(2008-8#2)(2013-1#1)
during total##8##2##(1992-9#1)(1995-9#1)(1996-2#1)(2007-8#1)(2008-8#2)(2013-1#1)(2013-7#1)
during tracking##2##2##(2008-6#1)(2012-2#1)
during training##7##2##(1993-3#1)(2008-5#3)(2011-2#2)(2012-1#1)
during transfection##2##2##(2008-6#1)(2011-1#1)
during transfer##2##2##(2007-12#1)(2008-7#1)
during transport to##3##3##(2007-8#1)(2007-9#1)(2013-1#1)
during transport##8##2##(1990-7#1)(1994-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#2)
during travel##2##2##(2007-2#2)
during treatment and##2##3##(2007-10#1)(2008-7#1)
during treatment for##2##3##(2011-1#1)(2011-2#1)
during treatment of##2##3##(2011-2#2)
during treatment with##11##3##(1990-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1994-8#1)(1996-6#1)(2008-1#1)(2009-12#1)(2009-8#1)(2012-3#1)
during treatment##45##2##(1990-10#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#1)(1992-2#1)(1992-8#1)(1994-8#1)(1996-6#1)(1997-4#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#6)(2012-3#4)(2013-1#3)
during triple combination therapy##2##4##(2013-1#2)
during tubulin unfolding##2##3##(1995-5#2)
during turnover of##2##3##(1992-3#1)(2008-1#1)
during two consecutive years##2##4##(2008-5#1)(2013-7#1)
during two consecutive##5##3##(1996-12#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-7#1)
during two seasons##2##3##(2008-10#1)(2012-8#1)
during two years##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
during two##19##2##(1994-9#1)(1996-12#1)(1996-4#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-8#1)(2013-7#1)(2013-8#1)
during ultrafast##2##2##(2008-3#2)
during unilateral practice##2##3##(2013-8#2)
during upper gastrointestinal endoscopy##2##4##(2010-4#1)(2012-2#1)
during use##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#1)
during vaginal##3##2##(2007-12#1)(2010-7#2)
during various activities and##2##4##(2009-10#2)
during various stages of##3##4##(1991-7#1)(2008-10#1)(2008-8#1)
during various##11##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-8#1)(2012-2#1)(2013-1#1)
during vertebrate development##2##3##(1994-8#1)(1997-4#1)
during viral##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
during virus replication##2##3##(1994-11#1)(2008-10#1)
during visual##2##2##(2008-10#1)(2013-8#1)
during waking##4##2##(1993-12#1)(2008-11#1)(2013-8#2)
during walking##5##2##(1997-2#2)(2008-12#1)(2010-3#1)(2013-1#1)
during wastewater treatment##3##3##(1997-4#1)(2013-1#2)
during which all##2##3##(2008-5#1)(2010-1#1)
during which no##2##3##(1990-11#1)(2008-6#1)
during which the##8##3##(1991-5#1)(1994-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-9#1)(2012-1#1)
during which they##4##3##(2008-10#2)(2008-7#1)(2010-8#1)
during which time##4##3##(1992-9#1)(1997-1#1)(2008-6#2)
during which##44##2##(1990-11#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-9#1)(1994-1#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-9#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
during winter months##2##3##(1991-8#1)(2007-7#1)
during winter##6##2##(1991-8#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)
during withdrawal##2##2##(1991-12#1)(1995-11#1)
during word processing##2##3##(2008-11#2)
during word##3##2##(1996-2#1)(2008-11#2)
during work##2##2##(1994-11#1)(2008-9#1)
during wound##2##2##(2008-10#1)(2008-5#1)
during years##2##2##(1995-6#1)(2007-8#1)
during yogic##2##2##(1991-10#1)(1991-12#1)
during your##2##2##(1994-3#1)(2007-12#1)
during##6043##1##(1990-10#6)(1990-11#19)(1990-12#21)(1990-2#19)(1990-3#26)(1990-4#1)(1990-5#43)(1990-6#28)(1990-7#17)(1990-8#17)(1990-9#22)(1991-1#6)(1991-10#7)(1991-11#17)(1991-12#39)(1991-2#31)(1991-3#17)(1991-4#1)(1991-5#26)(1991-6#28)(1991-7#2)(1991-8#20)(1991-9#30)(1992-1#2)(1992-10#11)(1992-11#11)(1992-12#36)(1992-2#18)(1992-3#44)(1992-4#6)(1992-5#21)(1992-6#38)(1992-7#1)(1992-8#17)(1992-9#18)(1993-1#23)(1993-10#5)(1993-11#11)(1993-12#48)(1993-2#16)(1993-3#26)(1993-5#9)(1993-6#14)(1993-8#13)(1993-9#15)(1994-1#5)(1994-10#1)(1994-11#20)(1994-12#24)(1994-2#30)(1994-3#37)(1994-5#17)(1994-6#23)(1994-7#6)(1994-8#30)(1994-9#33)(1995-1#8)(1995-11#20)(1995-12#48)(1995-2#27)(1995-3#31)(1995-4#5)(1995-5#24)(1995-6#35)(1995-8#14)(1995-9#14)(1996-1#10)(1996-11#9)(1996-12#25)(1996-2#28)(1996-3#14)(1996-4#6)(1996-5#36)(1996-6#20)(1996-7#9)(1996-8#1)(1996-9#21)(1997-1#6)(1997-2#29)(1997-3#24)(1997-4#38)(1997-5#5)(1997-6#31)(1997-7#12)(1997-8#10)(1997-9#3)(2006-10#10)(2006-12#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#43)(2007-11#47)(2007-12#89)(2007-2#22)(2007-3#1)(2007-4#2)(2007-5#11)(2007-6#7)(2007-7#41)(2007-8#91)(2007-9#8)(2008-1#65)(2008-10#798)(2008-11#264)(2008-12#103)(2008-2#81)(2008-3#156)(2008-4#67)(2008-5#197)(2008-6#74)(2008-7#254)(2008-8#96)(2008-9#131)(2009-1#10)(2009-10#29)(2009-11#18)(2009-12#27)(2009-2#12)(2009-3#29)(2009-4#17)(2009-5#20)(2009-6#12)(2009-7#20)(2009-8#53)(2009-9#16)(2010-1#19)(2010-10#20)(2010-11#24)(2010-12#23)(2010-2#18)(2010-3#32)(2010-4#32)(2010-5#30)(2010-6#10)(2010-7#19)(2010-8#54)(2010-9#20)(2011-1#90)(2011-10#2)(2011-2#283)(2011-3#6)(2011-7#1)(2012-1#28)(2012-12#94)(2012-2#148)(2012-3#103)(2012-4#1)(2012-5#7)(2012-6#2)(2012-7#1)(2012-8#2)(2013-1#263)(2013-7#28)(2013-8#120)
duringthe##3##1##(2008-2#1)(2009-8#1)(2013-8#1)
duroplasty##2##1##(2013-8#2)
durum cv##2##2##(2008-10#2)
durum wheat (T##2##3##(2008-10#1)(2012-3#1)
durum wheat in##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
durum wheat##27##2##(1991-12#1)(2008-10#21)(2008-8#1)(2012-3#1)(2013-8#3)
durum##41##1##(1991-12#1)(2008-10#33)(2008-12#2)(2008-8#1)(2012-3#1)(2013-8#3)
durum)##2##1##(2008-10#1)(2012-3#1)
dust aerosol##2##2##(2013-8#2)
dust and rock samples##2##4##(2008-10#2)
dust and##10##2##(1990-3#1)(1996-11#1)(2008-10#3)(2010-5#5)
dust control devices##4##3##(2009-12#4)
dust emissions##2##2##(2008-11#2)
dust exposure##5##2##(2007-6#1)(2008-10#3)(2009-12#1)
dust identification##2##2##(2013-8#2)
dust mite##6##2##(2010-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
dust or##2##2##(2008-10#2)
dust samples##9##2##(1991-12#2)(2008-10#5)(2010-5#2)
dust that##3##2##(1995-11#1)(2008-10#2)
dust types##3##2##(2008-10#3)
dust was##3##2##(1990-6#1)(2008-10#1)(2008-2#1)
dust##93##1##(1990-3#1)(1990-6#1)(1991-12#4)(1991-4#1)(1992-12#1)(1994-9#1)(1995-11#3)(1995-6#1)(1995-8#1)(1996-11#1)(1997-5#2)(2007-6#1)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2009-12#5)(2010-5#10)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#8)
dust)##3##1##(2008-10#2)(2008-3#1)
dusts##13##1##(1991-12#3)(1992-10#1)(1997-4#1)(2008-10#5)(2008-11#2)(2011-2#1)
dutch##2##1##(2008-6#1)(2011-1#1)
duties and obligations##2##3##(2008-6#2)
duties of the##2##3##(1992-6#1)(1993-3#1)
duties of##5##2##(1991-12#1)(1992-3#2)(1992-6#1)(1993-3#1)
duties##26##1##(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-8#1)(2008-11#2)(2008-6#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#1)
duty cycle of##2##3##(2008-2#1)(2008-3#1)
duty cycle ratio##3##3##(2008-3#3)
duty cycle##20##2##(1992-3#1)(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#10)
duty of##3##2##(1995-6#1)(2007-12#1)(2013-8#1)
duty ratio##2##2##(2008-3#2)
duty to protect##2##3##(1991-12#1)(2008-11#1)
duty to##12##2##(1991-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1997-5#2)(2007-3#1)(2008-11#1)(2008-3#1)(2010-9#1)(2013-8#1)
duty##55##1##(1990-2#1)(1991-12#2)(1991-6#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#3)(1996-2#1)(1997-3#1)(1997-5#2)(2007-11#4)(2007-12#3)(2007-3#1)(2008-11#1)(2008-2#4)(2008-3#15)(2008-8#2)(2009-6#1)(2010-9#1)(2013-8#4)
dw Pb after 7 days##2##4##(2011-1#2)
dwarf disease##4##2##(2008-10#4)
dwarf luteovirus##2##2##(2008-10#2)
dwarf mistletoe on##2##3##(2008-10#2)
dwarf mistletoe##6##2##(2008-10#6)
dwarf rat##2##2##(1995-12#2)
dwarf rats##3##2##(1995-12#3)
dwarf virus in##3##3##(2008-10#3)
dwarf virus##36##2##(2008-10#31)(2008-5#1)(2008-8#4)
dwarf##78##1##(1995-12#6)(2008-10#60)(2008-5#1)(2008-8#4)(2008-9#5)(2010-8#1)(2013-1#1)
dwarfed##3##1##(1994-2#1)(2008-10#1)(2011-1#1)
dwarfing and##3##2##(2008-10#3)
dwarfing##6##1##(2008-10#4)(2009-8#2)
dwarfism##6##1##(1995-8#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-1#2)
dwell function##3##2##(2008-3#3)
dwell time##6##2##(1990-11#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-7#1)
dwell##12##1##(1990-11#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#3)(2009-11#1)(2009-2#1)(2009-7#1)(2013-1#1)
dwellers##5##1##(1994-3#1)(2008-8#1)(2010-10#1)(2012-1#1)(2013-1#1)
dwelling##7##1##(2008-1#1)(2008-12#3)(2010-7#1)(2011-2#1)(2013-1#1)
dwellings##4##1##(1995-6#3)(2011-1#1)
dyad and##2##2##(2009-9#1)(2010-4#1)
dyad##10##1##(1990-11#1)(1995-2#1)(2009-9#4)(2010-4#2)(2010-5#1)(2012-2#1)
dyadic coping##2##2##(2010-5#1)(2012-2#1)
dyadic##4##1##(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)
dyads##14##1##(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-4#4)(2010-5#3)(2012-12#1)
dye (Cy##2##2##(2008-10#2)
dye acridine orange##2##3##(1991-11#1)(2008-9#1)
dye affinity##2##2##(1997-2#2)
dye and a##2##3##(1996-5#1)(2008-10#1)
dye and the##2##3##(2008-10#1)(2008-4#1)
dye and##11##2##(1992-3#1)(1994-12#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
dye application##2##2##(2008-5#2)
dye as##2##2##(1991-5#1)(2009-8#1)
dye by a##2##3##(2008-10#1)(2008-9#1)
dye by##4##2##(2008-10#3)(2008-9#1)
dye can be##2##3##(1994-12#1)(2008-8#1)
dye concentration##10##2##(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#3)
dye concentrations##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
dye content##3##2##(2008-10#2)(2010-4#1)
dye exclusion assay##3##3##(1990-12#1)(2008-11#2)
dye exclusion test##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
dye exclusion##9##2##(1990-12#2)(1992-9#1)(1994-12#1)(2008-11#3)(2008-8#1)(2008-9#1)
dye films##5##2##(2008-3#5)
dye fluo-3##2##2##(1995-5#1)(2008-9#1)
dye for##2##2##(2008-10#1)(2008-5#1)
dye has been##2##3##(2008-10#2)
dye in a##2##3##(2007-12#2)
dye in the##2##3##(2008-10#2)
dye in##8##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
dye injection##2##2##(2007-12#1)(2011-2#1)
dye into the##2##3##(2008-10#2)
dye into##3##2##(2008-10#2)(2010-4#1)
dye is##11##2##(1991-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)
dye laser amplifier##5##3##(2008-2#5)
dye laser in##3##3##(2008-2#2)(2009-4#1)
dye laser is##2##3##(2008-2#2)
dye laser pulses##2##3##(2008-2#1)(2008-3#1)
dye laser pumped by##2##4##(2008-2#2)
dye laser with a##2##4##(1996-11#1)(2008-2#1)
dye laser with##3##3##(1996-11#1)(2008-2#2)
dye laser##38##2##(1996-11#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#21)(2008-3#8)(2009-4#1)
dye lasers##11##2##(2008-2#5)(2008-3#6)
dye loading##3##2##(2008-4#1)(2010-4#2)
dye materials##2##2##(2010-2#2)
dye molecules are##2##3##(2008-3#1)(2011-1#1)
dye molecules in##3##3##(1992-6#1)(2007-11#2)
dye molecules##15##2##(1991-5#1)(1992-6#1)(1994-12#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#2)(2009-2#1)(2010-4#2)(2011-1#1)
dye released##3##2##(1990-12#1)(2008-10#2)
dye solution##2##2##(2007-12#1)(2008-9#1)
dye solutions##3##2##(2008-2#2)(2008-3#1)
dye stability##3##2##(2008-2#2)(2008-5#1)
dye that##5##2##(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)
dye to##6##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)
dye transfer##2##2##(1990-7#1)(2008-8#1)
dye uptake##5##2##(2008-10#1)(2008-11#3)(2008-9#1)
dye was##7##2##(1994-12#1)(2007-12#1)(2008-10#4)(2008-2#1)
dye were##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
dye with##6##2##(1990-12#1)(1992-6#1)(2008-10#2)(2008-4#1)(2010-5#1)
dye##402##1##(1990-12#5)(1990-2#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-5#5)(1991-9#1)(1992-11#1)(1992-3#3)(1992-6#5)(1992-9#2)(1993-11#1)(1994-12#10)(1994-2#1)(1994-6#1)(1995-5#1)(1996-11#2)(1996-12#2)(1996-5#1)(1997-2#2)(1997-7#1)(2006-6#1)(2007-11#7)(2007-12#21)(2008-1#1)(2008-10#123)(2008-11#12)(2008-2#49)(2008-3#46)(2008-4#13)(2008-5#9)(2008-7#1)(2008-8#8)(2008-9#19)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-4#9)(2010-5#2)(2010-7#1)(2011-1#7)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
dye-attached##2##1##(2008-10#2)
dye-doped liquid-crystal##2##2##(2007-12#2)
dye-doped photopolymer##2##2##(2008-3#2)
dye-doped poly(methyl methacrylate)##3##3##(2008-2#3)
dye-doped polymer##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
dye-doped polymer-dispersed liquid-crystal##2##3##(2007-11#2)
dye-doped solgel silica##2##3##(2008-3#2)
dye-doped##26##1##(2007-11#3)(2007-12#7)(2008-10#1)(2008-2#6)(2008-3#6)(2009-2#1)(2011-1#2)
dye-exclusion test##2##2##(2008-11#2)
dye-exclusion##4##1##(2008-11#3)(2008-9#1)
dye-laser##3##1##(2007-11#1)(2008-2#2)
dye-leakage##2##1##(1990-2#2)
dye-loaded##3##1##(1992-11#1)(2008-10#1)(2009-2#1)
dye-polymer##2##1##(2008-3#2)
dye-sensitized##2##1##(2008-3#1)(2009-11#1)
dye/drug##2##1##(2012-3#2)
dyed different colors##2##3##(2008-2#1)(2008-3#1)
dyed##7##1##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#4)
dyeing their hair##2##3##(1993-9#2)
dyeing##10##1##(1993-9#3)(2008-5#3)(2011-1#4)
dyes and##16##2##(1990-6#4)(2008-10#7)(2008-11#1)(2008-9#3)(2011-1#1)
dyes are too##2##3##(2008-10#1)(2008-9#1)
dyes are##7##2##(2007-11#1)(2008-10#4)(2008-9#1)(2010-2#1)
dyes by##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
dyes can##2##2##(2008-9#1)(2009-2#1)
dyes from##3##2##(2008-10#2)(2008-5#1)
dyes have##4##2##(2008-10#3)(2008-9#1)
dyes in soft drinks##2##4##(2008-10#2)
dyes in the##2##3##(2008-10#1)(2013-7#1)
dyes in##23##2##(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2013-7#1)
dyes is##2##2##(2008-10#1)(2009-12#1)
dyes of the##2##3##(1994-12#1)(2008-9#1)
dyes of##3##2##(1994-12#1)(2008-9#2)
dyes showed##2##2##(2008-10#1)(2009-12#1)
dyes that##4##2##(2008-10#2)(2008-9#2)
dyes was##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
dyes were used##2##3##(1994-12#1)(2008-3#1)
dyes were##8##2##(1994-12#1)(2008-10#3)(2008-3#3)(2009-12#1)
dyes with##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
dyes##183##1##(1990-6#4)(1992-3#1)(1993-9#1)(1994-12#3)(1995-5#1)(2006-6#1)(2007-11#9)(2007-12#4)(2007-7#1)(2008-10#76)(2008-11#3)(2008-2#7)(2008-3#13)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#16)(2009-10#2)(2009-12#7)(2009-2#3)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
dyes)##3##1##(2008-10#1)(2008-7#1)(2008-9#1)
dyestuff##2##1##(2008-10#2)
dyestuffs##3##1##(2008-10#2)(2008-5#1)
dying cells##4##2##(1996-12#1)(2008-1#1)(2008-4#1)(2008-9#1)
dying in##6##2##(1990-6#1)(1992-2#1)(1992-5#1)(2010-10#2)(2012-3#1)
dying neurons##2##2##(1992-12#1)(2007-10#1)
dying of cancer##2##3##(1997-7#1)(2008-7#1)
dying of##5##2##(1991-12#1)(1997-7#3)(2008-7#1)
dying or##2##2##(1993-12#1)(2012-12#1)
dying person##2##2##(1993-6#1)(2010-10#1)
dying with dignity##2##3##(2012-12#2)
dying##69##1##(1990-10#8)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-1#4)(1994-9#1)(1996-1#1)(1996-12#1)(1997-6#1)(1997-7#3)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#5)(2010-8#3)(2011-2#4)(2012-12#4)(2012-3#1)(2013-1#1)
dynactin complex##3##2##(1995-2#3)
dynactin##5##1##(1995-2#4)(2010-5#1)
dynamic 4D CT##2##3##(2012-1#2)
dynamic analysis##4##2##(2008-10#2)(2013-1#2)
dynamic and complex##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
dynamic and static lung volumes##2##5##(1992-6#2)
dynamic and static measurements##2##4##(2012-2#2)
dynamic and static##7##3##(1992-6#2)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#2)
dynamic and##23##2##(1992-6#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-2#2)(2013-8#2)
dynamic balance##2##2##(1990-6#1)(2008-7#1)
dynamic behavior of##7##3##(2007-12#3)(2008-2#3)(2008-9#1)
dynamic behavior##9##2##(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
dynamic binding capacity##2##3##(2013-1#2)
dynamic cellular##2##2##(2011-1#2)
dynamic changes in the##4##4##(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
dynamic changes in##9##3##(1993-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-8#2)
dynamic changes of##3##3##(2008-11#2)(2008-8#1)
dynamic changes##15##2##(1993-11#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#2)
dynamic coating##4##2##(2008-10#4)
dynamic compliance##3##2##(2013-7#3)
dynamic concentration range##2##3##(2008-10#2)
dynamic concentration##3##2##(2008-10#3)
dynamic conditions##6##2##(1992-12#2)(2006-6#1)(2008-10#1)(2008-7#1)(2012-4#1)
dynamic considerations##2##2##(2010-8#2)
dynamic contrast enhanced magnetic resonance imaging##2##6##(2010-11#2)
dynamic contrast##4##2##(2008-7#1)(2010-11#2)(2013-8#1)
dynamic contrast-enhanced##6##2##(1997-8#1)(2010-12#2)(2013-1#1)(2013-8#2)
dynamic deformation##2##2##(2008-3#2)
dynamic disorder and molecular memory in##2##6##(2012-2#2)
dynamic disorder##4##2##(2012-2#4)
dynamic environments##2##2##(2008-3#2)
dynamic equilibrium##3##2##(1992-3#1)(2008-10#1)(2008-8#1)
dynamic event tree##2##3##(2009-10#2)
dynamic event##4##2##(2008-3#1)(2009-10#2)(2009-11#1)
dynamic events such as##2##4##(2008-3#1)(2011-1#1)
dynamic events##5##2##(2008-1#1)(2008-3#3)(2011-1#1)
dynamic expression##3##2##(2008-5#1)(2013-8#2)
dynamic extraction##4##2##(2008-10#4)
dynamic features##2##2##(2008-3#2)
dynamic focusing with a##2##4##(2008-3#2)
dynamic focusing##4##2##(2008-3#4)
dynamic fringe-projection##2##2##(2008-3#2)
dynamic game##3##2##(2008-8#1)(2008-9#2)
dynamic grating##4##2##(2007-11#1)(2007-12#2)(2008-11#1)
dynamic hip screw##2##3##(2007-8#1)(2013-1#1)
dynamic hologram##2##2##(2007-11#1)(2008-3#1)
dynamic imaging##2##2##(2008-3#1)(2009-5#1)
dynamic in nature##2##3##(1996-3#1)(2009-9#1)
dynamic in##4##2##(1996-3#1)(2008-1#1)(2009-7#1)(2009-9#1)
dynamic increase in##2##3##(2007-11#1)(2008-12#1)
dynamic instabilities##2##2##(2007-11#1)(2013-1#1)
dynamic instability##2##2##(2008-9#2)
dynamic interactions between##2##3##(2012-2#2)
dynamic interactions##4##2##(2008-4#1)(2012-2#3)
dynamic interference##2##2##(2008-3#2)
dynamic joint##2##2##(2012-1#2)
dynamic leaching##2##2##(2008-10#2)
dynamic light scattering (DLS)##2##4##(2008-10#1)(2008-2#1)
dynamic light scattering##15##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#7)(2008-8#1)(2009-9#1)(2013-7#1)
dynamic light##16##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#7)(2008-8#1)(2009-9#1)(2013-7#1)
dynamic light-scattering data##3##3##(2008-3#3)
dynamic light-scattering##9##2##(2008-3#9)
dynamic linear range##3##3##(2008-10#3)
dynamic lung compliance##2##3##(1991-9#1)(2013-7#1)
dynamic lung##3##2##(1991-9#1)(2012-2#1)(2013-7#1)
dynamic measurement of##2##3##(2008-3#2)
dynamic measurement##3##2##(2008-10#1)(2008-3#2)
dynamic measurements of##2##3##(1990-8#1)(2008-10#1)
dynamic measurements##6##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
dynamic measures of perceptions (p &lt##2##6##(2013-1#2)
dynamic measures##4##2##(2008-3#2)(2013-1#2)
dynamic mechanisms##2##2##(2007-12#1)(2008-9#1)
dynamic method##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
dynamic mode##3##2##(2008-10#3)
dynamic model for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
dynamic model of the##2##4##(2007-12#1)(2011-3#1)
dynamic model of##3##3##(2007-12#1)(2008-8#1)(2011-3#1)
dynamic model that##2##3##(2007-11#1)(2008-7#1)
dynamic model##12##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)
dynamic models to##2##3##(2008-8#1)(2011-2#1)
dynamic models##3##2##(1996-4#1)(2008-8#1)(2011-2#1)
dynamic modification of##2##3##(2008-4#1)(2012-3#1)
dynamic modification protocol##2##3##(2008-10#2)
dynamic modification##4##2##(2008-10#2)(2008-4#1)(2012-3#1)
dynamic motion##3##2##(2008-3#1)(2010-8#2)
dynamic nanodevices##2##2##(2009-12#2)
dynamic nature of##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2010-8#1)
dynamic nuclear polarization##2##3##(2007-9#1)(2011-1#1)
dynamic optical##3##2##(2008-2#1)(2008-3#2)
dynamic organisation of##2##3##(2009-7#2)
dynamic pH junction##4##3##(2008-10#4)
dynamic pH##5##2##(2008-10#5)
dynamic patterns##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
dynamic pelvic MRI##2##3##(2011-2#2)
dynamic phase##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
dynamic phenomena##2##2##(1995-3#1)(2008-2#1)
dynamic process associated with##2##4##(2008-3#1)(2009-8#1)
dynamic process of##2##3##(2008-10#1)(2013-1#1)
dynamic process##8##2##(1995-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
dynamic processes##4##2##(1995-3#1)(2008-10#1)(2008-3#2)
dynamic programming##6##2##(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-3#1)
dynamic properties of##7##3##(1995-6#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#2)
dynamic properties##10##2##(1993-8#1)(1995-6#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#2)
dynamic protein##2##2##(2008-10#1)(2008-7#1)
dynamic quencher in##2##3##(1997-2#1)(2008-10#1)
dynamic quenching of the##2##4##(1997-2#1)(2008-8#1)
dynamic quenching of##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
dynamic quenching##5##2##(1997-2#1)(2008-10#3)(2008-8#1)
dynamic range and a##2##4##(2007-11#1)(2007-12#1)
dynamic range and sensitivity##2##4##(2008-3#2)
dynamic range and the##3##4##(2008-10#1)(2008-3#2)
dynamic range and##13##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#5)(2008-9#1)(2011-1#1)
dynamic range between 0##2##4##(2008-10#2)
dynamic range between 10##2##4##(2008-10#2)
dynamic range between##6##3##(2008-10#6)
dynamic range for the##3##4##(2008-10#2)(2008-3#1)
dynamic range for##8##3##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)
dynamic range from 0##4##4##(2008-10#4)
dynamic range from##12##3##(2008-10#12)
dynamic range is##3##3##(2007-12#1)(2008-10#2)
dynamic range loss##2##3##(2008-3#2)
dynamic range of 0##2##4##(2008-10#2)
dynamic range of 2##2##4##(2008-10#2)
dynamic range of 5 orders of magnitude##2##7##(2008-3#1)(2010-5#1)
dynamic range of the##11##4##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2013-8#1)
dynamic range of##41##3##(2007-11#2)(2007-12#2)(2008-10#21)(2008-2#3)(2008-3#9)(2008-5#1)(2009-8#1)(2010-5#1)(2013-8#1)
dynamic range was##7##3##(2008-10#7)
dynamic range##148##2##(1997-2#1)(2007-11#9)(2007-12#8)(2008-10#74)(2008-2#9)(2008-3#33)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#2)(2009-8#1)(2010-5#1)(2011-1#3)(2012-2#1)(2013-8#2)
dynamic ranges are##2##3##(2008-10#2)
dynamic ranges were##2##3##(2008-10#2)
dynamic ranges##13##2##(2008-10#13)
dynamic regulation of##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
dynamic response##4##2##(2008-10#3)(2010-7#1)
dynamic responses##2##2##(2008-10#1)(2011-1#1)
dynamic rupture##2##2##(1996-4#2)
dynamic signal##3##2##(2008-10#1)(2011-3#1)(2012-2#1)
dynamic simulation##4##2##(1992-4#1)(2008-11#1)(2008-3#1)(2008-6#1)
dynamic skin##2##2##(2008-6#2)
dynamic stabilization of##2##3##(1994-8#2)
dynamic stage migration with##2##4##(2011-2#2)
dynamic storage##2##2##(2008-3#2)
dynamic strain measurements##2##3##(2007-12#1)(2008-3#1)
dynamic strain sensitivity of##2##4##(2007-12#1)(2008-3#1)
dynamic strain##4##2##(2007-12#2)(2008-3#2)
dynamic subtraction##2##2##(2008-3#2)
dynamic surface tension detector (DSTD)##3##5##(2008-10#3)
dynamic surface tension detector##4##4##(2008-10#4)
dynamic surface tension##10##3##(2008-10#10)
dynamic system##2##2##(2008-10#1)(2008-11#1)
dynamic systems##2##2##(1991-12#1)(2012-2#1)
dynamic vertebral segment##2##3##(2011-2#2)
dynamic working range of##2##4##(2008-10#1)(2008-3#1)
dynamic working range##3##3##(2008-10#2)(2008-3#1)
dynamic##790##1##(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#5)(1992-3#3)(1992-4#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#4)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#4)(1996-6#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#35)(2007-12#26)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#197)(2008-11#26)(2008-12#5)(2008-2#25)(2008-3#123)(2008-4#4)(2008-5#15)(2008-6#9)(2008-7#20)(2008-8#18)(2008-9#23)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#4)(2010-10#4)(2010-11#4)(2010-12#6)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#12)(2011-2#19)(2011-3#3)(2011-9#1)(2012-1#5)(2012-12#3)(2012-2#30)(2012-3#4)(2012-4#1)(2013-1#18)(2013-7#11)(2013-8#18)
dynamic-programming##2##1##(2008-8#1)(2009-3#1)
dynamical behavior##2##2##(1994-8#2)
dynamical structure of##3##3##(1990-2#1)(1990-5#1)(2008-11#1)
dynamical structure##4##2##(1990-2#1)(1990-5#2)(2008-11#1)
dynamical system##2##2##(2010-10#2)
dynamical systems##7##2##(2007-12#1)(2008-1#1)(2008-7#1)(2009-8#3)(2010-10#1)
dynamical##36##1##(1990-2#1)(1990-5#3)(1994-8#3)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#7)(2010-10#4)(2010-7#1)(2010-8#2)(2010-9#1)(2012-2#1)
dynamically changing##2##2##(2008-10#1)(2012-3#1)
dynamically to##2##2##(1990-8#1)(2010-11#1)
dynamically unstable##3##2##(1992-5#1)(1996-4#1)(2008-8#1)
dynamically updated##2##2##(2008-6#2)
dynamically##51##1##(1990-8#1)(1992-5#1)(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#2)(1996-4#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
dynamics (MD)##4##2##(1992-9#1)(1993-11#1)(2008-10#2)
dynamics and function##4##3##(2008-10#1)(2008-4#2)(2013-8#1)
dynamics and patterns of##2##4##(2008-10#2)
dynamics and regulation of biological populations##2##6##(2008-8#2)
dynamics and the##8##3##(1991-9#1)(2008-1#1)(2008-2#1)(2008-8#2)(2010-11#1)(2012-2#1)(2012-3#1)
dynamics and their##2##3##(2009-11#1)(2013-8#1)
dynamics and##62##2##(1991-9#2)(1993-11#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#10)(2008-9#1)(2009-10#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#3)
dynamics appear to##2##3##(1994-9#1)(2008-8#1)
dynamics are controlled##2##3##(2008-3#1)(2008-7#1)
dynamics are##13##2##(1990-8#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2012-3#1)
dynamics as a##2##3##(2009-8#1)(2010-3#1)
dynamics as the##3##3##(2008-11#1)(2008-8#1)(2011-3#1)
dynamics as##6##2##(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-3#1)
dynamics at##3##2##(1990-8#1)(2007-12#1)(2013-8#1)
dynamics between##4##2##(2007-11#1)(2008-10#1)(2009-5#1)(2013-8#1)
dynamics by##7##2##(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)
dynamics can be##2##3##(2013-1#1)(2013-8#1)
dynamics can##4##2##(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
dynamics due to##2##3##(2008-9#1)(2011-1#1)
dynamics during##5##2##(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#2)
dynamics for##4##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)
dynamics found in##2##3##(2008-3#1)(2008-8#1)
dynamics found##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
dynamics in a recurrent neural network model##2##7##(2008-11#2)
dynamics in a##7##3##(2007-11#1)(2007-12#2)(2008-11#2)(2008-9#1)(2012-2#1)
dynamics in living##2##3##(2008-1#1)(2010-11#1)
dynamics in the##14##3##(1990-8#1)(1991-3#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-11#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-7#1)
dynamics in##66##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-8#2)(1995-5#1)(1996-12#1)(1996-2#2)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#5)(2008-11#8)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
dynamics is central to##2##4##(2009-5#1)(2011-2#1)
dynamics is##12##2##(1995-5#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
dynamics may##2##2##(2008-11#1)(2008-9#1)
dynamics of HIV-1 in Italy##2##5##(1992-9#2)
dynamics of HIV-1##3##3##(1992-9#3)
dynamics of a population##2##4##(2008-11#1)(2008-8#1)
dynamics of a##15##3##(1993-5#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2010-12#1)(2010-7#1)(2010-8#1)
dynamics of actin##3##3##(2007-12#1)(2008-9#1)(2012-2#1)
dynamics of an##4##3##(1992-3#1)(2007-12#2)(2008-5#1)
dynamics of bacterial##2##3##(2009-2#1)(2013-8#1)
dynamics of cortical##2##3##(1994-3#1)(2008-11#1)
dynamics of cytoplasmic##2##3##(2008-8#1)(2011-1#1)
dynamics of disease##3##3##(2008-10#2)(2008-9#1)
dynamics of each##3##3##(1995-5#1)(2008-10#2)
dynamics of electrons##2##3##(2007-12#1)(2012-2#1)
dynamics of evolution##2##3##(1997-6#1)(2008-8#1)
dynamics of gene##3##3##(2008-7#1)(2008-8#1)(2010-9#1)
dynamics of hTGF alpha##2##4##(1995-2#2)
dynamics of live##3##3##(2008-3#2)(2008-5#1)
dynamics of measles##2##3##(1995-5#2)
dynamics of plant##4##3##(2008-10#3)(2008-9#1)
dynamics of reproductive rate##2##4##(2012-12#2)
dynamics of the disease##2##4##(2008-10#2)
dynamics of the inoculum##2##4##(2008-10#2)
dynamics of the observed HIV-positive population size##2##7##(2008-1#2)
dynamics of the pathogen##2##4##(2008-10#2)
dynamics of the population##2##4##(2008-1#1)(2008-8#1)
dynamics of the##72##3##(1990-8#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1995-5#2)(2007-11#4)(2007-12#4)(2008-1#4)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-8#7)(2008-9#3)(2009-11#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-3#1)
dynamics of these##4##3##(1995-2#1)(1996-7#1)(2007-8#1)(2008-3#1)
dynamics of two##4##3##(2008-5#1)(2008-8#3)
dynamics of virus##2##3##(1994-8#1)(2008-10#1)
dynamics of word processing##3##4##(2008-11#3)
dynamics of##310##2##(1990-8#2)(1991-5#2)(1991-8#1)(1992-3#2)(1992-6#2)(1992-9#5)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#1)(1995-9#2)(1996-1#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#2)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#18)(2007-8#2)(2008-1#6)(2008-10#63)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#9)(2008-7#2)(2008-8#33)(2008-9#15)(2009-11#2)(2009-2#2)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#8)
dynamics on the##3##3##(2007-12#1)(2009-8#1)(2012-2#1)
dynamics on##6##2##(1995-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
dynamics or##3##2##(2008-4#1)(2008-9#2)
dynamics related to##2##3##(2007-9#1)(2013-7#1)
dynamics simulations and##2##3##(2008-3#1)(2009-9#1)
dynamics simulations of##12##3##(1992-6#1)(1993-11#2)(1993-5#1)(1995-3#1)(1995-5#2)(2012-2#1)(2013-1#4)
dynamics simulations##29##2##(1992-11#1)(1992-6#2)(1993-11#7)(1993-5#1)(1995-3#2)(1995-5#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-9#2)(2012-2#1)(2013-1#5)(2013-8#1)
dynamics study##2##2##(2012-2#1)(2013-8#1)
dynamics that are##2##3##(1991-3#1)(2008-3#1)
dynamics that##5##2##(1991-3#1)(1993-1#2)(2007-12#1)(2008-3#1)
dynamics through##2##2##(2008-10#1)(2011-2#1)
dynamics to##5##2##(1995-5#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-12#1)
dynamics was examined##2##3##(1993-1#1)(2009-6#1)
dynamics was##4##2##(1993-1#1)(2009-6#2)(2011-2#1)
dynamics were##6##2##(2008-10#4)(2008-11#1)(2008-9#1)
dynamics when##2##2##(2008-9#1)(2013-8#1)
dynamics with##12##2##(2007-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
dynamics within##2##2##(1993-12#1)(2008-8#1)
dynamics##837##1##(1990-12#1)(1990-2#1)(1990-8#7)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#3)(1991-9#4)(1992-11#2)(1992-3#3)(1992-6#6)(1992-8#4)(1992-9#6)(1993-1#3)(1993-11#12)(1993-12#4)(1993-2#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#4)(1995-5#11)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(2007-1#1)(2007-10#1)(2007-11#22)(2007-12#36)(2007-5#2)(2007-8#5)(2007-9#1)(2008-1#12)(2008-10#100)(2008-11#49)(2008-12#6)(2008-2#8)(2008-3#30)(2008-4#15)(2008-5#13)(2008-6#2)(2008-7#13)(2008-8#107)(2008-9#53)(2009-10#4)(2009-11#8)(2009-2#4)(2009-4#1)(2009-5#13)(2009-6#11)(2009-7#2)(2009-8#15)(2009-9#9)(2010-10#3)(2010-11#8)(2010-12#4)(2010-2#4)(2010-3#6)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#9)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#29)(2012-3#13)(2013-1#17)(2013-7#4)(2013-8#34)
dynamics?##2##1##(2008-8#1)(2013-8#1)
dynamin 1##3##2##(2013-8#3)
dynamized medicines##6##2##(2008-10#6)
dynamized##10##1##(2008-10#10)
dynamometer recordings##2##2##(2011-1#2)
dynamometer##7##1##(2007-11#1)(2008-12#2)(2009-3#1)(2011-1#3)
dynasties##2##1##(2013-8#2)
dyne/cm##2##1##(2008-10#2)
dyne/cm(2)##5##1##(2011-2#5)
dynein##7##1##(1991-2#1)(1995-2#1)(2010-5#1)(2012-2#4)
dynes##2##1##(2007-9#2)
dynode##2##1##(2008-2#2)
dynorphin A##2##2##(1991-1#2)
dynorphin A-(1-13) (0##2##3##(1995-12#2)
dynorphin##6##1##(1991-1#3)(1995-12#2)(2008-7#1)
dynorphin-ir##2##1##(1996-5#2)
dynorphins##3##1##(1994-9#3)
dysarthria##9##1##(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#4)(2008-12#1)
dysautonomia##4##1##(2008-10#4)
dyscalculic##2##1##(2010-2#2)
dyschondroplastic cartilage##3##2##(1991-9#3)
dyschondroplastic growth plate##2##3##(1991-9#2)
dyschondroplastic growth##3##2##(1991-9#2)(1997-3#1)
dyschondroplastic##7##1##(1991-9#5)(1997-3#2)
dyscrasia##3##1##(1992-12#1)(2011-2#1)(2013-8#1)
dysesthesia##3##1##(1997-4#1)(2008-3#1)(2008-5#1)
dysfluencies##2##1##(2008-2#1)(2011-1#1)
dysfunction (ED) is##2##3##(2009-5#1)(2010-5#1)
dysfunction (ED)##4##2##(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
dysfunction -##2##2##(2012-1#1)(2013-1#1)
dysfunction after##6##2##(1996-8#1)(1997-2#1)(2006-10#1)(2007-8#1)(2013-1#2)
dysfunction and cell death in##2##5##(1995-5#1)(2012-12#1)
dysfunction and cell death##3##4##(1995-5#1)(2008-1#1)(2012-12#1)
dysfunction and##45##2##(1991-7#1)(1991-9#1)(1993-12#1)(1994-7#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#1)(2010-1#1)(2010-10#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
dysfunction and/or##2##2##(1996-9#1)(2011-2#1)
dysfunction are##5##2##(1990-6#2)(1995-11#1)(2008-1#1)(2008-12#1)
dysfunction as an important##2##4##(2008-1#1)(2008-5#1)
dysfunction as an##3##3##(2008-1#1)(2008-4#1)(2008-5#1)
dysfunction as assessed##2##3##(2009-11#1)(2012-2#1)
dysfunction as##8##2##(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-1#2)(2012-2#1)
dysfunction associated with##4##3##(1995-2#1)(1995-8#1)(2007-10#1)(2008-3#1)
dysfunction by##3##2##(1996-9#1)(2008-3#1)(2011-2#1)
dysfunction could be##2##3##(1997-4#1)(2012-2#1)
dysfunction due to##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
dysfunction during##4##2##(1991-8#1)(2007-8#1)(2008-1#1)(2008-12#1)
dysfunction following##3##2##(1991-6#1)(1992-12#1)(2010-6#1)
dysfunction had##2##2##(2008-12#1)(2012-3#1)
dysfunction in Parkinson's disease##3##4##(2008-7#2)(2013-1#1)
dysfunction in a##4##3##(1993-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
dysfunction in both##4##3##(1994-5#1)(2009-5#1)(2012-12#1)(2013-1#1)
dysfunction in diabetes##2##3##(2010-10#1)(2010-11#1)
dysfunction in patients with##3##4##(2009-10#1)(2009-5#1)(2010-7#1)
dysfunction in patients##4##3##(2009-10#1)(2009-5#1)(2010-7#1)(2011-2#1)
dysfunction in the##8##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-8#1)(2010-9#1)
dysfunction in##50##2##(1992-12#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#3)
dysfunction induced by##3##3##(1992-11#2)(2011-1#1)
dysfunction is a##3##3##(2010-5#1)(2011-2#1)(2012-2#1)
dysfunction is not##2##3##(2008-7#1)(2008-8#1)
dysfunction is the##3##3##(2008-1#2)(2013-1#1)
dysfunction is##14##2##(2007-10#1)(2008-1#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
dysfunction leading to##2##3##(2008-1#2)
dysfunction may##5##2##(1997-8#1)(2007-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
dysfunction observed in##2##3##(2008-1#1)(2008-11#1)
dysfunction of the##12##3##(1991-2#1)(1993-12#1)(1995-11#1)(2007-8#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-9#1)(2012-1#1)
dysfunction of##21##2##(1991-2#2)(1993-12#1)(1995-11#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
dysfunction or##2##2##(2008-3#2)
dysfunction plays a##3##3##(1991-7#1)(2008-11#1)(2012-3#1)
dysfunction plays##4##2##(1991-7#1)(2008-1#1)(2008-11#1)(2012-3#1)
dysfunction that##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)
dysfunction was associated with##2##4##(1991-8#1)(2009-10#1)
dysfunction was##6##2##(1991-8#1)(2007-10#1)(2008-7#2)(2009-10#1)(2011-1#1)
dysfunction which##2##2##(2008-11#1)(2011-2#1)
dysfunction will be##2##3##(2011-1#1)(2011-2#1)
dysfunction with and without##2##4##(2007-8#1)(2013-1#1)
dysfunction with##9##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
dysfunction##437##1##(1990-12#1)(1990-5#1)(1990-6#4)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#2)(1992-5#1)(1992-8#1)(1993-12#5)(1993-8#2)(1994-3#1)(1994-5#2)(1994-7#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-8#1)(2006-10#1)(2007-10#12)(2007-11#6)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#13)(2008-1#22)(2008-10#13)(2008-11#11)(2008-12#18)(2008-2#6)(2008-3#15)(2008-4#8)(2008-5#5)(2008-6#9)(2008-7#25)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#5)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#7)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#10)(2010-10#6)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#12)(2011-2#28)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#15)(2012-3#15)(2013-1#32)(2013-7#4)(2013-8#9)
dysfunction)##2##1##(1994-6#1)(2007-12#1)
dysfunction]##6##1##(1997-2#1)(1997-6#2)(2008-6#1)(2012-3#1)(2013-8#1)
dysfunctional behaviour##2##2##(1992-9#1)(2008-7#1)
dysfunctional postural and movement strategies##2##5##(2008-12#2)
dysfunctional uterine bleeding##4##3##(1994-12#1)(2008-10#1)(2009-5#1)(2010-3#1)
dysfunctional##25##1##(1990-12#2)(1991-12#1)(1992-9#1)(1993-1#1)(1994-12#2)(1994-9#1)(2008-10#3)(2008-12#2)(2008-6#2)(2008-7#2)(2009-5#1)(2009-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
dysfunctions can##2##2##(1993-2#1)(2009-10#1)
dysfunctions in##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
dysfunctions of##2##2##(2008-10#1)(2009-12#1)
dysfunctions##18##1##(1990-2#1)(1993-12#1)(1993-2#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-5#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
dysgalactiae##3##1##(1993-2#1)(1996-8#2)
dysgenesis##11##1##(1995-8#5)(2008-1#3)(2008-7#3)
dysgenic females##2##2##(1995-8#2)
dysgenic##3##1##(1995-8#3)
dysglycemia##2##1##(2009-11#2)
dysgraphia##2##1##(2009-2#1)(2011-1#1)
dyshormonogenesis##2##1##(2008-1#2)
dyskaryosis##2##1##(1990-6#1)(1994-2#1)
dyskeratosis##4##1##(2008-11#1)(2013-1#3)
dyskerin##2##1##(2008-11#2)
dyskinesia in##2##2##(2008-7#1)(2012-2#1)
dyskinesia##15##1##(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(2008-7#7)(2012-2#3)(2013-1#1)
dyskinesias and##2##2##(2008-7#1)(2010-12#1)
dyskinesias##6##1##(2008-7#5)(2010-12#1)
dyskinesis##3##1##(1997-3#3)
dyslexia and##4##2##(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)
dyslexia is##2##2##(1996-2#1)(2008-12#1)
dyslexia##29##1##(1996-2#2)(2008-11#4)(2008-12#11)(2010-2#2)(2011-1#1)(2012-1#4)(2012-2#4)(2013-8#1)
dyslexic##5##1##(2008-11#1)(2008-12#2)(2010-2#2)
dyslexics##3##1##(2008-11#2)(2008-12#1)
dyslipidaemia in##2##2##(2008-6#1)(2012-3#1)
dyslipidaemia##18##1##(2008-3#1)(2008-4#1)(2008-6#3)(2008-8#6)(2012-2#4)(2012-3#1)(2013-1#2)
dyslipidemia and##8##2##(2008-1#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-8#2)
dyslipidemia in##6##2##(2008-1#2)(2008-3#2)(2011-2#2)
dyslipidemia of##3##2##(2008-1#1)(2008-3#2)
dyslipidemia##37##1##(1996-11#1)(2008-1#8)(2008-3#11)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2013-1#3)(2013-8#2)
dyslipidemias and##2##2##(1995-12#1)(2008-11#1)
dyslipidemias##6##1##(1991-11#1)(1995-12#1)(2008-11#2)(2008-2#1)(2008-7#1)
dyslipidemic and##2##2##(2011-2#1)(2012-3#1)
dyslipidemic drugs on##2##3##(2010-2#2)
dyslipidemic drugs##4##2##(2010-2#4)
dyslipidemic##10##1##(2008-10#1)(2008-4#2)(2010-2#4)(2011-2#2)(2012-3#1)
dysmenorrhea and##2##2##(1994-3#2)
dysmenorrhea##6##1##(1991-2#1)(1994-12#1)(1994-3#3)(1994-9#1)
dysmenorrhoea##4##1##(1994-9#3)(2009-10#1)
dysmorphic features##5##2##(1990-9#1)(1991-3#1)(2008-1#1)(2008-8#1)(2013-1#1)
dysmorphic##9##1##(1990-9#1)(1991-3#1)(2008-1#2)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
dysmorphisms##3##1##(1990-6#1)(2010-4#1)(2012-2#1)
dysmorphogenesis##2##1##(1993-12#1)(1995-3#1)
dysmorphology##3##1##(2007-12#3)
dysmotility##2##1##(2008-9#1)(2013-8#1)
dysostoses##2##1##(2007-12#2)
dysostosis##4##1##(2007-12#3)(2010-3#1)
dyspepsia in##2##2##(1995-10#1)(2011-2#1)
dyspepsia##16##1##(1991-3#1)(1993-9#1)(1995-10#5)(1995-6#2)(1997-1#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-1#2)
dyspepsia)##2##1##(1995-6#1)(2012-12#1)
dyspeptic patients##2##2##(2008-12#1)(2013-8#1)
dyspeptic symptoms in SX patients##2##5##(2008-12#2)
dyspeptic symptoms in##3##3##(2008-12#3)
dyspeptic symptoms##4##2##(2008-12#3)(2013-1#1)
dyspeptic##7##1##(2008-12#4)(2013-1#2)(2013-8#1)
dysphagia and##9##2##(1990-12#1)(1996-6#1)(1997-8#1)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
dysphagia in##7##2##(1993-2#3)(1993-6#1)(2007-8#1)(2011-1#1)(2011-2#1)
dysphagia symptoms##2##2##(2011-2#2)
dysphagia##66##1##(1990-12#1)(1990-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#8)(1993-6#4)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#4)(2007-8#5)(2008-1#3)(2008-12#2)(2008-5#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#9)(2013-1#2)(2013-7#1)(2013-8#5)
dysphasia##4##1##(1991-6#1)(1996-6#1)(2008-1#1)(2008-7#1)
dysphonia##8##1##(2007-8#3)(2008-12#1)(2010-8#3)(2013-1#1)
dysphoria##2##1##(1991-1#1)(2008-7#1)
dysphoric over-responsiveness##2##2##(1994-2#2)
dysphoric##6##1##(1994-2#2)(2008-11#1)(2009-10#2)(2010-10#1)
dysplasia (BPD)##2##2##(2009-9#1)(2010-5#1)
dysplasia and carcinoma##2##3##(1993-8#2)
dysplasia and##8##2##(1993-8#2)(2007-11#2)(2008-11#1)(2012-2#1)(2013-1#2)
dysplasia are##2##2##(2008-7#1)(2008-9#1)
dysplasia associated with##2##3##(1993-8#1)(2008-9#1)
dysplasia in the##3##3##(1992-12#1)(2008-5#1)(2008-8#1)
dysplasia in##10##2##(1992-12#1)(1992-9#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-4#1)
dysplasia is a##4##3##(1997-1#1)(1997-3#1)(2008-8#1)(2013-1#1)
dysplasia is##7##2##(1997-1#1)(1997-3#1)(2008-8#1)(2011-1#2)(2013-1#2)
dysplasia of the hip (DDH)##3##5##(2007-11#1)(2007-8#1)(2013-8#1)
dysplasia of the hip##19##4##(2007-11#8)(2007-8#9)(2012-12#1)(2013-8#1)
dysplasia of the##24##3##(1990-2#1)(2007-11#8)(2007-8#9)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
dysplasia of##29##2##(1990-2#1)(2007-11#8)(2007-8#9)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#1)
dysplasia was##6##2##(1990-11#1)(2007-11#2)(2011-1#2)(2013-8#1)
dysplasia were##3##2##(2007-11#2)(2008-9#1)
dysplasia with##4##2##(2008-9#1)(2012-2#1)(2013-1#2)
dysplasia##132##1##(1990-11#2)(1990-2#1)(1990-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#7)(1994-2#1)(1994-7#1)(1996-3#3)(1996-8#1)(1997-1#2)(1997-3#5)(2006-10#3)(2007-11#18)(2007-12#3)(2007-8#11)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-4#3)(2009-9#1)(2010-12#2)(2010-3#3)(2010-5#2)(2011-1#11)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
dysplasia)##3##1##(1996-6#1)(2007-11#1)(2012-2#1)
dysplasia]##2##1##(1990-2#1)(1992-5#1)
dysplasias##3##1##(1992-8#1)(2007-8#1)(2010-3#1)
dysplastic hip##4##2##(2007-11#2)(2007-8#2)
dysplastic hips in##2##3##(2007-8#2)
dysplastic hips##6##2##(2007-11#2)(2007-8#3)(2011-2#1)
dysplastic lesions##6##2##(1993-8#5)(2013-1#1)
dysplastic##32##1##(1993-8#6)(1995-12#1)(2007-11#4)(2007-8#6)(2008-10#3)(2008-2#1)(2008-3#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
dyspnea and fever##2##3##(2008-1#1)(2012-12#1)
dyspnea and##12##2##(2008-1#3)(2008-10#1)(2008-11#1)(2009-1#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#2)
dyspnea on##2##2##(2008-10#2)
dyspnea##67##1##(1990-10#1)(1990-12#2)(1991-11#1)(1991-9#1)(1992-9#1)(1993-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#7)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-5#1)(2010-6#2)(2010-8#4)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#6)
dyspnoea and##4##2##(2009-4#1)(2011-2#2)(2013-7#1)
dyspnoea on exertion and##2##4##(1991-5#1)(2013-7#1)
dyspnoea on exertion##3##3##(1991-5#1)(2007-8#1)(2013-7#1)
dyspnoea on##4##2##(1991-5#1)(2007-8#1)(2013-7#1)(2013-8#1)
dyspnoea with##2##2##(2010-12#1)(2010-7#1)
dyspnoea##29##1##(1990-6#1)(1991-5#1)(1995-8#1)(2007-8#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-10#5)(2010-12#1)(2010-7#1)(2011-2#4)(2013-1#2)(2013-7#2)(2013-8#2)
dysprosium IIP particles and##2##4##(2008-10#2)
dysprosium IIP particles##3##3##(2008-10#3)
dysprosium##11##1##(1994-3#1)(2008-10#9)(2012-2#1)
dysraphism and##2##2##(2008-7#1)(2012-2#1)
dysraphism##3##1##(2008-7#1)(2012-2#1)(2013-1#1)
dysregulated in tumors##2##3##(2008-9#1)(2009-4#1)
dysregulated in##5##2##(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
dysregulated##14##1##(1992-12#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-1#1)
dysregulation and##2##2##(2010-3#1)(2010-5#1)
dysregulation of the##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
dysregulation of##11##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
dysregulation##25##1##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
dysthymia##2##1##(1994-2#1)(2013-8#1)
dysthymic disorder##4##2##(2011-2#4)
dysthymic##8##1##(2011-2#8)
dystocia##2##1##(1995-12#1)(1997-1#1)
dystonia (CD)##2##2##(2008-2#1)(2008-7#1)
dystonia and##2##2##(2008-7#1)(2011-2#1)
dystonia following electric injury##2##4##(2008-7#2)
dystonia in the##2##3##(2008-7#1)(2012-12#1)
dystonia in##4##2##(2008-7#2)(2012-12#2)
dystonia##35##1##(2008-2#2)(2008-7#24)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#4)
dystonias##2##1##(2008-2#1)(2008-9#1)
dystonic reactions##2##2##(2008-7#1)(2012-12#1)
dystonic##4##1##(2008-2#1)(2008-7#1)(2012-12#2)
dystrophic epidermolysis##4##2##(1995-10#1)(2012-3#3)
dystrophic lesions##2##2##(2012-1#2)
dystrophic muscles##2##2##(2012-2#2)
dystrophic neurites##2##2##(1992-12#1)(2009-11#1)
dystrophic##16##1##(1992-12#1)(1995-10#1)(2008-11#1)(2009-11#1)(2009-8#1)(2010-12#2)(2012-1#3)(2012-2#3)(2012-3#3)
dystrophies##10##1##(2008-7#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#3)
dystrophin in##2##2##(1991-12#1)(1997-3#1)
dystrophin is##2##2##(1991-12#1)(1993-3#1)
dystrophin##17##1##(1991-12#4)(1992-8#1)(1993-3#4)(1994-8#2)(1995-12#1)(1997-3#3)(2008-7#1)(2011-2#1)
dystrophinopathy##2##1##(1997-3#2)
dystrophy in##2##2##(2011-1#1)(2013-1#1)
dystrophy##43##1##(1990-7#2)(1991-3#1)(1992-2#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-6#1)(1996-8#1)(1997-3#3)(2006-10#2)(2008-10#1)(2008-4#1)(2008-7#7)(2008-8#2)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#5)
dysuria and hematuria##2##3##(2008-10#2)
dysuria and##4##2##(2008-10#4)
dysuria##9##1##(2007-7#1)(2008-10#7)(2008-7#1)
début de##2##2##(2013-1#2)
décrit##2##1##(2009-4#1)(2011-2#1)
décès##3##1##(2009-10#1)(2013-1#2)
e and g##2##3##(1993-11#2)
e antigen##3##2##(1995-2#2)(2013-1#1)
e is the##2##3##(2008-10#1)(2008-4#1)
e was##3##2##(1992-6#1)(2008-10#2)
e##1322##1##(1990-11#5)(1990-12#8)(1990-2#7)(1990-5#10)(1990-6#4)(1990-7#7)(1990-8#6)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#1)(1992-11#7)(1992-12#2)(1992-2#3)(1992-3#9)(1992-5#3)(1992-6#3)(1992-8#8)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#5)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#11)(1994-3#6)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-11#7)(1995-12#12)(1995-2#8)(1995-3#5)(1995-5#6)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#14)(1997-3#9)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#33)(2007-12#19)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#298)(2008-11#74)(2008-12#11)(2008-2#31)(2008-3#58)(2008-4#37)(2008-5#38)(2008-6#11)(2008-7#39)(2008-8#39)(2008-9#29)(2009-1#1)(2009-10#9)(2009-11#6)(2009-12#4)(2009-2#5)(2009-3#5)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#13)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#6)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#8)(2010-4#5)(2010-5#7)(2010-6#1)(2010-7#8)(2010-8#8)(2010-9#2)(2011-1#20)(2011-10#1)(2011-2#38)(2012-1#5)(2012-12#11)(2012-2#26)(2012-3#9)(2012-7#1)(2012-9#2)(2013-1#25)(2013-7#3)(2013-8#13)
e(r)##9##1##(2008-9#9)
e)##4##1##(2008-10#1)(2008-7#2)(2008-9#1)
e-HIM##2##1##(2007-12#2)
e-Health tools##3##2##(2013-1#3)
e-Health##4##1##(2013-1#4)
e-Pedigree##2##1##(2009-6#2)
e-learning##2##1##(2008-12#2)
e-mail listserver##2##2##(2008-7#2)
e-mail messages##2##2##(2012-3#2)
e-mail##14##1##(1996-2#1)(2007-11#1)(2008-11#1)(2008-7#3)(2012-12#1)(2012-3#7)
e-mails were##3##2##(2012-3#3)
e-mails##5##1##(2008-7#1)(2012-3#4)
e-portfolio##3##1##(2008-12#3)
e-prescribing##2##1##(2008-4#1)(2012-3#1)
e-tongue for the determination of##2##5##(2008-10#2)
e-training##2##1##(2008-11#2)
e14##2##1##(1996-6#1)(2013-1#1)
e37a##4##1##(2008-8#4)
eEF-2##4##1##(1992-8#4)
eFDPs##2##1##(2011-2#2)
eGFR measures##2##2##(2013-1#2)
eGFR##3##1##(2013-1#3)
eGfp content##2##2##(2008-11#2)
eGfp##4##1##(2008-11#4)
eHEART##2##1##(2008-7#2)
eIF-2 alpha-subunit phosphorylation##4##3##(1994-5#4)
eIF-2 alpha-subunit##7##2##(1994-5#7)
eIF-2 beta in##2##3##(1994-6#2)
eIF-2 beta##4##2##(1994-6#4)
eIF-2 kinase(s)##3##2##(1994-5#3)
eIF-2##28##1##(1991-12#9)(1994-5#13)(1994-6#6)
eIF-2B##4##1##(1991-12#4)
eIF-5A##4##1##(1994-3#2)(1997-1#2)
eIF2##2##1##(2012-2#2)
eIF2α##5##1##(2012-2#4)(2013-7#1)
eIF4E in##6##2##(1997-7#6)
eIF4E##9##1##(1997-7#8)(2010-8#1)
eLOX-3##3##1##(2008-3#3)
eNOS and##2##2##(1996-12#1)(2009-10#1)
eNOS##8##1##(1996-12#2)(2008-10#2)(2008-12#1)(2009-10#1)(2010-4#1)(2012-3#1)
ePTFE (p=0##2##2##(2007-7#2)
ePTFE graft##2##2##(2007-8#1)(2011-3#1)
ePTFE grafts##2##2##(2007-7#2)
ePTFE prosthesis##2##2##(2011-3#2)
ePTFE##17##1##(2007-10#1)(2007-7#12)(2007-8#1)(2011-3#3)
eQTL hotspot##2##2##(2012-3#2)
eQTL##3##1##(2012-3#3)
eSR and NRT##2##3##(2008-9#2)
eSR##4##1##(2008-9#4)
eSRT programmes##2##2##(2008-9#2)
eSRT##7##1##(2008-9#7)
eV and the##2##3##(1995-2#1)(1996-7#1)
eV and##4##2##(1995-2#1)(1996-7#3)
eV##30##1##(1995-2#1)(1996-7#7)(1996-9#1)(2007-11#6)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#3)(2010-4#4)
eV)##5##1##(2007-12#1)(2008-10#1)(2008-2#3)
e])##3##1##(2012-12#3)
each 'omic field##2##3##(2012-12#2)
each PC##2##2##(1994-2#1)(2008-3#1)
each State##4##2##(1992-2#1)(1992-3#1)(1996-1#1)(1996-3#1)
each [NaCl]##2##2##(1997-2#2)
each a##2##2##(1995-2#1)(2013-7#1)
each abdominal##2##2##(1994-2#1)(2011-2#1)
each additional##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
each aerosol component##3##3##(2008-3#3)
each affected##2##2##(1997-3#1)(2008-3#1)
each agent##2##2##(1995-2#1)(2007-11#1)
each allele##2##2##(2008-10#2)
each alpha polypeptide##2##3##(1994-5#2)
each amino acid##4##3##(1993-11#1)(1994-8#1)(1994-9#1)(2008-10#1)
each aminoacid##2##2##(1992-9#2)
each analyte was##2##3##(2008-10#2)
each analyte##6##2##(2008-10#6)
each and##2##2##(1997-8#1)(2008-10#1)
each animal##4##2##(1994-2#1)(1995-5#1)(2008-10#1)(2008-7#1)
each application##2##2##(2008-10#1)(2008-5#1)
each approach##9##2##(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
each aptamer##2##2##(2007-11#2)
each area##11##2##(1991-12#1)(1995-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
each array##2##2##(2007-12#1)(2008-2#1)
each article##3##2##(1994-12#1)(1995-1#1)(2012-12#1)
each assay##9##2##(1990-12#1)(1996-12#2)(2008-10#2)(2008-4#2)(2008-9#1)(2011-2#1)
each assessment##2##2##(2008-10#2)
each associated with##3##3##(1991-2#1)(2007-12#1)(2008-10#1)
each at a different##2##4##(1996-1#1)(2008-3#1)
each at##3##2##(1996-1#1)(2008-3#1)(2008-5#1)
each bacterium##2##2##(2008-10#1)(2008-8#1)
each basepair##2##2##(2008-7#2)
each batch##2##2##(2008-11#2)
each beta polypeptide##2##3##(1994-5#2)
each block##2##2##(2008-11#1)(2008-8#1)
each bundle##2##2##(2008-7#1)(2013-1#1)
each carrying##2##2##(1993-12#1)(1996-10#1)
each case are##2##3##(1994-3#1)(2012-2#1)
each case in the##2##4##(1996-5#1)(2008-5#1)
each case##42##2##(1990-12#1)(1990-7#1)(1990-8#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
each category##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
each cause##2##2##(2008-10#2)
each caused##2##2##(1994-11#1)(2013-1#1)
each cavity##2##2##(2008-2#1)(2008-3#1)
each cell division##2##3##(2006-10#1)(2008-11#1)
each cell line##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
each cell type##2##3##(1995-12#1)(1997-3#1)
each cell##15##2##(1995-12#2)(1997-3#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
each channel##4##2##(1995-3#1)(2008-2#1)(2008-3#2)
each characterized by a##2##4##(1996-4#1)(2009-9#1)
each chemical##5##2##(2008-10#4)(2008-8#1)
each child##4##2##(1991-2#1)(1992-11#1)(2008-11#1)(2008-9#1)
each chromosome##5##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
each class of##3##3##(2008-11#1)(2008-12#1)(2010-2#1)
each class##4##2##(2007-11#1)(2008-11#1)(2008-12#1)(2010-2#1)
each classification##2##2##(2011-2#2)
each client##3##2##(2007-6#1)(2010-8#1)(2012-3#1)
each clinical##4##2##(1992-3#1)(2010-8#2)(2013-8#1)
each cluster##5##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
each collection##3##2##(2008-10#3)
each color##2##2##(2008-3#2)
each company##2##2##(2008-10#1)(2010-8#1)
each comparison was set to p&lt##2##6##(2010-6#1)(2010-9#1)
each comparison##3##2##(1997-7#1)(2010-6#1)(2010-9#1)
each comparison)##3##2##(1994-12#2)(1994-3#1)
each compartment##3##2##(1992-10#1)(2008-12#1)(2010-11#1)
each complex##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
each component of the##2##4##(2008-7#1)(2013-8#1)
each component of##3##3##(2008-2#1)(2008-7#1)(2013-8#1)
each component##17##2##(1996-9#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#1)
each composed of##2##3##(1996-12#1)(2008-3#1)
each compound##15##2##(1993-12#1)(1995-3#1)(2008-10#12)(2008-2#1)
each comprised of##2##3##(1990-8#1)(2010-11#1)
each comprising##2##2##(2008-10#1)(2012-2#1)
each condition##2##2##(2008-10#1)(2012-12#1)
each congener##2##2##(2008-10#2)
each consisting of##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-1#1)
each construct##2##2##(1995-8#1)(2008-10#1)
each contact##2##2##(1994-6#2)
each contain a##2##3##(1993-12#1)(1996-5#1)
each contain##3##2##(1993-12#1)(1995-2#1)(1996-5#1)
each contained##3##2##(2008-10#2)(2008-4#1)
each container##3##2##(2008-5#3)
each containing a marker(s) specifically mapped on chromosome 5##2##9##(1997-6#1)(1997-8#1)
each containing a single##2##4##(2008-10#2)
each containing a##6##3##(1997-6#1)(1997-8#1)(2008-10#4)
each containing##12##2##(1994-12#1)(1995-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-8#1)
each country is##2##3##(1994-1#1)(1995-1#1)
each country##7##2##(1994-1#1)(1995-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
each cross##3##2##(2008-10#3)
each cultivar##9##2##(2008-10#6)(2008-12#1)(2011-10#1)(2011-2#1)
each cycle##7##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#2)
each damage##2##2##(2009-7#1)(2011-2#1)
each data##2##2##(2007-12#1)(2008-2#1)
each day for##5##3##(1990-2#1)(1993-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
each day##19##2##(1990-2#4)(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#3)(2012-2#1)(2013-1#1)(2013-8#1)
each department##3##2##(1992-8#1)(1994-3#1)(1996-1#1)
each detector##2##2##(2008-2#2)
each device##2##2##(2010-8#1)(2011-2#1)
each dialysis session##4##3##(2007-7#1)(2008-1#3)
each different##2##2##(2008-10#2)
each dimension of##2##3##(1995-2#1)(2008-12#1)
each dimension was##2##3##(2011-2#2)
each dimension##6##2##(1995-2#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#2)
each disease##2##2##(2008-10#2)
each displayed##2##2##(1994-6#1)(2008-9#1)
each domain of##3##3##(1993-12#1)(1994-6#1)(2008-7#1)
each domain##8##2##(1991-12#1)(1993-12#3)(1994-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
each dose##2##2##(1993-12#1)(2012-3#1)
each drug##10##2##(1991-5#1)(1993-8#2)(1996-12#1)(2008-10#4)(2008-11#1)(2008-6#1)
each electrode##3##2##(2007-9#2)(2008-10#1)
each element##11##2##(2008-10#9)(2008-2#1)(2013-8#1)
each enantiomer##3##2##(2008-10#2)(2008-11#1)
each encoding a cytosolic##2##4##(1993-8#1)(2009-10#1)
each end of the##2##4##(1996-4#1)(2010-10#1)
each end##4##2##(1996-4#1)(2008-10#1)(2008-4#1)(2010-10#1)
each enzyme##6##2##(1991-2#1)(2008-10#4)(2008-4#1)
each essential oil##2##3##(2010-3#2)
each event##6##2##(1992-8#1)(1994-12#1)(2008-1#1)(2008-10#1)(2011-2#2)
each exercise##2##2##(2008-5#1)(2013-1#1)
each experiment##16##2##(1993-9#1)(1994-3#2)(2008-10#11)(2008-11#1)(2011-1#1)
each experimental##2##2##(2008-10#1)(2008-12#1)
each extract##3##2##(2008-10#2)(2008-5#1)
each factor was##2##3##(1997-4#1)(2011-1#1)
each factor##7##2##(1995-2#1)(1997-4#1)(2008-11#1)(2008-5#2)(2011-1#1)(2013-1#1)
each family##5##2##(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)
each fed##2##2##(2012-2#2)
each field##10##2##(2008-10#8)(2008-2#1)(2009-12#1)
each filter##2##2##(2008-10#1)(2008-3#1)
each food group##3##3##(2008-1#1)(2011-2#2)
each food##4##2##(2008-1#1)(2008-5#1)(2011-2#2)
each for testing##2##3##(2008-10#1)(2008-7#1)
each for##4##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
each form of##2##3##(1993-11#1)(1997-2#1)
each fraction of##2##3##(2008-5#1)(2008-6#1)
each fraction##7##2##(1991-12#1)(2008-10#4)(2008-5#1)(2008-6#1)
each frame is##2##3##(2008-6#1)(2011-1#1)
each frame##4##2##(2008-3#1)(2008-6#1)(2011-1#2)
each from##13##2##(1994-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2012-2#1)
each fungal species##2##3##(2008-10#2)
each fungal##3##2##(2008-10#3)
each gas##2##2##(1996-12#1)(2008-3#1)
each gene and##2##3##(2009-6#1)(2012-3#1)
each gene##10##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-9#1)(2012-3#1)
each generation##5##2##(2008-10#3)(2008-11#1)(2009-12#1)
each genotype##5##2##(1995-5#1)(2008-10#2)(2008-5#1)(2011-1#1)
each geographic##2##2##(2008-10#1)(2008-8#1)
each geometry##2##2##(2008-2#1)(2011-2#1)
each glucose tolerance group##2##4##(2011-2#2)
each glucose tolerance##3##3##(2011-2#2)(2012-7#1)
each group and##4##3##(1991-12#1)(1995-12#1)(2008-10#2)
each group of##4##3##(1994-7#1)(1995-5#1)(2008-5#1)(2009-7#1)
each group was##3##3##(2008-12#1)(2008-6#1)(2011-2#1)
each group were##9##3##(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
each group##74##2##(1991-12#3)(1991-8#2)(1992-3#1)(1992-5#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-1#1)(1997-1#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
each group)##4##2##(1994-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
each had##4##2##(1993-3#1)(1995-12#1)(2008-1#1)(2008-10#1)
each has##2##2##(2008-10#1)(2008-7#1)
each have##2##2##(2008-11#1)(2012-12#1)
each having a##3##3##(1995-2#1)(1995-6#1)(2008-2#1)
each having##6##2##(1995-2#1)(1995-6#1)(1997-7#1)(2008-2#1)(2008-4#1)(2013-1#1)
each hemisphere##2##2##(2007-12#1)(2008-11#1)
each hospital##2##2##(1993-12#1)(1995-2#1)
each host were##3##3##(2008-10#2)(2012-2#1)
each host##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
each hybrid##2##2##(2008-10#1)(2008-9#1)
each image##2##2##(2008-2#1)(2010-8#1)
each implement##2##2##(2008-10#1)(2008-12#1)
each in##4##2##(1994-5#1)(2008-10#2)(2011-2#1)
each individual case##3##3##(1990-3#1)(2008-10#1)(2010-8#1)
each individual patient##4##3##(1990-9#1)(2008-1#1)(2010-8#1)(2012-12#1)
each individual##43##2##(1990-3#1)(1990-5#1)(1990-9#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-12#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#2)(2011-1#3)(2012-12#2)(2013-7#1)(2013-8#2)
each individual's##3##2##(2007-12#1)(2010-4#1)(2012-3#1)
each injection of##2##3##(1997-2#1)(1997-7#1)
each inoculated##3##2##(2008-10#3)
each inoculation##4##2##(2008-10#4)
each inoculum##2##2##(2008-10#2)
each input channel to##2##4##(2008-3#2)
each input##6##2##(1991-5#1)(2008-2#1)(2008-3#4)
each interval##3##2##(1997-7#1)(2007-6#1)(2013-8#1)
each inversion##2##2##(2008-10#1)(2013-1#1)
each ion##3##2##(2008-10#3)
each is##4##2##(1990-8#1)(1995-11#1)(2008-3#1)(2010-5#1)
each isoform##3##2##(1992-9#1)(1995-11#1)(2008-11#1)
each isolate in##3##3##(2008-10#3)
each isolate##14##2##(2008-10#12)(2008-12#1)(2011-2#1)
each item##5##2##(1990-11#1)(1996-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
each iteration##3##2##(2007-11#1)(2007-9#1)(2008-3#1)
each key##2##2##(1993-2#1)(2012-12#1)
each laboratory##3##2##(2007-7#1)(2008-10#2)
each laser##4##2##(2007-12#1)(2008-2#3)
each layer is##3##3##(2008-3#2)(2013-8#1)
each layer##13##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#8)(2009-4#1)(2013-8#1)
each leaf##2##2##(2008-10#1)(2013-7#1)
each lens##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
each lesion##2##2##(2008-10#2)
each level of##3##3##(1996-3#1)(2008-1#1)(2008-11#1)
each level##8##2##(1992-6#1)(1994-12#2)(1996-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-8#1)
each library##4##2##(1992-1#1)(1997-4#1)(1997-6#1)(2008-9#1)
each ligand##2##2##(1992-3#1)(1996-2#1)
each lipid molecule##2##3##(1990-7#1)(1992-9#1)
each locality##3##2##(2008-11#1)(2011-1#1)(2013-7#1)
each location##7##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)
each locus##4##2##(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
each mRNA##2##2##(1994-6#1)(2008-9#1)
each male##3##2##(2008-8#3)
each marker##3##2##(2008-5#1)(2008-8#1)(2012-2#1)
each mating##2##2##(2008-10#1)(2013-1#1)
each may##2##2##(1994-2#1)(2008-10#1)
each measured##2##2##(2007-10#1)(2008-10#1)
each measurement##11##2##(2008-10#8)(2008-3#1)(2013-1#2)
each mechanism##2##2##(2008-10#1)(2008-8#1)
each medical##2##2##(1991-12#1)(1991-6#1)
each member of the##3##4##(1993-6#1)(2007-12#1)(2008-7#1)
each member##4##2##(1993-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
each menstrual cycle##3##3##(1994-9#1)(2008-2#1)(2012-3#1)
each metal in##2##3##(2008-10#2)
each metal ion##4##3##(2008-10#4)
each metal was##2##3##(2008-10#2)
each metal##12##2##(2008-10#11)(2008-5#1)
each method are discussed##2##4##(2008-4#2)
each method are##4##3##(2008-11#1)(2008-3#1)(2008-4#2)
each method were##2##3##(1992-11#1)(2008-10#1)
each method##16##2##(1992-11#1)(1992-12#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2011-2#1)(2012-3#1)(2013-7#1)
each miRNA can##2##3##(2008-11#1)(2011-2#1)
each microlens##2##2##(2008-2#1)(2008-3#1)
each microplot##2##2##(2008-10#2)
each mirror##3##2##(2007-11#1)(2008-3#2)
each modality##2##2##(1991-2#1)(2009-11#1)
each mode##2##2##(2008-3#1)(2011-1#1)
each model##8##2##(1992-3#1)(2008-10#4)(2008-4#1)(2011-2#1)(2013-1#1)
each modifier##2##2##(1993-11#1)(2008-10#1)
each molt##2##2##(2007-12#2)
each month from##2##3##(2008-10#2)
each month##10##2##(1990-9#1)(1992-5#1)(2008-10#6)(2010-6#1)(2011-1#1)
each morning##2##2##(1996-5#1)(2010-8#1)
each motif##2##2##(2008-7#1)(2008-9#1)
each muscle##2##2##(2007-12#1)(2010-9#1)
each mutant##12##2##(1990-5#1)(1992-6#3)(1994-5#2)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#2)(2008-4#1)
each mutation##2##2##(1991-6#1)(1997-4#1)
each nanodot##2##2##(2008-7#1)(2012-2#1)
each network's##2##2##(2010-10#2)
each neuron##3##2##(2008-11#1)(2009-10#1)(2010-11#1)
each nucleotide residue of double-stranded DNA##2##6##(2008-10#2)
each nucleotide residue##3##3##(2008-10#3)
each object##2##2##(2007-12#2)
each occasion##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
each of 10##2##3##(1996-3#1)(2008-10#1)
each of 2 years##3##4##(2008-10#3)
each of 3 years##3##4##(2008-10#3)
each of 4##2##3##(1992-6#2)
each of N##4##3##(2007-12#1)(2008-10#3)
each of five##2##3##(1993-1#1)(2008-10#1)
each of four##10##3##(1990-7#1)(1992-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2013-7#1)
each of its##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
each of seven##3##3##(1995-3#1)(2008-5#1)(2010-3#1)
each of several##3##3##(1994-9#1)(1996-3#1)(2008-10#1)
each of the 1##2##4##(1996-5#1)(2008-9#1)
each of the 12##3##4##(2008-10#2)(2008-5#1)
each of the 16##2##4##(2008-11#1)(2010-2#1)
each of the 3##2##4##(1991-5#1)(1997-4#1)
each of the clinical##3##4##(1992-1#1)(1995-12#1)(2012-12#1)
each of the components of##2##5##(1995-5#1)(2008-10#1)
each of the components##3##4##(1992-9#1)(1995-5#1)(2008-10#1)
each of the compounds##2##4##(1991-3#1)(2008-10#1)
each of the different##2##4##(1991-7#1)(2008-4#1)
each of the eight##5##4##(2007-11#1)(2008-10#2)(2008-7#1)(2009-5#1)
each of the five##2##4##(2008-10#2)
each of the following four##3##5##(1991-2#1)(1992-2#1)(2008-10#1)
each of the following##4##4##(1991-2#1)(1992-2#1)(2008-10#1)(2008-9#1)
each of the four##15##4##(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(2007-6#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
each of the individual##3##4##(1995-2#1)(1997-9#1)(2009-11#1)
each of the methods##3##4##(2008-10#2)(2008-5#1)
each of the new##2##4##(1991-12#1)(2008-10#1)
each of the other##3##4##(1995-3#1)(2008-10#1)(2012-12#1)
each of the proteins##2##4##(2008-4#1)(2008-7#1)
each of the species##3##4##(1996-5#1)(2008-10#2)
each of the three main##3##5##(2008-10#1)(2012-2#1)(2012-3#1)
each of the three##22##4##(1991-2#1)(1992-1#1)(1993-11#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
each of the two groups##2##5##(1995-12#1)(2008-10#1)
each of the two##13##4##(1992-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(2008-10#5)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
each of the##218##3##(1990-12#1)(1990-5#2)(1990-8#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-9#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#62)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#5)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
each of them##7##3##(1991-12#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-3#1)(2013-1#1)
each of these areas##2##4##(1992-3#1)(1997-2#1)
each of these categories##2##4##(2007-4#1)(2008-12#1)
each of these factors##2##4##(2008-11#1)(2011-2#1)
each of these genes##3##4##(1991-9#1)(2008-10#1)(2012-12#1)
each of these groups##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
each of these issues##2##4##(1995-2#1)(1996-3#1)
each of these models##2##4##(1994-3#1)(2013-1#1)
each of these pathways##3##4##(1995-12#1)(2007-11#1)(2008-4#1)
each of these processes##3##4##(2008-8#2)(2008-9#1)
each of these specific##2##4##(1994-2#1)(2008-11#1)
each of these syndromes##2##4##(2009-12#2)
each of these three##2##4##(1993-3#1)(1996-1#1)
each of these two##2##4##(2008-10#1)(2008-2#1)
each of these types of##2##5##(1991-1#1)(2008-7#1)
each of these##88##3##(1990-5#1)(1991-1#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#4)(2009-4#1)(2009-5#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
each of those##2##3##(1995-12#1)(2008-7#1)
each of three different##2##4##(2008-10#1)(2012-2#1)
each of three##19##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-8#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)
each of two##14##3##(1994-5#1)(1996-2#1)(1997-3#1)(2007-5#1)(2008-10#7)(2008-4#1)(2008-8#2)
each of which contains a##2##5##(1992-8#1)(2008-11#1)
each of which has##3##4##(1994-3#1)(1995-8#1)(2008-3#1)
each of which is##5##4##(1994-12#1)(1995-6#1)(2008-3#1)(2009-7#1)(2010-11#1)
each of which##21##3##(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
each of##454##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#3)(1991-1#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#5)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#4)(1996-5#5)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-9#1)(2006-11#1)(2007-11#6)(2007-12#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#126)(2008-11#14)(2008-12#6)(2008-2#6)(2008-3#16)(2008-4#7)(2008-5#13)(2008-6#3)(2008-7#15)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#3)(2009-12#5)(2009-2#2)(2009-4#2)(2009-5#5)(2009-7#6)(2010-10#1)(2010-11#2)(2010-2#3)(2010-3#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#3)
each oil##2##2##(2008-10#2)
each oligomer##2##2##(1990-7#1)(2008-10#1)
each on##2##2##(1993-2#1)(2008-2#1)
each one and##2##3##(2008-10#2)
each one of the##5##4##(1990-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
each one of##6##3##(1990-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-7#1)
each one##17##2##(1990-5#1)(1993-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
each orchard##4##2##(2008-10#4)
each organism##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
each other and also##3##4##(1993-3#1)(2008-10#2)
each other and##44##3##(1991-5#1)(1993-11#1)(1993-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
each other as well as with##2##6##(1993-8#1)(2008-10#1)
each other as##4##3##(1993-8#1)(1997-6#1)(2008-10#1)(2010-3#1)
each other but##4##3##(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
each other by##8##3##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-8#1)
each other for##6##3##(1992-8#1)(1995-6#1)(1997-7#1)(2008-3#2)(2008-4#1)
each other in the##6##4##(1996-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
each other in##21##3##(1990-11#1)(1990-12#1)(1992-12#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2009-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
each other is##2##3##(2009-10#1)(2013-1#1)
each other on the##2##4##(1997-1#1)(2008-7#1)
each other on##3##3##(1997-1#1)(2008-7#2)
each other or##2##3##(2008-11#1)(2008-6#1)
each other over##2##3##(2007-12#1)(2008-7#1)
each other than##5##3##(1993-6#1)(2008-10#3)(2008-8#1)
each other to##10##3##(1995-2#1)(1997-3#1)(2008-3#2)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
each other##260##2##(1990-11#1)(1990-12#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-12#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-6#1)(1994-9#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2006-10#2)(2006-6#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-10#56)(2008-11#13)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#7)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#7)
each other's##6##2##(1995-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)
each other?##2##2##(2008-8#1)(2011-2#1)
each others'##3##2##(2008-10#1)(2009-9#2)
each outbreak##3##2##(2008-8#2)(2009-3#1)
each parental species and##2##4##(2008-10#1)(2012-3#1)
each parental##4##2##(1997-7#1)(2008-10#1)(2008-4#1)(2012-3#1)
each part##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
each participant##7##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-4#1)(2013-1#1)
each particular case##2##3##(2008-11#1)(2011-2#1)
each particular##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
each party##2##2##(1996-2#2)
each passage##2##2##(2013-1#1)(2013-8#1)
each patch##2##2##(2008-3#1)(2008-9#1)
each pathogen##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
each patient and##3##3##(2008-10#1)(2009-6#1)(2011-3#1)
each patient will##2##3##(2011-2#1)(2013-8#1)
each patient##47##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#2)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
each patient's##6##2##(1991-2#1)(1992-9#1)(2008-6#1)(2010-4#1)(2012-3#1)(2013-1#1)
each peptide##5##2##(1993-6#1)(1996-12#1)(2008-8#2)(2008-9#1)
each person##2##2##(1994-12#1)(1996-5#1)
each perturbation##2##2##(2008-10#2)
each phase of the##3##4##(1991-2#1)(2007-8#1)(2012-12#1)
each phase of##4##3##(1991-2#1)(1991-3#1)(2007-8#1)(2012-12#1)
each phase##7##2##(1990-3#1)(1991-2#1)(1991-3#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
each pixel in the##2##4##(2008-2#1)(2008-3#1)
each pixel is##3##3##(2008-10#1)(2008-3#2)
each pixel##18##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#11)
each plant is##2##3##(2008-8#1)(2013-8#1)
each plant##7##2##(2008-10#2)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
each plot##9##2##(2008-10#8)(2008-6#1)
each point##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-2#1)(2013-7#1)
each polymeric##2##2##(2008-10#2)
each population was##2##3##(2008-10#1)(2010-8#1)
each population##10##2##(1994-9#2)(2008-10#5)(2009-8#1)(2010-8#1)(2012-2#1)
each position##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
each principal##2##2##(2008-1#1)(2008-10#1)
each probe was##2##3##(2008-10#2)
each probe##5##2##(2008-10#3)(2008-12#1)(2008-8#1)
each procedure##5##2##(1993-12#1)(1995-11#1)(2008-10#3)
each product##2##2##(2008-8#1)(2010-8#1)
each projection##3##2##(2011-1#1)(2012-1#2)
each protein was##2##3##(2008-10#1)(2008-8#1)
each protein##8##2##(1995-2#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
each psychiatric##2##2##(2012-1#2)
each pure##3##2##(2008-10#2)(2012-3#1)
each putative##2##2##(2008-10#2)
each quadrat##6##2##(2008-10#5)(2008-5#1)
each race##3##2##(2008-10#2)(2013-8#1)
each rat##3##2##(1991-12#1)(1997-2#1)(2008-11#1)
each ray##2##2##(2008-2#2)
each reagent##3##2##(2008-10#3)
each receptor subtype##2##3##(1994-6#1)(1995-11#1)
each receptor##3##2##(1994-6#1)(1995-11#1)(1997-2#1)
each recipient##2##2##(1996-2#1)(2011-3#1)
each record##2##2##(1996-3#1)(2010-8#1)
each reflected##2##2##(2007-11#1)(2008-3#1)
each region of##2##3##(1995-6#1)(2012-3#1)
each region to##2##3##(2008-10#2)
each region##11##2##(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
each representing##2##2##(2008-10#1)(2010-4#1)
each reproductive round##4##3##(1997-4#4)
each reproductive##5##2##(1997-4#4)(2008-5#1)
each research##2##2##(2008-11#1)(2013-1#1)
each residue##2##2##(2008-8#1)(2012-2#1)
each respective##3##2##(1996-5#1)(2007-12#1)(2008-3#1)
each round##2##2##(2008-12#1)(2008-8#1)
each run##2##2##(1995-6#1)(2008-10#1)
each sample injection##2##3##(2008-10#2)
each sample was##3##3##(2008-10#3)
each sample##32##2##(1991-3#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)
each sampling date##2##3##(2008-10#1)(2012-8#1)
each sampling time##2##3##(2008-10#1)(2008-6#1)
each sampling##10##2##(2007-5#2)(2008-10#4)(2008-12#1)(2008-6#2)(2012-8#1)
each scale##2##2##(2008-3#1)(2013-7#1)
each scan##3##2##(1992-3#1)(2008-3#1)(2011-2#1)
each scattering component##2##3##(2008-3#2)
each scenario##3##2##(1996-1#1)(2008-11#1)(2013-8#1)
each season##7##2##(2008-10#6)(2013-8#1)
each section##2##2##(2008-10#1)(2008-11#1)
each sector's##2##2##(1991-12#1)(1991-6#1)
each segment##5##2##(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
each selected##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
each sensillum type##2##3##(2007-12#2)
each sensor##7##2##(2008-10#2)(2008-2#1)(2008-3#4)
each sensory##2##2##(2007-12#2)
each sequence##4##2##(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
each series of peptides##2##4##(1995-3#2)
each service##3##2##(1994-1#1)(1994-3#1)(1995-1#1)
each session##6##2##(2007-7#1)(2008-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
each set of##3##3##(2008-10#1)(2008-7#1)(2009-1#1)
each set##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-3#1)
each sex##7##2##(2008-8#3)(2008-9#1)(2013-1#2)(2013-7#1)
each side##4##2##(2007-12#1)(2007-8#1)(2008-5#1)(2013-1#1)
each signal##3##2##(1997-7#1)(2007-9#1)(2010-8#1)
each single offspring##2##3##(2008-8#2)
each single##6##2##(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#2)
each site##11##2##(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-5#1)(2013-7#2)(2013-8#1)
each situation##2##2##(1996-2#1)(2008-3#1)
each soil##2##2##(2008-10#1)(2010-5#1)
each solution##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
each spatial##3##2##(2008-2#2)(2013-7#1)
each specialized for##2##3##(2007-12#1)(2008-11#1)
each species and##3##3##(2008-10#3)
each species has##2##3##(2010-4#1)(2010-7#1)
each species was##2##3##(2008-10#1)(2008-5#1)
each species were##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
each species##37##2##(1996-5#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-4#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)
each specific##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
each specimen##4##2##(2007-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
each spectral##2##2##(2008-3#1)(2009-4#1)
each spot##2##2##(2008-4#1)(2008-7#1)
each stage of the##3##4##(1995-9#1)(2008-12#1)(2013-8#1)
each stage of##6##3##(1995-9#1)(2008-12#1)(2008-4#1)(2010-12#1)(2013-8#2)
each stage##15##2##(1993-12#1)(1995-1#1)(1995-9#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-4#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#2)
each state##5##2##(1992-2#1)(1996-2#1)(2008-10#2)(2008-8#1)
each step of the##3##4##(1992-5#1)(1997-3#1)(2010-6#1)
each step of##5##3##(1991-5#1)(1992-5#1)(1997-3#1)(2009-3#1)(2010-6#1)
each step##11##2##(1991-5#2)(1992-5#1)(1994-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-1#1)
each strain and##3##3##(2008-10#2)(2012-3#1)
each strain was##2##3##(2008-10#2)
each strain##13##2##(1993-9#1)(1996-5#1)(2008-10#6)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#2)
each strand##2##2##(1992-3#1)(2010-5#1)
each strategy##3##2##(2008-12#1)(2008-3#1)(2008-8#1)
each stratum of##2##3##(1997-3#1)(2008-8#1)
each structural##2##2##(1990-9#1)(2008-10#1)
each structure##2##2##(1995-8#1)(2008-7#1)
each study group and##2##4##(2009-8#2)
each study##12##2##(1997-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#2)(2011-2#1)(2012-3#1)
each subfamily##2##2##(1995-3#2)
each subgroup##3##2##(2008-10#2)(2008-4#1)
each subject in##2##3##(2008-3#1)(2008-5#1)
each subject was##2##3##(2008-10#1)(2008-5#1)
each subject##12##2##(1997-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2010-8#1)(2011-2#1)
each subunit##6##2##(1990-5#2)(1992-6#1)(1994-5#1)(1997-2#1)(2008-9#1)
each successive##2##2##(1992-10#1)(2008-8#1)
each such##3##2##(2008-10#1)(2008-3#1)(2010-2#1)
each surface##2##2##(1991-5#1)(2008-10#1)
each surgical procedure##2##3##(1993-3#1)(2007-11#1)
each surgical##3##2##(1993-3#1)(2007-11#1)(2010-8#1)
each symptom dimension##2##3##(2011-2#2)
each symptom##3##2##(2008-7#1)(2011-2#2)
each system##3##2##(2008-10#2)(2008-9#1)
each task##2##2##(2007-6#1)(2009-11#1)
each technique##7##2##(2008-10#4)(2008-3#1)(2010-7#1)(2012-3#1)
each test sample##2##3##(2008-10#1)(2008-4#1)
each test##7##2##(1990-3#1)(2008-10#2)(2008-3#2)(2008-4#1)(2010-2#1)
each time the##2##3##(2009-9#1)(2010-12#1)
each time##12##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-10#1)(2011-2#1)(2012-2#1)
each tissue##5##2##(1990-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
each to##2##2##(1991-12#1)(2011-2#1)
each tooth was##2##3##(2010-3#1)(2011-2#1)
each tooth##4##2##(2008-11#1)(2010-3#2)(2011-2#1)
each topic##3##2##(1994-2#1)(1994-9#1)(2008-10#1)
each treatment group##6##3##(1992-6#1)(1994-9#2)(2007-8#1)(2012-3#1)(2013-1#1)
each treatment period##2##3##(1994-12#1)(2011-2#1)
each treatment##20##2##(1992-6#1)(1994-12#1)(1994-8#2)(1994-9#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
each tree##5##2##(2008-10#5)
each trial##11##2##(1992-11#1)(1993-12#1)(1994-3#1)(1997-3#1)(2008-5#3)(2009-10#2)(2010-5#1)(2013-8#1)
each triangle is##2##3##(2008-6#2)
each type of##17##3##(1990-5#1)(1993-11#1)(1994-9#1)(1997-4#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)
each type##21##2##(1990-5#1)(1993-11#1)(1993-2#1)(1994-9#1)(1997-4#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#3)(2010-8#1)(2011-2#1)
each unit##2##2##(1997-7#1)(2012-2#1)
each variable##4##2##(1992-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
each village##2##2##(2008-8#1)(2010-8#1)
each virus##9##2##(2008-10#8)(2008-5#1)
each vitamin##5##2##(2008-10#2)(2008-5#3)
each volunteer##3##2##(2008-5#1)(2011-2#2)
each ward##2##2##(2010-3#2)
each was##6##2##(1992-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
each wavelength##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
each week from##3##3##(1994-9#1)(2008-10#2)
each week##8##2##(1994-9#1)(2008-10#2)(2008-12#1)(2011-2#3)(2012-12#1)
each were##9##2##(1993-8#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-7#1)(2011-2#1)
each whey##2##2##(2008-10#2)
each wine##2##2##(2008-10#2)
each with a different##4##4##(2008-3#2)(2008-7#1)(2010-10#1)
each with a##7##3##(2007-11#1)(2007-9#1)(2008-3#2)(2008-7#1)(2010-10#1)(2011-2#1)
each with an##4##3##(1990-8#1)(1994-9#1)(2012-2#2)
each with its##2##3##(2008-4#1)(2008-9#1)
each with strong bootstrap support##2##5##(2008-10#2)
each with two##2##3##(2008-8#1)(2010-3#1)
each with##24##2##(1990-8#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-3#2)(2011-2#1)(2012-2#2)(2013-1#1)
each yard##2##2##(2008-10#2)
each year and##2##3##(1990-6#1)(2013-8#1)
each year from##2##3##(1992-12#1)(2008-10#1)
each year in##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
each year level##2##3##(1993-12#2)
each year of##2##3##(2008-10#1)(2011-1#1)
each year to##2##3##(1996-8#1)(2008-10#1)
each year##51##2##(1990-2#1)(1990-6#1)(1991-1#1)(1992-12#2)(1992-6#1)(1993-12#2)(1994-9#2)(1996-2#1)(1996-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-6#1)(2009-10#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
each zone##2##2##(2008-3#1)(2008-8#1)
each##3436##1##(1990-10#1)(1990-11#5)(1990-12#9)(1990-2#9)(1990-3#6)(1990-5#11)(1990-6#2)(1990-7#6)(1990-8#13)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#18)(1991-2#14)(1991-3#4)(1991-5#14)(1991-6#8)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#6)(1992-10#2)(1992-11#3)(1992-12#12)(1992-2#10)(1992-3#21)(1992-4#2)(1992-5#5)(1992-6#18)(1992-8#9)(1992-9#14)(1993-1#4)(1993-11#11)(1993-12#25)(1993-2#6)(1993-3#6)(1993-6#6)(1993-8#11)(1993-9#8)(1994-1#7)(1994-11#2)(1994-12#19)(1994-2#11)(1994-3#16)(1994-5#15)(1994-6#7)(1994-7#1)(1994-8#8)(1994-9#23)(1995-1#7)(1995-11#10)(1995-12#17)(1995-2#30)(1995-3#17)(1995-5#13)(1995-6#13)(1995-8#8)(1995-9#3)(1996-1#15)(1996-10#3)(1996-11#2)(1996-12#25)(1996-2#24)(1996-3#13)(1996-4#3)(1996-5#15)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#20)(1997-3#25)(1997-4#23)(1997-5#6)(1997-6#9)(1997-7#12)(1997-8#9)(1997-9#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-6#2)(2007-10#3)(2007-11#46)(2007-12#72)(2007-2#3)(2007-4#3)(2007-5#7)(2007-6#6)(2007-7#11)(2007-8#12)(2007-9#7)(2008-1#30)(2008-10#853)(2008-11#115)(2008-12#59)(2008-2#83)(2008-3#173)(2008-4#52)(2008-5#119)(2008-6#34)(2008-7#89)(2008-8#88)(2008-9#59)(2009-1#2)(2009-10#16)(2009-11#8)(2009-12#12)(2009-2#9)(2009-3#5)(2009-4#7)(2009-5#17)(2009-6#8)(2009-7#15)(2009-8#13)(2009-9#15)(2010-1#1)(2010-10#11)(2010-11#16)(2010-12#10)(2010-2#11)(2010-3#22)(2010-4#16)(2010-5#11)(2010-6#5)(2010-7#9)(2010-8#39)(2010-9#6)(2011-1#35)(2011-10#2)(2011-2#116)(2011-3#4)(2012-1#21)(2012-12#22)(2012-2#62)(2012-3#40)(2012-5#2)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#87)(2013-7#22)(2013-8#38)
each) and##2##2##(2008-10#1)(2008-11#1)
each) were##3##2##(1992-8#1)(2008-11#1)(2008-12#1)
each)##16##1##(1992-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
eager to##2##2##(1994-12#1)(2008-10#1)
eager##7##1##(1994-12#1)(1995-1#1)(2008-10#1)(2009-9#4)
eagerly anticipated##2##2##(2011-1#1)(2011-2#1)
eagerly##4##1##(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
ear and kernel rot of corn##2##6##(2008-10#2)
ear and kernel rot##4##4##(2008-10#4)
ear and nose##2##3##(2008-7#2)
ear and##11##2##(2008-10#5)(2008-4#1)(2008-7#3)(2010-5#1)(2013-1#1)
ear circumference##2##2##(2008-7#2)
ear development##2##2##(2008-10#1)(2013-1#1)
ear disease##4##2##(1991-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
ear edema assay##2##3##(2011-1#2)
ear edema##3##2##(2008-5#1)(2011-1#2)
ear height and GLS##2##4##(2008-10#2)
ear height##4##2##(2008-10#4)
ear in##2##2##(2011-2#1)(2013-1#1)
ear infection##2##2##(2007-7#1)(2008-8#1)
ear is a##2##3##(2008-9#1)(2011-2#1)
ear or##2##2##(1994-9#1)(2008-9#1)
ear rhabdomyosarcoma##2##2##(2012-12#2)
ear rot and aflatoxin production in##2##6##(2008-10#2)
ear rot and aflatoxin production##6##5##(2008-10#6)
ear rot and aflatoxin##7##4##(2008-10#7)
ear rot and##11##3##(2008-10#11)
ear rot severity##3##3##(2008-10#3)
ear rot##21##2##(2008-10#21)
ear rots and##3##3##(2008-10#3)
ear rots of maize and##2##5##(2008-10#1)(2008-8#1)
ear rots##7##2##(2008-10#6)(2008-8#1)
ear swelling##3##2##(2008-9#3)
ear was##3##2##(1990-12#1)(1996-5#1)(2009-1#1)
ear weight##2##2##(2011-2#2)
ear were##2##2##(1991-8#1)(2008-10#1)
ear##175##1##(1990-12#1)(1991-3#4)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#4)(1993-9#3)(1994-2#1)(1994-9#3)(1995-3#1)(1995-5#5)(1995-9#1)(1996-5#2)(1997-3#2)(2006-12#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#51)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#20)(2009-1#1)(2009-9#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#13)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#3)
earlier [Appl##2##2##(2008-3#2)
earlier age##5##2##(1993-12#1)(1996-7#1)(2008-3#1)(2011-2#1)(2013-1#1)
earlier and more##2##3##(1996-5#1)(2008-10#1)
earlier and was##2##3##(1994-11#1)(2008-2#1)
earlier and##17##2##(1991-9#1)(1992-3#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-7#3)(2011-2#1)(2012-2#1)(2013-8#1)
earlier as a##2##3##(1991-11#1)(2008-7#1)
earlier as##3##2##(1991-11#1)(2007-11#1)(2008-7#1)
earlier but##3##2##(1992-4#1)(2009-10#1)(2011-1#1)
earlier by the##2##3##(1996-4#1)(2008-11#1)
earlier by##4##2##(1993-9#1)(1996-4#1)(2008-1#1)(2008-11#1)
earlier data##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
earlier designs##2##2##(2007-12#1)(2008-3#1)
earlier detection and##3##3##(2008-7#1)(2010-12#1)(2011-2#1)
earlier detection##5##2##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#1)
earlier development##2##2##(1993-6#1)(2011-2#1)
earlier diagnosis##2##2##(2011-2#1)(2012-2#1)
earlier discharges##2##2##(1995-2#1)(1996-3#1)
earlier estimates##3##2##(1992-3#1)(1993-12#1)(2007-11#1)
earlier experiments##4##2##(1990-7#1)(2008-10#2)(2008-2#1)
earlier finding that##2##3##(1997-2#1)(2008-10#1)
earlier findings that##2##3##(1991-6#1)(1994-11#1)
earlier findings##6##2##(1991-6#1)(1992-12#2)(1994-11#1)(1995-6#1)(2008-7#1)
earlier for##2##2##(2008-10#1)(2008-2#1)
earlier from##2##2##(2008-10#1)(2012-3#1)
earlier hypothesis##2##2##(1991-5#1)(1993-2#1)
earlier identification of##2##3##(2008-7#1)(2011-1#1)
earlier in the##5##3##(1992-2#1)(1995-12#1)(2008-10#2)(2008-7#1)
earlier in this##2##3##(2008-9#1)(2011-2#1)
earlier in##17##2##(1990-11#1)(1991-6#1)(1992-2#1)(1992-9#1)(1995-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)
earlier intervention##2##2##(2007-10#1)(2008-12#1)
earlier models##3##2##(2008-8#1)(2010-10#1)(2012-2#1)
earlier observations in##2##3##(2007-6#1)(2008-10#1)
earlier onset of##3##3##(1991-9#1)(2010-8#1)(2013-1#1)
earlier onset than##2##3##(2008-1#1)(2008-11#1)
earlier onset##6##2##(1991-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#1)
earlier paper##7##2##(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2012-12#1)
earlier predictions##3##2##(1995-5#1)(2008-3#1)(2009-5#1)
earlier publication##2##2##(2008-10#1)(2008-3#1)
earlier published experimental##2##3##(2008-6#1)(2008-7#1)
earlier recommendations##2##2##(1992-8#1)(2008-9#1)
earlier reported##3##2##(1990-2#1)(2008-10#1)(2012-2#1)
earlier reports of##3##3##(1993-6#1)(2007-7#1)(2008-10#1)
earlier reports##9##2##(1991-12#1)(1993-6#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-11#1)
earlier research##5##2##(2008-2#2)(2008-3#2)(2009-2#1)
earlier results##3##2##(1993-2#1)(1995-3#1)(2013-1#1)
earlier return##2##2##(2011-2#1)(2012-12#1)
earlier stage of##4##3##(1992-5#1)(1997-7#1)(2008-10#1)(2010-1#1)
earlier stage##9##2##(1992-3#1)(1992-5#1)(1994-11#1)(1994-7#1)(1997-7#1)(2008-1#1)(2008-10#1)(2010-1#1)(2011-2#1)
earlier stages and##2##3##(1997-7#1)(2011-2#1)
earlier stages##3##2##(1997-7#1)(2007-11#1)(2011-2#1)
earlier start of##2##3##(1997-3#1)(2011-3#1)
earlier studies of##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
earlier studies we have##2##4##(2008-10#1)(2008-7#1)
earlier studies##26##2##(1990-11#1)(1990-8#1)(1991-6#1)(1992-10#1)(1993-3#1)(1993-6#1)(1994-2#1)(1996-12#2)(1996-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2012-3#1)
earlier study of the##2##4##(1996-5#1)(2008-10#1)
earlier study##14##2##(1991-3#1)(1993-12#2)(1994-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-2#1)(2010-3#1)
earlier than in developed##2##4##(1991-3#1)(2007-10#1)
earlier than in##4##3##(1991-3#1)(1996-5#1)(2007-10#1)(2009-6#1)
earlier than the##5##3##(1993-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
earlier than##25##2##(1990-5#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-12#2)(1994-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-6#2)(2010-6#1)(2011-2#3)(2013-1#1)(2013-7#1)
earlier that##3##2##(1991-12#1)(2008-11#1)(2009-12#1)
earlier to##2##2##(1992-9#1)(2008-10#1)
earlier use of##3##3##(1995-12#1)(2008-3#1)(2010-8#1)
earlier was##3##2##(2008-10#1)(2009-8#2)
earlier work on##2##3##(2008-10#1)(2011-1#1)
earlier work##9##2##(1991-12#1)(2008-10#5)(2008-11#1)(2010-3#1)(2011-1#1)
earlier##436##1##(1990-11#3)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#5)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#10)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#4)(1994-3#3)(1994-7#3)(1994-8#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#1)(2007-10#6)(2007-11#5)(2007-12#3)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#5)(2008-10#62)(2008-11#12)(2008-12#4)(2008-2#15)(2008-3#17)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#18)(2008-8#14)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#26)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#9)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#12)(2013-7#2)(2013-8#7)
earliest stage of##2##3##(1994-8#1)(2008-4#1)
earliest stage##4##2##(1994-8#1)(1995-1#1)(2008-4#1)(2012-2#1)
earliest stages##9##2##(1995-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-7#1)
earliest##51##1##(1990-2#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
earliness##2##1##(2008-10#2)
early -##2##2##(2006-8#1)(2013-1#1)
early 1980s##10##2##(1994-2#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
early 1990s in##2##3##(2008-10#2)
early 1990s##16##2##(1993-3#1)(1997-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)
early 2006##3##2##(2008-11#1)(2008-12#1)(2009-5#1)
early April##3##2##(1992-6#2)(2010-8#1)
early August##2##2##(1996-12#1)(2008-10#1)
early CT##2##2##(1990-3#2)
early ERCP##3##2##(2013-1#3)
early HIV##2##2##(1990-2#1)(2010-5#1)
early July##2##2##(2008-10#1)(2010-8#1)
early June##2##2##(2008-10#2)
early March##2##2##(1992-8#1)(2010-5#1)
early PD##2##2##(2008-7#1)(2010-12#1)
early Parkinson's disease##2##3##(2008-7#1)(2010-12#1)
early abortion of P##2##4##(2008-10#2)
early abortion of##4##3##(2008-10#4)
early abortion##5##2##(2008-10#4)(2008-8#1)
early activation of the##2##4##(1996-2#1)(2009-6#1)
early activation of##3##3##(1996-2#1)(2009-6#2)
early activation##5##2##(1992-3#1)(1996-2#1)(2008-9#1)(2009-6#2)
early adolescence##6##2##(1990-6#1)(2009-7#3)(2010-1#2)
early adolescent##6##2##(2009-7#3)(2010-4#1)(2010-7#1)(2010-9#1)
early adolescents##8##2##(2008-12#3)(2009-7#5)
early adolescents'##2##2##(2009-7#1)(2010-1#1)
early adopters of##2##3##(2008-12#1)(2013-1#1)
early adopters##3##2##(2008-12#1)(2010-8#1)(2013-1#1)
early adulthood##7##2##(1996-9#1)(2008-11#1)(2009-12#1)(2009-8#2)(2009-9#1)(2013-1#1)
early after the onset of symptoms##2##6##(2008-5#2)
early after the##5##3##(2008-5#2)(2011-2#2)(2013-1#1)
early after##8##2##(1996-6#1)(2007-7#1)(2007-8#1)(2008-5#2)(2011-2#2)(2013-1#1)
early age of onset##2##4##(2009-7#1)(2013-7#1)
early age##10##2##(1992-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
early alterations##2##2##(1992-12#1)(2012-2#1)
early and advanced##2##3##(1991-3#2)
early and late phase##2##4##(2008-11#1)(2010-8#1)
early and late replicating##2##4##(2008-12#2)
early and late stages of##2##5##(1992-6#1)(2008-5#1)
early and late##29##3##(1992-6#1)(1995-8#1)(1996-11#1)(1996-5#2)(1997-3#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
early and long-term##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
early and##61##2##(1991-3#2)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-3#1)(2007-11#1)(2007-8#6)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#3)
early appearance of##2##3##(2008-4#1)(2013-1#1)
early appearance##3##2##(2008-4#1)(2009-4#1)(2013-1#1)
early arterial##3##2##(2008-7#2)(2008-8#1)
early as##49##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-7#1)(2010-4#1)(2011-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
early assessment of##3##3##(2008-10#2)(2013-8#1)
early assessment##4##2##(1995-3#1)(2008-10#2)(2013-8#1)
early beginning of##2##3##(2007-11#1)(2009-5#1)
early biomarkers of##2##3##(1995-3#1)(2008-2#1)
early biomarkers##3##2##(1995-3#1)(2008-2#1)(2012-2#1)
early blight##2##2##(1992-8#1)(2008-10#1)
early brain damage##2##3##(1991-12#1)(1996-3#1)
early brain development in##2##4##(2007-12#2)
early brain##4##2##(1991-12#1)(1996-3#1)(2007-12#2)
early breast cancer##21##3##(1991-8#4)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-4#1)(2007-11#2)(2007-5#1)(2010-7#1)(2011-2#4)(2013-1#1)
early breast##23##2##(1991-8#4)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-4#2)(2007-11#2)(2007-5#1)(2010-7#1)(2011-2#4)(2013-1#1)
early brown rot infections##2##4##(2008-10#2)
early by##3##2##(2008-10#2)(2008-8#1)
early cancer##4##2##(2008-3#1)(2011-1#2)(2011-2#1)
early care##2##2##(1991-6#1)(2008-11#1)
early changes in##2##3##(1994-5#1)(1995-3#1)
early changes##4##2##(1994-5#1)(1995-3#1)(2008-8#1)(2011-1#1)
early child development initiatives##2##4##(2010-12#2)
early child development##10##3##(2008-11#2)(2010-12#7)(2013-8#1)
early child##13##2##(2008-11#3)(2008-2#1)(2010-12#7)(2013-8#2)
early childhood and##3##3##(2008-9#1)(2012-12#1)(2012-3#1)
early childhood education##2##3##(2008-11#1)(2010-12#1)
early childhood interventions##2##3##(2010-12#2)
early childhood##37##2##(1995-6#1)(1996-3#1)(1997-7#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#6)(2008-3#1)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#4)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
early clinical studies##2##3##(1994-11#1)(2008-7#1)
early clinical##13##2##(1993-5#1)(1994-11#1)(1997-3#2)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-11#1)(2012-2#1)(2013-1#2)
early complications and##2##3##(1994-12#1)(2011-2#1)
early complications of##2##3##(2011-2#1)(2013-1#1)
early complications##8##2##(1991-9#1)(1994-12#1)(1996-3#1)(2007-7#1)(2008-1#1)(2011-2#2)(2013-1#1)
early control##4##2##(2008-12#1)(2013-1#3)
early coronary##4##2##(1992-9#1)(2007-8#1)(2008-11#2)
early cv##2##2##(2008-10#2)
early data##2##2##(2008-2#1)(2008-5#1)
early days##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
early death and##2##3##(2010-12#1)(2011-2#1)
early death##6##2##(2007-7#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)
early decades of the##2##4##(2008-10#1)(2010-1#1)
early dendritic injury##2##3##(2008-7#2)
early detection and diagnosis##2##4##(2012-3#1)(2013-1#1)
early detection and intervention##3##4##(2007-8#1)(2008-11#1)(2012-2#1)
early detection and treatment##4##4##(1995-12#1)(2007-7#1)(2010-5#1)(2010-8#1)
early detection and##13##3##(1995-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
early detection of AI##2##4##(2011-2#2)
early detection of breast cancer##3##5##(2009-4#1)(2009-7#1)(2010-9#1)
early detection of cancer##2##4##(1990-10#1)(2008-4#1)
early detection of contralateral##2##4##(1990-8#2)
early detection of ototoxicity##2##4##(2007-7#2)
early detection of the##6##4##(2008-10#2)(2009-12#1)(2009-5#1)(2010-8#1)(2013-8#1)
early detection of##46##3##(1990-10#1)(1990-2#1)(1990-8#2)(1991-4#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-7#1)(1995-9#1)(1996-9#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
early detection##74##2##(1990-10#1)(1990-2#1)(1990-8#2)(1991-3#2)(1991-4#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-7#1)(1995-12#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
early development and##4##3##(1995-12#1)(1995-3#1)(2008-11#1)(2009-11#1)
early development in##3##3##(1995-2#1)(1996-5#1)(2009-3#1)
early development instrument##2##3##(2008-11#2)
early development of the mouse##2##5##(1992-12#1)(1993-3#1)
early development of the reconstructed egg##2##6##(2008-9#2)
early development of the##6##4##(1992-12#1)(1993-3#1)(1996-5#1)(2008-8#1)(2008-9#2)
early development of##13##3##(1992-12#1)(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-1#1)
early development##34##2##(1992-12#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
early developmental stages##5##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
early developmental##6##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-8#1)
early diabetic nephropathy##3##3##(2008-1#2)(2013-1#1)
early diagnosis and appropriate##2##4##(2007-7#1)(2013-1#1)
early diagnosis and immediate##3##4##(1996-9#1)(2007-8#1)(2011-2#1)
early diagnosis and prompt treatment##2##5##(2008-12#1)(2013-1#1)
early diagnosis and prompt##4##4##(2008-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
early diagnosis and successful treatment##2##5##(1993-6#1)(2013-7#1)
early diagnosis and treatment of##2##5##(2008-3#1)(2013-1#1)
early diagnosis and treatment##5##4##(1990-6#1)(2008-3#1)(2011-2#1)(2013-1#2)
early diagnosis and##32##3##(1990-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-1#2)(2009-2#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
early diagnosis as##2##3##(2007-2#1)(2013-1#1)
early diagnosis of colorectal##2##4##(1993-3#1)(1993-9#1)
early diagnosis of prostatic carcinoma##2##5##(1991-2#2)
early diagnosis of prostatic##3##4##(1991-2#2)(2009-5#1)
early diagnosis of##22##3##(1990-6#1)(1990-9#1)(1991-2#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-9#1)(1997-2#1)(2008-1#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
early diagnosis##78##2##(1990-3#1)(1990-6#3)(1990-9#2)(1991-2#2)(1991-5#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
early diagnostic##4##2##(1990-6#1)(2007-11#1)(2012-2#2)
early discharge##2##2##(1992-1#1)(2007-8#1)
early discrimination of##2##3##(2008-10#2)
early disease##5##2##(1996-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
early drinking##2##2##(2008-12#2)
early drug##3##2##(2008-8#2)(2009-7#1)
early during##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
early eighties##2##2##(2008-10#1)(2008-4#1)
early embryo##7##2##(2007-12#2)(2008-10#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-3#1)
early embryogenesis##12##2##(1994-12#2)(1997-4#1)(1997-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)
early embryonic development##3##3##(1995-2#1)(2009-3#1)(2012-2#1)
early embryonic mitoses##2##3##(2012-3#2)
early embryonic ventricular##2##3##(2008-11#2)
early embryonic##11##2##(1995-2#1)(2007-12#2)(2008-11#2)(2008-9#1)(2009-3#1)(2010-7#1)(2012-2#1)(2012-3#2)
early embryos##4##2##(1993-3#1)(1993-6#1)(2012-3#2)
early enough##3##2##(2011-3#2)(2012-2#1)
early environments##2##2##(2010-12#1)(2012-3#1)
early event of##3##3##(2007-4#1)(2009-12#2)
early event##6##2##(1990-7#1)(1991-1#1)(2007-4#1)(2009-12#2)(2010-3#1)
early events in##3##3##(1994-8#1)(1995-2#1)(2012-2#1)
early events##6##2##(1994-8#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-2#2)
early evidence##2##2##(2008-10#1)(2013-8#1)
early evolution of##2##3##(2008-9#1)(2009-6#1)
early evolution##3##2##(1993-12#1)(2008-9#1)(2009-6#1)
early experience##6##2##(1992-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
early experiences of##2##3##(2008-11#1)(2009-12#1)
early expression of the##2##4##(2007-12#1)(2008-7#1)
early extubation##4##2##(1996-12#1)(2006-10#1)(2007-9#1)(2012-3#1)
early fall##2##2##(2008-10#2)
early family formation##2##3##(2011-2#2)
early flowering##5##2##(1997-2#1)(1997-8#1)(2008-10#2)(2011-1#1)
early folding##3##2##(1992-3#2)(2008-8#1)
early forms of ARM##2##4##(2011-2#2)
early functional range of motion##2##5##(2013-1#2)
early gastric cancer##5##3##(1990-9#2)(2008-12#1)(2008-5#1)(2009-3#1)
early gastric##9##2##(1990-9#3)(1992-9#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2013-8#1)
early gene##6##2##(1991-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(2009-12#1)
early genes##10##2##(1993-6#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#2)(1996-12#1)(2012-2#1)
early genetic##3##2##(1995-11#1)(2007-12#1)(2012-12#1)
early germination##2##2##(2008-12#1)(2009-8#1)
early gestation##2##2##(1991-3#1)(2011-1#1)
early graft##3##2##(2007-8#1)(2008-8#1)(2011-2#1)
early growth##2##2##(1990-11#1)(1994-6#1)
early harvest##2##2##(2008-10#2)
early history##2##2##(2008-1#1)(2008-8#1)
early human##2##2##(1995-8#2)
early identification and##5##3##(1991-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
early identification of patients at risk of##2##7##(1992-12#1)(2008-8#1)
early identification of patients at risk##3##6##(1992-12#1)(2008-3#1)(2008-8#1)
early identification of patients at##4##5##(1992-12#2)(2008-3#1)(2008-8#1)
early identification of patients with##3##5##(1990-3#1)(2008-9#1)(2010-10#1)
early identification of patients##7##4##(1990-3#1)(1992-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
early identification of this##2##4##(2010-12#1)(2012-12#1)
early identification of##13##3##(1990-3#1)(1992-12#2)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-12#1)
early identification##19##2##(1990-3#1)(1991-6#1)(1992-12#2)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
early implantation##2##2##(2008-9#2)
early in a##2##3##(2008-10#1)(2008-11#1)
early in adolescence##2##3##(2009-7#1)(2013-1#1)
early in development and##2##4##(2008-10#1)(2008-7#1)
early in development##4##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
early in evolution##2##3##(1993-6#1)(1994-3#1)
early in gestation##2##3##(1993-5#1)(1993-6#1)
early in life##8##3##(1996-5#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
early in patients##2##3##(2011-2#2)
early in pregnancy##2##3##(1990-9#1)(2008-1#1)
early in the course of chronic##2##6##(2009-4#1)(2013-7#1)
early in the course of##9##5##(1996-11#1)(2006-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-7#1)
early in the epidemic##2##4##(2008-10#2)
early in the first##2##4##(2008-10#1)(2009-7#1)
early in the growing season##2##5##(2008-10#2)
early in the process of##2##5##(2008-8#1)(2009-4#1)
early in the process##3##4##(2008-10#1)(2008-8#1)(2009-4#1)
early in the season##3##4##(2008-10#2)(2008-8#1)
early in the##37##3##(1995-12#1)(1996-11#1)(2006-10#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#2)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
early in their##5##3##(2007-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
early in##85##2##(1990-9#1)(1992-10#1)(1993-5#1)(1993-6#2)(1994-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-2#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-4#2)(2009-7#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
early increase##2##2##(1995-2#1)(1997-1#1)
early indicators of##2##3##(2010-6#1)(2012-1#1)
early induction phase of drug-induced##2##5##(2008-10#2)
early induction##5##2##(1990-6#1)(1996-12#1)(1997-8#1)(2008-10#2)
early infancy##9##2##(1996-9#1)(1997-3#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-6#1)(2012-2#2)(2013-1#1)
early infant##2##2##(2008-1#1)(2009-9#1)
early infection##4##2##(1997-5#1)(2008-10#2)(2008-11#1)
early initiation of##4##3##(1991-1#1)(2009-4#1)(2010-5#1)(2011-2#1)
early initiation##6##2##(1991-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-2#1)
early intervention in bipolar disorder (BPD)##2##6##(2009-8#2)
early intervention in##4##3##(2009-8#3)(2013-1#1)
early intervention services##5##3##(1991-12#1)(1993-12#1)(1994-1#3)
early intervention with inhaled corticosteroids##2##5##(1996-7#1)(2008-11#1)
early intervention##33##2##(1991-12#5)(1992-12#1)(1993-12#1)(1994-1#3)(1995-1#1)(1996-7#1)(1997-2#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-9#2)(2009-8#5)(2010-10#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
early interventions##3##2##(1990-8#1)(1991-12#1)(1997-1#1)
early introduction of##2##3##(2008-10#1)(2011-2#1)
early invaders of the##2##4##(2008-11#2)
early invasive strategy##2##3##(2008-3#2)
early invasive##3##2##(1997-2#1)(2008-3#2)
early juvenile##2##2##(2007-12#1)(2007-5#1)
early lactation##2##2##(1996-8#1)(2012-2#1)
early leaf spot epidemics##2##4##(2008-10#2)
early leaf spot##4##3##(2008-10#4)
early learning and##2##3##(2008-11#1)(2010-12#1)
early learning##4##2##(2008-11#2)(2009-5#1)(2010-12#1)
early lesions##2##2##(1990-2#1)(2011-2#1)
early life and##2##3##(2011-1#1)(2012-2#1)
early life stages of##2##4##(2010-8#2)
early life stages##3##3##(2010-8#2)(2012-12#1)
early life##14##2##(1992-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)
early literacy##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
early management##2##2##(2011-2#1)(2013-8#1)
early manifestation of##3##3##(2009-5#1)(2012-2#1)(2012-3#1)
early maturation##2##2##(1993-5#1)(2008-11#1)
early middle##2##2##(1990-8#1)(2011-2#1)
early mobilization and##2##3##(2007-11#1)(2010-5#1)
early mobilization##3##2##(2007-11#1)(2010-5#1)(2011-2#1)
early modern times##2##3##(2008-10#1)(2012-2#1)
early modern##13##2##(2008-10#9)(2008-11#3)(2012-2#1)
early morning hours##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
early morning##11##2##(1995-12#1)(1997-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
early mortality in##2##3##(2010-4#1)(2013-8#1)
early mortality##8##2##(1992-1#1)(1992-9#1)(2007-8#1)(2008-1#1)(2009-4#2)(2010-4#1)(2013-8#1)
early mouse##2##2##(1997-7#1)(2008-11#1)
early neonatal##4##2##(1996-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
early neural development##3##3##(1992-9#1)(1994-12#1)(1997-7#1)
early nonresponse criterion or response criterion##2##6##(2012-3#2)
early obliteration##3##2##(2012-3#3)
early observation##2##2##(1994-2#1)(2010-8#1)
early on in the##4##4##(1994-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
early on##9##2##(1991-6#1)(1994-1#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
early onset Alzheimer's disease##2##4##(1995-12#1)(1996-2#1)
early onset and##2##3##(1997-3#1)(2011-1#1)
early onset of##4##3##(2007-2#1)(2008-8#1)(2009-7#1)(2011-2#1)
early onset##21##2##(1994-2#1)(1995-12#2)(1996-2#2)(1997-3#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#3)(2011-1#1)(2011-2#4)(2012-12#1)
early or late##3##3##(2011-2#1)(2011-3#1)(2013-1#1)
early or##5##2##(1995-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
early outcome##5##2##(2007-10#2)(2007-8#3)
early ovarian cancer##4##3##(2011-2#4)
early part of##6##3##(1991-8#1)(2008-1#1)(2008-10#1)(2008-9#2)(2012-2#1)
early participants##2##2##(2012-2#2)
early passage##2##2##(2008-10#1)(2008-5#1)
early period after##3##3##(2007-11#1)(2010-11#1)(2012-3#1)
early period##5##2##(1993-3#1)(2007-11#1)(2008-11#1)(2010-11#1)(2012-3#1)
early phase clinical##2##3##(2011-2#1)(2013-1#1)
early phase of##14##3##(1992-12#1)(1992-3#1)(1993-9#1)(1994-11#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#2)
early phase##27##2##(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1996-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#1)
early phases of##5##3##(1995-3#1)(2008-11#1)(2012-12#1)(2012-2#2)
early phases##6##2##(1991-8#1)(1995-3#1)(2008-11#1)(2012-12#1)(2012-2#2)
early planned operation##4##3##(1997-8#4)
early planned##5##2##(1997-8#5)
early plant growth##2##3##(2009-8#2)
early plant##3##2##(2008-10#1)(2009-8#2)
early post-operative##5##2##(1993-5#1)(2007-8#1)(2012-2#2)(2013-1#1)
early post-traumatic##2##2##(2008-8#1)(2011-2#1)
early postnatal hypoxia##4##3##(1993-12#4)
early postnatal life##3##3##(1994-2#1)(1994-8#1)(2008-11#1)
early postnatal period of##2##4##(1990-5#1)(1991-1#1)
early postnatal period##5##3##(1990-5#1)(1991-1#1)(1997-2#1)(2008-11#1)(2010-1#1)
early postnatal##18##2##(1990-5#2)(1991-1#1)(1993-12#4)(1994-2#1)(1994-6#2)(1994-8#1)(1997-2#2)(2008-11#2)(2008-4#1)(2010-1#1)(2012-12#1)
early postoperative complications##2##3##(2011-2#1)(2013-1#1)
early postoperative increase of##2##4##(1990-6#2)
early postoperative mortality##2##3##(2011-2#1)(2011-3#1)
early postoperative period##12##3##(1991-2#1)(1991-5#1)(1994-3#1)(1995-4#1)(2007-11#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-3#3)
early postoperative##28##2##(1990-6#2)(1991-2#1)(1991-5#2)(1992-5#1)(1994-3#1)(1995-4#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-9#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-3#4)(2013-1#2)
early pre-ecdysis##2##2##(2008-7#2)
early pregnancy##19##2##(1990-11#2)(1990-8#1)(1991-3#1)(1991-6#1)(1993-12#3)(1994-9#1)(1995-8#3)(1996-12#3)(2011-1#1)(2012-2#1)(2012-3#2)
early prenatal##2##2##(2008-4#1)(2013-7#1)
early presenting sign of##2##4##(2009-7#1)(2012-2#1)
early progenitor cells##2##3##(2008-11#1)(2013-1#1)
early promoter region##2##3##(1992-12#2)
early promoter##9##2##(1992-12#2)(1995-6#1)(1997-4#1)(1997-8#1)(2008-11#3)(2008-8#1)
early promoters##2##2##(1995-2#1)(1997-8#1)
early psychosis##9##2##(2008-1#5)(2011-1#4)
early psychosis&quot##3##2##(2013-8#3)
early ratings##2##2##(2008-10#1)(2008-2#1)
early reading##2##2##(2008-11#1)(2008-12#1)
early recognition and##4##3##(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
early recognition of##5##3##(2007-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-12#1)
early recognition##12##2##(2007-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
early recovery##3##2##(2007-9#1)(2010-4#1)(2010-7#1)
early recurrence##2##2##(2008-1#1)(2012-3#1)
early referral##4##2##(2007-12#1)(2008-1#2)(2012-3#1)
early region##2##2##(1995-2#2)
early rehabilitation and##2##3##(2007-11#1)(2013-8#1)
early rehabilitation of##2##3##(2007-11#2)
early rehabilitation##9##2##(2007-11#4)(2007-8#3)(2012-1#1)(2013-8#1)
early relapse##2##2##(2008-9#1)(2011-2#1)
early reoperation##3##2##(2012-12#3)
early repeat##2##2##(1992-8#2)
early repolarization syndrome##3##3##(2012-3#3)
early repolarization##5##2##(2010-1#1)(2012-3#4)
early response genes##4##3##(1992-12#1)(1992-7#1)(1994-8#2)
early response to##2##3##(1996-5#1)(2007-7#1)
early response##10##2##(1992-12#1)(1992-7#1)(1994-8#2)(1994-9#1)(1996-5#1)(2007-7#1)(2008-8#1)(2010-12#1)(2010-3#1)
early results are##2##3##(1995-11#1)(2011-2#1)
early results of##2##3##(2007-8#1)(2013-1#1)
early results##16##2##(1992-12#1)(1995-11#1)(2007-11#1)(2007-8#6)(2008-11#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
early revision##3##2##(2008-8#1)(2013-1#2)
early risk factors##2##3##(1991-12#1)(2010-4#1)
early risk of stroke##3##4##(2008-8#2)(2012-3#1)
early risk##6##2##(1991-12#1)(2008-10#1)(2008-8#2)(2010-4#1)(2012-3#1)
early screening of##3##3##(1995-2#1)(2007-7#1)(2008-12#1)
early screening##5##2##(1995-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
early season##2##2##(2008-10#2)
early secretory##2##2##(2008-10#1)(2008-7#1)
early sensory##2##2##(2007-12#1)(2008-11#1)
early septic complications##2##3##(2007-11#2)
early sexual activity##4##3##(2013-8#4)
early sexual debut##5##3##(2011-1#3)(2012-1#1)(2013-8#1)
early sexual##11##2##(2009-12#1)(2011-1#3)(2012-1#1)(2013-8#6)
early signaling events##4##3##(1991-3#1)(2008-10#3)
early signaling##5##2##(1991-3#1)(2008-10#4)
early signs##2##2##(2008-10#1)(2011-2#1)
early spermatids##2##2##(2008-7#2)
early spermatogenic cyst##3##3##(2012-2#3)
early spring infections##2##3##(2008-10#2)
early spring##10##2##(2008-10#8)(2011-2#2)
early stage breast cancer##2##4##(1994-8#1)(1995-9#1)
early stage breast##3##3##(1994-8#1)(1995-9#1)(2007-10#1)
early stage of the##7##4##(1990-6#1)(1991-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)
early stage of##44##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-5#1)(1993-12#2)(1994-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-5#3)(2008-8#1)(2008-9#5)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
early stage##85##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#3)
early stages and##2##3##(2010-8#1)(2012-3#1)
early stages in##2##3##(1996-12#1)(2008-9#1)
early stages of development##6##4##(1993-2#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
early stages of embryonic development##2##5##(2007-12#1)(2008-11#1)
early stages of the disease##2##5##(2008-10#1)(2008-11#1)
early stages of the##8##4##(1993-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
early stages of##59##3##(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#3)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#4)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#1)
early stages##80##2##(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#4)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-10#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
early step in##2##3##(1992-3#1)(1994-12#1)
early step of##2##3##(1994-3#1)(2008-6#1)
early step##5##2##(1992-3#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-6#1)
early steps in##3##3##(2007-12#1)(2008-4#1)(2009-8#1)
early steps of##4##3##(1992-2#1)(2008-2#1)(2008-4#1)(2011-2#1)
early steps##7##2##(1992-2#1)(2007-12#1)(2008-2#1)(2008-4#2)(2009-8#1)(2011-2#1)
early studies##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)
early subjective##3##2##(2008-5#2)(2009-6#1)
early successes##2##2##(1993-3#1)(1995-12#1)
early summer in##2##3##(1993-6#1)(2011-2#1)
early summer##4##2##(1993-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
early surgery##2##2##(1997-3#1)(2007-12#1)
early surgical intervention##5##3##(1994-6#1)(2007-12#1)(2008-7#1)(2010-3#1)(2012-2#1)
early surgical treatment##4##3##(1990-9#1)(2007-11#2)(2007-8#1)
early surgical##13##2##(1990-9#1)(1994-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
early symptoms of##2##3##(1992-9#1)(2008-10#1)
early symptoms##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
early termination of##2##3##(1993-2#1)(1995-2#1)
early therapeutic##2##2##(2011-2#1)(2013-1#1)
early therapy##2##2##(2008-3#1)(2010-8#1)
early through##2##2##(2008-10#1)(2009-7#1)
early time##2##2##(2008-11#1)(2012-4#1)
early times##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
early to mid-second trimester##2##4##(2007-12#2)
early to##16##2##(1991-2#1)(1992-6#1)(1993-11#1)(1995-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#2)(2011-3#2)
early treatment is##2##3##(1990-12#1)(2010-2#1)
early treatment of##5##3##(2007-11#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)
early treatment##12##2##(1990-12#1)(1996-11#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
early twentieth century##5##3##(2008-10#1)(2008-12#1)(2009-10#1)(2010-1#1)(2012-12#1)
early twentieth##8##2##(2008-10#1)(2008-12#1)(2009-10#1)(2010-1#3)(2012-12#1)(2013-1#1)
early twentieth-century##3##2##(2008-7#1)(2010-1#2)
early use of##5##3##(1991-12#1)(1994-3#1)(1997-2#1)(2011-1#2)
early vascular and neurological complications of supracondylar humerus fractures in##2##10##(2013-1#2)
early warning systems##2##3##(1991-12#1)(2008-10#1)
early warning##9##2##(1991-12#1)(1992-12#1)(2008-10#4)(2008-7#1)(2008-8#2)
early winter##2##2##(2008-10#1)(2013-7#1)
early work on##2##3##(2008-5#1)(2012-12#1)
early work##5##2##(1993-11#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
early years of##5##3##(1992-2#1)(1992-3#1)(1993-12#1)(2008-10#1)(2010-1#1)
early years##11##2##(1992-2#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#3)(2010-1#1)(2010-12#2)(2010-8#1)
early##2212##1##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#11)(1990-7#1)(1990-8#10)(1990-9#12)(1991-1#3)(1991-11#3)(1991-12#13)(1991-2#6)(1991-3#9)(1991-4#3)(1991-5#8)(1991-6#7)(1991-8#7)(1991-9#3)(1992-1#2)(1992-10#2)(1992-12#18)(1992-2#8)(1992-3#8)(1992-4#3)(1992-5#6)(1992-6#10)(1992-7#1)(1992-8#8)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#7)(1993-12#20)(1993-2#5)(1993-3#10)(1993-5#5)(1993-6#11)(1993-8#3)(1993-9#9)(1994-1#5)(1994-11#4)(1994-12#16)(1994-2#6)(1994-3#16)(1994-5#4)(1994-6#6)(1994-7#2)(1994-8#8)(1994-9#3)(1995-1#2)(1995-11#12)(1995-12#14)(1995-2#12)(1995-3#6)(1995-4#4)(1995-5#2)(1995-6#5)(1995-8#9)(1995-9#3)(1996-11#9)(1996-12#12)(1996-2#7)(1996-3#7)(1996-5#13)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#5)(1997-1#5)(1997-2#15)(1997-3#19)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#17)(2006-10#2)(2006-7#1)(2006-8#2)(2007-10#19)(2007-11#29)(2007-12#40)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#6)(2007-7#20)(2007-8#51)(2007-9#5)(2008-1#39)(2008-10#212)(2008-11#95)(2008-12#45)(2008-2#16)(2008-3#24)(2008-4#33)(2008-5#35)(2008-6#12)(2008-7#61)(2008-8#55)(2008-9#53)(2009-1#4)(2009-10#6)(2009-11#3)(2009-12#10)(2009-2#1)(2009-3#8)(2009-4#11)(2009-5#9)(2009-6#10)(2009-7#32)(2009-8#32)(2009-9#6)(2010-1#16)(2010-10#6)(2010-11#17)(2010-12#37)(2010-2#5)(2010-3#9)(2010-4#11)(2010-5#10)(2010-6#11)(2010-7#8)(2010-8#33)(2010-9#4)(2011-1#42)(2011-10#1)(2011-2#131)(2011-3#10)(2011-4#1)(2011-8#3)(2012-1#14)(2012-12#34)(2012-2#69)(2012-3#50)(2012-4#1)(2012-7#2)(2013-1#100)(2013-7#12)(2013-8#41)
early&quot##6##1##(1991-12#1)(2008-1#2)(2008-8#1)(2011-2#1)(2013-7#1)
early- and##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
early-##5##1##(2008-10#2)(2008-3#1)(2010-12#1)(2011-2#1)
early-arriving##2##1##(2008-2#2)
early-life##3##1##(2008-10#1)(2009-5#2)
early-onset parkinsonism with diurnal fluctuation##2##5##(2008-7#2)
early-onset##15##1##(1991-2#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2012-3#3)(2013-1#2)
early-phase##3##1##(1994-12#1)(2010-5#2)
early-season##2##1##(2008-10#2)
early-stage arrest of##2##3##(2013-1#2)
early-stage breast##2##2##(1995-4#1)(1995-8#1)
early-stage##14##1##(1995-4#1)(1995-8#1)(1995-9#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2012-1#1)(2013-1#3)(2013-8#1)
early-warning##2##1##(2008-8#2)
earmarked##2##1##(1994-9#1)(2008-10#1)
earn a##2##2##(1992-12#1)(2008-12#1)
earn##9##1##(1991-3#1)(1992-12#2)(1992-5#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-12#1)(2011-2#1)
earned##3##1##(1996-3#2)(2012-3#1)
earnest##2##1##(1993-3#1)(2009-6#1)
earning##6##1##(1990-12#1)(1992-1#1)(1994-12#2)(2008-11#1)(2010-8#1)
earnings and##2##2##(1995-2#1)(2008-10#1)
earnings in##4##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)
earnings of##2##2##(1992-2#1)(2010-12#1)
earnings##18##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1993-12#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
ears and tassels##2##3##(2008-8#2)
ears and##4##2##(2008-7#1)(2008-8#2)(2012-1#1)
ears was##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
ears were##2##2##(2008-10#2)
ears##35##1##(1991-3#1)(2007-7#1)(2008-10#9)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#9)(2011-2#3)(2012-1#1)(2012-3#3)
earth and##9##2##(2008-10#7)(2009-7#1)(2010-11#1)
earth elements (REE)##7##3##(2008-10#6)(2012-2#1)
earth elements##26##2##(2008-10#24)(2008-9#1)(2012-2#1)
earth ions##3##2##(2007-11#1)(2008-10#2)
earth is##3##2##(1991-9#1)(2008-10#1)(2008-2#1)
earth metal ions##6##3##(2008-10#6)
earth metal##17##2##(2008-10#17)
earth metals##9##2##(2008-10#9)
earth surface##3##2##(2008-10#2)(2008-8#1)
earth##123##1##(1991-9#1)(1996-4#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#102)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
earthquake and the##2##3##(1990-11#1)(2013-1#1)
earthquake and##3##2##(1990-11#1)(1992-12#1)(2013-1#1)
earthquake are##2##2##(1990-11#1)(1996-4#1)
earthquake clustering##2##2##(1996-4#2)
earthquake fault models##2##3##(1996-4#2)
earthquake generation##2##2##(1996-4#2)
earthquake in##7##2##(1996-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
earthquake nucleation##2##2##(1996-4#2)
earthquake of magnitude##2##3##(1990-11#1)(1996-4#1)
earthquake of##3##2##(1990-11#1)(1996-4#2)
earthquake on##2##2##(1996-4#1)(2013-8#1)
earthquake phenomena##2##2##(1996-4#2)
earthquake prediction is##2##3##(1996-4#2)
earthquake prediction##12##2##(1996-4#12)
earthquake##85##1##(1990-11#5)(1992-12#1)(1996-4#47)(2006-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#2)(2012-1#6)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#3)
earthquakes and##2##2##(1996-4#2)
earthquakes are##2##2##(1996-4#2)
earthquakes in##5##2##(1996-4#5)
earthquakes is##3##2##(1996-4#3)
earthquakes that##4##2##(1996-4#3)(2012-2#1)
earthquakes with##2##2##(1996-4#2)
earthquakes##46##1##(1990-11#4)(1996-4#38)(2008-3#2)(2010-8#1)(2012-2#1)
earths in##2##2##(2008-10#2)
earths##22##1##(1992-11#1)(2008-10#21)
earthworm gut metagenome##2##3##(2011-1#2)
earthworm##8##1##(2008-5#3)(2008-7#1)(2008-9#1)(2011-1#2)(2012-3#1)
earthworms##7##1##(2008-10#4)(2008-12#2)(2008-5#1)
earthy and musty odors in##2##5##(2008-10#2)
earthy and musty odors##3##4##(2008-10#3)
ease and##3##2##(2008-10#1)(2009-5#1)(2012-3#1)
ease in##6##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#2)
ease of access##2##3##(2008-12#1)(2011-2#1)
ease of alignment##2##3##(2008-2#2)
ease of discovery##2##3##(2012-2#2)
ease of fabrication##2##3##(2008-10#1)(2008-3#1)
ease of gastric tube placement##2##5##(2010-7#2)
ease of handling##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
ease of insertion##2##3##(2010-7#2)
ease of its##3##3##(2007-12#2)(2009-12#1)
ease of operation##3##3##(2008-10#1)(2008-11#2)
ease of performance##2##3##(1994-12#1)(2008-6#1)
ease of use of##4##4##(1994-3#1)(2009-12#1)(2012-3#1)(2013-1#1)
ease of use##9##3##(1992-12#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-6#1)(2009-10#1)(2009-12#1)(2012-3#1)(2013-1#1)
ease of##73##2##(1992-11#1)(1992-12#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-12#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#2)(2010-10#1)(2010-12#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
ease the##5##2##(1992-1#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-6#1)
ease their##2##2##(1992-1#1)(2009-9#1)
ease to##2##2##(2008-1#1)(2011-1#1)
ease##104##1##(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-4#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#1)
eased##2##1##(2007-11#1)(2011-2#1)
eases the##2##2##(1996-12#1)(2007-10#1)
eases##4##1##(1996-12#1)(2007-10#1)(2007-11#1)(2008-3#1)
easier access to##2##3##(2008-11#2)
easier and more##2##3##(2008-10#1)(2008-2#1)
easier and safer##2##3##(1996-1#1)(1996-9#1)
easier and##9##2##(1991-3#1)(1991-5#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-12#1)
easier if##2##2##(2008-9#1)(2010-2#1)
easier than##6##2##(2008-1#1)(2008-10#2)(2008-2#1)(2010-6#1)(2012-2#1)
easier to achieve##2##3##(2008-11#1)(2013-8#1)
easier to detect##2##3##(2008-10#1)(2008-5#1)
easier to implant##2##3##(2010-6#1)(2012-3#1)
easier to perform##2##3##(2008-10#1)(2008-4#1)
easier to use##3##3##(1992-3#1)(2008-10#1)(2012-2#1)
easier to##38##2##(1990-12#1)(1992-12#1)(1992-3#1)(1992-8#1)(1996-2#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
easier##89##1##(1990-11#1)(1990-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#1)(1995-1#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#6)(2009-1#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
easiest##6##1##(1990-3#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
easily accessed##2##2##(2008-10#2)
easily accessible to the##2##4##(1992-12#1)(2008-10#1)
easily accessible to##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
easily accessible##8##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)
easily accomplished##3##2##(1995-8#1)(2008-10#1)(2008-3#1)
easily achieved##7##2##(2008-1#1)(2008-10#5)(2008-9#1)
easily adapted to the##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
easily adapted to##8##3##(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-3#1)
easily adapted##9##2##(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-3#1)
easily administered##2##2##(1991-5#1)(1996-1#1)
easily aligned##2##2##(2008-2#2)
easily and quickly##5##3##(1990-6#1)(1992-12#1)(2008-10#2)(2008-11#1)
easily and rapidly##2##3##(2008-10#1)(2008-11#1)
easily and##17##2##(1990-6#1)(1992-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-6#1)(2011-2#1)(2012-3#2)(2013-7#1)
easily applicable##2##2##(1997-4#1)(2008-11#1)
easily applied##4##2##(2008-10#1)(2008-2#1)(2010-11#1)(2010-4#1)
easily available##11##2##(1990-6#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
easily be identified##2##3##(1996-12#1)(2008-2#1)
easily be modified##2##3##(1994-3#1)(2008-3#1)
easily be##47##2##(1990-2#1)(1990-9#1)(1994-3#2)(1996-12#2)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-3#2)
easily broken##2##2##(2008-10#1)(2012-2#1)
easily by##7##2##(1996-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)
easily calculated##2##2##(1997-3#1)(2009-12#1)
easily conjugated##2##2##(2008-10#2)
easily controlled##6##2##(1994-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-1#1)
easily converted##3##2##(2008-10#2)(2008-4#1)
easily detectable##2##2##(1990-8#1)(2007-10#1)
easily detected in##3##3##(2008-10#2)(2012-1#1)
easily detected##12##2##(1990-2#1)(1991-5#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-6#1)(2012-1#1)
easily determined##7##2##(1993-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)
easily differentiated##2##2##(2008-10#1)(2008-5#1)
easily distinguish the##2##3##(2008-10#2)
easily eliminated by##4##3##(2008-10#4)
easily excited##2##2##(2012-12#1)(2013-8#1)
easily explained##2##2##(2008-10#2)
easily from##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
easily identified##5##2##(1992-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
easily implemented##7##2##(1997-3#1)(2008-3#4)(2008-7#1)(2013-7#1)
easily in##3##2##(1991-2#1)(2007-7#1)(2008-2#1)
easily managed##2##2##(1991-3#1)(2008-8#1)
easily manipulated##2##2##(2008-2#1)(2008-4#1)
easily measurable##2##2##(1995-6#1)(2008-3#1)
easily measured##3##2##(1993-5#1)(2008-2#1)(2013-1#1)
easily measures##2##2##(2008-10#1)(2008-4#1)
easily missed##4##2##(1994-9#1)(2008-7#1)(2009-4#1)(2013-8#1)
easily modified##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
easily monitored by##2##3##(2008-10#1)(2008-11#1)
easily monitored##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
easily observed in##3##3##(2007-11#1)(2008-3#1)(2012-1#1)
easily observed##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2012-1#1)
easily obtainable##5##2##(2008-10#2)(2008-6#1)(2011-1#1)(2012-12#1)
easily obtained using##2##3##(1996-9#1)(2011-2#1)
easily obtained##6##2##(1993-12#1)(1996-5#1)(1996-9#1)(2007-12#1)(2009-3#1)(2011-2#1)
easily on the##2##3##(1992-12#1)(2013-1#1)
easily overlooked##3##2##(1997-6#1)(2007-8#2)
easily oxidizable##2##2##(2008-10#2)
easily performed using##2##3##(2008-9#1)(2010-11#1)
easily performed with a##2##4##(2008-10#1)(2011-2#1)
easily performed##11##2##(1990-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-9#1)(2010-11#2)(2011-2#1)
easily prepared##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2009-11#1)
easily provide the##2##3##(1991-3#1)(2008-3#1)
easily recognized##3##2##(2008-10#2)(2008-7#1)
easily recovered##3##2##(1997-8#1)(2007-11#2)
easily regenerated by##2##3##(2008-10#2)
easily regenerated##5##2##(2008-10#5)
easily renewable by##5##3##(2008-10#5)
easily result##2##2##(1991-12#1)(2008-7#1)
easily separated from##2##3##(2008-10#2)
easily separated##4##2##(2008-10#4)
easily solved by##2##3##(2008-3#1)(2011-2#1)
easily taken##2##2##(2008-10#2)
easily than##4##2##(1997-3#1)(2008-12#1)(2008-8#1)(2012-2#1)
easily the##2##2##(2008-2#1)(2009-6#1)
easily to##6##2##(1992-10#1)(1995-6#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
easily with##7##2##(2008-10#2)(2008-3#2)(2008-8#1)(2010-5#1)(2013-1#1)
easily##493##1##(1990-12#2)(1990-2#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#5)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#4)(1996-9#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-5#1)(2007-7#2)(2007-8#7)(2008-1#4)(2008-10#134)(2008-11#20)(2008-12#6)(2008-2#16)(2008-3#45)(2008-4#14)(2008-5#11)(2008-6#8)(2008-7#14)(2008-8#10)(2008-9#9)(2009-11#2)(2009-12#4)(2009-3#3)(2009-4#3)(2009-6#1)(2009-9#2)(2010-1#2)(2010-11#4)(2010-12#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#5)(2012-12#8)(2012-2#11)(2012-3#10)(2013-1#6)(2013-7#2)(2013-8#5)
easiness##4##1##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
easing##3##1##(1990-4#1)(2008-10#1)(2013-8#1)
east and##4##2##(2008-10#3)(2008-6#1)
east coast##4##2##(2008-10#1)(2009-12#1)(2010-8#2)
east of##8##2##(1992-2#1)(1996-11#1)(1996-4#1)(2008-10#2)(2008-12#2)(2008-8#1)
east##33##1##(1990-3#1)(1991-2#1)(1991-4#1)(1992-2#1)(1996-11#1)(1996-4#1)(2007-5#1)(2008-10#12)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-8#4)(2012-2#1)(2012-3#1)(2013-1#1)
east-west##5##1##(2008-10#3)(2008-2#2)
eastern Asia##3##2##(2008-8#2)(2008-9#1)
eastern Australia##3##2##(2008-10#2)(2011-2#1)
eastern Canada##4##2##(1993-2#1)(2008-10#1)(2009-6#1)(2010-8#1)
eastern Canadian##2##2##(2008-10#2)
eastern Europe##3##2##(1991-11#1)(2010-3#1)(2012-5#1)
eastern North America##8##3##(2008-10#6)(2008-8#2)
eastern North Carolina residents##2##4##(2013-1#2)
eastern North Carolina##3##3##(2008-10#1)(2013-1#2)
eastern North##11##2##(2008-10#7)(2008-8#2)(2013-1#2)
eastern Pacific##2##2##(2008-5#2)
eastern and Western Australia##2##4##(2008-10#2)
eastern and western Germany##2##4##(2009-10#2)
eastern and western##10##3##(2008-10#8)(2009-10#2)
eastern and##13##2##(2008-10#11)(2009-10#2)
eastern filbert blight##4##3##(2008-10#4)
eastern part of Nepal##2##4##(2008-7#1)(2012-3#1)
eastern populations##4##2##(2008-10#4)
eastern region##2##2##(2008-7#1)(2011-2#1)
eastern subpopulation##3##2##(2012-12#3)
eastern##119##1##(1991-11#1)(1992-1#1)(1992-8#2)(1993-2#1)(1996-6#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-1#2)(2008-10#56)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#3)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#6)(2011-2#4)(2012-12#3)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#5)
eastern-central Spain##2##2##(2008-10#2)
easy access to the##2##4##(1997-6#1)(2012-2#1)
easy access to##4##3##(1996-12#1)(1997-6#1)(2008-7#1)(2012-2#1)
easy access##6##2##(1996-12#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#1)(2012-2#1)
easy adaptation##2##2##(2008-10#2)
easy and efficient##2##3##(1994-12#1)(2007-11#1)
easy and safe##3##3##(1990-8#1)(2006-12#1)(2007-2#1)
easy and##24##2##(1990-8#1)(1991-3#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#1)
easy axis##2##2##(2007-12#1)(2012-2#1)
easy because##2##2##(1996-3#1)(2008-3#1)
easy construction of##3##3##(1990-5#1)(1994-12#1)(2013-8#1)
easy construction##4##2##(1990-5#1)(1994-12#1)(2008-10#1)(2013-8#1)
easy for##5##2##(2008-10#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)
easy from##2##2##(2008-10#1)(2013-1#1)
easy identification##2##2##(1993-9#1)(2008-10#1)
easy implementation##2##2##(2008-10#1)(2008-2#1)
easy listening and country##2##4##(1993-1#2)
easy listening##3##2##(1993-1#3)
easy method##2##2##(2007-8#1)(2008-10#1)
easy methodology##2##2##(2008-11#1)(2012-2#1)
easy operation##2##2##(2008-10#1)(2010-5#1)
easy or##2##2##(1994-3#1)(2008-9#1)
easy quantification of##2##3##(2008-11#1)(2012-2#1)
easy task##3##2##(2008-9#1)(2010-2#1)(2012-3#1)
easy technique to##2##3##(2010-9#1)(2011-1#1)
easy to access##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
easy to achieve##2##3##(1995-2#1)(2008-5#1)
easy to administer##3##3##(2008-7#1)(2010-7#1)(2010-8#1)
easy to adopt##2##3##(2011-2#1)(2012-12#1)
easy to align##2##3##(2008-3#2)
easy to apply##4##3##(2007-7#1)(2007-8#1)(2008-10#2)
easy to carry##3##3##(2008-10#3)
easy to compute##2##3##(2008-7#2)
easy to handle and##2##4##(2008-10#1)(2008-11#1)
easy to handle##6##3##(1990-6#1)(1990-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
easy to implement##7##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
easy to learn and##4##4##(2008-1#1)(2009-2#1)(2010-11#1)(2011-1#1)
easy to operate and##3##4##(2008-10#2)(2008-11#1)
easy to operate##4##3##(2008-10#3)(2008-11#1)
easy to perform and##2##4##(2008-5#1)(2009-5#1)
easy to perform##13##3##(1990-8#1)(1993-2#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
easy to prepare##2##3##(2008-10#2)
easy to see how##2##4##(2008-11#1)(2011-2#1)
easy to see##3##3##(1994-12#1)(2008-11#1)(2011-2#1)
easy to use and##2##4##(2008-10#1)(2008-9#1)
easy to use##16##3##(1991-11#1)(1991-9#1)(1994-1#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
easy to##111##2##(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#25)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#4)(2008-7#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
easy way##5##2##(1997-2#1)(2007-12#1)(2008-10#2)(2013-8#1)
easy##269##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-3#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#4)(1993-11#1)(1993-2#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-3#2)(1995-12#2)(1995-2#3)(1995-5#1)(1996-1#2)(1996-12#4)(1996-3#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#62)(2008-11#16)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#8)(2009-10#4)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#11)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#5)
easy-to-implement##4##1##(2007-11#2)(2008-12#2)
easy-to-use##8##1##(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#1)
eat##20##1##(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#3)(1997-1#1)(1997-4#1)(2008-3#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
eaten##4##1##(1997-4#1)(2008-1#1)(2008-5#1)(2011-2#1)
eaters##5##1##(2007-12#2)(2007-7#2)(2010-1#1)
eating and activity##2##3##(2009-6#1)(2013-1#1)
eating and body##2##3##(1997-7#1)(2007-12#1)
eating and physical activity##3##4##(2009-6#1)(2010-8#1)(2013-1#1)
eating and the##3##3##(1993-12#1)(2012-2#1)(2012-3#1)
eating and##16##2##(1991-8#1)(1993-12#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-6#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
eating attitudes##4##2##(2007-7#4)
eating behavior##6##2##(2008-11#2)(2008-4#2)(2011-1#1)(2012-12#1)
eating behaviors##2##2##(2008-11#1)(2012-3#1)
eating behaviour##3##2##(2011-2#1)(2012-1#2)
eating concerns##6##2##(2007-12#6)
eating disorder (ED)##2##3##(2012-2#1)(2013-8#1)
eating disorder symptomatology##2##3##(2007-12#2)
eating disorder##14##2##(1993-12#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-11#1)(2011-2#3)(2012-2#2)(2013-8#2)
eating disordered patients##2##3##(1993-12#2)
eating disordered##5##2##(1993-12#4)(2007-12#1)
eating disorders and##3##3##(2008-4#1)(2010-11#1)(2012-2#1)
eating disorders in##2##3##(2007-7#1)(2008-11#1)
eating disorders is##2##3##(1997-7#1)(2007-7#1)
eating disorders not otherwise specified (EDNOS)##2##6##(2007-7#1)(2012-2#1)
eating disorders not otherwise specified##3##5##(1993-12#1)(2007-7#1)(2012-2#1)
eating disorders##35##2##(1993-12#1)(1997-3#1)(1997-7#2)(2007-12#1)(2007-7#5)(2008-1#2)(2008-11#3)(2008-4#4)(2008-8#1)(2010-11#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)
eating disturbances##2##2##(2012-2#2)
eating for##2##2##(2008-4#1)(2010-1#1)
eating habits and##3##3##(2010-7#1)(2012-12#1)(2012-2#1)
eating habits##11##2##(1993-8#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-1#3)(2010-7#1)(2012-12#1)(2012-2#1)
eating in##5##2##(2007-12#1)(2007-7#2)(2008-4#2)
eating or##2##2##(1993-6#2)
eating patterns##4##2##(2007-12#1)(2008-11#2)(2008-7#1)
eating times##2##2##(1993-6#2)
eating##182##1##(1991-8#1)(1993-12#9)(1993-3#2)(1993-6#6)(1993-8#4)(1994-3#1)(1995-5#2)(1997-3#1)(1997-7#5)(1997-8#1)(2007-12#18)(2007-2#1)(2007-3#1)(2007-7#18)(2008-1#2)(2008-10#2)(2008-11#13)(2008-4#16)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#2)(2010-1#6)(2010-11#7)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#12)(2011-7#1)(2012-1#6)(2012-12#5)(2012-2#16)(2012-3#2)(2013-1#4)(2013-8#2)
eats##2##1##(1991-4#1)(2008-7#1)
eavesdropper##2##1##(2007-12#2)
eavesdropping attacks##2##2##(2008-2#2)
ebastine 10 or 20mg##2##4##(2008-3#2)
ebastine##5##1##(2007-11#1)(2008-3#4)
ebelactone B##5##2##(1995-6#1)(2010-10#4)
ebelactone##6##1##(1995-6#2)(2010-10#4)
eberconazole 1% cream##2##3##(2008-5#2)
eberconazole##5##1##(2008-5#5)
ecDHFR##2##1##(1995-2#2)
ecastophyllum##2##1##(2008-10#2)
ecc##2##1##(1993-9#2)
eccentric##6##1##(1991-3#1)(2008-3#1)(2008-6#1)(2010-3#1)(2013-1#2)
eccentrically located##2##2##(2007-12#1)(2008-3#1)
eccentricities##4##1##(1991-8#1)(2008-3#2)(2010-10#1)
eccentricity of##2##2##(2007-11#2)
eccentricity##6##1##(2007-11#2)(2008-2#1)(2008-3#2)(2008-7#1)
ecchymosis##2##1##(2008-10#1)(2011-1#1)
ecchymotic##2##1##(1990-2#1)(2008-12#1)
eccrine spiradenoma##2##2##(2007-7#2)
eccrine sweat##8##2##(1996-6#1)(2008-5#7)
eccrine##13##1##(1996-6#1)(2007-7#2)(2008-5#8)(2008-7#1)(2013-8#1)
ecdysial##3##1##(2008-7#3)
ecdysone##8##1##(1995-8#3)(2008-5#4)(2008-6#1)
ecdysteroid secretion by##3##3##(1995-11#3)
ecdysteroid secretion is##2##3##(1995-11#2)
ecdysteroid secretion##9##2##(1995-11#9)
ecdysteroid titer##2##2##(1995-11#2)
ecdysteroid##15##1##(1995-11#12)(2007-12#1)(2008-6#1)(2008-9#1)
ecdysteroidogenesis##2##1##(1995-11#2)
ecdysteroids##6##1##(1995-11#1)(2008-9#3)(2012-2#2)
echelle##3##1##(2008-3#3)
echinocandin##4##1##(2008-10#1)(2011-2#3)
echinocandins##4##1##(2008-10#1)(2008-7#1)(2011-2#2)
echinococcal cysts##2##2##(1995-12#1)(2008-7#1)
echinococcosis and##3##2##(1993-9#2)(2012-2#1)
echinococcosis##19##1##(1993-6#4)(1993-9#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#2)(2012-3#6)
echinococcosis]##2##1##(2008-10#1)(2012-3#1)
echinococcus##2##1##(2008-12#1)(2013-1#1)
echinoderm larval##4##2##(2011-2#4)
echinoderm##7##1##(2011-2#7)
echinoid##2##1##(2008-6#1)(2008-8#1)
echinomycin##5##1##(2008-10#5)
echo amplitudes of the##2##4##(2008-3#1)(2011-2#1)
echo experiments##2##2##(2008-8#2)
echo patterns##2##2##(1994-9#1)(1996-1#1)
echo planar imaging##2##3##(1992-3#2)
echo signals##3##2##(2007-12#1)(2010-8#1)(2012-3#1)
echo was##3##2##(2009-5#1)(2012-3#2)
echo##30##1##(1992-3#2)(1993-11#1)(1993-2#1)(1994-9#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#3)(2009-5#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#3)
echo-poor or inhomogeneous##2##3##(1990-9#2)
echocardiogram showed##2##2##(2011-2#1)(2013-1#1)
echocardiogram##10##1##(1992-2#1)(2007-10#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#2)
echocardiograms##6##1##(1992-2#1)(2010-4#1)(2011-2#1)(2012-1#2)(2013-1#1)
echocardiographic and##2##2##(2009-4#2)
echocardiographic control##2##2##(1997-5#1)(2007-8#1)
echocardiographic examination##3##2##(1997-5#1)(2008-4#1)(2008-7#1)
echocardiographic findings##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
echocardiographic recognition##2##2##(2008-11#2)
echocardiographic signs of ACP##2##4##(1991-11#2)
echocardiographic##23##1##(1990-8#1)(1991-11#3)(1997-5#2)(2007-8#3)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2009-4#2)(2011-2#1)(2012-3#2)(2013-1#1)
echocardiography and its newer modalities##2##5##(2011-2#2)
echocardiography and the##3##3##(2007-10#1)(2008-11#2)
echocardiography and##17##2##(1991-9#1)(1996-6#1)(2007-10#1)(2007-8#4)(2008-11#2)(2008-7#2)(2011-2#4)(2012-3#2)
echocardiography are##2##2##(2010-10#1)(2012-2#1)
echocardiography evaluation##2##2##(2007-8#1)(2011-2#1)
echocardiography has##3##2##(2007-8#1)(2011-2#2)
echocardiography in acute##2##3##(1991-11#1)(1997-3#1)
echocardiography in##6##2##(1991-11#1)(1996-6#1)(1997-3#1)(2007-8#1)(2009-4#1)(2013-7#1)
echocardiography is##2##2##(1994-11#1)(2007-8#1)
echocardiography performed##2##2##(1997-3#2)
echocardiography revealed a##2##3##(1997-4#1)(2007-10#1)
echocardiography revealed##6##2##(1997-4#1)(2007-10#1)(2007-8#1)(2013-1#3)
echocardiography showed##3##2##(2007-7#1)(2013-1#1)(2013-7#1)
echocardiography to##2##2##(2007-9#1)(2010-10#1)
echocardiography utilization##2##2##(2012-1#2)
echocardiography was performed##2##3##(1994-11#1)(2011-2#1)
echocardiography was##5##2##(1991-11#1)(1994-11#1)(2011-2#2)(2012-1#1)
echocardiography with##2##2##(1994-11#1)(2012-3#1)
echocardiography##123##1##(1991-11#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1994-11#4)(1995-3#1)(1996-3#1)(1996-6#3)(1997-3#4)(1997-4#1)(1997-8#3)(2006-10#1)(2007-10#3)(2007-7#3)(2007-8#17)(2007-9#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-4#1)(2008-7#5)(2009-1#2)(2009-10#2)(2009-4#1)(2010-10#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#18)(2012-1#7)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#2)
echocardiography]##4##1##(2008-9#1)(2009-5#1)(2010-8#1)(2013-8#1)
echoes in##3##2##(1993-5#1)(2007-12#1)(2011-2#1)
echoes##12##1##(1993-5#1)(2007-11#2)(2007-12#5)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
echogenic##4##1##(2007-7#2)(2013-1#2)
echogenicity##7##1##(1996-1#1)(2007-10#5)(2007-7#1)
echographic##3##1##(1991-5#1)(2007-8#1)(2008-10#1)
echography##7##1##(1990-3#1)(1990-5#1)(1991-5#1)(1993-3#1)(2007-8#1)(2008-5#1)(2010-6#1)
echolocating##3##1##(2009-8#3)
echotomography##3##1##(1991-5#1)(2007-7#2)
eclampsia##5##1##(2007-10#1)(2008-4#1)(2012-12#1)(2013-1#2)
eclipse##6##1##(1991-6#1)(2008-5#4)(2013-8#1)
eclosion##12##1##(1990-12#5)(1995-11#1)(2007-12#3)(2008-10#1)(2008-6#1)(2010-2#1)
eco-friendly##5##1##(2008-10#4)(2011-2#1)
ecologic estimates are##2##3##(1992-6#2)
ecologic estimates##3##2##(1992-6#3)
ecologic studies##2##2##(1990-6#1)(1992-6#1)
ecologic##10##1##(1990-6#1)(1992-6#7)(2007-2#1)(2011-2#1)
ecological adaptation##2##2##(2007-12#1)(2011-2#1)
ecological and epidemiological##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
ecological and evolutionary##4##3##(1996-6#1)(2008-8#1)(2010-12#1)(2013-1#1)
ecological and social##2##3##(2008-8#1)(2008-9#1)
ecological and##19##2##(1996-6#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-8#5)(2008-9#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
ecological approach##5##2##(2008-10#1)(2010-11#1)(2011-1#2)(2013-7#1)
ecological communities##8##2##(2008-8#4)(2008-9#3)(2013-1#1)
ecological conditions##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#2)(2013-7#1)
ecological constraints##12##2##(2008-10#1)(2008-8#11)
ecological context##2##2##(2012-12#1)(2012-3#1)
ecological contexts##2##2##(2008-5#1)(2010-3#1)
ecological data##2##2##(2008-5#1)(2010-1#1)
ecological diversity##2##2##(2008-10#1)(2011-2#1)
ecological effects##3##2##(2007-5#1)(2008-12#1)(2008-8#1)
ecological factors##8##2##(1992-11#1)(2007-10#1)(2008-6#1)(2008-8#3)(2010-10#1)(2012-3#1)
ecological genetics##2##2##(2008-8#2)
ecological impacts of##2##3##(2008-11#2)
ecological interactions##5##2##(2007-7#1)(2008-6#1)(2008-9#2)(2009-8#1)
ecological isolating barrier##2##3##(2008-10#2)
ecological literature##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
ecological model##4##2##(1991-12#1)(2008-1#1)(2010-11#2)
ecological models##7##2##(1991-12#1)(2008-3#1)(2008-9#1)(2011-1#4)
ecological niche##5##2##(1997-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
ecological niches on citrus and##2##5##(2008-10#2)
ecological niches##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
ecological or##3##2##(2008-10#1)(2008-8#1)(2010-12#1)
ecological populations##2##2##(2008-10#1)(2008-8#1)
ecological processes##4##2##(2008-10#1)(2008-8#2)(2012-2#1)
ecological properties##2##2##(2008-5#1)(2008-8#1)
ecological recovery##3##2##(1997-5#1)(2008-11#2)
ecological relevance##2##2##(1994-3#1)(2008-10#1)
ecological risk of##2##3##(2008-11#1)(2008-8#1)
ecological risk##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
ecological role##2##2##(2008-8#1)(2012-2#1)
ecological separation##2##2##(2008-8#1)(2012-2#1)
ecological studies##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
ecological study##2##2##(2008-6#1)(2008-9#1)
ecological systems##3##2##(1995-5#1)(2008-10#1)(2013-8#1)
ecological validity##2##2##(2010-9#1)(2012-12#1)
ecological variation##2##2##(2012-2#1)(2012-3#1)
ecological zones##4##2##(1996-4#3)(2008-8#1)
ecological##238##1##(1991-12#2)(1992-11#1)(1992-5#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-4#4)(1996-6#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-5#3)(2007-7#2)(2008-1#2)(2008-10#25)(2008-11#11)(2008-12#2)(2008-3#1)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#61)(2008-9#21)(2009-6#1)(2009-7#2)(2009-8#6)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#11)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#12)(2012-3#7)(2012-5#2)(2013-1#3)(2013-7#6)(2013-8#2)
ecologically important##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
ecologically relevant##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
ecologically valid##2##2##(2008-11#1)(2012-2#1)
ecologically##21##1##(1996-2#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
ecologies##2##1##(2008-9#2)
ecologiques de##2##2##(2008-5#2)
ecologists to##2##2##(2007-5#1)(2008-9#1)
ecologists##8##1##(2007-5#1)(2008-8#3)(2008-9#4)
ecology and the##2##3##(2008-7#1)(2008-8#1)
ecology and##19##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
ecology has##2##2##(2008-8#1)(2008-9#1)
ecology in##2##2##(2008-8#1)(2008-9#1)
ecology of the##5##3##(2008-10#1)(2008-5#2)(2009-10#1)(2010-8#1)
ecology of##25##2##(2007-12#1)(2007-5#1)(2008-10#8)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#3)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
ecology##86##1##(1997-6#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#19)(2008-9#13)(2009-10#1)(2009-4#3)(2009-8#2)(2010-1#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#4)(2013-8#2)
econazole##3##1##(1994-8#1)(2008-5#1)(2013-1#1)
econometric##3##1##(1993-12#1)(1997-1#1)(2008-11#1)
economic activity##4##2##(2010-7#1)(2011-2#3)
economic advantages of##2##3##(2008-3#1)(2010-6#1)
economic advantages##4##2##(2008-3#1)(2008-6#1)(2010-6#1)(2012-2#1)
economic alternative##2##2##(2008-10#1)(2008-3#1)
economic analyses are##2##3##(1993-12#1)(2013-8#1)
economic analyses##4##2##(1993-12#2)(2008-7#1)(2013-8#1)
economic analysis of##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
economic analysis##7##2##(1996-1#1)(1997-2#2)(2008-12#1)(2008-6#1)(2008-7#2)
economic and cultural##2##3##(1995-5#1)(2009-10#1)
economic and demographic##2##3##(1993-2#1)(2008-3#1)
economic and political##5##3##(1992-9#1)(1994-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
economic and social##4##3##(1992-1#2)(2008-11#1)(2011-1#1)
economic and##31##2##(1990-12#1)(1992-1#2)(1992-9#1)(1993-2#2)(1994-12#1)(1994-2#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
economic approach to##2##3##(2008-10#1)(2012-12#1)
economic approach##3##2##(2008-10#2)(2012-12#1)
economic aspects of##3##3##(1993-12#2)(2011-2#1)
economic barriers##2##2##(2008-7#1)(2013-1#1)
economic behavior##2##2##(1994-12#1)(2011-2#1)
economic benefit of##3##3##(1994-2#1)(2008-12#2)
economic benefit##6##2##(1994-2#1)(1996-3#1)(2008-1#1)(2008-12#2)(2013-1#1)
economic benefits of##3##3##(1996-1#1)(2008-10#1)(2011-2#1)
economic benefits to##2##3##(2008-3#1)(2011-1#1)
economic benefits##10##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
economic burden of##5##3##(1995-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-3#1)
economic burden to##2##3##(1995-11#1)(2009-8#1)
economic burden##10##2##(1995-11#2)(2007-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-1#1)
economic circumstances##2##2##(2008-10#1)(2008-7#1)
economic climate##4##2##(1992-12#1)(1992-3#1)(1994-1#1)(2008-11#1)
economic conditions##3##2##(1993-12#1)(1995-5#1)(2007-12#1)
economic considerations##2##2##(2007-12#1)(2008-7#1)
economic cost##7##2##(1993-2#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
economic costs of##2##3##(1994-2#1)(2008-11#1)
economic costs##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#2)
economic credentialing##3##2##(1991-12#2)(1992-1#1)
economic crisis in the##2##4##(2011-2#1)(2012-2#1)
economic crisis##4##2##(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
economic criteria##3##2##(1991-12#1)(1993-3#1)(2008-10#1)
economic damage##2##2##(2008-10#1)(2011-2#1)
economic data##5##2##(1994-12#1)(2007-10#1)(2007-8#2)(2008-6#1)
economic determinants of##2##3##(2009-10#2)
economic development##4##2##(1994-9#1)(2008-11#2)(2009-7#1)
economic disadvantage predicted##2##3##(2007-10#2)
economic disadvantage##4##2##(2007-10#3)(2010-9#1)
economic evaluation of##2##3##(2008-6#1)(2011-2#1)
economic evaluation##5##2##(2008-6#1)(2011-2#2)(2013-8#2)
economic evaluations##4##2##(2008-10#1)(2011-2#1)(2013-8#2)
economic factors##4##2##(1992-1#1)(1997-1#1)(2011-1#1)(2011-2#1)
economic forces##2##2##(1991-1#1)(1997-3#1)
economic foundation##2##2##(1993-12#1)(1994-2#1)
economic gains from##2##3##(1994-3#2)
economic gains##3##2##(1994-3#3)
economic growth##8##2##(1994-2#3)(1994-7#1)(2008-11#2)(2010-5#1)(2010-8#1)
economic impact of the##2##4##(1997-2#1)(2008-10#1)
economic impact of##6##3##(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
economic impact##17##2##(1992-6#1)(1994-2#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#5)(2008-8#1)(2011-2#3)
economic implications##4##2##(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
economic importance of##2##3##(2007-5#1)(2013-8#1)
economic importance##10##2##(2007-5#1)(2008-10#4)(2008-12#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
economic incentives##3##2##(1991-1#1)(2008-1#1)(2011-2#1)
economic independence##2##2##(2008-11#1)(2012-12#1)
economic indicators##7##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
economic injury level##2##3##(2008-8#1)(2011-2#1)
economic issues##3##2##(1991-12#1)(2008-10#1)(2008-6#1)
economic levers##2##2##(1995-2#2)
economic losses in##3##3##(2008-10#2)(2011-2#1)
economic losses to##2##3##(2009-2#1)(2011-2#1)
economic losses##12##2##(2007-12#2)(2007-6#1)(2008-10#5)(2009-2#1)(2010-4#1)(2011-2#2)
economic model##2##2##(2013-1#2)
economic or##2##2##(1997-1#1)(2013-7#1)
economic pressures##3##2##(1993-1#1)(1993-12#1)(1995-1#1)
economic problem##2##2##(2008-10#2)
economic problems##5##2##(1995-1#1)(2008-5#1)(2009-10#3)
economic realities##5##2##(1992-12#1)(1992-4#1)(1993-1#2)(2007-5#1)
economic reasons##2##2##(2008-10#1)(2011-2#1)
economic return##2##2##(2008-10#2)
economic savings##2##2##(1994-6#1)(1995-1#1)
economic scarcity##2##2##(2008-1#1)(2008-7#1)
economic significance##2##2##(2007-11#1)(2011-2#1)
economic status##4##2##(1992-8#1)(2008-1#2)(2009-5#1)
economic studies##4##2##(2011-2#4)
economic threat to##2##3##(2008-10#2)
economic trees##2##2##(2008-12#2)
economic use of##2##3##(2008-7#1)(2010-8#1)
economic value##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
economic variables##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
economic viability##2##2##(2007-5#1)(2008-7#1)
economic wealth##3##2##(2012-3#3)
economic##425##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#4)(1991-12#6)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-12#7)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#4)(1994-12#7)(1994-2#11)(1994-3#5)(1994-6#1)(1994-7#2)(1994-9#1)(1995-1#6)(1995-11#3)(1995-2#6)(1995-3#2)(1995-5#5)(1995-9#1)(1996-1#6)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#3)(1997-2#7)(1997-3#3)(1997-6#1)(1997-7#1)(2007-10#4)(2007-11#2)(2007-12#12)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#9)(2008-10#44)(2008-11#16)(2008-12#8)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#8)(2008-7#21)(2008-8#5)(2008-9#2)(2009-10#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#7)(2011-2#41)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#20)(2013-7#3)(2013-8#10)
economical and effective##2##3##(1994-2#1)(2013-1#1)
economical and environmentally##2##3##(2008-10#2)
economical and##17##2##(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-5#1)(2013-1#1)
economical aspects##2##2##(2008-6#2)
economical but##3##2##(1990-8#1)(1995-3#1)(2008-11#1)
economical##69##1##(1990-8#1)(1991-12#1)(1992-1#1)(1994-1#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(2008-1#2)(2008-10#20)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
economically efficient##2##2##(1994-2#1)(2008-10#1)
economically feasible##6##2##(1996-11#1)(2008-10#2)(2008-6#1)(2009-12#1)(2011-2#1)
economically important diseases##2##3##(2008-10#2)
economically important pathogen##2##3##(2008-10#2)
economically important##18##2##(2007-2#1)(2008-10#14)(2008-12#1)(2010-10#1)(2013-7#1)
economically significant##2##2##(2008-10#2)
economically viable##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
economically##51##1##(1993-3#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-2#2)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-10#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-7#1)(2013-8#2)
economics and finance##2##3##(1993-3#1)(1997-3#1)
economics and##6##2##(1993-2#1)(1993-3#1)(1997-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
economics in##2##2##(1994-8#1)(2008-1#1)
economics of##10##2##(1991-2#1)(1994-3#3)(1997-8#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-4#1)
economics##31##1##(1991-2#1)(1993-2#2)(1993-3#1)(1994-3#3)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
economies of scale##5##3##(1992-2#1)(1996-1#1)(1997-1#1)(2010-5#1)(2012-2#1)
economies of scope##2##3##(1997-1#2)
economies of##8##2##(1992-2#1)(1996-1#1)(1997-1#3)(1997-8#1)(2010-5#1)(2012-2#1)
economies##18##1##(1992-2#1)(1993-2#1)(1994-3#1)(1996-1#1)(1997-1#3)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#2)
economists##2##1##(1995-11#1)(1997-2#1)
economy and##5##2##(1994-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
economy during##2##2##(2008-11#1)(2011-2#1)
economy in##2##2##(2011-2#1)(2013-1#1)
economy is##2##2##(1991-1#1)(2011-2#1)
economy of scale##2##3##(2008-4#1)(2008-9#1)
economy of##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-8#1)
economy to##2##2##(2008-1#1)(2008-11#1)
economy##59##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-2#4)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#3)(1997-1#1)(1997-5#1)(1997-6#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#3)(2010-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
economywide##3##1##(1991-12#1)(1992-1#1)(1992-2#1)
ecophysiology##2##1##(2011-1#1)(2012-3#1)
ecosystem and##3##2##(1997-7#1)(2008-5#1)(2012-2#1)
ecosystem dynamics##2##2##(1990-8#1)(2008-9#1)
ecosystem health##2##2##(2008-10#1)(2008-7#1)
ecosystem in the##2##3##(2008-10#1)(2008-5#1)
ecosystem in##6##2##(2007-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-2#1)
ecosystem of the##2##3##(2008-6#1)(2008-9#1)
ecosystem of##3##2##(2008-12#1)(2008-6#1)(2008-9#1)
ecosystem services of##3##3##(2008-9#3)
ecosystem services##4##2##(2008-9#4)
ecosystem structure and process##3##4##(2008-9#3)
ecosystem such as##2##3##(1997-7#1)(2009-4#1)
ecosystem with##2##2##(2008-5#1)(2011-2#1)
ecosystem##63##1##(1990-8#1)(1991-3#1)(1997-7#4)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#15)(2009-4#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-5#1)(2012-9#1)(2013-7#1)
ecosystems and##3##2##(1995-1#1)(2009-2#1)(2011-1#1)
ecosystems as##2##2##(2008-8#1)(2010-4#1)
ecosystems in##2##2##(2008-10#2)
ecosystems is also##2##3##(2008-10#1)(2008-11#1)
ecosystems is##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
ecosystems of##2##2##(2008-8#1)(2008-9#1)
ecosystems with##2##2##(2008-9#2)
ecosystems##47##1##(1995-1#1)(1995-3#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#8)(2008-9#6)(2009-2#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-6#1)(2012-9#1)(2013-1#1)(2013-7#1)
ecotoxicity##2##1##(2008-11#2)
ecotoxicological risk##2##2##(2008-11#1)(2008-9#1)
ecotoxicological##12##1##(2008-10#3)(2008-11#7)(2008-5#1)(2008-9#1)
ecotype##12##1##(2008-10#12)
ecotypes of Arabidopsis thaliana##2##4##(2008-10#2)
ecotypes of Arabidopsis##3##3##(2008-10#3)
ecotypes of##4##2##(2008-10#4)
ecotypes##13##1##(2008-10#9)(2008-7#1)(2009-10#1)(2012-3#2)
ecstasy##2##1##(1997-6#1)(2012-1#1)
ectasia##6##1##(1997-3#3)(1997-8#1)(2007-8#1)(2008-11#1)
ectatic##4##1##(1997-3#3)(2008-12#1)
ecto-5' nucleotidase##6##2##(2008-4#6)
ecto-ATPase##3##1##(1994-12#1)(2008-4#2)
ecto-nucleoside triphosphate diphosphohydrolase 3 (NTPDase3)##3##5##(2008-4#3)
ecto-nucleoside triphosphate diphosphohydrolase 3##4##4##(2008-4#4)
ecto-nucleoside triphosphate diphosphohydrolase##5##3##(2008-4#5)
ecto-nucleoside triphosphate diphosphohydrolases (NTPDases)##2##4##(2008-4#2)
ecto-nucleoside triphosphate diphosphohydrolases##3##3##(2008-4#3)
ecto-nucleoside triphosphate##8##2##(2008-4#8)
ecto-nucleotidase eNTPDase 1-3 in##2##4##(2008-4#2)
ecto-nucleotidase##6##1##(2008-4#6)
ectocervix##3##1##(1994-12#1)(2012-3#2)
ectoderm and##5##2##(1994-12#2)(2007-12#1)(2008-11#1)(2008-7#1)
ectoderm##8##1##(1994-12#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
ectodermal dysplasia##3##2##(2008-7#2)(2012-12#1)
ectodermal origin##2##2##(2007-12#1)(2008-5#1)
ectodermal##15##1##(1992-9#1)(1993-12#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
ectodermic##2##1##(2008-7#1)(2012-3#1)
ectodomain of##2##2##(1997-1#2)
ectodomain##4##1##(1997-1#3)(2008-5#1)
ectomesenchymal##2##1##(2013-1#2)
ectomycorrhizal##3##1##(2012-6#3)
ectoparasite load##3##2##(2009-2#3)
ectoparasite##12##1##(1997-7#1)(2008-10#1)(2008-5#3)(2009-2#5)(2013-1#2)
ectoparasites##7##1##(1997-7#2)(2008-5#4)(2009-2#1)
ectoparasitic nematode damage##3##3##(2008-10#3)
ectoparasitic nematodes##2##2##(2008-10#2)
ectoparasitic##7##1##(2008-10#6)(2009-5#1)
ectoparasitosis##2##1##(2007-2#2)
ectophosphatase activities##2##2##(2008-10#2)
ectopia##3##1##(2008-10#1)(2011-2#1)(2013-8#1)
ectopias##3##1##(1996-5#3)
ectopic ACTH secretion##2##3##(1990-3#2)
ectopic ACTH##5##2##(1990-3#2)(2008-8#1)(2011-2#2)
ectopic bone formation##3##3##(2007-8#1)(2011-2#1)(2012-12#1)
ectopic bone##4##2##(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)
ectopic discharges##3##2##(2008-9#3)
ectopic expression in##2##3##(1993-12#1)(2009-8#1)
ectopic expression of##5##3##(1996-5#1)(2008-11#2)(2008-7#1)(2012-2#1)
ectopic expression##7##2##(1993-12#1)(1996-5#1)(2008-11#2)(2008-7#1)(2009-8#1)(2012-2#1)
ectopic phallus##2##2##(2008-10#2)
ectopic pregnancies##7##2##(1990-8#1)(1992-4#3)(1993-12#1)(1995-8#1)(2011-1#1)
ectopic pregnancy is a##2##4##(2009-6#1)(2013-1#1)
ectopic pregnancy is##3##3##(1997-2#1)(2009-6#1)(2013-1#1)
ectopic pregnancy##15##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-9#1)(1997-2#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
ectopic tachycardia##2##2##(2010-5#2)
ectopic third molar in the##2##5##(2013-1#2)
ectopic ureter##2##2##(2008-10#2)
ectopic##100##1##(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-4#3)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#6)(1997-2#2)(2007-8#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2010-5#2)(2011-1#7)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
ectopically expressed##2##2##(1994-12#1)(2008-4#1)
ectopically##7##1##(1994-12#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
ectoplasmic specialization##5##2##(2009-10#1)(2012-2#4)
ectoplasmic##6##1##(2009-10#2)(2012-2#4)
ectopy and##2##2##(1992-6#1)(2010-4#1)
ectopy##5##1##(1992-6#2)(1996-3#1)(2008-1#1)(2010-4#1)
ectothermic##2##1##(2008-12#1)(2008-6#1)
ectotherms to##2##2##(2008-8#2)
ectotherms##9##1##(1993-11#3)(2008-8#5)(2013-7#1)
eczema and atopy##2##3##(2010-6#2)
eczema and##4##2##(1991-2#1)(1993-8#1)(2010-6#2)
eczema##20##1##(1990-3#1)(1991-2#1)(1993-8#1)(1994-6#1)(1996-8#1)(2007-7#1)(2008-5#1)(2010-6#3)(2012-2#1)(2013-1#9)
eczematous##2##1##(1997-8#1)(2010-8#1)
ed##18##1##(1994-3#1)(1995-3#1)(2007-2#3)(2008-11#4)(2008-12#4)(2008-2#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-8#1)
edaphic##3##1##(2008-10#2)(2008-11#1)
edatrexate that##2##2##(2008-6#2)
edatrexate##4##1##(2008-6#4)
eddy-correlation measurements##3##2##(2008-3#3)
edema and erythema of the breast##2##6##(1993-8#2)
edema and erythema##3##3##(1993-8#3)
edema and##24##2##(1991-8#1)(1992-4#1)(1992-9#2)(1993-8#3)(2007-10#1)(2007-2#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)
edema assay##4##2##(2011-1#4)
edema associated with##2##3##(2007-10#1)(2009-4#1)
edema at##2##2##(1992-9#1)(2008-5#1)
edema formation in##5##3##(1992-6#1)(1994-8#1)(2008-2#1)(2008-8#1)(2010-10#1)
edema formation##9##2##(1992-6#2)(1994-8#2)(2008-10#1)(2008-2#1)(2008-8#2)(2010-10#1)
edema in a##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
edema in rat##2##3##(1992-6#1)(2008-2#1)
edema in the##2##3##(1993-8#1)(2009-9#1)
edema in##15##2##(1992-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
edema induced by##2##3##(2008-12#1)(2008-5#1)
edema is##3##2##(1992-2#1)(2007-10#1)(2008-7#1)
edema of the##5##3##(1992-9#1)(1994-6#1)(2006-10#1)(2007-8#1)(2010-8#1)
edema or##2##2##(1991-12#1)(2013-8#1)
edema to##2##2##(2006-10#1)(2010-2#1)
edema were##3##2##(1993-9#1)(2008-11#1)(2010-2#1)
edema with##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
edema##132##1##(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-2#5)(1992-4#1)(1992-6#3)(1992-9#7)(1993-8#4)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#1)(2006-10#2)(2006-7#1)(2007-10#6)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#1)(2010-12#1)(2010-2#6)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#14)(2011-7#3)(2012-12#1)(2012-2#2)(2013-1#8)(2013-7#2)(2013-8#1)
edema)##2##1##(2007-7#1)(2008-1#1)
edematous##2##1##(1990-3#1)(1995-11#1)
edentulism##3##1##(2011-7#1)(2012-2#1)(2013-1#1)
edentulous maxilla##4##2##(2009-4#1)(2011-7#1)(2013-1#2)
edentulous patient with##3##3##(2013-1#3)
edentulous patient##4##2##(2013-1#4)
edentulous patients##5##2##(1990-12#1)(2010-12#1)(2010-5#1)(2011-7#1)(2013-1#1)
edentulous##25##1##(1990-12#1)(1991-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-7#4)(2012-12#2)(2013-1#11)
edge and##6##2##(2008-3#1)(2008-8#1)(2009-11#1)(2010-11#1)(2013-7#1)(2013-8#1)
edge detection and##3##3##(2008-2#2)(2008-3#1)
edge detection##7##2##(2007-7#1)(2008-2#2)(2008-3#4)
edge dislocations##3##2##(2007-11#1)(2007-12#1)(2009-7#1)
edge effect##2##2##(2013-7#2)
edge effects##5##2##(1994-11#1)(2008-3#2)(2008-6#1)(2008-9#1)
edge enhanced##3##2##(2008-2#2)(2008-3#1)
edge enhancement of an##2##4##(2007-12#1)(2008-3#1)
edge enhancement of##4##3##(2007-12#1)(2008-3#3)
edge enhancement##10##2##(2007-12#1)(2008-2#4)(2008-3#5)
edge extraction##2##2##(2008-2#1)(2008-3#1)
edge image motion is##2##4##(2008-3#2)
edge image motion##3##3##(2008-3#3)
edge image waviness##5##3##(2008-3#5)
edge image##8##2##(2008-3#8)
edge in##3##2##(1995-2#1)(2008-2#1)(2011-2#1)
edge length##2##2##(2008-5#1)(2013-1#1)
edge lengths##2##2##(2008-10#1)(2013-1#1)
edge location##2##2##(2008-3#2)
edge of a##8##3##(2007-11#1)(2008-3#4)(2008-9#1)(2011-2#1)(2013-7#1)
edge of the hemilamina##2##4##(2011-2#2)
edge of the object##2##4##(2011-2#2)
edge of the photonic bandgap##2##5##(2007-12#1)(2008-2#1)
edge of the##27##3##(1992-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#5)(2012-3#1)
edge of this##2##3##(1994-5#1)(2008-2#1)
edge of##54##2##(1992-12#1)(1992-3#1)(1994-1#1)(1994-5#3)(1995-12#1)(1995-6#1)(1996-3#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
edge technique##2##2##(2008-2#2)
edge to##2##2##(2008-10#1)(2008-5#1)
edge waviness##2##2##(2008-3#2)
edge##189##1##(1990-11#2)(1990-4#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-1#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#1)(2007-10#1)(2007-11#5)(2007-12#14)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#23)(2008-3#51)(2008-5#5)(2008-6#8)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#6)(2013-8#3)
edge)##2##1##(2008-3#2)
edge-based##2##1##(2008-6#2)
edge-enhanced optical correlation with##2##4##(2008-3#2)
edge-enhanced optical correlation##5##3##(2007-12#2)(2008-3#3)
edge-enhanced##7##1##(2007-12#2)(2008-3#5)
edge-enhancement##2##1##(2008-2#1)(2008-3#1)
edge-pumped slab##2##2##(2007-11#2)
edge-pumped##3##1##(2007-11#3)
edge-to-edge##3##1##(2007-8#2)(2009-7#1)
edges and##3##2##(2008-3#2)(2013-1#1)
edges are##5##2##(2008-2#1)(2008-3#2)(2008-9#2)
edges have##2##2##(2008-3#1)(2008-9#1)
edges in##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
edges of Sc##2##3##(2008-2#1)(2008-3#1)
edges of an##2##3##(2007-11#1)(2008-2#1)
edges of the##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2010-7#1)(2011-2#1)
edges of##19##2##(1997-3#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-9#2)(2009-3#1)(2010-7#1)(2011-2#1)
edges provides##2##2##(2008-8#1)(2008-9#1)
edges##68##1##(1992-3#1)(1997-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#11)(2008-3#20)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#7)(2009-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#1)(2013-1#2)(2013-8#1)
edible films and coatings##2##4##(2010-7#2)
edible films and##3##3##(2010-7#3)
edible frogs and goldfish##2##4##(2008-12#2)
edible mushroom##3##2##(2008-10#2)(2008-11#1)
edible oil mixtures##2##3##(2008-10#2)
edible oil##3##2##(2008-10#3)
edible oils##8##2##(2008-10#7)(2011-2#1)
edible seaweed##4##2##(2008-10#4)
edible##44##1##(1994-3#1)(2008-10#22)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#4)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
edited by##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
edited in the##2##3##(1992-11#1)(1993-12#1)
edited in##4##2##(1990-11#1)(1992-11#2)(1993-12#1)
edited##14##1##(1990-11#2)(1990-7#1)(1992-11#4)(1993-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-1#1)(2012-2#1)
editing enzyme##2##2##(1992-11#2)
editing in##4##2##(1994-8#1)(2010-9#1)(2012-2#2)
editing is##4##2##(1990-11#1)(1990-7#1)(2010-9#2)
editing of the##2##3##(1994-8#1)(1997-2#1)
editing of##7##2##(1993-12#1)(1994-8#1)(1997-2#3)(2008-3#1)(2011-3#1)
editing process##2##2##(1995-5#2)
editing protein##10##2##(1994-8#10)
editing sites##2##2##(2010-9#2)
editing status of##2##3##(1995-5#2)
editing status##3##2##(1995-5#3)
editing##63##1##(1990-11#4)(1990-7#4)(1992-11#6)(1993-12#4)(1994-8#14)(1995-5#5)(1995-6#1)(1995-9#1)(1997-2#4)(2008-3#1)(2008-4#2)(2008-7#2)(2010-4#1)(2010-9#8)(2011-1#1)(2011-3#1)(2012-2#4)
edition of the Journal##2##4##(1997-1#1)(2011-2#1)
edition of the##6##3##(1997-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
edition of##9##2##(1993-12#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#1)
edition##18##1##(1993-12#1)(1993-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#1)(2013-8#1)
editions of##2##2##(2008-10#1)(2009-10#1)
editions##4##1##(2008-10#3)(2009-10#1)
editor##35##1##(1995-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(2008-11#5)(2008-12#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
editorial board##7##2##(2008-6#3)(2010-12#3)(2013-1#1)
editorial by##2##2##(1993-9#1)(1996-11#1)
editorial for##2##2##(2008-10#1)(2008-8#1)
editorial on##2##2##(1993-9#1)(1996-11#1)
editorial##26##1##(1993-12#1)(1993-9#2)(1996-11#2)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-6#3)(2008-8#1)(2009-4#1)(2010-12#6)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
editorials##6##1##(2008-10#1)(2011-1#4)(2012-12#1)
editors##9##1##(1993-12#1)(1994-1#1)(1995-1#1)(1996-12#1)(2007-12#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
edits##2##1##(2008-3#1)(2008-4#1)
edodes by##2##2##(2008-11#2)
edodes##8##1##(2008-10#1)(2008-11#7)
edu##3##1##(2008-7#1)(2010-12#1)(2012-2#1)
educate and counsel##2##3##(1993-2#1)(1997-6#1)
educate and##5##2##(1993-2#1)(1995-12#1)(1997-6#1)(2008-10#1)(2011-1#1)
educate both##3##2##(1994-1#1)(2008-12#1)(2009-11#1)
educate staff and##2##3##(1992-12#1)(2008-12#1)
educate the##5##2##(1992-1#1)(1994-1#2)(1994-5#1)(2011-2#1)
educate##38##1##(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-1#3)(1994-3#1)(1994-5#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-3#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
educated about the##2##3##(2008-11#1)(2012-12#1)
educated about##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
educated and##2##2##(1992-1#1)(2013-1#1)
educated in##2##2##(1994-1#1)(2008-12#1)
educated on##3##2##(2008-10#2)(2010-1#1)
educated than##2##2##(2008-12#1)(2012-12#1)
educated women##2##2##(1991-11#1)(1992-4#1)
educated##38##1##(1991-11#1)(1992-1#1)(1992-4#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
educating and##2##2##(1995-12#1)(2009-3#1)
educating parents of##2##3##(1996-3#1)(2013-7#1)
educating the##6##2##(1991-1#1)(1991-2#1)(1992-3#1)(1994-1#1)(1995-1#1)(2007-6#1)
educating##20##1##(1990-9#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-9#1)(2012-3#1)(2013-7#1)
education (IPE)##2##2##(2008-11#1)(2008-12#1)
education (health)##2##2##(1997-6#2)
education (p##2##2##(1994-3#1)(2010-8#1)
education about quality##2##3##(1993-3#2)
education about the##3##3##(1994-12#1)(2008-3#1)(2008-9#1)
education about##14##2##(1991-12#1)(1993-12#1)(1993-3#2)(1994-12#1)(2007-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-10#1)(2012-3#3)
education activities##5##2##(1994-1#1)(2007-11#1)(2008-1#1)(2008-9#2)
education and care##3##3##(2008-1#2)(2010-12#1)
education and clinical practice##3##4##(2007-10#1)(2008-11#2)
education and clinical##4##3##(2007-10#1)(2008-11#3)
education and experience##3##3##(1995-3#2)(2007-10#1)
education and how##2##3##(1993-11#1)(2011-2#1)
education and medical##3##3##(1991-3#1)(1993-1#1)(2010-12#1)
education and practice links##2##4##(2008-11#2)
education and practice##10##3##(1996-2#1)(2008-11#8)(2008-12#1)
education and professional##2##3##(2008-1#1)(2008-11#1)
education and research##3##3##(1995-12#1)(2008-10#1)(2008-9#1)
education and social##2##3##(1991-12#1)(2013-1#1)
education and support##2##3##(1992-2#1)(1993-12#1)
education and the##8##3##(1991-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(2008-11#1)(2011-2#2)(2013-1#1)
education and training for##2##4##(1994-2#1)(2008-11#1)
education and training needs##2##4##(1996-1#1)(2008-11#1)
education and training of##4##4##(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
education and training programme##3##4##(2008-12#3)
education and training programs##2##4##(1992-1#1)(2008-11#1)
education and training##22##3##(1991-1#1)(1992-1#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(2007-8#1)(2008-11#4)(2008-12#4)(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
education and##137##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#4)(1996-2#3)(1996-3#2)(1997-2#3)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#7)(2008-10#1)(2008-11#24)(2008-12#14)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#3)
education are##10##2##(1993-6#2)(1994-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-9#1)(2012-3#1)
education as a##2##3##(1991-2#1)(2010-4#1)
education as an##2##3##(1990-6#1)(2009-10#1)
education as##5##2##(1990-6#1)(1991-2#1)(2008-11#1)(2009-10#1)(2010-4#1)
education at the##3##3##(1991-2#1)(1994-11#1)(2013-1#1)
education at##7##2##(1991-2#1)(1994-11#1)(1996-3#1)(2008-1#1)(2008-11#2)(2013-1#1)
education can##2##2##(1993-11#1)(2008-11#1)
education class##3##2##(1991-2#1)(2007-10#1)(2007-2#1)
education classes##5##2##(2007-2#4)(2012-2#1)
education department##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
education during the##3##3##(1994-12#1)(1994-3#1)(2007-2#1)
education during##4##2##(1994-12#1)(1994-3#1)(2007-2#1)(2010-10#1)
education environments##2##2##(2008-12#1)(2012-3#1)
education for health##3##3##(1992-12#1)(1994-12#1)(2008-11#1)
education for nurses##5##3##(2008-11#1)(2008-12#3)(2008-9#1)
education for patients and##2##4##(2008-1#1)(2008-8#1)
education for the 21st century##2##5##(1991-1#1)(1994-2#1)
education for the##5##3##(1991-1#1)(1991-2#1)(1992-3#1)(1994-2#1)(2010-4#1)
education for##42##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-11#4)(2008-12#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#3)(2013-1#2)
education from##2##2##(1995-2#1)(2007-6#1)
education group##2##2##(2011-1#1)(2013-1#1)
education had##2##2##(2009-10#1)(2009-7#1)
education has##13##2##(1991-1#1)(1991-8#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#4)(2008-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
education in Canada##3##3##(1994-12#2)(1995-1#1)
education in a##4##3##(1992-12#1)(1997-1#1)(2009-5#1)(2012-3#1)
education in all##2##3##(1994-12#1)(2009-6#1)
education in health care quality is##2##6##(1993-3#2)
education in health care quality##3##5##(1993-3#3)
education in health##6##3##(1991-1#1)(1993-12#1)(1993-3#3)(2008-12#1)
education in managed care##4##4##(1997-3#3)(2008-12#1)
education in quality##2##3##(1993-3#2)
education in schools##2##3##(1996-3#1)(2011-2#1)
education in the United States##4##5##(1991-8#2)(1994-12#2)
education in the United##5##4##(1991-8#2)(1994-12#2)(2008-11#1)
education in the pre-registration##2##4##(2008-11#2)
education in the##24##3##(1990-5#1)(1991-1#1)(1991-8#2)(1993-11#1)(1993-8#1)(1994-12#2)(1994-3#1)(2007-6#1)(2008-11#5)(2008-12#4)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-1#1)
education in##92##2##(1990-5#1)(1990-6#1)(1991-1#2)(1991-8#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#6)(1993-8#1)(1994-12#9)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-5#1)(2007-5#1)(2007-6#1)(2008-11#12)(2008-12#9)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
education institutions##5##2##(2008-12#3)(2010-3#1)(2013-1#1)
education into##4##2##(2007-2#2)(2010-5#1)(2012-3#1)
education is a##3##3##(1990-6#1)(1993-6#1)(2007-5#1)
education is an##2##3##(1997-2#1)(2008-12#1)
education is central to##2##4##(2008-12#1)(2008-7#1)
education is not##4##3##(1994-12#1)(1996-2#1)(2008-11#1)(2008-12#1)
education is the##3##3##(2010-3#1)(2012-3#1)(2013-8#1)
education is##33##2##(1990-6#1)(1992-11#1)(1993-6#1)(1994-12#3)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-4#1)(2007-5#1)(2008-11#6)(2008-12#5)(2008-7#1)(2010-3#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
education level##10##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-12#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-1#2)
education levels##6##2##(1993-3#1)(2008-9#3)(2011-2#1)(2013-1#1)
education literature##2##2##(1994-12#1)(2013-1#1)
education may##4##2##(2008-11#1)(2008-12#1)(2013-8#2)
education movement##2##2##(2007-2#2)
education needs for##2##3##(1997-3#1)(2012-3#1)
education needs to##3##3##(1991-3#1)(2010-3#1)(2012-2#1)
education needs##10##2##(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2010-3#1)(2012-2#1)(2012-3#1)
education of clinical laboratory##2##4##(1994-12#2)
education of clinical##3##3##(1994-12#3)
education of health care administrators##2##5##(1992-2#1)(1993-3#1)
education of health care##3##4##(1992-2#1)(1993-3#1)(2008-12#1)
education of health professionals##3##4##(2008-11#3)
education of health##7##3##(1992-2#1)(1993-2#1)(1993-3#1)(2008-11#3)(2008-12#1)
education of hospital##2##3##(1991-12#1)(1996-8#1)
education of the##7##3##(1991-12#1)(1993-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(2007-7#1)(2008-10#1)
education of their##2##3##(1994-1#1)(2013-8#1)
education of##41##2##(1990-2#1)(1991-12#2)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#7)(2008-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#2)
education often##2##2##(1990-11#1)(2009-12#1)
education on the##4##3##(1990-3#1)(2008-8#1)(2010-9#1)(2013-1#1)
education on##15##2##(1990-3#1)(1991-1#1)(1993-12#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
education or##3##2##(2008-11#3)
education policy##2##2##(1994-2#1)(2012-3#1)
education program and##5##3##(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
education program that##3##3##(1996-3#1)(1997-3#1)(2010-8#1)
education program was##2##3##(2008-5#1)(2010-7#1)
education program##21##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#2)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
education programme##9##2##(1991-6#1)(2007-11#1)(2008-11#2)(2010-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
education programmes for##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
education programmes##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#2)(2011-1#1)(2013-1#2)
education programs for##2##3##(1995-9#1)(2007-10#1)
education programs have##2##3##(1996-3#1)(2008-12#1)
education programs in##2##3##(2007-12#1)(2010-3#1)
education programs##26##2##(1991-2#1)(1992-2#1)(1993-2#2)(1994-12#1)(1995-1#2)(1995-12#2)(1995-9#1)(1996-1#2)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-6#1)(2010-3#1)(2012-2#1)
education providers##2##2##(2008-11#2)
education regarding the##6##3##(1995-1#2)(2008-12#1)(2010-1#1)(2010-2#1)(2010-5#1)
education regarding##9##2##(1995-1#2)(1997-3#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-1#1)(2010-2#1)(2010-5#1)
education research##4##2##(2008-12#2)(2013-1#2)
education resources##4##2##(1991-3#3)(2008-6#1)
education services##3##2##(1993-3#1)(1995-1#1)(1995-12#1)
education session and##2##3##(2013-1#2)
education session##6##2##(2008-5#1)(2011-1#2)(2013-1#3)
education sessions##2##2##(2008-11#1)(2008-5#1)
education settings##3##2##(1991-12#1)(2013-8#2)
education should##4##2##(1994-12#1)(1996-8#1)(2008-12#1)(2009-5#1)
education strategies##2##2##(2007-10#1)(2008-3#1)
education system##5##2##(1992-8#1)(2008-1#1)(2008-10#1)(2008-11#2)
education through##3##2##(1990-2#1)(1994-2#1)(2008-12#1)
education to support##3##3##(2007-10#1)(2013-1#2)
education to the##3##3##(1992-12#1)(2007-10#1)(2008-12#1)
education to##20##2##(1992-1#1)(1992-12#1)(1992-8#1)(1994-3#1)(1996-1#1)(2007-10#3)(2007-4#1)(2008-12#4)(2008-7#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
education today##2##2##(2008-11#1)(2011-2#1)
education using a##2##3##(2009-12#1)(2013-1#1)
education was associated with##2##4##(2009-11#1)(2010-4#1)
education was##10##2##(1994-2#1)(2008-12#3)(2008-7#1)(2009-11#1)(2010-1#1)(2010-4#1)(2012-3#2)
education were##4##2##(1994-2#1)(1996-1#1)(2008-12#1)(2011-2#1)
education will be##2##3##(1997-3#1)(2012-1#1)
education will##5##2##(1995-1#1)(1997-3#1)(2007-5#1)(2008-11#1)(2012-1#1)
education with##3##2##(2007-3#1)(2011-2#1)(2012-3#1)
education within##2##2##(1992-2#1)(2008-11#1)
education workers##6##2##(2007-12#6)
education##1180##1##(1990-11#2)(1990-12#1)(1990-2#7)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#13)(1991-11#1)(1991-12#8)(1991-2#13)(1991-3#10)(1991-6#1)(1991-8#6)(1992-1#9)(1992-11#2)(1992-12#8)(1992-2#12)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#9)(1993-11#5)(1993-12#11)(1993-2#9)(1993-3#21)(1993-5#1)(1993-6#6)(1993-8#2)(1994-1#6)(1994-11#1)(1994-12#38)(1994-2#11)(1994-3#11)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#12)(1995-12#14)(1995-2#10)(1995-3#11)(1995-5#2)(1995-9#2)(1996-1#15)(1996-12#6)(1996-2#8)(1996-3#18)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#4)(1997-1#8)(1997-2#7)(1997-3#14)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#14)(2007-11#4)(2007-12#11)(2007-2#16)(2007-3#2)(2007-4#6)(2007-5#6)(2007-6#4)(2007-7#1)(2007-8#2)(2008-1#23)(2008-10#10)(2008-11#170)(2008-12#122)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#7)(2008-7#13)(2008-8#14)(2008-9#22)(2009-10#7)(2009-11#3)(2009-12#6)(2009-5#9)(2009-6#4)(2009-7#9)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#12)(2010-11#6)(2010-12#3)(2010-2#3)(2010-3#15)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#23)(2011-2#40)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#22)(2012-3#34)(2013-1#57)(2013-8#19)
education)##2##1##(1992-1#1)(2008-11#1)
education?##5##1##(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)
education]##12##1##(1990-11#1)(1992-4#1)(1992-9#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)(2012-3#1)
educational activities##2##2##(1991-9#1)(2010-8#1)
educational and occupational level##2##4##(2010-11#2)
educational and professional##2##3##(2008-12#1)(2012-12#1)
educational and support intervention##4##4##(2011-2#4)
educational and support##5##3##(2011-2#5)
educational and##24##2##(1993-1#1)(1993-12#1)(1994-1#1)(1996-2#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#2)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#1)
educational approach##2##2##(1994-2#1)(1996-11#1)
educational aspirations for their children##2##5##(2009-7#2)
educational aspirations##3##2##(1990-9#1)(2009-7#2)
educational attainment##10##2##(1994-3#1)(2008-11#1)(2009-10#1)(2009-7#4)(2010-11#1)(2010-7#1)(2013-8#1)
educational background##4##2##(1990-12#1)(1990-2#1)(1991-12#1)(2010-12#1)
educational backgrounds##2##2##(1994-2#1)(2008-9#1)
educational benefits##3##2##(1992-1#1)(2008-12#2)
educational campaigns##3##2##(1990-3#1)(2012-12#1)(2013-8#1)
educational context##2##2##(2008-12#1)(2011-2#1)
educational efforts##3##2##(1996-3#1)(1997-1#1)(2008-9#1)
educational evaluators##2##2##(2008-12#2)
educational expectations##3##2##(2009-7#3)
educational experience##3##2##(2008-12#1)(2011-2#1)(2013-7#1)
educational experiences##3##2##(2008-11#2)(2012-1#1)
educational formation##2##2##(2013-1#2)
educational forum##2##2##(2008-12#1)(2010-11#1)
educational inequalities in##2##3##(2009-10#1)(2013-1#1)
educational institutions##5##2##(2008-11#1)(2008-12#1)(2010-3#1)(2013-1#2)
educational intervention on##2##3##(2011-2#1)(2012-1#1)
educational intervention##10##2##(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)
educational interventions in the##2##4##(2008-4#1)(2012-2#1)
educational interventions in##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
educational interventions##10##2##(1991-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#3)(2013-1#1)
educational level and mother-infant interaction in##2##6##(1990-12#2)
educational level and mother-infant interaction##3##5##(1990-12#3)
educational level and##7##3##(1990-12#3)(1991-3#1)(1992-2#1)(2012-12#1)(2013-1#1)
educational level##14##2##(1990-12#3)(1990-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(2008-10#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
educational levels were##2##3##(1996-7#1)(2012-3#1)
educational levels##4##2##(1996-7#1)(2012-1#1)(2012-3#2)
educational material##2##2##(1996-4#1)(2008-3#1)
educational materials##5##2##(1991-1#1)(2008-3#1)(2010-9#3)
educational methods##2##2##(2008-11#1)(2012-2#1)
educational needs of##4##3##(1992-12#2)(1992-3#1)(2008-11#1)
educational needs##7##2##(1992-12#2)(1992-3#1)(1993-3#1)(1995-2#2)(2008-11#1)
educational outcomes for##2##3##(2008-11#1)(2008-12#1)
educational outcomes##6##2##(1991-1#1)(2007-4#1)(2008-11#2)(2008-12#1)(2011-1#1)
educational philosophy##2##2##(1992-2#1)(1993-1#1)
educational preparation and##2##3##(2008-11#1)(2008-9#1)
educational preparation##5##2##(2008-1#1)(2008-11#3)(2008-9#1)
educational process##3##2##(1993-3#1)(2008-12#1)(2012-1#1)
educational processes##4##2##(1992-2#1)(2008-12#3)
educational program##11##2##(1990-6#1)(1991-2#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
educational programme##3##2##(1995-6#1)(2008-11#2)
educational programmes##5##2##(2008-11#4)(2008-12#1)
educational programs and##2##3##(1996-1#1)(2008-12#1)
educational programs are##2##3##(1992-1#1)(1995-1#1)
educational programs in##2##3##(1992-1#1)(2008-1#1)
educational programs##16##2##(1990-2#1)(1992-1#3)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#3)(2007-10#1)(2008-1#2)(2008-12#2)(2012-2#1)
educational providers##3##2##(2008-11#2)(2008-12#1)
educational requirements##2##2##(1992-1#1)(1995-12#1)
educational seminars##2##2##(1991-2#1)(1996-3#1)
educational session##2##2##(2011-1#2)
educational sessions##6##2##(1993-3#1)(1994-3#1)(2008-6#2)(2012-3#1)(2013-1#1)
educational setting##2##2##(2007-12#1)(2008-12#1)
educational standards##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
educational strategies in the##2##4##(2007-6#2)
educational strategies##7##2##(1995-2#1)(2007-6#4)(2008-11#1)(2008-8#1)
educational strategy##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
educational system##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
educational systems##2##2##(2008-11#1)(2012-1#1)
educational##342##1##(1990-12#4)(1990-2#4)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#8)(1992-12#2)(1992-2#4)(1992-3#2)(1993-1#3)(1993-12#2)(1993-3#4)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#3)(1995-1#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#4)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#56)(2008-12#33)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#3)(2009-7#14)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#6)(2011-1#4)(2011-2#14)(2012-1#5)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#5)
educationalists are##2##2##(2008-11#2)
educationalists##12##1##(1995-1#1)(2008-11#10)(2008-9#1)
educationally)##2##1##(2008-11#2)
educative##2##1##(1993-12#1)(2008-12#1)
educator and##2##2##(2008-11#1)(2012-3#1)
educator in##3##2##(1996-3#1)(2008-11#2)
educator##17##1##(1993-12#1)(1996-3#1)(1997-2#2)(2007-2#4)(2008-11#4)(2008-12#3)(2012-12#1)(2012-3#1)
educator's##3##1##(1992-2#1)(2008-11#1)(2008-12#1)
educators and students##2##3##(2008-11#1)(2010-10#1)
educators and##10##2##(2007-11#1)(2007-2#2)(2008-11#1)(2008-12#3)(2010-10#1)(2011-2#1)(2013-1#1)
educators are##7##2##(1996-2#1)(2008-11#1)(2008-12#3)(2012-1#1)(2012-3#1)
educators can##5##2##(2007-2#1)(2008-12#3)(2010-3#1)
educators in##3##2##(2008-11#2)(2013-8#1)
educators may##3##2##(1996-3#1)(2007-2#1)(2008-12#1)
educators need to##4##3##(1996-3#1)(2008-12#2)(2008-9#1)
educators of##2##2##(1995-5#1)(2008-12#1)
educators scored highest in the##2##5##(2008-11#2)
educators should##2##2##(2007-2#1)(2013-8#1)
educators to##9##2##(2007-2#1)(2008-11#2)(2008-12#3)(2009-10#1)(2010-9#1)(2012-1#1)
educators who wish to##2##4##(2008-12#2)
educators who##3##2##(2008-11#1)(2008-12#2)
educators##100##1##(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#2)(2007-10#1)(2007-11#1)(2007-2#8)(2008-11#27)(2008-12#30)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
educators' critical thinking##2##3##(2008-11#2)
educators'##7##1##(2008-11#3)(2012-3#3)(2013-8#1)
educed##2##1##(2008-10#1)(2013-8#1)
edulis##4##1##(2008-11#2)(2010-5#2)
edwardsonii var##2##2##(2008-10#2)
edwardsonii##4##1##(2008-10#4)
ee##3##1##(1996-2#1)(1996-5#1)(2008-10#1)
ee)##3##1##(1996-5#2)(2008-6#1)
eel atrium##2##2##(2008-5#2)
eel##16##1##(1990-8#2)(2008-10#2)(2008-11#1)(2008-5#7)(2009-5#1)(2009-8#1)(2010-8#2)
eels##8##1##(2008-5#8)
een thuiswonende##2##2##(2012-12#2)
een werkdocument opgesteld##2##3##(2012-12#2)
een werkdocument##3##2##(2012-12#3)
een##11##1##(2012-12#11)
efavirenz were##2##2##(2008-5#2)
efavirenz##11##1##(2008-5#11)
efe gene##12##2##(2008-10#12)
efe homolog##2##2##(2008-10#2)
efe mutant##2##2##(2008-10#2)
efe mutants##2##2##(2008-10#2)
efe##21##1##(2008-10#21)
effacement##3##1##(1995-2#1)(2010-8#1)(2011-1#1)
effect -##2##2##(1995-12#1)(2008-11#1)
effect a##4##2##(1997-3#1)(2008-3#1)(2008-4#1)(2008-6#1)
effect after##3##2##(2007-11#1)(2008-5#1)(2010-5#1)
effect against the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
effect against##11##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2012-2#1)
effect also##9##2##(1991-9#1)(1993-3#1)(1995-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
effect among##4##2##(1990-3#1)(1992-8#1)(2008-12#1)(2008-5#1)
effect and can##2##3##(1991-6#1)(2008-2#1)
effect and the##12##3##(1994-11#1)(1994-2#2)(1996-6#1)(2008-3#2)(2008-7#1)(2010-6#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
effect and to##2##3##(2008-10#1)(2008-11#1)
effect and##78##2##(1990-10#1)(1990-7#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#2)(1996-12#1)(1996-2#1)(1996-6#4)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#11)(2008-11#4)(2008-2#4)(2008-3#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-8#3)
effect and/or##2##2##(2011-2#1)(2012-2#1)
effect appeared##3##2##(1992-8#1)(2008-5#1)(2011-2#1)
effect appears to be##4##4##(1990-2#1)(1991-5#1)(1994-8#1)(2008-8#1)
effect appears##5##2##(1990-2#1)(1991-5#1)(1994-8#1)(2008-11#1)(2008-8#1)
effect are##12##2##(1990-8#1)(1997-5#1)(1997-7#1)(2008-10#5)(2008-3#3)(2010-12#1)
effect as a function of##2##5##(2008-10#1)(2008-5#1)
effect as a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
effect as an##2##3##(2008-3#1)(2008-7#1)
effect as well##2##3##(1995-12#1)(2011-1#1)
effect as##13##2##(1992-6#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)
effect associated with##4##3##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
effect at a##2##3##(1993-8#1)(1995-5#1)
effect at an##2##3##(1992-8#1)(2008-10#1)
effect at the##6##3##(1992-5#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-6#1)(2009-8#1)
effect at##22##2##(1990-2#1)(1990-3#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
effect based on##2##3##(2008-10#1)(2010-11#1)
effect being##6##2##(1990-5#1)(1991-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
effect between the##2##3##(1993-3#1)(2008-10#1)
effect between##5##2##(1993-3#1)(2008-10#2)(2011-2#1)(2013-8#1)
effect both##2##2##(1993-12#1)(2008-2#1)
effect but##6##2##(1993-12#1)(1993-3#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
effect by##14##2##(1990-11#1)(1994-5#1)(1995-12#2)(1996-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
effect can be minimized##2##4##(2008-3#2)
effect can be used##2##4##(2007-12#1)(2008-10#1)
effect can be##16##3##(1992-8#1)(1994-3#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#6)(2008-5#1)(2008-8#1)(2009-9#1)
effect can cause##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
effect can##24##2##(1992-8#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-8#2)(2009-9#1)(2011-2#1)
effect cannot##2##2##(1990-8#1)(2009-2#1)
effect caused by a##2##4##(2007-12#2)
effect caused by the##3##4##(2008-10#3)
effect caused by##9##3##(2007-12#2)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)
effect compared with the##3##4##(1993-8#1)(2008-3#1)(2011-2#1)
effect compared with##4##3##(1993-8#1)(1997-2#1)(2008-3#1)(2011-2#1)
effect could be##9##3##(1991-9#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#1)(2013-8#1)
effect could##12##2##(1990-5#1)(1991-9#1)(1994-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#1)(2012-8#1)(2013-8#1)
effect depends on the##2##4##(1993-2#1)(2012-5#1)
effect did not##4##3##(1994-8#1)(1997-1#1)(2008-10#1)(2010-8#1)
effect differed##2##2##(2009-8#1)(2013-1#1)
effect disappeared##2##2##(1995-11#1)(2008-9#1)
effect does not involve##2##4##(1995-8#1)(1997-4#1)
effect does not##3##3##(1994-10#1)(1995-8#1)(1997-4#1)
effect does##4##2##(1994-10#1)(1995-8#1)(1997-4#1)(2008-11#1)
effect due to the##2##4##(1994-8#1)(2012-5#1)
effect due to##6##3##(1994-8#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-5#1)
effect during the##4##3##(2010-11#2)(2011-2#2)
effect during##5##2##(2010-11#2)(2011-2#3)
effect for all##2##3##(2008-10#1)(2008-5#1)
effect for the##6##3##(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)
effect for##43##2##(1991-8#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-11#3)(2007-7#1)(2008-10#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)(2009-7#2)(2010-1#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
effect from the##3##3##(1992-8#1)(2008-3#2)
effect from##11##2##(1992-8#1)(1997-7#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
effect gradually##2##2##(1995-2#1)(2010-5#1)
effect has been demonstrated##2##4##(2008-3#1)(2008-7#1)
effect has been##6##3##(1991-2#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-7#1)
effect has##11##2##(1990-8#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
effect have##3##2##(1990-2#1)(2008-10#1)(2012-1#1)
effect if the respondent##2##4##(2013-1#2)
effect if the##3##3##(1997-4#1)(2013-1#2)
effect if##5##2##(1997-4#1)(2008-7#1)(2009-7#1)(2013-1#2)
effect in a##8##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
effect in human##2##3##(1990-6#1)(1990-8#1)
effect in normal##2##3##(2012-2#1)(2012-3#1)
effect in patients##2##3##(2008-11#1)(2011-2#1)
effect in preventing##2##3##(1991-7#1)(2010-6#1)
effect in reducing##2##3##(1997-6#1)(2008-11#1)
effect in the vicinity of the##2##6##(2008-3#2)
effect in the##28##3##(1990-12#1)(1994-2#2)(1994-3#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-9#1)
effect in vitro##3##3##(1992-2#1)(2008-10#1)(2010-11#1)
effect in vivo##3##3##(1991-2#1)(1991-5#1)(1995-3#1)
effect in which##2##3##(1996-3#1)(2007-11#1)
effect in##153##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#4)(1992-2#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#5)(2007-12#11)(2008-1#2)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#22)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#3)(2009-2#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#2)(2013-8#4)
effect increases##2##2##(1995-5#1)(2008-8#1)
effect indicators##2##2##(2012-12#2)
effect induced by##3##3##(1990-2#1)(2008-3#2)
effect involving##2##2##(1992-8#1)(2013-1#1)
effect is attributed to##2##4##(1996-2#1)(2007-12#1)
effect is based on##2##4##(2007-12#1)(2008-7#1)
effect is caused by##2##4##(1991-6#1)(2008-2#1)
effect is demonstrated##3##3##(2007-11#2)(2012-2#1)
effect is dependent on the##4##5##(1997-6#1)(2008-5#1)(2009-10#1)(2011-2#1)
effect is dependent on##6##4##(1992-8#1)(1997-2#1)(1997-6#1)(2008-5#1)(2009-10#1)(2011-2#1)
effect is developed##2##3##(2008-2#1)(2008-3#1)
effect is due to##4##4##(1991-9#1)(2007-12#1)(2008-5#1)(2008-8#1)
effect is independent of the##2##5##(2008-4#1)(2009-10#1)
effect is less##2##3##(1990-2#1)(1991-2#1)
effect is likely to##2##4##(1996-6#1)(2011-2#1)
effect is mediated by##3##4##(1993-3#1)(2008-11#1)(2011-2#1)
effect is mediated##5##3##(1993-3#1)(1993-6#1)(2008-11#1)(2008-8#1)(2011-2#1)
effect is more##3##3##(2008-2#1)(2008-5#2)
effect is most##2##3##(1992-3#1)(2008-10#1)
effect is not##8##3##(1992-6#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
effect is observed at##2##4##(2007-12#1)(2008-10#1)
effect is observed in##2##4##(1992-9#1)(2008-12#1)
effect is observed##9##3##(1992-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2012-12#1)
effect is obtained##2##3##(1993-12#1)(2008-10#1)
effect is probably##2##3##(1990-10#1)(1991-9#1)
effect is shown to##2##4##(2008-3#2)
effect is specific##2##3##(1993-6#1)(1995-2#1)
effect is the difference##2##4##(2008-3#2)
effect is the result of##2##5##(2007-11#1)(2008-3#1)
effect is the##5##3##(2007-11#1)(2008-3#3)(2008-8#1)
effect is unknown##2##3##(1994-11#1)(2008-6#1)
effect is##145##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-8#2)(1995-2#4)(1995-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-6#2)(2007-10#1)(2007-11#8)(2007-12#6)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#16)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
effect it##2##2##(1990-2#1)(2008-3#1)
effect leads to##2##3##(2007-12#1)(2008-2#1)
effect levels##2##2##(2008-10#1)(2008-11#1)
effect may be##8##3##(1994-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2013-1#1)
effect may##13##2##(1992-4#1)(1994-8#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-11#1)(2013-1#1)
effect might be due to##2##5##(1991-2#1)(1995-11#1)
effect might be##3##3##(1991-2#1)(1995-11#1)(2008-5#1)
effect might##6##2##(1990-11#1)(1991-2#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
effect models##3##2##(1997-8#1)(2008-2#1)(2008-8#1)
effect modification##2##2##(1992-6#1)(2008-7#1)
effect must be##2##3##(1994-6#1)(2011-2#1)
effect observed for##2##3##(2007-12#1)(2010-12#1)
effect observed in the##3##4##(1993-8#1)(2008-10#2)
effect observed in##4##3##(1993-8#1)(2008-10#2)(2012-12#1)
effect observed##8##2##(1993-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-12#1)(2012-12#1)
effect occurred##3##2##(2008-1#1)(2008-10#2)
effect occurs in##2##3##(1993-8#1)(2008-7#1)
effect of 1##2##3##(1992-1#1)(2012-12#1)
effect of 2##3##3##(1993-6#1)(1996-2#1)(2008-12#1)
effect of 3##3##3##(1993-1#1)(1995-12#1)(2013-1#1)
effect of AFB(1)##2##3##(2008-10#2)
effect of AMDL##2##3##(1995-8#2)
effect of Ad-HGF on##2##4##(2008-9#2)
effect of B##2##3##(1992-3#1)(2008-10#1)
effect of CC-516##3##3##(2008-5#3)
effect of CD-ROM##2##3##(1991-3#2)
effect of CGRP##4##3##(1997-4#4)
effect of Ca(2+)##2##3##(2008-8#2)
effect of Cl(-)##2##3##(2008-10#1)(2009-8#1)
effect of DA-9601##2##3##(2008-11#2)
effect of E2##2##3##(1995-9#1)(1997-6#1)
effect of EA on##2##4##(2012-3#2)
effect of ET-1 on neutrophil migration##2##6##(1994-8#2)
effect of ET-1##5##3##(1994-11#1)(1994-8#4)
effect of Eucommia ulmoides leaf##2##5##(2010-2#2)
effect of HAART on##2##4##(2013-8#2)
effect of HAART##3##3##(2013-8#3)
effect of HER-2/neu##2##3##(1997-7#2)
effect of HIV##2##3##(1996-5#1)(2012-2#1)
effect of HNO(3)##2##3##(2008-10#2)
effect of IFN-gamma on##2##4##(1993-9#1)(2008-8#1)
effect of IPC##2##3##(2013-7#2)
effect of Id-1##2##3##(2008-8#2)
effect of L-NAME##2##3##(1995-12#1)(1995-5#1)
effect of LDH##2##3##(2008-11#2)
effect of MK-801##2##3##(1990-5#2)
effect of MOEE##3##3##(2008-10#3)
effect of N##2##3##(2007-12#1)(2010-8#1)
effect of NABE##2##3##(1991-9#2)
effect of NMDA##2##3##(1996-5#1)(2008-8#1)
effect of NOM##2##3##(2008-11#2)
effect of P##2##3##(1995-8#1)(2008-10#1)
effect of PTH##3##3##(1993-12#1)(2008-8#2)
effect of Primatone RL##2##4##(2008-7#2)
effect of RA and##2##4##(2008-11#2)
effect of RC-160##3##3##(1995-2#3)
effect of RNA##2##3##(1991-9#1)(2012-3#1)
effect of Safoof Mohazzil##3##4##(2013-1#3)
effect of Se(IV) on the##2##5##(2008-10#2)
effect of Sudan##2##3##(1996-12#2)
effect of TI on##2##4##(2008-10#2)
effect of UV##2##3##(2008-2#1)(2011-2#1)
effect of a drug##2##4##(1996-3#1)(2008-10#1)
effect of a finite##3##4##(2008-2#1)(2008-3#2)
effect of a new##2##4##(1992-3#1)(1996-1#1)
effect of a polymer##2##4##(2008-3#1)(2008-5#1)
effect of a single##5##4##(1991-8#1)(1993-3#1)(1994-8#1)(1997-7#1)(2008-10#1)
effect of a##84##3##(1990-7#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#2)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#6)(2008-5#12)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-3#2)(2012-8#1)(2013-1#2)
effect of acetyl-L-carnitine##3##3##(1992-7#2)(1997-2#1)
effect of acid concentration##2##4##(2008-10#1)(2013-1#1)
effect of acidic pH##2##4##(2008-8#2)
effect of activin##4##3##(1990-11#1)(1992-6#1)(1993-8#1)(1995-8#1)
effect of acupuncture and##2##4##(2012-3#1)(2013-1#1)
effect of acupuncture on##3##4##(2012-3#3)
effect of acupuncture##8##3##(1993-3#1)(1995-12#1)(2012-3#5)(2013-1#1)
effect of adding##5##3##(1997-3#1)(2008-10#2)(2010-4#1)(2012-2#1)
effect of additional##2##3##(1992-2#1)(2008-8#1)
effect of age at##2##4##(2008-9#1)(2009-5#1)
effect of age on##4##4##(1996-5#1)(2008-1#1)(2008-7#2)
effect of age##10##3##(1996-5#1)(1997-4#1)(2008-1#1)(2008-7#5)(2008-9#1)(2009-5#1)
effect of aging##8##3##(1990-7#1)(1994-6#2)(2008-7#5)
effect of all##2##3##(2010-2#1)(2013-1#1)
effect of alpha-trinositol##2##3##(1995-12#2)
effect of ambient##2##3##(2007-12#1)(2008-10#1)
effect of amiloride##2##3##(1991-5#1)(1992-5#1)
effect of amino acids on##2##5##(2008-10#1)(2011-2#1)
effect of amino acids##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
effect of amino##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
effect of an interphase on##2##5##(2009-6#2)
effect of an##18##3##(1990-7#1)(1992-5#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-12#1)(2009-6#3)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#2)
effect of arginine-vasopressin##3##3##(1995-12#3)
effect of aromatherapy##2##3##(2008-10#2)
effect of ascorbic##2##3##(2008-10#1)(2008-11#1)
effect of asymmetric##2##3##(2007-5#1)(2008-2#1)
effect of bcl-2##2##3##(2008-11#1)(2008-7#1)
effect of beam##2##3##(2008-3#2)
effect of beta##2##3##(1992-3#1)(1994-11#1)
effect of blood absorption on polarized##2##6##(2007-11#2)
effect of body##3##3##(2007-12#2)(2013-7#1)
effect of both the##2##4##(1997-1#1)(2011-1#1)
effect of both##7##3##(1997-1#1)(1997-4#1)(2006-6#1)(2008-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
effect of breastfeeding on##2##4##(1991-8#1)(2010-6#1)
effect of calcium##2##3##(1991-8#1)(2012-12#1)
effect of captopril on##5##4##(1992-5#1)(2008-10#2)(2008-7#2)
effect of carbachol##4##3##(1990-7#1)(1996-12#3)
effect of carbon nanotubes##2##4##(2008-10#1)(2010-5#1)
effect of cashew nut shell oil##2##6##(1992-2#2)
effect of castration##2##3##(1994-2#2)
effect of cationic lipid-mediated##2##4##(1996-12#2)
effect of cell##5##3##(1992-11#1)(2008-11#3)(2008-7#1)
effect of changes in##3##4##(1991-12#1)(1997-2#1)(2008-2#1)
effect of changes##5##3##(1991-12#1)(1997-2#1)(2008-2#1)(2008-5#1)(2012-2#1)
effect of chemical modification##3##4##(1990-8#1)(1992-6#1)(1995-2#1)
effect of chemical##4##3##(1990-8#1)(1992-6#1)(1995-2#1)(2008-10#1)
effect of chloride on the##2##5##(1994-5#2)
effect of chronic##5##3##(1994-2#2)(2008-10#1)(2009-3#1)(2013-1#1)
effect of clinical##2##3##(1995-3#1)(2010-8#1)
effect of cocaine was##2##4##(1993-12#1)(2013-8#1)
effect of cocaine##5##3##(1993-12#2)(2013-8#3)
effect of combined##2##3##(2009-4#1)(2013-8#1)
effect of combining##2##3##(1994-2#1)(2008-10#1)
effect of common##4##3##(2008-10#1)(2008-12#1)(2010-4#1)(2012-3#1)
effect of concurrent##2##3##(1990-6#1)(2011-2#1)
effect of copper##3##3##(1990-8#1)(2008-10#2)
effect of copper(II)##2##3##(2008-10#2)
effect of corn##2##3##(2008-10#1)(2011-2#1)
effect of coronary artery##2##4##(1994-11#1)(2007-8#1)
effect of cosmetics##2##3##(2008-5#2)
effect of counselling on the academic performance of college students##2##10##(2013-8#2)
effect of curcumin on the##2##5##(2008-11#2)
effect of curcumin##3##3##(2008-11#2)(2011-2#1)
effect of cyclic##2##3##(1993-6#1)(2012-7#1)
effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion in rats##2##13##(1995-12#2)
effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion##3##11##(1995-12#3)
effect of deltamethrin##2##3##(2008-10#1)(2013-1#1)
effect of deprenyl##3##3##(1994-6#1)(2009-12#2)
effect of dexamethasone##3##3##(1993-5#1)(1994-3#2)
effect of diazepam##2##3##(1991-12#1)(2008-6#1)
effect of diepoxybutane##2##3##(2008-7#2)
effect of diet##2##3##(1992-8#1)(1996-12#1)
effect of dietary##4##3##(1990-3#1)(1997-8#1)(2010-2#1)(2013-1#1)
effect of different##35##3##(1992-9#1)(1995-12#1)(1996-2#1)(2008-10#14)(2008-12#8)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#2)(2013-1#2)
effect of direct##4##3##(1997-2#1)(2008-5#1)(2013-8#2)
effect of doxorubicin##2##3##(2011-2#1)(2013-1#1)
effect of drugs##4##3##(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
effect of each factor##2##4##(1997-4#1)(2013-1#1)
effect of each##3##3##(1997-4#1)(2008-10#1)(2013-1#1)
effect of early##3##3##(1993-12#2)(2009-7#1)
effect of elevated##2##3##(2008-10#1)(2013-1#1)
effect of endothelin-1 on cardiac##2##5##(1992-3#2)
effect of endothelin-1 on##3##4##(1992-3#3)
effect of estrogen on##2##4##(1997-6#1)(2008-11#1)
effect of ethanol on the##2##5##(1992-6#1)(2008-7#1)
effect of ethanol on##3##4##(1992-6#1)(1994-9#1)(2008-7#1)
effect of ethanol##6##3##(1992-6#1)(1994-6#1)(1994-9#1)(1995-3#1)(2008-7#1)(2012-2#1)
effect of exenatide##2##3##(2012-3#2)
effect of exercise training##2##4##(2009-10#1)(2012-3#1)
effect of exercise##5##3##(1993-11#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
effect of exogenous##4##3##(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
effect of experimental parameters##3##4##(2008-10#3)
effect of experimental##5##3##(1990-7#1)(1991-8#1)(2008-10#3)
effect of exposure##4##3##(1991-12#1)(2007-12#1)(2008-10#1)(2009-12#1)
effect of extracellular##5##3##(1990-8#1)(2008-4#3)(2008-8#1)
effect of extract##2##3##(2008-12#1)(2011-3#1)
effect of family routines##2##4##(2010-9#2)
effect of family##4##3##(2010-9#2)(2011-2#1)(2013-1#1)
effect of fermented apple diet##2##5##(2010-2#2)
effect of finasteride##2##3##(1994-11#1)(2008-5#1)
effect of fluoride##2##3##(2008-10#1)(2013-1#1)
effect of foreign ions##4##4##(2008-10#4)
effect of forskolin##2##3##(2009-12#2)
effect of four##3##3##(1995-5#1)(2008-12#2)
effect of gastrin on##2##4##(1994-8#2)
effect of gastrin##3##3##(1994-8#2)(1997-1#1)
effect of gender##2##3##(2010-1#1)(2012-2#1)
effect of genistein on##2##4##(1993-3#1)(2010-10#1)
effect of glucocorticoids##3##3##(1994-9#1)(2008-9#1)(2012-1#1)
effect of glucose##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2010-11#1)
effect of glutamate##2##3##(1994-11#1)(2008-11#1)
effect of green##2##3##(2008-11#1)(2009-8#1)
effect of group-delay##2##3##(2007-11#1)(2008-3#1)
effect of growth factors##2##4##(1994-12#1)(1994-9#1)
effect of growth##4##3##(1994-12#1)(1994-9#1)(2008-10#1)(2008-6#1)
effect of guanabenz was##2##4##(2008-5#2)
effect of habitat##2##3##(2008-8#1)(2008-9#1)
effect of halide##2##3##(1994-5#1)(2008-10#1)
effect of heat stress on the antibacterial resistance and plasmid profile in Escherichia coli##2##14##(2008-12#2)
effect of heat stress on##3##5##(2008-12#3)
effect of heat##5##3##(1993-6#1)(2008-12#3)(2013-1#1)
effect of hemoglobin##3##3##(1990-8#2)(2008-10#1)
effect of heparin##2##3##(1997-2#1)(2008-11#1)
effect of high##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)
effect of highly variable topography on the spatial distribution of##2##10##(2013-7#2)
effect of histamine on##2##4##(1995-12#1)(2008-12#1)
effect of histamine##3##3##(1995-12#2)(2008-12#1)
effect of host##2##3##(2008-10#1)(2008-8#1)
effect of human##3##3##(1992-8#1)(1997-3#1)(2008-11#1)
effect of hydroalcoholic extract of##2##5##(2008-12#1)(2012-12#1)
effect of hydroalcoholic##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
effect of hydrogen##3##3##(2008-10#3)
effect of hypericin on the conformation and catalytic activity of##2##10##(2009-3#2)
effect of hypothermia on##2##4##(2008-9#1)(2010-9#1)
effect of increased##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)
effect of increasing##6##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-8#1)(2013-1#1)
effect of incubation temperature##2##4##(2011-2#2)
effect of inhibiting##2##3##(1992-12#1)(2012-2#1)
effect of insulin resistance##2##4##(2008-6#1)(2011-1#1)
effect of insulin##4##3##(1996-11#1)(2008-3#1)(2008-6#1)(2011-1#1)
effect of intensive##2##3##(1993-9#1)(1994-11#1)
effect of interferences from##2##4##(2008-10#2)
effect of interferences##6##3##(2008-10#6)
effect of interfering ions##4##4##(2008-10#4)
effect of interferon##3##3##(1991-8#1)(1997-5#1)(2006-10#1)
effect of intraoperative##3##3##(2007-8#2)(2008-7#1)
effect of intravenous##2##3##(1991-12#1)(2007-7#1)
effect of iron##3##3##(1992-8#1)(2009-8#2)
effect of its##2##3##(2008-10#1)(2012-2#1)
effect of jogging##2##3##(1991-8#2)
effect of laser##2##3##(2008-10#1)(2008-3#1)
effect of lateral##2##3##(1991-2#1)(2007-11#1)
effect of light on##2##4##(1993-12#1)(2008-10#1)
effect of light##8##3##(1993-12#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-3#1)
effect of lithium##3##3##(1994-8#1)(1996-12#1)(2009-8#1)
effect of local##2##3##(2008-9#1)(2011-2#1)
effect of long##2##3##(1993-2#1)(2008-7#1)
effect of long-term##3##3##(1996-12#1)(2007-12#1)(2009-12#1)
effect of low temperature##2##4##(2010-12#1)(2011-2#1)
effect of low##11##3##(1992-5#1)(1992-7#1)(1993-1#1)(1996-12#1)(2008-11#1)(2008-7#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-6#1)
effect of lowering##3##3##(2007-10#1)(2008-5#1)(2013-8#1)
effect of magnesium##2##3##(1995-12#1)(2008-10#1)
effect of magnetic field on the##2##6##(2008-10#1)(2008-8#1)
effect of manganese##3##3##(2008-10#3)
effect of massage on##2##4##(2008-12#1)(2009-3#1)
effect of massage##3##3##(2008-12#2)(2009-3#1)
effect of mechanical loading on the##2##6##(1994-6#1)(2009-8#1)
effect of melatonin on##2##4##(1990-5#1)(2010-12#1)
effect of melatonin##5##3##(1990-5#1)(2009-12#1)(2010-12#1)(2013-7#2)
effect of melittin on DPPC##2##5##(2008-10#2)
effect of membrane##4##3##(1990-8#1)(2008-10#1)(2009-9#1)(2010-5#1)
effect of metal ion##2##4##(2008-10#2)
effect of methotrexate##2##3##(1992-12#1)(1993-12#1)
effect of methylphenidate##2##3##(2008-9#1)(2012-2#1)
effect of morphine in##3##4##(1991-1#2)(1996-2#1)
effect of morphine##12##3##(1991-1#3)(1992-3#1)(1996-2#8)
effect of multiple##3##3##(1996-3#1)(2008-2#1)(2012-3#1)
effect of mutation##2##3##(1992-12#1)(2008-8#1)
effect of neuromuscular blockade on##2##5##(1993-1#1)(2012-12#1)
effect of nicotine on##4##4##(1991-1#1)(1996-2#2)(2010-8#1)
effect of nicotine##6##3##(1991-1#1)(1996-2#4)(2010-8#1)
effect of noradrenaline##2##3##(1995-12#2)
effect of number of##2##4##(2007-8#1)(2013-8#1)
effect of numerical aperture on##2##5##(2007-12#1)(2008-2#1)
effect of nutrient##3##3##(2008-10#2)(2008-11#1)
effect of ofloxacin##2##3##(1996-2#1)(2008-10#1)
effect of other ions in##2##5##(2008-10#2)
effect of other ions##4##4##(2008-10#4)
effect of other##10##3##(1991-12#1)(1996-2#1)(2008-10#6)(2008-9#1)(2009-12#1)
effect of ovarian##2##3##(1997-8#1)(2008-2#1)
effect of oxidized##2##3##(1996-2#1)(2010-12#1)
effect of oxygen##2##3##(1995-3#1)(2008-11#1)
effect of pH and##5##4##(2008-10#3)(2008-7#1)(2010-5#1)
effect of pH on the##4##5##(2008-10#3)(2008-8#1)
effect of pH on##8##4##(1991-5#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)
effect of pH##27##3##(1991-5#1)(2008-10#20)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
effect of partial##2##3##(2008-6#1)(2011-2#1)
effect of particle##2##3##(2008-10#2)
effect of phenylephrine on##2##4##(1990-12#1)(2012-3#1)
effect of phorbol##2##3##(1990-12#1)(1995-6#1)
effect of physical parameters##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
effect of physical##6##3##(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
effect of plant##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
effect of platelet##2##3##(1992-8#1)(1997-7#1)
effect of policies##2##3##(2012-2#2)
effect of postoperative##3##3##(2009-3#2)(2010-4#1)
effect of potential##3##3##(2008-10#2)(2011-1#1)
effect of prenatal##2##3##(1991-1#1)(1996-5#1)
effect of pressure##3##3##(2008-10#2)(2008-6#1)
effect of prolonged##2##3##(1997-2#1)(2009-3#1)
effect of protein##3##3##(1993-3#2)(1994-11#1)
effect of pyruvate in the##2##5##(2008-10#2)
effect of race and gender on patterns of rt-PA use##2##10##(2007-10#2)
effect of radiation##4##3##(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
effect of random errors##2##4##(2008-10#1)(2008-7#1)
effect of random##3##3##(2008-10#1)(2008-7#2)
effect of reaction##2##3##(2008-5#1)(2011-2#1)
effect of recombinant##6##3##(1990-11#1)(1992-3#1)(1994-8#1)(2007-8#1)(2011-3#2)
effect of reducing##3##3##(2008-2#1)(2008-9#1)(2011-2#1)
effect of refractive##2##3##(2008-3#2)
effect of rehabilitation##2##3##(1995-5#2)
effect of relative humidity (RH)##2##5##(2008-10#1)(2008-2#1)
effect of relative##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
effect of remifentanil##2##3##(2011-2#2)
effect of repeated##4##3##(1997-2#1)(2008-10#1)(2009-3#1)(2013-1#1)
effect of residual##2##3##(2008-2#1)(2008-3#1)
effect of resource aggregation##2##4##(2008-8#2)
effect of resource##3##3##(2007-12#1)(2008-8#2)
effect of retinol##4##3##(1994-8#1)(2008-5#3)
effect of rhodamine##2##3##(2008-10#2)
effect of salts on##2##4##(2008-10#1)(2009-10#1)
effect of sample##2##3##(2008-10#1)(2012-3#1)
effect of sampling##2##3##(2008-10#1)(2008-3#1)
effect of scattering and absorbing##3##5##(2008-3#3)
effect of scattering##4##3##(2008-3#4)
effect of selected##3##3##(1997-6#1)(2008-7#1)(2011-2#1)
effect of sensory##2##3##(1992-6#1)(2008-11#1)
effect of several##6##3##(1995-3#1)(1995-6#1)(2008-10#4)
effect of silica##2##3##(2008-10#2)
effect of similar##2##3##(1996-2#1)(1997-4#1)
effect of simulated microgravity##2##4##(2008-9#2)
effect of simultaneous##2##3##(2008-10#1)(2008-6#1)
effect of smoking##2##3##(1996-3#1)(2008-7#1)
effect of social##2##3##(2007-12#1)(2013-1#1)
effect of sodium##4##3##(1994-5#1)(1995-12#1)(2008-10#1)(2013-7#1)
effect of solar##3##3##(2008-10#2)(2010-1#1)
effect of solution pH##2##4##(2008-10#1)(2008-5#1)
effect of solvent##2##3##(2008-10#2)
effect of some##10##3##(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#1)
effect of specific##4##3##(1995-12#1)(1996-5#1)(2008-10#1)(2008-4#1)
effect of staged embolisation on seizure recurrence was##2##8##(1997-3#2)
effect of static##2##3##(2007-12#1)(2008-3#1)
effect of stress##2##3##(1997-4#1)(2009-7#1)
effect of substrate##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
effect of such a##2##4##(2008-11#1)(2008-5#1)
effect of such an##2##4##(2008-3#1)(2009-12#1)
effect of such##10##3##(1993-1#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-6#1)(2012-1#1)(2013-8#1)
effect of surgical##4##3##(1995-3#2)(2008-10#1)(2008-7#1)
effect of synthetic##2##3##(2008-10#1)(2012-1#1)
effect of tamoxifen on##2##4##(1993-12#2)
effect of temperature and##3##4##(1996-12#1)(2008-10#1)(2010-10#1)
effect of temperature on the##4##5##(1990-8#1)(1992-5#1)(2008-10#1)(2008-3#1)
effect of temperature on##10##4##(1990-8#1)(1992-5#1)(2008-10#5)(2008-3#1)(2008-6#1)(2009-8#1)
effect of temperature##22##3##(1990-8#1)(1992-5#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2009-8#1)(2010-10#1)(2010-4#1)(2013-7#1)
effect of testosterone on##2##4##(1996-5#1)(2008-9#1)
effect of testosterone##4##3##(1991-5#1)(1996-5#1)(2008-9#2)
effect of tetramethylpyrazine on the##2##5##(1991-6#2)
effect of the Gaussian##2##4##(2008-2#1)(2008-3#1)
effect of the atmosphere##2##4##(2008-2#1)(2008-3#1)
effect of the chemical##3##4##(1995-11#1)(2008-10#1)(2008-6#1)
effect of the drug on##2##5##(1996-3#1)(2008-8#1)
effect of the drug##7##4##(1991-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-8#1)
effect of the extract##2##4##(2010-3#1)(2010-5#1)
effect of the fields##2##4##(1992-11#1)(2008-3#1)
effect of the finite##2##4##(2008-2#1)(2008-3#1)
effect of the growth##2##4##(1997-1#1)(2008-7#1)
effect of the high##3##4##(2008-10#2)(2008-3#1)
effect of the intervention##2##4##(2008-12#1)(2010-10#1)
effect of the ion exchanger##2##5##(2008-10#2)
effect of the ionic##2##4##(1997-2#1)(2008-10#1)
effect of the metal##2##4##(2008-3#1)(2010-11#1)
effect of the mutations on##2##5##(1992-9#1)(1995-6#1)
effect of the mutations##3##4##(1992-9#1)(1995-6#1)(1997-2#1)
effect of the nature of the##2##6##(2008-10#2)
effect of the number of##3##5##(1994-8#1)(2007-8#1)(2011-2#1)
effect of the pasture trees on##2##6##(2008-5#2)
effect of the presence of##4##5##(2008-10#4)
effect of the radiation##3##4##(2008-7#1)(2013-7#2)
effect of the reagent##2##4##(1993-11#1)(2008-10#1)
effect of the relative##2##4##(2008-10#1)(2008-12#1)
effect of the thermal lens##2##5##(2008-3#2)
effect of the timing of##2##5##(2008-10#2)
effect of the transdermal administration of nicotine on insulin sensitivity in healthy individuals with and without##2##16##(2008-3#2)
effect of the two##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
effect of the##275##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#71)(2008-11#13)(2008-12#5)(2008-2#16)(2008-3#22)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#4)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#3)(2013-8#7)
effect of their##4##3##(1994-5#1)(2009-6#1)(2011-1#2)
effect of them##2##3##(1995-8#1)(2011-2#1)
effect of therapy##4##3##(2007-11#1)(2009-11#1)(2013-1#1)(2013-8#1)
effect of these##22##3##(1991-12#2)(1991-2#1)(1995-6#2)(1996-2#2)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
effect of thiourea##2##3##(1995-12#1)(2008-10#1)
effect of this intervention##2##4##(1990-9#1)(2008-3#1)
effect of this##13##3##(1990-12#2)(1990-9#1)(1993-11#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
effect of three##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
effect of thyroid##2##3##(1993-12#1)(2008-6#1)
effect of time##2##3##(2008-10#1)(2013-1#1)
effect of tissue##3##3##(1992-9#1)(2008-2#1)(2010-8#1)
effect of tolbutamide##2##3##(1991-12#2)
effect of treatment with##2##4##(1992-8#1)(2010-12#1)
effect of treatment##4##3##(1990-5#1)(1992-8#1)(1997-3#1)(2010-12#1)
effect of treatments##3##3##(1997-4#1)(2008-10#2)
effect of trehalose##2##3##(1997-2#1)(2008-10#1)
effect of two different##2##4##(2009-7#1)(2011-1#1)
effect of two##10##3##(1990-12#1)(1996-1#1)(2008-11#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
effect of utilization##2##3##(1991-3#1)(2007-10#1)
effect of vaccination##2##3##(1996-3#2)
effect of vanadium##2##3##(2008-10#1)(2011-2#1)
effect of variables##2##3##(2008-10#1)(2008-8#1)
effect of various parameters##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
effect of various##20##3##(1990-11#2)(1992-8#1)(1993-2#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#2)
effect of very low##2##4##(2008-7#2)
effect of vesicles formed from monoglycerides on human skin##2##9##(2008-5#2)
effect of vitamin C supplementation on##2##6##(1996-12#1)(1997-3#1)
effect of vitamin D##2##4##(2011-1#1)(2013-1#1)
effect of vitamin E##3##4##(1990-2#1)(1993-6#1)(2010-12#1)
effect of vitamin##17##3##(1990-2#1)(1990-3#1)(1991-12#1)(1993-6#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-12#1)(2011-1#2)(2013-1#1)
effect of water##5##3##(2008-10#3)(2008-7#2)
effect of weather##3##3##(2008-10#3)
effect of yeast (Saccharomyces##2##4##(2008-12#2)
effect of zinc##2##3##(2012-2#1)(2012-3#1)
effect of##2686##2##(1990-10#1)(1990-11#9)(1990-12#16)(1990-2#8)(1990-3#4)(1990-5#13)(1990-6#4)(1990-7#8)(1990-8#11)(1990-9#2)(1991-1#6)(1991-10#1)(1991-11#2)(1991-12#27)(1991-2#16)(1991-3#9)(1991-4#1)(1991-5#6)(1991-6#7)(1991-8#7)(1991-9#10)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#5)(1992-3#23)(1992-4#1)(1992-5#8)(1992-6#14)(1992-7#3)(1992-8#15)(1992-9#14)(1993-1#7)(1993-11#9)(1993-12#20)(1993-2#5)(1993-3#11)(1993-5#5)(1993-6#11)(1993-8#9)(1993-9#6)(1994-11#23)(1994-12#2)(1994-2#12)(1994-3#11)(1994-5#11)(1994-6#18)(1994-8#20)(1994-9#4)(1995-1#3)(1995-11#15)(1995-12#46)(1995-2#12)(1995-3#15)(1995-5#10)(1995-6#11)(1995-8#12)(1995-9#2)(1996-1#3)(1996-11#5)(1996-12#21)(1996-2#36)(1996-3#8)(1996-4#1)(1996-5#11)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#13)(1997-2#24)(1997-3#9)(1997-4#20)(1997-5#4)(1997-6#8)(1997-7#12)(1997-8#4)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-10#13)(2007-11#27)(2007-12#25)(2007-2#5)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#11)(2008-1#12)(2008-10#515)(2008-11#116)(2008-12#68)(2008-2#59)(2008-3#108)(2008-4#21)(2008-5#80)(2008-6#35)(2008-7#89)(2008-8#77)(2008-9#45)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#16)(2009-2#5)(2009-3#12)(2009-4#4)(2009-5#2)(2009-6#11)(2009-7#9)(2009-8#19)(2009-9#7)(2010-1#8)(2010-10#8)(2010-11#10)(2010-12#13)(2010-2#15)(2010-3#7)(2010-4#19)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#11)(2010-9#5)(2011-1#31)(2011-10#1)(2011-2#71)(2011-3#9)(2012-1#10)(2012-12#22)(2012-2#52)(2012-3#51)(2012-6#2)(2012-7#3)(2012-8#4)(2013-1#80)(2013-7#15)(2013-8#44)
effect on AD duration or seizure intensity##2##7##(1992-12#2)
effect on DNA ligase##2##4##(1993-3#1)(1997-7#1)
effect on DNA synthesis##2##4##(1993-6#1)(1993-8#1)
effect on DNA##7##3##(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1997-7#1)(2008-8#1)(2008-9#1)
effect on HIV##3##3##(1995-2#1)(2008-1#1)(2009-5#1)
effect on IL-1##2##3##(1996-12#1)(2007-2#1)
effect on P##3##3##(2008-10#2)(2008-6#1)
effect on a relevant##2##4##(2008-8#2)
effect on a##8##3##(1996-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#2)
effect on access to care##2##5##(1995-12#2)
effect on access##3##3##(1995-12#2)(1997-2#1)
effect on adult##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
effect on aflatoxin##2##3##(1992-9#1)(2008-10#1)
effect on angiogenesis##2##3##(2011-2#1)(2013-1#1)
effect on bacterial##2##3##(2008-10#1)(2008-5#1)
effect on basal##4##3##(1992-7#1)(1994-3#1)(1995-11#1)(1997-7#1)
effect on behavior##2##3##(1995-12#2)
effect on blood pressure and##2##5##(1997-8#1)(2008-7#1)
effect on blood pressure##6##4##(1991-6#1)(1993-2#1)(1997-8#1)(2008-7#1)(2008-8#1)(2010-4#1)
effect on bone##3##3##(1997-7#2)(2013-1#1)
effect on both the##2##4##(1997-2#1)(2008-10#1)
effect on both##10##3##(1991-12#1)(1991-2#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)
effect on brain function in##2##5##(2008-10#2)
effect on cell growth##2##4##(2008-11#2)
effect on cell##5##3##(1991-9#1)(2008-11#2)(2008-5#1)(2010-12#1)
effect on cerebral##2##3##(1991-5#1)(2007-10#1)
effect on chlorophyll##2##3##(2008-9#2)
effect on cholesterol##2##3##(1995-12#1)(2012-3#1)
effect on clinical##2##3##(2007-12#1)(2011-2#1)
effect on distribution of##2##4##(1995-3#1)(2008-10#1)
effect on distribution##4##3##(1995-3#1)(2008-10#3)
effect on early spermatogenic cyst survival in vitro##2##8##(2012-2#2)
effect on either##4##3##(1993-6#1)(1995-6#1)(2008-3#1)(2008-7#1)
effect on enzyme##2##3##(1994-6#1)(2008-2#1)
effect on expression of##2##4##(2008-9#1)(2012-3#1)
effect on fecundity##2##3##(2011-2#2)
effect on fibroblast##3##3##(2010-3#2)(2013-1#1)
effect on gene expression##2##4##(1996-12#1)(2008-10#1)
effect on gene transcription##2##4##(1993-6#2)
effect on gene##4##3##(1993-6#2)(1996-12#1)(2008-10#1)
effect on germination and seedling growth of##2##7##(2008-12#2)
effect on grooming##2##3##(1993-12#1)(1996-2#1)
effect on growth of##3##4##(1995-2#1)(2008-10#1)(2008-6#1)
effect on growth##6##3##(1994-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-2#1)
effect on hepatic##4##3##(1993-8#1)(1994-11#1)(2013-1#2)
effect on hospitals##2##3##(1993-1#1)(2008-11#1)
effect on human body##2##4##(2008-7#1)(2011-3#1)
effect on human##4##3##(1997-4#1)(2008-11#1)(2008-7#1)(2011-3#1)
effect on insulin secretion##2##4##(1995-8#1)(2011-1#1)
effect on insulin##3##3##(1994-6#1)(1995-8#1)(2011-1#1)
effect on its##4##3##(1991-3#1)(1995-2#1)(1995-5#1)(2013-7#1)
effect on lipid##5##3##(1993-9#1)(2008-12#2)(2008-4#1)(2010-4#1)
effect on local##2##3##(2008-9#1)(2010-3#1)
effect on memory##3##3##(1993-12#1)(1995-12#1)(2009-8#1)
effect on metabolism##2##3##(1992-11#1)(1995-6#1)
effect on mortality##3##3##(1995-2#1)(1995-5#1)(1997-4#1)
effect on motor##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
effect on mycelial##2##3##(2008-10#2)
effect on myocardial##2##3##(1995-3#1)(2013-1#1)
effect on normal##3##3##(1991-9#1)(1992-9#1)(2008-8#1)
effect on other##2##3##(2008-11#1)(2008-9#1)
effect on ozone##3##3##(1996-1#1)(2008-2#1)(2008-3#1)
effect on plasma##2##3##(1992-11#1)(2008-10#1)
effect on platelet function##2##4##(1991-11#1)(1997-4#1)
effect on platelet##4##3##(1991-11#1)(1992-4#1)(1997-4#1)(2008-8#1)
effect on proliferation##2##3##(1991-5#1)(1992-2#1)
effect on protein##2##3##(1994-12#1)(2008-4#1)
effect on pulmonary function##2##4##(1993-2#1)(1997-1#1)
effect on quality##2##3##(2012-1#1)(2012-2#1)
effect on rats##3##3##(2010-5#1)(2011-1#2)
effect on receptor##2##3##(1991-12#1)(1993-3#1)
effect on renal##2##3##(2008-12#1)(2011-2#1)
effect on respiration##2##3##(2009-5#1)(2012-2#1)
effect on retrieved##2##3##(2008-3#2)
effect on spread##3##3##(1996-5#1)(2008-10#2)
effect on stress-induced##2##3##(1997-4#1)(2008-11#1)
effect on substrate##2##3##(1997-4#1)(2008-7#1)
effect on survival##6##3##(1994-2#1)(2008-8#2)(2008-9#2)(2011-2#1)
effect on temperature##3##3##(1996-2#3)
effect on the ability of##2##5##(2007-10#1)(2008-10#1)
effect on the action##3##4##(1995-11#1)(2008-4#2)
effect on the activity of##3##5##(1994-5#1)(1994-6#1)(2008-10#1)
effect on the activity##5##4##(1992-6#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-11#1)
effect on the binding of##3##5##(1994-11#1)(1995-11#2)
effect on the cell##3##4##(2008-11#2)(2009-12#1)
effect on the clinical##2##4##(1990-6#1)(1994-6#1)
effect on the degree##2##4##(1991-3#1)(2008-9#1)
effect on the determination of##4##5##(2008-10#4)
effect on the determination##5##4##(2008-10#5)
effect on the development of##3##5##(1993-12#1)(2008-10#1)(2008-12#1)
effect on the disease##2##4##(2008-10#2)
effect on the evolution of##2##5##(2008-8#2)
effect on the expression of##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
effect on the expression##5##4##(1991-9#1)(2008-10#2)(2012-2#1)(2013-1#1)
effect on the final color##2##5##(2009-8#2)
effect on the final##4##4##(1991-6#1)(2008-5#1)(2009-8#2)
effect on the fluorescence##2##4##(1996-2#1)(2008-10#1)
effect on the formation of##2##5##(1992-5#1)(1993-3#1)
effect on the gene expression##2##5##(1993-3#1)(1993-9#1)
effect on the growth of##6##5##(1992-8#1)(1996-12#1)(2008-10#2)(2008-4#1)(2012-2#1)
effect on the normal##3##4##(1993-11#1)(1993-5#1)(2008-9#1)
effect on the number of##3##5##(1993-1#1)(1994-2#1)(1995-3#1)
effect on the optical##4##4##(2008-2#1)(2008-3#3)
effect on the oxidation of carminic acid##4##7##(2008-10#4)
effect on the oxidation of##12##5##(2008-10#12)
effect on the oxidation reaction of##3##6##(2008-10#3)
effect on the oxidation##15##4##(2008-10#15)
effect on the pathogen##2##4##(2008-10#2)
effect on the percentage of##2##5##(2010-4#1)(2011-2#1)
effect on the performance of##3##5##(2008-6#1)(2009-11#1)(2011-2#1)
effect on the plasma membrane##2##5##(1994-3#1)(2008-4#1)
effect on the plasma##4##4##(1992-9#1)(1994-3#1)(2008-4#1)(2013-8#1)
effect on the population##2##4##(2008-10#2)
effect on the proliferation of##3##5##(2008-11#1)(2008-8#1)(2011-2#1)
effect on the proliferation##5##4##(1993-6#1)(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
effect on the quality of##2##5##(1991-11#1)(2008-10#1)
effect on the rate of##6##5##(1992-2#1)(1992-5#1)(1995-3#2)(2008-10#1)(2008-6#1)
effect on the rate##7##4##(1992-2#1)(1992-5#1)(1995-2#1)(1995-3#2)(2008-10#1)(2008-6#1)
effect on the recovery of##3##5##(2008-10#3)
effect on the redox reaction between bromate and hydrochloric acid##2##10##(2008-10#2)
effect on the redox reaction between##3##6##(2008-10#3)
effect on the release of##5##5##(1990-12#1)(1990-2#1)(1995-11#2)(2006-6#1)
effect on the release##6##4##(1990-12#1)(1990-2#1)(1995-11#2)(2006-6#1)(2008-10#1)
effect on the responses of##2##5##(1997-2#1)(2008-10#1)
effect on the responses##3##4##(1992-2#1)(1997-2#1)(2008-10#1)
effect on the sensitivity of##2##5##(1994-6#1)(2008-4#1)
effect on the stripping##2##4##(2008-10#2)
effect on the underlying##3##4##(1990-2#1)(1996-3#1)(1997-4#1)
effect on the##381##3##(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#4)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#4)(1993-5#2)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#6)(1994-8#2)(1994-9#1)(1995-11#9)(1995-12#5)(1995-2#4)(1995-3#4)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#2)(1997-2#4)(1997-4#2)(1997-5#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#109)(2008-11#15)(2008-12#6)(2008-2#8)(2008-3#22)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#4)
effect on their##6##3##(1992-5#1)(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2009-4#1)
effect on these##5##3##(1990-2#1)(1992-3#1)(1994-9#1)(2012-3#1)(2013-7#1)
effect on this response##2##4##(1994-11#1)(2009-7#1)
effect on this##4##3##(1994-11#1)(2008-10#1)(2008-7#1)(2009-7#1)
effect on those##2##3##(1992-9#1)(2010-3#1)
effect on total##2##3##(2008-12#1)(2008-7#1)
effect on transcription##3##3##(1994-2#1)(1994-8#1)(1997-2#1)
effect on transformation##2##3##(1994-2#1)(2008-10#1)
effect on tree##2##3##(2008-10#1)(2009-8#1)
effect on tremor##2##3##(2008-7#1)(2012-3#1)
effect on water##2##3##(2007-5#1)(2008-8#1)
effect on young##3##3##(1993-12#2)(2013-1#1)
effect on##1111##2##(1990-11#3)(1990-12#8)(1990-2#8)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#6)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#5)(1992-12#8)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#8)(1992-6#3)(1992-7#1)(1992-8#7)(1992-9#10)(1993-1#4)(1993-11#7)(1993-12#9)(1993-2#5)(1993-3#8)(1993-5#4)(1993-6#13)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#4)(1994-2#10)(1994-3#7)(1994-5#7)(1994-6#10)(1994-8#13)(1994-9#4)(1995-1#2)(1995-11#15)(1995-12#18)(1995-2#16)(1995-3#12)(1995-5#6)(1995-6#11)(1995-8#7)(1996-1#1)(1996-11#1)(1996-12#9)(1996-2#13)(1996-3#6)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#2)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#9)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#4)(2006-6#2)(2007-10#5)(2007-11#9)(2007-12#6)(2007-2#1)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#200)(2008-11#44)(2008-12#27)(2008-2#17)(2008-3#40)(2008-4#25)(2008-5#24)(2008-6#10)(2008-7#31)(2008-8#37)(2008-9#18)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#5)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#6)(2010-4#8)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#30)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#14)(2012-3#15)(2012-4#1)(2012-5#1)(2013-1#29)(2013-7#7)(2013-8#8)
effect only in the##2##4##(2009-8#1)(2011-2#1)
effect only##7##2##(1994-9#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
effect or##3##2##(1991-1#1)(2008-7#1)(2011-2#1)
effect persisted##3##2##(1994-3#1)(2008-8#2)
effect produced by##3##3##(2008-10#1)(2008-5#2)
effect profile##6##2##(1996-3#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
effect provides##2##2##(2008-3#1)(2009-8#1)
effect relative to##2##3##(1992-12#1)(2008-10#1)
effect remains##2##2##(1992-9#1)(1995-8#1)
effect results from##2##3##(2011-1#1)(2011-2#1)
effect results in##2##3##(2008-3#2)
effect results##4##2##(2008-3#2)(2011-1#1)(2011-2#1)
effect should be##2##3##(1991-12#1)(2008-8#1)
effect should##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
effect shown##2##2##(1995-12#1)(2008-7#1)
effect similar to that of##3##5##(1997-3#1)(2008-11#2)
effect similar to##4##3##(1997-3#1)(2007-11#1)(2008-11#2)
effect size and##2##3##(2008-9#1)(2010-4#1)
effect size was##3##3##(2008-10#3)
effect size##18##2##(1997-5#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#3)(2009-9#1)(2010-4#2)(2010-5#1)
effect sizes for##2##3##(2008-10#1)(2013-1#1)
effect sizes were##2##3##(2008-10#1)(2011-2#1)
effect sizes##12##2##(1996-6#1)(2008-10#3)(2008-4#1)(2011-2#4)(2013-1#3)
effect studies##2##2##(1992-3#1)(2008-10#1)
effect such that##2##3##(1994-8#1)(2008-11#1)
effect such##3##2##(1991-2#1)(1994-8#1)(2008-11#1)
effect suggests##2##2##(1994-11#1)(2008-2#1)
effect than##10##2##(1990-7#1)(1992-2#1)(1993-11#1)(1994-11#1)(1995-5#1)(2008-10#2)(2008-5#1)(2009-10#1)(2013-1#1)
effect that could##2##3##(2008-11#1)(2013-7#1)
effect that is due to the##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
effect that is due to##4##5##(1993-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
effect that is##7##3##(1993-3#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#1)
effect that##36##2##(1990-5#2)(1993-3#1)(1993-5#2)(1994-6#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
effect the##7##2##(1992-3#1)(1994-9#1)(1996-1#1)(1996-8#1)(2008-10#2)(2008-12#1)
effect through the suppression of##2##5##(2008-3#1)(2008-6#1)
effect through the##3##3##(1993-9#1)(2008-3#1)(2008-6#1)
effect through##4##2##(1993-9#1)(2008-3#1)(2008-6#1)(2011-2#1)
effect to that##2##3##(1994-7#1)(1995-5#1)
effect to the##4##3##(2007-11#2)(2008-10#2)
effect to##21##2##(1992-8#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-5#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
effect under##5##2##(1992-8#1)(2008-10#2)(2008-11#1)(2009-10#1)
effect up to##2##3##(2008-11#2)
effect upon the##3##3##(1992-6#1)(1994-5#1)(2008-5#1)
effect upon##7##2##(1992-12#1)(1992-6#1)(1993-6#1)(1994-5#1)(1997-7#1)(2008-10#1)(2008-5#1)
effect using the##2##3##(2008-10#1)(2012-2#1)
effect using##4##2##(2008-10#2)(2010-2#1)(2012-2#1)
effect varied##4##2##(1995-5#1)(1996-5#1)(2008-10#1)(2009-7#1)
effect was also observed##3##4##(1996-5#1)(2008-5#1)(2010-8#1)
effect was also##7##3##(1990-5#1)(1994-5#1)(1996-5#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
effect was attributed to the##2##5##(2008-10#1)(2008-7#1)
effect was blocked by the##2##5##(1995-12#2)
effect was blocked by##3##4##(1995-12#2)(1996-12#1)
effect was blocked##4##3##(1995-12#2)(1996-12#1)(2008-9#1)
effect was confirmed##2##3##(1991-5#1)(2008-10#1)
effect was dependent on##2##4##(1990-11#1)(2008-9#1)
effect was dose-dependent##2##3##(1995-12#1)(2008-11#1)
effect was due to##5##4##(1991-9#1)(1995-11#1)(1995-12#1)(2008-9#1)(2011-2#1)
effect was employed##2##3##(1995-9#1)(2008-10#1)
effect was found in the##2##5##(1991-6#1)(1997-1#1)
effect was found in##4##4##(1991-6#1)(1992-4#1)(1997-1#1)(2008-11#1)
effect was found to##2##4##(1991-9#1)(1993-6#1)
effect was found##12##3##(1990-2#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-6#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
effect was greater##3##3##(2008-10#1)(2008-9#2)
effect was less##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
effect was mediated by##2##4##(1996-12#1)(2008-10#1)
effect was more pronounced##2##4##(1997-1#1)(2008-10#1)
effect was more##5##3##(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
effect was most pronounced##2##4##(1993-8#1)(2013-8#1)
effect was most##3##3##(1993-8#1)(2008-11#1)(2013-8#1)
effect was not consistently##2##4##(1990-3#1)(2012-2#1)
effect was not due to##2##5##(1997-7#1)(2008-11#1)
effect was not##15##3##(1990-3#1)(1991-1#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-10#1)(2012-2#2)
effect was noted##2##3##(2008-10#1)(2008-7#1)
effect was observed at##2##4##(1995-2#1)(2008-6#1)
effect was observed by##2##4##(1991-5#1)(2008-10#1)
effect was observed for##3##4##(2008-10#1)(2008-11#1)(2010-1#1)
effect was observed in the##3##5##(1996-12#1)(2008-10#1)(2008-5#1)
effect was observed in##4##4##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
effect was observed on the##3##5##(1995-2#1)(1995-3#1)(2008-10#1)
effect was observed on##6##4##(1995-2#1)(1995-3#1)(2007-10#1)(2008-10#3)
effect was observed with##2##4##(1995-2#1)(2008-5#1)
effect was observed##30##3##(1990-11#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-2#3)(1995-3#1)(1996-12#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)
effect was present##3##3##(2007-11#1)(2008-10#2)
effect was quantified##2##3##(2008-10#1)(2012-12#1)
effect was seen##2##3##(1993-6#1)(1996-5#1)
effect was significant##2##3##(2008-10#2)
effect was stronger##2##3##(2008-10#1)(2008-9#1)
effect was studied##2##3##(1990-5#1)(2008-10#1)
effect was the##2##3##(2008-10#1)(2009-7#1)
effect was used for##2##4##(1995-2#1)(2008-10#1)
effect was verified##2##3##(1990-6#1)(2008-10#1)
effect was##192##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-11#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-1#2)(1997-7#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#41)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#10)(2009-11#1)(2009-2#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
effect we##2##2##(1991-12#1)(1997-4#1)
effect were##8##2##(1995-2#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-3#2)(2011-2#1)
effect when the##6##3##(1992-12#1)(1993-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
effect when##14##2##(1991-6#1)(1992-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-3#2)(2008-6#1)(2011-1#1)(2011-2#1)
effect which may##2##3##(1990-6#1)(2012-3#1)
effect which##6##2##(1990-6#1)(1994-2#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
effect while##2##2##(1992-3#1)(2008-3#1)
effect will be##2##3##(1993-12#1)(2008-8#1)
effect with a##2##3##(2008-3#1)(2008-5#1)
effect with different##2##3##(2008-2#1)(2013-8#1)
effect with minimal##2##3##(2007-12#1)(2008-10#1)
effect with##20##2##(1996-6#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
effect##5714##1##(1990-10#4)(1990-11#23)(1990-12#30)(1990-2#26)(1990-3#9)(1990-4#1)(1990-5#37)(1990-6#12)(1990-7#14)(1990-8#21)(1990-9#3)(1991-1#12)(1991-10#1)(1991-11#5)(1991-12#38)(1991-2#29)(1991-3#20)(1991-4#1)(1991-5#15)(1991-6#21)(1991-7#2)(1991-8#17)(1991-9#25)(1992-1#6)(1992-10#3)(1992-11#14)(1992-12#23)(1992-2#13)(1992-3#40)(1992-4#5)(1992-5#19)(1992-6#28)(1992-7#4)(1992-8#37)(1992-9#29)(1993-1#13)(1993-11#23)(1993-12#45)(1993-2#15)(1993-3#29)(1993-5#11)(1993-6#34)(1993-8#24)(1993-9#9)(1994-1#2)(1994-10#2)(1994-11#51)(1994-12#13)(1994-2#41)(1994-3#28)(1994-5#29)(1994-6#41)(1994-7#1)(1994-8#47)(1994-9#17)(1995-1#6)(1995-11#41)(1995-12#83)(1995-2#50)(1995-3#33)(1995-5#28)(1995-6#28)(1995-8#27)(1995-9#3)(1996-1#6)(1996-11#6)(1996-12#40)(1996-2#65)(1996-3#24)(1996-4#2)(1996-5#25)(1996-6#17)(1996-7#4)(1996-8#6)(1996-9#3)(1997-1#21)(1997-2#45)(1997-3#24)(1997-4#43)(1997-5#9)(1997-6#16)(1997-7#39)(1997-8#10)(2006-10#2)(2006-11#1)(2006-6#4)(2006-7#1)(2007-10#22)(2007-11#85)(2007-12#86)(2007-2#8)(2007-4#1)(2007-5#6)(2007-6#6)(2007-7#10)(2007-8#17)(2008-1#26)(2008-10#1015)(2008-11#229)(2008-12#116)(2008-2#130)(2008-3#286)(2008-4#76)(2008-5#170)(2008-6#70)(2008-7#168)(2008-8#176)(2008-9#100)(2009-1#3)(2009-10#16)(2009-11#10)(2009-12#24)(2009-2#15)(2009-3#14)(2009-4#6)(2009-5#10)(2009-6#17)(2009-7#22)(2009-8#35)(2009-9#11)(2010-1#17)(2010-10#13)(2010-11#19)(2010-12#23)(2010-2#23)(2010-3#18)(2010-4#31)(2010-5#17)(2010-6#15)(2010-7#9)(2010-8#20)(2010-9#6)(2011-1#63)(2011-10#3)(2011-2#159)(2011-3#15)(2011-7#1)(2012-1#23)(2012-12#42)(2012-2#91)(2012-3#81)(2012-4#1)(2012-5#3)(2012-6#2)(2012-7#3)(2012-8#5)(2012-9#1)(2013-1#145)(2013-7#30)(2013-8#75)
effect&quot##4##1##(1997-2#2)(2008-5#1)(2008-8#1)
effect'##5##1##(1996-6#1)(2008-10#2)(2012-12#1)(2012-2#1)
effect) in##3##2##(2007-11#1)(2008-8#1)(2011-2#1)
effect)##21##1##(1990-11#1)(1990-2#1)(1990-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
effect?]##2##1##(1995-5#1)(1997-2#1)
effect]##3##1##(1997-6#1)(2011-2#1)(2013-8#1)
effected an##2##2##(1991-12#1)(1991-3#1)
effected by##7##2##(1990-5#1)(1993-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)
effected in##2##2##(1990-3#1)(2010-12#1)
effected the##2##2##(1991-6#1)(2008-12#1)
effected##25##1##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-9#2)(1994-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
effecting the##2##2##(1994-9#1)(2008-1#1)
effecting##11##1##(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
effective (p&lt##2##2##(2013-1#2)
effective Young's modulus##2##3##(2009-4#2)
effective absorption cross section of the##2##6##(2007-12#1)(2008-7#1)
effective absorption##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
effective activator##2##2##(1990-5#1)(2008-10#1)
effective adhesion of##2##3##(2006-6#2)
effective adjuvant##3##2##(1992-8#1)(1993-1#1)(1997-4#1)
effective against NSCLC##2##3##(1990-2#1)(2013-8#1)
effective against P##2##3##(2008-10#2)
effective against all##3##3##(2008-10#2)(2008-11#1)
effective against both##2##3##(2008-10#2)
effective against the##4##3##(1990-3#1)(2008-10#2)(2010-5#1)
effective against these##2##3##(2008-10#1)(2009-10#1)
effective against##41##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
effective agent##5##2##(1990-5#1)(1991-3#1)(2006-10#1)(2008-5#1)(2009-8#1)
effective alternative in the##2##4##(2008-7#1)(2011-2#1)
effective alternative to##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
effective alternative##13##2##(1995-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#3)(2013-8#1)
effective amongst##2##2##(2008-10#1)(2011-1#1)
effective analgesia##2##2##(2007-11#1)(2009-5#1)
effective and economical##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
effective and efficient##9##3##(1994-2#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-10#3)(2008-11#1)
effective and less toxic##2##4##(1991-8#1)(2012-3#1)
effective and more##2##3##(1996-3#1)(2007-8#1)
effective and reliable##4##3##(1997-7#1)(2008-10#2)(2013-1#1)
effective and safe in##3##4##(1995-5#1)(2008-1#1)(2010-12#1)
effective and safe##11##3##(1992-5#1)(1994-3#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
effective and selective##2##3##(1990-5#1)(2012-2#1)
effective and tolerable##2##3##(2008-8#1)(2010-8#1)
effective and well tolerated##9##4##(1990-12#1)(1991-11#1)(1991-6#1)(1994-2#1)(1996-2#1)(2008-11#2)(2008-7#1)(2011-2#1)
effective and well-tolerated##3##3##(1994-8#1)(2008-11#1)(2012-2#1)
effective and##98##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#2)(1994-2#4)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-7#1)(2007-10#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
effective anticancer##3##2##(2009-12#1)(2012-12#1)(2012-2#1)
effective antimicrobial##2##2##(2006-10#1)(2011-2#1)
effective antitumor##2##2##(1997-4#1)(2009-2#1)
effective antiviral##2##2##(2007-12#1)(2013-8#1)
effective aperture of the##2##4##(2007-11#1)(2008-3#1)
effective application of##2##3##(2008-12#1)(2010-12#1)
effective approach to##5##3##(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
effective approach##10##2##(1993-12#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
effective approaches to##3##3##(1996-2#1)(2008-11#1)(2008-7#1)
effective approaches##5##2##(1996-2#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
effective are##3##2##(2008-6#1)(2008-7#1)(2010-4#1)
effective area##9##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)
effective areas of the##2##4##(2008-10#1)(2008-3#1)
effective areas of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
effective areas##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
effective as a##8##3##(1992-5#1)(1993-5#1)(1995-9#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
effective as an##3##3##(1990-10#1)(1990-2#1)(2008-11#1)
effective as high##2##3##(1995-11#1)(2008-8#1)
effective as the##4##3##(1992-12#1)(1995-3#1)(2008-10#1)(2013-1#1)
effective as##48##2##(1990-10#1)(1990-2#2)(1991-3#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
effective assessment##2##2##(1993-12#1)(2009-2#1)
effective at reducing##3##3##(2008-10#2)(2008-7#1)
effective at the##3##3##(1990-5#1)(1994-11#1)(2008-10#1)
effective at##31##2##(1990-5#2)(1993-12#2)(1994-11#1)(1995-2#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
effective beam##2##2##(2008-2#1)(2012-1#1)
effective biocontrol agents##2##3##(2008-10#2)
effective biocontrol##5##2##(2008-10#5)
effective biological##2##2##(2008-10#1)(2008-8#1)
effective blood##2##2##(2008-11#1)(2008-12#1)
effective but##2##2##(1992-6#1)(2008-11#1)
effective by##2##2##(2008-10#1)(2008-2#1)
effective calibration##2##2##(2008-3#2)
effective cancer##3##2##(1997-4#1)(2011-2#1)(2012-2#1)
effective care##4##2##(1993-2#1)(1994-2#1)(1995-2#1)(2012-2#1)
effective carrier##2##2##(1991-5#1)(2010-7#1)
effective change in##2##3##(1990-9#1)(2008-7#1)
effective chemotherapy##3##2##(2010-3#2)(2011-1#1)
effective clinical placement##2##3##(2008-12#2)
effective clinical trials##2##3##(2008-8#1)(2011-2#1)
effective clinical##8##2##(1994-3#1)(1995-5#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
effective closure##2##2##(1992-2#1)(1996-9#1)
effective cognitive##2##2##(1993-12#1)(2007-8#1)
effective collaboration##3##2##(2008-11#1)(2008-12#2)
effective collection of##2##3##(2008-10#1)(2012-12#1)
effective combination for##2##3##(1991-4#1)(1996-11#1)
effective combination of##2##3##(1997-3#1)(2008-11#1)
effective combination##4##2##(1991-4#1)(1996-11#1)(1997-3#1)(2008-11#1)
effective communication##6##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2013-8#1)
effective communications##2##2##(1993-2#1)(2010-5#1)
effective components##2##2##(2008-11#1)(2008-2#1)
effective compounds against##2##3##(2008-10#1)(2011-3#1)
effective compounds##3##2##(1991-2#1)(2008-10#1)(2011-3#1)
effective concentration (EC(50))##2##3##(2008-10#2)
effective concentration of##4##3##(1995-5#1)(1997-4#1)(2008-10#1)(2008-9#1)
effective concentration values##2##3##(2008-10#2)
effective concentration##12##2##(1995-5#1)(1997-4#1)(2008-10#9)(2008-9#1)
effective concentrations##2##2##(1992-5#1)(2008-10#1)
effective control of##3##3##(1991-8#1)(2011-2#2)
effective control##8##2##(1991-8#1)(2008-10#3)(2011-2#4)
effective coping##4##2##(1992-3#1)(2008-11#1)(2010-10#1)(2011-2#1)
effective coverage##2##2##(2008-11#1)(2012-12#1)
effective delivery of##4##3##(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
effective delivery##6##2##(1995-3#1)(1997-1#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
effective design of##2##3##(2010-8#1)(2011-1#1)
effective detection##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
effective diffusion coefficient##2##3##(2008-10#1)(2008-2#1)
effective diffusion##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
effective discrimination##2##2##(2008-3#1)(2008-9#1)
effective disease control##3##3##(2008-10#3)
effective disease management##2##3##(2008-10#2)
effective disease##5##2##(2008-10#5)
effective dose (ED(50))##2##3##(2008-10#2)
effective dose (concentration) required for 90%##2##6##(2008-10#2)
effective dose of##4##3##(1995-2#1)(1997-8#1)(2012-2#1)(2013-8#1)
effective dose to##3##3##(1994-9#1)(1997-8#1)(2008-10#1)
effective dose##28##2##(1994-9#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#3)(1997-8#4)(2008-10#10)(2008-12#3)(2012-2#2)(2013-8#1)
effective drug for##2##3##(1992-2#1)(2008-7#1)
effective drug##5##2##(1992-2#1)(1994-3#1)(2008-1#1)(2008-7#1)(2012-3#1)
effective drugs for##3##3##(2007-2#1)(2008-7#2)
effective drugs##7##2##(1991-12#1)(1993-11#1)(1995-2#1)(2007-2#1)(2008-7#2)(2011-3#1)
effective enough to##2##3##(2008-11#1)(2012-2#1)
effective evaluation##2##2##(1995-5#1)(2011-2#1)
effective even##3##2##(1997-2#1)(2008-10#1)(2010-8#1)
effective for augmenting##2##3##(2012-2#1)(2013-1#1)
effective for both##2##3##(2008-2#2)
effective for control of##2##4##(2008-10#1)(2012-12#1)
effective for the management of##2##5##(2008-10#1)(2008-11#1)
effective for the treatment of##5##5##(2008-3#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-1#1)
effective for the##20##3##(1990-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-6#1)(2013-1#1)
effective for treating##3##3##(1997-7#1)(2008-7#1)(2010-4#1)
effective for##74##2##(1990-2#1)(1990-6#1)(1991-3#1)(1993-2#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#5)
effective form of treatment##2##4##(1997-6#1)(2008-7#1)
effective form of##4##3##(1993-2#1)(1996-8#1)(1997-6#1)(2008-7#1)
effective form##5##2##(1993-2#1)(1996-8#1)(1997-6#1)(2008-11#1)(2008-7#1)
effective framework##2##2##(1994-2#1)(2012-12#1)
effective group##4##2##(2007-11#1)(2008-3#2)(2009-5#1)
effective growth factors##2##3##(1993-5#2)
effective growth##3##2##(1993-5#2)(2008-11#1)
effective health##4##2##(1996-1#1)(1997-3#1)(2012-12#1)(2013-8#1)
effective hospital-physician relationships##2##3##(1991-3#2)
effective if##6##2##(2008-10#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-2#1)
effective immune responses##2##3##(2012-2#2)
effective immune##3##2##(1994-8#1)(2012-2#2)
effective immunity##2##2##(1995-5#1)(2008-3#1)
effective implementation##2##2##(2008-10#1)(2013-1#1)
effective in a##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
effective in achieving the##2##4##(2008-12#1)(2009-12#1)
effective in achieving##4##3##(2008-12#1)(2008-8#1)(2009-12#1)(2012-2#1)
effective in all patients##2##4##(2007-11#1)(2012-1#1)
effective in all##3##3##(2007-11#1)(2007-8#1)(2012-1#1)
effective in both##2##3##(2008-10#2)
effective in clinical trials##2##4##(2006-10#1)(2008-4#1)
effective in controlling the##2##4##(2008-7#1)(2013-1#1)
effective in controlling##8##3##(2008-1#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-1#1)
effective in creating##2##3##(1992-1#1)(1992-2#1)
effective in dealing with##2##4##(1993-12#1)(2008-2#1)
effective in decreasing the##3##4##(1996-12#1)(2012-12#1)(2013-1#1)
effective in detecting the##2##4##(2008-10#1)(2008-5#1)
effective in detecting##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
effective in eliminating##2##3##(1994-5#1)(2008-6#1)
effective in enhancing##2##3##(1997-8#1)(2009-1#1)
effective in helping##2##3##(2008-11#1)(2008-12#1)
effective in improving skin hydration##2##5##(2008-5#2)
effective in improving the##2##4##(2007-8#1)(2012-2#1)
effective in improving##8##3##(2007-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
effective in increasing##4##3##(1990-5#1)(1995-12#1)(2008-11#1)(2013-1#1)
effective in inducing##3##3##(1990-12#1)(1995-5#1)(2011-2#1)
effective in inhibiting the##2##4##(2008-10#1)(2008-7#1)
effective in inhibiting##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
effective in killing##2##3##(1990-7#1)(2012-12#1)
effective in lowering the##3##4##(1995-2#1)(2007-10#1)(2008-1#1)
effective in lowering##4##3##(1994-8#1)(1995-2#1)(2007-10#1)(2008-1#1)
effective in maintaining##2##3##(2007-7#1)(2010-1#1)
effective in managing##3##3##(1994-7#1)(2008-7#1)(2008-8#1)
effective in many##2##3##(1993-6#1)(2011-2#1)
effective in preventing##15##3##(1990-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
effective in producing##4##3##(1992-12#1)(1994-9#1)(1996-1#1)(2008-2#1)
effective in promoting##4##3##(2008-11#1)(2010-10#1)(2012-1#1)(2012-2#1)
effective in protecting against##2##4##(1993-5#1)(2008-10#1)
effective in protecting##6##3##(1992-3#1)(1993-5#1)(1997-6#1)(2007-8#1)(2008-10#2)
effective in reducing the severity of##2##6##(2008-10#2)
effective in reducing the##13##4##(1990-3#1)(1990-5#1)(1993-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)
effective in reducing##30##3##(1990-12#1)(1990-3#1)(1990-5#1)(1992-6#1)(1993-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
effective in removing##4##3##(1994-5#1)(2008-10#2)(2008-2#1)
effective in reversing##2##3##(1992-12#1)(1994-10#1)
effective in shifting##2##3##(1994-3#1)(2013-1#1)
effective in slowing the##2##4##(1995-3#1)(2012-12#1)
effective in slowing##3##3##(1995-3#1)(1995-5#1)(2012-12#1)
effective in suppressing the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
effective in suppressing##9##3##(1994-8#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-3#1)
effective in terms of##4##4##(1992-12#1)(2007-10#1)(2008-11#1)(2008-7#1)
effective in the management of##2##5##(2008-12#1)(2010-4#1)
effective in the prevention of##2##5##(2008-5#1)(2011-2#1)
effective in the prevention##3##4##(1993-11#1)(2008-5#1)(2011-2#1)
effective in the treatment of allergic rhinitis##3##7##(2007-11#3)
effective in the treatment of##16##5##(1992-2#1)(1994-9#1)(2007-11#7)(2008-3#1)(2009-3#1)(2010-5#1)(2011-2#2)(2013-1#2)
effective in the treatment##17##4##(1992-2#1)(1994-9#1)(2007-11#8)(2008-3#1)(2009-3#1)(2010-5#1)(2011-2#2)(2013-1#2)
effective in the##39##3##(1992-2#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-8#1)(2007-11#8)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
effective in their##2##3##(2008-11#1)(2008-9#1)
effective in this##5##3##(1997-4#1)(2007-8#1)(2008-11#3)
effective in treatment of##3##4##(2007-8#1)(2008-8#2)
effective in vitro##2##3##(1990-5#1)(2008-11#1)
effective in##295##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-4#1)(1997-6#2)(1997-8#2)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#12)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2008-1#5)(2008-10#41)(2008-11#14)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#18)(2013-8#3)
effective index of##2##3##(2008-2#1)(2008-3#1)
effective inhibition of##2##3##(1991-12#1)(1991-5#1)
effective inhibitor of##5##3##(1990-5#1)(1992-5#2)(1992-9#1)(2008-11#1)
effective inhibitor##8##2##(1990-5#1)(1992-5#4)(1992-9#1)(1994-8#1)(2008-11#1)
effective inhibitors of the##2##4##(1990-5#1)(1993-11#1)
effective inhibitors##4##2##(1990-5#1)(1993-11#1)(1994-12#2)
effective intervention for##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)
effective intervention##10##2##(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2009-11#1)(2010-5#1)(2013-1#1)
effective interventions that##2##3##(2012-3#1)(2013-8#1)
effective interventions##6##2##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
effective isolation##2##2##(2008-2#1)(2008-8#1)
effective leadership##3##2##(1993-1#1)(1994-3#1)(1997-2#1)
effective leaf rust resistance in##2##5##(2008-10#2)
effective learning##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2013-1#1)(2013-8#1)
effective length##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
effective managed care##3##3##(1993-12#1)(1995-1#2)
effective management and##2##3##(2007-5#1)(2012-12#1)
effective management of the##2##4##(2008-10#1)(2008-7#1)
effective management of##6##3##(2007-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)
effective management##16##2##(1990-12#1)(1994-2#1)(1996-8#1)(2007-5#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2010-1#1)(2012-12#1)(2012-2#1)
effective manual##3##2##(1996-3#2)(2008-12#1)
effective means by which##2##4##(2008-10#2)
effective means for the##2##4##(2008-10#1)(2008-11#1)
effective means for##4##3##(2008-10#3)(2008-11#1)
effective means of preventing##2##4##(2008-10#1)(2008-8#1)
effective means of reducing##2##4##(1993-11#1)(2008-3#1)
effective means of##17##3##(1990-8#1)(1993-11#1)(1994-11#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
effective means to control##4##4##(1993-12#1)(2008-10#2)(2008-6#1)
effective means to##6##3##(1993-12#1)(1995-1#1)(2008-10#2)(2008-6#1)(2008-8#1)
effective means##29##2##(1990-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1996-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
effective measurement##2##2##(1991-12#1)(2007-12#1)
effective measures to##4##3##(2008-8#2)(2012-2#1)(2013-1#1)
effective measures##7##2##(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
effective mechanism for##2##3##(1994-8#1)(2008-4#1)
effective medicines##2##2##(2008-10#1)(2010-2#1)
effective medium theory##3##3##(2008-3#3)
effective medium##9##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)
effective meetings##2##2##(1994-2#2)
effective method for treating##2##4##(2008-9#1)(2011-2#1)
effective method for##13##3##(1991-2#1)(2008-10#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-2#1)
effective method is##2##3##(2008-10#1)(2008-6#1)
effective method of##15##3##(1991-7#1)(1993-1#1)(1993-12#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-1#1)
effective method to reduce##2##4##(2008-5#1)(2013-1#1)
effective method to##9##3##(1990-12#1)(2008-10#4)(2008-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
effective method##42##2##(1990-12#1)(1991-2#1)(1991-7#1)(1993-1#1)(1993-12#2)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
effective methodology for identifying##2##4##(1995-3#1)(2010-8#1)
effective methods for the##2##4##(2007-11#1)(2008-10#1)
effective methods for##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
effective methods of##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
effective methods##11##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
effective migration rate##5##3##(2008-10#2)(2008-8#3)
effective model##3##2##(2008-3#1)(2008-8#1)(2009-11#1)
effective models are##2##3##(1993-12#1)(2008-10#1)
effective modulation of##2##3##(2008-8#1)(2011-2#1)
effective new##2##2##(1995-1#1)(1997-3#1)
effective nitrogen fixing microsymbiont of a diverse range of annual##2##10##(2011-2#2)
effective nonlinear coefficient##2##3##(2007-11#1)(2007-12#1)
effective nonlinear##3##2##(2007-11#1)(2007-12#2)
effective nonlinearity##3##2##(2007-11#1)(2007-12#2)
effective number of##2##3##(2008-7#1)(2010-8#1)
effective of##3##2##(1995-3#1)(2007-11#1)(2010-1#1)
effective on##7##2##(1990-5#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
effective one##2##2##(2008-12#1)(2008-3#1)
effective only##2##2##(2008-10#1)(2008-4#1)
effective operation##2##2##(1995-3#1)(2012-2#1)
effective optical##3##2##(2008-2#2)(2008-3#1)
effective or##4##2##(1997-1#1)(2008-10#1)(2010-6#1)(2011-1#1)
effective output##3##2##(1995-3#2)(2008-2#1)
effective particle##2##2##(2008-2#1)(2008-3#1)
effective partnership##2##2##(1994-1#1)(2008-11#1)
effective pest##2##2##(2008-10#1)(2011-2#1)
effective photosensitizer##2##2##(1992-8#1)(2012-3#1)
effective policies##3##2##(1994-3#1)(1995-6#1)(1997-3#1)
effective population size of##3##4##(2008-10#2)(2012-5#1)
effective population size##6##3##(2008-10#2)(2012-5#1)(2013-1#3)
effective population##7##2##(2008-10#2)(2012-5#1)(2013-1#4)
effective prevention of##3##3##(1993-11#1)(2009-4#1)(2009-7#1)
effective prevention##6##2##(1993-11#1)(2008-11#1)(2009-4#1)(2009-7#1)(2013-1#2)
effective primary##2##2##(2007-7#1)(2011-2#1)
effective procedure for##2##3##(2008-4#1)(2011-2#1)
effective procedure##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
effective production##2##2##(2008-10#1)(2008-3#1)
effective protection against##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
effective protection of##2##3##(2010-7#1)(2011-2#1)
effective protection##6##2##(2008-10#2)(2008-5#1)(2009-6#1)(2010-7#1)(2011-2#1)
effective psychosocial##2##2##(2008-4#2)
effective public health##4##3##(1995-1#1)(1997-1#1)(1997-3#1)(2010-12#1)
effective public##5##2##(1995-1#1)(1997-1#1)(1997-3#1)(2009-4#1)(2010-12#1)
effective quality improvement##2##3##(1993-12#1)(2013-1#1)
effective quality##5##2##(1993-12#2)(2010-7#1)(2012-2#1)(2013-1#1)
effective radius of curvature##2##4##(1992-3#1)(2008-2#1)
effective radius of##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
effective radius##14##2##(1992-3#1)(2008-10#1)(2008-2#3)(2008-3#9)
effective real-time##2##2##(2008-10#1)(2008-3#1)
effective recombination rate is##3##4##(2008-8#3)
effective refractive index and##2##4##(2008-2#1)(2008-3#1)
effective refractive index of spherical plastic pigments in a##2##9##(2008-3#2)
effective refractive index of##3##4##(2008-3#3)
effective refractive index##11##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#5)
effective refractory period of##3##4##(1992-6#1)(2008-11#2)
effective removal of##4##3##(1991-9#1)(2008-10#2)(2011-1#1)
effective resistance##3##2##(2008-10#2)(2008-7#1)
effective sample size##5##3##(2008-10#5)
effective scatterer size##3##3##(2008-3#3)
effective scatterer##5##2##(2008-3#5)
effective scattering##2##2##(2008-3#2)
effective screening##4##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
effective second##2##2##(1990-2#1)(1993-3#1)
effective separation##2##2##(2008-10#2)
effective size of a##4##4##(2007-12#2)(2008-8#2)
effective size of##7##3##(1990-11#1)(2007-12#2)(2008-10#1)(2008-8#3)
effective size##8##2##(1990-11#1)(2007-12#2)(2008-10#1)(2008-8#4)
effective solutions to##2##3##(2008-7#1)(2009-6#1)
effective solutions##3##2##(2008-7#1)(2009-6#1)(2013-1#1)
effective staff##2##2##(1992-3#1)(1993-12#1)
effective strategies in##3##3##(1996-3#1)(2008-10#1)(2010-10#1)
effective strategies to##3##3##(1993-12#1)(2008-11#1)(2010-6#1)
effective strategies##8##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-5#1)(2010-6#1)
effective strategy for the prevention and##2##6##(2011-2#1)(2013-1#1)
effective strategy for the##4##4##(2008-10#1)(2011-2#1)(2013-1#2)
effective strategy for##9##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#3)
effective strategy to##3##3##(2008-12#1)(2010-6#1)(2012-2#1)
effective strategy##14##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#3)
effective substitute for##2##3##(1997-7#1)(2008-1#1)
effective substrate##2##2##(1994-5#1)(1995-11#1)
effective suppression of##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
effective surface area##2##3##(2007-7#1)(2008-10#1)
effective surface##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
effective surgical##2##2##(2008-10#1)(2013-8#1)
effective systemic##2##2##(2007-11#1)(2010-3#1)
effective technique for##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2009-8#1)
effective technique to##3##3##(2007-8#1)(2008-10#2)
effective technique##11##2##(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
effective techniques##2##2##(1995-8#1)(2011-2#1)
effective technology##2##2##(1992-9#1)(2008-9#1)
effective than T(382)##2##3##(2008-10#2)
effective than a##2##3##(2008-4#1)(2009-7#1)
effective than the##12##3##(1995-2#2)(1995-9#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
effective than##70##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#2)(1995-2#3)(1995-9#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)
effective the##2##2##(1993-6#1)(2008-3#1)
effective therapeutic modality##3##3##(1993-2#1)(2007-7#2)
effective therapeutic strategies##4##3##(2008-1#1)(2008-5#1)(2009-5#1)(2011-2#1)
effective therapeutic##15##2##(1993-2#1)(1994-11#1)(1994-3#1)(2007-7#2)(2008-1#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#3)
effective therapies##4##2##(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
effective therapy and##3##3##(1992-6#1)(2008-6#1)(2013-1#1)
effective therapy for##3##3##(1991-4#1)(1997-5#1)(2007-10#1)
effective therapy##20##2##(1991-4#1)(1992-6#1)(1994-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
effective thickness##2##2##(2013-8#2)
effective third-order##2##2##(2007-12#2)
effective time##2##2##(1992-2#1)(2008-10#1)
effective to correct##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
effective to##22##2##(1992-8#2)(1993-6#1)(1994-1#2)(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
effective tool for##7##3##(1993-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)
effective tool in##4##3##(1996-3#1)(2007-11#1)(2008-10#1)(2010-5#1)
effective tool to manage##2##4##(1992-2#1)(2010-3#1)
effective tool to##8##3##(1992-2#1)(1994-3#1)(2008-10#1)(2010-10#1)(2010-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
effective tool##19##2##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-7#1)(2013-7#1)(2013-8#1)
effective training##4##2##(1996-12#1)(2008-12#1)(2010-8#1)(2013-8#1)
effective transverse##3##2##(1996-5#1)(2007-11#1)(2012-2#1)
effective treatment and##3##3##(1995-9#1)(2012-1#1)(2012-12#1)
effective treatment for symptomatic##2##4##(1993-3#1)(2012-3#1)
effective treatment for this##2##4##(2012-2#1)(2013-1#1)
effective treatment for##20##3##(1993-2#1)(1993-3#1)(1994-3#1)(1995-4#1)(2007-11#1)(2007-9#1)(2008-2#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
effective treatment is##2##3##(2007-7#1)(2008-8#1)
effective treatment modalities##2##3##(2008-7#1)(2010-8#1)
effective treatment of##10##3##(2008-1#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-2#3)(2013-1#2)(2013-8#1)
effective treatment option##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
effective treatment with##2##3##(1996-6#1)(1997-6#1)
effective treatment##70##2##(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#1)
effective treatments are available##2##4##(2008-11#1)(2010-10#1)
effective treatments for##4##3##(2007-11#1)(2008-6#2)(2012-3#1)
effective treatments##10##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
effective use in##2##3##(1991-2#1)(1993-12#1)
effective use of resources##2##4##(2007-8#1)(2008-10#1)
effective use of##10##3##(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)
effective use##14##2##(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-1#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)
effective utilization of##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
effective vaccination##2##2##(1995-5#1)(2013-1#1)
effective vaccine against##2##3##(1995-2#1)(2011-2#1)
effective vaccine##3##2##(1995-2#1)(1995-5#1)(2011-2#1)
effective values of##2##3##(2008-3#1)(2009-4#1)
effective volunteer##2##2##(1993-12#1)(1996-3#1)
effective wavelength##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
effective way of##4##3##(1991-2#1)(2007-11#1)(2007-8#1)(2008-7#1)
effective way to##9##3##(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
effective way##15##2##(1991-2#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
effective ways of##3##3##(1990-10#1)(1995-1#1)(2007-7#1)
effective ways to##2##3##(2007-11#1)(2008-1#1)
effective ways##5##2##(1990-10#1)(1995-1#1)(2007-11#1)(2007-7#1)(2008-1#1)
effective when given orally##2##4##(1992-12#1)(2006-10#1)
effective when the##2##3##(1995-2#1)(2008-9#1)
effective when##11##2##(1992-12#1)(1994-1#1)(1995-2#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
effective will##2##2##(1993-2#1)(2008-8#1)
effective with##7##2##(1993-12#1)(1994-12#1)(2008-10#3)(2008-9#1)(2012-12#1)
effective##2251##1##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#9)(1990-3#2)(1990-5#13)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#9)(1991-2#7)(1991-3#8)(1991-4#3)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#6)(1992-11#1)(1992-12#14)(1992-2#12)(1992-3#10)(1992-4#1)(1992-5#11)(1992-6#6)(1992-8#7)(1992-9#7)(1993-1#5)(1993-10#1)(1993-11#8)(1993-12#29)(1993-2#13)(1993-3#8)(1993-5#4)(1993-6#5)(1993-8#5)(1993-9#1)(1994-1#7)(1994-10#1)(1994-11#5)(1994-12#9)(1994-2#17)(1994-3#15)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#9)(1994-9#6)(1995-1#9)(1995-11#9)(1995-12#9)(1995-2#23)(1995-3#12)(1995-4#1)(1995-5#13)(1995-6#2)(1995-8#4)(1995-9#7)(1996-1#5)(1996-11#6)(1996-12#11)(1996-2#7)(1996-3#10)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#11)(1997-2#17)(1997-3#10)(1997-4#14)(1997-5#1)(1997-6#10)(1997-7#6)(1997-8#7)(2006-10#7)(2006-12#1)(2006-6#3)(2006-7#1)(2007-10#5)(2007-11#62)(2007-12#48)(2007-2#3)(2007-5#5)(2007-6#4)(2007-7#17)(2007-8#29)(2007-9#3)(2008-1#25)(2008-10#360)(2008-11#107)(2008-12#43)(2008-2#54)(2008-3#110)(2008-4#28)(2008-5#49)(2008-6#22)(2008-7#70)(2008-8#58)(2008-9#26)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#8)(2009-2#2)(2009-3#5)(2009-4#7)(2009-5#14)(2009-6#7)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#5)(2010-10#10)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#11)(2010-4#12)(2010-5#13)(2010-6#9)(2010-7#10)(2010-8#17)(2010-9#3)(2011-1#28)(2011-2#95)(2011-3#7)(2012-1#9)(2012-12#35)(2012-2#61)(2012-3#21)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#1)(2013-1#94)(2013-7#3)(2013-8#34)
effective-index method##2##2##(2007-11#1)(2008-2#1)
effective-index##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
effective?##2##1##(1993-2#1)(2008-11#1)
effectively accelerate the##2##3##(2007-11#1)(2008-10#1)
effectively and efficiently##4##3##(1993-12#1)(2010-8#2)(2012-1#1)
effectively and##14##2##(1993-12#1)(1994-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-11#1)(2010-8#2)(2012-1#1)
effectively applied to##2##3##(2008-10#1)(2013-1#1)
effectively applied##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
effectively be##3##2##(1991-1#1)(2009-8#1)(2012-1#1)
effectively blocked by##3##3##(1997-7#1)(2008-11#1)(2009-12#1)
effectively blocked##5##2##(1993-3#1)(1995-8#1)(1997-7#1)(2008-11#1)(2009-12#1)
effectively bound##2##2##(1995-6#1)(2008-11#1)
effectively by##4##2##(2007-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
effectively communicate##3##2##(1992-2#1)(1994-2#1)(2013-1#1)
effectively compete with##2##3##(1994-9#1)(1997-2#1)
effectively control the##4##3##(2007-11#1)(2008-7#2)(2010-8#1)
effectively control##5##2##(2007-11#1)(2008-7#2)(2010-10#1)(2010-8#1)
effectively controlled by##2##3##(2008-10#1)(2008-8#1)
effectively controlled##7##2##(1992-2#1)(2008-10#4)(2008-8#1)(2012-3#1)
effectively cured##2##2##(1996-9#1)(2011-2#1)
effectively deliver##2##2##(2008-11#1)(2008-7#1)
effectively eliminated the##2##3##(2008-10#1)(2008-8#1)
effectively eliminated##4##2##(1992-11#1)(2008-10#2)(2008-8#1)
effectively for##2##2##(2008-2#1)(2010-6#1)
effectively form##2##2##(2008-6#1)(2010-10#1)
effectively from a##2##3##(2008-10#1)(2008-6#1)
effectively from##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
effectively identify##2##2##(1993-11#1)(2008-9#1)
effectively implement##2##2##(1994-1#1)(2008-3#1)
effectively improved by a bimodal distribution##2##6##(2009-7#2)
effectively in a##2##3##(2008-10#1)(2008-9#1)
effectively in the##3##3##(1996-5#1)(2008-11#1)(2011-2#1)
effectively in##17##2##(1991-1#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2013-8#1)
effectively increase##5##2##(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#1)(2012-3#1)
effectively inhibit the##7##3##(1991-9#1)(1992-6#1)(1994-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
effectively inhibit##8##2##(1991-9#1)(1992-6#1)(1994-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
effectively inhibited the##2##3##(2008-6#1)(2008-9#1)
effectively inhibited##8##2##(1991-12#1)(1996-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
effectively inhibits##2##2##(1992-9#1)(2010-1#1)
effectively manage##4##2##(1996-2#1)(2007-11#1)(2008-7#1)(2010-7#1)
effectively managed with##2##3##(2006-10#1)(2008-8#1)
effectively perform their##2##3##(1991-3#1)(1995-1#1)
effectively perform##3##2##(1991-3#1)(1995-1#1)(2007-11#1)
effectively prevent##4##2##(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
effectively prevented##2##2##(1994-11#1)(1995-6#1)
effectively produce##3##2##(2008-10#1)(2008-11#2)
effectively provide##2##2##(1997-2#1)(2007-11#1)
effectively quenched##2##2##(2008-10#2)
effectively reduce the##2##3##(2007-11#1)(2008-3#1)
effectively reduce##8##2##(1996-1#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
effectively reduced the##2##3##(1995-6#1)(2008-11#1)
effectively reduced##5##2##(1995-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-7#1)
effectively remove##4##2##(2008-10#2)(2008-2#1)(2011-1#1)
effectively removed##2##2##(2012-12#1)(2013-1#1)
effectively reversed##2##2##(1994-11#1)(2011-2#1)
effectively separate##4##2##(2008-10#3)(2010-3#1)
effectively separated from##3##3##(2008-10#2)(2012-2#1)
effectively suppress##3##2##(2008-3#1)(2008-9#1)(2010-2#1)
effectively suppressed##6##2##(2007-11#1)(2008-10#4)(2008-8#1)
effectively than##6##2##(1993-2#1)(1994-8#1)(1996-2#1)(1997-6#1)(2010-4#1)(2013-1#1)
effectively the##4##2##(1995-5#1)(2008-10#1)(2008-8#1)(2012-12#1)
effectively to##8##2##(1994-2#1)(1994-8#1)(1997-1#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2013-8#1)
effectively treat##6##2##(1996-3#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
effectively used for##2##3##(2007-7#1)(2008-11#1)
effectively used##5##2##(1994-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)
effectively utilized##3##2##(1992-12#1)(2008-6#1)(2009-9#1)
effectively with the##4##3##(1994-3#1)(1996-2#1)(2007-8#1)(2008-11#1)
effectively with their##2##3##(2008-11#1)(2012-12#1)
effectively with##18##2##(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-12#1)(2013-1#1)
effectively##432##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#5)(1995-3#3)(1995-5#4)(1995-6#5)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#6)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#4)(1997-2#5)(1997-5#1)(1997-6#2)(1997-7#5)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#10)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#65)(2008-11#31)(2008-12#5)(2008-2#7)(2008-3#16)(2008-4#4)(2008-5#11)(2008-6#8)(2008-7#10)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#9)(2011-1#5)(2011-2#10)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#10)
effectively?##2##1##(1996-3#1)(2011-1#1)
effectiveness against##3##2##(2008-10#2)(2011-2#1)
effectiveness and efficiency##2##3##(1991-2#1)(1994-2#1)
effectiveness and impact##2##3##(2008-4#1)(2013-1#1)
effectiveness and safety of##6##4##(1993-2#1)(1997-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
effectiveness and safety##7##3##(1993-2#1)(1997-3#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
effectiveness and tolerability##2##3##(1990-3#1)(2008-10#1)
effectiveness and##43##2##(1990-3#1)(1990-6#1)(1991-2#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#2)(2013-8#1)
effectiveness are##3##2##(1993-3#1)(2011-2#1)(2013-7#1)
effectiveness as a##2##3##(1996-3#1)(2008-10#1)
effectiveness as##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
effectiveness assessment systems##2##3##(1994-12#2)
effectiveness assessment##5##2##(1994-12#5)
effectiveness at##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
effectiveness by##2##2##(1996-9#1)(2007-12#1)
effectiveness during##2##2##(1992-12#1)(2010-4#1)
effectiveness factor##2##2##(2008-6#2)
effectiveness for##4##2##(1997-2#1)(2007-11#1)(2009-11#1)(2013-8#1)
effectiveness has##2##2##(2008-12#1)(2012-12#1)
effectiveness in a##2##3##(2008-10#1)(2008-11#1)
effectiveness in the treatment of##2##5##(1990-3#1)(2012-3#1)
effectiveness in the##8##3##(1990-3#1)(1997-1#1)(2007-11#1)(2008-1#2)(2010-4#1)(2012-3#1)(2013-1#1)
effectiveness in##27##2##(1990-3#1)(1991-1#2)(1992-2#1)(1993-1#1)(1995-1#2)(1996-8#1)(1997-1#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-6#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
effectiveness is also##2##3##(2008-10#1)(2012-3#1)
effectiveness is##9##2##(1991-1#2)(2008-10#1)(2008-3#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
effectiveness of SIT##2##3##(2011-2#2)
effectiveness of a##28##3##(1990-6#1)(1992-1#3)(1992-2#1)(1994-12#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-11#1)(2007-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#1)(2010-8#1)(2012-3#2)
effectiveness of adjunctive##2##3##(2008-4#1)(2013-1#1)
effectiveness of an AO system##2##5##(2008-3#2)
effectiveness of an##7##3##(1995-2#1)(1997-1#1)(2008-3#2)(2008-8#1)(2010-10#1)(2012-2#1)
effectiveness of antimicrobial##2##3##(2011-2#1)(2013-1#1)
effectiveness of care##3##3##(1991-12#1)(1993-12#1)(2007-11#1)
effectiveness of global##2##3##(1994-1#1)(2013-1#1)
effectiveness of medical##2##3##(1994-11#1)(2010-6#1)
effectiveness of oral##2##3##(1997-7#1)(2012-2#1)
effectiveness of our##5##3##(1992-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-9#1)
effectiveness of patient##2##3##(1996-3#1)(2007-11#1)
effectiveness of stand-alone body image##2##5##(2007-12#2)
effectiveness of stand-alone##3##3##(2007-12#3)
effectiveness of such##2##3##(2008-8#1)(2010-12#1)
effectiveness of telemedicine##3##3##(1996-3#3)
effectiveness of the intervention##2##4##(1995-1#1)(2008-1#1)
effectiveness of the method##2##4##(2008-3#1)(2008-7#1)
effectiveness of the new##2##4##(2007-11#1)(2008-2#1)
effectiveness of the proposed##7##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
effectiveness of the##75##3##(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
effectiveness of these##11##3##(1991-1#1)(1992-6#1)(1993-8#1)(1996-1#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#2)
effectiveness of this approach##3##4##(1996-12#1)(2008-2#1)(2008-7#1)
effectiveness of this method##5##4##(1996-1#1)(2008-11#1)(2008-12#1)(2008-3#2)
effectiveness of this##26##3##(1990-11#1)(1990-2#1)(1990-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#2)
effectiveness of treatment and##2##4##(1996-3#1)(2012-2#1)
effectiveness of treatment of##2##4##(2008-3#1)(2008-7#1)
effectiveness of treatment##6##3##(1996-3#1)(2008-3#1)(2008-7#2)(2012-1#1)(2012-2#1)
effectiveness of treatments##2##3##(1990-2#1)(2007-12#1)
effectiveness of two##2##3##(1990-6#1)(2013-1#1)
effectiveness of using##3##3##(2007-5#1)(2008-11#1)(2012-12#1)
effectiveness of various##2##3##(2008-7#1)(2013-8#1)
effectiveness of##416##2##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#6)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#6)(1993-2#3)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-2#3)(1995-3#3)(1995-4#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#5)(1996-6#2)(1997-1#4)(1997-2#1)(1997-3#4)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#13)(2007-12#12)(2007-5#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#36)(2008-11#15)(2008-12#8)(2008-2#7)(2008-3#21)(2008-4#6)(2008-5#6)(2008-6#8)(2008-7#23)(2008-8#8)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#7)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#16)(2011-3#2)(2012-1#5)(2012-12#8)(2012-2#17)(2012-3#8)(2013-1#28)(2013-7#2)(2013-8#2)
effectiveness on##3##2##(1993-2#1)(2008-10#1)(2010-4#1)
effectiveness or##2##2##(2010-1#1)(2010-11#1)
effectiveness research##2##2##(1992-1#1)(1993-12#1)
effectiveness study##2##2##(2012-2#2)
effectiveness through##2##2##(1995-3#1)(1997-7#1)
effectiveness to##4##2##(2008-7#1)(2010-8#1)(2012-2#2)
effectiveness was evaluated##3##3##(1991-1#1)(1993-2#1)(2012-12#1)
effectiveness was##5##2##(1991-1#1)(1991-3#1)(1993-2#1)(2008-10#1)(2012-12#1)
effectiveness will##3##2##(1992-12#1)(1993-12#1)(1995-1#1)
effectiveness##661##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#10)(1991-12#3)(1991-2#4)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#10)(1992-12#4)(1992-2#10)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#12)(1993-2#11)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#10)(1994-2#5)(1994-3#7)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#10)(1995-2#3)(1995-3#7)(1995-4#1)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#7)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#3)(1997-3#6)(1997-7#4)(1997-8#1)(2007-10#1)(2007-11#16)(2007-12#14)(2007-2#1)(2007-5#3)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#10)(2008-10#50)(2008-11#22)(2008-12#10)(2008-2#7)(2008-3#25)(2008-4#8)(2008-5#11)(2008-6#16)(2008-7#28)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#3)(2010-1#3)(2010-10#6)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#13)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-2#30)(2011-3#2)(2012-1#5)(2012-12#17)(2012-2#25)(2012-3#14)(2012-7#2)(2012-8#1)(2013-1#41)(2013-7#5)(2013-8#6)
effectiveness?##2##1##(1995-12#1)(1997-4#1)
effectivness of strontium 89##2##4##(2007-11#2)
effectivness of##3##2##(2007-11#3)
effectivness##5##1##(2007-11#5)
effecton##2##1##(2008-11#2)
effector and target cells##3##4##(1990-12#3)
effector and##4##2##(1990-12#4)
effector cells such as##2##4##(1992-2#1)(1995-5#1)
effector cells with##2##3##(1992-2#1)(2008-4#1)
effector cells##20##2##(1990-12#2)(1992-2#3)(1993-6#1)(1993-9#1)(1995-2#1)(1995-5#1)(2008-4#7)(2008-8#2)(2011-2#1)(2013-1#1)
effector function in##2##3##(2010-5#1)(2012-2#1)
effector function##4##2##(1995-5#1)(2010-5#1)(2012-2#2)
effector functions##8##2##(1995-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2009-2#1)(2012-2#2)(2012-3#1)
effector mechanism##2##2##(1995-6#1)(2008-4#1)
effector mechanisms##7##2##(1994-2#1)(2008-10#5)(2011-2#1)
effector memory##3##2##(2011-1#1)(2013-8#2)
effector molecule##2##2##(2008-1#1)(2008-5#1)
effector molecules that##2##3##(1997-1#1)(1997-4#1)
effector molecules##4##2##(1994-8#1)(1997-1#1)(1997-4#1)(2012-2#1)
effector of the##3##3##(1992-6#1)(1995-8#1)(2008-4#1)
effector of##11##2##(1992-6#1)(1994-5#1)(1995-8#1)(1997-2#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)
effector protein##4##2##(2009-8#1)(2011-2#3)
effector systems##3##2##(1996-5#1)(2006-10#1)(2008-4#1)
effector##114##1##(1990-10#1)(1990-12#7)(1990-7#1)(1990-8#1)(1992-2#3)(1992-3#1)(1992-6#2)(1992-8#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#14)(2008-5#3)(2008-8#3)(2009-2#2)(2009-8#3)(2010-5#2)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#4)
effectors are##2##2##(1997-2#1)(2009-8#1)
effectors in the##2##3##(1990-10#1)(1990-3#1)
effectors is##2##2##(1990-8#1)(2011-2#1)
effectors of the##3##3##(1994-8#1)(2008-11#1)(2008-9#1)
effectors of##6##2##(1994-8#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-9#1)
effectors such as##4##3##(1990-8#2)(2009-3#1)(2010-11#1)
effectors##45##1##(1990-10#3)(1990-3#3)(1990-5#1)(1990-8#4)(1994-8#1)(1994-9#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#5)(2009-3#1)(2009-6#2)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
effects a##2##2##(2008-10#1)(2008-3#1)
effects across##3##2##(1995-8#1)(2012-3#1)(2013-1#1)
effects after##11##2##(1990-10#1)(1995-12#1)(1997-5#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)
effects against##10##2##(1994-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#2)
effects also##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
effects among##2##2##(2008-10#1)(2012-12#1)
effects analysis##5##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
effects and also##2##3##(2008-10#2)
effects and can##3##3##(1994-8#1)(1995-5#1)(2007-7#1)
effects and consequences of##2##4##(1996-3#1)(2008-7#1)
effects and increased##2##3##(1995-3#1)(2010-5#1)
effects and is##3##3##(1992-4#1)(2007-11#1)(2012-12#1)
effects and mechanism of##2##4##(2011-2#1)(2011-3#1)
effects and safety##3##3##(1995-2#1)(2011-2#2)
effects and social##2##3##(1990-12#1)(2008-8#1)
effects and that##3##3##(1992-8#1)(2008-7#2)
effects and the##15##3##(1991-1#1)(1993-11#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2009-10#1)(2012-3#1)(2013-1#1)
effects and their##3##3##(1992-12#1)(2008-7#1)(2012-3#1)
effects and to##3##3##(1996-3#1)(2008-3#1)(2008-4#1)
effects and##132##2##(1990-12#1)(1991-1#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2010-1#3)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
effects and/or##4##2##(1993-2#2)(2008-7#1)(2011-2#1)
effects appear to be##2##4##(2008-7#1)(2009-7#1)
effects appear##3##2##(2008-7#1)(2009-7#2)
effects are best##2##3##(1995-2#1)(2009-6#1)
effects are caused##2##3##(2011-2#2)
effects are discussed##5##3##(2007-11#1)(2008-10#3)(2008-4#1)
effects are due to##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
effects are important##2##3##(2008-2#1)(2008-8#1)
effects are included##2##3##(2007-12#1)(2008-8#1)
effects are independent##2##3##(1993-3#1)(2013-1#1)
effects are interpreted as##2##4##(1995-5#1)(2011-2#1)
effects are mediated through##2##4##(1990-11#1)(2013-8#1)
effects are mediated##4##3##(1990-11#1)(2008-4#1)(2008-5#1)(2013-8#1)
effects are more##2##3##(2008-3#2)
effects are not##11##3##(1991-1#1)(1991-12#1)(1992-8#1)(1994-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-7#2)(2010-3#1)(2010-5#1)
effects are observed##2##3##(1994-5#1)(1995-11#1)
effects are of##2##3##(1996-6#1)(2008-9#1)
effects are only##2##3##(2008-8#1)(2010-10#1)
effects are studied##2##3##(2008-2#1)(2008-9#1)
effects are the##2##3##(2008-10#2)
effects are##121##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#6)(2007-12#5)(2007-6#1)(2008-10#11)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#6)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
effects arising from##2##3##(1993-11#1)(2008-3#1)
effects arising##3##2##(1993-11#1)(2008-3#2)
effects as well as##3##4##(1995-5#1)(2008-6#1)(2008-8#1)
effects as##11##2##(1992-3#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
effects associated with the##3##4##(1997-8#1)(2009-12#1)(2010-10#1)
effects associated with##17##3##(1990-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#2)
effects associated##18##2##(1990-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#2)
effects at the cellular level##4##5##(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
effects at the##8##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-2#1)
effects at##17##2##(1996-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
effects because##2##2##(1996-12#1)(2008-3#1)
effects become more##2##3##(2008-10#1)(2008-9#1)
effects become##6##2##(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#1)
effects being##3##2##(1990-8#1)(2008-4#1)(2011-2#1)
effects between the##3##3##(2007-12#1)(2008-3#2)
effects between##15##2##(1994-8#1)(2007-12#1)(2007-6#2)(2008-10#2)(2008-3#3)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-3#2)
effects by binding to##2##4##(2008-4#1)(2008-7#1)
effects by interacting##2##3##(1990-5#1)(1994-11#1)
effects by the##2##3##(2008-2#1)(2012-2#1)
effects by##26##2##(1990-5#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#2)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-7#1)(2013-8#1)
effects can also be##2##4##(1997-7#1)(2012-12#1)
effects can be explained by##2##5##(2008-11#1)(2008-8#1)
effects can be##15##3##(1990-8#1)(1991-8#1)(1992-11#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-8#1)(2012-1#1)(2012-7#1)
effects can##26##2##(1990-8#1)(1991-8#1)(1992-11#1)(1994-3#1)(1997-1#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#5)(2010-8#1)(2012-1#1)(2012-12#2)(2012-7#1)
effects cause##2##2##(1996-12#1)(2008-9#1)
effects caused by aflatoxins##2##4##(2010-4#2)
effects caused by the##2##4##(1995-12#1)(2008-2#1)
effects caused by##8##3##(1995-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-4#2)
effects confirming##2##2##(1991-2#1)(2008-10#1)
effects could be##5##3##(1990-6#1)(1997-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
effects could##6##2##(1990-6#1)(1997-7#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-3#1)
effects depending on##2##3##(1995-12#1)(2010-5#1)
effects depends on the##2##4##(1991-11#1)(2008-8#1)
effects depends##3##2##(1991-11#1)(2008-8#1)(2012-12#1)
effects did not##2##3##(1993-3#1)(2012-2#1)
effects differed##4##2##(1990-12#1)(2008-10#1)(2010-4#1)(2012-6#1)
effects disappeared##2##2##(1991-2#1)(2008-10#1)
effects do not appear##2##4##(1996-6#1)(2007-12#1)
effects do not##3##3##(1996-6#1)(2007-12#1)(2013-1#1)
effects due to the##3##4##(1997-6#1)(2008-10#2)
effects due to##10##3##(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2009-7#1)
effects during##11##2##(1992-8#1)(1993-1#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
effects emerge##2##2##(2008-1#1)(2008-9#1)
effects especially##2##2##(2008-10#1)(2008-2#1)
effects exerted##2##2##(2008-10#1)(2008-4#1)
effects following##3##2##(1997-4#1)(2008-1#1)(2008-7#1)
effects for all##2##3##(2008-10#1)(2013-8#1)
effects for the patients##2##4##(1991-9#1)(2007-11#1)
effects for the##8##3##(1991-6#1)(1991-9#1)(1997-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-7#1)
effects for##31##2##(1991-6#1)(1991-9#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#9)(2008-3#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
effects found##2##2##(2008-2#1)(2008-7#1)
effects from the##5##3##(1997-6#1)(2008-2#1)(2009-5#1)(2009-8#1)(2011-2#1)
effects from##22##2##(1996-6#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
effects has been##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
effects has##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-4#1)
effects have also been##3##4##(1996-9#1)(2007-11#1)(2008-10#1)
effects have been found##2##4##(2008-2#1)(2008-9#1)
effects have been reported##3##4##(1993-11#1)(1993-3#1)(2012-2#1)
effects have been##13##3##(1990-2#1)(1992-11#1)(1993-11#1)(1993-3#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#3)(2012-2#1)
effects have demonstrated##2##3##(1994-5#1)(1995-5#1)
effects have##20##2##(1990-2#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-5#1)(1996-9#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-2#1)
effects in a highly##2##4##(2007-11#2)
effects in a##11##3##(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#2)(2008-9#1)(2012-2#1)
effects in all##2##3##(2009-8#1)(2011-2#1)
effects in an##6##3##(1995-3#1)(2007-12#3)(2008-2#1)(2011-2#1)
effects in both##6##3##(1990-2#1)(1992-5#1)(1992-8#1)(2008-10#1)(2008-11#1)(2010-12#1)
effects in different##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
effects in experimental##2##3##(2008-1#1)(2009-6#1)
effects in humans##5##3##(1991-1#2)(2007-9#1)(2008-10#1)(2011-2#1)
effects in many##2##3##(1995-11#1)(2012-3#1)
effects in patients with##5##4##(2007-7#1)(2009-10#1)(2009-8#1)(2013-1#2)
effects in patients##9##3##(2007-7#1)(2008-1#1)(2008-10#3)(2009-10#1)(2009-8#1)(2013-1#2)
effects in photoelastic##2##3##(2008-3#2)
effects in rats##2##3##(1991-12#1)(1997-2#1)
effects in static##2##3##(1992-3#1)(2008-2#1)
effects in the elevated plus-maze##2##5##(1993-3#2)
effects in the formation of##2##5##(2007-12#1)(2008-11#1)
effects in the presence of##4##5##(2007-12#1)(2008-10#1)(2008-8#1)(2009-9#1)
effects in the##38##3##(1990-4#1)(1990-7#1)(1991-5#1)(1993-3#3)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2010-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
effects in vivo##4##3##(1995-11#1)(2008-11#1)(2009-12#1)(2013-7#1)
effects in##208##2##(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#3)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#2)(1993-3#3)(1993-5#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#3)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2007-11#8)(2007-12#11)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#9)(2008-12#1)(2008-2#15)(2008-3#22)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
effects including##3##2##(1991-1#1)(2008-10#1)(2008-7#1)
effects increases with##2##3##(1996-6#1)(1997-3#1)
effects indicate that##2##3##(1991-5#1)(2008-10#1)
effects induced by a##2##4##(1996-2#1)(2008-7#1)
effects induced by##9##3##(1995-12#2)(1996-2#1)(1997-6#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-7#1)
effects induced##10##2##(1995-12#2)(1996-2#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-7#1)
effects into##2##2##(2008-2#1)(2008-8#1)
effects involved##2##2##(1997-3#1)(2008-8#1)
effects is less##2##3##(2008-8#2)
effects is##32##2##(1991-11#1)(1991-12#2)(1994-8#2)(1995-1#1)(1996-11#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#4)(2008-9#1)(2011-2#1)(2013-1#1)
effects led##2##2##(1991-9#1)(2008-8#1)
effects limit##3##2##(2008-9#1)(2009-12#1)(2010-11#1)
effects makes##2##2##(1990-6#1)(2007-12#1)
effects may be involved##2##4##(2008-10#1)(2008-7#1)
effects may be##11##3##(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#3)(2012-12#1)(2013-7#1)(2013-8#1)
effects may contribute to the##2##5##(2008-7#1)(2011-1#1)
effects may##17##2##(1994-8#1)(2008-10#2)(2008-3#1)(2008-7#4)(2008-9#3)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
effects mediated through##2##3##(1996-5#1)(2012-2#1)
effects mediated##3##2##(1996-5#1)(2010-1#1)(2012-2#1)
effects meta-analysis##2##2##(1996-3#1)(2008-10#1)
effects might##3##2##(1996-5#1)(2008-11#1)(2008-9#1)
effects model##6##2##(1993-11#1)(1997-4#1)(2008-10#1)(2008-11#2)(2011-1#1)
effects models for##3##3##(1997-7#2)(1997-8#1)
effects models##6##2##(1997-4#1)(1997-7#3)(1997-8#1)(2012-3#1)
effects must be##2##3##(1994-3#1)(2011-2#1)
effects observed in##4##3##(1996-9#1)(2008-1#2)(2012-3#1)
effects observed with the##2##4##(1993-1#1)(2008-10#1)
effects observed##14##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-1#1)(1996-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
effects occur in##2##3##(2008-8#1)(2009-7#1)
effects occur##3##2##(2008-8#1)(2009-7#1)(2012-3#1)
effects occurred##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
effects of 10##2##3##(2008-8#1)(2011-2#1)
effects of 17betaE(2) were##2##4##(2008-4#2)
effects of 17betaE(2)##3##3##(2008-4#3)
effects of 2##5##3##(1993-12#1)(1994-5#1)(1995-3#3)
effects of 5-HT##4##3##(1990-5#2)(1993-12#1)(2008-7#1)
effects of 6-mercaptopurine##2##3##(1992-9#2)
effects of 8-OH-DPAT in the##2##5##(1990-5#1)(1993-3#1)
effects of 8-OH-DPAT##3##3##(1990-5#2)(1993-3#1)
effects of CCK-8##2##3##(1994-2#1)(1995-11#1)
effects of CGRP##4##3##(1992-6#4)
effects of CR##5##3##(1994-5#2)(2008-10#2)(2008-11#1)
effects of DIP##3##3##(1994-8#3)
effects of DNA##2##3##(1995-8#1)(2012-3#1)
effects of EGF on##3##4##(1994-6#2)(2008-6#1)
effects of EGF##4##3##(1994-6#2)(2008-6#2)
effects of H##2##3##(1997-1#1)(2008-2#1)
effects of H2O2##2##3##(2008-10#1)(2013-8#1)
effects of HA##2##3##(2010-8#1)(2013-8#1)
effects of HG##2##3##(2008-7#2)
effects of HGF and EGF on##2##6##(1991-12#2)
effects of HIV-1 infection on the##2##6##(2008-11#1)(2008-2#1)
effects of HIV-1##3##3##(2008-11#2)(2008-2#1)
effects of ISIS 2302##3##4##(2008-10#3)
effects of LDL##5##3##(1992-5#1)(1994-9#4)
effects of LY 294002 on the##2##6##(2008-4#2)
effects of MDM2##2##3##(2013-1#2)
effects of N-acetylcysteine##2##3##(1991-9#2)
effects of NO2 and##2##4##(1996-12#2)
effects of NO2##3##3##(1996-12#3)
effects of NSAIDs##2##3##(2008-10#2)
effects of NaCl##2##3##(1997-2#1)(2008-10#1)
effects of PDGF##2##3##(1993-8#1)(1997-6#1)
effects of PDT##3##3##(1992-9#1)(2008-5#1)(2012-3#1)
effects of PIP2##2##3##(2008-8#2)
effects of RA##2##3##(1990-6#1)(2008-5#1)
effects of Rayleigh scattering##2##4##(2008-2#2)
effects of Rhizopus head rot##2##5##(2008-10#2)
effects of TCDD on DC##2##5##(2008-10#2)
effects of TCDD on##3##4##(2008-10#3)
effects of TNF are##2##4##(1991-12#1)(2008-9#1)
effects of TNF##3##3##(1991-12#1)(1997-2#1)(2008-9#1)
effects of TNP-470 on##2##4##(1994-12#2)
effects of Vpr and Vpx##2##5##(1997-3#2)
effects of a mutation##2##4##(2010-4#2)
effects of a novel##3##4##(1990-7#1)(1997-7#1)(2012-3#1)
effects of a number of possible##2##6##(2008-10#1)(2008-3#1)
effects of a single##3##4##(1990-7#1)(1992-4#1)(2008-7#1)
effects of a##77##3##(1990-7#2)(1990-9#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
effects of absorption##2##3##(2008-3#2)
effects of acetic acid##2##4##(2008-10#1)(2008-6#1)
effects of acute and##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
effects of acute##10##3##(1991-1#1)(1991-9#1)(1995-12#2)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
effects of added##2##3##(2008-10#2)
effects of adenosine on##2##4##(1996-5#1)(2008-4#1)
effects of adenosine##5##3##(1991-12#1)(1996-5#1)(2008-4#3)
effects of aflatoxins##2##3##(2010-4#2)
effects of age##7##3##(1991-12#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
effects of aging and##2##4##(1992-8#1)(2008-1#1)
effects of aging##3##3##(1992-8#1)(2008-1#1)(2008-7#1)
effects of air pollution on##2##5##(1997-1#1)(2008-11#1)
effects of air##3##3##(1994-3#1)(1997-1#1)(2008-11#1)
effects of alcohol##5##3##(1994-9#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-2#1)
effects of alcohols on##2##4##(1990-12#1)(1992-6#1)
effects of alpha-MSH and##2##4##(1993-5#1)(1995-2#1)
effects of aluminium##2##3##(2008-10#2)
effects of ammonium##2##3##(2008-7#1)(2012-2#1)
effects of amphetamine and##2##4##(1993-6#1)(1994-2#1)
effects of amphetamine##5##3##(1993-6#2)(1994-2#1)(2013-1#2)
effects of amphetamines##2##3##(2008-10#2)
effects of amplitude##2##3##(2007-11#2)
effects of an influenza pandemic on US hospitals##2##8##(2008-11#2)
effects of an integrated phonological awareness##2##6##(2011-1#2)
effects of an##19##3##(1991-9#1)(1992-3#1)(1994-8#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2013-1#1)
effects of and##2##3##(1995-2#1)(2008-5#1)
effects of androgen##2##3##(1990-11#1)(2008-5#1)
effects of angiotensins##3##3##(1997-7#3)
effects of antidepressant##2##3##(1990-5#1)(1996-7#1)
effects of aperture##2##3##(2008-2#1)(2008-3#1)
effects of bFGF##2##3##(1995-12#1)(2008-11#1)
effects of beam##2##3##(2008-3#2)
effects of beta-blockers against 2##2##5##(1995-6#2)
effects of bile acids##2##4##(1992-9#1)(2008-8#1)
effects of bile##3##3##(1990-8#1)(1992-9#1)(2008-8#1)
effects of body##3##3##(2008-9#1)(2013-1#1)(2013-7#1)
effects of both##10##3##(1991-5#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)
effects of broccoli residue##2##4##(2008-10#2)
effects of buprenorphine##2##3##(1991-1#2)
effects of cadmium##4##3##(1990-5#1)(1994-6#1)(2008-7#1)(2013-1#1)
effects of caffeine on##3##4##(1995-11#3)
effects of calcium##5##3##(1995-3#1)(2008-10#2)(2009-8#1)(2012-2#1)
effects of caloric restriction and##2##5##(2008-7#2)
effects of caloric restriction##4##4##(1994-5#1)(2008-10#1)(2008-7#2)
effects of cannabis##2##3##(2009-7#1)(2013-1#1)
effects of capsaicin##3##3##(1992-6#2)(1993-11#1)
effects of carbohydrate supplementation in a simulated competition of short terrestrial duathlon##2##12##(2008-5#2)
effects of cell##5##3##(1995-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
effects of changing##2##3##(1990-8#1)(1996-2#1)
effects of chemical##3##3##(2008-10#2)(2008-12#1)
effects of chemicals in##2##4##(1997-4#1)(2008-10#1)
effects of chemicals on##2##4##(2008-10#1)(2013-1#1)
effects of chemicals##6##3##(1997-4#1)(2008-10#2)(2008-11#1)(2012-1#1)(2013-1#1)
effects of chemotherapy##3##3##(1994-2#1)(2008-7#2)
effects of chlordiazepoxide##3##3##(1992-7#3)
effects of cholesterol on##2##4##(1990-2#1)(1992-6#1)
effects of chronic stress##2##4##(1991-1#1)(2008-11#1)
effects of chronic##16##3##(1990-6#1)(1991-1#3)(1991-4#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-6#1)(2013-1#3)
effects of cigarette smoke on the human skin##2##8##(2008-5#2)
effects of cigarette##3##3##(1992-9#1)(2008-5#2)
effects of cocaethylene on##2##4##(1996-12#2)
effects of cocaine and##3##4##(1991-1#2)(2010-11#1)
effects of cocaine##8##3##(1991-1#3)(1991-12#1)(2008-10#2)(2010-11#1)(2011-2#1)
effects of colony size on##2##5##(2008-9#2)
effects of constant##2##3##(1997-5#1)(2008-11#1)
effects of coronary##2##3##(2007-8#2)
effects of cupping##2##3##(2013-1#2)
effects of current##2##3##(1994-5#1)(2008-9#1)
effects of cyclic##2##3##(1993-3#1)(1994-2#1)
effects of cyclophosphamide##2##3##(1993-9#1)(2007-7#1)
effects of cyclosporine##2##3##(1995-12#1)(2008-10#1)
effects of decreased##2##3##(1995-2#1)(2011-2#1)
effects of deep breathing##2##4##(2012-2#2)
effects of dexamethasone and##2##4##(1993-3#1)(1994-3#1)
effects of dexamethasone##4##3##(1993-3#1)(1994-10#1)(1994-3#1)(2010-12#1)
effects of dexrazoxane##2##3##(2008-11#2)
effects of diabetes##2##3##(1996-2#1)(2012-1#1)
effects of diet and##2##4##(2008-10#1)(2013-1#1)
effects of diet##3##3##(2008-10#1)(2009-4#1)(2013-1#1)
effects of dietary protein##2##4##(1994-3#1)(2008-5#1)
effects of dietary restriction##2##4##(2008-7#2)
effects of dietary##9##3##(1992-11#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#4)(2009-8#1)
effects of different concentrations of##2##5##(1993-12#1)(2012-3#1)
effects of different types of##3##5##(2008-10#1)(2008-8#1)(2011-1#1)
effects of different##29##3##(1990-7#1)(1992-12#1)(1993-12#1)(1994-9#1)(2008-1#3)(2008-10#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
effects of discrete##2##3##(2007-11#1)(2008-10#1)
effects of disease##3##3##(2008-10#1)(2009-10#1)(2013-7#1)
effects of disk tilt and##2##5##(2008-2#2)
effects of dispersal##2##3##(2008-10#1)(2008-9#1)
effects of dispersion##2##3##(2007-11#2)
effects of disturbance##2##3##(2008-8#1)(2008-9#1)
effects of dobutamine##2##3##(1994-11#1)(1996-2#1)
effects of drug##5##3##(1992-10#1)(2008-10#2)(2009-9#1)(2011-3#1)
effects of drugs and##2##4##(1996-6#1)(1997-3#1)
effects of drugs on##2##4##(2010-9#1)(2011-2#1)
effects of drugs##12##3##(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-6#2)(1997-3#1)(2006-6#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-2#1)
effects of each##6##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2012-2#1)
effects of earlier##2##3##(1994-2#1)(2008-7#1)
effects of early##2##3##(2007-12#1)(2012-2#1)
effects of easily##2##3##(2008-10#2)
effects of either##3##3##(1991-9#1)(2008-10#1)(2009-12#1)
effects of electrical stimulation##2##4##(2008-9#1)(2009-10#1)
effects of electrical##4##3##(1994-5#1)(1997-6#1)(2008-9#1)(2009-10#1)
effects of endothelin-1 on##2##4##(1992-3#1)(1995-12#1)
effects of endothelin-1##5##3##(1991-12#1)(1991-5#1)(1992-3#1)(1995-12#2)
effects of environmental##8##3##(1991-12#1)(1994-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)
effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation##2##18##(2011-2#2)
effects of estrogen on the proliferation of##2##7##(2008-11#1)(2008-6#1)
effects of estrogen on##5##4##(2008-11#2)(2008-6#1)(2008-7#2)
effects of estrogen##7##3##(1994-9#1)(2008-11#2)(2008-6#1)(2008-7#3)
effects of ethanol##5##3##(1996-2#1)(1997-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
effects of ethyl##2##3##(1990-5#1)(2007-11#1)
effects of exercise training##2##4##(2008-7#1)(2011-2#1)
effects of exercise##4##3##(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
effects of experimental##4##3##(2008-10#4)
effects of extracellular##5##3##(1993-11#1)(2008-11#1)(2008-4#2)(2008-8#1)
effects of factors##2##3##(1995-8#1)(1995-9#1)
effects of family functioning on##2##5##(1996-1#2)
effects of family##5##3##(1996-1#2)(2010-7#1)(2010-8#1)(2013-1#1)
effects of feeding##2##3##(2010-2#2)
effects of film##2##3##(2008-10#1)(2008-3#1)
effects of financial##2##3##(1995-12#1)(2008-11#1)
effects of five different variables##2##5##(2008-10#2)
effects of five##4##3##(1992-9#1)(1993-12#1)(2008-10#2)
effects of flow##2##3##(2008-10#1)(2010-4#1)
effects of fluoride##2##3##(2008-10#1)(2013-1#1)
effects of fluoxetine and##2##4##(1997-6#2)
effects of foliar##2##3##(2008-10#2)
effects of food##5##3##(1994-2#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-8#1)
effects of fornix##2##3##(1993-3#2)
effects of free##3##3##(1991-9#1)(1994-6#1)(2008-5#1)
effects of frequent##3##3##(2009-7#2)(2009-8#1)
effects of fresh and##2##4##(2008-10#1)(2010-4#1)
effects of fungal##2##3##(2008-10#1)(2010-10#1)
effects of garlic oil on##2##5##(2008-9#1)(2012-2#1)
effects of gender##3##3##(2007-4#1)(2009-7#1)(2010-4#1)
effects of gene flow##2##4##(2008-9#1)(2013-1#1)
effects of gene##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
effects of genes##4##3##(1997-7#2)(2008-8#1)(2012-3#1)
effects of ghrelin##2##3##(2011-2#2)
effects of glucose##2##3##(1994-8#2)
effects of glyphosate##2##3##(2010-1#2)
effects of grade retention##2##4##(2008-12#2)
effects of heat##5##3##(2008-10#1)(2008-7#1)(2013-8#3)
effects of herbivory on##4##4##(2008-8#2)(2008-9#2)
effects of herbivory##6##3##(2008-8#3)(2008-9#3)
effects of high##7##3##(1990-11#1)(1992-9#1)(1993-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)
effects of histamine##3##3##(1991-5#1)(1996-5#2)
effects of histidine residues##2##4##(1992-8#2)
effects of host genotype##2##4##(2008-10#2)
effects of host##5##3##(2008-10#5)
effects of hydrogen##3##3##(1991-9#2)(2008-10#1)
effects of hypergravity##2##3##(2008-7#2)
effects of ibandronic acid on hormone- and drug-refractory prostate##2##9##(2011-2#2)
effects of imipramine and desipramine##2##5##(1990-5#2)
effects of imipramine##3##3##(1990-5#2)(1994-2#1)
effects of inaperisone##2##3##(1992-3#2)
effects of incident beam type on##2##6##(2008-2#2)
effects of increasing the##2##4##(1990-7#1)(1991-1#1)
effects of increasing##5##3##(1990-7#1)(1991-1#1)(1997-6#1)(2008-8#1)(2010-3#1)
effects of individual##2##3##(2008-2#1)(2008-4#1)
effects of inhibition of##2##4##(1994-3#1)(2008-9#1)
effects of initial##4##3##(2008-10#3)(2008-6#1)
effects of inorganic##2##3##(1993-12#1)(1995-3#1)
effects of insulin##5##3##(1990-7#1)(1996-3#1)(2008-3#1)(2008-4#1)(2010-10#1)
effects of interferon##2##3##(2008-8#1)(2010-11#1)
effects of interleukin-1 on##2##4##(1990-10#1)(1990-12#1)
effects of intramuscular##2##3##(2008-8#1)(2013-7#1)
effects of intrastriatal##3##3##(1995-12#1)(1995-5#1)(1997-2#1)
effects of ionizing##2##3##(2008-11#1)(2008-7#1)
effects of iron##2##3##(2008-10#2)
effects of ischemic preconditioning##2##4##(2010-12#1)(2013-7#1)
effects of its##2##3##(1995-11#1)(2008-9#1)
effects of kynurenate##2##3##(1991-5#2)
effects of lead at##2##4##(1995-3#2)
effects of lead on the##2##5##(1995-11#1)(1995-3#1)
effects of lead on##4##4##(1995-11#1)(1995-3#3)
effects of lead##8##3##(1995-11#1)(1995-3#5)(1997-4#1)(2011-1#1)
effects of lesions##5##3##(1992-10#1)(1992-11#1)(1994-3#2)(2008-4#1)
effects of light##6##3##(1990-10#1)(2008-10#2)(2008-3#3)
effects of linear##2##3##(2008-3#2)
effects of local##3##3##(2008-4#1)(2008-9#1)(2009-7#1)
effects of long##2##3##(1991-2#1)(2008-5#1)
effects of long-term##5##3##(1990-3#1)(1995-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
effects of low doses of##3##5##(2008-5#1)(2008-7#1)(2013-1#1)
effects of low##8##3##(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-6#1)(2013-1#1)
effects of low-dose##2##3##(2008-7#1)(2009-4#1)
effects of maternal##4##3##(1992-12#1)(2006-10#1)(2008-8#1)(2009-7#1)
effects of mechanical##2##3##(2008-6#1)(2010-9#1)
effects of mercuric##2##3##(2008-3#1)(2008-7#1)
effects of metallic##2##3##(2008-2#1)(2011-1#1)
effects of metformin in##2##4##(1995-8#1)(2008-3#1)
effects of midazolam##5##3##(1994-2#1)(1997-2#4)
effects of mobile phase##2##4##(2008-10#2)
effects of morphine on##2##4##(1994-2#1)(2008-12#1)
effects of morphine##6##3##(1992-3#1)(1994-2#1)(1995-3#1)(2008-12#3)
effects of mortality##2##3##(2008-8#1)(2013-7#1)
effects of multiple##3##3##(1995-12#1)(2008-3#1)(2008-8#1)
effects of muscarinic M2 and adenosine receptor agonists##2##8##(1995-12#2)
effects of muscle##3##3##(1995-2#2)(2011-2#1)
effects of music on##4##4##(1991-12#2)(2007-6#1)(2008-5#1)
effects of n-3##2##3##(2012-12#1)(2013-1#1)
effects of natural disasters on##2##5##(2013-1#2)
effects of natural##7##3##(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
effects of neuropeptide Y##3##4##(1995-12#2)(1997-4#1)
effects of noise##4##3##(2008-2#1)(2008-3#3)
effects of noscapine##2##3##(2008-11#2)
effects of nucleotides##2##3##(2008-11#1)(2008-4#1)
effects of objective##5##3##(2009-7#1)(2013-1#4)
effects of occlusal##2##3##(2010-3#1)(2010-6#1)
effects of occupational##2##3##(2008-6#1)(2008-9#1)
effects of okadaic acid on##2##5##(1992-8#1)(1993-8#1)
effects of omeprazole##2##3##(1993-11#2)
effects of opiate##2##3##(1991-1#1)(1995-12#1)
effects of opiates##2##3##(1991-1#2)
effects of optical##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
effects of oral##2##3##(1992-5#1)(2008-11#1)
effects of organic##2##3##(1992-3#1)(1994-9#1)
effects of other##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
effects of oxidative stress##2##4##(2008-5#1)(2010-5#1)
effects of ozone##2##3##(1992-3#2)
effects of pH and##4##4##(1996-5#1)(2008-10#3)
effects of pH on##2##4##(1991-5#1)(2008-5#1)
effects of pH##18##3##(1991-5#1)(1996-5#1)(2008-10#15)(2008-5#1)
effects of parameters##2##3##(2008-10#2)
effects of parental##2##3##(2008-9#2)
effects of partial##2##3##(1990-5#1)(2008-10#1)
effects of perceived##3##3##(2009-7#2)(2010-2#1)
effects of phenytoin##3##3##(1994-2#1)(1995-12#1)(2008-11#1)
effects of phorbol esters##2##4##(1992-12#1)(2010-12#1)
effects of phorbol##3##3##(1990-8#1)(1992-12#1)(2010-12#1)
effects of physical activity on##3##5##(2012-12#1)(2013-1#2)
effects of physical activity##4##4##(2012-12#2)(2013-1#2)
effects of physical##7##3##(2008-12#1)(2008-9#1)(2012-1#1)(2012-12#2)(2013-1#2)
effects of pile driving and other anthropogenic##2##7##(2010-8#2)
effects of plant age##2##4##(2008-10#2)
effects of plant##3##3##(2008-10#2)(2008-8#1)
effects of postwar appraisals##4##4##(2013-1#4)
effects of poverty##2##3##(2008-11#2)
effects of predation on##2##4##(2008-8#2)
effects of predation##5##3##(2008-8#4)(2008-9#1)
effects of prescription drug##2##4##(1995-1#2)
effects of pressure##3##3##(2008-10#3)
effects of prior##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
effects of produced water##2##4##(2013-1#2)
effects of prolonged##2##3##(2007-8#1)(2008-4#1)
effects of propranolol and dipyridamole on##2##6##(1994-5#2)
effects of prostaglandins##2##3##(1994-11#1)(2008-7#1)
effects of protein kinase C (PKC)##2##6##(1995-11#1)(1995-5#1)
effects of protein kinase C##3##5##(1995-11#2)(1995-5#1)
effects of protein##4##3##(1995-11#2)(1995-5#1)(2013-8#1)
effects of radiotherapy and##2##4##(2008-6#1)(2008-7#1)
effects of random##2##3##(1990-3#1)(2008-3#1)
effects of reaction##3##3##(2008-10#2)(2008-6#1)
effects of recombinant human##2##4##(1990-12#1)(1993-9#1)
effects of recombinant##6##3##(1990-12#1)(1991-12#1)(1993-9#1)(1995-12#1)(2008-11#2)
effects of red wine##3##4##(2008-10#1)(2008-7#2)
effects of redox-cycling##2##3##(2009-9#2)
effects of refractive-index##2##3##(2008-3#2)
effects of regional##3##3##(2008-2#1)(2008-9#2)
effects of remifentanil##2##3##(2011-2#1)(2012-12#1)
effects of retinoic acid##2##4##(1994-6#1)(2008-11#1)
effects of salicylic acid##2##4##(1993-11#1)(2008-10#1)
effects of sample volume##2##4##(2008-10#2)
effects of sample##4##3##(1995-1#1)(2008-10#2)(2009-10#1)
effects of sampling##2##3##(2008-10#1)(2013-7#1)
effects of saturation on the##3##5##(2008-3#3)
effects of sauna bathing for##2##5##(2008-7#2)
effects of scattering and##2##4##(2008-2#1)(2008-3#1)
effects of scattering##4##3##(2008-2#1)(2008-3#3)
effects of selective##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
effects of serotonergic##2##3##(1992-11#1)(1993-3#1)
effects of serotonin on##2##4##(1990-5#2)
effects of several variables##2##4##(2008-10#2)
effects of several##15##3##(1992-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#7)(2008-11#2)(2011-2#1)(2012-5#1)
effects of sex##2##3##(2009-9#1)(2013-1#1)
effects of short-term##2##3##(1995-12#1)(2012-2#1)
effects of simulated##2##3##(2008-9#1)(2012-5#1)
effects of six##2##3##(1995-5#1)(2008-5#1)
effects of skin##2##3##(2008-11#1)(2008-5#1)
effects of sleep##3##3##(2011-2#1)(2013-1#2)
effects of small##2##3##(2008-8#1)(2010-11#1)
effects of smoking##2##3##(2010-2#1)(2011-2#1)
effects of soil##2##3##(2008-10#2)
effects of solar##3##3##(2008-5#1)(2011-2#2)
effects of solvent##3##3##(2008-10#3)
effects of solvents and##2##4##(2007-11#1)(2008-10#1)
effects of somatostatin##2##3##(1997-4#1)(2008-4#1)
effects of some##14##3##(1993-8#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)
effects of sowing date##2##4##(2008-10#2)
effects of specific##8##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)
effects of spherical aberration on##2##5##(2008-3#2)
effects of statins##3##3##(2008-1#1)(2012-1#1)(2013-1#1)
effects of steroids##2##3##(2010-6#1)(2012-2#1)
effects of stress on##3##4##(2008-6#1)(2008-7#1)(2012-3#1)
effects of stress##6##3##(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-3#1)
effects of subcutaneous##3##3##(1991-6#3)
effects of successful##2##3##(1996-2#1)(2008-4#1)
effects of such##6##3##(1991-12#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-3#1)(2010-11#1)
effects of sunlight##2##3##(2008-5#1)(2011-2#1)
effects of surface##4##3##(1994-5#1)(2007-11#1)(2008-3#1)(2009-7#1)
effects of synthetic##3##3##(1990-9#1)(1995-12#1)(1997-1#1)
effects of systemic##2##3##(1994-2#2)
effects of temperature and duration of wetness##2##7##(2008-10#2)
effects of temperature and humidity##2##5##(2011-2#2)
effects of temperature and water concentration on the otolith incorporation of##2##11##(2010-8#2)
effects of temperature and##12##4##(1997-2#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-8#2)(2011-2#2)
effects of temperature##24##3##(1991-11#1)(1991-5#1)(1997-2#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#2)(2011-2#2)
effects of the aqueous##3##4##(2008-12#1)(2008-5#1)(2010-3#1)
effects of the consumption of##2##5##(2008-10#1)(2012-12#1)
effects of the different##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
effects of the drug were observed##2##6##(1990-9#1)(2008-11#1)
effects of the drug##4##4##(1990-3#1)(1990-9#1)(2008-11#1)(2012-1#1)
effects of the drugs on##2##5##(2008-10#2)
effects of the drugs##3##4##(2008-10#2)(2011-2#1)
effects of the economic##2##4##(2009-10#1)(2012-3#1)
effects of the ellipsometric parameters of HgI(2)##2##7##(2008-2#1)(2008-3#1)
effects of the extracts##2##4##(2008-5#1)(2010-3#1)
effects of the fungicide##2##4##(2008-10#2)
effects of the lectins##3##4##(1995-11#3)
effects of the mapping procedure when dominant##2##7##(2008-5#2)
effects of the mutation##3##4##(1993-8#2)(1993-9#1)
effects of the new##2##4##(2008-2#1)(2008-4#1)
effects of the policy##2##4##(2008-6#1)(2011-2#1)
effects of the sun##2##4##(1991-6#1)(2011-2#1)
effects of the treatment##3##4##(1995-12#1)(2008-10#1)(2012-2#1)
effects of the two##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
effects of the vaccination##3##4##(2011-2#3)
effects of the##220##3##(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#6)(1995-12#4)(1995-2#1)(1995-3#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#3)(1997-4#3)(1997-6#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#40)(2008-11#13)(2008-12#3)(2008-2#12)(2008-3#17)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#2)
effects of theanine##2##3##(2008-11#2)
effects of their##3##3##(1995-3#1)(2008-11#1)(2011-1#1)
effects of therapy##4##3##(1996-2#1)(2008-8#2)(2012-2#1)
effects of these agents##4##4##(1991-5#1)(1995-11#1)(2008-8#1)(2012-2#1)
effects of these compounds##2##4##(1990-11#1)(2011-2#1)
effects of these drugs##3##4##(1991-1#1)(1996-11#1)(2013-1#1)
effects of these mutations##3##4##(1993-11#1)(1993-3#1)(2008-11#1)
effects of these substances##2##4##(2008-7#1)(2009-7#1)
effects of these##47##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-8#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#2)
effects of this##20##3##(1990-5#1)(1991-2#2)(1994-10#1)(1994-8#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
effects of those##2##3##(1992-3#1)(2009-7#1)
effects of three##10##3##(1993-11#1)(1993-6#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-1#1)
effects of time##3##3##(1996-2#1)(2008-3#1)(2012-2#1)
effects of tobacco##3##3##(1991-4#1)(1992-6#1)(2013-1#1)
effects of toborinone##2##3##(2008-5#2)
effects of total dose##2##4##(2007-4#2)
effects of total##4##3##(1993-11#1)(1995-8#1)(2007-4#2)
effects of toxins##2##3##(2008-7#1)(2009-11#1)
effects of traditional##4##3##(2009-11#1)(2010-12#2)(2013-1#1)
effects of treatment##6##3##(1992-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-7#1)
effects of treatments were##2##4##(2008-5#1)(2008-8#1)
effects of treatments##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
effects of trophic cascades on##2##5##(2008-8#2)
effects of tumor cells##2##4##(2011-1#1)(2012-3#1)
effects of tumor##3##3##(1992-3#1)(2011-1#1)(2012-3#1)
effects of turbulence##2##3##(2008-3#2)
effects of two different##2##4##(1993-1#1)(2009-1#1)
effects of two##19##3##(1990-7#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-4#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2012-1#1)
effects of using##4##3##(2008-3#1)(2012-3#1)(2013-1#2)
effects of various cationic interferences on percent recovery of##2##9##(2008-10#2)
effects of various cationic interferences on##5##6##(2008-10#5)
effects of various cationic##6##4##(2008-10#6)
effects of various##28##3##(1991-2#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
effects of varying the##2##4##(1991-1#1)(2011-2#1)
effects of varying##13##3##(1991-1#1)(1991-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
effects of vitamin C administration##2##5##(2011-1#2)
effects of vitamin D##2##4##(2008-1#1)(2012-2#1)
effects of vitamin##5##3##(1993-12#1)(2008-1#1)(2011-1#2)(2012-2#1)
effects of vitamins##2##3##(1992-9#2)
effects of wavelength and wavelength mixing##2##6##(2013-1#2)
effects of zoledronic Acid##2##4##(2008-7#1)(2013-1#1)
effects of zoledronic##3##3##(2008-7#1)(2013-1#2)
effects of##2793##2##(1990-10#3)(1990-11#6)(1990-12#9)(1990-2#7)(1990-3#8)(1990-5#25)(1990-6#4)(1990-7#11)(1990-8#10)(1990-9#5)(1991-1#29)(1991-10#1)(1991-11#1)(1991-12#26)(1991-2#9)(1991-3#3)(1991-4#3)(1991-5#16)(1991-6#10)(1991-8#4)(1991-9#11)(1992-1#6)(1992-10#3)(1992-11#7)(1992-12#10)(1992-2#6)(1992-3#28)(1992-4#3)(1992-5#12)(1992-6#19)(1992-7#4)(1992-8#15)(1992-9#19)(1993-1#8)(1993-10#1)(1993-11#13)(1993-12#24)(1993-2#1)(1993-3#19)(1993-5#6)(1993-6#10)(1993-8#10)(1993-9#7)(1994-1#2)(1994-10#4)(1994-11#16)(1994-12#7)(1994-2#27)(1994-3#15)(1994-5#22)(1994-6#13)(1994-8#22)(1994-9#12)(1995-1#3)(1995-11#28)(1995-12#47)(1995-2#15)(1995-3#18)(1995-5#11)(1995-6#3)(1995-8#7)(1995-9#3)(1996-1#2)(1996-11#2)(1996-12#22)(1996-2#32)(1996-3#5)(1996-5#15)(1996-6#3)(1996-7#4)(1996-9#2)(1997-1#10)(1997-2#24)(1997-3#8)(1997-4#15)(1997-5#1)(1997-6#10)(1997-7#22)(1997-8#7)(2006-10#2)(2006-12#2)(2006-6#4)(2007-10#3)(2007-11#29)(2007-12#33)(2007-2#4)(2007-4#4)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#19)(2008-10#383)(2008-11#117)(2008-12#47)(2008-2#66)(2008-3#128)(2008-4#50)(2008-5#95)(2008-6#29)(2008-7#93)(2008-8#75)(2008-9#57)(2009-1#3)(2009-10#6)(2009-11#11)(2009-12#13)(2009-2#9)(2009-3#6)(2009-4#7)(2009-5#2)(2009-6#3)(2009-7#23)(2009-8#8)(2009-9#9)(2010-1#14)(2010-10#7)(2010-11#10)(2010-12#13)(2010-2#10)(2010-3#7)(2010-4#20)(2010-5#7)(2010-6#6)(2010-7#7)(2010-8#13)(2010-9#7)(2011-1#31)(2011-10#2)(2011-2#85)(2011-3#4)(2011-7#1)(2012-1#14)(2012-12#24)(2012-2#57)(2012-3#38)(2012-4#1)(2012-5#3)(2012-6#1)(2012-7#2)(2013-1#111)(2013-7#17)(2013-8#35)
effects often##2##2##(2008-11#1)(2010-12#1)
effects on DNA replication##2##4##(1994-5#1)(1997-3#1)
effects on DNA##3##3##(1993-8#1)(1994-5#1)(1997-3#1)
effects on FN##2##3##(1994-9#1)(2012-2#1)
effects on S##2##3##(2008-10#2)
effects on a##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
effects on alcohol##2##3##(1994-2#1)(2008-2#1)
effects on an##2##3##(1996-12#1)(2011-2#1)
effects on behavior##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
effects on binding##2##3##(1990-2#1)(1997-1#1)
effects on blood##6##3##(1994-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)
effects on bone##2##3##(2007-11#1)(2007-7#1)
effects on both the##2##4##(1996-1#1)(2007-11#1)
effects on both##8##3##(1994-9#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2013-1#1)
effects on cardiac##2##3##(2010-8#1)(2011-2#1)
effects on cell growth##2##4##(1996-2#1)(2008-11#1)
effects on cell##9##3##(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)
effects on cellular proliferation##2##4##(2013-7#2)
effects on cellular##4##3##(1997-1#1)(2008-9#1)(2013-7#2)
effects on child##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
effects on clinical##2##3##(2008-3#1)(2009-9#1)
effects on coronary##2##3##(2008-3#1)(2009-9#1)
effects on disease##3##3##(2008-10#3)
effects on enzyme##2##3##(1990-7#1)(1991-3#1)
effects on exercise##2##3##(2009-10#1)(2010-8#1)
effects on experimental##3##3##(1992-2#1)(2008-8#1)(2013-1#1)
effects on female##2##3##(2008-5#1)(2012-3#1)
effects on fitness##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
effects on gene expression##2##4##(2008-10#1)(2011-1#1)
effects on glucose and lipid metabolism##2##6##(1994-12#1)(2008-3#1)
effects on glucose##4##3##(1994-12#1)(1994-3#1)(2008-3#2)
effects on growth##7##3##(1994-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#2)
effects on hair##2##3##(2008-5#2)
effects on host##3##3##(2008-8#2)(2008-9#1)
effects on how##2##3##(2008-8#1)(2009-10#1)
effects on human health##4##4##(2008-10#4)
effects on human##9##3##(1995-3#1)(1997-4#1)(2008-10#4)(2008-5#1)(2012-1#1)(2013-1#1)
effects on immune##2##3##(2008-10#1)(2008-11#1)
effects on insect abundances##2##4##(2008-8#2)
effects on insect##4##3##(2008-8#4)
effects on intracellular##2##3##(1996-2#1)(2008-7#1)
effects on many different##2##4##(2008-4#1)(2010-3#1)
effects on many##3##3##(2008-4#1)(2010-3#1)(2013-8#1)
effects on mental##2##3##(2009-10#1)(2012-3#1)
effects on mortality##3##3##(1990-5#1)(2011-2#1)(2013-1#1)
effects on multiple##3##3##(2008-10#2)(2011-2#1)
effects on neuroendocrine##2##3##(1996-12#1)(2008-2#1)
effects on normal##2##3##(2008-10#1)(2013-8#1)
effects on other##4##3##(1993-8#1)(2008-12#1)(2008-3#1)(2008-8#1)
effects on perineal outcomes in 557 births##2##7##(2013-1#2)
effects on plant growth and##2##5##(2008-10#2)
effects on plant growth##4##4##(2008-10#4)
effects on plant##7##3##(2008-10#4)(2008-8#3)
effects on platelet activation##2##4##(2011-2#2)
effects on platelet function##3##4##(1991-12#2)(2006-6#1)
effects on platelet##6##3##(1991-12#3)(2006-6#1)(2011-2#2)
effects on population##2##3##(1991-6#1)(1996-5#1)
effects on pregnancy##2##3##(1991-3#1)(2013-1#1)
effects on protein##2##3##(1994-9#1)(2008-10#1)
effects on radiation##2##3##(1997-8#1)(2008-9#1)
effects on reaction##4##3##(2009-12#1)(2009-2#3)
effects on recovery##2##3##(2008-8#1)(2012-3#1)
effects on resolution in ion mobility spectrometry##2##7##(2008-10#2)
effects on serotonin##2##3##(1996-5#2)
effects on several##2##3##(1990-11#1)(2008-6#1)
effects on sexual##2##3##(1991-2#1)(2009-5#1)
effects on skin##3##3##(2008-5#2)(2008-9#1)
effects on soil resource heterogeneity##2##5##(2008-9#2)
effects on soil##4##3##(2008-10#1)(2008-12#1)(2008-9#2)
effects on some##4##3##(1994-2#1)(2008-12#1)(2008-9#1)(2012-12#1)
effects on spontaneous##2##3##(1993-9#1)(2006-6#1)
effects on substrate##2##3##(1990-11#1)(1995-2#1)
effects on survival##2##3##(2008-10#1)(2009-10#1)
effects on systemic##2##3##(1992-8#1)(2008-12#1)
effects on target cells##2##4##(1991-9#1)(2008-12#1)
effects on target##3##3##(1991-9#1)(1996-12#1)(2008-12#1)
effects on the accuracy of##2##5##(2008-2#1)(2008-3#1)
effects on the appearance of##2##5##(2008-2#1)(2008-5#1)
effects on the central nervous system##3##6##(1990-5#1)(1990-9#1)(2008-10#1)
effects on the environment##2##4##(1991-6#1)(2008-10#1)
effects on the expression of##2##5##(2008-10#1)(2013-8#1)
effects on the expression##4##4##(1993-6#1)(2008-10#1)(2010-5#1)(2013-8#1)
effects on the gastric##2##4##(1995-11#1)(2008-1#1)
effects on the growth of##7##5##(1990-11#1)(1991-5#1)(1994-8#1)(2008-10#2)(2008-5#1)(2010-8#1)
effects on the growth##9##4##(1990-11#1)(1991-5#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#1)
effects on the immune system##6##5##(1990-11#1)(1991-1#1)(1995-12#1)(2008-10#3)
effects on the release of##2##5##(1996-2#1)(1997-4#1)
effects on the skin##3##4##(2008-5#3)
effects on the surface##2##4##(2008-3#1)(2013-8#1)
effects on the survival and##2##5##(2010-2#1)(2010-8#1)
effects on the##193##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2007-11#5)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#38)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#8)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#2)
effects on this##3##3##(1990-12#1)(1995-2#1)(2011-2#1)
effects on tissue##3##3##(2008-1#1)(2011-1#2)
effects on various##2##3##(2008-10#1)(2008-11#1)
effects on water##2##3##(1991-5#1)(2009-10#1)
effects on yield##2##3##(2008-10#1)(2009-7#1)
effects on##743##2##(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#9)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#9)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-6#5)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#6)(1994-6#4)(1994-8#8)(1994-9#8)(1995-1#1)(1995-11#3)(1995-12#8)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#3)(1996-12#9)(1996-2#7)(1996-3#3)(1996-5#8)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2006-10#1)(2006-6#2)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#119)(2008-11#28)(2008-12#13)(2008-2#11)(2008-3#22)(2008-4#9)(2008-5#23)(2008-6#6)(2008-7#21)(2008-8#51)(2008-9#18)(2009-10#9)(2009-12#6)(2009-2#4)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#6)(2011-1#9)(2011-2#22)(2011-3#3)(2012-1#4)(2012-12#5)(2012-2#10)(2012-3#12)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#30)(2013-7#4)(2013-8#4)
effects only##2##2##(1993-3#1)(2011-1#1)
effects or associations##2##3##(2007-7#2)
effects or##18##2##(1990-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-6#1)(2007-7#2)(2008-10#2)(2008-7#3)(2008-8#3)(2010-8#1)(2012-3#1)(2013-1#1)
effects owing to##3##3##(2008-2#2)(2008-5#1)
effects play a##2##3##(2008-2#1)(2008-3#1)
effects play##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
effects primarily##2##2##(2008-6#1)(2012-2#1)
effects produced by##5##3##(1991-2#1)(1991-5#1)(1993-12#1)(2008-10#1)(2008-3#1)
effects produced##6##2##(1991-2#1)(1991-5#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-3#1)
effects provide##2##2##(2012-12#2)
effects rather than to##3##4##(1992-12#1)(2008-10#1)(2008-3#1)
effects related to##4##3##(1996-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
effects related##6##2##(1994-3#1)(1996-9#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
effects remain to be##2##4##(2010-7#1)(2011-2#1)
effects remain##3##2##(2010-7#1)(2011-2#1)(2012-12#1)
effects reported in##2##3##(2008-5#1)(2012-2#1)
effects reported##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
effects result from##4##3##(1993-12#1)(1997-7#1)(2008-6#1)(2008-9#1)
effects resulting from##6##3##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)
effects seem to be##2##4##(1997-4#1)(2008-10#1)
effects seen in##2##3##(2008-10#1)(2008-7#1)
effects seen with##2##3##(2008-8#1)(2011-2#1)
effects seen##5##2##(1991-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
effects should be considered##2##4##(2007-11#1)(2008-9#1)
effects should be##3##3##(1991-12#1)(2007-11#1)(2008-9#1)
effects should##4##2##(1991-12#1)(1996-6#1)(2007-11#1)(2008-9#1)
effects similar to##4##3##(1994-8#1)(2007-8#1)(2008-10#1)(2010-5#1)
effects such as frequency##2##4##(2007-11#1)(2012-1#1)
effects such as##16##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
effects than the##2##3##(2007-11#1)(2012-12#1)
effects than those##2##3##(2008-5#1)(2009-7#1)
effects than##9##2##(1996-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-12#1)(2012-12#1)
effects that are due to the##2##6##(2008-2#1)(2008-3#1)
effects that are due to##3##5##(2008-2#1)(2008-3#2)
effects that are##8##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-6#1)(2012-2#2)
effects that have been##2##4##(2008-11#1)(2008-8#1)
effects that have##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
effects that the##2##3##(1993-5#1)(2008-3#1)
effects that were##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-4#1)
effects that##45##2##(1991-2#1)(1993-5#1)(1995-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#9)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#3)(2013-1#2)
effects the##5##2##(1993-2#1)(1993-6#1)(1996-2#1)(2008-2#1)(2012-1#1)
effects through the##2##3##(1994-11#1)(2009-7#1)
effects through##10##2##(1993-6#1)(1994-11#1)(1994-6#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)
effects to the##4##3##(1994-8#1)(1996-6#1)(2008-1#1)(2008-4#1)
effects to##18##2##(1991-9#1)(1993-12#1)(1994-8#2)(1996-6#1)(1997-7#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2012-2#1)(2012-6#1)
effects towards##2##2##(1993-12#1)(2009-3#1)
effects triggered by the##2##4##(1995-12#1)(2008-7#1)
effects under##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
effects upon the##3##3##(1991-12#1)(1993-12#1)(2013-1#1)
effects upon##7##2##(1991-12#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2013-1#1)
effects using in##2##3##(2008-11#1)(2008-5#1)
effects using##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
effects via the##3##3##(1994-8#1)(2008-8#1)(2013-7#1)
effects via##5##2##(1990-8#1)(1991-12#1)(1994-8#1)(2008-8#1)(2013-7#1)
effects was##12##2##(1990-7#1)(1993-2#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#1)
effects well##2##2##(2008-5#1)(2008-7#1)
effects were achieved##3##3##(1997-8#1)(2008-2#1)(2008-3#1)
effects were also##5##3##(1993-3#1)(1994-6#1)(2008-10#3)
effects were considered##3##3##(2008-10#2)(2013-1#1)
effects were detected##4##3##(2008-10#3)(2011-2#1)
effects were evaluated by##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
effects were evaluated##6##3##(2008-10#4)(2008-11#1)(2008-5#1)
effects were examined by##2##4##(1992-11#1)(2010-5#1)
effects were examined##5##3##(1990-5#1)(1992-11#1)(2008-11#1)(2008-3#1)(2010-5#1)
effects were found##7##3##(1991-2#1)(1993-2#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-7#1)(2013-1#1)
effects were manifested##2##3##(2012-1#2)
effects were minimal##3##3##(1990-6#1)(1991-8#1)(1997-7#1)
effects were minimized by##2##4##(1997-2#1)(2008-10#1)
effects were more pronounced in##2##5##(2008-8#1)(2010-2#1)
effects were more pronounced##3##4##(2008-8#1)(2010-2#1)(2011-2#1)
effects were more##4##3##(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)
effects were negligible##2##3##(1991-8#1)(2008-10#1)
effects were not##9##3##(1991-1#1)(1994-2#1)(1995-12#1)(2008-10#3)(2008-11#1)(2010-10#1)(2011-2#1)
effects were noted##5##3##(1991-2#1)(1991-3#1)(2007-11#1)(2008-7#2)
effects were observed at##2##4##(1994-2#1)(1996-3#1)
effects were observed in the##4##5##(1995-12#1)(1995-3#1)(2008-10#1)(2008-2#1)
effects were observed in##10##4##(1995-12#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#2)(2010-4#1)
effects were observed##23##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)(1991-8#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-3#1)(1997-4#2)(2007-11#1)(2008-10#5)(2008-2#1)(2008-7#2)(2010-4#1)(2011-2#1)
effects were reported##2##3##(1990-5#1)(1991-11#1)
effects were seen on##2##4##(1995-12#1)(2008-7#1)
effects were seen##7##3##(1995-12#2)(1996-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)
effects were##158##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#2)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-12#4)(1995-3#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-7#2)(2007-9#1)(2008-10#40)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#6)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
effects when##5##2##(1994-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-4#1)
effects which are##3##3##(1997-4#1)(2008-4#1)(2013-7#1)
effects which can##2##3##(1992-12#1)(1996-3#1)
effects which##10##2##(1992-12#1)(1992-3#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)
effects will be##2##3##(1992-3#1)(1997-4#1)
effects will##5##2##(1992-3#1)(1997-4#1)(2007-11#1)(2008-11#1)(2012-3#1)
effects with other##2##3##(2008-7#2)
effects with respect to##2##4##(2011-2#1)(2013-1#1)
effects with the##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
effects with##25##2##(1991-2#1)(1991-6#1)(1992-12#1)(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#6)(2008-9#2)(2011-2#1)(2013-1#2)
effects within##3##2##(1994-11#1)(2012-2#2)
effects without##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
effects##5692##1##(1990-10#4)(1990-11#14)(1990-12#18)(1990-2#16)(1990-3#12)(1990-4#2)(1990-5#38)(1990-6#12)(1990-7#17)(1990-8#25)(1990-9#7)(1991-1#46)(1991-10#2)(1991-11#6)(1991-12#45)(1991-2#27)(1991-3#16)(1991-4#4)(1991-5#28)(1991-6#20)(1991-8#9)(1991-9#20)(1992-1#7)(1992-10#7)(1992-11#21)(1992-12#18)(1992-2#11)(1992-3#51)(1992-4#4)(1992-5#15)(1992-6#26)(1992-7#6)(1992-8#27)(1992-9#26)(1993-1#15)(1993-10#1)(1993-11#30)(1993-12#40)(1993-2#8)(1993-3#36)(1993-5#8)(1993-6#22)(1993-8#16)(1993-9#9)(1994-1#6)(1994-10#4)(1994-11#28)(1994-12#11)(1994-2#43)(1994-3#25)(1994-5#37)(1994-6#23)(1994-8#48)(1994-9#25)(1995-1#5)(1995-11#40)(1995-12#77)(1995-2#38)(1995-3#32)(1995-5#23)(1995-6#10)(1995-8#11)(1995-9#3)(1996-1#7)(1996-11#9)(1996-12#37)(1996-2#52)(1996-3#24)(1996-4#2)(1996-5#31)(1996-6#23)(1996-7#4)(1996-8#3)(1996-9#6)(1997-1#24)(1997-2#40)(1997-3#17)(1997-4#38)(1997-5#4)(1997-6#17)(1997-7#46)(1997-8#14)(2006-10#7)(2006-12#4)(2006-4#1)(2006-6#6)(2007-10#6)(2007-11#88)(2007-12#97)(2007-2#7)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#6)(2007-7#21)(2007-8#12)(2007-9#3)(2008-1#45)(2008-10#765)(2008-11#230)(2008-12#70)(2008-2#146)(2008-3#290)(2008-4#89)(2008-5#182)(2008-6#62)(2008-7#222)(2008-8#217)(2008-9#132)(2009-1#4)(2009-10#20)(2009-11#21)(2009-12#29)(2009-2#14)(2009-3#8)(2009-4#12)(2009-5#15)(2009-6#10)(2009-7#47)(2009-8#19)(2009-9#22)(2010-1#23)(2010-10#17)(2010-11#21)(2010-12#20)(2010-2#17)(2010-3#14)(2010-4#34)(2010-5#19)(2010-6#9)(2010-7#14)(2010-8#27)(2010-9#9)(2011-1#61)(2011-10#2)(2011-2#177)(2011-3#9)(2011-7#1)(2012-1#33)(2012-12#56)(2012-2#117)(2012-3#82)(2012-4#3)(2012-5#4)(2012-6#5)(2012-7#4)(2013-1#207)(2013-7#37)(2013-8#53)
effects&quot##5##1##(1991-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
effects'##2##1##(2012-12#1)(2012-2#1)
effects)##5##1##(1990-9#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
effects-based##2##1##(2012-2#2)
effects]##8##1##(1990-6#1)(1991-2#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1995-8#1)
effeminacy##2##1##(2008-10#1)(2009-5#1)
efferent connections of the striatum and the nucleus accumbens##2##9##(1997-3#2)
efferent connections##3##2##(1997-3#3)
efferent fibers##2##2##(1996-12#1)(1997-3#1)
efferent functions##2##2##(1997-3#1)(2008-1#1)
efferent nerve activity##2##3##(1997-7#2)
efferent nerve##3##2##(1997-7#2)(2007-10#1)
efferent projections##2##2##(1996-5#1)(2009-10#1)
efferent##21##1##(1992-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#5)(1997-7#2)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#3)(2009-10#1)(2011-2#2)
efferents##2##1##(1990-5#1)(1993-12#1)
effervescent method##4##2##(2010-3#4)
effervescent##6##1##(2008-10#1)(2010-3#4)(2012-2#1)
efficace##2##1##(2007-11#1)(2011-2#1)
efficacies of##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
efficacies##9##1##(1992-9#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
efficacious and safe##5##3##(1997-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
efficacious and##9##2##(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
efficacious at##2##2##(1995-11#1)(2008-2#1)
efficacious for the##2##3##(1995-11#1)(2008-7#1)
efficacious in preventing##2##3##(1991-3#1)(2007-7#1)
efficacious in reducing##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
efficacious in##14##2##(1991-3#1)(1992-1#1)(1994-11#2)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)
efficacious interventions##2##2##(2008-11#1)(2010-5#1)
efficacious method##3##2##(1990-5#1)(1993-5#1)(2011-2#1)
efficacious therapy##2##2##(1991-5#1)(2011-2#1)
efficacious to##2##2##(2008-8#1)(2013-1#1)
efficacious treatments##2##2##(2009-7#1)(2011-2#1)
efficacious##67##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-1#1)(1993-5#1)(1994-11#3)(1994-8#1)(1995-11#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2009-12#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
efficacy achieved by##2##3##(2008-10#2)
efficacy after##3##2##(1993-11#1)(2008-10#1)(2008-2#1)
efficacy against##12##2##(1994-11#1)(1995-3#1)(2008-10#4)(2008-5#2)(2010-11#1)(2011-2#1)(2013-1#2)
efficacy among##2##2##(1995-2#1)(2008-5#1)
efficacy analysis of##2##3##(2007-11#2)
efficacy analysis##4##2##(2007-11#3)(2011-2#1)
efficacy and effectiveness of##2##4##(2008-8#1)(2012-3#1)
efficacy and effectiveness##3##3##(2008-8#1)(2012-2#1)(2012-3#1)
efficacy and perceptual##2##3##(2008-5#2)
efficacy and risks of##2##4##(1993-11#1)(2008-7#1)
efficacy and safety data##2##4##(2008-8#2)
efficacy and safety in##2##4##(2008-5#1)(2012-2#1)
efficacy and safety of a##2##5##(2008-8#1)(2013-1#1)
efficacy and safety of this##3##5##(1992-2#1)(1997-3#1)(2008-11#1)
efficacy and safety of##21##4##(1990-9#1)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1997-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
efficacy and safety profile##3##4##(2007-8#1)(2008-5#1)(2008-6#1)
efficacy and safety##43##3##(1990-9#2)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)
efficacy and safety]##2##3##(1992-2#1)(2013-8#1)
efficacy and side effects##3##4##(1993-1#1)(1993-6#1)(1996-5#1)
efficacy and side##4##3##(1993-1#1)(1993-6#1)(1996-5#1)(2011-10#1)
efficacy and stability##2##3##(2008-11#1)(2008-5#1)
efficacy and the##4##3##(1990-2#1)(1990-3#1)(1994-6#1)(2008-5#1)
efficacy and their##2##3##(2010-5#1)(2011-2#1)
efficacy and to##2##3##(1994-11#1)(1996-3#1)
efficacy and tolerability of the##2##5##(1991-2#1)(2008-3#1)
efficacy and tolerability of##10##4##(1990-3#1)(1991-2#1)(1994-12#1)(2008-3#3)(2011-2#1)(2012-3#3)
efficacy and tolerability##14##3##(1990-3#1)(1990-6#1)(1991-2#1)(1994-12#1)(2007-11#1)(2008-3#4)(2008-5#1)(2011-2#1)(2012-3#3)
efficacy and toxicity of a combination of##2##7##(1991-8#1)(2007-10#1)
efficacy and toxicity of a##3##5##(1990-2#1)(1991-8#1)(2007-10#1)
efficacy and toxicity of##4##4##(1990-2#1)(1991-8#1)(2007-10#1)(2008-6#1)
efficacy and toxicity##8##3##(1990-2#2)(1991-8#1)(2007-10#1)(2008-6#1)(2009-11#1)(2012-3#1)(2013-8#1)
efficacy and##151##2##(1990-2#3)(1990-3#3)(1990-6#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#2)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#5)(2008-8#7)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#8)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#8)(2013-1#10)(2013-8#3)
efficacy are##3##2##(1994-2#1)(2008-2#1)(2008-3#1)
efficacy as##6##2##(1990-5#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
efficacy assesment##2##2##(1994-7#1)(2007-11#1)
efficacy assessment##2##2##(1993-12#1)(2008-5#1)
efficacy at the final##2##4##(2008-3#1)(2012-2#1)
efficacy at the##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
efficacy at##9##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
efficacy by##2##2##(2008-10#1)(2008-5#1)
efficacy comparable to##2##3##(1995-5#1)(2009-6#1)
efficacy compared to##2##3##(1995-2#1)(2008-7#1)
efficacy criteria##2##2##(2008-5#2)
efficacy depends on##2##3##(2013-1#1)(2013-8#1)
efficacy endpoint##3##2##(1994-9#1)(2008-7#2)
efficacy evaluations##2##2##(2008-5#2)
efficacy expectations##2##2##(2010-9#2)
efficacy for some##2##3##(1996-2#1)(2008-12#1)
efficacy for##16##2##(1991-9#1)(1995-5#1)(1995-8#1)(1996-2#2)(2007-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
efficacy in a##2##3##(2008-8#1)(2010-5#1)
efficacy in both##2##3##(1995-3#1)(2008-3#1)
efficacy in patients with##2##4##(2009-10#1)(2011-2#1)
efficacy in patients##3##3##(2009-10#1)(2009-9#1)(2011-2#1)
efficacy in reducing##2##3##(2008-3#1)(2011-2#1)
efficacy in the management of##2##5##(2008-9#1)(2010-4#1)
efficacy in the treatment of##2##5##(1997-7#1)(2008-5#1)
efficacy in the##7##3##(1997-7#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-4#1)(2013-1#1)
efficacy in this##2##3##(1990-12#1)(2009-4#1)
efficacy in vivo##4##3##(1995-3#1)(1997-4#1)(2008-4#1)(2013-1#1)
efficacy in##55##2##(1990-12#1)(1990-6#1)(1994-11#1)(1995-2#1)(1995-3#2)(1997-4#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
efficacy is not##2##3##(1995-12#1)(2009-8#1)
efficacy is##15##2##(1994-11#1)(1994-8#2)(1995-12#1)(1995-5#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2012-3#2)
efficacy may##2##2##(2008-5#1)(2012-12#1)
efficacy measure##4##2##(1994-9#2)(2008-7#1)(2012-2#1)
efficacy of DNA##2##3##(1994-5#1)(2013-1#1)
efficacy of SDZ ASM 981##2##5##(2007-11#2)
efficacy of a DNA vaccine##2##5##(2008-3#2)
efficacy of a cosmetic##2##4##(2008-5#1)(2013-7#1)
efficacy of a new##4##4##(1997-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
efficacy of a single##2##4##(2007-7#1)(2010-8#1)
efficacy of a##32##3##(1995-2#1)(1996-5#1)(1997-2#1)(1997-8#2)(2006-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-8#1)(2009-2#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
efficacy of acupuncture##2##3##(2007-10#1)(2012-3#1)
efficacy of aluminum##2##3##(1991-2#1)(2008-10#1)
efficacy of an##7##3##(1990-5#1)(1993-5#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)
efficacy of biocontrol##2##3##(2008-10#2)
efficacy of biological control##2##4##(2008-10#2)
efficacy of chemical##3##3##(2007-7#1)(2008-10#2)
efficacy of cytotoxic##2##3##(1997-5#1)(2008-5#1)
efficacy of different##4##3##(1994-12#1)(2008-10#2)(2013-8#1)
efficacy of duloxetine##2##3##(2008-3#2)
efficacy of entomopathogenic nematodes for##2##5##(2008-8#2)
efficacy of ethanolic extract of Lemon verbena##2##7##(2008-12#2)
efficacy of homeopathic##2##3##(1994-2#1)(2008-10#1)
efficacy of low molecular weight##2##5##(2007-10#1)(2008-7#1)
efficacy of low-dose oral corticosteroids##2##5##(2007-7#2)
efficacy of oral##3##3##(2006-10#2)(2012-2#1)
efficacy of psychosocial##2##3##(1992-12#1)(2009-7#1)
efficacy of such##7##3##(1997-7#1)(2008-5#5)(2011-1#1)
efficacy of systemic##2##3##(2008-10#1)(2008-8#1)
efficacy of the approach##3##4##(1995-2#1)(2008-10#2)
efficacy of the therapy##2##4##(1991-12#1)(2012-12#1)
efficacy of the##59##3##(1991-11#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-2#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
efficacy of therapeutic##3##3##(2007-12#1)(2008-11#1)(2010-2#1)
efficacy of these drugs##4##4##(1991-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
efficacy of these##8##3##(1991-8#1)(2008-10#2)(2008-11#2)(2010-5#1)(2010-6#1)(2012-12#1)
efficacy of this##11##3##(1992-8#1)(1994-5#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#2)
efficacy of two##2##3##(1993-1#1)(2008-3#1)
efficacy of using##2##3##(2008-9#1)(2011-2#1)
efficacy of various##3##3##(1992-8#1)(2006-10#1)(2008-2#1)
efficacy of vitamin A##2##4##(1997-8#1)(2008-11#1)
efficacy of##459##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#4)(2007-10#4)(2007-11#10)(2007-12#2)(2007-2#1)(2007-7#10)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#62)(2008-11#14)(2008-12#7)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#41)(2008-6#8)(2008-7#11)(2008-8#11)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#8)(2009-2#1)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#5)(2011-2#35)(2012-1#5)(2012-12#7)(2012-2#9)(2012-3#14)(2013-1#23)(2013-7#4)(2013-8#9)
efficacy on the##3##3##(1994-6#1)(2008-10#1)(2013-1#1)
efficacy on##6##2##(1994-6#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
efficacy or##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
efficacy studies##2##2##(1995-5#2)
efficacy testing##5##2##(1990-3#1)(1996-2#1)(2008-5#3)
efficacy tests in the##2##4##(2008-10#1)(2008-5#1)
efficacy than the##2##3##(2008-10#1)(2008-5#1)
efficacy than##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
efficacy to that##2##3##(2008-10#1)(2010-11#1)
efficacy to##8##2##(1990-9#1)(1995-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-11#1)(2013-1#1)
efficacy trial of##3##3##(1995-5#1)(2007-7#1)(2008-12#1)
efficacy trial##4##2##(1995-5#1)(2007-7#1)(2008-12#1)(2008-5#1)
efficacy trials##3##2##(1995-5#1)(2008-8#1)(2012-2#1)
efficacy under##3##2##(2008-10#3)
efficacy was found##2##3##(2008-11#1)(2008-5#1)
efficacy was highly variable##2##4##(2008-10#2)
efficacy was##12##2##(1997-4#1)(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#3)(2013-1#1)
efficacy were##2##2##(1990-9#1)(2011-2#1)
efficacy will be##2##3##(1992-3#1)(2008-5#1)
efficacy with##10##2##(1991-8#1)(1996-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-10#1)(2011-2#1)
efficacy##1024##1##(1990-10#1)(1990-12#2)(1990-2#5)(1990-3#6)(1990-5#2)(1990-6#5)(1990-7#1)(1990-9#4)(1991-1#1)(1991-11#6)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#2)(1992-9#4)(1993-1#6)(1993-11#5)(1993-12#6)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#6)(1994-2#10)(1994-3#3)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#9)(1995-3#6)(1995-5#15)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#5)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2006-10#4)(2007-10#8)(2007-11#20)(2007-12#4)(2007-2#2)(2007-7#16)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#114)(2008-11#28)(2008-12#13)(2008-2#10)(2008-3#24)(2008-4#11)(2008-5#110)(2008-6#18)(2008-7#38)(2008-8#37)(2008-9#7)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#9)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#8)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#5)(2011-1#8)(2011-10#1)(2011-2#66)(2011-3#2)(2012-1#8)(2012-12#21)(2012-2#21)(2012-3#30)(2013-1#49)(2013-7#5)(2013-8#15)
efficacy)##2##1##(1995-2#1)(2009-9#1)
efficiencies and##4##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
efficiencies are##9##2##(1991-12#1)(2007-11#1)(2008-2#3)(2008-3#3)(2011-3#1)
efficiencies as great as##2##4##(2008-2#1)(2008-3#1)
efficiencies as high as##2##4##(2007-12#2)
efficiencies as##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
efficiencies at##3##2##(2007-12#1)(2010-10#1)(2010-4#1)
efficiencies by##2##2##(2008-2#1)(2008-3#1)
efficiencies for the##5##3##(2008-10#1)(2008-3#2)(2009-8#1)(2010-5#1)
efficiencies for##12##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2009-8#1)(2010-5#1)
efficiencies in the##5##3##(1996-11#1)(2008-2#2)(2008-3#2)
efficiencies in##10##2##(1996-11#1)(2008-11#1)(2008-2#2)(2008-3#5)(2010-10#1)
efficiencies of as much as##3##5##(2007-11#1)(2007-12#2)
efficiencies of as##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
efficiencies of greater than##2##4##(2008-10#1)(2008-3#1)
efficiencies of the##5##3##(2007-12#1)(2008-11#1)(2008-3#3)
efficiencies of two##2##3##(2008-10#1)(2008-3#1)
efficiencies of up to##2##4##(2008-3#1)(2008-7#1)
efficiencies of##49##2##(1992-9#1)(1994-8#1)(1995-5#1)(1996-3#1)(2007-11#6)(2007-12#6)(2008-10#5)(2008-11#3)(2008-2#8)(2008-3#12)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
efficiencies over a##2##3##(2008-10#1)(2013-1#1)
efficiencies over##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
efficiencies were in##2##3##(2008-10#1)(2008-2#1)
efficiencies were##12##2##(2008-10#5)(2008-2#2)(2008-3#2)(2008-6#1)(2011-2#1)(2012-3#1)
efficiencies##150##1##(1991-12#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(2007-11#8)(2007-12#12)(2008-10#31)(2008-11#8)(2008-2#19)(2008-3#37)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)(2010-10#2)(2010-2#2)(2010-4#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#3)
efficiency (CE) and##2##3##(2008-10#1)(2008-9#1)
efficiency 0##2##2##(2008-10#2)
efficiency a##2##2##(2008-2#1)(2008-3#1)
efficiency above##2##2##(2007-9#1)(2008-11#1)
efficiency achieved##2##2##(2007-12#1)(2008-10#1)
efficiency after##2##2##(2008-10#1)(2008-3#1)
efficiency allows##2##2##(2008-3#1)(2013-8#1)
efficiency and a##8##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
efficiency and cost##2##3##(1996-2#1)(2008-10#1)
efficiency and effectiveness##4##3##(1993-3#1)(1995-3#1)(2007-9#1)(2010-8#1)
efficiency and expression##2##3##(2008-11#1)(2008-9#1)
efficiency and in##3##3##(1991-6#1)(2010-6#1)(2011-1#1)
efficiency and low##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
efficiency and mass##2##3##(2011-1#2)
efficiency and patient##2##3##(1991-6#1)(1997-3#1)
efficiency and reduce##2##3##(1994-2#1)(1996-2#1)
efficiency and reduced##2##3##(2007-12#1)(2008-3#1)
efficiency and safety##4##3##(2008-11#1)(2008-8#1)(2012-3#2)
efficiency and selectivity of##2##4##(2008-10#2)
efficiency and selectivity##5##3##(2008-10#5)
efficiency and signal-to-noise ratio##2##4##(2008-2#1)(2008-3#1)
efficiency and specificity of##2##4##(1997-2#1)(2010-5#1)
efficiency and stability##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
efficiency and the influence of##3##5##(2008-10#3)
efficiency and the##21##3##(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#6)(2008-6#1)(2012-3#1)
efficiency and to##4##3##(1993-3#1)(2008-3#2)(2011-1#1)
efficiency and toxicity##2##3##(1995-8#1)(2011-1#1)
efficiency and##146##2##(1990-5#1)(1991-6#2)(1992-3#1)(1993-3#2)(1994-2#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#7)(2007-8#1)(2007-9#2)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#13)(2008-3#28)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
efficiency are also##2##3##(2008-2#1)(2008-3#1)
efficiency are##7##2##(2008-2#3)(2008-3#2)(2008-9#1)(2010-8#1)
efficiency as a function of##4##5##(2008-10#1)(2008-11#1)(2008-3#2)
efficiency as high as##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
efficiency as well as##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
efficiency as##17##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2012-2#1)
efficiency at the##3##3##(1993-2#1)(2008-2#1)(2011-2#1)
efficiency at##5##2##(1993-2#1)(2007-11#1)(2008-2#2)(2011-2#1)
efficiency between##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2013-7#1)
efficiency both in##2##3##(2008-11#1)(2008-8#1)
efficiency by##11##2##(1992-6#2)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-2#2)(2013-1#1)
efficiency can be increased to##2##5##(2008-2#1)(2008-3#1)
efficiency can be##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
efficiency can##9##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)
efficiency close to##2##3##(2008-10#1)(2008-3#1)
efficiency could be##2##3##(2008-10#2)
efficiency data##2##2##(2007-11#1)(2008-2#1)
efficiency decreased##2##2##(2007-9#1)(2008-10#1)
efficiency depending##2##2##(2008-10#1)(2008-6#1)
efficiency depends on the##2##4##(2008-10#1)(2008-2#1)
efficiency depends on##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
efficiency did not##3##3##(2008-10#3)
efficiency during##4##2##(1990-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
efficiency enhancement##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
efficiency expressed as##2##3##(1994-9#1)(2008-10#1)
efficiency for a##3##3##(1994-5#1)(2008-10#1)(2008-3#1)
efficiency for the##2##3##(2008-10#1)(2008-3#1)
efficiency for##33##2##(1994-12#1)(1994-2#1)(1994-5#1)(2007-12#4)(2008-10#13)(2008-2#3)(2008-3#4)(2008-5#1)(2011-1#1)(2011-2#1)(2012-6#1)(2012-8#1)(2013-1#1)
efficiency from a##3##3##(2008-3#3)
efficiency from##10##2##(1997-1#1)(2007-11#2)(2008-10#1)(2008-3#5)(2013-8#1)
efficiency greater than##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
efficiency has##2##2##(2007-11#1)(2010-8#1)
efficiency have been##3##3##(2008-10#1)(2008-3#2)
efficiency higher than##2##3##(2008-3#1)(2010-1#1)
efficiency in a##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
efficiency in terms of##2##4##(2008-2#2)
efficiency in the +1##2##4##(2007-12#1)(2008-3#1)
efficiency in the -1 order##2##5##(2008-2#1)(2008-3#1)
efficiency in the##19##3##(1993-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#6)(2008-3#4)(2008-9#1)(2011-2#1)
efficiency in two##2##3##(2008-10#1)(2008-11#1)
efficiency in##57##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-12#1)(2007-11#6)(2007-12#4)(2007-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#3)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
efficiency increased by##3##3##(2008-3#3)
efficiency increased##7##2##(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#1)
efficiency indicators##2##2##(1997-2#1)(2010-8#1)
efficiency is approximately##2##3##(2008-2#2)
efficiency is as high as##2##5##(2007-12#1)(2008-2#1)
efficiency is demonstrated##2##3##(2007-11#1)(2008-3#1)
efficiency is obtained##2##3##(2007-12#1)(2008-10#1)
efficiency is required##2##3##(2011-1#1)(2011-2#1)
efficiency is strongly##2##3##(2008-3#2)
efficiency is##42##2##(1994-3#1)(2007-11#5)(2007-12#9)(2008-10#4)(2008-2#9)(2008-3#8)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
efficiency loss##2##2##(1997-1#1)(2007-12#1)
efficiency measurements##2##2##(2008-3#2)
efficiency near the##2##3##(2007-11#1)(2008-3#1)
efficiency near##4##2##(2007-11#3)(2008-3#1)
efficiency obtained with the##2##4##(2007-12#1)(2008-11#1)
efficiency obtained##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
efficiency of 0##9##3##(2007-11#5)(2007-12#3)(2008-10#1)
efficiency of 2##5##3##(2007-12#3)(2008-10#1)(2008-2#1)
efficiency of 25%##2##3##(2007-12#2)
efficiency of 26%##2##3##(2007-12#1)(2008-2#1)
efficiency of 28%##2##3##(2008-3#2)
efficiency of 30%##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
efficiency of 32##2##3##(2008-2#2)
efficiency of 33%##2##3##(2007-11#2)
efficiency of 34##2##3##(2007-11#1)(2008-2#1)
efficiency of 35%##3##3##(2007-11#2)(2007-12#1)
efficiency of 54%##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
efficiency of 90##2##3##(2007-11#1)(2008-3#1)
efficiency of DNA##2##3##(1993-9#1)(2008-11#1)
efficiency of a holographic grating##2##5##(2007-11#1)(2008-3#1)
efficiency of a##22##3##(1991-9#1)(1992-2#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)
efficiency of an##2##3##(2008-11#1)(2012-12#1)
efficiency of analyte##2##3##(2008-10#2)
efficiency of approximately##3##3##(2008-2#2)(2008-3#1)
efficiency of as much as##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
efficiency of care##2##3##(1996-3#1)(2008-3#1)
efficiency of current##2##3##(2008-10#2)
efficiency of different##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
efficiency of each##2##3##(2008-3#1)(2010-8#1)
efficiency of extraction##3##3##(2008-10#3)
efficiency of gene##3##3##(1994-11#1)(1995-12#1)(1997-3#1)
efficiency of greater than##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
efficiency of image##2##3##(2008-7#1)(2008-9#1)
efficiency of individual##2##3##(1992-2#1)(2012-3#1)
efficiency of ion##2##3##(2008-10#2)
efficiency of more than 40%##2##5##(2008-11#1)(2008-2#1)
efficiency of more than##6##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)
efficiency of oxalate absorption##2##4##(2012-2#2)
efficiency of ribosomal frameshifting##2##4##(1995-9#2)
efficiency of spinal anesthesia was##2##5##(2012-3#2)
efficiency of the 2##2##4##(2007-12#1)(2008-10#1)
efficiency of the extraction##2##4##(2008-10#2)
efficiency of the grating##2##4##(2007-11#1)(2008-3#1)
efficiency of the guidelines##2##4##(1994-2#2)
efficiency of the method##4##4##(2008-2#2)(2008-3#2)
efficiency of the process##2##4##(2008-10#1)(2008-5#1)
efficiency of the three##2##4##(2008-5#1)(2013-8#1)
efficiency of the##109##3##(1990-5#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#3)(1994-2#2)(1994-9#1)(1996-12#1)(1997-2#3)(1997-3#1)(1997-8#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-10#29)(2008-11#2)(2008-2#7)(2008-3#18)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#2)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
efficiency of these##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
efficiency of this process##2##4##(1994-5#1)(2008-10#1)
efficiency of this##11##3##(1993-12#1)(1994-5#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-10#1)(2013-1#1)
efficiency of those##2##3##(2007-12#1)(2008-11#1)
efficiency of tissue repair##2##4##(1993-2#2)
efficiency of transient##3##3##(2007-11#1)(2007-12#2)
efficiency of up to##2##4##(2008-10#1)(2011-2#1)
efficiency of##492##2##(1990-12#1)(1990-5#2)(1991-2#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#5)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#3)(1994-9#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#44)(2007-12#51)(2007-8#1)(2008-1#1)(2008-10#95)(2008-11#20)(2008-12#6)(2008-2#50)(2008-3#50)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#7)(2012-8#1)(2013-1#15)(2013-7#2)(2013-8#3)
efficiency on the##6##3##(1990-9#1)(2007-12#2)(2008-2#1)(2008-3#2)
efficiency on##8##2##(1990-9#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
efficiency or##2##2##(2008-10#1)(2013-1#1)
efficiency over a##2##3##(2008-3#2)
efficiency over the##2##3##(2008-10#1)(2008-3#1)
efficiency over##5##2##(2008-10#2)(2008-3#3)
efficiency reached##2##2##(2007-11#1)(2008-2#1)
efficiency simultaneously##2##2##(2008-10#1)(2008-3#1)
efficiency studies##2##2##(1992-9#1)(2008-10#1)
efficiency suggests##2##2##(1994-2#1)(2007-11#1)
efficiency than the##2##3##(1997-4#1)(2011-2#1)
efficiency than##8##2##(1992-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
efficiency that is##2##3##(2007-12#1)(2009-5#1)
efficiency that##6##2##(2007-12#3)(2008-10#1)(2009-5#1)(2012-2#1)
efficiency through##2##2##(2008-10#1)(2008-7#1)
efficiency to the##2##3##(2007-12#1)(2008-3#1)
efficiency to##11##2##(1994-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)(2013-7#1)
efficiency under##2##2##(1991-12#1)(2008-10#1)
efficiency upper bound of##2##4##(2007-12#2)
efficiency upper bound##3##3##(2007-12#3)
efficiency upper##4##2##(2007-12#4)
efficiency using##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
efficiency was 12##2##3##(2008-10#1)(2008-3#1)
efficiency was found to be##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
efficiency was found to##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
efficiency was measured##2##3##(2008-2#2)
efficiency was not##2##3##(2008-11#2)
efficiency was observed in##2##4##(2008-10#1)(2010-8#1)
efficiency was observed##4##3##(1990-5#1)(2008-10#1)(2008-6#1)(2010-8#1)
efficiency was slightly##2##3##(2008-7#1)(2011-2#1)
efficiency was##48##2##(1990-5#1)(1991-12#1)(1992-11#1)(1997-2#1)(2007-11#3)(2007-12#5)(2008-10#8)(2008-11#4)(2008-2#7)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
efficiency we##2##2##(2008-3#1)(2013-1#1)
efficiency were studied##2##3##(2008-10#2)
efficiency were##12##2##(1992-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
efficiency when compared##2##3##(2008-10#1)(2008-7#1)
efficiency when##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
efficiency with a##2##3##(2007-12#1)(2008-3#1)
efficiency with respect to##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
efficiency with which##3##3##(1992-2#1)(1993-3#1)(2008-3#1)
efficiency with##15##2##(1992-2#1)(1993-3#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)
efficiency without##3##2##(2008-10#2)(2008-3#1)
efficiency##1446##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#7)(1990-7#1)(1990-9#1)(1991-12#3)(1991-2#4)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#2)(1992-2#10)(1992-3#2)(1992-6#4)(1992-9#7)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#7)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#9)(1994-2#6)(1994-3#1)(1994-5#8)(1994-9#3)(1995-1#4)(1995-12#4)(1995-2#5)(1995-3#10)(1995-8#2)(1995-9#2)(1996-1#4)(1996-12#4)(1996-2#5)(1996-3#4)(1996-5#2)(1996-9#1)(1997-1#4)(1997-2#11)(1997-3#5)(1997-4#5)(1997-6#1)(1997-8#3)(2007-10#1)(2007-11#97)(2007-12#123)(2007-5#1)(2007-8#2)(2007-9#5)(2008-1#7)(2008-10#274)(2008-11#60)(2008-12#18)(2008-2#157)(2008-3#194)(2008-4#2)(2008-5#23)(2008-6#20)(2008-7#22)(2008-8#18)(2008-9#23)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#29)(2010-9#1)(2011-1#15)(2011-2#17)(2011-3#4)(2011-7#1)(2012-1#5)(2012-12#7)(2012-2#24)(2012-3#17)(2012-6#2)(2012-8#2)(2013-1#29)(2013-7#5)(2013-8#14)
efficiency&quot##2##1##(1992-3#1)(2008-9#1)
efficiency)##3##1##(2007-12#1)(2008-3#2)
efficiency]##2##1##(1990-9#1)(1993-6#1)
efficient ablation##2##2##(2011-1#2)
efficient accumulation of##2##3##(1997-4#1)(2008-9#1)
efficient algorithm for##2##3##(2008-3#1)(2013-1#1)
efficient algorithm##4##2##(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
efficient algorithms##2##2##(2008-3#1)(2009-2#1)
efficient allocation of##2##3##(2007-4#1)(2012-12#1)
efficient alternative to##4##3##(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)
efficient alternative##7##2##(1993-11#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
efficient amplification of##2##3##(2008-2#2)
efficient and accurate##3##3##(2009-8#1)(2010-4#1)(2012-2#1)
efficient and effective##5##3##(1994-2#1)(1994-8#1)(2008-12#1)(2008-2#1)(2012-3#1)
efficient and highly##2##3##(2008-10#1)(2008-11#1)
efficient and rapid##2##3##(2008-10#1)(2008-11#1)
efficient and reliable##2##3##(1997-2#1)(2012-1#1)
efficient and reproducible##2##3##(2008-4#2)
efficient and robust##4##3##(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
efficient and useful##2##3##(1996-12#1)(2011-2#1)
efficient and##55##2##(1991-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#6)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
efficient approach##5##2##(1991-12#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-3#1)
efficient as##9##2##(1990-12#1)(1991-9#1)(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)
efficient at##7##2##(1992-11#1)(1994-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
efficient because##2##2##(2008-11#1)(2012-3#1)
efficient catalytic##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
efficient compared to##3##3##(1991-12#1)(2008-10#1)(2008-12#1)
efficient compared##4##2##(1991-12#1)(2008-10#2)(2008-12#1)
efficient computation of##2##3##(2008-3#1)(2011-2#1)
efficient computation##3##2##(2008-3#1)(2009-11#1)(2011-2#1)
efficient computational##2##2##(2008-3#1)(2012-2#1)
efficient coupling between##2##3##(2007-11#1)(2007-12#1)
efficient coupling##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
efficient degenerate four-wave mixing##3##4##(2007-12#3)
efficient delivery of DNA##2##4##(1994-5#1)(2008-11#1)
efficient delivery of##5##3##(1994-5#1)(1996-3#1)(2008-11#1)(2010-10#1)(2011-1#1)
efficient design##3##2##(1996-2#1)(2008-3#2)
efficient detection scheme##3##3##(2007-12#1)(2012-2#2)
efficient detection##4##2##(2007-12#1)(2008-10#1)(2012-2#2)
efficient device##2##2##(1996-12#1)(2008-11#1)
efficient digestion##2##2##(2008-10#1)(2012-2#1)
efficient diode-pumped##2##2##(2007-12#1)(2008-3#1)
efficient elimination of##2##3##(2008-10#2)
efficient energy##3##2##(2007-12#2)(2009-2#1)
efficient enough to##2##3##(1992-12#1)(2008-3#1)
efficient estimators##2##2##(2008-10#1)(2008-7#1)
efficient experimentation in a##2##4##(2008-10#2)
efficient expression of##3##3##(1990-5#2)(1991-5#1)
efficient expression##5##2##(1990-5#2)(1991-5#1)(1997-6#1)(2008-11#1)
efficient extraction of##3##3##(2008-10#2)(2008-7#1)
efficient extraction##6##2##(2008-10#4)(2008-7#1)(2012-1#1)
efficient for the##2##3##(2008-10#1)(2008-5#1)
efficient for##11##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
efficient frequency doubling##3##3##(2007-12#1)(2008-3#2)
efficient frequency tripling##2##3##(2007-12#2)
efficient frequency##7##2##(2007-11#1)(2007-12#4)(2008-3#2)
efficient gene transfer##3##3##(1995-12#1)(2008-11#1)(2008-9#1)
efficient gene##5##2##(1995-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
efficient generation of##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
efficient implementation of a fuzzy associative memory##2##7##(2007-12#2)
efficient implementation of##3##3##(2007-12#2)(2008-3#1)
efficient in the##5##3##(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#1)
efficient in vitro##2##3##(2008-11#1)(2013-1#1)
efficient in##29##2##(1990-8#1)(1991-11#1)(1992-8#1)(1995-3#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#3)(2009-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
efficient infection##2##2##(2008-10#1)(2008-11#1)
efficient inhibition##2##2##(2007-11#1)(2008-10#1)
efficient isolation of##2##3##(2008-4#1)(2008-9#1)
efficient isolation##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
efficient light##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
efficient magnetic##2##2##(2008-10#2)
efficient management of##2##3##(1992-2#1)(1995-2#1)
efficient management##3##2##(1992-2#1)(1995-2#1)(2008-12#1)
efficient manner##4##2##(2008-7#1)(2008-9#1)(2010-4#1)(2013-8#1)
efficient markers##2##2##(1993-11#1)(2008-5#1)
efficient means by which##2##4##(2008-10#1)(2008-2#1)
efficient means of##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2012-12#1)
efficient means##11##2##(1995-2#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2012-12#1)
efficient method for the preparation of##2##6##(1992-9#1)(2007-11#1)
efficient method for the##8##4##(1991-9#1)(1992-9#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-3#1)
efficient method for##18##3##(1991-12#1)(1991-9#1)(1992-9#1)(1995-6#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-5#1)(2010-3#1)
efficient method of##8##3##(2007-11#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
efficient method to##5##3##(1997-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
efficient method##38##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-9#1)(1992-9#1)(1995-6#1)(1997-8#1)(2007-11#5)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
efficient methods for##2##3##(2008-10#1)(2010-4#1)
efficient methods##4##2##(2008-10#1)(2008-4#1)(2010-4#1)(2011-7#1)
efficient operation##7##2##(1993-2#1)(2008-10#1)(2008-2#4)(2010-10#1)
efficient oxygen##2##2##(1996-2#1)(2012-2#1)
efficient photosensitizer##2##2##(1994-12#1)(2012-3#1)
efficient preparation of##2##3##(2007-11#1)(2008-11#1)
efficient procedure for the##3##4##(2008-11#1)(2008-3#1)(2009-12#1)
efficient procedure for##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
efficient procedure##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
efficient production of##4##3##(1994-2#1)(2008-10#1)(2008-6#1)(2011-3#1)
efficient production system##3##3##(2008-7#1)(2008-9#2)
efficient production##8##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-3#1)
efficient protein##4##2##(1991-12#1)(2008-11#2)(2008-7#1)
efficient protocol for##2##3##(2008-10#1)(2008-9#1)
efficient protocols##2##2##(2008-9#1)(2013-7#1)
efficient pump##2##2##(2007-11#1)(2007-12#1)
efficient pumping##3##2##(2008-2#1)(2008-3#2)
efficient purification of##3##3##(1991-5#1)(1995-5#1)(2008-4#1)
efficient radiative##2##2##(2008-2#2)
efficient removal of##4##3##(2008-10#2)(2011-1#1)(2013-1#1)
efficient sampling##4##2##(2008-10#3)(2013-7#1)
efficient screening##3##2##(1997-3#1)(2008-10#2)
efficient second-harmonic generation##3##3##(2007-11#2)(2007-12#1)
efficient second-harmonic##4##2##(2007-11#2)(2007-12#2)
efficient separation of##3##3##(1994-12#1)(1996-12#1)(2008-10#1)
efficient separation##7##2##(1994-12#1)(1996-12#1)(2008-10#4)(2008-7#1)
efficient simulation##2##2##(2008-2#1)(2009-5#1)
efficient social##2##2##(1997-2#1)(2009-7#1)
efficient solutions##2##2##(2007-12#1)(2013-1#1)
efficient strategies##2##2##(2009-4#1)(2010-11#1)
efficient substrate##2##2##(1993-3#1)(1994-6#1)
efficient synthesis of##3##3##(1996-5#1)(2008-11#1)(2013-1#1)
efficient system for the##2##4##(1990-5#1)(2008-11#1)
efficient system for##5##3##(1990-5#1)(1993-8#1)(2008-11#1)(2008-2#2)
efficient system##6##2##(1990-5#1)(1993-8#1)(1995-2#1)(2008-11#1)(2008-2#2)
efficient technique for the##6##4##(1994-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
efficient technique for##8##3##(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
efficient technique##9##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
efficient than are##2##3##(2008-10#1)(2008-3#1)
efficient than the##8##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-2#1)(2009-9#2)
efficient than##34##2##(1990-12#1)(1990-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
efficient third-harmonic generation##2##3##(2007-11#1)(2007-12#1)
efficient to##3##2##(1997-2#1)(2010-4#1)(2012-3#1)
efficient tool##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
efficient transcription##2##2##(1992-12#1)(1994-12#1)
efficient transduction##2##2##(1993-6#1)(1994-5#1)
efficient transmission##2##2##(2007-12#1)(2008-10#1)
efficient treatment##4##2##(1992-3#1)(1996-3#1)(2008-10#1)(2011-2#1)
efficient under##2##2##(2008-3#1)(2013-1#1)
efficient use of the##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
efficient use of##13##3##(1992-2#1)(1995-1#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2013-1#1)
efficient utilization of##4##3##(1994-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
efficient utilization##5##2##(1994-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)
efficient vectors of##3##3##(2008-10#3)
efficient vectors##4##2##(2008-10#4)
efficient viral##2##2##(1997-8#1)(2013-1#1)
efficient way for##2##3##(1997-4#1)(2010-8#1)
efficient way to##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
efficient way##9##2##(1997-4#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-11#1)(2010-8#1)
efficient when##3##2##(1992-3#1)(2008-10#2)
efficient with##2##2##(1991-9#1)(2008-3#1)
efficient##864##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#6)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-5#3)(1991-9#4)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#5)(1994-5#8)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#4)(1996-5#4)(1997-1#1)(1997-2#8)(1997-3#6)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#3)(2007-10#1)(2007-11#41)(2007-12#54)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#5)(2008-10#142)(2008-11#50)(2008-12#9)(2008-2#47)(2008-3#73)(2008-4#18)(2008-5#16)(2008-6#13)(2008-7#16)(2008-8#12)(2008-9#19)(2009-10#1)(2009-11#7)(2009-12#7)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#12)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#16)(2012-3#17)(2012-5#1)(2013-1#20)(2013-7#3)(2013-8#8)
efficiently and effectively##2##3##(1997-1#1)(2008-7#1)
efficiently and produce##2##3##(2008-10#1)(2009-8#1)
efficiently and##18##2##(1992-2#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
efficiently as the##2##3##(1994-8#1)(2008-11#1)
efficiently as##5##2##(1990-5#1)(1994-8#1)(1995-12#1)(2008-11#2)
efficiently at##2##2##(1993-6#1)(1997-6#1)
efficiently by the##3##3##(1996-1#1)(2008-10#2)
efficiently by##5##2##(1996-1#1)(2008-10#3)(2008-2#1)
efficiently converted into##2##3##(1994-8#1)(2007-11#1)
efficiently converted##3##2##(1990-7#1)(1994-8#1)(2007-11#1)
efficiently electrocatalytic oxidation for##2##4##(2008-10#2)
efficiently expressed##2##2##(2008-8#1)(2009-10#1)
efficiently extracted##3##2##(2008-10#3)
efficiently for##4##2##(1992-11#1)(1995-2#1)(2007-12#1)(2008-3#1)
efficiently generate##2##2##(2007-12#1)(2009-3#1)
efficiently in##6##2##(1991-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-3#1)(2013-1#1)
efficiently inhibited##2##2##(2010-1#1)(2013-1#1)
efficiently into##3##2##(2007-12#1)(2008-2#1)(2010-6#1)
efficiently processed##2##2##(1991-9#1)(1995-5#1)
efficiently produce##3##2##(2008-2#1)(2008-6#1)(2008-9#1)
efficiently produced by##2##3##(2008-11#1)(2008-7#1)
efficiently produced##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
efficiently secreted##5##2##(1991-6#1)(1992-8#1)(2008-8#3)
efficiently separated##3##2##(2008-10#2)(2008-5#1)
efficiently than##10##2##(1990-12#1)(1992-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
efficiently the##2##2##(2008-10#1)(2008-2#1)
efficiently through##2##2##(2007-12#1)(2008-10#1)
efficiently to##7##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#2)
efficiently transmitted##4##2##(2008-10#4)
efficiently used##5##2##(2008-11#1)(2008-12#1)(2008-4#2)(2009-7#1)
efficiently vectored by##2##3##(2008-10#2)
efficiently with the##5##3##(1991-7#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
efficiently with##10##2##(1990-5#1)(1991-7#1)(1993-2#1)(1994-5#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
efficiently##263##1##(1990-12#3)(1990-5#3)(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#1)(2007-11#9)(2007-12#9)(2008-1#3)(2008-10#46)(2008-11#15)(2008-12#3)(2008-2#12)(2008-3#8)(2008-4#9)(2008-5#10)(2008-6#7)(2008-7#6)(2008-8#9)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#7)(2011-2#5)(2011-3#4)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#8)(2013-7#1)
effluent and##3##2##(2008-10#3)
effluent concentration##2##2##(2008-10#1)(2008-12#1)
effluent discharge##2##2##(2008-6#1)(2013-1#1)
effluent for##2##2##(2008-10#1)(2008-12#1)
effluent from the##3##3##(2008-10#2)(2008-6#1)
effluent from##5##2##(2008-10#4)(2008-6#1)
effluent of a##2##3##(2008-10#2)
effluent of the##2##3##(2008-10#1)(2013-1#1)
effluent of##6##2##(1994-6#1)(2008-10#4)(2013-1#1)
effluent range and##2##3##(2008-10#2)
effluent samples##3##2##(2008-10#3)
effluent was mixed with the flow of##2##7##(2008-10#2)
effluent was##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
effluent water##2##2##(2008-10#2)
effluent##75##1##(1994-6#2)(1995-3#1)(1996-12#1)(2007-5#1)(2007-7#1)(2008-10#43)(2008-11#3)(2008-12#7)(2008-5#1)(2008-6#3)(2008-7#4)(2010-5#1)(2011-2#3)(2013-1#4)
effluents from##2##2##(2008-10#2)
effluents in the##2##3##(2008-10#1)(2008-5#1)
effluents in##4##2##(2008-10#3)(2008-5#1)
effluents of##4##2##(2007-7#1)(2008-10#2)(2008-11#1)
effluents should##2##2##(2008-5#1)(2013-1#1)
effluents##34##1##(2007-7#1)(2008-10#23)(2008-11#1)(2008-5#2)(2013-1#7)
effluvium##11##1##(2008-5#7)(2008-8#3)(2012-3#1)
efflux and##5##2##(1990-2#1)(1992-12#1)(1993-12#1)(2008-11#1)(2011-1#1)
efflux by##2##2##(1990-2#1)(1992-6#1)
efflux from the##2##3##(1990-12#1)(1996-7#1)
efflux from##12##2##(1990-12#3)(1990-2#4)(1991-3#1)(1992-12#1)(1994-11#1)(1996-7#1)(2012-12#1)
efflux in##8##2##(1990-2#1)(1993-12#1)(1994-11#1)(1994-3#3)(1994-8#1)(2011-1#1)
efflux is##3##2##(1993-12#2)(2011-1#1)
efflux of DA##2##3##(1992-7#2)
efflux of the##2##3##(1990-11#1)(2008-9#1)
efflux of##13##2##(1990-11#2)(1992-5#1)(1992-7#2)(1993-12#2)(1994-8#2)(1997-7#1)(2008-5#1)(2008-7#1)(2008-9#1)
efflux pump##4##2##(1994-5#1)(2007-2#1)(2008-11#1)(2008-8#1)
efflux rate##2##2##(1990-2#1)(1992-6#1)
efflux stimulating##2##2##(1992-12#2)
efflux systems##2##2##(1990-2#1)(2008-10#1)
efflux transporters##2##2##(2011-2#1)(2012-12#1)
efflux was inhibited by##2##4##(1990-2#1)(1994-3#1)
efflux was##6##2##(1990-2#2)(1994-11#1)(1994-3#3)
efflux with##2##2##(1994-3#1)(1994-8#1)
efflux##99##1##(1990-11#2)(1990-12#5)(1990-2#18)(1991-3#2)(1992-12#5)(1992-5#1)(1992-6#3)(1992-7#2)(1993-12#11)(1994-11#3)(1994-3#12)(1994-5#1)(1994-8#6)(1996-7#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#4)(2011-2#1)(2012-12#2)(2013-1#1)
effort also##2##2##(1991-4#1)(2013-1#1)
effort and##8##2##(2008-10#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
effort angina##2##2##(2008-12#1)(2008-7#1)
effort between##3##2##(1994-12#1)(2008-7#1)(2012-2#1)
effort by the##7##3##(1992-1#1)(1995-12#2)(1997-3#1)(2007-12#1)(2010-8#1)(2011-2#1)
effort by##11##2##(1992-1#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
effort for##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
effort had##2##2##(1993-12#1)(1997-7#1)
effort has been directed toward##2##5##(2008-7#1)(2011-2#1)
effort has been directed##3##4##(2008-1#1)(2008-7#1)(2011-2#1)
effort has been made to##2##5##(1995-2#1)(2009-8#1)
effort has been made##4##4##(1995-2#1)(1997-6#1)(2009-7#1)(2009-8#1)
effort has been##12##3##(1992-9#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
effort has##16##2##(1992-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
effort in##10##2##(1991-2#1)(1993-12#1)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#2)(2010-9#1)
effort is needed to##2##4##(1994-12#1)(2008-1#1)
effort is##10##2##(1991-3#1)(1994-12#1)(1994-2#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
effort must be##3##3##(1996-11#1)(2008-4#2)
effort of the##3##3##(1991-2#1)(1991-3#1)(2008-10#1)
effort of##7##2##(1991-2#1)(1991-3#2)(1993-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
effort on the##2##3##(1990-12#1)(1995-1#1)
effort required##3##2##(1995-1#1)(1997-3#1)(2008-3#1)
effort that##4##2##(1994-1#1)(1994-12#1)(2008-8#1)(2011-2#1)
effort to develop##8##3##(1995-2#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-9#1)(2013-1#1)
effort to ensure##2##3##(1993-2#1)(2010-3#1)
effort to establish the##2##4##(1995-2#1)(2008-3#1)
effort to establish##3##3##(1991-3#1)(1995-2#1)(2008-3#1)
effort to identify##6##3##(1993-2#1)(1995-11#2)(1997-1#1)(2008-11#1)(2013-1#1)
effort to improve##5##3##(1991-3#1)(1993-12#1)(1994-3#1)(2010-10#1)(2012-3#1)
effort to increase##4##3##(1997-3#1)(2008-8#1)(2010-8#1)(2013-1#1)
effort to investigate##2##3##(2012-3#2)
effort to maintain##2##3##(1996-12#1)(2011-2#1)
effort to make##2##3##(2008-3#1)(2008-7#1)
effort to prevent and##2##4##(2008-1#1)(2011-1#1)
effort to prevent##4##3##(2008-1#1)(2010-11#1)(2011-1#1)(2012-12#1)
effort to promote##2##3##(1995-2#1)(2013-1#1)
effort to reduce##2##3##(1996-12#1)(2012-12#1)
effort to understand##3##3##(2008-3#1)(2008-5#1)(2009-9#1)
effort to##112##2##(1990-11#1)(1990-6#1)(1991-1#2)(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1996-1#3)(1996-12#4)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#5)(2010-10#1)(2010-11#1)(2010-3#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#8)(2013-1#4)(2013-8#2)
effort toward##2##2##(1994-3#1)(1997-3#1)
effort towards##2##2##(2009-10#1)(2012-2#1)
effort was##5##2##(1990-6#1)(1991-6#1)(1993-12#1)(2008-8#2)
effort will##3##2##(1994-9#1)(1996-2#1)(2008-8#1)
effort with##2##2##(1992-1#1)(2010-5#1)
effort##300##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1991-1#2)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#2)(1994-1#2)(1994-12#6)(1994-2#3)(1994-3#8)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#1)(1995-6#1)(1996-1#5)(1996-11#2)(1996-12#6)(1996-2#7)(1996-3#2)(1996-5#1)(1997-1#5)(1997-2#2)(1997-3#5)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#17)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#18)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#1)(2010-3#4)(2010-5#5)(2010-8#4)(2010-9#7)(2011-1#1)(2011-2#11)(2011-9#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#6)
effortful and##2##2##(2009-8#2)
effortful control abilities##3##3##(2011-2#3)
effortful control##5##2##(2009-8#1)(2011-2#4)
effortful##9##1##(1995-12#1)(2009-8#3)(2011-2#4)(2012-3#1)
efforts aimed at##3##3##(2009-5#1)(2010-12#1)(2012-3#1)
efforts and##19##2##(1991-6#2)(1992-12#1)(1994-3#3)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-11#1)(2009-9#1)(2012-2#1)(2013-1#1)
efforts are being##2##3##(2008-5#1)(2010-8#1)
efforts are focused on##3##4##(1994-9#1)(2008-5#1)(2009-4#1)
efforts are focused##4##3##(1994-9#1)(2008-5#1)(2009-4#1)(2009-6#1)
efforts are needed to##4##4##(1996-2#1)(2007-12#1)(2008-1#1)(2008-8#1)
efforts are needed##6##3##(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-8#1)
efforts are underway to develop##3##5##(1993-11#1)(2008-8#1)(2012-2#1)
efforts are underway##4##3##(1993-11#1)(1997-3#1)(2008-8#1)(2012-2#1)
efforts are##29##2##(1993-11#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
efforts as##2##2##(1994-1#1)(2010-8#1)
efforts at##2##2##(1994-12#1)(2010-6#1)
efforts by the##3##3##(1991-6#1)(1993-12#1)(1993-3#1)
efforts by##4##2##(1991-6#1)(1993-12#1)(1993-3#1)(2008-10#1)
efforts during##2##2##(1991-3#1)(1994-12#1)
efforts focus on##3##3##(1994-12#1)(2011-1#1)(2012-1#1)
efforts focused on##4##3##(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
efforts for##7##2##(1996-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)
efforts from the##2##3##(2008-11#1)(2009-6#1)
efforts from##5##2##(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-3#1)
efforts has##2##2##(2007-6#1)(2009-5#1)
efforts have been directed towards##2##5##(2008-10#1)(2008-7#1)
efforts have been directed##3##4##(2008-10#1)(2008-7#1)(2009-12#1)
efforts have been focused##2##4##(2008-10#1)(2011-2#1)
efforts have been made to develop##2##6##(2008-11#1)(2008-3#1)
efforts have been made to##5##5##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
efforts have been made##6##4##(1990-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
efforts have been##18##3##(1990-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
efforts have often been##2##4##(1994-12#1)(2010-11#1)
efforts have##27##2##(1990-5#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-7#1)
efforts in the##6##3##(1993-2#1)(1994-9#1)(2009-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
efforts in this##2##3##(1995-1#1)(2008-11#1)
efforts in##18##2##(1992-12#1)(1993-2#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-4#1)(2011-3#1)(2012-2#3)(2013-8#1)
efforts may be##2##3##(1992-3#1)(2008-4#1)
efforts must be##2##3##(1992-9#1)(1994-5#1)
efforts of the government##2##4##(1994-7#1)(1995-3#1)
efforts of the##6##3##(1992-1#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-1#1)(2008-10#1)
efforts of##22##2##(1992-1#2)(1992-4#1)(1993-3#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-3#3)(1995-5#1)(1996-1#2)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
efforts on behalf of##2##4##(1992-1#1)(2013-7#1)
efforts on##8##2##(1992-1#1)(1996-3#1)(1997-1#1)(2006-10#1)(2008-7#1)(2009-7#1)(2010-5#1)(2013-7#1)
efforts provided##2##2##(1997-1#1)(2011-2#1)
efforts related to##2##3##(1995-12#1)(2008-10#1)
efforts should be directed##2##4##(1996-1#1)(2007-7#1)
efforts should be##5##3##(1996-1#1)(2007-7#1)(2012-3#1)(2013-1#2)
efforts that have been##2##4##(1996-1#1)(2009-12#1)
efforts that##3##2##(1996-1#1)(2009-12#1)(2010-12#1)
efforts to combat##2##3##(1990-11#1)(1996-11#1)
efforts to control##2##3##(1995-1#1)(1997-1#1)
efforts to deal with##2##4##(1994-2#1)(2009-4#1)
efforts to develop a##4##4##(1993-6#1)(1996-3#1)(2008-11#1)(2009-6#1)
efforts to develop##9##3##(1993-6#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#1)
efforts to educate the##3##4##(1994-1#2)(1994-5#1)
efforts to educate##4##3##(1994-1#2)(1994-5#1)(2007-2#1)
efforts to explore the##2##4##(2008-5#1)(2013-7#1)
efforts to identify##2##3##(2007-12#1)(2008-4#1)
efforts to implement##2##3##(1994-1#1)(1995-2#1)
efforts to improve quality should be##2##6##(1995-3#1)(2013-1#1)
efforts to improve##10##3##(1993-3#1)(1994-2#1)(1995-3#2)(2007-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
efforts to increase the##2##4##(2008-10#1)(2008-4#1)
efforts to increase##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
efforts to maximize##2##3##(1994-3#1)(2010-5#1)
efforts to prevent##3##3##(1991-9#1)(1996-11#1)(2008-11#1)
efforts to provide##2##3##(1997-3#1)(2010-12#1)
efforts to quit##2##3##(2010-2#2)
efforts to reduce##2##3##(2008-11#1)(2011-1#1)
efforts to refine##2##3##(1994-7#1)(2010-11#1)
efforts to transfer##2##3##(1997-7#1)(2008-12#1)
efforts to understand##2##3##(2009-9#1)(2013-1#1)
efforts to##127##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#6)(1997-1#1)(1997-3#2)(1997-7#2)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#12)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
efforts towards##2##2##(2008-11#1)(2013-8#1)
efforts were made to##2##4##(1993-3#1)(2008-10#1)
efforts were##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#2)
efforts within the##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
efforts##438##1##(1990-11#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#3)(1992-3#3)(1992-4#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#1)(1994-1#8)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#2)(1994-7#2)(1994-9#4)(1995-1#5)(1995-11#1)(1995-12#9)(1995-2#5)(1995-3#9)(1995-5#4)(1995-9#1)(1996-1#12)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#10)(1996-6#1)(1996-9#1)(1997-1#11)(1997-2#3)(1997-3#6)(1997-4#1)(1997-7#3)(1997-9#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#4)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#29)(2008-11#24)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#10)(2008-7#6)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-8#7)(2011-1#3)(2011-10#1)(2011-2#15)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#18)(2012-3#11)(2013-1#15)(2013-7#3)(2013-8#2)
efforts?##3##1##(1994-9#1)(2013-1#2)
effusion and##8##2##(2007-12#1)(2007-8#1)(2008-10#2)(2009-3#2)(2010-5#1)(2012-3#1)
effusion in HVD##2##3##(2008-7#2)
effusion in##10##2##(2008-5#2)(2008-7#4)(2010-12#1)(2011-2#1)(2013-8#2)
effusion is a##2##3##(1991-6#1)(2011-2#1)
effusion is##4##2##(1991-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
effusion with##3##2##(2007-12#1)(2009-7#1)(2010-5#1)
effusion##75##1##(1991-12#4)(1991-6#1)(1992-2#2)(1997-3#1)(1997-4#3)(1997-8#1)(2007-12#5)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#1)(2009-3#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#4)(2011-2#4)(2012-3#1)(2013-1#8)(2013-8#10)
effusions and##2##2##(2007-12#1)(2011-2#1)
effusions of##2##2##(1992-2#1)(1994-8#1)
effusions##14##1##(1990-2#1)(1991-6#2)(1992-2#3)(1994-8#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
effusive pericarditis##2##2##(2007-8#2)
effusive##4##1##(1992-8#1)(2007-8#2)(2013-1#1)
efp##5##1##(1997-7#3)(2008-10#2)
efrapeptin##2##1##(2008-9#2)
efrapeptins##2##1##(2008-9#2)
eg##5##1##(2008-5#2)(2008-6#1)(2009-12#1)(2010-4#1)
egalitarian##3##1##(2009-7#1)(2013-1#1)(2013-8#1)
egg activation and##2##3##(2008-9#2)
egg activation in insects##2##4##(2008-9#2)
egg activation in##3##3##(2008-9#3)
egg activation##10##2##(2008-9#10)
egg and##5##2##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)
egg can##2##2##(2008-9#1)(2011-2#1)
egg capsule##6##2##(2007-12#1)(2008-12#5)
egg cell##10##2##(1991-5#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)
egg counting##2##2##(2008-5#2)
egg counts##4##2##(1996-12#3)(2008-10#1)
egg densities##2##2##(2008-10#1)(2011-2#1)
egg drop syndrome##3##3##(1997-7#1)(2008-8#2)
egg extract##3##2##(1993-2#1)(2008-1#1)(2008-8#1)
egg extracts cell-free##2##3##(2008-8#2)
egg extracts##4##2##(1993-2#1)(2008-8#2)(2008-9#1)
egg fertilization and##3##3##(1994-11#1)(2008-8#2)
egg hatch##2##2##(2008-10#2)
egg hatching and##2##3##(2008-11#1)(2008-5#1)
egg in##2##2##(1997-6#1)(2008-8#1)
egg is##2##2##(2007-12#1)(2008-12#1)
egg jelly##5##2##(1992-8#4)(1994-11#1)
egg layers##2##2##(2008-3#1)(2008-9#1)
egg laying habits and impact of##2##6##(2009-5#2)
egg laying##8##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-5#4)
egg limitation##3##2##(2008-8#1)(2008-9#2)
egg masses##7##2##(2008-10#4)(2010-8#3)
egg maturation##3##2##(2008-8#1)(2008-9#2)
egg membranes##2##2##(1993-6#1)(1997-6#1)
egg phosphatidylcholine vesicles##2##3##(1990-2#1)(2008-10#1)
egg phosphatidylcholine##4##2##(1990-2#2)(1997-7#1)(2008-10#1)
egg population##2##2##(2008-10#2)
egg product##3##2##(1990-6#1)(2011-2#2)
egg production for##2##3##(2008-12#1)(2008-8#1)
egg production##14##2##(1997-6#1)(2008-11#1)(2008-12#5)(2008-3#1)(2008-5#1)(2008-8#2)(2010-2#1)(2012-2#1)(2013-1#1)
egg quality##3##2##(2012-2#3)
egg recovery##3##2##(1996-12#3)
egg samples##2##2##(2008-10#2)
egg shedding##3##2##(1996-12#2)(2008-5#1)
egg size and##3##3##(1991-5#1)(2008-8#1)(2010-8#1)
egg size in##4##3##(1991-5#2)(2008-8#2)
egg size##19##2##(1991-5#5)(2008-12#1)(2008-8#10)(2008-9#1)(2010-8#2)
egg was##2##2##(2008-9#2)
egg weight##2##2##(2010-2#1)(2012-2#1)
egg white and##2##3##(2008-10#2)
egg white proteins##2##3##(2010-4#1)(2013-1#1)
egg white##12##2##(1994-8#1)(1997-2#1)(2008-10#5)(2008-7#1)(2010-4#1)(2012-12#2)(2013-1#1)
egg yolk cholesterol##2##3##(2010-2#2)
egg yolk##13##2##(1990-11#1)(1991-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#4)(2012-12#1)(2012-3#2)
egg##265##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-6#1)(1991-11#1)(1991-5#7)(1991-8#2)(1991-9#1)(1992-3#1)(1992-8#4)(1993-2#2)(1993-6#4)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-12#8)(1997-2#1)(1997-6#3)(1997-7#2)(2007-11#1)(2007-12#9)(2008-1#1)(2008-10#35)(2008-11#9)(2008-12#24)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#32)(2008-9#32)(2009-12#1)(2009-4#1)(2009-5#4)(2010-2#8)(2010-4#1)(2010-8#14)(2011-1#1)(2011-2#8)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#3)
egg-shaped asymmetric resonant cavities##2##4##(2007-11#2)
egg-shaped##3##1##(2007-11#3)
eggerthii##3##1##(1997-2#3)
eggfish##6##1##(2010-8#6)
eggplant##11##1##(2008-10#10)(2008-7#1)
eggs a##2##2##(1991-4#1)(2008-8#1)
eggs among##2##2##(2008-12#1)(2008-8#1)
eggs and larvae##2##3##(2008-8#1)(2013-1#1)
eggs and second-stage juveniles##2##4##(2008-10#2)
eggs and sperm##2##3##(2008-11#1)(2009-2#1)
eggs and##29##2##(1993-6#2)(1996-12#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-5#3)(2008-8#3)(2009-2#1)(2010-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
eggs are##3##2##(1991-5#1)(1997-6#1)(2008-5#1)
eggs as##2##2##(2008-8#1)(2008-9#1)
eggs at##3##2##(2008-5#1)(2008-6#1)(2010-8#1)
eggs containing##2##2##(2008-10#1)(2008-9#1)
eggs from##3##2##(2008-10#2)(2008-6#1)
eggs in the##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
eggs in##19##2##(1993-12#1)(1996-12#4)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2013-1#2)
eggs is##3##2##(1993-6#1)(2008-6#1)(2010-10#1)
eggs laid##3##2##(1995-2#1)(2008-3#1)(2013-7#1)
eggs of H##6##3##(2008-10#6)
eggs of the##4##3##(1993-6#1)(2007-10#1)(2007-12#1)(2008-5#1)
eggs of##18##2##(1993-6#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-5#1)
eggs or##3##2##(1991-5#1)(2008-9#1)(2010-8#1)
eggs per##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
eggs produced##2##2##(2010-8#1)(2012-12#1)
eggs that##2##2##(1991-5#1)(2008-10#1)
eggs through##2##2##(1993-6#1)(2007-12#1)
eggs to##4##2##(1991-5#1)(2008-10#1)(2008-9#1)(2009-2#1)
eggs using##2##2##(1996-12#1)(2008-10#1)
eggs were##5##2##(1996-12#2)(1997-6#1)(2008-10#1)(2008-12#1)
eggs which##3##2##(1993-6#1)(1996-12#1)(2008-12#1)
eggs with##4##2##(1997-6#1)(2008-5#1)(2008-8#1)(2010-10#1)
eggs##239##1##(1991-4#1)(1991-5#5)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#10)(1994-11#1)(1994-7#2)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#14)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(2007-10#1)(2007-12#6)(2007-6#2)(2008-1#1)(2008-10#45)(2008-11#7)(2008-12#11)(2008-3#3)(2008-4#2)(2008-5#21)(2008-6#5)(2008-8#25)(2008-9#17)(2009-2#3)(2009-4#1)(2010-10#9)(2010-2#2)(2010-5#2)(2010-8#8)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#7)(2013-7#2)(2013-8#1)
eggs)##2##1##(2008-8#2)
eggs/female##2##1##(2008-12#2)
eggshell membrane##4##2##(2008-10#4)
eggshell##6##1##(2007-12#2)(2008-10#4)
egl1##5##1##(2008-10#5)
egocentric and##2##2##(1994-3#1)(2013-1#1)
egocentric##8##1##(1994-3#4)(1994-8#1)(2013-1#3)
egress from##3##2##(2009-6#1)(2010-11#2)
egress##9##1##(1996-12#2)(2007-12#1)(2008-10#1)(2009-6#1)(2010-11#2)(2013-1#2)
egression##3##1##(2008-10#3)
ehrlichia chaffeensis&quot##2##2##(2013-1#2)
eicosanoid production##2##2##(1991-5#1)(1991-8#1)
eicosanoid release##2##2##(1991-5#2)
eicosanoid synthesis##3##2##(1992-12#1)(1995-11#2)
eicosanoid##11##1##(1991-5#4)(1991-8#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-11#2)
eicosanoids##8##1##(1994-2#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#4)
eicosapentaenoic acid (EPA) and##2##4##(2008-11#1)(2010-1#1)
eicosapentaenoic acid##4##2##(2008-11#2)(2008-3#1)(2010-1#1)
eicosapentaenoic acid-ethyl ester##2##3##(1991-2#2)
eicosapentaenoic##7##1##(1991-2#2)(2008-11#2)(2008-3#1)(2010-1#1)(2011-2#1)
eigenmode##2##1##(2007-11#1)(2008-3#1)
eigenmodes of##2##2##(2007-11#1)(2008-2#1)
eigenmodes##14##1##(1992-8#1)(2007-11#3)(2007-12#1)(2008-2#5)(2008-3#4)
eigenpolarizations##2##1##(2007-11#1)(2008-2#1)
eigenstates of##3##2##(2007-12#1)(2008-3#2)
eigenstates##10##1##(2007-12#2)(2008-2#1)(2008-3#7)
eigenvalue equation##2##2##(2007-12#1)(2008-3#1)
eigenvalue##6##1##(2007-12#1)(2008-3#5)
eigenvalues##4##1##(2008-2#1)(2008-3#2)(2013-1#1)
eigenvalues/eigenvectors##2##1##(2007-11#2)
eigenvector##4##1##(1992-6#1)(2008-2#3)
eigenvectors are##2##2##(2008-2#2)
eigenvectors of##2##2##(2008-6#1)(2009-9#1)
eigenvectors##8##1##(2007-12#3)(2008-2#3)(2008-6#1)(2009-9#1)
eight (9%)##2##2##(1996-9#1)(1997-3#1)
eight Ac elements##2##3##(2012-3#2)
eight Ac##3##2##(2012-3#3)
eight P##2##2##(2008-10#2)
eight SeaWiFS bands##2##3##(2008-3#2)
eight amino##2##2##(1994-5#1)(1997-9#1)
eight and##2##2##(1997-3#1)(1997-5#1)
eight animals##4##2##(1995-5#3)(1996-12#1)
eight cases of##2##3##(2008-5#1)(2011-2#1)
eight cases##7##2##(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)
eight cell##2##2##(2008-10#1)(2008-11#1)
eight channels##2##2##(2008-2#1)(2008-9#1)
eight clades##2##2##(2008-10#2)
eight clones##2##2##(2008-10#2)
eight components##2##2##(1997-3#1)(2008-10#1)
eight compounds##2##2##(2008-10#1)(2011-3#1)
eight consecutive##2##2##(2007-8#1)(2008-10#1)
eight different##15##2##(1993-12#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#1)
eight distinct##2##2##(1991-9#1)(1994-8#1)
eight dogs##3##2##(1992-5#2)(2012-1#1)
eight domains##2##2##(2010-10#1)(2013-1#1)
eight episodes of##2##3##(1993-1#1)(2008-1#1)
eight exons##2##2##(1993-12#1)(1997-7#1)
eight families##3##2##(1992-2#1)(1992-7#1)(2008-12#1)
eight females##2##2##(2008-5#1)(2008-7#1)
eight fold##3##2##(2007-7#1)(2008-2#1)(2009-10#1)
eight fragments were##2##3##(2008-8#2)
eight fragments##3##2##(2008-8#3)
eight genes##2##2##(1994-12#1)(2008-10#1)
eight groups that##2##3##(2008-10#1)(2010-4#1)
eight groups##3##2##(1992-9#1)(2008-10#1)(2010-4#1)
eight health##2##2##(2008-4#1)(2010-10#1)
eight healthy##6##2##(1992-11#1)(2008-3#2)(2008-5#2)(2012-2#1)
eight hours##2##2##(2008-11#1)(2008-5#1)
eight identified##2##2##(2008-10#1)(2010-12#1)
eight in##2##2##(1995-8#1)(1997-2#1)
eight isolates##5##2##(2007-12#1)(2008-10#4)
eight known##2##2##(1997-3#1)(2009-5#1)
eight major##2##2##(2008-10#1)(2009-10#1)
eight months later##2##3##(2013-1#1)(2013-8#1)
eight months of##2##3##(2008-3#1)(2008-6#1)
eight months##7##2##(1992-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
eight normal subjects##2##3##(1996-5#2)
eight normal##3##2##(1996-2#1)(1996-5#2)
eight of nine##2##3##(2008-10#1)(2008-7#1)
eight of the nine##2##4##(1997-3#1)(2008-7#1)
eight of the##7##3##(1992-3#1)(1993-12#1)(1996-2#1)(1997-3#1)(2008-5#1)(2008-7#2)
eight of them presented##2##4##(2008-4#1)(2008-7#1)
eight of them were##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
eight of them##6##3##(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#1)
eight of whom##2##3##(2007-7#1)(2008-6#1)
eight of##23##2##(1992-3#1)(1993-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2011-1#1)(2013-1#1)
eight or##2##2##(2008-3#1)(2008-9#1)
eight organic##2##2##(1992-3#1)(2008-10#1)
eight other isolates##2##3##(2008-10#2)
eight other##6##2##(1993-2#2)(2008-10#4)
eight out of##2##3##(1994-2#1)(2008-10#1)
eight pairs##2##2##(1995-3#1)(2008-10#1)
eight patients received##2##3##(2008-7#1)(2008-9#1)
eight patients treated##2##3##(1990-11#1)(2008-6#1)
eight patients with chronic##2##4##(1992-11#1)(2008-5#1)
eight patients with spontaneous##2##4##(2011-2#2)
eight patients with##12##3##(1990-12#1)(1990-3#1)(1992-11#1)(1992-6#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
eight patients##39##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-1#1)(1994-9#2)(1995-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#4)(2010-1#2)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#1)
eight percent of##2##3##(2013-1#2)
eight percent##4##2##(2012-3#1)(2013-1#3)
eight phthalates##2##2##(2008-10#2)
eight potential##2##2##(2008-5#1)(2008-8#1)
eight previously##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
eight primer pairs##2##3##(2008-10#2)
eight primer##3##2##(2008-10#3)
eight race clusters##2##3##(2008-10#2)
eight regions##2##2##(2008-10#1)(2011-2#1)
eight repeated##2##2##(2008-3#1)(2013-1#1)
eight replicate##6##2##(2008-10#6)
eight residues##2##2##(1990-2#1)(1990-5#1)
eight restriction enzymes##2##3##(2008-10#2)
eight samples##2##2##(1996-12#1)(2008-10#1)
eight sampling##2##2##(2008-10#1)(2013-7#1)
eight separate##2##2##(2008-3#1)(2008-4#1)
eight silt loams##2##3##(2008-10#2)
eight species of##2##3##(2008-10#2)
eight species##6##2##(2008-10#2)(2008-12#1)(2013-7#3)
eight strains using##2##3##(2008-10#2)
eight strains##3##2##(2008-10#3)
eight subjects##3##2##(1994-8#1)(1997-7#2)
eight times##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
eight to##4##2##(1992-1#1)(1992-3#1)(1997-5#1)(2012-3#1)
eight trees##2##2##(2008-10#2)
eight variables##3##2##(2008-10#3)
eight week##2##2##(2007-5#1)(2012-2#1)
eight weeks##9##2##(1990-11#1)(1992-5#1)(2007-7#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
eight were##4##2##(1990-11#1)(1997-8#1)(2008-1#1)(2011-2#1)
eight women##4##2##(1992-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
eight year old##2##3##(2007-7#1)(2013-1#1)
eight years of##2##3##(2012-3#1)(2013-1#1)
eight years##13##2##(1994-12#1)(1995-1#1)(1997-2#2)(2006-10#1)(2008-1#2)(2008-2#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
eight##589##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-12#6)(1993-2#4)(1993-6#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#2)(1995-8#1)(1996-12#7)(1996-2#3)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#11)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#5)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#7)(2007-5#1)(2007-7#8)(2007-8#7)(2008-1#12)(2008-10#164)(2008-11#9)(2008-12#10)(2008-2#6)(2008-3#15)(2008-4#8)(2008-5#25)(2008-6#13)(2008-7#23)(2008-8#8)(2008-9#14)(2009-10#4)(2009-12#2)(2009-4#3)(2009-5#3)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#3)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#21)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#12)(2013-1#15)(2013-7#9)(2013-8#3)
eight-channel##3##1##(2008-3#1)(2008-9#2)
eight-element##2##1##(2008-2#2)
eight-fold##2##1##(1997-2#1)(2008-10#1)
eight-week##5##1##(1990-2#1)(2009-11#1)(2011-1#3)
eight-year average##2##2##(1996-12#2)
eight-year##3##1##(1996-12#2)(2013-8#1)
eighteen##18##1##(1992-3#1)(1993-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#3)(2013-1#1)
eighteenth##5##1##(2008-10#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-2#1)
eighteenth-century##2##1##(2011-2#2)
eightfold##9##1##(1995-2#1)(1997-7#1)(2008-10#5)(2011-1#1)(2011-2#1)
eighth in##3##2##(1992-2#1)(2008-3#1)(2010-3#1)
eighth##22##1##(1992-2#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#4)(2013-1#1)
eighth-order super-Gaussian intensity##2##3##(2008-3#2)
eighties##6##1##(1991-4#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-4#1)(2012-12#1)
eights (Experiment##2##2##(2008-4#2)
eighty seven##2##2##(1997-4#1)(2008-1#1)
eighty##8##1##(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-1#2)
ein2-1 and##2##2##(2008-10#1)(2009-8#1)
ein2-1 plants##2##2##(2008-10#2)
ein2-1##8##1##(2008-10#7)(2009-8#1)
either &quot##5##2##(1991-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2011-1#1)
either (a)##2##2##(2008-5#1)(2013-8#1)
either 0##7##2##(1992-9#1)(1993-1#1)(1997-4#4)(2008-10#1)
either 1 or##2##3##(1992-10#1)(2008-10#1)
either 1##5##2##(1992-10#1)(1995-11#1)(1995-5#1)(2008-10#1)(2011-2#1)
either 1% ketoconazole##2##3##(2008-5#2)
either 1%##3##2##(2008-5#3)
either 10##3##2##(1994-6#1)(1995-6#1)(2009-7#1)
either 100##2##2##(1990-12#1)(2008-5#1)
either 2##3##2##(1990-11#1)(2008-5#1)(2013-1#1)
either 4##2##2##(1996-12#1)(2008-12#1)
either A##2##2##(1997-5#1)(2008-10#1)
either ACh or (1S##3##4##(1996-5#3)
either B##2##2##(1992-8#1)(2008-10#1)
either C##3##2##(2007-12#1)(2008-10#2)
either P##4##2##(2008-10#4)
either RNA or DNA##2##4##(1992-3#1)(2008-4#1)
either S##3##2##(1995-5#1)(2008-10#1)(2009-2#1)
either VUV light or Ar atoms##2##6##(2010-4#2)
either a placebo##3##3##(2008-5#2)(2012-2#1)
either a slow##2##3##(1992-5#1)(2007-12#1)
either a synthetic##2##3##(1994-5#1)(2008-3#1)
either a##103##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-4#3)(1997-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#3)(2008-9#5)(2009-12#2)(2009-2#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
either absent or##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
either absent##4##2##(2008-10#1)(2008-7#2)(2008-8#1)
either activate or##2##3##(1992-6#1)(2008-4#1)
either acute##2##2##(1995-5#1)(2009-10#1)
either aerobic or##2##3##(1995-6#1)(2013-1#1)
either after##3##2##(1991-8#1)(1994-9#1)(2013-1#1)
either age##2##2##(1990-3#1)(2008-7#1)
either agent alone##2##3##(1990-8#1)(1997-1#1)
either agent##5##2##(1990-11#1)(1990-8#1)(1997-1#1)(2009-5#1)(2009-6#1)
either all##5##2##(2008-10#1)(2010-6#1)(2012-12#1)(2013-8#2)
either alone or in combination with##7##6##(1994-8#1)(1997-6#1)(2007-3#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
either alone or in combination##10##5##(1994-8#1)(1997-6#1)(2007-3#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
either alone or in concert with##2##6##(2008-10#1)(2008-11#1)
either alone or in##13##4##(1994-8#1)(1997-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
either alone or##14##3##(1994-8#1)(1997-6#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
either alone##16##2##(1994-8#2)(1997-6#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
either an experimental##2##3##(2007-11#2)
either an increase##2##3##(2008-8#1)(2008-9#1)
either an##29##2##(1992-5#1)(1994-3#1)(1994-5#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
either are##2##2##(2007-11#1)(2008-9#1)
either as a##8##3##(1990-11#1)(1996-11#1)(2008-10#2)(2008-6#1)(2008-9#2)(2011-1#1)
either as acute or chronic in these nations##2##8##(2013-1#2)
either as##20##2##(1990-11#1)(1994-8#1)(1996-11#1)(1997-7#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2011-1#1)(2013-1#3)
either aspirin or clopidogrel##2##4##(2009-5#2)
either assay##2##2##(2008-10#2)
either assembly##2##2##(1997-3#1)(2011-2#1)
either at the##3##3##(1995-3#1)(1997-2#1)(2010-4#1)
either at##11##2##(1993-6#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-8#1)(2010-4#1)
either autologous##2##2##(1995-2#1)(2007-9#1)
either basal##2##2##(1990-12#1)(1997-4#1)
either based on##2##3##(2008-4#1)(2009-9#1)
either be##3##2##(2008-7#1)(2008-8#2)
either because##2##2##(2008-11#1)(2008-5#1)
either before or after##5##4##(1991-2#1)(1992-2#1)(1993-12#1)(2008-10#1)(2008-9#1)
either before or##6##3##(1991-2#1)(1992-2#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-9#1)
either between##5##2##(1990-3#1)(1991-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
either blood##2##2##(1994-6#1)(1996-6#1)
either by a##2##3##(2008-3#1)(2008-4#1)
either by an##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
either by chemical##2##3##(1990-5#1)(1993-3#1)
either by the##3##3##(2007-12#1)(2007-7#1)(2008-5#1)
either by using##3##3##(2008-10#2)(2008-7#1)
either by##94##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#2)(1994-1#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
either case the##3##3##(1995-5#1)(2008-10#1)(2011-1#1)
either case##8##2##(1995-5#1)(2008-10#4)(2008-7#1)(2009-4#1)(2011-1#1)
either caused##2##2##(2008-10#1)(2013-1#1)
either cell##3##2##(1991-9#1)(1993-9#1)(1997-7#1)
either color##2##2##(1995-5#1)(2012-2#1)
either conventional##2##2##(1995-2#1)(2008-10#1)
either coronary mortality##2##3##(2009-9#2)
either could##2##2##(2008-11#1)(2010-3#1)
either decreased or##2##3##(1993-1#1)(2008-10#1)
either decreased##3##2##(1993-1#1)(2008-10#2)
either diagnostic or##2##3##(1990-2#1)(2008-11#1)
either did not##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
either direct or indirect##2##4##(2008-9#1)(2009-9#1)
either direct or##3##3##(2008-1#1)(2008-9#1)(2009-9#1)
either direct##6##2##(2008-1#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)
either directly or indirectly##5##4##(1991-1#1)(1996-2#1)(2008-10#1)(2008-6#1)(2009-8#1)
either directly or##7##3##(1991-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-8#1)
either directly##17##2##(1991-1#1)(1991-12#1)(1996-2#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-6#1)(2012-2#1)
either disease##2##2##(2008-10#1)(2011-2#1)
either do not##4##3##(1993-11#1)(2007-2#1)(2008-10#1)(2013-8#1)
either drug alone##2##3##(2011-10#1)(2012-12#1)
either drug##3##2##(2008-7#1)(2011-10#1)(2012-12#1)
either due to##3##3##(2008-1#1)(2008-8#1)(2013-1#1)
either due##4##2##(1996-9#1)(2008-1#1)(2008-8#1)(2013-1#1)
either during##2##2##(1993-1#1)(2013-1#1)
either end of the molecule##2##5##(1996-7#1)(2008-8#1)
either end of the##5##4##(1994-8#1)(1995-2#1)(1996-7#1)(2008-3#1)(2008-8#1)
either end##6##2##(1994-8#1)(1995-2#1)(1996-7#1)(2008-11#1)(2008-3#1)(2008-8#1)
either enhance or##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
either enhance##5##2##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2011-2#1)
either enzyme##4##2##(1990-11#1)(1990-8#1)(1993-9#1)(2008-7#1)
either expensive##2##2##(2008-2#2)
either for##10##2##(1990-6#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-3#1)(2010-7#1)
either form##2##2##(1995-5#1)(2008-7#1)
either from the##6##3##(1991-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)
either from##13##2##(1991-3#1)(1994-5#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)
either fungus##3##2##(2008-10#3)
either gene##2##2##(1993-9#1)(1997-5#1)
either glucagon or dexamethasone##2##4##(1990-7#2)
either group##15##2##(1993-9#1)(1994-12#1)(1995-12#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-7#1)(2011-1#1)
either had##4##2##(2008-1#1)(2008-10#2)(2010-4#1)
either have##3##2##(1994-11#1)(2008-5#2)
either having##2##2##(2008-10#1)(2008-7#1)
either hemisphere##2##2##(2008-11#1)(2011-2#1)
either high or low##4##4##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
either high##9##2##(1995-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
either homophilic or heterophilic interactions of the CArG box binding factors##2##11##(1993-8#2)
either host##2##2##(2008-10#2)
either human##4##2##(2008-4#2)(2008-7#1)(2013-1#1)
either immediately##2##2##(1997-4#1)(2012-7#1)
either in a##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
either in blood or##2##4##(1990-2#1)(2006-10#1)
either in pure form or in pharmaceutical formulations##2##8##(2008-10#2)
either in terms of##3##4##(1993-9#1)(1997-8#1)(2013-7#1)
either in the presence or absence of##2##7##(1993-8#1)(2008-10#1)
either in the##18##3##(1991-12#1)(1992-5#1)(1993-10#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
either in vitro or in vivo##2##6##(1992-6#1)(1997-4#1)
either in vivo or in##2##5##(2008-4#2)
either in##62##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
either increase or decrease##3##4##(2008-3#1)(2008-7#1)(2010-12#1)
either increase##4##2##(1996-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
either increased or decreased##2##4##(1991-9#1)(2008-10#1)
either increased or##4##3##(1991-9#1)(1997-1#1)(2008-10#2)
either increased##5##2##(1991-9#1)(1997-1#1)(2008-10#2)(2008-8#1)
either increasing the##2##3##(2008-9#1)(2011-1#1)
either increasing##3##2##(1995-3#1)(2008-9#1)(2011-1#1)
either injured##2##2##(1993-12#1)(2008-4#1)
either instrument##2##2##(2008-10#1)(2013-1#1)
either intact##2##2##(1993-8#1)(2008-11#1)
either internal or external##2##4##(1990-2#1)(2008-7#1)
either internal##4##2##(1990-2#2)(1992-12#1)(2008-7#1)
either large##2##2##(1994-2#1)(2008-8#1)
either limited##2##2##(2008-9#1)(2012-2#1)
either local##3##2##(1990-11#1)(1995-5#1)(1997-5#1)
either locally or##2##3##(1997-3#1)(2012-2#1)
either low##2##2##(1990-7#1)(2008-10#1)
either maize##2##2##(2008-10#2)
either maternal##2##2##(1996-12#1)(2007-12#1)
either metal##2##2##(1995-2#1)(2008-10#1)
either method##4##2##(2007-7#1)(2008-4#1)(2010-7#2)
either more##4##2##(1994-12#1)(2008-10#1)(2010-11#1)(2012-6#1)
either natural##2##2##(2007-11#1)(2009-3#1)
either no or only##2##4##(2008-3#1)(2008-8#1)
either no or##3##3##(2008-3#1)(2008-8#1)(2010-1#1)
either no##8##2##(1995-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-4#1)
either normal or##3##3##(1990-2#1)(1993-12#1)(2008-3#1)
either normal saline##2##3##(2008-9#1)(2010-7#1)
either normal##5##2##(1990-2#1)(1993-12#1)(2008-3#1)(2008-9#1)(2010-7#1)
either not##5##2##(1992-3#1)(2007-7#1)(2008-10#1)(2008-7#2)
either of the other##2##4##(1993-11#1)(2008-8#1)
either of the two##9##4##(1991-12#2)(1994-8#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2012-2#1)
either of the##30##3##(1990-11#1)(1991-1#1)(1991-12#3)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#3)(2012-2#1)
either of these##6##3##(1991-9#1)(1994-2#1)(1994-8#1)(1996-2#1)(2008-10#1)(2011-10#1)
either of two##4##3##(1993-11#1)(1997-7#1)(2008-10#2)
either of##51##2##(1990-11#1)(1990-3#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-9#2)(1992-6#1)(1993-11#2)(1993-12#1)(1994-2#2)(1994-8#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-2#1)
either on the##2##3##(2008-10#1)(2008-4#1)
either on##12##2##(1991-8#1)(1994-1#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#2)
either one of the##2##4##(1997-3#1)(2008-7#1)
either one of two##3##4##(1990-12#2)(1997-3#1)
either one of##6##3##(1990-12#2)(1997-3#2)(2008-5#1)(2008-7#1)
either one or both##2##4##(1993-8#1)(2008-1#1)
either one or##3##3##(1991-5#1)(1993-8#1)(2008-1#1)
either one##15##2##(1990-12#2)(1991-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
either or both##2##3##(2008-10#1)(2008-4#1)
either or##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
either pH##2##2##(2008-10#1)(2010-12#1)
either parent##5##2##(2008-10#5)
either partially##3##2##(1993-8#1)(2008-4#1)(2012-3#1)
either placebo or##4##3##(1992-8#1)(2008-5#1)(2008-6#1)(2010-1#1)
either positive##3##2##(1994-1#1)(1997-3#1)(2008-8#1)
either positively or negatively##2##4##(2008-10#1)(2008-4#1)
either positively##3##2##(2008-10#2)(2008-4#1)
either primary or secondary##2##4##(1990-8#1)(1991-2#1)
either procedure##3##2##(1996-8#1)(2008-10#1)(2008-4#1)
either program##2##2##(1996-1#1)(1997-2#1)
either promoting##2##2##(2008-3#1)(2009-3#1)
either recombinant##3##2##(1995-6#2)(2007-7#1)
either red##2##2##(1990-12#1)(1992-12#1)
either reduced##3##2##(1996-12#1)(2008-11#1)(2008-7#1)
either resistance##2##2##(2008-10#2)
either risk##2##2##(2008-11#1)(2013-8#1)
either separately##2##2##(1994-6#1)(2008-11#1)
either sex##6##2##(1994-2#1)(1996-5#1)(2007-12#1)(2008-8#1)(2010-4#1)(2010-7#1)
either sexual##2##2##(1991-6#1)(2013-7#1)
either side of##13##3##(1991-5#1)(1996-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-8#1)(2013-7#1)
either side##17##2##(1991-5#1)(1993-12#1)(1996-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)(2013-7#1)
either single##2##2##(1992-3#1)(2008-5#1)
either sodium##2##2##(2008-10#2)
either specific##3##2##(2008-10#2)(2008-12#1)
either spontaneously or##2##3##(1997-2#1)(2009-8#1)
either strain##4##2##(1996-12#1)(2008-10#2)(2008-9#1)
either strand##2##2##(1990-11#1)(1992-3#1)
either subconjunctivally or##2##3##(2008-12#2)
either temperature##2##2##(2007-12#1)(2008-3#1)
either ten or##2##3##(1993-12#1)(1996-12#1)
either that##7##2##(1990-8#1)(1992-11#1)(1992-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
either the European or##2##4##(2008-10#2)
either the T##2##3##(1990-8#1)(2008-10#1)
either the active##2##3##(1997-6#1)(2008-11#1)
either the input or the output##2##6##(2008-2#2)
either the net##2##3##(2008-3#1)(2008-9#1)
either the posterior cutaneous##2##4##(1997-3#2)
either the presence of##2##4##(1995-9#1)(2007-10#1)
either the presence##3##3##(1995-9#1)(2007-10#1)(2008-7#1)
either the rate##2##3##(1991-5#1)(2008-8#1)
either the same##2##3##(1994-8#1)(2008-4#1)
either the skin##2##3##(2008-10#1)(2008-5#1)
either the##166##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#3)(1994-5#3)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#9)(2008-2#6)(2008-3#10)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#4)
either their##3##2##(2008-2#1)(2009-2#1)(2009-5#1)
either through the##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
either through##10##2##(1990-7#1)(1994-11#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)
either to the##6##3##(1990-5#1)(1991-8#1)(1991-9#1)(1997-7#1)(2008-10#1)(2008-7#1)
either to##23##2##(1990-5#1)(1991-8#1)(1991-9#1)(1993-10#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
either total##3##2##(1990-7#1)(2012-12#1)(2013-1#1)
either towards a##2##3##(1994-10#1)(2008-11#1)
either treated##3##2##(1991-11#1)(1995-8#1)(2007-10#1)
either treatment##5##2##(2008-10#2)(2008-3#1)(2009-8#1)(2013-1#1)
either two##2##2##(1997-7#1)(2011-2#1)
either under isothermal or under heating conditions##2##7##(2008-10#2)
either under##5##2##(2007-11#1)(2008-10#3)(2011-1#1)
either untreated##2##2##(1992-3#1)(2008-8#1)
either upstream or downstream##2##4##(1992-3#1)(2012-2#1)
either very##3##2##(1996-5#1)(2008-10#1)(2013-8#1)
either via the##2##3##(2007-12#1)(2010-5#1)
either via##4##2##(1997-7#1)(2007-12#1)(2008-4#1)(2010-5#1)
either virulent##3##2##(2008-10#2)(2008-5#1)
either visual##2##2##(2008-10#1)(2011-2#1)
either when##3##2##(2008-2#1)(2008-8#1)(2012-2#1)
either wild type##2##3##(1995-11#1)(2008-11#1)
either wild-type##2##2##(1997-7#1)(2008-11#1)
either with or without##4##4##(2006-5#1)(2008-10#1)(2008-5#2)
either with##23##2##(1990-10#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-5#1)(1994-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
either##2059##1##(1990-10#1)(1990-11#15)(1990-12#11)(1990-2#8)(1990-3#5)(1990-5#12)(1990-6#2)(1990-7#11)(1990-8#9)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#14)(1991-2#7)(1991-3#7)(1991-5#9)(1991-6#4)(1991-7#2)(1991-8#10)(1991-9#12)(1992-1#3)(1992-10#5)(1992-11#10)(1992-12#6)(1992-2#2)(1992-3#21)(1992-4#1)(1992-5#8)(1992-6#8)(1992-7#1)(1992-8#7)(1992-9#5)(1993-1#8)(1993-10#3)(1993-11#14)(1993-12#17)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#10)(1993-8#10)(1993-9#12)(1994-1#4)(1994-10#1)(1994-11#9)(1994-12#11)(1994-2#10)(1994-3#12)(1994-5#9)(1994-6#10)(1994-7#3)(1994-8#20)(1994-9#2)(1995-1#1)(1995-11#15)(1995-12#9)(1995-2#23)(1995-3#10)(1995-4#1)(1995-5#20)(1995-6#17)(1995-8#6)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#19)(1996-2#8)(1996-3#7)(1996-4#2)(1996-5#18)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#14)(1997-3#16)(1997-4#24)(1997-5#6)(1997-6#10)(1997-7#18)(1997-8#4)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#8)(2007-11#22)(2007-12#30)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#10)(2007-9#2)(2008-1#15)(2008-10#365)(2008-11#60)(2008-12#22)(2008-2#45)(2008-3#72)(2008-4#67)(2008-5#56)(2008-6#28)(2008-7#73)(2008-8#46)(2008-9#57)(2009-1#1)(2009-10#9)(2009-11#3)(2009-12#8)(2009-2#4)(2009-3#7)(2009-4#1)(2009-5#10)(2009-6#7)(2009-7#4)(2009-8#9)(2009-9#9)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#9)(2010-2#6)(2010-3#9)(2010-4#10)(2010-5#7)(2010-6#6)(2010-7#7)(2010-8#10)(2011-1#28)(2011-10#2)(2011-2#54)(2012-1#6)(2012-12#21)(2012-2#30)(2012-3#18)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#50)(2013-7#5)(2013-8#22)
ejaculate##6##1##(1991-11#1)(1997-8#3)(2009-4#1)(2013-1#1)
ejaculated##2##1##(2007-12#1)(2013-1#1)
ejaculates##2##1##(1991-6#1)(2012-3#1)
ejaculation and##3##2##(1991-2#2)(1991-6#1)
ejaculation##19##1##(1991-2#5)(1991-6#1)(1992-12#3)(1994-2#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-8#3)(2010-11#1)
ejaculatory duct##8##2##(2007-12#2)(2008-7#5)(2010-11#1)
ejaculatory sperm##4##2##(2008-12#4)
ejaculatory##16##1##(1997-8#3)(2007-12#2)(2008-12#4)(2008-7#5)(2009-5#1)(2010-11#1)
ejected##4##1##(2008-1#1)(2008-10#2)(2008-8#1)
ejection fraction and fractional fiber shortening##2##6##(2012-2#2)
ejection fraction and##6##3##(1993-2#2)(2009-5#1)(2012-2#2)(2013-1#1)
ejection fraction was##3##3##(1997-5#1)(2008-12#1)(2011-2#1)
ejection fraction##39##2##(1990-9#1)(1993-2#2)(1995-3#1)(1997-3#1)(1997-5#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#5)(2009-5#1)(2010-6#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
ejection of##3##2##(1994-11#1)(1997-7#2)
ejection pattern of ascospores##2##4##(2008-10#2)
ejection##57##1##(1990-9#2)(1993-2#2)(1994-11#5)(1995-3#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-7#2)(2007-8#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#7)(2009-11#1)(2009-5#1)(2010-6#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
el##2##1##(2011-2#1)(2013-1#1)
elaborate on##3##2##(2008-3#2)(2012-12#1)
elaborate##27##1##(1992-2#1)(1992-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#2)(2010-2#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#1)
elaborated a##3##2##(1992-2#1)(1996-12#1)(2013-1#1)
elaborated and##2##2##(2008-9#1)(2011-2#1)
elaborated as##2##2##(2008-10#1)(2008-5#1)
elaborated by##6##2##(1990-11#1)(1994-2#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-12#1)
elaborated for##3##2##(2008-10#3)
elaborated from##3##2##(1990-11#1)(2008-10#1)(2010-8#1)
elaborated in##2##2##(2011-1#1)(2012-12#1)
elaborated on##3##2##(2008-12#1)(2010-5#1)(2010-8#1)
elaborated upon##3##2##(1990-2#1)(2010-12#1)(2012-2#1)
elaborated with##3##2##(2008-10#2)(2008-2#1)
elaborated##50##1##(1990-11#2)(1990-2#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#2)(1994-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
elaborates on##2##2##(1991-6#1)(1994-12#1)
elaborates##5##1##(1991-6#1)(1993-1#1)(1994-12#1)(1994-3#1)(2008-5#1)
elaborating##4##1##(1994-5#1)(2008-10#2)(2008-7#1)
elaboration and##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
elaboration of##18##2##(1992-2#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-3#1)
elaboration procedure##2##2##(2008-2#2)
elaboration##33##1##(1991-3#1)(1992-2#1)(1994-3#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2012-12#1)(2012-3#2)
elafin##3##1##(1992-6#3)
elapsed between the##2##3##(1993-3#1)(2008-11#1)
elapsed between##3##2##(1993-3#1)(1996-3#1)(2008-11#1)
elapsed from the##2##3##(2008-10#1)(2008-11#1)
elapsed from##3##2##(1996-9#1)(2008-10#1)(2008-11#1)
elapsed since##3##2##(1993-6#1)(2007-5#1)(2008-2#1)
elapsed##13##1##(1993-3#1)(1993-6#1)(1994-2#1)(1996-3#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2010-12#1)(2011-2#1)
elasmobranchs##2##1##(1995-12#1)(2008-11#1)
elastase (PPE)##5##2##(1991-3#1)(1991-9#1)(2008-5#3)
elastase activity##6##2##(2008-5#3)(2008-7#3)
elastase and cathepsin G##3##4##(1991-9#1)(2008-6#1)(2008-7#1)
elastase and##7##2##(1991-9#1)(1992-8#1)(1994-5#1)(2008-5#2)(2008-6#1)(2008-7#1)
elastase by##2##2##(1993-8#1)(1995-2#1)
elastase in##2##2##(1990-2#1)(1993-9#1)
elastase is##2##2##(1994-6#1)(2008-5#1)
elastase or##3##2##(1990-12#1)(1993-6#1)(1994-5#1)
elastase##54##1##(1990-12#1)(1990-2#3)(1991-12#1)(1991-3#2)(1991-9#3)(1992-12#4)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-5#4)(1994-6#2)(1995-2#2)(1995-6#1)(2008-5#18)(2008-6#1)(2008-7#5)(2008-8#1)
elastase-induced##2##1##(1992-12#1)(2013-1#1)
elastic and##5##2##(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)
elastic backscatter##2##2##(2008-3#2)
elastic bandage##2##2##(1992-6#1)(2010-3#1)
elastic constants and##2##3##(1995-3#1)(2009-4#1)
elastic deformation##2##2##(2009-5#2)
elastic distortions##2##2##(2012-2#2)
elastic energy storage##2##3##(2007-12#2)
elastic energy##3##2##(2007-12#2)(2008-7#1)
elastic fiber##2##2##(2008-5#1)(2010-4#1)
elastic fibers##4##2##(1992-12#1)(2007-8#1)(2010-4#1)(2012-2#1)
elastic fibres##2##2##(2008-5#2)
elastic light scattering##3##3##(2008-3#3)
elastic moduli##3##2##(2009-7#2)(2010-4#1)
elastic modulus K##2##3##(2008-9#2)
elastic modulus and##3##3##(2010-10#1)(2012-2#2)
elastic modulus of the##2##4##(2009-7#1)(2010-4#1)
elastic modulus of##6##3##(1996-12#1)(2009-7#1)(2010-4#2)(2010-8#1)(2010-9#1)
elastic modulus##21##2##(1996-12#1)(2008-9#2)(2009-7#5)(2010-10#2)(2010-4#4)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#2)
elastic nail##3##2##(2012-2#3)
elastic properties of##6##3##(2008-10#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-8#1)
elastic properties##9##2##(2008-10#1)(2009-7#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2013-8#1)
elastic recoil and##2##3##(1991-12#1)(2013-7#1)
elastic recoil##7##2##(1991-12#1)(1992-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2013-1#1)(2013-7#1)
elastic scattering##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
elastic stiffness##2##2##(1992-7#1)(2009-7#1)
elastic tissue##2##2##(2009-7#1)(2010-8#1)
elastic tubes##3##2##(2011-1#1)(2012-1#1)(2012-2#1)
elastic##126##1##(1990-3#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-5#1)(1995-3#1)(1996-12#1)(1996-4#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#13)(2008-5#13)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#3)(2009-5#3)(2009-7#12)(2009-9#2)(2010-10#2)(2010-3#2)(2010-4#12)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#11)(2013-1#3)(2013-7#2)(2013-8#1)
elastic-backscatter lidar##4##2##(2008-2#1)(2008-3#3)
elastic-scattering##2##1##(2008-3#2)
elastica##2##1##(2007-8#1)(2008-12#1)
elastically##6##1##(1995-3#1)(1996-4#1)(2008-3#3)(2011-1#1)
elasticities##3##1##(1990-7#2)(1993-3#1)
elasticity and##11##2##(1992-5#1)(2008-10#1)(2008-5#4)(2009-4#2)(2009-7#1)(2011-2#1)(2012-2#1)
elasticity in##2##2##(1990-7#1)(2013-8#1)
elasticity is##4##2##(2008-5#3)(2013-8#1)
elasticity of the##7##3##(1992-11#1)(1994-3#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
elasticity of##10##2##(1992-11#1)(1994-3#2)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
elasticity on##2##2##(2008-3#1)(2009-9#1)
elasticity##72##1##(1990-7#1)(1992-11#1)(1992-5#1)(1993-3#1)(1994-3#2)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#21)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#5)(2013-8#10)
elastin and collagen##2##3##(2008-5#1)(2009-7#1)
elastin and##4##2##(1992-12#1)(2008-5#2)(2009-7#1)
elastin degradation (E##2##3##(2009-7#2)
elastin degradation##3##2##(2009-7#3)
elastin gene expression by##2##4##(1994-6#2)
elastin gene expression##3##3##(1994-6#3)
elastin peptides##2##2##(2008-7#2)
elastin##39##1##(1990-7#2)(1990-8#3)(1991-9#2)(1992-12#1)(1994-6#6)(2008-3#2)(2008-5#11)(2008-6#2)(2008-7#4)(2009-7#6)
elastins##2##1##(1991-9#2)
elastodynamic##2##1##(1996-4#2)
elastofibroma##4##1##(1991-6#2)(2009-4#2)
elastographic imaging##3##2##(2010-8#3)
elastography##6##1##(2009-4#1)(2009-9#1)(2010-8#3)(2012-2#1)
elastolytic##4##1##(1991-9#1)(1993-8#1)(2008-7#1)(2010-9#1)
elastomer##6##1##(1995-6#1)(2008-3#1)(2008-5#3)(2009-7#1)
elastomeric impression after##2##3##(2008-12#2)
elastomeric seals##2##2##(1996-1#1)(1996-2#1)
elastomeric##11##1##(1996-1#1)(1996-2#1)(2008-12#3)(2008-3#4)(2009-5#1)(2010-3#1)
elastomers##2##1##(2008-10#2)
elastosis##2##1##(2011-2#2)
elatius##8##1##(1996-5#1)(2008-10#7)
elav##2##1##(1994-12#1)(2008-10#1)
elbow and wrist joints##2##4##(1995-6#1)(2007-8#1)
elbow and wrist##3##3##(1995-6#1)(2007-8#1)(2008-12#1)
elbow and##4##2##(1995-6#1)(1997-6#1)(2007-8#1)(2008-12#1)
elbow ankylosis##2##2##(2011-2#2)
elbow flexion##8##2##(2008-9#8)
elbow is##3##2##(2008-12#1)(2008-8#2)
elbow joint and##2##3##(2007-8#1)(2008-9#1)
elbow joint##4##2##(2007-8#1)(2008-5#1)(2008-9#2)
elbow pain##2##2##(2008-12#1)(2008-8#1)
elbow##56##1##(1992-5#1)(1995-1#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-1#4)(2008-12#3)(2008-5#1)(2008-6#1)(2008-8#7)(2008-9#20)(2010-11#1)(2011-2#8)(2013-1#3)
elbows and##3##2##(1995-6#1)(2008-3#1)(2008-7#1)
elbows##5##1##(1995-6#1)(1996-9#1)(2006-10#1)(2008-3#1)(2008-7#1)
elder abuse##5##2##(1991-1#3)(1991-2#2)
elder##12##1##(1991-1#3)(1991-2#2)(1994-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-3#2)
elderly Australian veterans##2##3##(2011-2#2)
elderly Chinese##2##2##(1992-3#1)(2008-7#1)
elderly Medicare##3##2##(1991-1#1)(1993-12#1)(1997-2#1)
elderly adults who were enrolled in##2##6##(2012-12#2)
elderly adults##9##2##(2008-3#2)(2011-2#2)(2012-12#4)(2013-1#1)
elderly and disabled##2##3##(1995-3#1)(1996-1#1)
elderly and frail##2##3##(1994-1#1)(2013-8#1)
elderly and the##2##3##(1992-1#1)(2008-11#1)
elderly and##35##2##(1991-3#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-6#4)(1995-1#1)(1995-3#1)(1996-1#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2009-7#1)(2010-12#1)(2011-1#4)(2012-3#1)(2013-1#1)(2013-8#1)
elderly are##10##2##(1990-11#1)(1990-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
elderly atherosclerotic patients##2##3##(2008-7#2)
elderly care##4##2##(1993-12#2)(2008-7#1)(2012-12#1)
elderly clients##3##2##(1991-12#1)(1994-1#2)
elderly control subjects##2##3##(2008-7#2)
elderly controls##4##2##(1994-8#2)(2008-7#2)
elderly diabetic men##2##3##(2008-7#2)
elderly diabetics##5##2##(2008-7#1)(2008-9#4)
elderly female patients##2##3##(1990-2#1)(1991-5#1)
elderly female##4##2##(1990-2#1)(1991-5#1)(1993-6#1)(2012-2#1)
elderly in a##2##3##(2008-7#1)(2011-1#1)
elderly in##16##2##(1991-2#1)(1993-3#2)(1995-5#1)(2007-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
elderly individuals who##2##3##(2007-12#1)(2013-8#1)
elderly individuals##9##2##(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-6#1)(2013-8#3)
elderly inpatients##2##2##(2007-1#1)(2008-7#1)
elderly institutionalised##3##2##(2008-7#1)(2011-2#2)
elderly institutionalized##2##2##(1997-8#1)(2008-7#1)
elderly is##3##2##(2008-2#1)(2008-7#1)(2009-1#1)
elderly man##2##2##(2007-7#2)
elderly men and women with##2##5##(1992-2#1)(2008-3#1)
elderly men and##3##3##(1992-2#1)(1992-9#1)(2008-3#1)
elderly men##6##2##(1992-2#1)(1992-9#1)(2008-3#1)(2008-7#1)(2011-2#2)
elderly or##2##2##(1994-6#1)(1995-11#1)
elderly participants##4##2##(1993-12#1)(1995-2#1)(2012-1#1)(2013-1#1)
elderly patient and##2##3##(1992-1#1)(2013-1#1)
elderly patient##14##2##(1990-11#1)(1992-1#2)(1992-3#1)(1993-11#1)(1996-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2013-1#1)(2013-8#1)
elderly patients and##4##3##(1996-5#1)(2008-7#3)
elderly patients are##2##3##(1993-11#1)(2008-4#1)
elderly patients in##3##3##(1990-5#1)(1992-1#1)(1996-11#1)
elderly patients suffering from##4##4##(1991-11#1)(1993-9#1)(2008-7#2)
elderly patients with silent##2##4##(2008-7#2)
elderly patients with##27##3##(1990-2#1)(1990-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1996-7#2)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#13)(2008-8#1)(2011-2#1)
elderly patients##94##2##(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-12#1)(1994-3#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#2)(1997-2#1)(1997-8#2)(2007-11#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#32)(2008-8#2)(2009-8#1)(2009-9#1)(2011-2#7)(2012-12#1)(2012-3#2)(2013-8#1)
elderly people in##3##3##(1992-1#1)(2011-1#2)
elderly people with##2##3##(2011-1#1)(2012-3#1)
elderly people##23##2##(1990-3#2)(1991-11#1)(1992-1#1)(1994-3#1)(1994-9#1)(1995-3#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#9)(2011-2#2)(2012-3#1)
elderly person##5##2##(2008-11#1)(2008-6#2)(2012-3#2)
elderly persons##15##2##(1990-3#1)(1994-1#5)(1994-6#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-6#2)
elderly population and##2##3##(1991-3#1)(1996-3#1)
elderly population in##3##3##(2008-7#1)(2012-12#2)
elderly population##34##2##(1990-3#1)(1991-3#1)(1992-12#1)(1993-3#2)(1994-6#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#11)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
elderly residents##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)
elderly stroke survivors##2##3##(2007-10#2)
elderly subjects in##2##3##(2008-10#1)(2008-7#1)
elderly subjects were##2##3##(2008-7#2)
elderly subjects##20##2##(1993-1#1)(1993-9#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#11)(2013-1#1)
elderly survivors##2##2##(2012-1#2)
elderly volunteers##4##2##(2007-11#1)(2008-5#3)
elderly who are##2##3##(1992-2#1)(2012-2#1)
elderly who##3##2##(1992-2#1)(2008-2#1)(2012-2#1)
elderly with and without osteoporosis##2##5##(2010-3#2)
elderly with##10##2##(1991-2#1)(1991-6#1)(1997-2#1)(2008-7#2)(2010-3#4)(2012-3#1)
elderly women##15##2##(1990-9#1)(1991-4#2)(1991-8#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#3)
elderly##645##1##(1990-10#1)(1990-11#2)(1990-2#5)(1990-3#8)(1990-5#3)(1990-6#4)(1990-9#3)(1991-1#3)(1991-11#3)(1991-12#5)(1991-2#6)(1991-3#7)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#7)(1992-12#2)(1992-2#5)(1992-3#6)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#8)(1993-11#4)(1993-12#13)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#1)(1993-9#5)(1994-1#17)(1994-12#9)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#13)(1994-8#2)(1994-9#1)(1995-1#7)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#6)(1995-5#2)(1995-8#4)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#7)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#5)(2006-10#4)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#4)(2007-7#8)(2007-8#7)(2008-1#11)(2008-10#6)(2008-11#11)(2008-12#8)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#9)(2008-6#11)(2008-7#114)(2008-8#15)(2008-9#6)(2009-1#3)(2009-10#2)(2009-12#4)(2009-5#3)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#17)(2011-2#38)(2011-7#1)(2012-1#6)(2012-12#14)(2012-2#5)(2012-3#13)(2013-1#13)(2013-8#11)
elderly--ten##2##1##(2008-7#1)(2011-2#1)
elders in the##2##3##(2010-4#2)
elders in##4##2##(2010-4#4)
elders##17##1##(1992-2#1)(1993-12#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#5)(2012-12#1)(2012-2#1)(2013-1#1)
eldest##3##1##(2007-7#1)(2008-10#2)
elected euthanasia##2##2##(2013-8#2)
elected in##2##2##(2008-7#2)
elected officials##3##2##(1995-6#2)(2008-6#1)
elected to##5##2##(1991-3#1)(1995-1#2)(2008-6#1)(2012-12#1)
elected##29##1##(1991-1#1)(1991-3#1)(1995-1#2)(1995-6#2)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-6#2)(2008-7#3)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#3)
electing to##2##2##(1994-12#1)(2012-1#1)
election of##2##2##(2008-2#1)(2008-5#1)
election##10##1##(1990-3#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)
elections##3##1##(1995-3#1)(2008-4#1)(2008-7#1)
elective abdominal##2##2##(1992-6#2)
elective cesarean section##7##3##(1997-8#1)(2011-2#5)(2013-1#1)
elective coronary artery bypass grafting##2##5##(2007-8#2)
elective hip##2##2##(1990-6#1)(2013-1#1)
elective hospital##2##2##(1991-11#1)(1996-3#1)
elective lumbar spine surgery##4##4##(2012-12#4)
elective operations and##2##3##(1991-5#1)(1997-8#1)
elective operations##5##2##(1991-5#1)(1992-5#1)(1997-8#3)
elective orthopaedic patients##2##3##(2007-10#2)
elective orthopaedic##4##2##(2007-10#4)
elective surgery##17##2##(1990-11#2)(1990-2#1)(1992-5#1)(1995-1#1)(1996-3#1)(1996-9#1)(2006-12#1)(2008-7#1)(2010-7#2)(2010-8#3)(2012-1#1)(2012-2#1)(2013-1#1)
elective treatment##2##2##(2008-7#1)(2011-2#1)
elective##96##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#3)(1992-5#3)(1992-6#3)(1993-10#1)(1993-3#1)(1995-1#2)(1996-12#4)(1996-3#2)(1996-9#3)(1997-2#2)(1997-8#5)(2006-12#1)(2007-10#4)(2007-11#1)(2007-8#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2010-11#1)(2010-7#2)(2010-8#8)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#8)
electivity##2##1##(2010-8#2)
electocatalytic##2##1##(2008-10#2)
electric activity of##2##3##(1991-5#1)(2010-6#1)
electric activity##4##2##(1990-3#1)(1991-5#1)(2008-11#1)(2010-6#1)
electric arc furnace##2##3##(2008-10#1)(2013-1#1)
electric birefringence##2##2##(1990-7#2)
electric changes##2##2##(1993-8#2)
electric charge##3##2##(2008-4#1)(2008-5#2)
electric current density##2##3##(2013-1#2)
electric current##8##2##(1996-4#1)(1996-8#1)(2007-12#1)(2008-10#2)(2013-1#3)
electric currents##2##2##(1996-4#1)(2008-10#1)
electric dipole##3##2##(1997-6#1)(2007-12#2)
electric discharge machining##2##3##(2012-2#2)
electric discharge##3##2##(2008-7#1)(2012-2#2)
electric eel##3##2##(2008-10#2)(2009-8#1)
electric field and##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
electric field applied##3##3##(1990-8#1)(2007-11#1)(2008-2#1)
electric field by##3##3##(2008-3#2)(2009-12#1)
electric field change##3##3##(2007-12#2)(2008-3#1)
electric field distribution##2##3##(2008-3#2)
electric field during##2##3##(1990-12#1)(2008-3#1)
electric field envelope##3##3##(2008-3#3)
electric field in the##3##4##(2008-3#2)(2013-8#1)
electric field in##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2013-8#1)
electric field of a##2##4##(2007-12#2)
electric field of an##2##4##(2007-11#1)(2008-2#1)
electric field of##10##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
electric field strength and##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
electric field strength of##2##4##(2008-10#2)
electric field strength##8##3##(2007-12#1)(2008-10#5)(2008-3#2)
electric field to##2##3##(2008-10#1)(2008-2#1)
electric field was##2##3##(2007-11#1)(2008-9#1)
electric field##111##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-9#1)(1995-12#1)(1996-12#3)(1997-6#1)(2007-11#14)(2007-12#22)(2008-10#13)(2008-11#4)(2008-2#9)(2008-3#26)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#2)(2010-4#1)(2013-8#3)
electric fields in##4##3##(1997-6#2)(2007-11#1)(2008-3#1)
electric fields of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
electric fields##17##2##(1997-6#3)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
electric fish##5##2##(1996-5#1)(2009-8#2)(2010-8#2)
electric injury##3##2##(2008-7#3)
electric organ discharge##2##3##(2009-8#1)(2010-8#1)
electric organ##4##2##(1993-3#1)(2009-8#2)(2010-8#1)
electric parameters##3##2##(1997-6#3)
electric potential##4##2##(1996-8#1)(2008-10#2)(2008-6#1)
electric power##2##2##(2008-2#1)(2008-3#1)
electric properties##2##2##(1997-6#1)(2008-8#1)
electric shock##6##2##(1994-5#1)(1994-8#1)(1996-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
electric##223##1##(1990-12#1)(1990-3#1)(1990-7#4)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#2)(1996-8#3)(1997-2#1)(1997-6#10)(2007-11#16)(2007-12#28)(2007-8#2)(2008-1#2)(2008-10#26)(2008-11#7)(2008-2#14)(2008-3#34)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#10)(2009-12#3)(2009-8#5)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#5)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#4)
electric-field distribution at the##2##4##(2008-2#2)
electric-field##20##1##(2007-11#1)(2007-12#12)(2008-2#6)(2008-3#1)
electric-field-induced##6##1##(2007-11#2)(2007-12#3)(2008-3#1)
electric-power##2##1##(2008-3#2)
electric-power-sensing system##2##2##(2008-3#2)
electrical activity of##4##3##(1994-2#1)(1996-2#1)(2009-8#1)(2010-8#1)
electrical activity was##2##3##(1991-12#1)(1996-2#1)
electrical activity##21##2##(1990-7#1)(1991-12#1)(1994-2#1)(1994-3#1)(1996-2#4)(2008-1#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#6)(2013-8#1)
electrical and mechanical##6##3##(1994-3#1)(2008-10#3)(2008-7#1)(2010-8#1)
electrical and##13##2##(1994-3#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-8#1)
electrical auditory##2##2##(2008-9#2)
electrical breakdown##3##2##(1990-11#1)(1991-5#2)
electrical capacitance##2##2##(2008-5#2)
electrical cardioversion##2##2##(2013-1#1)(2013-8#1)
electrical characteristics##2##2##(1992-6#1)(2008-10#1)
electrical characterization of##2##3##(2009-11#2)
electrical charge##3##2##(2008-10#2)(2009-8#1)
electrical circuits##2##2##(2008-2#2)
electrical conductivity and##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
electrical conductivity of##2##3##(2008-10#1)(2012-2#1)
electrical conductivity##14##2##(2008-10#4)(2008-11#2)(2008-2#2)(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
electrical contact with##2##3##(2008-10#1)(2008-7#1)
electrical contact##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
electrical coupling##3##2##(2008-11#1)(2008-3#1)(2010-11#1)
electrical current##6##2##(1997-6#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-8#1)
electrical detection of##2##3##(2008-10#2)
electrical devices##2##2##(1992-3#1)(2008-7#1)
electrical discharge##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
electrical engineering##2##2##(2008-2#1)(2012-2#1)
electrical enrichment##2##2##(2008-10#2)
electrical events##3##2##(1994-5#2)(2010-8#1)
electrical field stimulation (EFS)##2##4##(1996-5#1)(1997-4#1)
electrical field stimulation##3##3##(1995-12#1)(1996-5#1)(1997-4#1)
electrical field##11##2##(1990-5#1)(1993-12#1)(1995-12#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
electrical impedance tomography##2##3##(2011-2#2)
electrical injury##5##2##(1994-5#5)
electrical insulation##2##2##(2008-10#1)(2009-11#1)
electrical isolation of##2##3##(2008-11#1)(2011-2#1)
electrical isolation##4##2##(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#1)
electrical measurements##4##2##(1996-4#1)(2007-12#1)(2008-7#1)(2010-12#1)
electrical memory##2##2##(2009-8#2)
electrical nerve stimulation##3##3##(1995-12#3)
electrical nerve##4##2##(1995-12#3)(2010-1#1)
electrical potential##5##2##(2008-10#2)(2008-12#1)(2008-9#1)(2012-1#1)
electrical potentials##2##2##(1995-2#2)
electrical power##2##2##(2008-3#2)
electrical properties of the##2##4##(2008-10#1)(2008-5#1)
electrical properties of##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2013-8#1)
electrical properties##8##2##(2008-10#1)(2008-5#1)(2009-11#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
electrical pulse##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
electrical pulses##4##2##(2007-11#3)(2009-11#1)
electrical recordings##2##2##(1997-7#1)(2013-1#1)
electrical requirements##2##2##(2010-9#2)
electrical resistance in##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
electrical resistance##15##2##(1994-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-9#1)(2009-11#1)(2011-2#2)(2013-1#1)
electrical resistivity##4##2##(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
electrical shock##3##2##(1994-5#3)
electrical signals##6##2##(2007-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#1)
electrical stimulation and##3##3##(1993-12#1)(2007-8#1)(2009-10#1)
electrical stimulation applied##2##3##(1992-11#1)(2009-10#1)
electrical stimulation for##2##3##(2008-1#1)(2010-10#1)
electrical stimulation may##2##3##(2008-1#1)(2008-9#1)
electrical stimulation of the SLN and##2##6##(1993-12#2)
electrical stimulation of the auditory##3##5##(2008-9#1)(2010-7#2)
electrical stimulation of the##23##4##(1990-5#1)(1990-7#3)(1990-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#9)(1994-2#1)(1996-2#2)(2008-9#1)(2010-7#2)
electrical stimulation of##28##3##(1990-5#1)(1990-7#3)(1990-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#9)(1993-3#1)(1994-2#1)(1995-12#1)(1996-2#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-7#2)
electrical stimulation on##3##3##(1992-8#1)(2008-9#1)(2012-1#1)
electrical stimulation was##2##3##(1990-5#1)(1994-2#1)
electrical stimulation##69##2##(1990-5#4)(1990-7#3)(1990-9#1)(1992-11#2)(1992-3#1)(1992-8#2)(1993-12#11)(1993-3#1)(1994-2#3)(1994-6#1)(1995-12#2)(1996-2#4)(1996-5#1)(1996-6#1)(1997-6#1)(2007-10#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-2#2)
electrical stimuli##3##2##(2008-1#1)(2008-9#1)(2009-8#1)
electrical stunning##6##2##(1990-9#3)(2010-2#1)(2011-1#2)
electrical trauma##3##2##(1994-5#3)
electrical##352##1##(1990-11#1)(1990-5#6)(1990-7#4)(1990-9#4)(1991-12#1)(1991-5#2)(1992-11#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#12)(1993-3#1)(1994-2#4)(1994-3#2)(1994-5#16)(1994-6#2)(1994-8#2)(1995-12#6)(1995-2#3)(1996-12#1)(1996-2#8)(1996-4#2)(1996-5#3)(1996-6#1)(1997-4#2)(1997-6#3)(1997-7#1)(2007-10#2)(2007-11#6)(2007-12#9)(2007-8#2)(2008-1#6)(2008-10#32)(2008-11#9)(2008-12#7)(2008-2#12)(2008-3#21)(2008-4#1)(2008-5#4)(2008-7#14)(2008-8#1)(2008-9#20)(2009-10#5)(2009-11#8)(2009-3#3)(2009-5#5)(2009-8#11)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#2)(2010-8#11)(2010-9#3)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#8)(2013-1#10)(2013-8#4)
electrical-to-optical conversion efficiency##2##3##(2007-12#1)(2008-2#1)
electrical-to-optical##3##1##(2007-12#1)(2008-2#2)
electrically addressed spatial light##2##4##(2008-3#2)
electrically addressed##4##2##(2008-3#4)
electrically calibrated##2##2##(2008-2#2)
electrically charged##2##2##(2008-10#2)
electrically controlled##3##2##(2008-3#3)
electrically evoked GABA efflux##2##4##(1993-12#2)
electrically evoked GABA##3##3##(1993-12#3)
electrically evoked stapedius reflex threshold##2##5##(2008-9#2)
electrically evoked stapedius reflex##4##4##(2008-9#4)
electrically evoked##15##2##(1993-12#4)(1995-12#5)(1996-12#1)(2008-9#5)
electrically modulated##2##2##(2007-11#1)(2008-2#1)
electrically neutral##2##2##(1995-2#1)(2010-7#1)
electrically permeabilised islets##2##3##(1990-12#2)
electrically pumped circular grating-coupled surface-emitting lasers##2##6##(2008-3#2)
electrically pumped##4##2##(2007-11#1)(2008-3#3)
electrically stimulated##9##2##(1990-5#2)(1992-3#1)(1995-3#1)(1997-2#1)(2008-9#1)(2009-9#1)(2010-4#1)(2013-1#1)
electrically switchable##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
electrically##78##1##(1990-12#2)(1990-5#2)(1992-3#1)(1992-8#1)(1993-12#6)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-2#5)(2008-3#16)(2008-7#2)(2008-9#7)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-7#2)(2010-9#1)(2012-2#1)(2013-1#1)
electrically-induced##2##1##(1990-5#1)(1991-5#1)
electricity##6##1##(1996-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-12#1)
electro##3##1##(2008-10#2)(2012-2#1)
electro-analytical##2##1##(2008-10#2)
electro-dissolution##2##1##(2008-10#2)
electro-oculographic##2##1##(1995-11#2)
electro-optic (EO) devices##2##3##(2008-2#2)
electro-optic (EO)##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
electro-optic coefficient##3##2##(2007-12#3)
electro-optic coefficients##3##2##(2008-3#3)
electro-optic crystal##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
electro-optic device is##2##3##(2008-2#1)(2008-3#1)
electro-optic device##3##2##(2008-2#2)(2008-3#1)
electro-optic devices##3##2##(2007-12#1)(2008-2#2)
electro-optic effect in##3##3##(2007-12#1)(2008-3#2)
electro-optic effect##11##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#4)
electro-optic feedback##2##2##(2007-12#2)
electro-optic lens and##3##3##(2008-2#1)(2008-3#2)
electro-optic modulation technique##2##3##(2008-3#1)(2013-8#1)
electro-optic modulation##5##2##(2008-2#1)(2008-3#1)(2013-8#3)
electro-optic modulator##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
electro-optic modulators##5##2##(2007-11#1)(2007-12#4)
electro-optic parametric##2##2##(2007-12#2)
electro-optic phase##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
electro-optic polymer##2##2##(2007-11#1)(2007-12#1)
electro-optic probe tip##2##3##(2008-3#2)
electro-optic sampling in a##2##4##(2007-11#1)(2007-12#1)
electro-optic sampling in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
electro-optic sampling##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
electro-optic##102##1##(2007-11#15)(2007-12#33)(2008-2#18)(2008-3#33)(2013-8#3)
electro-optical##10##1##(2007-11#1)(2008-2#5)(2008-3#4)
electro-optically##9##1##(2007-11#3)(2008-2#2)(2008-3#4)
electro-osmotic flow##2##2##(2008-10#2)
electro-oxidation##2##1##(2008-10#2)
electro-sensitive##2##1##(2008-10#2)
electro-sensory tests##2##2##(2007-11#2)
electro-sensory##3##1##(2007-11#3)
electro-transformation##3##1##(1993-9#3)
electroabsorption##6##1##(2007-11#1)(2007-12#2)(2008-2#3)
electroactive and##2##2##(2008-10#2)
electroactive interferences##2##2##(2008-10#2)
electroactive material##7##2##(2008-10#7)
electroactive polymer##2##2##(2008-10#1)(2010-4#1)
electroactive species##5##2##(1990-8#1)(2008-10#3)(2008-3#1)
electroactive substance##2##2##(2008-10#2)
electroactive substances##2##2##(2008-10#2)
electroactive##46##1##(1990-8#1)(2008-10#38)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-4#2)
electroactivity##2##1##(2008-10#2)
electroacupuncture (EA)##3##2##(1995-12#1)(1996-12#1)(2012-3#1)
electroacupuncture at##3##2##(2010-7#2)(2012-3#1)
electroacupuncture of different##2##3##(1996-12#1)(2012-3#1)
electroacupuncture of##3##2##(1996-12#1)(2012-3#2)
electroacupuncture##16##1##(1995-12#2)(1996-12#4)(2008-10#1)(2010-7#2)(2012-3#5)(2013-1#1)(2013-8#1)
electroanalysis##4##1##(2008-10#4)
electroanalytical applications##3##2##(2008-10#3)
electroanalytical behaviour of##2##3##(2008-10#2)
electroanalytical chemistry##2##2##(2008-10#1)(2010-7#1)
electroanalytical determination of##3##3##(2008-10#3)
electroanalytical determination##4##2##(2008-10#4)
electroanalytical method for the determination of##2##6##(2008-10#2)
electroanalytical method for##3##3##(2008-10#3)
electroanalytical method##5##2##(2008-10#5)
electroanalytical procedure##2##2##(2008-10#2)
electroanalytical techniques for##2##3##(2008-10#2)
electroanalytical techniques##4##2##(2008-10#4)
electroanalytical##29##1##(2008-10#28)(2010-7#1)
electroantennographic detector##3##2##(2008-10#3)
electroantennographic##4##1##(2008-10#4)
electrocardiogram (ECG) is##2##3##(2008-10#1)(2010-8#1)
electrocardiogram (ECG)##11##2##(2008-10#1)(2008-12#1)(2008-3#3)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)
electrocardiogram in##3##2##(1994-6#1)(2008-11#1)(2008-12#1)
electrocardiogram was normal##2##3##(1993-1#1)(2008-12#1)
electrocardiogram was##3##2##(1991-8#1)(1993-1#1)(2008-12#1)
electrocardiogram##35##1##(1991-8#1)(1993-1#1)(1994-5#2)(1994-6#3)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#7)(2009-11#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
electrocardiograms##2##1##(1993-11#1)(2008-7#1)
electrocardiographic and##2##2##(1991-12#1)(2008-7#1)
electrocardiographic changes##2##2##(2011-2#1)(2013-8#1)
electrocardiographic findings##2##2##(2009-7#1)(2013-8#1)
electrocardiographic##21##1##(1991-12#1)(1991-3#2)(1992-5#1)(1995-3#1)(2008-10#2)(2008-12#2)(2008-7#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
electrocardiography##4##1##(1993-1#1)(2008-7#1)(2010-1#1)(2010-8#1)
electrocatalysis of##6##2##(2008-10#5)(2008-6#1)
electrocatalysis##9##1##(2008-10#7)(2008-6#1)(2013-1#1)
electrocatalyst##3##1##(2008-10#3)
electrocatalytic activity for the oxidation of##2##6##(2008-10#2)
electrocatalytic activity toward NADH oxidation##3##5##(2008-10#3)
electrocatalytic activity toward##5##3##(2008-10#5)
electrocatalytic activity towards the oxidation of##2##6##(2008-10#2)
electrocatalytic activity towards the oxidation##3##5##(2008-10#3)
electrocatalytic activity towards##4##3##(2008-10#4)
electrocatalytic activity##13##2##(2008-10#13)
electrocatalytic current##2##2##(2008-10#2)
electrocatalytic detection of the##2##4##(1990-12#1)(2008-10#1)
electrocatalytic detection of##3##3##(1990-12#1)(2008-10#2)
electrocatalytic detection##4##2##(1990-12#2)(2008-10#2)
electrocatalytic effect##3##2##(2008-10#2)(2010-5#1)
electrocatalytic oxidation for##3##3##(2008-10#3)
electrocatalytic oxidation of##8##3##(2008-10#8)
electrocatalytic oxidation##11##2##(2008-10#11)
electrocatalytic reduction of##3##3##(2008-10#2)(2010-6#1)
electrocatalytic reduction peak current##2##4##(2008-10#2)
electrocatalytic reduction##7##2##(2008-10#6)(2010-6#1)
electrocatalytic##58##1##(1990-12#2)(2008-10#52)(2010-4#1)(2010-5#1)(2010-6#2)
electrocatalytically##2##1##(2008-10#2)
electrocauterization##3##1##(2007-7#3)
electrocautery and argon plasma##2##4##(2008-7#2)
electrocautery and##3##2##(2008-7#2)(2010-8#1)
electrocautery##10##1##(1991-3#1)(1994-12#2)(2008-7#2)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)
electrochemical (EC)##3##2##(2008-10#2)(2008-5#1)
electrochemical DNA##6##2##(2008-10#6)
electrochemical activity of##2##3##(2008-12#2)
electrochemical activity##4##2##(2008-10#2)(2008-12#2)
electrochemical analysis of##3##3##(2008-10#3)
electrochemical and##7##2##(2008-10#6)(2010-2#1)
electrochemical behavior of the##4##4##(2008-10#4)
electrochemical behavior of##19##3##(2008-10#18)(2010-6#1)
electrochemical behavior##22##2##(2008-10#21)(2010-6#1)
electrochemical behaviors of these##2##4##(2008-10#2)
electrochemical behaviors of##4##3##(2008-10#4)
electrochemical behaviour of##2##3##(2008-10#2)
electrochemical behaviour##4##2##(2008-10#4)
electrochemical biosensor for the##2##4##(2008-10#2)
electrochemical biosensor##3##2##(2008-10#3)
electrochemical biosensors##3##2##(2008-10#2)(2008-7#1)
electrochemical cell for##2##3##(2008-10#2)
electrochemical cell##12##2##(2007-12#1)(2008-10#10)(2010-2#1)
electrochemical characteristics of##4##3##(2008-10#4)
electrochemical characteristics##5##2##(2008-10#5)
electrochemical characterization##2##2##(2008-10#2)
electrochemical current##2##2##(2008-12#2)
electrochemical data indicate that##2##4##(1991-8#1)(1996-2#1)
electrochemical data##4##2##(1991-8#1)(1996-2#1)(1997-7#1)(2008-10#1)
electrochemical deposition##6##2##(2008-10#5)(2010-4#1)
electrochemical detection of the##2##4##(2008-10#2)
electrochemical detection of##8##3##(2008-10#6)(2008-12#2)
electrochemical detection##42##2##(1990-8#1)(1991-5#5)(1993-1#1)(1993-12#1)(2008-10#28)(2008-12#2)(2008-7#2)(2009-8#1)(2010-11#1)
electrochemical detector for##4##3##(2008-10#4)
electrochemical detector##16##2##(2008-10#14)(2008-6#1)(2012-1#1)
electrochemical detectors##4##2##(1992-11#1)(2008-10#2)(2012-1#1)
electrochemical determination of##9##3##(2008-10#9)
electrochemical enzyme-linked immunosorbent##2##3##(2008-10#2)
electrochemical flow##3##2##(2008-10#3)
electrochemical gradient##2##2##(2008-7#1)(2008-8#1)
electrochemical hydride generation and##3##4##(2008-10#3)
electrochemical hydride generation##10##3##(2008-10#10)
electrochemical hydride generator##4##3##(2008-10#4)
electrochemical hydride##14##2##(2008-10#14)
electrochemical immunoassay for##2##3##(2010-5#2)
electrochemical immunoassay##5##2##(2008-10#3)(2010-5#2)
electrochemical immunosensor for the##2##4##(2008-10#2)
electrochemical immunosensor##3##2##(2008-10#3)
electrochemical impedance spectroscopy (EIS)##4##4##(2008-10#4)
electrochemical impedance spectroscopy and##2##4##(2008-10#2)
electrochemical impedance spectroscopy##13##3##(2008-10#12)(2010-4#1)
electrochemical impedance##14##2##(2008-10#13)(2010-4#1)
electrochemical method for the##2##4##(2008-10#2)
electrochemical method for##3##3##(2008-10#3)
electrochemical method was##2##3##(2008-10#2)
electrochemical method##19##2##(2008-10#16)(2009-3#1)(2010-2#1)(2013-1#1)
electrochemical methods##14##2##(1996-2#1)(2008-10#11)(2010-2#1)(2010-7#1)
electrochemical oxidation of##13##3##(2008-10#13)
electrochemical oxidation##16##2##(2008-10#16)
electrochemical potential##7##2##(1997-8#7)
electrochemical preconcentration##3##2##(2008-10#3)
electrochemical pretreatment##4##2##(2008-10#4)
electrochemical probe##3##2##(2008-10#3)
electrochemical process##3##2##(2008-10#2)(2013-1#1)
electrochemical properties of the##2##4##(1996-5#1)(2008-10#1)
electrochemical properties of##9##3##(1996-5#1)(2008-10#5)(2008-8#3)
electrochemical properties##13##2##(1994-3#1)(1996-5#1)(2008-10#7)(2008-8#3)(2009-5#1)
electrochemical quantification##2##2##(2008-10#2)
electrochemical quartz crystal microbalance##3##4##(2008-10#3)
electrochemical reaction##7##2##(1990-12#1)(2008-10#6)
electrochemical reactions of##2##3##(2008-10#2)
electrochemical reactions##4##2##(2008-10#3)(2009-12#1)
electrochemical reactivity##2##2##(2008-10#1)(2013-1#1)
electrochemical redox potentials##3##3##(2008-10#3)
electrochemical redox##5##2##(2008-10#5)
electrochemical reduction back to hydroquinone##2##5##(2008-10#2)
electrochemical reduction back to##3##4##(2008-10#3)
electrochemical reduction back##4##3##(2008-10#4)
electrochemical reduction of##10##3##(2008-10#10)
electrochemical reduction##19##2##(2008-10#19)
electrochemical response of##4##3##(2008-10#4)
electrochemical response##12##2##(2008-10#12)
electrochemical responses##2##2##(2008-10#2)
electrochemical sensing##5##2##(2008-10#1)(2010-11#1)(2013-1#3)
electrochemical sensor##14##2##(2008-10#13)(2008-2#1)
electrochemical sensors##7##2##(2008-10#5)(2010-7#1)(2013-1#1)
electrochemical signals##3##2##(2008-10#3)
electrochemical studies##2##2##(2009-5#1)(2009-9#1)
electrochemical study of##2##3##(1995-5#1)(2008-10#1)
electrochemical synthesis##3##2##(2008-10#1)(2013-1#2)
electrochemical technique##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
electrochemical techniques##9##2##(2008-10#8)(2008-4#1)
electrochemical##458##1##(1990-12#1)(1990-8#1)(1991-5#5)(1991-8#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-2#3)(1996-5#1)(1997-7#1)(1997-8#7)(2007-12#3)(2008-10#364)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#7)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#3)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#10)
electrochemically controlled##2##2##(2008-10#1)(2008-3#1)
electrochemically deposited on a##2##4##(2008-10#2)
electrochemically deposited on##3##3##(2008-10#3)
electrochemically deposited##6##2##(2008-10#6)
electrochemically generated##7##2##(2008-10#5)(2008-4#1)(2010-7#1)
electrochemically inactive##2##2##(2008-10#2)
electrochemically initiated reaction##2##3##(2008-10#2)
electrochemically non-active complex##2##3##(2008-10#2)
electrochemically non-active##3##2##(2008-10#3)
electrochemically on##2##2##(2008-10#2)
electrochemically roughened##2##2##(2007-12#2)
electrochemically stable##2##2##(2008-10#1)(2010-4#1)
electrochemically with##2##2##(2008-10#2)
electrochemically##57##1##(2007-12#2)(2008-10#49)(2008-3#1)(2008-4#1)(2009-12#2)(2010-4#1)(2010-7#1)
electrochemiluminescence (ECL) of##2##3##(2008-10#2)
electrochemiluminescence (ECL)##4##2##(2008-10#3)(2010-7#1)
electrochemiluminescence detection##4##2##(2008-10#4)
electrochemiluminescence of lucigenin##2##3##(2008-10#2)
electrochemiluminescence of##5##2##(2008-10#5)
electrochemiluminescence##16##1##(2008-10#15)(2010-7#1)
electrochemiluminescent (ECL)##3##2##(2008-10#3)
electrochemiluminescent##8##1##(2008-10#8)
electrochemistry and##4##2##(2008-10#4)
electrochemistry of dopamine##3##3##(2008-10#3)
electrochemistry of the##2##3##(1990-8#1)(2008-10#1)
electrochemistry of##13##2##(1990-8#1)(2008-10#11)(2009-5#1)
electrochemistry##30##1##(1990-5#1)(1990-8#1)(1996-12#1)(2008-10#23)(2008-5#2)(2009-5#1)(2009-9#1)
electrochromatography##15##1##(1997-2#2)(2008-10#13)
electrochromic materials and##2##3##(2008-2#2)
electrochromic##5##1##(1996-4#1)(2008-2#3)(2008-3#1)
electrocoagulation##3##1##(1991-9#1)(2010-8#1)(2013-1#1)
electroconductance in##2##2##(2009-6#2)
electroconductance##4##1##(2009-6#4)
electroconvulsive shock##2##2##(2011-1#2)
electroconvulsive therapy##9##2##(2008-2#1)(2008-7#3)(2011-1#1)(2012-12#3)(2012-2#1)
electroconvulsive treatment##3##2##(1993-11#3)
electroconvulsive##17##1##(1993-11#3)(1996-12#2)(2008-2#1)(2008-7#3)(2009-10#1)(2011-1#3)(2012-12#3)(2012-2#1)
electrode (Ag/AgCl)##2##2##(2008-10#2)
electrode (BiFE)##4##2##(2008-10#4)
electrode (GCE)##16##2##(2008-10#16)
electrode (ISE)##14##2##(2008-10#14)
electrode (SCE)##2##2##(2008-10#2)
electrode E2##3##2##(2008-10#3)
electrode after##2##2##(2008-10#2)
electrode against##2##2##(2008-10#2)
electrode also##2##2##(2008-10#2)
electrode and a well-defined oxidation peak##2##6##(2008-10#2)
electrode and a##8##3##(2008-10#8)
electrode and its application in##2##5##(2008-10#2)
electrode and its application to##2##5##(2008-10#2)
electrode and its application##7##4##(2008-10#7)
electrode and its##13##3##(2008-10#13)
electrode and the detection##2##4##(2008-10#2)
electrode and the##13##3##(2008-10#11)(2008-9#1)(2013-1#1)
electrode and##68##2##(1990-5#1)(2007-9#1)(2008-10#61)(2008-12#1)(2008-5#1)(2008-9#1)(2009-11#1)(2013-1#1)
electrode applied##2##2##(2008-10#2)
electrode are##7##2##(2008-10#7)
electrode area##2##2##(2008-10#2)
electrode array##9##2##(2008-10#3)(2008-9#4)(2009-9#1)(2010-2#1)
electrode arrays##9##2##(2008-10#3)(2008-3#1)(2008-9#4)(2010-4#1)
electrode as a sensor##2##4##(2008-10#2)
electrode as a##9##3##(2008-10#8)(2008-9#1)
electrode as detector##2##3##(2008-10#2)
electrode as the##4##3##(1992-11#1)(2008-10#3)
electrode as##22##2##(1992-11#1)(2007-11#1)(2008-10#19)(2008-9#1)
electrode at pH##2##3##(1990-5#1)(2008-10#1)
electrode at##10##2##(1990-5#1)(2008-10#9)
electrode based on a##9##4##(2008-10#9)
electrode based on maltodextrin##2##4##(2008-10#2)
electrode based on the##2##4##(2008-10#2)
electrode based on##46##3##(2008-10#46)
electrode by the##2##3##(1995-6#1)(2008-10#1)
electrode by##20##2##(1995-6#1)(2008-10#19)
electrode can be used as a##3##6##(2008-10#3)
electrode can be used for the determination of##2##8##(2008-10#2)
electrode can be used for##4##5##(2008-10#4)
electrode can be used##13##4##(2008-10#13)
electrode can be##17##3##(2008-10#17)
electrode can##22##2##(2008-10#21)(2008-7#1)
electrode caused by##2##3##(2008-10#2)
electrode caused##3##2##(2008-10#3)
electrode characteristics##2##2##(2008-10#2)
electrode configurations##2##2##(2008-10#1)(2008-3#1)
electrode consisted of##2##3##(2008-10#2)
electrode containing##3##2##(2008-10#3)
electrode could be used for##3##5##(2008-10#3)
electrode could be used##5##4##(2008-10#5)
electrode could be##8##3##(2008-10#7)(2008-7#1)
electrode could##9##2##(2008-10#8)(2008-7#1)
electrode coupled to##2##3##(2008-10#2)
electrode covered with a##2##4##(2008-10#2)
electrode covered with##3##3##(2008-10#3)
electrode covered##4##2##(2008-10#4)
electrode design##2##2##(2008-9#2)
electrode detector##11##2##(2008-10#11)
electrode did not##2##3##(2008-10#2)
electrode doped with##2##3##(2008-10#2)
electrode exhibited a##6##3##(2008-10#6)
electrode exhibited##18##2##(2008-10#18)
electrode exhibits a Nernstian response##4##5##(2008-10#4)
electrode exhibits a Nernstian##7##4##(2008-10#7)
electrode exhibits a##14##3##(2008-10#14)
electrode exhibits good##2##3##(2008-10#2)
electrode exhibits high##2##3##(2008-10#2)
electrode exhibits##22##2##(2008-10#22)
electrode followed by##2##3##(2008-10#2)
electrode for bismuth(III)##2##3##(2008-10#2)
electrode for determination of##4##4##(2008-10#4)
electrode for glucose determination##2##4##(2008-10#2)
electrode for potentiometric titration of##2##5##(2008-10#2)
electrode for potentiometric##3##3##(2008-10#3)
electrode for salicylate##2##3##(2008-10#2)
electrode for the determination of Pb(2+)##2##6##(2008-10#2)
electrode for the determination of trace##2##6##(2008-10#2)
electrode for the determination of##17##5##(2008-10#17)
electrode for the oxidation of NADH is determined by cyclic voltammetry##2##11##(2008-10#2)
electrode for the##30##3##(1995-6#1)(2008-10#28)(2009-5#1)
electrode for##64##2##(1995-6#1)(2008-10#61)(2009-5#1)(2012-2#1)
electrode fouling and##2##3##(2008-10#2)
electrode fouling##5##2##(2008-10#5)
electrode from##3##2##(2008-10#2)(2010-8#1)
electrode gap##2##2##(2012-2#2)
electrode gave comparable results to##2##5##(2008-10#2)
electrode gave##3##2##(2008-10#3)
electrode geometry##2##2##(2008-10#1)(2008-3#1)
electrode gives##3##2##(1995-6#1)(2008-10#2)
electrode had a##2##3##(2008-10#2)
electrode had##3##2##(2008-10#3)
electrode has a##7##3##(2008-10#7)
electrode has been applied for##2##5##(2008-10#2)
electrode has been applied##3##4##(2008-10#3)
electrode has been developed##5##4##(2008-10#5)
electrode has been investigated in##3##5##(2008-10#2)(2009-10#1)
electrode has been utilized as an end point indicator electrode for the determination of##2##14##(2008-10#2)
electrode has been utilized as an end point indicator electrode##3##10##(2008-10#3)
electrode has been##25##3##(2008-10#24)(2009-10#1)
electrode has shown##2##3##(2008-10#2)
electrode has##39##2##(2008-10#37)(2009-10#1)(2012-2#1)
electrode have been studied##2##4##(2008-10#2)
electrode have been##3##3##(2008-10#3)
electrode in 0##3##3##(2008-10#3)
electrode in a##8##3##(2008-10#8)
electrode in alkaline##4##3##(1995-6#1)(2008-10#3)
electrode in both##2##3##(2008-10#2)
electrode in pH##2##3##(2008-10#2)
electrode in the presence of surfactants##2##6##(2008-10#2)
electrode in the presence of##7##5##(2008-10#7)
electrode in the presence##8##4##(2008-10#8)
electrode in the##21##3##(2008-10#20)(2012-3#1)
electrode in which##2##3##(2008-10#2)
electrode in##72##2##(1995-6#1)(2008-10#66)(2008-7#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-3#1)
electrode increased##3##2##(2008-10#3)
electrode insertion##5##2##(2008-9#3)(2010-12#1)(2011-2#1)
electrode into the##2##3##(2008-10#2)
electrode into##3##2##(2008-10#3)
electrode is a##2##3##(2008-10#2)
electrode is described##4##3##(1990-12#1)(2008-10#3)
electrode is proposed##2##3##(2008-10#2)
electrode is reported##4##3##(2008-10#4)
electrode is##52##2##(1990-12#1)(1995-6#2)(2008-10#47)(2008-12#1)(2013-1#1)
electrode kinetics##2##2##(2008-10#2)
electrode material to##2##3##(2008-10#2)
electrode material##7##2##(2008-10#6)(2013-8#1)
electrode materials and##2##3##(2007-12#1)(2008-10#1)
electrode materials for##2##3##(2008-10#1)(2013-1#1)
electrode materials##7##2##(2007-12#1)(2008-10#5)(2013-1#1)
electrode measurements##3##2##(1995-8#1)(2008-10#2)
electrode membrane##4##2##(2008-10#4)
electrode method and##2##3##(2008-10#2)
electrode modified by a##2##4##(2008-10#2)
electrode modified by##6##3##(2008-10#6)
electrode modified with a##6##4##(2008-10#6)
electrode modified with trinuclear ruthenium ammine complex##2##7##(2008-10#2)
electrode modified with##38##3##(1992-11#1)(2008-10#37)
electrode modified##46##2##(1992-11#1)(2008-10#45)
electrode obtained from##2##3##(2008-10#2)
electrode obtained##4##2##(2008-10#4)
electrode of##6##2##(2008-10#5)(2010-2#1)
electrode on##2##2##(2008-10#1)(2008-9#1)
electrode optoelectronic tweezers##2##3##(2009-5#2)
electrode performance##5##2##(2008-10#5)
electrode placed##2##2##(2008-3#1)(2008-6#1)
electrode placement and##2##3##(2010-7#1)(2012-2#1)
electrode placement in the##2##4##(2010-7#2)
electrode placement in##3##3##(2010-12#1)(2010-7#2)
electrode placement##6##2##(2010-12#1)(2010-7#4)(2012-2#1)
electrode polarized at 0##2##4##(2008-10#2)
electrode positioned opposite the outlet of##3##6##(2008-10#3)
electrode potential and##4##3##(2008-10#4)
electrode potential##11##2##(1993-8#1)(2008-10#10)
electrode potentiometry##2##2##(2008-10#2)
electrode preparation##2##2##(2008-10#2)
electrode prepared in the##2##4##(2008-10#2)
electrode prepared with##3##3##(2008-10#3)
electrode prepared##10##2##(2008-10#10)
electrode presented##2##2##(2008-10#2)
electrode process##5##2##(2008-10#5)
electrode provided a linear##2##4##(2008-10#2)
electrode provided well-resolved##2##3##(2008-10#2)
electrode provided##6##2##(2008-10#5)(2012-2#1)
electrode provides##3##2##(2008-10#3)
electrode reaction rate constant##2##4##(2008-10#1)(2008-8#1)
electrode reaction##6##2##(2008-10#5)(2008-8#1)
electrode reduction##3##2##(2008-10#3)
electrode responds to the##2##4##(2008-10#2)
electrode responds to##4##3##(2008-10#4)
electrode response is##3##3##(2008-10#3)
electrode response was##7##3##(2008-10#7)
electrode response##22##2##(2008-10#22)
electrode responses##3##2##(2008-10#3)
electrode revealed##10##2##(2008-10#10)
electrode selective##2##2##(2008-10#2)
electrode sensitive to##4##3##(2008-10#4)
electrode should be##3##3##(2008-10#2)(2012-2#1)
electrode should##4##2##(2008-10#3)(2012-2#1)
electrode showed a good##2##4##(2008-10#2)
electrode showed a##6##3##(2008-10#6)
electrode showed an##3##3##(2008-10#3)
electrode showed high selectivity for##2##5##(2008-10#2)
electrode showed high sensitivity##2##4##(2008-10#2)
electrode showed high##4##3##(2008-10#4)
electrode showed##19##2##(2008-10#19)
electrode shows a good selectivity for##2##6##(2008-10#2)
electrode shows a linear response##2##5##(2008-10#2)
electrode shows a linear##4##4##(2008-10#4)
electrode shows a##11##3##(2008-10#11)
electrode shows an##2##3##(2008-10#1)(2012-2#1)
electrode shows electrocatalytic activity##2##4##(2008-10#2)
electrode shows excellent##2##3##(2008-10#2)
electrode shows good##2##3##(2008-10#2)
electrode shows##26##2##(2008-10#24)(2009-10#1)(2012-2#1)
electrode site##2##2##(2008-7#1)(2010-8#1)
electrode studied##2##2##(2008-10#2)
electrode such as##2##3##(2008-10#2)
electrode surface and the##2##4##(2008-10#2)
electrode surface and##8##3##(2008-10#8)
electrode surface at##4##3##(2008-10#4)
electrode surface by##6##3##(2008-10#6)
electrode surface in##4##3##(2008-10#4)
electrode surface is##2##3##(2008-10#2)
electrode surface to##2##3##(2008-10#2)
electrode surface under##2##3##(2008-10#2)
electrode surface was##3##3##(2008-10#3)
electrode surface##93##2##(2008-10#91)(2008-9#1)(2009-12#1)
electrode surfaces##9##2##(1990-5#1)(2007-12#1)(2008-10#7)
electrode system##6##2##(2008-10#4)(2008-3#2)
electrode that##2##2##(2008-10#2)
electrode the##2##2##(2008-10#2)
electrode through##2##2##(2008-10#2)
electrode to assess##2##3##(2008-10#2)
electrode to##17##2##(1993-12#1)(2008-10#14)(2008-3#1)(2008-7#1)
electrode type##2##2##(2008-10#2)
electrode used as a##2##4##(2008-10#2)
electrode using cyclic voltammetry##2##4##(2008-10#2)
electrode using cyclic##3##3##(2008-10#3)
electrode using##12##2##(2008-10#11)(2008-9#1)
electrode voltammetric##2##2##(2008-10#2)
electrode was 7##2##3##(2008-10#2)
electrode was also##2##3##(2008-10#2)
electrode was applied##3##3##(2008-10#3)
electrode was constructed##3##3##(2008-10#3)
electrode was developed##5##3##(2008-10#5)
electrode was employed##2##3##(2008-10#2)
electrode was found to##2##4##(2008-10#2)
electrode was found##3##3##(2008-10#2)(2008-12#1)
electrode was investigated##4##3##(2008-10#4)
electrode was prepared and used##2##5##(2008-10#2)
electrode was prepared by the##2##5##(2008-10#2)
electrode was prepared by##3##4##(2008-10#3)
electrode was prepared##6##3##(2008-10#6)
electrode was studied in##2##4##(2008-10#2)
electrode was studied##4##3##(2008-10#4)
electrode was successfully applied##4##4##(2008-10#4)
electrode was successfully##6##3##(2008-10#6)
electrode was used as a##2##5##(2008-10#2)
electrode was used as an amperometric detector for##2##8##(2008-10#2)
electrode was used as an##4##5##(2008-10#4)
electrode was used as##8##4##(2008-10#8)
electrode was used for the determination of##2##7##(2008-10#2)
electrode was used for the potentiometric##2##6##(2008-10#2)
electrode was used for the##5##5##(2008-10#4)(2009-10#1)
electrode was used for##6##4##(2008-10#5)(2009-10#1)
electrode was used to##4##4##(2008-10#3)(2013-8#1)
electrode was used##22##3##(2008-10#20)(2009-10#1)(2013-8#1)
electrode was##118##2##(2008-10#111)(2008-12#2)(2008-9#3)(2009-10#1)(2013-8#1)
electrode were examined##3##3##(2008-10#3)
electrode were investigated##4##3##(2008-10#4)
electrode were studied by cyclic voltammetry (CV)##2##7##(2008-10#2)
electrode were studied##3##3##(2008-10#3)
electrode were##23##2##(2008-10#23)
electrode which##3##2##(2008-10#3)
electrode will##2##2##(2008-10#1)(2012-2#1)
electrode with 3##2##3##(2008-10#2)
electrode with LaF(3)-membrane and##2##4##(2008-10#2)
electrode with a##5##3##(2008-10#4)(2012-2#1)
electrode with the##3##3##(2008-10#3)
electrode with##29##2##(1990-12#1)(1991-7#1)(2008-10#25)(2012-2#2)
electrode without##2##2##(2008-10#2)
electrode##1832##1##(1990-12#2)(1990-2#1)(1990-5#5)(1990-8#2)(1991-5#3)(1991-7#1)(1991-8#1)(1992-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-3#2)(1995-6#8)(1995-8#1)(1996-2#1)(2007-11#2)(2007-12#3)(2007-9#2)(2008-10#1648)(2008-11#2)(2008-12#8)(2008-2#5)(2008-3#10)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#42)(2009-10#4)(2009-11#1)(2009-12#4)(2009-5#3)(2009-7#2)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#5)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#18)(2012-3#1)(2013-1#7)(2013-8#3)
electrode's##3##1##(2008-10#1)(2008-9#1)(2010-8#1)
electrode)##20##1##(2008-10#18)(2012-1#2)
electrodeposited imprinted sol-gel film##2##4##(2008-10#2)
electrodeposited on the##2##3##(2008-10#2)
electrodeposited on##3##2##(2008-10#3)
electrodeposited##16##1##(1990-4#1)(2008-10#14)(2010-4#1)
electrodeposition of##11##2##(2008-10#10)(2010-4#1)
electrodeposition was##2##2##(2008-10#2)
electrodeposition##25##1##(1992-3#1)(2007-11#1)(2008-10#21)(2010-4#2)
electrodes (ISE)##2##2##(2008-10#2)
electrodes (ISEs)##12##2##(2008-10#11)(2010-5#1)
electrodes (p = ##2##2##(2012-2#2)
electrodes and the##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
electrodes and their application to the##2##6##(2008-10#2)
electrodes and their##3##3##(2008-10#3)
electrodes and##27##2##(1992-12#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#3)(2013-1#1)
electrodes are found##2##3##(2008-10#2)
electrodes are suitable for##2##4##(2008-10#2)
electrodes are##21##2##(1992-11#1)(2008-10#19)(2013-1#1)
electrodes as##6##2##(2008-10#5)(2008-2#1)
electrodes based on 1##2##4##(2008-10#2)
electrodes based on anilino-(1##2##4##(2008-10#2)
electrodes based on the##3##4##(2008-10#3)
electrodes based on##35##3##(2008-10#35)
electrodes based##36##2##(2008-10#36)
electrodes by##5##2##(2008-10#5)
electrodes can be##3##3##(2008-10#3)
electrodes can##5##2##(2008-10#5)
electrodes coated with##3##3##(2008-10#3)
electrodes constructed##2##2##(2008-10#2)
electrodes display##2##2##(2008-10#2)
electrodes essentially##2##2##(2008-10#2)
electrodes exhibit a##2##3##(2008-10#2)
electrodes exhibit##5##2##(2008-10#5)
electrodes exhibited##3##2##(2008-10#3)
electrodes for lead##2##3##(2008-10#2)
electrodes for the detection of trace metals##2##7##(2008-10#2)
electrodes for the determination of##7##5##(2008-10#7)
electrodes for the measurement of##2##5##(2008-10#1)(2009-7#1)
electrodes for the##17##3##(2008-10#15)(2009-7#1)(2012-2#1)
electrodes for##39##2##(2008-10#32)(2008-2#1)(2008-7#1)(2009-7#1)(2010-6#1)(2012-2#2)(2013-1#1)
electrodes from##4##2##(2008-10#2)(2008-9#2)
electrodes has been##3##3##(2008-10#3)
electrodes have been developed##2##4##(2008-10#2)
electrodes have been##12##3##(2008-10#12)
electrodes have##15##2##(2008-10#15)
electrodes in a##4##3##(1992-11#1)(2008-10#3)
electrodes in series##2##3##(2008-10#2)
electrodes in the presence of##2##5##(2008-10#2)
electrodes in the##6##3##(2008-10#5)(2008-11#1)
electrodes in##27##2##(1992-11#1)(2008-10#24)(2008-11#1)(2010-8#1)
electrodes inserted##2##2##(2008-9#1)(2009-11#1)
electrodes is presented##2##3##(2008-10#2)
electrodes is reported##2##3##(2008-10#2)
electrodes is##19##2##(2007-12#1)(2008-10#13)(2008-3#2)(2010-7#1)(2011-1#1)(2012-2#1)
electrodes made from##2##3##(2008-10#2)
electrodes made of##2##3##(2008-10#2)
electrodes made##4##2##(2008-10#4)
electrodes modified by##2##3##(2008-10#2)
electrodes modified with##8##3##(2008-10#8)
electrodes modified##10##2##(2008-10#10)
electrodes of##2##2##(2008-10#2)
electrodes on the##3##3##(2008-3#3)
electrodes on##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)
electrodes or amperometric##2##3##(2008-10#2)
electrodes or##4##2##(2008-10#3)(2011-1#1)
electrodes possess##3##2##(2008-10#3)
electrodes prepared with##2##3##(2008-10#2)
electrodes prepared##6##2##(2008-10#5)(2008-12#1)
electrodes reported in literature##2##4##(2008-10#2)
electrodes revealed##2##2##(2008-10#2)
electrodes show##2##2##(2008-10#2)
electrodes showed##2##2##(2008-10#2)
electrodes tested##2##2##(2008-10#2)
electrodes that##3##2##(2007-11#1)(2008-10#2)
electrodes the##2##2##(2008-10#2)
electrodes to##10##2##(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
electrodes used as##2##3##(2008-10#2)
electrodes used##4##2##(2008-10#4)
electrodes using##6##2##(2008-10#5)(2008-9#1)
electrodes via##2##2##(2008-10#2)
electrodes was compared##2##3##(2008-10#2)
electrodes was found to##2##4##(2008-10#2)
electrodes was investigated##2##3##(2008-10#2)
electrodes was tested##2##3##(2008-10#2)
electrodes was##18##2##(2007-12#1)(2008-10#17)
electrodes were characterized##2##3##(2008-10#2)
electrodes were developed##2##3##(2008-10#2)
electrodes were fabricated##2##3##(2008-10#2)
electrodes were found to be##2##5##(2008-10#2)
electrodes were investigated##2##3##(2008-10#2)
electrodes were slightly##2##3##(2008-10#2)
electrodes were used for the##2##5##(2008-10#2)
electrodes were used to##2##4##(2008-10#1)(2012-12#1)
electrodes were used##5##3##(2008-10#4)(2012-12#1)
electrodes were##53##2##(2008-10#50)(2008-9#2)(2012-12#1)
electrodes with a##2##3##(2009-11#1)(2012-2#1)
electrodes with hydrogel and##2##4##(2008-10#2)
electrodes with##18##2##(2008-10#16)(2009-11#1)(2012-2#1)
electrodes##703##1##(1990-5#2)(1992-11#2)(1992-12#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#6)(2007-9#4)(2008-10#589)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#2)(2008-6#2)(2008-7#6)(2008-9#14)(2009-10#1)(2009-11#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#14)(2013-1#7)
electrodes)##2##1##(2008-10#2)
electrodiagnosis##2##1##(2012-3#2)
electrodiagnostic studies##2##2##(2012-3#2)
electrodiagnostic##5##1##(2006-12#1)(2008-9#2)(2012-3#2)
electrodialysis##3##1##(2008-10#2)(2013-1#1)
electrodissolution##6##1##(2008-10#6)
electrodynamic##3##1##(2008-10#1)(2008-2#1)(2008-7#1)
electrodynamics##3##1##(2007-11#1)(2008-3#1)(2012-2#1)
electroencephalogram (EEG)##5##2##(2009-8#2)(2010-7#1)(2012-12#1)(2012-2#1)
electroencephalogram##8##1##(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
electroencephalograms (EEG)##3##2##(1990-6#1)(1993-6#1)(2008-11#1)
electroencephalographic (EEG)##3##2##(2008-7#1)(2009-8#1)(2010-8#1)
electroencephalographic##5##1##(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-8#1)
electroencephalography (EEG)##6##2##(2008-4#2)(2008-7#3)(2010-8#1)
electroencephalography in##2##2##(1990-9#1)(2008-4#1)
electroencephalography##12##1##(1990-9#1)(1996-7#1)(2008-11#2)(2008-4#3)(2008-7#4)(2010-8#1)
electrogenerated chemiluminescence##5##2##(2008-10#4)(2010-7#1)
electrogenerated polymer##3##2##(2008-10#3)
electrogenerated##24##1##(2008-10#23)(2010-7#1)
electrogenic##3##1##(1990-11#1)(1990-12#1)(1990-5#1)
electroholographic##2##1##(2007-11#2)
electroholography##2##1##(2008-3#2)
electroimmunodiffusion##2##1##(1993-2#1)(1995-2#1)
electroinactive##4##1##(2008-10#4)
electroinjection##4##1##(2008-10#4)
electrokinetic capillary chromatography (MECC)##4##4##(1994-9#2)(2008-10#2)
electrokinetic capillary chromatography (MEKC) with##3##5##(2008-10#3)
electrokinetic capillary chromatography##14##3##(1994-9#4)(2008-10#10)
electrokinetic chromatography (MEKC)##10##3##(1990-8#1)(1994-9#2)(2008-10#6)(2010-7#1)
electrokinetic chromatography##30##2##(1990-8#4)(1994-9#4)(1996-5#3)(2008-10#17)(2010-7#2)
electrokinetic flow analysis system##3##4##(2008-10#3)
electrokinetic flow analysis##4##3##(2008-10#4)
electrokinetic##53##1##(1990-8#4)(1994-9#8)(1996-5#3)(2008-10#35)(2010-7#2)(2012-1#1)
electroless copper deposition on##2##4##(2010-4#2)
electroless copper##3##2##(2008-10#1)(2010-4#2)
electroless##5##1##(2008-10#3)(2010-4#2)
electroluminescence##2##1##(2007-11#1)(2010-4#1)
electrolysis of##2##2##(2008-11#2)
electrolysis time##6##2##(2008-10#6)
electrolysis##20##1##(2008-10#15)(2008-11#3)(2009-12#1)(2013-1#1)
electrolyte and##13##2##(1997-2#1)(2008-10#10)(2008-7#1)(2011-2#1)
electrolyte at##3##2##(2008-10#3)
electrolyte balance##7##2##(1991-2#1)(1993-12#1)(1994-6#1)(2007-8#1)(2010-7#2)(2012-2#1)
electrolyte composed##2##2##(1994-9#1)(2008-10#1)
electrolyte concentration##4##2##(2008-10#4)
electrolyte concentrations##2##2##(1991-9#1)(2008-10#1)
electrolyte containing##3##2##(2008-10#3)
electrolyte in##3##2##(2008-10#3)
electrolyte leakage and##2##3##(2008-10#2)
electrolyte leakage##16##2##(2008-10#13)(2008-12#3)
electrolyte of##2##2##(2008-10#2)
electrolyte on the##4##3##(2008-10#4)
electrolyte solution##10##2##(1994-3#1)(2008-10#9)
electrolyte solutions##6##2##(1996-5#1)(2008-10#5)
electrolyte species##2##2##(2008-10#2)
electrolyte used##3##2##(2008-10#3)
electrolyte using##3##2##(2008-10#3)
electrolyte was##4##2##(2008-10#4)
electrolyte##160##1##(1991-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#130)(2008-12#4)(2008-7#1)(2008-8#1)(2009-5#2)(2010-4#2)(2010-7#2)(2011-2#1)(2012-2#1)
electrolytes in##3##2##(2008-10#3)
electrolytes of##2##2##(2008-10#2)
electrolytes was##3##2##(2008-10#2)(2009-4#1)
electrolytes were##3##2##(2008-10#3)
electrolytes when##2##2##(2008-10#1)(2012-2#1)
electrolytes##70##1##(1991-6#1)(1993-2#1)(1994-6#1)(1996-5#1)(1996-6#1)(2008-10#50)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
electrolytic cell##6##2##(2008-10#6)
electrolytic deposition of##2##3##(2008-10#2)
electrolytic deposition##3##2##(2008-10#3)
electrolytic lesions of the##3##4##(1993-3#1)(1993-5#1)(2009-10#1)
electrolytic lesions##4##2##(1993-3#1)(1993-5#1)(2009-10#1)(2013-7#1)
electrolytic potentiometric titration method for the determination of ciprofloxacin##2##9##(2008-10#2)
electrolytic potentiometry##3##2##(2008-10#3)
electrolytic##36##1##(1992-11#1)(1992-8#1)(1993-3#1)(1993-5#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-2#1)(2009-10#1)(2013-7#1)
electrolytically enriched##2##2##(2008-10#2)
electrolytically##5##1##(2008-10#5)
electrolyzed reduced water and##2##4##(2008-11#1)(2012-3#1)
electrolyzed##4##1##(2008-10#2)(2008-11#1)(2012-3#1)
electromagnetic analysis of##2##3##(2008-3#2)
electromagnetic and##2##2##(1992-3#1)(2013-1#1)
electromagnetic diffraction theory##2##3##(2008-3#2)
electromagnetic diffraction##3##2##(2008-2#1)(2008-3#2)
electromagnetic enhancement of##2##3##(2013-8#2)
electromagnetic field and##3##3##(2007-11#2)(2008-3#1)
electromagnetic field in the##2##4##(2008-2#1)(2008-3#1)
electromagnetic field in##5##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)
electromagnetic field##16##2##(1992-4#1)(2007-11#2)(2007-12#2)(2008-12#3)(2008-2#3)(2008-3#4)(2013-7#1)
electromagnetic fields and##2##3##(1992-3#1)(2008-12#1)
electromagnetic fields are##2##3##(2008-2#1)(2008-8#1)
electromagnetic fields of##2##3##(2008-3#2)
electromagnetic fields##20##2##(1992-11#1)(1992-3#2)(2008-10#1)(2008-12#4)(2008-2#4)(2008-3#5)(2008-8#1)(2009-3#1)(2011-2#1)
electromagnetic flow##2##2##(2007-10#1)(2008-3#1)
electromagnetic interference##2##2##(2011-2#1)(2013-8#1)
electromagnetic methods##2##2##(2008-3#1)(2010-8#1)
electromagnetic pulses by use of##2##5##(2007-11#1)(2007-12#1)
electromagnetic pulses##5##2##(2007-11#2)(2007-12#3)
electromagnetic radiation##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-10#1)
electromagnetic scattering by##3##3##(2008-2#2)(2008-3#1)
electromagnetic scattering##7##2##(2008-2#4)(2008-3#3)
electromagnetic theory##7##2##(2008-2#1)(2008-3#6)
electromagnetic vector-field##2##2##(2008-2#2)
electromagnetic wave propagation##2##3##(2007-11#1)(2008-2#1)
electromagnetic wave theory##3##3##(2008-3#3)
electromagnetic wave##9##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)
electromagnetic wavelets##3##2##(2008-2#3)
electromagnetic waves in##2##3##(2008-3#2)
electromagnetic waves##12##2##(2007-12#1)(2008-2#1)(2008-3#4)(2010-7#1)(2012-2#2)(2012-3#3)
electromagnetic##146##1##(1992-11#1)(1992-3#4)(1992-4#1)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#13)(2008-10#1)(2008-12#7)(2008-2#31)(2008-3#47)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
electromagnetic-wave##2##1##(2007-12#1)(2008-3#1)
electromagnetically induced transparency (EIT) in##2##5##(2007-11#1)(2007-12#1)
electromagnetically induced transparency (EIT)##3##4##(2007-11#1)(2007-12#2)
electromagnetically induced transparency##6##3##(2007-11#2)(2007-12#4)
electromechanical arrest##3##2##(1991-3#1)(1996-9#2)
electromechanical mapping##2##2##(2013-7#2)
electromechanical##16##1##(1991-3#1)(1992-8#1)(1996-9#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-9#3)(2013-7#2)
electromembrane extraction##2##2##(2012-1#2)
electrometric##2##1##(2008-10#2)
electromigration##2##1##(1996-5#1)(2008-10#1)
electromobility shift##3##2##(1992-12#1)(2008-10#1)(2012-2#1)
electromotive force of galvanic##2##4##(2008-10#2)
electromotive force##6##2##(2007-12#2)(2008-10#4)
electromotive##7##1##(2007-12#2)(2008-10#5)
electromyogram##4##1##(1992-2#1)(1997-7#1)(2009-8#1)(2013-8#1)
electromyographic (EMG)##3##2##(1990-9#1)(2008-10#1)(2013-1#1)
electromyographic activity of the##5##4##(1995-2#1)(2010-6#2)(2010-9#2)
electromyographic activity##6##2##(1995-2#1)(2010-6#2)(2010-9#2)(2012-2#1)
electromyographic recordings##2##2##(1990-11#1)(1995-8#1)
electromyographic signal##3##2##(2010-6#1)(2010-9#2)
electromyographic##21##1##(1990-11#2)(1990-9#1)(1991-6#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#4)(2010-9#4)(2012-2#1)(2012-3#1)(2013-1#1)
electromyography (EMG)##4##2##(2008-3#1)(2010-8#1)(2010-9#1)(2012-12#1)
electromyography and##3##2##(1990-6#1)(2008-6#1)(2012-3#1)
electromyography##20##1##(1990-6#1)(1993-2#1)(1996-5#1)(2008-3#1)(2008-6#1)(2009-6#2)(2010-6#4)(2010-8#2)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
electron acceptor in the##2##4##(1992-6#1)(1995-2#1)
electron acceptor in##4##3##(1990-7#1)(1992-6#1)(1995-2#1)(2008-10#1)
electron acceptor##14##2##(1990-7#2)(1992-11#1)(1992-3#1)(1992-6#2)(1994-11#1)(1995-2#3)(2008-10#2)(2008-11#1)(2009-8#1)
electron acceptors##4##2##(1994-5#1)(1995-3#1)(2009-9#1)(2011-2#1)
electron and light##2##3##(2007-12#1)(2008-10#1)
electron and##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-7#1)
electron attachment rate##2##3##(2008-10#2)
electron beam evaporation##6##3##(2008-10#5)(2009-7#1)
electron beam induced deposition##2##4##(2009-11#2)
electron beam irradiated##2##3##(2009-7#2)
electron beam irradiation##6##3##(1991-6#1)(1992-12#1)(1994-11#2)(2008-11#1)(2009-7#1)
electron beam lithography##2##3##(2007-12#1)(2010-4#1)
electron beam##36##2##(1991-6#1)(1992-12#1)(1994-11#2)(1995-9#1)(2007-10#2)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-11#5)(2009-7#6)(2010-4#1)(2011-1#1)(2011-2#1)
electron beams##10##2##(2007-10#2)(2008-3#1)(2009-11#3)(2012-1#4)
electron bunches consist of trains of picosecond pulses extracted from a photocathode by a drive laser system##2##17##(2008-2#2)
electron capture detection (ECD)##2##4##(2008-10#2)
electron capture detection##6##3##(2008-10#6)
electron capture detector (ECD)##2##4##(2008-10#2)
electron capture detector##8##3##(2008-10#8)
electron capture##16##2##(2008-10#16)
electron carrier##2##2##(1991-5#1)(1993-11#1)
electron cyclotron##3##2##(1994-2#1)(2008-3#1)(2011-1#1)
electron deficient##2##2##(2008-10#1)(2012-3#1)
electron delocalization in##2##3##(2007-11#1)(2007-12#1)
electron dense granules##2##3##(2007-12#1)(2008-5#1)
electron dense material##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
electron dense materials##2##3##(2007-12#1)(2008-10#1)
electron dense##13##2##(1992-3#1)(2007-12#4)(2008-10#1)(2008-5#3)(2008-7#4)
electron densities##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
electron density in the##2##4##(2007-12#1)(2008-3#1)
electron density##18##2##(1991-3#1)(1992-9#2)(1993-8#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#2)(2008-3#1)(2008-9#2)
electron diffraction##2##2##(2008-10#1)(2009-8#1)
electron donating or##2##3##(2009-9#1)(2010-5#1)
electron donating##5##2##(2008-10#2)(2009-9#1)(2010-5#2)
electron donor##13##2##(1991-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-8#1)(1995-2#1)(2008-8#4)(2011-2#1)
electron donors and##2##3##(1994-5#1)(2008-10#1)
electron donors##4##2##(1992-8#1)(1994-5#1)(2008-10#1)(2009-9#1)
electron energies##3##2##(2007-10#1)(2008-3#2)
electron flow##4##2##(2008-4#1)(2009-10#3)
electron impact mass spectrometric##3##4##(2008-10#3)
electron impact##6##2##(2008-10#5)(2008-3#1)
electron injection##6##2##(2008-10#5)(2008-2#1)
electron ionization##2##2##(2008-10#2)
electron irradiation##2##2##(1995-9#2)
electron lucent granules##2##3##(2008-5#1)(2008-7#1)
electron lucent##5##2##(2007-12#1)(2008-5#2)(2008-7#2)
electron mediator##4##2##(2008-10#3)(2008-6#1)
electron mediators##2##2##(2008-10#2)
electron micrographs of##3##3##(1991-5#1)(2008-5#1)(2009-11#1)
electron micrographs##8##2##(1991-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-11#1)
electron microprobe##3##2##(1990-5#1)(2008-10#2)
electron microscope (SEM)##5##3##(2008-10#1)(2008-5#1)(2009-11#1)(2009-3#1)(2012-3#1)
electron microscope and##2##3##(1991-12#1)(1991-9#1)
electron microscope investigations##3##3##(2008-10#2)(2008-6#1)
electron microscope observations##4##3##(1995-6#2)(2008-10#1)(2012-3#1)
electron microscope##47##2##(1991-12#1)(1991-9#1)(1992-12#1)(1995-12#1)(1995-6#2)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-3#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#3)
electron microscopes##2##2##(2008-12#1)(2008-7#1)
electron microscopic examination##3##3##(1996-6#1)(2008-5#1)(2008-7#1)
electron microscopic level##4##3##(1991-9#1)(1995-3#1)(2008-7#2)
electron microscopic observations showed that##2##5##(1994-2#1)(2008-10#1)
electron microscopic observations##3##3##(1994-2#1)(2008-10#1)(2008-6#1)
electron microscopic studies##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
electron microscopic study##3##3##(1995-12#1)(1995-8#1)(1996-5#1)
electron microscopic##31##2##(1990-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-11#1)(2011-2#1)
electron microscopical study##2##3##(2007-12#2)
electron microscopical##7##2##(2007-12#3)(2008-7#4)
electron microscopy (EM)##4##3##(1992-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
electron microscopy (SEM)##37##3##(1992-2#1)(1996-3#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-7#4)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
electron microscopy (TEM)##16##3##(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
electron microscopy analysis##2##3##(2008-6#1)(2009-7#1)
electron microscopy and atomic force microscopy##2##6##(2008-2#1)(2010-2#1)
electron microscopy and by##2##4##(2008-10#1)(2008-7#1)
electron microscopy and image##2##4##(2008-4#1)(2008-9#1)
electron microscopy and##31##3##(1990-8#1)(1994-11#1)(1995-6#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-2#1)
electron microscopy confirmed the presence of##2##6##(2008-10#2)
electron microscopy images##2##3##(1997-2#1)(2008-10#1)
electron microscopy in order to##3##5##(2007-12#1)(2008-10#1)(2008-7#1)
electron microscopy in##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
electron microscopy observations##3##3##(2008-10#2)(2012-3#1)
electron microscopy of infected##2##4##(2008-10#1)(2008-8#1)
electron microscopy of the##4##4##(1993-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
electron microscopy of vascular corrosion casts and correlative light microscopy##2##10##(2011-2#2)
electron microscopy of##15##3##(1992-9#1)(1993-2#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#2)
electron microscopy revealed that##4##4##(1997-3#1)(2008-10#2)(2008-8#1)
electron microscopy revealed##9##3##(1994-7#1)(1997-3#1)(2008-10#5)(2008-8#1)(2013-8#1)
electron microscopy reveals that##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
electron microscopy reveals##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
electron microscopy showed that the##2##5##(1992-9#1)(2008-8#1)
electron microscopy showed that##6##4##(1992-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
electron microscopy showed##12##3##(1992-9#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)
electron microscopy studies##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
electron microscopy to determine the##2##5##(2008-10#1)(2009-7#1)
electron microscopy to determine##3##4##(2008-10#1)(2008-5#1)(2009-7#1)
electron microscopy to##11##3##(2007-12#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
electron microscopy using##3##3##(1994-8#1)(2008-10#2)
electron microscopy was used##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
electron microscopy was##6##3##(2007-12#1)(2008-10#2)(2008-5#2)(2010-6#1)
electron microscopy we demonstrated that##2##5##(1992-8#1)(2008-11#1)
electron microscopy we##4##3##(1992-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
electron microscopy were used##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
electron microscopy were##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
electron microscopy##317##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-2#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-2#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-6#4)(1996-3#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#22)(2007-6#2)(2007-7#3)(2008-1#2)(2008-10#98)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#25)(2008-6#4)(2008-7#19)(2008-8#10)(2008-9#7)(2009-10#1)(2009-11#6)(2009-2#4)(2009-5#1)(2009-7#9)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#4)
electron microscopy-energy dispersive##2##3##(2008-10#1)(2011-2#1)
electron paramagnetic resonance (EPR) spectroscopy##3##5##(1991-9#1)(2008-10#1)(2008-5#1)
electron paramagnetic resonance (EPR)##7##4##(1990-2#1)(1991-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)
electron paramagnetic resonance spectroscopy##4##4##(1993-11#2)(1997-1#1)(2008-10#1)
electron paramagnetic resonance##16##3##(1990-12#1)(1990-2#1)(1991-9#1)(1993-11#3)(1997-1#2)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-5#1)
electron pulse irradiation##2##3##(2008-8#1)(2008-9#1)
electron rich##2##2##(1996-5#1)(2012-3#1)
electron self-exchange##3##2##(1993-11#1)(1994-5#1)(1997-7#1)
electron spin resonance (ESR)##7##4##(1990-5#1)(2008-10#4)(2008-5#1)(2008-9#1)
electron spin resonance##12##3##(1990-5#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)
electron spin##14##2##(1990-5#1)(1993-11#1)(1996-2#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)
electron temperature was##2##3##(2008-3#2)
electron temperature##4##2##(2008-2#1)(2008-3#3)
electron to##2##2##(2008-10#1)(2009-12#1)
electron transfer (PET)##3##3##(2008-10#3)
electron transfer and##2##3##(1995-2#1)(2009-9#1)
electron transfer between the##3##4##(1995-2#1)(1995-5#1)(2008-10#1)
electron transfer between##10##3##(1992-6#1)(1995-2#1)(1995-5#1)(2008-10#6)(2008-8#1)
electron transfer by##2##3##(1993-8#1)(2008-10#1)
electron transfer can##2##3##(1992-6#1)(2009-9#1)
electron transfer chain##2##3##(1991-12#1)(2006-10#1)
electron transfer component##2##3##(1996-3#1)(2009-9#1)
electron transfer from the##2##4##(1995-2#1)(2008-10#1)
electron transfer from##5##3##(1994-5#1)(1995-2#1)(1997-7#1)(2008-10#2)
electron transfer in the##2##4##(1991-5#1)(1992-6#1)
electron transfer in##4##3##(1991-5#1)(1992-6#2)(1995-3#1)
electron transfer is##2##3##(2008-10#1)(2009-3#1)
electron transfer processes##2##3##(2008-10#2)
electron transfer rate between##2##4##(2008-10#1)(2008-8#1)
electron transfer rate constant##5##4##(2008-10#5)
electron transfer rate##11##3##(1991-8#1)(1993-11#1)(2008-10#8)(2008-8#1)
electron transfer reactions##2##3##(1990-5#1)(2008-5#1)
electron transfer to##5##3##(1992-6#1)(2008-10#3)(2009-9#1)
electron transfer was##5##3##(1990-5#1)(1995-2#2)(2008-10#2)
electron transfer##86##2##(1990-5#5)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#7)(1993-11#2)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#7)(1995-3#1)(1995-5#2)(1996-3#1)(1997-7#1)(2006-10#1)(2008-10#38)(2008-12#1)(2008-5#1)(2008-8#4)(2009-3#2)(2009-9#5)(2012-2#1)
electron transport activity##2##3##(1990-5#1)(1996-4#1)
electron transport and the##2##4##(2008-7#1)(2009-9#1)
electron transport and##3##3##(2008-7#1)(2009-9#2)
electron transport chain and##2##4##(2008-10#1)(2010-12#1)
electron transport rate##2##3##(2008-8#1)(2008-9#1)
electron transport system##2##3##(1991-5#1)(2013-1#1)
electron transport##39##2##(1990-11#1)(1990-5#2)(1991-12#1)(1991-5#2)(1992-11#1)(1994-11#1)(1994-3#3)(1995-2#1)(1995-3#1)(1996-4#4)(2008-10#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-9#6)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
electron tunneling wires##2##3##(2009-9#2)
electron tunneling##5##2##(1995-2#1)(2008-3#1)(2009-9#2)(2010-7#1)
electron withdrawing groups##2##3##(2007-11#1)(2009-9#1)
electron withdrawing##6##2##(2007-11#1)(2008-10#1)(2009-9#3)(2010-5#1)
electron##872##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#9)(1990-7#2)(1990-8#4)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#8)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#5)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#12)(1992-8#4)(1992-9#5)(1993-11#10)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#4)(1993-9#3)(1994-10#2)(1994-11#5)(1994-2#3)(1994-3#4)(1994-5#4)(1994-7#1)(1994-8#4)(1995-12#2)(1995-2#14)(1995-3#8)(1995-5#2)(1995-6#8)(1995-8#1)(1995-9#3)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#1)(1997-6#3)(1997-7#4)(2006-10#2)(2006-4#2)(2006-6#1)(2007-10#5)(2007-11#5)(2007-12#46)(2007-4#1)(2007-6#2)(2007-7#3)(2008-1#2)(2008-10#247)(2008-11#18)(2008-12#6)(2008-2#14)(2008-3#25)(2008-4#4)(2008-5#42)(2008-6#9)(2008-7#47)(2008-8#30)(2008-9#15)(2009-10#5)(2009-11#22)(2009-12#1)(2009-2#4)(2009-3#3)(2009-5#2)(2009-7#17)(2009-8#4)(2009-9#21)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#13)(2012-1#7)(2012-2#12)(2012-3#9)(2012-5#1)(2013-1#9)(2013-8#5)
electron-beam evaporation##5##2##(2008-2#2)(2008-3#3)
electron-beam lithography and##2##3##(2008-3#2)
electron-beam lithography##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
electron-beam##24##1##(2007-12#3)(2007-8#1)(2008-2#6)(2008-3#13)(2009-11#1)
electron-dense granular##2##2##(1992-11#1)(2008-7#1)
electron-dense inclusions##2##2##(2008-10#2)
electron-dense material##2##2##(2007-12#1)(2008-7#1)
electron-dense##23##1##(1990-8#1)(1992-11#1)(1992-2#1)(2007-12#4)(2008-10#11)(2008-7#5)
electron-lucent vacuoles##2##2##(2007-12#1)(2008-7#1)
electron-lucent##6##1##(2007-12#1)(2008-7#4)(2012-1#1)
electron-microscopic##3##1##(1997-2#2)(2008-10#1)
electron-opaque material##4##2##(2008-10#4)
electron-opaque##5##1##(2008-10#5)
electron-rich##2##1##(1996-5#1)(2009-12#1)
electron-transfer activity##2##2##(1995-2#2)
electron-transfer rate##2##2##(1995-2#1)(2008-10#1)
electron-transfer reactions##4##2##(1992-6#1)(1997-7#1)(2008-10#1)(2010-7#1)
electron-transfer##19##1##(1990-5#1)(1992-6#1)(1993-11#1)(1994-5#3)(1995-2#3)(1997-7#1)(2008-10#7)(2008-8#1)(2010-7#1)
electron-trapping device##3##2##(2008-3#3)
electron-trapping##4##1##(2007-12#1)(2008-3#3)
electron-withdrawing group##2##2##(1995-3#1)(1996-5#1)
electron-withdrawing##7##1##(1992-6#1)(1995-3#2)(1995-6#1)(1996-5#1)(2008-10#2)
electronegativity##2##1##(2007-11#1)(2009-9#1)
electroneurostimulation##2##1##(2012-1#2)
electronic absorption and##2##3##(1990-5#1)(2008-10#1)
electronic absorption spectrum##2##3##(1993-11#1)(1993-8#1)
electronic absorption##8##2##(1990-5#1)(1993-11#1)(1993-8#1)(1996-2#1)(2008-10#2)(2008-2#2)
electronic and manual##2##3##(2008-10#1)(2008-7#1)
electronic and steric##2##3##(1994-5#1)(2012-12#1)
electronic and##8##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-11#1)(2012-12#1)
electronic aroma##2##2##(2008-10#2)
electronic cell##2##2##(2008-4#1)(2008-9#1)
electronic chips##2##2##(2008-3#2)
electronic circuit##2##2##(2008-11#1)(2008-3#1)
electronic circuitry##2##2##(2008-7#2)
electronic circuits##2##2##(2008-2#1)(2008-3#1)
electronic communication between##2##3##(2008-10#1)(2009-9#1)
electronic communication##3##2##(2008-10#1)(2009-9#1)(2010-8#1)
electronic conduction##2##2##(2009-11#2)
electronic conductivity##2##2##(2008-10#2)
electronic control devices##2##3##(2010-1#2)
electronic control##5##2##(2007-12#1)(2008-3#1)(2010-1#2)(2010-8#1)
electronic coupling##8##2##(1995-2#2)(2008-10#1)(2009-11#2)(2010-2#2)(2012-2#1)
electronic data publishing##2##3##(1991-5#2)
electronic data##9##2##(1990-11#1)(1991-5#2)(1991-8#1)(1993-3#1)(2008-3#1)(2011-2#3)
electronic databases and##3##3##(2008-10#1)(2010-2#1)(2013-8#1)
electronic databases##12##2##(2008-10#1)(2009-2#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#2)
electronic device##4##2##(2008-10#1)(2008-7#1)(2009-11#2)
electronic devices##7##2##(2007-11#1)(2008-7#5)(2012-12#1)
electronic effects##3##2##(1992-10#1)(2010-2#2)
electronic emergency department##2##3##(2011-9#1)(2012-3#1)
electronic excitations##2##2##(2008-3#1)(2008-7#1)
electronic feedback##4##2##(2007-11#2)(2007-12#2)
electronic functionality##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
electronic health information##2##3##(1994-2#1)(2010-8#1)
electronic health record##8##3##(2007-12#1)(2010-8#2)(2013-1#5)
electronic health records##8##3##(2007-12#2)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
electronic health sciences library for the twenty-first century##2##8##(1996-12#2)
electronic health##20##2##(1994-2#1)(1996-12#2)(2007-12#3)(2010-4#2)(2010-8#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
electronic information##3##2##(1996-12#1)(1996-3#1)(1997-2#1)
electronic interactions##3##2##(1994-5#1)(2009-6#1)(2013-1#1)
electronic mail##5##2##(1992-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-2#1)
electronic means##2##2##(2007-11#1)(2008-3#1)
electronic media##3##2##(1991-5#1)(1993-12#1)(1997-2#1)
electronic medical databases##3##3##(2010-8#3)
electronic medical record##6##3##(1993-12#1)(1994-3#1)(1996-3#1)(2007-9#1)(2009-10#1)(2011-2#1)
electronic medical records##10##3##(1993-11#1)(2006-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#5)
electronic medical##22##2##(1993-11#1)(1993-12#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-8#6)(2011-2#3)(2012-3#5)
electronic microscopy##6##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)
electronic multichip##2##2##(2008-3#2)
electronic nerve stimulators##2##3##(2008-10#2)
electronic networks##2##2##(1996-3#1)(2008-3#1)
electronic noise##2##2##(2007-12#1)(2008-2#1)
electronic nose##13##2##(2008-10#8)(2008-11#2)(2012-2#3)
electronic parts##2##2##(2008-2#1)(2008-3#1)
electronic patient record##4##3##(1997-1#2)(2010-4#1)(2012-12#1)
electronic patient##5##2##(1997-1#2)(2008-7#1)(2010-4#1)(2012-12#1)
electronic portal imaging##3##3##(1993-9#1)(2008-2#1)(2009-2#1)
electronic processing##3##2##(2008-2#1)(2008-3#2)
electronic properties of the##2##4##(1996-2#2)
electronic properties of##3##3##(1992-8#1)(1996-2#2)
electronic properties##6##2##(1992-8#1)(1996-2#2)(2008-10#1)(2008-7#2)
electronic questionnaire##3##2##(2011-2#2)(2012-3#1)
electronic record##3##2##(1997-8#1)(2013-1#2)
electronic records##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
electronic search##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
electronic sensor array for label-free detection of single-nucleotide polymorphisms##2##9##(2013-1#2)
electronic sensor##4##2##(2008-10#2)(2013-1#2)
electronic sources##2##2##(1996-12#1)(2008-11#1)
electronic speckle pattern interferometry and##2##5##(2008-2#1)(2008-3#1)
electronic speckle pattern interferometry##8##4##(2008-2#4)(2008-3#4)
electronic speckle##11##2##(2008-2#5)(2008-3#6)
electronic speckle-pattern interferometer##2##3##(2008-3#2)
electronic speckle-pattern interferometry##5##3##(2008-3#5)
electronic speckle-pattern##7##2##(2008-3#7)
electronic spectra##3##2##(1997-7#1)(2008-10#2)
electronic state##4##2##(2007-12#1)(2008-10#3)
electronic states of##4##3##(2007-11#1)(2008-10#3)
electronic states##5##2##(2007-11#1)(2008-10#3)(2008-7#1)
electronic structure and##2##3##(2007-11#1)(2008-10#1)
electronic structure of##3##3##(1993-11#1)(1993-5#1)(2010-7#1)
electronic structure theory##2##3##(2008-11#2)
electronic structure##11##2##(1993-11#1)(1993-5#1)(1994-5#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-7#1)
electronic structures##2##2##(2010-7#1)(2012-2#1)
electronic systems##2##2##(2008-2#1)(2008-7#1)
electronic tongue (ET)##2##3##(2008-10#2)
electronic tongue based on##2##4##(2008-10#2)
electronic tongue for##2##3##(2008-10#2)
electronic tongue was##2##3##(2008-10#2)
electronic tongue##11##2##(2008-10#11)
electronic tongue&quot##2##2##(2008-10#2)
electronic tools##3##2##(2008-11#3)
electronic transition of##2##3##(2008-2#1)(2013-8#1)
electronic type##2##2##(2008-7#2)
electronic version##3##2##(1994-2#1)(2008-3#1)(2008-9#1)
electronic videoendoscope system##2##3##(2008-5#2)
electronic workshop##2##2##(2008-7#2)
electronic##412##1##(1990-11#1)(1990-5#1)(1990-8#3)(1991-5#7)(1991-8#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#1)(1995-1#2)(1995-2#4)(1995-3#3)(1996-1#1)(1996-12#6)(1996-2#4)(1996-3#7)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#15)(2007-12#10)(2007-9#1)(2008-1#3)(2008-10#62)(2008-11#16)(2008-2#28)(2008-3#47)(2008-4#1)(2008-5#4)(2008-7#31)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#8)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#7)(2010-4#3)(2010-7#2)(2010-8#13)(2011-1#1)(2011-2#15)(2011-9#2)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#15)(2013-8#4)
electronic-speckle-pattern interferometer##2##2##(2008-3#2)
electronical##3##1##(2007-12#1)(2008-11#2)
electronically controlled##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
electronically excited##2##2##(2008-2#1)(2010-7#1)
electronically tuned##4##2##(2007-11#1)(2007-12#3)
electronically##23##1##(1993-5#1)(1994-12#1)(1995-12#1)(2007-11#2)(2007-12#8)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-12#1)
electronics and##2##2##(2008-3#1)(2010-7#1)
electronics to##2##2##(2008-3#1)(2008-7#1)
electronics##39##1##(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#18)(2010-7#1)(2010-8#1)(2012-2#2)
electrons and holes##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
electrons and##6##2##(2007-11#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-8#1)
electrons for the##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
electrons from##2##2##(1994-8#1)(2008-11#1)
electrons in semiconductor heterostructures##2##4##(1990-12#1)(2007-12#1)
electrons in##5##2##(1990-12#1)(2007-10#1)(2007-12#1)(2008-3#1)(2012-2#1)
electrons of##2##2##(1996-2#1)(2008-7#1)
electrons or##2##2##(2010-12#1)(2010-2#1)
electrons to##2##2##(1991-5#1)(1994-8#1)
electrons##51##1##(1990-12#1)(1991-5#2)(1994-8#2)(1994-9#1)(1995-3#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#7)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#6)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#5)(2013-8#1)
electroosmosis pump##3##2##(2008-10#3)
electroosmosis##4##1##(2008-10#4)
electroosmotic flow (EOF) modifier##2##4##(1996-5#1)(1997-2#1)
electroosmotic flow (EOF)##5##3##(1996-5#1)(1997-2#1)(2008-10#3)
electroosmotic flow and##2##3##(1996-5#1)(2008-10#1)
electroosmotic flow modifier##2##3##(1994-9#1)(2008-10#1)
electroosmotic flow##13##2##(1994-9#2)(1996-5#2)(1997-2#1)(2008-10#7)(2009-12#1)
electroosmotic mobility##4##2##(1996-5#1)(2008-10#3)
electroosmotic pump flow injection system##2##5##(2008-10#2)
electroosmotic pump##4##2##(2008-10#4)
electroosmotic##23##1##(1994-9#2)(1996-5#3)(1997-2#1)(2008-10#16)(2009-12#1)
electrooxidation##4##1##(2008-10#4)
electropherogram##3##1##(2008-10#3)
electropherograms of##2##2##(1994-9#1)(2008-10#1)
electropherograms were##2##2##(2008-10#2)
electropherograms##9##1##(1994-9#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-6#1)
electrophiles##4##1##(1995-11#1)(2008-10#1)(2009-5#1)(2009-9#1)
electrophilic attack##2##2##(1996-5#1)(2009-8#1)
electrophilic##14##1##(1991-9#1)(1992-11#1)(1993-8#1)(1994-5#1)(1996-2#1)(1996-5#2)(2008-11#2)(2008-4#1)(2009-8#1)(2010-12#2)(2011-1#1)
electrophoregrams##3##1##(1990-7#1)(2008-10#2)
electrophoresed in##3##2##(1992-8#1)(2008-2#1)(2008-4#1)
electrophoresed##10##1##(1992-8#1)(1993-6#2)(2008-2#1)(2008-4#6)
electrophoresis (CE) has##3##3##(2008-10#2)(2008-5#1)
electrophoresis (CE) with electrochemical detection##2##5##(2008-10#2)
electrophoresis (CE) with##5##3##(2008-10#5)
electrophoresis (CE)##39##2##(1994-9#1)(1996-5#2)(1997-2#1)(2008-10#29)(2008-2#1)(2008-4#2)(2008-5#1)(2010-5#1)(2010-7#1)
electrophoresis (CZE)##20##2##(1994-9#1)(1996-5#1)(2008-10#18)
electrophoresis analysis##8##2##(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)
electrophoresis and detected##2##3##(2008-10#2)
electrophoresis and##36##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-4#5)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
electrophoresis are##3##2##(1996-5#1)(2008-4#1)(2008-9#1)
electrophoresis as##3##2##(1994-9#1)(2008-10#1)(2008-5#1)
electrophoresis assay##5##2##(1994-8#1)(1996-2#2)(1997-4#2)
electrophoresis at##2##2##(2008-10#2)
electrophoresis can be performed##2##4##(2008-3#1)(2008-4#1)
electrophoresis coupled to##2##3##(2008-10#1)(2010-5#1)
electrophoresis coupled##3##2##(2008-10#2)(2010-5#1)
electrophoresis for the separation of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
electrophoresis for the##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
electrophoresis for##10##2##(2008-10#6)(2008-2#1)(2008-4#2)(2008-5#1)
electrophoresis has##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
electrophoresis in the presence of##2##5##(1992-12#1)(2008-10#1)
electrophoresis in the##4##3##(1992-12#1)(1993-9#1)(1996-5#1)(2008-10#1)
electrophoresis in##14##2##(1991-1#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
electrophoresis indicated##2##2##(1991-12#1)(1992-9#1)
electrophoresis is a##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
electrophoresis is##9##2##(1994-9#1)(1995-2#1)(2008-10#5)(2008-4#2)
electrophoresis method for the determination of##3##6##(2008-10#3)
electrophoresis method for the##10##4##(1994-12#1)(1997-2#2)(2008-10#6)(2008-4#1)
electrophoresis method for##11##3##(1994-12#1)(1997-2#2)(2008-10#7)(2008-4#1)
electrophoresis method##17##2##(1994-12#1)(1997-2#2)(2008-10#12)(2008-4#1)(2009-8#1)
electrophoresis mobility##2##2##(2008-11#1)(2008-9#1)
electrophoresis of DNA##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
electrophoresis of the##2##3##(1990-5#1)(2008-10#1)
electrophoresis of##30##2##(1990-5#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#2)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-4#2)(2010-8#1)(2011-2#1)
electrophoresis on##2##2##(1991-12#1)(1995-2#1)
electrophoresis or##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
electrophoresis revealed##2##2##(1997-6#1)(2010-2#1)
electrophoresis separation##4##2##(2008-10#4)
electrophoresis showed##8##2##(1992-12#1)(1996-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-12#1)
electrophoresis system##7##2##(1991-12#1)(2008-10#6)
electrophoresis tandem mass spectrometry (mPC-CE-MS/MS)##2##5##(2008-10#2)
electrophoresis technique##3##2##(1995-8#1)(1997-4#1)(2008-10#1)
electrophoresis to##12##2##(1991-5#1)(1996-5#1)(1997-3#1)(2008-10#8)(2010-12#1)
electrophoresis under denaturing conditions##2##4##(1994-5#1)(2008-2#1)
electrophoresis under##3##2##(1994-5#1)(1995-5#1)(2008-2#1)
electrophoresis using##10##2##(1996-5#2)(2008-10#8)
electrophoresis was##9##2##(1991-12#1)(1994-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-3#2)(2013-1#1)
electrophoresis were##2##2##(2008-10#2)
electrophoresis whereas##2##2##(1991-9#1)(1994-6#1)
electrophoresis with a##2##3##(1994-9#1)(2008-10#1)
electrophoresis with amperometric detection##6##4##(2008-10#6)
electrophoresis with electrochemical detection (CE-ED) was##2##6##(2008-10#2)
electrophoresis with electrochemical detection##6##4##(2008-10#6)
electrophoresis with electrochemical##8##3##(2008-10#8)
electrophoresis with indirect##2##3##(1996-5#1)(2008-10#1)
electrophoresis with##42##2##(1991-12#1)(1992-8#1)(1994-9#4)(1996-5#1)(1997-2#1)(2008-10#33)(2008-8#1)
electrophoresis##614##1##(1990-10#2)(1990-11#6)(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#1)(1991-1#1)(1991-12#7)(1991-2#1)(1991-5#5)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#2)(1993-6#1)(1993-8#4)(1993-9#4)(1994-11#5)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#17)(1995-12#3)(1995-2#4)(1995-5#2)(1995-6#3)(1995-8#3)(1996-12#6)(1996-2#2)(1996-5#21)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#10)(1997-3#1)(1997-4#9)(1997-6#1)(2007-6#1)(2008-1#8)(2008-10#293)(2008-11#12)(2008-12#3)(2008-2#16)(2008-3#2)(2008-4#34)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#1)
electrophoresis)##4##1##(1990-2#1)(1990-8#1)(2008-10#1)(2008-4#1)
electrophoresis-tandem mass spectrometry##4##3##(1997-2#4)
electrophoretic analyses##2##2##(1992-11#1)(1993-9#1)
electrophoretic analysis of the##2##4##(1992-9#1)(1993-11#1)
electrophoretic analysis of##7##3##(1991-12#1)(1992-9#1)(1993-11#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-2#1)
electrophoretic analysis##11##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-11#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)
electrophoretic and chromatographic##2##3##(2008-4#1)(2008-5#1)
electrophoretic and##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
electrophoretic buffer##2##2##(1997-2#1)(2008-10#1)
electrophoretic determination of##3##3##(1994-9#1)(2008-10#2)
electrophoretic method for##2##3##(1992-6#1)(2008-10#1)
electrophoretic method was##4##3##(1996-5#1)(2008-10#3)
electrophoretic method##9##2##(1992-6#1)(1993-3#1)(1996-5#1)(2008-10#5)(2008-4#1)
electrophoretic microchip##2##2##(2008-10#2)
electrophoretic migration##2##2##(1990-5#1)(2008-10#1)
electrophoretic mobilities of##4##3##(1990-7#1)(2008-10#3)
electrophoretic mobilities##7##2##(1990-7#1)(1994-9#1)(2008-10#4)(2008-3#1)
electrophoretic mobility and##2##3##(1992-6#1)(1996-9#1)
electrophoretic mobility in##2##3##(1992-6#1)(1994-9#1)
electrophoretic mobility of##5##3##(1992-6#1)(1992-8#1)(1994-11#1)(2008-10#2)
electrophoretic mobility shift assay##4##4##(2008-11#2)(2008-4#1)(2011-2#1)
electrophoretic mobility shift assays##2##4##(1994-9#1)(2008-9#1)
electrophoretic mobility shift##7##3##(1994-9#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#1)
electrophoretic mobility##33##2##(1990-12#1)(1991-2#1)(1992-6#4)(1992-8#1)(1994-11#2)(1994-9#2)(1995-11#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
electrophoretic paint##2##2##(2008-10#2)
electrophoretic pattern##2##2##(2008-10#1)(2008-5#1)
electrophoretic patterns##2##2##(2012-12#2)
electrophoretic separation and##2##3##(2008-1#1)(2008-10#1)
electrophoretic separation of proteins##2##4##(2010-11#1)(2012-2#1)
electrophoretic separation of##5##3##(1994-9#1)(1997-2#1)(2008-4#1)(2010-11#1)(2012-2#1)
electrophoretic separation##9##2##(1994-12#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-11#1)(2012-2#1)
electrophoretic separations##2##2##(1996-5#1)(2008-10#1)
electrophoretic system incorporating an##2##4##(2008-10#2)
electrophoretic##134##1##(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#2)(1991-12#2)(1991-2#2)(1992-11#1)(1992-6#5)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#6)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#3)(1997-7#1)(2008-1#4)(2008-10#45)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#10)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
electrophoretically##8##1##(1994-5#1)(1997-2#1)(2008-10#2)(2008-4#3)(2008-8#1)
electrophoretogram of Magnolia officinalis seeds from##2##6##(2012-3#2)
electrophysiologic studies##4##2##(1990-3#2)(2008-9#2)
electrophysiologic study##3##2##(2007-8#1)(2008-12#2)
electrophysiologic##16##1##(1990-3#3)(1993-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-9#2)(2009-5#1)(2010-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
electrophysiological and psychophysical##2##3##(2008-9#2)
electrophysiological and##6##2##(1993-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)
electrophysiological characteristics##2##2##(1994-9#1)(2012-12#1)
electrophysiological effects of##2##3##(1992-9#1)(2008-7#1)
electrophysiological evidence##3##2##(1996-5#1)(1997-2#1)(1997-3#1)
electrophysiological findings##2##2##(1993-8#1)(2009-10#1)
electrophysiological methods##2##2##(1996-5#1)(2008-12#1)
electrophysiological properties##2##2##(2008-12#1)(2009-12#1)
electrophysiological studies##3##2##(1994-2#1)(2007-8#1)(2008-5#1)
electrophysiological techniques##3##2##(2008-4#2)(2008-5#1)
electrophysiological tests may be required for the diagnosis of delayed neuropathy of OP poisoning##2##14##(2013-1#2)
electrophysiological tests##3##2##(2012-2#1)(2013-1#2)
electrophysiological##61##1##(1990-9#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
electrophysiologically in##2##2##(1992-8#1)(1993-12#1)
electrophysiologically##13##1##(1990-7#1)(1992-8#1)(1993-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
electrophysiology and##2##2##(1993-12#1)(2012-3#1)
electrophysiology of##2##2##(2008-7#1)(2012-2#1)
electrophysiology study##2##2##(2008-11#2)
electrophysiology to##2##2##(2008-7#1)(2009-5#1)
electrophysiology##26##1##(1990-5#1)(1992-3#1)(1993-12#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
electroplating baths##3##2##(2008-10#3)
electroplating plant##3##2##(2008-10#3)
electroplating##11##1##(1994-9#1)(2008-10#10)
electropolymerization and##2##2##(2008-10#2)
electropolymerization of pyrrole##3##3##(2008-10#3)
electropolymerization of##12##2##(2008-10#12)
electropolymerization##22##1##(2008-10#21)(2008-5#1)
electropolymerized films of metal tetraaminophthalocyanines##2##5##(2008-10#2)
electropolymerized films of##3##3##(2008-10#3)
electropolymerized o-phenylenediamine film doped with##2##5##(2008-10#2)
electropolymerized o-phenylenediamine film##3##3##(2008-10#3)
electropolymerized onto##3##2##(2008-10#3)
electropolymerized##19##1##(1995-3#1)(2008-10#18)
electroporated##4##1##(1994-8#2)(2008-10#1)(2008-9#1)
electroporation and##2##2##(2008-9#1)(2009-11#1)
electroporation electrodes##2##2##(2009-11#2)
electroporation for##2##2##(2008-11#2)
electroporation has##2##2##(2008-9#1)(2009-11#1)
electroporation of##10##2##(1995-11#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#2)(2009-11#1)
electroporation protocol##2##2##(2008-11#1)(2008-9#1)
electroporation##44##1##(1990-11#1)(1990-5#2)(1994-2#1)(1994-5#1)(1995-11#1)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#2)(2008-11#13)(2008-2#3)(2008-4#1)(2008-9#7)(2009-11#7)
electroreduction##2##1##(2008-10#2)
electroresection##2##1##(1991-9#2)
electroshock##4##1##(1995-12#1)(2008-12#1)(2008-5#1)(2010-3#1)
electrospinning and mineralization##2##3##(2009-7#2)
electrospinning##11##1##(2009-12#1)(2009-7#3)(2010-10#5)(2012-1#2)
electrospray ionisation##2##2##(1995-5#1)(2008-10#1)
electrospray ionization (ESI)##2##3##(2008-10#2)
electrospray ionization MS##2##3##(2008-10#1)(2009-6#1)
electrospray ionization mass spectrometry##10##4##(1990-12#1)(1995-2#1)(1997-4#1)(2008-10#5)(2010-6#1)(2011-2#1)
electrospray ionization mass##13##3##(1990-12#1)(1995-2#1)(1997-4#1)(2008-10#8)(2010-6#1)(2011-2#1)
electrospray ionization##28##2##(1990-12#1)(1995-2#1)(1997-4#1)(2008-10#13)(2008-9#1)(2009-6#1)(2010-11#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#1)(2011-3#1)
electrospray ionization-ion mobility spectrometry##2##4##(2008-10#2)
electrospray ionization-ion##3##2##(2008-10#3)
electrospray ionization-mass spectrometry (ESI-MS)##3##4##(2008-5#1)(2011-1#2)
electrospray mass spectrometry (ESI-MS)##2##4##(2008-10#2)
electrospray mass spectrometry detection##4##4##(2008-10#4)
electrospray mass spectrometry was used##2##5##(2008-10#2)
electrospray mass spectrometry with##2##4##(2008-10#1)(2008-7#1)
electrospray mass spectrometry##18##3##(1991-2#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-12#1)(2008-10#11)(2008-7#2)
electrospray mass##19##2##(1991-2#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-12#1)(2008-10#11)(2008-7#3)
electrospray##66##1##(1990-12#1)(1991-2#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-2#2)(1997-4#1)(2008-10#37)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-11#2)(2010-6#1)(2010-7#2)(2011-1#5)(2011-2#1)(2011-3#1)
electrospray-mass spectrometry##2##2##(2008-10#2)
electrospun from##4##2##(2009-11#4)
electrospun scaffolds##2##2##(2009-7#2)
electrospun##14##1##(2008-5#2)(2009-11#5)(2009-12#1)(2009-7#5)(2009-9#1)
electrostatic adsorption##2##2##(2008-10#2)
electrostatic and hydrophobic##2##3##(1990-2#1)(2008-10#1)
electrostatic and##4##2##(1990-2#1)(1993-11#1)(2008-10#2)
electrostatic attraction##2##2##(2008-10#1)(2013-8#1)
electrostatic binding##3##2##(1990-2#1)(1997-2#2)
electrostatic component##2##2##(1995-2#1)(2008-4#1)
electrostatic effect##2##2##(1997-2#1)(2008-10#1)
electrostatic effects##2##2##(1994-8#1)(2008-7#1)
electrostatic field##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
electrostatic force##6##2##(2008-10#4)(2008-2#1)(2008-5#1)
electrostatic forces##4##2##(2008-10#1)(2009-5#3)
electrostatic free energy##2##3##(2008-4#2)
electrostatic gates##2##2##(2008-7#1)(2012-2#1)
electrostatic interaction between the##2##4##(2008-10#1)(2008-5#1)
electrostatic interaction between##5##3##(1995-5#1)(2008-10#1)(2008-5#1)(2012-6#1)(2013-1#1)
electrostatic interaction is##2##3##(2008-10#2)
electrostatic interaction of##3##3##(2008-10#3)
electrostatic interaction##15##2##(1995-5#1)(1996-5#1)(2008-10#10)(2008-5#1)(2012-6#1)(2013-1#1)
electrostatic interactions and##3##3##(2008-10#2)(2008-6#1)
electrostatic interactions of##2##3##(1990-12#1)(2008-10#1)
electrostatic interactions##20##2##(1990-12#1)(1994-5#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-4#4)(2008-6#1)(2013-1#3)
electrostatic model##2##2##(2007-11#1)(2008-7#1)
electrostatic potential##9##2##(1990-8#1)(1992-3#1)(1994-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#2)(2013-1#1)
electrostatic repulsion between##2##3##(2008-10#2)
electrostatic repulsion##4##2##(1990-8#1)(2008-10#2)(2008-8#1)
electrostatic self-assembly monolayer process##2##4##(2007-11#2)
electrostatic self-assembly##3##2##(2007-11#2)(2008-7#1)
electrostatic surface##2##2##(1994-5#2)
electrostatic##123##1##(1990-12#2)(1990-2#2)(1990-8#3)(1992-3#1)(1993-11#1)(1994-12#1)(1994-5#4)(1994-8#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#5)(2007-11#3)(2007-12#2)(2008-10#43)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#13)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2009-5#5)(2010-12#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#6)(2013-8#1)
electrostatically with##2##2##(2007-11#1)(2009-12#1)
electrostatically##9##1##(2007-11#1)(2008-10#5)(2008-4#1)(2009-12#1)(2011-2#1)
electrostatics and##2##2##(2008-10#1)(2008-4#1)
electrostatics##6##1##(2008-10#1)(2008-4#3)(2010-2#1)(2013-1#1)
electrostimulation##3##1##(1995-12#1)(2007-8#1)(2009-10#1)
electrostriction##3##1##(2007-12#1)(2008-10#1)(2008-2#1)
electrostrictive gratings##4##2##(2007-12#3)(2008-3#1)
electrostrictive##8##1##(2007-12#7)(2008-3#1)
electrosurgery and##3##2##(1996-1#2)(2012-3#1)
electrosurgery vs##2##2##(1996-1#2)
electrosurgery##7##1##(1996-1#4)(2012-3#3)
electrosurgical coagulation waveform##2##3##(1992-12#2)
electrosurgical loop conization##3##3##(1994-12#3)
electrosurgical loop##4##2##(1994-12#4)
electrosurgical resection##2##2##(1996-2#2)
electrosurgical##11##1##(1992-12#4)(1992-2#1)(1994-12#4)(1996-2#2)
electrosynthesis of##2##2##(2008-10#2)
electrosynthesized##2##1##(2008-10#2)
electrotherapy##2##1##(2008-12#1)(2010-12#1)
electrothermal AAS##2##2##(2008-10#2)
electrothermal atomic absorption spectrometric (ETAAS)##2##5##(2008-10#2)
electrothermal atomic absorption spectrometric determination of cadmium and lead##2##9##(2008-10#2)
electrothermal atomic absorption spectrometric determination of##4##6##(2008-10#4)
electrothermal atomic absorption spectrometric determination##5##5##(2008-10#5)
electrothermal atomic absorption spectrometric##8##4##(2008-10#8)
electrothermal atomic absorption spectrometry (ET AAS)##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS) determination of##2##7##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) is described##2##7##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) is##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS) using##2##6##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) with##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS)##28##5##(2008-10#28)
electrothermal atomic absorption spectrometry in##4##5##(2008-10#4)
electrothermal atomic absorption spectrometry with a##2##6##(2008-10#2)
electrothermal atomic absorption spectrometry with##9##5##(2008-10#9)
electrothermal atomic absorption spectrometry##105##4##(1995-6#1)(2008-10#104)
electrothermal atomic absorption##120##3##(1995-6#1)(2008-10#119)
electrothermal atomization atomic absorption spectrometry##4##5##(2008-10#4)
electrothermal atomization##7##2##(2008-10#7)
electrothermal vaporisation##3##2##(2008-10#3)
electrothermal vaporization (ETV)##2##3##(2008-10#2)
electrothermal vaporization inductively coupled plasma mass spectrometry##4##7##(2008-10#4)
electrothermal vaporization inductively coupled plasma##5##5##(2008-10#5)
electrothermal vaporization##15##2##(2008-10#15)
electrothermal vaporization-inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
electrothermal vaporizer for sample introduction##2##5##(2008-10#2)
electrothermal##160##1##(1995-6#1)(2008-10#155)(2008-3#1)(2008-8#3)
electroweak##2##1##(1992-8#2)
electroxidation of##2##2##(2008-10#2)
elegans and##7##2##(1990-5#1)(1995-6#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
elegans by##2##2##(2008-2#1)(2012-12#1)
elegans cell##2##2##(1994-12#1)(2008-7#1)
elegans embryo##3##2##(2007-12#3)
elegans embryogenesis##2##2##(2007-12#2)
elegans gene##2##2##(1990-11#1)(2007-11#1)
elegans genome encodes##2##3##(2007-12#2)
elegans genome##3##2##(2007-11#1)(2007-12#2)
elegans has##2##2##(2007-12#1)(2008-7#1)
elegans males##2##2##(2008-5#1)(2012-3#1)
elegans vulval induction##2##3##(1990-11#2)
elegans vulval##3##2##(1990-11#2)(2007-12#1)
elegans##104##1##(1990-11#4)(1990-5#4)(1993-12#2)(1994-11#2)(1994-12#4)(1995-3#4)(1995-6#3)(1995-9#1)(1996-6#2)(1997-7#2)(2007-11#8)(2007-12#19)(2007-8#2)(2008-10#10)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#14)(2008-9#4)(2012-12#3)(2012-3#5)(2013-1#2)
elegant approach##2##2##(2008-11#1)(2013-1#1)
elegant##11##1##(1994-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#2)(2009-7#1)(2011-1#1)(2013-1#1)
elegantin##2##1##(1990-5#2)
elegantulus##2##1##(2011-2#2)
element (CRE)##5##2##(1994-11#2)(1997-2#2)(2013-1#1)
element (RRE)##2##2##(1993-8#1)(1994-8#1)
element (TRE)##2##2##(1993-3#1)(1993-8#1)
element analyses##3##2##(2008-10#2)(2009-7#1)
element analysis of the##2##4##(2009-6#1)(2013-1#1)
element analysis of##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
element analysis##10##2##(2008-10#3)(2008-7#2)(2009-6#2)(2009-7#1)(2013-1#2)
element and a##2##3##(1995-2#1)(2008-3#1)
element and is##2##3##(2008-10#1)(2008-3#1)
element and the##2##3##(1993-8#1)(2012-3#1)
element and##13##2##(1993-8#1)(1995-2#2)(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-9#1)(2012-3#1)
element are##6##2##(1995-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-10#1)
element at##3##2##(1997-7#1)(2008-10#2)
element binding##5##2##(1991-2#1)(1996-12#2)(2008-3#1)(2012-2#1)
element by##3##2##(2006-4#1)(2008-10#2)
element can be##2##3##(1995-8#1)(2008-3#1)
element can##4##2##(1995-8#1)(2007-11#1)(2008-3#2)
element concentration##4##2##(1993-2#1)(2008-10#3)
element concentrations (Cu##2##3##(1993-2#2)
element concentrations in##2##3##(2008-10#2)
element concentrations##6##2##(1993-2#2)(2007-5#1)(2008-10#3)
element consists of a##4##4##(2008-3#4)
element content of##2##3##(2008-10#1)(2011-2#1)
element content##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
element determinations##2##2##(2008-10#2)
element for the##4##3##(1990-5#1)(2008-10#2)(2008-3#1)
element for##12##2##(1990-5#1)(1995-6#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-7#1)(2012-12#1)
element found in##2##3##(1992-3#1)(2008-10#1)
element from##2##2##(1991-6#1)(1993-12#1)
element has been##4##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
element has##6##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
element in a##5##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)
element in an##2##3##(2008-2#1)(2008-3#1)
element in strain##2##3##(2008-10#2)
element in the promoter##2##4##(1994-6#1)(2010-3#1)
element in the##25##3##(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
element in##57##2##(1990-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#3)(2012-3#3)(2013-1#1)
element is##22##2##(1991-11#1)(1993-11#1)(1995-2#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#8)(2012-3#1)(2013-1#1)
element located##3##2##(1991-2#1)(1995-2#1)(1995-8#1)
element may##2##2##(2007-2#1)(2008-10#1)
element method##5##2##(2008-7#2)(2009-11#1)(2009-7#1)(2013-8#1)
element of a##6##3##(2007-11#1)(2007-12#3)(2008-11#1)(2008-4#1)
element of human##2##3##(1994-8#1)(2009-7#1)
element of the##11##3##(1992-12#1)(1993-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
element of this##2##3##(1992-6#1)(2007-11#1)
element of##46##2##(1991-3#1)(1992-12#3)(1992-6#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-8#3)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(2006-10#1)(2007-11#4)(2007-12#4)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
element on the##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
element on##5##2##(1993-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
element or##4##2##(2008-10#3)(2008-9#1)
element such as##2##3##(2008-3#1)(2013-8#1)
element that has##2##3##(2008-3#2)
element that##15##2##(1991-12#1)(1994-8#1)(1995-2#1)(2007-11#2)(2008-11#1)(2008-3#7)(2012-2#1)(2012-3#1)
element to##7##2##(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)
element was##15##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1995-6#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-3#2)
element were##2##2##(2008-10#1)(2008-2#1)
element whose##2##2##(2008-3#1)(2012-2#1)
element with a##2##3##(1995-8#1)(2008-3#1)
element with##6##2##(1995-8#1)(2008-10#1)(2008-3#4)
element within##2##2##(1991-11#1)(1995-2#1)
element zinc in##2##3##(2008-10#1)(2012-2#1)
element##557##1##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#9)(1992-2#1)(1992-3#2)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#5)(1993-8#9)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-6#3)(1994-8#6)(1995-12#1)(1995-2#18)(1995-6#8)(1995-8#21)(1995-9#1)(1996-10#1)(1996-12#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(2006-10#2)(2006-4#1)(2007-11#13)(2007-12#17)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#112)(2008-11#10)(2008-12#1)(2008-2#25)(2008-3#84)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#14)(2008-8#4)(2008-9#12)(2009-10#3)(2009-11#1)(2009-5#3)(2009-6#3)(2009-7#11)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#8)(2012-3#10)(2013-1#13)(2013-8#7)
element's##3##1##(2008-9#1)(2012-2#2)
element(s)##3##1##(1992-12#2)(1995-2#1)
element)##2##1##(1995-6#1)(2008-10#1)
element-based##3##1##(2008-10#2)(2008-3#1)
element-binding protein (CREB)##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
element-binding protein##4##2##(2008-10#1)(2008-7#1)(2009-3#1)(2013-1#1)
element-binding##5##1##(2008-10#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#1)
element-dependent##3##1##(2008-10#3)
element-specific##2##1##(2008-10#2)
elemental Hg##2##2##(2008-10#2)
elemental analyses##9##2##(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#2)(2011-1#1)
elemental analysis and X-ray fluorescence techniques##2##6##(2008-10#2)
elemental analysis and X-ray##3##4##(2007-11#1)(2008-10#2)
elemental analysis and also by thermo gravimetric analysis##2##8##(2008-10#2)
elemental analysis and##13##3##(1996-2#1)(2007-11#2)(2008-10#9)(2010-3#1)
elemental analysis in##2##3##(2008-10#2)
elemental analysis of glass##2##4##(2008-10#2)
elemental analysis of##8##3##(2008-10#8)
elemental analysis##50##2##(1990-8#1)(1996-2#2)(2007-11#3)(2007-12#1)(2008-10#38)(2008-11#1)(2008-4#1)(2010-3#1)(2011-1#2)
elemental analyzer with thermal conductivity detector##2##6##(2008-10#2)
elemental and harmful transition##2##4##(2008-10#2)
elemental and thermogravimetric##2##3##(2008-10#2)
elemental and##5##2##(2008-10#5)
elemental association##3##2##(2008-10#3)
elemental carbon##4##2##(2008-10#3)(2010-11#1)
elemental composition of##6##3##(2008-10#5)(2012-2#1)
elemental composition##13##2##(2008-10#10)(2008-5#1)(2011-2#1)(2012-2#1)
elemental compositions of##2##3##(2008-10#2)
elemental concentrations in the##2##4##(2008-10#2)
elemental concentrations##6##2##(2008-10#3)(2008-5#3)
elemental determination##2##2##(2008-10#2)
elemental determinations##2##2##(2008-10#2)
elemental images##2##2##(2008-3#2)
elemental sulfur and polysulfides##2##4##(2008-10#2)
elemental sulfur##3##2##(2008-10#3)
elemental##134##1##(1990-8#1)(1993-6#1)(1995-6#1)(1996-2#2)(2007-11#6)(2007-12#3)(2008-10#93)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#6)(2010-11#2)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#3)
elementary analysis##2##2##(1995-12#1)(2013-8#1)
elementary and middle schools##2##4##(2012-2#2)
elementary and middle##3##3##(2012-2#3)
elementary bodies##3##2##(1993-9#1)(1996-12#1)(2007-7#1)
elementary events underlying force generation in neuronal lamellipodia##2##8##(2012-2#2)
elementary events underlying force generation##3##5##(2012-2#3)
elementary events##4##2##(2012-2#4)
elementary functions##4##2##(2008-3#3)(2011-1#1)
elementary school children##2##3##(2008-1#1)(2009-9#1)
elementary school student##2##3##(2011-2#1)(2012-12#1)
elementary school##12##2##(2008-1#2)(2008-5#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
elementary schools##7##2##(2008-12#4)(2009-11#1)(2011-1#1)(2012-2#1)
elementary##49##1##(1993-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-12#4)(2008-3#5)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#2)(2013-8#1)
elements (Al##2##2##(2008-10#2)
elements (As##5##2##(2008-10#5)
elements (CRE)##2##2##(1993-3#1)(1996-2#1)
elements (Pb##2##2##(2008-10#2)
elements (RE)##2##2##(2008-10#2)
elements (REEs)##5##2##(2008-10#4)(2008-9#1)
elements (TEs)##2##2##(2009-3#1)(2010-3#1)
elements (e##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
elements able to##2##3##(2008-10#1)(2008-2#1)
elements act##2##2##(1993-6#1)(2007-12#1)
elements amounts of##2##3##(2013-8#2)
elements and compounds##2##3##(1993-3#1)(2008-7#1)
elements and the##7##3##(1990-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
elements and their##4##3##(1993-11#1)(1993-6#1)(1997-4#1)(1997-7#1)
elements and##53##2##(1990-2#1)(1990-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
elements are also##2##3##(1995-8#1)(2008-10#1)
elements are compared with##2##4##(2008-3#2)
elements are conserved##2##3##(1994-8#1)(2010-9#1)
elements are in the range of##2##6##(2008-10#1)(2013-8#1)
elements are in##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
elements are presented##2##3##(2007-11#1)(2008-2#1)
elements are reported##2##3##(2008-2#1)(2013-1#1)
elements are used##3##3##(2007-11#1)(2008-3#2)
elements are##45##2##(1991-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#2)(2007-11#3)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#11)(2009-7#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-3#2)(2013-1#2)(2013-8#2)
elements as##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
elements associated with##2##3##(2008-10#1)(2008-2#1)
elements at the##3##3##(2008-3#2)(2008-9#1)
elements at##7##2##(1997-2#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)
elements based on##3##3##(2007-11#2)(2008-3#1)
elements bound to##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
elements bound##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
elements by inductively coupled plasma mass spectrometry##2##7##(2008-10#2)
elements by inductively coupled plasma##3##5##(2008-10#3)
elements by use of##2##4##(2007-11#1)(2008-2#1)
elements by##11##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-7#1)(2009-7#1)
elements can be achieved by##2##5##(2007-11#1)(2008-2#1)
elements can be measured##2##4##(2008-10#1)(2008-2#1)
elements can be##10##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#5)
elements can##12##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)
elements capable of##2##3##(2010-7#1)(2012-2#1)
elements content in##2##3##(2008-10#2)
elements content##3##2##(2008-10#3)
elements could be##2##3##(2008-10#1)(2008-2#1)
elements could##3##2##(1993-6#1)(2008-10#1)(2008-2#1)
elements derived from##3##3##(2008-11#1)(2012-3#2)
elements designed##2##2##(2008-11#1)(2008-3#1)
elements essential##2##2##(1991-9#1)(2008-1#1)
elements for a##2##3##(2008-2#1)(2008-5#1)
elements for the determination of##2##5##(2008-10#2)
elements for the##5##3##(2008-10#2)(2010-4#1)(2010-7#1)(2013-1#1)
elements for##27##2##(1991-12#1)(1993-8#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#2)(2008-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
elements found in the##2##4##(1994-12#1)(2008-4#1)
elements found in##3##3##(1990-5#1)(1994-12#1)(2008-4#1)
elements from the##3##3##(2008-3#1)(2011-2#1)(2012-3#1)
elements from##11##2##(1990-5#1)(1993-12#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-3#2)
elements governing##2##2##(1990-11#1)(1993-5#1)
elements has been##2##3##(2008-10#2)
elements have been##5##3##(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
elements have##8##2##(1993-6#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
elements in a##4##3##(1995-5#1)(2008-2#2)(2008-3#1)
elements in biological##2##3##(2008-10#1)(2008-11#1)
elements in bitter almond##2##4##(2013-8#2)
elements in coal by##2##4##(2008-10#2)
elements in coal##3##3##(2008-10#3)
elements in geological samples by##2##5##(2008-10#2)
elements in honey##2##3##(2008-10#2)
elements in hybrid##2##3##(2008-3#2)
elements in its##4##3##(1993-6#1)(1994-12#1)(1994-3#1)(2007-12#1)
elements in seawater##2##3##(2008-10#2)
elements in several##2##3##(2008-10#1)(2008-7#1)
elements in solid samples##2##4##(2008-10#2)
elements in solid##3##3##(2008-10#3)
elements in some##2##3##(2008-10#2)
elements in the same##2##4##(2008-10#1)(2009-7#1)
elements in the sample##2##4##(2008-10#2)
elements in the##33##3##(1990-5#1)(1993-11#1)(1993-12#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#14)(2008-2#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2013-8#1)
elements in their promoter##2##4##(1994-11#1)(1995-2#1)
elements in##144##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-7#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#72)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-8#3)
elements including##2##2##(1993-6#1)(1994-8#1)
elements investigated##3##2##(2008-10#3)
elements involved in##6##3##(1993-12#2)(1993-2#1)(2008-10#1)(2009-3#1)(2013-1#1)
elements is described##2##3##(2007-12#1)(2008-10#1)
elements is discussed##2##3##(2008-2#1)(2008-3#1)
elements is presented##3##3##(2008-2#1)(2008-3#2)
elements is##24##2##(1997-2#1)(2007-12#2)(2008-10#6)(2008-2#5)(2008-3#4)(2008-7#4)(2009-10#1)(2009-6#1)
elements make##2##2##(2008-2#2)
elements may be##3##3##(2008-11#1)(2008-3#1)(2012-3#1)
elements mediating##2##2##(1990-7#1)(1993-6#1)
elements necessary for##3##3##(1991-9#1)(1996-2#1)(2010-4#1)
elements observed##2##2##(2008-12#2)
elements of a successful##3##4##(1993-2#1)(1996-2#1)(1997-2#1)
elements of a##16##3##(1993-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)
elements of an##2##3##(1996-12#1)(2008-3#1)
elements of both##2##3##(1990-5#1)(2008-7#1)
elements of care##2##3##(1994-3#2)
elements of cell##2##3##(2008-9#1)(2011-1#1)
elements of coated##2##3##(2008-2#2)
elements of structure##2##3##(1992-3#1)(1995-5#1)
elements of the Mueller matrix##2##5##(2008-3#2)
elements of the Mueller##3##4##(2008-2#1)(2008-3#2)
elements of the##54##3##(1991-6#1)(1992-5#1)(1993-3#2)(1994-1#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
elements of these##2##3##(1995-12#1)(2008-3#1)
elements of this##4##3##(1993-6#1)(1994-12#1)(1994-5#1)(2010-8#1)
elements of transition##2##3##(1991-12#2)
elements of##159##2##(1990-11#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#2)(2007-11#4)(2007-12#7)(2007-8#3)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#8)(2008-3#16)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#8)(2009-11#1)(2009-5#1)(2010-1#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
elements on the##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
elements on##11##2##(1995-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2012-3#1)
elements or##5##2##(1993-2#1)(1994-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
elements present in##2##3##(2008-10#2)
elements present##4##2##(1991-9#1)(2008-10#3)
elements recoveries##2##2##(2008-10#2)
elements scale with positive allometry##2##5##(2011-2#2)
elements studied##3##2##(2008-10#3)
elements such as Ba##2##4##(2008-10#2)
elements such as the##3##4##(2008-9#1)(2009-7#1)(2010-5#1)
elements such as##16##3##(1993-3#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-3#1)
elements such##17##2##(1993-3#2)(2008-10#8)(2008-2#2)(2008-3#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-3#1)
elements tested##3##2##(1991-6#1)(2008-10#2)
elements that are##4##3##(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#1)
elements that can be##3##4##(1995-8#1)(2008-2#1)(2008-4#1)
elements that can##4##3##(1995-8#1)(2008-2#1)(2008-4#1)(2013-1#1)
elements that control the##2##4##(1992-5#1)(2007-12#1)
elements that control##4##3##(1991-11#1)(1992-5#1)(2007-12#1)(2012-3#1)
elements that may be##2##4##(2008-12#1)(2008-6#1)
elements that##29##2##(1991-11#1)(1992-5#2)(1994-11#1)(1995-3#1)(1995-8#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-3#3)(2013-1#3)
elements the##5##2##(2008-10#2)(2008-3#3)
elements to##12##2##(1991-12#1)(1992-5#1)(1993-12#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-10#1)(2010-8#2)(2013-8#1)
elements upstream##2##2##(1996-10#1)(1997-4#1)
elements using a##2##3##(2008-10#1)(2008-9#1)
elements was evaluated##2##3##(2007-8#1)(2008-10#1)
elements was##11##2##(1993-9#1)(1995-8#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-8#1)
elements were considered as chemical descriptors##2##6##(2008-10#2)
elements were determined by##2##4##(2008-10#2)
elements were determined##5##3##(2008-10#5)
elements were found to be##3##5##(1993-12#1)(1995-8#1)(2008-10#1)
elements were found to##4##4##(1993-12#1)(1995-8#1)(2008-10#2)
elements were found##7##3##(1993-12#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-5#1)
elements were identified in the##2##5##(1991-6#1)(1991-7#1)
elements were identified in##3##4##(1991-6#1)(1991-7#1)(2008-10#1)
elements were identified##4##3##(1991-6#1)(1991-7#1)(1995-8#1)(2008-10#1)
elements were investigated in##2##4##(2008-10#2)
elements were investigated##3##3##(2008-10#3)
elements were present##2##3##(1991-6#1)(2012-3#1)
elements were separated##2##3##(2008-10#2)
elements were used as##2##4##(2008-10#2)
elements were used##3##3##(2008-10#2)(2013-8#1)
elements were##56##2##(1991-6#3)(1991-7#1)(1993-12#2)(1994-3#1)(1995-8#2)(1997-7#1)(2007-11#2)(2008-10#34)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
elements when##2##2##(2008-10#2)
elements which##10##2##(1993-3#2)(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
elements will##2##2##(2008-10#1)(2011-1#1)
elements with a##2##3##(2008-2#1)(2009-1#1)
elements with the##6##3##(1995-2#1)(2008-10#2)(2008-3#2)(2009-3#1)
elements with##29##2##(1992-6#1)(1995-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2008-8#1)(2009-1#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
elements within the##8##3##(1995-6#1)(2008-10#5)(2008-4#1)(2009-7#1)
elements within##10##2##(1995-6#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-7#1)
elements##1276##1##(1990-11#2)(1990-2#1)(1990-5#8)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#9)(1991-7#2)(1991-9#6)(1992-1#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#1)(1993-11#3)(1993-12#18)(1993-2#3)(1993-3#9)(1993-5#3)(1993-6#13)(1993-8#6)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#2)(1994-8#6)(1995-12#5)(1995-2#7)(1995-3#2)(1995-5#4)(1995-6#4)(1995-8#24)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#4)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#5)(1997-5#1)(1997-7#6)(2006-4#1)(2007-10#1)(2007-11#29)(2007-12#38)(2007-7#1)(2007-8#9)(2008-1#3)(2008-10#394)(2008-11#35)(2008-12#10)(2008-2#85)(2008-3#144)(2008-4#15)(2008-5#10)(2008-6#4)(2008-7#26)(2008-8#9)(2008-9#22)(2009-1#1)(2009-10#9)(2009-11#2)(2009-12#2)(2009-3#6)(2009-5#3)(2009-6#6)(2009-7#6)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#25)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#29)(2013-1#24)(2013-7#1)(2013-8#18)
elements)##10##1##(1992-3#2)(2008-10#4)(2008-11#1)(2008-3#2)(2010-7#1)
elephantiasis##4##1##(1994-11#3)(2007-7#1)
elephants##2##1##(2008-8#1)(2012-2#1)
elevate brain##2##2##(1992-8#1)(1997-6#1)
elevate cAMP##2##2##(1993-6#1)(2008-5#1)
elevate or##2##2##(2007-11#1)(2009-8#1)
elevate plasma##2##2##(1992-8#1)(2008-1#1)
elevate the##8##2##(1993-12#1)(1995-8#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-6#1)(2011-2#1)
elevate##24##1##(1991-1#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-8#2)(1997-2#3)(1997-4#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2009-8#1)(2011-2#1)
elevated CO(2) concentration##3##3##(2008-10#3)
elevated CO(2)##8##2##(2008-10#7)(2012-12#1)
elevated Cae##2##2##(1991-12#2)
elevated ESR and##2##3##(2007-7#2)
elevated ESR##4##2##(1993-8#1)(1995-11#1)(2007-7#2)
elevated GM2 ganglioside and##2##4##(1996-5#2)
elevated H(2)O(2)##2##2##(2008-2#2)
elevated IgE values##2##3##(2008-10#2)
elevated K+ suppressed##2##3##(1997-1#2)
elevated K+##5##2##(1996-2#1)(1997-1#4)
elevated SHBG##2##2##(1990-2#2)
elevated TSH##5##2##(1991-2#1)(1995-8#1)(2008-4#1)(2012-12#2)
elevated X maze##2##3##(2011-2#2)
elevated [Ca2+]i##3##2##(1991-12#1)(1992-6#2)
elevated above##2##2##(1994-3#1)(2008-8#1)
elevated activity##2##2##(1993-12#1)(1994-8#1)
elevated and##6##2##(1993-3#1)(1996-6#1)(1997-6#1)(2008-5#1)(2009-1#1)(2012-2#1)
elevated as##3##2##(1990-6#1)(2008-10#1)(2008-5#1)
elevated at the##5##3##(1993-6#1)(2008-10#1)(2008-5#1)(2011-2#2)
elevated at##8##2##(1990-5#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
elevated blood pressure in the acute phase of##3##8##(1997-5#3)
elevated blood pressure in##4##4##(1997-5#3)(2008-5#1)
elevated blood pressure readings##2##4##(2008-5#2)
elevated blood pressure##14##3##(1990-2#1)(1997-2#1)(1997-5#5)(2007-10#1)(2008-5#3)(2008-7#1)(2008-8#1)(2012-2#1)
elevated blood##21##2##(1990-2#1)(1992-5#1)(1994-5#1)(1997-2#1)(1997-4#2)(1997-5#5)(2007-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2012-2#1)
elevated body##2##2##(2007-7#1)(2012-2#1)
elevated by a combination of PRL and##2##7##(2008-6#2)
elevated by a##3##3##(2008-10#1)(2008-6#2)
elevated by##13##2##(1990-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-6#2)(2012-2#1)(2013-1#1)
elevated calcium concentration at the resorptive site##2##7##(1991-12#2)
elevated circulating##2##2##(1991-12#1)(2013-1#1)
elevated compared##2##2##(2006-10#1)(2008-10#1)
elevated concentration of##2##3##(2008-10#1)(2008-6#1)
elevated concentrations of the##2##4##(2008-10#1)(2008-7#1)
elevated concentrations of##10##3##(1991-6#1)(1992-3#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
elevated corticosterone levels##3##3##(2008-7#3)
elevated creatine kinase##2##3##(2009-11#1)(2011-2#1)
elevated cyclic##2##2##(1994-6#1)(2009-10#1)
elevated cytosolic##2##2##(2008-11#1)(2009-9#1)
elevated daytime temperature##3##3##(2012-7#3)
elevated during the##2##3##(1993-1#1)(2008-10#1)
elevated during##4##2##(1993-1#1)(1994-2#1)(2008-10#1)(2013-8#1)
elevated erythrocyte sedimentation rate (ESR)##3##5##(2007-7#1)(2013-1#2)
elevated erythrocyte sedimentation rate##4##4##(2007-7#1)(2010-5#1)(2013-1#2)
elevated expression of the##2##4##(2008-10#1)(2009-8#1)
elevated expression of##3##3##(1990-5#1)(2008-10#1)(2009-8#1)
elevated extracellular##2##2##(1991-12#1)(2012-3#1)
elevated fasting##2##2##(2011-2#1)(2013-8#1)
elevated for##7##2##(1997-7#1)(2007-10#1)(2008-12#4)(2011-2#1)
elevated free##2##2##(1996-12#1)(2007-5#1)
elevated frequency##2##2##(2007-10#1)(2012-12#1)
elevated glucose##4##2##(1992-8#3)(2010-11#1)
elevated glutamate##2##2##(2008-11#2)
elevated immune##2##2##(2008-9#1)(2010-12#1)
elevated in patients with##3##4##(1992-6#1)(1994-9#1)(2007-10#1)
elevated in patients##4##3##(1992-6#1)(1994-9#1)(2007-10#1)(2008-12#1)
elevated in schizophrenia##2##3##(1993-9#2)
elevated in some##2##3##(1993-8#1)(2008-3#1)
elevated in stroke##2##3##(2007-10#2)
elevated in the##10##3##(1993-9#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#2)(2011-2#1)(2012-12#1)
elevated in two##2##3##(1990-9#1)(2008-7#1)
elevated in##58##2##(1990-2#3)(1990-9#1)(1991-4#1)(1991-7#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-6#2)(1993-8#3)(1993-9#5)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-10#3)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#3)(2012-12#1)(2013-1#2)
elevated insulin##2##2##(2007-12#1)(2010-11#1)
elevated intracranial pressure##2##3##(2011-2#2)
elevated iron levels##2##3##(2008-10#1)(2012-12#1)
elevated iron##3##2##(2008-10#2)(2012-12#1)
elevated lactate dehydrogenase##2##3##(2008-7#1)(2013-1#1)
elevated lactate##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
elevated level of##4##3##(1990-5#1)(1992-9#1)(1993-9#1)(1997-8#1)
elevated level##6##2##(1990-5#1)(1991-7#1)(1992-9#1)(1993-9#1)(1996-12#1)(1997-8#1)
elevated levels of extracellular##2##4##(1993-6#1)(1994-2#1)
elevated levels of persistent##2##4##(2008-11#2)
elevated levels of root##2##4##(2008-10#2)
elevated levels of serum##2##4##(1991-12#1)(2008-1#1)
elevated levels of the##4##4##(1994-8#1)(1995-2#1)(2008-10#1)(2009-10#1)
elevated levels of these##2##4##(1992-3#1)(1994-7#1)
elevated levels of##49##3##(1990-2#3)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#2)(1993-6#1)(1994-2#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#3)(1996-12#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#4)(2009-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)
elevated levels##52##2##(1990-2#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#2)(1993-6#1)(1994-2#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#3)(1996-12#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#4)(2009-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)
elevated liver enzymes##4##3##(2008-4#2)(2010-4#1)(2013-1#1)
elevated liver##5##2##(1992-6#1)(2008-4#2)(2010-4#1)(2013-1#1)
elevated on##3##2##(1992-5#1)(1993-12#1)(2012-2#1)
elevated pH##2##2##(1990-8#1)(2008-8#1)
elevated plasma insulin##2##3##(1994-8#1)(1996-12#1)
elevated plasma##12##2##(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
elevated pressures##2##2##(2008-3#1)(2010-4#1)
elevated rates of##2##3##(2012-2#1)(2013-8#1)
elevated rates##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
elevated red cell##2##3##(1992-12#1)(2008-4#1)
elevated resistance to##2##3##(2008-11#2)
elevated risk of ovarian cancer##2##5##(1994-9#1)(2012-2#1)
elevated risk of##4##3##(1991-1#1)(1994-9#1)(2009-10#1)(2012-2#1)
elevated risk##9##2##(1991-1#1)(1994-11#1)(1994-9#1)(1996-11#1)(2008-1#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
elevated serum creatinine##2##3##(2008-8#1)(2013-1#1)
elevated serum levels of##4##4##(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#1)
elevated serum##17##2##(1991-8#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#3)
elevated significantly##3##2##(1992-8#1)(1994-8#1)(1995-5#1)
elevated simultaneously##2##2##(2008-9#1)(2009-6#1)
elevated systolic pulmonary##2##3##(2010-10#1)(2010-6#1)
elevated temperature##11##2##(2008-10#3)(2008-3#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-6#1)(2012-7#3)
elevated temperatures and##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
elevated temperatures##18##2##(1990-5#1)(1990-7#1)(1991-9#1)(1994-12#1)(1995-11#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-7#2)(2010-4#1)
elevated the levels of##2##4##(2008-10#1)(2011-2#1)
elevated the##10##2##(1990-7#1)(1993-8#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-7#1)(2011-2#1)
elevated throughout the##3##3##(1992-3#1)(1994-2#1)(2008-12#1)
elevated titres of##2##3##(2008-7#2)
elevated to##2##2##(1990-11#1)(2013-8#1)
elevated total##2##2##(1997-8#1)(2008-10#1)
elevated white blood##2##3##(2007-8#1)(2011-1#1)
elevated with##2##2##(1990-12#1)(2008-9#1)
elevated##583##1##(1990-11#3)(1990-12#2)(1990-2#9)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#9)(1991-2#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#5)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#10)(1992-9#3)(1993-1#1)(1993-12#6)(1993-3#5)(1993-5#1)(1993-6#6)(1993-8#8)(1993-9#8)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#3)(1994-5#5)(1994-6#1)(1994-7#3)(1994-8#7)(1994-9#4)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-5#5)(1996-6#1)(1996-7#2)(1997-1#5)(1997-2#3)(1997-3#4)(1997-4#6)(1997-5#6)(1997-6#1)(1997-7#7)(1997-8#5)(2006-10#2)(2006-6#1)(2007-10#10)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#56)(2008-11#19)(2008-12#13)(2008-2#7)(2008-3#11)(2008-4#7)(2008-5#16)(2008-6#6)(2008-7#28)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#5)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#35)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#9)(2012-5#1)(2012-6#2)(2012-7#6)(2013-1#26)(2013-7#1)(2013-8#8)
elevates the##2##2##(1991-9#1)(2010-12#1)
elevates##8##1##(1990-2#1)(1991-9#1)(1994-2#1)(1994-6#1)(1997-1#1)(2010-12#2)(2013-1#1)
elevating##9##1##(1990-12#1)(1990-2#1)(1992-8#1)(1993-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#2)
elevation (STEMI)##2##2##(2008-3#1)(2012-3#1)
elevation acute coronary syndromes##2##4##(2008-3#2)
elevation acute coronary##3##3##(2008-3#2)(2013-8#1)
elevation acute##4##2##(2008-3#2)(2012-3#1)(2013-8#1)
elevation and##3##2##(2008-3#1)(2009-12#1)(2009-8#1)
elevation in circulating##2##3##(2008-10#1)(2012-2#1)
elevation in serum##2##3##(2007-10#1)(2013-1#1)
elevation in the##2##3##(1995-2#1)(2008-10#1)
elevation in##23##2##(1990-6#1)(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-5#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
elevation is##3##2##(1990-5#1)(1990-8#1)(1994-6#1)
elevation myocardial infarction##21##3##(2007-5#2)(2008-11#1)(2008-3#12)(2009-12#2)(2009-5#2)(2010-5#1)(2013-8#1)
elevation of IOP##2##3##(2011-2#2)
elevation of LH##2##3##(1995-3#1)(1997-2#1)
elevation of [Ca2+]c##2##3##(1991-12#1)(1995-8#1)
elevation of [Ca2+]i##2##3##(2011-3#2)
elevation of blood glucose##2##4##(1991-12#1)(2010-11#1)
elevation of blood pressure##2##4##(2008-9#1)(2009-7#1)
elevation of blood##4##3##(1991-12#1)(2008-9#1)(2009-7#1)(2010-11#1)
elevation of cAMP##3##3##(1993-3#1)(1997-2#1)(2010-1#1)
elevation of intracellular##4##3##(1990-2#1)(1990-8#1)(1991-9#1)(2008-11#1)
elevation of plasma##4##3##(1991-12#1)(1995-3#2)(2011-2#1)
elevation of segment ST##2##4##(2008-10#2)
elevation of serum##4##3##(2007-11#1)(2010-1#2)(2012-2#1)
elevation of the ST##4##4##(2008-10#4)
elevation of the [Na+]i/[K+]i ratio##2##5##(2008-8#2)
elevation of the segment ST##2##5##(2008-10#2)
elevation of the vitelline coat of ascidian eggs##2##8##(1993-6#2)
elevation of the##23##3##(1993-6#3)(1994-2#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-5#1)(2011-2#1)
elevation of total##2##3##(1995-3#1)(2008-4#1)
elevation of##89##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#3)(1991-5#1)(1991-9#2)(1992-3#3)(1993-11#1)(1993-3#1)(1993-6#4)(1994-2#1)(1995-12#1)(1995-3#4)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-5#1)(2011-2#4)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
elevation on##2##2##(2011-2#1)(2013-1#1)
elevation populations of##2##3##(2012-7#2)
elevation populations##3##2##(2012-7#3)
elevation was##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
elevation##210##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-3#3)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#5)(1993-9#1)(1994-2#2)(1994-6#3)(1995-12#2)(1995-2#1)(1995-3#7)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-6#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#31)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#3)(2010-11#1)(2010-2#1)(2010-5#2)(2011-2#6)(2011-3#2)(2012-2#4)(2012-3#4)(2012-7#3)(2013-1#4)(2013-8#3)
elevational##2##1##(2008-12#1)(2008-8#1)
elevations and##2##2##(2008-10#1)(2008-8#1)
elevations in systolic blood pressure##3##5##(1992-12#1)(2012-1#2)
elevations in##13##2##(1992-12#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#3)(2012-12#1)
elevations of##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
elevations were##2##2##(1990-12#1)(2008-10#1)
elevations with a central pore##2##5##(2007-12#2)
elevations with##3##2##(1991-8#1)(2007-12#2)
elevations##45##1##(1990-12#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#2)(2007-12#2)(2008-10#8)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-6#1)(2012-7#2)
eleven nucleotides##2##2##(1992-3#1)(1996-5#1)
eleven of##4##2##(2008-10#1)(2008-5#1)(2013-1#1)(2013-7#1)
eleven patients##3##2##(1991-8#1)(2008-4#1)(2012-2#1)
eleven subjects##2##2##(2008-5#1)(2010-6#1)
eleven##43##1##(1991-8#1)(1992-11#1)(1992-3#3)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-8#1)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
eleventh##3##1##(1995-5#1)(2008-6#1)(2012-12#1)
elicit AF##2##2##(2011-2#2)
elicit a##11##2##(1991-5#1)(1993-12#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-8#1)(2010-4#1)(2012-1#1)
elicit an immune##2##3##(1994-11#1)(2008-12#1)
elicit an##5##2##(1990-12#1)(1994-11#1)(2008-10#1)(2008-12#1)(2009-11#1)
elicit both##2##2##(1990-7#1)(2013-1#1)
elicit information##2##2##(1992-12#1)(2008-6#1)
elicit significant##2##2##(2008-10#1)(2008-9#1)
elicit the##12##2##(1991-2#1)(1995-11#1)(1996-3#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
elicit their##3##2##(1994-11#2)(2009-12#1)
elicit##101##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-12#2)(1994-11#5)(1994-8#3)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#4)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(2007-6#1)(2008-10#10)(2008-11#12)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
elicitation of the##3##3##(2008-10#2)(2008-4#1)
elicitation of##9##2##(1993-6#1)(2008-10#3)(2008-4#2)(2008-8#2)(2012-12#1)
elicitation phase##2##2##(2008-10#2)
elicitation##17##1##(1993-6#1)(1994-11#2)(2008-10#8)(2008-4#2)(2008-8#2)(2011-10#1)(2012-12#1)
elicited a##14##2##(1991-2#1)(1991-5#1)(1991-9#1)(1993-6#1)(1994-11#1)(1996-5#1)(2008-10#3)(2008-8#1)(2010-1#2)(2013-8#2)
elicited an##2##2##(1994-2#1)(2008-5#1)
elicited by Pseudomonas##2##3##(2008-10#2)
elicited by a##2##3##(1990-2#1)(1995-5#1)
elicited by an##2##3##(1994-8#1)(2009-2#1)
elicited by both##2##3##(2008-10#2)
elicited by electrical##2##3##(1995-12#1)(2008-7#1)
elicited by in vitro immunization##2##5##(2008-11#2)
elicited by noradrenaline##3##3##(1995-12#1)(1997-4#2)
elicited by the##11##3##(1995-5#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)
elicited by##75##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-8#2)(1993-12#4)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#6)(1995-5#3)(1995-8#1)(1996-5#1)(1997-2#2)(1997-4#3)(1997-7#3)(1997-8#1)(2007-7#1)(2008-10#15)(2008-11#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#2)(2009-7#1)(2009-8#2)(2010-3#1)(2010-9#1)(2013-8#3)
elicited concentration-dependent##2##2##(1997-4#1)(1997-7#1)
elicited greater##3##2##(2008-11#3)
elicited in the##2##3##(1994-8#1)(1995-3#1)
elicited in##6##2##(1990-12#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-2#1)
elicited only##3##2##(1990-2#1)(1993-8#1)(1994-3#1)
elicited systemic##2##2##(2008-10#2)
elicited the##5##2##(1993-11#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#1)
elicited##156##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-9#2)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#7)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-8#5)(1995-11#1)(1995-12#9)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#3)(1997-4#4)(1997-7#4)(1997-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#25)(2008-11#11)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-2#1)(2010-3#2)(2010-9#1)(2011-10#1)(2012-1#1)(2012-12#2)(2013-8#7)
elicitin production##3##2##(2008-10#3)
elicitin##10##1##(2008-10#10)
eliciting a##4##2##(1996-12#1)(2008-12#1)(2008-4#1)(2013-8#1)
eliciting the##3##2##(2008-10#2)(2012-2#1)
eliciting this##2##2##(1992-12#1)(1996-2#1)
eliciting##30##1##(1992-12#3)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
elicitins##6##1##(2008-10#6)
elicitor activity##2##2##(2008-10#2)
elicitor in##2##2##(2008-10#2)
elicitor properties##3##2##(2008-10#3)
elicitor##27##1##(1992-12#1)(1994-11#1)(2008-10#25)
elicitors of##2##2##(2008-10#2)
elicitors##9##1##(2008-10#9)
elicits REM sleep##2##3##(1990-7#2)
elicits a##6##2##(1994-8#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2013-8#1)
elicits an##2##2##(1993-3#1)(1994-11#1)
elicits the##2##2##(1997-2#1)(2009-8#1)
elicits##26##1##(1990-5#1)(1990-7#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-5#2)(2008-7#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#1)(2013-8#1)
eligibility and##2##2##(1995-12#1)(1996-1#1)
eligibility criteria##5##2##(2007-10#1)(2010-10#1)(2011-2#1)(2013-1#2)
eligibility on##2##2##(1992-2#1)(1996-1#1)
eligibility##26##1##(1992-2#5)(1993-6#1)(1994-2#3)(1995-12#3)(1995-2#2)(1996-1#2)(1997-2#2)(2007-10#1)(2008-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
eligible for promotion##2##3##(2012-3#2)
eligible for the##3##3##(1997-7#1)(1997-8#1)(2012-3#1)
eligible for this##3##3##(1997-3#1)(2013-1#1)(2013-8#1)
eligible for##31##2##(1990-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-3#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
eligible individuals##3##2##(1997-2#1)(2011-2#2)
eligible participants##2##2##(1995-1#1)(2013-1#1)
eligible patients were##3##3##(1997-7#1)(2010-12#1)(2012-2#1)
eligible patients##12##2##(1991-2#1)(1994-7#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
eligible physicians and##2##3##(1992-3#1)(2008-11#1)
eligible to##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
eligible##75##1##(1990-6#2)(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#4)(1995-2#2)(1996-1#1)(1996-2#1)(1997-2#4)(1997-3#1)(1997-7#4)(1997-8#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#2)
eligibles##2##1##(1995-12#2)
eliminate any##4##2##(1994-3#2)(2008-10#1)(2008-2#1)
eliminate it##2##2##(1996-8#1)(2008-4#1)
eliminate many##2##2##(1993-11#1)(2012-12#1)
eliminate much of the##2##4##(1996-2#1)(2010-11#1)
eliminate the effect of##2##4##(1997-2#1)(2008-10#1)
eliminate the error##2##3##(2008-3#2)
eliminate the influence of sample##2##5##(2008-10#1)(2013-8#1)
eliminate the instabilities##2##3##(2007-12#1)(2008-3#1)
eliminate the need for##5##4##(2008-10#2)(2008-2#1)(2008-8#1)(2010-11#1)
eliminate the potential for##2##4##(1992-2#1)(2011-2#1)
eliminate the##61##2##(1991-12#1)(1992-2#1)(1994-3#2)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#14)(2008-2#4)(2008-3#8)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#2)(2013-1#1)(2013-8#2)
eliminate these##4##2##(1995-5#1)(1997-7#1)(2008-3#1)(2013-1#1)
eliminate this##5##2##(1994-6#2)(1995-6#1)(1996-1#1)(2007-11#1)
eliminate##150##1##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#5)(1994-6#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#17)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#3)(2009-12#1)(2009-4#2)(2010-11#4)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
eliminated and##2##2##(2008-10#1)(2008-12#1)
eliminated by a##5##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
eliminated by the##10##3##(1990-5#1)(1996-12#1)(2008-10#7)(2008-7#1)
eliminated by##51##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1994-11#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-3#7)(2008-7#1)(2008-8#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
eliminated due to##4##3##(1991-6#1)(1994-8#1)(2007-2#1)(2013-8#1)
eliminated during##2##2##(2008-11#1)(2008-9#1)
eliminated from the##8##3##(1990-11#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)
eliminated from##10##2##(1990-11#1)(1992-1#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)
eliminated in the##2##3##(1994-9#1)(2013-8#1)
eliminated in##8##2##(1991-12#1)(1994-9#1)(1995-12#1)(2008-10#1)(2010-2#1)(2012-3#2)(2013-8#1)
eliminated the need for##4##4##(1996-1#1)(2008-11#2)(2008-2#1)
eliminated the need to##2##4##(2008-10#1)(2008-11#1)
eliminated the need##6##3##(1996-1#1)(2008-10#1)(2008-11#3)(2008-2#1)
eliminated the##16##2##(1990-3#1)(1993-12#1)(1994-9#1)(1996-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#1)(2008-8#1)
eliminated this##2##2##(1991-9#1)(2008-8#1)
eliminated through##2##2##(1997-8#1)(2008-7#1)
eliminated using##2##2##(2008-10#1)(2008-11#1)
eliminated via##2##2##(1994-12#1)(2008-10#1)
eliminated with a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
eliminated with the##2##3##(2008-10#2)
eliminated with##9##2##(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)
eliminated##192##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#5)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2008-10#67)(2008-11#13)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#5)
eliminates Ca(2+)-dependent inactivation##2##3##(1994-6#2)
eliminates possible##2##2##(2008-4#1)(2008-9#1)
eliminates the need for a##2##5##(1992-1#1)(2012-3#1)
eliminates the need for##12##4##(1992-1#1)(1994-9#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2012-3#1)
eliminates the need to##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
eliminates the need##16##3##(1992-1#1)(1994-9#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2012-3#1)
eliminates the risk of##2##4##(1995-1#1)(2011-2#1)
eliminates the##31##2##(1992-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#4)(2008-3#7)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
eliminates##60##1##(1992-1#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#2)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
eliminating the interference##2##3##(2008-10#2)
eliminating the need for##5##4##(2008-10#2)(2008-4#1)(2008-7#1)(2012-2#1)
eliminating the need##6##3##(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)
eliminating the negative##2##3##(2007-11#1)(2010-1#1)
eliminating the##35##2##(1995-8#1)(1996-2#2)(1997-3#2)(2007-11#3)(2008-10#11)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#3)(2008-7#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-2#1)
eliminating unnecessary##2##2##(1996-3#1)(2009-4#1)
eliminating##75##1##(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#3)(2007-11#3)(2007-12#2)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#11)(2008-4#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
elimination are##2##2##(1991-9#1)(2008-1#1)
elimination at##2##2##(1997-2#1)(2012-3#1)
elimination by##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
elimination capacity##3##2##(1990-11#1)(1991-6#2)
elimination from the##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
elimination from##7##2##(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
elimination half-life##3##2##(1991-12#2)(2008-10#1)
elimination in the##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
elimination in##9##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
elimination is##2##2##(1991-9#1)(2008-8#1)
elimination method##2##2##(2008-10#1)(2008-2#1)
elimination of interferences##4##3##(2008-10#4)
elimination of methanol##2##3##(1996-5#2)
elimination of some##2##3##(1997-7#1)(2008-10#1)
elimination of the##15##3##(1991-3#1)(1992-2#1)(1993-11#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)
elimination of##93##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#4)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#22)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#2)
elimination or##2##2##(2007-8#1)(2008-10#1)
elimination process##2##2##(1994-2#1)(2008-11#1)
elimination programmes##2##2##(2008-1#2)
elimination rate constant##2##3##(2008-11#1)(2012-12#1)
elimination rate##4##2##(1994-5#1)(2008-11#1)(2008-5#1)(2012-12#1)
elimination to##2##2##(1993-9#1)(2012-3#1)
elimination voltammetry##4##2##(2008-10#4)
elimination##193##1##(1990-11#2)(1990-12#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#3)(1991-9#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#7)(2008-10#46)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#10)(2012-2#2)(2012-3#4)(2013-1#4)
eliprodil##3##1##(1997-7#3)
elite L##2##2##(2008-10#2)
elite and high-performance##2##3##(2011-2#2)
elite and##4##2##(2008-9#1)(2011-2#3)
elite athletes##3##2##(2008-8#1)(2010-1#1)(2013-1#1)
elite inbreds##2##2##(2008-10#1)(2008-9#1)
elite junior##2##2##(2011-2#2)
elite soccer players##2##3##(1996-6#1)(2008-5#1)
elite winter wheat##2##3##(2008-10#2)
elite##44##1##(1990-6#1)(1993-2#1)(1993-6#1)(1996-6#1)(1996-8#1)(2007-11#5)(2008-10#12)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#2)(2009-7#3)(2010-1#1)(2011-2#8)(2012-1#1)(2013-1#1)
ellagic acid##23##2##(1992-9#2)(1994-6#8)(2008-10#2)(2008-5#2)(2009-6#2)(2011-2#7)
ellipse fields##2##2##(2007-11#2)
ellipse##9##1##(2007-11#4)(2008-10#2)(2008-2#2)(2008-7#1)
ellipse-specific fitting##2##2##(2007-11#2)
ellipses##2##1##(2008-4#1)(2012-2#1)
ellipsoid##6##1##(1990-2#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-3#1)
ellipsoidal##4##1##(2008-10#2)(2008-2#1)(2008-7#1)
ellipsoids of##2##2##(2008-2#1)(2012-1#1)
ellipsoids##9##1##(1997-3#1)(2008-2#3)(2008-3#4)(2012-1#1)
ellipsometer (PRPSE)##2##2##(2008-2#1)(2008-3#1)
ellipsometer configurations##2##2##(2008-2#2)
ellipsometer for##2##2##(2007-12#1)(2008-3#1)
ellipsometer is described that##2##4##(2008-2#2)
ellipsometer is##3##2##(2008-2#2)(2008-3#1)
ellipsometer##20##1##(2007-11#2)(2007-12#2)(2008-2#6)(2008-3#10)
ellipsometers##3##1##(2008-3#3)
ellipsometric data##4##2##(2008-10#1)(2008-3#3)
ellipsometric measurements##5##2##(2007-12#1)(2008-3#4)
ellipsometric parameters of##3##3##(2008-2#1)(2008-3#2)
ellipsometric parameters##6##2##(2008-2#2)(2008-3#4)
ellipsometric spectra##2##2##(2008-3#2)
ellipsometric##24##1##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#20)
ellipsometry characterization of##2##3##(2008-3#2)
ellipsometry for##3##2##(2007-11#2)(2008-3#1)
ellipsometry has##2##2##(2008-10#1)(2008-3#1)
ellipsometry measurements##2##2##(2008-3#2)
ellipsometry of##6##2##(2008-2#5)(2008-3#1)
ellipsometry was##2##2##(2008-2#2)
ellipsometry##50##1##(2007-11#4)(2008-10#4)(2008-2#12)(2008-3#29)(2008-7#1)
ellipsospora##2##1##(2008-10#2)
elliptic##12##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2010-8#1)
elliptical beams##2##2##(2007-12#1)(2008-3#1)
elliptical core##2##2##(2007-11#1)(2008-3#1)
elliptical cross section##4##3##(2008-2#4)
elliptical cross-sectional##2##2##(2008-2#1)(2008-7#1)
elliptical halos##4##2##(2008-3#4)
elliptical pump beam##2##3##(2007-11#1)(2007-12#1)
elliptical pump##3##2##(2007-11#1)(2007-12#2)
elliptical##35##1##(2007-11#5)(2007-12#3)(2008-10#5)(2008-2#6)(2008-3#14)(2008-7#1)(2012-2#1)
elliptical-core fiber##2##2##(2007-11#1)(2008-3#1)
elliptical-core fibers##2##2##(2008-3#2)
elliptical-core##6##1##(2007-11#1)(2008-3#5)
elliptically polarized beam##2##3##(2008-10#1)(2008-3#1)
elliptically polarized light##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
elliptically polarized##10##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)
elliptically##12##1##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#4)
ellipticity and the##2##3##(2007-12#1)(2008-3#1)
ellipticity and##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
ellipticity angle##2##2##(2008-3#2)
ellipticity at##3##2##(1992-6#1)(1993-11#1)(2008-3#1)
ellipticity of the##4##3##(1993-11#1)(2007-11#2)(2008-2#1)
ellipticity of##5##2##(1993-11#1)(2007-11#2)(2008-2#1)(2011-1#1)
ellipticity values##2##2##(1993-11#2)
ellipticity##27##1##(1990-5#1)(1992-6#1)(1993-11#4)(1994-3#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#8)(2008-5#2)(2011-1#1)
elm##7##1##(2008-10#7)
elongata##2##1##(2008-10#1)(2008-5#1)
elongate and##4##2##(1994-11#2)(2008-5#1)(2008-7#1)
elongate##15##1##(1994-11#3)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#4)(2012-2#2)
elongated and##2##2##(1994-8#1)(2008-11#1)
elongated cells##2##2##(2008-3#1)(2008-5#1)
elongated fragments##3##2##(1991-12#1)(1994-8#2)
elongated processes##3##2##(1994-8#2)(2007-12#1)
elongated##54##1##(1990-6#1)(1991-12#3)(1994-5#1)(1994-8#8)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#2)(1997-7#2)(2007-11#2)(2007-12#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
elongates##2##1##(2008-10#1)(2012-2#1)
elongating spermatids##2##2##(1991-9#1)(2012-2#1)
elongating##9##1##(1991-9#1)(1997-6#1)(2008-10#2)(2009-10#1)(2011-2#1)(2012-2#3)
elongation and##12##2##(1994-11#2)(1996-5#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)
elongation at##2##2##(2008-5#1)(2011-2#1)
elongation factor 2##4##3##(1992-8#1)(1993-3#2)(2008-11#1)
elongation factor##19##2##(1990-5#1)(1992-8#2)(1993-11#1)(1993-3#2)(1994-8#1)(1996-2#2)(2008-10#7)(2008-11#1)(2008-8#1)(2012-12#1)
elongation in##3##2##(1996-2#1)(2008-7#1)(2009-7#1)
elongation is##2##2##(1995-12#1)(2007-11#1)
elongation of the##6##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
elongation of##14##2##(1994-8#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
elongation rate##2##2##(2008-10#1)(2008-7#1)
elongation with##3##2##(1992-6#1)(2008-9#1)(2012-2#1)
elongation##104##1##(1990-5#3)(1991-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-3#2)(1993-5#1)(1994-11#2)(1994-8#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#4)(2013-8#1)
elongatus##3##1##(2013-1#2)(2013-7#1)
eloquent areas##4##2##(1996-3#1)(2008-7#2)(2012-3#1)
eloquent cortex##4##2##(2008-7#1)(2008-9#2)(2009-9#1)
eloquent##10##1##(1996-3#1)(2008-7#3)(2008-9#2)(2009-9#1)(2011-2#1)(2012-3#2)
else##13##1##(1992-11#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-11#1)(2012-12#1)
elsevier##8##1##(2008-10#4)(2008-11#4)
elsewhere in the body##3##4##(2007-12#1)(2010-6#1)(2011-2#1)
elsewhere in the series##5##4##(2008-4#5)
elsewhere in the world##2##4##(2008-10#1)(2011-2#1)
elsewhere in the##17##3##(1992-2#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-4#6)(2010-6#1)(2011-2#3)
elsewhere in this volume##2##4##(2008-11#1)(2008-2#1)
elsewhere in##24##2##(1992-2#1)(1996-1#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#6)(2010-6#1)(2011-2#3)
elsewhere##73##1##(1990-6#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#7)(2008-6#2)(2008-8#2)(2010-10#1)(2010-6#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
eluant##5##1##(2008-10#5)
eluate from##2##2##(1991-5#1)(1994-12#1)
eluate is##2##2##(2008-10#1)(2008-5#1)
eluate was monitored##2##3##(1990-8#1)(1993-2#1)
eluate was##8##2##(1990-8#1)(1993-2#1)(2008-10#6)
eluate were##3##2##(1990-8#2)(1994-6#1)
eluate##32##1##(1990-2#1)(1990-8#4)(1991-5#1)(1992-9#1)(1993-2#1)(1994-12#3)(1994-3#2)(1994-6#2)(2008-10#15)(2008-4#1)(2008-5#1)
eluates##14##1##(1992-6#1)(1992-9#1)(1994-12#1)(1996-12#3)(2008-10#8)
elucidate a potential##2##3##(2008-10#1)(2009-6#1)
elucidate genetic mechanisms of##2##4##(2008-10#2)
elucidate how##3##2##(2008-1#1)(2008-10#1)(2009-6#1)
elucidate the effect of##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
elucidate the effects of##2##4##(1997-4#1)(2008-10#1)
elucidate the functional role of##3##5##(1993-3#1)(1995-12#1)(1995-6#1)
elucidate the functional##5##3##(1993-3#1)(1994-3#1)(1995-12#1)(1995-6#1)(2008-8#1)
elucidate the mechanism of##4##4##(1993-11#1)(1995-11#1)(1997-7#1)(2008-10#1)
elucidate the mechanism##9##3##(1990-7#1)(1993-11#1)(1994-5#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
elucidate the mechanisms of##5##4##(1995-12#1)(2008-10#1)(2009-3#1)(2012-12#1)(2012-2#1)
elucidate the mechanisms##8##3##(1995-12#1)(1995-8#1)(1997-3#1)(2008-10#2)(2009-3#1)(2012-12#1)(2012-2#1)
elucidate the mode of##2##4##(2008-10#2)
elucidate the molecular mechanism of##2##5##(2008-10#1)(2008-9#1)
elucidate the molecular mechanism##4##4##(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
elucidate the molecular mechanisms##2##4##(1997-7#1)(2008-8#1)
elucidate the molecular##7##3##(1997-7#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-8#1)
elucidate the nature of the##2##5##(1994-2#1)(1995-6#1)
elucidate the nature of##4##4##(1994-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
elucidate the possible involvement of##2##5##(1992-6#1)(1994-6#1)
elucidate the precise##2##3##(1994-8#1)(2012-12#1)
elucidate the role of the##4##5##(1992-3#1)(1992-6#1)(2007-12#1)(2008-5#1)
elucidate the role of##12##4##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-5#1)(2009-8#1)(2013-7#1)
elucidate the structure-function relationship of##2##5##(1994-11#1)(2008-8#1)
elucidate the##131##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#26)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2012-6#1)(2013-7#1)(2013-8#1)
elucidate this##2##2##(1994-2#1)(1994-8#1)
elucidate why##2##2##(2007-4#1)(2011-2#1)
elucidate##187##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#42)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#5)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
elucidated and##6##2##(1991-6#1)(1995-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)
elucidated by##12##2##(1990-7#1)(1995-11#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-3#1)
elucidated from the##2##3##(2008-10#1)(2010-10#1)
elucidated in detail##2##3##(1996-5#1)(2008-10#1)
elucidated in##5##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
elucidated that##2##2##(2007-7#1)(2008-5#1)
elucidated the mechanism##2##3##(1993-11#1)(2010-11#1)
elucidated the##6##2##(1993-11#1)(1996-2#1)(2008-12#1)(2008-3#1)(2010-11#1)(2013-1#1)
elucidated using##2##2##(1995-5#1)(2008-10#1)
elucidated with##2##2##(2011-2#2)
elucidated##110##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#1)(1991-6#2)(1993-1#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#5)(2013-1#6)
elucidates the##3##2##(1996-3#1)(2008-3#1)(2010-12#1)
elucidates##4##1##(1996-3#1)(2008-3#2)(2010-12#1)
elucidating the mechanisms of##3##4##(2008-10#1)(2008-8#1)(2012-1#1)
elucidating the##18##2##(1990-12#1)(1992-9#1)(1993-11#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#1)(2012-1#1)
elucidating##27##1##(1990-12#1)(1991-12#1)(1992-9#1)(1993-11#1)(1996-5#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2012-1#1)
elucidation of an extraction equilibrium##2##5##(2008-10#2)
elucidation of small molecules using mass spectrometry##2##7##(2011-2#2)
elucidation of small molecules##3##4##(2011-2#3)
elucidation of the##15##3##(1994-10#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
elucidation of their##2##3##(2008-5#1)(2012-2#1)
elucidation of##38##2##(1994-10#1)(1994-3#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-8#1)
elucidation##42##1##(1990-5#1)(1994-10#1)(1994-3#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-8#1)
eluent and##10##2##(1990-8#1)(2008-10#9)
eluent concentration##5##2##(2008-10#5)
eluent containing##4##2##(2008-10#4)
eluent flow##3##2##(2008-10#3)
eluent is##3##2##(2008-10#3)
eluent liquid##2##2##(2008-10#1)(2008-7#1)
eluent on##2##2##(2008-10#2)
eluent solution##2##2##(2008-10#2)
eluent type and##2##3##(2008-10#2)
eluent type##4##2##(2008-10#4)
eluent volume##4##2##(2008-10#4)
eluent was##3##2##(2008-10#3)
eluent##103##1##(1990-8#3)(1995-6#3)(2008-10#95)(2008-7#2)
eluents##11##1##(1990-8#1)(1996-5#3)(2008-10#6)(2010-3#1)
elusive##43##1##(1990-4#1)(1991-12#1)(1992-9#1)(1994-10#1)(1994-6#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
elute the##2##2##(2008-10#1)(2008-4#1)
elute##3##1##(1990-5#1)(2008-10#1)(2008-4#1)
eluted and##2##2##(2008-10#2)
eluted as##3##2##(1991-8#1)(1997-2#1)(2008-10#1)
eluted at the same retention time as##2##7##(1990-2#1)(2008-11#1)
eluted at the##4##3##(1990-12#1)(1990-2#1)(2008-11#2)
eluted at##5##2##(1990-12#1)(1990-2#1)(1991-12#1)(2008-11#2)
eluted by 2M nitric acid and##2##6##(2008-10#2)
eluted by##8##2##(2008-10#8)
eluted directly##2##2##(2008-10#2)
eluted from a##5##3##(1990-11#1)(1990-12#1)(1992-12#1)(2008-10#2)
eluted from it##2##3##(1990-12#1)(2008-10#1)
eluted from the column with##3##5##(1990-12#1)(2008-10#2)
eluted from the column##8##4##(1990-12#1)(2008-10#7)
eluted from the resin##2##4##(2008-10#2)
eluted from the##16##3##(1990-12#1)(1992-12#1)(1994-9#1)(2008-10#12)(2008-4#1)
eluted from##30##2##(1990-11#1)(1990-12#4)(1992-12#2)(1992-6#1)(1994-9#1)(2007-10#1)(2008-10#18)(2008-4#1)(2012-2#1)
eluted in the##6##3##(1990-12#2)(1993-6#1)(2008-10#3)
eluted in##11##2##(1990-12#2)(1991-2#1)(1993-3#1)(1993-6#1)(2008-10#5)(2013-1#1)
eluted metals##3##2##(2008-10#3)
eluted quantitatively##2##2##(1990-12#1)(2008-10#1)
eluted with 0##5##3##(2008-10#5)
eluted with 1##4##3##(2008-10#4)
eluted with 2 mol l(-1)##2##5##(2008-10#2)
eluted with 2##3##3##(2008-10#3)
eluted with a small volume of##2##6##(2008-10#2)
eluted with a##7##3##(2008-10#6)(2008-4#1)
eluted with an##2##3##(1992-6#1)(2008-10#1)
eluted with ethanol##3##3##(2008-10#3)
eluted with isobutyl methyl ketone (IBMK) and introduced##2##8##(2008-10#2)
eluted with##49##2##(1992-6#1)(1993-6#1)(2008-10#43)(2008-4#1)(2008-5#2)(2008-6#1)
eluted##143##1##(1990-11#2)(1990-12#8)(1990-2#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-12#2)(1992-6#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-9#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-10#104)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2012-2#1)(2013-1#1)
elutes##3##1##(2008-10#3)
eluting agent##2##2##(2008-10#2)
eluting from a##2##3##(2008-10#2)
eluting from##4##2##(1990-5#1)(2008-10#3)
eluting stent##2##2##(2008-1#1)(2008-11#1)
eluting the##3##2##(2008-10#3)
eluting with##2##2##(2008-10#2)
eluting##30##1##(1990-5#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2010-5#1)(2013-1#1)
elution and##4##2##(1990-8#1)(2008-10#3)
elution assay##2##2##(1992-3#1)(1994-12#1)
elution buffer##2##2##(2008-4#2)
elution by##3##2##(2008-10#3)
elution conditions were##2##3##(2008-10#2)
elution conditions##5##2##(2008-10#5)
elution flow rate##2##3##(2008-10#2)
elution flow##4##2##(2008-10#4)
elution for##2##2##(2008-10#2)
elution from##7##2##(1990-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(2008-5#1)(2008-7#1)(2009-4#1)
elution in##2##2##(2008-10#2)
elution into##2##2##(1991-12#1)(2008-10#1)
elution is##3##2##(2008-10#3)
elution of Au##2##3##(2008-10#2)
elution of the##9##3##(1990-8#1)(1995-6#1)(2008-10#6)(2008-7#1)
elution of##33##2##(1990-12#1)(1990-8#1)(1991-12#1)(1995-6#1)(2008-10#26)(2008-4#2)(2008-7#1)
elution order of the enantiomers##2##5##(2008-10#2)
elution order of the##3##4##(2008-10#3)
elution order of##6##3##(2008-10#6)
elution order##8##2##(1995-3#1)(2008-10#7)
elution profile from##2##3##(1990-11#1)(2008-10#1)
elution profile##3##2##(1990-11#1)(1991-2#1)(2008-10#1)
elution profiles##2##2##(1990-12#1)(1994-8#1)
elution solution and interfering ions on the recovery of the##2##10##(2008-10#2)
elution solution and##3##3##(2008-10#3)
elution solution##5##2##(2008-10#5)
elution solvents##3##2##(2008-10#2)(2008-11#1)
elution system##2##2##(1996-5#1)(2008-10#1)
elution using##4##2##(2008-10#1)(2009-8#1)(2011-1#2)
elution volume##4##2##(1990-7#1)(2008-10#3)
elution was##8##2##(2008-10#8)
elution were##3##2##(2008-10#2)(2008-7#1)
elution with 0##5##3##(2008-10#5)
elution with a##2##3##(2008-10#1)(2013-1#1)
elution with acetonitrile-water##2##3##(2008-10#2)
elution with##36##2##(1990-8#1)(1991-5#1)(1993-11#1)(1994-6#1)(1995-11#1)(1996-5#1)(2008-10#25)(2011-1#4)(2013-1#1)
elution##220##1##(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#6)(1991-12#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#3)(2008-10#158)(2008-11#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#7)(2013-1#1)
elutriation##5##1##(1990-8#2)(1992-9#1)(2008-10#1)(2008-11#1)
elutropic strength##2##2##(2008-10#2)
elytra##3##1##(2007-12#3)
em##2##1##(2008-5#2)
emaciation##4##1##(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
email##7##1##(1996-8#1)(2008-1#2)(2008-12#1)(2009-2#1)(2010-9#1)(2011-2#1)
emanate##2##1##(1995-8#1)(2008-11#1)
emanating from the##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
emanating from##10##2##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-12#1)
emanating##11##1##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2010-12#1)
embargo##4##1##(1996-11#4)
embark on##5##2##(1994-2#1)(1996-2#1)(2008-12#1)(2009-6#1)(2010-12#1)
embark##6##1##(1994-2#1)(1996-2#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-12#1)
embarked on a##5##3##(1991-2#1)(1995-12#1)(1996-2#1)(2008-4#1)(2012-12#1)
embarked on##6##2##(1991-2#1)(1991-3#1)(1995-12#1)(1996-2#1)(2008-4#1)(2012-12#1)
embarked upon a##2##3##(1996-9#1)(2009-12#1)
embarked upon##4##2##(1993-1#1)(1996-9#1)(2009-12#1)(2010-3#1)
embarked##10##1##(1991-2#1)(1991-3#1)(1993-1#1)(1995-12#1)(1996-2#1)(1996-9#1)(2008-4#1)(2009-12#1)(2010-3#1)(2012-12#1)
embarking##4##1##(1991-2#1)(1997-1#1)(2008-1#1)(2009-11#1)
embarks on##2##2##(1992-12#1)(1997-3#1)
embarrassment##9##1##(1996-5#1)(1997-1#1)(2008-12#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#3)
embed##4##1##(2007-12#1)(2008-11#1)(2008-12#1)(2009-9#1)
embedded and##3##2##(1991-2#1)(2009-12#1)(2011-2#1)
embedded benzophenone##3##2##(2008-10#3)
embedded in a continuous##2##4##(2008-11#1)(2008-3#1)
embedded in a homogeneous##2##4##(1996-4#1)(2007-11#1)
embedded in a scattering medium##2##5##(2007-12#2)
embedded in a turbid medium##2##5##(2007-12#2)
embedded in a##23##3##(1992-6#1)(1996-4#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2009-10#1)(2009-11#1)(2013-1#1)
embedded in an##3##3##(2008-3#3)
embedded in paraffin##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
embedded in the low-temperature##2##4##(1990-8#1)(2008-8#1)
embedded in the##16##3##(1990-5#1)(1990-8#1)(1993-11#1)(1996-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)
embedded in##80##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#3)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-7#1)(2007-11#8)(2007-12#7)(2008-1#2)(2008-10#11)(2008-11#6)(2008-2#5)(2008-3#10)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
embedded inside##2##2##(2008-12#1)(2008-3#1)
embedded into##4##2##(1991-5#1)(2007-8#1)(2008-2#1)(2008-9#1)
embedded styrene-EGDMA##2##2##(2008-10#2)
embedded tissue##3##2##(1991-2#2)(1994-10#1)
embedded with##3##2##(2008-10#2)(2011-2#1)
embedded within the##5##3##(2007-11#1)(2008-3#1)(2009-7#1)(2012-12#1)(2012-2#1)
embedded within##9##2##(1997-7#1)(2007-11#1)(2008-3#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
embedded##146##1##(1990-5#1)(1990-8#1)(1991-2#3)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#3)(1993-9#1)(1994-10#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-7#2)(2007-11#11)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#9)(2008-12#1)(2008-2#8)(2008-3#15)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
embedding interprofessional##2##2##(2012-2#2)
embedding the vision##2##3##(2008-12#2)
embedding##18##1##(1990-7#1)(1990-8#1)(2007-8#1)(2008-10#3)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#3)(2012-2#2)(2013-1#1)
embeddings##2##1##(2008-6#2)
embelin content##2##2##(2012-2#2)
embelin##4##1##(2012-2#4)
embodied by##3##2##(1994-9#1)(2008-3#1)(2008-7#1)
embodied in the##2##3##(2009-10#1)(2010-10#1)
embodied in##4##2##(1995-3#1)(2009-10#1)(2010-10#1)(2010-7#1)
embodied##14##1##(1992-5#1)(1994-9#1)(1995-3#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-7#1)(2012-2#1)
embodies a##2##2##(2009-10#1)(2010-5#1)
embodies##7##1##(1997-3#1)(2008-8#1)(2009-10#2)(2010-5#1)(2012-2#2)
embodiment##3##1##(1996-6#1)(2008-3#1)(2009-10#1)
embolectomy is##2##2##(1991-3#1)(2007-10#1)
embolectomy##3##1##(1991-3#1)(2007-10#1)(2007-8#1)
emboli in the##2##3##(1996-8#1)(2013-8#1)
emboli##17##1##(1996-8#2)(1997-3#1)(2007-10#2)(2008-1#1)(2008-7#2)(2011-2#8)(2013-8#1)
embolic agents##2##2##(1996-9#2)
embolic event##2##2##(1996-6#1)(2008-7#1)
embolic events##4##2##(1996-6#1)(2008-7#1)(2010-4#1)(2010-5#1)
embolic stroke##2##2##(2008-10#1)(2008-7#1)
embolic##22##1##(1996-6#2)(1996-9#3)(2008-10#1)(2008-11#1)(2008-7#6)(2009-3#2)(2009-5#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
embolisation in a vein of##2##5##(1996-6#2)
embolisation in##3##2##(1996-6#2)(1997-6#1)
embolisation of the##3##3##(1996-3#1)(1997-6#1)(2011-2#1)
embolisation of##8##2##(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#3)(2008-7#1)(2011-2#1)
embolisation was##3##2##(1996-3#1)(1996-6#1)(1997-3#1)
embolisation with##2##2##(1997-3#1)(2007-10#1)
embolisation without##2##2##(1997-6#2)
embolisation##43##1##(1991-6#1)(1995-11#2)(1996-3#5)(1996-6#5)(1996-9#5)(1997-3#10)(1997-6#9)(2007-10#1)(2008-7#1)(2011-2#2)(2012-2#2)
embolisations##3##1##(1996-9#2)(2011-1#1)
embolised with acrylic glue##2##4##(1997-3#1)(1997-6#1)
embolised##9##1##(1996-3#1)(1997-3#2)(1997-6#5)(2008-7#1)
embolism (PE)##6##2##(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
embolism and##5##2##(1991-11#1)(1991-3#1)(2008-10#1)(2010-10#1)(2013-1#1)
embolism are##2##2##(1991-11#1)(2007-10#1)
embolism complicating##2##2##(2008-6#1)(2008-7#1)
embolism during##3##2##(1991-11#1)(2007-8#2)
embolism from##3##2##(2007-10#2)(2008-6#1)
embolism in the##2##3##(2009-3#1)(2012-12#1)
embolism in##6##2##(2008-7#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
embolism is##5##2##(2007-10#2)(2008-7#1)(2012-12#2)
embolism or##2##2##(2007-11#1)(2012-2#1)
embolism through a patent foramen ovale##2##6##(2008-7#2)
embolism##106##1##(1991-11#10)(1991-3#2)(1992-5#1)(1992-6#1)(1993-9#2)(1994-3#1)(1996-6#5)(1997-2#1)(2007-10#11)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#14)(2008-8#4)(2009-10#1)(2009-3#5)(2010-1#1)(2010-10#2)(2010-6#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
embolization alone##2##2##(2008-7#1)(2012-3#1)
embolization and##7##2##(1996-6#1)(1996-8#1)(2007-8#1)(2008-7#3)(2012-1#1)
embolization in the##3##3##(2007-8#1)(2008-7#1)(2010-11#1)
embolization in##7##2##(1997-8#1)(2006-12#1)(2007-8#1)(2008-7#2)(2009-10#1)(2010-11#1)
embolization is##3##2##(1992-9#1)(2008-7#1)(2012-3#1)
embolization of cerebral arteriovenous##2##4##(2008-7#2)
embolization of cerebral##4##3##(1991-3#1)(2008-7#3)
embolization of the##3##3##(1996-8#1)(2007-7#1)(2012-3#1)
embolization of##19##2##(1991-3#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-7#7)(2009-9#2)(2012-3#2)(2013-8#1)
embolization secondary to##2##3##(2008-1#1)(2012-3#1)
embolization should be##2##3##(1992-9#1)(2008-7#1)
embolization successfully##2##2##(2008-12#1)(2012-1#1)
embolization therapy##2##2##(2008-7#2)
embolization to be##2##3##(1991-2#1)(1992-9#1)
embolization to##4##2##(1991-2#1)(1992-9#1)(2008-7#1)(2013-1#1)
embolization was##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
embolization with##5##2##(1991-2#1)(2006-12#2)(2008-7#1)(2012-3#1)
embolization##102##1##(1991-2#2)(1991-3#2)(1992-9#5)(1993-6#1)(1996-6#1)(1996-8#3)(1997-8#4)(2006-12#6)(2007-10#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-11#2)(2008-12#2)(2008-7#33)(2009-10#1)(2009-9#3)(2010-11#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#10)(2013-1#4)(2013-8#1)
embolized preoperatively##2##2##(2006-12#1)(2008-7#1)
embolized##8##1##(1991-2#1)(2006-12#3)(2007-8#1)(2008-7#3)
embolus was##3##2##(2007-8#2)(2008-7#1)
embolus##10##1##(1992-2#1)(1992-6#1)(2007-8#4)(2008-6#1)(2008-7#3)
embossed##2##1##(2008-3#2)
embossing##4##1##(2008-2#2)(2008-3#2)
embrace the##6##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-8#1)(2013-8#1)
embrace##17##1##(1994-1#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2013-8#1)
embraced by##2##2##(2008-7#1)(2012-1#1)
embraced##7##1##(1995-12#1)(2008-10#1)(2008-7#1)(2009-9#2)(2012-1#1)(2013-1#1)
embracement##4##1##(2011-2#3)(2012-3#1)
embraces the##2##2##(1996-12#1)(2008-12#1)
embraces##4##1##(1996-12#1)(2008-10#1)(2008-12#1)(2012-12#1)
embracing the##2##2##(1992-12#1)(1997-1#1)
embracing##4##1##(1991-3#1)(1992-12#1)(1997-1#1)(2008-11#1)
embryo and##4##2##(1993-6#1)(1996-5#1)(2007-12#1)(2008-10#1)
embryo are##2##2##(2008-1#1)(2009-3#1)
embryo calvaria cell cultures##2##4##(1990-11#2)
embryo cells##4##2##(1990-7#1)(1992-11#2)(1992-2#1)
embryo concentration##2##2##(2008-9#2)
embryo development##8##2##(2008-5#1)(2008-9#2)(2009-8#3)(2011-2#2)
embryo fibroblasts and##3##3##(1991-5#1)(1993-6#1)(1993-8#1)
embryo fibroblasts##14##2##(1991-5#2)(1991-6#1)(1993-6#3)(1993-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-7#1)(2007-8#1)(2008-11#1)
embryo formation##3##2##(2009-8#1)(2011-2#2)
embryo from##2##2##(2008-10#2)
embryo has##2##2##(2008-11#1)(2011-1#1)
embryo implantation and##2##3##(2008-9#1)(2013-1#1)
embryo implantation##5##2##(1994-8#1)(1994-9#1)(2008-9#2)(2013-1#1)
embryo is##2##2##(1991-5#1)(2008-10#1)
embryo or female PGCs to##2##5##(2008-11#2)
embryo proteins from##2##3##(2008-10#2)
embryo proteins##3##2##(2008-10#3)
embryo quality##2##2##(2008-9#1)(2011-1#1)
embryo sac abortion##2##3##(2008-4#2)
embryo sac and##2##3##(2009-12#2)
embryo sac##13##2##(2008-11#4)(2008-4#3)(2009-12#3)(2009-8#3)
embryo sacs of##3##3##(2008-11#2)(2008-9#1)
embryo sacs##6##2##(2008-10#1)(2008-11#4)(2008-9#1)
embryo to##5##2##(1991-12#1)(1995-3#1)(2007-12#1)(2008-11#1)(2012-3#1)
embryo transfer##11##2##(1990-10#1)(1991-11#1)(1994-8#1)(1996-5#2)(1996-8#1)(1996-9#1)(2007-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
embryo transferred##2##2##(1996-5#2)
embryo was##2##2##(1991-12#1)(2008-11#1)
embryo##192##1##(1990-10#1)(1990-11#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-5#4)(1991-6#2)(1991-9#1)(1992-11#3)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#4)(1993-2#1)(1993-6#4)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-2#2)(1995-3#4)(1995-8#1)(1996-12#1)(1996-5#6)(1996-8#2)(1996-9#1)(1997-2#2)(1997-7#1)(2007-10#1)(2007-12#14)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#20)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#15)(2009-12#3)(2009-3#1)(2009-8#9)(2010-1#1)(2010-11#2)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#5)(2013-1#3)(2013-8#1)
embryo)##2##1##(2008-11#2)
embryo-fetal##3##1##(2011-2#3)
embryocidal##2##1##(1993-12#1)(2008-9#1)
embryogenesis abundant##3##2##(2008-10#2)(2008-9#1)
embryogenesis and##8##2##(1992-9#1)(1996-2#1)(2007-12#3)(2008-7#1)(2008-8#1)(2009-12#1)
embryogenesis by##2##2##(2007-12#1)(2009-3#1)
embryogenesis in##3##2##(2008-11#1)(2009-3#1)(2009-8#1)
embryogenesis is##3##2##(2008-7#1)(2010-9#1)(2012-1#1)
embryogenesis of##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
embryogenesis##73##1##(1991-5#1)(1992-9#1)(1993-6#2)(1994-12#4)(1995-2#1)(1995-8#1)(1996-2#1)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#11)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#3)(2009-2#1)(2009-3#3)(2009-7#2)(2009-8#5)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
embryogenic cultures of##2##3##(2008-7#2)
embryogenic cultures##3##2##(2008-7#3)
embryogenic##7##1##(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)
embryoid bodies (EBs)##5##3##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
embryoid bodies##6##2##(2008-10#1)(2008-11#2)(2008-9#2)(2011-2#1)
embryoid body##2##2##(2008-11#1)(2008-8#1)
embryoid##10##1##(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#4)(2011-2#1)
embryologic##3##1##(1992-6#1)(1997-3#1)(2008-10#1)
embryological limb development##2##3##(2009-3#2)
embryological##8##1##(2008-10#2)(2009-3#2)(2009-8#1)(2011-2#1)(2013-1#2)
embryology and##2##2##(2008-12#1)(2011-3#1)
embryology laboratory##2##2##(2008-11#2)
embryology to##2##2##(2008-11#1)(2009-3#1)
embryology##12##1##(1990-6#1)(2008-11#4)(2008-12#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
embryonal and fetal intestine##3##4##(1993-6#3)
embryonal carcinoma (EC) cell line##2##5##(1993-9#1)(2013-1#1)
embryonal carcinoma (EC)##3##3##(1993-9#1)(1994-9#1)(2013-1#1)
embryonal carcinoma cells##6##3##(1990-11#1)(1992-12#3)(1995-2#1)(2013-1#1)
embryonal carcinoma##11##2##(1990-11#1)(1992-12#3)(1992-6#1)(1993-9#2)(1994-9#1)(1995-2#1)(2013-1#2)
embryonal histology##2##2##(2013-1#2)
embryonal##28##1##(1990-11#1)(1992-12#3)(1992-6#1)(1993-6#3)(1993-9#3)(1994-11#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#5)
embryonated chicken eggs##4##3##(2007-6#2)(2008-9#2)
embryonated eggs##3##2##(2008-5#3)
embryonated##8##1##(2007-6#2)(2008-5#3)(2008-9#3)
embryonic and induced pluripotent stem cells##2##6##(2012-2#2)
embryonic and neonatal##6##3##(1996-5#4)(1997-6#1)(2008-11#1)
embryonic and##20##2##(1996-5#5)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-3#1)(2012-12#3)(2012-2#2)(2012-5#1)(2013-1#1)
embryonic brain and##2##3##(1997-6#1)(2008-9#1)
embryonic brain development in##2##4##(2007-12#2)
embryonic brain development##4##3##(2007-12#4)
embryonic brain of the grasshopper Schistocerca gregaria##4##7##(2007-12#4)
embryonic brain##15##2##(1997-6#1)(2007-12#12)(2008-8#1)(2008-9#1)
embryonic cDNA library##2##3##(1994-12#1)(1997-4#1)
embryonic carcinoma##2##2##(1997-2#2)
embryonic cells##2##2##(1996-5#1)(2010-7#1)
embryonic chick##4##2##(1995-5#1)(1996-2#1)(2008-11#1)(2008-9#1)
embryonic day 12##2##3##(2008-10#1)(2008-7#1)
embryonic day 15##4##3##(1992-12#1)(1993-3#1)(1994-2#1)(1996-12#1)
embryonic day##17##2##(1991-9#1)(1992-12#1)(1993-3#2)(1994-2#1)(1996-12#2)(1996-5#3)(2008-10#2)(2008-11#1)(2008-7#2)(2013-1#2)
embryonic days##3##2##(1994-3#1)(1996-12#1)(1996-5#1)
embryonic development and##2##3##(1993-12#1)(2009-3#1)
embryonic development##37##2##(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#2)(1997-4#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-3#2)(2009-5#1)(2010-5#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
embryonic diapause of##2##3##(2008-8#2)
embryonic epithelia##3##2##(2008-7#3)
embryonic fibroblasts##10##2##(1993-11#1)(1994-8#1)(1997-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2013-1#2)
embryonic germ##2##2##(2008-9#1)(2009-3#1)
embryonic kidneys##2##2##(1997-4#1)(1997-6#1)
embryonic lethal##3##2##(1995-11#1)(1995-2#1)(2008-8#1)
embryonic limb##2##2##(1996-5#1)(2008-11#1)
embryonic liver##3##2##(2013-1#3)
embryonic nervous tissue##2##3##(2012-1#2)
embryonic or##2##2##(2010-2#1)(2012-5#1)
embryonic rat##3##2##(1996-5#1)(2008-4#1)(2013-1#1)
embryonic reproductive##2##2##(2008-11#2)
embryonic stage##5##2##(1990-5#1)(2008-5#1)(2008-8#3)
embryonic stages##4##2##(1993-6#1)(1995-12#1)(1996-2#2)
embryonic stem (ES) cell##2##4##(2008-11#2)
embryonic stem (ES) cells to##2##5##(1995-11#1)(2008-9#1)
embryonic stem (ES) cells##11##4##(1992-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)
embryonic stem (ES)##13##3##(1992-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)
embryonic stem cell lines##4##4##(2008-8#2)(2008-9#2)
embryonic stem cell research##2##4##(2008-11#1)(2008-9#1)
embryonic stem cell##14##3##(2008-11#4)(2008-8#4)(2008-9#4)(2010-7#1)(2011-2#1)
embryonic stem cells (ESCs)##3##4##(2008-9#3)
embryonic stem cells (hESCs)##2##4##(2008-9#1)(2012-5#1)
embryonic stem cells and##2##4##(2008-9#1)(2012-12#1)
embryonic stem cells are##2##4##(2008-11#1)(2008-8#1)
embryonic stem cells can be##2##5##(2008-11#1)(2008-8#1)
embryonic stem cells have the##2##5##(2008-11#1)(2008-8#1)
embryonic stem cells in##3##4##(2008-11#2)(2012-3#1)
embryonic stem cells into##2##4##(2008-11#1)(2008-9#1)
embryonic stem cells to##4##4##(1995-2#1)(2008-8#1)(2008-9#1)(2009-3#1)
embryonic stem cells##48##3##(1992-12#1)(1995-2#4)(1997-8#1)(2008-10#1)(2008-11#16)(2008-4#1)(2008-8#4)(2008-9#12)(2009-3#2)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)
embryonic stem##76##2##(1992-12#2)(1994-9#1)(1995-11#1)(1995-2#5)(1997-8#2)(2008-10#1)(2008-11#24)(2008-4#1)(2008-8#10)(2008-9#17)(2009-12#1)(2009-3#3)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)
embryonic tissue##2##2##(1994-12#1)(2008-11#1)
embryonic tissues##4##2##(1994-8#1)(1997-4#1)(2008-1#1)(2008-7#1)
embryonic zebrafish##4##2##(2008-8#3)(2008-9#1)
embryonic##317##1##(1990-5#2)(1990-8#2)(1991-9#1)(1992-12#3)(1992-3#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#9)(1995-5#1)(1996-12#7)(1996-2#3)(1996-5#15)(1997-1#3)(1997-2#4)(1997-4#4)(1997-6#6)(1997-8#2)(2007-12#21)(2008-1#1)(2008-10#8)(2008-11#48)(2008-2#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#16)(2008-8#25)(2008-9#27)(2009-1#1)(2009-12#2)(2009-3#8)(2009-5#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-7#4)(2010-9#1)(2011-2#2)(2012-1#4)(2012-12#8)(2012-2#6)(2012-3#9)(2012-5#3)(2013-1#12)(2013-7#1)
embryos and fry##2##3##(2008-6#2)
embryos and##15##2##(1994-8#1)(1995-3#1)(1996-5#2)(2008-10#3)(2008-6#2)(2008-9#1)(2009-12#3)(2009-8#1)(2010-8#1)
embryos are##4##2##(2008-10#1)(2008-11#1)(2009-5#2)
embryos at##4##2##(1991-12#1)(1997-9#1)(2009-12#1)(2011-2#1)
embryos by##7##2##(1995-2#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
embryos correlates with##2##3##(2008-5#1)(2009-8#1)
embryos derived from donor##2##4##(1994-9#1)(2008-9#1)
embryos derived from##5##3##(1994-9#1)(2008-11#1)(2008-9#3)
embryos developing##2##2##(2008-11#1)(2009-12#1)
embryos during##2##2##(2009-7#1)(2013-1#1)
embryos for##2##2##(2008-11#2)
embryos form##2##2##(2007-12#1)(2012-1#1)
embryos from##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
embryos has##2##2##(1994-8#1)(1995-3#1)
embryos in the##4##3##(2007-12#2)(2008-8#1)(2010-3#1)
embryos in##9##2##(1992-3#2)(1995-2#1)(2007-12#2)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
embryos may##2##2##(1994-9#1)(2012-3#1)
embryos of the##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
embryos of various stages##2##4##(1997-4#1)(2008-5#1)
embryos of##14##2##(1993-3#1)(1993-9#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)
embryos on each explant##2##4##(2008-12#2)
embryos or##2##2##(1992-5#1)(2012-12#1)
embryos per##2##2##(2008-5#1)(2013-7#1)
embryos that##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
embryos to##3##2##(1994-8#1)(1996-8#1)(2008-1#1)
embryos treated with##2##3##(1993-12#1)(2008-11#1)
embryos using a##2##3##(1993-3#1)(1995-2#1)
embryos was##4##2##(1995-6#1)(2008-11#1)(2012-1#1)(2013-1#1)
embryos were exposed to##2##4##(1995-3#1)(1996-2#1)
embryos were##24##2##(1992-3#1)(1993-12#2)(1994-8#2)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2013-1#1)
embryos with a##2##3##(1991-5#1)(2013-7#1)
embryos with##5##2##(1991-5#1)(1993-6#1)(1996-5#1)(2011-1#1)(2013-7#1)
embryos##273##1##(1990-5#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#3)(1992-12#3)(1992-3#4)(1992-5#2)(1992-9#1)(1993-12#7)(1993-2#1)(1993-3#4)(1993-6#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#8)(1994-9#3)(1995-11#2)(1995-2#8)(1995-3#6)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#8)(1996-8#6)(1997-4#2)(1997-6#3)(1997-7#6)(1997-8#1)(1997-9#1)(2007-12#4)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#23)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#15)(2008-6#5)(2008-7#6)(2008-8#11)(2008-9#22)(2009-12#7)(2009-5#2)(2009-7#2)(2009-8#4)(2010-3#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#4)(2012-12#3)(2012-3#4)(2013-1#12)(2013-7#3)
emerge as a##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
emerge as##6##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-3#1)
emerge at the##2##3##(2008-3#1)(2008-8#1)
emerge by##2##2##(2008-11#1)(2008-9#1)
emerge early in##2##3##(2008-2#1)(2010-12#1)
emerge from the##6##3##(2006-12#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-11#1)(2010-4#1)
emerge from this##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
emerge from##17##2##(1990-12#1)(2006-12#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-2#1)
emerge in##5##2##(1995-1#1)(1996-2#1)(1996-5#1)(2009-10#1)(2009-2#1)
emerge that##3##2##(2006-5#1)(2009-5#1)(2011-1#1)
emerge when##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
emerge##70##1##(1990-12#1)(1990-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
emerged and##5##2##(1992-2#1)(1992-6#1)(1997-1#1)(2008-10#1)(2009-7#1)
emerged as 'doing##2##3##(2007-10#2)
emerged as a key##3##4##(2008-10#1)(2008-5#1)(2012-1#1)
emerged as a major##4##4##(1993-3#1)(1994-7#1)(2008-9#1)(2013-1#1)
emerged as a promising##4##4##(2008-11#1)(2008-9#1)(2010-8#1)(2012-2#1)
emerged as a##37##3##(1993-3#1)(1994-11#1)(1994-7#1)(1995-3#1)(1996-11#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
emerged as an effective##3##4##(1997-6#1)(2009-11#1)(2009-6#1)
emerged as an important##7##4##(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2013-3#1)(2013-8#1)
emerged as an##16##3##(1995-11#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-3#1)(2013-8#1)
emerged as important##2##3##(2010-11#1)(2011-2#1)
emerged as the gold standard##2##5##(2009-3#1)(2011-2#1)
emerged as the##11##3##(1992-12#1)(1997-1#1)(1997-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#2)(2011-2#1)(2011-7#1)(2013-1#1)
emerged as##82##2##(1992-12#1)(1993-3#1)(1994-11#1)(1994-7#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#2)(2007-2#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-3#1)(2013-8#5)
emerged at##2##2##(2008-10#1)(2009-6#1)
emerged between##5##2##(1991-12#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-12#1)
emerged for the##2##3##(2010-7#1)(2012-2#1)
emerged for##6##2##(2008-12#2)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
emerged from a##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
emerged from the analysis##2##4##(2008-11#1)(2013-1#1)
emerged from the data##3##4##(2008-11#1)(2010-12#1)(2012-12#1)
emerged from the fiber##2##4##(2008-10#1)(2008-3#1)
emerged from the##22##3##(1994-12#1)(1996-12#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)
emerged from##39##2##(1991-12#2)(1994-12#1)(1996-12#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#7)(2008-3#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#5)
emerged in the##6##3##(1990-6#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-1#1)(2010-10#1)
emerged in##24##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-3#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-1#2)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
emerged over the##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
emerged recently to##2##3##(2008-7#2)
emerged recently##3##2##(2007-2#1)(2008-7#2)
emerged that##3##2##(1996-1#1)(2008-10#1)(2009-9#1)
emerged to be##2##3##(2008-10#1)(2011-2#1)
emerged to##3##2##(2008-10#1)(2011-2#2)
emerged when##2##2##(2008-11#1)(2008-6#1)
emerged which##3##2##(1994-12#1)(2008-11#1)(2010-10#1)
emerged with##2##2##(1990-12#1)(2008-10#1)
emerged##263##1##(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#4)(1991-12#3)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-7#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#2)(2008-10#34)(2008-11#23)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#1)(2010-3#4)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#8)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#16)(2013-3#1)(2013-8#8)
emergence agitation##2##2##(2011-2#2)
emergence and the##2##3##(2007-12#1)(2008-12#1)
emergence and##10##2##(2007-12#2)(2008-10#3)(2008-12#2)(2010-4#1)(2012-3#1)(2013-1#1)
emergence by##6##2##(2008-10#5)(2008-8#1)
emergence from the##2##3##(2008-10#1)(2008-7#1)
emergence from##3##2##(2008-10#2)(2008-7#1)
emergence in the field##2##4##(2008-10#1)(2008-8#1)
emergence in##8##2##(2008-10#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2011-1#1)
emergence inhibitors##3##2##(2008-10#3)
emergence of T##2##3##(2008-6#2)
emergence of a new##5##4##(1994-1#1)(1994-12#1)(2008-10#2)(2013-1#1)
emergence of a##10##3##(1991-3#1)(1994-1#1)(1994-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#1)
emergence of extensively##2##3##(2008-10#1)(2010-5#1)
emergence of new##7##3##(1994-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-2#1)
emergence of resistance to##2##4##(2008-11#1)(2010-11#1)
emergence of resistance##4##3##(2008-11#2)(2008-7#1)(2010-11#1)
emergence of resistant##2##3##(2013-1#2)
emergence of sociality##2##3##(2008-8#2)
emergence of such##2##3##(2008-3#1)(2008-8#1)
emergence of the##6##3##(2008-10#1)(2008-5#1)(2008-6#2)(2013-8#2)
emergence of these##2##3##(2008-10#1)(2010-5#1)
emergence of this##3##3##(2008-10#2)(2012-2#1)
emergence of viral##2##3##(1996-1#1)(2013-1#1)
emergence of##114##2##(1990-7#1)(1991-3#2)(1991-4#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-1#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#14)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
emergence time##2##2##(2008-12#2)
emergence to##2##2##(2008-10#2)
emergence was##2##2##(2008-12#1)(2008-6#1)
emergence##200##1##(1990-7#1)(1991-3#2)(1991-4#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-1#1)(2006-10#1)(2007-12#8)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#54)(2008-11#14)(2008-12#12)(2008-3#1)(2008-5#1)(2008-6#8)(2008-7#4)(2008-8#10)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#15)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#3)
emergencies and require##2##3##(2011-1#1)(2011-3#1)
emergencies and##5##2##(2007-8#1)(2008-1#1)(2010-3#1)(2011-1#1)(2011-3#1)
emergencies in a##2##3##(2010-9#1)(2011-2#1)
emergencies in children##6##3##(2008-11#5)(2012-2#1)
emergencies in##16##2##(1995-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2009-4#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
emergencies managed at##2##3##(2011-2#1)(2013-1#1)
emergencies were##2##2##(2008-1#1)(2011-2#1)
emergencies##54##1##(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-12#3)(1995-12#1)(1996-8#1)(1997-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#2)(2008-11#5)(2008-8#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#5)(2013-1#4)
emergencies]##2##1##(1990-6#1)(1992-6#1)
emergency and##3##2##(1990-3#1)(1995-5#1)(2009-8#1)
emergency basis##3##2##(1992-1#1)(2011-1#1)(2012-3#1)
emergency caesarean section##3##3##(1993-10#1)(2011-2#1)(2012-12#1)
emergency caesarean##5##2##(1993-10#1)(1994-3#1)(2008-3#1)(2011-2#1)(2012-12#1)
emergency care##10##2##(1991-6#1)(1995-2#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-6#1)(2011-1#1)
emergency cesarean section##2##3##(1992-11#1)(2011-1#1)
emergency contraception##2##2##(2008-11#1)(2011-2#1)
emergency cover##2##2##(1990-3#1)(2011-2#1)
emergency department (ED)##11##3##(2007-5#3)(2008-11#1)(2008-3#2)(2009-6#2)(2010-8#1)(2011-9#1)(2012-2#1)
emergency department has##2##3##(2007-5#1)(2008-3#1)
emergency department management of##2##4##(2009-9#1)(2010-2#1)
emergency department management##3##3##(2008-3#1)(2009-9#1)(2010-2#1)
emergency department security##2##3##(1995-12#1)(1996-2#1)
emergency department visits##2##3##(2012-3#1)(2013-1#1)
emergency department##99##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-2#1)(2006-5#2)(2007-10#4)(2007-5#12)(2008-10#2)(2008-11#10)(2008-3#22)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)
emergency departments (EDs)##2##3##(2008-11#1)(2008-7#1)
emergency departments##14##2##(1991-12#1)(1991-3#1)(1991-6#1)(2007-5#2)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2012-3#1)(2013-8#1)
emergency drugs and equipment##2##4##(2008-1#2)
emergency for##2##2##(2006-7#1)(2011-2#1)
emergency health##2##2##(1991-6#1)(2008-1#1)
emergency in##12##2##(2007-5#1)(2011-2#1)(2013-8#10)
emergency medical care##3##3##(1997-8#1)(2010-8#2)
emergency medical service##3##3##(1996-3#2)(2010-4#1)
emergency medical services##4##3##(2008-3#2)(2008-9#1)(2013-7#1)
emergency medical##14##2##(1992-3#1)(1995-6#1)(1996-3#2)(1997-8#1)(2007-9#1)(2008-3#2)(2008-9#1)(2010-4#1)(2010-8#3)(2013-7#1)
emergency medication##3##2##(2007-2#2)(2010-5#1)
emergency medicine in##2##3##(2008-11#1)(2009-4#1)
emergency medicine##17##2##(1990-6#1)(1994-1#1)(1996-2#1)(2007-5#5)(2008-11#3)(2009-4#1)(2009-6#4)(2011-2#1)
emergency nurses##7##2##(2008-11#5)(2013-1#2)
emergency nursing##7##2##(2008-11#3)(2013-1#4)
emergency obstetric care##4##3##(2008-7#1)(2009-2#1)(2010-11#1)(2011-1#1)
emergency obstetric##6##2##(1994-1#1)(2008-7#1)(2009-2#1)(2010-11#1)(2011-1#2)
emergency operation##2##2##(1997-8#1)(2011-2#1)
emergency patients##3##2##(1991-2#1)(1993-1#1)(1993-2#1)
emergency physician should##2##3##(1994-3#1)(2012-3#1)
emergency physician##4##2##(1994-3#2)(2009-6#1)(2012-3#1)
emergency physicians##6##2##(2007-5#4)(2009-4#1)(2013-7#1)
emergency postpartum hysterectomy##2##3##(1995-12#2)
emergency preparedness##5##2##(2009-12#1)(2010-8#3)(2013-1#1)
emergency procedure##2##2##(1992-5#1)(2008-7#1)
emergency procedures in##2##3##(2008-12#2)
emergency procedures##3##2##(1997-5#1)(2008-12#2)
emergency response##6##2##(1991-3#1)(1992-12#1)(1996-4#1)(2008-3#1)(2008-7#1)(2013-1#1)
emergency room use##3##3##(1992-1#3)
emergency room with##5##3##(2008-3#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
emergency room##34##2##(1992-1#3)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#4)(2013-1#3)(2013-8#1)
emergency rooms##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
emergency service##5##2##(1994-5#1)(1996-9#1)(2007-11#1)(2007-8#1)(2012-3#1)
emergency services##12##2##(1992-11#1)(1993-11#1)(1993-12#3)(1996-1#3)(1996-4#1)(2008-11#1)(2012-12#1)(2012-3#1)
emergency situations and##3##3##(1990-6#1)(1995-3#1)(2009-6#1)
emergency situations##11##2##(1990-5#1)(1990-6#2)(1995-3#1)(2009-6#6)(2010-8#1)
emergency surgery##12##2##(1991-3#2)(1991-6#2)(1992-9#2)(1993-9#2)(2008-11#1)(2008-7#2)(2010-12#1)
emergency surgical care##2##3##(2008-6#1)(2010-8#1)
emergency thoracotomy##2##2##(1997-6#1)(2008-1#1)
emergency treatment of##2##3##(1993-9#1)(2011-2#1)
emergency treatment##8##2##(1993-9#1)(1996-1#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
emergency visits##2##2##(1996-1#2)
emergency##462##1##(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#4)(1991-12#2)(1991-2#1)(1991-3#5)(1991-6#5)(1992-1#6)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-6#1)(1993-9#5)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#7)(1996-2#3)(1996-3#2)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#3)(1997-6#1)(1997-8#2)(2006-5#4)(2006-7#1)(2007-10#6)(2007-11#1)(2007-12#5)(2007-2#3)(2007-5#26)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#9)(2008-11#30)(2008-12#5)(2008-3#32)(2008-4#3)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#6)(2009-6#15)(2009-8#2)(2009-9#6)(2010-1#1)(2010-11#4)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#13)(2011-1#9)(2011-2#22)(2011-3#1)(2011-9#1)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#39)(2013-7#3)(2013-8#15)
emergency]##2##1##(1992-5#1)(2012-2#1)
emergent iono-neuronal##4##2##(2009-5#4)
emergent literacy skills##2##3##(2011-2#2)
emergent literacy##6##2##(2009-9#1)(2011-2#5)
emergent properties##3##2##(2008-7#1)(2010-6#1)(2012-12#1)
emergent surgery##2##2##(2008-10#1)(2010-8#1)
emergent##42##1##(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-5#4)(2009-9#1)(2010-1#2)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#3)
emerges as a##5##3##(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)
emerges as##7##2##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)
emerges for##2##2##(1992-9#1)(2012-2#1)
emerges from a##2##3##(2008-11#1)(2013-1#1)
emerges from##7##2##(1990-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-1#1)
emerges in##3##2##(2008-1#1)(2010-3#1)(2010-4#1)
emerges that##2##2##(1990-9#1)(2011-2#1)
emerges##34##1##(1990-8#1)(1990-9#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
emerging and re-emerging diseases##2##4##(2011-1#2)
emerging and re-emerging##5##3##(2009-2#1)(2010-12#1)(2011-1#2)(2012-2#1)
emerging and##13##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-2#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
emerging application##2##2##(2008-7#1)(2011-2#1)
emerging applications##3##2##(2008-2#1)(2008-8#1)(2012-2#1)
emerging as a##12##3##(1992-1#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
emerging as an##5##3##(1992-1#1)(1996-12#1)(2008-7#1)(2011-2#2)
emerging as important##2##3##(2008-12#1)(2013-1#1)
emerging as the##3##3##(2007-12#1)(2008-1#2)
emerging as##27##2##(1992-1#2)(1996-12#1)(2006-10#1)(2007-12#1)(2008-1#4)(2008-12#2)(2008-3#2)(2008-7#5)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
emerging body of##2##3##(2010-8#1)(2012-1#1)
emerging clinical##4##2##(1992-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
emerging concept##3##2##(2008-3#1)(2008-7#1)(2010-1#1)
emerging disease in##3##3##(2009-8#1)(2010-4#1)(2012-12#1)
emerging disease##4##2##(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)
emerging diseases##6##2##(2007-12#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
emerging economies##2##2##(2008-5#1)(2011-2#1)
emerging evidence for##3##3##(2012-12#2)(2012-2#1)
emerging evidence of##2##3##(2008-4#1)(2010-8#1)
emerging evidence##9##2##(1994-5#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
emerging field of##7##3##(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2013-8#1)
emerging field##9##2##(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
emerging from a##2##3##(2007-11#1)(2008-2#1)
emerging from our##2##3##(2008-7#1)(2010-6#1)
emerging from the##6##3##(1990-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#1)
emerging from##21##2##(1990-2#1)(1990-4#1)(1991-1#1)(1994-2#1)(1996-5#1)(1996-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
emerging health care system##2##4##(1995-12#1)(1996-12#1)
emerging health##5##2##(1995-12#1)(1996-12#1)(1997-3#1)(2008-7#1)(2012-2#1)
emerging imaging##2##2##(2012-2#2)
emerging in the##4##3##(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
emerging in##8##2##(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-3#1)
emerging infections##2##2##(1997-3#1)(2008-11#1)
emerging infectious diseases##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
emerging infectious##4##2##(2007-7#2)(2008-10#1)(2011-2#1)
emerging issues and##2##3##(2008-6#2)
emerging issues##3##2##(1995-1#1)(2008-6#2)
emerging lateral roots##2##3##(2008-10#1)(2008-8#1)
emerging leaves##2##2##(2008-10#2)
emerging lessons about strategy and implementation##2##6##(1996-1#1)(1996-2#1)
emerging lessons##3##2##(1996-1#1)(1996-2#2)
emerging novel##2##2##(2009-12#1)(2013-1#1)
emerging on the##2##3##(2008-11#1)(2008-8#1)
emerging on##3##2##(2008-11#1)(2008-8#2)
emerging pathogen##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
emerging pathogens##3##2##(1996-1#1)(2011-2#1)(2013-8#1)
emerging patient##2##2##(2009-5#1)(2010-8#1)
emerging population of##2##3##(1992-1#1)(2009-6#1)
emerging public health##2##3##(2010-5#1)(2011-2#1)
emerging research##2##2##(2008-10#1)(2009-5#1)
emerging risk factors##2##3##(2011-1#2)
emerging risks##2##2##(1994-1#1)(2011-1#1)
emerging role of the##2##4##(1992-2#1)(2010-7#1)
emerging role of##4##3##(1992-2#1)(2008-7#1)(2010-7#1)(2012-2#1)
emerging role##6##2##(1992-2#2)(2008-7#1)(2010-7#1)(2012-2#2)
emerging story##2##2##(2008-4#1)(2008-7#1)
emerging strategy##2##2##(2008-10#1)(2010-5#1)
emerging technologies##2##2##(2008-10#1)(2008-9#1)
emerging that##2##2##(2011-2#1)(2013-8#1)
emerging to##2##2##(2006-10#1)(2008-10#1)
emerging treatment options##2##3##(2008-6#1)(2011-2#1)
emerging treatment##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
emerging trends##5##2##(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-12#1)
emerging understanding of##2##3##(2010-12#1)(2011-2#1)
emerging view##2##2##(2008-9#1)(2013-1#1)
emerging viruses of##2##3##(2013-8#2)
emerging##332##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-1#4)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-1#4)(1996-12#3)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#5)(2006-10#2)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#8)(2008-10#24)(2008-11#11)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#19)(2008-8#8)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#11)(2010-9#1)(2011-1#14)(2011-2#25)(2012-1#3)(2012-12#5)(2012-2#17)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#7)
emery paper&gt##2##2##(2008-10#2)
emery##3##1##(2008-10#3)
emesis and##3##2##(1991-2#1)(2010-3#1)(2013-1#1)
emesis induced##2##2##(1994-12#1)(2010-12#1)
emesis was##3##2##(2008-8#1)(2010-12#2)
emesis##23##1##(1990-12#1)(1991-2#1)(1992-12#1)(1994-12#1)(2008-5#4)(2008-7#5)(2008-8#2)(2010-12#3)(2010-3#1)(2011-2#2)(2013-1#2)
emesis)##2##1##(2008-7#2)
emetic##5##1##(2011-2#5)
emetine##6##1##(1994-10#1)(1995-3#5)
emetogenic##3##1##(2008-7#1)(2010-12#2)
emigrants##3##1##(2008-8#1)(2013-1#2)
emigrate##2##1##(2008-2#1)(2008-6#1)
emigrated##2##1##(2008-9#1)(2011-2#1)
emigrating##3##1##(2008-10#2)(2010-8#1)
emigration##6##1##(1993-6#1)(2008-8#3)(2009-4#1)(2011-1#1)
eminence##7##1##(1995-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#3)
eminent##3##1##(1994-9#1)(2007-5#1)(2011-2#1)
emission and excitation spectra##2##4##(2008-10#2)
emission and excitation##4##3##(2008-10#2)(2012-2#2)
emission and reflection##2##3##(2008-3#2)
emission and solar absorption##2##4##(2008-3#2)
emission and the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
emission and##25##2##(1994-6#1)(2007-11#3)(2007-12#4)(2008-10#5)(2008-2#1)(2008-3#8)(2008-5#1)(2012-2#2)
emission are##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
emission at the##3##3##(2007-11#1)(2008-3#2)
emission at##17##2##(1990-8#1)(1991-5#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#3)
emission band of##2##3##(2008-10#1)(2013-8#1)
emission band##4##2##(2008-10#2)(2008-2#1)(2013-8#1)
emission bands##2##2##(2008-10#1)(2008-7#1)
emission based##2##2##(2008-10#2)
emission by##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
emission caused by##2##3##(2008-10#2)
emission characteristics of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
emission characteristics##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
emission computed tomography##18##3##(1994-1#2)(1995-5#2)(1996-12#1)(1996-5#2)(1996-7#2)(2007-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2012-2#1)
emission computed##19##2##(1994-1#2)(1995-5#2)(1996-12#1)(1996-5#3)(1996-7#2)(2007-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2012-2#1)
emission data##2##2##(2008-2#1)(2008-3#1)
emission enhancement##2##2##(2007-11#1)(2008-10#1)
emission features##2##2##(1991-5#1)(2008-2#1)
emission filter##2##2##(2008-10#1)(2008-9#1)
emission for##3##2##(2007-12#2)(2008-10#1)
emission from a##8##3##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#1)
emission from an oscillating dipole inside a##2##7##(2008-2#2)
emission from an##3##3##(2008-2#2)(2008-3#1)
emission from the tip##2##4##(2007-11#2)
emission from the##10##3##(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
emission from##50##2##(1992-8#1)(2007-11#10)(2007-12#8)(2008-10#4)(2008-2#10)(2008-3#14)(2008-9#1)(2009-11#1)(2009-8#1)
emission generated##2##2##(2008-10#2)
emission in a##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
emission in the##8##3##(2007-12#1)(2008-2#3)(2008-3#3)(2011-2#1)
emission in##22##2##(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#8)(2011-2#1)
emission intensities of the##2##4##(2008-10#2)
emission intensities##3##2##(2008-10#3)
emission intensity of##3##3##(1996-12#1)(2008-10#2)
emission intensity##16##2##(1992-6#1)(1996-12#1)(2007-11#2)(2008-10#11)(2008-3#1)
emission into the##2##3##(2007-12#1)(2008-10#1)
emission is##21##2##(1993-11#1)(2007-11#3)(2007-12#5)(2008-10#5)(2008-2#1)(2008-3#5)(2013-8#1)
emission levels##2##2##(2008-3#2)
emission line##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
emission lines at##2##3##(2007-11#1)(2008-3#1)
emission lines of##2##3##(2008-10#2)
emission lines##11##2##(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#2)
emission maxima##9##2##(1995-5#1)(2008-10#7)(2008-9#1)
emission maximum at##6##3##(1990-5#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-8#2)
emission maximum##7##2##(1990-5#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-8#2)
emission mechanism##3##2##(2008-10#1)(2009-11#2)
emission monochromators##2##2##(2008-10#2)
emission of a##7##3##(2007-11#3)(2008-1#1)(2008-10#1)(2008-3#2)
emission of erbium-doped fluoride##2##4##(2007-12#2)
emission of light##2##3##(1990-5#1)(2008-3#1)
emission of the##5##3##(2007-11#2)(2007-12#1)(2008-10#2)
emission of these##4##3##(2007-11#1)(2008-10#3)
emission of##69##2##(1990-5#1)(1990-9#1)(1992-3#1)(1995-5#1)(1996-2#1)(2007-11#8)(2007-12#6)(2008-1#2)(2008-10#23)(2008-11#2)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#1)(2009-6#1)(2011-3#1)(2012-2#1)
emission peak of##2##3##(2008-10#2)
emission peak##7##2##(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
emission peaks##2##2##(1992-6#1)(2013-8#1)
emission power##3##2##(2008-3#3)
emission produced by##2##3##(2008-10#1)(2010-7#1)
emission properties of##4##3##(2008-10#1)(2008-2#1)(2009-11#1)(2013-8#1)
emission radiation##2##2##(2008-10#1)(2008-7#1)
emission rate##4##2##(2008-11#1)(2008-2#1)(2011-10#2)
emission rates##8##2##(2007-11#4)(2008-11#1)(2011-10#3)
emission shows##3##2##(2007-12#2)(2008-3#1)
emission source##3##2##(2008-10#2)(2008-3#1)
emission sources##8##2##(1992-3#2)(2008-10#4)(2008-11#2)
emission spectra and##2##3##(2008-10#1)(2008-3#1)
emission spectra for##2##3##(2008-10#2)
emission spectra of YAG##2##4##(2013-8#2)
emission spectra of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
emission spectra of##11##3##(1990-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)(2009-8#1)(2013-8#2)
emission spectra were##3##3##(1992-8#1)(2008-2#2)
emission spectra##34##2##(1990-12#1)(1990-5#1)(1992-8#1)(1995-5#1)(2007-12#1)(2008-10#11)(2008-2#5)(2008-3#4)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2013-8#3)
emission spectrometer##6##2##(2008-10#5)(2008-3#1)
emission spectrometric##4##2##(2008-10#4)
emission spectrometry (ICP OES) and##2##5##(2008-10#2)
emission spectrometry (ICP OES)##3##4##(2008-10#3)
emission spectrometry (ICP##4##3##(2008-10#4)
emission spectrometry (ICP-AES) with##2##4##(2008-10#2)
emission spectrometry (ICP-AES)##20##3##(2008-10#20)
emission spectrometry (ICP-OES) after##3##4##(2008-10#3)
emission spectrometry (ICP-OES) was##3##4##(2008-10#2)(2010-5#1)
emission spectrometry (ICP-OES)##15##3##(2008-10#14)(2010-5#1)
emission spectrometry coupled with##2##4##(2008-10#2)
emission spectrometry were##2##3##(2008-10#2)
emission spectrometry##115##2##(1992-3#1)(2008-10#113)(2010-5#1)
emission spectrophotometry##4##2##(2008-10#4)
emission spectroscopic##4##2##(1994-12#1)(2008-10#2)(2008-3#1)
emission spectroscopy (ICP-OES)##2##3##(2008-10#1)(2011-2#1)
emission spectroscopy in##3##3##(2008-10#2)(2008-2#1)
emission spectroscopy is##2##3##(2008-1#1)(2008-2#1)
emission spectroscopy##31##2##(1994-12#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#16)(2008-2#4)(2008-3#1)(2008-5#1)(2010-11#3)(2011-2#2)
emission spectrum of##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
emission spectrum##17##2##(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-2#1)(2013-8#2)
emission that is##2##3##(2008-2#1)(2010-7#1)
emission to##2##2##(2007-11#1)(2007-12#1)
emission tomography (PET)##17##3##(1990-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#4)(1996-7#1)(2008-1#1)(2008-7#1)(2008-8#2)(2010-3#1)(2012-12#1)(2012-2#1)
emission tomography in##3##3##(1996-2#1)(2008-12#1)(2008-7#1)
emission tomography##45##2##(1990-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#3)(1996-5#6)(1996-7#1)(2008-1#3)(2008-12#1)(2008-2#4)(2008-7#4)(2008-8#2)(2009-11#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
emission was monitored##3##3##(2008-10#3)
emission was observed##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
emission was##10##2##(2007-12#1)(2008-10#8)(2008-5#1)
emission wavelength at##4##3##(2008-10#4)
emission wavelength of##9##3##(1997-2#1)(2008-10#7)(2008-3#1)
emission wavelength##29##2##(1991-3#1)(1997-2#1)(2007-12#1)(2008-10#19)(2008-2#4)(2008-3#2)(2011-1#1)
emission wavelengths are##5##3##(2007-12#1)(2008-10#4)
emission wavelengths in##2##3##(2008-10#1)(2009-12#1)
emission wavelengths of the##2##4##(2008-10#1)(2008-3#1)
emission wavelengths of##5##3##(1990-8#1)(2008-10#3)(2008-3#1)
emission wavelengths were##4##3##(2008-10#3)(2008-3#1)
emission wavelengths##27##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-3#4)(2008-9#1)(2009-12#1)
emission were##6##2##(2008-10#4)(2010-4#1)(2011-10#1)
emission with##3##2##(2007-12#1)(2008-3#2)
emission within the##2##3##(2007-11#1)(2012-12#1)
emission##893##1##(1990-12#1)(1990-5#3)(1990-8#5)(1990-9#1)(1991-3#1)(1991-5#3)(1992-11#1)(1992-3#4)(1992-6#2)(1992-8#3)(1993-11#3)(1993-5#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#9)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#4)(1996-5#9)(1996-7#3)(1997-2#1)(1997-7#1)(2007-10#3)(2007-11#55)(2007-12#57)(2008-1#8)(2008-10#390)(2008-11#10)(2008-12#3)(2008-2#66)(2008-3#117)(2008-4#2)(2008-5#4)(2008-7#13)(2008-8#6)(2008-9#7)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#3)(2011-10#7)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#12)(2012-3#1)(2013-1#1)(2013-8#10)
emission)##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
emissions and the##2##3##(2008-11#2)
emissions and working areas##6##4##(2008-10#6)
emissions and##10##2##(2008-1#1)(2008-10#7)(2008-11#2)
emissions are##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2013-7#1)
emissions by the##2##3##(2008-3#2)
emissions by##5##2##(2008-11#2)(2008-3#2)(2009-5#1)
emissions for##3##2##(1991-6#1)(1996-3#1)(2008-10#1)
emissions from industrial plants##2##4##(2008-3#2)
emissions from the##2##3##(1992-3#1)(2011-2#1)
emissions from##18##2##(1992-3#1)(2007-12#3)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#4)(2011-10#1)(2011-2#2)(2012-2#1)
emissions in##2##2##(2008-11#1)(2013-8#1)
emissions of##11##2##(1991-6#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2011-10#2)
emissions##104##1##(1991-6#3)(1992-3#2)(1996-3#1)(2007-12#5)(2008-1#3)(2008-10#22)(2008-11#17)(2008-2#11)(2008-3#12)(2008-4#4)(2009-11#2)(2009-12#1)(2009-5#5)(2009-7#1)(2009-8#2)(2011-10#6)(2011-2#2)(2012-2#1)(2013-7#3)(2013-8#1)
emissions)##2##1##(2008-10#2)
emissive##3##1##(2008-3#1)(2009-5#1)(2012-12#1)
emissivities##7##1##(2008-3#1)(2013-8#6)
emissivity in the thermal infrared##2##5##(2008-3#2)
emissivity in##3##2##(2008-3#2)(2013-8#1)
emissivity is a##2##3##(2008-3#1)(2013-8#1)
emissivity is##3##2##(2008-3#2)(2013-8#1)
emissivity of a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
emissivity of the liquid##2##4##(2008-3#2)
emissivity of the##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
emissivity of##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
emissivity##35##1##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#18)(2013-8#12)
emit fluorescence##2##2##(2008-10#1)(2008-8#1)
emit##15##1##(1990-7#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-7#1)
emits bright##2##2##(2008-3#1)(2013-1#1)
emits light##3##2##(1990-8#1)(2008-10#1)(2010-7#1)
emits##20##1##(1990-8#1)(1991-5#1)(1993-11#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#4)(2008-9#1)(2010-7#1)(2013-1#1)
emittance##3##1##(2008-2#3)
emitted and##3##2##(2008-10#1)(2008-3#2)
emitted by a molecular fluorine##2##5##(2008-3#2)
emitted by a##6##3##(1992-1#1)(2007-11#1)(2007-12#2)(2008-3#2)
emitted by cars equipped with catalytic converters##2##7##(2008-11#2)
emitted by the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
emitted by##23##2##(1992-1#2)(2007-11#3)(2007-12#2)(2008-10#5)(2008-11#3)(2008-3#4)(2008-8#1)(2009-8#1)(2011-10#2)
emitted fluorescence##6##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
emitted from a##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2012-12#1)
emitted from the##6##3##(2008-10#2)(2008-11#1)(2008-3#3)
emitted from##16##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2010-12#1)(2012-12#1)(2013-8#1)
emitted in##2##2##(2008-10#1)(2008-2#1)
emitted light##4##2##(2007-11#1)(2008-10#2)(2012-12#1)
emitted##78##1##(1992-1#2)(1994-8#1)(1995-2#1)(2007-11#8)(2007-12#6)(2008-10#19)(2008-11#6)(2008-2#8)(2008-3#15)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-10#3)(2012-12#2)(2013-1#1)(2013-8#1)
emitter is##3##2##(2007-12#1)(2008-3#2)
emitter##18##1##(2007-11#3)(2007-12#6)(2008-10#3)(2008-3#6)
emitter)##2##1##(2007-10#1)(2008-7#1)
emitters with##3##2##(2007-11#1)(2007-12#2)
emitters##13##1##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#3)(2010-2#1)
emitting at##10##2##(2007-11#1)(2007-12#6)(2008-10#3)
emitting diode##16##2##(1991-2#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)
emitting in the##2##3##(2008-3#2)
emitting laser##2##2##(2007-12#1)(2008-2#1)
emitting near##2##2##(2007-12#1)(2008-3#1)
emitting particles##2##2##(1995-6#1)(2008-3#1)
emitting##60##1##(1991-2#1)(1994-8#1)(1995-6#1)(2007-11#2)(2007-12#11)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
emm gene##2##2##(2007-8#2)
emm##5##1##(2007-8#5)
emodin and physcion##2##3##(2008-10#2)
emodin##4##1##(2008-10#3)(2012-3#1)
emollient efficiency and activity##2##4##(2008-5#2)
emollient foam##4##2##(2010-8#4)
emollient##11##1##(2008-5#6)(2010-8#5)
emotion and##6##2##(1996-2#1)(2008-4#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
emotion dysregulation##2##2##(2012-12#2)
emotion expectancies##6##2##(2013-8#6)
emotion on##2##2##(2007-4#1)(2009-8#1)
emotion reactions engaged in more##2##5##(2012-12#2)
emotion understanding##2##2##(2009-4#1)(2012-12#1)
emotion##56##1##(1990-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(2007-4#1)(2007-8#3)(2008-11#13)(2008-4#1)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#5)(2012-1#1)(2012-12#10)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
emotion-focused coping##6##2##(2008-1#1)(2011-2#5)
emotion-focused##10##1##(1991-1#3)(2008-1#1)(2011-2#6)
emotional adaptation##2##2##(1996-1#1)(1997-4#1)
emotional and behavioral responses##2##4##(2010-1#2)
emotional and behavioral##4##3##(2009-7#1)(2010-1#2)(2012-3#1)
emotional and developmental##2##3##(1992-3#1)(2008-11#1)
emotional and social##2##3##(2011-2#1)(2013-8#1)
emotional and##15##2##(1991-2#1)(1992-3#2)(1995-1#1)(1996-3#1)(2008-11#2)(2008-6#1)(2009-7#1)(2010-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
emotional aspects##3##2##(1992-3#1)(1997-1#1)(2011-2#1)
emotional assessment##2##2##(2008-5#2)
emotional behaviour##2##2##(2009-10#2)
emotional burnout##2##2##(2008-10#1)(2008-11#1)
emotional climate##2##2##(1990-11#1)(2010-10#1)
emotional component##2##2##(2008-11#1)(2008-2#1)
emotional difficulties##2##2##(2011-2#1)(2012-1#1)
emotional disorders##5##2##(1995-1#1)(1997-2#1)(2006-10#1)(2008-8#1)(2012-2#1)
emotional distress during##2##3##(1992-2#1)(1995-1#1)
emotional distress##21##2##(1991-1#2)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#3)(1995-1#2)(1995-6#1)(1995-9#1)(1996-5#1)(1997-5#2)(2008-6#1)(2009-6#1)(2009-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
emotional exhaustion##6##2##(1996-2#1)(2008-11#2)(2010-7#1)(2013-1#2)
emotional expression##3##2##(2010-10#1)(2013-8#2)
emotional expressions##6##2##(2008-11#5)(2012-1#1)
emotional face##2##2##(2008-11#1)(2009-4#1)
emotional faces##2##2##(2008-1#1)(2008-11#1)
emotional facial expressions##3##3##(2008-1#2)(2008-6#1)
emotional facial##4##2##(2008-1#2)(2008-2#1)(2008-6#1)
emotional factors##4##2##(1990-11#1)(2009-12#1)(2009-5#1)(2012-12#1)
emotional functioning##3##2##(2008-2#1)(2008-6#2)
emotional functions##2##2##(2008-6#1)(2009-4#1)
emotional health##4##2##(2008-3#1)(2010-2#1)(2010-8#1)(2011-1#1)
emotional intelligence##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
emotional labour##2##2##(2008-11#2)
emotional load##2##2##(1994-2#1)(2008-11#1)
emotional needs##2##2##(1992-3#1)(2008-11#1)
emotional or##2##2##(1995-8#1)(2007-2#1)
emotional pain##2##2##(1996-3#1)(2013-1#1)
emotional perspective##2##2##(2008-11#2)
emotional problems##6##2##(2007-11#1)(2009-11#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
emotional processes##2##2##(1993-5#1)(2008-5#1)
emotional processing##2##2##(2008-11#1)(2013-1#1)
emotional reactions##6##2##(1993-11#1)(1993-2#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
emotional reactivity##3##2##(1993-5#1)(2007-8#1)(2008-1#1)
emotional response to##2##3##(2008-12#1)(2008-6#1)
emotional response##6##2##(1992-2#1)(1993-5#2)(2008-12#1)(2008-4#1)(2008-6#1)
emotional responses##4##2##(2007-6#1)(2008-11#1)(2009-10#1)(2010-9#1)
emotional stability##5##2##(1995-8#1)(2008-11#1)(2008-5#2)(2009-7#1)
emotional state##6##2##(2008-11#1)(2010-4#3)(2012-2#1)(2013-1#1)
emotional states##2##2##(2009-12#1)(2010-10#1)
emotional status##2##2##(2008-12#1)(2012-2#1)
emotional stimuli##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
emotional stress##2##2##(2011-2#1)(2013-1#1)
emotional support and education##2##4##(1994-3#2)
emotional support from##2##3##(1994-1#1)(2009-7#1)
emotional support##7##2##(1994-1#1)(1994-3#2)(2007-4#1)(2008-12#1)(2009-7#1)(2013-1#1)
emotional trauma##2##2##(1994-2#1)(2008-11#1)
emotional well-being##6##2##(1991-6#1)(2007-6#1)(2008-7#1)(2012-12#1)(2013-1#2)
emotional##256##1##(1990-11#4)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#7)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#4)(1994-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#36)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#5)(2008-5#11)(2008-6#15)(2008-7#5)(2008-8#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-2#3)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#18)(2013-8#10)
emotional-affective state and##2##3##(1990-3#2)
emotional-affective state##3##2##(1990-3#3)
emotional-affective##4##1##(1990-3#4)
emotionality and##3##2##(1994-2#1)(1994-6#1)(2010-10#1)
emotionality##10##1##(1993-3#1)(1994-2#2)(1994-6#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#2)
emotionally and##2##2##(1995-1#1)(2013-1#1)
emotionally challenging situations##4##3##(2008-11#4)
emotionally challenging##6##2##(2008-11#5)(2008-7#1)
emotionally less-stable##2##2##(2009-7#2)
emotionally related events##2##3##(1991-2#2)
emotionally related##3##2##(1991-2#2)(2011-2#1)
emotionally##26##1##(1991-2#2)(1991-8#1)(1992-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(2007-11#1)(2008-11#7)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
emotions and feelings##2##3##(2008-1#1)(2008-11#1)
emotions and##11##2##(1994-2#1)(2008-1#1)(2008-11#3)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
emotions as##2##2##(1997-3#1)(2009-10#1)
emotions in##4##2##(1997-2#1)(2008-1#1)(2013-8#2)
emotions of##3##2##(1990-11#1)(2012-2#1)(2013-8#1)
emotions with##2##2##(2012-12#2)
emotions##54##1##(1990-11#1)(1990-3#1)(1991-5#1)(1992-3#1)(1994-2#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-1#3)(2008-11#9)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#3)(2009-9#1)(2010-1#3)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#2)(2013-1#3)(2013-8#8)
empathic##2##1##(1995-5#1)(2011-2#1)
empathy##9##1##(1993-12#1)(1994-1#1)(1995-2#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
emperor##3##1##(1997-3#1)(2008-10#1)(2009-4#1)
emperor's new##2##2##(2008-4#1)(2009-12#1)
emphases on##3##2##(1992-1#2)(2012-12#1)
emphases##4##1##(1992-1#2)(2010-12#1)(2012-12#1)
emphasis and##2##2##(1994-12#1)(2008-11#1)
emphasis has been on##2##4##(1993-2#1)(1996-6#1)
emphasis has been placed on##2##5##(2008-12#1)(2013-8#1)
emphasis has been##5##3##(1993-2#1)(1995-12#1)(1996-6#1)(2008-12#1)(2013-8#1)
emphasis has##6##2##(1993-2#2)(1995-12#1)(1996-6#1)(2008-12#1)(2013-8#1)
emphasis in the##2##3##(2008-1#1)(2008-10#1)
emphasis in##5##2##(2008-1#1)(2008-10#1)(2009-7#1)(2013-1#2)
emphasis is laid on the##3##5##(2008-2#2)(2010-5#1)
emphasis is needed##2##3##(1993-1#1)(2008-1#1)
emphasis is on##8##3##(1991-2#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#2)(2012-2#1)
emphasis is placed on##15##4##(1992-1#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-3#1)
emphasis is put on##2##4##(2006-10#1)(2011-1#1)
emphasis is##37##2##(1991-2#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
emphasis of##5##2##(1996-6#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
emphasis on basic##2##3##(1991-12#1)(2009-3#1)
emphasis on diabetes##3##3##(2008-1#1)(2013-8#2)
emphasis on primary##2##3##(1993-11#1)(1996-12#1)
emphasis on quality##4##3##(1993-2#1)(1994-1#1)(1996-12#1)(2008-10#1)
emphasis on recent##2##3##(2009-8#1)(2011-2#1)
emphasis on small##2##3##(2008-9#1)(2011-2#1)
emphasis on structural##2##3##(1994-12#1)(2012-12#1)
emphasis on the current##2##4##(1995-8#1)(2012-12#1)
emphasis on the importance of##2##5##(1991-3#1)(2010-10#1)
emphasis on the roles of##2##5##(2011-2#1)(2012-12#1)
emphasis on the use of##5##5##(1994-9#1)(2008-5#1)(2008-7#1)(2010-8#2)
emphasis on the##62##3##(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
emphasis on their##2##3##(2007-12#1)(2008-12#1)
emphasis on##203##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#19)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#3)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#3)
emphasis placed on the##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
emphasis placed on##7##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-2#1)
emphasis placed##8##2##(1996-7#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-2#1)
emphasis should be placed on##3##5##(1997-3#1)(2008-10#1)(2008-11#1)
emphasis should be##5##3##(1997-3#1)(2008-10#2)(2008-11#2)
emphasis to##3##2##(1994-2#1)(2011-2#1)(2013-1#1)
emphasis upon##2##2##(1992-1#1)(2013-8#1)
emphasis was##2##2##(2008-5#1)(2008-7#1)
emphasis will be##2##3##(2008-3#1)(2008-4#1)
emphasis##295##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#29)(2008-11#24)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#4)(2010-9#4)(2011-1#2)(2011-2#9)(2012-12#4)(2012-2#9)(2012-3#9)(2013-1#9)(2013-7#1)(2013-8#7)
emphasise the importance of##3##4##(1991-6#1)(2008-11#2)
emphasise the##7##2##(1991-6#1)(2007-12#1)(2008-11#2)(2008-12#2)(2012-2#1)
emphasise##12##1##(1991-5#1)(1991-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
emphasised in nursing education##2##4##(2008-11#2)
emphasised that the##2##3##(2007-7#1)(2007-8#1)
emphasised that##3##2##(2007-7#1)(2007-8#1)(2008-11#1)
emphasised the##2##2##(2008-11#1)(2009-1#1)
emphasised##21##1##(1996-6#3)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#7)(2008-7#1)(2009-1#1)(2010-2#1)(2012-12#2)(2013-1#1)
emphasises the##5##2##(1997-7#1)(2007-12#1)(2010-12#1)(2012-1#1)(2012-6#1)
emphasises##8##1##(1997-7#1)(2007-12#1)(2007-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-6#1)
emphasising the##2##2##(2007-11#1)(2008-11#1)
emphasising##5##1##(1991-5#1)(2007-11#1)(2008-11#2)(2013-1#1)
emphasize a##3##2##(2006-10#1)(2008-7#1)(2012-2#1)
emphasize that a##2##3##(1990-9#1)(1992-12#1)
emphasize that the##4##3##(1997-1#1)(2008-2#1)(2009-6#1)(2010-10#1)
emphasize that##15##2##(1990-9#1)(1992-12#1)(1994-11#1)(1994-8#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-2#1)
emphasize the importance of the##2##5##(1991-12#1)(2009-10#1)
emphasize the importance of##21##4##(1990-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-3#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)
emphasize the need for##7##4##(1991-5#1)(1993-1#1)(2006-10#1)(2008-10#2)(2008-9#1)(2012-2#1)
emphasize the need to##2##4##(1990-5#1)(1991-2#1)
emphasize the need##9##3##(1990-5#1)(1991-2#1)(1991-5#1)(1993-1#1)(2006-10#1)(2008-10#2)(2008-9#1)(2012-2#1)
emphasize the role played by##2##5##(1996-5#1)(2008-11#1)
emphasize the role##4##3##(1993-6#1)(1996-5#1)(2007-11#1)(2008-11#1)
emphasize the##73##2##(1990-10#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1995-4#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
emphasize##115##1##(1990-10#1)(1990-5#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-9#2)(1993-1#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-6#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)
emphasized as##2##2##(1993-6#1)(2007-7#1)
emphasized by the##2##3##(1997-3#1)(2008-10#1)
emphasized for##2##2##(2008-10#1)(2009-3#1)
emphasized in##2##2##(1994-3#1)(2011-2#1)
emphasized on the##2##3##(1996-12#1)(2008-10#1)
emphasized on##3##2##(1996-12#1)(2008-10#1)(2008-12#1)
emphasized that the##3##3##(1990-2#1)(1993-12#1)(1996-12#1)
emphasized that##10##2##(1990-2#1)(1990-8#1)(1991-11#1)(1992-11#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)
emphasized the importance of a##3##5##(1996-1#1)(2008-10#1)(2008-11#1)
emphasized the importance of##9##4##(1993-12#1)(1996-1#2)(2008-10#2)(2008-11#2)(2008-9#1)(2009-2#1)
emphasized the importance##10##3##(1993-12#1)(1996-1#2)(2008-10#2)(2008-11#2)(2008-9#1)(2009-2#1)(2010-4#1)
emphasized the need for##2##4##(2007-12#1)(2008-11#1)
emphasized the need##3##3##(1990-3#1)(2007-12#1)(2008-11#1)
emphasized the##19##2##(1990-3#1)(1991-6#1)(1993-12#1)(1996-1#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-4#1)
emphasized##91##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-3#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
emphasizes a##2##2##(1990-2#1)(2009-3#1)
emphasizes identification of##2##3##(1995-2#1)(2008-4#1)
emphasizes that the##2##3##(1992-1#1)(2007-12#1)
emphasizes that##8##2##(1992-1#1)(1994-12#1)(1995-6#1)(2007-12#1)(2008-7#2)(2009-8#1)(2012-3#1)
emphasizes the importance of##11##4##(1991-6#1)(1994-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-7#1)(2009-11#1)(2009-7#2)(2010-4#1)(2011-1#1)
emphasizes the importance##12##3##(1991-6#1)(1992-4#1)(1994-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-7#1)(2009-11#1)(2009-7#2)(2010-4#1)(2011-1#1)
emphasizes the need for a##3##5##(1990-5#1)(2008-1#1)(2013-8#1)
emphasizes the need for##11##4##(1990-5#1)(1991-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2013-8#1)
emphasizes the need##12##3##(1990-5#1)(1991-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
emphasizes the role of##3##4##(2010-8#1)(2012-3#1)(2013-1#1)
emphasizes the role##4##3##(1996-2#1)(2010-8#1)(2012-3#1)(2013-1#1)
emphasizes the usefulness of##2##4##(1992-1#1)(2012-12#1)
emphasizes the value of##2##4##(2007-10#1)(2008-11#1)
emphasizes the##49##2##(1990-5#2)(1991-2#4)(1991-6#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
emphasizes##83##1##(1990-2#1)(1990-5#2)(1991-2#4)(1991-6#1)(1992-1#3)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-3#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#6)(2013-1#4)(2013-8#3)
emphasizing early##2##2##(1995-5#1)(1997-2#1)
emphasizing that##3##2##(1993-2#1)(2008-11#1)(2012-3#1)
emphasizing the importance of##6##4##(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-10#1)(2011-2#1)
emphasizing the need##2##3##(1992-2#1)(1993-2#1)
emphasizing the role of##2##4##(2007-12#1)(2007-7#1)
emphasizing the##26##2##(1990-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)
emphasizing##53##1##(1990-5#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
emphysema following##3##2##(1991-5#1)(2008-1#1)(2011-2#1)
emphysema in##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
emphysema##25##1##(1991-12#3)(1991-5#2)(1992-12#1)(1992-9#1)(1993-1#2)(1994-3#2)(1997-8#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#3)(2009-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
emphysematous cystitis##3##2##(2012-3#3)
emphysematous pyelonephritis##3##2##(2007-10#1)(2007-7#1)(2008-8#1)
emphysematous##7##1##(1991-12#1)(2007-10#1)(2007-7#1)(2008-8#1)(2012-3#3)
empire##2##1##(2007-5#1)(2008-10#1)
empiric therapy for##2##3##(2011-2#1)(2013-1#1)
empiric treatment##2##2##(2007-2#1)(2013-1#1)
empiric##11##1##(2007-11#1)(2007-2#1)(2008-12#2)(2008-9#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
empirical Bayes variable selection##2##4##(2012-3#2)
empirical Bayes##4##2##(1995-9#1)(2008-7#1)(2012-3#2)
empirical analyses##4##2##(1993-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
empirical analysis of##2##3##(1992-2#1)(1996-2#1)
empirical analysis##4##2##(1992-2#1)(1994-1#1)(1994-2#1)(1996-2#1)
empirical and theoretical##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
empirical and##6##2##(1994-5#1)(1995-2#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-12#1)
empirical approach##3##2##(2008-10#1)(2008-4#1)(2010-5#1)
empirical attention##3##2##(1993-1#1)(2010-1#1)(2012-12#1)
empirical data and##2##3##(2008-5#1)(2009-8#1)
empirical data are##2##3##(2011-2#1)(2011-3#1)
empirical data suggest that##2##4##(2008-2#1)(2010-6#1)
empirical data that##2##3##(2008-8#1)(2008-9#1)
empirical data##17##2##(1992-12#1)(1996-3#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
empirical determination##2##2##(2007-7#1)(2008-2#1)
empirical evidence and##2##3##(2009-8#1)(2013-8#1)
empirical evidence exists##3##3##(2008-11#1)(2008-8#2)
empirical evidence for##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2010-4#1)
empirical evidence to support the##2##5##(2008-11#1)(2008-7#1)
empirical evidence to support##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
empirical evidence to##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
empirical evidence##19##2##(2008-10#2)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#2)(2010-4#1)(2012-3#1)(2013-8#2)
empirical expressions##2##2##(2008-3#2)
empirical facts##2##2##(1992-12#1)(2013-1#1)
empirical findings##5##2##(1992-1#1)(1992-9#1)(2008-11#1)(2009-2#1)(2013-8#1)
empirical functions##2##2##(2008-10#2)
empirical information##2##2##(1992-12#1)(2010-9#1)
empirical investigation of##2##3##(1995-2#1)(2011-2#1)
empirical investigations##3##2##(1994-12#1)(1996-11#1)(2011-2#1)
empirical likelihood##4##2##(2009-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
empirical literature##4##2##(1993-3#1)(2007-12#2)(2013-1#1)
empirical model##4##2##(2008-2#1)(2008-3#3)
empirical observations##2##2##(2008-8#1)(2009-5#1)
empirical or##2##2##(1993-12#1)(2010-10#1)
empirical perspective##2##2##(1991-12#1)(2010-4#1)
empirical practice##2##2##(2011-2#1)(2011-3#1)
empirical relationship between##2##3##(2008-10#2)
empirical relationship##3##2##(2008-10#2)(2008-2#1)
empirical relationships##2##2##(2008-8#2)
empirical research that##3##3##(1996-3#1)(2008-12#1)(2010-10#1)
empirical research##12##2##(1993-12#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#2)
empirical results##7##2##(2008-10#1)(2008-3#2)(2008-8#3)(2013-1#1)
empirical studies in##3##3##(1996-1#1)(2008-11#1)(2013-1#1)
empirical studies to##2##3##(2008-9#1)(2012-12#1)
empirical studies##19##2##(1995-11#1)(1996-1#1)(1996-6#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2009-9#1)(2010-6#1)(2011-3#1)(2012-12#2)(2013-1#2)
empirical study##10##2##(1992-2#1)(1992-3#1)(1995-2#1)(2008-11#1)(2008-12#2)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
empirical support for the##2##4##(2008-11#1)(2011-1#1)
empirical support##6##2##(1992-3#1)(2008-11#1)(2008-4#1)(2008-9#2)(2011-1#1)
empirical test of##2##3##(2008-12#1)(2008-9#1)
empirical test##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
empirical testing##3##2##(2007-9#1)(2008-12#2)
empirical tests##3##2##(1993-3#1)(2008-8#2)
empirical treatment##7##2##(1994-3#1)(1996-11#1)(2007-12#2)(2008-11#1)(2008-6#1)(2009-4#1)
empirical work##4##2##(2008-11#1)(2008-8#2)(2008-9#1)
empirical yield loss models##2##4##(2008-12#2)
empirical##258##1##(1990-11#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-12#7)(1992-2#3)(1992-3#4)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#2)(1995-2#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-2#3)(1996-3#2)(1996-6#2)(1997-1#1)(1997-3#2)(2007-12#5)(2007-7#1)(2007-9#1)(2008-10#19)(2008-11#15)(2008-12#11)(2008-2#9)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#24)(2008-9#13)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#3)(2012-12#6)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#3)
empirically and##3##2##(1997-6#1)(2008-10#1)(2011-3#1)
empirically based##3##2##(1991-3#1)(2008-12#1)(2010-7#1)
empirically by##2##2##(1991-2#1)(2012-12#1)
empirically derived##4##2##(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
empirically determined##2##2##(1994-8#1)(2011-2#1)
empirically for##2##2##(1997-5#1)(2007-12#1)
empirically testable##2##2##(2008-2#1)(2010-1#1)
empirically##57##1##(1991-2#1)(1991-3#1)(1993-1#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-7#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
empiricism##3##1##(2008-12#1)(2008-3#1)(2012-12#1)
employ a##20##2##(1991-3#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-8#1)(2013-1#1)
employ different##4##2##(1994-6#1)(1996-9#1)(2010-10#1)(2013-1#1)
employ health##2##2##(1990-9#1)(1993-12#1)
employ in##3##2##(1996-2#1)(2012-12#1)(2013-8#1)
employ standard##2##2##(2008-3#1)(2010-4#1)
employ the use of##2##4##(2008-10#1)(2008-4#1)
employ the##6##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
employ these##4##2##(2008-4#2)(2008-8#1)(2010-11#1)
employ this##2##2##(2007-11#1)(2012-2#1)
employ to##2##2##(1991-12#1)(2012-12#1)
employ##92##1##(1990-2#4)(1990-9#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#8)(2008-11#6)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-10#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
employed Korean women##4##3##(2011-2#4)
employed a##20##2##(1990-8#1)(1991-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-8#1)
employed an##2##2##(1993-3#1)(2008-10#1)
employed and the##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
employed and##11##2##(1990-8#1)(1991-12#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-4#1)(2009-8#1)
employed as a##12##3##(1990-2#1)(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)
employed as an##2##3##(2008-10#2)
employed as the##10##3##(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)
employed as##43##2##(1990-2#2)(1991-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#22)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)
employed at a##2##3##(2008-10#1)(2008-9#1)
employed at the##2##3##(1990-2#1)(1997-2#1)
employed at##6##2##(1990-2#1)(1992-11#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-9#1)
employed by hospital##2##3##(1993-3#1)(2008-11#1)
employed by the##7##3##(1991-12#1)(1992-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
employed by##27##2##(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-3#1)(1996-1#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#1)(2009-10#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
employed clinically##2##2##(2009-12#1)(2013-1#1)
employed during##2##2##(1992-2#1)(1995-6#1)
employed epidemiologists##3##2##(2008-11#3)
employed for a##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
employed for an##2##3##(2008-10#1)(2008-3#1)
employed for quantitative measurement##3##4##(2008-10#2)(2008-3#1)
employed for quantitative##6##3##(2008-10#5)(2008-3#1)
employed for the analysis of##3##5##(2008-10#3)
employed for the assay of##2##5##(2008-10#2)
employed for the determination of##11##5##(2008-10#10)(2011-1#1)
employed for the development of##2##5##(2009-7#1)(2013-1#1)
employed for the preconcentration of##2##5##(2008-10#2)
employed for the treatment of##2##5##(2008-10#2)
employed for the##38##3##(1991-3#1)(1994-9#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
employed for##108##2##(1990-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#59)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
employed here##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
employed in a##5##3##(2007-11#2)(2008-10#1)(2008-12#1)(2013-1#1)
employed in addition to the##2##5##(1997-2#1)(1997-6#1)
employed in combination with##2##4##(1991-12#1)(2008-3#1)
employed in order to##4##4##(1997-7#1)(2008-10#1)(2008-11#1)(2009-7#1)
employed in the management of##2##5##(2008-2#1)(2013-1#1)
employed in the study##2##4##(2013-1#2)
employed in the##37##3##(1990-12#2)(1991-12#1)(1992-9#1)(1994-1#1)(1995-6#1)(1997-3#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-2#2)(2013-1#6)
employed in this study##3##4##(2008-10#3)
employed in this work##2##4##(2008-10#1)(2010-11#1)
employed in this##11##3##(2008-10#4)(2008-3#1)(2010-11#1)(2010-8#4)(2012-2#1)
employed in##111##2##(1990-12#3)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1992-9#1)(1993-1#3)(1993-2#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#5)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#8)
employed on##2##2##(1996-9#1)(2008-5#1)
employed only##2##2##(2008-10#1)(2008-4#1)
employed the##13##2##(1992-2#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
employed this##2##2##(2007-11#1)(2008-10#1)
employed to analyze##4##3##(2008-10#3)(2008-11#1)
employed to assess the##3##4##(1995-12#1)(1996-2#1)(1996-3#1)
employed to calculate##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
employed to characterize##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
employed to cluster##2##3##(2008-8#1)(2010-5#1)
employed to confirm the##2##4##(1990-6#1)(2013-8#1)
employed to confirm##3##3##(1990-6#1)(2008-7#1)(2013-8#1)
employed to demonstrate the##2##4##(2008-10#2)
employed to derive##2##3##(2008-3#2)
employed to detect##4##3##(2008-10#2)(2008-3#1)(2010-11#1)
employed to determine the##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
employed to determine##12##3##(1991-2#1)(1993-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-8#1)
employed to develop##3##3##(1994-3#1)(2007-11#1)(2011-2#1)
employed to elucidate the##2##4##(2008-10#1)(2008-6#1)
employed to estimate##2##3##(2008-10#1)(2008-9#1)
employed to evaluate the##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2013-8#1)
employed to evaluate##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-8#1)(2013-8#1)
employed to examine##2##3##(2008-10#1)(2010-12#1)
employed to extract##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
employed to gather data from##2##5##(2008-11#2)
employed to generate the##2##4##(1996-12#1)(2008-3#1)
employed to generate##7##3##(1995-5#1)(1996-12#1)(2008-2#1)(2008-3#3)(2008-4#1)
employed to identify##2##3##(2008-11#1)(2008-8#1)
employed to investigate the##4##4##(2008-10#2)(2008-11#1)(2009-7#1)
employed to investigate##6##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)
employed to measure the##5##4##(1991-2#1)(2008-10#2)(2008-3#1)(2010-7#1)
employed to measure##6##3##(1991-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
employed to monitor the##2##4##(2008-10#1)(2008-3#1)
employed to monitor##4##3##(2008-10#3)(2008-3#1)
employed to obtain the##3##4##(1993-8#1)(2008-10#1)(2013-1#1)
employed to obtain##6##3##(1993-8#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
employed to perform the##2##4##(2008-2#1)(2008-3#1)
employed to perform##3##3##(2008-2#2)(2008-3#1)
employed to predict the##2##4##(1990-8#1)(2009-7#1)
employed to predict##3##3##(1990-8#1)(2008-9#1)(2009-7#1)
employed to prevent##2##3##(2008-4#1)(2008-9#1)
employed to produce a##2##4##(2008-10#1)(2012-12#1)
employed to produce##3##3##(2008-10#2)(2012-12#1)
employed to study the##4##4##(2007-12#1)(2008-10#2)(2013-8#1)
employed to study##5##3##(2007-12#1)(2008-10#2)(2011-1#1)(2013-8#1)
employed to the##4##3##(2008-10#3)(2008-11#1)
employed to##185##2##(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-3#1)(1991-9#2)(1993-12#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-3#1)(2007-11#6)(2007-12#5)(2008-10#59)(2008-11#11)(2008-12#2)(2008-2#12)(2008-3#18)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-12#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#5)
employed was##3##2##(2008-10#3)
employed were##5##2##(1994-9#1)(2008-10#2)(2008-12#1)(2012-2#1)
employed with##7##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2010-8#1)
employed within the##2##3##(2008-11#1)(2008-2#1)
employed within##3##2##(1994-12#1)(2008-11#1)(2008-2#1)
employed##780##1##(1990-12#7)(1990-2#4)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#8)(1991-11#3)(1991-12#8)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#8)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#19)(2007-12#12)(2007-6#1)(2007-8#2)(2008-1#7)(2008-10#256)(2008-11#38)(2008-12#12)(2008-2#30)(2008-3#51)(2008-4#9)(2008-5#15)(2008-6#10)(2008-7#17)(2008-8#6)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#5)(2009-3#4)(2009-4#3)(2009-5#4)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#9)(2011-1#5)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#20)(2013-8#11)
employee and organization##2##3##(1991-2#2)
employee and##5##2##(1991-2#2)(1993-2#1)(1996-5#1)(2008-11#1)
employee benefits##3##2##(1991-3#2)(1993-1#1)
employee cost##2##2##(1992-3#1)(2008-11#1)
employee had##3##2##(1994-2#1)(1995-6#2)
employee has##2##2##(1996-5#1)(2008-1#1)
employee health##3##2##(1993-3#1)(1994-3#1)(1997-1#1)
employee involvement and##3##3##(1993-3#1)(1995-2#1)(1996-3#1)
employee involvement##5##2##(1993-3#1)(1995-2#2)(1996-3#2)
employee satisfaction##2##2##(1992-12#1)(1994-3#1)
employee support##2##2##(1991-1#1)(2008-12#1)
employee to##2##2##(1996-5#1)(2008-3#1)
employee##82##1##(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-2#5)(1993-3#2)(1994-12#2)(1994-2#6)(1994-3#2)(1995-1#3)(1995-2#5)(1995-3#1)(1995-6#6)(1996-12#1)(1996-3#3)(1996-5#8)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#4)(2012-12#1)(2012-3#1)
employees a##2##2##(1993-12#1)(2008-10#1)
employees about##2##2##(1996-12#1)(2007-10#1)
employees and the community##2##4##(1993-1#1)(1994-1#1)
employees and the##3##3##(1991-1#1)(1993-1#1)(1994-1#1)
employees and their##4##3##(1992-1#1)(1994-2#1)(1994-3#1)(2008-11#1)
employees and##16##2##(1991-1#1)(1991-2#1)(1992-1#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-11#1)
employees are##6##2##(1992-5#1)(1994-2#2)(2008-12#1)(2008-9#1)(2011-2#1)
employees at the##2##3##(1990-2#1)(1996-3#1)
employees at##3##2##(1990-2#1)(1996-3#1)(2010-6#1)
employees by##2##2##(1995-6#1)(2011-2#1)
employees can##3##2##(1993-2#1)(1995-2#1)(1997-3#1)
employees feel##2##2##(1997-3#2)
employees from##3##2##(1993-2#1)(1995-2#1)(1996-3#1)
employees have##2##2##(1993-3#1)(2011-2#1)
employees in the##3##3##(1993-3#1)(1994-2#1)(1996-9#1)
employees in##7##2##(1993-12#1)(1993-3#1)(1994-2#1)(1996-9#1)(2008-11#1)(2008-6#1)(2010-8#1)
employees is##3##2##(1994-1#1)(1994-3#1)(2008-11#1)
employees must##2##2##(1994-12#1)(1996-3#1)
employees of a##2##3##(1991-12#1)(2012-2#1)
employees of##4##2##(1991-12#1)(1993-3#1)(2012-2#1)(2012-3#1)
employees should##2##2##(1994-12#1)(2008-11#1)
employees to become##2##3##(1994-1#1)(2009-3#1)
employees to##7##2##(1993-1#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(2009-3#1)
employees were##4##2##(2008-12#4)
employees who##4##2##(1993-3#1)(1994-2#1)(1996-1#1)(2011-2#1)
employees with##4##2##(1991-12#1)(1997-5#2)(2012-3#1)
employees working##3##2##(1991-3#1)(2009-10#1)(2012-3#1)
employees##173##1##(1990-2#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#2)(1992-1#4)(1992-12#2)(1992-3#4)(1992-5#2)(1993-1#10)(1993-12#2)(1993-2#6)(1993-3#6)(1994-1#6)(1994-12#7)(1994-2#10)(1994-3#6)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#3)(1996-1#3)(1996-12#5)(1996-2#3)(1996-3#7)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#3)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#12)(2008-12#9)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#5)(2013-8#1)
employees' health##5##2##(1993-8#1)(1996-2#1)(1997-1#1)(2009-10#1)(2011-2#1)
employees' jobs##2##2##(1993-1#1)(1997-3#1)
employees'##12##1##(1993-1#1)(1993-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#1)(2009-10#3)(2010-6#1)(2011-2#1)(2012-3#1)
employees)##2##1##(1994-2#1)(1994-3#1)
employer and##2##2##(1997-2#1)(1997-5#1)
employer coalitions##2##2##(1994-12#1)(1995-12#1)
employer had##2##2##(1994-12#1)(1995-6#1)
employer refused##2##2##(1995-6#2)
employer##29##1##(1991-8#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-12#5)(1994-2#2)(1995-12#2)(1995-2#1)(1995-6#3)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#2)
employer's##10##1##(1993-12#1)(1994-12#3)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(2008-6#1)
employer-sponsored##6##1##(1993-3#1)(1996-3#1)(1997-2#2)(2008-11#2)
employers and employees##3##3##(1994-12#1)(1995-3#1)(2008-1#1)
employers and##8##2##(1994-1#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-3#1)(2010-3#1)
employers have##3##2##(1994-3#1)(1995-1#1)(1996-2#1)
employers to##4##2##(1991-2#1)(1994-12#1)(1996-3#1)(1996-5#1)
employers##53##1##(1991-1#2)(1991-2#2)(1991-3#2)(1992-11#2)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#2)(1994-12#5)(1994-2#1)(1994-3#8)(1995-1#3)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-3#1)(2012-3#2)(2013-1#1)
employing a new##2##3##(1990-7#1)(2008-10#1)
employing a prism array##2##4##(2008-3#2)
employing a set of##2##4##(2008-10#1)(2008-5#1)
employing a single##3##3##(2008-10#1)(2008-3#2)
employing a##58##2##(1990-12#3)(1990-5#1)(1990-7#1)(1992-10#1)(1992-2#2)(2007-11#1)(2007-12#5)(2008-10#23)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2012-2#1)
employing an##10##2##(1992-12#1)(1992-8#1)(1995-8#1)(2008-10#5)(2008-3#1)(2009-11#1)
employing both##5##2##(1994-9#1)(2008-10#3)(2008-11#1)
employing different##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
employing differential pulse##2##3##(2008-10#2)
employing flow injection##2##3##(2008-10#2)
employing methanol##2##2##(2008-10#1)(2012-2#1)
employing only##4##2##(2007-12#1)(2008-10#3)
employing reference##2##2##(2008-10#2)
employing the##24##2##(1990-12#1)(1992-3#1)(2008-10#10)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)
employing these##4##2##(1992-2#1)(1994-5#1)(2008-8#1)(2008-9#1)
employing this##2##2##(2007-7#1)(2008-10#1)
employing three different polymers##2##4##(2012-2#2)
employing three different##3##3##(2008-8#1)(2012-2#2)
employing three##6##2##(1991-2#1)(1994-3#1)(2008-10#1)(2008-8#1)(2012-2#2)
employing two##4##2##(1990-7#1)(2007-11#1)(2008-1#1)(2008-7#1)
employing##264##1##(1990-12#5)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#8)(2007-12#12)(2007-7#1)(2008-1#3)(2008-10#97)(2008-11#6)(2008-2#9)(2008-3#13)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)
employment and to##2##3##(1995-1#1)(2008-11#1)
employment and##7##2##(1991-6#1)(1991-9#1)(1994-7#1)(1995-1#1)(1997-5#1)(2008-11#1)(2011-1#1)
employment as##3##2##(1991-12#1)(1995-1#1)(2008-10#1)
employment contracts##3##2##(1992-3#1)(2008-11#1)(2008-9#1)
employment in##6##2##(1991-1#1)(1991-12#1)(1994-2#1)(2008-11#1)(2011-2#2)
employment of a##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
employment of the##2##3##(1992-9#1)(2008-10#1)
employment of##23##2##(1990-3#1)(1992-11#1)(1992-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
employment opportunities##5##2##(1992-12#1)(1996-2#2)(2008-6#1)(2008-9#1)
employment status##8##2##(1993-3#1)(1997-2#1)(2008-11#1)(2009-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
employment##123##1##(1990-3#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#7)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1995-1#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#7)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#2)(2009-9#4)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
employment)##2##1##(2009-9#1)(2010-11#1)
employment?##2##1##(1995-12#1)(1996-2#1)
employs a##21##2##(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#6)(2008-5#2)(2008-8#1)(2008-9#1)
employs an##4##2##(2008-10#3)(2008-9#1)
employs both##2##2##(2008-3#2)
employs only##2##2##(2007-12#1)(2008-10#1)
employs the same##2##3##(2008-10#1)(2013-1#1)
employs the##12##2##(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#1)(2009-5#1)(2013-1#1)
employs three##2##2##(2008-10#1)(2010-11#1)
employs two##5##2##(2008-10#2)(2008-3#3)
employs##91##1##(1990-7#1)(1990-8#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-11#7)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#24)(2008-12#1)(2008-2#8)(2008-3#21)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-11#1)(2010-8#3)(2013-1#3)
empop##3##1##(2008-12#3)
empower##8##1##(1992-2#1)(1992-3#1)(1993-1#1)(2008-11#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)
empowered by##2##2##(1993-12#1)(1995-12#1)
empowered##6##1##(1993-12#1)(1995-12#1)(1996-7#1)(2007-7#1)(2008-1#1)(2010-10#1)
empowering and##2##2##(2008-11#1)(2009-12#1)
empowering##12##1##(1993-1#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-11#3)(2008-7#1)(2009-12#1)(2010-10#1)(2010-8#1)
empowerment and##6##2##(1991-12#1)(1994-1#1)(1996-1#1)(1997-3#2)(2008-7#1)
empowerment approach##2##2##(1993-1#1)(1996-3#1)
empowerment of##2##2##(1993-1#1)(2008-11#1)
empowerment through##2##2##(1993-3#1)(1996-1#1)
empowerment to##2##2##(1995-1#1)(2008-1#1)
empowerment##31##1##(1991-12#1)(1991-2#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#3)(1995-1#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-7#2)(1997-3#3)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)
empowers##2##1##(1994-1#1)(1997-7#1)
emptied##2##1##(1990-5#1)(1995-11#1)
empty and##3##2##(2010-11#1)(2012-12#1)(2012-2#1)
empty capsid##2##2##(1992-8#2)
empty patches##2##2##(2008-8#2)
empty sella##2##2##(1991-11#1)(2013-1#1)
empty##31##1##(1990-7#1)(1991-11#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-8#6)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
emptying and intestinal transit##6##4##(2013-1#6)
emptying and##8##2##(1991-11#1)(2012-1#1)(2013-1#6)
emptying of##2##2##(1997-4#2)
emptying rate of##4##3##(1997-4#4)
emptying the##2##2##(2008-7#1)(2013-1#1)
emptying##31##1##(1990-12#1)(1991-11#1)(1993-10#2)(1994-2#1)(1994-3#1)(1997-4#9)(2008-3#2)(2008-7#2)(2012-1#1)(2012-2#3)(2013-1#8)
empyema thoracis##2##2##(2007-8#2)
empyema##18##1##(1990-3#1)(1990-9#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#3)(2008-5#1)(2010-1#4)(2010-12#1)(2012-1#2)(2012-2#1)(2012-8#1)
emsp14##3##1##(2010-10#3)
emulate the##2##2##(2008-11#1)(2008-3#1)
emulate##9##1##(1991-12#1)(2008-11#1)(2008-3#4)(2010-5#1)(2011-2#1)(2012-12#1)
emulates##2##1##(2008-12#1)(2008-5#1)
emulating##2##1##(2008-10#1)(2008-12#1)
emulgel##3##1##(1990-9#3)
emulsifiable concentrate formulations##3##3##(2008-10#3)
emulsifiable##4##1##(2008-10#3)(2011-2#1)
emulsification time##2##2##(2008-7#2)
emulsification##4##1##(2008-2#1)(2008-7#2)(2012-2#1)
emulsified in water##2##3##(2008-10#2)
emulsified in##5##2##(1995-5#1)(2008-10#3)(2008-4#1)
emulsified##13##1##(1994-3#1)(1995-5#1)(2008-10#9)(2008-4#1)(2011-2#1)
emulsifier concentration##2##2##(2008-5#1)(2008-7#1)
emulsifier##13##1##(2008-10#2)(2008-5#10)(2008-7#1)
emulsifier-free##2##1##(2008-5#2)
emulsifiers##2##1##(2008-5#1)(2008-6#1)
emulsifying activity##3##2##(2010-4#1)(2013-8#2)
emulsifying agent##2##2##(2008-10#2)
emulsifying##15##1##(2008-10#2)(2008-5#2)(2010-4#5)(2013-8#6)
emulsion PCR beads##2##3##(2012-2#2)
emulsion PCR##3##2##(2012-2#3)
emulsion and a##3##3##(2008-5#3)
emulsion and##12##2##(1993-12#1)(2008-10#3)(2008-5#8)
emulsion containing##4##2##(2008-5#3)(2009-11#1)
emulsion formed##2##2##(2008-10#2)
emulsion in the##2##3##(2008-5#2)
emulsion of##2##2##(1994-12#1)(2008-10#1)
emulsion or suspension##2##3##(2008-10#1)(2008-11#1)
emulsion polymerization##3##2##(2008-8#2)(2010-6#1)
emulsion samples##2##2##(2008-10#1)(2008-5#1)
emulsion solvent evaporation##2##3##(2010-5#1)(2013-1#1)
emulsion stability was##2##3##(2008-5#2)
emulsion stability##6##2##(2008-5#6)
emulsion structure##2##2##(2008-5#2)
emulsion to##3##2##(2008-5#3)
emulsion was##8##2##(1994-12#2)(2008-10#3)(2008-5#3)
emulsion were##2##2##(2008-11#1)(2008-5#1)
emulsion with##2##2##(2008-5#2)
emulsion##124##1##(1992-5#3)(1992-8#1)(1993-12#1)(1994-12#6)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#63)(2008-8#2)(2009-11#3)(2010-4#2)(2010-5#1)(2010-6#1)(2011-3#1)(2012-2#4)(2013-1#1)
emulsion)##2##1##(1992-9#1)(2008-5#1)
emulsions and##3##2##(2007-11#1)(2008-5#2)
emulsions as##2##2##(2008-2#1)(2010-4#1)
emulsions of##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
emulsions were##2##2##(2008-11#1)(2008-5#1)
emulsions with low concentrations of##2##5##(2008-5#2)
emulsions with low concentrations##3##4##(2008-5#3)
emulsions with##9##2##(2008-5#7)(2010-4#2)
emulsions##68##1##(2007-11#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#43)(2008-8#2)(2010-4#3)(2011-2#1)
en bloc and##2##3##(1996-3#1)(2008-7#1)
en bloc removal of the##2##5##(2007-8#1)(2008-7#1)
en bloc##8##2##(1996-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-2#1)
en consultation##2##2##(2013-1#2)
en een##2##2##(2012-12#2)
en route to a##2##4##(2007-9#1)(2009-9#1)
en route to##3##3##(2007-9#1)(2009-5#1)(2009-9#1)
en the##2##2##(2010-1#1)(2012-12#1)
en##77##1##(1991-6#1)(1993-2#1)(1994-8#1)(1996-2#2)(1996-3#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#5)(2008-9#1)(2009-10#1)(2009-4#4)(2009-5#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#15)(2012-12#9)(2013-1#19)
enable a more##2##3##(2008-10#1)(2008-11#1)
enable a##14##2##(1993-2#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2012-1#1)(2013-1#2)
enable an##3##2##(1991-5#1)(1993-1#1)(2008-11#1)
enable clinicians to##2##3##(2007-5#1)(2008-3#1)
enable comparisons##2##2##(1992-11#2)
enable determination of##2##3##(2008-10#1)(2008-2#1)
enable development##2##2##(2007-8#1)(2011-2#1)
enable diagnosis##2##2##(1992-9#1)(2008-9#1)
enable educators##2##2##(2008-11#1)(2008-12#1)
enable efficient##2##2##(2008-3#1)(2012-2#1)
enable health professionals to##2##4##(2008-11#2)
enable identification of##3##3##(2008-10#2)(2009-5#1)
enable more##2##2##(2008-1#1)(2011-1#1)
enable one to##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
enable patients##2##2##(2010-3#1)(2010-5#1)
enable rapid##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
enable students to##3##3##(2008-11#2)(2011-2#1)
enable students##4##2##(2008-11#2)(2008-12#1)(2011-2#1)
enable the detection of##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
enable the early##2##3##(2007-8#1)(2008-9#1)
enable the study of##2##4##(1994-11#1)(2011-2#1)
enable the study##3##3##(1994-11#1)(2011-2#1)(2012-3#1)
enable the##58##2##(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#1)(2010-10#2)(2010-9#1)(2011-2#8)(2012-2#3)(2012-3#1)
enable them to##6##3##(1994-9#1)(1997-3#1)(2008-11#1)(2009-12#1)(2010-3#1)(2012-1#1)
enable these##2##2##(1993-2#1)(2008-9#1)
enable to##2##2##(2008-10#1)(2012-12#1)
enable us to##11##3##(1992-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
enable##237##1##(1991-11#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#2)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#34)(2008-11#18)(2008-12#4)(2008-2#6)(2008-3#13)(2008-4#6)(2008-5#5)(2008-6#5)(2008-7#15)(2008-9#7)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#5)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#16)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#10)(2013-8#3)
enabled a##11##2##(1994-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)
enabled better##4##2##(2007-11#2)(2008-10#1)(2010-8#1)
enabled by##4##2##(2008-7#2)(2011-3#1)(2013-8#1)
enabled identification of##2##3##(2009-9#1)(2012-3#1)
enabled more##2##2##(2008-10#1)(2010-8#1)
enabled simultaneous##3##2##(2008-10#3)
enabled the selection of##2##4##(1991-11#1)(1993-1#1)
enabled the synthesis of##2##4##(2008-7#1)(2009-10#1)
enabled the##44##2##(1990-5#1)(1991-11#1)(1991-6#1)(1993-1#1)(1994-1#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-11#2)(2008-10#12)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2013-1#3)(2013-8#1)
enabled them to##2##3##(2008-12#1)(2008-9#1)
enabled to##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
enabled us to##20##3##(1990-7#1)(1992-2#1)(1994-5#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-1#2)
enabled##140##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#41)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#6)(2008-9#2)(2009-10#2)(2009-11#2)(2009-5#3)(2009-6#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
enablers##2##1##(1995-2#1)(1995-3#1)
enables a##8##2##(1991-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)
enables an accurate##2##3##(2008-10#1)(2010-12#1)
enables an##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
enables direct##2##2##(2008-10#1)(2008-8#1)
enables full##2##2##(2008-2#1)(2011-1#1)
enables high##2##2##(2008-6#1)(2011-2#1)
enables highly##2##2##(2008-3#1)(2010-8#1)
enables identification of##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
enables one to##13##3##(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#2)
enables one##14##2##(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#2)
enables optimization##2##2##(2008-11#1)(2008-7#1)
enables precise##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
enables proper##2##2##(2012-12#1)(2013-8#1)
enables quantitative##2##2##(2008-10#2)
enables the design of##2##4##(2008-10#1)(2008-7#1)
enables the design##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
enables the detection##2##3##(2008-10#2)
enables the determination of##3##4##(2008-10#3)
enables the determination##4##3##(2008-10#4)
enables the direct determination of##3##5##(2008-10#3)
enables the direct##4##3##(2008-10#3)(2010-5#1)
enables the measurement of##2##4##(2008-5#1)(2010-11#1)
enables the rapid##3##3##(2008-10#1)(2008-8#1)(2009-11#1)
enables the simultaneous##2##3##(2008-10#1)(2008-3#1)
enables the use of##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
enables the user to##2##4##(2008-4#1)(2008-9#1)
enables the##77##2##(1991-2#1)(1995-1#1)(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#26)(2008-11#6)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-8#1)
enables them to##2##3##(2008-10#1)(2008-11#1)
enables to decrease the##2##4##(2008-10#1)(2012-3#1)
enables to##6##2##(2008-10#1)(2008-11#2)(2008-5#2)(2012-3#1)
enables us to obtain##3##4##(1997-8#1)(2007-11#1)(2008-2#1)
enables us to##31##3##(1991-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#2)(2013-8#1)
enables us##32##2##(1991-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#2)(2013-8#1)
enables##273##1##(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1997-4#1)(1997-8#1)(2007-11#7)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#53)(2008-11#17)(2008-12#1)(2008-2#12)(2008-3#29)(2008-4#8)(2008-5#4)(2008-6#7)(2008-7#15)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#7)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#5)(2013-8#4)
enabling a##5##2##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
enabling an##2##2##(1995-3#1)(2013-1#1)
enabling and##2##2##(1995-11#1)(2007-11#1)
enabling both##2##2##(1991-11#1)(2008-10#1)
enabling detection##2##2##(2008-10#1)(2008-3#1)
enabling it to##2##3##(2007-11#1)(2011-1#1)
enabling rapid##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
enabling students to##2##3##(2008-11#2)
enabling technologies for##2##3##(2008-3#1)(2009-12#1)
enabling technologies##3##2##(2008-3#2)(2009-12#1)
enabling the simultaneous##2##3##(2008-3#1)(2010-6#1)
enabling the##21##2##(1990-3#1)(1993-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
enabling us to##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
enabling##110##1##(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-12#3)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#3)
enabling&quot##2##1##(1993-12#1)(1995-3#1)
enact##5##1##(1991-2#1)(1993-5#1)(1995-12#1)(2008-11#1)(2010-11#1)
enacted in##2##2##(1991-2#1)(1993-2#1)
enacted legislation##2##2##(1991-2#1)(2008-7#1)
enacted the##2##2##(1996-1#1)(1996-11#1)
enacted##20##1##(1991-2#3)(1992-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-1#2)(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
enacting##2##1##(2008-11#1)(2008-12#1)
enactment of risk##2##3##(2012-12#2)
enactment of the##2##3##(1991-12#1)(2011-1#1)
enactment of##5##2##(1991-12#1)(1996-3#1)(2011-1#1)(2012-12#2)
enactment##6##1##(1991-12#1)(1991-2#1)(1996-3#1)(2011-1#1)(2012-12#2)
enalapril##4##1##(1990-3#1)(1995-8#1)(2008-1#1)(2008-4#1)
enamel and dentin##5##3##(1991-2#1)(1991-5#1)(2008-7#1)(2012-12#2)
enamel and##8##2##(1991-2#2)(1991-5#1)(2008-7#2)(2011-2#1)(2012-12#2)
enamel hypoplasia in##2##3##(2008-12#2)
enamel were##2##2##(1995-9#1)(2011-2#1)
enamel with cavity##2##3##(2013-1#2)
enamel without cavity##2##3##(2013-1#2)
enamel##49##1##(1991-2#2)(1991-5#1)(1993-11#3)(1995-9#1)(2008-12#3)(2008-3#4)(2008-5#2)(2008-7#2)(2009-7#5)(2010-10#2)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#6)(2013-1#10)(2013-8#1)
enameloid matrix##2##2##(2008-7#2)
enameloid##3##1##(2008-7#3)
enamine##4##1##(1991-9#2)(2007-11#1)(2011-1#1)
enamines##4##1##(1991-9#3)(2007-11#1)
enantiomer for##2##2##(2008-6#1)(2012-3#1)
enantiomer in human##2##3##(2008-10#2)
enantiomer of##2##2##(2008-4#1)(2008-6#1)
enantiomer was##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
enantiomer##23##1##(1991-12#2)(1992-12#2)(1992-3#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2012-3#1)(2013-1#1)
enantiomeric amines##2##2##(1995-6#2)
enantiomeric composition of samples by##2##5##(2008-10#2)
enantiomeric composition of##5##3##(2008-10#5)
enantiomeric composition##7##2##(1991-12#1)(2008-10#6)
enantiomeric excess##3##2##(1994-3#1)(2008-10#2)
enantiomeric excesses##2##2##(2008-6#1)(2010-12#1)
enantiomeric forms of the##2##4##(1994-9#1)(1997-7#1)
enantiomeric forms##4##2##(1992-12#1)(1994-9#2)(1997-7#1)
enantiomeric fractions##2##2##(2008-10#2)
enantiomeric mixtures##4##2##(1994-9#1)(2008-10#3)
enantiomeric separation of##4##3##(1996-5#1)(2008-10#3)
enantiomeric separation##5##2##(1996-5#1)(2008-10#4)
enantiomeric##36##1##(1991-12#1)(1992-12#1)(1994-3#1)(1994-9#4)(1995-6#2)(1996-5#2)(1997-2#1)(1997-7#1)(2008-10#21)(2008-6#1)(2010-12#1)
enantiomerically pure##9##2##(1992-11#1)(1995-3#2)(1996-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-12#1)(2009-9#1)
enantiomerically##10##1##(1992-11#1)(1995-3#2)(1996-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-9#1)
enantiomers and##2##2##(2008-10#2)
enantiomers by##4##2##(1994-9#1)(2008-10#3)
enantiomers can be##2##3##(2008-10#2)
enantiomers in human##2##3##(2008-10#1)(2008-11#1)
enantiomers in##9##2##(1991-12#1)(1994-9#1)(2008-10#6)(2008-11#1)
enantiomers of the##3##3##(1992-11#1)(1995-2#1)(2008-10#1)
enantiomers of##19##2##(1990-8#1)(1992-11#1)(1992-12#1)(1995-2#1)(1995-3#1)(2008-10#10)(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
enantiomers on##3##2##(2008-10#3)
enantiomers was##3##2##(1990-12#1)(1995-2#1)(2008-10#1)
enantiomers were retained longest on the##2##6##(1995-3#2)
enantiomers were##7##2##(1991-12#1)(1992-3#1)(1994-8#2)(1995-3#2)(2008-10#1)
enantiomers##63##1##(1990-12#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#3)(1995-6#1)(1997-2#1)(2008-10#37)(2008-11#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
enantiopure##3##1##(2007-11#1)(2010-12#1)(2011-1#1)
enantiopurity##7##1##(2008-10#7)
enantioselective and##2##2##(2011-1#2)
enantioselective gas##2##2##(2008-10#2)
enantioselective membrane electrode based on##2##5##(2008-10#2)
enantioselective membrane electrode##3##3##(2008-10#3)
enantioselective membrane##6##2##(2008-10#6)
enantioselective separation of##3##3##(2008-10#3)
enantioselective separation##4##2##(2008-10#4)
enantioselective##36##1##(1992-8#1)(1995-6#1)(2008-10#29)(2008-7#1)(2009-10#1)(2011-1#3)
enantioselectivities were##2##2##(1994-9#1)(2008-11#1)
enantioselectivities##5##1##(1994-9#2)(1995-3#1)(2008-11#1)(2013-1#1)
enantioselectivity was##4##2##(2008-10#4)
enantioselectivity##20##1##(1992-8#1)(1994-9#2)(1995-6#2)(2008-10#13)(2009-10#1)(2011-1#1)
enantioseparation of clenbuterol##2##3##(2008-10#2)
enantioseparation of##4##2##(2008-10#2)(2010-4#1)(2013-1#1)
enantioseparation##9##1##(2008-10#6)(2010-4#1)(2013-1#2)
encapsidated##5##1##(1994-8#2)(2008-10#2)(2010-9#1)
encapsidation signal##2##2##(2009-7#2)
encapsidation##3##1##(2008-10#1)(2009-7#2)
encapsulant##4##1##(2008-10#1)(2008-3#2)(2008-7#1)
encapsulate the##2##2##(2009-12#1)(2013-8#1)
encapsulate##5##1##(2008-4#1)(2008-5#1)(2009-12#1)(2013-1#1)(2013-8#1)
encapsulated and##4##2##(1997-3#1)(2008-10#1)(2008-5#2)
encapsulated bacteria##3##2##(1990-9#1)(1994-9#1)(2009-5#1)
encapsulated by##6##2##(1991-5#1)(2008-10#3)(2008-12#1)(2011-3#1)
encapsulated form##2##2##(2008-5#2)
encapsulated in a##2##3##(2008-10#1)(2008-5#1)
encapsulated in##7##2##(1993-8#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-5#1)
encapsulated into##2##2##(2008-5#1)(2013-1#1)
encapsulated retinol##2##2##(2008-5#2)
encapsulated silica##2##2##(2008-10#2)
encapsulated with##3##2##(2007-12#1)(2008-5#1)(2009-8#1)
encapsulated##53##1##(1990-9#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-2#1)(1996-5#2)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#13)(2008-11#6)(2008-12#1)(2008-5#10)(2009-12#1)(2009-5#1)(2009-8#1)(2011-2#2)(2011-3#1)(2013-1#2)
encapsulates##2##1##(2008-3#1)(2013-8#1)
encapsulating peritoneal sclerosis (EPS)##2##4##(2011-2#2)
encapsulating peritoneal sclerosis##5##3##(2007-12#1)(2011-2#4)
encapsulating##8##1##(1994-12#1)(2007-12#1)(2008-10#1)(2011-2#4)(2012-2#1)
encapsulation and##2##2##(2008-11#1)(2012-12#1)
encapsulation efficiency##3##2##(2008-10#1)(2010-6#1)(2012-6#1)
encapsulation in##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
encapsulation of the##3##3##(2008-10#1)(2008-5#1)(2009-11#1)
encapsulation of##9##2##(1994-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-6#1)
encapsulation on the##3##3##(1996-5#1)(2008-11#1)(2008-5#1)
encapsulation##29##1##(1990-11#2)(1994-12#1)(1996-5#1)(2008-10#6)(2008-11#3)(2008-5#4)(2008-7#3)(2009-11#1)(2009-12#1)(2010-12#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-6#1)(2013-1#1)
encapsulation/release##6##1##(2009-11#6)
encased in a##2##3##(2008-10#2)
encasement##2##1##(2008-10#2)
encasing##2##1##(2011-1#2)
encephalitis (TBE)##3##2##(1996-11#1)(2007-2#1)(2008-8#1)
encephalitis and##2##2##(2010-8#1)(2011-1#1)
encephalitis in##4##2##(1993-9#1)(2008-7#1)(2008-8#2)
encephalitis virus in##2##3##(1995-12#1)(2007-2#1)
encephalitis virus##6##2##(1992-8#1)(1995-12#2)(2007-2#1)(2008-8#1)(2011-2#1)
encephalitis##34##1##(1992-8#2)(1993-9#1)(1995-12#2)(1995-5#2)(1996-11#1)(1996-3#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#4)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#6)
encephalitogenic##2##1##(1995-12#1)(2012-2#1)
encephalocele##5##1##(2011-2#1)(2012-3#3)(2013-7#1)
encephalomalacia##2##1##(1992-2#1)(1997-8#1)
encephalomyelitis (EAE)##6##2##(1994-6#1)(1995-12#1)(2007-11#1)(2010-12#1)(2012-2#2)
encephalomyelitis and##2##2##(2010-12#1)(2012-12#1)
encephalomyelitis in##2##2##(1995-12#1)(2012-12#1)
encephalomyelitis##18##1##(1991-11#1)(1994-6#1)(1995-12#2)(2007-11#1)(2010-12#2)(2011-2#1)(2012-12#6)(2012-2#3)(2013-7#1)
encephalomyocarditis virus##2##2##(1997-8#2)
encephalomyocarditis##4##1##(1997-4#1)(1997-8#2)(2010-7#1)
encephalopathies##4##1##(1991-3#1)(1996-5#1)(2008-11#1)(2008-4#1)
encephalopathy after##2##2##(1996-3#1)(2012-12#1)
encephalopathy in a##3##3##(1994-3#1)(2011-2#1)(2012-12#1)
encephalopathy##46##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-5#2)(1994-3#1)(1995-2#1)(1996-3#3)(1997-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-11#3)(2008-4#2)(2008-5#1)(2009-8#1)(2010-12#2)(2010-4#2)(2011-2#4)(2012-12#7)(2012-3#3)(2013-1#2)
enchondroma in##2##2##(2010-3#2)
enchondroma##4##1##(2008-9#1)(2010-3#3)
enchytraeid##2##1##(2008-11#1)(2010-8#1)
enchytraeids##3##1##(2008-10#3)
encircled##2##1##(1997-3#1)(2008-3#1)
encircles the follicle##2##3##(2011-2#2)
encircles##3##1##(1994-12#1)(2011-2#2)
encircling lymphovasculogenesis##3##2##(2011-2#3)
encircling##7##1##(1995-8#1)(2007-8#1)(2008-10#1)(2011-2#3)(2013-1#1)
enclose a##2##2##(2007-12#1)(2010-11#1)
enclose##4##1##(2007-12#1)(2008-6#2)(2010-11#1)
enclosed by the##2##3##(2009-11#1)(2010-11#1)
enclosed by##4##2##(2007-11#1)(2009-11#1)(2010-11#2)
enclosed in a##2##3##(2008-2#1)(2008-3#1)
enclosed in##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
enclosed##17##1##(1991-3#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#2)(2010-7#1)(2013-1#1)
encloses##3##1##(1995-2#1)(2007-12#1)(2008-11#1)
enclosing the##2##2##(2007-12#1)(2009-5#1)
enclosing##3##1##(2007-12#1)(2008-10#1)(2009-5#1)
enclosure calculation##2##2##(2008-2#2)
enclosure##9##1##(1996-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2012-2#2)(2013-8#1)
encode a protein of##6##4##(1990-8#1)(1991-9#1)(1993-12#1)(1994-12#1)(1996-6#1)(2008-10#1)
encode a protein##7##3##(1990-8#1)(1991-9#1)(1993-12#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-6#1)
encode a##35##2##(1990-11#1)(1990-8#2)(1991-9#1)(1992-10#1)(1992-4#1)(1993-12#3)(1993-2#3)(1994-12#3)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#2)
encode an##4##2##(1992-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
encode for##4##2##(1992-8#1)(1993-11#1)(1994-6#1)(2008-10#1)
encode novel##2##2##(1996-8#1)(2013-8#1)
encode proteins involved in##2##4##(1996-3#1)(2011-2#1)
encode proteins that##2##3##(1993-6#1)(1994-9#1)
encode proteins##7##2##(1993-12#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-3#1)(2011-2#1)(2012-3#1)
encode the alpha##2##3##(1990-7#1)(1994-12#1)
encode the##22##2##(1990-11#1)(1990-7#1)(1991-6#2)(1991-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-6#1)(2007-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
encode transcription##3##2##(1993-6#1)(1995-11#1)(2008-9#1)
encode##140##1##(1990-11#2)(1990-7#1)(1990-8#4)(1991-12#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-3#1)(1992-4#2)(1992-8#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-6#4)(1993-9#3)(1994-11#3)(1994-12#6)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#12)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#4)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#1)(2009-8#4)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
encoded a polypeptide##2##3##(1997-4#2)
encoded a protein of##3##4##(1992-3#1)(2008-9#1)(2010-5#1)
encoded a single##2##3##(1997-4#1)(2008-10#1)
encoded a##16##2##(1990-12#1)(1991-12#2)(1992-3#1)(1993-8#1)(1997-4#4)(2008-10#2)(2008-11#2)(2008-9#1)(2009-5#1)(2010-5#1)
encoded at##4##2##(1990-12#1)(1992-9#1)(1993-11#1)(2009-9#1)
encoded by a gene##2##4##(1996-3#1)(2008-8#1)
encoded by a single-copy gene##2##5##(1991-6#1)(1993-6#1)
encoded by a##15##3##(1990-11#1)(1991-6#2)(1992-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)
encoded by exons##2##3##(1997-8#1)(2010-5#1)
encoded by gene##2##3##(1994-12#1)(2009-7#1)
encoded by the gene##2##4##(1993-2#1)(1997-3#1)
encoded by the genes##2##4##(1993-9#1)(2009-10#1)
encoded by the small RNA of TSWV##2##7##(2008-10#2)
encoded by the small RNA##3##5##(2008-10#3)
encoded by the##44##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
encoded by two##5##3##(1991-6#1)(1992-6#1)(1993-6#1)(1993-9#1)(1997-7#1)
encoded by##118##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#3)(1991-9#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#3)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-10#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#4)
encoded in the##9##3##(1994-9#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-4#2)(2010-9#1)(2011-2#1)(2012-2#1)
encoded in this##2##3##(1997-3#1)(2008-10#1)
encoded in##22##2##(1993-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)
encoded on a##2##3##(2008-3#1)(2008-7#1)
encoded on##9##2##(1993-9#1)(1995-8#3)(2008-2#1)(2008-3#3)(2008-7#1)
encoded onto the##2##3##(2007-12#1)(2008-3#1)
encoded pattern##2##2##(2008-2#1)(2008-3#1)
encoded protein has##2##3##(1990-12#1)(1992-8#1)
encoded protein##5##2##(1990-12#1)(1992-8#1)(2008-11#2)(2008-9#1)
encoded proteins##4##2##(1994-12#1)(1997-4#1)(2008-7#1)(2013-8#1)
encoded the##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
encoded with a##2##3##(2008-2#1)(2008-3#1)
encoded##238##1##(1990-11#1)(1990-12#5)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#3)(1991-9#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#7)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#6)(1997-7#4)(1997-8#1)(2007-11#5)(2007-12#1)(2008-1#2)(2008-10#21)(2008-11#10)(2008-2#7)(2008-3#15)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#11)(2009-10#3)(2009-2#1)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#6)(2012-2#4)(2012-3#2)(2013-8#5)
encoder is##3##2##(2008-2#1)(2008-3#2)
encoder system##2##2##(2008-3#2)
encoder with##3##2##(2008-2#2)(2008-3#1)
encoder##17##1##(2006-4#1)(2008-2#6)(2008-3#9)(2013-8#1)
encoders##4##1##(2008-3#4)
encodes a mature##2##3##(1990-12#1)(1996-10#1)
encodes a novel protein##2##4##(1990-5#1)(1994-12#1)
encodes a novel##9##3##(1990-5#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-2#1)
encodes a polypeptide having##2##4##(1992-3#1)(1996-6#1)
encodes a polypeptide of##3##4##(1990-11#1)(1992-12#1)(1993-6#1)
encodes a polypeptide##7##3##(1990-11#1)(1992-12#1)(1992-3#1)(1993-6#1)(1996-6#1)(1997-3#1)(2008-10#1)
encodes a protein of##26##4##(1991-2#2)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#2)(1996-12#1)(1996-6#3)(1997-7#2)(2008-10#4)(2008-6#1)(2008-7#1)(2008-9#1)
encodes a protein that##2##4##(2007-7#1)(2012-12#1)
encodes a protein with a molecular##2##6##(1993-6#1)(2008-10#1)
encodes a protein with##11##4##(1990-5#1)(1993-6#1)(1994-12#1)(2008-10#2)(2008-6#1)(2008-8#3)(2009-10#1)(2010-2#1)
encodes a protein##44##3##(1990-5#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#2)(1994-11#2)(1994-12#3)(1995-8#1)(1996-12#1)(1996-6#4)(1997-3#1)(1997-7#2)(2007-7#1)(2008-10#6)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)(2012-12#1)
encodes a putative protein##2##4##(2008-10#1)(2010-5#1)
encodes a putative##5##3##(1993-9#1)(1994-12#1)(2008-10#2)(2010-5#1)
encodes a secreted protein##2##4##(2008-2#1)(2012-12#1)
encodes a small##5##3##(1993-8#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-3#1)
encodes a zinc finger-containing protein that##2##6##(1990-11#1)(1991-10#1)
encodes a##150##2##(1990-11#9)(1990-12#4)(1990-5#3)(1990-6#1)(1991-10#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#4)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#6)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#12)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#7)(1996-8#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#4)(1997-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-2#1)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#9)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-12#4)(2012-3#1)
encodes an enzyme##3##3##(2008-10#2)(2009-8#1)
encodes an##13##2##(1990-11#1)(1991-5#2)(1991-7#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-10#4)(2009-8#1)(2011-1#1)
encodes for a##2##3##(1994-11#1)(1996-12#1)
encodes for##3##2##(1994-11#1)(1996-12#1)(1997-3#1)
encodes the##32##2##(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#2)(1994-12#5)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#4)(2011-2#1)(2012-12#1)(2013-1#1)
encodes two##4##2##(1990-8#1)(1993-6#1)(2008-10#1)(2011-10#1)
encodes##246##1##(1990-11#10)(1990-12#5)(1990-5#5)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#5)(1991-6#1)(1991-7#3)(1991-9#3)(1992-11#1)(1992-12#5)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#3)(1993-6#10)(1993-8#4)(1993-9#1)(1994-11#5)(1994-12#20)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#8)(1996-8#1)(1997-2#2)(1997-3#5)(1997-4#2)(1997-7#4)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#13)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#5)(2012-3#1)(2013-1#1)
encoding 2-hydroxy-6-oxohepta-2##2##2##(1991-7#2)
encoding 6##2##2##(2008-8#1)(2011-2#1)
encoding DNA##2##2##(1995-8#1)(2008-10#1)
encoding a beta-thyroid hormone receptor##2##5##(1997-1#2)
encoding a human##2##3##(1994-12#1)(2008-8#1)
encoding a killer toxin##2##4##(1993-12#2)
encoding a liver UDP-glucuronosyltransferase (UDPGT)##2##5##(2008-11#2)
encoding a novel##2##3##(1994-12#1)(1997-7#1)
encoding a polypeptide of##6##4##(1990-5#1)(1991-12#1)(1995-2#1)(1995-8#1)(2008-8#1)(2013-1#1)
encoding a polypeptide##8##3##(1990-5#1)(1991-12#1)(1992-8#1)(1995-2#1)(1995-8#1)(1995-9#1)(2008-8#1)(2013-1#1)
encoding a polyprotein##2##3##(2008-10#1)(2008-8#1)
encoding a protein of##5##4##(1990-11#1)(1991-9#1)(1993-2#1)(1994-8#1)(2008-10#1)
encoding a protein with##3##4##(1994-6#1)(1997-7#1)(2008-8#1)
encoding a protein##17##3##(1990-11#2)(1990-5#1)(1991-9#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#2)
encoding a putative protein##2##4##(1995-6#1)(1997-4#1)
encoding a putative##8##3##(1992-3#1)(1994-12#2)(1995-6#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-8#1)
encoding a serine carboxypeptidase##2##4##(1994-12#2)
encoding a##110##2##(1990-11#3)(1990-12#1)(1990-5#4)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-12#4)(1993-2#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#14)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#5)(1995-8#2)(1995-9#2)(1996-12#2)(1997-1#2)(1997-3#2)(1997-4#2)(1997-7#6)(1997-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#1)(2013-1#1)(2013-8#1)
encoding alpha##2##2##(1993-6#1)(2008-8#1)
encoding alpha-sarcin##2##2##(1993-2#1)(1997-4#1)
encoding amino acid##2##3##(1997-4#1)(2008-7#1)
encoding an exo-beta-1##2##3##(2008-10#2)
encoding an##13##2##(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-7#1)
encoding and consolidation##2##3##(2007-8#1)(2009-10#1)
encoding and decoding of##2##4##(2008-3#2)
encoding and decoding##5##3##(2008-2#3)(2008-3#2)
encoding and##10##2##(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#4)(2009-10#1)
encoding apolipoprotein AI##2##3##(1993-12#2)
encoding aspartate aminotransferase##2##3##(1996-10#2)
encoding bFGF##2##2##(1992-9#1)(2008-5#1)
encoding beta-galactosidase##3##2##(1992-12#1)(1996-3#1)(2008-8#1)
encoding biosynthetic ornithine decarboxylase##2##4##(1994-12#2)
encoding bovine##4##2##(1991-12#1)(1991-2#1)(1993-2#2)
encoding capacity##2##2##(2008-2#1)(2008-3#1)
encoding cell-surface##3##2##(2008-2#3)
encoding chicken##3##2##(1993-12#1)(1993-2#1)(1994-12#1)
encoding components of##2##3##(1990-5#1)(2008-11#1)
encoding different##2##2##(1991-6#1)(1996-12#1)
encoding enzymes of##2##3##(2009-9#1)(2010-7#1)
encoding enzymes##3##2##(1997-2#1)(2009-9#1)(2010-7#1)
encoding exons##2##2##(2008-8#1)(2012-3#1)
encoding for the##10##3##(1992-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#2)
encoding for##18##2##(1992-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-5#2)(2011-1#1)(2012-2#1)
encoding gene was##2##3##(1990-5#1)(2008-11#1)
encoding gene##6##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)
encoding genes##6##2##(1997-4#1)(2008-10#1)(2009-10#1)(2011-2#2)(2012-3#1)
encoding human brain creatine kinase##2##5##(1991-6#2)
encoding human##25##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-6#4)(1992-3#1)(1992-8#1)(1993-2#1)(1994-11#3)(1994-12#2)(1995-6#1)(1997-7#1)(2008-11#1)(2008-8#4)(2008-9#1)
encoding is##3##2##(2007-12#2)(2008-11#1)
encoding its##3##2##(1992-9#1)(1993-2#1)(1993-8#1)
encoding key##3##2##(2008-8#1)(2009-5#1)(2012-3#1)
encoding mSTI1##2##2##(1997-7#2)
encoding mask##2##2##(2013-8#2)
encoding methods##2##2##(2008-3#2)
encoding of the##4##3##(1996-2#1)(2008-11#2)(2008-2#1)
encoding of##12##2##(1996-2#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2009-11#1)(2010-7#1)(2013-8#3)
encoding or##2##2##(1993-5#1)(2008-1#1)
encoding phytoene synthase and##2##4##(1995-2#1)(2010-10#1)
encoding phytoene##3##2##(1995-2#2)(2010-10#1)
encoding protein##2##2##(1991-7#1)(1995-6#1)
encoding proteins with##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
encoding proteins##7##2##(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-6#1)(2012-3#1)
encoding rat aldosterone synthase##2##4##(1990-5#2)
encoding rat##6##2##(1990-2#1)(1990-5#2)(1991-2#1)(1994-12#1)(1994-6#1)
encoding ribosomal protein##2##3##(1995-6#1)(1996-6#1)
encoding ribosomal##4##2##(1990-5#1)(1995-6#1)(1995-8#1)(1996-6#1)
encoding scheme##2##2##(2008-2#1)(2008-3#1)
encoding schemes##3##2##(2008-3#3)
encoding sequence##3##2##(1997-6#1)(2008-4#1)(2008-8#1)
encoding speed##2##2##(2008-2#2)
encoding strength##2##2##(2008-6#2)
encoding tRNA(TGASer)##2##2##(1991-6#2)
encoding task performance##2##3##(2013-1#2)
encoding task##4##2##(2013-1#4)
encoding technique##3##2##(2007-11#1)(2007-12#2)
encoding the 7-ku protein##2##4##(2008-9#2)
encoding the N-terminal##2##3##(1994-12#1)(1994-8#1)
encoding the alpha##3##3##(1993-2#2)(1995-2#1)
encoding the alpha-toxin##2##3##(2010-6#2)
encoding the chicken##2##3##(1991-6#2)
encoding the full-length##2##3##(1993-3#1)(1993-6#1)
encoding the high-affinity##2##3##(1996-12#1)(2008-7#1)
encoding the human##7##3##(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(2008-5#1)
encoding the largest subunit of##2##5##(1995-6#2)
encoding the major##6##3##(1991-9#2)(1993-2#1)(1994-12#1)(2008-10#1)(2008-5#1)
encoding the mouse##2##3##(1993-6#1)(2008-9#1)
encoding the precursor of##2##4##(1993-3#1)(1996-10#1)
encoding the predicted##2##3##(1997-4#1)(2008-10#1)
encoding the rat##3##3##(1992-12#1)(1992-3#1)(1993-3#1)
encoding the receptor##2##3##(1994-11#1)(1995-6#1)
encoding the replication##2##3##(1993-9#1)(2008-10#1)
encoding the small subunit##2##4##(1993-12#1)(1994-8#1)
encoding the small##3##3##(1993-12#1)(1993-6#1)(1994-8#1)
encoding the soluble##2##3##(1992-6#1)(1996-8#1)
encoding the transmembrane##2##3##(1990-7#1)(1994-8#1)
encoding the viral##3##3##(1995-2#1)(2008-9#1)(2009-5#1)
encoding the##186##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-6#4)(1991-7#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#8)(1993-3#6)(1993-6#6)(1993-8#7)(1993-9#4)(1994-11#3)(1994-12#18)(1994-2#1)(1994-8#6)(1995-11#1)(1995-12#2)(1995-2#6)(1995-6#8)(1995-8#3)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-5#1)(2009-9#1)(2010-6#4)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
encoding these##2##2##(1996-12#1)(2012-12#1)
encoding this protein##2##3##(1991-5#1)(1995-6#1)
encoding this##6##2##(1991-5#1)(1993-2#1)(1994-12#1)(1995-6#1)(2008-10#2)
encoding transcription factor##2##3##(2008-7#1)(2011-1#1)
encoding transcription##3##2##(1992-12#1)(2008-7#1)(2011-1#1)
encoding two##3##2##(1994-11#1)(2008-7#1)(2008-8#1)
encoding vitellogenin##2##2##(2008-6#2)
encoding with##4##2##(2008-3#4)
encoding##751##1##(1990-11#8)(1990-12#3)(1990-2#1)(1990-5#14)(1990-7#3)(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#19)(1991-7#4)(1991-9#9)(1992-10#1)(1992-11#1)(1992-12#9)(1992-3#5)(1992-4#3)(1992-6#4)(1992-8#6)(1992-9#9)(1993-11#2)(1993-12#18)(1993-2#24)(1993-3#7)(1993-5#2)(1993-6#13)(1993-8#11)(1993-9#6)(1994-11#12)(1994-12#54)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#18)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#12)(1995-3#1)(1995-6#22)(1995-8#11)(1995-9#3)(1996-10#5)(1996-12#12)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#5)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#12)(1997-4#13)(1997-5#1)(1997-6#8)(1997-7#16)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#9)(2007-8#5)(2008-1#4)(2008-10#49)(2008-11#22)(2008-12#1)(2008-2#20)(2008-3#31)(2008-4#8)(2008-5#9)(2008-6#6)(2008-7#16)(2008-8#29)(2008-9#17)(2009-10#8)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#4)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#1)(2010-5#2)(2010-6#4)(2010-7#4)(2011-1#5)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#13)(2013-8#8)
encompass the##6##2##(1997-2#1)(2008-12#1)(2008-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
encompass##19##1##(1991-1#1)(1994-8#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
encompassed by##3##2##(1993-3#1)(1994-3#1)(2007-12#1)
encompassed##4##1##(1993-3#1)(1994-3#1)(2007-12#1)(2009-9#1)
encompasses all the##2##3##(1995-2#1)(1997-8#1)
encompasses all##3##2##(1995-2#1)(1997-8#1)(2010-6#1)
encompasses important##2##2##(1996-3#1)(2008-10#1)
encompasses the##9##2##(1992-3#1)(1995-6#1)(2007-5#1)(2008-2#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-3#1)(2012-2#1)
encompasses##36##1##(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#3)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-7#1)
encompassing 10##2##2##(2008-5#1)(2012-1#1)
encompassing a##2##2##(2008-7#1)(2009-8#1)
encompassing an##2##2##(2008-8#1)(2009-4#1)
encompassing the entire##2##3##(1993-6#1)(1994-12#1)
encompassing the##12##2##(1990-8#1)(1991-5#1)(1991-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
encompassing##40##1##(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-6#2)(1994-12#2)(1995-2#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
encopresis##2##1##(1991-8#2)
encounter a##2##2##(2008-12#1)(2012-2#1)
encounter and##2##2##(2008-11#1)(2010-7#1)
encounter between##2##2##(1994-1#1)(2008-8#1)
encounter data##4##2##(1996-3#1)(1997-2#3)
encounter in##4##2##(2010-10#1)(2010-9#1)(2012-3#2)
encounter patients with##2##3##(2011-2#1)(2013-1#1)
encounter patients##4##2##(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
encounter rate and##2##3##(1994-3#1)(2008-9#1)
encounter rate##4##2##(1994-3#1)(2008-9#2)(2010-8#1)
encounter rates##3##2##(2008-9#3)
encounter when##3##2##(1996-1#1)(2008-4#1)(2008-7#1)
encounter with the##2##3##(1995-3#1)(2011-2#1)
encounter with##7##2##(1995-3#1)(1995-5#1)(2008-11#1)(2008-8#1)(2011-2#2)(2013-8#1)
encounter##80##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#3)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#2)(1997-2#5)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#7)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#3)(2013-8#2)
encountered a##4##2##(1995-4#1)(2009-8#1)(2011-2#2)
encountered and their##2##3##(1990-9#1)(2013-8#1)
encountered and##8##2##(1990-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-4#1)(2013-8#1)
encountered as##3##2##(1991-11#1)(2010-10#1)(2012-2#1)
encountered at##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
encountered by most##2##3##(1996-2#1)(2012-3#1)
encountered by the##7##3##(1992-1#1)(1993-6#1)(2008-11#1)(2009-3#1)(2013-1#3)
encountered by##22##2##(1992-1#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-2#2)(2009-3#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
encountered during the##4##3##(2008-10#1)(2008-11#2)(2010-12#1)
encountered during##11##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
encountered in a##5##3##(2007-7#1)(2008-10#3)(2009-10#1)
encountered in biological##2##3##(2008-10#1)(2009-11#1)
encountered in clinical practice##6##4##(2007-8#1)(2008-1#1)(2008-12#2)(2011-2#2)
encountered in clinical##9##3##(1990-8#1)(2007-8#1)(2008-1#1)(2008-12#2)(2011-1#1)(2011-2#3)
encountered in laboratory##2##3##(1995-9#1)(2008-7#1)
encountered in our##2##3##(2008-8#1)(2010-12#1)
encountered in soft##2##3##(2008-3#1)(2012-2#1)
encountered in the##19##3##(1992-3#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)
encountered in this##3##3##(1994-8#1)(2007-11#1)(2012-2#1)
encountered in two##2##3##(2008-7#1)(2008-9#1)
encountered in##101##2##(1990-8#2)(1991-12#1)(1991-3#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-3#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#5)(2013-1#1)
encountered patients with##2##3##(1995-8#1)(2008-8#1)
encountered were##2##2##(1997-8#1)(2008-1#1)
encountered when##8##2##(1993-2#1)(1994-2#1)(1996-9#1)(2008-10#2)(2008-3#1)(2008-4#2)
encountered while##2##2##(2008-10#1)(2011-2#1)
encountered with##6##2##(1996-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)
encountered##245##1##(1990-3#1)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-9#3)(1997-3#4)(1997-8#2)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#4)(2008-1#8)(2008-10#27)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#13)(2008-4#7)(2008-5#4)(2008-7#14)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#4)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#3)(2011-1#8)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#12)(2012-3#3)(2013-1#7)(2013-8#3)
encountering the##2##2##(1995-5#1)(2012-12#1)
encountering##10##1##(1993-12#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-1#1)(2012-12#1)
encounters and##3##2##(1991-6#1)(1991-9#1)(2011-2#1)
encounters in##4##2##(1991-6#1)(2007-11#1)(2008-10#1)(2010-10#1)
encounters the##2##2##(1991-3#1)(2008-3#1)
encounters with older##2##3##(2010-10#2)
encounters with##5##2##(2007-12#1)(2008-11#1)(2008-8#1)(2010-10#2)
encounters##41##1##(1991-3#1)(1991-6#5)(1991-9#2)(1993-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-5#1)(2010-10#7)(2010-8#1)(2011-2#4)(2013-1#1)
encourage a##4##2##(2009-8#1)(2012-12#1)(2013-1#2)
encourage and##3##2##(1991-2#1)(2010-10#1)(2011-2#1)
encourage authors to##3##3##(2013-1#3)
encourage further##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
encourage health##3##2##(1997-1#1)(2007-5#1)(2008-11#1)
encourage more##2##2##(2009-9#1)(2013-8#1)
encourage other##2##2##(1991-1#1)(2008-12#1)
encourage the development and##2##4##(2008-10#1)(2008-5#1)
encourage the development##3##3##(1994-3#1)(2008-10#1)(2008-5#1)
encourage the use of##3##4##(1996-6#1)(1996-9#1)(2008-11#1)
encourage the##13##2##(1994-3#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#2)(2011-2#1)(2013-8#1)
encourage their##2##2##(2007-9#1)(2008-11#1)
encourage them to##3##3##(1994-3#1)(1995-11#1)(2010-3#1)
encourage##92##1##(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-2#1)(1993-1#2)(1994-1#1)(1994-2#1)(1994-3#3)(1994-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#4)
encouraged a##2##2##(1996-1#1)(2008-11#1)
encouraged by##3##2##(1991-8#1)(1996-7#1)(2008-10#1)
encouraged the##9##2##(1993-12#1)(2007-10#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)
encouraged to do##2##3##(1993-1#1)(1993-3#1)
encouraged to participate in##2##4##(2008-11#1)(2009-6#1)
encouraged to report##2##3##(1993-1#1)(1997-3#1)
encouraged to utilize##2##3##(1991-3#1)(1996-12#1)
encouraged to##25##2##(1991-3#2)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1995-3#2)(1996-12#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-6#1)(2010-11#1)(2012-3#1)(2013-1#1)
encouraged when##2##2##(2008-11#1)(2011-2#1)
encouraged##62##1##(1991-3#2)(1991-8#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-4#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
encouragement and##5##2##(1992-12#1)(1993-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
encouragement##12##1##(1992-12#2)(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-10#1)(2012-3#1)(2013-1#2)
encourages##12##1##(1992-12#3)(1993-11#1)(1993-3#1)(1994-1#1)(1997-1#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
encouraging and##3##2##(2008-12#1)(2008-5#1)(2012-3#1)
encouraging data##2##2##(2008-7#1)(2013-1#1)
encouraging early results##2##3##(2007-8#1)(2010-6#1)
encouraging early##4##2##(2007-8#1)(2008-5#1)(2010-6#1)(2012-2#1)
encouraging for##4##2##(1995-12#1)(2008-1#1)(2008-11#1)(2008-12#1)
encouraging greater##2##2##(1994-2#1)(1996-12#1)
encouraging in##2##2##(1994-2#1)(2010-12#1)
encouraging on##2##2##(2008-1#1)(2008-7#1)
encouraging preclinical##2##2##(2010-4#1)(2013-8#1)
encouraging results with##2##3##(2008-10#1)(2008-8#1)
encouraging results##13##2##(1992-9#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-8#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)
encouraging students to##2##3##(2008-11#2)
encouraging the##5##2##(1993-11#1)(1994-1#1)(1994-12#1)(1994-7#1)(2008-11#1)
encouraging##82##1##(1991-4#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-7#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
encroachment of##2##2##(2008-12#1)(2010-12#1)
encroachment##3##1##(1990-2#1)(2008-12#1)(2010-12#1)
encrusted##2##1##(2008-10#1)(2008-2#1)
encrypted by use of##2##4##(2007-12#1)(2008-3#1)
encrypted by##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
encrypted information##3##2##(2008-3#3)
encrypted optical##3##2##(2007-12#1)(2008-3#2)
encrypted signal is##2##3##(2008-3#2)
encrypted signal##4##2##(2008-3#4)
encrypted##31##1##(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#21)(2008-7#1)
encryption algorithm##2##2##(2007-12#1)(2008-3#1)
encryption and decryption of optical memory in a LiNbO(3)##2##9##(2007-12#1)(2008-3#1)
encryption and decryption##3##3##(2007-12#1)(2008-3#2)
encryption and##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
encryption of digital data##2##4##(2008-3#2)
encryption of##4##2##(2007-12#1)(2008-3#3)
encryption system that uses##2##4##(2008-2#1)(2008-3#1)
encryption system##8##2##(2008-2#2)(2008-3#6)
encryption technique##3##2##(2007-11#1)(2008-3#2)
encryption##36##1##(2007-11#2)(2007-12#5)(2008-2#4)(2008-3#25)
encumbered by##2##2##(1994-3#1)(2008-11#1)
encumbered with##3##2##(1995-6#1)(1997-8#2)
encumbered##5##1##(1994-3#1)(1995-6#1)(1997-8#2)(2008-11#1)
encysted zoospores##2##2##(2008-10#2)
encysted##4##1##(1992-8#1)(2008-10#2)(2012-1#1)
encystment of zoospores##2##3##(2008-10#2)
encystment##6##1##(1992-8#1)(2008-10#5)
end and a##2##3##(2008-10#1)(2013-8#1)
end and side pump##2##4##(2008-2#2)
end and the##2##3##(2008-9#1)(2009-8#1)
end and##15##2##(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2013-8#1)
end diastolic##2##2##(1996-3#1)(2013-8#1)
end face##3##2##(2007-11#1)(2008-3#2)
end faces of##2##3##(2007-11#1)(2008-7#1)
end groups##3##2##(1992-12#1)(2008-10#2)
end in##10##2##(1990-3#1)(1990-5#1)(1996-2#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
end joining (NHEJ)##2##3##(1997-7#1)(2011-1#1)
end joining##5##2##(1993-2#2)(1997-7#2)(2011-1#1)
end labeling##7##2##(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)
end labelling of##2##3##(1994-10#1)(2011-1#1)
end labelling##3##2##(1994-10#2)(2011-1#1)
end matches the previously described gene##2##6##(1996-6#2)
end mirror and##2##3##(2008-3#2)
end mirror##4##2##(2008-3#4)
end mirrors##3##2##(2007-11#2)(2008-3#1)
end of 6th month it##2##5##(2011-2#2)
end of a glass##2##4##(2007-11#1)(2008-10#1)
end of a##22##3##(1992-12#1)(1993-11#1)(1994-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-8#2)(2013-1#1)
end of chromosome##3##3##(1995-6#1)(1996-6#1)(1997-7#1)
end of each##15##3##(1994-3#1)(1997-4#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
end of its##3##3##(1997-7#1)(2008-12#1)(2009-7#1)
end of life care##3##4##(2008-12#1)(2010-10#1)(2013-1#1)
end of life decisions##3##4##(2012-12#3)
end of life##11##3##(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#3)(2012-12#4)(2013-1#1)
end of one##3##3##(1995-8#1)(2008-4#1)(2008-6#1)
end of shelf life##2##4##(2011-2#2)
end of the cell##2##4##(2008-11#1)(2009-10#1)
end of the coding region of##2##6##(2008-4#1)(2008-8#1)
end of the experiment##10##4##(1992-9#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-1#1)
end of the fiber##2##4##(2007-12#1)(2008-10#1)
end of the first semester##2##5##(2008-10#1)(2012-3#1)
end of the first##6##4##(1996-12#1)(1996-3#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
end of the genome##4##4##(1994-8#1)(2008-10#2)(2008-11#1)
end of the lacZ##2##4##(1991-7#1)(1997-7#1)
end of the molecule##3##4##(1993-8#1)(1996-7#1)(2008-8#1)
end of the study##36##4##(1990-9#2)(1997-4#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#18)(2010-3#1)(2011-2#1)
end of the viral##3##4##(1992-12#2)(2008-10#1)
end of the##305##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#7)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#5)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#1)(2007-11#8)(2007-12#9)(2007-2#2)(2007-5#5)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#43)(2008-11#15)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#12)(2008-9#25)(2009-10#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#4)
end of this##11##3##(1995-2#1)(1996-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-5#1)(2011-3#1)(2012-12#1)
end of treatment##8##3##(1991-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2013-1#1)
end of##544##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#8)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#7)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#3)(1996-4#1)(1996-6#4)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#18)(1997-5#1)(1997-6#7)(1997-7#4)(2007-10#1)(2007-11#13)(2007-12#13)(2007-2#2)(2007-3#1)(2007-5#5)(2007-7#8)(2007-8#9)(2008-1#7)(2008-10#74)(2008-11#17)(2008-12#15)(2008-2#7)(2008-3#16)(2008-4#10)(2008-5#15)(2008-6#8)(2008-7#10)(2008-8#19)(2008-9#30)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#22)(2011-3#2)(2012-1#2)(2012-12#9)(2012-2#9)(2012-3#2)(2012-7#1)(2012-9#1)(2013-1#23)(2013-7#3)(2013-8#9)
end on##3##2##(1995-2#1)(1997-7#2)
end organ##2##2##(1992-6#1)(2012-12#1)
end plates##2##2##(1993-5#1)(2007-11#1)
end point in##2##3##(2008-10#1)(2009-11#1)
end point of the##2##4##(1990-10#1)(2008-10#1)
end point of##3##3##(1990-10#1)(2008-10#1)(2012-2#1)
end point was##3##3##(2007-7#1)(2008-11#1)(2012-1#1)
end point##23##2##(1990-10#1)(1990-6#1)(2007-10#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#2)(2012-1#1)(2012-12#1)(2012-2#1)
end points are##3##3##(1990-7#1)(2007-10#1)(2008-6#1)
end points of##2##3##(2008-10#1)(2012-3#1)
end points##19##2##(1990-12#1)(1990-7#1)(1992-6#1)(1993-11#1)(1995-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2010-2#2)(2012-3#1)(2013-1#3)
end product of the##2##4##(1995-2#1)(2008-2#1)
end product of##5##3##(1991-9#1)(1992-3#1)(1995-2#1)(2008-11#1)(2008-2#1)
end product##8##2##(1991-9#1)(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
end products in##2##3##(1993-5#1)(2011-1#1)
end products##18##2##(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#2)(1995-2#1)(2008-1#3)(2008-7#3)(2010-10#1)(2011-1#2)(2012-2#3)
end pumped by two 1##2##5##(2007-11#1)(2007-12#1)
end pumping##3##2##(2007-11#2)(2008-3#1)
end result of##2##3##(1996-3#1)(2007-7#1)
end result will be##2##4##(1997-3#1)(2010-8#1)
end result##7##2##(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2009-3#1)(2010-8#1)(2013-1#1)
end sequences##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
end stage renal disease (ESRD) patients##2##6##(1991-3#1)(1995-12#1)
end stage renal disease (ESRD)##11##5##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#1)(2007-7#3)(2008-1#1)(2012-2#1)
end stage renal disease and##2##5##(2011-2#1)(2013-1#1)
end stage renal disease##21##4##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(2007-7#4)(2008-1#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
end stage renal failure##3##4##(1997-8#2)(2008-1#1)
end stage renal##24##3##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(1997-8#2)(2007-7#4)(2008-1#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
end stage##28##2##(1991-11#1)(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(1997-8#2)(2007-7#4)(2008-1#2)(2008-4#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
end surface##2##2##(2007-12#2)
end surfaces##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
end than##2##2##(1995-11#1)(1995-8#1)
end the##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
end to the##2##3##(1992-6#1)(2008-3#1)
end to##8##2##(1991-3#1)(1992-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
end user##3##2##(1991-12#1)(1993-3#1)(2008-9#1)
end users##16##2##(1991-12#2)(1992-1#1)(1992-12#4)(1993-3#2)(1995-1#1)(1995-3#2)(1996-1#1)(1997-1#1)(2008-10#1)(2009-6#1)
end we##2##2##(2008-2#1)(2008-3#1)
end were##2##2##(1996-12#1)(2008-10#1)
end with a##2##3##(2008-12#1)(2008-8#1)
end with##6##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)
end##958##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#14)(1992-3#6)(1992-5#1)(1992-6#6)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#1)(1993-2#5)(1993-3#6)(1993-5#4)(1993-6#2)(1993-8#3)(1993-9#4)(1994-10#2)(1994-12#6)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#7)(1995-1#3)(1995-11#6)(1995-12#5)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#6)(1996-7#2)(1997-1#4)(1997-2#6)(1997-3#5)(1997-4#23)(1997-5#2)(1997-6#8)(1997-7#9)(1997-8#3)(2007-10#4)(2007-11#26)(2007-12#24)(2007-2#2)(2007-3#2)(2007-5#5)(2007-7#14)(2007-8#11)(2008-1#15)(2008-10#125)(2008-11#29)(2008-12#24)(2008-2#24)(2008-3#53)(2008-4#16)(2008-5#23)(2008-6#15)(2008-7#23)(2008-8#36)(2008-9#36)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#5)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#4)(2010-7#3)(2010-8#3)(2011-1#13)(2011-2#30)(2011-3#2)(2012-1#3)(2012-12#14)(2012-2#14)(2012-3#9)(2012-7#1)(2012-9#1)(2013-1#31)(2013-7#3)(2013-8#16)
end&quot##3##1##(2008-11#1)(2008-12#2)
end-##2##1##(2007-11#1)(2008-4#1)
end-capped##3##1##(1991-9#1)(2008-10#2)
end-channel##6##1##(2008-10#6)
end-column##4##1##(2008-10#4)
end-cooled##2##1##(2008-2#2)
end-diastolic##8##1##(1997-8#1)(2008-1#1)(2008-12#2)(2008-7#3)(2012-3#1)
end-joining##4##1##(2008-7#1)(2013-1#3)
end-labeled with##2##2##(2008-10#1)(2008-9#1)
end-labeled##6##1##(1993-8#1)(2008-10#3)(2008-2#1)(2008-9#1)
end-labelling##2##1##(2008-11#1)(2012-1#1)
end-of-life care##6##2##(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
end-of-life##14##1##(1994-12#1)(2009-11#1)(2010-10#1)(2010-4#4)(2011-2#1)(2012-12#4)(2012-3#2)
end-of-treatment##3##1##(2007-10#2)(2010-3#1)
end-on##2##1##(1997-7#2)
end-organ##3##1##(2010-6#1)(2011-1#1)(2012-2#1)
end-plate##2##1##(2008-9#1)(2012-1#1)
end-point detection##6##2##(2008-10#6)
end-point indication##3##2##(2008-10#3)
end-point of##4##2##(2008-10#3)(2011-2#1)
end-point was detected##2##3##(2008-10#2)
end-point was##4##2##(2008-10#2)(2011-1#1)(2012-2#1)
end-point##38##1##(1993-12#1)(1993-2#1)(1994-3#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-2#1)
end-points##5##1##(1993-6#1)(1995-12#1)(2008-10#2)(2012-2#1)
end-product##2##1##(1993-1#1)(2011-2#1)
end-pumped##10##1##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
end-pumping configuration##2##2##(2008-2#1)(2008-3#1)
end-stage PDR##6##2##(2013-1#6)
end-stage emphysema##2##2##(2006-10#1)(2012-1#1)
end-stage heart failure##5##3##(2010-6#2)(2010-8#2)(2012-3#1)
end-stage kidney failure##2##3##(2011-2#2)
end-stage kidney##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
end-stage liver disease##7##3##(1990-12#1)(2008-12#1)(2010-6#2)(2011-2#2)(2013-8#1)
end-stage lung diseases##2##3##(2011-3#2)
end-stage lung##3##2##(2011-3#3)
end-stage of##4##2##(1990-12#1)(1994-7#2)(2006-10#1)
end-stage proliferative diabetic retinopathy##2##4##(2013-1#2)
end-stage pulmonary disease##2##3##(1994-3#2)
end-stage pulmonary##3##2##(1994-3#2)(2011-3#1)
end-stage renal disease (ESRD) in##3##5##(2007-7#1)(2008-1#2)
end-stage renal disease (ESRD) patients##2##5##(2008-1#1)(2008-7#1)
end-stage renal disease (ESRD)##15##4##(1996-2#1)(2006-10#1)(2007-12#1)(2007-7#6)(2008-1#4)(2008-7#1)(2008-8#1)
end-stage renal disease and##2##4##(2008-1#2)
end-stage renal disease in##2##4##(2007-12#1)(2008-4#1)
end-stage renal disease is##2##4##(2007-7#1)(2011-1#1)
end-stage renal disease patients undergoing hemodialysis##2##6##(2008-7#1)(2010-5#1)
end-stage renal disease patients##6##4##(2007-12#1)(2008-7#3)(2010-5#2)
end-stage renal disease##49##3##(1994-12#1)(1994-5#1)(1996-2#1)(2006-10#2)(2007-12#4)(2007-7#9)(2008-1#15)(2008-10#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-5#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-1#2)
end-stage renal failure (ESRF)##3##4##(2008-1#2)(2008-4#1)
end-stage renal failure and##2##4##(2011-2#1)(2013-8#1)
end-stage renal failure##12##3##(1991-11#1)(2008-1#6)(2008-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
end-stage renal failure]##2##3##(2008-7#2)
end-stage renal##64##2##(1991-11#1)(1994-12#1)(1994-5#1)(1996-2#1)(2006-10#2)(2007-12#4)(2007-7#9)(2008-1#22)(2008-10#1)(2008-4#3)(2008-7#6)(2008-8#1)(2009-5#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
end-stage##109##1##(1990-12#2)(1991-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#2)(1996-2#1)(2006-10#4)(2007-11#1)(2007-12#4)(2007-7#9)(2008-1#22)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#6)(2008-8#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-6#4)(2010-8#3)(2011-1#1)(2011-2#6)(2011-3#6)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#14)(2013-8#2)
end-systolic##2##1##(1992-9#1)(1997-8#1)
end-tidal##3##1##(2012-3#3)
end-to-end anastomosis##2##2##(1991-9#1)(2007-8#1)
end-to-end stacking##3##2##(2009-6#3)
end-to-end##16##1##(1991-5#1)(1991-9#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#3)
end-to-side anastomosis##3##2##(2007-7#1)(2007-8#2)
end-to-side##8##1##(1993-3#2)(2007-7#1)(2007-8#2)(2008-9#1)(2013-7#2)
end-user training##2##2##(1991-3#1)(1997-1#1)
end-user##11##1##(1991-3#3)(1992-1#3)(1992-12#1)(1993-3#1)(1995-1#1)(1997-1#1)(2008-4#1)
end-users##3##1##(2010-4#1)(2013-1#2)
endanger##2##1##(1991-5#1)(2013-8#1)
endangered by##3##2##(1996-8#1)(1997-7#1)(2009-5#1)
endangered##18##1##(1991-5#2)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-8#1)(2013-1#2)(2013-7#2)
endangering##2##1##(1992-4#1)(1997-8#1)
endarterectomy for##3##2##(2008-7#1)(2008-8#1)(2010-9#1)
endarterectomy in##3##2##(1991-11#1)(1993-1#1)(2013-1#1)
endarterectomy is##2##2##(2009-7#2)
endarterectomy on##2##2##(1991-5#1)(1994-11#1)
endarterectomy##36##1##(1991-11#1)(1991-5#1)(1992-6#2)(1993-1#1)(1994-11#2)(1997-2#1)(2006-7#1)(2007-10#6)(2007-8#2)(2008-11#2)(2008-7#2)(2008-8#3)(2009-7#2)(2010-10#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-9#1)(2013-1#2)(2013-8#1)
endcap##6##1##(2008-4#6)
endcapped oligonucleotides##2##2##(2008-4#2)
endcapped##4##1##(2008-10#2)(2008-4#2)
endcaps##2##1##(2008-4#2)
endeavor to##2##2##(2007-7#1)(2008-2#1)
endeavor##13##1##(1991-12#1)(1992-12#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-2#2)(2008-4#1)
endeavors##2##1##(2007-7#1)(2008-11#1)
endeavour at the##2##3##(2008-5#1)(2009-6#1)
endeavour##8##1##(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2012-12#2)
endeavours to##3##2##(2008-12#2)(2009-4#1)
endeavours##6##1##(1992-3#1)(2008-12#2)(2009-4#1)(2010-11#1)(2010-12#1)
ended at the##2##3##(1993-12#1)(2008-10#1)
ended in the##4##3##(1997-3#1)(2008-12#1)(2008-7#1)(2013-1#1)
ended in##7##2##(1995-6#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
ended with##2##2##(2008-10#1)(2013-1#1)
ended##21##1##(1993-12#1)(1994-9#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
endemic and##4##2##(2007-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
endemic area for##4##3##(1996-11#1)(2008-5#2)(2012-2#1)
endemic area is known in the##2##6##(1996-11#2)
endemic area of##2##3##(1994-11#1)(2008-7#1)
endemic area##15##2##(1994-11#1)(1995-12#1)(1996-11#5)(2007-2#1)(2008-5#3)(2008-7#1)(2012-2#1)(2013-8#2)
endemic areas in##4##3##(1996-11#3)(2012-3#1)
endemic areas of##7##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#1)
endemic areas##31##2##(1990-9#1)(1991-11#1)(1993-3#1)(1994-11#3)(1996-11#6)(2006-10#2)(2007-12#2)(2007-2#4)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)
endemic circulation of##2##3##(2012-12#2)
endemic countries##4##2##(1996-6#1)(2007-2#2)(2008-5#1)
endemic disease##2##2##(1991-11#1)(2008-10#1)
endemic fish##3##2##(2008-5#2)(2012-2#1)
endemic focus of##3##3##(2008-5#2)(2008-8#1)
endemic for malaria##2##3##(2008-8#1)(2012-12#1)
endemic for this disease##2##4##(2007-12#1)(2009-8#1)
endemic for##8##2##(2007-12#1)(2008-5#1)(2008-8#2)(2009-8#2)(2012-12#2)
endemic fungal infections##2##3##(2011-2#2)
endemic in the##2##3##(2012-12#1)(2013-1#1)
endemic in##14##2##(1991-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
endemic region of##2##3##(2008-10#1)(2012-12#1)
endemic region##5##2##(2008-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
endemic regions in##2##3##(2012-3#1)(2013-8#1)
endemic regions of##2##3##(2007-2#1)(2011-2#1)
endemic regions##11##2##(1991-8#1)(2007-2#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
endemic situation##2##2##(2012-3#2)
endemic species##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
endemic to Costa Rica##2##4##(2008-5#2)
endemic to Costa Rica]##2##4##(2008-5#2)
endemic to Costa##4##3##(2008-5#4)
endemic to the##5##3##(1996-4#1)(2009-2#1)(2010-1#1)(2010-8#1)(2013-7#1)
endemic to##16##2##(1996-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#6)(2009-2#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-7#1)
endemic##161##1##(1990-9#1)(1991-11#6)(1991-8#2)(1992-8#1)(1993-3#1)(1994-11#4)(1995-12#1)(1995-3#1)(1996-11#12)(1996-4#2)(1996-6#2)(2006-10#2)(2007-12#7)(2007-2#11)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#18)(2008-7#1)(2008-8#10)(2009-2#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-8#3)(2011-2#13)(2011-3#1)(2012-12#8)(2012-2#6)(2012-3#14)(2013-1#3)(2013-7#4)(2013-8#4)
endemicity##7##1##(1994-11#1)(1994-9#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-1#1)(2012-12#1)
endemism##4##1##(1996-6#1)(2010-6#2)(2013-7#1)
ending in##2##2##(2007-12#1)(2007-7#1)
ending with a##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
ending with##6##2##(1994-3#2)(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#1)
ending##18##1##(1992-11#1)(1994-3#2)(1996-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-3#1)(2012-2#1)
endings are##2##2##(1995-12#1)(1995-3#1)
endings were##2##2##(2008-6#1)(2009-7#1)
endings##20##1##(1990-11#2)(1992-6#3)(1994-3#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-7#1)
endlessly single-mode##2##2##(2007-11#2)
endo##13##1##(1991-3#2)(1993-6#1)(1996-5#7)(2008-10#1)(2008-4#1)(2008-5#1)
endo-##3##1##(2007-8#1)(2009-3#1)(2009-6#1)
endo-1##2##1##(2008-10#2)
endo-2-cineolylol##2##1##(2008-5#2)
endo-PG##6##1##(2008-10#6)
endo-beta-1##3##1##(2008-10#3)
endoPG-disrupted mutant##2##2##(2008-10#2)
endoblasts##4##1##(2007-12#4)
endobronchial hamartoma##2##2##(2008-7#2)
endobronchial##19##1##(1992-8#3)(1994-9#5)(1995-8#1)(2007-8#1)(2008-3#1)(2008-7#2)(2010-2#1)(2010-8#3)(2013-1#1)(2013-7#1)
endocannabinoid system is##2##3##(2009-8#2)
endocardial radiofrequency (RF) ablation##2##4##(2007-8#1)(2010-6#1)
endocardial##3##1##(2007-8#2)(2010-6#1)
endocardiectomy and valvular##2##3##(2007-8#2)
endocarditis (IE)##3##2##(2006-6#1)(2011-2#2)
endocarditis after##2##2##(2007-8#1)(2008-1#1)
endocarditis and##5##2##(2007-12#2)(2007-8#1)(2011-2#1)(2012-2#1)
endocarditis caused by##3##3##(2007-12#3)
endocarditis in a##4##3##(1990-3#1)(2007-12#2)(2007-7#1)
endocarditis in##7##2##(1990-3#1)(1992-2#1)(2007-12#2)(2007-7#2)(2013-8#1)
endocarditis is##4##2##(1996-11#1)(2011-2#3)
endocarditis of the##2##3##(1997-2#2)
endocarditis of##4##2##(1997-2#2)(2009-5#2)
endocarditis to##2##2##(1996-11#1)(2011-2#1)
endocarditis was##2##2##(1997-8#1)(2007-7#1)
endocarditis##82##1##(1990-11#1)(1990-3#1)(1991-3#1)(1992-2#2)(1993-2#1)(1996-11#5)(1997-2#6)(1997-5#1)(1997-8#1)(2006-6#3)(2007-11#1)(2007-12#11)(2007-7#8)(2007-8#10)(2008-1#1)(2008-4#1)(2009-5#3)(2010-5#1)(2011-1#1)(2011-2#19)(2012-2#1)(2013-1#1)(2013-8#2)
endocarditis]##5##1##(1990-11#1)(1996-11#1)(1997-2#1)(1997-8#1)(2013-1#1)
endocervical button##2##2##(1991-2#2)
endocervical##14##1##(1990-2#3)(1991-2#3)(1992-1#2)(1992-2#1)(1994-12#1)(1994-9#1)(2009-6#2)(2011-2#1)
endocervix##3##1##(1992-3#1)(1994-12#1)(1997-7#1)
endochitinase activity##4##2##(2008-10#4)
endochitinase##11##1##(2008-10#11)
endochondral bone##2##2##(1991-5#1)(2012-12#1)
endocrine and neuroendocrine##4##3##(1994-5#1)(2008-5#2)(2008-8#1)
endocrine and##11##2##(1991-12#1)(1994-5#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
endocrine cell types##2##3##(1991-1#1)(2010-11#1)
endocrine cell##5##2##(1991-1#1)(2010-11#4)
endocrine cells##10##2##(1993-12#2)(1995-12#1)(1997-7#2)(2008-7#2)(2008-8#1)(2010-11#2)
endocrine components##2##2##(2008-7#1)(2013-8#1)
endocrine disease##2##2##(1990-3#1)(1991-2#1)
endocrine diseases##2##2##(1992-12#1)(2008-1#1)
endocrine disrupting chemicals##3##3##(2008-10#2)(2013-1#1)
endocrine disrupting##5##2##(2008-10#4)(2013-1#1)
endocrine disruptors have been##2##4##(2008-11#1)(2010-5#1)
endocrine disruptors##9##2##(2008-10#4)(2008-11#2)(2010-5#2)(2012-2#1)
endocrine dysfunction##2##2##(2008-7#1)(2012-3#1)
endocrine function##2##2##(1990-12#1)(1990-5#1)
endocrine functions##2##2##(1996-5#1)(2009-7#1)
endocrine glands##3##2##(1992-5#1)(2008-5#1)(2011-1#1)
endocrine neoplasia type##6##3##(1990-3#1)(1997-1#1)(2007-12#1)(2008-1#2)(2013-1#1)
endocrine neoplasia##9##2##(1990-3#1)(1997-1#1)(2007-12#1)(2008-1#2)(2009-1#1)(2009-4#1)(2013-1#2)
endocrine organ##2##2##(2009-2#1)(2009-6#1)
endocrine organs##4##2##(1990-11#1)(1990-7#3)
endocrine pancreas##6##2##(1991-7#1)(1994-12#2)(1994-8#1)(2008-1#1)(2010-11#1)
endocrine pancreatic##4##2##(1994-11#3)(2010-11#1)
endocrine regulation##2##2##(1991-3#1)(2008-4#1)
endocrine status##2##2##(1991-2#1)(2008-9#1)
endocrine system##10##2##(1990-5#1)(2007-12#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#1)(2013-1#1)
endocrine systems##4##2##(1990-3#1)(2008-2#1)(2008-5#1)(2010-5#1)
endocrine therapy in breast##2##4##(2007-10#1)(2013-8#1)
endocrine therapy##6##2##(1993-9#1)(2007-10#1)(2013-8#4)
endocrine treatment of breast cancer##2##5##(1990-11#2)
endocrine treatment of breast##3##4##(1990-11#2)(1997-7#1)
endocrine tumor##3##2##(2009-4#1)(2010-9#1)(2011-2#1)
endocrine tumors##4##2##(1992-7#1)(2010-9#2)(2011-2#1)
endocrine##178##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-7#3)(2007-10#2)(2007-12#2)(2007-7#1)(2008-1#5)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-7#9)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#2)(2010-11#10)(2010-5#3)(2010-9#3)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#6)
endocrine-disrupting##2##1##(2008-10#1)(2010-9#1)
endocrine-immune interactions##2##2##(2008-8#1)(2008-9#1)
endocrine-immune##3##1##(2008-8#1)(2008-9#1)(2012-3#1)
endocrinologic##4##1##(2008-10#1)(2008-11#2)(2013-1#1)
endocrinological##11##1##(1992-11#1)(2008-4#1)(2008-5#5)(2008-6#2)(2012-2#1)(2013-7#1)
endocrinologist##2##1##(2013-1#2)
endocrinologists##7##1##(1997-2#1)(2008-1#1)(2011-2#4)(2013-1#1)
endocrinology and##3##2##(2008-3#1)(2008-4#2)
endocrinology##19##1##(1993-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-11#2)(2009-7#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)
endocrinopathies in##2##2##(1997-3#1)(2013-1#1)
endocrinopathies##4##1##(1997-3#1)(2008-5#1)(2013-1#2)
endocrinopathy##2##1##(2008-10#2)
endocytic pathway##2##2##(1995-6#1)(2008-11#1)
endocytic pathways##2##2##(1996-2#1)(2012-2#1)
endocytic uptake##2##2##(1997-7#1)(2010-4#1)
endocytic vesicles##3##2##(1992-6#2)(1995-6#1)
endocytic##15##1##(1990-11#1)(1992-6#2)(1995-6#2)(1996-2#1)(1997-7#1)(2008-11#1)(2009-10#2)(2009-8#1)(2010-4#1)(2012-2#3)
endocytosed##4##1##(1993-8#1)(1994-9#1)(1995-6#1)(2008-1#1)
endocytosis and recycling in single##2##5##(1993-11#2)
endocytosis and recycling in##3##4##(1993-11#3)
endocytosis and recycling##4##3##(1990-11#1)(1993-11#3)
endocytosis and##8##2##(1990-11#2)(1993-11#3)(1993-9#1)(2008-7#1)(2013-1#1)
endocytosis in##2##2##(1993-11#1)(1993-8#1)
endocytosis of##2##2##(1991-6#1)(2008-1#1)
endocytosis##50##1##(1990-11#7)(1991-6#1)(1993-11#5)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#2)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
endoderm and the##2##3##(2008-6#2)
endoderm and##3##2##(2008-6#3)
endoderm in serum-free medium##2##4##(2008-9#2)
endoderm in##3##2##(2008-6#1)(2008-9#2)
endoderm##16##1##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#5)(2008-7#2)(2008-9#4)(2012-1#1)
endodermal cells##3##2##(2008-10#1)(2010-11#2)
endodermal##5##1##(1992-9#1)(2008-10#1)(2008-7#1)(2010-11#2)
endodontic infection##2##2##(2011-2#1)(2013-8#1)
endodontic infections##4##2##(2008-12#3)(2013-8#1)
endodontic retreatment of##2##3##(2012-12#1)(2013-1#1)
endodontic services##2##2##(2012-12#2)
endodontic therapy##3##2##(2012-3#2)(2013-1#1)
endodontic treatment##3##2##(2007-12#1)(2012-3#1)(2013-8#1)
endodontic##28##1##(2007-12#1)(2008-12#3)(2008-7#3)(2009-8#2)(2011-2#1)(2012-12#3)(2012-3#5)(2013-1#7)(2013-8#3)
endodontically treated##4##2##(2008-7#1)(2013-1#3)
endodontically##6##1##(2008-7#1)(2009-8#1)(2013-1#3)(2013-8#1)
endodontist##2##1##(2008-7#1)(2013-1#1)
endogenic##4##1##(1997-5#1)(2009-8#1)(2013-1#2)
endogenous &quot##2##2##(1994-5#1)(2013-7#1)
endogenous ADP##2##2##(2008-7#2)
endogenous DNA damage##3##3##(2008-7#1)(2010-2#2)
endogenous DNA##4##2##(2008-7#1)(2010-2#3)
endogenous Furin##2##2##(2008-11#2)
endogenous IFNalpha is##2##3##(2007-11#2)
endogenous L-type pyruvate kinase##2##4##(1990-8#2)
endogenous MSCs##3##2##(2012-12#3)
endogenous PGE2 synthesis##2##3##(1990-2#2)
endogenous PPARgamma ligand(s)##2##3##(2008-3#2)
endogenous PtdInsP2 and PtdInsP##2##4##(1993-6#2)
endogenous TSPO ligands##2##3##(2012-2#2)
endogenous ammonia##3##2##(1992-11#1)(1995-3#1)(2008-10#1)
endogenous and exogenous##6##3##(1992-5#1)(2008-1#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
endogenous and##7##2##(1992-5#1)(2008-1#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
endogenous anti-oxidants##2##2##(2012-2#2)
endogenous antioxidant activity##2##3##(1996-9#2)
endogenous antioxidant defense##3##3##(1996-9#1)(2008-7#2)
endogenous antioxidant enzymes and##2##4##(2009-12#1)(2013-8#1)
endogenous antioxidant enzymes##3##3##(2009-12#2)(2013-8#1)
endogenous antioxidant##8##2##(1996-9#3)(2008-7#2)(2009-12#2)(2013-8#1)
endogenous antioxidants##3##2##(1991-2#1)(1991-9#1)(1993-2#1)
endogenous calpain##2##2##(2010-11#2)
endogenous cannabinoids##2##2##(1997-8#2)
endogenous cations##2##2##(2008-10#2)
endogenous cell##2##2##(2008-12#1)(2008-7#1)
endogenous cholesterol##4##2##(1991-12#2)(1995-12#2)
endogenous circadian rhythm##2##3##(1997-6#2)
endogenous circadian##3##2##(1990-5#1)(1997-6#2)
endogenous components##3##2##(2008-8#1)(2010-11#2)
endogenous compounds##7##2##(1990-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-2#1)
endogenous concentrations of##2##3##(1991-9#1)(2012-1#1)
endogenous cytokines##5##2##(1996-12#5)
endogenous expression of##2##3##(2008-8#1)(2010-11#1)
endogenous factor##2##2##(1993-6#1)(1994-2#1)
endogenous fecal excretion of Zn##3##5##(2010-2#3)
endogenous fecal excretion of##5##4##(2010-2#5)
endogenous gene expression##2##3##(1995-2#1)(2008-9#1)
endogenous gene##6##2##(1990-5#1)(1991-9#1)(1995-2#1)(2008-2#1)(2008-9#2)
endogenous generation of##2##3##(2008-6#1)(2008-7#1)
endogenous genes and##2##3##(2008-9#1)(2009-3#1)
endogenous genes##7##2##(1995-6#1)(2008-9#5)(2009-3#1)
endogenous glutamate##2##2##(1996-5#1)(1997-6#1)
endogenous growth factors##2##3##(1994-5#1)(2013-1#1)
endogenous growth##3##2##(1994-5#1)(2008-5#1)(2013-1#1)
endogenous inflammatory##2##2##(1996-12#1)(2008-7#1)
endogenous inhibitor##2##2##(1992-6#1)(2009-4#1)
endogenous levels of##6##3##(1990-11#1)(1990-7#1)(1995-2#1)(2012-7#2)(2013-1#1)
endogenous levels##8##2##(1990-11#1)(1990-7#1)(1995-2#2)(2008-10#1)(2012-7#2)(2013-1#1)
endogenous ligand for##3##3##(1996-12#2)(1996-5#1)
endogenous ligand##5##2##(1990-5#1)(1996-12#2)(1996-5#1)(2011-2#1)
endogenous ligands for##4##3##(1994-2#2)(2008-5#1)(2009-9#1)
endogenous ligands##12##2##(1990-5#1)(1994-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-7#2)(2009-9#1)(2012-2#1)
endogenous lipid##2##2##(1994-12#1)(1996-2#1)
endogenous molecules##2##2##(2008-1#1)(2010-8#1)
endogenous mouse##4##2##(1992-11#3)(1996-6#1)
endogenous neuromodulator##2##2##(2008-2#1)(2008-7#1)
endogenous opiates##3##2##(1994-8#1)(1995-12#2)
endogenous opioid peptides##3##3##(1994-9#1)(2008-3#2)
endogenous opioid systems##2##3##(1991-5#1)(2008-11#1)
endogenous opioid##9##2##(1991-5#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-7#1)
endogenous opioids##2##2##(1995-12#1)(1996-5#1)
endogenous or##2##2##(1991-9#1)(2008-4#1)
endogenous oscillators and##2##3##(1994-5#2)
endogenous oscillators##3##2##(1994-5#3)
endogenous peptidases##2##2##(1996-2#2)
endogenous processes and##2##3##(2008-7#2)
endogenous processes##4##2##(2008-7#4)
endogenous protease##3##2##(1991-10#1)(1997-4#1)(2008-11#1)
endogenous protective##3##2##(2008-5#2)(2008-7#1)
endogenous regulatory mechanisms##2##3##(2008-11#2)
endogenous retrovirus##2##2##(2008-11#1)(2010-10#1)
endogenous rhythm##2##2##(1997-6#1)(2010-8#1)
endogenous serum##2##2##(1990-2#1)(2008-3#1)
endogenous small##2##2##(2008-7#1)(2009-8#1)
endogenous sphingosine##2##2##(1994-3#2)
endogenous substances##7##2##(1994-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
endogenous substrate##3##2##(1992-9#1)(1993-6#1)(1995-8#1)
endogenous substrates##7##2##(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(2008-5#1)
endogenous thiols##2##2##(2008-10#2)
endogenous vitamin E##2##3##(1991-2#1)(1995-6#1)
endogenous voltage-gated##2##2##(1994-2#1)(2008-4#1)
endogenous##427##1##(1990-11#2)(1990-12#2)(1990-2#4)(1990-5#7)(1990-7#4)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#5)(1991-5#4)(1991-6#1)(1991-9#4)(1992-11#6)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#8)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#7)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#2)(1994-5#9)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#11)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-10#1)(1996-12#11)(1996-2#5)(1996-5#4)(1996-6#2)(1996-9#3)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#8)(1997-8#5)(2007-11#2)(2007-5#1)(2008-1#4)(2008-10#29)(2008-11#32)(2008-12#2)(2008-2#3)(2008-3#11)(2008-4#8)(2008-5#13)(2008-6#2)(2008-7#25)(2008-8#13)(2008-9#10)(2009-12#4)(2009-3#2)(2009-4#1)(2009-7#3)(2009-8#8)(2009-9#3)(2010-10#1)(2010-11#9)(2010-12#1)(2010-2#8)(2010-8#3)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#4)(2012-7#2)(2013-1#2)(2013-7#3)(2013-8#2)
endogenously associated with##2##3##(1991-12#2)
endogenously expressing##2##2##(1992-11#1)(2008-8#1)
endogenously generated##2##2##(1994-3#1)(1996-8#1)
endogenously released and exogenously added ATP##2##6##(2008-4#2)
endogenously released##5##2##(1992-6#1)(1995-12#1)(1997-1#1)(2008-4#2)
endogenously synthesized##2##2##(1993-9#1)(2008-5#1)
endogenously##28##1##(1991-12#2)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-4#3)(2008-5#2)(2008-8#2)(2009-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
endoglucanase##10##1##(1990-5#1)(1991-9#3)(2008-10#3)(2008-6#2)(2008-9#1)
endoglycosidase##3##1##(1992-3#1)(1993-11#1)(1995-11#1)
endoglycosidases##2##1##(2008-4#2)
endoleak type Ib##2##3##(2011-3#2)
endoleak type##3##2##(2011-3#3)
endoleak##4##1##(2011-3#4)
endoleaks were##3##2##(2007-8#3)
endoleaks##7##1##(2007-8#6)(2010-12#1)
endoluminal sonography##3##2##(1990-9#3)
endoluminal##7##1##(1990-9#3)(1991-11#2)(2011-2#1)(2013-8#1)
endolymph##4##1##(2009-8#2)(2012-2#2)
endolymphatic sac##5##2##(2006-12#4)(2008-9#1)
endolymphatic##7##1##(1994-9#1)(2006-12#4)(2008-8#1)(2008-9#1)
endomembrane##2##1##(1994-8#1)(2009-10#1)
endometria##2##1##(1994-9#1)(1995-11#1)
endometrial ablation##6##2##(1993-1#2)(1996-1#1)(2009-5#1)(2010-9#2)
endometrial adenocarcinoma##6##2##(1994-9#2)(1995-3#1)(2011-2#3)
endometrial adenocarcinomas##2##2##(1994-9#1)(1995-3#1)
endometrial biopsy##5##2##(1991-12#2)(1994-9#1)(2011-2#1)(2012-2#1)
endometrial cancer cell line##2##4##(1993-3#1)(1995-12#1)
endometrial cancer cell##3##3##(1993-3#1)(1995-12#1)(2008-4#1)
endometrial cancer histotypes##2##3##(1994-9#2)
endometrial cancer is##2##3##(1990-10#1)(1991-12#1)
endometrial cancer##30##2##(1990-10#1)(1991-12#3)(1992-12#2)(1993-3#1)(1994-9#11)(1995-12#1)(2008-10#5)(2008-4#1)(2009-2#1)(2011-2#3)(2013-1#1)
endometrial cancer]##4##2##(1996-6#1)(2007-10#1)(2011-1#1)(2013-1#1)
endometrial carcinoma##15##2##(1991-3#1)(1992-2#1)(1993-12#1)(1994-9#3)(1995-3#3)(2008-11#1)(2011-2#4)(2012-1#1)
endometrial carcinomas and##2##3##(2011-2#2)
endometrial carcinomas were##2##3##(1994-9#1)(2011-2#1)
endometrial carcinomas##10##2##(1994-9#1)(2011-2#9)
endometrial cell##2##2##(1994-9#2)
endometrial cells##2##2##(1990-5#1)(2008-9#1)
endometrial cyst##2##2##(1992-3#2)
endometrial epithelial##2##2##(1994-9#1)(2008-3#1)
endometrial epithelium is##2##3##(1994-9#2)
endometrial epithelium##5##2##(1994-9#4)(2013-1#1)
endometrial extension##2##2##(1994-9#2)
endometrial glands##2##2##(2009-8#1)(2011-2#1)
endometrial hemostasis##2##2##(1994-9#2)
endometrial hyperplasia##5##2##(1994-9#4)(2011-2#1)
endometrial laser##2##2##(1994-12#2)
endometrial line##2##2##(1995-3#2)
endometrial opioids##2##2##(1994-9#2)
endometrial receptivity##4##2##(1994-9#1)(2008-9#2)(2012-3#1)
endometrial resection##5##2##(1991-11#1)(1991-8#1)(1996-2#3)
endometrial samples##2##2##(1995-12#2)
endometrial sampling##3##2##(1992-12#1)(2012-2#2)
endometrial stromal##7##2##(1994-9#3)(1995-12#1)(2009-4#1)(2009-5#2)
endometrial thickness##3##2##(1995-3#2)(1996-2#1)
endometrial tissue##4##2##(1994-9#1)(1995-3#3)
endometrial tumor##3##2##(1992-2#2)(1994-9#1)
endometrial##192##1##(1990-10#2)(1990-5#1)(1991-11#1)(1991-12#6)(1991-3#1)(1991-8#1)(1992-12#6)(1992-2#3)(1992-3#2)(1992-4#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-12#2)(1994-9#60)(1995-12#6)(1995-3#15)(1996-1#1)(1996-2#7)(1996-6#1)(2007-10#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#2)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#27)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#1)
endometrioid adenocarcinoma with##2##3##(2011-2#1)(2013-7#1)
endometrioid adenocarcinoma##5##2##(2011-2#2)(2013-7#3)
endometrioid##9##1##(1994-8#1)(1994-9#1)(2011-2#4)(2013-7#3)
endometriomas##5##1##(1992-3#2)(1996-1#3)
endometrioses##2##1##(2011-1#2)
endometriosis and##2##2##(1995-12#1)(2013-1#1)
endometriosis are##2##2##(1994-9#2)
endometriosis cells##3##2##(1995-12#3)
endometriosis in the##2##3##(2010-12#1)(2011-1#1)
endometriosis in##5##2##(1991-3#1)(2010-12#3)(2011-1#1)
endometriosis is a disease##2##4##(1994-9#2)
endometriosis is##5##2##(1992-2#2)(1994-9#3)
endometriosis of the##2##3##(1991-3#1)(2010-12#1)
endometriosis or##2##2##(1991-11#1)(1994-9#1)
endometriosis should be##2##3##(2009-8#1)(2013-1#1)
endometriosis was##2##2##(2010-12#1)(2011-1#1)
endometriosis which##3##2##(1992-5#1)(1994-9#2)
endometriosis##77##1##(1991-11#1)(1991-3#5)(1992-1#2)(1992-2#3)(1992-5#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#21)(1995-12#7)(1995-2#4)(1996-8#1)(2007-8#1)(2009-8#4)(2010-12#8)(2011-1#4)(2012-1#1)(2012-3#1)(2013-1#8)
endometrioticimplants##2##1##(2009-8#2)
endometritis and##2##2##(2012-3#2)
endometritis caused by##2##3##(2012-3#2)
endometritis##8##1##(2011-2#2)(2012-3#6)
endometrium and##6##2##(1990-5#1)(1991-3#2)(1994-9#1)(2012-3#2)
endometrium in the##3##3##(1994-9#2)(1995-11#1)
endometrium in##7##2##(1994-9#4)(1995-11#2)(2008-9#1)
endometrium is##4##2##(1994-9#1)(2011-2#1)(2012-3#2)
endometrium##73##1##(1990-5#1)(1991-12#1)(1991-3#2)(1993-11#1)(1993-9#1)(1994-3#2)(1994-9#24)(1995-11#3)(1995-12#1)(1995-3#3)(1996-2#2)(2008-4#3)(2008-9#2)(2010-12#2)(2011-1#2)(2011-2#13)(2012-2#1)(2012-3#6)(2013-8#3)
endomicroscopy##4##1##(2012-2#4)
endomyocardial biopsy##2##2##(2008-10#2)
endomyocardial fibrosis##4##2##(2007-8#3)(2009-5#1)
endomyocardial##9##1##(2007-8#5)(2008-10#3)(2009-5#1)
endomysium##4##1##(1991-11#1)(2010-2#1)(2013-1#2)
endonasal endoscopic##2##2##(2006-12#1)(2013-1#1)
endonasal surgery##2##2##(2013-1#2)
endonasal##7##1##(2006-12#1)(2011-2#1)(2012-1#2)(2013-1#3)
endonuclease III binding site##2##4##(1995-2#2)
endonuclease III##8##2##(1995-2#8)
endonuclease VII##2##2##(1995-12#2)
endonuclease activity in##2##3##(2008-8#2)
endonuclease activity of##2##3##(1990-7#2)
endonuclease activity##6##2##(1990-7#2)(1995-6#1)(2008-8#3)
endonuclease and##4##2##(1991-7#1)(2008-10#1)(2008-8#2)
endonuclease##49##1##(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-7#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#8)(1995-5#1)(1995-6#2)(1996-12#1)(1997-6#2)(2008-10#2)(2008-5#1)(2008-8#9)(2011-1#1)(2012-3#1)(2013-1#1)
endonucleases##9##1##(1993-9#2)(1994-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-2#1)
endoparasites##2##1##(1997-7#1)(2008-10#1)
endoparasitoid##3##1##(2009-8#1)(2010-2#1)(2010-4#1)
endopeptidase 24##4##2##(1990-5#1)(1992-6#3)
endopeptidase activity##3##2##(1990-2#1)(1990-5#1)(2008-11#1)
endopeptidase domain##2##2##(2009-6#2)
endopeptidase##21##1##(1990-2#1)(1990-5#6)(1991-2#2)(1992-3#1)(1992-6#3)(1995-6#1)(2008-11#3)(2008-5#2)(2009-6#2)
endopeptidases and##2##2##(2008-4#1)(2013-1#1)
endopeptidases##4##1##(2008-11#1)(2008-4#2)(2013-1#1)
endoperoxide##8##1##(1990-5#1)(1992-3#2)(1995-3#3)(1995-5#2)
endophalli##3##1##(2008-5#3)
endophallus##3##1##(2008-5#3)
endophenotypes##4##1##(2010-1#4)
endophthalmitis##9##1##(1991-11#7)(2011-2#2)
endophyte##10##1##(2008-10#9)(2008-8#1)
endophytes and##2##2##(2008-10#1)(2008-8#1)
endophytes are##2##2##(2008-8#1)(2010-6#1)
endophytes from##2##2##(2009-6#1)(2010-6#1)
endophytes were##2##2##(2008-10#2)
endophytes##17##1##(2008-10#3)(2008-8#8)(2009-6#1)(2010-6#5)
endophytic##14##1##(2008-10#12)(2010-6#1)(2011-2#1)
endophytism##3##1##(2010-6#3)
endoplasmic reticulum (ER)##20##3##(1991-11#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
endoplasmic reticulum and Golgi##2##4##(1994-11#1)(2008-5#1)
endoplasmic reticulum and##14##3##(1990-7#1)(1994-11#1)(1995-5#1)(1996-9#1)(2007-12#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#1)
endoplasmic reticulum to##3##3##(1992-3#1)(2008-1#1)(2010-8#1)
endoplasmic reticulum##95##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#2)(2007-12#7)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-5#2)(2008-7#10)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)
endoplasmic reticulum-Golgi system##2##3##(1994-11#2)
endoplasmic reticulum-Golgi##3##2##(1993-8#1)(1994-11#2)
endoplasmic reticulums##2##2##(2008-9#1)(2012-1#1)
endoplasmic##104##1##(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#5)(1994-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#2)(2007-12#8)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)
endopolygalacturonase gene##3##2##(2008-10#3)
endopolygalacturonase##8##1##(2008-10#8)
endoprostheses in##2##2##(1990-8#1)(2007-8#1)
endoprostheses##14##1##(1990-8#1)(1991-3#1)(2007-11#4)(2007-8#2)(2008-6#1)(2010-3#2)(2011-2#3)
endoprosthesis##6##1##(1990-2#1)(1992-4#1)(2007-11#2)(2008-10#1)(2010-3#1)
endoprosthetic replacement##3##2##(2008-6#3)
endoprosthetic##4##1##(2008-6#4)
endoprotease in the##2##3##(1991-9#1)(1997-1#1)
endoprotease##7##1##(1991-9#2)(1995-2#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-7#1)
endoproteinase##2##1##(1990-7#1)(1996-5#1)
endorectal MRI##2##2##(1997-8#2)
endorectal##4##1##(1997-8#2)(2013-1#2)
endoreduplication patterns##4##2##(2008-5#4)
endoreduplication##11##1##(2008-5#10)(2008-7#1)
endorse##2##1##(2007-12#1)(2013-1#1)
endorsed a##2##2##(2009-9#1)(2012-12#1)
endorsed by the##3##3##(1992-2#1)(2008-8#1)(2013-1#1)
endorsed by##6##2##(1991-1#1)(1992-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2013-1#1)
endorsed the##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
endorsed##22##1##(1991-1#1)(1991-12#1)(1992-2#2)(1993-3#1)(1995-1#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-9#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
endorsement of##7##2##(1991-2#1)(1994-12#1)(2008-9#1)(2009-7#2)(2009-9#1)(2013-1#1)
endorsement##8##1##(1991-2#1)(1994-12#1)(2008-10#1)(2008-9#1)(2009-7#2)(2009-9#1)(2013-1#1)
endorsing##4##1##(1993-11#1)(1996-11#1)(2009-11#1)(2013-1#1)
endos##4##1##(2012-3#4)
endos(00003) and##2##2##(2012-3#2)
endos(00003)##3##1##(2012-3#3)
endosalpingiosis##4##1##(2008-11#4)
endoscope are##2##2##(2008-3#2)
endoscope portion##4##2##(2008-5#4)
endoscope##24##1##(1990-11#1)(1990-9#1)(1991-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#6)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
endoscopes##11##1##(2007-11#1)(2008-3#5)(2008-5#1)(2011-1#2)(2011-2#1)(2013-7#1)
endoscopic adrenalectomy##2##2##(2012-12#2)
endoscopic and histological findings##3##4##(1991-3#1)(2008-10#1)(2013-1#1)
endoscopic and histopathological##2##3##(1991-3#1)(2011-2#1)
endoscopic and##9##2##(1991-3#2)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
endoscopic appearance##2##2##(2008-5#1)(2010-12#1)
endoscopic approach##3##2##(1996-3#1)(2011-2#2)
endoscopic balloon dilation##5##3##(2010-12#3)(2011-1#1)(2013-8#1)
endoscopic biopsies##3##2##(1990-10#1)(2009-8#2)
endoscopic coronary artery bypass grafting##2##5##(2007-8#2)
endoscopic cyst-gastrostomy##2##2##(2008-5#2)
endoscopic discectomy##2##2##(2008-12#2)
endoscopic drainage##2##2##(1991-3#1)(2011-1#1)
endoscopic endonasal##2##2##(2012-1#1)(2013-1#1)
endoscopic examination##9##2##(1990-6#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-1#1)(2011-2#1)(2013-1#1)
endoscopic excision##2##2##(1990-10#1)(2008-10#1)
endoscopic findings in##2##3##(2011-2#1)(2012-2#1)
endoscopic findings##8##2##(2008-10#1)(2008-5#3)(2011-2#1)(2012-2#1)(2013-8#2)
endoscopic gastrostomy##2##2##(1992-5#2)
endoscopic hemostasis was##2##3##(2012-2#2)
endoscopic hemostasis##3##2##(2012-2#3)
endoscopic imaging##3##2##(2008-2#2)(2008-3#1)
endoscopic injection##2##2##(2008-10#2)
endoscopic instruments##3##2##(1991-3#1)(1992-12#1)(1995-2#1)
endoscopic laser##4##2##(1992-2#2)(2010-9#1)(2012-2#1)
endoscopic microsurgery (TEM)##2##3##(1992-6#1)(2011-2#1)
endoscopic microsurgery##4##2##(1992-6#2)(2008-4#1)(2011-2#1)
endoscopic mucosal resection##2##3##(2009-4#1)(2013-8#1)
endoscopic operation##2##2##(1994-9#1)(2007-8#1)
endoscopic or##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
endoscopic papillotomy##4##2##(1991-3#2)(1997-8#2)
endoscopic procedure##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
endoscopic procedures##8##2##(1993-2#1)(2008-3#1)(2008-5#1)(2010-8#3)(2010-9#1)(2012-12#1)
endoscopic removal##2##2##(2008-5#1)(2009-7#1)
endoscopic resection of##2##3##(1997-8#1)(2007-7#1)
endoscopic resection##9##2##(1997-8#1)(2007-7#1)(2009-3#1)(2009-7#1)(2010-9#1)(2011-2#3)(2013-1#1)
endoscopic retrograde cholangiopancreatography##2##3##(2007-10#1)(2013-8#1)
endoscopic retrograde##3##2##(2007-10#1)(2007-8#1)(2013-8#1)
endoscopic sinus surgery##3##3##(2012-1#3)
endoscopic sinus##7##2##(2008-9#1)(2012-1#3)(2012-8#1)(2013-1#2)
endoscopic skull base surgery##2##4##(2011-2#2)
endoscopic skull-base surgery##2##3##(2012-1#2)
endoscopic sphincterotomy##6##2##(1990-2#1)(2007-8#3)(2008-5#2)
endoscopic stenting##2##2##(2012-2#2)
endoscopic stigmata of bleeding##2##4##(2007-8#2)
endoscopic submucosal dissection for##2##4##(2009-3#1)(2013-1#1)
endoscopic submucosal dissection##6##3##(2009-3#2)(2012-2#1)(2013-1#2)(2013-8#1)
endoscopic surgery is##2##3##(1993-3#1)(2006-12#1)
endoscopic surgery##8##2##(1991-3#1)(1993-3#1)(1994-9#1)(2006-12#1)(2007-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
endoscopic surgical procedures##2##3##(1994-3#1)(2008-3#1)
endoscopic surgical##3##2##(1994-3#2)(2008-3#1)
endoscopic system##4##2##(2010-8#1)(2011-2#3)
endoscopic technique##2##2##(2008-11#1)(2008-3#1)
endoscopic techniques##2##2##(2008-7#1)(2010-9#1)
endoscopic therapy for##2##3##(2010-12#1)(2012-2#1)
endoscopic therapy##7##2##(1990-9#1)(2008-4#1)(2009-4#1)(2010-12#2)(2012-2#2)
endoscopic transpapillary##3##2##(1990-3#2)(2013-1#1)
endoscopic transsphenoidal approach##5##3##(2011-2#5)
endoscopic treatment of##3##3##(1991-11#1)(1993-6#1)(2008-5#1)
endoscopic treatment was##2##3##(1990-9#1)(1993-6#1)
endoscopic treatment##14##2##(1990-9#1)(1991-11#1)(1993-2#1)(1993-6#2)(2008-10#3)(2008-5#1)(2012-2#2)(2013-1#3)
endoscopic ultrasonography (EUS)##2##3##(2008-2#1)(2013-1#1)
endoscopic ultrasonography##5##2##(1992-7#1)(1992-9#1)(2008-2#1)(2010-9#1)(2013-1#1)
endoscopic ultrasound (EUS)##2##3##(2008-2#1)(2010-12#1)
endoscopic ultrasound##6##2##(2008-2#1)(2009-8#1)(2010-12#1)(2013-1#3)
endoscopic##289##1##(1990-10#2)(1990-2#1)(1990-3#2)(1990-6#3)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#9)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1994-3#2)(1994-9#2)(1995-10#1)(1995-2#1)(1996-3#1)(1997-1#2)(1997-8#4)(2006-12#5)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#17)(2008-10#14)(2008-11#2)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#23)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#6)(2010-12#10)(2010-8#6)(2010-9#5)(2011-1#3)(2011-2#31)(2012-1#10)(2012-12#4)(2012-2#13)(2012-3#2)(2012-8#1)(2013-1#29)(2013-8#11)
endoscopically after##2##2##(1996-6#1)(2011-2#1)
endoscopically between##2##2##(1990-3#1)(2006-12#1)
endoscopically##24##1##(1990-3#1)(1990-8#1)(1992-11#1)(1993-9#1)(1994-2#1)(1996-6#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-12#4)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)
endoscopist##2##1##(2010-12#1)(2011-2#1)
endoscopy and##5##2##(1990-2#1)(2008-1#1)(2011-2#1)(2012-2#2)
endoscopy clinic##2##2##(1991-8#2)
endoscopy in the diagnosis of##2##5##(1997-8#1)(2007-2#1)
endoscopy in the##3##3##(1997-8#1)(2007-2#1)(2011-2#1)
endoscopy in##7##2##(1992-9#1)(1997-8#1)(2007-2#1)(2009-8#1)(2010-12#1)(2011-2#2)
endoscopy is##2##2##(1995-10#1)(2011-2#1)
endoscopy of the##2##3##(1990-6#1)(1993-6#1)
endoscopy showed##3##2##(1992-5#1)(2008-5#1)(2011-2#1)
endoscopy time##2##2##(1990-11#2)
endoscopy was##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
endoscopy with biopsy##2##3##(1990-11#1)(2012-1#1)
endoscopy with##4##2##(1990-11#1)(2007-11#1)(2012-1#1)(2013-8#1)
endoscopy##99##1##(1990-10#1)(1990-11#4)(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#2)(1991-8#2)(1992-11#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-10#3)(1996-3#1)(1997-8#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#7)(2008-7#1)(2009-10#1)(2009-8#3)(2010-12#6)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#19)(2012-1#1)(2012-2#6)(2013-1#2)(2013-8#2)
endoscopy]##2##1##(1990-2#1)(1992-4#1)
endosepsis in##3##2##(2008-10#3)
endosepsis##7##1##(2008-10#7)
endoskeletal structures##3##2##(2007-12#3)
endoskeletal##4##1##(2007-12#4)
endosomal membranes##2##2##(1995-6#1)(2009-8#1)
endosomal##8##1##(1995-6#3)(2008-1#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-8#1)
endosomal-lysosomal##2##1##(1992-12#1)(2008-5#1)
endosome##8##1##(1992-6#1)(1994-5#1)(1995-2#1)(2008-1#1)(2008-11#1)(2009-2#1)(2009-8#2)
endosomes by##2##2##(1995-6#2)
endosomes##23##1##(1990-11#1)(1992-6#3)(1995-11#1)(1995-5#1)(1995-6#6)(2008-1#2)(2008-4#2)(2009-10#3)(2009-2#4)
endosonography##4##1##(1994-3#3)(1995-3#1)
endosperm cell wall##2##3##(1995-6#2)
endosperm formation in Tulipa spp##2##5##(2009-12#2)
endosperm formation in##3##3##(2009-12#3)
endosperm formation##5##2##(2009-12#5)
endosperm is##2##2##(1991-11#1)(2008-5#1)
endosperm of##3##2##(1991-11#1)(2008-5#2)
endosperm proteins##2##2##(1995-3#1)(2008-10#1)
endosperm tissue##4##2##(1995-6#1)(2008-10#1)(2008-5#2)
endosperm##37##1##(1991-11#3)(1994-8#2)(1995-3#1)(1995-6#3)(2008-10#6)(2008-5#6)(2008-9#8)(2009-10#1)(2009-12#7)
endosperms##8##1##(2008-10#1)(2008-5#3)(2009-12#4)
endospore formation##3##2##(2008-10#2)(2011-2#1)
endospore##5##1##(1990-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
endospore-forming bacteria##7##2##(2008-10#7)
endospore-forming##8##1##(2008-10#7)(2011-2#1)
endospores##5##1##(2008-2#2)(2008-3#1)(2011-2#2)
endosseous##2##1##(2007-12#1)(2011-7#1)
endosteal##2##1##(1993-8#1)(2007-11#1)
endosulfan sulfate##2##2##(2008-10#2)
endosulfan##6##1##(2008-10#3)(2008-12#3)
endosymbiont##7##1##(1996-12#3)(2009-6#1)(2011-2#1)(2012-3#2)
endosymbionts##8##1##(1996-12#2)(2007-12#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-3#1)
endosymbiosis##3##1##(2009-8#1)(2011-2#1)(2012-2#1)
endosymbiotic##3##1##(2009-6#1)(2009-8#2)
endothel cells##2##2##(1992-5#2)
endothelia##2##1##(1995-2#1)(2008-9#1)
endothelial KATP##4##2##(2008-5#4)
endothelial NO synthase##3##3##(1995-11#2)(2010-4#1)
endothelial NOS (eNOS)##2##3##(2008-8#1)(2009-10#1)
endothelial activation##2##2##(2008-1#1)(2010-12#1)
endothelial and##6##2##(1993-6#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-11#1)
endothelial cell (EC)##2##3##(2012-3#1)(2012-4#1)
endothelial cell adhesion##4##3##(2009-11#4)
endothelial cell and##2##3##(1993-3#1)(2011-2#1)
endothelial cell binding##2##3##(1993-6#2)
endothelial cell count##2##3##(2011-2#2)
endothelial cell damage##3##3##(1996-12#1)(1996-9#1)(2007-10#1)
endothelial cell density##2##3##(2011-2#2)
endothelial cell differentiation##2##3##(2008-6#1)(2013-1#1)
endothelial cell growth factor##3##4##(1991-2#1)(1992-9#2)
endothelial cell growth##5##3##(1990-4#1)(1991-2#1)(1992-9#2)(2009-11#1)
endothelial cell killing##3##3##(1991-9#3)
endothelial cell line##2##3##(1995-11#1)(2008-10#1)
endothelial cell loss##3##3##(2011-2#3)
endothelial cell monolayers##3##3##(2008-1#1)(2008-10#2)
endothelial cell surfaces##2##3##(1995-2#2)
endothelial cell types##2##3##(1991-2#1)(1993-3#1)
endothelial cell##74##2##(1990-2#1)(1990-4#4)(1991-2#4)(1991-5#1)(1991-9#5)(1992-9#3)(1993-2#1)(1993-3#4)(1993-6#5)(1993-8#1)(1994-5#1)(1995-11#2)(1995-2#4)(1996-12#1)(1996-9#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2009-11#5)(2009-2#1)(2009-7#1)(2010-11#1)(2010-9#2)(2011-2#8)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
endothelial cells (EC)##3##3##(1990-12#1)(1990-2#1)(2008-1#1)
endothelial cells (ECs)##3##3##(1994-6#1)(2008-11#1)(2012-12#1)
endothelial cells (HUVEC)##9##3##(1993-11#1)(1994-8#1)(1997-1#1)(2008-8#2)(2008-9#2)(2010-3#1)(2012-2#1)
endothelial cells also##2##3##(1992-12#1)(2013-7#1)
endothelial cells and the##4##4##(1991-2#1)(1991-5#1)(1992-9#1)(2013-8#1)
endothelial cells and##18##3##(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#2)(1994-9#1)(1995-12#2)(1996-12#1)(2008-8#3)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
endothelial cells are##5##3##(1991-5#1)(1991-9#1)(2008-3#1)(2011-2#2)
endothelial cells at##2##3##(2008-12#1)(2012-12#1)
endothelial cells but##2##3##(1991-2#1)(1993-3#1)
endothelial cells by##9##3##(1991-12#1)(1991-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-8#1)(2008-9#1)(2010-1#1)
endothelial cells can be##3##4##(2008-9#3)
endothelial cells can##5##3##(1993-3#1)(2008-9#4)
endothelial cells for##2##3##(1996-12#1)(2008-11#1)
endothelial cells from the##2##4##(1991-9#1)(1993-6#1)
endothelial cells from##5##3##(1991-9#1)(1993-6#1)(1994-6#1)(2008-5#1)(2013-8#1)
endothelial cells in a##2##4##(1995-12#2)
endothelial cells in situ##3##4##(1991-12#3)
endothelial cells in the##2##4##(2010-6#1)(2012-2#1)
endothelial cells in##15##3##(1991-12#3)(1995-12#2)(1996-12#1)(1996-5#1)(1997-1#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#2)
endothelial cells is##7##3##(1991-9#1)(1993-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(2008-8#1)
endothelial cells isolated from##4##4##(1992-2#1)(1993-3#2)(2013-1#1)
endothelial cells may##3##3##(1991-5#1)(1993-6#1)(1995-12#1)
endothelial cells of the##3##4##(2007-12#1)(2012-2#1)(2013-8#1)
endothelial cells of##6##3##(1993-3#1)(2007-12#1)(2012-2#1)(2013-8#3)
endothelial cells only##2##3##(1993-6#1)(1997-1#1)
endothelial cells secrete##2##3##(1994-11#1)(2013-8#1)
endothelial cells that were incubated with VLDL##2##7##(1992-12#2)
endothelial cells that##5##3##(1990-2#2)(1992-12#2)(2008-4#1)
endothelial cells to##9##3##(1993-3#2)(1993-6#1)(1995-12#2)(2008-11#1)(2010-1#1)(2010-9#1)(2011-2#1)
endothelial cells was##7##3##(1990-2#1)(1991-2#1)(1992-12#2)(1993-12#1)(1994-11#1)(1997-7#1)
endothelial cells were##4##3##(1991-5#1)(1993-8#1)(2008-11#1)(2008-8#1)
endothelial cells with##6##3##(1990-5#1)(1991-9#1)(1994-11#1)(1994-8#1)(2009-5#1)(2010-9#1)
endothelial cells##273##2##(1990-12#4)(1990-2#9)(1990-5#3)(1991-12#7)(1991-2#5)(1991-5#9)(1991-9#13)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-3#16)(1993-6#7)(1993-8#3)(1993-9#1)(1994-11#6)(1994-5#3)(1994-6#6)(1994-8#3)(1994-9#6)(1995-11#4)(1995-12#10)(1996-12#5)(1996-5#1)(1997-1#6)(1997-7#3)(2007-12#1)(2008-1#5)(2008-10#4)(2008-11#17)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#10)(2009-10#1)(2009-3#3)(2009-5#2)(2009-7#2)(2010-1#7)(2010-11#2)(2010-3#1)(2010-6#2)(2010-9#2)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#8)
endothelial cells]##2##2##(2013-1#1)(2013-8#1)
endothelial damage##3##2##(2007-10#1)(2007-8#1)(2008-4#1)
endothelial dysfunction and##2##3##(2008-11#1)(2010-10#1)
endothelial dysfunction in##5##3##(2009-5#2)(2010-10#1)(2013-8#2)
endothelial dysfunction plays a key role in the##2##8##(2008-11#1)(2012-3#1)
endothelial dysfunction plays##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
endothelial dysfunction##28##2##(2007-8#2)(2008-1#4)(2008-11#4)(2008-3#4)(2008-4#2)(2008-7#1)(2009-10#1)(2009-5#2)(2010-10#4)(2011-2#1)(2012-3#1)(2013-8#2)
endothelial function and##2##3##(2008-7#1)(2012-12#1)
endothelial function by##2##3##(2012-3#2)
endothelial function##14##2##(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-8#2)
endothelial growth factor (VEGF)##24##4##(1992-3#1)(1994-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
endothelial growth factor and##3##4##(2008-9#1)(2009-5#1)(2012-1#1)
endothelial growth factor##40##3##(1992-3#2)(1994-11#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
endothelial growth factor/vascular permeability factor##2##5##(1994-3#2)
endothelial growth##45##2##(1991-9#1)(1992-3#2)(1994-11#1)(1994-3#2)(1997-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
endothelial health##3##2##(2011-2#1)(2012-3#2)
endothelial mitogens##2##2##(1992-3#1)(1997-7#1)
endothelial monolayers##2##2##(1996-2#1)(2008-10#1)
endothelial nitric oxide synthase gene##2##5##(2008-12#1)(2008-7#1)
endothelial nitric oxide synthase##3##4##(1997-3#1)(2008-12#1)(2008-7#1)
endothelial permeability##2##2##(1997-8#1)(2010-12#1)
endothelial progenitor cell for##2##4##(2012-12#1)(2013-1#1)
endothelial progenitor cells (EPCs)##3##4##(2009-11#1)(2012-12#2)
endothelial progenitor cells and##2##4##(2008-9#1)(2010-6#1)
endothelial progenitor cells##10##3##(2008-9#2)(2009-11#1)(2010-1#2)(2010-6#2)(2012-12#2)(2012-3#1)
endothelial progenitor##12##2##(2008-9#2)(2009-11#1)(2010-1#2)(2010-6#2)(2012-12#3)(2012-3#1)(2013-1#1)
endothelial proliferation##2##2##(1992-3#1)(1997-7#1)
endothelial##524##1##(1990-11#1)(1990-12#4)(1990-2#10)(1990-4#4)(1990-5#4)(1991-12#7)(1991-2#9)(1991-5#10)(1991-9#20)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#5)(1992-6#1)(1992-9#6)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#21)(1993-6#14)(1993-8#4)(1993-9#2)(1994-11#7)(1994-3#2)(1994-5#6)(1994-6#6)(1994-8#3)(1994-9#6)(1995-11#9)(1995-12#10)(1995-2#7)(1996-12#7)(1996-2#5)(1996-5#1)(1996-9#1)(1997-1#8)(1997-3#1)(1997-7#8)(1997-8#2)(2006-6#1)(2007-10#2)(2007-12#1)(2007-8#5)(2008-1#15)(2008-10#12)(2008-11#30)(2008-12#4)(2008-3#8)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#16)(2008-9#20)(2009-10#3)(2009-11#7)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#7)(2009-7#4)(2009-8#1)(2010-1#10)(2010-10#5)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#4)(2010-7#1)(2010-9#4)(2011-1#2)(2011-2#24)(2011-3#1)(2012-1#5)(2012-12#14)(2012-2#9)(2012-3#9)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#15)
endothelin (ET)##3##2##(1990-12#1)(1990-2#2)
endothelin 1##4##2##(1993-3#4)
endothelin ETA receptors##2##3##(1995-12#2)
endothelin antagonist##2##2##(1992-4#2)
endothelin during##2##2##(1994-11#1)(2008-5#1)
endothelin family##3##2##(1990-2#1)(1992-12#2)
endothelin levels##2##2##(1994-11#1)(2008-1#1)
endothelin receptor antagonist##2##3##(1994-11#1)(1995-12#1)
endothelin receptor##10##2##(1990-2#4)(1993-3#3)(1994-11#1)(1995-12#1)(2010-6#1)
endothelin receptors##3##2##(1994-11#2)(1997-4#1)
endothelin to##2##2##(1990-2#1)(1995-12#1)
endothelin##63##1##(1990-12#1)(1990-2#11)(1990-8#1)(1992-12#3)(1992-3#1)(1992-4#2)(1993-3#7)(1993-6#1)(1994-11#15)(1994-9#2)(1995-12#9)(1997-4#1)(2008-1#6)(2008-11#1)(2008-5#1)(2010-6#1)
endothelin-1 (100 nM) activated##2##4##(1995-12#2)
endothelin-1 (ET-1)##4##2##(1991-11#1)(1991-5#1)(1993-8#1)(1994-8#1)
endothelin-1 and -3##2##3##(1991-12#2)
endothelin-1 and##5##2##(1990-2#1)(1990-5#1)(1991-12#2)(1995-12#1)
endothelin-1 in the##2##3##(1993-3#1)(1995-11#1)
endothelin-1 in##3##2##(1991-8#1)(1993-3#1)(1995-11#1)
endothelin-1 is##2##2##(1990-8#2)
endothelin-1 was##3##2##(1990-5#2)(1995-12#1)
endothelin-1 were##2##2##(1990-8#1)(1991-12#1)
endothelin-1##53##1##(1990-12#2)(1990-2#2)(1990-5#5)(1990-8#6)(1991-11#2)(1991-12#4)(1991-5#1)(1991-8#2)(1992-3#7)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#13)(2006-7#1)(2008-1#1)(2010-5#1)
endothelin-3##5##1##(1991-12#2)(1994-12#2)(1994-3#1)
endothelin-A##2##1##(1994-12#1)(1996-6#1)
endothelin-B receptor gene##3##3##(1994-12#3)
endothelin-B receptor is essential##2##4##(1994-12#2)
endothelin-B receptor##7##2##(1994-12#7)
endothelin-B##8##1##(1994-12#8)
endothelin-receptor antagonist##2##2##(2009-10#1)(2010-10#1)
endothelium and##9##2##(1992-12#1)(1993-8#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-3#1)(2012-3#2)
endothelium but##2##2##(2010-11#1)(2012-12#1)
endothelium dependent##3##2##(1990-12#1)(1991-9#2)
endothelium in##4##2##(1992-9#1)(1996-9#1)(2008-9#1)(2011-2#1)
endothelium of##5##2##(1994-5#1)(2012-1#1)(2012-3#3)
endothelium or##2##2##(1995-12#1)(2008-7#1)
endothelium to##2##2##(1994-8#1)(2012-2#1)
endothelium##66##1##(1990-12#2)(1991-5#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-9#2)(1993-8#2)(1994-11#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#6)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-8#1)
endothelium-denuded##3##1##(1990-12#2)(1997-6#1)
endothelium-dependent relaxation##7##2##(1995-12#2)(1996-2#1)(2007-8#4)
endothelium-dependent relaxations##2##2##(1995-12#1)(2010-10#1)
endothelium-dependent##19##1##(1994-11#1)(1995-12#4)(1996-2#1)(1997-6#1)(2007-8#5)(2009-12#1)(2010-10#4)(2012-12#1)(2013-8#1)
endothelium-derived relaxing factor (EDRF)##2##4##(1991-9#2)
endothelium-derived relaxing factor##3##3##(1990-12#1)(1991-9#2)
endothelium-derived relaxing factors##2##3##(1991-12#1)(1993-3#1)
endothelium-derived relaxing##5##2##(1990-12#1)(1991-12#1)(1991-9#2)(1993-3#1)
endothelium-derived##10##1##(1990-12#1)(1991-12#1)(1991-6#1)(1991-9#2)(1993-3#1)(1994-11#1)(2007-10#1)(2010-11#1)(2010-5#1)
endothelium-independent##2##1##(1995-12#1)(1997-6#1)
endothelium-intact##4##1##(1990-12#2)(1993-8#2)
endothelium-mediated##2##1##(2008-8#1)(2013-8#1)
endotherm at##2##2##(1994-3#2)
endotherm##3##1##(1994-3#3)
endothermic transitions##2##2##(1990-7#2)
endothermic##3##1##(1990-7#2)(1995-5#1)
endothiapepsin##2##1##(1995-6#2)
endotoxemia in the##2##3##(1993-6#1)(2008-4#1)
endotoxemia##10##1##(1993-6#2)(1995-12#2)(1995-2#1)(2006-10#1)(2008-12#1)(2008-4#3)
endotoxin administration##2##2##(1991-9#1)(1996-12#1)
endotoxin and##3##2##(1991-3#1)(1995-2#1)(1996-12#1)
endotoxin in##2##2##(1994-7#1)(2008-5#1)
endotoxin levels##3##2##(1994-7#1)(2008-10#2)
endotoxin##36##1##(1990-12#4)(1991-3#1)(1991-9#2)(1992-3#1)(1994-3#1)(1994-7#7)(1995-2#2)(1996-12#9)(1996-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#1)
endotoxin-induced##3##1##(1994-8#1)(1996-12#2)
endotoxins##7##1##(1993-11#1)(1994-3#2)(2008-11#2)(2013-1#2)
endotracheal intubation##7##2##(1990-2#1)(2007-5#2)(2008-1#2)(2013-1#2)
endotracheal tube##7##2##(1996-3#1)(1996-9#1)(2007-11#1)(2008-8#2)(2010-7#1)(2012-12#1)
endotracheal##21##1##(1990-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(2007-11#2)(2007-5#2)(2008-1#2)(2008-8#2)(2009-3#1)(2010-10#4)(2010-7#1)(2012-12#1)(2013-1#2)
endovaginal ultrasound in the##2##4##(2009-6#2)
endovaginal ultrasound##3##2##(2009-6#3)
endovascular abdominal##3##2##(2010-12#1)(2011-3#1)(2012-1#1)
endovascular and##3##2##(2008-7#1)(2011-3#1)(2012-3#1)
endovascular aneurysm repair##2##3##(2007-8#1)(2013-1#1)
endovascular aortic aneurysm repair##2##4##(2012-2#2)
endovascular cooling##2##2##(2007-10#2)
endovascular embolization##6##2##(2006-12#1)(2008-12#1)(2008-7#2)(2012-1#2)
endovascular intervention##2##2##(2008-8#2)
endovascular management of##2##3##(2009-9#1)(2010-12#1)
endovascular management##3##2##(2009-9#1)(2010-12#1)(2011-2#1)
endovascular procedure##5##2##(1996-6#1)(2008-7#2)(2011-2#1)(2013-8#1)
endovascular procedures on the external carotid arteries##2##7##(1996-9#2)
endovascular procedures##8##2##(1996-6#1)(1996-9#3)(1997-6#1)(2007-8#1)(2008-7#1)(2011-2#1)
endovascular repair##2##2##(2010-12#1)(2010-8#1)
endovascular stent##4##2##(2008-11#2)(2012-2#2)
endovascular stent-graft##2##2##(2008-11#1)(2011-2#1)
endovascular surgery##4##2##(1995-11#1)(1996-9#1)(2008-7#1)(2012-3#1)
endovascular techniques##3##2##(1995-11#1)(1997-2#1)(2011-3#1)
endovascular therapy##4##2##(2008-12#1)(2008-7#1)(2010-8#2)
endovascular treatment of##4##3##(1996-9#1)(1997-3#1)(2008-10#1)(2011-3#1)
endovascular treatment##12##2##(1995-11#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#1)(2008-10#1)(2011-3#1)(2013-1#1)
endovascular##100##1##(1991-3#1)(1994-9#1)(1995-11#7)(1996-3#2)(1996-6#4)(1996-9#6)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#4)(2006-12#2)(2007-10#4)(2007-8#3)(2008-10#2)(2008-11#6)(2008-12#3)(2008-7#9)(2008-8#3)(2009-9#1)(2010-12#4)(2010-8#3)(2011-1#1)(2011-2#7)(2011-3#5)(2012-1#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
endowed with a rich##2##4##(2007-12#1)(2008-7#1)
endowed with a##5##3##(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
endowed with the ability to##2##5##(2008-4#2)
endowed with##13##2##(1990-3#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
endowment##2##1##(1993-3#1)(2008-5#1)
endowments##2##1##(2007-7#1)(2009-5#1)
endplate##4##1##(1995-12#1)(1997-5#1)(2008-4#2)
endpoint and##2##2##(2008-8#2)
endpoint is the##2##3##(2008-5#2)
endpoint is##6##2##(1992-9#2)(2008-5#3)(2008-7#1)
endpoint of neoplastic transformation in vitro##2##6##(2008-7#2)
endpoint of##10##2##(1997-4#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2010-4#1)
endpoint to##3##2##(1994-9#1)(2008-7#1)(2012-3#1)
endpoint was to##2##3##(2008-10#2)
endpoint was##6##2##(2008-10#3)(2008-7#1)(2010-12#1)(2010-8#1)
endpoint##53##1##(1992-12#1)(1992-9#6)(1994-9#1)(1996-12#1)(1997-3#1)(1997-4#2)(2006-10#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#4)(2008-7#12)(2008-8#3)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#3)
endpoint)##3##1##(2008-7#3)
endpoints and##3##2##(1992-9#1)(2008-7#1)(2013-1#1)
endpoints are##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
endpoints for the##3##3##(2007-11#1)(2008-11#2)
endpoints for##6##2##(2007-11#1)(2008-11#2)(2008-7#2)(2011-2#1)
endpoints in##4##2##(1994-9#1)(1997-4#1)(2008-11#1)(2008-8#1)
endpoints is##2##2##(2008-12#1)(2011-2#1)
endpoints of##2##2##(2011-2#1)(2012-1#1)
endpoints to##2##2##(2008-11#1)(2009-11#1)
endpoints were the##2##3##(2008-1#1)(2010-8#1)
endpoints were##8##2##(1994-9#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-4#1)(2010-8#1)
endpoints##60##1##(1992-10#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-8#1)(1996-2#2)(1997-4#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-5#4)(2008-7#7)(2008-8#3)(2009-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-1#1)(2013-1#4)
ends and##6##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)
ends are##2##2##(2008-2#1)(2008-4#1)
ends at##3##2##(1994-3#1)(2007-12#1)(2008-6#1)
ends in the##2##3##(1992-9#1)(1996-3#1)
ends in##3##2##(1992-9#1)(1996-3#1)(2008-7#1)
ends meet##2##2##(2010-6#2)
ends of the##21##3##(1993-12#1)(1993-3#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-2#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-2#1)
ends of##46##2##(1993-11#2)(1993-12#2)(1993-3#1)(1994-12#4)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#3)(2009-2#1)(2012-2#1)(2013-1#1)
ends on##3##2##(2008-2#2)(2008-8#1)
ends since##2##2##(1997-4#1)(2008-11#1)
ends to##3##2##(2008-4#2)(2008-9#1)
ends up in##2##3##(1992-3#1)(1995-11#1)
ends up##3##2##(1992-3#1)(1993-12#1)(1995-11#1)
ends with a##3##3##(2008-3#1)(2008-9#1)(2009-12#1)
ends with an##2##3##(2007-7#1)(2008-3#1)
ends with the##2##3##(2008-11#1)(2010-10#1)
ends with##11##2##(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)
ends##151##1##(1990-4#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#4)(1994-12#4)(1994-3#3)(1994-8#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#5)(2006-10#1)(2006-6#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-2#7)(2008-3#5)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
ends)##2##1##(1994-12#1)(2008-10#1)
endurance athletes##2##2##(2008-5#1)(2010-1#1)
endurance capacity##5##2##(1991-8#2)(2011-1#2)(2013-8#1)
endurance exercise##5##2##(2008-7#1)(2012-3#2)(2013-1#2)
endurance of bones##2##3##(2007-8#2)
endurance of##3##2##(2007-8#3)
endurance training (n = 30)##2##5##(2013-8#2)
endurance training##8##2##(2008-4#1)(2010-12#1)(2013-1#4)(2013-8#2)
endurance##39##1##(1991-8#2)(2007-8#5)(2008-12#2)(2008-4#1)(2008-5#5)(2008-7#1)(2010-1#3)(2010-12#3)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#7)(2013-8#3)
endure##2##1##(1994-12#1)(2008-8#1)
endured##5##1##(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2012-3#1)
enduring##13##1##(1992-2#1)(1994-1#1)(1995-5#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
enediolate##2##1##(2008-10#2)
enediyne antitumor##2##2##(2008-9#2)
enema showed##2##2##(2007-12#1)(2012-12#1)
enema##15##1##(1993-9#4)(1997-5#1)(1997-8#1)(2007-12#1)(2010-12#3)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
enemies##14##1##(1990-11#1)(2008-12#1)(2008-5#1)(2008-8#8)(2008-9#2)(2009-8#1)
enemy of##2##2##(2008-4#1)(2013-8#1)
enemy##6##1##(1997-3#1)(1997-4#1)(2008-4#1)(2008-8#2)(2013-8#1)
energetic and##2##2##(2008-10#1)(2008-7#1)
energetic costs of##2##3##(2008-9#2)
energetic costs##5##2##(2008-9#4)(2010-8#1)
energetic efficiency##4##2##(1993-8#1)(2008-7#2)(2009-12#1)
energetic level##3##2##(2008-8#3)
energetic materials##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
energetic metabolism##3##2##(2011-1#1)(2012-3#2)
energetic requirements##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
energetic state##4##2##(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)
energetic##61##1##(1990-8#1)(1993-8#1)(1994-11#1)(1994-3#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#12)(2009-12#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#3)
energetically costly##2##2##(2008-9#1)(2010-8#1)
energetically favorable##2##2##(1992-11#1)(2008-10#1)
energetically##12##1##(1992-11#1)(1992-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#2)
energetics in##3##2##(2010-8#3)
energetics of##6##2##(1990-8#1)(1997-2#2)(2008-10#1)(2010-12#1)(2011-1#1)
energetics##18##1##(1990-8#2)(1992-3#1)(1994-8#1)(1996-7#1)(1996-9#1)(1997-2#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-8#4)(2011-1#1)
energies and##7##2##(1991-6#1)(1996-5#1)(2008-1#1)(2008-10#1)(2010-2#3)
energies are##4##2##(1996-2#1)(2008-10#1)(2008-3#1)(2010-2#1)
energies as high as##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
energies as##8##2##(1997-2#1)(2007-11#3)(2007-12#3)(2008-3#1)
energies at##3##2##(2007-12#1)(2008-3#2)
energies below the##2##3##(2008-2#1)(2012-2#1)
energies below##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
energies for##4##2##(2007-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
energies in a##2##3##(2007-12#1)(2008-3#1)
energies in##7##2##(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)
energies of 1##2##3##(1996-7#1)(2008-3#1)
energies of 6##2##3##(1997-2#1)(2008-3#1)
energies of the##3##3##(1997-7#1)(2009-9#1)(2010-7#1)
energies of##36##2##(1990-8#6)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-7#1)(2012-12#2)(2013-1#1)
energies on the##2##3##(1993-12#1)(2007-12#1)
energies ranging##2##2##(2008-3#2)
energies than##2##2##(1996-7#1)(2007-11#1)
energies that##2##2##(1995-6#1)(2010-7#1)
energies were##2##2##(2007-12#1)(2013-1#1)
energies##127##1##(1990-8#7)(1991-5#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1995-6#2)(1996-2#2)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#4)(1997-7#1)(2007-10#1)(2007-11#8)(2007-12#17)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#10)(2008-3#23)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#2)(2010-2#8)(2010-4#3)(2010-7#3)(2011-1#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
energizing##2##1##(1991-1#1)(2007-2#1)
energy absorption and##3##3##(2008-1#2)(2011-2#1)
energy absorption by the##2##4##(2008-1#1)(2010-3#1)
energy absorption##6##2##(2008-1#3)(2010-3#2)(2011-2#1)
energy allocation##3##2##(2008-8#3)
energy and an##2##3##(2008-2#1)(2008-3#1)
energy and chemical reactivity##2##4##(2008-8#2)
energy and materials##2##3##(2008-9#2)
energy and phosphate##2##3##(1994-11#2)
energy and protein intakes##3##4##(2013-1#3)
energy and protein##5##3##(1991-12#1)(2013-1#4)
energy and the##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
energy and##57##2##(1991-12#1)(1992-12#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(2007-11#5)(2007-12#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
energy are##6##2##(1990-2#1)(1990-8#1)(2007-11#2)(2008-2#1)(2008-6#1)
energy at a##2##3##(1996-4#1)(2008-2#1)
energy at the##2##3##(1993-5#1)(2007-12#1)
energy at##11##2##(1993-5#1)(1996-4#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2012-2#1)
energy availability##2##2##(2008-8#1)(2010-1#1)
energy balance and##3##3##(2008-1#1)(2008-4#2)
energy balance##13##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2013-8#1)
energy barriers##4##2##(1990-3#2)(2008-4#1)(2011-1#1)
energy between the##2##3##(2009-11#1)(2009-5#1)
energy between##3##2##(2009-11#1)(2009-5#1)(2013-1#1)
energy budget##5##2##(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)
energy by##6##2##(1996-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)
energy can##2##2##(2008-4#1)(2009-7#1)
energy change##4##2##(2007-11#2)(2008-10#1)(2010-7#1)
energy charge##4##2##(1993-12#1)(1996-6#1)(2008-11#1)(2013-1#1)
energy coding##4##2##(2008-11#4)
energy compounds##2##2##(2007-10#2)
energy conformations##2##2##(1995-11#1)(2008-10#1)
energy conservation##8##2##(2007-11#1)(2008-2#2)(2010-8#1)(2012-2#4)
energy consumption##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
energy contained within##2##3##(2008-2#1)(2008-3#1)
energy content##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
energy contribution##5##2##(2008-4#1)(2013-1#2)(2013-8#2)
energy conversion efficiency##2##3##(2008-3#2)
energy conversion##6##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-3#2)
energy delivered by the##2##4##(2007-12#1)(2013-1#1)
energy delivered by##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
energy delivered##6##2##(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#3)
energy demand##5##2##(1992-9#1)(1994-5#1)(2008-11#1)(2013-1#2)
energy density at the geometrical focus and##2##7##(2008-3#2)
energy density at the##4##4##(2007-11#1)(2008-3#3)
energy density of##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
energy density##16##2##(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#7)(2008-5#1)
energy depletion##2##2##(2008-5#1)(2008-8#1)
energy deposition##3##2##(1994-3#1)(2008-7#1)(2013-1#1)
energy difference##2##2##(2008-3#1)(2010-7#1)
energy diffusion##3##2##(2009-2#3)
energy dispersive X-ray analysis##2##4##(2008-5#1)(2012-2#1)
energy dispersive X-ray fluorescence (EDXRF)##3##5##(2008-10#3)
energy dispersive X-ray fluorescence spectrometry##3##5##(2008-10#3)
energy dispersive X-ray fluorescence##8##4##(2008-10#8)
energy dispersive X-ray##15##3##(2008-10#11)(2008-5#1)(2008-9#1)(2012-2#2)
energy dispersive##18##2##(2008-10#14)(2008-5#1)(2008-9#1)(2012-2#2)
energy dissipation##17##2##(2008-7#12)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-6#1)
energy distribution##4##2##(2008-10#2)(2008-3#2)
energy donor##2##2##(1997-6#1)(2008-4#1)
energy efficiency of##2##3##(2008-10#1)(2008-2#1)
energy efficiency##8##2##(1993-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
energy electronic state becomes favorable##2##5##(2008-10#2)
energy electronic state##3##3##(2008-10#3)
energy electronic states of##3##4##(2008-10#3)
energy electronic##6##2##(2008-10#6)
energy expenditure and fertility##2##4##(2008-4#2)
energy expenditure and##3##3##(2008-1#1)(2008-4#2)
energy expenditure in##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
energy expenditure##26##2##(1992-3#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-4#5)(2008-5#3)(2010-8#3)(2012-2#2)(2013-1#2)(2013-8#2)
energy fluctuations of the##2##4##(2008-2#2)
energy fluctuations##4##2##(2007-11#1)(2008-2#3)
energy flux##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
energy for a##2##3##(2008-10#1)(2010-2#1)
energy for plasma formation##2##4##(2007-12#2)
energy for the##6##3##(1996-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
energy for##16##2##(1992-3#1)(1996-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-7#2)(2010-2#1)(2012-2#1)(2013-1#1)
energy formation from glutamine##2##4##(2008-11#2)
energy formation##3##2##(1994-5#1)(2008-11#2)
energy fractures of the distal tibia##2##6##(2007-8#2)
energy from beam##2##3##(2007-12#1)(2008-2#1)
energy from fat##2##3##(2008-3#2)
energy from the##3##3##(2007-12#2)(2009-12#1)
energy from##13##2##(1995-11#1)(2007-12#4)(2008-2#1)(2008-3#4)(2008-5#1)(2009-12#1)(2012-2#1)
energy function##5##2##(1995-3#1)(2008-3#3)(2008-7#1)
energy generation##2##2##(1991-3#1)(2008-11#1)
energy has##2##2##(2007-12#1)(2013-8#1)
energy homeostasis##10##2##(1994-2#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#1)(2013-1#2)(2013-7#1)
energy homoeostasis##2##2##(2008-3#1)(2009-8#1)
energy imparted##2##2##(1997-8#2)
energy in a##3##3##(2007-12#2)(2008-10#1)
energy in the##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
energy in##13##2##(1994-5#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#2)(2010-8#1)(2012-3#1)(2013-1#1)
energy increased##3##2##(2008-10#1)(2013-1#2)
energy increases##2##2##(1997-7#1)(2008-10#1)
energy indicates that##2##3##(1993-8#1)(2007-11#1)
energy input##2##2##(2008-5#1)(2013-1#1)
energy intake and##3##3##(1992-8#1)(1993-9#1)(2008-5#1)
energy intake as##3##3##(1997-8#2)(2008-5#1)
energy intake can##2##3##(2008-11#2)
energy intake##30##2##(1990-2#1)(1992-8#1)(1993-9#1)(1997-8#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#5)(2009-8#3)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#4)
energy is##19##2##(2007-11#6)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#5)(2008-9#1)
energy level##6##2##(1990-8#3)(1993-6#1)(2008-7#1)(2013-1#1)
energy levels of##3##3##(2008-12#1)(2008-2#1)(2008-8#1)
energy levels##10##2##(1990-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
energy loss##4##2##(2008-10#1)(2012-2#3)
energy losses##2##2##(2007-12#1)(2010-8#1)
energy malnutrition##3##2##(1991-8#1)(2007-8#1)(2012-2#1)
energy metabolism and##5##3##(1993-11#1)(1993-12#1)(2008-1#1)(2008-7#1)(2009-4#1)
energy metabolism in##4##3##(1994-5#1)(2008-11#1)(2008-7#1)(2010-8#1)
energy metabolism of the##2##4##(2008-11#1)(2008-7#1)
energy metabolism of##4##3##(2008-11#1)(2008-7#1)(2008-8#2)
energy metabolism##25##2##(1993-11#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-4#2)(2010-8#1)(2011-2#1)(2013-1#1)
energy minimization##5##2##(1991-5#1)(1992-4#1)(1993-11#1)(1996-5#1)(2008-10#1)
energy near##2##2##(2007-12#1)(2008-3#1)
energy needs##2##2##(1994-2#1)(2008-7#1)
energy obtained##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
energy of 1##3##3##(1995-2#1)(2007-12#1)(2008-2#1)
energy of 18##2##3##(2007-11#1)(2007-12#1)
energy of 5##2##3##(2007-11#1)(2010-4#1)
energy of a##3##3##(1992-5#1)(2007-11#2)
energy of as much as##2##5##(2007-11#1)(2007-12#1)
energy of hydration##2##3##(1995-11#1)(2008-10#1)
energy of the scattered##2##4##(2008-3#1)(2009-11#1)
energy of the##23##3##(1990-11#1)(1991-5#1)(1992-6#1)(1997-7#3)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-10#1)(2009-11#1)(2010-2#2)
energy of thermal##2##3##(2008-2#1)(2008-6#1)
energy of##95##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-6#1)(1992-3#2)(1992-5#3)(1992-6#2)(1993-1#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#3)(2007-11#15)(2007-12#11)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
energy on the##4##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
energy on##10##2##(1997-2#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)
energy or##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)
energy per##3##2##(2007-12#2)(2013-1#1)
energy production from##3##3##(2008-11#1)(2012-3#2)
energy production##10##2##(1994-2#1)(1996-5#1)(2008-11#2)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
energy profile##2##2##(1996-2#1)(2013-1#1)
energy provision##2##2##(2008-4#1)(2013-8#1)
energy range##8##2##(2006-4#1)(2007-11#1)(2008-2#4)(2008-3#1)(2013-8#1)
energy ratio##2##2##(2008-10#1)(2008-5#1)
energy recovery##2##2##(2008-10#1)(2012-12#1)
energy redistribution##2##2##(2007-1#1)(2007-12#1)
energy region##2##2##(2010-5#2)
energy required for##2##3##(2007-12#1)(2008-12#1)
energy required to##2##3##(1992-6#1)(2008-3#1)
energy required##5##2##(1992-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2011-2#1)
energy requirements##3##2##(2008-7#2)(2013-8#1)
energy reserves##4##2##(2008-7#1)(2008-8#2)(2013-1#1)
energy resolution##2##2##(2008-2#2)
energy shortage##2##2##(1994-5#2)
energy source for##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
energy source in a##2##4##(2007-8#1)(2008-7#1)
energy source##11##2##(1990-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#1)(2011-2#2)
energy sources##6##2##(1991-8#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
energy spread##2##2##(2010-9#2)
energy status and##2##3##(2010-8#1)(2013-1#1)
energy status##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
energy storage##8##2##(2007-12#3)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#2)
energy stored in##2##3##(2007-11#1)(2010-8#1)
energy stores##3##2##(2008-2#1)(2008-4#2)
energy supply##4##2##(1994-2#1)(1994-8#1)(2009-8#1)(2013-8#1)
energy surface##2##2##(2008-8#1)(2009-5#1)
energy than##9##2##(1996-5#1)(2007-11#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#1)
energy that is##2##3##(2007-12#2)
energy that##5##2##(2007-12#2)(2008-2#2)(2013-1#1)
energy the##2##2##(2008-7#1)(2008-9#1)
energy threshold##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
energy to a##3##3##(2008-3#1)(2008-9#1)(2010-2#1)
energy to accelerate the##2##4##(2008-10#2)
energy to be##2##3##(2008-3#1)(2008-7#1)
energy to##19##2##(2007-12#1)(2008-10#4)(2008-3#7)(2008-7#2)(2008-9#2)(2009-4#1)(2010-2#1)(2010-6#1)
energy transfer (BRET)##4##3##(2008-4#3)(2011-3#1)
energy transfer (FRET) between the##2##5##(2008-10#1)(2009-11#1)
energy transfer (FRET) between##3##4##(2008-1#1)(2008-10#1)(2009-11#1)
energy transfer (FRET)##13##3##(2008-1#1)(2008-10#3)(2008-4#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
energy transfer (LET)##3##3##(2008-7#3)
energy transfer and##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
energy transfer between them##2##4##(1996-12#1)(2012-2#1)
energy transfer between##10##3##(1991-5#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-7#1)(2012-2#3)
energy transfer from the##2##4##(2009-2#1)(2013-1#1)
energy transfer from##8##3##(1993-11#2)(1995-5#1)(2008-10#2)(2009-2#1)(2012-2#1)(2013-1#1)
energy transfer in##6##3##(1993-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2009-2#2)
energy transfer occurred##2##3##(2008-10#1)(2008-3#1)
energy transfer of##2##3##(2008-10#1)(2008-2#1)
energy transfer processes##2##3##(2008-8#2)
energy transfer to##2##3##(1995-6#1)(2008-10#1)
energy transfer##98##2##(1991-5#2)(1992-11#1)(1992-3#2)(1993-11#3)(1994-2#1)(1994-3#2)(1994-5#2)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#1)(2007-11#2)(2008-1#1)(2008-10#26)(2008-2#4)(2008-3#3)(2008-4#6)(2008-7#8)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#4)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-3#1)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
energy transfers##3##2##(1996-2#1)(2008-10#2)
energy transport##2##2##(2009-8#2)
energy turnover##3##2##(1994-5#1)(2008-7#2)
energy use##4##2##(2008-9#1)(2012-2#3)
energy value##5##2##(1990-8#3)(2008-10#1)(2010-4#1)
energy values##2##2##(2008-10#1)(2010-2#1)
energy variation##2##2##(2007-12#1)(2008-3#1)
energy via##2##2##(1992-6#1)(2009-12#1)
energy was found##2##3##(2008-3#1)(2008-5#1)
energy was greater##2##3##(2007-12#1)(2009-4#1)
energy was obtained##2##3##(2007-12#1)(2008-3#1)
energy was##25##2##(1990-2#1)(1992-3#1)(2007-12#2)(2007-8#3)(2008-10#4)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)
energy were##4##2##(2008-10#1)(2008-3#2)(2012-2#1)
energy with##5##2##(2007-12#2)(2008-3#2)(2011-2#1)
energy x-ray##2##2##(2010-1#1)(2012-12#1)
energy##1214##1##(1990-11#3)(1990-2#4)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#13)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#9)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#9)(1994-8#3)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-9#1)(1997-2#9)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#6)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#64)(2007-12#80)(2007-8#10)(2007-9#1)(2008-1#12)(2008-10#139)(2008-11#33)(2008-12#12)(2008-2#69)(2008-3#112)(2008-4#34)(2008-5#29)(2008-6#12)(2008-7#67)(2008-8#33)(2008-9#25)(2009-10#5)(2009-11#10)(2009-12#3)(2009-2#7)(2009-3#1)(2009-4#7)(2009-5#5)(2009-7#5)(2009-8#12)(2009-9#5)(2010-1#3)(2010-10#1)(2010-12#4)(2010-2#10)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#17)(2010-9#4)(2011-1#10)(2011-2#18)(2011-3#2)(2012-1#2)(2012-12#16)(2012-2#50)(2012-3#5)(2012-6#1)(2013-1#60)(2013-7#3)(2013-8#25)
energy) and##2##2##(2008-2#1)(2009-9#1)
energy)##6##1##(2007-12#2)(2008-2#2)(2008-3#1)(2009-9#1)
energy-##3##1##(1990-2#1)(1992-3#1)(2007-2#1)
energy-dependent##6##1##(1992-3#2)(1994-3#1)(1994-5#1)(2008-11#1)(2008-3#1)
energy-dispersive X-ray##5##2##(2008-10#4)(2013-1#1)
energy-dispersive##9##1##(2006-4#1)(2008-10#5)(2008-2#2)(2013-1#1)
energy-efficient##4##1##(2007-12#1)(2011-1#3)
energy-independent##2##1##(1991-12#1)(2008-7#1)
energy-matched continuous exercise and##2##4##(2013-8#2)
energy-matched continuous exercise##3##3##(2013-8#3)
energy-transfer##8##1##(1996-2#2)(2008-10#1)(2008-2#2)(2008-3#2)(2009-9#1)
enfants##4##1##(2008-11#4)
enflurane##4##1##(1990-2#3)(1991-6#1)
enforce##17##1##(1992-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
enforced by means of a##2##5##(2008-11#1)(2008-3#1)
enforced by the##4##3##(1991-12#1)(2008-7#1)(2011-2#2)
enforced by##8##2##(1991-12#1)(1991-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)
enforced the##2##2##(1993-12#1)(2012-12#1)
enforced##23##1##(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-12#1)(1994-2#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#4)(2012-12#1)
enforcement cloning##2##2##(1993-12#2)
enforcement of a##3##3##(2007-6#3)
enforcement of##9##2##(1997-6#1)(1997-7#1)(2007-2#1)(2007-6#3)(2008-11#1)(2009-7#1)(2011-2#1)
enforcement##28##1##(1991-12#1)(1992-3#1)(1993-12#2)(1994-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-2#1)(2007-6#3)(2008-1#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-2#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#3)
enforces##3##1##(2008-11#2)(2012-12#1)
enforcing##5##1##(2007-6#1)(2008-12#1)(2011-2#1)(2013-1#2)
enfuvirtide##2##1##(2008-8#1)(2011-2#1)
engage and##2##2##(2008-12#1)(2012-3#1)
engage in health##3##3##(2008-11#1)(2012-3#2)
engage in risky##3##3##(2008-3#2)(2009-9#1)
engage in social comparisons##2##4##(2007-12#2)
engage in the same##2##4##(2008-11#1)(2012-12#1)
engage in the##3##3##(2008-11#1)(2010-7#1)(2012-12#1)
engage in##58##2##(1990-2#1)(1992-6#1)(1993-1#1)(1994-3#1)(1996-3#1)(1997-3#2)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#1)
engage physicians##2##2##(1995-1#1)(2012-3#1)
engage students##2##2##(2008-12#2)
engage the##5##2##(1996-2#1)(2008-1#1)(2008-11#2)(2008-7#1)
engage themselves##2##2##(2008-12#1)(2010-4#1)
engage with##2##2##(1993-3#1)(2013-1#1)
engage##88##1##(1990-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#9)(2008-12#7)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#8)(2013-8#3)
engaged in a##7##3##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
engaged in more##4##3##(2009-7#1)(2012-12#2)(2012-2#1)
engaged in risky##2##3##(2013-8#2)
engaged in the##6##3##(1995-11#1)(2008-11#1)(2008-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
engaged in this##2##3##(2010-10#1)(2013-8#1)
engaged in##66##2##(1992-12#1)(1993-1#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#3)(2009-3#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#6)(2013-7#1)(2013-8#5)
engaged lifestyle##5##2##(2010-12#5)
engaged##84##1##(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#5)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#4)(2009-10#3)(2009-3#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#6)(2013-1#6)(2013-7#1)(2013-8#5)
engagement among##3##2##(2009-7#3)
engagement and##6##2##(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#2)(2013-1#1)
engagement in learning##2##3##(2009-7#1)(2011-1#1)
engagement in preventive##2##3##(2009-5#2)
engagement in school##3##3##(2009-7#3)
engagement in the##3##3##(1997-3#1)(2009-7#1)(2013-1#1)
engagement in##19##2##(1997-3#1)(2008-11#1)(2008-6#1)(2009-5#2)(2009-7#6)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#4)
engagement of##8##2##(2008-12#1)(2008-4#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
engagement strategies##3##2##(2012-2#3)
engagement trajectories##3##2##(2008-12#3)
engagement with##5##2##(2008-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
engagement##94##1##(1994-3#1)(1997-3#1)(2008-11#4)(2008-12#13)(2008-4#3)(2008-6#2)(2009-5#2)(2009-6#1)(2009-7#24)(2009-9#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#1)
engagements##2##1##(2007-2#1)(2008-11#1)
engages in##3##2##(1995-12#1)(2008-12#1)(2009-2#1)
engages##8##1##(1995-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2011-2#1)(2012-12#1)
engaging and##3##2##(2008-12#2)(2010-9#1)
engaging in##20##2##(1991-12#1)(1992-8#1)(2008-11#2)(2008-12#3)(2008-2#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
engaging the public##2##3##(2013-1#2)
engaging the##3##2##(2011-2#1)(2013-1#2)
engaging##38##1##(1991-12#1)(1992-8#1)(1997-2#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
engender##4##1##(1992-1#1)(2009-10#1)(2009-2#1)(2009-4#1)
engendered##2##1##(2008-11#1)(2013-1#1)
engendering##2##1##(2008-11#1)(2012-3#1)
engenders##2##1##(1994-1#1)(1995-3#1)
engine and##2##2##(1993-2#1)(2008-12#1)
engine is##3##2##(2008-2#1)(2010-8#2)
engine oil##2##2##(2008-10#2)
engine##30##1##(1993-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#7)(2008-3#10)(2010-8#3)(2012-2#1)(2013-1#1)(2013-8#1)
engineer or select for##2##4##(2011-1#2)
engineer the##2##2##(2008-11#1)(2012-2#1)
engineer##18##1##(1992-12#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-7#1)(2009-9#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-2#1)
engineer's##3##1##(1994-5#1)(1994-8#1)(2008-7#1)
engineered CHO cells##3##3##(2008-11#3)
engineered antibodies##2##2##(2008-10#2)
engineered cells##2##2##(2008-1#1)(2008-11#1)
engineered for##6##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-2#1)
engineered quasi-phase-matching structures in LiNbO(3) waveguides##2##6##(2007-12#2)
engineered resistance##2##2##(2008-10#2)
engineered strain##2##2##(2008-6#1)(2008-7#1)
engineered the##2##2##(1990-7#1)(2011-2#1)
engineered to contain##2##3##(2008-10#2)
engineered to express the##2##4##(2008-10#1)(2010-2#1)
engineered to express##4##3##(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#1)
engineered to produce##2##3##(2008-10#1)(2008-11#1)
engineered to secrete human##2##4##(2008-11#1)(2008-5#1)
engineered to secrete##4##3##(1997-4#2)(2008-11#1)(2008-5#1)
engineered to##22##2##(1994-8#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
engineered with##2##2##(1997-2#1)(2008-10#1)
engineered##104##1##(1990-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#4)(1995-6#1)(1997-2#4)(1997-3#1)(1997-4#2)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#13)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
engineering and regenerative medicine##9##4##(2008-11#1)(2008-5#2)(2009-7#1)(2010-10#2)(2012-5#2)(2012-6#1)
engineering and##24##2##(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#3)(2011-3#2)(2012-2#1)(2012-5#2)(2012-6#1)(2013-1#2)
engineering approach to##2##3##(2008-10#1)(2008-11#1)
engineering approaches##3##2##(1994-8#1)(2012-2#1)(2013-1#1)
engineering are##3##2##(1994-8#1)(2007-12#1)(2008-11#1)
engineering as##4##2##(1994-11#1)(2010-9#1)(2012-3#2)
engineering concepts##2##2##(1993-3#1)(2012-3#1)
engineering for##2##2##(2008-11#1)(2012-12#1)
engineering has##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
engineering in the##3##3##(1997-6#1)(2008-5#2)
engineering in##6##2##(1997-6#1)(2008-11#2)(2008-5#2)(2009-7#1)
engineering is##4##2##(1991-6#1)(2010-10#1)(2012-12#1)(2012-3#1)
engineering methods##3##2##(2008-7#1)(2008-9#1)(2010-8#1)
engineering of the##2##3##(2010-10#1)(2012-2#1)
engineering of tissues##2##3##(2010-10#2)
engineering of##17##2##(1995-3#1)(1997-2#1)(2008-11#2)(2008-6#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-10#3)(2011-1#2)(2012-2#2)(2013-1#1)
engineering or##2##2##(2009-7#1)(2012-3#1)
engineering strategies are##2##3##(2008-11#2)
engineering strategies to##2##3##(2008-11#1)(2012-3#1)
engineering strategies##6##2##(2008-11#4)(2012-3#2)
engineering surfaces##3##2##(2008-2#1)(2008-3#2)
engineering to##3##2##(2008-11#2)(2008-8#1)
engineering using##4##2##(2007-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
engineering##231##1##(1990-11#3)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-11#5)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#4)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-12#8)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#35)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#3)(2009-11#3)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#10)(2009-9#3)(2010-10#14)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#11)(2012-3#8)(2012-5#3)(2012-6#1)(2012-8#2)(2013-1#7)
engineering)##2##1##(2008-10#1)(2008-11#1)
engineering?##2##1##(1993-12#1)(2012-8#1)
engineers to##2##2##(2008-11#1)(2008-8#1)
engineers##17##1##(1990-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-11#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-3#1)
engines and##2##2##(2008-10#1)(2010-8#1)
engines is##2##2##(2008-11#1)(2010-8#1)
engines that##2##2##(2008-11#1)(2012-3#1)
engines##19##1##(2007-2#2)(2008-10#2)(2008-11#3)(2008-2#4)(2010-1#1)(2010-3#1)(2010-8#5)(2012-3#1)
engorging on##2##2##(1994-3#2)
engraft into##2##2##(2010-11#1)(2011-1#1)
engraft##5##1##(2008-11#1)(2010-11#2)(2011-1#1)(2012-12#1)
engrafted##7##1##(1992-1#1)(2010-11#1)(2010-12#2)(2012-12#1)(2013-1#2)
engraftment in##4##2##(2010-11#2)(2011-2#1)(2013-1#1)
engraftment of the##2##3##(2010-11#2)
engraftment of##7##2##(1994-5#1)(2008-11#1)(2010-11#4)(2012-12#1)
engraftment studies##3##2##(2008-4#3)
engraftment was##2##2##(2011-2#2)
engraftment##23##1##(1994-5#1)(2008-11#1)(2008-4#3)(2010-11#7)(2011-2#5)(2012-12#3)(2013-1#3)
engrailed in##2##2##(2007-12#2)
engrailed protein##3##2##(2007-12#3)
engrailed##12##1##(1993-2#1)(2007-12#11)
engraved##2##1##(2007-12#1)(2008-10#1)
engulfed##3##1##(2011-1#2)(2012-12#1)
engulfment##4##1##(2008-10#3)(2008-12#1)
enhance a##3##2##(1994-3#1)(1996-11#1)(1997-8#1)
enhance biological##2##2##(2008-10#2)
enhance bone##2##2##(2008-5#1)(2008-8#1)
enhance both##3##2##(2007-12#1)(2009-5#1)(2011-1#1)
enhance case management##2##3##(1997-3#2)
enhance cell##5##2##(1997-1#1)(2008-11#2)(2009-6#1)(2012-3#1)
enhance communication with##2##3##(2008-11#1)(2012-1#1)
enhance communication##6##2##(1991-12#1)(1995-12#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
enhance disease resistance##2##3##(2008-10#2)
enhance disease##4##2##(2008-10#3)(2012-2#1)
enhance energy##2##2##(2008-6#1)(2012-12#1)
enhance female##2##2##(2008-5#2)
enhance food availability for guppies##2##5##(2008-8#2)
enhance frequency##2##2##(1996-2#1)(2008-3#1)
enhance growth##2##2##(2008-10#1)(2011-2#1)
enhance health##2##2##(2008-4#1)(2013-1#1)
enhance immune##2##2##(2008-2#1)(2008-7#1)
enhance insulin##2##2##(1995-8#1)(2008-1#1)
enhance its stability##2##3##(1994-8#1)(2008-3#1)
enhance its##7##2##(1994-8#1)(1995-3#1)(2008-10#2)(2008-3#2)(2011-2#1)
enhance light##2##2##(2007-12#2)
enhance local diversity##2##3##(2008-8#2)
enhance local##3##2##(2008-3#1)(2008-8#2)
enhance or##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
enhance our understanding of the##3##5##(1991-3#1)(2008-7#1)(2010-3#1)
enhance our understanding of##9##4##(1991-3#1)(1993-12#1)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2013-1#1)
enhance our understanding##10##3##(1991-3#1)(1993-12#1)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2013-1#1)
enhance our##16##2##(1991-3#1)(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
enhance patient care##4##3##(1992-2#1)(1995-12#1)(2008-10#1)(2008-11#1)
enhance patient satisfaction##2##3##(1997-3#1)(2008-11#1)
enhance patient##8##2##(1992-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#2)(2010-3#2)
enhance performance and##2##3##(2008-10#1)(2008-8#1)
enhance performance##5##2##(1992-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
enhance plant##2##2##(2008-10#2)
enhance professional##3##2##(2008-12#1)(2009-6#1)(2013-8#1)
enhance protein##2##2##(1994-6#1)(2012-1#1)
enhance public health##2##3##(1996-2#1)(2008-11#1)
enhance quality##3##2##(1995-12#1)(1996-12#1)(1996-2#1)
enhance research##4##2##(1994-9#1)(2007-4#1)(2008-1#1)(2008-7#1)
enhance resistance##2##2##(2008-10#2)
enhance student learning##4##3##(2008-11#2)(2008-12#2)
enhance student##5##2##(2008-11#3)(2008-12#2)
enhance the CL##4##3##(2008-10#4)
enhance the ECL of Ru(bpy)(3)(2+) in##2##6##(2008-10#2)
enhance the ECL##3##3##(2008-10#3)
enhance the ability of the surgeon to perform##2##8##(2010-8#2)
enhance the ability of##4##4##(2008-4#1)(2008-8#1)(2010-8#2)
enhance the accuracy##3##3##(2008-10#2)(2008-6#1)
enhance the acetylcholinesterase##3##3##(2008-11#3)
enhance the cell surface##2##4##(2008-11#2)
enhance the cell##3##3##(1993-8#1)(2008-11#2)
enhance the chemiluminescence##2##3##(2008-10#2)
enhance the collection##2##3##(1995-12#1)(2007-11#1)
enhance the coupling##2##3##(2007-12#1)(2008-3#1)
enhance the differentiation##2##3##(2008-5#1)(2012-12#1)
enhance the educational##2##3##(1993-3#1)(2008-12#1)
enhance the effect of##4##4##(1997-5#1)(2008-6#2)(2013-1#1)
enhance the expression of##3##4##(1993-8#1)(1994-11#1)(1994-5#1)
enhance the expression##4##3##(1993-8#1)(1994-11#1)(1994-5#1)(2008-9#1)
enhance the health##2##3##(2008-1#1)(2008-7#1)
enhance the image##3##3##(1995-1#1)(2009-10#1)(2011-1#1)
enhance the likelihood of##2##4##(1992-12#1)(2008-8#1)
enhance the overall##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
enhance the potential##2##3##(2008-3#1)(2011-2#1)
enhance the probability##2##3##(2008-11#1)(2008-7#1)
enhance the process##2##3##(1994-2#1)(2008-11#1)
enhance the production of##2##4##(2008-11#1)(2012-3#1)
enhance the productivity##3##3##(1990-11#1)(2008-11#2)
enhance the quality of##2##4##(1991-2#1)(2010-4#1)
enhance the release of##2##4##(1990-12#1)(2008-10#1)
enhance the replication##2##3##(2013-1#2)
enhance the response##2##3##(1995-11#1)(2008-10#1)
enhance the secretion of##3##4##(2008-11#3)
enhance the sensitivity of##5##4##(2008-10#3)(2008-3#1)(2009-4#1)
enhance the sensitivity##8##3##(2008-10#5)(2008-2#1)(2008-3#1)(2009-4#1)
enhance the sorption##2##3##(2008-10#2)
enhance the surface##2##3##(2007-11#1)(2008-10#1)
enhance the understanding of##3##4##(2011-2#1)(2011-7#1)(2012-2#1)
enhance the##252##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#5)(2008-1#4)(2008-10#47)(2008-11#22)(2008-12#6)(2008-2#3)(2008-3#15)(2008-4#4)(2008-5#6)(2008-6#7)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#1)
enhance their ability to##2##4##(1995-1#1)(2010-1#1)
enhance their own##2##3##(1992-3#1)(2012-3#1)
enhance their performance##2##3##(2008-6#1)(2009-11#1)
enhance their##19##2##(1991-3#1)(1992-3#2)(1995-1#1)(1995-3#1)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-4#1)(2012-12#2)(2012-3#1)
enhance these##2##2##(1994-2#1)(2013-1#1)
enhance those##2##2##(1997-1#1)(2008-7#1)
enhance##582##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#5)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#5)(1993-3#4)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#6)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#5)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1997-1#4)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#10)(2007-12#14)(2007-4#1)(2007-7#1)(2008-1#7)(2008-10#86)(2008-11#46)(2008-12#13)(2008-2#6)(2008-3#23)(2008-4#10)(2008-5#22)(2008-6#12)(2008-7#21)(2008-8#20)(2008-9#9)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#18)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#9)(2012-4#1)(2013-1#22)(2013-8#6)
enhanced 2##2##2##(1994-6#1)(2008-10#1)
enhanced CT##2##2##(2008-7#1)(2013-8#1)
enhanced DNA##3##2##(1992-2#1)(1993-3#1)(2008-4#1)
enhanced ECL##6##2##(2008-10#6)
enhanced Kerr nonlinearity##2##3##(2007-11#2)
enhanced RLS intensity##5##3##(2008-10#5)
enhanced RLS signals##3##3##(2008-10#3)
enhanced RLS##10##2##(2008-10#10)
enhanced Raman scattering of##3##4##(2009-4#1)(2013-8#2)
enhanced Raman scattering##6##3##(2009-4#2)(2010-5#1)(2013-8#3)
enhanced Raman##7##2##(2008-10#1)(2009-4#2)(2010-5#1)(2013-8#3)
enhanced T cell##2##3##(1993-12#1)(2008-11#1)
enhanced US##2##2##(2008-7#2)
enhanced a##2##2##(2008-10#2)
enhanced ability to##2##3##(1994-8#1)(2010-8#1)
enhanced access to##2##3##(2008-11#1)(2009-4#1)
enhanced activity##2##2##(1992-12#1)(2007-12#1)
enhanced affinity for##2##3##(1992-3#2)
enhanced after##6##2##(1990-11#1)(1992-6#1)(2008-10#2)(2008-6#1)(2013-1#1)
enhanced and##9##2##(1997-4#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-9#1)(2009-2#1)(2013-1#1)
enhanced antibody production##2##3##(1995-5#1)(2008-11#1)
enhanced apple##2##2##(2008-10#2)
enhanced as##3##2##(1994-8#1)(2008-11#1)(2010-3#1)
enhanced at##4##2##(2007-12#1)(2008-10#2)(2009-8#1)
enhanced backscattering from a##2##4##(2007-12#2)
enhanced backscattering from##3##3##(2007-12#2)(2008-3#1)
enhanced backscattering peak##2##3##(2007-11#1)(2007-12#1)
enhanced backscattering##10##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#2)
enhanced because##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
enhanced binding##2##2##(1993-3#1)(2008-4#1)
enhanced both##2##2##(1994-6#1)(2008-11#1)
enhanced by a##7##3##(1990-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
enhanced by addition of##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
enhanced by an##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
enhanced by increased##2##3##(1996-12#1)(1996-2#1)
enhanced by oral administration of##2##5##(2008-10#1)(2008-11#1)
enhanced by reducing##2##3##(2008-10#1)(2008-7#1)
enhanced by the addition of##11##5##(1992-12#1)(1992-9#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)
enhanced by the development of##2##5##(2008-10#1)(2010-3#1)
enhanced by the presence of##6##5##(2008-10#5)(2008-6#1)
enhanced by the simultaneous##2##4##(1996-5#1)(2009-2#1)
enhanced by the##37##3##(1992-12#1)(1992-9#2)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-3#1)(2012-12#2)
enhanced by##159##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#2)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-4#3)(1997-7#1)(1997-8#1)(2006-6#3)(2007-11#6)(2007-12#6)(2007-2#1)(2008-1#1)(2008-10#44)(2008-11#10)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
enhanced capacity##2##2##(1994-11#1)(2009-5#1)
enhanced cell proliferation##2##3##(1992-12#1)(1993-9#1)
enhanced cell##7##2##(1992-12#1)(1992-6#1)(1993-9#1)(2008-11#4)
enhanced cellular productivity##2##3##(2008-11#2)
enhanced cellular##3##2##(2008-10#1)(2008-11#2)
enhanced chemical##3##2##(2008-10#1)(2009-11#2)
enhanced chemiluminescence##5##2##(1990-12#1)(2008-10#3)(2012-2#1)
enhanced clinical##2##2##(2009-4#1)(2011-2#1)
enhanced communication##2##2##(1990-7#1)(1996-12#1)
enhanced compared to##2##3##(1996-5#1)(2008-8#1)
enhanced compared with##3##3##(2007-11#1)(2013-1#2)
enhanced compared##5##2##(1996-5#1)(2007-11#1)(2008-8#1)(2013-1#2)
enhanced contrast##2##2##(2007-12#1)(2008-3#1)
enhanced current##2##2##(2008-10#1)(2008-8#1)
enhanced cytotoxicity##4##2##(1990-5#1)(1993-3#1)(1994-8#1)(2012-12#1)
enhanced depth imaging optical coherence tomography (EDI-OCT)##2##7##(2011-7#1)(2013-1#1)
enhanced disease##4##2##(2008-10#4)
enhanced drought##2##2##(2008-8#1)(2011-2#1)
enhanced due to the##2##4##(2008-10#2)
enhanced during##4##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
enhanced electrochemical sensing##2##3##(2013-1#2)
enhanced electrochemical##3##2##(2008-10#1)(2013-1#2)
enhanced endothelial##2##2##(1997-8#1)(2013-1#1)
enhanced expression and##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
enhanced expression of##9##3##(1990-2#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-2#1)
enhanced expression##13##2##(1990-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-2#2)
enhanced fluorescence##4##2##(1991-9#1)(2008-10#3)
enhanced formation of##4##3##(1990-7#1)(1993-3#1)(2008-11#1)(2013-1#1)
enhanced friendship networks and##2##4##(2008-4#2)
enhanced from##2##2##(1995-12#1)(2007-12#1)
enhanced greatly##3##2##(2008-10#2)(2008-8#1)
enhanced green fluorescent protein##3##4##(2008-11#3)
enhanced green##5##2##(2008-11#3)(2008-9#1)(2013-8#1)
enhanced growth of apple and##2##5##(2008-10#2)
enhanced growth of apple in##2##5##(2008-10#2)
enhanced growth of apple##5##4##(2008-10#5)
enhanced growth of##7##3##(1992-8#1)(2008-10#5)(2013-7#1)
enhanced growth##14##2##(1992-8#2)(2008-10#8)(2008-11#1)(2009-10#1)(2012-12#1)(2013-7#1)
enhanced host resistance to blast##2##5##(2008-10#2)
enhanced if##2##2##(2008-10#1)(2008-2#1)
enhanced immune##3##2##(2009-4#1)(2009-5#2)
enhanced in an##2##3##(2007-12#1)(2008-10#1)
enhanced in the presence of##4##5##(1991-12#1)(2007-2#1)(2008-10#1)(2013-1#1)
enhanced in the##12##3##(1991-12#1)(1992-12#1)(1993-12#1)(2007-2#1)(2008-10#5)(2008-2#1)(2009-8#1)(2013-1#1)
enhanced in##46##2##(1991-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-12#1)(1995-2#2)(1996-5#1)(1996-7#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#2)(2011-2#1)(2013-1#2)
enhanced inhibition of##3##3##(1991-12#1)(1991-4#1)(1993-11#1)
enhanced insulin##2##2##(1992-11#1)(1997-1#1)
enhanced intensity##3##2##(2008-10#3)
enhanced its##2##2##(1991-2#1)(2008-10#1)
enhanced levels of##7##3##(1994-1#2)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
enhanced light##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
enhanced lipid peroxidation##3##3##(1994-6#1)(2009-8#2)
enhanced lipolysis##2##2##(1991-12#1)(1994-11#1)
enhanced locomotor##2##2##(1993-6#1)(2012-2#1)
enhanced magnetic resonance imaging##3##4##(2010-11#2)(2013-1#1)
enhanced magnetic resonance##4##3##(2008-7#1)(2010-11#2)(2013-1#1)
enhanced markedly##3##2##(1991-5#1)(1994-8#2)
enhanced mass##2##2##(2008-12#1)(2010-7#1)
enhanced membrane##2##2##(1994-8#1)(1997-6#1)
enhanced memory##2##2##(2008-5#1)(2009-11#1)
enhanced metabolic##2##2##(1991-10#1)(2013-1#1)
enhanced molecular##2##2##(2008-11#1)(2010-12#1)
enhanced more than##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
enhanced more##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
enhanced neural##2##2##(2008-11#1)(2009-3#1)
enhanced nonlinear##2##2##(2007-12#1)(2008-10#1)
enhanced oospore##2##2##(2008-10#2)
enhanced optical coherence tomography for##2##5##(2007-12#2)
enhanced optical coherence tomography##3##4##(2007-12#3)
enhanced optical##7##2##(2007-11#2)(2007-12#4)(2008-7#1)
enhanced oxidative##2##2##(2009-8#1)(2013-1#1)
enhanced pathogen##3##2##(2008-10#3)
enhanced performance##2##2##(1995-5#1)(2008-8#1)
enhanced peroxidase##2##2##(2009-3#2)
enhanced phosphorylation in##2##3##(2008-8#2)
enhanced photobleaching##2##2##(2008-10#2)
enhanced populations of##3##3##(2008-10#3)
enhanced potency##3##2##(1990-12#1)(1991-3#1)(1995-5#1)
enhanced potentiometric selectivity toward##2##4##(2008-10#2)
enhanced potentiometric##3##2##(2008-10#3)
enhanced production of interferon-beta on the##2##6##(2008-11#2)
enhanced production of##3##3##(1995-3#1)(2008-11#2)
enhanced production##4##2##(1995-3#1)(2008-11#3)
enhanced protection##2##2##(1991-9#1)(1992-6#1)
enhanced q (Ab)##2##3##(2008-11#2)
enhanced ray-optics##3##2##(2008-3#3)
enhanced relative to##2##3##(1995-2#1)(2008-2#1)
enhanced release of##2##3##(1992-8#1)(1995-12#1)
enhanced replication of##2##3##(1995-12#1)(2010-11#1)
enhanced resistance of avian cells##2##5##(2008-3#2)
enhanced resistance of##3##3##(2008-3#2)(2011-1#1)
enhanced resistance to Sclerotium rolfsii##3##5##(2008-10#3)
enhanced resistance to##6##3##(1995-6#1)(2008-10#5)
enhanced resistance##11##2##(1995-6#1)(2008-10#7)(2008-3#2)(2011-1#1)
enhanced resolution##3##2##(2007-12#1)(2008-10#1)(2009-11#1)
enhanced resonance light scattering##4##4##(2008-10#4)
enhanced resonance##8##2##(2008-10#8)
enhanced responding selectively##2##3##(1993-6#2)
enhanced response##3##2##(1995-11#1)(2008-10#2)
enhanced second-harmonic##3##2##(2007-11#3)
enhanced secretion of##2##3##(2008-11#1)(2008-7#1)
enhanced secretion##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
enhanced selectivity##2##2##(2008-10#1)(2013-7#1)
enhanced sensitivity compared with##2##4##(2007-11#1)(2008-10#1)
enhanced sensitivity of##2##3##(1996-12#1)(2008-10#1)
enhanced sensitivity to##2##3##(2007-11#1)(2008-9#1)
enhanced sensitivity##10##2##(1996-12#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
enhanced significantly by##2##3##(2008-10#1)(2008-5#1)
enhanced significantly##4##2##(2008-10#1)(2008-3#1)(2008-5#2)
enhanced spatial resolution##2##3##(2007-11#1)(2007-12#1)
enhanced specific activity##2##3##(2008-7#1)(2011-1#1)
enhanced stability##3##2##(1992-11#1)(2012-12#2)
enhanced stress##2##2##(1995-12#1)(2011-2#1)
enhanced surface expression of##2##4##(1992-9#1)(2008-11#1)
enhanced surface##3##2##(1992-9#1)(1994-5#1)(2008-11#1)
enhanced survival##2##2##(1996-12#2)
enhanced susceptibility##2##2##(2008-10#2)
enhanced synthesis of prostanoids##2##4##(1992-8#2)
enhanced synthesis of##3##3##(1992-8#2)(2012-3#1)
enhanced the absorption##2##3##(2008-10#1)(2011-3#1)
enhanced the binding of##2##4##(1990-11#1)(1995-6#1)
enhanced the cell##2##3##(2008-11#2)
enhanced the contractile##2##3##(1990-5#2)
enhanced the cytotoxicity of##2##4##(2008-8#1)(2009-4#1)
enhanced the damage##2##3##(2008-10#1)(2008-9#1)
enhanced the expression of##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
enhanced the frequency of##2##4##(1993-8#1)(2009-2#1)
enhanced the growth##2##3##(1991-12#1)(2008-11#1)
enhanced the induction of##2##4##(2008-11#1)(2013-1#1)
enhanced the overall##2##3##(1997-2#1)(2011-1#1)
enhanced the release of##2##4##(1995-12#1)(2013-8#1)
enhanced the secretion of##2##4##(1993-12#1)(2008-11#1)
enhanced the sensitivity of the method##2##6##(2008-10#2)
enhanced the sensitivity##4##3##(2008-10#4)
enhanced the##111##2##(1990-11#1)(1990-5#4)(1991-12#3)(1992-3#2)(1992-6#1)(1992-9#3)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#4)(1995-6#1)(1996-2#2)(1997-2#4)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#10)(2008-12#2)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#5)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
enhanced their##4##2##(1993-12#1)(1994-8#1)(1995-11#1)(2012-1#1)
enhanced through the##3##3##(2008-10#1)(2008-6#1)(2010-7#1)
enhanced through##4##2##(1995-1#1)(2008-10#1)(2008-6#1)(2010-7#1)
enhanced tissue##2##2##(2008-5#1)(2010-3#1)
enhanced to##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
enhanced tolerance of##2##3##(1996-5#1)(2011-2#1)
enhanced tolerance##3##2##(1996-5#1)(2011-2#1)(2013-1#1)
enhanced transcription of##2##3##(1992-12#1)(1993-6#1)
enhanced transcription##3##2##(1992-12#1)(1993-6#1)(1993-9#1)
enhanced ultrafiltration##2##2##(2008-10#2)
enhanced upon##3##2##(1991-2#1)(1992-12#1)(2008-6#1)
enhanced when the##2##3##(2007-12#1)(2008-2#1)
enhanced when##10##2##(1993-6#1)(1994-1#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-2#1)
enhanced with the##2##3##(2007-11#1)(2008-10#1)
enhanced with##14##2##(1992-11#1)(1994-12#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-8#2)(2010-4#1)(2011-2#2)
enhanced yield##2##2##(1994-11#1)(2008-10#1)
enhanced##1130##1##(1990-11#5)(1990-12#3)(1990-2#5)(1990-5#8)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#10)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#5)(1992-6#4)(1992-8#10)(1992-9#10)(1993-1#1)(1993-11#4)(1993-12#10)(1993-2#2)(1993-3#5)(1993-6#8)(1993-8#8)(1993-9#2)(1994-1#3)(1994-11#10)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#6)(1994-8#12)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#15)(1995-2#11)(1995-3#9)(1995-4#1)(1995-5#5)(1995-6#4)(1996-1#1)(1996-12#10)(1996-2#5)(1996-3#2)(1996-5#5)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#6)(1997-6#5)(1997-7#5)(1997-8#2)(2006-6#3)(2007-11#38)(2007-12#38)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#271)(2008-11#78)(2008-12#9)(2008-2#18)(2008-3#33)(2008-4#19)(2008-5#36)(2008-6#17)(2008-7#30)(2008-8#27)(2008-9#21)(2009-10#4)(2009-11#6)(2009-2#7)(2009-3#4)(2009-4#9)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#8)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#8)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#11)(2012-2#15)(2012-3#9)(2012-5#1)(2012-7#1)(2013-1#37)(2013-7#3)(2013-8#13)
enhanced)##2##1##(1993-12#1)(2012-1#1)
enhancement and edge-enhanced correlation##2##4##(2008-3#2)
enhancement and suppression##2##3##(1995-6#1)(1997-2#1)
enhancement and##18##2##(1990-8#1)(1995-6#2)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#3)(2009-6#1)(2010-5#1)
enhancement as##2##2##(2007-12#1)(2008-3#1)
enhancement at##3##2##(1997-2#1)(2008-3#1)(2010-11#1)
enhancement by an##2##3##(2007-12#1)(2008-2#1)
enhancement by the##2##3##(1993-9#1)(2007-11#1)
enhancement by##13##2##(1992-8#1)(1993-9#1)(1994-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)
enhancement can be##2##3##(1993-3#1)(2008-10#1)
enhancement due to##2##3##(1992-8#1)(2008-10#1)
enhancement effect of##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
enhancement effect##17##2##(1990-8#1)(1997-2#3)(2008-10#9)(2008-3#1)(2008-9#1)(2009-12#1)(2013-8#1)
enhancement factor of##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
enhancement factor was##5##3##(2008-10#5)
enhancement factor##14##2##(2007-11#1)(2008-10#9)(2008-2#1)(2008-3#2)(2013-1#1)
enhancement factors##2##2##(2008-10#1)(2008-5#1)
enhancement for##8##2##(2008-10#3)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
enhancement from##2##2##(2007-12#2)
enhancement in CL##3##3##(2008-10#3)
enhancement in a##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
enhancement in both##2##3##(2008-12#1)(2008-3#1)
enhancement in selectivity coefficients##2##4##(2008-10#2)
enhancement in the##15##3##(1990-2#1)(1997-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2010-5#1)(2013-1#2)
enhancement in this##2##3##(1997-8#1)(2007-12#1)
enhancement in##56##2##(1990-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-8#3)(2007-11#7)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#2)
enhancement is achieved by##2##4##(2007-12#1)(2008-3#1)
enhancement is attributed to##2##4##(2007-11#1)(2008-10#1)
enhancement is not##3##3##(1993-9#1)(2007-12#1)(2008-11#1)
enhancement is##19##2##(1991-3#1)(1991-5#1)(1993-9#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#1)
enhancement mechanism##2##2##(2007-12#1)(2008-10#1)
enhancement occurs##2##2##(1991-3#1)(2008-2#1)
enhancement of a##5##3##(1996-2#1)(2008-10#2)(2008-9#1)(2010-5#1)
enhancement of antibody##2##3##(1994-5#1)(1995-11#1)
enhancement of bone##2##3##(1992-3#1)(2008-8#1)
enhancement of electrical activity##3##4##(1996-2#3)
enhancement of growth and##2##4##(2008-10#1)(2008-11#1)
enhancement of sensitivity##3##3##(2008-10#3)
enhancement of spontaneous emission rates##2##5##(2007-11#2)
enhancement of the emission##2##4##(2008-10#2)
enhancement of the fluorescence##2##4##(2008-10#2)
enhancement of the mass##2##4##(2008-10#1)(2013-8#1)
enhancement of the mutation frequency##2##5##(1997-3#2)
enhancement of the##68##3##(1990-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-1#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#7)(2007-12#4)(2008-10#25)(2008-11#5)(2008-3#4)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
enhancement of those##2##3##(2008-3#1)(2011-2#1)
enhancement of##213##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#3)(1996-12#2)(1996-2#6)(1996-9#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#3)(2006-6#1)(2007-11#11)(2007-12#12)(2008-1#1)(2008-10#62)(2008-11#14)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-6#1)(2013-1#4)(2013-8#3)
enhancement on##4##2##(1991-9#1)(1997-8#2)(2008-12#1)
enhancement or inhibition##2##3##(1993-12#1)(2008-7#1)
enhancement or##9##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2013-7#2)
enhancement resulting from##2##3##(1991-3#1)(2008-7#1)
enhancement than iodine##2##3##(1997-8#2)
enhancement than##3##2##(1997-8#3)
enhancement that##2##2##(2007-11#1)(2008-2#1)
enhancement to##3##2##(1995-6#1)(2007-11#1)(2013-1#1)
enhancement using##2##2##(1994-6#1)(2008-10#1)
enhancement via a##2##3##(1997-7#1)(2010-4#1)
enhancement via##3##2##(1997-7#1)(2008-5#1)(2010-4#1)
enhancement was found to##2##4##(1991-3#1)(2011-1#1)
enhancement was found##4##3##(1991-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
enhancement was significantly##2##3##(1996-12#1)(2008-10#1)
enhancement was##19##2##(1990-11#1)(1991-12#1)(1991-3#1)(1994-6#1)(1994-9#1)(1996-12#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#1)(2012-12#1)
enhancement with##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
enhancement##527##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#6)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#6)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#4)(1992-8#5)(1992-9#1)(1993-12#5)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-5#3)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#6)(1996-12#3)(1996-2#6)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-7#3)(1997-8#13)(2006-6#2)(2007-10#2)(2007-11#28)(2007-12#33)(2008-1#1)(2008-10#131)(2008-11#26)(2008-12#4)(2008-2#18)(2008-3#33)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#24)(2008-8#8)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#17)(2012-6#1)(2013-1#11)(2013-7#3)(2013-8#6)
enhancement)##2##1##(1990-8#1)(2012-12#1)
enhancements in the##2##3##(2008-10#1)(2013-8#1)
enhancements in##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
enhancements of the##2##3##(1995-11#1)(2008-2#1)
enhancements of##8##2##(1994-8#1)(1995-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-1#1)
enhancements to##3##2##(2007-12#1)(2010-8#1)(2011-1#1)
enhancements##26##1##(1992-12#1)(1992-3#1)(1993-12#1)(1994-8#2)(1995-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#3)(2013-1#1)(2013-8#1)
enhancer activity##7##2##(1991-11#3)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)
enhancer and##3##2##(1992-5#2)(2008-9#1)
enhancer are##2##2##(1991-5#1)(2008-4#1)
enhancer in##4##2##(1990-11#1)(1992-12#1)(1995-8#1)(2008-5#1)
enhancer is##3##2##(1990-11#2)(2008-10#1)
enhancer of rudimentary##2##3##(2008-9#2)
enhancer of##8##2##(1990-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
enhancer region of the XBP1 gene##2##6##(2011-2#2)
enhancer region##3##2##(1994-6#1)(2011-2#2)
enhancer was##2##2##(1990-11#1)(1992-5#1)
enhancer##62##1##(1990-11#7)(1990-12#1)(1991-11#5)(1991-5#3)(1992-10#1)(1992-12#1)(1992-5#3)(1992-6#1)(1993-11#1)(1993-2#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-2#3)(1995-8#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#6)(2011-2#3)(2012-3#4)
enhancers in the##2##3##(1995-6#1)(2008-8#1)
enhancers in##3##2##(1990-12#1)(1995-6#1)(2008-8#1)
enhancers of##5##2##(1994-12#1)(2008-5#1)(2008-8#1)(2012-3#2)
enhancers##26##1##(1990-12#1)(1991-5#3)(1992-11#1)(1993-12#1)(1994-12#3)(1995-6#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#3)(2011-2#1)(2012-3#2)
enhances NGF-dependent neurite outgrowth##3##4##(2008-4#3)
enhances a##2##2##(2008-12#1)(2013-1#1)
enhances and##2##2##(2009-3#1)(2010-3#1)
enhances binding of agonists to the##2##6##(1994-5#2)
enhances bone##2##2##(1997-7#1)(2008-8#1)
enhances both the##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
enhances both##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2010-11#1)
enhances expression of##2##3##(1997-7#1)(2008-9#1)
enhances its##3##2##(2007-12#2)(2008-3#1)
enhances only##2##2##(1997-7#2)
enhances our understanding of##2##4##(2008-7#1)(2012-12#1)
enhances our##3##2##(2008-2#1)(2008-7#1)(2012-12#1)
enhances recombinant protein##2##3##(2008-11#1)(2008-7#1)
enhances the effect of##4##4##(1996-2#1)(1997-7#1)(2007-4#1)(2012-6#1)
enhances the extraction efficiency##2##4##(2008-10#2)
enhances the sensitivity to##2##4##(2008-10#1)(2012-12#1)
enhances the sensitivity##3##3##(1997-7#1)(2008-10#1)(2012-12#1)
enhances the##63##2##(1990-2#1)(1991-12#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#4)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2012-6#2)(2013-1#1)
enhances##169##1##(1990-2#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#3)(1997-2#2)(1997-3#1)(1997-7#9)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#7)(2008-9#5)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2012-6#2)(2013-1#7)(2013-8#2)
enhancing acute performance##2##3##(2009-1#2)
enhancing and##2##2##(2009-4#1)(2010-10#1)
enhancing communications##2##2##(1992-2#1)(2010-2#1)
enhancing effect of vitamin A acetate##2##6##(2008-11#2)
enhancing effect of##8##3##(1992-2#1)(1995-12#3)(2008-10#2)(2008-11#2)
enhancing effect on the##6##4##(2008-10#5)(2008-6#1)
enhancing effect on##7##3##(2008-10#5)(2008-6#1)(2009-8#1)
enhancing effect##18##2##(1992-2#1)(1995-12#3)(1997-2#1)(2008-10#8)(2008-11#3)(2008-6#1)(2009-8#1)
enhancing effects of##3##3##(1992-5#1)(1994-5#1)(2008-8#1)
enhancing effects##5##2##(1992-5#1)(1994-5#1)(2008-5#1)(2008-8#2)
enhancing factor##10##2##(1990-11#2)(1993-6#1)(1994-11#1)(1994-2#5)(2008-10#1)
enhancing its##3##2##(2009-8#1)(2011-2#1)(2013-8#1)
enhancing lesions##2##2##(1991-6#1)(2013-8#1)
enhancing or##2##2##(2008-7#2)
enhancing patient##2##2##(2008-11#1)(2008-3#1)
enhancing protein production##2##3##(2008-11#1)(2008-7#1)
enhancing the capacity of##2##4##(1997-1#1)(1997-3#1)
enhancing the diffraction efficiency of##2##5##(2007-11#1)(2008-3#1)
enhancing the efficacy of##2##4##(2007-12#1)(2009-12#1)
enhancing the production of##3##4##(2008-11#2)(2011-1#1)
enhancing the quality##2##3##(2008-11#1)(2008-9#1)
enhancing the sensitivity of##2##4##(2008-10#1)(2008-3#1)
enhancing the sensitivity##3##3##(2008-10#2)(2008-3#1)
enhancing the##49##2##(1993-9#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
enhancing their##8##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2013-7#1)
enhancing##201##1##(1990-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#3)(1992-5#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#28)(2008-11#18)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#1)(2009-1#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#6)
enigma##8##1##(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
enigmatic##14##1##(1993-5#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)
enjoy enhanced levels of staff development and motivation and improve long-term financial performance##2##13##(1994-1#2)
enjoy more##2##2##(1991-12#1)(2008-11#1)
enjoy music##2##2##(2008-11#1)(2008-9#1)
enjoy the##2##2##(1996-3#1)(2008-11#1)
enjoy##17##1##(1990-2#1)(1991-12#2)(1992-2#1)(1994-1#2)(1996-3#1)(1996-5#1)(1997-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#2)(2010-3#1)
enjoyable and##2##2##(2008-11#1)(2008-8#1)
enjoyed a##2##2##(2008-11#1)(2008-9#1)
enjoyed considerable success in##2##4##(1996-6#1)(2008-7#1)
enjoyed the##2##2##(2008-4#1)(2009-10#1)
enjoyed##16##1##(1993-2#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
enjoying##2##1##(2008-7#1)(2008-9#1)
enjoyment##7##1##(2007-6#5)(2008-9#1)(2013-1#1)
enjoys a##2##2##(2008-1#1)(2012-1#1)
enjoys##6##1##(1996-9#1)(2008-1#1)(2012-1#2)(2013-1#2)
enkephalin##6##1##(1991-1#2)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#1)
enkephalins in rat##2##3##(1991-3#1)(1997-2#1)
enkephalins##4##1##(1991-3#1)(1994-2#1)(1997-2#1)(2009-7#1)
enlarge the##4##2##(2008-10#3)(2008-8#1)
enlarge##9##1##(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
enlarged and##3##2##(1993-12#1)(2007-11#1)(2008-7#1)
enlarged canopy##2##2##(2008-10#2)
enlarged in##3##2##(2008-10#2)(2008-11#1)
enlarged lymph nodes##4##3##(1990-8#1)(1993-3#1)(2012-3#1)(2013-8#1)
enlarged lymph##5##2##(1990-8#1)(1993-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
enlarged mediastinal lymph nodes##2##4##(1990-8#1)(2013-1#1)
enlarged or##2##2##(2008-10#1)(2009-10#1)
enlarged over##2##2##(2008-10#1)(2008-7#1)
enlarged with##2##2##(1997-7#1)(2008-10#1)
enlarged##66##1##(1990-8#2)(1993-12#1)(1993-3#1)(1995-2#1)(1995-4#1)(1996-6#3)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#4)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
enlargement and##8##2##(1996-7#1)(2007-10#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-5#1)(2013-8#1)
enlargement in##4##2##(2010-12#1)(2010-4#1)(2012-12#2)
enlargement is a##2##3##(2012-12#2)
enlargement is##3##2##(2008-7#1)(2012-12#2)
enlargement of the left##2##4##(2008-10#1)(2012-12#1)
enlargement of the##17##3##(1995-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
enlargement of##24##2##(1995-2#1)(1995-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#3)(2008-7#1)(2009-4#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
enlargement##57##1##(1990-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-5#1)(1997-7#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#3)(2008-3#4)(2008-7#4)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#12)(2012-2#2)(2012-3#1)(2013-8#1)
enlargements of the##2##3##(2008-7#1)(2013-1#1)
enlargements of##3##2##(1995-2#1)(2008-7#1)(2013-1#1)
enlargements##4##1##(1995-2#1)(2008-7#1)(2013-1#2)
enlarges the##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
enlarging the##3##2##(1994-2#1)(2007-12#1)(2008-3#1)
enlarging##12##1##(1990-2#1)(1994-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2012-3#1)(2013-1#1)
enlighten##3##1##(1993-3#1)(2008-8#1)(2013-1#1)
enlightened##4##1##(1995-3#1)(2008-12#1)(2012-2#1)(2012-3#1)
enlightening##5##1##(1995-9#1)(2008-11#2)(2010-3#1)(2012-3#1)
enlightenment##4##1##(1991-12#1)(1994-1#1)(1995-5#1)(2011-2#1)
enlisted##3##1##(1991-3#1)(1991-8#1)(1994-12#1)
enlisting##2##1##(1992-12#1)(2011-2#1)
enol##2##1##(2009-12#1)(2009-5#1)
enolase (NSE) in##4##3##(1990-2#1)(1990-6#1)(1992-11#1)(2011-2#1)
enolase (NSE)##5##2##(1990-2#1)(1990-6#1)(1992-11#1)(2011-2#2)
enolase and##2##2##(1991-6#1)(2013-8#1)
enolase##20##1##(1990-2#3)(1990-6#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#1)(1996-5#1)(2009-6#1)(2009-8#1)(2011-2#5)(2012-2#1)(2013-8#1)
enolate##5##1##(1996-5#3)(2007-11#1)(2007-12#1)
enological##2##1##(2008-10#2)
enone##2##1##(1996-5#1)(2010-7#1)
enormous cost##2##2##(2007-10#1)(2009-4#1)
enormous data##2##2##(2011-1#1)(2013-8#1)
enormous impact on##3##3##(2008-1#1)(2008-10#2)
enormous potential for##2##3##(2007-11#1)(2012-12#1)
enormous potential##5##2##(2007-11#2)(2008-10#1)(2009-7#1)(2012-12#1)
enormous promise##2##2##(2008-7#1)(2008-9#1)
enormous##54##1##(1992-3#1)(1994-1#2)(1995-12#1)(1995-2#1)(1997-5#1)(2006-4#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#5)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
enormously##5##1##(1991-12#1)(1994-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
enough evidence##2##2##(2007-2#1)(2011-2#1)
enough for field##2##3##(2011-1#2)
enough for the##4##3##(1994-1#1)(2008-1#1)(2008-10#1)(2010-6#1)
enough for##22##2##(1991-12#1)(1994-1#1)(1995-3#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-12#4)(2013-1#2)
enough in the##2##3##(2008-11#1)(2012-2#1)
enough in##5##2##(1997-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
enough information for##2##3##(2008-1#1)(2008-10#1)
enough information##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
enough justification for##2##3##(2008-11#1)(2008-2#1)
enough stability##2##2##(2008-10#1)(2008-8#1)
enough that##2##2##(2008-2#1)(2010-3#1)
enough time##2##2##(2008-8#2)
enough to allow##6##3##(1992-12#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-10#2)
enough to amplify##2##3##(2008-10#2)
enough to be##9##3##(1991-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
enough to cause##4##3##(1997-6#1)(2008-3#2)(2008-5#1)
enough to change##2##3##(2007-7#1)(2008-9#1)
enough to fit##2##3##(1994-2#1)(2007-12#1)
enough to have##3##3##(1994-1#1)(1995-11#1)(1996-4#1)
enough to improve##2##3##(2008-2#1)(2012-2#1)
enough to induce##3##3##(1990-12#1)(1996-5#1)(2008-10#1)
enough to interfere with##2##4##(2008-7#2)
enough to make##2##3##(2008-9#1)(2012-3#1)
enough to perform##3##3##(1997-2#1)(2008-1#1)(2008-10#1)
enough to permit the##2##4##(1997-2#1)(2008-2#1)
enough to produce##2##3##(2008-10#1)(2008-11#1)
enough to##119##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#3)(1992-12#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#5)(2009-4#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
enough##221##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-2#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#34)(2008-11#11)(2008-12#1)(2008-2#13)(2008-3#18)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#7)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#3)
enough?##4##1##(1992-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
enoxacin (ENO)##3##2##(2008-10#3)
enoxacin (ENX)##2##2##(2008-10#1)(2010-4#1)
enoxacin##6##1##(2008-10#4)(2010-4#2)
enoxaparin and sulodexide##2##3##(2013-8#2)
enoxaparin vs##2##2##(2008-10#1)(2013-8#1)
enoxaparin##15##1##(2007-10#3)(2007-7#3)(2008-10#2)(2008-3#4)(2013-8#3)
enoxaparin)##2##1##(2007-10#1)(2008-10#1)
enprofylline##2##1##(2007-8#2)
enquiry based learning##4##3##(2008-11#3)(2008-12#1)
enquiry was##3##2##(1991-9#1)(2008-10#2)
enquiry##15##1##(1991-9#1)(1995-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2012-2#1)
enquiry-based learning##3##2##(2008-12#3)
enrich cobalt and nickel##2##4##(2008-10#2)
enrich the##4##2##(1995-3#1)(2008-11#1)(2010-10#1)(2013-1#1)
enrich##19##1##(1995-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
enriched (137)Ba##4##2##(2010-8#4)
enriched and##3##2##(1991-6#1)(2008-10#1)(2012-12#1)
enriched at##3##2##(2008-10#2)(2012-3#1)
enriched by the##3##3##(2008-10#3)
enriched by##7##2##(1997-7#1)(2008-10#5)(2009-6#1)
enriched environment##11##2##(1991-2#2)(1992-11#8)(2008-7#1)
enriched fiber bundle##2##3##(1995-12#2)
enriched for the##3##3##(2008-10#1)(2009-12#1)(2009-8#1)
enriched for##9##2##(1994-12#1)(1997-5#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
enriched in a##2##3##(1997-3#1)(2008-10#1)
enriched in lycopene##2##3##(2010-4#2)
enriched in synaptic##2##3##(1995-6#1)(2008-1#1)
enriched in the##14##3##(1990-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-7#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-12#1)(2012-3#1)
enriched in transcriptionally active DNA##2##5##(1990-7#2)
enriched in##47##2##(1990-12#1)(1990-2#1)(1990-7#3)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#8)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#2)(2012-2#1)(2012-3#3)(2013-1#1)
enriched populations##2##2##(1995-11#1)(2009-3#1)
enriched solution##4##2##(2008-10#2)(2010-7#2)
enriched with the##2##3##(2008-10#2)
enriched with##18##2##(1995-2#1)(1996-2#1)(1996-5#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#1)
enriched##168##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#3)(1991-12#1)(1991-2#2)(1991-6#1)(1992-11#9)(1992-3#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#4)(1996-7#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2008-1#2)(2008-10#35)(2008-11#9)(2008-12#2)(2008-2#1)(2008-4#6)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#2)
enriches the##2##2##(2008-11#1)(2008-8#1)
enriches##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
enriching the##2##2##(2012-3#1)(2012-4#1)
enriching##9##1##(2008-10#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2012-2#1)(2012-3#1)(2012-4#1)
enrichment analysis##2##2##(2009-5#2)
enrichment and determination of silver##2##5##(2008-10#2)
enrichment and determination of##5##4##(2008-10#5)
enrichment and##12##2##(1996-12#1)(2008-10#9)(2009-8#1)(2013-7#1)
enrichment by##3##2##(1994-12#1)(1997-3#1)(2008-10#1)
enrichment culture was##3##3##(2008-6#2)(2008-7#1)
enrichment efficiency##2##2##(2008-10#2)
enrichment factor (EF)##4##3##(2008-10#4)
enrichment factor for##4##3##(2008-10#4)
enrichment factor of 100##2##4##(2008-10#2)
enrichment factor of##24##3##(2008-10#24)
enrichment factor was##3##3##(2008-10#3)
enrichment factor##44##2##(2008-10#44)
enrichment factors of##6##3##(2008-10#6)
enrichment factors##14##2##(2008-10#14)
enrichment for##5##2##(1994-12#1)(2008-2#3)(2008-5#1)
enrichment from##3##2##(2008-10#2)(2011-2#1)
enrichment has been##2##3##(2008-10#1)(2008-11#1)
enrichment in the##2##3##(2008-2#1)(2008-7#1)
enrichment in##9##2##(1990-8#1)(1996-5#3)(2008-2#1)(2008-7#3)(2009-8#1)
enrichment is##2##2##(1996-5#1)(2008-10#1)
enrichment method##2##2##(2008-10#2)
enrichment of metal ions in aquatic environments##2##7##(2008-10#2)
enrichment of metal ions##6##4##(2008-10#6)
enrichment of the protein##2##4##(1993-11#1)(1997-3#1)
enrichment of the##9##3##(1992-9#1)(1993-11#1)(1995-12#1)(1996-11#1)(1997-3#1)(2008-10#4)
enrichment of##59##2##(1992-9#2)(1993-11#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-11#1)(1997-3#1)(2008-10#33)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-4#1)(2013-7#3)
enrichment on##2##2##(2008-10#1)(2008-8#1)
enrichment over##2##2##(1990-5#1)(2008-10#1)
enrichment should##2##2##(2008-10#1)(2008-11#1)
enrichment system##3##2##(2008-10#2)(2011-2#1)
enrichment technique in minimal medium##2##5##(2012-2#2)
enrichment technique##4##2##(2008-10#2)(2012-2#2)
enrichment time##3##2##(2008-10#3)
enrichment was##2##2##(1996-5#1)(2013-1#1)
enrichment##255##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-8#2)(1992-9#2)(1993-11#5)(1994-1#1)(1994-12#3)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#6)(1997-3#3)(1997-7#1)(2007-7#1)(2008-10#142)(2008-11#6)(2008-2#5)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#3)(2009-4#2)(2009-5#4)(2009-8#4)(2010-11#2)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#5)(2012-2#6)(2012-3#3)(2012-4#1)(2013-1#1)(2013-7#4)
enrichments##5##1##(1994-3#1)(2008-7#2)(2009-4#1)(2013-8#1)
enrofloxacin and##2##2##(1997-3#1)(2008-12#1)
enrofloxacin##10##1##(1997-3#3)(2008-10#1)(2008-12#1)(2008-5#4)(2011-1#1)
enrol their children in malaria clinical##2##6##(2009-6#2)
enrol their children in##3##4##(2009-6#3)
enrol##5##1##(2009-6#5)
enroll##11##1##(1993-12#1)(1994-3#2)(1995-12#1)(1997-1#2)(1997-2#1)(2008-3#1)(2008-5#3)
enrolled and##4##2##(1995-12#1)(2007-12#1)(2013-1#2)
enrolled at##4##2##(1991-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
enrolled clinical pathways##2##3##(2010-8#2)
enrolled for the study##3##4##(2008-1#1)(2008-3#1)(2010-7#1)
enrolled for the##4##3##(2008-1#1)(2008-3#1)(2010-7#1)(2012-3#1)
enrolled for##7##2##(2008-1#1)(2008-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-3#1)
enrolled in a randomized##2##4##(1991-12#1)(2013-1#1)
enrolled in a##14##3##(1991-12#1)(1993-1#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
enrolled in an##3##3##(1993-12#1)(2008-11#1)(2009-11#1)
enrolled in the study##13##4##(1994-2#1)(1995-8#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
enrolled in the##28##3##(1992-2#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(2007-7#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)
enrolled in this study##6##4##(1994-12#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#2)
enrolled in this##9##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
enrolled in##84##2##(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#2)(1995-8#1)(1996-1#3)(1996-3#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2011-1#3)(2011-2#3)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
enrolled into##2##2##(1996-3#1)(2010-8#1)
enrolled nurse##2##2##(2007-10#1)(2008-12#1)
enrolled nurses##4##2##(2007-10#3)(2010-3#1)
enrolled patients##3##2##(2008-5#1)(2008-7#1)(2010-8#1)
enrolled##166##1##(1990-3#1)(1991-1#1)(1991-12#3)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#2)(1997-2#1)(2007-10#5)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#2)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#6)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#10)(2011-1#6)(2011-2#10)(2012-12#5)(2012-2#7)(2012-3#7)(2012-5#1)(2012-6#1)(2013-1#11)(2013-8#2)
enrolled)##3##1##(2008-1#1)(2008-4#2)
enrollee##4##1##(1993-3#2)(1996-1#1)(1997-3#1)
enrollee)##3##1##(1991-2#1)(1996-3#1)(2011-2#1)
enrollees are##3##2##(1994-2#2)(1997-3#1)
enrollees in prepaid##2##3##(1991-2#1)(1994-2#1)
enrollees in##5##2##(1991-2#1)(1994-2#1)(1996-2#2)(1997-2#1)
enrollees with##3##2##(1995-1#1)(1997-2#1)(2010-12#1)
enrollees##47##1##(1991-1#1)(1991-2#1)(1991-3#2)(1992-2#4)(1993-1#1)(1993-12#1)(1993-3#2)(1994-2#6)(1994-3#2)(1995-1#7)(1995-3#1)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#3)(2008-6#1)(2010-12#1)
enrollees'##4##1##(1991-1#1)(1997-2#1)(1997-3#2)
enrolling and##2##2##(1994-3#1)(1996-3#1)
enrolling in the##2##3##(1993-12#1)(1996-1#1)
enrolling in##3##2##(1993-12#1)(1995-12#1)(1996-1#1)
enrolling##10##1##(1991-2#1)(1993-12#1)(1994-3#1)(1995-12#3)(1996-1#1)(1996-3#1)(2008-5#1)(2010-11#1)
enrollment and##6##2##(1991-12#1)(1991-3#1)(1994-3#1)(1996-3#1)(2010-12#1)(2011-2#1)
enrollment decisions##3##2##(2009-6#3)
enrollment in health##2##3##(1991-3#1)(1995-1#1)
enrollment in##6##2##(1991-12#1)(1991-3#1)(1994-3#1)(1995-1#1)(1997-3#1)(2009-8#1)
enrollment of##2##2##(1991-1#1)(2008-12#1)
enrollment to##3##2##(1991-2#2)(2010-11#1)
enrollment##51##1##(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#4)(1992-2#2)(1993-3#2)(1994-2#1)(1994-3#7)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#2)(2007-4#1)(2008-12#1)(2008-5#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-5#2)(2013-1#3)
enrollments##2##1##(1992-1#1)(1994-12#1)
enrolls##2##1##(1990-2#1)(1997-1#1)
enrolment and##3##2##(2008-11#1)(2012-6#2)
enrolment in##2##2##(1997-3#1)(2008-7#1)
enrolment##11##1##(1997-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-7#3)(2009-3#1)(2012-12#1)(2012-6#2)
ensemble average##2##2##(2007-11#1)(2012-12#1)
ensemble of##10##2##(1994-5#2)(1997-2#1)(1997-6#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-3#1)
ensemble##21##1##(1994-5#2)(1997-2#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2009-10#1)(2010-3#1)(2012-12#1)
ensemble-averaged##3##1##(2007-11#1)(2008-2#2)
ensembles of GC neurons##2##4##(2008-11#2)
ensembles of##5##2##(2008-11#2)(2008-2#1)(2009-8#2)
ensembles##17##1##(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#4)(2009-8#2)(2012-1#1)(2013-8#2)
ensheath##2##1##(2008-7#2)
ensheathed##3##1##(2007-12#1)(2008-10#1)(2010-11#1)
ensheathing cells (OECs)##2##3##(2008-7#2)
ensheathing cells##5##2##(2008-7#5)
ensheathing##7##1##(2008-7#7)
ensiformis##2##1##(1993-6#1)(2008-10#1)
ensiling in##2##2##(2008-10#1)(2013-1#1)
ensiling##6##1##(2008-10#3)(2013-1#3)
ensis##3##1##(2012-2#3)
ensue##4##1##(2007-12#1)(2008-12#2)(2012-12#1)
ensued##5##1##(1993-10#1)(1995-12#1)(1997-1#1)(2008-10#1)(2012-2#1)
ensues##2##1##(2009-1#1)(2011-2#1)
ensuing##20##1##(1994-12#1)(1996-2#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
ensure a balanced##2##3##(1993-12#1)(2011-2#1)
ensure a successful##2##3##(2010-5#1)(2012-2#1)
ensure a##15##2##(1993-12#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
ensure adequate##8##2##(1990-5#1)(1995-1#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
ensure appropriate##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
ensure both##2##2##(1993-2#1)(1994-2#1)
ensure comparability##2##2##(1994-3#1)(2008-10#1)
ensure complete##4##2##(2008-10#2)(2008-11#2)
ensure data##3##2##(1994-3#1)(2008-10#2)
ensure greater##2##2##(2008-8#1)(2011-1#1)
ensure high quality##3##3##(1994-1#1)(1995-6#1)(2008-11#1)
ensure high##4##2##(1994-1#1)(1995-6#1)(2008-11#1)(2008-3#1)
ensure its##5##2##(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)
ensure optimal##3##2##(2008-10#1)(2009-8#1)(2010-10#1)
ensure proper##2##2##(1991-11#1)(2009-12#1)
ensure quality##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
ensure success##3##2##(2008-10#2)(2008-12#1)
ensure that individuals##2##3##(1994-2#1)(2009-6#1)
ensure that the##21##3##(1992-11#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
ensure that this##2##3##(1995-5#1)(2008-2#1)
ensure that##93##2##(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#2)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-6#2)(2009-7#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)
ensure the convergence##2##3##(1992-6#1)(2007-12#1)
ensure the most##2##3##(1992-2#1)(2008-10#1)
ensure the proper##2##3##(2008-7#1)(2010-4#1)
ensure the security##2##3##(1993-2#1)(1994-3#1)
ensure the##44##2##(1990-11#1)(1991-1#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#1)(2013-7#1)
ensure their##3##2##(1994-1#1)(2008-6#1)(2013-1#1)
ensure they are##3##3##(1995-12#1)(1996-12#1)(2013-1#1)
ensure they##4##2##(1994-2#1)(1995-12#1)(1996-12#1)(2013-1#1)
ensure##303##1##(1990-11#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#5)(1993-2#5)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#5)(1994-7#2)(1994-9#1)(1995-1#3)(1995-12#5)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#26)(2008-12#11)(2008-2#6)(2008-3#16)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#11)(2009-1#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#10)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#2)
ensured by a##2##3##(2008-10#1)(2008-3#1)
ensured by##8##2##(2007-11#1)(2008-10#2)(2008-3#3)(2010-7#1)(2012-2#1)
ensured that the##2##3##(1997-3#1)(1997-6#1)
ensured that##3##2##(1997-3#1)(1997-6#1)(2008-10#1)
ensured the##5##2##(1996-2#1)(2008-10#2)(2008-6#1)(2009-10#1)
ensured##29##1##(1990-3#1)(1991-5#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#9)(2008-3#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
ensures a##6##2##(1991-11#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
ensures an##2##2##(2008-10#1)(2008-3#1)
ensures continuous##2##2##(1992-5#1)(2008-2#1)
ensures high##2##2##(2007-7#1)(2012-3#1)
ensures perfect##2##2##(2007-11#1)(2008-2#1)
ensures that the##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
ensures that##10##2##(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-1#1)(2013-1#1)
ensures the##5##2##(1996-12#1)(2008-10#2)(2008-6#1)(2013-8#1)
ensures##45##1##(1991-11#1)(1991-2#1)(1992-5#1)(1994-3#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
ensuring access##2##2##(1996-1#1)(1996-3#1)
ensuring adequate##3##2##(1992-8#1)(2008-12#1)(2012-12#1)
ensuring enhanced##2##2##(2007-11#1)(2010-7#1)
ensuring safe##2##2##(2008-10#1)(2013-8#1)
ensuring that students have##2##4##(2008-11#1)(2012-12#1)
ensuring that their##2##3##(2008-4#1)(2010-9#1)
ensuring that##10##2##(1996-7#1)(1997-2#1)(1997-5#1)(2008-11#3)(2008-4#1)(2010-9#1)(2012-12#1)(2012-2#1)
ensuring the safety##2##3##(2010-6#1)(2011-2#1)
ensuring the##13##2##(1992-1#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
ensuring##76##1##(1990-11#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
ent-androsterone##2##1##(2008-8#2)
entA##4##1##(2008-10#4)
entactin##7##1##(1995-6#7)
entail a##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
entail##12##1##(1991-5#1)(1993-6#1)(1994-1#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-8#1)
entailed an##2##2##(2010-3#1)(2012-2#1)
entailed##11##1##(1991-2#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
entailing##2##1##(1997-3#1)(2008-9#1)
entails a##3##2##(1994-2#1)(2011-2#1)(2012-3#1)
entails the##9##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
entails##27##1##(1991-2#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)
entangled##6##1##(2007-11#2)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
entanglement##3##1##(2012-2#3)
entecavir and##3##2##(2009-8#2)(2013-1#1)
entecavir##5##1##(2009-8#3)(2013-1#2)
enter a##5##2##(1994-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2011-2#1)
enter and##2##2##(2008-10#1)(2012-2#1)
enter hair cells##3##3##(2009-8#1)(2012-2#2)
enter into a##2##3##(1993-3#1)(2008-9#1)
enter into the##3##3##(1991-2#1)(2008-5#1)(2008-8#1)
enter into##9##2##(1991-2#1)(1991-3#1)(1993-3#1)(1995-12#1)(2006-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
enter the cell##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-3#1)
enter the##36##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-2#1)(2009-6#1)(2010-1#1)(2011-2#3)(2011-3#1)(2012-3#1)
enter##80##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1993-3#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#2)(2010-1#1)(2011-2#7)(2011-3#1)(2012-2#5)(2012-3#1)
enteral nutrition for##2##3##(1993-6#1)(2013-1#1)
enteral nutrition##6##2##(1993-12#1)(1993-6#1)(2007-8#1)(2011-2#1)(2013-1#2)
enteral##8##1##(1993-12#1)(1993-6#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#3)
entered a##6##2##(1990-3#1)(1990-6#1)(1992-10#1)(1994-11#1)(2008-6#1)(2013-1#1)
entered an##2##2##(2008-5#1)(2011-2#1)
entered as##2##2##(2013-1#1)(2013-8#1)
entered clinical##2##2##(2008-3#1)(2008-7#1)
entered in a##2##3##(1993-11#1)(1993-5#1)
entered in the##3##3##(1992-6#1)(2007-8#1)(2008-7#1)
entered in##7##2##(1990-2#1)(1992-6#1)(1993-11#1)(1993-5#1)(1994-7#1)(2007-8#1)(2008-7#1)
entered into a##5##3##(1993-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)
entered into the##4##3##(2007-7#1)(2008-1#1)(2008-12#1)(2011-1#1)
entered into##13##2##(1993-1#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#1)(2011-1#1)(2012-1#1)(2013-1#1)
entered phase##2##2##(2008-5#1)(2011-2#1)
entered the internal##2##3##(2008-10#1)(2011-2#1)
entered the study##10##3##(1991-11#1)(1991-2#2)(1992-6#1)(1995-1#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
entered the##32##2##(1991-11#1)(1991-2#2)(1992-3#1)(1992-6#1)(1995-1#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-2#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#1)
entered##88##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-2#3)(1992-10#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-4#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
enteric bacteria##2##2##(2008-10#1)(2008-4#1)
enteric fever##3##2##(2011-2#1)(2012-3#2)
enteric nervous system##6##3##(1992-6#2)(2008-7#2)(2008-8#2)
enteric neurons##3##2##(1994-12#1)(2008-7#2)
enteric parasites##3##2##(1996-12#1)(2008-12#2)
enteric pathogen##4##2##(2011-1#2)(2011-2#1)(2013-8#1)
enteric pathogens##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
enteric##35##1##(1992-6#2)(1994-12#2)(1995-5#1)(1996-12#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#7)(2008-8#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
enterica ser##4##2##(1997-3#4)
enterica serovar Agona##5##3##(2007-6#5)
enterica serovar Tennessee##3##3##(1997-3#3)
enterica serovar Typhimurium##4##3##(2008-10#2)(2008-11#2)
enterica serovar##17##2##(1997-3#5)(2007-6#5)(2008-10#2)(2008-11#2)(2010-4#1)(2012-3#2)
enterica##24##1##(1997-3#9)(2007-6#7)(2007-7#1)(2008-10#2)(2008-11#2)(2010-4#1)(2012-3#2)
entering a##6##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)
entering an##2##2##(2008-10#1)(2012-3#1)
entering and##2##2##(2008-10#1)(2009-5#1)
entering clinical trials##3##3##(1996-6#1)(2008-10#1)(2010-5#1)
entering into##5##2##(1993-3#2)(1994-3#1)(2008-12#1)(2008-8#1)
entering medical##2##2##(2007-4#2)
entering the##23##2##(1990-3#1)(1991-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-5#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
entering##58##1##(1990-3#1)(1991-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-5#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
enteritidis in##3##2##(1990-6#1)(1994-7#1)(1995-9#1)
enteritidis infection##2##2##(1995-9#2)
enteritidis##21##1##(1990-12#1)(1990-6#3)(1991-11#2)(1993-2#1)(1994-7#1)(1995-9#9)(1997-3#1)(2007-8#2)(2008-10#1)
enteritis and##2##2##(1993-2#1)(2011-2#1)
enteritis in##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
enteritis##18##1##(1990-6#1)(1991-3#1)(1991-8#1)(1993-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#2)(2010-12#3)(2011-2#3)(2012-2#3)
enterobacterial repetitive intergenic consensus (ERIC)##2##5##(2008-10#2)
enterobacterial repetitive intergenic consensus##3##4##(2008-10#3)
enterobacterial repetitive##4##2##(2008-10#4)
enterobacterial##7##1##(1990-11#1)(1995-2#1)(2008-10#5)
enterococci##5##1##(1996-3#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
enterococcus##2##1##(2007-12#1)(2008-10#1)
enterocolitica and##2##2##(2013-8#2)
enterocolitica##17##1##(1992-5#1)(1996-12#2)(1997-4#5)(2007-7#4)(2008-11#2)(2013-8#3)
enterocolitis in##2##2##(2011-2#1)(2012-2#1)
enterocolitis##3##1##(2011-2#1)(2012-2#2)
enterocolitis]##2##1##(2010-6#1)(2011-2#1)
enterocyte effacement##2##2##(1995-2#1)(2011-1#1)
enterocyte##11##1##(1990-11#1)(1991-12#2)(1992-2#3)(1995-2#1)(1996-5#2)(2009-9#1)(2011-1#1)
enterocytes of##3##2##(1994-6#1)(1997-6#1)(2008-10#1)
enterocytes##18##1##(1990-11#1)(1990-12#1)(1991-12#2)(1992-2#1)(1993-6#1)(1994-6#4)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-8#1)(2009-9#1)(2013-8#1)
enterohemolysin##2##1##(1993-9#2)
enterohemorrhagic##2##1##(1995-2#1)(2008-9#1)
enterokinase##2##1##(1990-12#1)(2009-3#1)
enteroliths##2##1##(2010-12#2)
enteroparesis##2##1##(2012-3#2)
enteropathica##2##1##(1991-3#1)(2008-10#1)
enteropathogenic Escherichia coli (EPEC)##2##4##(1992-2#1)(2011-2#1)
enteropathogenic Escherichia coli##4##3##(1992-2#2)(2011-1#1)(2011-2#1)
enteropathogenic##6##1##(1992-2#2)(2011-1#2)(2011-2#2)
enteropathy##2##1##(1997-5#1)(2011-2#1)
enteroscopy##4##1##(2009-8#1)(2012-2#2)(2013-1#1)
enterotoxaemia##4##1##(1997-8#4)
enterotoxigenic Escherichia coli##2##3##(2008-8#2)
enterotoxigenic##3##1##(1991-8#1)(2008-8#2)
enterotoxin A##2##2##(1990-12#1)(1993-6#1)
enterotoxin production by##2##3##(1997-4#1)(2011-2#1)
enterotoxin production##5##2##(1997-4#2)(2011-2#3)
enterotoxin##17##1##(1990-12#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#2)(1994-8#1)(1995-2#1)(1997-4#2)(2008-10#1)(2011-2#4)
enterotoxins##2##1##(1997-4#1)(2009-9#1)
enterovirus 71 strain##2##3##(2013-8#2)
enterovirus 71##5##2##(2008-12#2)(2013-8#3)
enterovirus infection##2##2##(2011-1#2)
enterovirus were##2##2##(2011-1#2)
enterovirus##15##1##(2008-12#2)(2011-1#7)(2011-3#2)(2012-3#1)(2013-8#3)
enteroviruses##5##1##(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
enterprise as a whole##2##4##(1995-3#1)(1996-3#1)
enterprise data##2##2##(1997-1#1)(1997-3#1)
enterprise in##2##2##(1997-5#1)(2007-12#1)
enterprise##18##1##(1994-12#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-5#1)(2007-12#3)(2008-12#2)(2010-12#1)
enterprise-wide Electronic Health Record##2##4##(2008-7#2)
enterprises and##2##2##(1993-12#1)(1995-6#1)
enterprises##6##1##(1993-12#1)(1995-6#3)(2009-8#1)(2013-8#1)
enters the##13##2##(1992-4#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
enters##17##1##(1990-5#1)(1992-4#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#1)
entertained##2##1##(1992-12#1)(1993-9#1)
entertainment and##2##2##(1996-8#1)(2008-11#1)
entertainment##9##1##(1996-8#1)(2008-1#1)(2008-11#4)(2009-5#1)(2010-8#1)(2013-8#1)
enthalpic##2##1##(1996-2#1)(2008-10#1)
enthalpically##3##1##(1993-8#1)(2008-10#2)
enthalpies and##2##2##(1997-2#1)(2008-10#1)
enthalpies of##2##2##(1990-8#1)(1992-10#1)
enthalpies##9##1##(1990-8#2)(1992-10#1)(1997-2#3)(2008-10#3)
enthalpimetric measurements##2##2##(2008-10#2)
enthalpimetric##3##1##(2008-10#3)
enthalpy and entropy changes##2##4##(1996-2#1)(2008-10#1)
enthalpy and entropy of##3##4##(2008-10#2)(2008-4#1)
enthalpy and entropy##7##3##(1996-2#1)(1997-2#1)(2008-10#4)(2008-4#1)
enthalpy and free energy##2##4##(2008-10#2)
enthalpy and volume changes##2##4##(1990-8#2)
enthalpy and##11##2##(1990-8#2)(1996-2#1)(1997-2#1)(2008-10#6)(2008-4#1)
enthalpy change##5##2##(1990-8#1)(1993-8#1)(2008-10#2)(2008-11#1)
enthalpy estimates##4##2##(1997-2#4)
enthalpy in Tris##2##3##(1992-10#2)
enthalpy of folding##2##3##(1992-5#2)
enthalpy of##12##2##(1990-8#3)(1992-10#2)(1992-5#3)(1994-3#1)(1994-5#1)(2008-10#1)(2008-2#1)
enthalpy##54##1##(1990-8#7)(1992-10#4)(1992-5#3)(1993-8#3)(1994-3#2)(1994-5#1)(1995-2#1)(1996-2#2)(1997-2#10)(1997-7#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#2)
enthalpy-entropy compensation study revealed that##2##5##(2008-10#2)
enthalpy-entropy##3##1##(2008-10#3)
enthusiasm and##2##2##(1995-12#1)(2008-11#1)
enthusiasm for##5##2##(1996-3#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)
enthusiasm##12##1##(1995-12#1)(1996-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)
enthusiast##3##1##(1997-8#1)(2007-12#1)(2013-1#1)
enthusiastic##5##1##(1991-12#1)(1995-12#1)(1996-12#1)(2010-3#1)(2013-8#1)
enthusiasts##3##1##(1996-11#1)(2008-5#1)(2010-5#1)
entire cell##2##2##(2008-4#1)(2011-1#1)
entire chromosome##5##2##(1997-5#1)(2008-10#1)(2008-5#2)(2012-3#1)
entire concentration range##2##3##(2008-10#2)
entire genome##16##2##(1996-12#1)(1996-6#4)(1996-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2011-2#1)
entire genomes##4##2##(2008-4#2)(2008-7#1)(2009-10#1)
entire genomic sequence##2##3##(1996-12#1)(2008-10#1)
entire growing season##2##3##(2008-10#1)(2012-7#1)
entire internal##2##2##(2008-10#1)(2013-7#1)
entire length##7##2##(1990-5#1)(1996-10#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-2#1)(2009-7#1)
entire lifetime##4##2##(2008-10#1)(2009-2#2)(2011-2#1)
entire measurement##2##2##(2008-10#1)(2008-3#1)
entire method##2##2##(1997-3#1)(2008-10#1)
entire mtDNA control region sequences were generated and analyzed in a population sample from##2##14##(2008-12#2)
entire mtDNA##3##2##(2008-12#3)
entire open reading frame##4##4##(1990-12#1)(1993-6#1)(2008-8#1)(2013-8#1)
entire organism##2##2##(1994-11#1)(2008-4#1)
entire period of##2##3##(1992-11#1)(2008-11#1)
entire procedure for##2##3##(1991-12#1)(2010-6#1)
entire procedure##9##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-8#1)(2008-10#3)(2008-9#1)(2010-6#1)
entire region##4##2##(1995-6#1)(1996-6#1)(2009-7#1)(2011-2#1)
entire sequence of##5##3##(1991-3#1)(1993-6#1)(1996-8#1)(2008-5#1)(2013-8#1)
entire sequence##10##2##(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-5#1)(2013-8#1)
entire set of##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
entire spectral##2##2##(2008-2#1)(2008-3#1)
entire team##2##2##(1997-3#1)(2007-8#1)
entire to undulate (vs##2##4##(2008-5#2)
entire##391##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#6)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#1)(1996-6#8)(1996-8#3)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#1)(2007-11#7)(2007-12#12)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#57)(2008-11#8)(2008-12#8)(2008-2#14)(2008-3#19)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#23)(2008-8#10)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-7#4)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#6)(2012-7#2)(2012-9#1)(2013-1#6)(2013-3#1)(2013-7#1)(2013-8#2)
entirely by the##3##3##(2008-12#1)(2008-3#1)(2012-2#1)
entirely by##4##2##(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
entirely compatible with##2##3##(1994-12#1)(1995-3#1)
entirely consistent##3##2##(1990-11#1)(1990-6#1)(1993-12#1)
entirely different##4##2##(1994-11#1)(1997-4#1)(2010-8#1)(2012-3#1)
entirely eliminated##2##2##(1990-11#1)(2008-10#1)
entirely from##2##2##(1991-8#1)(1997-3#1)
entirely in##5##2##(1995-11#1)(2008-1#1)(2008-3#2)(2009-12#1)
entirely independent##2##2##(2008-10#1)(2008-9#1)
entirely new##5##2##(1990-12#1)(1993-2#1)(2008-3#2)(2010-3#1)
entirely of##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
entirely or##2##2##(2008-10#1)(2008-8#1)
entirely prevents the##2##3##(1991-2#1)(1995-5#1)
entirely suppresses##2##2##(2008-10#1)(2008-2#1)
entirely to the##2##3##(1993-8#1)(2008-3#1)
entirely to##3##2##(1993-12#1)(1993-8#1)(2008-3#1)
entirely with##3##2##(2008-2#2)(2008-5#1)
entirely within##2##2##(1996-5#1)(1997-1#1)
entirely##102##1##(1990-11#3)(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2007-10#1)(2007-11#2)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
entirety of##3##2##(1997-3#1)(1997-5#1)(2012-3#1)
entities and the##2##3##(2011-2#1)(2012-12#1)
entities and##4##2##(1996-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
entities are##5##2##(1991-3#1)(1991-8#1)(1994-2#1)(2007-11#1)(2008-7#1)
entities from##3##2##(2008-10#1)(2009-2#1)(2010-6#1)
entities in the##2##3##(2008-10#1)(2010-7#1)
entities in##8##2##(1991-12#1)(1991-6#1)(1993-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-7#1)(2011-1#1)
entities involved##3##2##(2009-11#1)(2012-1#1)(2013-1#1)
entities such as##4##3##(2008-3#1)(2011-2#2)(2012-2#1)
entities that##5##2##(1991-3#1)(1993-3#1)(1996-3#1)(2009-8#1)(2013-1#1)
entities which##3##2##(1991-8#1)(2011-1#1)(2012-12#1)
entities with a##2##3##(2008-3#1)(2011-2#1)
entities with##4##2##(1991-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
entities##91##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#3)(1994-1#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-2#1)(1996-3#5)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#5)(2010-10#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#3)(2013-8#1)
entitled &quot##11##2##(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
entitled the##2##2##(1996-2#1)(2011-2#1)
entitled to##9##2##(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-1#1)
entitled##36##1##(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#3)(1995-3#5)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
entitlement##6##1##(1992-2#1)(1992-8#1)(1993-2#1)(1995-2#1)(2011-2#1)(2012-3#1)
entitles##2##1##(1992-11#1)(2012-2#1)
entity and##8##2##(1990-3#1)(1993-12#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-1#1)(2013-1#2)
entity but##2##2##(1991-3#1)(2008-10#1)
entity for##2##2##(2009-12#1)(2009-6#1)
entity from##2##2##(2012-2#1)(2013-1#1)
entity in##7##2##(1993-12#1)(2007-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
entity is##5##2##(1992-2#1)(2007-12#1)(2008-2#1)(2011-1#1)(2013-8#1)
entity makes##2##2##(1996-12#1)(2009-5#1)
entity of##8##2##(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-1#1)
entity that is##2##3##(1993-8#1)(2011-2#1)
entity that##7##2##(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
entity which##2##2##(1990-10#1)(1996-12#1)
entity whose##3##2##(1991-6#1)(1993-10#1)(2012-2#1)
entity with##5##2##(1994-12#1)(2007-5#1)(2008-10#1)(2010-12#1)(2011-1#1)
entity##137##1##(1990-10#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#1)(1993-10#1)(1993-12#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#2)(1997-2#2)(1997-3#1)(2006-10#1)(2007-12#3)(2007-5#2)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#3)
entomological knowledge##2##2##(2010-1#2)
entomological##12##1##(2008-6#1)(2008-8#1)(2010-1#6)(2012-12#4)
entomologist##3##1##(2010-1#3)
entomologists##5##1##(2010-1#5)
entomology and parasitology##2##3##(2010-1#2)
entomology and##4##2##(2010-1#4)
entomology in Brazil##2##3##(2010-1#2)
entomology in##6##2##(2010-1#6)
entomology##23##1##(2010-1#23)
entomopathogenic fungi##2##2##(2008-5#2)
entomopathogenic nematodes for##3##3##(2008-8#2)(2011-2#1)
entomopathogenic##8##1##(2008-5#2)(2008-6#2)(2008-8#2)(2011-2#2)
entomopoxvirus##2##1##(2007-12#2)
entopeduncular##2##1##(1996-12#1)(1997-3#1)
entorhinal cortex and##2##3##(1994-3#1)(1997-2#1)
entorhinal cortex pars medialis##2##4##(1994-8#2)
entorhinal cortex##21##2##(1992-1#1)(1994-2#1)(1994-3#6)(1994-8#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#6)
entorhinal##24##1##(1991-5#1)(1992-1#1)(1992-11#1)(1994-2#1)(1994-3#6)(1994-8#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#6)(2009-8#1)
entorhinal-hippocampal loop##3##2##(2008-11#3)
entrained##5##1##(1995-11#1)(1995-3#1)(1996-12#1)(2008-2#1)(2008-5#1)
entrainer##2##1##(1990-5#1)(2013-1#1)
entrainment of the circadian oscillator##2##5##(1993-12#2)
entrainment of the##3##3##(1993-12#2)(2008-5#1)
entrainment of##5##2##(1990-5#2)(1993-12#2)(2008-5#1)
entrainment##10##1##(1990-5#2)(1993-12#2)(1994-2#1)(1994-3#1)(2008-5#2)(2012-2#2)
entrance and exit##2##3##(2008-3#2)
entrance and##3##2##(2008-2#1)(2008-3#2)
entrance aperture##2##2##(2008-2#1)(2008-3#1)
entrance into the##2##3##(1992-2#1)(2008-10#1)
entrance into##3##2##(1992-2#1)(2008-10#1)(2009-7#1)
entrance of##6##2##(1991-9#1)(1992-12#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-3#1)
entrance pupil##2##2##(2007-11#1)(2007-12#1)
entrance slit##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
entrance window##2##2##(2007-12#1)(2008-2#1)
entrance##36##1##(1991-9#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#1)
entrances##2##1##(2011-2#1)(2013-8#1)
entrants##5##1##(1991-12#1)(1994-1#1)(1994-3#1)(1997-2#1)(2007-7#1)
entrapment and##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
entrapment by estoppel##3##3##(1994-3#3)
entrapment by##4##2##(1994-3#3)(2012-3#1)
entrapment in##4##2##(2008-10#4)
entrapment of##6##2##(1993-8#1)(2008-10#3)(2008-11#2)
entrapment##33##1##(1992-11#1)(1992-2#1)(1993-8#1)(1994-3#3)(1994-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#3)(2012-3#1)(2012-6#1)
entrapped hepatocytes##2##2##(2008-11#2)
entrapped in a##3##3##(2008-10#3)
entrapped in lipid vesicles##2##4##(1990-2#2)
entrapped in the##4##3##(2008-10#4)
entrapped in##12##2##(1990-2#2)(2008-10#9)(2013-1#1)
entrapped peroxidase##2##2##(2008-10#2)
entrapped within the##2##3##(2008-10#1)(2008-8#1)
entrapped within##3##2##(2008-10#2)(2008-8#1)
entrapped##29##1##(1990-2#4)(1995-3#1)(2008-10#15)(2008-11#5)(2008-8#1)(2011-2#1)(2012-6#1)(2013-1#1)
entrapping a##2##2##(2008-7#1)(2011-1#1)
entrapping##6##1##(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
entraps##2##1##(1997-1#1)(2008-11#1)
entre##3##1##(2009-10#2)(2011-2#1)
entrepreneurial##2##1##(1997-3#1)(2011-2#1)
entrepreneurs##4##1##(1996-2#3)(2009-12#1)
entrepreneurship##3##1##(2009-12#2)(2011-2#1)
entries and##2##2##(1997-6#1)(2008-10#1)
entries from##2##2##(2008-10#1)(2008-7#1)
entries in the##2##3##(1992-2#1)(2011-2#1)
entries in##4##2##(1992-2#1)(2008-2#1)(2008-4#1)(2011-2#1)
entries into the##2##3##(2008-11#1)(2008-8#1)
entries into##4##2##(1993-6#1)(1993-8#1)(2008-11#1)(2008-8#1)
entries that used##2##3##(2008-10#2)
entries that##3##2##(2008-10#3)
entries were##2##2##(1993-6#1)(2008-10#1)
entries##26##1##(1992-2#1)(1993-6#3)(1993-8#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
entropically driven##3##2##(1993-8#3)
entropically##6##1##(1993-8#3)(2008-10#3)
entropies##2##1##(1997-2#1)(2008-10#1)
entropy analysis##2##2##(2007-12#2)
entropy and the##2##3##(2008-10#1)(2013-8#1)
entropy and##4##2##(1993-12#1)(1997-2#1)(2008-10#1)(2013-8#1)
entropy change##3##2##(1995-2#1)(1995-5#1)(2008-10#1)
entropy in##2##2##(1995-2#1)(2007-11#1)
entropy of the##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
entropy of##7##2##(1993-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-9#1)(2013-8#1)
entropy##42##1##(1990-8#1)(1992-6#1)(1993-12#4)(1993-3#1)(1995-2#3)(1995-5#2)(1996-2#2)(1997-2#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-7#1)(2013-8#3)
entrusted with##2##2##(2007-5#1)(2009-4#1)
entry and at##2##3##(1990-5#1)(2011-1#1)
entry and exit##2##3##(1994-9#1)(2008-5#1)
entry and were##2##3##(1990-5#1)(2011-1#1)
entry and##18##2##(1990-5#2)(1993-12#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#1)
entry criteria##2##2##(1997-5#1)(2011-2#1)
entry for##2##2##(1997-1#1)(2009-9#1)
entry in the##3##3##(1991-12#1)(1995-2#1)(2008-5#1)
entry in##5##2##(1991-12#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
entry inhibitors##7##2##(2011-2#6)(2011-3#1)
entry into S phase##2##4##(1992-10#2)
entry into S##4##3##(1992-10#2)(1994-3#1)(1997-7#1)
entry into mitosis##3##3##(1991-2#1)(2012-12#2)
entry into the##13##3##(1990-8#1)(1992-5#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
entry into##31##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-10#2)(1992-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#3)
entry is##2##2##(1990-12#1)(1994-6#1)
entry of the##2##3##(1997-6#1)(2008-5#1)
entry of##10##2##(1990-11#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)
entry point##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
entry points##3##2##(1995-2#1)(1996-3#1)(2008-10#1)
entry site (IRES)##3##3##(1997-8#1)(2008-10#1)(2008-9#1)
entry site##6##2##(1993-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
entry sites##4##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-8#1)
entry through##2##2##(1994-8#1)(2012-12#1)
entry to the first tongue##2##5##(1997-6#2)
entry to the first##3##4##(1997-6#2)(2008-11#1)
entry to the##6##3##(1997-6#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
entry to##12##2##(1994-12#1)(1997-6#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-11#1)(2012-2#1)(2012-3#1)
entry via##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
entry was##4##2##(1993-9#1)(2008-11#1)(2008-6#1)(2010-8#1)
entry##178##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#2)(1992-5#3)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#2)(1995-2#5)(1995-3#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#16)(2008-11#17)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#11)(2011-3#2)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#7)(2013-8#1)
entry-level##4##1##(1995-3#4)
entwined##2##1##(2008-1#1)(2010-1#1)
enucleated##9##1##(1992-10#2)(1994-8#1)(2008-9#6)
enucleation of the##2##3##(1992-9#1)(2009-4#1)
enucleation of##3##2##(1992-9#1)(2008-5#1)(2009-4#1)
enucleation rates##3##2##(2013-1#3)
enucleation##11##1##(1992-9#1)(2007-12#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#4)
enucleations##3##1##(1993-9#1)(2008-3#1)(2011-2#1)
enumerate the##3##2##(2009-7#1)(2010-2#1)(2010-8#1)
enumerate##5##1##(2008-4#2)(2009-7#1)(2010-2#1)(2010-8#1)
enumerated##8##1##(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)
enumerating##9##1##(2008-10#2)(2008-9#5)(2010-10#1)(2012-2#1)
enumeration and##4##2##(2008-10#2)(2008-9#2)
enumeration of these cells##2##4##(2008-9#1)(2010-1#1)
enumeration of##12##2##(1996-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-9#7)(2010-1#1)
enumeration task##3##2##(2013-8#3)
enumeration##27##1##(1996-3#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-9#15)(2010-1#1)(2010-8#1)(2013-8#3)
enuresis in##2##2##(2007-7#1)(2013-8#1)
enuresis was##3##2##(2007-7#3)
enuresis##26##1##(1991-3#1)(1994-8#1)(1997-5#1)(2007-7#11)(2008-10#3)(2013-8#9)
env are##2##2##(1994-8#1)(2008-9#1)
env gene##3##2##(2007-6#2)(2013-8#1)
env mRNAs##3##2##(1994-8#3)
env##15##1##(1994-12#1)(1994-7#2)(1994-8#4)(2007-6#2)(2008-11#2)(2008-9#3)(2013-8#1)
envelop the##2##2##(2008-6#1)(2008-7#1)
envelope (CE)##2##2##(2008-5#2)
envelope and##11##2##(1993-12#1)(1994-8#1)(2007-12#2)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#3)
envelope extremes##2##2##(2008-3#2)
envelope gene##2##2##(1994-8#1)(2013-1#1)
envelope glycoprotein gp120 of HIV-1##2##5##(1993-3#2)
envelope glycoprotein##8##2##(1991-2#1)(1993-3#2)(1995-5#1)(2008-10#1)(2008-4#1)(2013-8#2)
envelope glycoproteins##3##2##(1990-2#1)(1994-8#1)(2011-2#1)
envelope is a##2##3##(1994-5#1)(2008-8#1)
envelope is##5##2##(1994-5#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
envelope membrane##3##2##(1995-2#2)(2009-10#1)
envelope of the##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#1)
envelope of##8##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2009-8#1)(2013-1#1)
envelope protein or##2##3##(1993-12#1)(1995-5#1)
envelope protein##7##2##(1993-12#1)(1994-8#1)(1995-5#1)(2008-8#1)(2009-7#2)(2011-1#1)
envelope proteins##4##2##(1995-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
envelope##119##1##(1990-2#1)(1991-2#1)(1993-11#1)(1993-12#3)(1993-3#2)(1994-11#4)(1994-3#1)(1994-5#3)(1994-8#4)(1995-2#7)(1995-5#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#3)(2007-12#13)(2008-10#2)(2008-12#6)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#8)(2008-7#1)(2008-8#7)(2008-9#3)(2009-10#1)(2009-7#2)(2009-8#2)(2011-1#1)(2011-2#16)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
enveloped by##2##2##(2008-1#1)(2008-7#1)
enveloped in##2##2##(2007-12#1)(2008-10#1)
enveloped##12##1##(1994-6#2)(1994-8#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)
envelopes are##2##2##(2007-12#1)(2011-1#1)
envelopes##13##1##(1994-11#3)(1994-5#1)(2007-12#5)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
enveloping##2##1##(2008-5#1)(2008-7#1)
envelopment analysis##2##2##(1992-2#1)(2010-8#1)
envelopment##7##1##(1992-2#5)(2008-7#1)(2010-8#1)
environment allows##2##2##(1995-2#1)(2011-7#1)
environment and how##2##3##(2008-11#1)(2009-10#1)
environment and in##2##3##(1991-9#1)(2008-5#1)
environment and its##2##3##(2008-2#1)(2013-1#1)
environment and operators##2##3##(2012-2#2)
environment and provides a##2##4##(1995-6#1)(2008-3#1)
environment and provides##3##3##(1995-6#1)(2008-3#1)(2013-1#1)
environment and social##2##3##(1996-2#1)(2008-12#1)
environment and that##2##3##(2008-8#1)(2011-1#1)
environment and the##7##3##(1993-11#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
environment and to##2##3##(2008-7#1)(2013-8#1)
environment and##90##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-3#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#8)(2008-9#2)(2009-10#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
environment are##4##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
environment around##3##2##(1992-11#2)(1997-7#1)
environment as well as##2##4##(1996-12#1)(2008-11#1)
environment as##6##2##(1993-6#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
environment at trace levels##2##4##(2008-10#2)
environment at trace##3##3##(2008-10#3)
environment at##6##2##(2008-10#4)(2012-2#2)
environment based on##2##3##(2008-7#1)(2009-3#1)
environment became less controlled##2##4##(2008-10#2)
environment but##3##2##(2008-1#1)(2008-8#1)(2009-7#1)
environment by##7##2##(1995-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
environment can be##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
environment can##7##2##(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
environment conditions##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2013-7#1)
environment could##2##2##(1995-1#1)(2013-1#1)
environment due to##2##3##(2008-12#1)(2013-8#1)
environment during##3##2##(2007-12#1)(2008-10#2)
environment experiments##3##2##(2008-10#3)
environment for patients##2##3##(1992-3#1)(1995-2#1)
environment for the##2##3##(2008-7#1)(2011-1#1)
environment for their##3##3##(2008-4#2)(2008-9#1)
environment for##30##2##(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
environment has been##2##3##(2008-10#1)(2011-2#1)
environment has##8##2##(1991-2#1)(1993-12#1)(2008-10#4)(2011-2#1)(2012-7#1)
environment have been##2##3##(2008-10#1)(2011-1#1)
environment in order to##2##4##(2009-10#1)(2010-9#1)
environment in the##14##3##(1990-3#1)(1992-3#1)(1993-2#1)(1995-2#1)(1995-6#2)(1996-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
environment in which the##2##4##(1995-6#1)(2013-1#1)
environment in which they##2##4##(1994-1#1)(2008-8#1)
environment in which##12##3##(1991-12#1)(1991-2#1)(1994-1#1)(1994-12#1)(1995-6#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
environment in##40##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#3)(1996-7#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
environment interactions##2##2##(2008-10#1)(2013-1#1)
environment is a##2##3##(2012-3#1)(2013-8#1)
environment is critical to##2##4##(1992-12#1)(2008-10#1)
environment is##30##2##(1991-12#1)(1992-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
environment may##7##2##(1992-3#1)(1997-7#1)(2008-10#2)(2008-9#2)(2013-8#1)
environment might##2##2##(1992-2#1)(2008-10#1)
environment must##2##2##(1992-2#1)(2008-1#1)
environment of a##5##3##(1994-11#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-6#1)
environment of the cell##2##4##(1991-5#1)(2010-4#1)
environment of the region to##2##5##(2008-11#1)(2013-1#1)
environment of the##22##3##(1991-5#1)(1991-6#1)(1992-12#1)(1994-5#1)(1994-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-9#1)(2009-6#1)(2010-4#1)(2013-1#1)
environment of##55##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(2007-10#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-6#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
environment on the##9##3##(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-10#1)
environment on##16##2##(1990-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-1#1)(2010-10#1)(2012-3#1)
environment or##6##2##(1991-1#1)(1992-11#1)(1996-12#1)(2008-1#1)(2008-5#1)(2008-8#1)
environment over##2##2##(2007-5#1)(2008-8#1)
environment protection##2##2##(1994-3#1)(2012-2#1)
environment provided by##3##3##(2008-8#1)(2011-1#2)
environment required##2##2##(1992-9#1)(2011-1#1)
environment that##8##2##(1992-2#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-11#1)(2013-8#1)
environment through##2##2##(2008-8#1)(2010-7#1)
environment to be##2##3##(1996-3#1)(2010-9#1)
environment to the##2##3##(1997-2#1)(2008-10#1)
environment to##16##2##(1992-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-7#2)(2008-10#4)(2008-12#2)(2008-7#1)(2010-9#1)(2011-2#1)
environment upon##2##2##(1992-6#1)(2008-11#1)
environment was investigated##2##3##(1995-6#1)(2008-11#1)
environment was##15##2##(1991-1#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
environment were##4##2##(1995-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
environment where##12##2##(1991-12#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-6#1)(2009-9#1)
environment while##3##2##(1995-1#1)(2008-11#1)(2008-4#1)
environment will##2##2##(1996-3#1)(2008-12#1)
environment with##8##2##(1996-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-10#1)(2011-1#1)(2013-8#1)
environment within##3##2##(1990-2#2)(2008-12#1)
environment would##2##2##(1992-11#1)(2008-10#1)
environment##1052##1##(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#9)(1991-11#3)(1991-12#8)(1991-2#5)(1991-3#7)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#3)(1992-11#9)(1992-12#7)(1992-2#13)(1992-3#9)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#8)(1993-2#7)(1993-3#7)(1993-5#1)(1993-6#5)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#14)(1994-2#4)(1994-3#14)(1994-5#3)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#8)(1995-11#2)(1995-12#4)(1995-2#11)(1995-3#8)(1995-5#6)(1995-6#8)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#15)(1996-2#10)(1996-3#16)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#7)(1997-3#10)(1997-4#4)(1997-7#9)(2007-10#7)(2007-11#6)(2007-12#6)(2007-2#2)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#3)(2008-1#18)(2008-10#157)(2008-11#64)(2008-12#30)(2008-2#19)(2008-3#27)(2008-4#17)(2008-5#28)(2008-6#13)(2008-7#29)(2008-8#43)(2008-9#24)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#8)(2009-7#6)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#8)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#5)(2011-1#23)(2011-2#29)(2011-7#1)(2012-1#5)(2012-12#8)(2012-2#20)(2012-3#17)(2012-4#4)(2012-7#2)(2013-1#22)(2013-7#6)(2013-8#16)
environment&quot##3##1##(2008-10#1)(2008-6#1)(2008-8#1)
environment)##8##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#4)
environment-friendly##4##1##(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)
environment]##5##1##(1991-6#1)(1993-6#1)(1997-6#1)(2010-12#1)(2012-2#1)
environmental accounting##2##2##(2008-11#2)
environmental agent##2##2##(1991-12#2)
environmental agents are##3##3##(2008-10#1)(2011-1#2)
environmental agents##4##2##(2008-10#1)(2008-7#1)(2011-1#2)
environmental analysis and##2##3##(2008-10#1)(2008-11#1)
environmental analysis##17##2##(1994-9#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)
environmental and biological samples##17##4##(2008-10#17)
environmental and biological##20##3##(2008-10#20)
environmental and climatic##2##3##(2008-8#1)(2012-2#1)
environmental and clinical##2##3##(2008-11#1)(2011-2#1)
environmental and commodity samples##2##4##(2008-10#2)
environmental and developmental##2##3##(2008-7#1)(2009-8#1)
environmental and food##4##3##(2008-10#2)(2010-11#1)(2010-5#1)
environmental and genetic factors##6##4##(2007-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#2)
environmental and genetic##8##3##(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-4#1)
environmental and health##2##3##(1994-6#1)(2008-2#1)
environmental and industrial##3##3##(2008-10#3)
environmental and occupational exposures##2##4##(2008-12#1)(2013-1#1)
environmental and occupational##4##3##(2008-12#1)(2009-12#1)(2012-1#1)(2013-1#1)
environmental and pharmaceutical samples##2##4##(2008-10#2)
environmental and social##2##3##(2008-7#1)(2011-2#1)
environmental and waste##2##3##(2008-10#2)
environmental and##85##2##(1990-9#1)(1993-12#1)(1994-6#1)(2007-6#1)(2008-10#43)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-12#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
environmental and/or##2##2##(2008-10#1)(2008-4#1)
environmental applications##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
environmental areas##2##2##(2008-10#2)
environmental assessment##4##2##(2008-10#1)(2009-8#1)(2013-1#2)
environmental atmosphere##2##2##(2008-10#2)
environmental challenge##2##2##(2008-10#1)(2008-7#1)
environmental challenges##4##2##(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
environmental chamber##7##2##(2008-10#6)(2008-3#1)
environmental change and##2##3##(2011-2#1)(2013-1#1)
environmental change##8##2##(2008-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
environmental changes and##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
environmental changes##15##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#2)(2013-8#1)
environmental characteristics##3##2##(1992-12#1)(2007-11#1)(2011-1#1)
environmental chemicals##5##2##(1994-3#2)(2008-10#2)(2009-9#1)
environmental chemistry##5##2##(2008-10#4)(2008-7#1)
environmental compartments##6##2##(2008-10#1)(2008-11#1)(2008-5#4)
environmental compounds##2##2##(2008-10#1)(2009-6#1)
environmental concentrations of##2##3##(2008-10#2)
environmental concentrations##4##2##(2007-5#1)(2008-10#2)(2008-7#1)
environmental concern##2##2##(2008-12#1)(2008-5#1)
environmental concerns##3##2##(1994-7#1)(1996-1#1)(2008-10#1)
environmental conditions and##7##3##(1990-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
environmental conditions are##5##3##(2008-10#3)(2008-9#1)(2009-9#1)
environmental conditions can##2##3##(2008-3#1)(2008-8#1)
environmental conditions for the##2##4##(1994-3#1)(2008-10#1)
environmental conditions for##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
environmental conditions of##3##3##(1990-6#1)(2008-12#1)(2010-1#1)
environmental conditions over a##2##4##(2008-3#1)(2008-8#1)
environmental conditions over##3##3##(2008-3#1)(2008-8#2)
environmental conditions required##2##3##(2008-10#2)
environmental conditions such as##2##4##(2008-10#1)(2008-4#1)
environmental conditions that##2##3##(2008-10#2)
environmental conditions to##2##3##(2008-10#1)(2008-5#1)
environmental conditions were##2##3##(2008-10#2)
environmental conditions##98##2##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-9#1)(1996-12#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#42)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#8)(2008-9#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-8#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#2)
environmental constraints##3##2##(2010-6#2)(2011-2#1)
environmental contaminants##2##2##(1994-3#2)
environmental contamination##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
environmental control##2##2##(2008-10#1)(2010-5#1)
environmental cues and##3##3##(2009-8#1)(2012-1#1)(2012-12#1)
environmental cues in this##2##4##(2008-6#1)(2008-8#1)
environmental cues##6##2##(2008-6#1)(2008-8#1)(2009-8#1)(2012-1#2)(2012-12#1)
environmental data and##2##3##(2008-8#2)
environmental data##6##2##(2008-10#2)(2008-11#1)(2008-8#2)(2009-11#1)
environmental degradation##2##2##(2008-5#1)(2011-1#1)
environmental design##2##2##(1991-1#2)
environmental determinants##4##2##(2008-1#1)(2008-8#1)(2010-12#1)(2013-1#1)
environmental differences between##3##3##(2008-8#1)(2008-9#1)(2013-7#1)
environmental differences##6##2##(2008-8#2)(2008-9#1)(2012-3#2)(2013-7#1)
environmental disasters##2##2##(1997-5#2)
environmental education##3##2##(2007-5#3)
environmental effects and##2##3##(2008-11#1)(2008-9#1)
environmental effects at##2##3##(2008-2#1)(2010-3#1)
environmental effects in##2##3##(1994-2#1)(2008-2#1)
environmental effects##12##2##(1992-3#1)(1994-2#1)(1994-3#1)(1997-5#1)(2008-11#1)(2008-2#2)(2008-9#2)(2009-8#1)(2010-3#1)(2010-8#1)
environmental estrogenic mimics##2##3##(2010-5#2)
environmental exposure to##3##3##(2008-10#1)(2008-8#1)(2010-1#1)
environmental exposure##8##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#3)(2010-1#1)
environmental exposures##8##2##(1991-12#3)(1995-3#1)(2008-10#2)(2008-5#1)(2013-1#1)
environmental factor in##2##3##(2008-12#1)(2013-8#1)
environmental factor##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
environmental factors (e##2##3##(2008-4#1)(2008-7#1)
environmental factors affect##2##3##(2008-10#1)(2010-6#1)
environmental factors and the##2##4##(2008-8#1)(2011-1#1)
environmental factors and their##2##4##(2008-11#1)(2011-1#1)
environmental factors and##9##3##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#2)(2012-3#1)
environmental factors are##7##3##(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-5#1)(2013-7#1)
environmental factors have##2##3##(2008-7#1)(2011-3#1)
environmental factors in##5##3##(1997-5#1)(2006-10#2)(2008-11#1)(2011-1#1)
environmental factors influence##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
environmental factors influencing##2##3##(1993-1#1)(2009-10#1)
environmental factors on##3##3##(2008-10#1)(2012-2#2)
environmental factors such as##7##4##(1995-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
environmental factors that##8##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)
environmental factors##112##2##(1990-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-10#4)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#3)(2010-6#2)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#3)
environmental fate and##2##3##(1995-11#1)(2008-5#1)
environmental fate##5##2##(1995-11#3)(2008-5#2)
environmental feedback##2##2##(2008-8#2)
environmental fields##2##2##(2008-10#1)(2008-11#1)
environmental fluctuations##3##2##(2008-8#3)
environmental gradients##4##2##(2008-8#3)(2010-3#1)
environmental health services and##2##4##(1996-9#1)(1997-2#1)
environmental health services##7##3##(1996-9#4)(1997-2#3)
environmental health workforce##2##3##(2008-1#2)
environmental health##25##2##(1991-12#1)(1996-9#4)(1997-2#4)(2008-1#11)(2008-11#2)(2012-1#1)(2013-1#2)
environmental heterogeneity##4##2##(2008-10#1)(2008-8#3)
environmental immunity##2##2##(2008-3#2)
environmental impact##8##2##(1994-11#1)(1996-1#1)(2008-10#3)(2008-11#2)(2011-2#1)
environmental impacts of the##2##4##(2008-11#2)
environmental impacts of##3##3##(2008-11#3)
environmental impacts##6##2##(2008-11#4)(2008-12#1)(2013-8#1)
environmental influences on##3##3##(2007-12#1)(2008-8#1)(2013-1#1)
environmental influences##9##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#2)
environmental information##2##2##(2008-10#1)(2008-7#1)
environmental insult##2##2##(2008-7#1)(2012-2#1)
environmental insults##3##2##(2010-8#1)(2012-2#1)(2013-8#1)
environmental interactions##3##2##(1990-12#1)(2008-10#2)
environmental intervention##2##2##(2012-2#1)(2013-1#1)
environmental issues##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
environmental levels##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
environmental light##2##2##(1995-11#1)(2008-10#1)
environmental loads##2##2##(2008-3#2)
environmental management##2##2##(2008-11#1)(2008-8#1)
environmental materials by##2##3##(2008-10#2)
environmental matrices##10##2##(2008-10#8)(2008-11#2)
environmental measurements##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
environmental medicine##3##2##(1991-10#1)(2009-7#1)(2009-9#1)
environmental monitoring and##3##3##(2008-10#2)(2010-8#1)
environmental monitoring of##6##3##(2008-10#4)(2012-2#1)(2013-8#1)
environmental monitoring##27##2##(1997-4#1)(2008-10#17)(2008-2#2)(2008-4#1)(2009-11#1)(2010-8#1)(2012-2#3)(2013-8#1)
environmental noise##13##2##(2008-8#7)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#2)
environmental or##6##2##(1991-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)
environmental organic pollutants##2##3##(2008-10#2)
environmental oxygen##2##2##(2008-10#1)(2011-2#1)
environmental parameters##4##2##(1992-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
environmental perturbations##3##2##(2007-12#1)(2008-3#2)
environmental policy##2##2##(2008-11#2)
environmental pollutant##4##2##(2008-10#3)(2009-3#1)
environmental pollutants##11##2##(1994-3#1)(2008-10#9)(2008-7#1)
environmental pollution##8##2##(1990-9#1)(1997-4#1)(2007-7#1)(2008-10#3)(2009-12#1)(2010-7#1)
environmental problems##6##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)
environmental protection##2##2##(2008-10#1)(2008-11#1)
environmental quality##2##2##(2008-10#1)(2008-11#1)
environmental regulation of##2##3##(2008-10#1)(2009-8#1)
environmental remote sensing##2##3##(2008-8#2)
environmental requirements for##2##3##(1990-9#1)(2008-10#1)
environmental requirements##3##2##(1990-9#1)(2008-10#1)(2008-8#1)
environmental research##4##2##(2008-10#3)(2008-11#1)
environmental risk assessment##7##3##(2008-10#2)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#1)
environmental risk factors##8##3##(1992-12#2)(2007-10#1)(2008-11#1)(2010-11#1)(2012-12#2)(2012-2#1)
environmental risk##17##2##(1992-12#2)(2007-10#1)(2008-10#3)(2008-11#4)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
environmental safety##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
environmental sample##3##2##(2007-6#1)(2008-10#2)
environmental samples and##2##3##(2008-10#2)
environmental samples are##3##3##(2008-10#3)
environmental samples by##6##3##(2008-10#6)
environmental samples has##2##3##(2008-10#1)(2011-2#1)
environmental samples was##2##3##(2008-10#2)
environmental samples with satisfactory results##2##5##(2008-10#2)
environmental samples with##4##3##(2008-10#3)(2011-2#1)
environmental samples##102##2##(2008-10#91)(2008-11#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)
environmental scanning electron microscopy##3##4##(2008-10#1)(2008-9#2)
environmental science##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
environmental screening##2##2##(2008-10#1)(2009-5#1)
environmental settings##5##2##(2008-5#1)(2008-8#4)
environmental signal##2##2##(2008-8#1)(2011-1#1)
environmental signals##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
environmental significance##4##2##(2008-10#3)(2010-7#1)
environmental situations##2##2##(1995-11#1)(2008-10#1)
environmental sounds##3##2##(2008-9#3)
environmental sources of##3##3##(2008-2#1)(2008-5#1)(2008-8#1)
environmental sources##8##2##(2007-8#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-8#1)
environmental stimuli and##2##3##(2007-8#1)(2008-5#1)
environmental stimuli##10##2##(1992-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-11#1)
environmental stochasticity##3##2##(2008-8#1)(2008-9#2)
environmental stress and##2##3##(2008-10#1)(2011-2#1)
environmental stress##15##2##(2008-10#3)(2009-8#1)(2010-4#4)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
environmental stresses such as##2##4##(1997-2#1)(2008-1#1)
environmental stresses##10##2##(1994-11#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
environmental stressors and##2##3##(2009-8#1)(2010-4#1)
environmental stressors##9##2##(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#4)(2012-2#2)
environmental studies##3##2##(2008-10#3)
environmental suitability##2##2##(2008-10#1)(2008-8#1)
environmental systems##2##2##(2008-10#1)(2010-11#1)
environmental testing##2##2##(2008-10#1)(2010-2#1)
environmental thermal-hydrological regime##2##3##(2008-8#2)
environmental tobacco smoke##3##3##(1995-6#1)(1996-3#2)
environmental trigger##2##2##(2010-8#1)(2012-2#1)
environmental variability##4##2##(2008-8#3)(2010-8#1)
environmental variable##2##2##(2008-10#1)(2008-8#1)
environmental variables##13##2##(1992-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#2)(2013-7#1)
environmental variance##3##2##(2008-8#2)(2008-9#1)
environmental water samples by##2##4##(2008-10#2)
environmental water samples has been developed##2##6##(2008-10#2)
environmental water samples##11##3##(2008-10#11)
environmental water##14##2##(2008-10#13)(2008-9#1)
environmental waters (potable and polluted)##2##5##(2008-10#2)
environmental waters by##2##3##(2008-10#2)
environmental waters##10##2##(2008-10#10)
environmental##1186##1##(1990-12#3)(1990-6#3)(1990-8#1)(1990-9#5)(1991-1#3)(1991-10#1)(1991-12#10)(1991-6#2)(1992-12#8)(1992-2#1)(1992-3#5)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#8)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#8)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#6)(1996-12#2)(1996-3#4)(1996-9#4)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#1)(2006-10#4)(2007-10#1)(2007-11#2)(2007-12#8)(2007-5#5)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#16)(2008-10#425)(2008-11#61)(2008-12#14)(2008-2#16)(2008-3#22)(2008-4#15)(2008-5#33)(2008-6#8)(2008-7#33)(2008-8#95)(2008-9#27)(2009-10#3)(2009-11#5)(2009-12#7)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#16)(2009-9#6)(2010-1#5)(2010-10#3)(2010-11#6)(2010-12#1)(2010-2#5)(2010-3#6)(2010-4#11)(2010-5#8)(2010-6#5)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#24)(2011-2#42)(2011-3#1)(2012-1#9)(2012-12#12)(2012-2#24)(2012-3#13)(2012-5#1)(2012-9#3)(2013-1#25)(2013-7#6)(2013-8#12)
environmentally benign##3##2##(2008-10#2)(2012-2#1)
environmentally determined##2##2##(2008-8#2)
environmentally driven variability in##2##4##(2008-8#2)
environmentally friendly method##2##3##(2008-10#2)
environmentally friendly##8##2##(1992-3#1)(2008-10#7)
environmentally important##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)
environmentally induced bias in phenotypic estimates of##2##7##(2008-8#2)
environmentally induced bias##3##3##(2008-8#3)
environmentally induced##5##2##(2008-8#4)(2010-4#1)
environmentally relevant##6##2##(1994-8#1)(2008-10#3)(2008-5#1)(2008-7#1)
environmentally stable##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
environmentally##55##1##(1992-3#1)(1994-8#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-10#22)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#10)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#3)
environments and is##2##3##(1991-8#1)(2012-2#1)
environments and##22##2##(1990-11#1)(1991-8#1)(2007-10#1)(2008-10#5)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#2)
environments are##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
environments as##3##2##(1994-11#1)(2008-8#1)(2011-2#1)
environments based on##2##3##(2008-10#1)(2012-3#1)
environments between##2##2##(1992-8#1)(2011-2#1)
environments by##5##2##(1997-7#1)(2008-10#1)(2008-2#2)(2008-9#1)
environments can##5##2##(1996-4#1)(2008-8#2)(2008-9#2)
environments due to##2##3##(2008-10#1)(2010-5#1)
environments encountered##2##2##(2010-2#1)(2013-1#1)
environments for##4##2##(1996-12#1)(2008-11#2)(2011-2#1)
environments from##3##2##(2008-6#1)(2011-1#1)(2012-2#1)
environments has##3##2##(2008-10#1)(2012-2#2)
environments if##2##2##(1997-7#1)(2008-8#1)
environments in South##2##3##(2007-5#1)(2011-2#1)
environments in##8##2##(1991-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)
environments including##2##2##(2011-2#2)
environments is##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
environments of the##4##3##(1992-6#1)(2008-10#1)(2008-9#2)
environments of##7##2##(1992-6#1)(1992-8#1)(2008-10#2)(2008-12#1)(2008-9#2)
environments on##3##2##(1994-3#1)(2008-3#1)(2012-3#1)
environments such as##4##3##(2008-10#1)(2008-8#1)(2011-2#2)
environments that##7##2##(1992-2#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-3#1)
environments to##5##2##(2007-8#1)(2008-11#1)(2010-4#1)(2010-5#1)(2012-2#1)
environments via##2##2##(2008-5#1)(2010-4#1)
environments were##6##2##(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)
environments where##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2010-12#1)
environments with a##2##3##(2008-10#1)(2008-12#1)
environments with##7##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-1#1)
environments##387##1##(1990-11#1)(1991-1#3)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-2#4)(1994-11#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#6)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#3)(2007-8#2)(2008-1#4)(2008-10#68)(2008-11#15)(2008-12#5)(2008-2#11)(2008-3#21)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#48)(2008-9#22)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#6)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#26)(2012-1#1)(2012-12#1)(2012-2#16)(2012-3#12)(2012-5#2)(2013-1#7)(2013-7#2)(2013-8#5)
environments)##4##1##(2008-8#3)(2012-12#1)
envisage##9##1##(1991-6#1)(1992-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
envisaged for##4##2##(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
envisaged in the##2##3##(2008-10#1)(2008-3#1)
envisaged in##3##2##(1991-11#1)(2008-10#1)(2008-3#1)
envisaged##20##1##(1991-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
envision that##2##2##(2008-11#1)(2012-12#1)
envision the##3##2##(1993-2#1)(1994-12#1)(1994-2#1)
envision##8##1##(1993-2#2)(1993-5#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-11#1)(2012-12#1)
envisioned##7##1##(2007-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2012-2#1)
enzootic##4##1##(2008-10#1)(2008-9#1)(2011-2#2)
enzymatic activities and##2##3##(1990-3#1)(2010-12#1)
enzymatic activities of##4##3##(1993-12#1)(2008-10#2)(2008-5#1)
enzymatic activities##24##2##(1990-3#1)(1991-5#4)(1992-6#1)(1993-12#1)(1993-2#3)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-5#2)(2008-7#3)(2010-12#1)
enzymatic activity and##8##3##(1990-5#1)(1992-8#1)(1995-12#1)(2008-11#1)(2008-7#2)(2010-12#2)
enzymatic activity assay##2##3##(2008-10#1)(2008-4#1)
enzymatic activity in##5##3##(1994-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-10#1)
enzymatic activity is##3##3##(1990-11#1)(1994-6#1)(1994-9#1)
enzymatic activity of the##4##4##(1993-11#1)(2008-10#2)(2008-6#1)
enzymatic activity of##14##3##(1990-5#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-6#1)(2013-7#1)
enzymatic activity was##6##3##(1992-6#1)(1996-5#1)(2008-10#3)(2013-1#1)
enzymatic activity##83##2##(1990-11#1)(1990-12#3)(1990-5#2)(1991-12#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-6#2)(1996-12#2)(1996-5#1)(2008-10#14)(2008-11#6)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2009-2#1)(2010-12#3)(2011-1#1)(2013-1#5)(2013-7#1)
enzymatic analysis of##2##3##(1997-2#1)(2008-10#1)
enzymatic analysis##3##2##(1991-5#1)(1997-2#1)(2008-10#1)
enzymatic and non-enzymatic antioxidants##3##4##(2008-5#2)(2011-2#1)
enzymatic and non-enzymatic##6##3##(2008-10#1)(2008-5#4)(2011-2#1)
enzymatic and streptococcal binding##2##4##(1990-12#2)
enzymatic and##13##2##(1990-12#2)(1990-8#1)(1994-11#1)(2008-10#2)(2008-5#4)(2008-6#1)(2011-2#1)(2012-2#1)
enzymatic assay and##2##3##(2008-10#2)
enzymatic assay for##3##3##(1990-2#1)(1993-12#1)(1997-8#1)
enzymatic assay of##4##3##(1993-12#1)(2008-10#3)
enzymatic assay##13##2##(1990-2#2)(1993-12#3)(1993-3#1)(1997-3#1)(1997-8#1)(2008-10#5)
enzymatic assays for the##2##4##(1990-2#1)(2011-2#1)
enzymatic assays##8##2##(1990-2#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
enzymatic biosensors##2##2##(2008-10#2)
enzymatic catalysis##4##2##(1990-12#1)(1995-5#1)(2008-10#1)(2008-7#1)
enzymatic cleavage##5##2##(1996-12#1)(2008-12#1)(2008-7#1)(2010-12#2)
enzymatic cofactor##2##2##(1990-9#1)(2012-2#1)
enzymatic complex##3##2##(1990-11#1)(1997-2#1)(1997-7#1)
enzymatic complexes##2##2##(2008-5#1)(2013-8#1)
enzymatic conversion##2##2##(2008-7#1)(2013-1#1)
enzymatic degradation and##2##3##(1995-6#1)(2011-1#1)
enzymatic degradation of##3##3##(2008-10#3)
enzymatic degradation##10##2##(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(2008-10#4)(2011-1#1)
enzymatic digestibility##2##2##(2013-1#2)
enzymatic digestion of##2##3##(1990-5#1)(1991-5#1)
enzymatic digestion##5##2##(1990-5#2)(1991-5#1)(1994-12#1)(2013-1#1)
enzymatic extracts were##2##3##(2008-10#2)
enzymatic function##3##2##(1990-12#1)(1997-4#1)(2008-4#1)
enzymatic hydrolysis of cellulose##3##4##(2008-6#1)(2008-7#1)(2013-1#1)
enzymatic hydrolysis of urea##2##4##(2008-10#2)
enzymatic hydrolysis of##19##3##(1990-2#1)(2008-10#6)(2008-5#2)(2008-6#2)(2008-7#3)(2013-1#5)
enzymatic hydrolysis was##2##3##(2008-10#1)(2013-1#1)
enzymatic hydrolysis yield##2##3##(2008-6#1)(2013-1#1)
enzymatic hydrolysis##46##2##(1990-2#1)(1990-7#1)(1991-9#1)(2008-10#14)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#4)(2009-8#1)(2013-1#14)
enzymatic kinetics##3##2##(1996-2#1)(2008-9#1)(2012-2#1)
enzymatic label##3##2##(2008-10#3)
enzymatic levels##2##2##(1993-3#1)(2009-11#1)
enzymatic method for the##2##4##(1992-11#1)(2008-10#1)
enzymatic method##6##2##(1992-11#1)(1992-6#1)(2008-10#3)(2013-1#1)
enzymatic or##2##2##(1993-8#1)(2008-4#1)
enzymatic oxidation of##4##3##(1993-3#1)(2008-10#3)
enzymatic oxidation##6##2##(1993-3#1)(2008-10#5)
enzymatic pathways##2##2##(2009-11#1)(2011-1#1)
enzymatic pretreatment##3##2##(2008-6#3)
enzymatic probe##4##2##(2008-10#2)(2008-9#2)
enzymatic processes##2##2##(2008-10#1)(2013-1#1)
enzymatic products##2##2##(1994-12#2)
enzymatic profile##2##2##(2008-5#2)
enzymatic properties of##3##3##(1995-6#1)(2008-10#1)(2009-8#1)
enzymatic properties##4##2##(1991-2#1)(1995-6#1)(2008-10#1)(2009-8#1)
enzymatic purification of PCR products for direct sequencing##2##8##(2008-4#2)
enzymatic purification of##3##3##(2008-4#2)(2008-5#1)
enzymatic reaction and##4##3##(2008-10#3)(2011-2#1)
enzymatic reaction in the##2##4##(2008-6#2)
enzymatic reaction is##3##3##(2008-10#2)(2008-4#1)
enzymatic reaction of##5##3##(1991-5#1)(2008-10#4)
enzymatic reaction##38##2##(1990-3#1)(1990-8#2)(1991-5#2)(2008-10#23)(2008-4#3)(2008-6#3)(2008-7#2)(2009-5#1)(2011-2#1)
enzymatic reactions using##2##3##(2008-4#1)(2009-6#1)
enzymatic reactions##11##2##(1990-3#1)(1990-5#2)(1994-3#1)(2008-10#1)(2008-4#2)(2009-6#1)(2010-10#2)(2010-5#1)
enzymatic reactor was##2##3##(2008-10#2)
enzymatic reactor##3##2##(2008-10#3)
enzymatic reactors and their applications in proteome##2##7##(2008-12#2)
enzymatic reactors##6##2##(2008-12#6)
enzymatic reduction of##2##3##(1995-3#1)(2008-10#1)
enzymatic reduction##3##2##(1995-3#1)(2008-10#2)
enzymatic source##2##2##(2008-10#2)
enzymatic synthesis of##3##3##(1992-11#1)(2008-6#1)(2013-1#1)
enzymatic synthesis##5##2##(1992-11#1)(1994-8#1)(2008-6#1)(2010-7#1)(2013-1#1)
enzymatic system##4##2##(2008-10#3)(2011-1#1)
enzymatic systems##3##2##(1991-8#1)(2008-10#1)(2013-1#1)
enzymatic transformations##2##2##(1992-3#1)(2010-5#1)
enzymatic treatment##3##2##(1990-11#1)(2008-6#1)(2008-9#1)
enzymatic##462##1##(1990-11#3)(1990-12#9)(1990-2#6)(1990-3#4)(1990-5#7)(1990-7#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#10)(1991-8#1)(1991-9#2)(1992-11#4)(1992-12#1)(1992-3#3)(1992-6#5)(1992-8#2)(1993-11#2)(1993-12#5)(1993-2#5)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#4)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#5)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-8#1)(2008-10#139)(2008-11#8)(2008-12#9)(2008-2#1)(2008-4#17)(2008-5#20)(2008-6#18)(2008-7#26)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#6)(2012-2#5)(2012-6#1)(2013-1#32)(2013-7#2)(2013-8#2)
enzymatically active##12##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-6#1)(1995-6#1)(2008-4#2)(2011-1#2)(2013-7#1)
enzymatically and##3##2##(1990-11#1)(1992-3#1)(1994-12#1)
enzymatically by##4##2##(1994-3#1)(2008-2#1)(2008-4#1)(2008-9#1)
enzymatically cleaved##2##2##(1993-6#1)(2008-4#1)
enzymatically converted to##2##3##(2008-10#2)
enzymatically dissociated##3##2##(1994-11#1)(1995-5#1)(2008-11#1)
enzymatically produced hydrogen peroxide##2##4##(2008-10#2)
enzymatically produced##3##2##(2008-10#3)
enzymatically##46##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-9#1)(2009-9#1)(2011-1#2)(2013-7#1)
enzyme (ACE) inhibitor##3##3##(1990-2#1)(2008-1#1)(2008-7#1)
enzyme (ACE)##7##2##(1990-2#1)(1993-12#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-2#1)
enzyme activation##5##2##(1990-5#1)(1992-9#2)(1993-8#1)(2008-5#1)
enzyme active against##2##3##(2010-3#2)
enzyme active##6##2##(1994-8#1)(1995-6#3)(2010-3#2)
enzyme activities and##2##3##(1992-8#1)(2008-12#1)
enzyme activities for##2##3##(1995-3#1)(2008-4#1)
enzyme activities in both##2##4##(1994-11#1)(2008-9#1)
enzyme activities in##7##3##(1990-3#1)(1994-11#2)(1994-6#1)(2008-12#1)(2008-5#1)(2008-9#1)
enzyme activities involved in##2##4##(2008-10#2)
enzyme activities of##4##3##(1991-5#1)(1997-7#1)(2012-6#1)(2013-1#1)
enzyme activities were##7##3##(1990-5#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-10#2)(2013-1#1)
enzyme activities##41##2##(1990-3#1)(1990-5#1)(1991-12#2)(1991-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-11#5)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2011-10#1)(2012-6#1)(2013-1#3)
enzyme activity and the##2##4##(1990-11#1)(1997-6#1)
enzyme activity and##10##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-5#1)(1994-6#2)(1995-5#1)(1997-6#1)(2013-1#1)
enzyme activity at##2##3##(1997-2#1)(2008-10#1)
enzyme activity by##8##3##(1990-5#1)(1992-11#1)(1992-3#1)(1994-8#2)(2008-4#1)(2011-1#1)(2013-1#1)
enzyme activity can##2##3##(2011-2#1)(2013-1#1)
enzyme activity could##2##3##(2008-3#1)(2009-11#1)
enzyme activity in a##2##4##(1994-11#1)(1994-9#1)
enzyme activity in the liver##2##5##(1995-2#1)(2008-6#1)
enzyme activity in the##6##4##(1991-5#1)(1993-1#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-6#1)
enzyme activity in##20##3##(1991-5#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-6#2)(2008-7#2)(2011-2#2)(2012-12#1)(2013-1#1)
enzyme activity is##3##3##(1996-3#1)(2008-6#1)(2008-8#1)
enzyme activity measurement##2##3##(2008-10#1)(2008-5#1)
enzyme activity of##4##3##(1993-3#1)(2008-10#1)(2011-2#1)(2012-6#1)
enzyme activity was found to be##2##6##(1990-7#1)(2008-10#1)
enzyme activity was##19##3##(1990-11#1)(1990-5#1)(1990-7#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(2008-10#5)(2008-11#1)(2008-6#3)
enzyme activity were##3##3##(1990-5#1)(2008-6#1)(2013-1#1)
enzyme activity##158##2##(1990-11#3)(1990-12#2)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#4)(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#4)(1993-8#1)(1993-9#3)(1994-11#5)(1994-2#2)(1994-3#1)(1994-6#5)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#11)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#10)
enzyme against##3##2##(1990-11#1)(1990-5#1)(1992-5#1)
enzyme also##3##2##(1992-3#1)(1992-8#1)(1997-4#1)
enzyme analysis of the##2##4##(1997-3#1)(1997-4#1)
enzyme analysis##5##2##(1992-8#1)(1997-3#1)(1997-4#1)(2008-10#2)
enzyme and a##4##3##(1994-11#1)(1995-2#1)(2008-10#2)
enzyme and its##2##3##(1991-12#1)(1995-2#1)
enzyme and substrate##3##3##(1990-5#1)(1993-11#1)(1995-2#1)
enzyme and the##9##3##(1991-12#1)(1992-8#1)(1993-8#1)(1997-9#1)(2008-10#4)(2013-1#1)
enzyme and##59##2##(1990-5#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#4)(1993-8#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#5)(1995-5#2)(1995-6#3)(1997-2#1)(1997-9#1)(2008-10#10)(2008-11#2)(2008-6#2)(2008-7#1)(2013-1#1)
enzyme apparently##2##2##(1992-3#1)(1995-6#1)
enzyme are##10##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1996-12#1)(1997-4#1)(2008-4#1)(2008-7#1)(2010-2#1)
enzyme as a##3##3##(1992-3#1)(1994-8#1)(2008-10#1)
enzyme as##7##2##(1992-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-7#1)
enzyme assay for inhibitors of fungal sterol delta 14-reductase##2##9##(1991-5#2)
enzyme assay for##4##3##(1990-2#2)(1991-5#2)
enzyme assay##13##2##(1990-2#2)(1991-5#2)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#2)
enzyme assays and##2##3##(1990-5#1)(2008-10#1)
enzyme assays##4##2##(1990-5#1)(1994-12#1)(2008-10#1)(2008-6#1)
enzyme at##8##2##(1990-12#1)(1992-3#1)(1993-8#1)(1994-6#1)(2008-10#3)(2008-9#1)
enzyme binds##2##2##(1994-5#1)(1997-7#1)
enzyme biosensor based on pH-ISFETs##2##5##(2008-10#2)
enzyme biosensor for##2##3##(2008-10#2)
enzyme biosensor##5##2##(2008-10#5)
enzyme biosensors##3##2##(2008-10#3)
enzyme bound##5##2##(1990-12#1)(1991-5#1)(1994-5#1)(1995-6#1)(2009-8#1)
enzyme by phosphorylation##2##3##(1990-8#2)
enzyme by##20##2##(1990-11#1)(1990-8#2)(1991-10#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
enzyme can be##3##3##(1990-8#1)(1992-12#1)(2008-10#1)
enzyme can##7##2##(1990-8#1)(1992-12#2)(2008-10#3)(2008-8#1)
enzyme carboxypeptidase##2##2##(1990-5#1)(1995-8#1)
enzyme catalysis##5##2##(1990-7#1)(1991-7#1)(2008-1#1)(2008-10#1)(2010-4#1)
enzyme catalyzed the##2##3##(1991-9#1)(1994-11#1)
enzyme catalyzed##3##2##(1991-9#1)(1994-11#1)(2008-5#1)
enzyme catalyzes##2##2##(1990-11#1)(1990-12#1)
enzyme catalyzing the synthesis##2##4##(1992-6#1)(1994-11#1)
enzyme catalyzing the##3##3##(1992-6#1)(1994-11#1)(2008-7#1)
enzyme complex and##2##3##(2008-11#1)(2012-2#1)
enzyme complex##5##2##(1992-2#1)(2008-11#1)(2009-11#1)(2012-2#1)(2012-3#1)
enzyme component##3##2##(1992-9#1)(2008-9#2)
enzyme concentration##2##2##(2008-10#1)(2008-11#1)
enzyme concentrations##2##2##(1990-7#1)(2008-10#1)
enzyme conjugate as signal generator##2##5##(2008-7#2)
enzyme conjugate of##2##3##(1993-6#2)
enzyme conjugate##5##2##(1993-6#2)(2008-7#3)
enzyme consisting of##2##3##(1990-7#1)(1990-8#1)
enzyme consists of two dissimilar##2##5##(1990-2#1)(1993-11#1)
enzyme consists of##3##3##(1990-2#1)(1990-5#1)(1993-11#1)
enzyme contained##3##2##(1990-5#1)(1994-11#1)(1995-6#1)
enzyme containing##2##2##(2008-10#1)(2008-5#1)
enzyme contains##2##2##(1995-2#1)(1995-5#1)
enzyme conversion##2##2##(1995-3#1)(2008-6#1)
enzyme could be##3##3##(1994-11#1)(1997-7#1)(2008-10#1)
enzyme could##5##2##(1990-7#1)(1994-11#1)(1997-7#1)(2008-10#2)
enzyme did not##4##3##(1990-2#1)(1992-6#1)(1994-5#1)(2008-10#1)
enzyme digestion##6##2##(1993-12#1)(2008-10#2)(2008-11#2)(2008-4#1)
enzyme digests of##2##3##(2008-10#2)
enzyme digests##4##2##(1992-11#1)(1994-12#1)(2008-10#2)
enzyme displayed##3##2##(1992-8#1)(1995-2#1)(2011-1#1)
enzyme during##5##2##(1990-5#2)(2008-10#2)(2008-7#1)
enzyme electrode and##2##3##(2008-10#2)
enzyme electrode based on##2##4##(2008-10#2)
enzyme electrode for##3##3##(2008-10#3)
enzyme electrode has been##2##4##(2008-10#2)
enzyme electrode has##3##3##(2008-10#3)
enzyme electrode##23##2##(2008-10#23)
enzyme electrodes were##2##3##(2008-10#2)
enzyme electrodes##8##2##(2008-10#8)
enzyme elicited##2##2##(1993-11#1)(1996-2#1)
enzyme engineering##2##2##(1992-11#1)(1995-3#1)
enzyme exhibited a##2##3##(1994-11#1)(2008-6#1)
enzyme exhibited##3##2##(1994-11#1)(2008-6#1)(2012-2#1)
enzyme exhibits a##2##3##(1990-7#2)
enzyme extracts##2##2##(2008-7#1)(2010-3#1)
enzyme family##2##2##(1992-7#1)(2008-4#1)
enzyme for reaction at##2##4##(1992-11#1)(2008-10#1)
enzyme for the##2##3##(1993-8#1)(1997-1#1)
enzyme for##19##2##(1990-5#1)(1990-7#2)(1992-11#1)(1993-3#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-3#1)
enzyme form##3##2##(1990-11#1)(1991-9#1)(1992-12#1)
enzyme fractions##2##2##(2008-10#2)
enzyme from##28##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#4)(1992-6#3)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-2#3)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
enzyme function##5##2##(1991-3#1)(1991-9#1)(2008-2#1)(2011-1#1)(2012-2#1)
enzyme gene##4##2##(1994-9#1)(2008-10#1)(2008-12#1)(2012-5#1)
enzyme glucocerebrosidase##2##2##(1991-9#1)(1997-7#1)
enzyme had a##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
enzyme had an##3##3##(1990-11#1)(1990-8#1)(1995-8#1)
enzyme had##10##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)
enzyme has a molecular##2##4##(2008-8#1)(2009-2#1)
enzyme has a##5##3##(1990-11#1)(1990-5#1)(1993-11#1)(2008-8#1)(2009-2#1)
enzyme has been##7##3##(1990-5#1)(1990-7#1)(1993-8#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-3#1)
enzyme has##19##2##(1990-11#2)(1990-5#2)(1990-7#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#1)
enzyme highly##2##2##(1991-5#1)(1994-12#1)
enzyme immobilization##7##2##(2008-10#5)(2008-12#1)(2009-8#1)
enzyme immunoassay (EIA)##3##3##(1990-12#1)(2008-10#1)(2008-12#1)
enzyme immunoassay for clenbuterol##2##4##(2008-10#2)
enzyme immunoassay for human basic fibroblast growth factor##2##8##(1991-2#2)
enzyme immunoassay for##9##3##(1991-2#2)(1993-9#1)(1996-12#1)(2008-10#5)
enzyme immunoassay##32##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-2#2)(1991-5#3)(1992-3#1)(1993-2#1)(1993-9#3)(1995-9#1)(1996-12#3)(1997-2#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)
enzyme immunoassays##5##2##(1990-11#1)(1993-11#1)(1993-2#1)(2008-10#1)(2010-11#1)
enzyme immunosensing system##2##3##(2008-10#2)
enzyme in a body lotion##2##5##(2008-10#2)
enzyme in a##6##3##(1991-5#1)(1994-6#1)(1995-6#1)(2008-10#3)
enzyme in human##4##3##(1992-12#1)(2006-6#1)(2008-5#1)(2011-3#1)
enzyme in the presence of##3##5##(1990-7#1)(2008-10#1)(2008-4#1)
enzyme in the production of##2##5##(2008-4#1)(2010-2#1)
enzyme in the##28##3##(1990-5#1)(1990-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-6#2)(1995-2#2)(1997-6#1)(1997-7#1)(2008-10#7)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2012-2#1)
enzyme in vivo##3##3##(1990-12#1)(1992-11#1)(1996-2#1)
enzyme in##73##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#14)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
enzyme inactivation is##2##3##(1993-8#1)(2011-2#1)
enzyme inactivation##9##2##(1990-11#1)(1990-5#2)(1993-8#2)(1994-5#1)(2008-3#1)(2011-2#2)
enzyme increased##3##2##(1990-5#1)(1990-7#1)(1994-5#1)
enzyme inhibition##7##2##(1990-11#1)(2008-10#6)
enzyme inhibitor##10##2##(1992-11#1)(1992-9#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-9#1)(2012-3#1)(2013-1#1)
enzyme inhibitor)##2##2##(1992-8#1)(2008-1#1)
enzyme inhibitors and##4##3##(2008-1#1)(2010-5#1)(2011-2#2)
enzyme inhibitors or angiotensin II receptor##2##6##(1995-12#1)(2008-11#1)
enzyme inhibitors##20##2##(1991-9#1)(1992-9#1)(1993-3#1)(1995-12#1)(1996-6#2)(1997-4#2)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#2)(2013-1#1)
enzyme into##2##2##(1992-8#1)(2011-2#1)
enzyme involved in the biosynthesis of##2##6##(1992-8#1)(2008-9#1)
enzyme involved in the##5##4##(1990-11#1)(1992-3#1)(1992-8#1)(2008-11#1)(2008-9#1)
enzyme involved in##12##3##(1990-11#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
enzyme is a##6##3##(1990-11#1)(1993-11#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-9#1)
enzyme is about##2##3##(1990-12#1)(1992-8#1)
enzyme is also##2##3##(1990-5#1)(1991-5#1)
enzyme is not##5##3##(1991-9#1)(1992-10#1)(1995-6#1)(1997-4#1)(2012-6#1)
enzyme is##53##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#5)(1991-12#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-8#4)(1994-8#2)(1995-6#2)(1996-2#1)(1997-4#3)(1997-7#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2012-6#1)
enzyme kinetic parameters##2##3##(2008-10#2)
enzyme kinetic##3##2##(2008-10#2)(2011-1#1)
enzyme kinetics##5##2##(1990-8#1)(1992-3#1)(1992-8#1)(1997-6#1)(2011-3#1)
enzyme label##3##2##(1995-12#2)(2008-10#1)
enzyme labels##2##2##(2008-10#2)
enzyme lactate dehydrogenase##2##3##(1992-3#1)(1994-2#1)
enzyme layer##6##2##(2008-10#6)
enzyme levels in##2##3##(2008-4#1)(2008-5#1)
enzyme levels were##2##3##(2008-1#1)(2008-5#1)
enzyme levels##9##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#4)(2012-2#1)(2013-8#1)
enzyme linked immunosorbent assay (ELISA)##6##5##(1990-2#1)(1993-3#1)(2007-2#1)(2008-1#1)(2008-5#1)(2011-3#1)
enzyme linked immunosorbent assay##7##4##(1990-2#1)(1993-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-3#1)
enzyme linked immunosorbent##8##3##(1990-2#1)(1993-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-3#1)
enzyme linked##10##2##(1990-2#1)(1993-3#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-1#1)(2011-3#1)
enzyme loading##7##2##(2008-10#4)(2008-6#1)(2011-2#2)
enzyme lost##2##2##(1990-11#1)(2012-2#1)
enzyme may##4##2##(1995-3#1)(1997-2#1)(1997-4#1)(2008-10#1)
enzyme mediated##2##2##(1992-9#1)(2008-10#1)
enzyme molecule##5##2##(1990-5#1)(1992-11#1)(1993-8#1)(1994-11#1)(2012-2#1)
enzyme molecules##5##2##(2008-10#3)(2011-2#1)(2012-2#1)
enzyme nor a##2##3##(1993-3#1)(2008-10#1)
enzyme nor##5##2##(1991-12#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-9#1)
enzyme of the##6##3##(1990-7#1)(1994-11#1)(1994-8#1)(2008-1#1)(2010-12#1)(2011-1#1)
enzyme of##18##2##(1990-7#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-11#3)(1994-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-1#1)
enzyme on##6##2##(1990-7#1)(1993-11#1)(1995-6#1)(2008-10#3)
enzyme or##4##2##(1990-12#1)(1995-6#1)(2008-11#1)(2008-4#1)
enzyme per##2##2##(1990-2#1)(2008-10#1)
enzyme plays##2##2##(1992-10#1)(1992-6#1)
enzyme preparation##6##2##(1990-2#1)(1991-12#1)(1991-5#1)(1994-6#1)(1994-8#1)(2008-11#1)
enzyme preparations##5##2##(1990-5#1)(1992-11#1)(1997-7#1)(2008-7#2)
enzyme production##10##2##(1994-3#2)(2008-10#1)(2008-6#2)(2008-7#3)(2011-2#1)(2012-2#1)
enzyme properties##2##2##(1995-3#1)(2013-1#1)
enzyme protein##3##2##(1990-7#1)(1992-10#1)(1993-8#1)
enzyme purified from##4##3##(1993-8#2)(1994-6#1)(1995-2#1)
enzyme reacted##2##2##(1990-7#1)(1995-6#1)
enzyme reaction##14##2##(1990-5#1)(1991-5#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#7)(2011-2#1)
enzyme reactions##4##2##(1990-2#1)(1990-8#1)(1992-9#1)(2011-2#1)
enzyme reactor##5##2##(2008-10#4)(2008-6#1)
enzyme reactors##6##2##(1992-11#1)(2008-10#5)
enzyme recovery##3##2##(1995-11#1)(2008-6#2)
enzyme release##3##2##(1991-2#1)(1991-9#1)(1994-8#1)
enzyme remains##2##2##(1995-2#1)(2008-10#1)
enzyme replacement therapy is##2##4##(2006-10#1)(2008-10#1)
enzyme replacement therapy##6##3##(2006-10#1)(2008-10#2)(2008-11#1)(2012-12#2)
enzyme requirement##2##2##(2008-6#2)
enzyme resembles##2##2##(1992-6#1)(1997-6#1)
enzyme responsible for##4##3##(1990-8#1)(1994-6#1)(2008-1#1)(2008-11#1)
enzyme responsible##5##2##(1990-8#1)(1994-6#1)(2008-1#1)(2008-11#2)
enzyme secretion##3##2##(1994-8#1)(2008-10#1)(2012-1#1)
enzyme sensor##2##2##(2008-10#2)
enzyme sensors##4##2##(2008-10#4)
enzyme sequences##3##2##(1991-6#1)(2008-10#2)
enzyme showed a##3##3##(1992-6#1)(1995-2#1)(2013-1#1)
enzyme showed##6##2##(1990-10#1)(1992-3#1)(1992-6#1)(1995-2#1)(1997-4#1)(2013-1#1)
enzyme shows##3##2##(1992-1#1)(1995-2#1)(2008-8#1)
enzyme solutions##2##2##(2008-10#1)(2011-2#1)
enzyme source##2##2##(2008-10#1)(2008-5#1)
enzyme species##3##2##(1992-6#2)(1994-8#1)
enzyme stability##4##2##(1992-11#1)(2008-7#2)(2011-1#1)
enzyme structure##2##2##(2008-6#1)(2008-7#1)
enzyme subunit##6##2##(1990-10#1)(1990-7#2)(1994-5#2)(1994-6#1)
enzyme system in cholestatic rats##2##5##(2008-8#2)
enzyme system in##4##3##(2008-11#1)(2008-8#2)(2009-9#1)
enzyme system##12##2##(1993-11#1)(1993-8#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-9#3)
enzyme systems in##2##3##(1990-11#1)(2009-9#1)
enzyme systems##11##2##(1990-11#2)(1995-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-9#1)(2010-4#2)(2011-2#1)
enzyme telomerase##3##2##(2008-11#2)(2011-1#1)
enzyme than##2##2##(2008-5#1)(2009-9#1)
enzyme that can##2##3##(1994-6#1)(2008-10#1)
enzyme that catalyzes the first##2##5##(1997-1#1)(1997-2#1)
enzyme that catalyzes the##4##4##(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)
enzyme that has##2##3##(1993-12#1)(2009-11#1)
enzyme that hydrolyzes valaciclovir##2##4##(1995-6#2)
enzyme that is required for##2##5##(2008-9#1)(2009-8#1)
enzyme that is##6##3##(1994-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#2)
enzyme that##31##2##(1990-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
enzyme the##2##2##(1994-8#1)(2009-5#1)
enzyme through the##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
enzyme to be##2##3##(2008-10#1)(2009-8#1)
enzyme to the##4##3##(1992-12#1)(1993-11#1)(1995-6#1)(1995-8#1)
enzyme to##22##2##(1990-2#2)(1992-10#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#6)(2009-8#1)
enzyme tyrosinase##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
enzyme under##2##2##(1990-5#1)(2010-11#1)
enzyme variants##2##2##(1991-9#1)(2011-2#1)
enzyme was 3##2##3##(1992-3#1)(1995-6#1)
enzyme was also##3##3##(1992-12#1)(2008-11#2)
enzyme was evaluated##2##3##(1990-5#1)(1996-5#1)
enzyme was found to be##2##5##(1992-11#1)(1997-4#1)
enzyme was found to##3##4##(1992-11#1)(1997-4#1)(1997-6#1)
enzyme was found##4##3##(1992-11#1)(1997-4#1)(1997-6#1)(2008-7#1)
enzyme was immobilised on##2##4##(2008-10#2)
enzyme was immobilized on##2##4##(2008-10#2)
enzyme was immobilized##3##3##(2008-10#3)
enzyme was induced by##2##4##(1990-7#1)(1994-9#1)
enzyme was inhibited##2##3##(1990-5#1)(1991-12#1)
enzyme was obtained as##2##4##(1990-12#1)(1994-11#1)
enzyme was only##2##3##(1995-2#1)(1997-6#1)
enzyme was partially##2##3##(1991-9#1)(1993-6#1)
enzyme was performed##2##3##(1991-8#1)(2011-2#1)
enzyme was purified to##3##4##(1990-10#1)(1993-8#1)(1997-2#1)
enzyme was purified##7##3##(1990-10#1)(1993-8#1)(1994-6#1)(1994-8#2)(1997-2#2)
enzyme was stable##2##3##(1997-2#1)(2008-6#1)
enzyme was strictly##2##3##(1990-7#1)(2008-9#1)
enzyme was##93##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-5#2)(1990-7#3)(1990-8#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-5#2)(1997-2#4)(1997-4#1)(1997-6#5)(2008-10#15)(2008-11#2)(2008-6#5)(2008-7#4)(2008-9#2)(2011-2#2)(2013-1#1)
enzyme were##13##2##(1990-8#1)(1992-12#1)(1993-11#1)(1995-2#1)(1996-5#1)(1997-6#2)(2006-6#1)(2008-10#3)(2009-6#1)(2010-3#1)
enzyme when##2##2##(1993-6#1)(1995-3#1)
enzyme which catalyzes the##3##4##(1993-8#1)(2007-11#1)(2008-11#1)
enzyme which is##3##3##(1990-2#1)(1990-8#1)(1992-9#1)
enzyme which##16##2##(1990-2#1)(1990-5#1)(1990-8#3)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-5#1)
enzyme with a##5##3##(1993-6#1)(1994-5#1)(1995-8#1)(1997-2#1)(2009-11#1)
enzyme with an##2##3##(1995-6#1)(2008-10#1)
enzyme with##26##2##(1990-11#1)(1990-7#3)(1991-12#1)(1992-6#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-6#3)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2009-11#2)(2011-1#1)
enzyme would##2##2##(2008-6#1)(2012-2#1)
enzyme##1992##1##(1990-10#11)(1990-11#36)(1990-12#20)(1990-2#17)(1990-3#2)(1990-5#61)(1990-6#1)(1990-7#40)(1990-8#26)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#28)(1991-2#11)(1991-3#4)(1991-5#34)(1991-6#4)(1991-7#2)(1991-8#7)(1991-9#20)(1992-1#4)(1992-10#8)(1992-11#28)(1992-12#21)(1992-2#3)(1992-3#38)(1992-4#1)(1992-5#1)(1992-6#37)(1992-7#1)(1992-8#30)(1992-9#21)(1993-1#1)(1993-11#30)(1993-12#6)(1993-2#3)(1993-3#10)(1993-5#1)(1993-6#20)(1993-8#41)(1993-9#9)(1994-11#41)(1994-12#6)(1994-2#4)(1994-3#10)(1994-5#21)(1994-6#21)(1994-8#48)(1994-9#5)(1995-11#9)(1995-12#13)(1995-2#49)(1995-3#19)(1995-5#20)(1995-6#54)(1995-8#10)(1995-9#1)(1996-12#10)(1996-2#13)(1996-3#1)(1996-5#8)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#27)(1997-3#3)(1997-4#27)(1997-5#1)(1997-6#20)(1997-7#19)(1997-8#3)(1997-9#1)(2006-10#2)(2006-6#3)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#21)(2008-10#346)(2008-11#44)(2008-12#10)(2008-2#2)(2008-3#7)(2008-4#28)(2008-5#37)(2008-6#51)(2008-7#59)(2008-8#16)(2008-9#24)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#4)(2009-3#4)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#10)(2009-9#9)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#3)(2010-8#2)(2011-1#18)(2011-10#1)(2011-2#35)(2011-3#4)(2012-1#1)(2012-12#5)(2012-2#22)(2012-3#2)(2012-5#1)(2012-6#4)(2013-1#32)(2013-7#3)(2013-8#4)
enzyme's##14##1##(1990-12#1)(1990-5#1)(1991-12#1)(1993-11#2)(1993-8#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-10#2)(2011-1#1)
enzyme(s)##6##1##(1990-7#1)(1994-5#1)(1994-8#2)(1997-2#1)(2009-12#1)
enzyme) in##2##2##(1992-11#1)(1992-6#1)
enzyme)##12##1##(1990-12#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-5#3)(1994-8#1)(1995-6#1)(2008-10#1)(2008-5#2)
enzyme-altered lesions##2##2##(2008-4#2)
enzyme-based##3##1##(2008-10#1)(2010-2#1)(2010-4#1)
enzyme-bound amide hydrate##2##3##(1991-9#2)
enzyme-bound##5##1##(1991-9#2)(1992-3#1)(1992-6#1)(1993-11#1)
enzyme-catalyzed reaction and##3##3##(2008-10#3)
enzyme-catalyzed reaction##8##2##(1990-5#1)(2008-10#7)
enzyme-catalyzed reactions##2##2##(2008-7#2)
enzyme-catalyzed##14##1##(1990-5#1)(1993-8#1)(2008-10#7)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)
enzyme-containing##2##1##(2008-10#1)(2008-4#1)
enzyme-digested fucoidan extracts##2##3##(2008-11#2)
enzyme-digested fucoidan##3##2##(2008-11#3)
enzyme-gold##4##1##(1991-9#2)(2008-10#2)
enzyme-immobilized eggshell membrane##2##3##(2008-10#2)
enzyme-immobilized##3##1##(2008-10#3)
enzyme-inhibitor complex##8##2##(1991-3#1)(1992-2#2)(1992-9#1)(1993-11#2)(1993-8#1)(1996-12#1)
enzyme-inhibitor##14##1##(1991-3#1)(1992-2#3)(1992-6#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-8#1)(1996-12#1)(2008-10#2)
enzyme-labeled##5##1##(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#2)
enzyme-labelled##2##1##(1995-12#1)(2008-10#1)
enzyme-less##3##1##(2008-10#3)
enzyme-linked immunoassay##6##2##(2008-10#5)(2008-11#1)
enzyme-linked immunoassays##2##2##(1992-9#1)(2008-10#1)
enzyme-linked immunosorbant assays##2##3##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) absorbance values##2##6##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) analysis##2##5##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) and##6##5##(1992-5#1)(1997-6#1)(2008-10#4)
enzyme-linked immunosorbent assay (ELISA) for the determination of##2##8##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) for##6##5##(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
enzyme-linked immunosorbent assay (ELISA) is##2##5##(2008-10#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) method##4##5##(2008-10#3)(2010-5#1)
enzyme-linked immunosorbent assay (ELISA) was developed for##2##7##(1995-11#1)(2008-10#1)
enzyme-linked immunosorbent assay (ELISA) was##3##5##(1995-11#1)(2008-10#1)(2010-4#1)
enzyme-linked immunosorbent assay (ELISA)##45##4##(1990-8#1)(1992-5#1)(1993-9#1)(1994-3#2)(1995-11#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-10#23)(2008-11#2)(2008-4#5)(2008-6#1)(2010-4#2)(2010-5#1)(2011-2#1)(2013-7#1)
enzyme-linked immunosorbent assay and##4##4##(1997-6#1)(2008-10#2)(2009-5#1)
enzyme-linked immunosorbent assay for determination of##2##6##(2008-10#2)
enzyme-linked immunosorbent assay for##4##4##(1995-11#1)(2008-10#2)(2011-2#1)
enzyme-linked immunosorbent assay in##2##4##(2008-10#2)
enzyme-linked immunosorbent assay of##2##4##(2008-10#2)
enzyme-linked immunosorbent assay or##2##4##(2008-10#2)
enzyme-linked immunosorbent assay tests##2##4##(2008-10#2)
enzyme-linked immunosorbent assay using specific##2##5##(2008-10#2)
enzyme-linked immunosorbent assay using##6##4##(2008-10#5)(2010-4#1)
enzyme-linked immunosorbent assay with##2##4##(1997-4#1)(2008-10#1)
enzyme-linked immunosorbent assay##105##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#2)(1996-9#1)(1997-4#2)(1997-6#2)(2008-10#64)(2008-11#2)(2008-4#5)(2008-6#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#5)(2012-3#1)(2013-7#1)
enzyme-linked immunosorbent assays (ELISA)##4##4##(1995-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
enzyme-linked immunosorbent assays##9##3##(1993-2#1)(1995-12#1)(2008-10#5)(2011-2#1)(2013-1#1)
enzyme-linked immunosorbent##116##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#2)(1995-12#1)(1996-9#1)(1997-4#2)(1997-6#2)(2008-10#71)(2008-11#2)(2008-4#5)(2008-6#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-7#1)
enzyme-linked##135##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#3)(1995-12#1)(1996-9#1)(1997-4#2)(1997-6#2)(2008-10#83)(2008-11#3)(2008-4#6)(2008-6#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#7)(2012-3#1)(2013-1#1)(2013-7#1)
enzyme-mediated##8##1##(2008-10#5)(2009-9#2)(2010-10#1)
enzyme-specific##2##1##(2008-6#1)(2008-9#1)
enzyme-substrate complexes##2##2##(1994-5#2)
enzyme-substrate reaction##2##2##(1996-12#1)(2008-10#1)
enzyme-substrate##11##1##(1990-8#1)(1990-9#1)(1994-5#4)(1996-12#1)(2008-10#3)(2008-5#1)
enzyme-treated##2##1##(1990-7#1)(1994-12#1)
enzymeimmunoassays##2##1##(1995-12#2)
enzymelinked immunosorbent assay##3##3##(2008-10#3)
enzymes (Sma I##2##3##(1992-6#2)
enzymes -##2##2##(2008-10#1)(2011-1#1)
enzymes after##2##2##(2008-10#1)(2013-8#1)
enzymes against##2##2##(2008-9#1)(2009-12#1)
enzymes and for##2##3##(1995-5#1)(2008-10#1)
enzymes and is##2##3##(2008-12#1)(2013-8#1)
enzymes and lipid##2##3##(1994-11#1)(2008-6#1)
enzymes and the##4##3##(1997-6#1)(2008-10#2)(2008-2#1)
enzymes and##43##2##(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-6#2)(2006-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-8#3)
enzymes are discussed##3##3##(1995-11#1)(1996-3#1)(2010-4#1)
enzymes are##18##2##(1990-5#1)(1991-5#1)(1994-5#2)(1995-11#1)(1995-5#1)(1996-3#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#1)(2010-4#1)(2012-2#1)
enzymes as##3##2##(1991-5#1)(1995-3#1)(2008-6#1)
enzymes by##12##2##(1994-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-5#3)(2008-6#1)(2010-12#1)
enzymes can be##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
enzymes can##4##2##(1991-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
enzymes capable of##2##3##(2008-10#1)(2010-9#1)
enzymes catalyzing##2##2##(1994-8#1)(2008-9#1)
enzymes did not##2##3##(1996-5#1)(2008-8#1)
enzymes directly##2##2##(1991-5#1)(1994-3#1)
enzymes exhibited##2##2##(1990-8#1)(1997-7#1)
enzymes for which##2##3##(1992-3#1)(2008-10#1)
enzymes for##9##2##(1992-11#1)(1992-3#1)(1992-6#1)(1996-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
enzymes from the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
enzymes from##11##2##(1991-12#1)(1991-8#1)(1992-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2013-1#1)
enzymes function##2##2##(1993-5#1)(2011-2#1)
enzymes has been implicated in##2##5##(2008-4#1)(2012-12#1)
enzymes has been##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
enzymes have been##5##3##(1993-12#1)(1994-5#1)(1995-5#1)(2008-5#1)(2010-4#1)
enzymes have##8##2##(1993-12#1)(1994-5#1)(1995-5#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)
enzymes in a##3##3##(1993-8#1)(1996-3#1)(2008-9#1)
enzymes in an##2##3##(1995-6#1)(2012-2#1)
enzymes in both##3##3##(1994-8#1)(2007-8#1)(2008-9#1)
enzymes in cancer##2##3##(2008-4#1)(2010-12#1)
enzymes in the##13##3##(1993-5#1)(1994-11#1)(1995-11#1)(1995-9#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#2)
enzymes in this##3##3##(1992-5#1)(2009-9#1)(2011-1#1)
enzymes in##58##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#1)(1992-5#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
enzymes including##3##2##(2008-9#1)(2011-1#1)(2013-8#1)
enzymes induced by##2##3##(1991-2#1)(2008-5#1)
enzymes into##4##2##(1992-11#1)(2008-10#1)(2008-6#1)(2012-2#1)
enzymes involved in the##8##4##(1994-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2012-5#1)
enzymes involved in these##3##4##(1990-8#1)(2008-4#1)(2011-1#1)
enzymes involved in##26##3##(1990-8#1)(1991-4#1)(1993-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
enzymes involved##27##2##(1990-8#1)(1991-4#1)(1992-8#1)(1993-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
enzymes is the##2##3##(1996-12#1)(2008-10#1)
enzymes is##8##2##(1990-11#1)(1991-5#2)(1994-5#1)(1996-12#1)(2008-10#3)
enzymes isolated from##2##3##(2011-1#1)(2011-3#1)
enzymes may be##2##3##(1991-4#1)(2008-11#1)
enzymes may##7##2##(1991-4#1)(1995-5#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-9#1)
enzymes necessary for##2##3##(2008-7#1)(2012-2#1)
enzymes obtained##2##2##(2013-1#1)(2013-7#1)
enzymes of Aspergillus##2##3##(1997-2#2)
enzymes of the##8##3##(1991-4#1)(1993-3#1)(1994-12#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
enzymes of##24##2##(1991-4#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-2#2)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-9#1)(2010-7#2)(2012-2#1)(2013-8#2)
enzymes on the##2##3##(2008-10#2)
enzymes on##7##2##(1990-2#1)(1992-9#1)(1995-8#1)(2008-10#3)(2008-7#1)
enzymes or##3##2##(1994-8#1)(2007-2#1)(2008-7#1)
enzymes participating##2##2##(2013-1#2)
enzymes present in##3##3##(1997-3#1)(2007-12#1)(2008-1#1)
enzymes produced by##2##3##(2008-10#1)(2011-1#1)
enzymes responsible for the##2##4##(1991-7#1)(2008-2#1)
enzymes responsible for##4##3##(1991-7#1)(2008-2#1)(2008-4#2)
enzymes resulted in decreased##2##4##(1995-2#1)(2011-1#1)
enzymes revealed##3##2##(1990-5#1)(2008-10#2)
enzymes showed##3##2##(1994-8#1)(1996-5#1)(2008-12#1)
enzymes studied##3##2##(1995-12#1)(2008-5#2)
enzymes such as##7##3##(1995-5#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)
enzymes suggests##2##2##(1993-8#1)(2012-6#1)
enzymes superoxide dismutase##2##3##(1991-9#1)(2012-2#1)
enzymes that are##4##3##(1990-8#1)(1993-6#2)(2011-2#1)
enzymes that use##2##3##(2008-4#1)(2009-8#1)
enzymes that##18##2##(1990-8#1)(1992-3#1)(1993-6#2)(2008-1#1)(2008-4#4)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
enzymes themselves##2##2##(1993-5#1)(2008-10#1)
enzymes to be determined##2##4##(2010-3#2)
enzymes to the##2##3##(1990-7#1)(1991-5#1)
enzymes to##11##2##(1990-7#1)(1991-5#1)(1994-5#1)(1995-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#2)(2012-2#1)(2013-1#1)
enzymes used##2##2##(1997-2#1)(2008-10#1)
enzymes viz##3##2##(2013-1#3)
enzymes was##6##2##(1990-6#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)
enzymes were compared##2##3##(1995-2#1)(2008-4#1)
enzymes were found to be##2##5##(2008-10#1)(2011-1#1)
enzymes were measured##2##3##(1993-2#1)(2008-10#1)
enzymes were more##2##3##(1995-2#2)
enzymes were produced##2##3##(2008-10#2)
enzymes were purified to homogeneity##2##5##(1992-8#1)(1995-2#1)
enzymes were similar##2##3##(1995-2#1)(1995-5#1)
enzymes were used##2##3##(1997-3#1)(2008-10#1)
enzymes were##37##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-2#1)(1994-11#1)(1994-5#1)(1995-2#5)(1995-5#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
enzymes which is##2##3##(1990-7#1)(2009-6#1)
enzymes which##4##2##(1990-7#1)(1994-3#1)(2009-5#1)(2009-6#1)
enzymes whose##3##2##(1992-2#1)(1997-2#1)(2008-5#1)
enzymes with##6##2##(1992-6#2)(1992-8#1)(1995-5#1)(2011-1#1)(2013-8#1)
enzymes##752##1##(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#4)(1990-5#11)(1990-6#2)(1990-7#10)(1990-8#10)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#18)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#6)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#11)(1992-9#2)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#5)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#7)(1994-6#6)(1994-8#18)(1995-11#5)(1995-12#2)(1995-2#10)(1995-3#6)(1995-5#10)(1995-6#10)(1995-8#4)(1995-9#1)(1996-12#7)(1996-2#2)(1996-3#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#11)(1997-3#6)(1997-4#6)(1997-6#5)(1997-7#5)(2006-10#2)(2006-12#1)(2006-6#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#101)(2008-11#18)(2008-12#9)(2008-2#5)(2008-3#2)(2008-4#29)(2008-5#40)(2008-6#8)(2008-7#40)(2008-8#11)(2008-9#21)(2009-10#8)(2009-12#5)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#9)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#2)(2010-7#4)(2010-9#3)(2011-1#14)(2011-2#19)(2011-3#3)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#18)(2013-7#2)(2013-8#10)
enzymes'##2##1##(1993-11#1)(2013-1#1)
enzymic activity##2##2##(1992-3#1)(1994-9#1)
enzymic reaction mixture##2##3##(1991-5#2)
enzymic##12##1##(1990-9#1)(1991-5#5)(1992-12#2)(1992-3#1)(1992-8#1)(1994-9#1)(2008-10#1)
enzymically##2##1##(1993-8#1)(1996-5#1)
enzymogenes strain C3##3##3##(2008-10#3)
enzymogenes##6##1##(2008-10#6)
enzymology##3##1##(1995-3#1)(1996-12#1)(2009-9#1)
eosin B dye method##2##4##(1996-12#2)
eosin B##3##2##(1996-12#3)
eosin and##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
eosin##19##1##(1996-12#3)(2007-10#2)(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-2#3)(2013-1#3)
eosinophil accumulation##2##2##(1994-11#2)
eosinophil chemoattractant##2##2##(1994-11#2)
eosinophil chemotactic##2##2##(1992-6#2)
eosinophil count##2##2##(2007-7#1)(2012-3#1)
eosinophil peroxidase##2##2##(1992-12#2)
eosinophil##25##1##(1992-12#3)(1992-3#2)(1992-6#2)(1994-11#4)(1995-6#1)(1996-12#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-3#5)
eosinophil-derived neurotoxin##3##2##(1990-7#1)(1992-11#1)(2008-11#1)
eosinophil-specific genes##4##2##(2012-3#4)
eosinophilia and##3##2##(1990-9#1)(2008-10#1)(2010-5#1)
eosinophilia in peripheral blood##2##4##(1990-11#1)(2008-1#1)
eosinophilia in##4##2##(1990-11#1)(2008-1#1)(2010-5#2)
eosinophilia##31##1##(1990-11#2)(1990-3#1)(1990-9#1)(1991-12#2)(1993-6#1)(1995-1#1)(1996-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-5#4)(2010-6#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
eosinophilic cytoplasm##3##2##(1994-6#1)(2010-6#1)(2012-1#1)
eosinophilic differentiation in KU812 cells##4##5##(2008-11#4)
eosinophilic differentiation in##5##3##(2008-11#5)
eosinophilic enteritis##3##2##(2010-12#3)
eosinophilic esophagitis##2##2##(2013-1#1)(2013-7#1)
eosinophilic granular##2##2##(2008-5#2)
eosinophilic material##2##2##(2010-6#2)
eosinophilic pneumonia and eosinophilic pleural effusion##2##6##(1991-12#2)
eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus##2##9##(2008-1#2)
eosinophilic pneumonia##6##2##(1991-12#3)(2008-1#3)
eosinophilic variant of Wegener's granulomatosis##2##5##(2010-11#2)
eosinophilic##41##1##(1990-11#2)(1990-3#1)(1991-12#5)(1992-3#1)(1994-6#1)(2007-10#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-5#2)(2008-7#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#3)(2011-2#1)(2012-1#4)(2013-1#1)(2013-7#1)(2013-8#2)
eosinophillic##2##1##(2010-11#1)(2012-2#1)
eosinophils and lymphocytes##2##3##(1992-2#1)(2010-6#1)
eosinophils and##6##2##(1992-2#1)(1996-7#1)(2010-5#1)(2010-6#1)(2012-3#2)
eosinophils are##5##2##(1992-2#1)(1992-3#1)(2008-4#1)(2009-5#1)(2010-5#1)
eosinophils from##2##2##(1992-3#2)
eosinophils in the##4##3##(2008-1#2)(2012-3#2)
eosinophils in##6##2##(1992-3#1)(2008-1#2)(2012-3#3)
eosinophils into##2##2##(2008-10#2)
eosinophils with##2##2##(1991-12#1)(1995-8#1)
eosinophils##46##1##(1990-12#1)(1991-12#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#4)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#1)(2009-5#1)(2010-5#2)(2010-6#2)(2012-3#6)(2013-1#1)(2013-8#1)
eotaxin##3##1##(1994-11#2)(2012-3#1)
epact##2##1##(2010-12#2)
ependymal cells##2##2##(1991-7#1)(1996-5#1)
ependymal##4##1##(1991-7#1)(1996-5#1)(2008-12#2)
ependymomas##2##1##(1991-8#1)(1993-9#1)
eperisone-HCl was##2##2##(1996-2#2)
eperisone-HCl##3##1##(1996-2#3)
ephedra callus##3##2##(2008-10#3)
ephedra##4##1##(2008-10#4)
ephedrine derivatives in##3##3##(2008-10#3)
ephedrine derivatives##4##2##(2008-10#4)
ephedrine##15##1##(1994-9#1)(1995-2#3)(2007-10#1)(2007-5#1)(2008-10#9)
ephemeral fever##2##2##(2008-10#2)
ephemeral##6##1##(2008-10#3)(2008-8#2)(2008-9#1)
ephrin##2##1##(2008-7#2)
epi##6##1##(2008-6#6)
epi-fluorescence microscopy##2##2##(2008-10#2)
epi-fluorescence##4##1##(2008-10#4)
epi-inositol##3##1##(2008-11#3)
epi-spiro##3##1##(1996-5#3)
epiaortic ultrasound##4##2##(2007-8#4)
epiaortic##5##1##(2007-8#5)
epicardial##5##1##(2007-8#3)(2008-12#1)(2012-3#1)
epicatechin and##2##2##(2008-10#1)(2008-11#1)
epicatechin##16##1##(1993-8#2)(2008-10#11)(2008-11#2)(2012-3#1)
epicenter of##2##2##(2008-8#1)(2013-1#1)
epicenter##4##1##(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
epichlorohydrin##4##1##(2008-10#3)(2008-7#1)
epicondylalgia##4##1##(2008-12#4)
epicondyle##4##1##(1995-6#2)(2008-8#1)(2008-9#1)
epicondyles##2##1##(2007-11#1)(2011-2#1)
epicotyl segments##2##2##(2008-11#2)
epicotyls##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
epicrisis##2##1##(1995-11#1)(2010-8#1)
epicuticular hydrocarbon##3##2##(2008-8#3)
epicuticular waxes##3##2##(2008-10#3)
epicuticular##9##1##(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#4)
epidemic and the##2##3##(1990-12#1)(1993-3#1)
epidemic and##10##2##(1990-12#3)(1991-12#1)(1993-3#1)(1995-5#1)(2007-12#1)(2008-10#2)(2009-10#1)
epidemic as##2##2##(2007-12#1)(2008-10#1)
epidemic curve##4##2##(1994-9#2)(2007-12#1)(2008-10#1)
epidemic data##2##2##(2008-10#2)
epidemic development##5##2##(2008-10#5)
epidemic during the growing season##2##5##(2008-10#2)
epidemic during##3##2##(2008-10#2)(2011-1#1)
epidemic for##3##2##(1992-2#1)(2008-10#2)
epidemic form##2##2##(1991-12#1)(2013-8#1)
epidemic grows##2##2##(1992-12#1)(1997-8#1)
epidemic growth rate##2##3##(2008-10#2)
epidemic growth##4##2##(2007-7#1)(2008-10#3)
epidemic has##2##2##(2008-10#1)(2011-1#1)
epidemic in Latin##2##3##(1992-5#2)
epidemic in the Caribbean##2##4##(2008-4#1)(2009-7#1)
epidemic in the##5##3##(1995-1#1)(1996-6#1)(2008-4#1)(2009-7#1)(2011-2#1)
epidemic in##28##2##(1990-12#2)(1990-3#1)(1992-5#2)(1993-3#2)(1995-1#1)(1995-6#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
epidemic into areas of high##2##5##(2010-5#2)
epidemic is##5##2##(1991-12#1)(2007-7#1)(2008-10#1)(2010-5#1)(2012-3#1)
epidemic model##3##2##(1995-5#2)(2008-10#1)
epidemic occurred##3##2##(2008-10#2)(2011-2#1)
epidemic of##23##2##(1990-6#2)(1992-5#1)(1993-12#1)(1996-11#3)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-3#1)
epidemic on the##3##3##(1995-1#1)(1996-5#1)(2007-12#1)
epidemic onset##10##2##(2008-10#10)
epidemic outbreaks of##2##3##(2007-10#1)(2008-5#1)
epidemic outbreaks##3##2##(2007-10#1)(2008-5#1)(2008-7#1)
epidemic over##2##2##(2008-10#1)(2012-2#1)
epidemic progress of##3##3##(2008-10#3)
epidemic progress##5##2##(2008-10#5)
epidemic proportions##10##2##(2008-1#1)(2008-10#2)(2008-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
epidemic rate##2##2##(2008-10#2)
epidemic situation##3##2##(1990-11#1)(2012-3#2)
epidemic strains##3##2##(2011-1#3)
epidemic that has##2##3##(2010-12#1)(2011-2#1)
epidemic that##4##2##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
epidemic under control##2##3##(2007-7#1)(2008-8#1)
epidemic was##5##2##(2008-10#4)(2012-12#1)
epidemic with##2##2##(2010-5#1)(2011-3#1)
epidemic##304##1##(1990-11#1)(1990-12#9)(1990-3#3)(1990-6#5)(1991-12#7)(1992-12#1)(1992-2#2)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-3#4)(1993-6#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-11#7)(1996-3#2)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#6)(2007-2#4)(2007-7#9)(2008-1#7)(2008-10#113)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#5)(2011-1#6)(2011-2#8)(2011-3#2)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#6)
epidemic's##4##1##(1997-3#1)(1997-6#1)(2008-8#2)
epidemic?]##2##1##(1990-3#1)(1992-6#1)
epidemics and##5##2##(2008-10#4)(2008-7#1)
epidemics are##2##2##(2008-10#2)
epidemics at##3##2##(2008-10#2)(2008-9#1)
epidemics by##2##2##(2008-10#2)
epidemics caused by##5##3##(2008-10#4)(2012-3#1)
epidemics developing##2##2##(2008-10#2)
epidemics have been reported##3##4##(1991-12#1)(2008-10#2)
epidemics have been##4##3##(1991-12#1)(2008-10#2)(2008-8#1)
epidemics have##5##2##(1991-12#1)(2008-10#3)(2008-8#1)
epidemics in a##2##3##(2008-10#2)
epidemics in southern##2##3##(2008-10#1)(2011-2#1)
epidemics in sugar beet##2##4##(2008-10#2)
epidemics in tomato in##2##4##(2008-10#2)
epidemics in##35##2##(1993-6#1)(1995-5#2)(2007-12#1)(2007-7#2)(2008-10#24)(2011-2#3)(2012-2#2)
epidemics is##2##2##(2008-10#2)
epidemics occurred in##2##3##(2008-10#2)
epidemics of Fusarium##2##3##(2008-10#2)
epidemics of the disease##2##4##(2008-10#2)
epidemics of the past##2##4##(2008-10#2)
epidemics of the##5##3##(2008-10#5)
epidemics of##27##2##(1994-9#1)(2007-10#1)(2007-6#1)(2008-10#21)(2008-5#1)(2008-8#2)
epidemics on##4##2##(2008-10#4)
epidemics to##3##2##(2008-10#3)
epidemics was##6##2##(2008-10#5)(2011-2#1)
epidemics were compared##2##3##(2008-10#2)
epidemics were##8##2##(2008-10#8)
epidemics with##2##2##(2008-10#2)
epidemics##199##1##(1990-12#1)(1990-6#1)(1991-12#1)(1993-6#1)(1994-9#1)(1995-5#4)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#155)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-2#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
epidemiologic and##4##2##(1992-4#1)(2007-4#1)(2010-3#1)(2010-5#1)
epidemiologic characteristics of the patients##2##5##(1991-12#1)(2011-2#1)
epidemiologic characteristics##4##2##(1991-12#3)(2011-2#1)
epidemiologic data##6##2##(1995-5#1)(2009-2#1)(2009-9#1)(2011-2#2)(2013-8#1)
epidemiologic investigations##2##2##(1991-12#1)(1995-9#1)
epidemiologic studies of##2##3##(2008-7#1)(2008-8#1)
epidemiologic studies##19##2##(1991-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
epidemiologic study##5##2##(1992-12#1)(1994-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
epidemiologic surveillance##2##2##(1990-12#1)(2012-12#1)
epidemiologic##57##1##(1990-12#1)(1990-6#2)(1990-9#1)(1991-12#6)(1992-12#1)(1992-3#1)(1992-4#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#7)(2008-8#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
epidemiological analysis of##3##3##(1990-6#1)(1991-12#1)(1994-6#1)
epidemiological analysis##4##2##(1990-6#1)(1991-12#1)(1994-6#1)(2011-1#1)
epidemiological and clinical##7##3##(1990-6#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
epidemiological and etiological##2##3##(2008-10#2)
epidemiological and experimental##2##3##(2008-7#2)
epidemiological and##22##2##(1990-12#1)(1990-6#1)(1991-9#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
epidemiological aspects##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
epidemiological characteristics of##7##3##(1991-6#1)(2008-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
epidemiological characteristics##9##2##(1991-6#1)(2007-7#1)(2008-7#2)(2011-1#1)(2011-2#3)(2013-1#1)
epidemiological components##3##2##(2008-10#3)
epidemiological data (a##2##3##(1992-12#1)(2013-1#1)
epidemiological data on##2##3##(2007-12#1)(2008-8#1)
epidemiological data##18##2##(1992-12#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#6)(2008-8#1)(2009-12#1)(2013-1#3)(2013-7#1)
epidemiological evidence and##3##3##(1992-4#1)(2008-11#1)(2008-5#1)
epidemiological evidence##12##2##(1992-11#1)(1992-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-6#1)(2013-1#1)
epidemiological features##2##2##(1997-4#1)(2013-1#1)
epidemiological importance##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
epidemiological investigation##2##2##(1992-9#1)(2013-8#1)
epidemiological investigations##6##2##(1991-8#1)(1992-11#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
epidemiological methods##2##2##(2008-7#1)(2013-1#1)
epidemiological model of##2##3##(1994-3#1)(2008-10#1)
epidemiological model##5##2##(1994-3#1)(2008-10#3)(2008-8#1)
epidemiological parameters##2##2##(2008-10#2)
epidemiological patterns##2##2##(2008-11#2)
epidemiological perspective##2##2##(2008-11#2)
epidemiological profile of##3##3##(2008-9#1)(2013-1#2)
epidemiological profile##4##2##(2007-8#1)(2008-9#1)(2013-1#2)
epidemiological research##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#3)
epidemiological significance##2##2##(2008-10#1)(2011-1#1)
epidemiological situation in##3##3##(1992-5#1)(1994-6#1)(1996-6#1)
epidemiological situation##5##2##(1990-6#1)(1992-5#1)(1994-6#1)(1996-6#1)(2010-5#1)
epidemiological studies and##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
epidemiological studies are needed to##2##5##(2008-4#1)(2008-9#1)
epidemiological studies are##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
epidemiological studies have shown that##2##5##(1991-4#1)(2008-10#1)
epidemiological studies have shown##3##4##(1991-4#1)(2008-10#1)(2008-3#1)
epidemiological studies have##7##3##(1991-4#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
epidemiological studies indicate that##2##4##(2008-10#1)(2010-2#1)
epidemiological studies of##5##3##(1996-6#1)(2008-10#2)(2009-7#1)(2010-9#1)
epidemiological studies on##2##3##(1994-6#1)(2007-7#1)
epidemiological studies##45##2##(1991-12#1)(1991-4#1)(1991-9#1)(1994-2#1)(1994-6#1)(1996-6#2)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
epidemiological study of##5##3##(1991-9#1)(1995-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
epidemiological study on##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
epidemiological study##19##2##(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1995-3#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2011-2#2)(2012-12#1)(2012-2#1)
epidemiological surveillance of##2##3##(1991-2#1)(2013-8#1)
epidemiological surveillance##9##2##(1991-2#1)(2008-8#3)(2012-12#2)(2013-1#2)(2013-8#1)
epidemiological survey in##2##3##(2008-5#1)(2009-10#1)
epidemiological survey was##2##3##(1990-12#1)(2008-3#1)
epidemiological survey##6##2##(1990-12#1)(1990-3#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-1#1)
epidemiological surveys##4##2##(1996-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
epidemiological trends##2##2##(2008-11#1)(2008-8#1)
epidemiological unit##2##2##(2008-10#2)
epidemiological##277##1##(1990-12#2)(1990-3#1)(1990-6#3)(1990-8#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-3#2)(1994-2#1)(1994-3#2)(1994-6#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-6#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-7#3)(1997-8#1)(2007-12#6)(2007-2#4)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#53)(2008-11#14)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#10)(2008-7#20)(2008-8#14)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#17)(2011-3#1)(2012-12#10)(2012-2#3)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#5)
epidemiologically important##3##2##(2008-10#3)
epidemiologically##10##1##(1992-9#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#3)(2011-2#2)(2012-3#1)
epidemiologist##5##1##(1994-3#4)(2012-2#1)
epidemiologists##17##1##(1991-12#1)(1993-3#1)(1994-3#2)(2008-10#1)(2008-11#11)(2010-4#1)
epidemiology and the##2##3##(2010-3#1)(2013-8#1)
epidemiology and##30##2##(1991-2#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-3#3)(2013-8#1)
epidemiology approach##3##2##(2008-10#1)(2008-12#2)
epidemiology data##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
epidemiology department##2##2##(2008-11#2)
epidemiology has##3##2##(2008-10#2)(2012-3#1)
epidemiology in the##3##3##(1994-3#1)(2008-11#1)(2009-2#1)
epidemiology in##7##2##(1994-3#1)(2007-10#1)(2008-11#2)(2009-2#1)(2009-4#1)(2013-8#1)
epidemiology is##4##2##(1994-3#1)(2008-7#1)(2008-8#2)
epidemiology of dengue##3##3##(1992-6#1)(2007-10#1)(2011-3#1)
epidemiology of the##5##3##(2007-10#1)(2008-10#3)(2008-9#1)
epidemiology of##69##2##(1990-9#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(2007-10#2)(2007-12#3)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#1)(2013-1#5)(2013-8#4)
epidemiology services##2##2##(2008-11#2)
epidemiology studies##4##2##(1996-2#1)(2008-7#1)(2010-9#1)(2011-2#1)
epidemiology was##2##2##(2008-10#2)
epidemiology##217##1##(1990-12#2)(1990-9#2)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1994-2#1)(1994-3#5)(1994-6#1)(1995-12#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#42)(2008-11#13)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#23)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#8)
epidemiology]##2##1##(1990-6#1)(2008-8#1)
epidermal and cortical cells##2##4##(2008-10#1)(2008-9#1)
epidermal and cortical##5##3##(2008-10#3)(2008-12#1)(2008-9#1)
epidermal and dermal properties##2##4##(2008-5#2)
epidermal and dermal##6##3##(2008-5#6)
epidermal and##15##2##(2008-10#6)(2008-12#1)(2008-5#7)(2008-9#1)
epidermal barrier##2##2##(2008-5#1)(2012-2#1)
epidermal cell wall##2##3##(2008-10#2)
epidermal cell walls##5##3##(2008-10#5)
epidermal cell##15##2##(1990-11#1)(1993-12#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
epidermal cells by##3##3##(1994-6#1)(2008-10#2)
epidermal cells of##3##3##(2008-10#3)
epidermal cells##29##2##(1993-12#1)(1994-6#2)(2007-12#1)(2008-10#20)(2008-12#1)(2008-7#2)(2012-2#2)
epidermal degeneration##6##2##(2008-9#6)
epidermal function in hairless mice##2##5##(2012-2#2)
epidermal function##4##2##(2012-2#4)
epidermal growth factor (EGF) and##3##5##(1990-12#1)(1995-11#1)(2008-8#1)
epidermal growth factor (EGF)##24##4##(1990-12#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-7#1)
epidermal growth factor and##2##4##(1991-7#1)(1994-12#1)
epidermal growth factor receptor (EGFR) and##3##6##(1992-8#1)(1995-11#1)(2012-1#1)
epidermal growth factor receptor (EGFR)##11##5##(1992-8#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#3)(2012-1#2)(2012-3#1)
epidermal growth factor receptor and##4##5##(1991-11#1)(1992-8#1)(2008-11#1)(2011-2#1)
epidermal growth factor receptor inhibitors in##2##6##(2009-4#1)(2012-1#1)
epidermal growth factor receptor##29##4##(1991-11#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-8#1)(1995-11#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2011-2#3)(2012-1#4)(2012-3#3)
epidermal growth factor receptors##2##4##(1991-7#1)(1992-8#1)
epidermal growth factor##75##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#1)(1995-6#3)(1995-8#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#4)(2008-8#2)(2009-4#1)(2009-9#1)(2011-2#6)(2012-1#4)(2012-3#3)(2013-7#1)
epidermal growth factor-like domains##2##4##(1992-12#1)(1995-6#1)
epidermal growth factor-like growth factor##2##5##(1993-11#2)
epidermal growth factor-like##5##3##(1992-12#1)(1993-11#2)(1993-8#1)(1995-6#1)
epidermal growth##83##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-7#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-3#5)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-2#1)(1995-6#4)(1995-8#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#4)(2008-8#2)(2009-4#1)(2009-9#1)(2011-2#6)(2012-1#4)(2012-3#3)(2013-7#1)
epidermal hyperkeratosis and hyperplasia##2##4##(2008-9#2)
epidermal hyperkeratosis##3##2##(2008-9#3)
epidermal hyperplasia in##3##3##(2008-9#3)
epidermal hyperplasia were significantly increased in##2##6##(2008-9#2)
epidermal hyperplasia##18##2##(2008-9#18)
epidermal keratinocytes in##2##3##(1992-2#1)(2008-5#1)
epidermal keratinocytes##8##2##(1992-2#3)(2008-4#2)(2008-5#3)
epidermal layer##2##2##(2008-10#2)
epidermal layers of the eschar##3##5##(2013-8#3)
epidermal layers of##4##3##(2013-8#4)
epidermal melanin##2##2##(2008-5#1)(2010-8#1)
epidermal melanocytes##2##2##(1994-12#2)
epidermal necrolysis##3##2##(1992-2#1)(2007-7#2)
epidermal necrosis##4##2##(2008-9#4)
epidermal ornithine decarboxylase##2##3##(1992-8#2)
epidermal permeability barrier##2##3##(1994-5#1)(2008-5#1)
epidermal precursor cells##2##3##(2007-12#2)
epidermal proteins with molecular weights of 40##2##7##(1990-11#2)
epidermal stem cells##2##3##(2008-5#2)
epidermal thickness##2##2##(2008-5#2)
epidermal##265##1##(1990-11#5)(1990-12#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-7#2)(1992-12#2)(1992-2#5)(1992-3#3)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#5)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#3)(1994-8#3)(1995-11#3)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-5#1)(2007-12#9)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#43)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#41)(2008-7#8)(2008-8#3)(2008-9#35)(2009-10#3)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#7)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#5)
epidermidis##14##1##(1991-11#1)(1991-3#4)(1993-9#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-4#2)(2012-2#2)
epidermis and dermis##7##3##(1996-12#1)(2008-5#5)(2008-9#1)
epidermis and outer##5##3##(2008-10#5)
epidermis and##29##2##(1996-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#1)(2008-9#2)(2012-12#1)(2013-7#1)
epidermis at the##2##3##(2008-10#1)(2008-9#1)
epidermis can##2##2##(2008-5#2)
epidermis in##4##2##(1993-8#2)(2008-1#1)(2012-12#1)
epidermis is##3##2##(2008-12#1)(2008-5#1)(2010-7#1)
epidermis of the##2##3##(2008-10#1)(2008-12#1)
epidermis of##9##2##(1994-6#2)(1996-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)
epidermis##139##1##(1991-9#1)(1992-8#2)(1993-8#2)(1994-5#1)(1994-6#2)(1995-11#1)(1996-12#5)(1996-2#1)(1996-6#2)(2007-12#4)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#58)(2008-7#2)(2008-9#6)(2010-6#4)(2010-7#1)(2011-3#1)(2012-12#9)(2012-2#1)(2012-3#1)(2013-7#2)
epidermitis##2##1##(2013-8#2)
epidermoid cancer of cervix##5##4##(2013-1#5)
epidermoid carcinoma##3##2##(1992-9#1)(2008-10#2)
epidermoid cyst##5##2##(2007-8#2)(2008-7#3)
epidermoid##20##1##(1992-9#1)(1995-9#1)(2007-8#2)(2008-10#2)(2008-7#6)(2010-3#2)(2011-2#1)(2013-1#5)
epidermolysis bullosa##10##2##(1992-3#2)(2008-10#1)(2008-5#1)(2012-3#6)
epidermolysis##11##1##(1992-3#2)(1995-10#1)(2008-10#1)(2008-5#1)(2012-3#6)
epididymal and ejaculatory sperm cells were##2##6##(2008-12#2)
epididymal and ejaculatory sperm##3##4##(2008-12#3)
epididymal sperm were##2##3##(2008-12#2)
epididymal sperm##4##2##(2008-12#4)
epididymal spermatozoa##2##2##(1996-9#1)(2008-5#1)
epididymal##20##1##(1990-9#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1996-9#1)(1997-8#1)(2008-12#7)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#2)
epididymides##2##1##(2008-12#2)
epididymis and##4##2##(1997-6#1)(2008-12#1)(2008-9#1)(2011-1#1)
epididymis was##3##2##(1992-3#2)(2008-12#1)
epididymis##22##1##(1990-9#1)(1992-3#4)(1992-8#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-12#5)(2008-6#1)(2008-9#2)(2011-1#4)(2012-12#1)
epididymitis and orchitis##2##3##(1997-8#2)
epididymitis and##3##2##(1997-8#2)(2008-12#1)
epididymo-orchitis and##2##2##(2007-7#2)
epididymo-orchitis##4##1##(2007-7#2)(2011-2#2)
epidural abscess##10##2##(1991-3#1)(2008-5#1)(2009-5#2)(2011-2#2)(2012-3#4)
epidural anaesthesia for##2##3##(2007-8#2)
epidural anaesthesia##8##2##(1992-11#1)(2006-10#1)(2007-8#3)(2008-7#3)
epidural analgesia in##2##3##(1993-10#1)(2007-9#1)
epidural analgesia##7##2##(1993-10#3)(2007-2#1)(2007-9#2)(2012-12#1)
epidural and##6##2##(1992-11#1)(2009-4#1)(2012-3#1)(2013-1#3)
epidural anesthesia and##2##3##(2012-12#1)(2012-3#1)
epidural anesthesia for##2##3##(2012-3#1)(2013-1#1)
epidural anesthesia with##2##3##(2012-3#2)
epidural anesthesia##16##2##(2007-2#2)(2012-12#1)(2012-3#11)(2013-1#1)(2013-8#1)
epidural blood patch##2##3##(1993-10#2)
epidural blood##3##2##(1993-10#3)
epidural catheter##7##2##(1993-10#4)(2011-2#3)
epidural disc herniation##2##3##(2011-2#2)
epidural disc##3##2##(2011-2#3)
epidural hematoma##3##2##(2008-7#3)
epidural infusion##2##2##(1992-5#1)(2007-8#1)
epidural pressure in##2##3##(1993-10#2)
epidural pressure was##2##3##(1993-10#2)
epidural pressure##5##2##(1993-10#5)
epidural space##10##2##(1993-10#5)(2008-12#1)(2009-3#1)(2010-7#1)(2011-2#2)
epidural stimulation##2##2##(2010-7#1)(2013-1#1)
epidural##109##1##(1991-3#1)(1992-11#2)(1992-12#2)(1992-5#2)(1993-10#22)(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#5)(2007-8#6)(2007-9#3)(2008-12#1)(2008-5#1)(2008-7#11)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2010-7#4)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#16)(2012-8#1)(2013-1#6)(2013-8#1)
epidurals##2##1##(2007-2#2)
epifauna and##2##2##(2008-5#2)
epifluorescence microscopy and##2##3##(1992-6#1)(2008-10#1)
epifluorescence microscopy##7##2##(1992-6#2)(2008-10#4)(2008-8#1)
epifluorescence##10##1##(1992-6#2)(1994-5#1)(2008-1#1)(2008-10#5)(2008-8#1)
epifluorescent##2##1##(1996-2#1)(1997-4#1)
epigallocatechin gallate##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
epigallocatechin##5##1##(2008-10#2)(2008-11#2)(2008-5#1)
epigastralgia##3##1##(1992-9#1)(1993-9#1)(2013-1#1)
epigastric pain##6##2##(1996-8#1)(2008-5#2)(2013-1#2)(2013-8#1)
epigastric##11##1##(1991-5#1)(1996-8#1)(2008-5#2)(2008-9#1)(2013-1#5)(2013-8#1)
epigenetic alterations##3##2##(2009-4#2)(2009-6#1)
epigenetic approach##3##2##(1994-5#3)
epigenetic changes in##3##3##(1992-3#1)(2009-4#2)
epigenetic changes##7##2##(1992-3#1)(2009-4#4)(2011-1#1)(2011-2#1)
epigenetic control##2##2##(2011-1#2)
epigenetic events##2##2##(2009-4#1)(2013-8#1)
epigenetic factors##3##2##(2008-11#1)(2008-12#1)(2011-9#1)
epigenetic influence of##3##3##(2009-3#3)
epigenetic influence##4##2##(2009-3#4)
epigenetic information##2##2##(2009-3#1)(2012-2#1)
epigenetic marks##5##2##(2009-12#2)(2012-2#3)
epigenetic mechanisms of##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
epigenetic mechanisms##9##2##(2008-7#2)(2009-4#1)(2011-2#1)(2011-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
epigenetic modifications##2##2##(2012-2#2)
epigenetic phenomenon##2##2##(2011-2#2)
epigenetic processes##2##2##(2012-2#2)
epigenetic regulation of gene expression in##2##6##(2007-11#1)(2011-2#1)
epigenetic regulation of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-12#1)
epigenetic regulation##10##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#2)(2011-2#2)(2012-12#1)
epigenetic state##2##2##(2008-8#2)
epigenetic states##3##2##(2008-8#3)
epigenetic therapy##2##2##(2008-5#1)(2013-8#1)
epigenetic##99##1##(1992-3#1)(1994-5#3)(1995-2#3)(2007-11#5)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#5)(2008-8#8)(2009-10#2)(2009-12#2)(2009-3#14)(2009-4#9)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#7)(2011-9#2)(2012-12#2)(2012-2#13)(2012-3#1)(2013-1#1)(2013-8#4)
epigenetically silenced genes##2##3##(2007-11#1)(2009-4#1)
epigenetically silenced##3##2##(2007-11#2)(2009-4#1)
epigenetically##7##1##(2007-11#2)(2008-10#1)(2008-7#1)(2009-4#1)(2012-2#1)(2012-3#1)
epigenetics and epigenomics##2##3##(2009-4#2)
epigenetics and##4##2##(2008-7#1)(2009-4#2)(2012-2#1)
epigenetics##9##1##(2008-7#1)(2009-4#5)(2010-9#1)(2011-2#1)(2012-2#1)
epigenomic##2##1##(2009-3#1)(2012-12#1)
epigenomics##3##1##(2009-4#3)
epilepsies##2##1##(1990-9#1)(2008-5#1)
epilepsy and##7##2##(1990-7#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-11#1)(2011-1#1)(2011-2#1)
epilepsy are##2##2##(1996-3#1)(2013-1#1)
epilepsy health promotion##2##3##(2008-12#2)
epilepsy in##4##2##(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
epilepsy is##2##2##(1994-2#1)(2009-9#1)
epilepsy of##2##2##(2008-8#1)(2013-8#1)
epilepsy often##2##2##(2008-2#2)
epilepsy patients and##3##3##(2008-8#1)(2009-9#1)(2010-8#1)
epilepsy patients##15##2##(2008-1#1)(2008-7#1)(2008-8#8)(2009-8#1)(2009-9#1)(2010-8#3)
epilepsy service##3##2##(1997-8#3)
epilepsy was##2##2##(1996-6#1)(2013-8#1)
epilepsy with febrile seizure plus (GEFS+)##2##6##(2012-12#2)
epilepsy with##3##2##(2008-2#1)(2012-12#2)
epilepsy##114##1##(1990-3#1)(1990-7#1)(1990-9#2)(1991-11#1)(1992-5#2)(1992-9#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-9#2)(1997-4#1)(1997-8#10)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-12#3)(2008-2#6)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#15)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-3#1)(2010-8#6)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#3)
epilepsy]##2##1##(1996-9#1)(2008-11#1)
epileptic attacks##2##2##(1995-12#1)(2008-11#1)
epileptic patients##2##2##(2008-11#1)(2008-7#1)
epileptic seizure##4##2##(2010-12#3)(2010-4#1)
epileptic seizures in##2##3##(2011-1#1)(2012-3#1)
epileptic seizures##11##2##(1994-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-8#1)
epileptic women##2##2##(2008-2#1)(2008-3#1)
epileptic##42##1##(1990-5#1)(1990-9#1)(1991-12#1)(1994-2#1)(1995-12#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#7)(2011-1#2)(2012-3#1)(2013-8#1)
epilepticus##8##1##(1994-11#1)(2008-7#2)(2009-7#1)(2010-11#2)(2012-2#2)
epileptiform activity##4##2##(1996-5#3)(2008-2#1)
epileptiform##6##1##(1990-9#1)(1996-5#3)(2007-8#1)(2008-2#1)
epileptogenesis in##3##2##(2009-8#2)(2013-8#1)
epileptogenesis##7##1##(1996-12#1)(1997-2#1)(2008-1#1)(2009-8#3)(2013-8#1)
epileptogenic##4##1##(1991-1#1)(1996-5#1)(2008-1#1)(2009-8#1)
epimer##2##1##(1996-5#1)(2008-10#1)
epimerization of##3##2##(2007-12#1)(2008-5#1)(2010-7#1)
epimerization##7##1##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-1#1)
epimorphin##3##1##(1993-3#3)
epimyocardial##2##1##(2007-8#1)(2009-3#1)
epimysium and deep fasciae##3##4##(2013-1#3)
epinephrine (E) and##2##3##(2008-10#2)
epinephrine (E)##4##2##(2008-10#3)(2008-7#1)
epinephrine (EP)##2##2##(2008-10#2)
epinephrine and l-dopa##4##3##(2008-10#4)
epinephrine and##9##2##(1990-5#1)(1997-6#1)(2008-10#4)(2008-4#1)(2010-1#1)(2010-2#1)
epinephrine as##3##2##(1993-1#1)(2012-2#2)
epinephrine or##2##2##(1994-6#1)(1997-7#1)
epinephrine was##3##2##(1990-5#1)(1997-6#1)(2008-10#1)
epinephrine##61##1##(1990-5#5)(1990-8#1)(1991-12#1)(1991-9#1)(1993-1#5)(1994-6#4)(1997-6#2)(1997-7#1)(2007-8#1)(2008-10#26)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-2#2)(2012-2#3)(2013-1#2)
epinephrine-containing local anesthetic##2##3##(1993-1#2)
epinephrine-containing local##3##2##(1993-1#3)
epinephrine-free and epinephrine-containing local##2##4##(1993-1#2)
epinephrine-free##3##1##(1993-1#3)
epineural ganglion##3##2##(2008-9#3)
epinuclear##2##1##(2008-7#2)
epiphyseal cartilage##4##2##(1990-11#4)
epiphyseal chondrocytes##2##2##(2012-12#2)
epiphyseal plate##2##2##(2011-2#2)
epiphyseal plates##2##2##(1996-11#1)(2011-2#1)
epiphyseal##20##1##(1990-11#4)(1992-8#2)(1995-6#3)(1996-11#1)(2007-11#1)(2008-4#1)(2009-7#1)(2011-2#4)(2012-1#1)(2012-12#2)
epiphyses##4##1##(1995-6#3)(2011-1#1)
epiphysis of the##8##3##(1995-6#1)(2007-11#4)(2007-8#3)
epiphysis##18##1##(1995-6#1)(2007-11#7)(2007-8#3)(2008-8#5)(2013-7#1)(2013-8#1)
epiphytes##10##1##(2008-10#4)(2008-5#6)
epiphytic growth##2##2##(2008-10#2)
epiphytic populations of##2##3##(2008-10#2)
epiphytic##16##1##(2008-10#9)(2008-5#3)(2013-7#4)
epiphytotics##4##1##(2008-10#4)
epiretinal membranes##2##2##(2008-1#1)(2013-1#1)
epiretinal##4##1##(2008-1#1)(2011-2#2)(2013-1#1)
epirubicin and VP-16##2##3##(1992-12#2)
epirubicin in##4##2##(1990-10#3)(1993-2#1)
epirubicin##24##1##(1990-10#5)(1990-12#1)(1991-2#2)(1991-6#4)(1992-10#3)(1992-12#2)(1993-2#1)(1995-10#1)(2008-6#1)(2009-4#2)(2010-3#2)
episiotomy##2##1##(2010-11#1)(2011-2#1)
episode and##2##2##(1995-3#1)(1996-6#1)
episode in##5##2##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
episode of AP##2##3##(2013-1#2)
episode of acute##4##3##(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
episode of care##2##3##(1994-2#1)(1996-1#1)
episode of gross##2##3##(1992-9#1)(2008-10#1)
episode of the##2##3##(2008-7#1)(2013-1#1)
episode of##44##2##(1991-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-3#1)(1996-7#2)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#4)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
episode was##2##2##(1994-2#1)(2008-9#1)
episode were##2##2##(2007-4#1)(2010-2#1)
episode##82##1##(1990-12#1)(1991-3#3)(1991-8#1)(1992-5#1)(1992-9#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-5#1)(1997-8#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
episode-of-care analysis##2##2##(1994-12#2)
episodes and##12##2##(1995-12#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#4)(2010-10#1)
episodes could be##2##3##(2008-1#1)(2008-7#1)
episodes in the##2##3##(2008-1#1)(2008-10#1)
episodes in##12##2##(1991-8#1)(1991-9#1)(1994-9#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#2)(2012-12#1)
episodes occurred##2##2##(1990-12#1)(2007-7#1)
episodes of acute##4##3##(2008-1#2)(2008-10#1)(2011-2#1)
episodes of angina##2##3##(1990-8#1)(2008-10#1)
episodes of brain##2##3##(2012-3#2)
episodes of care##2##3##(1994-2#1)(1996-3#1)
episodes of coronary##2##3##(2007-8#1)(2008-7#1)
episodes of desaturation##2##3##(1993-1#2)
episodes of hypoglycemia##6##3##(1997-4#1)(2007-5#1)(2008-5#1)(2009-4#3)
episodes of meningitis in##2##4##(2008-7#1)(2013-7#1)
episodes of recurrent##2##3##(2010-6#1)(2012-3#1)
episodes of serious##2##3##(1994-6#1)(1995-3#1)
episodes of##90##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1993-1#4)(1993-12#1)(1993-3#1)(1994-2#3)(1994-6#3)(1995-3#2)(1995-5#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#1)(2009-4#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#5)(2013-7#1)
episodes that##2##2##(2007-7#1)(2008-1#1)
episodes were##6##2##(2007-7#2)(2008-1#1)(2008-10#1)(2012-3#2)
episodes with##3##2##(1992-8#1)(2010-2#1)(2011-2#1)
episodes##182##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-1#5)(1993-12#3)(1993-3#1)(1994-2#3)(1994-5#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#13)(2007-8#1)(2007-9#1)(2008-1#13)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#1)(2009-4#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#6)(2012-2#1)(2012-3#9)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#1)
episodes) of##2##2##(1997-2#1)(2008-10#1)
episodes)##6##1##(1990-12#1)(1991-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
episodes/patient-year (p = 0##2##4##(2011-2#2)
episodes/patient-year##3##1##(2011-2#3)
episodic hypoglycemia##2##2##(2011-1#2)
episodic memory impairment##2##3##(2009-6#2)
episodic memory##7##2##(2008-2#2)(2008-7#2)(2009-6#2)(2010-7#1)
episodic selection##2##2##(2008-10#2)
episodic##29##1##(1992-2#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#2)(2009-6#2)(2010-7#1)(2011-1#4)(2012-3#3)
episodically in##2##2##(1990-11#1)(2008-10#1)
episomal telomere sequence##2##3##(2008-11#2)
episomal##8##1##(1993-12#1)(1993-9#1)(1995-2#2)(2008-11#2)(2008-4#1)(2010-2#1)
epispadias##2##1##(2008-10#2)
epistasis is##2##2##(2013-1#2)
epistasis through##2##2##(2008-8#2)
epistasis##17##1##(1990-5#1)(1995-9#1)(1996-6#1)(2008-10#5)(2008-4#2)(2008-8#3)(2013-1#4)
epistatic effects were##2##3##(2008-10#2)
epistatic interaction##3##2##(2008-10#2)(2012-3#1)
epistatic interactions between##2##3##(2008-9#1)(2012-3#1)
epistatic interactions##7##2##(2008-10#2)(2008-4#2)(2008-9#1)(2012-3#2)
epistatic##14##1##(1997-7#1)(2008-10#6)(2008-4#2)(2008-9#1)(2010-5#1)(2012-3#3)
epistaxis and##3##2##(2011-1#3)
epistaxis##18##1##(1994-3#1)(2007-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
epistemic processes##2##2##(2008-5#2)
epistemic##4##1##(2008-5#3)(2010-9#1)
epistemological crisis in genomics##3##4##(2009-5#3)
epistemological##12##1##(1994-12#1)(2008-11#1)(2008-8#1)(2009-5#5)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
epistemology of##2##2##(2009-11#1)(2013-1#1)
epistemology##5##1##(1996-1#1)(2008-12#1)(2009-11#1)(2009-5#1)(2013-1#1)
epistome##2##1##(2011-2#2)
epitaxial growth##3##2##(1992-11#1)(2008-7#2)
epitaxial##9##1##(1990-12#1)(1991-9#1)(1992-11#1)(2007-11#1)(2008-3#2)(2008-7#2)(2009-6#1)
epitaxy and hydride vapor phase epitaxy##2##6##(2007-11#2)
epitaxy##12##1##(1994-9#1)(1995-3#1)(2007-11#5)(2007-12#1)(2009-11#4)
epithalamin in##2##2##(1994-5#2)
epithelia and##2##2##(1991-12#1)(2008-10#1)
epithelia in the##2##3##(2007-12#1)(2008-7#1)
epithelia of the##2##3##(1992-11#1)(2012-12#1)
epithelia of##4##2##(1992-11#1)(1997-6#1)(2008-10#1)(2012-12#1)
epithelia##30##1##(1990-7#1)(1991-12#2)(1992-11#1)(1994-6#2)(1997-6#2)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#4)(2008-6#1)(2008-7#5)(2009-10#1)(2012-12#1)(2013-8#3)
epithelial adenomatoid hamartoma of the##2##5##(2008-2#2)
epithelial adenomatoid hamartoma##3##3##(2008-2#3)
epithelial and mesenchymal##2##3##(2010-8#1)(2012-3#1)
epithelial and myoepithelial##5##3##(1990-12#1)(2007-5#3)(2013-8#1)
epithelial and non-epithelial##2##3##(1992-5#1)(1994-9#1)
epithelial and stromal cells##4##4##(2008-11#1)(2011-2#3)
epithelial and vascular smooth muscle##2##5##(2008-11#2)
epithelial and vascular##4##3##(1991-5#2)(2008-11#2)
epithelial and##25##2##(1990-12#1)(1991-5#2)(1992-5#1)(1994-9#1)(2007-5#3)(2008-10#1)(2008-11#4)(2009-5#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#2)
epithelial attachment##2##2##(2008-10#1)(2012-12#1)
epithelial barrier##2##2##(2008-10#1)(2009-6#1)
epithelial buccal cells##2##3##(2008-5#2)
epithelial cancer cells##2##3##(2013-1#1)(2013-8#1)
epithelial cancer##4##2##(1990-8#1)(2009-4#1)(2013-1#1)(2013-8#1)
epithelial cancers##2##2##(2008-11#1)(2009-5#1)
epithelial carcinoma##2##2##(1995-12#1)(2008-11#1)
epithelial cell function##2##3##(1991-9#1)(2011-2#1)
epithelial cell line##8##3##(1990-12#1)(1991-12#1)(1993-3#1)(1993-8#1)(2008-8#2)(2009-5#2)
epithelial cell lines##3##3##(1992-2#2)(1994-6#1)
epithelial cell proliferation##4##3##(1994-3#1)(1995-9#1)(2011-2#1)(2012-3#1)
epithelial cell##44##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-2#3)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-5#2)(2011-1#1)(2011-2#4)(2012-3#1)
epithelial cells and the##2##4##(1990-12#1)(2012-12#1)
epithelial cells and their##2##4##(1994-9#1)(2011-1#1)
epithelial cells and##17##3##(1990-12#1)(1991-2#1)(1992-3#1)(1994-8#1)(1994-9#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#3)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)
epithelial cells are##2##3##(1995-2#1)(2008-7#1)
epithelial cells but##2##3##(1993-11#1)(2013-1#1)
epithelial cells by##2##3##(1993-11#1)(2010-11#1)
epithelial cells could##2##3##(1991-11#1)(1995-11#1)
epithelial cells cultured##2##3##(1991-2#1)(1997-1#1)
epithelial cells from##7##3##(1990-11#1)(1990-12#1)(1990-7#2)(2007-11#1)(2008-3#1)(2011-2#1)
epithelial cells grown##2##3##(1990-12#1)(1991-9#1)
epithelial cells has##2##3##(2008-9#1)(2013-1#1)
epithelial cells in primary culture##2##5##(1993-3#1)(2008-6#1)
epithelial cells in##8##3##(1993-3#1)(1993-8#1)(1995-2#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
epithelial cells is##3##3##(2008-5#1)(2008-6#2)
epithelial cells isolated from##2##4##(1990-11#1)(1991-5#1)
epithelial cells of the##4##4##(1994-2#1)(1997-5#1)(2008-10#1)(2008-8#1)
epithelial cells of##17##3##(1994-2#2)(1994-5#2)(1996-5#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-8#1)(2012-12#4)(2013-1#1)
epithelial cells than##2##3##(1992-8#1)(2013-1#1)
epithelial cells that##4##3##(1990-12#2)(2009-12#1)(2009-6#1)
epithelial cells throughout the##2##4##(1997-1#1)(2008-7#1)
epithelial cells to##2##3##(2008-10#1)(2011-1#1)
epithelial cells under##2##3##(1990-12#1)(1990-2#1)
epithelial cells were##3##3##(1993-3#1)(2008-10#1)(2008-6#1)
epithelial cells with##7##3##(1992-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#2)
epithelial cells##189##2##(1990-11#3)(1990-12#7)(1990-2#4)(1990-7#2)(1991-11#3)(1991-12#1)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#3)(1992-12#4)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#5)(1993-3#3)(1993-8#2)(1994-11#4)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-5#1)(1997-1#4)(1997-2#1)(1997-5#1)(1997-6#2)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#8)(2008-11#12)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#12)(2008-7#5)(2008-8#3)(2008-9#5)(2009-12#3)(2009-6#1)(2010-1#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#11)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#2)
epithelial cells)##2##2##(2008-11#1)(2008-4#1)
epithelial components##2##2##(2008-11#1)(2010-8#1)
epithelial cycle##11##2##(2009-10#5)(2012-2#6)
epithelial differentiation##2##2##(1992-2#1)(2012-8#1)
epithelial hyperplasia (Heck's disease)##2##4##(1991-2#2)
epithelial hyperplasia##8##2##(1990-12#2)(1991-2#3)(1994-12#1)(1994-7#1)(1997-6#1)
epithelial layer##2##2##(1997-6#1)(2007-12#1)
epithelial layers##2##2##(2007-12#1)(2008-3#1)
epithelial lesions##3##2##(1992-12#1)(2007-12#1)(2008-6#1)
epithelial lining of the##2##4##(1992-1#1)(2007-12#1)
epithelial lining##4##2##(1992-1#1)(2007-12#1)(2008-7#1)(2010-5#1)
epithelial membrane antigen##9##3##(1991-12#1)(1992-2#1)(1994-8#3)(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
epithelial membrane##10##2##(1991-12#1)(1992-2#1)(1994-8#3)(2006-12#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
epithelial monolayers##2##2##(2007-12#2)
epithelial mucin (PEM)##2##3##(1990-12#1)(1993-2#1)
epithelial mucin##7##2##(1990-12#2)(1993-1#4)(1993-2#1)
epithelial origin##6##2##(1990-5#1)(1994-5#1)(1995-6#1)(2008-10#1)(2012-1#1)(2013-1#1)
epithelial ovarian cancer##2##3##(1994-12#1)(2010-8#1)
epithelial ovarian##6##2##(1994-12#1)(2007-7#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
epithelial permeability##4##2##(1991-9#1)(1993-2#1)(1994-6#1)(1997-1#1)
epithelial proliferation##4##2##(1991-12#1)(1993-3#1)(1994-3#1)(2012-12#1)
epithelial sodium channel##2##3##(2008-8#1)(2009-9#1)
epithelial surface##3##2##(1997-3#1)(1997-6#1)(2009-8#1)
epithelial tissue##5##2##(1993-3#1)(2011-1#4)
epithelial tissues##9##2##(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#5)
epithelial tumors##5##2##(1993-9#3)(2009-3#1)(2010-7#1)
epithelial tumours##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
epithelial##449##1##(1990-11#4)(1990-12#14)(1990-2#4)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#3)(1991-12#5)(1991-2#7)(1991-5#4)(1991-8#1)(1991-9#7)(1992-1#1)(1992-12#6)(1992-2#6)(1992-3#2)(1992-5#2)(1992-8#3)(1992-9#1)(1993-1#5)(1993-11#8)(1993-12#1)(1993-2#2)(1993-3#6)(1993-8#5)(1993-9#3)(1994-11#7)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#4)(1995-11#4)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#4)(1995-8#1)(1995-9#3)(1996-5#3)(1996-7#1)(1997-1#6)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#7)(2006-12#1)(2007-11#2)(2007-12#13)(2007-5#4)(2007-7#2)(2008-1#3)(2008-10#17)(2008-11#31)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#14)(2008-7#11)(2008-8#8)(2008-9#10)(2009-10#6)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#6)(2010-9#5)(2011-1#10)(2011-2#21)(2012-1#7)(2012-12#15)(2012-2#10)(2012-3#5)(2012-8#1)(2013-1#16)(2013-8#6)
epithelial-myoepithelial##3##1##(1991-6#2)(2007-5#1)
epithelial-to-mesenchymal transition##2##2##(2010-11#1)(2013-1#1)
epithelialization##2##1##(2008-10#2)
epithelioid hemangioendothelioma##2##2##(2006-10#1)(2009-9#1)
epithelioid##7##1##(1993-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
epithelium also##2##2##(1994-9#1)(2009-10#1)
epithelium and by##2##3##(1990-12#1)(2012-1#1)
epithelium and in##3##3##(2008-4#1)(2013-1#2)
epithelium and other##2##3##(2008-4#1)(2011-2#1)
epithelium and##21##2##(1990-12#1)(1990-3#1)(1991-5#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-4#2)(2008-7#2)(2009-10#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#5)
epithelium are##5##2##(1990-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-7#1)
epithelium as##3##2##(1992-2#1)(2006-12#1)(2007-12#1)
epithelium at the##3##3##(1994-5#1)(2007-12#1)(2008-5#1)
epithelium at##4##2##(1994-5#1)(2007-12#1)(2008-5#1)(2011-2#1)
epithelium by##3##2##(1995-11#1)(2008-5#1)(2013-1#1)
epithelium during spermiogenesis and spermiation##2##5##(2012-2#2)
epithelium during##6##2##(2008-7#1)(2012-1#2)(2012-2#3)
epithelium from##2##2##(2008-9#1)(2010-12#1)
epithelium in response to##2##4##(1994-6#1)(2008-6#1)
epithelium in##7##2##(1994-6#2)(1997-6#1)(2008-6#1)(2009-10#1)(2012-1#1)(2013-1#1)
epithelium is##6##2##(1994-9#2)(2007-12#2)(2008-7#1)(2009-10#1)
epithelium lining the##5##3##(1993-1#1)(2007-12#3)(2008-4#1)
epithelium lining##6##2##(1993-1#1)(2007-12#4)(2008-4#1)
epithelium may be##2##3##(1991-2#1)(2010-1#1)
epithelium of the##13##3##(1995-6#1)(2006-12#1)(2007-12#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
epithelium of##20##2##(1992-3#1)(1995-6#1)(1997-3#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
epithelium resulting in##2##3##(1992-3#1)(2008-11#1)
epithelium that##4##2##(1992-9#1)(2007-12#2)(2008-11#1)
epithelium to##4##2##(1995-6#1)(2008-11#1)(2008-6#1)(2011-2#1)
epithelium was##5##2##(1991-5#1)(1995-8#1)(2008-7#1)(2008-9#1)(2012-3#1)
epithelium were##2##2##(1994-5#1)(1997-1#1)
epithelium##231##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-9#2)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-9#2)(1994-1#1)(1994-5#2)(1994-6#3)(1994-9#7)(1995-11#4)(1995-12#2)(1995-6#2)(1995-8#5)(1995-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#2)(2007-12#19)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#6)(2008-2#2)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#1)(2008-9#7)(2009-10#16)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#11)(2011-7#3)(2012-1#7)(2012-12#3)(2012-2#11)(2012-3#5)(2013-1#11)(2013-8#3)
epithelium-derived factor (PEDF)##2##3##(2012-5#2)
epithelium-derived factor##4##2##(2008-7#2)(2012-5#2)
epithelium-derived##5##1##(2008-7#2)(2012-5#2)(2013-1#1)
epithelium]##2##1##(2008-1#1)(2011-2#1)
epithelization##2##1##(2008-11#1)(2011-2#1)
epitheloid hemangioendothelioma##2##2##(2009-5#2)
epitheloid##3##1##(2008-5#1)(2009-5#2)
epitope expression##2##2##(1993-1#1)(1997-7#1)
epitope in the##2##3##(1997-6#1)(2008-8#1)
epitope in##5##2##(1995-3#1)(1997-1#1)(1997-6#1)(2008-8#1)(2012-2#1)
epitope is##2##2##(2006-6#1)(2008-7#1)
epitope mapping##3##2##(1996-12#1)(2008-11#1)(2013-1#1)
epitope minigenes##2##2##(2008-8#2)
epitope of##5##2##(1993-9#1)(1995-2#1)(1996-12#2)(2013-1#1)
epitope on the##2##3##(1996-11#1)(2009-8#1)
epitope on##3##2##(1996-11#1)(1996-12#1)(2009-8#1)
epitope peptides##2##2##(2008-8#1)(2011-2#1)
epitope recognized by the##2##4##(2008-11#1)(2008-8#1)
epitope regions##4##2##(2008-11#4)
epitope##87##1##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-12#2)(1995-2#10)(1995-3#1)(1996-11#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-6#1)(2008-10#7)(2008-11#9)(2008-2#1)(2008-7#4)(2008-8#10)(2009-8#1)(2011-2#2)(2012-12#3)(2012-2#5)(2013-1#3)
epitope)##2##1##(1994-9#1)(2008-7#1)
epitope-tagged multisubunit protein##2##3##(2008-2#2)
epitope-tagged phosphatase 2A##2##3##(1992-9#2)
epitope-tagged##10##1##(1992-9#2)(1994-8#1)(1995-2#1)(2008-11#1)(2008-2#3)(2008-4#2)
epitopes and##5##2##(1991-5#1)(1993-1#1)(1994-8#1)(1997-4#1)(2011-2#1)
epitopes are##4##2##(1997-7#1)(2006-6#1)(2008-10#2)
epitopes as##2##2##(1990-5#1)(2008-11#1)
epitopes at##2##2##(1995-5#1)(2008-8#1)
epitopes common to##3##3##(1993-12#1)(1995-12#1)(1996-12#1)
epitopes from the##2##3##(1991-12#1)(2008-10#1)
epitopes have##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
epitopes identified by##2##3##(1996-12#1)(2008-10#1)
epitopes in the##3##3##(1993-2#1)(1997-3#1)(2006-6#1)
epitopes in##7##2##(1993-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-4#1)(2006-6#1)
epitopes of the##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
epitopes of##9##2##(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2011-2#1)(2012-2#1)
epitopes on the##4##3##(1993-1#1)(1994-8#1)(2008-5#1)(2008-8#1)
epitopes on##5##2##(1993-1#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
epitopes that##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
epitopes were##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
epitopes with##4##2##(1993-8#1)(2008-10#2)(2008-5#1)
epitopes##90##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-8#2)(1995-12#3)(1995-2#6)(1995-5#4)(1996-12#4)(1997-3#1)(1997-4#2)(1997-7#1)(2006-6#2)(2007-6#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#11)(2009-2#1)(2011-2#4)(2012-2#2)(2013-1#1)
epitopic##2##1##(1993-1#1)(2008-11#1)
epizootic##3##1##(1992-8#1)(2010-1#1)(2012-3#1)
epoch##3##1##(2008-10#2)(2008-2#1)
epochs##3##1##(2008-10#2)(2010-8#1)
epoetin alfa 80##2##3##(2008-7#2)
epoetin alfa##17##2##(2008-7#17)
epoetin beta##6##2##(2008-7#6)
epoetin##25##1##(2008-7#25)
eponemycin##3##1##(1991-12#3)
epoxidation of the##3##3##(1995-5#1)(1996-5#1)(2007-11#1)
epoxidation of##9##2##(1990-12#1)(1992-8#1)(1995-5#1)(1996-5#1)(2007-11#2)(2008-8#1)(2011-2#2)
epoxidation##15##1##(1990-12#2)(1992-8#1)(1995-5#1)(1996-5#2)(2007-11#4)(2008-8#1)(2011-2#4)
epoxide hydrolase activity##3##3##(1990-5#3)
epoxide hydrolase##12##2##(1990-11#1)(1990-5#4)(1992-8#2)(1996-8#1)(1997-7#2)(1997-8#1)(2011-2#1)
epoxide reductase##2##2##(2009-11#2)
epoxide##18##1##(1990-11#1)(1990-5#4)(1992-8#2)(1994-2#1)(1994-5#1)(1996-8#1)(1997-7#2)(1997-8#1)(2008-10#1)(2009-11#2)(2011-2#1)(2012-12#1)
epoxides##8##1##(1990-2#1)(1996-5#4)(2008-6#1)(2008-8#1)(2012-12#1)
epoxidized##2##1##(2007-11#1)(2008-10#1)
epoxy coatings##2##2##(2010-4#2)
epoxy group##2##2##(1996-5#1)(2008-10#1)
epoxy matrix##3##2##(2008-10#2)(2008-3#1)
epoxy resin and##2##3##(2008-10#1)(2008-3#1)
epoxy resin by##2##3##(2008-3#1)(2010-4#1)
epoxy resin##9##2##(2008-10#4)(2008-3#2)(2008-5#1)(2010-4#1)(2010-9#1)
epoxy resins##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
epoxy systems##2##2##(2008-10#2)
epoxy##35##1##(1996-5#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-4#6)(2010-9#1)(2013-1#1)
epoxyeicosatrienoic acid##2##2##(1990-2#1)(2013-1#1)
epristeride##3##1##(2008-5#3)
eprosartan from human plasma samples##2##5##(2008-10#2)
eprosartan##5##1##(2008-10#5)
epsM##2##1##(1993-9#2)
epsilon +##2##2##(1996-12#2)
epsilon 2##4##2##(1991-3#2)(1995-12#2)
epsilon 4 allele frequency##3##4##(1995-12#3)
epsilon 4 allele##5##3##(1995-12#4)(1995-5#1)
epsilon 4##7##2##(1995-12#6)(1995-5#1)
epsilon Ade##4##2##(1993-11#4)
epsilon Cyt##2##2##(1993-11#2)
epsilon and beta##3##3##(1991-5#1)(2008-8#2)
epsilon and the##2##3##(2008-10#1)(2008-4#1)
epsilon and zeta##2##3##(1993-3#1)(1995-11#1)
epsilon and##8##2##(1991-5#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-8#3)
epsilon is##2##2##(1995-2#1)(2009-6#1)
epsilon may##2##2##(1995-2#1)(1996-5#1)
epsilon##86##1##(1990-11#3)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1993-11#6)(1993-3#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#9)(1995-2#15)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-5#3)(1997-2#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-8#9)(2009-6#2)(2009-7#6)(2009-8#1)
epsilon(1)##4##1##(2008-3#4)
epsilon(C)##2##1##(2008-10#2)
epsilon)##3##1##(1990-8#1)(1993-3#1)(1994-8#1)
epsilon-viniferin##3##1##(2008-10#3)
epsilon4 allele##2##2##(2008-4#1)(2008-7#1)
epsps##5##1##(2008-9#5)
eq##2##1##(2008-10#2)
equal affinity##2##2##(1994-5#1)(2011-1#1)
equal amounts of left- and right-handed##2##6##(2008-7#1)(2010-12#1)
equal amounts of##8##3##(1990-8#1)(1997-7#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-12#1)
equal amounts##12##2##(1990-8#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-9#1)(2010-12#2)
equal and##4##2##(1995-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
equal density##2##2##(1994-2#1)(2008-2#1)
equal diffraction##2##2##(2007-12#2)
equal distribution##2##2##(1992-8#1)(2007-10#1)
equal efficiency##5##2##(1993-11#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
equal exposure##2##2##(1994-2#1)(2008-10#1)
equal for##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
equal frequencies##3##2##(2008-10#3)
equal frequency##2##2##(1997-3#1)(2008-10#1)
equal groups of##4##3##(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)
equal groups##9##2##(2007-7#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-2#1)(2012-2#1)
equal in size##2##3##(2007-12#1)(2008-10#1)
equal in##7##2##(1992-5#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
equal intensity##2##2##(1993-3#1)(2007-11#1)
equal male and female##2##4##(2008-8#2)
equal mixture of the##2##4##(2008-10#2)
equal mixture of##3##3##(1990-3#1)(2008-10#2)
equal numbers of##2##3##(2008-11#1)(2008-9#1)
equal numbers##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
equal or even##2##3##(2007-10#1)(2008-1#1)
equal or greater##4##3##(1997-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
equal or higher than 0##2##5##(2008-10#2)
equal or higher than##3##4##(2008-10#3)
equal or less than##2##4##(2011-2#2)
equal or lower than##2##4##(2008-10#1)(2011-2#1)
equal or superior##2##3##(1992-1#1)(2008-6#1)
equal or##16##2##(1992-1#1)(1996-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-8#1)(2011-2#3)(2013-1#1)
equal parts##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
equal proportions##4##2##(1990-11#1)(1991-5#1)(1995-12#1)(2008-10#1)
equal rates of##3##3##(1995-1#1)(2007-5#1)(2008-12#1)
equal rates##4##2##(1991-9#1)(1995-1#1)(2007-5#1)(2008-12#1)
equal sensitivities##2##2##(2009-6#2)
equal slopes##5##2##(2012-1#5)
equal to 0##15##3##(1990-3#3)(1990-6#2)(1991-5#1)(1994-5#1)(1996-3#1)(2008-10#5)(2008-3#1)(2008-5#1)
equal to 1##13##3##(1990-12#1)(1990-2#2)(1992-3#1)(1993-12#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
equal to 100##3##3##(1991-8#1)(1992-12#1)(2008-10#1)
equal to 2##4##3##(1992-6#1)(1993-2#1)(2008-3#2)
equal to 3##3##3##(1990-12#1)(2008-6#1)(2013-1#1)
equal to 40##2##3##(1992-8#1)(2008-3#1)
equal to 5##4##3##(1992-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
equal to 6##2##3##(1990-12#1)(1995-3#1)
equal to 65##2##3##(1990-5#1)(1992-6#1)
equal to 7##2##3##(1990-3#1)(2008-10#1)
equal to 70##2##3##(1991-4#1)(1995-3#1)
equal to a##4##3##(2008-10#1)(2008-2#1)(2013-1#2)
equal to or greater than##2##5##(1990-12#1)(1991-2#1)
equal to or larger than##2##5##(1995-9#1)(2007-11#1)
equal to or slightly##2##4##(1997-8#1)(2008-10#1)
equal to or##12##3##(1990-12#1)(1991-2#1)(1992-9#1)(1995-9#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2013-1#1)
equal to that of the##5##5##(1994-5#1)(1994-6#1)(2007-11#1)(2008-12#1)(2013-8#1)
equal to that of##11##4##(1992-5#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#1)
equal to that##15##3##(1992-5#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2011-2#1)(2013-8#1)
equal to the number of##4##5##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
equal to the radius##2##4##(2008-3#2)
equal to the sum of##3##5##(2008-10#2)(2008-3#1)
equal to the width of##2##5##(2007-11#1)(2013-1#1)
equal to the##38##3##(1992-12#1)(1993-9#1)(1995-3#2)(2007-11#2)(2007-12#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#12)(2008-8#1)(2008-9#3)(2009-12#1)(2013-1#1)
equal to those of##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
equal to those##5##3##(1990-5#1)(1992-3#1)(2008-10#1)(2008-2#2)
equal to zero##3##3##(2008-10#1)(2008-3#2)
equal to##194##2##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#4)(1990-5#3)(1990-6#3)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#9)(1992-1#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#2)(1994-6#1)(1995-3#5)(1995-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#41)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#26)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
equal variances##4##2##(2008-10#1)(2012-1#3)
equal volume of##6##3##(1991-12#1)(1992-6#1)(1997-2#1)(2008-12#1)(2011-2#1)(2012-2#1)
equal volume##8##2##(1991-12#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
equal weight to the##2##4##(1993-1#1)(2010-10#1)
equal##426##1##(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#5)(1990-5#3)(1990-6#3)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#9)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#6)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#11)(2007-12#9)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#81)(2008-11#10)(2008-12#10)(2008-2#15)(2008-3#48)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#16)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#13)(2012-1#10)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#2)
equaled or##2##2##(1994-12#1)(2008-10#1)
equaled##3##1##(1994-12#1)(2008-10#1)(2008-11#1)
equaling##2##1##(2008-1#1)(2009-11#1)
equality and##2##2##(2008-3#2)
equality of##3##2##(1996-3#2)(2013-1#1)
equality##14##1##(1996-3#2)(2007-11#1)(2008-2#3)(2008-3#4)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
equalization in##3##2##(2007-12#1)(2008-3#2)
equalization##14##1##(1993-3#1)(2007-12#1)(2008-2#3)(2008-3#8)(2013-1#1)
equalized##4##1##(2007-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
equalled##4##1##(1991-3#1)(1995-3#1)(1995-6#1)(2009-4#1)
equalling##2##1##(2008-10#1)(2009-4#1)
equally as##3##2##(1995-1#1)(2008-11#1)(2008-5#1)
equally between daughter cells##2##4##(2008-5#1)(2008-9#1)
equally effective against##3##3##(2008-10#2)(2012-2#1)
equally effective and well tolerated when##2##6##(1996-2#1)(2008-7#1)
equally effective as##2##3##(1995-11#1)(1995-3#1)
equally effective##18##2##(1992-12#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
equally efficacious##3##2##(1994-11#1)(2007-7#1)(2008-8#1)
equally from##3##2##(1994-1#1)(1997-7#1)(2011-1#1)
equally good##2##2##(1992-12#1)(1997-3#1)
equally important as##2##3##(1993-11#1)(1996-12#1)
equally important##10##2##(1993-11#1)(1993-2#1)(1996-12#1)(1997-4#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)
equally in both##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
equally in##11##2##(1995-12#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-3#1)
equally likely to##3##3##(1995-3#1)(2007-10#1)(2008-9#1)
equally likely##4##2##(1995-3#1)(2007-10#1)(2008-9#2)
equally long##2##2##(1992-12#1)(2007-11#1)
equally on##2##2##(1991-2#1)(1994-12#1)
equally potent in inhibiting the##2##5##(1992-3#2)
equally potent in##4##3##(1992-3#3)(2008-4#1)
equally potent##5##2##(1991-9#1)(1992-3#3)(2008-4#1)
equally spaced##5##2##(2008-2#1)(2008-3#3)(2008-7#1)
equally susceptible to##5##3##(1990-11#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-10#1)
equally susceptible##8##2##(1990-11#1)(1994-2#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-10#3)
equally the##2##2##(1997-3#1)(2012-2#1)
equally to##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
equally weighted fitting##2##3##(1990-8#2)
equally well by##2##3##(1992-4#1)(2008-10#1)
equally well for##3##3##(2008-12#1)(2008-4#1)(2011-2#1)
equally well##12##2##(1992-4#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2010-2#1)(2011-2#1)
equally##167##1##(1990-11#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-12#3)(1992-3#5)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1995-1#1)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
equals 1##2##2##(2008-3#1)(2008-8#1)
equals a##2##2##(2008-10#1)(2008-7#1)
equals or##2##2##(2007-11#1)(2008-10#1)
equals the##6##2##(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
equals##21##1##(1991-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2009-6#1)(2013-1#1)(2013-8#1)
equated##4##1##(2008-12#1)(2008-5#2)(2008-8#1)
equates##2##1##(2008-7#1)(2008-9#1)
equating##2##1##(2008-1#1)(2008-12#1)
equation a##2##2##(2008-10#1)(2008-3#1)
equation and a##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
equation and the##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
equation and##21##2##(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#1)
equation are compared##2##3##(2008-2#1)(2008-3#1)
equation are##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
equation can be##2##3##(1993-3#1)(2008-3#1)
equation can##3##2##(1993-3#1)(2008-10#1)(2008-3#1)
equation expresses##2##2##(2008-2#2)
equation expressing the##2##3##(2008-10#1)(2008-2#1)
equation for a##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
equation for all##2##3##(1996-12#1)(2008-8#1)
equation for normal glass dispersion and##2##6##(2008-3#2)
equation for the##10##3##(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)
equation for##45##2##(1993-6#1)(1994-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#8)(2008-2#6)(2008-3#11)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-7#1)(2013-8#1)
equation gives##2##2##(2008-2#1)(2008-3#1)
equation has been##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
equation has##5##2##(2008-10#2)(2008-3#1)(2009-8#1)(2011-3#1)
equation in an##2##3##(2007-11#1)(2008-2#1)
equation in the##2##3##(2008-10#1)(2008-3#1)
equation in##7##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-7#1)
equation indicated that##2##3##(2007-11#1)(2012-2#1)
equation involving##2##2##(1995-12#1)(2009-8#1)
equation is applied to##3##4##(2008-2#1)(2008-3#2)
equation is solved##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
equation is used##2##3##(2007-12#1)(2008-10#1)
equation is##31##2##(1990-8#1)(2007-12#2)(2008-10#4)(2008-2#9)(2008-3#13)(2009-10#1)(2013-1#1)
equation methods##2##2##(1994-2#1)(2008-3#1)
equation model of the##2##4##(2008-3#1)(2013-8#1)
equation model of##4##3##(2008-2#1)(2008-3#1)(2013-8#2)
equation model##11##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2012-12#1)(2013-8#3)
equation modeling (SEM) was used to##2##6##(2008-6#1)(2009-7#1)
equation modeling (SEM)##3##3##(2008-6#1)(2009-7#1)(2010-2#1)
equation modeling##15##2##(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#2)(2009-11#1)(2009-7#2)(2010-10#1)(2010-2#2)(2010-6#1)(2012-3#1)(2013-8#2)
equation models##3##2##(2008-12#1)(2008-3#1)(2009-10#1)
equation of the##12##3##(2008-10#7)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)
equation of##19##2##(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-8#2)(2009-10#1)(2009-8#1)
equation on##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
equation parameters##2##2##(1990-8#1)(2013-7#1)
equation psi =##2##3##(2008-2#2)
equation that describes##2##3##(2007-11#1)(2007-12#1)
equation that is##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
equation that relates the##3##4##(1994-9#1)(2008-3#2)
equation that##19##2##(1994-9#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)
equation to##9##2##(1997-2#1)(2008-1#1)(2008-2#2)(2008-3#4)(2012-3#1)
equation using the##2##3##(2008-2#1)(2008-3#1)
equation was obtained##2##3##(2008-10#1)(2013-8#1)
equation was##10##2##(1996-5#1)(2008-10#6)(2008-3#1)(2011-1#1)(2013-8#1)
equation where the##2##3##(2008-10#2)
equation which##2##2##(2008-10#1)(2013-1#1)
equation with##6##2##(1990-8#1)(2008-10#3)(2008-8#1)(2009-3#1)
equation##396##1##(1990-5#1)(1990-8#4)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-5#4)(1997-2#5)(2007-11#16)(2007-12#20)(2008-1#2)(2008-10#91)(2008-11#4)(2008-12#2)(2008-2#60)(2008-3#76)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#17)(2008-8#7)(2008-9#2)(2009-10#8)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#6)(2010-10#2)(2010-2#2)(2010-6#1)(2011-1#3)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#10)
equations and the##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
equations and##14##2##(1993-5#1)(1995-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#2)(2012-3#1)
equations approach##2##2##(1997-8#1)(2008-10#1)
equations are derived for##2##4##(2008-3#2)
equations are formulated##2##3##(2008-2#1)(2009-4#1)
equations are solved##3##3##(2008-3#1)(2009-6#1)(2010-10#1)
equations are used to##3##4##(2007-11#1)(2008-11#1)(2008-3#1)
equations are used##4##3##(2007-11#1)(2008-11#1)(2008-3#2)
equations are##24##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#12)(2009-4#1)(2009-6#1)(2010-10#1)(2013-1#1)
equations at##2##2##(2008-2#2)
equations by##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
equations can be##3##3##(2008-10#1)(2008-3#2)
equations could be used##2##4##(2008-10#1)(2008-11#1)
equations could be##3##3##(2008-10#2)(2008-11#1)
equations could##4##2##(2008-10#3)(2008-11#1)
equations describing the##3##3##(2008-3#2)(2013-8#1)
equations describing##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
equations for K(m)##2##3##(2008-10#2)
equations for the##16##3##(1990-8#1)(1995-5#1)(1996-12#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#3)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
equations for various##2##3##(2008-3#1)(2010-10#1)
equations for##47##2##(1990-8#1)(1990-9#1)(1993-5#1)(1995-5#1)(1996-12#1)(2007-11#3)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#12)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-8#2)
equations from##2##2##(2007-12#1)(2008-2#1)
equations have been##2##3##(1996-4#1)(2007-11#1)
equations in the##2##3##(2008-2#1)(2012-3#1)
equations in##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2012-3#1)
equations involving##2##2##(2008-3#1)(2008-9#1)
equations is obtained##2##3##(2008-2#1)(2008-3#1)
equations is##5##2##(1991-1#1)(2007-11#1)(2008-2#1)(2008-3#2)
equations of a##2##3##(2008-2#2)
equations of the##3##3##(1991-6#1)(2008-10#1)(2008-2#1)
equations of##10##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-11#1)(2013-1#1)(2013-8#1)
equations over##2##2##(2008-10#1)(2008-3#1)
equations relating the##2##3##(2008-10#1)(2008-8#1)
equations relating##3##2##(2008-10#2)(2008-8#1)
equations that describe##2##3##(2007-12#2)
equations that include##3##3##(2007-11#1)(2007-12#2)
equations that##21##2##(1994-9#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#8)(2008-8#1)
equations to##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-8#2)
equations were used to##2##4##(2008-10#2)
equations were##12##2##(1996-12#1)(2007-11#1)(2008-10#7)(2008-11#1)(2011-1#1)(2013-1#1)
equations with##3##2##(2008-10#1)(2008-3#1)(2010-11#1)
equations##298##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-6#2)(1991-8#1)(1991-9#1)(1993-5#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-4#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#17)(2007-12#16)(2008-1#1)(2008-10#59)(2008-11#11)(2008-2#34)(2008-3#64)(2008-4#1)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#7)(2013-1#4)(2013-8#11)
equator##3##1##(1992-7#1)(1995-6#1)(2010-6#1)
equatorial ligand##3##2##(1997-7#2)(2012-12#1)
equatorial ligands##2##2##(1997-7#2)
equatorial plane##4##2##(1996-2#1)(1997-7#1)(2008-3#2)
equatorial positions##2##2##(1996-5#1)(1997-7#1)
equatorial##17##1##(1995-11#1)(1996-2#1)(1996-5#1)(1997-7#6)(2008-3#4)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
equi##8##1##(1991-3#1)(1991-8#7)
equidistant##5##1##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-1#1)
equilibrate##2##1##(2008-4#1)(2008-8#1)
equilibrated at a(w) = 0##2##5##(2008-7#2)
equilibrated at##6##2##(1990-8#1)(2008-10#3)(2008-7#2)
equilibrated for##2##2##(2008-10#1)(2008-11#1)
equilibrated with##3##2##(2008-10#3)
equilibrated##18##1##(1990-11#1)(1990-8#1)(1993-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)
equilibrating##3##1##(2008-10#3)
equilibration temperature##2##2##(2008-10#2)
equilibration test##2##2##(2007-12#1)(2011-2#1)
equilibration time##8##2##(1992-3#1)(2008-10#7)
equilibration times##2##2##(2008-10#2)
equilibration##23##1##(1992-3#1)(1992-6#2)(1994-5#1)(1996-5#1)(2007-12#1)(2008-10#15)(2008-4#1)(2011-2#1)
equilibrative nucleoside##2##2##(1994-8#1)(1995-8#1)
equilibrative uridine transport##2##3##(1995-8#2)
equilibrative##5##1##(1994-8#2)(1995-8#3)
equilibria and##5##2##(2008-10#4)(2013-8#1)
equilibria are##3##2##(2008-10#2)(2008-8#1)
equilibria at the##2##3##(2008-10#2)
equilibria at##4##2##(1993-8#1)(2008-10#2)(2008-8#1)
equilibria between the##2##3##(2008-10#2)
equilibria between##4##2##(2008-10#4)
equilibria for##3##2##(2008-10#2)(2008-8#1)
equilibria in ethanol-aqueous solution of##2##5##(2008-10#2)
equilibria in the##2##3##(2008-10#2)
equilibria in##10##2##(2008-10#7)(2008-8#1)(2008-9#1)(2012-2#1)
equilibria involved in the binding of##2##6##(1990-8#2)
equilibria of magnesium(II) with purpurin##2##5##(2008-10#2)
equilibria of metal##2##3##(2008-10#2)
equilibria of some##3##3##(2008-10#3)
equilibria of the##2##3##(2008-10#2)
equilibria of##30##2##(1990-8#1)(1996-5#1)(2008-10#27)(2008-7#1)
equilibria were##3##2##(2008-10#2)(2008-8#1)
equilibria##102##1##(1990-8#3)(1993-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#80)(2008-7#1)(2008-8#8)(2008-9#2)(2012-2#2)(2012-3#1)(2013-8#1)
equilibrium and kinetic##4##3##(1990-8#1)(1992-3#1)(1997-2#1)(2008-9#1)
equilibrium and the##2##3##(1990-7#1)(2007-11#1)
equilibrium and##13##2##(1990-7#1)(1990-8#1)(1992-3#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
equilibrium between the##9##3##(1992-11#1)(1995-3#1)(2008-10#6)(2013-8#1)
equilibrium between##17##2##(1992-11#1)(1992-3#1)(1992-5#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#9)(2008-3#1)(2013-8#1)
equilibrium binding##7##2##(1993-11#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-8#1)(1997-2#2)
equilibrium by##3##2##(1995-2#1)(2008-10#2)
equilibrium calculations of OH number density##2##6##(2008-3#2)
equilibrium calculations##3##2##(2008-3#3)
equilibrium can##2##2##(2008-10#1)(2008-3#1)
equilibrium concentration##4##2##(2008-10#4)
equilibrium concentrations of##3##3##(1993-6#1)(2008-10#2)
equilibrium concentrations##4##2##(1993-6#1)(2008-10#3)
equilibrium conditions##4##2##(1997-2#2)(2008-10#1)(2008-5#1)
equilibrium constant for the##3##4##(1990-8#1)(2008-10#2)
equilibrium constant for##6##3##(1990-8#1)(1997-2#2)(2008-10#3)
equilibrium constant of##3##3##(1994-8#1)(1995-6#1)(2008-10#1)
equilibrium constant##24##2##(1990-8#2)(1993-11#1)(1994-8#2)(1995-6#1)(1996-2#2)(1997-2#4)(2007-12#1)(2008-10#11)
equilibrium constants and##3##3##(2008-10#3)
equilibrium constants for##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
equilibrium constants is##2##3##(2008-10#2)
equilibrium constants of##9##3##(2008-10#7)(2008-2#1)(2008-7#1)
equilibrium constants were##3##3##(2008-10#3)
equilibrium constants##47##2##(1990-8#2)(1991-8#1)(1997-2#2)(2008-10#38)(2008-2#2)(2008-4#1)(2008-7#1)
equilibrium data##3##2##(2008-10#2)(2008-12#1)
equilibrium denaturation##2##2##(1992-6#2)
equilibrium dialysis##7##2##(1993-12#1)(1993-6#1)(1994-6#1)(1995-2#2)(2008-10#1)(2008-11#1)
equilibrium dissociation constant of##2##4##(1993-6#1)(1994-5#1)
equilibrium dissociation constant##8##3##(1993-3#2)(1993-6#2)(1994-5#1)(1995-5#1)(1997-2#2)
equilibrium distribution of the low (alpha-) and high (beta-) energy##2##10##(2008-10#2)
equilibrium distribution of the##3##4##(2008-10#3)
equilibrium distribution of##5##3##(1990-7#1)(1995-2#1)(2008-10#3)
equilibrium equations##2##2##(2008-10#1)(2008-7#1)
equilibrium exchange##2##2##(1991-5#2)
equilibrium for the##2##3##(2010-7#1)(2010-8#1)
equilibrium for##6##2##(1993-3#1)(2008-10#3)(2010-7#1)(2010-8#1)
equilibrium in##9##2##(1991-9#1)(1994-3#1)(1996-2#1)(2008-10#5)(2008-12#1)
equilibrium is reached##2##3##(2008-10#2)
equilibrium is##8##2##(1992-3#1)(1996-2#1)(2008-10#4)(2008-5#1)(2008-9#1)
equilibrium measurements and##2##3##(1995-6#1)(2008-10#1)
equilibrium measurements##3##2##(1990-8#1)(1995-6#1)(2008-10#1)
equilibrium model##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
equilibrium of an asymmetric##2##4##(2008-10#2)
equilibrium of the##4##3##(2008-10#3)(2008-8#1)
equilibrium of##20##2##(1993-8#1)(2008-10#14)(2008-5#1)(2008-8#2)(2010-1#1)(2012-2#1)
equilibrium or##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
equilibrium partitioning##2##2##(2008-10#1)(2008-11#1)
equilibrium point##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
equilibrium population size##4##3##(2008-8#3)(2008-9#1)
equilibrium population sizes##2##3##(2008-8#1)(2008-9#1)
equilibrium population##7##2##(2008-8#5)(2008-9#2)
equilibrium potential##4##2##(1995-12#1)(1997-2#1)(2008-10#2)
equilibrium properties of##3##3##(1993-8#3)
equilibrium solutions##2##2##(2013-8#2)
equilibrium stability##2##2##(2008-10#1)(2013-8#1)
equilibrium system##3##2##(2008-10#2)(2008-9#1)
equilibrium systems##2##2##(2008-10#2)
equilibrium temperature##5##2##(2008-2#5)
equilibrium that is##2##3##(2008-10#1)(2008-9#1)
equilibrium unfolding##3##2##(1990-7#2)(1995-5#1)
equilibrium value##2##2##(2008-11#1)(2009-11#1)
equilibrium was reached##2##3##(2008-5#1)(2010-5#1)
equilibrium was##7##2##(2008-10#4)(2008-5#1)(2008-7#1)(2010-5#1)
equilibrium when##2##2##(2013-8#2)
equilibrium with the surrounding##3##4##(1995-6#1)(2008-10#1)(2009-11#1)
equilibrium with the##5##3##(1991-9#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-11#1)
equilibrium with##11##2##(1991-9#3)(1992-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)
equilibrium##441##1##(1990-11#1)(1990-7#6)(1990-8#12)(1991-2#2)(1991-5#3)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#1)(1992-3#4)(1992-5#2)(1992-6#8)(1993-11#3)(1993-12#1)(1993-3#3)(1993-6#5)(1993-8#7)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#2)(1996-2#6)(1996-5#3)(1996-7#3)(1997-2#15)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#171)(2008-11#5)(2008-12#10)(2008-2#10)(2008-3#11)(2008-4#5)(2008-5#7)(2008-7#6)(2008-8#24)(2008-9#14)(2009-10#2)(2009-11#2)(2009-5#5)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#11)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#9)
equiluminant##2##1##(1996-2#1)(1996-5#1)
equimolar amounts of##4##3##(1994-3#1)(1996-2#1)(2008-10#1)(2008-5#1)
equimolar amounts##5##2##(1994-3#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-5#1)
equimolar concentrations##3##2##(1991-12#1)(1993-6#1)(2008-10#1)
equimolar proportions##2##2##(1991-10#2)
equimolar to##2##2##(1993-12#2)
equimolar##33##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#2)(1991-12#2)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-5#2)(2008-7#1)
equine estrogens##2##2##(1996-5#2)
equine##19##1##(1991-6#1)(1992-8#2)(1996-5#2)(1997-4#1)(2008-10#3)(2008-9#2)(2009-10#1)(2009-7#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
equinovarus foot in##2##3##(2007-11#2)
equinovarus foot##4##2##(2007-11#4)
equip##7##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-3#1)(2012-12#1)
equiperdum##2##1##(1994-12#1)(2011-2#1)
equipment acquisition##3##2##(1994-3#1)(1995-3#1)(1996-1#1)
equipment and facilities##2##3##(2009-3#1)(2011-2#1)
equipment and materials##2##3##(1990-5#1)(2010-8#1)
equipment and technique##2##3##(1996-8#1)(1997-3#1)
equipment and the##2##3##(2008-6#1)(2012-2#1)
equipment and##29##2##(1990-5#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)
equipment as##2##2##(2008-8#1)(2010-5#1)
equipment at##2##2##(1992-11#1)(2008-3#1)
equipment for the##3##3##(1995-2#1)(2012-12#1)(2012-3#1)
equipment for##7##2##(1991-2#1)(1995-2#1)(2008-10#3)(2012-12#1)(2012-3#1)
equipment in the##2##3##(1991-1#1)(2010-12#1)
equipment in##8##2##(1990-9#1)(1991-1#1)(1995-1#1)(1997-2#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#1)
equipment inventory##3##2##(1992-3#1)(2011-2#2)
equipment is##6##2##(1994-6#1)(1995-1#1)(1996-12#1)(2008-10#2)(2010-8#1)
equipment maintenance insurance##2##3##(1996-2#2)
equipment maintenance##5##2##(1996-2#5)
equipment needed##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
equipment obtained from##2##3##(2008-4#2)
equipment or##2##2##(2008-10#1)(2009-6#1)
equipment originally##2##2##(2008-4#2)
equipment purchase and maintenance##2##4##(1991-1#1)(2008-9#1)
equipment purchase and##3##3##(1991-1#1)(1992-12#1)(2008-9#1)
equipment purchase##4##2##(1991-1#1)(1992-12#1)(1996-11#1)(2008-9#1)
equipment purchases##3##2##(1991-1#1)(1994-1#1)(1994-3#1)
equipment request forms##2##3##(1994-12#2)
equipment runovers##2##2##(2008-12#2)
equipment such as##3##3##(2007-11#1)(2008-12#1)(2013-8#1)
equipment to##2##2##(2008-10#1)(2008-11#1)
equipment used##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
equipment was##4##2##(1997-3#1)(2007-10#1)(2008-10#1)(2008-3#1)
equipment were##2##2##(2008-1#1)(2008-10#1)
equipment when##2##2##(2008-12#1)(2008-5#1)
equipment##248##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#5)(1992-3#5)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#8)(1994-6#1)(1995-1#6)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#13)(1996-3#6)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#26)(2008-11#12)(2008-12#8)(2008-2#2)(2008-3#9)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#6)(2009-3#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#5)(2011-1#4)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#3)(2013-8#3)
equipment)##2##1##(2008-10#1)(2008-5#1)
equipment]##3##1##(1992-5#1)(1997-8#1)(2012-3#1)
equipments##7##1##(2008-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-8#2)
equipoise exists##2##2##(2007-12#1)(2012-2#1)
equipoise##7##1##(2007-12#1)(2012-2#6)
equipotent to##3##2##(1995-3#1)(1996-2#1)(2008-8#1)
equipotent##6##1##(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-3#1)
equipped to deal with##2##4##(1995-9#1)(1996-1#1)
equipped to##8##2##(1993-2#1)(1995-9#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)
equipped with a chemiluminescence##3##4##(2008-10#3)
equipped with a transversely heated graphite##2##6##(2008-10#2)
equipped with a##35##3##(1990-4#1)(2006-4#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2013-1#2)
equipped with adaptive optics##2##4##(2007-11#2)
equipped with an##9##3##(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2010-1#1)(2012-2#1)
equipped with the##8##3##(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
equipped with two##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
equipped with##82##2##(1990-12#1)(1990-4#1)(1997-3#1)(2006-4#1)(2007-11#3)(2007-12#6)(2008-10#28)(2008-11#9)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-8#2)(2010-1#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#4)
equipped##99##1##(1990-12#1)(1990-4#1)(1993-12#1)(1993-2#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-8#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#28)(2008-11#10)(2008-12#1)(2008-3#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#4)
equisimilis##4##1##(1991-9#3)(2012-2#1)
equitable care##2##2##(1994-3#1)(2010-10#1)
equitable##14##1##(1991-1#1)(1994-3#1)(1995-12#1)(1996-1#2)(2008-1#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
equitably##3##1##(1993-3#1)(2008-11#1)(2011-1#1)
equitoxic##5##1##(1992-11#1)(1994-2#1)(2008-8#1)(2009-4#1)(2012-2#1)
equity accumulation##2##2##(1992-12#2)
equity and##3##2##(1991-12#1)(2008-11#1)(2011-2#1)
equity for##2##2##(1996-1#1)(2010-12#1)
equity in the health##3##4##(1990-12#2)(1992-12#1)
equity in the##7##3##(1990-12#2)(1992-12#1)(1995-1#1)(1996-1#3)
equity in##12##2##(1990-12#3)(1992-12#1)(1992-2#1)(1994-2#1)(1994-7#1)(1995-1#1)(1996-1#3)(2012-12#1)
equity of access##2##3##(1997-4#1)(2012-2#1)
equity of##6##2##(1992-12#1)(1995-1#1)(1996-1#1)(1997-4#1)(2008-11#1)(2012-2#1)
equity##54##1##(1990-12#3)(1991-12#2)(1992-12#10)(1992-2#1)(1992-3#1)(1993-1#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#3)(1995-12#1)(1996-1#7)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-11#2)(2010-12#3)(2010-4#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
equiv of##8##2##(1992-6#2)(1993-8#1)(1996-2#4)(2009-12#1)
equiv##9##1##(1992-6#2)(1993-8#1)(1996-2#4)(2009-12#1)(2010-5#1)
equivalence between results##2##3##(2008-10#2)
equivalence between the##2##3##(2007-12#1)(2008-10#1)
equivalence between##8##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-11#1)
equivalence in##2##2##(1990-8#1)(2009-11#1)
equivalence of the##2##3##(1995-1#1)(2012-3#1)
equivalence of two##2##3##(1995-9#1)(2010-5#1)
equivalence of##9##2##(1992-11#1)(1995-1#1)(1995-9#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-5#1)(2012-3#1)
equivalence or##2##2##(1995-2#1)(1995-5#1)
equivalence point was##3##3##(2008-10#3)
equivalence point##10##2##(2008-10#10)
equivalence ratio##4##2##(1996-12#1)(2008-2#1)(2008-3#2)
equivalence ratios##6##2##(2008-2#2)(2008-3#4)
equivalence with##3##2##(2008-10#2)(2008-11#1)
equivalence##67##1##(1990-8#1)(1992-11#1)(1993-11#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#4)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#1)
equivalence&quot##2##1##(1995-5#1)(2009-10#1)
equivalency##7##1##(1991-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#3)
equivalent (DE)##3##2##(2008-10#2)(2008-6#1)
equivalent amount of##4##3##(1991-2#1)(1992-6#1)(2008-10#2)
equivalent amounts##2##2##(1991-9#1)(2008-11#1)
equivalent and##2##2##(2008-3#1)(2009-10#1)
equivalent at##2##2##(2008-7#1)(2012-12#1)
equivalent circuit##2##2##(2008-10#1)(2013-8#1)
equivalent concentrations##3##2##(2008-10#2)(2008-7#1)
equivalent conventional##3##2##(2008-3#3)
equivalent dose##2##2##(2008-10#1)(2008-12#1)
equivalent effects##2##2##(1992-12#1)(1997-7#1)
equivalent efficacy with##2##3##(1991-8#1)(1996-1#1)
equivalent efficacy##3##2##(1991-8#1)(1996-1#1)(2010-11#1)
equivalent factor##2##2##(2008-10#2)
equivalent for##2##2##(1994-5#1)(2008-10#1)
equivalent in all##2##3##(1994-3#1)(2012-12#1)
equivalent in##8##2##(1990-11#1)(1990-2#1)(1992-12#1)(1994-3#1)(1995-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
equivalent isotropic scattering##2##3##(2008-3#2)
equivalent isotropic##4##2##(2008-3#4)
equivalent layers##3##2##(2008-3#3)
equivalent levels of##2##3##(1993-6#1)(1996-1#1)
equivalent levels to##2##3##(2011-2#1)(2013-1#1)
equivalent levels##6##2##(1993-6#1)(1995-11#1)(1996-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
equivalent model##8##2##(2008-5#8)
equivalent of a##4##3##(2007-11#1)(2008-3#1)(2010-11#1)(2010-5#1)
equivalent of the##3##3##(1992-12#1)(1995-8#1)(2007-11#1)
equivalent of##22##2##(1992-12#1)(1992-2#1)(1992-6#2)(1994-5#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-2#1)
equivalent particle##2##2##(2008-10#1)(2008-8#1)
equivalent performance##2##2##(1992-11#1)(2007-12#1)
equivalent phantom##2##2##(2011-1#2)
equivalent position##2##2##(1991-9#1)(1993-12#1)
equivalent protection against bronchial provocation##2##5##(1996-1#1)(1996-2#1)
equivalent to 1##4##3##(1991-5#1)(1991-8#1)(2008-10#1)(2010-4#1)
equivalent to a##7##3##(1992-6#1)(2008-10#5)(2012-3#1)
equivalent to holo human transferrin in##2##6##(2008-11#2)
equivalent to that of##8##4##(1994-9#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-12#1)(2011-1#1)
equivalent to that##10##3##(1994-9#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-12#1)(2011-1#1)
equivalent to the##18##3##(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2013-1#1)
equivalent to those achieved##2##4##(2008-10#2)
equivalent to those in##2##4##(1991-1#1)(2008-10#1)
equivalent to those##8##3##(1991-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
equivalent to wild-type Rev##2##4##(1993-8#2)
equivalent to##97##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-6#1)(1993-8#3)(1994-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-4#3)(1997-5#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#26)(2008-11#7)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
equivalent when##2##2##(2008-10#1)(2008-5#1)
equivalent with##2##2##(2008-10#1)(2010-9#1)
equivalent##351##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#6)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#1)(1996-1#5)(1996-2#4)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(2007-11#9)(2007-12#10)(2007-8#1)(2008-10#70)(2008-11#17)(2008-12#2)(2008-2#14)(2008-3#49)(2008-4#2)(2008-5#21)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
equivalent)##2##1##(1997-5#1)(2008-5#1)
equivalently##6##1##(1992-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
equivalents of##7##2##(1993-11#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-5#1)(2010-6#1)
equivalents##34##1##(1990-11#1)(1990-5#1)(1991-2#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-5#1)(2010-6#1)(2013-1#2)
equivocal lesions##2##2##(1994-1#2)
equivocal results##5##2##(1991-3#1)(1997-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
equivocal##25##1##(1991-3#1)(1994-1#3)(1994-6#1)(1997-5#1)(1997-8#3)(2007-12#1)(2008-1#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-4#1)(2012-12#1)(2013-7#1)
equol##5##1##(1993-12#2)(2010-1#3)
er##4##1##(2008-3#2)(2012-12#2)
er(3+)-doped##2##1##(2008-2#2)
era and the##2##3##(1996-1#1)(2009-5#1)
era and##4##2##(1995-9#1)(1996-1#1)(2009-5#2)
era has##2##2##(2008-10#1)(2012-12#1)
era in##6##2##(1991-2#1)(1991-8#1)(1997-2#1)(2008-11#1)(2009-5#1)(2012-3#1)
era of health care reform##4##5##(1993-12#1)(1997-3#1)(2010-5#1)(2010-8#1)
era of health reform##3##4##(1996-1#1)(1996-3#2)
era of health##7##3##(1993-12#1)(1996-1#1)(1996-3#2)(1997-3#1)(2010-5#1)(2010-8#1)
era of##47##2##(1991-5#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#3)
era to##2##2##(1993-6#1)(1994-3#1)
era##115##1##(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#2)(1993-6#1)(1994-3#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#2)(2009-4#2)(2009-5#4)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#9)(2011-7#1)(2012-12#4)(2012-3#4)(2013-1#6)(2013-8#1)
era&quot##2##1##(2007-11#1)(2010-3#1)
era]##3##1##(2008-10#2)(2012-2#1)
eradicate the disease##4##3##(1994-9#2)(2011-2#2)
eradicate##18##1##(1993-12#1)(1994-9#5)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#1)(2009-4#1)(2011-2#3)(2012-12#1)(2013-1#1)
eradicated from##4##2##(1990-3#2)(1994-9#1)(2007-2#1)
eradicated in##2##2##(1990-2#1)(1996-6#1)
eradicated##13##1##(1990-2#1)(1990-3#2)(1992-5#1)(1993-12#2)(1994-9#2)(1996-6#1)(2007-12#1)(2007-2#1)(2008-11#1)(2011-1#1)
eradicating##11##1##(1996-11#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
eradication and##2##2##(2008-10#1)(2011-2#1)
eradication as##2##2##(1993-12#1)(1997-1#1)
eradication in##2##2##(2011-1#1)(2012-12#1)
eradication is##2##2##(2008-10#1)(2009-4#1)
eradication of BE##2##3##(2010-12#2)
eradication of the organism##2##4##(1997-1#1)(2008-5#1)
eradication of the##7##3##(1992-6#1)(1993-2#1)(1997-1#1)(2008-4#1)(2008-5#2)(2011-2#1)
eradication of##30##2##(1992-6#1)(1993-12#2)(1993-2#1)(1994-8#1)(1995-5#1)(1997-1#3)(2007-12#1)(2007-7#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-2#4)(2012-1#1)
eradication programs##2##2##(2011-2#2)
eradication protocol##2##2##(2008-10#2)
eradication rate of##3##3##(1996-11#1)(2008-1#1)(2008-5#1)
eradication rate##7##2##(1996-11#1)(2008-1#3)(2008-5#1)(2010-12#1)(2011-2#1)
eradication therapy##6##2##(1996-11#2)(2010-12#2)(2012-2#1)(2013-1#1)
eradication##81##1##(1992-6#1)(1993-12#4)(1993-2#1)(1994-8#1)(1994-9#2)(1995-5#1)(1996-11#3)(1997-1#5)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-11#1)(2010-12#10)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)
eras##3##1##(2008-4#1)(2012-12#2)
erasable photorefractive##2##2##(2008-3#2)
erasable thermal phase-change superresolution##2##4##(2008-2#2)
erasable##7##1##(2007-12#2)(2008-2#3)(2008-3#2)
erase##2##1##(2008-7#1)(2010-3#1)
erased##4##1##(2007-12#1)(2008-3#3)
erasing##3##1##(1991-11#1)(2008-3#1)(2008-7#1)
erasure in a##2##3##(2007-12#1)(2008-3#1)
erasure in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
erasure##12##1##(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#4)
erasure-time constants##2##2##(2007-12#1)(2008-2#1)
erbium ions##5##2##(2007-12#2)(2008-10#1)(2008-2#2)
erbium laser##2##2##(2007-11#2)
erbium##18##1##(2007-11#2)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#3)(2008-7#1)
erbium-doped ZBLAN fiber##2##3##(2007-12#2)
erbium-doped fiber amplifier with##3##4##(2007-12#1)(2008-3#2)
erbium-doped fiber amplifier##15##3##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#6)
erbium-doped fiber amplifiers##7##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
erbium-doped fiber distributed-feedback##2##3##(2007-11#2)
erbium-doped fiber laser##5##3##(2007-12#3)(2008-3#2)
erbium-doped fiber ring laser##2##4##(2007-11#1)(2008-3#1)
erbium-doped fiber ring##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
erbium-doped fiber##36##2##(2007-11#9)(2007-12#13)(2008-2#4)(2008-3#10)
erbium-doped##46##1##(2007-11#10)(2007-12#18)(2008-2#5)(2008-3#13)
erbstatin##2##1##(1990-11#2)
erect##5##1##(2008-2#1)(2008-7#1)(2009-10#1)(2011-2#2)
erecta##2##1##(2008-10#1)(2008-5#1)
erectile dysfunction (ED)##2##3##(2010-10#1)(2011-2#1)
erectile dysfunction and##2##3##(2012-12#1)(2013-8#1)
erectile dysfunction are##2##3##(1990-6#2)
erectile dysfunction##13##2##(1990-6#3)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#2)
erectile function##4##2##(2011-2#1)(2012-3#3)
erectile tissue##2##2##(2008-1#1)(2012-3#1)
erectile##24##1##(1990-6#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-10#1)(2011-2#3)(2012-12#1)(2012-3#6)(2013-8#2)
erection##4##1##(1990-6#2)(2008-10#2)
erector spinae##4##2##(2008-5#1)(2009-6#1)(2012-12#2)
erectus##3##1##(2012-12#3)
ergogenic potential##2##2##(2008-5#2)
ergogenic##6##1##(2008-5#6)
ergometer##5##1##(2008-7#1)(2008-9#3)(2009-1#1)
ergonomic load##2##2##(1994-2#2)
ergonomic##9##1##(1994-2#2)(2008-11#2)(2008-6#2)(2010-3#1)(2011-2#1)(2013-1#1)
ergonomics##5##1##(1995-1#1)(1996-1#1)(2008-10#1)(2013-1#2)
ergosterol and##2##2##(1992-11#1)(2007-11#1)
ergosterol content##3##2##(2008-10#3)
ergosterol##15##1##(1992-11#1)(1997-2#4)(2007-11#1)(2008-10#7)(2008-3#1)(2008-7#1)
ergot alkaloid##2##2##(2008-7#1)(2008-8#1)
ergot in the Texas##2##4##(2008-10#2)
ergot##17##1##(1996-2#1)(2008-10#12)(2008-7#2)(2008-8#1)(2010-7#1)
ergot-favorable##2##1##(2008-10#2)
erinacea##2##1##(2010-8#2)
eriocalyx##4##1##(2008-12#4)
eriochrome##2##1##(2008-10#2)
eriophyid mite##2##2##(2008-10#2)
eriophyid mite-transmitted##3##2##(2008-10#3)
eriophyid mites##2##2##(2008-10#2)
eriophyid##7##1##(2008-10#7)
erlotinib treatment##2##2##(2012-1#1)(2012-2#1)
erlotinib##6##1##(2009-4#1)(2010-5#1)(2012-1#2)(2012-2#1)(2013-1#1)
ermE##2##1##(1990-5#2)
erode the##2##2##(1991-2#1)(2010-12#1)
erode##4##1##(1991-2#1)(1994-7#1)(1996-3#1)(2010-12#1)
eroded##4##1##(1996-6#1)(2008-8#1)(2009-8#1)(2010-11#1)
eroding##3##1##(1995-12#1)(2008-7#1)(2012-3#1)
erosion and##7##2##(2007-5#1)(2008-12#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
erosion of the##7##3##(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)
erosion of##12##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-2#2)
erosion##45##1##(1997-5#1)(2007-5#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#4)(2010-5#2)(2010-6#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
erosions and##6##2##(1995-12#4)(2011-2#1)(2013-1#1)
erosions in##5##2##(1996-11#1)(1997-6#1)(2011-2#2)(2013-1#1)
erosions##18##1##(1990-3#1)(1994-11#1)(1995-12#4)(1996-11#1)(1997-6#1)(2010-12#3)(2011-2#4)(2012-2#1)(2013-1#2)
erosive OLP##4##2##(2013-1#4)
erosive challenge##4##2##(2013-1#4)
erosive disease##2##2##(2006-10#2)
erosive##24##1##(1997-8#1)(2006-10#5)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#10)(2013-8#1)
err##2##1##(2009-10#1)(2011-2#1)
errata##28##1##(2007-11#11)(2007-12#14)(2008-2#2)(2008-3#1)
erratic##14##1##(1996-3#3)(2008-10#5)(2008-5#2)(2010-2#1)(2012-2#2)(2013-1#1)
erratum##2##1##(2008-2#2)
erroneous position data from##2##4##(2009-10#2)
erroneous results##2##2##(2008-3#1)(2013-8#1)
erroneous##17##1##(1996-11#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-2#2)(2008-3#3)(2009-10#3)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
erroneously##9##1##(1992-11#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)
error (MSE) for the##2##4##(2008-10#1)(2008-3#1)
error (RMSE)##2##2##(2008-2#1)(2011-2#1)
error analysis for##2##3##(2008-3#2)
error analysis is##2##3##(2008-3#2)
error analysis of##3##3##(2008-10#2)(2008-3#1)
error analysis##16##2##(2008-10#2)(2008-2#2)(2008-3#10)(2008-6#1)(2009-10#1)
error and the##4##3##(2008-3#3)(2009-10#1)
error and##29##2##(1992-12#1)(1992-9#3)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-6#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-1#2)(2012-12#1)(2013-1#1)
error are##6##2##(2008-10#1)(2008-3#5)
error as a##2##3##(2007-12#1)(2008-10#1)
error as##3##2##(2007-12#1)(2008-10#2)
error associated with the##2##4##(2008-3#2)
error associated with##3##3##(2008-3#2)(2008-6#1)
error at the##2##3##(2008-2#1)(2008-3#1)
error at##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
error bars##2##2##(2008-3#2)
error between the##2##3##(2007-11#1)(2013-8#1)
error between##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
error bounds##3##2##(2008-3#1)(2008-6#2)
error by##4##2##(1994-9#1)(2008-2#1)(2008-3#2)
error can be obtained from a##2##6##(2008-2#1)(2008-3#1)
error can be##5##3##(2008-2#1)(2008-3#2)(2008-6#2)
error can##6##2##(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)
error caused by the##6##4##(2008-2#2)(2008-3#4)
error caused by##8##3##(2008-2#4)(2008-3#4)
error code##2##2##(2011-2#2)
error compensation##2##2##(2007-11#1)(2008-3#1)
error correction##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
error covariance matrix##2##3##(2008-2#2)
error criterion##3##2##(2008-3#2)(2012-2#1)
error depends on##2##3##(2008-3#2)
error detection##2##2##(2008-2#1)(2008-3#1)
error due to##2##3##(2008-10#2)
error for the##6##3##(1991-5#1)(2008-10#2)(2008-12#1)(2013-1#2)
error for##19##2##(1991-5#1)(1993-6#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-9#1)(2010-5#1)(2013-1#2)
error from 3##2##3##(2007-11#1)(2008-10#1)
error function is##2##3##(2007-12#1)(2008-11#1)
error function that##2##3##(2007-12#1)(2008-11#1)
error function##4##2##(2007-12#2)(2008-11#2)
error functions were calculated for deducing the number of factors##2##10##(2008-10#2)
error functions##3##2##(2008-10#2)(2008-11#1)
error has been##2##3##(2008-3#1)(2012-12#1)
error has##3##2##(2008-3#2)(2012-12#1)
error in optical##2##3##(2008-2#1)(2008-3#1)
error in the##29##3##(1992-12#1)(1992-4#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#7)(2008-3#9)(2012-1#1)(2012-2#2)
error in##66##2##(1992-12#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-4#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#15)(2008-3#18)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#2)
error increases with the##2##4##(2008-2#1)(2008-3#1)
error inherent in the##2##4##(2008-10#2)
error is introduced##2##3##(2007-11#1)(2008-3#1)
error is less than##2##4##(2008-2#1)(2008-3#1)
error is not##2##3##(2008-3#2)
error is reduced##2##3##(2007-11#1)(2008-2#1)
error is##26##2##(1995-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#14)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
error less than##2##3##(2008-10#2)
error measure##2##2##(2008-3#2)
error models##3##2##(1997-4#1)(2008-3#1)(2012-1#1)
error modes##2##2##(2009-10#2)
error of &lt##5##3##(2008-10#1)(2008-2#4)
error of 0##7##3##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)
error of 1##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
error of 3##2##3##(2008-10#2)
error of 4##2##3##(2007-12#1)(2008-10#1)
error of cross##3##3##(2007-12#1)(2008-10#2)
error of less than##3##4##(2008-2#1)(2008-3#2)
error of measurement##2##3##(1992-5#1)(2010-12#1)
error of prediction (RSEP)##2##4##(2008-10#2)
error of prediction##12##3##(2008-10#11)(2013-8#1)
error of the##20##3##(2007-10#1)(2008-10#4)(2008-2#3)(2008-3#10)(2008-6#1)(2011-2#1)
error of this##2##3##(2008-10#1)(2008-2#1)
error of##107##2##(1990-8#1)(1992-5#1)(1993-6#1)(1995-3#1)(2007-10#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#44)(2008-12#1)(2008-2#12)(2008-3#23)(2008-6#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#5)
error on the##8##3##(1990-7#1)(1993-9#1)(2007-11#2)(2008-2#1)(2008-3#3)
error on##14##2##(1990-7#1)(1993-9#1)(1995-1#1)(2007-11#2)(2008-2#1)(2008-3#8)
error pattern##2##2##(2010-1#2)
error patterns##5##2##(2008-2#2)(2008-3#1)(2009-9#1)(2013-8#1)
error prevention and##4##3##(2011-1#4)
error prevention##5##2##(2011-1#5)
error probabilities##2##2##(1997-8#1)(2011-2#1)
error propagation##7##2##(2008-10#3)(2008-3#4)
error range##2##2##(2007-11#1)(2008-10#1)
error rate in##2##3##(2008-7#1)(2012-2#1)
error rate is##4##3##(2008-6#1)(2012-2#2)(2012-3#1)
error rate of##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
error rate that##2##3##(2013-1#2)
error rate was##2##3##(2010-8#1)(2012-3#1)
error rate##25##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#6)(2012-3#3)(2013-1#2)
error rates##8##2##(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
error reduction##3##2##(2008-10#1)(2008-2#2)
error signal##8##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#1)
error signals##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2013-8#1)
error source effects##2##3##(2008-3#2)
error sources and##2##3##(2008-2#1)(2008-3#1)
error sources are##2##3##(2008-2#1)(2008-3#1)
error sources##9##2##(2008-2#5)(2008-3#4)
error sum of squares (PRESS)##2##5##(2008-10#2)
error term##2##2##(2008-7#1)(2012-2#1)
error than the##2##3##(2008-10#1)(2008-3#1)
error than##3##2##(2008-10#1)(2008-3#2)
error that is due to##3##5##(2008-2#1)(2008-3#2)
error that is##6##3##(2008-2#2)(2008-3#3)(2009-9#1)
error that##12##2##(2008-2#3)(2008-3#8)(2009-9#1)
error to##2##2##(2008-3#1)(2012-3#1)
error treatment##2##2##(2008-2#1)(2008-3#1)
error type##2##2##(2009-8#2)
error variance##2##2##(2008-6#1)(2009-10#1)
error variances##2##2##(2012-3#2)
error was calculated##2##3##(2008-10#1)(2008-12#1)
error was close to##2##4##(2008-8#2)
error was##17##2##(1991-11#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-3#3)(2008-8#2)(2013-8#1)
error were##2##2##(2008-10#1)(2010-8#1)
error when the##3##3##(2008-3#2)(2009-10#1)
error when##5##2##(2008-10#2)(2008-3#2)(2009-10#1)
error with##3##2##(2008-3#3)
error##717##1##(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#2)(1992-12#3)(1992-4#1)(1992-5#1)(1992-9#6)(1993-11#2)(1993-2#1)(1993-6#2)(1993-9#2)(1994-6#1)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#20)(2007-12#21)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#153)(2008-11#9)(2008-12#7)(2008-2#98)(2008-3#217)(2008-4#2)(2008-6#15)(2008-7#13)(2008-8#5)(2008-9#6)(2009-10#7)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#3)(2009-9#5)(2010-1#4)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#4)(2011-1#8)(2011-2#9)(2012-1#6)(2012-12#2)(2012-2#12)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#12)
error)##7##1##(2008-10#6)(2008-2#1)
error-compensating##2##1##(2008-2#1)(2008-3#1)
error-control##2##1##(2008-3#2)
error-correcting##2##1##(2008-2#1)(2008-3#1)
error-correction##3##1##(2008-2#1)(2008-3#2)
error-diffusion##2##1##(2008-3#2)
error-free##2##1##(2007-11#2)
error-perception##2##1##(2008-11#2)
error-prone##3##1##(2008-8#1)(2011-1#2)
errorless trials##3##2##(1992-12#3)
errors (e##2##2##(2008-3#2)
errors and other##2##3##(2008-3#2)
errors and the##2##3##(1992-11#1)(2009-9#1)
errors and##32##2##(1990-11#1)(1992-11#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-2#6)(2008-3#9)(2008-4#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-1#3)
errors are also##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
errors are analyzed##2##3##(2007-12#1)(2008-2#1)
errors are introduced##2##3##(2008-3#2)
errors are present##2##3##(2008-11#1)(2008-3#1)
errors are##30##2##(1990-11#1)(1991-12#1)(1992-9#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#6)(2008-3#13)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)
errors arising from##2##3##(2008-3#1)(2008-9#1)
errors arising##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
errors as##3##2##(2008-2#1)(2008-3#2)
errors associated with##5##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)
errors at##3##2##(2008-12#1)(2008-3#2)
errors by##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
errors can be##4##3##(2008-10#1)(2008-3#3)
errors can##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
errors caused by the##3##4##(2008-3#3)
errors caused by##9##3##(2007-11#1)(2008-2#1)(2008-3#7)
errors could##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
errors depend##3##2##(2008-2#2)(2009-9#1)
errors due to##7##3##(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#2)
errors during##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)(2012-3#1)
errors for some##2##3##(2008-3#1)(2010-2#1)
errors for the##5##3##(2008-2#2)(2008-3#2)(2011-2#1)
errors for##12##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2010-2#1)(2011-2#1)
errors from##2##2##(2008-10#1)(2008-2#1)
errors have##2##2##(2008-10#1)(2008-3#1)
errors in a##2##3##(2008-3#2)
errors in determined water-leaving reflectance at 0##2##7##(2008-2#2)
errors in laser##2##3##(2008-2#1)(2008-3#1)
errors in signals transduced by phosphoproteins contribute to many human diseases##2##11##(2008-2#1)(2008-4#1)
errors in the calculated##2##4##(2008-3#1)(2013-8#1)
errors in the measured radiance##2##5##(2008-2#2)
errors in the##35##3##(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#10)(2008-3#13)(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
errors in##87##2##(1993-2#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#15)(2008-3#32)(2008-4#1)(2008-6#2)(2008-7#4)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-2#3)(2013-8#2)
errors into##4##2##(1992-6#1)(2008-3#3)
errors introduced by##2##3##(2007-11#1)(2008-3#1)
errors is##8##2##(2008-10#1)(2008-3#4)(2008-7#1)(2009-9#2)
errors leads##2##2##(2008-3#2)
errors made##2##2##(2008-10#1)(2012-12#1)
errors occurring in##2##3##(2013-8#2)
errors of 0##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
errors of a##3##3##(2008-2#1)(2008-3#2)
errors of less than##2##4##(2008-10#1)(2008-3#1)
errors of metabolism##4##3##(2008-11#1)(2008-4#3)
errors of prediction##4##3##(2008-10#4)
errors of the order of##2##5##(2008-2#1)(2008-3#1)
errors of the##19##3##(1997-8#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#7)(2009-9#1)
errors of##62##2##(1996-5#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#23)(2008-11#1)(2008-2#5)(2008-3#17)(2008-4#3)(2008-7#3)(2009-9#1)(2011-2#1)(2012-2#1)
errors on the##4##3##(2008-2#2)(2008-3#2)
errors on##7##2##(2007-10#1)(2008-2#3)(2008-3#3)
errors should be##2##3##(2008-2#1)(2008-3#1)
errors that are due to##3##5##(2007-11#1)(2008-2#2)
errors that are##7##3##(2007-11#1)(2008-2#2)(2008-3#3)(2009-8#1)
errors that arise##2##3##(2008-3#2)
errors that##12##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#6)(2009-8#1)(2009-9#1)
errors to##3##2##(2008-3#2)(2011-1#1)
errors was##2##2##(2008-10#1)(2008-3#1)
errors were found##2##3##(2008-11#1)(2013-8#1)
errors were##14##2##(1994-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2009-2#1)(2010-8#2)(2011-1#2)(2013-8#1)
errors which##2##2##(1990-8#1)(2010-3#1)
errors with##6##2##(1996-11#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-9#1)
errors##511##1##(1990-11#3)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#14)(2007-12#10)(2007-4#2)(2007-7#2)(2007-8#1)(2008-10#71)(2008-11#11)(2008-12#4)(2008-2#72)(2008-3#178)(2008-4#10)(2008-6#5)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-8#3)(2009-9#14)(2010-2#2)(2010-3#3)(2010-8#11)(2011-1#9)(2011-2#9)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#6)
errors)##2##1##(2008-2#2)
ertapenem##3##1##(2013-8#3)
erthali##3##1##(2008-6#3)
erupt##2##1##(2008-10#1)(2013-1#1)
erupted##4##1##(2008-10#3)(2013-1#1)
eruption and##3##2##(2007-12#1)(2008-8#1)(2010-6#1)
eruption of Mt##3##3##(2008-2#2)(2008-3#1)
eruption of the##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
eruption of##13##2##(2007-12#5)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2013-1#1)
eruption##34##1##(1994-9#1)(2007-12#8)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
eruptions and##2##2##(1992-3#1)(2007-7#1)
eruptions##8##1##(1992-3#2)(1997-3#1)(2007-7#3)(2008-7#1)(2010-6#1)
eruptive##2##1##(2010-6#1)(2012-3#1)
ervi##3##1##(2007-12#3)
eryAI##4##1##(1990-5#4)
erysimi##2##1##(2009-8#2)
erythema and##8##2##(1991-6#1)(2007-7#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
erythema in##2##2##(1994-12#1)(2008-5#1)
erythema is##2##2##(2008-5#2)
erythema multiforme##2##2##(2008-8#1)(2009-5#1)
erythema nodosum leprosum with##2##4##(2009-5#1)(2012-12#1)
erythema nodosum leprosum##7##3##(2008-5#1)(2009-5#2)(2012-12#4)
erythema nodosum##11##2##(1993-8#2)(1997-8#1)(2008-5#1)(2008-8#1)(2009-5#2)(2012-12#4)
erythema of the##3##3##(1993-8#2)(2008-7#1)
erythema##45##1##(1991-11#1)(1991-6#2)(1993-8#5)(1994-12#1)(1995-11#1)(1996-11#1)(1997-8#2)(2007-7#1)(2008-5#11)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#1)(2013-7#2)(2013-8#2)
erythemal##5##1##(2008-5#5)
erythematous macules##4##2##(2010-6#4)
erythematous##15##1##(1990-2#1)(2007-7#3)(2010-6#5)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
erythraea##5##1##(1990-5#5)
erythritol##4##1##(1991-5#2)(2008-6#2)
erythro##2##1##(1990-5#1)(1996-5#1)
erythroblastic islands##4##2##(2013-1#4)
erythroblastic##5##1##(2013-1#5)
erythroblastosis##2##1##(1990-8#1)(2012-12#1)
erythroblasts and##2##2##(1993-8#1)(2008-10#1)
erythroblasts were obtained##2##3##(2008-10#1)(2008-9#1)
erythroblasts##13##1##(1993-8#1)(1996-12#3)(2008-10#5)(2008-11#1)(2008-9#2)(2010-8#1)
erythrocyte &quot##3##2##(2008-8#3)
erythrocyte AChE##2##2##(1995-12#2)
erythrocyte acetylcholinesterase##2##2##(1992-8#1)(1994-8#1)
erythrocyte and platelet magnesium levels in##2##6##(2008-7#2)
erythrocyte and##3##2##(2008-5#1)(2008-7#2)
erythrocyte carnitine palmitoyltransferase##2##3##(1990-11#1)(1992-8#1)
erythrocyte count##2##2##(2008-9#2)
erythrocyte creatine##2##2##(1990-2#2)
erythrocyte deformability##2##2##(2009-11#2)
erythrocyte ghost##2##2##(1990-11#1)(2008-10#1)
erythrocyte ghosts and##2##3##(1993-11#1)(2009-8#1)
erythrocyte ghosts##5##2##(1993-11#2)(1994-2#1)(2008-10#1)(2009-8#1)
erythrocyte glutathione##4##2##(1992-1#1)(1996-12#3)
erythrocyte membrane##15##2##(1990-11#2)(1990-12#1)(1990-2#1)(1992-11#1)(1993-11#2)(1993-6#1)(1994-12#2)(1995-8#1)(2008-11#3)(2009-5#1)
erythrocyte membranes in##2##3##(1992-9#1)(1993-9#1)
erythrocyte membranes##12##2##(1990-2#1)(1991-5#2)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-8#2)(2009-8#2)
erythrocyte sedimentation rate (ESR)##4##4##(1997-6#1)(2007-7#1)(2013-1#2)
erythrocyte sedimentation rate are##2##4##(1993-2#1)(1997-8#1)
erythrocyte sedimentation rate##11##3##(1990-11#1)(1990-9#1)(1993-2#1)(1997-6#1)(1997-8#2)(2007-7#2)(2010-5#1)(2013-1#2)
erythrocyte sodium##2##2##(1992-12#1)(1995-8#1)
erythrocyte sodium-lithium counter-transport activity##3##4##(1992-6#3)
erythrocyte water##4##2##(1993-2#4)
erythrocyte##131##1##(1990-11#7)(1990-12#5)(1990-2#7)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#4)(1992-8#4)(1992-9#2)(1993-11#4)(1993-2#5)(1993-3#2)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#5)(1996-12#3)(1997-6#1)(1997-8#2)(2007-7#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#10)(2008-9#4)(2009-11#2)(2009-5#1)(2009-8#3)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#4)
erythrocyte/HepG2-type GT##2##2##(1990-11#2)
erythrocytes and lymphocytes##2##3##(1991-2#1)(2009-12#1)
erythrocytes and platelets##3##3##(1991-4#2)(2008-7#1)
erythrocytes and rat##2##3##(1991-5#1)(1992-6#1)
erythrocytes and##17##2##(1990-11#1)(1990-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1992-6#1)(1993-2#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)
erythrocytes at##2##2##(2007-10#1)(2008-7#1)
erythrocytes by a##2##3##(1994-2#1)(2008-10#1)
erythrocytes by##5##2##(1990-11#1)(1991-5#1)(1992-6#1)(1994-2#1)(2008-10#1)
erythrocytes decreased##2##2##(1991-9#1)(1993-8#1)
erythrocytes from##4##2##(1990-2#2)(1996-12#1)(2008-8#1)
erythrocytes in male and female##3##5##(2008-9#3)
erythrocytes in the##2##3##(1997-7#1)(2008-8#1)
erythrocytes in##6##2##(1997-7#1)(2008-8#1)(2008-9#4)
erythrocytes is##4##2##(1990-11#1)(1993-6#2)(2008-7#1)
erythrocytes of##6##2##(1990-12#1)(1990-2#1)(1991-12#1)(1996-12#1)(2008-11#1)(2008-9#1)
erythrocytes was observed##3##3##(2008-8#1)(2008-9#2)
erythrocytes was##7##2##(1990-7#1)(2008-10#1)(2008-8#1)(2008-9#4)
erythrocytes were observed##2##3##(1990-2#1)(2008-9#1)
erythrocytes were##6##2##(1990-11#2)(1990-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
erythrocytes##153##1##(1990-11#10)(1990-12#7)(1990-2#11)(1990-7#2)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#8)(1991-9#1)(1992-12#1)(1992-6#4)(1992-8#4)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-6#3)(1995-8#1)(1996-12#2)(1997-6#1)(1997-7#3)(2007-10#1)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#2)(2008-7#4)(2008-8#10)(2008-9#29)(2009-12#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
erythrocytic##3##1##(1994-8#1)(2010-2#1)(2012-12#1)
erythrocytosis##3##1##(1994-5#1)(2008-4#2)
erythrodysesthesia##2##1##(2008-7#2)
erythroid and basophilic##2##3##(1990-5#2)
erythroid and##3##2##(1990-5#2)(2008-11#1)
erythroid cells##10##2##(1991-5#1)(1994-8#3)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#2)
erythroid differentiation of##2##3##(1991-12#1)(1992-8#1)
erythroid differentiation related gene##2##4##(2008-8#2)
erythroid differentiation related##3##3##(2008-8#2)(2008-9#1)
erythroid differentiation##18##2##(1990-11#2)(1991-12#4)(1991-5#1)(1992-8#2)(1993-6#1)(1993-8#2)(1994-8#1)(2008-8#2)(2008-9#3)
erythroid##53##1##(1990-11#2)(1990-5#2)(1991-12#4)(1991-2#1)(1991-5#3)(1992-12#1)(1992-8#4)(1993-6#1)(1993-8#2)(1994-8#5)(2007-10#1)(2008-10#2)(2008-11#3)(2008-4#3)(2008-8#7)(2008-9#9)(2011-2#1)(2012-12#2)
erythroleukemia cell line##7##3##(1990-11#1)(1990-2#2)(1992-5#1)(1994-8#1)(2008-9#2)
erythroleukemia cell##8##2##(1990-11#1)(1990-2#2)(1991-9#1)(1992-5#1)(1994-8#1)(2008-9#2)
erythroleukemia cells##11##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-8#2)(1993-6#1)(1993-8#2)(2008-4#3)
erythroleukemia##26##1##(1990-11#3)(1990-2#2)(1991-2#2)(1991-9#2)(1992-5#1)(1992-8#2)(1993-6#2)(1993-8#2)(1994-8#3)(1995-3#1)(2008-4#3)(2008-9#2)(2009-9#1)
erythroleukemias##2##1##(1994-8#2)
erythromycin or tegaserod##2##3##(2010-6#2)
erythromycin or##3##2##(2010-6#3)
erythromycin resistance##2##2##(1993-12#1)(2008-6#1)
erythromycin##26##1##(1990-5#2)(1991-8#2)(1991-9#1)(1993-12#1)(1994-11#2)(2007-12#2)(2007-7#1)(2008-12#1)(2008-6#2)(2008-7#2)(2010-6#7)(2010-8#2)(2012-3#1)
erythron##4##1##(2008-9#4)
erythrophagocytosis assay##2##2##(1990-12#2)
erythrophores##2##1##(2008-5#2)
erythropoiesis in##2##2##(1992-8#1)(2013-1#1)
erythropoiesis##13##1##(1991-12#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#4)
erythropoiesis-stimulating agents##3##2##(2010-11#1)(2010-9#2)
erythropoietic agents##3##2##(2008-7#3)
erythropoietic##6##1##(2008-7#6)
erythropoietin (EPO)##8##2##(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-8#1)
erythropoietin (Epo) and##4##3##(1991-12#1)(2008-11#3)
erythropoietin in##4##2##(1990-9#1)(2007-7#1)(2011-2#1)(2012-12#1)
erythropoietin produced by##5##3##(2008-11#5)
erythropoietin##53##1##(1990-9#1)(1991-11#1)(1991-12#2)(1991-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-1#2)(2007-5#1)(2007-7#3)(2008-1#10)(2008-10#1)(2008-11#16)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
erythropoietin-associated##2##1##(2008-10#2)
erythropoietins##2##1##(2008-10#1)(2012-2#1)
erythroseptica##2##1##(2008-10#2)
erythrosine B##2##2##(2008-10#2)
erythrospilus##3##1##(2010-8#3)
erythrovirus##3##1##(2012-2#3)
erythroxyli is##2##2##(2008-10#2)
erythroxyli##11##1##(2008-10#11)
erytropoietin treatment##2##2##(2008-7#2)
erytropoietin##3##1##(2008-7#3)
es##2##1##(2008-10#1)(2008-11#1)
esca symptoms##3##2##(2008-10#3)
esca##8##1##(2008-10#8)
escalate##2##1##(2008-3#1)(2009-11#1)
escalated##4##1##(1990-12#1)(2008-8#1)(2010-3#1)(2012-2#1)
escalating costs##3##2##(2008-1#1)(2008-11#1)(2012-12#1)
escalating##15##1##(1990-11#1)(1991-3#1)(1992-8#2)(1993-9#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)
escalation events##3##2##(2009-10#3)
escalation in##2##2##(2008-7#1)(2010-4#1)
escalation of##5##2##(2008-1#1)(2008-7#1)(2009-7#1)(2012-12#1)(2013-1#1)
escalation vectors##2##2##(2009-10#2)
escalation##18##1##(1992-6#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#8)(2009-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
escalators##2##1##(2007-9#2)
escapable stress##2##2##(2008-11#2)
escape from the protein##2##4##(1990-8#2)
escape from the##6##3##(1990-8#2)(1996-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
escape from##11##2##(1990-8#2)(1996-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-2#1)(2011-2#1)
escape into the##2##3##(1996-12#1)(2008-1#1)
escape into##3##2##(1996-12#1)(2008-1#2)
escape of##5##2##(1995-3#2)(1996-12#1)(2008-1#1)(2008-10#1)
escape the##5##2##(1992-12#1)(2007-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
escape##45##1##(1990-8#2)(1992-12#1)(1995-3#2)(1996-12#8)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#1)(2010-7#1)(2011-2#1)(2013-1#2)
escaped from##2##2##(1994-9#1)(2010-10#1)
escaped##6##1##(1992-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(2010-10#1)(2011-2#1)
escapes##6##1##(1994-11#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
escaping##5##1##(1996-12#1)(2008-10#1)(2008-5#2)(2012-12#1)
eschar##7##1##(1992-5#1)(2007-2#1)(2013-8#5)
escitalopram##7##1##(2012-3#7)
esculenta##4##1##(2008-10#3)(2013-1#1)
esculenta)##3##1##(2008-10#3)
esculentum##13##1##(1993-12#1)(2008-10#12)
esculetin##6##1##(1992-9#1)(2008-11#1)(2011-1#4)
esenbecki mordax##2##2##(2008-5#2)
esmolol##3##1##(2007-8#3)
esomeprazole##7##1##(2011-2#6)(2013-1#1)
esophageal adenocarcinoma##6##2##(2008-12#2)(2009-4#1)(2010-6#2)(2013-1#1)
esophageal atresia##2##2##(2008-8#1)(2012-3#1)
esophageal body in##2##3##(2013-8#2)
esophageal body##4##2##(2013-8#4)
esophageal cancer and##2##3##(2008-8#1)(2010-12#1)
esophageal cancer##22##2##(1992-9#1)(2007-8#1)(2008-8#1)(2009-5#1)(2010-12#3)(2010-6#3)(2010-8#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
esophageal candidiasis##2##2##(1990-3#1)(2008-5#1)
esophageal carcinogenesis##3##2##(1992-5#3)
esophageal carcinoma cell lines##3##4##(1992-8#3)
esophageal carcinoma##8##2##(1992-8#3)(1993-8#1)(2008-5#2)(2012-12#2)
esophageal carcinomas##3##2##(1992-8#3)
esophageal diseases##4##2##(2013-1#4)
esophageal hiatal##2##2##(2008-12#1)(2011-2#1)
esophageal motility disorder##3##3##(2011-1#1)(2011-2#2)
esophageal motility disorders##2##3##(2013-8#2)
esophageal motility##10##2##(2011-1#1)(2011-2#2)(2013-8#7)
esophageal mucosa##2##2##(2008-5#2)
esophageal pH-metry##3##2##(1996-3#3)
esophageal squamous cell carcinoma##4##4##(2008-12#1)(2010-6#1)(2012-2#2)
esophageal squamous cell##5##3##(2008-12#1)(2010-6#1)(2012-2#3)
esophageal squamous##7##2##(2008-12#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-2#3)
esophageal varices##7##2##(2009-8#1)(2013-1#5)(2013-8#1)
esophageal varices]##2##2##(1992-2#1)(2013-1#1)
esophageal##142##1##(1990-12#1)(1990-3#1)(1990-8#1)(1992-2#1)(1992-5#3)(1992-6#3)(1992-8#7)(1992-9#4)(1993-8#1)(1993-9#1)(1996-3#3)(1997-8#1)(2007-8#7)(2008-12#4)(2008-5#8)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#5)(2010-6#7)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#19)(2013-7#2)(2013-8#28)
esophagectomy and##3##2##(2007-8#1)(2010-12#1)(2013-8#1)
esophagectomy for esophageal cancer##2##4##(2010-8#2)
esophagectomy for##3##2##(2010-8#2)(2013-8#1)
esophagectomy##12##1##(2007-8#1)(2009-7#1)(2010-12#1)(2010-8#4)(2013-8#5)
esophagitis and##3##2##(2008-5#1)(2013-8#2)
esophagitis in##3##2##(1992-5#1)(1996-6#1)(2013-1#1)
esophagitis with##2##2##(2008-5#1)(2011-2#1)
esophagitis##27##1##(1992-3#1)(1992-5#1)(1996-2#2)(1996-6#1)(2008-10#3)(2008-12#2)(2008-5#7)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#5)
esophagogastric##2##1##(1991-11#1)(1992-9#1)
esophagoscopic removal##3##2##(2007-8#3)
esophagoscopy##3##1##(1992-9#1)(2007-8#1)(2012-3#1)
esophagus and stomach##3##3##(2011-2#1)(2012-3#2)
esophagus and##13##2##(2007-7#1)(2007-8#3)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#3)(2013-8#2)
esophagus is a rare##2##4##(2011-2#1)(2013-1#1)
esophagus or##2##2##(2009-3#1)(2013-1#1)
esophagus##67##1##(1990-8#2)(1992-6#1)(1992-9#1)(1993-8#2)(1994-2#1)(2007-7#1)(2007-8#4)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#8)(2009-3#4)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#12)
especial##3##1##(1990-12#1)(2008-7#1)(2008-8#1)
especially M06 and PW6B95##2##4##(2012-12#2)
especially Staphylococcus aureus##2##3##(2007-12#1)(2010-5#1)
especially Streptococcus pneumoniae##2##3##(1994-9#2)
especially after##8##2##(1990-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)
especially against##3##2##(1993-8#1)(2010-5#1)(2012-12#1)
especially alpha-amylase##2##2##(1990-3#2)
especially among children and##2##4##(1991-6#1)(2010-7#1)
especially among patients##2##3##(2010-3#1)(2012-12#1)
especially among##13##2##(1991-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-12#2)(2012-3#1)
especially as it##2##3##(1994-1#1)(1997-3#1)
especially as the##2##3##(1994-9#1)(2008-8#1)
especially as they##2##3##(2008-3#1)(2010-7#1)
especially as##12##2##(1990-7#1)(1991-2#1)(1993-8#1)(1994-1#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)
especially at high##2##3##(1996-2#1)(2008-10#1)
especially at low##4##3##(2008-10#3)(2008-11#1)
especially at night##2##3##(1997-4#2)
especially at the##10##3##(1992-6#1)(1994-12#1)(2008-3#1)(2008-7#3)(2009-9#1)(2010-1#1)(2013-1#1)(2013-7#1)
especially at##27##2##(1992-6#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-4#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
especially because##3##2##(1996-11#1)(2009-1#1)(2013-1#1)
especially before##2##2##(1997-3#1)(2010-11#1)
especially between##3##2##(2007-6#1)(2008-10#1)(2008-3#1)
especially by##5##2##(1994-2#1)(2006-10#1)(2008-5#1)(2008-8#2)
especially clinical##2##2##(1994-9#1)(2010-7#1)
especially concerning##5##2##(2008-10#2)(2008-2#1)(2010-4#1)(2011-2#1)
especially coronary artery##2##3##(2008-1#1)(2010-8#1)
especially critical##2##2##(2008-2#1)(2009-11#1)
especially designed for##3##3##(1993-2#1)(2007-8#1)(2008-10#1)
especially designed##4##2##(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)
especially developed for##2##3##(1991-12#1)(1994-5#1)
especially difficult##5##2##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
especially during the##4##3##(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)
especially during##8##2##(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#1)
especially fatigue##2##2##(2008-7#1)(2009-5#1)
especially following##2##2##(2013-1#1)(2013-8#1)
especially for low##2##3##(1995-3#1)(2008-2#1)
especially for patients who##2##4##(1993-12#1)(2011-2#1)
especially for patients with##4##4##(2006-10#1)(2009-9#1)(2010-10#1)(2010-5#1)
especially for patients##6##3##(1993-12#1)(2006-10#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
especially for the##14##3##(1990-10#1)(1991-12#1)(1991-3#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
especially for those with##3##4##(2008-1#1)(2011-1#1)(2011-2#1)
especially for those##7##3##(1991-6#1)(2008-1#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
especially for##94##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#4)(2011-2#8)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
especially from a##2##3##(2012-12#1)(2013-8#1)
especially from large amounts of nitrate##2##6##(2008-10#2)
especially from the##2##3##(1994-9#1)(2012-2#1)
especially from##13##2##(1993-11#1)(1994-3#1)(1994-9#1)(2008-10#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
especially given##2##2##(1991-1#1)(2008-10#1)
especially high##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
especially if the##3##3##(1995-2#1)(1996-3#1)(2008-3#1)
especially if##9##2##(1995-2#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-8#2)
especially important for##4##3##(1994-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
especially important##18##2##(1991-6#1)(1992-12#1)(1992-5#1)(1993-10#1)(1994-11#1)(1994-3#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-3#1)
especially in a##2##3##(1992-9#1)(2011-2#1)
especially in areas##2##3##(1996-9#1)(2012-12#1)
especially in case of##2##4##(2010-8#1)(2011-2#1)
especially in cases##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
especially in certain##2##3##(2007-11#1)(2011-2#1)
especially in children##2##3##(2008-9#1)(2009-3#1)
especially in combination##2##3##(1994-7#1)(1995-5#1)
especially in developing countries##3##4##(2007-10#1)(2009-4#1)(2012-2#1)
especially in early##2##3##(2009-7#1)(2012-2#1)
especially in elderly##2##3##(2011-2#1)(2012-2#1)
especially in food##2##3##(2008-10#1)(2008-9#1)
especially in individuals with##2##4##(2011-2#2)
especially in long-term##2##3##(2008-10#1)(2008-5#1)
especially in males##2##3##(2010-12#1)(2011-2#1)
especially in patients with##6##4##(2007-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)
especially in patients##9##3##(1993-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)
especially in plants##2##3##(2009-6#1)(2009-8#1)
especially in prostate##2##3##(2011-2#1)(2013-1#1)
especially in relation to the##2##5##(1993-12#1)(2008-8#1)
especially in relation to##3##4##(1993-12#1)(1994-2#1)(2008-8#1)
especially in rural##3##3##(1996-12#1)(1997-4#1)(2012-12#1)
especially in sub-Saharan##2##3##(2008-8#1)(2012-2#1)
especially in subjects##2##3##(1990-8#1)(2013-1#1)
especially in terms of##2##4##(2008-10#1)(2008-12#1)
especially in the case of##8##5##(1991-6#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
especially in the case##9##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
especially in the context of##2##5##(2008-8#1)(2011-2#1)
especially in the developing world##3##5##(2008-1#1)(2008-12#1)(2009-4#1)
especially in the early stages##2##5##(1996-11#1)(2013-8#1)
especially in the field of##2##5##(2007-11#2)
especially in the field##3##4##(2007-11#2)(2008-6#1)
especially in the light of##2##5##(2008-10#1)(2008-11#1)
especially in the presence of##4##5##(1990-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
especially in the study of##2##5##(2008-10#1)(2008-3#1)
especially in the##87##3##(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#2)
especially in their##2##3##(1993-8#1)(2008-5#1)
especially in those cases in which traditional treatment methods do not give satisfactory results##2##14##(2007-11#1)(2007-8#1)
especially in those patients##2##4##(2007-8#1)(2013-8#1)
especially in those with an##2##5##(2010-5#1)(2012-2#1)
especially in those with##5##4##(1994-9#1)(2006-10#1)(2010-5#1)(2012-2#1)(2013-7#1)
especially in those##10##3##(1994-9#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-7#1)(2010-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
especially in women##5##3##(1991-8#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
especially in young##3##3##(2007-11#1)(2008-6#1)(2011-2#1)
especially in##261##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-7#4)(2007-8#6)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#8)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#26)(2011-7#1)(2012-1#2)(2012-12#12)(2012-2#9)(2012-3#6)(2012-8#1)(2013-1#14)(2013-7#4)(2013-8#5)
especially interesting##3##2##(2008-10#1)(2009-10#1)(2010-7#1)
especially of the##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
especially of##9##2##(1990-12#1)(1996-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
especially on the##4##3##(1992-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
especially on##7##2##(1992-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
especially over##2##2##(1995-2#1)(2012-3#1)
especially problematic##2##2##(1991-12#1)(2008-7#1)
especially prone to##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
especially regarding the##2##3##(2008-11#1)(2010-8#1)
especially relevant in##3##3##(1994-3#1)(1996-5#1)(2013-1#1)
especially relevant to##2##3##(2009-11#1)(2009-6#1)
especially relevant##5##2##(1994-3#1)(1996-5#1)(2009-11#1)(2009-6#1)(2013-1#1)
especially significant for##2##3##(1992-6#1)(1996-1#1)
especially significant##3##2##(1992-6#1)(1996-1#1)(2008-10#1)
especially since the##3##3##(1997-3#1)(2008-10#1)(2011-1#1)
especially since##6##2##(1997-3#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-11#1)(2011-1#1)
especially strong##2##2##(2008-10#1)(2008-2#1)
especially suitable for##5##3##(2007-12#1)(2008-3#3)(2008-5#1)
especially suitable##6##2##(2007-12#1)(2008-3#3)(2008-5#1)(2009-10#1)
especially susceptible to##2##3##(2008-9#1)(2009-2#1)
especially that of##3##3##(2009-10#1)(2011-3#1)(2013-8#1)
especially that##4##2##(2008-11#1)(2009-10#1)(2011-3#1)(2013-8#1)
especially the most##2##3##(1996-1#1)(2008-10#1)
especially the spatial pattern of the initial inocula##2##8##(2008-10#2)
especially the##58##2##(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#2)(2007-2#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#2)(2008-5#5)(2008-7#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
especially those involving##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
especially those of the##4##4##(1992-9#1)(1996-2#1)(2011-2#1)(2012-2#1)
especially those of##7##3##(1992-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
especially those that##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
especially those with##10##3##(1990-8#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
especially those##41##2##(1990-8#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-7#3)(2009-11#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
especially to the##2##3##(1995-11#1)(2008-9#1)
especially to##10##2##(1995-11#1)(1996-2#1)(2007-2#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
especially towards the##2##3##(2008-10#1)(2008-2#1)
especially true in##4##3##(1992-2#1)(2008-8#1)(2010-10#1)(2010-11#1)
especially true##13##2##(1990-12#1)(1992-2#1)(1994-2#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
especially under##2##2##(2011-2#1)(2012-12#1)
especially unpleasant for women##2##4##(2008-5#2)
especially useful for the##3##4##(1994-2#1)(2008-10#1)(2008-5#1)
especially useful for##5##3##(1994-2#1)(2008-10#2)(2008-2#1)(2008-5#1)
especially useful in the##2##4##(2007-12#1)(2007-9#1)
especially useful in##8##3##(1991-12#1)(1995-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-4#1)(2012-2#1)
especially useful##17##2##(1991-12#3)(1994-2#1)(1995-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)
especially valuable##2##2##(2011-2#1)(2013-1#1)
especially vulnerable to##3##3##(1994-6#1)(1995-2#1)(2008-7#1)
especially when combined with##2##4##(1994-9#1)(2007-12#1)
especially when compared with##2##4##(1995-6#1)(2008-10#1)
especially when it is##2##4##(2008-3#1)(2011-2#1)
especially when surgical##2##3##(2011-2#1)(2012-2#1)
especially when the rotation##2##4##(2008-2#1)(2008-3#1)
especially when the##13##3##(1991-2#1)(1992-3#1)(1995-8#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-5#1)(2012-2#1)
especially when their##2##3##(2008-6#1)(2009-6#1)
especially when there is##2##4##(2007-4#1)(2012-3#1)
especially when they are##3##4##(2008-7#1)(2008-8#1)(2013-1#1)
especially when they##6##3##(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
especially when##60##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-2#2)(2008-3#3)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
especially where there is##2##4##(2008-8#1)(2013-8#1)
especially where##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
especially with a##3##3##(2008-1#1)(2008-2#1)(2012-3#1)
especially with regard to##2##4##(2008-3#1)(2008-9#1)
especially with respect to##3##4##(2008-10#2)(2008-8#1)
especially with the##4##3##(1992-3#1)(1993-12#1)(2008-11#1)(2010-12#1)
especially with##22##2##(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2012-3#1)
especially young##2##2##(2009-5#1)(2012-3#1)
especially##1060##1##(1990-10#1)(1990-12#5)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#2)(1991-12#9)(1991-2#2)(1991-3#4)(1991-5#4)(1991-6#9)(1991-8#3)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#7)(1992-3#4)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#4)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#9)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#2)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#6)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#2)(2006-10#7)(2006-12#1)(2006-4#1)(2007-10#3)(2007-11#17)(2007-12#8)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#18)(2007-9#1)(2008-1#20)(2008-10#121)(2008-11#25)(2008-12#23)(2008-2#29)(2008-3#31)(2008-4#9)(2008-5#34)(2008-6#10)(2008-7#29)(2008-8#23)(2008-9#33)(2009-1#1)(2009-10#9)(2009-11#5)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#10)(2009-6#5)(2009-7#4)(2009-8#9)(2009-9#5)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#6)(2010-3#8)(2010-4#6)(2010-5#9)(2010-6#2)(2010-7#11)(2010-8#14)(2010-9#2)(2011-1#21)(2011-2#72)(2011-3#6)(2011-7#1)(2012-1#6)(2012-12#29)(2012-2#25)(2012-3#21)(2012-8#1)(2013-1#37)(2013-7#13)(2013-8#21)
essay is to##6##3##(1997-8#1)(2006-6#1)(2012-2#3)(2013-1#1)
essay provides##2##2##(2009-6#1)(2012-2#1)
essay will##4##2##(2008-1#1)(2008-12#3)
essay##34##1##(1995-1#1)(1997-8#2)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#6)(2009-10#1)(2009-6#1)(2010-1#2)(2012-12#4)(2012-2#11)(2013-1#2)
essays##2##1##(2008-10#1)(2013-7#1)
essence of the##8##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-7#1)
essence of##19##2##(1992-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)
essence##31##1##(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-2#1)(2007-11#2)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2013-1#1)
essential FAs##2##2##(2012-1#2)
essential amino acid##7##3##(2008-11#2)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
essential amino acids##4##3##(2008-5#1)(2010-4#2)(2012-2#1)
essential amino##11##2##(2008-11#2)(2008-3#1)(2008-5#3)(2010-4#2)(2011-2#1)(2012-2#2)
essential and##10##2##(1990-12#1)(1992-4#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
essential as##2##2##(1996-3#1)(2010-5#1)
essential aspect of##2##3##(2008-9#1)(2009-10#1)
essential but##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
essential carboxyl##2##2##(1993-3#1)(1993-6#1)
essential cell##2##2##(1990-2#1)(2008-10#1)
essential characteristics of##2##3##(1993-11#1)(2013-7#1)
essential component for the##2##4##(1996-12#1)(2012-2#1)
essential component in the##5##4##(2008-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
essential component in##6##3##(1990-5#1)(2008-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
essential component##31##2##(1990-5#1)(1991-6#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
essential components of##2##3##(1995-1#1)(2008-10#1)
essential components##6##2##(1994-8#1)(1995-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-11#1)
essential data##2##2##(2009-7#1)(2013-1#1)
essential due to##2##3##(1996-6#1)(2010-11#1)
essential dyspepsia##2##2##(1995-10#2)
essential effort##2##2##(2008-3#1)(2010-5#1)
essential elements of##5##3##(1991-1#1)(1991-2#1)(2007-11#1)(2007-12#1)(2008-4#1)
essential elements##8##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
essential factors##2##2##(2008-10#2)
essential fatty acid derivatives##2##4##(1990-3#1)(1996-7#1)
essential fatty acid##7##3##(1990-3#1)(1992-3#2)(1996-7#3)(2008-5#1)
essential fatty acids and##2##4##(2010-4#1)(2012-1#1)
essential fatty acids##6##3##(1990-3#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-1#1)(2013-1#1)
essential fatty##13##2##(1990-3#2)(1992-3#2)(1996-7#3)(2008-3#1)(2008-5#2)(2010-4#1)(2012-1#1)(2013-1#1)
essential feature##2##2##(1995-2#1)(2008-3#1)
essential features of the##4##4##(1991-9#1)(1994-12#1)(2008-10#1)(2013-8#1)
essential features of##7##3##(1991-5#1)(1991-9#2)(1994-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
essential features##9##2##(1991-5#1)(1991-9#2)(1994-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2013-8#1)
essential for a##5##3##(1996-12#1)(1996-3#1)(2008-5#2)(2011-2#1)
essential for activity##2##3##(1995-6#1)(2011-2#1)
essential for cellular##2##3##(2008-10#1)(2009-9#1)
essential for correct##2##3##(2008-2#1)(2009-8#1)
essential for development##2##3##(1994-12#1)(2012-3#1)
essential for effective##2##3##(1995-1#1)(2012-3#1)
essential for function##3##3##(1994-5#1)(1995-5#1)(2008-8#1)
essential for growth and##2##4##(1995-2#1)(2008-11#1)
essential for growth##4##3##(1990-5#1)(1995-2#1)(1995-8#1)(2008-11#1)
essential for intracellular processing##2##4##(1993-8#2)
essential for its##8##3##(1991-5#1)(1992-12#1)(1994-8#1)(2008-8#2)(2009-7#2)(2011-3#1)
essential for n-alkane assimilation##2##4##(1991-9#1)(1993-12#1)
essential for normal##3##3##(2009-10#1)(2011-2#1)(2012-3#1)
essential for nuclear##3##3##(1991-5#1)(1994-9#1)(2008-9#1)
essential for planning##2##3##(2007-8#1)(2011-2#1)
essential for reducing##2##3##(2007-11#1)(2010-5#1)
essential for successful##6##3##(1992-6#1)(1995-8#1)(2008-11#1)(2010-11#1)(2011-2#2)
essential for survival##2##3##(2008-7#1)(2010-2#1)
essential for the activity of the##2##6##(1994-6#2)
essential for the activity of##3##5##(1990-5#1)(1994-6#2)
essential for the antiviral activity of##2##6##(1990-2#2)
essential for the assembly of##2##5##(1997-4#1)(2008-8#1)
essential for the development of cell-free assays that reconstitute complicated cellular processes##2##12##(2008-4#2)
essential for the development of##6##5##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-1#1)
essential for the development##7##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2012-1#1)
essential for the expression of##2##5##(1990-5#1)(1997-2#1)
essential for the function of##4##5##(1993-12#2)(1995-6#1)(2008-11#1)
essential for the maintenance of##3##5##(2008-11#1)(2010-9#1)(2012-1#1)
essential for the survival of##2##5##(2008-9#1)(2009-8#1)
essential for the timely##2##4##(2008-10#1)(2011-2#1)
essential for the##85##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#2)(1997-4#2)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#3)(2009-8#5)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
essential for their##3##3##(1996-8#1)(2011-2#2)
essential for understanding the##2##4##(2008-10#2)
essential for understanding##3##3##(2008-10#2)(2012-2#1)
essential for viability##3##3##(1993-9#1)(1997-3#1)(1997-7#1)
essential for viral##3##3##(1997-3#1)(2008-10#1)(2012-12#1)
essential for##307##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-5#5)(1991-12#2)(1991-2#3)(1991-5#5)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#5)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#3)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#13)(2008-9#8)(2009-10#5)(2009-2#6)(2009-7#3)(2009-8#10)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#22)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#12)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#1)
essential function of##2##3##(1997-3#1)(2010-2#1)
essential functions##2##2##(2008-10#1)(2008-7#1)
essential gene##7##2##(1993-12#1)(1995-6#1)(1996-6#1)(2008-10#2)(2008-4#1)(2012-2#1)
essential genes in##4##3##(2008-10#1)(2012-2#3)
essential genes##11##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#8)
essential genetic##2##2##(2008-11#1)(2013-1#1)
essential growth##2##2##(1991-2#1)(2008-4#1)
essential health##2##2##(2009-6#1)(2011-1#1)
essential hypertension in##5##3##(1993-2#1)(2008-9#2)(2010-4#1)(2013-7#1)
essential hypertension is##2##3##(1990-2#1)(2009-1#1)
essential hypertension##32##2##(1990-2#1)(1992-6#1)(1992-8#2)(1993-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-1#2)(2010-4#4)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
essential hypertensive##2##2##(2010-4#1)(2013-8#1)
essential if##4##2##(1993-12#1)(2013-1#2)(2013-8#1)
essential impact##2##2##(2008-7#1)(2012-12#1)
essential in maintaining##2##3##(2009-5#1)(2013-7#1)
essential in obtaining##2##3##(2010-7#1)(2011-1#1)
essential in the management of##2##5##(2008-10#1)(2010-9#1)
essential in the##10##3##(1994-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-8#1)(2010-9#1)
essential in##36##2##(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#1)(2013-7#1)
essential information##4##2##(1993-2#1)(2008-1#1)(2008-11#1)(2012-2#1)
essential ingredient##2##2##(1997-3#1)(2007-2#1)
essential mixed##2##2##(1993-2#1)(2013-1#1)
essential nursing##2##2##(2008-11#1)(2008-12#1)
essential oil extracted##2##3##(2008-10#1)(2013-1#1)
essential oil from##3##3##(2008-12#1)(2010-5#1)(2012-3#1)
essential oil of Elephantopus scaber##2##5##(2008-11#2)
essential oil of the fruits##6##5##(2008-11#5)(2008-12#1)
essential oil of the##7##4##(2008-11#6)(2008-12#1)
essential oil of##14##3##(2008-11#10)(2008-12#1)(2008-5#3)
essential oil was##2##3##(2008-12#1)(2012-3#1)
essential oil were##3##3##(2007-1#1)(2012-3#2)
essential oil##44##2##(2007-1#2)(2008-10#3)(2008-11#10)(2008-12#5)(2008-5#5)(2010-3#3)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#6)
essential oils and their components##2##5##(2008-10#2)
essential oils and their##3##4##(2008-10#3)
essential oils and##4##3##(2008-10#3)(2012-12#1)
essential oils from##4##3##(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)
essential oils in##2##3##(2008-5#1)(2013-1#1)
essential oils of Thymus persicus and Thymus eriocalyx##2##8##(2008-12#2)
essential oils of##7##3##(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2013-1#1)
essential oils were##2##3##(2008-10#1)(2008-12#1)
essential oils##35##2##(2007-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#6)(2008-8#2)(2010-3#3)(2011-2#1)(2012-12#3)(2013-1#3)
essential parts of##2##3##(1991-2#1)(1994-9#1)
essential parts##3##2##(1991-2#1)(1994-9#1)(1996-3#1)
essential prerequisite for##4##3##(1994-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
essential prerequisite##7##2##(1994-6#1)(1995-12#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
essential properties##2##2##(2008-2#1)(2010-2#1)
essential regulatory##2##2##(1991-12#1)(1991-6#1)
essential requirement for##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
essential requirement##4##2##(1991-11#1)(1991-2#1)(2008-10#1)(2008-8#1)
essential role for the##2##4##(1996-2#1)(2008-6#1)
essential role for##4##3##(1994-12#1)(1994-8#1)(1996-2#1)(2008-6#1)
essential role in##22##3##(1990-5#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
essential role of##10##3##(1995-12#1)(1995-2#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
essential role##42##2##(1990-5#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
essential roles in##4##3##(1994-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
essential roles##7##2##(1994-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#2)
essential sequences##2##2##(1990-5#1)(1991-5#1)
essential skill##2##2##(2008-11#1)(2010-4#1)
essential skills in##2##3##(1995-1#2)
essential step in##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
essential step##9##2##(1990-12#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
essential steps##2##2##(2008-10#1)(2009-3#1)
essential structural##2##2##(2008-6#1)(2013-1#1)
essential survival##3##2##(2008-1#1)(2008-6#1)(2011-2#1)
essential thrombocytosis##2##2##(1997-7#2)
essential to achieve##3##3##(1995-5#1)(2008-3#1)(2009-2#1)
essential to identify##4##3##(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
essential to know##2##3##(2007-11#1)(2009-5#1)
essential to meet##2##3##(1991-2#1)(1997-3#1)
essential to the development##2##4##(2008-12#2)
essential to the##17##3##(1993-12#1)(1993-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(2007-2#1)(2008-12#3)(2008-2#1)(2008-9#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
essential to understand the##2##4##(2009-7#1)(2011-1#1)
essential to##112##2##(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#4)(1995-8#1)(1996-8#2)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#7)(2008-2#5)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-2#1)(2009-5#4)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#1)
essential trace element##4##3##(2008-10#2)(2012-2#2)
essential trace##6##2##(1990-2#1)(2008-10#2)(2010-11#1)(2012-2#2)
essential tremor##7##2##(2008-7#5)(2012-3#1)(2013-1#1)
essential use exemptions##2##3##(1996-1#2)
essential viral##2##2##(2013-1#2)
essential when##6##2##(1991-9#1)(1992-9#1)(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#1)
essential##1102##1##(1990-11#4)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#9)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#8)(1991-5#10)(1991-6#4)(1991-9#7)(1992-1#5)(1992-11#4)(1992-12#3)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#3)(1993-11#6)(1993-12#13)(1993-2#5)(1993-3#5)(1993-6#4)(1993-8#4)(1993-9#3)(1994-11#6)(1994-12#10)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#6)(1994-8#11)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#12)(1995-3#2)(1995-5#8)(1995-6#11)(1995-8#6)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#5)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#16)(1997-4#4)(1997-5#1)(1997-7#10)(1997-8#2)(2007-1#3)(2007-10#4)(2007-11#8)(2007-12#11)(2007-2#3)(2007-7#4)(2007-8#9)(2008-1#12)(2008-10#95)(2008-11#52)(2008-12#22)(2008-2#19)(2008-3#16)(2008-4#16)(2008-5#37)(2008-6#7)(2008-7#41)(2008-8#26)(2008-9#30)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#1)(2009-2#8)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#2)(2009-7#8)(2009-8#10)(2009-9#2)(2010-1#1)(2010-10#7)(2010-11#7)(2010-12#5)(2010-2#8)(2010-3#9)(2010-4#10)(2010-5#6)(2010-6#2)(2010-7#5)(2010-8#13)(2010-9#4)(2011-1#19)(2011-2#53)(2011-3#4)(2012-1#9)(2012-12#17)(2012-2#50)(2012-3#24)(2013-1#46)(2013-7#7)(2013-8#21)
essentiality##4##1##(2010-2#1)(2012-2#3)
essentially a##7##2##(1992-2#1)(1994-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-5#1)
essentially all##4##2##(2008-4#2)(2008-8#1)(2009-8#1)
essentially an##2##2##(2008-10#1)(2008-5#1)
essentially constant##3##2##(1992-11#1)(1994-1#1)(2008-3#1)
essentially different##3##2##(1992-9#1)(2007-12#1)(2008-7#1)
essentially equivalent##2##2##(1997-4#1)(2008-11#1)
essentially identical to the##2##4##(2008-10#1)(2008-8#1)
essentially identical to##5##3##(1991-5#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-8#1)
essentially identical##9##2##(1991-5#1)(1992-8#2)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
essentially independent of the##2##4##(1993-8#1)(2008-2#1)
essentially isotropic##2##2##(1993-11#1)(2012-2#1)
essentially limited to##2##3##(2008-10#1)(2010-8#1)
essentially no##3##2##(1990-11#1)(1993-8#1)(2010-5#1)
essentially normal##2##2##(2008-10#1)(2008-12#1)
essentially quantitative##2##2##(1996-5#1)(2008-10#1)
essentially similar##2##2##(2008-7#1)(2009-8#1)
essentially the same as##3##4##(1994-6#1)(1995-6#1)(2008-10#1)
essentially the same in##3##4##(1991-2#1)(2008-10#1)(2008-2#1)
essentially the same##11##3##(1991-2#1)(1994-1#1)(1994-6#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)
essentially the##14##2##(1990-12#1)(1991-2#1)(1994-1#1)(1994-6#1)(1995-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
essentially unaffected by##2##3##(1995-2#1)(2008-10#1)
essentially unaltered##6##2##(1991-12#1)(1992-9#2)(1994-11#1)(2008-10#1)(2012-2#1)
essentially unchanged##4##2##(1992-6#1)(1993-8#1)(2008-10#1)(2008-2#1)
essentially##153##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#1)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-8#2)(2007-11#4)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#3)(2013-8#1)
essentials##5##1##(1992-12#1)(1994-1#1)(2008-1#1)(2009-10#1)(2010-11#1)
essentiellement##2##1##(2011-2#1)(2013-1#1)
est fait##2##2##(2011-2#1)(2013-1#1)
est un##2##2##(2013-1#2)
est une##3##2##(2011-2#1)(2013-1#2)
est##29##1##(2008-5#5)(2011-2#7)(2013-1#17)
establish a common##2##3##(1995-3#1)(2007-4#1)
establish a method for##2##4##(2011-1#1)(2013-1#1)
establish a new##2##3##(1990-12#1)(2013-8#1)
establish a reference##2##3##(1991-5#1)(1993-2#1)
establish a simple##2##3##(2007-8#1)(2008-11#1)
establish a##73##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
establish an##10##2##(1992-5#1)(1996-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-2#1)
establish and maintain##5##3##(1993-1#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
establish and##8##2##(1991-1#1)(1993-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
establish early##3##2##(1997-1#1)(2008-1#1)(2008-8#1)
establish for##2##2##(1996-1#1)(2010-3#1)
establish if##2##2##(1994-11#1)(2008-5#1)
establish its##7##2##(1990-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-2#1)
establish national##3##2##(1996-12#1)(2007-12#2)
establish new##3##2##(1997-2#1)(2009-3#1)(2011-2#1)
establish suitable##3##2##(1992-2#1)(2008-10#1)(2011-2#1)
establish that a##3##3##(1995-2#1)(1995-9#1)(2008-11#1)
establish that the##3##3##(1993-11#1)(1994-11#1)(2008-3#1)
establish that##21##2##(1990-11#3)(1992-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
establish the diagnosis of##2##4##(2007-10#1)(2010-6#1)
establish the diagnosis##3##3##(2007-10#1)(2010-6#1)(2011-2#1)
establish the existence of##2##4##(1991-12#1)(1995-2#1)
establish the feasibility##2##3##(2010-12#1)(2013-1#1)
establish the mechanism##2##3##(1995-3#1)(2012-12#1)
establish the##99##2##(1991-12#1)(1991-6#1)(1992-1#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-10#4)(2007-11#4)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
establish their own##2##3##(1993-12#1)(2013-1#1)
establish their##6##2##(1993-12#1)(1994-8#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
establish tolerance##2##2##(1991-3#1)(2008-3#1)
establish whether##8##2##(1995-5#1)(1996-5#1)(1997-4#1)(2008-11#1)(2009-10#1)(2011-2#2)(2013-7#1)
establish##389##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2007-10#7)(2007-11#6)(2007-12#5)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#52)(2008-11#22)(2008-12#4)(2008-2#14)(2008-3#14)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#16)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#18)(2011-3#1)(2011-7#1)(2012-12#8)(2012-2#14)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#10)
established &quot##2##2##(2008-10#1)(2008-7#1)
established ELISA##2##2##(2008-10#1)(2008-11#1)
established a new##5##3##(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
established a novel##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
established a real-time quantitative##2##4##(2008-10#1)(2008-11#1)
established a simple##2##3##(1990-11#1)(2008-11#1)
established a##45##2##(1990-11#1)(1991-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#1)(1997-1#2)(1997-4#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
established according to the##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
established after##8##2##(1990-10#1)(2008-10#4)(2008-9#1)(2012-12#1)(2013-1#1)
established an in vitro immunization##2##5##(2008-11#2)
established an##10##2##(1993-12#1)(1996-12#1)(1996-2#1)(2008-11#3)(2009-3#1)(2010-3#2)(2013-1#1)
established and effective means##2##4##(2008-11#1)(2008-9#1)
established and the##5##3##(2008-12#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#1)
established and used for##2##4##(1992-8#1)(2010-6#1)
established and used##3##3##(1991-12#1)(1992-8#1)(2010-6#1)
established and##38##2##(1991-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(2007-11#1)(2007-6#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#4)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
established as a new##2##4##(2008-12#1)(2008-5#1)
established as a##11##3##(1993-9#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#2)
established as an important##2##4##(2008-2#1)(2008-8#1)
established as an##5##3##(2008-2#1)(2008-8#1)(2009-11#2)(2010-11#1)
established as the##5##3##(1995-5#1)(2008-10#2)(2010-12#1)(2011-2#1)
established as##37##2##(1993-9#1)(1994-8#1)(1995-5#1)(1996-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2009-11#2)(2009-5#1)(2010-11#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-8#1)
established at the##2##3##(2008-1#1)(2011-2#1)
established at##8##2##(1994-9#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#2)(2011-2#1)
established based on##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
established between a##3##3##(1990-9#1)(2008-9#1)(2012-1#1)
established between the##8##3##(2007-11#1)(2007-7#1)(2008-10#5)(2008-5#1)
established between##27##2##(1990-9#1)(1992-2#1)(2007-11#1)(2007-7#1)(2008-10#16)(2008-3#1)(2008-5#2)(2008-9#1)(2010-9#1)(2012-1#1)(2013-1#1)
established by X-ray##2##3##(1995-3#1)(1996-2#1)
established by a##4##3##(1992-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
established by comparing##2##3##(1995-5#1)(2007-11#1)
established by demonstrating##2##3##(1990-8#1)(1991-11#1)
established by flow##2##3##(1993-11#1)(2008-10#1)
established by means of##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
established by parallel##2##3##(2008-10#2)
established by the##20##3##(1991-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
established by##82##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#26)(2008-11#12)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
established clinical indications##2##3##(1992-3#1)(2008-7#1)
established coronary artery disease##4##4##(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)
established coronary##7##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-6#1)
established diagnostic criteria##2##3##(2011-2#1)(2013-8#1)
established diagnostic##4##2##(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
established disease##2##2##(1993-11#1)(2013-1#1)
established during the##3##3##(1997-4#1)(2007-5#1)(2008-11#1)
established during##5##2##(1997-4#1)(2007-5#1)(2008-11#1)(2010-9#2)
established early in##2##3##(2007-12#1)(2008-12#1)
established effect size##2##3##(2009-11#2)
established enrollees##2##2##(1995-1#2)
established for a##3##3##(1993-1#1)(1995-8#1)(2008-10#1)
established for different##2##3##(1995-6#1)(2008-10#1)
established for the first time##3##5##(1990-5#1)(2008-10#1)(2010-3#1)
established for the##19##3##(1990-11#1)(1990-5#1)(1996-12#1)(2007-12#1)(2008-10#7)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#1)
established for##52##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)(2013-8#1)
established four##2##2##(2008-5#1)(2013-8#1)
established from a##3##3##(1992-12#1)(1996-12#1)(2012-2#1)
established from embryonic##2##3##(2008-11#2)
established from##20##2##(1992-12#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
established function of##2##3##(1994-12#1)(2008-5#1)
established has##2##2##(1997-3#1)(2008-7#1)
established high##2##2##(2008-10#1)(2009-12#1)
established if##3##2##(1994-12#1)(1996-7#1)(2008-7#1)
established in 1978##2##3##(1991-12#1)(1994-12#1)
established in a##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
established in all##2##3##(1997-3#1)(2013-8#1)
established in several##2##3##(1996-9#1)(2010-5#1)
established in the##23##3##(1995-2#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-5#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
established in this##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
established in which##3##3##(2008-7#1)(2008-8#2)
established in##94##2##(1991-12#1)(1991-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#1)
established its##2##2##(2008-9#1)(2013-7#1)
established itself as##2##3##(1996-3#1)(2011-4#1)
established itself##3##2##(1996-3#1)(2008-10#1)(2011-4#1)
established mechanism##2##2##(1992-3#1)(2009-10#1)
established method is##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
established method##10##2##(2008-10#5)(2008-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
established methods##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
established model##3##2##(1996-12#1)(2011-1#1)(2013-8#1)
established on a##2##3##(1993-6#1)(2008-10#1)
established on the basis of the##3##6##(1990-9#1)(2007-11#1)(2008-3#1)
established on the basis of##7##5##(1990-9#1)(1994-5#1)(2007-11#3)(2008-3#1)(2012-2#1)
established on the##8##3##(1990-9#1)(1994-5#1)(2007-11#3)(2008-3#1)(2012-2#1)(2013-1#1)
established on##12##2##(1990-9#1)(1993-6#1)(1994-5#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
established only##2##2##(2007-12#1)(2010-12#1)
established or##3##2##(1997-3#1)(1997-4#1)(2013-1#1)
established osteoporosis##5##2##(1993-11#5)
established over the last##2##4##(2008-2#1)(2009-4#1)
established over the past##2##4##(2008-2#1)(2012-2#1)
established over the##5##3##(2008-10#1)(2008-2#2)(2009-4#1)(2012-2#1)
established over##6##2##(2008-10#2)(2008-2#2)(2009-4#1)(2012-2#1)
established primary##3##2##(1990-5#1)(1997-3#1)(2010-3#1)
established procedure##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
established rat##3##2##(2008-11#2)(2008-7#1)
established risk factors##3##3##(2008-3#1)(2011-2#2)
established risk##5##2##(2008-3#3)(2011-2#2)
established role in##2##3##(2007-4#1)(2012-12#1)
established role##3##2##(2007-4#1)(2008-5#1)(2012-12#1)
established spectrophotometrically##2##2##(2008-10#2)
established technique##2##2##(1991-1#1)(2012-12#1)
established that a##3##3##(2006-12#1)(2008-5#1)(2010-3#1)
established that all##2##3##(2008-10#1)(2013-1#1)
established that in##2##3##(2008-10#1)(2013-1#1)
established that the##19##3##(1990-8#1)(1992-9#1)(1993-6#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
established that this##5##3##(1990-10#1)(1997-7#1)(2006-4#1)(2008-10#1)(2011-2#1)
established that##73##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-7#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-3#2)(2013-1#2)(2013-8#1)
established the diagnosis of##2##4##(1990-11#1)(2007-7#1)
established the near##2##3##(2008-10#1)(2008-2#1)
established the##22##2##(1990-11#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2011-1#1)(2012-12#1)
established through##6##2##(1991-6#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2013-7#1)
established to be##2##3##(2008-10#2)
established to determine##3##3##(2008-10#2)(2008-11#1)
established to improve##3##3##(1996-1#1)(1996-3#1)(2008-3#1)
established to produce##2##3##(2008-11#1)(2008-5#1)
established to provide##2##3##(1996-3#1)(2008-10#1)
established to##36##2##(1992-6#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-5#1)(2009-11#3)(2011-2#2)
established treatments##2##2##(2007-8#1)(2010-5#1)
established two##4##2##(1994-8#1)(2008-10#1)(2008-5#2)
established under the##2##3##(1993-12#1)(1995-3#1)
established under##3##2##(1993-12#1)(1995-3#1)(2008-9#1)
established using a##2##3##(2008-10#1)(2008-11#1)
established using##9##2##(1997-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2013-8#1)
established were##2##2##(2008-10#1)(2008-11#1)
established whether##2##2##(2008-11#1)(2012-12#1)
established with the regression equation##2##5##(2008-10#2)
established with the##7##3##(2007-7#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-8#1)
established with##21##2##(1991-2#1)(1992-3#1)(2007-10#1)(2007-7#1)(2008-10#8)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#2)(2013-8#1)
established within the##2##3##(1990-6#1)(2012-6#1)
established within##4##2##(1990-6#1)(1995-11#1)(2008-12#1)(2012-6#1)
established yet##2##2##(2010-8#1)(2013-1#1)
established##1210##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#10)(1992-5#2)(1992-6#1)(1992-8#7)(1992-9#6)(1993-1#4)(1993-11#12)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#4)(1994-12#9)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#3)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#8)(1996-3#4)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#9)(1997-6#3)(1997-7#6)(1997-8#4)(1997-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#15)(2007-12#13)(2007-4#1)(2007-5#6)(2007-6#2)(2007-7#9)(2007-8#8)(2008-1#15)(2008-10#296)(2008-11#85)(2008-12#12)(2008-2#10)(2008-3#36)(2008-4#11)(2008-5#41)(2008-6#8)(2008-7#31)(2008-8#23)(2008-9#30)(2009-1#2)(2009-10#7)(2009-11#8)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#4)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#10)(2010-3#10)(2010-4#4)(2010-5#3)(2010-6#4)(2010-8#7)(2010-9#3)(2011-1#16)(2011-2#60)(2011-3#6)(2011-4#1)(2012-1#5)(2012-12#14)(2012-2#21)(2012-3#12)(2012-6#1)(2012-8#1)(2013-1#40)(2013-7#6)(2013-8#19)
establishes a new##2##3##(2008-11#1)(2013-1#1)
establishes a##11##2##(1991-8#1)(1995-1#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)
establishes an##3##2##(1994-11#1)(2012-2#1)(2012-3#1)
establishes that##5##2##(1995-5#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
establishes the relationship between##2##4##(2008-5#1)(2012-2#1)
establishes the##13##2##(1992-9#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
establishes##47##1##(1990-7#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
establishing a new##3##3##(1992-3#1)(1995-2#1)(2008-11#1)
establishing a##45##2##(1990-12#1)(1990-2#1)(1991-11#1)(1992-3#1)(1992-6#1)(1993-1#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
establishing an##6##2##(1990-8#1)(1992-3#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
establishing and maintaining a##2##4##(2008-2#1)(2008-4#1)
establishing and maintaining##5##3##(2008-2#1)(2008-4#1)(2009-2#1)(2010-7#1)(2011-1#1)
establishing and##8##2##(1992-3#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
establishing appropriate##2##2##(2008-11#1)(2008-7#1)
establishing criteria for##2##3##(1994-3#1)(1996-2#1)
establishing in##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
establishing new##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
establishing that##2##2##(1993-3#1)(2008-10#1)
establishing the diagnosis of##2##4##(1995-3#1)(2008-1#1)
establishing the diagnosis##4##3##(1991-2#1)(1995-3#1)(2008-1#1)(2013-1#1)
establishing the relationship##2##3##(1993-12#1)(2008-10#1)
establishing the##36##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1995-3#2)(1996-1#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#2)
establishing##182##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1992-2#1)(1992-3#4)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#3)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#6)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
establishment and maintenance of##5##4##(1996-11#1)(1997-2#1)(2008-9#1)(2012-3#1)(2013-1#1)
establishment and maintenance##7##3##(1996-11#1)(1997-2#1)(2008-9#1)(2009-8#2)(2012-3#1)(2013-1#1)
establishment and##13##2##(1996-11#1)(1997-2#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#2)(2012-3#1)(2013-1#2)
establishment in the##3##3##(2008-10#2)(2008-11#1)
establishment in##6##2##(2008-10#2)(2008-11#1)(2008-6#1)(2010-3#1)(2013-7#1)
establishment of a##27##3##(1991-12#1)(1991-2#1)(1993-2#1)(1996-2#2)(2006-6#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
establishment of an##8##3##(1991-9#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)
establishment of human##2##3##(2008-11#1)(2008-6#1)
establishment of native##2##3##(2008-9#1)(2013-7#1)
establishment of new##3##3##(2008-10#2)(2008-11#1)
establishment of recombinant protein##2##4##(2008-11#2)
establishment of social##2##3##(2008-11#2)
establishment of structures##2##3##(2008-12#1)(2012-12#1)
establishment of the##20##3##(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2013-8#1)
establishment of this##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
establishment of two##2##3##(2008-10#1)(2008-7#1)
establishment of##145##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#27)(2008-11#15)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#1)
establishment was##2##2##(2008-8#1)(2012-2#1)
establishment##189##1##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#37)(2008-11#17)(2008-12#4)(2008-2#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#2)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-9#1)(2013-1#6)(2013-7#3)(2013-8#1)
establishments were involved##2##3##(1996-1#2)
establishments##20##1##(1996-1#6)(2007-12#2)(2008-10#1)(2008-12#6)(2008-6#1)(2008-9#2)(2009-7#1)(2012-12#1)
estate##4##1##(1994-1#1)(1994-3#1)(1997-5#1)(2008-10#1)
esteem##7##1##(2007-10#1)(2007-12#4)(2008-11#1)(2011-1#1)
ester (BTH)##3##2##(2008-10#3)
ester analysis##3##2##(2008-10#2)(2009-10#1)
ester and methyl##2##3##(2008-10#2)
ester and##14##2##(1992-12#1)(1994-11#3)(1994-3#1)(1995-12#2)(2008-10#6)(2008-5#1)
ester carbonyl##4##2##(1993-11#3)(2008-10#1)
ester content##4##2##(1995-6#1)(2008-10#2)(2009-8#1)
ester formation##3##2##(1990-8#1)(1991-5#1)(2011-1#1)
ester fraction##2##2##(1995-2#2)
ester group##2##2##(1997-7#1)(2009-5#1)
ester groups##3##2##(2008-10#3)
ester is##2##2##(1995-2#1)(1997-1#1)
ester linkage to##3##3##(1992-3#1)(2008-10#2)
ester of##10##2##(1990-7#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-7#2)(2008-7#1)
ester on##4##2##(1990-8#2)(1995-6#1)(2008-10#1)
ester or##3##2##(1990-12#1)(1995-12#1)(2008-10#1)
ester prodrug of##2##3##(1995-6#1)(2008-5#1)
ester substrates##2##2##(1992-3#1)(2008-7#1)
ester synthesis##8##2##(1990-8#1)(2010-12#1)(2011-1#6)
ester to##3##2##(1990-5#1)(1995-12#1)(1997-2#1)
ester transfer protein gene##3##4##(2008-12#3)
ester transfer protein##9##3##(1995-5#2)(1995-8#1)(2008-12#6)
ester transfer##12##2##(1992-3#1)(1995-5#4)(1995-8#1)(2008-12#6)
ester treatment##3##2##(1993-8#1)(1995-6#1)(1997-1#1)
ester using##2##2##(2007-11#1)(2008-10#1)
ester was used##2##3##(1996-5#1)(2008-10#1)
ester was##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
ester with##2##2##(2007-11#1)(2008-7#1)
ester##287##1##(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#5)(1991-12#3)(1991-2#3)(1991-5#4)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#10)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#1)(1993-6#2)(1993-8#4)(1994-11#8)(1994-3#3)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#5)(1995-12#7)(1995-2#8)(1995-3#1)(1995-5#4)(1995-6#8)(1995-8#2)(1996-2#2)(1996-5#7)(1996-7#3)(1997-1#3)(1997-2#3)(1997-7#4)(2007-11#13)(2007-5#1)(2008-10#52)(2008-11#11)(2008-12#6)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#10)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
ester) and##2##2##(1997-2#1)(2008-10#1)
ester)##10##1##(1995-11#2)(1997-2#1)(2008-10#6)(2011-1#1)
ester-mediated##3##1##(1991-9#1)(1992-8#1)(1994-8#1)
ester-type polyurethane membrane##3##3##(2008-10#3)
ester-type##4##1##(2008-10#4)
esterase activities##3##2##(1992-3#1)(1995-2#1)(1996-12#1)
esterase activity##3##2##(1992-2#1)(1993-11#1)(2008-9#1)
esterase and##4##2##(1992-11#1)(1992-2#1)(2008-9#1)(2011-1#1)
esterase##41##1##(1990-2#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#3)(1997-2#1)(1997-5#2)(2008-10#7)(2008-11#2)(2008-5#1)(2008-9#4)(2011-1#9)(2013-1#1)
esterases and##3##2##(2011-1#2)(2011-2#1)
esterases from##2##2##(2011-1#1)(2013-1#1)
esterases##15##1##(1992-2#2)(1993-6#1)(2007-10#1)(2008-8#1)(2008-9#1)(2011-1#6)(2011-2#1)(2013-1#2)
esterification and##2##2##(1992-6#1)(2008-7#1)
esterification in murine macrophages##2##4##(1990-8#2)
esterification in##6##2##(1990-8#3)(1994-8#2)(2008-10#1)
esterification of cholesterol##2##3##(1993-6#1)(1995-3#1)
esterification of the##2##3##(1994-9#1)(2008-5#1)
esterification of##11##2##(1992-6#2)(1993-6#1)(1994-9#2)(1995-3#1)(1995-6#1)(2008-5#2)(2008-6#1)(2008-7#1)
esterification reaction##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
esterification##34##1##(1990-8#3)(1992-12#1)(1992-6#3)(1993-6#1)(1994-8#3)(1994-9#2)(1995-3#2)(1995-6#1)(2007-11#1)(2008-10#6)(2008-5#2)(2008-6#2)(2008-7#4)(2012-12#1)(2013-1#2)
esterified cholesterol##4##2##(1990-7#2)(2008-10#2)
esterified cholesterols and triacylglycerols in human##2##6##(1990-8#2)
esterified cholesterols##3##2##(1990-8#3)
esterified in##2##2##(1992-3#1)(1994-6#1)
esterified##19##1##(1990-7#2)(1990-8#3)(1992-3#1)(1994-11#2)(1994-6#1)(1995-2#1)(2007-11#1)(2008-10#5)(2008-5#2)(2012-2#1)
esters 8##2##2##(2007-11#2)
esters and the##2##3##(2008-5#1)(2011-1#1)
esters and##6##2##(1992-12#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
esters are##6##2##(1994-11#1)(1995-2#1)(2008-11#2)(2009-8#1)(2011-1#1)
esters from##3##2##(1996-5#1)(2007-11#1)(2008-5#1)
esters in the##3##3##(1994-8#1)(1995-2#1)(2008-11#1)
esters in##11##2##(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
esters mimic the action of insulin on the regulation of PEPCK gene##2##12##(1995-6#1)(1996-2#1)
esters of##16##2##(1991-12#1)(1991-5#1)(1992-12#2)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-1#1)
esters on the##2##3##(1990-12#1)(2008-10#1)
esters on##5##2##(1990-12#1)(2008-10#3)(2010-12#1)
esters or##2##2##(1992-3#1)(1995-6#1)
esters to##4##2##(1994-12#1)(2008-4#2)(2009-11#1)
esters was##2##2##(1995-2#1)(2010-12#1)
esters were##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
esters with##2##2##(1994-8#1)(2008-10#1)
esters##163##1##(1990-12#4)(1991-12#3)(1991-5#4)(1991-9#2)(1992-12#3)(1992-3#3)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#5)(1994-11#4)(1994-12#2)(1994-3#1)(1994-8#7)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#9)(1996-2#3)(1996-5#6)(2007-11#7)(2008-10#25)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#14)(2008-6#1)(2008-7#7)(2009-11#1)(2009-8#6)(2010-12#4)(2010-2#2)(2010-4#2)(2010-8#2)(2011-1#9)(2013-1#3)
esters)##2##1##(1993-8#1)(2008-10#1)
esthesioneuroblastoma##3##1##(2011-1#3)
esthetic and functional##2##3##(2009-8#1)(2012-2#1)
esthetic and##3##2##(1993-11#1)(2009-8#1)(2012-2#1)
esthetic outcomes of##2##3##(2013-1#2)
esthetic results of##2##3##(1990-9#1)(1993-8#1)
esthetic results##3##2##(1990-9#1)(1993-8#1)(2007-12#1)
esthetic##30##1##(1990-9#2)(1992-9#1)(1993-11#1)(1993-8#1)(2007-12#6)(2008-5#1)(2008-7#4)(2009-8#4)(2010-3#2)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
esthetically demanding##2##2##(2009-8#2)
esthetics##5##1##(1990-5#1)(2010-3#1)(2013-1#3)
estimate a##6##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
estimate and##5##2##(1992-6#1)(1996-3#1)(2008-9#1)(2009-12#1)(2010-2#1)
estimate both##2##2##(2008-2#1)(2013-1#1)
estimate depends##2##2##(1994-2#1)(1994-9#1)
estimate dispersal##2##2##(2013-1#2)
estimate for a##2##3##(1992-2#1)(2008-3#1)
estimate for the##5##3##(1990-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
estimate for##9##2##(1990-5#1)(1992-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2012-12#1)(2013-1#1)
estimate is##6##2##(1997-2#1)(2007-12#1)(2008-3#2)(2012-12#1)(2013-1#1)
estimate it##3##2##(1995-6#1)(2009-6#1)(2013-1#1)
estimate long-term##2##2##(2008-8#1)(2009-8#1)
estimate of 0##2##3##(2008-11#1)(2008-7#1)
estimate of a##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
estimate of its##2##3##(1990-3#1)(2008-12#1)
estimate of probability of##2##4##(1996-6#2)
estimate of the average##2##4##(1992-6#1)(2008-3#1)
estimate of the covariance##2##4##(1997-3#2)
estimate of the orientation##2##4##(2008-3#1)(2010-2#1)
estimate of the true##2##4##(2008-3#1)(2008-5#1)
estimate of the##52##3##(1990-11#1)(1991-12#1)(1992-1#1)(1992-6#2)(1993-12#1)(1994-9#1)(1995-9#1)(1996-3#1)(1997-3#4)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#2)
estimate of##96##2##(1990-11#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-3#4)(2007-11#2)(2007-12#4)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#15)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
estimate species##2##2##(2013-7#2)
estimate survival##3##2##(1990-9#1)(2008-10#1)(2008-6#1)
estimate that the##4##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
estimate that##13##2##(1993-12#1)(1994-9#1)(1996-11#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-5#2)
estimate the effect of##2##4##(2008-11#1)(2009-9#1)
estimate the effect##3##3##(2008-11#1)(2009-9#1)(2010-4#1)
estimate the effective##2##3##(2008-10#1)(2008-3#1)
estimate the frequency of##2##4##(2008-10#1)(2009-8#1)
estimate the incidence of##2##4##(2008-11#1)(2008-8#1)
estimate the parameters of##2##4##(2008-2#1)(2008-3#1)
estimate the parameters##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
estimate the potential##5##3##(1991-3#1)(2008-10#3)(2008-5#1)
estimate the prevalence of##7##4##(1994-9#1)(1995-10#1)(2007-7#1)(2008-12#1)(2009-10#1)(2010-4#1)(2013-8#1)
estimate the prevalence##9##3##(1994-9#1)(1995-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-4#1)(2013-8#2)
estimate the probability##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
estimate the proportion of##2##4##(2011-2#1)(2013-1#1)
estimate the risk##2##3##(2008-7#1)(2010-5#1)
estimate the##203##2##(1991-3#1)(1991-5#1)(1992-12#3)(1992-3#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#10)(2008-12#3)(2008-2#10)(2008-3#26)(2008-4#5)(2008-5#5)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#3)(2009-9#2)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
estimate their##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
estimate these parameters##2##3##(2008-8#1)(2010-3#1)
estimate these##4##2##(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
estimate this##2##2##(2007-12#1)(2008-10#1)
estimate with##2##2##(2008-3#1)(2012-12#1)
estimate##528##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#5)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#6)(1994-3#1)(1994-9#7)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#92)(2008-11#21)(2008-12#5)(2008-2#22)(2008-3#73)(2008-4#8)(2008-5#11)(2008-6#9)(2008-7#13)(2008-8#23)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#10)(2011-1#6)(2011-2#13)(2011-3#1)(2012-12#7)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#22)(2013-7#3)(2013-8#6)
estimated a##3##2##(1993-6#1)(2008-10#1)(2013-1#1)
estimated and the##2##3##(2008-10#1)(2010-8#1)
estimated and##14##2##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
estimated as +/-##2##3##(2008-10#2)
estimated as 0##7##3##(2008-10#6)(2008-12#1)
estimated as 3##2##3##(2008-10#1)(2008-3#1)
estimated as##37##2##(1990-11#1)(1990-2#1)(1993-8#1)(1995-1#1)(1995-12#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2010-4#1)
estimated at 0##3##3##(2008-10#3)
estimated at 1##3##3##(2008-1#1)(2009-7#1)(2010-3#1)
estimated at a##2##3##(2012-2#1)(2013-1#1)
estimated at the##2##3##(2008-10#1)(2009-11#1)
estimated at##33##2##(1991-1#1)(1992-12#1)(1992-2#1)(1995-2#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
estimated average##3##2##(1997-2#1)(2008-10#1)(2013-8#1)
estimated blood loss was##2##4##(2008-10#1)(2011-2#1)
estimated blood loss##4##3##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
estimated both##3##2##(1993-8#1)(2007-12#1)(2008-10#1)
estimated by a Kalman filter##2##5##(2009-9#1)(2010-5#1)
estimated by a##7##3##(1993-3#1)(1996-2#1)(2008-10#3)(2009-9#1)(2010-5#1)
estimated by an##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
estimated by analysis of##3##4##(2008-10#3)
estimated by assuming##2##3##(1995-3#1)(2008-10#1)
estimated by comparing##2##3##(2008-2#1)(2009-11#1)
estimated by fitting##2##3##(2008-10#1)(2008-7#1)
estimated by gel filtration##2##4##(1991-12#1)(1997-2#1)
estimated by means of##3##4##(1992-9#1)(2008-10#1)(2008-3#1)
estimated by measuring the##4##4##(1995-3#1)(2008-10#3)
estimated by measuring##5##3##(1995-3#1)(2008-10#3)(2009-8#1)
estimated by non-linear regression of {pK(a)##2##6##(2008-10#2)
estimated by the##11##3##(1993-9#1)(1994-3#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2013-1#1)
estimated by this##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
estimated by using a linear##2##5##(2008-10#2)
estimated by using a##3##4##(2008-10#2)(2010-6#1)
estimated by using##7##3##(1994-5#1)(2008-10#4)(2010-6#1)(2012-12#1)
estimated by##105##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-9#1)(1996-2#1)(1997-2#2)(2007-11#1)(2007-8#2)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
estimated convexity is##3##3##(2008-6#3)
estimated correlation##2##2##(1997-3#1)(2008-10#1)
estimated costs##3##2##(1995-1#2)(2012-12#1)
estimated detection limit##3##3##(2008-10#3)
estimated detection##5##2##(2008-10#4)(2012-1#1)
estimated disease##2##2##(2008-10#2)
estimated effective##2##2##(2008-10#1)(2013-1#1)
estimated experimentally##2##2##(2008-10#1)(2008-2#1)
estimated for each cultivar##2##4##(2008-10#2)
estimated for each##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
estimated for the##6##3##(1990-9#1)(1991-12#1)(1991-2#1)(1995-11#1)(2007-12#1)(2008-10#1)
estimated for##21##2##(1990-9#1)(1991-12#1)(1991-2#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
estimated from a##5##3##(2008-12#1)(2008-3#1)(2008-5#1)(2012-1#2)
estimated from electrophoretic##2##3##(1993-9#1)(2008-10#1)
estimated from literature##2##3##(2008-10#1)(2008-7#1)
estimated from the##23##3##(1991-3#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)
estimated from##60##2##(1990-11#1)(1991-3#1)(1992-10#1)(1993-9#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)
estimated genetic##2##2##(2008-9#1)(2011-1#1)
estimated gestational age##2##3##(1991-7#1)(1992-6#1)
estimated glomerular filtration rate##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
estimated in the##7##3##(1991-6#1)(1997-7#1)(2008-10#1)(2009-9#1)(2010-3#1)(2010-5#1)(2013-8#1)
estimated in##21##2##(1990-2#1)(1991-6#1)(1993-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
estimated maximum##2##2##(1993-8#1)(2012-2#1)
estimated molecular mass##2##3##(1995-2#1)(2008-11#1)
estimated molecular weight##5##3##(1990-12#1)(1993-11#1)(2008-10#1)(2009-9#1)(2012-2#1)
estimated molecular##7##2##(1990-12#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-2#1)
estimated or##2##2##(1996-8#1)(2008-10#1)
estimated parameters##2##2##(2008-10#1)(2013-7#1)
estimated pathophysiological concentrations##3##3##(1996-12#2)(1996-2#1)
estimated power##2##2##(2008-3#1)(2012-3#1)
estimated prevalence of##6##3##(1996-2#1)(2008-1#1)(2008-11#1)(2011-2#2)(2013-1#1)
estimated prevalence##7##2##(1996-2#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-1#1)(2013-1#1)
estimated rate##3##2##(1991-8#1)(1992-6#1)(1997-7#1)
estimated reduction##2##2##(1991-8#1)(1994-2#1)
estimated relative##2##2##(2008-10#2)
estimated scatter distribution##2##3##(2008-5#2)
estimated spectra##3##2##(2008-3#3)
estimated standard deviation##2##3##(2008-3#2)
estimated that in##2##3##(2008-11#1)(2009-4#1)
estimated that the##8##3##(1991-6#1)(1992-2#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-2#1)(2008-5#1)
estimated that##37##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-4#1)(2007-2#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#7)(2012-12#1)(2013-1#1)
estimated the expression##2##3##(2008-11#1)(2013-7#1)
estimated the##26##2##(1990-2#1)(1995-12#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
estimated theta parameter of the beta-binomial##2##6##(2008-10#2)
estimated through##2##2##(2008-5#1)(2013-1#1)
estimated to affect##2##3##(2008-5#1)(2012-12#1)
estimated to be 0##7##4##(1994-6#1)(2007-11#1)(2008-10#4)(2013-1#1)
estimated to be 1##7##4##(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-1#1)(2012-2#1)
estimated to be 10##3##4##(1990-12#1)(1992-12#1)(2008-3#1)
estimated to be 12##2##4##(2008-10#1)(2012-12#1)
estimated to be 2##5##4##(1994-9#1)(2008-10#3)(2008-2#1)
estimated to be 3##2##4##(2007-11#1)(2008-10#1)
estimated to be 6##2##4##(2008-10#1)(2008-11#1)
estimated to be 7##2##4##(2007-11#1)(2008-10#1)
estimated to be about##2##4##(1993-3#1)(2008-10#1)
estimated to be approximately##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
estimated to be higher##2##4##(2007-12#1)(2010-4#1)
estimated to be less than##5##5##(1990-11#1)(2008-10#2)(2008-3#2)
estimated to be of##2##4##(1992-3#1)(2008-5#1)
estimated to be within##2##4##(2008-3#1)(2013-7#1)
estimated to be##93##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1996-3#1)(1997-6#2)(2007-10#1)(2007-11#5)(2007-12#3)(2008-10#25)(2008-11#1)(2008-2#4)(2008-3#12)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
estimated to have##5##3##(1990-5#1)(1991-5#1)(1997-6#1)(2009-10#1)(2011-2#1)
estimated to occur##2##3##(1991-6#1)(2013-7#1)
estimated to range from 1##2##5##(2008-10#1)(2013-1#1)
estimated to range from##4##4##(1995-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
estimated to range##5##3##(1995-5#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
estimated to within##3##3##(2008-2#1)(2008-3#2)
estimated to##126##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#2)(1996-10#1)(1996-3#1)(1997-6#3)(2007-10#1)(2007-11#5)(2007-12#3)(2008-10#28)(2008-11#1)(2008-2#6)(2008-3#15)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#4)(2013-7#2)
estimated total##4##2##(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)
estimated type I error##2##4##(2012-3#2)
estimated uncertainty##3##2##(2008-2#2)(2008-3#1)
estimated under##3##2##(1995-11#1)(2008-10#1)(2009-11#1)
estimated using a##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
estimated using an##2##3##(2008-7#2)
estimated using multiple##2##3##(2008-10#1)(2011-2#1)
estimated using the##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
estimated using##22##2##(1994-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
estimated values##2##2##(2008-3#1)(2008-6#1)
estimated with Mie theory##2##4##(2008-2#1)(2008-3#1)
estimated with a##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
estimated with##19##2##(1993-11#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-6#2)(2008-8#1)(2011-2#1)(2012-3#1)
estimated within##2##2##(2008-10#1)(2008-2#1)
estimated##894##1##(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#5)(1992-4#1)(1992-6#5)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#4)(1993-6#2)(1993-8#4)(1993-9#3)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#6)(1995-12#6)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#3)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#2)(2007-10#3)(2007-11#10)(2007-12#14)(2007-2#2)(2007-5#2)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#254)(2008-11#21)(2008-12#9)(2008-2#38)(2008-3#69)(2008-4#3)(2008-5#24)(2008-6#14)(2008-7#23)(2008-8#24)(2008-9#9)(2009-10#1)(2009-11#6)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#12)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#5)(2011-1#3)(2011-2#32)(2012-1#9)(2012-12#17)(2012-2#19)(2012-3#14)(2013-1#23)(2013-7#9)(2013-8#6)
estimates a##2##2##(2007-11#1)(2011-2#1)
estimates also##2##2##(1997-3#1)(2012-2#1)
estimates and##10##2##(1991-12#1)(1992-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
estimates are used to##2##4##(1994-2#1)(1995-1#1)
estimates are used##4##3##(1994-2#1)(1995-1#1)(2008-3#1)(2008-9#1)
estimates are##20##2##(1991-3#1)(1991-6#1)(1992-6#2)(1992-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(1997-3#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
estimates at##2##2##(1997-3#1)(2008-3#1)
estimates based on a##2##4##(2008-3#1)(2008-8#1)
estimates based on##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
estimates between##3##2##(2008-10#2)(2010-8#1)
estimates by##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
estimates can be##4##3##(1992-6#2)(1995-12#1)(2008-8#1)
estimates can##5##2##(1992-3#1)(1992-6#2)(1995-12#1)(2008-8#1)
estimates derived from##4##3##(1995-9#1)(1997-2#1)(2008-10#2)
estimates for the##5##3##(1991-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)
estimates for##23##2##(1991-5#1)(1993-9#1)(1994-2#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2011-2#4)
estimates from##9##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-1#1)
estimates in a##2##3##(2007-11#1)(2008-9#1)
estimates in##3##2##(1995-2#1)(2007-11#1)(2008-9#1)
estimates indicate##2##2##(2008-1#1)(2008-3#1)
estimates is##4##2##(1991-2#1)(1992-9#1)(2008-2#2)
estimates may be##2##3##(1997-2#1)(2008-8#1)
estimates obtained by##2##3##(1996-8#1)(2008-4#1)
estimates obtained##4##2##(1993-3#1)(1996-8#1)(2008-10#1)(2008-4#1)
estimates of a and##2##4##(2008-2#1)(2008-3#1)
estimates of a##4##3##(1997-3#1)(2008-2#1)(2008-3#1)(2010-2#1)
estimates of a(z)##2##3##(2008-3#2)
estimates of both##2##3##(1992-5#1)(2010-4#1)
estimates of delta##2##3##(1992-5#1)(1995-2#1)
estimates of disease##2##3##(1992-9#1)(2008-10#1)
estimates of expenditures##2##3##(1995-2#1)(1997-1#1)
estimates of health##2##3##(1991-2#1)(1992-12#1)
estimates of inoculum##2##3##(2008-10#2)
estimates of insulin secretory function##2##5##(2010-10#2)
estimates of linear##2##3##(2008-12#1)(2008-8#1)
estimates of net##2##3##(1992-3#1)(2011-2#1)
estimates of selection and##2##4##(2008-8#2)
estimates of selection##5##3##(2008-8#4)(2010-4#1)
estimates of the attributable fraction##2##5##(1994-11#2)
estimates of the optical##2##4##(2008-2#1)(2008-3#1)
estimates of the probability of##2##5##(1992-9#1)(2012-3#1)
estimates of the strength of selection##2##6##(2008-8#1)(2010-4#1)
estimates of the##57##3##(1990-11#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#2)(2007-10#1)(2008-10#8)(2008-12#1)(2008-2#6)(2008-3#8)(2008-6#1)(2008-8#4)(2008-9#4)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
estimates of##179##2##(1990-11#1)(1990-8#1)(1991-2#4)(1991-3#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-9#4)(1993-3#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#3)(2007-10#1)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#18)(2008-4#1)(2008-6#1)(2008-8#15)(2008-9#10)(2009-5#3)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-7#2)(2013-1#3)(2013-3#1)(2013-7#1)
estimates on the##2##3##(1992-12#1)(1995-12#1)
estimates on##4##2##(1991-2#1)(1992-12#1)(1995-12#1)(1996-7#1)
estimates presented in##2##3##(1992-3#2)
estimates presented##3##2##(1992-3#3)
estimates reported##2##2##(2010-10#1)(2011-3#1)
estimates show that##2##3##(2008-8#2)
estimates show##3##2##(2008-3#1)(2008-8#2)
estimates that##8##2##(1990-2#1)(1992-9#1)(1993-12#1)(1994-9#2)(1996-3#1)(1996-4#1)(2008-10#1)
estimates the trajectory of##2##4##(2008-3#2)
estimates the##15##2##(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-2#3)(2008-3#4)(2010-1#1)(2010-6#1)(2011-2#1)(2013-8#1)
estimates to##3##2##(2008-10#1)(2010-3#1)(2013-7#1)
estimates under##2##2##(1992-6#1)(1995-2#1)
estimates using##2##2##(2008-10#1)(2010-8#1)
estimates vary##3##2##(1995-6#1)(2006-10#1)(2008-12#1)
estimates were 0##2##3##(2008-10#1)(2010-3#1)
estimates were comparable to those##2##5##(2008-10#1)(2008-8#1)
estimates were made##2##3##(1991-3#1)(2010-10#1)
estimates were obtained##2##3##(1996-9#1)(2013-7#1)
estimates were used to##3##4##(1990-9#1)(2008-10#2)
estimates were##21##2##(1990-9#1)(1991-3#1)(1991-6#1)(1993-1#1)(1996-9#1)(1997-3#1)(2008-10#8)(2008-3#1)(2008-8#3)(2010-10#1)(2010-3#1)(2013-7#1)
estimates when##2##2##(2009-10#1)(2010-2#1)
estimates with##4##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-3#1)
estimates##490##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#6)(1991-3#3)(1991-5#1)(1991-6#3)(1992-12#3)(1992-2#2)(1992-3#8)(1992-5#2)(1992-6#11)(1992-9#8)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-9#4)(1994-11#7)(1994-12#1)(1994-2#8)(1994-3#1)(1994-6#1)(1994-9#8)(1995-1#3)(1995-12#4)(1995-2#7)(1995-3#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#4)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#8)(1997-3#14)(1997-4#1)(1997-7#3)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#65)(2008-11#5)(2008-12#4)(2008-2#17)(2008-3#38)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#29)(2008-9#17)(2009-10#3)(2009-11#1)(2009-5#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#5)(2010-2#2)(2010-3#7)(2010-4#5)(2010-5#2)(2010-6#1)(2010-8#5)(2011-1#19)(2011-2#24)(2011-3#1)(2012-1#14)(2012-12#5)(2012-2#5)(2012-3#3)(2012-7#3)(2013-1#5)(2013-3#1)(2013-7#5)(2013-8#2)
estimating R(rs)##2##2##(2008-3#2)
estimating a##7##2##(1994-2#1)(1994-3#1)(1995-9#1)(1996-12#2)(1997-7#1)(2008-2#1)
estimating equation##6##2##(1994-2#1)(1995-2#1)(1995-9#1)(2009-5#1)(2012-12#2)
estimating equations##5##2##(1995-2#1)(1997-4#1)(1997-8#1)(2008-4#1)(2011-2#1)
estimating methodologies##2##2##(1997-1#1)(2008-7#1)
estimating recruitment##2##2##(2010-8#2)
estimating the equilibrium##2##3##(2008-10#1)(2008-2#1)
estimating the prevalence##2##3##(1995-12#1)(2009-10#1)
estimating the quantity##2##3##(1992-3#1)(2008-10#1)
estimating the risk of##2##4##(2011-2#1)(2012-12#1)
estimating the spectral reflectance of art paintings##2##7##(2008-3#2)
estimating the##68##2##(1991-11#1)(1991-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#17)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
estimating variables##2##2##(2008-10#1)(2008-11#1)
estimating##157##1##(1991-11#1)(1991-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#4)(1996-12#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#27)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-9#3)(2010-1#2)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#7)(2013-3#1)(2013-8#2)
estimation accuracy##2##2##(2013-8#2)
estimation after##2##2##(1992-6#1)(2008-10#1)
estimation algorithm##3##2##(2008-3#1)(2012-2#2)
estimation and prediction##2##3##(2008-10#1)(2009-11#1)
estimation and the##2##3##(1994-9#1)(2008-1#1)
estimation and##15##2##(1994-9#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#4)
estimation approach##2##2##(2008-6#1)(2009-9#1)
estimation are##2##2##(1995-9#1)(2008-10#1)
estimation as well as##2##4##(2008-10#1)(2008-7#1)
estimation at##2##2##(2008-2#1)(2012-2#1)
estimation by use of##2##4##(2008-2#1)(2008-3#1)
estimation by##6##2##(2008-2#2)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
estimation for##4##2##(2008-3#2)(2008-7#1)(2009-10#1)
estimation from##4##2##(1992-6#1)(2007-12#1)(2008-2#1)(2012-7#1)
estimation in##6##2##(1990-3#1)(2008-10#2)(2008-3#2)(2008-9#1)
estimation is##6##2##(2008-10#1)(2008-3#3)(2008-7#1)(2013-8#1)
estimation method##4##2##(1997-3#2)(2008-3#1)(2010-8#1)
estimation methods##3##2##(1992-6#1)(1994-2#1)(2008-10#1)
estimation model##2##2##(2008-3#1)(2013-8#1)
estimation of a##4##3##(2008-10#1)(2008-3#1)(2009-2#1)(2012-2#1)
estimation of acetaminophen##3##3##(2008-10#3)
estimation of binding parameters##3##4##(2008-10#3)
estimation of catechol##2##3##(2008-10#2)
estimation of central location##2##4##(2008-10#2)
estimation of conditional##2##3##(2008-10#2)
estimation of intensity and pleasantness##2##5##(2012-12#2)
estimation of intensity##4##3##(2012-12#4)
estimation of metformin hydrochloride##2##4##(2010-5#2)
estimation of norfloxacin and ornidazole in tablet dosage form##2##9##(2010-5#2)
estimation of plasma##2##3##(2008-3#1)(2008-7#1)
estimation of the activity coefficients of the##2##7##(2008-10#2)
estimation of the activity coefficients##3##5##(2008-10#3)
estimation of the impurity profile of##2##6##(2008-10#2)
estimation of the incidence##2##4##(2007-12#1)(2008-10#1)
estimation of the intracellular##2##4##(1990-7#1)(1992-12#1)
estimation of the local slopes##2##5##(2007-12#1)(2008-3#1)
estimation of the measurement uncertainty of##2##6##(2008-10#2)
estimation of the parameters##2##4##(1992-6#1)(2008-8#1)
estimation of the##77##3##(1990-7#1)(1992-12#2)(1992-6#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-9#2)(1996-9#2)(1997-3#1)(2007-11#4)(2007-12#3)(2008-10#24)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
estimation of vast covariance##2##4##(2012-12#1)(2013-1#1)
estimation of##218##2##(1990-7#1)(1990-8#1)(1992-12#2)(1992-6#2)(1992-9#1)(1993-2#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-6#2)(1995-9#2)(1996-9#2)(1997-3#2)(1997-4#1)(2007-11#6)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#72)(2008-11#5)(2008-12#3)(2008-2#12)(2008-3#22)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#4)(2010-5#7)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)
estimation on the female sternum##2##5##(1995-6#2)
estimation procedure for##2##3##(2008-6#1)(2010-1#1)
estimation procedure is##2##3##(2008-6#1)(2010-11#1)
estimation procedure##7##2##(1997-3#1)(2008-6#2)(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#1)
estimation procedures##4##2##(1997-7#1)(2007-12#1)(2012-3#2)
estimation schemes##4##2##(2008-3#1)(2010-12#3)
estimation techniques##2##2##(1994-11#1)(2008-10#1)
estimation trial for counterbalance order I (p &lt##2##8##(2013-8#2)
estimation trial##3##2##(2013-8#3)
estimation using##3##2##(1997-4#1)(2012-12#1)(2013-8#1)
estimation was##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
estimation window##3##2##(2007-12#3)
estimation with##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
estimation##390##1##(1990-3#2)(1990-7#1)(1990-8#1)(1992-12#2)(1992-6#5)(1992-9#1)(1993-2#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-6#4)(1995-9#3)(1996-12#1)(1996-9#2)(1997-3#6)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#11)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#97)(2008-11#5)(2008-12#3)(2008-2#23)(2008-3#57)(2008-4#2)(2008-5#3)(2008-6#9)(2008-7#9)(2008-8#2)(2008-9#3)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#5)(2010-5#9)(2010-6#2)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#12)(2012-2#14)(2012-3#9)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#14)
estimations are##3##2##(2008-10#1)(2008-3#2)
estimations in the##2##3##(2008-12#1)(2013-1#1)
estimations of the##2##3##(2008-2#1)(2013-8#1)
estimations of##9##2##(1990-5#1)(1994-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
estimations show##2##2##(2008-10#1)(2011-2#1)
estimations##28##1##(1990-5#1)(1994-10#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
estimator and##3##2##(1997-3#1)(2008-10#2)
estimator based on##2##3##(1992-6#1)(1997-7#1)
estimator for the##3##3##(1995-12#1)(2008-7#1)(2012-1#1)
estimator for##4##2##(1995-12#1)(2008-7#1)(2012-1#2)
estimator is##10##2##(1997-4#1)(1997-7#3)(2008-10#1)(2008-3#2)(2009-10#1)(2010-3#1)(2011-2#1)
estimator of the##7##3##(1995-2#1)(1996-3#1)(2008-10#2)(2010-3#2)(2012-12#1)
estimator of##13##2##(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-10#4)(2010-3#3)(2012-12#1)(2012-3#1)
estimator##54##1##(1992-6#2)(1992-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#3)(1997-4#2)(1997-7#4)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-7#1)(2009-10#3)(2010-3#8)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#4)
estimators are##5##2##(1997-7#1)(2008-2#1)(2008-6#1)(2010-11#1)(2010-3#1)
estimators of the##4##3##(1995-9#1)(2008-10#1)(2009-5#2)
estimators of##7##2##(1995-9#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-5#2)(2012-12#1)
estimators##37##1##(1991-6#1)(1992-6#2)(1995-9#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#3)(2008-10#5)(2008-2#3)(2008-6#1)(2008-7#6)(2009-10#1)(2009-5#2)(2010-11#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#3)
estradiol (E2)##7##2##(1993-1#1)(1994-9#2)(1995-12#1)(2008-10#1)(2008-5#1)(2010-5#1)
estradiol addition##2##2##(2008-11#2)
estradiol and progesterone##2##3##(2008-12#2)
estradiol and##14##2##(1990-11#1)(1991-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1994-5#2)(2008-10#1)(2008-12#2)(2012-3#1)(2013-1#1)
estradiol in##2##2##(2008-10#1)(2008-5#1)
estradiol is##2##2##(1994-3#1)(2008-11#1)
estradiol levels##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
estradiol or##3##2##(1992-5#1)(1993-5#1)(2008-6#1)
estradiol plus keoxifene##3##3##(1992-5#3)
estradiol plus##6##2##(1992-5#6)
estradiol receptor bindings##2##3##(1992-3#2)
estradiol receptor##3##2##(1992-3#3)
estradiol##67##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-3#1)(1992-3#8)(1992-4#1)(1992-5#9)(1993-1#1)(1993-5#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(2008-10#6)(2008-11#11)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#1)(2009-7#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
estradiol-17 beta##7##2##(1990-11#1)(1992-9#1)(1994-3#2)(1995-12#1)(1996-2#1)(2008-1#1)
estradiol-17beta##2##1##(2008-7#2)
estradiol-induced##2##1##(1992-5#1)(1994-3#1)
estradiol-treated##2##1##(1992-5#1)(2008-8#1)
estrangement##2##1##(2008-6#2)
estriol in##2##2##(2008-10#2)
estriol##9##1##(2008-10#6)(2008-11#3)
estrogen (ER) and progesterone##2##4##(1991-12#1)(2013-8#1)
estrogen and progesterone receptors##4##4##(1991-12#1)(1993-9#1)(1994-2#1)(2013-8#1)
estrogen and progesterone##9##3##(1991-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(2007-10#2)(2008-7#1)(2013-8#2)
estrogen and##15##2##(1991-12#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2013-8#2)
estrogen can##2##2##(2008-7#1)(2009-4#1)
estrogen concentrations##3##2##(2013-1#3)
estrogen could##2##2##(2010-5#2)
estrogen deficiency##2##2##(2008-3#1)(2011-2#1)
estrogen directly##2##2##(2008-11#2)
estrogen in##11##2##(1992-9#2)(1995-9#1)(2007-10#2)(2008-10#1)(2008-11#2)(2008-7#2)(2010-6#1)
estrogen levels##2##2##(2008-10#1)(2008-11#1)
estrogen receptive neurons##2##3##(1992-3#2)
estrogen receptor (ER) and progesterone receptor##2##6##(1997-7#1)(2011-2#1)
estrogen receptor (ER) and##4##4##(1995-4#1)(1997-7#1)(2008-11#1)(2011-2#1)
estrogen receptor (ER)##14##3##(1990-11#1)(1990-12#1)(1992-6#1)(1993-1#2)(1994-12#1)(1995-2#1)(1995-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
estrogen receptor (ER)-positive##2##3##(1993-9#1)(2011-2#1)
estrogen receptor alpha##4##3##(2008-11#1)(2008-12#2)(2011-2#1)
estrogen receptor antagonist##3##3##(2007-10#1)(2008-11#1)(2013-1#1)
estrogen receptor content##3##3##(1993-1#1)(2008-11#2)
estrogen receptor contents##3##3##(2008-11#3)
estrogen receptor gene##3##3##(1992-3#2)(1992-9#1)
estrogen receptor in##3##3##(1994-12#2)(2013-1#1)
estrogen receptor modulators##2##3##(2008-10#1)(2008-4#1)
estrogen receptor status##3##3##(1993-11#1)(1994-7#1)(1995-4#1)
estrogen receptor##85##2##(1990-11#2)(1990-12#1)(1990-5#2)(1991-2#2)(1992-10#2)(1992-3#3)(1992-6#2)(1992-9#2)(1993-1#3)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#9)(1994-7#1)(1995-11#2)(1995-2#2)(1995-4#2)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#23)(2008-12#2)(2008-4#2)(2008-6#1)(2010-5#2)(2011-1#2)(2011-2#3)(2013-1#3)
estrogen receptor-dependent pathway##2##3##(2013-1#2)
estrogen receptor-negative##2##2##(1997-7#1)(2011-1#1)
estrogen receptor-positive##4##2##(1992-4#1)(1997-7#1)(2008-11#1)(2011-1#1)
estrogen receptors (ER)##2##3##(2012-2#1)(2013-8#1)
estrogen receptors (ERs)##2##3##(1997-7#1)(2008-4#1)
estrogen receptors in the##2##4##(1994-9#1)(2007-10#1)
estrogen receptors in##3##3##(1994-9#1)(2007-10#2)
estrogen receptors##12##2##(1994-9#1)(1997-7#1)(2007-10#2)(2008-11#4)(2008-4#2)(2012-2#1)(2013-8#1)
estrogen regulation##2##2##(1990-5#1)(1994-8#1)
estrogen replacement therapy##3##3##(1993-11#1)(2007-7#1)(2011-2#1)
estrogen responsive##4##2##(1997-7#1)(2008-10#2)(2011-2#1)
estrogen responsiveness of##3##3##(1990-5#1)(1991-2#2)
estrogen responsiveness##4##2##(1990-5#1)(1991-2#3)
estrogen stimulated##3##2##(2008-11#3)
estrogen stimulation of##2##3##(1996-5#1)(2008-11#1)
estrogen therapy##4##2##(1994-9#1)(2007-10#1)(2008-4#1)(2008-7#1)
estrogen treatment##3##2##(1992-9#1)(1993-6#1)(1994-3#1)
estrogen##264##1##(1990-11#2)(1990-12#1)(1990-5#6)(1991-12#3)(1991-2#7)(1991-5#1)(1992-10#2)(1992-3#7)(1992-4#1)(1992-6#4)(1992-9#8)(1993-1#5)(1993-11#4)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#5)(1994-12#9)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#6)(1995-11#4)(1995-12#1)(1995-2#2)(1995-4#4)(1995-9#1)(1996-5#3)(1997-6#2)(1997-7#7)(2007-10#12)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#57)(2008-12#3)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#8)(2008-7#8)(2009-4#2)(2010-5#4)(2010-6#1)(2011-1#4)(2011-2#8)(2012-2#1)(2013-1#12)(2013-8#4)
estrogen-induced##7##1##(1992-5#2)(1994-9#2)(2007-10#1)(2008-11#1)(2009-4#1)
estrogen-mediated##2##1##(1992-3#1)(2007-10#1)
estrogen-modulated##2##1##(1990-8#1)(1992-9#1)
estrogen-regulated##2##1##(1992-6#1)(2011-2#1)
estrogen-responsive genes##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
estrogen-responsive##5##1##(1993-6#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#1)
estrogen-sensitive##3##1##(1992-3#1)(2009-4#2)
estrogenic activity##2##2##(2008-11#1)(2008-6#1)
estrogenic and##2##2##(1994-9#1)(2011-1#1)
estrogenic effect##2##2##(1991-3#1)(2012-3#1)
estrogenic effects##2##2##(2008-10#1)(2013-1#1)
estrogenic potency of dietary##3##4##(2008-10#3)
estrogenic potency##5##2##(2008-10#5)
estrogenic##31##1##(1991-3#1)(1994-8#1)(1994-9#1)(2008-10#11)(2008-11#5)(2008-6#1)(2010-5#5)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
estrogenicity and##2##2##(2008-10#1)(2008-4#1)
estrogenicity of##2##2##(2008-10#1)(2013-1#1)
estrogenicity##9##1##(2008-10#7)(2008-4#1)(2013-1#1)
estrogens and androgens##3##3##(2008-11#1)(2009-4#1)(2012-3#1)
estrogens and the##3##3##(1995-12#1)(2008-4#1)(2012-1#1)
estrogens and##9##2##(1993-11#1)(1994-8#1)(1995-12#1)(2008-11#2)(2008-4#1)(2009-4#1)(2012-1#1)(2012-3#1)
estrogens in##9##2##(1990-5#2)(1995-12#1)(1996-5#1)(2008-10#2)(2008-12#2)(2012-2#1)
estrogens play##2##2##(2008-4#1)(2009-7#1)
estrogens was##2##2##(1996-5#1)(2008-10#1)
estrogens##55##1##(1990-5#2)(1993-11#2)(1994-8#1)(1994-9#1)(1995-12#3)(1996-11#1)(1996-5#5)(1997-7#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#6)(2009-4#2)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#3)
estrone (E1)##2##2##(2008-10#1)(2013-1#1)
estrone as##2##2##(2008-10#2)
estrone##17##1##(1990-11#1)(1995-8#2)(1996-5#1)(2008-1#1)(2008-10#11)(2013-1#1)
estrous cycle##6##2##(1992-9#2)(1993-11#2)(2008-5#1)(2008-8#1)
estrous cycles##3##2##(1992-9#1)(1994-6#1)(2010-10#1)
estrous##11##1##(1992-9#3)(1993-11#2)(1994-6#1)(2008-12#2)(2008-5#1)(2008-8#1)(2010-10#1)
estrus response was##2##3##(2008-12#2)
estrus response##3##2##(2008-12#3)
estrus##18##1##(1992-9#2)(1993-11#2)(1996-12#1)(2008-12#6)(2008-8#1)(2013-1#6)
estuaries and##2##2##(2008-10#1)(2012-5#1)
estuaries##10##1##(1992-8#4)(2008-10#2)(2010-8#3)(2012-5#1)
estuarine and seawater##3##3##(2008-10#3)
estuarine and##9##2##(2008-10#6)(2013-1#1)(2013-7#2)
estuarine fish##2##2##(1992-8#1)(2010-8#1)
estuarine sediments##3##2##(2008-10#3)
estuarine##27##1##(1992-8#1)(2008-10#18)(2010-8#1)(2013-1#4)(2013-7#3)
estuary and##2##2##(2008-10#2)
estuary##18##1##(2008-10#5)(2008-5#3)(2010-5#3)(2010-8#1)(2013-1#6)
et Mor##2##2##(2008-8#2)
et al reported##2##3##(1990-9#1)(2011-1#1)
et al##470##2##(1990-11#9)(1990-12#3)(1990-2#2)(1990-5#13)(1990-7#2)(1990-8#11)(1990-9#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-5#3)(1991-6#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#9)(1993-3#6)(1993-6#2)(1993-8#6)(1993-9#3)(1994-11#3)(1994-12#8)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#15)(1997-3#9)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-4#2)(2007-11#4)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#33)(2008-12#7)(2008-2#9)(2008-3#17)(2008-4#9)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#13)(2009-10#2)(2009-2#2)(2009-3#13)(2009-4#1)(2009-5#5)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-2#2)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#5)(2011-2#41)(2012-12#8)(2012-3#9)(2013-1#9)(2013-8#6)
et aux##2##2##(2008-11#1)(2013-1#1)
et de la##4##3##(2011-2#1)(2013-1#3)
et de son##2##3##(2013-1#2)
et de##16##2##(2008-11#1)(2008-5#2)(2009-10#1)(2009-4#2)(2011-2#3)(2013-1#7)
et des##3##2##(2008-11#2)(2008-5#1)
et en##2##2##(2008-5#1)(2009-4#1)
et grossesse est rare##2##4##(2011-2#1)(2013-1#1)
et grossesse est##3##3##(2011-2#1)(2013-1#2)
et la mise en place d'un timbre##2##7##(2013-1#2)
et la##7##2##(2008-5#1)(2011-2#2)(2013-1#4)
et le##7##2##(2008-11#1)(2008-5#2)(2013-1#4)
et les##7##2##(1990-6#1)(2008-5#2)(2011-2#2)(2013-1#2)
et par##2##2##(2008-5#1)(2013-1#1)
et thérapeutique##2##2##(2013-1#2)
et une##4##2##(2008-11#1)(2013-1#3)
et##592##1##(1990-11#9)(1990-12#4)(1990-2#2)(1990-5#13)(1990-6#1)(1990-7#2)(1990-8#11)(1990-9#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-5#3)(1991-6#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#9)(1993-3#6)(1993-6#2)(1993-8#6)(1993-9#3)(1994-11#3)(1994-12#8)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#15)(1997-3#9)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-4#2)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#22)(2008-11#40)(2008-12#7)(2008-2#9)(2008-3#18)(2008-4#9)(2008-5#37)(2008-6#4)(2008-7#6)(2008-8#9)(2008-9#13)(2009-10#6)(2009-2#2)(2009-3#13)(2009-4#6)(2009-5#5)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-2#2)(2010-4#3)(2010-5#3)(2010-9#1)(2011-1#11)(2011-2#58)(2012-12#8)(2012-2#1)(2012-3#9)(2013-1#56)(2013-8#6)
eta of##2##2##(2008-10#2)
eta##11##1##(1992-8#1)(1994-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)
eta(h)##4##1##(2008-3#4)
eta(s)##2##1##(2008-3#2)
etalon aperture##5##2##(2008-2#3)(2008-3#2)
etalon as##2##2##(2007-11#1)(2008-3#1)
etalon effects##2##2##(2008-3#2)
etalon filters##2##2##(2008-3#2)
etalon for##3##2##(2007-11#2)(2008-3#1)
etalon into the##3##3##(2007-11#1)(2008-2#2)
etalon parameters##2##2##(2008-2#1)(2008-3#1)
etalon with##2##2##(2008-2#1)(2008-3#1)
etalon##54##1##(2007-11#10)(2007-12#4)(2008-2#12)(2008-3#28)
etalon-based##2##1##(2008-3#2)
etalons for##2##2##(2008-2#1)(2008-3#1)
etalons##14##1##(2007-11#1)(2008-2#3)(2008-3#10)
etanercept##5##1##(2006-10#1)(2008-8#3)(2012-1#1)
etc are##2##2##(2010-8#1)(2011-2#1)
etc##212##1##(1990-2#3)(1990-4#1)(1990-8#1)(1990-9#3)(1991-3#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#4)(1995-12#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#61)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#4)
etc)##11##1##(2007-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#3)
etch process##2##2##(2008-2#1)(2009-11#1)
etch##9##1##(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#2)
etched by##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
etched capillaries##2##2##(1997-2#2)
etched in a##2##3##(2007-11#1)(2008-2#1)
etched in##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
etched into##3##2##(2008-2#1)(2008-3#2)
etched##32##1##(1997-2#3)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#10)(2008-5#2)(2013-1#1)
etching and application of##2##4##(2008-12#2)
etching and##6##2##(2008-12#2)(2008-3#2)(2009-7#1)(2013-1#1)
etching are##3##2##(2007-11#2)(2007-12#1)
etching depth##4##2##(2008-2#2)(2008-3#2)
etching in##2##2##(2007-12#1)(2008-3#1)
etching of silicon##2##3##(2008-10#2)
etching of the##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
etching of##9##2##(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#1)
etching process##3##2##(1997-2#1)(2008-10#2)
etching processes##2##2##(2008-2#1)(2008-3#1)
etching rate##3##2##(2008-2#2)(2008-3#1)
etching solution##4##2##(2008-10#4)
etching the##3##2##(1997-2#1)(2008-3#2)
etching time##3##2##(2009-11#1)(2013-1#2)
etching##81##1##(1997-2#2)(2007-11#6)(2007-12#4)(2008-10#15)(2008-12#4)(2008-2#17)(2008-3#23)(2008-7#1)(2009-11#3)(2009-7#2)(2013-1#4)
ethacrynic acid##3##2##(1994-8#2)(2013-7#1)
ethambutol##4##1##(1991-11#1)(2008-1#1)(2008-10#1)(2008-8#1)
ethane##5##1##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
ethanethiol##2##1##(2008-10#2)
ethanol abuse##2##2##(2008-6#1)(2013-8#1)
ethanol administration##2##2##(1993-6#1)(2011-2#1)
ethanol after##2##2##(2008-10#1)(2013-8#1)
ethanol and Na2SO4##2##3##(2008-6#2)
ethanol and acetone##3##3##(2008-10#2)(2010-3#1)
ethanol and aqueous##2##3##(2012-2#2)
ethanol and methanol in plasma##2##5##(1991-5#2)
ethanol and methanol were##2##4##(1995-2#1)(2007-11#1)
ethanol and methanol##5##3##(1991-5#2)(1995-2#2)(2007-11#1)
ethanol and other##2##3##(2008-10#1)(2008-6#1)
ethanol and this##2##3##(2008-10#2)
ethanol and##47##2##(1990-11#1)(1991-1#1)(1991-5#3)(1992-7#1)(1994-7#2)(1995-2#2)(1995-5#1)(2007-11#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#4)(2009-12#2)(2010-3#1)(2012-2#2)(2013-1#2)
ethanol as a##2##3##(1991-1#1)(2008-6#1)
ethanol as##3##2##(1991-1#1)(2008-10#1)(2008-6#1)
ethanol at room temperature##2##4##(2007-11#1)(2008-10#1)
ethanol at##6##2##(1992-7#1)(1994-8#2)(2007-11#1)(2008-10#2)
ethanol by##3##2##(2008-10#2)(2008-6#1)
ethanol can be##3##3##(2008-10#1)(2008-6#2)
ethanol concentration between##2##3##(1990-12#1)(2008-10#1)
ethanol concentration##8##2##(1990-12#1)(1997-2#1)(2008-10#4)(2008-7#1)(2011-2#1)
ethanol concentrations and##2##3##(2008-11#1)(2008-6#1)
ethanol concentrations in##2##3##(1991-1#1)(2008-11#1)
ethanol concentrations##5##2##(1991-1#1)(2008-11#3)(2008-6#1)
ethanol consumption##5##2##(1992-1#1)(1996-2#2)(2011-2#2)
ethanol containing 0##2##3##(2008-9#2)
ethanol containing##3##2##(2008-10#1)(2008-9#2)
ethanol content##3##2##(2008-10#3)
ethanol exposure##6##2##(1991-1#1)(2009-12#2)(2011-2#3)
ethanol extract of Plectranthus amboinicus exhibited##2##6##(2012-2#2)
ethanol extract of Plectranthus amboinicus showed##2##6##(2012-2#2)
ethanol extract of Plectranthus amboinicus##8##5##(2012-2#8)
ethanol extract of noni##2##4##(2008-10#2)
ethanol extract of the##2##4##(2008-11#1)(2010-3#1)
ethanol extract of##19##3##(2008-10#4)(2008-11#1)(2010-3#2)(2010-5#1)(2011-3#1)(2012-2#9)(2013-7#1)
ethanol extract##21##2##(2008-10#5)(2008-11#1)(2010-3#2)(2010-5#1)(2011-3#1)(2012-2#9)(2013-7#1)(2013-8#1)
ethanol extracts##4##2##(2008-11#1)(2008-5#1)(2010-3#1)(2012-2#1)
ethanol fed rats##4##3##(1993-11#4)
ethanol fermentation##4##2##(2008-6#3)(2008-7#1)
ethanol fixation##2##2##(2008-11#1)(2008-9#1)
ethanol for##2##2##(1996-2#1)(2008-9#1)
ethanol from##11##2##(1997-7#2)(2008-10#2)(2008-6#5)(2011-2#2)
ethanol fuel##3##2##(2008-10#3)
ethanol has##2##2##(2008-10#1)(2008-6#1)
ethanol in a##2##3##(1997-7#1)(2008-10#1)
ethanol in all types of alcoholic beverages##2##7##(2008-10#2)
ethanol in different##2##3##(2008-10#2)
ethanol in the##7##3##(1993-12#1)(1997-2#1)(2008-10#3)(2009-10#1)(2011-2#1)
ethanol in##25##2##(1990-5#1)(1993-12#1)(1993-8#1)(1997-2#1)(1997-7#1)(2008-10#13)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
ethanol induced cell death##2##4##(2009-12#2)
ethanol induced##3##2##(2009-12#2)(2010-11#1)
ethanol ingestion##2##2##(1994-7#1)(2008-6#1)
ethanol injection##5##2##(1994-6#1)(1997-7#1)(2009-7#1)(2013-8#2)
ethanol is##5##2##(2008-10#3)(2008-6#1)(2010-5#1)
ethanol levels in##2##3##(2008-11#2)
ethanol levels##3##2##(2008-11#3)
ethanol metabolism is##2##3##(1992-6#2)
ethanol metabolism##4##2##(1992-6#3)(2008-11#1)
ethanol mixture##2##2##(2008-10#2)
ethanol on##6##2##(1992-6#1)(1992-7#1)(1994-9#1)(2008-10#1)(2008-7#1)(2009-7#1)
ethanol or##6##2##(1991-5#1)(1994-8#1)(2008-10#3)(2008-8#1)
ethanol orally##2##2##(2008-11#2)
ethanol poisoning##2##2##(1994-6#1)(2012-12#1)
ethanol precipitation##4##2##(1990-2#1)(2008-11#3)
ethanol production from##4##3##(2008-6#3)(2011-1#1)
ethanol production##12##2##(2008-6#8)(2011-1#2)(2013-1#2)
ethanol productivity##2##2##(2008-6#1)(2013-1#1)
ethanol reinforcement mechanisms##2##3##(2009-7#2)
ethanol reinforcement##3##2##(2009-7#3)
ethanol response##2##2##(2012-3#2)
ethanol solution##4##2##(2008-10#4)
ethanol solutions##2##2##(2008-10#1)(2008-3#1)
ethanol than##3##2##(1992-7#1)(1997-7#1)(2009-12#1)
ethanol to##5##2##(1990-12#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
ethanol using##2##2##(2008-6#1)(2013-1#1)
ethanol was##7##2##(1990-2#1)(1991-5#1)(1997-7#1)(2008-10#2)(2008-7#1)(2011-1#1)
ethanol were##6##2##(1991-5#1)(2008-10#5)
ethanol yield##4##2##(2008-6#3)(2013-1#1)
ethanol##487##1##(1990-11#2)(1990-12#7)(1990-2#2)(1990-5#1)(1991-1#8)(1991-2#1)(1991-5#7)(1992-1#1)(1992-6#9)(1992-7#8)(1993-11#4)(1993-12#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-5#2)(1994-6#4)(1994-7#4)(1994-8#3)(1994-9#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-2#6)(1997-1#2)(1997-2#3)(1997-7#13)(1997-8#2)(2006-10#1)(2007-11#4)(2008-10#145)(2008-11#23)(2008-12#4)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#55)(2008-7#10)(2008-8#5)(2008-9#12)(2009-10#2)(2009-12#8)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#1)(2010-11#1)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#8)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#12)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#11)
ethanol's motor impairment##3##3##(1997-2#3)
ethanol's##5##1##(1997-2#4)(2009-7#1)
ethanol) was##2##2##(1995-6#1)(2007-12#1)
ethanol)##7##1##(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#4)
ethanol-induced liver##2##2##(1994-7#1)(2009-8#1)
ethanol-induced motor incoordination##7##3##(1997-2#7)
ethanol-induced motor##11##2##(1997-2#11)
ethanol-induced oxidative##2##2##(1994-6#1)(2009-8#1)
ethanol-induced##23##1##(1992-6#1)(1994-5#1)(1994-6#1)(1994-7#1)(1997-2#11)(2009-7#1)(2009-8#3)(2012-3#3)(2013-8#1)
ethanol-precipitated##3##1##(2008-10#2)(2013-1#1)
ethanol-water mixtures##3##2##(1996-5#1)(2011-2#2)
ethanol-water solution##2##2##(2008-10#2)
ethanol-water##12##1##(1996-5#2)(2008-10#4)(2008-5#1)(2011-2#3)(2013-1#2)
ethanol/water and##2##2##(2008-10#1)(2009-9#1)
ethanol/water##7##1##(2008-10#2)(2008-9#1)(2009-9#4)
ethanolamine##6##1##(1991-11#1)(1992-3#1)(2008-10#2)(2008-7#1)(2010-3#1)
ethanolaminephosphate cytidylyltransferase##2##2##(1991-11#2)
ethanolic extract of Lemon verbena##5##5##(2008-12#5)
ethanolic extract of defatted C##2##5##(2008-10#2)
ethanolic extract of seeds of Moringa oleifera##2##7##(2008-10#2)
ethanolic extract of##17##3##(2008-10#5)(2008-12#5)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)
ethanolic extract was##2##3##(2008-10#2)
ethanolic extract##21##2##(2008-10#8)(2008-12#5)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)
ethanolic##36##1##(1990-12#1)(2008-10#15)(2008-12#5)(2008-5#3)(2008-6#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#4)
ethanolysis##4##1##(2008-10#4)
ethene##4##1##(2008-3#3)(2012-12#1)
ethenolysis##2##1##(2009-8#2)
ethenyl##2##1##(1992-11#1)(2007-11#1)
ethephon##6##1##(2006-11#3)(2008-10#1)(2011-1#2)
ether (18C6)##2##2##(2008-10#2)
ether (NPOE)##6##2##(2008-10#6)
ether (o-NPOE)##6##2##(2008-10#6)
ether analogue##2##2##(1994-8#2)
ether and##6##2##(1993-12#1)(2008-10#4)(2009-11#1)
ether as##4##2##(2008-10#4)
ether complex##2##2##(2008-10#2)
ether compounds##2##2##(2008-10#2)
ether extract##5##2##(1992-5#1)(2008-10#1)(2008-5#2)(2010-2#1)
ether extraction and##2##3##(2008-10#1)(2008-11#1)
ether extraction##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
ether extracts##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
ether from##2##2##(1990-8#1)(2008-10#1)
ether or##4##2##(1997-2#1)(2008-10#1)(2008-5#2)
ether to##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)
ether was found to##2##4##(2008-10#2)
ether was##3##2##(2008-10#3)
ether##147##1##(1990-8#1)(1991-12#1)(1992-5#1)(1993-12#2)(1994-2#1)(1994-8#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#5)(1997-2#1)(2007-11#2)(2008-10#85)(2008-11#3)(2008-12#6)(2008-2#2)(2008-5#13)(2008-7#1)(2009-11#1)(2009-12#4)(2009-8#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#4)
ether)##6##1##(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#2)
ether-type membrane##2##2##(2008-10#2)
ether-type polyurethane membrane##3##3##(2008-10#3)
ether-type##5##1##(2008-10#5)
etherify##2##1##(2013-1#2)
ethernet##2##1##(2007-11#1)(2008-3#1)
ethers and##4##2##(1992-3#1)(1994-12#1)(1996-5#1)(2008-10#1)
ethers as##2##2##(2008-10#2)
ethers for which the##2##4##(2008-10#2)
ethers for##3##2##(2008-10#3)
ethers using##2##2##(2008-10#2)
ethers with##2##2##(2008-10#1)(2009-8#1)
ethers##53##1##(1992-12#2)(1992-3#1)(1993-12#2)(1994-12#2)(1996-5#1)(2008-10#39)(2008-7#2)(2009-11#1)(2009-5#1)(2009-8#1)(2013-1#1)
ethic of##3##2##(1992-3#1)(1995-1#1)(2012-2#1)
ethic##9##1##(1992-2#1)(1992-3#3)(1994-2#1)(1995-1#1)(2008-11#1)(2012-2#2)
ethical and legal##3##3##(1997-2#1)(2008-11#1)(2008-12#1)
ethical and practical##4##3##(2008-11#1)(2010-3#3)
ethical and##14##2##(1994-11#1)(1997-2#1)(2007-2#1)(2008-11#3)(2008-12#1)(2009-7#1)(2010-3#4)(2011-2#1)(2013-8#1)
ethical aspects of the##3##4##(1991-3#1)(2008-11#1)(2012-2#1)
ethical aspects of##5##3##(1991-3#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
ethical aspects##6##2##(1991-3#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
ethical basis for##2##3##(1991-2#1)(1996-12#1)
ethical behavior in##3##3##(1996-12#1)(2008-12#2)
ethical behavior##4##2##(1996-12#1)(2008-1#1)(2008-12#2)
ethical challenges##4##2##(1996-2#1)(2011-1#2)(2012-2#1)
ethical concerns##3##2##(1995-1#1)(2008-11#1)(2008-12#1)
ethical conduct##3##2##(1995-12#1)(1996-12#1)(2012-2#1)
ethical considerations##5##2##(1996-2#1)(1996-6#2)(2008-11#1)(2008-7#1)
ethical decisions##3##2##(1992-3#1)(1995-12#1)(1995-5#1)
ethical dilemma##2##2##(2009-11#2)
ethical dilemmas##4##2##(1995-5#1)(2009-8#1)(2013-8#2)
ethical framework##2##2##(2012-2#1)(2013-8#1)
ethical guidelines##4##2##(1992-2#1)(1996-4#1)(2008-12#1)(2012-2#1)
ethical implications of##2##3##(1995-9#1)(2008-11#1)
ethical implications##4##2##(1995-9#1)(2008-11#1)(2008-12#1)(2008-9#1)
ethical issues and proposals for management##4##6##(2008-11#4)
ethical issues are##2##3##(2008-11#1)(2008-9#1)
ethical issues arising from##2##4##(2011-1#1)(2012-2#1)
ethical issues in##5##3##(1992-3#1)(2009-4#2)(2010-3#2)
ethical issues integral to nanobiotechnology##2##5##(2008-11#2)
ethical issues##29##2##(1992-3#1)(1994-12#2)(1995-1#1)(2007-7#1)(2008-1#1)(2008-11#11)(2008-9#3)(2009-4#2)(2010-3#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
ethical perspective##2##2##(2008-8#1)(2010-11#1)
ethical principle of##3##3##(1995-9#3)
ethical principles for##2##3##(1994-1#1)(2012-2#1)
ethical principles of##2##3##(2007-2#1)(2009-6#1)
ethical principles##9##2##(1994-1#1)(1994-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-2#2)(2013-1#1)
ethical problem##3##2##(1990-12#1)(2008-7#1)(2010-11#1)
ethical problems and##2##3##(1991-11#1)(1993-3#1)
ethical problems##5##2##(1991-11#1)(1991-3#1)(1993-3#1)(1995-1#1)(2013-1#1)
ethical questions##5##2##(1991-3#1)(1996-11#1)(2008-11#1)(2008-4#1)(2010-10#1)
ethical reasons##3##2##(2008-10#1)(2008-11#2)
ethical reflection##2##2##(2008-11#1)(2008-7#1)
ethical requirements##4##2##(1995-6#1)(2008-7#3)
ethical standards##3##2##(2008-4#1)(2009-6#1)(2011-2#1)
ethical##206##1##(1990-12#1)(1991-11#1)(1991-2#3)(1991-3#4)(1992-11#1)(1992-2#1)(1992-3#5)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-9#2)(1995-1#3)(1995-12#2)(1995-5#3)(1995-6#3)(1995-9#4)(1996-11#1)(1996-12#4)(1996-2#5)(1996-4#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#6)(2008-10#2)(2008-11#32)(2008-12#12)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#6)(2009-11#2)(2009-12#1)(2009-4#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#6)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#2)(2013-1#5)(2013-8#5)
ethical-social and legal aspects##2##4##(2011-2#2)
ethical/value##2##1##(1996-2#2)
ethically##9##1##(1991-3#1)(1992-3#1)(1995-5#1)(2008-9#1)(2009-6#1)(2010-11#2)(2011-2#2)
ethics and the##2##3##(1993-3#1)(2008-11#1)
ethics and##13##2##(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-1#1)(1997-6#1)(2007-3#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
ethics committee of the##2##4##(1993-1#1)(1997-5#1)
ethics committee##6##2##(1992-2#1)(1993-1#2)(1994-2#1)(1997-5#1)(2008-11#1)
ethics committees##10##2##(1992-2#2)(1993-1#1)(1995-1#1)(1996-11#3)(2009-6#1)(2010-3#1)(2011-2#1)
ethics education##2##2##(2013-8#2)
ethics for##2##2##(1994-1#1)(1994-3#1)
ethics in##6##2##(1991-3#1)(1994-3#2)(1996-12#1)(1997-8#1)(2011-3#1)
ethics of clinical##2##3##(1993-9#1)(1995-5#1)
ethics of##10##2##(1991-3#1)(1993-9#1)(1995-5#2)(1996-1#1)(1996-8#1)(2010-11#1)(2010-3#1)(2013-1#1)(2013-8#1)
ethics was not a major part of the curriculum##2##9##(1994-1#2)
ethics##107##1##(1991-1#1)(1991-12#2)(1991-3#3)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#4)(1992-5#1)(1993-1#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#6)(1994-2#1)(1994-3#3)(1995-1#3)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#9)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-3#2)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#9)
ethidium and##2##2##(1997-4#1)(2007-11#1)
ethidium bromide and##2##3##(1992-11#1)(2008-11#1)
ethidium bromide##12##2##(1990-2#2)(1990-7#1)(1992-11#1)(1993-12#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
ethidium##21##1##(1990-2#2)(1990-7#1)(1992-11#1)(1993-12#1)(1994-5#1)(1995-2#1)(1997-4#1)(2006-8#1)(2007-11#6)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-6#1)
ethinylestradiol +##2##2##(1994-5#2)
ethinylestradiol##9##1##(1994-5#2)(2008-10#2)(2011-3#5)
ethiology##3##1##(2008-10#1)(2008-11#1)(2013-7#1)
ethion and dichlorovos##2##3##(2008-10#2)
ethion and##3##2##(2008-10#3)
ethion##4##1##(2008-10#4)
ethiopathogenesis of##2##2##(2008-10#1)(2008-5#1)
ethiopathogenesis##3##1##(1997-8#1)(2008-10#1)(2008-5#1)
ethirimol##7##1##(2008-10#7)
ethmoid##5##1##(2008-11#1)(2011-2#3)(2013-1#1)
ethmoidal##3##1##(1996-5#1)(2006-12#1)(2011-2#1)
ethnic and##2##2##(1994-12#1)(2008-5#1)
ethnic background##2##2##(1991-12#1)(2010-1#1)
ethnic backgrounds##2##2##(1994-12#1)(2010-8#1)
ethnic belonging##2##2##(2009-7#2)
ethnic composition of school class##2##5##(2010-1#2)
ethnic composition of school##3##4##(2010-1#3)
ethnic composition of##5##3##(2009-5#1)(2010-1#4)
ethnic differences in##5##3##(2007-12#1)(2008-5#1)(2013-1#2)(2013-8#1)
ethnic differences##12##2##(2006-10#2)(2007-12#3)(2008-1#1)(2008-5#1)(2010-10#1)(2010-8#1)(2013-1#2)(2013-8#1)
ethnic disparities##5##2##(2008-1#1)(2011-2#3)(2012-3#1)
ethnic exploration and##2##3##(2009-7#2)
ethnic exploration##3##2##(2009-7#3)
ethnic group and##2##3##(2008-5#1)(2013-1#1)
ethnic group##15##2##(1997-8#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#2)(2013-1#1)
ethnic groups and##3##3##(1997-1#1)(2008-1#1)(2008-5#1)
ethnic groups in##5##3##(2008-1#1)(2008-9#2)(2012-12#2)
ethnic groups on##3##3##(2008-1#3)
ethnic groups##50##2##(1992-2#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-1#11)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-8#6)(2011-2#5)(2012-12#5)(2012-2#2)
ethnic identity##5##2##(2009-7#3)(2010-8#1)(2012-12#1)
ethnic minorities##10##2##(1990-6#1)(1997-5#1)(2008-10#1)(2008-8#5)(2009-5#1)(2010-4#1)
ethnic minority adolescents##2##3##(2010-1#2)
ethnic minority##5##2##(2009-7#1)(2010-1#2)(2011-1#1)(2012-2#1)
ethnic origin##4##2##(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
ethnic patients##2##2##(2010-8#2)
ethnic populations##11##2##(2008-8#1)(2010-8#6)(2011-1#3)(2012-12#1)
ethnic skin types##4##3##(2008-5#3)(2010-8#1)
ethnic skin##6##2##(2008-5#4)(2010-8#2)
ethnic specific##3##2##(2008-1#3)
ethnic##171##1##(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1994-12#2)(1995-2#1)(1997-1#1)(1997-5#1)(1997-8#2)(2006-10#2)(2007-12#4)(2008-1#18)(2008-10#8)(2008-12#4)(2008-3#2)(2008-5#17)(2008-7#2)(2008-8#9)(2008-9#5)(2009-10#2)(2009-5#4)(2009-7#11)(2010-1#8)(2010-10#2)(2010-4#1)(2010-8#26)(2011-1#4)(2011-2#12)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
ethnic/racial##2##1##(2009-7#1)(2010-2#1)
ethnically diverse sample of##4##4##(2009-7#2)(2010-1#2)
ethnically diverse sample##5##3##(2008-5#1)(2009-7#2)(2010-1#2)
ethnically diverse##12##2##(2008-12#1)(2008-5#1)(2009-7#2)(2009-9#1)(2010-1#3)(2011-2#1)(2012-3#2)(2013-7#1)
ethnically##16##1##(2008-1#1)(2008-12#1)(2008-5#1)(2009-7#2)(2009-9#1)(2010-1#5)(2010-8#1)(2011-2#1)(2012-3#2)(2013-7#1)
ethnically-diverse##2##1##(2008-12#1)(2009-4#1)
ethnicities##3##1##(2009-7#2)(2011-1#1)
ethnicity and##7##2##(2006-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#1)
ethnicity on##2##2##(2010-2#1)(2010-9#1)
ethnicity##37##1##(1996-11#1)(2006-10#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
ethno-epidemiological##2##1##(2008-1#2)
ethnocultural background##3##2##(2011-2#3)
ethnocultural communities##3##2##(1995-1#3)
ethnocultural##8##1##(1995-1#5)(2011-2#3)
ethnographic research##2##2##(2011-2#2)
ethnographic study##6##2##(1993-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-9#1)
ethnographic##16##1##(1993-1#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#4)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#3)
ethnography##8##1##(1997-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
ethological##4##1##(1995-6#1)(2008-9#1)(2011-2#2)
ethos of##2##2##(1995-9#1)(2009-3#1)
ethos##4##1##(1995-9#1)(1996-12#1)(2009-3#1)(2013-8#1)
ethosuximide##2##1##(1995-12#2)
ethoxylates##4##1##(2008-10#3)(2008-5#1)
ethoxyresorufin and##2##2##(1994-8#2)
ethoxyresorufin##6##1##(1993-12#1)(1994-8#4)(2008-11#1)
ethoxyresorufin-O-deethylase##2##1##(2008-11#1)(2008-7#1)
ethyl acetate and ethanol##2##4##(2008-10#2)
ethyl acetate and water fractions##2##5##(2008-10#2)
ethyl acetate and##7##3##(2008-10#7)
ethyl acetate as the##3##4##(2008-10#3)
ethyl acetate extract##2##3##(2010-2#1)(2011-1#1)
ethyl acetate##45##2##(1992-9#1)(1996-2#1)(2007-11#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
ethyl acetoacetate##2##2##(2008-11#1)(2012-3#1)
ethyl alcohol##8##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2011-1#1)
ethyl benzene and xylenes##2##4##(2008-10#2)
ethyl benzene and##3##3##(2008-10#3)
ethyl benzene##7##2##(2008-10#7)
ethyl beta-carboline-3-carboxylate##2##2##(1996-2#2)
ethyl bromoacetate##3##2##(1996-5#1)(2008-10#2)
ethyl cellulose##6##2##(2008-10#3)(2010-5#3)
ethyl ester derivative##2##3##(2008-7#2)
ethyl ester##25##2##(1992-6#4)(1995-2#1)(1995-3#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#2)
ethyl esters of##2##3##(1995-5#1)(2011-1#1)
ethyl esters##8##2##(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-1#2)
ethyl ethynyl ether##3##3##(2009-12#3)
ethyl group##2##2##(1995-3#1)(2011-2#1)
ethyl ketone##6##2##(2007-11#1)(2008-10#5)
ethyl propiolate##2##2##(2008-4#2)
ethyl xanthate##4##2##(2008-10#4)
ethyl##168##1##(1990-5#2)(1991-6#1)(1992-11#1)(1992-6#4)(1992-9#1)(1993-1#2)(1994-2#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-2#4)(1996-5#5)(1997-7#3)(2007-11#9)(2008-10#73)(2008-11#6)(2008-12#2)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#3)(2009-5#1)(2009-8#1)(2010-2#2)(2010-5#3)(2011-1#6)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
ethylacetate##2##1##(2008-10#2)
ethylacetoacetate##3##1##(2008-10#2)(2008-11#1)
ethylamine##3##1##(2007-11#2)(2008-10#1)
ethylarsine dichloride##3##2##(2008-11#3)
ethylation (Eth)##2##2##(2008-10#2)
ethylation##3##1##(2008-10#3)
ethylbenzene and xylene##2##3##(2008-10#2)
ethylbenzene##8##1##(1992-11#3)(2008-10#5)
ethylene and##3##2##(2008-10#2)(2008-11#1)
ethylene biosynthesis##2##2##(2008-10#2)
ethylene biosynthetic##2##2##(1995-2#1)(2008-10#1)
ethylene content##2##2##(2007-12#2)
ethylene diffusion##3##2##(2008-2#2)(2008-3#1)
ethylene dimethacrylate##3##2##(2008-10#3)
ethylene glycol and##2##3##(2008-10#2)
ethylene glycol dimethacrylate (EGDMA)##2##4##(2008-10#2)
ethylene glycol dimethacrylate##3##3##(2008-10#3)
ethylene glycol##18##2##(1992-6#1)(1997-5#1)(2008-10#10)(2008-3#4)(2012-12#1)(2013-8#1)
ethylene glycol-functionalized##2##2##(2008-10#2)
ethylene in##2##2##(2008-10#2)
ethylene insensitive mutants##3##3##(2008-10#1)(2009-6#2)
ethylene mutants##2##2##(2009-6#2)
ethylene oxide##3##2##(1992-3#1)(2011-2#1)(2012-12#1)
ethylene production##8##2##(2008-10#6)(2011-2#2)
ethylene treatments##2##2##(1993-12#2)
ethylene vinyl acetate copolymer##2##4##(1994-6#1)(2008-11#1)
ethylene##99##1##(1992-3#2)(1992-6#1)(1993-12#4)(1994-2#1)(1994-6#1)(1995-2#1)(1997-5#1)(2007-12#3)(2008-10#55)(2008-11#2)(2008-2#5)(2008-3#8)(2009-6#5)(2009-8#4)(2011-2#3)(2012-12#2)(2013-8#1)
ethylene-air##3##1##(2007-12#1)(2008-3#2)
ethylene-forming enzyme##3##2##(2008-10#3)
ethylene-insensitive##6##1##(2008-10#6)
ethylene-producing##2##1##(2008-10#2)
ethylenebisdithiocarbamate (Zineb)##2##2##(2008-10#2)
ethylenediamine##11##1##(1996-2#1)(2007-7#1)(2008-10#9)
ethylenediamine-N##5##1##(2008-10#4)(2008-5#1)
ethylenediaminetetraacetate (EDTA)##3##2##(1994-5#1)(2008-10#2)
ethylenediaminetetraacetate##5##1##(1990-8#1)(1994-5#1)(2008-10#3)
ethylenediaminetetraacetic acid (EDTA)##8##3##(2008-10#5)(2008-11#1)(2010-3#1)(2013-1#1)
ethylenediaminetetraacetic acid##12##2##(2008-10#8)(2008-11#1)(2010-3#1)(2013-1#2)
ethylenediaminetetraacetic##13##1##(2008-10#9)(2008-11#1)(2010-3#1)(2013-1#2)
ethyleneglycol##2##1##(2008-10#1)(2008-5#1)
ethylhexyl methoxycinnamate##2##2##(2008-5#2)
ethylhexylphosphates##2##1##(2008-10#2)
ethylmercury and phenylmercury##3##3##(2008-10#3)
ethylmercury and##4##2##(2008-10#4)
ethylmercury##5##1##(2008-10#5)
ethynyl##5##1##(1992-11#1)(2008-4#1)(2009-12#3)
ethynylestradiol##3##1##(1995-12#3)
etidronate##8##1##(1991-11#2)(2008-11#6)
etilefrine##7##1##(2007-8#7)
etiologic agent of##8##3##(1997-5#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
etiologic agent##12##2##(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#3)
etiologic agents##6##2##(2008-10#1)(2008-11#1)(2011-2#3)(2012-3#1)
etiologic and##3##2##(1991-3#1)(1991-6#1)(2012-3#1)
etiologic diagnosis of##2##3##(1990-3#1)(1997-4#1)
etiologic factor##2##2##(2007-5#1)(2010-3#1)
etiologic factors and##2##3##(2008-1#1)(2009-10#1)
etiologic factors for##2##3##(1992-10#1)(2008-7#1)
etiologic factors##9##2##(1992-10#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)
etiologic subtypes##2##2##(2007-10#2)
etiologic##47##1##(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-8#1)(1995-5#1)(1997-4#1)(1997-5#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#5)
etiological agent in##2##3##(2007-7#1)(2008-5#1)
etiological agent of##7##3##(1992-3#1)(1997-4#1)(2007-12#1)(2008-9#2)(2011-2#1)(2012-3#1)
etiological agent##10##2##(1992-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-5#2)(2008-9#2)(2011-2#1)(2012-3#1)
etiological agents##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
etiological and##3##2##(1990-6#1)(1992-5#1)(2008-4#1)
etiological factors known for Itai-Itai disease##3##6##(1997-4#3)
etiological factors##10##2##(1997-4#5)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)(2013-1#1)
etiological features##2##2##(2008-12#1)(2010-4#1)
etiological##44##1##(1990-6#2)(1991-12#1)(1992-3#1)(1992-5#2)(1997-4#6)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#2)(2010-4#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
etiologically distinct##2##2##(1997-5#1)(2012-12#1)
etiologically##6##1##(1997-5#1)(2007-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
etiologies and##4##2##(1993-8#1)(2009-4#1)(2012-2#1)(2012-3#1)
etiologies of##11##2##(1990-2#1)(2007-10#1)(2008-1#1)(2008-8#1)(2010-1#1)(2010-7#1)(2013-1#4)(2013-8#1)
etiologies##37##1##(1990-2#1)(1990-9#2)(1991-8#1)(1993-8#1)(2007-10#1)(2008-1#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
etiology affecting##2##2##(1997-8#1)(2008-10#1)
etiology and management of##4##4##(1991-3#1)(2009-10#3)
etiology and pathophysiology##2##3##(2008-7#1)(2011-1#1)
etiology and that##2##3##(2008-3#1)(2010-6#1)
etiology and treatment of##3##4##(2008-6#1)(2012-2#1)(2013-8#1)
etiology and treatment##4##3##(1991-2#1)(2008-6#1)(2012-2#1)(2013-8#1)
etiology and##34##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-3#1)(1997-3#1)(2007-10#2)(2007-8#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#3)(2009-9#1)(2010-6#1)(2011-1#6)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
etiology for the##2##3##(2008-1#1)(2011-2#1)
etiology for##6##2##(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
etiology has not yet been##2##5##(1990-6#1)(2008-10#1)
etiology has##4##2##(1990-6#1)(2008-10#2)(2012-3#1)
etiology in##4##2##(1992-11#1)(1995-8#1)(2008-1#1)(2008-6#1)
etiology is unknown##4##3##(1991-9#1)(2007-5#1)(2011-1#1)(2011-2#1)
etiology is##9##2##(1991-9#1)(2007-5#1)(2008-1#2)(2009-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
etiology of PD##2##3##(2008-7#2)
etiology of community acquired pneumonia##2##5##(2013-1#2)
etiology of disease##2##3##(2008-10#2)
etiology of hypospadias##2##3##(2008-10#2)
etiology of obesity##4##3##(2008-1#2)(2008-3#1)(2008-5#1)
etiology of osteosarcoma##2##3##(2010-3#2)
etiology of stroke##2##3##(2007-10#2)
etiology of the disease##6##4##(1991-11#1)(1991-9#2)(2007-12#1)(2008-10#1)(2009-10#1)
etiology of the diseases##3##4##(2008-10#2)(2008-3#1)
etiology of the underlying##2##4##(2013-8#2)
etiology of the##21##3##(1990-2#1)(1991-11#1)(1991-9#2)(1996-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#2)(2013-8#2)
etiology of this condition##3##4##(2009-3#1)(2011-2#1)(2013-1#1)
etiology of this disorder##2##4##(2007-11#2)
etiology of this##12##3##(1993-11#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
etiology of##128##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-10#3)(2007-11#5)(2007-12#2)(2008-1#5)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#10)(2013-8#4)
etiology remains##3##2##(1991-2#1)(2008-5#1)(2011-1#1)
etiology that##3##2##(2007-10#1)(2008-10#1)(2010-11#1)
etiology the##2##2##(1990-3#1)(2011-3#1)
etiology was confirmed##2##3##(2013-1#1)(2013-7#1)
etiology was##4##2##(1991-8#1)(2007-8#1)(2013-1#1)(2013-7#1)
etiology##288##1##(1990-11#1)(1990-2#1)(1990-3#3)(1990-6#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#4)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-10#9)(2007-11#6)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#14)(2008-10#27)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#17)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#4)(2010-7#3)(2010-8#1)(2011-1#8)(2011-2#15)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#12)(2013-1#19)(2013-7#1)(2013-8#5)
etiopathogenesis of the##2##3##(1990-2#1)(2007-11#1)
etiopathogenesis of##12##2##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1993-9#1)(1996-7#1)(2007-11#1)(2009-5#1)(2010-1#1)(2013-7#1)(2013-8#1)
etiopathogenesis##17##1##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1993-5#1)(1993-9#1)(1996-7#1)(2007-11#1)(2008-4#1)(2009-5#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
etiopathogenetic##5##1##(1990-8#1)(1990-9#1)(1991-6#1)(1992-6#1)(1993-5#1)
etiopathogenic##3##1##(2008-10#1)(2012-12#2)
etodolac##5##1##(2008-10#5)
etomidate##2##1##(1995-8#1)(2009-6#1)
etonogestrel and ethinylestradiol in plasma by LC-MS/MS##2##7##(2011-3#2)
etonogestrel and ethinylestradiol##3##3##(2011-3#3)
etonogestrel and##5##2##(2011-3#5)
etonogestrel##8##1##(2011-2#2)(2011-3#6)
etoposide (VP-16)##2##2##(1993-9#1)(2007-10#1)
etoposide and##4##2##(1996-8#2)(1997-4#1)(2008-11#1)
etoposide in##3##2##(1993-12#1)(1993-8#1)(1996-10#1)
etoposide##43##1##(1990-10#1)(1992-10#3)(1993-12#1)(1993-8#5)(1993-9#2)(1994-10#1)(1994-12#2)(1994-5#1)(1996-10#1)(1996-8#2)(1997-4#7)(1997-7#1)(2007-10#3)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#3)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
etoposide-induced##3##1##(2012-1#1)(2013-1#2)
etr1-1##2##1##(2008-10#2)
etre##2##1##(2008-5#2)
etretinate##4##1##(1991-11#3)(1992-2#1)
etunicatum##4##1##(2008-12#1)(2013-1#3)
et al##8##1##(2011-2#8)
eu##2##1##(1993-8#1)(2011-2#1)
eu- and##3##2##(2007-5#1)(2008-5#1)(2008-7#1)
eubacteria##3##1##(1990-2#1)(2008-8#2)
eubacterial##6##1##(1991-6#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-8#1)(2008-10#1)
eubacterium##3##1##(1990-7#1)(2009-8#2)
eucalypt species##2##2##(2008-10#1)(2010-3#1)
eucalypt##3##1##(2008-10#1)(2010-3#2)
eucalypts##2##1##(2008-10#1)(2010-3#1)
eucalyptus##13##1##(2007-12#1)(2008-10#2)(2008-5#5)(2008-6#1)(2009-3#2)(2011-2#2)
eucaryotic cells##4##2##(1994-11#1)(1994-2#1)(1994-9#2)
eucaryotic##6##1##(1991-5#1)(1994-11#1)(1994-2#1)(1994-9#2)(2008-8#1)
euchromatic regions##3##2##(2009-10#2)(2013-1#1)
euchromatic##6##1##(1993-9#1)(2008-5#1)(2009-10#3)(2013-1#1)
euchromatin##2##1##(1993-9#1)(2008-7#1)
eudermata##2##1##(2008-10#2)
eudicots##2##1##(2008-10#1)(2010-5#1)
eugenic abortion##2##2##(2013-1#2)
eugenic##3##1##(2008-10#1)(2013-1#2)
eugenol##8##1##(2008-5#2)(2009-12#4)(2011-2#1)(2012-3#1)
euglycemia##2##1##(2008-1#2)
eukaryal##2##1##(1993-9#1)(1994-12#1)
eukaryote##8##1##(1991-9#1)(1994-8#1)(1995-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
eukaryotes and is##2##3##(2010-8#1)(2012-2#1)
eukaryotes and##7##2##(1992-8#1)(1995-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#2)
eukaryotes are##4##2##(1995-2#1)(2008-7#1)(2009-6#2)
eukaryotes to##2##2##(2008-11#1)(2008-7#1)
eukaryotes##73##1##(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#2)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-7#3)(2008-1#2)(2008-11#5)(2008-5#1)(2008-7#8)(2008-8#3)(2009-10#3)(2009-2#3)(2009-5#2)(2009-6#3)(2009-8#1)(2010-1#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#6)(2012-3#2)
eukaryotic DNA polymerase##2##3##(1994-12#2)
eukaryotic DNA topoisomerase##3##3##(1995-5#2)(1995-6#1)
eukaryotic DNA##7##2##(1994-12#2)(1995-5#2)(1995-6#1)(1997-4#1)(2008-4#1)
eukaryotic DNA-binding##2##2##(1990-5#1)(1995-2#1)
eukaryotic GeneMark##2##2##(2008-4#2)
eukaryotic Hsc70##2##2##(1995-6#2)
eukaryotic RNases##2##2##(2009-2#2)
eukaryotic and prokaryotic##3##3##(1994-12#1)(1997-4#1)(2011-2#1)
eukaryotic and##4##2##(1994-12#1)(1995-2#1)(1997-4#1)(2011-2#1)
eukaryotic cell##11##2##(1993-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)
eukaryotic cells and##3##3##(1995-2#1)(1995-9#1)(2011-3#1)
eukaryotic cells as##2##3##(2008-11#1)(2009-6#1)
eukaryotic cells is##4##3##(2008-11#1)(2008-2#1)(2008-4#2)
eukaryotic cells using cationic##2##4##(2008-1#2)
eukaryotic cells##41##2##(1990-5#1)(1991-12#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-7#1)(2008-1#3)(2008-11#4)(2008-2#2)(2008-4#5)(2008-5#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
eukaryotic enzymes##2##2##(1993-11#1)(1995-6#1)
eukaryotic expression plasmid containing teloRZ##2##5##(2008-9#2)
eukaryotic expression vector##3##3##(1992-8#1)(2008-8#2)
eukaryotic expression vectors##2##3##(1997-4#1)(2011-3#1)
eukaryotic expression##8##2##(1992-8#1)(1997-4#1)(2008-8#2)(2008-9#2)(2009-9#1)(2011-3#1)
eukaryotic gene##3##2##(2008-2#1)(2008-9#2)
eukaryotic genes##4##2##(1996-2#1)(1996-3#1)(2008-9#1)(2012-12#1)
eukaryotic genomes##7##2##(1996-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#2)
eukaryotic initiation##3##2##(2010-4#1)(2011-2#1)(2012-2#1)
eukaryotic kingdoms##2##2##(2009-6#1)(2011-1#1)
eukaryotic mRNA##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
eukaryotic membrane proteins##2##3##(1990-11#1)(2011-1#1)
eukaryotic microbes##2##2##(2009-9#1)(2011-2#1)
eukaryotic nucleus##4##2##(2008-8#4)
eukaryotic organisms and##2##3##(1990-7#1)(2008-7#1)
eukaryotic organisms##5##2##(1990-7#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
eukaryotic origin##3##2##(1994-8#1)(1997-4#1)(2011-2#1)
eukaryotic phototrophs##2##2##(2012-2#2)
eukaryotic plasma membrane##2##3##(1990-11#1)(2009-6#1)
eukaryotic plasma-membrane protein##2##3##(1990-11#2)
eukaryotic protein##2##2##(1994-5#1)(2009-6#1)
eukaryotic proteins##2##2##(2008-4#1)(2008-7#1)
eukaryotic ribosomes##2##2##(1992-3#2)
eukaryotic sources##2##2##(1997-7#1)(2008-7#1)
eukaryotic species##3##2##(2008-7#1)(2008-9#1)(2009-10#1)
eukaryotic translation initiation factor##2##4##(1997-1#1)(2010-12#1)
eukaryotic##205##1##(1990-11#4)(1990-5#3)(1990-7#3)(1991-12#2)(1991-9#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#7)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#5)(1997-6#2)(1997-7#4)(2008-1#6)(2008-10#4)(2008-11#12)(2008-2#4)(2008-4#12)(2008-5#3)(2008-7#16)(2008-8#9)(2008-9#15)(2009-10#2)(2009-12#2)(2009-2#4)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#1)(2013-8#2)
eumetazoan##4##1##(2010-4#4)
eumusae##5##1##(2008-10#5)
eumusae)##2##1##(2008-10#2)
euphoria and##3##2##(2007-5#1)(2008-6#1)(2009-7#1)
euphoria##5##1##(1991-1#1)(2007-5#1)(2008-3#1)(2008-6#1)(2009-7#1)
euphratica##2##1##(2008-11#2)
euramericana 242##2##2##(2011-2#2)
euramericana##5##1##(2011-2#5)
euro##2##1##(2009-4#2)
europaeum##3##1##(2008-10#3)
europium (III) are##2##3##(2008-10#2)
europium (III) is##2##3##(2008-10#2)
europium (III)##8##2##(2008-10#8)
europium and ytterbium##2##3##(2008-10#2)
europium and##3##2##(2008-10#3)
europium in##3##2##(2008-10#3)
europium##27##1##(2008-10#25)(2008-3#1)(2012-2#1)
europium(III)##6##1##(2008-10#6)
europium-substituted heteropolytungstate##2##2##(2008-10#2)
euros per##2##2##(2007-8#1)(2008-10#1)
euros##3##1##(2007-8#2)(2008-10#1)
eurosids II##2##2##(2008-10#2)
euryarchaeon##4##1##(2012-2#4)
eusocial##5##1##(2008-8#4)(2010-4#1)
eutectic formation##4##2##(2013-1#4)
eutectic mixture of local##2##4##(1993-1#1)(2009-5#1)
eutectic##9##1##(1993-1#1)(1993-8#2)(2008-3#1)(2009-5#1)(2013-1#4)
euteiches and A##2##3##(2008-10#2)
euteiches and##3##2##(2008-10#3)
euteiches from##3##2##(2008-10#3)
euteiches in##3##2##(2008-10#3)
euteiches was##2##2##(2008-10#2)
euteiches##35##1##(2008-10#35)
euthanased##3##1##(1996-6#1)(1997-8#2)
euthanasia or assisted suicide was##2##5##(1991-8#2)
euthanasia or assisted suicide##6##4##(1991-8#6)
euthanasia program##2##2##(2008-12#2)
euthanasia##30##1##(1990-6#2)(1991-2#1)(1991-8#6)(1991-9#1)(1993-2#1)(1994-1#1)(1995-2#1)(1997-2#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#2)
euthanized##5##1##(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
euthermar##2##1##(2008-8#2)
euthymic##4##1##(1995-11#1)(1996-7#1)(2012-3#1)(2013-8#1)
euthyroid##11##1##(1990-6#1)(1990-9#1)(1991-9#1)(1995-12#1)(1996-5#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#2)
euthyroidism##3##1##(2011-1#3)
eutopic##4##1##(1995-12#3)(2013-8#1)
eutrophic remodeling##2##2##(2009-1#2)
eutrophic##3##1##(2009-1#3)
eutrophication##3##1##(2008-5#1)(2012-3#2)
eutrophus H16##3##2##(2008-6#3)
eutrophus##9##1##(2008-6#7)(2008-7#2)
evacuated to the##2##3##(1992-6#2)
evacuated to##3##2##(1992-6#3)
evacuated##6##1##(1992-6#3)(2008-3#1)(2008-7#1)(2012-2#1)
evacuation is##3##2##(2012-2#1)(2013-1#2)
evacuation of a child care center##2##6##(1994-2#2)
evacuation of a##5##3##(1991-11#1)(1991-2#1)(1994-2#2)(2008-7#1)
evacuation of the haematoma##2##4##(2008-7#2)
evacuation of the##5##3##(1997-6#1)(2008-7#2)(2009-3#1)(2012-12#1)
evacuation of##18##2##(1991-11#1)(1991-2#1)(1994-2#2)(1996-12#1)(1996-2#2)(1997-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
evacuation procedures##3##2##(1991-2#1)(1996-2#2)
evacuation##40##1##(1991-11#1)(1991-2#2)(1992-6#1)(1994-12#1)(1994-2#2)(1996-12#4)(1996-2#4)(1996-6#1)(1997-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
evacuee##2##1##(2008-5#1)(2011-2#1)
evacuees who##3##2##(2011-2#2)(2012-2#1)
evacuees##6##1##(2007-10#1)(2008-7#1)(2011-2#3)(2012-2#1)
evade this##2##2##(2010-3#2)
evade##10##1##(2008-10#3)(2009-3#1)(2010-3#2)(2010-6#1)(2012-12#1)(2013-1#2)
evagination##4##1##(2008-10#3)(2008-9#1)
evaluable for response##6##3##(1990-2#1)(1991-6#1)(2007-10#1)(2008-6#2)(2008-7#1)
evaluable for##9##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#1)(2007-10#1)(2008-6#3)(2008-7#1)
evaluable patients##10##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1996-1#1)(2008-3#1)(2008-6#2)(2013-8#1)
evaluable##30##1##(1990-10#2)(1990-12#2)(1990-2#4)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-8#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-3#1)(2008-6#5)(2008-7#2)(2013-8#1)
evaluate a new##3##3##(1991-1#1)(1997-4#1)(2008-6#1)
evaluate a##32##2##(1991-1#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
evaluate an##6##2##(1997-7#1)(2007-11#1)(2007-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
evaluate and compare##2##3##(2010-8#1)(2013-1#1)
evaluate and##14##2##(1993-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-5#2)(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
evaluate automated##2##2##(2008-10#2)
evaluate by##2##2##(1996-2#1)(2013-8#1)
evaluate clinical and##2##3##(2007-11#1)(2010-11#1)
evaluate clinical##7##2##(1995-2#1)(2007-11#1)(2007-4#1)(2007-8#2)(2010-11#1)(2011-2#1)
evaluate developmental##2##2##(2008-10#1)(2008-9#1)
evaluate drug##2##2##(2008-10#1)(2013-1#1)
evaluate existing##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
evaluate factors##3##2##(2007-7#1)(2008-1#1)(2008-12#1)
evaluate four##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
evaluate how well##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
evaluate how##9##2##(1993-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-7#1)(2013-8#1)
evaluate if##5##2##(1996-9#1)(2008-4#1)(2011-2#1)(2013-1#2)
evaluate in##2##2##(2008-1#1)(2010-6#1)
evaluate individual##2##2##(2008-1#1)(2008-5#1)
evaluate it##2##2##(2007-7#1)(2008-6#1)
evaluate its efficacy and safety##2##5##(2008-5#1)(2009-4#1)
evaluate its efficacy##3##3##(1990-12#1)(2008-5#1)(2009-4#1)
evaluate its##18##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-2#1)(1994-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2009-4#1)(2010-11#1)(2010-12#2)(2011-1#1)
evaluate job satisfaction##2##3##(2008-11#2)
evaluate numerically the##2##3##(2008-3#2)
evaluate oral##2##2##(2008-7#1)(2012-3#1)
evaluate patient##2##2##(1995-12#1)(2012-12#1)
evaluate performance of the##2##4##(2008-10#1)(2008-9#1)
evaluate possible##6##2##(1990-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
evaluate quality of##2##3##(2008-7#1)(2013-1#1)
evaluate severity##2##2##(1992-2#1)(2008-1#1)
evaluate the ability of##6##4##(1990-2#1)(1993-9#1)(1995-5#1)(2008-4#1)(2008-5#1)(2008-9#1)
evaluate the acute##2##3##(1996-9#1)(2008-3#1)
evaluate the antimicrobial##2##3##(2007-7#1)(2008-5#1)
evaluate the best##2##3##(2008-10#1)(2011-2#1)
evaluate the capacity of##3##4##(2008-4#1)(2013-1#2)
evaluate the clinical##5##3##(1995-3#1)(2011-2#2)(2013-1#2)
evaluate the current##2##3##(2008-4#1)(2008-5#1)
evaluate the diagnostic##5##3##(1991-2#1)(1992-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
evaluate the effect of different##3##5##(2008-12#1)(2010-4#1)(2012-2#1)
evaluate the effect of##47##4##(1990-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
evaluate the effect##48##3##(1990-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#3)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
evaluate the effectiveness of an##2##5##(1997-1#1)(2008-8#1)
evaluate the effectiveness of the##5##5##(1997-3#1)(2007-11#1)(2008-10#2)(2011-1#1)
evaluate the effectiveness of##25##4##(1991-2#1)(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)
evaluate the effectiveness##26##3##(1991-2#1)(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)
evaluate the effects of##30##4##(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluate the effects##31##3##(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluate the efficacy and##5##4##(1990-2#1)(2007-10#1)(2008-10#2)(2008-3#1)
evaluate the efficacy of a##6##5##(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
evaluate the efficacy of##26##4##(1993-1#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
evaluate the efficacy##33##3##(1990-2#1)(1993-1#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#4)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
evaluate the evidence##4##3##(1993-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
evaluate the extent to which##3##5##(2008-11#1)(2008-3#2)
evaluate the extent##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
evaluate the feasibility of##4##4##(1992-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
evaluate the feasibility##7##3##(1991-3#1)(1992-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
evaluate the frequency of##7##4##(1992-6#1)(1994-12#1)(2007-8#1)(2013-1#2)(2013-8#2)
evaluate the frequency##9##3##(1992-6#1)(1994-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2013-1#2)(2013-8#2)
evaluate the impact of a##4##5##(1996-1#1)(2008-11#1)(2008-3#1)(2012-3#1)
evaluate the impact of the##3##5##(1995-3#1)(2008-10#1)(2008-12#1)
evaluate the impact of##16##4##(1991-1#1)(1994-1#1)(1995-3#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#2)
evaluate the importance of##2##4##(1996-6#1)(2008-7#1)
evaluate the in vitro##2##4##(2008-5#1)(2012-2#1)
evaluate the incidence of##4##4##(1990-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
evaluate the incidence##6##3##(1990-3#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-3#1)(2013-1#1)
evaluate the influence of##10##4##(1990-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)(2013-7#1)
evaluate the influence##11##3##(1990-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-7#1)
evaluate the information##2##3##(1997-6#1)(2008-3#1)
evaluate the long-term##7##3##(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-3#1)
evaluate the mean##2##3##(2008-10#1)(2008-2#1)
evaluate the methods##2##3##(1995-2#1)(2008-10#1)
evaluate the new##2##3##(2008-10#1)(2010-8#1)
evaluate the operating characteristics of##2##5##(2009-10#1)(2012-3#1)
evaluate the parameters##2##3##(2011-2#1)(2013-1#1)
evaluate the participation of##2##4##(1995-12#1)(2008-11#1)
evaluate the performance of a##4##5##(2007-8#1)(2008-3#2)(2011-2#1)
evaluate the performance of the##4##5##(2007-8#1)(2008-3#1)(2010-8#2)
evaluate the performance of##14##4##(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#2)(2010-8#2)(2011-2#1)(2012-12#1)
evaluate the possibility to##2##4##(2008-11#1)(2010-12#1)
evaluate the possibility##6##3##(1992-2#1)(1994-5#1)(2007-8#1)(2008-11#2)(2010-12#1)
evaluate the potential role of##2##5##(1992-9#1)(2013-1#1)
evaluate the potential##7##3##(1992-9#1)(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2013-1#1)
evaluate the predictive##2##3##(2012-3#2)
evaluate the prevalence of##7##4##(2007-8#1)(2008-12#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
evaluate the prevalence##10##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
evaluate the properties of##2##4##(2008-5#1)(2012-12#1)
evaluate the quality of life##2##5##(2007-11#1)(2007-7#1)
evaluate the quality of##7##4##(1991-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2012-3#1)
evaluate the relationship between##4##4##(1995-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
evaluate the relationship##6##3##(1995-8#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
evaluate the relative##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
evaluate the reliability##3##3##(2007-12#1)(2010-10#1)(2013-8#1)
evaluate the reproducibility of the##2##5##(2008-10#1)(2008-12#1)
evaluate the reproducibility of##4##4##(2008-10#3)(2008-12#1)
evaluate the reproducibility##5##3##(2008-10#3)(2008-12#1)(2009-11#1)
evaluate the results of the##2##5##(2011-2#1)(2013-8#1)
evaluate the results of##6##4##(1997-8#1)(2007-8#1)(2008-9#1)(2011-2#2)(2013-8#1)
evaluate the results##7##3##(1997-8#1)(2007-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-8#1)
evaluate the risk of##6##4##(2007-11#2)(2008-11#1)(2008-8#1)(2011-2#2)
evaluate the risk##7##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
evaluate the robustness of##2##4##(2008-10#2)
evaluate the role of the##2##5##(2011-2#1)(2012-2#1)
evaluate the role of##14##4##(1992-8#1)(1994-9#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
evaluate the significance of##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
evaluate the survival##2##3##(1994-12#2)
evaluate the three-dimensional##2##3##(2008-2#2)
evaluate the total##3##3##(1994-3#1)(2008-10#1)(2011-3#1)
evaluate the treatment##2##3##(2011-2#2)
evaluate the use of##6##4##(1990-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
evaluate the validity##2##3##(2007-10#1)(2010-3#1)
evaluate the voltammetric behavior of##2##5##(2008-10#2)
evaluate the##716##2##(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#3)(1990-5#1)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#8)(2006-10#2)(2007-10#7)(2007-11#11)(2007-12#2)(2007-2#1)(2007-7#15)(2007-8#14)(2007-9#1)(2008-1#13)(2008-10#107)(2008-11#22)(2008-12#27)(2008-2#11)(2008-3#33)(2008-4#9)(2008-5#34)(2008-6#8)(2008-7#21)(2008-8#11)(2008-9#16)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#12)(2011-1#13)(2011-2#41)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#18)(2012-3#22)(2012-8#1)(2013-1#46)(2013-7#6)(2013-8#15)
evaluate their effectiveness##2##3##(1996-1#1)(2013-1#1)
evaluate their##22##2##(1990-2#1)(1994-3#1)(1996-1#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-2#2)(2013-1#3)(2013-8#1)
evaluate these##7##2##(1991-3#1)(1995-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-3#1)
evaluate this potential##2##3##(2009-12#1)(2013-1#1)
evaluate this##12##2##(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
evaluate those##2##2##(1994-3#1)(2007-11#1)
evaluate total system##2##3##(2011-1#2)
evaluate total##4##2##(1991-6#1)(2011-1#2)(2011-2#1)
evaluate treatment##4##2##(2008-6#1)(2008-7#1)(2010-9#1)(2013-8#1)
evaluate whether##27##2##(1993-8#2)(1994-12#2)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
evaluate##1229##1##(1990-11#2)(1990-12#5)(1990-2#8)(1990-3#5)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#7)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#3)(1994-11#2)(1994-12#9)(1994-2#4)(1994-3#7)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#5)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#11)(2006-10#2)(2007-10#9)(2007-11#23)(2007-12#3)(2007-2#1)(2007-4#3)(2007-5#3)(2007-7#21)(2007-8#23)(2007-9#2)(2008-1#21)(2008-10#169)(2008-11#39)(2008-12#41)(2008-2#22)(2008-3#50)(2008-4#19)(2008-5#54)(2008-6#16)(2008-7#41)(2008-8#20)(2008-9#34)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#1)(2010-3#10)(2010-4#3)(2010-5#5)(2010-6#8)(2010-7#4)(2010-8#18)(2010-9#1)(2011-1#23)(2011-2#68)(2011-3#3)(2011-7#1)(2012-1#4)(2012-12#11)(2012-2#27)(2012-3#33)(2012-8#1)(2012-9#1)(2013-1#76)(2013-7#11)(2013-8#29)
evaluated PRs##2##2##(1994-9#2)
evaluated a##9##2##(1994-3#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
evaluated according to the##6##4##(2008-10#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
evaluated according to##14##3##(2007-11#3)(2007-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluated across##2##2##(2010-7#1)(2013-1#1)
evaluated after##5##2##(1992-4#1)(2008-10#2)(2008-2#1)(2013-1#1)
evaluated against the##4##3##(1994-3#1)(1995-8#1)(2008-1#1)(2008-5#1)
evaluated against##15##2##(1994-3#1)(1995-8#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#3)(2013-1#1)
evaluated and a##2##3##(2007-12#1)(2008-11#1)
evaluated and applied##2##3##(2008-10#1)(2011-1#1)
evaluated and compared in##2##4##(2008-10#2)
evaluated and compared with the##2##5##(2008-10#2)
evaluated and compared with##7##4##(2008-10#7)
evaluated and compared##12##3##(2008-10#10)(2008-2#1)(2010-2#1)
evaluated and discussed##3##3##(2008-10#2)(2012-2#1)
evaluated and it##2##3##(2008-10#1)(2008-11#1)
evaluated and optimized##2##3##(2008-10#2)
evaluated and the calibration curve is linear over a range of 0##2##12##(2008-10#2)
evaluated and the possible detection mechanism##2##6##(2008-10#2)
evaluated and the##13##3##(1991-5#1)(2007-12#1)(2008-10#9)(2008-2#1)(2012-1#1)
evaluated and##60##2##(1991-5#1)(1992-3#1)(1992-6#1)(2007-12#2)(2008-10#38)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)
evaluated are##2##2##(1992-2#1)(2008-10#1)
evaluated as a function of the##3##6##(2008-10#1)(2008-2#1)(2009-8#1)
evaluated as a function of##8##5##(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)
evaluated as a##15##3##(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)
evaluated as an##3##3##(1994-9#1)(2008-10#1)(2008-2#1)
evaluated as inhibitors of##2##4##(1995-3#1)(2009-9#1)
evaluated as the relative standard deviation in solutions containing##2##9##(2008-10#2)
evaluated as the relative standard deviation##3##6##(2008-10#3)
evaluated as the##6##3##(2008-10#5)(2011-2#1)
evaluated as##58##2##(1990-8#2)(1993-1#1)(1993-2#1)(1994-9#1)(1995-3#2)(1996-9#1)(1997-2#1)(2008-10#21)(2008-11#1)(2008-2#6)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
evaluated at a##2##3##(1996-3#1)(2008-3#1)
evaluated at different##2##3##(2008-10#1)(2013-1#1)
evaluated at the standard state of the##2##7##(2008-10#2)
evaluated at the##8##3##(1990-3#1)(1991-9#1)(2008-10#5)(2008-5#1)
evaluated at three##5##3##(1993-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
evaluated at##30##2##(1990-3#1)(1991-9#1)(1993-2#1)(1996-3#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#2)(2013-1#2)
evaluated based on##6##3##(2007-8#1)(2008-10#2)(2008-7#1)(2012-2#2)
evaluated before treatment##3##3##(1994-6#1)(2008-4#1)(2011-2#1)
evaluated before##8##2##(1990-3#1)(1994-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
evaluated between##3##2##(1992-1#1)(2007-7#1)(2008-10#1)
evaluated both##5##2##(1996-9#1)(2008-10#1)(2009-10#1)(2010-7#1)(2012-3#1)
evaluated by a##8##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
evaluated by an##3##3##(1993-1#1)(2011-1#1)(2013-8#1)
evaluated by analysing##2##3##(2008-10#2)
evaluated by analysis of##3##4##(2008-10#3)
evaluated by analyzing a##2##4##(2008-10#2)
evaluated by analyzing their##2##4##(1997-3#1)(2008-10#1)
evaluated by analyzing##8##3##(1997-3#1)(2008-10#7)
evaluated by assaying##3##3##(2008-10#2)(2010-5#1)
evaluated by calculating the##2##4##(2008-11#1)(2008-5#1)
evaluated by calculating##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
evaluated by carrying out##2##4##(2008-10#2)
evaluated by comparing the##4##4##(1991-9#1)(2008-10#3)
evaluated by comparing with##2##4##(2008-10#1)(2008-5#1)
evaluated by comparing##9##3##(1991-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)
evaluated by comparison##5##3##(2008-10#4)(2008-2#1)
evaluated by computer##2##3##(2008-10#1)(2008-3#1)
evaluated by determining##4##3##(1997-4#1)(2008-10#3)
evaluated by five##2##3##(1997-2#1)(2008-10#1)
evaluated by immunohistochemistry##2##3##(1993-9#1)(2009-4#1)
evaluated by injecting##2##3##(2008-10#2)
evaluated by investigating##2##3##(2008-10#2)
evaluated by means of a##4##5##(1991-12#1)(2007-12#1)(2008-10#1)(2008-6#1)
evaluated by means of the##5##5##(1991-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
evaluated by means of##16##4##(1991-12#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
evaluated by measuring the##3##4##(1990-11#1)(1994-8#1)(2009-11#1)
evaluated by measuring##7##3##(1990-11#1)(1994-8#1)(1997-2#1)(2008-10#2)(2009-11#1)(2012-3#1)
evaluated by replicate analyses of##3##5##(2008-10#3)
evaluated by replicate##4##3##(2008-10#4)
evaluated by testing##3##3##(2008-10#2)(2013-8#1)
evaluated by the analysis of##4##5##(2008-10#4)
evaluated by the same##2##4##(2007-8#1)(2012-1#1)
evaluated by the##36##3##(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
evaluated by this##2##3##(2007-11#1)(2008-11#1)
evaluated by three##2##3##(2007-8#1)(2008-10#1)
evaluated by use of the##2##5##(2008-3#1)(2008-6#1)
evaluated by use of##6##4##(2008-2#2)(2008-3#3)(2008-6#1)
evaluated by using##14##3##(1992-3#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
evaluated by##274##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-12#2)(1992-3#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#1)(1997-8#1)(1997-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#8)(2008-10#109)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#8)(2008-6#7)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-3#3)(2010-5#1)(2011-1#5)(2011-2#9)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#11)(2013-8#7)
evaluated concentrations##2##2##(2013-1#2)
evaluated directly##3##2##(1996-2#1)(2008-10#2)
evaluated during a##2##3##(1995-2#1)(2007-10#1)
evaluated during the##4##3##(1992-2#1)(2008-7#1)(2013-8#2)
evaluated during##10##2##(1992-2#1)(1995-2#1)(1995-4#1)(1996-12#1)(2007-10#1)(2008-7#2)(2011-1#1)(2013-8#2)
evaluated every##4##2##(1993-6#1)(2009-8#1)(2013-8#2)
evaluated for clinical##2##3##(1991-11#1)(2011-2#1)
evaluated for determining##2##3##(2008-10#1)(2008-3#1)
evaluated for disease##2##3##(2008-10#2)
evaluated for four##2##3##(2008-10#2)
evaluated for in vitro##2##4##(2007-11#1)(2011-1#1)
evaluated for its accuracy##3##4##(1993-2#1)(2008-10#2)
evaluated for its capacity to##2##5##(2008-10#2)
evaluated for its##11##3##(1993-2#1)(2008-10#8)(2008-5#1)(2009-2#1)
evaluated for monitoring##2##3##(2008-10#1)(2008-5#1)
evaluated for possible##2##3##(1992-8#1)(2013-8#1)
evaluated for resistance to southern leaf blight (SLB)##2##8##(2008-10#2)
evaluated for resistance to##6##4##(2008-10#6)
evaluated for sensitivity##2##3##(2008-10#2)
evaluated for suppression of##2##4##(2008-10#2)
evaluated for the determination of##7##5##(2008-10#6)(2010-5#1)
evaluated for the first time##2##5##(2008-10#1)(2013-1#1)
evaluated for the presence of##2##5##(2008-1#1)(2008-11#1)
evaluated for the##42##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-2#1)(1994-5#1)(1994-6#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2010-5#1)(2011-3#1)(2012-1#1)(2013-1#1)
evaluated for their antibacterial##2##4##(2011-1#1)(2012-3#1)
evaluated for their##26##3##(1991-11#1)(1991-5#1)(1992-9#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-12#3)(2009-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
evaluated for use in##2##4##(2008-10#2)
evaluated for use##3##3##(1992-6#1)(2008-10#2)
evaluated for virulence##2##3##(2008-10#2)
evaluated for##213##2##(1990-12#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#96)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#9)(2008-5#9)(2008-6#4)(2008-7#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
evaluated four times##3##3##(2008-10#3)
evaluated from a##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
evaluated from the##9##3##(1995-6#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)
evaluated from##23##2##(1990-8#1)(1992-12#1)(1995-6#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)
evaluated further##4##2##(1992-3#1)(2008-10#2)(2008-4#1)
evaluated here##2##2##(2008-10#2)
evaluated histopathologically##2##2##(2008-7#1)(2013-1#1)
evaluated in a randomized##3##4##(1990-12#1)(2008-10#2)
evaluated in a##29##3##(1990-12#1)(1991-4#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#2)(2012-12#2)
evaluated in an##6##3##(1993-12#1)(2008-10#3)(2008-5#1)(2012-2#1)
evaluated in both##4##3##(2008-12#1)(2008-6#1)(2010-1#1)(2013-7#1)
evaluated in clinical trials##3##4##(2007-10#1)(2008-5#1)(2008-8#1)
evaluated in clinical##4##3##(2007-10#1)(2007-8#1)(2008-5#1)(2008-8#1)
evaluated in comparison##2##3##(2008-11#1)(2012-2#1)
evaluated in different##3##3##(1997-7#1)(2008-12#1)(2008-6#1)
evaluated in field##3##3##(2008-10#3)
evaluated in four##2##3##(1990-3#1)(2008-5#1)
evaluated in greenhouse##5##3##(2008-10#5)
evaluated in human##4##3##(1995-3#1)(1997-4#1)(2008-11#2)
evaluated in order to##3##4##(1994-8#1)(2007-11#1)(2008-10#1)
evaluated in patients with##2##4##(2008-3#1)(2013-1#1)
evaluated in patients##3##3##(2008-3#1)(2012-12#1)(2013-1#1)
evaluated in relation to##4##4##(1991-12#1)(2008-6#1)(2008-8#1)(2009-12#1)
evaluated in respect##2##3##(2008-10#1)(2008-5#1)
evaluated in term of relative standard deviation (R##2##8##(2008-10#2)
evaluated in term of relative standard deviation##3##7##(2008-10#3)
evaluated in terms of the##6##5##(2008-10#3)(2008-4#1)(2008-9#1)(2010-5#1)
evaluated in terms of their##2##5##(2008-10#1)(2008-3#1)
evaluated in terms of##18##4##(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-5#1)(2013-1#1)(2013-7#1)
evaluated in the context of##2##5##(2008-6#1)(2008-7#1)
evaluated in the field##3##4##(2008-10#2)(2012-3#1)
evaluated in the greenhouse##4##4##(2008-10#4)
evaluated in the presence of##3##5##(2008-10#2)(2008-12#1)
evaluated in the presence##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
evaluated in the##34##3##(1991-3#1)(1994-7#1)(1995-4#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
evaluated in this study##6##4##(1991-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2012-12#1)(2013-8#1)
evaluated in this##10##3##(1991-2#1)(1992-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
evaluated in vitro and##2##4##(2008-10#2)
evaluated in vitro##5##3##(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#2)
evaluated in vivo##2##3##(1995-3#1)(2013-1#1)
evaluated in##260##2##(1990-12#2)(1990-3#5)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#5)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#72)(2008-11#12)(2008-12#7)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#11)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#5)(2009-1#1)(2009-12#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#4)
evaluated included##3##2##(2011-2#2)(2013-8#1)
evaluated its##2##2##(2007-12#1)(2008-5#1)
evaluated numerically##4##2##(2008-2#1)(2008-3#2)(2010-8#1)
evaluated on a##4##3##(1992-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
evaluated on the basis of##8##5##(1991-1#1)(1991-3#1)(2007-7#1)(2007-8#2)(2008-5#2)(2008-7#1)
evaluated on the##15##3##(1990-7#1)(1991-1#1)(1991-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#3)(2008-7#1)(2013-8#1)
evaluated on##39##2##(1990-7#1)(1991-1#1)(1991-3#1)(1992-10#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-12#1)(2008-5#4)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
evaluated only##2##2##(2008-10#1)(2011-2#1)
evaluated over a##3##3##(2008-10#2)(2008-3#1)
evaluated over##8##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2012-3#1)
evaluated patient##2##2##(1997-2#1)(2008-3#1)
evaluated patients##3##2##(1990-12#1)(1996-9#1)(2011-2#1)
evaluated quantitatively##3##2##(2008-2#1)(2008-9#1)(2012-3#1)
evaluated regarding##2##2##(1990-3#1)(2013-1#1)
evaluated separately##2##2##(2007-11#1)(2008-10#1)
evaluated that the##2##3##(1995-11#1)(2012-12#1)
evaluated the ability of##2##4##(1995-11#1)(2008-10#1)
evaluated the clinical##3##3##(2010-6#1)(2013-1#2)
evaluated the differences##2##3##(2008-10#1)(2013-7#1)
evaluated the effect of the##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
evaluated the effect of##14##4##(1990-5#1)(1991-2#1)(1993-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-7#1)
evaluated the effectiveness of the##3##5##(1991-2#1)(2008-5#1)(2012-2#1)
evaluated the effectiveness of##5##4##(1991-2#1)(2008-12#1)(2008-5#1)(2012-2#2)
evaluated the effects of##8##4##(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-2#1)(2013-1#1)
evaluated the efficacy of##3##4##(2007-9#1)(2008-6#1)(2011-2#1)
evaluated the efficacy##4##3##(2007-9#1)(2008-6#1)(2011-2#2)
evaluated the expression of##3##4##(1995-11#1)(2011-2#1)(2012-12#1)
evaluated the frequency##2##3##(1997-3#1)(2008-7#1)
evaluated the impact of##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
evaluated the in##2##3##(1991-2#1)(1995-12#1)
evaluated the incidence of##2##4##(1991-8#1)(2008-8#1)
evaluated the influence of##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
evaluated the interaction of##2##4##(1993-6#1)(2008-6#1)
evaluated the mechanisms##2##3##(2008-4#1)(2012-12#1)
evaluated the performance of##4##4##(1994-6#1)(2008-10#1)(2008-2#1)(2011-1#1)
evaluated the potential of##2##4##(2008-10#1)(2012-3#1)
evaluated the potential##5##3##(1992-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
evaluated the role of##6##4##(1994-1#1)(1995-8#1)(1997-2#1)(2008-5#1)(2009-8#1)(2013-1#1)
evaluated the safety of##2##4##(2012-3#1)(2013-1#1)
evaluated the safety##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
evaluated the use of##2##4##(1996-12#1)(2008-10#1)
evaluated the use##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
evaluated the usefulness of##2##4##(1995-4#1)(2008-10#1)
evaluated the##166##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-6#2)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#9)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#1)
evaluated their##7##2##(1991-12#1)(1991-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
evaluated this##3##2##(1995-2#1)(2012-2#1)(2013-7#1)
evaluated through a##4##3##(1996-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
evaluated through the##7##3##(2007-8#1)(2008-10#5)(2008-12#1)
evaluated through##17##2##(1990-3#1)(1991-1#1)(1996-8#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
evaluated to assess##2##3##(1997-3#1)(2008-10#1)
evaluated to be 0##2##4##(2008-10#2)
evaluated to be##6##3##(2008-10#4)(2008-3#1)(2008-9#1)
evaluated to date##2##3##(1990-6#1)(1997-7#1)
evaluated to determine the##3##4##(1992-9#1)(2008-10#2)
evaluated to determine##6##3##(1992-9#1)(2008-10#4)(2008-9#1)
evaluated to ensure that##2##4##(2008-10#1)(2013-1#1)
evaluated to explain##2##3##(2008-5#1)(2013-8#1)
evaluated to identify##2##3##(1996-12#1)(2008-10#1)
evaluated to measure##2##3##(2008-10#1)(2008-9#1)
evaluated to##36##2##(1990-6#1)(1992-9#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#3)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
evaluated together with##2##3##(1994-6#1)(2008-2#1)
evaluated twice##2##2##(2011-2#1)(2013-1#1)
evaluated under##8##2##(1997-3#1)(2008-10#6)(2012-2#1)
evaluated using a##16##3##(1995-2#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
evaluated using an##2##3##(2008-10#1)(2011-2#1)
evaluated using data##2##3##(1990-12#1)(2008-10#1)
evaluated using the##16##3##(1996-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
evaluated using three##2##3##(2008-10#1)(2010-8#1)
evaluated using two##4##3##(2007-9#1)(2008-10#2)(2010-8#1)
evaluated using##91##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#33)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-9#2)(2009-11#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#5)
evaluated via##9##2##(1997-2#1)(2007-12#2)(2008-10#2)(2008-6#1)(2009-2#1)(2010-10#1)(2012-2#1)
evaluated was##4##2##(2008-10#4)
evaluated were##9##2##(1995-6#1)(2008-1#1)(2008-10#7)
evaluated when##4##2##(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)
evaluated whether the##3##3##(2009-2#1)(2013-1#2)
evaluated whether##8##2##(1997-3#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-4#1)(2012-12#1)(2013-1#2)
evaluated with a##10##3##(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-3#1)
evaluated with an##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
evaluated with regard to##2##4##(2008-2#1)(2013-1#1)
evaluated with respect to the##5##5##(2008-10#3)(2011-2#1)(2012-2#1)
evaluated with respect to##10##4##(1993-1#1)(2008-10#6)(2008-2#1)(2011-2#1)(2012-2#1)
evaluated with respect##11##3##(1993-1#1)(2008-10#7)(2008-2#1)(2011-2#1)(2012-2#1)
evaluated with the##9##3##(1990-5#1)(1990-7#1)(1996-11#1)(2007-8#1)(2008-10#3)(2013-1#2)
evaluated with##63##2##(1990-5#1)(1990-7#1)(1992-2#1)(1993-1#1)(1995-2#1)(1995-3#2)(1996-11#1)(1997-3#1)(1997-8#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)
evaluated within##3##2##(2008-10#1)(2008-11#2)
evaluated##2093##1##(1990-10#1)(1990-11#4)(1990-12#8)(1990-2#2)(1990-3#11)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#8)(1990-9#6)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#3)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#7)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#4)(1993-1#6)(1993-12#4)(1993-2#6)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#6)(1994-5#5)(1994-6#8)(1994-7#2)(1994-8#6)(1994-9#9)(1995-11#7)(1995-12#8)(1995-2#8)(1995-3#17)(1995-4#3)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#5)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#3)(1997-2#10)(1997-3#11)(1997-4#8)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#5)(1997-9#1)(2006-12#2)(2006-5#2)(2007-10#16)(2007-11#27)(2007-12#18)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#26)(2007-9#3)(2008-1#17)(2008-10#705)(2008-11#68)(2008-12#41)(2008-2#43)(2008-3#80)(2008-4#9)(2008-5#71)(2008-6#40)(2008-7#46)(2008-8#19)(2008-9#25)(2009-1#3)(2009-10#6)(2009-11#6)(2009-12#2)(2009-2#6)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#7)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#14)(2010-4#8)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#7)(2011-1#34)(2011-2#76)(2011-3#7)(2011-7#1)(2012-1#10)(2012-12#42)(2012-2#42)(2012-3#32)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#90)(2013-7#13)(2013-8#27)
evaluates a##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
evaluates the effect of##3##4##(2008-7#1)(2009-9#1)(2013-8#1)
evaluates the effectiveness of##2##4##(2008-7#1)(2010-5#1)
evaluates the impact of##2##4##(1995-12#1)(2010-11#1)
evaluates the##33##2##(1991-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
evaluates##60##1##(1991-12#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#3)(1997-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#3)(2009-9#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#4)
evaluating a##10##2##(1991-12#1)(1992-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#2)
evaluating access and quality##2##4##(1995-12#2)
evaluating an##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
evaluating and monitoring##2##3##(2007-11#1)(2011-2#1)
evaluating and##14##2##(1993-2#1)(1995-1#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)
evaluating biomass##2##2##(2008-10#1)(2013-1#1)
evaluating bone##3##2##(1997-6#1)(2012-1#2)
evaluating both##2##2##(1991-5#1)(1992-3#1)
evaluating cell##2##2##(2008-7#1)(2008-9#1)
evaluating different##3##2##(2010-8#1)(2012-1#1)(2013-1#1)
evaluating disease##5##2##(2008-10#4)(2012-2#1)
evaluating how##2##2##(1990-12#1)(2008-7#1)
evaluating human##2##2##(1992-3#1)(2008-2#1)
evaluating long-term##2##2##(2007-8#1)(2012-12#1)
evaluating potential##2##2##(2008-8#1)(2011-2#1)
evaluating public health surveillance systems##2##5##(2008-7#2)
evaluating quality##2##2##(1994-12#1)(1995-1#1)
evaluating the appropriateness of##2##4##(1991-12#1)(2009-8#1)
evaluating the cause##2##3##(2007-10#1)(2011-2#1)
evaluating the clinical##4##3##(1993-12#1)(1997-2#1)(2008-7#1)(2011-2#1)
evaluating the diagnostic##3##3##(2012-12#2)(2013-1#1)
evaluating the effect of##4##4##(2007-7#1)(2008-10#2)(2012-3#1)
evaluating the effectiveness of##3##4##(2008-2#1)(2008-4#1)(2008-7#1)
evaluating the effects of##5##4##(1996-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
evaluating the effects##6##3##(1996-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
evaluating the efficacy of##6##4##(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
evaluating the efficiency##2##3##(2007-12#1)(2008-10#1)
evaluating the humoral##2##3##(2007-10#1)(2008-10#1)
evaluating the impact of the##2##5##(1992-1#1)(2008-11#1)
evaluating the impact of##3##4##(1992-1#1)(2008-11#1)(2013-1#1)
evaluating the performance of the##2##5##(2008-10#1)(2008-3#1)
evaluating the performance of##6##4##(1996-8#1)(2007-11#1)(2008-10#2)(2008-3#2)
evaluating the performance##7##3##(1996-8#1)(2007-11#1)(2008-10#2)(2008-3#3)
evaluating the quality of##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
evaluating the safety##2##3##(2008-2#1)(2009-10#1)
evaluating the##134##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#3)(2006-10#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#4)(2013-8#2)
evaluating their##4##2##(2008-11#1)(2008-5#1)(2010-4#1)(2012-3#1)
evaluating this##5##2##(1991-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
evaluating treatment##2##2##(1996-6#1)(2007-8#1)
evaluating various##2##2##(2007-12#1)(2011-2#1)
evaluating##354##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#7)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-5#3)(1993-12#3)(1993-2#2)(1993-6#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#4)(1996-3#3)(1996-6#2)(1996-8#1)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#6)(2008-10#47)(2008-11#14)(2008-12#8)(2008-2#8)(2008-3#14)(2008-4#7)(2008-5#13)(2008-6#5)(2008-7#19)(2008-8#9)(2008-9#10)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-8#1)(2011-2#20)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#7)(2012-4#1)(2013-1#15)(2013-7#1)(2013-8#3)
evaluation after##3##2##(2007-8#1)(2008-6#1)(2013-1#1)
evaluation algorithms##2##2##(2008-3#2)
evaluation and comparison##3##3##(2008-10#2)(2008-5#1)
evaluation and diagnosis of##3##4##(1992-9#1)(2007-12#1)(2010-12#1)
evaluation and diagnosis##4##3##(1992-9#1)(2007-12#1)(2008-10#1)(2010-12#1)
evaluation and in##2##3##(1993-11#1)(2008-5#1)
evaluation and management of##5##4##(2006-5#1)(2007-12#1)(2007-8#1)(2008-9#1)(2013-8#1)
evaluation and management##9##3##(1992-6#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-3#1)(2008-9#1)(2013-8#1)
evaluation and monitoring of##3##4##(1995-5#1)(2011-2#1)(2011-3#1)
evaluation and prediction##4##3##(2008-10#2)(2010-12#2)
evaluation and therapy##2##3##(2011-2#1)(2013-8#1)
evaluation and treatment of##5##4##(2007-10#1)(2007-9#1)(2009-1#1)(2009-3#1)(2010-12#1)
evaluation and treatment planning##2##4##(2007-11#2)
evaluation and treatment##17##3##(1991-1#1)(1993-1#1)(1997-2#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-12#1)(2012-2#1)
evaluation and##106##2##(1991-1#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-5#2)(1996-7#1)(1997-2#3)(1997-3#2)(2006-5#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-12#5)(2010-5#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#4)
evaluation are##11##2##(1993-12#1)(1993-2#2)(1996-8#1)(2008-11#1)(2008-5#2)(2009-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
evaluation as well as##2##4##(1996-2#1)(1997-2#1)
evaluation as##6##2##(1996-2#1)(1996-3#1)(1997-2#2)(2008-4#1)(2012-3#1)
evaluation at##3##2##(1997-2#2)(2011-2#1)
evaluation based on##2##3##(2008-10#1)(2011-2#1)
evaluation before##2##2##(1991-11#1)(2008-7#1)
evaluation between##3##2##(2007-12#1)(2008-5#1)(2009-5#1)
evaluation by##9##2##(1993-1#1)(1994-6#1)(1996-9#1)(2008-10#2)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
evaluation can be##3##3##(1993-12#1)(2009-8#1)(2011-2#1)
evaluation criteria##4##2##(1991-3#1)(1993-12#1)(2008-7#1)(2012-3#1)
evaluation data##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
evaluation did not##2##3##(2007-10#1)(2013-8#1)
evaluation due to##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
evaluation examined the number of##2##5##(2013-1#2)
evaluation factors##2##2##(2011-2#2)
evaluation failed to##2##3##(2008-5#1)(2008-6#1)
evaluation followed##2##2##(1990-3#1)(2009-7#1)
evaluation following##2##2##(2008-10#1)(2012-2#1)
evaluation for a##2##3##(1997-3#1)(2008-7#1)
evaluation for the##5##3##(1992-6#1)(2008-10#1)(2008-7#2)(2008-8#1)
evaluation for##21##2##(1992-6#1)(1993-1#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#4)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#5)(2012-3#1)
evaluation form##4##2##(2007-8#1)(2012-2#2)(2013-1#1)
evaluation forms##2##2##(2008-12#1)(2012-2#1)
evaluation has been##2##3##(2008-10#1)(2008-3#1)
evaluation has##5##2##(1992-12#1)(2008-10#1)(2008-12#2)(2008-3#1)
evaluation in a##3##3##(1990-9#1)(1993-12#1)(2008-5#1)
evaluation in patients##2##3##(1990-2#1)(2011-2#1)
evaluation in the treatment of##2##5##(1990-12#1)(1992-12#1)
evaluation in the##8##3##(1990-12#1)(1992-12#1)(1997-2#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
evaluation in##38##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1997-2#2)(2006-6#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
evaluation included##4##2##(2010-4#1)(2011-2#2)(2013-1#1)
evaluation including##2##2##(2008-12#1)(2013-8#1)
evaluation instrument##2##2##(2008-10#1)(2012-3#1)
evaluation instruments##2##2##(1990-2#1)(2008-12#1)
evaluation is needed##2##3##(1996-3#1)(2010-11#1)
evaluation is performed##2##3##(2008-11#1)(2009-8#1)
evaluation is reported##2##3##(2007-11#1)(2008-5#1)
evaluation is##20##2##(1992-1#1)(1993-12#1)(1994-2#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-5#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
evaluation method##2##2##(2008-11#1)(2008-5#1)
evaluation methods##10##2##(1990-8#1)(1996-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2011-1#1)
evaluation of 1##2##3##(2011-1#1)(2012-3#1)
evaluation of 20##2##3##(2008-11#1)(2011-1#1)
evaluation of a child##2##4##(2008-11#1)(2010-7#1)
evaluation of a model for##2##5##(2008-1#1)(2008-7#1)
evaluation of a personal##2##4##(1993-6#2)
evaluation of a program##3##4##(1993-11#1)(1993-6#1)(2008-12#1)
evaluation of a##66##3##(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#4)(1994-1#2)(1995-1#1)(1995-12#1)(1996-2#2)(1997-2#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#5)
evaluation of acute##6##3##(2008-12#1)(2008-7#1)(2011-2#3)(2013-1#1)
evaluation of adult##2##3##(1996-5#1)(2008-5#1)
evaluation of all##2##3##(2011-2#1)(2013-1#1)
evaluation of alternative##2##3##(1992-12#1)(2008-10#1)
evaluation of an analytical##2##4##(2008-10#2)
evaluation of an innovative##2##4##(2008-12#2)
evaluation of an##19##3##(1992-12#1)(1994-1#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
evaluation of binding parameters##2##4##(2008-10#2)
evaluation of care##2##3##(1994-3#1)(1996-1#1)
evaluation of cell##3##3##(2007-2#1)(2008-4#1)(2013-1#1)
evaluation of chest pain##2##4##(2008-3#2)
evaluation of chronic wrist pain##2##5##(2008-9#2)
evaluation of clinical and##2##4##(2007-8#1)(2008-10#1)
evaluation of clinical##7##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-3#1)(2013-8#2)
evaluation of cognitive##2##3##(2008-7#1)(2008-9#1)
evaluation of common##3##3##(2008-1#1)(2008-10#1)(2010-8#1)
evaluation of coronary artery disease##3##5##(2008-12#1)(2009-4#1)(2010-11#1)
evaluation of coronary artery##4##4##(2008-12#1)(2009-4#1)(2010-11#1)(2011-2#1)
evaluation of coronary##5##3##(1992-5#1)(2008-12#1)(2009-4#1)(2010-11#1)(2011-2#1)
evaluation of dental##4##3##(2008-12#1)(2008-5#1)(2011-2#2)
evaluation of different##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)
evaluation of drug-related##2##3##(2008-8#1)(2011-2#1)
evaluation of each##2##3##(1991-6#1)(2008-10#1)
evaluation of effects##2##3##(2008-11#1)(2013-8#1)
evaluation of efficacy##3##3##(1990-9#2)(1997-3#1)
evaluation of eight##2##3##(2008-12#1)(2008-3#1)
evaluation of experimental##2##3##(2008-3#1)(2010-7#1)
evaluation of four##2##3##(2007-7#1)(2008-12#1)
evaluation of functional##2##3##(2008-10#1)(2008-7#1)
evaluation of graft##2##3##(2007-8#2)
evaluation of health##5##3##(1993-11#1)(1997-3#1)(2010-10#1)(2010-12#1)(2012-12#1)
evaluation of hospital##3##3##(1993-6#1)(1994-3#1)(1996-1#1)
evaluation of its##3##3##(2008-3#1)(2008-4#1)(2010-12#1)
evaluation of kinetic##2##3##(1990-6#1)(2008-10#1)
evaluation of large##2##3##(2008-5#1)(2010-8#1)
evaluation of life quality after HBI performed due to multiple skeletal dissemination##2##12##(2007-11#2)
evaluation of low back pain##2##5##(2007-8#1)(2010-1#1)
evaluation of marine##2##3##(2008-9#1)(2013-1#1)
evaluation of mechanical sufficiency of##2##5##(2007-11#2)
evaluation of mechanical##3##3##(2007-11#3)
evaluation of medical##3##3##(1992-1#1)(1994-2#1)(2009-9#1)
evaluation of more##2##3##(2007-5#1)(2008-10#1)
evaluation of multiple##2##3##(2010-11#1)(2013-8#1)
evaluation of natural##2##3##(1993-9#1)(2008-10#1)
evaluation of new##8##3##(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#2)(2013-1#1)
evaluation of novel##2##3##(1991-1#1)(2012-3#1)
evaluation of oral##2##3##(1995-2#1)(2008-1#1)
evaluation of other##3##3##(2008-10#1)(2012-3#1)(2013-7#1)
evaluation of pain##3##3##(1991-11#1)(2013-1#2)
evaluation of patients with##17##4##(1990-9#1)(1992-12#1)(1996-3#1)(1997-8#1)(2007-4#1)(2008-3#3)(2008-7#3)(2008-9#2)(2009-9#1)(2012-2#1)(2013-1#2)
evaluation of patients##22##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#1)(1994-6#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-4#1)(2008-3#3)(2008-7#3)(2008-9#2)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
evaluation of peroxide##2##3##(2008-10#2)
evaluation of platelets##2##3##(2008-9#2)
evaluation of possible##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
evaluation of potential immunotoxicity##2##4##(2008-10#2)
evaluation of potential##4##3##(2008-10#3)(2011-2#1)
evaluation of preoperative##2##3##(2012-1#1)(2012-2#1)
evaluation of pressure##2##3##(2010-4#1)(2011-1#1)
evaluation of prognostic##2##3##(1994-12#1)(2013-8#1)
evaluation of recovery##3##3##(1993-5#1)(2008-10#2)
evaluation of rectal##5##3##(1990-9#1)(2013-1#4)
evaluation of results##2##3##(1990-2#1)(1990-9#1)
evaluation of risk factors##2##4##(2007-7#1)(2010-8#1)
evaluation of serum##2##3##(1993-6#1)(2008-4#1)
evaluation of severe##2##3##(2012-1#1)(2013-8#1)
evaluation of some##4##3##(2008-10#2)(2012-1#1)(2012-2#1)
evaluation of student##2##3##(2008-11#1)(2008-12#1)
evaluation of students'##2##3##(1993-1#1)(2012-3#1)
evaluation of such##2##3##(1991-12#1)(2011-2#1)
evaluation of surface##2##3##(2008-3#2)
evaluation of symptoms##2##3##(1991-12#1)(2013-7#1)
evaluation of the accuracy of the##2##6##(2008-10#1)(2008-3#1)
evaluation of the airway is##2##5##(2007-12#2)
evaluation of the clinical##3##4##(1990-3#1)(2011-2#2)
evaluation of the correlation##3##4##(2008-10#3)
evaluation of the data##2##4##(2008-10#1)(2011-3#1)
evaluation of the effect of##3##5##(2008-12#1)(2008-6#1)(2009-4#1)
evaluation of the effectiveness of a##5##6##(1994-12#1)(2008-7#4)
evaluation of the effectiveness of##6##5##(1994-12#1)(2007-11#1)(2008-7#4)
evaluation of the effects of##8##5##(1991-1#1)(1997-8#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
evaluation of the efficacy of##3##5##(2007-12#1)(2008-5#1)(2011-1#1)
evaluation of the efficacy##4##4##(1994-6#1)(2007-12#1)(2008-5#1)(2011-1#1)
evaluation of the entire##2##4##(1991-11#1)(2008-12#1)
evaluation of the error##2##4##(2008-3#1)(2012-2#1)
evaluation of the first##2##4##(1996-7#1)(2008-12#1)
evaluation of the functional status of the##2##7##(1997-8#1)(2008-9#1)
evaluation of the hydropathy##2##4##(1990-5#2)
evaluation of the image##2##4##(2008-2#1)(2008-3#1)
evaluation of the impact of this##2##6##(2008-11#1)(2013-7#1)
evaluation of the impact of##5##5##(2007-11#2)(2008-11#1)(2009-2#1)(2013-7#1)
evaluation of the impact##6##4##(2007-11#2)(2008-11#1)(2008-3#1)(2009-2#1)(2013-7#1)
evaluation of the in vitro##2##5##(2008-5#2)
evaluation of the in##3##4##(2008-5#2)(2008-7#1)
evaluation of the method##2##4##(2008-10#2)
evaluation of the model##2##4##(2008-7#2)
evaluation of the morphology##2##4##(2007-8#1)(2008-11#1)
evaluation of the overlap##2##4##(2008-2#1)(2008-3#1)
evaluation of the patients##2##4##(2011-2#1)(2012-3#1)
evaluation of the phase##2##4##(2008-2#1)(2008-3#1)
evaluation of the results##5##4##(1990-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
evaluation of the severity of##2##5##(2007-8#1)(2011-2#1)
evaluation of the software##2##4##(2008-11#1)(2012-1#1)
evaluation of the specific##2##4##(2007-11#1)(2008-7#1)
evaluation of the toxicity of##2##5##(1992-3#1)(1996-12#1)
evaluation of the toxicity##3##4##(1992-3#1)(1996-12#1)(2008-7#1)
evaluation of the treatment##4##4##(1991-1#1)(2007-11#2)(2007-8#1)
evaluation of the uncertainties##2##4##(1995-6#1)(2008-3#1)
evaluation of the##255##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#2)(1997-6#1)(1997-8#3)(2007-10#1)(2007-11#13)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#37)(2008-11#11)(2008-12#8)(2008-2#8)(2008-3#16)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#20)(2008-9#6)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#5)
evaluation of their own##2##4##(1995-2#1)(2009-4#1)
evaluation of their##12##3##(1990-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2011-7#1)(2012-3#2)
evaluation of these##5##3##(1993-2#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
evaluation of this##8##3##(1991-12#1)(1991-5#1)(2007-10#1)(2008-11#2)(2008-5#1)(2013-1#2)
evaluation of total hip##2##4##(2008-8#2)
evaluation of transcript##2##3##(2008-10#2)
evaluation of treatment response##2##4##(2010-12#1)(2010-6#1)
evaluation of treatment##7##3##(1994-8#1)(2007-8#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)
evaluation of two##2##3##(2008-10#2)
evaluation of various##5##3##(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
evaluation of vascular##2##3##(1990-5#1)(2012-2#1)
evaluation of##964##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#5)(1990-5#5)(1990-6#3)(1990-8#3)(1990-9#8)(1991-1#4)(1991-11#4)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#6)(1992-12#4)(1992-2#3)(1992-3#3)(1992-5#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#5)(1993-3#3)(1993-5#2)(1993-6#9)(1993-9#1)(1994-1#5)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#4)(1995-6#4)(1996-1#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#5)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#2)(1997-6#1)(1997-8#5)(2007-10#6)(2007-11#32)(2007-12#17)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#11)(2008-1#10)(2008-10#130)(2008-11#37)(2008-12#30)(2008-2#24)(2008-3#47)(2008-4#7)(2008-5#41)(2008-6#9)(2008-7#50)(2008-8#17)(2008-9#34)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#9)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#17)(2011-2#45)(2011-3#3)(2011-7#2)(2012-1#7)(2012-12#8)(2012-2#24)(2012-3#29)(2013-1#42)(2013-7#4)(2013-8#15)
evaluation on the##2##3##(1990-9#1)(2012-2#1)
evaluation on##5##2##(1990-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
evaluation performed##2##2##(2007-11#1)(2012-12#1)
evaluation period##2##2##(2011-2#1)(2013-1#1)
evaluation points##2##2##(2008-3#2)
evaluation presented##2##2##(1992-2#1)(2008-12#1)
evaluation procedure##2##2##(2008-11#2)
evaluation procedures##3##2##(2008-3#2)(2010-7#1)
evaluation process##10##2##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2011-2#1)(2013-8#1)
evaluation program##2##2##(1995-2#1)(1997-2#1)
evaluation project##2##2##(1995-3#1)(2008-12#1)
evaluation research design for##2##4##(2013-1#2)
evaluation results##2##2##(2008-3#1)(2013-1#1)
evaluation revealed##5##2##(1996-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
evaluation scales##2##2##(1993-2#1)(2013-1#1)
evaluation should be##2##3##(2007-11#1)(2012-3#1)
evaluation should##3##2##(2007-11#1)(2008-8#1)(2012-3#1)
evaluation showed that##2##3##(2008-4#1)(2009-10#1)
evaluation showed##5##2##(2008-4#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
evaluation shows that##3##3##(1993-3#1)(1994-3#1)(2008-3#1)
evaluation shows##4##2##(1993-3#1)(1994-3#1)(2008-3#1)(2012-2#1)
evaluation strategies##3##2##(1996-2#1)(1997-2#1)(2008-5#1)
evaluation study##4##2##(1994-1#2)(2008-10#1)(2008-11#1)
evaluation suggests##2##2##(2008-11#2)
evaluation system for##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
evaluation system##11##2##(2008-10#1)(2008-11#4)(2008-3#1)(2010-8#1)(2011-2#2)(2012-3#2)
evaluation team##2##2##(2013-1#2)
evaluation techniques##3##2##(2008-3#1)(2008-7#1)(2010-5#1)
evaluation test##2##2##(2008-10#1)(2008-5#1)
evaluation that##2##2##(2012-12#1)(2012-3#1)
evaluation through##2##2##(2012-1#1)(2012-3#1)
evaluation to be##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
evaluation to##11##2##(1990-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-3#1)(2009-9#1)(2013-1#2)
evaluation tool##3##2##(1995-3#1)(2007-12#1)(2008-11#1)
evaluation tools##3##2##(1997-2#1)(2013-1#1)(2013-7#1)
evaluation units##3##2##(1994-12#3)
evaluation using##2##2##(2008-10#1)(2008-11#1)
evaluation was based on##2##4##(2007-11#1)(2011-2#1)
evaluation was performed##9##3##(1990-12#1)(2006-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
evaluation was undertaken##2##3##(2008-11#1)(2011-1#1)
evaluation was##25##2##(1990-12#1)(1993-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#2)(2009-3#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
evaluation were##2##2##(1996-9#1)(2008-12#1)
evaluation with##6##2##(2007-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2013-1#1)
evaluation##1701##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#4)(1990-3#8)(1990-5#5)(1990-6#7)(1990-8#4)(1990-9#10)(1991-1#5)(1991-11#6)(1991-12#9)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#10)(1992-11#1)(1992-12#8)(1992-2#4)(1992-3#3)(1992-5#4)(1992-6#2)(1992-9#2)(1993-1#6)(1993-11#6)(1993-12#11)(1993-2#10)(1993-3#7)(1993-5#2)(1993-6#9)(1993-9#1)(1994-1#8)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#8)(1994-5#2)(1994-6#6)(1994-8#1)(1994-9#2)(1995-1#6)(1995-12#2)(1995-2#7)(1995-3#8)(1995-5#7)(1995-6#5)(1996-1#5)(1996-11#1)(1996-12#7)(1996-2#9)(1996-3#9)(1996-5#5)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#23)(1997-3#10)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#6)(2006-10#5)(2006-12#2)(2006-5#2)(2006-6#1)(2007-10#17)(2007-11#52)(2007-12#33)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#20)(2007-9#3)(2008-1#15)(2008-10#185)(2008-11#76)(2008-12#55)(2008-2#36)(2008-3#73)(2008-4#20)(2008-5#69)(2008-6#16)(2008-7#71)(2008-8#27)(2008-9#56)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#6)(2009-4#5)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#5)(2010-12#18)(2010-2#3)(2010-3#12)(2010-4#6)(2010-5#12)(2010-6#4)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#25)(2011-2#96)(2011-3#6)(2011-7#3)(2012-1#11)(2012-12#15)(2012-2#44)(2012-3#60)(2013-1#80)(2013-7#5)(2013-8#37)
evaluation]##7##1##(1991-9#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-9#1)(2009-9#1)(2012-2#1)
evaluations and comparisons##2##3##(1995-2#2)
evaluations and##6##2##(1995-2#2)(1996-8#1)(2007-9#1)(2008-11#1)(2008-9#1)
evaluations are##4##2##(2008-2#2)(2008-5#1)(2010-1#1)
evaluations in##5##2##(1995-9#1)(2007-11#2)(2008-11#1)(2012-12#1)
evaluations indicate that##2##3##(2008-10#1)(2013-1#1)
evaluations is##2##2##(2008-5#1)(2012-1#1)
evaluations of nursing##2##3##(1991-3#1)(1997-3#1)
evaluations of the##5##3##(1991-3#1)(1993-1#1)(1996-2#1)(2008-3#1)(2008-6#1)
evaluations of their##3##3##(1992-3#1)(2010-3#1)(2012-2#1)
evaluations of##30##2##(1991-1#1)(1991-3#2)(1992-3#1)(1993-1#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-3#2)(2007-11#1)(2008-10#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#1)
evaluations on##4##2##(1994-12#1)(1996-3#1)(2008-10#1)(2009-11#1)
evaluations performed##2##2##(2008-1#1)(2008-11#1)
evaluations that##2##2##(1996-3#1)(2008-6#1)
evaluations were##5##2##(1993-1#1)(2007-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
evaluations##118##1##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1992-12#2)(1992-3#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-2#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-3#2)(1997-8#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#7)(2008-12#5)(2008-2#5)(2008-3#2)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
evaluative criteria##2##2##(1992-2#1)(1996-2#1)
evaluative study##2##2##(2008-11#2)
evaluative##14##1##(1992-2#1)(1992-3#1)(1993-1#2)(1995-3#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-3#1)(2009-6#1)(2011-1#1)(2012-3#1)
evaluators##6##1##(1995-2#1)(2008-12#2)(2009-8#1)(2013-1#2)
evanescent field##12##2##(2007-11#4)(2007-12#3)(2008-2#1)(2008-3#4)
evanescent modes##2##2##(2007-11#2)
evanescent optical waves##2##3##(2008-3#2)
evanescent wave penetration##2##3##(2008-10#1)(2008-3#1)
evanescent wave##9##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)
evanescent waves##3##2##(2008-3#3)
evanescent##36##1##(2007-11#9)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#14)(2011-1#1)
evanescent-wave fluorescence##2##2##(1997-7#1)(2008-3#1)
evanescent-wave spectroscopy##3##2##(2007-11#1)(2008-3#2)
evanescent-wave##13##1##(1997-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)(2010-7#2)
evanescently coupled##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
evanescently##5##1##(2008-2#1)(2008-3#3)(2012-2#1)
evansi and LATEX/T##2##3##(2011-2#2)
evansi##9##1##(2011-2#5)(2013-1#4)
evaporate##3##1##(1995-12#1)(2008-11#1)(2010-4#1)
evaporated and##2##2##(2008-10#1)(2008-3#1)
evaporated in##2##2##(2008-10#1)(2008-5#1)
evaporated on##2##2##(2007-12#1)(2008-10#1)
evaporated to dryness and##2##4##(2008-10#2)
evaporated to dryness##7##3##(2008-10#7)
evaporated under reduced pressure##2##4##(2008-11#2)
evaporated##28##1##(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#4)(2009-12#1)(2011-1#1)
evaporating##4##1##(1994-12#1)(2008-10#1)(2008-2#2)
evaporation and absorption##2##3##(2008-5#2)
evaporation and##10##2##(2008-10#5)(2008-3#1)(2008-5#2)(2011-1#2)
evaporation from##5##2##(2008-12#2)(2008-5#3)
evaporation in##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
evaporation manifold##2##2##(2008-11#2)
evaporation method##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
evaporation of sweat##2##3##(1992-3#1)(2008-5#1)
evaporation of the##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
evaporation of water##2##3##(2008-10#1)(2008-11#1)
evaporation of##16##2##(1992-3#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#4)
evaporation rate of##2##3##(2008-10#2)
evaporation rate##7##2##(2008-10#5)(2008-5#2)
evaporation technique##3##2##(2008-10#2)(2010-5#1)
evaporation to dryness##3##3##(2008-10#3)
evaporation##98##1##(1990-4#1)(1992-3#2)(1995-3#2)(1996-2#1)(2007-12#1)(2008-10#35)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#12)(2008-5#22)(2009-11#1)(2009-7#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#2)
evaporative light-scattering##2##2##(1995-3#2)
evaporative##8##1##(1995-3#2)(2008-10#3)(2008-5#1)(2008-7#1)(2012-5#1)
evaporator##7##1##(2008-10#6)(2008-6#1)
evapotranspiration##2##1##(2008-10#1)(2008-8#1)
evasion of##3##2##(2013-1#3)
evasion##5##1##(2009-8#1)(2011-1#1)(2013-1#3)
evasive##2##1##(2010-10#2)
even 1##3##2##(1990-11#1)(1992-6#1)(2008-8#1)
even 4##2##2##(1997-4#1)(2008-10#1)
even a few##2##3##(1990-11#1)(1996-11#1)
even a single##3##3##(2008-7#1)(2010-5#1)(2012-12#1)
even a##18##2##(1990-11#1)(1992-8#1)(1994-5#1)(1996-11#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#2)
even after 20##2##3##(1997-4#1)(2011-2#1)
even after 3##2##3##(1997-4#1)(2008-9#1)
even after a##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
even after adjusting for##3##4##(2008-3#1)(2012-1#2)
even after adjustment##2##3##(1990-12#1)(2010-8#1)
even after controlling for##8##4##(1994-2#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-12#2)(2012-3#1)(2013-1#1)
even after four##2##3##(2008-11#2)
even after long-term##2##3##(1991-12#1)(2008-9#1)
even after several##2##3##(2008-9#1)(2009-12#1)
even after the##7##3##(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
even after##79##2##(1990-12#2)(1991-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#7)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-7#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
even among populations##2##3##(2008-8#1)(2010-3#1)
even among those##2##3##(1991-12#1)(2008-3#1)
even among##10##2##(1991-12#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)
even an##2##2##(2008-10#1)(2008-12#1)
even as the##2##3##(1991-12#1)(1996-8#1)
even as##9##2##(1991-12#1)(1994-8#1)(1996-8#1)(2008-1#1)(2008-7#3)(2011-1#1)(2011-2#1)
even at a time when these##2##6##(2008-10#2)
even at a time when##3##5##(2008-10#3)
even at a##8##3##(2008-10#6)(2008-11#1)(2008-2#1)
even at concentrations as high as##3##6##(2008-10#1)(2008-11#2)
even at concentrations##4##3##(1994-6#1)(2008-10#1)(2008-11#2)
even at high##5##3##(1992-6#1)(2008-10#2)(2008-8#1)(2013-1#1)
even at low temperatures##2##4##(2007-12#1)(2011-2#1)
even at low##6##3##(1992-6#1)(1996-4#1)(2007-12#1)(2008-6#1)(2011-2#2)
even at the higher##2##4##(1997-4#1)(2007-8#1)
even at the highest##2##4##(2008-5#1)(2008-9#1)
even at the same##2##4##(2007-11#1)(2008-10#1)
even at the##10##3##(1995-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)
even at very high##3##4##(1990-12#1)(1991-5#1)(2012-3#1)
even at very low##3##4##(1992-12#1)(1993-8#1)(2008-10#1)
even at very##6##3##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(2008-10#1)(2012-3#1)
even at##58##2##(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
even be##5##2##(1997-7#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-2#1)
even before the##2##3##(1994-3#1)(1996-11#1)
even before##11##2##(1994-3#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-2#1)(2012-12#2)
even better##11##2##(1995-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-1#1)(2013-7#1)
even between##4##2##(1995-5#1)(1996-1#1)(1996-6#1)(2008-7#1)
even by the##2##3##(1992-5#1)(2009-6#1)
even by##6##2##(1992-5#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)
even cause##4##2##(2008-1#1)(2008-8#2)(2011-2#1)
even death##7##2##(1994-12#1)(2007-12#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-1#1)
even distribution of##7##3##(1990-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
even distribution##8##2##(1990-11#1)(1996-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
even during the##3##3##(2008-12#1)(2009-4#1)(2011-2#1)
even during##4##2##(2008-12#1)(2009-4#1)(2011-2#2)
even fast##2##2##(2008-11#1)(2008-3#1)
even faster##2##2##(2008-10#1)(2008-4#1)
even fatal##3##2##(1994-6#1)(2006-10#1)(2011-2#1)
even fewer##2##2##(1992-12#1)(2008-10#1)
even for a##3##3##(2007-11#1)(2012-2#1)(2013-8#1)
even for low##3##3##(2007-11#1)(2008-10#2)
even for short##2##3##(2008-3#2)
even for systems with##2##4##(2007-12#1)(2008-8#1)
even for the##2##3##(2007-11#1)(2011-2#1)
even for##53##2##(1991-6#1)(1991-8#1)(2007-11#5)(2007-12#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#13)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
even from a##2##3##(2008-11#1)(2009-10#1)
even from the##2##3##(2008-11#1)(2013-8#1)
even from##6##2##(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)(2013-8#1)
even further##6##2##(1995-12#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)
even greater##11##2##(1991-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
even harder##2##2##(1996-6#1)(2008-9#1)
even have##2##2##(2008-5#1)(2009-6#1)
even higher##18##2##(1991-6#1)(1992-9#1)(1994-3#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2012-12#1)(2012-3#1)
even if all##2##3##(2008-8#1)(2011-2#1)
even if it is##3##4##(2007-11#1)(2008-3#1)(2010-2#1)
even if it##5##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)
even if only##2##3##(1996-5#1)(2007-2#1)
even if the##29##3##(1990-5#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-8#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
even if they are##5##4##(1996-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
even if they##10##3##(1996-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-3#1)
even if##85##2##(1990-2#1)(1990-5#2)(1991-6#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
even improved##2##2##(2008-10#1)(2008-11#1)
even in a small##2##4##(2008-10#1)(2011-1#1)
even in a##6##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
even in case##2##3##(2008-11#1)(2012-1#1)
even in cases where##2##4##(1990-2#1)(2007-8#1)
even in cases with##3##4##(1990-12#1)(1991-5#1)(2011-2#1)
even in cases##7##3##(1990-12#1)(1990-2#1)(1991-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
even in patients with##2##4##(2008-7#1)(2010-6#1)
even in patients##4##3##(1991-8#1)(2007-7#1)(2008-7#1)(2010-6#1)
even in solution##2##3##(2010-12#1)(2013-8#1)
even in the absence of a##2##6##(1994-2#1)(2008-8#1)
even in the absence of ecological constraints##2##7##(2008-8#2)
even in the absence of##25##5##(1990-12#1)(1990-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#1)
even in the case of a##2##6##(1993-6#1)(2008-3#1)
even in the case of very high##2##7##(2008-10#2)
even in the case of##8##5##(1993-6#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-3#3)
even in the early##2##4##(2012-2#1)(2012-3#1)
even in the face of##2##5##(2008-11#1)(2008-5#1)
even in the presence of a##5##6##(1994-5#1)(2008-10#3)(2008-3#1)
even in the presence of hemin##2##6##(1994-5#2)
even in the presence of high##3##6##(1990-8#1)(2008-10#1)(2008-2#1)
even in the presence of large##3##6##(2007-11#1)(2008-10#2)
even in the presence of noise##2##6##(2008-2#1)(2008-9#1)
even in the presence of##36##5##(1990-12#1)(1990-8#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-5#3)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
even in the presence##37##4##(1990-12#1)(1990-8#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-5#3)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#3)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
even in the##93##3##(1990-12#2)(1990-8#3)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-11#1)(1995-2#2)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#6)(2008-2#2)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#3)
even in their##2##3##(2008-11#1)(2010-9#1)
even in this##3##3##(1991-3#1)(1992-6#1)(2012-3#1)
even in those##2##3##(1991-12#1)(2011-2#1)
even in very##2##3##(2008-10#1)(2008-11#1)
even in##186##2##(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#25)(2008-11#15)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#9)(2008-9#4)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#5)(2013-8#2)
even increase##2##2##(2008-10#1)(2008-8#1)
even increased##4##2##(1996-12#1)(1997-2#1)(2012-1#2)
even large##2##2##(2008-4#1)(2008-9#1)
even larger##7##2##(1992-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
even lead to a##2##4##(2007-7#1)(2008-10#1)
even lead to##4##3##(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)
even less is known about##2##5##(1994-3#1)(2009-8#1)
even less##7##2##(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#2)(2009-8#1)(2013-8#1)
even longer##2##2##(1993-12#1)(2012-3#1)
even low##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
even lower##5##2##(1990-3#1)(1994-5#1)(2008-10#1)(2008-8#1)(2010-12#1)
even minor##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
even moderate##4##2##(1992-3#1)(1994-11#1)(1997-4#1)(2008-8#1)
even more difficult##2##3##(1996-2#1)(2010-6#1)
even more important as##2##4##(1997-1#1)(2011-2#1)
even more important##5##3##(1997-1#1)(2007-11#1)(2007-9#1)(2008-5#1)(2011-2#1)
even more pronounced##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
even more rare than##2##4##(1991-11#1)(2013-1#1)
even more rare##3##3##(1991-11#1)(2013-1#2)
even more relevant##2##3##(1990-3#1)(1990-9#1)
even more severe##2##3##(1995-11#1)(2009-3#1)
even more so##2##3##(2008-7#1)(2013-1#1)
even more the##2##3##(1991-6#1)(2012-12#1)
even more useful##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
even more when##2##3##(1994-2#1)(1996-12#1)
even more##60##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
even negative##2##2##(2007-11#1)(2011-2#1)
even of##3##2##(1995-2#1)(1997-3#1)(2008-10#1)
even on a##3##3##(1995-2#1)(2007-9#1)(2008-11#1)
even on##7##2##(1995-1#1)(1995-2#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-9#1)
even only##2##2##(2008-11#1)(2010-3#1)
even prevent##3##2##(2008-1#1)(2009-12#1)(2012-3#1)
even rarer##8##2##(2007-7#1)(2008-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
even reduced##2##2##(2007-12#1)(2008-5#1)
even severe##3##2##(1991-3#1)(2007-2#1)(2008-7#1)
even showed##3##2##(1995-12#1)(2008-10#1)(2008-4#1)
even small##4##2##(1991-12#1)(1993-2#1)(2008-2#1)(2010-4#1)
even smaller##4##2##(1990-12#1)(1992-9#1)(2008-2#1)(2008-3#1)
even some##2##2##(2008-10#1)(2010-8#1)
even stronger##2##2##(1993-12#1)(1995-11#1)
even subtle##2##2##(1994-12#1)(2011-2#1)
even that##2##2##(2008-10#2)
even the expert##2##3##(1992-1#1)(1994-1#1)
even the most common##2##4##(1994-6#1)(2011-2#1)
even the most##7##3##(1990-8#1)(1992-3#1)(1994-6#1)(1995-3#1)(1997-1#1)(2008-5#1)(2011-2#1)
even the same##2##3##(2008-10#1)(2008-7#1)
even the smallest##3##3##(2008-3#1)(2010-11#1)(2013-1#1)
even the##39##2##(1990-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-1#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#4)(2012-3#2)(2013-1#1)
even they##2##2##(2008-8#1)(2011-2#1)
even those##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
even though a##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
even though both##2##3##(2008-1#1)(2008-10#1)
even though it is##4##4##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
even though it##10##3##(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-8#1)
even though its##2##3##(2007-12#1)(2008-5#1)
even though the sample##2##4##(2008-10#1)(2008-3#1)
even though the##33##3##(1990-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-6#1)(1997-2#3)(1997-7#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#2)
even though their##3##3##(2007-8#1)(2008-10#1)(2009-10#1)
even though there is##2##4##(1993-1#1)(2013-8#1)
even though they were##2##4##(1993-5#1)(2008-10#1)
even though they##5##3##(1993-2#1)(1993-5#1)(2008-10#1)(2008-8#1)(2010-10#1)
even though this##3##3##(1993-3#1)(1997-3#1)(2008-10#1)
even though we##2##3##(1994-3#1)(1997-7#1)
even though##111##2##(1990-12#1)(1990-5#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#3)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-8#1)(2013-7#1)(2013-8#1)
even to the##2##3##(2006-12#1)(2007-5#1)
even to##12##2##(1994-3#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
even today##2##2##(1995-5#1)(2011-2#1)
even under conditions of##2##4##(1992-3#1)(2008-10#1)
even under##10##2##(1992-3#1)(1993-3#1)(2008-10#5)(2008-11#1)(2011-1#1)(2012-1#1)
even up to##2##3##(2008-10#1)(2009-4#1)
even upon##2##2##(1995-2#1)(2008-10#1)
even using##2##2##(1990-12#1)(2008-10#1)
even when a##4##3##(1996-8#1)(2008-10#2)(2008-3#1)
even when all##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
even when challenged with##3##4##(2008-10#2)(2008-12#1)
even when challenged##4##3##(2008-10#3)(2008-12#1)
even when it is##2##4##(2008-9#1)(2012-2#1)
even when it##3##3##(2007-12#1)(2008-9#1)(2012-2#1)
even when only a##2##4##(1995-12#1)(2008-3#1)
even when the##38##3##(1990-9#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1996-11#1)(1996-9#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#1)(2013-1#2)(2013-8#1)
even when their##2##3##(2008-10#1)(2008-2#1)
even when there is a##2##5##(1993-8#1)(2013-1#1)
even when there is##4##4##(1993-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
even when they are##2##4##(1990-12#1)(1995-2#1)
even when they were##2##4##(2008-10#1)(2010-5#1)
even when they##7##3##(1990-12#1)(1993-12#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-8#1)(2010-5#1)
even when treatment##2##3##(1996-3#1)(2009-10#1)
even when##131##2##(1990-12#1)(1990-9#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#7)(2009-10#1)(2009-4#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#6)(2013-8#4)
even where##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
even with a small##2##4##(2008-2#1)(2008-3#1)
even with a##10##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-8#1)(2013-1#1)
even with air exposure##2##4##(1991-12#2)
even with an##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
even with high##2##3##(1993-12#1)(1997-4#1)
even with the##6##3##(1992-5#1)(1992-9#1)(1993-12#1)(2008-11#1)(2008-6#1)(2011-2#1)
even with these##2##3##(2008-8#1)(2013-8#1)
even with##50##2##(1990-8#1)(1991-12#2)(1992-11#1)(1992-5#1)(1992-9#2)(1993-12#2)(1995-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#2)
even within the same##2##4##(2007-7#1)(2010-2#1)
even within the##4##3##(2007-7#1)(2008-1#1)(2008-9#1)(2010-2#1)
even within##6##2##(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-2#1)
even without Sm##2##3##(1993-12#2)
even without##14##2##(1992-10#1)(1993-12#2)(1994-9#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-1#1)
even worse##3##2##(1992-3#1)(1995-6#1)(2008-11#1)
even years later##2##3##(2008-9#1)(2011-2#1)
even years##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
even##1446##1##(1990-11#4)(1990-12#10)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#7)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#15)(1991-3#3)(1991-5#4)(1991-6#4)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#11)(1992-8#2)(1992-9#6)(1993-1#2)(1993-11#1)(1993-12#13)(1993-2#6)(1993-3#9)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#5)(1994-1#3)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#12)(1994-5#8)(1994-6#8)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#7)(1995-12#8)(1995-2#14)(1995-3#3)(1995-5#7)(1995-6#6)(1996-1#1)(1996-11#4)(1996-12#7)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#6)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#8)(1997-3#8)(1997-4#11)(1997-5#2)(1997-6#4)(1997-7#10)(1997-8#3)(2006-10#4)(2006-12#3)(2006-4#1)(2007-10#4)(2007-11#32)(2007-12#32)(2007-2#6)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#2)(2008-1#25)(2008-10#204)(2008-11#72)(2008-12#14)(2008-2#29)(2008-3#82)(2008-4#13)(2008-5#43)(2008-6#15)(2008-7#62)(2008-8#53)(2008-9#38)(2009-10#10)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#11)(2009-9#1)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#11)(2010-4#9)(2010-5#8)(2010-6#5)(2010-7#3)(2010-8#13)(2010-9#3)(2011-1#15)(2011-2#63)(2011-3#1)(2012-1#9)(2012-12#12)(2012-2#21)(2012-3#19)(2012-7#1)(2012-8#1)(2013-1#41)(2013-7#8)(2013-8#23)
even-order##2##1##(2007-12#1)(2013-1#1)
even-symmetry##2##1##(2007-12#2)
evening and night shifts##2##4##(2009-5#2)
evening and##6##2##(1991-12#1)(2008-7#1)(2009-5#2)(2012-5#2)
evening primrose oil##3##3##(1990-3#1)(2008-5#2)
evening primrose##5##2##(1990-3#1)(2008-5#2)(2010-3#2)
evening##29##1##(1990-3#1)(1991-12#1)(1992-3#1)(1996-5#1)(1997-6#1)(2007-12#3)(2008-10#3)(2008-5#8)(2008-7#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-5#2)
evenly between##2##2##(1994-2#1)(2008-9#1)
evenly distributed in the##2##4##(2008-10#1)(2008-9#1)
evenly distributed on##2##3##(2007-12#1)(2008-8#1)
evenly distributed##10##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
evenly spaced sampling units##2##4##(2008-10#2)
evenly spaced##3##2##(2007-11#1)(2008-10#2)
evenly##23##1##(1993-12#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-8#1)
evenness and##2##2##(2013-7#2)
evenness index##2##2##(2008-8#1)(2013-7#1)
evenness##9##1##(2008-10#4)(2008-8#2)(2013-7#3)
event MON88017##2##2##(2011-2#2)
event after##2##2##(2008-11#1)(2013-8#1)
event among##2##2##(2008-1#1)(2008-11#1)
event analysis##2##2##(2008-9#1)(2011-2#1)
event and death##4##3##(2008-8#1)(2010-8#3)
event and the##5##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
event and##20##2##(1992-8#1)(1995-8#1)(1996-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-8#3)(2011-2#2)(2013-8#1)
event associated with##2##3##(2008-7#1)(2010-7#1)
event associated##3##2##(1996-2#1)(2008-7#1)(2010-7#1)
event between##3##2##(2007-10#1)(2008-10#1)(2008-11#1)
event but##2##2##(1991-12#1)(1994-8#1)
event can##2##2##(2007-12#1)(2011-2#1)
event data##10##2##(1995-9#1)(1997-3#1)(1997-4#5)(1997-8#1)(2008-8#2)
event definitions##2##2##(1997-4#2)
event during pregnancy##2##3##(2008-1#1)(2009-12#1)
event during##3##2##(2008-1#1)(2009-12#1)(2009-9#1)
event for##4##2##(1992-9#1)(1997-1#1)(2008-7#1)(2012-2#1)
event free survival##2##3##(2011-2#1)(2012-2#1)
event had occurred##2##3##(2008-10#1)(2008-8#1)
event has##2##2##(2008-10#1)(2011-1#1)
event in a##2##3##(1995-1#1)(2008-8#1)
event in the pathogenesis of##2##5##(2008-10#1)(2011-1#1)
event in the pathogenesis##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
event in the##13##3##(1990-7#1)(1992-8#1)(1995-9#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)
event in##32##2##(1990-7#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-9#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#2)(2010-11#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
event information##2##2##(2008-8#1)(2013-1#1)
event involves##2##2##(2008-3#1)(2009-10#1)
event is##15##2##(1991-2#1)(1991-5#1)(1993-11#1)(1994-10#1)(1994-9#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
event occurred in the##2##4##(2008-10#1)(2011-2#1)
event occurred##3##2##(2008-10#2)(2011-2#1)
event occurring##4##2##(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
event occurs##3##2##(1994-12#1)(2009-6#1)(2012-1#1)
event of a##4##3##(1990-9#1)(2008-7#1)(2008-9#1)(2011-2#1)
event of##22##2##(1990-3#1)(1990-9#1)(1991-6#1)(1992-1#1)(1994-12#2)(1997-2#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-1#1)(2010-12#1)(2011-2#5)(2013-1#1)
event or##3##2##(1997-4#2)(2011-2#1)
event probabilities##3##2##(1992-9#2)(2011-2#1)
event rate##5##2##(1995-2#1)(2008-11#1)(2008-3#2)(2008-8#1)
event rates##7##2##(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#3)(2013-1#1)
event related##2##2##(1995-5#1)(2008-11#1)
event remains unknown##2##3##(2008-10#1)(2012-2#1)
event reporting##4##2##(2008-11#2)(2012-3#1)(2013-1#1)
event reports##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
event that is##2##3##(1994-8#1)(2009-10#1)
event that occurs##2##3##(2007-12#1)(2012-3#1)
event that##17##2##(1994-8#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#3)(2012-3#2)
event to be##2##3##(2007-7#1)(2012-3#1)
event to##3##2##(2007-7#1)(2007-8#1)(2012-3#1)
event was##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
event were##3##2##(1992-8#1)(2008-10#1)(2008-5#1)
event which##3##2##(1990-5#1)(1995-12#1)(2008-10#1)
event with##3##2##(2008-10#2)(2008-9#1)
event within##2##2##(1994-3#1)(2013-1#1)
event would##2##2##(1997-5#1)(2009-2#1)
event##400##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#5)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#4)(1996-12#1)(1996-2#6)(1996-4#4)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#15)(1997-5#3)(1997-7#2)(1997-8#3)(2006-12#1)(2006-6#1)(2007-10#5)(2007-11#2)(2007-12#5)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#37)(2008-11#20)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#24)(2008-8#15)(2008-9#13)(2009-10#8)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#27)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#9)(2013-1#12)(2013-7#1)(2013-8#7)
event'##2##1##(1992-9#1)(1996-12#1)
event-based##2##1##(2008-1#1)(2013-7#1)
event-free survival (EFS) were##2##4##(2011-2#2)
event-free survival (EFS)##3##3##(2011-2#3)
event-free survival of##2##3##(2007-8#1)(2010-3#1)
event-free survival##6##2##(1994-10#1)(2007-8#1)(2010-3#1)(2011-2#3)
event-free##7##1##(1994-10#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-2#3)
event-related brain potential##3##3##(1995-12#1)(1996-5#1)(2008-11#1)
event-related brain##4##2##(1995-12#1)(1996-5#1)(2008-11#2)
event-related functional magnetic resonance imaging##2##5##(2008-11#1)(2012-1#1)
event-related functional##3##2##(2008-11#1)(2012-1#1)(2012-2#1)
event-related potential (ERP)##2##3##(1995-5#1)(2013-8#1)
event-related potential##3##2##(1995-5#2)(2013-8#1)
event-related potentials##5##2##(2007-8#1)(2008-11#3)(2008-7#1)
event-related##18##1##(1995-12#1)(1995-2#1)(1995-5#2)(1996-5#1)(2007-8#1)(2008-11#7)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#2)
eventration##2##1##(2010-5#2)
events -##2##2##(2008-4#1)(2008-7#1)
events after##4##2##(1991-3#1)(1992-9#1)(2007-8#1)(2009-5#1)
events among##2##2##(2008-11#1)(2008-8#1)
events and a##2##3##(1991-8#1)(1997-4#1)
events and are##2##3##(2008-3#1)(2012-2#1)
events and in##2##3##(2008-7#1)(2008-8#1)
events and may##2##3##(2012-12#1)(2013-7#1)
events and the##7##3##(1991-6#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
events and their##2##3##(2008-10#1)(2011-2#1)
events and##67##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-6#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-6#1)(1997-4#3)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-9#1)(2010-2#4)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
events are discussed##2##3##(1995-11#1)(2007-12#1)
events are necessary for##2##4##(1993-8#1)(2008-4#1)
events are not##3##3##(1992-8#1)(1996-2#1)(2008-7#1)
events are rare##2##3##(2008-10#1)(2008-9#1)
events are##29##2##(1992-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
events as well as##2##4##(2012-2#1)(2013-1#1)
events as##6##2##(2008-11#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
events associated with the##3##4##(1991-3#1)(1992-8#1)(2011-2#1)
events associated with##15##3##(1990-12#1)(1991-3#1)(1992-8#1)(1996-8#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
events at the##4##3##(1997-2#1)(2007-11#1)(2008-12#1)(2009-4#1)
events at##9##2##(1997-2#1)(2007-11#1)(2008-12#3)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
events before##2##2##(1992-4#1)(2008-12#1)
events between##5##2##(2007-12#1)(2008-10#3)(2013-8#1)
events both##2##2##(1994-5#1)(2008-1#1)
events but##2##2##(1996-4#1)(2008-10#1)
events by##7##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#1)
events can##6##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
events compared##2##2##(2008-11#1)(2008-7#1)
events could##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
events during the##2##3##(2008-11#1)(2008-2#1)
events during##15##2##(1991-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
events experienced##2##2##(1992-1#1)(2009-4#1)
events following##5##2##(1996-12#1)(2007-12#1)(2008-7#1)(2009-5#1)(2013-7#1)
events for patients##2##3##(2007-10#1)(2010-1#1)
events for##11##2##(1992-9#1)(1993-8#1)(1996-4#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-8#1)(2010-1#1)(2011-1#1)(2013-1#1)
events from the##2##3##(1997-5#1)(2012-3#1)
events from##9##2##(1993-8#1)(1994-2#1)(1997-5#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-3#1)
events has been##2##3##(2008-11#1)(2010-12#1)
events has##5##2##(2008-11#1)(2008-7#1)(2009-11#1)(2010-1#1)(2010-12#1)
events have##4##2##(1997-1#1)(2007-11#1)(2007-2#1)(2008-9#1)
events in a##2##3##(1992-11#1)(2008-11#1)
events in alendronate users##2##4##(2008-11#2)
events in biological##2##3##(2008-10#1)(2009-2#1)
events in both##3##3##(1996-4#1)(1997-8#1)(2011-2#1)
events in individual##2##3##(1997-7#1)(2009-9#1)
events in living cells##2##4##(2008-1#1)(2009-7#1)
events in patients with##3##4##(2008-1#1)(2008-7#1)(2009-12#1)
events in patients##5##3##(1990-5#1)(1993-2#1)(2008-1#1)(2008-7#1)(2009-12#1)
events in pediatric##3##3##(2010-5#1)(2012-3#2)
events in the##22##3##(1991-3#1)(1992-10#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-8#1)(2012-2#1)
events in this##5##3##(1994-8#2)(2008-8#1)(2009-11#1)(2010-8#1)
events in which##2##3##(2007-8#1)(2008-7#1)
events in##95##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#4)(1996-12#1)(1996-4#2)(1996-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#3)(2008-1#5)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
events including##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
events increase##2##2##(1997-3#1)(2008-7#1)
events induced##2##2##(2008-5#1)(2012-2#1)
events involved in##4##3##(1994-11#1)(2008-10#1)(2008-7#2)
events involving the##2##3##(1990-11#1)(1993-12#1)
events involving##4##2##(1990-11#1)(1993-12#1)(2011-2#1)(2013-1#1)
events is##6##2##(1991-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-1#1)(2011-2#1)
events leading to the establishment of##2##6##(1996-9#1)(2008-11#1)
events leading to the##6##4##(1991-5#1)(1992-3#1)(1993-8#1)(1996-9#1)(2008-10#1)(2008-11#1)
events leading to##12##3##(1991-5#1)(1992-3#1)(1993-8#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-3#1)
events leading##14##2##(1990-9#1)(1991-5#1)(1992-3#1)(1993-8#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-3#2)(2011-1#1)(2012-3#1)
events may be##2##3##(2008-8#2)
events may##6##2##(1991-12#1)(2008-2#1)(2008-8#3)(2012-1#1)
events observed in##2##3##(2008-5#1)(2013-7#1)
events observed##3##2##(1997-4#1)(2008-5#1)(2013-7#1)
events occur##3##2##(1995-12#1)(1996-4#1)(2008-10#1)
events occurred within##2##3##(2008-12#1)(2008-8#1)
events occurred##8##2##(1994-11#1)(1994-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
events occurring##5##2##(1994-5#1)(1995-2#1)(1995-6#1)(2008-2#1)(2012-6#1)
events of apoptosis##4##3##(1994-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
events of the##5##3##(1990-2#1)(1993-3#1)(2008-10#2)(2008-4#1)
events of##30##2##(1990-2#1)(1991-12#1)(1993-3#1)(1994-6#1)(1995-2#2)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2011-2#2)
events on a##2##3##(1995-3#1)(2008-10#1)
events on the##2##3##(1994-11#1)(2012-2#1)
events on##8##2##(1994-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-7#2)(2012-2#1)(2012-6#1)
events or##6##2##(2008-1#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-3#1)(2010-8#1)
events per##2##2##(2008-10#1)(2011-1#1)
events related to##7##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#1)
events require##2##2##(2008-10#1)(2012-3#1)
events required for##2##3##(1993-2#1)(1995-2#1)
events similar to those observed##2##5##(2008-10#2)
events such as the##2##4##(2009-5#1)(2012-12#1)
events such as##18##3##(1992-8#1)(1995-11#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
events suggests##2##2##(1996-11#1)(2008-8#1)
events that are##8##3##(1994-11#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-1#1)(2010-12#1)
events that have##2##3##(2008-9#1)(2011-2#1)
events that lead to the formation##2##6##(2008-12#1)(2012-2#1)
events that lead to##5##4##(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
events that led to the##2##5##(2008-7#1)(2011-2#1)
events that occur during##2##4##(2008-4#1)(2008-9#1)
events that occur##3##3##(1997-7#1)(2008-4#1)(2008-9#1)
events that regulate##2##3##(2008-1#1)(2012-2#1)
events that took place##2##4##(1997-5#1)(2008-9#1)
events that##53##2##(1991-2#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-1#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#7)(2008-8#1)(2008-9#5)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
events through##2##2##(2012-3#1)(2013-1#1)
events to##2##2##(1994-5#1)(2008-8#1)
events triggered by fire##2##4##(2009-10#2)
events triggered##3##2##(2008-7#1)(2009-10#2)
events underlying##5##2##(2008-10#1)(2009-10#1)(2012-2#3)
events was##12##2##(1990-11#1)(1990-3#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
events were identified##2##3##(2008-4#1)(2013-8#1)
events were observed##2##3##(2008-12#1)(2011-1#1)
events were similar##2##3##(2012-12#2)
events were the##2##3##(1991-2#1)(2008-10#1)
events were##28##2##(1991-2#1)(1992-11#1)(1992-8#1)(1994-6#1)(1995-6#2)(1996-1#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-7#1)(2009-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
events which##5##2##(1993-2#1)(1995-6#1)(2008-5#2)(2011-2#1)
events will##3##2##(2008-8#1)(2011-1#1)(2011-2#1)
events with##4##2##(1997-3#1)(2008-3#1)(2008-9#1)(2012-3#1)
events within the##3##3##(2008-1#1)(2008-11#1)(2009-10#1)
events within##4##2##(2008-1#1)(2008-11#1)(2009-10#1)(2013-8#1)
events##956##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-9#2)(1991-11#5)(1991-12#9)(1991-2#6)(1991-3#4)(1991-5#3)(1991-6#1)(1991-8#5)(1991-9#2)(1992-1#6)(1992-10#1)(1992-11#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#5)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#6)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#7)(1994-11#7)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#6)(1994-8#5)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#4)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#9)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#12)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#15)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#17)(2008-10#88)(2008-11#62)(2008-12#17)(2008-2#18)(2008-3#29)(2008-4#29)(2008-5#12)(2008-6#9)(2008-7#49)(2008-8#42)(2008-9#25)(2009-1#1)(2009-10#12)(2009-11#9)(2009-12#5)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#7)(2009-6#5)(2009-7#3)(2009-8#9)(2009-9#6)(2010-1#8)(2010-10#3)(2010-11#1)(2010-12#15)(2010-2#5)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#9)(2010-9#4)(2011-1#11)(2011-2#45)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#31)(2012-3#16)(2012-6#2)(2013-1#27)(2013-7#5)(2013-8#18)
events)##4##1##(1997-5#1)(2008-1#1)(2008-9#1)(2010-2#1)
events/gt-y##3##1##(2007-7#3)
eventual aim##2##2##(1995-2#1)(2008-11#1)
eventual resolution##2##2##(2008-10#1)(2012-2#1)
eventual##47##1##(1990-5#3)(1992-12#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-4#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
eventually be##6##2##(1992-3#1)(1992-6#1)(1994-5#1)(2007-10#1)(2008-12#1)(2008-5#1)
eventually cause##2##2##(2008-5#1)(2012-12#1)
eventually develop##4##2##(1991-1#1)(2008-1#1)(2008-7#1)(2012-1#1)
eventually die##2##2##(2008-1#1)(2010-3#1)
eventually increased##2##2##(1990-2#1)(2008-7#1)
eventually lead to##2##3##(2008-10#1)(2009-5#1)
eventually lead##3##2##(2008-10#2)(2009-5#1)
eventually leading to##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
eventually leads to##3##3##(1994-6#1)(1997-7#1)(2008-8#1)
eventually recovered##2##2##(2008-4#1)(2010-5#1)
eventually the##2##2##(2008-8#1)(2009-6#1)
eventually to##6##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)
eventually##125##1##(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#2)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#7)
ever achieved##2##2##(2007-12#2)
ever be##2##2##(2011-1#1)(2013-7#1)
ever been##4##2##(2008-12#1)(2008-4#1)(2012-3#2)
ever changing##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
ever developed##2##2##(2007-7#1)(2008-11#1)
ever generated directly from a laser oscillator##2##7##(2007-11#1)(2007-12#1)
ever generated directly from a##3##5##(2007-11#2)(2007-12#1)
ever greater##2##2##(2008-5#1)(2009-12#1)
ever having##2##2##(1997-1#1)(2011-1#1)
ever increasing##3##2##(1992-2#1)(2007-8#1)(2011-2#1)
ever more important##3##3##(1993-11#1)(1995-12#1)(1995-2#1)
ever more sophisticated##2##3##(2008-11#1)(2008-7#1)
ever more##14##2##(1993-11#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
ever reported in##2##3##(2008-4#1)(2008-7#1)
ever reported##8##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
ever since##4##2##(2007-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
ever that##2##2##(1993-1#1)(2008-10#1)
ever to be##2##3##(1992-1#1)(2008-3#1)
ever to##7##2##(1992-1#1)(1993-6#1)(1996-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)
ever##126##1##(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-6#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#7)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#4)
ever-changing##2##1##(1992-3#1)(2008-10#1)
ever-increasing##8##1##(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)
evergreen##3##1##(2011-10#3)
eversion##4##1##(2007-8#1)(2008-10#1)(2011-1#2)
eversmanni##2##1##(2008-6#2)
everted##2##1##(1991-2#1)(2008-5#1)
every 0##5##2##(2008-2#1)(2013-1#4)
every 1##4##2##(1990-3#1)(1991-12#1)(2008-10#1)(2013-1#1)
every 10##2##2##(2008-5#2)
every 12 h for##2##4##(1995-12#2)
every 12 hours##2##3##(1990-2#1)(2007-10#1)
every 12##6##2##(1990-2#1)(1995-12#2)(2007-10#1)(2008-10#1)(2009-8#1)
every 15 days##2##3##(2013-1#1)(2013-8#1)
every 15 min##2##3##(1995-11#1)(2008-5#1)
every 15 minutes##2##3##(2008-5#1)(2009-9#1)
every 15##6##2##(1995-11#1)(2008-5#2)(2009-9#1)(2013-1#1)(2013-8#1)
every 2 days##3##3##(2008-10#2)(2010-12#1)
every 2 h for##2##4##(1994-2#1)(2008-7#1)
every 2 weeks in##2##4##(1996-7#1)(2008-7#1)
every 2 weeks##16##3##(1996-7#1)(2008-10#1)(2008-6#4)(2008-7#7)(2010-3#1)(2013-1#2)
every 2 years##2##3##(1995-1#1)(2010-11#1)
every 2##28##2##(1994-2#1)(1994-9#1)(1995-1#1)(1996-7#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-6#4)(2008-7#8)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
every 21 days##4##3##(1991-4#1)(1991-6#1)(2008-10#1)(2013-1#1)
every 21##5##2##(1991-4#1)(1991-6#1)(1991-8#1)(2008-10#1)(2013-1#1)
every 24##2##2##(1996-3#1)(2008-8#1)
every 28 days##3##3##(1990-2#1)(1992-2#1)(2008-6#1)
every 3 days##4##3##(1997-6#1)(2008-10#2)(2010-12#1)
every 3 months##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
every 3 to##2##3##(2007-7#1)(2008-10#1)
every 3 weeks##10##3##(1990-10#1)(1991-2#1)(1991-6#1)(2007-10#1)(2008-10#2)(2008-6#1)(2008-7#2)(2010-3#1)
every 3##20##2##(1990-10#1)(1991-2#1)(1991-6#1)(1992-12#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
every 3-4##2##2##(2008-11#1)(2008-9#1)
every 30##2##2##(2008-5#1)(2009-4#1)
every 4 weeks##4##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-2#1)
every 4##10##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-11#1)(2008-10#1)(2012-12#1)
every 5 min##4##3##(1993-6#1)(2008-5#1)(2012-3#1)(2013-8#1)
every 5##9##2##(1991-12#1)(1993-6#1)(1995-11#1)(1996-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
every 6 months for##2##4##(2013-1#2)
every 6 months##4##3##(2007-8#1)(2013-1#3)
every 6##6##2##(1993-2#1)(2007-12#1)(2007-8#1)(2013-1#3)
every area of##2##3##(1994-1#1)(1996-1#1)
every case of##2##3##(1992-9#1)(2008-11#1)
every case##10##2##(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-5#2)
every clinical##2##2##(2008-10#1)(2012-2#1)
every day in##2##3##(2009-10#1)(2010-6#1)
every day##21##2##(1991-9#1)(1994-12#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-12#3)(2010-6#2)(2011-2#1)(2013-7#1)
every detector sees some fluorescence from every fluorochrome##2##8##(2008-9#2)
every dollar##2##2##(1993-3#1)(1994-1#1)
every effort##2##2##(1995-2#1)(1997-1#1)
every eight##2##2##(1992-11#1)(2008-5#1)
every five years##2##3##(2013-1#1)(2013-8#1)
every five##4##2##(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
every four##4##2##(2008-10#1)(2008-5#1)(2010-3#1)(2010-8#1)
every group##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
every isolate##3##2##(2008-10#3)
every laboratory##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)
every medical##2##2##(1991-3#1)(2010-12#1)
every month##4##2##(2007-11#1)(2007-7#1)(2008-6#1)(2013-1#1)
every new##2##2##(1995-2#1)(2008-10#1)
every other day for 27 days##2##6##(2008-10#2)
every other day for two weeks##2##6##(1994-12#1)(2008-7#1)
every other day for##5##4##(1994-12#1)(1995-3#1)(2008-10#2)(2008-7#1)
every other day##8##3##(1990-7#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
every other week##5##3##(1996-11#1)(2008-6#1)(2012-2#3)
every other##19##2##(1990-7#1)(1994-12#1)(1995-3#1)(1996-11#1)(2007-10#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#3)
every patient in##2##3##(1993-5#1)(2008-7#1)
every patient##9##2##(1990-3#1)(1993-12#1)(1993-5#1)(1994-9#1)(1996-6#1)(2008-6#1)(2008-7#2)(2009-4#1)
every plan##2##2##(1994-2#1)(1995-2#1)
every point of the##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
every point##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
every possible##2##2##(1997-7#1)(2008-10#1)
every reason to##2##3##(1991-5#1)(1996-3#1)
every sample##3##2##(1992-6#1)(2008-10#1)(2008-9#1)
every second##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)
every single case##2##3##(2007-11#1)(2010-11#1)
every single##6##2##(1990-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#1)(2010-11#1)
every six##2##2##(2008-11#1)(2012-3#1)
every sixth month##2##3##(1997-8#2)
every stage##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
every step in##2##3##(2008-8#1)(2011-1#1)
every step##4##2##(1993-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
every student##2##2##(2008-11#1)(2013-8#1)
every third##2##2##(1992-5#1)(1997-8#1)
every three##3##2##(1993-6#1)(2008-5#1)(2012-12#1)
every time##4##2##(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#1)
every two weeks##5##3##(2007-5#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
every two##7##2##(1990-8#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
every type of##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
every week##6##2##(1991-9#1)(1992-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
every year and##2##3##(2008-12#1)(2008-7#1)
every year##30##2##(1990-6#1)(1991-6#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
every##476##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#3)(1994-1#3)(1994-12#4)(1994-2#5)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#4)(2007-10#6)(2007-11#7)(2007-12#5)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#65)(2008-11#16)(2008-12#8)(2008-2#10)(2008-3#10)(2008-4#9)(2008-5#19)(2008-6#13)(2008-7#22)(2008-8#5)(2008-9#14)(2009-10#4)(2009-4#3)(2009-5#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#7)(2010-3#7)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#2)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#5)(2012-6#1)(2013-1#26)(2013-7#4)(2013-8#6)
every-3-week chemotherapy##2##2##(2008-7#2)
everybody##4##1##(1991-3#1)(1997-4#1)(2007-7#1)(2012-3#1)
everyday academic resilience##2##3##(2008-12#2)
everyday academic##3##2##(2008-12#2)(2012-1#1)
everyday experience##2##2##(2009-8#1)(2013-8#1)
everyday experiences##2##2##(2008-11#1)(2010-4#1)
everyday life and##2##3##(2007-11#1)(2008-12#1)
everyday life of##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
everyday life##12##2##(1995-6#1)(2007-11#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
everyday lives##3##2##(1995-6#1)(2009-8#1)(2012-2#1)
everyday practice##6##2##(1995-5#1)(1996-8#1)(1997-3#1)(2006-5#1)(2008-11#1)(2010-1#1)
everyday reality##2##2##(2009-10#2)
everyday##65##1##(1992-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-3#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
everyone involved##2##2##(2008-11#1)(2009-10#1)
everyone##16##1##(1992-12#1)(1993-1#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
everyone?##2##1##(1997-4#1)(2007-2#1)
everything else##2##2##(1994-3#1)(2008-3#1)
everything in##2##2##(1995-6#1)(2010-9#1)
everything##10##1##(1994-3#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
everywhere##11##1##(1991-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
evidence about the##5##3##(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#2)
evidence about##12##2##(1996-12#1)(2008-10#2)(2008-7#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
evidence accumulating##2##2##(2008-10#1)(2009-4#1)
evidence against the hypothesis##2##4##(1995-12#1)(2008-6#1)
evidence against the##3##3##(1995-12#1)(2008-6#1)(2008-7#1)
evidence against##4##2##(1995-12#1)(2008-12#1)(2008-6#1)(2008-7#1)
evidence also##2##2##(2010-10#1)(2011-2#1)
evidence and practice##2##3##(1993-12#2)
evidence and the##7##3##(1992-4#1)(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
evidence and##33##2##(1992-4#1)(1993-12#4)(1994-1#1)(1996-3#1)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#1)
evidence approach##2##2##(2007-12#1)(2008-10#1)
evidence are##2##2##(2008-8#1)(2009-8#1)
evidence argues##2##2##(1992-3#1)(2008-10#1)
evidence as the##2##3##(1997-8#1)(2010-3#1)
evidence as well as##2##4##(2008-8#1)(2011-1#1)
evidence as##5##2##(1997-8#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)
evidence at##3##2##(1993-12#1)(1996-3#1)(2008-11#1)
evidence available##2##2##(2008-12#1)(2011-1#1)
evidence base behind the##2##4##(2010-5#1)(2013-1#1)
evidence base for##7##3##(2008-2#1)(2010-5#1)(2012-1#1)(2012-12#2)(2013-1#2)
evidence base in##2##3##(2010-12#1)(2010-5#1)
evidence base is not##2##4##(2008-12#1)(2008-7#1)
evidence base of##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
evidence base to##2##3##(2008-8#1)(2011-10#1)
evidence base##25##2##(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#3)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
evidence based on##3##3##(2008-7#2)(2012-3#1)
evidence based practice - a##2##5##(2008-11#2)
evidence based practice##7##3##(2008-11#7)
evidence based studies##3##3##(2008-1#1)(2013-1#2)
evidence based##21##2##(1995-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-7#2)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
evidence behind the##2##3##(2011-2#1)(2013-8#1)
evidence being##2##2##(1997-4#1)(2008-6#1)
evidence can##2##2##(1993-12#1)(2008-11#1)
evidence concerning##3##2##(1990-6#1)(1991-2#1)(1993-12#1)
evidence confirms that##2##3##(2008-11#1)(2012-2#1)
evidence consistent with##2##3##(2008-10#1)(2008-11#1)
evidence continues to emerge##2##4##(1996-5#1)(2011-1#1)
evidence could be found##2##4##(1990-11#1)(1992-12#1)
evidence could be##3##3##(1990-11#1)(1992-12#1)(2008-8#1)
evidence demonstrates that##4##3##(2008-1#2)(2011-2#1)(2013-1#1)
evidence demonstrates##6##2##(2008-1#2)(2008-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
evidence demonstrating that##3##3##(2008-11#1)(2010-9#1)(2013-1#1)
evidence demonstrating the##2##3##(2008-3#1)(2011-2#1)
evidence demonstrating##5##2##(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
evidence does not##4##3##(1990-6#1)(1992-1#1)(1997-3#1)(2008-6#1)
evidence during##2##2##(2008-3#1)(2012-2#1)
evidence exists for the##2##4##(2010-8#1)(2011-2#1)
evidence exists that##4##3##(1993-11#1)(2009-8#1)(2011-2#2)
evidence exists to support##3##4##(1997-4#1)(2008-11#2)
evidence exists to##5##3##(1997-4#1)(2008-1#1)(2008-11#2)(2008-8#1)
evidence exists##13##2##(1993-11#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#3)
evidence favors##2##2##(2008-11#1)(2008-6#1)
evidence for a direct##2##4##(1994-5#1)(1997-2#1)
evidence for a novel##2##4##(1993-3#1)(1994-12#1)
evidence for a physical##2##4##(2008-7#1)(2009-10#1)
evidence for a role of##4##5##(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#1)
evidence for a role##5##4##(1990-5#1)(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#1)
evidence for a significant##4##4##(1991-12#1)(1993-12#1)(1995-5#1)(2012-3#1)
evidence for a##56##3##(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
evidence for an association##2##4##(1993-9#1)(2008-9#1)
evidence for an increase in##2##5##(2008-7#1)(2009-5#1)
evidence for an##17##3##(1990-5#1)(1991-12#1)(1993-9#1)(1994-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-4#1)(2012-12#1)(2012-3#1)
evidence for and against##4##4##(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#1)
evidence for any##3##3##(2007-8#1)(2008-2#1)(2012-2#1)
evidence for association##3##3##(1991-12#1)(1991-8#1)(1997-5#1)
evidence for both##4##3##(1994-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
evidence for different##2##3##(1992-3#1)(1992-6#1)
evidence for effectiveness of##2##4##(2008-1#1)(2012-12#1)
evidence for familial coaggregation##2##4##(1997-5#2)
evidence for functional##2##3##(1996-2#1)(2008-10#1)
evidence for further##2##3##(1995-2#1)(2008-10#1)
evidence for genetic##2##3##(2007-10#1)(2008-11#1)
evidence for inbreeding avoidance##2##4##(2008-9#2)
evidence for its##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
evidence for linkage##3##3##(1997-5#2)(2008-7#1)
evidence for lysosomal##2##3##(1991-12#1)(2012-12#1)
evidence for recombination##2##3##(2008-10#1)(2008-12#1)
evidence for separate##2##3##(1996-5#1)(2008-5#1)
evidence for strong##2##3##(2008-3#1)(2008-8#1)
evidence for substrate##2##3##(1992-3#1)(2012-3#1)
evidence for such##2##3##(2008-1#1)(2009-8#1)
evidence for the association or##2##5##(1997-5#2)
evidence for the association##3##4##(1997-5#2)(2009-8#1)
evidence for the effectiveness of##3##5##(2008-3#1)(2012-2#1)(2013-1#1)
evidence for the existence of a##2##6##(1990-5#1)(1994-12#1)
evidence for the existence of two##2##6##(1990-11#1)(1990-7#1)
evidence for the existence of##14##5##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-8#1)(1994-12#1)(1994-5#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)
evidence for the hypothesis that##2##5##(2008-12#1)(2011-2#1)
evidence for the involvement of the##2##6##(1992-3#1)(2007-8#1)
evidence for the involvement of##5##5##(1991-9#1)(1992-3#1)(1996-2#1)(2007-8#1)(2011-2#1)
evidence for the molecular##2##4##(1991-12#1)(2012-2#1)
evidence for the occurrence of##2##5##(1992-6#1)(2008-10#1)
evidence for the presence of##6##5##(1990-7#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
evidence for the restoration of##2##5##(2011-2#1)(2013-1#1)
evidence for the role of##4##5##(1997-2#1)(2008-10#1)(2010-4#1)(2011-2#1)
evidence for the simultaneous##2##4##(1994-5#1)(1995-3#1)
evidence for the##94##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2007-12#2)(2007-8#3)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
evidence for their##6##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
evidence for these##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
evidence for this##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
evidence for transmission of##2##4##(1996-3#1)(1997-6#1)
evidence for two distinct##2##4##(1993-11#1)(1996-2#1)
evidence for two##6##3##(1991-2#1)(1993-11#1)(1996-12#1)(1996-2#2)(2008-3#1)
evidence for##368##2##(1990-11#2)(1990-12#3)(1990-5#4)(1990-7#5)(1990-8#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-6#3)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#4)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#4)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#7)(1996-3#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#9)(1997-6#2)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#38)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#23)(2008-8#9)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#21)(2012-1#1)(2012-12#9)(2012-2#4)(2012-3#8)(2013-1#12)(2013-8#7)
evidence from a##3##3##(1994-11#1)(2008-7#1)(2011-2#1)
evidence from an##2##3##(1997-1#1)(2008-6#1)
evidence from animal##2##3##(1994-9#1)(1996-5#1)
evidence from functional##2##3##(2012-2#1)(2013-8#1)
evidence from studies##2##3##(2011-2#2)
evidence from the##8##3##(1994-3#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-10#1)(2010-12#3)
evidence from##63##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#2)(1994-11#1)(1994-3#2)(1994-9#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-6#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-8#1)
evidence gaps##2##2##(2009-3#1)(2011-1#1)
evidence has accumulated##3##3##(1992-3#1)(2008-7#1)(2013-8#1)
evidence has been presented that##2##5##(2008-4#1)(2010-11#1)
evidence has been##5##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
evidence has indicated that##2##4##(1993-11#1)(2008-5#1)
evidence has not##2##3##(2008-11#1)(2008-3#1)
evidence has shown that##4##4##(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
evidence has suggested##2##3##(2008-6#1)(2011-2#1)
evidence has##29##2##(1991-9#1)(1992-3#1)(1993-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#3)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
evidence implicating##2##2##(2008-1#1)(2012-2#1)
evidence in clinical##2##3##(1991-9#1)(1993-12#1)
evidence in favour of##2##4##(1993-3#1)(2013-1#1)
evidence in support of##3##4##(2008-11#1)(2010-5#1)(2011-2#1)
evidence in the literature of##2##5##(2008-7#1)(2010-1#1)
evidence in the literature##4##4##(1995-1#1)(2008-7#1)(2010-1#1)(2010-12#1)
evidence in the##8##3##(1990-9#1)(1993-12#1)(1995-1#1)(2008-6#2)(2008-7#1)(2010-1#1)(2010-12#1)
evidence in their##2##3##(2008-11#2)
evidence in this##2##3##(1995-5#1)(2008-12#1)
evidence in##32##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-6#1)(2007-12#1)(2008-11#5)(2008-12#1)(2008-6#2)(2008-7#3)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
evidence indicate that##10##3##(1990-11#1)(1996-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
evidence indicate##12##2##(1990-11#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
evidence indicated that the##2##4##(1992-12#1)(2008-10#1)
evidence indicated that##5##3##(1992-12#1)(2008-10#3)(2009-7#1)
evidence indicates that the##6##4##(1993-9#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)
evidence indicates that##35##3##(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-11#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
evidence indicates##38##2##(1990-9#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-11#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
evidence indicating that##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
evidence indicating##6##2##(1991-12#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
evidence into##6##2##(1996-6#1)(2008-3#1)(2008-7#3)(2013-7#1)
evidence is assessed as##2##4##(2013-8#2)
evidence is available##7##3##(1992-5#1)(2008-7#1)(2012-12#5)
evidence is consistent with##2##4##(2008-7#1)(2013-1#1)
evidence is lacking##2##3##(1993-12#1)(2010-12#1)
evidence is limited##2##3##(1993-12#1)(2008-12#1)
evidence is not##2##3##(2008-3#1)(2008-9#1)
evidence is presented that##4##4##(1994-12#1)(1995-2#1)(2008-10#2)
evidence is presented##6##3##(1994-12#1)(1995-2#1)(2007-10#1)(2008-10#2)(2013-1#1)
evidence is provided##2##3##(1992-12#1)(1996-5#1)
evidence is sparse##2##3##(1993-12#1)(2013-1#1)
evidence is still##2##3##(1994-12#1)(2009-10#1)
evidence is very##2##3##(1993-3#1)(2008-8#1)
evidence is##59##2##(1990-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#3)(1993-3#3)(1994-1#1)(1994-12#2)(1995-2#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2010-12#1)(2010-6#1)(2011-2#6)(2012-12#6)(2012-2#2)(2013-1#6)(2013-8#2)
evidence linking##4##2##(1996-1#1)(2007-11#1)(2008-8#1)(2011-2#1)
evidence links##2##2##(1993-9#1)(2007-12#1)
evidence may##2##2##(2011-1#1)(2012-2#1)
evidence mounts##2##2##(2008-11#1)(2013-1#1)
evidence now##2##2##(2007-12#1)(2012-12#1)
evidence obtained##3##2##(2009-3#1)(2010-8#1)(2012-2#1)
evidence of DNA##3##3##(1996-12#1)(2008-10#1)(2009-5#1)
evidence of HPV infection##2##4##(1991-2#2)
evidence of NF2##2##3##(2010-11#2)
evidence of a causal##2##4##(1990-6#1)(1997-3#1)
evidence of a genetic##2##4##(1993-8#1)(2011-2#1)
evidence of a positive##2##4##(1990-6#1)(1995-3#1)
evidence of a##43##3##(1990-10#1)(1990-12#1)(1990-6#2)(1991-12#2)(1993-11#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)
evidence of active##2##3##(1992-5#1)(2008-10#1)
evidence of an association between##2##5##(2008-6#1)(2009-10#1)
evidence of an##11##3##(1991-12#1)(1992-2#1)(1992-8#1)(1996-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)
evidence of any##6##3##(1990-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(2010-12#1)(2012-2#1)
evidence of atopy##2##3##(2007-7#2)
evidence of bacterial##2##3##(2006-5#1)(2010-4#1)
evidence of biphasic dose-response relationships##2##5##(2008-7#2)
evidence of bleeding##2##3##(2007-8#1)(2012-12#1)
evidence of bone##2##3##(2008-4#1)(2013-1#1)
evidence of chronic##4##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-5#1)
evidence of cross reactivity between##2##5##(1995-5#1)(2008-8#1)
evidence of decreased##2##3##(1991-12#1)(2013-1#1)
evidence of dengue##2##3##(2007-2#1)(2011-2#1)
evidence of different##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
evidence of disease recurrence##3##4##(2012-2#1)(2013-1#2)
evidence of disease##14##3##(1990-2#2)(1991-2#1)(1992-9#1)(2007-5#1)(2008-10#2)(2008-6#3)(2012-12#1)(2012-2#1)(2013-1#2)
evidence of disruption in the##2##5##(1995-8#1)(2008-8#1)
evidence of efficacy##2##3##(2008-8#1)(2012-2#1)
evidence of excessive##3##3##(1992-5#1)(1994-11#1)(2010-3#1)
evidence of extensive##2##3##(2007-2#1)(2008-5#1)
evidence of host##2##3##(2008-10#2)
evidence of infection##2##3##(2007-12#2)
evidence of interference between##2##4##(2007-11#1)(2009-5#1)
evidence of its##4##3##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
evidence of liver##2##3##(1993-12#1)(2009-8#1)
evidence of local recurrence or##2##5##(2007-12#1)(2008-6#1)
evidence of local recurrence##4##4##(2007-12#1)(2008-6#1)(2010-3#1)(2013-1#1)
evidence of local##6##3##(2007-12#1)(2007-4#1)(2008-6#1)(2010-3#1)(2012-7#1)(2013-1#1)
evidence of malignancy##3##3##(1992-2#1)(1994-12#1)(2008-10#1)
evidence of malignant##2##3##(1990-11#1)(2013-1#1)
evidence of multiple##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
evidence of necrosis##2##3##(1991-3#1)(1994-6#1)
evidence of new##2##3##(1997-5#1)(2008-10#1)
evidence of nonlinear##2##3##(2007-12#1)(2013-1#1)
evidence of old##2##3##(1995-3#1)(2008-7#1)
evidence of previous##6##3##(1997-3#1)(2007-12#2)(2007-8#1)(2008-12#1)(2009-8#1)
evidence of prior H1N1##2##4##(2012-12#2)
evidence of recurrence##6##3##(1990-8#1)(1993-1#1)(2008-10#1)(2011-2#2)(2013-8#1)
evidence of reduced##2##3##(1992-9#1)(2012-12#1)
evidence of relapse##2##3##(1991-4#1)(2013-1#1)
evidence of sexual##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
evidence of significant##2##3##(1995-5#1)(2008-10#1)
evidence of subclinical##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
evidence of systemic##2##3##(2008-7#1)(2009-8#1)
evidence of the effectiveness of##3##5##(2010-6#1)(2011-2#2)
evidence of the effectiveness##4##4##(2010-6#1)(2011-2#3)
evidence of the existence of the##2##6##(2008-3#1)(2010-5#1)
evidence of the existence of##5##5##(1995-12#1)(1995-8#1)(2008-3#1)(2010-5#1)(2010-8#1)
evidence of the##41##3##(1990-11#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-5#1)(1997-8#1)(2007-12#3)(2008-10#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-8#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-3#2)(2013-1#1)
evidence of their effectiveness##2##4##(1993-11#1)(2012-12#1)
evidence of their##5##3##(1993-11#1)(2008-10#2)(2008-6#1)(2012-12#1)
evidence of therapeutic##2##3##(2008-3#1)(2009-8#1)
evidence of this##4##3##(1993-2#1)(2007-12#1)(2008-3#1)(2008-5#1)
evidence of two##3##3##(2008-10#2)(2010-8#1)
evidence of##521##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#3)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#4)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#5)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#7)(1997-6#2)(1997-8#1)(2006-10#3)(2006-5#1)(2007-10#3)(2007-11#7)(2007-12#24)(2007-2#4)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#52)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#14)(2008-4#10)(2008-5#17)(2008-6#10)(2008-7#23)(2008-8#15)(2008-9#15)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#5)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#25)(2012-1#1)(2012-12#8)(2012-2#13)(2012-3#12)(2012-7#1)(2013-1#21)(2013-7#1)(2013-8#4)
evidence on a##3##3##(2007-5#2)(2008-10#1)
evidence on the effectiveness of##2##5##(2012-2#2)
evidence on the effects of##3##5##(2011-2#1)(2012-2#1)(2013-1#1)
evidence on the link between##2##5##(2008-11#2)
evidence on the##23##3##(1990-8#1)(1991-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-2#1)(2009-9#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
evidence on which to##2##4##(2008-11#2)
evidence on which##3##3##(2008-11#2)(2008-12#1)
evidence on##45##2##(1990-8#1)(1991-3#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
evidence pointing to##4##3##(1991-9#1)(1995-12#1)(1997-2#1)(2010-2#1)
evidence points to a##2##4##(2008-7#1)(2009-8#1)
evidence points to##5##3##(1990-8#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-7#1)
evidence presented##5##2##(1997-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
evidence provided by##3##3##(2008-7#1)(2008-8#2)
evidence regarding the##5##3##(1995-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-8#1)
evidence regarding##14##2##(1995-11#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
evidence relating##2##2##(1994-2#1)(2008-10#1)
evidence show##2##2##(2008-4#1)(2012-3#1)
evidence showing that##8##3##(1993-6#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-3#1)
evidence shows that the##3##4##(2006-10#1)(2008-9#1)(2009-4#1)
evidence shows that##8##3##(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-4#1)(2013-1#1)
evidence suggest that##5##3##(1991-9#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
evidence suggest##6##2##(1991-9#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#2)
evidence suggested that##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
evidence suggesting that##12##3##(1992-12#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
evidence suggesting the##2##3##(1994-6#1)(2008-8#1)
evidence suggesting##17##2##(1992-12#1)(1993-3#1)(1994-6#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
evidence suggests a##4##3##(1994-3#1)(2008-10#1)(2008-7#1)(2009-12#1)
evidence suggests an##2##3##(2007-11#1)(2010-7#1)
evidence suggests that it##2##4##(2008-7#1)(2013-8#1)
evidence suggests that the##7##4##(1994-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-2#1)
evidence suggests that these##2##4##(1990-12#1)(2009-7#1)
evidence suggests that they##2##4##(1993-6#1)(2008-3#1)
evidence suggests that this##3##4##(2007-8#1)(2009-8#1)(2013-1#1)
evidence suggests that##60##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-9#2)(1995-3#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#2)
evidence suggests##68##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-3#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#3)
evidence supporting a##3##3##(2007-10#1)(2008-5#1)(2013-1#1)
evidence supporting the efficacy##2##4##(2008-4#1)(2011-2#1)
evidence supporting the hypothesis that##4##5##(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)
evidence supporting the##16##3##(1992-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-3#1)
evidence supporting this##2##3##(2008-2#1)(2011-2#1)
evidence supporting##31##2##(1992-2#1)(1994-12#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
evidence supports the hypothesis that##2##5##(2008-4#1)(2008-7#1)
evidence supports the##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
evidence supports##8##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#2)
evidence surrounding the##2##3##(2008-8#1)(2010-5#1)
evidence that NF-E2##2##3##(1994-8#2)
evidence that R##2##3##(2008-10#2)
evidence that a##11##3##(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-7#2)(2009-2#1)(2009-8#1)(2010-6#1)
evidence that aggressive##2##3##(1991-8#1)(2012-3#1)
evidence that all##2##3##(2008-12#1)(2009-4#1)
evidence that an##2##3##(1992-3#1)(2008-7#1)
evidence that changes in##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
evidence that chronic##2##3##(1993-8#1)(2011-2#1)
evidence that elevated##2##3##(1991-12#1)(2008-8#1)
evidence that excessive##2##3##(2008-5#1)(2012-3#1)
evidence that extracellular##2##3##(2008-4#2)
evidence that has##2##3##(2010-5#1)(2011-2#1)
evidence that higher##2##3##(2008-10#1)(2008-9#1)
evidence that in##2##3##(2008-6#1)(2009-10#1)
evidence that it is##4##4##(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
evidence that it##6##3##(1997-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
evidence that most##2##3##(2008-8#1)(2008-9#1)
evidence that platelets##2##3##(2006-6#2)
evidence that such##2##3##(2007-8#1)(2009-11#1)
evidence that supports##3##3##(2007-11#1)(2008-3#1)(2008-9#1)
evidence that the presence of##2##5##(1993-11#1)(2008-10#1)
evidence that the two##2##4##(2008-10#1)(2010-2#1)
evidence that the##68##3##(1990-2#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-6#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
evidence that these##7##3##(1992-12#1)(1995-11#1)(2008-10#1)(2009-10#1)(2009-5#1)(2010-11#1)(2012-2#1)
evidence that they##3##3##(1996-5#1)(1997-3#1)(2011-2#1)
evidence that this is##2##4##(2008-1#1)(2008-2#1)
evidence that this##7##3##(1991-12#1)(1991-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-2#1)
evidence that two##6##3##(1993-8#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
evidence that##354##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#6)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-6#4)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#33)(2008-11#15)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#17)(2008-8#14)(2008-9#12)(2009-10#4)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#4)(2010-11#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#9)(2012-4#1)(2013-1#6)(2013-7#2)(2013-8#4)
evidence the##5##2##(2008-10#2)(2011-2#2)(2013-1#1)
evidence they##2##2##(1995-2#1)(2011-2#1)
evidence to consider##2##3##(1994-5#1)(2011-2#1)
evidence to date##4##3##(2007-11#1)(2008-11#1)(2010-1#1)(2011-2#1)
evidence to indicate that the##2##5##(2008-3#1)(2009-12#1)
evidence to indicate that##7##4##(1991-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#1)(2013-1#1)
evidence to justify##2##3##(2007-5#1)(2008-11#1)
evidence to practice##2##3##(1993-12#1)(2008-11#1)
evidence to recommend the##2##4##(2008-10#1)(2011-2#1)
evidence to recommend##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
evidence to suggest that the##5##5##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
evidence to suggest that##18##4##(1994-3#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
evidence to suggest##21##3##(1994-3#1)(1994-9#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
evidence to support a##4##4##(1996-9#1)(2007-12#1)(2008-2#1)(2012-3#1)
evidence to support the benefits of##2##6##(2007-11#1)(2008-11#1)
evidence to support the role##2##5##(2008-11#1)(2008-7#1)
evidence to support the use of##4##6##(2007-12#1)(2007-8#1)(2013-1#2)
evidence to support the##13##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2013-1#3)
evidence to support this##5##4##(2008-10#2)(2008-6#1)(2008-8#2)
evidence to support##28##3##(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
evidence to the##3##3##(1995-2#1)(2008-11#1)(2012-12#1)
evidence to##99##2##(1991-6#1)(1993-12#3)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1996-9#1)(2006-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#14)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
evidence used##2##2##(1992-1#1)(2013-8#1)
evidence using##4##2##(1995-12#1)(2012-12#3)
evidence was found for##2##4##(1997-5#1)(2008-10#1)
evidence was found that##3##4##(2007-12#1)(2008-10#1)(2009-1#1)
evidence was found##11##3##(1990-12#1)(1993-12#1)(1994-8#1)(1997-5#1)(2007-12#1)(2008-10#4)(2009-1#1)(2013-1#1)
evidence was obtained for##2##4##(2008-10#1)(2010-11#1)
evidence was obtained##4##3##(1996-8#1)(2008-10#1)(2010-11#1)(2012-2#1)
evidence was##22##2##(1990-12#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-5#1)(2007-12#1)(2008-10#5)(2009-1#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
evidence which suggests that##3##4##(1992-3#1)(1994-11#1)(2010-11#1)
evidence which##5##2##(1992-3#1)(1994-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
evidence will be##2##3##(1997-5#1)(2008-11#1)
evidence will##3##2##(1994-1#1)(1997-5#1)(2008-11#1)
evidence with respect to##2##4##(2008-5#1)(2012-12#1)
evidence with##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
evidence##2267##1##(1990-10#1)(1990-11#8)(1990-12#7)(1990-2#8)(1990-3#5)(1990-5#4)(1990-6#5)(1990-7#7)(1990-8#8)(1990-9#2)(1991-1#4)(1991-12#21)(1991-2#10)(1991-3#4)(1991-4#3)(1991-5#8)(1991-6#4)(1991-8#9)(1991-9#8)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#12)(1992-2#8)(1992-3#17)(1992-4#3)(1992-5#5)(1992-6#5)(1992-7#1)(1992-8#8)(1992-9#12)(1993-1#3)(1993-11#13)(1993-12#36)(1993-2#3)(1993-3#17)(1993-5#1)(1993-6#9)(1993-8#8)(1993-9#5)(1994-1#5)(1994-11#15)(1994-12#14)(1994-2#5)(1994-3#9)(1994-5#11)(1994-6#7)(1994-7#1)(1994-8#12)(1994-9#11)(1995-1#1)(1995-11#10)(1995-12#17)(1995-2#16)(1995-3#8)(1995-5#13)(1995-6#7)(1995-8#6)(1995-9#1)(1996-1#2)(1996-12#11)(1996-2#9)(1996-3#7)(1996-4#2)(1996-5#13)(1996-6#7)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#7)(1997-3#10)(1997-4#7)(1997-5#20)(1997-6#7)(1997-7#4)(1997-8#6)(2006-10#7)(2006-5#1)(2006-6#2)(2007-10#8)(2007-11#20)(2007-12#47)(2007-2#8)(2007-4#1)(2007-5#6)(2007-6#5)(2007-7#7)(2007-8#47)(2008-1#29)(2008-10#193)(2008-11#94)(2008-12#35)(2008-2#19)(2008-3#50)(2008-4#35)(2008-5#47)(2008-6#39)(2008-7#117)(2008-8#80)(2008-9#58)(2009-1#2)(2009-10#21)(2009-11#8)(2009-12#6)(2009-2#8)(2009-3#8)(2009-4#5)(2009-5#15)(2009-6#13)(2009-7#16)(2009-8#29)(2009-9#6)(2010-1#8)(2010-10#9)(2010-11#18)(2010-12#20)(2010-2#6)(2010-3#10)(2010-4#9)(2010-5#22)(2010-6#6)(2010-7#4)(2010-8#9)(2010-9#5)(2011-1#25)(2011-10#2)(2011-2#131)(2012-1#6)(2012-12#56)(2012-2#55)(2012-3#45)(2012-4#1)(2012-7#1)(2013-1#88)(2013-7#8)(2013-8#39)
evidence)##3##1##(2011-2#1)(2012-3#2)
evidence-base for##2##2##(2008-11#1)(2012-12#1)
evidence-based approach for the management of##2##6##(2010-5#1)(2011-2#1)
evidence-based approach##4##2##(1993-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
evidence-based approaches##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
evidence-based clinical##2##2##(2010-6#1)(2010-9#1)
evidence-based depression care##2##3##(2012-2#2)
evidence-based educational##2##2##(2008-11#1)(2008-8#1)
evidence-based guideline##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
evidence-based guidelines for the management of##2##6##(2008-9#1)(2010-12#1)
evidence-based guidelines##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
evidence-based interventions in##2##3##(2012-2#2)
evidence-based interventions##3##2##(2012-2#3)
evidence-based literature##2##2##(2008-7#1)(2013-8#1)
evidence-based management##2##2##(2011-2#2)
evidence-based medicine (EBM) and##2##4##(2012-12#1)(2013-8#1)
evidence-based medicine and##2##3##(2008-1#1)(2012-12#1)
evidence-based medicine##11##2##(2007-12#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-8#1)(2012-12#2)(2013-8#1)
evidence-based nursing##4##2##(2008-11#2)(2008-12#1)(2008-4#1)
evidence-based postoperative pain assessment practices##6##5##(2010-11#6)
evidence-based practice (EBP)##3##3##(2008-11#1)(2013-1#2)
evidence-based practice and##2##3##(2008-3#1)(2012-2#1)
evidence-based practice in##3##3##(2008-11#2)(2008-8#1)
evidence-based practice##21##2##(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-9#2)(2012-2#1)(2013-1#4)
evidence-based practices##5##2##(2010-10#2)(2010-5#1)(2010-7#1)(2012-2#1)
evidence-based recommendations for##2##3##(2007-12#1)(2010-8#1)
evidence-based review##4##2##(2008-3#1)(2008-8#1)(2011-2#2)
evidence-based strategies for##2##3##(2013-1#2)
evidence-based treatment##5##2##(2008-1#1)(2008-3#2)(2008-8#1)(2012-3#1)
evidence-based##144##1##(1993-12#2)(2007-12#6)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#19)(2008-12#5)(2008-3#10)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#2)(2009-12#1)(2009-3#2)(2009-8#1)(2010-10#3)(2010-11#7)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#10)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#15)(2012-3#3)(2013-1#13)(2013-8#3)
evidence?##2##1##(1996-1#1)(2008-7#1)
evidenced a##2##2##(1991-12#1)(2013-1#1)
evidenced by a##12##3##(1991-2#2)(1992-8#1)(1993-3#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
evidenced by the fact that##4##5##(1991-3#1)(1991-5#1)(2008-10#1)(2008-11#1)
evidenced by the##17##3##(1991-3#1)(1991-5#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2013-7#1)
evidenced by##68##2##(1991-2#3)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-4#1)(2009-7#1)(2010-4#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
evidenced in the##6##3##(1994-2#1)(1994-3#1)(1996-1#1)(2008-10#2)(2012-5#1)
evidenced in##13##2##(1994-2#1)(1994-3#2)(1994-5#1)(1996-1#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
evidenced that the##3##3##(2008-10#2)(2009-10#1)
evidenced that##5##2##(2007-11#1)(2008-10#2)(2008-5#1)(2009-10#1)
evidenced the##7##2##(2008-10#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
evidenced##123##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-4#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#4)(2013-7#3)(2013-8#1)
evidenced-based##2##1##(2008-5#1)(2008-9#1)
evidences are##2##2##(2010-11#1)(2012-12#1)
evidences for##5##2##(2008-10#2)(2009-12#1)(2010-3#1)(2012-2#1)
evidences from##2##2##(2008-7#1)(2010-8#1)
evidences in##2##2##(2008-8#1)(2009-5#1)
evidences indicate that##2##3##(2008-11#1)(2011-2#1)
evidences##24##1##(1997-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
evidencing the##2##2##(2008-10#2)
evidencing##6##1##(2008-1#1)(2008-10#2)(2008-12#1)(2009-6#1)(2013-1#1)
evident after##8##2##(1991-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2012-3#1)
evident and##5##2##(1990-2#1)(1990-5#1)(2008-3#1)(2008-9#1)(2009-10#1)
evident at all##2##3##(2011-2#1)(2013-1#1)
evident at days 14 and 21 p##2##7##(2008-5#2)
evident at##11##2##(1993-12#1)(1994-3#1)(1996-5#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#2)
evident between##2##2##(1993-12#1)(2010-10#1)
evident bleeding source was detected in only##2##7##(2011-2#2)
evident by##3##2##(1997-3#2)(2012-1#1)
evident for the##2##3##(1990-12#1)(2008-10#1)
evident for##8##2##(1990-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-3#1)(2012-3#1)
evident from our##2##3##(1994-11#1)(2008-3#1)
evident from the##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#2)
evident from##13##2##(1994-11#1)(1994-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2010-11#1)(2013-1#2)
evident improvement in PS##2##4##(1990-2#2)
evident improvement in##3##3##(1990-2#2)(2008-2#1)
evident in field##2##3##(2008-10#2)
evident in practice##2##3##(2008-11#2)
evident in the##18##3##(1990-11#1)(1993-11#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
evident in##55##2##(1990-11#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
evident on the plastid surface##2##5##(1997-6#2)
evident on the##3##3##(1996-6#1)(1997-6#2)
evident on##6##2##(1996-6#1)(1997-6#2)(2008-10#1)(2008-4#1)(2011-1#1)
evident over##3##2##(1990-12#1)(1992-8#1)(2007-10#1)
evident that the##8##3##(1993-1#1)(1993-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-3#1)
evident that##31##2##(1992-1#1)(1993-1#1)(1993-12#2)(1994-6#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
evident the##4##2##(2008-10#1)(2008-11#1)(2008-2#2)
evident when##3##2##(1992-2#1)(1995-3#1)(2011-1#1)
evident with##2##2##(1991-12#1)(2008-10#1)
evident##255##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#7)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#2)(1997-1#1)(1997-3#5)(1997-4#1)(1997-6#3)(1997-8#1)(2007-10#2)(2007-12#4)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#43)(2008-11#14)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#10)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#14)(2013-8#2)
evidential##3##1##(2008-12#1)(2009-7#1)(2013-8#1)
evidentiary pluralism##3##2##(2009-8#3)
evidently##11##1##(1990-6#1)(1992-3#1)(1992-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2012-2#1)
evil spirit or##2##3##(2009-10#1)(2012-3#1)
evil##5##1##(2009-10#3)(2012-3#2)
evince##2##1##(2006-10#1)(2012-2#1)
evisceration of##2##2##(2007-2#1)(2008-12#1)
evisceration##4##1##(1990-2#1)(2007-2#1)(2008-12#1)(2011-1#1)
evo-devo##2##1##(2010-7#1)(2012-12#1)
evocation##2##1##(2012-2#1)(2012-3#1)
evoke rapid##2##2##(2010-9#1)(2013-8#1)
evoke the##3##2##(1994-11#1)(2009-12#1)(2009-8#1)
evoke##21##1##(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1995-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-9#1)(2012-1#1)(2013-8#1)
evoked GABA efflux##3##3##(1993-12#3)
evoked GABA##4##2##(1993-12#4)
evoked a biphasic##2##3##(1992-9#1)(1997-2#1)
evoked a##8##2##(1990-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1995-12#1)(1996-5#1)(1997-2#1)
evoked and##3##2##(1997-7#1)(2008-4#2)
evoked by EFS##2##3##(1996-5#1)(1997-4#1)
evoked by electrical stimulation of the##2##6##(1993-12#1)(1996-2#1)
evoked by electrical stimulation of##3##5##(1993-12#1)(1995-12#1)(1996-2#1)
evoked by electrical stimulation##5##4##(1993-12#1)(1995-12#1)(1996-2#1)(1997-6#1)(2011-2#1)
evoked by low##2##3##(1992-3#1)(1995-11#1)
evoked by##34##2##(1990-9#1)(1992-3#3)(1993-12#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#7)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-11#2)(2008-4#2)(2008-7#2)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
evoked in the##4##3##(1992-3#2)(1996-5#2)
evoked in##6##2##(1992-3#2)(1995-12#1)(1996-5#3)
evoked magnetic fields##2##3##(1996-5#2)
evoked only##2##2##(1990-7#1)(2008-9#1)
evoked potential in##3##3##(1995-12#1)(2008-7#1)(2011-1#1)
evoked potential##11##2##(1992-8#2)(1995-12#2)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#3)
evoked potentials were##3##3##(1990-9#1)(1996-5#1)(1996-6#1)
evoked potentials##15##2##(1990-3#1)(1990-9#1)(1991-1#1)(1996-2#1)(1996-5#1)(1996-6#3)(1997-6#1)(2007-8#1)(2008-12#1)(2008-9#2)(2010-8#1)(2011-2#1)
evoked release##2##2##(1992-7#1)(1995-12#1)
evoked response was##2##3##(1990-5#1)(1995-12#1)
evoked response##5##2##(1990-5#1)(1991-1#2)(1995-12#1)(1995-5#1)
evoked responses in the##2##4##(1996-5#1)(2008-1#1)
evoked responses##3##2##(1991-12#1)(1996-5#1)(2008-1#1)
evoked the##5##2##(1994-11#1)(1994-2#1)(1995-11#1)(2008-5#1)(2008-9#1)
evoked##157##1##(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#4)(1991-12#3)(1992-12#1)(1992-3#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#10)(1993-3#3)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#6)(1995-12#21)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#14)(1996-6#3)(1997-2#4)(1997-4#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#14)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#1)
evokes a##3##2##(2009-12#1)(2009-4#1)(2013-8#1)
evokes ipsiversive circling##2##3##(1993-3#2)
evokes##19##1##(1990-5#1)(1992-7#1)(1993-3#2)(1994-6#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
evoking impulses on##2##3##(2008-8#2)
evoking the##2##2##(1994-5#1)(1997-2#1)
evoking##11##1##(1990-11#2)(1993-12#2)(1994-5#1)(1997-2#1)(1997-6#1)(2008-7#1)(2008-8#3)
evolution after##4##2##(1993-12#1)(1993-8#1)(2008-3#1)(2013-1#1)
evolution and biological##2##3##(1990-3#1)(2008-10#1)
evolution and development##2##3##(1994-12#1)(2012-12#1)
evolution and function of##3##4##(1993-2#1)(1996-2#1)(2008-9#1)
evolution and function##4##3##(1993-2#1)(1996-2#1)(2008-7#1)(2008-9#1)
evolution and illustrate recent developments in molecular evolution##2##8##(2009-5#1)(2011-2#1)
evolution and the##8##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
evolution and##57##2##(1990-3#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#5)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
evolution are not##2##3##(2008-10#2)
evolution are##3##2##(2008-10#2)(2010-5#1)
evolution as a##2##3##(2008-8#1)(2010-5#1)
evolution as##3##2##(1992-2#1)(2008-8#1)(2010-5#1)
evolution at the##3##3##(1990-6#1)(1992-6#1)(2013-1#1)
evolution at##5##2##(1990-6#1)(1992-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
evolution by##3##2##(1997-4#1)(2010-4#1)(2012-3#1)
evolution can be##2##3##(1997-6#1)(2007-12#1)
evolution can##3##2##(1997-6#1)(2007-12#1)(2008-10#1)
evolution depends##2##2##(2008-5#1)(2008-8#1)
evolution experiments##4##2##(1997-6#4)
evolution for##3##2##(2008-3#1)(2008-8#1)(2009-7#1)
evolution from##6##2##(1994-12#1)(1994-8#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
evolution has been##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
evolution has##7##2##(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#1)
evolution in Sceloporus##2##3##(2010-3#2)
evolution in a##7##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#1)
evolution in metapopulations##2##3##(2008-8#1)(2008-9#1)
evolution in plants##2##3##(2008-7#1)(2008-8#1)
evolution in the##11##3##(1992-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#3)(2012-3#2)(2013-1#1)
evolution in this##2##3##(2010-12#1)(2010-3#1)
evolution in##66##2##(1992-1#1)(1992-11#1)(1992-8#1)(1994-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#7)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#9)(2008-9#6)(2010-12#1)(2010-3#7)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
evolution is an##2##3##(1995-11#1)(2009-9#1)
evolution is correlated with##2##4##(2010-3#2)
evolution is the##5##3##(1997-6#1)(2008-12#1)(2011-10#1)(2011-2#1)(2012-3#1)
evolution is##23##2##(1993-3#1)(1995-11#1)(1997-3#1)(1997-6#2)(2006-7#1)(2008-1#1)(2008-12#1)(2008-8#2)(2009-11#1)(2009-9#1)(2010-3#3)(2011-10#1)(2011-2#3)(2012-3#4)
evolution may##4##2##(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)
evolution model##2##2##(1997-6#1)(2008-4#1)
evolution occurs##2##2##(2008-8#1)(2012-3#1)
evolution of HR##2##3##(2012-2#2)
evolution of a clinical advancement program##2##6##(1995-2#2)
evolution of a##11##3##(1995-2#2)(1997-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-1#2)
evolution of altruism##4##3##(2008-10#1)(2008-8#2)(2008-9#1)
evolution of an##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
evolution of behavior##2##3##(2008-8#2)
evolution of coloniality##2##3##(2008-9#2)
evolution of conspecific##2##3##(2008-8#2)
evolution of cooperation##5##3##(2008-8#4)(2010-4#1)
evolution of cuticular hydrocarbons##2##4##(2012-3#2)
evolution of desmoid tumors##2##4##(1997-8#2)
evolution of dispersal##4##3##(2008-8#3)(2008-9#1)
evolution of each##2##3##(2008-9#1)(2009-5#1)
evolution of egg size##2##4##(1991-5#2)
evolution of eukaryotic##2##3##(1990-7#1)(2008-8#1)
evolution of exploitation##2##3##(1995-5#2)
evolution of fitter influenza strains##2##5##(2012-2#2)
evolution of generalized reciprocity##2##4##(2012-3#2)
evolution of health##2##3##(1996-1#1)(1996-3#1)
evolution of honest##2##3##(1995-5#1)(2008-9#1)
evolution of human##4##3##(1997-8#1)(2009-8#1)(2010-10#1)(2012-12#1)
evolution of hybrid##2##3##(2010-12#1)(2010-3#1)
evolution of interacting phenotypes##2##4##(2008-8#2)
evolution of its##3##3##(1992-1#1)(2008-10#1)(2008-4#1)
evolution of language##2##3##(2012-3#1)(2013-8#1)
evolution of life##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
evolution of male##3##3##(2008-8#2)(2008-9#1)
evolution of mate recognition##2##4##(2008-8#1)(2008-9#1)
evolution of more##2##3##(2008-4#1)(2008-9#1)
evolution of nuclear##2##3##(2008-8#1)(2010-3#1)
evolution of parasite virulence##4##4##(2008-8#4)
evolution of parasite##5##3##(2008-8#5)
evolution of phenotypic##2##3##(2008-9#1)(2013-1#1)
evolution of plant##3##3##(2008-10#2)(2008-8#1)
evolution of public##2##3##(1996-12#1)(2008-12#1)
evolution of races##2##3##(2008-10#2)
evolution of resistance##5##3##(1995-6#2)(2008-8#1)(2008-9#1)(2010-4#1)
evolution of sex##4##3##(2008-8#1)(2009-2#2)(2010-3#1)
evolution of sexually##2##3##(2008-8#1)(2008-9#1)
evolution of sociality##4##3##(2008-8#2)(2013-1#2)
evolution of such##2##3##(1994-12#1)(2007-12#1)
evolution of the coprinoid mushroom genus Parasola##2##7##(2010-3#2)
evolution of the disease##4##4##(1993-11#1)(2008-11#1)(2008-8#1)(2012-2#1)
evolution of the emission##2##4##(2007-12#1)(2008-2#1)
evolution of the funnel warts##2##5##(2007-12#2)
evolution of the skin-color##2##4##(2008-6#2)
evolution of the##115##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#13)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
evolution of their##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
evolution of thermal##3##3##(1990-2#1)(2008-8#2)
evolution of these##6##3##(1995-3#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-7#1)
evolution of this##5##3##(2008-1#1)(2009-10#1)(2010-6#1)(2011-2#2)
evolution of traits##2##3##(2008-8#2)
evolution of vertebrate##2##3##(2010-5#1)(2013-1#1)
evolution of##544##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#4)(1997-9#1)(2006-10#2)(2007-10#2)(2007-11#7)(2007-12#12)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#46)(2008-11#12)(2008-12#5)(2008-2#19)(2008-3#11)(2008-4#6)(2008-5#1)(2008-6#6)(2008-7#14)(2008-8#111)(2008-9#46)(2009-10#8)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#5)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#14)(2010-4#9)(2010-5#6)(2010-6#5)(2010-7#7)(2010-8#3)(2011-1#4)(2011-2#10)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#15)(2013-1#17)(2013-7#2)(2013-8#8)
evolution on islands##2##3##(1996-6#2)
evolution on##4##2##(1996-6#2)(1997-8#1)(2008-10#1)
evolution over the##2##3##(1994-3#1)(1996-3#1)
evolution over time##2##3##(2008-5#1)(2013-1#1)
evolution over##5##2##(1992-3#1)(1994-3#1)(1996-3#1)(2008-5#1)(2013-1#1)
evolution process##2##2##(2008-10#1)(2012-2#1)
evolution rate##3##2##(1991-6#1)(2008-11#1)(2008-9#1)
evolution that##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
evolution to##8##2##(1991-3#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-8#2)(2011-1#2)
evolution toward##6##2##(1991-4#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-4#1)
evolution was##7##2##(1991-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2012-1#1)(2013-1#2)
evolution with##5##2##(2007-12#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
evolution within the##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
evolution within##4##2##(2008-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
evolution##1012##1##(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#6)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#3)(1994-12#7)(1994-3#4)(1994-5#1)(1994-8#4)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#6)(1996-4#3)(1996-5#3)(1996-6#6)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#25)(1997-8#6)(1997-9#2)(2006-10#2)(2006-7#1)(2007-10#3)(2007-11#14)(2007-12#25)(2007-7#1)(2007-8#3)(2008-1#11)(2008-10#78)(2008-11#17)(2008-12#8)(2008-2#25)(2008-3#17)(2008-4#11)(2008-5#7)(2008-6#11)(2008-7#36)(2008-8#153)(2008-9#69)(2009-1#1)(2009-10#11)(2009-11#4)(2009-12#3)(2009-2#7)(2009-3#1)(2009-4#3)(2009-5#10)(2009-6#10)(2009-7#2)(2009-8#11)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#37)(2010-4#19)(2010-5#14)(2010-6#8)(2010-7#7)(2010-8#4)(2011-1#9)(2011-10#1)(2011-2#32)(2012-1#4)(2012-12#12)(2012-2#24)(2012-3#42)(2013-1#37)(2013-7#3)(2013-8#11)
evolutionally##2##1##(1991-6#1)(2008-1#1)
evolutionarily conserved and##3##3##(1995-6#1)(1997-7#1)(2009-5#1)
evolutionarily conserved in##3##3##(1991-6#1)(1993-6#1)(2009-8#1)
evolutionarily conserved protein##2##3##(1997-1#1)(1997-7#1)
evolutionarily conserved##18##2##(1991-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
evolutionarily related##2##2##(1993-12#1)(1994-8#1)
evolutionarily significant##3##2##(1995-2#1)(2008-8#1)(2009-2#1)
evolutionarily stable and##2##3##(2008-8#2)
evolutionarily stable strategy (ESS)##5##4##(2008-8#2)(2008-9#3)
evolutionarily stable strategy##7##3##(2008-8#2)(2008-9#5)
evolutionarily stable##24##2##(2008-8#11)(2008-9#13)
evolutionarily##67##1##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(1996-6#1)(1997-1#1)(1997-7#2)(2008-10#3)(2008-11#1)(2008-7#3)(2008-8#15)(2008-9#13)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-6#1)(2011-2#3)(2012-3#4)(2013-1#1)
evolutionary adaptation##4##2##(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
evolutionary age##2##2##(1997-4#1)(2011-2#1)
evolutionary and##5##2##(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
evolutionary approach##2##2##(2008-7#1)(2010-5#1)
evolutionary behavior##2##2##(2007-12#1)(2008-8#1)
evolutionary behavioral##2##2##(2008-8#2)
evolutionary biologists##2##2##(2008-8#1)(2008-9#1)
evolutionary biology and##3##3##(1997-7#1)(2009-5#1)(2009-6#1)
evolutionary biology##10##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2012-3#1)
evolutionary biotechnology##2##2##(1997-6#2)
evolutionary causes##2##2##(2008-8#1)(2009-5#1)
evolutionary change##10##2##(1996-12#1)(2007-11#1)(2008-7#1)(2008-8#2)(2010-4#4)(2012-3#1)
evolutionary changes in##4##3##(2008-11#1)(2008-8#1)(2010-3#2)
evolutionary changes##6##2##(2007-12#1)(2008-11#1)(2008-8#1)(2010-3#2)(2010-4#1)
evolutionary consequences of##5##3##(2008-8#3)(2009-2#1)(2013-1#1)
evolutionary consequences##9##2##(2008-8#4)(2008-9#2)(2009-2#1)(2009-6#1)(2013-1#1)
evolutionary conservation##5##2##(1991-6#2)(1993-2#2)(2013-8#1)
evolutionary conserved##2##2##(1992-8#1)(2008-7#1)
evolutionary context##2##2##(1997-5#1)(2008-8#1)
evolutionary developmental##2##2##(2012-12#1)(2012-3#1)
evolutionary distance##2##2##(1995-2#1)(2010-7#1)
evolutionary distances##4##2##(2008-4#3)(2010-7#1)
evolutionary divergence##5##2##(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
evolutionary dynamics of##5##3##(2008-7#1)(2008-8#2)(2010-8#1)(2012-3#1)
evolutionary dynamics##10##2##(2008-7#1)(2008-8#4)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#2)
evolutionary event##3##2##(2008-10#2)(2008-9#1)
evolutionary force##4##2##(2008-9#1)(2012-3#1)(2013-1#2)
evolutionary forces##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-3#1)
evolutionary function##2##2##(2008-9#1)(2012-3#1)
evolutionary genetic##2##2##(2008-8#2)
evolutionary genomics##2##2##(2008-7#2)
evolutionary histories of##2##3##(2012-2#1)(2012-3#1)
evolutionary histories##4##2##(2008-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
evolutionary history and##3##3##(2010-3#1)(2010-6#1)(2013-1#1)
evolutionary history of##5##3##(1994-12#1)(2008-10#2)(2008-8#1)(2009-2#1)
evolutionary history##15##2##(1994-12#1)(2008-10#4)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-6#1)(2013-1#1)
evolutionary importance##2##2##(1996-6#1)(2008-9#1)
evolutionary inferences##3##2##(2010-3#2)(2013-1#1)
evolutionary lineage##2##2##(2011-2#2)
evolutionary lineages##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
evolutionary links##2##2##(2009-5#1)(2009-8#1)
evolutionary longevity##2##2##(2013-1#2)
evolutionary mechanisms##5##2##(2008-8#1)(2009-6#1)(2010-4#1)(2012-12#2)
evolutionary model##3##2##(1997-4#1)(2008-8#2)
evolutionary models##3##2##(2008-10#1)(2010-3#2)
evolutionary optimization##2##2##(1997-6#2)
evolutionary origin of the##3##4##(2007-12#3)
evolutionary origin of##8##3##(2007-12#3)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#2)
evolutionary origin##15##2##(1990-5#2)(1997-2#1)(2007-12#3)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-3#1)(2013-1#2)
evolutionary origins of##4##3##(2008-11#1)(2009-6#1)(2010-6#1)(2013-8#1)
evolutionary origins##8##2##(2008-10#3)(2008-11#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-8#1)
evolutionary perspective on the##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
evolutionary perspective##5##2##(2008-8#2)(2008-9#1)(2009-8#1)(2012-3#1)
evolutionary potential of##2##3##(2008-10#2)
evolutionary potential##4##2##(2008-10#3)(2008-8#1)
evolutionary process##5##2##(1994-3#1)(2007-12#1)(2010-4#1)(2010-5#1)(2012-3#1)
evolutionary processes responsible for##2##4##(1996-6#2)
evolutionary processes##15##2##(1993-12#1)(1995-5#1)(1996-6#2)(2008-10#3)(2008-8#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-3#2)(2013-7#1)
evolutionary programming##2##2##(2008-4#2)
evolutionary questions##2##2##(2008-1#1)(2010-12#1)
evolutionary rate##2##2##(2012-2#1)(2012-3#1)
evolutionary relationship between##3##3##(1990-5#1)(1994-8#1)(2008-12#1)
evolutionary relationship with##2##3##(1990-5#1)(2008-7#1)
evolutionary relationship##7##2##(1990-5#2)(1993-11#1)(1994-8#1)(2008-12#1)(2008-7#1)(2013-8#1)
evolutionary relationships among the##2##4##(2008-10#2)
evolutionary relationships among##3##3##(1994-11#1)(2008-10#2)
evolutionary relationships between##2##3##(2007-6#1)(2008-7#1)
evolutionary relationships of##2##3##(1994-11#1)(2008-10#1)
evolutionary relationships##15##2##(1994-11#2)(1994-3#1)(2007-6#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#2)(2013-8#1)
evolutionary response is##2##3##(2008-8#2)
evolutionary response##4##2##(2008-8#3)(2012-3#1)
evolutionary role##2##2##(2008-8#2)
evolutionary scenarios##2##2##(2009-5#1)(2011-2#1)
evolutionary significance of##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
evolutionary significance##4##2##(2007-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
evolutionary strategies can##2##3##(1997-6#2)
evolutionary strategies##3##2##(1997-6#3)
evolutionary studies##3##2##(1996-4#1)(2008-5#1)(2008-7#1)
evolutionary success##2##2##(2010-3#1)(2013-1#1)
evolutionary theory##6##2##(2008-10#1)(2009-6#1)(2010-3#1)(2012-12#1)(2012-2#2)
evolutionary time##3##2##(2008-1#1)(2008-11#1)(2010-3#1)
evolutionary tree of##2##3##(1991-6#1)(2009-5#1)
evolutionary trees with##2##3##(1994-3#1)(2008-4#1)
evolutionary trees##3##2##(1994-3#1)(2008-4#2)
evolutionary trends##2##2##(2007-12#1)(2010-3#1)
evolutionary##395##1##(1990-5#5)(1991-6#4)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-6#4)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#8)(1997-7#1)(1997-9#2)(2007-11#1)(2007-12#15)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#38)(2008-11#6)(2008-12#2)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#22)(2008-8#62)(2008-9#23)(2009-10#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-5#10)(2009-6#12)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#16)(2010-4#9)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#2)(2011-2#10)(2011-3#2)(2012-12#6)(2012-2#8)(2012-3#24)(2013-1#17)(2013-7#1)(2013-8#9)
evolutions##3##1##(1994-2#1)(1996-3#1)(2008-10#1)
evolutive##3##1##(1994-9#1)(2008-7#1)(2009-4#1)
evolvability##2##1##(2010-10#2)
evolvable##2##1##(1997-6#1)(2010-10#1)
evolve and be##2##3##(2012-12#1)(2013-1#1)
evolve and##8##2##(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
evolve as a result of##2##5##(2008-11#1)(2008-8#1)
evolve as a##4##3##(2008-11#1)(2008-8#3)
evolve as##8##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2012-3#1)
evolve at##2##2##(2008-7#1)(2008-8#1)
evolve from##3##2##(2007-5#1)(2008-10#1)(2011-1#1)
evolve in close##2##3##(1994-12#1)(2008-8#1)
evolve in##8##2##(1990-6#1)(1993-1#1)(1994-12#1)(2008-8#3)(2010-3#1)(2011-2#1)
evolve independently##2##2##(2008-10#1)(2008-8#1)
evolve into a##2##3##(1992-12#1)(2008-2#1)
evolve into##6##2##(1992-12#1)(1996-3#1)(1997-2#1)(2008-2#1)(2009-12#1)(2011-2#1)
evolve more rapidly##2##3##(1991-6#1)(1995-11#1)
evolve more##3##2##(1991-6#1)(1995-11#1)(2008-9#1)
evolve over##2##2##(2008-6#1)(2010-3#1)
evolve to##5##2##(1995-5#1)(1997-3#1)(2007-12#1)(2008-11#1)(2011-2#1)
evolve under##5##2##(1994-12#1)(2008-8#4)
evolve when##4##2##(2008-8#3)(2010-10#1)
evolve##103##1##(1990-6#1)(1991-6#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#2)(2007-5#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#25)(2008-9#8)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#5)(2010-3#5)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)
evolved a##3##2##(1990-8#1)(2008-2#1)(2010-1#1)
evolved and##5##2##(1994-8#1)(2008-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
evolved as a##6##3##(1994-8#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-7#1)
evolved as the scientific community##2##5##(2012-2#2)
evolved as##9##2##(1994-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
evolved before the##2##3##(2008-8#1)(2008-9#1)
evolved by##6##2##(1995-6#1)(2008-10#2)(2008-3#2)(2008-4#1)
evolved directly from##2##3##(2010-8#1)(2011-1#1)
evolved during the##2##3##(2008-11#1)(2013-8#1)
evolved during##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
evolved from an##2##3##(1992-3#1)(2008-11#1)
evolved from the##8##3##(1995-6#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
evolved from##21##2##(1992-3#1)(1993-1#1)(1994-12#2)(1995-6#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
evolved gas analysis##6##3##(2008-10#6)
evolved gas##9##2##(2008-10#9)
evolved in response to the##2##5##(2008-9#1)(2010-5#1)
evolved in response to##6##4##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)
evolved in the##6##3##(1991-1#1)(2008-10#2)(2010-3#1)(2010-4#1)(2012-2#1)
evolved in##18##2##(1991-1#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
evolved independently##2##2##(2008-10#1)(2013-8#1)
evolved into a##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
evolved into two##2##3##(2007-6#1)(2008-7#1)
evolved into##13##2##(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-12#1)(2013-1#1)
evolved lines##2##2##(2008-8#2)
evolved over the last##3##4##(1994-3#1)(2007-7#1)(2010-6#1)
evolved over the##5##3##(1994-3#1)(2007-7#1)(2008-7#1)(2010-6#1)(2011-2#1)
evolved over time##2##3##(1994-1#1)(2013-1#1)
evolved over##9##2##(1994-1#1)(1994-3#1)(1997-1#1)(2007-7#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
evolved sequences##2##2##(1995-2#2)
evolved the##2##2##(2008-11#1)(2011-2#1)
evolved through##4##2##(2007-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
evolved to be##2##3##(2008-10#1)(2008-11#1)
evolved to complement##2##3##(2008-7#1)(2013-8#1)
evolved to##18##2##(1992-6#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
evolved under##4##2##(1997-9#1)(2007-12#1)(2009-6#1)(2011-2#1)
evolved via##2##2##(2011-1#1)(2012-3#1)
evolved with the##2##3##(1997-3#1)(2010-3#1)
evolved with##5##2##(1996-9#1)(1997-3#1)(2008-8#1)(2010-3#1)(2012-1#1)
evolved##204##1##(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1994-1#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-9#2)(2007-10#1)(2007-12#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#11)(2008-8#13)(2008-9#7)(2009-1#1)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#5)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#7)
evolves from##2##2##(2007-12#1)(2010-3#1)
evolves in a##2##3##(2007-11#1)(2012-3#1)
evolves in##4##2##(2007-11#2)(2008-11#1)(2012-3#1)
evolves to##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
evolves##25##1##(1996-1#1)(1997-3#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#4)(2008-9#3)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#2)
evolving and##2##2##(1996-3#1)(2010-12#1)
evolving health care##4##3##(1994-1#1)(1997-2#1)(2008-1#2)
evolving in response to##2##4##(1994-2#1)(2013-8#1)
evolving in##7##2##(1991-2#1)(1993-2#1)(1994-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
evolving into##2##2##(1996-12#1)(2010-1#1)
evolving latent projections (HELP)##2##4##(2008-10#2)
evolving over time##2##3##(2008-10#1)(2013-1#1)
evolving populations##2##2##(2008-8#1)(2012-3#1)
evolving role of##6##3##(1993-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2009-2#1)(2009-5#1)
evolving role##7##2##(1993-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2009-2#1)(2009-5#1)(2012-3#1)
evolving systems##2##2##(1997-6#1)(2008-8#1)
evolving the##3##2##(1994-2#2)(2010-7#1)
evolving to##2##2##(2007-10#1)(2011-2#1)
evolving with##2##2##(2007-7#1)(2009-4#1)
evolving##102##1##(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#2)(1994-2#5)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#5)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
ewe##5##1##(1994-3#1)(2008-8#1)(2009-4#2)(2010-2#1)
ewes aged##2##2##(2008-9#2)
ewes and##3##2##(1991-8#1)(2010-2#2)
ewes with##3##2##(1996-12#1)(2010-12#2)
ewes##27##1##(1991-8#2)(1994-3#1)(1996-12#2)(2008-12#3)(2008-9#8)(2009-4#1)(2010-12#4)(2010-2#3)(2011-1#3)
ewing##2##1##(2008-6#2)
ex Benth)##2##2##(2008-12#2)
ex MbSA)##3##2##(2011-2#3)
ex Planch##2##2##(2008-12#2)
ex Steud##2##2##(2008-8#2)
ex ante##2##2##(1992-2#1)(2008-7#1)
ex post##2##2##(2008-1#1)(2008-7#1)
ex situ##9##2##(2007-12#1)(2008-10#1)(2008-3#3)(2012-12#2)(2013-7#2)
ex vivo and in vivo##2##5##(2008-3#1)(2008-5#1)
ex vivo and##4##3##(2008-11#1)(2008-3#1)(2008-5#2)
ex vivo approach##2##3##(2008-4#1)(2008-5#1)
ex vivo assay##2##3##(2008-11#1)(2008-5#1)
ex vivo expansion##3##3##(2008-11#2)(2008-4#1)
ex vivo gene transfer##2##4##(1997-4#2)
ex vivo models##2##3##(2006-6#1)(2008-7#1)
ex vivo stimulation##2##3##(2008-4#1)(2009-6#1)
ex vivo##74##2##(1991-8#2)(1995-3#1)(1997-4#4)(2006-6#4)(2007-11#2)(2008-10#2)(2008-11#15)(2008-3#1)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)
ex##111##1##(1991-8#2)(1992-2#1)(1994-5#2)(1994-8#1)(1995-3#1)(1997-1#1)(1997-4#4)(2006-6#4)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#15)(2008-12#6)(2008-3#5)(2008-4#5)(2008-5#14)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#2)
ex-smokers##6##1##(1991-3#2)(1994-6#1)(1996-3#1)(1997-4#1)(2008-11#1)
ex-type strain V##3##3##(2008-10#3)
ex-type strain##4##2##(2008-10#4)
ex-type##5##1##(2008-10#5)
ex-vivo##5##1##(2007-12#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#1)
exacerbate or buffer##2##3##(2009-8#1)(2012-12#1)
exacerbate the##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
exacerbate##15##1##(1990-5#1)(1992-6#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2009-6#1)(2009-8#1)(2012-12#1)(2013-7#1)
exacerbated by##9##2##(1991-8#1)(1992-3#1)(1995-6#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-1#1)(2011-10#1)
exacerbated in##4##2##(2008-8#1)(2009-9#1)(2013-1#2)
exacerbated the##4##2##(1996-3#1)(2008-7#1)(2009-8#1)(2013-1#1)
exacerbated when##2##2##(2008-9#1)(2012-7#1)
exacerbated##23##1##(1991-8#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#5)
exacerbates##5##1##(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
exacerbating viral infections##2##3##(2010-6#2)
exacerbating##8##1##(1993-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#2)(2012-12#2)
exacerbation and##2##2##(2010-11#1)(2013-8#1)
exacerbation of chronic##5##3##(1997-4#1)(2006-10#1)(2008-10#1)(2010-2#1)(2011-2#1)
exacerbation of the##2##3##(2012-2#1)(2013-8#1)
exacerbation of##17##2##(1991-4#1)(1995-12#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
exacerbation##33##1##(1991-4#1)(1995-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#7)(2013-8#3)
exacerbations and the presence of##2##5##(2008-7#1)(2012-12#1)
exacerbations and##4##2##(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
exacerbations are##2##2##(2008-3#2)
exacerbations in##3##2##(2008-5#1)(2010-8#2)
exacerbations of asthma##3##3##(2007-11#2)(2012-12#1)
exacerbations of##12##2##(1996-11#1)(2007-11#2)(2007-12#1)(2008-7#2)(2010-5#2)(2011-2#2)(2012-12#2)
exacerbations##41##1##(1996-11#1)(2007-11#3)(2007-12#1)(2008-11#2)(2008-3#4)(2008-5#3)(2008-7#5)(2010-5#6)(2010-8#2)(2011-2#10)(2012-12#3)(2013-8#1)
exact a##3##2##(2008-3#1)(2013-1#2)
exact and##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
exact calculation##2##2##(2008-3#2)
exact calculations##2##2##(2008-3#2)
exact cause##3##2##(1993-1#1)(2013-8#2)
exact determination of##2##3##(2008-10#1)(2008-5#1)
exact diagnosis of##3##3##(1990-10#1)(1995-5#1)(2011-2#1)
exact diagnosis##5##2##(1990-10#1)(1990-12#1)(1995-5#1)(2010-3#1)(2011-2#1)
exact etiology##2##2##(1991-3#1)(2013-1#1)
exact in##3##2##(2007-11#1)(2008-3#1)(2012-12#1)
exact mechanism of##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)
exact mechanism##8##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-7#1)(2013-1#1)
exact mechanisms##3##2##(1990-3#1)(1991-4#1)(2012-3#1)
exact method##3##2##(1994-9#1)(2008-3#1)(2013-8#1)
exact order values##2##3##(2008-2#2)
exact pathogenesis##2##2##(2008-11#1)(2013-8#1)
exact position of the##2##4##(2008-3#2)
exact power##2##2##(1992-6#1)(1995-2#1)
exact ray##4##2##(2008-2#1)(2008-3#2)(2008-6#1)
exact results##2##2##(2008-2#1)(2008-3#1)
exact role##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
exact solution for##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
exact solution of##2##3##(2008-2#1)(2012-2#1)
exact solution##10##2##(2007-12#3)(2008-2#2)(2008-3#3)(2008-6#1)(2012-2#1)
exact solutions of##2##3##(1993-5#1)(2007-12#1)
exact solutions##7##2##(1993-5#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)
exact test##7##2##(1995-12#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
exact test)##2##2##(1997-5#1)(2008-7#1)
exact tests##2##2##(1996-3#1)(2012-2#1)
exact theory##2##2##(2007-12#1)(2008-2#1)
exact values##4##2##(2008-2#2)(2008-3#2)
exact##234##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#4)(1996-6#1)(1997-4#1)(1997-5#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#21)(2008-3#55)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#4)
exacting##2##1##(1991-2#1)(1992-2#1)
exactly at the##2##3##(1994-8#1)(2008-8#1)
exactly at##3##2##(1994-8#1)(2008-8#2)
exactly for##2##2##(2008-2#1)(2008-7#1)
exactly how##2##2##(2007-12#1)(2008-5#1)
exactly known##2##2##(2008-10#2)
exactly mimic##2##2##(2008-1#1)(2009-7#1)
exactly that##2##2##(1993-1#1)(2008-9#1)
exactly the same##5##3##(1990-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2009-11#1)
exactly the##10##2##(1990-8#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)
exactly this##2##2##(2007-11#1)(2007-12#1)
exactly to the##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
exactly to##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
exactly with the##2##3##(2008-10#1)(2009-5#1)
exactly with##3##2##(2008-10#1)(2008-2#1)(2009-5#1)
exactly##66##1##(1990-12#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-1#4)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
exaggerate the##3##2##(1997-3#1)(2008-7#1)(2008-8#1)
exaggerate##4##1##(1997-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
exaggerated application##2##2##(2008-5#2)
exaggerated immune##2##2##(2008-10#1)(2008-4#1)
exaggerated##29##1##(1990-12#1)(1992-2#2)(1993-3#1)(1994-2#1)(1996-11#2)(1996-2#1)(1997-1#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#3)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
exaggeration of##2##2##(2008-5#1)(2012-2#1)
exaggeration##4##1##(1990-11#1)(1990-6#1)(2008-5#1)(2012-2#1)
exam and##4##2##(2008-12#1)(2011-2#3)
exam##41##1##(1991-3#1)(1991-6#4)(1992-5#1)(1994-12#1)(1994-2#2)(1996-1#1)(1996-2#1)(2008-10#1)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
examen##2##1##(2011-2#1)(2013-1#1)
examination after##3##2##(1990-11#1)(2008-7#1)(2013-8#1)
examination alone##2##2##(1995-4#1)(1996-6#1)
examination also##2##2##(2008-12#1)(2011-2#1)
examination and a##6##3##(1990-6#1)(1993-9#1)(1995-2#1)(2007-11#1)(2009-3#1)(2012-12#1)
examination and laboratory##2##3##(1991-3#1)(2008-11#1)
examination and radiographs##2##3##(2008-11#1)(2013-1#1)
examination and the##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
examination and treatment skills##2##4##(2012-1#2)
examination and treatment##3##3##(2007-11#1)(2012-1#2)
examination and##60##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-5#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-11#1)(1997-8#1)(2007-11#5)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
examination are##11##2##(1990-6#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
examination as a##2##3##(1994-12#1)(2011-1#1)
examination at 1##2##3##(2011-2#2)
examination at##4##2##(2007-10#1)(2008-12#1)(2011-2#2)
examination by means of##2##4##(2007-11#1)(2009-11#1)
examination can be##2##3##(1992-12#1)(1997-8#1)
examination can##4##2##(1992-12#1)(1997-8#1)(2008-4#1)(2012-12#1)
examination confirmed the diagnosis of##4##5##(2006-12#1)(2008-6#1)(2008-8#1)(2013-1#1)
examination confirmed##5##2##(2006-12#1)(2007-8#1)(2008-6#1)(2008-8#1)(2013-1#1)
examination demonstrated a##2##3##(2008-10#1)(2008-6#1)
examination demonstrated that##2##3##(1995-12#1)(2008-11#1)
examination demonstrated##10##2##(1995-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
examination did not show any##2##5##(2008-10#1)(2013-8#1)
examination did not show##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
examination disclosed##2##2##(2008-10#1)(2008-7#1)
examination during##3##2##(1994-9#1)(1996-12#1)(2011-2#1)
examination failed to##2##3##(1997-3#1)(2008-7#1)
examination for##7##2##(1996-12#1)(2007-4#1)(2007-7#2)(2009-5#1)(2011-2#1)(2012-3#1)
examination format##2##2##(1994-2#2)
examination had##2##2##(1997-3#1)(2007-8#1)
examination has##2##2##(2007-8#1)(2008-4#1)
examination in general##2##3##(1990-9#1)(2008-11#1)
examination in the##3##3##(1990-6#1)(1997-4#1)(2007-8#1)
examination in##24##2##(1990-6#1)(1990-9#1)(1991-3#1)(1995-12#1)(1996-11#1)(1997-3#2)(1997-4#2)(2007-11#2)(2007-8#3)(2008-1#2)(2008-11#2)(2008-7#3)(2010-4#1)(2011-2#1)(2012-1#1)
examination included##2##2##(1996-9#1)(2008-12#1)
examination including##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
examination indicated that##3##3##(1991-12#1)(2008-10#1)(2008-6#1)
examination indicated##4##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-6#1)
examination is##10##2##(1991-2#1)(1991-3#1)(1994-12#1)(1995-11#1)(2008-11#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#2)
examination may decrease##2##3##(2013-1#1)(2013-8#1)
examination of Fasciola##2##3##(1996-12#2)
examination of a##7##3##(1996-12#1)(2008-10#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-12#1)
examination of an##3##3##(2007-8#1)(2008-1#1)(2013-1#1)
examination of blood##2##3##(1991-3#1)(2009-11#1)
examination of both##3##3##(1994-9#1)(1995-6#1)(2008-5#1)
examination of choice##2##3##(2007-11#1)(2011-7#1)
examination of early##2##3##(2010-1#1)(2010-4#1)
examination of infected##2##3##(2008-10#1)(2008-9#1)
examination of lymph##2##3##(1992-2#1)(2013-7#1)
examination of lymphoid tissues##2##4##(2008-10#2)
examination of patients##2##3##(1996-8#1)(2007-9#1)
examination of pleural effusion##2##4##(1997-4#1)(2008-1#1)
examination of the brain##2##4##(2008-7#1)(2013-1#1)
examination of the literature##2##4##(1991-12#1)(1993-11#1)
examination of the lung##2##4##(1992-11#1)(1996-3#1)
examination of the resected specimen##2##5##(1992-6#1)(2008-10#1)
examination of the resected##3##4##(1992-6#1)(1997-3#1)(2008-10#1)
examination of the skin##3##4##(1990-3#1)(1996-6#1)(1997-3#1)
examination of the specimen##2##4##(2008-6#1)(2012-12#1)
examination of the tumors revealed##2##5##(2008-6#1)(2010-3#1)
examination of the##94##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#2)(2011-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
examination of their##3##3##(1996-12#1)(1996-3#1)(2007-11#1)
examination of these##6##3##(1993-12#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-6#1)
examination of this##2##3##(1991-2#1)(2008-10#1)
examination of##233##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#7)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#1)
examination or##3##2##(1994-12#1)(2008-5#1)(2013-7#1)
examination performed##2##2##(1990-12#1)(2008-7#1)
examination proved to be##2##4##(1990-10#1)(1991-6#1)
examination proved##4##2##(1990-10#1)(1991-6#1)(2008-5#1)(2012-12#1)
examination results##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
examination revealed a cystic mass in the##2##7##(2007-8#1)(2011-2#1)
examination revealed a cystic mass##3##5##(2007-8#1)(2008-9#1)(2011-2#1)
examination revealed a##16##3##(1992-9#1)(1993-9#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-9#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
examination revealed an##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
examination revealed increased##3##3##(2011-1#2)(2011-2#1)
examination revealed severe##2##3##(1993-12#1)(2011-1#1)
examination revealed that the##3##4##(1994-7#1)(2008-10#1)(2013-1#1)
examination revealed that##9##3##(1994-12#1)(1994-7#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
examination revealed the##5##3##(1990-10#1)(2008-11#1)(2009-1#1)(2012-2#1)(2013-8#1)
examination revealed##58##2##(1990-10#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-7#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2010-6#2)(2011-1#5)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
examination should##2##2##(1992-9#1)(2007-11#1)
examination showed a##4##3##(1993-9#1)(2007-8#1)(2011-1#1)(2013-1#1)
examination showed bilateral##2##3##(2008-10#1)(2012-2#1)
examination showed extensive##2##3##(1995-3#1)(2010-12#1)
examination showed that the##3##4##(1995-2#1)(2011-2#1)(2013-8#1)
examination showed##25##2##(1993-9#1)(1994-7#1)(1995-2#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
examination special attention##2##3##(1991-11#1)(2007-11#1)
examination techniques##3##2##(1997-4#2)(1997-8#1)
examination than##2##2##(1997-3#1)(2012-2#1)
examination that##2##2##(1993-2#1)(2011-2#1)
examination the##3##2##(1992-2#1)(2008-7#1)(2011-2#1)
examination through a##2##3##(2012-12#2)
examination to##5##2##(1994-6#1)(2008-10#1)(2010-7#1)(2011-2#2)
examination under##4##2##(1992-12#2)(1994-2#1)(2010-8#1)
examination used in##2##3##(2007-10#1)(2007-11#1)
examination using##3##2##(1992-5#1)(2008-11#1)(2011-2#1)
examination usually##2##2##(1997-3#1)(2012-12#1)
examination verified##2##2##(1997-3#1)(2007-10#1)
examination was carried out##2##4##(1991-6#1)(2008-1#1)
examination was conducted##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
examination was normal##2##3##(2007-12#1)(2010-7#1)
examination was performed in the##2##5##(2007-11#2)
examination was performed in##3##4##(1996-6#1)(2007-11#2)
examination was performed##6##3##(1996-6#1)(1997-4#1)(2007-11#2)(2007-8#2)
examination was used##2##3##(2010-8#1)(2011-1#1)
examination was##31##2##(1990-9#1)(1991-6#1)(1993-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#2)
examination were performed##2##3##(2012-12#1)(2013-1#1)
examination were##6##2##(2009-7#1)(2010-4#1)(2012-12#1)(2013-1#3)
examination with a##2##3##(1994-7#1)(2008-9#1)
examination with##13##2##(1990-2#1)(1990-9#1)(1994-7#1)(1996-12#1)(1997-3#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-7#1)(2008-9#2)(2011-2#1)
examination##895##1##(1990-10#5)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#2)(1990-6#9)(1990-8#4)(1990-9#7)(1991-11#4)(1991-12#9)(1991-2#6)(1991-3#8)(1991-6#6)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#2)(1992-5#7)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#4)(1993-9#4)(1994-12#7)(1994-2#7)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#4)(1994-9#2)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#4)(1995-6#3)(1995-8#1)(1995-9#3)(1996-11#4)(1996-12#15)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#6)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#15)(1997-4#6)(1997-5#4)(1997-7#1)(1997-8#12)(2006-10#4)(2006-12#3)(2006-5#2)(2007-10#10)(2007-11#33)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#14)(2007-8#28)(2007-9#3)(2008-1#17)(2008-10#42)(2008-11#29)(2008-12#23)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#21)(2008-6#10)(2008-7#45)(2008-8#13)(2008-9#19)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#6)(2010-10#5)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#7)(2010-4#9)(2010-5#3)(2010-6#11)(2010-7#3)(2010-8#10)(2011-1#20)(2011-2#49)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#23)(2012-2#27)(2012-3#17)(2012-7#1)(2013-1#31)(2013-7#3)(2013-8#21)
examination)##3##1##(2008-7#1)(2008-8#1)(2012-3#1)
examination]##2##1##(1990-2#1)(1997-8#1)
examinations after##3##2##(1990-6#1)(1996-11#1)(1996-5#1)
examinations and##11##2##(1990-8#1)(1997-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)
examinations are##6##2##(1990-12#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)
examinations at the nearest hospital##2##5##(1997-4#2)
examinations at the##3##3##(1997-4#3)
examinations at##4##2##(1993-12#1)(1997-4#3)
examinations for##3##2##(1990-3#1)(1991-7#1)(2010-6#1)
examinations have##2##2##(1991-7#1)(1992-4#1)
examinations in##7##2##(1991-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#2)
examinations including##3##2##(2008-12#1)(2010-6#1)(2013-1#1)
examinations is##2##2##(1997-8#1)(2013-1#1)
examinations of the##8##3##(1992-10#1)(1994-12#1)(1995-6#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
examinations of##20##2##(1991-11#1)(1992-10#1)(1992-11#1)(1994-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-8#3)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
examinations on##3##2##(2007-10#1)(2011-2#2)
examinations performed##2##2##(2007-11#1)(2012-2#1)
examinations showed##3##2##(1993-5#1)(2008-6#1)(2010-8#1)
examinations that##2##2##(2008-11#1)(2010-6#1)
examinations under##2##2##(1995-5#1)(2011-7#1)
examinations using##2##2##(1997-8#1)(2011-2#1)
examinations was##4##2##(1990-10#1)(2008-10#1)(2008-4#1)(2012-3#1)
examinations were carried out##2##4##(1992-8#1)(2008-5#1)
examinations were performed in##3##4##(2007-7#1)(2011-2#1)(2012-12#1)
examinations were performed##7##3##(2007-11#2)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
examinations were##16##2##(1990-8#1)(1992-8#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
examinations with##2##2##(1992-9#1)(2008-9#1)
examinations##175##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#3)(1991-6#3)(1991-7#5)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-12#3)(1994-6#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#1)(1997-8#12)(2007-10#3)(2007-11#6)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#6)(2008-12#7)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#8)(2008-9#4)(2009-12#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#2)(2010-6#4)(2010-8#3)(2011-2#12)(2011-3#2)(2011-7#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#2)
examine a##12##2##(1995-3#1)(1996-12#1)(2007-11#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
examine and##4##2##(1992-11#1)(1993-12#1)(1994-1#1)(2010-9#1)
examine both the##2##3##(2008-1#1)(2012-2#1)
examine both##4##2##(2008-1#2)(2008-5#1)(2012-2#1)
examine changes in##2##3##(1992-2#1)(2012-2#1)
examine data##2##2##(1994-3#1)(2012-12#1)
examine different##2##2##(2009-7#1)(2011-1#1)
examine factors that##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
examine factors##5##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
examine genetic diversity##2##3##(2008-10#1)(2012-1#1)
examine how the##3##3##(2008-8#1)(2010-10#1)(2010-7#1)
examine how##19##2##(1993-2#1)(1995-6#1)(2008-1#1)(2008-2#2)(2008-7#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
examine if##5##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)
examine in##5##2##(1995-5#1)(2007-12#1)(2008-8#1)(2009-7#1)(2010-8#1)
examine its impact on##2##4##(2011-2#1)(2013-1#1)
examine its##8##2##(1994-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
examine other##2##2##(2006-8#1)(2008-7#1)
examine our##2##2##(1995-5#1)(1996-3#1)
examine possible mechanisms##2##3##(1991-5#1)(2008-11#1)
examine possible##5##2##(1991-5#1)(1997-1#1)(2008-11#1)(2008-4#1)(2010-7#1)
examine prophylactic##2##2##(1991-2#1)(2009-12#1)
examine recent##2##2##(2008-10#1)(2008-7#1)
examine some of the##2##4##(2008-12#1)(2008-8#1)
examine some##3##2##(2008-12#1)(2008-8#1)(2013-8#1)
examine that##2##2##(2011-2#1)(2012-2#1)
examine the association between##6##4##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
examine the association##7##3##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-1#1)
examine the changes##3##3##(1992-2#1)(2007-8#1)(2013-8#1)
examine the conditions##4##3##(2007-12#1)(2008-8#2)(2009-7#1)
examine the consequences of##5##4##(1995-2#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-8#1)
examine the contribution of##2##4##(2008-10#1)(2008-11#1)
examine the development of##3##4##(2008-11#1)(2008-5#1)(2012-2#1)
examine the effect of##20##4##(1991-10#1)(1992-6#1)(1993-12#1)(1994-11#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2012-2#2)(2013-1#1)
examine the effects of##22##4##(1991-12#1)(1992-1#1)(1993-3#1)(1995-5#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#3)
examine the efficiency of##2##4##(2008-11#1)(2008-5#1)
examine the evidence for##2##4##(2008-6#1)(2011-2#1)
examine the evolution of##2##4##(2007-12#1)(2009-8#1)
examine the expression of##4##4##(1993-8#1)(1994-6#1)(1995-2#1)(2008-8#1)
examine the expression##5##3##(1991-5#1)(1993-8#1)(1994-6#1)(1995-2#1)(2008-8#1)
examine the extent to which the##2##6##(1991-12#1)(2008-1#1)
examine the extent to which##5##5##(1991-12#1)(2008-1#1)(2008-8#1)(2009-9#1)(2012-2#1)
examine the feasibility of##3##4##(2007-12#1)(2008-11#1)(2008-9#1)
examine the function of##2##4##(1991-12#1)(2008-5#1)
examine the general##2##3##(2008-2#1)(2009-10#1)
examine the hypothesis that##3##4##(1992-6#1)(2008-10#1)(2008-3#1)
examine the impact of the##2##5##(1994-2#1)(2008-3#1)
examine the impact of##10##4##(1991-3#1)(1994-2#1)(1994-3#1)(1997-2#1)(2007-10#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-2#1)
examine the implications##2##3##(1994-2#1)(2008-3#1)
examine the in##2##3##(1990-3#1)(2012-2#1)
examine the influence of##6##4##(1994-9#1)(1995-3#1)(2008-11#2)(2008-12#1)(2008-3#1)
examine the issue##2##3##(2008-12#1)(2008-7#1)
examine the mechanism##2##3##(1995-2#1)(2008-7#1)
examine the mechanisms by which##2##5##(2008-7#2)
examine the potential##3##3##(2008-11#1)(2008-7#1)(2009-9#1)
examine the regulation of##3##4##(2008-4#1)(2008-9#2)
examine the relation between##2##4##(1995-5#1)(1996-9#1)
examine the relationship between##17##4##(1992-2#1)(1994-5#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
examine the relationship of##3##4##(1994-2#1)(2011-2#1)(2012-2#1)
examine the relationship##20##3##(1992-2#1)(1994-2#1)(1994-5#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
examine the relative##3##3##(1996-1#1)(2008-8#1)(2008-9#1)
examine the role of the##4##5##(1991-2#1)(1993-12#1)(1995-2#1)(1996-5#1)
examine the role of##13##4##(1991-2#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
examine the role##14##3##(1991-2#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-9#2)(2010-3#1)(2011-2#1)
examine the roles##3##3##(1992-3#1)(1995-12#1)(2008-7#1)
examine the student##2##3##(1993-1#1)(2008-11#1)
examine the temporal##3##3##(2008-10#1)(2008-3#2)
examine the value of##2##4##(1990-2#1)(1990-8#1)
examine the various##2##3##(1994-1#1)(2009-10#1)
examine the##381##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#5)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#6)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#9)(1995-3#4)(1995-5#3)(1995-6#1)(1996-1#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#3)(2007-11#5)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#30)(2008-11#27)(2008-12#10)(2008-2#13)(2008-3#23)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#19)(2008-8#17)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#2)(2010-11#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#7)(2013-8#6)
examine their##6##2##(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)(2013-1#1)
examine these factors##2##3##(2008-2#1)(2009-10#1)
examine these influences##2##3##(1990-2#1)(2009-9#1)
examine these##10##2##(1990-2#1)(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-9#1)(2012-2#2)
examine this##9##2##(1990-5#1)(1993-1#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#2)
examine whether a##4##3##(1997-6#1)(2008-10#1)(2008-7#1)(2010-5#1)
examine whether or not##3##4##(2007-6#1)(2008-11#2)
examine whether the##8##3##(1990-12#1)(1993-12#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-6#2)(2011-1#1)
examine whether##34##2##(1990-12#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
examine why##2##2##(2008-10#1)(2011-2#1)
examine##694##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#7)(1992-3#3)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#11)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#4)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-12#3)(1995-2#10)(1995-3#5)(1995-5#5)(1995-6#2)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#9)(2007-12#12)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#4)(2008-1#8)(2008-10#48)(2008-11#52)(2008-12#19)(2008-2#20)(2008-3#28)(2008-4#7)(2008-5#18)(2008-6#8)(2008-7#31)(2008-8#27)(2008-9#22)(2009-10#8)(2009-11#3)(2009-12#6)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#10)(2009-8#4)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#6)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#12)(2011-2#29)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#27)(2012-3#8)(2012-5#1)(2013-1#19)(2013-8#10)
examined 34##2##2##(1991-6#1)(2013-1#1)
examined a##5##2##(1990-8#1)(2008-10#1)(2010-11#2)(2012-1#1)
examined after##8##2##(1993-8#2)(1994-5#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
examined again##2##2##(1990-2#1)(1991-11#1)
examined among##6##2##(1992-2#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-6#1)(2012-2#1)
examined and appraised##2##3##(1994-2#1)(2008-10#1)
examined and compared with##2##4##(1992-5#1)(2011-2#1)
examined and compared##4##3##(1992-5#1)(2008-10#2)(2011-2#1)
examined and discussed##4##3##(1991-5#1)(2008-3#1)(2008-5#1)(2008-7#1)
examined and it##2##3##(1990-3#1)(2008-10#1)
examined and optimized##3##3##(2008-10#2)(2008-8#1)
examined and the##11##3##(1991-3#1)(1992-6#1)(1994-6#1)(2008-10#6)(2008-8#1)(2008-9#1)
examined and##53##2##(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-6#1)(2006-4#1)(2007-12#1)(2008-10#21)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#4)(2013-1#1)
examined appear to##2##3##(1993-12#1)(2008-3#1)
examined are##2##2##(2011-2#2)
examined as a##12##3##(1990-12#1)(1991-3#1)(1994-5#1)(1997-7#1)(2008-10#5)(2009-8#1)(2010-1#1)(2012-2#1)
examined as an##3##3##(2008-10#3)
examined as the##2##3##(2007-10#1)(2008-10#1)
examined as well##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
examined as##29##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#1)(1994-5#1)(1997-7#1)(2007-10#1)(2008-10#14)(2008-2#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)
examined associations between##2##3##(2011-2#1)(2013-1#1)
examined at a##2##3##(2008-10#1)(2008-3#1)
examined at different##4##3##(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
examined at the##5##3##(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2011-2#1)
examined at##26##2##(1990-12#1)(1992-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#2)
examined because of##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
examined because##4##2##(1994-5#1)(2007-11#1)(2011-2#1)(2012-3#1)
examined before##2##2##(2008-1#1)(2009-6#1)
examined both in##2##3##(1992-12#1)(2008-3#1)
examined both##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)
examined by a##3##3##(1990-3#1)(1991-2#1)(2008-2#1)
examined by applying##2##3##(2008-10#1)(2009-11#1)
examined by comparing the##2##4##(2008-10#1)(2008-8#1)
examined by comparing##3##3##(2008-10#1)(2008-8#2)
examined by differential pulse##2##4##(2008-10#2)
examined by direct##2##3##(2008-3#1)(2012-3#1)
examined by electron microscopy##3##4##(2008-10#1)(2008-7#2)
examined by electron##5##3##(1993-11#1)(2008-10#1)(2008-7#3)
examined by fluorescence##2##3##(1997-2#1)(2008-8#1)
examined by fluorescent microscopy##2##4##(1997-2#1)(2008-1#1)
examined by immunohistochemistry##3##3##(1994-10#1)(1995-12#1)(2007-12#1)
examined by light##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
examined by means of##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
examined by measuring the##2##4##(1994-2#1)(1995-5#1)
examined by measuring##5##3##(1992-11#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
examined by scanning electron microscopy##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
examined by surface electromyography##2##4##(1990-6#1)(2009-6#1)
examined by the##7##3##(1993-11#1)(2008-10#3)(2008-5#2)(2013-1#1)
examined by transmission electron microscopy##3##5##(1997-6#1)(2008-10#1)(2008-5#1)
examined by using various##2##4##(2008-10#1)(2009-11#1)
examined by using##7##3##(2008-10#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)
examined by##141##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#36)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#5)
examined cases##3##2##(1991-12#1)(1997-8#1)(2009-4#1)
examined compared to##2##3##(1993-12#1)(2008-11#1)
examined compared##3##2##(1993-12#1)(2008-11#1)(2012-3#1)
examined competition##2##2##(2008-8#1)(2008-9#1)
examined differences in##3##3##(1994-2#1)(2010-10#1)(2013-1#1)
examined differences##4##2##(1994-2#1)(2009-5#1)(2010-10#1)(2013-1#1)
examined do not appear to##2##5##(1995-3#1)(2006-8#1)
examined during a##2##3##(1990-3#1)(2008-5#1)
examined during##6##2##(1990-3#1)(1992-6#1)(2008-10#1)(2008-5#1)(2012-8#1)(2013-7#1)
examined factors##4##2##(1993-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
examined following##3##2##(1990-7#1)(1997-6#1)(2008-6#1)
examined for a##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
examined for all##2##3##(1991-1#1)(2008-10#1)
examined for each##2##3##(1996-5#1)(2008-11#1)
examined for its##7##3##(1992-5#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
examined for the presence of the##2##6##(2008-10#2)
examined for the presence of##7##5##(1990-3#1)(2008-10#5)(2008-5#1)
examined for the##26##3##(1990-3#1)(1991-12#1)(1991-8#1)(1992-3#1)(1997-8#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2013-1#1)
examined for their ability to##8##5##(1993-11#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)
examined for their##16##3##(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-4#1)
examined for various##2##3##(1993-3#1)(2007-12#1)
examined for##121##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#6)(2008-5#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
examined four##2##2##(2008-11#1)(2013-7#1)
examined from the##5##3##(1992-3#1)(2007-11#1)(2008-3#1)(2010-1#1)(2013-1#1)
examined from various##2##3##(1990-11#1)(2009-6#1)
examined from##11##2##(1990-11#1)(1992-3#1)(1993-3#1)(1996-4#1)(1997-3#1)(2007-11#1)(2008-3#1)(2009-6#1)(2010-1#1)(2010-8#1)(2013-1#1)
examined gender differences in##2##4##(2008-4#1)(2009-7#1)
examined genetically##2##2##(2008-10#1)(2008-8#1)
examined have##2##2##(2008-3#1)(2008-7#1)
examined here##5##2##(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2010-3#1)
examined herein##2##2##(1993-12#1)(2008-5#1)
examined histologically##5##2##(1995-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
examined histopathologically##3##2##(2008-5#1)(2012-1#2)
examined how the##2##3##(2008-12#1)(2008-8#1)
examined how##14##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2013-1#4)(2013-8#1)
examined if##2##2##(2007-11#1)(2012-12#1)
examined in 23##2##3##(1996-6#1)(2008-5#1)
examined in a greenhouse##2##4##(2008-10#2)
examined in a sample of##3##5##(2008-11#1)(2008-9#1)(2011-2#1)
examined in a##24##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-6#2)(1995-12#1)(1996-7#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-2#2)(2013-1#1)
examined in comparison with##3##4##(1991-9#1)(2008-11#1)(2009-9#1)
examined in cultured human##2##4##(1994-6#1)(2008-11#1)
examined in cultured##5##3##(1990-8#1)(1994-6#1)(1995-12#1)(1996-7#1)(2008-11#1)
examined in detail##9##3##(1991-12#1)(1992-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-12#1)
examined in different##2##3##(2008-10#1)(2008-12#1)
examined in field##2##3##(2008-10#2)
examined in greater##2##3##(1992-5#1)(2013-1#1)
examined in human##2##3##(1993-3#1)(1993-6#1)
examined in membranes from##2##4##(1993-1#1)(1993-6#1)
examined in one##2##3##(1992-3#1)(2012-3#1)
examined in order to##5##4##(1996-12#2)(2008-10#3)
examined in our##2##3##(1997-4#1)(2008-10#1)
examined in rats##4##3##(1992-11#1)(1994-5#1)(1995-12#1)(1997-7#1)
examined in relation to the##4##5##(1990-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
examined in relation to##9##4##(1990-3#2)(1994-8#1)(1997-6#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-8#1)
examined in situ##2##3##(1995-3#1)(2011-2#1)
examined in terms of##3##4##(1991-3#1)(2008-11#1)(2008-12#1)
examined in the context of##4##5##(1993-3#1)(2008-11#2)(2009-11#1)
examined in the current study##2##5##(1996-5#1)(2009-8#1)
examined in the presence of##2##5##(2008-10#1)(2008-11#1)
examined in the present study##2##5##(1993-3#1)(1994-2#1)
examined in the##40##3##(1990-5#1)(1991-5#2)(1993-1#1)(1993-3#3)(1994-2#2)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#2)(2009-11#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
examined in this study##9##4##(1990-3#1)(1991-4#1)(1992-9#1)(1995-6#1)(2008-10#5)
examined in this##15##3##(1990-3#1)(1991-3#1)(1991-4#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)
examined in vitro and##4##4##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
examined in vitro##6##3##(1992-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
examined in which##2##3##(2008-10#1)(2008-3#1)
examined in##216##2##(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#2)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#39)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#2)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
examined included##2##2##(1994-5#1)(1996-6#1)
examined including##2##2##(1991-5#1)(1997-7#1)
examined intrinsic##2##2##(1991-2#1)(1992-6#1)
examined is##3##2##(1993-3#1)(2008-4#1)(2008-7#1)
examined its##3##2##(1992-9#1)(1994-12#1)(2009-11#1)
examined length of##2##3##(1993-12#1)(1994-1#1)
examined on the##2##3##(1995-12#1)(2008-3#1)
examined on##16##2##(1991-7#1)(1993-12#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-7#1)(2010-8#1)
examined over a##3##3##(1991-3#1)(1991-9#1)(2008-8#1)
examined over##5##2##(1991-3#1)(1991-9#1)(1996-3#1)(2008-10#1)(2008-8#1)
examined parameters##2##2##(2008-6#1)(2011-1#1)
examined patients##2##2##(1990-9#1)(2008-7#1)
examined protein##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
examined samples##3##2##(2008-10#2)(2008-3#1)
examined self-reported##2##2##(2008-11#1)(2013-1#1)
examined system##2##2##(2009-8#1)(2012-1#1)
examined that##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
examined the ability of##6##4##(1990-5#1)(1995-8#1)(2008-10#2)(2010-2#2)
examined the association between##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
examined the association##4##3##(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
examined the associations##2##3##(1994-7#1)(2009-7#1)
examined the characteristics##3##3##(1994-12#1)(2007-12#1)(2008-11#1)
examined the correlates of##2##4##(1993-1#1)(2012-3#1)
examined the correlation between##3##4##(1993-11#1)(1996-11#1)(2013-8#1)
examined the correlation##4##3##(1993-11#1)(1996-11#1)(2008-12#1)(2013-8#1)
examined the development of##2##4##(1991-2#1)(1996-5#1)
examined the effect of different##2##5##(1992-9#1)(1995-12#1)
examined the effect of##41##4##(1991-2#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-7#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#6)(2008-5#1)(2008-6#2)(2008-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
examined the effectiveness of##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
examined the effects of a##2##5##(2008-12#1)(2010-4#1)
examined the effects of adenosine##2##5##(2008-4#2)
examined the effects of##47##4##(1990-8#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#3)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
examined the effects##48##3##(1990-8#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#3)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
examined the efficacy of##3##4##(2009-1#1)(2012-3#1)(2013-1#1)
examined the expression of##8##4##(1992-9#1)(1994-2#1)(1996-12#2)(1997-6#1)(2008-4#1)(2008-7#1)(2008-8#1)
examined the expression##9##3##(1992-9#1)(1994-2#1)(1996-12#2)(1997-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
examined the extent to which##2##5##(1997-3#1)(2008-9#1)
examined the functional##3##3##(1991-8#1)(1995-8#1)(2008-7#1)
examined the genetic structure##2##4##(2008-10#2)
examined the genetic##4##3##(2008-10#2)(2009-5#1)(2011-2#1)
examined the influence of##8##4##(1990-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
examined the interaction of##2##4##(1995-6#1)(2008-11#1)
examined the possibility##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
examined the potential##3##3##(1992-11#1)(1992-5#1)(2012-7#1)
examined the presence##2##3##(1992-3#1)(2010-3#1)
examined the relationship between the##4##5##(1997-6#1)(2008-11#1)(2010-6#1)(2011-2#1)
examined the relationship between##20##4##(1994-7#1)(1995-2#1)(1995-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
examined the relationship##21##3##(1994-7#1)(1995-2#1)(1995-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
examined the relationships between##2##4##(2010-1#1)(2012-3#1)
examined the relationships##3##3##(2008-11#1)(2010-1#1)(2012-3#1)
examined the relative##5##3##(1992-11#1)(2007-12#2)(2009-5#1)(2009-8#1)
examined the response of##2##4##(2008-10#1)(2013-1#1)
examined the role of the##4##5##(1993-6#1)(1994-3#1)(1997-7#1)(2008-10#1)
examined the role of##17##4##(1991-12#1)(1993-6#1)(1994-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-9#1)(2010-4#1)(2012-3#2)
examined the roles of##2##4##(1995-12#1)(2008-11#1)
examined the temporal##2##3##(2008-11#1)(2013-8#1)
examined the##345##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#4)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#1)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#7)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-6#4)(1997-7#2)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#12)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#29)(2008-11#30)(2008-12#8)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#7)(2012-7#1)(2013-1#18)(2013-8#4)
examined their##6##2##(1992-11#1)(1995-6#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
examined these##4##2##(1990-12#1)(1994-9#1)(2008-3#1)(2009-5#1)
examined this##6##2##(1990-5#1)(1992-3#1)(1995-3#1)(2008-8#1)(2009-6#1)(2012-2#1)
examined three##2##2##(1993-2#1)(2007-12#1)
examined through##2##2##(2008-3#1)(2010-8#1)
examined tissues##3##2##(2008-8#1)(2009-8#2)
examined to assess the##2##4##(2008-5#1)(2008-8#1)
examined to date##2##3##(1991-9#1)(2009-5#1)
examined to determine if##2##4##(1994-2#1)(2009-7#1)
examined to determine the##3##4##(1993-3#1)(2008-10#2)
examined to determine##11##3##(1991-8#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(2008-10#5)(2009-7#1)
examined to elucidate##2##3##(2008-7#1)(2010-8#1)
examined to evaluate the##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
examined to reveal##2##3##(1995-1#1)(2008-10#1)
examined to##33##2##(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-6#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-8#2)(2013-1#2)
examined two##4##2##(1997-4#1)(2008-5#1)(2009-9#1)(2011-2#1)
examined under a##2##3##(2013-1#1)(2013-8#1)
examined under##5##2##(1997-4#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
examined using a##14##3##(1992-6#2)(1993-11#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-6#1)(2012-2#1)
examined using an##6##3##(1991-12#1)(1991-9#1)(1992-3#1)(1994-11#1)(2008-11#1)(2011-2#1)
examined using data##2##3##(2008-10#2)
examined using immunohistochemical##2##3##(1992-3#1)(1993-6#1)
examined using light and electron microscopy##2##6##(2008-10#1)(2008-7#1)
examined using light##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
examined using the chloramphenicol##2##4##(1992-12#1)(1992-6#1)
examined using the##6##3##(1990-2#1)(1992-12#1)(1992-6#1)(2008-10#1)(2008-7#1)(2010-12#1)
examined using##79##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-12#3)(2007-8#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
examined via##2##2##(1996-4#1)(2008-10#1)
examined was##3##2##(1993-12#1)(2008-10#2)
examined ways to##2##3##(1995-3#1)(2008-10#1)
examined were##14##2##(1991-1#1)(1991-10#1)(1993-8#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-5#3)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
examined whether or not##3##4##(2008-11#1)(2008-6#2)
examined whether providing##2##3##(1996-2#1)(2013-1#1)
examined whether the##8##3##(1992-12#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-6#1)(2009-2#1)(2009-8#1)(2013-1#1)
examined whether##48##2##(1990-11#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
examined which##3##2##(1991-12#1)(1995-11#1)(2011-2#1)
examined with a##3##3##(1996-2#1)(2008-10#2)
examined with an##3##3##(2008-1#1)(2008-3#1)(2008-9#1)
examined with the##6##3##(1995-5#1)(1997-3#1)(2008-10#2)(2009-10#1)(2012-12#1)
examined with##28##2##(1991-10#1)(1993-1#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-3#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2012-12#1)(2012-2#1)
examined within##2##2##(1997-7#1)(2008-10#1)
examined##2087##1##(1990-10#1)(1990-11#6)(1990-12#9)(1990-2#9)(1990-3#12)(1990-5#9)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#4)(1991-1#8)(1991-10#3)(1991-11#3)(1991-12#22)(1991-2#12)(1991-3#11)(1991-4#1)(1991-5#7)(1991-6#8)(1991-7#2)(1991-8#7)(1991-9#8)(1992-1#2)(1992-11#11)(1992-12#15)(1992-2#6)(1992-3#18)(1992-4#2)(1992-5#7)(1992-6#9)(1992-8#7)(1992-9#7)(1993-1#7)(1993-11#9)(1993-12#24)(1993-2#7)(1993-3#19)(1993-5#1)(1993-6#11)(1993-8#12)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#11)(1994-12#9)(1994-2#17)(1994-3#9)(1994-5#15)(1994-6#6)(1994-7#4)(1994-8#10)(1994-9#2)(1995-1#5)(1995-11#11)(1995-12#23)(1995-2#13)(1995-3#11)(1995-4#2)(1995-5#16)(1995-6#8)(1995-8#9)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#20)(1996-2#9)(1996-3#2)(1996-4#2)(1996-5#13)(1996-6#6)(1996-7#5)(1996-9#4)(1997-1#3)(1997-2#18)(1997-3#18)(1997-4#17)(1997-5#3)(1997-6#12)(1997-7#10)(1997-8#10)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#9)(2007-11#20)(2007-12#41)(2007-2#7)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#14)(2008-1#14)(2008-10#413)(2008-11#94)(2008-12#36)(2008-2#32)(2008-3#65)(2008-4#14)(2008-5#65)(2008-6#24)(2008-7#61)(2008-8#35)(2008-9#19)(2009-1#2)(2009-10#7)(2009-11#12)(2009-12#7)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#10)(2009-6#7)(2009-7#17)(2009-8#19)(2009-9#8)(2010-1#9)(2010-10#7)(2010-11#3)(2010-12#4)(2010-2#8)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#5)(2010-7#10)(2010-8#12)(2010-9#4)(2011-1#18)(2011-2#63)(2011-3#1)(2012-1#8)(2012-12#10)(2012-2#26)(2012-3#31)(2012-7#2)(2012-8#1)(2013-1#75)(2013-7#6)(2013-8#21)
examined)##3##1##(1991-12#1)(1992-11#1)(2008-5#1)
examinee##2##1##(2008-12#1)(2011-2#1)
examinees##2##1##(1995-4#1)(2012-3#1)
examiner training##2##2##(1996-2#2)
examiner##14##1##(1993-12#2)(1995-3#1)(1996-2#3)(2007-11#1)(2008-1#1)(2008-12#2)(2011-2#3)(2013-1#1)
examiners##5##1##(1990-3#1)(2008-10#1)(2008-12#2)(2013-1#1)
examines Medicare##2##2##(1994-3#1)(1995-12#1)
examines a##6##2##(1992-2#1)(1994-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2012-2#1)
examines and##4##2##(2008-11#1)(2008-9#2)(2012-3#1)
examines both##2##2##(2010-8#1)(2013-1#1)
examines how the##2##3##(2007-2#1)(2008-11#1)
examines how##16##2##(1994-1#1)(1996-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#2)
examines its##2##2##(1993-3#1)(2007-11#1)
examines proposed##2##2##(1994-2#1)(2008-2#1)
examines some of the##5##4##(1992-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#1)
examines the contribution of##2##4##(2008-12#1)(2008-7#1)
examines the current##2##3##(2007-2#1)(2009-5#1)
examines the dynamics and##2##4##(2009-10#1)(2011-2#1)
examines the effect##3##3##(1991-12#1)(1994-2#1)(2008-12#1)
examines the effects of##5##4##(1991-5#1)(1993-3#1)(2008-10#1)(2008-5#1)(2010-11#1)
examines the evidence for##2##4##(2011-2#1)(2013-1#1)
examines the evolution of##2##4##(1991-12#1)(2011-2#1)
examines the evolution##3##3##(1991-12#1)(1996-3#1)(2011-2#1)
examines the experiences of##2##4##(2008-11#1)(2009-7#1)
examines the feasibility of##2##4##(1992-1#1)(2008-10#1)
examines the impact of##5##4##(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-11#1)
examines the importance of##2##4##(1993-6#1)(1994-12#1)
examines the importance##3##3##(1993-6#1)(1994-12#1)(1995-1#1)
examines the influence of##3##4##(1995-2#1)(2008-6#1)(2008-7#1)
examines the influence##5##3##(1995-2#2)(2008-6#1)(2008-7#1)(2012-3#1)
examines the relationship between the##3##5##(1994-3#1)(1997-3#1)(2009-5#1)
examines the relationship between##6##4##(1994-3#1)(1995-12#1)(1997-3#1)(2008-6#1)(2009-5#1)(2013-1#1)
examines the relationship##7##3##(1994-3#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2009-5#1)(2013-1#1)
examines the role of##3##4##(1992-12#1)(2008-11#1)(2012-12#1)
examines the safety and##2##4##(2007-2#1)(2008-10#1)
examines the use of##2##4##(1995-3#1)(2009-5#1)
examines the##135##2##(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#3)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#2)(1997-3#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2008-1#2)(2008-10#7)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-2#9)(2012-12#4)(2012-3#2)(2013-1#3)
examines two##2##2##(2008-1#1)(2010-4#1)
examines various##2##2##(1996-7#1)(2008-2#1)
examines ways##2##2##(1995-1#1)(2008-9#1)
examines what##3##2##(1991-3#1)(2008-9#1)(2009-7#1)
examines whether##6##2##(1993-3#1)(1994-12#1)(2008-11#2)(2010-2#1)(2010-7#1)
examines##258##1##(1990-5#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#5)(1992-12#4)(1992-2#2)(1992-3#1)(1993-1#4)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#1)(1994-1#4)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#3)(1994-6#1)(1995-1#5)(1995-12#5)(1995-2#6)(1995-3#3)(1996-1#4)(1996-12#6)(1996-2#5)(1996-3#5)(1996-7#1)(1997-1#1)(1997-3#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-4#1)(2007-5#2)(2008-1#7)(2008-10#10)(2008-11#17)(2008-12#5)(2008-2#4)(2008-3#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#10)(2012-2#3)(2012-3#7)(2013-1#7)(2013-8#1)
examining a##2##2##(2008-11#1)(2008-5#1)
examining both##2##2##(2008-9#1)(2010-3#1)
examining how##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
examining its effects on##2##4##(1997-2#1)(2011-2#1)
examining its##5##2##(1993-2#1)(1996-3#1)(1997-2#1)(2011-2#1)(2013-8#1)
examining potential##2##2##(2008-4#1)(2012-2#1)
examining the effect of##3##4##(1994-9#1)(1996-2#1)(2012-1#1)
examining the effects of##3##4##(1992-6#1)(1994-3#1)(2008-4#1)
examining the most recent##2##4##(1993-5#1)(2007-12#1)
examining the response of##2##4##(2008-11#1)(2008-9#1)
examining the role of##3##4##(1992-6#1)(1995-2#1)(2009-8#1)
examining the##70##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-6#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
examining their##4##2##(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)
examining this##3##2##(2008-1#1)(2009-7#1)(2010-8#1)
examining whether##4##2##(1993-3#1)(1994-3#1)(1995-12#1)(2009-7#1)
examining##179##1##(1990-11#1)(1990-2#1)(1991-1#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#14)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#11)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#2)
example and##5##2##(1992-6#1)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#1)
example data##5##2##(1994-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)
example for the##4##3##(2008-10#1)(2008-2#2)(2013-8#1)
example for##5##2##(2008-10#1)(2008-2#2)(2013-8#2)
example from the##4##3##(1992-12#1)(1995-9#1)(1997-3#1)(2013-8#1)
example from##8##2##(1992-12#1)(1995-9#1)(1996-6#1)(1997-3#1)(2008-7#1)(2008-8#1)(2013-8#2)
example in##8##2##(1994-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
example is given to##2##4##(1997-3#1)(2012-2#1)
example is given##6##3##(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
example is presented##2##3##(1995-9#1)(2008-9#1)
example is provided##2##3##(1997-4#1)(2008-3#1)
example is the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)
example is##22##2##(1995-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#1)
example it is##2##3##(2007-12#1)(2008-3#1)
example it##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
example of a naturally occurring##2##5##(2011-1#1)(2011-2#1)
example of a practical application##2##5##(2008-10#1)(2008-3#1)
example of a practical##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
example of a##32##3##(1990-8#1)(1991-2#1)(1992-8#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
example of an##3##3##(1995-6#1)(2007-9#1)(2008-11#1)
example of application##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
example of how##11##3##(1993-12#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
example of process##2##3##(2008-12#1)(2013-8#1)
example of such a##3##4##(1993-11#1)(2007-11#1)(2008-5#1)
example of such##5##3##(1992-12#1)(1993-11#1)(1996-4#1)(2007-11#1)(2008-5#1)
example of the latter##2##4##(1994-9#1)(2007-12#1)
example of the potential##2##4##(2007-12#1)(2008-10#1)
example of the use of##3##5##(2007-11#1)(2008-10#1)(2010-5#1)
example of the##36##3##(1990-8#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-6#1)(1997-1#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-3#4)(2008-4#3)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
example of these##2##3##(2008-10#1)(2009-5#1)
example of this is##2##4##(2008-3#1)(2009-8#1)
example of this##6##3##(1995-1#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)
example of##175##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-6#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-3#2)(1997-7#1)(2006-4#1)(2007-11#5)(2007-12#7)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#5)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
example that##8##2##(1992-6#1)(1995-12#1)(2007-12#2)(2008-3#1)(2010-11#1)(2013-1#2)
example the##7##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-7#1)(2011-2#1)
example to illustrate##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
example to##14##2##(1994-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-8#1)
example ultrahigh-spatial-resolution laser-backlit##2##3##(2008-3#2)
example using data from##2##4##(1992-6#1)(1996-3#1)
example using##6##2##(1992-6#1)(1996-3#1)(2008-11#1)(2009-10#1)(2012-1#1)(2013-7#1)
example##652##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#6)(1994-3#5)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#3)(1995-6#6)(1995-9#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#13)(2007-12#22)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#10)(2008-10#90)(2008-11#29)(2008-12#12)(2008-2#30)(2008-3#49)(2008-4#20)(2008-5#22)(2008-6#5)(2008-7#32)(2008-8#24)(2008-9#20)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#21)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#14)(2012-3#12)(2013-1#7)(2013-7#1)(2013-8#11)
examples and##2##2##(2008-11#1)(2008-4#1)
examples are discussed in##2##4##(2008-3#1)(2008-4#1)
examples are given of##2##4##(2008-11#1)(2008-4#1)
examples are given to##2##4##(1995-5#1)(2009-12#1)
examples are given##5##3##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)
examples are presented to##2##4##(2008-3#1)(2012-2#1)
examples are presented##8##3##(1993-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
examples are provided##2##3##(2008-7#2)
examples are shown##2##3##(2008-2#1)(2008-3#1)
examples are##36##2##(1990-2#1)(1992-11#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#3)(2009-12#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#3)
examples can##2##2##(1997-6#1)(2009-11#1)
examples demonstrate##2##2##(2008-10#1)(2008-2#1)
examples for##6##2##(1990-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-10#1)
examples from the authors'##2##4##(1992-1#1)(2008-7#1)
examples from the emergency medicine literature have been included##2##9##(2007-5#2)
examples from the literature with##2##5##(2007-4#1)(2010-10#1)
examples from the literature##3##4##(2007-4#1)(2008-10#1)(2010-10#1)
examples from the##14##3##(1992-1#1)(1993-12#1)(1996-4#1)(2007-4#1)(2007-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-7#1)
examples from##26##2##(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#2)(1994-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-2#1)
examples illustrate the##2##3##(1992-3#1)(1997-7#1)
examples illustrating the##2##3##(2008-9#2)
examples in the##3##3##(1992-2#1)(1993-3#1)(2008-10#1)
examples in##7##2##(1992-2#1)(1993-3#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-2#1)
examples include##4##2##(1994-12#1)(2009-6#1)(2010-12#1)(2010-7#1)
examples of a##3##3##(1992-12#1)(1997-3#1)(2009-8#1)
examples of analytical##2##3##(2008-10#1)(2008-11#1)
examples of applications##2##3##(1995-6#1)(2008-11#1)
examples of convergent evolution##2##4##(2011-2#2)
examples of each##2##3##(1997-1#1)(2008-4#1)
examples of efforts to integrate public health and##2##8##(1995-2#2)
examples of fabricated##2##3##(2008-2#2)
examples of how to##2##4##(1993-2#1)(1994-3#1)
examples of how##5##3##(1993-2#1)(1994-12#1)(1994-3#1)(1997-3#1)(2008-12#1)
examples of its use##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
examples of its##4##3##(2008-3#1)(2008-4#1)(2008-9#1)(2010-9#1)
examples of some of the##3##5##(1997-2#1)(2008-9#1)(2011-2#1)
examples of some##5##3##(1997-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)
examples of such##4##3##(2012-2#1)(2013-1#2)(2013-8#1)
examples of the application of##2##5##(2008-10#1)(2008-9#1)
examples of the most##2##4##(2007-11#1)(2008-4#1)
examples of the use of##2##5##(2008-11#1)(2008-3#1)
examples of the##14##3##(1993-6#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#2)
examples of these##3##3##(1997-3#1)(2008-11#1)(2008-12#1)
examples of this##4##3##(1996-5#1)(2007-11#1)(2008-11#1)(2008-3#1)
examples of##140##2##(1991-3#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#3)(1994-9#3)(1995-1#1)(1995-2#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#14)(2008-4#8)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
examples reported in##2##3##(1991-5#1)(2007-11#1)
examples suggest that##2##3##(1991-1#1)(1996-4#1)
examples that##3##2##(2007-11#1)(2009-12#1)(2010-10#1)
examples to illustrate##2##3##(1997-7#1)(2010-4#1)
examples to##4##2##(1997-7#1)(2008-11#1)(2009-11#1)(2010-4#1)
examples we##2##2##(2007-11#1)(2011-1#1)
examples were##2##2##(2008-10#2)
examples where the##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
examples where##4##2##(1992-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
examples which##2##2##(1990-8#1)(2013-8#1)
examples will be##4##3##(1991-5#1)(1997-2#1)(2008-10#1)(2013-8#1)
examples will##5##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
examples##348##1##(1990-12#1)(1990-2#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#3)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-3#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#3)(2006-10#1)(2006-12#1)(2006-4#3)(2007-11#7)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2008-1#4)(2008-10#38)(2008-11#13)(2008-12#5)(2008-2#15)(2008-3#34)(2008-4#12)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#10)(2009-10#2)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#6)(2013-8#7)
exams in the##2##3##(2007-8#1)(2013-1#1)
exams in##3##2##(1995-1#1)(2007-8#1)(2013-1#1)
exams##15##1##(1991-3#2)(1994-5#1)(1995-1#2)(1995-2#1)(1996-2#1)(2007-8#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
exanthem##4##1##(2007-7#2)(2008-11#1)(2010-8#1)
exanthema##2##1##(1993-11#1)(2007-7#1)
excavation##4##1##(1990-5#1)(1997-5#1)(2008-10#1)(2008-5#1)
excavations##2##1##(2008-10#1)(2008-5#1)
exceed 1##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
exceed 2##3##2##(2008-10#1)(2008-3#1)(2009-3#1)
exceed a certain##2##3##(2008-3#1)(2008-8#1)
exceed a critical##2##3##(2008-8#1)(2008-9#1)
exceed a##8##2##(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)
exceed the needs##2##3##(1994-2#1)(1995-1#1)
exceed the##19##2##(1994-2#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#2)(2013-1#1)(2013-8#1)
exceed those##4##2##(1990-11#1)(1994-12#1)(1996-12#1)(2008-9#1)
exceed three##2##2##(1997-5#1)(2008-9#1)
exceed##79##1##(1990-11#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-5#1)(1997-8#1)(2007-11#3)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-3#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
exceeded 0##3##2##(2008-10#2)(2008-9#1)
exceeded 20##2##2##(1990-5#1)(2008-10#1)
exceeded 25%##2##2##(2008-10#1)(2008-5#1)
exceeded 30##2##2##(2008-10#1)(2011-2#1)
exceeded 5##2##2##(2007-11#1)(2008-10#1)
exceeded 90%##3##2##(1997-2#1)(2008-10#2)
exceeded a certain##2##3##(2007-11#1)(2011-2#1)
exceeded a##5##2##(2007-11#1)(2008-11#2)(2008-8#1)(2011-2#1)
exceeded that of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
exceeded that##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
exceeded the minimal##2##3##(2008-3#1)(2012-2#1)
exceeded the##17##2##(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
exceeded what was##2##3##(2008-3#1)(2008-8#1)
exceeded##86##1##(1990-12#1)(1990-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-5#2)(1995-6#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-4#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
exceeding 1##6##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)
exceeding 2##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
exceeding 20##3##2##(2008-10#3)
exceeding 50%##2##2##(2008-11#1)(2010-4#1)
exceeding a##3##2##(2008-10#1)(2008-7#2)
exceeding increases##2##2##(1991-12#1)(1991-2#1)
exceeding the##11##2##(1995-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2013-1#1)
exceeding those##2##2##(1997-4#1)(2008-7#1)
exceeding##64##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-4#3)(2007-11#1)(2007-12#4)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
exceedingly rare##11##2##(2008-11#1)(2008-7#1)(2009-1#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)
exceedingly##14##1##(2008-10#1)(2008-11#2)(2008-7#1)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)
exceeds 0##2##2##(2007-11#1)(2008-3#1)
exceeds 10##2##2##(2007-11#1)(2008-3#1)
exceeds 2##2##2##(2008-10#1)(2008-2#1)
exceeds 80%##2##2##(2007-11#1)(2007-12#1)
exceeds a threshold##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
exceeds that of##6##3##(1990-11#1)(1991-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-5#1)
exceeds that##9##2##(1990-11#1)(1991-11#1)(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)
exceeds the number of##3##4##(1993-9#1)(1995-12#1)(2008-9#1)
exceeds the threshold##2##3##(1996-8#1)(2008-10#1)
exceeds the##17##2##(1990-8#1)(1993-9#1)(1995-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#2)(2013-1#1)
exceeds##67##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
excellence and##4##2##(1994-2#1)(1995-3#1)(1996-1#1)(2012-3#1)
excellence in clinical##2##3##(1995-1#2)
excellence in##9##2##(1992-3#1)(1993-1#1)(1995-1#2)(1996-8#1)(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
excellence##31##1##(1990-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1994-1#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
excellent affinity##2##2##(2008-10#2)
excellent agreement between the##3##4##(2008-2#1)(2008-7#1)(2013-1#1)
excellent agreement between##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
excellent agreement with experimental##2##4##(1993-11#1)(2007-12#1)
excellent agreement with the##16##4##(1990-8#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#2)(2011-2#1)
excellent agreement with those##2##4##(2008-10#1)(2008-3#1)
excellent agreement with##30##3##(1990-8#1)(1993-11#1)(1995-2#1)(2007-11#2)(2007-12#4)(2008-10#7)(2008-2#3)(2008-3#6)(2009-5#1)(2009-9#2)(2011-2#1)(2012-2#1)
excellent agreement##46##2##(1990-8#1)(1993-11#1)(1995-2#1)(2007-11#3)(2007-12#6)(2008-10#11)(2008-2#4)(2008-3#12)(2008-7#1)(2009-5#1)(2009-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
excellent agreements##2##2##(2008-10#2)
excellent analytical##2##2##(2008-10#2)
excellent and##8##2##(1993-12#1)(2006-6#1)(2008-10#2)(2008-5#2)(2011-2#1)(2012-1#1)
excellent antibacterial##2##2##(2010-4#1)(2012-3#1)
excellent by##2##2##(1993-2#1)(1996-9#1)
excellent candidates for##2##3##(2007-12#1)(2009-5#1)
excellent catalytic activity##6##3##(2008-10#6)
excellent catalytic##7##2##(2008-10#7)
excellent clinical##2##2##(2008-1#1)(2012-12#1)
excellent correlation between the##3##4##(1992-2#1)(2008-10#2)
excellent correlation between##6##3##(1992-2#1)(1995-2#1)(2008-10#3)(2008-5#1)
excellent correlation to the##2##4##(1990-12#2)
excellent correlation##12##2##(1990-12#2)(1992-2#1)(1995-2#1)(2008-10#6)(2008-2#1)(2008-5#1)
excellent correspondence with##2##3##(2008-10#2)
excellent cosmetic and functional results##2##5##(1991-9#1)(2008-9#1)
excellent cosmetic##4##2##(1991-9#1)(2008-10#1)(2008-9#1)(2009-5#1)
excellent derivative yields##2##3##(2008-10#2)
excellent diagnostic##3##2##(1990-6#2)(1995-12#1)
excellent discriminating ability##2##3##(2008-10#2)
excellent discrimination##3##2##(2007-11#2)(2008-10#1)
excellent early##2##2##(2008-10#1)(2011-2#1)
excellent efficacy##2##2##(1995-3#1)(2008-10#1)
excellent electrocatalytic activity towards##2##4##(2008-10#2)
excellent electrocatalytic activity##5##3##(2008-10#5)
excellent electrocatalytic##7##2##(2008-10#7)
excellent electronic##2##2##(2008-10#1)(2008-7#1)
excellent enrichment factor##2##3##(2008-10#2)
excellent enrichment##3##2##(2008-10#3)
excellent fit##3##2##(2008-11#1)(2008-2#1)(2013-1#1)
excellent for##3##2##(1995-2#1)(2008-10#2)
excellent function##4##2##(2007-8#1)(2008-6#1)(2008-9#1)(2013-1#1)
excellent functional recovery##2##3##(2008-12#1)(2008-6#1)
excellent functional##4##2##(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
excellent graft##2##2##(2007-8#1)(2013-1#1)
excellent in##7##2##(1990-6#1)(1992-2#1)(1996-9#2)(2008-10#1)(2008-7#1)(2011-2#1)
excellent linear dynamic relationship in the range of##2##8##(2008-10#2)
excellent linear##4##2##(1996-2#1)(2008-10#3)
excellent linearity over the##2##4##(2008-10#1)(2009-9#1)
excellent linearity##5##2##(2008-10#2)(2008-3#1)(2009-9#1)(2011-3#1)
excellent local control##2##3##(2008-10#1)(2008-6#1)
excellent long-term survival##2##3##(2007-8#1)(2012-3#1)
excellent long-term##4##2##(2007-8#1)(2008-10#1)(2009-12#1)(2012-3#1)
excellent material##2##2##(2007-11#1)(2013-1#1)
excellent model##4##2##(1995-3#1)(1997-3#1)(2008-7#1)(2009-3#1)
excellent models##2##2##(1994-12#1)(2010-7#1)
excellent opportunities to##2##3##(2012-2#2)
excellent optical##2##2##(2008-2#1)(2011-1#1)
excellent or good##4##3##(1991-8#1)(1997-6#1)(2008-3#1)(2012-1#1)
excellent or##6##2##(1990-6#1)(1991-8#1)(1997-6#1)(2008-3#1)(2011-1#1)(2012-1#1)
excellent organizations##2##2##(1994-12#2)
excellent outcome was##2##3##(2007-8#1)(2013-1#1)
excellent outcome##4##2##(2007-8#1)(2008-10#1)(2012-12#1)(2013-1#1)
excellent outcomes##3##2##(1994-12#1)(2008-11#1)(2008-9#1)
excellent patient##2##2##(1997-1#1)(2008-12#1)
excellent performance in##2##3##(2008-10#1)(2008-7#1)
excellent performance of the##3##4##(2007-11#2)(2013-1#1)
excellent performance of##5##3##(2007-11#2)(2007-7#1)(2008-10#1)(2013-1#1)
excellent performance##11##2##(2007-11#2)(2007-7#1)(2008-10#5)(2008-7#1)(2012-2#1)(2013-1#1)
excellent precision##3##2##(1990-2#1)(2008-10#2)
excellent prognosis##3##2##(1997-1#1)(2006-10#1)(2008-10#1)
excellent properties##2##2##(2008-10#2)
excellent quality##2##2##(1991-6#1)(2013-1#1)
excellent quantitative##2##2##(2008-3#1)(2011-2#1)
excellent recoveries and##2##3##(2008-10#2)
excellent recovery##2##2##(2008-7#1)(2012-3#1)
excellent reliability##2##2##(2012-12#1)(2012-2#1)
excellent repeatability##2##2##(2008-10#2)
excellent reproducibility##4##2##(2008-10#4)
excellent resolution##2##2##(1991-12#1)(2008-7#1)
excellent response to##2##3##(2006-10#1)(2008-7#1)
excellent response##6##2##(2006-10#1)(2007-7#2)(2008-10#2)(2008-7#1)
excellent result##2##2##(1991-6#1)(2012-2#1)
excellent results in##3##3##(1990-6#1)(2008-6#1)(2008-8#1)
excellent results were obtained##2##4##(2008-10#2)
excellent results##20##2##(1990-6#2)(1991-2#1)(1991-4#1)(1993-3#1)(1996-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)
excellent retrievals of the##2##4##(2008-2#2)
excellent role##2##2##(1993-6#1)(2008-10#1)
excellent safety##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
excellent selectivity for##6##3##(2008-10#6)
excellent selectivity##8##2##(2008-10#7)(2011-1#1)
excellent sensitivity and specificity##2##4##(2011-2#2)
excellent sensitivity##8##2##(2008-10#3)(2008-9#1)(2011-2#3)(2012-2#1)
excellent skin compatibility##2##3##(2008-5#2)
excellent skin##3##2##(2008-5#3)
excellent source of##2##3##(2007-12#1)(2012-2#1)
excellent spatial##2##2##(2008-3#1)(2008-7#1)
excellent stability and##2##3##(2008-10#1)(2008-3#1)
excellent stability for##3##3##(2008-10#2)(2008-11#1)
excellent stability##8##2##(2008-10#4)(2008-11#1)(2008-3#2)(2013-1#1)
excellent substrate##2##2##(1992-11#1)(1994-8#1)
excellent temporal##2##2##(2007-12#1)(2008-10#1)
excellent throughput##2##2##(2008-10#2)
excellent tolerability##3##2##(1994-6#1)(1997-8#1)(2008-5#1)
excellent visualization##3##2##(1993-12#1)(1994-3#1)(2011-7#1)
excellent with##5##2##(1992-2#1)(1996-11#1)(1996-9#1)(2008-10#2)
excellent yields##6##2##(2007-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)
excellent##568##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-6#6)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#3)(1991-8#3)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#2)(1997-3#3)(1997-6#2)(1997-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#14)(2007-12#10)(2007-4#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#162)(2008-11#6)(2008-12#6)(2008-2#20)(2008-3#33)(2008-4#5)(2008-5#14)(2008-6#5)(2008-7#21)(2008-8#4)(2008-9#19)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#1)(2009-9#4)(2010-10#1)(2010-12#2)(2010-4#2)(2010-6#2)(2010-7#4)(2010-8#3)(2011-1#5)(2011-2#21)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#17)(2012-3#7)(2013-1#20)(2013-8#1)
excellently##4##1##(1992-5#1)(2007-12#1)(2008-3#1)(2008-7#1)
excels##2##1##(2007-12#1)(2008-11#1)
except 2##2##2##(1991-8#1)(2012-2#1)
except CE-UV##2##2##(2008-10#2)
except a##3##2##(1992-3#1)(1997-7#1)(2008-3#1)
except at the highest dose##2##5##(1992-3#1)(1993-6#1)
except at the highest##4##4##(1992-3#1)(1993-6#1)(2008-10#2)
except at the##6##3##(1992-3#1)(1993-6#1)(2008-10#3)(2008-3#1)
except at##8##2##(1992-3#1)(1993-6#1)(2008-10#5)(2008-3#1)
except exon##2##2##(1994-12#1)(1997-8#1)
except for 2##2##3##(2008-10#1)(2012-1#1)
except for Ca(II) and Ba(II)##3##5##(2008-10#3)
except for Fe and##2##4##(2008-10#2)
except for a single##2##4##(1993-1#1)(2008-2#1)
except for a##10##3##(1993-1#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
except for isolates##2##3##(2008-10#2)
except for one##6##3##(1991-12#1)(1992-5#1)(2008-10#2)(2008-7#1)(2011-2#1)
except for the##41##3##(1990-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#2)(1994-12#1)(1994-5#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#10)(2008-12#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#3)
except for two##4##3##(1991-1#1)(2008-10#2)(2008-11#1)
except for##156##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-12#4)(2007-2#1)(2008-10#52)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
except in cases of life endangerment##2##6##(1996-5#2)
except in one case##2##4##(1993-9#1)(2008-10#1)
except in one##5##3##(1992-8#1)(1993-9#1)(2008-10#2)(2011-2#1)
except in the case of##5##5##(1996-8#1)(2008-10#3)(2008-11#1)
except in the##14##3##(1990-6#1)(1992-9#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-2#1)
except in##34##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-6#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
except of##2##2##(2007-2#1)(2008-11#1)
except on##2##2##(2008-10#1)(2012-2#1)
except one patient##2##3##(2007-7#1)(2008-5#1)
except one##18##2##(1992-5#1)(1995-2#1)(1997-8#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)
except that a##2##3##(2008-3#1)(2012-3#1)
except that in##2##3##(2008-10#1)(2008-3#1)
except that one##3##3##(1992-2#1)(2008-4#1)(2008-9#1)
except that the##10##3##(1991-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-8#1)(2013-1#1)(2013-8#1)
except that##29##2##(1990-11#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-8#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
except the##23##2##(1991-5#1)(1993-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#2)
except those from Jk(a-b-)##2##4##(1995-6#2)
except those with##2##3##(2007-10#1)(2008-10#1)
except those##8##2##(1995-11#1)(1995-6#2)(2007-10#1)(2008-10#2)(2008-3#1)(2008-9#1)
except two##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
except under##2##2##(1992-12#1)(2007-8#1)
except when the##3##3##(1992-3#1)(2008-8#1)(2009-8#1)
except when##8##2##(1992-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-8#1)
except##404##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#8)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-5#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#4)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#5)(1996-8#1)(1997-2#3)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#4)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#8)(2007-2#3)(2007-6#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#116)(2008-11#16)(2008-12#9)(2008-2#3)(2008-3#15)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#10)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#5)
excepted##2##1##(2008-5#1)(2010-7#1)
excepting##3##1##(2008-10#2)(2008-5#1)
exception from##2##2##(1995-3#1)(2009-4#1)
exception is##5##2##(1991-5#1)(1994-8#1)(1994-9#1)(2007-12#1)(2012-12#1)
exception not##2##2##(2011-2#2)
exception of the##20##3##(1990-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1996-11#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-9#2)(2011-2#2)
exception of##102##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-10#27)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
exception to the##4##3##(1993-1#1)(1995-12#1)(1997-8#1)(2008-10#1)
exception to this rule##2##4##(1992-1#1)(1996-5#1)
exception to this##4##3##(1992-1#1)(1996-5#1)(2010-8#1)(2012-3#1)
exception to##9##2##(1992-1#1)(1993-1#1)(1995-12#1)(1996-5#1)(1997-8#1)(2008-10#2)(2010-8#1)(2012-3#1)
exception was the##2##3##(1995-6#1)(2013-1#1)
exception was##5##2##(1995-6#1)(2008-10#3)(2013-1#1)
exception##154##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#4)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
exception'##2##1##(1990-9#1)(2011-2#1)
exceptional accesses##2##2##(2008-1#2)
exceptional case of##4##3##(1997-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
exceptional cases of##2##3##(2008-2#1)(2008-9#1)
exceptional cases##3##2##(1990-9#1)(2008-2#1)(2008-9#1)
exceptional##43##1##(1990-9#1)(1991-12#1)(1991-8#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)
exceptionally good##2##2##(2006-4#1)(2007-12#1)
exceptionally high##2##2##(2007-8#1)(2008-11#1)
exceptionally low##2##2##(2008-2#1)(2008-3#1)
exceptionally rare##2##2##(2008-10#1)(2012-1#1)
exceptionally##31##1##(1991-3#1)(1994-8#1)(1995-11#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2012-1#1)(2013-8#1)
exceptions the##2##2##(2008-10#1)(2008-8#1)
exceptions to##3##2##(1996-5#1)(2007-11#1)(2010-8#1)
exceptions were##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
exceptions##38##1##(1990-11#1)(1990-9#1)(1992-9#1)(1994-12#1)(1994-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
excerpts from##3##2##(1994-1#1)(2007-11#1)(2008-5#1)
excerpts##5##1##(1991-8#1)(1994-1#1)(2007-11#1)(2008-5#1)(2008-9#1)
excess I(-) to form I(3)(-)##2##5##(2008-10#2)
excess I(-) to##3##3##(2008-10#3)
excess adiposity##2##2##(2012-2#2)
excess allele sharing##4##3##(1997-5#4)
excess and##5##2##(1991-12#2)(1991-5#1)(2008-7#1)(2010-8#1)
excess cancer mortality##2##3##(1991-12#2)
excess cancer##4##2##(1991-12#3)(1991-3#1)
excess demand##6##2##(1995-2#5)(2008-11#1)
excess for##3##2##(1991-6#2)(2008-10#1)
excess fraction method##3##3##(2008-3#3)
excess free##2##2##(1995-8#1)(1997-2#1)
excess from the##2##3##(2008-10#2)
excess has##2##2##(1991-12#1)(2008-10#1)
excess hazard##3##2##(1997-7#3)
excess hazards##2##2##(1997-7#2)
excess iron##2##2##(2008-10#1)(2013-8#1)
excess loss##2##2##(2008-3#2)
excess may##2##2##(1994-2#1)(2008-4#1)
excess mortality##4##2##(1990-9#1)(1991-12#1)(1993-1#1)(1993-12#1)
excess noise##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
excess observed##2##2##(1992-10#1)(2013-1#1)
excess of 2##2##3##(2007-11#1)(2008-10#1)
excess of an##2##3##(1996-5#1)(2007-12#1)
excess of ascorbic acid##2##4##(2008-10#2)
excess of cationic##2##3##(1995-2#2)
excess of choline##2##3##(1995-6#2)
excess of hydrocarbons##2##3##(2008-10#2)
excess of mastocytes##2##3##(1991-11#2)
excess of sgk##2##3##(2008-8#2)
excess of sodium##3##3##(2008-10#3)
excess of the##10##3##(1992-8#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-6#1)(2008-10#3)(2008-4#1)(2012-2#1)
excess of unlabeled##3##3##(1991-12#2)(1993-9#1)
excess of##131##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#3)(1991-12#4)(1991-6#2)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#4)(2007-12#4)(2008-10#50)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-4#1)(2012-2#1)
excess or##2##2##(2006-10#1)(2008-5#1)
excess over the##2##3##(1993-12#1)(2008-2#1)
excess over##5##2##(1991-5#2)(1993-12#1)(2008-10#1)(2008-2#1)
excess reagent##4##2##(2008-10#4)
excess risk##6##2##(1991-12#1)(1996-2#1)(1996-3#1)(2008-7#1)(2011-2#1)(2012-6#1)
excess thymidine##2##2##(2008-11#2)
excess unlabeled##4##2##(1995-11#3)(1997-4#1)
excess was##4##2##(1993-9#1)(2008-10#2)(2013-1#1)
excess weight##5##2##(2008-11#1)(2009-10#1)(2010-4#1)(2013-1#2)
excess##357##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#13)(1991-3#1)(1991-5#3)(1991-6#4)(1991-9#2)(1992-10#1)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-7#3)(1995-11#3)(1995-12#1)(1995-2#9)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-11#1)(1996-2#2)(1996-3#3)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#5)(1997-7#5)(2006-10#2)(2007-11#7)(2007-12#6)(2008-1#1)(2008-10#98)(2008-11#15)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#9)(2008-5#7)(2008-7#10)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#2)(2009-7#2)(2009-8#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-6#1)(2013-1#13)(2013-8#1)
excess-loss compensation schemes##2##3##(2008-7#2)
excess-noise factor##2##2##(2007-11#1)(2008-3#1)
excesses of##3##2##(2008-10#3)
excesses##5##1##(2008-10#3)(2008-6#1)(2010-12#1)
excessive GWG##3##2##(2013-1#3)
excessive alcohol##2##2##(1996-3#1)(2013-1#1)
excessive amounts of##2##3##(2008-10#2)
excessive and##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
excessive antigen-specific cytokine responses##2##4##(2008-11#2)
excessive bleeding##2##2##(1997-7#1)(2006-12#1)
excessive blood loss during##2##4##(2007-8#1)(2011-1#1)
excessive blood loss##3##3##(2007-8#1)(2011-1#2)
excessive bone resorption##2##3##(2007-11#1)(2013-1#1)
excessive grooming##2##2##(1994-8#2)
excessive irrigation##2##2##(2008-10#2)
excessive neuronal processing##2##3##(2008-11#2)
excessive neuronal##3##2##(1995-12#1)(2008-11#2)
excessive or##2##2##(1990-3#1)(2010-1#1)
excessive production of##2##3##(1992-5#1)(2008-11#1)
excessive production##3##2##(1992-5#1)(2008-11#1)(2013-1#1)
excessive scar formation##2##3##(2008-9#1)(2010-8#1)
excessive sedation##2##2##(2008-5#1)(2008-7#1)
excessive use of##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
excessive weight##2##2##(2008-10#1)(2013-1#1)
excessive##139##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#9)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#9)(2013-8#1)
excessively large##2##2##(2007-12#1)(2009-8#1)
excessively long##2##2##(1997-3#1)(2012-12#1)
excessively##13##1##(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
exchange activity##3##2##(1990-11#1)(1992-10#2)
exchange and gel##2##3##(2008-10#2)
exchange and hydrophobic##2##3##(1991-5#1)(1992-11#1)
exchange and the##2##3##(1997-7#1)(2008-3#1)
exchange and verification##2##3##(2008-7#2)
exchange and##35##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-7#3)(2010-8#1)(2012-3#1)(2013-1#1)
exchange approach##2##2##(2008-11#1)(2008-12#1)
exchange as well as##3##4##(1997-3#1)(2008-10#1)(2008-7#1)
exchange as##6##2##(1995-12#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
exchange between a##2##3##(1991-8#1)(2011-1#1)
exchange between##12##2##(1990-9#1)(1991-8#1)(1993-11#2)(1994-1#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-5#1)(2011-1#2)
exchange by##4##2##(1993-11#1)(2007-6#1)(2008-10#1)(2008-3#1)
exchange can##2##2##(2008-10#1)(2013-1#1)
exchange capacities##2##2##(2008-10#2)
exchange capacity (CEC)##2##3##(2008-10#2)
exchange capacity of the##2##4##(2008-10#2)
exchange capacity##6##2##(2008-10#6)
exchange cartridges##2##2##(2008-10#1)(2008-5#1)
exchange chromatographic##3##2##(2008-10#3)
exchange chromatography and##5##3##(1994-6#1)(1994-8#1)(1997-6#1)(2008-7#2)
exchange chromatography##21##2##(1990-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#3)(2009-3#2)(2009-9#1)(2011-2#1)
exchange column for##2##3##(2008-10#2)
exchange column was##2##3##(2008-10#1)(2008-11#1)
exchange column##18##2##(1992-12#1)(1992-3#1)(2008-10#14)(2008-11#2)
exchange columns##7##2##(1991-5#1)(1992-9#1)(2008-10#5)
exchange coupling##2##2##(1997-7#1)(2007-11#1)
exchange efficiency##3##2##(2011-2#3)
exchange equilibrium##4##2##(1993-11#1)(2008-10#3)
exchange experiments##3##2##(1991-5#1)(1994-5#1)(2008-4#1)
exchange factor##11##2##(1991-12#1)(1994-8#3)(1995-2#1)(2008-6#1)(2010-11#1)(2012-12#2)(2013-8#2)
exchange factors##5##2##(1994-8#1)(1995-2#1)(2008-6#1)(2009-5#1)(2013-8#1)
exchange for##7##2##(1993-12#1)(1995-6#1)(1997-1#2)(2008-10#1)(2008-12#1)(2012-2#1)
exchange from##2##2##(2008-3#1)(2013-8#1)
exchange has##2##2##(2008-10#1)(2008-5#1)
exchange high##2##2##(1995-3#1)(1995-6#1)
exchange ideas with##2##3##(1995-3#1)(2008-10#1)
exchange in the##5##3##(1995-2#1)(1997-1#1)(2008-7#2)(2010-5#1)
exchange in##22##2##(1990-8#1)(1992-4#1)(1992-5#2)(1995-2#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-4#1)(2010-5#1)(2012-5#1)
exchange information##2##2##(1995-1#1)(2010-8#1)
exchange is##6##2##(1995-8#1)(1996-2#1)(1997-1#2)(2007-12#1)(2012-12#1)
exchange kinetics##6##2##(1992-4#1)(1995-6#1)(2008-10#4)
exchange mass spectrometry##4##3##(2008-4#1)(2012-1#3)
exchange may##2##2##(2008-10#1)(2008-3#1)
exchange membrane##4##2##(2008-10#4)
exchange membranes##4##2##(2008-10#3)(2013-1#1)
exchange model##4##2##(2008-10#2)(2008-7#1)(2010-11#1)
exchange of DNA##2##3##(2008-10#2)
exchange of cobalt(II) ion##2##4##(1996-2#2)
exchange of genetic##2##3##(2008-10#2)
exchange of information between the##2##5##(1992-11#1)(1992-12#1)
exchange of information##7##3##(1991-2#3)(1992-11#1)(1992-12#1)(1996-12#1)(2011-2#1)
exchange of knowledge##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
exchange of scientific##2##3##(2010-11#1)(2010-5#1)
exchange of the##7##3##(1991-6#1)(1991-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-7#1)
exchange of##58##2##(1990-11#1)(1990-2#2)(1991-2#3)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#1)(2007-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-7#4)(2008-9#2)(2010-11#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#3)
exchange on##5##2##(1994-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-1#1)
exchange or##5##2##(1994-3#1)(1995-2#1)(1995-5#2)(2008-10#1)
exchange parameters##2##2##(2007-11#1)(2008-12#1)
exchange primarily in the##2##4##(1997-1#2)
exchange procedure##3##2##(2007-11#2)(2008-10#1)
exchange process##5##2##(1995-11#1)(1995-2#1)(2008-12#1)(2008-7#1)(2010-3#1)
exchange processes##2##2##(1993-12#1)(2008-10#1)
exchange project##2##2##(2010-3#2)
exchange rate of##2##3##(2008-12#1)(2012-2#1)
exchange rate##6##2##(2008-10#2)(2008-12#1)(2008-7#2)(2012-2#1)
exchange reaction of##2##3##(2008-10#2)
exchange reaction##7##2##(1993-11#2)(2008-10#5)
exchange reactions##2##2##(1990-7#1)(1996-2#1)
exchange resin Amberlite##2##3##(2008-10#2)
exchange resin Dowex##2##3##(2008-10#2)
exchange resin##22##2##(2008-10#22)
exchange resins##7##2##(2008-10#7)
exchange separation##2##2##(2008-10#2)
exchange systems##4##2##(2008-10#2)(2008-7#2)
exchange techniques##2##2##(2008-10#2)
exchange the##4##2##(1990-12#1)(1997-1#1)(2008-10#2)
exchange to##2##2##(2008-10#2)
exchange transfusion using a##2##4##(1990-8#2)
exchange transfusion##6##2##(1990-8#4)(1991-6#1)(1994-12#1)
exchange using##2##2##(1995-2#1)(2008-10#1)
exchange volume##2##2##(2007-12#1)(2011-2#1)
exchange was##6##2##(1995-5#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
exchange with a##2##3##(2007-12#1)(2008-10#1)
exchange with the##5##3##(1990-2#1)(1993-11#1)(1995-6#1)(2008-1#1)(2008-10#1)
exchange with##13##2##(1990-2#1)(1991-12#1)(1993-11#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2011-2#3)
exchange##568##1##(1990-11#5)(1990-12#3)(1990-2#5)(1990-6#2)(1990-7#1)(1990-8#7)(1990-9#4)(1991-1#1)(1991-12#2)(1991-2#5)(1991-5#5)(1991-6#3)(1991-8#2)(1991-9#5)(1992-10#3)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#3)(1992-4#5)(1992-5#3)(1992-8#2)(1992-9#2)(1993-11#9)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#11)(1995-3#6)(1995-5#8)(1995-6#7)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#9)(1996-5#1)(1997-1#13)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#5)(1997-8#1)(2007-11#8)(2007-12#7)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#180)(2008-11#17)(2008-12#8)(2008-2#4)(2008-3#8)(2008-4#10)(2008-5#6)(2008-6#2)(2008-7#25)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-3#3)(2010-4#6)(2010-5#2)(2010-8#5)(2011-1#2)(2011-2#18)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#9)(2013-8#7)
exchange) across the##2##3##(1997-7#2)
exchange)##6##1##(1997-7#2)(2008-10#2)(2008-9#1)(2011-2#1)
exchange-mass spectrometry##2##2##(2008-4#2)
exchangeable aluminum##3##2##(2008-10#3)
exchangeable sites##4##2##(1995-6#4)
exchangeable##18##1##(1992-4#1)(1995-6#5)(2008-10#7)(2010-12#1)(2010-8#1)(2011-2#3)
exchanged between##2##2##(2007-7#1)(2013-1#1)
exchanged with##4##2##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
exchanged##19##1##(1992-6#1)(1993-11#1)(1994-5#1)(2007-11#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-5#1)(2013-1#1)
exchanger Dowex##2##2##(2008-10#2)
exchanger and##5##2##(1991-8#1)(1993-3#2)(2008-10#2)
exchanger by##2##2##(2008-10#2)
exchanger in high performance liquid chromatography##2##6##(2008-10#2)
exchanger in##5##2##(2008-10#5)
exchanger was used##2##3##(2008-10#2)
exchanger was##4##2##(1994-5#2)(2008-10#2)
exchanger##69##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#2)(1992-1#1)(1993-3#4)(1994-5#2)(1995-5#3)(2008-10#52)(2012-12#1)(2013-7#1)
exchangers has been##2##3##(2008-10#2)
exchangers##17##1##(1990-5#1)(1992-2#2)(1993-12#2)(1997-2#1)(2008-10#7)(2008-11#2)(2008-8#2)
exchanges and##3##2##(1992-2#1)(1993-12#1)(1997-5#1)
exchanges between the##2##3##(1993-12#1)(2008-7#1)
exchanges in the##2##3##(1992-4#1)(2010-9#1)
exchanges in##4##2##(1992-4#1)(2008-11#2)(2010-9#1)
exchanges of##2##2##(1992-6#1)(2013-1#1)
exchanges##38##1##(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-2#2)(1995-9#1)(1996-2#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-7#2)(2007-12#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
exchanging the##2##2##(1995-8#1)(2008-10#1)
exchanging with##3##2##(1994-2#1)(2008-10#1)(2012-12#1)
exchanging##14##1##(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-2#1)(2010-10#1)(2010-8#2)(2012-12#1)
excimer laser and a##2##4##(2007-12#2)
excimer laser is##2##3##(2008-3#2)
excimer laser pulses##2##3##(2008-2#2)
excimer laser with##3##3##(2007-11#2)(2008-3#1)
excimer laser##30##2##(1991-3#1)(2007-11#3)(2007-12#4)(2008-2#9)(2008-3#13)
excimer lasers for##2##3##(2007-11#1)(2008-3#1)
excimer lasers in##3##3##(2008-3#3)
excimer lasers##10##2##(2007-11#2)(2008-2#2)(2008-3#6)
excimer##43##1##(1991-3#1)(1992-6#1)(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#12)(2008-3#19)
excimer-laser##3##1##(2007-12#2)(2008-3#1)
excimer-laser-induced densification##2##2##(2007-12#2)
excimer-laser-induced##3##1##(2007-12#2)(2008-3#1)
excipient concentrations##3##2##(2012-2#1)(2013-8#2)
excipient##15##1##(2008-10#3)(2008-5#4)(2011-2#1)(2012-2#5)(2013-8#2)
excipients and##5##2##(1992-11#1)(2008-10#4)
excipients are being used in early phases of clinical trials to support novel therapeutic entities##2##15##(2012-2#2)
excipients are##6##2##(2012-2#6)
excipients did not interfere in##2##5##(2008-5#1)(2010-5#1)
excipients rendering the method suitable for##2##6##(2008-10#2)
excipients used as additives in pharmaceuticals do not interfere##2##9##(2008-10#2)
excipients used as additives##3##4##(2008-10#3)
excipients used##5##2##(2008-10#3)(2012-2#2)
excipients##46##1##(1992-11#1)(2008-10#25)(2008-5#2)(2010-5#5)(2011-2#1)(2012-2#12)
exciplex##2##1##(1992-8#1)(2008-2#1)
excise the##2##2##(2008-10#1)(2009-7#1)
excise##5##1##(1994-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2009-7#1)
excised and##6##2##(1992-1#1)(2008-10#1)(2009-1#1)(2011-2#2)(2012-12#1)
excised antenna##2##2##(2008-10#2)
excised broccoli head##2##3##(2008-10#2)
excised from the##2##3##(1995-11#1)(2008-10#1)
excised from##6##2##(1993-12#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
excised human SC##2##3##(2008-5#2)
excised human epidermis##5##3##(2008-3#1)(2008-5#4)
excised human##9##2##(1996-5#1)(2007-11#1)(2008-3#1)(2008-5#6)
excised inside-out##3##2##(1995-5#1)(2008-8#1)(2012-2#1)
excised leaf tissues##5##3##(2008-10#5)
excised leaf##8##2##(2008-10#8)
excised leaves##4##2##(2008-10#4)
excised membrane patches##2##3##(1994-11#1)(2008-8#1)
excised roots##3##2##(2008-10#2)(2008-12#1)
excised specimen##3##2##(2007-8#1)(2009-5#1)(2011-1#1)
excised the##2##2##(1991-5#1)(2011-1#1)
excised##101##1##(1990-12#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#2)(2007-11#1)(2007-8#2)(2008-10#27)(2008-12#3)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#1)(2008-8#3)(2008-9#3)(2009-1#2)(2009-3#1)(2009-5#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#1)
excising##3##1##(1991-6#1)(1994-3#1)(2011-2#1)
excision and reconstruction##2##3##(2007-11#1)(2007-12#1)
excision and##22##2##(1993-6#1)(1994-11#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#4)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
excision as##2##2##(1992-6#1)(2008-6#1)
excision biopsy##2##2##(2008-6#1)(2008-7#1)
excision followed by##3##3##(1990-2#1)(2008-6#1)(2008-7#1)
excision from##2##2##(2009-3#1)(2011-2#1)
excision in##6##2##(1990-3#1)(2007-11#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
excision is the treatment of choice##2##6##(2007-8#1)(2009-4#1)
excision is the##3##3##(2007-12#1)(2007-8#1)(2009-4#1)
excision is##9##2##(2007-12#1)(2007-8#1)(2008-6#2)(2008-9#2)(2009-4#1)(2010-3#2)
excision of a##7##3##(1994-12#1)(2008-6#1)(2008-9#2)(2012-2#1)(2013-1#2)
excision of an##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
excision of benign##2##3##(1991-2#1)(2011-2#1)
excision of malignant##2##3##(2008-6#1)(2011-2#1)
excision of skin##2##3##(2007-12#1)(2013-1#1)
excision of the cyst was##2##5##(2007-7#1)(2007-8#1)
excision of the lesion##2##4##(2008-6#1)(2009-3#1)
excision of the tumor##4##4##(1992-9#1)(2008-10#1)(2009-3#1)(2013-8#1)
excision of the ulnar slip of the flexor digitorum superficialis##2##10##(2008-9#2)
excision of the##42##3##(1990-10#1)(1990-6#1)(1992-2#1)(1992-6#2)(1992-9#1)(1994-2#2)(1994-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#2)(2008-9#4)(2009-1#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
excision of##90##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-2#2)(1991-6#1)(1992-2#2)(1992-6#3)(1992-9#1)(1994-12#1)(1994-2#4)(1994-5#1)(1995-4#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-6#5)(2008-7#2)(2008-9#7)(2009-1#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
excision repair and##2##3##(1994-9#1)(2008-11#1)
excision repair##13##2##(1993-3#1)(1994-9#2)(1995-9#2)(1997-6#1)(2008-1#1)(2008-11#6)
excision to##2##2##(1995-5#1)(2007-8#1)
excision was achieved##2##3##(2008-6#1)(2008-7#1)
excision was done to##2##4##(2007-8#1)(2012-3#1)
excision was done##5##3##(2007-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
excision was##11##2##(1992-6#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
excision with##5##2##(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)
excision##227##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-2#2)(1991-6#1)(1992-2#4)(1992-6#6)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#4)(1995-4#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#9)(2008-1#2)(2008-10#14)(2008-11#7)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#20)(2008-7#7)(2008-8#1)(2008-9#13)(2009-1#1)(2009-12#2)(2009-3#5)(2009-4#4)(2009-5#5)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#3)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#13)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#9)(2013-1#14)(2013-7#1)(2013-8#1)
excisional biopsy of the##2##4##(2010-11#1)(2011-2#1)
excisional biopsy revealed##2##3##(2010-11#1)(2013-1#1)
excisional biopsy##8##2##(2007-12#1)(2010-11#2)(2011-2#2)(2013-1#3)
excisional cone##2##2##(1991-1#1)(1992-2#1)
excisional conization##3##2##(1991-1#3)
excisional##19##1##(1991-1#5)(1992-2#2)(1994-12#1)(1995-4#1)(2007-12#1)(2009-2#1)(2010-11#2)(2011-2#2)(2012-12#1)(2013-1#3)
excisions of##2##2##(2007-11#1)(2008-9#1)
excisions##9##1##(1994-6#1)(1994-9#1)(2007-11#1)(2008-6#1)(2008-7#3)(2008-9#1)(2012-1#1)
excitability and##5##2##(2008-7#1)(2008-8#2)(2010-7#1)(2012-2#1)
excitability as##2##2##(1997-6#1)(2012-2#1)
excitability in##3##2##(1991-2#1)(1993-12#1)(2011-2#1)
excitability of##7##2##(1992-3#2)(1994-3#1)(1995-12#1)(1997-2#1)(2010-7#2)
excitability on##2##2##(2009-3#2)
excitability##41##1##(1991-2#1)(1992-3#4)(1993-12#3)(1994-12#1)(1994-3#1)(1995-12#2)(1997-2#1)(1997-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-3#2)(2010-7#3)(2011-2#2)(2012-2#4)(2013-8#3)
excitable tissues##2##2##(2008-8#1)(2012-3#1)
excitable##4##1##(2008-8#1)(2009-9#1)(2012-3#2)
excitation and detection##3##3##(1995-5#1)(2011-2#1)(2013-1#1)
excitation and emission maxima at##3##5##(2008-10#3)
excitation and emission maxima##5##4##(2008-10#4)(2008-9#1)
excitation and emission of##2##4##(2007-11#1)(2008-3#1)
excitation and emission spectra##4##4##(1992-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
excitation and emission wavelength##2##4##(2008-10#2)
excitation and emission wavelengths are##4##5##(2008-10#4)
excitation and emission wavelengths of##3##5##(1990-8#1)(2008-10#1)(2008-3#1)
excitation and emission wavelengths were##3##5##(2008-10#3)
excitation and emission wavelengths##17##4##(1990-8#1)(2008-10#14)(2008-3#2)
excitation and emission##39##3##(1990-8#1)(1992-8#1)(2007-11#1)(2008-10#29)(2008-3#4)(2008-4#1)(2008-9#2)
excitation and probing##2##3##(2008-3#2)
excitation and reference##2##3##(2008-10#2)
excitation and the##2##3##(2007-11#1)(2008-10#1)
excitation and##56##2##(1990-8#1)(1992-8#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#32)(2008-2#1)(2008-3#10)(2008-4#1)(2008-9#3)(2011-2#1)(2013-1#1)
excitation at 248 nm##2##4##(2008-2#1)(2008-3#1)
excitation at 355 nm##2##4##(2007-11#1)(2011-1#1)
excitation at 490 nm##2##4##(1993-11#1)(2008-10#1)
excitation at##22##2##(1990-8#1)(1993-11#1)(1995-3#1)(1997-2#1)(2007-11#2)(2008-10#8)(2008-2#4)(2008-3#3)(2011-1#1)
excitation beam##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)
excitation beams##4##2##(2007-11#1)(2008-3#3)
excitation by##6##2##(1992-3#1)(2007-12#1)(2008-2#1)(2008-3#3)
excitation can##3##2##(2007-11#1)(2008-3#1)(2012-3#1)
excitation conditions##2##2##(2008-10#1)(2008-9#1)
excitation emission##5##2##(2008-10#5)
excitation energy##5##2##(2007-12#1)(2008-3#2)(2008-8#1)(2010-2#1)
excitation fluorescence##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
excitation for##3##2##(2007-11#1)(2008-3#2)
excitation from##2##2##(1995-11#1)(2008-2#1)
excitation geometry##4##2##(2008-3#4)
excitation in the##3##3##(2007-11#1)(2007-12#1)(2013-1#1)
excitation in##9##2##(2007-11#2)(2007-12#4)(2008-2#1)(2013-1#2)
excitation intensity##3##2##(2008-2#2)(2008-3#1)
excitation laser fluence##2##3##(2008-2#1)(2008-3#1)
excitation laser light##3##3##(2008-10#1)(2008-3#2)
excitation laser##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
excitation light source for PDT##2##5##(2008-5#2)
excitation light source##3##3##(2008-3#1)(2008-5#2)
excitation light##18##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#7)(2008-5#2)(2008-7#1)(2013-8#1)
excitation microscopy##4##2##(2008-1#2)(2008-3#2)
excitation of a##3##3##(2007-11#2)(2007-12#1)
excitation of the##9##3##(1992-8#1)(2007-11#4)(2007-12#1)(2008-3#2)(2009-6#1)
excitation of##32##2##(1992-8#1)(1994-2#1)(1996-2#1)(2007-11#10)(2007-12#7)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2009-6#1)(2011-1#1)
excitation on##2##2##(1991-5#1)(2008-3#1)
excitation photons##2##2##(2008-2#2)
excitation power of the##2##4##(2008-2#1)(2012-2#1)
excitation power##5##2##(2007-12#2)(2008-2#2)(2012-2#1)
excitation process##3##2##(2007-11#2)(2007-12#1)
excitation scheme##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
excitation signal##3##2##(2008-10#3)
excitation source and a##2##4##(2008-10#2)
excitation source##13##2##(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#1)(2008-7#1)
excitation spectra of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
excitation spectra##13##2##(2006-4#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-7#1)(2012-2#1)(2013-8#1)
excitation spectrum##4##2##(2008-3#1)(2011-1#1)(2013-8#2)
excitation temperature##2##2##(2008-10#2)
excitation to##2##2##(2008-10#1)(2008-3#1)
excitation transfer##2##2##(1992-8#2)
excitation using an##2##3##(2008-10#2)
excitation using##3##2##(2008-10#2)(2011-1#1)
excitation was##3##2##(1994-2#1)(2007-11#1)(2008-10#1)
excitation wavelength and##2##3##(2008-10#1)(2008-3#1)
excitation wavelength in##2##3##(2007-12#1)(2013-1#1)
excitation wavelength of##10##3##(1997-2#1)(2008-10#7)(2008-3#2)
excitation wavelength##25##2##(1994-5#1)(1997-2#1)(2007-12#3)(2008-10#12)(2008-2#1)(2008-3#4)(2008-9#1)(2010-1#1)(2013-1#1)
excitation wavelengths##5##2##(2008-10#3)(2008-3#2)
excitation with a##2##3##(2008-2#1)(2008-3#1)
excitation with an##2##3##(2007-11#1)(2008-3#1)
excitation with##9##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2012-3#1)
excitation##409##1##(1990-8#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#4)(1993-11#1)(1994-11#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(2006-4#1)(2007-11#41)(2007-12#35)(2008-1#6)(2008-10#103)(2008-11#3)(2008-2#42)(2008-3#98)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#10)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#9)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#4)
excitation-and-collection##2##1##(2008-3#2)
excitation-emission matrix##3##2##(2008-10#3)
excitation-emission##9##1##(2008-10#8)(2013-8#1)
excitations in the##4##3##(1990-4#1)(2008-3#1)(2008-7#1)(2012-2#1)
excitations in##10##2##(1990-4#2)(1992-11#1)(1993-5#1)(2007-12#1)(2008-3#1)(2008-7#2)(2012-2#2)
excitations##20##1##(1990-4#2)(1992-11#1)(1993-5#2)(1994-8#1)(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#3)(2012-2#4)
excitatory amino acid##10##3##(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-11#1)(1995-12#1)(2008-7#4)
excitatory amino acids##2##3##(1990-11#2)
excitatory amino##12##2##(1990-11#2)(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-11#1)(1995-12#1)(2008-7#4)
excitatory and inhibitory recurrent connections##2##5##(2008-11#2)
excitatory and inhibitory##8##3##(1996-12#1)(2007-12#1)(2008-11#3)(2008-7#2)(2009-8#1)
excitatory effects##2##2##(1994-2#1)(1995-11#1)
excitatory input##2##2##(1996-12#1)(1997-3#1)
excitatory neurons##2##2##(1997-3#1)(2008-11#1)
excitatory neurotransmission##5##2##(1994-11#2)(1995-6#1)(1997-4#1)(1997-6#1)
excitatory neurotransmitter##3##2##(1990-8#1)(1994-8#1)(2008-4#1)
excitatory or inhibitory##2##3##(1996-2#1)(1997-3#1)
excitatory post-synaptic##2##2##(1995-12#2)
excitatory postsynaptic potential##3##3##(1992-3#1)(1997-2#2)
excitatory postsynaptic potentials (EPSPs)##2##4##(1995-5#1)(1996-5#1)
excitatory postsynaptic potentials##3##3##(1995-12#1)(1995-5#1)(1996-5#1)
excitatory postsynaptic##7##2##(1992-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#2)(2009-12#1)
excitatory responses##2##2##(1992-8#1)(1996-5#1)
excitatory synapses##7##2##(1996-2#1)(1997-2#1)(2008-11#1)(2008-7#2)(2012-2#1)(2012-3#1)
excitatory synaptic transmission in the hippocampus##2##6##(1995-12#1)(1997-2#1)
excitatory synaptic transmission in the##3##5##(1995-12#1)(1997-2#2)
excitatory synaptic transmission##7##3##(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#2)
excitatory synaptic##9##2##(1990-7#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#2)(2009-9#1)
excitatory transmission##4##2##(1992-8#1)(1997-4#2)(2012-2#1)
excitatory##87##1##(1990-11#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-12#2)(1994-11#3)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#8)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#3)(1996-5#4)(1997-2#8)(1997-3#4)(1997-4#5)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#9)(2008-4#1)(2008-7#9)(2009-12#1)(2009-8#2)(2009-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
excite##10##1##(1991-3#1)(1993-12#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-8#1)(2012-2#1)
excited HCl##2##2##(2008-10#1)(2008-2#1)
excited and##2##2##(2007-11#1)(2007-12#1)
excited at 295 nm##2##4##(1992-12#2)
excited at##13##2##(1992-12#3)(1996-12#1)(2007-11#4)(2007-12#1)(2008-10#4)
excited by a##8##3##(2007-12#4)(2008-10#1)(2008-3#2)(2013-8#1)
excited by the##6##3##(1992-12#1)(2008-2#1)(2008-3#3)(2008-9#1)
excited by##35##2##(1992-12#1)(1993-12#1)(1995-11#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#9)(2008-10#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-9#1)(2011-1#1)(2013-8#1)
excited delirium##3##2##(2010-1#3)
excited in a##3##3##(2007-12#3)
excited in##5##2##(2007-12#4)(2009-11#1)
excited photosensitizer##2##2##(1992-12#2)
excited singlet state of##3##4##(1995-6#1)(2010-2#2)
excited singlet state##5##3##(1995-6#1)(2008-10#2)(2010-2#2)
excited singlet##6##2##(1995-6#1)(2008-10#3)(2010-2#2)
excited state lifetime##2##3##(2009-6#1)(2009-9#1)
excited state##20##2##(1995-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-12#2)(2009-6#3)(2009-9#1)(2010-2#4)(2010-7#1)(2012-2#1)
excited states of##4##3##(2007-12#1)(2008-10#2)(2010-7#1)
excited states##10##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2010-7#1)
excited to##2##2##(1992-4#1)(1993-11#1)
excited using##2##2##(2008-10#1)(2012-12#1)
excited wave##2##2##(2008-3#1)(2009-8#1)
excited with the##2##3##(2008-10#1)(2008-2#1)
excited with##8##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)
excited##167##1##(1992-12#6)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#2)(1995-11#2)(1995-6#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-7#2)(2007-1#2)(2007-11#15)(2007-12#25)(2008-10#25)(2008-2#17)(2008-3#31)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-6#4)(2009-8#1)(2009-9#1)(2010-1#5)(2010-2#6)(2010-7#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
excited-state absorption cross##3##3##(2008-3#3)
excited-state absorption##17##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#13)
excited-state##30##1##(1991-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#17)
excitement in##2##2##(2009-3#1)(2012-2#1)
excitement##10##1##(1990-3#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-3#1)(2012-2#1)
excites##4##1##(1993-12#1)(1995-11#1)(2008-3#1)(2008-4#1)
exciting and##6##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-12#1)
exciting area##2##2##(2008-11#1)(2011-2#1)
exciting at 277nm##2##3##(2008-10#2)
exciting field of##2##3##(2008-7#1)(2011-1#1)
exciting field##3##2##(1992-9#1)(2008-7#1)(2011-1#1)
exciting new##6##2##(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
exciting perspectives##2##2##(1994-9#1)(2008-8#1)
exciting radiation##3##2##(2008-3#3)
exciting time##2##2##(1991-3#1)(2012-12#1)
exciting times##2##2##(2008-10#1)(2010-4#1)
exciting##70##1##(1991-3#2)(1992-12#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#1)(2009-5#4)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
exciton chirality##2##2##(2008-10#2)
exciton splitting on the##2##4##(1994-5#2)
exciton splitting##4##2##(1994-5#4)
exciton##10##1##(1994-5#6)(2007-11#1)(2008-10#2)(2008-11#1)
excitonic properties of the dimeric##2##5##(2010-2#2)
excitonic##5##1##(2007-12#1)(2008-7#1)(2010-2#3)
excitotoxic cascade##2##2##(1995-5#2)
excitotoxic lesions of the##2##4##(1993-6#2)
excitotoxic lesions of##3##3##(1992-10#1)(1993-6#2)
excitotoxic neuronal##2##2##(1994-11#1)(1995-12#1)
excitotoxic process##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
excitotoxic##17##1##(1992-10#1)(1993-5#1)(1993-6#2)(1994-11#1)(1995-12#4)(1995-5#4)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
excitotoxicity is##2##2##(1994-11#1)(1995-12#1)
excitotoxicity##8##1##(1990-7#1)(1994-11#1)(1995-12#3)(1995-5#1)(2008-7#1)(2009-12#1)
exclude a##7##2##(1991-11#1)(1991-12#2)(2008-1#1)(2008-12#1)(2008-8#1)(2012-1#1)
exclude its##2##2##(2008-5#1)(2008-8#1)
exclude other##3##2##(2008-1#1)(2009-8#1)(2012-3#1)
exclude the presence of##2##4##(2008-1#1)(2008-3#1)
exclude the##10##2##(1990-10#1)(1991-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
exclude##51##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#2)(1991-12#3)(1991-2#1)(1993-1#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
excluded and##6##2##(1991-11#1)(1993-6#1)(1994-12#1)(1997-8#1)(2008-12#1)(2013-1#1)
excluded as##3##2##(1997-4#1)(2009-3#1)(2011-1#1)
excluded because of##3##3##(1990-6#1)(2007-10#1)(2008-7#1)
excluded because##4##2##(1990-6#1)(2007-10#1)(2008-10#1)(2008-7#1)
excluded by##6##2##(1990-9#1)(1991-6#1)(1992-3#1)(1995-2#1)(1996-3#1)(2007-10#1)
excluded even##2##2##(1997-5#1)(2013-1#1)
excluded from the##27##3##(1991-1#1)(1991-12#2)(1993-12#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2010-1#1)(2011-2#4)(2013-1#3)
excluded from##36##2##(1991-1#1)(1991-12#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#5)(2013-1#3)
excluded in##4##2##(1993-9#1)(1997-5#1)(2008-1#1)(2011-1#1)
excluded other##4##2##(1990-3#1)(1990-6#1)(2013-1#1)(2013-8#1)
excluded the##3##2##(1996-3#1)(1997-5#1)(2008-10#1)
excluded##137##1##(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#6)(1997-8#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#5)(2011-8#1)(2012-12#5)(2013-1#10)(2013-8#5)
excluded) were##2##2##(2010-8#1)(2013-7#1)
excluder##8##1##(2008-10#8)
excludes the##2##2##(2012-2#1)(2013-1#1)
excludes##6##1##(1991-2#1)(1995-3#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
excluding a poly(A) tail##2##4##(2008-10#2)
excluding other##2##2##(2006-10#1)(2012-2#1)
excluding the 3'-poly (A) tail##2##5##(2008-9#2)
excluding the possibility##2##3##(1995-5#1)(2009-10#1)
excluding the##9##2##(1993-8#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)
excluding their##2##2##(1992-12#1)(2012-12#1)
excluding those with##3##3##(1992-6#1)(1993-8#1)(2013-1#1)
excluding those##4##2##(1992-6#1)(1993-8#1)(2008-10#1)(2013-1#1)
excluding##36##1##(1992-12#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
exclusion and##5##2##(1990-12#1)(1991-12#1)(1997-1#1)(2008-11#1)(2011-2#1)
exclusion assay##4##2##(1990-12#1)(2008-11#2)(2013-1#1)
exclusion chromatography##12##2##(1991-12#1)(1991-9#1)(1994-12#1)(1995-6#1)(2008-10#7)(2011-2#1)
exclusion criteria were##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
exclusion criteria##11##2##(2007-11#1)(2008-5#1)(2009-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
exclusion diet and##2##3##(1997-6#2)
exclusion diet##5##2##(1997-6#5)
exclusion from##2##2##(1990-8#1)(2008-10#1)
exclusion in##2##2##(1997-6#1)(2008-8#1)
exclusion of other##2##3##(2008-3#1)(2008-7#1)
exclusion of patients##4##3##(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
exclusion of the##5##3##(1991-8#1)(1992-9#1)(2008-8#2)(2012-1#1)
exclusion of women##2##3##(1991-3#1)(2009-10#1)
exclusion of##52##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-9#1)(1993-2#2)(1993-9#3)(1994-2#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)
exclusion or##2##2##(2008-10#1)(2012-2#1)
exclusion probabilities and##2##3##(2008-5#1)(2008-9#1)
exclusion##141##1##(1990-12#3)(1990-8#2)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-2#2)(1993-9#3)(1994-12#2)(1994-2#1)(1995-11#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#6)(2007-11#1)(2008-1#1)(2008-10#25)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#11)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#1)(2012-7#1)(2013-1#4)
exclusionary##3##1##(1991-1#1)(1997-2#1)(2008-1#1)
exclusions##3##1##(1991-12#1)(2008-3#1)(2012-12#1)
exclusive and##4##2##(1992-3#1)(2010-12#1)(2010-6#1)(2011-2#1)
exclusive breastfeeding##4##2##(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
exclusive home ranges##4##3##(2008-8#2)(2008-9#2)
exclusive interaction##2##2##(2008-10#1)(2008-4#1)
exclusive of the##2##3##(1994-11#1)(1995-6#1)
exclusive of##6##2##(1992-3#1)(1994-11#1)(1995-6#1)(2006-10#1)(2008-3#1)(2010-3#1)
exclusive regioselective fragmentation of##2##4##(1996-5#2)
exclusive use##2##2##(2007-8#1)(2008-10#1)
exclusive##69##1##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#2)(1992-12#1)(1992-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-5#2)(2006-10#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
exclusively 5 min after##2##4##(2008-12#2)
exclusively Arab##2##2##(2008-1#2)
exclusively at the##4##3##(1990-8#1)(1992-11#1)(1995-2#1)(2008-10#1)
exclusively at##6##2##(1990-8#1)(1992-11#1)(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#1)
exclusively binarized correlation-calculation method##2##4##(2008-3#2)
exclusively binarized##3##2##(2008-3#3)
exclusively by##5##2##(1994-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
exclusively derived from##2##3##(2008-10#1)(2008-4#1)
exclusively expressed in##4##3##(1995-5#1)(2008-5#1)(2008-8#1)(2012-2#1)
exclusively expressed##5##2##(1994-8#1)(1995-5#1)(2008-5#1)(2008-8#1)(2012-2#1)
exclusively for##4##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
exclusively found##2##2##(1991-3#1)(2008-10#1)
exclusively from##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
exclusively gave the##2##3##(1996-5#2)
exclusively in the##10##3##(1990-5#1)(1992-3#1)(1993-9#1)(1994-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-3#1)
exclusively in##22##2##(1990-5#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)
exclusively of##2##2##(1995-12#1)(2008-10#1)
exclusively on the##5##3##(1997-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-10#1)
exclusively on##15##2##(1992-3#1)(1993-11#1)(1993-3#1)(1997-6#1)(2007-8#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-10#2)(2010-12#1)(2012-2#1)(2013-8#1)
exclusively present##3##2##(2008-10#2)(2009-8#1)
exclusively targeted##2##2##(2012-2#2)
exclusively through the##2##3##(2008-10#1)(2008-3#1)
exclusively to the##5##3##(1991-12#1)(1995-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
exclusively to##10##2##(1991-12#1)(1992-2#1)(1995-4#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-5#1)(2012-2#1)
exclusively with##5##2##(1997-4#1)(2008-10#1)(2008-9#2)(2010-3#1)
exclusively within##2##2##(2008-10#1)(2008-5#1)
exclusively##164##1##(1990-11#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#5)(2008-1#4)(2008-10#34)(2008-11#7)(2008-12#5)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#5)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#8)(2012-3#2)(2013-8#2)
exclusivity##2##1##(1995-3#1)(2009-9#1)
excreta##3##1##(1992-8#1)(2011-2#2)
excrete##3##1##(2008-7#1)(2010-1#1)(2013-1#1)
excreted a##2##2##(1993-9#1)(2013-1#1)
excreted by##3##2##(2008-10#3)
excreted in bile##2##3##(1991-12#2)
excreted in the urine##4##4##(1995-3#1)(2007-7#1)(2012-2#1)(2013-8#1)
excreted in the##5##3##(1995-3#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-8#1)
excreted in urine##2##3##(1994-12#1)(2008-10#1)
excreted in##12##2##(1991-12#2)(1994-12#1)(1995-3#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
excreted into urine##2##3##(1993-9#1)(1995-3#1)
excreted into##3##2##(1993-9#1)(1995-3#1)(2008-10#1)
excreted##39##1##(1991-11#1)(1991-12#3)(1992-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
excreting##4##1##(1991-11#1)(1995-9#1)(2008-11#1)(2013-1#1)
excretion (p less than 0##2##5##(1990-2#2)
excretion and##6##2##(1993-12#1)(1995-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)
excretion does##2##2##(1995-11#1)(1996-12#1)
excretion in the##2##3##(1994-8#1)(2011-2#1)
excretion in##16##2##(1992-3#1)(1994-8#1)(1996-5#1)(1997-8#4)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
excretion is##2##2##(2013-1#1)(2013-8#1)
excretion of arsenic##5##3##(1995-11#5)
excretion of gold##2##3##(1994-5#2)
excretion of the##2##3##(1994-5#1)(2008-10#1)
excretion of two##2##3##(1991-12#2)
excretion of##55##2##(1990-3#2)(1990-5#1)(1991-12#5)(1991-3#1)(1993-12#1)(1993-9#2)(1994-12#1)(1994-5#6)(1995-11#9)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#2)(2010-2#5)(2010-6#1)(2012-2#4)
excretion on the##2##3##(1990-12#1)(2013-1#1)
excretion or##2##2##(1994-5#1)(2008-6#1)
excretion rate of##3##3##(1994-7#1)(2009-11#1)(2013-8#1)
excretion rate##6##2##(1994-7#1)(2008-5#1)(2009-11#1)(2012-1#1)(2012-3#1)(2013-8#1)
excretion rates of##4##3##(1991-12#1)(1993-12#2)(1997-8#1)
excretion was##4##2##(1992-9#1)(1995-2#1)(1996-6#1)(2010-2#1)
excretion with##5##2##(1992-11#2)(1992-3#1)(1995-2#1)(2008-7#1)
excretion##160##1##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#2)(1991-11#1)(1991-12#9)(1991-3#1)(1992-11#3)(1992-3#2)(1992-9#1)(1993-12#7)(1993-8#1)(1993-9#3)(1994-12#1)(1994-5#9)(1994-7#1)(1994-8#1)(1995-11#11)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#6)(1997-7#2)(1997-8#8)(2007-11#2)(2007-7#2)(2008-1#3)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#3)(2010-2#8)(2010-6#1)(2011-2#6)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)(2013-8#5)
excretions##3##1##(1995-12#1)(2008-12#1)(2008-7#1)
excretory duct in the silk gland of the sugarcane borer Diatraea saccharalis##2##12##(2007-12#2)
excretory duct##4##2##(2007-12#4)
excretory pore##3##2##(2008-10#2)(2008-5#1)
excretory##12##1##(1995-12#1)(2007-12#4)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
excretory/secretory antigens of##2##3##(1992-8#2)
excretory/secretory products##2##2##(1992-8#1)(1996-12#1)
excretory/secretory##4##1##(1992-8#3)(1996-12#1)
excurrents##3##1##(2008-9#3)
excursion of##4##2##(2008-10#1)(2012-2#3)
excursion was##3##2##(2012-2#3)
excursion##15##1##(2008-10#1)(2008-2#1)(2009-10#1)(2010-10#1)(2011-2#4)(2012-2#7)
excursions##7##1##(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-11#1)(2012-3#1)(2012-5#1)
excuses##2##1##(2007-2#2)
executable##2##1##(2008-3#1)(2013-1#1)
execute their##2##2##(1994-1#1)(2008-12#1)
execute##16##1##(1990-10#1)(1990-11#1)(1991-3#1)(1993-2#1)(1994-1#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
executed by a##2##3##(1993-12#1)(2009-10#1)
executed by##3##2##(1993-12#1)(2008-5#1)(2009-10#1)
executed on##2##2##(2008-3#1)(2011-1#1)
executed to##3##2##(1990-3#1)(2009-12#1)(2011-2#1)
executed##20##1##(1990-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
executes##3##1##(2007-11#1)(2008-3#1)(2009-4#1)
executing a##3##2##(2008-12#1)(2009-1#1)(2009-11#1)
executing##6##1##(2008-12#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-11#1)(2013-1#1)
execution and withholding of##2##4##(2013-8#2)
execution and##6##2##(1990-3#1)(1995-2#1)(2008-10#1)(2008-6#1)(2013-8#2)
execution of a##3##3##(1992-3#1)(2009-8#1)(2013-8#1)
execution of many##2##3##(2008-10#1)(2008-9#1)
execution of the##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
execution of##22##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#3)(2011-1#2)(2012-12#2)(2013-1#2)(2013-8#3)
execution time of##2##3##(2012-2#2)
execution time##5##2##(2008-3#2)(2009-5#1)(2012-2#2)
execution##51##1##(1990-3#1)(1991-3#2)(1991-6#2)(1992-3#1)(1993-12#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#4)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#5)
executive authorities##4##2##(2011-2#4)
executive compensation##3##2##(2008-11#3)
executive control##3##2##(2008-4#1)(2013-8#2)
executive director of the##2##4##(1992-3#1)(1992-8#1)
executive director##3##2##(1992-3#1)(1992-8#1)(1993-1#1)
executive directors of##2##3##(1993-1#1)(1995-3#1)
executive directors##5##2##(1993-1#2)(1994-12#1)(1995-3#1)(1997-3#1)
executive dysfunction##4##2##(2007-11#2)(2009-10#1)(2012-1#1)
executive function tasks##3##3##(2013-8#3)
executive function##17##2##(1995-11#2)(2007-8#1)(2008-2#1)(2008-6#1)(2009-10#5)(2012-1#2)(2012-2#1)(2013-8#4)
executive functioning##4##2##(2007-8#2)(2009-10#2)
executive functions in##2##3##(2007-11#1)(2010-6#1)
executive functions##13##2##(2007-11#2)(2008-2#1)(2008-6#1)(2009-10#2)(2009-2#1)(2009-6#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
executive information systems##2##3##(1993-2#2)
executive information##3##2##(1993-2#3)
executive leadership##3##2##(1996-1#1)(1996-3#1)(2007-10#1)
executive management in##2##3##(1996-1#1)(2008-11#1)
executive resources##2##2##(2008-4#1)(2009-9#1)
executive##108##1##(1992-3#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#5)(1994-1#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#4)(2007-8#4)(2008-1#8)(2008-11#5)(2008-2#2)(2008-4#2)(2008-6#2)(2008-8#1)(2009-10#10)(2009-2#2)(2009-6#3)(2009-9#2)(2010-3#3)(2010-6#2)(2011-2#5)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#9)
executives and##4##2##(1994-12#2)(1995-1#1)(1995-2#1)
executives are##4##2##(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#1)
executives for##2##2##(1994-12#1)(1995-12#1)
executives in this##2##3##(1993-1#1)(1995-3#1)
executives in##9##2##(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-7#1)
executives who##3##2##(1991-12#2)(1996-2#1)
executives##57##1##(1990-4#1)(1991-12#4)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#9)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#6)(1996-3#3)(1997-5#1)(2008-1#2)(2008-11#3)(2008-7#1)(2011-2#1)
exemplar##5##1##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)
exemplars##2##1##(2010-11#1)(2012-2#1)
exemplary service##2##2##(1996-2#1)(2008-1#1)
exemplary##7##1##(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-12#1)(2011-2#1)
exemplified by high##2##3##(2008-7#1)(2011-2#1)
exemplified by the##10##3##(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
exemplified by##22##2##(1990-5#1)(1993-2#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
exemplified in##2##2##(2008-5#1)(2008-8#1)
exemplified with petrochemical##2##3##(2008-10#2)
exemplified##28##1##(1990-5#1)(1993-2#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
exemplifies how##2##2##(2011-1#1)(2012-12#1)
exemplifies the##2##2##(2008-11#1)(2011-1#1)
exemplifies##9##1##(2008-11#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
exemplify how##2##2##(1991-1#1)(2008-9#1)
exemplify the##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
exemplify##10##1##(1991-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#1)
exemplifying results of##2##3##(2008-3#2)
exemplifying##4##1##(2008-3#2)(2008-4#1)(2008-8#1)
exempt from##2##2##(1992-3#1)(2009-10#1)
exempt##6##1##(1992-12#1)(1992-3#1)(1994-12#1)(1996-11#1)(2008-10#1)(2009-10#1)
exemption and##3##2##(1991-2#1)(2008-11#2)
exemption by##2##2##(1995-2#1)(1996-2#1)
exemption for##3##2##(1996-1#2)(2009-9#1)
exemption is##3##2##(1996-2#1)(1997-5#1)(2008-11#1)
exemption##24##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-5#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-11#1)(1996-2#4)(1997-5#1)(2008-11#5)(2009-9#1)
exemptions##8##1##(1993-2#2)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#1)
exenatide##7##1##(2012-3#7)
exendin 9-39##2##2##(1996-2#2)
exendin receptors##4##2##(1994-8#4)
exendin##7##1##(1994-8#4)(1996-2#2)(2011-2#1)
exendin-4##7##1##(1994-8#6)(2011-2#1)
exenteration##2##1##(2011-1#2)
exercise (SSE)##2##2##(2013-1#1)(2013-8#1)
exercise alone##2##2##(2010-5#1)(2013-1#1)
exercise and a##3##3##(2008-3#1)(2012-2#2)
exercise and physical activity##3##4##(1995-2#1)(1995-3#1)(2007-2#1)
exercise and the##4##3##(1993-11#1)(2008-10#1)(2008-7#1)(2010-10#1)
exercise and##39##2##(1990-3#1)(1992-12#1)(1992-3#1)(1993-11#2)(1995-2#1)(1995-3#1)(1996-11#2)(1996-9#1)(1997-2#1)(2007-2#1)(2007-6#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#5)
exercise are##7##2##(1995-6#1)(2008-5#2)(2009-3#1)(2012-2#1)(2013-1#2)
exercise as a##2##3##(2013-1#1)(2013-8#1)
exercise as well as##3##4##(1994-5#1)(2008-3#1)(2008-8#1)
exercise as##7##2##(1993-11#1)(1994-5#1)(2008-3#1)(2008-8#1)(2010-1#1)(2013-1#1)(2013-8#1)
exercise at##2##2##(2012-12#1)(2013-8#1)
exercise behavior##2##2##(2007-12#1)(2013-1#1)
exercise bout##4##2##(2008-5#1)(2013-1#1)(2013-8#2)
exercise by##2##2##(2013-7#1)(2013-8#1)
exercise can##3##2##(1993-1#1)(2011-2#1)(2012-12#1)
exercise capability##2##2##(1991-3#2)
exercise capacity##9##2##(1997-8#1)(2008-10#1)(2009-10#1)(2010-10#5)(2012-2#1)
exercise did not##2##3##(1997-4#1)(2012-1#1)
exercise during##3##2##(2007-12#1)(2007-6#1)(2008-8#1)
exercise enjoyment##4##2##(2007-6#4)
exercise for##9##2##(2008-10#1)(2008-11#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#3)
exercise group##4##2##(1991-8#1)(1992-3#2)(2011-2#1)
exercise habits##2##2##(1995-5#1)(2011-1#1)
exercise has##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
exercise in a patient who##2##5##(2010-5#2)
exercise in patients with neuromuscular diseases##2##6##(2008-7#2)
exercise in patients with##3##4##(1996-9#1)(2008-7#2)
exercise in the##2##3##(2008-12#1)(2010-12#1)
exercise in##23##2##(1992-12#1)(1993-11#1)(1996-9#1)(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-12#2)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#5)
exercise induced##4##2##(1996-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
exercise intensity##4##2##(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
exercise intervention##2##2##(2010-4#1)(2013-1#1)
exercise is mediated##2##3##(1993-11#1)(2013-8#1)
exercise is##6##2##(1993-11#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#2)
exercise may##4##2##(1992-3#2)(1993-11#1)(2008-6#1)
exercise of##7##2##(1991-12#1)(1995-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2012-3#1)
exercise on a##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
exercise on physical fitness##2##4##(2010-4#2)
exercise on physical##3##3##(2010-4#2)(2011-1#1)
exercise on the##3##3##(2008-7#1)(2010-4#1)(2013-8#1)
exercise on##25##2##(1992-3#2)(1993-6#1)(1995-11#1)(2008-10#1)(2008-12#2)(2008-7#3)(2008-8#1)(2009-1#1)(2010-12#2)(2010-4#3)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
exercise or##8##2##(2008-5#3)(2008-7#1)(2013-1#2)(2013-8#2)
exercise performance##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
exercise program##11##2##(1993-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2009-4#1)(2012-1#2)(2013-1#3)
exercise programs for OA##3##4##(2013-1#3)
exercise programs for##5##3##(2013-1#5)
exercise programs##9##2##(2012-2#1)(2013-1#8)
exercise protocol##2##2##(2013-8#2)
exercise recommendations##3##2##(2011-1#3)
exercise stress testing##2##3##(2008-7#2)
exercise stress##7##2##(1993-1#1)(2008-10#3)(2008-7#3)
exercise test##7##2##(1990-3#1)(1992-4#2)(1996-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
exercise testing and##3##3##(1996-3#1)(1996-6#1)(2008-3#1)
exercise testing##12##2##(1991-8#1)(1993-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)
exercise tests##2##2##(1991-11#1)(1996-6#1)
exercise than##2##2##(1991-12#1)(2007-11#1)
exercise that##3##2##(2008-11#1)(2008-5#1)(2009-4#1)
exercise therapy##5##2##(1997-3#1)(2008-11#1)(2008-12#1)(2010-9#1)(2012-3#1)
exercise to##7##2##(1991-2#1)(1995-11#1)(1996-3#1)(2007-6#2)(2008-12#2)
exercise tolerance and##4##3##(2008-1#1)(2010-8#2)(2013-8#1)
exercise tolerance in patients with COPD##2##6##(2013-7#1)(2013-8#1)
exercise tolerance in patients with##3##5##(2013-7#2)(2013-8#1)
exercise tolerance in##4##3##(2013-7#2)(2013-8#2)
exercise tolerance measured##2##3##(1991-3#2)
exercise tolerance##15##2##(1991-3#2)(2008-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2013-7#3)(2013-8#3)
exercise training and##2##3##(2012-3#1)(2013-1#1)
exercise training on##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
exercise training##13##2##(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#3)(2013-1#6)
exercise under##3##2##(2010-12#1)(2013-8#2)
exercise was##10##2##(1992-12#1)(1994-7#1)(2008-10#3)(2008-12#2)(2008-7#1)(2010-4#1)(2011-1#1)
exercise were##2##2##(2008-11#1)(2008-3#1)
exercise when##2##2##(2008-5#1)(2013-1#1)
exercise with instruments##2##3##(2007-6#2)
exercise with##6##2##(2007-6#3)(2009-1#2)(2010-4#1)
exercise##551##1##(1990-3#3)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-6#1)(1991-8#3)(1992-11#1)(1992-12#10)(1992-2#1)(1992-3#8)(1992-4#2)(1993-1#2)(1993-11#9)(1993-2#4)(1993-6#2)(1994-12#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#3)(1996-3#2)(1996-6#4)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-6#22)(2007-8#3)(2008-1#7)(2008-10#21)(2008-11#20)(2008-12#23)(2008-2#1)(2008-3#17)(2008-5#19)(2008-6#2)(2008-7#32)(2008-8#3)(2008-9#2)(2009-1#4)(2009-10#2)(2009-11#2)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#6)(2010-10#10)(2010-11#2)(2010-12#10)(2010-2#1)(2010-3#3)(2010-4#9)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#16)(2011-2#17)(2011-3#1)(2012-1#5)(2012-12#7)(2012-2#13)(2012-3#14)(2013-1#74)(2013-7#7)(2013-8#51)
exercise) and##2##2##(1992-3#1)(2013-8#1)
exercise)##3##1##(1992-3#1)(2013-8#2)
exercise-induced anaphylaxis##9##2##(1991-11#3)(2010-1#3)(2010-6#3)
exercise-induced asthma (EIA)##2##3##(1995-6#1)(2010-5#1)
exercise-induced asthma##4##2##(1995-6#1)(1997-1#1)(2010-5#2)
exercise-induced bronchoconstriction##2##2##(2010-1#2)
exercise-induced oxidative stress##2##3##(1992-9#1)(2008-5#1)
exercise-induced##31##1##(1991-11#4)(1992-9#1)(1993-11#1)(1995-6#1)(1996-6#1)(1997-1#1)(2008-5#3)(2008-7#1)(2010-1#6)(2010-5#2)(2010-6#4)(2011-2#1)(2013-1#2)(2013-8#3)
exercise-intensity domains##2##2##(2009-1#2)
exercised to##2##2##(2007-12#1)(2008-10#1)
exercised##14##1##(1991-6#1)(1993-6#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-8#2)
exercises and##9##2##(1990-6#1)(2007-8#2)(2008-1#1)(2010-6#2)(2011-1#2)(2012-2#1)
exercises are##2##2##(2007-11#1)(2013-1#1)
exercises as##2##2##(2007-11#1)(2008-6#1)
exercises at##2##2##(2010-9#1)(2013-8#1)
exercises in##6##2##(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-2#1)
exercises is##2##2##(2007-11#1)(2007-8#1)
exercises of the##4##3##(1991-5#1)(2007-11#1)(2007-8#2)
exercises of##5##2##(1991-5#1)(2007-11#2)(2007-8#2)
exercises on##4##2##(1991-12#1)(2008-10#1)(2009-1#1)(2012-3#1)
exercises that##2##2##(1995-2#1)(2010-9#1)
exercises to##2##2##(2009-10#1)(2012-2#1)
exercises were performed##2##3##(2008-10#1)(2011-1#1)
exercises were##3##2##(2008-10#1)(2010-9#1)(2011-1#1)
exercises##81##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#7)(2007-2#1)(2007-7#1)(2007-8#10)(2008-1#1)(2008-10#3)(2008-12#4)(2008-6#1)(2008-9#1)(2009-1#3)(2009-10#2)(2010-1#1)(2010-12#1)(2010-6#4)(2010-9#4)(2011-1#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#5)
exercising on##2##2##(2011-1#1)(2011-2#1)
exercising##7##1##(1993-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
exeresis##8##1##(1990-3#3)(1990-6#1)(1991-11#1)(1994-6#2)(2008-5#1)
exergonic##2##1##(2010-7#2)
exert a dual##2##3##(1991-5#1)(2008-4#1)
exert a negative##2##3##(2009-7#1)(2013-1#1)
exert a##19##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
exert an inhibitory##2##3##(1993-5#1)(1994-10#1)
exert an##6##2##(1993-5#1)(1994-10#1)(1994-7#1)(1996-9#1)(2008-5#1)(2011-2#1)
exert anti-inflammatory##2##2##(2009-6#1)(2010-10#1)
exert antioxidant##2##2##(1991-9#1)(1992-9#1)
exert distinct effects on##2##4##(1995-3#1)(2012-12#1)
exert its##9##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-11#1)(2011-1#1)(2012-2#2)
exert numerous##2##2##(2008-10#1)(2008-3#1)
exert similar##2##2##(1995-11#1)(2008-10#1)
exert strong##2##2##(2008-11#2)
exert substantial##2##2##(1990-8#1)(2008-10#1)
exert the##4##2##(1993-6#1)(1997-3#1)(2008-10#1)(2008-9#1)
exert their effects on##2##4##(1991-12#1)(2008-4#1)
exert their effects##4##3##(1991-12#1)(2008-4#1)(2008-8#1)(2010-5#1)
exert their##16##2##(1990-5#1)(1991-12#1)(1993-3#1)(1993-8#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
exert##107##1##(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-7#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-9#1)(1997-3#1)(2007-7#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
exerted a strong##2##3##(2008-9#1)(2010-10#1)
exerted a##11##2##(1992-2#1)(1993-12#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-10#1)(2012-3#1)(2012-4#1)
exerted by the##8##3##(1990-7#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-2#1)
exerted by these##2##3##(2008-4#1)(2009-8#1)
exerted by various##2##3##(2007-12#1)(2008-5#1)
exerted by##25##2##(1990-7#1)(1991-12#1)(1993-8#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-2#1)(2013-1#3)
exerted direct##2##2##(1992-6#1)(1995-11#1)
exerted no##4##2##(1992-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
exerted on a dielectric sphere in##2##6##(2008-3#2)
exerted on a##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
exerted on the##4##3##(2008-10#2)(2008-3#1)(2009-6#1)
exerted on##11##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#4)(2009-6#1)
exerted the##2##2##(2008-10#1)(2008-5#1)
exerted via##2##2##(2008-11#1)(2008-5#1)
exerted##79##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#3)
exerting a##4##2##(1993-5#1)(1995-12#1)(2008-7#1)(2013-1#1)
exerting##14##1##(1993-5#1)(1994-5#1)(1995-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
exertion in##2##2##(2008-10#1)(2012-3#1)
exertion was##2##2##(2007-8#1)(2013-8#1)
exertion##17##1##(1991-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-10#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
exertional compartment syndrome##2##3##(2007-11#2)
exertional dyspnea##2##2##(2008-1#1)(2012-12#1)
exertional##6##1##(1992-2#1)(2007-11#2)(2008-1#1)(2011-2#1)(2012-12#1)
exerts a strong##3##3##(1994-3#2)(2009-8#1)
exerts a trophic effect on the##2##6##(1993-5#1)(1993-6#1)
exerts a##14##2##(1992-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-12#1)(1996-5#1)(1996-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)
exerts an inhibitory effect on##2##5##(1992-5#1)(2008-10#1)
exerts an##7##2##(1990-3#1)(1992-5#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
exerts differential##2##2##(1993-3#1)(1996-2#1)
exerts important##2##2##(1992-3#1)(2008-8#1)
exerts its activity##2##3##(1994-2#1)(2013-1#1)
exerts its effect##2##3##(1993-3#1)(2011-3#1)
exerts its effects on##2##4##(1994-12#1)(2013-1#1)
exerts its effects##5##3##(1994-12#1)(2008-8#1)(2009-11#1)(2009-6#1)(2013-1#1)
exerts its##20##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2011-3#1)(2013-1#2)
exerts potent##2##2##(1993-1#1)(2009-8#1)
exerts##62##1##(1990-11#1)(1990-12#1)(1990-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
exfoliated cells##2##2##(1992-9#1)(1997-4#1)
exfoliated##7##1##(1991-2#1)(1992-9#1)(1997-4#1)(2008-10#2)(2010-4#1)(2013-8#1)
exfoliation##5##1##(2008-10#1)(2008-5#2)(2011-2#2)
exfoliative cytology##2##2##(2013-8#2)
exfoliative dermatitis##2##2##(2007-7#1)(2008-8#1)
exfoliative##6##1##(2007-7#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#2)
exgA##5##1##(2008-10#5)
exhalation##4##1##(1993-3#1)(1996-1#1)(1996-2#1)(2013-7#1)
exhaled air##4##2##(1991-3#1)(2008-10#2)(2011-2#1)
exhaled breath condensate##2##3##(2010-5#2)
exhaled breath##3##2##(2008-10#1)(2010-5#2)
exhaled nitric oxide##3##3##(2010-5#2)(2012-1#1)
exhaled##15##1##(1991-3#1)(1995-3#1)(1996-6#3)(1997-1#1)(2008-10#3)(2010-5#4)(2011-2#1)(2012-1#1)
exhaust and##2##2##(2008-10#1)(2008-3#1)
exhaust gas##2##2##(2008-10#2)
exhaust gases##2##2##(2008-10#1)(2008-2#1)
exhaust particles##6##2##(2008-10#6)
exhaust to##2##2##(2008-10#1)(2008-3#1)
exhaust##26##1##(2008-10#14)(2008-11#2)(2008-2#3)(2008-3#7)
exhausted by##2##2##(2008-2#1)(2010-8#1)
exhausted##14##1##(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
exhausting##2##1##(2012-1#1)(2012-2#1)
exhaustion of##3##2##(1995-3#1)(2008-10#1)(2010-11#1)
exhaustion was##2##2##(2008-11#1)(2013-8#1)
exhaustion##32##1##(1995-3#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#8)(2008-5#1)(2009-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#4)(2013-1#2)(2013-8#7)
exhaustive exercise decreased##2##3##(2013-1#2)
exhaustive exercise##12##2##(2011-2#1)(2012-1#1)(2013-1#10)
exhaustive treadmill##3##2##(2012-1#2)(2013-1#1)
exhaustive##32##1##(1991-2#1)(1991-9#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-1#3)(2013-1#13)
exhaustively##2##1##(2010-7#1)(2012-2#1)
exhausts##4##1##(2008-2#1)(2008-3#3)
exhibit a good##2##3##(2008-10#2)
exhibit a high degree of##2##5##(2008-10#1)(2008-4#1)
exhibit a high##5##3##(1990-6#1)(2008-10#2)(2008-3#1)(2008-4#1)
exhibit a lower##2##3##(1992-3#1)(2007-12#1)
exhibit a marked##2##3##(1990-2#1)(2008-4#1)
exhibit a maximum##3##3##(2008-10#2)(2008-3#1)
exhibit a negative##2##3##(1996-3#1)(2009-6#1)
exhibit a peak at##2##4##(2008-10#2)
exhibit a significant##2##3##(1993-12#1)(2008-7#1)
exhibit a wide range of##2##5##(2007-12#1)(2008-3#1)
exhibit a##78##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-9#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#23)(2008-11#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
exhibit an array of##2##4##(2010-4#1)(2013-8#1)
exhibit an increase in##2##4##(1996-3#1)(2009-11#1)
exhibit an unusual##2##3##(1997-7#1)(2008-10#1)
exhibit an##16##2##(1992-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-5#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-1#1)(2013-8#2)
exhibit analogous##2##2##(2007-11#1)(2008-3#1)
exhibit any##6##2##(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2011-2#1)
exhibit both##2##2##(2007-11#1)(2012-2#1)
exhibit considerably##2##2##(2008-10#1)(2010-11#1)
exhibit defects in##2##3##(2008-4#1)(2009-8#1)
exhibit differences in##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
exhibit different##11##2##(1992-8#1)(1995-2#2)(2008-10#3)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#2)
exhibit elevated levels of##2##4##(2010-12#1)(2011-2#1)
exhibit elevated##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
exhibit enhanced##4##2##(1991-3#1)(1995-2#1)(2008-8#1)(2013-7#1)
exhibit excellent##4##2##(2008-10#2)(2008-7#1)(2009-9#1)
exhibit extensive##2##2##(2008-10#1)(2009-5#1)
exhibit fast##2##2##(2008-10#2)
exhibit good##4##2##(2008-10#2)(2009-5#1)(2013-8#1)
exhibit greater##2##2##(1990-5#1)(2008-2#1)
exhibit high##7##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-8#1)
exhibit improved##2##2##(2007-12#1)(2008-9#1)
exhibit increased##3##2##(1992-6#1)(1992-8#1)(2008-11#1)
exhibit independent##2##2##(1993-8#1)(2008-8#1)
exhibit large##2##2##(2008-11#1)(2010-10#1)
exhibit larger##2##2##(2008-9#1)(2013-8#1)
exhibit low##4##2##(1991-9#1)(2007-12#1)(2008-9#1)(2012-5#1)
exhibit lower##4##2##(1993-11#1)(1993-9#1)(2008-9#1)(2010-4#1)
exhibit many##4##2##(2008-11#1)(2008-7#1)(2010-2#1)(2013-8#1)
exhibit mode##2##2##(2007-12#1)(2008-3#1)
exhibit moderate##2##2##(1996-12#1)(2008-10#1)
exhibit more##2##2##(2012-2#1)(2013-8#1)
exhibit multiple##2##2##(2008-11#1)(2008-7#1)
exhibit negligible##2##2##(1996-12#1)(2008-10#1)
exhibit no obvious##2##3##(1990-5#1)(2007-12#1)
exhibit no##6##2##(1990-5#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-5#1)(2008-9#1)
exhibit numerous##2##2##(2008-7#1)(2009-12#1)
exhibit poor##2##2##(2009-11#1)(2012-3#1)
exhibit potent##4##2##(1991-5#1)(2008-5#2)(2009-12#1)
exhibit reduced##2##2##(2008-9#2)
exhibit remarkable##2##2##(2008-3#1)(2012-3#1)
exhibit several##3##2##(2009-3#1)(2013-1#2)
exhibit significant##9##2##(1993-11#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2012-2#1)
exhibit significantly##3##2##(1995-5#1)(2008-10#1)(2008-9#1)
exhibit similar##4##2##(1995-3#1)(1996-12#1)(2007-11#1)(2008-8#1)
exhibit size-dependent##2##2##(2008-10#1)(2008-7#1)
exhibit slip##2##2##(1996-4#2)
exhibit strong##6##2##(1994-2#1)(2007-12#1)(2008-10#3)(2008-2#1)
exhibit the same##5##3##(1993-8#1)(1994-11#1)(1997-2#1)(2008-3#1)(2008-5#1)
exhibit the##26##2##(1990-12#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-8#1)(1997-2#2)(1997-6#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-5#1)(2013-1#1)
exhibit this##5##2##(1990-7#1)(2008-7#2)(2008-8#1)(2011-2#1)
exhibit two##3##2##(1996-2#1)(2008-3#1)(2009-11#1)
exhibit unique##2##2##(2008-10#1)(2009-11#1)
exhibit unusual##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
exhibit variable##2##2##(2008-10#1)(2008-7#1)
exhibit various##2##2##(2008-10#1)(2011-1#1)
exhibit##461##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-6#4)(1992-8#4)(1993-11#5)(1993-12#4)(1993-3#1)(1993-8#4)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1995-11#3)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#3)(1996-12#3)(1996-2#6)(1996-3#4)(1996-4#3)(1996-5#5)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#4)(1997-8#1)(2007-1#1)(2007-11#11)(2007-12#16)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#78)(2008-11#15)(2008-12#2)(2008-2#10)(2008-3#20)(2008-4#10)(2008-5#9)(2008-6#2)(2008-7#21)(2008-8#20)(2008-9#16)(2009-10#4)(2009-11#6)(2009-12#7)(2009-3#3)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#14)(2012-3#4)(2012-5#1)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#9)
exhibited 2+##2##2##(1993-12#2)
exhibited 93%##2##2##(1990-8#1)(1995-8#1)
exhibited a Nernstian response for##2##5##(2008-10#2)
exhibited a clear##2##3##(2008-8#1)(2009-6#1)
exhibited a distinct##2##3##(2008-10#2)
exhibited a good##3##3##(2008-10#3)
exhibited a greater##4##3##(1995-5#1)(2008-10#2)(2011-2#1)
exhibited a high##9##3##(1990-5#1)(1992-12#1)(1994-11#1)(2008-10#4)(2008-6#1)(2010-11#1)
exhibited a linear response##3##4##(2008-10#3)
exhibited a linear##5##3##(2008-10#5)
exhibited a marked##3##3##(2008-10#1)(2010-4#1)(2012-1#1)
exhibited a mutagenic##2##3##(1996-2#2)
exhibited a period of maximum susceptibility from midbloom until##2##9##(2008-10#2)
exhibited a range of##3##4##(1995-6#1)(2007-12#1)(2008-8#1)
exhibited a remarkable##2##3##(2012-2#1)(2013-1#1)
exhibited a significant decrease in##2##5##(1993-12#1)(1993-6#1)
exhibited a significant##9##3##(1990-7#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2013-8#1)
exhibited a significantly##2##3##(2008-7#1)(2008-8#1)
exhibited a single##4##3##(1994-5#1)(1995-11#1)(1997-2#1)(2008-10#1)
exhibited a slope efficiency of##2##5##(2007-11#2)
exhibited a specific##2##3##(1990-12#1)(1990-5#1)
exhibited a strong##3##3##(1996-12#1)(2007-11#1)(2010-8#1)
exhibited a tendency##2##3##(1996-9#1)(2008-4#1)
exhibited a typical##2##3##(2009-11#1)(2011-2#1)
exhibited a very##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
exhibited a##139##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#42)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
exhibited aggregated cytoplasm and##2##4##(2008-10#2)
exhibited an apparent##2##3##(1997-4#1)(2013-1#1)
exhibited an excellent##3##3##(2008-10#3)
exhibited an increase in##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
exhibited an##24##2##(1995-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#2)(2009-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
exhibited antifungal activity against##2##4##(2008-10#1)(2009-2#1)
exhibited any##2##2##(1992-6#1)(1994-12#1)
exhibited better##4##2##(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
exhibited both##2##2##(1990-5#1)(1997-2#1)
exhibited by a##7##3##(1992-5#1)(1993-12#1)(1996-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
exhibited by an##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
exhibited by the##13##3##(1990-2#1)(1990-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1995-3#1)(1996-8#1)(2007-6#1)(2008-10#2)(2008-7#2)(2009-8#1)
exhibited by these##4##3##(1996-2#1)(2007-11#1)(2008-10#1)(2011-3#1)
exhibited by##48##2##(1990-2#1)(1990-8#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-2#2)(1996-8#1)(2007-11#2)(2007-12#1)(2007-6#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
exhibited characteristic##2##2##(2008-10#1)(2011-2#1)
exhibited comparable##2##2##(2008-11#1)(2008-8#1)
exhibited complete##2##2##(1997-7#1)(2008-10#1)
exhibited components of partial resistance in greenhouse tests##2##8##(2008-10#2)
exhibited considerable##3##2##(2008-10#2)(2010-3#1)
exhibited decreased##2##2##(1996-9#1)(2008-10#1)
exhibited differences in##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
exhibited different levels of##2##4##(2008-10#2)
exhibited different##5##2##(2008-10#4)(2010-11#1)
exhibited distinct##2##2##(1997-6#1)(2013-1#1)
exhibited elevated##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
exhibited enhanced##5##2##(1992-3#1)(2008-10#2)(2009-6#1)(2013-1#1)
exhibited equivalent##2##2##(1993-6#2)
exhibited excellent##8##2##(2008-10#5)(2008-3#1)(2011-2#1)(2012-3#1)
exhibited extensive chlorosis to##2##4##(2008-10#2)
exhibited extensive##3##2##(2008-10#3)
exhibited fast##2##2##(2008-10#2)
exhibited faster##2##2##(1996-9#1)(2008-10#1)
exhibited good reproducibility##3##3##(2008-10#2)(2013-1#1)
exhibited good stability and##2##4##(2008-10#1)(2013-8#1)
exhibited good stability##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
exhibited good##14##2##(2008-10#10)(2010-4#1)(2013-1#2)(2013-8#1)
exhibited greater##7##2##(1990-5#1)(1990-7#1)(2008-10#1)(2011-2#2)(2012-3#2)
exhibited high selectivity##4##3##(2008-10#3)(2013-1#1)
exhibited high sensitivity##3##3##(2008-10#2)(2013-1#1)
exhibited high##21##2##(1990-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-10#12)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#2)
exhibited higher##9##2##(2008-10#1)(2008-5#2)(2008-9#1)(2010-4#1)(2012-1#1)(2013-1#2)(2013-8#1)
exhibited highly##2##2##(1995-3#1)(2009-5#1)
exhibited in the##2##3##(1991-5#1)(2008-10#1)
exhibited in##9##2##(1991-5#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
exhibited increased##3##2##(1994-5#1)(2008-12#1)(2008-8#1)
exhibited inhibitory##2##2##(1990-5#1)(2013-1#1)
exhibited less##2##2##(1995-2#1)(2008-10#1)
exhibited little##4##2##(1991-1#1)(1995-2#1)(2008-10#2)
exhibited longer##2##2##(1997-6#1)(2009-12#1)
exhibited low##5##2##(1996-12#1)(2008-10#2)(2008-3#1)(2009-3#1)
exhibited maximum##3##2##(2008-8#1)(2009-6#1)(2012-2#1)
exhibited more than##3##3##(2008-5#2)(2011-2#1)
exhibited more##12##2##(1994-9#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
exhibited mosaic symptoms##2##3##(2008-10#2)
exhibited much##2##2##(1994-11#1)(2010-4#1)
exhibited nearly##3##2##(1995-11#1)(2008-10#1)(2009-5#1)
exhibited no##17##2##(1990-8#1)(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
exhibited one well-defined##2##3##(2008-10#2)
exhibited one##3##2##(2008-10#3)
exhibited only##2##2##(1997-6#1)(2011-1#1)
exhibited partial##2##2##(2008-1#1)(2013-8#1)
exhibited poor##2##2##(2008-9#1)(2013-1#1)
exhibited reduced##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
exhibited resistance to##2##3##(2008-10#1)(2008-11#1)
exhibited resistance##4##2##(2008-10#2)(2008-11#2)
exhibited severe##2##2##(2008-10#2)
exhibited significant differences##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
exhibited significant##24##2##(1993-9#1)(1994-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#3)(2013-1#1)(2013-8#2)
exhibited significantly higher##2##3##(2008-10#1)(2008-12#1)
exhibited significantly lower##2##3##(1993-12#1)(1996-1#1)
exhibited significantly##8##2##(1993-12#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-11#1)(2013-1#1)
exhibited similar##7##2##(1990-7#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
exhibited slightly##3##2##(1994-8#1)(2008-10#2)
exhibited some##4##2##(1991-8#1)(1993-12#1)(1994-5#1)(2008-10#1)
exhibited specific##2##2##(2008-10#1)(2011-1#1)
exhibited specificity##2##2##(1992-12#1)(2013-1#1)
exhibited spontaneous##2##2##(2008-11#1)(2008-6#1)
exhibited strong antifungal activities##2##4##(2008-10#1)(2013-1#1)
exhibited strong##10##2##(1992-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2013-1#1)
exhibited stronger##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
exhibited substantial##3##2##(1992-9#1)(2006-12#1)(2008-12#1)
exhibited that the##2##3##(1992-6#1)(2008-10#1)
exhibited the best##4##3##(2008-10#3)(2008-5#1)
exhibited the greatest##2##3##(2008-10#1)(2009-9#1)
exhibited the highest##5##3##(2008-10#4)(2011-2#1)
exhibited the lowest##3##3##(2008-3#2)(2009-4#1)
exhibited the phenotype of##2##4##(1997-2#1)(1997-8#1)
exhibited the same##6##3##(1990-7#1)(1994-8#1)(1995-12#1)(2008-10#3)
exhibited the strongest##3##3##(2008-10#1)(2009-7#1)(2010-2#1)
exhibited the##41##2##(1990-12#1)(1990-7#2)(1991-2#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#15)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
exhibited unique characteristics##2##3##(2008-10#1)(2010-4#1)
exhibited unique##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
exhibited very##6##2##(1994-12#1)(1995-2#1)(1997-6#1)(2008-10#3)
exhibited when##2##2##(2008-10#1)(2008-7#1)
exhibited wide##3##2##(2008-10#2)(2008-7#1)
exhibited##746##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#8)(1990-6#2)(1990-7#7)(1990-8#4)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#5)(1992-3#3)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#10)(1993-6#3)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#6)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-2#5)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#1)(2007-6#3)(2007-8#2)(2008-1#2)(2008-10#242)(2008-11#29)(2008-12#10)(2008-2#4)(2008-3#15)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#17)(2008-8#17)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#3)(2009-9#3)(2010-11#4)(2010-2#1)(2010-3#8)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#15)(2012-3#10)(2013-1#32)(2013-7#2)(2013-8#10)
exhibiting a##15##2##(1990-5#1)(1992-8#1)(1993-12#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-7#1)
exhibiting an##9##2##(1992-11#1)(1994-11#1)(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-5#1)
exhibiting both##2##2##(1992-12#1)(2011-2#1)
exhibiting differential##2##2##(1991-2#1)(2008-8#1)
exhibiting high##5##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-6#1)
exhibiting higher##2##2##(2008-10#1)(2011-2#1)
exhibiting low##4##2##(1991-2#1)(1996-12#1)(2008-10#1)(2008-2#1)
exhibiting reduced##2##2##(2008-10#1)(2012-2#1)
exhibiting the highest##2##3##(2010-8#1)(2013-8#1)
exhibiting the same##2##3##(2007-11#1)(2008-10#1)
exhibiting the##9##2##(2007-11#1)(2008-10#5)(2010-8#1)(2013-7#1)(2013-8#1)
exhibiting this##2##2##(1996-2#1)(2011-2#1)
exhibiting varying##2##2##(2008-10#2)
exhibiting very##2##2##(2007-11#1)(2008-4#1)
exhibiting##120##1##(1990-5#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#6)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#30)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2009-10#1)(2009-3#1)(2009-9#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#4)(2013-7#2)(2013-8#3)
exhibits a Nernstian response for##5##5##(2008-10#5)
exhibits a Nernstian response##6##4##(2008-10#6)
exhibits a Nernstian##9##3##(2008-10#9)
exhibits a fast response time##2##5##(2008-10#2)
exhibits a fast##4##3##(2008-10#3)(2008-3#1)
exhibits a good##3##3##(2008-10#2)(2008-3#1)
exhibits a high##4##3##(1992-11#1)(2008-10#2)(2008-11#1)
exhibits a higher##2##3##(2008-10#1)(2008-5#1)
exhibits a linear response over##2##5##(2008-10#2)
exhibits a linear response to##2##5##(2008-10#2)
exhibits a linear response##6##4##(2008-10#6)
exhibits a linear##8##3##(2008-10#8)
exhibits a maximum##2##3##(2008-2#2)
exhibits a positive##2##3##(1995-5#1)(2008-8#1)
exhibits a simple##2##3##(2007-11#1)(2009-12#1)
exhibits a strong##2##3##(2008-10#2)
exhibits a very good##2##4##(2008-10#2)
exhibits a##94##2##(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#2)(1997-7#1)(2007-11#5)(2007-12#5)(2008-10#41)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
exhibits an excellent##2##3##(2008-10#2)
exhibits an##20##2##(1990-8#1)(1991-2#1)(1993-11#2)(1995-8#2)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#4)(2009-9#1)
exhibits characteristic##2##2##(2007-11#1)(2008-10#1)
exhibits enhanced##2##2##(2008-8#1)(2009-10#1)
exhibits excellent##6##2##(2007-9#1)(2008-10#3)(2008-2#1)(2012-2#1)
exhibits for##2##2##(1992-6#1)(2011-2#1)
exhibits good##10##2##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
exhibits high selectivity for##2##4##(2008-10#2)
exhibits high selectivity##3##3##(2008-10#3)
exhibits high virulence on##2##4##(2008-10#2)
exhibits high##12##2##(1990-5#1)(1992-3#1)(1995-11#1)(2008-10#7)(2008-11#1)(2009-8#1)
exhibits low##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
exhibits mixed##3##2##(1992-3#2)(2009-8#1)
exhibits more##2##2##(1991-12#1)(2008-10#1)
exhibits no##4##2##(1995-2#1)(2008-10#3)
exhibits only a##2##3##(1990-11#1)(2007-12#1)
exhibits specific##2##2##(1993-6#1)(2008-12#1)
exhibits strong##7##2##(1997-2#1)(2007-12#2)(2008-10#3)(2008-7#1)
exhibits the same##2##3##(2008-2#1)(2008-8#1)
exhibits the##15##2##(1990-8#1)(1991-3#1)(1994-8#2)(1995-6#1)(2008-10#6)(2008-2#2)(2008-8#1)(2009-4#1)
exhibits two##3##2##(2007-12#1)(2008-10#1)(2009-7#1)
exhibits very##2##2##(2008-10#2)
exhibits##313##1##(1990-11#1)(1990-5#3)(1990-7#3)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#2)(1992-7#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#3)(1994-8#3)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#14)(2007-12#20)(2007-9#1)(2008-10#104)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#26)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
exhumations##3##1##(1995-6#3)
exine##4##1##(2011-2#4)
exist a##2##2##(1992-9#1)(2010-11#1)
exist along##2##2##(2007-5#1)(2008-10#1)
exist among a##2##3##(1996-1#1)(2008-9#1)
exist among the##2##3##(2007-12#1)(2010-8#1)
exist among##5##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)
exist and the##2##3##(2011-2#1)(2012-2#1)
exist and##11##2##(1993-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
exist as a##2##3##(1990-12#1)(2008-10#1)
exist as##9##2##(1990-12#1)(1994-8#1)(2008-10#3)(2008-9#2)(2011-3#1)(2012-2#1)
exist at##6##2##(1991-9#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-5#1)(2008-10#1)
exist between regions##2##3##(2007-5#1)(2011-1#1)
exist between the##8##3##(1991-3#1)(1994-5#2)(1996-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)
exist between these##2##3##(2008-10#1)(2010-10#1)
exist between##24##2##(1991-3#1)(1992-8#1)(1994-5#2)(1994-6#1)(1995-12#1)(1996-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
exist but##2##2##(1997-3#1)(2008-10#1)
exist concerning##2##2##(2007-10#1)(2008-4#1)
exist different##2##2##(2008-3#1)(2008-8#1)
exist during##2##2##(2008-1#1)(2012-12#1)
exist even when##2##3##(1994-5#1)(2008-10#1)
exist even##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
exist for renal nurses in##2##5##(2007-10#2)
exist for the##4##3##(1992-3#1)(1995-5#1)(2007-12#1)(2009-7#1)
exist for these##2##3##(2008-7#1)(2011-2#1)
exist for##28##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-2#1)
exist in a##5##3##(1991-1#1)(1994-2#1)(1995-3#1)(2008-7#2)
exist in all##2##3##(1995-11#1)(1996-3#1)
exist in bone marrow##2##4##(2008-5#1)(2012-12#1)
exist in some##2##3##(2008-10#1)(2008-9#1)
exist in the area of##2##5##(2008-11#1)(2008-2#1)
exist in the literature##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
exist in the##39##3##(1990-12#1)(1990-8#1)(1993-11#1)(1994-5#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#5)(2009-7#1)(2010-8#1)(2012-3#1)
exist in##96##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#3)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)
exist mainly##2##2##(2008-10#1)(2008-9#1)
exist on a##2##3##(1992-3#1)(2007-11#1)
exist on the##3##3##(2008-11#1)(2009-9#1)(2013-1#1)
exist on##9##2##(1990-8#1)(1992-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2009-9#1)(2013-1#1)
exist only in##4##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
exist regarding##3##2##(2009-5#1)(2011-2#1)(2012-3#1)
exist that##5##2##(1993-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
exist to detect##2##3##(2008-4#1)(2010-1#1)
exist to support##2##3##(1995-2#1)(2008-7#1)
exist to##17##2##(1995-2#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
exist today##2##2##(2008-10#1)(2010-3#1)
exist two##2##2##(1995-2#1)(2008-3#1)
exist which##2##2##(1995-3#1)(1996-4#1)
exist within the##2##3##(1994-9#1)(2008-7#1)
exist within##3##2##(1994-9#1)(2008-7#1)(2008-8#1)
exist##357##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#3)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-11#6)(2007-12#8)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#6)(2008-10#38)(2008-11#14)(2008-12#3)(2008-2#11)(2008-3#15)(2008-4#7)(2008-5#9)(2008-6#5)(2008-7#8)(2008-8#15)(2008-9#19)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#12)(2011-3#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#11)(2013-8#5)
exist?##3##1##(1994-8#1)(1996-2#1)(2008-8#1)
exist?]##3##1##(1992-2#1)(1994-3#1)(1997-5#1)
existed among##10##2##(1992-3#1)(2008-10#4)(2008-12#1)(2010-11#1)(2011-1#1)(2012-2#2)
existed as##2##2##(1993-8#1)(1995-6#1)
existed between the##7##3##(1992-3#1)(1993-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
existed between##18##2##(1990-2#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(2007-5#1)(2008-10#3)(2008-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
existed for##4##2##(1993-12#1)(2007-5#1)(2008-10#1)(2008-3#1)
existed in South America##2##4##(2008-10#2)
existed in supernatant##2##3##(1997-4#1)(2008-8#1)
existed in the genome of##2##5##(2008-9#2)
existed in the##11##3##(1990-5#1)(1990-8#1)(1992-1#1)(1993-8#1)(1996-4#1)(2008-10#2)(2008-9#2)(2011-2#1)(2013-1#1)
existed in##32##2##(1990-5#1)(1990-8#1)(1992-1#1)(1992-5#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-4#1)(1997-4#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
existed##85##1##(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#4)(1993-2#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#2)(1995-6#1)(1995-8#2)(1996-4#1)(1997-4#1)(1997-8#1)(2007-2#1)(2007-5#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#5)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
existence and uniqueness of##3##4##(2008-11#1)(2009-10#1)(2013-8#1)
existence and##16##2##(1990-5#1)(1991-12#1)(1993-5#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
existence of a characteristic##2##4##(1996-4#1)(2008-3#1)
existence of a highly##2##4##(1992-3#1)(1995-2#1)
existence of a##69##3##(1990-5#2)(1990-8#3)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#5)(1995-3#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2012-2#2)(2013-1#2)(2013-8#1)
existence of additional##2##3##(1996-2#1)(2009-2#1)
existence of an##15##3##(1990-5#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-8#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-3#1)
existence of bidirectional##2##3##(2008-2#1)(2008-5#1)
existence of distinct##3##3##(1990-8#1)(1995-8#1)(2008-10#1)
existence of multiple##4##3##(1991-5#1)(2007-8#1)(2008-10#1)(2008-7#1)
existence of rate isomorphy##2##4##(2008-8#2)
existence of subsets##2##3##(1997-8#1)(2008-9#1)
existence of such a##2##4##(1992-12#1)(1996-4#1)
existence of such##4##3##(1992-12#1)(1996-4#1)(2008-4#1)(2010-3#1)
existence of the##16##3##(1990-7#1)(1990-8#1)(1991-3#1)(1993-11#1)(1994-11#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-7#1)(2010-2#1)(2010-5#1)
existence of this##5##3##(1990-8#1)(1992-6#1)(1995-2#1)(1996-3#1)(2008-2#1)
existence of two groups##2##4##(1991-1#1)(2008-10#1)
existence of two##12##3##(1990-11#1)(1990-7#1)(1991-1#1)(1992-3#1)(1993-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)
existence of##306##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-5#3)(1990-7#2)(1990-8#7)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#6)(1992-3#5)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#5)(1997-7#6)(1997-8#1)(1997-9#1)(2007-11#4)(2007-12#11)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#42)(2008-11#12)(2008-12#1)(2008-2#9)(2008-3#11)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#3)(2009-2#3)(2009-3#1)(2009-5#3)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#5)
existence##345##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-5#4)(1990-7#2)(1990-8#7)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#5)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#2)(1997-9#1)(2007-11#4)(2007-12#12)(2007-5#1)(2007-6#1)(2007-8#4)(2008-10#44)(2008-11#15)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#17)(2008-9#6)(2009-1#1)(2009-10#4)(2009-2#3)(2009-3#1)(2009-5#3)(2009-7#4)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#8)
existent in the##2##3##(2008-10#1)(2008-3#1)
existent##6##1##(1994-1#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)
existential dimensions##2##2##(2009-5#1)(2012-3#1)
existential##6##1##(1991-2#1)(1993-6#1)(1994-6#1)(2009-5#1)(2012-3#2)
existing Na narrow-band temperature##2##4##(2008-2#2)
existing analytical##2##2##(2008-10#1)(2008-2#1)
existing and future##2##3##(2008-10#1)(2012-2#1)
existing and##6##2##(1996-1#1)(1997-8#1)(2007-11#1)(2008-10#2)(2012-2#1)
existing as##3##2##(1993-8#1)(2008-10#2)
existing between the##2##3##(2008-10#2)
existing between##7##2##(1994-3#1)(1994-8#1)(2008-10#3)(2008-11#1)(2011-1#1)
existing chemical##4##2##(2008-10#3)(2011-1#1)
existing clinical##4##2##(2008-1#1)(2010-10#1)(2010-8#1)(2011-8#1)
existing data##10##2##(1994-1#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-10#1)(2012-12#1)(2013-1#1)
existing equipment##2##2##(1994-12#1)(1995-1#1)
existing evidence for##2##3##(2011-2#2)
existing evidence##7##2##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
existing experimental##2##2##(2008-2#1)(2010-10#1)
existing governance and information technology efforts were leveraged to minimize additional bioprocess resources required##2##14##(2012-2#2)
existing health care##3##3##(1995-1#1)(1996-2#1)(2008-11#1)
existing health##7##2##(1994-3#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-12#1)
existing in a##2##3##(1993-8#1)(2013-1#1)
existing in different##2##3##(2008-9#1)(2009-11#1)
existing in the##15##3##(1994-9#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2013-7#1)(2013-8#2)
existing in##28##2##(1993-5#1)(1993-8#1)(1994-9#1)(1995-5#1)(1997-6#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
existing information##3##2##(1995-1#1)(2008-11#1)(2010-10#1)
existing lesions##2##2##(1991-8#2)
existing lidar##2##2##(2008-3#2)
existing literature has##2##3##(2008-12#1)(2013-1#1)
existing literature on the##3##4##(1996-11#1)(2008-2#1)(2008-5#1)
existing literature on##6##3##(1992-12#1)(1993-12#1)(1996-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
existing literature##19##2##(1992-12#1)(1993-12#1)(1996-11#1)(1996-2#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#2)(2009-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
existing methods for##7##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#2)(2013-1#1)
existing methods##23##2##(1990-2#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#3)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
existing models of##3##3##(2007-11#1)(2008-7#1)(2009-9#1)
existing models##7##2##(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-9#1)
existing national##2##2##(2008-11#1)(2012-3#1)
existing problems##4##2##(2008-2#1)(2010-12#1)(2011-3#1)(2012-3#1)
existing programs##4##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
existing regulations##2##2##(1992-11#1)(1995-3#1)
existing research by##2##3##(2010-3#1)(2013-1#1)
existing research##4##2##(2008-11#1)(2008-6#1)(2010-3#1)(2013-1#1)
existing services##2##2##(1997-3#1)(2012-3#1)
existing statutory##2##2##(1995-6#1)(2008-11#1)
existing studies##3##2##(2008-6#1)(2009-12#1)(2012-2#1)
existing systems##3##2##(1997-3#1)(2008-7#1)(2010-8#1)
existing techniques##3##2##(2008-10#1)(2008-2#2)
existing theory##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
existing therapies##2##2##(2008-6#1)(2012-2#1)
existing versions of##2##3##(2008-10#1)(2008-2#1)
existing work##2##2##(2012-12#1)(2013-8#1)
existing##466##1##(1990-2#2)(1990-7#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#2)(1994-1#3)(1994-12#6)(1994-2#2)(1994-3#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#4)(2008-1#4)(2008-10#59)(2008-11#30)(2008-12#8)(2008-2#21)(2008-3#28)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#19)(2008-8#14)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#4)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#7)(2011-2#14)(2011-3#1)(2011-8#1)(2011-9#1)(2012-1#1)(2012-12#12)(2012-2#14)(2012-3#12)(2013-1#15)(2013-7#2)(2013-8#12)
exists a##20##2##(1990-12#1)(1990-5#2)(1991-8#1)(1992-2#1)(1992-9#1)(1994-12#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
exists about the##3##3##(2007-11#1)(2008-10#1)(2009-11#1)
exists among the##2##3##(1997-8#1)(2007-7#1)
exists among##6##2##(1996-12#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-8#1)
exists and##6##2##(1990-6#1)(1993-12#1)(2007-10#1)(2008-8#1)(2012-12#2)
exists as a dimer in the##2##6##(1992-3#1)(1997-7#1)
exists as a dimer##3##4##(1992-3#1)(1994-8#1)(1997-7#1)
exists as a##12##3##(1992-11#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-8#1)(1997-7#1)(2008-10#1)
exists as to the##2##4##(2010-10#1)(2013-1#1)
exists as to##3##3##(2010-10#1)(2013-1#2)
exists as two##2##3##(1993-11#1)(1995-11#1)
exists as##21##2##(1990-9#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-4#1)(2013-1#2)(2013-8#1)
exists at##5##2##(1991-9#1)(1993-12#1)(1993-3#1)(2008-3#1)(2008-8#1)
exists between phosphodiesterase inhibition and ischemic preconditioning##2##7##(2007-8#2)
exists between the##13##3##(1991-2#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2009-9#1)
exists between##38##2##(1990-2#1)(1991-2#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#4)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
exists demonstrating the##2##3##(2008-10#1)(2008-4#1)
exists demonstrating##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
exists for a##3##3##(1993-8#1)(2007-12#1)(2008-5#1)
exists for the##7##3##(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
exists for##23##2##(1993-12#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)
exists in a##4##3##(1993-8#1)(1994-11#1)(2012-3#1)(2013-1#1)
exists in an##2##3##(1995-6#1)(2008-9#1)
exists in both##2##3##(2008-11#1)(2009-11#1)
exists in common bean##2##4##(2008-10#1)(2013-8#1)
exists in equilibrium##2##3##(1992-5#1)(2012-2#1)
exists in most##2##3##(1994-3#1)(1996-2#1)
exists in multiple##2##3##(1990-6#1)(2013-8#1)
exists in the##17##3##(1992-6#1)(1993-3#2)(1994-12#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#1)(2013-1#1)
exists in these##3##3##(1990-3#1)(1997-6#1)(2008-10#1)
exists in two forms##3##4##(1991-12#1)(1993-8#1)(2008-10#1)
exists in two##5##3##(1991-12#1)(1991-3#1)(1993-8#1)(2008-10#1)(2008-5#1)
exists in##72##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-3#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
exists near##2##2##(2007-12#1)(2008-3#1)
exists on the##5##3##(1996-2#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
exists on##9##2##(1992-3#1)(1995-12#1)(1996-2#1)(2008-8#1)(2009-11#1)(2009-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
exists only in##2##3##(2009-8#1)(2010-5#1)
exists over##2##2##(1995-3#1)(2008-9#1)
exists regarding the##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
exists regarding##8##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-5#1)
exists that can##2##3##(2008-10#1)(2012-12#1)
exists that##13##2##(1990-12#1)(1993-11#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-9#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#3)(2012-12#1)
exists to support the##2##4##(2008-11#1)(2008-9#1)
exists to support##4##3##(1997-4#1)(2008-11#2)(2008-9#1)
exists to##10##2##(1991-9#1)(1992-6#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
exists when##3##2##(1992-4#1)(2008-3#1)(2012-2#1)
exists with##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
exists within the##4##3##(1994-8#1)(2008-10#2)(2012-12#1)
exists within##7##2##(1994-8#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2012-12#1)
exists##335##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-8#5)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#3)(1996-11#2)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#4)(2007-12#10)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#33)(2008-11#14)(2008-12#7)(2008-2#6)(2008-3#14)(2008-4#5)(2008-5#7)(2008-7#12)(2008-8#17)(2008-9#11)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#14)(2012-12#5)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#8)
exit aperture##3##2##(2008-10#1)(2008-3#2)
exit from the##6##3##(1990-7#1)(1994-3#1)(2008-3#2)(2009-6#1)(2012-12#1)
exit from##8##2##(1990-7#1)(1994-3#1)(2008-3#2)(2009-6#1)(2011-2#2)(2012-12#1)
exit of##3##2##(2008-2#2)(2009-10#1)
exit pupil##4##2##(2008-3#4)
exit site##14##2##(2007-12#5)(2007-7#5)(2008-5#1)(2011-2#3)
exit the##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
exit to##2##2##(1994-9#1)(2012-3#1)
exit voltage##2##2##(2008-10#2)
exit##65##1##(1990-3#1)(1990-7#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-1#3)(2007-12#5)(2007-7#6)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#16)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
exit-pupil##3##1##(2008-3#3)
exit-site cleansing##3##2##(2007-12#3)
exit-site infection##4##2##(2007-12#2)(2011-2#2)
exit-site##9##1##(2007-12#5)(2011-2#4)
exiting the top and the bottom of the atmosphere##2##9##(2008-2#2)
exiting the top##3##3##(2008-2#3)
exiting the##6##2##(2008-2#4)(2008-9#1)(2012-12#1)
exiting##11##1##(1996-5#1)(2008-2#6)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)
exits from##2##2##(2008-10#2)
exits##3##1##(2008-10#2)(2011-2#1)
exitsite##2##1##(2007-12#2)
exo##3##1##(1991-3#1)(1993-3#1)(1996-5#1)
exo- and##2##2##(1993-11#1)(1994-6#1)
exo-anomeric##2##1##(1990-5#1)(1992-12#1)
exo-antigen was##2##2##(2008-5#2)
exo-antigen##5##1##(2008-5#5)
exo-beta-1##13##1##(1992-11#2)(2008-10#11)
exoantigen##2##1##(2008-5#2)
exocarp##5##1##(2008-10#5)
exocellular##2##1##(1990-5#1)(1996-3#1)
exochitinase##4##1##(2008-10#4)
exocortis disease##2##2##(2008-10#2)
exocortis##7##1##(2008-10#7)
exocortis-like##3##1##(2008-10#3)
exocrine and endocrine##3##3##(2009-7#2)(2013-8#1)
exocrine pancreas##4##2##(2012-12#3)(2013-8#1)
exocrine pancreatic##4##2##(1992-11#1)(2008-8#1)(2012-12#2)
exocrine##13##1##(1992-11#1)(1993-3#1)(2007-10#1)(2008-8#1)(2009-7#2)(2012-12#5)(2013-8#2)
exocytic##2##1##(1997-7#1)(2012-2#1)
exocytosis and##5##2##(1993-11#1)(1997-7#1)(2010-11#2)(2012-12#1)
exocytosis in the##2##3##(1992-8#1)(1995-3#1)
exocytosis in##12##2##(1990-8#1)(1992-8#1)(1993-6#1)(1995-3#1)(2008-4#2)(2008-8#2)(2009-8#1)(2012-12#3)
exocytosis is##2##2##(2008-8#2)
exocytosis of##5##2##(1995-11#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-8#1)
exocytosis without##2##2##(1995-11#2)
exocytosis##54##1##(1990-8#2)(1992-6#3)(1992-8#1)(1993-11#4)(1993-6#1)(1995-11#5)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#5)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#5)(2011-2#1)(2012-12#7)(2012-2#1)
exocytotic process##2##2##(1992-7#1)(2008-4#1)
exocytotic##9##1##(1990-12#1)(1992-7#1)(1993-3#1)(1994-8#1)(2008-12#1)(2008-4#2)(2010-11#2)
exoenzyme C3##3##2##(1992-3#1)(1993-6#1)(1996-5#1)
exoenzyme##11##1##(1990-2#3)(1992-3#5)(1993-6#1)(1996-5#1)(2012-6#1)
exogastric##2##1##(1992-5#2)
exogenous ADP##3##2##(2008-7#3)
exogenous EFAs##2##2##(1994-11#2)
exogenous GH##3##2##(2008-1#2)(2010-5#1)
exogenous MLT was##2##3##(2013-7#2)
exogenous MLT##3##2##(2013-7#3)
exogenous VEGF(165)##2##2##(2008-9#2)
exogenous [3H]PtdIns##3##2##(1993-6#3)
exogenous addition of##2##3##(2008-10#2)
exogenous agents##2##2##(1994-5#1)(2008-12#1)
exogenous agonist##2##2##(1995-12#1)(2008-9#1)
exogenous alkylresorcinols##2##2##(2008-11#2)
exogenous application of##7##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#1)(2013-8#1)
exogenous cGMP##3##2##(2008-4#3)
exogenous cholesterol##2##2##(1992-6#1)(1994-8#1)
exogenous ethanol##2##2##(2008-7#1)(2011-2#1)
exogenous factors##8##2##(1990-2#1)(1990-8#1)(1991-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#1)
exogenous gene##6##2##(2008-8#3)(2008-9#3)
exogenous genes for##2##3##(1994-5#1)(2012-3#1)
exogenous genes##5##2##(1994-5#2)(1996-5#1)(2012-3#2)
exogenous glucose##2##2##(1992-9#1)(2011-1#1)
exogenous hTERT##2##2##(2008-11#2)
exogenous hormones##3##2##(2008-7#1)(2008-8#2)
exogenous insulin therapy##2##3##(2010-12#2)
exogenous insulin##4##2##(2010-11#1)(2010-12#2)(2012-2#1)
exogenous peptide##2##2##(1994-8#1)(2008-4#1)
exogenous plant##2##2##(2008-10#1)(2008-9#1)
exogenous signals##2##2##(2008-11#1)(2010-10#1)
exogenous substances##3##2##(1990-11#1)(2008-11#1)(2008-5#1)
exogenous substrate for##2##3##(1995-11#1)(2008-5#1)
exogenous substrate##4##2##(1990-10#1)(1991-2#1)(1995-11#1)(2008-5#1)
exogenous substrates##2##2##(1991-11#1)(2008-11#1)
exogenous surfactant will##2##3##(1997-1#2)
exogenous surfactant##5##2##(1997-1#3)(2008-8#2)
exogenous wt-p53##2##2##(1997-7#2)
exogenous##215##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#3)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-6#2)(1996-2#3)(1996-5#1)(1996-9#3)(1997-1#4)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#2)(2008-1#4)(2008-10#16)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#12)(2008-8#16)(2008-9#12)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#3)(2013-8#2)
exogenously added##8##2##(1990-11#2)(1992-9#1)(1993-6#1)(2008-11#2)(2008-4#2)
exogenously administered##2##2##(1995-2#1)(2008-7#1)
exogenously applied##3##2##(2008-2#2)(2011-10#1)
exogenously supplied##5##2##(1993-6#1)(2008-10#1)(2008-11#2)(2010-11#1)
exogenously##25##1##(1990-11#2)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1995-2#1)(2008-10#2)(2008-11#6)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-10#1)
exoglc1##4##1##(2008-10#4)
exoglucanase##3##1##(1997-1#3)
exoglycosidases##4##1##(1993-12#1)(2008-4#1)(2009-8#2)
exome##3##1##(2012-3#3)
exon 1 was##2##3##(1992-3#1)(2008-8#1)
exon 1##13##2##(1990-11#1)(1990-5#2)(1992-3#1)(1994-12#1)(2008-2#4)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
exon 11##3##2##(1990-8#1)(1991-12#1)(2013-1#1)
exon 14 and##2##3##(1993-11#1)(2008-10#1)
exon 16##2##2##(1990-7#1)(2008-7#1)
exon 19 of##2##3##(1990-7#2)
exon 19##4##2##(1990-7#4)
exon 2##5##2##(1990-12#1)(1991-1#1)(1991-2#1)(1993-6#1)(2008-12#1)
exon 3 of##2##3##(1991-1#1)(1993-6#1)
exon 3##8##2##(1991-1#1)(1991-2#1)(1992-8#1)(1993-6#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-2#1)
exon 4##5##2##(1990-5#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-12#1)
exon 5##4##2##(1997-7#1)(1997-8#2)(2011-1#1)
exon 6##3##2##(1991-12#1)(1993-8#1)(2008-10#1)
exon 7##6##2##(1993-3#2)(1993-8#2)(2008-7#1)(2009-8#1)
exon 8##4##2##(1993-8#2)(1994-12#1)(2008-7#1)
exon 9 of##2##3##(1997-7#1)(2008-12#1)
exon 9##5##2##(1995-12#2)(1997-7#1)(2008-12#2)
exon VIII##3##2##(1993-6#3)
exon and the##2##3##(1991-5#1)(1991-9#1)
exon and##8##2##(1990-11#1)(1990-8#1)(1991-5#2)(1991-6#1)(1991-9#1)(1993-2#1)(1993-6#1)
exon boundaries##2##2##(1997-7#1)(2008-9#1)
exon contains the##2##3##(1991-6#2)
exon of the##2##3##(1990-11#1)(2009-5#1)
exon of##5##2##(1990-11#1)(1997-8#1)(2009-5#1)(2012-1#1)(2012-3#1)
exon sequences##2##2##(1997-2#1)(2008-7#1)
exon shuffling##3##2##(1992-3#1)(1997-9#1)(2008-7#1)
exon structure of the##2##4##(1991-9#2)
exon trapping##2##2##(1996-2#1)(1997-2#1)
exon##140##1##(1990-11#3)(1990-12#1)(1990-5#3)(1990-7#8)(1990-8#4)(1991-1#2)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#5)(1991-9#3)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#8)(1993-8#10)(1994-12#6)(1994-8#1)(1994-9#1)(1995-12#3)(1995-6#2)(1996-10#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-7#7)(1997-8#4)(1997-9#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-12#6)(2008-2#5)(2008-7#7)(2008-8#2)(2008-9#4)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
exon-exon junctions##2##2##(1991-6#1)(2012-2#1)
exon-intron structure##2##2##(1993-3#2)
exon-intron##4##1##(1993-3#2)(1993-6#1)(1994-11#1)
exon/intron##3##1##(1992-3#1)(1996-8#1)(1997-8#1)
exonic##5##1##(1993-12#2)(1993-2#1)(1996-12#1)(1997-7#1)
exons 2##4##2##(1990-12#1)(1994-12#1)(1997-7#1)(2008-7#1)
exons 20##2##2##(1990-8#1)(2010-5#1)
exons 3a and 3b##2##4##(1993-11#2)
exons and three introns##2##4##(1994-11#1)(2010-5#1)
exons and##15##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-8#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#1)
exons encode##2##2##(1991-6#1)(1992-3#1)
exons encoding##2##2##(1991-6#1)(2008-7#1)
exons in the##3##3##(2008-4#2)(2008-8#1)
exons in##6##2##(1990-8#1)(2008-4#3)(2008-8#2)
exons interrupted by##3##3##(1991-6#1)(1993-3#1)(1994-12#1)
exons of the##3##3##(1992-10#1)(1992-8#1)(2010-12#1)
exons of##10##2##(1992-10#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-8#2)(2010-12#1)
exons separated by##2##3##(1992-12#1)(1994-12#1)
exons spanning##3##2##(1996-8#1)(1997-7#1)(2008-7#1)
exons that span##2##3##(1994-11#1)(1996-10#1)
exons that##3##2##(1993-6#1)(1994-11#1)(1996-10#1)
exons were##4##2##(1996-2#1)(1997-2#1)(1997-6#1)(2008-8#1)
exons which##4##2##(1993-2#1)(1997-2#1)(1997-6#1)(1997-8#1)
exons##127##1##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#5)(1991-2#1)(1991-5#2)(1991-6#8)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#5)(1993-8#5)(1994-11#4)(1994-12#6)(1995-8#4)(1996-10#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#9)(1997-6#3)(1997-7#3)(1997-8#3)(2008-10#1)(2008-12#2)(2008-4#7)(2008-7#9)(2008-8#5)(2008-9#6)(2009-9#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-3#1)
exonuclease III##4##2##(1994-12#2)(1995-5#1)(2008-8#1)
exonuclease activity##8##2##(1995-2#2)(1997-6#4)(1997-8#1)(2010-2#1)
exonuclease domain##2##2##(1997-6#1)(1997-8#1)
exonuclease domains##2##2##(1997-6#1)(1997-8#1)
exonuclease##23##1##(1991-9#1)(1994-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1997-6#8)(1997-8#4)(2008-10#1)(2008-8#1)(2010-2#2)
exophytic mass##2##2##(2012-12#1)(2012-3#1)
exophytic##5##1##(1991-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
exoplasmic loops##2##2##(1992-12#2)
exopolymer##3##1##(2008-10#2)(2011-2#1)
exopolysaccharide##3##1##(2008-10#1)(2008-6#2)
exoproteins##3##1##(1995-8#2)(1997-2#1)
exosite##2##1##(1990-7#1)(1993-11#1)
exoskeleton and##2##2##(2007-12#1)(2008-7#1)
exoskeleton##8##1##(1993-12#1)(2007-12#4)(2008-12#1)(2008-7#1)(2012-1#1)
exoskeletons##3##1##(2007-12#1)(2008-5#1)(2009-7#1)
exosomes and##2##2##(2009-2#2)
exosomes##6##1##(2009-2#3)(2010-12#1)(2012-2#1)(2013-8#1)
exostoses##4##1##(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)
exothermic and spontaneous nature of sorption##2##6##(2008-10#2)
exothermic and spontaneous nature of##3##5##(2008-10#3)
exothermic##9##1##(1990-7#1)(1990-8#1)(1996-2#1)(2008-10#5)(2011-1#1)
exotic felids##3##2##(2009-4#3)
exotic pathogen##2##2##(2008-10#1)(2009-2#1)
exotic species##4##2##(2008-5#1)(2010-3#3)
exotic##28##1##(2007-12#2)(2007-2#3)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#2)(2009-4#4)(2010-3#4)(2011-2#2)(2012-2#2)
exotics##2##1##(2008-9#2)
exotoxin A##4##2##(1993-3#1)(1997-4#1)(2008-10#2)
exotoxin##9##1##(1990-8#1)(1993-3#1)(1997-4#1)(2008-10#2)(2008-5#4)
exotoxins##2##1##(1994-2#1)(2011-2#1)
expand as##2##2##(2008-10#1)(2009-11#1)
expand in##2##2##(1997-3#1)(2008-5#1)
expand the current##2##3##(2008-10#1)(2010-11#1)
expand the knowledge##2##3##(2011-2#1)(2013-7#1)
expand the scope of##2##4##(1997-7#1)(2008-4#1)
expand the use of##2##4##(1994-2#1)(1996-12#1)
expand the##28##2##(1994-2#2)(1995-12#2)(1996-12#1)(1997-4#2)(1997-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
expand their##5##2##(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)
expand this##3##2##(1994-3#2)(1995-12#1)
expand to##2##2##(1990-8#1)(2008-1#1)
expand##84##1##(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-5#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#2)(1995-12#4)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-1#4)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-11#3)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
expandable##10##1##(1992-4#1)(1992-9#1)(2007-8#3)(2008-11#1)(2008-7#2)(2009-3#1)(2013-1#1)
expanded and##5##2##(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)
expanded as a##2##3##(2008-10#2)
expanded bed##2##2##(2008-4#1)(2008-6#1)
expanded beyond the##2##3##(2008-11#1)(2008-7#1)
expanded by##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
expanded during the past##3##4##(1991-12#1)(1992-3#1)(2008-9#1)
expanded for##2##2##(2007-11#1)(2007-12#1)
expanded from##3##2##(2008-11#1)(2008-5#1)(2008-6#1)
expanded graphite##3##2##(2008-10#3)
expanded in size##2##3##(2008-7#1)(2011-1#1)
expanded in##10##2##(1990-8#1)(1995-3#2)(2008-2#2)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
expanded inventory of##2##3##(2008-7#2)
expanded its clinical##2##3##(2008-5#1)(2011-7#1)
expanded its##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2011-7#1)
expanded measuring range##2##3##(2008-10#2)
expanded our understanding##2##3##(2009-10#1)(2009-8#1)
expanded the##2##2##(2008-8#1)(2010-8#1)
expanded their##3##2##(1996-2#1)(2010-4#2)
expanded to a##2##3##(2007-5#1)(2008-2#1)
expanded to include##5##3##(1991-9#1)(1995-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
expanded to the##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
expanded to##24##2##(1990-6#1)(1991-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-9#1)(2012-2#1)(2013-1#1)
expanded uncertainties##3##2##(2008-10#2)(2008-2#1)
expanded uncertainty##5##2##(2008-10#5)
expanded use of##2##3##(1994-12#1)(2008-2#1)
expanded with##4##2##(2008-5#1)(2008-8#1)(2010-10#1)(2010-6#1)
expanded##188##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-9#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-12#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#31)(2008-11#11)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#8)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#1)(2011-7#1)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
expanded-bed##3##1##(2008-4#1)(2008-6#2)
expander##6##1##(1992-5#1)(1993-11#1)(2008-3#2)(2011-2#1)(2013-1#1)
expanders##3##1##(1992-9#1)(2008-3#1)(2011-2#1)
expanding access to care##2##4##(1996-3#1)(2012-3#1)
expanding access to##6##3##(1996-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
expanding and##4##2##(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
expanding areas of##2##3##(1996-3#1)(2010-7#1)
expanding culture is washed##2##4##(2008-8#2)
expanding drop##2##2##(2008-10#2)
expanding field of##2##3##(1994-5#1)(1994-9#1)
expanding field##5##2##(1994-3#1)(1994-5#1)(1994-9#1)(2008-5#1)(2008-7#1)
expanding limits##2##2##(2012-3#2)
expanding list of##2##3##(2007-7#1)(2013-1#1)
expanding role of##2##3##(1996-2#1)(2009-4#1)
expanding the##16##2##(1993-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)
expanding##91##1##(1990-4#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#4)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#6)(2013-1#4)(2013-8#1)
expands on the##2##3##(2007-5#1)(2008-1#1)
expands our##2##2##(2008-11#1)(2012-2#1)
expands the##5##2##(1991-5#1)(2008-10#2)(2008-8#1)(2011-1#1)
expands upon##2##2##(2008-4#1)(2012-12#1)
expands##27##1##(1991-3#1)(1991-5#1)(1992-7#1)(1993-8#1)(1995-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#2)(2009-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
expansa##8##1##(1993-6#2)(2008-10#6)
expanse of##2##2##(2006-12#1)(2008-9#1)
expansile##2##1##(2013-1#2)
expansion and the##2##3##(2008-2#1)(2009-8#1)
expansion and##22##2##(1994-11#1)(1995-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-8#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
expansion as well as##2##4##(2008-3#1)(2008-7#1)
expansion as##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
expansion at##3##2##(1997-3#1)(2008-2#1)(2008-8#1)
expansion by##2##2##(1994-10#1)(2011-2#1)
expansion coefficients of the##2##4##(2007-11#1)(2008-2#1)
expansion during##4##2##(2009-10#2)(2010-11#1)(2010-8#1)
expansion for##2##2##(2008-10#1)(2009-5#1)
expansion from##2##2##(2008-12#1)(2011-2#1)
expansion has##2##2##(1992-5#1)(2012-12#1)
expansion in the##4##3##(2007-7#1)(2008-2#1)(2010-8#1)(2013-1#1)
expansion in##11##2##(1990-6#1)(1994-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-8#1)(2013-1#1)
expansion into##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
expansion is used##2##3##(2008-3#1)(2008-6#1)
expansion is##4##2##(1992-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
expansion method##2##2##(2008-11#1)(2012-2#1)
expansion of antigen-specific##3##3##(2008-11#1)(2012-12#1)(2012-2#1)
expansion of brain##2##3##(2007-10#1)(2012-3#1)
expansion of hematopoietic cells##2##4##(2008-11#2)
expansion of hematopoietic##4##3##(2008-11#4)
expansion of human hematopoietic##2##4##(2008-11#2)
expansion of human##3##3##(2008-11#2)(2008-8#1)
expansion of managed care##2##4##(1991-3#1)(1994-3#1)
expansion of the##34##3##(1993-1#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
expansion of##107##2##(1991-12#1)(1991-3#2)(1992-12#1)(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#13)(2008-11#18)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
expansion order##4##2##(2008-2#4)
expansion to the##2##3##(2008-10#1)(2009-1#1)
expansion to##4##2##(2008-10#1)(2008-4#1)(2009-1#1)(2009-6#1)
expansion was##2##2##(2008-7#1)(2011-2#1)
expansion with##2##2##(2008-3#1)(2008-8#1)
expansion##268##1##(1990-6#1)(1991-12#1)(1991-3#4)(1992-1#1)(1992-12#1)(1992-5#2)(1993-1#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#4)(1997-4#2)(1997-5#1)(2006-10#1)(2007-10#3)(2007-11#6)(2007-12#10)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#43)(2008-11#24)(2008-12#3)(2008-2#16)(2008-3#21)(2008-4#5)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#3)(2009-10#4)(2009-11#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#10)(2011-8#1)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#3)
expansion-survival trade-off##2##2##(2008-8#2)
expansions of##2##2##(2008-8#1)(2010-1#1)
expansions##15##1##(1992-11#1)(1995-12#2)(1996-1#1)(1996-2#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-1#2)(2010-1#2)(2010-7#1)
expansive growth##2##2##(2013-1#2)
expansive lesions##2##2##(1993-3#1)(1995-11#1)
expansive##10##1##(1993-3#1)(1994-3#1)(1995-11#1)(2007-12#1)(2008-7#1)(2009-3#1)(2010-4#1)(2013-1#3)
expansum and##3##2##(2008-10#3)
expansum conidia##2##2##(2008-10#2)
expansum on##2##2##(2008-10#2)
expansum##25##1##(2008-10#25)
expatriate personnel##2##2##(2007-2#2)
expect a##3##2##(1996-3#1)(2007-11#1)(2008-11#1)
expect and##3##2##(1990-8#2)(1997-3#1)
expect better##2##2##(2011-1#1)(2011-2#1)
expect from##2##2##(2008-7#1)(2009-9#1)
expect in the##2##3##(1996-2#1)(2013-7#1)
expect that the##4##3##(1991-5#1)(1992-6#1)(2008-1#1)(2011-2#1)
expect that##13##2##(1991-5#1)(1992-6#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
expect the##5##2##(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
expect them to##2##3##(1997-7#1)(2010-4#1)
expect to see##3##3##(1995-12#1)(1996-2#1)(2008-8#1)
expect to##13##2##(1994-12#1)(1995-12#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-7#1)(2013-8#1)
expect##67##1##(1990-8#2)(1991-5#1)(1992-6#1)(1993-1#1)(1994-12#3)(1994-3#2)(1995-12#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
expect?##2##1##(1993-2#2)
expectancies for##5##2##(1994-2#1)(2008-11#1)(2011-2#2)(2013-8#1)
expectancies were##2##2##(2008-11#1)(2013-8#1)
expectancies##21##1##(1994-2#4)(2008-11#3)(2008-8#1)(2010-3#1)(2011-1#3)(2011-2#3)(2013-8#6)
expectancy and quality of life##2##5##(2011-2#1)(2012-12#1)
expectancy and##5##2##(2008-11#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-12#1)
expectancy as##5##2##(1994-2#2)(1996-3#1)(1996-6#1)(2008-7#1)
expectancy in##10##2##(1993-1#1)(1996-11#1)(1996-3#3)(1997-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)
expectancy is##3##2##(1997-6#1)(2008-11#1)(2008-7#1)
expectancy were##2##2##(1996-3#1)(2008-11#1)
expectancy##69##1##(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-2#5)(1994-6#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-3#9)(1996-6#1)(1996-8#1)(1997-6#3)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-12#2)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
expectancy)##2##1##(2010-4#1)(2012-12#1)
expectant management of##2##3##(2011-1#1)(2013-8#1)
expectant management##4##2##(2008-10#1)(2011-1#2)(2013-8#1)
expectant mothers##3##2##(1991-12#1)(1992-12#1)(2009-4#1)
expectant##9##1##(1991-12#1)(1992-12#1)(2007-2#2)(2008-10#1)(2009-4#1)(2011-1#2)(2013-8#1)
expectation for##3##2##(1991-1#1)(2008-10#1)(2012-3#1)
expectation in##2##2##(1991-8#1)(2008-10#1)
expectation of the##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
expectation of##7##2##(1990-10#1)(1992-3#1)(1994-3#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)
expectation that##6##2##(1992-8#1)(1997-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
expectation values##2##2##(2007-11#1)(2008-10#1)
expectation##46##1##(1990-10#1)(1991-1#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#2)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
expectation-maximization (EM) approach##2##3##(2008-2#1)(2010-8#1)
expectation-maximization (EM)##3##2##(2008-2#1)(2010-8#1)(2012-3#1)
expectations about##4##2##(1992-12#1)(1993-12#1)(1995-2#2)
expectations and the##2##3##(2008-9#2)
expectations and youth's##2##3##(2009-7#2)
expectations and##15##2##(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#2)(1997-1#1)(1997-8#1)(2008-12#1)(2008-9#3)(2009-11#1)(2009-7#2)(2013-1#1)
expectations are##2##2##(1995-1#1)(2009-7#1)
expectations at##2##2##(2008-5#1)(2009-7#1)
expectations based on the##2##4##(1995-2#1)(2007-11#1)
expectations for a##2##3##(2008-10#1)(2008-9#1)
expectations for the##2##3##(1995-12#1)(2007-8#1)
expectations for##13##2##(1991-1#1)(1992-1#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
expectations from a##2##3##(2008-10#1)(2011-2#1)
expectations from##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
expectations in##2##2##(2008-6#1)(2012-12#1)
expectations of a##3##3##(2008-9#1)(2010-10#1)(2013-1#1)
expectations of the multidisciplinary pain rehabilitation programme##2##7##(2013-1#2)
expectations of the rehabilitation##2##4##(2013-1#2)
expectations of the##10##3##(1995-1#2)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#5)
expectations of##43##2##(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-2#1)(1996-3#3)(1997-1#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-5#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#10)
expectations on##2##2##(2009-7#2)
expectations over time##2##3##(2008-9#2)
expectations regarding the##3##3##(1993-6#1)(2007-4#1)(2008-7#1)
expectations regarding##4##2##(1993-6#1)(2007-4#1)(2008-7#1)(2011-2#1)
expectations that students##2##3##(2010-3#1)(2012-1#1)
expectations that##6##2##(1993-2#1)(1995-3#1)(1997-1#1)(2010-3#1)(2012-1#1)(2012-12#1)
expectations to##3##2##(2008-12#1)(2010-9#1)(2011-2#1)
expectations when##2##2##(2011-2#2)
expectations##182##1##(1991-1#2)(1991-6#1)(1992-1#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#3)(1994-2#3)(1994-3#1)(1995-1#6)(1995-12#3)(1995-2#8)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#6)(1997-1#4)(1997-2#3)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#10)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#14)(2009-11#1)(2009-5#1)(2009-7#7)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#15)(2013-8#1)
expected a##2##2##(2008-11#1)(2012-12#1)
expected and observed##4##3##(2008-10#1)(2008-9#2)(2013-8#1)
expected and##8##2##(1991-12#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-9#2)(2013-8#1)
expected at##2##2##(2008-2#1)(2008-5#1)
expected based on##3##3##(1991-2#1)(1995-1#1)(2008-10#1)
expected based##5##2##(1991-2#1)(1992-6#1)(1995-1#1)(2008-10#1)(2008-11#1)
expected because of##2##3##(2008-10#1)(2008-3#1)
expected because the##2##3##(1995-11#1)(2008-7#1)
expected because##5##2##(1995-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
expected biological##2##2##(2008-10#1)(2012-1#1)
expected by##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
expected changes in##2##3##(1991-1#1)(1997-2#1)
expected changes##4##2##(1991-1#1)(1997-2#1)(2008-1#2)
expected during##2##2##(1990-8#1)(2008-5#1)
expected effects of##2##3##(2007-11#1)(2008-3#1)
expected effects##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
expected for a##8##3##(1990-7#1)(1992-3#1)(1993-11#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)
expected for an##2##3##(1992-3#1)(2007-11#1)
expected for the##6##3##(1992-11#1)(1992-3#2)(2008-3#1)(2008-5#1)(2013-8#1)
expected for##35##2##(1990-7#1)(1992-11#1)(1992-3#5)(1993-11#1)(1994-5#1)(1995-8#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
expected frequency##2##2##(1995-2#1)(1997-2#1)
expected from a##2##3##(1994-3#1)(2008-10#1)
expected from the##12##3##(1990-7#1)(1992-12#2)(1992-8#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
expected from##34##2##(1990-7#1)(1992-12#2)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)
expected future##2##2##(2008-8#2)
expected genetic diversity##2##3##(2008-10#2)
expected genetic##3##2##(2008-10#2)(2010-5#1)
expected growth##2##2##(2008-9#1)(2011-1#1)
expected heterozygosities##2##2##(2011-2#1)(2012-1#1)
expected heterozygosity##3##2##(2008-5#1)(2013-8#2)
expected high##2##2##(2008-3#1)(2009-3#1)
expected if##2##2##(1990-5#1)(2008-9#1)
expected in a##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
expected in normal##2##3##(1990-12#1)(1994-8#1)
expected in the general population##2##5##(2008-7#2)
expected in the##11##3##(1991-3#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-8#2)
expected in this##2##3##(2008-11#1)(2008-2#1)
expected in##37##2##(1990-12#1)(1991-3#1)(1992-2#2)(1993-1#1)(1993-5#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2011-1#1)(2012-3#1)(2013-8#1)
expected mortality##2##2##(1994-12#1)(2007-8#1)
expected not##2##2##(2009-7#1)(2010-11#1)
expected number of##4##3##(1990-9#1)(2008-10#2)(2011-2#1)
expected numbers##2##2##(2008-10#2)
expected of##4##2##(1992-12#1)(1992-6#1)(2007-4#1)(2008-9#1)
expected on the basis of the##3##6##(1992-5#2)(1993-9#1)
expected on the basis of##5##5##(1990-5#1)(1991-2#1)(1992-5#2)(1993-9#1)
expected outcome##2##2##(1997-1#1)(2008-9#1)
expected outcomes##5##2##(1993-3#1)(1994-3#1)(1996-1#1)(2008-3#1)(2010-6#1)
expected performance of##2##3##(2008-2#1)(2008-3#1)
expected performance##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
expected potential##2##2##(2009-3#2)
expected results and##2##3##(2008-10#1)(2008-9#1)
expected results##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
expected runtime##4##2##(2010-2#4)
expected size##4##2##(1992-8#1)(1993-8#1)(1995-9#1)(2008-10#1)
expected sizes##3##2##(1991-5#1)(1995-12#1)(2008-10#1)
expected that it will##2##4##(1990-2#1)(2008-10#1)
expected that it##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
expected that the##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
expected that this##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
expected that##29##2##(1990-12#1)(1990-2#1)(1991-1#1)(1994-3#1)(1994-5#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
expected the##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
expected time to extinction##3##4##(2008-9#3)
expected time to##4##3##(2008-5#1)(2008-9#3)
expected time##6##2##(2008-10#1)(2008-5#2)(2008-9#3)
expected to achieve##2##3##(1994-2#1)(2008-11#1)
expected to arise##3##3##(2008-4#1)(2010-5#1)(2012-3#1)
expected to assume##2##3##(1995-1#1)(2010-10#1)
expected to be more##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
expected to be useful##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
expected to be##42##3##(1992-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-9#3)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
expected to become##2##3##(1994-2#1)(2008-6#1)
expected to contribute to the##2##5##(1992-12#1)(1996-6#1)
expected to depend on##3##4##(2008-7#2)(2012-12#1)
expected to evolve##2##3##(2008-8#1)(2010-8#1)
expected to form##3##3##(2008-3#1)(2008-6#2)
expected to have a##4##4##(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
expected to have##13##3##(1994-6#1)(1995-5#1)(1997-4#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
expected to identify##2##3##(1994-12#1)(2008-8#1)
expected to improve the##2##4##(2008-10#2)
expected to improve##5##3##(1997-6#1)(2008-1#1)(2008-10#2)(2010-8#1)
expected to increase##7##3##(1991-12#1)(1994-9#1)(1996-11#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
expected to occur##2##3##(2008-7#1)(2012-12#1)
expected to play a##2##4##(2008-3#1)(2010-8#1)
expected to play##3##3##(2008-3#1)(2008-4#1)(2010-8#1)
expected to produce##3##3##(1993-11#1)(1994-5#1)(2008-6#1)
expected to provide##4##3##(1991-3#1)(2008-3#2)(2012-3#1)
expected to reach##2##3##(1992-6#1)(2012-2#1)
expected to remain##3##3##(1994-5#1)(1996-5#1)(2010-5#1)
expected to replace##2##3##(1995-1#1)(2012-3#1)
expected to respond to##2##4##(2008-12#1)(2009-2#1)
expected to respond##3##3##(2008-12#1)(2008-8#1)(2009-2#1)
expected to yield##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
expected to##201##2##(1990-12#1)(1991-1#2)(1991-12#1)(1991-3#2)(1992-12#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-4#4)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#14)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#14)(2008-8#4)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#9)(2013-8#1)
expected under##3##2##(2008-10#3)
expected value##3##2##(1997-4#1)(2008-10#1)(2008-6#1)
expected values of##2##3##(1990-6#1)(2012-3#1)
expected values##6##2##(1990-6#1)(1995-5#1)(2007-7#1)(2008-10#2)(2012-3#1)
expected waiting time##2##3##(1994-2#2)
expected with respect to##2##4##(1994-12#1)(2008-2#1)
expected with##6##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-10#1)
expected##764##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#4)(1991-12#7)(1991-2#4)(1991-3#4)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#8)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#2)(1993-1#4)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#5)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#4)(1994-5#8)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#4)(1997-8#4)(2006-12#1)(2007-10#1)(2007-11#12)(2007-12#15)(2007-4#2)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#101)(2008-11#35)(2008-12#6)(2008-2#16)(2008-3#54)(2008-4#6)(2008-5#29)(2008-6#13)(2008-7#33)(2008-8#24)(2008-9#31)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#4)(2010-8#7)(2011-1#6)(2011-2#15)(2012-1#5)(2012-12#13)(2012-2#9)(2012-3#14)(2012-7#2)(2013-1#18)(2013-7#2)(2013-8#9)
expectedly##2##1##(2008-3#1)(2011-2#1)
expecting an##2##2##(1997-4#1)(1997-8#1)
expecting##7##1##(1997-4#1)(1997-8#1)(2007-10#1)(2008-5#1)(2010-10#1)(2010-8#2)
expectorant##2##1##(1996-1#2)
expectoration##6##1##(1991-11#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)
expects to launch##2##3##(2008-5#2)
expects to##5##2##(1994-1#1)(2008-5#3)(2008-7#1)
expects##8##1##(1993-1#1)(1994-1#1)(2008-5#4)(2008-7#1)(2010-12#1)
expedient and##2##2##(1993-1#1)(1996-2#1)
expedient##4##1##(1993-1#1)(1996-2#1)(2010-2#1)(2012-12#1)
expedite the##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
expedite##8##1##(1992-2#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
expedited##3##1##(1997-2#1)(2007-9#1)(2008-10#1)
expediting##2##1##(2008-3#1)(2010-12#1)
expeditions##2##1##(2009-10#2)
expeditious##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
expeditiously##2##1##(2007-12#1)(2008-10#1)
expelled##2##1##(2008-7#1)(2008-8#1)
expended on##2##2##(2011-2#1)(2013-7#1)
expended##4##1##(1992-9#1)(2008-2#1)(2011-2#1)(2013-7#1)
expenditure and##8##2##(1991-2#1)(1992-5#1)(1993-12#1)(2008-1#1)(2008-4#2)(2012-2#1)(2013-7#1)
expenditure estimates##3##2##(1992-3#1)(1995-12#1)(1996-3#1)
expenditure for##2##2##(1991-2#1)(2012-2#1)
expenditure in##5##2##(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)
expenditure of##5##2##(1990-11#1)(1994-2#1)(2010-8#2)(2013-8#1)
expenditure on food##2##3##(2012-2#2)
expenditure on##8##2##(1993-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#2)(2013-1#2)
expenditure to##2##2##(1995-12#1)(2012-2#1)
expenditure was##2##2##(2008-9#1)(2013-8#1)
expenditure##102##1##(1990-11#1)(1991-1#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#2)(2008-9#6)(2010-8#9)(2011-1#3)(2012-1#2)(2012-2#6)(2013-1#8)(2013-7#2)(2013-8#3)
expenditures and##11##2##(1992-1#1)(1992-12#2)(1992-2#1)(1995-12#1)(1996-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
expenditures are##3##2##(1993-2#1)(2008-7#1)(2013-1#1)
expenditures associated with thyroid disorders##2##5##(2013-1#2)
expenditures by##4##2##(1995-2#1)(1996-1#1)(1997-3#1)(2010-12#1)
expenditures for##18##2##(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#3)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-11#1)(2009-5#1)
expenditures from##2##2##(1994-3#1)(1995-2#1)
expenditures grow##2##2##(1993-3#1)(1996-2#1)
expenditures have##2##2##(1992-2#1)(1997-2#1)
expenditures in the United States##2##5##(1993-3#1)(1995-1#1)
expenditures in##9##2##(1991-12#1)(1991-2#1)(1992-1#2)(1993-3#1)(1994-2#1)(1995-1#1)(1997-1#1)(2008-7#1)
expenditures of##4##2##(1992-12#1)(1994-1#1)(1994-2#1)(1997-1#1)
expenditures on health##2##3##(1990-11#1)(2013-7#1)
expenditures on##6##2##(1990-11#1)(1994-2#2)(1997-1#1)(2009-3#1)(2013-7#1)
expenditures per##2##2##(1993-12#1)(1995-1#1)
expenditures than##2##2##(1991-12#2)
expenditures through##3##2##(1992-3#1)(1993-3#1)(1996-2#1)
expenditures to##3##2##(1992-12#1)(1992-3#1)(2013-1#1)
expenditures was##2##2##(2013-1#2)
expenditures were##5##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)(2011-2#1)
expenditures##152##1##(1990-11#1)(1990-2#2)(1991-12#5)(1991-2#5)(1991-3#3)(1992-1#4)(1992-12#8)(1992-2#3)(1992-3#13)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#10)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#10)(1994-3#3)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#6)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#7)(1997-2#1)(1997-3#5)(2008-11#4)(2008-12#1)(2008-7#3)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#15)(2013-7#4)(2013-8#1)
expense and##2##2##(1996-3#1)(2008-12#1)
expense in##2##2##(1996-2#1)(2008-12#1)
expense is##2##2##(1990-11#1)(2008-3#1)
expense of##25##2##(1990-9#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
expense##48##1##(1990-11#1)(1990-9#1)(1992-1#1)(1993-12#1)(1994-1#4)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-2#3)(1996-3#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
expenses and##5##2##(1995-3#1)(1997-1#1)(2008-11#2)(2008-12#1)
expenses are##2##2##(1991-6#1)(1994-1#1)
expenses for##4##2##(1994-7#1)(2007-12#1)(2008-12#1)(2010-8#1)
expenses of##4##2##(1993-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
expenses that##2##2##(1992-1#1)(1992-12#1)
expenses to##2##2##(2008-12#1)(2009-8#1)
expenses##61##1##(1990-11#1)(1990-12#2)(1990-4#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#3)(1993-1#2)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(2007-12#1)(2007-4#1)(2008-11#6)(2008-12#7)(2008-3#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
expensive alternatives##2##2##(1992-1#1)(1993-11#1)
expensive and time consuming##2##4##(1994-1#1)(2008-12#1)
expensive and##20##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
expensive cases##2##2##(1992-12#2)
expensive commercial##2##2##(2008-10#2)
expensive drugs##4##2##(1997-6#1)(2008-11#1)(2010-4#1)(2010-5#1)
expensive equipment##2##2##(2009-5#1)(2009-6#1)
expensive in##3##2##(1993-3#1)(1994-12#1)(2008-10#1)
expensive or##3##2##(2008-2#1)(2010-11#1)(2013-7#1)
expensive than##7##2##(1994-12#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
expensive##125##1##(1990-3#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#3)(1994-3#2)(1994-8#1)(1995-12#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-5#1)(1997-1#2)(1997-4#2)(1997-6#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#20)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
experience a##16##2##(1992-5#1)(1994-11#1)(1997-4#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
experience about the##3##3##(1992-5#1)(1996-2#1)(2012-2#1)
experience about##4##2##(1990-5#1)(1992-5#1)(1996-2#1)(2012-2#1)
experience also##2##2##(1996-1#1)(2008-6#1)
experience an##3##2##(1994-6#1)(2008-7#2)
experience and data##2##3##(1990-8#1)(1993-9#1)
experience and that##2##3##(2008-11#1)(2009-9#1)
experience and the##7##3##(1992-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
experience and training##2##3##(1994-12#1)(2008-9#1)
experience and##73##2##(1990-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
experience are not##2##3##(2008-4#1)(2012-3#1)
experience are##5##2##(1992-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#1)
experience as a##8##3##(1994-12#1)(1994-2#1)(1995-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#1)
experience as##12##2##(1994-12#1)(1994-2#1)(1995-3#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#2)
experience at a tertiary care##2##5##(2008-6#1)(2013-8#1)
experience at a##4##3##(2008-6#2)(2010-11#1)(2013-8#1)
experience at one u##2##4##(2013-1#2)
experience at the##8##3##(1990-10#1)(1991-2#1)(1992-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-9#1)(2011-2#1)
experience at##22##2##(1990-10#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-3#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
experience both##3##2##(1995-11#1)(2007-2#1)(2008-2#1)
experience by##4##2##(1995-11#1)(1995-8#1)(2008-11#1)(2008-6#1)
experience can be##2##3##(1993-12#1)(2008-5#1)
experience caring for##2##3##(2008-11#2)
experience challenges##2##2##(2007-2#1)(2012-3#1)
experience chemotherapy-induced##2##2##(2008-7#2)
experience demonstrates that##3##3##(1991-6#1)(2007-8#1)(2008-10#1)
experience demonstrates##4##2##(1991-6#1)(1995-2#1)(2007-8#1)(2008-10#1)
experience difficulties##2##2##(2008-12#1)(2010-10#1)
experience during##4##2##(1994-3#1)(1995-1#1)(2008-11#1)(2009-9#1)
experience for the##4##3##(1992-12#1)(1994-1#2)(2008-12#1)
experience for##8##2##(1992-12#1)(1992-6#1)(1993-1#1)(1994-1#2)(2008-11#1)(2008-12#2)
experience from a##2##3##(2008-3#1)(2013-8#1)
experience from the##4##3##(1990-11#1)(1996-12#1)(2008-10#1)(2010-3#1)
experience from##17##2##(1990-11#1)(1992-6#1)(1995-3#1)(1996-12#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
experience gained during##2##3##(1995-2#1)(2008-6#1)
experience gained##6##2##(1992-5#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
experience has been##4##3##(2008-11#2)(2008-7#1)(2008-9#1)
experience has shown that##2##4##(1997-2#1)(2008-10#1)
experience has##8##2##(1997-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2011-2#1)
experience having##3##2##(1997-2#1)(2012-3#2)
experience higher levels of##2##4##(2007-12#1)(2008-8#1)
experience higher rates of##2##4##(2008-9#1)(2013-1#1)
experience higher##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
experience in a##5##3##(1993-9#1)(1997-3#1)(2007-8#1)(2008-11#1)(2010-11#1)
experience in developing##2##3##(1996-12#1)(2010-12#1)
experience in health##2##3##(1994-2#1)(1996-2#1)
experience in mitral valve repair using the Cosgrove-Edwards annuloplasty ring##2##10##(2007-8#2)
experience in the field of TBI##2##6##(2007-4#2)
experience in the field of##3##5##(1990-3#1)(2007-4#2)
experience in the##17##3##(1990-3#2)(1990-5#1)(1991-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-4#2)(2008-10#2)(2008-11#1)(2010-3#1)(2011-2#3)
experience in treating##3##3##(1991-9#1)(1992-3#1)(2013-1#1)
experience in##94##2##(1990-3#2)(1990-5#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-9#5)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-2#2)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#2)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#4)
experience increased##2##2##(2008-3#1)(2010-9#1)
experience indicate that##2##3##(2007-11#1)(2010-12#1)
experience indicate##3##2##(1990-10#1)(2007-11#1)(2010-12#1)
experience indicates that##2##3##(2008-7#1)(2013-1#1)
experience indicates##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
experience into##2##2##(2008-11#2)
experience is##14##2##(1991-3#1)(1991-6#1)(1992-11#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-11#3)(2008-7#1)(2011-2#1)(2013-1#1)
experience may be##2##3##(1997-8#1)(2008-11#1)
experience may##5##2##(1992-12#1)(1994-3#1)(1997-8#1)(2008-11#2)
experience might##2##2##(1990-8#1)(2010-4#1)
experience more##7##2##(1997-2#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
experience of HIV/AIDS##2##3##(2008-1#2)
experience of SIP##2##3##(1993-6#2)
experience of a##14##3##(1990-3#1)(1991-9#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-3#2)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
experience of biliary##2##3##(1990-5#1)(1993-9#1)
experience of black fathers concerning support for their wives/partners during labour##2##11##(2010-3#2)
experience of childbirth##2##3##(1995-1#1)(2007-2#1)
experience of family##2##3##(1991-12#1)(2008-11#1)
experience of one##4##3##(1993-12#1)(1994-12#1)(2008-12#1)(2009-2#1)
experience of social support after the death of a child##2##10##(2009-5#2)
experience of social##3##3##(1996-11#1)(2009-5#2)
experience of stress##3##3##(1996-9#1)(2009-7#1)(2012-1#1)
experience of such##2##3##(1990-2#1)(2007-8#1)
experience of the surgeon##3##4##(1996-12#1)(2009-5#1)(2011-1#1)
experience of the treatment of##2##5##(1992-5#1)(1993-9#1)
experience of the##37##3##(1990-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-6#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
experience of this##2##3##(2010-6#1)(2011-2#1)
experience of undertaking##2##3##(2008-11#2)
experience of using##2##3##(2008-10#1)(2008-7#1)
experience of##192##2##(1990-11#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#3)(1994-1#4)(1994-11#1)(1994-12#3)(1994-2#1)(1995-1#3)(1995-10#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-9#4)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-8#3)(2008-1#6)(2008-10#6)(2008-11#13)(2008-12#11)(2008-2#1)(2008-3#4)(2008-6#4)(2008-7#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#7)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)
experience on the##5##3##(1990-9#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-7#1)
experience on##15##2##(1990-12#1)(1990-3#2)(1990-9#1)(1993-9#1)(1995-12#1)(1995-3#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-8#2)(2009-7#1)
experience or##5##2##(2011-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
experience reported##3##2##(1991-2#1)(1994-9#1)(1995-1#1)
experience should not be##2##4##(1993-3#1)(1996-1#1)
experience should##3##2##(1993-3#1)(1996-1#1)(2008-7#1)
experience show##2##2##(1990-3#1)(2011-3#1)
experience shows that##2##3##(2007-8#1)(2010-9#1)
experience suggests that##4##3##(1993-3#1)(2009-5#1)(2012-2#1)(2013-8#1)
experience suggests##5##2##(1992-2#1)(1993-3#1)(2009-5#1)(2012-2#1)(2013-8#1)
experience supports##2##2##(1991-1#1)(2008-7#1)
experience symptoms of##2##3##(2012-12#1)(2013-1#1)
experience symptoms##3##2##(1995-11#1)(2012-12#1)(2013-1#1)
experience that##4##2##(1994-12#1)(2008-1#1)(2008-4#1)(2009-6#1)
experience the##8##2##(1991-12#1)(1991-3#1)(1992-5#1)(1996-9#1)(2008-9#1)(2009-7#1)(2010-9#1)(2012-3#1)
experience their##2##2##(1994-3#1)(1997-2#1)
experience to be##2##3##(2008-12#2)
experience to date##3##3##(1996-2#1)(2008-8#1)(2012-1#1)
experience to##14##2##(1994-3#1)(1996-2#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-8#1)(2012-1#1)
experience using the##2##3##(1991-3#1)(2007-8#1)
experience using##6##2##(1991-3#1)(2007-8#1)(2010-6#2)(2011-2#1)(2013-7#1)
experience was a##3##3##(2008-1#1)(2008-12#2)
experience was##6##2##(2008-1#1)(2008-12#2)(2010-8#1)(2012-1#1)(2013-1#1)
experience were##3##2##(1992-7#1)(2008-11#1)(2008-12#1)
experience when##2##2##(2007-11#1)(2008-1#1)
experience will##2##2##(1994-3#1)(2008-10#1)
experience with 2##2##3##(1997-2#1)(2007-12#1)
experience with a##5##3##(1992-8#1)(1994-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
experience with an##4##3##(1990-12#1)(1997-7#1)(2008-11#1)(2008-7#1)
experience with imipenem-cilastatin in##2##4##(1991-2#2)
experience with other##2##3##(1992-12#1)(1995-5#1)
experience with the first##2##4##(1996-2#1)(1996-8#1)
experience with the use of##5##5##(1990-8#1)(2007-8#1)(2008-12#1)(2008-8#1)(2012-3#1)
experience with the##20##3##(1990-8#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#1)
experience with this##7##3##(1993-3#1)(1996-1#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2012-2#1)
experience with##126##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-5#3)(1992-8#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#2)(2006-7#1)(2007-11#3)(2007-12#4)(2007-5#2)(2007-6#1)(2007-8#7)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#2)(2008-3#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#7)(2009-11#2)(2010-11#2)(2010-3#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#7)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
experience##1248##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#11)(1990-5#4)(1990-6#2)(1990-8#5)(1990-9#5)(1991-1#3)(1991-11#1)(1991-12#11)(1991-2#11)(1991-3#7)(1991-5#3)(1991-6#6)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#10)(1992-2#12)(1992-3#5)(1992-4#1)(1992-5#9)(1992-6#3)(1992-7#4)(1992-8#5)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#13)(1993-2#5)(1993-3#7)(1993-5#2)(1993-6#3)(1993-9#12)(1994-1#12)(1994-11#2)(1994-12#13)(1994-2#9)(1994-3#15)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#16)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#8)(1995-3#14)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#13)(1996-11#2)(1996-12#13)(1996-2#12)(1996-3#6)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#6)(1997-1#3)(1997-2#14)(1997-3#8)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2006-10#2)(2006-12#2)(2006-7#1)(2007-10#7)(2007-11#25)(2007-12#20)(2007-2#9)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#38)(2007-9#4)(2008-1#36)(2008-10#33)(2008-11#80)(2008-12#45)(2008-2#3)(2008-3#21)(2008-4#11)(2008-5#5)(2008-6#22)(2008-7#36)(2008-8#20)(2008-9#34)(2009-1#1)(2009-10#2)(2009-11#9)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#19)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#6)(2010-1#1)(2010-10#10)(2010-11#8)(2010-12#6)(2010-2#3)(2010-3#17)(2010-4#3)(2010-5#8)(2010-6#7)(2010-7#1)(2010-8#9)(2010-9#6)(2011-1#9)(2011-2#67)(2011-3#8)(2011-7#1)(2012-1#10)(2012-12#23)(2012-2#31)(2012-3#26)(2013-1#48)(2013-7#3)(2013-8#23)
experience&quot##2##1##(1994-12#1)(2013-1#1)
experience)##10##1##(1994-3#1)(1995-3#3)(1997-2#1)(2007-11#1)(2008-11#1)(2009-11#1)(2011-2#2)
experience-based##3##1##(1997-1#1)(2008-8#1)(2013-1#1)
experience-dependent plasticity##2##2##(2007-8#1)(2009-3#1)
experience-dependent##4##1##(2007-8#1)(2009-3#1)(2010-7#1)(2012-2#1)
experience]##28##1##(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-3#2)(1991-5#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-2#1)(1995-5#1)(1996-8#1)(2008-10#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
experienced a case of a##2##5##(2010-6#1)(2012-1#1)
experienced a case of##3##4##(2008-12#1)(2010-6#1)(2012-1#1)
experienced a greater impact on##2##5##(2013-1#2)
experienced a significant decrease##2##4##(1996-3#1)(2008-5#1)
experienced a significant##4##3##(1994-1#1)(1996-3#1)(2008-5#1)(2008-8#1)
experienced a total of##2##4##(1992-2#1)(2008-7#1)
experienced a transition##2##3##(1996-3#1)(2012-12#1)
experienced a##40##2##(1991-12#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-5#1)(1996-3#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
experienced an##7##2##(1991-6#1)(1994-6#1)(1996-5#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
experienced and##2##2##(1995-3#1)(2007-12#1)
experienced as##2##2##(1995-1#1)(2008-11#1)
experienced at least one episode of##2##6##(1994-6#1)(2008-6#1)
experienced at least one severe (grade##2##6##(2008-10#2)
experienced at least one##4##4##(1994-6#1)(2008-10#2)(2008-6#1)
experienced at least##5##3##(1994-6#1)(2008-10#2)(2008-6#1)(2011-1#1)
experienced at##8##2##(1994-6#1)(2007-11#1)(2008-10#2)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
experienced by a##3##3##(2007-12#1)(2009-8#1)(2012-2#1)
experienced by parents##2##3##(1992-2#1)(1993-3#1)
experienced by patients in the##3##5##(2008-6#1)(2010-10#2)
experienced by patients##6##3##(1996-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-10#2)
experienced by the##9##3##(1990-10#1)(1991-12#1)(1991-9#1)(2007-2#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2013-1#1)
experienced by##39##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
experienced delayed##2##2##(1991-9#1)(2012-2#1)
experienced difficulties with##2##3##(2008-12#1)(2010-4#1)
experienced difficulties##3##2##(2008-12#1)(2010-3#1)(2010-4#1)
experienced during the##3##3##(2010-4#1)(2012-3#1)(2013-7#1)
experienced during##6##2##(2008-8#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-7#1)
experienced fever##2##2##(2008-1#1)(2008-7#1)
experienced greater##2##2##(2008-12#1)(2013-1#1)
experienced hands##4##2##(1994-2#2)(2008-10#1)(2011-2#1)
experienced high##2##2##(2008-10#1)(2012-12#1)
experienced in the##8##3##(1994-3#1)(1996-1#1)(1996-6#1)(2006-12#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-1#1)
experienced in this##2##3##(2009-6#1)(2010-7#1)
experienced in##23##2##(1994-12#1)(1994-3#1)(1996-1#1)(1996-6#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-6#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
experienced individuals##2##2##(2011-2#2)
experienced interventional##2##2##(1997-6#1)(2008-3#1)
experienced less##3##2##(1991-12#1)(1993-2#1)(2008-9#1)
experienced minimal##2##2##(1994-2#1)(1995-3#1)
experienced more symptoms##2##3##(1995-6#1)(1995-8#1)
experienced more##6##2##(1994-6#1)(1995-6#1)(1995-8#1)(2008-9#1)(2011-2#1)(2012-1#1)
experienced nausea##2##2##(2008-7#2)
experienced negative##2##2##(1997-2#1)(2010-3#1)
experienced no further##2##3##(2008-10#1)(2013-1#1)
experienced no##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
experienced pain##2##2##(2010-12#1)(2010-3#1)
experienced physicians##2##2##(1991-6#1)(1993-3#1)
experienced practitioner##2##2##(2008-11#2)
experienced practitioners##3##2##(1994-2#1)(2008-4#1)(2011-2#1)
experienced rats##3##2##(1995-12#3)
experienced serious##3##2##(1994-6#1)(1996-3#1)(2012-6#1)
experienced sexual##2##2##(1992-1#1)(2012-2#1)
experienced significant##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
experienced some##3##2##(1994-3#1)(1996-9#1)(2013-1#1)
experienced stress##2##2##(1991-11#1)(2011-2#1)
experienced symptoms##2##2##(2007-8#1)(2013-1#1)
experienced the##5##2##(1990-10#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)
experienced transient##4##2##(1990-10#1)(2008-9#1)(2010-3#1)(2012-3#1)
experienced was##2##2##(2008-12#1)(2009-4#1)
experienced##389##1##(1990-10#5)(1990-6#2)(1991-11#1)(1991-12#6)(1991-3#3)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#10)(1992-12#2)(1992-2#4)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#4)(1995-1#4)(1995-10#1)(1995-12#5)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#4)(2006-12#2)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#19)(2008-12#12)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#6)(2008-7#19)(2008-8#13)(2008-9#12)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-3#6)(2010-4#4)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#26)(2012-1#5)(2012-12#5)(2012-2#12)(2012-3#10)(2012-6#1)(2013-1#19)(2013-7#1)(2013-8#4)
experiences a##4##2##(1990-6#1)(1991-2#1)(2008-2#1)(2008-8#1)
experiences after##2##2##(1992-4#1)(2010-10#1)
experiences among##3##2##(2009-11#1)(2012-12#1)(2012-2#1)
experiences and attitudes##2##3##(1995-2#1)(2012-1#1)
experiences and outcomes##2##3##(2008-10#1)(2009-7#1)
experiences and perceptions of##2##4##(2008-11#1)(2010-10#1)
experiences and perceptions##3##3##(2008-11#2)(2010-10#1)
experiences and that##2##3##(2007-10#1)(2013-8#1)
experiences and the##3##3##(2008-12#1)(2013-1#2)
experiences and##40##2##(1993-3#1)(1995-2#1)(1996-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#5)(2008-12#3)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
experiences are##5##2##(1992-10#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-12#1)
experiences as a##3##3##(1991-3#1)(1996-1#1)(2007-2#1)
experiences as they##2##3##(1992-3#1)(2010-3#1)
experiences as##7##2##(1991-3#1)(1992-3#1)(1996-1#1)(2007-2#1)(2009-11#1)(2010-3#1)(2013-8#1)
experiences at##2##2##(1995-12#1)(2008-10#1)
experiences during the##2##3##(1996-12#1)(2008-2#1)
experiences during##5##2##(1996-12#1)(2008-2#1)(2009-9#1)(2012-3#1)(2013-8#1)
experiences for##4##2##(1996-1#1)(2008-11#2)(2008-12#1)
experiences from the##2##3##(1997-6#1)(2008-10#1)
experiences from##6##2##(1990-6#1)(1991-3#1)(1997-6#1)(2008-10#1)(2010-8#1)(2013-1#1)
experiences in caring for patients##3##5##(2010-7#2)(2010-8#1)
experiences in caring for##4##4##(2010-7#2)(2010-8#1)(2011-2#1)
experiences in the##7##3##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)
experiences in this##2##3##(2008-11#2)
experiences in##27##2##(1991-2#1)(1995-12#1)(1996-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#3)(2008-4#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
experiences may be##3##3##(2008-12#1)(2013-1#2)
experiences of a##7##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2013-8#1)
experiences of general student nurses on their first clinical placement##2##10##(2008-12#2)
experiences of general student nurses on their first clinical##3##9##(2008-12#3)
experiences of health##3##3##(2008-1#2)(2010-3#1)
experiences of healthcare##2##3##(2008-12#2)
experiences of living in##2##4##(1993-1#1)(2009-5#1)
experiences of living##3##3##(1993-1#1)(2008-12#1)(2009-5#1)
experiences of nurses##3##3##(2008-11#1)(2013-8#2)
experiences of one##2##3##(1992-3#1)(2008-11#1)
experiences of psilocybin users and non-users##3##6##(2013-8#3)
experiences of psilocybin users##4##4##(2013-8#4)
experiences of spirituality##3##3##(2010-11#1)(2013-1#2)
experiences of students##2##3##(2008-11#2)
experiences of the##15##3##(1992-2#1)(1994-1#1)(1995-12#1)(1997-3#2)(2008-11#2)(2008-12#1)(2009-7#1)(2010-10#2)(2010-3#1)(2012-3#1)(2013-1#2)
experiences of three##2##3##(1996-12#1)(2008-6#1)
experiences of what##2##3##(2010-10#2)
experiences of working##2##3##(1997-1#1)(2011-1#1)
experiences of##120##2##(1990-6#1)(1991-2#1)(1992-2#2)(1992-3#1)(1993-1#1)(1994-1#2)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-3#3)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#19)(2008-12#18)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-5#5)(2009-7#4)(2009-8#2)(2010-10#5)(2010-11#1)(2010-3#4)(2010-4#2)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#8)(2013-8#11)
experiences reported##2##2##(1990-6#1)(2010-11#1)
experiences that##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
experiences through##2##2##(2010-10#1)(2010-7#1)
experiences to##2##2##(2008-1#1)(2013-1#1)
experiences were##5##2##(1992-2#1)(2008-10#2)(2010-2#1)(2012-12#1)
experiences will##3##2##(2007-2#1)(2008-11#2)
experiences with integrated TB and HIV##2##6##(2010-4#2)
experiences with nursing##2##3##(2008-12#2)
experiences with the##4##3##(1997-3#1)(2007-7#1)(2008-11#1)(2013-7#1)
experiences with##34##2##(1992-12#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-1#3)(1997-3#3)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2012-3#1)(2013-7#1)
experiences within##2##2##(2010-4#1)(2013-8#1)
experiences##407##1##(1990-6#4)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#4)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#6)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#4)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#14)(2008-11#48)(2008-12#38)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#1)(2009-5#9)(2009-7#7)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#11)(2010-11#4)(2010-12#1)(2010-2#5)(2010-3#8)(2010-4#5)(2010-5#2)(2010-7#3)(2010-8#8)(2011-1#9)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#7)(2013-1#28)(2013-7#1)(2013-8#22)
experiences]##4##1##(1991-2#1)(1993-6#1)(1997-6#1)(2009-10#1)
experiencing a##2##2##(2008-11#1)(2011-1#1)
experiencing adverse##2##2##(1996-2#1)(2011-2#1)
experiencing an##4##2##(2008-11#3)(2008-12#1)
experiencing dramatic##2##2##(2008-12#2)
experiencing hot flashes##2##3##(2008-7#2)
experiencing it##2##2##(2010-3#1)(2010-6#1)
experiencing more##2##2##(2008-10#1)(2009-11#1)
experiencing negative##2##2##(2012-3#1)(2013-1#1)
experiencing the##4##2##(2011-2#2)(2012-3#1)(2013-8#1)
experiencing##64##1##(1991-2#2)(1992-2#1)(1994-2#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-11#8)(2008-12#4)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-3#4)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
experiential activities##2##2##(2008-11#2)
experiential knowledge##2##2##(2008-11#2)
experiential learning activities##2##3##(1994-12#1)(2008-11#1)
experiential learning##16##2##(1994-12#3)(1995-1#3)(2008-11#7)(2009-8#1)(2010-3#1)(2012-1#1)
experiential##37##1##(1992-12#1)(1994-12#3)(1994-9#1)(1995-1#3)(1995-2#1)(1996-1#2)(2008-1#2)(2008-11#15)(2008-4#1)(2008-6#1)(2009-8#2)(2010-10#2)(2010-3#1)(2012-1#1)(2013-8#1)
experiment (1##2##2##(1992-9#1)(2008-7#1)
experiment (i##2##2##(2008-10#1)(2008-4#1)
experiment 1##10##2##(1994-8#1)(2007-12#1)(2008-10#5)(2010-2#2)(2010-8#1)
experiment 2##9##2##(1994-8#1)(2007-12#1)(2008-10#5)(2010-2#2)
experiment A##2##2##(2008-10#2)
experiment B##2##2##(2008-10#2)
experiment and a##2##3##(2008-10#1)(2008-5#1)
experiment and increased##2##3##(2008-10#1)(2012-2#1)
experiment and the##3##3##(1991-3#1)(1997-3#1)(2008-7#1)
experiment and##24##2##(1991-3#1)(1992-9#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#2)
experiment are presented##2##3##(2008-3#2)
experiment are##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
experiment as##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
experiment at##6##2##(1990-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)
experiment by##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
experiment can##2##2##(2008-4#2)
experiment cockle##2##2##(1996-12#2)
experiment condition##2##2##(2008-10#1)(2013-8#1)
experiment conducted with##2##3##(2008-9#1)(2012-12#1)
experiment conducted##4##2##(1994-11#1)(2008-10#1)(2008-9#1)(2012-12#1)
experiment demonstrated that##2##3##(1995-8#1)(2008-9#1)
experiment demonstrated##4##2##(1992-11#1)(1995-8#1)(2008-2#1)(2008-9#1)
experiment demonstrates the##2##3##(2007-11#1)(2008-10#1)
experiment design##4##2##(2008-10#2)(2008-11#1)(2010-8#1)
experiment examined the##3##3##(1993-6#1)(2010-2#1)(2011-2#1)
experiment examined##4##2##(1993-6#1)(2010-2#1)(2010-7#1)(2011-2#1)
experiment for the##2##3##(1996-12#1)(2007-11#1)
experiment for##7##2##(1996-12#1)(2007-11#3)(2008-5#1)(2012-1#1)(2013-8#1)
experiment groups##3##2##(1996-12#1)(2008-12#2)
experiment has been##2##3##(2008-10#1)(2008-3#1)
experiment has##9##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
experiment in the##3##3##(2008-10#2)(2008-8#1)
experiment in which a##2##4##(2007-11#1)(2008-2#1)
experiment in which##11##3##(1994-2#1)(1995-3#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
experiment in##31##2##(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#2)(1996-8#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#1)
experiment included##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
experiment involving##2##2##(2007-12#1)(2008-4#1)
experiment is found##2##3##(2008-2#2)
experiment is to##3##3##(2008-10#1)(2008-3#2)
experiment is##24##2##(1991-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#7)(2012-2#1)
experiment may##2##2##(1995-5#1)(2008-3#1)
experiment of the##2##3##(2008-11#1)(2008-12#1)
experiment of##8##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2013-8#1)
experiment on the##5##3##(1992-2#1)(1993-6#2)(2012-2#2)
experiment on##11##2##(1992-2#1)(1993-6#2)(2008-3#3)(2008-4#1)(2009-8#1)(2011-3#1)(2012-2#2)
experiment results##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-8#1)
experiment revealed that##2##3##(1993-12#1)(2008-6#1)
experiment reveals that the##2##4##(2008-3#1)(2008-8#1)
experiment show that the##2##4##(2008-2#1)(2008-3#1)
experiment show that##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
experiment show##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
experiment showed that the##2##4##(1990-2#1)(2008-8#1)
experiment showed that##9##3##(1990-2#1)(1995-3#1)(2008-10#1)(2008-12#2)(2008-8#2)(2008-9#2)
experiment showed##10##2##(1990-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#2)
experiment shows##2##2##(2007-12#1)(2008-3#1)
experiment suggests##2##2##(2007-12#1)(2008-10#1)
experiment that tested##2##3##(1997-3#1)(2008-9#1)
experiment that##9##2##(1997-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#2)
experiment the##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#2)
experiment to show the##2##4##(2008-3#1)(2010-8#1)
experiment to test##2##3##(2008-10#1)(2008-3#1)
experiment to##19##2##(1994-11#1)(1994-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#3)
experiment two##2##2##(2009-4#1)(2010-1#1)
experiment using a##2##3##(2008-2#1)(2008-3#1)
experiment using##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
experiment was a##2##3##(2008-10#2)
experiment was carried out in##3##5##(2008-10#1)(2008-11#1)(2008-6#1)
experiment was carried out using##2##5##(2008-12#2)
experiment was carried out##9##4##(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#2)(2008-8#1)(2010-5#1)
experiment was conducted at the##3##5##(2008-12#2)(2011-1#1)
experiment was conducted in##4##4##(2008-10#1)(2008-12#2)(2012-7#1)
experiment was conducted to determine the effect of##2##8##(2008-10#1)(2008-12#1)
experiment was conducted to determine the##4##6##(2008-10#2)(2008-12#1)(2013-8#1)
experiment was conducted to determine##5##5##(1992-3#1)(2008-10#2)(2008-12#1)(2013-8#1)
experiment was conducted to evaluate the##2##6##(2008-12#2)
experiment was conducted to##11##4##(1992-2#1)(1992-3#1)(2008-10#3)(2008-12#4)(2008-9#1)(2013-8#1)
experiment was conducted##24##3##(1992-2#1)(1992-3#1)(2008-10#4)(2008-12#10)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-6#1)(2012-7#1)(2013-8#1)
experiment was designed to test the##2##6##(1997-8#1)(2008-10#1)
experiment was designed to##6##4##(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-10#1)
experiment was performed##4##3##(1997-6#1)(2008-3#2)(2009-8#1)
experiment was repeated##2##3##(1992-6#1)(2008-11#1)
experiment was to##4##3##(1992-7#1)(1993-12#1)(1997-2#1)(2009-4#1)
experiment was##70##2##(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-12#2)(1994-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#13)(2008-11#3)(2008-12#18)(2008-3#4)(2008-5#3)(2008-6#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-6#1)(2012-7#1)(2013-8#1)
experiment we##4##2##(2007-11#1)(2009-10#1)(2010-8#1)(2013-8#1)
experiment were##4##2##(2006-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
experiment when##2##2##(2008-10#1)(2008-3#1)
experiment where##2##2##(1997-6#1)(2008-12#1)
experiment with a##2##3##(2007-12#1)(2008-3#1)
experiment with##19##2##(1991-3#1)(1991-5#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)
experiment##707##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#2)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#9)(1993-3#3)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#5)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-5#3)(1996-8#1)(1997-2#4)(1997-3#4)(1997-4#4)(1997-6#6)(1997-8#1)(2006-4#1)(2007-11#28)(2007-12#26)(2007-8#1)(2008-1#6)(2008-10#153)(2008-11#17)(2008-12#31)(2008-2#36)(2008-3#99)(2008-4#15)(2008-5#18)(2008-6#10)(2008-7#15)(2008-8#24)(2008-9#23)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#8)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#9)(2011-1#7)(2011-2#3)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#11)(2012-3#2)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#6)(2013-7#4)(2013-8#15)
experiment]##2##1##(1990-9#1)(2012-3#1)
experimental As(III)##2##2##(2008-10#2)
experimental access##2##2##(2008-7#1)(2009-9#1)
experimental accuracy##2##2##(2008-2#1)(2008-3#1)
experimental allergic encephalomyelitis (EAE)##2##4##(1994-6#1)(2007-11#1)
experimental allergic encephalomyelitis##3##3##(1994-6#1)(2007-11#1)(2011-2#1)
experimental allergic neuritis##2##3##(1993-5#1)(1994-6#1)
experimental allergic##5##2##(1993-5#1)(1994-6#2)(2007-11#1)(2011-2#1)
experimental analysis of##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
experimental analysis##5##2##(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
experimental and a control##3##4##(2008-12#1)(2010-12#1)(2013-1#1)
experimental and calculated##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
experimental and clinical studies have shown that##2##7##(2008-7#1)(2012-1#1)
experimental and clinical studies have##3##5##(1996-9#1)(2008-7#1)(2012-1#1)
experimental and clinical studies##8##4##(1994-2#1)(1996-9#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-5#1)
experimental and clinical##20##3##(1991-6#1)(1991-9#1)(1994-2#1)(1994-7#1)(1996-9#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-7#1)(2011-2#1)(2012-1#1)(2012-5#1)
experimental and computational##5##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
experimental and control groups were##2##5##(1991-12#1)(2008-12#1)
experimental and control groups##4##4##(1991-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
experimental and control##6##3##(1991-12#1)(2008-12#1)(2011-1#2)(2011-2#2)
experimental and modeling##2##3##(2008-7#2)
experimental and numerical approaches##2##4##(2008-3#1)(2009-7#1)
experimental and numerical results that##2##5##(2007-11#1)(2007-12#1)
experimental and numerical results##7##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
experimental and numerical##11##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)(2009-7#2)
experimental and observational##2##3##(2008-9#1)(2012-12#1)
experimental and simulated##3##3##(2008-11#1)(2008-3#2)
experimental and theoretical results##4##4##(2007-12#1)(2008-3#3)
experimental and theoretical studies##2##4##(2007-12#1)(2013-1#1)
experimental and theoretical##17##3##(1992-11#1)(1992-3#1)(2007-12#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2009-11#1)(2013-1#2)(2013-8#1)
experimental and##98##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#17)(2008-5#3)(2008-6#2)(2008-7#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#3)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#6)(2013-8#1)
experimental animal models##8##3##(1992-6#1)(1993-11#1)(1995-5#1)(1997-3#1)(2008-11#1)(2009-10#1)(2010-4#2)
experimental animal studies##2##3##(1991-12#1)(2008-12#1)
experimental animal##16##2##(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-4#2)(2012-2#1)(2013-1#1)
experimental animals and humans##2##4##(2008-3#1)(2010-3#1)
experimental animals and##4##3##(1995-5#1)(1996-5#1)(2008-3#1)(2010-3#1)
experimental animals##24##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
experimental anxiety##2##2##(1993-3#1)(2008-7#1)
experimental approach to the##3##4##(1991-6#1)(2007-11#1)(2008-10#1)
experimental approach to##5##3##(1991-6#1)(2007-11#1)(2008-10#2)(2008-11#1)
experimental approach used##2##3##(1994-8#1)(2008-10#1)
experimental approach##18##2##(1990-2#1)(1990-8#1)(1991-6#1)(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2009-7#1)(2012-2#2)
experimental approaches for##2##3##(2008-4#1)(2008-7#1)
experimental approaches in##2##3##(2008-4#1)(2011-1#1)
experimental approaches to##3##3##(1994-9#1)(2008-7#1)(2008-8#1)
experimental approaches##12##2##(1994-9#1)(1995-6#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-7#2)(2008-8#2)(2011-1#1)
experimental arrangement##4##2##(2008-2#1)(2008-3#3)
experimental atherosclerosis in the##2##4##(2008-3#1)(2013-1#1)
experimental atherosclerosis##3##2##(1997-8#1)(2008-3#1)(2013-1#1)
experimental autoimmune encephalomyelitis (EAE)##3##4##(2010-12#1)(2012-2#2)
experimental autoimmune encephalomyelitis##6##3##(1995-12#1)(2010-12#2)(2012-2#2)(2013-7#1)
experimental autoimmune##7##2##(1995-12#2)(2010-12#2)(2012-2#2)(2013-7#1)
experimental basis for##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
experimental biases##3##2##(2008-10#1)(2008-2#2)
experimental brain diabetes##2##3##(2009-11#2)
experimental calibration matrix##3##3##(2008-10#3)
experimental calibration##6##2##(2008-10#5)(2008-3#1)
experimental characterization of##2##3##(2007-12#1)(2010-8#1)
experimental characterization##3##2##(2007-12#1)(2008-3#1)(2010-8#1)
experimental colitis##2##2##(1992-6#1)(2011-3#1)
experimental comparison of##2##3##(2008-10#1)(2012-3#1)
experimental comparison##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
experimental condition is##2##3##(2008-3#1)(2008-7#1)
experimental condition##8##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
experimental conditions and##6##3##(2008-10#5)(2009-12#1)
experimental conditions for the##3##4##(2008-10#2)(2008-3#1)
experimental conditions for##9##3##(2008-10#7)(2008-3#1)(2008-9#1)
experimental conditions in##2##3##(1993-3#1)(2008-10#1)
experimental conditions is##3##3##(1997-4#1)(2008-10#2)
experimental conditions of##3##3##(1992-4#1)(2008-10#2)
experimental conditions such as##3##4##(2008-10#2)(2011-1#1)
experimental conditions used##3##3##(1997-3#1)(2008-10#1)(2010-11#1)
experimental conditions was##3##3##(2008-10#3)
experimental conditions were investigated##4##4##(2008-10#4)
experimental conditions were##15##3##(1991-6#1)(2008-10#13)(2008-11#1)
experimental conditions where##2##3##(1992-12#1)(2008-10#1)
experimental conditions##178##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-6#3)(1992-12#1)(1992-4#1)(1993-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#109)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#2)(2011-1#2)
experimental configuration##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
experimental data and the theoretical##2##5##(2008-2#1)(2008-3#1)
experimental data and theoretical##2##4##(2007-11#1)(2010-10#1)
experimental data and##15##3##(1996-12#1)(2007-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-10#1)
experimental data are available##2##4##(1995-3#1)(2008-7#1)
experimental data are##10##3##(1990-5#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-10#1)
experimental data available##3##3##(2007-12#1)(2008-7#1)(2009-10#1)
experimental data by##2##3##(2008-10#2)
experimental data demonstrate that##2##4##(2007-11#1)(2008-3#1)
experimental data for a##2##4##(2008-2#2)
experimental data for the##2##4##(2007-12#1)(2008-7#1)
experimental data for##10##3##(1997-2#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#3)(2011-2#1)
experimental data from##6##3##(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
experimental data have##2##3##(2008-10#1)(2008-8#1)
experimental data is##3##3##(2007-12#1)(2008-10#2)
experimental data obtained from##2##4##(1997-7#1)(2008-3#1)
experimental data obtained##7##3##(1995-3#1)(1997-7#1)(2008-10#3)(2008-3#2)
experimental data of##4##3##(2008-2#2)(2008-7#1)(2008-8#1)
experimental data on the##4##4##(2009-3#1)(2009-5#1)(2010-10#1)(2013-8#1)
experimental data on##7##3##(2008-3#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-10#1)(2013-1#1)(2013-8#1)
experimental data points##3##3##(2008-10#2)(2008-7#1)
experimental data regarding##2##3##(2008-8#1)(2013-8#1)
experimental data set##2##3##(1995-5#1)(2008-2#1)
experimental data sets##3##3##(2008-10#2)(2008-7#1)
experimental data show that##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
experimental data taken from##2##4##(2007-12#1)(2008-10#1)
experimental data that##3##3##(2008-3#2)(2011-2#1)
experimental data to the##4##4##(2008-2#3)(2009-2#1)
experimental data to##6##3##(2008-2#3)(2008-3#1)(2008-7#1)(2009-2#1)
experimental data was##3##3##(1993-6#1)(2008-10#2)
experimental data were##5##3##(1995-2#1)(2008-10#1)(2008-3#2)(2008-5#1)
experimental data with##5##3##(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#1)
experimental data##200##2##(1990-5#1)(1990-6#1)(1990-8#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#7)(2007-12#10)(2008-1#1)(2008-10#37)(2008-11#7)(2008-2#27)(2008-3#28)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#20)(2008-8#7)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#5)(2013-8#6)
experimental databases##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
experimental demonstration at##2##3##(2008-2#1)(2012-2#1)
experimental demonstration of a##3##4##(2007-11#1)(2008-2#1)(2012-2#1)
experimental demonstration of the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
experimental demonstration of##15##3##(2007-11#4)(2007-12#7)(2008-2#2)(2008-3#1)(2012-2#1)
experimental demonstration with##2##3##(2007-11#1)(2008-3#1)
experimental demonstration##21##2##(2007-11#5)(2007-12#7)(2008-2#4)(2008-3#3)(2012-2#2)
experimental demonstrations of##2##3##(2008-9#1)(2012-3#1)
experimental dependencies##2##2##(2008-10#1)(2008-2#1)
experimental design and##7##3##(1997-2#1)(2008-10#4)(2008-8#1)(2009-2#1)
experimental design approach##4##3##(2008-10#4)
experimental design method##3##3##(2008-10#1)(2008-7#2)
experimental design to##2##3##(2008-5#1)(2009-8#1)
experimental design was applied to##2##5##(2008-10#1)(2008-5#1)
experimental design was used to##2##5##(2008-11#1)(2010-5#1)
experimental design was used##6##4##(2008-10#4)(2008-11#1)(2010-5#1)
experimental design was##11##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-7#1)
experimental design with##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
experimental design##74##2##(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#39)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2009-2#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
experimental design-neural##2##2##(2008-10#2)
experimental designs##17##2##(1992-9#1)(1994-11#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
experimental determination of##2##3##(2008-3#2)
experimental device##2##2##(2008-3#2)
experimental diabetes in##2##3##(2008-4#1)(2011-2#1)
experimental diabetes##6##2##(1994-8#1)(2008-1#2)(2008-4#1)(2011-2#2)
experimental diabetic##2##2##(2008-1#1)(2008-10#1)
experimental diet##2##2##(2012-2#2)
experimental diets for##2##3##(1993-11#1)(2010-2#1)
experimental diets##6##2##(1993-11#1)(2010-2#3)(2012-2#2)
experimental domain##2##2##(2008-10#2)
experimental ecosystems##2##2##(2008-8#2)
experimental effort##2##2##(2008-10#1)(2008-3#1)
experimental enrichment factor##2##3##(2008-10#2)
experimental equipment##2##2##(2008-6#2)
experimental error of##2##3##(2008-10#2)
experimental error##13##2##(1990-7#2)(1990-8#1)(1991-5#1)(1993-11#2)(1995-5#1)(2008-10#5)(2008-3#1)
experimental errors##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
experimental estimation of the##2##4##(2008-10#1)(2008-2#1)
experimental evaluation##5##2##(2008-3#2)(2008-5#1)(2008-6#1)(2012-2#1)
experimental evidence for a##2##4##(1990-7#1)(1992-9#1)
experimental evidence for##6##3##(1990-7#1)(1992-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
experimental evidence has##2##3##(2011-2#2)
experimental evidence indicates that##2##4##(2008-5#1)(2012-2#1)
experimental evidence of the##3##4##(2007-12#2)(2011-1#1)
experimental evidence of##14##3##(2007-11#3)(2007-12#6)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
experimental evidence showing that##2##4##(2007-11#1)(2008-7#1)
experimental evidence that the##5##4##(1990-2#1)(1993-11#1)(1996-7#1)(2008-2#1)(2008-8#1)
experimental evidence that##9##3##(1990-2#1)(1993-11#1)(1996-7#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#1)
experimental evidence to support this##2##5##(2008-10#1)(2008-8#1)
experimental evidence to##3##3##(1991-6#1)(2008-10#1)(2008-8#1)
experimental evidence##51##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1996-5#1)(1996-7#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
experimental evidences##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
experimental evolution##5##2##(2008-10#1)(2012-3#1)(2013-1#3)
experimental exposure##4##2##(2007-12#1)(2008-7#3)
experimental facilities##2##2##(2008-3#2)
experimental factors on##2##3##(2008-10#2)
experimental factors##5##2##(1993-6#1)(2008-10#3)(2011-2#1)
experimental field study of##2##4##(2008-9#1)(2010-1#1)
experimental field##4##2##(2008-10#2)(2008-9#1)(2010-1#1)
experimental findings##8##2##(1992-3#1)(1995-9#1)(2008-11#3)(2008-3#2)(2012-1#1)
experimental fungicide##2##2##(2008-10#2)
experimental geometry##2##2##(2008-3#2)
experimental group (B)##2##3##(2013-1#2)
experimental group and##3##3##(1993-12#1)(2008-12#2)
experimental group had##2##3##(2008-11#1)(2010-4#1)
experimental group of##3##3##(1991-12#1)(2007-10#1)(2008-11#1)
experimental group received##3##3##(2007-11#2)(2010-12#1)
experimental group showed##2##3##(2008-10#1)(2010-12#1)
experimental group was##2##3##(2007-8#1)(2010-6#1)
experimental group##53##2##(1991-12#2)(1992-9#1)(1993-12#2)(1993-6#1)(1994-3#2)(1995-1#1)(2007-10#1)(2007-11#5)(2007-8#2)(2008-10#2)(2008-11#7)(2008-12#10)(2009-6#2)(2010-12#2)(2010-4#2)(2010-6#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
experimental groups of##3##3##(1997-6#1)(2007-8#1)(2008-12#1)
experimental groups were##3##3##(1993-12#1)(2008-12#1)(2013-7#1)
experimental groups##28##2##(1991-2#1)(1993-12#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-8#1)(2008-12#6)(2008-5#3)(2009-11#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
experimental host range##6##3##(2008-10#6)
experimental implementation is##3##3##(2008-11#1)(2008-3#2)
experimental implementation of##2##3##(2008-2#2)
experimental implementation##6##2##(2008-11#1)(2008-2#2)(2008-3#3)
experimental in##2##2##(2008-11#1)(2008-3#1)
experimental infection with##2##3##(1991-8#1)(1997-3#1)
experimental infection##3##2##(1991-8#1)(1997-3#1)(2008-10#1)
experimental information##2##2##(2008-3#1)(2008-7#1)
experimental inoculation##2##2##(1993-8#1)(2008-10#1)
experimental investigation of the##13##4##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#6)(2012-1#1)
experimental investigation of##18##3##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#7)(2012-1#1)
experimental investigation##26##2##(1997-2#2)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#8)(2009-6#1)(2012-1#1)(2012-2#1)
experimental investigations of the##2##4##(2008-3#2)
experimental investigations of##4##3##(2008-3#2)(2008-6#1)(2010-10#1)
experimental investigations##8##2##(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)(2010-10#1)(2010-5#1)
experimental levels##2##2##(2008-7#2)
experimental manipulation of##2##3##(2008-7#1)(2008-8#1)
experimental manipulation##3##2##(2008-7#1)(2008-8#2)
experimental manipulations##5##2##(1997-6#1)(2008-4#2)(2008-8#1)(2012-2#1)
experimental measurement of the##2##4##(2008-2#1)(2008-3#1)
experimental measurement of##3##3##(2008-2#1)(2008-3#2)
experimental measurement##4##2##(2008-2#1)(2008-3#3)
experimental measurements and##2##3##(2008-3#2)
experimental measurements are##2##3##(1990-11#1)(2008-3#1)
experimental measurements of the##2##4##(2007-11#1)(2008-3#1)
experimental measurements of##5##3##(2007-11#2)(2008-3#2)(2010-10#1)
experimental measurements##21##2##(1990-11#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#10)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)
experimental metastasis&quot##2##2##(1990-6#1)(2008-1#1)
experimental method for##3##3##(2008-10#1)(2008-3#2)
experimental method is##2##3##(1992-9#1)(2008-3#1)
experimental method to measure the##2##5##(2008-2#2)
experimental method to##3##3##(2008-2#2)(2008-3#1)
experimental method was developed##2##4##(1990-2#1)(2008-3#1)
experimental method##14##2##(1990-2#1)(1990-3#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2009-5#1)
experimental methods##8##2##(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2010-12#1)(2012-3#1)(2012-7#1)
experimental model for##3##3##(1993-1#1)(1994-3#1)(2008-10#1)
experimental model of##5##3##(1994-2#1)(2008-12#1)(2008-5#1)(2013-1#2)
experimental model systems##2##3##(1997-6#1)(2008-10#1)
experimental model##23##2##(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2011-2#1)(2013-1#2)
experimental models are##2##3##(2007-10#1)(2009-7#1)
experimental models of##7##3##(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-6#1)
experimental models##25##2##(1991-9#1)(1994-11#2)(1994-12#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
experimental murine##2##2##(2008-4#1)(2012-2#1)
experimental observation of the##2##4##(2007-12#2)
experimental observation of##11##3##(2007-11#5)(2007-12#6)
experimental observation##15##2##(2007-11#5)(2007-12#6)(2008-11#1)(2008-3#3)
experimental observations and##2##3##(1997-3#1)(2008-2#1)
experimental observations of##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)
experimental observations##19##2##(1994-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#3)(2009-9#1)(2010-7#1)(2013-8#1)
experimental options##2##2##(2008-9#1)(2010-8#1)
experimental or control group##2##4##(2007-11#1)(2008-11#1)
experimental or##4##2##(2007-11#1)(2008-11#1)(2012-12#1)(2013-1#1)
experimental paradigm##3##2##(2007-9#1)(2008-7#1)(2012-2#1)
experimental parameters for##2##3##(2008-10#2)
experimental parameters have been optimized##2##5##(2008-10#2)
experimental parameters have been##3##4##(2008-10#3)
experimental parameters on the##2##4##(1997-2#1)(2008-10#1)
experimental parameters such as the##2##5##(2008-10#1)(2013-8#1)
experimental parameters such as##4##4##(2008-10#3)(2013-8#1)
experimental parameters were##6##3##(1995-5#1)(2008-10#5)
experimental parameters##39##2##(1994-2#1)(1995-5#1)(1997-2#1)(2008-10#33)(2010-4#1)(2011-1#1)(2013-8#1)
experimental period##9##2##(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2011-2#2)(2012-5#2)
experimental plant##2##2##(2008-8#2)
experimental plot##2##2##(2008-10#1)(2013-7#1)
experimental plots##5##2##(2008-10#5)
experimental pneumothorax##2##2##(1990-5#2)
experimental populations##7##2##(1997-7#1)(2008-8#2)(2011-1#1)(2013-1#3)
experimental procedure for##2##3##(2008-3#1)(2008-5#1)
experimental procedure##5##2##(2008-3#1)(2008-5#1)(2008-8#2)(2010-3#1)
experimental procedures for##3##3##(1996-12#1)(2008-4#1)(2008-7#1)
experimental procedures##9##2##(1990-7#1)(1996-12#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-7#1)
experimental program##3##2##(1996-2#1)(2008-3#1)(2011-7#1)
experimental protocols##5##2##(1997-4#1)(2008-4#1)(2008-7#1)(2008-9#2)
experimental rats##6##2##(2011-2#2)(2012-2#1)(2013-1#3)
experimental realization of a##2##4##(2007-11#1)(2007-12#1)
experimental realization of##4##3##(2007-11#2)(2007-12#1)(2012-2#1)
experimental repetitions##2##2##(2008-10#2)
experimental research##5##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
experimental result shows that##2##4##(2007-11#1)(2007-12#1)
experimental result##10##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
experimental results and a theoretical##2##5##(2008-3#2)
experimental results and a##4##4##(2007-12#1)(2008-3#3)
experimental results and##19##3##(1993-11#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
experimental results are also presented##2##5##(2008-3#2)
experimental results are also##3##4##(2008-10#1)(2008-3#2)
experimental results are compared with a##3##6##(2007-12#1)(2008-3#2)
experimental results are compared with##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
experimental results are presented that demonstrate the##2##7##(2007-12#1)(2008-3#1)
experimental results are presented that##3##5##(2007-12#2)(2008-3#1)
experimental results are presented to##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
experimental results are presented##20##4##(2007-12#4)(2008-2#5)(2008-3#11)
experimental results are shown##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
experimental results are##48##3##(2007-11#3)(2007-12#8)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#25)
experimental results at##2##3##(2008-3#2)
experimental results demonstrate that the##2##5##(1997-2#1)(2008-3#1)
experimental results demonstrate that##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
experimental results demonstrate the##2##4##(2008-2#1)(2008-3#1)
experimental results demonstrate##6##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
experimental results for a##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
experimental results for the##5##4##(2008-10#2)(2008-3#3)
experimental results for##18##3##(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#5)(2008-3#7)(2008-7#1)
experimental results from##8##3##(1992-11#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#3)(2013-1#1)
experimental results indicate that the##6##5##(1990-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
experimental results indicate that##10##4##(1990-12#1)(2008-10#3)(2008-3#3)(2008-6#2)(2012-3#1)
experimental results indicate##12##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-6#2)(2012-3#1)
experimental results indicated that the##2##5##(2008-10#1)(2009-8#1)
experimental results indicated that##5##4##(2008-10#2)(2008-9#2)(2009-8#1)
experimental results is##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
experimental results obtained for##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
experimental results obtained from##2##4##(2007-11#1)(2008-3#1)
experimental results obtained with##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
experimental results obtained##9##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)
experimental results of a##3##4##(2008-2#2)(2008-3#1)
experimental results of an##2##4##(2007-12#1)(2008-3#1)
experimental results of the##7##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)
experimental results of##23##3##(2007-11#3)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#9)
experimental results on the##2##4##(2007-11#1)(2008-2#1)
experimental results on##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
experimental results reveal that the##2##5##(2008-10#1)(2008-3#1)
experimental results reveal##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
experimental results show a##2##4##(2008-3#1)(2011-2#1)
experimental results show that the improved##2##6##(2008-3#1)(2013-8#1)
experimental results show that the##11##5##(2008-10#2)(2008-2#4)(2008-3#3)(2013-8#2)
experimental results show that##19##4##(2008-10#3)(2008-2#4)(2008-3#6)(2008-8#1)(2013-8#5)
experimental results show##25##3##(2008-10#3)(2008-2#7)(2008-3#8)(2008-8#1)(2011-2#1)(2013-8#5)
experimental results showed that the##5##5##(1993-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
experimental results showed that##7##4##(1993-12#1)(2008-10#2)(2008-3#1)(2008-8#2)(2013-8#1)
experimental results support the##2##4##(2008-10#1)(2010-12#1)
experimental results that##6##3##(2007-8#1)(2008-2#1)(2008-3#3)(2010-8#1)
experimental results using a##2##4##(2008-3#1)(2008-6#1)
experimental results was##4##3##(2008-10#1)(2008-2#2)(2008-7#1)
experimental results were##8##3##(2007-12#1)(2008-10#3)(2008-2#1)(2010-4#1)(2011-2#2)
experimental results with##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
experimental results##315##2##(1990-12#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-12#2)(1995-11#2)(1995-3#2)(1996-5#1)(1997-2#4)(1997-4#1)(1997-7#1)(2007-11#18)(2007-12#25)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#4)(2008-2#51)(2008-3#108)(2008-5#2)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#5)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#7)
experimental samples##2##2##(2008-10#1)(2010-2#1)
experimental selective COX-2##2##3##(2008-10#2)
experimental sensitivity##2##2##(2007-11#1)(2009-6#1)
experimental set-up##6##2##(2007-8#1)(2008-10#4)(2008-7#1)
experimental settings##2##2##(2008-11#2)
experimental setup and##4##3##(2007-11#1)(2008-3#1)(2010-12#1)(2010-4#1)
experimental setup for##2##3##(2008-10#1)(2008-3#1)
experimental setup is##4##3##(2008-3#4)
experimental setup##25##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#16)(2008-6#1)(2010-10#1)(2010-12#1)(2010-4#1)
experimental setups to##2##3##(2007-12#1)(2008-2#1)
experimental setups##4##2##(2007-12#2)(2008-2#1)(2010-11#1)
experimental site##3##2##(2008-10#1)(2008-12#2)
experimental situations##5##2##(2007-12#2)(2008-10#1)(2008-3#1)(2011-2#1)
experimental spectra##9##2##(2008-10#1)(2008-2#3)(2008-3#5)
experimental steps are##3##3##(2008-10#3)
experimental steps##4##2##(2008-10#3)(2008-4#1)
experimental strategies##2##2##(2008-4#1)(2008-7#1)
experimental strategy##2##2##(2008-11#1)(2008-5#1)
experimental studies have shown that##3##5##(2007-10#1)(2009-7#1)(2012-2#1)
experimental studies have shown##4##4##(2007-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
experimental studies have##8##3##(2007-10#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
experimental studies in##2##3##(2008-8#1)(2009-8#1)
experimental studies of##5##3##(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#1)
experimental studies on the##2##4##(2007-11#1)(2008-3#1)
experimental studies on##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
experimental studies##41##2##(1995-3#1)(1996-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
experimental study aimed at##2##4##(1992-9#1)(2008-2#1)
experimental study in##3##3##(2008-9#1)(2009-4#1)(2012-3#1)
experimental study of an optical isolator##2##6##(2008-3#2)
experimental study of the evolution of##2##6##(2008-2#1)(2008-7#1)
experimental study of the##11##4##(2007-12#4)(2008-2#4)(2008-3#2)(2008-7#1)
experimental study of##21##3##(2007-11#3)(2007-12#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-7#1)(2012-12#1)
experimental study on the##2##4##(2008-9#1)(2011-1#1)
experimental study was##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
experimental study##44##2##(1990-9#1)(1992-9#1)(1993-3#1)(1996-6#1)(2007-11#3)(2007-12#6)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#9)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
experimental study]##2##2##(1990-9#1)(2013-1#1)
experimental support for##2##3##(2008-10#1)(2008-8#1)
experimental system for##4##3##(1993-2#1)(1996-2#1)(2008-2#1)(2008-9#1)
experimental system that uses a##2##5##(2008-3#2)
experimental system##24##2##(1993-2#1)(1994-10#1)(1994-2#2)(1996-2#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
experimental systems##5##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
experimental technique##8##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
experimental techniques##7##2##(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)
experimental test of##3##3##(2007-10#1)(2008-9#2)
experimental test##7##2##(2007-10#1)(2007-11#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#1)
experimental testing##2##2##(2008-3#1)(2009-5#1)
experimental tests and##2##3##(2011-2#2)
experimental tests of##2##3##(2008-2#1)(2008-8#1)
experimental tests##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#2)
experimental therapy of##2##3##(1995-2#1)(2008-4#1)
experimental therapy##4##2##(1995-2#1)(1997-8#1)(2008-4#2)
experimental time##2##2##(1995-5#1)(2008-7#1)
experimental time-resolved##2##2##(2008-3#1)(2012-2#1)
experimental tool##2##2##(1997-6#1)(2007-11#1)
experimental tools##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
experimental treatment##7##2##(1990-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-6#2)(2010-9#1)
experimental treatments##2##2##(1994-8#1)(2010-9#1)
experimental trends##2##2##(2008-3#2)
experimental uncertainty##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)
experimental unit##2##2##(2008-10#2)
experimental vaccines##6##2##(1997-6#3)(2008-11#1)(2008-4#1)(2012-12#1)
experimental validation is##2##3##(2008-11#1)(2009-11#1)
experimental validation of##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2012-3#1)
experimental validation##11##2##(2007-12#1)(2008-11#2)(2008-2#3)(2008-3#2)(2009-11#1)(2011-2#1)(2012-3#1)
experimental validations##2##2##(2008-3#2)
experimental value of##2##3##(2008-10#2)
experimental value##3##2##(2008-10#3)
experimental values for the##2##4##(1993-11#1)(1995-6#1)
experimental values of the##2##4##(2008-10#1)(2008-3#1)
experimental values of##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
experimental values##11##2##(1993-11#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)
experimental variables affecting the fluorescence intensity##2##6##(2008-10#2)
experimental variables affecting the##3##4##(2008-10#3)
experimental variables such as##3##4##(2008-10#3)
experimental variables that influence##2##4##(2008-10#2)
experimental variables##18##2##(2008-10#18)
experimental verification have been conducted##2##5##(2008-2#1)(2008-3#1)
experimental verification of a negative index of refraction##2##8##(2007-11#2)
experimental verification of the##2##4##(2007-12#1)(2008-3#1)
experimental verification of##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
experimental verification##13##2##(1995-3#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#6)(2011-2#1)
experimental work##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
experimental works##2##2##(1997-7#1)(2008-10#1)
experimental##2246##1##(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#4)(1990-6#5)(1990-7#4)(1990-8#6)(1990-9#2)(1991-1#1)(1991-12#9)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#6)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#8)(1993-1#1)(1993-11#7)(1993-12#8)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#6)(1994-3#4)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#8)(1995-5#7)(1995-6#7)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#11)(1996-3#1)(1996-5#9)(1996-6#3)(1996-7#1)(1996-9#2)(1997-2#19)(1997-3#4)(1997-4#3)(1997-6#10)(1997-7#6)(1997-8#5)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#7)(2007-11#90)(2007-12#107)(2007-4#2)(2007-8#7)(2007-9#1)(2008-1#20)(2008-10#462)(2008-11#75)(2008-12#38)(2008-2#158)(2008-3#338)(2008-4#38)(2008-5#49)(2008-6#27)(2008-7#94)(2008-8#53)(2008-9#33)(2009-10#5)(2009-11#7)(2009-12#6)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#7)(2009-7#10)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#9)(2010-11#7)(2010-12#13)(2010-2#9)(2010-3#2)(2010-4#11)(2010-5#6)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#22)(2011-2#44)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#12)(2012-2#42)(2012-3#20)(2012-5#3)(2012-7#1)(2012-9#1)(2013-1#58)(2013-7#7)(2013-8#25)
experimentally a##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
experimentally an##2##2##(2007-11#2)
experimentally analyzed##3##2##(2007-12#2)(2008-5#1)
experimentally and compared with theory##2##5##(2008-2#1)(2008-3#1)
experimentally and is##2##3##(2007-11#1)(2008-3#1)
experimentally and numerically##3##3##(2007-11#2)(2007-12#1)
experimentally and theoretically that the##3##5##(1997-1#1)(1997-2#1)(2008-3#1)
experimentally and theoretically##14##3##(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)
experimentally and##31##2##(1997-1#1)(1997-2#1)(2007-11#7)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#10)(2008-7#1)(2011-3#1)
experimentally as##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
experimentally by use of##3##4##(2007-11#1)(2008-2#2)
experimentally by using##2##3##(2008-2#1)(2008-3#1)
experimentally by##11##2##(1992-2#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
experimentally confirmed##5##2##(2008-2#2)(2008-3#2)(2009-6#1)
experimentally demonstrate a##4##3##(2007-11#4)
experimentally demonstrate an##2##3##(2007-12#2)
experimentally demonstrate that##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
experimentally demonstrate##22##2##(2007-11#9)(2007-12#6)(2008-2#2)(2008-3#5)
experimentally demonstrated a##3##3##(2008-3#2)(2012-2#1)
experimentally demonstrated by use of##4##5##(2008-3#4)
experimentally demonstrated by##5##3##(2008-3#5)
experimentally demonstrated in##3##3##(1997-6#1)(2007-12#1)(2008-3#1)
experimentally demonstrated that##2##3##(2007-12#1)(2008-3#1)
experimentally demonstrated##29##2##(1997-6#1)(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#15)(2011-2#1)(2012-2#1)
experimentally derived##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
experimentally determined##14##2##(1994-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-7#2)(2011-2#1)
experimentally evaluated##3##2##(2007-12#1)(2008-3#2)
experimentally examine the##2##3##(2008-2#1)(2008-3#1)
experimentally examined##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
experimentally filled##3##2##(2009-7#3)
experimentally for a##2##3##(2008-3#1)(2008-7#1)
experimentally for the##4##3##(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
experimentally for what is believed to be the first time##2##10##(2007-11#2)
experimentally for##12##2##(1994-8#1)(1997-6#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)
experimentally identified##2##2##(1997-6#1)(2009-5#1)
experimentally in a photorefractive##2##4##(2007-12#1)(2008-3#1)
experimentally in a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
experimentally in an##2##3##(2008-3#1)(2008-9#1)
experimentally in the##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
experimentally in##18##2##(1997-8#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#1)
experimentally induced anxiety levels##2##4##(2007-6#2)
experimentally induced inflammatory##2##3##(1990-11#1)(1993-3#1)
experimentally induced phantom sensations##2##4##(2007-12#2)
experimentally induced urethral inflammation##3##4##(1990-7#3)
experimentally induced##19##2##(1990-11#1)(1990-7#3)(1992-6#1)(1993-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(2007-12#2)(2007-6#2)(2008-12#1)(2009-11#1)(2010-8#1)(2012-3#2)
experimentally infected with##2##3##(2008-12#1)(2008-5#1)
experimentally infected##6##2##(1996-12#1)(2008-12#1)(2008-5#2)(2010-1#1)(2013-1#1)
experimentally investigated for##2##3##(2007-11#1)(2008-3#1)
experimentally investigated the##2##3##(2008-2#1)(2012-2#1)
experimentally investigated##12##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2012-2#1)
experimentally manipulated##2##2##(2008-8#1)(2010-5#1)
experimentally measured responses##2##3##(2008-10#1)(2008-11#1)
experimentally measured##17##2##(1997-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2009-5#1)(2010-2#1)
experimentally observed features##2##3##(2008-2#1)(2008-7#1)
experimentally observed in##3##3##(2007-11#1)(2007-12#2)
experimentally observed##23##2##(1993-11#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#7)(2008-2#3)(2008-3#1)(2008-7#2)(2009-5#1)(2012-2#1)
experimentally obtained results##2##3##(2008-1#1)(2008-3#1)
experimentally obtained##13##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#8)(2008-7#1)
experimentally on##2##2##(2008-2#1)(2008-6#1)
experimentally recorded##2##2##(2008-3#1)(2009-8#1)
experimentally relevant##2##2##(2009-5#1)(2009-7#1)
experimentally shown that##2##3##(2007-12#1)(2008-10#1)
experimentally shown to##2##3##(2007-11#1)(2007-12#1)
experimentally shown##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
experimentally studied##7##2##(1992-5#1)(2007-12#3)(2008-2#1)(2008-3#2)
experimentally tested##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-9#1)
experimentally that a##3##3##(2007-11#1)(2008-3#2)
experimentally that the##8##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
experimentally that##21##2##(2007-11#5)(2007-12#3)(2008-2#4)(2008-3#8)(2009-11#1)
experimentally the##11##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)(2011-2#1)
experimentally through##2##2##(2008-10#1)(2008-5#1)
experimentally to be##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
experimentally to##5##2##(2007-11#1)(2008-3#3)(2008-5#1)
experimentally using##2##2##(2008-10#1)(2008-2#1)
experimentally verified by a##2##4##(2007-12#1)(2008-3#1)
experimentally verified by##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2011-1#1)
experimentally verified for##2##3##(2008-3#2)
experimentally verified in##2##3##(1990-2#1)(2007-11#1)
experimentally verified##15##2##(1990-2#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-3#4)(2008-7#1)(2011-1#1)
experimentally verify the##3##3##(2007-11#1)(2008-10#2)
experimentally verify##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
experimentally well-characterized##2##2##(2007-11#2)
experimentally with a##3##3##(2007-12#1)(2008-3#2)
experimentally with##7##2##(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-3#3)
experimentally##513##1##(1990-11#1)(1990-2#1)(1990-7#3)(1991-5#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#4)(1997-6#6)(1997-8#2)(2007-10#1)(2007-11#64)(2007-12#66)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#34)(2008-11#6)(2008-12#2)(2008-2#62)(2008-3#141)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#4)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2012-9#1)(2013-1#4)(2013-8#1)
experimentally-induced MD cutaneous lymphoma lesions##2##5##(2008-5#2)
experimentation and##4##2##(1990-12#1)(1991-9#1)(2008-10#1)(2012-12#1)
experimentation in##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
experimentation is##2##2##(1991-12#1)(2013-1#1)
experimentation to##2##2##(1991-3#1)(2011-2#1)
experimentation was##3##2##(2008-10#2)(2009-5#1)
experimentation with##2##2##(2009-12#1)(2013-8#1)
experimentation##41##1##(1990-12#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-2#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
experimented with##2##2##(2008-11#1)(2011-2#1)
experimented##5##1##(1993-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
experimenter##9##1##(2007-6#3)(2008-1#1)(2008-11#2)(2008-4#1)(2012-12#1)(2012-3#1)
experimenters##4##1##(1996-2#1)(2008-5#1)(2009-5#2)
experimenting with##3##2##(1992-1#1)(1994-3#1)(2013-1#1)
experiments 1 and 2##2##4##(2008-10#1)(2008-11#1)
experiments against##3##2##(2008-8#1)(2013-7#2)
experiments aimed at##2##3##(1994-11#1)(2008-7#1)
experiments allow##2##2##(2008-2#1)(2008-7#1)
experiments also##3##2##(1990-7#1)(2008-11#1)(2008-3#1)
experiments and a##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
experiments and by##2##3##(2008-10#2)
experiments and genetic##2##3##(2008-11#1)(2008-8#1)
experiments and in##3##3##(1991-12#1)(1995-9#1)(2010-5#1)
experiments and numerical##2##3##(2007-11#1)(2008-3#1)
experiments and the##3##3##(2008-10#2)(2008-3#1)
experiments and##43##2##(1991-12#1)(1992-12#1)(1995-8#2)(1995-9#1)(2007-11#3)(2007-12#4)(2008-10#14)(2008-11#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-2#2)(2013-8#1)
experiments are based##2##3##(2008-10#1)(2008-3#1)
experiments are carried out##3##4##(2008-10#1)(2008-3#2)
experiments are described##2##3##(2008-11#1)(2008-4#1)
experiments are discussed##2##3##(1990-11#1)(2009-12#1)
experiments are in##2##3##(2007-11#1)(2008-7#1)
experiments are part of a larger study designed to investigate the influence of husbandry parameters on the life history of the##2##21##(2008-11#2)
experiments are performed in##2##4##(2007-11#1)(2008-10#1)
experiments are performed##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
experiments are presented that##2##4##(2008-3#1)(2009-12#1)
experiments are presented##4##3##(2008-2#1)(2008-3#2)(2009-12#1)
experiments are used to##2##4##(2008-2#1)(2011-3#1)
experiments are##42##2##(1990-11#1)(1991-12#1)(1991-6#1)(1993-11#1)(1994-10#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#8)(2008-4#3)(2008-7#2)(2009-12#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-3#1)
experiments as well as##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
experiments as well##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
experiments as##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
experiments at##7##2##(1996-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-10#1)
experiments because##2##2##(2007-12#1)(2008-11#1)
experiments between##2##2##(2008-10#1)(2008-5#1)
experiments by means of##2##4##(2008-10#1)(2008-2#1)
experiments by##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
experiments can##4##2##(2006-4#1)(2009-10#1)(2010-12#1)(2011-3#1)
experiments carried out on##2##4##(2008-10#1)(2008-5#1)
experiments carried out##7##3##(1996-12#1)(2008-10#1)(2008-5#2)(2008-6#2)(2009-5#1)
experiments compared with the##2##4##(2008-10#2)
experiments compared##3##2##(2008-10#3)
experiments conducted at two locations##2##5##(2008-10#2)
experiments conducted at##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
experiments conducted by##2##3##(1995-12#1)(2008-9#1)
experiments conducted in##5##3##(2008-10#4)(2010-8#1)
experiments conducted with##2##3##(1990-7#1)(2008-3#1)
experiments conducted##19##2##(1990-7#1)(1995-12#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-8#1)(2013-7#1)
experiments confirmed that##2##3##(2008-10#1)(2008-11#1)
experiments confirmed the##2##3##(2007-8#1)(2008-10#1)
experiments confirmed##5##2##(2007-8#1)(2008-10#3)(2008-11#1)
experiments could##2##2##(2008-11#1)(2009-8#1)
experiments demonstrate that the##2##4##(2008-10#1)(2008-4#1)
experiments demonstrate that##7##3##(1995-5#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#2)
experiments demonstrate the##4##3##(1995-2#1)(2008-3#3)
experiments demonstrate##12##2##(1995-2#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)
experiments demonstrated that both##2##4##(1994-5#1)(2008-11#1)
experiments demonstrated that the##4##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-6#1)
experiments demonstrated that##16##3##(1992-11#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-7#1)
experiments demonstrated##17##2##(1992-11#1)(1992-12#1)(1993-11#1)(1994-12#2)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-7#1)
experiments described##4##2##(1991-9#1)(2008-10#1)(2008-3#1)(2013-7#1)
experiments designed to##3##3##(1992-3#1)(2008-3#1)(2009-2#1)
experiments designed##5##2##(1992-12#1)(1992-3#2)(2008-3#1)(2009-2#1)
experiments do not##2##3##(2008-10#1)(2008-3#1)
experiments employing##2##2##(2008-2#1)(2008-7#1)
experiments examine##2##2##(2008-9#1)(2010-4#1)
experiments examined##2##2##(2008-10#1)(2008-4#1)
experiments for the##2##3##(2008-10#1)(2008-3#1)
experiments for##9##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)
experiments from##5##2##(2008-10#4)(2009-10#1)
experiments further established that##2##4##(2008-10#2)
experiments further##3##2##(2008-10#2)(2008-4#1)
experiments give##2##2##(1993-11#1)(1996-2#1)
experiments has been##2##3##(1994-5#1)(2007-12#1)
experiments has##3##2##(1994-5#2)(2007-12#1)
experiments have also been##3##4##(2008-10#2)(2008-6#1)
experiments have been carried out##4##5##(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
experiments have been performed##3##4##(1995-11#1)(2008-3#1)(2008-6#1)
experiments have been##11##3##(1993-11#1)(1995-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-8#1)
experiments have demonstrated##2##3##(1997-6#1)(2007-11#1)
experiments have identified##2##3##(2008-10#1)(2008-11#1)
experiments have indicated##2##3##(1990-2#1)(1996-3#1)
experiments have provided##3##3##(1991-2#1)(2009-12#1)(2010-4#1)
experiments have shown that##5##4##(1991-9#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-4#1)
experiments have##34##2##(1990-2#1)(1991-2#1)(1991-9#1)(1993-11#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2009-12#1)(2010-2#1)(2010-4#2)(2012-3#1)(2013-1#1)(2013-8#1)
experiments identified##2##2##(1996-2#1)(2008-10#1)
experiments in a##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
experiments in contact##2##3##(2008-10#2)
experiments in mammalian##2##3##(1991-5#1)(2008-10#1)
experiments in mice##2##3##(2008-10#1)(2009-6#1)
experiments in the greenhouse##2##4##(2008-10#2)
experiments in the##12##3##(1993-8#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2009-5#1)
experiments in which a##3##4##(2007-11#1)(2008-2#1)(2009-6#1)
experiments in which the##6##4##(1990-5#1)(2008-3#2)(2008-7#2)(2011-2#1)
experiments in which##18##3##(1990-12#1)(1990-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#1)
experiments in##86##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-6#3)(2007-11#2)(2007-12#3)(2008-10#30)(2008-11#7)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
experiments included##2##2##(2008-10#2)
experiments including##2##2##(1991-9#1)(2010-2#1)
experiments indicate that the##3##4##(1993-6#1)(2008-7#1)(2009-6#1)
experiments indicate that##13##3##(1992-11#1)(1993-6#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-3#1)(2011-2#1)
experiments indicated that the##6##4##(1990-11#1)(1990-5#2)(1997-4#1)(2008-10#2)
experiments indicated that##15##3##(1990-11#1)(1990-5#2)(1994-5#1)(1997-4#1)(2008-10#8)(2008-6#1)(2013-1#1)
experiments indicated the##3##3##(1997-3#1)(2007-12#1)(2010-2#1)
experiments indicated##21##2##(1990-11#1)(1990-5#2)(1992-11#1)(1994-5#1)(1995-11#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#8)(2008-6#1)(2010-2#1)(2011-1#1)(2013-1#1)
experiments investigated the effects##2##4##(1994-8#1)(2011-2#1)
experiments investigated##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
experiments involving##7##2##(1993-11#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
experiments is##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
experiments it was found that##2##5##(1995-12#1)(2008-2#1)
experiments it##5##2##(1990-2#1)(1994-2#1)(1995-12#1)(1997-6#1)(2008-2#1)
experiments led to the##3##4##(2008-7#1)(2009-2#1)(2010-7#1)
experiments of a##3##3##(1995-3#1)(2008-3#1)(2012-3#1)
experiments of the##3##3##(1992-12#1)(2008-4#1)(2008-5#1)
experiments of##20##2##(1992-12#1)(1993-11#1)(1993-3#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
experiments on the##9##3##(1990-11#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)
experiments on##45##2##(1990-11#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-5#2)(1995-3#1)(1996-4#1)(1997-5#1)(2007-12#5)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#4)(2010-1#1)(2010-4#1)(2010-9#1)(2012-2#2)(2013-1#1)
experiments or##2##2##(2008-4#1)(2010-11#1)
experiments over two##2##3##(2008-10#1)(2013-8#1)
experiments performed on##2##3##(1990-2#1)(2008-2#1)
experiments performed with the##3##4##(2008-10#2)(2009-8#1)
experiments performed with##4##3##(2008-10#3)(2009-8#1)
experiments performed##10##2##(1990-2#1)(1994-11#1)(2008-10#5)(2008-2#1)(2009-8#1)(2011-2#1)
experiments proved that the##2##4##(2009-3#1)(2013-8#1)
experiments proved that##3##3##(2009-3#1)(2012-3#1)(2013-8#1)
experiments proved##4##2##(2009-3#1)(2009-4#1)(2012-3#1)(2013-8#1)
experiments provide an##2##3##(2011-1#1)(2013-8#1)
experiments provide##4##2##(2008-11#1)(2009-2#1)(2011-1#1)(2013-8#1)
experiments reported here##5##3##(1990-5#1)(1993-6#1)(1995-2#1)(2008-7#2)
experiments reported##6##2##(1990-5#1)(1993-6#1)(1995-2#1)(2008-7#2)(2012-2#1)
experiments reveal that##2##3##(1992-8#1)(2008-10#1)
experiments reveal##4##2##(1992-8#1)(2008-10#2)(2008-8#1)
experiments revealed that the##2##4##(1993-8#1)(2008-10#1)
experiments revealed that##14##3##(1993-8#1)(1994-2#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)
experiments revealed the##3##3##(1994-8#1)(2008-10#1)(2009-12#1)
experiments revealed##20##2##(1990-5#1)(1991-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)
experiments should##2##2##(2008-8#1)(2010-11#1)
experiments show that the proposed##2##5##(2009-9#1)(2010-8#1)
experiments show that the##11##4##(1990-11#1)(1991-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)
experiments show that##21##3##(1990-11#1)(1990-5#1)(1991-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
experiments show the##2##3##(2008-3#1)(2012-1#1)
experiments show##25##2##(1990-11#1)(1990-5#1)(1991-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
experiments showed that a##2##4##(1997-7#1)(2008-10#1)
experiments showed that the##9##4##(1991-7#1)(2007-12#2)(2008-10#5)(2008-3#1)
experiments showed that there##2##4##(2008-6#1)(2008-9#1)
experiments showed that##29##3##(1990-7#1)(1991-7#1)(1991-8#1)(1992-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)
experiments showed the##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
experiments showed##36##2##(1990-7#1)(1991-7#1)(1991-8#1)(1992-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#5)
experiments showing##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
experiments such as##4##3##(1995-3#1)(2007-11#2)(2008-2#1)
experiments suggest that the##2##4##(1994-8#1)(1996-5#1)
experiments suggest that##12##3##(1990-5#1)(1990-7#1)(1991-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-5#2)(1997-2#1)(2007-12#1)(2008-8#1)(2009-6#1)
experiments suggest##14##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-5#2)(1997-2#1)(2007-12#1)(2008-8#1)(2009-6#1)
experiments suggested##2##2##(1992-12#1)(2008-7#1)
experiments support the##2##3##(2008-10#1)(2012-3#1)
experiments support##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
experiments tested the##2##3##(1993-3#1)(2009-11#1)
experiments than##2##2##(2008-3#1)(2009-9#1)
experiments that can be performed##3##5##(2008-11#1)(2008-4#2)
experiments that can##4##3##(2008-11#1)(2008-4#2)(2010-10#1)
experiments that##18##2##(1990-5#1)(1993-2#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-10#1)(2010-4#1)
experiments the##3##2##(2008-11#2)(2008-7#1)
experiments to demonstrate##2##3##(2008-7#1)(2008-8#1)
experiments to determine the##2##4##(1993-2#1)(2008-3#1)
experiments to determine##3##3##(1993-2#1)(2008-3#1)(2010-8#1)
experiments to test##3##3##(2008-2#1)(2008-9#2)
experiments to##23##2##(1993-2#1)(1993-3#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-2#2)
experiments together with##2##3##(1990-7#1)(2008-10#1)
experiments under##3##2##(2008-10#3)
experiments using a##2##3##(2009-10#1)(2010-1#1)
experiments using different##2##3##(2008-10#1)(2008-5#1)
experiments using the##3##3##(1993-8#1)(2007-8#1)(2008-7#1)
experiments using##30##2##(1990-12#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-1#1)(2011-2#1)
experiments utilizing##5##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
experiments was conducted##2##3##(1997-4#1)(2010-4#1)
experiments was##13##2##(1993-8#1)(1994-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)
experiments we##5##2##(1990-12#1)(1995-12#1)(1997-4#1)(2007-11#1)(2012-2#1)
experiments were carried out at##4##5##(2008-10#4)
experiments were carried out in the##2##6##(2008-10#1)(2008-4#1)
experiments were carried out in##8##5##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2013-1#1)
experiments were carried out to##9##5##(2008-10#2)(2008-2#3)(2008-5#1)(2008-6#2)(2013-1#1)
experiments were carried out under##2##5##(2008-10#1)(2011-2#1)
experiments were carried out with##2##5##(2008-10#1)(2008-3#1)
experiments were carried out##33##4##(1991-5#1)(1997-4#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2010-2#2)(2010-8#1)(2011-2#2)(2013-1#2)
experiments were conducted in a##4##5##(2008-10#1)(2008-5#1)(2011-2#2)
experiments were conducted in##9##4##(2007-11#1)(2008-10#5)(2008-5#1)(2011-2#2)
experiments were conducted to determine the##2##6##(2008-10#1)(2010-11#1)
experiments were conducted to determine##3##5##(2008-10#1)(2010-11#1)(2011-2#1)
experiments were conducted to investigate the##3##6##(2008-10#1)(2008-12#1)(2008-6#1)
experiments were conducted to study the effects of##2##8##(2008-10#2)
experiments were conducted to study the##4##6##(2008-10#4)
experiments were conducted to test##2##5##(2008-10#1)(2008-11#1)
experiments were conducted to##17##4##(1991-5#1)(1996-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-6#1)(2010-11#1)(2011-2#1)(2012-3#1)
experiments were conducted using##2##4##(1991-12#1)(2008-11#1)
experiments were conducted with##6##4##(2008-10#4)(2010-2#1)(2010-8#1)
experiments were conducted##39##3##(1991-12#1)(1991-5#1)(1996-2#1)(2007-11#1)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-3#1)
experiments were designed to##4##4##(1993-3#1)(1993-6#1)(2008-7#1)(2009-11#1)
experiments were done##2##3##(1990-5#1)(2011-2#1)
experiments were performed at##2##4##(1993-3#1)(2008-6#1)
experiments were performed for##2##4##(2008-10#1)(2008-3#1)
experiments were performed in order to##3##6##(1995-5#1)(2008-10#2)
experiments were performed in##7##4##(1993-12#1)(1995-5#1)(2008-10#4)(2008-11#1)
experiments were performed on##5##4##(1992-6#1)(1994-11#1)(1995-2#1)(2008-5#1)(2008-8#1)
experiments were performed to evaluate the##2##6##(2008-3#1)(2008-5#1)
experiments were performed to##8##4##(1995-11#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
experiments were performed using##2##4##(2008-10#2)
experiments were performed with a##3##5##(1990-12#1)(2008-10#1)(2008-2#1)
experiments were performed with##4##4##(1990-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
experiments were performed##37##3##(1990-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(2006-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-8#1)(2011-2#1)
experiments were used to##3##4##(2008-10#2)(2008-8#1)
experiments were used##4##3##(2008-10#3)(2008-8#1)
experiments were##135##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#48)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#7)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-2#3)(2010-8#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#2)
experiments where the##2##3##(2008-10#1)(2012-2#1)
experiments where##8##2##(1992-6#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
experiments which##2##2##(1994-11#1)(2011-1#1)
experiments will be##2##3##(1991-5#1)(2008-10#1)
experiments will##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
experiments with a##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
experiments with an##6##3##(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
experiments with rats##3##3##(2008-5#3)
experiments with the uniformly [(13)C##2##5##(2009-7#2)
experiments with the##5##3##(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#2)
experiments with this##2##3##(2007-11#1)(2008-10#1)
experiments with two##2##3##(2008-10#1)(2012-2#1)
experiments with various##2##3##(1991-6#1)(1993-8#1)
experiments with##107##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#3)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#3)(2008-10#21)(2008-11#6)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#3)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)(2013-7#1)
experiments yield##2##2##(2008-10#1)(2008-3#1)
experiments##1587##1##(1990-11#6)(1990-12#6)(1990-2#4)(1990-5#14)(1990-7#7)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#7)(1992-10#2)(1992-11#7)(1992-12#6)(1992-2#1)(1992-3#7)(1992-5#2)(1992-6#7)(1992-8#5)(1992-9#3)(1993-11#11)(1993-12#7)(1993-2#3)(1993-3#13)(1993-6#6)(1993-8#9)(1993-9#3)(1994-10#1)(1994-11#9)(1994-12#6)(1994-2#9)(1994-3#4)(1994-5#12)(1994-6#6)(1994-8#8)(1994-9#3)(1995-11#7)(1995-12#13)(1995-2#8)(1995-3#7)(1995-5#7)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#8)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#3)(1996-8#1)(1997-2#9)(1997-3#7)(1997-4#8)(1997-5#1)(1997-6#10)(1997-7#4)(1997-8#1)(2006-10#1)(2006-4#3)(2006-6#3)(2007-10#1)(2007-11#33)(2007-12#45)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#401)(2008-11#78)(2008-12#12)(2008-2#62)(2008-3#124)(2008-4#34)(2008-5#45)(2008-6#38)(2008-7#61)(2008-8#48)(2008-9#35)(2009-10#7)(2009-11#2)(2009-12#7)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#3)(2010-2#13)(2010-3#2)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#9)(2011-2#19)(2011-3#4)(2012-1#3)(2012-12#3)(2012-2#20)(2012-3#9)(2013-1#13)(2013-7#6)(2013-8#14)
experiments)##11##1##(1991-8#1)(1992-6#1)(1992-8#1)(1995-11#1)(2008-10#4)(2008-8#1)(2009-5#1)(2013-1#1)
expert centers##2##2##(2008-3#1)(2012-2#1)
expert consensus##2##2##(2013-1#2)
expert group##6##2##(1990-11#1)(2008-10#1)(2008-11#2)(2010-12#1)(2012-3#1)
expert in the##3##3##(1993-12#1)(1995-11#1)(2011-2#1)
expert in##7##2##(1993-12#1)(1994-12#1)(1995-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
expert opinion when##2##3##(1993-12#2)
expert opinion##10##2##(1993-12#2)(1996-2#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
expert opinions##3##2##(1995-5#1)(2011-2#2)
expert panel - EPACT II##2##5##(2010-12#2)
expert panel##7##2##(2007-12#1)(2010-12#5)(2012-2#1)
expert practice in##2##3##(2008-11#2)
expert system##8##2##(1990-7#1)(2008-10#6)(2011-2#1)
expert systems##3##2##(1992-3#1)(1996-2#1)(2011-2#1)
expert witness##4##2##(1994-3#1)(2008-1#1)(2008-4#1)(2012-2#1)
expert working##2##2##(1991-9#1)(2008-5#1)
expert##127##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#3)(1993-12#4)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#9)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-10#3)(2010-12#9)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#10)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)
expertise and resources##3##3##(1990-12#1)(2008-12#1)(2013-1#1)
expertise and##14##2##(1990-11#1)(1990-12#1)(1994-1#2)(1995-3#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#2)(2010-8#1)(2011-2#1)(2013-1#1)
expertise for##2##2##(1996-2#1)(2013-1#1)
expertise in##5##2##(1992-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
expertise is##5##2##(1995-11#1)(1996-2#1)(2007-8#1)(2008-12#1)(2009-7#1)
expertise of a##2##3##(2007-12#1)(2011-2#1)
expertise of the##4##3##(1992-1#1)(1997-8#1)(2011-1#1)(2011-2#1)
expertise of##9##2##(1992-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-8#1)(2007-12#1)(2011-1#1)(2011-2#2)
expertise to##4##2##(1995-1#1)(2008-1#1)(2008-11#1)(2009-5#1)
expertise with##2##2##(2008-11#1)(2009-2#1)
expertise##85##1##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1992-3#2)(1993-12#2)(1993-3#1)(1994-1#6)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-3#2)(1996-1#1)(1996-2#3)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-9#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
expertises##2##1##(2011-2#2)
experts and##9##2##(1990-6#1)(1996-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
experts are##3##2##(1992-8#1)(1993-12#1)(2013-1#1)
experts for##2##2##(2010-12#1)(2012-12#1)
experts from the region##2##4##(2008-8#1)(2009-8#1)
experts from the##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
experts from##9##2##(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#3)(2011-10#1)(2011-8#1)(2013-1#1)
experts in the field##2##4##(2008-10#1)(2008-6#1)
experts in the##4##3##(2008-10#1)(2008-6#2)(2013-1#1)
experts in##11##2##(2007-2#1)(2008-10#1)(2008-5#3)(2008-6#2)(2008-7#1)(2011-10#1)(2012-2#1)(2013-1#1)
experts on##2##2##(1996-2#1)(2008-10#1)
experts say##3##2##(1996-2#1)(1996-3#1)(2013-7#1)
experts to##3##2##(1995-12#1)(2011-10#1)(2011-2#1)
experts was##2##2##(1990-2#1)(2007-12#1)
experts who##2##2##(2010-10#2)
experts##103##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-3#3)(1992-2#1)(1992-8#1)(1993-12#3)(1994-1#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-2#4)(1996-3#2)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#8)(2010-5#1)(2010-8#2)(2011-10#5)(2011-2#7)(2011-8#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
experts'##7##1##(1992-9#1)(2007-8#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
expirated blood##2##2##(2010-5#2)
expirated##3##1##(2010-5#3)
expiration##5##1##(1990-11#1)(1990-9#1)(2008-7#2)(2010-5#1)
expiratory flow##13##2##(1990-6#3)(1996-1#1)(2007-2#1)(2008-1#4)(2008-3#1)(2008-7#1)(2009-1#1)(2009-6#1)
expiratory pressure##3##2##(1991-2#1)(1997-3#2)
expiratory volume in##6##3##(2007-2#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
expiratory volume##7##2##(2007-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
expiratory##40##1##(1990-6#3)(1991-11#1)(1991-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#2)(2007-2#3)(2007-5#1)(2007-8#3)(2008-1#5)(2008-11#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
expired air##3##2##(2008-6#1)(2011-1#2)
expired##13##1##(1992-9#1)(1995-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#2)(2008-1#3)(2008-6#1)(2011-1#2)
expiry##2##1##(2008-1#2)
explain a##6##2##(1994-5#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
explain all the##3##3##(1991-11#1)(1996-5#1)(2008-3#1)
explain all##6##2##(1991-11#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
explain both##2##2##(1991-9#1)(2008-5#1)
explain cetuximab##2##2##(2008-5#2)
explain differences in the##3##4##(1992-12#1)(2008-10#1)(2008-8#1)
explain differences in##4##3##(1992-12#1)(1996-3#1)(2008-10#1)(2008-8#1)
explain differences##5##2##(1992-12#1)(1996-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
explain how the##2##3##(2008-3#1)(2008-8#1)
explain how to##3##3##(1990-3#1)(2008-9#1)(2010-11#1)
explain how##19##2##(1990-3#1)(1991-12#1)(1993-2#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)
explain in##2##2##(1997-8#1)(2012-2#1)
explain its##4##2##(1993-8#1)(2008-11#1)(2009-6#1)(2013-8#1)
explain most##2##2##(2008-10#1)(2008-9#1)
explain phenotypic##2##2##(2011-2#1)(2013-8#1)
explain previous##2##2##(2007-12#1)(2009-5#1)
explain some of the observed##2##5##(2008-10#1)(2008-8#1)
explain some of the##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
explain some of##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
explain some##7##2##(1991-6#1)(1992-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
explain that##3##2##(1996-5#1)(2008-2#1)(2012-2#1)
explain the coexistence of##2##4##(2008-8#1)(2008-9#1)
explain the differences##3##3##(1991-11#1)(1992-2#1)(2010-8#1)
explain the discrepancy##2##3##(1991-1#1)(1993-9#1)
explain the effect of##3##4##(1990-12#1)(1994-5#1)(2008-7#1)
explain the effect##4##3##(1990-12#1)(1994-5#1)(2008-3#1)(2008-7#1)
explain the evolution of##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
explain the experimental results##3##4##(2007-11#1)(2008-1#1)(2008-9#1)
explain the high##3##3##(2008-10#2)(2008-3#1)
explain the higher##2##3##(2008-1#2)
explain the low##4##3##(1994-1#1)(1996-11#1)(2008-10#1)(2008-5#1)
explain the lower infant mortality##2##5##(2013-1#2)
explain the lower##4##3##(2007-12#1)(2008-10#1)(2013-1#2)
explain the molecular##2##3##(1991-9#1)(2009-5#1)
explain the observation that##2##4##(1993-11#1)(1995-9#1)
explain the observed##13##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-2#2)
explain the occurrence of##2##4##(2008-8#1)(2012-3#1)
explain the onset##2##3##(2008-2#1)(2008-7#1)
explain the presence of##2##4##(1995-11#1)(2008-10#1)
explain the rationale for##2##4##(1992-2#1)(2009-6#1)
explain the reasons##2##3##(2007-7#1)(2013-1#1)
explain the role of##2##4##(2007-11#1)(2011-1#1)
explain the variability##3##3##(1993-12#1)(2008-8#2)
explain the##233##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#30)(2008-11#9)(2008-2#5)(2008-3#13)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#13)(2008-8#15)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#9)(2013-1#6)(2013-8#1)
explain their##8##2##(1995-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-10#1)(2011-2#2)
explain these results##4##3##(2006-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
explain these##10##2##(1993-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2012-2#1)
explain this behavior##2##3##(2008-9#1)(2012-2#1)
explain this phenomenon##2##3##(2008-4#1)(2009-8#1)
explain this##12##2##(1995-2#1)(1996-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
explain why a##2##3##(1993-9#1)(2012-12#1)
explain why the##4##3##(1994-8#1)(2007-12#1)(2008-10#1)(2012-3#1)
explain why##27##2##(1991-8#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
explain##445##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#4)(1994-1#1)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#4)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#12)(2007-12#11)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#58)(2008-11#12)(2008-12#5)(2008-2#8)(2008-3#22)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#20)(2008-8#28)(2008-9#14)(2009-10#4)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#12)(2011-7#1)(2012-1#2)(2012-12#8)(2012-2#16)(2012-3#11)(2012-4#1)(2013-1#9)(2013-8#6)
explainable by##4##2##(1992-3#1)(1995-12#2)(2008-9#1)
explainable##6##1##(1992-3#1)(1995-12#2)(1997-7#1)(2008-9#1)(2012-2#1)
explained a##3##2##(1992-8#1)(2008-10#2)
explained about##2##2##(2008-10#1)(2012-3#1)
explained almost half of the##2##5##(2011-2#2)
explained and##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
explained approximately##2##2##(2008-5#1)(2012-3#1)
explained as a##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
explained as the##2##3##(1990-11#1)(2008-10#1)
explained as##12##2##(1990-11#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#2)(2009-6#1)
explained at##2##2##(1990-2#1)(2008-12#1)
explained between##3##2##(2008-10#2)(2009-5#1)
explained by a##18##3##(1990-11#1)(1993-1#1)(1993-8#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-8#3)(2008-9#1)
explained by an##7##3##(1994-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
explained by assuming the##4##4##(2008-10#3)(2013-1#1)
explained by assuming##8##3##(2008-10#4)(2008-11#1)(2008-3#2)(2013-1#1)
explained by comparison with##2##4##(1997-6#1)(2008-8#1)
explained by differences between##2##4##(2008-10#1)(2011-2#1)
explained by differences in##2##4##(2009-12#1)(2009-7#1)
explained by differences##5##3##(2008-10#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#1)
explained by differential##2##3##(2008-10#1)(2009-7#1)
explained by its##5##3##(1992-8#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-2#1)
explained by the fact that the##2##6##(1992-1#1)(2008-11#1)
explained by the fact that##3##5##(1992-1#1)(2008-11#1)(2008-4#1)
explained by the higher##2##4##(2008-11#1)(2013-1#1)
explained by the increased##2##4##(2008-10#1)(2009-2#1)
explained by the presence of##2##5##(2008-10#1)(2008-3#1)
explained by the underlying##2##4##(2008-11#2)
explained by the##63##3##(1990-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
explained by these##2##3##(2008-8#1)(2012-3#1)
explained by use of##2##4##(2008-3#2)
explained by##196##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-8#1)(1992-1#1)(1992-12#3)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#39)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#10)(2008-9#5)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#1)
explained from an##2##3##(2008-10#1)(2012-3#1)
explained from the##2##3##(2013-8#2)
explained from##5##2##(2008-10#2)(2012-3#1)(2013-8#2)
explained how##2##2##(1993-12#1)(2013-1#1)
explained in detail##2##3##(2008-10#2)
explained in terms of a##3##5##(1993-8#2)(2013-7#1)
explained in terms of the##5##5##(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)
explained in terms of##19##4##(1990-8#1)(1991-3#1)(1992-12#1)(1993-8#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
explained in the##2##3##(2008-4#1)(2008-7#1)
explained in##27##2##(1990-8#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-8#2)(1997-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
explained more than##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
explained most of the##2##4##(2008-10#2)
explained most variance##2##3##(2008-9#2)
explained most##4##2##(2008-10#2)(2008-9#2)
explained on the basis of##3##5##(1990-5#1)(2008-10#1)(2008-3#1)
explained on##4##2##(1990-5#1)(1996-2#1)(2008-10#1)(2008-3#1)
explained only##3##2##(1993-8#1)(2008-7#1)(2008-9#1)
explained that##2##2##(2008-7#1)(2013-8#1)
explained the##7##2##(1992-11#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)
explained this##2##2##(1997-7#1)(2008-8#1)
explained through the##2##3##(2008-10#2)
explained through##4##2##(2007-11#1)(2008-1#1)(2008-10#2)
explained to##2##2##(2008-7#1)(2010-3#1)
explained up to##5##3##(2008-10#5)
explained using a##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
explained using the##2##3##(2008-10#2)
explained using##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
explained with##5##2##(1994-3#1)(1996-3#1)(2008-10#1)(2008-3#2)
explained##419##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#4)(1990-8#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#4)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-8#1)(2007-10#3)(2007-11#13)(2007-12#6)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#115)(2008-11#13)(2008-12#6)(2008-2#8)(2008-3#23)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#12)(2008-8#17)(2008-9#12)(2009-10#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#10)(2013-1#20)(2013-7#1)(2013-8#4)
explaining an##2##2##(1997-8#1)(2009-10#1)
explaining between##2##2##(2008-10#2)
explaining over##2##2##(2008-10#2)
explaining the observed##2##3##(1993-11#1)(2008-10#1)
explaining the##18##2##(1990-8#1)(1993-11#1)(1993-12#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-12#1)
explaining##71##1##(1990-8#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-2#2)(1997-2#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
explains an##2##2##(2008-2#1)(2013-7#1)
explains how the##6##3##(1991-1#2)(1995-1#1)(2009-10#1)(2009-11#1)(2010-5#1)
explains how to##3##3##(1993-3#1)(2008-12#1)(2008-4#1)
explains how##18##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1997-3#1)(2008-12#1)(2008-4#2)(2009-10#2)(2009-11#1)(2010-5#1)(2013-8#1)
explains the##34##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
explains these##2##2##(2008-9#1)(2012-2#1)
explains this##3##2##(2007-11#1)(2007-12#1)(2012-3#1)
explains why the##2##3##(1992-5#1)(2008-1#1)
explains why##14##2##(1991-1#1)(1991-3#1)(1992-10#1)(1992-5#2)(1993-1#1)(1994-8#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
explains##92##1##(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#7)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
explanation and##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
explanation based on##2##3##(2008-9#1)(2013-1#1)
explanation could be##2##3##(2006-10#1)(2008-5#1)
explanation for a##2##3##(1994-11#1)(1997-5#1)
explanation for how##2##3##(2010-1#1)(2010-3#1)
explanation for the lack of##4##5##(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
explanation for the previously##2##4##(1992-3#1)(2011-1#1)
explanation for the##40##3##(1990-5#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1994-8#2)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
explanation for these##5##3##(1995-8#1)(1997-2#1)(2008-9#1)(2010-1#1)(2010-12#1)
explanation for this phenomenon is##2##5##(2008-4#1)(2008-8#1)
explanation for this##12##3##(1992-2#1)(1992-3#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
explanation for##81##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#1)(1994-11#2)(1994-8#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-5#1)(2007-11#4)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#8)(2008-9#8)(2010-1#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#2)
explanation is offered##2##3##(1996-9#1)(2008-7#1)
explanation is that##2##3##(1993-8#1)(2009-7#1)
explanation is##8##2##(1993-8#1)(1996-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)
explanation of a##2##3##(1991-5#1)(2008-10#1)
explanation of the phenomenon##2##4##(2008-11#1)(2008-3#1)
explanation of the##18##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
explanation of this phenomenon##2##4##(1991-6#1)(2008-2#1)
explanation of this##6##3##(1990-12#1)(1991-6#1)(1993-3#1)(1997-1#1)(2008-10#1)(2008-2#1)
explanation of why##2##3##(1993-1#1)(2010-8#1)
explanation of##42##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-3#1)(2010-8#1)(2012-2#1)(2012-7#1)(2013-7#1)(2013-8#1)
explanation that is##2##3##(2007-11#1)(2008-10#1)
explanation why##2##2##(1997-1#1)(2012-2#1)
explanation##163##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#4)(1996-4#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#6)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#3)(2010-10#2)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#3)
explanations are##5##2##(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)
explanations for the##8##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
explanations for these##3##3##(2009-11#1)(2011-1#1)(2012-12#1)
explanations for this##7##3##(1991-2#1)(1992-12#1)(1993-11#1)(2007-10#1)(2008-8#2)(2011-2#1)
explanations for##25##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
explanations of the##3##3##(1991-11#1)(2008-5#1)(2010-1#1)
explanations of##12##2##(1990-11#1)(1991-11#1)(1991-3#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2013-1#1)
explanations that##2##2##(1993-6#1)(2012-12#1)
explanations to the##2##3##(2008-10#1)(2008-8#1)
explanations to##3##2##(1993-9#1)(2008-10#1)(2008-8#1)
explanations##67##1##(1990-11#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-2#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#1)(2009-7#2)(2009-9#6)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
explanatory factors##3##2##(1997-8#1)(2008-7#2)
explanatory power##6##2##(1993-3#1)(1997-1#1)(2008-10#3)(2010-4#1)
explanatory value##2##2##(1995-11#1)(2008-11#1)
explanatory variables on##2##3##(2008-10#1)(2008-4#1)
explanatory variables##14##2##(1992-1#1)(1992-6#2)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#3)(2008-4#1)(2010-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
explanatory##39##1##(1990-2#1)(1992-1#1)(1992-12#1)(1992-6#3)(1993-3#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-4#1)(2012-1#1)(2013-7#1)(2013-8#2)
explant culture##2##2##(1995-9#1)(1996-5#1)
explant cultures##3##2##(1994-3#1)(1995-9#1)(1996-5#1)
explant for##3##2##(2008-12#1)(2013-1#2)
explant outgrowth##2##2##(2008-11#2)
explant##21##1##(1994-3#1)(1995-9#2)(1996-5#2)(2008-10#1)(2008-11#5)(2008-12#4)(2008-7#1)(2010-9#2)(2011-3#1)(2013-1#2)
explantation of the##2##3##(2007-8#1)(2008-9#1)
explantation of##3##2##(2007-8#1)(2008-9#2)
explantation##12##1##(2007-8#1)(2008-10#2)(2008-9#8)(2010-4#1)
explanted endovascular##2##2##(2008-11#2)
explanted retina##2##2##(2010-1#2)
explanted##16##1##(1993-9#1)(2008-10#1)(2008-11#3)(2008-9#3)(2010-1#2)(2010-4#1)(2012-12#3)(2012-3#1)(2013-1#1)
explants from##3##2##(1996-5#1)(2008-10#1)(2013-1#1)
explants indicate##2##2##(1993-11#1)(2013-1#1)
explants kept##2##2##(2009-7#1)(2010-1#1)
explants of##3##2##(2008-12#2)(2008-7#1)
explants was##2##2##(2008-8#1)(2010-9#1)
explants were##2##2##(1996-5#1)(2008-12#1)
explants##41##1##(1990-3#1)(1993-11#1)(1994-5#1)(1996-5#7)(2008-10#1)(2008-12#13)(2008-7#1)(2008-8#2)(2009-7#3)(2010-1#4)(2010-2#1)(2010-9#2)(2013-1#4)
explicable##3##1##(2008-4#1)(2008-5#1)(2008-7#1)
explicate the##3##2##(2008-12#1)(2012-2#1)(2013-7#1)
explicate##5##1##(2008-12#2)(2010-10#1)(2012-2#1)(2013-7#1)
explicating##3##1##(2008-7#1)(2009-9#1)(2010-7#1)
explicit analytical##2##2##(2008-3#2)
explicit and##3##2##(2008-12#1)(2008-7#1)(2009-9#1)
explicit attitudes toward fatness##4##4##(2007-12#4)
explicit attitudes toward##5##3##(2007-12#4)(2009-9#1)
explicit attitudes##11##2##(2007-12#6)(2009-9#5)
explicit expressions of##2##3##(2008-10#2)
explicit expressions##3##2##(2008-10#2)(2008-3#1)
explicit goal to##2##3##(2008-11#2)
explicit goal##3##2##(2008-11#3)
explicit or##3##2##(2013-1#3)
explicit representation of the##2##4##(2008-4#1)(2008-8#1)
explicit simulation model##2##3##(2008-8#1)(2008-9#1)
explicit solvent##6##2##(1995-3#1)(2008-4#1)(2009-7#1)(2010-2#3)
explicit use of the##2##4##(2008-7#1)(2008-9#1)
explicit##108##1##(1991-12#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#3)(1997-7#1)(2007-12#9)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#13)(2008-9#5)(2009-10#1)(2009-7#1)(2009-9#7)(2010-12#3)(2010-2#3)(2010-5#1)(2010-8#3)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
explicit-solvent##2##1##(2012-2#1)(2013-1#1)
explicitly considered##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
explicitly defined##2##2##(1994-6#1)(2008-2#1)
explicitly for##2##2##(2008-3#2)
explicitly include##2##2##(2008-10#1)(2009-8#1)
explicitly includes##3##2##(1994-2#1)(1996-4#1)(2008-2#1)
explicitly the##3##2##(1995-5#1)(2008-2#1)(2008-3#1)
explicitly##68##1##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#10)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#3)
explode##2##1##(1991-1#1)(2008-5#1)
exploding##2##1##(1993-3#1)(2009-9#1)
exploit it##2##2##(2007-11#1)(2009-1#1)
exploit the high##2##3##(2007-12#2)
exploit the##20##2##(2007-11#1)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)
exploit##44##1##(1992-3#1)(1997-1#1)(2007-11#2)(2007-12#6)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
exploitation and##3##2##(1995-5#1)(2008-1#1)(2008-8#1)
exploitation as a##2##3##(2008-2#1)(2011-2#1)
exploitation by##3##2##(1996-12#1)(2012-3#1)(2013-1#1)
exploitation of a##2##3##(2008-2#1)(2008-8#1)
exploitation of the Ni(III)/Ni(II)##2##4##(2008-10#2)
exploitation of the##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)
exploitation of##23##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-1#4)(2012-1#1)
exploitation strategies##5##2##(2008-8#5)
exploitation##60##1##(1994-11#1)(1994-12#1)(1995-3#1)(1995-5#7)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
exploitative##3##1##(1995-5#1)(2008-8#1)(2008-9#1)
exploited and##3##2##(2008-5#1)(2012-2#1)(2013-7#1)
exploited as##4##2##(2008-10#3)(2013-1#1)
exploited because##2##2##(1997-4#1)(2011-2#1)
exploited by##6##2##(1993-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-2#1)
exploited for the determination of##2##5##(1992-11#1)(2008-3#1)
exploited for the##4##3##(1992-11#1)(2008-3#1)(2009-3#1)(2011-2#1)
exploited for##14##2##(1992-11#1)(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-3#2)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
exploited in order to##2##4##(2008-10#2)
exploited in the##2##3##(2008-1#1)(2008-10#1)
exploited in##14##2##(1996-11#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)
exploited is##2##2##(2008-7#1)(2009-3#1)
exploited sites##2##2##(2008-5#2)
exploited the##4##2##(1992-4#1)(1994-2#1)(2007-12#1)(2008-10#1)
exploited to determine##2##3##(2008-10#1)(2008-8#1)
exploited to develop##4##3##(2008-1#1)(2008-10#2)(2009-6#1)
exploited to##25##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-7#1)
exploited##105##1##(1990-8#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-4#1)(2007-11#3)(2007-12#2)(2008-1#3)(2008-10#26)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-6#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)
exploiting a priori information##2##4##(2008-2#1)(2008-3#1)
exploiting a##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
exploiting its##2##2##(2010-3#1)(2012-3#1)
exploiting multicommutation and##2##3##(2008-10#2)
exploiting multicommutation##3##2##(2008-10#3)
exploiting the parental care of##2##5##(2008-9#2)
exploiting the##20##2##(1990-8#1)(1994-11#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)
exploiting this##2##2##(2008-2#1)(2008-7#1)
exploiting two##2##2##(2008-10#1)(2011-1#1)
exploiting##56##1##(1990-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-7#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#19)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#3)(2008-9#4)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
exploits the##14##2##(1990-11#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2009-9#1)(2012-2#2)(2013-7#1)
exploits##29##1##(1990-11#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#10)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2012-2#2)(2013-1#1)(2013-7#1)
exploration and production##2##3##(2008-6#2)
exploration and##10##2##(1992-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#2)(2010-7#1)(2011-1#1)(2013-1#1)
exploration for##4##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-2#1)
exploration is##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
exploration of a##2##3##(2009-8#1)(2013-1#1)
exploration of the##34##3##(1990-2#1)(1990-6#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-12#4)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#2)
exploration of this##2##3##(2009-5#1)(2012-5#1)
exploration of##70##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#2)(2013-8#4)
exploration revealed a##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
exploration to##3##2##(2008-7#1)(2013-1#2)
exploration via##3##2##(2009-5#1)(2010-10#1)(2010-7#1)
exploration##133##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#1)(2009-5#3)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#8)(2013-8#4)
explorations into##2##2##(2008-2#1)(2012-3#1)
explorations of##2##2##(2009-4#1)(2010-11#1)
explorations##7##1##(2007-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-2#1)(2012-3#1)
explorative##9##1##(1991-3#1)(1992-5#1)(2009-12#1)(2011-2#3)(2013-1#3)
exploratory analysis##5##2##(1995-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
exploratory and##2##2##(2008-11#1)(2012-3#1)
exploratory behavior##4##2##(1993-6#2)(1996-2#1)(2008-8#1)
exploratory data analysis##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
exploratory descriptive study##2##3##(2010-3#1)(2010-5#1)
exploratory descriptive##4##2##(1992-1#1)(2010-3#2)(2010-5#1)
exploratory factor analyses##3##3##(2009-11#1)(2009-9#1)(2010-11#1)
exploratory factor analysis##2##3##(2008-10#1)(2009-12#1)
exploratory factor##5##2##(2008-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-11#1)
exploratory investigation of reactions##2##4##(2008-10#2)
exploratory laparotomy##6##2##(1990-2#1)(1993-6#1)(1993-9#1)(2008-7#1)(2011-2#2)
exploratory studies##2##2##(2008-1#1)(2008-7#1)
exploratory study of##3##3##(1995-3#1)(2009-5#1)(2010-10#1)
exploratory study was undertaken##2##4##(2008-11#2)
exploratory study was##3##3##(2008-11#2)(2011-2#1)
exploratory study##26##2##(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
exploratory##96##1##(1990-2#1)(1991-12#1)(1991-8#2)(1992-1#1)(1992-2#1)(1993-2#2)(1993-3#1)(1993-6#3)(1993-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-7#2)(2009-9#1)(2010-10#3)(2010-11#3)(2010-3#3)(2010-5#1)(2010-6#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#5)(2013-8#1)
explore a##7##2##(1991-12#1)(1994-12#1)(1995-8#1)(2008-11#2)(2008-9#1)(2013-7#1)
explore and##8##2##(1991-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)
explore how to##2##3##(2010-5#1)(2012-3#1)
explore how##11##2##(1995-12#1)(1997-3#1)(2008-11#1)(2008-8#2)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
explore its##2##2##(2009-8#1)(2012-1#1)
explore many##2##2##(1996-2#1)(2010-12#1)
explore more##3##2##(2008-11#1)(2008-7#1)(2011-3#1)
explore new##2##2##(2008-8#1)(2010-3#1)
explore nursing##2##2##(2008-12#1)(2010-10#1)
explore possible##5##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
explore relationships##2##2##(2013-1#2)
explore some of the##5##4##(1994-1#1)(2008-7#2)(2010-5#1)(2012-2#1)
explore some of##6##3##(1991-5#1)(1994-1#1)(2008-7#2)(2010-5#1)(2012-2#1)
explore the consequences of##4##4##(2008-8#2)(2009-8#1)(2010-10#1)
explore the consequences##5##3##(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)
explore the current##2##3##(1997-1#1)(2009-4#1)
explore the diversity##2##3##(2010-2#1)(2010-3#1)
explore the effects of##8##4##(1995-9#1)(2007-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
explore the evolution of##2##4##(2008-8#2)
explore the experiences##2##3##(2011-1#1)(2013-8#1)
explore the factors##2##3##(2008-8#1)(2011-2#1)
explore the issues of##2##4##(2008-12#1)(2011-2#1)
explore the mechanism of##2##4##(1994-6#1)(1996-2#1)
explore the mechanisms underlying##2##4##(2008-9#2)
explore the method's##2##3##(1997-3#1)(2008-2#1)
explore the possibility of##4##4##(1993-12#1)(1993-3#1)(2008-11#1)(2012-3#1)
explore the possibility##5##3##(1993-12#1)(1993-3#1)(1995-11#1)(2008-11#1)(2012-3#1)
explore the possible##2##3##(2008-9#1)(2012-12#1)
explore the potential for##2##4##(2008-10#1)(2008-11#1)
explore the potential of##5##4##(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
explore the potential##9##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)(2013-1#1)
explore the reasons why##2##4##(1991-2#1)(2013-1#1)
explore the relationship between##6##4##(1995-1#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#1)
explore the relationship##7##3##(1995-1#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#1)(2013-8#1)
explore the relationships between##3##4##(2010-8#1)(2011-1#1)(2012-2#1)
explore the relationships##4##3##(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
explore the role of##5##4##(1992-12#1)(1996-5#1)(2008-1#1)(2008-11#1)(2012-12#1)
explore the sensitivity##2##3##(2007-12#1)(2008-6#1)
explore the structural##2##3##(2008-8#1)(2011-2#1)
explore the use of##5##4##(1996-7#1)(2008-10#2)(2008-5#1)(2008-8#1)
explore the##182##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(2006-10#1)(2007-12#7)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#13)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#3)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#4)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#12)(2011-2#8)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#4)
explore their##4##2##(1994-6#1)(2008-11#1)(2010-8#1)(2011-2#1)
explore these##2##2##(1992-9#1)(2012-12#1)
explore this possibility##5##3##(1993-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
explore this##11##2##(1993-11#1)(1993-6#1)(1997-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2013-1#1)(2013-8#2)
explore two##2##2##(2007-11#1)(2008-3#1)
explore various##2##2##(2008-5#1)(2012-3#1)
explore ways##3##2##(1994-1#1)(1997-1#1)(2011-2#1)
explore what##2##2##(2008-1#1)(2012-12#1)
explore whether##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2013-1#1)
explore##358##1##(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#5)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#2)(1996-5#1)(1996-7#2)(1997-1#3)(1997-3#4)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#18)(2008-11#22)(2008-12#11)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#19)(2008-9#8)(2009-10#2)(2009-11#3)(2009-12#4)(2009-4#2)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#10)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#19)(2011-2#12)(2011-3#2)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#13)(2013-1#24)(2013-7#4)(2013-8#7)
explored and##10##2##(1992-1#1)(1992-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
explored as a##4##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
explored as##10##2##(1995-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-12#1)
explored aspects##2##2##(2007-12#1)(2012-12#1)
explored at##3##2##(1995-2#1)(2008-10#2)
explored by##7##2##(1993-12#1)(1995-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)
explored for##12##2##(2008-10#5)(2008-3#1)(2008-7#1)(2009-12#2)(2010-2#1)(2012-2#1)(2012-5#1)
explored how##5##2##(2008-11#1)(2008-12#1)(2009-7#1)(2012-3#1)(2013-1#1)
explored in a##4##3##(1990-12#1)(2008-10#1)(2008-7#1)(2010-1#1)
explored in detail##3##3##(2008-3#2)(2012-2#1)
explored in relation to##3##4##(1996-1#1)(2007-12#1)(2008-2#1)
explored in the##3##3##(2008-10#2)(2009-10#1)
explored in this article##2##4##(1992-1#1)(1994-2#1)
explored in this paper##3##4##(1990-8#1)(2007-10#1)(2008-12#1)
explored in this##5##3##(1990-8#1)(1992-1#1)(1994-2#1)(2007-10#1)(2008-12#1)
explored in##33##2##(1990-12#1)(1990-8#1)(1991-8#2)(1992-1#1)(1994-2#1)(1996-1#1)(1996-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
explored several##2##2##(2008-3#1)(2008-9#1)
explored the analytical##2##3##(2008-10#2)
explored the effect##2##3##(1990-8#1)(2008-9#1)
explored the idea##2##3##(2008-10#1)(2008-8#1)
explored the impact of##3##4##(2008-11#1)(2013-1#2)
explored the nature##2##3##(2007-10#1)(2010-3#1)
explored the patterns of##2##4##(2008-4#1)(2009-8#1)
explored the perceptions of##2##4##(2008-11#1)(2010-9#1)
explored the perceptions##3##3##(2008-11#1)(2010-11#1)(2010-9#1)
explored the possibility of using##2##5##(2007-11#1)(2008-10#1)
explored the possibility of##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
explored the possibility##4##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
explored the possible##2##3##(1996-1#1)(2009-10#1)
explored the potential##2##3##(2008-5#2)
explored the role of##3##4##(2008-7#1)(2010-1#1)(2012-2#1)
explored the use of##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
explored the##64##2##(1990-8#1)(1991-9#1)(1992-2#1)(1993-12#3)(1994-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
explored these issues##2##3##(2009-5#1)(2012-2#1)
explored this##2##2##(2008-6#1)(2013-1#1)
explored to convert##2##3##(2008-10#1)(2008-6#1)
explored to##8##2##(1995-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
explored using a##3##3##(1993-1#1)(2008-1#1)(2013-7#1)
explored using##7##2##(1993-1#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
explored with##4##2##(2010-9#1)(2012-12#2)(2013-1#1)
explored##313##1##(1990-12#1)(1990-8#3)(1991-1#1)(1991-2#2)(1991-3#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-9#2)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(2007-10#4)(2007-11#1)(2007-12#8)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#46)(2008-11#22)(2008-12#10)(2008-2#8)(2008-3#14)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#10)(2008-9#10)(2009-10#5)(2009-12#3)(2009-5#5)(2009-7#5)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#9)(2012-2#8)(2012-3#4)(2012-5#1)(2013-1#17)(2013-7#2)(2013-8#3)
explorers##2##1##(1994-3#1)(2012-2#1)
explores a##2##2##(2009-10#1)(2012-2#1)
explores access to##2##3##(2008-11#1)(2008-12#1)
explores how a##2##3##(2008-12#1)(2009-3#1)
explores how##10##2##(2008-11#2)(2008-12#1)(2008-4#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-9#1)(2011-2#1)(2013-8#1)
explores possible##2##2##(1992-3#1)(2008-7#1)
explores recent##2##2##(1996-3#1)(2008-11#1)
explores several##3##2##(1994-2#1)(1995-3#1)(2008-12#1)
explores some of the##4##4##(1992-2#1)(2008-1#1)(2008-7#2)
explores the consequences of##2##4##(2007-1#1)(2008-8#1)
explores the development of##2##4##(1994-12#1)(2010-10#1)
explores the evolution of##2##4##(1995-2#1)(1996-3#1)
explores the impact of##3##4##(1997-1#1)(2008-11#1)(2013-8#1)
explores the possibility of##2##4##(2008-10#1)(2011-2#1)
explores the possibility##3##3##(2008-10#1)(2011-2#2)
explores the relationship between##3##4##(1996-2#2)(2011-2#1)
explores the relationship of##2##4##(1996-2#1)(2007-2#1)
explores the relationship##5##3##(1996-2#3)(2007-2#1)(2011-2#1)
explores the role##2##3##(2008-1#1)(2011-2#1)
explores the use of##3##4##(1992-9#1)(2008-10#1)(2011-2#1)
explores the##71##2##(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#3)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#2)(1997-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
explores whether##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
explores##137##1##(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#5)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#6)(1996-3#3)(1997-1#4)(1997-3#1)(1997-4#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#6)(2008-11#14)(2008-12#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#8)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#9)
exploring the changes in##2##4##(2008-11#1)(2013-8#1)
exploring the effect of place of birth and comparing third stage management of labor##2##14##(2013-1#2)
exploring the effect of##4##4##(2008-11#1)(2010-2#1)(2013-1#2)
exploring the impact of a##2##5##(2008-11#1)(2012-1#1)
exploring the impact of##3##4##(2008-11#1)(2009-4#1)(2012-1#1)
exploring the##38##2##(1994-6#1)(1995-2#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
exploring their##3##2##(2008-11#1)(2008-7#1)(2009-7#1)
exploring##75##1##(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
explosion due to##2##3##(2009-10#2)
explosion in##3##2##(2007-7#1)(2007-8#1)(2008-11#1)
explosion of research##3##3##(2008-5#1)(2013-1#2)
explosion of##12##2##(1992-9#1)(1993-2#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#2)
explosion##24##1##(1992-2#1)(1992-9#1)(1993-2#1)(2006-10#1)(2007-7#1)(2007-8#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#3)(2011-2#1)(2013-1#4)
explosions and##2##2##(2008-10#1)(2012-2#1)
explosions##5##1##(1992-6#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
explosive compounds and##2##3##(2008-10#2)
explosive compounds##3##2##(2008-10#3)
explosive disorder##2##2##(2011-2#2)
explosive odor##2##2##(2008-10#2)
explosive substances##2##2##(2009-10#2)
explosive##44##1##(1993-6#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2011-2#3)(2013-8#1)
explosively##2##1##(2008-10#1)(2010-3#1)
explosives and##5##2##(2008-10#5)
explosives detection##5##2##(2008-10#5)
explosives in soil##2##3##(2008-10#2)
explosives in##7##2##(2008-10#7)
explosives is##2##2##(2008-10#2)
explosives using##3##2##(2008-10#3)
explosives were##2##2##(2008-10#2)
explosives##63##1##(2008-10#57)(2008-11#4)(2008-3#1)(2009-10#1)
exponent n##2##2##(2008-2#1)(2009-12#1)
exponent of the##2##3##(2008-2#1)(2008-3#1)
exponent of##5##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)
exponent##15##1##(2008-10#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-8#1)(2012-2#2)
exponential cell growth##2##3##(2008-11#2)
exponential decay##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
exponential decrease##4##2##(1995-2#1)(2008-11#2)(2008-3#1)
exponential function##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
exponential functions##6##2##(1994-11#1)(2008-10#1)(2008-3#2)(2009-4#2)
exponential growth in##2##3##(2008-11#1)(2011-2#1)
exponential growth of##2##3##(2007-11#1)(2013-8#1)
exponential growth phase and##2##4##(2008-11#2)
exponential growth phase##9##3##(2008-11#6)(2008-7#2)(2011-2#1)
exponential growth##22##2##(1994-11#1)(1995-8#1)(1995-9#1)(2007-11#1)(2008-11#7)(2008-7#6)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
exponential increase in the##3##4##(1995-3#1)(2009-6#1)(2012-2#1)
exponential increase in##5##3##(1995-3#1)(2007-12#1)(2009-11#1)(2009-6#1)(2012-2#1)
exponential increase of##2##3##(1995-9#1)(2008-10#1)
exponential increase##8##2##(1995-3#1)(1995-9#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-6#1)(2012-2#2)
exponential law##2##2##(2008-10#1)(2013-8#1)
exponential model##8##2##(1992-6#1)(1995-9#1)(2008-10#5)(2013-8#1)
exponential or##2##2##(2008-10#1)(2008-2#1)
exponential phase##14##2##(1991-6#1)(1993-8#1)(1994-8#1)(2008-11#9)(2008-7#1)(2011-2#1)
exponential to the##2##3##(2007-12#1)(2011-2#1)
exponential to##3##2##(1991-6#1)(2007-12#1)(2011-2#1)
exponential with##2##2##(1990-7#1)(2008-3#1)
exponential##139##1##(1990-7#1)(1991-12#1)(1991-6#2)(1992-6#2)(1992-9#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-5#1)(2007-10#2)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#29)(2008-11#20)(2008-2#7)(2008-3#17)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-2#5)(2013-1#2)(2013-8#4)
exponential-Gompertzian##2##1##(1991-6#2)
exponential-curve fitting##2##2##(2008-2#1)(2008-3#1)
exponential-curve##3##1##(2008-2#1)(2008-3#2)
exponential-growth phase##2##2##(2008-11#2)
exponentially and##2##2##(2008-10#2)
exponentially decaying##2##2##(2008-3#1)(2010-1#1)
exponentially distributed##5##2##(1994-2#1)(1995-6#1)(2008-1#1)(2008-8#2)
exponentially growing##4##2##(1993-11#1)(1995-2#1)(2008-11#1)(2012-3#1)
exponentially in##2##2##(2007-8#1)(2013-8#1)
exponentially over##2##2##(2007-12#1)(2008-7#1)
exponentially tapered T-tube model##2##4##(2008-3#2)
exponentially with increasing##6##3##(1990-7#1)(2008-10#4)(2008-3#1)
exponentially with the##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
exponentially with time##3##3##(2008-10#2)(2009-11#1)
exponentially with##17##2##(1990-7#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2013-8#1)
exponentially##54##1##(1990-7#1)(1993-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#8)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-7#1)(2013-8#3)
exponents for##2##2##(1990-12#1)(2008-8#1)
exponents##3##1##(1990-12#1)(1993-5#1)(2008-8#1)
export from the##2##3##(1997-4#1)(2012-2#1)
export in##2##2##(2008-10#1)(2008-7#1)
export of##9##2##(1991-2#1)(1992-11#1)(2008-10#2)(2008-8#1)(2009-9#1)(2011-2#2)(2011-3#1)
export to##2##2##(2008-12#1)(2012-2#1)
export with##2##2##(2008-8#2)
export##50##1##(1991-2#1)(1991-6#1)(1992-11#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-5#4)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-9#1)(2011-2#9)(2011-3#5)(2012-2#4)
exported to##2##2##(1995-6#1)(2007-6#1)
exported##7##1##(1991-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(2007-6#1)(2008-11#1)(2008-9#1)
exports##4##1##(1992-5#1)(2007-5#1)(2012-2#1)(2013-1#1)
expose the##12##2##(1992-1#1)(1994-8#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
expose themselves to##2##3##(1992-9#1)(2008-7#1)
expose##30##1##(1992-1#1)(1992-9#1)(1994-8#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
exposed PS##2##2##(2008-11#2)
exposed and nonexposed##2##3##(2008-10#1)(2011-1#1)
exposed and##13##2##(1990-11#1)(1990-5#1)(1990-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
exposed at##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
exposed body##2##2##(2008-1#1)(2008-5#1)
exposed by a##2##3##(2008-9#2)
exposed by##4##2##(2008-10#1)(2008-9#3)
exposed cells##3##2##(1997-4#2)(2008-7#1)
exposed diaphragma sellae##2##3##(2011-2#2)
exposed directly##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
exposed during##2##2##(2008-10#2)
exposed females##3##2##(2008-9#3)
exposed for##12##2##(1991-12#1)(1995-12#1)(2008-10#1)(2008-12#3)(2008-9#3)(2011-1#1)(2011-2#2)
exposed group##3##2##(1994-5#1)(2008-12#1)(2009-12#1)
exposed groups was similar to that of##4##7##(2008-8#1)(2008-9#3)
exposed groups was similar to that##8##6##(2008-8#3)(2008-9#5)
exposed groups##13##2##(2008-8#3)(2008-9#10)
exposed hydrophobic##2##2##(1993-9#1)(2008-10#1)
exposed in vitro to##2##4##(2008-11#1)(2008-7#1)
exposed in vitro##3##3##(1996-5#1)(2008-11#1)(2008-7#1)
exposed in##14##2##(1991-9#1)(1995-5#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#1)
exposed individuals##4##2##(1991-12#3)(1995-3#1)
exposed loop##2##2##(1993-12#1)(1995-8#1)
exposed males was##2##3##(2008-9#2)
exposed males##10##2##(2008-9#10)
exposed mice##5##2##(1995-3#1)(2008-10#2)(2008-9#2)
exposed more##2##2##(2007-12#1)(2008-12#1)
exposed nurses##2##2##(2012-1#2)
exposed on the soil surface##2##5##(2008-10#1)(2008-11#1)
exposed on the##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
exposed on##4##2##(1991-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
exposed only##3##2##(1997-8#1)(2008-9#2)
exposed over##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
exposed parts of the body##2##5##(2007-7#2)
exposed parts of the##3##4##(2007-7#2)(2008-7#1)
exposed patients##3##2##(2012-2#1)(2013-1#2)
exposed persons##2##2##(2008-7#1)(2013-8#1)
exposed population##5##2##(1991-12#1)(2009-10#1)(2011-2#2)(2013-1#1)
exposed populations##4##2##(1991-12#1)(2008-10#1)(2008-9#2)
exposed subjects##3##2##(2008-10#1)(2010-11#1)(2011-1#1)
exposed the##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
exposed to 0##5##3##(2008-10#1)(2008-12#2)(2008-9#2)
exposed to 1##5##3##(1992-9#1)(2008-11#1)(2008-9#3)
exposed to 10##3##3##(1992-3#1)(1995-11#1)(2008-10#1)
exposed to 100##2##3##(2008-10#2)
exposed to 100%##2##3##(1993-12#1)(2008-10#1)
exposed to 2##4##3##(1992-12#1)(1993-12#1)(2008-10#1)(2008-8#1)
exposed to 3##2##3##(2008-12#1)(2008-8#1)
exposed to 50##2##3##(1997-4#2)
exposed to AhR ligands##2##4##(2008-10#2)
exposed to DES##3##3##(2008-10#3)
exposed to EGF##3##3##(1994-6#3)
exposed to H(2)S##2##3##(2008-10#2)
exposed to HIV##2##3##(2008-5#1)(2009-7#1)
exposed to IOFB##3##3##(2009-12#3)
exposed to LPS##2##3##(1995-12#1)(2008-11#1)
exposed to NaCl##2##3##(2008-10#2)
exposed to NaF##2##3##(1990-8#1)(2013-1#1)
exposed to UV light##2##4##(2008-10#2)
exposed to UV-C##2##3##(1995-12#1)(2008-12#1)
exposed to a single pulsed electric field##2##7##(2008-9#2)
exposed to a single##4##4##(1993-12#1)(2008-10#1)(2008-9#2)
exposed to a##36##3##(1990-2#3)(1993-12#1)(1994-6#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
exposed to air warming##2##4##(2012-5#1)(2012-6#1)
exposed to air##4##3##(2007-11#1)(2008-10#1)(2012-5#1)(2012-6#1)
exposed to ambient##4##3##(2008-10#1)(2008-3#1)(2009-9#1)(2012-7#1)
exposed to an##6##3##(1997-4#2)(2008-12#1)(2008-3#1)(2011-2#2)
exposed to bFGF##2##3##(2008-11#2)
exposed to cadmium##2##3##(1993-12#1)(2008-10#1)
exposed to chronic##2##3##(2008-10#1)(2010-4#1)
exposed to cocaine##2##3##(1991-5#1)(2010-11#1)
exposed to cold##2##3##(2011-2#2)
exposed to constant temperatures of##2##5##(2008-10#2)
exposed to constant##5##3##(2008-10#3)(2008-5#1)(2012-4#1)
exposed to dichloroacetic acid for 26 or##2##7##(2008-9#2)
exposed to dichloroacetic acid in the drinking water##4##8##(2008-9#4)
exposed to dichloroacetic acid in##5##5##(2008-9#5)
exposed to dichloroacetic acid##8##4##(2008-9#8)
exposed to diethylstilbestrol##3##3##(1990-7#2)(2008-10#1)
exposed to different##8##3##(1991-6#1)(1996-5#1)(2008-10#4)(2011-1#1)(2013-1#1)
exposed to environmental##5##3##(1995-6#1)(2008-1#1)(2010-4#3)
exposed to high##7##3##(1991-5#1)(1992-6#1)(1994-2#2)(2008-7#1)(2012-2#1)(2013-1#1)
exposed to hypoxia##2##3##(1991-2#1)(2013-1#1)
exposed to increased##2##3##(2008-7#1)(2010-4#1)
exposed to ionizing radiation##2##4##(1996-6#1)(2008-9#1)
exposed to ionizing##3##3##(1996-6#1)(2008-7#1)(2008-9#1)
exposed to light##4##3##(2007-12#1)(2008-10#1)(2009-4#1)(2009-9#1)
exposed to low##5##3##(1992-9#1)(2008-12#1)(2008-7#2)(2010-4#1)
exposed to mealybugs##3##3##(2008-10#3)
exposed to methanol##2##3##(1995-3#2)
exposed to natural##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
exposed to negative nonparental adult##2##5##(2009-7#2)
exposed to periods of##2##4##(2008-10#2)
exposed to potentially##2##3##(1990-8#1)(1994-3#1)
exposed to radiation##4##3##(1997-3#1)(2008-7#3)
exposed to selection##2##3##(2008-10#1)(2008-9#1)
exposed to severe##2##3##(1994-5#1)(2008-10#1)
exposed to simulated##2##3##(2008-5#1)(2013-7#1)
exposed to sodium bromate##3##4##(2008-9#3)
exposed to soil##2##3##(2008-10#1)(2012-6#1)
exposed to solar##2##3##(2008-5#1)(2011-2#1)
exposed to temperatures ranging from##2##5##(2008-10#2)
exposed to the aqueous##2##4##(1994-2#1)(1995-12#1)
exposed to the combination##2##4##(1990-2#1)(1991-12#1)
exposed to the environment##2##4##(2008-11#1)(2008-5#1)
exposed to the external environment##2##5##(1995-3#1)(2008-5#1)
exposed to the##47##3##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-3#1)(2009-9#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
exposed to these##2##3##(1990-11#1)(1997-4#1)
exposed to tobacco smoke##2##4##(1991-12#1)(1994-2#1)
exposed to tobacco##4##3##(1991-12#1)(1993-6#1)(1994-2#1)(2013-1#1)
exposed to##518##2##(1990-11#2)(1990-12#2)(1990-2#6)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#4)(1991-11#2)(1991-12#7)(1991-2#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#7)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#6)(1994-6#6)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#8)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#3)(1997-2#3)(1997-3#1)(1997-4#10)(1997-6#2)(2006-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#96)(2008-11#23)(2008-12#14)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#21)(2008-8#10)(2008-9#42)(2009-11#2)(2009-12#6)(2009-3#1)(2009-4#2)(2009-7#4)(2009-9#5)(2010-11#4)(2010-4#8)(2010-5#4)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#24)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#21)(2013-7#2)(2013-8#6)
exposed workers##7##2##(1994-9#1)(2008-10#1)(2009-12#3)(2010-12#1)(2011-2#1)
exposed##748##1##(1990-11#4)(1990-12#2)(1990-2#8)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#1)(1991-11#2)(1991-12#15)(1991-2#3)(1991-4#1)(1991-5#5)(1991-6#1)(1991-9#2)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#8)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-12#9)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#7)(1994-6#6)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#10)(1995-2#1)(1995-3#7)(1995-5#6)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#3)(1997-2#4)(1997-3#1)(1997-4#12)(1997-6#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#121)(2008-11#32)(2008-12#22)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#19)(2008-6#3)(2008-7#29)(2008-8#15)(2008-9#85)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#10)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#4)(2009-9#6)(2010-11#5)(2010-12#1)(2010-3#1)(2010-4#9)(2010-5#4)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#39)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#4)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#31)(2013-7#3)(2013-8#8)
exposes the##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
exposes##6##1##(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)
exposing the##8##2##(1993-9#1)(1995-12#1)(1997-4#1)(2007-8#1)(2008-11#1)(2010-4#1)(2013-1#2)
exposing##29##1##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#1)(1993-9#1)(1995-12#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
exposition of the##4##3##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#1)
exposition of##5##2##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
exposition to fluoroscopy##2##3##(2013-1#2)
exposition to##3##2##(1992-11#1)(2013-1#2)
exposition##15##1##(1990-12#1)(1992-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2009-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
exposure -##2##2##(2008-4#1)(2011-2#1)
exposure affects##2##2##(2010-8#1)(2012-3#1)
exposure also##2##2##(1995-12#1)(2008-10#1)
exposure among infants##2##3##(1992-12#1)(2011-2#1)
exposure among##4##2##(1991-12#1)(1992-12#1)(2011-2#1)(2012-2#1)
exposure and any##2##3##(2008-11#1)(2011-2#1)
exposure and in##2##3##(1994-2#1)(2007-8#1)
exposure and outcome##2##3##(1994-2#2)
exposure and response##2##3##(2008-7#1)(2012-1#1)
exposure and subsequent##3##3##(1990-5#1)(2007-12#1)(2008-7#1)
exposure and that##2##3##(1995-8#1)(2010-11#1)
exposure and the##4##3##(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
exposure and was##2##3##(1990-5#1)(2008-5#1)
exposure and##80##2##(1990-10#1)(1990-5#4)(1990-8#1)(1991-12#3)(1992-12#1)(1992-3#1)(1992-6#3)(1994-12#1)(1994-2#3)(1994-3#1)(1995-2#1)(1995-8#1)(1996-6#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)
exposure are necessary##2##3##(2008-10#1)(2009-11#1)
exposure are##9##2##(2007-12#1)(2008-10#1)(2008-7#3)(2009-11#1)(2010-11#1)(2013-1#2)
exposure as##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#2)
exposure assessment and##2##3##(2008-5#1)(2011-2#1)
exposure assessment##4##2##(2008-5#1)(2008-6#1)(2011-2#2)
exposure at TNT concentrations##2##4##(2008-12#2)
exposure at a##2##3##(2008-10#1)(2010-11#1)
exposure at the##5##3##(1995-2#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
exposure at##14##2##(1995-2#1)(1997-4#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
exposure between##2##2##(2008-10#1)(2008-7#1)
exposure by##3##2##(2008-11#2)(2013-1#1)
exposure can be##3##3##(1995-11#1)(2011-1#1)(2012-3#1)
exposure can impair the##2##4##(2008-10#2)
exposure can result in##2##4##(1996-12#1)(2011-2#1)
exposure can##8##2##(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-3#1)
exposure causes##2##2##(2008-10#1)(2011-2#1)
exposure chamber##2##2##(2008-10#1)(2008-5#1)
exposure concentration##7##2##(1990-5#1)(1996-12#1)(2008-7#2)(2008-9#3)
exposure concentrations##3##2##(1990-5#1)(1993-8#1)(2008-7#1)
exposure conditions##2##2##(1992-11#2)
exposure did not##2##3##(2008-10#1)(2010-8#1)
exposure does not##2##3##(1994-2#1)(2011-2#1)
exposure dose of##2##3##(2007-12#2)
exposure dose##8##2##(1992-3#1)(2007-12#4)(2008-10#2)(2009-11#1)
exposure duration##2##2##(2011-2#1)(2013-1#1)
exposure during##11##2##(1992-2#1)(1992-3#1)(1993-1#2)(1995-12#1)(1995-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
exposure for the##2##3##(2009-7#1)(2011-1#1)
exposure for##14##2##(1991-9#1)(1992-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-8#1)
exposure from##8##2##(1991-12#1)(1992-3#1)(1995-3#1)(1996-6#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#1)
exposure group##2##2##(2008-10#1)(2011-2#1)
exposure has been##4##3##(1990-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
exposure in a##3##3##(1990-2#1)(2008-11#1)(2008-7#1)
exposure in human##2##3##(2008-12#1)(2013-8#1)
exposure in mice##2##3##(1992-2#1)(2008-4#1)
exposure in the##6##3##(1991-12#1)(1995-12#1)(2009-12#1)(2011-2#2)(2012-3#1)
exposure in unison##2##3##(2009-12#2)
exposure in vivo##2##3##(1995-3#1)(2009-9#1)
exposure in##37##2##(1990-2#1)(1991-12#3)(1991-3#1)(1992-11#2)(1992-2#1)(1993-3#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#3)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
exposure increased##2##2##(2008-12#1)(2012-12#1)
exposure increases##2##2##(1991-5#1)(2009-12#1)
exposure induced##2##2##(2008-10#1)(2013-1#1)
exposure is associated with##4##4##(1996-12#1)(2008-10#2)(2008-7#1)
exposure is not##2##3##(2008-8#1)(2013-1#1)
exposure is##17##2##(1991-5#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
exposure level##3##2##(1993-3#1)(1997-4#1)(2008-10#1)
exposure levels##6##2##(1992-3#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
exposure limits##3##2##(2008-12#3)
exposure may be##2##3##(2008-7#2)
exposure may have##2##3##(1995-12#1)(2008-10#1)
exposure may##13##2##(1994-11#1)(1994-5#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
exposure of 1##4##3##(2008-10#2)(2013-1#2)
exposure of a##2##3##(2007-11#1)(2009-8#1)
exposure of an unloaded germanosilicate fiber##2##6##(2008-3#2)
exposure of an##4##3##(2008-3#3)(2011-1#1)
exposure of cells to##5##4##(1992-2#1)(1993-3#1)(1994-12#1)(1997-4#2)
exposure of cells##6##3##(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-4#2)
exposure of children to##2##4##(1997-4#1)(2008-11#1)
exposure of human##7##3##(1992-8#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(2008-5#1)(2011-1#1)
exposure of humans to##4##4##(1993-3#1)(1994-5#1)(2008-7#1)(2011-2#1)
exposure of hydrophobic##2##3##(1992-6#1)(1995-3#1)
exposure of mammalian cells to##2##5##(1994-11#1)(1994-8#1)
exposure of mycelium of P##2##5##(2008-10#2)
exposure of rats to##2##4##(1993-12#1)(2012-2#1)
exposure of rats##3##3##(1993-12#1)(2008-12#1)(2012-2#1)
exposure of skin to##2##4##(2008-5#2)
exposure of skin##3##3##(2008-5#3)
exposure of the cells to a##2##6##(1990-5#1)(2008-11#1)
exposure of the cells to##4##5##(1990-5#1)(1992-3#1)(1992-8#1)(2008-11#1)
exposure of the whole body##2##5##(1992-3#1)(2008-7#1)
exposure of the##42##3##(1990-5#1)(1990-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-2#1)(1997-8#1)(2006-12#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
exposure of##155##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-8#7)(1994-10#1)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#6)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#14)(2008-11#7)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#7)(2008-9#4)(2009-1#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#4)(2013-1#10)(2013-8#2)
exposure on the##4##3##(1996-12#1)(2008-10#1)(2008-6#1)(2009-7#1)
exposure on##22##2##(1992-4#1)(1992-9#1)(1993-12#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-4#1)
exposure or##3##2##(2008-10#2)(2012-2#1)
exposure period and##2##3##(2008-2#1)(2008-5#1)
exposure period##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
exposure periods of##2##3##(2008-10#1)(2011-2#1)
exposure periods##6##2##(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
exposure produced##2##2##(1990-5#1)(1991-5#1)
exposure response is proportional to exposure to a power##2##9##(2008-7#2)
exposure response is##3##3##(2008-7#3)
exposure response##8##2##(2008-7#8)
exposure resulted in##4##3##(1990-7#1)(1992-12#1)(2008-9#1)(2013-1#1)
exposure results in##2##3##(1996-5#1)(2013-1#1)
exposure significantly##2##2##(1991-5#1)(2008-10#1)
exposure studies##2##2##(1996-9#1)(2011-2#1)
exposure study##2##2##(2008-10#2)
exposure than##2##2##(2008-10#1)(2012-2#1)
exposure through##2##2##(2012-2#1)(2013-1#1)
exposure time and##3##3##(2008-10#1)(2008-3#2)
exposure time in##3##3##(2008-10#2)(2008-6#1)
exposure time was##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
exposure time were##2##3##(2008-10#2)
exposure time##34##2##(1990-2#2)(1996-12#2)(2007-12#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#4)
exposure times and##2##3##(2008-12#1)(2008-5#1)
exposure times for##2##3##(1996-2#1)(2008-3#1)
exposure times##14##2##(1990-2#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2012-2#1)
exposure to 1 microM##3##4##(1990-2#2)(1993-9#1)
exposure to 1##4##3##(1990-2#2)(1991-9#1)(1993-9#1)
exposure to 10 nM TPA for##2##6##(1993-9#2)
exposure to 10##3##3##(1993-3#1)(1993-9#2)
exposure to 2##2##3##(2008-10#1)(2013-1#1)
exposure to 280-nm light##2##4##(1995-5#2)
exposure to 4 mol/l MgCl2##3##5##(1995-12#3)
exposure to 4##5##3##(1995-12#3)(2008-7#1)(2013-1#1)
exposure to 5%##2##3##(1991-2#1)(1994-6#1)
exposure to 50##2##3##(2008-10#2)
exposure to 7##2##3##(1997-4#1)(1997-7#1)
exposure to 85% relative humidity at 85 degrees C for##2##10##(2008-2#2)
exposure to Al##3##3##(2013-8#3)
exposure to DES in adult##2##5##(2008-10#2)
exposure to GLAD##2##3##(2011-2#2)
exposure to HBO##2##3##(1993-12#2)
exposure to HG##2##3##(2008-7#2)
exposure to HIV##2##3##(1991-11#1)(2008-7#1)
exposure to NO2##2##3##(1992-9#2)
exposure to OP pesticides##2##4##(2010-5#2)
exposure to PMA##2##3##(1993-6#1)(1997-1#1)
exposure to TPA##3##3##(1993-9#2)(1994-9#1)
exposure to UV light##3##4##(1994-6#2)(1997-3#1)
exposure to UV##5##3##(1994-6#2)(1997-3#1)(2008-5#1)(2011-2#1)
exposure to UVB##2##3##(2008-5#2)
exposure to VCZ at the##2##5##(2008-10#2)
exposure to VCZ##4##3##(2008-10#4)
exposure to a drug##2##4##(2008-8#1)(2010-11#1)
exposure to a##31##3##(1992-8#1)(1997-4#1)(1997-8#2)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-11#2)(2012-12#5)
exposure to aflatoxins##3##3##(1991-11#2)(2008-12#1)
exposure to an enriched environment around##2##6##(1992-11#2)
exposure to an enriched environment##3##5##(1992-11#3)
exposure to an##6##3##(1992-11#3)(2008-10#1)(2008-4#1)(2013-1#1)
exposure to asbestos in place##2##5##(1991-12#2)
exposure to asbestos in##3##4##(1991-12#2)(1997-5#1)
exposure to asbestos is well established##2##6##(1991-12#1)(1995-2#1)
exposure to asbestos used in railroads##2##6##(1991-12#2)
exposure to asbestos##10##3##(1991-12#7)(1992-11#1)(1995-2#1)(1997-5#1)
exposure to benzene##3##3##(2008-10#1)(2008-11#2)
exposure to biological##2##3##(2012-3#2)
exposure to both CO concentrations##2##5##(1990-5#2)
exposure to both##6##3##(1990-5#2)(1992-3#1)(2008-10#1)(2010-5#2)
exposure to cadmium##2##3##(2008-7#1)(2008-8#1)
exposure to cigarette smoke##2##4##(1993-8#1)(2008-5#1)
exposure to cocaine##2##3##(1990-7#1)(1996-12#1)
exposure to cold##2##3##(1994-11#1)(2008-3#1)
exposure to delta##2##3##(1991-4#2)
exposure to dexamethasone##2##3##(1991-12#2)
exposure to dietary##2##3##(2007-5#1)(2008-10#1)
exposure to different##5##3##(1996-12#1)(2006-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
exposure to drugs##2##3##(2008-10#1)(2008-7#1)
exposure to endocrine disruptors##2##4##(2008-10#1)(2008-11#1)
exposure to environmental factors##2##4##(2011-2#1)(2013-1#1)
exposure to environmental##5##3##(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
exposure to extremely##2##3##(2008-12#2)
exposure to focused##2##3##(2007-12#1)(2008-5#1)
exposure to gamma-rays##2##3##(2008-7#2)
exposure to harmful##2##3##(1990-8#1)(2009-12#1)
exposure to heat stress##2##4##(1995-5#2)
exposure to heat##4##3##(1995-11#1)(1995-5#2)(2008-10#1)
exposure to heavy metals##5##4##(2008-10#3)(2013-1#2)
exposure to high##3##3##(1996-2#1)(2007-12#1)(2008-11#1)
exposure to hot##2##3##(1992-6#1)(2009-12#1)
exposure to humans##2##3##(1995-11#1)(1997-4#1)
exposure to hyperbaric oxygen##2##4##(1993-12#2)
exposure to infected##2##3##(1996-3#1)(2007-7#1)
exposure to infection in the vaccinated##2##6##(1994-2#2)
exposure to infection##8##3##(1994-2#8)
exposure to light##5##3##(1997-6#2)(2008-10#1)(2008-3#1)(2012-3#1)
exposure to low doses of##2##5##(2008-7#2)
exposure to low doses##3##4##(1996-6#1)(2008-7#2)
exposure to low##7##3##(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-7#2)
exposure to multiple##2##3##(2008-8#1)(2011-1#1)
exposure to nitrous oxide##3##4##(1993-1#1)(2008-7#2)
exposure to organic solvents##2##4##(1990-8#2)
exposure to organic##3##3##(1990-8#2)(2009-8#1)
exposure to oxygen##2##3##(1990-5#1)(1993-12#1)
exposure to ozone##2##3##(1992-3#1)(2011-2#1)
exposure to parasites##2##3##(2008-8#1)(2008-9#1)
exposure to persistent organochlorine residuals##2##5##(2008-8#2)
exposure to persistent##3##3##(2008-8#3)
exposure to pollutants##2##3##(2008-10#1)(2012-3#1)
exposure to polycyclic aromatic hydrocarbons##2##5##(1992-3#2)
exposure to predators##2##3##(2008-8#1)(2008-9#1)
exposure to radiation##3##3##(2008-7#1)(2008-9#1)(2013-7#1)
exposure to repeated##2##3##(2010-12#1)(2012-3#1)
exposure to sodium##3##3##(1995-8#1)(2008-12#1)(2008-9#1)
exposure to soil##3##3##(2008-10#2)(2012-5#1)
exposure to solvents##3##3##(1990-2#1)(1990-8#1)(2008-7#1)
exposure to sun##2##3##(1991-6#1)(2013-8#1)
exposure to sunlight##4##3##(2011-2#4)
exposure to supraconducive##2##3##(2008-10#2)
exposure to the fungicides##2##4##(2008-10#2)
exposure to the##39##3##(1992-1#1)(1992-11#1)(1992-7#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
exposure to these compounds##3##4##(1992-8#1)(2008-10#1)(2008-8#1)
exposure to these##9##3##(1992-8#1)(1994-3#1)(2008-10#2)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
exposure to thin-and-beautiful media images##2##5##(2007-12#2)
exposure to threat-relevant stimuli##2##4##(2012-2#2)
exposure to three##2##3##(2008-7#1)(2012-12#1)
exposure to tobacco smoke##3##4##(1991-4#1)(1994-2#1)(2013-1#1)
exposure to tobacco##5##3##(1991-11#1)(1991-4#1)(1991-5#1)(1994-2#1)(2013-1#1)
exposure to valproic acid##2##4##(2010-3#1)(2011-1#1)
exposure to various##3##3##(1992-11#1)(2008-10#2)
exposure to violence and##2##4##(2008-11#1)(2009-9#1)
exposure to violence##5##3##(2008-11#1)(2009-9#4)
exposure to zinc##2##3##(1992-6#1)(2010-11#1)
exposure to##594##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#5)(1991-11#6)(1991-12#17)(1991-2#1)(1991-4#6)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#7)(1992-12#2)(1992-2#2)(1992-3#8)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#3)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#7)(1994-11#2)(1994-2#11)(1994-3#1)(1994-5#3)(1994-6#5)(1994-9#2)(1995-11#4)(1995-12#9)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#5)(1996-2#3)(1996-3#4)(1996-5#3)(1996-6#3)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#12)(2007-2#2)(2007-5#1)(2007-7#4)(2008-1#1)(2008-10#77)(2008-11#24)(2008-12#11)(2008-2#8)(2008-3#5)(2008-4#9)(2008-5#19)(2008-6#3)(2008-7#27)(2008-8#19)(2008-9#14)(2009-12#5)(2009-5#2)(2009-7#5)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#6)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#28)(2012-1#1)(2012-12#10)(2012-2#7)(2012-3#13)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#10)
exposure up to##2##3##(2008-10#2)
exposure using##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
exposure variable##2##2##(2008-7#2)
exposure was found to##3##4##(2008-10#2)(2009-7#1)
exposure was not##2##3##(1994-6#1)(1996-12#1)
exposure was observed##2##3##(1992-6#1)(2008-11#1)
exposure was##26##2##(1991-12#1)(1992-11#2)(1992-6#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)
exposure were also##3##3##(2008-12#1)(2009-9#1)(2012-2#1)
exposure were##9##2##(1991-12#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
exposure when the##2##3##(1992-9#1)(1995-3#1)
exposure when##3##2##(1992-9#1)(1995-3#1)(2008-11#1)
exposure with##11##2##(1991-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)
exposure##1605##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#7)(1990-5#18)(1990-6#2)(1990-7#4)(1990-8#7)(1990-9#1)(1991-1#3)(1991-11#8)(1991-12#43)(1991-2#3)(1991-3#2)(1991-4#6)(1991-5#7)(1991-6#1)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#16)(1992-12#6)(1992-2#8)(1992-3#18)(1992-4#1)(1992-5#2)(1992-6#14)(1992-7#1)(1992-8#6)(1992-9#8)(1993-1#6)(1993-11#2)(1993-12#12)(1993-2#1)(1993-3#10)(1993-5#1)(1993-6#2)(1993-8#14)(1993-9#8)(1994-10#1)(1994-11#8)(1994-12#3)(1994-2#20)(1994-3#4)(1994-5#6)(1994-6#13)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#6)(1995-12#19)(1995-2#7)(1995-3#20)(1995-4#1)(1995-5#7)(1995-6#2)(1995-8#3)(1996-1#4)(1996-12#24)(1996-2#7)(1996-3#8)(1996-5#5)(1996-6#8)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#23)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#3)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#4)(2007-10#1)(2007-11#8)(2007-12#37)(2007-2#5)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#10)(2008-1#3)(2008-10#211)(2008-11#63)(2008-12#34)(2008-2#20)(2008-3#37)(2008-4#22)(2008-5#66)(2008-6#11)(2008-7#91)(2008-8#41)(2008-9#35)(2009-1#3)(2009-11#3)(2009-12#15)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#12)(2009-8#5)(2009-9#10)(2010-1#1)(2010-10#2)(2010-11#10)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#10)(2010-8#10)(2010-9#3)(2011-1#21)(2011-2#89)(2012-1#7)(2012-12#21)(2012-2#29)(2012-3#29)(2012-4#2)(2012-5#1)(2013-1#66)(2013-7#1)(2013-8#21)
exposure)##6##1##(1992-9#1)(2008-10#3)(2008-11#1)(2008-7#1)
exposure-based practice##2##2##(2009-11#2)
exposure-based##5##1##(2009-11#3)(2010-5#1)(2012-2#1)
exposure-disease##2##1##(1997-1#1)(2011-1#1)
exposure-response patterns##2##2##(2008-7#2)
exposure-response relations in##2##3##(2008-7#2)
exposure-response relations##3##2##(2008-7#3)
exposure-response##9##1##(1991-12#1)(2008-7#8)
exposures among##2##2##(2008-12#1)(2011-2#1)
exposures and##8##2##(2008-10#2)(2008-6#1)(2008-7#2)(2009-9#1)(2011-1#1)(2013-1#1)
exposures are##4##2##(2007-12#1)(2008-7#3)
exposures for##3##2##(2008-10#2)(2009-7#1)
exposures from##3##2##(2008-11#1)(2013-1#2)
exposures have##2##2##(2008-10#1)(2008-7#1)
exposures in the##2##3##(2007-8#1)(2008-10#1)
exposures in##8##2##(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
exposures of##2##2##(2007-7#1)(2009-7#1)
exposures or##4##2##(1992-9#1)(1995-3#1)(2008-2#1)(2008-3#1)
exposures to a##2##3##(1994-3#1)(2011-1#1)
exposures to the##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
exposures to##31##2##(1990-8#1)(1992-10#1)(1993-12#1)(1994-3#2)(1996-12#1)(1996-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
exposures##137##1##(1990-8#1)(1991-12#6)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#2)(1995-3#1)(1996-12#5)(1996-6#2)(1997-7#3)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#27)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-4#2)(2010-5#1)(2011-1#6)(2011-2#4)(2012-2#2)(2013-1#9)(2013-8#2)
exposures)##2##1##(1992-3#2)
expounded in##2##2##(2008-12#1)(2008-3#1)
expounded##3##1##(2008-12#1)(2008-3#1)(2008-8#1)
express a##15##2##(1991-5#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)
express an##5##2##(1991-12#1)(1991-9#1)(1993-3#1)(2008-4#1)(2008-7#1)
express and purify##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
express and##6##2##(1995-1#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-2#1)
express both the##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
express both##6##2##(1994-11#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
express fears##2##2##(1992-8#1)(2008-11#1)
express full-length human##2##3##(1992-11#1)(1996-12#1)
express full-length##3##2##(1992-11#1)(1996-12#1)(2008-11#1)
express functional##3##2##(1991-12#1)(1993-5#1)(2008-4#1)
express high levels of##5##4##(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)
express high##6##2##(1995-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)
express human##2##2##(2008-8#2)
express insulin##2##2##(2008-11#1)(2010-11#1)
express low levels of##2##4##(1993-3#1)(2011-2#1)
express low##4##2##(1993-3#2)(2010-6#1)(2011-2#1)
express mRNA for##2##3##(1993-3#1)(2008-7#1)
express more##2##2##(2008-11#1)(2009-9#1)
express multiple##4##2##(1996-12#2)(2012-12#1)(2012-2#1)
express new##2##2##(1992-9#1)(2008-4#1)
express numerous##2##2##(1992-3#1)(2008-4#1)
express only##3##2##(1992-12#1)(1993-3#1)(2008-7#1)
express primarily##2##2##(1992-3#2)
express proteins##2##2##(1994-5#1)(1995-5#1)
express recombinant##4##2##(2008-11#3)(2008-7#1)
express several##2##2##(2008-2#1)(2008-4#1)
express significant##2##2##(1994-6#1)(1996-5#1)
express specific##2##2##(1991-5#1)(2008-5#1)
express substance-P immunoreactivity##2##3##(1995-12#2)
express the gene##2##3##(1996-5#1)(2009-6#1)
express the##43##2##(1990-11#1)(1991-2#1)(1991-5#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#3)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#1)
express these##2##2##(2008-7#1)(2008-8#1)
express two##2##2##(1995-6#1)(2008-9#1)
express various##2##2##(2008-4#2)
express very low##2##3##(1992-3#2)
express##268##1##(1990-11#1)(1991-12#2)(1991-2#2)(1991-5#4)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#8)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-3#8)(1993-5#2)(1993-6#2)(1993-8#1)(1994-11#6)(1994-12#2)(1994-2#4)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#9)(1996-2#1)(1996-5#5)(1996-6#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#22)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#17)(2008-5#6)(2008-7#12)(2008-8#9)(2008-9#16)(2009-10#1)(2009-12#1)(2009-3#4)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#6)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#3)
express-FIIAA##4##1##(2008-10#4)
expressed CD25##3##2##(2008-11#3)
expressed a desire for##2##4##(1996-2#1)(2010-8#1)
expressed a desire##3##3##(1993-12#1)(1996-2#1)(2010-8#1)
expressed a##12##2##(1993-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
expressed abundantly in the##2##4##(1993-3#1)(1993-6#1)
expressed across##2##2##(2008-10#1)(2012-12#1)
expressed after the##2##3##(2007-11#1)(2010-5#1)
expressed after##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
expressed alone##3##2##(1995-2#2)(2009-8#1)
expressed an##2##2##(1995-11#1)(1995-8#1)
expressed and purified##4##3##(1994-9#1)(2009-3#1)(2009-6#1)(2012-2#1)
expressed and secreted##2##3##(1990-8#1)(2009-8#1)
expressed and##19##2##(1990-8#1)(1992-3#2)(1992-8#1)(1994-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#2)(2012-2#2)(2013-8#1)
expressed as R##3##3##(2008-10#3)
expressed as RSD##2##3##(2008-10#2)
expressed as a fraction of##2##5##(1991-9#1)(2008-9#1)
expressed as a function of##2##5##(2008-10#2)
expressed as a linear##2##4##(2008-3#1)(2008-7#1)
expressed as a proportion of##2##5##(1996-9#1)(2007-12#1)
expressed as a##30##3##(1991-9#1)(1992-6#2)(1992-9#1)(1993-2#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#1)
expressed as an##2##3##(2008-10#2)
expressed as cumulative##2##3##(2008-11#1)(2008-5#1)
expressed as high##2##3##(1997-2#1)(2008-6#1)
expressed as relative standard deviation (R##3##6##(2008-10#3)
expressed as relative standard deviation (s(r))##3##6##(2008-10#3)
expressed as relative standard deviation of##4##6##(2008-10#4)
expressed as relative standard deviation##21##5##(2008-10#20)(2009-8#1)
expressed as relative standard##22##4##(2008-10#21)(2009-8#1)
expressed as relative##24##3##(2008-10#23)(2009-8#1)
expressed as the number of##2##5##(2008-10#1)(2008-12#1)
expressed as the##14##3##(1995-2#1)(1996-1#1)(2006-6#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-5#2)
expressed as##131##2##(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-8#3)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#63)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
expressed at a##5##3##(1991-2#1)(1992-12#1)(1993-3#1)(1994-6#1)(2008-10#1)
expressed at different##2##3##(1996-2#1)(2011-2#1)
expressed at high levels in the##3##6##(1995-2#1)(1996-2#1)(2008-1#1)
expressed at high levels in##6##5##(1991-9#1)(1995-2#2)(1996-2#1)(1997-6#1)(2008-1#1)
expressed at high levels##9##4##(1991-9#2)(1995-2#2)(1996-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2013-7#1)
expressed at high##11##3##(1990-5#1)(1991-9#2)(1995-2#2)(1996-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-8#1)(2013-7#1)
expressed at low levels in##2##5##(1990-12#1)(1993-2#1)
expressed at low##4##3##(1990-12#1)(1993-2#1)(2007-11#1)(2008-8#1)
expressed at the##7##3##(1993-6#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-7#1)
expressed at##45##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-12#3)(1996-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
expressed both in##2##3##(1997-4#1)(2008-8#1)
expressed both##4##2##(1997-4#1)(2008-6#1)(2008-8#2)
expressed by P##3##3##(2008-10#1)(2008-4#2)
expressed by a##10##3##(1992-11#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-3#1)(2013-1#1)
expressed by alpha2##2##3##(2008-11#2)
expressed by cells in##2##4##(2010-8#1)(2011-2#1)
expressed by cutting##2##3##(2008-9#2)
expressed by the##12##3##(1990-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-1#1)
expressed by these##2##3##(1991-5#1)(1992-2#1)
expressed by##93##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#4)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
expressed cDNA##4##2##(1991-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
expressed concern about##3##3##(1996-1#1)(2008-9#1)(2009-6#1)
expressed concern on##2##3##(1990-2#1)(1996-1#1)
expressed concern##5##2##(1990-2#1)(1996-1#2)(2008-9#1)(2009-6#1)
expressed constitutively##2##2##(1993-12#1)(1995-6#1)
expressed differentially##2##2##(1997-7#1)(2008-9#1)
expressed during the##3##3##(2008-10#2)(2008-11#1)
expressed during##16##2##(1992-5#1)(1992-6#1)(1993-3#2)(1994-6#1)(1995-6#1)(1997-6#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
expressed ectopically using the CaMV 35S promoter in a heterologous tobacco plant system##2##13##(1997-2#1)(1997-8#1)
expressed either##3##2##(1991-2#1)(1995-12#1)(1997-7#1)
expressed emotion##2##2##(1990-11#1)(2011-2#1)
expressed enzyme##5##2##(1990-12#1)(1991-5#1)(1993-8#2)(1995-5#1)
expressed exclusively in##4##3##(1990-5#1)(1993-9#1)(1994-8#1)(2008-1#1)
expressed from a##2##3##(2010-10#1)(2012-3#1)
expressed from the##3##3##(1994-11#1)(2007-7#1)(2008-11#1)
expressed from##10##2##(1993-6#1)(1994-11#1)(2007-7#1)(2008-11#1)(2008-8#2)(2010-10#1)(2011-1#1)(2012-3#2)
expressed gene##6##2##(1995-8#1)(1995-9#1)(1996-10#1)(1997-8#1)(2008-10#1)(2012-2#1)
expressed genes and##2##3##(2008-11#1)(2010-3#1)
expressed genes from##4##3##(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)
expressed genes on##2##3##(1996-10#1)(2008-7#1)
expressed genes##25##2##(1996-10#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#3)(2011-1#1)(2012-3#1)
expressed grade 3-4)##2##3##(2008-10#2)
expressed high level of##2##4##(2008-8#2)
expressed high##4##2##(2008-10#1)(2008-8#2)(2010-3#1)
expressed highly##2##2##(1991-12#1)(2012-12#1)
expressed human##2##2##(1995-11#1)(2008-7#1)
expressed in 3T3-L1##2##3##(1995-8#1)(2008-3#1)
expressed in Bacillus subtilis##2##4##(1990-11#1)(2009-3#1)
expressed in CHO cells##3##4##(1992-10#1)(2008-4#2)
expressed in CHO##5##3##(1992-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
expressed in COS 1 cells##3##5##(2008-11#3)
expressed in COS cells##3##4##(1991-9#1)(1992-3#1)(2008-8#1)
expressed in COS##7##3##(1991-9#1)(1992-3#1)(2008-11#4)(2008-8#1)
expressed in COS-1 cells##3##4##(1992-10#1)(1992-6#1)(1993-3#1)
expressed in COS-7 cells##4##4##(1990-11#1)(1994-11#1)(1994-6#1)(2008-9#1)
expressed in COS-7##5##3##(1990-11#1)(1994-11#1)(1994-6#1)(2008-4#1)(2008-9#1)
expressed in Chinese Hamster Ovary (CHO) cells##2##7##(1993-3#1)(2008-11#1)
expressed in Chinese##3##3##(1990-12#1)(1993-3#1)(2008-11#1)
expressed in E##10##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1994-6#2)(1997-6#1)(1997-7#1)(2008-4#1)(2008-9#1)
expressed in Escherichia coli and##4##5##(1992-8#1)(1994-3#1)(1995-2#1)(2008-10#1)
expressed in Escherichia coli using##2##5##(1991-3#1)(1993-8#1)
expressed in Escherichia coli##24##4##(1990-11#2)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)
expressed in Saccharomyces cerevisiae##3##4##(1990-12#2)(1993-8#1)
expressed in Xenopus laevis oocytes##2##5##(1992-3#1)(1994-8#1)
expressed in Xenopus oocytes##8##4##(1990-11#1)(1991-9#1)(1995-11#3)(1995-5#1)(2008-4#2)
expressed in Xenopus##10##3##(1990-11#1)(1991-9#1)(1992-3#1)(1994-8#1)(1995-11#3)(1995-5#1)(2008-4#2)
expressed in a cell- or tissue-specific manner##2##7##(1995-8#1)(1996-2#1)
expressed in a developmentally##2##4##(1993-3#1)(2008-11#1)
expressed in a small##2##4##(1995-5#1)(1996-5#1)
expressed in a subset of##2##5##(2008-8#1)(2009-8#1)
expressed in a tissue-##2##4##(1994-5#1)(2008-5#1)
expressed in a wide##2##4##(1992-3#1)(2008-1#1)
expressed in a##26##3##(1990-8#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)
expressed in adult##3##3##(1995-6#1)(2008-7#1)(2011-2#1)
expressed in all##14##3##(1990-12#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#2)
expressed in an##3##3##(1991-9#1)(2008-11#1)(2008-3#1)
expressed in bacteria##2##3##(1994-11#1)(2008-4#1)
expressed in both the##2##4##(2008-6#1)(2008-8#1)
expressed in both##6##3##(1994-12#1)(1995-11#1)(1995-2#1)(2008-6#1)(2008-8#1)(2012-3#1)
expressed in brain##2##3##(1993-6#1)(1995-6#1)
expressed in cells##3##3##(1992-9#1)(1993-3#1)(2008-8#1)
expressed in cultured##2##3##(1991-12#1)(2008-2#1)
expressed in different##5##3##(1995-11#1)(2007-12#1)(2008-8#2)(2010-12#1)
expressed in embryonic stem##2##4##(1997-8#1)(2008-4#1)
expressed in embryonic##4##3##(1996-12#1)(1997-8#1)(2008-11#1)(2008-4#1)
expressed in human##9##3##(1994-11#1)(1994-9#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2012-12#1)(2012-3#1)
expressed in insect cells##3##4##(1993-6#1)(1994-8#1)(2008-7#1)
expressed in large amounts in##2##5##(1992-6#1)(2008-6#1)
expressed in liver##2##3##(1997-7#1)(2013-1#1)
expressed in mammalian cells and##2##5##(1996-2#1)(2008-8#1)
expressed in mammalian cells##5##4##(1995-6#1)(1996-2#1)(2008-8#3)
expressed in mammalian##6##3##(1995-2#1)(1995-6#1)(1996-2#1)(2008-8#3)
expressed in many cells##2##4##(1997-7#1)(2013-8#1)
expressed in many##5##3##(1992-3#1)(1997-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
expressed in most##2##3##(1992-8#1)(1996-10#1)
expressed in murine##3##3##(1991-9#1)(1992-12#2)
expressed in neonatal##2##3##(1994-6#2)
expressed in neurons and##3##4##(1995-5#2)(2012-3#1)
expressed in normal##7##3##(1990-5#1)(1991-12#1)(1992-8#1)(1994-8#1)(2008-5#1)(2008-9#1)(2013-1#1)
expressed in plant##2##3##(1997-2#1)(2008-10#1)
expressed in rat##5##3##(1992-11#1)(1993-5#1)(1994-6#1)(1996-2#1)(2008-11#1)
expressed in relatively##2##3##(2008-1#1)(2008-11#1)
expressed in single##2##3##(1996-12#1)(2008-10#1)
expressed in small##3##3##(1996-12#1)(2008-4#2)
expressed in some##2##3##(2008-11#1)(2012-12#1)
expressed in stable##2##3##(2008-10#1)(2012-2#1)
expressed in terms of the##3##5##(2008-2#3)
expressed in terms of##13##4##(1990-8#1)(1993-9#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-7#1)(2013-1#1)
expressed in testis##3##3##(1995-6#1)(1995-8#1)(2008-8#1)
expressed in the adult##3##4##(1997-7#1)(2008-7#1)(2013-1#1)
expressed in the brain##2##4##(1997-2#2)
expressed in the cells##2##4##(1995-8#1)(2008-7#1)
expressed in the central nervous system##2##6##(1995-8#1)(1996-12#1)
expressed in the central##3##4##(1995-8#1)(1996-12#1)(2008-3#1)
expressed in the form of##2##5##(2008-10#1)(2009-3#1)
expressed in the human##4##4##(1990-5#1)(1990-8#1)(1994-6#1)(1994-9#1)
expressed in the kidney##2##4##(1997-4#1)(2008-7#1)
expressed in the lens##2##4##(1993-3#1)(2008-11#1)
expressed in the liver##3##4##(1990-11#1)(1995-2#1)(1995-8#1)
expressed in the mammalian##2##4##(2008-8#2)
expressed in the nervous system##3##5##(1995-5#1)(1997-4#1)(2008-8#1)
expressed in the pituitary##3##4##(1992-10#1)(2008-4#2)
expressed in the plasma membrane##2##5##(1992-9#1)(2010-12#1)
expressed in the presence of##2##5##(2008-11#2)
expressed in the##111##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#2)(1997-2#6)(1997-4#2)(1997-6#1)(1997-7#3)(2007-12#2)(2008-10#5)(2008-11#8)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
expressed in these cells##3##4##(1990-12#1)(2008-11#1)(2008-6#1)
expressed in these##4##3##(1990-12#1)(1995-2#1)(2008-11#1)(2008-6#1)
expressed in tissues##4##3##(1992-11#2)(1993-12#1)(2008-7#1)
expressed in transgenic##4##3##(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
expressed in tumors##2##3##(1997-7#1)(2011-2#1)
expressed in two##2##3##(1991-12#1)(1995-12#1)
expressed in various##4##3##(1993-3#1)(1994-12#1)(1997-8#1)(2011-2#1)
expressed in vascular##2##3##(2009-10#1)(2012-12#1)
expressed in vitro##5##3##(1992-8#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-10#1)
expressed in yeast##9##3##(1991-12#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-9#1)
expressed in##556##2##(1990-11#8)(1990-12#7)(1990-5#3)(1990-8#6)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#9)(1992-10#4)(1992-11#4)(1992-12#4)(1992-3#7)(1992-6#4)(1992-8#8)(1992-9#4)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#8)(1993-5#1)(1993-6#8)(1993-8#7)(1993-9#2)(1994-10#1)(1994-11#9)(1994-12#9)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#8)(1994-8#8)(1994-9#5)(1995-11#7)(1995-12#4)(1995-2#9)(1995-3#2)(1995-5#9)(1995-6#8)(1995-8#10)(1996-10#2)(1996-12#10)(1996-2#7)(1996-5#2)(1997-1#2)(1997-2#9)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#12)(1997-8#3)(2007-11#1)(2007-12#5)(2008-1#4)(2008-10#34)(2008-11#30)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#19)(2008-5#13)(2008-6#7)(2008-7#18)(2008-8#31)(2008-9#17)(2009-10#5)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-5#4)(2010-7#2)(2011-1#3)(2011-2#13)(2012-12#7)(2012-2#6)(2012-3#11)(2013-1#7)(2013-7#1)(2013-8#7)
expressed inE##4##2##(2008-8#2)(2008-9#2)
expressed independently##2##2##(1991-9#1)(2008-10#1)
expressed intense##3##2##(1996-5#3)
expressed into##2##2##(1992-9#1)(1995-6#1)
expressed intracellularly##3##2##(1994-11#1)(2008-2#1)(2008-5#1)
expressed low##3##2##(1994-12#1)(2011-2#1)(2012-2#1)
expressed mRNA##2##2##(1996-9#1)(2008-4#1)
expressed markers##2##2##(1994-3#1)(2010-12#1)
expressed miRNAs##3##2##(2013-8#3)
expressed more##5##2##(1995-3#1)(2008-11#1)(2010-11#1)(2012-12#1)(2013-8#1)
expressed on cell##2##3##(1991-9#1)(1994-2#1)
expressed on the##4##3##(1990-12#1)(1990-7#1)(1992-12#1)(2010-4#1)
expressed on##29##2##(1990-12#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
expressed only in the##2##4##(2008-11#1)(2008-5#1)
expressed only in##6##3##(1992-8#1)(1994-11#1)(1994-12#1)(2008-11#1)(2008-5#2)
expressed only##12##2##(1991-12#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#2)(2012-2#1)
expressed plasma##2##2##(2008-8#1)(2010-12#1)
expressed positive##2##2##(1995-6#1)(2012-1#1)
expressed predominantly in the adrenal gland##2##6##(1993-3#2)
expressed predominantly in the brain##2##5##(1995-12#1)(2008-6#1)
expressed predominantly in the##5##4##(1993-3#2)(1995-12#1)(1997-2#1)(2008-6#1)
expressed predominantly##6##2##(1993-3#2)(1995-12#1)(1995-8#1)(1997-2#1)(2008-6#1)
expressed preferentially in##3##3##(1997-2#2)(2008-8#1)
expressed preferentially##4##2##(1995-2#1)(1997-2#2)(2008-8#1)
expressed product##2##2##(1992-2#1)(2008-8#1)
expressed protein was##3##3##(1992-12#1)(2008-8#1)(2010-6#1)
expressed protein##18##2##(1992-12#2)(1993-6#2)(1994-11#2)(1995-11#1)(1997-4#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-3#2)(2013-1#1)
expressed proteins##16##2##(1993-8#1)(1994-5#1)(1995-11#1)(2008-4#2)(2008-9#1)(2010-12#5)(2011-3#4)(2012-3#1)
expressed relative to##5##3##(1994-11#1)(2008-5#1)(2013-1#3)
expressed separately##2##2##(1995-8#1)(2010-5#1)
expressed sequence tag (EST)##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
expressed sequence tags (EST) and##2##5##(1995-9#1)(1997-2#1)
expressed sequence tags (ESTs) from##2##5##(2008-7#1)(2010-10#1)
expressed sequence tags (ESTs) in##2##5##(2012-3#1)(2013-8#1)
expressed sequence tags (ESTs)##8##4##(1995-8#1)(1997-6#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-8#1)
expressed sequence tags from##3##4##(2008-8#1)(2010-4#2)
expressed sequence tags##17##3##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#4)(2012-3#1)(2013-8#1)
expressed sequence##20##2##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#4)(2012-3#1)(2013-8#1)
expressed several##2##2##(1991-11#1)(1993-9#1)
expressed significantly##2##2##(1994-8#1)(2008-11#1)
expressed slightly higher##2##3##(1993-2#1)(2008-11#1)
expressed soluble##2##2##(1994-8#1)(2008-8#1)
expressed specifically in the##3##4##(1993-12#2)(1995-2#1)
expressed specifically in##7##3##(1993-12#2)(1993-8#1)(1995-2#1)(2008-10#2)(2008-8#1)
expressed specifically##8##2##(1993-12#2)(1993-8#1)(1995-2#1)(2008-10#2)(2008-8#1)(2008-9#1)
expressed strongly in##2##3##(1994-8#1)(1995-5#1)
expressed that the##2##3##(1997-1#1)(2008-5#1)
expressed the view that##2##4##(1997-8#1)(2008-7#1)
expressed the##27##2##(1990-8#1)(1992-3#2)(1993-3#2)(1993-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-7#2)(2009-10#2)(2010-4#1)(2010-6#1)
expressed their##2##2##(1996-5#1)(2009-9#1)
expressed them##2##2##(1997-7#1)(2008-11#1)
expressed these##2##2##(1993-8#1)(1994-12#1)
expressed through##3##2##(2008-12#1)(2010-2#1)(2012-12#1)
expressed throughout the##2##3##(1991-5#1)(2012-7#1)
expressed throughout##5##2##(1991-5#1)(1993-2#1)(2008-5#1)(2011-2#1)(2012-7#1)
expressed to##3##2##(1990-5#1)(1993-6#1)(2008-2#1)
expressed transiently##2##2##(1992-9#1)(1993-9#1)
expressed two##2##2##(1995-6#1)(1995-8#1)
expressed ubiquitously##6##2##(1992-12#1)(1993-3#1)(1995-6#1)(1996-10#1)(1997-7#1)(2010-7#1)
expressed under the control of##5##5##(1990-8#1)(1992-12#1)(1997-4#1)(2008-10#1)(2008-8#1)
expressed under the##6##3##(1990-8#1)(1992-12#1)(1997-4#1)(2008-10#1)(2008-8#2)
expressed under##8##2##(1990-8#1)(1992-12#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#2)
expressed via##2##2##(2008-10#1)(2012-3#1)
expressed was secreted##2##3##(1990-8#1)(2008-8#1)
expressed was##3##2##(1990-8#2)(2008-8#1)
expressed widely##2##2##(1997-4#1)(2008-9#1)
expressed wild-type##2##2##(1995-2#1)(2008-10#1)
expressed with##2##2##(1997-6#1)(2008-3#1)
expressed within##2##2##(1997-9#1)(2008-10#1)
expressed##1455##1##(1990-11#12)(1990-12#17)(1990-2#2)(1990-5#7)(1990-7#1)(1990-8#14)(1991-11#4)(1991-12#10)(1991-2#11)(1991-3#2)(1991-5#14)(1991-6#1)(1991-8#3)(1991-9#18)(1992-10#5)(1992-11#5)(1992-12#13)(1992-2#2)(1992-3#16)(1992-4#2)(1992-5#1)(1992-6#11)(1992-8#12)(1992-9#10)(1993-11#5)(1993-12#13)(1993-2#6)(1993-3#22)(1993-5#1)(1993-6#16)(1993-8#16)(1993-9#10)(1994-10#2)(1994-11#20)(1994-12#15)(1994-2#5)(1994-3#3)(1994-5#3)(1994-6#11)(1994-8#21)(1994-9#10)(1995-11#19)(1995-12#10)(1995-2#22)(1995-3#6)(1995-5#12)(1995-6#18)(1995-8#18)(1995-9#3)(1996-1#4)(1996-10#5)(1996-12#21)(1996-2#13)(1996-3#2)(1996-5#11)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#16)(1997-3#2)(1997-4#19)(1997-6#13)(1997-7#23)(1997-8#6)(1997-9#1)(2006-6#1)(2007-11#5)(2007-12#8)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#10)(2008-10#161)(2008-11#82)(2008-12#8)(2008-2#22)(2008-3#14)(2008-4#38)(2008-5#28)(2008-6#15)(2008-7#44)(2008-8#79)(2008-9#43)(2009-10#16)(2009-12#4)(2009-3#8)(2009-4#2)(2009-5#1)(2009-6#8)(2009-8#11)(2009-9#7)(2010-1#4)(2010-10#2)(2010-11#7)(2010-12#14)(2010-2#1)(2010-3#8)(2010-4#12)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#2)(2011-1#11)(2011-2#25)(2011-3#7)(2012-1#3)(2012-12#15)(2012-2#18)(2012-3#25)(2012-5#1)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#16)
expressed)##3##1##(1991-12#2)(2008-11#1)
expresses a high##2##3##(1993-3#1)(2008-10#1)
expresses a##6##2##(1992-3#1)(1993-3#1)(2008-10#2)(2010-5#1)(2012-2#1)
expresses both##2##2##(1992-8#1)(1997-1#1)
expresses low levels of##2##4##(1994-12#1)(1994-8#1)
expresses the##9##2##(1991-9#1)(1995-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-2#2)
expresses##44##1##(1990-12#1)(1990-5#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
expressing GAP-43##2##2##(1993-12#1)(1995-12#1)
expressing IL-1ra in brain##2##4##(2008-8#2)
expressing a dominant negative##2##4##(2013-7#2)
expressing a humanized##2##3##(2008-11#1)(2008-7#1)
expressing a##32##2##(1990-5#2)(1992-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
expressing an##3##2##(2008-2#1)(2010-11#1)(2011-2#1)
expressing both##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
expressing breast cancer cells##2##4##(2010-6#2)
expressing cells##8##2##(1993-12#1)(1993-3#1)(1995-12#1)(2008-11#3)(2008-9#2)
expressing either##5##2##(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-10#1)
expressing enhanced green fluorescent protein##2##5##(2008-11#2)
expressing enhanced green##3##3##(2008-11#2)(2013-8#1)
expressing genes##2##2##(1995-5#1)(2008-2#1)
expressing high##2##2##(2008-10#1)(2008-4#1)
expressing human##6##2##(1991-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-11#1)
expressing its##3##2##(1991-8#1)(2008-11#1)(2013-1#1)
expressing only##2##2##(1996-12#1)(2008-10#1)
expressing or##2##2##(1996-5#1)(2008-11#1)
expressing recombinant proteins##2##3##(1993-9#1)(2008-4#1)
expressing recombinant##4##2##(1993-9#1)(2008-11#2)(2008-4#1)
expressing the FLAG-tagged protein by##2##5##(2008-2#2)
expressing the alpha##3##3##(1993-9#1)(1995-11#2)
expressing the human##4##3##(1992-8#1)(2008-11#3)
expressing the mouse##2##3##(1993-8#1)(1997-2#1)
expressing the variant##2##3##(1991-12#1)(1993-3#1)
expressing the##72##2##(1991-12#1)(1991-9#1)(1992-2#1)(1992-8#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-6#2)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#6)(2008-2#4)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-8#1)(2010-3#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
expressing these##2##2##(1993-8#1)(2008-10#1)
expressing this protein##2##3##(2008-4#1)(2013-1#1)
expressing this##4##2##(1994-5#1)(1994-8#1)(2008-4#1)(2013-1#1)
expressing##301##1##(1990-11#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#6)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#6)(1995-12#3)(1995-2#12)(1995-5#4)(1995-6#4)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#41)(2008-11#40)(2008-2#8)(2008-3#1)(2008-4#11)(2008-6#1)(2008-7#9)(2008-8#16)(2008-9#11)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-10#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#2)
expression activity of##2##3##(2008-11#1)(2008-9#1)
expression after##7##2##(1994-3#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-4#1)
expression alone is##2##3##(1990-12#1)(1996-12#1)
expression alone##3##2##(1990-12#1)(1996-12#1)(2012-12#1)
expression along##2##2##(1990-12#1)(2013-1#1)
expression also##6##2##(1993-9#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
expression alterations##2##2##(2008-10#1)(2012-3#1)
expression among##3##2##(1992-10#1)(2009-6#1)(2012-3#1)
expression analyses##5##2##(1994-11#1)(1996-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
expression analysis and##4##3##(2008-7#2)(2008-8#1)(2010-5#1)
expression analysis of a##3##4##(2008-2#1)(2008-4#1)(2010-5#1)
expression analysis of##13##3##(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-12#1)(2010-3#1)(2010-5#2)
expression analysis##30##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-2#1)(2012-3#1)
expression and abolishes##2##3##(1995-6#1)(2008-8#1)
expression and activation##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
expression and activity in##2##4##(2010-3#1)(2012-3#1)
expression and activity of the##2##5##(1995-5#1)(2008-1#1)
expression and activity of##3##4##(1995-5#1)(1996-12#1)(2008-1#1)
expression and activity##8##3##(1995-5#2)(1996-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-3#1)
expression and apoptosis##2##3##(2008-10#1)(2010-8#1)
expression and as##2##3##(2008-10#1)(2013-1#1)
expression and cell##2##3##(2008-7#1)(2009-5#1)
expression and characterization of human##2##5##(1994-6#1)(2009-9#1)
expression and characterization of##3##4##(1994-6#1)(2008-9#1)(2009-9#1)
expression and characterization##5##3##(1994-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)
expression and decreased##2##3##(1994-11#1)(2011-2#1)
expression and differentiation##2##3##(1993-11#1)(2008-10#1)
expression and distribution of##2##4##(1994-12#1)(2008-7#1)
expression and enzyme activity##2##4##(1994-11#1)(2011-2#1)
expression and function of##8##4##(1993-8#1)(1994-8#1)(2007-12#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-7#1)
expression and function##11##3##(1993-8#1)(1994-10#1)(1994-8#1)(2007-12#2)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#2)(2013-7#1)
expression and functional##2##3##(2008-11#1)(2009-10#1)
expression and gene##3##3##(2008-11#1)(2008-4#1)(2008-6#1)
expression and in##2##3##(2008-11#1)(2008-8#1)
expression and its##2##3##(2008-12#1)(2009-10#1)
expression and localization of##4##4##(1992-11#1)(1993-6#2)(2013-1#1)
expression and localization##5##3##(1992-11#1)(1993-6#2)(2012-2#1)(2013-1#1)
expression and mutagenesis##2##3##(1990-5#2)
expression and of##2##3##(1994-11#1)(2008-4#1)
expression and presentation of##2##4##(1996-12#1)(2008-8#1)
expression and proliferation##3##3##(1994-9#1)(1996-12#2)
expression and purification of the##2##5##(1994-6#1)(2009-9#1)
expression and purification of##7##4##(1994-6#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-9#1)(2013-1#1)
expression and purification##9##3##(1994-6#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#1)
expression and regulation##4##3##(1995-11#1)(2008-9#1)(2009-11#1)(2012-12#1)
expression and secretion of##5##4##(1991-9#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-5#1)
expression and secretion##9##3##(1991-9#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#2)(2011-2#1)
expression and subcellular##3##3##(1996-6#1)(2008-9#2)
expression and synthesis##2##3##(1992-5#1)(2008-10#1)
expression and the##13##3##(1991-11#1)(1991-9#1)(1995-6#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)
expression and tissue##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
expression and viral##2##3##(2008-10#1)(2011-3#1)
expression and##263##2##(1990-12#1)(1990-2#3)(1990-5#3)(1991-10#1)(1991-11#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-6#4)(1994-7#3)(1994-8#3)(1994-9#3)(1995-11#3)(1995-12#2)(1995-2#6)(1995-5#3)(1995-6#3)(1996-12#6)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#18)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#16)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#14)(2008-9#13)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#12)(2013-7#3)(2013-8#3)
expression and/or##3##2##(1994-7#1)(2008-11#1)(2008-3#1)
expression appeared##2##2##(1995-12#1)(2008-10#1)
expression appears##2##2##(1997-6#1)(2008-10#1)
expression are useful##2##3##(2008-11#1)(2011-1#1)
expression are##17##2##(1992-3#1)(1993-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
expression arrays##3##2##(2008-7#1)(2008-8#1)(2009-5#1)
expression as a##2##3##(1992-9#1)(2007-10#1)
expression as well as##5##4##(1990-12#1)(1993-6#1)(1994-8#1)(2008-8#1)(2011-2#1)
expression as##10##2##(1990-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(2007-10#1)(2008-8#1)(2011-2#1)
expression assay was##2##3##(1992-12#1)(1993-8#1)
expression assay##7##2##(1992-12#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-4#1)(2008-11#2)
expression assays##3##2##(1993-8#2)(1995-6#1)
expression at the##13##3##(1991-12#1)(1991-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
expression at##22##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
expression becomes restricted to the presumptive##2##6##(1994-12#2)
expression becomes##3##2##(1994-12#2)(2011-2#1)
expression between##6##2##(1994-12#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-8#2)
expression but also##2##3##(2008-7#1)(2012-3#1)
expression but not##2##3##(1990-5#1)(1994-8#1)
expression but##5##2##(1990-5#1)(1991-3#1)(1994-8#1)(2008-7#1)(2012-3#1)
expression by RNA interference##3##4##(2008-8#1)(2009-9#1)(2011-2#1)
expression by glucocorticoids##2##3##(1994-9#1)(2008-11#1)
expression by stromal cells##2##4##(1993-9#2)
expression by the##4##3##(1995-6#1)(1997-7#1)(2008-7#1)(2008-8#1)
expression by##67##2##(1991-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1993-3#1)(1993-9#2)(1994-11#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-6#6)(1996-12#1)(1996-2#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-2#4)(2012-3#2)
expression can be##7##3##(1991-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)
expression can##10##2##(1991-12#1)(1992-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-10#1)
expression cassette was##2##3##(1997-4#1)(2013-1#1)
expression cassette##8##2##(1993-9#1)(1997-4#3)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
expression cassettes##5##2##(1991-6#1)(2008-11#3)(2008-5#1)
expression categories##2##2##(2008-11#2)
expression caused##2##2##(1997-7#1)(2008-10#1)
expression changes##4##2##(2008-10#3)(2010-4#1)
expression characterization of##3##3##(2008-8#1)(2008-9#2)
expression cloning##2##2##(1993-3#1)(2008-2#1)
expression coincides with the##2##4##(2009-8#1)(2013-8#1)
expression compared to##3##3##(1992-5#1)(1994-11#1)(2008-10#1)
expression compared##4##2##(1992-5#1)(1994-11#1)(1995-5#1)(2008-10#1)
expression consistent with##2##3##(2010-6#1)(2012-12#1)
expression construct##6##2##(1992-8#1)(1992-9#1)(2008-11#3)(2008-4#1)
expression constructs##2##2##(1992-9#1)(2008-7#1)
expression correlates with##4##3##(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
expression correlates##5##2##(2009-8#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
expression could be detected in##2##5##(1995-6#1)(2012-2#1)
expression could be##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
expression could not be##2##4##(2007-10#1)(2008-7#1)
expression could##8##2##(1990-12#1)(1994-2#1)(1994-6#1)(1995-6#1)(2007-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
expression data from##3##3##(2008-4#1)(2008-7#1)(2009-4#1)
expression data obtained##2##3##(2008-4#1)(2009-4#1)
expression data##32##2##(1993-11#1)(1993-12#1)(2008-4#7)(2008-7#9)(2009-10#2)(2009-4#4)(2009-9#1)(2010-1#1)(2010-10#3)(2011-3#1)(2012-3#1)(2013-1#1)
expression derived##2##2##(2008-3#2)
expression did##2##2##(1994-7#1)(2008-7#1)
expression differences##2##2##(2008-4#1)(2012-3#1)
expression domains##4##2##(1994-8#1)(2007-12#1)(2012-1#2)
expression during development##3##3##(1991-9#1)(2009-10#1)(2012-3#1)
expression during in##2##3##(1994-9#1)(2010-1#1)
expression during the##2##3##(1997-8#1)(2008-7#1)
expression during##21##2##(1991-2#1)(1991-9#1)(1992-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-3#2)
expression efficiency of##2##3##(1997-8#1)(2008-11#1)
expression efficiency##4##2##(1997-8#1)(2008-11#3)
expression enhances##2##2##(2007-4#1)(2008-7#1)
expression experiments##4##2##(1994-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
expression factor gene##2##3##(1997-3#2)
expression factor##3##2##(1997-3#3)
expression following##2##2##(1995-11#1)(2010-12#1)
expression for the mean##2##4##(2007-11#1)(2008-10#1)
expression for the##33##3##(1992-6#1)(1994-3#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-2#9)(2008-3#9)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)
expression for three##2##3##(1996-2#1)(2010-1#1)
expression for##55##2##(1991-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-11#5)(2007-12#3)(2008-10#6)(2008-2#9)(2008-3#13)(2008-6#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-8#1)
expression from the##2##3##(1994-9#1)(1995-6#1)
expression from##9##2##(1991-12#1)(1994-9#1)(1995-2#1)(1995-6#2)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
expression governs the##2##3##(1994-6#1)(2008-11#1)
expression had a##3##3##(1992-5#1)(2007-4#1)(2011-2#1)
expression had##5##2##(1992-5#1)(2007-4#1)(2009-4#1)(2010-3#1)(2011-2#1)
expression has been##2##3##(1993-3#1)(2008-3#1)
expression has##7##2##(1993-3#1)(1994-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2012-12#1)
expression have been##2##3##(2008-2#1)(2010-12#1)
expression have not been##2##4##(1995-6#1)(2008-11#1)
expression have##7##2##(1993-9#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)
expression in COS cells##3##4##(1992-9#1)(1993-8#1)(1997-9#1)
expression in Drosophila##2##3##(1997-7#1)(2008-10#1)
expression in E##4##3##(1991-5#1)(1992-3#1)(1997-4#1)(2008-4#1)
expression in Escherichia coli##12##4##(1991-7#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-12#3)(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#1)
expression in MC##3##3##(1994-8#3)
expression in Saccharomyces cerevisiae##4##4##(1993-9#1)(1994-12#1)(1996-3#1)(2008-8#1)
expression in St##2##3##(2008-10#2)
expression in Xenopus laevis##2##4##(2008-11#1)(2010-2#1)
expression in Xenopus##3##3##(1995-11#1)(2008-11#1)(2010-2#1)
expression in a##16##3##(1991-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-3#1)(2008-8#2)(2009-8#2)(2011-2#1)(2012-12#1)(2013-8#1)
expression in acute myeloid leukemia##2##5##(2007-10#1)(2010-4#1)
expression in acute##4##3##(2007-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
expression in all##2##3##(1991-2#1)(1995-6#1)
expression in an##2##3##(1993-2#1)(2008-4#1)
expression in bone marrow##3##4##(2007-10#1)(2010-12#1)(2010-8#1)
expression in both##3##3##(1992-12#1)(1997-7#1)(2011-2#1)
expression in bovine##3##3##(1990-8#1)(1992-10#1)(1995-5#1)
expression in cancer##2##3##(2008-11#1)(2009-3#1)
expression in cell##2##3##(2012-1#1)(2012-12#1)
expression in cells##5##3##(2008-11#1)(2008-2#1)(2009-7#1)(2010-11#1)(2013-1#1)
expression in colorectal##2##3##(2008-12#1)(2010-12#1)
expression in cultured##4##3##(1995-12#1)(2008-11#1)(2008-5#2)
expression in diabetes##2##3##(1996-12#1)(2010-11#1)
expression in hepatocytes##2##3##(1993-3#1)(2008-8#1)
expression in hippocampus##2##3##(1994-12#1)(2010-12#1)
expression in human astrocytoma cells##2##5##(1993-6#1)(1995-12#1)
expression in human tumors##2##4##(2008-11#1)(2008-4#1)
expression in human vascular endothelial cells##2##6##(1993-6#1)(2010-1#1)
expression in human##20##3##(1990-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
expression in humans##3##3##(1996-9#1)(2008-4#1)(2008-7#1)
expression in macrophages##2##3##(1994-11#1)(1995-12#1)
expression in malignant tissues##2##4##(2008-12#2)
expression in mammalian cells##11##4##(1992-9#1)(1993-6#2)(1994-8#1)(1997-4#2)(2008-11#3)(2008-2#1)(2008-8#1)
expression in mammary##3##3##(1997-6#1)(2008-8#2)
expression in mouse##3##3##(1991-12#1)(2008-11#1)(2008-9#1)
expression in multiple##2##3##(1997-7#1)(2008-4#1)
expression in murine##2##3##(1991-2#1)(2010-3#1)
expression in music##2##3##(2013-8#2)
expression in normal and##2##4##(1992-3#1)(1993-3#1)
expression in normal##5##3##(1992-3#1)(1993-12#1)(1993-3#1)(2011-1#1)(2012-12#1)
expression in peripheral blood##2##4##(1996-9#1)(2013-1#1)
expression in peripheral##4##3##(1991-5#1)(1996-9#1)(2008-7#1)(2013-1#1)
expression in photosynthetic tissues##3##4##(2008-9#3)
expression in plaques##2##3##(1991-10#2)
expression in prostate##2##3##(2011-2#2)
expression in rat##11##3##(1991-1#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-12#1)(2008-8#1)(2008-9#2)
expression in rats with##2##4##(2012-3#2)
expression in rats##3##3##(2012-1#1)(2012-3#2)
expression in relation to##2##4##(1995-5#1)(2008-7#1)
expression in response to##10##4##(1993-8#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-6#1)
expression in small##2##3##(1996-12#1)(2013-1#1)
expression in stem cells##2##4##(2010-7#1)(2011-2#1)
expression in the absence of##2##5##(1991-12#1)(2008-11#1)
expression in the adult##2##4##(1996-12#1)(2012-12#1)
expression in the brain##4##4##(1994-12#1)(1995-12#1)(2008-11#1)(2009-12#1)
expression in the brains##2##4##(1996-5#1)(2008-6#1)
expression in the central##3##4##(1996-12#2)(2008-10#1)
expression in the cerebral cortex##2##5##(1991-2#1)(1996-12#1)
expression in the developing##3##4##(1993-11#1)(1996-5#1)(2012-3#1)
expression in the frontal cortex of##2##6##(1995-2#2)
expression in the kidney##3##4##(2008-11#1)(2008-7#1)(2009-6#1)
expression in the pancreas##2##4##(2013-7#2)
expression in the presence of##2##5##(1994-9#1)(2008-10#1)
expression in the rat brain##4##5##(1993-12#1)(1996-12#3)
expression in the rat##7##4##(1992-8#1)(1993-12#1)(1995-11#1)(1996-12#3)(1997-6#1)
expression in the##99##3##(1991-12#1)(1991-2#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1996-10#1)(1996-12#16)(1996-5#5)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#3)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
expression in these##5##3##(1991-2#1)(1994-3#1)(1995-6#1)(2010-7#1)(2013-1#1)
expression in transfected##2##3##(1995-12#1)(2008-11#1)
expression in transgenic##3##3##(1997-6#1)(2008-9#1)(2011-10#1)
expression in transient##2##3##(1993-6#1)(2008-11#1)
expression in tumor##3##3##(1992-2#1)(2009-3#1)(2010-7#1)
expression in various##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
expression in vitro##2##3##(1993-8#1)(2008-7#1)
expression in vivo is##2##4##(1994-11#1)(2008-10#1)
expression in vivo##3##3##(1994-11#1)(1997-4#1)(2008-10#1)
expression in wild-type##2##3##(2008-7#2)
expression in##514##2##(1990-12#4)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#7)(1992-9#3)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#10)(1993-8#8)(1993-9#5)(1994-11#9)(1994-12#10)(1994-2#4)(1994-3#5)(1994-6#2)(1994-8#6)(1994-9#2)(1995-11#4)(1995-12#17)(1995-2#13)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#22)(1996-3#2)(1996-5#6)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#5)(1997-6#4)(1997-7#5)(1997-9#2)(2007-10#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#29)(2008-11#33)(2008-12#3)(2008-2#2)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#21)(2008-8#17)(2008-9#16)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#3)(2011-1#4)(2011-10#3)(2011-2#16)(2012-1#5)(2012-12#10)(2012-2#10)(2012-3#8)(2013-1#17)(2013-7#5)(2013-8#7)
expression increased##2##2##(1992-12#1)(2008-11#1)
expression indicated that the##2##4##(1995-8#1)(2012-2#1)
expression indicated that##3##3##(1995-8#1)(2010-11#1)(2012-2#1)
expression induced by##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
expression induced##4##2##(2008-10#2)(2008-4#1)(2008-8#1)
expression inversely correlated with##2##4##(2007-8#1)(2010-11#1)
expression is a##3##3##(1995-2#1)(2008-8#1)(2009-4#1)
expression is accompanied by##2##4##(1994-8#1)(1995-12#1)
expression is also##3##3##(1990-2#1)(2008-9#1)(2013-1#1)
expression is associated with##5##4##(1995-6#1)(2008-4#1)(2009-4#1)(2013-1#1)(2013-7#1)
expression is correlated##2##3##(2008-10#1)(2009-5#1)
expression is derived for the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
expression is derived for##5##4##(2007-11#2)(2008-2#1)(2008-3#2)
expression is derived##6##3##(2007-11#3)(2008-2#1)(2008-3#2)
expression is detected in##3##4##(1996-12#1)(2013-1#2)
expression is given for the##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
expression is given##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
expression is in##2##3##(1996-12#1)(2011-3#1)
expression is induced by##2##4##(1995-12#1)(2008-5#1)
expression is not##4##3##(1994-2#1)(2007-12#1)(2008-6#1)(2012-3#1)
expression is one##2##3##(1996-12#1)(2008-1#1)
expression is regulated by##6##4##(1992-8#1)(1993-11#1)(1993-5#1)(1995-5#1)(1996-2#1)(2008-9#1)
expression is regulated in##2##4##(1994-11#1)(2011-1#1)
expression is regulated##10##3##(1992-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-11#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-9#1)(2011-1#1)
expression is restricted to##2##4##(2008-1#1)(2008-11#1)
expression is still##2##3##(2011-2#1)(2012-12#1)
expression is stimulated by##2##4##(1990-5#1)(1992-12#1)
expression is##111##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#3)(1993-5#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#3)(2007-11#4)(2007-12#5)(2008-1#2)(2008-10#3)(2008-11#7)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)
expression kinetics##3##2##(1993-6#1)(1995-2#1)(2008-11#1)
expression lasted##2##2##(2008-8#2)
expression leads to##2##3##(1993-12#1)(2009-5#1)
expression led to##2##3##(1994-12#1)(2012-12#1)
expression level in##8##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-1#1)
expression level of the##6##4##(1992-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-9#2)
expression level of##31##3##(1992-3#1)(1995-11#1)(1997-3#1)(1997-8#2)(2008-10#2)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
expression level was##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2009-3#1)
expression level##55##2##(1991-9#1)(1992-3#1)(1994-8#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#5)(2008-11#7)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-5#2)(2011-2#1)(2012-1#2)(2012-5#1)(2013-1#3)(2013-8#1)
expression levels and##9##3##(1995-12#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-2#2)(2012-3#2)
expression levels are##3##3##(2008-11#2)(2012-1#1)
expression levels in the##2##4##(2008-11#1)(2013-1#1)
expression levels in##9##3##(1993-3#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#2)(2013-1#2)
expression levels of PFLP in root tissue##2##7##(2008-10#2)
expression levels of SEAP##2##4##(2008-11#2)
expression levels of the##2##4##(2008-11#1)(2012-3#1)
expression levels of these##3##4##(1993-6#1)(1995-3#1)(2011-2#1)
expression levels of##36##3##(1991-5#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#10)(2008-7#5)(2008-9#2)(2009-8#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
expression levels or##2##3##(2008-7#1)(2009-2#1)
expression levels were##9##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)
expression levels##99##2##(1991-5#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#19)(2008-2#1)(2008-5#1)(2008-7#14)(2008-8#1)(2008-9#7)(2009-2#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#4)
expression libraries##3##2##(1992-8#1)(1993-12#1)(2008-4#1)
expression library in lambda##2##4##(1994-11#1)(1994-8#1)
expression library using##2##3##(1993-9#1)(1997-4#1)
expression library was constructed##2##4##(1990-11#1)(2008-9#1)
expression library was##3##3##(1990-11#1)(2008-8#1)(2008-9#1)
expression library with##2##3##(1991-2#1)(1997-7#1)
expression library##12##2##(1990-11#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-8#2)(2008-9#2)
expression lines##2##2##(2008-5#2)
expression may be regulated##2##4##(1992-3#1)(1995-2#1)
expression may be##10##3##(1990-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-2#2)(1996-12#2)(2010-11#1)(2010-4#1)
expression may contribute to##2##4##(1996-12#1)(1996-5#1)
expression may represent##2##3##(1995-12#1)(1996-5#1)
expression may##20##2##(1990-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-5#2)(1997-6#1)(2010-11#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
expression microarrays##3##2##(2008-7#1)(2008-8#1)(2012-12#1)
expression might##3##2##(1994-10#1)(2007-10#1)(2008-7#1)
expression modulation##2##2##(2008-8#1)(2011-2#1)
expression observed##2##2##(2008-7#1)(2012-1#1)
expression occurred##3##2##(1994-6#1)(1995-2#1)(2008-11#1)
expression of 11β-HSD1##2##3##(2013-1#2)
expression of A20##2##3##(1992-7#2)
expression of BDNF mRNA##2##4##(1997-2#1)(2012-1#1)
expression of BDNF##4##3##(1997-2#2)(1997-6#1)(2012-1#1)
expression of BIM##2##3##(2008-8#2)
expression of BMP-2/4##2##3##(2011-2#2)
expression of BMP-7##2##3##(2011-2#2)
expression of Bcl-2 and Bax##3##5##(2008-9#2)(2013-7#1)
expression of Bcl-2 and##4##4##(2008-9#2)(2012-12#1)(2013-7#1)
expression of Bcl-2##6##3##(2008-9#2)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
expression of C##2##3##(1995-3#1)(2008-8#1)
expression of CBS##2##3##(2013-8#2)
expression of CD in##2##4##(1994-5#1)(2008-7#1)
expression of CD##3##3##(1994-5#2)(2008-7#1)
expression of CD14##2##3##(2008-10#1)(2008-4#1)
expression of CD38##2##3##(1994-11#1)(2008-9#1)
expression of CSE##2##3##(2013-8#2)
expression of CYP1A1 mRNA##2##4##(2008-11#2)
expression of CYP1A1##3##3##(1995-11#1)(2008-11#2)
expression of CYP2E1##2##3##(1990-11#1)(2008-8#1)
expression of CYP3A-like##2##3##(2013-1#2)
expression of ER and PR##2##5##(2013-8#2)
expression of ER##4##3##(1995-4#1)(2008-6#1)(2013-8#2)
expression of ERalpha##2##3##(2008-12#2)
expression of FIX protein##2##4##(1995-2#2)
expression of Fos-LI##2##3##(1994-2#2)
expression of GPNMB##2##3##(2009-4#2)
expression of HBD-2##2##3##(2011-3#2)
expression of HCMV genes##2##4##(1997-3#2)
expression of HGF##2##3##(2008-9#1)(2011-2#1)
expression of HLA class I heavy chains##2##7##(1997-9#2)
expression of HLA class I##3##5##(1994-5#1)(1997-9#2)
expression of HLA##4##3##(1994-5#1)(1997-9#3)
expression of HO-1##4##3##(2008-4#2)(2011-2#2)
expression of ICAM-1 mRNA and infiltration of PMNLs and##2##9##(2010-1#2)
expression of ICAM-1 mRNA##3##4##(2010-1#3)
expression of IGF-I##5##3##(1994-2#1)(1996-2#2)(2008-11#2)
expression of IGF-IR##2##3##(2008-8#2)
expression of LTP##3##3##(1995-2#1)(1997-2#1)(2012-3#1)
expression of MHC class II##2##5##(1993-6#1)(2008-8#1)
expression of MHC class##3##4##(1993-6#1)(2008-1#1)(2008-8#1)
expression of MHC##4##3##(1993-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
expression of MyoD1 in##2##4##(1992-8#2)
expression of MyoD1##3##3##(1992-8#3)
expression of Noxa##2##3##(2010-3#1)(2012-12#1)
expression of P-glycoprotein and##2##4##(1995-11#1)(2008-11#1)
expression of P-glycoprotein##4##3##(1995-11#2)(1997-4#1)(2008-11#1)
expression of P-selectin##2##3##(1997-7#1)(2008-9#1)
expression of RNA##2##3##(1996-2#1)(2008-9#1)
expression of SSTR2##3##3##(2011-2#3)
expression of TGF-beta 1##2##4##(1990-5#1)(1994-11#1)
expression of TGF-beta##3##3##(1990-5#1)(1992-9#1)(1994-11#1)
expression of TH and##2##4##(1996-12#1)(2013-1#1)
expression of TH in the##2##5##(2008-10#2)
expression of TH##5##3##(1996-12#2)(2008-10#2)(2013-1#1)
expression of TPO##2##3##(2008-8#2)
expression of TRPV2##2##3##(2011-2#2)
expression of WT1##2##3##(2011-2#2)
expression of a cytoskeletal protein##2##5##(1995-12#2)
expression of a gene##3##4##(1997-6#1)(2008-10#1)(2009-8#1)
expression of a receptor##2##4##(1992-12#1)(1995-6#1)
expression of a reporter gene##4##5##(1994-12#1)(1997-7#1)(2008-8#1)(2010-10#1)
expression of a reporter##5##4##(1994-12#1)(1997-7#1)(2008-11#1)(2008-8#1)(2010-10#1)
expression of a wide variety of##2##6##(1990-5#1)(1996-3#1)
expression of a##70##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#4)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-10#2)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
expression of active##2##3##(1992-3#1)(2008-11#1)
expression of adenosine##2##3##(1993-6#2)
expression of adhesion molecules##3##4##(1995-5#1)(2008-1#1)(2012-2#1)
expression of aggrecan mRNA compared with##2##6##(2008-11#2)
expression of aggrecan##3##3##(1992-1#1)(2008-11#2)
expression of alpha##3##3##(1991-12#2)(1992-12#1)
expression of aminopeptidase N##2##4##(1995-8#2)
expression of an##8##3##(1990-3#1)(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#1)(1997-4#1)(2008-5#1)(2008-9#1)
expression of angiotensin##3##3##(1991-9#2)(1996-5#1)
expression of antioxidant##2##3##(1990-3#1)(2011-2#1)
expression of apoptosis and proliferation##2##5##(2012-1#2)
expression of auxin##2##3##(2008-8#1)(2008-9#1)
expression of beta-actin mRNA##2##4##(1995-12#2)
expression of beta-actin##3##3##(1995-12#3)
expression of beta-galactosidase##3##3##(1993-12#1)(1997-8#1)(2008-8#1)
expression of biglycan##2##3##(2012-1#2)
expression of both##7##3##(1990-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-6#1)(2008-10#1)(2009-12#1)
expression of brain-derived neurotrophic factor##2##5##(1997-2#1)(2012-1#1)
expression of c-Fos gene##3##4##(2013-1#3)
expression of c-Met receptor##3##4##(2011-2#3)
expression of c-fos in##2##4##(1996-5#1)(1997-2#1)
expression of c-fos##3##3##(1996-5#1)(1997-2#1)(2008-9#1)
expression of c-jun##3##3##(1991-12#1)(1991-9#1)(1995-8#1)
expression of c-kit##2##3##(2008-11#1)(2011-2#1)
expression of c-myc##6##3##(1992-8#1)(1993-11#1)(1993-2#1)(2008-11#1)(2008-8#2)
expression of cell cycle##2##4##(2008-11#1)(2013-1#1)
expression of cell surface##4##4##(2008-10#1)(2008-11#2)(2008-4#1)
expression of cell##8##3##(2008-10#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
expression of cellular##4##3##(1997-6#1)(2008-11#1)(2010-1#1)(2011-2#1)
expression of certain##5##3##(1992-3#1)(1993-6#2)(1997-8#1)(2008-9#1)
expression of chemokines##2##3##(2008-10#1)(2013-1#1)
expression of class I MHC##2##5##(1990-5#1)(2008-4#1)
expression of cloned genes in##2##5##(1990-5#1)(1991-9#1)
expression of cloned genes##3##4##(1990-5#1)(1991-9#1)(1993-9#1)
expression of cloned##5##3##(1990-5#1)(1991-9#1)(1993-9#1)(1997-4#2)
expression of constitutive##2##3##(1994-11#1)(1994-8#1)
expression of core##2##3##(2006-10#1)(2011-2#1)
expression of cyclin##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
expression of cytokine##2##3##(1996-12#1)(2013-1#1)
expression of cytokines##3##3##(1994-8#1)(1997-8#1)(2012-2#1)
expression of decorin##2##3##(2007-8#1)(2012-1#1)
expression of different##2##3##(2008-3#1)(2008-4#1)
expression of each##3##3##(1995-11#1)(1996-12#1)(2008-10#1)
expression of either##3##3##(1993-9#1)(1994-7#1)(2013-8#1)
expression of estrogen##2##3##(2008-12#1)(2013-8#1)
expression of exogenous gene in transgenic plant##2##7##(2008-9#2)
expression of exogenous gene##3##4##(2008-9#3)
expression of extracellular matrix##2##4##(1990-5#1)(1994-12#1)
expression of five##2##3##(2008-10#1)(2010-10#1)
expression of foreign gene##2##4##(2008-9#2)
expression of foreign genes##4##4##(1995-5#1)(1997-4#1)(1997-8#1)(2008-11#1)
expression of foreign##7##3##(1995-5#2)(1997-4#1)(1997-8#1)(2008-11#1)(2008-9#2)
expression of full-length##3##3##(1995-2#2)(2008-9#1)
expression of functional##3##3##(1994-12#1)(2008-7#1)(2008-9#1)
expression of gangliosides and galactolipids##2##5##(1996-5#2)
expression of genes associated with##2##5##(2008-10#1)(2013-1#1)
expression of genes encoding##3##4##(1996-3#1)(2009-10#1)(2012-2#1)
expression of genes that##2##4##(2010-10#1)(2012-3#1)
expression of genes##18##3##(1991-9#1)(1993-9#2)(1994-8#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
expression of gicerin##2##3##(1997-6#2)
expression of glutamate##3##3##(1990-8#1)(1996-2#1)(2012-12#1)
expression of green fluorescent protein##2##5##(2008-7#2)
expression of group I metabotropic glutamate receptors##2##7##(1996-12#2)
expression of growth##4##3##(1992-8#1)(1992-9#1)(2008-11#1)(2008-9#1)
expression of hFIX##2##3##(2008-8#1)(2008-9#1)
expression of harpin protein gene in transgenic##2##7##(2008-8#2)
expression of heat shock protein##5##5##(1994-11#3)(1994-8#1)(1995-5#1)
expression of heat shock##7##4##(1994-11#4)(1994-8#2)(1995-5#1)
expression of hepatitis B virus##2##5##(1994-8#1)(2008-8#1)
expression of hepatitis B##3##4##(1994-8#1)(2008-8#2)
expression of heterologous genes##3##4##(1991-9#1)(1994-12#1)(2008-5#1)
expression of heterologous##4##3##(1991-9#1)(1994-12#1)(2008-5#1)(2008-7#1)
expression of human##12##3##(1993-9#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#3)
expression of hundreds of##2##4##(2008-4#1)(2013-8#1)
expression of induced resistance##2##4##(2008-10#2)
expression of inducible nitric oxide synthase##4##6##(1995-12#1)(1996-12#2)(2008-5#1)
expression of inducible##5##3##(1995-12#1)(1996-12#3)(2008-5#1)
expression of inflammation-responsive##2##3##(2013-1#2)
expression of its##3##3##(1990-2#1)(2008-8#1)(2013-1#1)
expression of key##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
expression of lambdaN gene##3##4##(2008-8#2)(2008-9#1)
expression of listeriolysin O by##2##5##(1996-12#2)
expression of liver##2##3##(2008-11#1)(2009-8#1)
expression of mRNA##4##3##(2008-4#1)(2008-7#1)(2013-1#2)
expression of mRNAs for##2##4##(1995-2#1)(1996-12#1)
expression of mRNAs##5##3##(1995-2#1)(1996-12#2)(2008-11#1)(2013-1#1)
expression of major histocompatibility complex class##2##6##(2008-10#1)(2013-1#1)
expression of many##6##3##(1997-4#1)(2008-4#2)(2008-7#1)(2010-4#1)(2010-7#1)
expression of matrix metalloproteinase##2##4##(2008-9#1)(2013-1#1)
expression of matrix metalloproteinases##2##4##(2008-9#1)(2009-5#1)
expression of matrix##5##3##(2008-9#2)(2009-5#1)(2012-3#1)(2013-1#1)
expression of metalloproteinase##2##3##(1992-6#2)
expression of mouse##2##3##(1997-7#1)(2008-11#1)
expression of multiple##3##3##(1996-5#1)(2012-12#2)
expression of neurotrophins##2##3##(1996-12#1)(2008-7#1)
expression of nuclear##2##3##(1991-12#1)(2010-12#1)
expression of one##2##3##(1992-9#1)(2011-2#1)
expression of other##7##3##(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#1)
expression of p-NF-kBp65 (Ser 536)##2##5##(2010-3#2)
expression of p-NF-kBp65##3##3##(2010-3#3)
expression of p16INK4A##2##3##(1997-7#2)
expression of p53##4##3##(2007-8#1)(2008-10#1)(2009-4#1)(2013-1#1)
expression of pain##2##3##(1996-2#2)
expression of pathogenesis-related (PR)##2##4##(2008-10#2)
expression of pathogenesis-related##3##3##(2008-10#2)(2011-10#1)
expression of plasminogen##2##3##(1992-6#1)(2008-4#1)
expression of progesterone##2##3##(1993-11#1)(2013-8#1)
expression of proinflammatory##2##3##(1994-8#1)(2009-8#1)
expression of protein##3##3##(1992-3#2)(1993-8#1)
expression of proteins and##2##4##(1994-9#1)(1996-5#1)
expression of proteins##4##3##(1992-3#1)(1994-9#1)(1996-5#1)(2008-2#1)
expression of rat##8##3##(1990-11#2)(1990-8#2)(1993-3#2)(2008-4#1)(2008-8#1)
expression of receptor##2##3##(1995-8#1)(2007-11#1)
expression of recombinant human##3##4##(2008-11#2)(2008-8#1)
expression of recombinant protein##2##4##(2008-11#2)
expression of recombinant proteins##4##4##(2008-11#4)
expression of recombinant##15##3##(1992-9#1)(2008-11#10)(2008-4#1)(2008-8#2)(2011-2#1)
expression of resistance##4##3##(2008-10#4)
expression of several members of the##2##6##(1992-3#1)(2008-11#1)
expression of several##12##3##(1991-9#1)(1992-3#2)(1992-8#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
expression of sodium channel##2##4##(1996-12#2)
expression of somatostatin receptors##2##4##(1997-2#1)(2012-3#1)
expression of some##6##3##(1990-6#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-9#1)(2010-11#1)
expression of specific##6##3##(1991-12#1)(1994-3#1)(2008-1#1)(2008-4#1)(2008-9#1)(2012-2#1)
expression of stress##2##3##(2008-10#1)(2008-11#1)
expression of such##2##3##(1991-12#1)(1993-9#1)
expression of sucrase-isomaltase##2##3##(1990-12#2)
expression of surface##2##3##(1995-8#1)(2012-2#1)
expression of survivin in##2##4##(2010-1#1)(2011-2#1)
expression of target genes##3##4##(2009-3#1)(2010-4#1)(2011-2#1)
expression of tga1a##2##3##(2008-9#2)
expression of the &quot##2##4##(2008-1#1)(2008-9#1)
expression of the GIP gene##2##5##(1995-11#2)
expression of the GUS gene##2##5##(1997-2#2)
expression of the HMG2 gene##2##5##(1995-2#2)
expression of the alpha##3##4##(1993-9#2)(1995-2#1)
expression of the angiogenic phenotype##2##5##(2013-1#2)
expression of the calcitonin gene##2##5##(1990-12#1)(1990-2#1)
expression of the chicken##2##4##(1991-5#1)(1993-12#1)
expression of the corresponding gene##2##5##(1995-8#1)(2011-1#1)
expression of the corresponding##4##4##(1995-8#1)(2008-7#1)(2009-8#1)(2011-1#1)
expression of the disease##2##4##(1995-5#1)(2012-3#1)
expression of the early##2##4##(1992-12#1)(2007-12#1)
expression of the endogenous##2##4##(1991-9#1)(2008-11#1)
expression of the first##2##4##(1995-2#1)(2009-9#1)
expression of the gene##15##4##(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)
expression of the genes for##2##5##(1997-2#1)(2010-11#1)
expression of the genes##8##4##(1991-5#1)(1993-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2010-11#1)(2013-1#1)
expression of the homeobox-containing gene Msx1##2##6##(1994-11#2)
expression of the human##4##4##(1990-12#1)(1991-11#1)(1992-5#1)(1997-7#1)
expression of the indicator trait##2##5##(2008-9#2)
expression of the inhibitory##2##4##(1997-1#1)(2012-12#1)
expression of the inserted##2##4##(1997-8#2)
expression of the lacZ reporter##3##5##(1997-6#2)(2009-12#1)
expression of the mouse##2##4##(1996-12#1)(2008-11#1)
expression of the mutant##2##4##(1992-3#1)(2008-10#1)
expression of the rat##2##4##(1992-12#1)(1992-6#1)
expression of the receptor##3##4##(1991-5#1)(1992-9#1)(1994-12#1)
expression of the reporter gene was##2##6##(1994-2#1)(2008-11#1)
expression of the reporter gene##5##5##(1994-2#1)(2008-11#2)(2008-9#1)(2011-1#1)
expression of the somatostatin gene##2##5##(1995-8#2)
expression of the tumor##2##4##(2007-8#1)(2012-3#1)
expression of the two##5##4##(1991-12#1)(1991-9#1)(2008-11#1)(2008-9#1)(2013-8#1)
expression of the various##2##4##(1993-5#1)(2008-4#1)
expression of the viral##3##4##(1993-6#1)(1994-8#1)(1995-2#1)
expression of the##308##3##(1990-11#5)(1990-12#3)(1990-2#1)(1990-5#8)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#4)(1992-1#2)(1992-10#2)(1992-12#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#6)(1993-1#1)(1993-11#3)(1993-12#4)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#6)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#12)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#8)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#6)(1997-8#7)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#21)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#5)
expression of their##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
expression of these diseases##2##4##(1994-5#1)(2008-3#1)
expression of these genes in##3##5##(1995-12#1)(1996-12#1)(2008-11#1)
expression of these genes##6##4##(1995-12#2)(1996-12#1)(1997-8#1)(2008-11#1)(2013-1#1)
expression of these two genes##2##5##(1991-9#1)(1994-11#1)
expression of these##28##3##(1990-8#1)(1991-9#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
expression of this enzyme##2##4##(1994-6#1)(1994-8#1)
expression of this gene##3##4##(1995-6#1)(1997-7#1)(2008-10#1)
expression of this novel##2##4##(1994-6#1)(1996-12#1)
expression of this protein##5##4##(1993-1#1)(1997-4#1)(2008-10#2)(2012-12#1)
expression of this receptor gene was##2##6##(1991-5#2)
expression of this##22##3##(1991-2#1)(1991-5#2)(1993-1#1)(1994-6#2)(1994-8#4)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#4)(2009-9#1)(2010-2#1)(2012-12#1)
expression of those##3##3##(1995-2#1)(2007-12#1)(2013-8#1)
expression of three##4##3##(1992-3#1)(1993-3#1)(2008-10#2)
expression of topoisomerase II##2##4##(1993-8#2)
expression of topoisomerase##3##3##(1993-8#3)
expression of transcription factors##3##4##(1994-11#2)(2009-10#1)
expression of two forms of##2##5##(1992-12#1)(1995-5#1)
expression of two or##2##4##(2010-1#1)(2012-2#1)
expression of two##9##3##(1992-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
expression of type##4##3##(1992-8#1)(2008-10#1)(2010-11#1)(2010-6#1)
expression of various cell##2##4##(1992-10#1)(2013-1#1)
expression of various##5##3##(1992-10#1)(2008-1#1)(2008-2#1)(2008-8#1)(2013-1#1)
expression of vascular endothelial growth factor##2##6##(2009-5#2)
expression of viral##2##3##(2008-11#1)(2008-9#1)
expression of wcmmVtg##2##3##(2010-5#2)
expression of yellow gene##2##4##(2008-8#2)
expression of##1642##2##(1990-11#12)(1990-12#12)(1990-2#4)(1990-3#2)(1990-5#16)(1990-6#2)(1990-7#3)(1990-8#7)(1991-1#1)(1991-11#1)(1991-12#13)(1991-2#8)(1991-3#2)(1991-5#9)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#16)(1992-1#3)(1992-10#3)(1992-12#13)(1992-2#1)(1992-3#23)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#17)(1992-9#15)(1993-1#4)(1993-11#7)(1993-12#9)(1993-2#3)(1993-3#19)(1993-5#5)(1993-6#18)(1993-8#14)(1993-9#14)(1994-11#26)(1994-12#21)(1994-2#8)(1994-3#4)(1994-5#10)(1994-6#9)(1994-7#4)(1994-8#22)(1994-9#8)(1995-11#11)(1995-12#21)(1995-2#31)(1995-3#4)(1995-4#1)(1995-5#8)(1995-6#13)(1995-8#18)(1995-9#3)(1996-10#1)(1996-11#1)(1996-12#42)(1996-2#12)(1996-3#3)(1996-5#15)(1996-6#1)(1997-1#3)(1997-2#18)(1997-3#8)(1997-4#15)(1997-5#1)(1997-6#13)(1997-7#21)(1997-8#20)(1997-9#3)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#4)(2008-1#10)(2008-10#103)(2008-11#117)(2008-12#5)(2008-2#7)(2008-3#7)(2008-4#46)(2008-5#26)(2008-6#10)(2008-7#41)(2008-8#76)(2008-9#75)(2009-10#5)(2009-11#1)(2009-12#9)(2009-2#2)(2009-3#7)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#17)(2009-9#9)(2010-1#9)(2010-10#4)(2010-11#13)(2010-12#6)(2010-2#3)(2010-3#8)(2010-4#5)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#11)(2011-10#3)(2011-2#64)(2011-3#9)(2012-1#13)(2012-12#34)(2012-2#31)(2012-3#21)(2013-1#49)(2013-7#8)(2013-8#38)
expression ofthe##2##2##(2008-11#2)
expression on both##2##3##(2008-10#1)(2008-4#1)
expression on cell##2##3##(2008-11#1)(2008-7#1)
expression on day 12 and##2##5##(1995-12#2)
expression on day##3##3##(1995-12#3)
expression on the breast epithelial mucin##2##6##(1993-1#2)
expression on the##9##3##(1993-1#2)(1995-2#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-4#1)
expression on##33##2##(1992-10#1)(1993-1#2)(1993-12#2)(1995-10#1)(1995-12#3)(1995-2#3)(1996-2#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2010-4#1)(2013-1#2)
expression or function of##2##4##(2007-12#1)(2012-12#1)
expression or function##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
expression or##10##2##(1991-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-11#2)(2012-12#1)(2013-1#1)
expression over##2##2##(2008-11#1)(2008-7#1)
expression pattern and##3##3##(2008-7#1)(2008-9#1)(2010-3#1)
expression pattern during##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
expression pattern in##3##3##(2008-8#2)(2012-12#1)
expression pattern is##2##3##(2008-11#1)(2012-2#1)
expression pattern of human##2##4##(1997-7#1)(2008-5#1)
expression pattern of the segment polarity gene engrailed##2##8##(2007-12#2)
expression pattern of the##6##4##(1992-3#1)(1995-6#1)(1996-12#1)(2007-12#2)(2008-10#1)
expression pattern of##24##3##(1992-3#1)(1993-2#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
expression pattern was##2##3##(2010-12#2)
expression pattern##52##2##(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#3)(1997-7#2)(2007-12#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-8#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
expression patterns during##2##3##(2008-10#1)(2009-10#1)
expression patterns in##8##3##(1994-8#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)
expression patterns of Hira##2##4##(2008-7#2)
expression patterns of genes##2##4##(2010-1#1)(2011-1#1)
expression patterns of##18##3##(1991-5#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#5)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
expression patterns were##2##3##(1994-8#1)(2007-11#1)
expression patterns##54##2##(1991-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#1)(1996-12#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#7)(2009-10#2)(2009-5#1)(2010-1#2)(2010-12#4)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
expression plasmid containing##5##3##(1992-12#1)(1993-8#1)(1994-11#1)(2008-9#2)
expression plasmid##15##2##(1990-8#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-11#3)(2008-4#1)(2008-9#4)
expression plasmids##13##2##(1993-12#1)(1993-6#2)(1997-8#2)(2008-1#1)(2008-5#1)(2008-8#4)(2008-9#2)
expression presented by##2##3##(1992-6#2)
expression product##4##2##(2008-8#1)(2008-9#3)
expression profile data##3##3##(2008-7#3)
expression profile in##5##3##(1997-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
expression profile of the##2##4##(2010-6#1)(2012-2#1)
expression profile of##12##3##(1996-10#1)(1996-2#2)(2008-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
expression profile with##3##3##(1996-10#1)(1996-2#1)(2009-6#1)
expression profile##28##2##(1996-10#2)(1996-2#3)(1997-6#1)(2008-4#1)(2008-7#5)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#2)
expression profiles and##2##3##(2008-7#1)(2012-2#1)
expression profiles in##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
expression profiles is##2##3##(2008-2#1)(2008-7#1)
expression profiles of the##2##4##(1996-10#1)(2008-5#1)
expression profiles of##12##3##(1996-10#2)(1996-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
expression profiles were##2##3##(1995-2#1)(2008-10#1)
expression profiles##46##2##(1993-8#1)(1995-2#1)(1996-10#3)(1996-2#1)(1996-8#1)(2008-10#7)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
expression profiling data##3##3##(2008-2#1)(2008-7#2)
expression profiling in##4##3##(2008-10#1)(2008-7#1)(2010-3#1)(2013-1#1)
expression profiling of##11##3##(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-11#1)(2012-3#1)
expression profiling on##2##3##(2008-7#1)(2013-8#1)
expression profiling studies##2##3##(2008-2#1)(2009-4#1)
expression profiling##34##2##(2008-10#5)(2008-11#2)(2008-2#2)(2008-6#2)(2008-7#11)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
expression provides##2##2##(1992-6#1)(1994-7#1)
expression rates##3##2##(2006-12#1)(2008-11#2)
expression ratios were##2##3##(2008-10#1)(2011-2#1)
expression ratios##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
expression reached##3##2##(1997-2#1)(2008-8#1)(2008-9#1)
expression regulation##5##2##(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
expression results##3##2##(1993-8#1)(2008-9#1)(2012-3#1)
expression sequence##2##2##(1997-2#1)(2008-9#1)
expression serves as a##2##4##(1997-9#1)(2008-4#1)
expression showed a##2##3##(1993-11#1)(2011-2#1)
expression showed that##2##3##(1997-7#1)(2008-10#1)
expression showed##5##2##(1993-11#1)(1995-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
expression shows##2##2##(2007-12#1)(2008-6#1)
expression signal##2##2##(1996-12#1)(2008-8#1)
expression signatures##4##2##(2009-6#3)(2013-1#1)
expression significantly##3##2##(2008-8#1)(2011-2#1)(2012-1#1)
expression studies in##4##3##(1996-6#2)(2008-4#1)(2008-7#1)
expression studies of##3##3##(1993-3#1)(2008-5#1)(2008-8#1)
expression studies##17##2##(1993-3#1)(1996-6#2)(1997-4#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2011-2#1)(2012-2#1)
expression study##2##2##(2009-4#1)(2012-3#1)
expression system and##3##3##(1994-5#1)(2008-11#2)
expression system for Saccharomyces cerevisiae##2##5##(1991-9#2)
expression system for##4##3##(1991-9#2)(2008-4#1)(2011-2#1)
expression system in which the##2##5##(1991-9#1)(1992-12#1)
expression system in which##3##4##(1991-9#1)(1992-10#1)(1992-12#1)
expression system in yeast##2##4##(1990-8#1)(1993-9#1)
expression system in##5##3##(1990-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-9#1)
expression system is##2##3##(1997-2#1)(2008-2#1)
expression system to##2##3##(1997-3#1)(2008-11#1)
expression system using##2##3##(1994-11#1)(1997-4#1)
expression system##58##2##(1990-8#1)(1991-2#1)(1991-9#3)(1992-10#2)(1992-12#2)(1992-8#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#4)(1997-3#1)(1997-4#7)(1997-7#1)(2008-11#7)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-2#1)
expression systems and##2##3##(1996-12#1)(2008-11#1)
expression systems are##2##3##(2008-4#1)(2009-9#1)
expression systems##16##2##(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)
expression takes place in##2##4##(1992-6#1)(2012-12#1)
expression technique##2##2##(1994-8#1)(2008-7#1)
expression technology##5##2##(2008-11#4)(2011-2#1)
expression tends to##2##3##(1992-6#1)(1996-12#1)
expression than##2##2##(1996-12#1)(2008-11#1)
expression that is##4##3##(1995-2#2)(2008-2#1)(2008-8#1)
expression that##14##2##(1994-9#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)
expression through##4##2##(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
expression time##4##2##(1997-2#1)(1997-3#1)(2008-9#2)
expression to the##3##3##(1996-12#1)(2008-7#1)(2010-3#1)
expression to##20##2##(1992-9#2)(1993-12#1)(1993-3#1)(1994-9#1)(1996-12#1)(1997-1#1)(2007-11#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-3#2)
expression under##6##2##(1991-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)
expression unit##2##2##(2008-11#1)(2008-7#1)
expression used##2##2##(1995-2#1)(2012-3#1)
expression using##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#2)
expression varied##2##2##(2008-10#1)(2012-3#1)
expression vector and the##2##4##(1997-6#1)(2008-8#1)
expression vector and##6##3##(1991-9#1)(1992-8#2)(1997-6#1)(2007-7#1)(2008-8#1)
expression vector containing the##3##4##(1990-5#1)(1991-9#1)(2008-11#1)
expression vector containing##5##3##(1990-5#1)(1991-9#1)(1994-9#1)(2008-11#1)(2008-8#1)
expression vector of human tumor necrosis factor alpha (hTNF-alpha) gene and its expression in a cyanobacterium##2##16##(2008-8#2)
expression vector of##3##3##(2008-8#3)
expression vector system##6##3##(1997-4#3)(2008-11#2)(2008-7#1)
expression vector was##5##3##(1992-8#1)(1993-8#1)(1994-8#1)(1995-8#1)(2008-9#1)
expression vector##78##2##(1990-11#1)(1990-5#5)(1991-2#1)(1991-9#4)(1992-3#1)(1992-8#3)(1993-6#2)(1993-8#2)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#4)(1997-6#2)(1997-8#3)(2007-7#1)(2008-10#3)(2008-11#10)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#12)(2008-9#4)(2010-11#1)(2010-5#1)
expression vectors and their use##2##5##(1997-4#2)
expression vectors and##6##3##(1993-3#1)(1997-4#3)(2008-11#1)(2008-8#1)
expression vectors containing##2##3##(1994-10#1)(2008-8#1)
expression vectors for HIV-1 Tat and Rev##2##7##(1993-2#2)
expression vectors for##6##3##(1990-5#1)(1993-2#2)(1994-3#1)(2008-5#1)(2008-8#1)
expression vectors in##3##3##(1991-6#1)(2008-11#1)(2008-8#1)
expression vectors using##2##3##(1994-12#1)(2008-11#1)
expression vectors were constructed##3##4##(1997-4#1)(2008-9#2)
expression vectors were##4##3##(1994-12#1)(1997-4#1)(2008-9#2)
expression vectors which##2##3##(1993-6#1)(1996-6#1)
expression vectors with the##2##4##(2008-11#2)
expression vectors##55##2##(1990-5#1)(1991-6#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1994-10#1)(1994-12#5)(1994-3#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-4#8)(1997-8#1)(2008-10#1)(2008-11#10)(2008-2#2)(2008-5#1)(2008-8#5)(2008-9#4)(2011-3#1)
expression via the##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
expression via##5##2##(1995-2#1)(2008-11#1)(2009-2#1)(2010-10#1)(2011-2#1)
expression was also##5##3##(1996-5#1)(2008-10#1)(2008-8#2)(2011-2#1)
expression was analyzed##2##3##(2008-10#1)(2013-1#1)
expression was closely correlated with the##2##6##(1992-9#1)(2008-10#1)
expression was detected by##3##4##(1995-12#1)(2008-10#1)(2012-3#1)
expression was detected in##4##4##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
expression was detected##8##3##(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
expression was down regulated##2##4##(2008-8#1)(2008-9#1)
expression was either##2##3##(2008-9#1)(2012-2#1)
expression was elevated##2##3##(1993-6#1)(1997-3#1)
expression was enhanced##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
expression was examined##4##3##(1992-3#1)(2007-12#1)(2008-5#1)(2008-9#1)
expression was found in##3##4##(1993-9#1)(2013-1#2)
expression was found##6##3##(1993-9#1)(1997-6#1)(2008-8#1)(2013-1#2)(2013-8#1)
expression was increased in##4##4##(1994-11#1)(2007-8#1)(2008-4#1)(2008-8#1)
expression was increased##5##3##(1994-11#1)(2007-8#1)(2008-4#1)(2008-8#2)
expression was investigated in##4##4##(1990-3#1)(1996-12#1)(2008-10#1)(2012-3#1)
expression was investigated using##2##4##(1993-6#1)(2010-5#1)
expression was investigated##6##3##(1990-3#1)(1993-6#1)(1996-12#1)(2008-10#1)(2010-5#1)(2012-3#1)
expression was limited##2##3##(1995-2#1)(2012-2#1)
expression was not##6##3##(1991-9#1)(1995-5#1)(1997-4#1)(2008-8#2)(2011-2#1)
expression was observed in leaf##2##5##(2008-10#2)
expression was observed in the##4##5##(1992-8#1)(1993-2#1)(1997-4#1)(2011-2#1)
expression was observed in##15##4##(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2011-2#1)
expression was observed##18##3##(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
expression was obtained##2##3##(1991-2#1)(1997-8#1)
expression was related to##2##4##(2008-10#1)(2013-1#1)
expression was restricted to the##2##5##(2008-11#1)(2008-8#1)
expression was restricted to##3##4##(1997-8#1)(2008-11#1)(2008-8#1)
expression was retained and apoptosis was prevented##2##7##(1995-2#2)
expression was significantly higher##2##4##(2008-10#1)(2012-3#1)
expression was significantly less##2##4##(1995-12#1)(2008-10#1)
expression was significantly##9##3##(1995-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2012-3#1)
expression was slightly##2##3##(2012-1#1)(2012-12#1)
expression was studied##2##3##(1995-5#1)(2011-2#1)
expression was transiently##2##3##(1997-2#1)(2008-11#1)
expression was##152##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#6)(1995-2#4)(1995-5#3)(1996-12#3)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#20)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#13)(2008-9#9)(2009-4#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#1)
expression were also##2##3##(2008-10#2)
expression were detected##3##3##(1995-11#1)(2012-2#2)
expression were found##2##3##(2008-7#1)(2011-10#1)
expression were not##2##3##(1994-9#1)(2008-7#1)
expression were##23##2##(1990-12#1)(1991-12#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-11#2)(1996-5#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2010-11#1)(2011-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
expression when the##2##3##(1991-9#1)(2008-7#1)
expression when##5##2##(1991-9#1)(1994-8#1)(1995-12#1)(2008-11#1)(2008-7#1)
expression which##3##2##(1992-1#1)(1996-12#1)(2008-5#1)
expression while##2##2##(2008-5#1)(2013-8#1)
expression with a##2##3##(1997-8#1)(2008-9#1)
expression with the##4##3##(1993-9#1)(1994-3#1)(1997-7#1)(2008-11#1)
expression with##16##2##(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
expression within the##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
expression within##7##2##(2007-12#1)(2008-11#1)(2008-9#2)(2009-7#1)(2010-12#1)(2012-3#1)
expression without##2##2##(1994-11#1)(2008-5#1)
expression##4764##1##(1990-11#17)(1990-12#25)(1990-2#8)(1990-3#3)(1990-5#36)(1990-6#2)(1990-7#5)(1990-8#12)(1991-1#3)(1991-10#3)(1991-11#6)(1991-12#27)(1991-2#22)(1991-3#6)(1991-5#20)(1991-6#7)(1991-7#3)(1991-8#1)(1991-9#36)(1992-1#6)(1992-10#11)(1992-11#3)(1992-12#22)(1992-2#3)(1992-3#38)(1992-4#1)(1992-5#9)(1992-6#20)(1992-7#3)(1992-8#41)(1992-9#31)(1993-1#6)(1993-11#18)(1993-12#35)(1993-2#9)(1993-3#38)(1993-5#10)(1993-6#58)(1993-8#42)(1993-9#41)(1994-10#5)(1994-11#66)(1994-12#54)(1994-2#18)(1994-3#14)(1994-5#18)(1994-6#27)(1994-7#14)(1994-8#54)(1994-9#29)(1995-10#1)(1995-11#31)(1995-12#65)(1995-2#94)(1995-3#5)(1995-4#2)(1995-5#22)(1995-6#41)(1995-8#27)(1995-9#5)(1996-10#10)(1996-11#1)(1996-12#115)(1996-2#32)(1996-3#5)(1996-5#31)(1996-6#7)(1996-8#2)(1996-9#2)(1997-1#10)(1997-2#43)(1997-3#23)(1997-4#60)(1997-5#2)(1997-6#31)(1997-7#40)(1997-8#40)(1997-9#12)(2006-10#3)(2006-12#2)(2006-6#2)(2007-10#8)(2007-11#19)(2007-12#40)(2007-2#2)(2007-4#2)(2007-7#4)(2007-8#8)(2008-1#29)(2008-10#305)(2008-11#371)(2008-12#12)(2008-2#56)(2008-3#49)(2008-4#154)(2008-5#67)(2008-6#28)(2008-7#228)(2008-8#238)(2008-9#216)(2009-10#31)(2009-11#4)(2009-12#14)(2009-2#9)(2009-3#17)(2009-4#24)(2009-5#13)(2009-6#14)(2009-7#4)(2009-8#48)(2009-9#20)(2010-1#24)(2010-10#15)(2010-11#42)(2010-12#35)(2010-2#6)(2010-3#34)(2010-4#15)(2010-5#25)(2010-6#11)(2010-7#14)(2010-8#14)(2010-9#4)(2011-1#40)(2011-10#7)(2011-2#172)(2011-3#15)(2012-1#30)(2012-12#79)(2012-2#91)(2012-3#79)(2012-5#2)(2012-7#2)(2013-1#131)(2013-7#19)(2013-8#72)
expression) and##2##2##(2008-6#1)(2008-8#1)
expression)##9##1##(1992-3#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-6#2)(2008-8#1)(2010-3#1)(2012-12#1)
expression/secretion##2##1##(1991-9#1)(2013-1#1)
expressional##3##1##(1993-11#2)(2008-8#1)
expressionefficiency##2##1##(2008-11#2)
expressions and##4##2##(2008-11#1)(2008-3#1)(2013-1#2)
expressions are derived for the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
expressions are given for##2##4##(2008-2#1)(2008-3#1)
expressions are obtained for the##2##5##(2008-3#2)
expressions are obtained for##3##4##(2008-3#3)
expressions are presented for##2##4##(2007-12#1)(2008-7#1)
expressions are##14##2##(1997-4#1)(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2012-3#1)(2013-1#1)
expressions can be used to##2##5##(2008-10#1)(2010-2#1)
expressions can be used##3##4##(2008-10#1)(2010-2#1)(2012-3#1)
expressions for the M(2) factor and##2##6##(2007-12#1)(2008-3#1)
expressions for the##25##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#10)(2008-3#9)(2008-8#1)
expressions for##41##2##(1995-9#1)(2007-11#5)(2007-12#5)(2008-10#1)(2008-2#14)(2008-3#12)(2008-8#1)(2010-7#2)
expressions from the literature are##2##5##(2008-2#1)(2008-3#1)
expressions from the literature##3##4##(2008-2#2)(2008-3#1)
expressions from the##4##3##(2008-2#2)(2008-3#2)
expressions from##5##2##(2008-2#2)(2008-3#2)(2012-1#1)
expressions have##2##2##(1992-6#1)(2011-2#1)
expressions in##8##2##(2008-1#2)(2008-11#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
expressions of emotion##4##3##(1995-1#1)(2008-11#3)
expressions of the##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
expressions of##37##2##(1990-2#1)(1991-12#1)(1992-9#1)(1995-1#2)(1995-12#1)(1995-4#1)(1996-1#1)(1996-2#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#3)(2011-3#1)(2012-2#3)(2013-8#2)
expressions that##2##2##(2008-3#2)
expressions were##12##2##(1992-9#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2012-3#4)(2013-8#1)
expressions when##2##2##(2008-11#2)
expressions##184##1##(1990-2#1)(1990-3#1)(1991-12#1)(1992-6#3)(1992-9#2)(1995-1#2)(1995-12#3)(1995-4#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-11#7)(2007-12#9)(2007-8#2)(2008-1#7)(2008-10#5)(2008-11#25)(2008-12#1)(2008-2#19)(2008-3#28)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#10)(2013-1#5)(2013-8#5)
expressionvector system##2##2##(2008-11#2)
expressive dysphasia##2##2##(1996-6#1)(2008-7#1)
expressive morpho-syntactic##2##2##(2011-1#2)
expressive vocabulary##2##2##(2008-12#2)
expressive##21##1##(1992-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#2)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#3)(2012-2#1)(2012-3#1)
expressly##3##1##(1990-11#1)(2008-9#1)(2011-2#1)
expressway##2##1##(2012-2#2)
expulsion of##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
expulsion##7##1##(1993-8#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#2)
exquisite sensitivity to##2##3##(2008-4#1)(2012-2#1)
exquisite sensitivity##3##2##(2008-4#1)(2012-2#2)
exquisite##7##1##(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#2)
exquisitely sensitive to the##2##4##(2012-2#2)
exquisitely sensitive to##4##3##(2008-7#1)(2008-9#1)(2012-2#2)
exquisitely##6##1##(1990-11#1)(2008-7#1)(2008-9#2)(2012-2#2)
exsanguination##2##1##(2008-4#1)(2013-1#1)
exstrophy in##4##2##(2008-10#3)(2009-5#1)
exstrophy is##2##2##(2008-10#2)
exstrophy##32##1##(2008-10#29)(2009-5#1)(2011-2#2)
exstrophy-epispadias complex##3##2##(2008-10#3)
extant##26##1##(1994-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#3)(2011-2#2)(2012-2#3)(2012-3#1)
extend a##3##2##(1996-2#1)(2008-7#1)(2011-3#1)
extend and##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
extend beyond the##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
extend beyond##10##2##(1995-2#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
extend from the##6##3##(1995-11#1)(1997-4#1)(1997-8#1)(2007-12#2)(2010-12#1)
extend from##7##2##(1995-11#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-5#1)(2010-12#1)
extend into the##2##3##(1997-8#1)(2007-8#1)
extend it##2##2##(1996-12#1)(2008-3#1)
extend its applicability##2##3##(2008-10#2)
extend its##4##2##(2008-10#3)(2008-12#1)
extend our##4##2##(1994-12#1)(1996-3#1)(2008-8#1)(2009-2#1)
extend out##2##2##(1995-12#1)(2008-2#1)
extend previous research##2##3##(2009-4#1)(2013-8#1)
extend previous studies##2##3##(1994-12#1)(2008-3#1)
extend previous##5##2##(1994-12#1)(1994-8#1)(2008-3#1)(2009-4#1)(2013-8#1)
extend the in vivo##2##4##(2008-10#1)(2009-11#1)
extend the indications##2##3##(2008-10#1)(2011-7#1)
extend the method to##2##4##(2008-2#2)
extend the method##3##3##(2008-2#2)(2009-9#1)
extend the range of##2##4##(2008-10#1)(2008-3#1)
extend the tunability##2##3##(2007-11#1)(2007-12#1)
extend the utility of##2##4##(2008-11#1)(2013-1#1)
extend the##76##2##(1991-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-11#3)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
extend their##5##2##(1993-3#1)(1994-8#1)(2008-11#1)(2008-3#1)(2010-12#1)
extend these##4##2##(1994-3#1)(2008-8#1)(2008-9#2)
extend this##7##2##(2007-12#1)(2008-11#1)(2008-3#3)(2008-6#1)(2011-2#1)
extend to the##4##3##(2007-11#2)(2007-12#1)(2009-1#1)
extend to##16##2##(1991-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-4#1)(2010-8#1)(2013-8#1)
extend##183##1##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#4)(2007-11#6)(2007-12#11)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#18)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#7)(2011-3#1)(2011-7#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#2)
extended Jones##2##2##(2008-3#2)
extended Kalman filter##3##3##(2008-2#1)(2008-3#2)
extended X-ray absorption fine structure (EXAFS)##2##6##(1996-2#1)(2010-11#1)
extended X-ray absorption fine structure##3##5##(1996-2#1)(2008-9#1)(2010-11#1)
extended an##2##2##(2008-5#1)(2010-5#1)
extended and##3##2##(1997-8#2)(2008-3#1)
extended beyond the##2##3##(2008-6#1)(2010-10#1)
extended biliverdins##4##2##(1990-8#3)(1992-3#1)
extended by a##2##3##(1997-4#1)(2008-10#1)
extended by adding##2##3##(2007-8#1)(2008-11#1)
extended by##15##2##(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2013-8#1)
extended cavity##3##2##(2007-11#1)(2007-12#2)
extended colostrum##3##2##(2012-2#3)
extended depth-of-field##2##2##(2007-12#2)
extended extinction##4##2##(2008-5#4)
extended families##3##2##(2008-1#2)(2012-3#1)
extended for the analysis of##2##5##(2008-10#2)
extended for the##4##3##(2008-10#2)(2008-3#1)(2010-4#1)
extended for use##2##3##(2008-10#1)(2008-3#1)
extended for##17##2##(1990-8#1)(1997-4#1)(2008-10#7)(2008-2#1)(2008-3#5)(2010-4#1)(2010-8#1)
extended form of##2##3##(1990-7#1)(2008-10#1)
extended from the##6##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
extended from##16##2##(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
extended in##2##2##(1995-3#1)(2008-10#1)
extended into the##4##3##(1990-5#1)(1993-12#1)(2008-8#1)(2008-9#1)
extended into##8##2##(1990-5#1)(1993-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)
extended life span##2##3##(2008-11#1)(2008-3#1)
extended life##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
extended linear##2##2##(2008-10#2)
extended longevity##2##2##(2008-7#1)(2009-5#1)
extended multiple processes##2##3##(1997-3#2)
extended multiple##3##2##(1994-12#1)(1997-3#2)
extended neurites##2##2##(1993-12#1)(1997-3#1)
extended onto the##2##3##(1994-12#1)(2008-2#1)
extended over the##2##3##(2007-11#1)(2008-3#1)
extended over##3##2##(1991-5#1)(2007-11#1)(2008-3#1)
extended period of##6##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-2#1)
extended period##9##2##(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#2)
extended periods of time##4##4##(2008-10#2)(2008-11#1)(2008-4#1)
extended periods of##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
extended periods##10##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)
extended position##2##2##(2008-12#1)(2008-9#1)
extended posterolateral-subcostal thoracotomy##2##3##(2007-8#2)
extended previous##2##2##(2008-10#1)(2008-9#1)
extended primers##2##2##(2008-10#1)(2008-9#1)
extended range##2##2##(2008-10#1)(2008-3#1)
extended regions of##2##3##(1997-7#1)(2008-3#1)
extended release matrix tablets##2##4##(2010-5#2)
extended release##3##2##(2010-5#3)
extended shelf life##2##3##(2007-3#1)(2010-7#1)
extended spectrum beta##2##3##(2007-7#1)(2012-2#1)
extended spectrum##5##2##(2007-7#2)(2008-11#1)(2008-3#1)(2012-2#1)
extended structure##2##2##(1997-2#2)
extended studies##3##2##(1992-5#1)(1994-12#1)(2009-12#1)
extended the life span of##2##5##(1992-5#1)(2008-7#1)
extended the##18##2##(1990-5#2)(1992-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
extended these studies##2##3##(2008-10#1)(2008-11#1)
extended these##5##2##(1990-5#1)(1991-12#1)(1994-2#1)(2008-10#1)(2008-11#1)
extended this##2##2##(2010-1#1)(2010-4#1)
extended thymectomy##3##2##(2007-8#3)
extended time##4##2##(1996-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
extended to a##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)
extended to all##3##3##(1990-6#1)(1992-2#1)(2007-11#1)
extended to allow for##2##4##(1994-11#1)(1997-4#1)
extended to allow##3##3##(1992-6#1)(1994-11#1)(1997-4#1)
extended to deal##2##3##(2008-3#1)(2008-6#1)
extended to include the##2##4##(2008-3#1)(2009-2#1)
extended to include##5##3##(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#1)
extended to many##2##3##(1997-6#1)(2010-1#1)
extended to other##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
extended to the##19##3##(1991-4#1)(1992-9#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-3#2)(2013-8#1)
extended to##108##2##(1990-6#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#7)(2007-12#3)(2007-8#3)(2008-10#15)(2008-11#1)(2008-2#7)(2008-3#20)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-2#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
extended two##2##2##(1997-3#1)(2008-10#1)
extended up to##4##3##(2008-10#3)(2008-2#1)
extended version of##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
extended with a##3##3##(2007-12#1)(2008-11#1)(2009-12#1)
extended with##6##2##(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)
extended##494##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#5)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#4)(1997-3#7)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#5)(2007-11#21)(2007-12#15)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#13)(2008-1#5)(2008-10#67)(2008-11#17)(2008-12#4)(2008-2#23)(2008-3#72)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#24)(2008-8#9)(2008-9#9)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#11)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#6)
extended-MDR##4##1##(2008-11#4)
extended-cavity diode laser stabilized##2##4##(2008-3#2)
extended-cavity diode laser##6##3##(2007-12#2)(2008-3#4)
extended-cavity diode##7##2##(2007-12#3)(2008-3#4)
extended-cavity semiconductor laser##2##3##(2007-12#1)(2008-3#1)
extended-cavity semiconductor##3##2##(2007-12#2)(2008-3#1)
extended-cavity##10##1##(2007-12#5)(2008-3#5)
extended-prime codes##3##2##(2008-2#3)
extended-release carvedilol##4##2##(2010-4#4)
extended-release form##2##2##(2008-6#1)(2013-1#1)
extended-release formulation of diltiazem##3##4##(1992-8#3)
extended-release formulation##4##2##(1992-8#4)
extended-release metoprolol in##2##3##(2010-4#2)
extended-release metoprolol##5##2##(2010-4#5)
extended-release##22##1##(1992-8#5)(1995-11#1)(2008-6#1)(2010-12#1)(2010-4#9)(2011-1#1)(2012-3#1)(2013-1#3)
extended-spectrum##2##1##(2009-5#1)(2013-8#1)
extenders in##2##2##(1991-12#1)(1995-3#1)
extenders##4##1##(1991-12#1)(1995-3#1)(1996-12#2)
extending a##2##2##(1995-2#1)(2008-8#1)
extending from the##9##3##(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)
extending from##17##2##(1995-12#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2013-1#1)
extending into the frontal sinus##2##5##(2011-2#2)
extending into the right##2##4##(2011-2#1)(2013-1#1)
extending into the##10##3##(1997-8#1)(2007-12#1)(2007-8#1)(2010-12#1)(2011-2#4)(2013-1#1)(2013-7#1)
extending into##14##2##(1992-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-7#2)(2010-12#1)(2011-2#4)(2013-1#1)(2013-7#1)
extending its##2##2##(2008-6#1)(2010-12#1)
extending over##5##2##(1990-6#1)(1991-5#1)(1992-8#1)(2007-8#1)(2008-2#1)
extending the duration of##2##4##(2008-11#2)
extending the##20##2##(1992-9#1)(1994-9#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
extending their##2##2##(2008-7#2)
extending through the##2##3##(2007-12#1)(2008-2#1)
extending throughout##2##2##(2008-10#1)(2009-9#1)
extending to the##7##3##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-1#1)(2013-1#1)
extending to##10##2##(1991-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
extending##110##1##(1990-6#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#2)(1994-11#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-3#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
extends a##3##2##(2007-11#1)(2008-10#1)(2009-12#1)
extends at least##3##3##(1992-3#1)(2007-11#1)(2007-12#1)
extends beyond##4##2##(1993-6#1)(2007-4#1)(2008-7#1)(2010-5#1)
extends from the##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
extends from##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
extends in##3##2##(1993-12#1)(1994-11#1)(2008-8#1)
extends into the##2##3##(1994-12#1)(2007-12#1)
extends its##2##2##(2007-11#1)(2008-3#1)
extends life##2##2##(1995-6#1)(2008-4#1)
extends out##2##2##(2007-12#1)(2012-2#1)
extends over##6##2##(1991-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
extends past the##2##3##(2008-10#1)(2012-12#1)
extends previous findings##2##3##(2008-7#1)(2010-2#1)
extends previous work in##2##4##(2010-5#1)(2013-8#1)
extends previous work##3##3##(2008-12#1)(2010-5#1)(2013-8#1)
extends previous##8##2##(1994-3#1)(1996-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
extends the capabilities of##2##4##(2007-11#1)(2008-2#1)
extends the range of##2##4##(2007-11#1)(2008-3#1)
extends the##30##2##(1993-12#1)(1994-11#1)(1996-5#1)(1997-3#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2010-2#1)(2011-2#2)(2011-3#2)(2012-3#2)
extends these##2##2##(2008-11#1)(2008-8#1)
extends to the##5##3##(1994-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-9#1)
extends to##12##2##(1993-2#1)(1994-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-9#1)(2013-1#1)
extends##109##1##(1991-6#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#9)(2007-12#8)(2007-4#1)(2007-6#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
extensibility and##2##2##(2007-11#1)(2008-5#1)
extensibility##14##1##(2007-11#8)(2008-5#3)(2009-12#1)(2012-1#1)(2012-3#1)
extensible##2##1##(2008-2#1)(2010-8#1)
extension AROM##4##2##(2008-12#4)
extension analysis of##4##3##(1993-2#1)(1993-8#1)(1997-8#1)(2008-10#1)
extension analysis##9##2##(1990-11#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#1)
extension and the##4##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
extension and##25##2##(1990-11#1)(1990-12#1)(1991-9#1)(1995-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
extension at##2##2##(1995-6#1)(2008-11#1)
extension by##3##2##(1992-9#1)(1994-2#1)(2008-7#1)
extension experiments##3##2##(1993-12#1)(1993-8#1)(1995-8#1)
extension for##2##2##(2008-10#1)(2008-3#1)
extension in the##2##3##(1994-9#1)(1995-9#1)
extension in##4##2##(1994-9#1)(1995-9#1)(2010-11#1)(2012-2#1)
extension into the##8##3##(2007-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2013-1#2)
extension is##5##2##(2007-11#1)(2007-8#1)(2008-7#2)(2012-2#1)
extension moment compared to Group 1##2##6##(2011-2#2)
extension of a##8##3##(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-8#1)
extension of our##4##3##(1997-2#1)(2008-10#1)(2008-3#2)
extension of survival##2##3##(1991-12#1)(1995-12#1)
extension of the liquid hydrocarbon model##2##6##(1992-5#2)
extension of the scalar##2##4##(2008-2#1)(2008-3#1)
extension of the system##2##4##(2008-3#2)
extension of the tuning range##2##5##(2007-11#1)(2008-2#1)
extension of the well-known##2##4##(2007-12#1)(2008-3#1)
extension of the##68##3##(1990-3#1)(1990-6#1)(1992-3#2)(1992-5#2)(1993-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-6#1)(1997-6#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#11)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#1)(2010-1#1)(2010-5#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#3)
extension of these##3##3##(2007-11#2)(2011-2#1)
extension of this##6##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)
extension of what##2##3##(1991-12#1)(2008-2#1)
extension of##135##2##(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-5#2)(1993-3#1)(1993-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-6#2)(1997-2#1)(1997-6#1)(2007-11#7)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#17)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#1)
extension on##2##2##(2008-10#1)(2009-6#1)
extension peptide##3##2##(1990-5#3)
extension phase##4##2##(1997-2#4)
extension range of##3##3##(2008-12#2)(2008-5#1)
extension study##2##2##(2010-8#1)(2010-9#1)
extension temperature##2##2##(1996-12#1)(2008-10#1)
extension that##3##2##(1995-12#1)(2007-12#1)(2007-7#1)
extension time##2##2##(2008-10#1)(2008-7#1)
extension to a##2##3##(1995-9#1)(2008-12#1)
extension to the##4##3##(1997-6#1)(2008-3#2)(2009-7#1)
extension to##13##2##(1994-12#1)(1995-9#1)(1997-6#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-1#1)(2013-8#1)
extension was##6##2##(1993-2#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-3#1)
extension with##2##2##(2007-11#1)(2012-2#1)
extension##366##1##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#3)(1992-5#2)(1992-9#1)(1993-12#5)(1993-2#4)(1993-3#2)(1993-5#2)(1993-8#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#7)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#4)(1996-6#2)(1997-2#10)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#11)(2007-12#12)(2007-4#2)(2007-7#3)(2007-8#5)(2008-1#10)(2008-10#33)(2008-11#8)(2008-12#15)(2008-2#13)(2008-3#25)(2008-4#6)(2008-5#8)(2008-6#5)(2008-7#21)(2008-8#10)(2008-9#8)(2009-1#1)(2009-10#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#11)(2012-2#4)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#4)
extensions and##2##2##(2008-10#1)(2008-3#1)
extensions of the##2##3##(2008-3#2)
extensions of##7##2##(1994-11#2)(2007-11#1)(2008-3#2)(2008-8#1)(2013-7#1)
extensions only##2##2##(1990-12#1)(2008-10#1)
extensions to##3##2##(2008-2#1)(2008-7#1)(2009-10#1)
extensions##28##1##(1990-12#2)(1994-11#3)(1995-12#1)(1996-10#1)(1997-6#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
extensive analysis##4##2##(2008-10#2)(2008-7#1)(2010-8#1)
extensive and##9##2##(1991-5#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-9#1)
extensive aortic##2##2##(2010-8#1)(2012-2#1)
extensive application##2##2##(1993-2#1)(2013-8#1)
extensive areas of##2##3##(2008-10#1)(2008-5#1)
extensive bone##2##2##(2008-12#2)
extensive cell##2##2##(2008-11#1)(2008-6#1)
extensive changes in##2##3##(1994-1#1)(2008-9#1)
extensive changes##4##2##(1994-1#1)(1997-1#1)(2008-9#1)(2010-11#1)
extensive chlorosis to conidial inoculations##2##5##(2008-10#2)
extensive chlorosis to##3##3##(2008-10#3)
extensive chlorosis##6##2##(2008-10#6)
extensive clinical##2##2##(1992-9#1)(2008-10#1)
extensive commentary##2##2##(2008-9#2)
extensive damage##2##2##(2008-10#1)(2008-9#1)
extensive data##5##2##(1991-2#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-1#1)
extensive digital postprocessing##2##3##(2008-3#2)
extensive dissection of the##2##4##(2008-9#1)(2010-10#1)
extensive diversity in##2##3##(2008-10#2)
extensive downstream##2##2##(2008-4#1)(2009-10#1)
extensive evaluation##3##2##(2012-3#1)(2013-8#2)
extensive experience##3##2##(1996-1#1)(2008-3#1)(2012-3#1)
extensive exposure##2##2##(2008-7#1)(2011-2#1)
extensive fibrosis##2##2##(2008-12#1)(2012-12#1)
extensive genetic##2##2##(1991-2#1)(2013-8#1)
extensive homology with that of##2##5##(1990-11#1)(1993-6#1)
extensive homology with##5##3##(1990-11#1)(1990-2#1)(1993-6#1)(1994-12#1)(1994-2#1)
extensive homology##8##2##(1990-11#1)(1990-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#1)
extensive in##2##2##(2008-5#1)(2009-3#1)
extensive information about##2##3##(1996-8#1)(2007-12#1)
extensive investigation##4##2##(2008-10#1)(2008-7#2)(2008-9#1)
extensive investigations##2##2##(2007-7#1)(2012-12#1)
extensive junction restructuring##2##3##(2009-10#2)
extensive knowledge of##2##3##(2008-8#1)(2009-8#1)
extensive knowledge##4##2##(1993-2#1)(2008-8#1)(2009-8#1)(2012-12#1)
extensive lesions of the##2##4##(1995-3#1)(2011-2#1)
extensive literature review##4##3##(2007-4#1)(2008-12#1)(2011-2#1)(2012-2#1)
extensive literature search was##2##4##(1996-12#1)(2011-2#1)
extensive literature##9##2##(1996-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#1)
extensive necrosis##3##2##(1991-12#1)(1994-5#1)(2012-2#1)
extensive network##2##2##(1994-12#1)(2007-12#1)
extensive numerical##2##2##(2008-2#1)(2008-3#1)
extensive obstruction##2##2##(1991-8#1)(2010-6#1)
extensive palm injuries##2##3##(2011-2#2)
extensive pilomatrixoma-like##3##2##(2013-7#3)
extensive preclinical##2##2##(2010-6#2)
extensive range of##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
extensive research##4##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
extensive resection##2##2##(1994-7#1)(2011-2#1)
extensive review of the literature##4##5##(1995-1#1)(1996-12#1)(1997-5#1)(2009-3#1)
extensive review of##5##3##(1995-1#1)(1996-12#1)(1997-5#1)(2008-11#1)(2009-3#1)
extensive sample##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
extensive sampling##2##2##(2009-11#1)(2010-12#1)
extensive sequence##3##2##(1997-8#1)(2008-4#1)(2009-10#1)
extensive similarity to##2##3##(1994-6#2)
extensive similarity##4##2##(1994-6#3)(1995-6#1)
extensive simulation and##2##3##(2008-2#1)(2008-3#1)
extensive simulation##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
extensive studies on##3##3##(1991-4#1)(2008-12#1)(2013-1#1)
extensive studies##4##2##(1991-12#1)(1991-4#1)(2008-12#1)(2013-1#1)
extensive surface##2##2##(2008-10#1)(2008-7#1)
extensive surgical debridement##2##3##(2007-8#1)(2010-12#1)
extensive surgical##3##2##(2007-8#1)(2010-12#1)(2012-3#1)
extensive test##2##2##(2010-2#2)
extensive testing##2##2##(1996-1#1)(2008-3#1)
extensive than the##2##3##(1994-5#1)(2008-8#1)
extensive than##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
extensive tissue##2##2##(2008-12#1)(2011-2#1)
extensive toxicological##2##2##(1996-1#1)(1996-2#1)
extensive use of the##3##4##(1990-9#1)(2008-10#1)(2008-3#1)
extensive use of##10##3##(1990-9#1)(1991-6#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)
extensive use##11##2##(1990-9#1)(1991-6#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)(2013-1#1)
extensive##454##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#4)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-12#4)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#10)(2008-1#3)(2008-10#61)(2008-11#11)(2008-12#8)(2008-2#6)(2008-3#14)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#23)(2008-8#11)(2008-9#16)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#9)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#5)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#22)(2012-1#2)(2012-12#7)(2012-2#10)(2012-3#9)(2012-7#1)(2013-1#13)(2013-7#5)(2013-8#6)
extensively and##3##2##(2008-4#1)(2010-5#1)(2010-7#1)
extensively as##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
extensively by the##2##3##(1997-4#1)(2007-5#1)
extensively by##4##2##(1993-3#1)(1997-4#1)(2007-5#1)(2013-1#1)
extensively colonized##2##2##(2008-10#2)
extensively documented by##2##3##(1991-11#1)(2008-2#1)
extensively drug-resistant TB##5##3##(2008-10#1)(2010-5#4)
extensively drug-resistant tuberculosis##2##3##(2008-10#1)(2009-4#1)
extensively drug-resistant##7##2##(2008-10#2)(2009-4#1)(2010-5#4)
extensively evaluated##2##2##(2008-10#2)
extensively for##5##2##(1990-8#1)(1994-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
extensively in the##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
extensively in##18##2##(1995-12#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
extensively metabolized##2##2##(1990-11#1)(2010-11#1)
extensively methylated##2##2##(1993-2#1)(1997-4#1)
extensively studied in##4##3##(2008-10#1)(2008-8#1)(2009-11#1)(2012-1#1)
extensively studied##18##2##(1991-2#1)(1994-11#1)(1996-4#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2009-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
extensively the##2##2##(1990-8#1)(1997-2#1)
extensively to##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-12#1)
extensively used in##5##3##(1992-11#1)(1996-2#1)(2008-10#2)(2008-2#1)
extensively used##11##2##(1992-11#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2012-2#1)
extensively washed membrane fractions##2##4##(1996-2#2)
extensively washed##3##2##(1995-11#1)(1996-2#2)
extensively with##2##2##(2008-10#2)
extensively##158##1##(1990-11#2)(1990-8#3)(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#4)(1996-4#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#8)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
extensor carpi##3##2##(1996-6#1)(2008-12#1)(2008-9#1)
extensor digitorum longus##3##3##(2008-9#2)(2010-3#1)
extensor digitorum##4##2##(2008-9#2)(2009-5#1)(2010-3#1)
extensor muscle afferents on the timing of locomotor##2##8##(1997-2#2)
extensor muscle afferents##3##3##(1997-2#3)
extensor muscle##7##2##(1997-2#4)(2007-8#3)
extensor muscles##2##2##(1995-8#1)(2007-12#1)
extensor surfaces of##2##3##(2007-7#1)(2010-6#1)
extensor surfaces##3##2##(2006-10#1)(2007-7#1)(2010-6#1)
extensor##33##1##(1993-12#1)(1993-3#1)(1995-8#2)(1996-6#1)(1997-2#6)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-5#2)(2010-3#1)(2010-6#1)(2012-2#1)
extent and kinetics##2##3##(1995-11#1)(2012-2#1)
extent and the##2##3##(1995-6#1)(2008-3#1)
extent and##25##2##(1993-11#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-6#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
extent as##9##2##(1992-11#2)(1993-6#1)(2008-10#3)(2008-3#1)(2012-12#1)(2013-8#1)
extent at##3##2##(1990-12#1)(1995-11#1)(2013-1#1)
extent by##9##2##(1994-8#1)(1996-6#1)(2008-3#3)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
extent for##2##2##(2008-10#1)(2012-12#1)
extent from the##2##3##(2008-10#1)(2008-11#1)
extent in the##5##3##(1990-12#1)(1992-9#1)(1997-2#1)(1997-9#1)(2008-10#1)
extent in##19##2##(1990-12#2)(1990-3#1)(1991-5#1)(1992-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
extent of DNA##3##3##(1992-3#1)(1994-8#1)(2008-5#1)
extent of MTX##2##3##(1992-8#2)
extent of P##2##3##(2008-10#1)(2012-2#1)
extent of activation by##2##4##(1990-5#1)(1990-7#1)
extent of disease##5##3##(1992-12#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
extent of improvement##2##3##(2008-10#2)
extent of infection##3##3##(2008-10#3)
extent of involvement##3##3##(1990-12#1)(1996-12#1)(1997-8#1)
extent of lipid peroxidation was##2##5##(2008-4#1)(2008-7#1)
extent of lipid peroxidation##3##4##(2008-4#1)(2008-7#2)
extent of microbial reduction##2##4##(1997-4#2)
extent of participation##2##3##(1996-12#1)(2008-3#1)
extent of phosphorylation##2##3##(1990-5#1)(1992-6#1)
extent of resection##3##3##(1994-12#1)(2007-8#1)(2008-9#1)
extent of response##2##3##(1990-12#1)(1995-12#1)
extent of spatial##2##3##(2007-11#1)(2008-10#1)
extent of subclinical atherosclerosis##2##4##(2008-11#2)
extent of surgical resection##3##4##(1990-9#1)(2008-7#2)
extent of surgical##6##3##(1990-9#1)(2008-7#3)(2012-12#1)(2013-1#1)
extent of the disease##5##4##(1994-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
extent of the lesion##2##4##(2008-6#1)(2008-7#1)
extent of the##41##3##(1990-12#1)(1991-6#1)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
extent of these effects##2##4##(1992-3#1)(1997-2#1)
extent of these##3##3##(1992-3#1)(1997-2#1)(2008-7#1)
extent of tumor##2##3##(2008-10#1)(2008-11#1)
extent of##276##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#7)(1992-6#6)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#3)(1995-12#3)(1995-3#2)(1995-5#1)(1995-9#1)(1996-12#4)(1996-2#3)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#49)(2008-11#11)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#20)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#9)(2012-12#3)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#7)
extent on##5##2##(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
extent score##3##2##(2008-3#2)(2012-1#1)
extent than by##2##3##(1995-11#1)(2012-2#1)
extent than the##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
extent than##16##2##(1990-9#1)(1991-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
extent that##13##2##(1990-11#2)(1991-8#1)(1992-1#1)(1994-6#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-3#1)
extent the##17##2##(1993-12#1)(1993-9#1)(1995-6#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
extent to which the##14##4##(1991-12#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
extent to which##73##3##(1990-2#1)(1991-12#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#9)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
extent to##80##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#9)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
extent with##2##2##(1993-12#1)(2008-2#1)
extent##644##1##(1990-11#4)(1990-12#10)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#3)(1991-12#8)(1991-3#1)(1991-5#3)(1991-6#4)(1991-8#4)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#10)(1992-5#1)(1992-6#10)(1992-8#4)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#4)(1993-5#2)(1993-6#5)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#8)(1995-5#3)(1995-6#4)(1995-8#5)(1995-9#1)(1996-12#6)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#5)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#4)(1997-9#2)(2007-10#2)(2007-11#9)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#3)(2007-8#1)(2008-1#6)(2008-10#92)(2008-11#31)(2008-12#8)(2008-2#9)(2008-3#21)(2008-4#8)(2008-5#16)(2008-6#6)(2008-7#29)(2008-8#13)(2008-9#7)(2009-12#1)(2009-2#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#8)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#24)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#14)(2012-3#8)(2012-6#1)(2013-1#11)(2013-7#2)(2013-8#7)
extents of##3##2##(1990-5#1)(2008-7#1)(2010-6#1)
extents##15##1##(1990-5#2)(1992-11#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-7#2)(2010-6#1)
exterior environments##2##2##(1993-2#2)
exterior##12##1##(1993-2#4)(1995-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-1#1)
externa##11##1##(1991-3#2)(1994-9#1)(2008-5#2)(2008-6#5)(2013-7#1)
external ATP and GTP##2##4##(2008-4#2)
external ATP##4##2##(1994-8#1)(2008-4#3)
external Ca2+ and##2##3##(1990-12#1)(1993-12#1)
external Ca2+##12##2##(1990-12#2)(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#2)(1993-12#3)(1993-3#1)(1995-11#1)
external H+##2##2##(1990-11#2)
external Na+##3##2##(1992-11#1)(1992-5#1)(1993-12#1)
external RT##2##2##(2010-3#2)
external agents##2##2##(1992-9#1)(2008-5#1)
external and internal colonization of##2##5##(2008-10#2)
external and internal morphology##2##4##(2008-5#1)(2013-7#1)
external and internal##18##3##(1993-1#1)(1993-12#1)(1996-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#1)(2013-7#1)
external and skeletal anomalies##2##4##(1993-12#2)
external and##24##2##(1993-1#1)(1993-12#3)(1996-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
external appearance##2##2##(2008-10#1)(2010-8#1)
external aqueous##2##2##(1990-11#1)(2008-10#1)
external auditory canal##5##3##(2008-7#2)(2008-9#1)(2011-2#1)(2013-7#1)
external auditory##8##2##(1994-2#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#2)(2013-7#1)
external beam irradiation with##2##4##(1991-2#1)(1994-3#1)
external beam irradiation##4##3##(1991-2#1)(1994-3#1)(2009-2#1)(2011-2#1)
external beam radiation therapy##3##4##(2008-6#1)(2008-7#2)
external beam radiation##4##3##(2008-6#2)(2008-7#2)
external beam radiotherapy of##2##4##(2012-12#1)(2013-1#1)
external beam radiotherapy##7##3##(1995-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-12#2)(2013-1#1)
external beam##22##2##(1991-2#1)(1993-11#1)(1994-3#1)(1995-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-6#4)(2008-7#2)(2009-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
external binding##2##2##(2008-4#2)
external calcium concentration##2##3##(1990-2#2)
external calcium##8##2##(1990-2#5)(1990-5#1)(1994-2#1)(1995-11#1)
external calibration (EC)##2##3##(2008-10#2)
external calibration with##2##3##(2008-10#2)
external calibration##12##2##(2008-10#12)
external carotid arteries##4##3##(1991-5#1)(1996-9#2)(2011-2#1)
external carotid artery##9##3##(1997-3#2)(1997-6#5)(2006-12#1)(2008-7#1)
external carotid##18##2##(1991-5#2)(1996-9#5)(1997-3#2)(1997-6#5)(2006-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
external cavities##2##2##(2007-11#1)(2007-12#1)
external cavity containing a##2##4##(2007-11#1)(2007-12#1)
external cavity diode laser##4##4##(2008-2#1)(2008-3#3)
external cavity diode##5##3##(2008-2#2)(2008-3#3)
external cavity##23##2##(2007-11#4)(2007-12#3)(2008-2#4)(2008-3#12)
external compression##2##2##(2008-6#1)(2010-12#1)
external conditions##3##2##(2007-12#1)(2011-2#2)
external contamination##2##2##(2008-10#2)
external control##2##2##(2007-11#1)(2013-1#1)
external cues##4##2##(2008-11#2)(2008-7#1)(2009-8#1)
external customer requirements##2##3##(1996-3#2)
external customers##2##2##(1993-2#1)(1996-2#1)
external devices##2##2##(2008-3#1)(2008-8#1)
external diameter##2##2##(1990-7#1)(2007-8#1)
external disturbances##3##2##(2007-12#2)(2008-3#1)
external electric field##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-9#1)
external evidence##2##2##(1996-6#2)
external factors##10##2##(1991-2#1)(1991-6#1)(1996-1#1)(1996-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-5#1)
external feedback##3##2##(2008-2#3)
external feeding symptoms##2##3##(2011-2#2)
external fixation of##3##3##(2009-4#2)(2012-2#1)
external fixation with##3##3##(2007-11#1)(2007-8#1)(2008-12#1)
external fixation##15##2##(2007-11#1)(2007-8#3)(2008-12#2)(2008-8#2)(2008-9#1)(2009-4#3)(2010-12#1)(2012-2#2)
external fixator##4##2##(2007-8#4)
external fixators##3##2##(2008-8#2)(2011-2#1)
external forces##4##2##(1995-12#1)(2008-6#1)(2009-12#1)(2012-3#1)
external genitalia##3##2##(2007-12#1)(2008-1#2)
external iliac artery##2##3##(2011-2#1)(2013-1#1)
external iliac##3##2##(2011-2#2)(2013-1#1)
external imagery##6##2##(1992-12#6)
external information and##2##3##(2011-2#1)(2012-2#1)
external information in##2##3##(1992-10#1)(1997-8#1)
external information##7##2##(1992-10#1)(1992-9#1)(1997-8#1)(2008-7#1)(2011-2#2)(2012-2#1)
external input##2##2##(2008-11#2)
external inputs##2##2##(2008-11#1)(2009-6#1)
external irradiation##2##2##(1990-10#1)(2011-2#1)
external lesions##3##2##(2011-2#3)
external light source##2##3##(2007-12#1)(2013-8#1)
external light##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
external magnetic field##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
external medium##7##2##(1991-5#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)
external mirror##3##2##(2008-3#3)
external morphology of##2##3##(2007-12#1)(2013-1#1)
external morphology##4##2##(2007-12#3)(2013-1#1)
external oblique##3##2##(2012-12#2)(2012-2#1)
external optical##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
external or internal##3##3##(1996-12#1)(2013-8#2)
external osmolarity##4##2##(1991-11#3)(1994-12#1)
external otitis##3##2##(2008-5#3)
external pH##6##2##(1990-7#1)(1995-6#2)(1997-7#1)(2012-12#2)
external perturbations##2##2##(2008-3#1)(2010-10#1)
external power##3##2##(2008-3#1)(2011-2#2)
external prosthetic##2##2##(2010-3#2)
external publics##2##2##(2008-12#2)
external radiation##2##2##(1990-2#1)(2008-4#1)
external radiotherapy##3##2##(1990-6#1)(2007-5#1)(2008-7#1)
external reference##2##2##(2008-10#1)(2013-8#1)
external resonant##4##2##(2007-11#1)(2007-12#3)
external responsibility##2##2##(2010-2#2)
external ring cavity##2##3##(2007-12#1)(2008-2#1)
external root resorption##4##3##(2013-1#4)
external rotation##11##2##(2007-11#3)(2007-8#3)(2009-3#3)(2013-1#2)
external seeding##2##2##(2008-2#2)
external signal##2##2##(1990-12#1)(2007-12#1)
external signals##2##2##(2010-10#2)
external solution##2##2##(1996-2#1)(2008-8#1)
external sources of##2##3##(1995-3#1)(2008-9#1)
external sources##3##2##(1995-3#1)(2008-3#1)(2008-9#1)
external standard method##2##3##(2008-5#1)(2011-1#1)
external standard##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
external standards##2##2##(2008-10#1)(2012-2#1)
external stimulation##2##2##(2011-1#1)(2012-2#1)
external stimuli and##2##3##(1990-9#1)(2009-6#1)
external stimuli can##2##3##(2008-1#1)(2008-2#1)
external stimuli such as##2##4##(2008-10#1)(2010-12#1)
external stimuli##10##2##(1990-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2012-2#1)
external stink bug##3##3##(2011-2#3)
external structure##2##2##(1994-3#2)
external substrate##2##2##(2008-7#2)
external surface of the##2##4##(1996-5#1)(2008-10#1)
external surface of##3##3##(1994-11#1)(1996-5#1)(2008-10#1)
external surface##5##2##(1994-11#1)(1996-5#1)(2008-10#3)
external surfaces##3##2##(1990-8#1)(2008-3#1)(2009-5#1)
external to the##6##3##(1993-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-3#1)
external transport##2##2##(1995-5#1)(1995-6#1)
external validation##8##2##(2008-10#7)(2013-8#1)
external validity##2##2##(2010-10#1)(2013-1#1)
external vertebral venous plexus##3##4##(2011-2#3)
external voltage##2##2##(2007-11#1)(2008-2#1)
external##682##1##(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#6)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#2)(1991-5#4)(1991-6#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#10)(1992-2#1)(1992-3#2)(1992-5#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#11)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#3)(1995-9#1)(1996-1#5)(1996-12#3)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#32)(2007-12#32)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#16)(2007-9#2)(2008-1#9)(2008-10#70)(2008-11#19)(2008-12#9)(2008-2#33)(2008-3#50)(2008-4#8)(2008-5#13)(2008-6#7)(2008-7#30)(2008-8#18)(2008-9#10)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#4)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#8)(2010-12#4)(2010-2#4)(2010-3#6)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#35)(2012-12#8)(2012-2#10)(2012-3#3)(2013-1#20)(2013-7#4)(2013-8#9)
external)##2##1##(2008-10#1)(2010-2#1)
external-cavity diode laser##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
external-cavity diode##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
external-cavity laser diode##3##3##(2007-12#1)(2008-3#2)
external-cavity laser##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
external-cavity semiconductor diode##2##3##(2007-11#2)
external-cavity semiconductor laser##4##3##(2007-12#3)(2008-3#1)
external-cavity semiconductor lasers##3##3##(2007-12#3)
external-cavity semiconductor##9##2##(2007-11#2)(2007-12#6)(2008-3#1)
external-cavity surface-emitting##2##2##(2007-12#2)
external-cavity##35##1##(2007-11#7)(2007-12#16)(2008-2#5)(2008-3#7)
externalized##3##1##(2008-11#1)(2008-2#2)
externalizing and internalizing behaviors##2##4##(2009-7#1)(2009-9#1)
externalizing and internalizing##4##3##(2008-2#1)(2009-7#1)(2009-9#2)
externalizing behavior##3##2##(2008-12#3)
externalizing problems##4##2##(2008-9#2)(2012-12#1)(2013-1#1)
externalizing##21##1##(1995-2#1)(2008-12#4)(2008-2#2)(2008-9#2)(2009-7#2)(2009-9#2)(2012-12#6)(2013-1#2)
externally applied electric field##2##4##(2007-11#2)
externally applied##5##2##(2007-11#3)(2007-12#1)(2011-2#1)
externally imposed##2##2##(1996-4#1)(2010-10#1)
externally##29##1##(1991-9#1)(1994-8#1)(1996-4#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#2)(2011-2#2)
extinct and##2##2##(2008-1#1)(2008-7#1)
extinct##14##1##(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)
extinction and absorption efficiencies from the##2##6##(2008-3#2)
extinction and absorption##3##3##(2008-2#1)(2008-3#2)
extinction and backscatter##6##3##(2008-2#1)(2008-3#5)
extinction and##23##2##(2008-2#5)(2008-3#16)(2008-9#1)(2013-8#1)
extinction at##2##2##(1990-11#1)(2008-2#1)
extinction between##2##2##(2008-2#1)(2008-3#1)
extinction boundary##2##2##(2008-8#2)
extinction by##3##2##(2008-3#2)(2008-6#1)
extinction coefficient k##3##3##(2008-2#2)(2008-3#1)
extinction coefficient of the##4##4##(2008-10#1)(2008-3#3)
extinction coefficient of##7##3##(2008-10#3)(2008-3#4)
extinction coefficient##28##2##(1991-12#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-2#5)(2008-3#14)(2008-9#1)
extinction coefficients and##2##3##(2008-10#2)
extinction coefficients at##4##3##(2008-2#1)(2008-3#3)
extinction coefficients of the##2##4##(2008-3#1)(2009-9#1)
extinction coefficients of##8##3##(2008-10#2)(2008-2#2)(2008-3#2)(2009-2#1)(2009-9#1)
extinction coefficients that are due to##2##6##(2008-2#1)(2008-3#1)
extinction coefficients##24##2##(2007-11#1)(2008-10#6)(2008-2#5)(2008-3#10)(2009-2#1)(2009-9#1)
extinction data##6##2##(2008-3#6)
extinction error##3##2##(2008-3#3)
extinction has##2##2##(2008-3#1)(2008-9#1)
extinction in the##3##3##(1993-3#1)(2008-3#2)
extinction in##12##2##(1991-12#1)(1993-3#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#3)
extinction measurements in##2##3##(2008-3#2)
extinction measurements##6##2##(2008-2#1)(2008-3#5)
extinction of a##2##3##(2008-5#1)(2008-8#1)
extinction of the##6##3##(1992-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)
extinction of this population##2##4##(2008-9#2)
extinction of##18##2##(1992-3#1)(1993-9#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#5)(2008-9#5)(2009-8#1)
extinction or##3##2##(1993-6#1)(2008-3#1)(2013-8#1)
extinction probabilities and colonization probabilities##2##5##(2008-8#2)
extinction probabilities and##3##3##(2008-8#3)
extinction probabilities are (almost) equal should one##2##7##(2008-8#2)
extinction probabilities##7##2##(2008-8#7)
extinction profile##6##2##(2008-3#6)
extinction profiles##4##2##(2008-2#1)(2008-3#3)
extinction pulses##5##2##(1997-5#5)
extinction rate##5##2##(2008-8#3)(2008-9#2)
extinction rates##3##2##(2008-8#3)
extinction ratio of the##4##4##(2008-2#1)(2008-3#3)
extinction ratio of##10##3##(2007-12#1)(2008-2#3)(2008-3#5)(2010-4#1)
extinction ratio##18##2##(2007-11#4)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#7)(2010-4#1)
extinction ratios##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
extinction risk in##2##3##(2008-8#1)(2008-9#1)
extinction risk##7##2##(2008-8#4)(2008-9#3)
extinction spectra of##3##3##(2007-11#1)(2008-3#2)
extinction spectra##4##2##(2007-11#1)(2008-3#3)
extinction that is due to##2##5##(2008-2#1)(2008-3#1)
extinction threshold##2##2##(2008-8#2)
extinction times##2##2##(2008-8#2)
extinction trials##7##2##(2008-5#7)
extinction were##2##2##(2008-5#2)
extinction##295##1##(1990-11#1)(1991-12#2)(1991-5#1)(1992-12#3)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-3#1)(1997-5#6)(2007-11#9)(2007-12#3)(2008-1#1)(2008-10#11)(2008-2#36)(2008-3#106)(2008-5#17)(2008-6#1)(2008-8#57)(2008-9#21)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
extinction-colonization dynamics##2##2##(2008-8#1)(2008-9#1)
extinction-to-backscatter ratio##2##2##(2008-2#1)(2008-3#1)
extinction-to-backscatter ratios##4##2##(2008-2#2)(2008-3#2)
extinction-to-backscatter##7##1##(2008-2#3)(2008-3#4)
extinctions and##2##2##(1997-5#1)(2008-8#1)
extinctions of##2##2##(1997-5#1)(2007-12#1)
extinctions on##3##2##(1997-5#1)(2008-8#2)
extinctions##23##1##(1997-5#10)(2007-12#1)(2008-3#2)(2008-8#9)(2008-9#1)
extinguished##12##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#9)
extirpation of the##2##3##(1994-5#1)(2008-7#1)
extirpation of##3##2##(1994-5#1)(2008-7#1)(2008-9#1)
extirpation##7##1##(1994-5#1)(1996-8#1)(2008-10#1)(2008-7#3)(2008-9#1)
extirpations##2##1##(1993-2#1)(2012-2#1)
extirpative##2##1##(2007-12#1)(2013-1#1)
extra copies of##2##3##(1992-11#1)(2008-10#1)
extra corporeal##2##2##(2008-1#2)
extra methylene group##2##3##(2008-10#2)
extra pulmonary involvement##2##3##(2011-2#2)
extra pulmonary##5##2##(2011-2#4)(2012-3#1)
extra sampling points##2##3##(2008-2#2)
extra sampling##3##2##(2008-2#3)
extra segments##3##2##(2008-5#3)
extra step##2##2##(1990-4#1)(2008-2#1)
extra survival##3##2##(1995-12#3)
extra systoles)##2##2##(2011-1#2)
extra##93##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
extra- and intra-cellular##2##3##(1993-11#1)(2008-11#1)
extra- and intracellular##6##3##(2008-11#2)(2010-10#2)(2012-2#1)(2013-8#1)
extra- and##11##2##(1993-11#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-10#2)(2012-2#1)(2013-8#1)
extra-##12##1##(1993-11#1)(2008-10#2)(2008-11#3)(2008-7#2)(2010-10#2)(2012-2#1)(2013-8#1)
extra-adrenal##4##1##(1990-6#1)(2008-4#1)(2012-2#2)
extra-anatomic bypass grafting##2##3##(2012-1#2)
extra-anatomic bypass##3##2##(2007-8#1)(2012-1#2)
extra-anatomic##5##1##(2007-8#3)(2012-1#2)
extra-articular distal radius fractures##3##4##(2008-9#3)
extra-articular migration of##2##3##(2013-1#2)
extra-articular##10##1##(2007-8#1)(2008-9#3)(2009-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
extra-axial hemorrhagic##2##2##(2012-3#2)
extra-axial##6##1##(2008-2#1)(2011-2#1)(2012-3#4)
extra-cellular domain##2##2##(1995-12#1)(2008-5#1)
extra-cellular matrix##2##2##(1994-11#1)(2008-5#1)
extra-cellular##6##1##(1994-11#1)(1995-12#1)(2008-1#1)(2008-5#3)
extra-corporeal##2##1##(2007-7#1)(2007-8#1)
extra-heavy crude oil##2##3##(2008-10#2)
extra-hepatic metastasis##2##2##(2008-10#2)
extra-hepatic tissues##2##2##(1992-11#1)(2008-5#1)
extra-hepatic##9##1##(1992-11#1)(1992-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
extra-hospital mortality in##2##3##(2011-2#2)
extra-hospital mortality##4##2##(2011-2#4)
extra-intestinal manifestations##2##2##(2010-12#2)
extra-laboratory##2##1##(2013-1#2)
extra-nodal##2##1##(2012-3#1)(2013-1#1)
extra-pancreatic##4##1##(1994-8#3)(2008-2#1)
extra-pulmonary##6##1##(2007-8#1)(2009-8#1)(2010-3#1)(2013-1#2)(2013-8#1)
extra-renal##3##1##(2008-4#1)(2009-3#1)(2013-1#1)
extraarticular##5##1##(1990-6#3)(2012-12#2)
extracapsular cataract##2##2##(1991-9#1)(2011-2#1)
extracapsular##6##1##(1990-9#1)(1991-9#1)(1995-9#1)(2008-8#1)(2011-2#2)
extracardiac##3##1##(2007-8#1)(2010-10#1)(2010-12#1)
extracavity##3##1##(2007-12#2)(2008-2#1)
extracellular 5-HT##2##2##(1997-6#1)(2008-7#1)
extracellular ATP and##4##3##(2008-4#3)(2013-8#1)
extracellular ATP##15##2##(1991-9#1)(1993-8#1)(2008-4#12)(2013-8#1)
extracellular Ca++##3##2##(1991-9#2)(1993-8#1)
extracellular Ca2+ and##2##3##(1991-12#1)(1996-12#1)
extracellular Ca2+##19##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-8#2)(1994-6#2)(1995-12#1)(1996-12#1)(2008-8#1)
extracellular CaM##3##2##(2008-8#3)
extracellular DA in##2##3##(2008-7#2)
extracellular DA##5##2##(2008-7#5)
extracellular K+##4##2##(1994-2#1)(1997-1#1)(1997-2#1)(2008-8#1)
extracellular NA##2##2##(2008-7#2)
extracellular Na+##4##2##(1990-2#1)(1990-7#1)(1992-5#1)(1993-8#1)
extracellular PP(i) levels##2##3##(2008-4#2)
extracellular PP(i)##4##2##(2008-4#4)
extracellular accumulation##2##2##(2008-6#1)(2010-10#1)
extracellular alpha-amylase##2##2##(2008-10#2)
extracellular and##7##2##(1993-12#1)(1993-6#1)(1994-9#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
extracellular cAMP levels##2##3##(1996-2#2)
extracellular cAMP##3##2##(1996-2#2)(1997-3#1)
extracellular calcium and##2##3##(1990-5#1)(1994-2#1)
extracellular calcium on the##2##4##(1990-8#1)(1991-12#1)
extracellular calcium##20##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#4)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#2)(1995-11#2)(1996-9#1)(2008-11#1)(2008-8#1)
extracellular component of the TSH receptor##2##6##(1990-12#1)(1991-9#1)
extracellular component of the##3##4##(1990-12#1)(1991-9#2)
extracellular concentration##3##2##(1994-12#1)(1997-7#1)(2008-11#1)
extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens##2##9##(1994-8#2)
extracellular concentrations of acetylcholine in neostriatum##3##6##(1994-8#3)
extracellular concentrations of##4##3##(1992-7#1)(1994-8#3)
extracellular cysteine##2##2##(1991-12#1)(1991-9#1)
extracellular domain of the##9##4##(1990-12#1)(1991-5#1)(1992-12#2)(1992-9#1)(1995-2#1)(1996-5#1)(2008-4#1)(2008-8#1)
extracellular domain of##16##3##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#5)(1992-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-8#1)
extracellular domain##38##2##(1990-12#2)(1991-12#2)(1991-5#1)(1991-6#2)(1992-12#6)(1992-9#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1995-11#3)(1995-2#2)(1995-5#1)(1996-5#2)(2008-11#2)(2008-4#3)(2008-8#2)(2009-8#1)
extracellular domains of the##2##4##(1991-6#1)(2008-4#1)
extracellular domains of##5##3##(1991-6#2)(1991-9#1)(2008-4#1)(2012-12#1)
extracellular domains##7##2##(1991-6#2)(1991-9#1)(1993-8#1)(1995-11#1)(2008-4#1)(2012-12#1)
extracellular dopamine##2##2##(1993-6#1)(1994-2#1)
extracellular electron##2##2##(2008-7#1)(2009-9#1)
extracellular environment and##3##3##(1991-9#1)(2008-11#1)(2008-4#1)
extracellular environment##10##2##(1991-9#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
extracellular enzymatic activities##2##3##(2008-10#1)(2008-5#1)
extracellular enzyme##2##2##(2008-10#1)(2012-6#1)
extracellular exo-beta-1##2##2##(2008-10#2)
extracellular exosomes##2##2##(2009-2#2)
extracellular fatty acid binding protein##2##5##(2008-8#2)
extracellular field##2##2##(1995-12#1)(2008-7#1)
extracellular fluid##5##2##(2007-8#2)(2008-7#1)(2008-8#1)(2012-2#1)
extracellular free Ca2+##2##3##(1990-2#1)(1994-2#1)
extracellular free##3##2##(1990-2#1)(1994-2#1)(2012-12#1)
extracellular glutamate##2##2##(2008-7#2)
extracellular levels of##4##3##(1991-1#1)(1994-8#1)(1996-2#1)(1997-2#1)
extracellular ligand##3##2##(1992-12#2)(1993-3#1)
extracellular ligand-binding##2##2##(2008-8#1)(2012-2#1)
extracellular loop)##2##2##(1993-3#2)
extracellular loops of the membrane spanning region of human thyrotropin receptor##2##11##(1991-12#2)
extracellular loops of the##3##4##(1991-12#3)
extracellular matrices##4##2##(1994-6#1)(2008-11#2)(2008-7#1)
extracellular matrix (ECM) components##2##4##(2009-8#1)(2012-2#1)
extracellular matrix (ECM)##13##3##(1994-9#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-6#1)(2013-8#1)
extracellular matrix and##7##3##(1995-8#1)(2006-6#1)(2007-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)
extracellular matrix components##3##3##(2008-7#1)(2010-9#1)(2011-1#1)
extracellular matrix deposition##3##3##(2008-1#1)(2008-9#1)(2009-7#1)
extracellular matrix for##2##3##(2008-5#1)(2009-12#1)
extracellular matrix genes##4##3##(1990-5#1)(1991-5#1)(1992-8#1)(2008-7#1)
extracellular matrix in##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
extracellular matrix protein##2##3##(2009-8#1)(2012-1#1)
extracellular matrix proteins such as##2##5##(2008-5#1)(2008-9#1)
extracellular matrix proteins##13##3##(1994-12#2)(2008-11#2)(2008-5#1)(2008-9#2)(2009-12#1)(2010-11#2)(2012-1#2)(2012-12#1)
extracellular matrix##99##2##(1990-5#3)(1991-5#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-3#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#5)(2008-11#6)(2008-4#2)(2008-5#9)(2008-7#3)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#2)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#1)(2013-8#2)
extracellular matrix)##2##2##(1992-9#2)
extracellular matrix-rich##3##2##(2010-12#1)(2010-4#2)
extracellular mediators##2##2##(2008-5#1)(2009-3#1)
extracellular messenger##2##2##(2008-4#2)
extracellular neuronal activity in##2##4##(2008-4#2)
extracellular neuronal activity##3##3##(2008-11#1)(2008-4#2)
extracellular neurotensin-like immunoreactivity##2##3##(1997-7#2)
extracellular nucleotides##13##2##(2008-4#12)(2013-8#1)
extracellular oxidative enzymes##2##3##(2008-10#2)
extracellular pH##5##2##(1992-3#1)(1993-3#1)(2008-10#1)(2008-4#2)
extracellular polysaccharide##3##2##(1995-11#1)(2008-10#2)
extracellular polysaccharides##2##2##(2008-10#1)(2008-6#1)
extracellular portion of##2##3##(1990-11#1)(1994-2#1)
extracellular potassium##2##2##(2008-8#1)(2009-8#1)
extracellular potential##2##2##(1993-12#1)(2008-5#1)
extracellular products##2##2##(1990-11#1)(2007-6#1)
extracellular protease produced by##2##4##(2008-10#2)
extracellular protease##7##2##(1992-12#1)(1997-4#1)(2008-10#5)
extracellular protein##2##2##(2008-10#2)
extracellular proteins of M##2##4##(1995-2#2)
extracellular proteins of##4##3##(1995-2#4)
extracellular proteins##5##2##(1995-2#4)(2012-1#1)
extracellular purines##3##2##(2013-8#3)
extracellular recording##3##2##(1991-2#1)(1995-12#1)(2009-10#1)
extracellular recordings##3##2##(1994-2#1)(1996-5#1)(1997-2#1)
extracellular region##3##2##(1992-12#1)(1993-2#1)(2008-4#1)
extracellular regions of##2##3##(2008-4#1)(2011-2#1)
extracellular secretion of##4##3##(1993-9#3)(2008-5#1)
extracellular signal##3##2##(1991-5#1)(1993-6#1)(2008-4#1)
extracellular signal-regulated kinase (ERK)##3##4##(2009-8#1)(2011-2#1)(2013-1#1)
extracellular signal-regulated kinase 1/2##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
extracellular signal-regulated kinase##8##3##(2008-10#1)(2009-8#1)(2010-12#2)(2011-2#3)(2013-1#1)
extracellular signal-regulated kinases##3##3##(1995-6#1)(2008-4#1)(2011-2#1)
extracellular signal-regulated##11##2##(1995-6#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-12#2)(2011-2#4)(2013-1#1)
extracellular signaling molecules##2##3##(2008-4#1)(2010-1#1)
extracellular signaling##3##2##(2008-4#1)(2010-1#1)(2013-8#1)
extracellular signals##7##2##(1994-11#1)(1995-2#1)(1996-5#1)(2008-1#1)(2009-8#2)(2012-12#1)
extracellular space##9##2##(1992-11#1)(1994-8#1)(1996-5#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-9#1)(2012-3#1)
extracellular stimuli##5##2##(1994-11#1)(1996-2#2)(2008-4#1)(2011-2#1)
extracellular structures##2##2##(2008-8#2)
extracellular substrate##2##2##(1996-8#2)
extracellular vesicles##5##2##(2013-8#5)
extracellular##576##1##(1990-11#4)(1990-12#5)(1990-2#5)(1990-5#7)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#13)(1991-2#2)(1991-5#4)(1991-6#5)(1991-9#13)(1992-11#1)(1992-12#13)(1992-3#4)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#10)(1993-11#1)(1993-12#9)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#7)(1993-8#9)(1993-9#5)(1994-11#5)(1994-12#5)(1994-2#8)(1994-3#4)(1994-6#3)(1994-8#9)(1994-9#5)(1995-11#9)(1995-12#5)(1995-2#9)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#5)(1996-5#8)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#3)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#4)(2008-1#6)(2008-10#34)(2008-11#21)(2008-4#64)(2008-5#16)(2008-6#9)(2008-7#24)(2008-8#19)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#7)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#11)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-2#12)(2012-1#6)(2012-12#6)(2012-2#3)(2012-3#4)(2012-6#2)(2013-1#5)(2013-8#15)
extracellular-superoxide dismutase##3##2##(1992-11#2)(1993-12#1)
extracellularly and##2##2##(1992-12#1)(2008-6#1)
extracellularly in##2##2##(1995-6#1)(2008-8#1)
extracellularly recorded##2##2##(1993-12#1)(1997-7#1)
extracellularly##12##1##(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-6#1)(1997-7#1)(2008-4#1)(2008-6#2)(2008-8#1)(2011-2#2)
extracerebral##4##1##(1991-3#1)(2008-7#2)(2012-2#1)
extrachromosomal DNA##2##2##(2007-12#1)(2008-10#1)
extrachromosomal element##2##2##(1995-2#2)
extrachromosomal##8##1##(1995-2#3)(2007-12#3)(2008-10#2)
extracolonic##3##1##(2008-1#1)(2009-12#2)
extraconal##2##1##(2011-2#2)
extracorporeal blood##2##2##(2007-7#1)(2008-3#1)
extracorporeal circuit##5##2##(1992-1#2)(2008-1#1)(2008-10#2)
extracorporeal circulation and##2##3##(2007-8#1)(2010-6#1)
extracorporeal circulation in##3##3##(1996-11#1)(2007-8#1)(2010-8#1)
extracorporeal circulation is##2##3##(2010-8#2)
extracorporeal circulation##17##2##(1996-11#1)(2007-8#2)(2010-6#1)(2010-8#9)(2012-3#3)(2013-1#1)
extracorporeal circulation]##2##2##(2010-8#1)(2012-3#1)
extracorporeal elimination##2##2##(1990-12#1)(1991-11#1)
extracorporeal liver support##2##3##(2008-11#2)
extracorporeal membrane oxygenation (ECMO)##2##4##(2010-5#1)(2011-2#1)
extracorporeal membrane oxygenation##3##3##(2009-7#1)(2010-5#1)(2011-2#1)
extracorporeal shock wave lithotripsy (ESWL)##2##5##(2007-7#1)(2009-5#1)
extracorporeal shock wave lithotripsy##8##4##(1990-8#1)(2007-10#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
extracorporeal shock wave therapy##2##4##(1997-6#2)
extracorporeal shock wave##10##3##(1990-8#1)(1997-6#2)(2007-10#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
extracorporeal shockwave lithotripsy##3##3##(2013-1#3)
extracorporeal therapies##2##2##(2010-5#2)
extracorporeal ultrafiltration##3##2##(2007-12#3)
extracorporeal##64##1##(1990-12#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-1#4)(1995-1#2)(1996-11#1)(1997-6#2)(2007-10#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-5#3)(2010-6#2)(2010-8#10)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#5)(2013-8#1)
extracorporeally##2##1##(1994-5#1)(2007-8#1)
extracranial carotid##4##2##(1992-5#2)(2007-10#1)(2008-7#1)
extracranial metastases have been##2##4##(2007-10#2)
extracranial metastases##3##2##(2007-10#3)
extracranial orbital decompression##3##3##(2008-7#3)
extracranial##31##1##(1992-5#2)(1997-4#1)(2007-10#6)(2007-12#1)(2008-11#5)(2008-7#9)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#4)
extracranial-intracranial##2##1##(2008-7#1)(2012-2#1)
extract (0##2##2##(2008-10#1)(2012-2#1)
extract (CC-516)##2##2##(2008-5#2)
extract a##3##2##(2008-3#1)(2009-8#1)(2010-5#1)
extract administration##2##2##(1993-2#1)(2011-1#1)
extract against##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
extract and its constituents##2##4##(2008-10#2)
extract and its##4##3##(2008-10#3)(2008-11#1)
extract and to##2##3##(2008-10#2)
extract and##33##2##(1990-7#1)(1994-2#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
extract are##2##2##(2008-10#1)(2008-5#1)
extract as a##3##3##(2008-10#1)(2008-5#2)
extract as well as##2##4##(2008-11#1)(2008-5#1)
extract as##9##2##(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#1)(2009-6#1)(2011-2#1)
extract at an##2##3##(1990-2#1)(1994-2#1)
extract at##5##2##(1990-2#1)(1994-2#1)(2008-10#1)(2010-5#1)(2013-7#1)
extract by##2##2##(2008-11#1)(2008-5#1)
extract can be##2##3##(2009-6#1)(2011-1#1)
extract can##3##2##(2008-11#1)(2009-6#1)(2011-1#1)
extract concentration##2##2##(1994-2#1)(2008-7#1)
extract containing##3##2##(1992-9#1)(2008-10#2)
extract derived##2##2##(1997-7#1)(2008-8#1)
extract dose##2##2##(2008-10#2)
extract for##7##2##(1993-2#1)(2008-10#1)(2008-12#1)(2011-2#2)(2013-1#2)
extract from a##3##3##(2008-11#3)
extract from an##2##3##(2008-3#1)(2008-5#1)
extract from the##3##3##(1990-2#1)(2008-10#2)
extract from##25##2##(1990-11#1)(1990-2#2)(1991-5#1)(1992-11#1)(1993-2#1)(1995-2#1)(1996-12#2)(2008-10#10)(2008-11#3)(2008-3#1)(2008-5#2)
extract had##2##2##(1990-5#1)(1991-12#1)
extract has been##3##3##(1990-2#1)(2008-11#1)(2011-1#1)
extract in a dose-dependent manner##2##5##(2008-12#1)(2012-3#1)
extract in an##2##3##(2008-10#1)(2008-5#1)
extract in##12##2##(1992-5#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2009-4#1)(2012-3#1)(2013-8#1)
extract inhibited##2##2##(2008-11#1)(2012-2#1)
extract is##12##2##(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-8#1)
extract of A##5##3##(2008-5#1)(2010-5#1)(2011-1#1)(2013-7#2)
extract of Azadirachta indica##3##4##(2008-12#2)(2010-3#1)
extract of Garcinia cambogia##2##4##(2012-2#2)
extract of P##3##3##(2008-10#1)(2013-1#2)
extract of Rubia##4##3##(2012-2#4)
extract of U##2##3##(2008-12#1)(2008-5#1)
extract of leaves of##3##4##(2008-10#1)(2011-1#1)(2011-3#1)
extract of leaves##4##3##(2008-10#2)(2011-1#1)(2011-3#1)
extract of seeds of##3##4##(2008-10#2)(2013-7#1)
extract of the leaves##2##4##(2010-3#2)
extract of the roots of##2##5##(2010-6#1)(2011-1#1)
extract of the seeds of Euphorbia lathyris L##2##8##(2011-1#2)
extract of the seeds of##3##5##(2007-11#1)(2011-1#2)
extract of the##21##3##(1992-3#1)(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#5)(2010-3#2)(2010-6#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-7#1)
extract of##150##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#27)(2008-11#9)(2008-12#16)(2008-5#7)(2008-8#5)(2009-6#1)(2010-2#1)(2010-3#6)(2010-5#6)(2010-6#1)(2010-9#1)(2011-1#9)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#23)(2012-3#1)(2013-1#10)(2013-7#5)(2013-8#1)
extract on##13##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#5)(2010-1#1)(2013-1#2)(2013-7#1)
extract or##4##2##(1997-3#1)(2008-10#3)
extract reduced##2##2##(2008-11#1)(2013-7#1)
extract reduces##3##2##(1993-2#1)(2008-11#1)(2009-6#1)
extract relevant##2##2##(2008-9#1)(2010-7#1)
extract remarkably##2##2##(2008-11#2)
extract residual##2##2##(2008-10#1)(2008-2#1)
extract samples##2##2##(2008-10#2)
extract showed the##2##3##(2008-5#1)(2009-6#1)
extract showed##9##2##(2008-10#2)(2008-12#1)(2008-5#2)(2009-6#1)(2010-5#1)(2011-1#1)(2013-7#1)
extract significantly inhibited root length more than shoot##2##8##(2008-12#2)
extract significantly##5##2##(2008-12#3)(2009-6#1)(2010-3#1)
extract solution##2##2##(2008-10#1)(2009-5#1)
extract the##29##2##(1996-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#9)(2008-3#9)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
extract thermodynamic##2##2##(1997-2#1)(2008-3#1)
extract to##3##2##(1990-7#1)(2008-10#1)(2008-5#1)
extract using##2##2##(1994-12#1)(2008-10#1)
extract was determined##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
extract was formulated##2##3##(2008-5#2)
extract was given##2##3##(2008-10#1)(2013-1#1)
extract was prepared from##2##4##(1995-2#1)(2008-12#1)
extract was prepared##3##3##(1995-2#1)(2008-12#1)(2008-5#1)
extract was tested##2##3##(2008-5#1)(2009-11#1)
extract was##37##2##(1990-2#2)(1995-2#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-5#6)(2009-11#1)(2010-5#2)(2011-1#2)(2013-1#2)(2013-7#1)
extract were investigated##3##3##(2008-5#2)(2011-2#1)
extract were##9##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2011-2#1)
extract whereas##2##2##(1993-2#1)(2008-10#1)
extract which##2##2##(2008-12#1)(2008-9#1)
extract##677##1##(1990-11#2)(1990-12#3)(1990-2#9)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#3)(1992-11#2)(1992-12#1)(1992-3#5)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#6)(1993-11#1)(1993-12#2)(1993-2#6)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-5#2)(1994-8#5)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#175)(2008-11#65)(2008-12#39)(2008-2#4)(2008-3#17)(2008-4#3)(2008-5#69)(2008-6#4)(2008-7#4)(2008-8#13)(2008-9#8)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#11)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-2#5)(2010-3#11)(2010-4#1)(2010-5#14)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#20)(2011-2#14)(2011-3#3)(2012-12#1)(2012-2#31)(2012-3#4)(2013-1#22)(2013-7#14)(2013-8#9)
extract)##4##1##(2008-10#1)(2008-11#1)(2013-8#2)
extract-induced##2##1##(1990-2#1)(2008-10#1)
extractability and selectivity of univalent metal picrates##2##7##(2008-10#2)
extractability and selectivity##3##3##(2008-10#3)
extractability is##2##2##(2008-10#2)
extractability of##13##2##(1994-8#1)(2008-10#11)(2008-7#1)
extractability with##3##2##(1992-6#1)(2008-10#2)
extractability##31##1##(1992-6#1)(1994-8#2)(2008-10#27)(2008-7#1)
extractable arsenic##3##2##(2008-10#2)(2010-5#1)
extractable by##2##2##(1992-9#1)(2008-10#1)
extractable contents##2##2##(2008-10#2)
extractable from##2##2##(2008-10#2)
extractable in##2##2##(2008-10#2)
extractable to##2##2##(2008-10#2)
extractable with##4##2##(2008-10#3)(2008-11#1)
extractable##41##1##(1992-9#1)(1994-8#1)(1995-11#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2010-5#1)
extractable-energy##2##1##(2008-2#2)
extractant and chemical modifier##2##4##(2008-10#2)
extractant and##6##2##(2008-10#6)
extractant composition##3##2##(2008-10#3)
extractant concentration##3##2##(2008-10#3)
extractant for##5##2##(2008-10#5)
extractant has been developed for##2##5##(2008-10#2)
extractant has been##3##3##(2008-10#3)
extractant is##2##2##(2008-10#2)
extractant of##2##2##(2008-10#2)
extractant##54##1##(2008-10#54)
extractants and##2##2##(2008-10#2)
extractants for##2##2##(2008-10#2)
extractants used##2##2##(2008-10#2)
extractants was##2##2##(2008-10#2)
extractants##26##1##(2008-10#26)
extracted DNA##4##2##(2008-10#2)(2008-12#2)
extracted and derivatized##2##3##(1990-8#1)(2011-3#1)
extracted and determined##2##3##(2008-10#2)
extracted and purified##2##3##(1993-6#1)(2012-2#1)
extracted and##24##2##(1990-8#1)(1993-6#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
extracted arsenic##3##2##(2008-10#3)
extracted as##7##2##(2007-2#1)(2008-10#6)
extracted at##6##2##(1993-9#1)(1996-12#1)(2008-10#4)
extracted based##2##2##(2013-1#2)
extracted by maceration##2##3##(2013-1#2)
extracted by means of##2##4##(2008-3#2)
extracted by the##5##3##(2008-10#1)(2008-11#1)(2010-3#1)(2011-1#2)
extracted by using##4##3##(2008-10#3)(2008-11#1)
extracted by##48##2##(1990-2#1)(1991-7#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#3)(2008-3#5)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#1)(2013-1#3)
extracted compounds##4##2##(2008-10#2)(2012-1#2)
extracted directly##2##2##(2008-12#1)(2008-3#1)
extracted for orthodontic reasons##3##4##(2013-8#3)
extracted for##8##2##(2008-10#3)(2011-2#1)(2012-1#1)(2013-8#3)
extracted from 10##2##3##(2008-10#1)(2008-2#1)
extracted from a##12##3##(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2009-4#1)(2010-4#1)(2012-3#1)
extracted from an##3##3##(2008-10#1)(2008-3#2)
extracted from cultured##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
extracted from different##4##3##(1995-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
extracted from each##2##3##(2008-12#1)(2010-8#1)
extracted from human##2##3##(2008-10#1)(2008-5#1)
extracted from rats##2##3##(1990-5#1)(2010-6#1)
extracted from samples##2##3##(2008-10#1)(2008-12#1)
extracted from soil samples##2##4##(2008-10#2)
extracted from soil##6##3##(2008-10#6)
extracted from the blood##3##4##(1994-5#1)(2013-1#1)(2013-8#1)
extracted from the culture##2##4##(1994-2#1)(2008-12#1)
extracted from the sample##2##4##(2008-10#1)(2013-1#1)
extracted from the samples##2##4##(2008-10#2)
extracted from the##59##3##(1990-8#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-5#1)(1994-8#2)(1996-8#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#4)
extracted from tissues##2##3##(2008-9#1)(2013-1#1)
extracted from##205##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#79)(2008-11#4)(2008-12#8)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#9)(2008-7#1)(2008-8#4)(2008-9#5)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-11#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#7)(2013-8#5)
extracted in a##2##3##(2007-12#1)(2008-10#1)
extracted in chloroform##5##3##(2008-10#5)
extracted in the##2##3##(2008-10#2)
extracted in to##2##3##(2008-10#2)
extracted in##16##2##(2007-12#1)(2008-10#14)(2008-5#1)
extracted into 1##2##3##(2008-10#2)
extracted into a##2##3##(2008-10#2)
extracted into an##2##3##(2008-10#2)
extracted into chloroform##6##3##(2008-10#6)
extracted into dichloromethane##3##3##(2008-10#3)
extracted into the acetonitrile layer with high yield##2##8##(2008-10#2)
extracted into the organic phase##3##5##(2008-10#3)
extracted into the organic##4##4##(2008-10#4)
extracted into the surfactant-rich phase##2##5##(2008-10#1)(2008-7#1)
extracted into the upper phase in the pH##2##8##(2008-10#2)
extracted into the upper phase##3##5##(2008-10#3)
extracted into the##17##3##(2008-10#16)(2008-7#1)
extracted into##39##2##(1990-8#1)(2008-10#37)(2008-7#1)
extracted lipids##2##2##(1990-12#1)(2008-10#1)
extracted metal##2##2##(2008-10#2)
extracted more##2##2##(2008-10#2)
extracted on##3##2##(1991-2#1)(2008-10#1)(2009-11#1)
extracted protein##2##2##(2008-4#1)(2008-8#1)
extracted pulse##2##2##(2008-10#1)(2008-3#1)
extracted quantitatively with##3##3##(2008-10#3)
extracted quantitatively##4##2##(2008-10#4)
extracted sequentially##2##2##(1992-8#1)(2008-8#1)
extracted simultaneously##2##2##(2008-10#2)
extracted species is##3##3##(2008-10#3)
extracted species were##2##3##(2008-10#2)
extracted species##11##2##(2008-10#11)
extracted teeth##2##2##(1991-3#1)(2009-8#1)
extracted to the##3##3##(2008-10#3)
extracted to##7##2##(2008-10#4)(2008-3#1)(2008-5#1)(2009-6#1)
extracted under the optimum##2##4##(2008-10#2)
extracted under the##3##3##(2008-10#3)
extracted under##4##2##(2007-8#1)(2008-10#3)
extracted using a##2##3##(1990-8#1)(2008-10#1)
extracted using##4##2##(1990-8#1)(2008-10#2)(2011-2#1)
extracted with HA and 4% (v/v) Triton X-100 in the pH range of##2##13##(2008-10#2)
extracted with a##5##3##(2008-10#5)
extracted with diethyl ether to obtain extract##2##7##(2008-11#2)
extracted with methanol##2##3##(2008-10#1)(2008-5#1)
extracted with the##2##3##(1997-2#1)(2008-10#1)
extracted with water##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
extracted with##57##2##(1993-8#1)(1996-5#1)(1997-2#2)(2008-10#38)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
extracted##585##1##(1990-12#4)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-8#4)(1995-11#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#3)(1997-6#3)(1997-7#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-8#3)(2008-10#308)(2008-11#12)(2008-12#17)(2008-2#6)(2008-3#23)(2008-4#4)(2008-5#21)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-3#5)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#10)(2012-3#4)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#9)
extracting and##2##2##(2008-2#1)(2012-2#1)
extracting solution##2##2##(2008-10#1)(2010-5#1)
extracting solutions##2##2##(2008-10#2)
extracting solvent was##2##3##(2008-10#2)
extracting solvent##6##2##(2008-10#6)
extracting the##9##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2012-8#1)
extracting##57##1##(1996-12#1)(2007-12#2)(2008-10#34)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#3)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-8#1)
extraction (CPE)##4##2##(2008-10#4)
extraction (K(ex))##2##2##(2008-10#2)
extraction (MAE) for the##2##4##(2008-10#2)
extraction (MAE)##4##2##(2008-10#4)
extraction (SFE) and##2##3##(2008-10#2)
extraction (SFE)##12##2##(2008-10#12)
extraction (SPE) and##5##3##(2008-10#4)(2008-11#1)
extraction (SPE) by##2##3##(2008-10#2)
extraction (SPE) cartridge##2##3##(2008-10#1)(2011-1#1)
extraction (SPE) has##2##3##(2008-10#1)(2013-1#1)
extraction (SPE) method##3##3##(2008-10#3)
extraction (SPE) of the##2##4##(2008-10#2)
extraction (SPE) on##2##3##(2008-10#2)
extraction (SPE) procedures for##2##4##(2008-10#2)
extraction (SPE) using##4##3##(2008-10#4)
extraction (SPE)##53##2##(1997-2#1)(2008-10#49)(2008-11#1)(2011-1#1)(2013-1#1)
extraction (n =##2##3##(1994-7#2)
extraction ability and selectivity##3##4##(2008-10#3)
extraction ability of##2##3##(2008-10#2)
extraction ability##6##2##(2008-10#6)
extraction and HPLC determination of##2##5##(2008-10#2)
extraction and a##2##3##(2008-10#2)
extraction and clean-up##5##3##(2008-10#5)
extraction and degradation##2##3##(2012-1#2)
extraction and derivatization##2##3##(2008-10#1)(2008-11#1)
extraction and desorption##4##3##(2008-10#4)
extraction and determination of bismuth in##3##6##(2008-10#3)
extraction and determination of trace##2##5##(2008-10#2)
extraction and determination of##14##4##(2008-10#14)
extraction and gas chromatography##2##4##(2008-10#2)
extraction and gas chromatography-mass spectrometry##3##5##(2008-10#3)
extraction and gas chromatography-mass##4##4##(2008-10#4)
extraction and gas##6##3##(2008-10#6)
extraction and graphite furnace atomic absorption##3##6##(2008-10#3)
extraction and in##2##3##(2008-10#2)
extraction and on-line##2##3##(2008-10#2)
extraction and potentiometry##2##3##(2008-10#2)
extraction and preconcentration##4##3##(2008-10#4)
extraction and purification##4##3##(2008-10#3)(2008-8#1)
extraction and quantification of##2##4##(1992-3#1)(2008-10#1)
extraction and selective##2##3##(2008-10#2)
extraction and separation of##3##4##(2008-10#2)(2012-3#1)
extraction and separation##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
extraction and simultaneous spectrophotometric determination of##2##6##(2008-10#2)
extraction and solvent##2##3##(2008-10#2)
extraction and spectrophotometric determination of##2##5##(2008-10#2)
extraction and spectrophotometric determination##3##4##(2008-10#3)
extraction and spectrophotometric##4##3##(2008-10#4)
extraction and standard addition##2##4##(2008-10#2)
extraction and stripping##3##3##(2008-10#3)
extraction and the##8##3##(2008-10#6)(2008-11#1)(2011-2#1)
extraction and##150##2##(1990-8#1)(1992-11#1)(1992-3#1)(1997-2#2)(2008-10#127)(2008-11#5)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
extraction and/or##2##2##(2008-10#2)
extraction approach##2##2##(2008-10#2)
extraction are also##2##3##(2008-10#1)(2008-2#1)
extraction are found to be##2##5##(2008-10#2)
extraction are##10##2##(2008-10#8)(2008-11#1)(2008-2#1)
extraction as well as##2##4##(2008-10#2)
extraction as##6##2##(1995-12#1)(2008-10#5)
extraction at##8##2##(1994-11#1)(2008-10#5)(2012-1#1)(2013-1#1)
extraction behavior of divalent##2##4##(2008-10#2)
extraction behavior of the##2##4##(2008-10#2)
extraction behavior of##6##3##(2008-10#6)
extraction behavior##7##2##(2008-10#7)
extraction behaviour of##5##3##(2008-10#5)
extraction by using##2##3##(2008-10#2)
extraction by##13##2##(2008-10#10)(2008-8#1)(2011-2#2)
extraction capacity of##2##3##(1991-8#1)(2008-10#1)
extraction cartridge##2##2##(1997-2#1)(2008-10#1)
extraction cartridges##3##2##(2008-10#3)
extraction chromatographic resin##4##3##(2008-10#4)
extraction chromatographic separation of##2##4##(2008-10#2)
extraction chromatographic separation##4##3##(2008-10#4)
extraction chromatographic##13##2##(2008-10#13)
extraction chromatography material##2##3##(2008-10#2)
extraction chromatography##11##2##(2008-10#11)
extraction coil##3##2##(2008-10#3)
extraction column##2##2##(2008-10#1)(2009-8#1)
extraction condition##2##2##(2008-10#2)
extraction conditions on##2##3##(2008-10#1)(2008-6#1)
extraction conditions were##4##3##(2008-10#4)
extraction conditions##14##2##(2008-10#13)(2008-6#1)
extraction constant of##4##3##(2008-10#4)
extraction constant##14##2##(2008-10#14)
extraction constants##5##2##(2008-10#5)
extraction coupled##2##2##(2008-10#2)
extraction data##3##2##(2008-10#3)
extraction device##4##2##(1997-2#2)(2008-10#2)
extraction disks##3##2##(2008-10#3)
extraction does not##2##3##(2008-10#2)
extraction efficiencies for the##2##4##(2009-8#1)(2010-5#1)
extraction efficiencies for##3##3##(2008-10#1)(2009-8#1)(2010-5#1)
extraction efficiencies##7##2##(2008-10#5)(2009-8#1)(2010-5#1)
extraction efficiency and selectivity##4##4##(2008-10#4)
extraction efficiency and##8##3##(2008-10#8)
extraction efficiency as##2##3##(2008-10#2)
extraction efficiency for##3##3##(2008-10#3)
extraction efficiency of the##5##4##(2008-10#5)
extraction efficiency of##14##3##(2008-10#13)(2012-1#1)
extraction efficiency was##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
extraction efficiency were##3##3##(2008-10#3)
extraction efficiency##54##2##(2007-12#1)(2008-10#47)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#2)(2012-2#1)
extraction equilibria of##3##3##(2008-10#3)
extraction equilibria##4##2##(2008-10#4)
extraction equilibrium constants##4##3##(2008-10#4)
extraction equilibrium of##2##3##(2008-10#2)
extraction equilibrium##10##2##(2008-10#10)
extraction followed by##14##3##(2008-10#12)(2008-6#1)(2013-1#1)
extraction for the determination of##2##5##(2008-10#2)
extraction for##12##2##(2008-10#10)(2008-5#1)(2013-1#1)
extraction from soil##2##3##(2008-10#2)
extraction from the##2##3##(2008-10#2)
extraction from##23##2##(2008-10#20)(2008-12#1)(2010-2#1)(2011-2#1)
extraction gas##2##2##(2008-10#2)
extraction gave##2##2##(1993-8#1)(2008-10#1)
extraction has been developed##3##4##(2008-10#3)
extraction has been##4##3##(2008-10#4)
extraction has##5##2##(1990-5#1)(2008-10#4)
extraction in a##5##3##(2008-10#3)(2008-2#1)(2012-1#1)
extraction in an ultrasonic bath##2##5##(2008-10#2)
extraction in the presence of##2##5##(2008-10#2)
extraction in the##6##3##(2008-10#3)(2008-3#2)(2009-8#1)
extraction in##20##2##(1994-11#1)(2008-10#13)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-1#1)
extraction into chloroform##2##3##(2008-10#2)
extraction into##10##2##(2008-10#10)
extraction is an##2##3##(2008-10#1)(2008-2#1)
extraction is performed by##2##4##(2008-10#1)(2008-3#1)
extraction is##17##2##(2008-10#14)(2008-2#1)(2008-3#1)(2008-7#1)
extraction kinetics##2##2##(2008-10#2)
extraction mechanism was##2##3##(2008-10#2)
extraction mechanism##6##2##(2008-10#6)
extraction medium##5##2##(2008-10#5)
extraction membrane and##2##3##(2008-10#2)
extraction membrane##4##2##(2008-10#4)
extraction method and the##2##4##(2008-10#2)
extraction method and##3##3##(2008-10#3)
extraction method for the##5##4##(2008-10#5)
extraction method for##7##3##(2008-10#6)(2008-4#1)
extraction method in##2##3##(2008-10#1)(2012-3#1)
extraction method is##2##3##(2008-10#2)
extraction method of##4##3##(2008-10#2)(2013-8#2)
extraction method using##3##3##(2008-10#3)
extraction method was also##2##4##(2008-10#2)
extraction method was##3##3##(2008-10#3)
extraction method##37##2##(2008-10#31)(2008-4#1)(2009-8#1)(2012-3#2)(2013-8#2)
extraction methodology##3##2##(2008-10#3)
extraction methods were##2##3##(2008-10#2)
extraction methods##14##2##(2008-10#11)(2008-12#1)(2012-3#1)(2013-1#1)
extraction of Cd(2+)##2##3##(2008-10#2)
extraction of Co##2##3##(2008-10#2)
extraction of Co(II) and Zn(II) by##2##6##(2008-10#2)
extraction of Co(II) and Zn(II)##3##5##(2008-10#3)
extraction of Cr(VI)##2##3##(2008-10#2)
extraction of Cu(II)##2##3##(2008-10#2)
extraction of DNA##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
extraction of PAHs##2##3##(2008-10#2)
extraction of U(VI)##4##3##(2008-10#4)
extraction of U/Pu##2##3##(2008-10#2)
extraction of a##7##3##(2008-10#6)(2012-2#1)
extraction of acids from##3##4##(2008-10#3)
extraction of alkali metal picrates with##2##6##(2008-10#2)
extraction of an##2##3##(2008-10#1)(2011-2#1)
extraction of analyte from water##2##5##(2008-10#2)
extraction of astaxanthin from crustaceans##2##5##(2008-10#2)
extraction of b(5)##3##3##(2008-7#3)
extraction of both metals##2##4##(2008-10#2)
extraction of both##4##3##(2008-10#4)
extraction of chromium(VI)##3##3##(2008-10#3)
extraction of copper##3##3##(2008-10#3)
extraction of copper(II) ions##2##4##(2008-10#2)
extraction of copper(II)##3##3##(2008-10#3)
extraction of free##2##3##(2008-10#2)
extraction of gallium##2##3##(2008-10#2)
extraction of genistein##3##3##(2012-2#3)
extraction of iron(III) and titanium(IV)##2##5##(2008-10#2)
extraction of iron(III) and##3##4##(2008-10#3)
extraction of iron(III)##5##3##(2008-10#5)
extraction of lanthanoids(III) with##2##4##(2008-10#2)
extraction of magnesium##2##3##(2008-10#2)
extraction of membrane proteins##2##4##(2008-7#2)
extraction of mercury from##2##4##(2008-10#2)
extraction of mercury species##2##4##(2008-10#2)
extraction of mercury##4##3##(2008-10#4)
extraction of mercury(II) from##2##4##(2008-10#2)
extraction of mercury(II)##3##3##(2008-10#3)
extraction of metal ions by##2##5##(2008-10#2)
extraction of metal ions##6##4##(2008-10#6)
extraction of metal##7##3##(2008-10#7)
extraction of metals from##3##4##(2008-10#3)
extraction of metals##7##3##(2008-10#6)(2011-2#1)
extraction of organic##2##3##(2008-10#2)
extraction of page-formatted binary digital data##2##6##(2008-2#2)
extraction of phenol##2##3##(2008-10#1)(2012-1#1)
extraction of platinum(II) with##2##4##(2008-10#2)
extraction of polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
extraction of rhodium(III)##2##3##(2008-10#2)
extraction of soil##2##3##(2008-10#2)
extraction of some##2##3##(2008-10#2)
extraction of tanshinones from Salvia miltiorrhiza bunge##2##7##(2008-10#2)
extraction of the##42##3##(1992-10#1)(1992-3#1)(1994-8#1)(1996-5#1)(1996-6#1)(2008-10#21)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
extraction of these##3##3##(2008-10#3)
extraction of thorium(IV) and uranium(VI)##2##5##(2008-10#2)
extraction of tin(IV)##2##3##(2008-10#2)
extraction of total##2##3##(2008-10#2)
extraction of trivalent##2##3##(2008-10#2)
extraction of uranium##4##3##(2008-10#4)
extraction of urinary##2##3##(1990-8#1)(1997-2#1)
extraction of vanillin and##2##4##(2008-10#2)
extraction of volatile organic compounds##2##5##(2008-10#2)
extraction of volatile##3##3##(2008-10#3)
extraction of##334##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-3#1)(1992-10#1)(1992-3#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#247)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#12)(2008-9#2)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#7)(2012-1#7)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
extraction on##3##2##(1996-5#1)(2008-10#2)
extraction or separation##2##3##(2008-10#2)
extraction or##10##2##(1992-11#1)(1992-8#1)(2008-10#7)(2008-3#1)
extraction parameters##6##2##(2008-10#6)
extraction performance##2##2##(2008-10#2)
extraction period##2##2##(2008-10#2)
extraction phase##2##2##(2008-10#2)
extraction preconcentration##6##2##(2008-10#6)
extraction procedure and##4##3##(1992-9#1)(2008-10#3)
extraction procedure for the##4##4##(2008-10#4)
extraction procedure for##15##3##(2008-10#15)
extraction procedure of##2##3##(2008-10#2)
extraction procedure was developed##2##4##(2008-10#2)
extraction procedure was optimized##2##4##(2008-10#2)
extraction procedure was##8##3##(2008-10#8)
extraction procedure with##2##3##(2008-10#2)
extraction procedure##60##2##(1990-5#1)(1992-9#1)(2008-10#57)(2011-2#1)
extraction procedures were##3##3##(2008-10#3)
extraction procedures##25##2##(1997-1#1)(2007-7#1)(2008-10#20)(2008-7#1)(2012-3#2)
extraction process for##2##3##(2008-10#1)(2012-3#1)
extraction process was##6##3##(2008-10#6)
extraction process##34##2##(1992-3#1)(2008-10#26)(2008-4#1)(2008-6#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
extraction processes of##2##3##(2008-10#1)(2012-2#1)
extraction processes##3##2##(2008-10#2)(2012-2#1)
extraction protocol##6##2##(2008-10#4)(2008-4#1)(2011-2#1)
extraction provided##2##2##(2008-10#2)
extraction rate and##2##3##(2011-2#2)
extraction rate data##3##3##(2008-10#3)
extraction rate is##3##3##(2008-10#1)(2008-8#2)
extraction rate of platinum(II) was##2##5##(2008-10#2)
extraction rate of platinum(II)##3##4##(2008-10#3)
extraction rate##14##2##(2008-10#8)(2008-8#2)(2011-2#4)
extraction recoveries##3##2##(2008-10#2)(2011-2#1)
extraction recovery##2##2##(2008-10#2)
extraction reservoir (H)##2##3##(2008-10#2)
extraction reservoir##3##2##(2008-10#3)
extraction resin was##2##3##(2008-10#2)
extraction resin##8##2##(2008-10#8)
extraction scheme##4##2##(2008-10#4)
extraction schemes##4##2##(2008-10#4)
extraction selectivity for##4##3##(2008-10#4)
extraction selectivity of##3##3##(2008-10#3)
extraction selectivity##9##2##(2008-10#9)
extraction separation of##5##3##(2008-10#5)
extraction separation##9##2##(2008-10#9)
extraction site##2##2##(2007-12#2)
extraction solution##5##2##(2008-10#5)
extraction solvent was##2##3##(2008-10#2)
extraction solvent##11##2##(2008-10#10)(2009-6#1)
extraction solvents##6##2##(2008-10#6)
extraction species##2##2##(2008-10#2)
extraction spectrophotometric determination of##3##4##(2008-10#3)
extraction stage##3##2##(2008-10#3)
extraction step was##2##3##(2008-10#1)(2008-7#1)
extraction step##13##2##(2008-10#10)(2008-7#2)(2013-1#1)
extraction studies##2##2##(2008-10#2)
extraction study of##3##3##(2008-10#3)
extraction such as##3##3##(2008-10#2)(2008-2#1)
extraction support##3##2##(2008-10#3)
extraction system and##3##3##(2008-10#3)
extraction system for##3##3##(2008-10#3)
extraction system on##2##3##(2008-10#2)
extraction system using##2##3##(2008-10#2)
extraction system##30##2##(2008-10#29)(2008-5#1)
extraction systems##9##2##(2008-10#7)(2008-7#1)(2012-1#1)
extraction technique for##5##3##(2008-10#5)
extraction technique was##2##3##(2008-10#1)(2013-8#1)
extraction technique##16##2##(1991-12#1)(1992-11#1)(1996-12#1)(2007-8#1)(2008-10#9)(2008-3#1)(2012-1#1)(2013-8#1)
extraction techniques have been##2##4##(2008-10#2)
extraction techniques##8##2##(2008-10#8)
extraction temperature##9##2##(2008-10#8)(2012-1#1)
extraction through##2##2##(2008-10#2)
extraction time and total analyte pulse width##2##7##(2008-10#2)
extraction time and total##3##4##(2008-10#3)
extraction time and##12##3##(2008-10#12)
extraction time of##4##3##(2008-10#4)
extraction time##56##2##(2008-10#53)(2009-8#1)(2012-1#2)
extraction time)##3##2##(2008-10#3)
extraction times##4##2##(2008-10#4)
extraction to##4##2##(2008-10#2)(2008-2#1)(2008-9#1)
extraction under##2##2##(2008-10#2)
extraction using a##2##3##(2008-10#2)
extraction using the##2##3##(2008-10#2)
extraction using##22##2##(1997-2#1)(2008-10#18)(2011-2#1)(2012-2#1)(2013-8#1)
extraction vessel (H)##2##3##(2008-10#2)
extraction vessel##7##2##(2008-10#7)
extraction vial##2##2##(2008-10#2)
extraction was also##2##3##(1991-2#1)(2008-10#1)
extraction was applied to##2##4##(2008-10#2)
extraction was applied##4##3##(1994-11#1)(2008-10#3)
extraction was carried out##2##4##(2008-10#2)
extraction was developed##2##3##(2008-10#2)
extraction was performed##2##3##(2008-10#2)
extraction was used to extract##2##5##(2008-10#2)
extraction was used to##5##4##(2008-10#5)
extraction was##31##2##(1991-2#1)(1994-11#1)(2008-10#27)(2008-11#1)(2008-2#1)
extraction were##7##2##(2008-10#6)(2011-1#1)
extraction with a mixture of##2##5##(2008-10#2)
extraction with a##4##3##(2008-10#4)
extraction with acidic##2##3##(2008-10#1)(2008-8#1)
extraction with chloroform##2##3##(2008-10#2)
extraction with ethyl acetate##2##4##(1996-2#1)(2011-3#1)
extraction with n-hexane##2##3##(2008-10#2)
extraction with the##3##3##(2008-10#2)(2008-12#1)
extraction with##46##2##(1990-5#1)(1991-7#1)(1996-2#1)(2008-10#39)(2008-12#1)(2008-8#1)(2011-3#1)(2013-1#1)
extraction yield of##3##3##(2008-10#2)(2008-7#1)
extraction yield##5##2##(2008-10#4)(2008-7#1)
extraction yields##3##2##(2008-10#3)
extraction##1837##1##(1990-11#1)(1990-12#3)(1990-5#6)(1990-7#1)(1990-8#3)(1991-12#2)(1991-2#2)(1991-3#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#4)(1992-3#4)(1992-8#4)(1992-9#1)(1993-8#1)(1994-11#5)(1994-6#1)(1994-7#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#11)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#13)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1504)(2008-11#9)(2008-12#13)(2008-2#25)(2008-3#17)(2008-4#7)(2008-5#8)(2008-6#12)(2008-7#23)(2008-8#5)(2008-9#6)(2009-11#1)(2009-6#2)(2009-8#5)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#22)(2011-3#1)(2012-1#27)(2012-12#1)(2012-2#9)(2012-3#8)(2013-1#14)(2013-8#9)
extraction)##5##1##(2008-10#5)
extraction-ability and -selectivity of##2##4##(2008-10#2)
extraction-ability and -selectivity##3##3##(2008-10#3)
extraction-selectivity##3##1##(2008-10#3)
extraction-spectrophotometric determination of##5##3##(2008-10#5)
extraction-spectrophotometric method for the determination of##2##6##(2008-10#2)
extraction-spectrophotometric##8##1##(2008-10#8)
extractions of##2##2##(2008-10#2)
extractions on##2##2##(2010-3#2)
extractions were##8##2##(1990-12#1)(2008-10#6)(2011-2#1)
extractions with##5##2##(1997-4#1)(2008-10#3)(2008-4#1)
extractions##38##1##(1990-12#1)(1990-5#1)(1991-9#1)(1993-1#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-10#22)(2008-12#1)(2008-2#2)(2008-4#1)(2010-3#2)(2011-2#1)(2012-1#1)(2013-1#1)
extractions)##2##1##(2008-10#1)(2008-12#1)
extractive fermentation##3##2##(2011-2#3)
extractive flow injection analysis##2##4##(2008-10#2)
extractive preconcentration and separation of##3##5##(2008-10#3)
extractive preconcentration##10##2##(2008-10#10)
extractive separation of##3##3##(2008-10#3)
extractive##31##1##(1994-11#1)(2008-10#26)(2009-6#1)(2011-2#3)
extractograms##2##1##(2008-10#2)
extractor has##2##2##(2008-10#2)
extractor##22##1##(1996-12#1)(2008-10#19)(2008-11#1)(2008-3#1)
extractors##3##1##(2008-10#3)
extracts after##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
extracts against##2##2##(2008-12#1)(2010-3#1)
extracts and acetylcholine##2##3##(2010-3#2)
extracts and in##2##3##(2008-10#2)
extracts and##26##2##(1992-3#1)(1992-8#1)(1992-9#1)(1994-6#1)(1996-5#1)(2008-10#14)(2008-5#2)(2008-7#1)(2010-3#2)(2012-2#1)(2013-8#1)
extracts are##5##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
extracts as##2##2##(2008-5#2)
extracts but##2##2##(1990-11#1)(1997-7#1)
extracts by##13##2##(1992-3#1)(1992-6#1)(1992-8#1)(1994-6#1)(2008-10#7)(2008-4#1)(2010-12#1)
extracts can be##3##3##(2008-10#2)(2013-8#1)
extracts can##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
extracts contained only##2##3##(2008-10#2)
extracts containing T4 lysozyme##2##4##(2008-10#2)
extracts containing##7##2##(1990-5#1)(1994-5#1)(2008-10#5)
extracts could be##2##3##(2008-10#1)(2008-5#1)
extracts derived from##3##3##(2008-10#2)(2010-3#1)
extracts exhibited##3##2##(2008-12#1)(2011-1#1)(2013-8#1)
extracts for##8##2##(1991-7#1)(1993-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-8#1)
extracts from Glycyrrhiza uralensis Fisch##2##5##(2008-11#2)
extracts from HeLa cells##2##4##(1993-8#1)(2008-2#1)
extracts from a##2##3##(1996-12#1)(2008-10#1)
extracts from mammalian cells##2##4##(1995-2#1)(2008-2#1)
extracts from the##8##3##(1993-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)
extracts from##71##2##(1990-12#1)(1991-12#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#24)(2008-11#6)(2008-2#3)(2008-5#5)(2008-8#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
extracts had##3##2##(1990-5#1)(1991-12#1)(1992-8#1)
extracts has been##2##3##(1994-12#1)(2008-10#1)
extracts has##4##2##(1994-12#1)(1994-6#1)(2008-10#1)(2010-7#1)
extracts have been##2##3##(2008-10#2)
extracts have##5##2##(1993-3#1)(1996-2#1)(2008-10#2)(2012-2#1)
extracts in##6##2##(1990-5#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-1#1)
extracts indicated##2##2##(2008-10#1)(2013-1#1)
extracts indicates that##2##3##(1996-2#1)(1997-7#1)
extracts is a##2##3##(2008-11#1)(2008-4#1)
extracts is described##2##3##(2008-10#2)
extracts is##7##2##(1994-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)
extracts obtained from##3##3##(2008-10#2)(2013-1#1)
extracts obtained##9##2##(1992-8#1)(2008-10#5)(2012-1#2)(2013-1#1)
extracts of A##3##3##(2008-10#2)(2008-12#1)
extracts of E##2##3##(1997-6#1)(2008-12#1)
extracts of Inula##2##3##(2008-10#2)
extracts of a##4##3##(1992-8#1)(1995-2#1)(1995-5#1)(2008-10#1)
extracts of human##4##3##(1990-12#1)(1994-12#1)(1994-8#1)(2008-10#1)
extracts of infected potato leaves##2##5##(2008-10#2)
extracts of infected potato##3##4##(2008-10#3)
extracts of infected##4##3##(2008-10#4)
extracts of soil##2##3##(2008-10#1)(2008-11#1)
extracts of the leaves of##2##5##(2010-2#1)(2010-3#1)
extracts of the samples##2##4##(2008-10#1)(2011-1#1)
extracts of the##11##3##(1992-8#1)(1994-11#1)(1997-2#1)(2008-10#5)(2010-2#1)(2010-3#1)(2011-1#1)
extracts of these##2##3##(1990-11#1)(1992-2#1)
extracts of this##3##3##(1993-6#1)(1997-2#1)(2008-10#1)
extracts of##106##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-8#3)(1992-9#1)(1993-6#3)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-10#38)(2008-11#10)(2008-12#5)(2008-5#4)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-3#4)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#4)
extracts on the##3##3##(2008-12#1)(2008-5#1)(2010-3#1)
extracts on##9##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2010-3#2)
extracts or##3##2##(1994-11#1)(2008-10#1)(2013-8#1)
extracts prepared from##2##3##(2008-11#1)(2008-7#1)
extracts prepared were##2##3##(2008-12#1)(2008-5#1)
extracts prepared##6##2##(1993-6#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)
extracts produced##2##2##(2008-10#1)(2008-12#1)
extracts reduce the##2##3##(2008-10#1)(2010-2#1)
extracts revealed that##2##3##(1992-12#1)(2008-10#1)
extracts revealed##4##2##(1992-12#1)(2008-10#3)
extracts show##2##2##(2008-10#2)
extracts showed##4##2##(1990-5#1)(2008-10#1)(2011-1#1)(2012-1#1)
extracts significantly##2##2##(2008-10#1)(2008-11#1)
extracts tested##2##2##(2008-5#2)
extracts that##6##2##(1990-11#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
extracts the##3##2##(2008-10#2)(2008-7#1)
extracts to##6##2##(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)(2013-1#1)
extracts using##7##2##(2008-10#5)(2008-4#1)(2011-1#1)
extracts was##17##2##(1990-5#1)(1994-12#1)(2008-10#12)(2008-12#1)(2008-5#1)(2013-1#1)
extracts were analysed by gas chromatography##2##6##(2008-10#2)
extracts were analysed by##3##4##(2008-10#3)
extracts were analyzed##3##3##(2008-10#2)(2011-1#1)
extracts were carried out by##2##5##(2008-10#2)
extracts were determined using the##2##5##(2008-10#2)
extracts were determined##4##3##(2008-10#2)(2008-6#1)(2011-1#1)
extracts were evaluated##4##3##(2008-10#2)(2013-1#1)(2013-7#1)
extracts were fractionated by##2##4##(2008-10#1)(2008-5#1)
extracts were fractionated##3##3##(2008-10#2)(2008-5#1)
extracts were obtained##3##3##(2008-10#2)(2008-5#1)
extracts were screened##2##3##(2008-10#1)(2008-5#1)
extracts were tested##2##3##(1993-6#1)(2008-11#1)
extracts were##53##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1992-9#1)(1993-6#2)(1995-2#1)(1996-5#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-5#6)(2008-6#1)(2011-1#2)(2013-1#1)(2013-7#1)
extracts which##3##2##(1991-8#1)(1997-2#1)(2007-2#1)
extracts with a##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
extracts with##9##2##(1990-2#1)(2008-10#5)(2008-5#1)(2012-1#1)(2013-8#1)
extracts##618##1##(1990-10#1)(1990-11#8)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#6)(1990-7#2)(1990-8#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#9)(1992-9#7)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#12)(1993-8#3)(1994-11#3)(1994-12#6)(1994-5#1)(1994-6#5)(1994-8#7)(1995-11#2)(1995-2#8)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(2007-12#1)(2007-2#4)(2008-1#1)(2008-10#260)(2008-11#38)(2008-12#18)(2008-2#4)(2008-3#1)(2008-4#8)(2008-5#50)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#5)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#5)(2010-3#12)(2010-7#1)(2011-1#10)(2011-2#2)(2012-1#6)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#16)
extracts)##3##1##(1990-5#1)(1992-9#1)(2008-5#1)
extracurricular activities##8##2##(1992-2#2)(2009-7#6)
extracurricular##9##1##(1992-2#2)(2009-7#7)
extradural anterior clinoidectomy via the trans-SOF approach##3##7##(2011-2#3)
extradural haematoma##3##2##(2008-8#3)
extradural##21##1##(2006-12#2)(2007-7#2)(2007-8#1)(2008-12#2)(2008-7#5)(2008-8#3)(2011-2#3)(2012-12#1)(2012-3#2)
extradurally##3##1##(2006-12#1)(2008-10#1)(2010-7#1)
extraembryonic coelomic fluid##3##3##(1995-8#3)
extraembryonic tissues##2##2##(2012-1#2)
extraembryonic##7##1##(1995-8#3)(1997-4#1)(2012-1#3)
extragenic##6##1##(1990-11#1)(1990-5#1)(2008-10#4)
extragenital##4##1##(1992-5#1)(2007-7#1)(2007-8#1)(2009-5#1)
extragonadal##2##1##(1995-2#1)(2008-5#1)
extrahepatic biliary lithiasis##2##3##(1991-5#2)
extrahepatic biliary##3##2##(1991-5#2)(1993-9#1)
extrahepatic cholestasis##4##2##(1993-9#4)
extrahepatic##15##1##(1991-5#2)(1991-8#1)(1993-9#5)(1994-8#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
extraintestinal infections caused by##2##4##(1990-6#1)(1997-3#1)
extraintestinal infections##3##2##(1990-6#2)(1997-3#1)
extraintestinal manifestations##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
extraintestinal neoplasia in##2##3##(2013-8#2)
extraintestinal neoplasias##2##2##(2013-8#2)
extraintestinal##15##1##(1990-6#3)(1997-3#2)(1997-5#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#5)
extraluminal##3##1##(1993-9#1)(2009-7#1)(2011-2#1)
extramammary Paget's disease##2##3##(1993-1#1)(2012-12#1)
extramarital##2##1##(2007-8#1)(2013-1#1)
extramedullary masses may##2##3##(2011-2#2)
extramedullary masses##5##2##(2011-2#5)
extramedullary plasmacytoma of the thyroid##2##5##(2009-3#2)
extramedullary plasmacytoma##4##2##(2009-3#3)(2012-12#1)
extramedullary spinal##2##2##(2008-7#1)(2012-3#1)
extramedullary##20##1##(1993-2#1)(2008-10#1)(2008-7#3)(2009-3#3)(2011-2#6)(2012-12#2)(2012-3#3)(2013-1#1)
extramucosal##2##1##(1992-9#1)(2009-8#1)
extramural##4##1##(1991-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
extraneous signals##2##2##(2008-2#2)
extraneous##13##1##(1991-12#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-12#3)
extraneural##2##1##(2008-7#1)(2010-11#1)
extranodal##6##1##(1990-11#1)(2008-5#2)(2009-8#2)(2013-1#1)
extraocular muscles##8##2##(1997-3#6)(2008-7#1)(2011-1#1)
extraocular##10##1##(1997-3#7)(2008-7#1)(2011-1#2)
extraoral##2##1##(2011-2#2)
extraordinarily high##2##2##(1992-9#1)(1997-3#1)
extraordinarily large##2##2##(2007-12#2)
extraordinarily stable##2##2##(2006-12#1)(2008-11#1)
extraordinarily##17##1##(1990-8#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1997-3#1)(2006-12#1)(2007-12#3)(2008-10#3)(2008-11#1)(2010-5#1)
extraordinary electroconductance##2##2##(2009-6#2)
extraordinary index##2##2##(2008-3#2)
extraordinary polarization##2##2##(2008-3#2)
extraordinary rays##2##2##(2008-2#2)
extraordinary refractive-index##2##2##(2008-2#1)(2008-3#1)
extraordinary##36##1##(1990-10#2)(1993-6#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-2#9)(2008-3#11)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-3#1)(2012-2#1)
extrapelvic endometriosis##2##2##(2009-8#1)(2013-1#1)
extrapelvic##3##1##(2009-8#1)(2013-1#2)
extrapleural##6##1##(2007-8#3)(2010-8#1)(2012-2#2)
extrapolate the##2##2##(2008-11#1)(2012-2#1)
extrapolate##9##1##(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-2#1)
extrapolated from##2##2##(2008-11#1)(2009-5#1)
extrapolated to other##2##3##(2008-5#1)(2008-8#1)
extrapolated to##8##2##(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)
extrapolated##18##1##(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2012-2#1)
extrapolating results##2##2##(2008-1#1)(2008-8#1)
extrapolating the##2##2##(2008-10#1)(2010-4#1)
extrapolating##8##1##(1995-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-9#1)(2010-4#1)
extrapolation in##2##2##(1991-12#1)(1992-2#1)
extrapolation is##2##2##(1990-8#1)(2008-7#1)
extrapolation length ratio##2##3##(2008-3#2)
extrapolation of the##3##3##(1996-4#1)(2008-2#1)(2008-5#1)
extrapolation of##5##2##(1996-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
extrapolation to##2##2##(1995-11#1)(2008-10#1)
extrapolation##23##1##(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-6#1)(1995-11#1)(1996-4#1)(2007-5#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#1)
extrapolations of##2##2##(2008-2#1)(2008-7#1)
extrapolations##6##1##(1992-6#1)(2008-2#2)(2008-7#2)(2010-6#1)
extrapulmonary hydatid##2##2##(2013-1#2)
extrapulmonary sites##2##2##(1991-12#1)(2013-1#1)
extrapulmonary tuberculosis##2##2##(1996-11#2)
extrapulmonary##15##1##(1990-6#1)(1991-12#1)(1996-11#3)(1997-1#1)(2008-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#5)
extrapyramidal motor##2##2##(1995-2#1)(2008-4#1)
extrapyramidal side##3##2##(1992-12#1)(2008-6#2)
extrapyramidal symptoms##2##2##(2008-8#1)(2008-9#1)
extrapyramidal##15##1##(1990-6#1)(1991-1#1)(1992-12#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)
extraradical##3##1##(2008-11#3)
extrarenal##3##1##(1994-5#1)(2007-7#1)(2008-1#1)
extraretinal##2##1##(2010-8#1)(2011-2#1)
extraribosomal functions##2##2##(2008-7#2)
extraskeletal osteosarcoma##5##2##(2008-6#4)(2012-1#1)
extraskeletal##9##1##(1993-8#1)(2008-6#4)(2012-1#1)(2012-2#2)(2012-3#1)
extrasolar planets##2##2##(2008-2#1)(2008-3#1)
extrasolar##3##1##(2008-2#1)(2008-3#2)
extrastriate visual cortex##3##3##(1990-8#1)(2012-2#2)
extrastriate##7##1##(1990-8#3)(2008-11#2)(2012-2#2)
extrasystole##3##1##(1996-3#2)(1996-6#1)
extrasystoles##9##1##(1992-5#1)(1996-3#2)(1996-6#4)(2008-4#1)(2012-1#1)
extraterrestrial solar irradiance##2##3##(2008-2#2)
extraterrestrial##4##1##(1997-5#1)(2008-2#3)
extrathoracic##4##1##(1994-12#1)(2008-11#2)(2008-7#1)
extrathyroidal##2##1##(2012-3#1)(2013-1#1)
extrauterine pregnancy in##2##3##(1996-6#2)
extrauterine pregnancy##3##2##(1994-12#1)(1996-6#2)
extrauterine##7##1##(1992-4#1)(1994-12#2)(1996-6#2)(2009-4#1)(2009-5#1)
extravasated Evans' blue dye concentration in the masseter muscle##2##9##(2008-4#2)
extravasated Evans' blue dye concentration##3##5##(2008-4#3)
extravasated##4##1##(2008-10#1)(2008-4#3)
extravasation and##2##2##(2010-11#1)(2013-1#1)
extravasation into the##2##3##(2008-10#1)(2008-7#1)
extravasation into##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
extravasation of adriamycin##2##3##(2008-6#2)
extravasation of##4##2##(1993-12#1)(1995-12#1)(2008-6#2)
extravasation##15##1##(1992-3#1)(1993-12#1)(1995-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#2)(2010-11#1)(2011-1#1)(2013-1#1)
extravasations##2##1##(2013-1#2)
extravascular lung water##4##3##(1994-8#4)
extravascular##6##1##(1994-8#4)(2008-1#1)(2008-4#1)
extraversion##5##1##(2008-7#1)(2009-8#2)(2011-1#2)
extravesical##3##1##(1993-11#1)(2007-10#1)(2008-1#1)
extravesicular##2##1##(1990-2#1)(1992-6#1)
extrema##4##1##(1993-11#1)(2008-2#1)(2008-3#2)
extreme case##2##2##(2008-10#1)(2010-3#1)
extreme cases##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
extreme conditions##5##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)
extreme developmental phenotypes##2##3##(2011-1#2)
extreme elevation##2##2##(1992-5#1)(2007-7#1)
extreme flexion and##2##3##(2008-8#2)
extreme hardness and insolubility##2##4##(2008-10#2)
extreme heat##3##2##(1996-12#1)(2011-1#1)(2011-2#1)
extreme of##3##2##(1997-3#1)(2008-2#1)(2012-3#1)
extreme outgroups that elicit disgust##2##5##(2008-11#2)
extreme outgroups##3##2##(2008-11#3)
extreme penoscrotal transposition##2##3##(2008-10#2)
extreme phenotype approach##2##3##(2012-3#2)
extreme phenotype##3##2##(2012-3#3)
extreme phenotypes##3##2##(2008-8#3)
extreme phenotypic##2##2##(2008-9#1)(2009-6#1)
extreme positions##2##2##(2007-12#2)
extreme rarity##2##2##(2008-5#1)(2011-2#1)
extreme results##2##2##(1995-12#1)(1997-7#1)
extreme scale-down##2##2##(2013-1#2)
extreme sensitivity to##2##3##(2007-11#1)(2009-6#1)
extreme sensitivity##3##2##(2007-11#1)(2009-6#1)(2010-11#1)
extreme thermal##2##2##(1995-2#1)(2011-2#1)
extreme ultraviolet##15##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#7)
extreme##176##1##(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-6#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#9)(2007-12#4)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#23)(2008-11#6)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#13)(2008-9#5)(2009-11#1)(2009-6#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#4)(2011-1#4)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#5)(2013-7#1)
extreme-UV##4##1##(2008-2#1)(2008-3#3)
extreme-ultraviolet (EUV) lithography##2##3##(2008-3#2)
extreme-ultraviolet (EUV) radiation##2##3##(2008-3#2)
extreme-ultraviolet (EUV)##11##2##(2007-11#2)(2008-3#9)
extreme-ultraviolet and soft-x-ray##2##3##(2008-2#1)(2008-3#1)
extreme-ultraviolet lithography##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
extreme-ultraviolet radiation source based on a##2##6##(2008-3#2)
extreme-ultraviolet wavelength region##2##3##(2007-11#2)
extreme-ultraviolet##49##1##(2007-11#10)(2007-12#1)(2008-2#6)(2008-3#32)
extremely accurate##2##2##(1994-2#1)(2008-3#1)
extremely challenging to##2##3##(2010-11#1)(2010-5#1)
extremely challenging##4##2##(2010-11#1)(2010-2#1)(2010-5#1)(2012-3#1)
extremely common in##3##3##(1990-9#1)(2008-1#1)(2008-5#1)
extremely common##4##2##(1990-9#1)(2008-1#1)(2008-11#1)(2008-5#1)
extremely complex##9##2##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
extremely difficult to##2##3##(1995-6#1)(2012-2#1)
extremely difficult##10##2##(1994-12#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2012-2#1)
extremely diverse##3##2##(2008-10#1)(2009-4#1)(2010-3#1)
extremely effective for##3##3##(2008-11#1)(2009-3#1)(2010-4#1)
extremely effective##5##2##(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-3#1)
extremely efficient##4##2##(1995-2#1)(2007-11#1)(2008-10#2)
extremely expensive##2##2##(1996-2#1)(2008-5#1)
extremely frequent##2##2##(1991-6#1)(1996-6#1)
extremely high concentrations of##2##4##(1997-4#1)(2008-10#1)
extremely high levels of##2##4##(1991-6#1)(2008-7#1)
extremely high peak##2##3##(2008-3#1)(2008-5#1)
extremely high##33##2##(1990-6#1)(1991-5#1)(1991-6#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-4#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-5#1)(2011-3#1)(2012-12#1)
extremely homogeneous##2##2##(1990-3#1)(2012-3#1)
extremely important in##2##3##(2008-8#1)(2011-2#1)
extremely important##14##2##(1992-2#1)(1995-9#2)(1996-6#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)
extremely large##12##2##(1992-8#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#6)(2011-2#1)(2013-1#1)
extremely limited##3##2##(2007-2#1)(2008-1#1)(2010-10#1)
extremely long##4##2##(1992-12#1)(1997-3#1)(2007-12#1)(2008-7#1)
extremely low birth weight infants born at the border of viability##2##11##(2012-2#2)
extremely low birth weight infants##4##5##(1991-6#1)(2008-11#1)(2012-2#2)
extremely low birth weight##7##4##(1991-6#1)(2008-11#4)(2012-2#2)
extremely low concentrations##2##3##(1990-11#1)(2008-6#1)
extremely low frequency electromagnetic fields##4##5##(1992-11#1)(2008-12#2)(2011-2#1)
extremely low frequency of##2##4##(1994-8#1)(2008-5#1)
extremely low frequency##6##3##(1992-11#1)(1994-8#1)(2008-12#2)(2008-5#1)(2011-2#1)
extremely low##35##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-8#1)(1994-8#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-6#2)(2011-2#3)(2012-2#2)
extremely poor##4##2##(2011-2#2)(2012-12#1)(2012-3#1)
extremely premature##2##2##(1996-11#1)(2008-11#1)
extremely promising##2##2##(2008-10#1)(2010-10#1)
extremely rare and##10##3##(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
extremely rare case of a##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
extremely rare case of##5##4##(1990-5#1)(2008-10#1)(2008-8#1)(2013-1#2)
extremely rare complication of##2##4##(2011-1#1)(2013-1#1)
extremely rare complication##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
extremely rare in##8##3##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
extremely rare occurrence##2##3##(2007-7#1)(2012-12#1)
extremely rare tumours##2##3##(2007-8#1)(2013-1#1)
extremely rare##79##2##(1990-5#1)(1991-9#1)(1993-12#1)(1994-9#1)(1995-5#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-12#6)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
extremely robust##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
extremely safe##2##2##(1991-9#1)(1994-5#1)
extremely sensitive to##10##3##(1990-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-3#2)(2009-5#1)(2009-8#1)
extremely sensitive##15##2##(1990-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)
extremely short##7##2##(1994-12#1)(2007-11#1)(2008-2#3)(2011-2#2)
extremely simple##2##2##(2008-2#1)(2008-3#1)
extremely slow##3##2##(1991-5#1)(1995-2#1)(2008-10#1)
extremely small##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
extremely stable##3##2##(2007-11#1)(2008-10#2)
extremely strong##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
extremely susceptible to##2##3##(2008-10#1)(2013-1#1)
extremely thermophilic##4##2##(1990-7#1)(2008-8#2)(2011-2#1)
extremely useful for the##2##4##(1997-2#1)(2008-4#1)
extremely useful for##9##3##(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)
extremely useful in##3##3##(1991-9#1)(2008-12#1)(2010-12#1)
extremely useful##15##2##(1991-5#1)(1991-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2010-12#1)
extremely valuable##4##2##(1994-5#1)(1995-12#1)(2008-11#1)(2012-2#1)
extremely variable##5##2##(1991-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
extremely weak##3##2##(1995-5#1)(2007-11#1)(2008-10#1)
extremely well suited for##2##4##(2008-4#1)(2011-1#1)
extremely well##6##2##(1990-11#1)(1990-12#1)(1994-12#1)(2008-4#1)(2008-8#1)(2011-1#1)
extremely##423##1##(1990-11#4)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#3)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#49)(2008-11#19)(2008-12#11)(2008-2#14)(2008-3#29)(2008-4#8)(2008-5#11)(2008-6#8)(2008-7#12)(2008-8#13)(2008-9#6)(2009-3#4)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#23)(2011-3#3)(2012-1#1)(2012-12#10)(2012-2#12)(2012-3#7)(2013-1#18)(2013-7#1)(2013-8#3)
extremes of the##5##3##(2008-10#1)(2008-5#1)(2008-8#2)(2012-3#1)
extremes of##8##2##(1993-11#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-1#1)(2012-3#1)
extremes were##2##2##(2008-7#1)(2012-2#1)
extremes##23##1##(1993-11#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
extremities and face##3##3##(2009-5#1)(2013-1#2)
extremities and##11##2##(1993-6#1)(2007-12#1)(2007-7#1)(2008-6#2)(2008-7#1)(2009-5#2)(2010-6#1)(2013-1#2)
extremities has been##2##3##(1997-4#1)(2009-3#1)
extremities is##2##2##(2008-7#1)(2010-11#1)
extremities of##4##2##(1992-3#1)(1997-8#1)(2007-7#1)(2010-6#1)
extremities or##3##2##(2008-3#1)(2008-6#2)
extremities were##2##2##(1990-12#1)(1992-6#1)
extremities with##3##2##(2006-10#1)(2008-7#1)(2010-3#1)
extremities##81##1##(1990-12#2)(1990-5#1)(1991-4#1)(1992-3#1)(1992-6#7)(1993-6#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-4#2)(1997-8#4)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#8)(2008-7#5)(2009-10#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-3#3)(2010-6#4)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
extremity CT##2##2##(2008-7#2)
extremity amputations##2##2##(2009-12#1)(2010-3#1)
extremity and##6##2##(1993-9#1)(2008-6#2)(2010-3#1)(2012-2#1)(2013-1#1)
extremity defects##3##2##(2010-6#1)(2011-2#2)
extremity fractures##2##2##(2009-3#1)(2012-2#1)
extremity function##5##2##(1996-3#1)(2007-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
extremity in##3##2##(1992-6#1)(2008-12#1)(2010-9#1)
extremity injuries##4##2##(1992-6#1)(2008-9#1)(2013-1#2)
extremity localized##2##2##(2010-3#2)
extremity musculoskeletal##2##2##(1996-3#1)(2010-9#1)
extremity of the##2##3##(1991-11#1)(2008-7#1)
extremity of##6##2##(1991-11#1)(1993-8#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)
extremity or##2##2##(2008-6#2)
extremity sarcoma##2##2##(2008-6#2)
extremity sarcomas##4##2##(2008-6#3)(2010-3#1)
extremity to##3##2##(2007-10#1)(2011-2#2)
extremity treated with##2##3##(2010-3#1)(2010-8#1)
extremity venous##2##2##(2010-7#1)(2011-2#1)
extremity was##2##2##(2007-11#1)(2008-12#1)
extremity weakness##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
extremity were##2##2##(2008-6#1)(2010-3#1)
extremity##134##1##(1990-12#1)(1991-11#1)(1991-12#1)(1992-6#3)(1993-8#1)(1993-9#1)(1995-8#1)(1996-3#4)(2007-10#3)(2007-11#7)(2007-7#2)(2008-12#8)(2008-3#1)(2008-6#20)(2008-7#6)(2008-8#4)(2008-9#6)(2009-1#2)(2009-10#1)(2009-12#1)(2009-3#4)(2009-5#1)(2009-8#1)(2010-3#10)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#18)(2012-2#8)(2012-3#3)(2013-1#9)
extrinsic and##2##2##(2008-5#1)(2010-10#1)
extrinsic apoptotic pathway##2##3##(2009-9#1)(2011-2#1)
extrinsic apoptotic##3##2##(2009-9#1)(2010-3#1)(2011-2#1)
extrinsic compression##2##2##(2008-1#1)(2010-12#1)
extrinsic factors##8##2##(1990-6#1)(1996-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)
extrinsic noise##2##2##(2008-2#1)(2010-10#1)
extrinsic photoconductors##3##2##(2008-3#3)
extrinsic polypeptides in PSII particles##3##5##(2008-4#3)
extrinsic polypeptides##6##2##(1990-5#1)(2008-4#5)
extrinsic religiosity and##2##3##(2009-7#2)
extrinsic skin##2##2##(2008-5#1)(2011-2#1)
extrinsic surface##2##2##(2008-6#1)(2009-11#1)
extrinsic work values##4##3##(2010-10#4)
extrinsic work##5##2##(1996-1#1)(2010-10#4)
extrinsic##68##1##(1990-5#2)(1990-6#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#9)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#8)(2012-1#2)(2013-1#2)
extruded##7##1##(1991-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#2)
extrudes##3##1##(2008-11#1)(2008-5#2)
extrusion and heat treatment##2##4##(2012-2#2)
extrusion of##4##2##(1996-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
extrusion processes##3##2##(2008-10#3)
extrusion##28##1##(1990-11#1)(1990-2#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
extubated##4##1##(1990-2#1)(2007-9#1)(2012-2#2)
extubation after##2##2##(2007-8#2)
extubation and##3##2##(2006-10#1)(2007-8#1)(2010-7#1)
extubation was##2##2##(2007-8#2)
extubation##18##1##(1993-1#1)(1995-5#1)(1996-12#1)(2006-10#2)(2007-11#1)(2007-8#7)(2007-9#1)(2010-10#1)(2010-7#1)(2012-3#1)(2013-1#1)
exuberant##3##1##(2007-7#1)(2008-12#1)(2011-2#1)
exudate in##2##2##(1997-8#1)(2008-1#1)
exudate##7##1##(1991-12#1)(1992-5#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)
exudates and##2##2##(1994-12#1)(2010-4#1)
exudates from##10##2##(2007-10#1)(2008-10#9)
exudates on##3##2##(2008-10#3)
exudates were##2##2##(2008-10#1)(2012-8#1)
exudates##30##1##(1991-8#1)(1994-12#1)(2007-10#1)(2008-10#21)(2008-6#2)(2010-4#1)(2010-8#2)(2012-8#1)
exudation in##2##2##(1997-3#1)(2008-10#1)
exudation##5##1##(1997-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
exudative type##2##2##(2008-1#1)(2011-2#1)
exudative##9##1##(2008-1#1)(2008-11#1)(2010-9#1)(2011-2#3)(2013-1#1)(2013-8#2)
exuded##2##1##(2009-8#2)
eye and##15##2##(1994-3#1)(1995-3#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-4#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
eye bank##2##2##(2010-10#1)(2011-2#1)
eye care products##2##3##(1992-11#2)
eye care##7##2##(1992-11#2)(2011-2#1)(2011-7#2)(2012-12#2)
eye centers##2##2##(2008-11#2)
eye colour pattern##2##3##(2010-8#2)
eye contact with##2##3##(2008-11#1)(2011-2#1)
eye contact##5##2##(2008-11#2)(2008-6#2)(2011-2#1)
eye disease##8##2##(2008-2#1)(2008-7#4)(2010-8#1)(2011-7#1)(2012-12#1)
eye drop##3##2##(2008-10#1)(2008-7#2)
eye drops##8##2##(1990-11#1)(1994-2#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#2)
eye field##8##2##(2007-12#8)
eye fixation##2##2##(2008-2#1)(2013-1#1)
eye focusing##2##2##(2010-8#2)
eye for##3##2##(2011-1#1)(2013-7#1)(2013-8#1)
eye from##2##2##(2007-12#1)(2008-7#1)
eye gaze##7##2##(2007-4#1)(2008-11#4)(2008-6#1)(2012-12#1)
eye has##2##2##(2008-3#1)(2013-8#1)
eye in the##3##3##(1992-10#1)(2008-3#1)(2010-8#1)
eye in##8##2##(1992-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)
eye is##6##2##(2007-11#1)(2007-12#3)(2008-11#1)(2008-3#1)
eye lens##6##2##(1993-2#2)(2008-2#1)(2008-3#2)(2011-1#1)
eye lid and##2##3##(2007-7#1)(2011-1#1)
eye lid##3##2##(2007-7#2)(2011-1#1)
eye make-up##3##2##(2008-5#3)
eye movement amplitude##2##3##(2008-7#2)
eye movement##9##2##(1990-7#1)(1991-5#1)(1991-9#1)(2008-11#1)(2008-7#4)(2013-8#1)
eye movements and##2##3##(2010-5#1)(2013-8#1)
eye movements in##2##3##(2008-7#1)(2009-2#1)
eye movements were analyzed in five subjects with Parkinson's disease (PD) and five age-matched controls##2##15##(2008-7#2)
eye movements were##5##3##(1991-5#1)(2008-7#4)
eye movements##16##2##(1991-5#3)(1992-8#1)(2008-3#1)(2008-7#7)(2009-2#2)(2010-5#1)(2013-8#1)
eye of the##5##3##(1992-9#1)(1994-2#1)(2007-12#1)(2009-7#1)(2011-2#1)
eye of##7##2##(1992-9#1)(1994-2#1)(1994-3#1)(2007-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
eye opening##5##2##(2007-10#3)(2008-7#2)
eye protection##2##2##(1990-9#1)(2009-5#1)
eye region##2##2##(2007-12#1)(2010-1#1)
eye surgery##2##2##(1991-11#1)(2008-11#1)
eye view##3##2##(1993-9#1)(2013-1#2)
eye were##3##2##(2007-11#1)(2008-11#1)(2009-5#1)
eye with##3##2##(2008-7#1)(2010-10#1)(2011-2#1)
eye##351##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#1)(1990-9#2)(1991-11#1)(1991-5#5)(1991-9#1)(1992-10#3)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-2#5)(1994-3#3)(1994-8#3)(1995-12#1)(1995-3#1)(1995-9#3)(1996-12#1)(1996-3#1)(1997-2#4)(1997-3#1)(2006-10#2)(2007-10#3)(2007-11#5)(2007-12#36)(2007-4#1)(2007-7#4)(2007-9#1)(2008-10#12)(2008-11#18)(2008-12#2)(2008-2#13)(2008-3#15)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#28)(2008-9#7)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-1#9)(2010-10#7)(2010-11#1)(2010-2#2)(2010-5#4)(2010-8#9)(2010-9#1)(2011-1#13)(2011-2#29)(2011-3#2)(2011-7#7)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#14)(2013-7#5)(2013-8#8)
eye's##3##1##(2007-11#1)(2007-12#2)
eye-gaze##3##1##(2008-6#1)(2009-10#1)(2009-9#1)
eye-safe##6##1##(2007-11#1)(2008-2#1)(2008-3#4)
eye-tracking assessments of RJA##3##4##(2013-1#3)
eye-tracking##7##1##(2013-1#6)(2013-8#1)
eyeball was##2##2##(2008-2#1)(2009-2#1)
eyeball##6##1##(2008-2#1)(2008-6#1)(2009-2#3)(2010-11#1)
eyeballs##3##1##(1992-8#1)(2009-2#1)(2011-1#1)
eyeblink##2##1##(1994-3#2)
eyeblinks##3##1##(1992-8#3)
eyebrow raises##4##2##(2010-3#4)
eyebrow##7##1##(2010-3#5)(2012-12#2)
eyebrows##3##1##(1995-6#1)(2008-7#1)(2010-3#1)
eyedrops##2##1##(1990-9#1)(1994-2#1)
eyelid and##3##2##(2008-5#2)(2010-8#1)
eyelid crease##3##2##(2010-8#3)
eyelid eversion##2##2##(2011-1#2)
eyelid of##2##2##(1994-8#1)(2010-8#1)
eyelid##28##1##(1992-12#1)(1994-8#1)(2007-10#1)(2008-5#6)(2010-8#14)(2011-1#4)(2011-2#1)
eyelids##4##1##(2006-10#1)(2007-10#1)(2010-6#1)(2011-1#1)
eyepiece##3##1##(2008-3#3)
eyes and##11##2##(1992-6#1)(1995-11#1)(1996-12#1)(2007-10#1)(2008-11#1)(2008-5#2)(2009-10#1)(2010-8#1)(2013-1#2)
eyes are##3##2##(1994-3#1)(2008-5#1)(2010-8#1)
eyes at##2##2##(2008-7#1)(2013-1#1)
eyes closed##3##2##(1996-5#1)(2008-7#2)
eyes from##2##2##(2007-12#1)(2011-1#1)
eyes in##4##2##(1993-3#1)(2008-2#1)(2008-5#1)(2008-7#1)
eyes is##2##2##(2008-5#1)(2011-7#1)
eyes of the##3##3##(2008-1#1)(2009-7#1)(2013-1#1)
eyes of##19##2##(1992-6#1)(1994-3#1)(1995-9#1)(2007-12#2)(2008-1#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#5)(2013-8#1)
eyes suffering from##2##3##(2013-1#2)
eyes was##2##2##(2008-10#1)(2012-2#1)
eyes were##4##2##(1993-3#1)(2008-5#2)(2013-1#1)
eyes with##2##2##(1991-2#1)(2013-1#1)
eyes##131##1##(1990-11#1)(1990-12#2)(1991-2#1)(1991-3#1)(1992-6#6)(1993-12#1)(1993-3#3)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#7)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#14)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#17)(2013-7#1)(2013-8#4)
eyes) and##2##2##(1990-12#1)(2007-12#1)
eyes)##9##1##(1990-12#2)(2007-12#1)(2011-2#4)(2013-1#2)
eyes-closed##3##1##(1995-5#1)(2013-8#2)
eyes-open##2##1##(2013-8#2)
eyespot of##2##2##(2008-10#1)(2012-3#1)
eyespot resistance##2##2##(2008-10#2)
eyespot that##2##2##(2009-10#1)(2012-3#1)
eyespot##24##1##(2008-10#10)(2008-9#1)(2009-10#2)(2012-2#5)(2012-3#6)
eyespots##10##1##(2008-9#7)(2012-2#2)(2012-3#1)
eyestalk ganglia of the blue crab##2##6##(1994-11#1)(2007-12#1)
eyestalk ganglia##3##2##(1994-11#1)(2007-12#2)
eyestalk posture##4##2##(2008-5#4)
eyestalk##12##1##(1994-11#2)(2007-12#4)(2008-5#6)
ezetimibe and low-dose##3##3##(2011-2#3)
ezetimibe and##4##2##(2011-2#3)(2013-1#1)
ezetimibe##10##1##(2011-2#4)(2012-2#3)(2013-1#3)
ezrin##4##1##(1995-3#1)(2010-3#3)
f numbers##2##2##(2008-3#2)
f##381##1##(1990-12#2)(1992-6#4)(1993-2#1)(1994-5#1)(1995-12#1)(1997-3#2)(1997-6#4)(2007-11#2)(2007-12#7)(2007-2#3)(2008-10#337)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
f(2)##2##1##(2008-3#1)(2010-8#1)
f(C)##3##1##(2008-11#3)
f(a)##3##1##(2008-2#3)
f(c) is##2##2##(2008-3#2)
f(c)##4##1##(2008-2#1)(2008-3#3)
f(e)##2##1##(1997-7#2)
f(r)##2##1##(2008-2#1)(2008-3#1)
f(s)##2##1##(2008-3#2)
f(t)##2##1##(1997-7#2)
f(v) levels##2##2##(2008-2#2)
f(v)##6##1##(2008-2#5)(2008-3#1)
f-IMRT and dual-arc RapidArc were##2##5##(2013-1#2)
f-IMRT##4##1##(2013-1#4)
f-element##2##1##(2010-5#2)
f-number##3##1##(2008-3#2)(2009-5#1)
f/1##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
f/10 port##2##2##(2008-2#2)
f1##4##1##(2009-10#4)
fLA-MC-ICPMS##2##1##(2013-8#2)
fLCI##2##1##(2011-1#2)
fLumo##3##1##(2013-1#3)
fMLP##9##1##(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#3)(2008-10#1)(2008-4#2)
fMLP-induced##5##1##(1995-6#2)(1996-2#1)(2008-4#2)
fMLP-stimulated##3##1##(1995-6#1)(2008-4#2)
fMRI and##2##2##(2008-5#1)(2009-9#1)
fMRI data##6##2##(2008-11#5)(2009-6#1)
fMRI investigation##2##2##(2008-11#1)(2013-8#1)
fMRI of##2##2##(1995-12#1)(2009-9#1)
fMRI scanner##2##2##(2008-11#1)(2012-2#1)
fMRI studies##2##2##(2008-11#1)(2012-1#1)
fMRI study##6##2##(2008-1#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
fMRI to##2##2##(1995-12#1)(2008-11#1)
fMRI##50##1##(1995-12#3)(1996-2#2)(2008-1#2)(2008-11#15)(2008-5#2)(2009-2#1)(2009-6#3)(2009-8#1)(2009-9#7)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#6)
fRBCs##4##1##(2011-2#4)
fabA##4##1##(1992-8#4)
faba bean (Vicia faba)##3##4##(2008-10#2)(2009-8#1)
faba bean##13##2##(2008-10#11)(2008-12#1)(2009-8#1)
faba##32##1##(2008-10#16)(2008-12#5)(2008-8#6)(2009-8#4)(2012-2#1)
fabae##10##1##(2008-10#6)(2009-8#4)
fabella##4##1##(2011-2#4)
fabric and##2##2##(2008-11#1)(2008-6#1)
fabric in##2##2##(2008-7#2)
fabric##21##1##(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#3)
fabricate a new##2##3##(2007-11#1)(2008-10#1)
fabricate a##7##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-11#1)(2011-1#1)
fabricate an##2##2##(2008-3#2)
fabricate the##7##2##(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2013-1#1)
fabricate##49##1##(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#10)(2008-12#2)(2008-2#6)(2008-3#8)(2008-7#3)(2008-8#3)(2009-11#4)(2010-12#1)(2011-1#1)(2013-1#2)
fabricated a compact##2##3##(2007-11#1)(2008-2#1)
fabricated a##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2012-2#1)
fabricated and characterized##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
fabricated and tested##3##3##(2007-11#1)(2008-2#1)(2009-7#1)
fabricated and##16##2##(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#5)(2009-7#1)
fabricated as##4##2##(2008-10#2)(2008-3#2)
fabricated at the end of##2##5##(2008-10#2)
fabricated at the##3##3##(2008-10#2)(2008-2#1)
fabricated by a combination of##2##5##(2007-11#1)(2008-3#1)
fabricated by a##7##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-4#1)
fabricated by direct##2##3##(2008-2#1)(2008-3#1)
fabricated by electron-beam lithography##2##4##(2008-2#1)(2008-3#1)
fabricated by electron-beam##3##3##(2008-2#1)(2008-3#2)
fabricated by layer-by-layer##3##3##(2008-10#2)(2009-11#1)
fabricated by means of##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
fabricated by the##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
fabricated by use of##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
fabricated by using##2##3##(2008-10#1)(2013-8#1)
fabricated by##75##2##(1992-11#1)(1994-2#1)(2007-11#7)(2007-12#8)(2007-8#1)(2008-10#16)(2008-2#7)(2008-3#24)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-1#1)(2013-1#2)(2013-8#2)
fabricated device##2##2##(2007-11#1)(2008-2#1)
fabricated for the##2##3##(2008-10#1)(2013-1#1)
fabricated for##8##2##(2007-12#1)(2008-10#1)(2008-3#2)(2009-11#2)(2010-12#1)(2013-1#1)
fabricated from Gwent##2##3##(2008-10#2)
fabricated from a##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
fabricated from fluorinated polyimides##3##4##(2008-2#3)
fabricated from glass##2##3##(2009-7#2)
fabricated from##19##2##(2007-11#3)(2008-10#6)(2008-2#4)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#2)(2010-4#1)
fabricated in a##2##3##(2008-3#2)
fabricated in gallium phosphide by##2##5##(2008-3#2)
fabricated in lithium##2##3##(2007-12#1)(2008-3#1)
fabricated in##22##2##(1995-11#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#11)(2008-7#1)(2009-12#1)
fabricated on a##5##3##(2008-10#2)(2008-2#3)
fabricated on an##2##3##(2008-10#1)(2008-3#1)
fabricated on both##2##3##(2008-2#1)(2008-7#1)
fabricated on##16##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#4)(2008-7#2)
fabricated the##3##2##(2008-2#1)(2008-3#2)
fabricated to##8##2##(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2010-2#1)(2012-1#1)
fabricated upon##3##2##(2007-12#2)(2008-3#1)
fabricated using a##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
fabricated using the##2##3##(2008-10#1)(2009-11#1)
fabricated using##11##2##(2008-10#3)(2008-12#1)(2008-7#4)(2009-11#2)(2012-2#1)
fabricated with a##5##3##(2007-11#1)(2008-3#4)
fabricated with the##2##3##(2008-3#2)
fabricated with##21##2##(2007-11#2)(2007-12#2)(2008-2#6)(2008-3#9)(2008-5#1)(2010-4#1)
fabricated without##2##2##(2007-11#1)(2008-10#1)
fabricated##310##1##(1992-11#1)(1994-2#1)(1995-11#1)(2007-11#26)(2007-12#31)(2007-8#1)(2008-10#58)(2008-11#1)(2008-12#3)(2008-2#47)(2008-3#93)(2008-5#1)(2008-7#9)(2008-8#1)(2009-11#6)(2009-12#2)(2009-5#3)(2009-6#1)(2009-7#4)(2010-12#2)(2010-2#2)(2010-4#4)(2012-1#2)(2012-2#2)(2013-1#6)(2013-8#2)
fabricating a##4##2##(2007-12#1)(2008-3#2)(2013-1#1)
fabricating##25##1##(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#7)(2009-11#2)(2010-8#1)(2012-2#2)(2013-1#1)
fabrication and assembly##2##3##(2008-3#2)
fabrication and characterization of##6##4##(2007-11#1)(2007-12#2)(2008-12#1)(2008-2#1)(2009-9#1)
fabrication and characterization##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2009-9#1)
fabrication and##26##2##(2007-11#1)(2007-12#4)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
fabrication as well as##2##4##(2008-10#1)(2008-7#1)
fabrication by##2##2##(2008-10#1)(2010-9#1)
fabrication errors and##3##3##(2008-2#1)(2008-3#2)
fabrication errors##8##2##(2007-11#1)(2008-2#4)(2008-3#3)
fabrication is##4##2##(2007-11#1)(2008-3#3)
fabrication method is##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
fabrication method##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#2)
fabrication methods##2##2##(2008-10#2)
fabrication of a##15##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
fabrication of continuous##2##3##(2007-11#2)
fabrication of diffractive optical elements##3##5##(2008-2#1)(2008-3#2)
fabrication of diffractive##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
fabrication of fiber##2##3##(2007-11#1)(2007-12#1)
fabrication of films##2##3##(2008-12#2)
fabrication of optical##2##3##(2007-12#1)(2008-2#1)
fabrication of the##3##3##(2008-10#1)(2008-3#2)
fabrication of thin-film##2##3##(2008-10#1)(2008-3#1)
fabrication of##90##2##(2007-11#12)(2007-12#7)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#9)(2008-3#19)(2008-4#1)(2008-7#7)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#2)
fabrication procedure##2##2##(2008-10#1)(2008-2#1)
fabrication procedures##2##2##(2008-2#1)(2008-3#1)
fabrication process was##2##3##(2007-11#1)(2008-3#1)
fabrication process##12##2##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2010-9#1)(2012-1#1)
fabrication processes##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2012-2#1)
fabrication technique of##3##3##(2008-2#3)
fabrication technique##7##2##(2008-2#5)(2008-3#1)(2009-5#1)
fabrication techniques##5##2##(2007-11#1)(2008-2#2)(2009-9#1)(2010-9#1)
fabrication##236##1##(2007-11#22)(2007-12#14)(2008-10#38)(2008-11#2)(2008-12#6)(2008-2#35)(2008-3#64)(2008-4#3)(2008-5#2)(2008-7#11)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#3)(2009-7#2)(2009-9#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#6)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#2)
fabriciella##7##1##(2013-8#7)
fabrics##14##1##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2010-4#1)(2010-5#1)(2012-3#1)
fabry-perot interferometer##5##2##(2008-2#1)(2008-3#4)
fabry-perot##6##1##(2008-2#1)(2008-3#5)
fac-Re(CO)(3)(dpknph)Cl in##4##2##(2008-10#4)
fac-Re(CO)(3)(dpknph)Cl##17##1##(2008-10#17)
facades##4##1##(2008-2#2)(2008-3#2)
face SC##2##2##(2008-5#2)
face a dilemma##2##3##(1994-1#1)(2008-11#1)
face a##6##2##(1992-3#1)(1994-1#1)(1995-1#1)(2008-11#1)(2013-1#2)
face an##2##2##(1994-12#1)(1996-2#1)
face and name associations##2##4##(2012-1#2)
face and name##4##3##(2012-1#4)
face and voice##4##3##(2009-10#1)(2012-1#3)
face and##25##2##(1991-11#1)(1996-11#1)(1996-3#1)(2008-5#5)(2008-7#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-1#7)
face as##2##2##(1996-1#1)(2008-11#1)
face care system##2##3##(2008-5#2)
face care##4##2##(2008-5#4)
face challenges in##3##3##(1995-3#1)(1997-3#1)(2007-3#1)
face challenges##4##2##(1995-3#1)(1997-3#1)(2007-3#1)(2008-7#1)
face cue##3##2##(2008-2#3)
face expression##3##2##(2009-10#3)
face fitting##2##2##(2010-4#2)
face for##3##2##(1997-3#1)(2008-5#1)(2010-3#1)
face images##2##2##(1995-6#1)(2008-11#1)
face in##9##2##(1994-2#1)(1996-7#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#2)
face increased##2##2##(2008-10#1)(2011-2#1)
face is##3##2##(2008-3#1)(2008-5#1)(2010-1#1)
face it##2##2##(1994-12#1)(1995-5#1)
face major##2##2##(2008-10#1)(2008-6#1)
face many##3##2##(2009-10#1)(2010-3#1)(2011-2#1)
face mask treatment##2##3##(2009-7#2)
face mask##5##2##(2007-8#1)(2009-7#4)
face membrane##2##2##(1990-2#2)
face numerous##2##2##(1991-2#1)(2012-2#1)
face of a##2##3##(2009-7#1)(2012-12#1)
face of the##14##3##(1992-12#1)(1992-3#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#2)(2013-1#1)
face of##53##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#2)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#6)(2012-12#3)(2013-1#1)
face or##2##2##(2009-10#1)(2013-8#1)
face perception##4##2##(2008-11#2)(2012-1#2)
face processing##3##2##(2008-1#2)(2008-11#1)
face prolonged##2##2##(2012-2#1)(2013-1#1)
face recognition##3##2##(2007-8#1)(2008-3#1)(2008-7#1)
face representation##3##2##(1996-5#3)
face the challenge of##2##4##(1997-3#1)(2008-1#1)
face the challenge##3##3##(1994-2#1)(1997-3#1)(2008-1#1)
face the##16##2##(1990-6#1)(1994-1#1)(1994-2#2)(1995-3#1)(1997-3#1)(1997-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-11#1)(2011-1#1)(2013-1#1)
face to face##3##3##(1996-11#1)(2008-10#1)(2013-8#1)
face to##5##2##(1996-11#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
face unprecedented##2##2##(1997-1#1)(2008-11#1)
face validity##3##2##(1996-2#1)(2008-7#2)
face when attempting to##3##4##(2008-4#3)
face when##4##2##(2008-4#3)(2013-1#1)
face with the##2##3##(2010-8#1)(2012-3#1)
face with##7##2##(2008-10#1)(2008-6#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
face##353##1##(1990-11#1)(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#3)(1992-3#3)(1993-1#3)(1993-11#1)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#4)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#4)(1995-5#1)(1995-6#6)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-5#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#5)(2008-10#10)(2008-11#20)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#23)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#1)(2009-10#10)(2009-11#1)(2009-12#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#2)(2010-1#6)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-6#5)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#18)(2012-1#11)(2012-12#12)(2012-2#4)(2012-3#6)(2013-1#23)(2013-7#3)(2013-8#5)
face)##4##1##(2008-11#2)(2008-2#1)(2012-3#1)
face-selective neurons##2##2##(2009-10#2)
face-selective##3##1##(2007-8#1)(2009-10#2)
face-specific hypothesis##2##2##(2008-11#2)
face-specific##3##1##(2008-11#3)
face-to-face interview##2##2##(2011-1#1)(2013-1#1)
face-to-face interviews with##2##3##(2009-5#1)(2012-1#1)
face-to-face interviews##5##2##(2009-5#2)(2010-10#1)(2012-1#1)(2013-8#1)
face-to-face##19##1##(1991-1#1)(1996-5#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#2)(2010-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
faced by the National##2##4##(1997-3#1)(2008-11#1)
faced by the##8##3##(1997-3#1)(2007-11#1)(2008-11#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
faced by##33##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
faced during##2##2##(2008-10#1)(2012-2#1)
faced in the##2##3##(2007-5#1)(2013-1#1)
faced in##4##2##(2007-5#1)(2008-11#1)(2010-1#1)(2013-1#1)
faced the challenge of##2##4##(2009-10#1)(2012-3#1)
faced the##6##2##(2008-2#1)(2008-8#1)(2009-10#2)(2012-3#1)(2013-1#1)
faced with a##6##3##(1990-11#1)(1995-3#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
faced with an##2##3##(2008-11#1)(2012-2#1)
faced with many##2##3##(2010-5#1)(2012-12#1)
faced with the challenge of##5##5##(1991-12#1)(1996-1#1)(2008-12#1)(2010-5#1)(2012-2#1)
faced with the question of##2##5##(1996-12#1)(1997-1#1)
faced with the##14##3##(1991-12#1)(1992-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
faced with##40##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
faced##95##1##(1990-11#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#2)(2009-3#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
faces a##2##2##(2008-12#1)(2008-7#1)
faces and voices##3##3##(2012-1#3)
faces and##9##2##(2007-8#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-1#5)
faces are##6##2##(1993-2#1)(2007-8#1)(2008-1#2)(2008-3#1)(2012-12#1)
faces by##2##2##(1996-3#1)(2008-11#1)
faces challenges##2##2##(2009-7#1)(2011-2#1)
faces high##2##2##(1995-3#1)(2012-12#1)
faces in the##4##3##(1991-12#1)(2009-4#1)(2010-4#1)(2011-2#1)
faces in##5##2##(1991-12#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
faces of the##4##3##(2008-2#2)(2008-3#1)(2008-7#1)
faces of##11##2##(1992-9#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#2)
faces than##2##2##(2007-8#1)(2008-11#1)
faces that consistently looked##2##4##(2010-10#2)
faces that##4##2##(2008-11#1)(2010-10#3)
faces the##2##2##(1992-3#1)(2012-3#1)
faces were presented##2##3##(2008-11#1)(2009-9#1)
faces with##3##2##(2008-11#1)(2008-5#2)
faces##119##1##(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#11)(2008-1#9)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#7)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#5)(2009-10#3)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#7)(2010-11#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-1#5)(2012-12#5)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
facet joint angle##2##3##(2012-12#2)
facet joint##7##2##(1996-9#1)(2011-2#2)(2012-12#3)(2012-3#1)
facet joints##6##2##(1996-9#2)(2009-3#1)(2011-2#1)(2013-8#2)
facet modal reflectivity##3##3##(2008-3#3)
facet model##2##2##(2008-3#2)
facet of##3##2##(1992-9#1)(2008-3#1)(2008-5#1)
facet reflectivities##2##2##(2008-3#2)
facet reflectivity##2##2##(2008-3#2)
facet##40##1##(1992-9#1)(1996-9#4)(2007-11#2)(2007-12#4)(2008-3#16)(2008-5#1)(2009-10#1)(2009-3#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
facets of the##4##3##(1991-2#1)(2007-12#1)(2008-2#1)(2008-4#1)
facets of##16##2##(1991-2#1)(1992-2#1)(1993-5#1)(1994-12#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
facets##33##1##(1991-2#1)(1992-2#1)(1993-5#1)(1994-12#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
facial aging##2##2##(2008-7#2)
facial analysis##2##2##(2012-12#2)
facial and hand abnormalities##2##4##(1997-3#2)
facial and oral##2##3##(1997-3#1)(2007-12#1)
facial and##5##2##(1997-3#4)(2007-12#1)
facial appearance##2##2##(1996-3#1)(2008-5#1)
facial approximation##2##2##(2009-2#2)
facial asymmetry##2##2##(2007-12#1)(2012-12#1)
facial attractiveness##2##2##(2008-5#2)
facial attributes##4##2##(2008-5#4)
facial bones##2##2##(2009-1#1)(2011-2#1)
facial components##4##2##(1995-6#4)
facial cosmetic##3##2##(2007-12#1)(2008-5#1)(2012-12#1)
facial expression##12##2##(1996-2#1)(2008-11#7)(2008-2#1)(2008-6#2)(2013-8#1)
facial expressions in##2##3##(2008-1#1)(2008-11#1)
facial expressions of emotion##2##4##(2008-11#2)
facial expressions##28##2##(1990-3#1)(2007-8#2)(2008-1#4)(2008-11#13)(2008-6#1)(2009-4#3)(2009-8#2)(2012-2#1)(2013-8#1)
facial feature##2##2##(2012-12#2)
facial features##6##2##(2007-8#1)(2008-1#1)(2011-1#2)(2012-12#1)(2012-2#1)
facial image##3##2##(1995-6#2)(2010-3#1)
facial injuries##3##2##(2010-1#3)
facial model##2##2##(2008-6#2)
facial morphology and##2##3##(2010-8#2)
facial morphology##4##2##(2009-8#1)(2010-8#3)
facial motion##4##2##(2007-8#4)
facial movement##2##2##(2010-3#2)
facial nerve activity##3##3##(1997-6#3)
facial nerve branches##2##3##(2011-2#2)
facial nerve cross-stimulation##2##3##(2008-9#2)
facial nerve palsy##7##3##(2007-8#3)(2011-2#3)(2013-8#1)
facial nerve paralysis##2##3##(2008-9#1)(2011-2#1)
facial nerve stimulation and##2##4##(2008-9#2)
facial nerve stimulation##5##3##(2008-9#5)
facial nerve##40##2##(1997-6#5)(2006-12#3)(2007-8#3)(2008-12#3)(2008-7#3)(2008-9#11)(2011-2#10)(2012-3#1)(2013-8#1)
facial nerves##3##2##(2011-2#2)(2012-3#1)
facial pain and##2##3##(2008-7#1)(2011-2#1)
facial pain patients##4##3##(1993-1#4)
facial pain##10##2##(1993-1#6)(2008-7#1)(2011-2#2)(2012-12#1)
facial palsy##7##2##(1996-8#1)(2006-12#2)(2007-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
facial paralysis##3##2##(1991-6#1)(2007-10#1)(2011-2#1)
facial preferences##2##2##(2012-12#2)
facial profile##2##2##(2008-7#1)(2013-1#1)
facial puffiness##2##2##(2010-5#1)(2012-2#1)
facial reconstruction##4##2##(1995-6#3)(2007-12#1)
facial rejuvenation##2##2##(2008-7#2)
facial selectivity##3##2##(1996-5#2)(2009-9#1)
facial skeleton is##2##3##(2007-12#1)(2011-2#1)
facial skeleton##7##2##(1992-4#1)(2007-12#3)(2011-2#1)(2012-3#2)
facial skin cancer##2##3##(2007-12#2)
facial skin##15##2##(1994-9#1)(1997-2#1)(2007-12#3)(2008-5#9)(2008-6#1)
facial stimuli##2##2##(2008-2#2)
facial structures##2##2##(2008-6#2)
facial tonic##2##2##(2008-5#2)
facial wrinkles##3##2##(2008-5#3)
facial##292##1##(1990-11#1)(1990-3#1)(1991-6#2)(1992-4#1)(1993-1#6)(1994-9#2)(1995-6#14)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#7)(1997-5#1)(1997-6#5)(1997-8#1)(2006-12#5)(2007-10#2)(2007-12#13)(2007-7#1)(2007-8#12)(2008-1#6)(2008-11#22)(2008-12#6)(2008-2#3)(2008-5#36)(2008-6#14)(2008-7#13)(2008-9#15)(2009-1#1)(2009-2#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#6)(2011-1#2)(2011-2#24)(2012-12#11)(2012-2#3)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#4)
facies##2##1##(2007-8#1)(2011-1#1)
facile approach for##2##3##(2008-12#1)(2008-2#1)
facile approach##3##2##(2008-12#1)(2008-2#1)(2009-9#1)
facile conversion to the##2##4##(1995-3#1)(1996-5#1)
facile route##2##2##(2008-10#1)(2010-2#1)
facile synthesis##3##2##(2007-11#1)(2012-2#1)(2012-3#1)
facile##38##1##(1990-5#1)(1991-12#2)(1994-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#2)
facilitate a##12##2##(1992-8#1)(2007-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
facilitate accurate##2##2##(2008-7#1)(2010-9#1)
facilitate an##4##2##(1993-2#1)(1994-12#1)(2007-12#1)(2011-1#1)
facilitate and##5##2##(1992-2#1)(1995-3#1)(2008-12#1)(2010-4#1)(2010-8#1)
facilitate better##2##2##(1996-9#1)(2011-2#1)
facilitate critical##2##2##(1991-12#1)(2008-11#1)
facilitate early##2##2##(2010-6#1)(2011-2#1)
facilitate effective##3##2##(1992-3#1)(2008-11#2)
facilitate further##5##2##(1995-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#1)
facilitate future##2##2##(1995-8#1)(2008-5#1)
facilitate genetic##2##2##(2008-10#2)
facilitate identification of##3##3##(1997-7#1)(2008-10#1)(2008-6#1)
facilitate investigations##2##2##(2008-3#1)(2010-6#1)
facilitate its##6##2##(2008-10#2)(2008-4#1)(2008-7#2)(2013-8#1)
facilitate management of##2##3##(1992-3#1)(2008-10#1)
facilitate maximum##2##2##(1994-12#1)(2013-1#1)
facilitate molecular##2##2##(2008-10#1)(2008-9#1)
facilitate or##3##2##(2008-9#1)(2009-5#1)(2013-8#1)
facilitate physical##2##2##(2008-7#1)(2012-2#1)
facilitate positive##2##2##(2008-12#1)(2008-5#1)
facilitate readability##2##2##(2007-5#2)
facilitate research##2##2##(2008-6#1)(2009-11#1)
facilitate screening##2##2##(1993-12#1)(2013-1#1)
facilitate studies##2##2##(2008-10#1)(2012-3#1)
facilitate successful##2##2##(1995-2#1)(2011-1#1)
facilitate the coexistence of different species##2##6##(2008-10#1)(2008-8#1)
facilitate the construction of##2##4##(1994-12#1)(1996-8#1)
facilitate the creation of##2##4##(1993-6#1)(2008-10#1)
facilitate the creation##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
facilitate the design of##2##4##(1994-8#1)(2011-2#1)
facilitate the design##3##3##(1994-8#1)(1995-6#1)(2011-2#1)
facilitate the development of more##2##5##(1996-9#1)(2008-1#1)
facilitate the development of new##3##5##(1992-1#1)(2008-11#1)(2008-7#1)
facilitate the development of novel##2##5##(2009-4#1)(2013-1#1)
facilitate the development of##20##4##(1992-1#1)(1993-12#1)(1994-6#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#3)(2009-4#1)(2010-3#1)(2011-2#1)(2013-1#1)
facilitate the development##21##3##(1992-1#1)(1993-12#1)(1994-6#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#3)(2009-4#1)(2010-3#2)(2011-2#1)(2013-1#1)
facilitate the diagnosis and##2##4##(2008-12#1)(2012-3#1)
facilitate the diagnosis##4##3##(2008-12#1)(2009-10#1)(2012-3#1)(2013-7#1)
facilitate the diagnostic##2##3##(1997-4#1)(2013-7#1)
facilitate the dispersal of##2##4##(2008-10#1)(2012-3#1)
facilitate the evolution of##2##4##(1996-6#1)(2008-8#1)
facilitate the further understanding of the##2##6##(1991-12#1)(2008-10#1)
facilitate the growth##3##3##(1994-1#1)(1996-3#1)(2008-4#1)
facilitate the identification of##3##4##(1993-3#1)(2008-10#1)(2009-6#1)
facilitate the identification##4##3##(1990-7#1)(1993-3#1)(2008-10#1)(2009-6#1)
facilitate the implementation of##3##4##(1994-12#1)(1996-3#1)(1997-2#1)
facilitate the implementation##4##3##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)
facilitate the induction of long-term potentiation##2##6##(1995-12#2)
facilitate the induction of##3##4##(1995-12#3)
facilitate the maintenance of##2##4##(1996-8#1)(2009-8#1)
facilitate the oxidation of##2##4##(1996-4#1)(2008-10#1)
facilitate the selection##2##3##(1997-4#1)(2007-12#1)
facilitate the study of##5##4##(1990-7#1)(1993-12#1)(2008-9#1)(2009-10#1)(2012-3#1)
facilitate the use of##2##4##(1990-12#1)(2009-3#1)
facilitate the##145##2##(1990-10#1)(1990-12#1)(1990-7#2)(1991-12#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-5#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-6#1)(1994-8#3)(1995-12#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#10)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#2)
facilitate their##5##2##(2008-10#2)(2009-2#1)(2010-5#1)(2012-3#1)
facilitate this##4##2##(1994-8#1)(2007-10#1)(2012-3#1)(2013-1#1)
facilitate timely##2##2##(2008-10#1)(2008-11#1)
facilitate transmission##2##2##(2013-1#2)
facilitate treatment##2##2##(2009-8#1)(2012-3#1)
facilitate understanding of##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
facilitate understanding##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
facilitate use of##3##3##(1996-3#1)(2008-3#2)
facilitate viral##2##2##(2009-2#1)(2010-1#1)
facilitate##432##1##(1990-10#1)(1990-12#1)(1990-7#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#5)(1995-1#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-12#2)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-11#8)(2007-12#8)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#45)(2008-11#26)(2008-12#18)(2008-2#4)(2008-3#10)(2008-4#12)(2008-5#7)(2008-6#6)(2008-7#21)(2008-8#8)(2008-9#14)(2009-10#9)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#10)(2012-12#4)(2012-2#8)(2012-3#12)(2013-1#19)(2013-7#4)(2013-8#6)
facilitated and##3##2##(1996-6#1)(2008-11#1)(2008-4#1)
facilitated by a new##2##4##(1995-12#1)(2012-3#1)
facilitated by a##4##3##(1995-12#1)(2008-2#1)(2008-9#1)(2012-3#1)
facilitated by the##11##3##(1990-11#1)(1993-6#1)(1995-1#1)(1995-12#1)(2008-10#3)(2008-4#2)(2010-5#1)(2013-8#1)
facilitated by##36##2##(1990-11#2)(1990-2#1)(1991-7#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
facilitated diffusion##2##2##(1992-3#1)(2008-10#1)
facilitated if##2##2##(1993-12#1)(2007-10#1)
facilitated in##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
facilitated the analysis of##2##4##(2008-10#2)
facilitated the##25##2##(1993-6#2)(1994-8#1)(1995-3#1)(1996-1#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
facilitated through the##2##3##(2008-10#1)(2012-1#1)
facilitated through##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2012-1#1)
facilitated transport through the nuclear pore complex##2##7##(1994-11#2)
facilitated transport##4##2##(1994-11#3)(2007-12#1)
facilitated##144##1##(1990-11#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#5)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-5#1)(1994-8#4)(1995-1#1)(1995-12#3)(1995-3#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#19)(2008-11#16)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
facilitates a##2##2##(1992-1#1)(1995-6#1)
facilitates detection##2##2##(1996-12#1)(2008-3#1)
facilitates early##2##2##(2007-9#1)(2009-2#1)
facilitates isolation of##2##3##(2008-11#1)(2008-2#1)
facilitates long-term potentiation##2##3##(1995-12#2)
facilitates the access##2##3##(2011-2#1)(2012-2#1)
facilitates the detection of##2##4##(2008-3#1)(2008-6#1)
facilitates the development of##2##4##(1990-5#1)(1992-11#1)
facilitates the interpretation of the##2##5##(2008-10#1)(2012-2#1)
facilitates the##32##2##(1990-5#2)(1992-11#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-7#1)(2011-2#4)(2012-2#2)(2013-1#1)
facilitates##114##1##(1990-5#2)(1990-9#2)(1991-2#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-3#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#4)
facilitating a##2##2##(2007-11#1)(2008-11#1)
facilitating factors##2##2##(2010-3#1)(2013-8#1)
facilitating learning##2##2##(2008-11#1)(2013-8#1)
facilitating subsequent##2##2##(2007-8#1)(2013-8#1)
facilitating the analysis##2##3##(2010-5#1)(2012-2#1)
facilitating the development of##2##4##(2008-11#1)(2012-12#1)
facilitating the implementation of##2##4##(1995-3#1)(2008-2#1)
facilitating the translation of##2##4##(2009-11#1)(2010-12#1)
facilitating the transport of##2##4##(1993-11#1)(1994-3#1)
facilitating the##28##2##(1991-9#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
facilitating their##2##2##(2008-10#1)(2008-12#1)
facilitating##94##1##(1990-3#1)(1990-5#1)(1991-1#3)(1991-9#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#14)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
facilitation between##3##2##(2008-10#1)(2008-8#2)
facilitation in patient care##3##4##(2010-8#3)
facilitation in##6##2##(1995-5#2)(2008-12#1)(2010-8#3)
facilitation induced by##2##3##(1995-5#1)(2008-8#1)
facilitation of the##3##3##(1991-2#1)(1993-11#1)(2008-11#1)
facilitation of##16##2##(1991-2#1)(1993-11#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-2#1)(2012-3#2)
facilitation##40##1##(1991-2#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-5#4)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#7)(2009-1#1)(2010-10#2)(2010-8#3)(2012-1#1)(2012-2#1)(2012-3#3)
facilitative glucose transporter##5##3##(1991-12#2)(1993-6#2)(2008-7#1)
facilitative glucose##6##2##(1991-12#2)(1993-6#2)(2008-7#1)(2010-2#1)
facilitative##13##1##(1991-12#2)(1993-6#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
facilitator and##2##2##(1996-12#1)(2008-11#1)
facilitator##12##1##(1991-2#1)(1993-12#2)(1996-12#2)(2007-5#1)(2008-11#2)(2008-12#3)(2008-7#1)
facilitators and##2##2##(1995-3#1)(2012-2#1)
facilitators as##2##2##(2010-10#1)(2010-5#1)
facilitators in##2##2##(1994-2#1)(2013-1#1)
facilitators of##5##2##(1995-3#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
facilitators##24##1##(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#2)(2008-12#2)(2008-9#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)
facilitators'##2##1##(2010-10#2)
facilitatory effect##3##2##(1991-2#2)(1994-3#1)
facilitatory##7##1##(1990-5#1)(1991-2#2)(1994-3#1)(1995-11#1)(2008-4#1)(2008-7#1)
facilities and of##2##3##(2008-10#1)(2008-8#1)
facilities and##20##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-3#2)(1996-6#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
facilities are##10##2##(1991-2#1)(1992-5#1)(1993-3#1)(1997-2#1)(2007-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2011-1#1)
facilities as##3##2##(1992-1#1)(1995-1#1)(2007-6#1)
facilities available##3##2##(1994-3#1)(1996-11#1)(1997-8#1)
facilities by##3##2##(1995-12#1)(1995-2#1)(1997-3#1)
facilities can##5##2##(1991-12#1)(1993-1#1)(1993-12#1)(1997-3#1)(2011-2#1)
facilities for handicapped##2##3##(1992-5#2)
facilities for##5##2##(1992-5#2)(1997-8#1)(2008-8#1)(2011-1#1)
facilities have##7##2##(1991-3#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-1#1)(2007-4#1)
facilities in the##6##3##(1991-3#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)
facilities in##21##2##(1991-3#1)(1992-2#1)(1992-5#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#2)(2010-5#1)(2012-12#1)
facilities is##2##2##(1991-12#1)(2011-1#1)
facilities may##3##2##(2007-4#1)(2008-1#1)(2012-12#1)
facilities of##4##2##(1992-2#1)(1995-2#1)(1995-6#1)(2007-12#1)
facilities or other##2##3##(1994-3#1)(1995-6#1)
facilities or##4##2##(1991-2#1)(1994-3#1)(1995-6#1)(2008-3#1)
facilities should develop##2##3##(1994-1#1)(2011-2#1)
facilities should##4##2##(1994-1#1)(1996-2#1)(2008-3#1)(2011-2#1)
facilities to##9##2##(1991-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-1#1)
facilities were##8##2##(1991-1#1)(1992-5#1)(1994-3#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
facilities with##5##2##(1992-2#1)(1995-12#2)(2007-12#1)(2008-7#1)
facilities##274##1##(1990-2#1)(1990-5#1)(1991-1#5)(1991-12#8)(1991-2#4)(1991-3#6)(1992-1#3)(1992-12#5)(1992-2#7)(1992-5#8)(1992-8#2)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#7)(1994-1#4)(1994-12#6)(1994-2#1)(1994-3#10)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#6)(1995-6#3)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#5)(1997-5#2)(1997-6#1)(1997-8#4)(2007-10#1)(2007-12#14)(2007-2#1)(2007-4#2)(2007-6#2)(2007-7#2)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#2)(2008-3#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#5)
facilities'##2##1##(1993-12#1)(2008-4#1)
facility and##6##2##(1991-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)
facility as##2##2##(2008-3#1)(2009-10#1)
facility at##2##2##(1992-6#1)(2011-2#1)
facility for##8##2##(1992-11#1)(1992-6#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-3#1)(2010-8#1)
facility has##2##2##(1991-3#1)(2011-2#1)
facility in response to##2##4##(1992-2#1)(1993-12#1)
facility in##7##2##(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(2008-8#2)(2012-3#1)
facility is the first##2##4##(1993-12#1)(1995-3#1)
facility is##5##2##(1991-12#1)(1993-12#1)(1995-3#1)(2008-3#1)(2011-2#1)
facility level##2##2##(1991-1#1)(1994-12#1)
facility management##3##2##(1992-2#3)
facility managers##2##2##(1992-2#1)(1995-2#1)
facility master plan##3##3##(1992-2#3)
facility of##3##2##(2008-2#1)(2008-9#1)(2012-3#1)
facility providing##2##2##(2008-10#1)(2013-1#1)
facility residents##2##2##(1995-2#1)(2008-12#1)
facility should##3##2##(1994-12#2)(2011-1#1)
facility to the##2##3##(1991-11#1)(2008-3#1)
facility to##11##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-2#2)(1994-3#1)(2008-3#2)(2011-2#1)
facility with##8##2##(1992-6#1)(1996-2#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
facility##194##1##(1991-1#7)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#5)(1992-1#4)(1992-11#3)(1992-12#2)(1992-2#14)(1992-5#6)(1992-6#5)(1993-1#2)(1993-12#5)(1993-2#4)(1993-3#2)(1994-1#1)(1994-12#8)(1994-2#3)(1994-3#5)(1995-12#1)(1995-2#3)(1995-3#6)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#3)(1997-1#1)(1997-3#4)(1997-6#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#4)
facility's##7##1##(1992-1#2)(1992-2#1)(1994-12#1)(2007-10#1)(2008-3#1)(2011-2#1)
facility-level##2##1##(1992-3#1)(1997-2#1)
facility-related problems##2##2##(1994-12#2)
facing health care##3##3##(1991-2#1)(1995-1#1)(1996-3#1)
facing health##6##2##(1990-12#1)(1991-2#1)(1995-1#1)(1996-3#1)(2008-7#2)
facing increasing##2##2##(1991-9#1)(1993-3#1)
facing many##2##2##(2008-11#1)(2010-12#1)
facing modern##2##2##(2008-3#1)(2008-4#1)
facing our##2##2##(1992-2#1)(1993-2#1)
facing the Nation##2##3##(1992-3#1)(1993-3#1)
facing the##24##2##(1991-1#1)(1991-10#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
facing us##3##2##(2007-7#1)(2008-10#1)(2010-6#1)
facing##94##1##(1990-12#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#3)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
fact a##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
fact has##2##2##(1994-6#1)(2008-3#1)
fact is that##4##3##(1995-2#1)(1996-3#1)(2008-10#1)(2012-1#1)
fact is##8##2##(1995-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#2)(2012-1#1)(2013-1#1)
fact of##3##2##(2008-10#1)(2008-6#1)(2009-10#1)
fact or fancy?##2##3##(1992-12#1)(1993-2#1)
fact or##3##2##(1992-12#1)(1993-2#1)(2008-3#1)
fact suggests the##2##3##(2008-3#1)(2009-4#1)
fact suggests##4##2##(1993-8#1)(2008-11#1)(2008-3#1)(2009-4#1)
fact that is##2##3##(2008-10#1)(2008-8#1)
fact that it##7##3##(1990-3#1)(1993-6#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
fact that only##2##3##(2008-10#1)(2008-6#1)
fact that the study was##2##5##(1993-3#1)(2008-11#1)
fact that the##71##3##(1990-2#1)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-3#2)(1993-6#1)(1994-8#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#10)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-3#1)(2013-1#2)
fact that there are no##2##5##(2008-10#1)(2008-2#1)
fact that there are##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)
fact that there is##2##4##(2008-10#1)(2009-8#1)
fact that there##9##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-8#1)
fact that this##6##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-3#1)
fact that##268##2##(1990-11#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#5)(1992-5#1)(1992-9#3)(1993-1#1)(1993-3#2)(1993-6#3)(1993-9#2)(1994-2#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(2007-11#4)(2007-12#7)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#46)(2008-11#18)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#5)(2013-8#1)
fact the##4##2##(1992-12#1)(1996-12#1)(1996-4#1)(2013-1#1)
fact##463##1##(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#4)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#2)(1992-12#3)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#6)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#1)(2007-11#8)(2007-12#10)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#8)(2008-10#68)(2008-11#24)(2008-12#2)(2008-2#5)(2008-3#19)(2008-4#9)(2008-5#16)(2008-6#7)(2008-7#17)(2008-8#11)(2008-9#17)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#6)(2011-2#12)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#2)
fact-based##2##1##(1997-2#1)(2009-5#1)
factitious disorder##3##2##(1993-2#1)(2010-12#2)
factitious##8##1##(1993-2#3)(1997-2#1)(2008-9#2)(2010-12#2)
facto##5##1##(2007-5#1)(2008-10#1)(2008-7#2)(2011-1#1)
factor (COUP-TF)##2##2##(1992-11#1)(1996-5#1)
factor (CRF)##5##2##(1990-12#1)(1996-12#1)(1997-4#1)(2008-3#1)(2008-4#1)
factor (EF)##6##2##(1993-9#1)(2008-10#4)(2013-1#1)
factor (G-CSF)##7##2##(1994-11#1)(1994-3#2)(1996-5#1)(2006-10#1)(2008-7#2)
factor (GM-CSF)##8##2##(1992-3#3)(1992-8#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
factor (HSF)##2##2##(1995-11#1)(2010-2#1)
factor (LIF)##12##2##(1991-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-4#2)(2009-3#2)
factor (M-CSF)##4##2##(1990-5#1)(1991-5#1)(1994-6#1)(2008-11#1)
factor (MIF)##2##2##(2008-10#1)(2012-2#1)
factor (PAF)##6##2##(1991-5#1)(1995-3#1)(1997-7#2)(2008-3#1)(2009-3#1)
factor (RF)##4##2##(2011-2#1)(2012-2#1)(2013-1#2)
factor 0##2##2##(2008-10#2)
factor 1##21##2##(1990-5#1)(1994-8#3)(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-3#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
factor 1)##2##2##(1995-2#2)
factor 1-alpha##3##2##(2008-10#2)(2013-1#1)
factor 100##2##2##(2008-10#2)
factor 17##2##2##(1994-3#1)(2008-10#1)
factor 1alpha##5##2##(2008-10#4)(2009-8#1)
factor 2 in##2##3##(1993-3#1)(1995-2#1)
factor 2##13##2##(1990-8#1)(1992-8#1)(1993-3#2)(1994-12#1)(1995-2#4)(2008-11#1)(2010-4#1)(2010-6#1)(2011-2#1)
factor 3##6##2##(1990-8#1)(1996-2#2)(2008-3#1)(2010-12#1)(2011-1#1)
factor 4##10##2##(1990-5#1)(1990-8#1)(1992-8#6)(1994-12#1)(2013-1#1)
factor B##4##2##(1994-11#1)(2008-4#1)(2009-8#1)(2013-1#1)
factor BEF-1##3##2##(1995-6#3)
factor H##9##2##(1997-9#1)(2009-6#8)
factor I##11##2##(1991-5#2)(1993-2#1)(2007-7#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
factor IX and X##2##4##(2008-7#2)
factor IX and##3##3##(1995-2#1)(2008-7#2)
factor IX deficiency mouse##2##4##(2008-8#2)
factor IX in##2##3##(2008-9#2)
factor IX mutant protein##2##4##(2008-9#2)
factor IX mutant##3##3##(2008-9#3)
factor IX promoter##2##3##(1990-5#2)
factor IX##29##2##(1990-5#5)(1995-2#3)(2008-7#2)(2008-8#7)(2008-9#12)
factor IgG##2##2##(1996-2#2)
factor K##2##2##(2008-3#1)(2008-5#1)
factor M(2) that##2##3##(2008-2#2)
factor M(2)##3##2##(2007-11#1)(2008-2#2)
factor TFIIB and##2##3##(1995-2#1)(2008-9#1)
factor TFIIF##2##2##(1995-6#1)(1997-3#1)
factor V##2##2##(1991-11#1)(1997-7#1)
factor VII##3##2##(2008-7#2)(2008-8#1)
factor VIII and##2##3##(2010-6#1)(2011-2#1)
factor VIII gene##4##3##(2008-12#4)
factor VIII##12##2##(2008-12#5)(2008-5#1)(2008-7#1)(2008-9#2)(2010-6#1)(2011-2#2)
factor VIIa##12##2##(1995-6#6)(2007-8#3)(2008-8#1)(2008-9#1)(2011-2#1)
factor Va##11##2##(1993-11#4)(1994-5#7)
factor X##3##2##(1990-5#1)(1995-6#1)(2008-11#1)
factor XI is activated##2##4##(1991-9#2)
factor XI##7##2##(1991-9#7)
factor XIII in protein-free##2##4##(2008-11#2)
factor XIII in##3##3##(2008-11#3)
factor XIII production##2##3##(2008-11#2)
factor XIII##11##2##(1995-12#2)(2008-11#9)
factor XIIIa##3##2##(1995-12#2)(2008-11#1)
factor XIIa##2##2##(1991-9#2)
factor Xa##10##2##(1990-7#1)(1991-3#2)(1993-11#2)(1994-5#4)(2012-12#1)
factor activities##2##2##(2007-10#1)(2007-12#1)
factor activity##6##2##(1990-12#1)(1991-12#2)(1991-6#1)(2008-1#1)(2008-6#1)
factor affecting the##2##3##(2008-11#1)(2013-1#1)
factor affecting##7##2##(1994-3#1)(2007-9#1)(2008-11#2)(2008-5#1)(2013-1#2)
factor against##7##2##(1995-12#1)(2009-11#2)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
factor alone##3##2##(1992-3#1)(1995-2#1)(2008-3#1)
factor alpha##23##2##(1990-5#1)(1991-9#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1997-1#1)(2008-11#2)(2008-7#1)(2008-8#2)(2011-2#2)(2013-8#1)
factor also##2##2##(1994-6#1)(2011-2#1)
factor among##2##2##(1994-2#1)(2008-8#1)
factor analyses##6##2##(2007-12#1)(2009-11#1)(2009-9#1)(2010-11#2)(2012-2#1)
factor analysis and##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2012-1#1)
factor analysis followed by##2##4##(2008-10#2)
factor analysis is##2##3##(2008-10#2)
factor analysis of##4##3##(1996-7#1)(2008-10#1)(2010-6#1)(2011-2#1)
factor analysis using##2##3##(2008-10#2)
factor analysis was applied to##2##5##(2008-10#2)
factor analysis was used to##2##5##(1993-12#1)(2010-6#1)
factor analysis was##7##3##(1993-12#1)(2008-10#3)(2010-6#2)(2011-2#1)
factor analysis##49##2##(1993-12#1)(1996-7#1)(2007-8#1)(2008-10#31)(2008-11#2)(2008-12#1)(2009-12#1)(2010-1#1)(2010-6#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
factor and a##2##3##(2008-10#1)(2009-11#1)
factor and its##4##3##(1991-7#1)(2008-9#1)(2009-5#1)(2012-2#1)
factor and regression line between##2##5##(2008-10#2)
factor and several##2##3##(1993-8#1)(1997-7#1)
factor and the##10##3##(1990-9#1)(1991-11#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-2#2)
factor and##69##2##(1990-12#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#2)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-3#2)(1996-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#2)(2013-8#3)
factor are##2##2##(1993-8#1)(2008-4#1)
factor as a##2##3##(1994-2#1)(2008-3#1)
factor as an##3##3##(1994-2#1)(2008-5#1)(2009-8#1)
factor as##8##2##(1994-2#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)
factor associated with##5##3##(2007-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
factor associated##6##2##(1994-6#1)(2007-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
factor at##3##2##(1994-2#1)(2008-10#1)(2012-1#1)
factor b##4##2##(1993-12#4)
factor between##4##2##(1994-3#1)(1997-3#1)(2008-10#2)
factor binding and##3##3##(1990-12#1)(1993-3#1)(1995-6#1)
factor binding site##2##3##(1992-9#1)(2012-3#1)
factor binding sites##5##3##(1990-12#1)(1994-11#1)(1997-8#1)(2008-4#1)(2012-3#1)
factor binding to##2##3##(1993-3#1)(1995-12#1)
factor binding##19##2##(1990-12#2)(1992-4#1)(1992-9#1)(1993-3#4)(1993-8#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-3#2)
factor bound##3##2##(1993-3#1)(1996-2#1)(2008-7#1)
factor by##8##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
factor can be##3##3##(1993-6#1)(2007-11#1)(2010-10#1)
factor can##9##2##(1990-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(2007-11#1)(2008-12#1)(2008-3#1)(2010-10#2)
factor concentration##2##2##(1995-2#1)(2008-11#1)
factor contributing to the##2##4##(2007-7#1)(2008-7#1)
factor contributing to##6##3##(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)
factor could be##2##3##(1997-5#1)(2008-10#1)
factor could##3##2##(1994-8#1)(1997-5#1)(2008-10#1)
factor determining population structure##2##4##(2008-10#2)
factor determining the##6##3##(1993-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
factor determining##10##2##(1991-3#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
factor domain##3##2##(1990-12#1)(1990-8#1)(2012-12#1)
factor during##2##2##(2008-10#1)(2008-6#1)
factor eIF-2##2##2##(1994-6#2)
factor effects##2##2##(1997-2#1)(2009-7#1)
factor equal to##2##3##(2007-12#1)(2008-3#1)
factor explaining##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
factor expression in##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
factor expression##7##2##(1997-1#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
factor family##2##2##(1995-2#1)(2012-3#1)
factor for IgA##2##3##(1994-2#1)(2008-11#1)
factor for a##2##3##(2008-10#1)(2012-2#1)
factor for cardiac##2##3##(1994-11#1)(2008-7#1)
factor for cutaneous##2##3##(2008-9#1)(2012-2#1)
factor for developing##8##3##(1992-9#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-2#2)(2012-5#1)(2013-8#1)
factor for overall survival##2##4##(2008-6#1)(2011-2#1)
factor for successful##4##3##(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#1)
factor for the development of##4##5##(2008-1#1)(2008-11#1)(2012-12#1)(2012-3#1)
factor for the successful##2##4##(2008-10#1)(2012-3#1)
factor for the##21##3##(1992-10#1)(1992-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)
factor for their##2##3##(2011-2#1)(2012-2#1)
factor for these##2##3##(2009-9#1)(2013-8#1)
factor for this##2##3##(2008-10#1)(2009-7#1)
factor for various##2##3##(1996-6#1)(2007-11#1)
factor for##182##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2006-8#1)(2007-10#7)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#21)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#11)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#3)
factor from##8##2##(1990-7#1)(1991-12#1)(1994-2#1)(1994-6#2)(1995-2#1)(1996-7#1)(2008-8#1)
factor g##2##2##(2008-2#1)(2008-3#1)
factor gene and##2##3##(2008-10#1)(2012-2#1)
factor gene##10##2##(1990-5#1)(1993-8#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#2)
factor genes in##2##3##(1992-9#1)(2008-10#1)
factor genes##7##2##(1992-9#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2013-7#1)
factor had##3##2##(1990-2#1)(1991-12#1)(1993-12#1)
factor has been isolated##2##4##(1991-12#1)(1995-6#1)
factor has been purified to##2##5##(1990-12#1)(2008-8#1)
factor has been##5##3##(1990-12#1)(1991-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
factor has##10##2##(1990-12#1)(1991-12#1)(1992-3#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)
factor have been##3##3##(2006-10#1)(2008-3#1)(2009-4#1)
factor in a##4##3##(1991-12#1)(2007-12#1)(2008-1#1)(2013-8#1)
factor in bovine##2##3##(1991-8#1)(1995-12#1)
factor in cardiac surgery##2##4##(2007-8#1)(2011-2#1)
factor in determining the degree of disability##2##7##(2008-7#2)
factor in determining the##7##4##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)
factor in determining##10##3##(1993-3#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)
factor in developing##2##3##(1996-12#1)(1996-3#1)
factor in early breast cancer##2##5##(1995-4#1)(2007-5#1)
factor in establishing##2##3##(1997-3#1)(2008-10#1)
factor in explaining##3##3##(2008-8#1)(2009-7#1)(2012-12#1)
factor in patients with##3##4##(2008-7#2)(2012-12#1)
factor in preventing##2##3##(2008-10#1)(2011-1#1)
factor in promoting##2##3##(2008-11#1)(2009-11#1)
factor in rat##3##3##(1993-6#1)(1997-6#1)(2008-9#1)
factor in skin aging##2##4##(2008-5#1)(2011-2#1)
factor in the decision##2##4##(2010-3#1)(2013-1#1)
factor in the development of##5##5##(1993-9#1)(1994-5#1)(1997-2#1)(2008-12#1)(2011-2#1)
factor in the etiology of##2##5##(2008-1#1)(2008-5#1)
factor in the growth##2##4##(1993-9#1)(2013-8#1)
factor in the occurrence of##2##5##(1996-7#1)(2013-1#1)
factor in the pathogenesis of##4##5##(1991-3#1)(1997-7#1)(2012-2#1)(2013-1#1)
factor in the##51##3##(1991-11#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#2)(1993-12#1)(1993-8#1)(1993-9#2)(1994-5#1)(1995-6#1)(1996-7#2)(1997-2#2)(1997-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#4)
factor in their##2##3##(1997-8#1)(2011-2#1)
factor in this##5##3##(1990-5#1)(1993-12#1)(2008-5#1)(2011-2#2)
factor in##201##2##(1990-12#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-3#2)(1991-4#1)(1991-8#2)(1992-1#2)(1992-12#2)(1992-3#2)(1992-6#2)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-5#2)(1995-12#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#3)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#8)
factor induced##3##2##(1993-3#1)(1994-12#1)(1995-12#1)
factor induces##2##2##(1990-7#1)(1997-7#1)
factor infertility##4##2##(1996-9#1)(2007-10#1)(2008-1#1)(2011-2#1)
factor influencing the##2##3##(1993-12#1)(1995-3#1)
factor influencing##5##2##(1993-12#1)(1995-3#1)(1996-2#1)(2008-7#1)(2011-2#1)
factor inhibitor##2##2##(2012-3#2)
factor involved in##4##3##(1995-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
factor is a##5##3##(1991-12#1)(1993-6#1)(1994-2#2)(1995-6#1)
factor is an##3##3##(1991-9#1)(1994-6#1)(2008-10#1)
factor is described##2##3##(1990-2#1)(1995-2#1)
factor is expressed##2##3##(1991-2#1)(2008-3#1)
factor is likely to be##2##5##(1990-2#1)(2008-10#1)
factor is the##3##3##(1993-8#1)(2008-3#1)(2012-1#1)
factor is##55##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-3#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2011-3#1)(2011-4#1)(2012-1#1)(2013-8#2)
factor known##2##2##(1992-8#1)(2008-11#1)
factor leading to##2##3##(1991-2#1)(2006-10#1)
factor levels in##4##3##(1991-6#1)(2007-2#1)(2008-7#1)(2013-1#1)
factor levels##6##2##(1991-6#2)(2007-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
factor limiting##4##2##(1997-3#1)(2007-11#1)(2008-8#1)(2009-12#1)
factor mRNA expression in the##2##5##(1997-2#1)(1997-6#1)
factor mRNA##6##2##(1993-11#1)(1994-6#1)(1997-2#1)(1997-6#2)(2008-9#1)
factor may be##3##3##(1992-9#1)(2009-3#1)(2013-1#1)
factor may##6##2##(1992-11#1)(1992-9#1)(1994-12#1)(1994-8#1)(2009-3#1)(2013-1#1)
factor mediated##2##2##(2008-9#1)(2009-7#1)
factor modification##2##2##(2008-3#1)(2010-9#1)
factor modulated##2##2##(1994-5#1)(2008-10#1)
factor more##2##2##(2008-10#1)(2008-5#1)
factor most##2##2##(1993-6#1)(2010-10#1)
factor obtained##3##2##(2008-10#3)
factor of 0##7##3##(1992-8#1)(2008-10#6)
factor of 10##11##3##(1992-3#3)(1994-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2012-2#1)
factor of 100 was##3##4##(2008-10#3)
factor of 100##5##3##(2008-10#5)
factor of 16##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
factor of 17##2##3##(1991-3#1)(2011-1#1)
factor of 2##18##3##(1992-12#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)
factor of 20##4##3##(2008-10#3)(2008-8#1)
factor of 200##2##3##(2008-10#1)(2012-2#1)
factor of 23##2##3##(2008-10#2)
factor of 25##3##3##(2008-10#3)
factor of 30##3##3##(1993-9#1)(1995-3#1)(2008-10#1)
factor of 33##2##3##(2008-10#2)
factor of 40##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
factor of 5##6##3##(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
factor of a##2##3##(2008-2#1)(2008-3#1)
factor of about##3##3##(2008-10#2)(2008-5#1)
factor of approximately##2##3##(2008-10#1)(2008-3#1)
factor of ca##2##3##(1995-2#1)(2008-10#1)
factor of the##18##3##(1993-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-4#1)(2010-8#2)(2013-7#2)
factor of this##2##3##(2008-10#2)
factor of##247##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-3#4)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-11#11)(2007-12#10)(2007-5#1)(2007-8#1)(2008-10#88)(2008-11#3)(2008-2#15)(2008-3#31)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#2)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)
factor on the##3##3##(1994-8#1)(2008-3#1)(2008-5#1)
factor on##12##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-3#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-3#2)(2008-5#1)(2010-12#1)(2013-1#1)
factor or factors##2##3##(2008-6#1)(2010-11#1)
factor or##8##2##(1990-3#1)(1991-7#1)(1991-9#1)(1993-6#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
factor pathway inhibitor##2##3##(1992-10#2)
factor produced by##4##3##(1990-7#1)(1992-9#1)(2008-10#1)(2008-6#1)
factor promotes##2##2##(1995-12#1)(2009-3#1)
factor promoting##2##2##(1997-4#1)(2008-10#1)
factor reached##2##2##(2007-8#2)
factor receptor##53##2##(1990-12#2)(1991-11#1)(1991-7#2)(1992-8#2)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-5#1)(2011-2#3)(2012-1#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
factor receptors are##2##3##(2008-1#1)(2008-4#1)
factor receptors##13##2##(1991-7#1)(1992-8#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-12#2)
factor regulating##3##2##(1991-5#1)(1994-11#1)(2008-4#1)
factor regulation##2##2##(1994-8#1)(2008-12#1)
factor related##3##2##(1991-2#1)(1997-7#1)(2012-2#1)
factor remains##2##2##(1991-11#1)(1994-8#1)
factor required by##2##3##(1994-12#1)(2009-8#1)
factor required##3##2##(1994-12#1)(1995-6#1)(2009-8#1)
factor responsible for##5##3##(1994-5#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-3#1)
factor scores##2##2##(1994-2#1)(1996-5#1)
factor screening##3##2##(1991-6#1)(1994-11#1)(2008-11#1)
factor secreted by##3##3##(1990-4#1)(1991-9#1)(1994-12#1)
factor specific to##2##3##(2007-12#1)(2011-2#1)
factor structure of the##3##4##(2008-10#1)(2009-5#1)(2013-8#1)
factor structure##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2013-8#1)
factor studied##2##2##(1993-12#1)(2008-11#1)
factor studies##2##2##(1997-4#1)(2008-10#1)
factor such as##2##3##(2008-3#1)(2011-1#1)
factor support##3##2##(2008-7#3)
factor suppresses##2##2##(1991-9#1)(2008-10#1)
factor than##2##2##(1997-7#1)(2008-3#1)
factor that can##3##3##(1992-8#1)(2008-1#1)(2013-7#1)
factor that contributes to##2##4##(2008-3#1)(2008-9#1)
factor that could##2##3##(2008-3#1)(2012-2#1)
factor that has been##2##4##(1991-9#1)(1996-12#1)
factor that has##3##3##(1991-9#1)(1992-9#1)(1996-12#1)
factor that is related to##2##5##(2008-12#1)(2008-3#1)
factor that is##5##3##(1992-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
factor that limits the##2##4##(2007-11#1)(2008-3#1)
factor that may##2##3##(2008-7#1)(2010-11#1)
factor that plays##2##3##(2008-10#1)(2008-6#1)
factor that was##2##3##(2008-10#1)(2012-12#1)
factor that##46##2##(1991-2#1)(1991-9#1)(1992-8#3)(1992-9#1)(1994-11#1)(1994-7#1)(1996-12#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
factor to the##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
factor to##21##2##(1991-2#1)(1991-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
factor used in this work was##2##6##(2008-10#2)
factor values##2##2##(2008-10#1)(2008-6#1)
factor was 0##3##3##(2008-8#1)(2008-9#2)
factor was introduced##2##3##(2008-11#1)(2008-9#1)
factor was not##2##3##(2007-12#1)(2012-12#1)
factor was##42##2##(1990-6#1)(1990-7#1)(1993-11#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-8#2)(2008-9#3)(2010-1#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
factor were determined##3##3##(2007-8#1)(2008-12#2)
factor were##10##2##(1991-12#1)(1991-9#3)(1996-2#1)(2007-8#2)(2008-12#2)(2012-1#1)
factor which may##3##3##(1993-12#1)(1995-6#1)(2007-11#1)
factor which##17##2##(1990-11#1)(1990-7#1)(1991-11#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-5#1)
factor whose##3##2##(1991-2#1)(1997-3#1)(2012-2#1)
factor with##6##2##(1990-2#1)(1991-5#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-4#1)
factor##2654##1##(1990-11#14)(1990-12#19)(1990-2#9)(1990-3#2)(1990-4#2)(1990-5#24)(1990-6#2)(1990-7#16)(1990-8#14)(1990-9#3)(1991-1#1)(1991-11#8)(1991-12#35)(1991-2#19)(1991-3#11)(1991-4#1)(1991-5#7)(1991-6#8)(1991-7#6)(1991-8#6)(1991-9#27)(1992-1#2)(1992-10#4)(1992-11#5)(1992-12#15)(1992-2#7)(1992-3#29)(1992-4#3)(1992-6#7)(1992-7#4)(1992-8#27)(1992-9#30)(1993-1#6)(1993-11#17)(1993-12#23)(1993-2#5)(1993-3#23)(1993-5#2)(1993-6#21)(1993-8#14)(1993-9#17)(1994-10#2)(1994-11#28)(1994-12#20)(1994-2#20)(1994-3#12)(1994-5#20)(1994-6#18)(1994-7#1)(1994-8#35)(1994-9#8)(1995-11#14)(1995-12#29)(1995-2#50)(1995-3#8)(1995-4#2)(1995-5#5)(1995-6#37)(1995-8#15)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#16)(1996-2#22)(1996-3#5)(1996-4#1)(1996-5#14)(1996-6#3)(1996-7#6)(1996-8#5)(1996-9#3)(1997-1#8)(1997-2#13)(1997-3#14)(1997-4#9)(1997-5#2)(1997-6#13)(1997-7#18)(1997-8#5)(1997-9#1)(2006-10#6)(2006-8#2)(2007-10#23)(2007-11#39)(2007-12#29)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#24)(2007-9#1)(2008-1#28)(2008-10#328)(2008-11#116)(2008-12#28)(2008-2#41)(2008-3#114)(2008-4#38)(2008-5#55)(2008-6#27)(2008-7#60)(2008-8#62)(2008-9#62)(2009-10#5)(2009-11#11)(2009-12#7)(2009-2#3)(2009-3#14)(2009-4#3)(2009-5#10)(2009-6#8)(2009-7#17)(2009-8#21)(2009-9#5)(2010-1#5)(2010-10#11)(2010-11#13)(2010-12#5)(2010-2#5)(2010-3#9)(2010-4#6)(2010-5#6)(2010-6#11)(2010-7#3)(2010-8#10)(2010-9#3)(2011-1#35)(2011-2#99)(2011-3#2)(2011-4#1)(2012-1#22)(2012-12#29)(2012-2#53)(2012-3#37)(2012-5#4)(2012-7#1)(2013-1#61)(2013-7#12)(2013-8#33)
factor&quot##3##1##(1993-6#1)(1997-8#1)(2008-8#1)
factor(s) which##2##2##(1992-12#2)
factor(s)##13##1##(1992-12#5)(1992-9#2)(1993-3#1)(1995-2#1)(1996-5#2)(2008-10#1)(2008-12#1)
factor) and##3##2##(1995-6#1)(1997-7#1)(2008-5#1)
factor)##17##1##(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#2)(1997-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)
factor-##3##1##(1991-5#1)(1995-6#1)(2010-10#1)
factor-1 and##2##2##(1993-11#1)(2013-1#1)
factor-1##17##1##(1990-12#1)(1990-5#1)(1991-6#1)(1992-12#1)(1993-11#2)(1994-11#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
factor-2##11##1##(1995-12#2)(1997-2#2)(1997-4#2)(2008-11#1)(2008-4#2)(2012-2#1)(2013-8#1)
factor-alpha##44##1##(1992-12#2)(1992-3#1)(1992-8#5)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-9#1)(1996-12#2)(1996-2#1)(1997-7#2)(2007-11#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-9#2)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
factor-beta (TGF-beta)##7##2##(1990-2#1)(1993-3#1)(1996-5#1)(2008-11#2)(2008-9#1)(2009-3#1)
factor-beta##23##1##(1990-2#3)(1991-12#1)(1992-2#1)(1992-3#2)(1993-3#2)(1993-6#1)(1994-11#2)(1995-11#1)(1996-5#1)(2008-11#2)(2008-6#1)(2008-9#3)(2009-3#1)(2013-1#2)
factor-binding##8##1##(1991-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(2008-4#2)(2008-7#1)
factor-dependent cell##2##2##(1995-2#1)(2008-4#1)
factor-encoding##3##1##(1991-6#3)
factor-induced##8##1##(1991-8#1)(1992-10#1)(1992-3#1)(1994-8#1)(1995-2#1)(1997-1#1)(2010-8#1)(2011-2#1)
factor-like peptides##2##2##(1990-12#1)(1991-12#1)
factor-like##8##1##(1990-12#1)(1991-12#1)(1992-12#1)(1993-11#2)(1993-8#1)(1994-12#1)(1995-6#1)
factor-producing##2##1##(1995-6#1)(2011-2#1)
factor-related##3##1##(1994-8#1)(2009-3#2)
factor]##2##1##(1993-2#1)(1994-9#1)
factored in##2##2##(2008-10#1)(2013-8#1)
factored##3##1##(1996-12#1)(2008-10#1)(2013-8#1)
factorial analysis##5##2##(2008-10#5)
factorial and central composite##2##4##(2008-10#2)
factorial and##6##2##(2007-2#1)(2008-10#5)
factorial design and Doehlert##2##4##(2008-10#2)
factorial design and a##2##4##(2008-10#2)
factorial design and##5##3##(2008-10#5)
factorial design experiment##2##3##(2008-10#1)(2008-6#1)
factorial design is##2##3##(2008-10#2)
factorial design to##3##3##(2008-10#2)(2010-3#1)
factorial design was employed##3##4##(2008-10#2)(2008-6#1)
factorial design was used for optimization of##2##7##(2008-10#2)
factorial design was used to##3##5##(2008-10#3)
factorial design was used##6##4##(2008-10#5)(2013-8#1)
factorial design was##11##3##(2008-10#9)(2008-6#1)(2013-8#1)
factorial design with##3##3##(2008-10#1)(2010-2#1)(2010-4#1)
factorial design##58##2##(1994-3#1)(2008-10#45)(2008-11#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
factorial designs##5##2##(2008-10#5)
factorial experiment##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
factorial experiments##2##2##(2008-10#1)(2008-5#1)
factorial##95##1##(1994-3#1)(2007-2#1)(2008-10#74)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
factories in##2##2##(1994-9#1)(2008-8#1)
factories##4##1##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
factorization##7##1##(1997-4#1)(2007-11#2)(2008-10#3)(2008-3#1)
factorized##2##1##(2007-12#1)(2013-8#1)
factors (GEFs)##2##2##(1994-12#1)(1995-8#1)
factors (TFs)##5##2##(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
factors (e##9##2##(1990-12#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
factors (eg##3##2##(2008-3#1)(2010-1#1)(2011-2#1)
factors (i##8##2##(1990-9#1)(1993-3#2)(2008-10#1)(2008-11#3)(2008-7#1)
factors (insulin##2##2##(1990-8#1)(1994-3#1)
factors (sex##2##2##(1993-2#1)(2009-12#1)
factors -##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
factors VIII and IX##2##4##(2011-2#2)
factors accounted for an additional##2##5##(2010-10#1)(2010-5#1)
factors accounted for##6##3##(1994-2#1)(2008-10#1)(2010-10#2)(2010-5#1)(2013-8#1)
factors accounting for##2##3##(1992-3#1)(2008-10#1)
factors across##3##2##(1993-2#1)(2011-2#1)(2012-12#1)
factors acting##4##2##(1990-12#1)(1996-12#1)(2008-10#1)(2008-9#1)
factors affect the ability##2##4##(2008-10#1)(2008-9#1)
factors affect the##7##3##(1991-1#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-9#1)(2009-7#1)
factors affect##10##2##(1991-1#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-7#1)(2010-6#1)(2013-1#1)
factors affecting it##2##3##(1993-3#1)(2007-10#1)
factors affecting the determination##2##4##(2008-10#2)
factors affecting the hydride generation##3##5##(2008-10#3)
factors affecting the response##2##4##(2008-10#1)(2008-6#1)
factors affecting the##39##3##(1992-1#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)
factors affecting##72##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
factors after##2##2##(1991-12#1)(2013-1#1)
factors also influence the##2##4##(1994-9#1)(2008-6#1)
factors also##6##2##(1993-12#1)(1994-9#1)(2008-10#1)(2008-6#1)(2009-10#1)(2013-1#1)
factors among##9##2##(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
factors and by##3##3##(2008-11#2)(2013-1#1)
factors and cardiovascular##2##3##(2008-2#1)(2009-4#1)
factors and diabetes mellitus##2##4##(2008-1#1)(2008-11#1)
factors and disease##2##3##(2008-10#1)(2011-2#1)
factors and genetic##2##3##(2010-3#1)(2012-3#1)
factors and interaction##2##3##(1997-1#1)(2008-10#1)
factors and mechanisms##2##3##(2010-4#1)(2013-8#1)
factors and of##2##3##(1991-6#1)(2013-1#1)
factors and other##3##3##(1995-8#1)(2008-5#1)(2009-8#1)
factors and the##17##3##(1994-9#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2013-1#2)
factors and their##12##3##(1991-12#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#3)
factors and therapy of##2##4##(2007-5#1)(2008-1#1)
factors and##195##2##(1990-5#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#7)(2008-10#19)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#6)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#5)
factors are all##2##3##(1990-6#1)(2008-8#1)
factors are associated with##5##4##(2008-11#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
factors are considered##4##3##(1991-6#1)(2008-10#2)(2013-1#1)
factors are discussed##3##3##(1990-9#1)(1995-3#1)(2008-10#1)
factors are important##3##3##(2008-1#1)(2008-7#1)(2010-2#1)
factors are involved in the##2##5##(2008-7#1)(2009-5#1)
factors are involved in##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
factors are involved##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
factors are known to##2##4##(2008-5#1)(2012-2#1)
factors are known##3##3##(2008-5#1)(2008-6#1)(2012-2#1)
factors are not##3##3##(2008-11#1)(2010-11#1)(2011-1#1)
factors are of great##2##4##(1994-1#1)(2008-10#1)
factors are of##4##3##(1994-1#1)(1997-7#1)(2008-10#1)(2010-12#1)
factors are presented##4##3##(1993-1#1)(1993-3#1)(2007-8#1)(2011-2#1)
factors are required##2##3##(2008-9#1)(2010-1#1)
factors are responsible for the##3##5##(1994-12#1)(2010-11#1)(2011-2#1)
factors are responsible for##5##4##(1994-12#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
factors are reviewed##2##3##(1994-2#1)(2008-4#1)
factors are the##5##3##(1993-9#1)(2008-10#2)(2011-2#2)
factors are thought to##2##4##(1995-2#1)(2013-1#1)
factors are##127##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#2)
factors as a##2##3##(1994-8#1)(2008-5#1)
factors as the##4##3##(1990-2#1)(2008-3#1)(2008-8#1)(2009-11#1)
factors as well as the##2##5##(1995-5#1)(2008-10#1)
factors as well as##5##4##(1995-5#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-1#1)
factors as well##6##3##(1990-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-1#1)
factors as##28##2##(1990-2#1)(1990-3#1)(1994-8#1)(1995-2#1)(1995-5#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
factors associated with PNE##2##4##(2007-7#2)
factors associated with adherence##2##4##(1996-3#1)(2012-3#1)
factors associated with an increased##2##5##(1994-12#1)(2008-3#1)
factors associated with anemia among##2##5##(2011-2#2)
factors associated with delirium among##2##5##(2010-10#2)
factors associated with early sexual##2##5##(2013-8#2)
factors associated with extra-hospital mortality##3##5##(2011-2#3)
factors associated with failure##2##4##(2010-12#1)(2010-6#1)
factors associated with oral##2##4##(2008-1#1)(2013-1#1)
factors associated with severe periodontitis##2##5##(2008-10#2)
factors associated with the##18##4##(1991-12#1)(1994-12#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-5#1)(2009-5#2)(2010-2#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
factors associated with these##2##4##(2008-9#1)(2012-12#1)
factors associated with this##3##4##(2008-1#1)(2008-2#1)(2012-2#1)
factors associated with unplanned endotracheal self-extubation##2##6##(2010-10#2)
factors associated with##103##3##(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2008-1#5)(2008-10#5)(2008-2#2)(2008-3#6)(2008-5#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#12)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#8)
factors associated##104##2##(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#5)(2008-2#2)(2008-3#6)(2008-5#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#12)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#8)
factors at the##4##3##(1997-4#1)(2008-9#1)(2009-4#1)(2012-12#1)
factors at##8##2##(1997-4#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
factors before##3##2##(1994-3#1)(2009-7#2)
factors behind##2##2##(2008-1#1)(2008-10#1)
factors besides##2##2##(1997-1#1)(2008-10#1)
factors between the##2##3##(2008-10#1)(2011-1#1)
factors between##5##2##(2008-10#2)(2009-10#1)(2009-8#1)(2011-1#1)
factors binding##5##2##(1990-5#1)(2008-10#1)(2008-7#1)(2008-9#2)
factors but##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
factors by##9##2##(1991-2#1)(1993-11#1)(1994-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)
factors calculated##2##2##(2007-8#1)(2008-2#1)
factors can affect##2##3##(2008-10#1)(2012-2#1)
factors can be##7##3##(1995-3#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
factors can have##2##3##(2008-10#1)(2009-8#1)
factors can influence the##2##4##(2008-5#1)(2013-1#1)
factors can influence##5##3##(2008-5#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
factors can##28##2##(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
factors causing##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
factors combined##2##2##(2012-3#1)(2013-8#1)
factors comprising##2##2##(2007-5#1)(2011-2#1)
factors considered##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
factors contain##3##2##(1996-2#1)(2008-9#1)(2010-10#1)
factors contribute to the##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
factors contribute to##5##3##(1991-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
factors contributed to##3##3##(1990-6#1)(2007-12#1)(2012-3#1)
factors contributing to the##9##4##(1991-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-4#1)(2009-7#1)(2011-1#1)
factors contributing to##24##3##(1991-1#2)(1992-11#1)(1994-12#1)(1996-1#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2011-1#3)(2012-2#1)(2012-3#1)
factors contributing##25##2##(1991-1#2)(1992-11#1)(1994-12#1)(1996-1#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2011-1#3)(2012-2#1)(2012-3#1)
factors controlling the##2##3##(2007-5#1)(2008-5#1)
factors controlling##7##2##(1991-12#1)(2007-5#1)(2008-10#1)(2008-5#4)
factors correlated with##2##3##(2008-10#1)(2011-2#1)
factors could be##6##3##(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
factors could##9##2##(1996-12#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
factors derived from##4##3##(1990-7#1)(2008-3#1)(2008-5#1)(2012-3#1)
factors determine the##2##3##(1992-6#1)(1993-12#1)
factors determined by##2##3##(2008-5#1)(2011-1#1)
factors determining the##4##3##(1996-11#1)(2008-10#2)(2011-2#1)
factors determining##9##2##(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-9#2)(2011-2#2)
factors did not##2##3##(1992-9#1)(1996-8#1)
factors do not##5##3##(1992-9#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-9#1)
factors driving##4##2##(1991-3#1)(1993-3#1)(2008-8#1)(2011-1#1)
factors during the##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
factors during##7##2##(1992-12#1)(2008-11#3)(2010-1#1)(2012-12#1)(2013-8#1)
factors emerged##2##2##(2007-12#1)(2011-2#1)
factors encoded##2##2##(2010-4#1)(2011-1#1)
factors explaining the##2##3##(2008-10#2)
factors explaining##3##2##(2008-10#3)
factors expressed##2##2##(2008-9#1)(2013-1#1)
factors for CAD##4##3##(1996-2#1)(2011-1#3)
factors for HIV infection##3##4##(2007-12#1)(2008-5#2)
factors for atherosclerosis##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
factors for both##2##3##(2008-3#1)(2008-5#1)
factors for cancer##2##3##(2011-2#1)(2012-6#1)
factors for development of##2##4##(2008-12#1)(2008-7#1)
factors for disease##2##3##(1994-3#1)(2008-10#1)
factors for falls##2##3##(2008-7#2)
factors for hypoxemia##3##3##(2012-2#3)
factors for renal-cell cancer##2##4##(1992-10#2)
factors for stroke##5##3##(2007-10#4)(2008-8#1)
factors for successful##5##3##(1995-5#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-1#1)
factors for suicide##3##3##(2008-11#1)(2009-7#2)
factors for survival were##2##4##(2006-10#1)(2010-3#1)
factors for survival##5##3##(2006-10#1)(2009-1#1)(2010-3#2)(2012-3#1)
factors for the development of##3##5##(2008-1#1)(2011-1#1)(2013-7#1)
factors for the development##4##4##(1993-3#1)(2008-1#1)(2011-1#1)(2013-7#1)
factors for the##24##3##(1993-3#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#2)
factors for uterine cervical neoplasms##2##5##(2012-12#2)
factors for##266##2##(1990-6#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#1)(1993-2#2)(1993-3#4)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(2006-10#2)(2006-6#1)(2007-10#10)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#19)(2008-11#9)(2008-12#6)(2008-3#12)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#17)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#4)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-2#20)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#10)(2012-3#8)(2012-6#2)(2013-1#16)(2013-7#2)(2013-8#11)
factors found in##2##3##(2008-10#2)
factors found##5##2##(1994-1#1)(2008-10#3)(2012-12#1)
factors from##12##2##(1990-12#1)(1991-8#1)(1992-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
factors had##6##2##(1990-12#1)(2008-10#2)(2008-7#1)(2009-7#1)(2012-3#1)
factors has been##3##3##(1993-3#1)(2007-10#1)(2007-12#1)
factors has##7##2##(1991-8#1)(1993-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-9#1)
factors have been identified as##2##5##(2008-1#1)(2008-11#1)
factors have been identified that can##2##6##(2008-12#1)(2008-6#1)
factors have been identified##6##4##(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-11#1)(2011-1#1)
factors have been##15##3##(1992-10#1)(1993-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-1#1)
factors have not##2##3##(2008-10#1)(2008-12#1)
factors have##32##2##(1991-6#1)(1992-10#1)(1993-3#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)(2013-8#1)
factors identified by##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
factors identified##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
factors implicated in the##2##4##(1991-8#1)(2009-5#1)
factors implicated in##3##3##(1991-8#1)(2008-1#1)(2009-5#1)
factors in a##8##3##(1993-10#1)(2010-4#2)(2010-6#1)(2012-2#1)(2013-8#3)
factors in an##2##3##(1997-6#1)(2009-10#1)
factors in causing##2##3##(2008-10#1)(2009-4#1)
factors in combination##3##3##(1992-12#1)(1994-11#1)(2008-8#1)
factors in designing##2##3##(1996-1#1)(2011-1#1)
factors in determining the##3##4##(1994-12#1)(2007-8#1)(2008-10#1)
factors in determining##8##3##(1994-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-8#1)(2011-2#1)
factors in early##2##3##(2008-7#1)(2011-2#1)
factors in human##2##3##(1993-8#1)(2008-4#1)
factors in implant site development##2##5##(2007-12#2)
factors in its##2##3##(2006-10#1)(2008-7#1)
factors in muscle##2##3##(1994-2#1)(2008-3#1)
factors in radiation pulmonary carcinogenesis##2##5##(2008-7#2)
factors in relation to##2##4##(2009-4#1)(2012-2#1)
factors in the etiology##2##4##(2008-1#1)(2008-8#1)
factors in the pathogenesis of##3##5##(1997-6#1)(2008-1#1)(2013-8#1)
factors in the study##2##4##(2008-10#1)(2010-1#1)
factors in the##72##3##(1990-9#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#16)
factors in these##2##3##(1996-2#1)(2008-4#1)
factors in various##2##3##(2008-6#1)(2013-1#1)
factors in##232##2##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#1)(1997-9#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#13)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#4)(2010-8#2)(2011-1#7)(2011-2#15)(2011-9#1)(2012-1#4)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#5)(2013-8#24)
factors include the##2##3##(2010-12#1)(2011-1#1)
factors include##14##2##(1992-12#1)(1993-1#1)(1993-3#1)(1993-9#1)(1995-2#1)(2007-11#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
factors included in the##2##4##(2008-10#2)
factors included##8##2##(1990-6#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-9#1)(2013-1#1)
factors including age##3##3##(2011-2#2)(2013-8#1)
factors including the##3##3##(2008-11#1)(2009-11#1)(2011-2#1)
factors including##22##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
factors increase the##3##3##(1995-3#1)(2008-2#1)(2008-7#1)
factors increase##4##2##(1991-12#1)(1995-3#1)(2008-2#1)(2008-7#1)
factors independently##2##2##(2008-7#1)(2013-1#1)
factors inducing##3##2##(2008-10#1)(2013-1#2)
factors influence the##7##3##(1992-1#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
factors influence##17##2##(1992-1#1)(1992-11#1)(1996-1#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
factors influenced##2##2##(2008-12#1)(2008-7#1)
factors influencing the determination of##2##5##(2008-10#2)
factors influencing the##18##3##(1992-12#1)(1993-1#1)(1993-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-6#1)(2012-3#1)
factors influencing this##2##3##(1991-6#1)(2011-2#1)
factors influencing##48##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
factors interact in##2##3##(2008-11#1)(2008-8#1)
factors interact with##3##3##(2008-3#1)(2008-9#1)(2012-12#1)
factors interact##5##2##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
factors interacting with##2##3##(1997-4#1)(2008-6#1)
factors interacting##3##2##(1997-4#1)(2008-11#1)(2008-6#1)
factors into##3##2##(2008-7#1)(2009-7#1)(2011-1#1)
factors investigated##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
factors involved and##2##3##(1990-6#1)(2009-8#1)
factors involved in the##6##4##(1997-6#1)(1997-8#2)(2008-11#1)(2009-6#1)(2011-2#1)
factors involved in##18##3##(1993-12#1)(1994-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-5#2)(2009-6#1)(2011-2#1)(2013-1#2)
factors involved##25##2##(1990-6#1)(1993-12#1)(1994-6#1)(1994-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-6#2)(2009-8#1)(2011-2#1)(2013-1#3)
factors is necessary##2##3##(1995-6#1)(2008-11#1)
factors is the##2##3##(2009-10#1)(2010-7#1)
factors is##24##2##(1991-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
factors known to##4##3##(1995-8#1)(2007-12#1)(2007-7#1)(2008-1#1)
factors known##7##2##(1995-8#1)(1997-4#3)(2007-12#1)(2007-7#1)(2008-1#1)
factors leading to the##2##4##(1991-12#1)(2010-6#1)
factors leading to##9##3##(1991-12#1)(2007-11#1)(2008-1#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-1#1)
factors led##2##2##(2008-10#1)(2009-7#1)
factors like##6##2##(2008-11#2)(2008-4#1)(2009-4#1)(2010-5#1)(2012-12#1)
factors likely to##3##3##(1997-3#1)(1997-4#1)(2008-2#1)
factors limiting the##2##3##(2008-3#1)(2008-7#1)
factors limiting##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
factors linked to##4##3##(2007-12#1)(2007-2#1)(2013-1#2)
factors may be more##2##4##(2013-1#2)
factors may be##13##3##(1994-2#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
factors may contribute to the##3##5##(1992-10#1)(2011-2#1)(2012-3#1)
factors may contribute##4##3##(1992-10#1)(1996-2#1)(2011-2#1)(2012-3#1)
factors may play##2##3##(2008-2#1)(2013-1#1)
factors may##37##2##(1992-10#1)(1992-2#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)
factors might##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
factors must be considered##3##4##(2009-10#1)(2009-8#1)(2013-8#1)
factors must be##7##3##(1993-2#1)(1996-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2013-8#1)
factors namely##2##2##(2008-10#2)
factors necessary for##2##3##(2008-1#1)(2009-8#1)
factors need##2##2##(2008-9#1)(2010-10#1)
factors not##2##2##(2008-11#1)(2011-1#1)
factors obtained##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
factors of 0##2##3##(2008-10#1)(2008-9#1)
factors of ADRs##2##3##(2011-2#2)
factors of allergic rhinitis##2##4##(2008-3#1)(2013-1#1)
factors of anemia##2##3##(2011-2#1)(2012-12#1)
factors of atherosclerosis##2##3##(2008-7#2)
factors of cardiovascular diseases in##2##5##(1991-6#1)(2009-10#1)
factors of cardiovascular diseases##3##4##(1991-6#1)(2008-11#1)(2009-10#1)
factors of job strain in##2##5##(2008-10#2)
factors of job##4##3##(1991-12#1)(2008-10#2)(2010-12#1)
factors of recurrent##4##3##(2007-8#4)
factors of risk##2##3##(1993-9#1)(2012-3#1)
factors of the##19##3##(1991-6#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-8#1)(2012-1#1)(2013-1#2)(2013-8#2)
factors of this##3##3##(1994-12#1)(2007-8#1)(2008-9#1)
factors of##141##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-8#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#3)(2009-4#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#11)
factors on infrared##2##3##(2008-10#1)(2012-2#1)
factors on the##19##3##(1991-12#1)(1992-3#1)(1993-12#2)(1994-12#1)(1995-6#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#2)(2012-2#1)(2013-1#2)(2013-7#1)
factors on##65##2##(1990-6#1)(1991-12#1)(1992-3#2)(1992-9#2)(1993-12#3)(1994-12#1)(1994-5#1)(1995-1#1)(1995-6#2)(1996-2#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
factors or##12##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(2007-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
factors other than##8##3##(1990-2#1)(1990-5#1)(1991-2#1)(1995-2#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
factors over##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
factors play a role in the##2##6##(2008-12#1)(2008-5#1)
factors play a##3##3##(2008-12#1)(2008-5#1)(2010-10#1)
factors play##7##2##(1993-12#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
factors played a role in##3##5##(2008-12#1)(2008-6#1)(2008-9#1)
factors plays a##2##3##(1994-12#1)(2008-11#1)
factors predisposing##2##2##(2008-4#1)(2010-6#1)
factors present in##2##3##(1990-12#1)(1992-8#1)
factors present##6##2##(1990-12#1)(1992-8#1)(1994-2#1)(2008-11#1)(2008-8#1)(2010-10#1)
factors probably##4##2##(1992-10#1)(1996-3#1)(2008-6#1)(2008-7#1)
factors rather than##2##3##(2007-10#1)(2010-5#1)
factors regulating the##2##3##(1997-7#1)(2011-1#1)
factors regulating##5##2##(1997-7#1)(2007-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
factors related to the##9##4##(1991-12#1)(1992-3#1)(2008-1#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
factors related to##26##3##(1990-8#1)(1991-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
factors related with##2##3##(2008-10#1)(2013-8#1)
factors related##28##2##(1990-8#1)(1991-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
factors relating to##2##3##(1994-12#1)(2011-2#1)
factors released##2##2##(2012-4#1)(2013-1#1)
factors remain##2##2##(2008-10#2)
factors remains##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
factors required for##6##3##(1990-5#1)(1995-3#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
factors required##8##2##(1990-5#1)(1992-9#1)(1995-3#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
factors responsible for the##3##4##(1997-4#1)(1997-7#1)(2008-12#1)
factors responsible for##13##3##(1991-6#1)(1992-12#1)(1995-12#1)(1997-4#2)(1997-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
factors seem to##2##3##(2008-10#1)(2008-5#1)
factors should be considered##6##4##(1992-8#1)(1993-1#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-9#1)
factors should be##7##3##(1992-8#1)(1993-1#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
factors show##2##2##(2007-8#1)(2010-6#1)
factors showed##3##2##(2008-1#1)(2008-7#1)(2012-12#1)
factors significantly##5##2##(1996-3#1)(2007-9#1)(2008-7#1)(2011-1#1)(2011-2#1)
factors such as age and##3##5##(1990-3#1)(1994-3#1)(2012-12#1)
factors such as age##4##4##(1990-3#1)(1994-3#1)(2008-10#1)(2012-12#1)
factors such as genetic##2##4##(1996-3#1)(2008-1#1)
factors such as organic##2##4##(2008-10#1)(2008-12#1)
factors such as pH##3##4##(1995-11#1)(2008-10#2)
factors such as platelet-derived growth##2##5##(1995-11#2)
factors such as the##10##4##(1994-8#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
factors such as##97##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1993-12#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#5)(2008-10#14)(2008-11#7)(2008-12#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
factors tested##2##2##(1993-12#1)(1994-12#1)
factors than the##2##3##(2008-11#1)(2009-7#1)
factors than##6##2##(1996-12#1)(2007-11#1)(2008-11#1)(2009-5#1)(2009-7#1)(2012-1#1)
factors that affect the##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
factors that affect##12##3##(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)
factors that are associated with##4##5##(1994-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
factors that are important##2##4##(2008-8#1)(2010-2#1)
factors that are involved in##4##5##(1993-12#1)(2006-6#1)(2008-11#1)(2008-7#1)
factors that are##23##3##(1991-5#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
factors that can##3##3##(1992-1#1)(2008-2#1)(2013-1#1)
factors that contribute to the##4##5##(2008-10#2)(2008-11#1)(2008-3#1)
factors that contribute to##13##4##(1996-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
factors that control##2##3##(1990-7#1)(2010-12#1)
factors that could##7##3##(1990-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2013-1#1)(2013-8#1)
factors that determine the##3##4##(2008-2#1)(2008-9#1)(2011-1#1)
factors that determine##8##3##(1993-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-7#1)
factors that determines##2##3##(2008-10#1)(2008-3#1)
factors that explain##2##3##(2007-11#1)(2007-7#1)
factors that facilitate##2##3##(2008-11#1)(2008-12#1)
factors that have been##4##4##(1995-2#1)(1997-1#1)(2008-10#1)(2011-2#1)
factors that have##8##3##(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
factors that hinder##2##3##(2008-7#1)(2011-2#1)
factors that impact##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
factors that increase##2##3##(2009-12#1)(2010-6#1)
factors that induce##3##3##(1994-5#1)(1994-9#1)(2008-3#1)
factors that influence the sensitivity of##2##6##(2008-11#1)(2008-2#1)
factors that influence the##22##4##(1991-11#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2010-10#1)(2011-1#1)(2013-8#1)
factors that influence##35##3##(1991-11#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#3)(2009-6#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
factors that influenced the##6##4##(1990-10#1)(1991-2#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
factors that influenced##8##3##(1990-10#1)(1991-2#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
factors that inhibit the##2##4##(2007-10#1)(2010-12#1)
factors that interact with##4##4##(1992-12#1)(1997-4#1)(2008-10#1)(2008-2#1)
factors that lead to##4##4##(2007-12#1)(2008-2#1)(2013-1#1)(2013-7#1)
factors that lead##5##3##(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)(2013-7#1)
factors that led to##3##4##(2008-3#1)(2008-8#1)(2009-4#1)
factors that limit the##2##4##(2008-2#1)(2008-3#1)
factors that limit##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
factors that make##2##3##(1992-2#1)(2007-12#1)
factors that may be##3##4##(2008-10#1)(2010-1#1)(2010-4#1)
factors that may##13##3##(1993-1#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
factors that might influence##2##4##(1993-1#1)(2010-2#1)
factors that might##9##3##(1993-1#1)(1993-12#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#2)(2010-2#1)
factors that need to be considered when##2##7##(2008-4#1)(2009-1#1)
factors that predict##5##3##(1995-3#1)(1995-9#1)(2008-2#1)(2012-12#1)(2013-8#1)
factors that predispose to##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
factors that regulate the##2##4##(1995-6#1)(1996-12#1)
factors that regulate##6##3##(1995-6#1)(1995-8#1)(1996-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
factors that shape the##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
factors that should be##2##4##(1992-12#1)(2013-1#1)
factors that should##3##3##(1992-12#1)(2008-11#1)(2013-1#1)
factors that underlie##2##3##(2008-8#1)(2009-3#1)
factors that were##5##3##(1997-4#1)(2007-7#1)(2008-12#1)(2010-8#1)(2012-3#1)
factors that will##2##3##(1995-2#1)(1997-1#1)
factors that##267##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#3)(1993-1#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(2006-6#2)(2007-10#4)(2007-11#1)(2007-12#4)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#26)(2008-11#12)(2008-12#6)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#5)(2008-7#11)(2008-8#11)(2008-9#12)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#5)
factors themselves##2##2##(1995-6#1)(2008-10#1)
factors then##2##2##(2008-5#1)(2010-2#1)
factors through##3##2##(1994-8#1)(2009-7#1)(2010-10#1)
factors to be##4##3##(2007-10#1)(2008-10#1)(2010-8#1)(2012-12#1)
factors to consider in##2##4##(1993-1#1)(2009-12#1)
factors to consider when##2##4##(1991-12#1)(2009-8#1)
factors to consider##4##3##(1991-12#1)(1993-1#1)(2009-12#1)(2009-8#1)
factors to predict##4##3##(1994-2#1)(1995-4#1)(2007-12#1)(2013-8#1)
factors to regulate##4##3##(1994-5#1)(1995-2#1)(2008-9#1)(2011-2#1)
factors to the##10##3##(1992-12#1)(1992-5#1)(1994-9#1)(1996-12#1)(1997-5#1)(2008-11#1)(2009-2#1)(2009-4#1)(2012-2#1)(2013-1#1)
factors to##52##2##(1990-3#1)(1991-12#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#3)(1997-5#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
factors together##2##2##(1995-5#1)(2012-3#1)
factors under##2##2##(1992-2#1)(2009-9#1)
factors underlying##3##2##(1993-1#1)(2012-12#1)(2013-8#1)
factors used in##2##3##(1992-12#1)(2008-10#1)
factors vary##2##2##(2007-11#1)(2008-5#1)
factors was##11##2##(1991-12#1)(1991-6#1)(1992-6#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
factors were all##2##3##(2008-11#1)(2011-1#1)
factors were associated with##7##4##(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-1#2)(2012-2#1)
factors were considered##2##3##(2008-3#1)(2008-7#1)
factors were determined##2##3##(2008-12#1)(2013-1#1)
factors were explored##2##3##(2009-5#1)(2013-1#1)
factors were found to be##3##5##(1994-2#1)(2008-2#1)(2012-2#1)
factors were found##4##3##(1994-2#1)(2008-2#1)(2011-2#1)(2012-2#1)
factors were identified##4##3##(2008-10#1)(2009-3#1)(2010-3#1)(2012-12#1)
factors were investigated##5##3##(2008-10#5)
factors were more important##2##4##(2008-7#1)(2008-9#1)
factors were obtained##2##3##(2008-6#1)(2008-7#1)
factors were studied##2##3##(2010-7#1)(2011-2#1)
factors were systematically##2##3##(2008-10#1)(2012-12#1)
factors were##77##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
factors when##4##2##(1994-1#2)(2008-6#1)(2012-3#1)
factors which affect the##3##4##(2008-10#1)(2008-8#1)(2010-8#1)
factors which affect##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)
factors which are##3##3##(1990-11#1)(1990-6#1)(2013-8#1)
factors which can##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
factors which could##2##3##(2007-11#1)(2008-10#1)
factors which determine the##3##4##(1992-6#1)(1997-2#1)(2008-10#1)
factors which have been##2##4##(2007-10#1)(2010-8#1)
factors which have##4##3##(1990-11#1)(2007-10#1)(2008-11#1)(2010-8#1)
factors which influence the##2##4##(2008-11#1)(2013-8#1)
factors which influence##4##3##(2008-11#1)(2010-9#1)(2013-8#2)
factors which may affect##2##4##(2008-10#1)(2008-12#1)
factors which may##5##3##(1990-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
factors which might##2##3##(1991-6#1)(2008-5#1)
factors which were##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
factors which##52##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#2)(1991-6#1)(1992-1#1)(1992-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#2)(2010-9#2)(2011-2#1)(2013-1#1)(2013-8#3)
factors will##5##2##(2008-9#2)(2010-6#1)(2010-8#1)(2013-1#1)
factors with##13##2##(1990-6#1)(1992-12#1)(1993-6#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2009-9#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
factors within##2##2##(1994-12#1)(2010-3#1)
factors##3646##1##(1990-10#1)(1990-11#5)(1990-12#15)(1990-2#4)(1990-3#6)(1990-5#8)(1990-6#20)(1990-7#3)(1990-8#4)(1990-9#7)(1991-1#5)(1991-11#7)(1991-12#29)(1991-2#8)(1991-3#9)(1991-4#4)(1991-5#5)(1991-6#13)(1991-7#1)(1991-8#7)(1991-9#1)(1992-1#9)(1992-10#7)(1992-11#9)(1992-12#24)(1992-2#11)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#7)(1992-8#8)(1992-9#10)(1993-1#14)(1993-10#1)(1993-11#8)(1993-12#29)(1993-2#14)(1993-3#23)(1993-5#7)(1993-6#10)(1993-8#7)(1993-9#15)(1994-1#7)(1994-11#14)(1994-12#26)(1994-2#19)(1994-3#15)(1994-5#9)(1994-6#7)(1994-7#3)(1994-8#15)(1994-9#10)(1995-1#5)(1995-11#9)(1995-12#17)(1995-2#13)(1995-3#16)(1995-4#1)(1995-5#6)(1995-6#14)(1995-8#14)(1995-9#3)(1996-1#9)(1996-10#1)(1996-11#5)(1996-12#28)(1996-2#26)(1996-3#18)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#12)(1997-2#11)(1997-3#9)(1997-4#26)(1997-5#7)(1997-6#5)(1997-7#10)(1997-8#11)(1997-9#1)(2006-10#12)(2006-6#4)(2007-10#56)(2007-11#30)(2007-12#35)(2007-2#4)(2007-4#2)(2007-5#5)(2007-6#4)(2007-7#26)(2007-8#29)(2007-9#5)(2008-1#70)(2008-10#387)(2008-11#155)(2008-12#63)(2008-2#58)(2008-3#79)(2008-4#58)(2008-5#85)(2008-6#50)(2008-7#157)(2008-8#76)(2008-9#89)(2009-1#5)(2009-10#19)(2009-11#4)(2009-12#17)(2009-2#11)(2009-3#5)(2009-4#27)(2009-5#33)(2009-6#15)(2009-7#31)(2009-8#33)(2009-9#5)(2010-1#13)(2010-10#37)(2010-11#18)(2010-12#13)(2010-2#14)(2010-3#18)(2010-4#18)(2010-5#16)(2010-6#25)(2010-7#11)(2010-8#30)(2010-9#12)(2011-1#100)(2011-2#198)(2011-3#2)(2011-9#1)(2012-1#21)(2012-12#84)(2012-2#100)(2012-3#70)(2012-4#1)(2012-5#2)(2012-6#3)(2013-1#160)(2013-3#2)(2013-7#22)(2013-8#104)
factors) and##4##2##(1990-6#1)(2007-10#1)(2011-2#1)(2012-3#1)
factors)##12##1##(1990-6#1)(1991-6#1)(1995-11#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
factors]##11##1##(1990-9#1)(1991-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
factory workers##6##2##(1991-12#3)(2008-11#3)
factory##19##1##(1991-12#3)(2007-12#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-8#1)(2009-12#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
facts about##4##2##(1994-9#1)(1996-8#1)(1997-1#1)(2008-10#1)
facts and##7##2##(1991-2#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2012-12#1)(2013-1#1)
facts of##2##2##(2007-11#1)(2007-4#1)
facts that##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2010-7#1)
facts##46##1##(1990-2#1)(1990-5#2)(1991-2#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-11#1)(1994-1#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#2)(2006-10#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#1)
factual##5##1##(1992-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(2008-10#1)
facultative anaerobes##3##2##(2008-12#3)
facultative##8##1##(1990-2#1)(1991-8#1)(2008-12#4)(2008-5#1)(2011-2#1)
facultatively##3##1##(2008-10#2)(2011-2#1)
faculties and##2##2##(2011-1#1)(2013-1#1)
faculties##5##1##(1991-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
faculty and##5##2##(1993-2#1)(1996-1#2)(2008-11#1)(2013-1#1)
faculty applicants##3##2##(2012-3#3)
faculty are##3##2##(2008-11#1)(2010-3#1)(2012-3#1)
faculty as##3##2##(2008-12#2)(2013-1#1)
faculty development and curriculum renewal##2##5##(1993-2#2)
faculty development for##2##3##(2009-12#2)
faculty development program##3##3##(2012-3#2)(2013-1#1)
faculty development##12##2##(1993-2#2)(1996-2#1)(2009-12#2)(2011-1#1)(2012-1#1)(2012-3#3)(2013-1#2)
faculty from##3##2##(1992-1#1)(2008-12#1)(2009-4#1)
faculty in##5##2##(1993-1#1)(2008-11#1)(2009-4#1)(2012-1#1)(2012-3#1)
faculty member##2##2##(1993-2#1)(1996-1#1)
faculty members and##2##3##(1996-2#1)(2008-5#1)
faculty members##15##2##(1992-1#2)(1996-2#1)(1996-3#3)(2008-11#2)(2008-12#3)(2008-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
faculty of##5##2##(2008-11#1)(2008-12#2)(2009-10#1)(2011-1#1)
faculty practice##5##2##(2008-11#3)(2008-12#2)
faculty regarding##3##2##(2008-11#2)(2008-12#1)
faculty research##4##2##(1996-1#1)(2008-12#1)(2010-3#2)
faculty that##2##2##(2008-11#1)(2008-12#1)
faculty to##3##2##(1993-1#1)(2008-11#1)(2010-3#1)
faculty who##3##2##(2008-11#1)(2012-3#2)
faculty##134##1##(1991-12#1)(1992-1#3)(1992-6#1)(1993-1#3)(1993-2#7)(1994-9#1)(1995-1#1)(1996-1#10)(1996-2#2)(1996-3#3)(1997-2#2)(2007-10#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#20)(2008-12#20)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-4#7)(2010-3#9)(2011-1#3)(2012-1#3)(2012-2#1)(2012-3#16)(2013-1#9)(2013-8#1)
fad or##2##2##(1996-1#1)(2007-5#1)
fad##5##1##(1991-3#1)(1992-12#1)(1995-3#1)(1996-1#1)(2007-5#1)
fade away##2##2##(2009-5#1)(2010-4#1)
fade##5##1##(2008-2#2)(2008-3#1)(2009-5#1)(2010-4#1)
fading is##2##2##(2007-12#1)(2008-2#1)
fading##13##1##(1991-3#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-4#1)(2008-5#3)
faecal alpha-1-antitrypsin##3##2##(1993-8#3)
faecal coliform levels##2##3##(2007-5#2)
faecal coliform##3##2##(2007-5#3)
faecal egg counts##3##3##(1996-12#3)
faecal egg##4##2##(1996-12#3)(2011-1#1)
faecal excretion##4##2##(1991-11#1)(1995-11#3)
faecal incontinence##3##2##(1991-8#1)(2011-1#2)
faecal material##3##2##(1996-11#1)(1997-5#1)(2007-6#1)
faecal occult blood test##3##4##(1993-8#3)
faecal occult blood##5##3##(1993-8#5)
faecal samples from##7##3##(1996-12#2)(2007-7#1)(2011-2#1)(2013-1#3)
faecal samples were collected##2##4##(1996-12#1)(2007-7#1)
faecal samples were##3##3##(1996-12#1)(2007-7#2)
faecal samples##16##2##(1996-12#7)(2007-7#3)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
faecal##52##1##(1991-11#1)(1991-8#1)(1992-5#1)(1993-8#11)(1995-11#4)(1996-11#1)(1996-12#13)(1997-5#1)(2007-5#3)(2007-6#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#4)(2011-2#1)(2013-1#3)
faecalis##10##1##(1990-6#1)(1995-5#1)(2007-11#2)(2008-11#1)(2010-3#1)(2010-4#1)(2013-1#3)
faecaluria##2##1##(2009-1#1)(2012-12#1)
faeces and tissues##2##3##(1994-7#1)(1996-11#1)
faeces and##3##2##(1994-7#1)(1996-11#1)(2012-2#1)
faeces by##3##2##(2008-10#3)
faeces of##6##2##(1993-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
faeces##24##1##(1990-12#1)(1991-11#2)(1993-2#1)(1994-7#1)(1996-11#1)(1996-12#3)(1997-3#1)(2008-10#4)(2008-11#2)(2008-5#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
faible##3##1##(2008-11#1)(2008-5#1)(2011-2#1)
faibles##2##1##(2008-11#1)(2008-5#1)
fail and##2##2##(2008-7#1)(2011-2#1)
fail because##2##2##(2011-2#1)(2013-1#1)
fail in##2##2##(1996-6#1)(2010-11#1)
fail their##2##2##(2008-5#1)(2011-2#1)
fail to be##2##3##(1997-4#1)(2008-7#1)
fail to capture##2##3##(1995-5#1)(2008-1#1)
fail to control##2##3##(2009-5#1)(2012-2#1)
fail to correlate with##2##4##(2011-2#2)
fail to describe##2##3##(2008-6#1)(2012-3#1)
fail to detect##4##3##(1991-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
fail to discriminate against foreign songs recorded at 18##2##9##(2008-8#2)
fail to discriminate##3##3##(1990-11#1)(2008-8#2)
fail to exhibit##3##3##(1994-11#2)(1996-3#1)
fail to facilitate##2##3##(1995-1#1)(2008-10#1)
fail to match##2##3##(2008-10#1)(2013-8#1)
fail to provide##4##3##(1995-11#1)(1995-5#1)(1996-9#1)(2008-12#1)
fail to show##2##3##(1996-1#1)(2009-10#1)
fail to stimulate##3##3##(1990-8#1)(1997-7#1)(2008-5#1)
fail to use##2##3##(2009-10#1)(2011-3#1)
fail to##89##2##(1990-11#1)(1990-8#2)(1991-1#1)(1991-12#2)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
fail##114##1##(1990-11#1)(1990-8#2)(1991-1#1)(1991-12#2)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-11#2)(1994-3#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
failed and##2##2##(1990-6#1)(2013-1#1)
failed ankle prosthesis##2##3##(2010-5#2)
failed ankle##3##2##(2010-5#3)
failed attempts to develop##2##4##(2007-10#1)(2012-2#1)
failed attempts to##3##3##(1996-5#1)(2007-10#1)(2012-2#1)
failed because##2##2##(1991-1#1)(2013-1#1)
failed conservative treatment##2##3##(2007-11#1)(2008-9#1)
failed conservative##3##2##(2007-11#1)(2008-9#1)(2011-2#1)
failed for##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
failed in##6##2##(1991-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2010-8#1)
failed initial##2##2##(2013-1#1)(2013-8#1)
failed limb salvage##2##3##(2008-6#2)
failed or##2##2##(2010-12#1)(2013-1#1)
failed previous##2##2##(2008-10#1)(2011-1#1)
failed prosthetic grafts##2##3##(2007-7#2)
failed the##2##2##(2009-10#1)(2010-8#1)
failed to achieve##2##3##(2008-6#1)(2011-2#1)
failed to address##2##3##(2009-11#1)(2009-6#1)
failed to affect##3##3##(1995-12#1)(1995-2#1)(1995-8#1)
failed to alter the##2##4##(1994-5#1)(2008-5#1)
failed to alter##4##3##(1992-6#1)(1993-12#1)(1994-5#1)(2008-5#1)
failed to antagonize##2##3##(1997-2#2)
failed to attenuate the spatial learning deficit produced by##2##9##(1993-12#2)
failed to attenuate the##3##4##(1992-8#1)(1993-12#2)
failed to attenuate##4##3##(1992-8#1)(1993-12#2)(1997-1#1)
failed to benefit##2##3##(2008-10#1)(2012-2#1)
failed to bind##2##3##(1990-12#1)(1995-2#1)
failed to cause##3##3##(1993-11#1)(1996-12#1)(2008-10#1)
failed to complement the##2##4##(1994-12#1)(2008-8#1)
failed to complement##3##3##(1994-12#1)(1997-4#1)(2008-8#1)
failed to confirm##2##3##(2006-8#1)(2008-1#1)
failed to demonstrate any##2##4##(2009-4#1)(2011-1#1)
failed to demonstrate##7##3##(1995-5#1)(1996-5#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-3#1)
failed to detect any##2##4##(1993-2#1)(2008-10#1)
failed to detect the##3##4##(2008-10#2)(2008-5#1)
failed to detect##16##3##(1992-6#1)(1993-2#1)(1994-10#1)(1994-2#1)(1997-3#2)(2007-6#1)(2008-10#5)(2008-5#2)(2008-6#1)(2009-8#1)
failed to develop symptoms##2##4##(1997-6#1)(2008-10#1)
failed to develop##3##3##(1997-6#1)(2008-10#2)
failed to do so##2##4##(1995-8#1)(1997-1#1)
failed to enhance##4##3##(1991-6#1)(1994-5#1)(2008-10#1)(2008-11#1)
failed to form##3##3##(2008-8#2)(2013-1#1)
failed to germinate##2##3##(2008-10#2)
failed to give##2##3##(2008-12#1)(2012-12#1)
failed to identify##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
failed to improve##6##3##(1991-4#1)(1993-12#1)(1993-3#1)(1997-2#1)(2006-10#1)(2008-10#1)
failed to induce the##3##4##(1992-2#1)(1992-8#1)(2008-10#1)
failed to induce##6##3##(1992-12#1)(1992-2#1)(1992-8#1)(1997-7#1)(2008-10#1)(2008-5#1)
failed to influence##2##3##(1995-12#1)(1997-2#1)
failed to inhibit the##5##4##(1990-7#1)(1991-5#1)(1993-6#1)(1995-11#1)(1997-1#1)
failed to inhibit##8##3##(1990-7#1)(1990-8#1)(1991-5#1)(1993-6#1)(1995-11#1)(1995-12#2)(1997-1#1)
failed to keep##2##3##(1996-2#1)(1996-3#1)
failed to meet the##2##4##(1997-4#1)(2008-11#1)
failed to meet##4##3##(1995-12#1)(1997-4#1)(2008-11#2)
failed to predict##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
failed to prevent##4##3##(1993-10#1)(1994-2#1)(1995-8#1)(1996-8#1)
failed to produce##8##3##(1993-9#1)(2008-10#6)(2008-4#1)
failed to promote##2##3##(1991-2#1)(1997-7#1)
failed to protect##3##3##(1992-6#1)(1995-8#1)(1997-6#1)
failed to provide adequate##2##4##(2011-2#1)(2012-2#1)
failed to provide##6##3##(1990-3#1)(1997-5#1)(2008-10#1)(2011-2#1)(2012-2#2)
failed to reach##3##3##(1992-11#1)(1994-3#1)(2007-10#1)
failed to reduce the infarct##2##5##(1995-12#1)(2011-2#1)
failed to reduce the##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
failed to reduce##4##3##(1995-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
failed to respond to##11##4##(1990-2#2)(1994-3#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
failed to reveal any##5##4##(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-12#1)
failed to reveal##8##3##(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-9#2)(2012-12#1)
failed to reverse##2##3##(1992-6#1)(1996-9#1)
failed to show a##5##4##(1994-2#2)(1994-3#1)(2008-1#1)(2008-10#1)
failed to show an##2##4##(1994-2#1)(2008-5#1)
failed to show any##2##4##(2008-5#1)(2010-2#1)
failed to show##14##3##(1991-6#1)(1994-2#3)(1994-3#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#1)
failed to significantly##2##3##(1997-2#1)(2008-11#1)
failed to stimulate##3##3##(1990-11#1)(1990-8#1)(1991-5#1)
failed to support sporulation##2##4##(2008-10#2)
failed to support##5##3##(2008-10#4)(2012-5#1)
failed to suppress##2##3##(1991-2#1)(2008-10#1)
failed to yield##3##3##(1994-5#1)(2008-1#1)(2008-5#1)
failed to##258##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#6)(1994-3#5)(1994-5#3)(1994-8#2)(1995-11#2)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#1)(1995-8#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#43)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#5)(2008-7#13)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#2)(2010-6#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#5)
failed with##2##2##(1993-12#1)(2008-9#1)
failed##361##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#6)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#1)(1995-8#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#5)(2008-10#55)(2008-11#13)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#8)(2008-7#16)(2008-8#8)(2008-9#7)(2009-10#3)(2009-11#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#16)(2013-8#1)
failing hearts##2##2##(2010-12#1)(2010-5#1)
failing hemodialysis grafts and##2##4##(2008-1#2)
failing to##10##2##(1992-9#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-1#3)
failing##30##1##(1992-9#1)(1994-12#1)(1995-9#1)(1997-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
fails for##2##2##(2008-2#2)
fails in the##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
fails in##5##2##(2007-12#1)(2008-3#2)(2008-8#1)(2010-11#1)
fails to detect##2##3##(1997-3#1)(2011-2#1)
fails to meet the##3##4##(1995-2#1)(1997-1#1)(2011-2#1)
fails to produce##2##3##(1991-1#1)(1994-2#1)
fails to protect##2##3##(1991-6#1)(2009-6#1)
fails to provide##2##3##(1996-5#1)(2008-3#1)
fails to##45##2##(1990-11#1)(1990-7#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-6#1)(1994-2#2)(1994-6#1)(1995-2#3)(1995-6#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#2)(2008-8#4)(2009-6#1)(2010-12#1)(2010-4#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
fails##61##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-6#1)(1994-2#2)(1994-6#1)(1995-2#3)(1995-6#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#2)(2008-8#6)(2009-6#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
failure (MOF)##4##2##(1992-5#1)(1997-1#1)(2008-4#1)(2009-7#1)
failure after##10##2##(1990-9#2)(1994-3#1)(1996-12#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
failure analysis##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
failure and a##4##3##(1992-5#1)(2008-1#1)(2008-7#1)(2009-4#1)
failure and acute##2##3##(2008-3#1)(2010-8#1)
failure and death##3##3##(1993-10#1)(2008-7#1)(2010-5#1)
failure and default##2##3##(2013-8#2)
failure and is##2##3##(2009-7#1)(2011-2#1)
failure and secondary##3##3##(1991-5#1)(1993-3#1)(2012-2#1)
failure and##63##2##(1990-3#1)(1990-9#1)(1991-5#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#4)
failure are##7##2##(1990-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)
failure as the##2##3##(2008-1#1)(2008-9#1)
failure as##6##2##(1996-11#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)
failure associated with##4##3##(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
failure at##5##2##(1997-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
failure by##3##2##(1994-8#1)(2008-11#1)(2013-8#1)
failure can be##2##3##(2007-7#1)(2012-12#1)
failure can##3##2##(2007-7#1)(2008-8#1)(2012-12#1)
failure cases##3##2##(1996-3#3)
failure continues to##2##3##(2008-11#1)(2008-3#1)
failure could##2##2##(2008-11#1)(2010-11#1)
failure did not##2##3##(1997-8#1)(2010-6#1)
failure due to##11##3##(1995-3#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
failure during the##2##3##(2008-4#1)(2011-2#1)
failure following##3##2##(1995-9#1)(2006-6#1)(2008-9#1)
failure for##2##2##(1995-3#1)(2012-2#1)
failure from##4##2##(1996-3#1)(1996-6#1)(2006-10#1)(2007-8#1)
failure has been##3##3##(1992-2#1)(2007-8#1)(2011-2#1)
failure has##6##2##(1992-2#1)(1994-7#1)(1996-6#1)(2007-8#1)(2008-3#1)(2011-2#1)
failure in a patient with##2##5##(2008-1#1)(2010-5#1)
failure in a##3##3##(2008-1#1)(2008-7#1)(2010-5#1)
failure in children##2##3##(2008-11#1)(2011-2#1)
failure in critically ill patients##3##5##(2007-8#1)(2008-3#1)(2008-5#1)
failure in the##16##3##(1991-8#1)(1994-6#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-4#4)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
failure in##63##2##(1990-8#1)(1991-8#1)(1993-12#1)(1994-6#2)(1995-2#1)(1995-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#12)(2008-11#3)(2008-3#2)(2008-4#9)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#1)
failure is a##3##3##(1996-6#1)(2008-3#1)(2010-3#1)
failure is one of the##3##5##(2008-7#1)(2010-8#1)(2011-2#1)
failure is the##2##3##(2008-1#1)(2008-3#1)
failure is##27##2##(1991-3#1)(1992-2#1)(1993-6#1)(1994-5#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-1#5)(2008-3#3)(2008-7#1)(2008-8#1)(2010-3#2)(2010-8#3)(2011-1#1)(2011-2#3)(2013-1#1)
failure may##3##2##(1992-2#1)(1992-5#1)(1996-6#1)
failure mode and effects analysis##3##5##(2008-10#1)(2011-2#1)(2012-2#1)
failure mode of##2##3##(2008-10#1)(2013-1#1)
failure mode##8##2##(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
failure modes of##2##3##(2009-10#1)(2009-7#1)
failure modes##3##2##(2009-10#1)(2009-7#1)(2013-1#1)
failure of Vim DBS##2##4##(2012-3#2)
failure of a##3##3##(1991-11#1)(1991-2#1)(2007-12#1)
failure of conservative##2##3##(2011-2#1)(2013-1#1)
failure of endoscopic therapy##2##4##(2010-12#2)
failure of endoscopic##3##3##(2008-2#1)(2010-12#2)
failure of response##2##3##(1991-5#1)(2012-1#1)
failure of the procedure##2##4##(2008-7#1)(2011-2#1)
failure of the##24##3##(1990-6#1)(1991-1#1)(1991-6#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-2#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#3)(2011-2#3)(2012-12#1)
failure of##103##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-4#2)(1996-8#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)
failure on the##4##3##(1994-5#1)(2006-10#2)(2008-10#1)
failure on##7##2##(1994-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2013-1#2)
failure or##15##2##(1992-6#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#2)
failure patients##17##2##(1995-3#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#4)(2012-2#2)(2013-1#1)
failure probability of##3##3##(2007-12#1)(2008-8#1)(2009-10#1)
failure probability##7##2##(1990-11#1)(2007-12#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-7#1)
failure properties##2##2##(2009-7#2)
failure rate of##2##3##(2008-11#1)(2011-2#1)
failure rate##6##2##(1991-6#1)(1992-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
failure rates##4##2##(2011-2#2)(2012-12#1)(2012-2#1)
failure refractory to##2##3##(1994-7#1)(2011-3#1)
failure remains##2##2##(2011-2#1)(2012-12#1)
failure requiring##2##2##(2008-1#1)(2012-2#1)
failure should be##2##3##(1990-3#1)(2011-2#1)
failure showed##2##2##(2008-1#1)(2008-5#1)
failure strength of##2##3##(2008-2#1)(2012-2#1)
failure such as##2##3##(2010-8#1)(2013-1#1)
failure syndrome##2##2##(2008-11#1)(2011-2#1)
failure time data##5##3##(1997-4#5)
failure time##11##2##(1997-3#2)(1997-4#5)(2008-10#2)(2012-3#2)
failure times##2##2##(1997-4#2)
failure to achieve##2##3##(1994-12#1)(2013-1#1)
failure to complete##3##3##(2008-10#1)(2008-2#1)(2010-6#1)
failure to diagnose##3##3##(1995-6#3)
failure to follow##2##3##(2008-11#1)(2009-6#1)
failure to respond to##2##4##(1994-12#1)(2008-5#1)
failure to thrive##6##3##(1994-3#1)(2007-7#1)(2008-1#1)(2010-6#2)(2011-1#1)
failure to##66##2##(1990-6#1)(1991-12#2)(1991-3#1)(1993-12#3)(1993-2#1)(1994-12#3)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
failure types##2##2##(1995-9#1)(2009-7#1)
failure was significantly higher in##2##5##(1996-12#1)(2007-7#1)
failure was significantly##3##3##(1996-12#1)(2007-7#1)(2008-7#1)
failure was##15##2##(1991-2#1)(1991-3#1)(1992-6#1)(1996-12#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)
failure were##4##2##(2008-1#1)(2008-6#1)(2012-2#2)
failure who are##2##3##(1993-2#1)(2010-6#1)
failure who##6##2##(1993-2#1)(1994-12#1)(2008-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
failure with preserved ejection fraction##2##5##(2011-2#2)
failure with##18##2##(1990-9#1)(1991-11#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#4)(2012-3#1)(2013-1#4)
failure without##2##2##(1993-2#1)(2008-1#1)
failure##993##1##(1990-11#2)(1990-2#2)(1990-3#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#9)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#6)(1991-5#3)(1991-6#4)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#7)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#9)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#3)(1994-7#4)(1994-8#2)(1994-9#2)(1995-12#6)(1995-2#2)(1995-3#8)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#2)(1996-11#3)(1996-12#5)(1996-2#6)(1996-3#10)(1996-4#2)(1996-5#1)(1996-6#9)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#9)(1997-4#9)(1997-5#3)(1997-7#1)(1997-8#5)(2006-10#8)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#25)(2007-8#23)(2008-1#71)(2008-10#42)(2008-11#37)(2008-12#5)(2008-2#4)(2008-3#49)(2008-4#35)(2008-5#9)(2008-6#11)(2008-7#50)(2008-8#20)(2008-9#15)(2009-10#19)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#18)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#5)(2010-12#9)(2010-3#11)(2010-4#1)(2010-5#5)(2010-6#14)(2010-8#20)(2010-9#1)(2011-1#13)(2011-2#70)(2011-3#4)(2012-1#2)(2012-12#18)(2012-2#25)(2012-3#30)(2013-1#52)(2013-8#19)
failure&quot##3##1##(1992-5#1)(2008-3#1)(2009-10#1)
failure)##5##1##(2008-9#1)(2009-9#1)(2013-1#3)
failure?##2##1##(2008-7#1)(2009-4#1)
failure?]##2##1##(1993-2#1)(1996-11#1)
failure]##18##1##(1990-3#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-7#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
failures and the##2##3##(2007-12#1)(2008-7#1)
failures and##13##2##(1990-11#1)(1991-2#1)(1993-1#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#2)
failures are##2##2##(1990-11#1)(2012-3#1)
failures could##2##2##(1994-3#2)
failures have##2##2##(2009-10#1)(2011-2#1)
failures in##4##2##(1991-8#1)(1993-12#1)(1997-4#1)(2008-5#1)
failures of##4##2##(1990-11#1)(2010-3#1)(2012-3#1)(2012-5#1)
failures that##2##2##(2011-2#1)(2012-12#1)
failures to##2##2##(1994-12#1)(2008-9#1)
failures were reported##2##3##(2009-8#1)(2012-12#1)
failures were##5##2##(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
failures with##3##2##(2010-10#1)(2010-12#1)(2013-1#1)
failures##86##1##(1990-11#3)(1991-2#2)(1991-8#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#5)(1994-9#1)(1995-3#2)(1996-11#3)(1996-3#2)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#1)
faint##11##1##(1990-7#1)(1991-12#1)(1995-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-6#1)
fainting##2##1##(2008-1#1)(2008-10#1)
faints and syncope##2##3##(2008-7#2)
fair and bad in##2##4##(2007-11#2)
fair and legitimate##2##3##(2008-7#2)
fair and one##2##3##(2007-11#1)(2009-3#1)
fair and##10##2##(1991-2#1)(1996-1#1)(2007-11#4)(2008-7#2)(2009-3#1)(2011-1#1)
fair in##4##2##(2007-11#3)(2008-6#1)
fair to good##2##3##(1996-7#1)(2010-6#1)
fair to substantial##2##3##(1997-8#2)
fair to##5##2##(1996-7#1)(1997-8#3)(2010-6#1)
fair##59##1##(1990-2#1)(1990-6#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#3)(2007-11#9)(2007-12#1)(2007-8#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
fair-rental##3##1##(1992-1#3)
fairground##2##1##(2012-2#2)
fairly accurate##3##2##(1992-6#2)(2008-11#1)
fairly close##2##2##(2008-10#1)(2008-5#1)
fairly constant##3##2##(1996-12#1)(2008-10#2)
fairly good agreement##2##3##(2008-2#1)(2008-5#1)
fairly good##12##2##(1990-10#1)(1991-6#1)(1996-6#1)(1997-5#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
fairly high##4##2##(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
fairly large amounts##2##3##(2008-11#1)(2008-3#1)
fairly large##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
fairly low##3##2##(2008-10#1)(2012-12#2)
fairly rapid##4##2##(2008-10#4)
fairly robust##2##2##(2008-3#1)(2012-1#1)
fairly selective##3##2##(1995-3#1)(2008-10#2)
fairly well with data obtained using atomic absorption spectrometry##2##9##(2008-10#2)
fairly well with data obtained using##3##6##(2008-10#3)
fairly well with data obtained##4##5##(2008-10#4)
fairly well##10##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)
fairly##108##1##(1990-10#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-6#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#32)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
fairness and##2##2##(1992-2#2)
fairness in##2##2##(2009-6#1)(2011-2#1)
fairness##8##1##(1992-2#2)(1992-3#1)(1994-3#1)(1997-3#1)(2008-8#1)(2009-6#1)(2011-2#1)
fairy##2##1##(2008-11#1)(2008-8#1)
fait##5##1##(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#2)
faite de##2##2##(2013-1#2)
faite##3##1##(2011-2#1)(2013-1#2)
faith and##4##2##(1991-2#1)(1997-5#1)(2008-12#1)(2009-11#1)
faith claims##3##2##(1993-12#2)(1994-2#1)
faith development##4##2##(2008-12#2)(2011-1#2)
faith in the##3##3##(1997-6#1)(2008-4#1)(2012-2#1)
faith in##4##2##(1990-9#1)(1997-6#1)(2008-4#1)(2012-2#1)
faith##28##1##(1990-9#1)(1991-2#1)(1992-2#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1997-5#2)(1997-6#2)(2008-1#2)(2008-12#6)(2008-4#1)(2009-11#1)(2009-5#2)(2011-1#2)(2012-2#1)(2013-1#1)
faith-based##3##1##(2009-5#2)(2012-2#1)
faithful##4##1##(1990-12#1)(1991-2#1)(1993-12#1)(2007-12#1)
faithfully##6##1##(1990-8#1)(1996-2#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
fake##3##1##(2008-2#2)(2011-3#1)
falcatum##2##1##(2008-10#1)(2008-5#1)
falciparum and 78##2##3##(2007-7#2)
falciparum and P##2##3##(2007-7#1)(2012-12#1)
falciparum and##9##2##(1992-6#1)(2007-7#3)(2008-10#1)(2010-12#1)(2010-2#2)(2012-12#1)
falciparum circumsporozoite##2##2##(1990-12#1)(1991-5#1)
falciparum genome##2##2##(2010-2#1)(2012-3#1)
falciparum in infected blood##2##4##(1991-2#2)
falciparum in##5##2##(1991-2#2)(1991-8#1)(1992-6#1)(1997-4#1)
falciparum malaria and##2##3##(2007-2#1)(2007-7#1)
falciparum malaria in a patient##2##5##(2007-2#2)
falciparum malaria in##4##3##(2007-2#3)(2012-2#1)
falciparum malaria##24##2##(1991-2#1)(1997-4#1)(2007-2#7)(2007-7#1)(2008-8#2)(2011-2#3)(2012-2#2)(2012-3#7)
falciparum parasites in infants##2##4##(1995-12#2)
falciparum plasmepsin##2##2##(2008-4#2)
falciparum##94##1##(1990-12#3)(1991-2#4)(1991-4#1)(1991-5#5)(1991-8#1)(1992-6#2)(1993-2#3)(1994-12#2)(1995-12#2)(1997-4#3)(2007-2#10)(2007-7#4)(2008-10#2)(2008-4#2)(2008-8#9)(2008-9#1)(2009-10#1)(2010-12#2)(2010-2#4)(2011-2#5)(2012-12#6)(2012-2#7)(2012-3#11)(2013-7#3)(2013-8#1)
fall 1999##2##2##(2008-10#2)
fall and early spring##2##4##(2008-10#1)(2011-2#1)
fall and rise of##3##4##(1990-7#1)(1993-3#1)(2007-11#1)
fall and spring##2##3##(2008-10#1)(2008-12#1)
fall and##12##2##(1990-7#1)(1993-3#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
fall armyworm cells##2##3##(1994-9#2)
fall below the##4##3##(2008-10#2)(2008-4#1)(2009-8#1)
fall crops##2##2##(2008-10#2)
fall down##2##2##(2007-2#1)(2008-6#1)
fall in the##7##3##(1995-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
fall in##35##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#3)(1997-4#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#8)(2010-12#1)(2010-7#2)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
fall into one of##2##4##(1997-1#1)(2010-3#1)
fall into one##3##3##(1997-1#1)(2008-2#1)(2010-3#1)
fall into the##3##3##(1996-4#1)(2008-1#1)(2008-4#1)
fall into three##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
fall into two##2##3##(1994-12#1)(2008-10#1)
fall into##16##2##(1990-5#1)(1994-11#1)(1994-12#1)(1996-4#1)(1997-1#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#1)
fall of 1997##2##3##(2008-3#1)(2008-7#1)
fall of##16##2##(1991-2#1)(1996-1#1)(2007-2#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)(2011-9#1)(2012-3#1)
fall on##3##2##(2007-12#1)(2008-4#1)(2013-1#1)
fall onto##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
fall short of the##2##4##(2008-10#1)(2008-11#1)
fall short of##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
fall short##4##2##(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#1)
fall to##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
fall under the##2##3##(2008-2#1)(2011-2#1)
fall under##3##2##(2008-2#1)(2009-11#1)(2011-2#1)
fall within a##2##3##(1993-12#1)(2008-8#1)
fall within the##2##3##(1990-2#1)(2008-11#1)
fall within##6##2##(1990-2#1)(1991-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
fall##188##1##(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#6)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#5)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2008-1#2)(2008-10#52)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-2#4)(2011-9#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
fall-planted##2##1##(2008-10#2)
fallacy##3##1##(1995-1#1)(2008-2#1)(2011-2#1)
fallax and##2##2##(2008-10#2)
fallax from M##2##3##(2008-10#2)
fallax in##2##2##(2008-10#2)
fallax isolates##2##2##(2008-10#2)
fallax was##2##2##(2008-10#2)
fallax##26##1##(2008-10#25)(2008-5#1)
falled##2##1##(2007-11#2)
fallen##13##1##(1993-6#1)(1995-12#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)
falling asleep##5##2##(2007-6#5)
falling in between##2##3##(2008-5#1)(2008-9#1)
falling in##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2008-9#1)
falling into the##2##3##(1994-2#1)(2010-8#1)
falling into##4##2##(1991-1#1)(1994-2#1)(2008-7#1)(2010-8#1)
falling off##3##2##(1993-2#1)(2009-3#1)(2012-3#1)
falling short##2##2##(1991-3#1)(1994-3#1)
falling to##4##2##(2008-11#2)(2008-2#1)(2012-3#1)
falling within##2##2##(2008-10#1)(2012-2#1)
falling##47##1##(1990-2#1)(1991-1#1)(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-6#5)(2008-10#3)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
fallopian tube reanastomosis##2##3##(1996-2#2)
fallopian tube##18##2##(1991-3#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-7#1)(1996-2#2)(2011-1#2)(2012-3#2)(2013-1#1)
fallopian tubes##2##2##(1991-12#1)(1996-2#1)
fallopian##21##1##(1991-12#1)(1991-3#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-7#1)(1996-2#3)(2008-7#1)(2011-1#2)(2012-3#2)(2013-1#1)
fallout##2##1##(1994-9#1)(2012-2#1)
fallow##6##1##(2008-10#4)(2008-12#1)(2011-2#1)
falls among##3##2##(2008-7#3)
falls and##7##2##(1990-9#1)(1992-4#1)(1994-12#1)(2007-11#1)(2008-7#2)(2010-11#1)
falls below##3##2##(1995-8#1)(2008-3#2)
falls in blood pressure##2##4##(1990-5#1)(1995-12#1)
falls in the##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
falls in##15##2##(1990-5#2)(1991-9#1)(1994-12#2)(1994-6#2)(1995-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
falls into the##4##3##(1991-3#1)(2008-3#1)(2009-6#1)(2009-7#1)
falls into##5##2##(1991-3#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)
falls significantly##2##2##(1997-1#1)(2010-4#1)
falls to##4##2##(1994-12#1)(1996-3#1)(1997-3#1)(2007-11#1)
falls within the##2##3##(2008-3#1)(2010-10#1)
falls within##3##2##(2008-3#2)(2010-10#1)
falls##84##1##(1990-5#2)(1990-9#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-12#5)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#13)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#8)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#4)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
false alarms##2##2##(1996-4#1)(2008-3#1)
false and##2##2##(2008-7#1)(2011-2#1)
false aneurysm of the##2##4##(2007-8#2)
false aneurysm##3##2##(2007-8#3)
false belief##2##2##(2008-11#1)(2008-9#1)
false beliefs about##2##3##(2008-7#1)(2012-3#1)
false discovery rate##5##3##(2008-7#1)(2010-3#2)(2012-3#1)(2013-8#1)
false discovery rates##2##3##(2009-9#1)(2012-3#1)
false discovery##7##2##(2008-7#1)(2009-9#1)(2010-3#2)(2012-3#2)(2013-8#1)
false lumen##5##2##(1991-2#1)(2008-11#3)(2011-2#1)
false memories##2##2##(2008-2#2)
false negative results##7##3##(1990-6#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-7#1)
false negative##12##2##(1990-6#1)(1992-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)
false negatives with the##2##4##(1991-4#2)
false negatives##9##2##(1991-4#2)(1994-11#1)(1996-9#2)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
false positive and##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
false positive findings##2##3##(2008-8#2)
false positive results##4##3##(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#1)
false positive##20##2##(1990-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-2#2)(2012-2#1)
false positives##8##2##(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
false##106##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-4#2)(1992-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-9#2)(1997-2#2)(1997-4#5)(1997-5#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-8#4)(2008-1#2)(2008-10#9)(2008-11#10)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-3#4)(2011-2#9)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#2)
false-alarm rates##2##2##(2008-10#1)(2008-2#1)
false-alarm##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
false-negative report##2##2##(1992-8#2)
false-negative results##6##2##(1990-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
false-negative##12##1##(1990-3#1)(1992-8#4)(1994-1#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
false-negatives##6##1##(2010-10#1)(2012-12#5)
false-positive CEA values in the##2##5##(1991-4#2)
false-positive result##2##2##(1990-3#1)(1996-9#1)
false-positive results##8##2##(1990-3#1)(1997-4#1)(2008-11#1)(2008-7#2)(2011-2#2)(2012-12#1)
false-positive##24##1##(1990-3#3)(1991-4#2)(1996-12#1)(1996-9#1)(1997-4#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
false-positives##4##1##(1991-2#1)(2008-7#1)(2010-10#1)(2012-12#1)
falsely##7##1##(1995-2#1)(1996-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#2)
fam##2##1##(2008-5#1)(2013-8#1)
familial AD##3##2##(1994-8#1)(1995-8#1)(1996-5#1)
familial Alzheimer disease##3##3##(1990-3#3)
familial Alzheimer's disease##2##3##(1995-8#1)(1996-5#1)
familial Mediterranean fever##2##3##(1992-9#1)(1997-5#1)
familial adenomatous polyposis (FAP)##4##4##(2008-11#1)(2008-4#1)(2009-12#2)
familial adenomatous polyposis and##2##4##(1991-6#1)(2012-3#1)
familial adenomatous polyposis coli##3##4##(2007-4#1)(2012-1#2)
familial adenomatous polyposis##13##3##(1991-6#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-12#5)(2011-2#1)(2012-1#2)(2012-3#1)
familial aggregation##3##2##(1992-9#1)(2011-1#2)
familial amyloidotic polyneuropathy in##2##4##(1990-5#2)
familial amyloidotic polyneuropathy##4##3##(1990-5#2)(1992-8#2)
familial and sporadic##2##3##(2007-10#1)(2010-12#1)
familial and##4##2##(1991-6#1)(1997-5#1)(2007-10#1)(2010-12#1)
familial association of##2##3##(2008-7#1)(2010-4#1)
familial autosomal dominant##3##3##(1997-8#2)(2008-8#1)
familial breast cancer##2##3##(1997-8#1)(2007-5#1)
familial cardiac amyloidosis##2##3##(1992-8#2)
familial caregivers of ventilator-assisted children##2##5##(2010-7#2)
familial coaggregation##9##2##(1997-5#9)
familial combined hyperlipidemia##2##3##(1993-12#2)
familial disease with##2##3##(2008-7#1)(2011-2#1)
familial episodic ataxias##2##3##(2012-3#2)
familial factors##4##2##(2007-7#1)(2008-10#1)(2010-3#1)(2011-2#1)
familial form of##3##3##(1997-3#1)(2008-7#1)(2012-1#1)
familial glucocorticoid deficiency##2##3##(1993-11#2)
familial hypercholesterolaemia##2##2##(1992-12#1)(2012-2#1)
familial hypercholesterolemia (FH)##2##3##(1993-12#1)(2007-10#1)
familial hypercholesterolemia##7##2##(1990-12#1)(1990-2#1)(1991-11#3)(1993-12#1)(2007-10#1)
familial incidence##2##2##(2008-7#2)
familial juvenile##2##2##(2007-7#1)(2008-4#1)
familial medullary thyroid carcinoma##2##4##(1990-3#1)(2008-1#1)
familial moyamoya disease population##2##4##(2007-10#2)
familial moyamoya disease##7##3##(2007-10#7)
familial multiple sclerosis##2##3##(2011-2#2)
familial occurrence of##2##3##(1990-9#1)(1991-3#1)
familial occurrence##3##2##(1990-9#1)(1991-3#1)(2010-6#1)
familial or##3##2##(1996-11#1)(2007-10#1)(2009-5#1)
familial polyposis##2##2##(1990-6#2)
familial susceptibility##2##2##(2012-12#1)(2013-8#1)
familial tendency##2##2##(2011-2#1)(2012-12#1)
familial##166##1##(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#2)(1990-6#2)(1990-9#2)(1991-1#2)(1991-11#3)(1991-2#2)(1991-3#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#5)(1993-6#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-5#3)(1997-3#1)(1997-5#13)(1997-7#1)(1997-8#3)(2007-10#14)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#5)(2008-7#11)(2008-8#3)(2009-10#1)(2009-12#6)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#9)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#1)(2013-8#1)
familiar and unfamiliar faces##2##4##(2008-1#2)
familiar and unfamiliar##6##3##(2008-1#2)(2010-2#4)
familiar and##9##2##(1994-8#1)(2007-12#1)(2008-1#2)(2010-2#4)(2011-2#1)
familiar faces##3##2##(2008-1#3)
familiar herdmates and##2##3##(2010-2#2)
familiar local##2##2##(2008-4#2)
familiar melodies##3##2##(2008-9#3)
familiar objects##3##2##(1993-6#1)(2007-12#2)
familiar or##2##2##(2010-2#2)
familiar to##5##2##(1990-6#1)(1995-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
familiar tool##2##2##(2007-12#1)(2009-2#1)
familiar with its clinical##2##4##(2008-11#1)(2013-8#1)
familiar with its##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
familiar with the##14##3##(1991-1#1)(1992-2#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-8#1)(2012-2#1)
familiar with##26##2##(1990-8#1)(1991-1#1)(1992-2#1)(1994-5#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-8#1)
familiar##88##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-10#2)(1992-2#1)(1993-6#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-1#2)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#8)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
familiarity and##3##2##(1993-1#1)(2008-8#1)(2012-1#1)
familiarity for##2##2##(1997-1#1)(2008-8#1)
familiarity with the##6##3##(1991-2#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-2#1)(2013-1#1)
familiarity with##15##2##(1991-2#1)(1993-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
familiarity##30##1##(1991-2#1)(1993-1#2)(1993-3#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#1)
familiarize##5##1##(1992-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
familiarized with##3##2##(1995-3#1)(2012-1#1)(2012-12#1)
familiarized##5##1##(1995-3#1)(2012-1#3)(2012-12#1)
families according to their##2##4##(1992-4#1)(2008-5#1)
families and children##2##3##(1995-1#1)(2012-3#1)
families and patients with##2##4##(2008-1#1)(2011-2#1)
families and the##2##3##(2007-7#1)(2012-12#1)
families and two##2##3##(1992-1#1)(2008-7#1)
families and##39##2##(1990-12#1)(1990-6#1)(1991-12#3)(1992-1#1)(1994-2#1)(1995-1#2)(1995-3#1)(1995-5#1)(1996-11#1)(1997-7#1)(1997-9#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
families are##13##2##(1991-12#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
families as##4##2##(1991-12#2)(2008-7#1)(2011-1#1)
families by##2##2##(2007-5#1)(2009-11#1)
families can##2##2##(2009-5#1)(2012-3#1)
families completed##2##2##(1997-2#1)(2009-8#1)
families containing##2##2##(2010-11#1)(2011-1#1)
families could##2##2##(1992-4#1)(2008-7#1)
families during##3##2##(2007-11#1)(2013-1#2)
families encounter##2##2##(2010-9#1)(2012-3#1)
families for##4##2##(1991-12#1)(1994-1#1)(2008-11#1)(2008-8#1)
families from the##2##3##(2008-10#2)
families from##10##2##(1990-3#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#1)
families had##3##2##(1995-1#1)(2008-10#1)(2012-2#1)
families has been##2##3##(1992-7#1)(2012-2#1)
families has##3##2##(1992-12#1)(1992-7#1)(2012-2#1)
families have been##4##3##(1993-3#1)(1997-5#1)(2010-12#1)(2011-1#1)
families have##10##2##(1991-12#1)(1993-3#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#1)(2010-12#2)(2011-1#1)(2013-1#1)
families in health care##2##4##(1991-3#1)(1992-3#1)
families in health##3##3##(1991-12#1)(1991-3#1)(1992-3#1)
families in the##2##3##(2008-10#1)(2011-2#1)
families in##20##2##(1991-12#1)(1991-3#2)(1992-3#1)(1997-1#2)(1997-4#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2010-9#6)(2011-2#1)(2013-7#1)
families indicated that##3##3##(2008-10#2)(2010-8#1)
families indicated##4##2##(2008-10#3)(2010-8#1)
families is##4##2##(2007-11#1)(2008-1#1)(2008-7#1)(2013-1#1)
families manage##2##2##(2008-6#1)(2010-7#1)
families might##2##2##(1991-12#1)(2008-9#1)
families of children with##5##4##(1995-1#2)(1995-12#1)(2008-4#1)(2012-2#1)
families of children##6##3##(1995-1#3)(1995-12#1)(2008-4#1)(2012-2#1)
families of gap junction proteins##2##5##(2008-7#2)
families of older people##2##4##(2010-10#2)
families of proteins##2##3##(1994-5#1)(2008-9#1)
families of the##2##3##(2008-10#1)(2008-8#1)
families of this##2##3##(2008-4#1)(2013-8#1)
families of##61##2##(1990-12#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-2#4)(1994-5#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#5)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-8#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
families on##2##2##(1992-7#1)(2008-8#1)
families or##2##2##(1994-11#1)(2008-11#1)
families regarding##2##2##(2008-11#1)(2010-4#1)
families segregating##2##2##(1997-5#2)
families should##2##2##(2008-11#1)(2012-3#1)
families tested##2##2##(2008-10#1)(2011-2#1)
families that##7##2##(1994-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#2)(2013-1#1)
families to produce##2##3##(2008-8#2)
families to the##2##3##(1997-9#1)(2009-6#1)
families to##6##2##(1997-9#1)(2008-1#1)(2008-8#2)(2009-6#1)(2009-9#1)
families using##2##2##(2008-9#1)(2009-9#1)
families was##3##2##(1995-1#1)(1997-5#1)(2012-3#1)
families were identified##4##3##(1996-3#1)(1997-5#1)(2008-12#1)(2013-7#1)
families were##16##2##(1996-3#1)(1997-5#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
families while##3##2##(1991-12#1)(2008-11#1)(2009-11#1)
families who had##2##3##(1990-10#1)(1997-2#1)
families who have##2##3##(1995-1#1)(2010-9#1)
families who##6##2##(1990-10#1)(1993-2#1)(1995-1#1)(1997-2#1)(2010-9#1)(2013-8#1)
families whose##3##2##(1991-3#1)(2008-11#1)(2008-7#1)
families with children##4##3##(1995-5#1)(1997-2#1)(2010-12#1)(2012-2#1)
families with more##2##3##(2010-9#1)(2013-7#1)
families with the##2##3##(1993-1#1)(1997-5#1)
families with##44##2##(1990-12#2)(1991-11#1)(1992-1#1)(1993-1#2)(1993-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-5#4)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
families would##2##2##(2008-10#2)
families##622##1##(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#2)(1990-6#3)(1991-1#1)(1991-11#2)(1991-12#14)(1991-2#2)(1991-3#6)(1992-1#4)(1992-12#3)(1992-2#5)(1992-3#7)(1992-4#2)(1992-6#1)(1992-7#3)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#9)(1995-12#3)(1995-2#1)(1995-3#6)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#1)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#2)(1997-5#18)(1997-6#3)(1997-7#4)(1997-9#4)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#16)(2008-10#58)(2008-11#37)(2008-12#14)(2008-2#3)(2008-3#5)(2008-4#12)(2008-5#11)(2008-6#7)(2008-7#24)(2008-8#19)(2008-9#20)(2009-10#5)(2009-11#7)(2009-2#2)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#9)(2009-9#13)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#11)(2011-1#15)(2011-10#3)(2011-2#24)(2012-12#12)(2012-2#6)(2012-3#19)(2013-1#14)(2013-7#7)(2013-8#10)
families' lived experience##2##3##(2009-9#2)
families' lived##3##2##(2009-9#3)
families'##7##1##(1995-1#2)(2009-9#3)(2010-7#1)(2013-8#1)
families) and##2##2##(2008-11#1)(2010-8#1)
families) was##2##2##(2008-10#1)(2008-11#1)
families) were##2##2##(2008-10#1)(2008-5#1)
families)##9##1##(2007-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2010-8#1)
families]##3##1##(1990-2#1)(1990-3#1)(2008-9#1)
familism##3##1##(2008-9#1)(2009-7#2)
familistic values##2##2##(2010-1#2)
family 'Chitinophagaceae'##2##2##(2011-2#2)
family (solute carriers##2##3##(2008-7#2)
family 2##2##2##(1994-11#2)
family 46##2##2##(2009-2#2)
family Coriobacteriaceae##2##2##(2011-2#2)
family Deferribacteraceae##2##2##(2011-2#2)
family Geminiviridae##3##2##(2008-10#3)
family Geminiviridae)##3##2##(2008-10#3)
family Halobacteriaceae##2##2##(2011-2#2)
family Intrasporangiaceae##3##2##(2011-2#3)
family Potyviridae)##3##2##(2008-10#3)
family Segniliparaceae##2##2##(2011-2#2)
family adaptation##4##2##(1996-2#3)(2010-9#1)
family and a##2##3##(2008-7#1)(2013-1#1)
family and are##3##3##(1996-12#1)(1997-8#1)(2008-4#1)
family and community##5##3##(1993-3#1)(1993-5#1)(1994-2#1)(1997-6#1)(2010-8#1)
family and economic##2##3##(2012-12#2)
family and friends supported##2##4##(2007-4#2)
family and friends##8##3##(1992-12#2)(2007-4#3)(2011-1#1)(2011-2#1)(2013-1#1)
family and health##2##3##(2012-1#1)(2013-8#1)
family and may be involved in##2##6##(1997-2#1)(2008-8#1)
family and peer connections and prosocial norms##2##7##(2013-1#2)
family and peer connections##3##4##(2013-1#3)
family and peer##4##3##(2007-2#1)(2013-1#3)
family and school##2##3##(2010-1#1)(2013-1#1)
family and social##2##3##(2010-11#1)(2013-1#1)
family and the##5##3##(1990-12#2)(1997-9#1)(2008-10#1)(2013-8#1)
family and##85##2##(1990-12#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
family approach##2##2##(2011-2#1)(2012-3#1)
family are discussed##2##3##(1994-11#1)(2008-12#1)
family are##16##2##(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#2)(1996-12#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-8#1)(2011-1#1)(2011-2#1)
family as a##2##3##(1990-12#1)(2008-5#1)
family as##5##2##(1990-12#1)(1992-12#1)(1993-12#1)(2008-4#1)(2008-5#1)
family background##2##2##(2007-2#1)(2011-2#1)
family by##2##2##(1992-6#1)(1994-11#1)
family called##2##2##(2008-4#1)(2011-1#1)
family can be##2##3##(1990-5#1)(2012-3#1)
family can##3##2##(1990-5#1)(2012-12#1)(2012-3#1)
family care##2##2##(2009-5#1)(2010-10#1)
family caregivers of##2##3##(2008-6#1)(2011-2#1)
family caregivers##12##2##(1991-1#1)(2006-5#1)(2007-12#1)(2008-6#1)(2009-11#1)(2010-4#3)(2011-2#1)(2013-1#1)(2013-8#2)
family characteristics##5##2##(1993-6#1)(2008-11#1)(2009-10#1)(2011-2#2)
family classified as a domain of unknown function##2##8##(2010-10#2)
family communication##3##2##(2009-8#2)(2013-8#1)
family conflict##3##2##(2007-9#1)(2009-9#2)
family connectedness and body satisfaction##3##5##(2010-10#3)
family connectedness##5##2##(2010-10#5)
family consists of a##2##4##(1996-2#1)(2008-9#1)
family consists of##4##3##(1996-2#1)(1996-5#1)(2008-7#1)(2008-9#1)
family context##2##2##(2008-9#1)(2010-7#1)
family dinners##7##2##(2010-8#1)(2013-1#6)
family doctor##3##2##(1990-3#1)(2007-2#1)(2010-12#1)
family doctors and##2##3##(1996-11#1)(2010-4#1)
family doctors in North Holland (n =##3##7##(1991-8#3)
family doctors in##5##3##(1991-8#5)
family doctors##10##2##(1991-8#7)(1996-11#1)(2008-11#1)(2010-4#1)
family dynamics##5##2##(2008-11#2)(2009-11#2)(2013-1#1)
family effects##3##2##(2008-10#1)(2009-9#2)
family environment##7##2##(1991-6#1)(2008-7#3)(2008-9#2)(2012-3#1)
family essential for##2##3##(1991-5#1)(1995-5#1)
family factors##5##2##(1996-1#1)(2007-9#1)(2010-4#1)(2013-8#2)
family financial strain##2##3##(2007-10#2)
family for##2##2##(2008-5#1)(2011-2#1)
family formation and##2##3##(2009-10#1)(2011-2#1)
family formation##10##2##(2008-8#1)(2009-10#5)(2011-2#4)
family from##5##2##(1995-6#1)(1997-2#2)(1997-7#1)(2008-10#1)
family functioning and##3##3##(2008-9#1)(2013-1#2)
family functioning as##2##3##(2009-7#1)(2013-1#1)
family functioning profile##2##3##(2011-1#2)
family functioning was##3##3##(2013-1#3)
family functioning##21##2##(1996-1#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2011-1#2)(2013-1#10)
family gene##3##2##(1996-12#1)(1997-6#1)(2008-11#1)
family has been##4##3##(1991-6#1)(1993-12#1)(1994-12#1)(1997-6#1)
family has##7##2##(1991-6#1)(1993-12#1)(1994-12#1)(1997-6#1)(2008-4#1)(2008-7#1)(2011-1#1)
family have been##3##3##(1991-6#1)(2008-7#1)(2009-10#1)
family have##6##2##(1991-6#1)(1992-7#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
family health care model##2##4##(2011-2#2)
family health##8##2##(2008-11#1)(2008-12#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-8#1)
family histories of##2##3##(2008-3#1)(2011-2#1)
family history and##4##3##(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
family history for##2##3##(2008-10#1)(2012-3#1)
family history of T2DM##5##4##(2009-9#3)(2013-1#2)
family history of breast cancer##2##5##(1991-12#1)(1993-1#1)
family history of type 2 diabetes mellitus##2##7##(2008-3#1)(2009-9#1)
family history of##32##3##(1990-9#1)(1991-1#1)(1991-12#1)(1993-1#1)(1994-2#1)(1995-11#1)(1997-6#1)(2007-10#1)(2008-3#5)(2008-6#2)(2008-7#2)(2008-9#1)(2009-9#4)(2010-6#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
family history was##2##3##(2008-4#1)(2008-7#1)
family history##63##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1993-1#1)(1994-12#2)(1994-2#1)(1995-11#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-3#8)(2008-4#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-9#4)(2010-6#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
family in a##2##3##(1993-12#1)(2008-1#1)
family in the##4##3##(1993-12#2)(1993-6#1)(2008-7#1)
family in##20##2##(1991-11#1)(1991-2#1)(1993-12#3)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2013-8#1)
family includes##2##2##(1993-12#1)(2010-1#1)
family income of##2##3##(1993-6#1)(2013-8#1)
family income##8##2##(1993-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
family interaction##2##2##(2009-11#2)
family into##3##2##(1994-8#1)(2008-6#1)(2010-1#1)
family involvement##3##2##(2009-6#1)(2011-1#1)(2012-2#1)
family is involved in the##2##5##(1995-8#1)(2013-1#1)
family is##10##2##(1994-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
family kinases##5##2##(1995-11#1)(1995-6#3)(2012-12#1)
family level##4##2##(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
family life in the##2##4##(2010-4#1)(2013-1#1)
family life in##3##3##(2010-4#1)(2013-1#2)
family life##7##2##(2009-9#1)(2010-4#1)(2011-2#2)(2013-1#3)
family management##2##2##(2007-9#1)(2008-5#1)
family may##2##2##(1994-12#1)(2011-2#1)
family meals##4##2##(2013-1#4)
family means##2##2##(2008-10#2)
family medicine specialty##2##3##(2008-12#2)
family medicine##8##2##(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-12#4)
family member##12##2##(1992-2#1)(1992-3#2)(1993-2#3)(1995-8#1)(1996-12#1)(1996-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
family members and friends##3##4##(1996-3#2)(2011-1#1)
family members and##7##3##(1993-12#1)(1996-3#2)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
family members are##6##3##(1996-9#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#2)
family members have##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
family members in##7##3##(1990-5#1)(1992-2#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
family members of individuals with schizophrenia or other psychotic illnesses##2##10##(2011-2#2)
family members of individuals with##3##5##(2011-2#3)
family members of individuals##4##4##(2011-2#4)
family members of people with##2##5##(2009-11#1)(2011-2#1)
family members of##8##3##(2008-11#2)(2009-11#1)(2011-2#5)
family members often##2##3##(2010-4#1)(2011-2#1)
family members or##2##3##(2009-6#1)(2011-1#1)
family members with##3##3##(1994-12#1)(1997-3#1)(2009-5#1)
family members##99##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#10)(2008-4#3)(2008-6#4)(2008-7#3)(2008-9#3)(2009-11#2)(2009-12#2)(2009-5#3)(2009-6#3)(2010-11#2)(2010-4#2)(2011-1#5)(2011-2#14)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)
family members'##5##2##(1990-12#1)(1997-3#2)(2009-9#1)(2011-2#1)
family model##2##2##(1996-3#2)
family of adaptor proteins##2##4##(2012-12#2)
family of cysteine proteases##4##4##(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
family of enzymes##5##3##(1994-6#1)(2008-4#2)(2008-9#1)(2009-5#1)
family of genes##2##3##(1994-11#1)(1995-8#1)
family of growth factors##2##4##(1994-11#1)(1996-12#1)
family of intracellular##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
family of lipid##2##3##(1995-5#1)(2010-9#1)
family of long##2##3##(1995-12#1)(1996-6#1)
family of mammalian##3##3##(1995-3#2)(2008-11#1)
family of operators in##2##4##(2011-2#2)
family of peptides##2##3##(1992-6#1)(1995-12#1)
family of protein tyrosine kinases##2##5##(1996-2#2)
family of protein##4##3##(1991-11#1)(1996-2#2)(2008-10#1)
family of proteins in##3##4##(1994-9#1)(2010-10#1)(2012-12#1)
family of proteins that##2##4##(1994-6#1)(2008-4#1)
family of proteins##18##3##(1990-5#1)(1991-9#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-12#1)(2013-8#2)
family of receptors##3##3##(1992-3#1)(1993-2#1)(1993-5#1)
family of sequences##2##3##(2008-3#1)(2008-7#1)
family of serine/threonine##2##3##(1993-6#1)(1995-2#1)
family of transcription factors##7##4##(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(2008-4#1)(2009-8#2)
family of transmembrane proteins##3##4##(2008-10#1)(2009-8#2)
family of transmembrane##4##3##(1993-12#1)(2008-10#1)(2009-8#2)
family of tumors##3##3##(2008-6#2)(2011-2#1)
family of##246##2##(1990-5#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#7)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-9#1)(2007-11#2)(2007-12#7)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#11)(2008-5#3)(2008-6#8)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#3)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#3)(2010-2#2)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#9)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#4)
family or##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
family physician##9##2##(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(1997-4#2)(2008-10#1)
family physician's##2##2##(1995-3#1)(1997-2#1)
family physicians and##2##3##(2008-10#1)(2008-7#1)
family physicians in##2##3##(1995-9#1)(1996-11#1)
family physicians##11##2##(1991-3#1)(1995-9#1)(1996-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-4#1)
family physicians]##2##2##(1996-10#1)(1996-6#1)
family planning and##3##3##(1996-3#1)(2008-11#1)(2010-7#1)
family planning clinics##4##3##(1991-1#1)(1993-2#1)(1994-8#1)(2007-12#1)
family planning for##2##3##(1992-4#1)(1994-3#1)
family planning programs##4##3##(1997-2#2)(2008-7#2)
family planning services and##2##4##(1994-8#2)
family planning services##5##3##(1994-8#4)(1996-12#1)
family planning was##3##3##(1992-4#3)
family planning##47##2##(1991-1#5)(1991-3#1)(1991-6#1)(1992-4#8)(1992-5#1)(1993-2#2)(1994-3#3)(1994-7#1)(1994-8#7)(1994-9#2)(1996-12#1)(1996-3#1)(1997-2#4)(1997-5#1)(2007-12#1)(2008-11#2)(2008-7#4)(2010-1#1)(2010-7#1)
family plays an##2##3##(1993-3#1)(2012-12#1)
family policy##3##2##(2010-12#1)(2010-4#2)
family practice at##2##3##(1990-6#2)
family practice residency##2##3##(1992-1#1)(1995-3#1)
family practice##10##2##(1990-6#2)(1991-6#1)(1992-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(2008-1#1)(2012-3#1)
family practice]##2##2##(1992-4#1)(1996-6#1)
family problems##4##2##(1992-1#3)(2009-9#1)
family protein##2##2##(2008-10#1)(2010-12#1)
family proteins and##2##3##(2008-11#1)(2013-8#1)
family proteins as##2##3##(2011-2#1)(2012-12#1)
family proteins##10##2##(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-12#3)(2013-7#1)(2013-8#1)
family psychopathology and##2##3##(2008-11#2)
family relationship##2##2##(2011-2#1)(2012-12#1)
family relationships##6##2##(2007-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
family responsibilities##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
family reveals##2##2##(1993-12#1)(2008-4#1)
family risk##2##2##(1994-2#1)(2012-1#1)
family satisfaction##3##2##(1997-1#1)(2010-2#1)(2012-2#1)
family should##2##2##(2008-5#1)(2011-2#1)
family situation##2##2##(1992-3#1)(2008-9#1)
family size intentions are##2##4##(2009-12#2)
family size intentions##5##3##(2009-12#5)
family size was##2##3##(1992-4#2)
family size##15##2##(1990-6#1)(1992-4#4)(1996-8#2)(2008-12#2)(2009-12#5)(2011-2#1)
family stress##3##2##(1992-1#1)(1996-1#1)(2007-10#1)
family studies##3##2##(1990-3#1)(2008-12#1)(2009-6#1)
family study##6##2##(1991-11#1)(1992-5#1)(2007-1#1)(2007-7#1)(2008-1#1)(2013-8#1)
family support systems##2##3##(2009-7#2)
family support##14##2##(1991-12#1)(1995-1#1)(1997-2#2)(2007-8#2)(2008-7#3)(2009-7#3)(2011-1#1)(2012-12#1)
family than##2##2##(1996-1#1)(2008-12#1)
family that##5##2##(1993-6#1)(1993-9#1)(2008-8#1)(2012-12#1)(2012-3#1)
family therapy##5##2##(1990-12#1)(1996-6#1)(2007-7#1)(2008-11#1)(2008-9#1)
family transcription##2##2##(1995-6#1)(2012-1#1)
family type##2##2##(2011-1#1)(2013-1#1)
family violence##4##2##(1993-12#1)(1994-1#1)(1995-12#2)
family was##5##2##(1994-11#1)(1997-8#1)(2008-5#1)(2009-9#1)(2011-2#1)
family well being##2##3##(1995-1#2)
family were##5##2##(1993-3#1)(1993-8#1)(1993-9#1)(2008-11#1)(2008-2#1)
family which includes##2##3##(1994-12#1)(1996-12#1)
family which is represented by E##2##6##(1997-6#1)(1997-8#1)
family which##10##2##(1994-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#1)
family who##3##2##(2007-10#1)(2007-7#1)(2012-12#1)
family with a##4##3##(2007-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
family with autosomal##3##3##(1997-5#1)(1997-8#1)(2011-1#1)
family with the##2##3##(2009-8#1)(2012-3#1)
family with##22##2##(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-7#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-2#1)(2012-3#1)
family##1697##1##(1990-10#2)(1990-11#3)(1990-12#12)(1990-2#2)(1990-3#4)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#8)(1991-11#6)(1991-12#14)(1991-2#7)(1991-3#3)(1991-5#7)(1991-6#9)(1991-8#8)(1991-9#2)(1992-1#7)(1992-11#1)(1992-12#9)(1992-2#4)(1992-3#12)(1992-4#14)(1992-5#5)(1992-6#11)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#6)(1993-11#4)(1993-12#21)(1993-2#11)(1993-3#10)(1993-5#2)(1993-6#13)(1993-8#2)(1993-9#4)(1994-1#5)(1994-10#3)(1994-11#16)(1994-12#27)(1994-2#12)(1994-3#5)(1994-5#3)(1994-6#6)(1994-7#3)(1994-8#15)(1994-9#8)(1995-1#6)(1995-11#7)(1995-12#9)(1995-2#14)(1995-3#10)(1995-5#10)(1995-6#16)(1995-8#10)(1995-9#2)(1996-1#9)(1996-10#1)(1996-11#4)(1996-12#12)(1996-2#20)(1996-3#8)(1996-5#2)(1996-6#5)(1996-8#4)(1996-9#5)(1997-1#2)(1997-2#15)(1997-3#12)(1997-4#11)(1997-5#5)(1997-6#9)(1997-7#11)(1997-8#11)(1997-9#3)(2006-5#1)(2007-1#2)(2007-10#7)(2007-11#9)(2007-12#18)(2007-2#5)(2007-4#3)(2007-5#1)(2007-7#9)(2007-8#3)(2007-9#4)(2008-1#16)(2008-10#115)(2008-11#52)(2008-12#23)(2008-2#7)(2008-3#21)(2008-4#29)(2008-5#29)(2008-6#27)(2008-7#65)(2008-8#34)(2008-9#34)(2009-10#17)(2009-11#13)(2009-12#11)(2009-2#3)(2009-4#1)(2009-5#12)(2009-6#9)(2009-7#11)(2009-8#15)(2009-9#27)(2010-1#8)(2010-10#26)(2010-11#9)(2010-12#4)(2010-2#3)(2010-3#8)(2010-4#13)(2010-5#2)(2010-6#6)(2010-7#6)(2010-8#8)(2010-9#8)(2011-1#32)(2011-2#136)(2011-3#1)(2012-1#9)(2012-12#40)(2012-2#19)(2012-3#32)(2013-1#78)(2013-7#3)(2013-8#33)
family's##13##1##(1992-3#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#2)(1996-1#1)(2007-2#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
family)##6##1##(1993-11#1)(1997-5#1)(2008-10#1)(2008-4#1)(2011-2#2)
family-based intervention##3##2##(2008-1#1)(2008-12#1)(2009-12#1)
family-based interventions##2##2##(2008-6#1)(2013-1#1)
family-based therapy##2##2##(2008-6#2)
family-based##14##1##(2008-1#1)(2008-12#1)(2008-4#3)(2008-6#3)(2009-12#1)(2012-3#4)(2013-1#1)
family-centered approach##2##2##(2012-12#1)(2013-1#1)
family-centered care##8##2##(1991-12#2)(1991-3#2)(1992-3#1)(1993-12#1)(1994-3#1)(1995-1#1)
family-centered intervention##2##2##(1993-3#1)(2013-7#1)
family-centered neonatal intensive care services##2##5##(1991-12#2)
family-centered programs##2##2##(1991-12#2)
family-centered services in neonatal intensive care##3##6##(1991-12#3)
family-centered services##4##2##(1991-12#3)(1993-12#1)
family-centered##26##1##(1991-12#9)(1991-3#2)(1992-3#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-1#2)(1995-3#1)(2010-9#2)(2012-12#1)(2013-1#1)(2013-7#2)
family-centred##2##1##(2007-11#1)(2008-11#1)
family-focused##2##1##(2010-9#1)(2011-2#1)
family-planning##2##1##(1994-3#1)(2008-8#1)
family-school##2##1##(2012-12#2)
family-wise error rate (FWER)##2##4##(2009-9#1)(2012-3#1)
family/friends##3##1##(1996-3#1)(2010-2#2)
family]##3##1##(1990-12#1)(1997-8#1)(2008-5#1)
famine and##4##2##(2008-1#1)(2011-1#3)
famine##8##1##(2008-1#1)(2008-10#2)(2011-1#5)
famotidine in##3##2##(2008-10#3)
famotidine##10##1##(2008-10#6)(2010-9#1)(2012-2#3)
famous##12##1##(1993-3#1)(1994-3#1)(2008-1#2)(2008-11#1)(2008-9#2)(2009-7#2)(2012-2#1)(2012-3#1)(2013-7#1)
fan angle##3##2##(2008-2#3)
fan out##2##2##(1994-1#1)(2008-2#1)
fan##10##1##(1994-1#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)
fan-beam DT##4##2##(2008-3#4)
fan-beam##8##1##(2008-3#7)(2009-5#1)
fan-out##9##1##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)
fanconi##2##1##(2008-1#1)(2008-4#1)
fanning behavior##2##2##(2013-8#2)
fanning##12##1##(2008-2#2)(2008-3#7)(2013-8#3)
fantail and##4##2##(2010-8#4)
fantail##6##1##(2010-8#6)
fantasies##2##1##(1992-3#1)(2009-10#1)
fantasy##6##1##(1993-12#1)(1995-8#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
far a##2##2##(1991-6#1)(1997-3#1)
far above the##2##3##(2008-10#1)(2008-2#1)
far and##6##2##(1991-12#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
far as 1##2##3##(1997-6#1)(2008-10#1)
far as the authors are aware##2##6##(2011-2#2)
far as the authors##3##4##(1991-1#1)(2011-2#2)
far as the##13##3##(1990-10#1)(1991-1#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#3)(2012-12#1)
far as we know##8##4##(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
far as we##11##3##(1993-6#1)(1994-1#1)(1994-7#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
far as##50##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-9#1)(1993-6#1)(1994-1#1)(1994-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
far away from ore body rock##3##6##(2013-8#3)
far away from ore body##4##5##(2013-8#4)
far away from the##3##4##(1995-10#1)(2007-11#1)(2011-2#1)
far away from##8##3##(1995-10#1)(2007-11#1)(2007-2#1)(2011-2#1)(2013-8#4)
far away##9##2##(1995-10#1)(1996-4#1)(2007-11#1)(2007-2#1)(2011-2#1)(2013-8#4)
far been identified##2##3##(1991-12#1)(2007-7#1)
far been##16##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-2#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
far below the##8##3##(1990-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2011-2#1)
far below##11##2##(1990-5#1)(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-6#1)(2011-2#1)
far better than##3##3##(1997-1#1)(2007-11#1)(2008-10#1)
far better##4##2##(1997-1#1)(2007-11#1)(2008-10#2)
far beyond the##5##3##(1992-12#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)
far beyond##10##2##(1992-12#1)(1995-6#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#1)
far closer##2##2##(2008-2#1)(2008-7#1)
far exceeded##2##2##(2008-2#1)(2008-8#1)
far exceeding##2##2##(1991-2#1)(2008-7#1)
far exceeds the##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
far fewer##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
far field##20##2##(2007-11#4)(2007-12#2)(2008-2#9)(2008-3#5)
far fields##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
far for##3##2##(1996-1#1)(2007-8#1)(2010-2#1)
far from an##2##3##(2008-10#1)(2008-3#1)
far from being completely##2##4##(2007-7#1)(2008-5#1)
far from being##7##3##(1996-2#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)
far from ideal##3##3##(2008-3#1)(2008-6#1)(2012-12#1)
far from that##2##3##(2008-3#1)(2009-10#1)
far from the source are##2##5##(2008-3#2)
far from the source##3##4##(2008-3#3)
far from the start position##2##5##(2008-6#2)
far from the##14##3##(1993-8#1)(1996-4#1)(2007-9#1)(2008-10#1)(2008-3#4)(2008-6#3)(2011-2#1)(2012-1#1)(2012-2#1)
far from##45##2##(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-2#1)(1996-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2009-10#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
far greater##3##2##(2009-4#1)(2011-1#1)(2011-2#1)
far has been##2##3##(2008-12#1)(2012-12#1)
far has##3##2##(2007-12#1)(2008-12#1)(2012-12#1)
far higher than##3##3##(1992-3#1)(2008-7#1)(2011-2#1)
far higher##4##2##(1992-3#1)(2008-7#2)(2011-2#1)
far in the##8##3##(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
far in##12##2##(1995-12#1)(2007-11#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
far indicates that the##2##4##(1995-11#1)(2008-4#1)
far is##3##2##(1994-5#1)(2008-7#1)(2013-8#1)
far larger##2##2##(1994-2#1)(1997-4#1)
far less##13##2##(1992-8#1)(1993-2#1)(1995-12#1)(2008-11#1)(2008-3#3)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
far lower##5##2##(1996-1#1)(2008-11#1)(2008-2#1)(2009-7#1)(2011-2#1)
far more complex##3##3##(2009-12#1)(2009-5#1)(2009-7#1)
far more frequent than##2##4##(1995-2#1)(1997-3#1)
far more likely to##2##4##(2008-6#1)(2013-1#1)
far more##20##2##(1992-2#1)(1992-3#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
far no##3##2##(1997-2#1)(2009-5#1)(2011-2#1)
far not been##2##3##(2010-3#1)(2010-6#1)
far not##5##2##(1991-11#1)(1995-5#1)(2008-10#1)(2010-3#1)(2010-6#1)
far only##7##2##(1990-11#1)(1992-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)
far outweigh the##2##3##(1993-3#1)(2009-5#1)
far removed from##2##3##(1995-5#1)(2008-7#1)
far should we##2##3##(2007-10#1)(2008-1#1)
far should##3##2##(1990-3#1)(2007-10#1)(2008-1#1)
far studied##2##2##(2008-10#1)(2008-5#1)
far superior to##2##3##(1996-12#1)(2008-11#1)
far the dominant##2##3##(1993-1#1)(2008-7#1)
far the##15##2##(1990-5#2)(1993-1#1)(1994-11#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#1)
far to##4##2##(1991-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
far too##6##2##(1991-12#1)(1992-5#1)(1995-6#1)(2008-11#1)(2008-8#1)(2012-3#1)
far unknown##3##2##(1992-8#1)(1994-6#1)(2011-1#1)
far western##5##2##(2008-4#4)(2011-2#1)
far##513##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#5)(1993-6#3)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#2)(2007-10#4)(2007-11#15)(2007-12#14)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#48)(2008-11#15)(2008-12#4)(2008-2#22)(2008-3#36)(2008-4#11)(2008-5#11)(2008-6#10)(2008-7#29)(2008-8#8)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#9)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#8)(2011-2#28)(2012-1#1)(2012-12#10)(2012-2#11)(2012-3#1)(2012-8#1)(2013-1#15)(2013-7#2)(2013-8#13)
far-UV##2##1##(1992-3#1)(1992-6#1)
far-field beam##3##2##(2008-2#1)(2008-3#2)
far-field detection##4##2##(2008-3#4)
far-field diffraction pattern##3##3##(2007-11#1)(2008-3#2)
far-field diffraction##4##2##(2007-11#1)(2008-3#3)
far-field intensity##3##2##(2008-2#1)(2008-3#2)
far-field output##2##2##(2008-3#2)
far-field pattern##2##2##(2007-11#1)(2008-2#1)
far-field patterns##3##2##(2007-11#2)(2008-2#1)
far-field radiation##2##2##(2007-12#1)(2008-3#1)
far-field scattering##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
far-field##65##1##(2007-11#7)(2007-12#6)(2008-2#19)(2008-3#30)(2009-5#2)(2012-2#1)
far-from-degenerate##2##1##(2007-12#2)
far-infrared Fourier-transform##2##2##(2008-3#2)
far-infrared spectroscopy##2##2##(2007-12#1)(2008-2#1)
far-infrared##19##1##(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#8)
far-reaching effects##2##2##(2008-10#1)(2008-12#1)
far-reaching##8##1##(1992-3#1)(1993-12#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
far-ultraviolet##4##1##(1990-5#1)(2008-3#3)
faraday##3##1##(2008-2#1)(2008-3#2)
fare##4##1##(1992-12#1)(1995-12#1)(1996-11#1)(2009-12#1)
fared##2##1##(1990-8#1)(2011-2#1)
farinae##3##1##(2011-2#3)
faring##4##1##(2009-5#1)(2009-7#1)(2012-3#1)(2013-1#1)
farm and##2##2##(2011-2#2)
farm animal##2##2##(1990-6#1)(2011-2#1)
farm animals##2##2##(1994-5#1)(2008-11#1)
farm families##2##2##(2008-12#2)
farm in the Himalayan state of Jammu and Kashmir##2##9##(2011-2#2)
farm in the##3##3##(2011-2#2)(2012-2#1)
farm in##4##2##(2007-6#1)(2011-2#2)(2012-2#1)
farm managers##2##2##(2008-12#2)
farm of the##2##3##(2008-12#1)(2013-7#1)
farm of##3##2##(2008-12#1)(2011-1#1)(2013-7#1)
farm safety day##2##3##(2013-1#2)
farm safety days##2##3##(2013-1#2)
farm safety##7##2##(2008-12#3)(2013-1#4)
farm size##2##2##(2008-12#1)(2008-5#1)
farm where##2##2##(1991-8#1)(2008-10#1)
farm workers##12##2##(2007-7#1)(2008-12#8)(2010-4#2)(2011-2#1)
farm##80##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-7#2)(1996-12#2)(1997-5#2)(2007-6#2)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#29)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-4#4)(2011-1#2)(2011-2#7)(2012-2#2)(2013-1#4)(2013-7#1)
farm-related activities##2##2##(2008-12#2)
farm-related injuries##2##2##(2008-12#2)
farm-related##5##1##(2008-12#5)
farmed##6##1##(1991-8#1)(1993-2#1)(1994-7#1)(2008-12#1)(2013-1#2)
farmer##11##1##(1995-11#1)(1995-8#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-12#4)(2011-2#1)(2013-1#1)
farmer-managed##3##1##(2008-12#3)
farmers and##4##2##(1992-5#1)(1997-7#1)(2008-12#1)(2011-2#1)
farmers had##3##2##(1996-3#2)(2011-1#1)
farmers in##3##2##(2008-12#1)(2010-1#2)
farmers keeping domestic##2##3##(1996-3#2)
farmers keeping##3##2##(1995-8#1)(1996-3#2)
farmers kept mainly##2##3##(2011-1#2)
farmers who kept domestic animals##2##5##(1995-8#2)
farmers##40##1##(1992-3#1)(1992-5#1)(1995-8#3)(1996-12#1)(1996-3#9)(1996-8#1)(1997-7#2)(2007-7#2)(2008-10#1)(2008-12#7)(2008-8#1)(2010-1#3)(2011-1#5)(2011-2#2)(2013-7#1)
farmers'##5##1##(2008-10#2)(2008-12#1)(2010-1#1)(2011-2#1)
farming communities##3##2##(2008-11#1)(2009-8#2)
farming has##2##2##(2008-12#1)(2013-1#1)
farming in##4##2##(2008-12#2)(2011-2#2)
farming practices##2##2##(2008-10#1)(2011-1#1)
farming safety##2##2##(2008-12#2)
farming with##3##2##(2008-12#3)
farming##38##1##(1991-8#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#16)(2008-5#1)(2008-7#1)(2009-8#4)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#1)
farms and##7##2##(1990-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-4#2)
farms are##2##2##(2010-4#1)(2011-1#1)
farms around Charlottetown##2##3##(2012-3#2)
farms from##3##2##(1994-7#1)(1996-12#1)(2008-12#1)
farms has been##2##3##(2007-12#1)(2008-6#1)
farms in the##5##3##(1991-8#1)(1994-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
farms in##12##2##(1991-8#1)(1994-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-4#2)(2011-2#1)(2011-3#1)(2013-1#1)
farms of##3##2##(2008-12#1)(2012-12#1)(2012-2#1)
farms or##2##2##(2007-12#1)(2013-1#1)
farms was##2##2##(1997-5#1)(2008-5#1)
farms were##4##2##(1996-12#1)(2007-6#1)(2008-10#1)(2012-12#1)
farms with a history of##2##5##(1996-12#2)
farms with##3##2##(1996-12#2)(2008-10#1)
farms within##2##2##(2008-12#1)(2013-1#1)
farms##75##1##(1990-3#2)(1991-8#1)(1994-7#2)(1996-12#5)(1997-5#2)(1997-6#3)(2007-12#2)(2007-6#2)(2008-10#13)(2008-12#9)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-4#7)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)
farnesyl cysteine##2##2##(2008-10#2)
farnesyl diphosphate##5##2##(1993-9#1)(1995-2#3)(2008-8#1)
farnesyl pyrophosphate##2##2##(1990-12#2)
farnesyl##10##1##(1990-12#2)(1993-9#1)(1995-2#3)(1997-7#1)(2008-10#2)(2008-8#1)
farnesylated##7##1##(1992-9#3)(1997-7#2)(2008-10#2)
farnesylation##2##1##(1993-9#1)(2008-5#1)
farnesyltransferase##12##1##(1992-12#2)(1993-11#3)(1993-9#2)(1994-8#2)(1995-2#2)(2008-5#1)
farrowing##3##1##(1996-12#2)(2013-8#1)
farsighted##2##1##(2008-11#1)(2009-7#1)
farther##3##1##(1994-9#1)(2008-1#1)(2008-10#1)
fascia is##3##2##(2009-1#3)
fascia oriented##2##2##(2013-1#2)
fascia##32##1##(1991-2#3)(1992-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-1#8)(2009-3#1)(2009-6#1)(2009-9#8)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
fasciae##6##1##(2009-3#3)(2013-1#3)
fascial closure##6##2##(1991-1#2)(1991-2#2)(1992-1#1)(1992-2#1)
fascial dehiscence##2##2##(1991-2#2)
fascial flap##6##2##(2007-12#1)(2008-9#1)(2009-1#4)
fascial incisions##2##2##(1992-1#1)(1992-2#1)
fascial##34##1##(1991-1#2)(1991-2#5)(1992-1#3)(1992-2#3)(2007-11#1)(2007-12#1)(2008-9#5)(2009-1#4)(2009-9#5)(2011-2#2)(2013-1#3)
fascicle##8##1##(2007-12#1)(2008-7#7)
fascicles##2##1##(2009-5#1)(2010-12#1)
fascicularis##2##1##(1994-2#1)(2011-2#1)
fasciculata##3##1##(1990-5#1)(1995-11#1)(2011-2#1)
fasciculate##2##1##(2007-12#2)
fasciculation##3##1##(1992-12#1)(1996-12#1)(1997-3#1)
fasciculus##6##1##(1996-5#5)(2007-10#1)
fascifrons##2##1##(2008-10#2)
fasciitis and the##2##3##(2012-2#2)
fasciitis in the head and neck##2##6##(1995-8#1)(2007-12#1)
fasciitis is##2##2##(2006-10#1)(2012-2#1)
fasciitis##18##1##(1990-11#2)(1995-8#1)(2006-10#8)(2007-12#1)(2007-8#2)(2012-2#3)(2013-8#1)
fascinated##2##1##(2008-1#1)(2012-2#1)
fascinating and##3##2##(2008-5#1)(2009-10#1)(2011-1#1)
fascinating##15##1##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)
fascination with##3##2##(1994-6#1)(2007-8#1)(2008-5#1)
fascination##4##1##(1994-6#1)(2007-8#1)(2008-5#1)(2012-1#1)
fasciocutaneous flap##4##2##(2008-9#1)(2010-11#1)(2011-2#2)
fasciocutaneous##7##1##(2008-9#2)(2010-11#1)(2011-2#3)(2012-2#1)
fasciolosis transmission##3##2##(2008-8#3)
fasciolosis##12##1##(2008-12#4)(2008-8#7)(2009-8#1)
fasciotomy##2##1##(2007-11#1)(2009-1#1)
fascisepala leaf##2##2##(2008-10#2)
fascisepala##5##1##(2008-10#5)
fashion and##7##2##(1990-5#1)(1992-12#1)(1992-3#1)(1997-2#1)(2008-10#2)(2009-11#1)
fashion by##5##2##(1990-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-8#1)
fashion designer##2##2##(1992-4#2)
fashion for##2##2##(2008-10#1)(2008-9#1)
fashion from##3##2##(1992-6#1)(1994-11#1)(2013-8#1)
fashion in the##2##3##(1997-2#1)(2008-9#1)
fashion in##13##2##(1991-5#1)(1992-12#1)(1992-8#1)(1993-8#1)(1995-2#2)(1997-2#1)(2007-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
fashion that##4##2##(1994-12#1)(2008-10#1)(2009-11#1)(2012-12#1)
fashion through##2##2##(2008-10#1)(2008-3#1)
fashion to the##2##3##(1994-12#1)(2006-6#1)
fashion to##11##2##(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-9#1)(1997-8#1)(2006-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
fashion with a##4##3##(1993-8#1)(1997-7#1)(2008-11#1)(2013-8#1)
fashion with the##2##3##(1995-6#1)(2007-8#1)
fashion with##11##2##(1991-9#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
fashion##186##1##(1990-2#1)(1990-5#3)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-7#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#3)(2008-9#6)(2009-11#3)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#7)
fashioned##2##1##(2008-10#1)(2012-3#1)
fashions##2##1##(1991-5#1)(1993-3#1)
fast (&gt##2##2##(2007-12#1)(2013-8#1)
fast (&lt##2##2##(2008-10#1)(2009-3#1)
fast Fourier transform (FFT)##2##4##(2008-3#2)
fast Fourier transform##8##3##(1997-6#1)(2008-2#1)(2008-3#5)(2012-2#1)
fast Fourier transformation##2##3##(2008-10#1)(2013-1#1)
fast Fourier##12##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2012-2#1)(2013-1#1)
fast Hankel transform##2##3##(2008-3#2)
fast K(+)##2##2##(2008-8#2)
fast algebraic##2##2##(2007-11#1)(2009-12#1)
fast analysis of##2##3##(2008-10#2)
fast analysis##7##2##(2008-10#5)(2010-9#1)(2011-1#1)
fast and accurate##9##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)
fast and easy##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
fast and effective method##2##4##(2008-10#1)(2008-7#1)
fast and effective##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
fast and efficient extraction##2##4##(2008-10#1)(2012-1#1)
fast and efficient##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
fast and inexpensive##2##3##(1992-11#1)(2008-10#1)
fast and precise##2##3##(2008-10#1)(2008-2#1)
fast and reliable##11##3##(2008-10#6)(2008-2#1)(2009-12#1)(2010-12#1)(2010-8#1)(2013-1#1)
fast and reproducible##4##3##(2008-10#3)(2008-9#1)
fast and robust##3##3##(2008-10#2)(2010-9#1)
fast and sensitive method##2##4##(2008-10#2)
fast and sensitive##10##3##(2008-10#8)(2008-11#1)(2008-9#1)
fast and simple method for the##2##6##(1995-3#1)(2007-11#1)
fast and simple method##3##4##(1995-3#1)(2007-11#1)(2008-10#1)
fast and simple##7##3##(1995-3#1)(2007-11#1)(2008-10#4)(2012-2#1)
fast and slow##8##3##(1990-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)
fast and stable##4##3##(2008-10#3)(2009-12#1)
fast and##102##2##(1990-5#1)(1991-5#1)(1992-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#47)(2008-11#3)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#7)(2009-12#2)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
fast as##6##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-3#2)(2012-2#1)
fast atom bombardment mass spectrometry##2##5##(1994-3#2)
fast atom bombardment mass##4##4##(1990-12#1)(1994-3#2)(2008-10#1)
fast atom bombardment##6##3##(1990-12#1)(1991-2#1)(1994-3#2)(1995-3#1)(2008-10#1)
fast atom##8##2##(1990-12#1)(1991-2#1)(1993-11#1)(1994-3#2)(1995-3#1)(2007-12#1)(2008-10#1)
fast axis##3##2##(2007-11#1)(2007-12#2)
fast but##2##2##(2008-10#1)(2008-9#1)
fast chemiluminescence (CL) flow-injection##2##4##(2008-10#2)
fast chemiluminescence##3##2##(2008-10#3)
fast convergence##3##2##(2007-12#1)(2008-10#2)
fast convex aspheric##2##3##(2008-3#2)
fast desensitization##2##2##(2011-1#2)
fast determination of##4##3##(2008-10#3)(2008-2#1)
fast developing##2##2##(2008-5#1)(2009-10#1)
fast disintegrating dosage##2##3##(2010-5#2)
fast dissolving##3##2##(2010-3#1)(2010-5#1)(2012-2#1)
fast enough to##3##3##(2008-2#1)(2008-3#2)
fast evaluation##3##2##(2008-10#1)(2008-3#2)
fast extraction##3##2##(2008-10#2)(2008-2#1)
fast flow##2##2##(2007-11#1)(2011-2#1)
fast food##4##2##(2008-7#1)(2009-5#1)(2011-2#2)
fast formation of##2##3##(2008-10#1)(2008-3#1)
fast growing##5##2##(1997-4#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
fast growth##2##2##(1997-1#1)(2008-9#1)
fast heating##2##2##(2008-3#2)
fast implementation of##2##3##(2010-12#1)(2012-2#1)
fast in situ##2##3##(2008-2#1)(2008-3#1)
fast in##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
fast inactivation-deficient hNa(v)1##3##3##(2008-8#3)
fast incorporation of##2##3##(1994-12#2)
fast method for##9##3##(2008-10#8)(2008-11#1)
fast method has been developed##3##5##(2008-10#3)
fast method##14##2##(2008-10#13)(2008-11#1)
fast neutron mutagenesis##2##3##(2008-7#2)
fast neutron##5##2##(1994-3#1)(2008-6#1)(2008-7#3)
fast neutrons##2##2##(1995-8#1)(2008-6#1)
fast nonlinear##3##2##(2007-12#3)
fast nuclear-magnetic-resonance##2##2##(2008-11#2)
fast optical##3##2##(1996-5#1)(2007-11#1)(2007-12#1)
fast or##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
fast phase of##2##3##(1991-12#1)(1991-2#1)
fast phase##3##2##(1991-12#1)(1991-2#1)(2008-4#1)
fast radiative transfer model##2##4##(2008-3#2)
fast rate##4##2##(2008-10#1)(2008-9#3)
fast response (&lt##2##3##(2008-10#2)
fast response and##5##3##(2008-10#5)
fast response time (&lt##3##4##(2008-10#3)
fast response time (within 10-30s)##2##5##(2008-10#2)
fast response time and##4##4##(2008-10#4)
fast response time of ca##2##5##(2008-10#2)
fast response time of##19##4##(2008-10#19)
fast response time##35##3##(2007-11#1)(2008-10#34)
fast response##51##2##(2007-11#1)(2008-10#49)(2009-10#1)
fast scan##2##2##(1992-3#1)(2008-7#1)
fast scanning##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
fast semiconductor saturable##2##3##(2007-11#1)(2007-12#1)
fast separation##3##2##(2008-10#3)
fast time##3##2##(1990-2#2)(2008-3#1)
fast to compute##2##3##(2008-3#1)(2008-6#1)
fast to##3##2##(2008-3#2)(2008-6#1)
fast track##3##2##(1992-1#1)(2007-8#1)(2010-5#1)
fast tracks##2##2##(2007-9#1)(2011-1#1)
fast transient##2##2##(2008-10#1)(2008-2#1)
fast transmittance##2##2##(2008-3#2)
fast two-dimensional##2##2##(2008-3#2)
fast wave##2##2##(1994-8#2)
fast waves##3##2##(1994-8#3)
fast when##2##2##(2008-9#1)(2013-8#1)
fast##652##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#1)(1991-12#7)(1991-2#2)(1991-5#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1993-11#1)(1993-5#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#13)(2007-12#38)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#251)(2008-11#8)(2008-12#1)(2008-2#16)(2008-3#81)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#22)(2008-8#7)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#1)(2009-5#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#9)(2010-8#3)(2010-9#3)(2011-1#10)(2011-2#11)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#13)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
fast&quot##2##1##(2007-12#1)(2008-12#1)
fast-Fourier-transform##3##1##(2008-2#1)(2008-3#2)
fast-atom bombardment##2##2##(1995-11#1)(2008-4#1)
fast-flow##2##1##(2008-2#1)(2011-2#1)
fast-food consumption##3##2##(2009-5#2)(2013-1#1)
fast-food##4##1##(1994-6#1)(2009-5#2)(2013-1#1)
fast-growing##5##1##(2008-10#2)(2008-8#1)(2010-8#1)(2012-2#1)
fast-moving##2##1##(1995-12#1)(2008-3#1)
fast-scanning##2##1##(2007-12#1)(2008-2#1)
fast-spiking##2##1##(2008-1#1)(2008-11#1)
fast-start performance##2##2##(2010-8#2)
fast-start##3##1##(2010-8#3)
fast-twitch##4##1##(1994-9#2)(1996-2#2)
fasted and fed##2##3##(2008-11#1)(2008-7#1)
fasted animals##3##2##(1992-12#1)(1994-8#2)
fasted for##2##2##(1994-8#1)(2008-7#1)
fasted human VLDL##2##3##(1995-6#2)
fasted overnight##2##2##(1995-11#1)(2011-2#1)
fasted rats##7##2##(1991-12#1)(1993-6#1)(1993-8#2)(1994-8#2)(2008-11#1)
fasted##33##1##(1991-12#2)(1991-3#2)(1992-12#1)(1993-6#1)(1993-8#3)(1994-8#8)(1995-11#1)(1995-6#4)(1996-12#1)(2008-11#2)(2008-3#1)(2008-7#6)(2011-2#1)
fasten##4##1##(2010-11#1)(2012-1#1)(2012-2#2)
fastening##3##1##(2008-7#2)(2012-2#1)
faster and easier##3##3##(2008-10#1)(2008-4#1)(2010-6#1)
faster and larger##3##3##(1990-5#1)(2008-3#1)(2012-2#1)
faster and less##2##3##(2008-10#1)(2008-11#1)
faster and more efficient##2##4##(2008-10#1)(2009-2#1)
faster and more##11##3##(2007-12#2)(2008-10#4)(2008-11#2)(2008-7#1)(2009-10#1)(2009-2#1)
faster and##26##2##(1990-5#1)(1996-5#2)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-6#1)(2012-2#1)(2012-3#1)
faster at##2##2##(2008-11#1)(2008-5#1)
faster because##2##2##(1992-2#1)(2008-10#1)
faster but##2##2##(1991-12#1)(2008-3#1)
faster electrophoretic mobility##2##3##(1996-9#1)(2008-10#1)
faster flow##2##2##(2008-2#1)(2010-4#1)
faster for##2##2##(2007-12#1)(2008-10#1)
faster in patients with coexisting brain##2##6##(2007-11#2)
faster in patients##4##3##(2007-11#2)(2008-7#1)(2013-8#1)
faster in response to##2##4##(2008-11#1)(2008-9#1)
faster in the presence of##2##5##(1996-5#1)(2008-11#1)
faster in the##5##3##(1991-5#1)(1993-11#1)(1996-5#1)(2008-11#1)(2008-8#1)
faster in##20##2##(1991-2#1)(1991-5#1)(1993-11#1)(1996-5#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#2)(2010-8#1)(2013-8#1)
faster on##3##2##(2007-11#1)(2008-10#2)
faster rate than##4##3##(1991-3#1)(1992-12#1)(2008-2#1)(2008-3#1)
faster rate##6##2##(1991-12#1)(1991-3#1)(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
faster recovery and##2##3##(1991-3#1)(1993-2#1)
faster recovery##6##2##(1991-3#1)(1993-2#1)(1996-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
faster response##3##2##(1996-2#1)(2010-2#1)(2012-12#1)
faster scanning##2##2##(2008-7#1)(2012-12#1)
faster separation##2##2##(1996-5#1)(2008-10#1)
faster than any other##5##4##(1994-3#2)(2008-10#1)(2008-6#1)(2012-3#1)
faster than any##6##3##(1994-3#2)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
faster than in##4##3##(2008-10#3)(2008-11#1)
faster than men##2##3##(2013-8#2)
faster than normal##2##3##(1992-11#1)(2007-8#1)
faster than that of the##3##5##(1995-2#1)(1995-3#1)(2008-10#1)
faster than that of##5##4##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-2#1)
faster than that##8##3##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-2#1)
faster than the overall economy##2##5##(1995-3#1)(1997-1#1)
faster than the##19##3##(1991-5#1)(1993-1#1)(1993-6#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)
faster than those of##2##4##(2008-7#2)
faster than those##5##3##(2008-2#1)(2008-7#3)(2010-8#1)
faster than##81##2##(1990-9#1)(1991-5#2)(1992-11#2)(1992-8#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#5)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-8#1)(2012-2#4)(2012-3#2)(2013-8#2)
faster the##3##2##(2007-10#1)(2008-10#2)
faster to##5##2##(1994-5#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-5#1)
faster when the##2##3##(2008-9#1)(2013-1#1)
faster when##4##2##(1997-4#1)(2008-9#1)(2012-2#1)(2013-1#1)
faster with a##2##3##(2008-10#1)(2012-3#1)
faster with##7##2##(1995-1#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
faster##269##1##(1990-11#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#4)(1996-3#1)(1996-5#8)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(2007-10#2)(2007-11#8)(2007-12#6)(2007-8#3)(2008-1#2)(2008-10#62)(2008-11#16)(2008-2#7)(2008-3#19)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#16)(2008-8#9)(2008-9#5)(2009-10#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-12#3)(2012-2#9)(2012-3#8)(2013-1#4)(2013-8#6)
fastest growing##6##2##(1994-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
fastest##24##1##(1994-3#2)(1995-3#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
fastidiosa by##2##2##(2008-10#2)
fastidiosa can##2##2##(2008-10#2)
fastidiosa cell number##2##3##(2008-10#2)
fastidiosa in##7##2##(2008-10#7)
fastidiosa isolated from##2##3##(2008-10#2)
fastidiosa strains from##3##3##(2008-10#3)
fastidiosa strains were##2##3##(2008-10#2)
fastidiosa strains##11##2##(2008-10#11)
fastidiosa subsp##4##2##(2008-10#4)
fastidiosa to##2##2##(2008-10#2)
fastidiosa was##3##2##(2008-10#3)
fastidiosa##77##1##(2008-10#77)
fastidious bacterium##2##2##(2008-10#2)
fastidious##6##1##(2008-10#2)(2008-9#2)(2011-1#1)(2011-2#1)
fasting and fed##2##3##(1994-8#1)(2008-3#1)
fasting and postprandial##4##3##(2011-1#3)(2012-3#1)
fasting and##12##2##(1994-12#2)(1994-8#1)(2008-11#1)(2008-3#2)(2008-7#2)(2011-1#3)(2012-3#1)
fasting blood glucose##4##3##(1993-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
fasting blood sugar and##2##4##(2008-8#1)(2011-2#1)
fasting blood sugar##5##3##(2008-12#2)(2008-8#1)(2010-10#1)(2011-2#1)
fasting blood##13##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
fasting condition##2##2##(2011-1#1)(2012-3#1)
fasting glucose##12##2##(1991-7#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
fasting glucose/insulin ratio and##2##4##(1992-6#1)(2008-3#1)
fasting healthy##2##2##(1992-9#1)(2008-5#1)
fasting hyperglycaemia##2##2##(1994-12#1)(2008-1#1)
fasting hyperglycemia##3##2##(1991-7#3)
fasting insulin##2##2##(1992-6#1)(2008-3#1)
fasting plasma glucose (FPG)##2##4##(1994-12#1)(2011-2#1)
fasting plasma glucose and##3##4##(1990-8#1)(2010-10#1)(2012-3#1)
fasting plasma glucose##10##3##(1990-8#1)(1994-12#1)(2008-3#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-7#1)
fasting plasma triglyceride and cholesterol levels were##2##7##(1993-3#1)(1994-11#1)
fasting plasma##14##2##(1990-8#2)(1993-3#1)(1994-11#1)(1994-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-7#1)
fasting serum lipid profiles##2##4##(2008-3#2)
fasting serum triglycerides##3##3##(1992-6#2)(2008-3#1)
fasting serum##6##2##(1992-6#2)(2008-3#4)
fasting##118##1##(1990-12#1)(1990-8#3)(1991-3#1)(1991-5#1)(1991-7#4)(1992-6#6)(1992-9#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#5)(1994-8#1)(1997-2#1)(2007-5#1)(2008-1#6)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#19)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2010-10#2)(2010-4#1)(2010-6#1)(2011-1#8)(2011-2#7)(2012-2#2)(2012-3#13)(2012-7#1)(2013-1#5)(2013-8#1)
fastness##3##1##(2008-10#2)(2013-8#1)
fat accumulation and##2##3##(2008-3#1)(2012-1#1)
fat accumulation##5##2##(1994-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)
fat acid##2##2##(2011-1#2)
fat and cholesterol##2##3##(1990-8#1)(1995-2#1)
fat and energy##2##3##(2008-5#2)
fat and liver##2##3##(2008-1#2)
fat and thin##2##3##(2007-12#2)
fat and##33##2##(1990-7#1)(1990-8#1)(1993-9#1)(1994-2#1)(1995-2#2)(1997-8#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-4#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
fat area##4##2##(2008-3#2)(2008-5#2)
fat as##2##2##(1997-7#1)(2008-4#1)
fat attenuation##2##2##(2011-2#1)(2013-1#1)
fat bodies##2##2##(1997-4#1)(2008-10#1)
fat cell necrosis in##2##4##(2012-1#2)
fat cell necrosis##3##3##(2012-1#3)
fat cell##6##2##(1994-11#1)(1994-12#1)(2012-1#4)
fat cells and##2##3##(1997-1#1)(2012-2#1)
fat cells##6##2##(1992-11#1)(1997-1#1)(2008-3#1)(2012-1#1)(2012-2#2)
fat color##2##2##(2010-2#2)
fat colour##2##2##(2010-4#2)
fat consumption is##2##3##(1990-2#2)
fat content of##3##3##(2008-12#1)(2008-4#1)(2010-2#1)
fat content##8##2##(2008-12#2)(2008-4#1)(2010-2#1)(2010-4#2)(2012-2#2)
fat deposition##2##2##(2010-4#2)
fat diet##5##2##(1996-12#2)(2007-8#1)(2008-3#1)(2013-1#1)
fat distribution##8##2##(1990-9#1)(2008-11#1)(2008-3#1)(2010-6#5)
fat embolism##6##2##(2008-8#2)(2009-3#4)
fat emulsion##3##2##(2008-10#2)(2008-5#1)
fat free mass##2##3##(2008-5#2)
fat from##2##2##(1995-2#2)
fat graft##4##2##(2006-12#1)(2011-2#3)
fat grafting##6##2##(2010-8#1)(2013-1#5)
fat in the##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)(2012-2#1)
fat in##9##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#2)(2012-2#1)
fat injection##5##2##(2011-2#3)(2013-1#2)
fat intake##7##2##(1994-12#1)(2008-1#1)(2008-11#1)(2008-4#3)(2010-3#1)
fat is##5##2##(1991-2#1)(2007-8#1)(2008-11#2)(2012-2#1)
fat loss##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
fat mass and percentage##2##4##(1997-7#1)(2008-7#1)
fat mass and##4##3##(1997-7#1)(2008-5#1)(2008-7#1)(2010-8#1)
fat mass is##2##3##(1990-9#1)(2008-2#1)
fat mass##14##2##(1990-9#1)(1997-7#1)(1997-8#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2010-8#1)(2012-2#1)
fat milk##4##2##(1993-11#1)(2008-10#3)
fat necrosis of the newborn##2##5##(2012-2#2)
fat necrosis of the##3##4##(2007-10#1)(2012-2#2)
fat necrosis##14##2##(2007-10#4)(2011-1#1)(2012-2#5)(2013-1#4)
fat necrosis/oil cysts##2##3##(2013-1#2)
fat or##2##2##(2008-7#1)(2012-12#1)
fat pad adipose precursor cells##2##5##(1990-11#2)
fat pad##10##2##(1990-11#2)(1993-6#1)(2008-11#1)(2008-12#3)(2008-9#3)
fat pads##3##2##(2008-11#3)
fat percentage##4##2##(2008-5#2)(2008-8#1)(2009-7#1)
fat products##2##2##(2008-10#2)
fat redistribution##2##2##(2008-3#2)
fat reduction##2##2##(2010-4#2)
fat reserves##4##2##(1997-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
fat restriction##7##2##(1990-2#2)(2008-4#4)(2010-4#1)
fat samples##2##2##(2008-10#1)(2008-7#1)
fat showed##2##2##(2008-7#1)(2010-4#1)
fat that##2##2##(2008-5#1)(2010-4#1)
fat thickness##3##2##(2010-2#1)(2011-1#1)(2013-1#1)
fat tissue##8##2##(1994-5#1)(2011-1#2)(2012-1#3)(2012-3#1)(2012-8#1)
fat to##4##2##(2010-4#2)(2012-2#2)
fat transplant##2##2##(1997-3#2)
fat transplantation##6##2##(1997-3#4)(2012-2#2)
fat was##2##2##(2008-3#1)(2010-4#1)
fat were significantly##2##3##(2008-7#1)(2013-1#1)
fat were##4##2##(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
fat with##4##2##(1994-2#1)(2008-1#1)(2008-7#1)(2012-2#1)
fat words more negatively and##2##5##(2007-12#2)
fat words##3##2##(2007-12#3)
fat##395##1##(1990-11#3)(1990-12#1)(1990-2#5)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-11#3)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#2)(1995-2#8)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#7)(1997-4#1)(1997-7#2)(1997-8#4)(2006-10#1)(2006-12#1)(2007-10#5)(2007-11#2)(2007-12#13)(2007-8#2)(2008-1#9)(2008-10#28)(2008-11#14)(2008-12#10)(2008-2#3)(2008-3#21)(2008-4#15)(2008-5#27)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#3)(2009-3#5)(2009-4#2)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#33)(2010-6#8)(2010-8#3)(2011-1#8)(2011-2#12)(2012-1#9)(2012-12#4)(2012-2#31)(2012-3#1)(2012-4#2)(2012-8#1)(2013-1#28)(2013-7#1)(2013-8#1)
fat)##5##1##(1990-8#1)(1996-12#1)(2008-5#2)(2008-6#1)
fat-free##3##1##(2007-8#1)(2008-10#1)(2012-2#1)
fat-tailed kernels##3##2##(2008-8#3)
fat-tailed##7##1##(2008-12#2)(2008-8#3)(2008-9#2)
fatal accidents##2##2##(1996-12#1)(1996-2#1)
fatal acute##2##2##(1991-8#1)(2013-1#1)
fatal and non-fatal incidents involving tourists in Thailand##3##8##(2007-2#3)
fatal and non-fatal incidents involving tourists##5##6##(2007-2#5)
fatal and non-fatal##7##3##(2007-2#5)(2011-2#1)(2012-2#1)
fatal and##8##2##(2007-2#5)(2011-2#2)(2012-2#1)
fatal arrhythmias##2##2##(2010-8#1)(2011-2#1)
fatal cancer##2##2##(1996-6#1)(2010-5#1)
fatal case of intravascular coagulation##2##5##(2012-3#2)
fatal case of##6##3##(1992-9#1)(2007-12#1)(2011-1#1)(2012-3#3)
fatal cases##3##2##(1995-5#1)(2008-11#1)(2013-8#1)
fatal complication of##2##3##(2011-2#1)(2012-3#1)
fatal complication##5##2##(2007-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
fatal complications##4##2##(2007-11#2)(2008-10#1)(2012-12#1)
fatal damage to##2##3##(2008-7#2)
fatal disease##7##2##(1993-2#1)(1993-3#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-1#1)
fatal in the##2##3##(1990-9#1)(2008-9#1)
fatal in##4##2##(1990-9#1)(1997-4#1)(2008-10#1)(2008-9#1)
fatal infection##2##2##(2007-8#1)(2013-1#1)
fatal neurodegenerative##2##2##(1997-3#1)(2010-12#1)
fatal or##2##2##(1990-9#1)(1991-11#1)
fatal outcome in##3##3##(2009-7#1)(2011-2#1)(2013-8#1)
fatal outcome##11##2##(1995-8#1)(2006-10#1)(2007-8#1)(2008-12#1)(2009-1#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#2)
fatal paediatric case of##2##4##(2008-11#2)
fatal to##2##2##(2008-10#1)(2008-7#1)
fatal trauma##3##2##(2012-12#3)
fatal##141##1##(1990-9#2)(1991-11#1)(1991-2#1)(1991-8#3)(1992-4#1)(1992-9#3)(1993-2#1)(1993-3#2)(1993-6#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#4)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#6)(2007-8#5)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#15)(2012-1#1)(2012-12#9)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#3)
fatalities have##2##2##(1991-9#1)(2007-2#1)
fatalities##15##1##(1991-9#1)(1993-12#1)(1995-11#1)(1995-3#3)(2007-2#1)(2008-12#3)(2010-11#2)(2011-2#1)(2012-12#2)
fatality rate and##2##3##(1995-5#1)(2008-8#1)
fatality rate##5##2##(1995-5#1)(2008-3#1)(2008-8#2)(2011-1#1)
fatality rates##8##2##(1990-2#1)(2008-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
fatality##21##1##(1990-2#1)(1995-5#1)(2007-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
fate and effects of dimethicone and cyclotetrasiloxane##2##7##(2008-5#2)
fate and##7##2##(1995-11#1)(1996-11#1)(2008-10#1)(2008-5#2)(2010-6#1)(2011-1#1)
fate decisions are##2##3##(2009-12#2)
fate decisions##6##2##(2008-11#2)(2009-12#3)(2009-8#1)
fate determination##2##2##(2008-10#1)(2008-7#1)
fate during##2##2##(1993-6#1)(2013-8#1)
fate for##2##2##(1995-2#1)(2008-6#1)
fate in##4##2##(2008-11#1)(2009-12#1)(2012-1#1)(2012-12#1)
fate of the##11##3##(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-1#1)
fate of##42##2##(1990-9#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-3#2)(1995-2#1)(1995-8#1)(1996-12#1)(2007-11#2)(2008-1#2)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-4#1)(2012-2#1)(2013-1#1)
fate##96##1##(1990-9#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-3#2)(1995-11#3)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#11)(2008-11#11)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#3)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#2)
fates of##2##2##(2007-12#1)(2009-5#1)
fates##17##1##(1990-11#2)(1994-12#1)(2007-12#5)(2009-12#2)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#4)
father and##4##2##(2007-10#1)(2007-7#1)(2008-12#1)(2008-7#1)
father as a##2##3##(1994-2#1)(2012-12#1)
father##27##1##(1990-12#1)(1994-12#1)(1994-2#1)(1995-6#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-7#1)(2010-9#1)(2011-1#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
father's incarceration and##2##3##(2012-12#2)
father's incarceration##3##2##(2012-12#3)
father's##5##1##(1990-12#1)(2008-4#1)(2012-12#3)
fathers and##2##2##(2008-12#1)(2009-5#1)
fathers of##6##2##(1992-2#1)(1994-6#2)(1997-3#1)(2008-10#1)(2010-11#1)
fathers were##3##2##(2007-4#1)(2009-7#1)(2010-3#1)
fathers who##3##2##(2009-5#1)(2010-3#2)
fathers##39##1##(1992-2#1)(1993-6#1)(1994-12#2)(1994-6#2)(1997-3#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-8#1)(2009-5#7)(2009-7#4)(2010-11#2)(2010-3#8)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
fathers' social##2##2##(2009-5#2)
fathers'##9##1##(1990-2#1)(2009-5#4)(2009-7#4)
fatigability##2##1##(2012-2#1)(2012-3#1)
fatigue analyses##2##2##(2009-7#2)
fatigue and##21##2##(1996-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-7#3)(2009-1#1)(2009-11#1)(2009-7#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
fatigue caused by##2##3##(2008-5#2)
fatigue development##4##2##(2008-5#4)
fatigue effects in##2##3##(2009-8#1)(2013-8#1)
fatigue in patients with##2##4##(2008-7#2)
fatigue in##5##2##(1992-2#1)(2008-12#1)(2008-7#3)
fatigue of##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
fatigue protocols##4##2##(2013-8#4)
fatigue resistance and roughness##2##4##(2008-5#2)
fatigue syndrome (CFS)##2##3##(2009-10#1)(2010-1#1)
fatigue syndrome##11##2##(1993-2#1)(1993-7#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-1#2)(2012-3#1)
fatigue was##4##2##(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
fatigue##146##1##(1991-6#2)(1992-2#7)(1992-9#1)(1993-2#1)(1993-7#1)(1993-9#5)(1995-5#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-3#2)(2008-5#14)(2008-6#6)(2008-7#13)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-5#2)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#4)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#8)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#11)
fatigued muscle##2##2##(1991-12#2)
fatigued##4##1##(1991-12#2)(2008-10#1)(2010-8#1)
fatness and thinness##4##3##(2007-12#4)
fatness##13##1##(2007-12#8)(2008-1#1)(2008-10#2)(2010-4#1)(2012-2#1)
fats and oils##2##3##(2008-10#1)(2011-1#1)
fats and##5##2##(1990-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
fats##12##1##(1990-2#1)(1990-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
fattening pigs from##2##3##(1990-3#2)
fattening pigs##8##2##(1990-3#8)
fattening##14##1##(1990-3#8)(2008-10#1)(2008-12#1)(2010-4#3)(2013-1#1)
fatter##2##1##(2007-12#1)(2012-12#1)
fatty acid (FA)##2##3##(2008-6#1)(2012-1#1)
fatty acid analysis##2##3##(1992-3#1)(2008-10#1)
fatty acid and##9##3##(1990-8#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2012-3#2)
fatty acid beta-oxidation##5##3##(1992-11#1)(1994-6#3)(1996-12#1)
fatty acid binding protein##7##4##(1994-8#2)(1995-2#2)(2008-8#2)(2009-8#1)
fatty acid binding##8##3##(1994-8#2)(1995-2#2)(2008-8#2)(2009-8#1)(2013-1#1)
fatty acid biosynthesis##2##3##(1995-6#1)(1996-6#1)
fatty acid biosynthetic##3##3##(1992-4#3)
fatty acid chain##3##3##(1993-8#3)
fatty acid chains##2##3##(1993-8#1)(1997-2#1)
fatty acid composition of the##4##5##(1991-12#1)(1992-10#1)(2010-4#1)(2013-1#1)
fatty acid composition of##14##4##(1991-12#2)(1991-2#1)(1992-10#1)(1992-12#1)(1996-7#1)(2008-11#1)(2008-7#2)(2010-4#3)(2011-1#1)(2013-1#1)
fatty acid composition with a##2##5##(1994-8#1)(2010-4#1)
fatty acid composition##27##3##(1991-12#3)(1991-2#1)(1992-10#1)(1992-12#2)(1994-8#1)(1996-7#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-5#3)(2010-4#5)(2011-1#3)(2013-1#1)
fatty acid compositions##5##3##(2008-11#1)(2010-2#3)(2012-2#1)
fatty acid concentrations##3##3##(1994-12#1)(2008-12#1)(2009-4#1)
fatty acid content##3##3##(1990-5#1)(2008-5#2)
fatty acid contents##2##3##(1996-7#1)(2008-10#1)
fatty acid desaturase gene##2##4##(1996-6#1)(2010-4#1)
fatty acid desaturase##5##3##(1993-6#1)(1996-6#2)(2010-4#1)(2013-1#1)
fatty acid esters##4##3##(1991-9#2)(2008-11#1)(2008-7#1)
fatty acid ethyl ester synthase##2##5##(1992-6#2)
fatty acid ethyl ester synthase-III in##2##6##(1992-6#2)
fatty acid ethyl ester##4##4##(1992-6#4)
fatty acid ethyl##5##3##(1992-6#4)(2008-11#1)
fatty acid for##2##3##(2008-11#1)(2008-5#1)
fatty acid from##3##3##(1992-8#1)(2008-10#1)(2013-1#1)
fatty acid in##4##3##(2008-11#1)(2013-1#3)
fatty acid metabolism and##2##4##(2008-1#1)(2008-3#1)
fatty acid metabolism in##3##4##(1995-2#1)(2008-1#1)(2012-2#1)
fatty acid metabolism##8##3##(1995-2#1)(2008-1#2)(2008-3#1)(2012-2#4)
fatty acid methyl ester (FAME) profiles##2##6##(2008-10#2)
fatty acid methyl ester (FAME)##4##5##(2008-10#4)
fatty acid methyl ester analysis##2##5##(2008-10#2)
fatty acid methyl ester##7##4##(2008-10#7)
fatty acid methyl esters (FAMEs)##3##5##(2008-10#2)(2013-1#1)
fatty acid methyl esters##6##4##(2008-10#4)(2009-8#1)(2013-1#1)
fatty acid methyl##14##3##(1997-2#1)(2008-10#11)(2009-8#1)(2013-1#1)
fatty acid of##2##3##(1994-2#1)(2008-12#1)
fatty acid oxidation in##3##4##(1995-2#1)(2008-1#2)
fatty acid oxidation##11##3##(1993-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-1#6)(2008-11#1)
fatty acid profile in##3##4##(2010-4#2)(2013-1#1)
fatty acid profile##5##3##(1996-7#1)(2010-11#1)(2010-4#2)(2013-1#1)
fatty acid profiles##11##3##(1991-12#1)(2008-10#6)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
fatty acid release##3##3##(1991-12#3)
fatty acid supplementation##2##3##(1992-9#1)(1993-6#1)
fatty acid synthesis##5##3##(1992-4#1)(1992-8#1)(1995-6#2)(2012-2#1)
fatty acid##254##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#9)(1991-2#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#4)(1992-6#4)(1992-8#5)(1992-9#3)(1993-3#1)(1993-6#2)(1993-8#8)(1993-9#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#4)(1995-11#2)(1995-2#6)(1995-5#1)(1995-6#5)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-7#4)(1997-2#2)(2008-1#9)(2008-10#31)(2008-11#9)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#2)(2009-4#2)(2009-5#4)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#9)(2010-4#11)(2011-1#5)(2011-2#2)(2012-1#2)(2012-2#8)(2012-3#2)(2013-1#19)
fatty acid-binding protein##2##3##(1994-8#2)
fatty acids and fatty##2##4##(1994-8#1)(1995-3#1)
fatty acids and##25##3##(1990-8#2)(1991-12#2)(1991-5#1)(1992-8#2)(1994-8#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-5#3)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#4)(2013-1#2)
fatty acids are used##2##4##(1994-12#1)(2008-8#1)
fatty acids are##10##3##(1994-12#1)(1995-6#1)(1996-7#2)(2008-5#2)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
fatty acids as##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
fatty acids at##3##3##(1992-6#1)(1994-12#1)(2012-2#1)
fatty acids bound to##2##4##(1994-12#2)
fatty acids by##3##3##(1994-6#1)(2008-12#1)(2008-5#1)
fatty acids from grape seed##2##5##(2008-10#2)
fatty acids from the##2##4##(1992-12#1)(1994-8#1)
fatty acids from##12##3##(1990-2#1)(1990-8#1)(1991-12#1)(1992-12#1)(1994-8#2)(2008-10#4)(2008-6#1)(2009-8#1)
fatty acids has##2##3##(1990-2#2)
fatty acids have##2##3##(1990-3#1)(2008-10#1)
fatty acids in both##2##4##(2008-11#1)(2010-4#1)
fatty acids in the##9##4##(1990-5#1)(1990-6#1)(1991-12#1)(1996-5#1)(2008-11#1)(2010-4#2)(2012-1#1)(2012-2#1)
fatty acids in##28##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#5)(1991-6#1)(1992-3#3)(1995-6#1)(1996-5#1)(2008-11#3)(2008-5#1)(2008-6#2)(2010-4#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
fatty acids is##2##3##(1992-8#1)(2008-12#1)
fatty acids of the##2##4##(1994-11#1)(2008-9#1)
fatty acids of##7##3##(1992-3#1)(1993-11#1)(1994-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
fatty acids on##2##3##(1993-6#1)(2012-12#1)
fatty acids or##2##3##(1995-6#1)(2012-2#1)
fatty acids present in the##2##5##(1990-12#1)(2013-8#1)
fatty acids released from##3##4##(1990-8#2)(1991-12#1)
fatty acids released##4##3##(1990-8#2)(1991-12#1)(2008-10#1)
fatty acids that##2##3##(1994-11#1)(2008-10#1)
fatty acids to##2##3##(1990-2#1)(1992-8#1)
fatty acids via##2##3##(1992-6#1)(1993-9#1)
fatty acids was##6##3##(1990-5#1)(1990-8#1)(1992-3#1)(2008-11#2)(2013-1#1)
fatty acids were determined##2##4##(2008-10#1)(2012-2#1)
fatty acids were found as high as##2##7##(2008-11#2)
fatty acids were##10##3##(1990-8#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)
fatty acids which##3##3##(2011-1#2)(2013-1#1)
fatty acids with##2##3##(1994-8#1)(2012-2#1)
fatty acids##269##2##(1990-12#3)(1990-2#7)(1990-3#3)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#8)(1991-12#10)(1991-5#1)(1991-6#2)(1992-10#2)(1992-12#1)(1992-3#6)(1992-6#2)(1992-8#4)(1993-11#1)(1993-3#1)(1993-6#5)(1993-9#2)(1994-11#5)(1994-12#5)(1994-6#2)(1994-8#5)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-3#5)(1996-5#2)(1996-7#2)(1997-2#1)(2008-1#2)(2008-10#35)(2008-11#9)(2008-12#5)(2008-3#3)(2008-4#1)(2008-5#23)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#4)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#11)(2010-6#2)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#17)(2012-3#1)(2013-1#14)(2013-8#3)
fatty acyl##3##2##(1994-5#1)(1997-2#1)(2012-12#1)
fatty acyl-CoA##3##2##(1994-8#1)(1995-5#1)(1996-5#1)
fatty change in##6##3##(2008-9#6)
fatty change##8##2##(2008-9#7)(2012-12#1)
fatty infiltration of##2##3##(2011-2#2)
fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)##2##8##(2013-1#2)
fatty liver disease (NAFLD)##3##4##(2010-6#1)(2013-1#2)
fatty liver disease##7##3##(2008-5#1)(2010-10#1)(2010-6#2)(2011-2#1)(2013-1#2)
fatty liver##14##2##(1997-3#3)(2006-10#1)(2008-5#1)(2010-10#1)(2010-6#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
fatty tissue##5##2##(1993-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-5#1)
fatty##580##1##(1990-11#2)(1990-12#3)(1990-2#8)(1990-3#4)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#11)(1991-12#19)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-10#4)(1992-11#1)(1992-12#4)(1992-3#10)(1992-4#4)(1992-6#6)(1992-8#9)(1992-9#3)(1993-11#1)(1993-3#3)(1993-6#8)(1993-8#8)(1993-9#6)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#7)(1994-8#11)(1994-9#4)(1995-11#3)(1995-2#9)(1995-3#4)(1995-5#2)(1995-6#9)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#8)(1996-5#4)(1996-6#3)(1996-7#6)(1997-2#5)(1997-3#3)(1997-4#1)(2006-10#1)(2007-8#1)(2008-1#12)(2008-10#67)(2008-11#19)(2008-12#8)(2008-3#8)(2008-4#4)(2008-5#34)(2008-6#7)(2008-7#11)(2008-8#4)(2008-9#8)(2009-4#2)(2009-5#5)(2009-8#6)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#10)(2010-3#1)(2010-4#22)(2010-6#4)(2010-8#1)(2011-1#13)(2011-2#10)(2012-1#6)(2012-12#3)(2012-2#28)(2012-3#3)(2013-1#37)(2013-8#5)
fatty-acid fingerprints##2##2##(2008-10#2)
fatty-acid##6##1##(1994-3#1)(2008-10#5)
faujasite##3##1##(2008-10#3)
fault junctions##2##2##(1996-4#2)
fault networks##2##2##(1996-4#2)
fault of##3##2##(1991-12#1)(1996-4#1)(2007-11#1)
fault slip##2##2##(1996-4#2)
fault system##6##2##(1996-4#6)
fault zone##7##2##(1996-4#7)
fault##53##1##(1990-11#2)(1991-12#1)(1996-4#38)(2006-10#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-10#1)(2012-2#4)
faulting##3##1##(1990-11#1)(1996-4#1)(2008-3#1)
faults in##4##2##(1995-12#1)(1996-4#2)(2012-2#1)
faults of the##2##3##(1996-4#2)
faults of##3##2##(1996-4#2)(2007-8#1)
faults with##3##2##(1996-4#3)
faults##27##1##(1995-12#1)(1996-4#23)(2007-8#1)(2009-7#1)(2012-2#1)
faulty##7##1##(1993-3#1)(1997-6#1)(2007-7#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-2#1)
faun tail##3##2##(2010-6#3)
fauna of##6##2##(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#3)
fauna##16##1##(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#3)(2012-2#1)(2013-1#3)(2013-7#1)
faunal##3##1##(1997-5#1)(2013-7#2)
favor a##3##2##(1990-11#1)(1993-2#1)(2011-1#1)
favor needle exchanges##2##3##(1997-5#2)
favor one##3##2##(1995-6#1)(2008-9#1)(2012-12#1)
favor the evolution of##2##4##(2008-8#2)
favor the formation of##3##4##(1992-3#1)(1993-5#1)(2009-12#1)
favor the##22##2##(1991-1#1)(1992-3#1)(1993-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#2)(2007-8#1)(2008-10#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
favor##98##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#3)(1991-2#1)(1991-9#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-5#7)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#9)(2008-9#10)(2009-10#2)(2009-12#1)(2009-8#1)(2011-1#3)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#2)
favorability##3##1##(2008-10#3)
favorable and##3##2##(2008-10#1)(2013-1#2)
favorable clinical##2##2##(2008-11#1)(2011-2#1)
favorable conditions for##2##3##(2008-10#1)(2008-11#1)
favorable conditions##9##2##(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)
favorable effect on##2##3##(1992-11#1)(2008-3#1)
favorable effects##2##2##(2008-10#1)(2009-9#1)
favorable environmental conditions##2##3##(2008-10#2)
favorable environmental##3##2##(2008-10#2)(2013-8#1)
favorable for practices that involved##2##5##(2010-4#2)
favorable for the##3##3##(1993-11#1)(2008-10#2)
favorable for##17##2##(1990-11#1)(1992-3#2)(1993-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2009-6#1)(2010-4#2)
favorable habitat##2##2##(2008-10#1)(2008-5#1)
favorable impact##2##2##(2008-10#1)(2013-1#1)
favorable in##4##2##(1997-8#1)(2009-4#1)(2013-1#2)
favorable outcome##8##2##(2007-10#3)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
favorable outcomes##5##2##(1995-4#1)(2008-3#2)(2012-2#1)(2012-3#1)
favorable performance##2##2##(2008-10#1)(2013-1#1)
favorable prognosis##4##2##(2007-10#1)(2012-3#1)(2013-1#2)
favorable results##2##2##(2012-1#1)(2013-1#1)
favorable safety##2##2##(2007-9#1)(2008-8#1)
favorable to the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
favorable to##7##2##(2008-10#5)(2008-5#1)(2008-8#1)
favorable##183##1##(1990-11#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-3#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-8#1)(1993-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-10#5)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#52)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-4#3)(2010-7#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#16)(2013-8#3)
favorably affected##2##2##(1991-9#1)(1993-3#1)
favorably cardiac function##2##3##(2011-2#2)
favorably compared with those##2##4##(2008-10#2)
favorably compared with##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
favorably compared##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
favorably in##2##2##(1990-9#1)(2008-10#1)
favorably than##2##2##(2008-6#1)(2008-7#1)
favorably to##10##2##(1992-2#1)(1993-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
favorably with the##2##3##(1994-1#1)(2007-11#1)
favorably with those##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
favorably with##26##2##(1994-1#1)(2007-11#2)(2008-10#9)(2008-2#2)(2008-3#8)(2008-6#1)(2008-9#2)(2009-5#1)
favorably##61##1##(1990-9#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1996-9#1)(2007-11#4)(2007-12#1)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#3)(2009-5#1)(2009-9#1)(2011-2#3)(2012-12#1)
favored a##4##2##(1996-1#2)(2008-10#1)(2012-3#1)
favored budding##2##2##(2008-10#2)
favored by a high##3##4##(2008-8#1)(2013-1#2)
favored by increasing##2##3##(1997-2#1)(2008-10#1)
favored by low##2##3##(2008-10#2)
favored by selection##2##3##(2008-9#1)(2013-8#1)
favored by the##3##3##(1993-2#1)(2008-6#1)(2008-8#1)
favored by##17##2##(1992-8#1)(1993-2#1)(1997-2#1)(2008-10#5)(2008-6#1)(2008-8#2)(2008-9#2)(2013-1#3)(2013-8#1)
favored in##2##2##(1990-8#1)(2008-10#1)
favored over##3##2##(1995-3#1)(2008-8#1)(2009-11#1)
favored the##3##2##(1995-11#1)(2008-10#2)
favored when##2##2##(2008-8#1)(2008-9#1)
favored##62##1##(1990-11#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-1#3)(1997-2#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
favoring the##4##2##(1990-6#1)(1997-3#1)(2008-6#1)(2013-1#1)
favoring##30##1##(1990-12#1)(1990-6#1)(1991-4#1)(1992-12#1)(1995-6#1)(1996-2#1)(1997-3#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
favorite##4##1##(2008-10#1)(2008-4#1)(2013-1#2)
favors a##3##2##(2008-6#1)(2008-9#2)
favors the##9##2##(1990-12#1)(1990-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#2)
favors##39##1##(1990-12#1)(1990-8#2)(1993-12#1)(1994-2#1)(1995-2#2)(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#10)(2008-9#3)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
favour of##23##2##(1990-6#1)(1991-2#1)(1992-11#1)(1993-3#1)(1995-11#1)(1995-5#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2009-9#1)(2010-3#1)(2011-2#3)(2013-1#1)
favour the##4##2##(1997-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
favour##44##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#2)(1992-11#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
favourable clinical##2##2##(1991-6#1)(2008-5#1)
favourable course##2##2##(1991-6#1)(2007-8#1)
favourable effect of##2##3##(2008-10#1)(2012-2#1)
favourable effect##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2012-2#1)
favourable for##4##2##(1990-9#1)(1997-7#1)(2008-5#1)(2010-8#1)
favourable in##4##2##(2007-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
favourable outcome##5##2##(1991-11#1)(2008-4#1)(2010-10#1)(2010-3#1)(2011-1#1)
favourable pharmacokinetic and##2##3##(2008-11#1)(2008-7#1)
favourable pharmacokinetic##3##2##(2008-11#1)(2008-7#1)(2009-7#1)
favourable physical properties of##2##4##(1990-8#1)(2008-1#1)
favourable physical##3##2##(1990-8#1)(2008-1#1)(2008-5#1)
favourable response##2##2##(2008-10#1)(2011-2#1)
favourable than##2##2##(2008-10#1)(2008-6#1)
favourable with##4##2##(1991-8#1)(2008-5#1)(2010-12#1)(2011-1#1)
favourable##82##1##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-5#1)(1993-2#2)(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-2#4)(2013-1#4)(2013-8#1)
favourably to##4##2##(1992-5#1)(2007-12#1)(2007-7#1)(2008-10#1)
favourably with the##5##3##(2007-11#1)(2008-10#3)(2012-2#1)
favourably with those##2##3##(2008-10#2)
favourably with##12##2##(1991-9#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2012-2#1)
favourably##25##1##(1991-5#1)(1991-9#1)(1992-5#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#3)(2012-2#1)
favoured by##3##2##(1990-5#1)(2010-10#1)(2012-3#1)
favoured in##2##2##(2008-10#1)(2010-12#1)
favoured the##2##2##(2008-10#1)(2008-4#1)
favoured when##2##2##(2008-10#1)(2008-11#1)
favoured##20##1##(1990-5#1)(1991-6#1)(1993-3#1)(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#2)(2010-10#1)(2010-12#2)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#1)
favouring the##3##2##(2008-4#1)(2008-5#1)(2008-6#1)
favouring##5##1##(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)
favourite sleeping positions##2##3##(1992-11#2)
favourite##5##1##(1992-11#2)(2008-5#1)(2010-5#1)(2011-2#1)
favours the formation of##2##4##(2008-10#2)
favours##9##1##(1994-8#1)(1995-12#1)(1996-6#1)(2007-11#1)(2008-10#2)(2010-10#1)(2012-3#1)(2013-1#1)
fbn-1 gene##2##2##(1997-8#2)
fc##2##1##(2008-10#2)
fcc##3##1##(1995-3#1)(2008-10#2)
fcu-7AL##2##1##(2008-10#2)
fd##5##1##(1994-12#4)(2008-8#1)
fd-tet##2##1##(1997-4#1)(2008-4#1)
fdh##4##1##(1995-8#4)
fe##2##1##(2008-2#1)(2012-2#1)
fear and disgust levels##2##4##(2012-2#2)
fear and disgust##7##3##(2009-8#2)(2012-2#3)(2013-8#2)
fear and##15##2##(1990-12#1)(1994-3#1)(2008-4#1)(2009-8#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
fear attentional biases##3##3##(2010-7#3)
fear conditioning and##2##3##(2008-11#1)(2008-4#1)
fear conditioning is##2##3##(1997-7#1)(2008-4#1)
fear conditioning##12##2##(1997-7#4)(2008-11#6)(2008-4#2)
fear during##2##2##(2012-1#1)(2012-2#1)
fear for##2##2##(2008-6#1)(2009-5#1)
fear in##5##2##(1993-1#1)(2008-11#2)(2010-9#2)
fear learning##2##2##(2008-11#2)
fear levels##3##2##(2012-2#3)
fear of blushing##2##3##(2010-4#2)
fear of cancer being detected##2##5##(1991-6#1)(1992-2#1)
fear of cancer##3##3##(1991-6#1)(1992-2#1)(2013-1#1)
fear of death##2##3##(1996-6#2)
fear of the unknown##2##4##(2011-2#2)
fear of the##5##3##(1994-1#1)(2011-1#1)(2011-2#2)(2013-1#1)
fear of##47##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-2#1)(1994-1#2)(1996-5#1)(1996-6#5)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-11#1)(2010-4#2)(2011-1#5)(2011-2#8)(2012-12#2)(2013-1#4)(2013-8#1)
fear reactions in##2##3##(1994-2#1)(2012-12#1)
fear reactions##3##2##(1994-2#2)(2012-12#1)
fear that##3##2##(1994-1#1)(1996-3#1)(2008-11#1)
fear to##3##2##(1997-7#1)(2007-2#1)(2011-2#1)
fear##149##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#6)(1993-2#1)(1994-1#3)(1994-2#2)(1994-3#1)(1996-3#1)(1996-5#1)(1996-6#5)(1997-3#2)(1997-7#6)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#20)(2008-12#1)(2008-2#1)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-7#4)(2010-9#3)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#5)
fear-potentiated startle in mice##2##4##(2008-4#2)
fear-potentiated startle##4##2##(2008-4#4)
fear-potentiated##5##1##(2008-11#1)(2008-4#4)
fear-potentiation##2##1##(2008-11#2)
feared HIV##2##2##(1995-12#2)
feared##8##1##(1995-12#2)(1996-6#1)(1996-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-3#1)
fearful expression##2##2##(2007-4#2)
fearful facial expressions##2##3##(2008-11#2)
fearful temperament and##3##3##(2012-12#3)
fearful##15##1##(2007-4#4)(2008-11#4)(2008-6#1)(2009-9#2)(2012-12#4)
fears about##3##2##(2007-12#1)(2008-11#1)(2010-2#1)
fears and anxieties##4##3##(2011-2#4)
fears and##8##2##(1995-2#1)(2007-8#1)(2008-3#1)(2011-2#4)(2012-12#1)
fears in##3##2##(1992-1#1)(2007-8#1)(2010-10#1)
fears of##2##2##(2007-2#1)(2009-10#1)
fears that##3##2##(2008-10#2)(2012-12#1)
fears##44##1##(1992-1#1)(1992-8#1)(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#7)(2012-12#3)(2013-8#1)
feasibilities##3##1##(2008-10#1)(2008-3#2)
feasibility and efficacy of##2##4##(2008-6#2)
feasibility and safety of##8##4##(2007-8#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
feasibility and##26##2##(1991-3#1)(1992-2#2)(1994-2#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#2)(2009-11#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
feasibility demonstration of a practical##2##5##(2008-3#2)
feasibility for a##2##3##(2010-10#1)(2011-2#1)
feasibility for##7##2##(1997-4#1)(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
feasibility of a##11##3##(1990-5#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-10#1)(2010-12#1)
feasibility of an##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
feasibility of developing##4##3##(1994-3#1)(2008-10#1)(2009-7#2)
feasibility of employing##3##3##(2008-10#2)(2008-2#1)
feasibility of implementing##3##3##(1992-2#1)(2007-11#1)(2012-2#1)
feasibility of our method##2##4##(2007-12#1)(2008-3#1)
feasibility of our##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
feasibility of selective##2##3##(1995-11#1)(2011-2#1)
feasibility of the SI-MSFA##2##4##(2008-10#2)
feasibility of the method##4##4##(2008-11#1)(2008-3#2)(2008-5#1)
feasibility of the##35##3##(1991-5#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#1)(2008-8#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
feasibility of these##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
feasibility of this approach##2##4##(2007-12#1)(2008-10#1)
feasibility of this method##5##4##(2007-11#2)(2008-10#2)(2008-3#1)
feasibility of this##12##3##(1991-3#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-3#1)(2013-8#1)
feasibility of using a##2##4##(2008-3#2)
feasibility of using##20##3##(1994-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-8#1)(2010-5#1)(2011-2#1)
feasibility of##189##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#2)(1996-3#2)(1997-8#2)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#1)(2007-8#5)(2007-9#1)(2008-10#42)(2008-11#7)(2008-2#15)(2008-3#29)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
feasibility study and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
feasibility study of##4##3##(1990-12#1)(1994-6#1)(2007-10#1)(2013-1#1)
feasibility study on the##2##4##(2010-7#1)(2013-1#1)
feasibility study on##4##3##(2008-7#1)(2009-12#1)(2010-7#1)(2013-1#1)
feasibility study##21##2##(1990-12#1)(1993-1#1)(1994-12#1)(1994-6#1)(2007-10#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#2)
feasibility to##4##2##(2008-10#3)(2008-11#1)
feasibility##275##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-2#2)(1996-3#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#2)(2007-10#4)(2007-11#9)(2007-12#8)(2007-2#1)(2007-8#6)(2007-9#1)(2008-10#57)(2008-11#9)(2008-2#17)(2008-3#34)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#2)(2010-10#4)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#5)
feasible alternative##2##2##(2008-10#1)(2013-7#1)
feasible and effective in##2##4##(2008-11#1)(2012-1#1)
feasible and effective##5##3##(2008-11#1)(2008-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
feasible and safe##4##3##(2011-2#2)(2012-12#1)(2012-2#1)
feasible and##25##2##(1992-2#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
feasible at##3##2##(1996-2#1)(2008-9#1)(2010-8#1)
feasible but##2##2##(1995-5#1)(2008-8#1)
feasible for##10##2##(1992-2#1)(1995-2#1)(2007-8#1)(2008-12#1)(2008-3#3)(2011-2#1)(2013-1#1)(2013-8#1)
feasible in the##5##3##(2007-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
feasible in##14##2##(1991-2#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2013-1#2)(2013-8#1)
feasible method##2##2##(1992-12#1)(2008-10#1)
feasible option##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
feasible to implement##2##3##(2008-5#1)(2013-1#1)
feasible to##12##2##(1994-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2013-1#2)(2013-8#1)
feasible tool##2##2##(2008-11#1)(2008-7#1)
feasible using##2##2##(2008-11#1)(2008-9#1)
feasible when the##2##3##(2008-10#1)(2009-11#1)
feasible when##3##2##(1992-6#1)(2008-10#1)(2009-11#1)
feasible with##8##2##(1997-6#1)(2008-10#2)(2008-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
feasible##189##1##(1990-10#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#27)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#14)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#8)(2008-9#5)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#9)
feasible?##3##1##(2007-10#1)(2008-10#1)(2011-2#1)
feasibly##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
feather as a source of energy##2##6##(2008-6#2)
feather disease in##2##3##(2008-5#2)
feather disease##6##2##(1992-2#1)(2008-5#5)
feather follicular nodules##3##3##(1997-6#3)
feather follicular##4##2##(1997-6#4)
feather quality##3##2##(2008-9#3)
feather waste##3##2##(2008-6#3)
feather##32##1##(1992-2#1)(1997-6#4)(2007-5#1)(2008-5#7)(2008-6#12)(2008-9#6)(2009-7#1)
feather-degrading bacterial isolates##2##3##(2008-6#2)
feathers##4##1##(2007-6#1)(2008-5#2)(2008-9#1)
feathery mottle virus##4##3##(2008-10#4)
feathery mottle##7##2##(2008-10#7)
feature a##3##2##(2008-3#1)(2009-10#1)(2009-7#1)
feature and##4##2##(1990-6#1)(1994-12#1)(1996-1#1)(2008-12#1)
feature are##2##2##(1990-8#1)(1996-5#1)
feature at##3##2##(1994-11#1)(2008-2#1)(2008-3#1)
feature between##2##2##(2007-10#1)(2008-2#1)
feature can##2##2##(1991-12#1)(2008-11#1)
feature characteristic##2##2##(1995-12#1)(1997-8#1)
feature dimensions##2##2##(2008-10#1)(2009-5#1)
feature extraction##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
feature for##4##2##(1992-3#1)(1994-11#1)(2007-12#1)(2011-2#1)
feature in the##5##3##(1992-3#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-5#1)
feature in##17##2##(1991-5#1)(1992-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#2)(2010-1#1)(2010-5#1)(2011-2#1)
feature is that the##2##4##(2006-10#1)(2012-3#1)
feature is that##4##3##(1990-6#1)(2006-10#1)(2008-3#1)(2012-3#1)
feature is the##2##3##(2008-3#1)(2011-2#1)
feature is##10##2##(1990-6#1)(1991-8#1)(1994-6#1)(2006-10#1)(2008-3#3)(2008-6#1)(2011-2#1)(2012-3#1)
feature issue##12##2##(2008-2#4)(2008-3#8)
feature may be##2##3##(2009-2#1)(2010-12#1)
feature not##2##2##(1994-3#1)(2008-8#1)
feature of Alzheimer's disease (AD)##2##5##(1996-2#1)(2008-7#1)
feature of a##2##3##(2010-12#1)(2012-3#1)
feature of all##2##3##(1991-9#1)(2008-9#1)
feature of cell##2##3##(2008-10#1)(2009-5#1)
feature of chronic##2##3##(2011-2#1)(2013-8#1)
feature of cutaneous##2##3##(1996-11#1)(2012-12#1)
feature of diabetes##2##3##(2008-10#1)(2011-2#1)
feature of eukaryotes##2##3##(2008-11#1)(2008-7#1)
feature of many##2##3##(1991-9#1)(1995-2#1)
feature of our##2##3##(1994-5#1)(1995-2#1)
feature of the method is##3##5##(2008-10#2)(2008-3#1)
feature of the proposed##2##4##(2008-10#1)(2008-3#1)
feature of the system##2##4##(2008-2#1)(2008-9#1)
feature of the underlying##2##4##(2007-7#1)(2011-2#1)
feature of the##41##3##(1990-9#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
feature of these##8##3##(1991-3#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
feature of this case##2##4##(2007-7#1)(2010-6#1)
feature of this##13##3##(1993-1#1)(2007-7#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)
feature of##150##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#19)(2008-11#9)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#10)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#4)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
feature on the##3##3##(1991-5#1)(1996-6#1)(2008-12#1)
feature reduction##2##2##(2008-11#1)(2010-8#1)
feature results##2##2##(2008-10#1)(2009-6#1)
feature selection##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
feature selectivity of##2##3##(2008-11#1)(2008-7#1)
feature selectivity##3##2##(2008-11#1)(2008-7#2)
feature size##4##2##(2008-3#3)(2009-11#1)
feature sizes##5##2##(2008-10#1)(2008-2#3)(2008-7#1)
feature that may##2##3##(1995-3#1)(2008-2#1)
feature that the##2##3##(2008-12#1)(2008-3#1)
feature that##6##2##(1995-3#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
feature to##3##2##(1994-12#1)(2012-3#2)
feature vector##2##2##(2008-10#1)(2008-3#1)
feature was the##2##3##(1992-10#1)(1992-3#1)
feature was##8##2##(1992-10#1)(1992-3#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
feature##358##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#6)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#13)(2008-12#5)(2008-2#21)(2008-3#36)(2008-4#5)(2008-5#5)(2008-6#13)(2008-7#16)(2008-8#7)(2008-9#14)(2009-10#3)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#4)(2010-8#1)(2011-1#4)(2011-2#11)(2012-12#4)(2012-2#6)(2012-3#8)(2013-1#3)(2013-7#4)(2013-8#4)
feature-based##2##1##(2007-8#1)(2012-3#1)
featured a##3##2##(1992-12#1)(1992-8#1)(2008-10#1)
featured in the##2##3##(1995-2#1)(1995-3#1)
featured in##4##2##(1995-2#1)(1995-3#1)(2008-2#1)(2009-3#1)
featured##15##1##(1992-12#1)(1992-8#1)(1993-2#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)
featureless##3##1##(2008-2#1)(2008-8#1)(2009-5#1)
features (Study##2##2##(2009-11#2)
features a##10##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
features among##2##2##(1994-8#1)(2007-12#1)
features an##4##2##(1997-7#1)(2007-11#1)(2008-3#2)
features and advantages of##2##4##(1996-1#1)(2008-11#1)
features and differential##2##3##(2008-4#1)(2009-3#1)
features and functions##2##3##(2011-2#1)(2012-2#1)
features and management of##3##4##(2008-11#1)(2010-5#1)(2012-3#1)
features and management##4##3##(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
features and prognostic##2##3##(1990-9#1)(2012-3#1)
features and the##8##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
features and treatment of##2##4##(2011-2#1)(2012-2#1)
features and treatment##4##3##(1992-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
features and tumor-associated lymphoid proliferation in##2##6##(2008-11#2)
features and##80##2##(1990-9#2)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-5#1)(1996-1#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
features are also##2##3##(2008-7#1)(2011-2#1)
features are discussed##4##3##(2008-2#3)(2008-7#1)
features are given##2##3##(2007-11#1)(2008-3#1)
features are important##2##3##(1997-8#1)(2013-1#1)
features are presented##2##3##(2012-3#1)(2013-1#1)
features are similar to those##2##5##(1992-2#1)(2008-5#1)
features are the##2##3##(1990-6#1)(1995-11#1)
features are##51##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1997-4#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
features as a##3##3##(2008-11#1)(2010-6#1)(2011-1#1)
features as the##2##3##(2007-11#1)(2008-10#1)
features as##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-6#1)(2011-1#1)
features associated with the##2##4##(2008-10#1)(2013-1#1)
features associated with##7##3##(2007-10#1)(2007-12#1)(2008-10#1)(2009-12#1)(2013-1#2)(2013-8#1)
features at##3##2##(2008-1#1)(2008-2#1)(2013-1#1)
features between##2##2##(2008-4#1)(2010-8#1)
features both##2##2##(2008-10#1)(2013-7#1)
features by##4##2##(2008-10#2)(2008-3#1)(2010-12#1)
features can##2##2##(2008-3#1)(2009-6#1)
features characteristic for##2##3##(2008-10#1)(2008-7#1)
features characteristic of the##2##4##(1990-10#1)(1997-7#1)
features characteristic of##4##3##(1990-10#1)(1991-9#1)(1997-7#1)(2008-7#1)
features characteristic##6##2##(1990-10#1)(1991-9#1)(1997-7#1)(2008-10#1)(2008-7#2)
features combined##2##2##(1996-12#1)(2008-10#1)
features compared##2##2##(2007-10#1)(2008-2#1)
features compatible with##2##3##(1992-9#1)(2009-6#1)
features consistent with##4##3##(2008-10#1)(2008-6#1)(2010-11#2)
features could##2##2##(2008-10#1)(2011-2#1)
features described above##2##3##(1996-2#1)(2008-7#1)
features described##6##2##(1996-2#1)(2008-7#2)(2010-8#2)(2013-7#1)
features differentiating##2##2##(2008-5#1)(2008-6#1)
features due to##2##3##(2008-10#1)(2009-11#1)
features for the##5##3##(1997-7#1)(2007-11#1)(2010-12#1)(2012-5#1)(2012-8#1)
features for##16##2##(1991-9#1)(1993-12#1)(1994-9#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-5#1)(2012-8#1)
features from the##2##3##(2008-9#1)(2011-1#1)
features from##9##2##(1996-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-7#1)
features has been##4##3##(2008-2#1)(2008-4#2)(2010-10#1)
features have been identified##2##4##(2008-2#1)(2008-9#1)
features have##7##2##(1990-6#1)(1997-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-5#1)
features in cancer##2##3##(2010-8#1)(2011-2#1)
features in common##3##3##(1997-5#1)(2008-8#2)
features in the##12##3##(1991-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#1)
features in##38##2##(1991-2#1)(1995-6#1)(1995-8#2)(1997-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)
features include a##2##3##(2008-2#1)(2012-2#1)
features include##9##2##(1991-1#1)(1993-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-12#1)(2012-2#1)
features including##5##2##(2008-6#1)(2009-8#1)(2010-3#1)(2011-1#2)
features is reported##2##3##(1990-6#1)(2008-12#1)
features is##4##2##(1990-6#1)(2007-7#1)(2008-12#1)(2008-2#1)
features less than 60 nm##2##5##(2007-12#2)
features made##2##2##(2008-10#1)(2012-3#1)
features may##2##2##(2009-1#1)(2011-1#1)
features mimicking##2##2##(2008-12#1)(2012-2#1)
features not only##2##3##(1997-3#1)(2009-8#1)
features not##3##2##(1997-3#1)(2008-11#1)(2009-8#1)
features observed in##4##3##(2008-10#1)(2009-3#1)(2010-5#1)(2013-8#1)
features observed##5##2##(2008-10#1)(2008-3#1)(2009-3#1)(2010-5#1)(2013-8#1)
features of 12 patients##2##4##(2007-8#1)(2013-1#1)
features of Burkitt's lymphoma##2##4##(2008-1#2)
features of PfTrx-2##2##3##(2012-2#2)
features of Sjögren's syndrome##3##4##(2008-7#3)
features of a##17##3##(1990-11#1)(1990-6#1)(1991-6#1)(1993-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
features of acute##2##3##(2010-5#1)(2013-1#1)
features of an##2##3##(1992-12#1)(2008-3#1)
features of aplasia of the##2##5##(2011-1#2)
features of atypical##2##3##(2009-5#1)(2011-2#1)
features of benign##2##3##(1994-5#1)(2008-8#1)
features of both sets of##2##5##(2010-4#2)
features of both##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#2)
features of each##3##3##(1996-12#1)(2008-7#1)(2012-2#1)
features of essential tremor##2##4##(2008-7#2)
features of food##2##3##(1993-6#2)
features of human##4##3##(2008-10#1)(2010-9#1)(2012-2#1)(2013-8#1)
features of inflammatory##2##3##(2006-10#1)(2009-4#1)
features of interest##2##3##(2008-11#1)(2008-2#1)
features of learned##2##3##(2008-8#2)
features of metabolic syndrome##2##4##(2008-3#1)(2011-1#1)
features of optical##2##3##(2007-11#2)
features of our##3##3##(1991-9#1)(1993-8#1)(2012-2#1)
features of patients with##3##4##(2007-2#1)(2008-8#1)(2013-8#1)
features of patients##4##3##(2007-2#1)(2007-8#1)(2008-8#1)(2013-8#1)
features of primary##2##3##(2008-7#1)(2009-3#1)
features of pulmonary##2##3##(2008-6#1)(2011-2#1)
features of size##2##3##(2008-2#1)(2009-11#1)
features of social##3##3##(2008-4#1)(2008-6#1)(2013-1#1)
features of systemic##3##3##(2008-8#1)(2011-2#2)
features of the active site##2##5##(1992-11#1)(1992-4#1)
features of the case##2##4##(2008-7#1)(2013-1#1)
features of the disease##3##4##(1991-12#1)(2010-12#1)(2012-1#1)
features of the flow-through##2##4##(2008-10#2)
features of the measured##2##4##(2008-3#2)
features of the metabolic syndrome##7##5##(2008-3#5)(2008-5#2)
features of the most##2##4##(2008-5#1)(2012-2#1)
features of the original##2##4##(1993-12#1)(2009-8#1)
features of the proposed##2##4##(2008-10#1)(2008-3#1)
features of the relationship between##2##5##(1994-5#1)(2012-3#1)
features of the##152##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#4)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-12#1)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#5)(2008-3#20)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#2)(2009-11#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
features of their##4##3##(2007-11#1)(2009-12#1)(2009-5#1)(2009-8#1)
features of these##11##3##(1991-8#1)(1994-11#1)(1997-7#1)(2006-4#1)(2008-3#2)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
features of this organism##18##4##(2011-2#18)
features of this rare##2##4##(1991-2#1)(1994-2#1)
features of this uncommon disease and##2##6##(1993-5#1)(2008-12#1)
features of this uncommon##3##4##(1993-5#1)(2008-12#1)(2011-2#1)
features of this##36##3##(1991-2#1)(1991-6#1)(1993-1#1)(1993-5#1)(1994-2#1)(1996-10#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#20)(2013-8#1)
features of two cases##2##4##(1990-5#1)(1994-6#1)
features of two##3##3##(1990-5#1)(1994-6#1)(2008-8#1)
features of##548##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#4)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-12#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#4)(2006-10#3)(2006-4#1)(2007-10#2)(2007-11#13)(2007-12#15)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#7)(2008-1#14)(2008-10#42)(2008-11#11)(2008-12#9)(2008-2#16)(2008-3#36)(2008-4#6)(2008-5#13)(2008-6#8)(2008-7#23)(2008-8#16)(2008-9#7)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#11)(2011-2#49)(2012-1#5)(2012-12#4)(2012-2#24)(2012-3#11)(2012-9#1)(2013-1#21)(2013-7#1)(2013-8#6)
features often##2##2##(1997-7#1)(2012-3#1)
features on the##5##3##(1991-5#1)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
features on##9##2##(1991-5#1)(2008-3#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
features or##4##2##(2008-11#1)(2008-8#1)(2010-5#1)(2012-3#1)
features prompted##2##2##(2007-8#1)(2008-7#1)
features resembling##4##2##(1994-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
features responsible for the##2##4##(1992-6#1)(2010-12#1)
features responsible for##3##3##(1992-6#1)(1995-8#1)(2010-12#1)
features revealed##2##2##(1997-8#1)(2008-10#1)
features show##2##2##(1991-5#1)(2008-2#1)
features similar to the##2##4##(2006-12#1)(2008-9#1)
features similar to those##2##4##(1991-11#1)(2008-12#1)
features similar to##5##3##(1991-11#1)(2006-12#1)(2008-12#1)(2008-5#1)(2008-9#1)
features simulating##2##2##(1993-2#1)(2008-7#1)
features such as a##3##4##(2007-11#1)(2008-10#2)
features such as personality##2##4##(1994-2#1)(2009-10#1)
features such as##26##3##(1992-2#1)(1994-2#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#3)(2009-10#1)(2009-12#2)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
features suggest that##4##3##(1993-9#1)(2007-11#1)(2008-5#1)(2012-2#1)
features suggest##5##2##(1993-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
features suggestive of##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
features surrounding the translation initiation sites##2##6##(1996-8#2)
features surrounding the##3##3##(1996-8#2)(1997-2#1)
features than##2##2##(1996-3#1)(2008-3#1)
features that are characteristic of##2##5##(1992-9#1)(1994-8#1)
features that are important for##2##5##(2010-10#1)(2011-1#1)
features that are##14##3##(1992-9#1)(1994-5#1)(1994-8#1)(1996-3#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#2)
features that distinguish##4##3##(1991-12#1)(2009-4#1)(2012-1#1)(2013-8#1)
features that have##2##3##(2008-9#1)(2010-8#1)
features that make it##2##4##(1997-2#1)(2008-9#1)
features that make##5##3##(1996-11#1)(1997-2#1)(2008-9#1)(2011-2#1)(2013-7#1)
features that may##3##3##(1995-11#1)(2007-5#1)(2008-10#1)
features that result from##2##4##(2008-3#2)
features that should be##2##4##(2010-8#1)(2011-2#1)
features that were##3##3##(2007-11#1)(2010-12#1)(2013-1#1)
features that##59##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-11#3)(2007-12#3)(2007-5#2)(2008-10#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
features the##5##2##(1990-8#1)(1992-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
features to be##2##3##(2008-3#1)(2008-8#1)
features to##13##2##(1991-12#1)(1996-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
features was##2##2##(2008-6#1)(2012-12#1)
features were associated with##2##4##(2008-10#1)(2008-4#1)
features were consistent with##2##4##(2007-8#1)(2010-11#1)
features were not##2##3##(2007-10#1)(2013-1#1)
features were##25##2##(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2009-12#1)(2010-11#1)(2012-2#1)(2013-1#2)
features which may##2##3##(2008-3#1)(2013-1#1)
features which##9##2##(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
features with a##2##3##(2008-10#1)(2009-10#1)
features with##14##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
features within the##2##3##(2007-11#1)(2008-11#1)
features within##4##2##(1994-3#1)(2007-11#1)(2008-11#1)(2009-10#1)
features##1426##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#7)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#3)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#5)(1991-5#3)(1991-6#7)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#6)(1993-5#3)(1993-6#5)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#9)(1994-2#4)(1994-3#4)(1994-5#7)(1994-6#3)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#9)(2006-10#5)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#10)(2007-11#35)(2007-12#38)(2007-2#2)(2007-5#7)(2007-6#1)(2007-7#11)(2007-8#11)(2008-1#26)(2008-10#114)(2008-11#43)(2008-12#20)(2008-2#50)(2008-3#98)(2008-4#21)(2008-5#34)(2008-6#32)(2008-7#66)(2008-8#30)(2008-9#21)(2009-1#2)(2009-10#14)(2009-11#15)(2009-12#15)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#7)(2009-6#3)(2009-7#5)(2009-8#13)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#9)(2010-12#10)(2010-2#1)(2010-3#5)(2010-4#12)(2010-5#10)(2010-6#5)(2010-7#2)(2010-8#26)(2010-9#4)(2011-1#30)(2011-10#1)(2011-2#96)(2012-1#8)(2012-12#19)(2012-2#49)(2012-3#29)(2012-5#3)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#48)(2013-7#5)(2013-8#20)
features)##3##1##(2010-8#1)(2011-2#1)(2012-12#1)
features]##3##1##(1993-3#1)(2008-7#1)(2012-12#1)
featuring the##2##2##(1997-7#1)(2009-8#1)
featuring##12##1##(1992-12#1)(1992-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#2)
febrile and##2##2##(1996-12#1)(2007-7#1)
febrile convulsions##2##2##(1991-11#1)(1993-7#1)
febrile episodes##2##2##(2008-5#1)(2008-7#1)
febrile illness and##2##3##(2007-2#1)(2009-5#1)
febrile illness##6##2##(1997-8#1)(2007-2#2)(2009-5#1)(2012-3#1)(2013-8#1)
febrile infections##3##2##(2008-10#2)(2011-2#1)
febrile morbidity##5##2##(1994-2#1)(1995-1#1)(1995-12#2)(1996-1#1)
febrile neutropenia and##3##3##(2008-7#3)
febrile neutropenia in cycle 1##2##5##(2008-7#2)
febrile neutropenia in the##2##4##(2008-11#2)
febrile neutropenia in##4##3##(2008-11#2)(2008-7#2)
febrile neutropenia##22##2##(2008-11#5)(2008-6#1)(2008-7#16)
febrile neutropenic patients##2##3##(2010-11#1)(2013-1#1)
febrile returning travellers##3##3##(2007-2#3)
febrile seizures##2##2##(2006-5#1)(2012-12#1)
febrile urinary infections##2##3##(2008-10#2)
febrile##69##1##(1991-11#1)(1991-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#1)(1997-8#1)(2006-5#1)(2007-2#7)(2007-7#1)(2008-10#5)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#18)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
fecal and##2##2##(2009-3#1)(2009-4#1)
fecal bacterial concentrations##3##3##(2009-4#3)
fecal blood loss##3##3##(1991-6#1)(1993-3#1)(2009-10#1)
fecal blood##5##2##(1991-6#2)(1993-3#2)(2009-10#1)
fecal coliforms##3##2##(2008-10#2)(2008-5#1)
fecal excretion of##7##3##(1994-5#1)(2008-10#1)(2010-2#5)
fecal markers##2##2##(2013-8#2)
fecal occult blood testing##2##4##(2009-12#1)(2010-8#1)
fecal occult blood##5##3##(1990-8#1)(1991-3#1)(1994-2#1)(2009-12#1)(2010-8#1)
fecal pellets##2##2##(2008-5#2)
fecal samples of##2##3##(2012-12#1)(2012-3#1)
fecal samples were##3##3##(2009-4#2)(2012-12#1)
fecal samples##7##2##(2009-4#2)(2012-12#3)(2012-3#2)
fecal##65##1##(1990-12#2)(1990-8#2)(1991-12#1)(1991-3#2)(1991-6#2)(1993-3#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-10#6)(2008-5#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#12)(2010-12#1)(2010-2#7)(2010-8#1)(2011-2#6)(2012-12#3)(2012-3#3)(2013-1#1)(2013-8#3)
feces and##8##2##(1996-12#2)(2007-10#1)(2008-10#1)(2008-5#2)(2009-4#1)(2013-1#1)
feces by##2##2##(1993-2#1)(2008-10#1)
feces in##3##2##(1991-3#1)(2008-12#2)
feces of##3##2##(2007-10#1)(2009-4#1)(2012-2#1)
feces was##2##2##(1990-8#1)(2012-2#1)
feces##43##1##(1990-6#1)(1990-8#4)(1991-12#1)(1991-3#2)(1993-2#4)(1996-12#3)(2007-10#3)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#4)(2009-4#3)(2009-6#2)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
feces]##3##1##(1993-6#1)(1995-12#1)(2008-5#1)
fecundity and##8##2##(2008-11#1)(2008-8#2)(2008-9#2)(2010-8#2)(2011-2#1)
fecundity effects##2##2##(2011-2#2)
fecundity of##5##2##(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
fecundity on##3##2##(2008-8#3)
fecundity or##2##2##(2008-11#1)(2008-8#1)
fecundity ranged from##2##3##(2008-12#2)
fecundity rates##5##2##(1991-3#1)(2008-12#4)
fecundity was##3##2##(2008-9#1)(2009-4#1)(2012-12#1)
fecundity##58##1##(1991-3#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-12#8)(2008-3#1)(2008-8#11)(2008-9#11)(2009-4#1)(2010-8#7)(2011-2#5)(2012-12#3)(2012-3#2)(2013-7#3)
fed 0##4##2##(2008-10#1)(2008-7#1)(2010-2#2)
fed 7 days prior to##2##5##(1996-12#2)
fed a diet containing##3##4##(1990-11#1)(1991-12#1)(1992-9#1)
fed a diet##8##3##(1990-11#1)(1991-12#1)(1992-9#1)(1995-11#1)(1995-2#1)(2008-12#2)(2013-1#1)
fed a high##3##3##(1997-5#1)(2011-2#1)(2013-1#1)
fed a high-fat diet##2##4##(2012-2#1)(2013-1#1)
fed a##32##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-4#2)(2010-2#2)(2011-2#1)(2012-2#2)(2013-1#6)
fed ad libitum##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
fed ad##4##2##(1991-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
fed an##2##2##(1993-6#1)(2007-8#1)
fed and##4##2##(1990-6#1)(1994-8#2)(2008-7#1)
fed animals##2##2##(1990-7#1)(1994-8#1)
fed back into the##2##4##(2008-2#1)(2008-3#1)
fed back into##3##3##(2008-2#1)(2008-3#2)
fed back##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
fed batch##2##2##(2008-7#1)(2011-2#1)
fed black currant##2##3##(1994-2#2)
fed by the posterior##2##4##(2008-7#2)
fed by the##3##3##(1991-5#1)(2008-7#2)
fed by##8##2##(1991-5#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#4)
fed daily##3##2##(2008-10#1)(2008-6#1)(2012-12#1)
fed diet and carcinogens like Gr##2##6##(2008-10#2)
fed diet##4##2##(2008-10#3)(2010-2#1)
fed diets containing##8##3##(1995-8#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)
fed diets##10##2##(1995-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)
fed either a##4##3##(1997-4#3)(2010-2#1)
fed either##6##2##(1997-4#3)(2009-12#1)(2010-2#1)(2013-1#1)
fed ethanol##3##2##(2008-11#3)
fed every##2##2##(2008-11#1)(2008-8#1)
fed experimental diets##2##3##(2010-2#1)(2012-2#1)
fed for##2##2##(2008-12#1)(2012-2#1)
fed into the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
fed into##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
fed mice##2##2##(2013-1#2)
fed more##2##2##(2008-8#1)(2010-8#1)
fed normal low protein##2##4##(2008-10#2)
fed on the##2##3##(2008-7#1)(2010-4#1)
fed on##19##2##(1991-12#1)(1995-2#1)(1997-4#1)(1997-8#2)(2008-10#7)(2008-5#1)(2008-6#3)(2008-7#1)(2010-4#1)(2013-1#1)
fed one of##2##3##(2009-9#1)(2012-2#1)
fed one##3##2##(2008-12#1)(2009-9#1)(2012-2#1)
fed rats##15##2##(1992-12#1)(1993-11#4)(1993-8#2)(1994-2#1)(1994-8#3)(1997-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
fed soybean##2##2##(2008-12#1)(2012-2#1)
fed state##4##2##(1991-3#1)(1996-5#1)(2008-3#1)(2012-2#1)
fed the PC diet##2##4##(2010-2#2)
fed the control##2##3##(2010-2#1)(2012-2#1)
fed the experimental##2##3##(1993-11#1)(2012-2#1)
fed the##24##2##(1992-9#1)(1993-11#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-2#9)(2012-2#6)
fed to the##3##3##(2008-6#1)(2009-2#1)(2012-2#1)
fed to##8##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-2#1)(2010-4#1)(2012-2#1)
fed upon by##2##3##(1990-11#1)(2008-10#1)
fed with a##8##3##(2008-12#1)(2008-7#1)(2011-2#5)(2012-2#1)
fed with high##2##3##(2008-9#1)(2012-12#1)
fed with##25##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)
fed##294##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#3)(1994-8#8)(1995-11#1)(1995-2#2)(1995-8#2)(1996-12#4)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#2)(2007-12#2)(2007-8#2)(2008-10#27)(2008-11#18)(2008-12#13)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#7)(2008-6#12)(2008-7#17)(2008-8#9)(2008-9#4)(2009-12#1)(2009-2#1)(2009-4#6)(2009-5#1)(2009-9#1)(2010-2#20)(2010-4#4)(2010-6#1)(2010-8#1)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#25)(2013-1#18)
fed)##3##1##(2008-10#2)(2008-7#1)
fed-batch addition of fresh substrate##2##5##(2011-2#2)
fed-batch bioreactors##2##2##(2008-11#1)(2008-7#1)
fed-batch cultivation##2##2##(2008-7#2)
fed-batch cultivations##5##2##(2008-7#5)
fed-batch culture of##3##3##(2008-11#3)
fed-batch culture##14##2##(2008-11#8)(2008-6#2)(2008-7#4)
fed-batch cultures of a##2##4##(2008-11#2)
fed-batch cultures of##3##3##(2008-11#2)(2008-7#1)
fed-batch cultures##8##2##(2008-11#7)(2008-7#1)
fed-batch fermentation##3##2##(1992-11#1)(2008-7#1)(2013-1#1)
fed-batch mode##3##2##(2008-11#2)(2008-7#1)
fed-batch process##3##2##(2008-11#2)(2011-1#1)
fed-batch system##3##2##(2008-6#3)
fed-batch##66##1##(1992-11#1)(2008-11#25)(2008-6#9)(2008-7#22)(2011-1#1)(2011-2#5)(2013-1#3)
fedbatch fermentation##5##2##(2008-7#5)
fedbatch##6##1##(2008-7#6)
federal agencies##2##2##(1992-1#1)(1996-1#1)
federal and local##2##3##(2008-6#1)(2013-1#1)
federal and state agencies##2##4##(1997-3#1)(2008-10#1)
federal and state##11##3##(1991-2#1)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2008-10#3)(2012-3#1)(2013-1#1)
federal and##13##2##(1991-2#1)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2008-10#3)(2008-6#1)(2012-3#1)(2013-1#2)
federal funding##2##2##(2007-4#1)(2008-10#1)
federal government##14##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)
federal health care##3##3##(1991-2#1)(1993-12#1)(1994-12#1)
federal health policy##2##3##(1996-12#1)(1996-3#1)
federal health##7##2##(1991-2#1)(1993-12#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2009-5#1)
federal law##3##2##(1994-12#1)(1995-1#1)(1996-12#1)
federal level##3##2##(1994-12#1)(2008-12#1)(2010-9#1)
federal mandate##2##2##(1996-2#1)(2010-5#1)
federal or state##3##3##(1993-2#1)(1995-2#1)(2013-1#1)
federal or##4##2##(1993-2#1)(1995-2#1)(2012-2#1)(2013-1#1)
federal regulations##7##2##(1991-2#1)(1992-12#1)(1994-1#1)(1995-2#2)(1996-3#1)(2008-10#1)
federal regulatory##2##2##(1996-1#1)(2010-9#1)
federal requirements##4##2##(1993-12#1)(1993-2#1)(1993-3#1)(1995-2#1)
federal states##2##2##(2010-4#2)
federal tax##2##2##(1992-12#1)(1993-2#1)
federal##121##1##(1990-10#1)(1990-7#1)(1991-1#3)(1991-12#1)(1991-2#3)(1992-1#4)(1992-12#3)(1992-3#2)(1993-1#3)(1993-12#2)(1993-2#6)(1993-3#2)(1994-1#1)(1994-12#3)(1994-3#3)(1995-1#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-6#3)(1996-1#7)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#3)(2010-4#3)(2010-5#1)(2010-9#2)(2011-2#1)(2011-9#2)(2012-2#2)(2012-3#2)(2013-1#3)
federalism##5##1##(2010-4#4)(2012-3#1)
federally funded research##2##3##(1995-2#2)
federally funded##7##2##(1995-2#3)(2008-11#1)(2008-6#1)(2010-3#1)(2013-1#1)
federally mandated##2##2##(1995-2#1)(1996-1#1)
federally##10##1##(1995-2#4)(1996-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-3#1)(2013-1#1)
federally-funded##2##1##(1995-12#1)(1996-12#1)
federated##5##1##(2010-4#1)(2013-8#4)
fee for service system##2##4##(1997-5#1)(2013-8#1)
fee for service##5##3##(1992-2#1)(1993-3#1)(1997-5#1)(2006-10#1)(2013-8#1)
fee for##8##2##(1990-9#1)(1992-2#1)(1993-3#2)(1997-5#1)(2006-10#1)(2008-4#1)(2013-8#1)
fee reductions##4##2##(1994-1#1)(1994-12#3)
fee schedule##22##2##(1991-12#1)(1992-1#4)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#9)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2012-3#1)
fee schedules##5##2##(1992-3#2)(1993-3#3)
fee setting and rationing--it will outline a values clarification plan and finally will conclude by providing a framework for making moral decisions##2##22##(1994-1#2)
fee to the##2##3##(1996-3#2)
fee##55##1##(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#6)(1994-1#13)(1994-12#4)(1994-9#2)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#3)(1997-3#1)(1997-5#1)(2006-10#1)(2008-4#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
fee-for-service (FFS) patients##2##3##(1995-3#1)(1996-2#1)
fee-for-service (FFS)##10##2##(1993-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#5)
fee-for-service plans##2##2##(1994-1#1)(2009-8#1)
fee-for-service reimbursement##2##2##(1991-1#1)(1995-1#1)
fee-for-service sector##3##2##(1993-1#1)(1993-3#1)(1997-2#1)
fee-for-service system##3##2##(2006-10#3)
fee-for-service##34##1##(1991-1#1)(1991-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#3)(1995-12#1)(1995-3#3)(1996-12#2)(1996-2#3)(1997-1#1)(1997-2#7)(2006-10#3)(2009-8#1)
feed additives##8##2##(2008-10#7)(2010-4#1)
feed and##13##2##(1997-6#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
feed back##2##2##(2008-11#1)(2008-12#1)
feed concentration##4##2##(2008-7#4)
feed consumption##4##2##(2008-12#4)
feed containing##2##2##(2008-10#1)(2008-8#1)
feed control measures##2##3##(2010-4#2)
feed conversion ratio##7##3##(2008-12#5)(2008-5#1)(2013-1#1)
feed conversion ratios##2##3##(1997-6#1)(2008-5#1)
feed conversion##12##2##(1997-6#1)(2008-12#5)(2008-5#3)(2010-8#1)(2013-1#1)(2013-7#1)
feed cost##2##2##(2008-12#2)
feed efficiency##3##2##(2008-12#1)(2010-2#1)(2013-7#1)
feed flow##4##2##(2008-10#2)(2008-6#2)
feed for a##2##3##(1990-2#1)(2008-7#1)
feed for##6##2##(1990-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#2)
feed forward neural##2##3##(2008-10#1)(2010-8#1)
feed forward##4##2##(2008-10#1)(2008-11#1)(2010-8#2)
feed intake and##3##3##(2008-5#1)(2010-2#1)(2012-2#1)
feed intake##9##2##(1997-3#1)(2008-12#1)(2008-5#1)(2010-2#4)(2012-2#1)(2013-1#1)
feed on the##3##3##(2008-2#1)(2008-9#1)(2009-6#1)
feed on##9##2##(1997-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
feed or##2##2##(2008-10#1)(2008-5#1)
feed rate##5##2##(1997-2#1)(2008-11#2)(2008-7#2)
feed rates with a##2##4##(2008-11#1)(2008-7#1)
feed rates##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
feed samples##4##2##(2008-10#3)(2010-4#1)
feed solution##6##2##(2008-10#5)(2008-6#1)
feed the##2##2##(2007-12#1)(2008-6#1)
feed to##2##2##(1995-11#1)(2008-10#1)
feed utilization (FCR##2##3##(2008-12#2)
feed were fed##2##3##(1997-3#1)(2008-12#1)
feed were##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
feed##186##1##(1990-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-3#3)(1997-6#4)(2007-11#1)(2007-12#4)(2007-6#1)(2008-10#56)(2008-11#9)(2008-12#22)(2008-2#1)(2008-4#2)(2008-5#12)(2008-6#8)(2008-7#11)(2008-8#4)(2008-9#4)(2009-4#1)(2009-6#1)(2010-11#2)(2010-2#6)(2010-4#8)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#2)
feed)##2##1##(2008-10#2)
feed-back##2##1##(1992-3#1)(2009-8#1)
feed-forward artificial neural##3##3##(2008-10#3)
feed-forward backpropagation##2##2##(2008-2#2)
feed-forward loop##3##2##(2008-11#1)(2008-2#1)(2013-1#1)
feed-forward neural network##2##3##(2008-10#1)(2008-3#1)
feed-forward neural##3##2##(2008-10#1)(2008-3#2)
feed-forward##19##1##(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2013-1#2)
feedback about##5##2##(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
feedback after each trial##2##4##(2009-10#2)
feedback and the##2##3##(1991-12#1)(2008-12#1)
feedback and##19##2##(1991-12#1)(1991-3#1)(1995-5#1)(1995-6#1)(2007-12#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-9#1)(2012-3#1)
feedback as##2##2##(2007-10#1)(2013-1#1)
feedback between reduced plant cover and increased##2##7##(2008-8#2)
feedback between##3##2##(2008-7#1)(2008-8#2)
feedback can##2##2##(2007-12#1)(2009-8#1)
feedback circuit##2##2##(2007-11#1)(2007-12#1)
feedback control of##5##3##(2008-2#1)(2008-3#1)(2013-1#3)
feedback control##9##2##(2008-2#3)(2008-3#3)(2013-1#3)
feedback effects##2##2##(2008-10#1)(2008-9#1)
feedback field##3##2##(2007-11#1)(2008-3#2)
feedback fields##2##2##(2008-3#2)
feedback following##2##2##(2009-10#2)
feedback for##6##2##(1996-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-9#1)
feedback from the##6##3##(1994-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#2)
feedback from##22##2##(1994-3#1)(1995-12#1)(2007-11#3)(2007-12#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#4)
feedback in##8##2##(1995-11#1)(1996-2#1)(2007-11#2)(2008-3#1)(2009-10#1)(2009-8#1)(2009-9#1)
feedback is##9##2##(1994-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-10#1)(2012-2#1)(2012-3#1)
feedback laser##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
feedback loop##15##2##(1991-5#2)(1991-7#1)(2007-11#3)(2007-12#1)(2008-3#2)(2009-8#3)(2009-9#1)(2010-5#1)(2012-2#1)
feedback loops##6##2##(2008-12#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#2)
feedback mechanism##8##2##(1994-12#1)(1995-12#1)(2008-10#1)(2010-10#4)(2011-2#1)
feedback mechanisms##3##2##(1996-2#1)(2008-2#1)(2011-1#1)
feedback mirror##2##2##(2007-11#1)(2007-12#1)
feedback of##8##2##(1993-1#1)(1995-11#1)(1996-12#1)(2007-8#1)(2008-2#1)(2012-2#3)
feedback on their##2##3##(1995-1#1)(1995-6#1)
feedback on##10##2##(1995-1#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
feedback or##2##2##(1994-5#1)(2007-11#1)
feedback parameters##2##2##(2007-11#1)(2013-1#1)
feedback regarding##3##2##(1996-1#1)(2007-12#1)(2012-12#1)
feedback regulation of##3##3##(1990-8#1)(2009-10#1)(2012-2#1)
feedback regulation##6##2##(1990-2#1)(1990-8#1)(1995-2#1)(2009-10#1)(2010-7#1)(2012-2#1)
feedback showed##2##2##(2007-12#1)(2013-8#1)
feedback sources##3##2##(2007-10#2)(2013-8#1)
feedback system is##2##3##(2007-12#1)(2008-10#1)
feedback system##7##2##(1996-12#1)(2007-12#2)(2008-1#1)(2008-10#2)(2010-3#1)
feedback technique##2##2##(2007-11#1)(2007-12#1)
feedback that##5##2##(1995-1#1)(2007-11#2)(2008-3#1)(2013-1#1)
feedback through##2##2##(1996-3#1)(2007-11#1)
feedback to mentors##2##3##(2012-3#2)
feedback to reduce##2##3##(1994-12#1)(2008-3#1)
feedback to the##5##3##(1992-9#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
feedback to##20##2##(1992-9#1)(1994-12#1)(1996-1#2)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
feedback version##2##2##(2008-10#2)
feedback waveguide##2##2##(2013-8#2)
feedback##347##1##(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#3)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#3)(1996-1#3)(1996-10#1)(1996-12#7)(1996-2#3)(1996-3#4)(2007-10#9)(2007-11#35)(2007-12#37)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#15)(2008-12#5)(2008-2#17)(2008-3#40)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#1)(2009-10#11)(2009-12#2)(2009-3#2)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#7)(2010-10#11)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#12)(2012-3#6)(2013-1#17)(2013-8#8)
feedback-based flow##3##2##(2008-10#3)
feedback-based##7##1##(2008-10#6)(2013-1#1)
feedback-induced##2##1##(2007-12#1)(2009-8#1)
feedbacks##4##1##(2007-11#1)(2008-8#1)(2008-9#1)(2010-10#1)
feeder cells##10##2##(1993-9#6)(2008-11#1)(2008-8#2)(2008-9#1)
feeder layer of##2##3##(1993-3#1)(1993-9#1)
feeder to##2##2##(1997-3#1)(1997-6#1)
feeder##28##1##(1992-12#2)(1993-3#1)(1993-9#8)(1997-3#3)(1997-6#1)(2006-12#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#3)(2011-10#1)
feeder-free culture##2##2##(2008-11#1)(2012-5#1)
feeder-independent culture##2##2##(2008-9#2)
feeder-independent##4##1##(2008-9#4)
feeders and##3##2##(2008-7#2)(2008-9#1)
feeders in##3##2##(1992-12#2)(2008-7#1)
feeders to##2##2##(1997-6#1)(2006-12#1)
feeders##17##1##(1992-12#3)(1997-3#1)(1997-6#1)(2006-12#2)(2008-7#6)(2008-9#3)(2011-2#1)
feedforward frequency response##2##3##(2009-9#1)(2010-5#1)
feedforward loops##2##2##(2008-11#2)
feedforward neural networks trained by back-propagation##2##6##(2008-10#2)
feedforward##11##1##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-9#1)(2010-5#1)(2012-2#1)
feedhorn-coupled##2##1##(2008-3#2)
feeding (p##2##2##(1990-2#1)(2011-1#1)
feeding a##2##2##(2008-10#1)(2008-3#1)
feeding activity##2##2##(2011-2#2)
feeding and reproductive##2##3##(2008-5#1)(2009-8#1)
feeding and the##2##3##(1991-12#1)(2008-8#1)
feeding and##15##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-8#1)(1996-2#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#2)
feeding aphids##2##2##(2009-8#2)
feeding apparatus and##2##3##(2010-8#1)(2013-1#1)
feeding apparatus##6##2##(2010-8#5)(2013-1#1)
feeding arteries##4##2##(1996-8#1)(2008-7#2)(2008-9#1)
feeding artery##3##2##(2007-7#1)(2008-1#1)(2008-7#1)
feeding at##2##2##(2009-8#1)(2012-12#1)
feeding behavior and is##2##4##(1995-5#1)(2007-12#1)
feeding behavior and##3##3##(1995-5#1)(2007-12#1)(2008-4#1)
feeding behavior in##4##3##(1993-6#1)(2008-11#1)(2008-5#1)(2008-9#1)
feeding behavior##11##2##(1993-6#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2013-8#1)
feeding behaviors##2##2##(2008-5#1)(2012-2#1)
feeding bioassays##2##2##(2008-10#1)(2011-2#1)
feeding by##3##2##(2008-9#1)(2009-8#1)(2011-2#1)
feeding damage##2##2##(2008-10#1)(2011-2#1)
feeding difficulties##6##2##(2008-4#2)(2010-9#4)
feeding for##2##2##(1997-4#1)(2010-5#1)
feeding frequency##6##2##(2008-11#3)(2008-12#3)
feeding glucose##2##2##(2010-2#2)
feeding guilds##2##2##(2008-6#2)
feeding habits of##2##3##(2008-5#2)
feeding habits##8##2##(2007-12#1)(2008-10#1)(2008-5#4)(2008-8#2)
feeding in food-deprived rats##2##4##(1993-12#2)
feeding in the##8##3##(1994-3#3)(2008-10#1)(2010-8#1)(2012-2#3)
feeding in##19##2##(1990-2#2)(1992-5#1)(1993-12#2)(1994-3#3)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)(2012-2#5)
feeding is##6##2##(1991-6#1)(2007-12#1)(2008-11#1)(2010-2#1)(2010-6#1)(2012-2#1)
feeding itself and##2##3##(2008-9#2)
feeding may##2##2##(2012-12#2)
feeding medium##4##2##(2008-10#3)(2008-7#1)
feeding of the##3##3##(1995-1#1)(2009-8#1)(2011-2#1)
feeding of##16##2##(1992-5#1)(1992-9#1)(1994-7#1)(1995-1#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
feeding on infected##2##3##(2008-10#2)
feeding on the##3##3##(2008-10#2)(2012-2#1)
feeding on##26##2##(1994-8#2)(1995-2#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#2)
feeding or##3##2##(1997-2#1)(2008-4#1)(2012-2#1)
feeding pedicles##2##2##(1996-9#1)(1997-3#1)
feeding period##2##2##(2008-10#1)(2012-2#1)
feeding periods##2##2##(2008-10#1)(2013-1#1)
feeding potential##2##2##(2008-12#1)(2010-2#1)
feeding practices and behaviours##3##4##(2010-6#3)
feeding practices and##4##3##(2010-6#4)
feeding practices##5##2##(1990-2#1)(2010-6#4)
feeding preferences##2##2##(2008-10#1)(2011-2#1)
feeding rates##4##2##(2008-9#3)(2010-8#1)
feeding regimes##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
feeding sites in the##2##4##(1994-3#1)(2008-10#1)
feeding sites of##2##3##(2008-10#2)
feeding sites##10##2##(1994-3#1)(2007-12#1)(2008-10#8)
feeding situation##4##2##(1990-12#4)
feeding status##2##2##(2007-10#1)(2010-4#1)
feeding strategy can##2##3##(2008-7#2)
feeding strategy for##2##3##(2008-6#1)(2008-7#1)
feeding strategy##10##2##(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#5)
feeding studies##2##2##(2008-10#1)(2008-11#1)
feeding systems##3##2##(2010-4#3)
feeding the##2##2##(1995-12#1)(2010-6#1)
feeding time##2##2##(2008-7#1)(2011-2#1)
feeding to##2##2##(2008-10#1)(2008-11#1)
feeding trial##2##2##(2008-10#2)
feeding tube##2##2##(1994-12#2)
feeding vessels##2##2##(1996-6#1)(2008-7#1)
feeding was##6##2##(1990-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
feeding with##3##2##(2008-2#1)(2010-5#1)(2011-2#1)
feeding##400##1##(1990-12#5)(1990-2#7)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-5#2)(1992-9#2)(1993-12#5)(1993-6#4)(1994-12#2)(1994-2#2)(1994-3#7)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#4)(2007-11#1)(2007-12#9)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#48)(2008-11#30)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#22)(2008-6#8)(2008-7#24)(2008-8#7)(2008-9#17)(2009-10#1)(2009-4#3)(2009-6#1)(2009-8#15)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#8)(2010-4#5)(2010-5#8)(2010-6#8)(2010-8#12)(2010-9#6)(2011-1#4)(2011-2#30)(2012-12#3)(2012-2#18)(2013-1#4)(2013-7#2)(2013-8#2)
feeding)##4##1##(2008-10#1)(2009-8#1)(2010-2#2)
feedings##2##1##(1992-5#1)(2008-7#1)
feedlot##2##1##(2013-1#2)
feeds and##3##2##(2007-2#1)(2008-10#1)(2011-2#1)
feeds without prior sample treatment or destruction through direct application of the fibre-optic probe on the sample##2##17##(2008-10#2)
feeds##24##1##(1993-3#1)(2007-2#2)(2008-10#12)(2008-12#2)(2008-6#1)(2009-8#1)(2010-7#2)(2011-2#2)(2012-1#1)
feedstock for biodiesel production##2##4##(2009-3#2)
feedstock for##4##2##(2008-6#2)(2009-3#2)
feedstock##11##1##(2008-6#3)(2008-7#1)(2009-3#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
feedstocks##7##1##(2008-10#2)(2008-6#3)(2010-12#1)(2013-1#1)
feedstuff##2##1##(1996-6#1)(2008-11#1)
feedstuffs and##3##2##(1994-9#2)(2008-10#1)
feedstuffs##5##1##(1994-9#2)(2008-10#2)(2008-6#1)
feel about##2##2##(2012-1#1)(2013-8#1)
feel and##3##2##(2010-5#1)(2012-12#2)
feel comfortable##3##2##(1991-3#1)(1996-2#1)(2012-3#1)
feel more##5##2##(1993-11#1)(1994-1#2)(1997-3#1)(2010-8#1)
feel of the hair##2##4##(2008-5#2)
feel strongly that##2##3##(1995-1#1)(2010-5#1)
feel that##8##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-6#1)(2013-1#1)
feel the##3##2##(1992-3#1)(2008-8#1)(2012-3#1)
feel well##2##2##(2008-10#1)(2008-3#1)
feel##57##1##(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#4)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#2)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#6)(2008-8#3)(2009-6#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
feeling in##2##2##(2008-11#2)
feeling of##8##2##(1990-11#1)(1994-1#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-3#1)(2013-8#1)
feeling##38##1##(1990-11#1)(1994-1#1)(1994-12#2)(1995-2#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
feelings about physical activity##3##4##(2009-6#3)
feelings about the##2##3##(1992-3#1)(2008-5#1)
feelings about##8##2##(1992-3#2)(1995-12#1)(1996-3#1)(2008-5#1)(2009-6#3)
feelings and##6##2##(1992-3#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-3#1)(2013-1#1)
feelings of anxiety##2##3##(1995-1#1)(2012-3#1)
feelings of loneliness##2##3##(2009-12#1)(2011-2#1)
feelings of##16##2##(1993-3#1)(1995-1#1)(1995-2#1)(2008-11#1)(2009-12#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
feelings##54##1##(1991-3#1)(1992-2#1)(1992-3#3)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#2)(2007-2#2)(2008-1#3)(2008-11#4)(2008-5#2)(2008-9#1)(2009-12#1)(2009-6#5)(2009-9#2)(2010-10#2)(2010-11#1)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#1)
feels##6##1##(1991-6#1)(1996-5#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
fees are##5##2##(1993-3#1)(1994-1#4)
fees for##5##2##(1993-3#1)(1994-1#1)(1996-3#1)(2008-11#2)
fees in##4##2##(1994-1#1)(1996-3#1)(1997-1#1)(1997-2#1)
fees to##2##2##(1994-1#2)
fees under##2##2##(1994-12#1)(1996-3#1)
fees##52##1##(1990-9#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-1#20)(1994-12#1)(1994-2#2)(1995-12#2)(1996-12#4)(1996-3#7)(1997-1#3)(1997-2#1)(2008-11#2)(2008-4#1)
feet at##2##2##(2010-3#2)
feet in##4##2##(2009-10#1)(2010-11#1)(2010-3#1)(2012-3#1)
feet##48##1##(1994-12#1)(1994-8#1)(1996-3#1)(1996-5#2)(1997-5#1)(1997-8#1)(2007-2#2)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2009-10#1)(2010-11#3)(2010-12#1)(2010-3#3)(2010-9#5)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#6)
feet)##6##1##(1990-9#1)(2009-5#1)(2010-3#1)(2011-2#3)
felbamate was##2##2##(1995-12#2)
felbamate##9##1##(1995-12#9)
felbinac##5##1##(1994-2#5)
felids##4##1##(2009-4#4)
feline immunodeficiency virus##3##3##(1997-3#2)(2012-3#1)
feline leukemia virus##2##3##(2008-11#1)(2012-3#1)
feline model##2##2##(2008-4#2)
feline##12##1##(1997-3#2)(2008-11#4)(2008-4#2)(2012-3#2)(2013-8#2)
felis and##2##2##(2013-8#2)
fell and##2##2##(1995-1#1)(2006-10#1)
fell below##2##2##(2007-12#1)(2011-2#1)
fell by 14##2##3##(1990-3#1)(1992-5#1)
fell by##5##2##(1990-12#1)(1990-3#1)(1991-5#1)(1992-5#1)(1993-3#1)
fell from##6##2##(1991-8#1)(1995-3#1)(1995-9#1)(1996-7#1)(2012-12#1)(2012-2#1)
fell into one##2##3##(2008-10#1)(2008-5#1)
fell into the##2##3##(1996-3#1)(2013-8#1)
fell into two##3##3##(2008-5#2)(2008-8#1)
fell into##8##2##(1991-1#1)(1996-3#1)(2008-10#1)(2008-5#3)(2008-8#1)(2013-8#1)
fell on##3##2##(1996-9#1)(2011-2#1)(2013-8#1)
fell onto a##2##3##(2011-2#1)(2013-1#1)
fell onto##3##2##(2011-2#1)(2013-1#2)
fell out of##2##3##(1991-5#1)(2008-9#1)
fell outside the##2##3##(1995-2#1)(1997-5#1)
fell sharply##3##2##(1990-12#1)(1992-6#1)(2008-10#1)
fell short of the##3##4##(2008-1#1)(2008-5#1)(2012-12#1)
fell short of##4##3##(2008-1#1)(2008-5#1)(2010-3#1)(2012-12#1)
fell to &lt##2##3##(1994-8#1)(2008-10#1)
fell to a##3##3##(1993-3#1)(1995-12#1)(2008-7#1)
fell to##10##2##(1990-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
fell within the##4##3##(2008-10#3)(2008-5#1)
fell within##6##2##(1996-2#1)(1997-4#1)(2008-10#3)(2008-5#1)
fell##73##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#1)(1991-5#3)(1991-8#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
felled##2##1##(2008-10#2)
fellow##14##1##(1991-2#1)(1992-6#1)(1995-3#1)(1996-1#1)(1996-8#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-7#1)
fellows and##2##2##(2008-5#1)(2011-2#1)
fellows##13##1##(1994-1#1)(1996-1#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#3)(2012-1#1)(2013-8#1)
fellowship experience##3##2##(2012-1#3)
fellowship in##2##2##(1993-1#1)(2011-2#1)
fellowship program##2##2##(2008-4#1)(2012-12#1)
fellowship to##2##2##(1993-2#1)(2008-6#1)
fellowship training##2##2##(2010-5#1)(2012-1#1)
fellowship were##2##2##(2012-1#2)
fellowship##23##1##(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#6)(2012-1#7)(2012-12#1)
fellowships in##2##2##(1994-12#1)(2008-10#1)
fellowships##8##1##(1993-2#3)(1994-12#1)(1994-3#1)(2008-10#1)(2010-3#1)(2012-1#1)
felodipine##3##1##(1992-8#1)(2008-10#1)(2012-3#1)
felon##3##1##(2008-9#3)
felt by the##2##3##(1992-3#1)(2009-3#1)
felt by##4##2##(1992-3#1)(1996-12#1)(2008-11#1)(2009-3#1)
felt in##2##2##(2008-5#1)(2010-1#1)
felt it##2##2##(2012-2#1)(2013-1#1)
felt more confident##2##3##(2008-11#1)(2013-7#1)
felt more##3##2##(2008-11#1)(2008-12#1)(2013-7#1)
felt significantly more##2##3##(1993-2#1)(2010-8#1)
felt that it##3##3##(2010-3#1)(2012-12#1)(2013-1#1)
felt that the##5##3##(1993-1#2)(1997-8#1)(2007-7#1)(2008-9#1)
felt that they had##2##4##(1992-6#1)(2007-7#1)
felt that they##4##3##(1992-6#1)(1997-6#1)(2007-7#1)(2011-1#1)
felt that##29##2##(1991-3#1)(1992-6#1)(1993-1#3)(1993-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-7#2)(2008-12#2)(2008-5#2)(2008-9#2)(2009-4#2)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
felt the##2##2##(1995-12#1)(2008-11#1)
felt they had##2##3##(1995-1#1)(2008-1#1)
felt they##6##2##(1995-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-8#1)(2013-7#1)
felt to be##6##3##(1991-1#1)(1997-3#1)(2009-1#1)(2009-5#1)(2012-2#1)(2013-1#1)
felt to##8##2##(1991-1#1)(1997-3#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#1)(2013-1#1)
felt##86##1##(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#3)(1993-2#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#5)(2008-2#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#1)
female (74/207##2##2##(2007-2#2)
female B6C3F(1) mice were administered 0##4##6##(2008-9#4)
female B6C3F(1) mice##5##3##(2008-9#5)
female BALB/c mice##3##3##(1992-5#1)(2008-9#2)
female BALB/c##4##2##(1992-5#1)(2008-10#1)(2008-9#2)
female CD rats##2##3##(2008-10#2)
female CHCs were##2##3##(2012-3#2)
female DNA##3##2##(1992-11#2)(2008-12#1)
female F344##2##2##(1992-9#1)(2012-1#1)
female F344/N rats were administered 0##4##6##(2008-9#4)
female F344/N rats##7##3##(2008-9#7)
female Japanese flounder##2##3##(2009-7#2)
female PGCs##3##2##(2008-11#3)
female Sprague-Dawley rats##2##3##(2008-10#1)(2011-2#1)
female Tg##43##2##(2008-8#3)(2008-9#40)
female Wistar rats were##2##4##(2013-1#1)(2013-7#1)
female Wistar rats##5##3##(1994-2#1)(2008-12#1)(2013-1#2)(2013-7#1)
female Wistar##6##2##(1994-2#1)(2008-12#1)(2012-1#1)(2013-1#2)(2013-7#1)
female adolescents##3##2##(1992-11#1)(2008-11#1)(2012-2#1)
female and male cells##2##4##(1990-3#2)
female and male rats##5##4##(1990-11#1)(1992-8#1)(1994-2#1)(1994-6#1)(2013-1#1)
female and male##20##3##(1990-11#1)(1990-3#2)(1992-11#1)(1992-3#1)(1992-8#3)(1994-2#2)(1994-6#1)(2007-12#2)(2008-12#2)(2008-5#1)(2010-4#1)(2010-8#2)(2013-1#1)
female and##40##2##(1990-11#1)(1990-3#3)(1992-11#1)(1992-3#1)(1992-8#3)(1993-12#1)(1994-11#1)(1994-2#2)(1994-6#1)(1997-8#2)(2007-12#2)(2008-12#3)(2008-5#4)(2009-10#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#4)(2013-1#3)(2013-8#2)
female animals##2##2##(1990-12#1)(2008-8#1)
female biased##2##2##(1997-3#1)(2010-8#1)
female bodies##2##2##(2007-12#2)
female body##4##2##(1991-6#1)(2008-6#1)(2009-10#1)(2010-12#1)
female breast cancer##6##3##(1990-12#2)(1992-2#1)(1997-7#1)(2007-4#1)(2009-5#1)
female breast##12##2##(1990-11#1)(1990-12#3)(1991-2#1)(1992-2#1)(1992-3#1)(1997-7#1)(2007-11#1)(2007-4#1)(2008-3#1)(2009-5#1)
female broiler##2##2##(2008-12#2)
female buffalo meat##3##3##(2010-4#3)
female carriers##4##2##(2007-7#1)(2008-2#1)(2011-2#2)
female cells##3##2##(2008-12#1)(2008-4#2)
female child##5##2##(2008-10#3)(2010-1#1)(2010-3#1)
female children##2##2##(1994-7#1)(2008-7#1)
female choice##3##2##(2008-8#3)
female college students##2##3##(1992-12#1)(2008-12#1)
female condoms##2##2##(2011-2#1)(2012-12#1)
female controls##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
female core study rats##2##4##(2008-9#2)
female diagnosed with##2##3##(2011-2#1)(2013-1#1)
female died##2##2##(1997-6#1)(2008-9#1)
female excess##2##2##(1991-6#1)(2008-7#1)
female fecundity##4##2##(2008-8#2)(2008-9#2)
female figure silhouettes##2##3##(2007-12#2)
female fitness##6##2##(2008-8#3)(2008-9#3)
female gender##5##2##(2007-10#1)(2007-12#1)(2011-2#1)(2013-1#2)
female genital schistosomiasis (FGS)##3##4##(1996-12#3)
female genital schistosomiasis##5##3##(1996-12#5)
female genital system and##2##4##(1995-9#1)(2007-12#1)
female genital tract##6##3##(1990-2#1)(1990-8#1)(1994-1#1)(1996-12#1)(2009-2#1)(2011-2#1)
female genital tracts##3##3##(2008-7#3)
female genital##18##2##(1990-2#1)(1990-5#1)(1990-8#1)(1994-1#1)(1995-9#1)(1996-12#6)(2007-12#1)(2008-7#3)(2009-2#1)(2011-2#1)(2012-3#1)
female group##3##2##(1990-11#1)(2008-7#1)(2011-1#1)
female groups##4##2##(1990-11#1)(2007-12#1)(2008-12#1)(2008-9#1)
female had##3##2##(1995-3#1)(2007-8#1)(2011-2#1)
female heterogamety and TSD##2##4##(2010-3#2)
female hormone##2##2##(1991-6#1)(2008-10#1)
female imago of C##2##4##(2013-8#2)
female in the##3##3##(1993-2#1)(2008-7#1)(2011-2#1)
female in##8##2##(1990-3#2)(1993-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
female infant##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
female infertility##2##2##(1990-9#1)(2010-11#1)
female inhabitants in 1981)##2##4##(1992-10#2)
female is##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
female liver##2##2##(1995-6#1)(2008-6#1)
female lower genital tract##2##4##(1992-3#1)(2011-2#1)
female managers##4##2##(2012-3#4)
female mate##2##2##(2008-8#1)(2008-9#1)
female mating decisions##2##3##(2008-8#2)
female medical students##2##3##(2007-4#1)(2013-8#1)
female meiosis##3##2##(2008-12#1)(2008-5#2)
female meiotic##3##2##(2008-5#1)(2008-9#1)(2012-3#1)
female mice and##2##3##(2008-12#1)(2008-6#1)
female mice were dermally administered 0##3##6##(2008-9#3)
female mice were given nutrient-sufficient (+) or -deficient (-)##2##9##(1997-4#2)
female mice were subjected to the individual and combined stresses of dietary cadmium##2##13##(1997-4#2)
female mice were subjected to the individual and combined stresses of dietary##3##12##(1997-4#3)
female mice were##11##3##(1997-4#6)(2008-8#1)(2008-9#3)(2012-2#1)
female mice##26##2##(1992-8#1)(1995-11#1)(1995-12#1)(1997-4#6)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#13)(2012-2#1)
female migration##4##2##(2011-2#4)
female multiple mating can##2##4##(2008-8#2)
female multiple mating##5##3##(2008-8#5)
female nursing##2##2##(2008-11#1)(2011-2#1)
female observers##2##2##(2008-5#2)
female of##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
female offspring of##2##3##(1995-8#1)(2008-10#1)
female offspring##4##2##(1995-8#1)(2008-10#2)(2008-9#1)
female or##4##2##(2008-10#1)(2008-5#1)(2009-9#1)(2013-1#1)
female p53 haploinsufficient mice were administered 0##2##7##(2008-9#2)
female p53 haploinsufficient mice were exposed to drinking water containing 0##5##11##(2008-9#5)
female p53 haploinsufficient mice were exposed to##6##7##(2008-9#6)
female p53 haploinsufficient mice were##11##5##(2008-8#1)(2008-9#10)
female p53 haploinsufficient mice##20##4##(2008-8#3)(2008-9#17)
female p53##21##2##(2008-8#3)(2008-9#18)
female parent##4##2##(2008-10#4)
female parents##2##2##(2008-5#1)(2008-8#1)
female participants were##2##3##(2008-10#1)(2008-5#1)
female participants##5##2##(2007-12#2)(2008-10#1)(2008-5#1)(2009-4#1)
female patient presented with##4##4##(2007-7#1)(2010-3#1)(2011-1#1)(2013-1#1)
female patient was admitted to##2##5##(1993-6#2)
female patient was admitted##3##4##(1993-6#2)(2013-1#1)
female patient was##6##3##(1993-6#2)(2007-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
female patient who had##4##4##(2007-10#1)(2008-12#1)(2009-2#1)(2013-8#1)
female patient who presented with##3##5##(2010-5#1)(2012-3#1)(2013-7#1)
female patient who##10##3##(2007-10#1)(2008-12#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
female patient with a##4##4##(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
female patient with##21##3##(1991-8#1)(1992-12#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#2)(2009-4#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)
female patient##61##2##(1991-8#1)(1992-12#2)(1992-5#1)(1993-6#3)(1995-12#1)(1996-3#1)(2007-10#2)(2007-7#2)(2008-1#2)(2008-11#2)(2008-12#4)(2008-6#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
female patients in##2##3##(2007-11#1)(2011-2#1)
female patients with##8##3##(1996-8#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
female patients##34##2##(1990-2#1)(1991-5#1)(1992-10#1)(1994-7#1)(1996-11#1)(1996-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
female physical attractiveness##2##3##(2007-12#2)
female physicians who##2##3##(2011-2#2)
female physicians##5##2##(1993-6#1)(2011-2#4)
female plants##2##2##(2008-10#2)
female population##4##2##(1993-1#1)(2010-12#1)(2011-1#2)
female preference##4##2##(2008-8#3)(2009-9#1)
female preferences for call duration in##2##6##(2009-9#2)
female preferences for call duration##3##5##(2009-9#3)
female preferences for##4##3##(2009-9#4)
female preferences##7##2##(2008-8#2)(2009-9#5)
female presented to##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
female presented with a##3##4##(1990-2#1)(2008-7#1)(2012-3#1)
female presented with##5##3##(1990-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
female presented##10##2##(1990-2#1)(1994-12#1)(1994-7#1)(2008-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
female presenting##3##2##(2008-4#1)(2010-11#1)(2013-8#1)
female prostitute##2##2##(1996-5#1)(2008-5#1)
female rat pituitary##4##3##(1990-11#1)(1992-12#3)
female rat##8##2##(1990-11#2)(1992-12#3)(1996-12#1)(1996-5#1)(2013-7#1)
female ratio##4##2##(2008-1#1)(2008-7#1)(2008-8#1)(2012-3#1)
female rats and##3##3##(1993-6#1)(1995-11#1)(1995-2#1)
female rats at rest##2##4##(2013-1#2)
female rats but only##2##4##(1994-2#2)
female rats had##2##3##(2008-9#1)(2013-1#1)
female rats showed##3##3##(1994-11#1)(2008-12#1)(2013-1#1)
female rats was##2##3##(1995-3#1)(2008-12#1)
female rats were##5##3##(1995-12#1)(2008-11#1)(2008-9#1)(2013-1#2)
female rats##51##2##(1990-11#2)(1992-12#1)(1992-5#2)(1993-5#1)(1993-6#2)(1994-11#2)(1994-2#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-8#3)(2008-10#1)(2008-11#3)(2008-12#4)(2008-8#1)(2008-9#2)(2009-11#1)(2010-1#1)(2012-1#1)(2012-3#1)(2013-1#12)
female reproduction##2##2##(2008-9#1)(2012-1#1)
female reproductive success##2##3##(2008-8#1)(2009-12#1)
female reproductive system##3##3##(2007-12#1)(2007-7#1)(2010-8#1)
female reproductive tract##7##3##(1996-12#3)(2010-3#1)(2011-1#3)
female reproductive tracts##2##3##(2008-5#1)(2011-2#1)
female reproductive##18##2##(1996-12#3)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#1)
female sex workers##3##3##(2010-8#2)(2012-1#1)
female sex##13##2##(1990-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#4)(2010-8#2)(2012-1#1)(2012-3#1)
female sexual partners##2##3##(1991-2#1)(1993-9#1)
female sexual##5##2##(1991-2#1)(1993-5#1)(1993-9#1)(2009-10#1)(2012-3#1)
female sexuals##4##2##(2008-8#4)
female soccer player##2##3##(2006-10#2)
female sperm storage##2##3##(2007-12#1)(2008-6#1)
female students at##2##3##(2009-5#1)(2012-12#1)
female students in##2##3##(2007-7#1)(2011-1#1)
female students##10##2##(1990-2#1)(2007-7#1)(2008-1#1)(2009-5#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
female subjects were##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
female subjects##15##2##(1994-12#1)(1996-12#1)(2008-10#1)(2008-5#9)(2010-8#1)(2012-3#1)(2013-1#1)
female suffered##2##2##(1997-6#1)(2012-2#1)
female swordtails##4##2##(2009-9#4)
female than male##2##3##(1994-6#1)(2008-7#1)
female three-spined sticklebacks##2##3##(2008-9#1)(2010-8#1)
female tigers##3##2##(2009-4#3)
female to male##2##3##(1997-7#1)(2012-3#1)
female to##4##2##(1997-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
female underwent##3##2##(1992-10#1)(2007-8#1)(2008-1#1)
female university##2##2##(2007-12#1)(2012-2#1)
female victims##4##2##(1993-8#1)(2009-9#2)(2011-2#1)
female volunteers##11##2##(1994-5#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#6)
female was##8##2##(1992-9#1)(1994-7#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-5#1)(2011-1#1)(2013-1#1)
female were##3##2##(2007-2#1)(2008-7#1)(2011-2#1)
female white New Zealand rabbits were anesthetized##2##7##(1992-3#2)
female white##3##2##(1992-3#2)(2010-5#1)
female who had##2##3##(1994-12#1)(2008-7#1)
female who presented with a##2##5##(2012-3#1)(2013-1#1)
female who presented with an##2##5##(2011-1#1)(2011-2#1)
female who presented with##9##4##(2008-12#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
female who presented##11##3##(1992-4#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
female who suffered from##2##4##(2007-10#2)
female who was##3##3##(2008-12#1)(2008-7#1)(2011-1#1)
female who##20##2##(1992-4#1)(1994-12#1)(2007-10#2)(2008-12#2)(2008-6#1)(2008-7#3)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
female whole-body##3##2##(2013-8#3)
female with a##7##3##(1994-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
female with acute##2##3##(2007-12#1)(2012-1#1)
female with##33##2##(1990-6#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#3)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#1)
female##1167##1##(1990-11#9)(1990-12#6)(1990-2#4)(1990-3#5)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#2)(1991-2#2)(1991-5#1)(1991-6#9)(1991-8#2)(1992-1#1)(1992-10#4)(1992-11#4)(1992-12#10)(1992-2#2)(1992-3#11)(1992-4#3)(1992-5#4)(1992-6#1)(1992-8#6)(1992-9#3)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#3)(1993-6#7)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#9)(1994-2#9)(1994-3#3)(1994-5#5)(1994-6#3)(1994-7#6)(1994-9#2)(1995-11#3)(1995-12#9)(1995-2#2)(1995-3#5)(1995-6#6)(1995-8#6)(1995-9#2)(1996-11#1)(1996-12#16)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2006-10#2)(2007-10#6)(2007-11#4)(2007-12#35)(2007-2#4)(2007-4#2)(2007-6#2)(2007-7#10)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#51)(2008-11#22)(2008-12#40)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#65)(2008-6#12)(2008-7#42)(2008-8#66)(2008-9#135)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#8)(2009-8#4)(2009-9#22)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#6)(2010-3#7)(2010-4#5)(2010-5#8)(2010-6#2)(2010-7#4)(2010-8#13)(2010-9#1)(2011-1#18)(2011-2#55)(2012-1#12)(2012-12#19)(2012-2#17)(2012-3#48)(2013-1#63)(2013-7#12)(2013-8#22)
female) aged##2##2##(1993-9#1)(2008-7#1)
female) and##2##2##(2008-2#1)(2011-2#1)
female) were##3##2##(2007-7#1)(2008-12#1)(2010-1#1)
female)##21##1##(1993-9#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-7#3)(2008-8#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#3)(2013-1#1)
female- and##2##2##(1990-8#1)(2008-10#1)
female-biased##5##1##(1994-8#2)(2008-8#1)(2008-9#1)(2013-7#1)
female-search##6##1##(2008-5#1)(2008-6#5)
female-searching##4##1##(2008-5#1)(2008-6#3)
female/male##2##1##(2008-7#1)(2013-8#1)
females (37##2##2##(2008-1#1)(2011-2#1)
females (46##2##2##(2008-1#2)
females (5##2##2##(2008-7#1)(2012-2#1)
females (mean##3##2##(2007-12#1)(2008-1#1)(2008-4#1)
females (p &lt##4##3##(1993-6#1)(2007-7#1)(2008-1#1)(2008-11#1)
females administered 12 mg/kg##2##4##(2008-9#2)
females administered##4##2##(2008-9#4)
females after##5##2##(1993-8#1)(1995-3#2)(2008-10#1)(2012-12#1)
females aged##8##2##(1992-9#1)(1994-6#1)(1995-6#1)(1997-4#1)(2008-12#1)(2008-3#1)(2008-5#2)
females and 6##2##3##(2008-7#1)(2008-8#1)
females and 8 males##2##4##(2008-7#1)(2012-2#1)
females and I##2##3##(2012-3#2)
females and four##2##3##(1996-9#1)(2011-2#1)
females and males in##2##4##(2008-5#1)(2013-8#1)
females and males of##2##4##(2008-6#1)(2011-2#1)
females and males##7##3##(2008-5#2)(2008-6#1)(2011-2#2)(2013-7#1)(2013-8#1)
females and renal tubule degeneration##2##5##(2008-9#2)
females and two males##2##4##(2007-7#1)(2008-9#1)
females and##69##2##(1991-8#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#5)(1995-10#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#12)(2009-10#2)(2009-12#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#5)(2013-8#2)
females appear to##2##3##(2008-9#2)
females are more##2##3##(2008-10#1)(2008-9#1)
females are##16##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-7#1)(2012-3#2)(2013-7#2)
females as##3##2##(1995-6#1)(2008-12#1)(2012-3#1)
females at 26 weeks##3##4##(2008-9#3)
females at 27 weeks and in##2##6##(2008-9#2)
females at 27 weeks##4##4##(2008-9#4)
females at 43 weeks##4##4##(2008-9#4)
females at##17##2##(1993-6#1)(1996-12#1)(2008-3#1)(2008-9#13)(2010-7#1)
females began##3##2##(1997-4#2)(2008-12#1)
females but##2##2##(1994-2#1)(2008-8#1)
females by##2##2##(2009-8#1)(2012-3#1)
females can gain##3##3##(2008-8#3)
females can##6##2##(2008-8#3)(2008-9#2)(2012-2#1)
females carrying##2##2##(1993-6#1)(2008-9#1)
females during##4##2##(1990-12#1)(2008-8#1)(2012-2#2)
females engaged in##2##3##(2008-9#1)(2009-5#1)
females exposed to dichloroacetic acid in the drinking water for##2##10##(2008-9#2)
females exposed to dichloroacetic acid##3##5##(2008-9#3)
females exposed to##5##3##(2008-9#5)
females exposed##7##2##(2008-9#7)
females fed##2##2##(2008-6#2)
females for##4##2##(1991-6#1)(1995-6#1)(2008-8#1)(2011-1#1)
females from each##2##3##(1991-2#1)(2008-1#1)
females from the##3##3##(2009-12#1)(2012-12#1)(2012-3#1)
females from##6##2##(1991-2#1)(2008-1#1)(2009-12#1)(2012-12#2)(2012-3#1)
females gain##2##2##(2008-8#2)
females had a##2##3##(2009-5#1)(2013-7#1)
females had higher##2##3##(1991-12#1)(2012-12#1)
females had##8##2##(1991-12#1)(2008-9#3)(2009-5#1)(2012-12#1)(2013-1#1)(2013-7#1)
females have##3##2##(2008-5#2)(2008-9#1)
females having##6##2##(1997-4#3)(1997-7#1)(2011-2#2)
females in a##2##3##(2007-12#1)(2013-8#1)
females in both studies##7##4##(2008-9#7)
females in both##8##3##(2008-9#7)(2013-8#1)
females in the##9##3##(1993-6#1)(2008-5#1)(2008-8#1)(2008-9#5)(2009-10#1)
females in##34##2##(1993-6#1)(1995-8#2)(1997-4#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#14)(2009-10#1)(2009-8#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
females is##6##2##(1995-6#1)(1996-8#1)(2008-3#1)(2008-9#3)
females may##6##2##(1995-6#1)(2008-8#4)(2012-12#1)
females might##2##2##(2009-5#1)(2010-4#1)
females mutant##2##2##(1991-5#1)(2008-9#1)
females of both##2##3##(2008-7#1)(2013-7#1)
females of the same reproductive status##3##6##(1997-4#3)
females of the same##4##4##(1995-9#1)(1997-4#3)
females of the##8##3##(1991-12#1)(1995-9#1)(1997-4#3)(2008-10#1)(2008-5#1)(2013-1#1)
females of##23##2##(1991-12#1)(1992-12#1)(1993-12#1)(1995-8#1)(1995-9#1)(1997-4#3)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-7#1)
females preferred##4##2##(2008-8#1)(2009-9#1)(2013-8#2)
females raising##2##2##(2012-12#2)
females reported using##2##3##(2012-12#2)
females reported##4##2##(2008-4#1)(2008-5#1)(2012-12#2)
females should##2##2##(2008-9#2)
females showed a##2##3##(2008-1#1)(2009-10#1)
females than in##6##3##(1994-2#1)(2008-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
females than males##5##3##(2008-1#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)
females than##13##2##(1993-9#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)
females that were##2##3##(2010-8#1)(2012-12#1)
females that##4##2##(2009-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
females the##4##2##(1995-9#1)(2007-12#1)(2008-7#1)(2011-2#1)
females to forage##2##3##(2008-9#2)
females to##8##2##(2008-7#1)(2008-8#3)(2008-9#3)(2012-3#1)
females treated by##2##3##(2008-9#2)
females use##2##2##(2008-8#2)
females was less##2##3##(2008-9#2)
females was similar to that##10##5##(2008-9#10)
females was##22##2##(1994-6#1)(1997-7#1)(2007-12#1)(2008-9#18)(2009-8#1)
females were decreased##3##3##(2008-9#3)
females were exposed to##2##4##(2008-10#1)(2008-4#1)
females were generally##2##3##(2008-9#2)
females were greater than those of the controls##2##8##(2008-8#1)(2008-9#1)
females were greater than those of the##4##7##(2008-8#1)(2008-9#3)
females were less than those of the control groups##2##9##(2008-9#2)
females were less than those of the##4##7##(2008-9#4)
females were less than##5##4##(2008-9#5)
females were less##7##3##(2008-9#7)
females were maintained##4##3##(1997-4#3)(2010-8#1)
females were significantly greater than those##3##6##(2008-9#3)
females were significantly increased##3##4##(2008-9#3)
females were significantly less than those of the vehicle controls##3##10##(2008-9#3)
females were significantly##10##3##(2008-9#10)
females were##55##2##(1991-12#1)(1996-12#1)(1997-3#1)(1997-4#7)(2008-10#5)(2008-4#2)(2008-8#2)(2008-9#26)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#2)(2013-8#1)
females when##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
females who##4##2##(1995-2#2)(1997-8#1)(2009-5#1)
females with a mean age of##2##6##(1995-10#1)(2007-7#1)
females with a##4##3##(1995-10#1)(2007-7#1)(2008-11#1)(2012-2#1)
females with##17##2##(1991-5#1)(1995-10#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
females##816##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#3)(1991-5#3)(1991-6#9)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#8)(1994-3#1)(1994-6#9)(1994-7#1)(1995-10#2)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#10)(1995-8#10)(1995-9#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#28)(1997-7#3)(1997-8#2)(2006-10#1)(2007-10#2)(2007-12#14)(2007-2#1)(2007-7#14)(2007-8#4)(2008-1#16)(2008-10#24)(2008-11#12)(2008-12#12)(2008-2#1)(2008-3#7)(2008-4#15)(2008-5#39)(2008-6#8)(2008-7#27)(2008-8#67)(2008-9#177)(2009-1#1)(2009-10#8)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#7)(2010-11#2)(2010-3#4)(2010-4#5)(2010-7#4)(2010-8#9)(2011-1#6)(2011-2#28)(2012-12#25)(2012-2#8)(2012-3#23)(2013-1#14)(2013-7#31)(2013-8#14)
females) and##4##2##(1993-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
females) of##2##2##(2008-7#1)(2010-4#1)
females) was##2##2##(2013-1#1)(2013-7#1)
females) were##3##2##(1993-6#1)(2008-3#1)(2011-1#1)
females) with a##2##3##(2007-8#1)(2008-6#1)
females) with##7##2##(1993-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)
females)##65##1##(1990-3#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#4)(1995-6#2)(2007-7#4)(2007-8#1)(2008-11#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#9)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
female &gt##3##1##(2012-12#3)
feminine transsexuals##3##2##(2013-1#3)
feminine##11##1##(2008-9#1)(2009-10#3)(2012-3#2)(2013-1#5)
feminist##7##1##(1991-6#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-11#1)
feminization##4##1##(2008-8#3)(2008-9#1)
femme##5##1##(2008-12#2)(2013-1#3)
femora##2##1##(2007-11#1)(2009-10#1)
femoral access##4##2##(2007-7#1)(2011-2#3)
femoral and tibial##2##3##(2009-3#1)(2013-1#1)
femoral and##4##2##(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
femoral approach##3##2##(1996-3#1)(2011-2#2)
femoral arteries##3##2##(1994-8#1)(2008-4#1)(2008-7#1)
femoral artery##16##2##(2006-7#1)(2007-8#6)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#3)
femoral bone##6##2##(1995-6#2)(2007-11#4)
femoral bypass##2##2##(2008-1#1)(2012-3#1)
femoral catheters##2##2##(2007-7#1)(2011-2#1)
femoral chordotonal##2##2##(2007-12#1)(2008-7#1)
femoral condylar##2##2##(1992-3#1)(2013-1#1)
femoral condyle##3##2##(2011-2#1)(2013-1#2)
femoral cortex##2##2##(1995-6#1)(2013-1#1)
femoral epiphysis##4##2##(2008-8#2)(2013-7#1)(2013-8#1)
femoral fracture##6##2##(2008-12#2)(2009-4#1)(2013-1#3)
femoral fractures##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
femoral growth##4##2##(2007-11#4)
femoral head and##2##3##(2009-3#1)(2009-7#1)
femoral head in the##2##4##(2007-11#1)(2009-4#1)
femoral head in##4##3##(2007-11#1)(2009-10#1)(2009-4#2)
femoral head necrosis##3##3##(1992-11#1)(1994-7#1)(2009-3#1)
femoral head sphericity##2##3##(2009-4#2)
femoral head was##2##3##(2009-4#2)
femoral head##36##2##(1992-11#1)(1992-6#2)(1994-7#1)(2006-10#1)(2007-11#3)(2007-8#3)(2008-5#1)(2008-8#3)(2009-10#1)(2009-3#11)(2009-4#7)(2009-7#1)(2012-12#1)
femoral heads##3##2##(2009-4#2)(2013-1#1)
femoral hip replacement##2##3##(2008-7#2)
femoral hip##3##2##(2008-7#3)
femoral lengthening##2##2##(2007-11#1)(2013-1#1)
femoral metaphyseal##2##2##(2013-1#2)
femoral metaphysis##2##2##(1991-11#1)(1993-8#1)
femoral nail##2##2##(2010-11#1)(2013-1#1)
femoral neck BMD##4##3##(2010-1#1)(2010-3#1)(2011-2#2)
femoral neck and##3##3##(2006-10#1)(2010-3#1)(2013-1#1)
femoral neck fracture##3##3##(2007-11#1)(2007-8#2)
femoral neck fractures in##3##4##(2009-3#3)
femoral neck fractures##10##3##(1991-9#4)(2007-8#2)(2009-3#4)
femoral neck##39##2##(1991-11#1)(1991-9#4)(2006-10#4)(2007-11#3)(2007-8#8)(2008-4#1)(2009-3#8)(2010-1#1)(2010-3#3)(2011-2#4)(2013-1#2)
femoral nerve palsy secondary to##3##5##(2009-3#3)
femoral nerve palsy##4##3##(2009-3#4)
femoral nerve symptoms##2##3##(2009-3#2)
femoral nerve##9##2##(1993-12#2)(2009-3#7)
femoral or##2##2##(2011-2#1)(2013-1#1)
femoral osteotomy##2##2##(2007-8#1)(2013-1#1)
femoral shaft fractures in##2##4##(2012-2#2)
femoral shaft##5##2##(2007-11#2)(2009-3#1)(2012-2#2)
femoral shortening osteotomy fixed with interlocking intramedullary nail##2##8##(2013-1#2)
femoral shortening osteotomy fixed with interlocking##3##6##(2013-1#3)
femoral shortening osteotomy fixed with##4##5##(2013-1#4)
femoral vein##10##2##(2007-7#2)(2008-1#2)(2008-4#1)(2011-3#3)(2012-2#1)(2013-1#1)
femoral venous##2##2##(2011-2#1)(2013-1#1)
femoral vessels##2##2##(2008-10#1)(2012-2#1)
femoral##236##1##(1991-11#2)(1991-9#4)(1992-11#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-8#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-6#4)(1996-3#1)(2006-10#5)(2006-7#1)(2007-11#20)(2007-12#1)(2007-7#4)(2007-8#20)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#6)(2009-10#1)(2009-3#29)(2009-4#13)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-3#4)(2011-1#1)(2011-2#27)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#34)(2013-7#1)(2013-8#2)
femoral-tibial contact##2##2##(2013-1#2)
femorale##3##1##(2007-11#3)
femoris and##2##2##(2010-4#1)(2012-1#1)
femoris muscle##8##2##(1995-12#1)(2008-12#4)(2011-2#2)(2012-1#1)
femoris##20##1##(1995-12#1)(2008-12#5)(2008-7#1)(2010-4#7)(2011-2#3)(2012-1#3)
femoro-popliteal##2##1##(1990-5#1)(2011-2#1)
femoropopliteal##6##1##(1997-8#1)(2011-2#5)
femtogram##3##1##(2008-10#3)
femtomolar##3##1##(2008-10#2)(2010-1#1)
femtomole levels##2##2##(2008-4#1)(2010-7#1)
femtomole##3##1##(2008-10#1)(2008-4#1)(2010-7#1)
femtomoles##2##1##(1990-8#1)(2008-10#1)
femtosecond (fs)##2##2##(2007-11#1)(2007-12#1)
femtosecond Cr(4+)##5##2##(2007-12#5)
femtosecond Ti##8##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
femtosecond amplifier is demonstrated##2##4##(2007-12#2)
femtosecond and picosecond##2##3##(2007-11#1)(2007-12#1)
femtosecond fiber laser##2##3##(2008-3#2)
femtosecond fiber##3##2##(2007-11#1)(2008-3#2)
femtosecond infrared##2##2##(2007-11#2)
femtosecond laser ablation MC-ICP-MS##2##4##(2013-8#2)
femtosecond laser based##2##3##(2007-12#1)(2011-1#1)
femtosecond laser beam##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
femtosecond laser pulse##6##3##(2007-11#5)(2007-12#1)
femtosecond laser pulses in##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
femtosecond laser pulses propagating in air##2##6##(2007-11#1)(2007-12#1)
femtosecond laser pulses##27##3##(2007-11#7)(2007-12#16)(2008-2#1)(2008-3#3)
femtosecond laser##63##2##(2007-11#18)(2007-12#29)(2008-2#1)(2008-3#6)(2010-1#1)(2011-1#6)(2013-8#2)
femtosecond lasers##6##2##(2007-11#2)(2008-2#1)(2008-3#3)
femtosecond light pulses##2##3##(2007-12#2)
femtosecond mid-infrared##3##2##(2007-11#1)(2007-12#2)
femtosecond mode-locked##3##2##(2007-11#3)
femtosecond optical parametric generator##2##4##(2007-12#1)(2008-2#1)
femtosecond optical parametric##6##3##(2007-11#2)(2007-12#2)(2008-2#2)
femtosecond optical pulse propagating in air##2##6##(2007-11#2)
femtosecond optical pulses##2##3##(2007-12#1)(2008-3#1)
femtosecond optical##13##2##(2007-11#5)(2007-12#3)(2008-2#2)(2008-3#1)(2011-1#1)(2012-2#1)
femtosecond parametric amplification##2##3##(2007-12#2)
femtosecond parametric##3##2##(2007-12#3)
femtosecond polarization##2##2##(2007-11#2)
femtosecond pulse propagation in##2##4##(2007-11#2)
femtosecond pulse##14##2##(2007-11#7)(2007-12#6)(2008-3#1)
femtosecond pulsed##2##2##(2007-11#1)(2008-3#1)
femtosecond pulses and##2##3##(2007-11#1)(2007-12#1)
femtosecond pulses at##2##3##(2007-11#1)(2007-12#1)
femtosecond pulses by use of a##3##6##(2007-11#2)(2007-12#1)
femtosecond pulses by use of##5##5##(2007-11#4)(2007-12#1)
femtosecond pulses by##8##3##(2007-11#6)(2007-12#2)
femtosecond pulses from a##4##4##(2007-12#4)
femtosecond pulses in a##5##4##(2007-11#1)(2007-12#4)
femtosecond pulses in##8##3##(2007-11#2)(2007-12#6)
femtosecond pulses is##2##3##(2007-11#1)(2007-12#1)
femtosecond pulses with##2##3##(2007-11#1)(2007-12#1)
femtosecond pulses##45##2##(2007-11#19)(2007-12#23)(2008-2#2)(2008-3#1)
femtosecond pump pulses##2##3##(2007-11#1)(2007-12#1)
femtosecond pump-probe##2##2##(2007-11#1)(2007-12#1)
femtosecond pumping##2##2##(2007-12#1)(2008-2#1)
femtosecond time##2##2##(2007-11#1)(2007-12#1)
femtosecond traveling-wave optical parametric amplification##2##5##(2007-12#2)
femtosecond##234##1##(2007-11#79)(2007-12#105)(2008-2#12)(2008-3#25)(2010-1#1)(2011-1#9)(2012-2#1)(2013-8#2)
femtosecond-pulse##4##1##(2007-11#2)(2007-12#2)
femtoseconds##2##1##(2008-3#1)(2010-12#1)
femur - 49 cases##2##4##(2007-11#2)
femur after##2##2##(2007-11#1)(2012-3#1)
femur and humerus##2##3##(2007-11#1)(2012-2#1)
femur and lumbar##2##3##(1997-4#2)
femur and##12##2##(1997-4#3)(2007-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
femur as##2##2##(2007-11#1)(2011-2#1)
femur fractures in##2##3##(2007-11#2)
femur fractures##6##2##(2007-11#3)(2007-8#2)(2011-2#1)
femur from##2##2##(1995-6#1)(2011-2#1)
femur in##5##2##(2007-11#4)(2008-8#1)
femur is##2##2##(2007-11#1)(2012-2#1)
femur of##3##2##(2007-11#1)(2008-6#1)(2009-4#1)
femur resection##2##2##(2007-11#2)
femur using##3##2##(2008-4#1)(2009-3#1)(2011-2#1)
femur with##2##2##(2008-5#2)
femur##121##1##(1991-11#3)(1994-7#1)(1995-6#4)(1997-4#5)(2006-10#1)(2007-11#44)(2007-2#1)(2007-8#8)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#7)(2008-7#3)(2008-8#1)(2009-3#6)(2009-4#2)(2010-3#3)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)
femurs and##2##2##(2007-11#2)
femurs of female##2##3##(2013-1#2)
femurs of##3##2##(2013-1#3)
femurs##7##1##(2007-11#3)(2013-1#4)
fenarimol##5##1##(2008-10#4)(2011-2#1)
fenbendazole##3##1##(2008-10#3)
fenbuconazole##4##1##(2008-10#4)
fence lizards##2##2##(2008-8#2)
fence##4##1##(2008-3#2)(2008-8#2)
fenestra ( approximately 1##2##4##(2008-9#2)
fenestrated A1 segment##3##3##(2013-8#3)
fenestrated A1##4##2##(2013-8#4)
fenestrated proximal##3##2##(2013-8#3)
fenestrated stent grafts##2##3##(2010-12#1)(2010-8#1)
fenestrated##14##1##(1994-8#1)(2008-5#1)(2010-12#2)(2010-8#1)(2013-8#9)
fenestration and##2##2##(2010-5#1)(2012-12#1)
fenestration##8##1##(2008-2#1)(2008-5#4)(2010-5#2)(2012-12#1)
fenitrothion##4##1##(2008-10#3)(2012-12#1)
fenofibrate##2##1##(1991-3#1)(2008-1#1)
fens##2##1##(2008-8#2)
fenspiride reduced the##2##3##(1995-12#2)
fenspiride##5##1##(1995-12#5)
fentanyl##15##1##(1991-1#1)(1993-1#5)(1996-6#2)(2007-8#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
feral##7##1##(1997-6#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#2)
ferbam in##4##2##(2008-10#4)
ferbam##10##1##(2008-10#10)
ferment##10##1##(1992-11#1)(1993-12#1)(2008-5#1)(2008-6#3)(2009-3#1)(2011-2#1)(2012-3#2)
fermentable sugar production##3##3##(2013-1#3)
fermentable sugar##4##2##(2013-1#4)
fermentans##4##1##(1994-12#1)(2011-2#3)
fermentation and##5##2##(1997-4#1)(2008-6#2)(2008-7#2)
fermentation broth of##2##3##(2009-6#1)(2013-1#1)
fermentation broth##7##2##(2008-6#2)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#2)
fermentation by##4##2##(1990-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
fermentation can be##2##3##(2008-11#1)(2008-7#1)
fermentation data##2##2##(2008-6#2)
fermentation factors##2##2##(2012-2#2)
fermentation for##2##2##(2008-6#1)(2013-1#1)
fermentation in a##3##3##(2008-6#1)(2008-7#1)(2012-3#1)
fermentation in##4##2##(2008-6#1)(2008-7#1)(2012-3#2)
fermentation inhibitors##2##2##(2011-1#2)
fermentation media##2##2##(2008-10#2)
fermentation medium##7##2##(1997-2#1)(2008-6#4)(2008-8#2)
fermentation of the##2##3##(2008-6#2)
fermentation of##16##2##(1993-9#2)(1995-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2011-2#3)(2013-1#1)
fermentation pathway##2##2##(2008-6#2)
fermentation performance of recombinant##2##4##(2008-6#2)
fermentation process##20##2##(1992-11#1)(2008-10#9)(2008-11#3)(2008-6#3)(2010-4#1)(2011-2#2)(2012-3#1)
fermentation processes for##2##3##(1997-2#2)
fermentation processes##7##2##(1997-2#2)(2008-10#2)(2008-6#2)(2011-2#1)
fermentation product##2##2##(2008-6#1)(2012-2#1)
fermentation products##5##2##(2008-6#3)(2013-1#2)
fermentation rate##2##2##(2012-3#2)
fermentation samples##2##2##(2008-10#2)
fermentation traits##4##2##(2012-3#4)
fermentation using##5##2##(2008-6#2)(2008-7#2)(2011-2#1)
fermentation was##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
fermentation with##5##2##(2008-10#1)(2008-6#2)(2011-2#2)
fermentation##216##1##(1990-5#1)(1992-11#1)(1993-9#2)(1995-5#2)(1995-6#1)(1995-8#1)(1997-2#3)(1997-4#2)(2008-10#28)(2008-11#8)(2008-6#65)(2008-7#36)(2008-8#5)(2009-6#1)(2010-4#1)(2011-1#7)(2011-2#13)(2012-2#7)(2012-3#19)(2013-1#13)
fermentations were carried out##2##4##(2008-7#2)
fermentations were##3##2##(2008-6#1)(2008-7#2)
fermentations with##4##2##(2008-10#1)(2008-6#1)(2008-7#2)
fermentations##21##1##(2008-10#5)(2008-11#2)(2008-6#7)(2008-7#5)(2012-3#1)(2013-1#1)
fermentative quality##2##2##(2013-1#2)
fermentative##11##1##(2008-11#1)(2008-6#3)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#2)
fermented milk##7##2##(1991-3#1)(2008-11#3)(2010-2#2)(2013-1#1)
fermented products##2##2##(2009-11#2)
fermented sausages of Basilicata region##2##5##(2010-4#2)
fermented sausages##7##2##(2010-4#5)(2013-1#2)
fermented with Lactobacillus delbrueckii ssp##2##5##(2008-11#2)
fermented##35##1##(1991-3#1)(1997-1#1)(1997-4#2)(2008-11#5)(2008-6#2)(2008-8#2)(2009-11#3)(2009-5#1)(2010-2#6)(2010-4#5)(2011-1#1)(2011-2#1)(2013-1#5)
fermenter##5##1##(2008-6#5)
fermenters##5##1##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
fermenting##6##1##(2008-10#3)(2012-3#3)
fermentor##5##1##(2008-10#1)(2008-6#1)(2008-9#2)(2012-2#1)
fermentors##2##1##(2008-11#1)(2011-2#1)
ferments##2##1##(2008-6#1)(2011-2#1)
fermion##4##1##(1990-12#1)(1991-9#1)(2012-2#2)
fern species##2##2##(2008-5#1)(2008-8#1)
fern##11##1##(1994-11#2)(1994-9#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#1)(2013-7#1)
fernandi##3##1##(2010-3#3)
ferredoxin reductase-like protein##2##3##(1997-7#2)
ferredoxin##14##1##(1990-12#2)(1990-5#1)(1991-5#2)(1994-5#3)(1995-5#2)(1997-7#2)(2008-11#1)(2008-7#1)
ferredoxin-NADP+ oxidoreductase##2##2##(1992-3#2)
ferredoxins##5##1##(1994-5#3)(1995-5#2)
ferret##9##1##(2008-1#2)(2008-5#1)(2008-6#5)(2010-4#1)
ferric anguibactin transport##3##3##(2011-2#3)
ferric anguibactin##4##2##(2011-2#4)
ferric iron##2##2##(2008-10#1)(2009-2#1)
ferric nitrilotriacetate##2##2##(2008-4#2)
ferric reducing ability##2##3##(2008-11#2)
ferric reducing antioxidant power##2##4##(2012-2#2)
ferric reducing##4##2##(2008-11#2)(2012-2#2)
ferric##34##1##(1990-5#1)(1990-8#3)(1993-8#2)(1994-6#2)(1997-7#2)(2008-10#9)(2008-11#3)(2008-4#2)(2008-5#1)(2009-2#1)(2011-2#6)(2012-2#2)
ferricenium##3##1##(1995-2#3)
ferricyanide and##3##2##(2008-10#3)
ferricyanide as##2##2##(2008-10#2)
ferricyanide by##2##2##(1994-3#1)(2008-10#1)
ferricyanide reduction##2##2##(1992-6#2)
ferricyanide was##2##2##(2008-10#2)
ferricyanide##30##1##(1992-11#2)(1992-6#2)(1994-3#1)(2008-10#23)(2009-9#1)(2010-2#1)
ferriprotoporphyrin IX##3##2##(1993-8#3)
ferriprotoporphyrin##4##1##(1993-8#3)(1994-8#1)
ferritin H mRNA##2##3##(1990-5#1)(1994-11#1)
ferritin H##6##2##(1990-5#4)(1994-11#2)
ferritin aggregation##3##2##(2013-8#3)
ferritin and haptoglobin##2##3##(1996-12#2)
ferritin and transferrin##2##3##(1996-5#1)(2007-7#1)
ferritin and##7##2##(1996-12#2)(1996-5#1)(2007-7#1)(2008-1#2)(2011-2#1)
ferritin concentration##2##2##(1993-11#1)(2012-1#1)
ferritin heavy chain mRNA##3##4##(1997-6#3)
ferritin heavy chain##5##3##(1990-5#1)(1997-6#4)
ferritin in human serum##2##4##(2008-10#2)
ferritin in the##5##3##(1993-11#1)(2008-7#1)(2012-1#3)
ferritin in##8##2##(1993-11#1)(2008-10#3)(2008-7#1)(2012-1#3)
ferritin levels##6##2##(1993-11#1)(2007-7#1)(2009-8#1)(2013-8#3)
ferritin##70##1##(1990-5#7)(1993-11#4)(1994-11#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-6#4)(2007-7#4)(2008-1#3)(2008-10#7)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-1#8)(2012-12#1)(2013-1#2)(2013-8#13)
ferrocene##5##1##(2008-10#4)(2012-12#1)
ferrocenyl##2##1##(2008-10#1)(2009-9#1)
ferrochelatase in##3##2##(1991-5#3)
ferrochelatase##4##1##(1991-5#4)
ferrochromium-producing workers##2##2##(1994-5#2)
ferrocyanide and##2##2##(1992-6#2)
ferrocyanide##13##1##(1992-6#4)(2008-10#9)
ferrocytochrome c##4##2##(1994-5#4)
ferroelectric domains##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
ferroelectric liquid crystals##4##3##(2008-2#1)(2008-3#3)
ferroelectric liquid##5##2##(2008-2#1)(2008-3#4)
ferroelectric liquid-crystal (FLC) devices##2##4##(2008-2#1)(2008-3#1)
ferroelectric liquid-crystal spatial light modulator##7##5##(2007-12#1)(2008-2#3)(2008-3#3)
ferroelectric liquid-crystal##14##2##(2007-12#1)(2008-2#7)(2008-3#6)
ferroelectric##30##1##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#14)(2008-3#12)
ferroelectricity##2##1##(2007-12#2)
ferrofluid##4##1##(2008-2#3)(2008-7#1)
ferroin##3##1##(2008-10#3)
ferromagnetic coupling##2##2##(1992-11#1)(1997-7#1)
ferromagnetic nanoparticles##3##2##(2008-7#1)(2009-11#1)(2012-2#1)
ferromagnetic state##2##2##(1997-7#1)(2007-11#1)
ferromagnetic##20##1##(1992-11#1)(1992-3#1)(1996-12#1)(1997-7#4)(2007-11#4)(2008-7#6)(2009-11#2)(2012-2#1)
ferromagnetically coupled##2##2##(1991-5#2)
ferrooxidans and##2##2##(2008-6#2)
ferrooxidans mer##2##2##(1990-11#2)
ferrooxidans##9##1##(1990-11#4)(2008-6#2)(2008-8#3)
ferrous cytochrome P450cam##2##3##(1994-6#2)
ferrous form of##2##3##(1994-6#2)
ferrous ions and##2##3##(1990-12#2)
ferrous ions##6##2##(1990-12#3)(2008-10#1)(2009-11#1)(2013-1#1)
ferrous sulfate##2##2##(2008-11#2)
ferrous##25##1##(1990-12#3)(1990-8#2)(1992-8#2)(1993-8#1)(1994-6#4)(2008-10#6)(2008-11#3)(2008-5#1)(2009-11#1)(2013-1#2)
ferrozine##6##1##(2008-10#6)
ferry##2##1##(2007-2#1)(2012-2#1)
ferryl##2##1##(1991-9#1)(1994-5#1)
fertile leaves##3##2##(2013-7#3)
fertile males##2##2##(1997-4#1)(2008-5#1)
fertile women##3##2##(1990-2#1)(2011-1#2)
fertile##41##1##(1990-2#2)(1996-10#1)(1996-12#2)(1996-3#1)(1997-4#3)(2008-10#9)(2008-12#5)(2008-5#5)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)
fertilisation##8##1##(1990-2#2)(1990-6#1)(1991-3#1)(1992-9#2)(1996-8#1)(2011-10#1)
fertiliser##2##1##(2011-2#1)(2012-12#1)
fertilisers##3##1##(2008-10#3)
fertility amendments##2##2##(2008-10#2)
fertility and##9##2##(1991-6#1)(1994-3#2)(1997-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-5#1)(2011-1#1)
fertility decisions##2##2##(2011-2#2)
fertility desires##3##2##(2011-1#3)
fertility disorders##2##2##(1991-11#2)
fertility has##3##2##(1991-12#1)(1995-6#1)(2008-4#1)
fertility in the##2##3##(1997-1#1)(2012-2#1)
fertility in##11##2##(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-2#2)
fertility is##2##2##(2008-4#1)(2009-10#1)
fertility of##4##2##(2012-3#3)(2013-7#1)
fertility rate in##2##3##(2009-10#1)(2012-3#1)
fertility rate##4##2##(1996-2#1)(2008-8#1)(2009-10#1)(2012-3#1)
fertility treatment##2##2##(2011-1#2)
fertility was##2##2##(1994-8#1)(2008-12#1)
fertility##127##1##(1990-2#1)(1991-11#3)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-6#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#12)(2009-10#13)(2009-12#3)(2009-5#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-1#10)(2011-2#8)(2012-2#7)(2012-3#7)(2013-1#1)(2013-7#3)
fertilization and##7##2##(1994-11#1)(1996-9#1)(2008-12#1)(2008-7#1)(2008-8#2)(2013-1#1)
fertilization chamber##4##2##(2007-12#4)
fertilization in##6##2##(1994-9#1)(1995-6#1)(2008-10#1)(2008-9#1)(2011-1#2)
fertilization is##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
fertilization of##2##2##(1995-6#1)(2013-1#1)
fertilization success##4##2##(2008-8#3)(2013-1#1)
fertilization was##2##2##(1990-10#1)(1995-6#1)
fertilization with##2##2##(2008-11#1)(2012-3#1)
fertilization##97##1##(1990-10#1)(1991-11#1)(1993-1#1)(1994-11#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-6#4)(1996-9#4)(1997-2#1)(1997-6#2)(1997-8#1)(2007-12#5)(2008-10#9)(2008-11#6)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#12)(2008-9#7)(2009-12#4)(2009-2#1)(2009-8#2)(2010-8#2)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)
fertilize the##2##2##(2009-2#1)(2010-7#1)
fertilize##6##1##(2008-7#1)(2008-8#2)(2009-2#1)(2010-7#1)(2012-12#1)
fertilized chicken eggs##2##3##(2008-1#1)(2008-4#1)
fertilized eggs of##2##3##(2008-11#1)(2010-5#1)
fertilized eggs##10##2##(1993-3#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-5#2)(2010-5#2)(2010-8#1)
fertilized##18##1##(1993-3#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2010-5#2)(2010-8#1)(2012-12#1)
fertilizer and##2##2##(2008-10#2)
fertilizer application##3##2##(1990-9#1)(1996-12#1)(2008-12#1)
fertilizer in##2##2##(2008-10#1)(2008-12#1)
fertilizer samples##2##2##(2008-10#2)
fertilizer to##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
fertilizer##34##1##(1990-9#1)(1996-12#2)(2008-10#19)(2008-12#9)(2008-2#1)(2013-8#2)
fertilizers and##2##2##(2008-10#1)(2009-8#1)
fertilizers##11##1##(2008-10#7)(2008-12#2)(2009-8#1)(2012-1#1)
fertilizes##2##1##(1995-2#1)(2008-9#1)
fertilizing##2##1##(2008-12#1)(2008-8#1)
ferulic acid and##5##3##(1994-5#1)(2008-10#1)(2011-1#2)(2013-8#1)
ferulic acid##27##2##(1994-5#9)(2008-10#12)(2008-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
ferulic##29##1##(1994-5#10)(2008-10#13)(2008-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
feruloyl##2##1##(2011-1#1)(2013-1#1)
fervidus##3##1##(2011-2#3)
fervor##2##1##(1992-11#2)
fescue and##3##2##(2008-10#2)(2008-8#1)
fescue##24##1##(2008-10#22)(2008-8#2)
festival##5##1##(2008-11#1)(2009-10#4)
festucae##2##1##(2008-8#2)
fetal DNA##2##2##(2010-11#1)(2012-2#1)
fetal alcohol spectrum disorders##2##4##(2008-11#2)
fetal alcohol spectrum##3##3##(2008-11#2)(2013-1#1)
fetal alcohol##6##2##(2008-11#4)(2008-3#1)(2013-1#1)
fetal and neonatal##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
fetal and##10##2##(1992-8#1)(1994-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#1)
fetal aneuploidy##3##2##(1996-12#3)
fetal anomalies##5##2##(2008-11#4)(2013-1#1)
fetal astrocytes##2##2##(1992-6#2)
fetal bladder outflow obstruction##2##4##(2008-10#2)
fetal blood sampling and##2##4##(1996-3#2)
fetal blood sampling##5##3##(1990-9#1)(1996-3#3)(2008-4#1)
fetal blood##6##2##(1990-9#1)(1996-3#3)(2008-4#1)(2012-2#1)
fetal bovine serum (FBS)##6##4##(1995-3#1)(2008-11#5)
fetal bovine serum and##2##4##(1992-11#1)(2010-3#1)
fetal bovine serum##16##3##(1990-6#1)(1992-11#3)(1994-11#1)(1995-12#1)(1995-3#1)(2008-11#8)(2010-3#1)
fetal bovine##17##2##(1990-6#1)(1992-11#3)(1994-11#1)(1995-12#1)(1995-3#1)(2008-11#8)(2010-3#1)(2012-3#1)
fetal brain##7##2##(1993-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
fetal calf serum (FCS)##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
fetal calf serum##9##3##(1990-7#1)(1992-6#2)(1995-2#1)(2008-11#3)(2008-7#1)(2013-1#1)
fetal calf##10##2##(1990-7#1)(1992-6#2)(1992-8#1)(1995-2#1)(2008-11#3)(2008-7#1)(2013-1#1)
fetal care##2##2##(2008-11#2)
fetal cell##4##2##(1996-12#2)(2012-3#2)
fetal cells in##2##3##(1996-12#2)
fetal cells##12##2##(1994-6#3)(1996-12#3)(2008-4#1)(2012-1#1)(2012-3#4)
fetal chromosomal abnormalities##4##3##(1995-8#4)
fetal chromosomal##5##2##(1995-8#4)(1996-12#1)
fetal death##4##2##(1992-5#1)(2008-7#1)(2013-1#2)
fetal demise##4##2##(2008-11#1)(2009-1#1)(2010-8#1)(2012-3#1)
fetal development##5##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
fetal distress##4##2##(1990-9#1)(1992-10#1)(1994-3#1)(2012-12#1)
fetal erythroblasts in maternal blood##3##5##(1996-12#3)
fetal growth and##4##3##(1993-3#1)(1995-12#1)(2008-11#1)(2011-1#1)
fetal growth retardation##2##3##(1994-3#1)(1995-8#1)
fetal growth##15##2##(1993-3#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2011-1#3)(2012-2#1)(2013-1#2)
fetal heart rate (FHR)##2##4##(1994-3#1)(1994-5#1)
fetal heart rate##4##3##(1993-10#1)(1994-3#2)(1994-5#1)
fetal heart##5##2##(1993-10#1)(1994-3#2)(1994-5#1)(2011-2#1)
fetal hemoglobin levels##2##3##(2012-12#2)
fetal hemoglobin##8##2##(1992-12#1)(1992-3#2)(1996-12#1)(2008-10#1)(2009-9#1)(2012-12#2)
fetal human oligodendrocytes and astrocytes##2##5##(1996-5#2)
fetal human oligodendrocytes##3##3##(1996-5#3)
fetal human##5##2##(1996-5#4)(1997-2#1)
fetal hypoxia##3##2##(1994-5#3)
fetal kidney##2##2##(1994-11#1)(2008-10#1)
fetal life##5##2##(1993-3#1)(2008-10#1)(2012-2#2)(2013-1#1)
fetal liver and##3##3##(1990-11#1)(2008-9#1)(2013-1#1)
fetal liver or##2##3##(2008-10#1)(2008-4#1)
fetal liver##16##2##(1990-11#1)(1990-5#1)(1997-7#2)(2008-10#2)(2008-4#3)(2008-8#4)(2008-9#2)(2013-1#1)
fetal loss and under-2-years##3##4##(2011-1#3)
fetal loss##7##2##(2006-10#1)(2011-1#4)(2013-1#1)(2013-8#1)
fetal losses##2##2##(1996-3#1)(2007-7#1)
fetal lung##7##2##(1993-3#1)(1994-9#1)(1995-12#1)(1995-8#3)(2008-4#1)
fetal malformation##2##2##(2008-3#1)(2008-7#1)
fetal malformations was##2##3##(2008-3#1)(2011-2#1)
fetal malformations##3##2##(2008-3#1)(2011-2#2)
fetal membranes##4##2##(1994-9#2)(1995-2#1)(2012-3#1)
fetal mice##2##2##(2008-10#1)(2008-7#1)
fetal monitoring##2##2##(1994-3#1)(2010-2#1)
fetal monitors##2##2##(2011-2#2)
fetal neural##2##2##(1994-8#1)(2009-10#1)
fetal or##4##2##(1991-2#1)(1994-2#1)(1995-11#1)(2008-10#1)
fetal outcome##2##2##(1992-4#1)(2011-2#1)
fetal plasma##2##2##(1990-12#1)(1995-8#1)
fetal pyelectasis##2##2##(2007-8#1)(2008-7#1)
fetal rat brain##2##3##(1994-11#1)(1996-12#1)
fetal rat##6##2##(1990-12#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)
fetal red blood cells##3##4##(1994-6#1)(2008-9#1)(2011-2#1)
fetal red##4##2##(1994-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
fetal retina##2##2##(1996-5#2)
fetal scalp##2##2##(1990-9#1)(1994-5#1)
fetal survival##2##2##(2008-4#1)(2012-2#1)
fetal thymus and liver##2##4##(2008-10#1)(2008-11#1)
fetal thymus##5##2##(2008-10#4)(2008-11#1)
fetal tissue##2##2##(1995-9#1)(1996-2#1)
fetal tissues##2##2##(1990-11#2)
fetal trophoblasts##2##2##(1994-9#1)(1996-12#1)
fetal##390##1##(1990-11#7)(1990-12#3)(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-11#1)(1991-2#3)(1991-6#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#7)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#5)(1993-3#3)(1993-6#4)(1994-11#3)(1994-2#3)(1994-3#9)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#15)(1995-9#1)(1996-11#2)(1996-12#21)(1996-2#3)(1996-3#4)(1996-5#9)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#34)(2008-3#3)(2008-4#9)(2008-7#15)(2008-8#6)(2008-9#6)(2009-1#2)(2009-10#3)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#7)(2010-2#2)(2010-3#3)(2010-8#1)(2011-1#7)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#15)(2013-1#29)(2013-8#1)
fetal-maternal hemorrhage##3##2##(1992-9#3)
feto-maternal outcome in pregnancies with abnormal liquor volume##2##8##(2012-12#2)
fetomaternal hemorrhage (FMH)##2##3##(1994-6#1)(2011-2#1)
fetomaternal hemorrhage##3##2##(1994-6#2)(2011-2#1)
fetomaternal##4##1##(1994-6#2)(2011-2#1)(2012-3#1)
fetoprotein##5##1##(1990-9#1)(1991-8#2)(2008-10#1)(2013-7#1)
fetus and##7##2##(1992-11#1)(1995-11#1)(2007-11#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-3#1)
fetus during##3##2##(1990-9#1)(2007-10#1)(2011-2#1)
fetus in##4##2##(2007-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
fetus is##4##2##(1990-7#1)(1990-9#1)(1993-6#1)(2010-11#1)
fetus ssp##2##2##(2011-1#2)
fetus was##2##2##(1990-2#1)(1997-8#1)
fetus with##3##2##(1994-12#1)(2008-7#1)(2010-4#1)
fetus##69##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#2)(1992-10#1)(1992-11#1)(1993-12#2)(1993-6#2)(1994-12#2)(1994-5#2)(1994-7#2)(1995-11#1)(1995-8#3)(1996-11#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-11#4)(2010-4#1)(2010-8#2)(2011-1#14)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)
fetuses and##4##2##(1991-3#1)(2007-11#2)(2010-11#1)
fetuses of##2##2##(1993-12#1)(1996-12#1)
fetuses was##2##2##(1992-6#1)(1996-12#1)
fetuses were examined##2##3##(1990-2#1)(1993-12#1)
fetuses were##4##2##(1990-2#1)(1993-12#1)(1996-12#1)(1996-3#1)
fetuses with normal##2##3##(2008-11#1)(2012-12#1)
fetuses with##8##2##(1990-2#1)(1990-5#1)(1993-12#1)(1996-12#2)(2008-11#1)(2011-2#1)(2012-12#1)
fetuses##48##1##(1990-2#3)(1990-5#3)(1991-3#1)(1991-6#1)(1992-6#2)(1993-10#1)(1993-12#7)(1994-5#1)(1995-11#2)(1996-12#7)(1996-3#1)(2007-11#3)(2008-11#3)(2008-4#1)(2008-7#2)(2010-11#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#2)
fever and pain##2##3##(1996-11#1)(2012-12#1)
fever and##22##2##(1992-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1996-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
fever cases##2##2##(1994-11#1)(2013-8#1)
fever for##3##2##(2008-7#1)(2009-4#1)(2011-2#1)
fever group##4##2##(1991-8#2)(1995-12#2)
fever has##2##2##(1992-3#1)(1992-6#1)
fever in children##3##3##(2007-2#1)(2008-10#1)(2008-11#1)
fever in the##3##3##(1996-12#1)(2008-7#2)
fever in##19##2##(1992-3#1)(1994-12#1)(1994-3#3)(1995-9#1)(1996-12#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-8#1)
fever is a##3##3##(2008-4#1)(2008-5#1)(2011-1#1)
fever is##5##2##(2007-7#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)
fever of long duration##2##4##(2007-7#1)(2008-7#1)
fever of##5##2##(2007-7#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
fever or##2##2##(2011-2#1)(2012-3#1)
fever persisted##2##2##(2008-1#1)(2011-1#1)
fever was##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
fever were##4##2##(2007-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
fever with renal syndrome##8##4##(1991-3#1)(2013-1#7)
fever with##15##2##(1991-3#1)(1992-9#1)(2006-5#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#7)(2013-8#2)
fever##254##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-2#3)(1992-3#3)(1992-6#3)(1992-9#3)(1993-2#1)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-6#3)(1995-9#2)(1996-11#2)(1996-12#6)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2006-10#2)(2006-5#4)(2007-12#13)(2007-2#9)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#7)(2008-7#16)(2008-8#3)(2009-10#1)(2009-11#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2010-1#4)(2010-12#5)(2010-4#1)(2010-8#1)(2011-1#9)(2011-2#20)(2012-12#5)(2012-2#6)(2012-3#9)(2013-1#10)(2013-8#19)
fever)##2##1##(1996-8#1)(2013-1#1)
fever-like##2##1##(1994-2#2)
fever]##4##1##(1990-9#1)(1992-2#1)(1994-3#1)(1997-4#1)
feverfew extracts##4##2##(2008-10#4)
feverfew##9##1##(2008-10#9)
feverish##2##1##(1990-9#1)(2008-5#1)
fevers##11##1##(1990-10#1)(1990-2#1)(1994-11#2)(1996-3#1)(2007-12#1)(2007-2#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
few additional##2##2##(2008-10#2)
few adverse effects##2##3##(2008-7#1)(2008-8#1)
few adverse##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
few and##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
few are##4##2##(1995-1#1)(1996-1#1)(2008-10#1)(2013-7#1)
few as##11##2##(1995-3#1)(2008-10#5)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
few attempts##3##2##(1993-6#1)(1997-2#1)(2008-7#1)
few case reports##2##3##(2008-6#1)(2012-2#1)
few case##3##2##(2008-6#1)(2010-7#1)(2012-2#1)
few cases have been reported in the literature##4##8##(2007-7#1)(2009-5#1)(2011-1#1)(2013-7#1)
few cases have been reported in the##5##7##(1997-8#1)(2007-7#1)(2009-5#1)(2011-1#1)(2013-7#1)
few cases have been reported in##7##6##(1997-8#2)(2007-7#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
few cases have been reported##12##5##(1991-8#1)(1997-8#2)(2006-10#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
few cases have been##13##4##(1991-8#1)(1997-8#2)(2006-10#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
few cases have##14##3##(1990-12#1)(1991-8#1)(1997-8#2)(2006-10#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
few cases of##11##3##(1994-3#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
few cases where##2##3##(2007-7#1)(2013-1#1)
few cases##46##2##(1990-12#1)(1991-11#1)(1991-4#1)(1991-8#1)(1994-3#1)(1996-11#1)(1997-2#1)(1997-8#2)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
few cells##8##2##(1991-10#1)(1992-6#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
few centimeters##3##2##(2008-2#1)(2008-3#2)
few changes##2##2##(2008-10#1)(2009-10#1)
few complications##5##2##(1990-11#1)(1991-2#1)(2009-3#1)(2010-7#1)(2013-1#1)
few components##2##2##(2008-3#2)
few compounds##3##2##(1990-9#1)(1994-5#1)(2008-10#1)
few contraindications##2##2##(2011-2#1)(2012-3#1)
few data available##2##3##(1990-6#1)(2008-8#1)
few data on##2##3##(1992-3#1)(1996-2#1)
few data##11##2##(1990-6#1)(1992-3#1)(1996-2#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2012-3#1)
few days after##8##3##(1992-4#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-5#1)(2008-8#2)(2011-2#1)
few days of##4##3##(1990-9#2)(2007-10#1)(2012-3#1)
few days##27##2##(1990-9#2)(1991-4#1)(1992-4#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2010-4#1)(2011-2#3)(2012-3#1)
few decades has##2##3##(2008-4#1)(2008-7#1)
few decades##23##2##(1993-9#1)(1994-5#1)(1995-1#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#1)(2012-2#3)(2013-1#2)(2013-8#1)
few degrees off##2##3##(2007-11#1)(2008-3#1)
few differences in the##2##4##(2008-10#1)(2008-8#1)
few differences in##3##3##(2008-10#2)(2008-8#1)
few documented cases##2##3##(1996-5#1)(2013-1#1)
few eggs##3##2##(1991-5#1)(2008-9#2)
few examples of##6##3##(2008-10#2)(2008-9#2)(2010-12#1)(2011-2#1)
few examples##8##2##(1996-4#1)(2008-10#3)(2008-9#2)(2010-12#1)(2011-2#1)
few exceptions##10##2##(1992-9#1)(2007-8#1)(2008-10#4)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)
few genes##2##2##(2008-10#1)(2009-10#1)
few have been##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
few have##7##2##(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
few hours after the##2##4##(1990-9#1)(2008-6#1)
few hours after##8##3##(1990-9#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2012-12#1)
few hours to##2##3##(2008-10#1)(2008-12#1)
few hours##24##2##(1990-8#1)(1990-9#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
few hundred##7##2##(1994-5#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)
few if any##3##3##(2008-10#1)(2008-4#1)(2011-3#1)
few in the period##2##4##(1990-6#2)
few individuals are##2##3##(1994-11#1)(2008-10#1)
few individuals##4##2##(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#1)
few infants##2##2##(1994-6#1)(2012-2#1)
few information on##2##3##(2009-8#1)(2013-7#1)
few information##3##2##(2009-8#1)(2013-7#2)
few isolates##2##2##(2008-10#1)(2010-4#1)
few key##2##2##(1993-12#2)
few large##4##2##(1994-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
few large-scale##2##2##(2010-7#1)(2011-2#1)
few methods exist for##2##4##(2008-9#1)(2010-6#1)
few methods##4##2##(2008-4#1)(2008-9#1)(2010-6#1)(2012-3#1)
few microliters##2##2##(2008-10#2)
few minutes after##2##3##(1990-11#1)(1996-1#1)
few minutes and##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
few minutes to##3##3##(2007-12#1)(2008-4#1)(2010-7#1)
few minutes##18##2##(1990-11#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-7#1)(2012-12#1)
few models##2##2##(2008-11#1)(2008-8#1)
few months of##3##3##(1996-9#1)(2011-1#1)(2012-2#1)
few months##11##2##(1991-4#1)(1992-8#1)(1996-9#1)(2007-2#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
few number of##2##3##(2008-10#1)(2008-12#1)
few of the##7##3##(1991-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-9#1)
few of them##2##3##(1997-8#1)(2011-2#1)
few of these##6##3##(1990-2#1)(1993-12#1)(1995-6#1)(2008-3#1)(2008-8#1)(2012-12#1)
few of##18##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)
few optical##2##2##(2007-12#1)(2008-3#1)
few or no##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
few or##6##2##(2008-10#1)(2008-11#1)(2008-9#2)(2010-3#1)(2010-5#1)
few other##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
few papers##2##2##(1997-8#1)(2008-11#1)
few patients have##2##3##(2006-10#1)(2008-7#1)
few patients with##2##3##(1997-3#1)(2008-7#1)
few patients##12##2##(1992-3#1)(1994-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2008-5#1)(2008-7#3)(2013-1#1)
few physicians##2##2##(1990-2#1)(2008-12#1)
few plants##2##2##(2008-10#1)(2013-7#1)
few problems##2##2##(2007-8#1)(2008-10#1)
few protein##2##2##(2008-7#2)
few publications##4##2##(2008-11#1)(2009-5#2)(2010-8#1)
few published##2##2##(1991-5#1)(2008-11#1)
few recent studies##2##3##(2008-10#2)
few recent##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
few references to the##2##4##(1992-12#1)(2009-7#1)
few reported cases of##2##4##(2010-3#1)(2011-1#1)
few reported cases##4##3##(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)
few reported##5##2##(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
few reports about##2##3##(2008-10#1)(2011-2#1)
few reports have##4##3##(2007-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
few reports in the literature##2##5##(2008-9#1)(2009-3#1)
few reports of##8##3##(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
few reports on##2##3##(2008-10#1)(2008-7#1)
few reports that##2##3##(2012-1#1)(2012-3#1)
few reports##26##2##(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
few side effects##4##3##(2008-2#1)(2010-5#1)(2011-3#1)(2012-12#1)
few simple##3##2##(1994-1#1)(2008-2#1)(2010-7#1)
few spores##2##2##(2008-10#2)
few studies are##2##3##(2008-5#1)(2013-8#1)
few studies have been##3##4##(1993-9#1)(2008-4#1)(2012-3#1)
few studies have examined the##5##5##(1993-1#1)(1997-4#1)(2007-11#1)(2008-7#1)(2013-8#1)
few studies have examined##6##4##(1993-1#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
few studies have explored the##2##5##(2008-2#1)(2010-1#1)
few studies have##21##3##(1993-1#1)(1993-9#1)(1997-4#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
few studies on##2##3##(1997-6#1)(2008-1#1)
few studies that##4##3##(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)
few studies were##2##3##(2007-7#1)(2009-10#1)
few studies##51##2##(1990-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
few such##4##2##(2008-8#1)(2009-10#1)(2010-6#2)
few symptoms##2##2##(2008-10#1)(2013-1#1)
few systematic studies##2##3##(1996-2#1)(2011-2#1)
few to##5##2##(1994-9#1)(1996-4#2)(2009-11#1)(2009-4#1)
few trials##2##2##(1995-2#1)(2007-5#1)
few types of##2##3##(2008-7#1)(2010-9#1)
few viable##2##2##(2008-10#2)
few weeks##13##2##(1990-11#1)(1990-3#1)(1993-11#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2009-7#1)(2012-2#1)
few were##2##2##(1990-8#1)(1991-12#1)
few who##2##2##(1994-12#1)(1995-1#1)
few words##5##2##(2008-8#3)(2008-9#1)(2011-2#1)
few years ago##5##3##(1990-11#1)(1992-9#1)(1997-7#1)(2008-3#1)(2010-8#1)
few years by##2##3##(1996-4#1)(2011-2#1)
few years have seen##2##4##(1997-8#1)(2009-3#1)
few years have##4##3##(1992-12#1)(1997-8#1)(2008-8#1)(2009-3#1)
few years later##2##3##(1991-6#1)(2008-8#1)
few years of life##2##4##(1996-9#1)(2008-12#1)
few years of##3##3##(1996-9#1)(2008-12#1)(2008-9#1)
few years there##2##3##(1994-9#1)(2008-3#1)
few years##86##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-9#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#5)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#3)
few μm##2##2##(2011-1#2)
few##1056##1##(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#5)(1990-8#7)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#5)(1991-4#3)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#4)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#8)(1994-5#3)(1994-6#5)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#2)(1996-1#2)(1996-11#3)(1996-12#6)(1996-2#4)(1996-3#4)(1996-4#5)(1996-5#6)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#8)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#10)(1997-7#4)(1997-8#6)(2006-10#3)(2007-10#7)(2007-11#14)(2007-12#33)(2007-2#4)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#14)(2008-10#159)(2008-11#37)(2008-12#14)(2008-2#28)(2008-3#64)(2008-4#17)(2008-5#29)(2008-6#7)(2008-7#41)(2008-8#31)(2008-9#31)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#9)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#5)(2010-6#11)(2010-7#7)(2010-8#7)(2010-9#1)(2011-1#12)(2011-2#38)(2011-3#2)(2012-1#6)(2012-12#17)(2012-2#24)(2012-3#14)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#35)(2013-7#9)(2013-8#10)
few&quot##2##1##(1994-1#1)(2013-8#1)
few-cycle optical##2##2##(2007-11#1)(2007-12#1)
few-cycle##4##1##(2007-11#1)(2007-12#3)
few-mode fiber##2##2##(2007-11#1)(2007-12#1)
few-mode fibers##5##2##(2007-11#5)
few-mode##7##1##(2007-11#6)(2007-12#1)
few-tillering##4##1##(2008-9#4)
fewer admissions##2##2##(1991-3#1)(2011-1#1)
fewer and##2##2##(2008-10#1)(2009-8#1)
fewer appressoria developed##2##3##(2008-10#2)
fewer ascospores##2##2##(2008-10#2)
fewer categories and##2##3##(1993-12#1)(2008-7#1)
fewer children##2##2##(2010-5#1)(2012-2#1)
fewer complications##9##2##(1990-11#1)(1990-8#1)(1995-12#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#3)
fewer days##2##2##(1997-2#1)(2008-7#1)
fewer deaths##2##2##(1990-5#1)(2012-2#1)
fewer experiments##2##2##(2008-11#1)(2009-9#1)
fewer had##2##2##(1995-3#1)(1997-3#1)
fewer hospital##2##2##(1992-2#1)(1996-9#1)
fewer hospitals##3##2##(1994-2#2)(1996-2#1)
fewer hours##2##2##(2010-7#1)(2012-1#1)
fewer in number##2##3##(1991-12#1)(2008-10#1)
fewer in##3##2##(1991-12#1)(2008-10#1)(2008-6#1)
fewer lesions##2##2##(2008-10#2)
fewer monitor units##2##3##(2013-1#2)
fewer problems##2##2##(1990-12#1)(2009-11#1)
fewer resources##5##2##(1991-12#1)(1993-2#1)(1997-2#1)(2008-11#2)
fewer side effects than##2##4##(2007-10#1)(2012-12#1)
fewer side effects##8##3##(1997-3#1)(2007-10#1)(2008-2#1)(2008-9#1)(2009-12#2)(2011-2#1)(2012-12#1)
fewer side##9##2##(1996-5#1)(1997-3#1)(2007-10#1)(2008-2#1)(2008-9#1)(2009-12#2)(2011-2#1)(2012-12#1)
fewer studies##2##2##(2011-2#1)(2012-3#1)
fewer symptom-days##2##2##(2013-1#2)
fewer symptoms##2##2##(2009-9#1)(2011-1#1)
fewer than 100##2##3##(2008-10#1)(2008-11#1)
fewer than 20##2##3##(1993-9#1)(2007-5#1)
fewer than 25 patients##3##4##(2011-2#3)
fewer than##17##2##(1992-9#1)(1993-9#1)(1994-3#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-3#1)(2011-2#4)
fewer treatment##2##2##(1991-3#1)(1996-11#1)
fewer##254##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#4)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-12#4)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#7)(2008-10#49)(2008-11#9)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#6)(2009-11#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#12)(2013-8#3)
fewest##6##1##(1990-3#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
fexofenadine##2##1##(2007-11#1)(2010-3#1)
fg cell(-1) for##2##3##(2008-10#2)
fg of##9##2##(1994-2#1)(2008-10#8)
fg##19##1##(1994-2#1)(2008-10#17)(2012-3#1)
fi##2##1##(2008-8#1)(2009-11#1)
fiber (100##2##2##(2008-10#2)
fiber Bragg grating (FBG)##3##4##(2007-11#2)(2008-3#1)
fiber Bragg grating and##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
fiber Bragg grating as##2##4##(2008-2#1)(2008-3#1)
fiber Bragg grating reflectors##2##4##(2007-11#2)
fiber Bragg grating##35##3##(2007-11#12)(2007-12#9)(2008-2#3)(2008-3#11)
fiber Bragg gratings in hydrogenated##2##5##(2007-11#2)
fiber Bragg gratings is presented##2##5##(2007-11#2)
fiber Bragg gratings is##3##4##(2007-11#2)(2008-3#1)
fiber Bragg gratings written##2##4##(2008-3#2)
fiber Bragg gratings##32##3##(2007-11#12)(2007-12#9)(2008-2#2)(2008-3#8)(2013-8#1)
fiber Bragg##68##2##(2007-11#24)(2007-12#19)(2008-2#5)(2008-3#19)(2013-8#1)
fiber Fabry-Perot interferometer (FFPI)##3##4##(2007-11#2)(2008-2#1)
fiber Fabry-Perot temperature sensor##2##4##(2007-11#2)
fiber Fabry-Perot##8##2##(2007-11#5)(2008-2#2)(2013-8#1)
fiber Raman amplifiers##4##3##(2007-11#3)(2007-12#1)
fiber Raman##5##2##(2007-11#4)(2007-12#1)
fiber amplifier (EDFA)##3##3##(2008-10#1)(2008-2#2)
fiber amplifier employing##2##3##(2007-11#1)(2007-12#1)
fiber amplifier in##2##3##(2007-12#2)
fiber amplifier with an##2##4##(2007-12#2)
fiber amplifier with##5##3##(2007-12#3)(2008-3#2)
fiber amplifier##30##2##(2007-11#7)(2007-12#11)(2008-10#1)(2008-2#5)(2008-3#6)
fiber amplifiers##11##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#3)
fiber and a single##2##4##(2007-12#1)(2008-2#1)
fiber and a##7##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)
fiber and an##2##3##(2008-3#2)
fiber and its##2##3##(2007-11#1)(2008-3#1)
fiber and the##12##3##(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
fiber and##48##2##(2007-11#12)(2007-12#9)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#11)(2009-6#1)(2011-2#2)(2012-2#2)
fiber are##8##2##(1994-2#1)(2007-12#2)(2008-3#4)(2008-6#1)
fiber array##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
fiber as a##2##3##(2007-11#1)(2008-2#1)
fiber as well as the##2##5##(2008-10#1)(2009-7#1)
fiber as##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#1)
fiber at##5##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
fiber based##4##2##(2007-12#1)(2008-10#1)(2011-1#2)
fiber birefringence##2##2##(2007-11#1)(2010-4#1)
fiber bragg grating sensors based on##2##6##(2008-2#1)(2008-3#1)
fiber bragg grating##4##3##(2008-2#3)(2008-3#1)
fiber bragg gratings##2##3##(2008-3#2)
fiber bragg##6##2##(2008-2#3)(2008-3#3)
fiber bundle for##2##3##(2008-2#2)
fiber bundle has##2##3##(2008-3#2)
fiber bundle##13##2##(1991-2#1)(1995-12#2)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#2)
fiber bundles##7##2##(2008-10#1)(2008-3#4)(2013-1#2)
fiber bus networks##2##3##(2007-12#2)
fiber by use of##2##4##(2007-12#2)
fiber by using##2##3##(2008-3#2)
fiber by##12##2##(1992-11#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#1)(2008-3#3)
fiber can be used to##2##5##(2007-11#1)(2008-3#1)
fiber can be##7##3##(2007-11#4)(2007-12#2)(2008-3#1)
fiber can##8##2##(2007-11#4)(2007-12#3)(2008-3#1)
fiber cavity##4##2##(2007-11#2)(2007-12#2)
fiber cells##5##2##(2008-10#4)(2008-9#1)
fiber characteristics##3##2##(2008-3#1)(2010-4#2)
fiber coated with##2##3##(2008-2#1)(2009-8#1)
fiber coating##2##2##(2008-10#2)
fiber coatings##6##2##(2008-10#5)(2009-12#1)
fiber collimators##3##2##(2008-3#3)
fiber content##2##2##(1991-12#2)
fiber control##2##2##(2008-3#2)
fiber core##12##2##(2007-11#2)(2007-12#7)(2008-3#3)
fiber coupled light emitting diode##2##5##(2008-10#2)
fiber coupler is##2##3##(2007-12#2)
fiber coupler##9##2##(2007-11#5)(2007-12#3)(2008-10#1)
fiber couplers##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
fiber coupling##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
fiber cylindrical microelectrode-based detector##2##4##(2008-10#2)
fiber damage##3##2##(1992-11#3)
fiber development##2##2##(2008-8#1)(2008-9#1)
fiber devices##3##2##(2007-12#1)(2008-3#2)
fiber diameter##2##2##(2007-12#2)
fiber diameters##2##2##(2008-2#1)(2008-3#1)
fiber dispersion##2##2##(2007-11#1)(2008-2#1)
fiber distributed-feedback laser##2##3##(2007-11#1)(2008-3#1)
fiber distributed-feedback lasers by##2##4##(2007-11#1)(2008-3#1)
fiber distributed-feedback lasers##3##3##(2007-11#1)(2008-3#2)
fiber distributed-feedback##6##2##(2007-11#2)(2008-3#4)
fiber electrodes##3##2##(1992-11#1)(1997-2#1)(2008-10#1)
fiber end##4##2##(2008-2#1)(2008-3#3)
fiber ends##2##2##(2007-12#2)
fiber exhibits##2##2##(2007-12#2)
fiber expansion##3##2##(2008-10#2)(2008-9#1)
fiber filter##5##2##(2007-5#1)(2008-10#3)(2008-3#1)
fiber filters##6##2##(2008-10#4)(2008-11#1)(2008-2#1)
fiber followed by##2##3##(2008-10#1)(2008-3#1)
fiber for the##2##3##(2008-10#1)(2008-3#1)
fiber for##11##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)
fiber from##8##2##(1993-11#3)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
fiber gives rise to##2##4##(2007-12#1)(2008-3#1)
fiber grating##24##2##(2007-11#6)(2007-12#7)(2008-3#11)
fiber gratings and##2##3##(2008-3#2)
fiber gratings by use of##2##5##(2007-11#1)(2007-12#1)
fiber gratings by##4##3##(2007-11#1)(2007-12#3)
fiber gratings over##2##3##(2007-11#1)(2008-3#1)
fiber gratings with##3##3##(2007-12#2)(2008-3#1)
fiber gratings##34##2##(2007-11#7)(2007-12#13)(2008-2#1)(2008-3#12)(2013-8#1)
fiber has a##4##3##(2007-11#1)(2007-12#3)
fiber has been developed and##2##5##(2008-10#1)(2008-3#1)
fiber has been##8##3##(2007-11#4)(2008-10#2)(2008-3#2)
fiber has##12##2##(2007-11#5)(2007-12#3)(2008-10#2)(2008-3#2)
fiber image guide##3##3##(2008-3#3)
fiber in a##2##3##(2007-12#1)(2008-3#1)
fiber in the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
fiber in##9##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)
fiber increases##2##2##(2007-12#2)
fiber initiation and##2##3##(2008-8#2)
fiber interferometer##3##2##(2007-11#3)
fiber into##2##2##(2008-10#1)(2008-3#1)
fiber is also##2##3##(2008-2#1)(2008-3#1)
fiber is experimentally##3##3##(2007-12#1)(2008-3#2)
fiber is obtained##2##3##(2007-11#1)(2007-12#1)
fiber is presented##2##3##(2007-11#1)(2008-3#1)
fiber is proposed##2##3##(2007-11#1)(2008-2#1)
fiber is used for##2##4##(2008-2#2)
fiber is used##3##3##(2007-11#1)(2008-2#2)
fiber is##37##2##(2007-11#10)(2007-12#8)(2008-10#3)(2008-2#6)(2008-3#9)(2013-1#1)
fiber laser and##3##3##(2007-11#2)(2008-2#1)
fiber laser as a##2##4##(2008-3#2)
fiber laser by use of##2##5##(2007-12#1)(2008-2#1)
fiber laser by##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
fiber laser cavity##5##3##(2008-2#3)(2008-3#2)
fiber laser for##2##3##(2008-3#2)
fiber laser had a##2##4##(2008-2#2)
fiber laser in##2##3##(2007-12#1)(2008-2#1)
fiber laser mode locked and##2##5##(2007-12#2)
fiber laser operating##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
fiber laser sensor##3##3##(2007-11#2)(2008-3#1)
fiber laser source##2##3##(2008-3#2)
fiber laser system##3##3##(2007-12#3)
fiber laser that##2##3##(2007-12#2)
fiber laser was##2##3##(2007-12#1)(2008-2#1)
fiber laser with a##6##4##(2007-11#3)(2008-2#1)(2008-3#2)
fiber laser with an##2##4##(2007-11#1)(2007-12#1)
fiber laser with##12##3##(2007-11#5)(2007-12#2)(2008-2#3)(2008-3#2)
fiber laser##93##2##(1997-6#1)(2007-11#27)(2007-12#30)(2008-2#15)(2008-3#19)(2009-7#1)
fiber lasers with lasing##2##4##(2007-12#2)
fiber lasers with##6##3##(2007-11#1)(2007-12#3)(2008-2#2)
fiber lasers##18##2##(2007-11#1)(2007-12#11)(2008-2#5)(2008-3#1)
fiber length##4##2##(2007-11#2)(2008-2#1)(2009-7#1)
fiber link##2##2##(2007-11#1)(2007-12#1)
fiber loading##2##2##(2009-7#2)
fiber loop mirror##2##3##(2007-12#1)(2008-2#1)
fiber loop##8##2##(2007-11#1)(2007-12#1)(2008-2#6)
fiber loss##3##2##(2007-12#2)(2008-2#1)
fiber materials##2##2##(1991-1#1)(2007-12#1)
fiber may##2##2##(2008-3#1)(2008-5#1)
fiber mode##2##2##(2007-12#1)(2008-3#1)
fiber of##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
fiber offers##2##2##(2007-11#1)(2007-12#1)
fiber optic probe##2##3##(2008-10#2)
fiber optic sensor##10##3##(2008-10#10)
fiber optic sensors##2##3##(2008-10#2)
fiber optic surface plasmon resonance##2##5##(2008-10#2)
fiber optic system##3##3##(2008-10#2)(2008-2#1)
fiber optic##29##2##(2008-10#25)(2008-2#1)(2008-3#1)(2010-6#1)(2011-1#1)
fiber optical parametric##5##3##(2007-11#5)
fiber optics##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
fiber orientation##2##2##(2007-11#1)(2013-1#1)
fiber plexus##3##2##(1992-3#3)
fiber power##2##2##(2007-12#1)(2008-2#1)
fiber probe##5##2##(2007-12#4)(2008-3#1)
fiber ring laser##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
fiber ring resonator##2##3##(2007-12#1)(2008-3#1)
fiber ring##15##2##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#5)
fiber segments##2##2##(2008-2#2)
fiber sensor##11##2##(2007-11#4)(2007-12#1)(2008-10#5)(2008-2#1)
fiber shows##2##2##(2008-10#1)(2008-3#1)
fiber soliton##2##2##(2007-12#2)
fiber source##3##2##(2007-12#2)(2008-2#1)
fiber structure##2##2##(2007-12#1)(2008-3#1)
fiber systems##8##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
fiber taper##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
fiber technology##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
fiber temperature sensor##2##3##(2007-11#1)(2008-2#1)
fiber temperature##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
fiber that is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
fiber that will##2##3##(2008-3#2)
fiber that##11##2##(2007-11#4)(2007-12#3)(2008-3#4)
fiber the##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
fiber tip##7##2##(1992-1#1)(1995-2#1)(2008-2#2)(2008-3#3)
fiber tips##3##2##(2007-12#2)(2008-2#1)
fiber to the##2##3##(2007-11#1)(2008-2#1)
fiber to##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
fiber tracts##2##2##(2008-11#1)(2008-4#1)
fiber transmission##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
fiber types##2##2##(1991-12#1)(1993-5#1)
fiber used##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
fiber was fabricated##2##3##(2007-11#1)(2012-1#1)
fiber was placed##2##3##(2008-10#1)(2008-3#1)
fiber was used to##3##4##(2007-11#1)(2008-10#2)
fiber was used##5##3##(1992-1#1)(2007-11#1)(2008-10#2)(2008-3#1)
fiber was##26##2##(1991-12#3)(1992-1#2)(2007-11#5)(2007-12#1)(2008-10#11)(2008-3#3)(2012-1#1)
fiber waveguide##2##2##(2007-11#1)(2007-12#1)
fiber waveguides##2##2##(2008-2#1)(2008-3#1)
fiber were##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
fiber when##2##2##(2007-12#1)(2008-3#1)
fiber with a##9##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#2)
fiber with an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
fiber with random fluctuations of birefringence##2##6##(2008-3#2)
fiber with##30##2##(2007-11#8)(2007-12#7)(2008-10#1)(2008-2#6)(2008-3#7)(2013-1#1)
fiber without##2##2##(2007-12#1)(2008-3#1)
fiber##1422##1##(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#12)(1991-2#1)(1991-9#2)(1992-1#4)(1992-11#6)(1992-12#2)(1992-3#3)(1993-11#6)(1993-5#1)(1993-9#1)(1994-2#2)(1995-12#2)(1995-2#3)(1996-12#2)(1997-2#1)(1997-6#3)(2007-11#298)(2007-12#294)(2007-5#1)(2008-10#166)(2008-11#21)(2008-2#166)(2008-3#305)(2008-4#3)(2008-5#4)(2008-6#11)(2008-7#5)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#2)(2010-1#4)(2010-10#1)(2010-2#2)(2010-4#10)(2010-6#1)(2010-8#2)(2011-1#9)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#7)(2012-5#1)(2013-1#8)(2013-8#4)
fiber's##11##1##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#4)
fiber) and##2##2##(2008-10#2)
fiber)##4##1##(2008-10#3)(2011-1#1)
fiber-based optical##2##2##(2007-11#1)(2007-12#1)
fiber-based##13##1##(2007-11#4)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)
fiber-ceramic matrix composite material model##2##5##(2009-7#2)
fiber-coupled##12##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#7)
fiber-feedback OPO##2##2##(2007-11#2)
fiber-feedback##3##1##(2007-11#3)
fiber-grating##2##1##(2007-12#1)(2008-3#1)
fiber-in-tube liquid phase microextraction##2##4##(2008-10#2)
fiber-optic Bragg grating##2##3##(2008-3#2)
fiber-optic DNA biosensor##3##3##(2008-9#3)
fiber-optic DNA biosensors##2##3##(2008-9#2)
fiber-optic DNA##5##2##(2008-9#5)
fiber-optic Doppler imaging catheter for##2##5##(2007-12#2)
fiber-optic Raman##2##2##(2008-2#1)(2011-1#1)
fiber-optic beam delivery##3##3##(2008-2#1)(2008-3#2)
fiber-optic beam##4##2##(2008-2#2)(2008-3#2)
fiber-optic bragg grating sensors##2##4##(2008-2#1)(2008-3#1)
fiber-optic bundle##3##2##(2008-2#3)
fiber-optic communication##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
fiber-optic connector assemblies##2##3##(2008-3#2)
fiber-optic current sensor##2##3##(2008-3#2)
fiber-optic distributed temperature sensor##2##4##(2007-12#2)
fiber-optic gas-sensor array by##2##4##(2008-3#2)
fiber-optic gyroscope##2##2##(2007-12#2)
fiber-optic imaging##2##2##(2007-12#1)(2008-3#1)
fiber-optic immunosensor##2##2##(2008-10#2)
fiber-optic polarimetric##2##2##(2007-12#1)(2008-2#1)
fiber-optic probe##5##2##(2008-10#2)(2008-3#3)
fiber-optic probes##2##2##(2008-10#1)(2011-1#1)
fiber-optic quantum key distribution##2##4##(2007-11#2)
fiber-optic sensor based on##2##4##(2007-12#1)(2008-3#1)
fiber-optic sensor that##2##3##(2008-3#2)
fiber-optic sensor##11##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#7)
fiber-optic sensors##4##2##(2008-2#2)(2008-3#2)
fiber-optic soliton##2##2##(2007-12#2)
fiber-optic strain##2##2##(2007-12#1)(2008-2#1)
fiber-optic system##2##2##(2008-2#1)(2011-1#1)
fiber-optic trap##3##2##(2008-2#3)
fiber-optic##133##1##(2007-11#14)(2007-12#18)(2008-10#10)(2008-2#33)(2008-3#49)(2008-9#5)(2011-1#4)
fiber-optic-based surface plasmon resonance##2##4##(2008-10#2)
fiber-optic-based##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
fiber-ring laser##2##2##(2007-12#2)
fiber-ring##4##1##(2007-12#4)
fiber-to-fiber##2##1##(2008-10#2)
fiberglass##2##1##(2008-9#1)(2013-7#1)
fibermesh##3##1##(2008-11#3)
fiberoptic bronchoscopy##3##2##(1994-12#1)(2008-7#2)
fiberoptic light##2##2##(1990-8#1)(2011-2#1)
fiberoptic##14##1##(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#2)(1993-12#1)(1994-12#1)(2007-12#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)
fiberport collimator##2##2##(2008-10#2)
fibers and are##2##3##(2008-3#1)(2008-4#1)
fibers and in##3##3##(2007-12#1)(2009-9#1)(2012-2#1)
fibers and the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
fibers and was##2##3##(2008-10#1)(2008-3#1)
fibers and##40##2##(1991-12#1)(1992-3#1)(1994-8#1)(1997-2#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
fibers are discussed##3##3##(1991-1#1)(2007-11#1)(2013-1#1)
fibers are presented##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
fibers are reported##2##3##(2007-11#1)(2008-2#1)
fibers are##29##2##(1991-1#1)(1991-12#1)(1992-3#1)(1996-12#1)(2007-11#7)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2013-1#2)
fibers as a function of##2##5##(2007-11#2)
fibers as##7##2##(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#1)
fibers at##5##2##(2007-12#2)(2008-2#1)(2008-5#1)(2013-8#1)
fibers by the##3##3##(1991-2#2)(2007-11#1)
fibers by use of##3##4##(2007-11#2)(2008-3#1)
fibers by using##3##3##(2008-2#1)(2008-3#2)
fibers by##16##2##(1991-2#2)(2007-11#4)(2007-12#3)(2008-2#1)(2008-3#6)
fibers can be observed##2##4##(1990-5#1)(2007-12#1)
fibers can be##5##3##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#2)
fibers can##7##2##(1990-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
fibers causes a##2##3##(1990-7#1)(2008-3#1)
fibers due##2##2##(2008-2#1)(2010-1#1)
fibers for receiving (part##2##4##(2008-2#2)
fibers for##15##2##(1991-1#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#5)(2010-2#1)
fibers from the##6##3##(1991-12#1)(1993-12#1)(1993-9#1)(1996-12#1)(2007-12#1)(2008-3#1)
fibers from##10##2##(1991-12#3)(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
fibers have##2##2##(2008-10#1)(2008-3#1)
fibers in the contralateral ventral root##2##6##(1993-12#2)
fibers in the contralateral##4##4##(1993-12#4)
fibers in the presence of##2##5##(2007-11#1)(2007-12#1)
fibers in the##22##3##(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-12#8)(1996-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#1)
fibers in which##2##3##(2007-11#1)(2008-2#1)
fibers in##32##2##(1990-3#1)(1990-5#1)(1991-12#3)(1992-12#1)(1992-6#1)(1993-12#8)(1996-12#2)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-1#1)(2012-2#1)
fibers increased##2##2##(2008-3#1)(2009-9#1)
fibers innervating the##2##3##(1992-12#1)(2007-12#1)
fibers is described##2##3##(2008-10#1)(2008-3#1)
fibers is proposed##2##3##(2007-11#1)(2008-2#1)
fibers is##12##2##(1991-12#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2013-1#1)
fibers may##2##2##(1991-12#1)(2007-11#1)
fibers of passage##2##3##(1992-11#2)
fibers of the##4##3##(1990-5#1)(1994-6#1)(1997-3#1)(2007-12#1)
fibers of##13##2##(1990-5#2)(1992-11#2)(1994-6#2)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
fibers on the##2##3##(2007-11#1)(2008-2#1)
fibers on##6##2##(1991-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)
fibers or##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-1#1)
fibers subjected to##2##3##(2007-12#2)
fibers that are##3##3##(1991-1#1)(2007-12#1)(2008-2#1)
fibers that##10##2##(1991-1#1)(1996-5#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-9#1)
fibers to##13##2##(1995-12#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-2#3)(2008-3#3)
fibers was##8##2##(1992-3#1)(1996-5#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)
fibers were also observed in##2##5##(2008-5#1)(2008-7#1)
fibers were determined##2##3##(2007-11#1)(2008-2#1)
fibers were evaluated##2##3##(2008-10#1)(2009-11#1)
fibers were first##2##3##(2008-9#1)(2009-11#1)
fibers were seen in##3##4##(1991-12#3)
fibers were used##2##3##(2007-11#1)(2008-10#1)
fibers were##33##2##(1990-5#2)(1991-12#5)(1992-12#1)(1994-11#1)(1997-3#1)(2007-11#4)(2007-12#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#3)(2009-7#2)
fibers with a##4##3##(2007-11#3)(2007-12#1)
fibers with an##2##3##(2007-12#1)(2008-3#1)
fibers with diameters of##2##4##(2007-12#1)(2008-3#1)
fibers with high##4##3##(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
fibers with stress-induced birefringence##2##4##(2008-2#1)(2008-3#1)
fibers with##39##2##(1990-3#1)(1995-2#1)(2007-11#11)(2007-12#14)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2011-2#1)
fibers##624##1##(1990-12#1)(1990-3#2)(1990-5#7)(1990-7#3)(1991-1#3)(1991-12#26)(1991-2#3)(1991-3#1)(1991-9#1)(1992-11#3)(1992-12#8)(1992-3#5)(1992-6#5)(1993-12#10)(1993-5#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#2)(1995-2#6)(1995-6#1)(1996-12#7)(1996-5#5)(1997-2#3)(1997-3#6)(1997-4#2)(1997-7#1)(2006-12#3)(2007-11#99)(2007-12#95)(2007-8#1)(2008-10#37)(2008-11#3)(2008-2#65)(2008-3#101)(2008-4#3)(2008-5#9)(2008-6#8)(2008-7#4)(2008-8#2)(2008-9#7)(2009-11#6)(2009-7#13)(2009-8#1)(2009-9#4)(2010-1#5)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#8)(2013-8#2)
fibers&quot##2##1##(1991-12#2)
fibrate##3##1##(2006-10#1)(2008-1#1)(2008-5#1)
fibrates##6##1##(2008-6#1)(2011-1#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
fibre and##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
fibre diameter and##3##3##(2009-7#2)(2010-4#1)
fibre friction##3##2##(2008-5#3)
fibre in the##2##3##(1993-9#1)(2008-10#1)
fibre is##3##2##(1994-3#1)(1997-4#1)(2008-10#1)
fibre optic##3##2##(2008-10#3)
fibre orientation##2##2##(2009-7#2)
fibre type##5##2##(2008-10#1)(2011-2#4)
fibre types##4##2##(2008-10#1)(2011-2#3)
fibre##102##1##(1991-12#1)(1992-6#1)(1993-9#3)(1994-3#2)(1995-11#1)(1995-12#2)(1996-12#2)(1996-5#1)(1997-4#1)(1997-8#1)(2008-10#32)(2008-11#2)(2008-3#1)(2008-5#14)(2008-7#2)(2009-7#10)(2009-9#1)(2010-4#5)(2010-6#1)(2011-2#8)(2012-2#8)(2013-1#3)
fibre-optic probe for the##2##4##(2008-10#2)
fibre-optic probe##7##2##(2008-10#6)(2010-4#1)
fibre-optic##8##1##(2008-10#7)(2010-4#1)
fibreboard##3##1##(2008-10#3)
fibreoptic##2##1##(1995-10#1)(2007-8#1)
fibres and##3##2##(1995-5#1)(2008-5#1)(2012-3#1)
fibres are##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
fibres could##2##2##(1996-5#1)(2008-7#1)
fibres from the##2##3##(1996-5#1)(2009-7#1)
fibres in the##2##3##(1993-12#1)(1996-2#1)
fibres in##5##2##(1993-12#1)(1996-2#2)(1996-5#1)(2013-8#1)
fibres of##2##2##(1991-3#1)(2009-7#1)
fibres was##2##2##(1996-2#1)(1997-3#1)
fibres were affected most##2##4##(2011-2#2)
fibres were##9##2##(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#1)(2011-2#3)(2013-8#1)
fibres##72##1##(1991-12#1)(1991-3#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-5#2)(1996-2#4)(1996-5#4)(1997-3#6)(1997-4#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#8)(2008-7#9)(2008-9#1)(2009-7#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
fibril bundles##2##2##(2010-4#1)(2011-2#1)
fibril formation##6##2##(1992-8#1)(1994-8#1)(2010-11#3)(2012-2#1)
fibril##18##1##(1991-11#1)(1992-3#3)(1992-8#1)(1994-5#1)(1994-8#1)(2007-8#1)(2008-3#3)(2009-8#1)(2010-11#3)(2010-4#1)(2011-2#1)(2012-2#1)
fibrillar layer##2##2##(2008-5#2)
fibrillar material in##3##3##(1994-5#2)(2008-7#1)
fibrillar material##9##2##(1994-5#5)(2007-12#1)(2008-10#2)(2008-7#1)
fibrillar structures##2##2##(2008-5#1)(2010-10#1)
fibrillar##28##1##(1992-11#1)(1994-5#5)(1994-8#1)(1997-7#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-5#5)(2008-7#2)(2008-8#3)(2010-10#1)(2010-4#2)
fibrillary glomerulonephritis##2##2##(1993-2#2)
fibrillary##17##1##(1990-7#1)(1992-8#3)(1993-2#2)(1994-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-7#3)(2009-1#1)
fibrillation (AF)##8##2##(2007-8#4)(2010-12#1)(2012-12#2)(2012-3#1)
fibrillation and##12##2##(1994-11#1)(1995-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
fibrillation during occlusion##2##3##(1995-12#2)
fibrillation during##4##2##(1995-12#2)(2007-8#1)(2008-12#1)
fibrillation in##8##2##(1993-3#1)(1995-12#2)(2007-10#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
fibrillation induced by##2##3##(1996-3#1)(2011-2#1)
fibrillation is##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
fibrillation was##3##2##(1992-6#1)(2007-10#1)(2012-1#1)
fibrillation##100##1##(1990-12#2)(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#6)(1996-3#3)(1996-6#1)(1996-8#1)(1997-5#2)(1997-7#1)(2007-10#4)(2007-7#1)(2007-8#19)(2008-1#2)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
fibrillin##2##1##(2007-8#1)(2013-1#1)
fibrillin-1 gene##2##2##(1997-8#2)
fibrillin-1##4##1##(1997-8#2)(2012-2#1)(2013-1#1)
fibrillization##2##1##(2010-11#2)
fibrillogenesis##7##1##(1994-8#1)(1996-2#2)(2008-9#1)(2012-1#3)
fibrils and##3##2##(2008-1#1)(2010-4#1)(2012-1#1)
fibrils are##5##2##(1993-2#2)(1994-8#2)(2008-1#1)
fibrils in the##2##3##(1995-6#1)(1996-5#1)
fibrils in##3##2##(1995-6#1)(1996-5#1)(2008-7#1)
fibrils of the##2##3##(2008-5#2)
fibrils of##4##2##(1993-2#1)(2008-11#1)(2008-5#2)
fibrils were present##3##3##(1994-8#2)(2012-1#1)
fibrils were##6##2##(1992-6#1)(1994-8#3)(2008-6#1)(2012-1#1)
fibrils with##2##2##(1994-5#1)(2009-8#1)
fibrils##51##1##(1992-6#4)(1993-2#5)(1994-5#1)(1994-8#6)(1995-6#1)(1996-5#1)(2008-1#4)(2008-11#1)(2008-5#7)(2008-6#1)(2008-7#8)(2009-8#6)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)
fibrin and##2##2##(1994-3#2)
fibrin clot##2##2##(1994-5#1)(1995-6#1)
fibrin clots##2##2##(1994-5#1)(1995-12#1)
fibrin degradation##2##2##(2011-2#2)
fibrin deposition##2##2##(1994-3#2)
fibrin formation##2##2##(1991-9#1)(2010-12#1)
fibrin glue##6##2##(1992-3#1)(1992-5#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-9#1)
fibrin plate##2##2##(1994-5#1)(2010-3#1)
fibrin polymerization##3##2##(1994-9#1)(1995-3#1)(2011-2#1)
fibrin sealant##2##2##(1992-3#1)(2009-6#1)
fibrin stimulates prostacyclin production of human##2##6##(1994-9#2)
fibrin##51##1##(1991-9#2)(1992-3#2)(1992-5#1)(1994-3#4)(1994-5#5)(1994-9#5)(1995-12#2)(1995-3#1)(1995-6#2)(1997-2#1)(1997-4#1)(2006-12#1)(2007-8#2)(2008-11#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#9)(2012-1#2)(2012-3#1)
fibrinogen and##5##2##(1990-5#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-5#1)
fibrinogen binding##4##2##(1991-9#1)(1995-2#1)(2006-6#2)
fibrinogen by##3##2##(1993-11#1)(1997-2#1)(2008-10#1)
fibrinogen coated surface##2##3##(1997-7#2)
fibrinogen coated##3##2##(1997-7#3)
fibrinogen concentration##6##2##(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#2)
fibrinogen concentrations are##2##3##(1996-2#2)
fibrinogen concentrations##3##2##(1996-2#2)(2008-10#1)
fibrinogen measurement is##2##3##(2008-10#2)
fibrinogen measurement##6##2##(2008-10#6)
fibrinogen molecules##3##2##(1992-8#1)(1994-6#2)
fibrinogen receptor##10##2##(1993-8#5)(1997-7#1)(2006-6#4)
fibrinogen standard and##2##3##(2008-10#2)
fibrinogen standard##4##2##(2008-10#4)
fibrinogen to##4##2##(1995-2#2)(1997-2#1)(2006-6#1)
fibrinogen was##2##2##(2007-7#1)(2008-10#1)
fibrinogen##97##1##(1990-2#1)(1990-5#3)(1990-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#5)(1994-5#2)(1994-6#2)(1995-2#7)(1996-2#5)(1997-2#3)(1997-7#7)(2006-6#14)(2007-7#2)(2008-10#27)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2010-6#1)(2011-2#4)(2012-3#2)
fibrinogen-based collagen fleece##2##3##(2013-8#2)
fibrinogen-based collagen##3##2##(2013-8#3)
fibrinogenase##3##1##(1992-8#2)(1994-6#1)
fibrinogenolytic##2##1##(1994-5#1)(1994-6#1)
fibrinolysis and##3##2##(1991-3#1)(1996-6#1)(2007-12#1)
fibrinolysis in##2##2##(2008-7#2)
fibrinolysis with##2##2##(1991-3#1)(2008-7#1)
fibrinolysis##25##1##(1991-3#4)(1991-6#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-6#2)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-7#3)(2010-3#2)(2013-1#1)
fibrinolytic activity was##2##3##(2010-3#2)
fibrinolytic activity##9##2##(1990-5#1)(1993-12#1)(1994-5#3)(2010-3#4)
fibrinolytic enzyme component A##2##4##(2008-9#2)
fibrinolytic enzyme##3##2##(2008-9#3)
fibrinolytic system##5##2##(1993-12#1)(1994-3#1)(1997-1#3)
fibrinolytic therapy##3##2##(2007-5#2)(2013-1#1)
fibrinolytic##33##1##(1990-5#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-5#7)(1997-1#3)(2007-5#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-3#4)(2013-1#2)(2013-8#2)
fibrinopeptide A##2##2##(1997-2#1)(2008-3#1)
fibrinopeptide B##2##2##(1996-2#1)(1997-2#1)
fibrinopeptide##4##1##(1996-2#1)(1997-2#2)(2008-3#1)
fibrinopurulent inflammation##2##2##(1997-3#2)
fibrinopurulent##3##1##(1997-3#3)
fibrinous##2##1##(1997-3#2)
fibro-osseous lesions##4##2##(2007-12#3)(2013-7#1)
fibro-osseous##6##1##(2007-12#3)(2011-2#1)(2013-1#1)(2013-7#1)
fibroadenoma##13##1##(1990-10#1)(1990-12#1)(1992-2#1)(1992-9#1)(1994-7#5)(2007-11#1)(2007-7#1)(2008-10#1)(2012-1#1)
fibroadenomas##4##1##(1992-9#1)(1994-12#2)(1995-11#1)
fibroblast and keratinocyte cells##2##4##(2012-3#2)
fibroblast and keratinocyte##3##3##(2008-9#1)(2012-3#2)
fibroblast and##7##2##(1990-11#1)(1995-3#2)(2008-5#1)(2008-9#1)(2012-3#2)
fibroblast cell line##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
fibroblast cell lines##6##3##(1990-5#1)(1994-11#1)(2008-12#1)(2008-2#2)(2011-2#1)
fibroblast cell##15##2##(1990-5#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
fibroblast cells on##2##3##(2008-11#2)
fibroblast cells were##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
fibroblast cells##18##2##(1991-2#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-5#2)(2008-9#1)(2009-12#1)(2012-12#1)(2013-1#1)
fibroblast culture medium##2##3##(1990-11#1)(1993-3#1)
fibroblast cultures##3##2##(1990-3#1)(1990-8#1)(1997-4#1)
fibroblast glycosaminoglycan synthesis##2##3##(1992-9#2)
fibroblast glycosaminoglycan##3##2##(1992-9#3)
fibroblast growth factor (FGF)##2##4##(1991-2#1)(2008-11#1)
fibroblast growth factor (aFGF)##2##4##(1990-8#1)(1997-7#1)
fibroblast growth factor (bFGF) and##4##5##(1991-12#1)(1995-12#2)(2008-11#1)
fibroblast growth factor (bFGF)##10##4##(1991-12#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-12#3)(1997-6#1)(2008-11#1)(2008-5#1)
fibroblast growth factor and##3##4##(1990-7#1)(1997-6#1)(2008-7#1)
fibroblast growth factor is##2##4##(1994-6#1)(1995-12#1)
fibroblast growth factor receptor 3##2##5##(2008-3#2)
fibroblast growth factor receptor##3##4##(2007-12#1)(2008-3#2)
fibroblast growth factor##60##3##(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#5)(1992-3#2)(1992-9#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#4)(1995-11#2)(1995-12#9)(1996-12#1)(1996-5#1)(1997-6#2)(1997-7#2)(2007-12#1)(2008-11#7)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
fibroblast growth factor-2 (FGF-2)##2##4##(1997-4#1)(2008-11#1)
fibroblast growth factor-2##5##3##(1997-4#2)(2008-11#1)(2008-4#2)
fibroblast growth factors##3##3##(1990-12#1)(2008-7#2)
fibroblast growth##75##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#5)(1992-3#2)(1992-9#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#4)(1995-11#2)(1995-12#10)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#3)(1997-6#2)(1997-7#2)(2007-12#1)(2008-11#8)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
fibroblast proliferation##6##2##(1995-3#1)(1997-3#1)(2008-5#1)(2008-9#1)(2010-3#2)
fibroblast##159##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#3)(1991-12#3)(1991-2#6)(1991-9#1)(1992-3#2)(1992-9#6)(1993-3#1)(1993-6#3)(1994-11#3)(1994-12#2)(1994-6#4)(1994-8#1)(1995-11#5)(1995-12#10)(1995-3#4)(1995-6#1)(1996-12#2)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#2)(2007-12#1)(2008-10#3)(2008-11#16)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#12)(2008-7#4)(2008-8#3)(2008-9#6)(2009-12#1)(2009-8#3)(2010-3#3)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#8)(2013-8#1)
fibroblast-like cells##4##2##(2007-8#1)(2008-11#2)(2008-9#1)
fibroblast-like##13##1##(2007-8#1)(2008-11#6)(2008-9#2)(2010-3#1)(2012-1#1)(2013-8#2)
fibroblastic sarcoma##2##2##(2008-7#2)
fibroblastic##12##1##(1991-9#1)(1992-5#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-3#1)(2012-2#1)(2013-1#1)
fibroblastoid##4##1##(2008-11#1)(2012-1#2)(2013-1#1)
fibroblasts (MEFs)##2##2##(2008-2#1)(2011-2#1)
fibroblasts (line FLK)##2##3##(1995-8#1)(2008-11#1)
fibroblasts and peripheral blood lymphocytes##2##5##(1991-12#1)(2008-1#1)
fibroblasts and the##4##3##(1992-8#1)(2008-5#3)
fibroblasts and##30##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-6#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-5#7)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
fibroblasts are##5##2##(1990-3#1)(1990-5#1)(1992-8#1)(1993-11#1)(2009-4#1)
fibroblasts as##5##2##(1994-11#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-7#1)
fibroblasts at##2##2##(1994-6#1)(2013-1#1)
fibroblasts by##9##2##(1990-8#1)(1992-9#1)(1994-12#1)(1995-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#1)
fibroblasts constitutively##2##2##(1995-6#2)
fibroblasts exposed to##2##3##(2012-2#1)(2013-1#1)
fibroblasts from patients with metabolic disorders of peroxisomal origin##2##9##(1993-8#2)
fibroblasts from##15##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-5#1)(1991-7#1)(1993-3#1)(1993-8#2)(1994-11#2)(1995-11#1)(1995-8#1)(1996-7#2)(1997-7#1)
fibroblasts grown on perforated Si-membranes##2##5##(1995-11#2)
fibroblasts in response to##2##4##(1995-11#1)(2008-10#1)
fibroblasts in vitro##2##3##(1992-9#1)(1995-2#1)
fibroblasts in##12##2##(1992-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
fibroblasts induced to die by##2##5##(1994-8#2)
fibroblasts is##3##2##(1990-3#1)(1991-6#1)(1995-8#1)
fibroblasts or##2##2##(2008-1#1)(2013-1#1)
fibroblasts than##2##2##(1990-3#1)(1991-5#1)
fibroblasts that##2##2##(1991-2#1)(2008-4#1)
fibroblasts to##5##2##(1990-9#1)(1995-8#1)(2008-2#1)(2012-2#1)(2012-3#1)
fibroblasts treated with##3##3##(2008-10#1)(2008-9#2)
fibroblasts was##5##2##(1990-3#1)(1990-8#1)(1992-11#1)(1993-6#1)(1993-9#1)
fibroblasts were treated with##3##4##(1997-6#1)(2008-5#1)(2012-2#1)
fibroblasts were##11##2##(1992-11#1)(1992-12#1)(1995-8#1)(1997-6#1)(2008-5#3)(2008-7#1)(2012-2#1)(2013-1#2)
fibroblasts with##7##2##(1990-5#1)(1992-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-11#1)(2013-1#1)
fibroblasts without##2##2##(1990-2#1)(1997-7#1)
fibroblasts##291##1##(1990-12#2)(1990-2#5)(1990-3#8)(1990-5#8)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#6)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#9)(1992-9#5)(1993-11#3)(1993-12#3)(1993-3#2)(1993-6#3)(1993-8#6)(1993-9#6)(1994-11#10)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#2)(1995-11#6)(1995-12#6)(1995-2#7)(1995-3#4)(1995-6#5)(1995-8#10)(1996-12#1)(1996-7#2)(1997-1#4)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#9)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#12)(2008-12#1)(2008-2#4)(2008-4#3)(2008-5#25)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-4#1)(2009-8#3)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#18)(2013-8#3)
fibrocartilage##3##1##(2008-9#1)(2009-7#2)
fibrocytes##3##1##(1990-11#1)(2008-9#2)
fibrocytic cells##2##2##(2008-7#2)
fibroepithelial polyp##3##2##(2008-11#1)(2009-5#2)
fibrogenesis and##2##2##(2008-9#2)
fibrogenesis##6##1##(1994-6#1)(2006-10#1)(2008-9#4)
fibrohistiocytic tumor##3##2##(2007-8#3)
fibroid##3##1##(2011-1#1)(2013-8#2)
fibroids##10##1##(1991-8#1)(1993-12#3)(1994-2#3)(1994-9#1)(2010-11#1)(2011-1#1)
fibroin membranes##2##2##(2012-8#2)
fibroin##11##1##(2008-11#2)(2008-5#2)(2008-9#1)(2012-2#1)(2012-8#5)
fibroma of the##3##3##(1994-2#1)(2008-7#1)(2013-7#1)
fibroma##17##1##(1994-2#1)(2007-12#2)(2008-7#2)(2009-1#2)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#4)
fibromas##5##1##(1997-3#1)(2007-12#2)(2010-12#1)(2011-2#1)
fibromatoses##2##1##(1994-5#1)(2008-6#1)
fibromatosis and##2##2##(2007-8#1)(2008-6#1)
fibromatosis in childhood##2##3##(2007-5#2)
fibromatosis in##3##2##(1990-6#1)(2007-5#2)
fibromatosis is a rare##2##4##(1994-5#1)(2012-3#1)
fibromatosis with##3##2##(1990-6#1)(2011-2#2)
fibromatosis##27##1##(1990-6#2)(1994-5#2)(1997-7#3)(2007-12#2)(2007-5#2)(2007-8#1)(2008-6#9)(2011-2#3)(2012-3#3)
fibromuscular dysplasia##2##2##(1990-2#1)(1991-8#1)
fibromuscular##5##1##(1990-2#2)(1990-7#1)(1991-8#1)(2008-7#1)
fibromyalgia syndrome##4##2##(1990-6#1)(1997-8#1)(2009-11#1)(2010-12#1)
fibromyalgia##18##1##(1990-6#1)(1994-1#1)(1997-6#2)(1997-8#2)(2006-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#2)
fibronectin (FN)##6##2##(1990-8#1)(1993-9#1)(1994-11#1)(2010-4#1)(2012-2#1)(2012-5#1)
fibronectin and##5##2##(1992-9#1)(2008-11#3)(2008-7#1)
fibronectin by##2##2##(1990-7#1)(2007-11#1)
fibronectin expression##2##2##(1994-9#1)(2010-11#1)
fibronectin in##5##2##(1990-7#1)(1993-8#1)(2008-7#2)(2012-2#1)
fibronectin into##2##2##(2008-1#2)
fibronectin matrix##4##2##(2008-1#4)
fibronectin or matrigel##2##3##(2008-11#2)
fibronectin or##4##2##(2008-11#4)
fibronectin protein##2##2##(2011-2#2)
fibronectin receptor##2##2##(1992-12#1)(1993-9#1)
fibronectin type III##2##3##(1992-12#1)(1993-8#1)
fibronectin values and##2##3##(2008-7#2)
fibronectin was##2##2##(2008-7#1)(2010-1#1)
fibronectin##86##1##(1990-12#1)(1990-5#1)(1990-7#7)(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-8#7)(1993-9#2)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#3)(2007-11#1)(2008-1#9)(2008-11#15)(2008-4#1)(2008-7#7)(2010-1#1)(2010-11#4)(2010-4#1)(2011-2#5)(2012-1#3)(2012-2#2)(2012-5#1)
fibronectin-##2##1##(2008-11#2)
fibronectin-coated dishes was about##2##4##(2008-11#2)
fibronectin-coated dishes##3##2##(2008-11#3)
fibronectin-degrading##2##1##(1994-5#2)
fibroproliferative disorders##2##2##(2008-9#2)
fibrosarcoma cell line##2##3##(1994-11#1)(2008-11#1)
fibrosarcoma##15##1##(1991-8#1)(1992-5#1)(1992-8#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
fibrosarcoma)##2##1##(1992-5#1)(2008-6#1)
fibrosclerotic##2##1##(2008-5#2)
fibrosing mediastinitis##2##2##(2007-8#2)
fibrosing##3##1##(1997-8#1)(2007-8#2)
fibrosis (CF) is##2##3##(1997-1#1)(2013-1#1)
fibrosis (CF)##9##2##(1990-3#1)(1990-8#1)(1997-1#2)(2007-12#1)(2008-5#1)(2011-3#2)(2013-1#1)
fibrosis (n =##2##3##(1994-3#2)
fibrosis and##30##2##(1991-12#2)(1993-11#1)(1994-5#1)(1994-9#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-9#4)(2009-11#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
fibrosis as##4##2##(1991-1#1)(2012-1#1)(2013-1#2)
fibrosis associated with##3##3##(2006-10#1)(2008-1#2)
fibrosis from##4##2##(2008-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
fibrosis has##2##2##(2007-6#1)(2009-8#1)
fibrosis in the##3##3##(1993-2#1)(2008-6#1)(2008-9#1)
fibrosis in##18##2##(1993-2#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-1#3)(2013-1#3)(2013-8#2)
fibrosis is##8##2##(1991-12#2)(2008-1#1)(2010-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
fibrosis may##2##2##(1991-9#1)(2011-2#1)
fibrosis of the##7##3##(2008-5#1)(2008-9#2)(2009-7#1)(2011-1#1)(2013-1#2)
fibrosis of##8##2##(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-1#1)(2013-1#2)
fibrosis was##3##2##(1994-2#2)(2013-8#1)
fibrosis with##3##2##(2006-10#1)(2007-8#1)(2010-5#1)
fibrosis##220##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#9)(1991-2#4)(1991-3#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#5)(1994-9#1)(1995-8#1)(1995-9#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-3#4)(1997-5#1)(1997-8#1)(2006-10#7)(2007-11#2)(2007-12#1)(2007-6#3)(2007-7#1)(2007-8#8)(2008-1#6)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#10)(2010-12#2)(2010-3#1)(2010-5#5)(2011-1#4)(2011-2#11)(2011-3#7)(2012-1#7)(2012-12#11)(2012-2#4)(2012-3#5)(2013-1#20)(2013-7#1)(2013-8#12)
fibrosis]##6##1##(1990-3#1)(1991-2#1)(1994-2#1)(2007-6#1)(2008-1#1)(2013-1#1)
fibrositis##2##1##(1991-6#1)(1993-11#1)
fibrostenotic Crohn's disease##4##3##(2010-12#4)
fibrostenotic##6##1##(2010-12#6)
fibrosus##4##1##(2009-1#1)(2009-3#1)(2012-2#2)
fibrotic changes##2##2##(2008-1#2)
fibrotic##15##1##(2007-8#1)(2008-1#3)(2008-11#3)(2008-5#1)(2008-9#2)(2009-8#2)(2010-11#1)(2011-2#1)(2012-12#1)
fibrous and##2##2##(2008-12#1)(2011-2#1)
fibrous bands##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
fibrous dysplasia of the##2##4##(2008-8#1)(2013-1#1)
fibrous dysplasia with aneurysmal bone cyst##2##6##(2013-1#2)
fibrous dysplasia##11##2##(2006-10#1)(2007-11#1)(2007-12#2)(2008-8#1)(2010-12#1)(2010-3#1)(2013-1#4)
fibrous histiocytoma (MFH)##3##3##(1990-8#1)(2008-6#1)(2012-1#1)
fibrous histiocytoma##15##2##(1990-12#3)(1990-8#2)(2008-11#1)(2008-6#7)(2010-12#1)(2012-1#1)
fibrous layer##2##2##(1997-3#1)(2007-11#1)
fibrous matrix##7##2##(2008-11#7)
fibrous network##2##2##(2008-7#2)
fibrous proteins##2##2##(2008-6#2)
fibrous roots##2##2##(2008-10#2)
fibrous stroma##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
fibrous structure##2##2##(2008-3#1)(2008-7#1)
fibrous tissue##8##2##(1990-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)
fibrous tremolite##3##2##(1991-12#3)
fibrous tumor (SFT) of the pleura##2##6##(2007-5#1)(2007-8#1)
fibrous tumor##3##2##(2007-5#2)(2007-8#1)
fibrous tumors##2##2##(2007-8#1)(2012-2#1)
fibrous tumour of the pleura##2##5##(2011-1#2)
fibrous tumour of##3##3##(2011-1#3)
fibrous##100##1##(1990-12#3)(1990-3#1)(1990-8#2)(1991-12#3)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-5#2)(2007-8#3)(2008-10#5)(2008-11#15)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#9)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#4)(2010-3#3)(2010-5#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#9)
fibrovascular##2##1##(2008-1#1)(2010-6#1)
fibula##6##1##(2008-4#1)(2008-8#1)(2009-1#1)(2010-3#1)(2012-2#1)(2013-1#1)
fibular (peroneal) nerve##2##3##(2012-3#2)
fibular graft##2##2##(2008-6#1)(2010-6#1)
fibular nerve##3##2##(1997-8#1)(2012-3#2)
fibular##9##1##(1997-8#1)(2008-6#2)(2009-1#1)(2010-6#1)(2012-3#4)
fiction##3##1##(1990-2#1)(2009-11#1)(2010-5#1)
fictitious##2##1##(1991-1#1)(1996-5#1)
fictive##2##1##(1993-12#1)(2008-2#1)
fideistic##3##1##(2013-1#3)
fidelity and##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
fidelity during##2##2##(2012-2#1)(2013-1#1)
fidelity in the##2##3##(1995-6#1)(2008-3#1)
fidelity in##4##2##(1994-8#1)(1995-6#1)(2007-12#1)(2008-3#1)
fidelity of the##2##3##(2007-12#1)(2008-3#1)
fidelity of##12##2##(2007-12#1)(2008-10#1)(2008-3#6)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
fidelity to##2##2##(2008-4#1)(2013-1#1)
fidelity##50##1##(1993-11#1)(1994-8#1)(1995-6#2)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
field (0##2##2##(2009-11#2)
field (4##2##2##(1996-2#1)(2008-3#1)
field -##2##2##(2008-11#1)(2009-12#1)
field EPSP and##2##3##(1991-12#1)(1995-12#1)
field EPSP##3##2##(1991-12#1)(1995-12#1)(1996-5#1)
field above##2##2##(2008-3#2)
field after##3##2##(2008-10#2)(2008-11#1)
field along the##2##3##(2007-10#1)(2009-11#1)
field analysis of BTEX in##2##5##(2008-10#2)
field analysis of##3##3##(2008-10#3)
field analysis##9##2##(1995-3#1)(2008-10#4)(2009-3#2)(2010-12#1)(2011-2#1)
field and a##6##3##(2007-11#3)(2007-12#3)
field and for##2##3##(2008-10#1)(2008-2#1)
field and greenhouse experiments##2##4##(2008-10#1)(2008-8#1)
field and greenhouse##6##3##(2008-10#5)(2008-8#1)
field and growth-chamber##2##3##(2008-10#2)
field and of##2##3##(2008-10#1)(2008-2#1)
field and the##8##3##(1994-1#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
field and to the##2##4##(1997-1#1)(2007-12#1)
field and##75##2##(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#25)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
field applied to the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
field applied##6##2##(1990-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
field are the##2##3##(2008-4#1)(2010-8#1)
field are##15##2##(1992-3#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
field around the##2##3##(2008-3#1)(2012-12#1)
field around##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
field as a function of##2##5##(2007-11#1)(2007-12#1)
field as a##6##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-10#1)
field as well as##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
field as##12##2##(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-7#1)
field associated with##2##3##(2007-12#2)
field at a##2##3##(1995-11#1)(2008-10#1)
field at the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
field at##12##2##(1990-4#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)
field autocorrelation function##2##3##(2008-3#2)
field autocorrelation##3##2##(2008-3#3)
field based on##2##3##(2008-2#1)(2012-12#1)
field beans##2##2##(2012-2#2)
field being##2##2##(2008-3#1)(2008-7#1)
field by a##2##3##(2007-12#1)(2008-3#1)
field by##11##2##(1994-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-12#1)(2010-8#1)
field calculations##2##2##(2008-2#1)(2010-12#1)
field campaign##2##2##(2008-3#2)
field campaigns##2##2##(2008-3#2)
field can be used##2##4##(2007-11#1)(2008-3#1)
field can be##12##3##(2007-11#5)(2007-12#2)(2008-2#1)(2008-3#4)
field can##14##2##(2007-11#5)(2007-12#2)(2008-2#1)(2008-3#4)(2008-9#2)
field collections of Hessian fly##2##5##(2011-2#2)
field collections of##3##3##(2008-10#1)(2011-2#2)
field collections##5##2##(2008-10#1)(2010-2#1)(2011-2#3)
field component##2##2##(2007-11#1)(2008-3#1)
field components##2##2##(2007-11#1)(2007-12#1)
field conditions and##4##3##(2008-10#3)(2008-5#1)
field conditions at##4##3##(2008-10#4)
field conditions in##4##3##(2008-10#4)
field conditions##50##2##(1997-6#1)(2008-10#41)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-8#2)
field correlations##2##2##(2008-3#2)
field created by##2##3##(2008-10#1)(2008-2#1)
field curvature##2##2##(2008-3#2)
field data from##2##3##(1994-8#1)(2008-10#1)
field data with##2##3##(2008-10#1)(2008-3#1)
field data##20##2##(1994-8#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-3#5)(2008-8#2)(2008-9#1)
field densities##2##2##(2008-10#1)(2011-2#1)
field dependence##2##2##(1997-7#1)(2012-2#1)
field deployment##2##2##(2008-3#1)(2011-1#1)
field depolarization##3##2##(1993-12#3)
field depth##2##2##(2008-3#2)
field detection##2##2##(2008-10#1)(2010-4#1)
field direction##3##2##(2008-3#2)(2013-8#1)
field distribution in##3##3##(2007-12#1)(2008-3#2)
field distribution of the##2##4##(2007-12#2)
field distribution of##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
field distribution##16##2##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#8)
field distributions of the##2##4##(2007-12#1)(2008-2#1)
field distributions##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
field during##3##2##(1990-12#1)(2008-3#1)(2008-9#1)
field effect on##2##3##(2008-10#2)
field effect transistor (FET)##2##4##(2008-10#1)(2009-6#1)
field effect transistor (ISFET)##2##4##(2008-10#2)
field effect transistor##8##3##(2008-10#7)(2009-6#1)
field effect##14##2##(2008-1#1)(2008-10#10)(2009-6#3)
field effects##2##2##(2008-10#2)
field emission scanning electron microscopy##2##5##(2008-10#1)(2011-2#1)
field emission scanning##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
field emission##4##2##(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
field enhancement##4##2##(2007-11#2)(2007-12#1)(2009-12#1)
field environment##4##2##(2008-10#3)(2008-3#1)
field environments##2##2##(2008-10#2)
field epidemic##3##2##(2008-10#3)
field excitatory postsynaptic potentials##2##4##(1995-12#1)(1996-5#1)
field excitatory##3##2##(1995-12#2)(1996-5#1)
field experience##3##2##(1996-1#1)(2007-7#1)(2008-1#1)
field experiences##2##2##(1996-1#2)
field experiment##31##2##(1993-6#2)(1994-2#1)(2008-10#18)(2008-12#2)(2008-3#1)(2008-8#5)(2008-9#2)
field experiments conducted in##2##4##(2008-10#2)
field experiments conducted##5##3##(2008-10#5)
field experiments from##3##3##(2008-10#3)
field experiments in which##2##4##(2008-10#1)(2008-9#1)
field experiments in##4##3##(2008-10#3)(2008-9#1)
field experiments on##2##3##(2008-10#1)(2008-8#1)
field experiments showed##2##3##(2008-10#1)(2008-9#1)
field experiments that##2##3##(2008-9#2)
field experiments were conducted in##2##5##(2008-10#2)
field experiments were conducted to study the##3##7##(2008-10#3)
field experiments were conducted to##4##5##(2008-10#4)
field experiments were conducted##7##4##(2008-10#6)(2008-12#1)
field experiments with##3##3##(2008-10#2)(2012-2#1)
field experiments##62##2##(2008-10#45)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#4)(2008-9#6)(2010-8#1)(2012-2#1)
field exposure##3##2##(1992-3#1)(1992-4#1)(2008-2#1)
field flow preconcentration system##2##4##(2008-10#2)
field for 5##2##3##(1992-11#1)(2008-10#1)
field for a##3##3##(2007-11#1)(2008-12#1)(2010-12#1)
field for##22##2##(1992-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)
field formulation##2##2##(2008-2#2)
field from the##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
field from##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
field galls##2##2##(2008-10#2)
field gel electrophoresis (PFGE)##2##4##(1992-6#1)(2008-10#1)
field gel electrophoresis##11##3##(1991-9#1)(1992-6#1)(1995-8#1)(2008-10#3)(2012-3#5)
field gradients##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
field grown##2##2##(2008-10#1)(2011-2#1)
field has been##3##3##(1993-12#1)(2008-3#1)(2008-4#1)
field has##9##2##(1993-12#2)(1994-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-8#1)(2011-2#1)
field have##5##2##(1997-4#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-7#1)
field hospital##3##2##(1992-6#3)
field in a##10##3##(1992-6#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
field in the focal##2##4##(2008-3#2)
field in the future##2##4##(2010-8#1)(2013-8#1)
field in the##15##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#2)
field in which##2##3##(2007-11#1)(2008-10#1)
field in##49##2##(1990-2#1)(1992-6#1)(2007-11#3)(2007-12#6)(2008-10#12)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-8#3)
field induced##2##2##(1997-6#1)(2008-8#1)
field inside##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
field intensity##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
field into##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
field is critical##2##3##(2008-10#2)
field is in##3##3##(2007-2#1)(2008-3#1)(2008-8#1)
field is presented##3##3##(1997-7#1)(2008-11#1)(2008-8#1)
field is##50##2##(1990-11#1)(1992-9#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#9)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
field isolate##5##2##(1994-8#1)(2007-6#1)(2008-10#3)
field isolates of##4##3##(2007-6#1)(2008-10#2)(2008-12#1)
field isolates were##3##3##(2008-10#3)
field isolates##23##2##(1996-12#1)(2007-6#4)(2008-10#15)(2008-12#1)(2011-1#2)
field level##3##2##(2008-10#1)(2009-5#1)(2011-10#1)
field locations in##2##3##(2008-10#1)(2011-2#1)
field locations##9##2##(2008-10#6)(2008-11#1)(2011-2#2)
field makes##2##2##(1994-1#1)(2008-9#1)
field management##2##2##(2008-12#2)
field material##2##2##(2008-10#1)(2013-7#1)
field may##2##2##(2007-10#1)(2010-2#1)
field measurement##2##2##(2008-3#2)
field measurements##12##2##(2008-10#2)(2008-2#1)(2008-3#8)(2010-5#1)
field method for##2##3##(2008-10#2)
field method##6##2##(2008-10#4)(2013-1#2)
field monitoring##3##2##(2008-10#3)
field notes##2##2##(2010-3#1)(2012-2#1)
field observations of##2##3##(2007-12#1)(2008-9#1)
field observations##9##2##(2007-12#1)(2008-10#4)(2008-8#2)(2008-9#2)
field of 10##2##3##(1996-2#1)(2008-10#1)
field of a##12##3##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#3)(2013-8#1)
field of an##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
field of application##2##3##(2008-5#1)(2008-7#1)
field of biocatalysis##2##3##(2008-7#1)(2011-1#1)
field of biology##2##3##(2008-7#1)(2009-6#1)
field of flow##2##3##(2008-10#2)
field of human##2##3##(2008-2#1)(2013-1#1)
field of interest##3##3##(2008-10#2)(2008-7#1)
field of investigation##2##3##(2010-2#1)(2013-1#1)
field of laboratory##2##3##(1994-12#1)(2008-10#1)
field of medical##3##3##(2009-11#1)(2010-8#1)(2013-8#1)
field of nanotechnology##2##3##(2008-7#1)(2010-5#1)
field of percutaneous##2##3##(2009-4#1)(2013-8#1)
field of plant##3##3##(2009-6#1)(2009-8#1)(2012-1#1)
field of research##4##3##(1994-9#1)(2008-5#1)(2008-7#1)(2010-11#1)
field of science##3##3##(2008-11#1)(2009-3#1)(2011-2#1)
field of selenium##2##3##(2008-10#1)(2010-11#1)
field of social##3##3##(1995-5#1)(2008-11#1)(2010-10#1)
field of study##5##3##(1997-2#1)(1997-7#1)(2008-11#1)(2008-9#1)(2010-10#1)
field of the##17##3##(1997-3#3)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-5#1)(2013-8#1)
field of view (FOV)##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
field of view and##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
field of view is##5##4##(2007-11#1)(2008-3#4)
field of view of##9##4##(2007-11#2)(2008-2#2)(2008-3#4)(2009-8#1)
field of view##56##3##(1994-5#1)(2007-11#5)(2007-12#2)(2008-2#9)(2008-3#30)(2008-6#3)(2008-7#1)(2008-9#2)(2009-8#2)(2010-12#1)
field of view)##2##3##(2007-11#2)
field of##368##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-6#4)(1991-8#1)(1992-1#3)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-9#3)(1995-1#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#3)(2007-10#2)(2007-11#17)(2007-12#15)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#9)(2008-12#9)(2008-2#18)(2008-3#47)(2008-4#5)(2008-5#13)(2008-6#5)(2008-7#16)(2008-8#3)(2008-9#11)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#5)(2010-10#5)(2010-11#4)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#4)(2013-1#4)(2013-8#15)
field on the##3##3##(2008-10#2)(2008-8#1)
field on##12##2##(2007-11#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-8#2)(2012-1#2)
field or plot-level disease severity)##2##5##(2008-10#2)
field or plot-level disease##3##4##(2008-10#3)
field or##7##2##(2008-10#6)(2008-5#1)
field over##2##2##(2007-11#1)(2008-2#1)
field performance of##2##3##(2008-10#2)
field performance##3##2##(2008-10#3)
field placement##2##2##(1997-2#1)(2007-10#1)
field plants##2##2##(2008-10#2)
field plot in##2##3##(2008-10#2)
field plot##5##2##(2008-10#5)
field plots in##5##3##(2008-10#5)
field plots were inoculated with##2##5##(2008-10#2)
field plots with##2##3##(2008-10#2)
field plots##24##2##(2008-10#23)(2008-9#1)
field poling##2##2##(2007-12#1)(2008-3#1)
field population of##2##3##(2008-10#1)(2008-12#1)
field population##9##2##(1995-12#1)(2008-10#4)(2008-12#1)(2011-2#3)
field populations of the##2##4##(2008-10#1)(2008-9#1)
field populations of##12##3##(2008-10#10)(2008-9#1)(2011-2#1)
field populations was##2##3##(2008-10#2)
field populations were##2##3##(2008-10#2)
field populations##30##2##(2008-10#26)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
field portable##3##2##(2008-10#3)
field potential##4##2##(1990-5#1)(1993-12#1)(1994-8#1)(1995-12#1)
field potentials##7##2##(1993-12#1)(1995-12#2)(2008-11#2)(2008-7#2)
field produced by##4##3##(1995-12#1)(2008-12#1)(2008-3#2)
field produced##5##2##(1995-12#1)(2008-12#1)(2008-3#3)
field profiles##2##2##(2007-12#1)(2008-8#1)
field resistance in##4##3##(2008-10#4)
field resistance to##3##3##(2008-10#3)
field resistance##15##2##(2008-10#15)
field resistant isolates##2##3##(2008-10#2)
field resistant##4##2##(2008-10#4)
field results##6##2##(2007-11#1)(2008-10#4)(2009-11#1)
field samples and##2##3##(2008-10#1)(2010-2#1)
field samples by##2##3##(2008-10#1)(2012-12#1)
field samples##14##2##(1994-8#1)(2008-10#10)(2010-2#1)(2012-12#1)(2013-7#1)
field sampling##2##2##(2007-12#1)(2008-5#1)
field scale##4##2##(2008-10#3)(2011-2#1)
field screening of##3##3##(2008-10#2)(2008-2#1)
field season##2##2##(2008-10#2)
field seasons##3##2##(2008-10#3)
field setting##2##2##(2008-10#1)(2011-2#1)
field sites in##3##3##(2008-10#2)(2011-2#1)
field sites##11##2##(2008-10#8)(2011-2#1)(2012-2#1)(2013-8#1)
field situations##2##2##(1990-9#1)(1993-12#1)
field size##6##2##(1992-10#2)(1993-9#1)(2008-3#2)(2011-1#1)
field sizes at##2##3##(2007-4#1)(2008-3#1)
field sizes##8##2##(1993-9#1)(2007-4#1)(2008-3#6)
field soil samples##2##3##(2008-10#2)
field soil that was##2##4##(2008-10#2)
field soil was##2##3##(2008-10#2)
field soil with##2##3##(2008-10#2)
field soil##20##2##(2008-10#20)
field soils##4##2##(2008-10#4)
field speciation of##2##3##(2008-10#2)
field stimulation##4##2##(1990-5#1)(1995-12#1)(1996-5#1)(1997-4#1)
field strain##4##2##(2011-2#4)
field strains##2##2##(2008-10#1)(2011-2#1)
field strength and##5##3##(1990-5#1)(2007-12#1)(2008-10#2)(2008-3#1)
field strength of##6##3##(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#3)
field strength##22##2##(1990-5#1)(1992-3#1)(1995-11#1)(1996-12#2)(1997-7#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#3)(2010-9#1)
field strengths##4##2##(1997-6#1)(2008-3#1)(2008-7#1)(2010-8#1)
field stress##2##2##(2008-3#2)
field structure##2##2##(2007-11#1)(2008-3#1)
field structures##2##2##(2008-3#1)(2012-2#1)
field studies in##2##3##(2008-10#2)
field studies with##2##3##(2008-10#1)(2008-8#1)
field studies##20##2##(1994-3#1)(2007-1#1)(2007-2#1)(2008-10#14)(2008-8#1)(2009-7#1)(2013-8#1)
field study of the##2##4##(2008-9#1)(2010-1#1)
field study of##3##3##(2008-9#2)(2010-1#1)
field study##18##2##(2008-10#9)(2008-12#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
field surrounding##3##2##(2008-11#1)(2008-3#1)(2009-7#1)
field survey##3##2##(1994-2#1)(2008-10#1)(2008-12#1)
field surveys and##2##3##(2008-10#1)(2013-7#1)
field surveys##3##2##(1992-11#1)(2008-10#1)(2013-7#1)
field technique##2##2##(2008-10#1)(2009-2#1)
field test##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
field testing##5##2##(1993-3#1)(2008-10#2)(2008-12#2)
field tests##9##2##(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2011-8#1)
field that is##4##3##(2008-2#2)(2008-3#2)
field that was##3##3##(2007-11#1)(2007-12#2)
field that##18##2##(1993-1#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2010-5#1)
field the##5##2##(2008-10#1)(2008-2#1)(2011-2#2)(2012-1#1)
field through##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
field to be##2##3##(2007-11#2)
field to the##7##3##(2007-12#2)(2008-2#2)(2008-3#3)
field to##28##2##(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
field transmission##2##2##(2008-10#1)(2008-9#1)
field trial##9##2##(1990-6#1)(1996-12#1)(2008-10#6)(2010-10#1)
field trials conducted in##3##4##(2008-10#3)
field trials in##4##3##(1993-3#1)(2008-10#3)
field trials planted##2##3##(2008-10#2)
field trials with##2##3##(2008-10#2)
field trials##35##2##(1993-3#1)(1994-2#1)(2008-10#29)(2008-12#1)(2008-4#1)(2010-10#1)(2011-2#1)
field under##2##2##(2008-10#1)(2008-12#1)
field use##2##2##(1997-7#1)(2013-1#1)
field using##2##2##(1995-8#1)(2010-6#1)
field was##18##2##(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-3#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
field were##10##2##(1994-12#1)(2008-10#6)(2008-5#1)(2011-2#1)(2013-1#1)
field when##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
field where##3##2##(2008-10#2)(2008-7#1)
field which##4##2##(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
field with a##3##3##(1995-12#1)(2008-10#1)(2012-12#1)
field with an##2##3##(1996-6#1)(2007-8#1)
field with##17##2##(1995-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-3#1)
field within the##3##3##(1990-7#1)(2008-2#1)(2009-7#1)
field within##4##2##(1990-7#1)(2008-12#1)(2008-2#1)(2009-7#1)
field work##4##2##(1994-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
field##2400##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#6)(1992-9#2)(1993-1#3)(1993-12#10)(1993-2#3)(1993-3#9)(1993-5#1)(1993-6#3)(1993-9#2)(1994-1#5)(1994-12#6)(1994-2#12)(1994-3#10)(1994-5#2)(1994-8#5)(1994-9#3)(1995-1#6)(1995-11#4)(1995-12#11)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#4)(1996-12#10)(1996-2#17)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#9)(1997-4#3)(1997-6#6)(1997-7#11)(1997-8#2)(2006-10#6)(2006-7#1)(2007-1#1)(2007-10#11)(2007-11#97)(2007-12#116)(2007-2#3)(2007-4#6)(2007-5#2)(2007-6#5)(2007-7#3)(2007-8#6)(2008-1#14)(2008-10#764)(2008-11#41)(2008-12#47)(2008-2#104)(2008-3#269)(2008-4#12)(2008-5#33)(2008-6#14)(2008-7#42)(2008-8#50)(2008-9#64)(2009-10#10)(2009-11#12)(2009-12#9)(2009-2#7)(2009-3#6)(2009-4#5)(2009-5#16)(2009-6#8)(2009-7#7)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#9)(2010-11#8)(2010-12#15)(2010-2#10)(2010-3#1)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#10)(2010-8#18)(2010-9#3)(2011-1#20)(2011-10#2)(2011-2#81)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#13)(2012-12#24)(2012-2#34)(2012-3#18)(2012-8#2)(2013-1#21)(2013-7#5)(2013-8#28)
field)##10##1##(1995-3#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)
field-based##5##1##(1993-3#1)(2008-1#1)(2008-10#2)(2010-8#1)
field-collected##7##1##(2008-10#6)(2011-2#1)
field-dependent absorption coefficient##2##3##(2008-3#2)
field-deployable##2##1##(2008-10#2)
field-effect transistor##8##2##(1991-5#2)(1995-8#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-5#1)
field-effect transistors (ISFETs)##2##3##(2008-10#2)
field-effect transistors##9##2##(2008-10#7)(2008-7#2)
field-effect##19##1##(1991-5#2)(1995-8#1)(2007-11#3)(2008-10#8)(2008-7#3)(2009-5#2)
field-emission scanning electron microscopy##2##4##(2008-10#2)
field-emission##3##1##(2008-10#2)(2008-7#1)
field-enhanced##2##1##(2007-12#2)
field-flow fractionation##9##2##(2008-10#7)(2011-2#2)
field-grown plants##2##2##(1994-11#1)(2008-10#1)
field-grown potato crops##2##3##(2008-10#2)
field-grown##11##1##(1994-11#1)(2008-10#10)
field-laboratory##2##1##(2008-10#2)
field-of-view##2##1##(2008-3#2)
field-programmable gate arrays##3##3##(2008-2#1)(2008-3#2)
field-programmable gate##4##2##(2008-2#1)(2008-3#2)(2009-3#1)
field-programmable##6##1##(2008-2#2)(2008-3#3)(2009-3#1)
field-test kits##2##2##(2008-10#2)
field-test##3##1##(1995-2#1)(2008-10#2)
field-tested##4##1##(1992-3#1)(1993-1#1)(2008-10#1)(2012-3#1)
fieldable##2##1##(2008-10#1)(2008-2#1)
fields a##2##2##(1991-6#1)(2008-3#1)
fields across##2##2##(1994-9#1)(2008-10#1)
fields and a##3##3##(1991-12#1)(2007-12#1)(2008-12#1)
fields and far fields generated by sources in the presence of##2##11##(2007-12#2)
fields and optical##2##3##(2008-2#1)(2011-2#1)
fields and the##2##3##(2008-3#2)
fields and to##2##3##(2008-10#1)(2008-3#1)
fields and was##2##3##(2008-10#2)
fields and##32##2##(1991-12#1)(1992-3#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#3)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)
fields applied##2##2##(1990-7#1)(1994-5#1)
fields are also##2##3##(2008-10#1)(2008-8#1)
fields are##19##2##(1995-6#1)(2007-11#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-12#1)(2010-11#1)(2011-2#1)
fields as##10##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2011-3#1)(2012-2#1)
fields at##5##2##(2008-10#4)(2008-2#1)
fields between##2##2##(2008-10#1)(2008-2#1)
fields but##2##2##(2008-10#2)
fields by use of##2##4##(2008-3#2)
fields by##7##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-5#1)
fields cropped##3##2##(2008-10#3)
fields during##3##2##(1992-3#1)(2008-10#2)
fields for##9##2##(1992-11#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#2)
fields from##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
fields generated by##3##3##(2007-12#3)
fields have been##2##3##(2008-10#1)(2008-7#1)
fields in California##2##3##(2008-10#2)
fields in Illinois##3##3##(2008-10#3)
fields in Iowa##2##3##(2008-10#2)
fields in Minnesota##3##3##(2008-10#3)
fields in New York##2##4##(2008-10#2)
fields in North##3##3##(2008-10#3)
fields in Ohio##3##3##(2008-10#3)
fields in a##2##3##(2007-11#1)(2008-3#1)
fields in all states##3##4##(2008-10#3)
fields in different##4##3##(2008-10#3)(2008-12#1)
fields in four##2##3##(2008-10#2)
fields in the##14##3##(1993-9#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-8#1)(2011-10#1)
fields in##86##2##(1993-12#1)(1993-3#1)(1993-9#1)(1996-2#1)(1996-5#1)(1997-6#2)(2007-11#2)(2007-12#4)(2008-10#52)(2008-12#2)(2008-2#4)(2008-3#10)(2008-8#2)(2011-10#1)(2013-1#1)(2013-8#1)
fields inside the##2##3##(1996-12#1)(2013-8#1)
fields is##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
fields located in the##2##4##(1996-2#1)(2008-10#1)
fields located in##3##3##(1996-2#1)(2008-10#2)
fields located##5##2##(1996-2#1)(2008-10#4)
fields may##2##2##(1995-6#1)(2008-7#1)
fields of a##6##3##(1995-6#1)(2008-10#1)(2008-3#3)(2012-2#1)
fields of both##3##3##(2008-1#2)(2008-7#1)
fields of research##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
fields of simple##3##3##(1996-2#1)(2008-11#1)(2008-2#1)
fields of the##3##3##(2008-3#3)
fields of view##3##3##(2008-2#1)(2008-3#2)
fields of##75##2##(1990-9#1)(1991-6#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#15)(2008-5#6)(2008-6#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
fields on##6##2##(1992-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)
fields or##2##2##(2008-10#1)(2010-12#1)
fields planted to##3##3##(2008-10#2)(2011-2#1)
fields planted##4##2##(2008-10#3)(2011-2#1)
fields recorded##2##2##(2008-11#1)(2008-2#1)
fields showed##2##2##(1995-11#1)(2013-1#1)
fields such as##8##3##(1993-2#1)(2007-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-8#1)(2011-2#1)
fields surveyed##2##2##(2008-10#2)
fields that are##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2009-9#2)
fields that##16##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2009-9#2)(2011-2#2)(2012-12#1)(2012-3#1)
fields to##6##2##(1992-3#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
fields was##4##2##(1990-5#1)(2008-10#2)(2008-2#1)
fields were randomly selected##2##4##(2008-10#2)
fields were##17##2##(1992-10#1)(1993-9#1)(2007-10#4)(2008-10#11)
fields will be##2##3##(1996-12#1)(2008-11#1)
fields will##3##2##(1992-3#1)(1996-12#1)(2008-11#1)
fields with G##2##3##(2008-10#2)
fields with a##3##3##(2008-10#2)(2008-2#1)
fields with maize##2##3##(2008-10#2)
fields with##21##2##(1997-3#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#3)(2008-6#1)
fields within##4##2##(2008-10#3)(2008-7#1)
fields##670##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#3)(1992-10#1)(1992-11#3)(1992-3#16)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#4)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#4)(1997-3#1)(1997-6#3)(2006-4#1)(2007-10#13)(2007-11#28)(2007-12#38)(2007-5#1)(2007-8#4)(2008-1#7)(2008-10#247)(2008-11#17)(2008-12#13)(2008-2#37)(2008-3#71)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#4)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2011-3#2)(2011-4#1)(2011-8#1)(2012-1#3)(2012-12#4)(2012-2#9)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#6)
fields)##2##1##(2008-12#1)(2012-3#1)
fields]##2##1##(1996-1#1)(2011-2#1)
fieldwork and##2##2##(2009-5#1)(2013-1#1)
fieldwork in##2##2##(2008-12#1)(2009-10#1)
fieldwork##5##1##(2008-12#1)(2009-10#1)(2009-5#1)(2013-1#1)(2013-7#1)
fieldworkers in##2##2##(1995-9#1)(1997-1#1)
fifteen beta-agonists##4##2##(2011-1#4)
fifteen minutes##2##2##(2008-1#1)(2008-11#1)
fifteen months##2##2##(1995-11#1)(1997-1#1)
fifteen patients##2##2##(1994-2#1)(2008-1#1)
fifteen years##2##2##(2008-9#1)(2009-7#1)
fifteen##31##1##(1992-3#2)(1994-2#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-9#2)(2009-7#1)(2009-8#1)(2011-1#6)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#2)(2013-8#1)
fifteenth##2##1##(2012-3#1)(2013-8#1)
fifth and sixth##3##3##(2007-12#1)(2010-1#1)(2013-7#1)
fifth and##4##2##(2007-12#1)(2008-10#1)(2010-1#1)(2013-7#1)
fifth harmonic##6##2##(2007-11#3)(2008-2#2)(2008-3#1)
fifth instar larvae##2##3##(1995-11#1)(1997-8#1)
fifth instar##5##2##(1995-11#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-11#1)
fifth metatarsal##5##2##(2010-11#2)(2012-12#1)(2012-2#2)
fifth of the##4##3##(1990-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
fifth of those##2##3##(1990-11#1)(2008-7#1)
fifth of##10##2##(1990-11#1)(1990-9#1)(1996-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
fifth pleonal##2##2##(2007-12#2)
fifth year of##3##3##(1992-12#1)(1994-3#1)(2008-10#1)
fifth year##4##2##(1992-12#1)(1994-3#1)(2008-10#2)
fifth##110##1##(1990-11#1)(1990-12#2)(1990-7#2)(1990-9#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-3#3)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-3#3)(1997-8#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-4#2)(2010-1#1)(2010-11#4)(2010-3#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)
fifth-harmonic##3##1##(2007-12#1)(2008-3#2)
fifth-order nonlinear susceptibility of##2##4##(2007-11#2)
fifth-order spherical aberration##3##3##(2008-3#3)
fifth-order##9##1##(2007-11#3)(2008-2#2)(2008-3#4)
fifty patients##2##2##(1992-12#1)(2008-5#1)
fifty three##2##2##(1993-1#1)(2008-1#1)
fifty years ago##3##3##(2009-8#1)(2010-8#1)(2011-2#1)
fifty years of##2##3##(2010-1#1)(2012-3#1)
fifty years##11##2##(1991-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#3)
fifty##27##1##(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-11#1)(1996-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#5)
fifty-five##4##1##(1990-3#1)(1992-1#1)(2007-10#1)(2007-8#1)
fifty-six##3##1##(1995-2#1)(2008-8#1)(2012-2#1)
fifty-three##2##1##(1993-2#1)(2012-3#1)
fig orchards##2##2##(2008-10#2)
fig pollinator trees##2##3##(2008-10#2)
fig##9##1##(2008-10#9)
fight against the##5##3##(1993-3#1)(1993-6#1)(2009-7#1)(2013-1#1)(2013-8#1)
fight against##19##2##(1993-12#2)(1993-3#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
fight for##2##2##(2008-11#1)(2012-12#1)
fight in##2##2##(1993-2#1)(1996-5#1)
fight over##2##2##(1990-8#1)(1997-5#1)
fight the##4##2##(1994-3#1)(2007-2#1)(2009-7#1)(2013-7#1)
fight violence##2##2##(1995-2#2)
fight##52##1##(1990-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-1#2)(1995-2#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
fighters##3##1##(1993-2#1)(2007-1#2)
fighting AIDS##2##2##(1990-11#1)(2008-7#1)
fighting##15##1##(1990-11#1)(1991-12#2)(1992-2#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-7#1)(2013-8#2)
fights and##2##2##(2008-9#2)
fights in##2##2##(2008-9#2)
fights on##2##2##(1995-6#1)(2008-9#1)
fights##12##1##(1995-6#1)(2008-10#1)(2008-9#10)
figs##4##1##(2008-10#4)
figural##2##1##(2007-12#1)(2008-11#1)
figure errors##2##2##(2008-3#2)
figure for##2##2##(1996-8#1)(2008-10#1)
figure in the##2##3##(1990-6#1)(2008-7#1)
figure in##5##2##(1990-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
figure is##4##2##(1993-8#1)(2008-3#2)(2008-4#1)
figure of merit is##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
figure of merit##15##3##(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)
figure of the##2##3##(2011-2#1)(2012-12#1)
figure of##22##2##(2007-11#5)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#6)(2009-10#1)(2011-2#1)(2012-12#1)
figure rating##2##2##(2007-12#2)
figure silhouettes##4##2##(2007-12#4)
figure was##2##2##(1990-6#1)(2007-11#1)
figure with##2##2##(2007-12#2)
figure##65##1##(1990-6#2)(1992-1#1)(1992-2#1)(1992-4#1)(1993-8#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-8#1)(2007-11#8)(2007-12#13)(2007-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
figure-eight fiber laser##2##3##(2007-11#2)
figure-of-8##5##1##(2009-3#5)
figured##4##1##(2008-12#1)(2008-3#2)(2011-3#1)
figures and##4##2##(1994-3#1)(2008-6#1)(2008-9#2)
figures are##4##2##(1996-1#1)(1997-6#1)(2008-9#1)(2013-1#1)
figures from##3##2##(1990-9#1)(1997-6#1)(2011-2#1)
figures in the##4##3##(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
figures in##6##2##(1994-1#1)(2008-12#1)(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
figures of merit and interferences are also discussed##2##8##(2008-10#2)
figures of merit are##3##4##(2008-10#3)
figures of merit for##2##4##(2008-10#1)(2011-2#1)
figures of merit of the##8##5##(2008-10#8)
figures of merit were##3##4##(2008-10#3)
figures of merit##28##3##(2008-10#26)(2008-3#1)(2011-2#1)
figures of##35##2##(1992-5#1)(1996-12#1)(2007-11#1)(2008-10#28)(2008-3#1)(2011-2#2)(2012-2#1)
figures were##6##2##(1992-2#1)(1994-7#1)(1997-5#1)(2008-10#2)(2008-11#1)
figures##101##1##(1990-6#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-5#3)(1993-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1996-1#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#7)(2007-11#1)(2007-12#3)(2008-10#34)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#4)
figuring is##3##2##(2008-3#3)
figuring##8##1##(2008-3#8)
fijiensis##7##1##(2008-10#7)
filaggrin##3##1##(2008-5#3)
filament and##2##2##(2008-2#1)(2008-7#1)
filament bundles at the##3##4##(2012-2#3)
filament bundles at##4##3##(2012-2#4)
filament bundles##5##2##(2012-2#5)
filament formation##2##2##(2008-5#1)(2009-12#1)
filament network##2##2##(2008-1#1)(2008-5#1)
filament networks##3##2##(2008-7#1)(2009-9#1)(2011-2#1)
filament structure##2##2##(2008-11#2)
filament velocity##2##2##(1993-9#1)(1997-7#1)
filament##71##1##(1991-1#1)(1991-12#1)(1991-5#1)(1992-3#2)(1993-8#2)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-11#5)(2007-12#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-5#4)(2010-8#1)(2011-2#3)(2012-2#6)
filamentary##2##1##(2007-11#1)(2010-10#1)
filamentation is##2##2##(2007-11#1)(2008-8#1)
filamentation of##2##2##(2007-11#1)(2007-12#1)
filamentation##7##1##(2007-11#5)(2007-12#1)(2008-8#1)
filamentous actin (F-actin)##4##3##(1994-6#1)(1994-8#1)(1997-6#1)(2008-11#1)
filamentous actin##8##2##(1994-6#2)(1994-8#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
filamentous actinomycetes##2##2##(2008-10#2)
filamentous and##2##2##(2008-6#1)(2008-7#1)
filamentous ascomycete##2##2##(1995-6#1)(2012-3#1)
filamentous bacteria##2##2##(2008-5#1)(2012-2#1)
filamentous bacteriophage##3##2##(1991-5#1)(2008-10#1)(2008-8#1)
filamentous bacteriophages##4##2##(1997-4#2)(2008-4#1)(2008-8#1)
filamentous cyanobacterium##3##2##(1992-12#1)(2008-11#1)(2008-6#1)
filamentous fungi and##4##3##(1991-9#1)(2007-11#1)(2008-10#1)(2011-2#1)
filamentous fungi that##2##3##(1994-5#1)(2010-7#1)
filamentous fungi##28##2##(1991-9#1)(1994-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#4)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#2)(2012-3#1)(2013-8#1)
filamentous fungus##4##2##(1993-2#1)(2008-11#1)(2008-5#1)(2010-10#1)
filamentous material in the##2##4##(2008-10#2)
filamentous material##5##2##(2008-10#4)(2008-7#1)
filamentous phage and##2##3##(1993-8#1)(2008-11#1)
filamentous phage##4##2##(1990-11#1)(1993-8#1)(1994-12#1)(2008-11#1)
filamentous viruses##2##2##(2008-4#1)(2008-7#1)
filamentous##97##1##(1990-11#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#6)(2008-4#2)(2008-5#6)(2008-6#12)(2008-7#8)(2008-8#4)(2008-9#2)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
filaments and##8##2##(1992-9#1)(1993-8#3)(2007-12#1)(2008-8#1)(2009-10#1)(2011-2#1)
filaments are##4##2##(2008-5#1)(2008-6#1)(2009-10#2)
filaments containing##3##2##(1997-7#3)
filaments in the##2##3##(1994-8#1)(2008-10#1)
filaments in##9##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-8#3)(2009-10#2)(2009-12#1)
filaments is##4##2##(1994-6#1)(2008-7#2)(2008-8#1)
filaments moving##2##2##(1997-7#2)
filaments of the##2##3##(1993-12#1)(2008-11#1)
filaments of##5##2##(1993-12#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-8#1)
filaments to##2##2##(2007-11#1)(2008-10#1)
filaments were##6##2##(1997-3#1)(2008-7#1)(2008-8#2)(2010-5#1)(2012-1#1)
filaments with a##2##3##(1995-2#1)(1997-2#1)
filaments with alanines substituted at##2##5##(1995-2#2)
filaments with##6##2##(1995-2#4)(1997-2#1)(2008-7#1)
filaments##117##1##(1991-5#1)(1991-8#1)(1992-6#2)(1992-9#3)(1993-12#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-6#2)(1994-8#1)(1995-2#7)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#6)(2007-11#5)(2007-12#6)(2008-1#4)(2008-10#3)(2008-11#5)(2008-5#2)(2008-6#2)(2008-7#18)(2008-8#15)(2008-9#4)(2009-10#7)(2009-12#1)(2009-8#1)(2009-9#4)(2010-5#2)(2011-2#1)(2012-1#2)(2012-2#1)
filamentsin vitro##2##2##(2008-8#2)
filaria##2##1##(1990-8#1)(2010-1#1)
filarial parasite Setaria digitata##3##4##(1991-5#1)(1994-11#2)
filarial parasite##5##2##(1991-5#2)(1994-11#3)
filarial##11##1##(1991-5#3)(1991-9#1)(1994-11#5)(2007-7#1)(2008-4#1)
filariasis elimination in##2##3##(2008-1#2)
filariasis elimination##5##2##(2008-1#5)
filariasis##12##1##(1993-12#1)(1994-11#1)(2007-7#1)(2008-1#6)(2008-4#1)(2010-1#1)(2012-2#1)
file and##2##2##(2008-10#1)(2008-9#1)
file format##5##2##(2007-7#1)(2008-4#1)(2008-9#2)(2011-1#1)
file formats##3##2##(2008-7#1)(2008-9#2)
file is##2##2##(1994-1#1)(2008-4#1)
file of##2##2##(1994-3#1)(2011-2#1)
file which##3##2##(1991-3#1)(2008-7#1)(2013-1#1)
file##57##1##(1990-2#2)(1991-12#1)(1991-2#2)(1991-3#3)(1992-2#2)(1992-5#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-3#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#6)(2008-9#12)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
filed a complaint##2##3##(1995-12#1)(1996-5#1)
filed a##3##2##(1995-12#1)(1995-6#1)(1996-5#1)
filed an IND##2##3##(2008-5#2)
filed an##5##2##(1995-12#1)(1995-6#1)(2008-5#3)
filed by##7##2##(1995-12#3)(1995-6#2)(1996-12#1)(1996-5#1)
filed in##6##2##(1991-1#1)(1995-6#1)(2007-9#1)(2008-5#1)(2009-11#2)
filed##29##1##(1991-1#1)(1993-12#1)(1995-12#5)(1995-6#6)(1996-12#1)(1996-5#2)(1997-5#4)(2007-9#1)(2008-10#1)(2008-5#5)(2009-11#2)
files and the##2##3##(1992-2#1)(1994-2#1)
files and##12##2##(1991-1#1)(1992-2#1)(1994-2#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-11#1)(2011-2#1)
files are##2##2##(1991-8#1)(1992-12#1)
files in the##2##3##(2008-9#1)(2011-3#1)
files in##3##2##(1991-2#1)(2008-9#1)(2011-3#1)
files of##10##2##(1990-2#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2012-2#1)
files##63##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1996-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#3)(2008-7#1)(2008-9#9)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
filgrastim in##3##2##(2008-7#3)
filgrastim##15##1##(2008-7#15)
filiform and##4##2##(2007-12#2)(2008-7#2)
filiform apparatus##2##2##(2008-11#1)(2009-8#1)
filiform##10##1##(1992-2#1)(2007-12#3)(2008-11#1)(2008-7#4)(2009-8#1)
filing##2##1##(1991-1#1)(2012-3#1)
filings and##3##2##(2008-10#2)(2008-11#1)
filings##8##1##(2008-10#3)(2008-11#4)(2008-5#1)
filipin staining##2##2##(1992-6#2)
fill factor##8##2##(2007-11#2)(2008-2#2)(2008-3#4)
fill factors##6##2##(2008-2#3)(2008-3#3)
fill in the##2##3##(1995-6#1)(2010-9#1)
fill in##7##2##(1995-6#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-1#1)
fill its##2##2##(1991-2#1)(1995-6#1)
fill the##11##2##(1993-3#1)(1995-5#1)(1996-12#1)(2008-1#2)(2008-10#4)(2008-3#1)(2013-1#1)
fill this gap##2##3##(2010-2#1)(2010-9#1)
fill##54##1##(1991-2#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#8)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
fill-factor##2##1##(2008-2#1)(2008-3#1)
filled by the##2##3##(1992-5#1)(2008-5#1)
filled by##6##2##(1992-5#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-3#1)
filled in a questionnaire##2##4##(1993-3#1)(1994-9#1)
filled in a syringe prior to their determination by##2##9##(2008-10#2)
filled in a syringe##3##4##(2008-10#3)
filled in a##6##3##(1993-3#1)(1994-9#1)(2008-10#4)
filled in the##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
filled in##10##2##(1993-3#1)(1994-9#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-2#1)(2013-1#1)
filled out questionnaires##2##3##(2010-2#1)(2011-2#1)
filled out the##3##3##(2006-10#1)(2008-11#1)(2012-1#1)
filled out##9##2##(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
filled recycled##2##2##(2009-3#2)
filled resins##3##2##(2009-7#3)
filled teeth##2##2##(2008-1#2)
filled up##2##2##(2013-1#2)
filled with a liquid##2##4##(2008-3#2)
filled with a##13##3##(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-9#1)
filled with glass##2##3##(2008-10#2)
filled with mycelium##2##3##(2008-10#2)
filled with round synaptic vesicles and##2##6##(1995-12#1)(1997-2#1)
filled with the##5##3##(2007-12#1)(2008-10#3)(2009-7#1)
filled with##82##2##(1990-10#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#8)(2007-7#2)(2008-10#28)(2008-11#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#3)
filled##131##1##(1990-10#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#11)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#36)(2008-11#5)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#7)(2008-9#2)(2009-10#1)(2009-3#4)(2009-7#6)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#1)(2013-1#8)
filler particle size##2##3##(2008-12#2)
filler##9##1##(2008-12#2)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#3)(2013-1#1)
fillers##9##1##(2009-7#6)(2010-4#1)(2012-2#1)(2013-1#1)
filling and dilatation of the##2##5##(2008-7#2)
filling and##4##2##(2008-10#1)(2008-4#1)(2008-7#2)
filling in##6##2##(1991-6#1)(2008-3#4)(2013-1#1)
filling material##2##2##(2008-12#1)(2013-1#1)
filling materials##3##2##(1990-5#1)(2010-3#1)(2012-2#1)
filling of repeat prescriptions]##2##4##(1993-11#1)(1993-6#1)
filling of the##3##3##(2008-2#1)(2008-7#1)(2012-2#1)
filling of##8##2##(1993-11#1)(1993-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
filling or##3##2##(1991-2#1)(2007-11#1)(2008-2#1)
filling pressures##2##2##(2008-3#1)(2011-2#1)
filling the##8##2##(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2012-2#1)
filling##69##1##(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-11#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#5)(2009-7#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#7)
fillings##10##1##(1993-8#4)(1995-6#4)(2008-10#1)(2008-3#1)
fills of##2##2##(2007-12#2)
fills##6##1##(2007-12#2)(2009-6#1)(2011-2#1)(2013-1#2)
film and a##2##3##(2008-3#2)
film and substrate##2##3##(2008-3#2)
film and the##11##3##(2007-12#1)(2008-10#6)(2008-3#3)(2009-5#1)
film and to##2##3##(2007-11#1)(2008-3#1)
film and##30##2##(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#9)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
film are##7##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
film as a##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
film as the##4##3##(2008-10#3)(2008-3#1)
film as##10##2##(2007-11#1)(2008-10#7)(2008-3#2)
film at the##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
film at##5##2##(1997-2#1)(2008-10#3)(2008-11#1)
film based##2##2##(2008-10#2)
film bearing 2##2##3##(2008-10#2)
film becomes##2##2##(2007-12#1)(2008-3#1)
film by##9##2##(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-10#1)
film can be detected##2##4##(2008-10#1)(2008-2#1)
film can be##8##3##(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-4#1)
film can##9##2##(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-4#1)(2009-7#1)
film causes##2##2##(2008-10#2)
film changes##2##2##(2008-10#1)(2008-3#1)
film characteristics##2##2##(2008-3#1)(2008-5#1)
film coated glassy carbon electrode (GCE)##2##6##(2008-10#2)
film coated glassy carbon electrode##5##5##(2008-10#5)
film coated glassy carbon##6##4##(2008-10#6)
film coated on a glassy carbon electrode##2##7##(2008-10#2)
film coated on##3##3##(2008-10#3)
film coated##13##2##(2008-10#12)(2008-3#1)
film coating methods##2##3##(2009-7#2)
film composed of##3##3##(2008-10#2)(2008-3#1)
film considerably##2##2##(2008-10#2)
film consisting of##2##3##(2008-10#2)
film containing##5##2##(2008-10#4)(2008-2#1)
film dehydration/rehydration approach##2##3##(1994-12#2)
film deposited by##3##3##(2008-2#1)(2008-3#2)
film deposited upon##2##3##(2007-11#2)
film deposited##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
film deposition rate##2##3##(2009-7#2)
film deposition##3##2##(2008-10#1)(2009-7#2)
film doped with##5##3##(2007-12#1)(2008-10#4)
film during##2##2##(2007-12#1)(2008-10#1)
film electrode (BiFE)##3##3##(2008-10#3)
film electrode##30##2##(2008-10#29)(2008-12#1)
film electrodes for the##3##4##(2008-10#3)
film electrodes for##4##3##(2008-10#4)
film electrodes##27##2##(2008-10#25)(2008-12#2)
film exhibited high selectivity toward##2##5##(2008-10#1)(2013-1#1)
film exhibited##4##2##(2007-11#1)(2008-10#2)(2013-1#1)
film for the##2##3##(2008-10#1)(2009-10#1)
film for##6##2##(2007-11#1)(2008-10#3)(2008-3#1)(2009-10#1)
film formation##5##2##(2008-10#2)(2008-5#1)(2010-4#2)
film formed by##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
film formed##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
film had##2##2##(2008-10#1)(2008-2#1)
film has been##2##3##(2008-10#1)(2008-3#1)
film has##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
film immobilized##2##2##(2008-10#2)
film in the##2##3##(2008-10#1)(2008-5#1)
film in##5##2##(1994-12#1)(2008-10#3)(2008-5#1)
film increases##2##2##(2008-11#1)(2008-3#1)
film indicated##2##2##(2007-7#1)(2008-10#1)
film is along the direction of##2##6##(2008-2#1)(2008-3#1)
film is also##2##3##(2008-10#1)(2008-11#1)
film is##27##2##(2007-11#3)(2007-12#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2009-6#1)
film library##4##2##(1996-1#1)(1996-2#1)(1996-3#2)
film mammography##2##2##(1995-4#2)
film material##2##2##(2008-10#1)(2008-2#1)
film modified electrode##7##3##(2008-10#7)
film modified electrodes##2##3##(2008-10#2)
film modified##15##2##(2008-10#14)(2008-5#1)
film of the##2##3##(2008-3#1)(2008-5#1)
film of water##2##3##(2008-10#1)(2011-2#1)
film of##30##2##(2007-11#1)(2008-10#21)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2011-2#1)
film on a glassy carbon electrode##3##6##(2008-10#3)
film on a glassy carbon##4##5##(2008-10#4)
film on a##10##3##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
film on glass##2##3##(2008-10#1)(2009-7#1)
film on the##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
film on##26##2##(2007-12#1)(2008-10#15)(2008-2#2)(2008-3#5)(2009-10#1)(2009-7#1)(2012-3#1)
film or##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
film over the##2##3##(2008-10#2)
film over##3##2##(2008-10#3)
film overlaid on##2##3##(2007-11#1)(2008-3#1)
film preparation##2##2##(2008-10#2)
film prepared##2##2##(2008-10#2)
film properties##4##2##(2008-10#1)(2008-3#2)(2009-7#1)
film showed a##2##3##(1993-6#1)(1995-3#1)
film surface##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)
film surfaces##2##2##(2007-12#1)(2009-7#1)
film that##2##2##(2008-10#2)
film thickness and##3##3##(2008-10#2)(2008-3#1)
film thickness of##2##3##(2008-10#1)(2008-7#1)
film thickness on the##2##4##(2008-10#2)
film thickness##31##2##(2007-12#1)(2008-10#14)(2008-2#3)(2008-3#8)(2008-7#2)(2009-6#3)
film thicknesses##3##2##(2008-2#1)(2009-10#2)
film to##9##2##(2007-12#1)(2008-10#7)(2009-6#1)
film under##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
film upon a##2##3##(2007-11#1)(2008-3#1)
film upon##3##2##(2007-11#1)(2008-3#2)
film used##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
film using stable ground-state complex##2##5##(2008-10#2)
film using##4##2##(2008-10#2)(2009-10#1)(2012-3#1)
film was characterized by##3##4##(2008-10#3)
film was characterized##4##3##(2008-10#3)(2009-10#1)
film was found to be##2##5##(2008-10#2)
film was investigated in##2##4##(2008-10#1)(2008-5#1)
film was investigated##4##3##(2008-10#3)(2008-5#1)
film was obtained##2##3##(2008-10#2)
film was prepared by##2##4##(2008-10#2)
film was##36##2##(1994-3#1)(2008-10#27)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)
film were##9##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
film with a##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
film with##17##2##(2007-11#3)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
film##781##1##(1991-12#2)(1992-5#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-4#2)(1996-1#1)(1996-2#2)(1996-3#2)(1997-2#6)(1997-8#4)(2006-4#1)(2007-11#28)(2007-12#36)(2007-7#2)(2008-1#3)(2008-10#406)(2008-11#11)(2008-12#6)(2008-2#46)(2008-3#102)(2008-4#2)(2008-5#23)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#7)(2009-11#4)(2009-12#1)(2009-4#6)(2009-5#5)(2009-6#13)(2009-7#14)(2009-9#2)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#3)
film's##5##1##(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
film)##4##1##(2008-10#2)(2008-3#1)(2008-8#1)
film-based treatment planning##2##3##(2009-11#2)
film-based##7##1##(2008-10#1)(2008-12#3)(2008-7#1)(2009-11#2)
film-modified electrode was##2##3##(2008-10#2)
film-modified electrode##3##2##(2008-10#3)
film-modified##4##1##(2008-10#4)
film-plated carbon paste electrode##2##4##(2008-10#2)
film-related##2##1##(2009-11#2)
film-substrate##4##1##(2007-12#1)(2008-3#3)
filmless##2##1##(1997-8#2)
films (approximately##2##2##(2007-12#1)(2008-2#1)
films and a##2##3##(2007-12#1)(2008-3#1)
films and the##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
films and their##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
films and##36##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#3)(2009-11#1)(2010-7#4)
films are considered##2##3##(1992-5#1)(2008-10#1)
films are prepared##2##3##(2008-10#2)
films are reported##4##3##(2008-2#1)(2008-3#1)(2009-11#1)(2010-4#1)
films are##26##2##(1992-5#1)(2007-12#5)(2008-10#7)(2008-2#3)(2008-3#8)(2009-11#1)(2010-4#1)
films as saturable absorbers##2##4##(2007-11#1)(2008-3#1)
films as##9##2##(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2013-1#1)
films at 193 nm##2##4##(2008-3#2)
films at a##2##3##(2008-3#1)(2009-11#1)
films at room temperature##2##4##(2007-12#1)(2008-10#1)
films at the##3##3##(1994-3#1)(2007-11#1)(2008-10#1)
films at##13##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#4)(2009-11#1)(2013-1#1)
films based on##2##3##(2008-10#1)(2008-3#1)
films by the##2##3##(2008-10#1)(2008-2#1)
films by##9##2##(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)
films can be##4##3##(2008-10#1)(2008-3#3)
films can##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
films cast from##3##3##(2008-10#1)(2010-4#2)
films cast##4##2##(2008-10#2)(2010-4#2)
films coated on##2##3##(2008-10#1)(2008-2#1)
films coated##3##2##(2008-10#2)(2008-2#1)
films composed of##2##3##(2008-10#1)(2008-12#1)
films containing##11##2##(2008-10#7)(2008-2#1)(2009-11#1)(2010-4#1)(2013-1#1)
films deposited by##2##3##(2008-3#2)
films deposited on##9##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
films deposited##12##2##(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#4)
films disclosed##2##2##(2008-1#2)
films doped with##2##3##(2007-12#1)(2008-10#1)
films during##2##2##(2008-1#1)(2008-10#1)
films exhibit##6##2##(1993-11#1)(2007-12#2)(2008-6#1)(2008-8#1)(2009-11#1)
films fabricated##4##2##(2008-12#2)(2008-3#2)
films for##19##2##(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-5#1)
films formed on##2##3##(2008-3#2)
films formed##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
films from##7##2##(2008-10#2)(2008-2#3)(2008-3#1)(2009-10#1)
films had##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
films has been##3##3##(2008-10#1)(2008-3#2)
films has##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
films have been studied##2##4##(2008-10#1)(2008-3#1)
films have been##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
films have##11##2##(2008-10#2)(2008-2#2)(2008-3#5)(2010-4#1)(2011-2#1)
films having##2##2##(2008-12#2)
films in a##2##3##(2007-12#1)(2008-3#1)
films in the##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
films in##12##2##(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)
films increased##2##2##(2007-12#1)(2013-8#1)
films is discussed in##2##4##(2008-10#1)(2008-5#1)
films is reported##2##3##(2008-10#1)(2009-12#1)
films is##23##2##(2007-11#1)(2007-12#1)(2008-10#9)(2008-3#7)(2008-5#1)(2009-11#2)(2009-12#2)
films made from##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
films made of##2##3##(2008-11#2)
films made##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)
films may##2##2##(2007-12#1)(2010-4#1)
films modified by collagen##2##4##(2008-5#2)
films modified##4##2##(2008-10#2)(2008-5#2)
films obtained from##2##3##(2008-10#1)(2009-11#1)
films obtained##3##2##(2008-10#2)(2009-11#1)
films of a##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
films of pentane##2##3##(2008-3#2)
films of tantalum oxide##2##4##(2008-2#2)
films of tin oxide##2##4##(2008-10#2)
films of##34##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-2#5)(2008-3#8)(2008-7#1)(2010-2#1)
films on a##2##3##(2008-10#2)
films on glassy carbon##2##4##(2008-10#2)
films on##21##2##(2007-12#2)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-4#1)
films prepared by the##3##4##(2008-11#3)
films prepared by##8##3##(2008-10#1)(2008-11#3)(2008-3#4)
films prepared##12##2##(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#4)
films self-assembled##2##2##(2008-10#2)
films show##2##2##(2008-10#1)(2008-3#1)
films showed a##3##3##(1995-6#1)(2008-1#1)(2008-10#1)
films showed##7##2##(1995-6#1)(2008-1#4)(2008-10#2)
films that are##2##3##(2007-12#1)(2008-3#1)
films that##9##2##(2007-12#1)(2008-12#1)(2008-3#4)(2012-2#1)(2012-3#2)
films to##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)
films under##2##2##(2008-10#1)(2008-3#1)
films upon##2##2##(2008-10#1)(2008-3#1)
films using##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
films via##2##2##(2008-10#1)(2009-11#1)
films was determined##2##3##(2008-10#1)(2008-2#1)
films was investigated##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
films was measured##2##3##(2008-3#2)
films was##17##2##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2009-11#1)(2009-12#1)(2013-8#1)
films were analyzed by##2##4##(2008-10#1)(2008-3#1)
films were characterized by##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
films were characterized##5##3##(2007-11#1)(2008-10#3)(2008-5#1)
films were deposited##3##3##(2008-3#2)(2009-12#1)
films were investigated##6##3##(2007-12#1)(2008-10#2)(2008-2#3)
films were measured by##2##4##(2007-12#2)
films were measured##3##3##(2007-12#2)(2008-10#1)
films were prepared by##4##4##(2008-10#2)(2008-8#1)(2013-8#1)
films were prepared from##2##4##(2008-3#1)(2008-5#1)
films were prepared##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
films were studied##4##3##(2008-10#3)(2008-3#1)
films were synthesized##2##3##(2008-10#1)(2008-8#1)
films were##60##2##(2007-11#1)(2007-12#4)(2008-10#24)(2008-11#1)(2008-2#8)(2008-3#10)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#2)(2009-7#1)(2010-4#1)(2013-8#2)
films with a##8##3##(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)
films with high##3##3##(2008-2#2)(2008-3#1)
films with large##3##3##(2008-2#1)(2008-3#2)
films with##30##2##(2007-12#2)(2008-10#3)(2008-2#6)(2008-3#13)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
films##708##1##(1990-12#1)(1990-4#1)(1990-8#2)(1991-12#3)(1992-5#1)(1992-8#2)(1993-11#2)(1993-5#1)(1994-1#2)(1994-3#3)(1995-6#2)(1997-8#2)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#28)(2007-12#56)(2007-2#2)(2007-7#2)(2008-1#8)(2008-10#197)(2008-11#20)(2008-12#13)(2008-2#70)(2008-3#166)(2008-4#1)(2008-5#26)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#17)(2009-12#5)(2009-5#5)(2009-7#1)(2010-2#1)(2010-4#16)(2010-5#1)(2010-7#6)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#8)
films)##4##1##(1992-5#1)(2008-10#2)(2008-3#1)
filomicelles##4##1##(2008-7#4)
filopodia##6##1##(1995-11#2)(2008-6#1)(2008-7#2)(2012-7#1)
filter and a##9##3##(2007-11#1)(2008-2#1)(2008-3#6)(2008-5#1)
filter and neighboring-direction averaging##2##4##(2008-2#2)
filter and the##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
filter and##29##2##(1991-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#12)(2008-5#1)(2008-9#1)(2013-8#1)
filter applications##3##2##(2007-12#1)(2008-2#2)
filter are##3##2##(2007-11#1)(2008-3#1)(2010-8#1)
filter as a##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
filter as##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
filter based on the##3##4##(2008-2#1)(2008-3#2)
filter binding##2##2##(1993-8#2)
filter by using##2##3##(2008-10#1)(2008-3#1)
filter can be##2##3##(2008-2#1)(2008-3#1)
filter can##4##2##(2008-2#1)(2008-3#3)
filter characteristics of##2##3##(2007-12#2)
filter characteristics##4##2##(2007-12#2)(2008-2#2)
filter correlation##2##2##(2007-12#2)
filter design##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
filter effect##5##2##(2008-10#3)(2008-11#2)
filter for disjoint noise##2##4##(2008-2#2)
filter for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
filter for use in##2##4##(2008-3#2)
filter for##25##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#10)(2008-3#8)
filter function can##2##3##(2008-3#2)
filter function##3##2##(2008-2#1)(2008-3#2)
filter has been##2##3##(2007-11#1)(2008-3#1)
filter has##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
filter hybridization##2##2##(2010-10#1)(2012-3#1)
filter in a hybrid##2##4##(2007-11#2)
filter in the##2##3##(1997-8#1)(2008-5#1)
filter in##8##2##(1997-8#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-5#3)
filter include##2##2##(2008-2#2)
filter is also##2##3##(2007-11#1)(2008-3#1)
filter is described##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
filter is designed##2##3##(2008-2#1)(2008-3#1)
filter is used to##3##4##(2007-11#1)(2008-3#2)
filter is used##4##3##(2007-11#1)(2008-3#3)
filter is##30##2##(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#12)(2008-5#1)
filter materials##3##2##(1993-3#1)(2008-3#1)(2008-5#1)
filter medium##2##2##(2008-10#2)
filter monochromator for##2##3##(2008-2#2)
filter of##2##2##(1990-8#1)(2008-3#1)
filter on##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-1#1)
filter or##4##2##(2008-10#2)(2008-3#2)
filter out##2##2##(2008-10#1)(2010-8#1)
filter pads##2##2##(2007-5#2)
filter paper and##2##3##(2008-10#2)
filter paper cylinder (C)##3##4##(2008-10#3)
filter paper in##2##3##(2008-10#1)(2008-5#1)
filter paper##38##2##(2008-10#28)(2008-12#1)(2008-5#2)(2010-8#1)(2011-2#5)(2012-2#1)
filter performance##3##2##(2008-3#2)(2010-8#1)
filter plane##3##2##(2008-3#3)
filter radiometer##4##2##(2008-3#4)
filter radiometers##4##2##(2008-2#4)
filter results##2##2##(2007-12#1)(2008-10#1)
filter samples##4##2##(2008-10#3)(2008-11#1)
filter set##2##2##(2008-3#1)(2008-9#1)
filter sets##2##2##(2008-3#1)(2008-9#1)
filter shows##2##2##(2008-2#1)(2008-3#1)
filter structure##2##2##(2007-7#2)
filter structures##2##2##(2007-11#1)(2008-2#1)
filter technique##3##2##(1997-4#1)(2007-5#1)(2008-2#1)
filter testing##2##2##(1993-3#2)
filter that can##2##3##(2007-11#1)(2008-3#1)
filter that is##2##3##(2008-3#2)
filter that permits##2##3##(2007-12#1)(2008-3#1)
filter that##14##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#8)
filter the##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
filter to achieve##2##3##(2008-2#1)(2008-3#1)
filter to reject the##2##4##(2008-3#1)(2008-7#1)
filter to##18##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-7#1)
filter type##2##2##(2008-10#1)(2011-2#1)
filter unique to##2##3##(2008-2#2)
filter was##10##2##(1992-6#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)
filter were##5##2##(2008-10#3)(2008-3#2)
filter with a##8##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
filter with##12##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)(2012-1#1)
filter##549##1##(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#4)(1993-3#4)(1993-8#2)(1995-3#1)(1996-12#1)(1996-6#1)(1997-4#2)(1997-8#3)(2007-11#29)(2007-12#43)(2007-5#3)(2007-7#3)(2008-1#2)(2008-10#89)(2008-11#12)(2008-12#1)(2008-2#112)(2008-3#166)(2008-4#1)(2008-5#18)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#6)(2009-12#1)(2009-9#2)(2010-10#1)(2010-5#2)(2010-8#6)(2011-1#1)(2011-2#7)(2012-1#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
filter's##4##1##(2008-2#2)(2008-3#2)
filter)##5##1##(2008-2#2)(2008-3#2)(2012-1#1)
filter-based##4##1##(2008-10#1)(2008-3#3)
filterability##2##1##(2008-7#2)
filterable##3##1##(2008-10#3)
filtered Rayleigh##2##2##(2008-2#1)(2008-3#1)
filtered and##7##2##(1994-5#1)(2008-10#4)(2012-1#1)(2013-7#1)
filtered backprojection##2##2##(2011-1#1)(2012-1#1)
filtered backpropagation and##2##3##(2008-3#2)
filtered supernatant##2##2##(2008-12#2)
filtered through a##2##3##(1992-3#1)(2008-5#1)
filtered through##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
filtered to##2##2##(2008-3#1)(2008-9#1)
filtered##48##1##(1992-3#1)(1994-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#10)(2008-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-3#1)(2013-1#1)(2013-7#1)
filtering a##2##2##(2007-11#1)(2008-10#1)
filtering and its##2##3##(2008-2#2)
filtering and##8##2##(2007-12#2)(2008-2#2)(2008-3#4)
filtering at##2##2##(1992-12#1)(2008-3#1)
filtering by##2##2##(2007-12#1)(2008-3#1)
filtering for##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
filtering in a joint##2##4##(2008-2#1)(2008-3#1)
filtering in a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
filtering in the##3##3##(2008-3#3)
filtering in##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
filtering is##9##2##(2008-1#1)(2008-2#3)(2008-3#4)(2008-6#1)
filtering method##6##2##(2007-12#1)(2008-1#1)(2010-8#2)(2011-1#1)(2012-2#1)
filtering of the##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-11#1)
filtering of##13##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)(2010-11#1)(2012-2#1)
filtering technique##3##2##(2008-3#3)
filtering techniques##4##2##(2008-2#3)(2009-10#1)
filtering the##4##2##(2007-11#1)(2008-3#1)(2008-6#1)(2009-8#1)
filtering with##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
filtering##139##1##(1992-12#1)(1992-3#1)(2007-11#15)(2007-12#15)(2008-1#3)(2008-10#4)(2008-2#32)(2008-3#49)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-8#4)(2011-1#2)(2012-2#2)
filters after##2##2##(1990-12#1)(2008-10#1)
filters and polyurethane foam##2##4##(2008-11#1)(2010-5#1)
filters and##17##2##(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#3)
filters are presented##2##3##(2008-10#1)(2008-3#1)
filters are##14##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2013-1#1)
filters as##2##2##(2008-10#1)(2008-2#1)
filters based on##2##3##(2007-11#1)(2008-3#1)
filters by##3##2##(2008-10#2)(2008-2#1)
filters can be##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
filters collected##2##2##(2008-10#2)
filters constructed##2##2##(2007-12#1)(2008-3#1)
filters exhibit##2##2##(2007-12#1)(2008-2#1)
filters for the##3##3##(2008-2#1)(2008-3#2)
filters for##15##2##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#6)(2008-7#1)(2008-9#1)
filters formed##2##2##(2008-3#2)
filters have been##2##3##(2008-10#1)(2008-2#1)
filters have##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
filters in front of the##2##5##(2007-12#1)(2008-2#1)
filters in the##5##3##(2007-11#1)(2008-3#3)(2011-2#1)
filters in wavelength-division multiplexing systems##2##5##(2007-11#1)(2007-12#1)
filters in##18##2##(1990-12#1)(1992-12#1)(1993-3#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#7)(2008-7#1)(2008-9#1)(2011-2#1)
filters is the##2##3##(2008-2#1)(2008-3#1)
filters is##14##2##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#2)
filters of##5##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
filters on##2##2##(2007-12#1)(2008-6#1)
filters that were##2##3##(2008-3#1)(2013-1#1)
filters that##9##2##(1990-12#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
filters to##9##2##(1991-12#1)(2008-2#1)(2008-3#5)(2008-9#1)(2013-1#1)
filters used in##2##3##(1993-3#1)(1997-1#1)
filters used##3##2##(1993-3#1)(1997-1#1)(2008-3#1)
filters using##2##2##(2007-12#1)(2008-7#1)
filters was##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
filters were analyzed by##2##4##(2008-5#2)
filters were##11##2##(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2011-1#1)
filters with##13##2##(2007-11#3)(2007-12#1)(2008-3#7)(2008-6#1)(2008-9#1)
filters##291##1##(1990-12#3)(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-3#3)(1996-12#2)(1996-3#1)(1997-1#1)(2007-10#5)(2007-11#19)(2007-12#26)(2008-1#2)(2008-10#29)(2008-11#5)(2008-2#37)(2008-3#96)(2008-4#4)(2008-5#14)(2008-6#7)(2008-7#8)(2008-9#7)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#2)(2013-1#7)(2013-8#1)
filters)##3##1##(2008-10#2)(2008-3#1)
filtrate and##4##2##(2008-10#4)
filtrate of a##2##3##(1991-5#1)(2008-10#1)
filtrate of##8##2##(1991-5#1)(2008-10#7)
filtrate was injected##2##3##(2008-10#1)(2008-5#1)
filtrate was##7##2##(1994-5#1)(2008-10#5)(2008-5#1)
filtrate##39##1##(1990-2#1)(1991-5#1)(1994-5#1)(2008-10#29)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#1)
filtrated##3##1##(2008-10#2)(2011-1#1)
filtrates of##10##2##(1992-9#1)(2008-10#8)(2008-11#1)
filtrates was##2##2##(2008-10#2)
filtrates##24##1##(1992-9#1)(2008-10#21)(2008-11#1)(2008-6#1)
filtration after##3##2##(1995-5#1)(2007-11#1)(2011-2#1)
filtration and a##2##3##(2008-10#2)
filtration and##25##2##(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1994-6#2)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
filtration chromatography and##5##3##(1990-2#1)(1994-8#1)(2008-10#3)
filtration chromatography##17##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#6)(2008-11#1)(2009-3#1)(2010-2#1)
filtration for##2##2##(1995-11#1)(2008-10#1)
filtration in##3##2##(1992-6#1)(1997-8#1)(2008-4#1)
filtration is##2##2##(2008-10#2)
filtration of extracts##2##3##(1993-3#1)(1993-6#1)
filtration of the##2##3##(1990-2#1)(2008-10#1)
filtration of##6##2##(1990-2#1)(1992-11#1)(1993-3#1)(1993-6#1)(2008-10#1)(2008-3#1)
filtration rate##19##2##(1995-12#3)(1996-6#4)(2008-1#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
filtration through##2##2##(1990-8#1)(1997-8#1)
filtration was used to##2##4##(1995-11#1)(2008-7#1)
filtration was##3##2##(1995-11#1)(1997-8#1)(2008-7#1)
filtration##174##1##(1990-12#3)(1990-2#6)(1990-5#1)(1990-7#5)(1990-8#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#2)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#4)(2007-11#1)(2008-1#1)(2008-10#45)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#1)(2009-3#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
fimA and fimF##4##3##(2008-10#4)
fimA##5##1##(2008-10#5)
fimF genes##3##2##(2008-10#3)
fimF##5##1##(2008-10#5)
fimbria##2##1##(1996-12#1)(2012-12#1)
fimbria-fornix lesioned rats##2##3##(1994-8#2)
fimbria-fornix lesions##2##2##(1994-8#2)
fimbria-fornix##4##1##(1994-8#4)
fimbriae##10##1##(1995-5#1)(1996-12#4)(2008-10#1)(2008-8#3)(2011-1#1)
fimbriae)##2##1##(1992-2#2)
fimbrial##13##1##(1996-6#1)(2008-10#6)(2012-12#6)
fimbriata complex##2##2##(2008-10#2)
fimbriata on the##2##3##(2008-10#2)
fimbriata##11##1##(2008-10#11)
fimbriate##2##1##(2007-12#1)(2008-10#1)
fin rays##2##2##(2013-7#2)
fin##21##1##(1993-12#1)(2008-11#2)(2008-5#3)(2008-8#1)(2010-8#3)(2011-2#1)(2013-7#10)
fin)##3##1##(2010-8#3)
fin-to-limb##2##1##(2012-12#2)
final ABO##2##2##(1994-6#2)
final DII##2##2##(2008-10#2)
final IgA concentration##2##3##(2008-11#2)
final MAb##3##2##(2008-11#2)(2008-7#1)
final R factor of##2##4##(1991-3#1)(2008-8#1)
final R factor##3##3##(1991-3#1)(2008-8#2)
final R##7##2##(1991-3#1)(1993-8#1)(1996-5#1)(1997-7#2)(2008-8#2)
final Si layer##3##3##(2007-11#3)
final admission##2##2##(1992-9#2)
final amount of disease##2##4##(2008-10#2)
final analysis of##2##3##(2009-3#1)(2012-2#1)
final analysis##9##2##(1992-3#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-2#2)(2013-8#1)
final analytical##2##2##(1994-6#1)(2008-3#1)
final antibody titer##2##3##(2008-11#2)
final antibody##3##2##(2008-11#3)
final assessment##3##2##(2007-8#1)(2008-7#2)
final body weight##2##3##(2010-4#1)(2012-2#1)
final body##3##2##(2010-4#1)(2012-2#2)
final cell concentration##2##3##(2008-6#1)(2008-7#1)
final cell density##3##3##(2008-11#3)
final cell##8##2##(2008-11#4)(2008-6#2)(2008-7#1)(2011-2#1)
final concentration of##5##3##(1990-12#1)(1991-9#1)(1995-12#1)(2008-10#1)(2013-1#1)
final conclusions##2##2##(1990-6#1)(2008-1#1)
final cost##2##2##(2008-2#1)(2008-6#1)
final data##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
final decision##6##2##(1992-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(2011-1#1)(2012-3#1)
final decline##2##2##(2008-10#2)
final design##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
final determination##3##2##(2008-10#3)
final diagnosis and##3##3##(1994-6#1)(2010-12#1)(2012-12#1)
final diagnosis of##8##3##(1990-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-3#1)
final diagnosis was##4##3##(1993-12#1)(2008-7#1)(2010-11#1)(2013-8#1)
final diagnosis##22##2##(1990-3#1)(1991-6#1)(1993-12#1)(1994-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
final disease incidence##3##3##(2008-10#3)
final disease intensity##3##3##(2008-10#3)
final disease severity##3##3##(2008-10#3)
final disease##11##2##(2008-10#11)
final evaluation##4##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)
final extract##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
final follow-up##4##2##(2007-8#3)(2008-9#1)
final height##4##2##(2007-11#2)(2008-4#1)(2008-6#1)
final incidence##3##2##(2008-10#3)
final lactic acid concentration of##2##5##(2008-6#2)
final mean body weights##2##4##(2008-9#2)
final mean body##4##3##(2008-9#4)
final measurements are##2##3##(2008-8#2)
final measurements##3##2##(2007-7#1)(2008-8#2)
final model consists of##2##4##(1992-4#1)(1997-4#1)
final model is##2##3##(2008-10#2)
final model##10##2##(1992-4#1)(1997-4#1)(2008-10#5)(2008-9#1)(2009-7#2)
final models were##2##3##(2008-10#1)(2011-2#1)
final number of##3##3##(2008-10#2)(2013-1#1)
final number##4##2##(2008-10#3)(2013-1#1)
final outcome##7##2##(1991-6#1)(1991-8#1)(2007-11#1)(2008-7#2)(2009-5#1)(2012-12#1)
final outcomes##3##2##(1997-7#1)(2008-9#1)(2013-1#1)
final output##2##2##(2007-11#1)(2008-3#1)
final ozonides##4##2##(1996-5#4)
final pH##2##2##(2008-10#1)(2008-12#1)
final part##6##2##(1993-12#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
final phase##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)
final procedure##2##2##(1996-3#1)(2008-4#1)
final product of the##2##4##(2008-10#2)
final product##24##2##(1990-7#1)(1992-3#1)(1994-12#1)(1994-6#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#2)(2010-4#1)(2012-2#2)(2013-1#1)
final products##5##2##(1996-5#1)(2008-10#2)(2008-4#1)(2011-2#1)
final protein##4##2##(1995-5#1)(2008-1#1)(2008-11#1)(2008-5#1)
final regulations##2##2##(1991-1#1)(1997-3#1)
final report##4##2##(1993-3#1)(1993-9#1)(2008-8#1)(2011-1#1)
final reports##2##2##(1993-12#1)(2012-3#1)
final residue##2##2##(2008-10#2)
final restoration##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
final result##10##2##(1993-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2013-1#1)
final results and the different##2##5##(2008-10#2)
final results##6##2##(2008-10#4)(2008-6#1)(2013-1#1)
final rule##4##2##(1993-3#1)(1996-12#1)(1996-3#2)
final sample##3##2##(2011-1#1)(2013-1#2)
final section##7##2##(1990-12#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#3)
final solution##10##2##(2008-10#10)
final specific activity of##2##4##(1990-7#1)(1997-6#1)
final specific activity##3##3##(1990-7#1)(1997-6#2)
final stage of##5##3##(2008-2#1)(2008-7#3)(2010-10#1)
final stages##6##2##(1990-5#1)(1997-8#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
final steps of##3##3##(1992-12#1)(1997-7#1)(2008-4#1)
final steps##4##2##(1991-6#1)(1992-12#1)(1997-7#1)(2008-4#1)
final support##3##2##(2008-2#1)(2008-4#2)
final system##2##2##(2008-2#1)(2009-10#1)
final test##3##2##(2010-3#2)(2013-1#1)
final volume##5##2##(2008-10#5)
final year of##3##3##(2008-11#2)(2008-12#1)
final##590##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#6)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-9#1)(1996-12#3)(1996-3#5)(1996-5#12)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#5)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#15)(2007-12#7)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#116)(2008-11#32)(2008-12#8)(2008-2#14)(2008-3#30)(2008-4#18)(2008-5#15)(2008-6#12)(2008-7#26)(2008-8#8)(2008-9#13)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#23)(2011-2#26)(2011-7#1)(2012-1#10)(2012-12#4)(2012-2#11)(2012-3#5)(2012-9#1)(2013-1#18)(2013-7#2)(2013-8#5)
final-year##2##1##(2013-1#2)
finalistic##2##1##(2012-3#2)
finalized##3##1##(2008-1#1)(2008-10#1)(2012-1#1)
finally a##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
finally achieved##2##2##(2006-10#1)(2013-1#1)
finally applied to the##2##4##(2008-10#2)
finally applied to##3##3##(2008-10#3)
finally applied##4##2##(2008-10#4)
finally be##2##2##(2010-12#1)(2012-2#1)
finally confirmed##3##2##(1996-6#1)(2007-7#1)(2011-2#1)
finally discuss##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
finally resulted in##2##3##(2008-10#1)(2012-2#1)
finally the##10##2##(1990-10#1)(1992-3#1)(1993-11#1)(1993-8#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
finally to##8##2##(2008-1#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-6#1)
finally treated##2##2##(2007-8#2)
finally##202##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#40)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#5)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#12)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#2)
finance and##2##2##(2008-11#1)(2008-12#1)
finance##28##1##(1990-4#1)(1991-2#2)(1992-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-4#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-8#1)
financed by the##4##3##(1994-1#1)(1995-2#1)(1996-1#1)(1996-2#1)
financed by##6##2##(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2010-4#1)
financed competition##3##2##(1992-2#3)
financed##16##1##(1992-2#3)(1994-1#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-12#1)(2010-4#1)(2012-1#1)
finances##3##1##(1994-1#1)(1996-3#1)(2013-8#1)
financial and operational##3##3##(1992-2#1)(1997-3#1)(2010-8#1)
financial and personnel##2##3##(1997-3#1)(2008-10#1)
financial and##20##2##(1992-2#1)(1993-12#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1997-3#2)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-8#2)(2012-12#1)
financial arrangements##3##2##(1993-1#3)
financial attitudes##2##2##(2010-10#2)
financial behavior##2##2##(2010-10#2)
financial benefit##2##2##(1993-3#1)(2012-12#1)
financial benefits##4##2##(1993-1#1)(1993-2#1)(2007-10#1)(2009-12#1)
financial burden##7##2##(1996-1#1)(2007-12#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-8#2)
financial burdens##2##2##(1996-3#1)(2008-8#1)
financial commitment##2##2##(1994-1#1)(1994-9#1)
financial consequences##2##2##(2008-11#1)(2008-3#1)
financial constraints##3##2##(1992-3#1)(2007-12#1)(2007-7#1)
financial data##3##2##(1992-1#1)(1995-12#1)(2012-12#1)
financial gains##2##2##(1991-2#1)(1993-12#1)
financial impact##4##2##(1991-2#1)(2008-11#1)(2008-9#1)(2010-8#1)
financial implications of##2##3##(1996-1#1)(2008-11#1)
financial implications##4##2##(1996-1#1)(1997-8#1)(2007-7#1)(2008-11#1)
financial incentives in##2##3##(1994-1#1)(1996-12#1)
financial incentives##10##2##(1991-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-8#1)
financial indicators##3##2##(2008-11#3)
financial learning##3##2##(2010-10#3)
financial losses##2##2##(1992-1#1)(1997-5#1)
financial management##10##2##(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-11#3)
financial need##2##2##(1992-3#1)(2008-12#1)
financial performance under##2##3##(1993-1#1)(1993-3#1)
financial performance##17##2##(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#3)(1995-1#1)(2008-11#2)(2008-6#1)(2012-3#1)
financial planning##4##2##(1991-12#1)(1994-2#1)(1996-2#1)(1997-1#1)
financial pressures##2##2##(2008-11#1)(2013-1#1)
financial resources##13##2##(1991-3#1)(1992-12#2)(1993-11#1)(1994-1#1)(1997-7#1)(2008-1#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#2)
financial risk##10##2##(1992-12#1)(1993-3#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(2011-1#2)
financial slack##2##2##(2008-11#2)
financial socialization##3##2##(2010-10#3)
financial status##3##2##(1993-12#1)(2008-11#2)
financial strain##5##2##(2007-10#2)(2011-2#1)(2013-1#2)
financial support##5##2##(1996-3#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
financial systems##3##2##(1994-3#1)(1996-1#1)(1997-3#1)
financial viability##2##2##(1991-12#1)(1996-2#1)
financial##263##1##(1990-4#2)(1991-1#1)(1991-12#5)(1991-2#4)(1991-3#2)(1992-1#3)(1992-12#9)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#10)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#5)(1993-6#1)(1994-1#11)(1994-12#6)(1994-2#9)(1994-3#4)(1994-9#1)(1995-1#5)(1995-12#5)(1995-2#1)(1995-3#1)(1996-1#6)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#5)(1996-4#1)(1997-1#6)(1997-2#3)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#26)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#14)(2010-2#1)(2010-3#3)(2010-5#4)(2010-8#6)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#7)
financially##14##1##(1991-1#1)(1993-3#1)(1994-1#1)(1994-2#2)(1996-1#1)(1996-3#3)(2008-1#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
financing and delivery##3##3##(1993-2#1)(1996-12#1)(2011-1#1)
financing and##11##2##(1993-2#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-5#1)(2008-11#1)(2008-7#1)(2011-1#1)
financing decisions##2##2##(1994-12#2)
financing for##2##2##(1996-3#1)(2011-1#1)
financing health care##3##3##(1993-3#1)(1996-3#1)(2008-1#1)
financing health##4##2##(1993-3#1)(1995-2#1)(1996-3#1)(2008-1#1)
financing in##3##2##(1991-3#1)(1993-2#1)(1993-3#1)
financing is##2##2##(1994-2#1)(1995-3#1)
financing of health care##3##4##(1992-3#1)(1995-1#1)(2008-11#1)
financing of the health##2##4##(1992-12#1)(2013-8#1)
financing of the##3##3##(1992-1#1)(1992-12#1)(2013-8#1)
financing of##16##2##(1992-1#4)(1992-12#1)(1992-3#1)(1993-2#2)(1994-2#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#2)
financing options##2##2##(2008-1#2)
financing##96##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#5)(1992-12#2)(1992-3#2)(1993-1#1)(1993-2#10)(1993-3#5)(1993-6#1)(1994-1#2)(1994-12#3)(1994-2#7)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#6)(1995-3#1)(1996-1#4)(1996-12#4)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#5)(2008-10#1)(2008-11#5)(2008-6#1)(2008-7#5)(2011-1#2)(2012-1#1)(2012-12#1)(2013-8#3)
finasteride for##2##2##(1995-9#1)(2008-5#1)
finasteride in human plasma##2##4##(2011-2#2)
finasteride##14##1##(1994-11#4)(1995-9#1)(2008-5#4)(2011-2#4)(2012-3#1)
finch##5##1##(1997-2#1)(2008-8#4)
finches##10##1##(1997-2#1)(2008-8#8)(2008-9#1)
find a common##3##3##(1990-8#1)(2007-12#1)(2011-2#1)
find a new##4##3##(1995-2#1)(2007-8#1)(2008-5#1)(2011-2#1)
find a possible##4##3##(2007-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
find a weak##2##3##(2008-10#2)
find a##62##2##(1990-3#1)(1990-8#2)(1991-12#1)(1992-1#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
find an association between##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
find an##21##2##(1992-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
find and##5##2##(1994-1#1)(1994-3#1)(1996-8#1)(2008-11#1)(2012-2#1)
find any significant difference##2##4##(2007-8#1)(2009-10#1)
find any significant##4##3##(2007-8#1)(2008-5#1)(2009-10#1)(2012-3#1)
find any##8##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-10#2)(2010-6#1)(2012-3#1)
find application in the##2##4##(2008-11#1)(2012-2#1)
find applications in the##2##4##(2008-10#1)(2010-7#1)
find applications in##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
find at least##2##3##(1997-6#1)(2008-9#1)
find better##2##2##(2011-3#1)(2012-2#1)
find differences##2##2##(2008-5#1)(2010-5#1)
find evidence for##2##3##(2008-8#1)(2012-3#1)
find evidence of##2##3##(2011-2#1)(2012-2#1)
find evidence that##2##3##(2008-9#1)(2012-2#1)
find evidence##6##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
find good agreement##2##3##(2008-3#2)
find good##4##2##(2007-12#1)(2008-3#2)(2008-6#1)
find human##2##2##(2008-4#1)(2008-5#1)
find it difficult to cope##2##5##(1992-6#1)(2010-10#1)
find it difficult to##3##4##(1992-6#1)(2008-11#1)(2010-10#1)
find it##6##2##(1992-6#1)(1992-8#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-2#1)
find little##2##2##(2009-7#1)(2009-9#1)
find many##4##2##(1995-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
find new##4##2##(1991-1#1)(1997-2#1)(2008-3#1)(2011-2#1)
find no evidence for##2##4##(1990-7#1)(2009-10#1)
find no##4##2##(1990-7#1)(2008-11#1)(2009-10#2)
find out how##3##3##(1990-2#1)(2008-5#1)(2011-2#1)
find out the##12##3##(1990-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
find out##33##2##(1990-2#3)(1990-6#1)(1991-11#1)(1991-6#1)(1993-6#1)(1994-9#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)
find that an##2##3##(1991-9#1)(2010-2#1)
find that even##2##3##(1994-11#1)(2011-2#1)
find that for##2##3##(2008-2#1)(2008-3#1)
find that in##4##3##(2008-3#1)(2010-3#1)(2013-1#2)
find that the calculated activation barriers of the##2##8##(2008-10#2)
find that the data##2##4##(1992-2#1)(1994-12#1)
find that the presence of##2##5##(1995-11#1)(2008-10#1)
find that the##52##3##(1990-11#1)(1990-7#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
find that there are two##2##5##(2008-3#1)(2008-9#1)
find that there are##3##4##(1993-12#1)(2008-3#1)(2008-9#1)
find that there##5##3##(1991-3#1)(1993-12#1)(1994-3#1)(2008-3#1)(2008-9#1)
find that these##2##3##(2009-3#1)(2009-9#1)
find that they have##2##4##(1993-1#1)(1993-9#1)
find that while##2##3##(2013-1#2)
find that##171##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#5)(1992-3#2)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#3)(1995-11#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#7)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#23)(2008-5#2)(2008-7#6)(2008-8#12)(2008-9#7)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-2#3)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#8)(2013-8#1)
find the optimal##4##3##(1992-12#1)(2008-10#1)(2008-3#2)
find the possible##2##3##(2007-11#1)(2008-6#1)
find the relationship##3##3##(2011-3#1)(2013-8#2)
find the##73##2##(1990-12#1)(1990-6#1)(1992-12#2)(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-11#3)(2007-12#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
find their##2##2##(1995-2#1)(2013-8#1)
find themselves in a##4##4##(1993-12#2)(2008-1#1)(2008-11#1)
find themselves##12##2##(1992-12#1)(1993-12#2)(1994-1#2)(1994-2#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
find this##2##2##(2007-11#1)(2008-9#1)
find use##2##2##(2007-12#1)(2008-3#1)
find ways to##4##3##(1992-12#1)(1995-9#1)(1996-5#1)(2008-9#1)
find ways##5##2##(1990-9#1)(1992-12#1)(1995-9#1)(1996-5#1)(2008-9#1)
find wide use##2##3##(2007-11#1)(2008-10#1)
find wide##4##2##(2007-11#1)(2008-10#2)(2012-3#1)
find##574##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#5)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-1#5)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#5)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#4)(2006-8#1)(2007-10#2)(2007-11#16)(2007-12#17)(2007-7#2)(2007-8#3)(2008-1#7)(2008-10#45)(2008-11#19)(2008-12#7)(2008-2#23)(2008-3#46)(2008-4#10)(2008-5#15)(2008-6#7)(2008-7#14)(2008-8#27)(2008-9#22)(2009-10#10)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#18)(2011-3#3)(2012-1#2)(2012-12#8)(2012-2#27)(2012-3#15)(2013-1#21)(2013-7#2)(2013-8#7)
finder##2##1##(2008-9#1)(2009-2#1)
finders##3##1##(2008-4#2)(2008-9#1)
finding a suitable##2##3##(1992-6#1)(2009-12#1)
finding a##11##2##(1992-6#1)(1995-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
finding an##4##2##(1996-1#1)(2007-12#1)(2008-11#1)(2008-6#1)
finding and##11##2##(1991-8#1)(1993-6#1)(1994-11#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#1)
finding at##2##2##(2011-2#2)
finding by##3##2##(1990-8#1)(2008-10#1)(2010-4#1)
finding demonstrates that##2##3##(1996-12#1)(2008-7#1)
finding during##4##2##(1992-9#1)(1993-5#1)(2008-12#1)(2010-12#1)
finding effective##2##2##(2007-11#1)(2008-9#1)
finding has##6##2##(1994-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
finding in a##2##3##(2008-12#1)(2009-6#1)
finding in the##3##3##(2007-8#1)(2011-2#2)
finding in this##2##3##(2011-1#2)
finding in##35##2##(1991-9#1)(1992-8#1)(1992-9#2)(1994-2#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#3)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
finding indicates##6##2##(1992-8#1)(1994-12#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-9#1)
finding information on the##2##4##(2010-3#2)
finding information on##3##3##(1994-3#1)(2010-3#2)
finding is consistent with##4##4##(1993-8#1)(2008-11#1)(2008-6#1)(2010-2#1)
finding is that##5##3##(1992-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
finding is the##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
finding is##24##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)
finding its##2##2##(1992-5#1)(2008-6#1)
finding may##6##2##(1990-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)
finding more##3##2##(1991-1#1)(1994-3#1)(2010-4#1)
finding new##2##2##(2011-2#1)(2012-3#1)
finding of a##11##3##(1990-11#1)(1992-9#1)(1993-9#1)(1996-12#2)(2006-10#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
finding of an##3##3##(1990-9#1)(1992-2#1)(1995-11#1)
finding of significant##2##3##(1997-5#1)(2013-1#1)
finding of these##3##3##(1990-3#1)(1993-12#1)(1994-10#1)
finding of this study##4##4##(1997-8#1)(2009-7#2)(2011-1#1)
finding of this##6##3##(1996-7#1)(1997-8#1)(2008-5#1)(2009-7#2)(2011-1#1)
finding of##61##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#2)(1997-5#1)(1997-8#2)(2006-10#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#2)(2010-12#1)(2010-3#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
finding on##5##2##(1995-2#1)(2010-11#1)(2011-2#1)(2013-1#2)
finding out how##2##3##(1994-6#1)(1996-3#1)
finding out##4##2##(1994-12#1)(1994-6#1)(1996-3#1)(2008-7#1)
finding represents##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
finding solutions to##3##3##(1994-12#1)(1996-3#1)(2008-2#1)
finding suggests that the##3##4##(1993-6#2)(2009-8#1)
finding suggests that##18##3##(1990-7#1)(1992-11#1)(1992-2#1)(1993-6#2)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
finding suggests##22##2##(1990-3#1)(1990-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#2)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
finding supports the##3##3##(1990-11#2)(1996-3#1)
finding supports##5##2##(1990-11#2)(1996-3#1)(2008-10#1)(2008-12#1)
finding that both##2##3##(1993-6#1)(1996-5#1)
finding that correlated with##2##4##(1996-1#2)
finding that it is##2##4##(2008-11#1)(2009-7#1)
finding that the##12##3##(1990-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-2#1)(2008-10#3)(2008-5#1)
finding that##68##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-6#4)(1996-1#2)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
finding the optimal##4##3##(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
finding the##15##2##(1992-12#1)(1995-11#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
finding their way##2##3##(1992-1#1)(2011-2#1)
finding was a##3##3##(1990-8#1)(1993-12#1)(2008-11#1)
finding was that the##2##4##(2008-10#1)(2010-5#1)
finding was that##6##3##(1992-12#1)(1995-6#1)(2008-10#2)(2008-7#1)(2010-5#1)
finding was the##5##3##(1990-2#1)(1992-5#1)(2008-12#2)(2009-8#1)
finding was##24##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-11#1)(1995-5#1)(1995-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
finding ways##2##2##(2008-12#1)(2009-11#1)
finding##488##1##(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#3)(1992-5#4)(1992-6#3)(1992-8#2)(1992-9#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#7)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#5)(1995-11#5)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#36)(2008-11#19)(2008-12#12)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#10)(2008-7#22)(2008-8#8)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#1)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#6)(2010-7#5)(2010-8#1)(2011-1#14)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#11)(2012-2#9)(2012-3#10)(2013-1#17)(2013-7#3)(2013-8#8)
findings (i)##2##2##(1994-8#1)(1995-6#1)
findings about the##3##3##(1992-3#1)(2008-5#1)(2009-5#1)
findings about##4##2##(1992-3#1)(2008-5#1)(2009-5#1)(2012-12#1)
findings across##2##2##(1995-11#1)(2008-12#1)
findings after##3##2##(1990-3#1)(2010-9#1)(2011-2#1)
findings along with##2##3##(2012-1#1)(2013-1#1)
findings also indicate that##2##4##(2012-2#1)(2013-1#1)
findings also indicate##3##3##(2009-2#1)(2012-2#1)(2013-1#1)
findings also suggest that##5##4##(1993-1#1)(1995-2#1)(2008-8#1)(2009-7#1)(2010-8#1)
findings also suggest##6##3##(1993-1#1)(1995-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-8#1)
findings also##17##2##(1993-1#1)(1994-12#1)(1995-2#1)(1995-6#1)(2008-11#2)(2008-4#2)(2008-8#1)(2009-2#1)(2009-7#2)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
findings among##4##2##(2008-1#1)(2010-2#1)(2011-2#2)
findings and clinical##5##3##(1991-8#1)(1993-11#1)(2012-12#3)
findings and implications##2##3##(1996-2#2)
findings and policy implications##2##4##(1991-12#2)
findings and recommendations##2##3##(2009-10#1)(2011-2#1)
findings and the##8##3##(1995-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#2)
findings and treatment##2##3##(1997-3#1)(2008-10#1)
findings and##80##2##(1990-3#1)(1991-12#2)(1991-8#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#3)(1996-5#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-8#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)
findings appear##2##2##(1991-5#1)(2008-10#1)
findings are as follows##2##4##(2008-7#1)(2008-8#1)
findings are compared with##2##4##(2008-7#1)(2011-2#1)
findings are compared##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
findings are considered##2##3##(1993-3#1)(2010-1#1)
findings are consistent with the##3##5##(1992-3#1)(2011-2#1)(2013-8#1)
findings are consistent with##9##4##(1992-10#1)(1992-3#1)(1996-5#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
findings are described##4##3##(1991-3#1)(1995-3#1)(2008-6#1)(2013-7#1)
findings are discussed and recommendations for##2##6##(2008-12#1)(2009-7#1)
findings are discussed and##3##4##(2008-12#1)(2009-7#1)(2012-1#1)
findings are discussed in light of##2##6##(2010-7#1)(2012-12#1)
findings are discussed in relation to the##3##7##(2008-12#1)(2008-7#1)(2012-2#1)
findings are discussed in relation to##5##6##(1993-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-2#1)
findings are discussed in relation##6##5##(1990-8#1)(1993-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-2#1)
findings are discussed in terms of evolutionary psychological explanations of mate selection##2##12##(2007-12#2)
findings are discussed in terms of##7##6##(1991-2#1)(1992-5#1)(2007-12#2)(2008-10#1)(2009-12#1)(2010-2#1)
findings are discussed in##18##4##(1990-8#1)(1991-2#1)(1992-5#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#2)
findings are discussed##36##3##(1990-8#1)(1991-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-1#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)
findings are fairly consistent##2##4##(1990-2#1)(1994-2#1)
findings are in##2##3##(1994-2#1)(2010-11#1)
findings are more##3##3##(1993-12#1)(1997-3#1)(2008-5#1)
findings are of##3##3##(1992-12#1)(1994-8#1)(2008-10#1)
findings are often##2##3##(2008-7#1)(2009-9#1)
findings are presented##4##3##(1993-2#1)(1997-3#1)(2008-11#1)(2011-2#1)
findings are related to##2##4##(2007-7#1)(2009-10#1)
findings are reported##3##3##(1994-6#1)(2008-6#1)(2009-7#1)
findings are supported by##2##4##(2008-3#1)(2008-5#1)
findings are supported##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
findings are##125##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-9#1)(1996-5#1)(1997-3#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#4)(2007-7#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
findings as well as##2##4##(2008-7#1)(2009-3#1)
findings as##5##2##(1994-3#1)(1995-5#1)(1997-8#1)(2008-7#1)(2009-3#1)
findings associated with##4##3##(1997-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
findings at##4##2##(1993-5#1)(1995-3#1)(2008-10#1)(2008-9#1)
findings between##3##2##(2009-10#1)(2012-12#2)
findings by##8##2##(1990-2#1)(1992-4#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#1)
findings can be explained by##2##5##(2008-11#1)(2008-9#1)
findings can be##6##3##(1995-11#1)(2008-11#2)(2008-6#1)(2008-9#1)(2012-2#1)
findings can##7##2##(1995-11#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-9#1)(2012-2#1)
findings cannot##2##2##(2008-11#1)(2010-12#1)
findings concerning the##3##3##(1991-2#1)(2008-11#1)(2009-7#1)
findings concerning##7##2##(1991-2#1)(2008-11#3)(2008-4#1)(2009-7#1)(2011-2#1)
findings confirm the##4##3##(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#1)
findings confirm##7##2##(2008-10#1)(2008-11#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-1#1)
findings confirmed that##2##3##(2010-1#1)(2011-2#1)
findings confirmed the diagnosis of##2##5##(2008-12#1)(2010-5#1)
findings confirmed the diagnosis##3##4##(2008-12#1)(2008-9#1)(2010-5#1)
findings confirmed the##4##3##(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
findings confirmed##7##2##(1994-8#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-2#1)
findings consistent with##2##3##(2008-10#2)
findings contribute to the##2##4##(2012-3#1)(2013-1#1)
findings contribute to##3##3##(2009-12#1)(2012-3#1)(2013-1#1)
findings could be##4##3##(1991-8#1)(2007-10#1)(2011-1#1)(2012-2#1)
findings could##7##2##(1991-8#1)(1994-3#1)(2007-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
findings demonstrate a##4##3##(1991-12#1)(1995-5#1)(2007-7#1)(2012-12#1)
findings demonstrate that the##2##4##(1993-12#1)(1997-4#1)
findings demonstrate that##13##3##(1993-12#1)(1993-6#1)(1995-11#1)(1997-4#2)(2007-12#1)(2008-5#2)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
findings demonstrate the importance of##2##5##(1993-3#1)(2010-7#1)
findings demonstrate the##6##3##(1993-3#1)(2008-1#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
findings demonstrate##27##2##(1990-5#1)(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-5#1)(1997-4#2)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#2)
findings demonstrated that##3##3##(1994-1#1)(2008-11#1)(2010-5#1)
findings demonstrated##5##2##(1994-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-5#1)
findings do not support the##2##5##(2009-7#1)(2013-8#1)
findings do not support##3##4##(1991-6#1)(2009-7#1)(2013-8#1)
findings do not##5##3##(1991-12#1)(1991-6#1)(2009-7#1)(2013-8#2)
findings during##3##2##(2008-3#1)(2009-8#1)(2011-2#1)
findings emphasize the##5##3##(1991-5#1)(1992-10#1)(1993-6#1)(2007-6#1)(2008-10#1)
findings establish##2##2##(1990-11#1)(2012-2#1)
findings except##2##2##(2008-7#1)(2009-2#1)
findings extend##2##2##(1996-7#1)(2013-8#1)
findings for a##2##3##(2007-9#1)(2008-2#1)
findings for the##8##3##(1991-5#1)(1994-8#1)(2008-1#1)(2008-10#2)(2009-11#1)(2009-9#1)(2012-1#1)
findings for##31##2##(1991-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
findings from a study##6##4##(1990-11#1)(1992-11#1)(1995-11#1)(2007-12#1)(2008-12#1)(2009-5#1)
findings from a##18##3##(1990-11#1)(1990-8#1)(1992-11#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-12#2)(2009-5#1)(2012-2#2)(2012-3#1)
findings from an##2##3##(1995-3#1)(2008-11#1)
findings from brain imaging studies in the offspring of individuals with BPD as well as in first-episode patients##2##18##(2009-8#2)
findings from brain imaging##3##4##(2008-11#1)(2009-8#2)
findings from our##2##3##(1991-12#1)(2010-2#1)
findings from studies of##2##4##(2008-1#1)(2011-1#1)
findings from studies##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
findings from the Canadian##2##4##(2008-12#2)
findings from the survey##2##4##(1994-3#1)(1996-1#1)
findings from the##18##3##(1992-9#1)(1994-3#1)(1996-1#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2009-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
findings from this##4##3##(1992-1#1)(2008-6#1)(2009-3#1)(2012-1#1)
findings from two##3##3##(1994-1#1)(1995-1#1)(2009-9#1)
findings from##69##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-9#2)(1993-12#1)(1994-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#2)(2008-6#2)(2009-1#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
findings further##4##2##(2008-7#2)(2009-4#1)(2009-5#1)
findings had##3##2##(1993-1#1)(2012-1#1)(2012-2#1)
findings have been##2##3##(1990-6#1)(2008-12#1)
findings have implications for##3##4##(1992-2#1)(2010-10#1)(2012-2#1)
findings have implications##4##3##(1992-2#1)(2010-10#1)(2012-2#1)(2012-3#1)
findings have important implications##4##4##(2008-10#2)(2009-8#1)(2012-1#1)
findings have important##6##3##(1994-12#1)(2008-1#1)(2008-10#2)(2009-8#1)(2012-1#1)
findings have provided##2##3##(2008-4#1)(2008-8#1)
findings have shown##3##3##(2008-4#1)(2010-1#1)(2012-2#1)
findings have##33##2##(1990-6#1)(1992-2#1)(1994-12#1)(1996-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)
findings help##2##2##(2008-5#1)(2013-8#1)
findings highlight that##2##3##(2011-2#1)(2013-1#1)
findings highlight the need to##2##5##(2008-10#1)(2011-2#1)
findings highlight the need##4##4##(2008-10#1)(2011-2#2)(2013-1#1)
findings highlight the##10##3##(1995-12#1)(2008-10#1)(2009-2#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
findings highlight##13##2##(1995-12#1)(2008-10#1)(2009-2#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
findings identify##2##2##(2008-1#1)(2013-1#1)
findings illustrate that##3##3##(1994-3#1)(2008-9#1)(2012-2#1)
findings illustrate the##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
findings illustrate##8##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)
findings implicate##2##2##(2009-9#1)(2012-2#1)
findings imply that##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
findings imply##4##2##(2008-10#1)(2008-9#2)(2012-2#1)
findings in a patient with##2##5##(2007-10#1)(2011-2#1)
findings in a##9##3##(1990-11#1)(1994-10#1)(1996-12#1)(2007-10#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)
findings in captive##2##3##(2007-12#1)(2008-5#1)
findings in children with##2##4##(2011-2#2)
findings in children##3##3##(2008-1#1)(2011-2#2)
findings in different##2##3##(2011-2#1)(2013-1#1)
findings in our##2##3##(2010-10#1)(2011-2#1)
findings in patients with##5##4##(1990-12#1)(1997-8#1)(2007-8#1)(2008-7#1)(2012-12#1)
findings in patients##6##3##(1990-12#1)(1997-8#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
findings in relation to the##2##5##(2008-8#1)(2008-9#1)
findings in relation to##4##4##(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)
findings in the control##2##4##(1996-7#1)(2008-10#1)
findings in the field##2##4##(2009-10#1)(2012-2#1)
findings in the literature##2##4##(2009-10#1)(2012-1#1)
findings in the##15##3##(1990-11#1)(1990-9#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#2)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
findings in this##6##3##(1992-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)
findings in vitro##2##3##(1994-11#1)(2008-7#1)
findings in women##2##3##(1996-12#1)(2011-1#1)
findings in##117##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-11#2)(1996-12#2)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-8#2)(2006-10#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#4)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#14)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)
findings include the##2##3##(1993-3#1)(2011-2#1)
findings include##7##2##(1993-1#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-9#1)(2011-2#1)
findings included a##4##3##(1991-12#1)(1992-3#1)(2008-9#1)(2010-5#1)
findings included##9##2##(1991-12#1)(1992-3#1)(1996-1#1)(2007-7#1)(2008-5#1)(2008-9#3)(2010-5#1)
findings indicate a##8##3##(1994-11#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
findings indicate that ET-1##2##4##(1991-5#1)(1993-3#1)
findings indicate that both##2##4##(1995-12#1)(1997-5#1)
findings indicate that the##15##4##(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#2)(1995-6#1)(1996-2#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-11#1)(2012-12#1)
findings indicate that there are##2##5##(1992-1#1)(1993-3#1)
findings indicate that##88##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-12#3)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-4#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#3)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
findings indicate the##5##3##(1993-12#2)(2008-12#1)(2008-5#1)(2008-7#1)
findings indicate##108##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-12#5)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#3)(2009-3#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-8#2)
findings indicated that##17##3##(1994-11#1)(1994-8#1)(2007-12#2)(2007-7#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
findings indicated##18##2##(1994-11#1)(1994-8#1)(2007-12#2)(2007-7#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
findings indicating##2##2##(1994-8#1)(2008-4#1)
findings into##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
findings is discussed##2##3##(2009-7#1)(2011-2#1)
findings is##9##2##(1995-8#1)(2007-12#1)(2007-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
findings lend##2##2##(2008-5#1)(2010-1#1)
findings made##2##2##(2007-5#1)(2010-3#1)
findings may be of##3##4##(1990-6#1)(2008-11#1)(2012-2#1)
findings may be##7##3##(1990-6#1)(1990-8#1)(1991-2#1)(2007-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
findings may have##5##3##(1993-12#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
findings may help##2##3##(2007-10#1)(2013-1#1)
findings may open new##2##4##(2008-4#1)(2010-11#1)
findings may provide##4##3##(1993-1#1)(1996-4#1)(2008-10#1)(2008-6#1)
findings may##31##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-4#1)(2006-6#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-2#4)(2012-3#1)(2013-1#3)
findings might##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
findings must##2##2##(1991-11#1)(2013-1#1)
findings obtained by##2##3##(2008-10#1)(2011-2#1)
findings obtained from##4##3##(1991-2#1)(1996-11#1)(1996-4#1)(2009-8#1)
findings obtained in##3##3##(1994-12#1)(2008-5#1)(2011-1#1)
findings obtained##11##2##(1990-8#1)(1991-2#1)(1994-12#1)(1995-9#1)(1996-11#1)(1996-4#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
findings of a cross-sectional study##2##5##(2010-3#1)(2011-2#1)
findings of a study##2##4##(1992-3#1)(1997-3#1)
findings of a##34##3##(1990-3#1)(1991-12#1)(1991-8#1)(1992-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-2#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-6#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#2)
findings of all##2##3##(2008-5#1)(2009-2#1)
findings of an##5##3##(1992-3#1)(1994-2#1)(1995-6#1)(2008-12#1)(2008-4#1)
findings of other investigators##2##4##(1990-3#1)(1994-8#1)
findings of other##3##3##(1990-3#1)(1994-8#1)(2008-1#1)
findings of patients with##2##4##(1996-11#1)(1997-8#1)
findings of several##2##3##(2008-11#1)(2008-7#1)
findings of sexual abuse##2##4##(2009-9#2)
findings of the study##5##4##(2007-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
findings of the##30##3##(1990-8#1)(1994-1#1)(1995-11#2)(1996-3#1)(2007-10#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#2)
findings of this study are##5##5##(1992-8#1)(2008-11#1)(2008-7#1)(2011-1#2)
findings of this study##26##4##(1992-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-9#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#3)
findings of this##36##3##(1992-8#1)(1993-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-9#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-4#2)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#3)
findings of##201##2##(1990-3#2)(1990-8#1)(1991-12#1)(1991-8#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-7#1)(1997-3#2)(1997-7#1)(1997-8#7)(2006-10#2)(2006-12#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-1#8)(2008-10#9)(2008-11#13)(2008-12#10)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#14)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#13)(2013-8#3)
findings offer##4##2##(1993-8#1)(1995-1#1)(2011-1#1)(2012-2#1)
findings on MR##2##3##(1997-8#2)
findings on the role of##2##5##(1991-1#1)(2009-10#1)
findings on the##17##3##(1991-1#1)(1991-12#1)(1994-1#1)(1994-8#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)
findings on##48##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
findings or##2##2##(2007-10#1)(2008-7#1)
findings point to an##2##4##(1991-11#1)(1991-2#1)
findings point to the need for##4##6##(1991-3#1)(1994-2#1)(2008-10#1)(2009-9#1)
findings point to##8##3##(1991-11#1)(1991-2#1)(1991-3#1)(1994-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-3#1)
findings present##3##2##(2008-12#1)(2008-9#1)(2010-12#1)
findings presented##4##2##(1993-3#1)(2008-11#1)(2008-8#1)(2010-8#1)
findings proved##2##2##(2008-11#1)(2012-12#1)
findings provide a##9##3##(1990-3#1)(1991-8#1)(2007-11#1)(2007-8#1)(2008-9#1)(2012-2#2)(2013-1#2)
findings provide evidence that##4##4##(1991-12#1)(1994-8#1)(1995-2#1)(1997-3#1)
findings provide##29##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
findings provided##2##2##(1994-6#1)(2010-8#1)
findings question the##2##3##(1996-2#1)(2013-1#1)
findings regarding the##5##3##(1992-12#1)(1993-3#1)(2008-11#1)(2012-2#1)(2013-8#1)
findings regarding##8##2##(1992-12#1)(1993-3#1)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
findings related to##4##3##(1996-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
findings reported in##3##3##(2008-12#1)(2011-3#1)(2012-3#1)
findings reported##4##2##(1993-8#1)(2008-12#1)(2011-3#1)(2012-3#1)
findings represent a##2##3##(1997-3#1)(2008-10#1)
findings represent##3##2##(1997-3#1)(2008-10#1)(2009-10#1)
findings require##3##2##(1996-7#1)(2008-11#1)(2011-2#1)
findings reveal an##2##3##(1995-2#1)(2010-8#1)
findings reveal the##2##3##(2009-5#1)(2012-2#1)
findings reveal##7##2##(1991-11#1)(1995-2#1)(1996-12#1)(2009-5#2)(2010-8#1)(2012-2#1)
findings revealed a##4##3##(2009-12#1)(2011-2#2)(2012-12#1)
findings revealed an##2##3##(2008-1#1)(2008-5#1)
findings revealed that##3##3##(2008-10#1)(2008-12#1)(2010-3#1)
findings revealed##16##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
findings seem to suggest that##2##5##(2009-7#1)(2012-12#1)
findings seem to##3##3##(2009-6#1)(2009-7#1)(2012-12#1)
findings seem##4##2##(2008-7#1)(2009-6#1)(2009-7#1)(2012-12#1)
findings should be##3##3##(2008-11#1)(2009-11#1)(2013-1#1)
findings should##6##2##(1994-1#1)(2008-11#1)(2009-11#1)(2012-2#2)(2013-1#1)
findings show that the##5##4##(1996-5#1)(2010-3#1)(2011-2#1)(2012-2#2)
findings show that##24##3##(1993-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#3)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#1)
findings show##39##2##(1990-8#1)(1991-2#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#12)
findings showed a##5##3##(1991-11#1)(1994-12#1)(2007-2#1)(2009-1#1)(2013-8#1)
findings showed that##5##3##(2008-10#2)(2008-12#1)(2010-2#1)(2011-2#1)
findings showed##21##2##(1991-11#1)(1991-8#1)(1994-12#1)(1994-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-1#1)(2010-2#1)(2010-6#3)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#2)
findings showing##3##2##(2008-7#2)(2013-7#1)
findings strongly suggest that##2##4##(1995-12#1)(2009-7#1)
findings strongly suggest##3##3##(1995-12#1)(2009-7#1)(2012-3#1)
findings strongly support the##3##4##(1995-12#1)(1997-7#1)(2008-5#1)
findings strongly##6##2##(1995-12#2)(1997-7#1)(2008-5#1)(2009-7#1)(2012-3#1)
findings such as##3##3##(1997-8#1)(2007-7#1)(2010-12#1)
findings suggest a role for##4##5##(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)
findings suggest a role##5##4##(1990-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)
findings suggest a##14##3##(1990-5#1)(1990-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-5#1)
findings suggest an##6##3##(1992-12#1)(1992-2#1)(1994-12#1)(1996-3#1)(1997-8#1)(2008-9#1)
findings suggest different##2##3##(2008-10#1)(2012-2#1)
findings suggest its##2##3##(2008-5#1)(2013-1#1)
findings suggest that a##7##4##(1990-2#1)(1992-1#1)(1993-8#1)(1995-3#1)(2007-12#1)(2013-1#1)(2013-8#1)
findings suggest that an##2##4##(1992-2#1)(2012-2#1)
findings suggest that the barrier##2##5##(2008-10#1)(2008-7#1)
findings suggest that the##39##4##(1990-11#1)(1990-6#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#2)(1994-11#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-2#1)(1996-5#2)(1997-7#1)(2007-4#1)(2008-10#1)(2008-11#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
findings suggest that there are##3##5##(1992-3#1)(1993-2#1)(2008-7#1)
findings suggest that there##4##4##(1992-3#1)(1993-2#1)(2008-7#1)(2008-8#1)
findings suggest that##191##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#4)(1992-3#2)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#5)
findings suggest the need##2##4##(1992-2#1)(2010-4#1)
findings suggest the##14##3##(1992-2#2)(1992-6#1)(1993-3#2)(1994-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-8#2)
findings suggest##241##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-2#3)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#7)(1992-3#2)(1992-6#4)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#6)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#11)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#6)
findings suggested a##2##3##(1994-6#1)(2008-7#1)
findings suggested that##12##3##(1991-12#1)(1994-11#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-9#2)(2011-2#1)(2013-1#2)(2013-8#1)
findings suggested##17##2##(1990-7#1)(1991-12#1)(1994-11#1)(1994-6#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#3)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
findings suggestive of##2##3##(2008-7#2)
findings support the notion that##2##5##(2008-7#1)(2009-8#1)
findings support the##15##3##(1990-12#1)(1991-7#1)(1994-11#1)(1994-2#1)(1996-7#1)(2007-11#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
findings support##22##2##(1990-12#1)(1990-8#1)(1991-7#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
findings that can##2##3##(2008-10#1)(2010-6#1)
findings that have##2##3##(2008-10#1)(2008-11#1)
findings that the##5##3##(1992-12#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-8#1)
findings that##35##2##(1990-7#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-5#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)
findings the##4##2##(1990-8#1)(2007-8#1)(2008-10#2)
findings to further##2##3##(2008-12#2)
findings to the##4##3##(1994-2#1)(2007-5#1)(2008-10#1)(2008-7#1)
findings to##18##2##(1990-6#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)
findings underscore the##3##3##(1991-2#1)(1995-2#1)(2008-5#1)
findings was that##2##3##(1991-6#1)(2011-2#1)
findings was##8##2##(1991-3#1)(1991-6#1)(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#2)
findings were as follows##3##4##(1990-10#1)(1997-2#1)(2008-7#1)
findings were classified##2##3##(1990-9#1)(2008-7#1)
findings were compatible with##4##4##(1991-8#2)(2007-8#1)(2011-2#1)
findings were confirmed by##2##4##(2008-10#1)(2010-11#1)
findings were confirmed##7##3##(1993-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#1)(2011-2#1)
findings were consistent with##4##4##(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
findings were correlated##2##3##(1995-3#1)(2012-2#1)
findings were discussed##2##3##(2009-8#1)(2010-1#1)
findings were not significant in the remaining##2##7##(2009-2#2)
findings were suggestive of##2##4##(2008-7#1)(2009-1#1)
findings were##60##2##(1990-10#1)(1990-9#2)(1991-3#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
findings which##4##2##(1992-11#1)(1995-11#1)(2008-11#1)(2009-4#1)
findings will be##2##3##(1993-2#1)(2011-1#1)
findings will help##4##3##(1993-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
findings will##10##2##(1993-2#2)(2008-11#2)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
findings with respect to##3##4##(1994-3#1)(2008-1#1)(2008-5#1)
findings with the##4##3##(1991-2#1)(2008-10#2)(2010-7#1)
findings with those##2##3##(2008-10#1)(2010-12#1)
findings with##20##2##(1990-3#1)(1991-2#1)(1994-1#1)(1994-3#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)
findings would##2##2##(2008-6#1)(2011-2#1)
findings##2146##1##(1990-10#1)(1990-11#9)(1990-12#5)(1990-2#5)(1990-3#10)(1990-5#5)(1990-6#7)(1990-7#5)(1990-8#10)(1990-9#4)(1991-1#4)(1991-10#1)(1991-11#6)(1991-12#16)(1991-2#15)(1991-3#8)(1991-4#1)(1991-5#5)(1991-6#5)(1991-7#1)(1991-8#11)(1991-9#1)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#15)(1992-2#9)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#8)(1992-9#3)(1993-1#10)(1993-11#4)(1993-12#23)(1993-2#10)(1993-3#15)(1993-5#3)(1993-6#6)(1993-8#5)(1993-9#7)(1994-1#9)(1994-10#1)(1994-11#12)(1994-12#12)(1994-2#17)(1994-3#13)(1994-5#2)(1994-6#8)(1994-7#1)(1994-8#17)(1994-9#3)(1995-1#11)(1995-11#15)(1995-12#16)(1995-2#10)(1995-3#10)(1995-4#2)(1995-5#7)(1995-6#9)(1995-8#4)(1995-9#3)(1996-1#3)(1996-11#8)(1996-12#13)(1996-2#10)(1996-3#10)(1996-4#2)(1996-5#12)(1996-6#3)(1996-7#6)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#26)(1997-4#7)(1997-5#4)(1997-6#4)(1997-7#8)(1997-8#24)(2006-10#5)(2006-12#3)(2006-6#3)(2007-1#1)(2007-10#15)(2007-11#11)(2007-12#28)(2007-2#3)(2007-4#5)(2007-5#4)(2007-6#2)(2007-7#12)(2007-8#11)(2007-9#2)(2008-1#42)(2008-10#115)(2008-11#101)(2008-12#49)(2008-2#8)(2008-3#27)(2008-4#26)(2008-5#43)(2008-6#22)(2008-7#85)(2008-8#43)(2008-9#52)(2009-1#5)(2009-10#15)(2009-11#8)(2009-12#12)(2009-2#8)(2009-3#10)(2009-4#7)(2009-5#20)(2009-6#8)(2009-7#23)(2009-8#17)(2009-9#18)(2010-1#9)(2010-10#8)(2010-11#9)(2010-12#17)(2010-2#11)(2010-3#10)(2010-4#9)(2010-5#9)(2010-6#15)(2010-7#7)(2010-8#16)(2010-9#6)(2011-1#34)(2011-10#1)(2011-2#116)(2011-3#4)(2011-7#2)(2011-8#1)(2012-1#24)(2012-12#47)(2012-2#102)(2012-3#37)(2012-7#1)(2013-1#95)(2013-7#4)(2013-8#60)
finds a##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
finds its##2##2##(1993-11#1)(2011-2#1)
finds itself##2##2##(1993-3#1)(2008-11#1)
finds that##6##2##(1992-2#1)(1994-2#2)(1995-2#1)(1995-9#1)(1996-1#1)
finds the##3##2##(1991-3#1)(1996-1#1)(1997-6#1)
finds##32##1##(1991-3#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-2#2)(1995-2#3)(1995-9#1)(1996-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-1#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-1#1)(2013-1#1)
fine and coarse##4##3##(2008-10#1)(2008-3#3)
fine and##5##2##(2008-10#1)(2008-3#3)(2012-1#1)
fine chlorotic streaks##2##3##(2008-10#2)
fine grain##2##2##(2008-10#1)(2008-3#1)
fine mapping##5##2##(2008-11#2)(2008-4#1)(2009-10#1)(2009-5#1)
fine needle aspiration (FNA)##2##4##(2008-6#1)(2008-7#1)
fine needle aspiration biopsy##3##4##(1991-6#1)(1992-8#1)(1997-2#1)
fine needle aspiration cytology and##2##5##(2013-8#2)
fine needle aspiration cytology in the##2##6##(1990-6#1)(2011-2#1)
fine needle aspiration cytology in##4##5##(1990-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
fine needle aspiration cytology##12##4##(1990-10#1)(1990-6#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#4)
fine needle aspiration##21##3##(1990-10#2)(1990-6#2)(1991-3#1)(1991-6#2)(1992-8#1)(1997-2#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#4)
fine needle biopsy##2##3##(1991-2#1)(1991-3#1)
fine needle##29##2##(1990-10#3)(1990-6#2)(1991-2#1)(1991-3#2)(1991-6#2)(1992-5#1)(1992-8#1)(1994-7#2)(1997-2#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#4)
fine particle mass##3##3##(1996-2#2)(1997-2#1)
fine particles##3##2##(1995-6#1)(2008-12#2)
fine spectral##2##2##(2007-11#1)(2008-3#1)
fine structure analysis##2##3##(2007-7#1)(2008-10#1)
fine structure and##2##3##(1990-12#1)(2007-12#1)
fine structure in##2##3##(2007-11#1)(2007-12#1)
fine structure is##2##3##(2008-10#1)(2008-2#1)
fine structure of the##4##4##(1992-1#1)(2007-12#1)(2008-7#1)(2008-8#1)
fine structure of##9##3##(1992-1#1)(2007-12#4)(2008-7#3)(2008-8#1)
fine structure##24##2##(1990-12#1)(1992-1#1)(1996-2#1)(2007-11#2)(2007-12#6)(2007-7#1)(2008-10#3)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#2)
fine structures##2##2##(2008-3#2)
fine surface##2##2##(2008-3#2)
fine tune the##2##3##(2008-3#1)(2008-9#1)
fine tuning##2##2##(1996-5#1)(2007-11#1)
fine variations in some##2##4##(1993-5#1)(2008-8#1)
fine##153##1##(1990-10#3)(1990-12#1)(1990-6#2)(1991-2#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-3#1)(1994-7#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#3)(1996-5#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#5)(2007-12#7)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#16)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
fine-grained disturbances##2##2##(2008-8#2)
fine-grained##5##1##(2008-8#4)(2009-3#1)
fine-level##2##1##(2008-10#2)
fine-needle aspirate biopsies##2##3##(2008-9#2)
fine-needle aspiration (FNA)##2##3##(2007-5#2)
fine-needle aspiration biopsy (FNAB)##3##4##(2008-6#1)(2011-1#1)(2011-2#1)
fine-needle aspiration biopsy##6##3##(2008-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
fine-needle aspiration cytology##2##3##(2008-10#1)(2008-6#1)
fine-needle aspiration##13##2##(1994-6#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-6#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
fine-needle##17##1##(1990-5#1)(1994-6#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-6#3)(2008-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
fine-scale##3##1##(1994-12#1)(2007-11#1)(2008-3#1)
fine-structure##2##1##(2008-10#2)
fine-tune##3##1##(2008-4#1)(2008-5#1)(2012-12#1)
fine-tuned##2##1##(2008-10#1)(2012-2#1)
fine-tuning and##2##2##(1995-1#1)(2009-7#1)
fine-tuning of##4##2##(1995-9#1)(2008-10#1)(2012-3#1)(2013-8#1)
fine-tuning the##2##2##(1992-3#1)(2010-8#1)
fine-tuning##11##1##(1992-3#1)(1995-1#1)(1995-9#2)(2008-10#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
finely tuned##6##2##(1992-12#1)(1994-12#2)(1996-2#1)(2006-10#1)(2008-11#1)
finely##17##1##(1992-12#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-2#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)
fineneedle aspiration##2##2##(1993-12#2)
finer##4##1##(1995-3#1)(2008-3#1)(2012-2#1)(2013-1#1)
fines##3##1##(1993-3#1)(1995-12#1)(2008-8#1)
finesse##10##1##(1996-2#1)(2007-12#1)(2008-2#3)(2008-3#5)
finfish##2##1##(1992-8#2)
finger and##3##2##(1992-6#1)(1996-2#1)(2013-1#1)
finger breadth##2##2##(2012-12#2)
finger counting##2##2##(2013-8#2)
finger family##3##2##(1997-3#1)(1997-7#1)(1997-9#1)
finger in##6##2##(1990-5#1)(1991-2#2)(2007-11#1)(2008-9#2)
finger marks##2##2##(2012-2#2)
finger motifs##2##2##(1991-9#2)
finger movements##2##2##(1996-2#1)(2008-11#1)
finger pressure was##2##3##(2008-1#2)
finger pressure##5##2##(2008-1#4)(2008-5#1)
finger protein##10##2##(1990-11#1)(1992-7#2)(1996-6#1)(1997-3#3)(1997-7#1)(2007-12#1)(2013-1#1)
finger tapping##3##2##(1991-12#1)(1994-3#1)(2008-7#1)
finger that##3##2##(2008-12#1)(2008-9#1)(2010-10#1)
finger transcription factor##2##3##(2010-2#1)(2012-2#1)
finger##115##1##(1990-11#3)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#9)(1991-5#3)(1991-8#1)(1991-9#3)(1992-6#1)(1992-7#2)(1992-8#3)(1994-3#1)(1994-6#1)(1996-2#5)(1996-6#2)(1997-3#4)(1997-7#2)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#23)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#8)
finger-like##4##1##(1992-3#1)(2007-12#2)(2009-7#1)
fingerlings##4##1##(2008-10#3)(2013-1#1)
fingernails##3##1##(2010-5#3)
fingerprint and##4##2##(1996-12#1)(2008-10#3)
fingerprint data##2##2##(2008-10#2)
fingerprint of##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
fingerprint pattern was##2##3##(2011-2#2)
fingerprint pattern##6##2##(2008-10#2)(2011-2#4)
fingerprint patterns##10##2##(2008-10#7)(2011-2#3)
fingerprint probe##4##2##(2008-10#4)
fingerprint profiles were##2##3##(2008-10#2)
fingerprint profiles##3##2##(2008-10#3)
fingerprint to##2##2##(2008-10#2)
fingerprint types##4##2##(2008-10#3)(2011-2#1)
fingerprint with##2##2##(2008-10#2)
fingerprint##78##1##(1992-8#1)(1993-8#2)(1996-12#1)(2007-12#4)(2008-10#49)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#9)(2012-2#1)(2012-3#1)(2013-8#2)
fingerprinted by##2##2##(2008-10#1)(2011-2#1)
fingerprinted##3##1##(2008-10#2)(2011-2#1)
fingerprinting and##3##2##(2008-10#3)
fingerprinting by##2##2##(2008-10#2)
fingerprinting data##2##2##(2008-10#1)(2008-4#1)
fingerprinting of##4##2##(1996-12#1)(2008-10#3)
fingerprinting using##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
fingerprinting was used to##2##4##(2008-10#1)(2008-5#1)
fingerprinting with four##2##3##(2008-10#2)
fingerprinting with##5##2##(2008-10#5)
fingerprinting##49##1##(1993-8#1)(1995-6#1)(1996-12#2)(2008-10#37)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-5#1)
fingerprints and##6##2##(2008-10#4)(2011-3#2)
fingerprints for##4##2##(2008-10#3)(2013-1#1)
fingerprints from##2##2##(2008-10#2)
fingerprints identical to##2##3##(2008-10#2)
fingerprints identified##3##2##(2008-10#2)(2008-4#1)
fingerprints in##3##2##(2008-10#1)(2011-2#2)
fingerprints of the##2##3##(2008-10#2)
fingerprints of##18##2##(2008-10#11)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
fingerprints showed##2##2##(2008-10#2)
fingerprints using##2##2##(2008-10#2)
fingerprints were identified from the##2##5##(2008-10#2)
fingerprints were##10##2##(2008-10#9)(2008-8#1)
fingerprints##73##1##(2008-10#50)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#4)(2012-2#1)(2012-3#1)(2013-1#1)
fingers and##3##2##(1997-7#1)(2008-6#1)(2013-8#1)
fingers at##4##2##(2008-1#1)(2010-10#1)(2011-1#2)
fingers in##4##2##(2011-2#1)(2013-8#3)
fingers of the##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
fingers of##5##2##(1992-8#1)(2008-10#2)(2008-5#1)(2009-5#1)
fingers##43##1##(1990-11#1)(1991-12#1)(1991-6#1)(1992-8#3)(1993-2#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-7#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-5#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
fingers)##3##1##(2008-9#2)(2013-1#1)
fingertip features##3##2##(2012-12#3)
fingertip reconstruction##2##2##(2008-9#2)
fingertip##8##1##(1994-3#1)(2008-9#3)(2011-2#1)(2012-12#3)
finish with##2##2##(2008-7#1)(2011-2#1)
finish##5##1##(2007-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
finished genome sequence##3##3##(2007-11#1)(2011-2#2)
finished product##2##2##(2008-10#1)(2008-5#1)
finished products##2##2##(2008-5#2)
finished sequence##2##2##(2008-4#1)(2008-7#1)
finished with##3##2##(2008-3#1)(2012-3#2)
finished within##4##2##(1995-3#1)(2008-10#1)(2010-5#1)(2011-1#1)
finished##36##1##(1992-1#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
finishes##2##1##(1995-6#1)(2012-12#1)
finishing diet##3##2##(2008-12#2)(2010-2#1)
finishing performance##2##2##(2008-12#2)
finishing period##2##2##(2008-12#1)(2013-1#1)
finishing pigs##10##2##(2010-2#4)(2012-2#6)
finishing##34##1##(1990-3#1)(2007-8#1)(2008-10#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#7)(2010-4#1)(2010-7#1)(2012-2#6)(2012-7#1)(2013-1#1)
finite and infinite##2##3##(2008-3#2)
finite aperture##2##2##(2008-3#2)
finite apertures##2##2##(2007-12#1)(2008-3#1)
finite bandwidth of##2##3##(2007-12#1)(2008-3#1)
finite circular cylinders##2##3##(2008-2#2)
finite depth##2##2##(2008-2#1)(2008-3#1)
finite element (FE) models##2##4##(2008-7#1)(2013-1#1)
finite element (FE)##4##3##(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)
finite element analysis##6##3##(2008-7#2)(2009-6#1)(2009-7#1)(2013-1#2)
finite element formulation##2##3##(2008-7#2)
finite element method##4##3##(2008-7#2)(2009-7#1)(2013-8#1)
finite element model##4##3##(2008-2#1)(2008-7#1)(2011-2#2)
finite element modeling##4##3##(2007-7#2)(2008-6#1)(2009-7#1)
finite element models##2##3##(2008-7#1)(2013-1#1)
finite element##28##2##(2007-7#2)(2008-2#1)(2008-6#2)(2008-7#9)(2009-6#1)(2009-7#5)(2011-2#2)(2013-1#5)(2013-8#1)
finite elements##2##2##(2008-7#1)(2011-2#1)
finite extent##4##2##(2007-12#2)(2008-3#2)
finite life##2##2##(2008-11#1)(2008-9#1)
finite periodic and quasi-periodic##2##4##(2008-3#2)
finite rate of increase (lambda)##2##5##(2011-2#2)
finite resources##2##2##(1992-3#1)(1995-12#1)
finite response time of the##2##5##(2007-12#2)
finite response time##3##3##(2007-12#2)(2008-3#1)
finite sample performance##2##3##(2009-10#1)(2010-3#1)
finite sample##3##2##(2009-10#1)(2010-11#1)(2010-3#1)
finite##129##1##(1990-5#1)(1990-8#1)(1992-3#1)(1995-12#1)(1996-4#3)(1997-3#1)(1997-7#1)(2007-11#8)(2007-12#8)(2007-7#2)(2008-11#3)(2008-2#18)(2008-3#36)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#5)(2010-11#1)(2010-3#1)(2011-2#5)(2013-1#8)(2013-8#2)
finite-aperture##5##1##(2008-2#3)(2008-3#2)
finite-difference beam propagation method##2##4##(2008-3#2)
finite-difference time-domain (FDTD) technique##2##4##(2008-3#2)
finite-difference time-domain (FDTD)##6##3##(2007-11#1)(2008-3#5)
finite-difference time-domain calculations##2##3##(2007-12#2)
finite-difference time-domain method##9##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)(2013-8#1)
finite-difference time-domain simulations##2##3##(2008-3#2)
finite-difference time-domain##24##2##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#14)(2013-8#1)
finite-difference##28##1##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#18)(2013-8#1)
finite-element analysis##5##2##(2008-3#4)(2008-5#1)
finite-element method##3##2##(2008-2#3)
finite-element model##2##2##(1994-5#1)(2008-3#1)
finite-element##18##1##(1994-5#1)(2008-2#3)(2008-3#12)(2008-5#1)(2008-8#1)
finite-element-based beam-propagation method##2##3##(2008-3#2)
finite-impulse-response##2##1##(2008-2#2)
finite-length##3##1##(2008-10#1)(2008-2#2)
finite-sample performance##2##2##(2010-2#1)(2012-3#1)
finite-sized##2##1##(2007-12#1)(2008-3#1)
fins and limbs##2##3##(2012-12#2)
fins of##2##2##(2009-7#2)
fins##10##1##(2008-5#2)(2009-7#2)(2010-8#1)(2012-12#5)
fipronil##3##1##(2011-2#3)
fir (Abies##2##2##(2008-10#2)
fir trees##3##2##(2008-10#3)
fir##14##1##(2008-10#11)(2011-2#2)(2013-7#1)
fir-woods##2##1##(2011-2#2)
fire assays##2##2##(2008-10#2)
fire blight and##2##3##(2008-10#2)
fire blight of##2##3##(2008-10#2)
fire blight pathogen##2##3##(2008-10#1)(2008-8#1)
fire blight warning systems in Israel##2##6##(2008-10#2)
fire blight##37##2##(2008-10#36)(2008-8#1)
fire environment and##2##3##(1996-12#2)
fire environment##4##2##(1996-12#4)
fire in##3##2##(1993-12#1)(2007-2#1)(2008-11#1)
fire safety##2##2##(1994-12#1)(1996-2#1)
fire suppressants##2##2##(2008-2#2)
fire test methods##2##3##(1996-12#2)
fire test##3##2##(1996-12#3)
fire tests##3##2##(1996-12#3)
fire was##2##2##(1995-6#1)(2009-10#1)
fire##122##1##(1990-8#3)(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#2)(1995-6#4)(1996-12#34)(1996-2#2)(1996-6#1)(1997-2#1)(2007-12#4)(2007-2#1)(2008-10#42)(2008-11#4)(2008-2#2)(2008-8#3)(2009-10#7)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
firearm availability##2##2##(2012-2#2)
firearm##6##1##(2008-10#2)(2009-2#2)(2012-2#2)
fired from a 9-mm-bore gas gun at a##2##8##(2008-3#2)
fired in##2##2##(1997-5#1)(2013-1#1)
fired##12##1##(1991-3#1)(1995-12#2)(1995-6#1)(1997-5#3)(2008-3#2)(2009-12#1)(2011-2#1)(2013-1#1)
firefly luciferase gene##2##3##(1997-1#1)(2008-11#1)
firefly luciferase##8##2##(1991-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#2)
firefly##9##1##(1991-9#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#2)
fireplace##2##1##(2008-10#2)
fires in##3##2##(1992-3#1)(2008-12#1)(2010-9#1)
fires is##2##2##(1996-12#2)
fires##18##1##(1992-3#3)(1996-12#11)(2008-12#1)(2010-9#1)(2011-1#1)(2011-2#1)
firewood##3##1##(2008-10#1)(2011-2#2)
firework##3##1##(2012-2#3)
firing following the A6-cut##2##4##(2008-6#2)
firing frequency##2##2##(1993-12#1)(2013-1#1)
firing in the##2##3##(1992-3#1)(2008-6#1)
firing in##7##2##(1992-3#1)(1995-12#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-6#2)
firing of the##2##3##(1993-12#1)(2008-11#1)
firing of##8##2##(1993-12#1)(1996-2#1)(2007-8#1)(2008-11#3)(2009-10#1)(2013-1#1)
firing pattern##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
firing patterns##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
firing process##3##2##(2008-10#3)
firing rate of##2##3##(1995-12#2)
firing rate##15##2##(1994-2#2)(1995-12#2)(1996-2#4)(2008-11#5)(2008-7#1)(2009-10#1)
firing rates and##2##3##(2008-11#2)
firing rates of##2##3##(1995-12#2)
firing rates##10##2##(1992-11#1)(1995-12#2)(2008-1#1)(2008-11#5)(2009-5#1)
firing stages##2##2##(2008-10#2)
firing##96##1##(1992-11#1)(1992-3#1)(1993-12#6)(1994-2#2)(1995-11#1)(1995-12#6)(1996-2#12)(1997-5#1)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#6)(2008-11#23)(2008-2#1)(2008-3#1)(2008-6#11)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#2)(2009-5#1)(2013-1#2)(2013-8#1)
firings##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
firm and##2##2##(1990-11#1)(1993-3#1)
firm recommendations##2##2##(2012-12#1)(2013-1#1)
firm##48##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-8#1)(1993-1#1)(1993-3#3)(1993-5#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-1#5)(1997-2#1)(2007-11#3)(2007-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
firm's##5##1##(1991-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(2007-4#1)
firmer##2##1##(2007-12#1)(2008-11#1)
firming##2##1##(2008-5#2)
firmly attached to##2##3##(2008-3#2)
firmly established##6##2##(1995-8#1)(2007-12#1)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#1)
firmly##20##1##(1990-11#1)(1990-12#1)(1993-1#1)(1994-12#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2009-10#1)(2009-7#1)(2012-2#1)(2013-1#1)
firmness##8##1##(2008-10#1)(2008-5#6)(2011-2#1)
firms and##2##2##(1992-2#1)(1995-3#1)
firms in##2##2##(1995-3#1)(1997-1#1)
firms##23##1##(1991-3#1)(1992-2#1)(1992-3#2)(1993-1#3)(1993-2#2)(1994-1#2)(1994-2#3)(1995-3#2)(1996-12#1)(1997-1#3)(1997-3#2)(2012-2#1)
first &quot##2##2##(2008-8#1)(2012-2#1)
first 10 days##3##3##(2008-10#2)(2008-5#1)
first 10##8##2##(1991-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
first 100##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
first 173 bp##2##3##(1996-5#2)
first 173##4##2##(1996-5#4)
first 19##2##2##(2008-10#1)(2013-1#1)
first 2 years of##4##4##(1995-1#1)(2008-10#1)(2008-8#1)(2010-5#1)
first 2 years##6##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)
first 2##22##2##(1995-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
first 22##3##2##(1990-11#1)(2007-8#1)(2013-1#1)
first 25##4##2##(1993-12#1)(2008-9#2)(2012-2#1)
first 3##20##2##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
first 33##2##2##(1996-3#1)(2008-7#1)
first 60##8##2##(1991-9#1)(1992-12#1)(1992-3#3)(1993-3#2)(2012-12#1)
first CR##3##2##(2008-10#1)(2011-2#2)
first Rytov##4##2##(2008-2#4)
first Stokes##9##2##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#1)
first a##5##2##(1992-1#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
first admission##3##2##(1991-11#1)(2008-7#1)(2011-2#1)
first aid##4##2##(2007-2#1)(2008-1#1)(2010-8#2)
first algorithm##2##2##(2008-6#2)
first analyze##2##2##(2008-8#1)(2008-9#1)
first and last##5##3##(1997-3#1)(2008-10#2)(2008-8#1)(2012-2#1)
first and second dissociation constants##2##5##(2008-10#2)
first and second dissociation##3##4##(2008-10#3)
first and second order##2##4##(2010-5#1)(2011-1#1)
first and second period##4##4##(1996-3#2)(2011-2#2)
first and second year##2##4##(1995-5#1)(2012-12#1)
first and second##46##3##(1990-8#1)(1992-11#1)(1992-5#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#2)(2013-8#1)
first and the last phases##2##5##(1990-3#2)
first and the last##4##4##(1990-3#2)(2008-10#1)(2008-7#1)
first and the##15##3##(1990-3#2)(1991-9#1)(1992-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-7#1)
first and then##5##3##(1995-6#1)(2007-11#1)(2008-10#2)(2011-1#1)
first and##88##2##(1990-12#1)(1990-3#2)(1990-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-11#4)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
first antibody##2##2##(1994-11#1)(2008-11#1)
first appear##2##2##(1991-2#1)(2008-11#1)
first appearance of##2##3##(1995-12#2)
first appearance##4##2##(1990-9#1)(1992-2#1)(1995-12#2)
first appeared in##2##3##(2008-5#1)(2012-2#1)
first appeared##4##2##(1992-9#1)(2008-5#1)(2008-7#1)(2012-2#1)
first appears##2##2##(1994-9#1)(2008-12#1)
first application of this##2##4##(2007-11#1)(2008-3#1)
first application of##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
first application##14##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2011-1#1)
first applied to the##2##4##(2008-10#1)(2008-8#1)
first applied to##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
first applied##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
first approach to##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
first approach##7##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
first approximation##2##2##(1990-5#1)(2008-2#1)
first article##2##2##(1990-3#1)(1991-2#1)
first assay##3##2##(2008-10#2)(2008-5#1)
first assessment and##2##3##(1993-12#1)(2009-4#1)
first assessment##6##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-4#1)
first attempt in##3##3##(2010-2#1)(2010-7#2)
first attempt of##2##3##(2007-8#1)(2010-7#1)
first attempt to##8##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
first attempt##16##2##(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
first author##3##2##(1992-6#1)(2007-8#1)(2010-3#1)
first baby##2##2##(2013-1#2)
first basic protocol##4##3##(2008-4#4)
first basic##6##2##(1992-2#1)(2008-4#5)
first because##2##2##(2008-10#1)(2011-2#1)
first before##2##2##(1996-3#1)(2011-2#1)
first being##4##2##(1994-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
first biochemical##3##2##(1992-3#1)(1994-11#1)(2011-1#1)
first birth##6##2##(1993-9#1)(2009-10#1)(2009-5#3)(2010-8#1)
first by the##2##3##(2007-12#1)(2008-10#1)
first by##11##2##(1990-6#1)(1994-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
first call##2##2##(2007-10#1)(2010-1#1)
first calving##2##2##(2012-2#2)
first campaign##2##2##(1997-6#1)(2010-1#1)
first cancer##3##2##(1990-8#2)(1991-8#1)
first cannulation##3##2##(2007-7#3)
first carpometacarpal##2##2##(2008-9#2)
first case in##4##3##(2007-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
first case of a##8##4##(1997-8#1)(2008-12#1)(2009-3#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
first case of##34##3##(1994-6#1)(1995-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)
first case was##3##3##(2008-8#1)(2010-11#1)(2013-1#1)
first case##65##2##(1991-2#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-12#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-2#1)(2009-3#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#5)
first characterization of##3##3##(1997-4#1)(2008-10#1)(2010-3#1)
first chemotherapy cycle##2##3##(2007-7#2)
first chemotherapy##3##2##(2007-7#2)(2013-1#1)
first child##2##2##(1992-4#1)(2009-10#1)
first choice antibiotic in##2##4##(1990-3#1)(1990-6#1)
first choice for##6##3##(1991-6#1)(1997-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
first choice in##3##3##(1993-9#1)(2007-11#1)(2013-1#1)
first choice of##4##3##(1992-9#1)(2011-10#1)(2012-2#1)(2013-1#1)
first choice therapy##2##3##(2008-3#1)(2008-8#1)
first choice##26##2##(1990-3#1)(1990-6#1)(1991-6#2)(1992-9#1)(1993-9#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-10#2)(2011-2#2)(2012-2#2)(2013-1#3)
first class##3##2##(1994-11#2)(2010-8#1)
first climatological##2##2##(2008-3#2)
first clinical##12##2##(1990-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-5#1)(2010-2#1)(2012-12#2)(2013-1#1)
first clone##2##2##(1990-5#1)(2008-2#1)
first cohort was##2##3##(2011-2#2)
first cohort##4##2##(2008-11#1)(2011-2#2)(2013-7#1)
first column was##2##3##(1990-8#1)(2008-10#1)
first column##5##2##(1990-8#3)(2008-10#2)
first complete remission##2##3##(2011-2#2)
first complete##13##2##(2008-10#1)(2011-2#12)
first component##3##2##(1990-11#1)(1992-6#1)(2009-8#1)
first comprehensive##6##2##(1996-2#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
first confirmed##2##2##(2008-10#1)(2010-3#1)
first contact##2##2##(1994-3#1)(1995-1#1)
first converted##2##2##(2008-10#1)(2008-2#1)
first course##2##2##(1990-6#2)
first data set##2##3##(1995-9#1)(2008-10#1)
first data##7##2##(1995-12#1)(1995-9#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
first day after##3##3##(1990-12#1)(2007-8#1)(2012-3#1)
first day of##8##3##(1990-12#2)(1992-5#1)(1993-12#2)(2006-4#1)(2008-10#1)(2013-1#1)
first day##17##2##(1990-12#4)(1991-6#1)(1992-5#1)(1993-12#2)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
first degree relatives##4##3##(2007-5#1)(2007-7#3)
first degree##6##2##(1992-4#1)(2007-5#1)(2007-7#3)(2012-3#1)
first demonstrated##2##2##(2008-2#1)(2008-7#1)
first demonstration of a##6##4##(1990-12#1)(1993-11#1)(1993-9#1)(1994-3#1)(2007-12#1)(2008-2#1)
first demonstration of##23##3##(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-5#1)(2007-11#3)(2007-12#5)(2008-10#4)(2008-2#1)(2008-8#1)(2010-5#1)(2013-1#1)
first demonstration##31##2##(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-1#1)(1997-2#1)(2007-11#3)(2007-12#5)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#2)(2009-8#1)(2010-5#1)(2012-1#1)(2013-1#1)
first derivative UV-spectrophotometry##2##3##(2008-10#2)
first derivative at##2##3##(2008-10#2)
first derivative spectra of##2##4##(2008-10#2)
first derivative spectra##8##3##(2008-10#6)(2008-12#2)
first derivative spectrophotometry##2##3##(2008-10#2)
first derivative##29##2##(1991-5#1)(2008-10#25)(2008-12#2)(2008-2#1)
first derive a##2##3##(2007-11#1)(2008-2#1)
first describe how##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
first describe the##3##3##(2008-10#2)(2013-8#1)
first describe##8##2##(2008-10#3)(2009-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
first described by##5##3##(2008-11#1)(2010-5#1)(2011-1#2)(2011-2#1)
first described in##14##3##(1990-12#1)(1995-8#1)(1996-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
first described##32##2##(1990-12#1)(1992-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
first description in##2##3##(2011-2#2)
first description of##11##3##(1993-12#1)(1995-6#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
first description##16##2##(1993-12#1)(1995-6#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-8#1)
first design##4##2##(2008-2#3)(2012-2#1)
first detected at##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
first detected in the##4##4##(1995-11#1)(2008-10#3)
first detected in##7##3##(1995-11#1)(1997-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
first detected##15##2##(1993-3#1)(1995-11#1)(1997-2#1)(1997-6#1)(2008-10#5)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#3)
first detection##3##2##(2008-10#2)(2011-2#1)
first developed##6##2##(2008-10#3)(2008-11#1)(2009-10#1)(2010-6#1)
first development##2##2##(2008-12#2)
first diagnosed##2##2##(2008-10#1)(2012-3#1)
first direct evidence that##6##4##(1995-2#1)(1996-12#2)(2007-7#1)(2008-10#2)
first direct##11##2##(1993-3#1)(1995-2#1)(1996-12#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#1)
first discovered##2##2##(1992-8#1)(1993-8#1)
first discuss the##5##3##(1996-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
first discuss##7##2##(1996-2#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
first dorsal web space##3##4##(2008-9#3)
first dorsal##4##2##(2008-9#4)
first drug##2##2##(1994-2#1)(2008-9#1)
first egg##4##2##(2008-12#3)(2009-4#1)
first encounter##4##2##(2008-11#2)(2010-7#1)(2011-1#1)
first episode of psychosis##3##4##(1996-7#1)(2011-1#2)
first episode of##5##3##(1996-7#1)(2008-7#1)(2011-1#2)(2011-2#1)
first episode##6##2##(1996-7#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#1)
first established in##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
first established##5##2##(1994-12#1)(1994-8#1)(2008-11#1)(2008-6#1)(2012-2#1)
first estimate##2##2##(1994-2#1)(1995-2#1)
first evaluated##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
first event##4##2##(1990-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
first ever stroke##2##3##(2007-10#1)(2009-10#1)
first ever##5##2##(2007-10#1)(2008-3#1)(2009-10#1)(2010-12#1)(2012-12#1)
first evidence for##5##3##(1991-12#1)(1992-3#1)(2008-10#1)(2012-3#1)(2013-8#1)
first evidence##22##2##(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
first examination##6##2##(1991-2#1)(1996-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-1#1)
first examine##2##2##(1995-5#1)(2008-7#1)
first examined##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
first examples of this##2##4##(1996-5#1)(2007-11#1)
first exon##12##2##(1991-5#1)(1991-6#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-10#1)(1997-7#1)(2009-5#1)(2012-1#1)
first exons and promoters##2##4##(2008-4#2)
first exons##5##2##(1995-8#1)(1997-6#1)(2008-4#3)
first experience in##3##3##(2007-10#1)(2007-9#1)(2011-2#1)
first experience##6##2##(2007-10#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
first experiment##11##2##(1996-12#1)(2008-10#7)(2010-8#1)(2013-1#1)(2013-8#1)
first experimental evidence for##3##4##(1990-7#1)(2008-11#1)(2008-7#1)
first experimental evidence##9##3##(1990-2#1)(1990-7#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-7#2)
first experimental##23##2##(1990-2#1)(1990-7#1)(2007-11#4)(2007-12#9)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)
first expressed##2##2##(2007-12#1)(2008-7#1)
first field##2##2##(2008-10#1)(2008-3#1)
first five years of##3##4##(1992-2#1)(1996-12#1)(2011-2#1)
first five years##4##3##(1992-2#1)(1996-12#1)(2008-9#1)(2011-2#1)
first five##10##2##(1990-3#1)(1992-2#1)(1993-3#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
first focus##2##2##(2007-12#1)(2013-1#1)
first follows##2##2##(2008-2#1)(2008-7#1)
first for##4##2##(1994-2#1)(1996-5#1)(2007-12#1)(2008-5#1)
first formal##2##2##(1996-1#1)(2008-10#1)
first four##10##2##(1993-8#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
first from##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-1#1)
first generation of##2##3##(2010-7#1)(2011-2#1)
first generation##7##2##(1991-12#1)(1991-6#1)(2007-11#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)
first give a##2##3##(2008-6#1)(2013-8#1)
first give##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
first glance##7##2##(1991-12#1)(1995-12#1)(2008-11#1)(2008-2#1)(2009-11#1)(2012-1#1)(2013-8#1)
first grade##6##2##(2008-10#1)(2008-11#1)(2008-12#4)
first group of patients##2##4##(2011-1#1)(2012-3#1)
first group of##7##3##(1992-8#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#3)
first group received##2##3##(1994-6#1)(2008-5#1)
first group was##2##3##(1990-2#1)(2008-11#1)
first group##33##2##(1990-2#3)(1991-5#1)(1992-8#1)(1994-12#1)(1994-6#1)(1997-3#1)(2007-8#4)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#2)(2011-1#1)(2011-2#3)(2012-3#6)(2013-1#3)
first half of##15##3##(1990-3#1)(1992-3#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)
first half##16##2##(1990-3#1)(1992-3#1)(1992-6#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)
first harvest##3##2##(2008-10#3)
first hospital##2##2##(1992-12#1)(2008-10#1)
first hot##2##2##(2008-3#1)(2013-8#1)
first hypothesis##3##2##(1994-3#1)(2008-8#2)
first identified and##2##3##(1993-6#1)(1997-1#1)
first identified in the##2##4##(2008-7#1)(2013-7#1)
first identified in yeast##2##4##(2008-7#1)(2012-2#1)
first identified in##6##3##(1995-6#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-7#1)
first identified##12##2##(1993-6#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-9#1)(2012-2#1)(2013-7#1)
first in the##4##3##(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
first in vivo##3##3##(2008-3#1)(2009-2#1)(2010-5#1)
first in##17##2##(1993-2#1)(1993-3#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
first increases##2##2##(2008-10#1)(2008-9#1)
first incubated with##2##3##(1997-7#1)(2008-6#1)
first indication##3##2##(2008-5#1)(2009-2#1)(2010-4#1)
first insights into the##2##4##(2008-9#1)(2013-1#1)
first instance##7##2##(1993-11#1)(2008-11#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-1#2)
first instar larvae##2##3##(2007-12#1)(2010-10#1)
first instar##6##2##(2007-12#4)(2008-10#1)(2010-10#1)
first international##4##2##(2008-12#1)(2012-2#1)(2013-8#2)
first interview##3##2##(2008-11#1)(2008-4#1)(2009-12#1)
first introduced##8##2##(1991-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#2)(2011-2#1)
first intron is##2##3##(1994-12#1)(2008-9#1)
first intron of##6##3##(1991-11#1)(1992-6#1)(1997-7#1)(2008-9#2)(2012-3#1)
first intron##21##2##(1991-11#1)(1991-6#1)(1992-6#1)(1993-2#3)(1993-6#1)(1994-12#2)(1997-7#1)(2008-7#1)(2008-9#7)(2010-5#1)(2012-3#2)
first intronic##2##2##(1997-7#1)(2008-5#1)
first investigated##2##2##(2008-12#1)(2008-5#1)
first investigation of##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
first investigation##6##2##(1996-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-8#1)
first involves##2##2##(1994-11#1)(2008-4#1)
first is a##8##3##(1991-9#1)(1992-11#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#1)
first is based on##4##4##(2008-3#2)(2008-4#2)
first is##28##2##(1991-9#1)(1992-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-8#2)(2009-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
first isolated##3##2##(1990-12#1)(2007-7#1)(2011-2#1)
first issue of the Journal of Pediatric Urology##2##8##(2008-10#2)
first issue of##7##3##(2008-10#2)(2010-12#3)(2013-1#1)(2013-8#1)
first issue##9##2##(2008-1#1)(2008-10#2)(2010-12#3)(2013-1#2)(2013-8#1)
first kind##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
first known##5##2##(1992-5#1)(2007-11#1)(2007-12#1)(2011-2#1)(2013-1#1)
first lactation##2##2##(1996-8#1)(2008-12#1)
first language##3##2##(1995-1#1)(2010-1#1)(2013-8#1)
first large-scale##2##2##(2008-7#1)(2008-8#1)
first lateral##2##2##(2007-12#1)(2009-12#1)
first law##2##2##(2008-10#1)(2008-5#1)
first layer of the##2##4##(2008-10#1)(2008-3#1)
first layer##6##2##(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)
first lesson##3##2##(1991-12#1)(2007-5#1)(2008-10#1)
first line therapy##4##3##(1992-6#1)(1993-12#1)(1996-7#1)(2008-8#1)
first line tool for##2##4##(2008-1#1)(2008-12#1)
first line treatment##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
first line##31##2##(1992-6#1)(1993-12#2)(1994-8#1)(1996-3#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-7#1)(2008-8#4)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
first linker repeat##2##3##(2008-6#2)
first linker##3##2##(2008-6#3)
first look##3##2##(1997-3#1)(2009-5#1)(2010-6#1)
first manifestation of##6##3##(1991-3#1)(1996-11#1)(2008-9#2)(2011-2#2)
first manifestation##8##2##(1991-3#1)(1996-11#1)(1997-8#1)(2008-9#2)(2011-2#3)
first manifestations##2##2##(2008-9#2)
first maturity##2##2##(2008-12#1)(2008-5#1)
first measurement##5##2##(2008-12#1)(2008-3#1)(2010-5#2)(2012-8#1)
first medical##3##2##(1990-12#1)(1991-6#1)(1991-8#1)
first meiotic##2##2##(2008-11#1)(2013-1#1)
first metatarsal##6##2##(2008-12#4)(2012-2#2)
first metatarsophalangeal joint##4##3##(2006-10#1)(2009-10#1)(2010-5#2)
first method##13##2##(1994-2#1)(2008-10#5)(2008-3#2)(2008-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
first model##3##2##(1992-6#1)(2008-7#1)(2008-8#1)
first molar with##4##3##(2012-12#2)(2013-1#2)
first molars##5##2##(2011-2#2)(2012-12#1)(2013-1#2)
first months of life##2##4##(2013-1#2)
first months of##5##3##(1990-10#1)(2007-11#1)(2011-2#1)(2013-1#2)
first months##6##2##(1990-10#1)(1992-1#1)(2007-11#1)(2011-2#1)(2013-1#2)
first named##2##2##(2007-12#1)(2008-10#1)
first need##2##2##(1995-1#1)(2012-2#1)
first objective##2##2##(2008-3#1)(2010-5#1)
first observed at##3##3##(1990-7#1)(2008-10#2)
first observed in the##2##4##(2008-10#1)(2008-7#1)
first observed in##6##3##(2008-10#4)(2008-7#1)(2012-1#1)
first observed##15##2##(1990-7#1)(2008-10#12)(2008-7#1)(2012-1#1)
first occurrence##2##2##(1997-3#1)(2008-6#1)
first of all the##2##4##(1997-3#1)(2007-8#1)
first of all##4##3##(1990-9#1)(1997-3#1)(2007-11#1)(2007-8#1)
first of its kind##3##4##(2007-7#1)(2008-12#1)(2012-2#1)
first of its##4##3##(1995-12#1)(2007-7#1)(2008-12#1)(2012-2#1)
first of the##5##3##(1994-5#1)(2008-3#1)(2008-9#1)(2012-12#2)
first of these##8##3##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
first of##33##2##(1990-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
first on##5##2##(2008-10#5)
first one is##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)
first one##25##2##(1990-3#1)(1992-6#1)(1994-6#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#2)(2011-2#2)(2013-1#1)
first operation##6##2##(1991-3#1)(1992-9#1)(2007-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
first or second##3##3##(2008-7#2)(2013-1#1)
first or##7##2##(1990-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2012-12#1)(2013-1#1)
first order in##2##3##(2007-12#1)(2008-10#1)
first order kinetics##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
first order of##2##3##(1995-6#1)(2008-3#1)
first order reaction##2##3##(2008-10#2)
first order##30##2##(1990-2#1)(1995-6#1)(1997-2#1)(2006-4#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2009-9#1)(2010-5#3)(2012-12#1)(2012-2#1)
first oxidation##2##2##(1996-5#1)(2009-9#1)
first part is##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
first part of the##10##4##(1990-3#2)(1992-12#1)(1992-6#1)(1993-6#1)(1995-3#1)(1997-4#1)(2008-1#1)(2008-5#1)(2009-6#1)
first part of this unit##3##5##(2008-2#1)(2008-4#2)
first part of this##9##4##(1992-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2010-12#1)(2012-12#1)(2012-2#1)
first part of##21##3##(1990-3#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1995-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
first part##30##2##(1990-3#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
first pass##2##2##(2007-11#1)(2008-1#1)
first passage##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
first patient##11##2##(1990-8#1)(1992-10#1)(1995-11#1)(1996-6#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2009-1#1)(2011-2#1)(2013-1#1)
first patients##2##2##(1997-3#1)(2012-3#1)
first peak is##2##3##(1992-9#1)(2010-3#1)
first peak##12##2##(1991-12#1)(1992-11#1)(1992-8#1)(1992-9#1)(1996-12#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#2)
first performed##5##2##(1994-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-8#1)
first permanent##4##2##(1995-2#1)(2013-1#3)
first phase insulin secretion##2##4##(2010-11#1)(2011-2#1)
first phase##20##2##(1990-12#1)(1991-12#2)(1992-3#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-7#1)(2010-11#1)(2011-2#1)(2011-3#1)
first population##3##2##(2008-10#3)
first possibility##2##2##(2008-10#1)(2008-2#1)
first post##2##2##(1990-3#1)(2008-4#1)
first postnatal day##2##3##(1991-2#1)(1993-3#1)
first postnatal##6##2##(1991-2#1)(1993-3#1)(1996-5#1)(1997-2#3)
first postoperative##4##2##(1990-2#1)(2007-10#1)(2010-4#1)(2011-2#1)
first practice##5##2##(1992-8#1)(2008-11#3)(2008-9#1)
first pregnancy##4##2##(1992-6#1)(2012-12#3)
first presentation##4##2##(2007-8#1)(2008-4#2)(2011-2#1)
first presented##4##2##(2007-12#1)(2010-11#1)(2012-2#1)(2012-3#1)
first principal component##2##3##(2008-10#1)(2013-1#1)
first principles##5##2##(1992-3#1)(1995-3#1)(2007-11#1)(2008-4#1)(2013-1#1)
first priority##4##2##(1992-12#1)(1997-4#2)(2010-8#1)
first promoter is##2##3##(1991-9#2)
first proposed and applied##2##4##(2008-10#1)(2012-1#1)
first proposed by##2##3##(2008-3#1)(2008-5#1)
first proposed##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-1#1)
first prototype##2##2##(2008-10#1)(2008-3#1)
first proximal##2##2##(2008-10#1)(2012-2#1)
first published in##2##3##(1997-8#1)(2012-12#1)
first published##8##2##(1990-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
first purification step##2##3##(1991-5#1)(2008-10#1)
first quarter##3##2##(1997-3#1)(2008-5#2)
first recognition##3##2##(2008-1#1)(2008-11#1)(2009-3#1)
first recognized##6##2##(1992-9#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-1#1)
first record in##2##3##(2008-10#2)
first record##5##2##(1997-4#1)(2008-10#4)
first recorded in##2##3##(2008-10#2)
first recorded##3##2##(2008-10#2)(2008-5#1)
first report in the##2##4##(2007-10#1)(2008-5#1)
first report in##5##3##(2007-10#1)(2007-9#1)(2008-1#1)(2008-5#1)(2013-8#1)
first report that##11##3##(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
first report##145##2##(1990-5#1)(1990-6#1)(1990-7#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-8#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#42)(2008-11#9)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
first reported case of##24##4##(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
first reported case##26##3##(1991-2#1)(1991-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
first reported in the##2##4##(2008-12#1)(2009-2#1)
first reported in##6##3##(2008-10#4)(2008-12#1)(2009-2#1)
first reported use of##2##4##(2008-10#2)
first reported##43##2##(1991-2#1)(1991-9#1)(1992-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
first reports##2##2##(2007-8#1)(2008-5#1)
first results##8##2##(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-1#1)
first root##2##2##(2008-12#1)(2011-2#1)
first round of##3##3##(1995-12#1)(2007-11#1)(2011-1#1)
first round##6##2##(1991-6#2)(1995-12#1)(2007-11#2)(2011-1#1)
first saccade in##2##3##(2009-2#2)
first saccade##4##2##(2009-2#4)
first sample##3##2##(2008-10#2)(2011-2#1)
first section##8##2##(1991-3#1)(1992-6#1)(2008-10#2)(2008-4#4)
first seen in##2##3##(2008-8#1)(2010-12#1)
first seen##4##2##(1996-12#1)(2008-8#1)(2010-12#1)(2011-2#1)
first semester##8##2##(1991-12#1)(2007-10#2)(2008-10#1)(2010-3#1)(2012-3#2)(2013-8#1)
first sensor##2##2##(2008-10#2)
first series##4##2##(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
first session##2##2##(2008-5#2)
first set of##4##3##(1995-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
first set##6##2##(1995-12#1)(2008-10#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
first settlement of##3##3##(2008-10#2)(2008-8#1)
first show##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
first sign of##5##3##(1993-2#1)(2007-11#1)(2011-2#2)(2013-8#1)
first signs of##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
first site##2##2##(1993-12#1)(2008-8#1)
first six##6##2##(1991-6#1)(1993-2#1)(1996-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
first sonication##3##2##(2008-10#3)
first spawning##2##2##(2008-12#1)(2010-8#1)
first species##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
first stage of the##5##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)
first stage of##8##3##(2008-10#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#2)
first stage##18##2##(1990-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-5#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
first stand-alone##2##2##(2008-2#1)(2008-9#1)
first step for##6##3##(1993-6#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
first step in the##12##4##(1993-11#1)(1995-2#2)(1996-1#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
first step in##32##3##(1990-7#1)(1992-6#1)(1993-11#1)(1994-3#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
first step is to##3##4##(1995-12#1)(2008-1#1)(2008-4#1)
first step is##6##3##(1995-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-8#1)
first step of the##5##4##(1992-8#1)(2008-10#1)(2008-12#2)(2013-8#1)
first step of##20##3##(1992-8#1)(1994-8#1)(1996-2#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-8#2)
first step the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
first step to##8##3##(1992-12#1)(1993-2#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-2#2)(2012-3#1)
first step toward the##4##4##(2007-11#1)(2009-1#1)(2009-4#1)(2009-7#1)
first step toward##16##3##(1992-6#1)(1995-6#1)(1997-7#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)
first step towards##4##3##(1994-11#1)(1994-12#1)(2008-7#1)(2010-12#1)
first step##126##2##(1990-7#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#3)
first steps in the##2##4##(2008-10#1)(2012-2#1)
first steps##10##2##(1992-6#1)(1996-3#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-10#1)(2012-2#1)
first studies##2##2##(1996-7#1)(2008-10#1)
first study##27##2##(1992-8#1)(1994-3#1)(1995-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
first subgroup##2##2##(2008-10#1)(2009-7#1)
first successful##6##2##(2007-11#2)(2007-4#1)(2007-7#1)(2008-7#1)(2008-9#1)
first suggested##2##2##(1992-9#1)(2008-10#1)
first survey of##2##3##(1997-8#1)(2012-2#1)
first symptom##6##2##(1990-12#2)(1997-3#1)(2007-11#1)(2008-12#1)(2012-2#1)
first system##6##2##(2008-10#3)(2008-11#1)(2008-3#2)
first task##2##2##(1991-2#1)(1991-3#1)
first ten##4##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
first tested by##2##3##(1994-3#1)(2008-3#1)
first tested##7##2##(1994-3#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-3#3)
first the##8##2##(1992-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
first therapeutic##3##2##(2007-11#1)(2012-2#1)(2013-8#1)
first three months of##4##4##(1991-8#1)(2007-7#1)(2009-7#1)(2010-8#1)
first three months##7##3##(1990-6#1)(1991-8#1)(2007-7#2)(2008-6#1)(2009-7#1)(2010-8#1)
first three weeks##4##3##(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
first three##33##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
first time and##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
first time from##10##3##(1990-5#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#3)
first time in##36##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-2#1)(1994-11#2)(1994-12#1)(1995-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#3)
first time users##4##3##(1996-9#4)
first time##426##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#5)(1997-2#3)(2006-4#1)(2007-1#1)(2007-11#27)(2007-12#36)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#101)(2008-11#6)(2008-12#3)(2008-2#25)(2008-3#32)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#3)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#6)(2011-3#3)(2012-12#1)(2012-2#11)(2012-3#2)(2012-8#1)(2013-1#20)(2013-8#4)
first to the##5##3##(1990-8#1)(1991-6#1)(1994-8#1)(2008-12#1)(2010-3#1)
first to##48##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#2)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-3#1)
first tone##2##2##(1995-12#1)(1996-5#1)
first total##2##2##(2013-1#2)
first transannular [4+3] cycloaddition##2##4##(2009-10#2)
first transformed##2##2##(2008-10#1)(2008-3#1)
first transition##2##2##(1992-6#2)
first treated with##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
first trial##3##2##(2008-5#1)(2008-8#1)(2009-4#1)
first trimester##19##2##(1990-3#1)(1990-6#1)(1990-9#1)(1992-2#3)(1993-3#2)(1994-9#2)(1996-12#2)(2007-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#3)
first two experiments were##2##4##(1994-2#1)(2008-6#1)
first two patients##2##3##(1992-4#1)(2010-5#1)
first two phases##4##3##(1993-12#1)(1996-1#1)(1996-2#1)(2008-3#1)
first two protocols describe##2##4##(2008-4#2)
first two protocols##3##3##(2008-4#3)
first two##69##2##(1990-8#1)(1991-2#1)(1992-4#1)(1993-12#1)(1993-8#2)(1994-2#3)(1994-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
first type of##4##3##(1997-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
first type##9##2##(1997-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
first under##2##2##(2008-10#1)(2008-2#1)
first use of a##2##4##(2007-11#1)(2008-10#1)
first use of##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
first use##7##2##(2007-11#1)(2008-10#1)(2008-3#3)(2009-7#1)(2012-2#1)
first used to##3##3##(2008-11#2)(2008-3#1)
first used##7##2##(2008-10#2)(2008-11#3)(2008-3#1)(2011-10#1)
first using##2##2##(2008-5#2)
first visit to##2##3##(2008-1#1)(2013-8#1)
first visit##4##2##(1994-2#1)(2008-1#1)(2008-10#1)(2013-8#1)
first was##9##2##(1995-5#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)
first wave##4##2##(2008-11#2)(2010-5#1)(2011-1#1)
first week of##8##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
first week##16##2##(1990-12#1)(1991-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
first were##2##2##(1993-8#1)(2008-10#1)
first with the##4##3##(2008-10#1)(2008-3#1)(2013-1#2)
first with##11##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
first year in##2##3##(1994-12#1)(2008-12#1)
first year of life##12##4##(1994-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(2008-1#2)(2008-12#1)(2008-7#2)(2013-1#2)
first year of practice##2##4##(2007-10#1)(2012-3#1)
first year of##40##3##(1990-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#5)
first year students##2##3##(2008-12#1)(2013-1#1)
first year##78##2##(1990-11#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-3#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#3)(1997-1#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#9)(2013-8#1)
first years of life##3##4##(1995-6#1)(2013-1#2)
first years of##6##3##(1995-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#2)
first years##8##2##(1995-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#2)
first##4160##1##(1990-10#4)(1990-11#12)(1990-12#23)(1990-2#13)(1990-3#12)(1990-4#1)(1990-5#10)(1990-6#12)(1990-7#11)(1990-8#22)(1990-9#13)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#15)(1991-2#14)(1991-3#10)(1991-4#1)(1991-5#12)(1991-6#24)(1991-8#7)(1991-9#9)(1992-1#8)(1992-10#4)(1992-11#7)(1992-12#14)(1992-2#12)(1992-3#18)(1992-4#7)(1992-5#10)(1992-6#26)(1992-8#19)(1992-9#13)(1993-1#4)(1993-11#12)(1993-12#18)(1993-2#19)(1993-3#19)(1993-5#2)(1993-6#19)(1993-8#13)(1993-9#7)(1994-1#5)(1994-11#17)(1994-12#22)(1994-2#17)(1994-3#21)(1994-5#6)(1994-6#13)(1994-7#2)(1994-8#12)(1994-9#11)(1995-1#9)(1995-11#12)(1995-12#25)(1995-2#20)(1995-3#13)(1995-4#1)(1995-5#16)(1995-6#24)(1995-8#10)(1995-9#3)(1996-1#8)(1996-10#2)(1996-11#4)(1996-12#23)(1996-2#14)(1996-3#22)(1996-4#3)(1996-5#20)(1996-6#10)(1996-7#4)(1996-8#5)(1996-9#12)(1997-1#8)(1997-2#24)(1997-3#24)(1997-4#12)(1997-5#4)(1997-6#16)(1997-7#16)(1997-8#10)(2006-10#7)(2006-12#1)(2006-4#3)(2007-1#4)(2007-10#26)(2007-11#103)(2007-12#131)(2007-2#6)(2007-4#3)(2007-5#11)(2007-6#1)(2007-7#37)(2007-8#43)(2007-9#5)(2008-1#38)(2008-10#661)(2008-11#131)(2008-12#78)(2008-2#124)(2008-3#180)(2008-4#74)(2008-5#93)(2008-6#61)(2008-7#107)(2008-8#90)(2008-9#99)(2009-1#4)(2009-10#26)(2009-11#15)(2009-12#12)(2009-2#12)(2009-3#7)(2009-4#11)(2009-5#17)(2009-6#7)(2009-7#22)(2009-8#17)(2009-9#10)(2010-1#12)(2010-10#13)(2010-11#15)(2010-12#20)(2010-2#9)(2010-3#29)(2010-4#16)(2010-5#29)(2010-6#10)(2010-7#9)(2010-8#32)(2010-9#5)(2011-1#62)(2011-10#4)(2011-2#193)(2011-3#8)(2011-4#1)(2011-8#1)(2012-1#16)(2012-12#50)(2012-2#94)(2012-3#54)(2012-8#2)(2013-1#149)(2013-3#1)(2013-7#8)(2013-8#56)
first- and second-order##4##3##(2007-11#1)(2008-3#1)(2008-5#2)
first- and##10##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2012-12#1)
first-##12##1##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2010-3#1)(2012-12#1)
first-aid##2##1##(1991-6#1)(2008-12#1)
first-come##2##1##(1997-1#2)
first-degree relative##2##2##(1997-5#1)(2010-3#1)
first-degree relatives of patients with##2##5##(1991-11#1)(2012-12#1)
first-degree relatives of##5##3##(1991-11#3)(2007-10#1)(2012-12#1)
first-degree relatives##11##2##(1991-11#3)(1995-9#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#2)
first-degree##13##1##(1991-11#3)(1995-9#1)(1997-5#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-8#2)
first-derivative spectrophotometric##2##2##(2008-10#2)
first-derivative spectrophotometry##2##2##(2008-10#2)
first-derivative##15##1##(2008-10#15)
first-dimension##3##1##(2008-4#3)
first-episode patients##4##2##(2009-8#4)
first-episode schizophrenia##2##2##(2008-6#2)
first-episode##7##1##(2008-6#2)(2009-8#4)(2011-1#1)
first-ever clinical##2##2##(2009-10#2)
first-ever stroke##4##2##(2007-10#3)(2008-8#1)
first-ever##10##1##(1996-2#1)(2007-10#4)(2007-8#1)(2008-8#1)(2009-10#3)
first-generation process##2##2##(2008-11#2)
first-generation teeth##3##2##(2008-7#3)
first-generation##10##1##(1994-2#1)(2008-11#2)(2008-2#1)(2008-7#3)(2008-8#1)(2010-4#1)(2011-2#1)
first-grade##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
first-guess##2##1##(2008-3#2)
first-instar larvae##2##2##(2008-10#2)
first-level##2##1##(1991-2#1)(1994-12#1)
first-line agents##3##2##(1996-11#1)(2008-9#1)(2012-2#1)
first-line chemotherapy for metastatic gastric cancer##2##6##(2010-12#2)
first-line chemotherapy##8##2##(1992-10#1)(2007-10#1)(2008-6#2)(2010-12#3)(2013-8#1)
first-line nurse managers##2##3##(1997-2#2)
first-line therapy for##4##3##(1994-12#1)(2008-3#1)(2008-8#1)(2010-12#1)
first-line therapy of##2##3##(2007-2#1)(2010-11#1)
first-line therapy with sunitinib##2##4##(2013-1#2)
first-line therapy with##3##3##(2013-1#3)
first-line therapy##13##2##(1992-8#1)(1994-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#2)(2013-1#3)(2013-8#1)
first-line treatment for##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
first-line treatment in##3##3##(1997-3#1)(2011-2#2)
first-line treatment of##4##3##(2008-8#1)(2011-2#2)(2013-8#1)
first-line treatment##12##2##(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#2)(2011-2#4)(2013-7#1)(2013-8#1)
first-line treatments##2##2##(1992-8#1)(2008-9#1)
first-line##68##1##(1992-10#1)(1992-3#1)(1992-8#3)(1993-2#1)(1994-12#1)(1994-8#1)(1996-11#1)(1997-2#3)(1997-3#1)(2007-10#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-11#2)(2010-12#11)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
first-order Taylor series##2##3##(1994-2#1)(2008-3#1)
first-order approximation##2##2##(2007-11#1)(2008-3#1)
first-order derivative##4##2##(2008-10#3)(2011-1#1)
first-order diffraction##2##2##(2007-12#1)(2008-3#1)
first-order dispersion##2##2##(2007-11#1)(2008-3#1)
first-order kinetic##2##2##(1992-3#1)(2008-5#1)
first-order perturbation##2##2##(1997-7#1)(2008-3#1)
first-order processes##3##2##(2008-10#2)(2008-5#1)
first-order quasi-phase matching##2##3##(2007-12#2)
first-order rate constant##3##3##(1992-6#1)(1995-6#1)(2008-10#1)
first-order rate##5##2##(1992-6#1)(1995-6#1)(2008-10#3)
first-order reaction##4##2##(1990-7#1)(1994-3#1)(2008-10#2)
first-order##79##1##(1990-7#1)(1992-3#2)(1992-5#1)(1992-6#4)(1994-2#1)(1994-3#1)(1995-3#2)(1995-6#1)(1997-7#1)(2007-11#6)(2007-12#10)(2007-8#1)(2008-10#17)(2008-11#1)(2008-2#4)(2008-3#23)(2008-5#2)(2011-1#1)
first-pass##4##1##(1992-8#1)(1994-9#1)(1997-8#1)(2013-1#1)
first-person##3##1##(2013-8#3)
first-phase insulin secretion response##2##4##(2008-1#2)
first-phase response##2##2##(1990-2#1)(2008-1#1)
first-phase##4##1##(1990-2#1)(2008-1#3)
first-round PCR##4##2##(1997-4#3)(2008-10#1)
first-round##6##1##(1997-4#3)(2008-10#3)
first-semester##2##1##(2007-10#2)
first-served##2##1##(1997-1#2)
first-step##2##1##(2008-10#1)(2008-4#1)
first-time##5##1##(2007-2#1)(2008-7#1)(2012-3#1)(2013-1#2)
first-trimester##4##1##(1996-8#1)(2011-1#2)(2012-3#1)
first-world##3##1##(2008-5#1)(2009-8#2)
first-year college students##2##3##(2010-10#2)
first-year harvest fields##2##3##(2008-10#2)
first-year survivorship##2##2##(2008-9#2)
first-year##12##1##(1994-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-10#2)(2010-3#2)(2012-12#1)(2012-3#1)
first?##2##1##(2008-11#1)(2012-3#1)
firstly developed##4##2##(2008-10#4)
firstly to##2##2##(2008-10#1)(2010-8#1)
firstly with##2##2##(1991-3#1)(2008-10#1)
firstly##45##1##(1990-5#1)(1991-3#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
fiscal 1995##2##2##(1995-6#2)
fiscal and##5##2##(1991-12#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-3#1)
fiscal constraint##2##2##(1993-1#1)(1996-12#1)
fiscal impacts##2##2##(1991-1#1)(2008-1#1)
fiscal integrity##3##2##(1992-1#3)
fiscal intermediaries##2##2##(1992-1#1)(1996-12#1)
fiscal restraint##2##2##(1995-3#1)(1997-2#1)
fiscal year (FY)##3##3##(1992-12#1)(1993-12#1)(1996-1#1)
fiscal year 1991##2##3##(1992-1#1)(1997-1#1)
fiscal year##12##2##(1991-1#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-12#1)(1997-1#1)(1997-2#1)
fiscal years##3##2##(1992-12#1)(1993-1#1)(2012-2#1)
fiscal##52##1##(1991-1#2)(1991-12#2)(1992-1#6)(1992-12#2)(1992-2#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#3)(1995-6#4)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#3)(2008-1#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
fiscally##2##1##(1991-1#1)(2008-1#1)
fischeri ATCC 7744##2##3##(1994-11#2)
fischeri##13##1##(1994-11#2)(2008-10#9)(2012-3#1)(2013-8#1)
fish (p = 0##4##4##(2011-2#4)
fish Catla catla##2##3##(2008-7#2)
fish Diapterus rhombeus##2##3##(2008-5#2)
fish and fly##2##3##(1993-12#1)(1996-5#1)
fish and invertebrate##3##3##(2007-5#2)(2013-7#1)
fish and##32##2##(1993-12#1)(1995-11#1)(1996-5#3)(2007-5#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#5)(2008-9#3)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#2)
fish antifreeze##2##2##(1994-9#2)
fish are##3##2##(1992-8#1)(1997-4#1)(2008-1#1)
fish at##2##2##(1990-8#1)(2013-7#1)
fish biodiversity##3##2##(2013-7#3)
fish bone##2##2##(2011-2#2)
fish by##3##2##(2007-10#1)(2009-7#1)(2010-5#1)
fish capture##2##2##(2009-5#2)
fish cartilage##3##2##(2008-5#3)
fish cells##6##2##(1992-6#2)(2008-11#4)
fish communities##2##2##(2008-5#1)(2008-9#1)
fish community in##2##3##(2008-5#1)(2013-7#1)
fish community##6##2##(2008-5#2)(2011-2#1)(2013-7#3)
fish consumption advisories##2##3##(1997-4#2)
fish consumption##8##2##(1997-4#2)(2008-1#4)(2011-2#1)(2013-7#1)
fish diversity##3##2##(2011-2#1)(2013-7#2)
fish eating frequency##3##3##(1993-8#3)
fish eating##4##2##(1993-8#4)
fish egg size##2##3##(2008-8#2)
fish egg##3##2##(2008-8#3)
fish exposed to##4##3##(2008-10#1)(2010-5#1)(2010-8#2)
fish farming##3##2##(1991-8#1)(2008-12#1)(2011-2#1)
fish fed##2##2##(2008-12#1)(2008-7#1)
fish freshness##6##2##(2008-10#6)
fish from the control site##3##5##(2008-7#3)
fish from the##6##3##(2008-11#1)(2008-7#4)(2013-1#1)
fish from##8##2##(2008-11#2)(2008-3#1)(2008-7#4)(2013-1#1)
fish growth##3##2##(2010-5#1)(2013-7#2)
fish have not##2##3##(2012-3#2)
fish host##2##2##(2009-2#1)(2013-1#1)
fish in the##10##3##(1997-4#1)(2008-2#2)(2008-5#2)(2009-9#1)(2010-8#3)(2013-7#1)
fish in##15##2##(1997-4#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-5#2)(2009-9#1)(2010-8#3)(2011-2#1)(2013-7#2)
fish intake##2##2##(2008-1#1)(2008-2#1)
fish is to##2##3##(2008-11#1)(2008-5#1)
fish is##3##2##(2008-11#1)(2008-5#2)
fish kairomones##2##2##(2008-9#2)
fish kills in##2##3##(1992-8#2)
fish kills##4##2##(1992-8#4)
fish larvae##2##2##(2008-8#1)(2010-8#1)
fish liver##2##2##(2008-10#1)(2010-5#1)
fish may##2##2##(2008-7#1)(2013-7#1)
fish meal##3##2##(2008-12#3)
fish muscle was##2##3##(2008-10#2)
fish muscle##4##2##(2008-10#4)
fish of the genus Puntius Hamilton 1822##2##7##(2008-12#2)
fish of the##5##3##(2008-12#3)(2008-5#1)(2013-7#1)
fish of##9##2##(2008-10#2)(2008-12#3)(2008-5#1)(2010-5#1)(2013-7#2)
fish oil supplementation##2##3##(2010-1#2)
fish oil##10##2##(1990-2#2)(1990-5#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-1#3)(2012-1#1)
fish oils##3##2##(1990-7#1)(2008-6#1)(2010-1#1)
fish on##2##2##(2010-2#1)(2011-1#1)
fish opened##2##2##(2008-5#2)
fish otolith##2##2##(2008-10#1)(2008-7#1)
fish otoliths by electrothermal vaporization inductively coupled plasma mass spectrometry##2##10##(2008-10#2)
fish pathogen##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
fish pathogens##2##2##(2008-9#1)(2009-6#1)
fish population##2##2##(2008-8#1)(2009-2#1)
fish products##3##2##(2008-10#1)(2011-2#2)
fish samples were##3##3##(2008-12#2)(2013-7#1)
fish samples##14##2##(2008-10#8)(2008-12#4)(2012-2#1)(2013-7#1)
fish scales and##2##3##(2008-7#1)(2013-7#1)
fish scales##4##2##(2008-7#1)(2012-2#1)(2013-7#2)
fish should##2##2##(2008-1#1)(2008-7#1)
fish silage (diet##2##3##(2008-12#2)
fish silage##4##2##(2008-12#4)
fish skin##2##2##(2008-11#1)(2008-7#1)
fish species from##2##3##(2008-11#1)(2008-5#1)
fish species of##3##3##(2008-10#1)(2008-12#2)
fish species##37##2##(1991-9#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-12#6)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#2)(2010-5#1)(2010-8#8)(2011-2#2)(2012-3#1)(2013-7#1)
fish sperm DNA (fsDNA)##4##4##(2008-10#4)
fish sperm DNA##12##3##(2008-10#12)
fish stocks##2##2##(2010-9#1)(2013-7#1)
fish the##2##2##(2008-5#1)(2008-7#1)
fish tissue##4##2##(1997-4#2)(2008-10#2)
fish tissues and urine##2##4##(2008-10#2)
fish tissues##4##2##(2008-10#3)(2012-12#1)
fish to##6##2##(2008-11#1)(2008-4#1)(2009-6#2)(2012-2#1)(2012-3#1)
fish trade##2##2##(2007-5#2)
fish treated with 17-MT and##2##5##(2013-7#2)
fish treated with 17-MT##3##4##(2013-7#3)
fish treated with##4##3##(2013-7#4)
fish two##2##2##(2008-1#1)(2010-5#1)
fish was##3##2##(1992-10#1)(2008-8#1)(2013-7#1)
fish were in##2##3##(2008-5#1)(2010-8#1)
fish were##19##2##(1992-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-8#5)(2013-7#4)
fish when compared##2##3##(2008-11#1)(2008-7#1)
fish with##6##2##(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)
fish##559##1##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#5)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-6#3)(1992-8#9)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#4)(1994-11#3)(1994-2#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#1)(1996-2#1)(1996-5#5)(1997-4#8)(1997-9#1)(2007-10#2)(2007-12#1)(2007-5#8)(2008-1#13)(2008-10#89)(2008-11#26)(2008-12#33)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#34)(2008-6#3)(2008-7#39)(2008-8#20)(2008-9#13)(2009-2#4)(2009-4#1)(2009-5#11)(2009-6#6)(2009-7#4)(2009-8#3)(2009-9#4)(2010-1#8)(2010-2#2)(2010-4#1)(2010-5#20)(2010-8#42)(2010-9#1)(2011-1#1)(2011-2#23)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#7)(2013-1#6)(2013-7#47)
fisheries in the##2##3##(2008-10#1)(2013-7#1)
fisheries in##3##2##(2007-5#1)(2008-10#1)(2013-7#1)
fisheries management and##2##3##(2007-5#1)(2010-8#1)
fisheries management##5##2##(2007-5#2)(2010-8#2)(2013-7#1)
fisheries##16##1##(2007-5#7)(2008-10#1)(2009-5#2)(2010-8#4)(2013-7#2)
fisherman##2##1##(1991-6#2)
fishermen##10##1##(1993-11#4)(1995-6#1)(2007-5#1)(2008-5#1)(2011-2#3)
fishers##3##1##(2007-5#3)
fishery in##3##2##(2007-5#2)(2013-7#1)
fishery is##3##2##(2007-5#2)(2008-5#1)
fishery management##2##2##(2007-5#1)(2008-5#1)
fishery##28##1##(2007-5#12)(2008-12#1)(2008-5#4)(2010-8#3)(2013-7#8)
fishes and##4##2##(1995-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
fishes can##2##2##(2010-8#2)
fishes from the##2##3##(2007-5#1)(2008-5#1)
fishes from##4##2##(2007-5#1)(2008-5#3)
fishes in the##3##3##(2010-8#1)(2013-1#2)
fishes in##4##2##(2008-9#1)(2010-8#1)(2013-1#2)
fishes of##2##2##(2008-7#1)(2011-2#1)
fishes with##3##2##(2010-8#3)
fishes##68##1##(1990-12#2)(1993-5#1)(1995-12#1)(1996-6#1)(2007-5#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-5#6)(2008-7#7)(2008-8#8)(2008-9#2)(2010-8#21)(2011-2#1)(2012-2#3)(2013-1#3)(2013-7#3)
fishes)##2##1##(2008-5#2)
fishing and farming communities##2##4##(2009-8#2)
fishing and##4##2##(2008-5#1)(2009-8#3)
fishing mortality##3##2##(2008-5#1)(2010-8#1)(2013-7#1)
fishing practices in##2##3##(2013-7#2)
fishing season##2##2##(2013-7#2)
fishing##22##1##(2008-12#1)(2008-5#4)(2009-7#2)(2009-8#4)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#6)
fission of##3##2##(1992-8#1)(2009-10#2)
fission products##6##2##(2008-10#5)(2013-1#1)
fission yeast Schizosaccharomyces pombe##10##4##(1995-2#2)(1995-8#2)(1995-9#1)(1997-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)
fission yeast##28##2##(1991-2#1)(1993-9#1)(1994-12#1)(1995-2#4)(1995-8#3)(1995-9#1)(1997-3#1)(2008-2#2)(2008-7#6)(2008-9#1)(2009-3#4)(2009-8#1)(2011-2#1)(2012-3#1)
fission##45##1##(1991-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-2#4)(1995-6#1)(1995-8#3)(1995-9#1)(1997-3#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-7#6)(2008-9#1)(2009-10#2)(2009-3#4)(2009-6#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
fissure##12##1##(1990-3#1)(1996-7#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
fissures##5##1##(1994-11#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
fist##4##1##(1992-6#1)(1994-2#1)(2008-4#1)(2011-2#1)
fistula (AVF)##5##2##(2007-7#3)(2008-1#1)(2008-7#1)
fistula after##2##2##(1990-9#1)(1995-11#1)
fistula and one##2##3##(2008-1#2)
fistula and stenosis##2##3##(1992-9#1)(2010-12#1)
fistula and##12##2##(1992-6#1)(1992-9#1)(1993-5#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
fistula animals##3##2##(2008-7#3)
fistula are##2##2##(1995-11#1)(1996-12#1)
fistula as a##2##3##(1995-11#1)(2007-10#1)
fistula associated with diverticular disease##3##5##(2008-6#3)
fistula between the##2##3##(2012-12#2)
fistula developed##2##2##(1991-3#1)(1996-3#1)
fistula for hemodialysis##2##3##(2007-7#1)(2008-1#1)
fistula formation##5##2##(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
fistula in a##3##3##(1990-9#1)(2008-1#1)(2008-10#1)
fistula in##12##2##(1990-9#1)(1993-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
fistula is a rare##2##4##(2007-8#1)(2009-1#1)
fistula is a##3##3##(2007-8#2)(2009-1#1)
fistula is the##2##3##(2007-7#2)
fistula is##10##2##(1997-3#1)(2006-12#1)(2007-7#2)(2007-8#3)(2009-1#1)(2012-12#1)(2013-1#1)
fistula of the##3##3##(1993-2#1)(1996-9#1)(2013-8#1)
fistula rate##3##2##(2008-10#1)(2009-5#2)
fistula that##2##2##(2007-8#1)(2008-12#1)
fistula using##2##2##(2007-8#1)(2012-12#1)
fistula was found##2##3##(2008-7#1)(2013-1#1)
fistula was##11##2##(1994-9#1)(1996-9#3)(1997-3#1)(2007-7#2)(2008-7#1)(2013-1#3)
fistula with a##2##3##(2006-12#1)(2013-1#1)
fistula with##4##2##(2006-12#1)(2007-8#1)(2013-1#2)
fistula##172##1##(1990-9#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-2#3)(1993-5#2)(1993-6#1)(1994-3#1)(1994-9#2)(1995-11#4)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#10)(1997-3#8)(2006-12#2)(2007-10#1)(2007-11#1)(2007-7#18)(2007-8#15)(2008-1#9)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#9)(2008-8#1)(2009-1#5)(2009-5#3)(2010-11#1)(2010-12#3)(2010-8#1)(2011-2#4)(2011-3#2)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#14)(2013-8#6)
fistula) and##2##2##(1995-11#1)(2008-1#1)
fistula)##3##1##(1995-11#1)(2008-1#2)
fistulae (AVF)##4##2##(1996-9#2)(2007-7#1)(2008-7#1)
fistulae are##2##2##(2007-7#1)(2008-11#1)
fistulae is##2##2##(1995-11#1)(2008-11#1)
fistulae was##2##2##(1990-3#1)(2007-7#1)
fistulae##37##1##(1990-3#2)(1991-6#1)(1992-2#2)(1994-9#1)(1995-11#1)(1996-9#9)(2006-12#1)(2007-7#7)(2007-8#1)(2008-1#2)(2008-11#2)(2008-7#3)(2009-5#1)(2012-2#3)(2013-1#1)
fistulas and##3##2##(1997-8#1)(2008-7#2)
fistulas are##3##2##(1996-12#2)(2008-7#1)
fistulas at##2##2##(1996-3#1)(2008-1#1)
fistulas created##2##2##(2007-7#2)
fistulas in##4##2##(1996-12#1)(2007-12#1)(2007-7#2)
fistulas were##3##2##(1993-2#1)(1995-11#2)
fistulas with##3##2##(1995-11#1)(2007-7#1)(2013-1#1)
fistulas##62##1##(1990-6#1)(1991-3#2)(1991-5#1)(1993-2#1)(1993-5#1)(1995-11#7)(1996-12#7)(1996-3#3)(1996-6#1)(1997-8#4)(2007-12#1)(2007-7#10)(2007-8#3)(2008-1#7)(2008-7#7)(2010-12#3)(2012-12#1)(2013-1#2)
fistulas]##2##1##(1991-5#1)(1993-2#1)
fistulizing and fibrostenotic Crohn's disease##2##5##(2010-12#2)
fistulizing##5##1##(2008-10#1)(2010-12#3)(2010-8#1)
fistulous formation##2##2##(2007-8#2)
fistulous##5##1##(2007-8#2)(2008-11#1)(2008-7#1)(2009-5#1)
fit a simple##2##3##(1990-7#1)(2008-9#1)
fit a##10##2##(1990-7#1)(1991-5#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-2#2)(2008-9#1)
fit across##2##2##(2008-10#1)(2009-9#1)
fit all##3##2##(1994-3#1)(2007-12#1)(2013-8#1)
fit and##12##2##(1993-12#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
fit best##2##2##(2008-10#2)
fit between their##2##3##(1993-1#1)(2009-10#1)
fit between##7##2##(1993-1#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-5#1)(2009-7#1)(2012-3#1)
fit by##3##2##(1991-12#1)(2008-10#1)(2008-2#1)
fit constellations##2##2##(2009-10#2)
fit experimental##2##2##(2008-3#1)(2010-11#1)
fit for practice##4##3##(2008-11#2)(2008-12#1)(2012-12#1)
fit for the##6##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)
fit for##18##2##(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)
fit in the##3##3##(1994-2#1)(2008-10#2)
fit in##7##2##(1994-2#1)(1994-5#1)(2008-10#5)
fit indices##4##2##(2012-2#3)(2013-1#1)
fit into a##3##3##(1997-3#1)(2008-2#1)(2009-9#1)
fit into the##7##3##(1992-3#1)(1993-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2013-1#1)
fit into##20##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
fit of the##9##3##(2008-10#6)(2008-2#1)(2010-6#1)(2011-2#1)
fit of##18##2##(1996-3#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#2)(2010-6#1)(2011-1#1)(2011-2#1)
fit parameters##4##2##(2008-10#1)(2008-3#2)(2008-8#1)
fit than##4##2##(2008-10#2)(2009-8#1)(2013-8#1)
fit the Rasch##2##3##(2012-2#2)
fit the data well##2##4##(1997-1#1)(1997-2#1)
fit the data##6##3##(1997-1#1)(1997-2#1)(2008-3#3)(2009-8#1)
fit the field data##2##4##(2008-10#2)
fit the model##2##3##(2008-8#1)(2013-8#1)
fit the observed##2##3##(1997-7#1)(2008-10#1)
fit the##40##2##(1990-8#2)(1991-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#7)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
fit these##2##2##(1990-5#1)(1997-8#1)
fit to a##6##3##(2007-1#1)(2007-12#1)(2008-10#3)(2010-11#1)
fit to the data##3##4##(2008-10#2)(2010-8#1)
fit to the full molecular line shape in conjunction with in situ##2##12##(2008-3#2)
fit to the observed data##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
fit to the observed##5##4##(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)
fit to the##23##3##(1996-12#1)(2008-10#9)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-8#1)
fit to##42##2##(1994-8#1)(1995-12#1)(1996-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-2#3)(2008-3#8)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
fit was obtained##2##3##(1995-5#1)(2011-2#1)
fit was##6##2##(1995-5#1)(1995-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
fit well with the##2##4##(2008-1#1)(2011-2#1)
fit well with##4##3##(1993-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
fit well##6##2##(1993-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
fit with##5##2##(2008-10#1)(2009-4#1)(2013-1#1)(2013-8#2)
fit##289##1##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#2)(2007-1#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#71)(2008-11#7)(2008-12#4)(2008-2#14)(2008-3#32)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#4)(2009-10#8)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#3)(2013-1#7)(2013-8#8)
fit-for-purpose##2##1##(2010-11#2)
fit?##2##1##(1995-12#1)(1997-2#1)
fitness (number of seeds##2##4##(2008-9#2)
fitness and its##2##3##(2008-9#1)(2012-2#1)
fitness and that##2##3##(2008-10#1)(2008-8#1)
fitness and to##2##3##(2008-3#1)(2012-2#1)
fitness and##19##2##(1994-2#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-8#3)(2008-9#3)(2010-8#1)(2012-2#4)(2012-3#1)(2013-1#1)
fitness are##2##2##(2008-10#1)(2008-9#1)
fitness at##2##2##(2008-8#2)
fitness benefit##2##2##(2008-10#1)(2008-8#1)
fitness benefits##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
fitness by##4##2##(2008-8#1)(2008-9#2)(2012-2#1)
fitness components of##2##3##(2008-10#1)(2008-8#1)
fitness components##14##2##(1995-2#1)(2008-10#2)(2008-8#8)(2008-9#2)(2013-1#1)
fitness consequences of##4##3##(2008-8#3)(2008-9#1)
fitness consequences##5##2##(2008-8#4)(2008-9#1)
fitness cost##5##2##(2008-10#1)(2008-8#4)
fitness costs##4##2##(2008-8#1)(2008-9#2)(2010-2#1)
fitness effects##3##2##(2012-3#1)(2013-1#2)
fitness for##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
fitness function##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
fitness functions##2##2##(2008-1#1)(2008-8#1)
fitness gain functions##3##3##(2008-9#3)
fitness have been##2##3##(2008-8#1)(2008-9#1)
fitness in the##3##3##(2008-10#1)(2008-9#2)
fitness in##17##2##(1997-7#2)(2008-10#4)(2008-11#1)(2008-8#5)(2008-9#5)
fitness is a##2##3##(2008-8#2)
fitness is##7##2##(2008-7#1)(2008-8#5)(2008-9#1)
fitness landscape##2##2##(2008-1#1)(2013-1#1)
fitness level##5##2##(2008-5#1)(2013-1#1)(2013-8#3)
fitness measures##2##2##(2008-8#2)
fitness of females##2##3##(2008-9#2)
fitness of the##6##3##(2008-10#4)(2008-8#2)
fitness of##22##2##(1990-8#1)(2008-10#11)(2008-7#1)(2008-8#6)(2008-9#3)
fitness payoffs##2##2##(2008-8#2)
fitness through increased##2##3##(2008-8#1)(2008-9#1)
fitness to##3##2##(2008-12#1)(2008-8#1)(2009-3#1)
fitness was##2##2##(2008-10#2)
fitness##265##1##(1990-8#1)(1991-3#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#47)(2008-11#2)(2008-12#2)(2008-3#6)(2008-5#3)(2008-7#3)(2008-8#89)(2008-9#43)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#4)(2010-10#2)(2010-2#1)(2010-4#4)(2010-8#2)(2011-2#1)(2012-2#10)(2012-3#10)(2013-1#10)(2013-8#5)
fitness)##3##1##(2008-8#1)(2010-10#2)
fitnesses of##3##2##(2008-8#1)(2013-1#2)
fitnesses##4##1##(2008-8#1)(2013-1#3)
fits all##2##2##(2008-11#1)(2008-7#1)
fits into##3##2##(1992-6#1)(2008-11#1)(2010-5#1)
fits the data##3##3##(1997-2#1)(1997-7#1)(2008-7#1)
fits the##8##2##(1991-1#1)(1993-11#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
fits to##3##2##(1997-2#1)(2008-3#2)
fits well##2##2##(2008-10#2)
fits with##4##2##(1993-1#1)(1994-3#1)(2008-8#1)(2010-8#1)
fits##46##1##(1991-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-3#1)(1996-1#2)(1997-2#4)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#4)(2008-3#6)(2008-6#2)(2008-7#2)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
fitted as##2##2##(1992-6#1)(2008-3#1)
fitted by a##2##3##(2008-3#1)(2011-2#1)
fitted by##4##2##(1991-6#1)(2008-3#2)(2011-2#1)
fitted in the wavelength range##2##5##(2008-3#2)
fitted in##3##2##(2008-10#1)(2008-3#2)
fitted into a##2##3##(2008-5#1)(2008-9#1)
fitted into##3##2##(2008-5#1)(2008-9#1)(2010-5#1)
fitted model##3##2##(2008-10#2)(2008-8#1)
fitted the##8##2##(1991-12#1)(2008-10#5)(2008-2#1)(2011-1#1)
fitted to a##11##3##(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2011-2#1)
fitted to data##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
fitted to experimental##3##3##(2008-3#2)(2008-7#1)
fitted to the##14##3##(1996-2#1)(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#3)
fitted to##45##2##(1996-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#6)(2008-3#8)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
fitted values##2##2##(1995-9#1)(2008-10#1)
fitted well with##2##3##(2008-10#1)(2008-2#1)
fitted well##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
fitted with a##15##3##(1991-12#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)(2013-1#2)
fitted with the##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
fitted with##26##2##(1991-12#2)(1992-12#1)(1994-3#1)(1994-8#1)(1997-2#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
fitted##120##1##(1991-12#3)(1991-6#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-2#3)(1997-7#2)(2007-11#1)(2007-8#1)(2008-10#34)(2008-11#2)(2008-2#10)(2008-3#19)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#1)(2009-7#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-3#4)(2013-1#4)(2013-8#1)
fitter##3##1##(2012-2#3)
fitting a##6##2##(1994-2#1)(2008-10#4)(2008-2#1)
fitting and##3##2##(1995-2#1)(2008-2#1)(2013-1#1)
fitting in##3##2##(1990-8#1)(2008-11#1)(2008-9#1)
fitting method##3##2##(2008-3#1)(2010-2#1)(2010-5#1)
fitting of the##7##3##(1990-8#1)(2008-10#2)(2008-2#2)(2008-3#2)
fitting of##14##2##(1990-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-9#2)
fitting procedure is##2##3##(2008-10#1)(2008-3#1)
fitting procedure##7##2##(2008-10#3)(2008-3#3)(2008-9#1)
fitting sessions##2##2##(2008-9#2)
fitting the data##5##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)
fitting the experimental data to the##2##6##(2008-2#2)
fitting the experimental data##3##4##(2008-10#1)(2008-2#2)
fitting the##24##2##(1990-8#1)(2008-10#7)(2008-2#6)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)
fitting them to##2##3##(2008-10#1)(2010-1#1)
fitting them##3##2##(2008-10#1)(2008-3#1)(2010-1#1)
fitting to a##2##3##(2007-12#1)(2008-3#1)
fitting to##5##2##(2007-12#1)(2008-12#1)(2008-3#2)(2008-8#1)
fitting with##3##2##(2007-11#1)(2008-4#1)(2010-2#1)
fitting##152##1##(1990-8#4)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-1#1)(1997-2#3)(2006-4#1)(2007-11#5)(2007-12#2)(2008-10#26)(2008-11#3)(2008-12#2)(2008-2#20)(2008-3#23)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#16)(2009-10#1)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-4#7)(2010-5#1)(2010-8#1)(2011-2#1)(2012-7#1)(2013-1#1)(2013-8#3)
five (35##2##2##(2008-3#1)(2008-7#1)
five 1##3##2##(2008-10#2)(2009-8#1)
five Candida##2##2##(2008-5#2)
five PTKs##2##2##(1993-3#2)
five adult##3##2##(1996-6#2)(2007-8#1)
five amino##2##2##(1992-9#1)(1994-5#1)
five analytes##2##2##(2008-10#2)
five and six##4##3##(1990-3#1)(2007-11#2)(2008-10#1)
five and ten year##2##4##(2008-8#2)
five and ten years##2##4##(2008-12#1)(2008-4#1)
five and ten##4##3##(2008-12#1)(2008-4#1)(2008-8#2)
five and three##2##3##(1996-8#1)(2008-3#1)
five and##15##2##(1990-3#1)(1995-1#1)(1996-8#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)
five animals##2##2##(2008-7#1)(2009-4#1)
five anions##2##2##(2008-10#2)
five are##2##2##(2008-5#2)
five areas##4##2##(1993-1#2)(1997-1#1)(2010-10#1)
five bipolar##2##2##(2007-12#1)(2010-11#1)
five case##2##2##(1992-3#1)(2012-12#1)
five cases of##8##3##(2008-3#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
five cases##22##2##(1991-6#1)(1991-8#1)(1996-11#1)(1997-3#3)(1997-8#2)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#2)
five categories##6##2##(1995-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-6#1)
five cell lines##2##3##(2012-2#2)
five cell##4##2##(2008-11#1)(2008-6#1)(2012-2#2)
five certified##2##2##(2008-10#1)(2008-11#1)
five children##4##2##(1995-5#1)(1996-11#1)(2008-9#1)(2011-2#1)
five clones##3##2##(1997-7#3)
five clusters##4##2##(2007-12#1)(2008-10#3)
five commercial##3##2##(2008-10#3)
five commercially##2##2##(2008-10#2)
five common##2##2##(2008-10#1)(2009-7#1)
five commonly##2##2##(2008-1#1)(2008-8#1)
five complete open reading frames (ORFs)##2##6##(1995-9#1)(1997-3#1)
five complete open reading frames##3##5##(1995-9#2)(1997-3#1)
five complete##4##2##(1990-3#1)(1995-9#2)(1997-3#1)
five compounds##3##2##(2008-10#3)
five conditions##2##2##(1995-2#1)(2013-8#1)
five consecutive##4##2##(1995-3#1)(1995-8#1)(2007-6#1)(2008-5#1)
five continents##4##2##(2008-10#3)(2012-3#1)
five copies of the##2##4##(1993-8#1)(2008-10#1)
five corresponding##2##2##(2008-10#1)(2008-6#1)
five countries##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
five courses of ifosfamide##2##4##(2008-6#2)
five cultivars of##2##3##(2008-10#2)
five cultivars##5##2##(2008-10#4)(2009-8#1)
five cycles##2##2##(2008-5#1)(2013-1#1)
five cysteine##2##2##(1993-8#1)(1994-11#1)
five days in##2##3##(2008-5#1)(2013-1#1)
five days of treatment##2##4##(2008-12#1)(2008-5#1)
five days of##4##3##(2007-7#1)(2008-12#2)(2008-5#1)
five days per week##2##4##(2008-9#1)(2013-1#1)
five days##20##2##(1991-3#1)(1992-5#1)(1992-8#1)(1995-12#1)(1996-8#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-5#3)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-1#2)
five decades##5##2##(1994-12#1)(1996-3#1)(2009-5#1)(2010-8#1)(2012-3#1)
five determinations##3##2##(2008-10#3)
five different concentrations##2##3##(2008-10#1)(2008-5#1)
five different groups##3##3##(2008-10#2)(2008-5#1)
five different##46##2##(1990-8#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#2)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-5#1)(2013-1#1)
five differentials##3##2##(2008-10#3)
five dimensions##2##2##(2013-1#2)
five distinct##5##2##(1991-5#1)(1994-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
five districts of##2##3##(2010-8#1)(2012-12#1)
five elements##2##2##(2008-10#1)(2008-8#1)
five endometriosis##2##2##(1995-12#2)
five experimental##2##2##(2008-10#2)
five experiments##5##2##(1993-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
five factors##2##2##(2008-6#1)(2010-11#1)
five families##2##2##(1992-7#1)(2008-10#1)
five fold##2##2##(1991-2#1)(2008-11#1)
five fractions of##2##3##(2008-10#2)
five fractions##3##2##(2008-10#3)
five free##2##2##(2008-10#1)(2008-3#1)
five from##2##2##(1997-3#1)(2008-5#1)
five general##2##2##(2007-7#1)(2008-5#1)
five genes that##2##3##(2008-10#2)
five genes##8##2##(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#4)(2008-7#1)
five genetic##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
five genotypes##3##2##(2008-10#1)(2008-12#2)
five geographic##2##2##(1993-1#1)(2008-10#1)
five goals##2##2##(1991-2#1)(1995-3#1)
five groups##11##2##(1990-12#1)(1991-6#1)(1993-9#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)
five had##4##2##(1992-5#1)(1992-9#1)(2009-10#1)(2011-2#1)
five heavy##2##2##(2008-10#2)
five hospitals##2##2##(1992-6#1)(1995-3#1)
five hours##2##2##(1990-9#1)(1992-12#1)
five human##2##2##(2007-11#1)(2008-7#1)
five important##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
five in the##3##3##(2007-7#1)(2008-1#1)(2008-11#1)
five in##5##2##(1992-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
five independent##3##2##(2007-11#1)(2008-10#2)
five individual##3##2##(1997-6#1)(2008-10#2)
five individuals##2##2##(2008-6#1)(2013-8#1)
five introns##2##2##(1994-8#1)(2008-10#1)
five isolates of##3##3##(1996-12#1)(2008-10#2)
five isolates##7##2##(1996-12#1)(2008-10#6)
five key##3##2##(1991-3#1)(2008-3#1)(2011-1#1)
five known##3##2##(1997-8#1)(2008-11#1)(2008-4#1)
five large##2##2##(2008-11#1)(2009-4#1)
five layers##2##2##(2008-10#1)(2008-9#1)
five lesions##2##2##(2008-10#1)(2008-6#1)
five level##2##2##(2007-10#1)(2008-10#1)
five levels of##2##3##(2008-10#1)(2008-3#1)
five locations throughout##2##3##(2008-10#2)
five locations##5##2##(1992-11#1)(2008-10#3)(2008-4#1)
five loci##3##2##(2008-12#2)(2009-2#1)
five main##2##2##(2008-11#2)
five major##7##2##(1996-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
five male##8##2##(1996-7#1)(2008-9#6)(2013-1#1)
five males and##2##3##(2007-7#1)(2008-9#1)
five males##3##2##(2007-7#1)(2008-5#1)(2008-9#1)
five markers##2##2##(1997-5#1)(2008-10#1)
five measurement##2##2##(1996-2#1)(2008-11#1)
five measurements##6##2##(2008-10#6)
five members of the##2##4##(1991-2#1)(1993-12#1)
five members of##3##3##(1991-2#1)(1993-12#1)(2009-10#1)
five min of##2##3##(1991-12#1)(2012-1#1)
five minutes of##2##3##(2008-10#1)(2008-3#1)
five minutes##7##2##(1996-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)
five month##2##2##(2007-8#1)(2010-4#1)
five months later##2##3##(2009-6#1)(2012-2#1)
five months##10##2##(1990-9#2)(1993-11#1)(1995-9#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
five naturally##2##2##(2008-10#2)
five new##3##2##(1997-3#1)(2008-12#1)(2008-8#1)
five observers##2##2##(1997-8#1)(2008-5#1)
five of the seven##4##4##(1993-3#1)(1996-6#1)(2008-10#1)(2008-8#1)
five of the six##3##4##(1994-8#1)(2008-10#2)
five of the##12##3##(1990-12#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-8#2)(1996-6#1)(2008-10#3)(2008-8#1)(2008-9#1)
five of them##3##3##(1992-5#1)(2008-5#1)(2008-9#1)
five of these##7##3##(2006-6#1)(2008-10#3)(2008-7#1)(2008-9#1)(2013-1#1)
five of which##2##3##(2008-10#1)(2010-3#1)
five of##31##2##(1990-12#1)(1990-2#1)(1991-6#2)(1992-5#1)(1993-3#1)(1994-12#1)(1994-8#2)(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2012-3#1)(2013-1#1)
five or more##2##3##(1997-1#1)(2008-6#1)
five or six##3##3##(1991-6#1)(2008-8#1)(2013-7#1)
five or##9##2##(1991-6#1)(1997-1#1)(1997-4#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-7#1)
five orders of##2##3##(2008-10#1)(2008-3#1)
five orders##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
five other##9##2##(1992-2#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-6#1)
five others##2##2##(1995-12#1)(2011-3#1)
five out of seven##2##4##(2008-10#1)(2008-9#1)
five out of##6##3##(1994-2#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-3#1)
five pCP plants##2##3##(2008-10#2)
five pairs of##2##3##(2007-11#1)(2007-12#1)
five parameters##5##2##(1993-11#1)(2008-10#1)(2008-3#1)(2008-7#2)
five particles##2##2##(2008-3#2)
five pathogens##4##2##(2008-10#4)
five patients were##3##3##(2007-11#1)(2009-3#1)(2013-1#1)
five patients who##2##3##(2008-9#1)(2011-2#1)
five patients with a##2##4##(2013-1#2)
five patients with##13##3##(1990-9#1)(1991-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2012-3#1)(2013-1#2)
five patients##35##2##(1990-9#1)(1991-5#1)(1991-9#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#1)(2009-12#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#4)
five pea lines##2##3##(2008-10#2)
five percent of##2##3##(2008-6#1)(2011-1#1)
five percent##4##2##(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
five periods##2##2##(2010-8#1)(2012-9#1)
five physicians##2##2##(1997-6#1)(2008-11#1)
five plant##2##2##(2008-10#1)(2008-8#1)
five plants##2##2##(2008-5#1)(2009-12#1)
five points along##2##3##(2011-2#2)
five points##5##2##(1991-2#1)(2008-10#1)(2011-2#2)(2013-7#1)
five populations##2##2##(2008-10#2)
five previously##2##2##(2008-10#1)(2011-2#1)
five primary##2##2##(1990-12#1)(1993-2#1)
five protein bands##2##3##(2008-10#2)
five proteins##2##2##(1994-12#1)(1995-5#1)
five regions##2##2##(2008-10#2)
five repeated##2##2##(2008-10#1)(2011-1#1)
five replant soils##2##3##(2008-10#2)
five replicate analysis of##2##4##(2008-10#2)
five replicate determinations of##2##4##(2008-10#2)
five replicate determinations##3##3##(2008-10#3)
five replicate##7##2##(2008-10#7)
five replicates##3##2##(2008-10#3)
five resistant##2##2##(2008-10#2)
five risk##2##2##(1997-1#1)(2009-7#1)
five rows##2##2##(2008-10#1)(2008-5#1)
five sample injections##2##3##(2008-10#2)
five selected##3##2##(1993-1#1)(1996-5#1)(2008-10#1)
five sequences##2##2##(1995-6#1)(2013-1#1)
five servings of fruits or vegetables##2##6##(1994-2#1)(2010-8#1)
five soils##3##2##(2008-10#2)(2008-12#1)
five species in the phylum chordata##2##6##(1996-5#2)
five species in##4##3##(1996-5#2)(2008-10#1)(2008-9#1)
five species of the genus##2##5##(2010-8#2)
five species of##6##3##(2007-12#1)(2008-10#2)(2010-8#2)(2013-1#1)
five species##20##2##(1990-11#1)(1996-5#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2010-8#2)(2013-1#1)
five stages##5##2##(1990-10#2)(1994-2#1)(2008-7#1)(2013-1#1)
five states##3##2##(1993-3#1)(2008-10#2)
five steps##2##2##(2008-10#2)
five strains of##2##3##(1997-4#1)(2008-10#1)
five strains or four strains without GUT9##2##7##(2008-10#2)
five strains##7##2##(1997-4#1)(2008-10#4)(2011-2#2)
five studies##2##2##(1994-3#1)(2011-2#1)
five subjects with##3##3##(1991-8#1)(2008-7#2)
five successive##2##2##(2008-10#2)
five susceptible genotypes##2##3##(2008-10#2)
five tasks##2##2##(2010-3#2)
five teacher actions to encourage##3##5##(2008-4#3)
five teacher actions##5##3##(2008-4#5)
five teacher##6##2##(2008-4#6)
five techniques##3##2##(2007-8#1)(2008-3#1)(2008-5#1)
five telescopes##2##2##(2008-3#2)
five times greater than##4##4##(1993-1#1)(2007-12#1)(2008-10#1)(2009-6#1)
five times higher than##2##4##(2008-10#1)(2008-3#1)
five times longer##2##3##(2008-10#2)
five times the##3##3##(2008-10#2)(2008-2#1)
five times##25##2##(1990-7#1)(1993-1#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#2)(2012-2#1)
five to seven##2##3##(1991-6#1)(2008-11#1)
five to ten##3##3##(1992-5#1)(1994-9#1)(1996-2#1)
five to##9##2##(1991-6#1)(1992-5#1)(1994-9#1)(1996-2#2)(2007-12#2)(2007-5#1)(2008-11#1)
five toroidal##2##2##(2008-3#2)
five trace##2##2##(2008-11#1)(2008-3#1)
five trials##2##2##(1997-3#1)(2008-10#1)
five type##2##2##(2007-8#2)
five types of##4##3##(1993-2#1)(2008-10#1)(2011-2#1)(2012-1#1)
five types##5##2##(1993-2#1)(1997-6#1)(2008-10#1)(2011-2#1)(2012-1#1)
five variables##5##2##(2008-10#4)(2008-2#1)
five viruses##2##2##(2008-10#2)
five volunteers##3##2##(1992-3#1)(1996-5#1)(2008-11#1)
five wavelengths##2##2##(2008-10#1)(2008-2#1)
five weeks##7##2##(1990-11#1)(1990-3#1)(1992-4#2)(2012-12#1)(2012-2#2)
five were##7##2##(1991-4#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
five women##2##2##(1991-5#1)(2013-8#1)
five year period (1996-2000)##2##4##(2007-7#2)
five year period##5##3##(2007-7#3)(2011-1#1)(2011-2#1)
five year##14##2##(1997-2#1)(2006-8#1)(2007-7#4)(2008-1#3)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
five years after the##3##4##(1991-9#1)(1994-9#1)(2008-10#1)
five years after##5##3##(1991-9#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-9#1)
five years ago##2##3##(1997-3#1)(2010-9#1)
five years in##3##3##(1997-5#1)(1997-6#1)(2008-1#1)
five years later##3##3##(2012-2#3)
five years of age##2##4##(2011-2#1)(2012-3#1)
five years of##5##3##(1991-8#1)(1992-2#1)(1996-12#1)(2011-2#1)(2012-3#1)
five years post-implant##3##3##(2008-9#3)
five years##59##2##(1990-12#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-11#2)(1996-12#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
five years' experience##2##3##(1990-3#1)(2012-12#1)
five##1323##1##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#5)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#5)(1991-1#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#7)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#3)(1992-5#6)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#5)(1993-11#5)(1993-12#9)(1993-2#6)(1993-3#7)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#10)(1994-2#9)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#4)(1995-12#8)(1995-2#8)(1995-3#8)(1995-5#9)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#9)(1996-2#7)(1996-3#6)(1996-5#9)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#16)(1997-4#5)(1997-5#6)(1997-6#5)(1997-7#7)(1997-8#9)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#14)(2007-12#13)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#14)(2007-8#13)(2007-9#1)(2008-1#21)(2008-10#346)(2008-11#38)(2008-12#21)(2008-2#12)(2008-3#32)(2008-4#13)(2008-5#51)(2008-6#24)(2008-7#27)(2008-8#26)(2008-9#44)(2009-10#3)(2009-12#6)(2009-2#4)(2009-3#5)(2009-4#6)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#4)(2010-2#1)(2010-3#7)(2010-4#7)(2010-5#2)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#16)(2011-2#45)(2011-3#2)(2012-1#6)(2012-12#12)(2012-2#20)(2012-3#14)(2012-5#1)(2012-9#2)(2013-1#33)(2013-7#4)(2013-8#17)
five)##2##1##(2008-10#1)(2008-7#1)
five-##3##1##(1993-6#1)(2007-11#1)(2008-10#1)
five-aperture shearing and##2##3##(2008-3#2)
five-base##2##1##(1990-7#1)(1993-12#1)
five-carbon##2##1##(2012-3#2)
five-component##2##1##(2008-10#2)
five-day##3##1##(1992-2#1)(1997-5#1)(2008-2#1)
five-dimensional##3##1##(2007-12#2)(2008-9#1)
five-fold##6##1##(1994-5#1)(2008-10#5)
five-membered##3##1##(1996-2#1)(2007-11#2)
five-part##8##1##(1991-12#1)(1992-1#1)(1992-2#2)(1996-2#1)(2008-10#3)
five-point relative pose problem##2##4##(2008-6#2)
five-point##4##1##(2008-12#1)(2008-6#2)(2013-7#1)
five-step##4##1##(1995-1#1)(1996-5#1)(1997-3#1)(2008-11#1)
five-wave longitudinal study##2##3##(2009-7#2)
five-year follow-up##2##2##(2008-7#1)(2008-8#1)
five-year longitudinal##2##2##(2012-2#2)
five-year period##10##2##(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#2)(1994-3#1)(2007-7#1)(2008-10#1)(2008-12#1)
five-year study##3##2##(1990-5#1)(2008-11#1)(2008-7#1)
five-year survival rate##2##3##(2006-10#1)(2012-1#1)
five-year survival##5##2##(2006-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
five-year##30##1##(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-2#1)(1993-12#1)(1994-3#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
five-year-old##4##1##(2008-11#1)(2008-9#2)(2013-1#1)
fivefold higher##3##2##(1993-2#1)(2008-10#2)
fivefold increase in##2##3##(2008-10#1)(2008-7#1)
fivefold##11##1##(1993-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)
fix the##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-2#1)
fix##22##1##(1991-8#1)(1993-3#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#7)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
fixated with##3##2##(1991-9#1)(2009-3#2)
fixated##7##1##(1991-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-3#3)
fixating##2##1##(2008-11#1)(2009-2#1)
fixation (nif) genes##2##3##(2008-4#1)(2008-9#1)
fixation after##3##2##(2007-8#1)(2011-2#1)(2013-8#1)
fixation and##14##2##(1991-6#1)(2007-11#1)(2008-10#1)(2008-8#2)(2008-9#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
fixation but##2##2##(2009-2#1)(2009-4#1)
fixation by##3##2##(1996-5#1)(2008-2#1)(2012-12#1)
fixation can##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
fixation device##6##2##(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#2)
fixation devices##5##2##(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
fixation followed by##2##3##(2008-7#1)(2008-9#1)
fixation for##6##2##(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
fixation group##4##2##(2009-3#4)
fixation has been##3##3##(2007-8#1)(2010-5#1)(2012-2#1)
fixation has##5##2##(2007-8#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
fixation in the##6##3##(2007-8#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2013-1#1)
fixation in##19##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#4)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
fixation is a##2##3##(2009-10#1)(2012-2#1)
fixation is##7##2##(1991-9#1)(2007-8#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
fixation method##2##2##(2008-11#1)(2008-8#1)
fixation methods##2##2##(2007-12#1)(2012-2#1)
fixation of a##3##3##(1997-7#1)(2007-11#1)(2009-4#1)
fixation of an OCD loose body##2##6##(2013-1#2)
fixation of pathological fracture##2##4##(2007-11#2)
fixation of pathological fractures##3##4##(2007-11#3)
fixation of pathological##5##3##(2007-11#5)
fixation of the##14##3##(2007-12#1)(2007-8#3)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#2)(2012-2#1)(2013-1#1)
fixation of##44##2##(1997-7#1)(2007-11#7)(2007-12#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2010-12#1)(2010-3#2)(2011-2#2)(2012-2#6)(2012-3#1)(2013-1#4)
fixation procedure##2##2##(1993-12#1)(2008-10#1)
fixation protocol##2##2##(2008-9#1)(2009-8#1)
fixation remains##2##2##(2008-10#1)(2008-11#1)
fixation should be##2##3##(2009-4#1)(2012-12#1)
fixation surface##3##2##(2008-11#3)
fixation techniques for##2##3##(2008-12#1)(2012-3#1)
fixation techniques have been described##2##5##(2010-3#1)(2012-2#1)
fixation techniques##7##2##(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)
fixation test##3##2##(1992-5#1)(1992-6#1)(2013-1#1)
fixation through##2##2##(2012-2#1)(2013-1#1)
fixation to the##2##3##(2008-10#1)(2008-8#1)
fixation to##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-12#1)
fixation using##2##2##(2007-8#1)(2008-12#1)
fixation was used in##3##4##(2008-7#1)(2009-3#2)
fixation was used##5##3##(2007-8#1)(2008-7#1)(2009-3#3)
fixation was##11##2##(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#3)(2011-2#1)(2013-1#2)
fixation with##10##2##(1995-2#1)(2007-11#1)(2007-8#2)(2008-12#1)(2009-3#2)(2011-2#1)(2012-2#2)
fixation##296##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2007-11#18)(2007-12#5)(2007-8#16)(2008-1#1)(2008-10#14)(2008-11#16)(2008-12#6)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#16)(2008-8#10)(2008-9#21)(2009-1#1)(2009-10#3)(2009-2#7)(2009-3#18)(2009-4#4)(2009-7#2)(2009-8#3)(2010-12#5)(2010-3#5)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#17)(2012-12#8)(2012-2#21)(2012-3#11)(2012-8#1)(2013-1#31)(2013-8#1)
fixation)##4##1##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)
fixation-free rehalogenating bleaching##2##3##(2008-3#2)
fixation-free rehalogenating##3##2##(2008-3#3)
fixations##4##1##(1990-6#1)(2008-11#1)(2009-2#1)(2013-1#1)
fixative solution##2##2##(2008-9#1)(2010-9#1)
fixative##9##1##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)
fixatives##3##1##(1996-5#1)(2008-5#1)(2008-9#1)
fixator##8##1##(2007-8#5)(2008-8#2)(2012-2#1)
fixators##5##1##(2007-11#2)(2008-8#2)(2011-2#1)
fixed a##2##2##(2008-10#1)(2009-7#1)
fixed and##17##2##(1991-4#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-1#1)(2012-2#1)
fixed angle##2##2##(2008-9#2)
fixed at##9##2##(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)
fixed bed##6##2##(1994-5#2)(2008-11#4)
fixed by##5##2##(1993-9#1)(2008-10#2)(2008-12#1)(2010-8#1)
fixed cell##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
fixed cells##8##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-9#5)
fixed combination##3##2##(1991-6#1)(2013-1#2)
fixed concentrations of##2##3##(1992-3#1)(1997-4#1)
fixed effects##2##2##(1995-2#1)(2012-3#1)
fixed in formalin##2##3##(2008-7#1)(2008-8#1)
fixed in the##5##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
fixed in##20##2##(1993-11#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
fixed interference method (FIM) indicate##3##5##(2008-10#3)
fixed interference method (FIM)##4##4##(2008-10#4)
fixed interference method##6##3##(2008-10#6)
fixed interference##7##2##(2008-10#7)
fixed muscle weakness##2##3##(1991-12#2)
fixed nitrogen##4##2##(2008-4#1)(2008-9#2)(2011-2#1)
fixed on Sephadex##2##3##(2008-10#2)
fixed on a##6##3##(2007-11#1)(2008-10#5)
fixed on the##5##3##(1994-12#1)(2007-12#1)(2008-10#2)(2010-8#1)
fixed on##16##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-3#1)(2010-8#1)
fixed or##3##2##(2008-4#1)(2012-1#1)(2013-1#1)
fixed parameter controller##2##3##(1997-2#2)
fixed parameter##3##2##(1997-2#2)(2008-9#1)
fixed phase mask##2##3##(2007-11#1)(2008-3#1)
fixed point##5##2##(1990-4#1)(2011-2#4)
fixed polarizer##3##2##(2008-3#3)
fixed prostheses##2##2##(2009-8#1)(2011-7#1)
fixed samples##2##2##(2008-7#1)(2008-9#1)
fixed time and initial rate##2##5##(2008-10#2)
fixed time and##3##3##(2008-10#3)
fixed time##8##2##(2008-10#7)(2012-2#1)
fixed tissue##2##2##(2008-9#2)
fixed to the##2##3##(2008-10#1)(2008-6#1)
fixed to##5##2##(1995-3#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-6#1)
fixed triangular waves##2##3##(2008-10#2)
fixed values##2##2##(1995-2#1)(2007-12#1)
fixed weight##2##2##(1993-3#1)(1996-2#1)
fixed while##2##2##(2008-2#1)(2008-3#1)
fixed with a##4##3##(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#1)
fixed with##15##2##(1990-12#1)(1990-8#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#3)(2013-1#5)
fixed##377##1##(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#2)(1992-2#1)(1992-3#4)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#83)(2008-11#11)(2008-12#9)(2008-2#15)(2008-3#40)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#10)(2008-9#16)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#13)(2011-7#2)(2012-1#4)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#15)(2013-8#4)
fixed)##2##1##(2008-10#1)(2008-9#1)
fixed-##2##1##(1995-12#1)(2007-12#1)
fixed-analyzer##6##1##(2008-2#1)(2008-3#5)
fixed-bed bioreactor##2##2##(2008-11#2)
fixed-bed column##2##2##(2008-12#2)
fixed-bed reactor##4##2##(2008-11#2)(2008-7#1)(2009-2#1)
fixed-bed##9##1##(2008-11#5)(2008-12#2)(2008-7#1)(2009-2#1)
fixed-dose##2##1##(2008-11#1)(2009-4#1)
fixed-pattern##3##1##(2008-2#2)(2008-3#1)
fixed-polarizer##5##1##(2008-2#1)(2008-3#4)
fixed-price region##3##2##(1995-2#3)
fixed-price##5##1##(1993-12#1)(1995-2#4)
fixed-ratio##2##1##(1991-12#1)(2011-2#1)
fixed-removable prosthesis##2##2##(2013-1#2)
fixed-strain recovery##2##2##(2009-7#2)
fixed-time (45##2##2##(2008-5#2)
fixed-time method##2##2##(2008-10#2)
fixed-time##6##1##(2008-10#3)(2008-5#3)
fixing and staining##2##3##(2008-8#1)(2008-9#1)
fixing the##6##2##(1991-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
fixing##28##1##(1991-11#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#3)(2013-1#1)
fixtures##2##1##(2008-3#1)(2008-6#1)
flaccid paralysis##6##2##(2009-3#1)(2010-8#4)(2011-1#1)
flaccid##8##1##(2009-3#2)(2010-8#5)(2011-1#1)
flaccidifolious##2##1##(2013-1#2)
flag leaf and panicle itself##2##5##(2008-12#2)
flag leaf and panicle##3##4##(2008-12#3)
flag leaf and##4##3##(2008-12#3)(2008-9#1)
flag leaf##13##2##(2008-10#7)(2008-12#5)(2008-9#1)
flag leaves and##4##3##(2008-12#1)(2008-9#3)
flag leaves of##2##3##(2008-10#2)
flag leaves##15##2##(2008-10#7)(2008-12#3)(2008-9#5)
flag shoot subpopulation of E##2##5##(2008-10#2)
flag shoot subpopulation##4##3##(2008-10#4)
flag shoot##5##2##(2008-10#5)
flag shoots for##2##3##(2008-10#2)
flag shoots##5##2##(2008-10#5)
flag##44##1##(2008-10#25)(2008-12#13)(2008-9#6)
flagella##16##1##(1991-2#2)(2007-12#9)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)
flagellar##9##1##(1990-2#2)(1991-2#1)(1993-12#2)(1994-8#1)(2007-12#1)(2008-10#1)(2008-4#1)
flagellate zoospores##2##2##(2008-10#2)
flagellate##5##1##(1996-2#1)(2007-12#2)(2008-10#2)
flagellated##2##1##(1992-8#1)(2008-7#1)
flagellin##6##1##(1990-2#2)(1991-9#1)(1993-9#1)(1997-4#1)(2009-6#1)
flagellins of##3##2##(1990-2#3)
flagellins##8##1##(1990-2#8)
flagellomeres##3##1##(2007-12#3)
flagellum and##3##2##(2007-12#2)(2008-7#1)
flagellum is##2##2##(2007-12#1)(2008-5#1)
flagellum##22##1##(2007-12#7)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#10)(2009-8#1)
flags are##3##2##(2008-12#1)(2010-8#2)
flags##10##1##(1997-4#1)(2008-10#1)(2008-12#5)(2010-8#2)(2013-7#1)
flail##3##1##(2007-12#1)(2009-4#1)(2013-1#1)
flakes##2##1##(2008-5#2)
flaking##2##1##(2008-10#1)(2008-5#1)
flaky##2##1##(2008-5#1)(2011-2#1)
flame AAS after##2##3##(2008-10#2)
flame AAS method##2##3##(2008-10#2)
flame AAS was used##2##4##(2008-10#2)
flame AAS##15##2##(2008-10#15)
flame absorption##2##2##(2008-10#2)
flame and the##2##3##(2008-10#1)(2008-3#1)
flame and##7##2##(2008-10#4)(2008-2#2)(2008-3#1)
flame at##2##2##(2008-10#1)(2008-2#1)
flame atomic absorption spectrometer (FAAS)##2##5##(2008-10#2)
flame atomic absorption spectrometer##11##4##(2008-10#11)
flame atomic absorption spectrometric determination of##3##6##(2008-10#3)
flame atomic absorption spectrometric determination##4##5##(2008-10#4)
flame atomic absorption spectrometric##13##4##(2008-10#13)
flame atomic absorption spectrometry (AAS)##2##5##(2008-10#2)
flame atomic absorption spectrometry (FAAS) and##6##6##(2008-10#6)
flame atomic absorption spectrometry (FAAS) determination of##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) for##2##6##(2008-10#2)
flame atomic absorption spectrometry (FAAS) is proposed##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) is##5##6##(2008-10#5)
flame atomic absorption spectrometry (FAAS) was developed##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) was##4##6##(2008-10#4)
flame atomic absorption spectrometry (FAAS)##49##5##(2008-10#49)
flame atomic absorption spectrometry and UV-visible spectrophotometric methods##2##8##(2008-10#2)
flame atomic absorption spectrometry and##4##5##(2008-10#4)
flame atomic absorption spectrometry for##3##5##(2008-10#3)
flame atomic absorption spectrometry in##2##5##(2008-10#2)
flame atomic absorption spectrometry is##4##5##(2008-10#4)
flame atomic absorption spectrometry was used##2##6##(2008-10#2)
flame atomic absorption spectrometry with##2##5##(2008-10#2)
flame atomic absorption spectrometry##129##4##(2008-10#128)(2013-8#1)
flame atomic absorption spectrophotometry (FAAS)##4##5##(2008-10#4)
flame atomic absorption spectrophotometry##10##4##(2008-10#10)
flame atomic absorption spectroscopy##2##4##(2008-10#1)(2011-2#1)
flame atomic absorption##173##3##(2008-10#171)(2011-2#1)(2013-8#1)
flame atomic emission##2##3##(2008-10#2)
flame atomic##177##2##(2008-10#175)(2011-2#1)(2013-8#1)
flame by use of##2##4##(2008-2#1)(2008-3#1)
flame emission##2##2##(2008-10#2)
flame in##2##2##(2008-10#1)(2008-2#1)
flame ionisation##3##2##(2008-10#3)
flame ionization detection##3##3##(2008-10#1)(2008-5#2)
flame ionization detector##6##3##(2008-10#4)(2008-11#1)(2012-1#1)
flame ionization##9##2##(2008-10#5)(2008-11#1)(2008-5#2)(2012-1#1)
flame is##4##2##(2008-10#1)(2008-2#3)
flame photometric detector##3##3##(2008-10#3)
flame photometric##6##2##(2008-10#6)
flame structure##4##2##(2008-3#4)
flame temperatures and##2##3##(2008-2#1)(2008-3#1)
flame that##2##2##(2008-3#2)
flame was##3##2##(2008-10#1)(2008-3#2)
flame were##2##2##(2008-2#1)(2008-3#1)
flame where##2##2##(2008-1#1)(2008-10#1)
flame with##2##2##(2008-3#2)
flame##322##1##(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#248)(2008-11#2)(2008-2#29)(2008-3#31)(2008-5#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
flame-AAS##2##1##(2008-10#2)
flame-synthesized##2##1##(2008-3#2)
flames and##2##2##(2008-3#2)
flames are##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
flames at##3##2##(2008-2#1)(2008-3#2)
flames by##2##2##(2007-12#1)(2008-3#1)
flames were##2##2##(2008-3#2)
flames##51##1##(1994-12#1)(2007-12#2)(2008-2#9)(2008-3#39)
flank pain##4##2##(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
flank##13##1##(1993-8#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
flanked by a##2##3##(1993-8#1)(2012-3#1)
flanked by two##4##3##(1994-12#1)(2007-12#3)
flanked by##16##2##(1990-12#1)(1993-8#1)(1994-12#1)(1995-8#3)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#3)(2008-10#2)(2008-8#1)(2012-3#1)
flanked##19##1##(1990-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-8#3)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#3)(2008-10#3)(2008-8#1)(2012-3#1)
flanking DNA of##3##3##(2008-11#2)(2008-8#1)
flanking DNA##4##2##(1991-6#1)(2008-11#2)(2008-8#1)
flanking genomic##2##2##(1995-2#1)(1997-7#1)
flanking markers##3##2##(2008-10#2)(2008-5#1)
flanking region of the human##2##5##(1993-12#2)
flanking region of the##5##4##(1991-9#2)(1993-12#2)(1993-3#1)
flanking region of##7##3##(1991-5#1)(1991-9#2)(1993-12#3)(1993-3#1)
flanking region##19##2##(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1994-11#1)(1995-2#1)(1996-10#1)(2008-12#1)(2008-7#1)
flanking regions and##2##3##(1994-11#1)(1995-5#1)
flanking regions of##3##3##(1992-3#1)(1993-6#1)(1997-4#1)
flanking regions were##2##3##(1993-8#1)(2008-8#1)
flanking regions##14##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-4#2)(2008-8#1)
flanking sequence##6##2##(1990-12#1)(1990-8#1)(1993-12#1)(1995-2#3)
flanking sequences##12##2##(1992-12#1)(1994-11#1)(1994-12#2)(1995-2#3)(1995-6#1)(1997-7#1)(2008-10#2)(2011-10#1)
flanking the axoneme##2##3##(2007-12#2)
flanking the peptidyl-tRNA hydrolase-encoding gene##2##5##(1994-12#2)
flanking the##24##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-6#1)(1994-12#3)(1994-5#1)(1995-2#2)(1995-8#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-3#1)
flanking##101##1##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#6)(1994-5#1)(1995-2#12)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#2)(1997-6#1)(1997-7#2)(2007-12#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-4#1)(2010-8#1)(2011-10#1)(2012-3#1)
flanks##4##1##(1990-3#1)(1992-9#1)(1995-3#1)(1997-7#1)
flap after##2##2##(1994-12#1)(2013-1#1)
flap and##8##2##(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2013-1#1)
flap are##2##2##(2007-5#1)(2008-7#1)
flap based on##3##3##(2008-9#2)(2011-2#1)
flap closure##3##2##(2011-2#1)(2012-2#2)
flap coverage##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
flap design##3##2##(2007-12#1)(2009-8#1)(2013-1#1)
flap for##11##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-11#2)(2011-2#3)
flap has been##2##3##(2007-12#1)(2011-2#1)
flap has##3##2##(2007-12#1)(2011-2#2)
flap in breast reconstruction##2##4##(1990-9#2)
flap in the##3##3##(1991-5#1)(2008-10#1)(2013-8#1)
flap in##16##2##(1990-9#2)(1991-4#1)(1991-5#2)(2007-12#3)(2008-10#1)(2008-9#1)(2011-2#5)(2013-8#1)
flap is a##3##3##(2007-12#2)(2008-9#1)
flap is contraindicated##2##3##(2008-9#1)(2012-12#1)
flap is##10##2##(2007-12#2)(2007-8#1)(2008-4#1)(2008-9#3)(2011-2#1)(2012-12#2)
flap of the##3##3##(1991-5#1)(2011-2#2)
flap of##5##2##(1991-5#1)(1993-3#1)(2011-2#3)
flap perfusion##2##2##(2013-1#2)
flap reconstruction##4##2##(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
flap reconstructions##2##2##(2012-2#2)
flap salvage##2##2##(2008-4#1)(2008-9#1)
flap that##2##2##(2007-12#2)
flap to treat##2##3##(2011-2#1)(2013-1#1)
flap to##6##2##(2008-9#2)(2011-2#3)(2013-1#1)
flap was##11##2##(1991-4#1)(1992-9#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2011-2#1)(2013-1#2)
flap with##3##2##(1991-4#1)(2008-9#1)(2012-12#1)
flap##196##1##(1990-9#4)(1991-4#3)(1991-5#5)(1992-9#1)(1993-11#2)(1993-3#1)(1994-12#1)(2006-12#1)(2007-12#28)(2007-5#5)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#10)(2008-9#32)(2009-1#5)(2009-12#1)(2009-7#1)(2009-8#3)(2010-11#3)(2011-2#34)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#16)(2013-8#2)
flap&quot##3##1##(1991-4#1)(1995-3#2)
flapless surgery##4##2##(2013-1#4)
flapless##7##1##(2013-1#7)
flapping##3##1##(1990-9#1)(2007-12#2)
flaps and##9##2##(1990-6#1)(2007-12#1)(2008-4#1)(2009-5#4)(2011-2#2)
flaps are##6##2##(2007-12#1)(2008-9#1)(2012-2#4)
flaps for##5##2##(2011-2#2)(2012-2#3)
flaps have##3##2##(2011-2#1)(2012-2#2)
flaps in head and neck##2##5##(2008-4#2)
flaps in##7##2##(2007-12#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-2#1)
flaps include##2##2##(2007-12#1)(2011-2#1)
flaps is##2##2##(2011-2#1)(2012-2#1)
flaps may##2##2##(2009-5#1)(2011-2#1)
flaps of##2##2##(2008-4#1)(2012-1#1)
flaps were harvested##2##3##(2008-9#2)
flaps were used##2##3##(2008-9#1)(2012-2#1)
flaps were##7##2##(2008-9#6)(2012-2#1)
flaps with##2##2##(2008-4#1)(2010-6#1)
flaps##96##1##(1990-6#3)(1991-4#1)(1991-5#1)(2007-12#10)(2008-12#3)(2008-4#5)(2008-9#21)(2009-5#7)(2010-6#2)(2011-2#16)(2012-1#1)(2012-12#2)(2012-2#19)(2013-1#4)(2013-8#1)
flare characterization of##2##3##(2008-3#2)
flare is##2##2##(1990-7#1)(1992-5#1)
flare##9##1##(1990-7#1)(1992-5#1)(1996-1#1)(2008-3#3)(2008-5#3)
flared##2##1##(2007-12#1)(2010-1#1)
flares of##2##2##(2008-7#1)(2011-2#1)
flares##4##1##(1992-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
flash of ions due to the ionisation of##2##8##(2008-10#2)
flash of##3##2##(2008-10#2)(2010-12#1)
flash photolysis##5##2##(1990-3#1)(1991-12#1)(1995-2#2)(2008-8#1)
flash x rays##2##3##(2008-3#2)
flash x-ray##3##2##(2008-3#3)
flash##24##1##(1990-3#1)(1991-12#1)(1995-2#2)(1997-1#1)(2008-10#3)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#2)(2010-12#1)(2013-1#1)
flash-lamp-pumped Nd##2##2##(2007-12#1)(2008-2#1)
flash-lamp-pumped dye laser##3##3##(2008-2#2)(2008-3#1)
flash-lamp-pumped##10##1##(2007-12#2)(2008-2#5)(2008-3#3)
flashbackers##4##1##(1996-7#4)
flashbacks##5##1##(1996-7#5)
flashes in##6##2##(2008-7#4)(2009-5#1)(2012-3#1)
flashes##27##1##(1992-11#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#18)(2009-5#2)(2012-3#1)
flashover##6##1##(1996-12#5)(2008-3#1)
flask by##2##2##(2008-10#1)(2008-11#1)
flask containing##2##2##(2007-11#1)(2008-11#1)
flask cultures##3##2##(2008-11#2)(2008-6#1)
flask in##2##2##(2008-10#1)(2008-11#1)
flask##23##1##(2007-11#1)(2008-10#5)(2008-11#13)(2008-12#1)(2008-4#1)(2008-6#2)
flasks and##4##2##(2008-11#3)(2008-6#1)
flasks using##4##2##(2008-11#1)(2008-7#2)(2011-2#1)
flasks were##2##2##(2008-11#1)(2008-6#1)
flasks##26##1##(1995-11#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2011-2#6)
flat and##4##2##(1995-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
flat body posture##4##3##(1991-2#4)
flat cell##2##2##(2008-10#2)
flat cells with##3##3##(1993-8#1)(2007-12#2)
flat end##2##2##(2008-10#2)
flat or##4##2##(2007-12#1)(2008-3#1)(2008-8#2)
flat plate##3##2##(2008-11#1)(2008-7#2)
flat silver grains##2##3##(2008-3#2)
flat spectral##2##2##(2007-11#1)(2008-3#1)
flat substrates##2##2##(2007-12#1)(2008-10#1)
flat surface##4##2##(2008-3#2)(2010-10#1)(2013-1#1)
flat surfaces##5##2##(2008-3#4)(2010-7#1)
flat top beam profile was used in single point mode sampling##2##11##(2008-10#2)
flat with##2##2##(1995-3#1)(2007-12#1)
flat##112##1##(1991-2#8)(1993-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#1)(1997-2#1)(1997-3#1)(2007-11#10)(2007-12#7)(2007-5#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#28)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#2)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
flat-field spectrograph##2##2##(2008-3#2)
flat-field##10##1##(2008-3#10)
flat-flame burner for##2##3##(2008-2#1)(2008-3#1)
flat-flame burner##5##2##(2008-2#2)(2008-3#3)
flat-panel##2##1##(2007-12#1)(2011-1#1)
flat-topped##5##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
flatband attenuator##2##2##(2007-11#2)
flatband##3##1##(2007-11#3)
flatbed scanner##2##2##(2008-12#1)(2008-3#1)
flatfish##3##1##(1996-2#2)(2012-2#1)
flatness and##2##2##(2007-11#1)(2008-11#1)
flatness distortion##3##2##(2008-2#3)
flatness of the##2##3##(2008-3#2)
flatness of##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
flatness##16##1##(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#8)(2008-3#4)
flats##6##1##(2007-5#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-9#1)
flattened cells##2##2##(1990-6#1)(2013-1#1)
flattened##22##1##(1990-6#1)(1993-12#1)(1994-12#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-9#1)(2011-2#2)(2013-1#1)
flattening of the##7##3##(1990-3#1)(2007-12#1)(2008-5#1)(2011-2#4)
flattening of##8##2##(1990-3#1)(1995-1#1)(2007-12#1)(2008-5#1)(2011-2#4)
flattening the##2##2##(2007-12#1)(2008-3#1)
flattening##13##1##(1990-3#1)(1995-1#1)(2007-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#4)
flattop##3##1##(2008-2#1)(2008-3#2)
flattopped##2##1##(2008-2#1)(2008-3#1)
flatworm##2##1##(2008-5#2)
flavanol##2##1##(2010-4#1)(2012-3#1)
flavanols##2##1##(2008-10#1)(2012-12#1)
flavanone##5##1##(2007-11#4)(2012-3#1)
flavescens##2##1##(2008-11#2)
flavida##3##1##(2011-2#3)
flavilium cation##3##2##(2008-10#3)
flavin adenine dinucleotide##2##3##(1992-12#1)(1993-11#1)
flavin adenine##3##2##(1992-12#1)(1993-11#1)(2008-10#1)
flavin mononucleotide##2##2##(1992-12#1)(2009-3#1)
flavin##14##1##(1990-12#1)(1992-1#2)(1992-12#3)(1993-11#1)(1994-11#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)
flavipes##3##1##(2008-1#2)(2011-2#1)
flavodoxin and##4##2##(1994-5#4)
flavodoxin gene##3##2##(1997-7#3)
flavodoxin##12##1##(1994-5#8)(1997-7#4)
flavoenzyme##6##1##(1990-12#1)(1990-7#2)(1992-11#1)(1994-11#1)(1995-5#1)
flavone##6##1##(1994-11#2)(2007-11#1)(2008-10#2)(2013-8#1)
flavone-C-glycoside##2##1##(2008-10#2)
flavone-C-glycosides##3##1##(2008-10#3)
flavones##6##1##(2008-10#1)(2008-11#1)(2011-3#2)(2012-3#1)(2013-8#1)
flavonoid aglycones##3##2##(2008-11#3)
flavonoid derivatives##2##2##(1993-8#2)
flavonoid glycosides##2##2##(2008-11#1)(2008-12#1)
flavonoid structure##2##2##(2008-10#1)(2008-11#1)
flavonoid##33##1##(1993-8#2)(2007-11#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#2)(2009-12#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#3)
flavonoids and##6##2##(2008-10#2)(2008-12#1)(2009-8#1)(2013-1#2)
flavonoids are##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
flavonoids as##2##2##(2008-4#1)(2008-5#1)
flavonoids from##5##2##(2008-5#1)(2010-9#1)(2012-12#2)(2012-3#1)
flavonoids in H##2##3##(2008-10#2)
flavonoids in the##7##3##(2008-10#1)(2008-11#2)(2008-5#3)(2009-10#1)
flavonoids in##17##2##(2008-10#9)(2008-11#2)(2008-5#3)(2009-10#2)(2011-2#1)
flavonoids of##3##2##(2008-10#2)(2013-8#1)
flavonoids was##2##2##(2007-11#1)(2008-10#1)
flavonoids were##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
flavonoids##91##1##(1992-5#1)(1993-8#1)(2007-11#3)(2008-10#34)(2008-11#11)(2008-12#1)(2008-4#3)(2008-5#12)(2008-9#1)(2009-10#5)(2009-11#1)(2009-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
flavonols##3##1##(2008-10#2)(2008-11#1)
flavopiridol##4##1##(2008-5#4)
flavoprotein containing##2##2##(1993-11#1)(1994-8#1)
flavoprotein which##2##2##(1991-12#1)(1992-3#1)
flavoprotein##5##1##(1991-12#1)(1992-3#1)(1993-11#1)(1994-8#1)(1996-8#1)
flavor and##3##2##(1992-5#1)(2008-6#1)(2010-2#1)
flavor compounds##3##2##(2008-10#1)(2012-2#2)
flavor##18##1##(1992-5#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-6#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-2#3)
flavors##9##1##(1991-3#2)(1995-2#1)(2008-10#4)(2009-9#1)(2010-9#1)
flavour##10##1##(2008-10#4)(2008-5#1)(2010-4#4)(2012-3#1)
flavoviridis##2##1##(2008-6#2)
flavus and F##2##3##(2008-10#2)
flavus and##14##2##(2008-10#14)
flavus by##2##2##(2008-10#2)
flavus can be divided into the S and L strains##2##10##(2008-10#2)
flavus in##4##2##(2008-10#3)(2008-12#1)
flavus infection and aflatoxin accumulation##2##5##(2008-10#2)
flavus infection and##3##3##(2008-10#3)
flavus infection##7##2##(2008-10#7)
flavus infection)##2##2##(2008-10#2)
flavus is##3##2##(2008-10#3)
flavus isolates##2##2##(2008-10#2)
flavus was grown##2##3##(2008-10#2)
flavus was##6##2##(2008-10#6)
flavus were##2##2##(2008-10#2)
flavus##91##1##(2008-1#1)(2008-10#84)(2008-12#2)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
flavus-inoculated rows##2##2##(2008-10#2)
flaw in##2##2##(2008-2#1)(2013-1#1)
flaw##3##1##(2008-2#1)(2009-7#1)(2013-1#1)
flawed##9##1##(1991-3#1)(1995-12#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2010-2#1)(2011-2#1)(2012-3#1)
flaws and##3##2##(2008-12#1)(2008-2#1)(2013-1#1)
flaws in##2##2##(1992-1#1)(2008-12#1)
flaws##16##1##(1992-1#1)(2008-10#1)(2008-12#6)(2008-2#1)(2008-9#1)(2009-7#2)(2010-7#1)(2011-2#1)(2013-1#2)
flax roots##3##2##(2008-10#3)
flax seeds##3##2##(1992-8#2)(2012-3#1)
flax##13##1##(1992-8#2)(2008-10#9)(2008-12#1)(2012-3#1)
flaxseed flour##10##2##(2010-4#10)
fldA gene##5##2##(1997-7#5)
fldA##7##1##(1997-7#7)
flea beetle populations##2##3##(2008-10#2)
flea##13##1##(2007-2#2)(2008-10#9)(2012-3#2)
fleas##8##1##(1990-6#2)(1995-2#1)(1997-6#1)(2007-2#2)(2012-3#1)(2013-1#1)
flecainide##2##1##(2011-2#1)(2012-3#1)
flecks##2##1##(2008-10#1)(2010-4#1)
fled##3##1##(1994-9#2)(2008-11#1)
fleece score##3##2##(1997-5#3)
fleece##11##1##(1997-5#8)(2007-8#1)(2013-8#2)
fleeing##2##1##(1996-2#1)(1997-2#1)
fleet##6##1##(1996-12#1)(2008-11#2)(2009-7#1)(2013-7#2)
fleeting##3##1##(1992-5#1)(2009-8#1)(2010-3#1)
flesh##5##1##(1990-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
fleshy fruits##4##2##(2008-8#1)(2008-9#3)
fleshy##9##1##(1992-1#1)(2008-8#2)(2008-9#5)(2013-1#1)
fleur de peau'##2##3##(2008-5#2)
fleur de##3##2##(2008-5#3)
flex##3##1##(2007-12#1)(2008-7#1)(2008-9#1)
flexed and##2##2##(2008-12#2)
flexed left lateral (P &lt##2##5##(1993-10#2)
flexed left lateral##5##3##(1993-10#5)
flexed##20##1##(1993-10#5)(1995-3#1)(1997-8#6)(2007-12#1)(2007-8#1)(2008-12#3)(2008-6#1)(2008-7#1)(2013-1#1)
flexibility and friction##2##3##(1997-3#2)
flexibility and##20##2##(1992-1#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
flexibility by##3##2##(1997-2#1)(1997-8#1)(2008-9#1)
flexibility for##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
flexibility in patients with##2##4##(2008-10#1)(2010-12#1)
flexibility in the##4##3##(1994-11#1)(2008-3#1)(2010-1#1)(2011-1#1)
flexibility in##22##2##(1991-1#1)(1994-11#2)(1994-6#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#3)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
flexibility is##3##2##(1992-3#1)(1993-11#1)(2009-8#1)
flexibility may##2##2##(1995-6#1)(2008-10#1)
flexibility of a##2##3##(2011-2#1)(2012-12#1)
flexibility of the##14##3##(1990-3#1)(1991-5#1)(1992-6#1)(1995-11#1)(1995-6#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)
flexibility of this##2##3##(1997-8#1)(2008-10#1)
flexibility of##33##2##(1990-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2011-9#1)(2012-12#1)(2013-7#1)
flexibility to accommodate##2##3##(2008-10#1)(2009-9#1)
flexibility to meet##2##3##(1993-12#1)(1997-3#1)
flexibility to##10##2##(1992-12#1)(1993-12#1)(1994-2#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-2#1)
flexibility##142##1##(1990-12#1)(1990-3#1)(1990-4#2)(1991-1#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#3)(1993-12#1)(1994-11#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#3)(2009-5#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#5)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
flexible and can be##2##4##(2007-12#1)(2012-3#1)
flexible and##15##2##(1992-2#1)(1994-12#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
flexible approach to##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
flexible behavioral##2##2##(2008-9#2)
flexible data##2##2##(2008-7#1)(2008-9#1)
flexible electronics##2##2##(2008-7#2)
flexible enough to##3##3##(2007-12#1)(2008-10#1)(2009-8#1)
flexible enough##4##2##(2007-12#1)(2008-10#1)(2009-8#1)(2011-1#1)
flexible hysteroscopy##2##2##(1993-12#2)
flexible method for##2##3##(1994-3#1)(2008-10#1)
flexible method of##2##3##(1997-3#1)(2007-12#1)
flexible method##4##2##(1994-3#1)(1997-3#1)(2007-12#1)(2008-10#1)
flexible methods of##2##3##(2008-7#1)(2010-10#1)
flexible mirror##3##2##(2007-11#1)(2008-3#2)
flexible nanostructures##2##2##(2008-7#2)
flexible polyimide##2##2##(2008-10#2)
flexible response##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
flexible strategy##2##2##(2009-5#2)
flexible technique##2##2##(2008-3#1)(2008-8#1)
flexible to##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
flexible way##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
flexible##179##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#2)(1994-12#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#1)(1997-3#3)(1997-6#2)(1997-7#1)(2006-10#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#10)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#4)(2008-9#6)(2009-11#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#9)(2012-3#5)(2013-1#4)(2013-8#1)
flexibly than##2##2##(2008-7#2)
flexibly##4##1##(2008-10#1)(2008-7#2)(2009-6#1)
flexicurity##5##1##(2012-2#5)
flexing##6##1##(2007-12#3)(2008-12#2)(2008-9#1)
flexion and extension##4##3##(1991-6#1)(1996-6#1)(2007-8#2)
flexion and##12##2##(1991-6#1)(1996-6#1)(2007-12#1)(2007-8#2)(2008-8#3)(2009-3#2)(2011-2#1)(2012-2#1)
flexion angle##5##2##(2011-2#1)(2013-1#4)
flexion at##2##2##(2009-11#1)(2013-8#1)
flexion by##3##2##(2008-9#3)
flexion deformity##2##2##(2008-9#1)(2009-3#1)
flexion excursion##2##2##(2011-2#2)
flexion in the##4##3##(2007-8#1)(2008-8#1)(2008-9#1)(2010-9#1)
flexion in##7##2##(2007-8#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-9#1)
flexion is##3##2##(2008-9#3)
flexion of the##8##3##(2007-8#1)(2008-2#1)(2008-9#3)(2009-1#1)(2010-3#1)(2012-2#1)
flexion of##11##2##(2007-8#1)(2008-2#1)(2008-9#5)(2009-1#1)(2010-3#1)(2012-2#1)(2013-1#1)
flexion phase##3##2##(1997-2#3)
flexion with the##2##3##(1993-3#1)(2010-9#1)
flexion with##3##2##(1993-3#1)(2010-9#2)
flexion##86##1##(1991-6#1)(1993-3#1)(1994-6#1)(1996-6#1)(1997-2#3)(2007-11#1)(2007-12#1)(2007-8#6)(2008-12#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#21)(2009-1#2)(2009-11#1)(2009-3#5)(2010-3#1)(2010-9#6)(2011-1#2)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
flexneri 2a strain##2##3##(2008-9#2)
flexneri injectisomes##2##2##(2013-8#2)
flexneri##9##1##(1993-12#2)(2008-10#1)(2008-9#2)(2012-3#2)(2013-8#2)
flexor and extensor##5##3##(1993-12#1)(2007-12#1)(2007-8#3)
flexor digitorum brevis##2##3##(2010-5#2)
flexor digitorum superficialis##5##3##(2008-9#2)(2009-5#2)(2012-2#1)
flexor digitorum##10##2##(2008-12#1)(2008-5#2)(2008-9#2)(2009-5#2)(2010-5#2)(2012-2#1)
flexor hallucis longus tendon##3##4##(2010-3#1)(2010-7#2)
flexor hallucis longus##4##3##(2009-10#1)(2010-3#1)(2010-7#2)
flexor pollicis longus tendon##2##4##(2008-9#2)
flexor pollicis longus##4##3##(2007-11#2)(2008-9#2)
flexor spasms due to a##2##5##(2009-11#2)
flexor spasms##4##2##(2009-11#4)
flexor tendon sheath ganglion##2##4##(2008-9#2)
flexor tendon sheath##3##3##(2008-9#3)
flexor tendons and the##2##4##(2008-9#2)
flexor##45##1##(1993-12#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#4)(2009-5#3)(2010-3#1)(2010-5#2)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
flexuosa##4##1##(2008-6#3)(2010-3#1)
flexuous filamentous##2##2##(2008-10#2)
flexuous particles##2##2##(2008-10#2)
flexuous rod-shaped##2##2##(2008-10#2)
flexuous##6##1##(2008-10#6)
flexural modulus##2##2##(2009-7#2)
flexural resonance frequency shift of a piezoelectric microcantilever sensor##2##9##(2009-5#2)
flexural resonance frequency shift of##3##5##(2009-5#3)
flexural resonance frequency shift##4##4##(2009-5#4)
flexural rigidity##2##2##(2008-12#2)
flexural strength of##4##3##(2008-12#2)(2009-7#2)
flexural strength##13##2##(2008-12#5)(2009-7#8)
flexural##27##1##(2007-12#2)(2008-12#8)(2008-5#2)(2009-5#4)(2009-7#10)(2013-1#1)
flexure##12##1##(1990-11#1)(1990-3#1)(1993-9#2)(2008-12#4)(2009-7#1)(2012-12#1)(2013-8#2)
flg22##2##1##(2009-6#2)
flg22-triggered resistance##2##2##(2009-6#2)
flg22-triggered##3##1##(2009-6#3)
flicker##7##1##(1990-3#2)(2007-9#2)(2012-1#3)
flies (Diptera##3##2##(2007-12#2)(2010-4#1)
flies (Raphidioptera)##2##2##(2008-12#2)
flies and##8##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-1#1)
flies are##3##2##(2008-12#2)(2008-9#1)
flies from##2##2##(2008-10#1)(2011-2#1)
flies in##4##2##(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
flies to##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
flies was##3##2##(2008-12#1)(2013-8#2)
flies##86##1##(1990-3#1)(1991-5#1)(1993-9#1)(1995-2#1)(1995-6#10)(1997-7#1)(2007-12#7)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#7)(2008-9#11)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-4#3)(2011-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
flies'##2##1##(2007-11#1)(2010-1#1)
flies)##2##1##(2008-10#1)(2008-5#1)
flies/trap/week)##2##1##(2013-8#2)
flight ability##3##2##(2008-6#2)(2013-1#1)
flight and##2##2##(1996-12#1)(2008-3#1)
flight behavior##2##2##(2008-10#1)(2008-9#1)
flight for##2##2##(2007-12#1)(2008-2#1)
flight muscles##3##2##(2008-9#3)
flight season##3##2##(2008-5#1)(2012-3#2)
flight tests##2##2##(1996-12#1)(2008-3#1)
flight transect##2##2##(2008-2#2)
flight tunnel##3##2##(2011-2#3)
flight##81##1##(1991-2#1)(1996-12#6)(2007-12#7)(2007-2#1)(2007-3#1)(2008-10#9)(2008-11#2)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#8)(2009-8#1)(2009-9#4)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)
flight-capable##3##1##(2008-9#3)
flightless G##2##2##(2008-9#2)
flightless individuals##2##2##(2008-9#2)
flightless##7##1##(2008-8#1)(2008-9#6)
flights are##2##2##(2008-3#2)
flights from##2##2##(2008-3#1)(2010-3#1)
flights has##2##2##(1990-6#1)(2008-3#1)
flights of the##2##3##(2008-2#1)(2008-3#1)
flights##14##1##(1990-6#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-3#6)(2008-9#1)(2010-3#1)(2010-5#1)
flint##5##1##(2007-12#1)(2008-10#4)
flip##2##1##(2008-10#1)(2008-3#1)
flip-chip##2##1##(2008-2#1)(2008-3#1)
flip-flop of##4##2##(1990-11#1)(1992-6#1)(1994-5#2)
flip-flop##15##1##(1990-11#2)(1992-6#1)(1994-5#12)
flipping##2##1##(2007-11#1)(2008-3#1)
float glass##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
float##8##1##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
float-glass substrates##2##2##(2008-2#2)
float-glass##3##1##(2008-2#2)(2008-3#1)
floater##4##1##(2008-8#2)(2008-9#2)
floaters##11##1##(2008-10#1)(2008-8#9)(2008-9#1)
floating AH109A cells##3##3##(2008-11#3)
floating population##2##2##(2008-9#1)(2012-3#1)
floating tablets##4##2##(2012-2#4)
floating##28##1##(1990-12#2)(2007-8#1)(2008-11#6)(2008-7#1)(2008-9#3)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-7#1)
floc size##2##2##(2008-7#2)
floc strength##2##2##(2008-7#2)
floc##6##1##(2008-10#2)(2008-7#4)
flocculated##2##1##(2008-11#2)
flocculation during##2##2##(2008-7#2)
flocculation##22##1##(1995-6#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#10)(2013-1#1)
flocculosa as##2##2##(2008-10#2)
flocculosa from other##2##3##(2008-10#2)
flocculosa##9##1##(2008-10#9)
flock A##4##2##(1997-3#4)
flock of##3##2##(1993-2#1)(1997-3#1)(2008-5#1)
flock##14##1##(1993-2#1)(1997-3#9)(1997-6#1)(2008-5#2)(2012-1#1)
flocks and##2##2##(2008-5#2)
flocks during##2##2##(1997-3#1)(1997-6#1)
flocks in##3##2##(1997-3#1)(2007-12#1)(2008-5#1)
flocks of##2##2##(1997-3#1)(2011-2#1)
flocks was##2##2##(2008-5#1)(2011-2#1)
flocks##22##1##(1996-6#1)(1997-3#7)(1997-6#1)(2007-12#1)(2007-6#2)(2008-3#1)(2008-5#6)(2011-2#3)
flocs and##2##2##(2008-7#2)
flocs##4##1##(2008-7#3)(2013-1#1)
flood depth##2##2##(2008-10#2)
flood in##2##2##(1996-6#1)(2013-8#1)
flood water##4##2##(1996-6#1)(2008-10#3)
flood##16##1##(1991-2#1)(1996-6#2)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2009-3#1)(2013-8#2)
flooded##5##1##(2006-12#1)(2007-5#1)(2008-10#2)(2013-8#1)
flooding##19##1##(1991-2#1)(2007-5#2)(2008-10#1)(2008-5#2)(2008-8#2)(2009-10#1)(2012-5#7)(2013-1#2)(2013-8#1)
floodlight##2##1##(2008-2#2)
floodplain##7##1##(2008-5#1)(2010-8#2)(2013-7#4)
floods in##2##2##(1996-6#1)(2008-10#1)
floods##10##1##(1992-12#1)(1996-6#3)(2008-10#1)(2010-8#1)(2013-8#4)
floor and##8##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
floor before##2##2##(1995-6#1)(1997-2#1)
floor of##7##2##(1996-5#1)(1996-6#1)(1997-2#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
floor plate##6##2##(1993-12#2)(1994-12#4)
floor##70##1##(1991-8#1)(1993-12#2)(1994-12#5)(1995-6#3)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#7)(2007-12#3)(2008-10#11)(2008-11#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2011-2#5)(2012-1#3)(2012-2#1)(2012-3#3)(2013-1#4)
floor)##2##1##(2008-2#1)(2013-8#1)
floors##4##1##(1991-8#1)(1996-12#2)(2008-3#1)
flora and##5##2##(2008-5#2)(2010-10#1)(2011-2#1)(2013-7#1)
flora from##2##2##(2007-7#1)(2008-5#1)
flora in the##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
flora in##7##2##(2007-7#2)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
flora with##3##2##(1995-3#1)(2007-7#1)(2009-5#1)
flora##43##1##(1990-6#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-4#1)(1997-5#1)(2007-6#1)(2007-7#5)(2008-10#1)(2008-5#10)(2008-9#1)(2009-10#1)(2009-5#4)(2010-1#1)(2010-10#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#2)
floral and##4##2##(2007-6#1)(2008-10#2)(2011-2#1)
floral homeotic##2##2##(2008-8#2)
floral induction##2##2##(1996-2#1)(2012-2#1)
floral infection##2##2##(2008-10#2)
floral integration has##2##3##(2009-8#2)
floral integration##7##2##(2009-8#7)
floral organ identity##3##3##(1997-2#1)(1997-8#1)(2008-8#1)
floral organs##7##2##(2008-10#3)(2008-8#4)
floral traits##10##2##(2008-8#6)(2009-8#4)
floral variants##3##2##(2008-9#3)
floral##64##1##(1996-2#1)(1997-2#2)(1997-8#1)(2007-6#1)(2008-10#15)(2008-8#18)(2008-9#6)(2009-6#3)(2009-8#13)(2011-10#1)(2011-2#1)(2012-2#2)
floras of##3##2##(2008-8#3)
floras##4##1##(2008-8#4)
floret mouth##2##2##(2008-10#2)
floret##7##1##(2008-10#7)
florets##11##1##(2008-10#9)(2008-8#1)(2012-3#1)
floribunda 821##4##2##(2008-10#4)
floribunda##6##1##(1990-7#1)(2008-10#5)
florid cystic endosalpingiosis of the colon##2##6##(2008-11#2)
florid##7##1##(1990-3#1)(2008-1#1)(2008-11#3)(2011-2#1)(2012-2#1)
florisil cartridges##2##2##(2008-10#2)
florisil column##2##2##(2008-10#1)(2008-11#1)
florisil##5##1##(2008-10#4)(2008-11#1)
floristic relationships##2##2##(2008-8#2)
floristic similarity between EAS##2##4##(2008-8#2)
floristic similarity between##3##3##(2008-8#3)
floristic##11##1##(2008-5#2)(2008-8#5)(2013-7#4)
flos##2##1##(2013-8#2)
flotation and##3##2##(2008-10#2)(2011-2#1)
flotation##19##1##(1990-6#1)(2008-10#14)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
flotation-extraction##2##1##(2008-10#2)
flounder##10##1##(1994-11#1)(2008-6#2)(2008-8#1)(2009-7#4)(2010-8#2)
flour and##4##2##(1990-3#1)(1993-12#1)(2008-10#2)
flour beetle##3##2##(1992-8#1)(2008-12#1)(2008-9#1)
flour is##2##2##(2008-10#1)(2012-2#1)
flour was##3##2##(2008-10#2)(2010-4#1)
flour were##2##2##(2010-4#1)(2012-2#1)
flour##65##1##(1990-3#6)(1991-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1997-2#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#11)(2011-2#1)(2012-2#12)(2013-1#1)
flour)##6##1##(2008-10#4)(2013-1#2)
flourish in##2##2##(1992-3#1)(1994-1#1)
flourish##5##1##(1992-3#1)(1994-1#1)(1994-12#1)(1996-1#1)(2009-5#1)
flourished##2##1##(1993-12#1)(2008-3#1)
flow (EOF)##6##2##(1996-5#1)(1997-2#1)(2008-10#4)
flow after##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
flow allows##2##2##(2008-11#1)(2008-9#1)
flow analysis (MSFA)##3##3##(2008-10#3)
flow analysis (SI-MSFA)##2##3##(2008-10#2)
flow analysis by##2##3##(2008-10#2)
flow analysis database##2##3##(2008-10#2)
flow analysis in##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
flow analysis method##2##3##(2008-10#2)
flow analysis of##4##3##(2008-10#4)
flow analysis system##10##3##(2008-10#10)
flow analysis systems##3##3##(2008-10#3)
flow analysis was##2##3##(1991-12#1)(2007-8#1)
flow analysis##66##2##(1991-12#1)(2007-8#2)(2008-10#60)(2008-9#2)(2009-6#1)
flow analyzer##2##2##(2008-10#2)
flow and a##3##3##(1995-12#1)(2008-3#1)(2009-11#1)
flow and blood##2##3##(2008-7#1)(2013-8#1)
flow and image cytometry##4##4##(2008-9#4)
flow and the##7##3##(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2011-2#1)
flow and##82##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-3#1)(1991-9#1)(1994-2#1)(1995-12#5)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-10#3)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-11#2)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
flow apparatus##2##2##(2008-10#2)
flow approach##2##2##(2008-10#2)
flow as##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
flow assembly##2##2##(2008-10#2)
flow at different##2##3##(2009-6#1)(2013-1#1)
flow at the##9##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2012-3#1)
flow at##16##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#4)(2009-11#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
flow behavior##3##2##(2007-7#1)(2011-2#2)
flow between the##3##3##(2007-7#1)(2008-5#1)(2012-3#1)
flow between##15##2##(2007-7#1)(2008-10#4)(2008-5#1)(2009-2#1)(2011-2#2)(2012-3#4)(2013-1#2)
flow by##8##2##(2007-8#2)(2008-1#1)(2008-2#1)(2008-7#1)(2010-8#1)(2013-8#2)
flow can be##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#2)
flow can##6##2##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#2)
flow cell and##6##3##(2008-10#6)
flow cell for##4##3##(2008-10#4)
flow cell in the##2##4##(2008-10#2)
flow cell is##2##3##(2008-10#2)
flow cell made##2##3##(2008-10#2)
flow cell to##3##3##(2008-10#3)
flow cell was##3##3##(2008-10#2)(2008-7#1)
flow cell were##3##3##(2008-10#3)
flow cell with a##3##4##(2008-10#3)
flow cell with##4##3##(2008-10#4)
flow cell##79##2##(2007-11#1)(2008-10#77)(2008-7#1)
flow cells combined with##2##4##(2008-10#2)
flow cells were##3##3##(2008-10#3)
flow cells##15##2##(2008-10#15)
flow chamber##5##2##(2008-1#2)(2008-10#1)(2008-11#2)
flow channel##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
flow channels##2##2##(2008-10#1)(2011-2#1)
flow characteristics of LIMA-LAD anastomoses##2##5##(2007-8#2)
flow chart##5##2##(1992-2#2)(1993-9#1)(1995-2#1)(2008-4#1)
flow compared with##2##3##(1995-12#1)(1995-2#1)
flow conditions by##2##3##(2008-10#2)
flow conditions##24##2##(1991-3#1)(1997-1#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)
flow configuration##2##2##(2008-10#2)
flow control##2##2##(2008-7#2)
flow cytometer for##2##3##(2008-4#1)(2008-9#1)
flow cytometer to##5##3##(1994-2#2)(2008-9#3)
flow cytometer##32##2##(1994-2#2)(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#24)
flow cytometers are##2##3##(2008-9#2)
flow cytometers##11##2##(2008-4#1)(2008-9#8)(2010-8#1)(2012-2#1)
flow cytometric DNA##4##3##(1993-1#1)(1994-12#1)(2008-2#1)(2008-6#1)
flow cytometric analysis and##2##4##(1993-2#1)(2008-5#1)
flow cytometric analysis confirmed##2##4##(2009-12#2)
flow cytometric analysis of##11##4##(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#5)(2012-3#1)
flow cytometric analysis##25##3##(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#9)(2009-12#2)(2012-3#2)
flow cytometric approach to##2##4##(2008-11#1)(2008-9#1)
flow cytometric approach##4##3##(1995-9#1)(2006-6#1)(2008-11#1)(2008-9#1)
flow cytometric assay for##3##4##(1990-12#2)(2008-9#1)
flow cytometric assay##4##3##(1990-12#2)(1997-7#1)(2008-9#1)
flow cytometric assays##2##3##(2008-9#2)
flow cytometric detection##3##3##(2008-10#1)(2008-9#2)
flow cytometric determination of##2##4##(2008-9#2)
flow cytometric platelet##2##3##(2011-2#2)
flow cytometric procedure##2##3##(2006-6#1)(2008-9#1)
flow cytometric sorting of##2##4##(2008-10#1)(2012-2#1)
flow cytometric studies##2##3##(1993-8#1)(2008-9#1)
flow cytometric study of##2##4##(1993-8#1)(2008-4#1)
flow cytometric study##4##3##(1993-8#1)(2008-4#1)(2008-6#1)(2008-7#1)
flow cytometric##83##2##(1990-12#4)(1993-1#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-9#2)(1997-7#1)(2006-6#2)(2008-10#4)(2008-11#6)(2008-2#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#32)(2009-12#2)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
flow cytometry analysis##8##3##(1994-12#1)(1995-8#1)(1997-2#1)(1997-7#2)(2007-10#1)(2008-4#1)(2008-9#1)
flow cytometry and is##2##4##(2008-4#1)(2008-9#1)
flow cytometry and microscopy##2##4##(2008-9#2)
flow cytometry and##17##3##(1994-12#1)(1995-4#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#9)(2010-7#1)(2011-2#1)
flow cytometry approaches##2##3##(2008-9#2)
flow cytometry are##3##3##(2008-3#1)(2008-9#2)
flow cytometry assay##2##3##(2008-8#1)(2012-2#1)
flow cytometry data analysis##2##4##(2008-8#1)(2008-9#1)
flow cytometry data##6##3##(2008-8#2)(2008-9#4)
flow cytometry for the##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
flow cytometry for##7##3##(2008-11#2)(2008-7#1)(2008-9#4)
flow cytometry has##5##3##(2008-9#5)
flow cytometry have been##3##4##(2008-9#3)
flow cytometry have##4##3##(1992-8#1)(2008-9#3)
flow cytometry in##11##3##(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#6)(2009-2#1)
flow cytometry measurements##4##3##(1995-8#1)(2008-4#1)(2008-9#2)
flow cytometry method to##2##4##(1990-12#1)(2012-2#1)
flow cytometry method##4##3##(1990-12#2)(2008-9#1)(2012-2#1)
flow cytometry methods##2##3##(2008-4#1)(2008-8#1)
flow cytometry of##4##3##(2008-9#3)(2012-1#1)
flow cytometry on##2##3##(1993-11#1)(2008-11#1)
flow cytometry that##2##3##(2008-3#1)(2008-9#1)
flow cytometry to##3##3##(2006-6#1)(2008-11#1)(2008-9#1)
flow cytometry using##2##3##(2008-4#1)(2008-9#1)
flow cytometry utilizing##2##3##(2008-9#1)(2009-2#1)
flow cytometry with##2##3##(1993-8#1)(2011-2#1)
flow cytometry##229##2##(1990-12#2)(1990-8#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#3)(2006-6#3)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#14)(2008-3#3)(2008-4#17)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#118)(2009-12#1)(2009-2#2)(2009-6#2)(2010-7#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
flow data##3##2##(1996-12#1)(2008-9#1)(2013-7#1)
flow decreased##2##2##(1993-3#1)(1996-5#1)
flow diagram##2##2##(2008-10#2)
flow direction##5##2##(2007-11#2)(2008-10#1)(2009-11#1)(2012-3#1)
flow disturbances##3##2##(2007-7#3)
flow during the##2##3##(2007-8#1)(2008-10#1)
flow during##7##2##(1995-12#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-7#1)
flow dynamics in##2##3##(2010-3#1)(2012-3#1)
flow dynamics##4##2##(2010-3#1)(2012-3#3)
flow electroporation##3##2##(2008-11#3)
flow experiment##2##2##(2008-3#1)(2008-4#1)
flow field of##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
flow field that##2##3##(2008-3#2)
flow field##12##2##(2008-11#3)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#1)
flow field-flow fractionation channel##2##4##(2008-10#2)
flow field-flow fractionation##5##3##(2008-10#3)(2011-2#2)
flow fields##10##2##(1996-12#2)(2008-11#1)(2008-2#5)(2008-3#2)
flow filtration##6##2##(2008-10#2)(2008-7#4)
flow for##7##2##(2007-7#1)(2007-8#2)(2008-7#1)(2010-1#1)(2010-4#1)(2013-1#1)
flow from the##5##3##(1996-4#1)(1996-9#1)(2007-8#1)(2008-5#1)(2010-12#1)
flow from##10##2##(1995-12#1)(1996-4#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
flow has been##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
flow hydride generation##3##3##(2008-10#3)
flow immunoassay##2##2##(1990-12#2)
flow in a##4##3##(1996-9#1)(2008-3#1)(2008-7#1)(2011-2#1)
flow in carbon nanotubes and##2##5##(2008-7#2)
flow in patients with##2##4##(1996-5#1)(2008-5#1)
flow in the subarachnoid space##2##5##(2008-7#2)
flow in the##18##3##(1992-1#1)(1993-3#1)(1996-12#1)(1996-6#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-8#1)(2012-1#1)(2012-3#1)
flow in##61##2##(1991-11#1)(1992-1#1)(1992-6#2)(1993-3#2)(1994-9#1)(1995-5#3)(1996-12#1)(1996-5#3)(1996-6#2)(1996-9#1)(2007-10#3)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
flow increase in temporal and parietal##2##6##(2008-2#2)
flow increase##7##2##(1996-2#1)(2008-10#1)(2008-2#3)(2008-4#2)
flow increased##3##2##(2006-10#1)(2008-11#1)(2008-4#1)
flow indices##3##2##(1995-3#3)
flow induced##2##2##(1992-6#1)(2012-2#1)
flow initially without analyte##2##4##(2008-10#2)
flow initially##5##2##(2007-8#1)(2008-10#4)
flow injection (FI) analysis##4##4##(2008-10#4)
flow injection (FI) manifold##3##4##(2008-10#3)
flow injection (FI) method for##3##5##(2008-10#3)
flow injection (FI) method##6##4##(2008-10#6)
flow injection (FI) on-line##4##4##(2008-10#4)
flow injection (FI) system for the##2##6##(2008-10#2)
flow injection (FI) system for##3##5##(2008-10#3)
flow injection (FI) system was##2##5##(2008-10#2)
flow injection (FI) system##13##4##(2008-10#13)
flow injection (FI) with##2##4##(2008-10#2)
flow injection (FI)##56##3##(2008-10#56)
flow injection ICP-MS##2##3##(2008-10#2)
flow injection amperometric##2##3##(2008-10#2)
flow injection analyser##2##3##(2008-10#2)
flow injection analysis (FIA) for the##3##6##(2008-10#3)
flow injection analysis (FIA) is##3##5##(2008-10#3)
flow injection analysis (FIA) of##2##5##(2008-10#2)
flow injection analysis (FIA) system coupled##2##6##(2008-10#2)
flow injection analysis (FIA) system with##2##6##(2008-10#2)
flow injection analysis (FIA) system##10##5##(2008-10#9)(2008-11#1)
flow injection analysis (FIA) technique for##2##6##(2008-10#2)
flow injection analysis (FIA) with##3##5##(2008-10#3)
flow injection analysis (FIA)##39##4##(2008-10#38)(2008-11#1)
flow injection analysis and##6##4##(2008-10#6)
flow injection analysis by##2##4##(2008-10#2)
flow injection analysis for##5##4##(2008-10#5)
flow injection analysis manifold##2##4##(2008-10#2)
flow injection analysis method##2##4##(2008-10#2)
flow injection analysis of##14##4##(2008-10#14)
flow injection analysis stopped-flow##2##4##(2008-10#2)
flow injection analysis system for##2##5##(2008-10#2)
flow injection analysis system##6##4##(2008-10#6)
flow injection analysis systems##2##4##(2008-10#2)
flow injection analysis using##2##4##(2008-10#2)
flow injection analysis with amperometric detection##2##6##(2008-10#2)
flow injection analysis with##14##4##(2008-10#14)
flow injection analysis##139##3##(1992-11#1)(2008-10#136)(2008-11#1)(2008-9#1)
flow injection and sequential injection##2##5##(2008-10#2)
flow injection and##4##3##(2008-10#4)
flow injection approach##4##3##(2008-10#4)
flow injection catalytic spectrophotometric method is proposed for the##2##9##(2008-10#2)
flow injection catalytic##3##3##(2008-10#3)
flow injection chemiluminescence (CL) method is##2##6##(2008-10#2)
flow injection chemiluminescence (CL) method##3##5##(2008-10#3)
flow injection chemiluminescence method is##2##5##(2008-10#2)
flow injection chemiluminescence system##2##4##(2008-10#2)
flow injection chemiluminescence##9##3##(2008-10#9)
flow injection conditions##2##3##(2008-10#2)
flow injection configuration##2##3##(2008-10#2)
flow injection determination of amylase activity##2##6##(2008-10#2)
flow injection determination of calcium and fluoride in natural and borehole water with conventional##2##14##(2008-10#2)
flow injection determination of##12##4##(2008-10#12)
flow injection determination##15##3##(2008-10#15)
flow injection electrochemiluminescent inhibition method##2##5##(2008-10#2)
flow injection hydride generation atomic absorption##2##6##(2008-10#2)
flow injection hydride generation atomic##3##5##(2008-10#3)
flow injection hydride generation##5##4##(2008-10#5)
flow injection inductively coupled plasma atomic emission##2##7##(2008-10#2)
flow injection inductively coupled plasma##3##5##(2008-10#3)
flow injection manifold##7##3##(2008-10#7)
flow injection method for the##6##5##(2008-10#6)
flow injection method for##8##4##(2008-10#8)
flow injection method is described for the##2##7##(2008-10#2)
flow injection method is##5##4##(2008-10#5)
flow injection method##26##3##(2008-10#26)
flow injection mode##4##3##(2008-10#4)
flow injection on-line preconcentration with##2##5##(2008-10#2)
flow injection on-line preconcentration##3##4##(2008-10#3)
flow injection on-line##9##3##(2008-10#9)
flow injection photometric method##3##4##(2008-10#3)
flow injection photometric##4##3##(2008-10#4)
flow injection potentiometric##2##3##(2008-10#2)
flow injection potentiometry##4##3##(2008-10#4)
flow injection preconcentration##2##3##(2008-10#2)
flow injection procedure for##3##4##(2008-10#3)
flow injection procedure##4##3##(2008-10#4)
flow injection sorption##2##3##(2008-10#2)
flow injection spectrophotometric determination of##4##5##(2008-10#4)
flow injection spectrophotometric method for the determination of##2##8##(2008-10#2)
flow injection spectrophotometric method for##3##5##(2008-10#3)
flow injection spectrophotometric method##4##4##(2008-10#4)
flow injection spectrophotometric##9##3##(2008-10#9)
flow injection spectrophotometry##3##3##(2008-10#3)
flow injection system and##8##4##(2008-10#8)
flow injection system coupled with##2##5##(2008-10#2)
flow injection system coupled##4##4##(2008-10#4)
flow injection system for the determination of dissolved silver at##2##10##(2008-10#2)
flow injection system for the determination of##4##7##(2008-10#4)
flow injection system for the##7##5##(2008-10#7)
flow injection system for##13##4##(2008-10#13)
flow injection system has been developed##2##6##(2008-10#2)
flow injection system is described##3##5##(2008-10#3)
flow injection system is proposed##2##5##(2008-10#2)
flow injection system is##8##4##(2008-10#8)
flow injection system was##2##4##(2008-10#2)
flow injection system with spectrophotometric##2##5##(2008-10#2)
flow injection system with##12##4##(2008-10#12)
flow injection system##71##3##(2008-10#71)
flow injection systems##4##3##(2008-10#4)
flow injection technique for##3##4##(2008-10#3)
flow injection technique##9##3##(2008-10#9)
flow injection time-based method##2##4##(2008-10#2)
flow injection with amperometric detection##3##5##(2008-10#3)
flow injection with##7##3##(2008-10#7)
flow injection##487##2##(1992-11#1)(2007-12#1)(2008-10#483)(2008-11#1)(2008-9#1)
flow injection-based##2##2##(2008-10#2)
flow injection-hydride##5##2##(2008-10#5)
flow injection-inductively coupled plasma##3##4##(2008-10#3)
flow injection-pervaporation##2##2##(2008-10#2)
flow injection/stopped-flow detection technique##2##4##(2008-10#2)
flow instrument##2##2##(2008-10#1)(2008-9#1)
flow into the##2##3##(2008-10#1)(2008-7#1)
flow is described##2##3##(2008-2#1)(2008-7#1)
flow is##21##2##(1991-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
flow levels##2##2##(2008-7#2)
flow manifold##10##2##(2008-10#10)
flow may##2##2##(1990-11#1)(2007-8#1)
flow measurements and##3##3##(1997-6#1)(2011-2#2)
flow measurements to##2##3##(1995-8#1)(2007-12#1)
flow measurements with##4##3##(1996-6#1)(2007-11#2)(2008-3#1)
flow measurements##14##2##(1995-8#1)(1996-6#3)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#2)
flow meter##3##2##(2007-10#1)(2010-2#1)(2012-2#1)
flow meters##3##2##(1991-3#1)(1997-2#1)(2008-10#1)
flow method##6##2##(2008-10#4)(2008-6#1)(2010-8#1)
flow methodologies##2##2##(2008-10#2)
flow methodology##2##2##(2008-10#1)(2008-9#1)
flow methods applied to the##2##5##(2008-10#2)
flow methods##4##2##(2008-10#4)
flow mode##3##2##(2008-10#3)
flow model##2##2##(2008-7#2)
flow models##2##2##(2008-5#1)(2011-2#1)
flow monitoring##2##2##(2007-7#1)(2008-10#1)
flow network##3##2##(2008-10#3)
flow of 400##2##3##(2008-10#1)(2008-4#1)
flow of a##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-2#1)
flow of information##3##3##(1994-2#1)(1996-11#1)(2008-11#1)
flow of nitrogen##3##3##(2008-10#3)
flow of the sample##3##4##(2008-10#3)
flow of the##11##3##(2007-10#1)(2008-10#9)(2008-5#1)
flow of water##2##3##(2009-11#1)(2011-2#1)
flow of##82##2##(1990-11#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-8#2)(2008-1#3)(2008-10#31)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
flow on a regional level##2##5##(2008-10#2)
flow on the##3##3##(1992-7#1)(2008-11#1)(2010-6#1)
flow on##5##2##(1992-7#1)(2008-10#2)(2008-11#1)(2010-6#1)
flow or##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
flow output##2##2##(2007-8#2)
flow path##2##2##(2008-10#1)(2008-7#1)
flow paths##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
flow patterns##5##2##(1991-11#1)(2007-10#1)(2009-2#1)(2010-3#1)(2010-8#1)
flow phantom##2##2##(2007-11#1)(2011-1#1)
flow preconcentration system##4##3##(2008-10#4)
flow preconcentration##5##2##(2008-10#5)
flow procedure based on multicommutation##2##5##(2008-10#2)
flow procedure##4##2##(2008-10#4)
flow profiles##3##2##(2007-7#1)(2008-3#1)(2012-2#1)
flow program##3##2##(2008-10#3)
flow programming##2##2##(2008-10#2)
flow programs##2##2##(2008-10#2)
flow properties##4##2##(2008-2#3)(2012-2#1)
flow provides##2##2##(2008-12#1)(2012-3#1)
flow range##3##2##(2008-10#3)
flow rate (Ql/Qa)##2##3##(1995-3#2)
flow rate 0##3##3##(2008-10#3)
flow rate F(B)##2##3##(2008-10#2)
flow rate and concentration of##2##5##(2008-10#2)
flow rate and interfering ions on the recovery of the##2##10##(2008-10#2)
flow rate and sample volume##3##5##(2008-10#3)
flow rate and temperature##2##4##(2008-10#1)(2010-4#1)
flow rate and the##2##4##(2008-7#2)
flow rate and volume##2##4##(2008-10#2)
flow rate and##36##3##(1996-12#1)(1996-3#1)(2008-10#29)(2008-12#1)(2008-7#2)(2010-4#1)(2013-8#1)
flow rate during##2##3##(2008-10#2)
flow rate for the##3##4##(2007-7#1)(2008-10#2)
flow rate for##4##3##(2007-7#1)(2008-10#3)
flow rate gradient##2##3##(2011-2#2)
flow rate have been##2##4##(2008-10#2)
flow rate in the##2##4##(2008-10#2)
flow rate is##4##3##(1994-2#1)(2008-10#3)
flow rate of 0##9##4##(2008-10#7)(2008-5#1)(2011-1#1)
flow rate of 1 ml/min##2##5##(2008-10#1)(2010-3#1)
flow rate of 1##28##4##(2008-10#21)(2008-5#2)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)
flow rate of 2##6##4##(2008-10#6)
flow rate of 3##4##4##(2008-10#3)(2008-4#1)
flow rate of 30##2##4##(2008-10#1)(2013-8#1)
flow rate of 4##4##4##(2008-10#4)
flow rate of 5##2##4##(2008-10#2)
flow rate of 6##4##4##(2008-10#4)
flow rate of 6mlmin(-1)##2##4##(2008-10#2)
flow rate of about##2##4##(2008-10#1)(2008-7#1)
flow rate of carrier gas##2##5##(2008-10#2)
flow rate of carrier##3##4##(2008-10#3)
flow rate of metal##2##4##(2008-10#2)
flow rate of sample solution##2##5##(2008-10#2)
flow rate of sample##3##4##(2008-10#3)
flow rate of the mobile phase##2##6##(2008-10#2)
flow rate of the perfusate##2##5##(1991-9#2)
flow rate of the sample solution##2##6##(2008-10#2)
flow rate of the titrant solution##2##6##(2008-10#2)
flow rate of the##12##4##(1991-9#2)(1996-3#1)(2008-10#9)
flow rate of##104##3##(1991-9#2)(1996-12#1)(1996-3#1)(2008-10#87)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
flow rate on the##4##4##(1997-2#2)(2008-10#2)
flow rate on##7##3##(1997-2#2)(2008-10#3)(2008-6#2)
flow rate or##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
flow rate was##9##3##(1995-3#1)(2008-10#6)(2011-1#1)(2012-3#1)
flow rate were##7##3##(1990-12#1)(2008-10#6)
flow rate##302##2##(1990-12#1)(1991-9#4)(1993-8#2)(1994-2#2)(1995-3#4)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#5)(2007-12#1)(2007-7#1)(2008-10#219)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#8)(2008-8#2)(2008-9#1)(2009-11#1)(2010-3#2)(2010-4#2)(2010-9#1)(2011-1#7)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#6)
flow rate) were##5##3##(2008-10#5)
flow rate)##6##2##(2008-10#6)
flow rates and##8##3##(2008-10#7)(2008-6#1)
flow rates between##3##3##(1996-12#1)(1996-2#1)(2008-10#1)
flow rates of sample and eluent##2##6##(2008-10#2)
flow rates of sample solution and eluent##2##7##(2008-10#2)
flow rates of sample##4##4##(2008-10#4)
flow rates of##16##3##(1991-9#1)(1996-2#1)(2008-10#14)
flow rates##78##2##(1991-3#1)(1991-9#1)(1995-3#1)(1996-1#1)(1996-12#4)(1996-2#3)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#50)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#1)(2010-4#5)
flow rates)##2##2##(2008-10#2)
flow ratio##2##2##(2008-10#1)(2008-11#1)
flow ratiometry##4##2##(2008-10#4)
flow reactor##2##2##(2008-2#1)(2008-7#1)
flow reactors##2##2##(2008-2#2)
flow reserve##3##2##(2008-7#2)(2013-1#1)
flow resistance##2##2##(2008-7#2)
flow results##3##2##(2008-10#1)(2008-4#1)(2009-6#1)
flow reversal##5##2##(2008-10#5)
flow reversals##3##2##(2008-10#3)
flow sensor on a chip for the determination of terbutaline in human serum##2##13##(2008-10#2)
flow sensor##3##2##(2008-10#3)
flow showed##2##2##(2008-10#1)(2008-11#1)
flow signals##3##2##(2008-3#2)(2008-8#1)
flow sorters##2##2##(2008-9#2)
flow stress##2##2##(2009-7#2)
flow system allowed##2##3##(2008-10#2)
flow system and##4##3##(2008-10#3)(2008-9#1)
flow system comprised##2##3##(2008-10#2)
flow system for simultaneous determination of iron and chromium in steel alloys##2##12##(2008-10#2)
flow system for the determination of##8##6##(2008-10#8)
flow system for the##12##4##(2008-10#12)
flow system for##20##3##(2008-10#20)
flow system has been##2##4##(2008-10#2)
flow system is proposed for##2##5##(2008-10#2)
flow system is proposed##3##4##(2008-10#3)
flow system is##5##3##(2008-10#5)
flow system to##2##3##(2008-10#2)
flow system was assembled##2##4##(2008-10#2)
flow system was##12##3##(2008-10#12)
flow system with a##3##4##(2008-10#3)
flow system with##7##3##(2008-10#6)(2008-4#1)
flow system##111##2##(1992-12#1)(2008-10#106)(2008-2#1)(2008-4#2)(2008-9#1)
flow systems and##3##3##(2008-10#2)(2008-4#1)
flow systems is##2##3##(2008-10#2)
flow systems##22##2##(1997-6#1)(2008-10#18)(2008-11#2)(2008-4#1)
flow tagging##3##2##(2007-12#1)(2008-3#2)
flow technique##3##2##(2008-10#1)(2010-8#2)
flow techniques are##2##3##(2008-10#2)
flow techniques for##2##3##(2008-10#2)
flow techniques##9##2##(2008-10#9)
flow that##3##2##(1990-7#1)(2007-10#1)(2012-3#1)
flow through cell##3##3##(2008-10#3)
flow through the##13##3##(1997-1#1)(2008-12#4)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)
flow through##22##2##(1993-12#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2011-1#1)
flow titration of iron(II)##2##4##(2008-10#2)
flow titration of##3##3##(2008-10#3)
flow titration##8##2##(2008-10#8)
flow titrations##2##2##(2008-10#2)
flow to the##8##3##(1990-8#1)(1992-1#1)(1993-3#1)(2008-12#2)(2008-8#1)(2011-2#1)(2013-1#1)
flow to##14##2##(1990-8#1)(1992-1#1)(1993-3#1)(1995-3#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-8#1)(2011-2#3)(2013-1#1)
flow type quartz crystal microbalance##2##5##(2008-10#2)
flow type##4##2##(2008-10#4)
flow velocities in the##5##4##(1996-2#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-7#1)
flow velocities of##2##3##(2007-12#1)(2008-7#1)
flow velocities##9##2##(1996-2#1)(1996-6#1)(2007-12#2)(2008-11#2)(2008-7#3)
flow velocity and##7##3##(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
flow velocity in##3##3##(1996-3#1)(2007-10#1)(2008-7#1)
flow velocity of a##2##4##(2011-1#1)(2011-2#1)
flow velocity of the##3##4##(1996-3#1)(2008-3#1)(2011-2#1)
flow velocity of##7##3##(1996-3#1)(2007-12#1)(2008-3#1)(2011-1#1)(2011-2#3)
flow velocity was##3##3##(2008-7#3)
flow velocity##42##2##(1996-2#1)(1996-3#2)(1996-6#1)(2007-10#2)(2007-11#7)(2007-12#2)(2008-11#2)(2008-2#2)(2008-3#6)(2008-7#7)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)
flow via##2##2##(2007-8#1)(2008-7#1)
flow was higher##2##3##(2007-7#1)(2008-5#1)
flow was measured with##2##4##(1996-2#1)(2008-4#1)
flow was measured##5##3##(1996-2#1)(2006-10#1)(2007-8#1)(2008-4#1)(2011-2#1)
flow was significantly##2##3##(1995-5#1)(2006-10#1)
flow was##22##2##(1992-11#1)(1995-5#1)(1996-2#1)(1996-5#1)(2006-10#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-2#1)(2011-1#1)(2011-2#3)(2012-3#1)
flow were investigated##2##3##(1995-12#1)(2008-10#1)
flow were measured##3##3##(2006-10#1)(2008-12#1)(2013-3#1)
flow were##13##2##(1990-7#1)(1995-12#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-3#1)(2013-8#1)
flow while##2##2##(2008-10#1)(2011-2#1)
flow with##8##2##(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2011-1#1)(2011-2#1)
flow within##2##2##(2007-12#1)(2008-10#1)
flow##2790##1##(1990-11#3)(1990-12#12)(1990-3#3)(1990-5#4)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#2)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#9)(1991-5#2)(1991-6#1)(1991-9#8)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#1)(1993-8#7)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#9)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#10)(1995-2#4)(1995-3#15)(1995-4#1)(1995-5#9)(1995-8#5)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#12)(1996-2#13)(1996-3#6)(1996-4#2)(1996-5#11)(1996-6#12)(1996-7#1)(1996-9#6)(1997-1#9)(1997-2#9)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#5)(2006-10#7)(2006-6#8)(2006-7#1)(2007-10#22)(2007-11#22)(2007-12#22)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#20)(2007-8#39)(2007-9#1)(2008-1#18)(2008-10#1401)(2008-11#72)(2008-12#16)(2008-2#44)(2008-3#64)(2008-4#52)(2008-5#29)(2008-6#17)(2008-7#109)(2008-8#25)(2008-9#218)(2009-1#1)(2009-10#5)(2009-11#8)(2009-12#7)(2009-2#7)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#4)(2010-1#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#10)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#11)(2010-9#2)(2011-1#22)(2011-2#75)(2011-3#2)(2012-1#9)(2012-12#6)(2012-2#23)(2012-3#26)(2012-4#1)(2013-1#31)(2013-3#1)(2013-7#5)(2013-8#17)
flow)##5##1##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
flow-assisted##2##1##(2008-10#2)
flow-based analytical##2##2##(2008-10#2)
flow-based procedures##2##2##(2008-10#2)
flow-based##13##1##(2008-10#11)(2008-9#2)
flow-cell##5##1##(2007-11#1)(2008-10#4)
flow-chart##2##1##(1990-6#1)(1992-2#1)
flow-cytometric##2##1##(2008-11#1)(2013-7#1)
flow-dependent##3##1##(1992-9#1)(1993-8#1)(2008-9#1)
flow-field##2##1##(2008-11#1)(2008-2#1)
flow-induced##3##1##(1991-9#1)(2008-2#1)(2009-11#1)
flow-injection (FI) method##2##3##(2008-10#2)
flow-injection (FI)##8##2##(2008-10#8)
flow-injection analysis (FIA) system##4##4##(2008-10#4)
flow-injection analysis (FIA)##14##3##(2008-10#14)
flow-injection analysis of##2##3##(2008-10#2)
flow-injection analysis system##3##3##(2008-10#3)
flow-injection analysis with a##2##4##(1995-6#1)(2008-10#1)
flow-injection analysis with##3##3##(1995-6#1)(2008-10#2)
flow-injection analysis##43##2##(1992-11#1)(1995-6#1)(2008-10#41)
flow-injection atomic absorption##2##3##(2008-10#2)
flow-injection biosensor##2##2##(1995-3#1)(2008-10#1)
flow-injection chemiluminescence (CL) method for##2##5##(2008-10#2)
flow-injection chemiluminescence (CL) system##2##4##(2008-10#2)
flow-injection chemiluminescence (CL)##4##3##(2008-10#4)
flow-injection chemiluminescence##6##2##(2008-10#6)
flow-injection determination of##9##3##(2008-10#9)
flow-injection fluorimetric##2##2##(2008-10#2)
flow-injection ion spray ionization tandem mass spectrometry##2##7##(2008-10#2)
flow-injection liposome immunoanalysis (FILIA)##2##4##(2008-10#2)
flow-injection manifold for##2##3##(2008-10#2)
flow-injection manifold##6##2##(2008-10#6)
flow-injection method for the determination of##3##6##(2008-10#3)
flow-injection method for the##4##4##(2008-10#4)
flow-injection method for##5##3##(2008-10#5)
flow-injection method is proposed for the determination of##3##8##(2008-10#3)
flow-injection method is proposed for the##4##6##(2008-10#4)
flow-injection method is##5##3##(2008-10#5)
flow-injection method##12##2##(2008-10#12)
flow-injection multisensor system##2##3##(2008-10#2)
flow-injection procedure for##3##3##(2008-10#3)
flow-injection procedure##5##2##(2008-10#5)
flow-injection sampling##2##2##(2010-4#2)
flow-injection spectrophotometric method has been developed for the##2##8##(2008-10#2)
flow-injection spectrophotometric method##3##3##(2008-10#3)
flow-injection spectrophotometric procedure is proposed for##2##6##(2008-10#2)
flow-injection spectrophotometric##6##2##(2008-10#6)
flow-injection system coupled##2##3##(2008-10#2)
flow-injection system for the spectrophotometric determination of##2##7##(2008-10#2)
flow-injection system for the##5##4##(2008-10#5)
flow-injection system for##7##3##(2008-10#7)
flow-injection system made up by a 16-way switching valve##2##9##(2008-10#2)
flow-injection system with a##2##4##(2008-10#2)
flow-injection system with##5##3##(2008-10#5)
flow-injection system##26##2##(1995-3#1)(2008-10#25)
flow-injection techniques##2##2##(2008-10#2)
flow-injection variables##2##2##(2008-10#2)
flow-injection with##2##2##(2008-10#2)
flow-injection##180##1##(1992-11#2)(1995-3#2)(1995-6#1)(2008-10#173)(2010-4#2)
flow-mediated##6##1##(2008-11#5)(2009-5#1)
flow-rate and##3##2##(2008-10#3)
flow-rate of 0##3##3##(2008-10#3)
flow-rate of 1##6##3##(1991-5#1)(1996-5#1)(2008-10#3)(2008-5#1)
flow-rate of##14##2##(1991-5#1)(1996-5#1)(2008-10#11)(2008-5#1)
flow-rate##27##1##(1991-5#1)(1991-9#1)(1996-5#1)(1997-2#2)(2008-10#20)(2008-5#1)(2008-9#1)
flow-rates##2##1##(2008-10#2)
flow-sorted##3##1##(1991-2#1)(1994-11#1)(2012-2#1)
flow-structure interaction##3##2##(2009-11#3)
flow-through cell and##2##3##(2008-10#2)
flow-through cell for##4##3##(2008-10#4)
flow-through cell##12##2##(2008-10#10)(2008-3#1)(2013-1#1)
flow-through electrode##4##2##(2008-10#4)
flow-through ion-selective electrodes##2##3##(2008-10#2)
flow-through multisensor##2##2##(2008-10#2)
flow-through optical##3##2##(2008-10#3)
flow-through pretreatment##2##2##(2013-1#2)
flow-through pretreatments##3##2##(2013-1#3)
flow-through sensor array##2##3##(2008-10#2)
flow-through sensor for ofloxacin##2##4##(2008-10#2)
flow-through sensor is##2##3##(2008-10#2)
flow-through sensor##8##2##(2008-10#8)
flow-through solid phase##2##3##(2008-10#2)
flow-through##82##1##(2008-10#73)(2008-3#1)(2013-1#8)
flow-type##3##1##(2008-10#3)
flow-velocity##3##1##(2007-12#3)
flow-volume curves##2##2##(1997-2#1)(2010-8#1)
flow-volume##4##1##(1996-3#1)(1997-2#1)(2010-8#2)
flowable composite##4##2##(2008-12#2)(2013-1#2)
flowable##6##1##(2008-12#2)(2008-2#1)(2008-4#1)(2013-1#2)
flowcharts##2##1##(1996-2#1)(2008-4#1)
flowed through the##3##3##(2008-10#2)(2010-8#1)
flowed through##4##2##(2007-12#1)(2008-10#2)(2010-8#1)
flowed##8##1##(2007-12#1)(2008-10#6)(2010-8#1)
flower age at inoculation##3##4##(2008-10#3)
flower age##4##2##(2008-10#4)
flower and fruit##3##3##(2008-10#2)(2008-5#1)
flower and##9##2##(2008-10#5)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
flower blight##4##2##(2008-10#4)
flower break virus##2##3##(2008-10#2)
flower break##3##2##(2008-10#3)
flower buds##4##2##(2008-10#3)(2008-8#1)
flower color##2##2##(2008-8#1)(2008-9#1)
flower development##5##2##(1997-2#1)(1997-8#2)(2008-8#1)(2010-9#1)
flower extracts##5##2##(2008-10#4)(2008-5#1)
flower infection##5##2##(2008-10#5)
flower of D##2##3##(2013-1#2)
flower petals and fruit##2##4##(2008-10#1)(2008-4#1)
flower petals of##2##3##(2008-10#1)(2010-3#1)
flower petals##5##2##(2008-10#3)(2008-4#1)(2010-3#1)
flower physical##2##2##(2009-12#2)
flower production##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
flower size##2##2##(2009-12#2)
flower stigmas##3##2##(2008-10#3)
flower thrips##8##2##(2008-10#5)(2009-8#1)(2011-2#2)
flower visiting##2##2##(2007-12#2)
flower##123##1##(1993-2#1)(1996-2#2)(1997-2#2)(1997-8#4)(2007-11#1)(2007-12#2)(2008-10#57)(2008-12#4)(2008-4#1)(2008-5#7)(2008-8#10)(2008-9#1)(2009-12#8)(2009-5#3)(2009-6#3)(2009-8#2)(2010-3#2)(2010-4#1)(2010-9#1)(2011-10#1)(2011-2#4)(2012-2#2)(2013-1#4)
flower-specific##2##1##(1997-2#1)(1997-8#1)
flowering and fruiting##2##3##(2008-12#1)(2012-4#1)
flowering and##6##2##(1997-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-4#1)(2012-6#1)
flowering by a##2##3##(2008-8#2)
flowering in cereals##2##3##(2009-8#2)
flowering in##4##2##(2008-8#1)(2009-8#2)(2012-2#1)
flowering of##2##2##(2008-10#1)(2008-6#1)
flowering plants##8##2##(2008-8#1)(2008-9#2)(2009-8#2)(2010-5#3)
flowering stage##4##2##(2008-12#3)(2013-8#1)
flowering time##10##2##(1997-2#1)(1997-8#2)(2008-8#1)(2009-8#2)(2012-3#3)(2012-7#1)
flowering types##2##2##(2008-10#2)
flowering##84##1##(1990-7#2)(1996-10#1)(1997-2#2)(1997-8#3)(2008-10#25)(2008-12#6)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#6)(2009-8#8)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#5)(2012-4#1)(2012-6#1)(2012-7#1)(2013-8#3)
flowers and##8##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)
flowers are##4##2##(2008-10#1)(2008-9#2)(2012-3#1)
flowers as##2##2##(2008-5#1)(2012-2#1)
flowers in##5##2##(2008-10#3)(2009-5#1)(2012-2#1)
flowers inoculated on the day of anthesis##2##7##(2008-10#2)
flowers of Polygonum##2##3##(2012-3#2)
flowers of##10##2##(2008-10#4)(2009-6#1)(2012-3#5)
flowers on healthy##2##3##(2008-10#2)
flowers on##3##2##(2008-10#3)
flowers that opened##3##3##(2008-10#3)
flowers that##5##2##(2008-10#5)
flowers to##2##2##(2008-10#1)(2013-8#1)
flowers was not##2##3##(2008-10#2)
flowers was##3##2##(2008-10#3)
flowers were##9##2##(2008-10#8)(2011-2#1)
flowers when##2##2##(2008-10#2)
flowers##104##1##(2007-11#2)(2007-12#1)(2008-10#59)(2008-12#4)(2008-5#5)(2008-8#7)(2008-9#6)(2009-5#3)(2009-6#1)(2009-8#2)(2011-10#1)(2011-2#2)(2012-2#2)(2012-3#7)(2013-1#1)(2013-8#1)
flowing aqueous##2##2##(2008-10#2)
flowing blood##2##2##(2008-3#1)(2008-7#1)
flowing fluid##2##2##(2008-9#1)(2011-2#1)
flowing in the##2##3##(2007-11#1)(2007-12#1)
flowing on##2##2##(2008-10#1)(2008-2#1)
flowing solutions##3##2##(2008-10#3)
flowing stream of##3##3##(2008-10#3)
flowing stream techniques##4##3##(2008-10#4)
flowing stream##8##2##(2008-10#8)
flowing streams##5##2##(2008-10#5)
flowing system##3##2##(2008-10#3)
flowing the##2##2##(2008-10#2)
flowing through the##2##3##(2008-10#2)
flowing through##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
flowing##62##1##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#43)(2008-11#2)(2008-2#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
flowing-stream##2##1##(2008-10#2)
flowmetry##5##1##(1991-12#1)(1996-5#1)(2007-7#1)(2008-5#1)(2013-1#1)
flown on the##3##3##(2008-2#1)(2008-3#2)
flown##4##1##(2008-2#1)(2008-3#3)
flowrate##4##1##(2008-6#3)(2008-7#1)
flows (of##2##2##(2008-9#1)(2011-1#1)
flows and the##2##3##(1994-2#1)(1997-6#1)
flows and##4##2##(1994-2#1)(1997-6#1)(2008-11#1)(2008-3#1)
flows has been##2##3##(2008-10#2)
flows in a##2##3##(2008-10#1)(2008-8#1)
flows in the##2##3##(2008-2#1)(2008-3#1)
flows in##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)
flows is##2##2##(2008-10#1)(2009-11#1)
flows of##2##2##(1997-3#1)(2008-10#1)
flows through##2##2##(1991-3#1)(2008-10#1)
flows##63##1##(1991-3#1)(1994-2#3)(1995-3#1)(1996-12#1)(1997-3#3)(1997-6#1)(2006-10#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#15)(2008-7#3)(2008-8#1)(2008-9#5)(2009-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#5)
floxuridine##3##1##(1992-10#2)(2008-7#1)
flu in##2##2##(2010-4#2)
flu##9##1##(2008-11#1)(2009-10#1)(2010-4#5)(2011-1#1)(2013-1#1)
flu-like symptoms##3##2##(2008-6#1)(2008-7#1)(2008-8#1)
flu-like##7##1##(1990-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)
fluazinam##2##1##(2008-10#2)
fluconazole and itraconazole##4##3##(2008-5#4)
fluconazole and ketoconazole##3##3##(2008-11#1)(2008-5#2)
fluconazole and##12##2##(1991-3#1)(1996-11#1)(2008-11#1)(2008-5#9)
fluconazole##27##1##(1991-2#1)(1991-3#1)(1996-11#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#19)
fluctuant##3##1##(2008-10#1)(2010-3#1)(2012-2#1)
fluctuate in##2##2##(1996-6#1)(2008-8#1)
fluctuate##6##1##(1996-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)
fluctuated between 0##2##3##(2008-5#1)(2012-3#1)
fluctuated between##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
fluctuated##7##1##(2008-10#3)(2008-12#1)(2008-5#2)(2012-3#1)
fluctuates##3##1##(2008-8#2)(2011-3#1)
fluctuating asymmetry and##2##3##(2008-9#2)
fluctuating asymmetry##4##2##(2008-8#2)(2008-9#2)
fluctuating conditions##4##2##(2008-10#2)(2008-9#2)
fluctuating environments##2##2##(2008-8#1)(2010-4#1)
fluctuating selection##2##2##(2008-8#1)(2012-3#1)
fluctuating targets##2##2##(2007-12#2)
fluctuating temperature##2##2##(2008-10#2)
fluctuating##37##1##(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2010-4#1)(2010-7#1)(2012-3#2)
fluctuation and##2##2##(2007-11#1)(2013-1#1)
fluctuation in size and##2##4##(1993-9#1)(2007-12#1)
fluctuation in the##2##3##(2008-2#2)
fluctuation in##8##2##(1993-9#1)(2007-12#2)(2008-2#2)(2008-8#1)(2010-8#1)(2013-1#1)
fluctuation is##3##2##(2008-3#2)(2013-1#1)
fluctuation of##6##2##(1994-11#1)(1996-12#1)(2007-11#2)(2008-10#1)(2011-3#1)
fluctuation that is due to##2##5##(2008-3#2)
fluctuation with a##2##3##(2007-10#1)(2008-2#1)
fluctuation##61##1##(1993-9#1)(1994-11#1)(1996-12#1)(1996-3#2)(2007-10#1)(2007-11#7)(2007-12#7)(2008-10#2)(2008-2#7)(2008-3#9)(2008-7#3)(2008-8#1)(2010-8#1)(2010-9#3)(2011-3#1)(2012-2#1)(2013-1#12)(2013-7#1)
fluctuations about the##2##3##(1993-11#2)
fluctuations allows us to##2##4##(2008-3#2)
fluctuations and the##3##3##(1990-7#1)(2008-3#1)(2008-7#1)
fluctuations and##9##2##(1990-7#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)
fluctuations are due to##2##4##(1995-2#1)(1996-4#1)
fluctuations are##10##2##(1995-2#1)(1996-4#2)(2007-11#2)(2008-2#2)(2008-3#3)
fluctuations at##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
fluctuations can##5##2##(2008-8#5)
fluctuations during##3##2##(2007-11#1)(2007-12#1)(2008-5#1)
fluctuations in a##2##3##(2007-12#1)(2008-8#1)
fluctuations in population size##2##4##(1996-6#1)(2008-8#1)
fluctuations in species'##2##3##(2008-9#2)
fluctuations in the##24##3##(1992-5#1)(1994-11#1)(1994-3#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)(2013-7#1)
fluctuations in tremor at rest##2##5##(2008-7#2)
fluctuations in##63##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1992-5#1)(1994-11#1)(1994-3#1)(1996-4#1)(1996-6#2)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#6)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#3)(2010-10#1)(2010-8#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-7#1)
fluctuations is##3##2##(2007-12#1)(2008-3#2)
fluctuations observed in##2##3##(2007-11#2)
fluctuations observed##3##2##(1994-3#1)(2007-11#2)
fluctuations of a##2##3##(2008-3#2)
fluctuations of approximately##2##3##(2007-12#1)(2008-10#1)
fluctuations of seismicity##2##3##(1996-4#2)
fluctuations of the##11##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2011-2#1)(2012-2#1)
fluctuations of##33##2##(1991-12#1)(1996-12#2)(1996-4#2)(1996-6#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-2#4)(2008-3#9)(2008-9#1)(2011-2#1)(2012-2#2)
fluctuations that##2##2##(2008-11#1)(2008-3#1)
fluctuations to##5##2##(2008-2#2)(2008-3#3)
fluctuations were##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
fluctuations##226##1##(1990-3#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-12#1)(1992-5#1)(1993-11#2)(1994-11#1)(1994-3#2)(1995-2#1)(1996-12#2)(1996-4#5)(1996-6#4)(1997-2#1)(2007-11#16)(2007-12#19)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#27)(2008-3#51)(2008-5#4)(2008-6#1)(2008-7#19)(2008-8#18)(2008-9#6)(2009-11#2)(2009-4#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#9)(2012-3#1)(2012-5#2)(2013-7#1)(2013-8#1)
fluctuations)##2##1##(2007-12#1)(2008-7#1)
flucytosine##4##1##(1990-11#2)(2011-2#2)
fludarabine##5##1##(2009-12#4)(2012-2#1)
flue dust##2##2##(2008-10#2)
flue dusts##2##2##(2008-10#2)
flue gas##4##2##(2008-10#3)(2008-3#1)
flue##8##1##(2008-10#7)(2008-3#1)
fluence and##5##2##(2008-2#2)(2008-3#3)
fluence field##4##2##(2012-1#4)
fluence for##2##2##(2008-3#2)
fluence of 0##2##3##(2008-2#1)(2008-3#1)
fluence of##7##2##(2008-2#3)(2008-3#4)
fluence peaks##2##2##(2008-3#2)
fluence profiles and water depth##2##5##(2009-11#2)
fluence rate##6##2##(1995-2#1)(2008-2#1)(2008-3#1)(2011-1#2)(2012-3#1)
fluence rates##3##2##(2008-7#3)
fluence to##2##2##(2008-3#2)
fluence##56##1##(1992-6#1)(1995-2#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#9)(2008-3#24)(2008-7#3)(2009-11#2)(2011-1#2)(2012-1#6)(2012-3#1)
fluence-limiting defects##3##2##(2008-3#3)
fluence-limiting##4##1##(2008-3#4)
fluences above##2##2##(2007-12#1)(2008-3#1)
fluences of##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#2)
fluences##19##1##(2007-11#5)(2007-12#3)(2008-2#4)(2008-3#4)(2008-7#2)(2011-2#1)
fluency and##2##2##(1996-2#1)(2010-6#1)
fluency in##4##2##(2008-12#1)(2011-2#1)(2013-1#2)
fluency##24##1##(1996-2#2)(1996-7#1)(2008-12#7)(2008-2#5)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#4)
fluent speakers and speakers who##2##5##(2008-2#2)
fluent speakers##3##2##(2008-2#3)
fluent##9##1##(1993-12#1)(2008-2#7)(2012-12#1)
flufenamic##4##1##(2008-10#4)
fluid (CSF) leak##4##3##(2008-7#1)(2009-6#1)(2011-2#2)
fluid (CSF)##39##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2009-11#1)(2009-6#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#1)
fluid (median##2##2##(1995-8#2)
fluid after##2##2##(2006-7#1)(2013-1#1)
fluid analysis##3##2##(2007-5#1)(2011-2#1)(2012-3#1)
fluid and a##3##3##(1991-3#1)(1992-2#1)(2008-10#1)
fluid and electrolyte balance##3##4##(1991-2#1)(1994-6#1)(2007-8#1)
fluid and electrolyte##6##3##(1991-2#1)(1994-12#1)(1994-6#1)(2007-8#1)(2009-5#2)
fluid and the##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
fluid and##37##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-12#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-3#2)(2008-4#1)(2008-9#2)(2009-5#2)(2012-2#1)(2013-8#1)
fluid are##3##2##(1996-6#1)(2007-11#1)(2007-8#1)
fluid at##3##2##(1990-11#1)(2008-7#1)(2012-2#1)
fluid balance##4##2##(1991-6#1)(2011-2#3)
fluid bed granulation##2##3##(2008-11#2)
fluid by##5##2##(1993-6#1)(2008-10#2)(2008-5#2)
fluid can##2##2##(2008-2#1)(2008-3#1)
fluid cells##3##2##(1992-6#2)(1994-2#1)
fluid chromatography (SFC)##4##3##(2008-10#4)
fluid chromatography##10##2##(2008-10#10)
fluid collections##4##2##(2009-6#1)(2009-9#2)(2010-6#1)
fluid containing##2##2##(1991-9#1)(2008-6#1)
fluid contains##2##2##(1990-11#1)(2008-8#1)
fluid correlated##2##2##(1994-7#1)(1996-12#1)
fluid culture##2##2##(2009-3#1)(2009-8#1)
fluid cultures##2##2##(2007-12#1)(2008-12#1)
fluid during early##2##3##(1997-5#1)(2011-1#1)
fluid during##3##2##(1997-5#1)(2011-1#1)(2011-2#1)
fluid dynamic analysis##2##3##(2013-1#2)
fluid dynamic##8##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#3)(2013-1#2)
fluid dynamics (CFD)##3##3##(2008-11#1)(2008-6#1)(2010-3#1)
fluid dynamics##14##2##(1991-9#1)(1996-12#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#2)(2010-4#1)
fluid examination##2##2##(2008-1#1)(2013-8#1)
fluid extraction (SFE)##11##3##(2008-10#11)
fluid extraction of##8##3##(2008-10#7)(2012-3#1)
fluid extraction was used to##2##5##(2008-10#2)
fluid extraction##28##2##(2008-10#25)(2008-11#1)(2012-2#1)(2012-3#1)
fluid findings##3##2##(2006-10#2)(2008-1#1)
fluid flow and##3##3##(2009-11#1)(2011-2#1)(2012-2#1)
fluid flow in##2##3##(2008-7#2)
fluid flow is##2##3##(2007-11#1)(2010-8#1)
fluid flow##18##2##(1996-4#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#5)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
fluid for##4##2##(1992-11#1)(1997-3#1)(2006-10#1)(2008-5#1)
fluid from infected##4##3##(2008-10#4)
fluid from patients with##4##4##(1990-2#3)(1994-9#1)
fluid from the##3##3##(1991-5#1)(2008-10#2)
fluid from##17##2##(1990-2#4)(1991-5#1)(1993-8#2)(1994-9#1)(2008-10#8)(2009-4#1)
fluid has##2##2##(2007-8#1)(2008-10#1)
fluid homeostasis##2##2##(2008-4#1)(2008-7#1)
fluid in the##8##3##(1990-12#1)(1992-5#1)(1993-10#1)(1994-8#1)(1997-3#1)(2008-12#1)(2008-5#1)(2008-7#1)
fluid in##24##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-10#1)(1993-2#1)(1994-8#2)(1997-3#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
fluid increased##2##2##(2008-5#1)(2012-12#1)
fluid injections##2##2##(1994-8#2)
fluid intake##5##2##(2007-7#2)(2010-1#1)(2012-1#1)(2013-8#1)
fluid is##4##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
fluid lactase activity##2##3##(1991-12#2)
fluid lactase##3##2##(1991-12#3)
fluid lamellar signal##3##3##(1994-5#3)
fluid leakage##2##2##(2008-7#1)(2012-3#1)
fluid leaks##6##2##(2006-12#1)(2011-2#4)(2012-1#1)
fluid may##2##2##(2008-1#1)(2008-7#1)
fluid obtained##2##2##(1994-11#1)(1996-6#1)
fluid of a##2##3##(2007-12#1)(2007-8#1)
fluid of patients with##3##4##(1992-2#1)(2009-6#1)(2010-12#1)
fluid of patients##4##3##(1992-2#1)(1994-8#1)(2009-6#1)(2010-12#1)
fluid of the##2##3##(1990-5#1)(1991-2#1)
fluid of##20##2##(1990-5#2)(1991-2#1)(1992-2#1)(1993-1#1)(1994-7#1)(1994-8#1)(1995-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
fluid on##2##2##(2007-7#1)(2008-7#1)
fluid or##3##2##(1995-11#1)(2010-4#1)(2011-2#1)
fluid overload##6##2##(2007-7#4)(2011-2#2)
fluid percussion##4##2##(1993-12#3)(1995-12#1)
fluid phase##3##2##(1992-6#1)(2010-5#2)
fluid pressure in the##2##4##(1996-4#1)(2012-1#1)
fluid pressure##3##2##(1996-4#1)(2007-11#1)(2012-1#1)
fluid protein##2##2##(1997-3#1)(2007-8#1)
fluid reasoning##4##2##(2008-11#4)
fluid resuscitation##4##2##(2010-10#1)(2011-2#2)(2013-1#1)
fluid retention##4##2##(1995-12#1)(1997-3#1)(1997-8#1)(2011-1#1)
fluid room temperature phosphorescence##2##4##(2008-10#2)
fluid samples from##5##3##(1993-12#1)(1993-8#1)(2008-5#2)(2012-3#1)
fluid samples##9##2##(1990-9#1)(1991-2#1)(1993-12#1)(1993-8#1)(2008-5#2)(2012-2#2)(2012-3#1)
fluid shear stress##2##3##(2011-2#1)(2012-2#1)
fluid shear##5##2##(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)
fluid shifts and##2##3##(2010-1#1)(2010-7#1)
fluid shifts##3##2##(2010-1#2)(2010-7#1)
fluid taken##2##2##(1991-2#1)(2008-10#1)
fluid technology##3##2##(2012-2#3)
fluid that##2##2##(2008-3#1)(2009-12#1)
fluid therapy##5##2##(1992-11#1)(2011-2#3)(2012-3#1)
fluid transport systems##3##3##(1990-8#3)
fluid transport##5##2##(1990-8#4)(2010-2#1)
fluid using##2##2##(1990-2#1)(2007-12#1)
fluid velocities##2##2##(2008-3#2)
fluid velocity##2##2##(2008-7#2)
fluid volume##4##2##(2007-12#2)(2008-9#1)(2012-12#1)
fluid was analyzed for##2##4##(2010-5#1)(2012-2#1)
fluid was##14##2##(1990-12#1)(1992-12#1)(1995-3#1)(1996-12#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
fluid were##6##2##(1991-12#1)(1995-11#1)(1995-8#1)(2007-12#1)(2008-10#2)
fluid which##2##2##(1995-12#1)(2008-9#1)
fluid with##2##2##(2007-12#1)(2011-1#1)
fluid##650##1##(1990-11#3)(1990-12#7)(1990-2#8)(1990-5#3)(1990-6#3)(1990-8#4)(1990-9#3)(1991-12#9)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#6)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#3)(1993-10#2)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-7#3)(1994-8#12)(1994-9#6)(1995-11#5)(1995-12#7)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#9)(1996-12#12)(1996-2#2)(1996-4#2)(1996-6#2)(1996-8#1)(1997-3#5)(1997-5#1)(1997-8#4)(2006-10#8)(2006-12#4)(2006-7#1)(2007-10#2)(2007-11#6)(2007-12#15)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#9)(2008-1#11)(2008-10#103)(2008-11#15)(2008-12#11)(2008-2#4)(2008-3#17)(2008-4#7)(2008-5#14)(2008-6#3)(2008-7#42)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#6)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#10)(2011-2#39)(2011-7#2)(2012-1#3)(2012-12#6)(2012-2#20)(2012-3#15)(2013-1#7)(2013-7#2)(2013-8#6)
fluid)##2##1##(2008-10#1)(2011-2#1)
fluid-flow velocity##2##2##(2007-12#2)
fluid-fluid level##4##2##(2011-2#4)
fluid-particle systems##2##2##(2008-2#2)
fluid-phase##2##1##(1990-11#1)(1993-6#1)
fluidic axicon##2##2##(2009-6#2)
fluidic circuit##2##2##(2009-5#2)
fluidic##13##1##(2007-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2009-5#3)(2009-6#3)(2009-9#1)
fluidics##3##1##(2008-10#1)(2008-9#2)
fluidity and##6##2##(1990-12#1)(1991-9#1)(1995-11#2)(2008-8#1)(2008-9#1)
fluidity gradient##2##2##(2008-8#2)
fluidity in the##2##3##(1990-12#1)(1991-5#1)
fluidity in##3##2##(1990-12#1)(1991-5#1)(1995-8#1)
fluidity is##2##2##(1992-6#1)(1995-8#1)
fluidity of the##4##3##(1992-6#1)(2008-6#1)(2008-7#1)(2008-9#1)
fluidity of##10##2##(1990-7#1)(1991-5#2)(1992-6#1)(1995-8#1)(2008-6#1)(2008-7#1)(2008-9#3)
fluidity##39##1##(1990-11#1)(1990-12#3)(1990-7#4)(1991-5#7)(1991-9#1)(1992-6#3)(1994-11#1)(1994-2#2)(1995-11#2)(1995-8#3)(1996-12#1)(1997-1#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2011-2#1)
fluidized bed bioreactor##4##3##(2008-11#4)
fluidized bed##7##2##(2008-11#4)(2008-7#3)
fluidized##8##1##(2008-11#5)(2008-7#3)
fluidizing##3##1##(1991-5#1)(1995-11#2)
fluids (plasma##2##2##(2008-10#2)
fluids administered##2##2##(1990-2#1)(2008-3#1)
fluids and tissues##2##3##(2008-10#2)
fluids and##18##2##(1990-2#2)(1993-1#1)(1993-2#1)(1996-4#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
fluids are##2##2##(2008-9#1)(2011-2#1)
fluids by##7##2##(1990-8#1)(1992-1#1)(2008-10#5)
fluids from patients with##2##4##(1990-2#2)
fluids from##7##2##(1990-2#4)(1996-12#1)(2008-7#1)(2011-1#1)
fluids in##4##2##(1991-1#1)(1996-3#1)(2008-10#2)
fluids is##4##2##(1990-12#1)(2008-10#2)(2008-9#1)
fluids of##6##2##(1990-11#1)(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#1)
fluids should##2##2##(2007-8#1)(2008-10#1)
fluids such as##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
fluids that##2##2##(1991-11#1)(2008-7#1)
fluids was##2##2##(1990-2#1)(2008-10#1)
fluids were##4##2##(1995-11#1)(2007-7#1)(2008-10#2)
fluids with##5##2##(1993-1#1)(2008-10#2)(2009-11#1)(2010-4#1)
fluids within##2##2##(1990-12#1)(2008-10#1)
fluids##180##1##(1990-11#1)(1990-12#4)(1990-2#8)(1990-8#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-7#2)(2007-12#2)(2007-7#3)(2007-8#2)(2008-10#68)(2008-11#1)(2008-3#6)(2008-4#11)(2008-5#3)(2008-7#6)(2008-9#5)(2009-11#2)(2009-2#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
fluke##5##1##(1992-6#1)(1996-12#1)(2008-12#3)
flumazenil (10##2##2##(1993-12#2)
flumazenil##3##1##(1992-5#1)(1993-12#2)
flumethrin and##3##2##(2008-10#3)
flumethrin##6##1##(1996-12#3)(2008-10#3)
flumioxazin##2##1##(2008-10#2)
flumorph##6##1##(2008-10#6)
flunarizine (FZ)##2##2##(1993-6#1)(2008-10#1)
flunarizine in##3##2##(1990-3#2)(1993-6#1)
flunarizine##8##1##(1990-3#4)(1993-6#2)(2008-10#2)
fluo-3##8##1##(1990-2#2)(1991-5#2)(1995-5#2)(2006-6#1)(2008-9#1)
fluoranthene##5##1##(2008-10#5)
fluorapatite##3##1##(2007-11#1)(2008-10#2)
fluorene##6##1##(2008-10#5)(2008-4#1)
fluorenyl##2##1##(1993-11#1)(2011-1#1)
fluorescamine##3##1##(2008-10#3)
fluoresce##2##1##(1992-12#1)(2010-3#1)
fluorescein and##2##2##(1993-6#1)(2008-3#1)
fluorescein angiography##2##2##(2011-1#1)(2011-2#1)
fluorescein isothiocyanate (FITC)-labeled##2##3##(2008-10#2)
fluorescein isothiocyanate##5##2##(2008-10#4)(2008-4#1)
fluorescein was##5##2##(1990-12#1)(1995-5#2)(2008-10#1)(2008-12#1)
fluorescein were##2##2##(1996-5#1)(2008-10#1)
fluorescein##56##1##(1990-12#2)(1990-5#2)(1991-8#2)(1993-6#1)(1995-2#1)(1995-5#7)(1996-12#1)(1996-5#1)(2008-10#22)(2008-12#6)(2008-3#1)(2008-4#2)(2008-9#3)(2009-8#2)(2011-1#2)(2011-2#1)
fluorescein-conjugated##2##1##(1990-12#1)(2008-9#1)
fluorescein-hydrazide##2##1##(2008-10#2)
fluorescein-labeled##3##1##(1996-12#1)(2008-10#1)(2008-11#1)
fluorescence (FL)##3##2##(2008-10#3)
fluorescence (LIF)##16##2##(2008-10#5)(2008-2#5)(2008-3#6)
fluorescence (SyF)##2##2##(2008-10#2)
fluorescence (TPF)##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
fluorescence activated cell sorting##3##4##(2008-11#1)(2009-12#1)(2011-2#1)
fluorescence activity##2##2##(2008-1#1)(2008-10#1)
fluorescence after##5##2##(2008-10#3)(2008-4#1)(2008-8#1)
fluorescence analysis##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
fluorescence and UV-vis##2##3##(2008-10#2)
fluorescence and absorption##3##3##(2007-11#1)(2008-2#1)(2010-4#1)
fluorescence and excitation##2##3##(2008-10#1)(2008-3#1)
fluorescence and flow##2##3##(2008-10#1)(2008-9#1)
fluorescence and reflectance##2##3##(2008-3#2)
fluorescence and the##5##3##(1993-11#1)(2007-11#2)(2008-10#1)(2008-3#1)
fluorescence and##38##2##(1992-11#1)(1993-11#1)(1995-5#1)(2007-11#3)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#4)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)
fluorescence anisotropy of the##2##4##(2008-10#1)(2008-2#1)
fluorescence anisotropy of##4##3##(1990-2#1)(1994-2#1)(2008-10#1)(2008-2#1)
fluorescence anisotropy##8##2##(1990-11#1)(1990-2#1)(1992-6#1)(1994-2#1)(2008-10#3)(2008-2#1)
fluorescence are##2##2##(2007-11#1)(2008-3#1)
fluorescence as the##2##3##(1994-5#1)(2008-10#1)
fluorescence as well as##2##4##(1996-2#1)(2008-2#1)
fluorescence as##5##2##(1994-5#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
fluorescence assay using##2##3##(2008-10#1)(2008-11#1)
fluorescence assay##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
fluorescence at##9##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-8#1)(2008-9#1)
fluorescence based##3##2##(1997-7#1)(2008-1#1)(2008-10#1)
fluorescence but##3##2##(2008-10#2)(2011-1#1)
fluorescence by##8##2##(1991-5#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-9#1)
fluorescence can be##2##3##(2008-10#1)(2008-4#1)
fluorescence can##4##2##(2008-1#1)(2008-10#1)(2008-4#2)
fluorescence change was##2##3##(1995-6#2)
fluorescence changes observed##2##3##(1994-5#2)
fluorescence changes##13##2##(1992-6#1)(1994-5#4)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#2)(2008-10#1)(2008-3#1)
fluorescence characteristics of##3##3##(2008-10#2)(2008-3#1)
fluorescence characteristics##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
fluorescence complementation (BiFC) analysis##2##4##(2008-4#2)
fluorescence complementation (BiFC)##3##3##(2008-4#2)(2012-2#1)
fluorescence confocal##2##2##(2007-12#1)(2008-2#1)
fluorescence contribution to the##2##4##(2007-12#1)(2008-3#1)
fluorescence contribution##3##2##(2007-12#2)(2008-3#1)
fluorescence correlation spectroscopy and##2##4##(1997-6#1)(2007-12#1)
fluorescence correlation spectroscopy##6##3##(1997-6#3)(2007-12#1)(2008-10#1)(2008-3#1)
fluorescence data obtained##2##3##(2007-12#1)(2008-10#1)
fluorescence data##7##2##(2007-12#1)(2008-10#4)(2008-3#1)(2009-4#1)
fluorescence decay##3##2##(1993-11#1)(2008-10#1)(2008-3#1)
fluorescence decays##5##2##(2008-10#3)(2008-2#2)
fluorescence derivatization##7##2##(1990-8#3)(1997-2#1)(2008-10#3)
fluorescence detection at##2##3##(2008-10#2)
fluorescence detection for##4##3##(1990-8#1)(2008-10#3)
fluorescence detection has##2##3##(1997-6#1)(2008-10#1)
fluorescence detection in##2##3##(2007-11#1)(2008-10#1)
fluorescence detection is##2##3##(1992-11#1)(2008-10#1)
fluorescence detection of##5##3##(2008-10#3)(2008-2#2)
fluorescence detection was##3##3##(1996-5#1)(2007-11#1)(2008-10#1)
fluorescence detection with##2##3##(2007-12#1)(2008-10#1)
fluorescence detection##76##2##(1990-8#3)(1991-5#3)(1992-11#1)(1992-8#1)(1996-5#3)(1997-2#4)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#45)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
fluorescence detector for capillary electrophoresis##4##5##(2008-10#4)
fluorescence detector was##2##3##(2008-10#2)
fluorescence detector##16##2##(2008-10#16)
fluorescence detectors##3##2##(1990-8#1)(2008-3#1)(2008-4#1)
fluorescence determination of##5##3##(2008-10#5)
fluorescence diffuse optical tomography (FDOT)##2##5##(2007-12#1)(2012-12#1)
fluorescence dyes##2##2##(2008-4#1)(2008-9#1)
fluorescence emission band##2##3##(2008-10#2)
fluorescence emission from##3##3##(2008-3#1)(2008-9#1)(2009-8#1)
fluorescence emission intensity##3##3##(1992-6#1)(2008-10#2)
fluorescence emission maximum at##3##4##(1994-6#1)(2008-8#2)
fluorescence emission maximum##4##3##(1994-6#1)(2008-10#1)(2008-8#2)
fluorescence emission of these compounds in##2##6##(2008-10#2)
fluorescence emission of##8##3##(2008-1#1)(2008-10#4)(2008-3#3)
fluorescence emission peak##2##3##(1995-2#1)(2008-8#1)
fluorescence emission spectra##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
fluorescence emission spectroscopy##2##3##(1994-6#1)(2008-10#1)
fluorescence emission##55##2##(1992-6#1)(1994-6#3)(1995-2#1)(1995-5#2)(2008-1#2)(2008-10#26)(2008-2#1)(2008-3#11)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-4#1)
fluorescence emissions##6##2##(2008-10#3)(2008-2#2)(2009-5#1)
fluorescence endoscopic##3##2##(2008-2#3)
fluorescence energy transfer (FET)##2##4##(1994-2#1)(2008-10#1)
fluorescence energy transfer##10##3##(1994-2#1)(1995-6#1)(1996-12#2)(2008-10#6)
fluorescence enhancement for##2##3##(2008-10#1)(2011-1#1)
fluorescence enhancement of Au nanoparticles##2##5##(2008-10#2)
fluorescence enhancement of the##3##4##(2008-10#3)
fluorescence enhancement of##11##3##(1992-6#2)(2008-10#9)
fluorescence enhancement##20##2##(1991-3#2)(1992-6#2)(2008-10#14)(2008-7#1)(2011-1#1)
fluorescence excitation and emission spectra##3##5##(1992-8#1)(2008-10#1)(2008-9#1)
fluorescence excitation and emission##4##4##(1992-8#1)(2008-10#2)(2008-9#1)
fluorescence excitation emission matrices##2##4##(2008-10#2)
fluorescence excitation light##2##3##(2008-10#1)(2008-3#1)
fluorescence excitation spectra##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
fluorescence excitation using##2##3##(2008-10#1)(2011-1#1)
fluorescence excitation##21##2##(1992-8#1)(2006-4#1)(2007-11#2)(2008-10#7)(2008-2#4)(2008-3#4)(2008-9#1)(2011-1#1)
fluorescence excitation-emission matrices##2##3##(2008-10#2)
fluorescence excitation-emission##3##2##(2008-10#3)
fluorescence experiments##7##2##(1990-2#1)(1994-6#1)(1995-5#2)(2008-10#1)(2009-4#2)
fluorescence for##4##2##(1994-8#1)(1995-5#1)(2008-10#1)(2008-3#1)
fluorescence from a##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
fluorescence from an##2##3##(2007-11#1)(2008-3#1)
fluorescence from the##2##3##(2008-10#1)(2008-3#1)
fluorescence from##20##2##(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#2)(2009-11#1)(2012-2#1)
fluorescence guided resection (FGR) and photodynamic therapy (PDT)##2##8##(2009-4#2)
fluorescence has been##2##3##(2008-10#1)(2008-3#1)
fluorescence has##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
fluorescence have##2##2##(2008-2#2)
fluorescence images of a##2##4##(2008-2#2)
fluorescence images of##3##3##(2008-2#2)(2008-3#1)
fluorescence images##7##2##(2007-12#2)(2008-2#3)(2008-3#2)
fluorescence imaging in##2##3##(2007-12#1)(2008-3#1)
fluorescence imaging is##2##3##(2008-3#2)
fluorescence imaging of##6##3##(2007-12#1)(2008-3#3)(2008-5#1)(2009-8#1)
fluorescence imaging system##3##3##(2007-12#1)(2008-3#1)(2011-3#1)
fluorescence imaging through##3##3##(2008-2#2)(2008-3#1)
fluorescence imaging##28##2##(2007-12#4)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#10)(2008-5#1)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#2)
fluorescence immunoassay##2##2##(2008-10#2)
fluorescence in a##2##3##(2008-3#1)(2012-2#1)
fluorescence in situ hybridisation (FISH)##2##5##(1994-12#1)(2009-8#1)
fluorescence in situ hybridisation##4##4##(1994-12#1)(2008-12#2)(2009-8#1)
fluorescence in situ hybridization (FISH) and##2##6##(1997-2#1)(2011-1#1)
fluorescence in situ hybridization (FISH)##13##5##(1993-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2011-1#1)
fluorescence in situ hybridization (Q-FISH)##2##5##(2008-1#2)
fluorescence in situ hybridization (QFISH)##2##5##(2008-9#2)
fluorescence in situ hybridization of##2##5##(2008-9#1)(2010-3#1)
fluorescence in situ hybridization##34##4##(1993-12#1)(1994-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#3)(2008-11#3)(2008-4#4)(2008-5#5)(2008-7#1)(2008-9#8)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)
fluorescence in situ##38##3##(1993-12#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-4#4)(2008-5#5)(2008-7#1)(2008-9#8)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)
fluorescence in the cytoplasm##2##4##(2008-9#2)
fluorescence in the presence of##2##5##(1994-2#1)(2008-10#1)
fluorescence in the##9##3##(1994-2#1)(1997-2#1)(2008-10#4)(2008-9#3)
fluorescence in##64##2##(1993-12#1)(1994-12#2)(1994-2#1)(1994-8#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#5)(2008-7#1)(2008-9#11)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
fluorescence in-situ##2##2##(2008-5#1)(2012-3#1)
fluorescence increase##3##2##(2008-10#3)
fluorescence intensities of the##2##4##(2008-10#2)
fluorescence intensities vary linearly with the concentration of##2##8##(2008-10#2)
fluorescence intensities##11##2##(2008-10#8)(2008-11#1)(2008-9#2)
fluorescence intensity and the##5##4##(2008-10#5)
fluorescence intensity and##10##3##(2007-11#1)(2008-10#8)(2013-8#1)
fluorescence intensity at##4##3##(2007-11#2)(2008-10#2)
fluorescence intensity changes of##2##4##(2008-10#1)(2008-4#1)
fluorescence intensity distributions within##2##4##(2008-3#2)
fluorescence intensity distributions##3##3##(2008-3#2)(2010-12#1)
fluorescence intensity from the##2##4##(2008-10#1)(2008-3#1)
fluorescence intensity from##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
fluorescence intensity is proportional to the concentration of##2##8##(2008-10#1)(2008-12#1)
fluorescence intensity is proportional to the##3##6##(2008-10#1)(2008-12#1)(2008-3#1)
fluorescence intensity is##5##3##(2008-10#3)(2008-12#1)(2008-3#1)
fluorescence intensity measured##2##3##(2008-3#2)
fluorescence intensity of salicylic acid##2##5##(2008-10#2)
fluorescence intensity of scopoletin##2##4##(2008-10#2)
fluorescence intensity of the foot protein labeled with##2##8##(1992-3#2)
fluorescence intensity of the system##2##5##(2008-10#2)
fluorescence intensity of the##14##4##(1990-12#1)(1992-3#2)(1995-11#1)(1995-6#1)(2008-10#8)(2008-5#1)
fluorescence intensity of##31##3##(1990-12#1)(1992-3#2)(1994-12#1)(1995-11#1)(1995-6#1)(2007-11#1)(2008-10#19)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2013-7#1)
fluorescence intensity ratio##6##3##(2008-10#1)(2008-2#3)(2008-3#2)
fluorescence intensity that##2##3##(2008-10#1)(2008-9#1)
fluorescence intensity was linear over a##2##6##(2008-10#2)
fluorescence intensity was##9##3##(2008-10#9)
fluorescence intensity##107##2##(1990-12#1)(1990-5#1)(1992-3#3)(1994-12#1)(1995-11#1)(1995-5#2)(1995-6#1)(2007-11#5)(2008-10#61)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-12#1)(2013-7#1)(2013-8#3)
fluorescence is observed##2##3##(2008-10#2)
fluorescence is quenched##2##3##(1990-12#1)(2008-7#1)
fluorescence is##22##2##(1990-12#2)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)
fluorescence labeled##2##2##(2008-10#1)(2009-12#1)
fluorescence labeling##5##2##(1992-8#1)(1993-2#2)(2008-4#1)(2008-9#1)
fluorescence lidar##2##2##(2008-2#1)(2008-3#1)
fluorescence lifetime and##3##3##(1991-5#1)(1995-5#1)(2008-3#1)
fluorescence lifetime images##3##3##(2007-12#1)(2011-1#2)
fluorescence lifetime imaging (FLIM)##2##4##(2007-11#1)(2011-1#1)
fluorescence lifetime imaging##8##3##(2007-11#1)(2007-12#4)(2009-4#1)(2011-1#2)
fluorescence lifetime in##2##3##(2008-3#2)
fluorescence lifetime of##5##3##(1994-5#1)(2007-11#1)(2008-10#2)(2009-4#1)
fluorescence lifetime##26##2##(1991-5#1)(1994-5#1)(1995-5#1)(1997-2#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#5)(2009-4#2)(2011-1#5)
fluorescence lifetimes of the##2##4##(2007-12#1)(2008-10#1)
fluorescence lifetimes##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
fluorescence light##2##2##(2008-3#2)
fluorescence loss in photobleaching (FLIP)##2##5##(2008-1#2)
fluorescence maxima##3##2##(1992-8#1)(2008-10#2)
fluorescence measurement of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
fluorescence measurement##8##2##(2008-10#2)(2008-2#2)(2008-3#3)(2013-8#1)
fluorescence measurements of##5##3##(1995-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
fluorescence measurements##17##2##(1991-3#1)(1992-10#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-9#1)(2009-2#1)(2011-1#1)
fluorescence method for##2##3##(2008-10#2)
fluorescence method##4##2##(2008-10#4)
fluorescence methods##2##2##(2008-1#1)(2008-10#1)
fluorescence microscope##11##2##(1993-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)
fluorescence microscopes##2##2##(2008-3#1)(2008-9#1)
fluorescence microscopic##3##2##(1994-9#2)(2009-10#1)
fluorescence microscopy and##6##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
fluorescence microscopy for##3##3##(2008-1#1)(2009-5#1)(2012-2#1)
fluorescence microscopy in##5##3##(1996-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
fluorescence microscopy is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
fluorescence microscopy##67##2##(1991-5#1)(1991-9#2)(1994-5#2)(1995-5#2)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-1#3)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#7)(2009-12#1)(2009-5#1)(2009-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)
fluorescence modes##2##2##(2008-2#1)(2012-2#1)
fluorescence molecular probe##2##3##(2013-8#2)
fluorescence monitoring of##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
fluorescence observed##2##2##(1994-12#1)(2008-3#1)
fluorescence of 1##2##3##(2008-10#2)
fluorescence of GFP##2##3##(2008-4#1)(2008-9#1)
fluorescence of a##2##3##(2008-3#1)(2008-4#1)
fluorescence of native enzyme##2##4##(1995-6#2)
fluorescence of the##27##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1995-2#1)(1997-2#1)(2006-6#1)(2008-10#12)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)
fluorescence of these##2##3##(2008-10#2)
fluorescence of##95##2##(1990-11#1)(1990-2#1)(1990-5#3)(1991-12#1)(1991-5#3)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-2#2)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#40)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#1)(2013-8#1)
fluorescence on the##2##3##(2008-10#1)(2008-3#1)
fluorescence on##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
fluorescence optosensing##2##2##(2008-10#2)
fluorescence or##3##2##(2008-10#2)(2008-2#1)
fluorescence peak at##2##3##(2007-11#1)(2008-10#1)
fluorescence polarization and##2##3##(2008-4#1)(2008-8#1)
fluorescence polarization anisotropy##2##3##(1991-3#1)(2008-3#1)
fluorescence polarization immunoassay##5##3##(1993-8#3)(2008-10#2)
fluorescence polarization##21##2##(1990-12#1)(1991-1#1)(1991-3#1)(1991-5#1)(1993-8#3)(1995-5#1)(1995-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-8#2)(2008-9#1)
fluorescence postlabeling##4##2##(1991-5#4)
fluorescence probe for##5##3##(1994-8#1)(2008-10#2)(2008-12#2)
fluorescence probe##15##2##(1994-8#2)(2008-10#6)(2008-12#2)(2008-9#2)(2013-8#3)
fluorescence probes##4##2##(2008-3#2)(2008-8#2)
fluorescence profiles##2##2##(2008-2#2)
fluorescence properties of the##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
fluorescence properties of##7##3##(1990-12#1)(1992-6#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
fluorescence properties##12##2##(1990-12#1)(1992-6#1)(1994-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-4#1)
fluorescence property of##2##3##(1996-12#1)(2008-10#1)
fluorescence quantum yield##9##3##(1994-12#1)(2008-10#3)(2008-3#3)(2008-9#1)(2009-4#1)
fluorescence quantum##10##2##(1994-12#1)(2008-10#4)(2008-3#3)(2008-9#1)(2009-4#1)
fluorescence quenching agent for alternant##2##5##(2008-10#2)
fluorescence quenching agent for##4##4##(2008-10#4)
fluorescence quenching agent##5##3##(2008-10#5)
fluorescence quenching data##2##3##(1995-6#1)(2008-10#1)
fluorescence quenching efficiency I0/I##2##4##(2013-8#2)
fluorescence quenching method##4##3##(2008-10#4)
fluorescence quenching of CdSe nanocrystals##3##5##(2008-10#3)
fluorescence quenching of a##3##4##(2008-10#3)
fluorescence quenching of##14##3##(2008-10#14)
fluorescence quenching reaction##3##3##(2008-10#3)
fluorescence quenching##50##2##(1991-8#1)(1993-8#1)(1995-2#4)(1995-6#1)(1997-8#1)(2008-10#38)(2008-2#1)(2008-8#1)(2013-8#2)
fluorescence reaction##3##2##(1990-8#1)(2008-10#2)
fluorescence reactions##2##2##(2008-10#2)
fluorescence readout##3##2##(2008-3#3)
fluorescence recovery after photobleaching (FRAP)##4##5##(2008-1#2)(2008-7#1)(2008-9#1)
fluorescence recovery after photobleaching##5##4##(2008-1#3)(2008-7#1)(2008-9#1)
fluorescence recovery##9##2##(2008-1#3)(2008-10#4)(2008-7#1)(2008-9#1)
fluorescence resonance energy transfer (FRET) from a##2##7##(2008-10#2)
fluorescence resonance energy transfer (FRET)##7##5##(2008-10#3)(2008-4#2)(2009-4#1)(2013-7#1)
fluorescence resonance energy transfer##12##4##(1992-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-4#2)(2009-4#1)(2010-2#1)(2013-7#1)
fluorescence resonance energy##13##3##(1992-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-4#1)(2010-2#1)(2013-7#1)
fluorescence scan##2##2##(2008-10#2)
fluorescence signal at##2##3##(2008-10#1)(2008-3#1)
fluorescence signal from the##2##4##(2008-10#1)(2008-2#1)
fluorescence signal on##2##3##(2008-10#1)(2008-9#1)
fluorescence signal##24##2##(2007-11#2)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-9#2)
fluorescence signals from##2##3##(2008-2#2)
fluorescence signals were observed##2##4##(2008-10#1)(2008-11#1)
fluorescence signals were##3##3##(2008-10#2)(2008-11#1)
fluorescence signals##16##2##(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
fluorescence spectra and##2##3##(2008-10#1)(2009-2#1)
fluorescence spectra of##8##3##(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#1)
fluorescence spectra were##3##3##(2008-10#3)
fluorescence spectra##30##2##(1990-5#1)(2007-11#1)(2008-10#18)(2008-2#3)(2008-3#4)(2008-8#1)(2008-9#1)(2009-2#1)
fluorescence spectral##5##2##(2008-10#2)(2008-2#3)
fluorescence spectrometer##5##2##(2008-10#3)(2008-3#1)(2013-8#1)
fluorescence spectrometric detection##3##3##(2008-10#3)
fluorescence spectrometric##7##2##(2008-10#7)
fluorescence spectrometry (HG-AFS)##4##3##(2008-10#4)
fluorescence spectrometry (HGAFS)##3##3##(2008-10#3)
fluorescence spectrometry after##3##3##(2008-10#3)
fluorescence spectrometry for the##2##4##(2008-10#2)
fluorescence spectrometry for##4##3##(2008-10#4)
fluorescence spectrometry using##2##3##(2008-10#2)
fluorescence spectrometry was used##2##4##(2008-10#2)
fluorescence spectrometry was##4##3##(2008-10#4)
fluorescence spectrometry##60##2##(2008-10#60)
fluorescence spectroscopic##2##2##(1995-6#1)(2008-10#1)
fluorescence spectroscopy and##8##3##(1995-6#1)(2008-10#4)(2008-3#1)(2010-4#1)(2013-8#1)
fluorescence spectroscopy for the##2##4##(2008-4#1)(2010-4#1)
fluorescence spectroscopy for##3##3##(2008-3#1)(2008-4#1)(2010-4#1)
fluorescence spectroscopy of##5##3##(2007-11#1)(2008-11#1)(2008-3#3)
fluorescence spectroscopy##54##2##(1990-11#1)(1990-5#1)(1991-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(2007-11#2)(2008-10#21)(2008-11#1)(2008-3#6)(2008-4#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-4#3)(2013-1#1)(2013-8#5)
fluorescence spectrum of##5##3##(2007-11#1)(2008-10#3)(2008-9#1)
fluorescence spectrum##10##2##(1994-8#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-9#1)
fluorescence study##3##2##(1994-5#1)(1995-3#1)(2008-10#1)
fluorescence suppression##2##2##(2007-12#2)
fluorescence system##3##2##(2008-10#3)
fluorescence technique##6##2##(1994-5#1)(2008-10#4)(2008-4#1)
fluorescence techniques##5##2##(1995-5#1)(2008-10#2)(2008-3#1)(2008-7#1)
fluorescence that is##2##3##(2008-2#2)
fluorescence that##4##2##(2008-10#2)(2008-2#2)
fluorescence through##3##2##(1992-3#1)(2007-11#1)(2009-11#1)
fluorescence titration##2##2##(1990-5#1)(1997-2#1)
fluorescence to##6##2##(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
fluorescence upon binding##2##3##(1995-6#1)(2008-10#1)
fluorescence using partial##2##3##(2008-10#2)
fluorescence using##3##2##(1990-7#1)(2008-10#2)
fluorescence was monitored##3##3##(1990-8#1)(1996-2#1)(2008-10#1)
fluorescence was observed in##2##4##(2008-10#1)(2008-11#1)
fluorescence was observed##6##3##(1992-6#1)(2008-10#4)(2008-11#1)
fluorescence was visualized##2##3##(2008-9#2)
fluorescence was##24##2##(1990-8#1)(1992-6#1)(1992-9#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-9#4)(2013-8#1)
fluorescence wavelength##2##2##(1995-5#1)(2008-10#1)
fluorescence wavelength-time matrices##2##3##(2011-1#2)
fluorescence were##2##2##(2008-2#1)(2008-3#1)
fluorescence when##3##2##(2008-10#1)(2008-2#1)(2009-5#1)
fluorescence with a##3##3##(2008-10#2)(2008-2#1)
fluorescence with##10##2##(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#1)(2012-3#1)
fluorescence yield in##2##3##(2007-12#1)(2008-11#1)
fluorescence yield##10##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2012-2#2)
fluorescence##1723##1##(1990-11#4)(1990-12#5)(1990-2#4)(1990-5#8)(1990-7#2)(1990-8#11)(1991-1#1)(1991-12#1)(1991-3#5)(1991-5#17)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#6)(1992-5#1)(1992-6#8)(1992-8#5)(1992-9#5)(1993-11#7)(1993-12#1)(1993-2#2)(1993-8#4)(1994-12#7)(1994-2#4)(1994-3#1)(1994-5#16)(1994-6#5)(1994-8#8)(1994-9#2)(1995-11#2)(1995-2#9)(1995-3#1)(1995-5#24)(1995-6#12)(1995-8#2)(1996-12#6)(1996-2#5)(1996-4#1)(1996-5#4)(1996-6#1)(1997-2#15)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#2)(2006-4#1)(2006-6#1)(2007-11#49)(2007-12#44)(2007-6#1)(2008-1#22)(2008-10#703)(2008-11#27)(2008-12#7)(2008-2#121)(2008-3#196)(2008-4#38)(2008-5#15)(2008-7#12)(2008-8#22)(2008-9#71)(2009-10#2)(2009-11#6)(2009-12#7)(2009-2#4)(2009-4#10)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#23)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#16)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#26)
fluorescence)##3##1##(1991-5#2)(2012-12#1)
fluorescence-activated cell sorting (FACS)##2##4##(2008-4#1)(2009-11#1)
fluorescence-activated cell sorting##4##3##(1992-6#1)(2008-4#2)(2009-11#1)
fluorescence-activated cell##5##2##(1992-6#1)(2008-4#2)(2009-11#1)(2010-8#1)
fluorescence-based detection##2##2##(2008-9#1)(2009-12#1)
fluorescence-based##8##1##(2008-10#4)(2008-2#1)(2008-9#2)(2009-12#1)
fluorescence-detected circular dichroism##2##3##(2008-10#2)
fluorescence-detected##4##1##(1994-5#1)(2006-4#1)(2008-10#2)
fluorescence-intensity##2##1##(1990-11#1)(2009-4#1)
fluorescence-labeled##3##1##(1994-5#1)(2008-4#1)(2008-7#1)
fluorescencein situ hybridization (FISH)##2##4##(2008-8#2)
fluorescens 5064##5##2##(2008-10#5)
fluorescens A506##7##2##(2008-10#7)
fluorescens Pf-5 is##2##3##(2008-10#2)
fluorescens Pf-5##3##2##(2008-10#3)
fluorescens Q8r1-96##3##2##(2008-10#3)
fluorescens RG 26##2##3##(2008-10#2)
fluorescens SS101##4##2##(2008-10#4)
fluorescens WCS374r##2##2##(2008-10#2)
fluorescens and##3##2##(2008-10#3)
fluorescens m6418##3##2##(2008-10#3)
fluorescens strain A506 and Pantoea agglomerans##2##6##(2008-10#2)
fluorescens strain A506##8##3##(2008-10#8)
fluorescens strain##13##2##(2008-10#13)
fluorescens##84##1##(2008-10#82)(2008-8#1)(2011-1#1)
fluorescent DNA##2##2##(1991-6#1)(2008-9#1)
fluorescent PCR##2##2##(2008-10#1)(2008-4#1)
fluorescent Pseudomonas spp##7##3##(2008-10#7)
fluorescent Pseudomonas##8##2##(2008-10#8)
fluorescent amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
fluorescent amplified fragment length polymorphism##3##5##(2008-10#3)
fluorescent analog##3##2##(1992-6#1)(1994-8#1)(1995-11#1)
fluorescent antibody test##2##3##(2008-5#1)(2012-3#1)
fluorescent antibody##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
fluorescent assay##2##2##(1993-11#1)(2008-4#1)
fluorescent beads##2##2##(2008-10#1)(2008-4#1)
fluorescent calcium##2##2##(1990-2#1)(1991-5#1)
fluorescent cells##4##2##(2007-10#1)(2008-11#2)(2008-4#1)
fluorescent chelate##2##2##(2008-10#2)
fluorescent complexes##2##2##(2008-10#1)(2008-4#1)
fluorescent compound##4##2##(2008-10#3)(2008-11#1)
fluorescent compounds##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
fluorescent contrast##2##2##(2008-5#1)(2012-2#1)
fluorescent derivative##2##2##(1997-2#1)(2008-10#1)
fluorescent derivatives##2##2##(1993-11#1)(2008-10#1)
fluorescent derivatization##3##2##(2008-10#3)
fluorescent detection of##5##3##(1997-7#1)(2008-10#2)(2008-9#1)(2009-7#1)
fluorescent detection##8##2##(1997-7#1)(2008-10#5)(2008-9#1)(2009-7#1)
fluorescent determination of##2##3##(2008-10#2)
fluorescent dextran##2##2##(1995-12#1)(1997-3#1)
fluorescent dye is##2##3##(2008-4#2)
fluorescent dye##20##2##(1990-2#1)(1991-11#1)(1992-6#2)(1997-7#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#4)(2009-12#1)(2010-2#1)(2013-1#1)
fluorescent dyes that##2##3##(2008-9#2)
fluorescent dyes##18##2##(2006-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-2#1)
fluorescent emission##2##2##(1995-5#1)(2008-1#1)
fluorescent hybridization to##2##3##(2008-4#1)(2009-5#1)
fluorescent hybridization##3##2##(2008-4#1)(2009-5#1)(2010-8#1)
fluorescent imaging##2##2##(2008-1#1)(2008-10#1)
fluorescent in situ hybridization (FISH)##2##5##(2010-12#1)(2010-3#1)
fluorescent in situ hybridization##8##4##(1997-4#1)(2008-4#2)(2010-12#2)(2010-3#1)(2012-3#1)(2013-1#1)
fluorescent in##9##2##(1997-4#1)(2008-10#1)(2008-4#2)(2010-12#2)(2010-3#1)(2012-3#1)(2013-1#1)
fluorescent indicator##3##2##(1994-6#1)(2008-10#1)(2008-3#1)
fluorescent indicators##2##2##(1990-8#1)(2008-9#1)
fluorescent intensity was##2##3##(2008-10#2)
fluorescent intensity##6##2##(2008-1#1)(2008-10#5)
fluorescent intercalator displacement##2##3##(2008-4#2)
fluorescent label##2##2##(1993-11#1)(2008-9#1)
fluorescent labeling of##5##3##(2008-10#1)(2008-4#2)(2008-9#1)(2013-7#1)
fluorescent labeling##10##2##(1992-3#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-9#2)(2013-7#1)
fluorescent lifetime##3##2##(2008-2#1)(2009-10#2)
fluorescent light##9##2##(1994-12#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)
fluorescent marker for##2##3##(1996-6#1)(2008-11#1)
fluorescent marker##4##2##(1994-2#1)(1996-6#1)(2007-11#1)(2008-11#1)
fluorescent markers##3##2##(2008-10#1)(2009-5#1)(2009-9#1)
fluorescent membrane##3##2##(1993-11#1)(1996-6#1)(2008-11#1)
fluorescent metabolites with##2##3##(1993-8#2)
fluorescent method##2##2##(2008-1#1)(2008-10#1)
fluorescent microscope##3##2##(1992-6#1)(2008-9#1)(2011-1#1)
fluorescent microscopy##5##2##(1990-5#1)(1997-2#1)(2008-1#1)(2008-9#1)(2012-1#1)
fluorescent microspheres##3##2##(2007-11#1)(2008-3#1)(2008-4#1)
fluorescent molecules##6##2##(2007-11#1)(2008-10#1)(2008-3#3)(2008-4#1)
fluorescent nanoparticles were##2##3##(2008-10#1)(2010-4#1)
fluorescent nanoparticles##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2010-4#1)
fluorescent optode membrane for sodium ion##2##6##(2008-10#2)
fluorescent or##2##2##(2008-7#1)(2013-1#1)
fluorescent organic##2##2##(2008-10#1)(2010-4#1)
fluorescent pH indicator##2##3##(2008-10#2)
fluorescent pattern##2##2##(1991-6#2)
fluorescent probe for##2##3##(1991-5#1)(2008-10#1)
fluorescent probe##25##2##(1990-11#2)(1990-7#1)(1991-12#1)(1991-5#2)(1992-3#2)(1992-6#2)(1993-9#1)(1997-7#1)(2008-10#9)(2008-4#1)(2008-8#1)(2009-12#1)(2013-8#1)
fluorescent probes and##4##3##(2007-11#1)(2008-9#2)(2009-8#1)
fluorescent probes##20##2##(2007-11#2)(2008-10#3)(2008-4#1)(2008-9#9)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)
fluorescent probing##2##2##(2008-10#2)
fluorescent product##3##2##(1994-11#1)(2008-10#2)
fluorescent protein (FP)##2##3##(2008-7#1)(2008-9#1)
fluorescent protein (GFP)##24##3##(1996-6#1)(1997-4#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2011-3#1)(2013-8#1)
fluorescent protein as a##2##4##(1996-6#1)(2008-11#1)
fluorescent protein in##4##3##(2008-11#3)(2008-7#1)
fluorescent protein##64##2##(1996-6#2)(1997-4#1)(1997-8#1)(2008-1#3)(2008-10#12)(2008-11#15)(2008-4#2)(2008-7#9)(2008-8#4)(2008-9#7)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
fluorescent proteins in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
fluorescent proteins that##2##3##(2008-3#1)(2008-4#1)
fluorescent proteins##15##2##(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#4)(2009-4#3)(2009-9#1)
fluorescent pseudomonad##6##2##(2008-10#6)
fluorescent pseudomonads##6##2##(2008-10#6)
fluorescent quantitative##5##2##(2008-10#1)(2013-8#4)
fluorescent reagent##9##2##(1990-8#1)(2008-10#8)
fluorescent sensor for##2##3##(2008-10#2)
fluorescent sensor##4##2##(2008-10#4)
fluorescent sheet##2##2##(2008-3#2)
fluorescent signal##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)
fluorescent signals##4##2##(2007-11#1)(2008-10#1)(2008-4#2)
fluorescent species##2##2##(2008-10#2)
fluorescent spectrum of##2##3##(2008-10#1)(2008-8#1)
fluorescent spectrum##3##2##(1993-6#1)(2008-10#1)(2008-8#1)
fluorescent staining##7##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)
fluorescent substrate##3##2##(1997-4#1)(2008-10#2)
fluorescent tracers##2##2##(1996-5#1)(1997-2#1)
fluorescent triazole##2##2##(2008-10#2)
fluorescent##538##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-5#5)(1991-6#4)(1991-9#2)(1992-3#5)(1992-6#7)(1992-9#2)(1993-11#7)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#1)(1996-5#1)(1996-6#4)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#14)(2008-10#191)(2008-11#31)(2008-12#4)(2008-2#7)(2008-3#23)(2008-4#34)(2008-5#4)(2008-7#14)(2008-8#8)(2008-9#40)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#7)
fluorescently labeled##16##2##(1992-3#1)(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#3)(2008-9#2)(2010-3#1)(2012-3#1)
fluorescently labelled##3##2##(2008-11#1)(2008-2#1)(2009-12#1)
fluorescently##24##1##(1992-3#1)(1995-5#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-4#4)(2008-9#4)(2009-12#1)(2010-3#1)(2012-3#1)
fluorescently-labeled##2##1##(2008-10#1)(2008-9#1)
fluoresces##2##1##(2008-3#1)(2008-9#1)
fluorescing##13##1##(1994-6#1)(1995-2#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)
fluoride (NaF)##5##2##(2008-10#4)(2013-1#1)
fluoride and carbonate##3##3##(2008-10#3)
fluoride and##11##2##(2008-10#8)(2008-12#1)(2011-2#1)(2013-1#1)
fluoride anion##2##2##(2011-1#2)
fluoride as##2##2##(1993-11#1)(2013-1#1)
fluoride at##2##2##(2008-5#1)(2013-1#1)
fluoride but##2##2##(1994-9#1)(2008-10#1)
fluoride concentration in##3##3##(2008-10#3)
fluoride concentration##4##2##(2008-10#4)
fluoride determination##2##2##(2008-10#2)
fluoride fiber laser with##2##4##(2008-2#2)
fluoride fiber##3##2##(2007-12#1)(2008-2#2)
fluoride fibers##2##2##(2007-12#1)(2008-2#1)
fluoride glass##2##2##(2007-12#2)
fluoride in the##2##3##(2008-12#1)(2013-1#1)
fluoride in##20##2##(1992-12#1)(1996-2#2)(2008-10#12)(2008-12#2)(2012-1#1)(2013-1#2)
fluoride ion in##3##3##(2008-10#3)
fluoride ion is##2##3##(2008-10#2)
fluoride ion selective electrode##2##4##(2008-10#1)(2008-5#1)
fluoride ion##14##2##(2008-10#12)(2008-5#2)
fluoride ion-selective electrode##7##3##(2008-10#7)
fluoride ions##5##2##(2008-10#4)(2008-4#1)
fluoride is##4##2##(1995-5#1)(2008-10#2)(2009-5#1)
fluoride levels##2##2##(2008-12#1)(2012-2#1)
fluoride load##2##2##(2008-12#2)
fluoride or##2##2##(1991-11#1)(2008-10#1)
fluoride present##2##2##(2008-10#2)
fluoride salt##2##2##(2008-10#1)(2009-9#1)
fluoride salts##2##2##(1994-5#1)(2008-10#1)
fluoride was##3##2##(1994-6#1)(1995-12#1)(2008-10#1)
fluoride with##5##2##(1994-11#1)(2007-12#1)(2008-10#3)
fluoride##212##1##(1990-12#1)(1990-2#4)(1991-11#3)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-11#4)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#7)(1995-5#3)(1996-12#2)(1996-2#3)(2007-11#1)(2007-12#7)(2008-10#100)(2008-11#2)(2008-12#9)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#3)(2009-9#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#17)
fluoride) and##2##2##(1992-12#1)(2008-10#1)
fluoride)##4##1##(1992-12#2)(2008-10#2)
fluoride-selective electrode##3##2##(2008-10#3)
fluoride-selective membrane##2##2##(2008-10#2)
fluoride-selective##5##1##(2008-10#5)
fluorides in##2##2##(2008-10#1)(2008-12#1)
fluorides##8##1##(1996-2#1)(2008-10#5)(2008-12#1)(2010-12#1)
fluorimeter##3##1##(2008-10#2)(2009-10#1)
fluorimetric analysis of##4##3##(2008-10#4)
fluorimetric assay##3##2##(2008-10#3)
fluorimetric data##2##2##(2008-10#2)
fluorimetric detection##22##2##(1990-8#2)(1991-5#1)(1997-2#1)(2008-10#18)
fluorimetric detector##3##2##(2008-10#3)
fluorimetric determination of##13##3##(2008-10#13)
fluorimetric determination##16##2##(2008-10#16)
fluorimetric method for the determination of##6##6##(2008-10#6)
fluorimetric method for##7##3##(2008-10#7)
fluorimetric method has been##2##4##(2008-10#2)
fluorimetric method##18##2##(2008-10#18)
fluorimetric methods reported##2##3##(2008-10#2)
fluorimetric methods##6##2##(2008-10#6)
fluorimetric study of##2##3##(2008-10#2)
fluorimetric##92##1##(1990-2#1)(1990-8#2)(1991-5#1)(1995-12#1)(1997-2#1)(2008-10#86)
fluorimetrically##7##1##(1990-8#1)(2008-10#6)
fluorimetry for##4##2##(2008-10#4)
fluorimetry##16##1##(1994-3#1)(2008-10#15)
fluorinated functionality##2##2##(2009-9#2)
fluorinated##28##1##(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#2)(2009-9#5)(2010-2#2)(2010-4#1)(2013-1#2)
fluorination assisted electrothermal vaporization (FETV)-inductively coupled plasma optical emission spectrometry (ICP-OES)##2##11##(2008-10#2)
fluorination##3##1##(2008-10#3)
fluorine determination##2##2##(2008-10#2)
fluorine in blood##2##3##(2008-10#2)
fluorine in the air##2##4##(2008-10#2)
fluorine in the##4##3##(2008-10#3)(2009-9#1)
fluorine in##10##2##(2008-10#9)(2009-9#1)
fluorine laser##2##2##(2008-3#2)
fluorine##30##1##(1991-6#1)(1993-6#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-2#1)(2008-3#3)(2009-9#3)(2012-3#1)
fluorite##2##1##(2008-3#1)(2010-4#1)
fluoro group##4##2##(1991-12#3)(2009-9#1)
fluoro-substituted##3##1##(1995-3#1)(2012-3#2)
fluoroacetate##3##1##(1993-11#1)(2011-1#2)
fluoroapatite##2##1##(2013-1#2)
fluorochrome##24##1##(1990-12#3)(1990-2#1)(1991-6#2)(2007-11#3)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#4)
fluorochrome-conjugated antibodies##2##2##(2008-4#1)(2008-9#1)
fluorochrome-conjugated##4##1##(2008-4#1)(2008-9#3)
fluorochromes##18##1##(1990-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#12)
fluorocitrate##2##1##(1997-6#2)
fluorodeoxyglucose##3##1##(1993-9#1)(2008-1#1)(2010-3#1)
fluorogenic probe##2##2##(2008-10#2)
fluorogenic reagent##4##2##(2008-10#4)
fluorogenic substrate##3##2##(1992-9#1)(1996-12#2)
fluorogenic substrates##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
fluorogenic##22##1##(1992-9#1)(1996-12#3)(1997-3#1)(2008-10#14)(2008-4#2)(2008-9#1)
fluorography and##2##2##(1990-12#1)(2008-4#1)
fluorography##5##1##(1990-12#1)(1990-7#1)(1992-3#1)(1992-8#1)(2008-4#1)
fluoroimmunoassay##10##1##(1990-8#2)(2008-10#8)
fluoroimmunosensor for##2##2##(2008-10#2)
fluoroimmunosensor##4##1##(2008-10#4)
fluoroionophores##4##1##(2008-10#4)
fluorometer##4##1##(2008-1#1)(2008-10#3)
fluorometric detection##4##2##(1995-11#1)(2008-10#3)
fluorometric determination of##5##3##(2008-10#5)
fluorometric enzyme immunoassay for 17beta-estradiol##2##5##(2008-10#2)
fluorometric enzyme##3##2##(2008-10#3)
fluorometric method for##2##3##(1996-12#1)(2008-10#1)
fluorometric method##4##2##(1996-12#1)(2008-10#3)
fluorometric quantification of##2##3##(2008-10#2)
fluorometric##33##1##(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1995-11#1)(1996-12#2)(2008-10#25)(2011-2#1)
fluorometrically at##4##2##(1997-2#1)(2008-10#3)
fluorometrically##8##1##(1990-8#1)(1993-3#1)(1997-2#1)(2008-10#5)
fluorometry##4##1##(1991-12#1)(1992-9#1)(2008-10#1)(2013-8#1)
fluorophor##2##1##(2008-10#1)(2008-3#1)
fluorophore and##2##2##(1994-6#1)(2008-9#1)
fluorophore concentration##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
fluorophore for##2##2##(2008-10#1)(2009-4#1)
fluorophore is##2##2##(2008-10#2)
fluorophore##44##1##(1991-9#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-5#2)(1997-2#4)(2007-12#3)(2008-1#2)(2008-10#13)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-9#2)(2009-4#1)(2010-5#1)(2012-2#1)
fluorophore-assisted##2##1##(2008-11#1)(2008-5#1)
fluorophores and##2##2##(2007-11#1)(2008-9#1)
fluorophores have##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
fluorophores in the##3##3##(2008-1#1)(2008-4#1)(2009-12#1)
fluorophores that can##2##3##(2008-1#1)(2008-2#1)
fluorophores that##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2009-5#1)
fluorophores to##3##2##(2008-1#1)(2008-4#2)
fluorophores with##3##2##(2008-6#2)(2009-12#1)
fluorophores##51##1##(1990-8#1)(1995-5#3)(2007-11#1)(2008-1#6)(2008-10#8)(2008-2#3)(2008-3#4)(2008-4#4)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-5#2)(2010-2#2)(2012-2#6)
fluorophosphate##3##1##(1990-7#1)(2008-10#2)
fluorophosphine##2##1##(1996-2#2)
fluorophotometer at##2##2##(1993-2#1)(2008-10#1)
fluoropolymer##4##1##(2008-10#3)(2012-2#1)
fluoropyrimidine##4##1##(1992-8#4)
fluoroquinolone derivatives##2##2##(2008-10#2)
fluoroquinolone##11##1##(1991-3#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-7#1)(2011-2#1)(2012-3#1)
fluoroquinolones and##4##2##(2007-12#1)(2007-7#1)(2008-10#1)(2010-6#1)
fluoroquinolones in##3##2##(2007-12#1)(2008-10#2)
fluoroquinolones was##2##2##(2008-10#1)(2008-7#1)
fluoroquinolones were##2##2##(2007-7#1)(2008-10#1)
fluoroquinolones##25##1##(2007-12#2)(2007-7#3)(2008-10#11)(2008-7#5)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
fluoroscopic##5##1##(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
fluoroscopically guided##2##2##(1993-1#1)(2009-3#1)
fluoroscopy to##2##2##(2008-10#1)(2008-7#1)
fluoroscopy##18##1##(1993-12#1)(1994-9#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#2)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
fluorosis##5##1##(1990-6#1)(1991-11#2)(2012-1#2)
fluorosulfate##4##1##(1996-2#4)
fluorouracil and##2##2##(1995-10#1)(2008-7#1)
fluorouracil##18##1##(1990-2#4)(1991-2#1)(1991-3#2)(1992-10#1)(1992-8#6)(1995-10#1)(2007-5#1)(2008-5#1)(2008-7#1)
fluorous##3##1##(2008-5#1)(2010-4#2)
fluorozirconate glass##2##2##(2007-12#2)
fluorozirconate##4##1##(1991-1#1)(2007-12#2)(2008-3#1)
fluoxetine and its main metabolite norfluoxetine##2##6##(2008-10#2)
fluoxetine and its##6##3##(1997-6#1)(2008-10#5)
fluoxetine and norfluoxetine##3##3##(2008-10#2)(2010-8#1)
fluoxetine and##13##2##(1997-6#2)(2008-10#8)(2010-8#1)(2012-2#1)(2013-1#1)
fluoxetine in##6##2##(1996-3#1)(2007-7#1)(2008-10#3)(2013-1#1)
fluoxetine was##2##2##(2008-10#1)(2008-7#1)
fluoxetine##42##1##(1996-3#1)(1997-5#1)(1997-6#3)(2007-7#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#7)
fluoximesterone##2##1##(1992-8#2)
flupenthixol and ritanserin##2##3##(1996-5#2)
flupenthixol##7##1##(1993-6#1)(1996-5#6)
fluphenazine##5##1##(2008-10#5)
flupirtine##7##1##(1995-12#7)
flurbiprofen as##2##2##(2011-2#2)
flurbiprofen sodium eye drops##2##4##(2011-3#2)
flurbiprofen##17##1##(1995-3#1)(2008-10#4)(2008-5#2)(2011-2#4)(2011-3#6)
flush##2##1##(2007-8#1)(2008-7#1)
flushed##5##1##(1995-3#1)(2008-11#1)(2008-3#1)(2013-1#2)
flushing reaction##4##2##(1994-5#4)
flushing##13##1##(1991-9#1)(1994-11#1)(1994-5#4)(1994-9#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-3#1)
flusilazole##3##1##(2008-10#3)
fluticasone propionate (FP)##3##3##(1996-1#1)(1996-2#2)
fluticasone propionate##5##2##(1996-1#1)(1996-2#2)(2007-11#2)
flutter##8##1##(2007-8#2)(2010-11#3)(2011-2#1)(2012-3#2)
flutter/fibrillation##2##1##(2010-5#2)
fluvastatin##3##1##(2008-1#2)(2008-5#1)
fluvial-deltaic##2##1##(2008-5#2)
fluvialis##2##1##(2007-10#2)
fluviatilis##3##1##(1993-3#1)(1997-3#2)
fluvoxamine##3##1##(2008-3#1)(2008-6#1)(2012-3#1)
flux analysis##5##2##(2008-2#1)(2008-7#3)(2013-1#1)
flux and storage##2##3##(2008-8#2)
flux and the##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)
flux and##13##2##(1990-6#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-8#1)
flux between##2##2##(2007-11#1)(2008-7#1)
flux can##2##2##(2008-7#1)(2010-10#1)
flux concentration##2##2##(2008-3#2)
flux density of##4##3##(2008-10#4)
flux density was##4##3##(1995-6#1)(2008-10#3)
flux density##17##2##(1995-6#2)(2008-10#12)(2008-2#2)(2010-10#1)
flux distribution##4##2##(2008-2#1)(2009-5#1)(2013-1#2)
flux distributions##3##2##(2008-3#1)(2008-7#1)(2009-5#1)
flux from##2##2##(2008-10#1)(2010-8#1)
flux has##2##2##(2008-3#1)(2009-11#1)
flux in a##2##3##(2008-3#1)(2013-1#1)
flux in the##2##3##(2008-10#1)(2008-7#1)
flux in##7##2##(1991-1#1)(1991-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
flux is##5##2##(1997-5#1)(2008-3#2)(2008-7#1)(2009-11#1)
flux measurements##5##2##(1995-3#1)(2008-11#1)(2008-3#3)
flux of the##2##3##(2008-11#1)(2008-2#1)
flux of##22##2##(1997-5#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#2)(2012-2#1)
flux rate##2##2##(1991-5#1)(2008-7#1)
flux through the pyruvate-dehydrogenase complex##2##5##(1991-3#2)
flux through the##7##3##(1991-3#2)(1994-8#1)(1997-2#1)(2008-11#2)(2008-3#1)
flux through##13##2##(1990-11#1)(1991-3#3)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
flux to##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
flux was initiated by the##2##5##(1990-11#2)
flux was##5##2##(1990-11#2)(1991-5#2)(1993-3#1)
flux##204##1##(1990-11#5)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#4)(1991-5#5)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#2)(1997-2#1)(1997-5#5)(2006-4#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#12)(2008-2#14)(2008-3#22)(2008-5#5)(2008-6#8)(2008-7#31)(2008-8#2)(2008-9#1)(2009-11#4)(2009-12#1)(2009-5#2)(2010-10#5)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#1)
flux)##7##1##(1991-3#2)(2008-2#1)(2008-7#3)(2012-2#1)
flux-grown BBO##2##2##(2008-2#2)
flux-grown KTiOPO(4)##2##2##(2007-12#1)(2008-2#1)
flux-grown##4##1##(2007-12#1)(2008-2#3)
fluxes across##2##2##(2008-10#1)(2008-9#1)
fluxes and##5##2##(1995-11#2)(2008-10#1)(2008-7#1)(2008-8#1)
fluxes for##3##2##(2008-7#2)(2013-1#1)
fluxes in Japanese forests##2##4##(2012-2#2)
fluxes in##4##2##(1992-6#1)(1993-3#1)(2012-2#2)
fluxes of both##2##3##(2008-6#2)
fluxes of##9##2##(1992-7#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-6#2)
fluxes through##2##2##(1996-5#1)(2008-6#1)
fluxes were observed##2##3##(1991-5#1)(2008-3#1)
fluxes were##3##2##(1991-5#1)(1993-3#1)(2008-3#1)
fluxes within##2##2##(2008-7#1)(2009-10#1)
fluxes##66##1##(1990-5#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-3#2)(1995-11#3)(1996-5#1)(2007-11#2)(2008-10#5)(2008-11#14)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#11)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#5)(2013-1#1)
fluxional##2##1##(1996-2#1)(1997-7#1)
fly (Diptera##2##2##(2011-2#2)
fly and##2##2##(2008-9#1)(2009-5#1)
fly ash and sediment##2##4##(2008-10#2)
fly ash and##7##3##(2008-10#6)(2008-3#1)
fly ash is##3##3##(2008-10#2)(2008-3#1)
fly ash precipitates##4##3##(2008-10#4)
fly ash sample##2##3##(2008-3#2)
fly ash samples by##2##4##(2008-10#2)
fly ash samples##10##3##(2008-10#10)
fly ash##35##2##(2008-10#30)(2008-3#5)
fly ash)##3##2##(2008-10#3)
fly height tester##2##3##(2008-3#2)
fly height##4##2##(2008-3#4)
fly is##3##2##(2008-10#2)(2010-10#1)
fly research##2##2##(2008-12#1)(2013-1#1)
fly with##2##2##(2008-10#1)(2008-6#1)
fly##127##1##(1990-5#1)(1991-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1996-5#2)(1997-7#1)(2007-12#8)(2008-10#42)(2008-11#4)(2008-12#2)(2008-3#11)(2008-6#3)(2008-7#3)(2008-9#8)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-5#2)(2011-2#17)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
fly&quot##2##1##(2008-10#2)
fly's##2##1##(2008-2#1)(2012-3#1)
flying##13##1##(1992-3#1)(1994-3#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-8#1)
flying-height variation along the##2##4##(2008-3#2)
flying-height##4##1##(2008-3#4)
fmol and##3##2##(1997-2#2)(2009-7#1)
fmol for##5##2##(2008-10#5)
fmol l(-1) to##2##3##(2008-10#2)
fmol mg-1##2##2##(1996-5#2)
fmol mg-1)##2##2##(1996-5#2)
fmol of##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
fmol##27##1##(1994-8#1)(1994-9#1)(1996-5#5)(1997-2#6)(2008-10#12)(2008-6#1)(2009-7#1)
fmol/egg##2##1##(1991-12#2)
fmol/mg protein and##2##3##(1990-8#1)(1991-12#1)
fmol/mg protein##11##2##(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-6#2)
fmol/mg protein)##2##2##(1990-11#1)(1994-8#1)
fmol/mg##16##1##(1990-11#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1993-12#2)(1993-3#1)(1994-6#2)(1994-8#1)(1995-12#2)
fmol/mg) in##2##2##(1994-9#2)
fmol/mg)##5##1##(1991-12#1)(1994-9#2)(1995-12#2)
fmol/ml in##2##2##(1991-5#2)
fmol/ml##4##1##(1991-5#2)(1994-12#2)
fo##2##1##(1997-2#1)(1997-6#1)
foam and C(18)##2##3##(2008-10#2)
foam and emulsion bilayers##3##4##(1992-5#3)
foam and##9##2##(1992-5#3)(2008-10#5)(2010-8#1)
foam bilayer is##3##3##(1992-5#3)
foam bilayer##4##2##(1992-5#4)
foam cell formation and##2##4##(1996-3#1)(2013-1#1)
foam cell formation##5##3##(1995-3#1)(1996-3#1)(2013-1#3)
foam cells##3##2##(1990-8#1)(2013-1#2)
foam followed##2##2##(2008-10#2)
foam fractionation##2##2##(2008-6#2)
foam generated##2##2##(1996-12#1)(2008-6#1)
foam in##2##2##(2008-7#1)(2010-8#1)
foam packed##2##2##(2008-10#2)
foam was##2##2##(1996-12#1)(2008-6#1)
foam without##2##2##(1996-12#1)(2008-10#1)
foam##109##1##(1990-8#1)(1992-5#11)(1995-3#1)(1996-12#4)(1996-3#2)(2007-12#3)(2008-10#47)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#13)(2008-7#3)(2009-7#3)(2010-5#1)(2010-8#4)(2012-2#3)(2012-3#1)(2013-1#5)
foamate##4##1##(2008-6#4)
foaming cloth cleanser##3##3##(2010-8#3)
foaming cloth##6##2##(2010-8#6)
foaming properties##2##2##(2010-4#2)
foaming##13##1##(2007-11#1)(2008-10#2)(2008-5#1)(2010-4#2)(2010-8#6)(2011-2#1)
foams is##2##2##(2008-10#1)(2008-3#1)
foams##21##1##(1996-12#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#5)(2010-8#1)
foamy macrophages##4##2##(2007-7#1)(2010-3#1)(2012-12#1)(2012-2#1)
focal adhesion kinase##2##3##(1996-12#1)(2012-2#1)
focal adhesion##3##2##(1996-12#1)(2010-4#1)(2012-2#1)
focal adhesion-like process underlies##2##4##(2008-7#2)
focal adhesion-like process##3##3##(2008-7#3)
focal adhesions##4##2##(2008-7#2)(2010-4#1)(2012-12#1)
focal and general##2##3##(2008-10#2)
focal and segmental glomerulosclerosis (FSGS)##3##5##(2007-7#1)(2008-1#1)(2012-2#1)
focal and segmental glomerulosclerosis##6##4##(2007-7#2)(2008-1#3)(2012-2#1)
focal and segmental##8##3##(2007-7#2)(2008-1#4)(2011-2#1)(2012-2#1)
focal and##14##2##(2007-7#2)(2008-1#4)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
focal anisoplanatism##2##2##(2007-11#2)
focal areas of##2##3##(1990-6#1)(2012-12#1)
focal brain##2##2##(1996-6#1)(2008-11#1)
focal cerebral ischemia in##3##4##(1995-12#1)(1997-2#1)(2012-12#1)
focal cerebral ischemia##11##3##(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#2)(2007-10#2)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
focal cerebral##16##2##(1995-12#1)(1996-11#1)(1996-12#3)(1997-2#1)(1997-6#2)(2007-10#2)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
focal chronic active inflammation of the##2##6##(2008-9#2)
focal demyelination of the##2##4##(2008-7#2)
focal demyelination##5##2##(2008-7#4)(2011-2#1)
focal depth##3##2##(2008-2#1)(2008-3#2)
focal disease##4##2##(1991-2#3)(2013-1#1)
focal epidemics##4##2##(2008-10#4)
focal epilepsy##2##2##(1996-12#1)(2008-8#1)
focal epithelial hyperplasia##2##3##(1991-2#2)
focal hepatic lesion##3##3##(1997-8#3)
focal hepatic##4##2##(1997-8#4)
focal initiation##2##2##(1997-3#2)
focal ischaemia-reperfusion##2##2##(2008-7#2)
focal ischemia by##2##3##(2007-10#2)
focal ischemia was##2##3##(2007-10#2)
focal ischemia##8##2##(1997-2#1)(2007-10#6)(2008-4#1)
focal length in##2##3##(2008-2#1)(2008-3#1)
focal length of a##4##4##(2008-2#1)(2008-3#3)
focal length of##8##3##(2007-11#1)(2008-2#2)(2008-3#5)
focal length##18##2##(2007-11#1)(2008-2#5)(2008-3#12)
focal lengths of##2##3##(2007-12#2)
focal lengths##8##2##(2007-12#2)(2008-3#6)
focal lesions##2##2##(2008-7#1)(2012-2#1)
focal line##2##2##(2007-11#1)(2008-3#1)
focal liver lesions (FLLs)##2##4##(2010-12#2)
focal liver lesions in##3##4##(2010-12#3)
focal liver lesions##17##3##(2008-7#4)(2010-12#12)(2012-2#1)
focal liver##19##2##(2008-1#1)(2008-7#5)(2010-12#12)(2012-2#1)
focal motor##3##2##(1992-11#1)(2010-1#2)
focal neural lesions##2##3##(2011-2#2)
focal neural##4##2##(2007-8#1)(2011-2#3)
focal neurological##3##2##(1992-6#1)(1996-9#1)(2007-10#1)
focal nodular hyperplasia##2##3##(1990-9#1)(1993-5#1)
focal orientation discontinuities##2##3##(1995-11#2)
focal plane array##2##3##(2008-2#2)
focal plane is##2##3##(2007-12#1)(2008-3#1)
focal plane of the##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
focal plane of##8##3##(2007-11#1)(2007-12#1)(2008-3#6)
focal plane##28##2##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#16)(2008-4#1)(2011-2#1)
focal planes##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
focal point of the##5##4##(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
focal point of##9##3##(1992-3#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-3#3)
focal point##21##2##(1992-3#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#11)
focal position in the##2##4##(2007-11#1)(2008-2#1)
focal position in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
focal position is##2##3##(2007-12#1)(2008-3#1)
focal position##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2013-8#1)
focal positions in##2##3##(2008-3#2)
focal positions##4##2##(2008-3#4)
focal power##3##2##(2008-2#1)(2008-3#2)
focal region##17##2##(2007-11#3)(2007-12#3)(2008-3#11)
focal regions##3##2##(1997-8#1)(2008-2#2)
focal segmental glomerulosclerosis in##3##4##(2007-7#1)(2007-8#1)(2008-1#1)
focal segmental glomerulosclerosis##7##3##(2007-7#2)(2007-8#1)(2008-1#4)
focal segmental##8##2##(2007-7#3)(2007-8#1)(2008-1#4)
focal spot distribution##2##3##(2011-1#2)
focal spot##18##2##(2007-12#2)(2008-2#1)(2008-3#6)(2008-7#1)(2010-1#1)(2011-1#5)(2012-2#2)
focal to##2##2##(2008-5#1)(2012-2#1)
focal trees##2##2##(2008-10#2)
focal volume##5##2##(2008-2#2)(2008-3#2)(2012-2#1)
focal##357##1##(1990-6#1)(1990-9#2)(1991-2#5)(1992-11#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-11#1)(1996-12#5)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#5)(2007-10#9)(2007-11#12)(2007-12#17)(2007-7#6)(2007-8#3)(2008-1#10)(2008-10#16)(2008-11#3)(2008-2#22)(2008-3#87)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#24)(2008-8#5)(2008-9#4)(2009-10#2)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#12)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#18)(2012-12#7)(2012-2#14)(2012-3#7)(2013-1#6)(2013-8#5)
focal-length##4##1##(2008-10#1)(2008-3#3)
focal-plane array##3##2##(2008-2#2)(2008-3#1)
focal-plane arrays##4##2##(2008-2#3)(2008-3#1)
focal-plane##10##1##(2008-2#5)(2008-3#5)
focalized##4##1##(2008-10#4)
focally##10##1##(1990-2#1)(1991-6#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-5#2)(2010-12#1)(2013-1#1)(2013-7#1)
foci and##6##2##(1992-3#1)(2007-11#2)(2007-12#1)(2013-1#2)
foci are##6##2##(2007-11#3)(2007-2#2)(2008-9#1)
foci by##2##2##(2008-10#1)(2008-11#1)
foci enlarged##2##2##(2008-10#2)
foci in heated##2##3##(2011-2#2)
foci in the lung##2##4##(2012-1#1)(2013-1#1)
foci in the##8##3##(1991-6#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
foci in##13##2##(1991-6#1)(1997-6#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
foci of infection##2##3##(2008-10#1)(2011-2#1)
foci of the##2##3##(2008-10#1)(2008-9#1)
foci of##21##2##(1993-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#2)(2011-2#3)(2012-3#1)(2013-1#2)
foci were##8##2##(1990-6#1)(1992-3#2)(2007-11#1)(2008-10#4)
foci##101##1##(1990-6#1)(1991-6#1)(1992-3#4)(1993-3#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-11#8)(2007-12#3)(2007-2#3)(2008-10#39)(2008-11#3)(2008-3#4)(2008-6#1)(2008-8#1)(2008-9#6)(2009-8#1)(2010-11#2)(2010-2#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#7)
focus a##2##2##(2007-11#1)(2007-12#1)
focus and a##2##3##(2007-12#1)(2008-10#1)
focus and##19##2##(1993-12#2)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#2)(2009-5#3)(2010-8#1)(2013-1#1)
focus at the##2##3##(2010-10#1)(2013-8#1)
focus attention on##3##3##(1992-2#1)(1996-1#1)(2007-7#1)
focus can be##2##3##(1993-12#1)(2008-3#1)
focus can##3##2##(1993-12#1)(1995-3#1)(2008-3#1)
focus for the##3##3##(1995-3#1)(2008-12#1)(2009-7#1)
focus for##11##2##(1995-3#2)(1996-3#1)(2008-11#1)(2008-12#2)(2008-4#2)(2009-7#1)(2011-2#1)(2012-2#1)
focus group and##2##3##(2012-12#1)(2013-1#1)
focus group approach##3##3##(2008-11#1)(2012-12#2)
focus group discussion##2##3##(2010-8#1)(2013-1#1)
focus group discussions (N =##2##5##(2010-2#1)(2012-2#1)
focus group discussions with##2##4##(2007-7#1)(2009-6#1)
focus group discussions##14##3##(2007-7#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
focus group interview##3##3##(1992-2#1)(2008-11#2)
focus group interviews were conducted and data##2##7##(2008-11#1)(2012-3#1)
focus group interviews with##2##4##(2010-10#1)(2011-2#1)
focus group interviews##10##3##(2008-11#3)(2008-12#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
focus group study was to##2##5##(2008-9#1)(2010-5#1)
focus group study##5##3##(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
focus group transcripts##2##3##(1997-3#1)(2011-1#1)
focus group##47##2##(1992-2#1)(1996-2#1)(1997-3#1)(2007-7#2)(2008-11#9)(2008-12#4)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
focus groups and##5##3##(2008-12#1)(2008-6#1)(2010-10#1)(2012-3#2)
focus groups of##2##3##(2008-11#1)(2008-7#1)
focus groups to##4##3##(1994-12#1)(1997-3#1)(2008-10#1)(2010-5#1)
focus groups were##5##3##(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
focus groups with##3##3##(2009-5#2)(2011-1#1)
focus groups##48##2##(1991-12#1)(1994-12#2)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#4)(2007-10#1)(2008-10#1)(2008-11#6)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#3)(2010-10#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#7)(2013-1#1)
focus has been on##3##4##(1996-2#1)(2012-12#1)(2013-1#1)
focus has been##8##3##(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
focus has shifted to use of##2##6##(2007-11#1)(2013-1#1)
focus has shifted##3##3##(1995-12#1)(2007-11#1)(2013-1#1)
focus has##11##2##(1995-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
focus in the##4##3##(1997-4#1)(2008-11#1)(2009-1#1)(2011-2#1)
focus in##15##2##(1991-9#1)(1992-2#1)(1996-1#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
focus is on the##4##4##(2008-11#2)(2008-3#1)(2011-2#1)
focus is on##13##3##(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
focus is to##3##3##(1997-3#1)(2009-3#1)(2012-2#1)
focus is##23##2##(1994-1#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#4)(2008-9#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)
focus measure##3##2##(2008-2#3)
focus more##5##2##(1997-1#1)(2007-7#1)(2008-11#2)(2012-2#1)
focus of attention in##2##4##(1997-2#1)(2008-12#1)
focus of attention##7##3##(1997-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-7#1)(2013-1#2)
focus of current interest##2##4##(2008-5#1)(2008-7#1)
focus of health care##3##4##(1994-3#3)
focus of intense##5##3##(2008-6#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)
focus of interest##3##3##(2007-5#1)(2008-7#1)(2013-1#1)
focus of investigation##2##3##(1997-4#1)(2008-9#1)
focus of research##3##3##(1997-1#1)(2007-7#1)(2008-9#1)
focus of study##2##3##(2007-2#1)(2008-12#1)
focus of the objective lens##2##5##(2008-2#1)(2008-3#1)
focus of the##23##3##(1991-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
focus of this article is on##2##6##(2008-10#1)(2010-2#1)
focus of this article is the##2##6##(1996-2#1)(2008-11#1)
focus of this article is to##2##6##(2008-1#1)(2012-2#1)
focus of this article is##7##5##(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-2#2)
focus of this review is on##2##6##(2008-10#1)(2011-1#1)
focus of this review is to illustrate the##2##8##(2008-7#1)(2012-2#1)
focus of this review is to##3##6##(2008-1#1)(2008-7#1)(2012-2#1)
focus of this review is##6##5##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
focus of this review will be on##2##7##(2008-6#1)(2011-1#1)
focus of this review##15##4##(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)
focus of this study##4##4##(1992-2#1)(2008-11#1)(2009-6#1)(2010-10#1)
focus of this##36##3##(1992-12#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
focus of##132##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1994-2#1)(1994-3#5)(1995-1#2)(1995-12#2)(1995-6#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#5)(2008-1#3)(2008-10#7)(2008-11#9)(2008-12#6)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#1)
focus on a specific##2##4##(1994-12#1)(2008-9#1)
focus on a##11##3##(1994-12#1)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
focus on and##2##3##(2007-11#1)(2011-2#1)
focus on current##2##3##(2008-7#1)(2013-8#1)
focus on efficacy##2##3##(2008-5#1)(2010-8#1)
focus on evaluating the##2##4##(1991-12#1)(2008-3#1)
focus on health promotion##2##4##(2008-1#1)(2008-12#1)
focus on health##5##3##(1995-3#1)(1996-3#1)(2008-1#2)(2008-12#1)
focus on helping parents##2##4##(1993-1#1)(1994-1#1)
focus on helping##3##3##(1993-1#1)(1994-1#1)(2012-12#1)
focus on how##6##3##(1996-2#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2012-12#1)
focus on identifying##2##3##(2012-1#1)(2012-3#1)
focus on improving##2##3##(1991-6#1)(2010-7#1)
focus on maximizing##2##3##(1994-12#1)(2008-1#1)
focus on prevention##2##3##(1991-3#1)(1994-12#1)
focus on recent##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
focus on research##2##3##(2008-3#1)(2008-7#1)
focus on some##3##3##(1997-3#1)(2008-7#1)(2009-4#1)
focus on the care##2##4##(1996-1#1)(2010-8#1)
focus on the cellular##2##4##(2008-7#1)(2009-12#1)
focus on the contribution of##2##5##(2008-11#1)(2008-7#1)
focus on the dynamics##2##4##(2008-10#1)(2013-8#1)
focus on the effects of##3##5##(1994-2#1)(2008-11#2)
focus on the effects##4##4##(1994-2#1)(2008-10#1)(2008-11#2)
focus on the following##3##4##(1996-3#1)(2008-1#1)(2008-3#1)
focus on the goals##2##4##(1994-1#1)(1994-3#1)
focus on the link between##2##5##(2010-1#2)
focus on the needs of##2##5##(1993-12#1)(1996-1#1)
focus on the potential##2##4##(2008-11#1)(2012-12#1)
focus on the recent##2##4##(1994-12#1)(2011-2#1)
focus on the results of##2##5##(2008-7#1)(2010-12#1)
focus on the role of##2##5##(2011-2#1)(2013-1#1)
focus on the role##4##4##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
focus on the use of##4##5##(2008-10#2)(2008-11#1)(2008-3#1)
focus on the##110##3##(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-3#2)(1997-3#1)(1997-8#1)(2008-1#3)(2008-10#8)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
focus on their##2##3##(2008-10#1)(2011-2#1)
focus on these issues##2##4##(1993-3#1)(2009-12#1)
focus on these##3##3##(1993-3#1)(2009-12#1)(2010-3#1)
focus on##347##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#4)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#1)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1996-1#2)(1996-11#1)(1996-2#4)(1996-3#4)(1996-6#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#14)(2008-10#17)(2008-11#19)(2008-12#7)(2008-2#4)(2008-3#14)(2008-4#6)(2008-5#5)(2008-7#16)(2008-8#14)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#9)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#3)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#11)(2011-10#1)(2011-2#18)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#8)(2012-3#5)(2012-6#1)(2013-1#15)(2013-7#1)(2013-8#10)
focus specifically on##2##3##(2008-12#1)(2008-8#1)
focus than##3##2##(2008-10#1)(2008-3#2)
focus that##3##2##(2007-12#2)(2010-12#1)
focus the##5##2##(2007-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#1)
focus their attention##3##3##(1993-6#1)(2008-12#1)(2008-7#1)
focus their##7##2##(1992-12#1)(1993-6#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
focus to##5##2##(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(2009-9#1)
focus was a##2##3##(1990-3#1)(2008-11#1)
focus was on##2##3##(2009-4#1)(2012-12#1)
focus was to##2##3##(2011-2#1)(2012-12#1)
focus was##14##2##(1990-3#1)(1993-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)
focus wave##3##2##(2007-11#3)
focus which##3##2##(1991-12#1)(1994-2#1)(1997-1#1)
focus while##2##2##(2008-11#1)(2008-3#1)
focus will be on the##2##5##(2008-4#1)(2010-11#1)
focus will be on##3##4##(2008-11#1)(2008-4#1)(2010-11#1)
focus with a##2##3##(2008-10#1)(2008-2#1)
focus with##3##2##(2008-10#2)(2008-2#1)
focus within##2##2##(1997-2#1)(2008-11#1)
focus would##2##2##(2008-11#1)(2009-3#1)
focus##859##1##(1990-11#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#3)(1991-12#8)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-6#1)(1993-1#3)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#11)(1994-2#9)(1994-3#11)(1994-5#1)(1994-9#1)(1995-1#7)(1995-11#1)(1995-12#9)(1995-2#3)(1995-3#7)(1995-6#1)(1996-1#9)(1996-11#1)(1996-2#8)(1996-3#11)(1996-6#1)(1997-1#6)(1997-2#11)(1997-3#11)(1997-4#4)(1997-8#1)(2007-10#4)(2007-11#16)(2007-12#18)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#10)(2007-8#1)(2008-1#20)(2008-10#49)(2008-11#61)(2008-12#29)(2008-2#21)(2008-3#47)(2008-4#15)(2008-5#16)(2008-6#6)(2008-7#28)(2008-8#19)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#20)(2009-6#10)(2009-7#5)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#12)(2010-11#6)(2010-12#4)(2010-2#3)(2010-3#7)(2010-4#2)(2010-5#7)(2010-6#3)(2010-7#6)(2010-8#7)(2010-9#3)(2011-1#22)(2011-10#1)(2011-2#37)(2011-3#1)(2012-1#5)(2012-12#18)(2012-2#21)(2012-3#16)(2012-6#1)(2013-1#30)(2013-7#2)(2013-8#13)
focus)##5##1##(2007-12#1)(2008-3#1)(2008-6#2)(2009-6#1)
focus-error##3##1##(2008-2#3)
focus-grid##2##1##(2008-2#2)
focus]##2##1##(1990-6#1)(1997-4#1)
focused 800-nm##2##2##(2007-12#1)(2008-3#1)
focused Gaussian beam##4##3##(2008-2#1)(2008-3#3)
focused Gaussian beams##2##3##(2007-12#1)(2008-3#1)
focused Gaussian##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
focused almost exclusively on##2##4##(1993-3#1)(2013-8#1)
focused and##3##2##(1994-12#1)(2008-1#1)(2008-3#1)
focused approach##2##2##(1992-3#1)(2008-7#1)
focused as##2##2##(1995-2#1)(2012-12#1)
focused at the##2##3##(2008-11#1)(2008-2#1)
focused at##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
focused attention on##3##3##(1992-12#1)(1995-12#1)(2006-10#1)
focused attention to##2##3##(1994-2#1)(1995-5#1)
focused attention##6##2##(1992-12#1)(1994-2#1)(1995-12#1)(1995-5#2)(2006-10#1)
focused beam##9##2##(2007-11#3)(2008-2#2)(2008-3#4)
focused beams in##2##3##(2007-11#1)(2008-3#1)
focused beams##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
focused by a##2##3##(2007-11#1)(2008-2#1)
focused by##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
focused care##14##2##(1993-1#1)(1993-2#4)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#3)
focused femtosecond laser##2##3##(2007-12#1)(2011-1#1)
focused femtosecond##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2011-1#1)
focused in##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
focused intensity##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
focused into a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
focused into##5##2##(2007-12#1)(2008-10#1)(2008-3#3)
focused ion beam##2##3##(2008-10#2)
focused irradiation of infrared femtosecond laser pulses##2##7##(2007-12#2)
focused laser beam##8##3##(2008-2#2)(2008-3#3)(2009-5#2)(2011-1#1)
focused laser light##2##3##(2008-3#1)(2008-5#1)
focused laser##13##2##(2007-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2009-5#2)(2011-1#1)
focused mainly on the##2##4##(2008-10#2)
focused mainly on##5##3##(1993-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
focused microwave##15##2##(2008-10#15)
focused microwave-assisted##4##2##(2008-10#4)
focused on &quot##2##3##(1994-2#1)(2008-4#1)
focused on a##5##3##(1997-2#1)(2007-12#1)(2008-3#1)(2009-8#1)(2013-1#1)
focused on adults##2##3##(2012-2#1)(2013-1#1)
focused on both##2##3##(2011-2#1)(2012-2#1)
focused on drug##2##3##(2008-11#1)(2010-2#1)
focused on early##2##3##(1997-3#1)(2012-2#1)
focused on how##4##3##(1996-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
focused on improving##2##3##(2010-8#1)(2010-9#1)
focused on management from the perspective of##2##7##(2008-1#2)
focused on modifying##2##3##(2009-11#1)(2012-2#1)
focused on other traffic-related actors##2##5##(2011-2#2)
focused on prevention##2##3##(2007-7#2)
focused on the identification of##2##5##(1997-4#1)(2011-1#1)
focused on the role of##7##5##(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
focused on the role##8##4##(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
focused on the use of##3##5##(1997-4#1)(2011-7#1)(2013-1#1)
focused on the##98##3##(1990-8#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#10)
focused on these##5##3##(1991-5#1)(1993-1#1)(1996-3#1)(2008-11#1)(2012-2#1)
focused on uncovering##2##3##(2006-10#1)(2008-5#1)
focused on understanding##2##3##(2009-7#1)(2010-3#1)
focused on younger##2##3##(2012-12#2)
focused on##282##2##(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#31)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#19)(2011-7#1)(2011-9#1)(2012-1#3)(2012-12#3)(2012-2#10)(2012-3#7)(2013-1#23)(2013-7#1)(2013-8#3)
focused onto##3##2##(2008-2#3)
focused primarily on##5##3##(1990-12#1)(1995-12#1)(1996-2#1)(2008-3#1)(2012-2#1)
focused spot##8##2##(2007-11#3)(2008-2#3)(2008-3#2)
focused the##2##2##(1995-2#1)(2008-3#1)
focused their##3##2##(2008-10#1)(2009-1#1)(2012-12#1)
focused to a##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
focused to##8##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
focused ultrasound (TFU)##2##3##(2008-10#2)
focused ultrasound##10##2##(2007-12#1)(2008-10#7)(2011-2#1)(2013-1#1)
focused upon##5##2##(1991-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2013-1#1)
focused with##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
focused##554##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#5)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#7)(1996-3#5)(1996-4#1)(1996-6#1)(1997-1#6)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#21)(2007-12#24)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#10)(2008-10#73)(2008-11#16)(2008-12#4)(2008-2#28)(2008-3#64)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#2)(2010-10#4)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-2#25)(2011-7#1)(2011-9#1)(2012-1#3)(2012-12#6)(2012-2#13)(2012-3#8)(2013-1#26)(2013-7#1)(2013-8#5)
focused-ion-beam milling##3##2##(2008-3#3)
focused-microwave##2##1##(2008-10#2)
focuses attention on the##2##4##(1993-9#1)(2008-4#1)
focuses attention on##4##3##(1993-9#1)(2008-4#1)(2011-1#1)(2012-2#1)
focuses of##3##2##(2007-8#1)(2008-2#1)(2013-8#1)
focuses on &quot##2##3##(2008-4#1)(2010-1#1)
focuses on a##3##3##(1995-12#1)(2011-1#1)(2012-12#1)
focuses on biological##2##3##(2008-7#1)(2011-2#1)
focuses on clinical##2##3##(2006-12#1)(2012-3#1)
focuses on how##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
focuses on improving##2##3##(1996-2#1)(2007-2#1)
focuses on issues##3##3##(1996-2#1)(1997-1#1)(2009-11#1)
focuses on key##2##3##(1996-12#1)(2008-1#1)
focuses on methods##2##3##(2008-1#1)(2010-9#1)
focuses on our##2##3##(2009-10#1)(2009-3#1)
focuses on recent##4##3##(1990-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
focuses on some of the##2##5##(1992-12#1)(2010-12#1)
focuses on some##4##3##(1992-12#1)(2008-4#1)(2010-12#1)(2011-2#1)
focuses on the application of##3##5##(2007-4#1)(2008-10#1)(2011-2#1)
focuses on the construction##2##4##(2008-4#1)(2010-8#1)
focuses on the development of##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
focuses on the different##2##4##(1991-2#1)(2008-7#1)
focuses on the effect of##3##5##(1995-9#1)(2008-10#1)(2008-5#1)
focuses on the identification of##2##5##(1991-12#1)(2008-7#1)
focuses on the importance of##2##5##(1992-12#1)(2010-12#1)
focuses on the issue of##2##5##(2009-10#2)
focuses on the key##2##4##(1991-7#1)(2010-12#1)
focuses on the practical##2##4##(2008-11#1)(2008-4#1)
focuses on the recent advances in##2##6##(2012-12#1)(2012-2#1)
focuses on the recent advances##3##5##(2012-12#1)(2012-2#1)(2012-3#1)
focuses on the recent##5##4##(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
focuses on the role of##2##5##(2008-10#1)(2012-2#1)
focuses on the role##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
focuses on the safety##2##4##(1992-2#1)(1993-12#1)
focuses on the strengths##2##4##(2008-10#1)(2012-2#1)
focuses on the use of##3##5##(2008-11#1)(2008-7#1)(2013-1#1)
focuses on the##117##3##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1995-2#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#1)
focuses on those##2##3##(2008-12#1)(2008-8#1)
focuses on three##2##3##(1991-1#1)(2008-1#1)
focuses on two##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
focuses on##230##2##(1990-11#2)(1990-6#2)(1991-1#3)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#9)(2008-10#16)(2008-11#11)(2008-12#6)(2008-3#5)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#5)(2009-11#4)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#1)(2013-8#2)
focuses particularly on##2##3##(2008-3#1)(2009-5#1)
focuses primarily on##2##3##(1996-1#1)(2008-10#1)
focuses the##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
focuses upon##5##2##(1991-2#1)(1997-2#2)(2008-11#1)(2008-7#1)
focuses##263##1##(1990-11#2)(1990-6#2)(1991-1#3)(1991-12#1)(1991-2#4)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#18)(2008-11#13)(2008-12#6)(2008-2#3)(2008-3#8)(2008-4#13)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#6)(2009-10#5)(2009-11#4)(2009-12#1)(2009-3#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#9)(2013-1#2)(2013-8#3)
focusing (IEF)##5##2##(1990-12#1)(1993-8#1)(2008-11#2)(2008-4#1)
focusing and##9##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)
focusing attention on the##2##4##(1993-8#1)(2012-12#1)
focusing attention##3##2##(1993-8#1)(2012-12#1)(2012-2#1)
focusing based on fringe pattern matching##2##6##(2008-2#2)
focusing based on##3##3##(2008-2#3)
focusing conditions##3##2##(2007-12#2)(2008-3#1)
focusing depth##2##2##(2007-11#2)
focusing effect##4##2##(2008-10#1)(2008-3#3)
focusing in##3##2##(2007-12#1)(2008-3#2)
focusing into##2##2##(2008-3#2)
focusing is##2##2##(2008-3#1)(2011-1#1)
focusing lens##5##2##(2008-3#5)
focusing mainly on##3##3##(1996-3#1)(2008-10#1)(2011-1#1)
focusing of femtosecond##2##3##(2007-11#2)
focusing of the laser beam##2##5##(2007-11#1)(2008-10#1)
focusing of the##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
focusing of##18##2##(1991-12#1)(2007-11#6)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-8#1)
focusing on a##2##3##(2008-3#1)(2008-7#1)
focusing on clinical##2##3##(1997-2#1)(2008-4#1)
focusing on incidence##2##3##(2009-12#1)(2013-1#1)
focusing on problems##2##3##(1994-3#1)(1997-3#1)
focusing on quality##2##3##(2007-5#1)(2008-10#1)
focusing on specific##2##3##(2013-1#1)(2013-8#1)
focusing on studies##2##3##(2008-11#1)(2012-12#1)
focusing on the development of##3##5##(1992-2#1)(2008-10#1)(2008-9#1)
focusing on the##32##3##(1992-2#2)(1993-1#1)(1993-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
focusing on their##3##3##(2008-5#1)(2009-12#1)(2012-2#1)
focusing on this##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
focusing on##123##2##(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#2)(2008-1#3)(2008-10#7)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#4)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
focusing properties of##3##3##(2008-3#3)
focusing properties##4##2##(2008-3#4)
focusing the radiation on the##2##5##(2008-3#2)
focusing the##8##2##(1991-1#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-3#3)
focusing was##3##2##(2008-10#2)(2008-3#1)
focusing with a##3##3##(2007-11#1)(2008-3#2)
focusing with high-numerical-aperture##2##3##(2007-12#1)(2008-3#1)
focusing with##7##2##(1992-11#1)(2007-11#2)(2007-12#1)(2008-3#3)
focusing##275##1##(1990-12#1)(1991-1#2)(1991-12#3)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#23)(2007-12#13)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#21)(2008-11#11)(2008-12#1)(2008-2#19)(2008-3#47)(2008-4#11)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#5)(2010-10#3)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#4)
focussed microwave system##2##3##(2008-10#2)
focussed on how##2##3##(2009-8#1)(2010-9#1)
focussed on the##4##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)
focussed on##12##2##(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-9#3)(2013-8#1)
focussed##22##1##(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-7#1)(2009-8#1)(2010-9#3)(2013-8#1)
focusses on the##2##3##(2008-9#1)(2011-2#1)
focussing on##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2013-1#1)
focussing##7##1##(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-12#1)(2013-1#1)
fodrin##3##1##(2011-1#3)
foe?##3##1##(1991-12#1)(1996-3#1)(2013-8#1)
foes##2##1##(2007-4#1)(2008-7#1)
foetal MRI##3##2##(2012-2#3)
foetal bovine##2##2##(1993-3#1)(2008-11#1)
foetal bradycardia##3##2##(1992-5#2)(2011-2#1)
foetal death##4##2##(1991-9#1)(1996-11#1)(2008-4#1)(2012-2#1)
foetal deaths##2##2##(2008-4#1)(2008-7#1)
foetal exon##2##2##(2008-7#2)
foetal haemoglobin (HbF)##2##3##(2009-3#1)(2009-4#1)
foetal haemoglobin##4##2##(2009-3#2)(2009-4#2)
foetal liver##4##2##(1990-5#1)(2008-10#3)
foetal morbidity##2##2##(1991-9#1)(2008-7#1)
foetal mortality##2##2##(1991-9#1)(2007-2#1)
foetal outcome in##2##3##(1995-6#1)(2010-11#1)
foetal outcome##4##2##(1995-6#1)(2008-7#1)(2010-11#1)(2011-1#1)
foetal##58##1##(1990-5#3)(1990-9#1)(1991-9#3)(1992-5#3)(1993-3#1)(1993-6#3)(1994-6#1)(1995-6#2)(1995-8#1)(1996-11#3)(1996-3#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-4#4)(2008-5#2)(2008-7#5)(2009-3#2)(2009-4#2)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#5)(2013-1#1)
foetidus##2##1##(1990-9#1)(2008-6#1)
foeto-maternal##2##1##(2009-1#1)(2009-3#1)
foetus and##3##2##(1993-6#1)(2008-5#2)
foetus##26##1##(1990-5#1)(1991-9#2)(1992-4#5)(1992-5#2)(1993-6#4)(1996-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#3)(2008-7#3)(2009-8#1)(2011-2#1)
foetuses##8##1##(1990-5#1)(1990-7#3)(2008-11#3)(2009-3#1)
fog##6##1##(1997-1#1)(2008-10#3)(2008-3#2)
fogs##2##1##(2008-3#2)
foil##11##1##(2008-1#1)(2008-10#2)(2008-3#5)(2009-11#3)
foils##9##1##(1997-6#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)
folate and 5dfol##2##3##(1995-2#2)
folate and vitamin##3##3##(1992-9#1)(2008-3#2)
folate and##6##2##(1992-9#1)(1995-2#2)(2008-3#2)(2009-8#1)
folate as##2##2##(2008-7#2)
folate deficiency##8##2##(1992-9#3)(1993-6#2)(2008-7#3)
folate intake##2##2##(1997-5#1)(1997-8#1)
folate level##3##2##(1993-12#2)(2008-7#1)
folate levels in the##2##4##(2008-7#2)
folate levels in##5##3##(1992-9#3)(2008-7#2)
folate levels##7##2##(1992-9#4)(2008-7#3)
folate on##2##2##(1992-10#1)(1992-9#1)
folate receptor##3##2##(1994-6#2)(2011-1#1)
folate supplementation##3##2##(1992-9#2)(2008-7#1)
folate synthesis##3##2##(2011-2#3)
folate transporter##3##2##(1994-6#3)
folate turnover##2##2##(1992-9#1)(2011-2#1)
folate##81##1##(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#16)(1993-12#5)(1993-6#3)(1994-6#8)(1995-2#7)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-3#4)(2008-7#13)(2009-12#2)(2009-3#1)(2009-8#3)(2011-1#2)(2011-2#6)(2012-3#1)(2013-8#2)
folate-conjugated and##2##2##(2012-12#2)
folate-mediated##3##1##(1992-10#2)(2012-2#1)
folate-receptor-overexpressing##2##1##(2012-12#2)
folates##6##1##(1990-2#1)(1997-5#1)(2011-2#2)(2012-2#2)
fold after##3##2##(1990-5#1)(1994-11#1)(2008-11#1)
fold and##9##2##(1995-5#1)(2008-10#1)(2008-5#5)(2011-2#2)
fold compared to that##2##4##(2008-11#2)
fold compared to##3##3##(2008-11#3)
fold comprising##2##2##(2010-10#2)
fold higher concentrations##2##3##(2008-11#2)
fold higher in##2##3##(1990-8#1)(2008-6#1)
fold higher than that##3##4##(1992-3#1)(1993-8#1)(1994-6#1)
fold higher than the##2##4##(1993-8#1)(2011-2#1)
fold higher than##5##3##(1992-3#1)(1993-8#2)(1994-6#1)(2011-2#1)
fold higher##13##2##(1990-7#1)(1990-8#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(2008-11#3)(2008-6#1)(2011-2#1)
fold in the##3##3##(1990-8#1)(1993-12#1)(2008-5#1)
fold in##6##2##(1990-8#1)(1993-12#1)(1993-9#1)(1996-12#1)(2008-5#1)(2012-2#1)
fold increase in the dissolution rate of mefenamic acid##2##9##(2012-2#2)
fold increase in the##6##4##(1990-2#1)(1992-8#1)(1996-5#1)(2008-10#1)(2012-2#2)
fold increase in##10##3##(1990-2#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2012-2#2)
fold increase##13##2##(1990-2#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-8#1)(1996-5#1)(2008-10#1)(2008-11#2)(2011-2#2)(2012-2#2)
fold into##2##2##(2008-7#1)(2008-9#1)
fold lower##3##2##(1990-12#1)(1990-8#1)(2008-10#1)
fold more##2##2##(1991-2#1)(1993-6#1)
fold of the##3##3##(1990-8#1)(1993-11#1)(1995-8#1)
fold of##8##2##(1990-8#1)(1992-8#1)(1993-11#2)(1994-5#1)(1995-5#1)(1995-8#1)(2008-4#1)
fold over##2##2##(1993-8#2)
fold range##2##2##(1996-12#1)(2008-2#1)
fold stimulation of##2##3##(1990-12#1)(1991-2#1)
fold stimulation##3##2##(1990-12#1)(1990-8#1)(1991-2#1)
fold to##2##2##(1993-11#1)(1997-2#1)
fold with a##2##3##(1993-8#1)(2010-10#1)
fold with##4##2##(1993-8#1)(2008-10#1)(2010-10#2)
fold##146##1##(1990-12#3)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#5)(1991-2#3)(1991-4#1)(1991-5#2)(1992-3#2)(1992-7#2)(1992-8#4)(1993-11#3)(1993-12#2)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#3)(1995-8#1)(1996-12#2)(1996-5#2)(1997-2#2)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#16)(2008-2#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#6)(2010-5#2)(2011-2#6)(2011-3#1)(2012-2#9)(2013-1#3)
fold)##2##1##(1994-12#1)(2008-4#1)
foldable##2##1##(2011-2#1)(2013-1#1)
foldase mimics##2##2##(2011-2#2)
folded MIN##2##2##(2008-2#2)
folded and 8 M urea-denatured state of SUMO from Drosophila melanogaster##2##11##(2009-7#2)
folded and##6##2##(1993-11#1)(1995-5#1)(1997-4#1)(2009-7#2)(2010-5#1)
folded as##2##2##(1991-5#1)(2008-4#1)
folded design##2##2##(2008-2#1)(2008-3#1)
folded into##2##2##(2008-10#1)(2008-7#1)
folded or unfolded##2##3##(1993-11#1)(2008-4#1)
folded protein##3##2##(1993-11#1)(1995-2#1)(1997-2#1)
folded proteins##2##2##(1995-2#1)(2013-1#1)
folded reversal##2##2##(2008-3#2)
folded##61##1##(1990-5#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-11#4)(1993-9#1)(1994-3#1)(1995-2#4)(1995-5#2)(1997-2#6)(1997-4#2)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#11)(2008-4#4)(2008-7#3)(2009-7#3)(2009-9#2)(2010-5#1)(2012-2#1)(2013-1#4)
folders##2##1##(2008-11#1)(2008-12#1)
folding and assembly##3##3##(1994-11#1)(1994-12#1)(1994-8#1)
folding and maturation of##3##4##(2009-6#2)(2010-4#1)
folding and oxidation##3##3##(2008-1#3)
folding and##25##2##(1991-6#2)(1991-9#1)(1994-11#2)(1994-12#2)(1994-8#1)(2008-1#3)(2008-10#1)(2008-4#6)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-4#1)
folding are##2##2##(1992-5#1)(1993-8#1)
folding behavior##3##2##(2008-9#3)
folding by##2##2##(2008-1#1)(2009-8#1)
folding can be##2##3##(2008-1#1)(2011-2#1)
folding can##3##2##(2008-1#1)(2010-4#1)(2011-2#1)
folding catalysts##2##2##(2008-7#2)
folding from the##2##3##(1992-5#2)
folding in##2##2##(1990-7#1)(1992-10#1)
folding intermediate##2##2##(1992-3#1)(1992-6#1)
folding intermediates##6##2##(1990-7#1)(1992-3#1)(1993-11#1)(1997-4#2)(2008-4#1)
folding into##2##2##(1995-2#1)(2006-12#1)
folding is##3##2##(1992-3#1)(2007-12#1)(2009-9#1)
folding kinetics##2##2##(2008-9#1)(2010-5#1)
folding leaf##2##2##(2008-8#2)
folding leaves##2##2##(2008-8#2)
folding of a##2##3##(1992-6#1)(1997-2#1)
folding of the##5##3##(1990-12#1)(1992-6#1)(1995-3#1)(2007-11#1)(2008-7#1)
folding of this##2##3##(1993-2#1)(1997-6#1)
folding of##17##2##(1990-12#1)(1992-6#3)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-4#1)
folding or assembly##2##3##(1994-12#2)
folding or##3##2##(1993-11#1)(1994-12#2)
folding process##4##2##(1991-6#2)(2007-11#1)(2008-1#1)
folding reactions##3##2##(1992-6#3)
folding stage##2##2##(2008-8#2)
folding units##2##2##(1993-8#1)(1997-6#1)
folding##156##1##(1990-12#1)(1990-5#1)(1990-7#4)(1991-6#6)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#9)(1992-5#6)(1992-6#10)(1993-11#4)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#6)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1997-2#3)(1997-4#2)(1997-6#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#8)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#14)(2008-5#1)(2008-7#7)(2008-8#9)(2008-9#5)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#4)(2010-4#7)(2010-5#2)(2011-2#3)(2012-2#2)
folds and the##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
folds and##8##2##(1994-8#1)(1995-3#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
folds for##2##2##(2008-11#1)(2012-1#1)
folds in the##2##3##(2007-12#1)(2008-4#1)
folds in##3##2##(1991-11#1)(2007-12#1)(2008-4#1)
folds into a##2##3##(1995-2#1)(2008-11#1)
folds into##6##2##(1995-2#1)(1997-4#2)(2008-11#1)(2008-4#1)(2008-9#1)
folds or##2##2##(1997-3#1)(2009-5#1)
folds to##2##2##(1992-6#1)(2012-2#1)
folds##51##1##(1990-7#1)(1990-8#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-8#1)(1995-2#1)(1995-3#2)(1997-3#1)(1997-4#2)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#6)(2013-1#1)
foliaceus##5##1##(1991-12#1)(2009-5#4)
foliage and##3##2##(2008-10#3)
foliage infection##2##2##(2008-10#2)
foliage mass##2##2##(2012-9#2)
foliage may##2##2##(2008-10#2)
foliage of##5##2##(2008-10#4)(2010-6#1)
foliage to##2##2##(2008-10#2)
foliage was##2##2##(2008-10#2)
foliage were##2##2##(2008-10#2)
foliage##47##1##(2008-10#42)(2008-5#1)(2010-6#1)(2011-2#1)(2012-9#2)
foliage-inoculated plants##2##2##(2008-10#2)
foliar SDS severity##3##3##(2008-10#3)
foliar SDS symptoms##2##3##(2008-10#2)
foliar SDS##5##2##(2008-10#5)
foliar and##5##2##(2008-10#5)
foliar application of##5##3##(2008-10#5)
foliar blight##2##2##(2008-10#2)
foliar disease in##3##3##(2008-10#2)(2012-3#1)
foliar disease of##3##3##(2008-10#3)
foliar disease##11##2##(2008-10#10)(2012-3#1)
foliar diseases of barley in the##2##6##(2008-10#2)
foliar diseases of##6##3##(2008-10#6)
foliar diseases##11##2##(2008-10#11)
foliar epidemics##2##2##(2008-10#2)
foliar pathogens##2##2##(2008-10#1)(2013-8#1)
foliar spray and##2##3##(2008-10#2)
foliar spray of##2##3##(2008-10#2)
foliar spray##6##2##(2008-10#5)(2011-2#1)
foliar symptoms and##2##3##(2008-10#2)
foliar symptoms of##2##3##(2008-10#2)
foliar symptoms##9##2##(2008-10#9)
foliar terpene##2##2##(2011-10#2)
foliar##87##1##(2008-10#75)(2008-12#3)(2008-8#2)(2011-10#3)(2011-2#1)(2012-3#1)(2013-8#2)
foliar-drench##2##1##(2008-10#2)
folic acid (FA)##2##3##(2009-7#1)(2009-8#1)
folic acid in##3##3##(1992-9#1)(2008-7#1)(2009-8#1)
folic acid intake##2##3##(2010-1#1)(2012-1#1)
folic acid##29##2##(1992-9#4)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-5#3)(2011-1#1)(2012-1#4)(2013-8#2)
folic##31##1##(1992-9#4)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#2)(2010-1#3)(2010-5#4)(2011-1#1)(2012-1#4)(2013-8#2)
folimycin##3##1##(1993-6#3)
folinic acid in##2##3##(1992-2#1)(1993-12#1)
folinic acid##10##2##(1992-2#2)(1992-8#2)(1993-12#1)(2006-10#1)(2007-10#1)(2008-10#2)(2012-2#1)
folk medicinal##2##2##(2008-12#1)(2008-9#1)
folk medicine since##2##3##(2008-10#2)
folk medicine##3##2##(2008-10#2)(2010-5#1)
folk remedy for##2##3##(2008-10#1)(2011-1#1)
folk##13##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#4)(2010-5#1)(2011-1#1)
folklore##5##1##(2009-10#3)(2010-3#1)(2013-7#1)
follicle cells at the anterior pole##2##6##(2007-12#2)
follicle cells in##4##3##(2008-6#2)(2008-7#2)
follicle cells of##4##3##(2008-6#2)(2008-7#2)
follicle cells##17##2##(1991-5#1)(2007-12#4)(2008-6#6)(2008-7#5)(2012-2#1)
follicle epithelium##2##2##(2008-5#1)(2008-9#1)
follicle has##2##2##(1991-9#1)(2008-5#1)
follicle in the##2##3##(2008-12#1)(2012-3#1)
follicle in##3##2##(2008-12#1)(2008-5#1)(2012-3#1)
follicle is##2##2##(1990-8#1)(2011-2#1)
follicle stem##2##2##(2012-2#1)(2013-7#1)
follicle stimulating hormone (FSH) in##2##5##(1993-11#2)
follicle stimulating hormone (FSH)##5##4##(1990-11#1)(1993-11#2)(2011-2#1)(2012-2#1)
follicle stimulating hormone##6##3##(1990-11#1)(1993-11#2)(2007-7#1)(2011-2#1)(2012-2#1)
follicle with##2##2##(1994-7#1)(2008-12#1)
follicle without##2##2##(2008-5#1)(2012-3#1)
follicle##62##1##(1990-11#1)(1990-3#2)(1990-8#1)(1991-5#1)(1991-9#3)(1993-11#2)(1994-7#2)(1995-12#1)(2007-12#4)(2007-7#1)(2008-12#4)(2008-4#1)(2008-5#9)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#1)(2009-4#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
follicle-stimulating hormone (FSH)##3##3##(2010-5#2)(2011-1#1)
follicle-stimulating hormone##11##2##(1990-2#1)(1990-4#1)(1991-3#2)(2008-4#2)(2010-5#2)(2011-1#1)(2012-12#1)(2013-1#1)
follicles and##7##2##(1992-9#1)(2008-12#5)(2008-9#1)
follicles in##5##2##(1996-2#1)(2008-12#3)(2012-3#1)
follicles of##2##2##(1997-3#1)(2008-11#1)
follicles with##3##2##(2012-3#3)
follicles##81##1##(1990-9#1)(1992-9#1)(1994-7#1)(1995-12#6)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-11#5)(2008-12#25)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#11)(2008-9#6)(2009-4#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-3#7)(2013-7#1)
follicular atresia in##2##3##(2008-7#1)(2008-8#1)
follicular atresia was##2##3##(2008-7#1)(2008-8#1)
follicular atresia##8##2##(2008-7#5)(2008-8#3)
follicular cell hypertrophy##3##3##(2008-9#3)
follicular cell##5##2##(2008-12#1)(2008-9#3)(2012-1#1)
follicular cells##2##2##(2008-7#2)
follicular dendritic##3##2##(2009-4#1)(2011-1#2)
follicular development and atresia##2##4##(2008-8#1)(2010-3#1)
follicular development##3##2##(2008-8#2)(2010-3#1)
follicular epithelium##4##2##(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#1)
follicular fluid##6##2##(1990-12#2)(1991-12#1)(1991-9#1)(2007-10#1)(2012-3#1)
follicular growth##4##2##(2008-12#2)(2008-5#1)(2010-11#1)
follicular layer##2##2##(2008-12#1)(2008-6#1)
follicular lymphoma##2##2##(2010-11#2)
follicular lymphomas##2##2##(2009-4#1)(2010-11#1)
follicular maturation##3##2##(1990-9#2)(2010-8#1)
follicular neoplasia&quot##2##2##(1997-2#2)
follicular secretory depletion##2##3##(2008-9#2)
follicular thyroid##3##2##(1994-12#1)(2008-4#2)
follicular unit-like wigs##5##3##(2012-3#5)
follicular##83##1##(1990-10#1)(1990-12#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-12#2)(1995-12#2)(1997-2#2)(1997-5#1)(1997-6#4)(2007-10#2)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#5)(2009-4#2)(2009-8#1)(2010-11#4)(2010-3#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-2#1)(2012-3#8)
folliculitis##3##1##(2006-10#2)(2008-5#1)
folliculogenesis##2##1##(1995-12#1)(2008-12#1)
follistatin##4##1##(1992-6#2)(1992-8#1)(1994-11#1)
follow a linear##2##3##(2007-12#1)(2008-10#1)
follow a similar##2##3##(1994-8#1)(2007-12#1)
follow a##21##2##(1993-6#1)(1994-8#1)(1995-5#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
follow any##2##2##(2007-11#1)(2008-7#1)
follow established##2##2##(1993-1#1)(2008-6#1)
follow from##3##2##(1992-3#1)(1992-5#1)(1995-1#1)
follow general##2##2##(2009-7#1)(2011-2#1)
follow one of two##2##4##(2008-12#1)(2009-8#1)
follow the kinetics of the##2##5##(1995-9#1)(2008-10#1)
follow the kinetics of##3##4##(1995-9#1)(2008-10#2)
follow the movement of##2##4##(2008-1#1)(2008-10#1)
follow the patient's##2##3##(1994-12#1)(2012-12#1)
follow the same pattern as##2##5##(1991-12#1)(2008-10#1)
follow the same##4##3##(1991-12#1)(1997-2#1)(2007-12#1)(2008-10#1)
follow the trend##2##3##(1990-11#1)(2008-10#1)
follow the##67##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#2)(1992-11#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-9#1)(1996-5#1)(1997-2#2)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
follow their##3##2##(2008-11#1)(2010-10#1)(2013-1#1)
follow theoretical##2##2##(1995-2#1)(2007-11#1)
follow to##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
follow up after##2##3##(1990-8#1)(2013-8#1)
follow up and##2##3##(2010-8#1)(2011-2#1)
follow up are##2##3##(2012-3#2)
follow up for##2##3##(2007-8#1)(2013-8#1)
follow up in the##2##4##(2008-8#1)(2009-6#1)
follow up in##3##3##(2008-8#1)(2009-6#1)(2011-2#1)
follow up is##3##3##(2010-11#1)(2011-2#1)(2013-8#1)
follow up of 5##2##4##(1992-6#1)(2007-8#1)
follow up of##12##3##(1990-9#1)(1992-6#1)(1993-2#1)(1994-7#1)(1996-3#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
follow up period was##2##4##(2011-2#1)(2013-1#1)
follow up period##9##3##(1991-2#1)(1996-9#1)(2007-7#2)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#2)
follow up since##2##3##(2008-4#1)(2013-1#1)
follow up study##2##3##(2007-7#1)(2013-1#1)
follow up was##4##3##(2007-8#1)(2009-11#1)(2010-3#1)(2011-2#1)
follow up were##2##3##(2007-8#1)(2013-1#1)
follow up##102##2##(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-7#1)(1995-5#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#2)(2007-7#3)(2007-8#7)(2008-1#2)(2008-10#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#3)(2011-2#10)(2012-2#2)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#5)
follow##277##1##(1990-11#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#3)(2007-7#5)(2007-8#9)(2008-1#4)(2008-10#29)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#19)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#22)(2013-7#1)(2013-8#5)
follow-on study in##2##3##(2008-5#1)(2008-6#1)
follow-on study##3##2##(2008-5#1)(2008-6#2)
follow-on##4##1##(2008-10#1)(2008-5#1)(2008-6#2)
follow-up (mean##4##2##(1992-9#1)(1995-5#1)(2011-3#1)(2012-12#1)
follow-up (p##2##2##(1991-8#1)(2013-8#1)
follow-up MR##5##2##(1996-6#4)(2012-2#1)
follow-up MRI##2##2##(2012-2#1)(2013-8#1)
follow-up a##2##2##(2010-5#1)(2013-1#1)
follow-up after##11##2##(1990-3#1)(1992-1#1)(1993-1#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
follow-up among##2##2##(2008-6#1)(2012-12#1)
follow-up and prognostic##2##3##(1996-8#1)(1997-5#1)
follow-up and##21##2##(1992-9#2)(1996-8#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-8#1)
follow-up angiography##3##2##(1997-3#1)(2007-8#1)(2008-7#1)
follow-up appointment##4##2##(1994-3#1)(2008-4#1)(2013-1#2)
follow-up appointments##2##2##(2008-4#1)(2013-1#1)
follow-up are##4##2##(1992-4#1)(2008-10#1)(2011-2#1)(2012-12#1)
follow-up as##2##2##(2011-2#1)(2012-12#1)
follow-up assessment##3##2##(2007-2#1)(2008-11#1)(2008-7#1)
follow-up at##5##2##(1991-2#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
follow-up based on##2##3##(1992-6#1)(1994-11#1)
follow-up both##2##2##(1991-1#1)(2012-2#1)
follow-up care##4##2##(1996-1#1)(2009-10#1)(2013-1#2)
follow-up clinical##2##2##(2008-11#1)(2008-3#1)
follow-up data from##2##3##(1995-5#1)(2008-4#1)
follow-up data##6##2##(1992-6#1)(1995-5#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
follow-up duration was 11##2##4##(2008-10#1)(2013-8#1)
follow-up duration was##4##3##(2007-8#1)(2008-10#2)(2013-8#1)
follow-up evaluation##4##2##(2008-10#1)(2008-9#2)(2012-2#1)
follow-up evaluations##2##2##(1993-12#1)(1994-12#1)
follow-up examination of##2##3##(1990-11#1)(1992-2#1)
follow-up examination##8##2##(1990-11#2)(1992-2#1)(1992-5#1)(1996-9#1)(1997-3#1)(2008-7#2)
follow-up examinations##6##2##(1996-11#1)(1997-3#1)(2008-12#1)(2008-7#2)(2008-9#1)
follow-up for a##2##3##(2008-8#1)(2011-1#1)
follow-up for##12##2##(1990-12#1)(1990-6#1)(1993-11#1)(1994-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#3)(2012-3#1)
follow-up from##2##2##(2008-6#1)(2013-1#1)
follow-up imaging##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
follow-up in a randomized##2##4##(1995-11#1)(2008-10#1)
follow-up in a##3##3##(1995-11#1)(2008-10#1)(2012-3#1)
follow-up in the##3##3##(1991-3#1)(1993-10#1)(1994-3#1)
follow-up in##16##2##(1991-3#1)(1993-10#1)(1994-3#1)(1995-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#3)(2012-3#1)(2013-1#1)
follow-up information##4##2##(1991-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
follow-up interval##3##2##(2008-7#2)(2010-8#1)
follow-up interview##2##2##(2013-8#2)
follow-up is necessary##4##3##(1992-5#1)(1997-8#1)(2011-1#1)(2012-12#1)
follow-up is needed to##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
follow-up is needed##4##3##(1997-3#1)(2007-12#1)(2007-8#1)(2011-2#1)
follow-up is##17##2##(1990-6#1)(1992-5#1)(1992-6#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
follow-up may##3##2##(1993-11#1)(2008-11#1)(2008-7#1)
follow-up of 1##4##3##(1990-6#1)(1996-6#1)(2007-10#1)(2013-1#1)
follow-up of 15 months (range##2##5##(2010-12#1)(2012-2#1)
follow-up of 15##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
follow-up of 25##2##3##(1990-12#1)(1991-6#1)
follow-up of 3##3##3##(1992-6#1)(2009-3#1)(2012-2#1)
follow-up of 30 months##2##4##(1993-9#1)(2009-3#1)
follow-up of 30##3##3##(1993-9#1)(2008-7#1)(2009-3#1)
follow-up of 46##2##3##(1994-2#1)(1996-9#1)
follow-up of 48 months##2##4##(1992-12#1)(2008-8#1)
follow-up of 5 years##2##4##(2006-12#1)(2008-6#1)
follow-up of 5##4##3##(1990-6#1)(1992-6#1)(2006-12#1)(2008-6#1)
follow-up of 60##2##3##(2008-1#1)(2011-2#1)
follow-up of 65##2##3##(1993-2#1)(2007-8#1)
follow-up of 8 years##2##4##(1990-2#1)(2009-3#1)
follow-up of 8##4##3##(1990-2#1)(2008-8#1)(2009-3#1)(2012-12#1)
follow-up of a patient##2##4##(2012-3#1)(2013-1#1)
follow-up of a##4##3##(2011-1#1)(2012-3#1)(2013-1#2)
follow-up of at least##2##4##(1991-2#1)(2012-12#1)
follow-up of patients with##8##4##(1990-6#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
follow-up of patients##12##3##(1990-6#1)(1990-9#2)(1995-2#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-9#1)(2012-2#2)(2013-1#1)
follow-up of the##10##3##(1990-12#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#2)
follow-up of these patients##2##4##(2006-10#1)(2008-4#1)
follow-up of these##3##3##(2006-10#1)(2008-4#1)(2010-9#1)
follow-up of this##3##3##(1997-8#1)(2009-8#1)(2011-1#1)
follow-up of treated##3##3##(1991-2#1)(2008-6#1)(2011-2#1)
follow-up of##131##2##(1990-12#4)(1990-2#1)(1990-6#5)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-6#3)(1996-9#1)(1997-4#3)(1997-8#5)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#11)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#5)
follow-up one patient##2##3##(1994-11#1)(2007-8#1)
follow-up one##3##2##(1994-11#1)(2007-8#1)(2008-12#1)
follow-up over##2##2##(2007-12#1)(2013-8#1)
follow-up period and##2##3##(2008-7#2)
follow-up period averaged##2##3##(1994-11#1)(2009-10#1)
follow-up period of 3##2##4##(2008-6#1)(2008-7#1)
follow-up period of##7##3##(1990-8#1)(2007-10#1)(2008-6#2)(2008-7#2)(2013-1#1)
follow-up period was##9##3##(1990-9#1)(1996-12#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-3#1)(2012-5#1)(2013-1#1)
follow-up period##47##2##(1990-8#1)(1990-9#1)(1991-6#2)(1994-11#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#8)(2009-10#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#8)(2013-8#1)
follow-up periods of##4##3##(1991-12#1)(2012-12#2)(2013-1#1)
follow-up periods##7##2##(1991-12#1)(2007-10#1)(2011-1#1)(2012-12#3)(2013-1#1)
follow-up programs is##2##3##(2008-11#2)
follow-up programs##9##2##(2008-11#9)
follow-up questionnaire##4##2##(1997-2#1)(2007-2#1)(2008-11#2)
follow-up questionnaires##2##2##(2008-11#1)(2008-8#1)
follow-up report on##2##3##(1991-12#1)(2008-4#1)
follow-up report##3##2##(1991-12#1)(2008-4#1)(2013-1#1)
follow-up results are##2##3##(1990-9#1)(1994-2#1)
follow-up results##4##2##(1990-9#1)(1994-2#1)(2012-12#2)
follow-up revealed##4##2##(1991-8#1)(1994-3#1)(2008-9#1)(2010-9#1)
follow-up services##2##2##(2007-11#1)(2010-8#1)
follow-up showed that##2##3##(1992-5#1)(2013-1#1)
follow-up showed##4##2##(1991-2#1)(1992-5#1)(2013-1#2)
follow-up studies in##2##3##(2008-11#1)(2009-8#1)
follow-up studies##12##2##(1990-8#1)(1991-8#1)(1992-6#1)(1992-9#1)(1997-2#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#1)
follow-up study in patients##2##4##(1992-2#1)(1997-8#1)
follow-up study in##3##3##(1992-2#1)(1997-8#2)
follow-up study of four##2##4##(2008-7#2)
follow-up study of##8##3##(1990-6#1)(1991-2#1)(1994-3#1)(1995-1#1)(1997-4#1)(2008-7#2)(2012-3#1)
follow-up study was##2##3##(1994-3#1)(2008-11#1)
follow-up study##21##2##(1990-6#1)(1991-1#2)(1991-2#1)(1991-3#2)(1992-2#1)(1992-6#1)(1994-3#2)(1995-1#1)(1997-4#1)(1997-8#2)(2008-11#1)(2008-7#3)(2012-12#1)(2012-3#1)(2013-8#1)
follow-up study]##3##2##(1990-3#1)(1994-11#1)(1996-6#1)
follow-up survey was##2##3##(2007-12#1)(2008-9#1)
follow-up survey##6##2##(1994-2#2)(1997-1#1)(2007-12#1)(2008-9#1)(2010-12#1)
follow-up test##2##2##(2012-2#2)
follow-up the patient is##2##4##(2007-8#1)(2008-6#1)
follow-up the patient##3##3##(2007-8#1)(2008-6#1)(2013-1#1)
follow-up the##5##2##(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
follow-up time of##2##3##(2007-8#1)(2008-8#1)
follow-up time was 10##2##4##(1990-2#1)(2012-3#1)
follow-up time was##7##3##(1990-2#1)(1993-1#1)(2007-11#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
follow-up time##14##2##(1990-2#1)(1993-1#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-6#3)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
follow-up to##4##2##(1995-2#1)(1996-8#1)(2008-4#1)(2013-1#1)
follow-up treatment##2##2##(2011-2#1)(2012-2#1)
follow-up until##3##2##(1993-12#1)(2010-1#1)(2013-1#1)
follow-up visit##5##2##(1993-2#1)(2008-1#1)(2010-10#1)(2012-3#1)(2013-1#1)
follow-up was 1##3##3##(2007-11#2)(2010-3#1)
follow-up was 10##3##3##(1996-9#1)(2008-10#1)(2008-9#1)
follow-up was 8##2##3##(2008-3#1)(2013-8#1)
follow-up was available##2##3##(1993-9#1)(2008-6#1)
follow-up was of##3##3##(1993-9#1)(2012-2#2)
follow-up was##45##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-9#2)(1996-9#1)(2007-11#2)(2007-7#2)(2007-8#5)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#4)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
follow-up were##7##2##(1996-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-5#1)
follow-up when##2##2##(1994-2#1)(2009-10#1)
follow-up will be##2##3##(1992-2#1)(2007-8#1)
follow-up with##10##2##(1993-3#1)(1996-7#1)(2008-10#2)(2008-12#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
follow-up##864##1##(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#5)(1990-5#2)(1990-6#10)(1990-8#3)(1990-9#6)(1991-1#4)(1991-11#1)(1991-12#8)(1991-2#7)(1991-3#4)(1991-4#1)(1991-6#6)(1991-8#6)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#7)(1992-6#10)(1992-8#2)(1992-9#6)(1993-1#4)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#1)(1993-9#5)(1994-1#1)(1994-11#6)(1994-12#3)(1994-2#8)(1994-3#6)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#4)(1995-3#2)(1995-5#5)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-6#10)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#13)(2006-10#3)(2006-12#3)(2007-1#1)(2007-10#11)(2007-11#17)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#33)(2008-1#19)(2008-10#18)(2008-11#40)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#22)(2008-5#6)(2008-6#24)(2008-7#47)(2008-8#18)(2008-9#20)(2009-1#1)(2009-10#7)(2009-11#4)(2009-3#11)(2009-4#3)(2009-5#5)(2009-6#2)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#4)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#16)(2011-2#46)(2011-3#3)(2012-1#1)(2012-12#32)(2012-2#25)(2012-3#18)(2012-5#3)(2012-6#2)(2013-1#55)(2013-7#1)(2013-8#16)
follow-up)##4##1##(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
follow-up]##5##1##(1990-9#1)(1991-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
follow-ups are needed to##2##4##(2013-1#2)
follow-ups of##3##2##(2012-12#3)
follow-ups##11##1##(1993-1#1)(2008-1#1)(2008-8#1)(2012-12#4)(2013-1#4)
followed 10##2##2##(2008-7#1)(2013-8#1)
followed a pattern similar to##2##5##(2008-10#2)
followed a quadratic##2##3##(2008-10#1)(2008-7#1)
followed a##23##2##(1990-8#1)(1994-12#1)(1994-2#1)(2008-10#11)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
followed an##2##2##(1995-2#1)(2013-1#1)
followed and##2##2##(2008-10#1)(2008-9#1)
followed at the##2##3##(2011-2#1)(2012-2#1)
followed at##11##2##(1992-2#1)(1993-1#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-2#1)
followed both##2##2##(2008-10#1)(2008-5#1)
followed by 1##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
followed by 12##3##3##(2007-10#2)(2008-5#1)
followed by 2##3##3##(2008-12#1)(2008-3#1)(2009-5#1)
followed by 4##3##3##(1997-6#1)(2008-10#1)(2013-1#1)
followed by 6 months in general practice##2##7##(1995-6#2)
followed by A##2##3##(2011-2#1)(2013-1#1)
followed by GC-MS analysis##2##4##(2008-10#1)(2008-5#1)
followed by GC-MS##3##3##(2008-10#2)(2008-5#1)
followed by ICP-MS##2##3##(2008-10#2)
followed by PCR##2##3##(1993-3#1)(2008-2#1)
followed by SDS-PAGE analysis##2##4##(1991-5#1)(1994-8#1)
followed by SDS-PAGE##4##3##(1990-11#1)(1991-5#1)(1993-3#1)(1994-8#1)
followed by TEGDMA##2##3##(2013-1#2)
followed by UV##2##3##(2008-10#1)(2013-1#1)
followed by Varimax rotation##2##4##(2008-10#2)
followed by Western blotting with##2##5##(1991-8#1)(1997-1#1)
followed by Western blotting##3##4##(1991-8#1)(1997-1#1)(2008-7#1)
followed by Western##4##3##(1991-8#1)(1992-8#1)(1997-1#1)(2008-7#1)
followed by a &quot##3##4##(1992-12#1)(2008-10#2)
followed by a computational strategy##2##5##(2008-10#2)
followed by a computational##3##4##(2008-10#3)
followed by a continuous infusion of##2##6##(1992-5#1)(2007-10#1)
followed by a decline to##2##5##(1990-7#1)(1991-2#1)
followed by a decline##3##4##(1990-3#1)(1990-7#1)(1991-2#1)
followed by a decrease##4##4##(1993-12#1)(2008-11#1)(2008-6#1)(2010-5#1)
followed by a delayed##2##4##(2008-11#1)(2008-3#1)
followed by a discussion of the##5##6##(1997-3#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)
followed by a discussion of##12##5##(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
followed by a discussion##13##4##(1994-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
followed by a larger##2##4##(1997-3#1)(2008-8#1)
followed by a left##2##4##(2008-6#1)(2012-3#1)
followed by a long##3##4##(1992-3#1)(1994-12#1)(2008-7#1)
followed by a longer##2##4##(2008-3#1)(2009-8#1)
followed by a more##2##4##(1992-12#1)(1996-3#1)
followed by a production phase##2##5##(2008-11#2)
followed by a second##3##4##(1990-5#1)(1995-5#1)(2008-10#1)
followed by a sharp##2##4##(2008-10#1)(2008-11#1)
followed by a slow##5##4##(1990-2#1)(1994-6#1)(1997-1#1)(2008-3#2)
followed by a sudden##2##4##(1995-3#1)(2007-12#1)
followed by a sustained##3##4##(1990-2#1)(1992-6#1)(1995-12#1)
followed by a##167##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-12#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#4)
followed by acute##2##3##(2008-1#1)(2012-3#1)
followed by addition of##3##4##(1996-5#1)(1997-7#1)(2008-10#1)
followed by adjuvant##5##3##(1990-9#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
followed by alkaline##2##3##(2008-6#1)(2009-9#1)
followed by all##4##3##(1992-11#1)(1997-3#1)(2008-9#1)(2012-2#1)
followed by amikacin##2##3##(1991-3#2)
followed by an accumulation period##2##5##(2008-10#2)
followed by an evaluation of matrix spiking and recovery analyses##3##10##(2008-10#3)
followed by an exponential decrease##2##5##(1995-2#1)(2008-11#1)
followed by an increase##3##4##(1994-11#1)(1994-3#1)(2008-11#1)
followed by an##28##3##(1992-12#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-8#1)(1996-5#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
followed by analysis of##3##4##(1991-2#1)(1992-2#1)(1993-2#1)
followed by analysis##4##3##(1991-2#1)(1992-2#1)(1993-2#1)(2008-4#1)
followed by annealing##2##3##(2007-11#1)(2008-2#1)
followed by application of##3##4##(1992-2#1)(2008-10#1)(2012-2#1)
followed by atomic absorption##2##4##(2008-10#2)
followed by both##2##3##(2008-10#1)(2011-2#1)
followed by carbon##2##3##(2008-10#1)(2012-12#1)
followed by cell##2##3##(1995-11#1)(2008-11#1)
followed by chemical##3##3##(2008-10#2)(2008-2#1)
followed by chemotherapy##3##3##(2007-8#2)(2013-8#1)
followed by cleavage##2##3##(1993-11#1)(1997-3#1)
followed by complete##3##3##(1992-8#1)(1993-11#1)(2007-7#1)
followed by continuous##2##3##(2008-10#2)
followed by controlled##2##3##(2007-10#1)(2008-11#1)
followed by corn##2##3##(2008-10#2)
followed by death##2##3##(2008-11#1)(2012-3#1)
followed by deprotection##3##3##(1996-5#3)
followed by diabetes mellitus##2##4##(2007-7#2)
followed by differential pulse##2##4##(2008-10#2)
followed by differential##3##3##(2008-10#2)(2010-8#1)
followed by direct##4##3##(1992-8#1)(2007-11#1)(2008-10#2)
followed by either##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
followed by electrophoresis##2##3##(2008-2#1)(2008-4#1)
followed by elution with##4##4##(1994-6#1)(2008-10#3)
followed by external##2##3##(1990-2#1)(2008-9#1)
followed by extraction into##2##4##(2008-10#2)
followed by extraction##7##3##(2008-10#6)(2008-4#1)
followed by fitting##2##3##(2007-12#1)(2010-2#1)
followed by flame atomic absorption spectrometry##2##6##(2008-10#2)
followed by fluorescence##2##3##(1990-8#1)(1996-6#1)
followed by four##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
followed by further##3##3##(2008-10#2)(2013-1#1)
followed by gas chromatography##2##4##(2008-10#2)
followed by gas chromatography-mass spectrometry##2##5##(2008-10#1)(2012-1#1)
followed by gas##4##3##(2008-10#3)(2012-1#1)
followed by gastrointestinal##2##3##(2008-8#1)(2010-5#1)
followed by gel##3##3##(1994-8#1)(2008-10#1)(2012-2#1)
followed by heart##2##3##(2007-7#1)(2008-5#1)
followed by high performance liquid chromatography with##2##7##(2008-10#2)
followed by high-performance liquid chromatography with fluorescence detection##2##8##(2008-10#2)
followed by high-performance liquid chromatography##3##5##(2008-10#3)
followed by high-performance liquid##4##4##(1991-5#1)(2008-10#3)
followed by histopathological examination##2##4##(2008-8#1)(2013-7#1)
followed by hybridization##2##3##(2008-10#1)(2012-2#1)
followed by hydrolysis##2##3##(1996-5#1)(2008-4#1)
followed by immunoblotting##2##3##(1993-3#1)(2012-3#1)
followed by in vitro##2##4##(1991-11#1)(1996-2#1)
followed by increased##2##3##(1990-8#1)(2013-1#1)
followed by incubation##2##3##(2008-2#1)(2008-5#1)
followed by inductively coupled##2##4##(2008-10#2)
followed by ion##2##3##(2008-10#2)
followed by irradiation with##2##4##(1990-11#1)(2007-11#1)
followed by its##2##3##(1995-12#1)(2008-10#1)
followed by liquid##5##3##(2008-10#4)(2010-5#1)
followed by locomotion##2##3##(1993-3#1)(1997-2#1)
followed by manual##2##3##(2008-4#1)(2013-1#1)
followed by measurement of the##3##5##(1997-4#1)(2008-10#1)(2008-4#1)
followed by on-line elution##2##4##(2008-10#2)
followed by on-line##6##3##(2008-10#6)
followed by one##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
followed by oral##2##3##(2007-7#1)(2009-11#1)
followed by other##3##3##(2008-4#1)(2008-7#1)(2009-12#1)
followed by physical##3##3##(1997-2#1)(2008-1#1)(2010-6#1)
followed by potentiometric##2##3##(2008-10#2)
followed by progressive##3##3##(1992-12#1)(2008-3#1)(2012-3#1)
followed by races##2##3##(2008-10#2)
followed by radiation therapy##3##4##(2006-12#1)(2008-7#1)(2011-1#1)
followed by radiation##4##3##(2006-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
followed by radiotherapy##7##3##(1990-6#1)(1991-9#1)(1996-9#2)(2008-8#2)(2010-11#1)
followed by rapid##2##3##(1992-8#1)(1996-7#1)
followed by reaction##2##3##(2008-12#1)(2013-1#1)
followed by reduction of the##2##5##(2008-10#2)
followed by reduction with##5##4##(1996-5#4)(2007-11#1)
followed by reduction##9##3##(1991-2#1)(1996-5#4)(2007-11#1)(2008-10#3)
followed by removal of the##3##5##(1996-5#1)(2008-4#1)(2010-10#1)
followed by removal of##5##4##(1991-5#1)(1996-5#1)(2008-10#1)(2008-4#1)(2010-10#1)
followed by reperfusion for##2##4##(1993-3#1)(2010-1#1)
followed by reperfusion##5##3##(1993-3#1)(1995-12#1)(2008-12#1)(2010-1#1)(2010-6#1)
followed by reversed-phase##2##3##(1996-12#1)(2008-10#1)
followed by secondary##3##3##(2008-10#2)(2008-11#1)
followed by selective##2##3##(2008-10#2)
followed by separation##2##3##(1990-8#1)(2008-10#1)
followed by several##2##3##(2007-11#1)(2008-3#1)
followed by simple##2##3##(2008-10#1)(2008-4#1)
followed by simultaneous##2##3##(1992-6#1)(2013-1#1)
followed by single-flap##2##3##(2008-7#2)
followed by slow##2##3##(1992-8#1)(2010-7#1)
followed by solid-phase##2##3##(2008-10#1)(2008-5#1)
followed by some##2##3##(2008-10#1)(2009-8#1)
followed by spectrophotometric##2##3##(2008-10#2)
followed by spinal##2##3##(2007-11#2)
followed by staining with##2##4##(1990-7#1)(2008-4#1)
followed by subsequent##2##3##(1997-4#1)(2008-10#1)
followed by superinfection with##2##4##(1993-8#1)(2008-8#1)
followed by surgical intervention##2##4##(2008-12#1)(2011-1#1)
followed by surgical##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
followed by symptoms##2##3##(1996-6#1)(2013-8#1)
followed by the Tukey's##2##4##(2008-10#1)(2013-8#1)
followed by the demonstration of##2##5##(1995-12#2)
followed by the group##2##4##(2008-5#1)(2013-8#1)
followed by the other##2##4##(2008-1#1)(2008-10#1)
followed by the provision of##2##5##(2008-7#1)(2012-12#1)
followed by the superior##2##4##(2008-11#1)(2010-9#1)
followed by the##65##3##(1990-9#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#2)(1995-11#1)(1995-12#2)(1995-3#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
followed by their##3##3##(1994-10#1)(1997-8#1)(2013-1#1)
followed by those##4##3##(1992-3#1)(1996-5#1)(2008-5#1)(2013-8#1)
followed by total##2##3##(2007-5#1)(2013-7#1)
followed by treatment with##7##4##(1995-11#1)(1995-3#1)(1996-5#2)(2008-11#1)(2008-4#1)(2012-3#1)
followed by treatment##8##3##(1995-11#1)(1995-3#1)(1996-5#2)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
followed by two##5##3##(1995-12#1)(1995-2#1)(1995-6#1)(2011-2#1)(2012-2#1)
followed by ultrasound##2##3##(1995-12#1)(2009-7#1)
followed by visual##2##3##(2007-6#1)(2013-8#1)
followed by##1130##2##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#7)(1990-3#2)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#3)(1991-11#2)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#7)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#3)(1992-12#8)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#4)(1992-8#10)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#1)(1993-2#3)(1993-3#9)(1993-5#1)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#3)(1995-11#6)(1995-12#12)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#23)(1996-6#8)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#8)(1997-4#5)(1997-6#4)(1997-7#3)(1997-8#2)(2006-12#2)(2007-10#5)(2007-11#13)(2007-12#10)(2007-3#1)(2007-5#6)(2007-6#4)(2007-7#26)(2007-8#9)(2007-9#1)(2008-1#16)(2008-10#267)(2008-11#40)(2008-12#21)(2008-2#14)(2008-3#22)(2008-4#37)(2008-5#32)(2008-6#14)(2008-7#27)(2008-8#19)(2008-9#22)(2009-1#1)(2009-11#3)(2009-12#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#11)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#9)(2010-6#5)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#13)(2011-2#28)(2011-3#1)(2012-1#4)(2012-12#11)(2012-2#12)(2012-3#17)(2012-8#1)(2013-1#45)(2013-7#7)(2013-8#27)
followed closely##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
followed during the##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
followed during##5##2##(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
followed each##3##2##(1990-3#1)(2007-11#1)(2008-11#1)
followed for 1##2##3##(1991-12#1)(2012-3#1)
followed for 2##2##3##(1993-2#1)(2008-7#1)
followed for 4 years##2##4##(2011-2#2)
followed for 4##4##3##(1991-4#1)(2011-2#2)(2013-1#1)
followed for a total of##2##5##(1993-9#2)
followed for a##3##3##(1993-9#2)(2009-4#1)
followed for an average of##3##5##(1992-8#1)(2008-10#1)(2009-10#1)
followed for at least##2##4##(1996-1#1)(2011-1#1)
followed for##33##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-2#2)(1993-9#2)(1996-1#1)(1996-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
followed in our##2##3##(2008-1#1)(2011-2#1)
followed in the##6##3##(1992-5#1)(2008-10#4)(2009-11#1)
followed in##22##2##(1992-5#1)(1994-12#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-5#1)(2009-11#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
followed into##2##2##(1995-12#1)(2009-7#1)
followed on##2##2##(2008-10#1)(2008-6#1)
followed only##2##2##(1990-12#1)(1997-3#1)
followed over a period of##2##5##(2008-10#2)
followed over a##3##3##(2007-7#1)(2008-10#2)
followed over##5##2##(2007-7#1)(2008-10#3)(2012-7#1)
followed regularly##2##2##(1997-8#1)(2008-7#1)
followed the Poisson##2##3##(1995-6#1)(2008-10#1)
followed the order##2##3##(1994-3#1)(2008-8#1)
followed the same##4##3##(1995-12#1)(1996-5#1)(1997-2#1)(2008-7#1)
followed the##33##2##(1991-8#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2012-12#1)(2013-1#1)
followed through##4##2##(1991-1#1)(2006-10#1)(2008-10#1)(2008-11#1)
followed to##10##2##(1991-12#1)(1993-12#1)(1994-3#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)
followed until##3##2##(2008-8#1)(2012-6#1)(2013-1#1)
followed up after##4##3##(1997-2#1)(2007-11#1)(2008-5#1)(2013-1#1)
followed up at least for##2##5##(1995-4#1)(2011-2#1)
followed up at##7##3##(1995-3#1)(1995-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)
followed up by##2##3##(1991-11#1)(2012-12#1)
followed up for 12 months##2##5##(2008-6#1)(2011-2#1)
followed up for a##3##4##(2007-8#1)(2008-8#1)(2013-8#1)
followed up for an average period of##2##7##(2007-7#1)(2008-4#1)
followed up for one year##2##5##(2011-1#1)(2012-12#1)
followed up for##22##3##(1991-9#1)(1995-5#1)(1996-9#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
followed up long enough for outcomes to occur•Control for extraneous risk##2##11##(2012-12#2)
followed up long enough for outcomes to##3##7##(2012-12#3)
followed up to##3##3##(1993-9#1)(2007-10#1)(2008-10#1)
followed up##61##2##(1990-3#1)(1991-11#1)(1991-9#1)(1993-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
followed using##4##2##(2008-10#3)(2008-6#1)
followed with##9##2##(1993-11#1)(1997-2#1)(1997-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
followed zero order##2##3##(2008-10#1)(2012-12#1)
followed##1474##1##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#8)(1990-3#4)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#8)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#4)(1992-11#5)(1992-12#8)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#5)(1992-8#11)(1992-9#3)(1993-1#3)(1993-11#6)(1993-12#4)(1993-2#6)(1993-3#9)(1993-5#1)(1993-8#6)(1993-9#6)(1994-10#1)(1994-11#6)(1994-12#7)(1994-2#6)(1994-3#8)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-11#7)(1995-12#17)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#7)(1995-6#6)(1995-8#4)(1995-9#1)(1996-1#2)(1996-12#8)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#24)(1996-6#8)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#9)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#6)(2006-10#1)(2006-12#2)(2007-10#6)(2007-11#19)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#7)(2007-6#4)(2007-7#29)(2007-8#16)(2007-9#1)(2008-1#23)(2008-10#331)(2008-11#51)(2008-12#28)(2008-2#16)(2008-3#28)(2008-4#39)(2008-5#41)(2008-6#21)(2008-7#48)(2008-8#25)(2008-9#27)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#13)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#11)(2010-6#6)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#21)(2011-2#43)(2011-3#1)(2012-1#5)(2012-12#21)(2012-2#19)(2012-3#22)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#62)(2013-7#8)(2013-8#33)
followed-up at the##2##3##(2008-1#1)(2011-2#1)
followed-up at##3##2##(1991-6#1)(2008-1#1)(2011-2#1)
followed-up for##3##2##(2007-7#1)(2008-1#1)(2012-2#1)
followed-up##12##1##(1991-6#1)(1993-9#1)(2007-7#1)(2008-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
following 10##4##2##(2007-6#1)(2008-10#2)(2008-9#1)
following 2##3##2##(2008-10#2)(2010-1#1)
following 24 hours of##3##4##(2011-1#3)
following 24 hours##4##3##(2007-10#1)(2011-1#3)
following 30##5##2##(1992-3#1)(1997-4#2)(2013-1#2)
following 4##2##2##(2008-5#2)
following 5##2##2##(1994-6#1)(2013-8#1)
following C-ADR##5##2##(2012-12#5)
following DNA replication##2##3##(1995-9#1)(2009-3#1)
following LPS##2##2##(2008-10#2)
following RA##2##2##(2007-8#2)
following SAH##2##2##(2007-10#1)(2008-7#1)
following TBI##2##2##(2010-9#1)(2012-2#1)
following TCA overdose##2##3##(2010-1#2)
following UV mutagenesis of the##2##5##(2008-10#2)
following UV##3##2##(1996-9#1)(2008-10#2)
following a fall##2##3##(2013-1#2)
following a fracture##2##3##(2009-3#1)(2012-2#1)
following a frontal##2##3##(2008-7#1)(2011-2#1)
following a low-energy fracture##2##4##(2008-8#2)
following a minor##2##3##(1991-11#1)(2008-8#1)
following a normal##2##3##(1994-5#1)(2013-1#1)
following a review of##2##4##(1992-6#1)(2012-12#1)
following a right##2##3##(2008-8#1)(2013-1#1)
following a rise in body core temperature##2##7##(2008-5#2)
following a short##2##3##(1995-12#1)(2008-10#1)
following a similar##2##3##(1993-11#1)(1995-2#1)
following a simple##2##3##(1992-12#1)(2008-2#1)
following a single##4##3##(1996-5#1)(2008-10#1)(2009-2#1)(2012-2#1)
following a stroke##2##3##(2008-7#1)(2013-1#1)
following a##108##2##(1990-3#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#3)(1997-2#1)(1997-4#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#7)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#2)
following abdominal##2##2##(1997-8#1)(2011-2#1)
following ablation##2##2##(1991-5#1)(2008-10#1)
following acquisition##3##2##(1993-5#2)(2008-10#1)
following activation##2##2##(1995-12#1)(2008-11#1)
following acute dosing with##2##4##(1995-3#2)
following acute##10##2##(1990-12#1)(1990-6#1)(1995-3#3)(2007-10#1)(2008-11#1)(2009-10#2)(2012-2#1)
following addition of##2##3##(2008-10#2)
following administration of##7##3##(1992-5#1)(1996-8#1)(1997-7#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
following administration##8##2##(1992-5#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
following adrenalectomy##2##2##(2008-11#1)(2008-8#1)
following air##2##2##(2007-2#1)(2008-10#1)
following amendment##2##2##(2008-10#2)
following amputation##4##2##(2008-6#2)(2009-3#2)
following an acute##2##3##(1994-6#1)(2011-1#1)
following an ischaemic##2##3##(1993-9#1)(2008-8#1)
following an oral##2##3##(2008-10#1)(2009-11#1)
following an##31##2##(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
following analysis##2##2##(2008-11#1)(2012-2#1)
following ankle##3##2##(2009-1#2)(2012-3#1)
following anterior cruciate ligament##2##4##(2008-12#1)(2013-1#1)
following anti-cancer therapy##2##3##(2012-12#2)
following anti-cancer##3##2##(2012-12#3)
following any##2##2##(2008-9#1)(2013-1#1)
following aortic##3##2##(1990-6#2)(2012-2#1)
following application of##5##3##(1996-5#1)(2008-10#3)(2008-3#1)
following application##6##2##(1996-5#1)(2008-10#4)(2008-3#1)
following article##13##2##(1991-3#2)(1993-12#1)(1993-3#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#2)(2012-2#1)(2013-1#1)
following aspects of##2##3##(2008-2#1)(2008-4#1)
following aspects##4##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
following atrial septal defect##2##4##(2007-8#1)(2008-11#1)
following balloon##2##2##(2008-11#1)(2008-4#1)
following bilateral##3##2##(1993-12#1)(1994-3#1)(2011-2#1)
following blunt chest trauma##2##4##(2007-8#2)
following blunt##5##2##(2007-8#3)(2008-7#2)
following bone marrow##3##3##(1997-7#1)(2008-11#2)
following brain##3##2##(1993-5#1)(2008-7#1)(2013-1#1)
following breast-conserving surgery and##2##4##(1994-8#1)(1995-9#1)
following breeding##2##2##(2008-9#2)
following brief acquisition and various amounts of extinction##2##8##(2008-5#2)
following brief##3##2##(2008-5#2)(2009-6#1)
following capillary electrophoresis##2##3##(2008-10#2)
following cardiac##3##2##(2010-11#1)(2010-5#1)(2012-1#1)
following case##4##2##(1991-1#1)(2008-7#1)(2013-1#2)
following cellular##2##2##(1992-12#1)(1994-8#1)
following cervical##2##2##(2008-12#1)(2012-12#1)
following cessation of##3##3##(1995-12#1)(2009-9#1)(2012-1#1)
following challenge with##2##3##(2008-10#2)
following challenge##4##2##(2008-10#2)(2008-5#1)(2009-5#1)
following changes##2##2##(2008-10#1)(2013-8#1)
following characteristics of##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
following characteristics##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2010-8#1)(2013-1#2)
following chemical##2##2##(2008-10#1)(2008-5#1)
following chemotherapy##5##2##(1993-8#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-2#1)
following chronic##6##2##(1997-2#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2013-1#1)
following co-culture with##2##3##(2008-11#2)
following cochlear implantation in##3##4##(2008-9#3)
following cochlear implantation##9##3##(2008-9#9)
following coinoculation##2##2##(2008-10#2)
following cold pressor test##2##4##(1990-5#2)
following cold##3##2##(1990-5#2)(2008-10#1)
following combined##2##2##(1991-1#1)(1994-8#1)
following complete resection of##2##4##(2007-10#1)(2008-6#1)
following complete##6##2##(1995-11#1)(2007-10#1)(2008-6#1)(2011-2#1)(2012-3#2)
following compounds##2##2##(2011-2#2)
following conclusions##11##2##(1990-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
following conditions##7##2##(1995-2#1)(1996-5#1)(2008-10#3)(2008-6#1)(2011-2#1)
following continuous##5##2##(1995-8#1)(2008-10#3)(2009-9#1)
following coronary artery bypass##2##4##(2006-6#1)(2007-11#1)
following coronary##5##2##(1995-12#1)(1996-9#1)(2006-6#1)(2007-11#1)(2008-4#1)
following data##4##2##(1994-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
following day##7##2##(1993-12#1)(1996-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
following definition##2##2##(1992-3#1)(2009-6#1)
following definitive##2##2##(2008-10#1)(2012-3#1)
following diagnosis##3##2##(1997-3#1)(2008-6#2)
following different##2##2##(2007-8#1)(2013-8#1)
following digestion of##2##3##(1993-2#1)(1995-6#1)
following digestion with##2##3##(1991-12#1)(1992-6#1)
following digestion##4##2##(1991-12#1)(1992-6#1)(1993-2#1)(1995-6#1)
following direct##2##2##(1993-11#1)(2007-5#1)
following disease##2##2##(2008-10#1)(2012-3#1)
following dissolution##2##2##(1991-1#1)(2008-10#1)
following drug##3##2##(2008-4#1)(2011-2#2)
following each##2##2##(1992-3#1)(2013-8#1)
following eight weeks##2##3##(1990-11#1)(2007-7#1)
following either##4##2##(1997-7#1)(2008-5#1)(2008-6#1)(2011-2#1)
following electrical stimulation of the sciatic nerve##2##7##(1990-7#2)
following electrical stimulation##3##3##(1990-7#2)(1994-6#1)
following endoscopic anterior skull base surgery##2##6##(2011-2#2)
following endoscopic##5##2##(2011-2#3)(2012-2#2)
following endotoxin##2##2##(1996-12#1)(2008-12#1)
following excision of##3##3##(2008-6#2)(2013-1#1)
following experimental##4##2##(1990-5#1)(1997-3#1)(2008-10#2)
following exposure in##2##3##(1995-3#1)(1996-6#1)
following exposure of##3##3##(1993-8#1)(1994-8#1)(2008-10#1)
following exposure to##20##3##(1990-5#1)(1990-7#1)(1992-6#1)(1993-11#1)(1994-6#1)(1995-5#2)(1997-3#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)(2012-3#2)(2013-8#1)
following exposure##27##2##(1990-5#1)(1990-7#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
following expression##2##2##(1993-8#1)(2008-3#1)
following extensive##2##2##(2007-2#1)(2008-10#1)
following extraction##4##2##(1990-5#1)(2007-12#1)(2008-10#2)
following factors##4##2##(2008-6#1)(2008-7#2)(2011-2#1)
following feeding on source plants##2##5##(2008-10#2)
following feeding on the##2##4##(2008-10#2)
following feeding on##5##3##(2008-10#5)
following feeding##6##2##(2008-10#5)(2010-2#1)
following findings##4##2##(1992-3#1)(1996-4#1)(2006-12#1)(2012-3#1)
following focal cerebral ischemia in##2##5##(1997-2#1)(2012-12#1)
following focal cerebral ischemia##3##4##(1996-12#1)(1997-2#1)(2012-12#1)
following focal##4##2##(1996-12#1)(1997-2#1)(2009-10#1)(2012-12#1)
following fusion for##2##3##(2012-12#2)
following general##3##2##(1995-11#1)(2008-3#1)(2010-7#1)
following groups##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
following harvest##2##2##(2008-10#2)
following head injury complicated by acute bacterial meningitis##2##8##(2008-9#2)
following head##3##2##(2008-7#1)(2008-9#2)
following heart-lung transplantation##2##3##(1992-6#2)
following heat shock##2##3##(1994-8#1)(1996-12#1)
following heat##4##2##(1994-8#1)(1996-12#1)(2008-10#1)(2009-3#1)
following high##2##2##(2008-10#1)(2008-7#1)
following high-dose chemotherapy and autologous bone marrow transplantation##2##8##(1994-8#1)(1995-9#1)
following high-dose##3##2##(1994-8#1)(1995-8#1)(1995-9#1)
following hospital discharge##3##3##(1997-3#1)(2007-11#1)(2012-12#1)
following hospitalization##3##2##(1991-2#2)(2009-10#1)
following hypospadias repair##2##3##(2008-10#1)(2009-5#1)
following immunization##2##2##(1995-5#1)(2008-9#1)
following immunoprecipitation with##2##3##(1994-2#1)(1997-6#1)
following implantation of a##2##4##(2010-5#2)
following implantation of##3##3##(2008-11#1)(2010-5#2)
following implantation##7##2##(2008-11#1)(2008-12#1)(2008-9#2)(2010-5#2)(2012-2#1)
following implementation##2##2##(1992-3#1)(1994-2#1)
following in vitro##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
following in vivo##2##3##(2008-10#1)(2008-4#1)
following in##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)
following induction##2##2##(1995-11#1)(2008-10#1)
following infection of##2##3##(1996-12#1)(2008-5#1)
following infection with##2##3##(1997-6#1)(2008-10#1)
following infection##9##2##(1994-9#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-5#1)
following ingestion of##4##3##(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
following initial##2##2##(1997-7#1)(2008-4#1)
following initiation of##2##3##(2010-5#1)(2010-6#1)
following injection of##3##3##(1995-3#1)(2008-1#1)(2010-6#1)
following injection##6##2##(1995-3#1)(1996-2#1)(2008-1#1)(2010-6#3)
following injury##7##2##(1993-12#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
following inoculation in##2##3##(2008-10#2)
following inoculation of leaves with##2##5##(2008-10#2)
following inoculation of##6##3##(2008-10#6)
following inoculation with##4##3##(2008-10#4)
following inoculation##25##2##(2008-10#24)(2008-5#1)
following insertion of##2##3##(2007-10#1)(2007-7#1)
following intra-NAS##2##2##(1993-12#2)
following intranasal##2##2##(2008-10#2)
following intraseptal##2##2##(1993-12#2)
following introduction of##2##3##(1992-9#1)(2008-5#1)
following introduction##4##2##(1992-9#1)(2008-5#1)(2008-8#2)
following ionizing radiation##2##3##(1995-12#1)(2008-7#1)
following irradiation by##2##3##(2008-3#2)
following irradiation##4##2##(2008-3#2)(2008-7#1)(2008-9#1)
following is##5##2##(1996-2#2)(2008-11#1)(2012-12#1)(2013-8#1)
following ischemia##2##2##(1995-12#1)(1996-9#1)
following ischemic##2##2##(2007-10#1)(2007-8#1)
following its##9##2##(1992-12#1)(1993-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#2)
following kidney##2##2##(1994-5#1)(2007-7#1)
following laparoscopic##3##2##(1996-8#1)(2010-8#1)(2013-1#1)
following lateral tunnel##2##3##(2010-5#2)
following lesion##2##2##(1991-2#1)(1992-12#1)
following lesions of the##2##4##(1993-3#1)(1994-3#1)
following lesions of##3##3##(1993-3#1)(1994-3#1)(1996-5#1)
following lesions##4##2##(1993-12#1)(1993-3#1)(1994-3#1)(1996-5#1)
following ligand##2##2##(1990-8#1)(1994-11#1)
following liver injury##3##3##(2013-1#3)
following liver transplantation##3##3##(1992-12#1)(2008-5#1)(2009-6#1)
following liver##7##2##(1992-12#1)(2008-5#1)(2009-6#1)(2010-6#1)(2013-1#3)
following local##3##2##(2008-6#2)(2013-1#1)
following loss of##2##3##(2009-3#1)(2012-2#1)
following low##2##2##(1996-2#1)(1996-6#1)
following lung transplantation##2##3##(2011-2#1)(2011-3#1)
following mastectomy##2##2##(1990-9#1)(2013-1#1)
following mild##5##2##(1991-9#1)(1996-12#1)(2008-7#2)(2013-8#1)
following minor##3##2##(1991-11#1)(2008-9#2)
following mitosis##2##2##(1995-2#2)
following multiple##2##2##(1994-5#1)(1996-9#1)
following musculoskeletal injury##3##3##(2013-1#3)
following myocardial infarction##2##3##(1990-3#1)(1992-12#1)
following myocardial##4##2##(1990-3#1)(1992-12#1)(1993-2#1)(2012-2#1)
following neonatal##2##2##(1993-3#1)(1997-2#1)
following nerve##2##2##(1993-5#1)(2008-6#1)
following nitric acid##2##3##(2008-10#2)
following observations##2##2##(1995-11#1)(2008-7#1)
following on-line##2##2##(2008-10#2)
following oncological surgery##3##3##(1996-3#1)(2008-4#2)
following one##4##2##(2006-5#1)(2007-2#1)(2008-2#1)(2008-7#1)
following optimization of##2##3##(2008-10#2)
following oral administration of##4##4##(1995-12#1)(2008-10#1)(2008-11#2)
following oral administration##6##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#3)
following oral##8##2##(1990-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#3)
following paediatric cochlear implantation##2##4##(2008-9#2)
following paediatric##4##2##(2008-9#2)(2009-10#2)
following paper##5##2##(1991-3#1)(1995-5#1)(2008-5#1)(2012-3#1)(2013-1#1)
following parameters were studied##2##4##(2008-10#2)
following parameters were##6##3##(2007-11#1)(2008-10#4)(2013-8#1)
following parameters##12##2##(1991-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-8#1)(2013-8#1)
following partial hepatectomy##3##3##(1994-11#2)(1995-6#1)
following partial##5##2##(1991-12#1)(1994-11#2)(1995-6#1)(2010-2#1)
following percutaneous balloon compression##2##4##(2008-7#2)
following percutaneous coronary##2##3##(2008-12#1)(2009-5#1)
following percutaneous transluminal coronary angioplasty (PTCA)##2##6##(2008-5#2)
following percutaneous##7##2##(2007-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-5#1)
following performance criteria##2##3##(2008-10#2)
following perinatal##2##2##(2007-4#1)(2008-10#1)
following peripheral inflammation##2##3##(1997-2#2)
following peripheral nerve injury##2##4##(2008-9#2)
following peripheral##4##2##(1997-2#2)(2008-9#2)
following physical##2##2##(1990-6#1)(2013-1#1)
following plants##2##2##(2008-5#1)(2013-1#1)
following points##2##2##(2008-8#1)(2010-1#1)
following previous##3##2##(2007-12#1)(2009-10#1)(2013-7#1)
following primary intracerebral hemorrhage##2##4##(2007-10#2)
following primary##7##2##(1992-8#1)(2007-10#2)(2008-11#1)(2008-7#2)(2011-2#1)
following procedure##3##2##(1990-5#1)(2008-10#2)
following procedures##2##2##(2008-1#1)(2010-6#1)
following properties##3##2##(1993-3#1)(2008-10#2)
following prosthetic##2##2##(1994-8#1)(2008-10#1)
following publication of##2##3##(1997-7#1)(2010-12#1)
following questions##10##2##(1994-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-7#1)
following radical##2##2##(1992-12#1)(1992-9#1)
following radiotherapy and##2##3##(1993-9#1)(2008-7#1)
following radiotherapy##3##2##(1993-9#1)(2008-7#2)
following recent##2##2##(1990-2#1)(2007-8#1)
following recommendations##2##2##(2008-10#1)(2013-1#1)
following recovery##2##2##(1994-6#1)(2008-7#1)
following reimplantation##3##2##(2008-9#1)(2012-2#2)
following removal of##3##3##(2008-5#1)(2008-7#1)(2009-7#1)
following renal transplantation##2##3##(2008-7#1)(2008-8#1)
following repair##2##2##(2007-8#1)(2013-8#1)
following repeated partial ischemia##2##4##(1994-2#2)
following repeated##8##2##(1992-7#1)(1994-2#3)(1995-5#1)(2008-10#1)(2009-11#1)(2011-2#1)
following report##2##2##(2008-5#1)(2012-2#1)
following results were##3##3##(2007-11#1)(2008-10#2)
following results##10##2##(1992-6#1)(2007-11#1)(2008-10#3)(2008-6#2)(2008-7#1)(2011-2#1)(2012-3#1)
following right##3##2##(2007-10#2)(2007-8#1)
following second##2##2##(1991-12#1)(1993-1#1)
following section##2##2##(1997-3#1)(2013-8#1)
following separation##4##2##(1990-5#1)(2008-10#3)
following sequence##3##2##(1991-12#1)(1992-12#1)(2008-10#1)
following serum##2##2##(1992-9#1)(1995-11#1)
following severe##2##2##(2008-7#2)
following sexual assault##2##3##(2010-3#1)(2012-3#1)
following situations##3##2##(1993-1#1)(1993-11#1)(2013-1#1)
following six##3##2##(1992-12#1)(2008-1#1)(2008-4#1)
following skin##3##2##(1992-6#1)(2008-5#2)
following small##2##2##(1992-5#1)(2008-7#1)
following sodium dodecyl##2##3##(1990-5#1)(1991-12#1)
following soybean##2##2##(2011-2#2)
following species##2##2##(2010-4#1)(2013-1#1)
following specific##2##2##(2008-10#1)(2008-3#1)
following spinal cord injury##2##4##(2007-11#1)(2008-5#1)
following spinal cord##3##3##(1993-12#1)(2007-11#1)(2008-5#1)
following spinal##4##2##(1993-12#1)(2007-11#1)(2008-5#1)(2011-2#1)
following spring##5##2##(2008-10#4)(2008-8#1)
following stages##2##2##(2008-7#1)(2013-1#1)
following standard##2##2##(2008-10#1)(2013-7#1)
following stimulation of the##2##4##(1991-2#1)(2008-11#1)
following stimulation with##2##3##(1993-6#1)(2008-10#1)
following stimulation##5##2##(1991-2#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
following stroke##10##2##(1997-2#1)(2007-10#3)(2008-2#1)(2008-7#3)(2008-8#1)(2013-1#1)
following study##3##2##(2007-11#1)(2008-7#1)(2011-1#1)
following subcutaneous injection##2##3##(2013-1#2)
following subcutaneous##3##2##(1993-1#1)(2013-1#2)
following such##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
following sun exposure##3##3##(2008-5#3)
following surgery are##2##3##(1991-1#1)(2007-8#1)
following surgery for##2##3##(2008-7#2)
following surgery##24##2##(1991-1#2)(1993-12#2)(1994-3#3)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#5)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
following surgical##8##2##(2007-11#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-9#3)(2010-3#1)
following symptoms##2##2##(2008-5#1)(2008-6#1)
following synthesis##3##2##(1991-9#1)(1995-8#1)(1997-4#1)
following systemic administration of##2##4##(1992-3#1)(2007-10#1)
following systemic administration##3##3##(1992-3#1)(1995-12#1)(2007-10#1)
following systemic##5##2##(1992-3#1)(1993-6#1)(1995-12#2)(2007-10#1)
following tests##3##2##(1991-6#1)(1997-2#1)(2011-2#1)
following that##3##2##(1996-10#1)(2008-2#1)(2011-2#1)
following the WHO##2##3##(1990-12#1)(2012-12#1)
following the addition of HGF##3##5##(2008-11#3)
following the addition of##4##4##(2008-11#4)
following the administration of the##2##5##(1993-1#1)(1993-5#1)
following the administration of##7##4##(1993-1#1)(1993-5#1)(1994-10#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-2#1)
following the birth of##2##4##(1993-12#1)(1996-9#1)
following the cessation of##2##4##(1995-6#1)(2010-3#1)
following the first##4##3##(1993-11#1)(1993-3#1)(1996-12#1)(2013-1#1)
following the initial##2##3##(2007-8#1)(2008-1#1)
following the injection of##2##4##(2008-7#1)(2009-12#1)
following the intervention##2##3##(2008-4#1)(2013-1#1)
following the introduction of the##3##5##(2008-10#2)(2012-3#1)
following the introduction of##5##4##(2007-11#1)(2008-10#2)(2011-1#1)(2012-3#1)
following the last##2##3##(1992-8#1)(1996-12#1)
following the methods recommended##2##4##(2012-12#2)
following the onset of##2##4##(2008-1#1)(2008-4#1)
following the principles of##2##4##(2011-2#1)(2013-1#1)
following the procedure##2##3##(2008-10#1)(2008-7#1)
following the removal of##3##4##(1993-1#1)(2008-11#1)(2008-7#1)
following the review##2##3##(2007-12#1)(2008-7#1)
following the same##2##3##(2009-10#1)(2013-1#1)
following the second##2##3##(1994-12#1)(2008-3#1)
following the use of##6##4##(1995-11#1)(1995-4#1)(2007-10#2)(2012-2#1)(2012-3#1)
following the##187##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-7#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#18)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#3)
following their##11##2##(1996-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-5#1)(2013-1#2)(2013-8#2)
following themes##3##2##(2008-11#1)(2008-12#1)(2012-1#1)
following therapy##2##2##(1990-6#1)(2008-10#1)
following thermal##2##2##(2008-9#1)(2009-3#1)
following these##3##2##(1996-12#1)(2008-1#1)(2008-10#1)
following this##5##2##(2008-11#1)(2008-6#1)(2009-7#1)(2010-3#1)(2010-5#1)
following three##9##2##(1994-2#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2013-1#1)
following tissue solubilization##2##3##(2008-10#2)
following tooth extraction##4##3##(2007-12#4)
following topical##2##2##(1992-2#1)(2008-5#1)
following topics##4##2##(1995-12#1)(1996-1#1)(1996-3#1)(2008-1#1)
following total hip arthroplasty##2##4##(2011-2#1)(2012-2#1)
following total hip replacement##4##4##(2007-11#1)(2010-10#3)
following total hip##7##3##(1994-3#1)(2007-11#1)(2010-10#3)(2011-2#1)(2012-2#1)
following total##10##2##(1994-3#1)(1996-6#1)(2007-11#1)(2008-8#1)(2010-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
following transarterial##2##2##(1996-9#1)(2013-7#1)
following transfection##2##2##(1991-11#1)(1997-7#1)
following transient expression##2##3##(1992-9#1)(1994-11#1)
following transient##5##2##(1990-7#1)(1992-9#1)(1994-11#1)(1996-12#1)(2009-12#1)
following transplantation of##2##3##(1992-12#1)(2012-12#1)
following transplantation##5##2##(1992-12#1)(2008-7#1)(2011-2#1)(2012-12#2)
following transsphenoidal surgery for##2##4##(2008-7#2)
following trauma and##3##3##(2008-9#2)(2013-1#1)
following trauma##4##2##(2008-8#1)(2008-9#2)(2013-1#1)
following traumatic brain injury in##2##5##(1993-12#1)(2012-2#1)
following traumatic brain injury##3##4##(1993-12#1)(2007-11#1)(2012-2#1)
following traumatic##5##2##(1993-12#1)(2007-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
following treatment for##2##3##(2008-6#2)
following treatment in##3##3##(1992-5#1)(1995-2#1)(2007-7#1)
following treatment of cells with##2##5##(2008-11#2)
following treatment of##7##3##(1990-5#1)(1992-1#1)(2008-11#2)(2008-4#1)(2012-2#1)(2012-3#1)
following treatment with either##2##4##(1997-1#1)(2008-6#1)
following treatment with##13##3##(1990-10#1)(1990-12#1)(1992-4#1)(1997-1#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
following treatment##45##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-5#2)(1993-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#5)(2009-9#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-8#1)
following tumour excision##2##3##(2008-6#2)
following tumour##3##2##(2008-4#1)(2008-6#2)
following two different##2##3##(2008-10#2)
following two##12##2##(1990-11#1)(1992-2#1)(1995-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
following unilateral##5##2##(1991-2#2)(1994-3#1)(1997-7#1)(2008-5#1)
following up##2##2##(1992-3#1)(2008-10#1)
following vaccination##8##2##(1995-5#1)(2007-2#2)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#1)
following variables##6##2##(2008-11#1)(2008-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
following variations##2##2##(1996-5#1)(2008-10#1)
following various##2##2##(2007-12#1)(2013-1#1)
following volcanic##2##2##(1990-6#1)(2008-9#1)
following weight loss##2##3##(2013-8#2)
following were##4##2##(1997-8#1)(2008-11#1)(2008-7#1)(2010-11#1)
following which##3##2##(2008-10#2)(2012-12#1)
following wide##2##2##(1992-2#1)(2008-6#1)
following withdrawal of##2##3##(2007-10#1)(2008-7#1)
following year##6##2##(1994-7#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)
following years##2##2##(1996-3#1)(2008-4#1)
following##2251##1##(1990-10#1)(1990-11#8)(1990-12#9)(1990-2#5)(1990-3#5)(1990-5#12)(1990-6#10)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#6)(1991-10#1)(1991-11#6)(1991-12#11)(1991-2#12)(1991-3#7)(1991-5#7)(1991-6#7)(1991-7#1)(1991-8#3)(1991-9#12)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#19)(1992-2#7)(1992-3#23)(1992-4#1)(1992-5#6)(1992-6#9)(1992-7#1)(1992-8#10)(1992-9#6)(1993-1#7)(1993-10#4)(1993-11#11)(1993-12#31)(1993-2#3)(1993-3#13)(1993-5#7)(1993-6#8)(1993-8#8)(1993-9#13)(1994-1#4)(1994-10#3)(1994-11#5)(1994-12#12)(1994-2#13)(1994-3#15)(1994-5#7)(1994-6#9)(1994-7#3)(1994-8#14)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#16)(1995-12#23)(1995-2#11)(1995-3#11)(1995-4#1)(1995-5#8)(1995-6#11)(1995-8#9)(1995-9#6)(1996-1#2)(1996-10#1)(1996-12#24)(1996-2#9)(1996-3#13)(1996-4#1)(1996-5#10)(1996-6#8)(1996-8#3)(1996-9#8)(1997-1#4)(1997-2#13)(1997-3#14)(1997-4#14)(1997-5#4)(1997-6#7)(1997-7#9)(1997-8#5)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#27)(2007-11#26)(2007-12#27)(2007-2#9)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#16)(2007-8#26)(2007-9#1)(2008-1#18)(2008-10#317)(2008-11#69)(2008-12#31)(2008-2#20)(2008-3#35)(2008-4#34)(2008-5#68)(2008-6#45)(2008-7#105)(2008-8#36)(2008-9#73)(2009-1#3)(2009-10#15)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#15)(2009-4#2)(2009-5#10)(2009-6#6)(2009-7#5)(2009-8#7)(2009-9#5)(2010-1#5)(2010-10#6)(2010-11#6)(2010-12#11)(2010-2#8)(2010-3#13)(2010-4#6)(2010-5#12)(2010-6#17)(2010-7#6)(2010-8#8)(2010-9#3)(2011-1#28)(2011-2#83)(2011-3#5)(2012-1#11)(2012-12#45)(2012-2#45)(2012-3#44)(2013-1#107)(2013-7#10)(2013-8#31)
following)##2##1##(2008-3#2)
follows a##24##2##(1990-7#2)(1991-5#1)(1993-8#1)(1994-5#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-12#1)(2010-3#1)(2013-1#2)
follows an earlier##2##3##(1993-12#1)(2007-10#1)
follows an##8##2##(1991-12#1)(1993-12#1)(2007-10#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
follows from##4##2##(2008-3#2)(2012-12#1)(2013-8#1)
follows that the##3##3##(1990-11#1)(1994-8#1)(2009-11#1)
follows that##10##2##(1990-11#1)(1993-11#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-1#1)
follows the same pattern as##2##5##(1997-7#1)(2008-10#1)
follows the same pattern##3##4##(1994-9#1)(1997-7#1)(2008-10#1)
follows the##28##2##(1990-11#1)(1991-3#3)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-7#2)(2008-8#1)(2010-8#1)(2012-12#1)(2012-7#1)(2013-8#1)
follows##216##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#3)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#6)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-11#1)(1996-2#4)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-7#2)(1997-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#35)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#15)(2008-8#6)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2012-4#1)(2012-7#2)(2013-1#10)(2013-8#5)
followup was##2##2##(2013-1#2)
followup with##2##2##(2013-1#2)
followup##19##1##(1991-1#1)(1991-8#1)(1995-12#1)(1997-6#1)(2007-12#1)(2007-8#1)(2009-4#1)(2010-8#1)(2012-3#3)(2013-1#8)
fonction##2##1##(2007-8#1)(2011-2#1)
fontani##3##1##(2011-2#3)
food abundance##2##2##(2010-8#2)
food additive##5##2##(1993-11#1)(1994-3#1)(2008-6#1)(2009-11#1)(2011-2#1)
food additives and##2##3##(2008-11#1)(2011-2#1)
food additives##8##2##(1992-9#2)(1994-3#1)(2008-11#2)(2010-9#2)(2011-2#1)
food allergens##4##2##(1990-8#1)(2007-10#1)(2008-10#1)(2010-5#1)
food allergy and##2##3##(1991-11#1)(2011-2#1)
food allergy##6##2##(1991-11#1)(2010-5#4)(2011-2#1)
food analysis##9##2##(2008-10#8)(2011-1#1)
food and agriculture##2##3##(1997-2#1)(2010-7#1)
food and beverage##4##3##(2008-10#1)(2008-12#1)(2010-9#1)(2012-2#1)
food and beverages##5##3##(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#2)
food and environmental##2##3##(2008-10#2)
food and feed samples##2##4##(2008-10#2)
food and feed##9##3##(1993-12#1)(2008-10#8)
food and feeds##3##3##(1993-3#1)(2010-7#2)
food and medicine##3##3##(1996-11#3)
food and nutrient intake##2##4##(2010-6#2)
food and pharmaceutical industries##2##4##(2008-6#1)(2008-9#1)
food and water intake##2##4##(1993-12#1)(2013-1#1)
food and water##6##3##(1991-2#2)(1993-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
food and##62##2##(1991-2#2)(1992-5#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1996-11#3)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-9#1)(2011-2#2)(2012-2#4)(2013-1#1)
food antigens##2##2##(2008-10#1)(2008-11#1)
food as well as##2##4##(2008-10#2)
food as##5##2##(2008-10#2)(2008-2#1)(2009-4#1)(2012-2#1)
food at##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
food availability for##3##3##(2008-8#3)
food availability##9##2##(1994-2#1)(2008-5#1)(2008-8#3)(2008-9#2)(2012-12#1)(2012-2#1)
food available##3##2##(2008-5#1)(2008-9#1)(2012-12#1)
food bolus##3##2##(2007-12#2)(2009-7#1)
food borne##2##2##(2011-2#2)
food but##3##2##(1993-6#1)(2008-5#1)(2009-5#1)
food by##3##2##(1992-12#1)(1997-6#1)(2008-10#1)
food carrying##2##2##(1993-6#2)
food chain##19##2##(1994-3#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#3)(2011-2#2)(2013-1#1)(2013-8#1)
food chains are##2##3##(2008-9#2)
food chains by##2##3##(2008-8#1)(2008-9#1)
food chains##11##2##(2008-8#4)(2008-9#6)(2013-1#1)
food choice##7##2##(1991-1#1)(2010-6#1)(2012-1#5)
food choices##3##2##(2008-5#1)(2012-1#1)(2012-2#1)
food components##2##2##(2008-10#1)(2012-2#1)
food conditions##2##2##(2008-9#2)
food consumption and##4##3##(1994-2#1)(1997-4#1)(2008-5#1)(2008-7#1)
food consumption by##2##3##(1997-4#1)(2008-4#1)
food consumption in##2##3##(1994-6#1)(2008-3#1)
food consumption##21##2##(1990-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2010-6#1)(2012-2#3)
food containing##4##2##(2008-10#2)(2011-2#1)(2013-7#1)
food control##3##2##(2008-10#2)(2011-2#1)
food conversion##2##2##(2010-8#1)(2013-7#1)
food crops##2##2##(2011-2#2)
food deprivation##13##2##(1991-1#1)(1993-12#1)(1995-5#1)(1997-2#2)(2011-1#8)
food for##7##2##(1992-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)
food formulations##2##2##(2008-6#1)(2012-2#1)
food fortification programs##2##3##(2012-1#2)
food frequency questionnaire##3##3##(1993-9#1)(2011-1#1)(2013-1#1)
food frequency##4##2##(1993-9#1)(1995-2#1)(2011-1#1)(2013-1#1)
food from##3##2##(1991-12#1)(1994-3#1)(2008-10#1)
food group##4##2##(2008-1#1)(2011-1#1)(2011-2#2)
food guide##4##2##(2011-2#4)
food guides##4##2##(2011-2#4)
food habits##5##2##(2008-11#1)(2012-2#2)(2013-7#2)
food handler-associated##2##2##(2009-3#2)
food handlers in##2##3##(2009-3#1)(2013-1#1)
food handlers##4##2##(2007-12#1)(2009-3#2)(2013-1#1)
food handling##4##2##(1994-3#1)(2007-12#1)(2010-4#1)(2012-2#1)
food hoarding##2##2##(2008-9#2)
food in##11##2##(1992-12#1)(1993-6#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2012-3#1)(2013-1#1)
food industry##10##2##(1996-11#2)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#3)(2012-2#2)
food ingestion##3##2##(2008-7#2)(2012-2#1)
food ingredients##5##2##(1994-3#1)(2011-2#3)(2012-2#1)
food insecurity##4##2##(1994-12#1)(2008-1#2)(2012-12#1)
food intake and energy##2##4##(2008-3#1)(2008-4#1)
food intake and##16##3##(1992-8#1)(1993-8#1)(1997-3#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#3)(2013-8#2)
food intake as##2##3##(1996-2#1)(2008-11#1)
food intake during##2##3##(2008-7#1)(2008-9#1)
food intake following 24 hours of food deprivation##2##8##(2011-1#2)
food intake of the##2##4##(2008-7#1)(2012-3#1)
food intake of##4##3##(1996-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
food intake was##2##3##(1993-8#1)(2010-8#1)
food intake##59##2##(1992-8#1)(1993-12#1)(1993-8#2)(1995-5#1)(1996-2#5)(1997-3#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#4)(2008-9#1)(2009-12#3)(2009-5#1)(2009-8#2)(2010-6#3)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#3)
food intolerance##2##2##(1997-6#2)
food is##8##2##(1993-6#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
food item##3##2##(1993-9#1)(2008-5#1)(2009-5#1)
food items##14##2##(1993-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-4#1)(2009-5#4)(2011-2#1)
food manufacturing##3##2##(1994-3#3)
food of##4##2##(1997-4#1)(2008-9#1)(2013-8#2)
food on the##2##3##(2008-11#1)(2009-10#1)
food on##3##2##(1997-1#1)(2008-11#1)(2009-10#1)
food or solution##2##3##(2008-4#2)
food or water##2##3##(2007-2#1)(2008-2#1)
food or##12##2##(1993-6#1)(1994-11#1)(1995-10#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-4#2)(2011-2#2)(2012-2#1)
food packaging##4##2##(1994-3#2)(2008-10#1)(2010-7#1)
food pairing##2##2##(2012-2#2)
food particles##3##2##(2008-6#1)(2008-7#2)
food pathogens##2##2##(1997-4#1)(2008-9#1)
food pellets##2##2##(1993-12#1)(1993-6#1)
food poisoning##5##2##(1990-6#1)(2011-2#4)
food preferences in##2##3##(2008-4#1)(2012-2#1)
food preferences##3##2##(2008-4#1)(2012-12#1)(2012-2#1)
food preparation##3##2##(2010-4#1)(2012-2#2)
food preservation##2##2##(2010-7#1)(2011-2#1)
food preservative##4##2##(2008-11#1)(2008-6#1)(2008-8#2)
food prices##2##2##(1992-5#1)(2012-12#1)
food processing##2##2##(2008-9#1)(2011-2#1)
food product##2##2##(1997-4#1)(2011-2#1)
food production##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
food products has##2##3##(2008-1#1)(2008-10#1)
food products with##4##3##(2008-10#2)(2010-7#1)(2011-2#1)
food products##32##2##(1992-11#2)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#10)(2009-5#1)(2009-8#2)(2010-7#5)(2011-2#6)(2013-1#1)
food protein##2##2##(2008-10#1)(2008-5#1)
food purchases##2##2##(2011-2#2)
food quality and safety##2##4##(2010-7#1)(2011-2#1)
food quality##5##2##(2008-10#2)(2008-9#1)(2010-7#1)(2011-2#1)
food quantity and##2##3##(2008-9#2)
food quantity##4##2##(2008-9#4)
food ration##4##2##(2010-8#4)
food rations##2##2##(2010-8#2)
food records##3##2##(1994-12#1)(2013-1#2)
food resource##2##2##(2008-5#1)(2010-8#1)
food resources regulated the size of##2##6##(2008-8#2)
food resources##7##2##(2008-8#5)(2008-9#1)(2012-3#1)
food restriction on the##3##4##(1990-3#1)(1993-12#2)
food restriction##10##2##(1990-3#6)(1990-9#1)(1993-12#2)(2008-4#1)
food safety and nutritional status in##2##6##(2012-12#2)
food safety and##4##3##(2012-12#2)(2012-2#1)(2013-1#1)
food safety in the home##2##5##(2007-12#2)
food safety in##3##3##(2007-12#2)(2012-12#1)
food safety##23##2##(1990-3#1)(2007-12#7)(2008-10#1)(2008-11#2)(2010-4#1)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#1)
food samples after digestion##2##4##(2008-10#2)
food samples by##2##3##(2008-10#2)
food samples is##2##3##(2008-10#2)
food samples##34##2##(2008-10#32)(2008-11#1)(2011-1#1)
food scores##2##2##(1991-12#2)
food security of##2##3##(1994-12#1)(2008-1#1)
food security##10##2##(1994-12#3)(1997-7#1)(2008-1#4)(2008-10#1)(2011-1#1)
food served##2##2##(1995-2#2)
food service establishments##2##3##(2007-12#2)
food service managers##2##3##(1996-1#2)
food service workers##2##3##(1995-1#2)
food service##7##2##(1995-1#3)(1996-1#2)(2007-12#2)
food source##7##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#2)
food sources##2##2##(2008-10#1)(2008-8#1)
food specific##2##2##(1990-6#2)
food spoilage and##2##3##(2011-2#2)
food spoilage##7##2##(2008-7#1)(2011-2#6)
food substances##6##2##(1997-4#3)(2008-11#3)
food supplementation##2##2##(1996-12#1)(2008-5#1)
food supply##9##2##(1990-6#1)(1997-4#1)(2007-12#2)(2008-10#1)(2009-3#1)(2010-6#1)(2012-1#1)(2012-2#1)
food to eat it##2##4##(1993-6#2)
food to##9##2##(1993-6#4)(1997-4#1)(2008-9#1)(2010-4#2)(2013-1#1)
food type##2##2##(2008-1#1)(2008-11#1)
food types##8##2##(2007-12#2)(2008-10#1)(2008-11#2)(2008-8#2)(2010-6#1)
food utilization##2##2##(2008-12#1)(2008-9#1)
food was##4##2##(1992-12#1)(1993-9#1)(2009-10#1)(2009-11#1)
food web##16##2##(2008-10#1)(2008-8#4)(2008-9#11)
food webs and the##2##4##(2008-8#1)(2008-9#1)
food webs and##3##3##(2008-8#1)(2008-9#2)
food webs##15##2##(2008-8#5)(2008-9#7)(2012-12#2)(2012-2#1)
food were##2##2##(2008-1#1)(2008-5#1)
food with a##2##3##(1992-11#1)(2012-2#1)
food with##7##2##(1992-11#1)(1994-3#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
food##985##1##(1990-2#2)(1990-3#7)(1990-6#5)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#4)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#8)(1993-3#3)(1993-5#1)(1993-6#20)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#26)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#3)(1996-1#2)(1996-11#5)(1996-12#2)(1996-2#5)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#23)(1997-6#4)(1997-7#2)(2007-10#3)(2007-11#1)(2007-12#26)(2007-2#2)(2007-7#3)(2008-1#24)(2008-10#153)(2008-11#30)(2008-12#9)(2008-2#6)(2008-3#5)(2008-4#20)(2008-5#33)(2008-6#14)(2008-7#20)(2008-8#39)(2008-9#60)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#5)(2009-4#3)(2009-5#14)(2009-6#1)(2009-7#1)(2009-8#11)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#10)(2010-5#12)(2010-6#12)(2010-7#18)(2010-8#12)(2010-9#4)(2011-1#21)(2011-2#77)(2012-1#13)(2012-12#19)(2012-2#53)(2012-3#4)(2013-1#19)(2013-7#7)(2013-8#10)
food)##2##1##(2007-12#1)(2008-11#1)
food- and water-borne pathogens##2##4##(2011-1#2)
food-based##4##1##(2009-11#4)
food-borne pathogen##2##2##(2008-7#1)(2008-9#1)
food-borne##5##1##(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
food-deprived rats##4##2##(1993-12#2)(1993-6#1)(1997-2#1)
food-deprived##5##1##(1993-12#2)(1993-6#1)(1995-5#1)(1997-2#1)
food-derived##2##1##(1992-6#1)(2012-2#1)
food-hoarding##2##1##(2008-9#2)
food-related life##5##2##(2012-2#5)
food-related waste##2##2##(1996-1#2)
food-related##10##1##(1993-6#1)(1996-1#2)(2011-2#1)(2012-2#5)(2012-3#1)
food-stuffs##2##1##(2008-10#1)(2013-8#1)
foodborne botulism##2##2##(2007-12#1)(2011-2#1)
foodborne disease##8##2##(2007-12#8)
foodborne diseases##3##2##(2012-2#3)
foodborne illness##4##2##(2007-12#2)(2011-2#2)
foodborne parasites##2##2##(2007-12#2)
foodborne pathogen##2##2##(2011-1#1)(2011-2#1)
foodborne pathogens##6##2##(2007-12#1)(2008-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
foodborne##35##1##(1992-4#1)(2007-12#19)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#4)
foods and beverages##4##3##(2008-10#1)(2012-12#2)(2012-2#1)
foods and food##2##3##(2007-12#1)(2011-2#1)
foods and##19##2##(1996-11#1)(1997-4#1)(2007-12#2)(2008-10#3)(2008-11#2)(2010-1#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#3)
foods as##2##2##(2008-10#2)
foods at##3##2##(1994-9#1)(2007-12#1)(2012-2#1)
foods by##4##2##(2008-10#3)(2010-2#1)
foods consumed##2##2##(1994-9#1)(2010-4#1)
foods for##3##2##(1994-3#1)(1997-2#1)(2008-9#1)
foods has##2##2##(2008-10#1)(2010-7#1)
foods in##6##2##(1997-2#1)(2008-1#3)(2008-10#1)(2012-2#1)
foods is##2##2##(1994-3#1)(2008-1#1)
foods may##2##2##(2008-4#1)(2009-11#1)
foods of##3##2##(2008-1#1)(2012-2#2)
foods on##2##2##(2012-12#2)
foods or##2##2##(2008-4#1)(2011-2#1)
foods rich in##5##3##(1997-8#2)(2010-6#2)(2012-1#1)
foods that##4##2##(2008-11#2)(2012-1#1)(2012-12#1)
foods through##2##2##(2010-1#1)(2011-2#1)
foods were also##2##3##(2008-1#1)(2010-6#1)
foods were##5##2##(2008-1#2)(2008-4#1)(2010-6#2)
foods with##6##2##(2007-12#1)(2008-10#3)(2011-1#1)(2011-2#1)
foods##164##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-10#2)(1993-6#1)(1994-1#1)(1994-3#6)(1994-9#3)(1995-2#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#2)(2007-12#8)(2007-2#1)(2007-3#1)(2008-1#15)(2008-10#29)(2008-11#6)(2008-12#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#7)(2010-7#1)(2011-1#1)(2011-2#14)(2012-1#7)(2012-12#6)(2012-2#15)(2013-1#1)(2013-7#1)(2013-8#1)
foods)##2##1##(2008-1#2)
foodservice##15##1##(1992-1#1)(1993-2#3)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)
foodstuff samples##2##2##(2008-10#2)
foodstuff##4##1##(2007-12#1)(2008-10#3)
foodstuffs and##2##2##(2008-10#1)(2011-2#1)
foodstuffs have been##2##3##(1997-4#1)(2008-10#1)
foodstuffs##22##1##(1990-8#1)(1997-4#1)(2008-10#15)(2010-3#1)(2011-2#4)
foot and ankle##17##3##(2008-12#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#6)(2012-3#1)
foot and mouth disease in the##2##6##(2008-12#2)
foot and mouth disease in##4##5##(2008-12#4)
foot and mouth disease##8##4##(2008-12#5)(2011-2#1)(2013-8#2)
foot and mouth##9##3##(2008-12#5)(2011-2#2)(2013-8#2)
foot and##33##2##(2007-8#1)(2008-12#6)(2008-8#1)(2009-10#1)(2009-3#1)(2010-3#3)(2010-5#1)(2010-7#3)(2011-2#6)(2012-2#7)(2012-3#1)(2013-8#2)
foot care##3##2##(2013-1#2)(2013-8#1)
foot deformity##9##2##(1990-9#1)(2007-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#4)
foot drop##4##2##(2008-6#2)(2009-11#2)
foot during##2##2##(1996-11#1)(2008-7#1)
foot in##3##2##(2007-11#3)
foot melanoma##4##2##(2012-3#4)
foot of##3##2##(1992-2#1)(2008-3#1)(2013-1#1)
foot pain##3##2##(2010-3#2)(2011-2#1)
foot protein##10##2##(1992-3#8)(1995-6#2)
foot rot##2##2##(2008-10#1)(2008-8#1)
foot syndrome##4##2##(2011-1#1)(2012-12#3)
foot ulcer##5##2##(2007-7#1)(2008-8#2)(2010-10#1)(2013-1#1)
foot ulcers##6##2##(2008-5#2)(2010-10#3)(2012-2#1)
foot were##3##2##(1997-8#1)(2007-11#1)(2007-7#1)
foot with##2##2##(2008-12#1)(2010-3#1)
foot##188##1##(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#9)(1994-8#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#12)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#10)(2009-11#2)(2009-3#3)(2009-4#1)(2010-10#4)(2010-11#4)(2010-12#1)(2010-3#23)(2010-5#5)(2010-7#3)(2010-9#2)(2011-1#1)(2011-2#15)(2012-12#5)(2012-2#19)(2012-3#12)(2013-1#11)(2013-8#5)
foot-and-mouth disease virus##3##3##(1994-8#2)(2011-1#1)
foot-and-mouth disease##7##2##(1994-8#2)(2007-6#1)(2009-2#1)(2011-1#1)(2013-1#2)
foot/hand cases##2##2##(2008-8#2)
football##5##1##(2009-1#1)(2010-5#1)(2010-9#1)(2013-1#2)
footballers##2##1##(2012-1#1)(2012-3#1)
foothold in##2##2##(2008-11#1)(2008-12#1)
foothold##3##1##(2007-12#1)(2008-11#1)(2008-12#1)
footplate##4##1##(2008-9#2)(2011-1#2)
footprint analysis##2##2##(1993-11#1)(2008-8#1)
footprint of the##2##3##(2008-4#1)(2013-1#1)
footprint of##5##2##(2008-4#1)(2010-5#1)(2012-2#2)(2013-1#1)
footprint##18##1##(1993-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-1#3)(2012-2#2)(2013-1#1)
footprinting analysis##2##2##(1990-5#1)(2008-9#1)
footprinting and##5##2##(1994-9#1)(1995-6#1)(1997-7#1)(2008-2#1)(2008-9#1)
footprinting##23##1##(1990-5#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-2#2)(2008-4#6)(2008-7#2)(2008-8#1)(2008-9#2)
footprints##3##1##(2008-3#2)(2011-1#1)
footshock##5##1##(2008-11#2)(2008-4#3)
footwear##3##1##(1990-3#1)(2010-3#2)
for &gt##19##2##(1993-11#1)(1995-2#3)(1996-7#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-6#1)(2013-1#1)
for &lt##2##2##(2011-2#2)
for &quot##33##2##(1990-5#1)(1991-8#1)(1992-6#1)(1992-8#3)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-4#3)(2011-2#1)(2012-2#1)
for 'Oketsu'##2##2##(2008-10#2)
for 'Okrun'##2##2##(2008-10#2)
for 'Spanco'##3##2##(2008-10#3)
for (1)##4##2##(1991-5#1)(1992-3#1)(2008-4#1)(2012-12#1)
for /(see text)/##2##3##(2013-8#2)
for 0 to##2##3##(2008-10#1)(2008-12#1)
for 0##39##2##(1991-6#2)(1997-2#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2012-2#3)
for 1 and##2##3##(1995-3#1)(2012-3#1)
for 1 h at##2##4##(1993-12#1)(2008-6#1)
for 1 h or##3##4##(1995-12#1)(2008-2#2)
for 1 h the##2##4##(2007-11#1)(2008-5#1)
for 1 h##19##3##(1990-12#1)(1992-12#1)(1992-6#2)(1993-12#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
for 1 hour##2##3##(1993-8#1)(2008-10#1)
for 1 hr##2##3##(1993-9#1)(2009-11#1)
for 1 min##3##3##(1995-12#1)(2008-10#2)
for 1 month##2##3##(2010-3#1)(2011-2#1)
for 1 mug ml(-1)##2##4##(2008-10#2)
for 1 mug##3##3##(2008-10#3)
for 1 or##2##3##(2008-10#1)(2013-8#1)
for 1 to 2##2##4##(2012-3#1)(2013-8#1)
for 1 to##8##3##(1991-12#1)(1993-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
for 1 week (n =##2##5##(2007-10#2)
for 1 week in the presence of##2##7##(2008-10#2)
for 1 week##11##3##(2007-10#2)(2008-10#3)(2008-11#2)(2008-6#1)(2009-7#1)(2011-2#1)(2013-8#1)
for 1 x##2##3##(2008-10#2)
for 1 year after##2##4##(1992-8#1)(1997-1#1)
for 1 year##10##3##(1992-8#1)(1992-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2009-7#1)(2011-2#1)(2012-12#1)
for 1##123##2##(1990-12#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-7#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#48)(2008-11#4)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-7#2)(2009-8#1)(2010-3#2)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#5)
for 1-3##2##2##(2008-10#1)(2008-5#1)
for 10 and##3##3##(1997-2#1)(2008-10#2)
for 10 consecutive days##2##4##(2011-2#2)
for 10 consecutive##5##3##(2008-10#2)(2011-2#2)(2013-8#1)
for 10 days and##2##4##(2010-3#1)(2011-2#1)
for 10 days##11##3##(1990-12#1)(1991-8#1)(1992-6#1)(1993-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#2)
for 10 days)##3##3##(1990-12#1)(1992-11#1)(2011-1#1)
for 10 determinations of##2##4##(2008-10#2)
for 10 h##5##3##(2008-10#2)(2008-12#1)(2008-9#1)(2012-2#1)
for 10 min in##2##4##(1990-12#1)(1990-8#1)
for 10 min##18##3##(1990-11#1)(1990-12#1)(1990-8#1)(1993-11#1)(1993-3#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(2006-11#1)(2007-3#1)(2008-10#4)(2008-4#2)(2008-7#1)
for 10 minutes##3##3##(2008-11#1)(2008-12#1)(2010-1#1)
for 10 months##4##3##(2007-8#2)(2008-10#2)
for 10 mug##2##3##(2008-10#2)
for 10 replicate determinations of##2##5##(2008-10#2)
for 10 replicate determinations##6##4##(2008-10#6)
for 10 replicate injections##2##4##(2008-10#2)
for 10 replicate##8##3##(2008-10#8)
for 10 samples##2##3##(2008-10#1)(2010-6#1)
for 10 successive##2##3##(2008-10#2)
for 10 times##2##3##(2008-10#2)
for 10 weeks##2##3##(2008-3#1)(2012-12#1)
for 10 years##9##3##(1992-3#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
for 10##109##2##(1990-11#1)(1990-12#4)(1990-8#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(2006-11#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#43)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
for 100##9##2##(2007-11#1)(2008-10#6)(2008-3#1)(2011-2#1)
for 100%##2##2##(2008-10#1)(2008-2#1)
for 1000##2##2##(2008-11#1)(2008-2#1)
for 105##3##2##(1994-6#1)(1996-10#1)(2009-12#1)
for 10min in an##2##4##(2008-10#2)
for 10min##6##2##(2008-10#6)
for 10 days##3##2##(2013-1#3)
for 11 months##2##3##(1995-2#1)(2008-7#1)
for 11 replicate determinations of##2##5##(2008-10#2)
for 11 replicate##5##3##(2008-10#5)
for 11##17##2##(1995-2#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
for 110##2##2##(2008-10#1)(2013-8#1)
for 12 d##2##3##(2011-2#2)
for 12 days##4##3##(1992-11#1)(1995-12#1)(2008-1#1)(2008-11#1)
for 12 h##9##3##(1991-9#1)(1996-2#2)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)
for 12 hours##3##3##(1993-6#1)(2010-2#1)(2012-12#1)
for 12 months##8##3##(1990-6#1)(2007-5#2)(2008-3#2)(2008-6#1)(2010-1#1)(2011-2#1)
for 12 to##2##3##(2008-10#2)
for 12 weeks and##2##4##(2008-5#2)
for 12 weeks##14##3##(2007-10#1)(2008-1#3)(2008-10#3)(2008-4#1)(2008-5#4)(2011-2#1)(2013-7#1)
for 12##56##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-11#2)(1993-6#1)(1995-12#1)(1996-2#2)(1997-3#1)(2007-10#1)(2007-5#2)(2008-1#4)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#2)
for 120 min##2##3##(2008-10#1)(2010-2#1)
for 120##3##2##(2008-10#2)(2010-2#1)
for 120s##3##2##(2008-10#3)
for 13 days##4##3##(1990-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
for 13 years##2##3##(2008-8#1)(2011-1#1)
for 13##13##2##(1990-11#1)(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
for 13C##2##2##(1995-11#1)(1995-6#1)
for 14 days##18##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-10#1)(1995-12#2)(2008-10#4)(2008-11#2)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
for 14 weeks##6##3##(2008-10#1)(2008-9#4)(2013-1#1)
for 14##33##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-10#1)(1995-12#3)(2008-10#10)(2008-11#3)(2008-6#1)(2008-9#4)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
for 15 STR##3##3##(2008-12#3)
for 15 days and##3##4##(2008-10#3)
for 15 days##8##3##(2008-10#3)(2008-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
for 15 min with##2##4##(1994-6#2)
for 15 min##12##3##(1992-10#1)(1994-6#2)(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#4)(2012-3#1)(2013-8#1)
for 15 or##2##3##(1995-12#1)(2010-2#1)
for 15 weeks##2##3##(1995-11#1)(2008-4#1)
for 15##47##2##(1992-10#1)(1993-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#4)(2008-4#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
for 15min##4##2##(2008-10#2)(2013-1#2)
for 16 d##2##3##(2009-4#1)(2011-2#1)
for 16 weeks##5##3##(1992-10#1)(1994-2#1)(2008-9#1)(2010-2#1)(2013-1#1)
for 16 years##2##3##(2010-3#1)(2013-1#1)
for 16##22##2##(1990-6#1)(1991-11#1)(1992-10#1)(1994-1#1)(1994-2#1)(1995-12#1)(2006-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#3)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
for 17 days##4##3##(2008-9#2)(2011-2#1)(2012-2#1)
for 17##14##2##(1991-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)
for 18 h##4##3##(1996-2#1)(1997-4#1)(2008-11#1)(2009-6#1)
for 18 hours##2##3##(1993-8#1)(2010-6#1)
for 18 months##4##3##(1996-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
for 18##15##2##(1993-8#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-4#2)(2008-10#3)(2008-11#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#2)
for 180##3##2##(2008-10#2)(2008-2#1)
for 18C6##2##2##(2008-10#2)
for 19##5##2##(1995-9#1)(2008-10#3)(2008-12#1)
for 190##2##2##(1995-12#1)(2008-12#1)
for 193 nm##2##3##(2008-3#2)
for 1984##2##2##(1992-2#1)(1993-3#1)
for 1988##3##2##(1990-12#1)(1991-3#1)(1992-2#1)
for 1992##2##2##(1995-2#2)
for 1994##5##2##(1994-1#1)(1995-3#2)(1996-12#1)(1997-1#1)
for 1996 and 1997##2##4##(2008-10#2)
for 1996##3##2##(2008-10#2)(2008-11#1)
for 1997##2##2##(2008-5#1)(2011-2#1)
for 1h##2##2##(2010-6#1)(2013-1#1)
for 1 week##2##2##(2013-1#2)
for 2 and##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
for 2 days##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
for 2 h with##2##4##(1995-8#1)(2008-10#1)
for 2 h##14##3##(1990-2#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-8#3)(2008-10#4)(2008-5#1)(2008-6#1)(2010-2#1)
for 2 hours##3##3##(1992-12#1)(2007-7#1)(2012-2#1)
for 2 min##3##3##(1993-1#1)(2008-10#2)
for 2 months and the##2##5##(2008-10#1)(2008-5#1)
for 2 months##8##3##(1990-2#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2011-2#1)
for 2 of 3##3##4##(2007-11#2)(2008-10#1)
for 2 or##2##3##(2008-10#1)(2008-11#1)
for 2 to##3##3##(1993-1#1)(1993-2#1)(2008-5#1)
for 2 week##2##3##(2008-11#2)
for 2 weeks and##2##4##(2007-7#1)(2008-10#1)
for 2 weeks with##2##4##(1995-12#1)(2008-5#1)
for 2 weeks##29##3##(1991-8#1)(1992-3#1)(1992-8#2)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#3)(2008-7#1)(2008-9#4)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
for 2 x##2##3##(2008-10#2)
for 2 years##10##3##(1995-11#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-9#1)
for 2##146##2##(1990-11#1)(1990-2#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#3)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-8#3)(1996-12#1)(1996-2#2)(1997-7#4)(2007-11#3)(2007-7#2)(2008-1#1)(2008-10#51)(2008-11#12)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#2)(2008-9#5)(2009-3#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
for 2-[125I]iodomelatonin##2##2##(1995-12#2)
for 20 days##3##3##(1995-3#1)(2008-10#1)(2013-8#1)
for 20 h##4##3##(2007-11#1)(2008-10#1)(2008-9#1)(2010-5#1)
for 20 min##13##3##(1990-2#1)(1992-3#1)(1993-11#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-2#1)
for 20 mul loop)##2##4##(2008-10#2)
for 20 mul##3##3##(2008-10#3)
for 20 or##3##3##(2008-7#1)(2008-9#2)
for 20 weeks##4##3##(1990-7#1)(2008-9#3)
for 20##43##2##(1990-2#1)(1990-7#1)(1992-3#1)(1993-11#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#18)(2008-11#2)(2008-5#2)(2008-7#3)(2008-9#6)(2010-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
for 20% of##3##3##(1993-12#1)(1997-7#1)(2008-10#1)
for 2004##2##2##(2008-10#1)(2010-2#1)
for 2005##2##2##(2008-8#1)(2012-12#1)
for 2006##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
for 2015##2##2##(2008-8#1)(2010-12#1)
for 20min##2##2##(2008-10#1)(2013-1#1)
for 20s##4##2##(2008-10#4)
for 21 consecutive days##2##4##(2008-10#1)(2012-3#1)
for 21 days##7##3##(1995-3#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)
for 21 h##2##3##(1996-5#1)(2008-5#1)
for 21 of the##2##4##(2008-7#1)(2012-3#1)
for 21##20##2##(1992-3#1)(1994-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#3)(2012-3#2)
for 22 days##3##3##(1992-12#1)(2008-9#1)(2012-2#1)
for 22##11##2##(1992-12#1)(1992-3#2)(1993-3#1)(1996-6#1)(2008-10#4)(2008-9#1)(2012-2#1)
for 23##3##2##(1991-3#1)(2008-10#1)(2008-7#1)
for 24 and##2##3##(2008-12#1)(2013-1#1)
for 24 h and##2##4##(2007-2#1)(2008-9#1)
for 24 h at##2##4##(1990-5#1)(2008-12#1)
for 24 h in##6##4##(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)
for 24 h with##2##4##(1995-3#1)(2008-11#1)
for 24 h##43##3##(1990-12#1)(1990-5#1)(1992-12#1)(1993-12#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#2)(1997-7#1)(2007-2#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
for 24 hours with##2##4##(2008-10#1)(2011-2#1)
for 24 hours##8##3##(1992-6#1)(1996-9#2)(2007-10#1)(2008-10#2)(2008-11#1)(2011-2#1)
for 24 hr##2##3##(1993-9#1)(2008-11#1)
for 24 hrs##5##3##(1992-11#1)(2008-10#4)
for 24 months##3##3##(2007-7#1)(2007-8#1)(2010-1#1)
for 24 to 48##2##4##(2008-1#1)(2008-10#1)
for 24 to##3##3##(2008-1#1)(2008-10#1)(2009-9#1)
for 24##76##2##(1990-10#1)(1990-12#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
for 24-48##2##2##(1994-8#1)(1996-2#1)
for 24-h##2##2##(1995-11#2)
for 240 min##4##3##(1996-12#1)(2008-6#1)(2010-1#2)
for 24h##6##2##(1990-11#1)(1993-6#1)(2008-10#2)(2012-3#1)(2013-1#1)
for 25 min##2##3##(1991-2#1)(1997-2#1)
for 25##8##2##(1991-2#1)(1997-2#1)(2008-1#2)(2008-10#3)(2008-7#1)
for 250 ml sample##2##4##(2008-10#2)
for 26 or 39 weeks##5##5##(2008-9#5)
for 26 or 41 weeks##5##5##(2008-9#5)
for 26 or##12##3##(2008-9#12)
for 26 weeks with additional groups of 10 males and 10 females##3##12##(2008-9#3)
for 26 weeks##17##3##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#13)(2010-11#1)
for 26##32##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#25)(2010-11#1)(2012-2#1)
for 27 of##2##3##(1994-1#1)(2008-10#1)
for 27 or 43 weeks##4##5##(2008-9#4)
for 27 weeks##5##3##(2008-9#5)
for 27##14##2##(1994-1#1)(2007-10#1)(2008-10#3)(2008-9#9)
for 28 days resulted in##2##5##(2008-10#1)(2008-12#1)
for 28 days##12##3##(1994-6#1)(1994-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-1#3)
for 28##17##2##(1994-6#1)(1994-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#4)(2010-6#1)(2013-1#3)
for 29 days##2##3##(1992-11#2)
for 29##3##2##(1992-11#2)(1995-12#1)
for 290##2##2##(2008-9#1)(2009-11#1)
for 2min##2##2##(2008-10#2)
for 2x2##2##2##(2010-1#2)
for 3 and 5 days##2##5##(1992-5#1)(2013-1#1)
for 3 and##4##3##(1990-5#1)(1992-5#1)(1997-4#1)(2013-1#1)
for 3 d##2##3##(2008-8#1)(2011-2#1)
for 3 days and##2##4##(2007-7#1)(2007-8#1)
for 3 days followed by##3##5##(1991-11#1)(1996-6#1)(2008-10#1)
for 3 days##22##3##(1990-2#1)(1991-11#1)(1992-9#1)(1993-6#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
for 3 dimensional conformal##2##4##(2012-12#2)
for 3 h at 37°C##2##5##(2013-1#2)
for 3 h at##4##4##(1993-12#1)(2013-1#3)
for 3 h##12##3##(1990-7#1)(1991-9#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#3)
for 3 hours##3##3##(2008-8#2)(2012-2#1)
for 3 min of preconcentration time##2##6##(2008-10#2)
for 3 min##10##3##(2008-10#4)(2008-11#1)(2013-1#5)
for 3 months at##2##4##(2008-10#1)(2008-5#1)
for 3 months##23##3##(1991-12#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-9#3)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#2)
for 3 of##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
for 3 successive##2##3##(2007-10#1)(2008-10#1)
for 3 weeks##11##3##(1990-11#1)(1992-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#1)
for 3 years##8##3##(1992-6#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-8#1)
for 3##133##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#3)(2007-10#4)(2007-11#2)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#7)(2009-4#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#4)
for 3'##2##2##(1994-11#1)(1997-4#1)
for 3-4 days##2##3##(1995-2#1)(2008-5#1)
for 3-4##3##2##(1994-9#1)(1995-2#1)(2008-5#1)
for 3-5##2##2##(2007-11#1)(2007-7#1)
for 3-D##2##2##(2008-11#1)(2008-3#1)
for 30 and 60##2##4##(1994-11#1)(1995-3#1)
for 30 and##3##3##(1994-11#1)(1995-3#1)(2006-10#1)
for 30 days on##2##4##(1993-3#1)(2008-7#1)
for 30 days##10##3##(1993-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#2)(2012-2#1)(2013-1#1)
for 30 min and##3##4##(1990-12#1)(1992-9#1)(1995-12#1)
for 30 min at##3##4##(1992-12#1)(2008-10#1)(2010-1#1)
for 30 min followed by##2##5##(1996-5#1)(2010-1#1)
for 30 min in##3##4##(1992-6#1)(2008-10#2)
for 30 min was##2##4##(1994-3#1)(2013-1#1)
for 30 min##26##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-6#2)(2008-7#1)(2010-1#2)(2010-10#1)(2013-1#1)
for 30 min)##3##3##(1990-12#1)(1992-3#1)(1997-3#1)
for 30 minutes##5##3##(1990-8#1)(1994-3#1)(2007-10#1)(2008-12#1)(2011-1#1)
for 30 s##6##3##(2008-10#3)(2008-9#1)(2011-2#1)(2013-1#1)
for 30 successive##2##3##(2008-10#2)
for 30 years##4##3##(1996-3#1)(1996-8#1)(2011-2#1)(2012-2#1)
for 30##67##2##(1990-12#2)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-12#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#18)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#2)(2010-1#2)(2010-10#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)
for 300##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
for 30min##5##2##(2008-10#4)(2013-1#1)
for 30s##3##2##(2008-10#3)
for 31##3##2##(1991-2#1)(2011-2#1)(2012-2#1)
for 31% of the##2##4##(2007-5#1)(2010-10#1)
for 32##2##2##(2008-10#1)(2013-1#1)
for 33##3##2##(1993-8#1)(2008-7#1)(2013-1#1)
for 34##3##2##(2007-2#1)(2008-10#1)(2011-2#1)
for 35 days##2##3##(2008-12#1)(2012-12#1)
for 35 weeks##2##3##(1992-9#1)(2013-1#1)
for 35##6##2##(1992-9#1)(1996-5#1)(2008-12#1)(2012-12#2)(2013-1#1)
for 36 h##3##3##(2008-10#3)
for 36##9##2##(1991-5#1)(1997-1#1)(2007-7#1)(2008-10#4)(2012-12#1)(2013-1#1)
for 38 days when stored at##2##6##(2008-10#2)
for 39 weeks##4##3##(2008-9#4)
for 39##5##2##(2008-10#1)(2008-9#4)
for 3D##8##2##(2007-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-12#1)(2009-3#1)(2011-7#1)(2012-2#1)
for 3min##2##2##(2008-10#2)
for 3 years##2##2##(2012-6#1)(2012-9#1)
for 4 and##3##3##(1990-5#1)(1992-12#1)(2008-10#1)
for 4 days and##2##4##(2010-3#1)(2010-5#1)
for 4 days##10##3##(1993-3#1)(1997-2#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-5#1)(2011-1#1)
for 4 h and##2##4##(1992-8#1)(2008-10#1)
for 4 h at##2##4##(1990-12#1)(2008-5#1)
for 4 h day(-1) for##2##5##(2008-12#2)
for 4 h##10##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(2008-10#1)(2008-12#2)(2008-5#2)(2010-2#1)
for 4 hr##2##3##(1995-2#1)(2008-11#1)
for 4 months in##2##4##(2008-10#1)(2011-1#1)
for 4 months##5##3##(1991-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
for 4 or##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
for 4 to##2##3##(1991-4#1)(2008-5#1)
for 4 weeks were##2##4##(2007-7#1)(2008-10#1)
for 4 weeks##12##3##(1996-12#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
for 4 weeks)##2##3##(1992-12#1)(1996-7#1)
for 4 wks##2##3##(2013-1#2)
for 4 years##7##3##(2008-10#3)(2008-7#1)(2010-6#1)(2011-2#2)
for 4##79##2##(1990-12#2)(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-2#1)(1996-7#1)(1997-2#2)(2007-10#1)(2007-7#2)(2008-10#17)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#3)
for 4% of##2##3##(1997-6#1)(2008-10#1)
for 4-5##2##2##(1997-4#1)(2008-10#1)
for 4-NP determination##2##3##(2008-10#2)
for 4-aminophenol##2##2##(2008-10#2)
for 40 days##2##3##(2008-5#1)(2012-1#1)
for 40 min##3##3##(2008-10#2)(2009-12#1)
for 40 weeks##5##3##(2008-8#3)(2008-9#2)
for 40##17##2##(1994-11#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#1)
for 40% of##3##3##(1994-11#1)(2008-1#1)(2013-1#1)
for 41 weeks##7##3##(2008-9#7)
for 41##8##2##(2008-10#1)(2008-9#7)
for 42 days##2##3##(2008-10#1)(2008-7#1)
for 42 weeks (equivalent to##2##5##(2008-9#2)
for 42##6##2##(2008-10#2)(2008-7#1)(2008-9#2)(2011-3#1)
for 43##4##2##(1993-11#1)(2008-9#3)
for 44%##2##2##(1990-10#1)(2008-10#1)
for 45 min##3##3##(1990-12#1)(1991-5#1)(2011-1#1)
for 45##5##2##(1990-12#1)(1991-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
for 45%##3##2##(1991-6#1)(2009-2#1)(2012-2#1)
for 48 h##22##3##(1990-11#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
for 48 hours##2##3##(1992-8#1)(2008-11#1)
for 48 hr##3##3##(1994-8#1)(1995-2#1)(2012-12#1)
for 48 hrs##2##3##(2008-8#2)
for 48 to##2##3##(1990-10#1)(1992-2#1)
for 48 weeks##2##3##(1990-6#1)(1992-11#1)
for 48##35##2##(1990-10#1)(1990-11#1)(1990-6#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-4#1)(2008-8#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
for 5 days##18##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-9#1)(1996-6#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-12#1)(2011-2#1)
for 5 h##2##3##(1991-2#1)(2008-11#1)
for 5 min with##2##4##(2008-10#1)(2009-12#1)
for 5 min##8##3##(1992-9#1)(1997-2#1)(2008-10#5)(2009-12#1)
for 5 months##5##3##(1994-6#1)(1995-2#1)(2008-10#3)
for 5 of##2##3##(2007-11#1)(2008-10#1)
for 5 to##2##3##(2008-1#1)(2008-11#1)
for 5 weeks##6##3##(1991-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)
for 5 x##2##3##(2008-3#1)(2009-11#1)
for 5 years after##4##4##(2007-8#1)(2008-12#1)(2008-7#1)(2013-8#1)
for 5 years and##2##4##(1995-4#1)(2013-8#1)
for 5 years##11##3##(1995-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-8#2)
for 5##84##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-6#1)(1997-2#2)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-7#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#2)
for 5-10##2##2##(2008-10#1)(2010-3#1)
for 5-HT##4##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-2#1)
for 50 and##2##3##(2008-10#2)
for 50 cycles##2##3##(2008-10#1)(2008-8#1)
for 50 s##2##3##(2008-10#2)
for 50##13##2##(2008-10#8)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-12#1)
for 50% of the maximum number of apothecia to##2##9##(2008-10#2)
for 50% of the##5##4##(2008-10#4)(2008-7#1)
for 50% of##6##3##(1991-2#1)(2008-10#4)(2008-7#1)
for 50%##12##2##(1991-2#1)(1992-12#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-7#1)
for 50-300##2##2##(2008-10#2)
for 52##2##2##(1990-8#1)(1991-12#1)
for 54##2##2##(2008-12#1)(2011-1#1)
for 55##2##2##(2008-10#1)(2008-6#1)
for 56##2##2##(1993-3#1)(2011-1#1)
for 57##2##2##(1992-1#1)(1993-11#1)
for 5min at##2##3##(2008-10#1)(2012-1#1)
for 5min##6##2##(2008-10#5)(2012-1#1)
for 6 and##2##3##(2008-3#1)(2011-2#1)
for 6 days in##2##4##(1995-8#1)(2008-10#1)
for 6 days##7##3##(1995-11#1)(1995-2#1)(1995-8#3)(2008-10#1)(2008-4#1)
for 6 h##5##3##(1990-12#1)(1994-8#1)(2008-10#1)(2008-6#1)(2010-5#1)
for 6 min##3##3##(2008-10#3)
for 6 months after##2##4##(2008-1#1)(2013-1#1)
for 6 months at##2##4##(2007-11#1)(2008-10#1)
for 6 months in##2##4##(1996-3#1)(2008-10#1)
for 6 months or longer##2##5##(2008-6#1)(2011-2#1)
for 6 months##32##3##(1991-12#1)(1996-3#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#7)(2009-5#1)(2010-10#1)(2010-3#1)(2010-6#2)(2011-2#2)(2013-1#3)(2013-8#3)
for 6 of##2##3##(2008-10#1)(2009-10#1)
for 6 weeks after##2##4##(1990-12#1)(1992-3#1)
for 6 weeks in##2##4##(2008-10#1)(2013-1#1)
for 6 weeks##22##3##(1990-12#1)(1992-3#1)(1992-8#1)(1995-12#1)(1996-6#1)(2007-8#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-6#1)(2012-2#3)(2013-1#2)
for 6 weeks)##3##3##(1992-3#1)(1996-6#1)(2008-8#1)
for 6 years##4##3##(1990-3#1)(1996-12#1)(2008-10#1)(2008-12#1)
for 6##92##2##(1990-12#2)(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#8)(2009-1#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#5)(2012-2#3)(2013-1#5)(2013-8#3)
for 60 days##5##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
for 60 min##8##3##(1993-9#1)(1994-8#1)(2008-10#5)(2010-2#1)
for 60 s##6##3##(1993-8#1)(2008-10#3)(2008-12#2)
for 60##24##2##(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(2008-10#10)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2013-1#2)
for 60% of all##2##4##(2008-5#1)(2011-2#1)
for 60% of##4##3##(1992-6#1)(2008-5#1)(2009-5#1)(2011-2#1)
for 60s##4##2##(2008-10#4)
for 61%##2##2##(2008-11#1)(2012-1#1)
for 63##2##2##(2008-1#1)(2012-12#1)
for 631##2##2##(2008-10#1)(2013-1#1)
for 64 days##2##3##(2008-10#1)(2008-5#1)
for 64##3##2##(1997-6#1)(2008-10#1)(2008-5#1)
for 66##2##2##(2012-12#1)(2012-3#1)
for 67%##2##2##(1990-8#1)(1992-3#1)
for 6h##2##2##(2013-1#2)
for 7 consecutive days before and##2##6##(2008-10#1)(2011-2#1)
for 7 consecutive days##5##4##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
for 7 consecutive##6##3##(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-2#1)
for 7 d)##2##3##(2008-10#2)
for 7 days and##3##4##(2008-5#1)(2010-1#1)(2011-2#1)
for 7 days or##2##4##(1994-3#1)(2008-10#1)
for 7 days prior to##2##5##(2008-10#2)
for 7 days##26##3##(1992-8#1)(1994-3#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
for 7 days)##2##3##(1994-6#1)(2008-11#1)
for 7 h##2##3##(2008-12#1)(2010-8#1)
for 7 or##2##3##(1990-12#1)(1995-3#1)
for 7 years##2##3##(2008-10#1)(2013-1#1)
for 7##57##2##(1990-11#1)(1990-12#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#5)(2008-5#3)(2008-6#2)(2008-7#3)(2009-12#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#1)
for 7-methyl-dGp and 7-ethyl-dGp##2##4##(2008-12#2)
for 7-methyl-dGp##3##2##(2008-12#3)
for 70##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
for 72 h to##2##4##(2008-10#2)
for 72 h with##2##4##(1993-11#1)(1995-8#1)
for 72 h##11##3##(1991-9#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
for 72 hours##2##3##(1993-3#1)(2011-3#1)
for 72##17##2##(1991-9#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-3#1)(2012-12#1)
for 74%##2##2##(1992-8#1)(1997-7#1)
for 78##3##2##(1993-11#1)(2008-10#1)(2009-9#1)
for 8 days##6##3##(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#2)
for 8 h##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
for 8 months##6##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
for 8 weeks and##2##4##(2008-4#1)(2008-5#1)
for 8 weeks in##2##4##(2008-8#1)(2013-1#1)
for 8 weeks##13##3##(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#1)(2010-1#1)(2011-3#1)(2013-1#2)
for 8 years##3##3##(2008-10#3)
for 8##45##2##(1991-8#1)(1992-5#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-10#1)(1997-6#1)(2008-10#16)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-3#1)(2013-1#5)
for 8-14##2##2##(1991-9#2)
for 80##3##2##(1994-11#1)(2008-10#1)(2009-7#1)
for 80% of the variance in##2##6##(2008-10#1)(2012-3#1)
for 80% of the##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
for 80% of##4##3##(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
for 80%##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
for 81##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
for 82##2##2##(2008-10#1)(2008-12#1)
for 84##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
for 85##2##2##(1996-12#1)(2011-2#1)
for 85% of the##4##4##(1996-2#1)(2008-10#2)(2010-12#1)
for 85% of##6##3##(1990-8#1)(1996-2#1)(2008-10#2)(2010-12#1)(2011-2#1)
for 88##2##2##(2008-12#1)(2012-2#1)
for 89##2##2##(1995-12#1)(2008-10#1)
for 89% of the##2##4##(1991-2#1)(2009-4#1)
for 8h##3##2##(2008-10#3)
for 9 d##3##3##(2011-2#3)
for 9 days##3##3##(1995-12#1)(2008-11#1)(2011-1#1)
for 9 months##6##3##(1996-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
for 9 weeks##2##3##(1994-5#1)(2012-1#1)
for 9##20##2##(1991-1#1)(1993-3#1)(1994-1#1)(1994-5#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#1)
for 90 days##3##3##(1995-12#1)(2008-12#1)(2010-8#1)
for 90 min##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
for 90 minutes##3##3##(1994-3#1)(2008-10#2)
for 90##14##2##(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#2)
for 90% of the isolates##2##5##(2008-7#1)(2011-2#1)
for 90% of##4##3##(1991-3#1)(2008-12#1)(2008-7#1)(2011-2#1)
for 90%##7##2##(1991-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)
for 91##4##2##(2007-6#1)(2008-10#1)(2010-8#1)(2011-2#1)
for 96 h in the presence of##2##7##(1992-8#1)(2008-7#1)
for 96 h##6##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)
for 96 hr##2##3##(1993-9#2)
for 96##10##2##(1992-8#1)(1993-9#2)(2007-12#1)(2008-10#2)(2008-12#2)(2008-7#1)(2010-3#1)
for A and B procedures##2##5##(2008-10#2)
for A and##3##3##(1992-12#1)(2008-10#2)
for A vs##2##3##(2011-2#2)
for A##17##2##(1992-12#1)(1995-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-7#1)(2011-2#2)(2013-7#1)
for A3##3##2##(1990-8#2)(1995-3#1)
for AA##6##2##(2007-7#2)(2008-10#4)
for ACE##2##2##(2008-7#1)(2010-2#1)
for ACR##2##2##(2008-10#2)
for ACTH##3##2##(1993-11#1)(1995-11#1)(2011-2#1)
for AD##3##2##(2008-5#1)(2008-7#2)
for ADP and##2##3##(2006-6#1)(2008-10#1)
for ADP in##2##3##(2006-6#1)(2008-7#1)
for ADP##6##2##(1991-8#1)(2006-6#2)(2008-10#1)(2008-7#2)
for AF##3##2##(2010-12#2)(2012-2#1)
for AG##3##2##(1995-2#1)(2008-10#2)
for AIDS and##2##3##(1995-12#1)(2008-5#1)
for AIDS##19##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#3)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-5#1)(2007-2#1)(2008-5#1)(2011-2#1)
for AIDS-related##4##2##(1995-12#1)(1995-2#1)(2008-5#1)(2008-6#1)
for AL##2##2##(2008-10#2)
for ALI##2##2##(2008-8#1)(2010-12#1)
for ALS##3##2##(1996-5#1)(2009-9#2)
for AM1##3##2##(2008-10#3)
for AMI##2##2##(1992-3#1)(1993-10#1)
for AP and##4##3##(1993-12#1)(2012-3#3)
for AP##6##2##(1993-12#1)(1995-2#1)(2012-3#3)(2013-1#1)
for APP and##2##3##(1992-12#1)(1996-12#1)
for APP##3##2##(1992-12#2)(1996-12#1)
for APR to powdery mildew##2##5##(2008-10#2)
for AR##3##2##(2010-1#1)(2011-2#1)(2012-2#1)
for ARC##2##2##(2007-12#1)(2008-10#1)
for ARF-C isolates##2##3##(2008-10#2)
for ARF-L##2##2##(2008-10#2)
for ART##4##2##(2010-8#1)(2011-1#2)(2011-2#1)
for ASA##2##2##(2008-10#2)
for AT##2##2##(1993-8#2)
for AT2 receptors##3##3##(1991-12#1)(1995-12#2)
for ATCase##2##2##(1997-2#2)
for ATP III criteria)##2##4##(2008-3#2)
for ATP and##3##3##(1991-9#1)(1992-8#1)(1995-2#1)
for ATP binding##2##3##(1995-5#1)(2008-4#1)
for ATP in##2##3##(1993-6#1)(2008-7#1)
for ATP was observed##2##4##(1993-6#1)(1994-8#1)
for ATP was##3##3##(1993-6#1)(1994-8#1)(1995-5#1)
for ATP##21##2##(1990-5#1)(1991-9#1)(1992-8#1)(1993-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(2008-10#3)(2008-3#2)(2008-4#3)(2008-7#1)
for AVMs##3##2##(1997-3#1)(1997-6#1)(2008-7#1)
for AZTTP and##2##3##(1993-3#2)
for Aboriginal##5##2##(2008-12#2)(2008-4#1)(2008-6#2)
for Action##3##2##(2010-10#2)(2011-2#1)
for Active##2##2##(2010-10#1)(2011-1#1)
for Acute Lung Injury##2##4##(2010-12#2)
for Acute##6##2##(2008-1#1)(2008-12#1)(2010-12#2)(2012-2#1)(2012-3#1)
for Adults##2##2##(1991-1#1)(1995-2#1)
for Advanced Medical Studies##2##4##(1994-12#2)
for Advanced##6##2##(1994-12#2)(1997-3#1)(1997-7#1)(2012-2#1)(2012-3#1)
for Africa##2##2##(2008-8#1)(2012-2#1)
for African Americans with CKD##2##5##(2010-4#2)
for African Americans##5##3##(2008-4#2)(2010-4#2)(2012-2#1)
for African##6##2##(2008-4#2)(2010-4#2)(2011-1#1)(2012-2#1)
for Ag and##2##3##(2008-10#1)(2008-3#1)
for Ag##6##2##(2008-10#5)(2008-3#1)
for Ag(+)##4##2##(2008-10#4)
for Ag(I)##2##2##(2008-10#2)
for Aging##2##2##(2010-5#1)(2012-3#1)
for Al##5##2##(2007-11#1)(2008-10#3)(2009-8#1)
for Al(III) and##3##3##(2008-10#3)
for Al(III)##4##2##(2008-10#4)
for Ala##2##2##(1990-7#1)(1993-3#1)
for Alzheimer##2##2##(1993-2#1)(2008-7#1)
for Alzheimer's disease (AD)##5##4##(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
for Alzheimer's disease##9##3##(1992-12#1)(1993-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
for Alzheimer's disease?##2##3##(2008-5#1)(2009-10#1)
for Alzheimer's##11##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2011-2#1)(2013-1#1)
for American Indian##3##3##(1991-3#2)(2011-2#1)
for Anabaptist##2##2##(2008-12#2)
for Animal Health##7##3##(2011-2#7)
for Animal##8##2##(2011-2#7)(2013-8#1)
for Antimicrobial Stewardship##2##3##(2013-1#2)
for Aortic##2##2##(2012-1#2)
for ArF-excimer laser light##2##4##(2008-3#2)
for Arabidopsis##2##2##(2008-7#1)(2011-10#1)
for Aroclor##2##2##(2008-10#2)
for As and Se##4##4##(2008-10#4)
for As and##9##3##(2008-10#8)(2008-12#1)
for As##27##2##(2008-10#24)(2008-12#1)(2011-1#1)(2013-1#1)
for As(III) and As(V)##4##4##(2008-10#3)(2010-5#1)
for As(III) and##5##3##(2008-10#4)(2010-5#1)
for As(III)##14##2##(2008-10#13)(2010-5#1)
for As(III+V)##3##2##(2008-10#3)
for As(V) and##4##3##(2008-10#4)
for As(V)##8##2##(2008-10#8)
for Asian and##2##3##(1997-2#1)(2010-4#1)
for Asian##4##2##(1997-2#1)(2007-12#1)(2010-4#1)(2010-8#1)
for Asn##2##2##(1992-9#1)(1993-8#1)
for Assessment of##2##3##(2008-10#2)
for Asthma##4##2##(2009-6#1)(2010-5#3)
for Atmospheric##2##2##(2008-3#2)
for Au##2##2##(2008-10#2)
for Aujeszky's disease virus##2##4##(2008-11#1)(2011-2#1)
for Australian##6##2##(1992-1#1)(2007-11#3)(2008-11#1)(2011-1#1)
for B cell##4##3##(1995-5#1)(2008-4#2)(2012-12#1)
for B lymphocytes##3##3##(1991-3#1)(2010-5#2)
for B##22##2##(1991-3#1)(1992-12#1)(1995-12#1)(1995-5#1)(2008-10#6)(2008-12#1)(2008-4#3)(2008-5#2)(2008-9#1)(2010-5#2)(2011-2#2)(2012-12#1)
for B-cell epitope identification##2##4##(2008-10#2)
for B-cell malignancies##2##3##(2010-11#2)
for B-cell##5##2##(2008-10#2)(2008-7#1)(2010-11#2)
for B73 x Tex6##2##4##(2008-10#2)
for BC##2##2##(1992-8#1)(2008-10#1)
for BDNF##4##2##(1996-12#2)(2013-1#1)(2013-8#1)
for BET inhibitor##2##3##(2012-12#2)
for BMI##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
for BNCT are##2##3##(1994-3#2)
for BP##2##2##(2008-10#2)
for BSA and 0##2##4##(2008-10#2)
for BSA and##6##3##(2008-10#6)
for BSA##7##2##(2008-10#7)
for Ba##6##2##(2008-10#2)(2008-12#1)(2010-5#1)(2010-8#2)
for Batten disease##3##3##(1994-11#3)
for Bcl-2##2##2##(2013-8#2)
for Bi##2##2##(2008-10#2)
for Bioinformatics and##2##3##(2008-7#1)(2013-8#1)
for Biological Control of##4##4##(2008-10#4)
for Biomedical Research##2##3##(2009-12#1)(2012-2#1)
for Biomedical##3##2##(2009-12#1)(2010-8#1)(2012-2#1)
for Bone##2##2##(2008-6#1)(2010-9#1)
for Bragg##2##2##(2007-12#2)
for Brassica##2##2##(2011-10#2)
for Brazilian##2##2##(1991-6#1)(2010-3#1)
for Breast Cancer##6##3##(1994-12#1)(1994-7#2)(1995-4#1)(1997-7#1)(2011-2#1)
for Breast##11##2##(1990-12#2)(1992-8#1)(1994-12#1)(1994-7#2)(1995-4#1)(1997-7#2)(2011-2#1)(2013-1#1)
for British##2##2##(1996-3#1)(2008-8#1)
for Brucella##3##2##(2011-2#1)(2012-2#2)
for C points##3##3##(2007-11#3)
for C##23##2##(1991-8#1)(1993-8#1)(1994-12#1)(2007-11#3)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)
for C(18) and##2##3##(2008-10#2)
for C/EBP##2##2##(1993-12#1)(1997-8#1)
for CA##4##2##(1997-6#2)(2008-10#2)
for CABG##2##2##(2007-8#2)
for CAD##7##2##(1991-8#1)(1996-2#1)(2010-8#2)(2011-1#3)
for CAT##2##2##(1995-8#1)(2008-4#1)
for CBB resistance##2##3##(2008-10#2)
for CCPA##2##2##(1995-12#2)
for CD##3##2##(2008-2#1)(2010-12#2)
for CD30##2##2##(2012-3#2)
for CD34 and##2##3##(2008-11#1)(2013-1#1)
for CD34##4##2##(2008-11#1)(2009-11#2)(2013-1#1)
for CD86##2##2##(2008-10#2)
for CDP##2##2##(1997-2#2)
for CDT##2##2##(1993-8#1)(1997-2#1)
for CE-MRA##2##2##(2008-7#2)
for CEC##2##2##(2008-10#1)(2010-1#1)
for CES5##2##2##(2009-9#2)
for CF##3##2##(1997-1#1)(2008-10#1)(2011-3#1)
for CGRP##3##2##(1992-6#2)(1992-9#1)
for CH(3)Hg(+)##4##2##(2008-10#4)
for CH(4)##2##2##(2008-2#1)(2012-2#1)
for CHF##3##2##(1995-12#3)
for CI 13227##3##3##(2008-10#3)
for CI##4##2##(2007-10#1)(2008-10#3)
for CIN##3##2##(1992-10#1)(1992-8#1)(2011-1#1)
for CLL##2##2##(1995-2#1)(2011-2#1)
for CLM##3##2##(2007-2#1)(2008-10#1)(2012-3#1)
for CML##2##2##(2012-12#2)
for CMV##5##2##(2007-7#2)(2008-10#3)
for CNS##3##2##(1995-12#1)(2008-4#1)(2009-6#1)
for CNTF##2##2##(1990-5#1)(1996-2#1)
for CO##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
for CO(2) laser light##2##4##(2008-2#1)(2008-3#1)
for CO(2) laser##3##3##(2008-2#1)(2008-3#2)
for CO(2)##12##2##(2008-2#5)(2008-3#6)(2012-2#1)
for CO2##5##2##(1997-6#2)(2008-2#2)(2008-3#1)
for COD##3##2##(2008-10#3)
for COPD##4##2##(1995-12#1)(2011-2#3)
for COX subunit VIb##3##4##(1991-6#3)
for CP##6##2##(2008-10#4)(2011-2#2)
for CPM##2##2##(2008-7#2)
for CPS patients##2##3##(2008-4#2)
for CRC##3##2##(2012-2#3)
for CRT##4##2##(2008-10#3)(2008-3#1)
for CS##4##2##(2013-1#4)
for CT##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
for CTP##2##2##(1991-11#1)(1992-6#1)
for CTV##2##2##(2008-10#2)
for CTVpros##2##2##(2012-12#2)
for CTVpvs##3##2##(2012-12#3)
for CVD##5##2##(2008-1#1)(2008-7#1)(2009-4#1)(2011-1#1)(2013-8#1)
for CYP1A1##2##2##(1994-8#1)(2008-10#1)
for CYP2D6 genotyping##2##3##(2008-10#2)
for CYP2E1##2##2##(2008-8#2)
for Ca and##4##3##(1991-5#1)(2008-10#3)
for Ca##7##2##(1991-5#1)(2008-10#6)
for Ca(2+)##8##2##(1996-5#1)(2008-10#3)(2009-7#3)(2013-1#1)
for Ca2+##7##2##(1990-2#1)(1990-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(2010-11#1)
for California##2##2##(1992-2#1)(1995-3#1)
for Canada##3##2##(1991-2#1)(1996-12#1)(1996-3#1)
for Canadian health care##3##4##(1991-1#1)(1992-1#1)(2007-12#1)
for Canadian##10##2##(1991-1#1)(1992-1#2)(1995-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)
for Cancer Therapy##2##3##(2012-2#1)(2013-1#1)
for Cancer##9##2##(1991-12#1)(1994-12#1)(1994-8#1)(1995-4#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
for Candida albicans##2##3##(1992-6#1)(2008-5#1)
for Candida##6##2##(1992-6#1)(2008-5#5)
for Cardiovascular Health##2##3##(2008-11#1)(2013-1#1)
for Cardiovascular##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
for Care##3##2##(1997-3#1)(2008-11#1)(2008-12#1)
for Cat-floc##2##2##(2008-10#2)
for Catholic healthcare##2##3##(1997-3#2)
for Catholic##4##2##(1991-1#1)(1997-3#3)
for Cd and Pb##3##4##(2008-10#3)
for Cd and##11##3##(2008-10#11)
for Cd determination##2##3##(2008-10#2)
for Cd in##2##3##(2008-10#2)
for Cd##37##2##(1997-4#1)(2008-10#35)(2008-12#1)
for Cd(2+) ions##2##3##(2008-10#2)
for Cd(2+)##5##2##(2008-10#5)
for Cd(II) and##3##3##(2008-10#3)
for Cd(II)##15##2##(2008-10#15)
for CdSe##3##2##(2008-3#3)
for Central##2##2##(2008-1#1)(2013-1#1)
for Ceratitis capitata (Wied##2##4##(2008-6#2)
for Change##2##2##(1995-3#1)(2007-2#1)
for Child##3##2##(1993-6#1)(2008-11#2)
for Childhood##2##2##(2011-1#1)(2013-8#1)
for Children and##2##3##(2009-7#1)(2010-12#1)
for Children with##2##3##(1994-3#1)(2012-2#1)
for Children##13##2##(1991-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-2#2)(2013-8#1)
for Chilean children##2##3##(2013-1#2)
for Chinese##5##2##(1995-6#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-2#1)
for Chlamydia##4##2##(1996-8#1)(2008-12#2)(2008-5#1)
for Chromosome##2##2##(2008-11#1)(2012-3#1)
for Chronic##2##2##(2013-1#1)(2013-8#1)
for Cl(-)##2##2##(2008-10#2)
for ClO(3)(-)##3##2##(2008-10#3)
for Clinical Laboratory##3##3##(1994-12#1)(2008-5#1)(2010-8#1)
for Clinical##11##2##(1994-12#2)(1997-2#3)(1997-7#1)(2007-2#1)(2008-5#2)(2009-11#1)(2010-8#1)
for Co and 0##2##4##(2008-10#2)
for Co and##4##3##(2008-10#4)
for Co##10##2##(2008-10#10)
for Co(2+)##3##2##(2008-10#3)
for Co(II) and##2##3##(2008-10#2)
for Co(II)##10##2##(2008-10#10)
for Colombia##3##2##(2012-12#2)(2013-1#1)
for Common##2##2##(2008-10#1)(2012-3#1)
for Complex##2##2##(2011-2#1)(2012-2#1)
for Computing##2##2##(2009-9#2)
for Control of##3##3##(2008-10#3)
for Costa Rica##2##3##(2008-5#2)
for Cr and##2##3##(2008-10#2)
for Cr in##2##3##(2008-10#2)
for Cr##14##2##(2008-10#13)(2008-12#1)
for Cr(III) and Cr(VI) was##3##5##(2008-10#3)
for Cr(III) and Cr(VI)##5##4##(2008-10#5)
for Cr(III) ions##2##3##(2008-10#2)
for Cr(III) over a wide variety of metal ions##2##9##(2008-10#2)
for Cr(III) over a wide##3##5##(2008-10#3)
for Cr(III)##15##2##(2008-10#15)
for Cr(VI) and Cr(III)##4##4##(2008-10#4)
for Cr(VI) and from##2##4##(2008-10#2)
for Cr(VI) and##9##3##(2008-10#9)
for Cr(VI)##17##2##(2008-10#17)
for Crohn's disease##8##3##(1995-8#1)(1996-2#1)(1996-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
for Cryptosporidium##2##2##(2007-8#1)(2012-12#1)
for Cs(+)##2##2##(2008-10#2)
for Cu and Mn##4##4##(2008-10#4)
for Cu and Zn##5##4##(2008-10#5)
for Cu and##14##3##(2008-10#12)(2013-8#2)
for Cu in##2##3##(2008-10#1)(2012-2#1)
for Cu##42##2##(1996-2#1)(1997-4#4)(2008-10#33)(2012-2#1)(2013-8#3)
for Cu(2+) ions over##2##4##(2008-10#2)
for Cu(2+) ions##3##3##(2008-10#3)
for Cu(2+) over##2##3##(2008-10#2)
for Cu(2+)##14##2##(2008-10#12)(2008-12#2)
for Cu(II) and##6##3##(2008-10#5)(2013-1#1)
for Cu(II) over a wide##2##5##(2008-10#2)
for Cu(II)##24##2##(2008-10#23)(2013-1#1)
for CuHCF##2##2##(2008-10#2)
for CyA and##3##3##(2008-10#3)
for CyA##5##2##(2008-10#5)
for Cypermethrin and##2##3##(2008-10#2)
for Cys##2##2##(2008-10#2)
for D##10##2##(2008-10#5)(2008-5#3)(2011-2#1)(2013-7#1)
for DA##3##2##(2008-10#2)(2008-5#1)
for DAPI with##2##3##(1992-3#2)
for DBP##2##2##(1993-12#1)(2008-10#1)
for DBS(-) ion over a wide##2##6##(2008-10#2)
for DBS(-)##3##2##(2008-10#3)
for DBT##2##2##(2008-11#2)
for DDH##2##2##(2007-8#2)
for DDT##2##2##(1991-9#1)(2008-10#1)
for DEET##2##2##(2008-5#2)
for DEHP##2##2##(2008-10#1)(2008-5#1)
for DHEA##2##2##(1994-6#1)(2008-4#1)
for DKA##2##2##(1994-12#2)
for DM##2##2##(2011-2#2)
for DMA##3##2##(2008-10#3)
for DNA and##3##3##(1994-3#1)(1996-2#1)(2009-10#1)
for DNA binding and##2##4##(1990-11#1)(2008-8#1)
for DNA binding##5##3##(1990-11#1)(1991-5#1)(1992-6#1)(1995-6#1)(2008-8#1)
for DNA content##2##3##(2008-9#2)
for DNA damage##3##3##(1991-5#1)(1993-12#1)(1997-4#1)
for DNA delivery and##2##4##(2008-11#1)(2010-8#1)
for DNA detection##3##3##(2008-10#3)
for DNA electrochemical sensor##2##4##(2008-10#2)
for DNA fragmentation##2##3##(2008-1#1)(2008-11#1)
for DNA fragments##2##3##(2008-10#1)(2008-3#1)
for DNA interstrand##2##3##(1993-11#1)(2008-11#1)
for DNA ploidy and##2##4##(2008-9#2)
for DNA synthesis##6##3##(1992-10#1)(1993-11#1)(1993-6#1)(1995-11#1)(2008-4#2)
for DNA##77##2##(1990-11#2)(1991-5#2)(1992-10#1)(1992-6#4)(1993-11#3)(1993-12#1)(1993-3#3)(1993-6#1)(1994-3#2)(1995-11#1)(1995-6#2)(1995-8#2)(1996-2#2)(1996-6#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#7)(2009-10#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
for DON accumulation##2##3##(2008-10#2)
for DON##3##2##(2008-10#3)
for DOP##2##2##(2008-10#2)
for DPV##2##2##(2008-10#2)
for DRE function##2##3##(1995-6#2)
for DS##2##2##(2008-7#1)(2012-12#1)
for DSB##2##2##(1995-2#1)(1995-6#1)
for DSM-IV-TR##2##2##(2011-1#1)(2012-12#1)
for Delta##3##2##(1997-5#2)(2008-10#1)
for Depression##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
for Detecting##2##2##(2008-10#2)
for Detection of##2##3##(2008-10#1)(2012-3#1)
for Determining##2##2##(1996-5#1)(2008-10#1)
for Development of##2##3##(2012-2#1)(2013-1#1)
for Diabetes##3##2##(1990-11#2)(2012-3#1)
for Disease Control##28##3##(1992-2#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
for Disease##35##2##(1992-2#1)(1993-12#2)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-3#1)
for Diseases Control##2##3##(2010-4#1)(2012-12#1)
for Domestic Violence##3##3##(2012-12#2)(2013-1#1)
for Doppler optical coherence tomography##2##5##(2007-12#2)
for Doppler##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#1)
for Down syndrome##4##3##(1996-12#2)(1997-2#2)
for Down's syndrome##10##3##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#5)
for Down's##11##2##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#6)
for Drosophila##5##2##(1995-6#1)(2008-7#1)(2008-9#3)
for Drug##2##2##(2009-11#1)(2010-11#1)
for DuP##2##2##(1991-5#2)
for Dy and Eu by##2##5##(2008-10#2)
for Dy and Eu##3##4##(2008-10#3)
for Dy##4##2##(2008-10#4)
for E and##3##3##(2008-10#3)
for E##15##2##(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-2#1)
for E1 and##2##3##(2008-10#2)
for E2##5##2##(2008-10#3)(2008-5#2)
for E3##2##2##(2008-10#2)
for ED##5##2##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
for EEG##2##2##(2008-4#1)(2010-7#1)
for EGC than EGCG in##2##5##(2008-10#2)
for EGF##7##2##(1991-12#2)(1991-7#1)(1992-7#1)(1993-3#1)(2008-8#1)(2010-5#1)
for EI##2##2##(2008-6#1)(2011-1#1)
for ENO##3##2##(2008-10#3)
for ENX and##2##3##(2008-10#2)
for EO##2##2##(2008-2#1)(2012-12#1)
for EPOF##3##2##(1993-12#3)
for EPS##2##2##(2007-12#2)
for ER and##2##3##(1995-4#1)(2013-1#1)
for ER##3##2##(1995-4#1)(2009-8#1)(2013-1#1)
for ERK##2##2##(2008-4#2)
for ES##3##2##(2008-8#1)(2010-5#2)
for ET##2##2##(1990-2#1)(2008-9#1)
for Early##5##2##(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#2)
for Earth-looking##2##2##(2008-2#1)(2008-3#1)
for Economic##5##2##(1993-2#1)(1993-3#2)(1994-1#1)(2008-11#1)
for Electrical##3##2##(2007-12#1)(2008-12#1)(2009-7#1)
for Emergency##3##2##(1995-11#1)(2007-9#1)(2008-1#1)
for End-Stage##2##2##(2010-6#1)(2010-8#1)
for England and##3##3##(2008-11#1)(2012-12#2)
for England##4##2##(2008-11#1)(2008-12#1)(2012-12#2)
for Enhanced##2##2##(2011-1#1)(2013-8#1)
for Environmental##3##2##(1992-11#1)(2008-10#1)(2008-3#1)
for Er##2##2##(2007-12#1)(2008-2#1)
for Eu##3##2##(2008-10#3)
for Europe##2##2##(1991-12#1)(2011-2#1)
for European##10##2##(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#2)
for Evaluating the##3##3##(2007-12#1)(2008-10#2)
for Evaluating##6##2##(2007-12#1)(2008-10#3)(2008-7#1)(2013-7#1)
for Evaluation of##2##3##(2008-10#2)
for F##9##2##(1995-2#1)(2008-10#8)
for F1-27##2##2##(2008-10#2)
for FBZ##2##2##(2008-10#2)
for FHB resistance##6##3##(2008-10#6)
for FHB##8##2##(2008-10#8)
for FIA##3##2##(2008-10#3)
for FISH analysis##2##3##(2008-4#2)
for FISH##3##2##(2008-4#3)
for FM##2##2##(2009-11#1)(2010-12#1)
for FRET##2##2##(2008-4#1)(2008-9#1)
for FTIR determination of##2##4##(2008-10#2)
for Family##2##2##(1994-3#1)(1997-3#1)
for Fe and##5##3##(2008-10#5)
for Fe##13##2##(2008-10#12)(2008-5#1)
for Fe(2+)##3##2##(2008-10#3)
for Fe(II) and##2##3##(2008-10#2)
for Fe(II)##3##2##(2008-10#3)
for Fe(III) and##2##3##(2008-10#2)
for Fe(III)##10##2##(2008-10#9)(2008-5#1)
for Fourier transform infrared##2##4##(2008-10#1)(2008-8#1)
for Fourier transform##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
for Fourier##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
for France##3##2##(1990-8#2)(2008-10#1)
for Functional Genomics##3##3##(2008-4#1)(2008-7#2)
for Functional##4##2##(2008-4#1)(2008-7#3)
for Fusarium wilt of##2##4##(2008-10#2)
for Fusarium wilt##5##3##(2008-10#5)
for Fusarium##8##2##(1997-6#2)(2008-10#6)
for G proteins in##2##4##(1993-6#1)(1995-6#1)
for G##5##2##(1991-2#1)(1993-6#1)(1995-6#1)(2008-10#2)
for G1/S transition##2##3##(1993-8#1)(1997-1#1)
for GAP-43##2##2##(1995-12#1)(2008-7#1)
for GC##2##2##(2008-10#1)(2011-1#1)
for GI##2##2##(2012-3#1)(2013-8#1)
for GPP##2##2##(2008-9#2)
for GSH##2##2##(1990-2#1)(2008-10#1)
for GTP##3##2##(1991-12#1)(1995-6#1)(1995-8#1)
for Gaussian##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
for Graves'##2##2##(1992-8#1)(2008-7#1)
for Group##6##2##(2008-10#1)(2008-8#1)(2009-6#1)(2012-2#3)
for Guam and##3##3##(2008-10#3)
for H##10##2##(2008-1#3)(2008-10#4)(2008-5#1)(2011-1#1)(2012-12#1)
for H(+)##3##2##(2008-10#3)
for H(2)O and##2##3##(2008-2#2)
for H(2)O##4##2##(2008-2#3)(2008-3#1)
for H(2)O(2) and##2##3##(2008-10#1)(2013-1#1)
for H(2)O(2) in##3##3##(2008-10#3)
for H(2)O(2)##10##2##(2008-10#8)(2008-2#1)(2013-1#1)
for HA and##2##3##(1997-4#1)(2011-2#1)
for HA##6##2##(1997-4#1)(2008-10#3)(2011-2#1)(2013-8#1)
for HBV and##2##3##(2007-7#1)(2013-1#1)
for HBV##7##2##(1990-8#1)(2007-7#2)(2008-1#1)(2008-7#1)(2009-5#1)(2013-1#1)
for HBsAg##3##2##(2008-7#2)(2013-8#1)
for HCB##2##2##(2008-10#2)
for HCC##7##2##(1990-8#1)(1992-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
for HCV infection##2##3##(2011-2#2)
for HCV##7##2##(1994-8#1)(2007-7#3)(2008-1#1)(2011-2#2)
for HCl##3##2##(2008-10#2)(2013-1#1)
for HClO and ClO(2)(-)##2##4##(2008-10#2)
for HClO##3##2##(2008-10#3)
for HD and##2##3##(2008-1#1)(2008-9#1)
for HD##5##2##(2007-7#1)(2008-1#1)(2008-9#3)
for HDL-cholesterol##3##2##(1992-11#1)(1994-11#2)
for HER-2- and control-transfected##2##4##(1997-7#2)
for HHNK)##2##2##(1994-12#2)
for HIT##3##2##(2010-3#1)(2013-1#2)
for HIV among##2##3##(2011-2#1)(2013-1#1)
for HIV and##3##3##(1997-5#1)(2007-7#1)(2009-8#1)
for HIV antibodies##5##3##(1995-12#1)(1996-5#4)
for HIV care##3##3##(2013-1#3)
for HIV infection in##2##4##(2007-7#1)(2008-5#1)
for HIV infection##13##3##(1994-9#1)(1995-1#2)(1995-9#1)(1996-5#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-5#2)(2011-2#1)(2012-2#1)
for HIV or##2##3##(1995-6#1)(1996-8#1)
for HIV-1##8##2##(1991-9#1)(1993-2#2)(1993-3#1)(1996-9#1)(2007-7#1)(2009-9#1)(2010-5#1)
for HIV-infected patients##2##3##(1995-6#1)(2011-3#1)
for HIV-infected##5##2##(1993-9#1)(1995-6#1)(2008-10#1)(2011-3#1)(2012-12#1)
for HIV-positive individuals##2##3##(1992-12#1)(1994-1#1)
for HIV-positive women##2##3##(2008-12#1)(2009-4#1)
for HIV-positive##6##2##(1992-12#1)(1994-1#1)(2008-12#1)(2009-4#2)(2010-10#1)
for HIV/AIDS##3##2##(1992-12#1)(1995-3#1)(2009-6#1)
for HLH##2##2##(2011-2#2)
for HMO##3##2##(1996-2#1)(1997-1#1)(1997-2#1)
for HMOs##2##2##(1997-2#1)(1997-6#1)
for HMX##3##2##(2008-10#3)
for HORs##2##2##(2008-7#2)
for HPLC##7##2##(2008-10#7)
for HPV##5##2##(1991-2#1)(1992-3#1)(1993-9#1)(2008-8#1)(2013-7#1)
for HQ##2##2##(2008-10#2)
for HR##2##2##(1996-5#1)(2008-10#1)
for HRP##5##2##(2008-10#5)
for HSA and##2##3##(2008-10#2)
for HSA##7##2##(2008-10#7)
for HSV-II##2##2##(2007-7#2)
for HTLV-I##2##2##(2008-8#2)
for Haemophilus influenzae##2##3##(1997-3#1)(2011-1#1)
for Han##2##2##(1995-6#1)(2008-8#1)
for Hb##3##2##(2008-10#1)(2011-2#2)
for HbA(1c) testing has##2##4##(2008-6#2)
for HbA(1c) testing##3##3##(2008-6#3)
for Health and##7##3##(1996-4#1)(1996-7#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
for Health##24##2##(1992-8#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#2)(2007-6#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-5#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
for Healthcare Industry Performance##3##4##(1994-12#1)(1995-3#1)(1996-9#1)
for Healthcare##11##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-9#1)(2010-8#2)(2011-2#1)
for Helicobacter pylori##2##3##(1996-11#1)(1996-8#1)
for Helicobacter##3##2##(1996-11#1)(1996-8#1)(2010-12#1)
for Hemodialysis##5##2##(2008-1#3)(2008-4#1)(2011-2#1)
for Herring testis DNA##2##4##(2008-10#2)
for Hg and##2##3##(2008-10#2)
for Hg##7##2##(2008-10#6)(2008-12#1)
for Hg(2+) and CH(3)Hg(+)##4##4##(2008-10#4)
for Hg(2+) and MeHg(+)##3##4##(2008-10#3)
for Hg(2+) and##10##3##(2008-10#10)
for Hg(2+)##16##2##(2008-10#16)
for Hg(II)##9##2##(2008-10#9)
for High##2##2##(2008-11#1)(2008-7#1)
for Hispanics##2##2##(2012-12#2)
for Hodgkin's disease##6##3##(1992-12#1)(1995-8#1)(1995-9#2)(2007-7#2)
for Hoechst dye uptake##2##4##(2008-11#2)
for Hoechst##3##2##(2008-11#3)
for Hospital##2##2##(1991-12#1)(1991-3#1)
for Human##2##2##(2008-10#1)(2008-5#1)
for I##3##2##(2008-10#3)
for ICP-AES##3##2##(2008-10#3)
for ICP-MS##4##2##(2008-10#4)
for ICU##2##2##(2007-11#1)(2011-2#1)
for IGF-I and##2##3##(1992-9#1)(1993-9#1)
for IGF-I##7##2##(1992-9#1)(1993-8#1)(1993-9#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
for IGF-II##2##2##(1990-5#2)
for IHD and##2##3##(1995-12#2)
for IL-1##6##2##(1990-12#3)(1995-2#2)(1996-12#1)
for IL-12##2##2##(2008-4#1)(2011-2#1)
for IL-2 and IL-4##3##4##(2008-11#3)
for IL-2##5##2##(1990-12#1)(1994-5#1)(2008-11#3)
for IL-4##2##2##(1992-5#1)(2008-7#1)
for IL-7##2##2##(1995-2#1)(2008-4#1)
for IM##2##2##(2007-10#1)(2008-10#1)
for IMP##2##2##(1995-6#1)(2008-10#1)
for IND##2##2##(2008-10#2)
for IPM##2##2##(2008-10#2)
for IPV##2##2##(2010-11#2)
for IR##2##2##(2008-10#1)(2008-3#1)
for ISEs with##2##3##(2008-10#2)
for ITS region##2##3##(2008-10#2)
for IVF##2##2##(1990-2#1)(2013-1#1)
for IVH##2##2##(2008-7#2)
for Ig##2##2##(1994-11#1)(1994-2#1)
for IgA##3##2##(1994-2#1)(2008-1#1)(2008-11#1)
for IgG##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
for Improved##2##2##(2008-10#1)(2010-2#1)
for In Planta Detection of##2##5##(2008-10#2)
for In Vivo##2##3##(2010-6#1)(2013-1#1)
for In##4##2##(2008-10#2)(2010-6#1)(2013-1#1)
for India##3##2##(1994-3#1)(1996-1#1)(2012-1#1)
for Indian##2##2##(2008-12#1)(2013-1#1)
for Indigenous##2##2##(2008-1#1)(2011-1#1)
for Induction##2##2##(2008-3#1)(2013-1#1)
for Infectious Diseases##3##3##(1994-9#1)(1996-11#1)(2013-8#1)
for Infectious##4##2##(1994-9#1)(1996-11#1)(2008-8#1)(2013-8#1)
for Integrated##2##2##(2008-10#2)
for International##2##2##(1996-11#1)(1997-2#1)
for Its##2##2##(2008-10#2)
for Japanese encephalitis##2##3##(2011-2#2)
for Japanese native horses##2##4##(2013-1#2)
for Japanese nurses##2##3##(2008-11#2)
for Japanese women##2##3##(1994-12#1)(1996-3#1)
for Japanese##10##2##(1994-12#1)(1996-3#1)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
for K##3##2##(2008-10#3)
for K(+) than for Na(+)##2##5##(2008-10#2)
for K(+)##6##2##(2008-10#5)(2012-2#1)
for KATP##2##2##(1995-2#1)(1996-9#1)
for Karim##2##2##(2008-12#2)
for Kupffer cells##2##3##(1991-2#1)(1992-6#1)
for L##6##2##(1995-6#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-1#1)(2013-8#1)
for L-dopa##2##2##(2008-10#2)
for L-lysine##2##2##(2008-7#1)(2013-1#1)
for LBP##2##2##(2010-9#2)
for LC##2##2##(2008-10#1)(2013-1#1)
for LCA##2##2##(2010-10#1)(2011-2#1)
for LDH##2##2##(2008-11#1)(2010-4#1)
for LDL##3##2##(1990-12#1)(1995-6#1)(2008-6#1)
for LDL-cholesterol##2##2##(1992-11#1)(2008-5#1)
for LGL##2##2##(1990-12#2)
for LPA##2##2##(2010-3#1)(2011-2#1)
for LPL##2##2##(1992-3#1)(1993-8#1)
for LRYGB versus##2##3##(2013-1#2)
for LTC insurance##2##3##(1992-12#2)
for LTC##3##2##(1992-12#2)(1994-2#1)
for LTP##3##2##(1990-5#1)(1995-2#1)(2009-8#1)
for LV and MTX##3##4##(2008-10#3)
for LVH detection##2##3##(2009-1#2)
for LVH##3##2##(2009-1#3)
for La##2##2##(2008-10#2)
for La(3+)##3##2##(2008-10#3)
for La(III) ions##2##3##(2008-10#2)
for La(III)##7##2##(2008-10#7)
for Latino prisoners##2##3##(1997-5#2)
for Leishmania##6##2##(2007-12#2)(2008-7#4)
for Leptospira antibodies##2##3##(2007-7#2)
for Li(+)##2##2##(2008-10#2)
for Li/Na and K/Na mixed cation chloride sodalites##2##8##(2008-10#2)
for LiNbO(3)##2##2##(2007-11#1)(2007-12#1)
for Liver##2##2##(2008-11#1)(2011-2#1)
for Living##2##2##(1996-1#1)(2008-11#1)
for Lp(a)##5##2##(1993-2#2)(1995-2#1)(1995-6#1)(2008-6#1)
for Lr34/Yr18##3##2##(2008-10#3)
for Lyme borreliosis##2##3##(1994-6#1)(2008-10#1)
for Lyme disease##2##3##(1992-1#1)(2008-8#1)
for Lyme##4##2##(1992-1#1)(1994-6#1)(2008-10#1)(2008-8#1)
for M =##2##3##(2008-10#2)
for M##22##2##(1994-7#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-6#2)(2010-12#1)(2012-2#1)(2013-1#1)
for MARYBLYT##2##2##(2008-10#2)
for MAS##3##2##(1996-2#2)(2008-10#1)
for MB3##2##2##(1992-3#2)
for MBT##2##2##(2008-11#2)
for MBr1##2##2##(1990-12#2)
for MBr8##2##2##(1990-12#2)
for MC##2##2##(2008-10#1)(2012-12#1)
for MCA and DCA##2##4##(2008-10#2)
for MDCT of the gastrointestinal tract##2##6##(2008-7#2)
for MDCT##4##2##(2008-7#4)
for MDIs##2##2##(1996-1#2)
for MDR##2##2##(2011-2#1)(2013-1#1)
for MDS##4##2##(2008-10#1)(2009-8#3)
for MG##4##2##(2008-10#3)(2008-6#1)
for MH##2##2##(2012-1#2)
for MI##2##2##(2008-3#1)(2013-1#1)
for MIPAS##2##2##(2008-3#2)
for MLP##3##2##(2008-10#3)
for MM##2##2##(2010-4#2)
for MMA and##2##3##(2008-10#2)
for MR imaging of##2##4##(2008-7#1)(2010-9#1)
for MR##4##2##(1992-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
for MRI of##2##3##(2010-9#1)(2011-2#1)
for MRI##14##2##(1991-12#1)(1992-3#3)(1995-5#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
for MS##5##2##(1995-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
for MT in##2##3##(1993-12#1)(2008-10#1)
for MT##7##2##(1993-12#1)(2008-10#6)
for Magicicada##2##2##(2008-9#2)
for Malaria##2##2##(2007-2#1)(2012-2#1)
for Management##2##2##(2007-7#1)(2011-2#1)
for Maori##3##2##(2008-1#3)
for Mathematical##2##2##(2013-8#2)
for Medicaid managed care##3##4##(1996-2#1)(1997-2#2)
for Medicaid recipients##2##3##(1992-2#1)(1997-2#1)
for Medicaid##19##2##(1991-2#2)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#3)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#4)(2013-1#2)
for Medical##9##2##(1990-3#1)(1994-12#1)(1994-2#1)(2008-12#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
for Medicare and Medicaid##4##4##(1991-3#1)(1996-2#2)(2008-11#1)
for Medicare beneficiaries##6##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)
for Medicare enrollees##2##3##(1991-3#1)(1996-12#1)
for Medicare patients##3##3##(1993-12#2)(1995-3#1)
for Medicare payment##2##3##(1994-12#1)(1996-1#1)
for Medicare##35##2##(1991-1#1)(1991-3#3)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-3#1)
for Mental Health##2##3##(2008-11#2)
for Mg##9##2##(2008-10#8)(2008-3#1)
for Mg(2+)##3##2##(2008-10#3)
for MgADP##2##2##(1992-3#1)(2008-8#1)
for MgGDP##2##2##(1992-3#2)
for Micronesia##2##2##(2008-1#1)(2008-10#1)
for Mn and##2##3##(2008-10#2)
for Mn##8##2##(2008-10#6)(2010-8#2)
for Mn(II)##4##2##(2008-10#4)
for Mo##2##2##(2008-10#2)
for Mo(VI)##2##2##(2008-10#2)
for Mobile##2##2##(2009-3#1)(2010-11#1)
for Monitoring##2##2##(1992-2#1)(2008-10#1)
for Mycobacterium tuberculosis##4##3##(2007-8#1)(2011-2#2)(2013-1#1)
for Mycoplasma##3##2##(1992-5#1)(2007-12#1)(2012-3#1)
for Mäori##3##2##(2008-1#3)
for N##3##2##(2007-12#1)(2008-6#2)
for N(2)O##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
for N-acetylcysteine##2##2##(1992-12#1)(1993-11#1)
for NA and##3##3##(2008-10#1)(2008-7#2)
for NA##5##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#2)
for NAA##3##2##(2008-10#2)(2008-7#1)
for NAD##4##2##(1990-7#1)(2008-10#3)
for NAD+ and##2##3##(1990-7#2)
for NAD+##3##2##(1990-11#1)(1990-7#2)
for NADH##6##2##(1990-11#1)(1992-6#1)(2008-10#3)(2008-11#1)
for NADPH##3##2##(1991-5#1)(1992-3#1)(1995-11#1)
for NB1-RGB cells##2##3##(2008-11#2)
for NB1-RGB##3##2##(2008-11#3)
for NBD-labeled##2##2##(1993-11#2)
for NDELA##3##2##(2008-5#3)
for NE##4##2##(2008-10#3)(2008-3#1)
for NF2##2##2##(1997-3#1)(2008-10#1)
for NGF##2##2##(1995-5#1)(1996-2#1)
for NH(3)##4##2##(2008-2#1)(2008-3#3)
for NHS##2##2##(1996-8#1)(2008-11#1)
for NL-3 D##2##3##(2008-10#2)
for NMDA##2##2##(1996-2#1)(1997-2#1)
for NMR##2##2##(2010-7#1)(2013-1#1)
for NN127##2##2##(2008-10#2)
for NO##6##2##(1994-11#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-6#1)
for NO(2)##3##2##(2008-10#3)
for NO(3)(-)##2##2##(2008-10#2)
for NPY##2##2##(1995-3#1)(1997-2#1)
for NR##2##2##(2008-10#2)
for NS0##2##2##(2008-11#2)
for Na##6##2##(2008-10#6)
for Na(+) and K(+)##4##4##(2008-10#4)
for Na(+) over##2##3##(2008-10#2)
for Na(+)##9##2##(2008-10#9)
for National##3##2##(1995-6#1)(1997-2#1)(2012-12#1)
for Nd##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for Nepalese##2##2##(2008-10#1)(2012-3#1)
for New##2##2##(1995-2#1)(2012-3#1)
for Ni and##4##3##(2008-10#4)
for Ni##18##2##(1997-4#2)(2008-10#15)(2008-5#1)
for Ni(2+) bioaccumulation##2##3##(2013-1#2)
for Ni(2+)##4##2##(2008-10#1)(2010-11#1)(2013-1#2)
for Ni(II) and##2##3##(2008-10#2)
for Ni(II)##13##2##(2008-10#13)
for Nicotine##2##2##(2011-2#1)(2013-1#1)
for Nod##2##2##(1994-8#1)(2011-2#1)
for Non-small Cell Lung Cancer##2##5##(2010-8#1)(2012-1#1)
for Nursing and##3##3##(2008-11#2)(2008-12#1)
for Nursing##15##2##(2008-11#10)(2008-12#2)(2012-3#1)(2013-1#2)
for O(3)##2##2##(2008-10#1)(2008-3#1)
for O2##2##2##(1997-2#2)
for OA##7##2##(2010-11#1)(2013-1#6)
for OCT imaging##2##3##(2007-11#1)(2011-7#1)
for OP##2##2##(2010-5#1)(2011-2#1)
for OPCAB##3##2##(2007-8#2)(2007-9#1)
for OTC and SCP##2##4##(2008-10#2)
for OTC and##3##3##(2008-10#3)
for OTC in##2##3##(2008-10#2)
for OTC##5##2##(2008-10#5)
for Older##3##2##(2010-10#1)(2011-1#1)(2013-8#1)
for Optical##2##2##(2008-2#1)(2008-3#1)
for Organic##2##2##(1996-5#1)(2009-5#1)
for P##42##2##(1992-5#1)(2007-7#2)(2008-10#34)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-7#1)
for P1##4##2##(1996-12#1)(2008-9#1)(2012-3#2)
for P4 and##2##3##(2008-5#2)
for P4##3##2##(2008-5#3)
for P450##10##2##(1993-6#6)(1994-6#1)(1995-3#1)(2008-4#1)(2009-9#1)
for P567 and P556##2##4##(2008-2#2)
for P567 and##3##3##(2008-2#3)
for P567##4##2##(2008-2#3)(2008-3#1)
for PA##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
for PAH##2##2##(2008-10#1)(2010-10#1)
for PAHs with##3##3##(2008-10#3)
for PAHs##9##2##(2008-10#8)(2010-5#1)
for PAV##2##2##(2008-10#2)
for PB##2##2##(2008-10#2)
for PC##5##2##(1991-5#2)(1996-5#1)(2007-12#1)(2008-10#1)
for PCP##2##2##(2008-10#2)
for PCR##6##2##(1994-8#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-5#1)
for PD##3##2##(2008-7#2)(2009-10#1)
for PDT##4##2##(2008-5#2)(2011-1#1)(2012-3#1)
for PE and/or DVT##2##4##(2012-2#2)
for PE##7##2##(2010-6#1)(2011-2#2)(2012-2#4)
for PET imaging of##2##4##(2010-6#2)
for PETN##2##2##(2008-10#2)
for PG##3##2##(2008-10#3)
for PGGT-I##2##2##(1995-2#2)
for PGP-AML##3##2##(2011-2#3)
for PH##2##2##(2008-1#1)(2008-9#1)
for PI##2##2##(2008-10#2)
for PKC##4##2##(1992-9#2)(1994-2#2)
for PLDD##2##2##(2007-8#2)
for PLS##2##2##(2008-10#2)
for PME##2##2##(1991-9#2)
for POST##6##2##(2012-2#6)
for PP##2##2##(2008-11#1)(2008-5#1)
for PPH##2##2##(1997-5#2)
for PR##3##2##(2008-10#3)
for PRE than for POST throughout the experiment and##2##9##(2012-2#2)
for PRE than for POST##5##5##(2012-2#5)
for PRE##6##2##(2012-2#6)
for PSA promoter##2##3##(2008-9#2)
for PVA##2##2##(2008-5#2)
for Pacific##2##2##(2008-1#1)(2012-12#1)
for Parkinson's Disease##2##3##(2008-11#1)(2009-10#1)
for Parkinson's disease##3##3##(2008-7#1)(2009-11#1)(2012-2#1)
for Parkinson's##6##2##(2008-11#1)(2008-7#2)(2009-10#1)(2009-11#1)(2012-2#1)
for Part B physicians' services##2##5##(1991-2#2)
for Partial##4##2##(1991-1#2)(2008-10#2)
for Passive##5##2##(2008-3#5)
for Pathogenicity##2##2##(2008-10#2)
for Patient##2##2##(1993-12#1)(2011-1#1)
for Patients with##2##3##(2010-6#1)(2010-8#1)
for Patients##3##2##(2006-10#1)(2010-6#1)(2010-8#1)
for Pb and Cu##2##4##(2008-10#2)
for Pb and##10##3##(1997-4#2)(2008-10#8)
for Pb by using##2##4##(2008-10#2)
for Pb##30##2##(1992-3#1)(1997-4#2)(2008-10#24)(2008-12#1)(2013-8#2)
for Pb(2+) over a wide variety of other metal ions##2##10##(2008-10#2)
for Pb(2+) over a wide variety of##3##7##(2008-10#3)
for Pb(2+) over a wide##4##5##(2008-10#4)
for Pb(2+) over##5##3##(2008-10#5)
for Pb(2+)##8##2##(2008-10#8)
for Pb(II) and##3##3##(2008-10#3)
for Pb(II)##17##2##(2008-10#17)
for Pediatric##2##2##(1995-5#1)(2010-10#1)
for Peptide##3##2##(2008-4#1)(2012-12#1)(2012-3#1)
for Physical##2##2##(2008-10#1)(2009-9#1)
for Phytophthora infestans##2##3##(2008-10#2)
for Phytophthora ramorum##2##3##(2008-10#2)
for Phytophthora##6##2##(2008-10#6)
for Pi7(t)##2##2##(2008-10#2)
for Plasmodium falciparum##2##3##(2008-8#1)(2012-3#1)
for Pr##4##2##(2008-10#3)(2008-3#1)
for Predicting##3##2##(2008-10#3)
for Prevention##3##2##(1997-3#2)(2012-3#1)
for Proton##4##2##(2012-12#4)
for Pseudomonas##3##2##(1991-3#1)(2007-7#1)(2008-7#1)
for Psychiatric##3##2##(2008-11#2)(2013-1#1)
for Pu##3##2##(2008-10#3)
for Public Health##9##3##(1995-12#2)(1996-1#3)(1997-3#1)(2008-11#1)(2011-1#1)(2012-12#1)
for Public##10##2##(1990-6#1)(1995-12#2)(1996-1#3)(1997-3#1)(2008-11#1)(2011-1#1)(2012-12#1)
for Puccinia##2##2##(2008-10#2)
for Pyoderma gangrenosum and ankylosing spondylitis##2##6##(2010-12#2)
for Pyoderma gangrenosum##4##3##(2010-12#4)
for Q switching##2##3##(2008-3#2)
for Q##5##2##(2008-10#1)(2008-3#2)(2012-5#2)
for QTL##4##2##(2008-10#1)(2008-7#1)(2008-8#2)
for Quality##14##2##(1995-2#1)(1996-3#1)(2008-12#1)(2012-2#4)(2013-1#7)
for Quantitative##2##2##(2008-10#1)(2008-3#1)
for R##5##2##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)
for RA##4##2##(1996-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
for RAPD##8##2##(2008-10#5)(2008-5#2)(2013-7#1)
for RB##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
for RDX##4##2##(2008-10#4)
for RE##2##2##(2008-10#2)
for REEs were##2##3##(2008-10#2)
for REEs##5##2##(2008-10#5)
for RFLP##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
for RHD gene##3##3##(2012-2#3)
for RNA polymerase##2##3##(1994-12#1)(2010-11#1)
for RNA##6##2##(1992-3#1)(1994-12#1)(2008-4#2)(2010-11#1)(2011-1#1)
for RNAi##2##2##(2008-2#2)
for RNs##2##2##(2010-10#2)
for ROI##2##2##(2010-2#2)
for RT##7##2##(2008-11#1)(2010-3#6)
for Raman##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
for Rapid##2##2##(2008-10#1)(2013-1#1)
for Rb##2##2##(1993-11#1)(2008-10#1)
for Renal##2##2##(2008-1#1)(2013-8#1)
for Research and Education##2##4##(2008-2#1)(2013-8#1)
for Research and Treatment of Cancer (EORTC)##3##7##(1994-3#1)(2008-1#1)(2010-11#1)
for Research and Treatment of Cancer##6##6##(1994-3#1)(2008-1#1)(2008-7#3)(2010-11#1)
for Research and Treatment of##7##5##(1994-3#1)(2008-1#1)(2008-7#3)(2010-11#1)(2011-2#1)
for Research and##10##3##(1994-3#1)(2008-1#1)(2008-2#1)(2008-7#3)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
for Research##12##2##(1994-3#1)(2008-1#1)(2008-2#1)(2008-7#3)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
for Resistance to##11##3##(2008-10#11)
for Rhodamine 6G##2##3##(2008-2#1)(2008-3#1)
for RsGshT##2##2##(1995-2#2)
for Ru(bpy)(3)(2+)/TPrA system##3##3##(2008-10#3)
for Ru(phen)(3)(2+)/TPrA##3##2##(2008-10#3)
for Rubella##2##2##(2007-7#2)
for Russian##2##2##(1997-1#1)(2008-2#1)
for S##21##2##(1990-3#2)(1991-8#1)(1991-9#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#2)
for S-100 protein##3##3##(1993-8#1)(2006-12#1)(2011-2#1)
for S-100##4##2##(1993-8#1)(2006-12#1)(2008-11#1)(2011-2#1)
for SAM-NS##3##2##(2008-10#3)
for SAP##2##2##(2013-1#1)(2013-8#1)
for SAR##2##2##(2008-8#2)
for SBTKR##2##2##(2008-8#2)
for SBWMV##2##2##(2008-10#2)
for SC##3##2##(2008-10#1)(2008-5#2)
for SCD##2##2##(2009-9#1)(2012-3#1)
for SCI##2##2##(2008-8#2)
for SCMV resistance were##2##4##(2008-10#2)
for SCP in##2##3##(2008-10#2)
for SCP##3##2##(2008-10#3)
for SD-NS##3##2##(2008-10#3)
for SHG##2##2##(2007-11#1)(2008-3#1)
for SIDS in the prone position##2##6##(1992-11#2)
for SIDS when##2##3##(1991-11#1)(1992-11#1)
for SIDS##9##2##(1991-11#1)(1992-11#5)(1992-4#1)(2008-1#1)(2011-1#1)
for SILS##4##2##(2013-1#4)
for SIN##2##2##(2008-3#1)(2013-1#1)
for SIP##3##2##(1993-6#3)
for SIT with other##2##4##(2011-2#2)
for SLB resistance##2##3##(2008-10#2)
for SM-NS##2##2##(2008-10#2)
for SNP genotyping and mapping in##2##6##(2012-3#2)
for SNP genotyping##4##3##(2012-3#3)(2013-1#1)
for SNP##5##2##(2012-3#4)(2013-1#1)
for SO(2)##2##2##(2008-10#1)(2008-3#1)
for SPA##2##2##(2008-9#1)(2009-8#1)
for SPL##2##2##(2011-1#2)
for SPME##5##2##(2008-10#5)
for SPR##3##2##(2008-10#2)(2008-2#1)
for SS##3##2##(2009-11#1)(2011-2#1)(2013-8#1)
for SSI##2##2##(1995-12#1)(2008-8#1)
for SSLB resistance in##2##4##(2008-10#2)
for SSLB resistance##4##3##(2008-10#4)
for SSR variation##3##3##(2008-10#3)
for SSR##4##2##(2008-10#4)
for SSTR2##2##2##(1994-11#1)(1995-2#1)
for ST elevation myocardial infarction##2##5##(2009-12#1)(2013-8#1)
for ST##3##2##(2008-3#1)(2009-12#1)(2013-8#1)
for STR##2##2##(2008-12#2)
for SY##2##2##(2008-10#2)
for Saccharomyces cerevisiae##5##3##(1991-9#2)(1995-6#1)(2008-2#2)
for Sb##2##2##(2008-10#2)
for Sb(III) and Sb(V)##4##4##(2008-10#4)
for Sb(III) and from##2##4##(2008-10#2)
for Sb(III) and##9##3##(2008-10#9)
for Sb(III)##11##2##(2008-10#11)
for Sb(V)##6##2##(2008-10#6)
for Schistosoma##2##2##(2008-10#1)(2008-8#1)
for Sclerotinia##3##2##(2008-10#3)
for Screening of##2##3##(2007-11#1)(2013-8#1)
for Se in##2##3##(2008-10#1)(2011-2#1)
for Se##4##2##(2008-10#3)(2011-2#1)
for Se(IV) and##2##3##(2008-10#2)
for Se(IV)##7##2##(2008-10#7)
for Se(VI)##4##2##(2008-10#4)
for Se-GSH-Px-##2##2##(1991-12#2)
for Selecting##2##2##(2008-10#1)(2008-3#1)
for Sensitive##2##2##(2008-10#2)
for Ser##2##2##(1991-9#1)(1992-4#1)
for Shiga toxin B##2##4##(2009-2#2)
for Shiga toxin##3##3##(2009-2#2)(2012-2#1)
for Si##5##2##(2008-10#3)(2008-7#2)
for Smoking##2##2##(1991-5#1)(2013-1#1)
for Social##3##2##(2011-1#1)(2012-1#1)(2012-2#1)
for South##5##2##(2011-2#3)(2013-1#1)(2013-8#1)
for Southern blot analysis##3##4##(2008-2#1)(2008-4#2)
for Southern hybridization##2##3##(1992-6#1)(2008-10#1)
for Southern##5##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-4#2)
for Stage##3##2##(1997-7#1)(2008-6#1)(2010-8#1)
for Standardization##6##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
for Standards in##2##3##(2008-7#1)(2013-1#1)
for Streptococcus##3##2##(1992-5#1)(2011-2#1)(2012-2#1)
for Structural##2##2##(2008-11#1)(2008-4#1)
for Stys's##2##2##(2013-8#2)
for Substance Abuse##2##3##(2010-6#1)(2012-12#1)
for T cell##2##3##(1992-2#1)(2012-3#1)
for T cells##2##3##(1995-2#1)(2013-8#1)
for T##14##2##(1991-8#1)(1992-2#1)(1995-2#1)(2008-10#4)(2008-12#1)(2008-6#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
for T-cell##2##2##(2009-8#1)(2013-7#1)
for T3##4##2##(1990-3#1)(1990-8#1)(1991-2#1)(2008-12#1)
for TAC##2##2##(2008-10#2)
for TB##4##2##(1996-3#1)(2010-4#1)(2010-5#1)(2013-1#1)
for TBI patients##2##3##(2007-11#1)(2008-9#1)
for TBI##3##2##(2007-11#1)(2008-9#2)
for TBT##2##2##(2008-11#2)
for TC##5##2##(2008-10#1)(2009-5#1)(2011-2#2)(2013-1#1)
for TCP##3##2##(1992-6#3)
for TE and TM polarizations##2##5##(2008-2#2)
for TE and TM##3##4##(2008-2#3)
for TE applications is##2##4##(2010-10#2)
for TE applications##4##3##(2010-10#4)
for TE polarization and##2##4##(2008-2#1)(2008-3#1)
for TE polarization##3##3##(2008-2#1)(2008-3#2)
for TE##10##2##(2008-2#4)(2008-3#2)(2010-10#4)
for TERS##2##2##(2012-1#2)
for TM polarization##3##3##(2007-12#1)(2008-3#2)
for TM##6##2##(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#3)
for TMA and ovalbumin##2##4##(2008-10#2)
for TMA##4##2##(2008-10#4)
for TMV##2##2##(2008-10#2)
for TNS##2##2##(2008-10#2)
for TNT##6##2##(2008-10#6)
for TQM in health care##2##5##(1994-2#2)
for TQM##3##2##(1994-2#3)
for TS##3##2##(2008-10#1)(2008-7#2)
for TSAb##2##2##(1991-9#2)
for TUG##2##2##(2010-3#2)
for TYL##2##2##(2008-10#2)
for TYLCV##2##2##(2008-10#2)
for TYLCV-Is##2##2##(2008-10#2)
for Tartrazine##2##2##(2008-10#2)
for The##3##2##(1990-9#1)(1992-3#1)(2011-2#1)
for Ti##2##2##(2007-11#1)(2008-10#1)
for Tomato spotted wilt virus##2##5##(2008-10#2)
for Tomato##3##2##(2008-10#3)
for Toxoplasma##3##2##(2007-7#2)(2008-5#1)
for Transmission##2##2##(2008-10#1)(2008-12#1)
for Treatment of##4##3##(1995-4#1)(2008-12#1)(2010-8#1)(2011-1#1)
for Treatment##5##2##(1995-4#1)(2008-12#1)(2008-2#1)(2010-8#1)(2011-1#1)
for Type 1 diabetes##2##4##(2010-10#2)
for Type##3##2##(2010-10#3)
for U##4##2##(1996-12#1)(2008-10#1)(2008-12#2)
for U(VI) and Th(IV)##9##4##(2008-10#9)
for U(VI) over##4##3##(2008-10#4)
for U(VI)##19##2##(2008-10#19)
for UK##2##2##(1991-3#1)(2008-11#1)
for UO(2)(2+)##3##2##(2008-10#3)
for UV##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
for V and Jsa##2##4##(1994-12#2)
for V##9##2##(1994-12#2)(2008-10#5)(2008-4#1)(2010-3#1)
for V(V) and##2##3##(2008-10#2)
for V(V)##3##2##(2008-10#3)
for VO(2+)##3##2##(2008-10#3)
for VOCs analysis##2##3##(2008-10#2)
for Verification of##2##3##(2008-10#1)(2012-2#1)
for Vero cells##2##3##(2008-11#2)
for Verticillium##2##2##(2008-10#2)
for Veterinary##2##2##(2008-11#1)(2011-2#1)
for Volunteer##11##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#3)(1995-12#2)(1995-3#1)(1996-12#1)
for WDNC##2##2##(1991-6#2)
for WHO criteria##2##3##(2008-3#2)
for West##2##2##(1997-8#1)(2007-12#1)
for White##3##2##(2008-10#1)(2009-7#1)(2012-2#1)
for Women##6##2##(1991-2#1)(1996-12#2)(2009-12#1)(2012-3#1)(2013-1#1)
for X##7##2##(2008-10#7)
for X-ray##5##2##(1995-2#1)(2007-12#2)(2008-11#1)(2008-4#1)
for Zn and##5##3##(1997-4#2)(2008-10#2)(2011-2#1)
for Zn##21##2##(1997-4#4)(2008-10#14)(2010-11#1)(2011-2#1)(2013-8#1)
for Zn(2+)##3##2##(2008-10#3)
for Zn(II) and##4##3##(2008-10#4)
for Zn(II)##14##2##(2008-10#14)
for Zr##2##2##(2008-10#2)
for a &quot##2##3##(1993-12#1)(1994-2#1)
for a 0##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
for a 1##6##3##(2007-11#1)(2008-10#4)(2008-3#1)
for a 1-m##3##3##(2008-3#3)
for a 10##3##3##(1990-2#1)(1996-3#1)(2008-10#1)
for a 2##2##3##(2007-12#1)(2008-10#1)
for a 2-min##2##3##(2008-10#2)
for a 20##2##3##(2008-10#2)
for a 25##2##3##(2008-10#2)
for a 4##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
for a 5-min##2##3##(2008-10#1)(2008-2#1)
for a 5-ml sample was 0##2##6##(2008-10#2)
for a Gaussian##2##3##(2008-3#2)
for a GnRH##2##3##(1993-3#1)(1995-11#1)
for a Medicare##2##3##(1992-2#2)
for a New##2##3##(2008-10#2)
for a beam##3##3##(2007-12#1)(2008-3#2)
for a better understanding of the mechanisms##2##7##(2011-2#1)(2012-3#1)
for a better understanding of the##4##6##(1991-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
for a better understanding of##6##5##(1991-12#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
for a better##18##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-11#1)(1996-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-3#1)
for a birefringence vector distribution##2##5##(2008-3#2)
for a broad range of##3##5##(2007-11#1)(2011-2#1)(2012-2#1)
for a broad##4##3##(2007-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
for a broader##5##3##(1992-12#1)(2007-11#1)(2008-11#1)(2009-11#1)(2011-2#1)
for a calibration##3##3##(2008-10#2)(2008-2#1)
for a case##2##3##(1995-2#1)(2008-8#1)
for a cell to##2##4##(2008-7#1)(2010-4#1)
for a cell##5##3##(2008-11#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#1)
for a certain##4##3##(2007-12#1)(2008-10#2)(2013-8#1)
for a cervical##2##3##(2011-2#1)(2013-1#1)
for a challenging##2##3##(1996-3#1)(2008-12#1)
for a change in##3##4##(2010-11#1)(2011-2#1)(2012-2#1)
for a change##5##3##(1991-1#1)(1997-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
for a chemical##2##3##(2008-2#1)(2008-3#1)
for a child##2##3##(1992-3#1)(2012-2#1)
for a children's##2##3##(1991-1#1)(1994-3#1)
for a circular##2##3##(2008-2#2)
for a class of systems with the object at infinity and another for##2##13##(2008-3#2)
for a class of##6##4##(1992-12#1)(2007-11#1)(2008-3#3)(2008-8#1)
for a clinical##8##3##(1997-2#1)(1997-4#1)(2008-12#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
for a cohort##2##3##(2012-12#1)(2013-1#1)
for a combined##3##3##(2008-3#1)(2009-9#1)(2013-1#1)
for a common##6##3##(1992-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(2009-12#1)(2012-3#1)
for a compact##2##3##(2007-12#1)(2008-3#1)
for a complete##7##3##(1991-1#1)(1992-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-4#1)
for a complex##4##3##(1995-2#1)(2008-10#2)(2008-9#1)
for a component##2##3##(1995-6#2)
for a comprehensive analysis of the##2##6##(1990-5#1)(1997-6#1)
for a comprehensive##6##3##(1990-5#1)(1992-2#1)(1993-3#1)(1997-6#1)(2013-1#1)(2013-8#1)
for a concentration of##6##4##(2008-10#6)
for a concentration range##3##4##(2008-10#1)(2008-2#2)
for a concentration##10##3##(2008-10#7)(2008-2#2)(2009-8#1)
for a considerable##3##3##(1990-3#1)(2008-11#1)(2008-9#1)
for a constant analyte mass##2##5##(2008-10#2)
for a constant##6##3##(2008-10#2)(2008-3#2)(2008-8#1)(2013-8#1)
for a continuous##6##3##(2008-10#2)(2008-11#1)(2008-3#2)(2013-8#1)
for a coordinated##2##3##(1995-1#1)(2007-12#1)
for a correct##4##3##(1991-5#1)(1991-6#1)(1992-9#1)(2008-10#1)
for a crystal with##2##4##(2007-12#1)(2008-3#1)
for a crystal##3##3##(2007-12#1)(2008-3#2)
for a data##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
for a decision##2##3##(1997-3#1)(2008-9#1)
for a deep##2##3##(2008-3#1)(2011-2#1)
for a defined##4##3##(1992-3#1)(1995-1#1)(2008-7#1)(2012-12#1)
for a definition##2##3##(2011-2#1)(2012-1#1)
for a depth##2##3##(2008-3#2)
for a desired##2##3##(2008-1#1)(2008-10#1)
for a detailed##3##3##(2008-10#1)(2008-3#2)
for a diagnosis of##4##4##(2009-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
for a dietitian in an##2##5##(1993-12#2)
for a difference##2##3##(2008-11#1)(2010-11#1)
for a different##5##3##(1990-12#1)(1992-2#1)(2007-12#1)(2008-11#2)
for a differential##3##3##(1990-10#1)(2008-3#1)(2011-2#1)
for a digital##2##3##(2008-2#1)(2008-3#1)
for a direct interaction##2##4##(1995-2#1)(1997-2#1)
for a direct##7##3##(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-9#1)
for a distinct##2##3##(1994-1#1)(1994-2#1)
for a dry##2##3##(2008-10#1)(2008-3#1)
for a dual##2##3##(1993-3#1)(2010-1#1)
for a duration of##2##4##(2008-10#1)(2013-8#1)
for a family of##4##4##(1993-6#1)(1995-2#1)(1997-7#1)(2010-2#1)
for a family##5##3##(1992-3#1)(1993-6#1)(1995-2#1)(1997-7#1)(2010-2#1)
for a few years##2##4##(2008-8#1)(2009-2#1)
for a few##14##3##(1990-9#1)(1992-4#1)(1996-3#1)(1996-4#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#3)(2009-2#1)(2012-2#1)
for a fiber##2##3##(2007-11#1)(2008-3#1)
for a fiber-optic##2##3##(2007-12#1)(2008-2#1)
for a final##3##3##(1992-8#1)(2008-12#1)(2013-7#1)
for a finite##2##3##(2007-12#1)(2008-2#1)
for a fixed period of time##2##6##(2008-10#1)(2008-12#1)
for a fixed##5##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)
for a flow##2##3##(2007-10#1)(2008-10#1)
for a follow-up##2##3##(1993-2#1)(1994-6#1)
for a full##2##3##(2008-2#1)(2008-3#1)
for a fully##3##3##(2008-2#1)(2008-3#1)(2010-10#1)
for a further##6##3##(1991-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)
for a general##8##3##(1992-2#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
for a generic##2##3##(2008-2#1)(2013-8#1)
for a genetic##2##3##(1997-8#1)(2008-5#1)
for a given initial condition##2##5##(2008-11#2)
for a given laser##2##4##(2007-12#1)(2008-2#1)
for a given set of##3##5##(2008-3#1)(2009-11#1)(2011-3#1)
for a given value of##2##5##(2008-10#2)
for a given##57##3##(1990-5#1)(1992-2#1)(1993-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#2)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#12)(2008-4#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-3#1)(2013-1#1)
for a good##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
for a gravitational-wave##2##3##(2008-2#1)(2008-3#1)
for a great##3##3##(1994-5#1)(2008-6#1)(2012-12#1)
for a greater response and##2##5##(2013-1#2)
for a greater##3##3##(2011-3#1)(2013-1#2)
for a group of##4##4##(1993-2#1)(1995-1#1)(2008-11#1)(2009-3#1)
for a group##5##3##(1993-2#1)(1995-1#1)(2007-4#1)(2008-11#1)(2009-3#1)
for a growing##2##3##(2008-11#1)(2008-9#1)
for a health care system##3##5##(1996-3#1)(2008-1#1)(2008-7#1)
for a health care##4##4##(1996-12#1)(1996-3#1)(2008-1#1)(2008-7#1)
for a health##6##3##(1993-9#1)(1995-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-7#1)
for a hexagonal##2##3##(2008-3#2)
for a high level of##2##5##(2008-10#2)
for a high##8##3##(1993-9#1)(1996-2#1)(2007-10#1)(2008-10#3)(2010-4#1)(2010-7#1)
for a high-power##2##3##(2007-12#1)(2008-3#1)
for a higher##4##3##(1994-12#1)(2008-11#1)(2008-4#1)(2009-12#1)
for a highly##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
for a hospital to##2##4##(1991-12#1)(1992-12#1)
for a hospital##7##3##(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1997-8#1)(2010-8#2)
for a hypothetical##2##3##(1992-12#1)(2011-2#1)
for a job##3##3##(1990-2#1)(1991-3#1)(1993-1#1)
for a known##2##3##(1991-1#1)(1993-6#1)
for a large complex##2##4##(2008-10#1)(2008-3#1)
for a large number of##3##5##(1991-8#1)(2008-10#1)(2010-12#1)
for a large proportion of##4##5##(1992-12#1)(1996-2#1)(1997-6#1)(2008-10#1)
for a large variety of##2##5##(1992-9#1)(2008-9#1)
for a large##29##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-9#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#4)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
for a large-scale##2##3##(1997-6#1)(2010-1#1)
for a larger##3##3##(1992-2#1)(1996-3#1)(2008-10#1)
for a laser##3##3##(2007-11#1)(2008-3#2)
for a less##2##3##(1993-6#1)(2007-7#1)
for a limited range of##2##5##(2008-3#1)(2008-8#1)
for a limited##5##3##(1993-3#1)(2008-10#2)(2008-3#1)(2008-8#1)
for a long period in##2##5##(2008-3#1)(2008-8#1)
for a long period of time##2##6##(2008-4#1)(2009-12#1)
for a long period##4##4##(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)
for a long range##2##4##(2008-3#2)
for a long time after##2##5##(1993-8#1)(1997-2#1)
for a long time and##2##5##(2011-1#1)(2011-2#1)
for a long time in##2##5##(2008-10#1)(2012-3#1)
for a long time##33##4##(1990-5#1)(1991-11#1)(1991-9#1)(1993-8#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
for a long##44##3##(1990-5#1)(1991-11#1)(1991-9#1)(1992-11#1)(1993-8#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
for a long-term##4##3##(1994-12#1)(1996-2#1)(2008-10#1)(2011-1#1)
for a longer period of time than##2##7##(1993-3#1)(2008-1#1)
for a longer period of time##4##6##(1993-3#1)(1995-6#1)(2008-1#1)(2010-12#1)
for a longer period##6##4##(1991-9#1)(1993-3#1)(1995-6#1)(2008-1#1)(2008-5#1)(2010-12#1)
for a longer time##3##4##(1991-3#1)(2008-10#1)(2008-5#1)
for a longer##11##3##(1991-3#1)(1991-9#1)(1993-3#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2010-12#1)(2013-1#1)
for a low##5##3##(1990-12#1)(1993-12#1)(2007-10#1)(2008-10#1)(2008-2#1)
for a major part of the##2##6##(2008-10#1)(2008-3#1)
for a major##6##3##(1991-5#1)(1992-3#1)(1995-3#2)(2008-10#1)(2008-3#1)
for a majority of##3##4##(1996-1#1)(2008-7#1)(2012-2#1)
for a malignant##3##3##(2008-6#1)(2009-1#1)(2009-3#1)
for a managed care network##2##5##(1995-3#2)
for a managed care##4##4##(1993-3#1)(1995-3#2)(1997-3#1)
for a matrix##2##3##(2008-3#2)
for a maximum of##4##4##(1991-6#1)(1994-3#1)(2008-10#1)(2008-11#1)
for a maximum##6##3##(1991-6#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
for a mean of##4##4##(1993-1#1)(2008-8#1)(2009-4#1)(2012-2#1)
for a mean period of##2##5##(1990-2#1)(2008-1#1)
for a mean##7##3##(1990-2#1)(1993-1#1)(2008-1#2)(2008-8#1)(2009-4#1)(2012-2#1)
for a median##2##3##(1990-8#1)(1991-2#1)
for a medical linear accelerator##2##5##(2008-3#1)(2009-11#1)
for a medical##5##3##(1991-6#1)(2008-3#1)(2009-11#1)(2010-2#1)(2011-2#1)
for a meeting##2##3##(2008-7#1)(2012-12#1)
for a metal##3##3##(2007-11#1)(2008-2#2)
for a method##2##3##(2008-10#1)(2008-3#1)
for a mild##2##3##(1997-3#1)(2011-2#1)
for a minimum of two##2##5##(2010-2#1)(2013-8#1)
for a minimum of##5##4##(1990-6#1)(1991-2#1)(1994-8#1)(2010-2#1)(2013-8#1)
for a minimum##8##3##(1990-6#1)(1991-2#1)(1992-12#1)(1994-8#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-8#1)
for a minority##2##3##(2006-6#1)(2008-1#1)
for a mixed##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
for a mixture of##2##4##(1996-2#1)(2008-10#1)
for a mobile facility##2##4##(1992-5#2)
for a model of##3##4##(1996-3#1)(2008-10#1)(2013-8#1)
for a model##5##3##(1994-2#1)(1996-3#1)(2008-10#1)(2008-2#1)(2013-8#1)
for a modest##2##3##(1996-3#1)(1997-3#1)
for a molecular##2##3##(2008-4#1)(2008-5#1)
for a month##2##3##(2008-11#2)
for a more accurate##2##4##(1990-8#1)(2008-2#1)
for a more effective##2##4##(2011-1#1)(2013-1#1)
for a more##18##3##(1990-8#1)(1991-6#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#2)
for a multimodal##2##3##(2007-10#1)(2010-3#1)
for a multiple##2##3##(1992-10#1)(1995-2#1)
for a national##6##3##(1991-11#1)(1993-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2013-8#1)
for a near##2##3##(2008-10#2)
for a negative##2##3##(2010-7#1)(2013-1#1)
for a neuroprotective##2##3##(2008-4#1)(2008-7#1)
for a new approach##2##4##(1994-1#1)(2010-5#1)
for a new era##2##4##(1996-2#1)(2009-4#1)
for a new generation of##2##5##(2008-10#1)(2008-7#1)
for a new sample##2##4##(2008-10#2)
for a new##43##3##(1991-1#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-12#1)
for a normally incident plane wave##2##6##(2008-3#2)
for a novel##9##3##(1993-3#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-10#1)(2012-3#1)
for a number of different##5##5##(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)
for a number of patients##2##5##(2011-3#1)(2012-12#1)
for a number of physical##2##5##(2008-10#1)(2008-2#1)
for a number of reasons##5##5##(1996-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)
for a number of years##4##5##(1992-12#1)(1993-3#1)(2008-2#2)
for a number of##44##4##(1991-12#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-8#1)
for a panel of##2##4##(2008-10#1)(2008-5#1)
for a parallel##2##3##(2007-12#1)(2008-3#1)
for a particular patient##2##4##(1992-8#1)(2009-10#1)
for a particular trajectory##2##4##(1994-8#2)
for a particular##21##3##(1990-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-5#1)(1995-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
for a patient with ELKD on hemodialysis##2##7##(2013-8#2)
for a patient with##9##4##(1997-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-12#2)(2013-1#1)(2013-8#2)
for a patient##12##3##(1997-4#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#2)(2013-1#1)(2013-8#3)
for a peptide##3##3##(1993-11#1)(1994-9#1)(2008-11#1)
for a perfect##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
for a perfectly##2##3##(2008-2#1)(2008-3#1)
for a period of 3 months##2##6##(2008-10#1)(2009-8#1)
for a period of 3##3##5##(2008-10#1)(2008-4#1)(2009-8#1)
for a period of one month##3##6##(2008-10#1)(2008-9#1)(2013-1#1)
for a period of one##4##5##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
for a period of time##2##5##(1993-8#1)(2008-11#1)
for a period of two months##2##6##(2008-10#1)(2009-11#1)
for a period of two##3##5##(2008-10#1)(2008-4#1)(2009-11#1)
for a period of##34##4##(1990-12#1)(1990-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
for a period##36##3##(1990-12#1)(1990-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
for a phase##4##3##(2007-7#1)(2008-3#3)
for a phylogenetic##2##3##(2007-12#1)(2007-6#1)
for a planar##2##3##(2007-12#2)
for a plane##2##3##(2008-2#1)(2008-3#1)
for a polypeptide of##2##4##(1994-12#1)(2008-10#1)
for a polypeptide##4##3##(1994-12#1)(1995-2#1)(2008-10#1)(2008-8#1)
for a population##2##3##(1995-5#1)(1996-2#1)
for a positive##5##3##(1992-1#1)(1992-2#1)(1997-2#1)(2012-2#1)(2013-1#1)
for a possible##7##3##(1990-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1997-5#1)(2008-10#1)(2012-3#1)
for a precise##2##3##(2008-10#1)(2012-3#1)
for a preconcentration time of 120 s##2##7##(2008-10#2)
for a preconcentration time of##4##5##(2008-10#4)
for a preliminary##2##3##(1995-11#1)(2009-10#1)
for a primary##7##3##(1995-1#1)(1996-3#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-11#1)(2012-2#1)
for a program##2##3##(1994-2#1)(1995-2#1)
for a prolonged period##2##4##(2008-7#2)
for a prolonged time##2##4##(2008-11#1)(2008-5#1)
for a prolonged##4##3##(2008-11#1)(2008-5#1)(2008-7#2)
for a proper##3##3##(1990-2#1)(2012-2#1)(2013-7#1)
for a proposed##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
for a prospective payment system##3##5##(1991-1#2)(1992-2#1)
for a prospective##5##3##(1991-1#2)(1992-2#1)(2007-8#1)(2008-7#1)
for a protective effect of##2##5##(1994-9#1)(2012-12#1)
for a protective effect##3##4##(1994-9#1)(1996-12#1)(2012-12#1)
for a protective##4##3##(1994-9#1)(1995-12#1)(1996-12#1)(2012-12#1)
for a protein of##7##4##(1990-2#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)
for a protein that is##2##5##(2008-4#2)
for a protein that##3##4##(1990-12#1)(2008-4#2)
for a protein with##2##4##(1995-8#1)(2011-2#1)
for a protein##20##3##(1990-12#1)(1990-2#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#3)(1997-2#2)(1997-3#2)(2008-2#1)(2008-4#2)(2011-2#2)(2013-1#1)
for a pump power of##2##5##(2007-12#2)
for a pump##3##3##(2007-12#2)(2008-3#1)
for a pupil##2##3##(2007-11#1)(2008-2#1)
for a putative new member##2##5##(1997-3#1)(1997-8#1)
for a putative##5##3##(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#2)
for a quantitative##4##3##(1997-6#1)(2008-10#1)(2008-7#1)(2010-7#1)
for a quartz##2##3##(2008-10#2)
for a random##2##3##(2008-9#1)(2012-3#1)
for a range of##20##4##(1994-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
for a rapid##6##3##(2008-10#4)(2010-5#1)(2011-2#1)
for a reaction##2##3##(1990-7#1)(1997-2#1)
for a reconsideration of##2##4##(2008-1#1)(2009-3#1)
for a reduction in##3##4##(1993-12#1)(2008-9#1)(2013-1#1)
for a reduction##4##3##(1993-12#1)(2007-12#1)(2008-9#1)(2013-1#1)
for a regenerative##2##3##(2008-11#1)(2008-3#1)
for a regular##3##3##(2008-7#1)(2011-2#2)
for a relationship between##6##4##(1991-6#1)(2013-8#5)
for a relatively short time##2##5##(1995-11#1)(2008-10#1)
for a relatively##5##3##(1992-12#1)(1995-11#1)(2008-10#2)(2008-3#1)
for a reliable##3##3##(2008-10#3)
for a representative##4##3##(2008-10#1)(2009-5#1)(2011-2#2)
for a research##3##3##(2008-12#2)(2012-2#1)
for a right##2##3##(2007-8#1)(2011-1#1)
for a role of the##2##5##(2008-8#2)
for a role of##8##4##(1990-8#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-8#2)
for a role##9##3##(1990-5#1)(1990-8#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-8#2)
for a rural##2##3##(1991-3#1)(1997-2#1)
for a sample amount of##2##5##(2008-10#2)
for a sample containing##3##4##(2008-10#3)
for a sample injection volume of##2##6##(2008-10#2)
for a sample injection##3##4##(2008-10#3)
for a sample of 2##2##5##(1992-12#1)(1992-3#1)
for a sample of##5##4##(1992-12#1)(1992-3#1)(1994-1#1)(2008-8#1)(2012-12#1)
for a sample volume of##3##5##(2008-10#3)
for a sample##18##3##(1992-12#1)(1992-3#1)(1994-1#1)(2007-12#1)(2008-10#12)(2008-8#1)(2012-12#1)
for a sampling volume of##2##5##(2008-10#2)
for a second##5##3##(1992-1#1)(1997-3#1)(2008-10#2)(2008-8#1)
for a secondary##2##3##(1990-5#1)(2007-8#1)
for a selected group of##2##5##(1994-6#1)(2008-10#1)
for a selected##4##3##(1994-6#1)(2008-10#1)(2008-3#1)(2009-10#1)
for a selective##2##3##(2008-10#2)
for a semiconductor laser##2##4##(2008-2#1)(2008-3#1)
for a sensing length of##2##5##(2007-11#1)(2007-12#1)
for a sensitive##4##3##(2008-10#3)(2008-3#1)
for a sensitivity of##2##4##(2008-3#1)(2012-3#1)
for a separate##2##3##(1992-1#1)(2012-3#1)
for a series of##12##4##(1991-5#1)(2007-11#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)
for a set of##8##4##(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
for a short period of##2##5##(2008-4#1)(2008-5#1)
for a short period##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
for a short time##2##4##(1991-3#1)(2008-11#1)
for a short##8##3##(1991-3#1)(1994-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
for a shorter time##2##4##(1990-2#1)(1996-2#1)
for a shorter##5##3##(1990-2#1)(1992-12#1)(1996-2#1)(2006-10#1)(2007-7#1)
for a signal##2##3##(2008-2#1)(2008-3#1)
for a significant proportion of the##2##6##(1993-3#1)(2009-9#1)
for a significant proportion of##3##5##(1993-3#1)(2009-9#1)(2010-12#1)
for a significant##12##3##(1991-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#1)
for a similar##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
for a simple and##2##4##(1993-8#1)(2008-9#1)
for a simple##6##3##(1993-8#1)(2007-12#1)(2008-11#2)(2008-9#1)(2013-1#1)
for a simulation of##2##4##(2008-3#2)
for a simultaneous determination of##2##5##(2008-10#2)
for a single point calibration of a GC/FID system##2##9##(2008-10#2)
for a single##29##3##(1991-2#1)(1992-1#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
for a skin##2##3##(1997-3#1)(2008-5#1)
for a small##7##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)
for a solution containing 5##2##5##(2008-10#2)
for a solution containing##6##4##(2008-10#6)
for a solution##7##3##(2008-10#7)
for a sounding rocket high-resolution spectrometer##2##6##(2008-3#2)
for a spaceborne##2##3##(2008-2#2)
for a spatial##2##3##(2007-12#1)(2008-3#1)
for a specific##14##3##(1991-2#1)(1993-12#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)
for a specified period of time##2##6##(1993-3#1)(2008-11#1)
for a specified##5##3##(1990-2#1)(1992-12#1)(1992-9#1)(1993-3#1)(2008-11#1)
for a spherical##2##3##(2008-3#2)
for a stable##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
for a standard##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
for a study of the##3##5##(1997-2#1)(2008-10#1)(2008-8#1)
for a study##6##3##(1997-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
for a subset of##3##4##(1995-8#1)(2008-10#2)
for a substantial##2##3##(2008-8#1)(2011-2#1)
for a successful##11##3##(1991-9#1)(1992-12#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-10#1)(2012-3#1)
for a survey of##2##4##(1996-12#1)(2008-10#1)
for a sustainable##3##3##(2008-5#1)(2010-10#1)(2010-7#1)
for a system that##2##4##(2008-10#1)(2008-3#1)
for a system with##3##4##(2008-2#2)(2008-3#1)
for a system##6##3##(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)
for a test##5##3##(1991-12#1)(1996-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
for a thorough##2##3##(2008-3#1)(2010-2#1)
for a time##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
for a total of 10##2##5##(1993-12#1)(1993-9#1)
for a total of##22##4##(1990-11#1)(1990-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-5#1)(1996-10#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#4)(2012-12#1)(2013-7#1)
for a total##26##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-5#1)(1996-10#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#2)(2009-11#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)
for a trace##2##3##(2008-10#1)(2008-3#1)
for a trial of##3##4##(1991-11#1)(2010-4#1)(2012-2#1)
for a trial##5##3##(1991-11#1)(1995-9#1)(2010-4#1)(2010-8#1)(2012-2#1)
for a tropical atmosphere##2##4##(2008-2#2)
for a tumor##2##3##(2007-8#1)(2011-2#1)
for a tunable##2##3##(2008-2#1)(2008-3#1)
for a typical##6##3##(1994-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
for a unique##4##3##(1994-1#1)(1995-11#1)(2008-10#1)(2013-1#1)
for a variable##2##3##(2008-1#1)(2010-6#1)
for a variety of applications##3##5##(1997-4#1)(2009-10#1)(2009-12#1)
for a variety of biological##2##5##(2008-10#1)(2011-2#1)
for a variety of physical##2##5##(2008-10#1)(2008-2#1)
for a variety of potential##3##5##(2008-6#1)(2008-7#1)(2009-10#1)
for a variety of purposes##2##5##(1991-7#1)(2012-3#1)
for a variety of reasons##3##5##(1995-12#1)(2008-9#1)(2011-1#1)
for a variety of therapeutic##2##5##(1994-5#1)(1994-6#1)
for a variety of##58##4##(1991-12#1)(1991-7#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
for a very##6##3##(1993-3#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-7#1)
for a virtual##2##3##(2008-3#1)(2013-8#1)
for a wave##2##3##(2007-11#1)(2008-2#1)
for a wavelength##2##3##(2008-3#2)
for a week##3##3##(1995-6#1)(2008-7#1)(2012-12#1)
for a wide range of applications##2##6##(2010-12#1)(2012-2#1)
for a wide range of conditions##2##6##(2008-10#1)(2009-7#1)
for a wide range of##24##5##(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
for a wide variety of##14##5##(1992-11#1)(1992-3#1)(1996-12#1)(1996-5#1)(2008-11#2)(2008-3#3)(2008-5#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-2#1)
for a wide##43##3##(1992-11#1)(1992-3#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-8#1)
for a year##2##3##(2008-5#1)(2011-1#1)
for a yield##2##3##(2008-10#2)
for a##2308##2##(1990-10#1)(1990-11#4)(1990-12#10)(1990-2#10)(1990-3#1)(1990-4#1)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#6)(1990-9#4)(1991-1#7)(1991-11#5)(1991-12#10)(1991-2#12)(1991-3#6)(1991-5#6)(1991-6#8)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#6)(1992-10#2)(1992-11#5)(1992-12#19)(1992-2#12)(1992-3#16)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#4)(1992-9#8)(1993-1#7)(1993-11#6)(1993-12#21)(1993-2#8)(1993-3#16)(1993-6#6)(1993-8#7)(1993-9#10)(1994-1#6)(1994-11#7)(1994-12#17)(1994-2#9)(1994-3#3)(1994-5#8)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#8)(1995-11#6)(1995-12#9)(1995-2#17)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#9)(1995-8#6)(1995-9#5)(1996-1#6)(1996-10#1)(1996-12#11)(1996-2#15)(1996-3#15)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#18)(1997-3#18)(1997-4#6)(1997-5#5)(1997-6#10)(1997-7#9)(1997-8#9)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#8)(2007-11#49)(2007-12#81)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#8)(2007-9#1)(2008-1#25)(2008-10#342)(2008-11#78)(2008-12#33)(2008-2#144)(2008-3#287)(2008-4#36)(2008-5#37)(2008-6#23)(2008-7#62)(2008-8#52)(2008-9#43)(2009-1#2)(2009-10#14)(2009-11#9)(2009-12#12)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#9)(2009-9#8)(2010-1#2)(2010-10#9)(2010-11#7)(2010-12#13)(2010-2#5)(2010-3#5)(2010-4#7)(2010-5#8)(2010-6#3)(2010-7#7)(2010-8#13)(2010-9#5)(2011-1#18)(2011-10#1)(2011-2#55)(2011-3#4)(2011-7#1)(2012-1#4)(2012-12#26)(2012-2#41)(2012-3#23)(2012-8#1)(2013-1#42)(2013-7#4)(2013-8#33)
for abandoning##2##2##(1996-2#1)(2008-9#1)
for abdominal pain##2##3##(1992-9#1)(2008-7#1)
for abdominal surgery##2##3##(2012-2#2)
for abdominal##11##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-9#1)(1994-8#1)(2008-7#2)(2009-11#1)(2012-2#2)(2012-3#1)
for aberration##2##2##(2008-3#2)
for ability to##3##3##(1990-5#1)(1995-6#1)(2008-10#1)
for ablation##3##2##(1995-11#1)(2007-8#1)(2011-2#1)
for abnormal##2##2##(1991-11#1)(2008-11#1)
for abortion##5##2##(1991-1#2)(1993-2#1)(1996-8#1)(2013-1#1)
for abortions##2##2##(1994-2#1)(1996-5#1)
for about 4##2##3##(2008-10#1)(2008-9#1)
for about##32##2##(1992-6#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-6#1)(1997-6#1)(2008-10#11)(2008-11#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)
for abrasion in##2##3##(2008-7#2)
for absolute cell##2##3##(2008-9#2)
for absolute interferometry##2##3##(2008-3#2)
for absolute##11##2##(2007-11#2)(2008-10#1)(2008-3#5)(2008-9#3)
for absorbance detection##2##3##(2008-10#1)(2008-3#1)
for absorbance##6##2##(2008-10#5)(2008-3#1)
for absorption and##2##3##(2008-3#1)(2008-7#1)
for absorption##7##2##(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
for abundant##2##2##(2008-11#1)(2008-9#1)
for abuse##4##2##(1991-1#1)(1996-4#1)(2007-12#2)
for academic##8##2##(1996-1#1)(2008-1#1)(2008-11#2)(2009-9#1)(2010-3#1)(2010-4#1)(2013-8#1)
for accelerated##3##2##(1990-12#1)(2008-3#1)(2011-2#1)
for accelerating the##4##3##(2008-3#1)(2010-10#1)(2011-1#2)
for accelerating##7##2##(2008-3#1)(2010-10#1)(2010-11#1)(2011-1#2)(2013-1#1)(2013-8#1)
for acceptance##2##2##(2008-6#1)(2013-1#1)
for access to##3##3##(1993-12#1)(1993-2#1)(2009-8#1)
for access##4##2##(1993-12#1)(1993-2#1)(2009-8#1)(2010-8#1)
for accessing##8##2##(1997-2#1)(2008-4#4)(2009-10#2)(2012-3#1)
for acclimating to##2##3##(2008-8#2)
for accomplishing this##2##3##(1991-3#1)(2008-9#1)
for accomplishing##5##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
for accountability##6##2##(1992-1#1)(1993-1#1)(1993-12#1)(1995-3#1)(1996-1#1)(2012-2#1)
for accreditation##4##2##(1993-2#2)(1995-1#1)(2008-7#1)
for accumulation of##6##3##(1990-3#1)(2008-10#3)(2008-9#1)(2011-2#1)
for accumulation##7##2##(1990-3#1)(2008-10#4)(2008-9#1)(2011-2#1)
for accuracy##6##2##(1992-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
for accurate and##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
for accurate assessment of##2##4##(2008-10#2)
for accurate determination of##2##4##(2007-12#1)(2008-9#1)
for accurate diagnosis##2##3##(2008-7#1)(2012-2#1)
for accurate measurement of##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
for accurate##44##2##(1990-3#1)(1994-2#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
for accurately measuring##2##3##(2008-3#2)
for accurately##5##2##(2008-2#1)(2008-3#4)
for acetabular##2##2##(2008-11#2)
for acetaminophen##4##2##(1991-9#1)(2008-10#2)(2008-3#1)
for acetone##4##2##(2008-10#4)
for acetylcholine##3##2##(1996-12#2)(1996-2#1)
for achievement of##2##3##(1995-6#1)(2008-10#1)
for achievement##3##2##(1990-4#1)(1995-6#1)(2008-10#1)
for achieving a##2##3##(1994-3#1)(2012-12#1)
for achieving improvement in##2##4##(1993-12#1)(2008-11#1)
for achieving optimal##2##3##(1991-12#1)(2008-3#1)
for achieving the best##2##4##(2007-8#1)(2013-8#1)
for achieving the##4##3##(1992-12#1)(1997-4#1)(2007-8#1)(2013-8#1)
for achieving this##2##3##(1992-12#1)(2008-2#1)
for achieving##41##2##(1991-12#1)(1992-12#2)(1993-1#1)(1993-12#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#7)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
for acid##7##2##(2008-10#5)(2008-4#1)(2008-9#1)
for acidic##2##2##(1994-5#1)(2011-2#1)
for acitric##2##2##(2008-5#2)
for acne##3##2##(2008-5#2)(2012-12#1)
for acoustic neuroma##2##3##(2008-7#1)(2011-2#1)
for acquired diseases##2##3##(1994-5#1)(2008-5#1)
for acquired immunodeficiency syndrome##3##4##(1993-1#1)(1995-1#1)(2013-1#1)
for acquired##7##2##(1993-1#1)(1994-5#1)(1995-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
for acquiring##3##2##(2008-3#2)(2011-1#1)
for acquisition of##2##3##(2008-1#1)(2012-1#1)
for acquisition##3##2##(1993-6#1)(2008-1#1)(2012-1#1)
for actin##3##2##(1994-5#1)(1997-7#1)(2007-12#1)
for action##8##2##(1991-2#1)(1992-6#1)(1993-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
for actionable##2##2##(1996-3#1)(1997-1#1)
for actions##4##2##(1993-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
for activating##3##2##(1992-10#1)(2008-7#1)(2008-9#1)
for activation of the##2##4##(1995-6#1)(2008-11#1)
for activation of##6##3##(1990-5#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-6#1)
for activation##10##2##(1990-2#1)(1990-5#1)(1994-3#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-6#1)(2013-8#1)
for active tuberculosis##2##3##(1996-3#1)(2007-12#1)
for active##21##2##(1991-12#1)(1991-6#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-1#1)
for activities of daily living and##2##6##(1995-3#1)(2011-2#1)
for activity and##3##3##(1993-9#1)(2008-4#1)(2011-2#1)
for activity of the##2##4##(1995-6#1)(2006-6#1)
for activity of##4##3##(1995-6#1)(2006-6#1)(2008-4#1)(2008-5#1)
for activity##20##2##(1990-7#1)(1991-11#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-6#2)(1997-1#1)(2006-6#1)(2008-10#3)(2008-4#2)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#2)
for actual##4##2##(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
for acupuncture##2##2##(2008-10#1)(2012-3#1)
for acute AP##2##3##(2013-1#2)
for acute abdominal pain##2##4##(2008-7#2)
for acute care##3##3##(1992-2#1)(2008-7#1)(2011-2#1)
for acute coronary syndrome and##2##5##(2008-3#2)
for acute coronary syndrome##4##4##(2008-11#1)(2008-3#3)
for acute coronary syndromes##4##4##(2008-3#3)(2011-2#1)
for acute coronary##8##3##(2008-11#1)(2008-3#6)(2011-2#1)
for acute disease##3##3##(1997-8#3)
for acute heart failure##2##4##(2008-3#2)
for acute ischemic stroke##12##4##(2006-7#2)(2007-10#8)(2008-8#2)
for acute lymphoblastic##2##3##(2008-7#1)(2010-6#1)
for acute myocardial infarction##6##4##(1990-3#1)(1995-12#1)(1997-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
for acute myocardial ischemia##2##4##(1997-2#1)(2010-8#1)
for acute myocardial##11##3##(1990-3#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-8#1)(2013-1#1)
for acute renal failure##2##4##(2008-1#1)(2008-11#1)
for acute stroke##3##3##(2007-10#1)(2007-9#1)(2008-8#1)
for acute variceal##2##3##(1995-8#1)(2008-8#1)
for acute##101##2##(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#7)(2006-7#3)(2007-10#10)(2007-11#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#5)(2009-11#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#10)(2013-1#3)(2013-8#1)
for adaptation and##3##3##(1996-6#1)(2008-9#1)(2010-3#1)
for adaptation to##3##3##(1990-2#1)(2008-8#2)
for adaptation##8##2##(1990-2#1)(1992-3#1)(1996-6#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-3#1)
for adaptive evolution##2##3##(2008-8#2)
for adaptive optics##3##3##(2007-11#1)(2007-12#2)
for adaptive##12##2##(2007-11#3)(2007-12#3)(2008-3#1)(2008-6#1)(2008-8#3)(2010-2#1)
for added ADP##2##3##(1992-3#2)
for addiction##3##2##(1993-3#1)(2008-12#1)(2012-3#1)
for adding##5##2##(1991-12#1)(1994-12#1)(2008-3#1)(2008-4#2)
for addition of##2##3##(2007-11#1)(2008-10#1)
for addition##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
for additional information##2##3##(2008-10#1)(2011-2#1)
for additional research##2##3##(2008-6#1)(2010-10#1)
for additional##20##2##(1990-7#1)(1993-12#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
for addressing questions##2##3##(2008-9#1)(2013-1#1)
for addressing the##2##3##(1996-12#1)(2009-5#1)
for addressing these##5##3##(1994-12#1)(1996-1#1)(1997-1#1)(2008-12#2)
for addressing##20##2##(1993-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#2)
for adenine##2##2##(1994-12#1)(1995-8#1)
for adenocarcinoma of the pancreas##2##5##(1990-9#1)(1994-8#1)
for adenocarcinoma of the##4##4##(1990-9#1)(1993-2#1)(1994-2#1)(1994-8#1)
for adenocarcinoma##5##2##(1990-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(2009-1#1)
for adenomas##2##2##(2008-1#2)
for adenosine##4##2##(1993-12#1)(1994-8#1)(1995-3#1)(2009-4#1)
for adenovirus##2##2##(2008-11#2)
for adequacy##3##2##(1992-12#1)(2008-5#1)(2011-2#1)
for adequate management##2##3##(2008-8#1)(2013-1#1)
for adequate##12##2##(1993-9#1)(1995-2#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-3#1)(2013-1#1)(2013-8#1)
for adherent cells##2##3##(2008-4#1)(2008-9#1)
for adherent##5##2##(1992-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
for adhesion and##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
for adhesion to##2##3##(2012-1#1)(2013-1#1)
for adhesion##9##2##(2006-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
for adipocyte##2##2##(2006-8#1)(2011-2#1)
for adjusting the##3##3##(1996-3#1)(2008-10#1)(2012-2#1)
for adjusting##7##2##(1991-1#1)(1992-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
for adjustment##4##2##(2007-11#1)(2009-8#3)
for adjuvant systemic##2##3##(2007-5#1)(2008-10#1)
for adjuvant therapy##2##3##(1993-11#1)(2008-10#1)
for adjuvant##7##2##(1993-11#1)(1993-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2012-3#1)
for administering aerosol pentamidine##2##4##(1996-12#2)
for administering##4##2##(1996-12#2)(2008-4#1)(2011-2#1)
for administration##4##2##(1992-1#1)(1992-12#1)(1997-1#1)(2008-5#1)
for administrative directors of radiology##3##5##(1995-2#1)(1995-3#2)
for administrative##6##2##(1991-9#1)(1992-4#1)(1995-2#1)(1995-3#2)(1996-3#1)
for administrators##3##2##(1992-3#1)(1993-1#1)(1996-3#1)
for admission to##2##3##(1995-5#1)(2011-2#1)
for admission##7##2##(1995-2#1)(1995-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
for adnexal surgery##2##3##(1996-3#2)
for adnexal##3##2##(1996-3#3)
for adolescent girls##2##3##(2008-1#1)(2013-1#1)
for adolescent##11##2##(1991-1#1)(2008-1#1)(2008-7#1)(2009-7#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
for adolescents with cancer##2##4##(1993-3#1)(2010-11#1)
for adolescents with##6##3##(1993-3#2)(1996-12#1)(2010-1#1)(2010-11#1)(2011-2#1)
for adolescents##18##2##(1992-6#1)(1993-2#1)(1993-3#2)(1995-12#2)(1996-12#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#2)(2010-1#1)(2010-11#1)(2011-2#1)
for adopting##3##2##(1990-2#2)(2010-2#1)
for adoption##2##2##(2010-12#1)(2013-1#1)
for adriamycin in##2##3##(1990-2#2)
for adriamycin##4##2##(1990-2#2)(1992-6#1)(2008-10#1)
for adsorption##4##2##(2008-10#3)(2008-7#1)
for adsorptive##2##2##(2008-10#2)
for adult hepatocytes##2##3##(2008-11#2)
for adult patients##2##3##(2007-8#1)(2008-7#1)
for adult##27##2##(1994-11#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
for adult-plant##3##2##(2008-10#3)
for adults in##2##3##(2008-8#1)(2013-1#1)
for adults with developmental##2##4##(2010-12#1)(2012-2#1)
for adults with##4##3##(2007-6#1)(2009-2#1)(2010-12#1)(2012-2#1)
for adults##15##2##(1996-8#1)(1997-1#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
for advanced Parkinson's disease##2##4##(2008-7#1)(2010-12#1)
for advanced breast cancer##2##4##(1994-7#1)(1997-7#1)
for advanced disease##2##3##(1992-10#1)(1993-12#1)
for advanced gastric##2##3##(1991-4#1)(2012-3#1)
for advanced gonarthrosis##2##3##(2007-8#2)
for advanced lateral skull base##2##5##(2011-2#2)
for advanced non-small cell lung cancer##3##6##(1990-2#1)(1994-12#1)(2010-8#1)
for advanced practice nurses##2##4##(2008-12#1)(2012-2#1)
for advanced stages##2##3##(2007-8#1)(2012-3#1)
for advanced##33##2##(1990-2#1)(1991-4#1)(1992-10#2)(1992-5#1)(1993-12#2)(1994-12#1)(1994-7#1)(1997-7#1)(2007-11#1)(2007-8#4)(2008-12#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
for advances in##3##3##(2008-10#2)(2008-11#1)
for advancing the##3##3##(1993-3#1)(2008-7#1)(2012-2#1)
for advancing##5##2##(1993-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
for adverse effects##2##3##(2007-12#1)(2008-7#1)
for adverse##7##2##(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
for advice##2##2##(1990-3#1)(2008-11#1)
for advising##2##2##(2010-3#2)
for aerobic##3##2##(1994-2#1)(2007-7#1)(2008-7#1)
for aerosol optical thicknesses as##2##5##(2008-2#1)(2008-3#1)
for aerosol##12##2##(1992-3#2)(1997-1#2)(2008-10#2)(2008-2#2)(2008-3#4)
for aesthetic##3##2##(1992-9#1)(2010-8#2)
for affected##2##2##(1997-5#1)(1997-6#1)
for affective##2##2##(1995-11#1)(2008-5#1)
for affinity##6##2##(1990-12#1)(1991-5#2)(2008-4#1)(2009-11#1)(2009-12#1)
for aflatoxin##5##2##(2008-10#3)(2010-4#1)(2010-5#1)
for age and gender##3##4##(2008-11#1)(2010-9#1)(2012-1#1)
for age and sex##5##4##(1995-11#1)(1995-5#1)(2008-3#1)(2008-7#1)(2008-8#1)
for age and size at life-history transitions##2##7##(2008-8#2)
for age and size at##3##5##(2008-8#3)
for age and##18##3##(1993-10#1)(1995-11#1)(1995-5#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#4)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
for age of onset##2##4##(1997-5#1)(2009-7#1)
for age##56##2##(1991-12#3)(1992-2#1)(1993-10#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-3#2)(1997-5#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
for aged and disabled Medicare##2##5##(1991-2#1)(1997-1#1)
for aged##3##2##(1991-2#1)(1994-12#1)(1997-1#1)
for agency##2##2##(1994-2#1)(1996-3#1)
for agents##2##2##(2008-10#1)(2011-2#1)
for ages##2##2##(1992-10#1)(2012-2#1)
for aggregate##2##2##(2008-10#1)(2012-12#1)
for aggregation of##2##3##(1997-3#1)(2008-10#1)
for aggregation##4##2##(1994-5#1)(1997-3#1)(2006-6#1)(2008-10#1)
for aggressive##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
for aggressiveness were##2##3##(2008-10#2)
for aggressiveness##7##2##(2008-10#7)
for aging and##2##3##(1994-5#1)(2012-2#1)
for aging of##2##3##(1994-5#1)(2009-12#1)
for aging research##3##3##(2009-5#2)(2012-3#1)
for aging##8##2##(1994-5#2)(2008-3#1)(2009-12#1)(2009-5#2)(2012-2#1)(2012-3#1)
for agonists##3##2##(1993-3#1)(1997-7#2)
for aiding##2##2##(2008-9#1)(2010-5#1)
for air and##2##3##(2008-10#1)(2008-2#1)
for air pollution##2##3##(1992-9#1)(2008-11#1)
for air##8##2##(1992-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-10#1)
for airborne or spaceborne##2##4##(2008-3#2)
for airborne or##3##3##(2008-2#1)(2008-3#2)
for airborne##8##2##(2008-10#3)(2008-2#1)(2008-3#4)
for alanine##3##2##(1993-8#1)(1994-6#1)(2008-10#1)
for albumin##2##2##(2008-11#1)(2012-2#1)
for alcohol abuse##2##3##(1990-2#2)
for alcohol and##2##3##(2008-1#1)(2009-6#1)
for alcohol dependence##2##3##(2008-2#1)(2012-2#1)
for alcohol determination in##2##4##(2008-10#2)
for alcohol determination##3##3##(2008-10#3)
for alcohol problems##2##3##(2008-11#2)
for alcohol use##2##3##(2008-11#1)(2009-7#1)
for alcohol##19##2##(1990-2#2)(1992-3#1)(1992-9#1)(1993-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
for alcohol-abusing##2##2##(1990-2#1)(1992-5#1)
for alcoholism##6##2##(1991-1#1)(1994-2#2)(2008-10#1)(2008-2#2)
for aldosterone##2##2##(1992-12#2)
for alendronate##2##2##(2008-10#1)(2008-11#1)
for aligning##3##2##(2008-3#1)(2008-4#2)
for aliphatic##2##2##(1995-3#1)(2008-10#1)
for alkali and alkaline earth metal##2##6##(2008-10#2)
for alkali metal##2##3##(2008-10#2)
for alkali##7##2##(2008-10#6)(2008-2#1)
for alkaline##2##2##(2008-10#2)
for all Medicaid##2##3##(1991-1#1)(1991-9#1)
for all Se##2##3##(2008-10#2)
for all age groups##2##4##(2008-5#1)(2009-5#1)
for all analyses##2##3##(2008-10#1)(2008-11#1)
for all analytes##5##3##(1996-5#1)(2008-10#4)
for all analytical##2##3##(2008-10#2)
for all but one##2##4##(1990-12#2)
for all but##4##3##(1990-12#2)(2008-10#2)
for all cases of##3##4##(2008-10#2)(2008-7#1)
for all cases##8##3##(1993-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)
for all cell lines##2##4##(1992-9#1)(2008-11#1)
for all cell##3##3##(1992-9#1)(2008-11#1)(2008-4#1)
for all children with##2##4##(1994-3#1)(2008-11#1)
for all children##3##3##(1994-3#1)(2008-11#1)(2012-2#1)
for all components##3##3##(2008-10#3)
for all compounds##6##3##(2008-10#6)
for all conditions##3##3##(2008-9#1)(2012-1#2)
for all cultivars##2##3##(2008-10#1)(2009-8#1)
for all data sets##2##4##(2008-10#2)
for all data##3##3##(1993-8#1)(2008-10#2)
for all eight##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
for all elements and##2##4##(2008-10#2)
for all elements##10##3##(2008-10#7)(2008-3#1)(2011-2#2)
for all entries##2##3##(2008-10#2)
for all experiments##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
for all five##2##3##(2008-10#1)(2008-8#1)
for all food##2##3##(1993-9#1)(2008-11#1)
for all four##4##3##(1991-9#1)(1992-6#1)(1995-2#1)(2011-2#1)
for all groups were##2##4##(2008-12#1)(2008-5#1)
for all groups##4##3##(1992-2#1)(1997-4#1)(2008-12#1)(2008-5#1)
for all health care providers##2##5##(1994-3#1)(2007-2#1)
for all hospitals##4##3##(1992-12#1)(1995-1#1)(1996-12#1)(2008-3#1)
for all major##2##3##(2008-10#1)(2008-8#1)
for all medical##4##3##(1992-11#1)(1994-2#1)(1995-12#1)(2008-11#1)
for all members##2##3##(2006-6#1)(2008-11#1)
for all metal##2##3##(2008-10#2)
for all new##2##3##(1995-3#1)(2008-10#1)
for all of the##8##4##(1990-5#1)(1990-8#1)(1992-2#1)(1995-11#1)(2008-10#3)(2008-3#1)
for all of them##2##4##(2008-10#1)(2008-9#1)
for all of##14##3##(1990-5#1)(1990-8#1)(1992-2#1)(1995-11#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-9#2)(2010-9#1)
for all parameters except##2##4##(2008-3#1)(2009-8#1)
for all parameters##4##3##(1997-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
for all participants##2##3##(2008-10#1)(2009-8#1)
for all patients was##2##4##(1997-4#1)(2010-3#1)
for all patients with##3##4##(2008-3#1)(2009-8#1)(2011-2#1)
for all patients##21##3##(1991-12#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-2#1)(1997-4#1)(2008-1#1)(2008-3#3)(2008-4#1)(2009-8#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
for all populations##2##3##(2008-10#1)(2009-9#1)
for all races##2##3##(1995-12#1)(2010-3#1)
for all relevant##2##3##(2012-12#1)(2013-1#1)
for all samples##6##3##(2008-10#5)(2012-2#1)
for all sites##2##3##(2008-10#2)
for all species investigated##2##4##(2008-11#1)(2012-5#1)
for all species##8##3##(2008-10#5)(2008-11#1)(2008-7#1)(2012-5#1)
for all steps of the##2##5##(2008-10#2)
for all steps##4##3##(2008-10#2)(2008-4#2)
for all strains##4##3##(2008-10#1)(2008-5#2)(2008-7#1)
for all students##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
for all tested##3##3##(2008-10#1)(2008-2#1)(2009-8#1)
for all the analytes##3##4##(2008-10#2)(2011-1#1)
for all the compounds##4##4##(2008-10#3)(2008-7#1)
for all the elements##6##4##(2008-10#4)(2013-8#2)
for all the examined##2##4##(2008-10#1)(2008-3#1)
for all the metal ions##2##5##(2008-10#2)
for all the parameters##6##4##(1992-2#1)(1992-3#1)(2008-12#3)(2009-8#1)
for all the patients##2##4##(1990-6#1)(2007-8#1)
for all the samples##5##4##(1990-7#2)(2008-10#3)
for all the three analytes##2##5##(2008-10#2)
for all the three pesticides##2##5##(2008-10#2)
for all the three##4##4##(2008-10#4)
for all the traits##2##4##(2008-12#1)(2008-4#1)
for all the##78##3##(1990-3#1)(1990-6#2)(1990-7#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#34)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#4)
for all these##4##3##(1994-5#1)(1996-5#1)(2008-10#1)(2010-3#1)
for all three analytes##3##4##(2008-10#3)
for all three##18##3##(1992-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-4#1)(2011-2#2)(2012-1#1)
for all time periods##2##4##(2008-10#1)(2009-11#1)
for all time##3##3##(2008-10#1)(2009-11#1)(2013-8#1)
for all treatments##3##3##(2008-10#2)(2011-2#1)
for all types of##2##4##(2008-10#1)(2009-5#1)
for all##509##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#4)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-6#1)(2007-11#7)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#4)(2008-10#159)(2008-11#17)(2008-12#14)(2008-2#7)(2008-3#28)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#12)(2008-8#10)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-12#3)(2010-3#4)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#17)(2012-1#8)(2012-12#5)(2012-2#3)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#7)
for all-optical##2##2##(2008-2#2)
for all-solid-state##2##2##(2008-10#2)
for allergen##2##2##(2007-11#1)(2008-10#1)
for allergic rhinitis##4##3##(2007-11#2)(2008-5#1)(2013-1#1)
for allergic##5##2##(1990-3#1)(2007-11#2)(2008-5#1)(2013-1#1)
for alleviating##6##2##(2008-10#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#2)
for allied health##2##3##(1996-2#2)
for allocating##4##2##(1992-3#1)(1995-3#1)(2008-11#1)(2010-2#1)
for allowing##3##2##(2010-4#1)(2011-2#2)
for almost all the##2##4##(2008-12#1)(2010-2#1)
for almost all##8##3##(2007-6#1)(2008-10#4)(2008-12#1)(2010-2#1)(2011-2#1)
for almost one##3##3##(1997-7#1)(2009-12#1)(2012-3#1)
for almost##19##2##(1993-3#1)(1996-11#1)(1997-5#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
for alopecia##2##2##(2007-7#1)(2013-8#1)
for alpha##6##2##(1990-11#1)(1990-7#2)(1992-3#1)(1993-3#1)(1995-11#1)
for alpha-amylase##2##2##(1991-5#1)(1994-11#1)
for alpha-ketoglutarate##2##2##(2008-4#1)(2008-8#1)
for alteration of##2##3##(1990-6#1)(1994-8#1)
for altered##3##2##(1991-5#1)(1992-10#1)(1993-3#1)
for altering the##2##3##(2008-4#1)(2008-5#1)
for alternative model rural hospitals##2##5##(1993-12#2)
for alternative##11##2##(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1996-1#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-12#1)(2013-1#1)
for alternatives##4##2##(1994-9#1)(1995-2#1)(2008-11#1)(2008-7#1)
for altitudes##2##2##(2008-3#2)
for aluminium and manganese##2##4##(2008-10#2)
for aluminium and##5##3##(2008-10#4)(2008-3#1)
for aluminium##11##2##(1992-3#1)(2008-10#9)(2008-3#1)
for aluminum were##2##3##(2008-10#2)
for aluminum##5##2##(2008-10#5)
for alveolar##4##2##(1993-2#1)(1994-3#2)(2007-8#1)
for amalgam##4##2##(1990-9#2)(2012-12#2)
for ambient##2##2##(2008-10#1)(2008-2#1)
for ambulance##2##2##(2010-3#1)(2012-1#1)
for ambulatory care##6##3##(1991-3#1)(1993-12#1)(1994-3#2)(1997-3#2)
for ambulatory surgery##5##3##(1991-1#3)(1995-2#1)(1997-2#1)
for ambulatory therapy of acute##2##5##(1994-2#2)
for ambulatory##16##2##(1991-1#3)(1991-3#1)(1993-12#1)(1994-2#2)(1994-3#2)(1995-2#1)(1996-2#2)(1997-2#1)(1997-3#2)(2013-1#1)
for amine##2##2##(2008-10#2)
for amines##2##2##(2008-10#2)
for amino acid##4##3##(1992-3#1)(2008-10#1)(2008-4#1)(2009-9#1)
for amino##5##2##(1992-3#1)(1994-9#1)(2008-10#1)(2008-4#1)(2009-9#1)
for amitriptyline##2##2##(1995-2#2)
for ammonia##4##2##(1995-3#1)(2007-12#1)(2008-10#2)
for ammonium and##2##3##(2008-10#2)
for ammonium dihydrogenphosphate##2##3##(2008-10#2)
for ammonium##13##2##(2008-10#13)
for amniocentesis##2##2##(1990-9#1)(2012-3#1)
for amorphous##2##2##(1995-11#1)(2008-10#1)
for amounts##2##2##(1994-5#1)(2008-1#1)
for amperometric detection of NADH##2##5##(2008-10#2)
for amperometric detection of##4##4##(2008-10#4)
for amperometric determination of ascorbic acid##2##6##(2008-10#2)
for amperometric determination of##5##4##(2008-10#4)(2010-5#1)
for amperometric##12##2##(2008-10#11)(2010-5#1)
for ampicillin##2##2##(2007-7#1)(2008-10#1)
for amplification and##2##3##(1993-12#1)(2011-2#1)
for amplification of the##3##4##(2008-10#2)(2008-2#1)
for amplification of##7##3##(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)
for amplification##12##2##(1991-6#1)(1993-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
for amplified##2##2##(2007-12#1)(2008-10#1)
for amplifying##5##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
for amputation##2##2##(2008-6#2)
for amylin##5##2##(1991-12#3)(1993-11#1)(2008-9#1)
for amyloid##3##2##(1994-5#1)(1994-8#1)(1995-12#1)
for an aberration-corrected concave grating for##2##6##(2008-3#2)
for an absorbed pump##2##4##(2008-2#1)(2008-3#1)
for an accumulation##3##3##(1994-5#1)(2008-10#2)
for an accurate diagnosis##3##4##(2007-2#1)(2008-1#1)(2010-6#1)
for an accurate##5##3##(2007-2#1)(2008-1#1)(2008-3#1)(2010-6#1)(2013-1#1)
for an active optical##2##4##(2008-3#2)
for an active##3##3##(2007-11#1)(2008-3#2)
for an acute##3##3##(1991-1#1)(1991-6#1)(1997-3#1)
for an additional##11##3##(1996-1#1)(1996-2#2)(2008-10#3)(2008-3#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
for an adult##2##3##(1992-3#1)(2013-1#1)
for an altered##2##3##(1992-6#1)(2012-1#1)
for an alternative##2##3##(2007-10#1)(2012-2#1)
for an analysis of##2##4##(2008-10#1)(2008-3#1)
for an appropriate##3##3##(1994-3#1)(2007-12#1)(2008-3#1)
for an arbitrary##4##3##(2008-2#1)(2008-3#3)
for an array of##2##4##(1996-1#1)(2008-2#1)
for an assessment##2##3##(2008-9#2)
for an association between##2##4##(1997-5#1)(2008-9#1)
for an association##3##3##(1993-9#1)(1997-5#1)(2008-9#1)
for an automated##2##3##(2008-10#1)(2008-3#1)
for an average of 10##2##5##(2007-8#1)(2012-2#1)
for an average of 26##2##5##(2008-1#1)(2009-10#1)
for an average of##13##4##(1990-12#1)(1991-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
for an average##18##3##(1990-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
for an early detection of the##2##6##(2010-8#1)(2013-8#1)
for an early##6##3##(1992-8#1)(2008-8#2)(2010-8#1)(2013-1#1)(2013-8#1)
for an effective##7##3##(1992-5#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-2#1)(2012-2#2)
for an efficient##2##3##(2008-10#2)
for an elevated##2##3##(1992-9#1)(2012-3#1)
for an elongated dihydrogen##2##4##(1997-7#2)
for an ensemble of##2##4##(2008-3#1)(2010-3#1)
for an equivalent##2##3##(2008-10#1)(2008-3#1)
for an essential##2##3##(2008-11#1)(2008-4#1)
for an evaluation##2##3##(2008-10#1)(2008-9#1)
for an extended period##2##4##(1997-2#1)(2008-11#1)
for an extended##4##3##(1992-8#1)(1997-2#1)(2008-11#2)
for an hour##2##3##(1992-12#1)(2008-10#1)
for an ideal##2##3##(2007-12#1)(2008-3#1)
for an important##2##3##(1995-12#1)(2007-7#1)
for an incident##2##3##(2007-12#1)(2008-2#1)
for an increase in##5##4##(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)
for an increase##6##3##(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)
for an increased risk of##2##5##(2008-11#1)(2013-1#1)
for an increased##3##3##(2008-11#2)(2013-1#1)
for an increasing share of total##2##6##(1991-2#1)(1996-2#1)
for an increasing##4##3##(1991-2#1)(1991-3#1)(1996-2#1)(2008-3#1)
for an independent##2##3##(2008-10#1)(2008-6#1)
for an individual patient##2##4##(1992-8#1)(2008-2#1)
for an individual##7##3##(1992-12#1)(1992-6#1)(1992-8#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
for an infectious##2##3##(1997-3#1)(2009-1#1)
for an initial##3##3##(1995-3#1)(1997-5#1)(2008-7#1)
for an input##2##3##(2008-2#1)(2008-3#1)
for an instrument##4##3##(1997-7#1)(2008-2#1)(2008-3#2)
for an integrated health care system##2##6##(1994-1#1)(1996-12#1)
for an integrated##4##3##(1994-1#1)(1996-12#1)(1996-3#1)(2008-7#1)
for an interferometer##2##3##(2007-11#1)(2008-3#1)
for an intermediate##2##3##(1993-11#1)(2008-7#1)
for an international##4##3##(2008-10#1)(2008-11#1)(2009-10#2)
for an intrinsic##3##3##(1990-12#1)(2007-11#1)(2007-12#1)
for an invasive##2##3##(1994-12#1)(2008-10#1)
for an inverse relationship between##4##5##(2010-4#1)(2013-8#3)
for an inverse##5##3##(2008-10#1)(2010-4#1)(2013-8#3)
for an iterative##3##3##(2007-11#2)(2008-2#1)
for an old drug##2##4##(1996-3#1)(2008-1#1)
for an old##4##3##(1993-8#1)(1996-3#1)(2008-1#1)(2008-5#1)
for an on-line##2##3##(2008-10#2)
for an open##2##3##(2007-8#1)(2013-8#1)
for an optical##7##3##(2008-10#1)(2008-2#4)(2008-3#2)
for an optically##3##3##(2008-2#1)(2008-3#2)
for an optimal##4##3##(2007-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
for an optimum##3##3##(1997-2#1)(2008-11#1)(2008-3#1)
for an optoelectronic##2##3##(2008-1#1)(2008-3#1)
for an organization's##2##3##(1994-3#1)(2009-10#1)
for an unambiguous##2##3##(2008-10#1)(2008-3#1)
for an understanding of##2##4##(2008-10#1)(2008-2#1)
for an##413##2##(1990-12#4)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#5)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#12)(2007-12#15)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#9)(2008-10#42)(2008-11#13)(2008-12#4)(2008-2#31)(2008-3#61)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#6)(2013-8#7)
for anaesthesia##2##2##(2008-8#1)(2011-2#1)
for anal cancer##5##3##(1991-6#2)(2010-12#3)
for analgesic##3##2##(2010-7#1)(2011-1#2)
for analyses of##4##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
for analyses##6##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
for analysing the##3##3##(1991-9#1)(2011-2#2)
for analysing##18##2##(1991-9#1)(1992-6#2)(1992-9#2)(1994-3#1)(1995-12#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-7#2)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)
for analysis and##5##3##(1992-2#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
for analysis by##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2010-6#1)
for analysis in##2##3##(2008-10#1)(2008-12#1)
for analysis is##3##3##(2008-10#2)(2010-4#1)
for analysis of RNA##2##4##(2008-9#1)(2011-3#1)
for analysis of a##2##4##(2008-4#1)(2012-12#1)
for analysis of large##2##4##(2008-4#1)(2008-7#1)
for analysis of the##7##4##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)
for analysis of these##3##4##(1995-9#1)(2008-10#2)
for analysis of##80##3##(1990-8#2)(1993-12#1)(1995-11#1)(1995-9#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#39)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#2)(2008-9#6)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-12#2)(2012-2#1)
for analysis##133##2##(1990-12#1)(1990-8#2)(1991-8#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-9#1)(1997-2#2)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#52)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-7#5)(2008-9#11)(2009-1#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#4)
for analyte ions##2##3##(2008-10#2)
for analyte##5##2##(2008-10#5)
for analytes##4##2##(2008-10#4)
for analytical SEC##2##3##(1997-2#2)
for analytical and##4##3##(1997-3#1)(2008-10#1)(2010-3#1)(2012-2#1)
for analytical applications##2##3##(2007-12#1)(2008-10#1)
for analytical chemists##2##3##(2008-10#2)
for analytical determination of paraquat##2##5##(2008-10#2)
for analytical methods##2##3##(2008-9#1)(2010-9#1)
for analytical preconcentration##2##3##(2008-10#2)
for analytical purposes##6##3##(2008-10#4)(2010-7#1)(2011-2#1)
for analytical##30##2##(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
for analyzing a##2##3##(2008-3#1)(2008-4#1)
for analyzing and##2##3##(2007-11#1)(2009-7#1)
for analyzing the##14##3##(1997-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#5)(2009-11#1)(2012-3#1)(2013-1#1)
for analyzing##56##2##(1992-3#2)(1992-6#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#5)(2008-4#11)(2008-7#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
for anatomical##2##2##(1995-11#1)(1996-7#1)
for ancient##2##2##(2008-10#1)(2008-12#1)
for and against##5##3##(1997-4#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#1)
for and how##2##3##(1993-3#1)(1997-2#1)
for and the##3##3##(2008-2#1)(2008-3#2)
for and##32##2##(1991-11#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#3)
for androgen##2##2##(2008-9#1)(2009-2#1)
for anemia##5##2##(2008-10#1)(2008-7#2)(2010-9#1)(2013-1#1)
for angina##2##2##(1991-5#1)(2011-2#1)
for angiogenesis##2##2##(2012-12#1)(2013-8#1)
for angiography##2##2##(1993-6#1)(2008-9#1)
for angioplasty##2##2##(2008-1#1)(2008-5#1)
for angiotensin##6##2##(1993-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(2012-1#1)
for angles less than##2##4##(2008-3#2)
for angles##4##2##(2008-2#1)(2008-3#3)
for angular##4##2##(2007-11#1)(2008-3#1)(2013-1#2)
for animal cell culture##3##4##(2008-11#2)(2008-7#1)
for animal cell##5##3##(2008-11#4)(2008-7#1)
for animal genome database development##2##5##(2008-7#2)
for animal##20##2##(1990-12#1)(1993-11#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-6#1)(2008-7#4)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
for animals##2##2##(2007-11#1)(2013-1#1)
for anionic ring-opening##2##3##(2012-12#2)
for anionic surfactant##2##3##(2008-10#2)
for anionic surfactants##2##3##(2008-10#2)
for anionic##9##2##(1990-12#1)(1994-12#1)(2008-10#5)(2012-12#2)
for anions and##2##3##(2008-10#2)
for anions##4##2##(2008-10#4)
for anisotropic##2##2##(2008-10#1)(2008-3#1)
for ankle arthrosis with##2##4##(2008-12#2)
for ankle arthrosis##3##3##(2008-12#2)(2011-2#1)
for ankle##5##2##(2008-12#4)(2011-2#1)
for anodic stripping##2##3##(2008-10#2)
for anodic##3##2##(2008-10#3)
for anomalous##2##2##(1995-11#1)(2007-8#1)
for another 15 days##2##4##(2008-10#2)
for another##18##2##(1990-7#1)(1993-2#1)(1994-12#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-1#1)(2010-3#3)(2011-1#1)(2011-2#1)(2013-7#1)
for answers##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
for antenatal care##2##3##(2007-2#1)(2012-3#1)
for antenatal##3##2##(1995-6#1)(2007-2#1)(2012-3#1)
for anterior cruciate ligament##2##4##(2008-11#1)(2012-2#1)
for anterior##4##2##(1990-5#1)(2008-11#1)(2008-7#1)(2012-2#1)
for anthracnose##3##2##(2008-10#3)
for anthropogenic##2##2##(2008-11#2)
for anti-HCV antibodies##2##3##(2008-1#2)
for anti-HCV##4##2##(2007-7#1)(2008-1#2)(2013-8#1)
for anti-HIV##2##2##(1996-5#1)(2011-3#1)
for anti-KLH IgM##2##3##(2008-10#1)(2008-9#1)
for anti-KLH##3##2##(2008-10#2)(2008-9#1)
for anti-aging properties##2##3##(2008-5#2)
for anti-cancer therapy##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
for anti-cancer##7##2##(1997-1#1)(2008-9#1)(2011-2#2)(2013-1#3)
for antibacterial activity##2##3##(1995-3#1)(2007-11#1)
for antibacterial##4##2##(1995-3#1)(2007-11#1)(2008-12#1)(2008-8#1)
for antibiotic##6##2##(1990-3#1)(2008-8#2)(2010-6#1)(2012-3#1)(2013-8#1)
for antibiotics##5##2##(2007-11#1)(2008-4#1)(2010-8#3)
for antibodies specific for##2##4##(1991-8#1)(2008-10#1)
for antibodies to##5##3##(1990-12#1)(1992-5#1)(2007-12#1)(2008-10#1)(2012-3#1)
for antibodies##12##2##(1990-12#1)(1990-3#1)(1991-8#1)(1992-5#1)(1992-8#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-9#1)(2012-3#1)
for antibody labeling and time-resolved fluoroimmunoassay##2##6##(2008-10#2)
for antibody##14##2##(1995-5#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
for anticancer##4##2##(2008-5#1)(2010-7#1)(2012-2#2)
for antiestrogen##2##2##(2008-10#1)(2008-11#1)
for antifungal activity##2##3##(2007-11#1)(2008-9#1)
for antifungal susceptibility##2##3##(2008-5#1)(2011-2#1)
for antifungal##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#1)
for antihypertensive therapy##3##3##(1992-8#2)(2013-8#1)
for antimicrobial resistance##2##3##(2011-2#1)(2012-2#1)
for antimicrobial##9##2##(2007-8#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-2#2)(2013-1#1)
for antimony##2##2##(2008-10#2)
for antioxidant##6##2##(1991-9#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-7#1)
for antioxidants##3##2##(2008-10#3)
for antiradical##2##2##(2008-11#1)(2008-5#1)
for antisense##2##2##(1993-3#1)(2008-5#1)
for antithrombin III##3##3##(1995-2#3)
for antiviral##4##2##(1991-2#1)(1995-9#1)(2007-12#2)
for anxiety##3##2##(2008-12#1)(2010-8#1)(2011-2#1)
for any cell##2##3##(2008-10#1)(2008-9#1)
for any combination of##2##4##(1995-9#1)(2008-3#1)
for any desired##2##3##(1994-8#1)(2011-2#1)
for any given##10##3##(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
for any of the##6##4##(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
for any of##8##3##(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
for any one##3##3##(1995-3#1)(2009-12#1)(2012-2#1)
for any other##3##3##(1993-2#1)(1997-5#1)(2012-2#1)
for any type of##2##4##(2007-12#1)(2008-4#1)
for any value of##2##4##(2008-3#2)
for any##110##2##(1990-3#1)(1992-2#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-5#2)(2007-11#5)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#10)(2008-12#2)(2008-2#10)(2008-3#14)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#6)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
for aortic valve##3##3##(2007-8#1)(2009-5#2)
for aortic##8##2##(1997-8#1)(2007-8#3)(2009-5#2)(2010-8#1)(2013-3#1)
for apatite##2##2##(2008-10#1)(2013-1#1)
for apical##2##2##(2008-9#1)(2009-8#1)
for apolipoprotein##2##2##(1990-7#1)(2012-2#1)
for apoptosis in##2##3##(1995-2#1)(2013-8#1)
for apoptosis##7##2##(1995-2#4)(1996-12#1)(2008-8#1)(2013-8#1)
for apothecia##2##2##(2008-10#2)
for appendicitis##2##2##(2008-7#1)(2011-2#1)
for apple##3##2##(1997-2#1)(2008-10#2)
for application as##2##3##(2008-10#2)
for application in the##5##4##(2008-10#4)(2013-1#1)
for application in##21##3##(1993-11#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#3)(2010-8#1)(2011-2#1)(2013-1#1)
for application of the##3##4##(2008-3#2)(2013-8#1)
for application of##11##3##(1990-5#1)(1994-11#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2013-1#1)(2013-8#2)
for application to the##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
for application to##13##3##(2007-12#2)(2008-10#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2012-1#1)
for application##51##2##(1990-12#1)(1990-5#1)(1993-11#1)(1994-11#1)(1995-12#1)(2007-12#2)(2007-8#1)(2008-10#21)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
for applications in optical##2##4##(2007-12#2)
for applications in which##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
for applications in##21##3##(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-7#1)(2010-2#1)(2012-12#1)(2013-8#1)
for applications of##5##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)
for applications such as##6##4##(1995-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
for applications to##2##3##(2008-3#1)(2009-10#1)
for applications##43##2##(1995-11#1)(2007-11#5)(2007-12#3)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
for applied##2##2##(2009-11#1)(2011-1#1)
for applying the##6##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
for applying##13##2##(2007-11#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
for approaching##2##2##(2008-7#2)
for appropriate selection##2##3##(2007-7#1)(2011-1#1)
for appropriate##26##2##(1991-3#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
for approval by the##2##4##(2008-5#1)(2012-3#1)
for approximately 25% of##2##4##(2011-2#1)(2012-2#1)
for approximately 3##2##3##(2008-10#1)(2010-1#1)
for approximately 3%##2##3##(2008-1#1)(2008-12#1)
for approximately 50% of##2##4##(2008-4#1)(2009-10#1)
for approximately six months##2##4##(1990-6#1)(2008-8#1)
for approximately##37##2##(1990-3#1)(1990-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
for aquaculture##2##2##(2008-5#1)(2010-11#1)
for aquatic##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
for aqueous dispersions##2##3##(1990-7#2)
for aqueous solutions##2##3##(2008-10#1)(2008-3#1)
for aqueous##11##2##(1990-7#2)(2008-10#7)(2008-3#1)(2009-2#1)
for arbitrary fiber##2##3##(2008-2#2)
for arbitrary geometries##2##3##(2007-11#1)(2008-3#1)
for arbitrary##16##2##(1994-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#4)(2012-2#1)(2013-1#1)
for archaeological##2##2##(2008-10#2)
for area##3##2##(1991-12#1)(1996-2#1)(2008-10#1)
for arginine##2##2##(1991-8#1)(2008-10#1)
for aromatase##3##2##(1991-5#1)(1993-8#1)(2008-4#1)
for aromatic cations##2##3##(2008-10#2)
for aromatic##3##2##(2008-10#3)
for around 20##2##3##(2008-10#2)
for around##4##2##(2008-10#3)(2013-8#1)
for array##6##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#2)
for arrhythmia diagnostics##2##3##(2010-8#2)
for arrhythmia##4##2##(2007-8#1)(2009-3#1)(2010-8#2)
for arsenic and selenium##4##4##(2008-10#4)
for arsenic compounds##2##3##(2008-10#2)
for arsenic determination in##3##4##(2008-10#3)
for arsenic determination##7##3##(2008-10#7)
for arsenic speciation in environmental samples##2##6##(2008-10#2)
for arsenic speciation in environmental##3##5##(2008-10#3)
for arsenic speciation in##5##4##(2008-10#5)
for arsenic species##2##3##(2008-10#2)
for arsenic##25##2##(2008-10#25)
for arsenite##4##2##(2008-10#4)
for arterial##3##2##(1990-8#1)(2008-4#1)(2012-1#1)
for arteriovenous malformation##2##3##(2008-7#2)
for arteriovenous##5##2##(2007-10#1)(2007-7#1)(2008-7#3)
for arthritis##2##2##(2006-10#1)(2008-7#1)
for articles published between##2##4##(2008-7#1)(2012-12#1)
for articles published##6##3##(2008-7#1)(2012-12#5)
for articles##8##2##(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#5)
for artificial##2##2##(2008-10#2)
for aryl##2##2##(1997-4#1)(2010-8#1)
for as long as possible##2##5##(1991-8#1)(1997-4#1)
for as long as##6##4##(1991-8#1)(1994-12#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#1)
for as much##3##3##(1994-5#1)(2008-7#2)
for as##11##2##(1991-8#1)(1994-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-7#2)
for ascending##2##2##(1991-6#1)(2013-1#1)
for ascertaining##2##2##(2008-4#1)(2008-9#1)
for ascorbate##2##2##(1990-9#1)(2008-10#1)
for ascorbic acid and##3##4##(2008-10#3)
for ascorbic acid##14##3##(2008-10#14)
for ascospore##2##2##(2008-10#2)
for ascospores##3##2##(2008-10#3)
for aspartate and Mg2+ of##2##5##(1995-6#2)
for aspartate and##3##3##(1995-6#3)
for aspartate##5##2##(1995-6#4)(2008-4#1)
for aspartic##2##2##(1995-6#1)(2008-10#1)
for aspiration##2##2##(1993-10#1)(2011-2#1)
for assay##3##2##(1990-3#1)(2008-10#1)(2008-4#1)
for assaying##9##2##(1992-6#1)(2008-10#2)(2008-2#1)(2008-4#5)
for assays##2##2##(2008-10#1)(2008-4#1)
for assembling##4##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
for assembly of##2##3##(1995-6#1)(1997-2#1)
for assembly##3##2##(1995-6#1)(1997-2#1)(2009-2#1)
for assessing and##2##3##(1990-2#1)(2009-10#1)
for assessing drug##2##3##(1997-4#1)(2008-4#1)
for assessing the effects of##3##5##(2008-5#1)(2009-12#1)(2010-5#1)
for assessing the mouse auditory system##2##6##(2008-4#2)
for assessing the quality of##2##5##(2010-2#1)(2010-4#1)
for assessing the##39##3##(1990-3#1)(1993-12#1)(1994-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#2)
for assessing toxic##2##3##(2008-10#1)(2008-11#1)
for assessing##101##2##(1990-2#1)(1990-3#1)(1991-1#2)(1992-11#1)(1992-3#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-2#2)(2011-8#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#9)(2013-8#2)
for assessment and##2##3##(2009-9#1)(2013-8#1)
for assessment of the##5##4##(1992-5#1)(1994-5#1)(1997-8#1)(2009-5#1)(2009-8#1)
for assessment of##34##3##(1992-5#1)(1993-1#1)(1993-9#1)(1994-5#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#4)(2009-5#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
for assessment##41##2##(1992-5#1)(1993-1#1)(1993-9#1)(1994-5#1)(1996-1#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#4)(2009-11#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
for assigning##3##2##(1996-12#1)(2008-12#1)(2008-7#1)
for assistance##3##2##(1991-5#1)(1996-2#1)(2010-12#1)
for assisted living##2##3##(2008-12#2)
for assisted##4##2##(2008-12#2)(2008-7#1)(2011-1#1)
for association of##4##3##(1991-8#1)(1997-5#1)(2008-10#1)(2008-9#1)
for association with##3##3##(1991-12#1)(1995-2#1)(2009-7#1)
for association##10##2##(1991-12#1)(1991-8#1)(1995-2#1)(1997-5#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)
for associations of##3##3##(2008-10#2)(2012-1#1)
for associations##4##2##(2008-10#2)(2010-2#1)(2012-1#1)
for assuring the##2##3##(2010-11#1)(2012-2#1)
for assuring##4##2##(1997-1#1)(2010-11#1)(2011-2#1)(2012-2#1)
for asthma or##2##3##(1997-6#1)(2008-11#1)
for asthma##14##2##(1995-12#1)(1996-2#1)(1997-6#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2010-5#2)(2010-9#1)(2012-12#1)
for astigmatism##2##2##(2007-12#1)(2008-3#1)
for astrocytes##2##2##(2008-11#1)(2009-6#1)
for astronomical##4##2##(2008-2#2)(2008-3#2)
for asymmetry parameters##2##3##(2008-2#2)
for asymptomatic women##2##3##(1995-2#1)(1995-4#1)
for asymptomatic##5##2##(1995-2#1)(1995-4#1)(2008-5#1)(2011-2#1)(2011-3#1)
for at least 1 year##2##5##(2008-5#1)(2011-2#1)
for at least 1##4##4##(2007-10#2)(2008-5#1)(2011-2#1)
for at least 10 days on##2##6##(2007-6#2)
for at least 10 weeks##2##5##(2007-6#1)(2008-10#1)
for at least 10##5##4##(2007-6#3)(2007-7#1)(2008-10#1)
for at least 12##2##4##(2008-1#1)(2008-10#1)
for at least 15##2##4##(1990-12#1)(2007-11#1)
for at least 2 months##4##5##(2008-10#4)
for at least 2 weeks##3##5##(2008-10#3)
for at least 2##9##4##(2008-10#8)(2008-9#1)
for at least 20 days##2##5##(1992-3#1)(1995-12#1)
for at least 20##3##4##(1992-3#1)(1995-12#1)(2008-10#1)
for at least 24 h##3##5##(1993-8#1)(1995-12#1)(2008-10#1)
for at least 24 hours##2##5##(1991-5#1)(1992-6#1)
for at least 24##5##4##(1991-5#1)(1992-6#1)(1993-8#1)(1995-12#1)(2008-10#1)
for at least 3 months##10##5##(2008-10#9)(2010-5#1)
for at least 3##12##4##(2007-10#1)(2008-10#9)(2010-5#1)(2011-2#1)
for at least 30##2##4##(1991-6#1)(1995-2#1)
for at least 4 weeks##2##5##(2008-10#1)(2013-1#1)
for at least 4 years##2##5##(1993-11#1)(2008-8#1)
for at least 4##4##4##(1993-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
for at least 40 days##2##5##(1990-11#1)(2008-10#1)
for at least 48 h##2##5##(1991-2#1)(2008-10#1)
for at least 5 months##2##5##(2007-6#1)(2008-10#1)
for at least 5 weeks##2##5##(1994-2#1)(2013-1#1)
for at least 5##8##4##(1990-5#1)(1994-2#1)(1997-4#1)(2007-6#1)(2008-10#2)(2008-6#1)(2013-1#1)
for at least 6 months at##2##6##(2008-10#1)(2008-8#1)
for at least 6 months##5##5##(1996-1#1)(2008-10#3)(2008-8#1)
for at least 6 weeks##2##5##(1990-9#1)(2008-10#1)
for at least 6##7##4##(1990-9#1)(1996-1#1)(2008-10#4)(2008-8#1)
for at least 8##2##4##(2008-10#1)(2009-10#1)
for at least 90##2##4##(1996-12#1)(2008-10#1)
for at least a##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
for at least five years##2##5##(1993-6#1)(2012-2#1)
for at least five##3##4##(1993-6#1)(2011-1#1)(2012-2#1)
for at least one year##5##5##(1993-12#1)(2008-11#2)(2009-9#1)(2011-1#1)
for at least one##11##4##(1993-12#1)(1993-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)
for at least six##2##4##(2009-6#1)(2013-8#1)
for at least some##2##4##(2008-10#1)(2012-3#1)
for at least three##2##4##(1994-6#1)(2010-8#1)
for at least two months##3##5##(2008-10#1)(2008-6#2)
for at least two##5##4##(1994-2#1)(2008-10#1)(2008-6#2)(2008-9#1)
for at least##114##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-2#2)(1994-6#1)(1995-12#2)(1995-2#3)(1996-1#1)(1996-12#1)(1997-4#1)(2007-10#3)(2007-11#2)(2007-6#4)(2007-7#1)(2008-1#1)(2008-10#42)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
for at##117##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-2#2)(1994-6#2)(1995-12#2)(1995-2#3)(1996-1#1)(1996-12#1)(1997-4#1)(2007-10#3)(2007-11#2)(2007-6#4)(2007-7#1)(2008-1#1)(2008-10#42)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
for atenolol##2##2##(2008-10#2)
for atherogenesis##3##2##(1990-2#2)(2006-6#1)
for atherosclerosis and cardiovascular diseases##2##5##(2008-1#1)(2008-10#1)
for atherosclerosis and##4##3##(2008-1#1)(2008-10#1)(2008-4#2)
for atherosclerosis##12##2##(1990-2#1)(2007-10#3)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)
for atherosclerotic##3##2##(2007-10#1)(2008-5#1)(2008-7#1)
for atmospheric##18##2##(2007-12#1)(2008-2#5)(2008-3#12)
for atomic##2##2##(2008-10#2)
for atopic dermatitis##2##3##(2011-1#2)
for atopic##3##2##(2008-3#1)(2011-1#2)
for atrazine and##2##3##(2008-10#2)
for atrazine determination##2##3##(2008-10#2)
for atrazine##9##2##(2008-10#9)
for atrial fibrillation##3##3##(2007-8#1)(2008-3#1)(2009-7#1)
for atrial septal defect##2##4##(2008-11#2)
for atrial##8##2##(1996-11#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-3#2)(2009-7#1)
for attaching##2##2##(2008-4#1)(2008-5#1)
for attaining##6##2##(2008-10#1)(2008-9#2)(2011-1#1)(2013-1#2)
for attending to##2##3##(2013-1#2)
for attending##3##2##(1992-12#1)(2013-1#2)
for attention##2##2##(2008-1#1)(2008-9#1)
for attention-deficit/hyperactivity disorder (ADHD)##2##4##(2008-2#1)(2011-2#1)
for attenuating##2##2##(2006-10#1)(2008-3#1)
for atypical pneumonia and hemorrhagic##2##5##(2010-6#2)
for atypical pneumonia##3##3##(2010-6#3)
for atypical##4##2##(2008-7#1)(2010-6#3)
for augmenting##3##2##(2010-11#1)(2012-2#1)(2013-1#1)
for authentication and##2##3##(2008-11#1)(2011-2#1)
for autism##3##2##(1997-8#1)(2008-11#1)(2013-8#1)
for autoantibodies##2##2##(1996-11#1)(2013-7#1)
for autoimmune##5##2##(1997-2#1)(2007-7#1)(2010-6#1)(2012-3#2)
for autologous stem cell##2##4##(2012-12#1)(2012-4#1)
for autologous##6##2##(1995-1#1)(1996-9#1)(2008-8#1)(2012-12#1)(2012-4#1)(2013-1#1)
for automated cell##2##3##(1996-12#1)(2008-11#1)
for automated evolution experiments in vitro##2##6##(1997-6#2)
for automated sample##2##3##(2008-10#2)
for automated##24##2##(1996-12#1)(1997-4#2)(1997-6#2)(2008-10#12)(2008-11#1)(2008-2#2)(2008-4#2)(2010-5#1)(2012-1#1)
for automatic##11##2##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-12#1)
for automatically##4##2##(2008-11#1)(2010-8#1)(2011-2#1)(2011-3#1)
for automating the##2##3##(2008-10#1)(2008-2#1)
for automation to##2##3##(2008-10#2)
for automation##5##2##(1992-11#1)(2008-10#4)
for autonomous##4##2##(1993-9#1)(1994-12#1)(2008-3#1)(2009-11#1)
for autoradiography##2##2##(2008-4#2)
for available##3##2##(2010-8#2)(2013-1#1)
for avascular necrosis##2##3##(2007-8#2)
for average##2##2##(1991-2#1)(1994-2#1)
for avirulence##4##2##(2008-10#4)
for avoiding the##2##3##(1994-2#1)(2010-8#1)
for avoiding##12##2##(1992-2#1)(1992-3#1)(1994-2#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
for awarding##2##2##(1992-2#1)(2007-11#1)
for awareness##2##2##(2011-2#2)
for axillary##2##2##(1995-9#1)(2008-5#1)
for bFGF and its receptor##2##5##(1995-12#2)
for bFGF##5##2##(1990-5#1)(1992-3#1)(1995-12#3)
for babies##4##2##(1990-2#1)(1992-4#1)(1997-1#1)(2008-11#1)
for backpropagation##2##2##(2008-10#2)
for backscatter##2##2##(2008-2#1)(2008-3#1)
for bacoside A##2##3##(2012-2#2)
for bacteria##4##2##(1994-9#1)(2008-11#1)(2010-10#1)(2013-8#1)
for bacterial blight resistance##3##4##(2008-10#3)
for bacterial blight##6##3##(2008-10#5)(2009-10#1)
for bacterial growth##3##3##(2008-4#1)(2008-6#1)(2012-2#1)
for bacterial pathogens##2##3##(2007-7#1)(2008-7#1)
for bacterial##31##2##(1990-12#1)(2007-7#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
for balancing##3##2##(1992-2#1)(1996-1#1)(2013-1#1)
for band 3##2##3##(1993-11#1)(2008-3#1)
for band intensity and band area measurements##2##7##(2008-10#2)
for band##6##2##(1993-11#1)(2008-10#2)(2008-3#2)(2008-5#1)
for bandwidth##2##2##(2007-11#1)(2008-3#1)
for barrier function##2##3##(2008-5#2)
for barrier##3##2##(2008-5#2)(2008-7#1)
for basal cell##3##3##(2007-5#1)(2007-7#1)(2012-3#1)
for basal##4##2##(2007-5#1)(2007-7#1)(2010-11#1)(2012-3#1)
for baseline##5##2##(2008-10#1)(2008-12#1)(2009-7#1)(2010-8#1)(2013-1#1)
for basic and##2##3##(2008-10#1)(2013-8#1)
for basic fibroblast growth factor##3##5##(1990-5#1)(1994-6#1)(2008-7#1)
for basic research##4##3##(1995-3#1)(2008-11#1)(2008-6#1)(2011-2#1)
for basic##22##2##(1990-5#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
for batch and##5##3##(2008-10#4)(2008-11#1)
for batch##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
for beam##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
for beams##2##2##(2008-3#2)
for beef##2##2##(2010-4#1)(2012-3#1)
for beginning multiple##2##3##(2008-3#2)
for beginning##3##2##(2008-11#1)(2008-3#2)
for behavior##2##2##(2010-5#1)(2010-9#1)
for behavioral##9##2##(1995-1#1)(2007-10#1)(2008-4#1)(2008-6#1)(2008-8#4)(2009-11#1)
for behaviors##2##2##(1993-6#1)(2008-8#1)
for being##4##2##(2008-11#1)(2010-10#1)(2013-1#1)(2013-8#1)
for bending##2##2##(1993-8#1)(2008-10#1)
for benefit##2##2##(2008-2#1)(2011-2#1)
for benign colorectal##2##3##(2011-2#2)
for benign diseases##2##3##(1990-6#2)
for benign esophageal diseases##2##4##(2013-1#2)
for benign esophageal##4##3##(2012-1#1)(2013-1#3)
for benign##16##2##(1990-6#4)(1991-2#1)(1992-9#1)(1993-12#1)(2008-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
for benzene##4##2##(2008-10#4)
for benzophenone-3##2##2##(2008-5#2)
for berberine##2##2##(2008-10#2)
for bereaved parents##3##3##(2008-11#3)
for beryllium##3##2##(2008-10#3)
for best##4##2##(2007-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
for beta##5##2##(1990-7#1)(1991-2#1)(1993-6#2)(1995-11#1)
for beta-galactosidase##4##2##(1993-9#1)(1995-12#1)(1997-8#1)(2008-11#1)
for better data on clinical##2##5##(1994-1#2)
for better health##2##3##(2008-10#1)(2012-12#1)
for better nutritional##2##3##(1995-2#1)(2007-12#1)
for better understanding of the##2##5##(2007-5#1)(2008-10#1)
for better understanding of##4##4##(2007-5#1)(2008-10#1)(2009-8#1)(2013-1#1)
for better understanding the##2##4##(2010-8#1)(2011-2#1)
for better understanding##7##3##(1997-8#1)(2007-5#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
for better##41##2##(1991-2#1)(1991-5#1)(1994-1#2)(1994-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-8#1)(2007-12#2)(2007-5#2)(2007-7#1)(2008-10#7)(2008-3#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
for between##4##2##(1991-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
for beveling##2##2##(2008-3#2)
for bias##3##2##(2007-10#1)(2008-2#1)(2012-3#1)
for biaxial##2##2##(2006-4#1)(2007-11#1)
for bicompartmental##2##2##(2013-1#2)
for bidirectional communications##2##3##(2008-2#1)(2008-3#1)
for bilateral cochlear##3##3##(2012-2#3)
for bilateral##12##2##(2007-2#1)(2008-10#3)(2008-7#1)(2009-3#2)(2012-2#5)
for biliary##5##2##(1990-9#1)(2008-11#1)(2010-12#1)(2011-2#2)
for bilirubin##2##2##(2008-10#2)
for binary##6##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
for binding of the##2##4##(1990-5#1)(1994-12#1)
for binding of##6##3##(1990-5#1)(1991-2#1)(1992-3#1)(1992-5#1)(1994-12#1)(2008-10#1)
for binding to class##3##4##(1993-3#2)(2008-4#1)
for binding to four-way##2##4##(1994-9#2)
for binding to the##3##4##(1991-3#1)(1995-5#1)(2008-10#1)
for binding to##22##3##(1991-2#2)(1991-3#1)(1993-1#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-4#1)
for binding with##2##3##(2008-10#2)
for binding##47##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#3)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)
for bioactive##3##2##(2008-11#1)(2011-1#1)(2012-6#1)
for bioanalytical assays##2##3##(2008-10#1)(2010-11#1)
for biochemical and##2##3##(2008-4#1)(2013-1#1)
for biochemical##12##2##(1992-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2013-1#2)
for biocontrol efficacy##2##3##(2008-10#2)
for biocontrol of##2##3##(2008-5#1)(2012-2#1)
for biocontrol##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
for biodiesel production##4##3##(2009-3#4)
for biodiscovery##3##2##(2011-1#3)
for biofilm##2##2##(2008-7#1)(2008-9#1)
for biofuel production##2##3##(2011-1#1)(2013-1#1)
for biological activity##3##3##(1993-8#1)(2008-11#1)(2013-1#1)
for biological and##3##3##(2008-10#2)(2010-2#1)
for biological applications##3##3##(2009-12#1)(2012-12#1)(2013-1#1)
for biological control of plant##2##5##(2008-10#2)
for biological control of postharvest diseases##2##6##(2008-10#2)
for biological control of##10##4##(2008-10#10)
for biological control##17##3##(2008-10#15)(2008-11#1)(2008-8#1)
for biological removal of inhibitors from lignocellulosic##2##7##(2011-1#2)
for biological systems##2##3##(2008-10#1)(2008-5#1)
for biological tissues##2##3##(2007-12#1)(2012-12#1)
for biological##52##2##(1991-9#1)(1992-12#1)(1992-9#2)(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#22)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2010-2#1)(2010-3#2)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#2)
for biologically##3##2##(1995-3#1)(2008-10#1)(2010-4#1)
for biologists##4##2##(2008-7#2)(2008-8#1)(2008-9#1)
for biology##2##2##(2008-7#1)(2012-2#1)
for biomarker discovery##3##3##(2008-4#1)(2010-5#1)(2013-8#1)
for biomarker##4##2##(2008-4#1)(2010-11#1)(2010-5#1)(2013-8#1)
for biomedical and##2##3##(1991-12#1)(1993-3#1)
for biomedical applications##9##3##(1994-11#1)(1994-3#1)(2007-12#1)(2008-5#3)(2009-7#2)(2010-2#1)
for biomedical research##3##3##(1993-3#1)(2008-9#1)(2010-12#1)
for biomedical##19##2##(1991-12#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-9#1)(2007-12#1)(2008-5#4)(2008-9#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)
for biomolecular##4##2##(2008-11#1)(2008-12#1)(2009-11#1)(2009-2#1)
for biopharmaceuticals##2##2##(2008-11#1)(2008-8#1)
for biopsy and##2##3##(1990-2#1)(2007-8#1)
for biopsy##9##2##(1990-2#1)(2007-8#1)(2008-1#4)(2008-4#1)(2011-2#1)(2012-3#1)
for bioreactor##2##2##(2008-11#1)(2011-2#1)
for bioremediation of aquaculture effluents##2##5##(2008-5#2)
for bioremediation of##4##3##(2008-5#2)(2012-2#2)
for biosensing##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
for biosensor##4##2##(2008-10#3)(2010-5#1)
for biosensors##5##2##(1995-3#1)(2008-10#3)(2008-11#1)
for biosynthesis##3##2##(2008-10#2)(2008-7#1)
for biotechnological applications##3##3##(2010-11#1)(2011-1#1)(2011-2#1)
for biotechnology##4##2##(2008-11#2)(2009-5#1)(2011-1#1)
for biotin##3##2##(1995-2#1)(2008-4#1)(2008-9#1)
for biotinylation of##3##3##(2008-1#2)(2008-4#1)
for bipolar affective##2##3##(1997-5#2)
for bipolar disorder##2##3##(1997-5#2)
for bipolar##7##2##(1993-1#1)(1997-5#5)(2008-3#1)
for birefringence##4##2##(2007-11#1)(2008-3#3)
for birth incidence##2##3##(2008-11#2)
for bismuth##5##2##(2008-10#4)(2010-11#1)
for bitter##2##2##(2010-5#1)(2013-8#1)
for bivalve##2##2##(2010-11#1)(2012-1#1)
for black##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
for bladder cancer##5##3##(2007-10#1)(2008-4#3)(2009-9#1)
for bladder##8##2##(1991-8#1)(1994-5#1)(2007-10#1)(2008-4#3)(2009-9#1)(2012-2#1)
for bleeding##5##2##(1990-2#1)(1995-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
for blood culture##2##3##(2011-2#2)
for blood glucose##2##3##(2007-10#1)(2008-5#1)
for blood pressure##6##3##(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2013-8#1)
for blood##31##2##(1990-8#1)(1991-3#1)(1992-12#1)(1994-3#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-5#2)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#2)(2012-12#2)(2012-3#1)(2013-8#2)
for bloodborne##2##2##(2007-2#1)(2007-4#1)
for blue##3##2##(2007-11#1)(2007-12#1)(2010-4#1)
for board##2##2##(1992-3#1)(2008-11#1)
for body composition##3##3##(2008-5#1)(2008-7#1)(2009-11#1)
for body image##2##3##(2007-12#1)(2012-2#1)
for body mass index##2##4##(2011-1#1)(2013-8#1)
for body##17##2##(2007-12#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
for bond lengths and 1##2##5##(1992-4#1)(2008-8#1)
for bond lengths and##4##4##(1992-4#1)(2008-8#2)(2008-9#1)
for bond##7##2##(1992-4#2)(2008-8#3)(2008-9#2)
for bonding##2##2##(1990-3#1)(2008-2#1)
for bone and soft tissue sarcomas##4##6##(2008-6#4)
for bone marrow##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
for bone metastases##6##3##(2007-11#4)(2008-10#1)(2010-3#1)
for bone tissue engineering##4##4##(2009-7#3)(2012-6#1)
for bone tissue##5##3##(2009-7#3)(2011-2#1)(2012-6#1)
for bone##41##2##(1990-5#1)(1994-12#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#7)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#6)(2008-8#1)(2009-12#1)(2009-4#2)(2009-7#5)(2010-3#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)
for boron neutron capture therapy##3##5##(1994-3#3)
for boron##4##2##(1994-3#3)(2008-10#1)
for both a##3##3##(2007-12#2)(2008-3#1)
for both agricultural and##2##4##(2008-10#1)(2008-11#1)
for both analytes and the##2##5##(2008-10#2)
for both analytes##9##3##(2008-10#8)(2013-1#1)
for both antioxidants##2##3##(2008-10#2)
for both boys and girls##2##5##(1994-2#1)(2010-1#1)
for both cations##3##3##(2008-10#3)
for both cell types##2##4##(1995-8#1)(1996-12#1)
for both cell##3##3##(1995-2#1)(1995-8#1)(1996-12#1)
for both classes of##2##4##(2008-11#1)(2008-7#1)
for both coherent and##2##4##(2007-12#1)(2008-2#1)
for both components##3##3##(1990-2#1)(2008-10#1)(2008-2#1)
for both compounds##2##3##(2008-10#2)
for both conditions##3##3##(2008-9#1)(2010-5#1)(2012-2#1)
for both coronary##3##3##(1993-12#2)(2009-7#1)
for both current##2##3##(1997-1#1)(2010-8#1)
for both detectors##2##3##(2011-1#2)
for both diagnosis and##3##4##(2008-12#2)(2008-9#1)
for both diagnostic##2##3##(2008-9#1)(2010-3#1)
for both direct##2##3##(1996-2#1)(1997-4#1)
for both drugs##5##3##(1990-9#1)(2008-10#4)
for both elements##2##3##(2008-10#2)
for both enantiomers##2##3##(2008-10#2)
for both families and##2##4##(1991-12#2)
for both fungi##2##3##(2008-10#1)(2008-5#1)
for both genders##2##3##(2011-2#1)(2013-1#1)
for both gene expression and##2##5##(1990-5#1)(2010-10#1)
for both groups##9##3##(1991-1#1)(1994-2#1)(2008-10#2)(2008-11#2)(2009-11#1)(2009-3#1)(2013-8#1)
for both human##2##3##(1991-2#1)(2008-10#1)
for both in vitro and in vivo##2##7##(1994-12#1)(2008-11#1)
for both inpatient and outpatient##2##5##(1995-2#1)(1996-3#1)
for both its##2##3##(1994-5#1)(2008-1#1)
for both local##2##3##(2008-1#1)(2008-11#1)
for both males and females##3##5##(2008-9#1)(2009-8#1)(2013-7#1)
for both medical and##2##4##(1994-12#1)(1996-6#1)
for both men and women##3##5##(2009-10#1)(2009-7#1)(2011-1#1)
for both metals##4##3##(2008-10#4)
for both methods##7##3##(1992-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)
for both mother and##2##4##(2008-1#1)(2012-12#1)
for both normal##2##3##(2008-10#1)(2009-1#1)
for both of the##2##4##(2007-4#1)(2009-10#1)
for both of##4##3##(2007-4#1)(2008-10#2)(2009-10#1)
for both oils##3##3##(2008-10#2)(2008-11#1)
for both patients and##3##4##(1992-4#1)(2009-6#1)(2011-2#1)
for both patients##4##3##(1992-4#1)(2008-7#1)(2009-6#1)(2011-2#1)
for both polarization states##2##4##(2008-3#2)
for both populations##2##3##(2008-8#1)(2013-7#1)
for both primary##2##3##(2008-1#1)(2008-11#1)
for both procedures##2##3##(2008-10#1)(2008-4#1)
for both processes##2##3##(1993-8#1)(2008-10#1)
for both samples##3##3##(1996-7#1)(2008-10#2)
for both sexes at##2##4##(2011-2#1)(2013-1#1)
for both sexes in##3##4##(1991-6#1)(1997-4#1)(2008-10#1)
for both sexes##10##3##(1991-6#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
for both species##14##3##(1993-11#1)(1993-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-7#2)
for both spore##2##3##(2008-10#2)
for both static and##2##4##(2008-2#1)(2008-3#1)
for both substrates##4##3##(1991-9#1)(1994-6#1)(2008-5#1)(2011-2#1)
for both systems##2##3##(2008-10#2)
for both techniques##4##3##(2007-10#2)(2008-10#2)
for both the individual##2##4##(2008-5#1)(2011-1#1)
for both the patient and the##2##6##(1991-12#1)(2012-12#1)
for both the##61##3##(1990-2#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
for both these##3##3##(2008-12#1)(2008-5#1)(2011-2#1)
for both types of##6##4##(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
for both viruses##2##3##(2008-10#2)
for both water and##2##4##(2008-3#1)(2012-12#1)
for both women##2##3##(1996-3#1)(2008-3#1)
for both##628##2##(1990-11#3)(1990-2#3)(1990-3#2)(1990-5#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#6)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-5#5)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#2)(1997-7#2)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#10)(2007-12#19)(2007-2#2)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#9)(2008-10#165)(2008-11#23)(2008-12#12)(2008-2#34)(2008-3#46)(2008-4#12)(2008-5#12)(2008-6#6)(2008-7#17)(2008-8#12)(2008-9#16)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#4)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-2#15)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#9)(2013-1#7)(2013-7#6)(2013-8#4)
for both)##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
for boundary##2##2##(2008-2#1)(2008-3#1)
for bovine serum albumin (BSA)##4##5##(2008-10#3)(2008-7#1)
for bovine serum albumin##5##4##(2008-10#4)(2008-7#1)
for bovine serum##6##3##(1991-9#1)(2008-10#4)(2008-7#1)
for bovine##17##2##(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#2)(1993-8#1)(1995-11#1)(2008-10#6)(2008-5#1)(2008-7#1)
for bowel preparation##2##3##(2011-2#1)(2013-1#1)
for bowel##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
for boys and girls##5##4##(2008-11#1)(2009-7#2)(2010-4#1)(2012-3#1)
for boys and##7##3##(1993-8#1)(2008-11#1)(2009-7#2)(2010-4#1)(2012-3#1)(2013-1#1)
for boys##20##2##(1990-9#1)(1993-8#1)(2007-12#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-4#2)(2012-3#2)(2013-1#2)
for brain metastases##2##3##(1995-9#2)
for brain##17##2##(1990-3#2)(1992-11#1)(1995-5#1)(1995-9#2)(1996-2#2)(1996-3#1)(2008-11#2)(2008-4#1)(2009-10#2)(2010-12#1)(2012-2#1)(2013-1#1)
for breaking##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
for breast and##5##3##(1990-6#1)(1990-8#1)(1993-9#1)(2008-10#1)(2013-1#1)
for breast cancer in##2##4##(1992-10#1)(1995-4#1)
for breast cancer patients in##2##5##(1993-1#1)(1994-7#1)
for breast cancer patients##4##4##(1991-12#1)(1993-1#1)(1994-7#1)(1995-2#1)
for breast cancer##42##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-10#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-7#2)(1995-11#1)(1995-2#1)(1995-4#2)(1995-8#1)(1995-9#3)(1996-10#1)(1997-3#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-2#4)(2012-2#2)(2013-7#1)(2013-8#2)
for breast cancer]##2##3##(1996-9#1)(2011-3#1)
for breast cancers##2##3##(1990-11#1)(1993-11#1)
for breast reconstruction##3##3##(1992-5#2)(2013-1#1)
for breast##64##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-5#2)(1992-7#1)(1993-1#2)(1993-11#2)(1993-6#1)(1993-9#1)(1994-7#2)(1995-11#1)(1995-2#1)(1995-4#2)(1995-8#2)(1995-9#3)(1996-10#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
for breeding for##2##3##(2008-10#2)
for breeding opportunities##2##3##(2008-8#1)(2008-9#1)
for breeding##10##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#3)(2012-1#1)
for bridging##2##2##(2008-3#2)
for bringing##4##2##(1996-4#1)(2008-10#1)(2010-8#1)(2011-1#1)
for broad-spectrum##2##2##(2008-10#1)(2009-10#1)
for broadband##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
for broadcasting##2##2##(2008-3#2)
for bromide##4##2##(2008-10#3)(2011-1#1)
for bronchial##3##2##(2007-8#1)(2010-2#2)
for brown rot##2##3##(2008-10#2)
for brown##3##2##(2008-10#2)(2013-1#1)
for bubble growth##2##3##(2007-12#2)
for budding##2##2##(2008-10#1)(2008-2#1)
for building a##4##3##(1994-3#1)(1995-6#1)(2008-7#1)(2010-8#1)
for building and##2##3##(2008-10#1)(2011-1#1)
for building the##2##3##(2008-10#1)(2013-8#1)
for building##16##2##(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2010-8#1)(2011-1#2)(2013-8#1)
for bulk##3##2##(2008-10#1)(2008-3#2)
for burn##2##2##(2009-6#1)(2012-3#1)
for burnout##2##2##(2008-10#1)(2010-2#1)
for business##3##2##(1991-12#2)(1994-2#1)
for by a##6##3##(1990-2#1)(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
for by the##7##3##(1992-11#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-1#1)
for by##44##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1992-11#1)(1992-6#3)(1994-3#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
for cAMP-dependent protein kinase##2##4##(1993-3#2)
for cDNA##2##2##(2008-10#1)(2008-7#1)
for cabin##2##2##(1996-12#1)(2008-1#1)
for cadmium and##7##3##(2008-10#7)
for cadmium determination in seawater##2##5##(2008-10#2)
for cadmium determination in##4##4##(2008-10#4)
for cadmium determination##5##3##(2008-10#5)
for cadmium in##2##3##(2008-10#2)
for cadmium##33##2##(1996-7#1)(1997-4#1)(2007-12#1)(2008-10#29)(2008-11#1)
for caesarean##5##2##(2006-10#1)(2008-11#1)(2009-7#1)(2010-11#1)(2012-12#1)
for caffeine##3##2##(2008-10#2)(2008-5#1)
for calcaneal##2##2##(2010-3#1)(2012-2#1)
for calcium and##3##3##(2008-10#2)(2013-1#1)
for calcium##12##2##(1990-2#1)(1993-6#1)(1994-2#1)(2008-1#1)(2008-10#5)(2008-9#1)(2010-4#1)(2013-1#1)
for calcium-mediated##2##2##(1992-3#1)(2008-8#1)
for calculating sample size for##2##5##(2007-7#2)
for calculating sample size##3##4##(2007-7#3)
for calculating the phase##3##4##(2008-2#3)
for calculating the reflection##2##4##(2008-3#2)
for calculating the##23##3##(2007-12#2)(2008-10#2)(2008-2#9)(2008-3#10)
for calculating weight##3##3##(2010-3#3)
for calculating##45##2##(1994-3#1)(1995-9#1)(2007-12#3)(2007-7#3)(2008-10#3)(2008-2#11)(2008-3#14)(2008-8#1)(2009-12#1)(2010-3#3)(2010-8#1)(2012-3#1)(2013-1#2)
for calculation of the##5##4##(1996-3#1)(2008-10#2)(2008-3#2)
for calculation of##12##3##(1996-3#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-8#1)
for calculation##13##2##(1996-3#1)(2008-10#4)(2008-3#6)(2008-4#1)(2008-8#1)
for calendar##2##2##(1991-2#1)(1995-12#1)
for calf thymus DNA (ctDNA)##2##5##(2008-10#2)
for calf thymus DNA and##2##5##(2008-10#2)
for calf thymus DNA##9##4##(2008-10#9)
for calibrating##2##2##(2008-11#1)(2008-4#1)
for calibration and validation subset partitioning##2##6##(2008-10#2)
for calibration and##4##3##(2008-10#4)
for calibration of a##2##4##(2008-10#1)(2008-3#1)
for calibration of the##2##4##(1991-5#1)(2008-3#1)
for calibration of##5##3##(1991-5#1)(2008-10#2)(2008-3#2)
for calibration##21##2##(1991-5#1)(2008-10#15)(2008-3#3)(2008-9#1)(2010-6#1)
for calmodulin##3##2##(1993-6#3)
for cancer and##2##3##(2009-12#1)(2010-9#1)
for cancer cell##3##3##(2008-11#2)(2013-1#1)
for cancer cells##2##3##(2008-11#1)(2011-2#1)
for cancer control##2##3##(1997-1#2)
for cancer diagnosis##3##3##(2010-6#1)(2012-12#2)
for cancer gene therapy##4##4##(1994-5#2)(2008-8#1)(2011-2#1)
for cancer imaging##2##3##(2008-1#2)
for cancer immunotherapy##4##3##(2008-11#4)
for cancer of the##3##4##(2007-8#2)(2009-11#1)
for cancer of##4##3##(1992-8#1)(2007-8#2)(2009-11#1)
for cancer pain##4##3##(1997-5#1)(2008-7#3)
for cancer patients in##2##4##(1990-6#1)(2012-2#1)
for cancer patients##8##3##(1990-6#1)(1991-12#1)(1992-3#1)(1994-6#1)(1996-2#1)(1997-4#1)(2009-12#1)(2012-2#1)
for cancer prevention and##3##4##(1997-1#1)(2008-7#2)
for cancer prevention##4##3##(1997-1#1)(2008-7#2)(2009-3#1)
for cancer research##3##3##(2008-11#1)(2009-12#1)(2009-4#1)
for cancer risk assessment##2##4##(2008-7#2)
for cancer risk##3##3##(2008-7#3)
for cancer survivors##2##3##(2008-7#2)
for cancer therapy##11##3##(1994-5#3)(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
for cancer##104##2##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-5#8)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-2#1)(1997-1#3)(1997-4#1)(1997-5#1)(1997-7#1)(2007-4#4)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#10)(2008-5#3)(2008-7#15)(2008-8#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#10)(2012-12#4)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#4)
for cancer-related##2##2##(1990-8#1)(2008-7#1)
for cancers##6##2##(1992-12#1)(1995-9#1)(1997-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
for candidate##4##2##(1995-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
for canine##6##2##(2008-10#3)(2012-3#3)
for cannabis##2##2##(1997-8#1)(2012-12#1)
for capacity##3##2##(2009-5#1)(2010-11#1)(2010-8#1)
for capillary electrophoresis (CE)##2##4##(2008-10#2)
for capillary electrophoresis using##2##4##(2008-10#2)
for capillary electrophoresis##12##3##(2008-10#10)(2008-2#2)
for capillary gas##2##3##(2011-1#2)
for capillary##16##2##(2008-10#12)(2008-2#2)(2011-1#2)
for capital##2##2##(1994-3#2)
for capturing##9##2##(1992-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
for carbendazim##2##2##(2008-10#2)
for carbohydrate##4##2##(1997-6#1)(2008-6#1)(2008-9#1)(2013-1#1)
for carbon dioxide##2##3##(2008-10#2)
for carbon monoxide##3##3##(1996-12#1)(2008-10#1)(2010-10#1)
for carbon##8##2##(1990-8#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-10#1)
for carbonate##2##2##(2008-10#2)
for carboxin resistance##2##3##(2008-10#2)
for carboxylic##2##2##(2008-10#1)(2012-3#1)
for carcinoma in##2##3##(1992-10#1)(1994-12#1)
for carcinoma of the vulva##2##5##(1992-3#2)
for carcinoma of the##4##4##(1990-9#2)(1992-3#2)
for carcinoma##6##2##(1990-9#2)(1992-10#1)(1992-3#2)(1994-12#1)
for cardiac imaging##2##3##(2010-3#1)(2010-8#1)
for cardiac resynchronization therapy##2##4##(2008-12#1)(2011-2#1)
for cardiac risk surveillance##2##4##(2009-3#2)
for cardiac risk##3##3##(2007-8#1)(2009-3#2)
for cardiac surgery##3##3##(1997-8#1)(2008-5#1)(2010-8#1)
for cardiac transplantation##2##3##(2007-8#2)
for cardiac valve##2##3##(2007-8#1)(2010-8#1)
for cardiac##33##2##(1992-5#1)(1993-12#1)(1994-11#1)(1997-8#1)(2007-10#1)(2007-8#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-8#4)(2011-2#3)(2012-3#2)
for cardiopulmonary bypass##2##3##(2007-8#1)(2010-8#1)
for cardiovascular disease and##2##4##(2008-3#1)(2012-2#1)
for cardiovascular disease in##3##4##(1994-11#1)(2011-1#1)(2012-12#1)
for cardiovascular disease risk factors##2##5##(1991-6#2)
for cardiovascular disease##18##3##(1991-6#2)(1992-5#1)(1994-11#1)(2006-10#1)(2008-1#1)(2008-3#6)(2011-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
for cardiovascular diseases##6##3##(1994-11#1)(2008-1#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
for cardiovascular disorders##3##3##(2008-7#1)(2010-6#1)(2012-2#1)
for cardiovascular effects##2##3##(1995-12#1)(2011-2#1)
for cardiovascular events##6##3##(2008-10#1)(2008-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
for cardiovascular risk##5##3##(2008-3#1)(2009-1#1)(2009-10#1)(2011-2#1)(2012-3#1)
for cardiovascular##50##2##(1991-6#2)(1992-5#1)(1993-3#1)(1994-11#2)(1995-12#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#8)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
for care and##4##3##(2007-12#1)(2007-8#1)(2008-3#1)(2013-1#1)
for care delivery##2##3##(2008-11#1)(2012-3#1)
for care in##3##3##(1992-11#1)(1993-1#1)(2012-12#1)
for care of##5##3##(2009-5#3)(2013-1#1)(2013-8#1)
for care##23##2##(1992-11#1)(1993-1#1)(1994-3#1)(1995-12#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#2)(2009-5#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
for careful##6##2##(1991-2#1)(1995-1#1)(2008-9#1)(2009-4#1)(2009-8#1)(2013-1#1)
for caregivers##6##2##(2007-10#1)(2008-6#2)(2009-11#1)(2013-1#2)
for carers##2##2##(1996-11#1)(2011-1#1)
for carotid endarterectomy##5##3##(1992-6#1)(1997-2#1)(2007-8#1)(2010-3#1)(2010-7#1)
for carotid stenosis##5##3##(2008-11#1)(2008-7#3)(2011-2#1)
for carotid##15##2##(1992-6#1)(1997-2#2)(2007-8#1)(2008-11#2)(2008-7#4)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
for carpal tunnel##2##3##(2008-5#1)(2008-9#1)
for carpogenic germination of##2##4##(2008-10#2)
for carpogenic germination##4##3##(2008-10#4)
for carrier to carrier transfer##2##5##(2008-11#2)
for carrier##3##2##(1996-12#1)(2008-11#2)
for carrying out##9##3##(1991-5#1)(1993-3#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)
for cartilage tissue engineering##3##4##(2008-5#3)
for cartilage##5##2##(1991-5#1)(2008-5#3)(2009-9#1)
for case management##4##3##(1991-12#1)(1996-1#2)(2012-2#1)
for case mix##5##3##(1992-12#1)(1995-2#3)(2010-12#1)
for case##13##2##(1991-12#1)(1992-12#1)(1993-12#1)(1995-2#3)(1996-1#2)(2008-12#1)(2008-2#2)(2010-12#1)(2012-2#1)
for case-mix##2##2##(1991-2#1)(1994-2#1)
for cases in which##4##4##(1990-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
for cases of##4##3##(1991-12#1)(2008-1#1)(2008-9#1)(2013-8#1)
for cases with##2##3##(2008-2#1)(2010-3#1)
for cases##13##2##(1990-6#1)(1991-12#1)(1995-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-8#1)
for casting##3##2##(1995-6#1)(2008-5#2)
for catalysis##7##2##(1990-7#1)(1993-11#2)(1994-11#1)(1995-2#1)(2009-2#1)(2011-2#1)
for catalytic activity##5##3##(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(2012-12#1)
for catalytic##10##2##(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)
for catechol and##3##3##(2008-10#3)
for catechol##8##2##(2008-10#8)
for category##2##2##(2009-2#1)(2011-2#1)
for cathepsin D##2##3##(1990-5#2)
for cathepsin##3##2##(1990-5#2)(2008-7#1)
for cations##3##2##(1996-5#1)(2008-10#2)
for cattle##3##2##(1994-3#1)(2008-6#1)(2010-4#1)
for causal##2##2##(2008-7#1)(2010-9#1)
for causes##3##2##(1991-8#1)(1994-2#1)(2007-7#1)
for causing##6##2##(1992-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
for caution##7##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-9#1)(2013-1#1)
for cavity##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
for cell analysis##2##3##(2008-4#1)(2011-2#1)
for cell apoptosis##2##3##(2008-11#1)(2008-8#1)
for cell attachment##2##3##(2009-12#1)(2010-9#1)
for cell culture##10##3##(2008-11#9)(2008-7#1)
for cell cycle##2##3##(2008-11#1)(2008-9#1)
for cell differentiation##2##3##(1991-12#1)(2011-2#1)
for cell division##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
for cell growth and##2##4##(1995-9#1)(2008-7#1)
for cell growth in a##2##5##(2008-11#1)(2008-7#1)
for cell growth##11##3##(1990-5#1)(1993-11#1)(1994-5#1)(1995-6#1)(1995-9#1)(2008-11#4)(2008-7#2)
for cell lines##2##3##(2008-11#2)
for cell maintenance##2##3##(1994-5#2)
for cell membrane##2##3##(1994-5#2)
for cell proliferation and##2##4##(2008-8#1)(2012-2#1)
for cell proliferation##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
for cell surface##3##3##(2008-4#1)(2008-9#2)
for cell therapy##2##3##(2010-11#1)(2012-3#1)
for cell transformation##2##3##(2008-11#1)(2008-8#1)
for cell##97##2##(1990-2#1)(1990-5#1)(1991-12#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-5#7)(1995-11#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-11#33)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
for cell-to-cell##2##2##(2008-10#1)(2011-2#1)
for cells grown in##2##4##(1991-11#1)(2008-11#1)
for cells grown##5##3##(1991-11#2)(2008-10#1)(2008-11#1)(2013-1#1)
for cells in suspension##2##4##(2008-11#2)
for cells in##5##3##(2008-11#2)(2009-10#1)(2010-1#1)(2013-8#1)
for cells with##3##3##(1990-8#2)(2008-11#1)
for cells##22##2##(1990-8#2)(1991-11#2)(1992-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#2)(2009-10#1)(2010-1#1)(2013-1#1)(2013-8#1)
for cellular therapy##2##3##(2008-11#1)(2012-12#1)
for cellular##16##2##(1991-5#1)(1992-8#1)(1995-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-12#1)
for central and##2##3##(1993-5#1)(2007-8#1)
for central nervous system##2##4##(1995-3#1)(2013-8#1)
for central##10##2##(1991-3#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2013-8#1)
for centuries##4##2##(1991-12#1)(1991-6#1)(1997-6#1)(2009-8#1)
for ceramic##2##2##(1991-3#1)(2008-10#1)
for ceramide##2##2##(1995-2#1)(1996-2#1)
for cerebral arteriovenous malformations##2##4##(1996-3#1)(2008-7#1)
for cerebral infarction##2##3##(1991-11#1)(2007-10#1)
for cerebral##11##2##(1991-11#1)(1993-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-10#1)(2008-7#2)(2008-9#1)(2012-12#1)
for certain cancers##2##3##(2008-8#1)(2009-10#1)
for certain classes of##2##4##(2011-2#1)(2013-8#1)
for certain conditions##2##3##(2008-2#1)(2008-3#1)
for certain drugs##2##3##(1990-2#1)(2008-11#1)
for certain patients##2##3##(2007-10#1)(2008-8#1)
for certain##33##2##(1990-2#1)(1991-12#1)(1992-8#1)(1992-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
for certificated seeds##2##3##(2008-12#2)
for certified##2##2##(2008-10#2)
for cervical cancer and##2##4##(1992-8#1)(2013-1#1)
for cervical cancer##12##3##(1991-6#1)(1992-10#2)(1992-2#1)(1992-8#1)(1993-2#1)(1995-9#1)(2008-4#1)(2008-8#1)(2009-5#2)(2013-1#1)
for cervical intraepithelial neoplasia##2##4##(1991-2#1)(2013-1#1)
for cervical##23##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1995-2#1)(1995-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-12#2)(2013-1#2)
for cesium ion over alkali##2##5##(2008-10#2)
for cesium ion over##4##4##(2008-10#4)
for cesium##9##2##(2008-10#9)
for change and##2##3##(1995-3#1)(2010-1#1)
for change in health##2##4##(1996-3#1)(1997-8#1)
for change in the##3##4##(1994-1#1)(1995-1#1)(2007-2#1)
for change in##6##3##(1994-1#1)(1995-1#1)(1996-3#1)(1997-8#1)(2007-2#1)(2011-2#1)
for change##26##2##(1991-2#3)(1992-3#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#4)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
for changes in the##2##4##(1993-11#1)(2008-10#1)
for changes in##17##3##(1991-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-3#1)
for changes##20##2##(1991-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
for changing##6##2##(1994-6#1)(1996-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
for characterisation of##2##3##(2008-1#1)(2008-10#1)
for characterising the##3##3##(2008-10#2)(2012-1#1)
for characterising##8##2##(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-1#2)
for characteristic##2##2##(1996-11#1)(2008-10#1)
for characterization of a##2##4##(2008-3#2)
for characterization of the##2##4##(2007-12#1)(2013-8#1)
for characterization of##18##3##(1992-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#2)(2013-8#1)
for characterization##20##2##(1992-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#1)(2010-12#2)(2010-6#1)(2010-7#2)(2013-8#1)
for characterizing the##14##3##(1992-1#1)(1994-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-3#1)
for characterizing##33##2##(1992-1#1)(1994-11#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)
for charge##2##2##(2008-10#1)(2013-1#1)
for charge-density##2##2##(2006-4#2)
for checking##2##2##(1995-9#1)(2012-2#1)
for chemical analysis##5##3##(2008-10#3)(2010-7#2)
for chemical identification##2##3##(2008-10#1)(2008-2#1)
for chemical##25##2##(1990-11#1)(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-7#2)(2013-1#1)(2013-7#1)
for chemicals##3##2##(2008-11#1)(2008-2#1)(2011-3#1)
for chemiluminescence##3##2##(2008-10#3)
for chemoprevention of prostate cancer##2##5##(1995-9#2)
for chemoprevention of##5##3##(1995-9#3)(2011-2#1)(2013-1#1)
for chemoprevention##8##2##(1995-9#3)(2008-11#2)(2011-2#2)(2013-1#1)
for chemotherapy##5##2##(1991-5#1)(1997-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
for chest pain##2##3##(2008-3#1)(2012-2#1)
for chest wall reconstruction##4##4##(2012-2#4)
for chest wall##5##3##(2009-3#1)(2012-2#4)
for chest##7##2##(2008-3#1)(2009-3#1)(2012-2#5)
for chicken##2##2##(1991-6#1)(2008-5#1)
for chickpea##2##2##(2008-10#2)
for child and adolescent##2##4##(1993-1#1)(2008-11#1)
for child##4##2##(1993-1#1)(1996-2#1)(2008-11#2)
for childbearing##2##2##(1997-3#1)(2007-2#1)
for childhood immunizations##2##3##(1996-12#2)
for childhood##10##2##(1991-3#1)(1996-12#3)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
for children aged 2##2##4##(1995-3#1)(2012-3#1)
for children aged##4##3##(1995-3#1)(2010-6#1)(2012-2#1)(2012-3#1)
for children and adolescents in São##2##6##(2008-9#2)
for children and adolescents##7##4##(1991-2#1)(1992-1#1)(2008-11#1)(2008-9#3)(2010-3#1)
for children and families##2##4##(1992-2#1)(1992-3#1)
for children and parents##2##4##(1992-1#1)(1997-2#1)
for children and pregnant women##3##5##(1995-2#2)(2013-8#1)
for children and youth##2##4##(2008-11#1)(2008-12#1)
for children and##19##3##(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1995-2#2)(1995-3#1)(1997-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-9#3)(2009-10#1)(2010-3#1)(2013-8#1)
for children in##7##3##(1991-3#1)(1992-3#1)(1995-5#2)(2012-12#1)(2012-2#1)(2013-1#1)
for children is##2##3##(2009-9#1)(2011-2#1)
for children over 1 year of age##2##7##(2011-2#2)
for children under##2##3##(2008-9#1)(2013-1#1)
for children who are##2##4##(1991-8#1)(2012-2#1)
for children with chronic illnesses##2##5##(1995-12#1)(1996-3#1)
for children with chronic##4##4##(1995-12#1)(1996-3#1)(1997-2#2)
for children with newly diagnosed cancer##2##6##(1993-1#2)
for children with sickle cell anaemia##2##6##(2009-4#2)
for children with special health care needs##2##7##(1995-12#2)
for children with special needs##2##5##(1991-12#1)(1997-2#1)
for children with special##4##4##(1991-12#1)(1995-12#2)(1997-2#1)
for children with##34##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#2)(1993-12#1)(1995-1#1)(1995-12#3)(1996-3#2)(1997-2#3)(2006-10#1)(2008-11#2)(2008-9#1)(2009-4#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
for children##115##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-12#2)(1993-6#1)(1994-1#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#3)(1996-12#1)(1996-3#3)(1997-2#4)(1997-4#1)(1997-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-11#9)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#8)(2009-10#1)(2009-4#2)(2009-5#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#15)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
for children's mental health##2##4##(2008-4#1)(2010-12#1)
for children's##6##2##(1994-3#1)(2007-12#1)(2008-4#1)(2010-12#1)(2012-12#2)
for children/adolescents##2##2##(2008-9#2)
for chiral##3##2##(2008-10#2)(2010-4#1)
for chirped##2##2##(2007-11#1)(2008-3#1)
for chitosan##2##2##(2008-10#2)
for chloride determination##4##3##(2008-10#4)
for chloride##8##2##(1995-12#1)(2008-10#7)
for chloride)##2##2##(2008-10#2)
for chlorine dioxide##2##3##(2008-10#2)
for chlorine##3##2##(2008-10#2)(2008-2#1)
for chloroform and dichloromethane##2##4##(2008-10#2)
for chloroform##3##2##(2008-10#3)
for chlorophyll a##2##3##(2008-10#1)(2008-3#1)
for chlorophyll##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
for chlorpyrifos##2##2##(2008-10#2)
for chlortetracycline##2##2##(2008-10#2)
for choice##2##2##(1997-2#1)(1997-3#1)
for cholera toxin##2##3##(1993-8#1)(2008-11#1)
for cholera##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
for cholesterol##10##2##(1992-6#1)(1994-11#1)(1996-11#2)(2008-10#4)(2008-8#1)(2013-8#1)
for cholesteryl##2##2##(1992-3#1)(1995-8#1)
for cholinergic neurons##2##3##(1997-2#1)(2009-3#1)
for cholinergic##3##2##(1997-2#1)(2009-3#1)(2013-8#1)
for cholinesterase##2##2##(2008-10#2)
for chondrocyte##2##2##(1991-11#1)(2008-11#1)
for chondrocytes culture##2##3##(2007-11#2)
for chondrocytes##3##2##(2007-11#3)
for choosing an##2##3##(2008-2#1)(2008-4#1)
for choosing the##2##3##(2008-10#1)(2013-1#1)
for choosing##11##2##(1992-8#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2010-11#1)(2012-3#1)(2013-1#1)
for chromatic##2##2##(1996-2#1)(2007-11#1)
for chromatic-dispersion compensation##2##3##(2007-12#2)
for chromatin##2##2##(1995-2#1)(2008-9#1)
for chromatographic analysis##3##3##(2008-10#3)
for chromatographic determination of##2##4##(2008-10#2)
for chromatographic determination##3##3##(2008-10#3)
for chromatographic separation##4##3##(2008-10#3)(2008-4#1)
for chromatographic##13##2##(2008-1#1)(2008-10#11)(2008-4#1)
for chromium determination##2##3##(2008-10#2)
for chromium speciation##2##3##(2008-10#2)
for chromium##10##2##(2008-10#10)
for chromium(VI)##3##2##(2008-10#3)
for chromosomal##4##2##(2008-11#1)(2008-7#1)(2012-3#2)
for chromosome##14##2##(1996-10#1)(1996-12#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#2)(2012-3#1)
for chronic Achilles tendinosis##2##4##(2009-10#1)(2010-3#1)
for chronic and##2##3##(2008-7#1)(2008-8#1)
for chronic care##2##3##(1997-1#2)
for chronic conditions##2##3##(1997-2#1)(2009-10#1)
for chronic dialysis##2##3##(2007-7#1)(2008-4#1)
for chronic disease##3##3##(1993-3#2)(1997-8#1)
for chronic diseases##3##3##(1997-2#1)(2007-11#1)(2008-4#1)
for chronic hemodialysis##2##3##(1991-6#1)(2008-1#1)
for chronic hepatitis C##4##4##(2009-3#1)(2009-5#1)(2010-6#1)(2012-2#1)
for chronic hepatitis##5##3##(2009-3#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-2#1)
for chronic illness##3##3##(1991-12#1)(2012-12#2)
for chronic lymphocytic leukemia##2##4##(2008-7#1)(2009-6#1)
for chronic lymphocytic##3##3##(2008-7#1)(2009-6#1)(2012-2#1)
for chronic myeloid leukaemia##2##4##(1990-9#1)(1997-8#1)
for chronic myeloid leukemia##3##4##(1993-8#2)(2012-12#1)
for chronic myeloid##5##3##(1990-9#1)(1993-8#2)(1997-8#1)(2012-12#1)
for chronic obstructive pulmonary disease##3##5##(2010-5#1)(2011-2#2)
for chronic obstructive##4##3##(1991-4#1)(2010-5#1)(2011-2#2)
for chronic pain##3##3##(2008-8#2)(2009-4#1)
for chronic renal failure##2##4##(1990-3#1)(1994-5#1)
for chronic total occlusion##2##4##(2008-11#2)
for chronic total##3##3##(2008-11#3)
for chronic##75##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-3#2)(1993-8#2)(1994-5#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#4)(2008-8#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
for chronically##2##2##(1997-1#1)(1997-2#1)
for ciprofloxacin##3##2##(2008-10#2)(2010-8#1)
for circulating##5##2##(2008-10#4)(2012-3#1)
for circumstances##2##2##(2008-11#1)(2008-7#1)
for circumventing the##2##3##(2008-11#1)(2012-12#1)
for citation##2##2##(1995-3#1)(2013-1#1)
for cited##2##2##(1993-3#1)(2008-10#1)
for citrate##3##2##(1997-8#1)(2010-3#1)(2011-2#1)
for clarification##2##2##(1991-12#1)(2007-7#1)
for class II MHC##2##4##(1993-3#2)
for class II##3##3##(1993-3#2)(2013-1#1)
for class##6##2##(1993-3#2)(1997-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
for classical##5##2##(1994-11#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)
for classification of##2##3##(2007-12#1)(2008-8#1)
for classification##10##2##(1994-9#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2010-8#1)(2012-2#1)
for classifying##7##2##(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-8#2)(2012-12#1)
for clean##2##2##(2008-10#1)(2011-2#1)
for clean-up##2##2##(2008-10#2)
for cleaning##4##2##(2008-10#2)(2008-9#2)
for clear##2##2##(2010-3#1)(2011-1#1)
for clearance##3##2##(1991-8#1)(1997-5#1)(2008-5#1)
for cleavage of##2##3##(2008-10#1)(2008-6#1)
for cleavage##3##2##(1990-5#1)(2008-10#1)(2008-6#1)
for cleaved##2##2##(2008-2#1)(2008-3#1)
for cleft lip##2##3##(2009-6#1)(2012-12#1)
for cleft##3##2##(2009-6#1)(2011-2#1)(2012-12#1)
for clenbuterol##5##2##(2008-10#4)(2010-5#1)
for client care##3##3##(1992-3#1)(2008-11#1)(2008-4#1)
for client##5##2##(1992-3#1)(1996-12#1)(2008-11#1)(2008-4#1)(2013-8#1)
for clientele##2##2##(1992-2#1)(1995-3#1)
for clients with##3##3##(2007-6#1)(2011-1#2)
for clients##4##2##(2007-6#1)(2008-1#1)(2011-1#2)
for clinic##3##2##(1990-12#1)(1992-8#1)(1995-12#1)
for clinical application of##2##4##(2008-8#1)(2010-11#1)
for clinical application##6##3##(1996-9#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
for clinical applications##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
for clinical assessment##4##3##(1993-12#1)(2008-3#1)(2009-10#1)(2013-1#1)
for clinical care##2##3##(1995-3#1)(2011-2#1)
for clinical characteristics##2##3##(2008-12#1)(2012-3#1)
for clinical data##2##3##(1996-2#1)(1997-3#1)
for clinical decision support##3##4##(1991-9#1)(1993-2#1)(1997-3#1)
for clinical decision##4##3##(1991-9#1)(1993-2#1)(1997-3#1)(2007-11#1)
for clinical diagnosis##2##3##(2008-3#1)(2008-9#1)
for clinical diagnostics##2##3##(2008-3#1)(2008-7#1)
for clinical education##2##3##(2008-12#1)(2013-8#1)
for clinical evaluation##4##3##(1992-12#1)(1995-5#1)(1997-3#1)(2011-2#1)
for clinical experience##2##3##(1992-5#1)(2010-3#1)
for clinical investigation##2##3##(2008-12#1)(2013-8#1)
for clinical laboratories##2##3##(2008-12#1)(2008-4#1)
for clinical management of##2##4##(2007-2#1)(2013-1#1)
for clinical management##6##3##(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
for clinical monitoring##2##3##(1994-9#1)(2007-12#1)
for clinical nursing##2##3##(1990-2#1)(2008-12#1)
for clinical practice and##4##4##(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
for clinical practice##14##3##(1990-5#1)(1993-2#1)(1994-3#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#2)(2012-2#1)
for clinical purposes##2##3##(1990-8#1)(2010-11#1)
for clinical research##7##3##(1994-12#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-2#2)(2013-1#1)
for clinical routine##2##3##(1991-11#1)(2008-1#1)
for clinical studies##5##3##(1990-9#1)(2007-11#1)(2010-10#1)(2012-3#1)(2013-8#1)
for clinical testing##2##3##(2008-4#1)(2008-5#1)
for clinical trials in##2##4##(2006-6#1)(2012-3#1)
for clinical trials##10##3##(1991-9#1)(1996-9#1)(1997-4#1)(2006-6#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
for clinical use in the##3##5##(2007-11#1)(2007-8#1)(2009-12#1)
for clinical use in##9##4##(1991-9#1)(1994-12#1)(2007-11#2)(2007-8#1)(2008-6#1)(2009-12#1)(2011-2#1)(2011-3#1)
for clinical use##18##3##(1991-9#1)(1993-2#1)(1994-12#1)(1996-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-10#1)(2009-12#1)(2010-12#1)(2011-2#2)(2011-3#1)
for clinical##160##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-11#1)(1994-12#5)(1994-3#4)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#3)(1997-4#2)(2006-6#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#8)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#4)
for clinically##7##2##(1993-2#1)(1994-2#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-3#1)
for clinicians and##2##3##(1994-1#1)(2008-12#1)
for clinicians to##5##3##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
for clinicians##20##2##(1994-1#1)(1994-3#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
for cloacal##2##2##(1996-12#1)(2008-10#1)
for clomiphene-resistant polycystic##2##3##(2007-7#2)
for clone##2##2##(1993-12#1)(2008-7#1)
for cloned##2##2##(2008-10#1)(2008-8#1)
for clones##3##2##(1993-12#1)(1993-6#1)(2008-4#1)
for cloning##4##2##(1991-9#1)(1994-12#1)(1996-2#1)(2008-4#1)
for close##2##2##(1991-2#1)(2010-5#1)
for closed##2##2##(2007-8#1)(2012-2#1)
for closing the##2##3##(1995-2#1)(2011-1#1)
for closing##4##2##(1995-2#1)(2007-8#1)(2011-1#1)(2012-1#1)
for closure of##4##3##(2007-8#2)(2008-11#1)(2011-2#1)
for closure##5##2##(2007-8#2)(2008-11#1)(2011-2#2)
for clotting##2##2##(1990-5#1)(2007-7#1)
for cloud##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
for cloudless##2##2##(2008-3#2)
for cluster##2##2##(2008-10#2)
for clustered binary##2##3##(1995-2#2)
for clustered##3##2##(1994-6#1)(1995-2#2)
for clustering##3##2##(1997-4#1)(2008-2#1)(2008-4#1)
for coastal waters##2##3##(2008-2#2)
for coated##2##2##(1997-1#1)(2008-10#1)
for coatings##3##2##(2008-2#1)(2008-3#2)
for cobalt determination in##2##4##(2008-10#2)
for cobalt##7##2##(2008-10#7)
for cobalt(II)##2##2##(1996-2#1)(2008-10#1)
for cocaine dependent##2##3##(2009-7#2)
for cocaine##14##2##(1991-1#4)(1991-12#1)(1993-6#1)(2008-10#3)(2009-11#1)(2009-7#4)
for cochlear implantation in##2##4##(2008-9#2)
for cochlear implantation##10##3##(2008-9#7)(2012-2#3)
for cochlear implants##2##3##(2008-9#2)
for cochlear##13##2##(2008-9#10)(2012-2#3)
for coded-aperture imaging##3##3##(2008-2#1)(2008-3#2)
for codominant##2##2##(2008-10#1)(2008-5#1)
for coexistence##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
for coexisting##2##2##(1992-8#1)(2007-11#1)
for coffee##2##2##(1990-6#1)(2008-10#1)
for cognitive enhancement##2##3##(1994-6#2)
for cognitive function##2##3##(2008-7#1)(2012-1#1)
for cognitive##12##2##(1994-6#2)(1996-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#1)
for coherent Doppler lidar##4##4##(2008-2#1)(2008-3#3)
for coherent##13##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#6)
for cold##2##2##(1990-6#1)(2008-12#1)
for colitis and##2##3##(1994-2#2)
for collaboration and##2##3##(1993-12#1)(2008-11#1)
for collaboration##6##2##(1992-12#1)(1993-12#1)(1996-1#1)(1997-3#1)(2008-11#1)(2008-4#1)
for collaborative work##2##3##(1993-12#1)(2008-11#1)
for collaborative##4##2##(1993-12#1)(2008-11#1)(2008-4#1)(2013-8#1)
for collagen##2##2##(2008-7#1)(2009-7#1)
for collecting and##2##3##(1992-1#1)(2008-9#1)
for collecting the fluorescence##2##4##(2008-2#2)
for collecting##13##2##(1992-1#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
for collection of##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
for collection##8##2##(1996-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
for colon and##2##3##(2008-5#1)(2011-2#1)
for colon cancer prevention##2##4##(1995-9#1)(2009-11#1)
for colon cancer##5##3##(1995-9#1)(1997-5#1)(2009-11#1)(2011-1#1)(2011-2#1)
for colon##7##2##(1995-9#1)(1997-5#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#2)
for colonic##3##2##(1993-5#1)(2011-2#2)
for colonies##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
for colonisation##2##2##(2006-6#1)(2008-7#1)
for colonization##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
for colonoscopy##3##2##(2011-2#3)
for colony A and##2##4##(2011-2#2)
for colony B##2##3##(2011-2#2)
for colony density##2##3##(2008-10#2)
for colony##10##2##(2008-10#3)(2008-2#1)(2008-9#1)(2011-2#4)(2012-5#1)
for color development##2##3##(1991-2#1)(2008-10#1)
for color##7##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
for colorectal cancer##11##3##(1990-6#1)(1991-6#2)(1993-3#1)(1993-9#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
for colorectal carcinoma##2##3##(1992-8#1)(2013-1#1)
for colorectal##18##2##(1990-6#1)(1991-6#2)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#4)
for colorimetric##4##2##(2008-10#3)(2008-4#1)
for colour##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2010-4#1)
for colouring##2##2##(2008-5#2)
for colposcopy##5##2##(1992-10#2)(1992-3#1)(2008-11#2)
for column preconcentration and##2##4##(2008-10#2)
for column preconcentration##3##3##(2008-10#3)
for column##6##2##(2008-10#5)(2008-2#1)
for combination therapy in##2##4##(2008-2#1)(2010-10#1)
for combination therapy##3##3##(2008-2#1)(2008-6#1)(2010-10#1)
for combination vaccines##3##3##(1995-5#3)
for combination##9##2##(1992-9#1)(1995-5#3)(2007-12#1)(2008-2#1)(2008-6#1)(2010-10#1)(2012-12#1)
for combinations of##2##3##(2007-7#1)(2008-10#1)
for combinatorial chemistry##3##3##(1997-3#2)(1997-4#1)
for combined##11##2##(1995-5#2)(1997-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
for combining##5##2##(1997-4#1)(2007-12#1)(2008-9#1)(2010-9#1)(2011-1#1)
for combustion##2##2##(1996-12#1)(2008-3#1)
for comet##2##2##(1997-4#1)(1997-5#1)
for comfort##2##2##(2007-10#1)(2007-12#1)
for commercial samples were##2##4##(2008-10#1)(2008-5#1)
for commercial samples##3##3##(2008-10#2)(2008-5#1)
for commercial use##3##3##(2008-10#3)
for commercial##16##2##(1994-11#2)(1997-7#1)(2008-10#9)(2008-3#1)(2008-5#2)(2011-2#1)
for commercially available##2##3##(2008-11#1)(2008-3#1)
for common clinical##3##3##(2008-7#1)(2010-8#1)(2013-1#1)
for common##13##2##(1991-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
for commonly##2##2##(2008-10#1)(2008-4#1)
for communicating quality##2##3##(1997-3#2)
for communicating##6##2##(1997-3#3)(2010-4#1)(2010-8#1)(2013-1#1)
for communication##6##2##(1997-1#1)(2009-6#1)(2009-8#1)(2010-12#3)
for communications##2##2##(1993-12#1)(2007-11#1)
for community health##2##3##(1996-2#1)(2008-11#1)
for community hospitals##2##3##(1993-3#1)(1995-1#1)
for community mental health##2##4##(1996-1#1)(1997-3#1)
for community nurses##2##3##(1996-2#2)
for community##15##2##(1992-6#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-2#3)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
for community-acquired##2##2##(2007-12#1)(2013-8#1)
for compact##2##2##(2008-3#2)
for comparative analysis##2##3##(2009-10#1)(2009-6#1)
for comparative genomics##2##3##(2008-7#2)
for comparative purposes##2##3##(1997-4#1)(2008-10#1)
for comparative studies##3##3##(2006-6#1)(2008-10#2)
for comparative##16##2##(1995-3#1)(1997-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-7#3)(2009-10#1)(2009-6#1)(2012-2#1)(2012-3#1)
for comparing the##6##3##(2008-10#1)(2008-4#1)(2008-5#2)(2012-3#2)
for comparing two##3##3##(1997-4#2)(2008-4#1)
for comparing##19##2##(1992-9#1)(1994-6#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
for comparison of##6##3##(2008-10#4)(2008-2#1)(2012-12#1)
for comparison with##2##3##(2008-3#1)(2010-8#1)
for comparison##48##2##(1991-3#2)(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2009-6#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-12#1)
for comparisons of##3##3##(1997-5#1)(2008-3#1)(2008-5#1)
for comparisons##6##2##(1992-3#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
for compatibility type##2##3##(2008-10#2)
for compatible##2##2##(2008-7#1)(2011-2#1)
for compensating for##2##3##(2007-11#2)
for compensating##6##2##(2007-11#2)(2008-10#1)(2008-3#3)
for compensation##2##2##(1992-11#1)(1995-9#1)
for compensatory##2##2##(2008-4#1)(2013-1#1)
for competing##2##2##(1993-6#1)(1996-3#1)
for competitive##5##2##(1991-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
for complementary##8##2##(2006-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#2)
for complementation##3##2##(1993-9#1)(1997-7#1)(2008-9#1)
for complete blood##3##3##(2008-10#2)(2008-7#1)
for complete##29##2##(1991-1#1)(1992-2#2)(1992-9#1)(1995-5#1)(1996-2#1)(2007-11#3)(2008-10#6)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)
for completely##4##2##(2007-11#1)(2008-1#1)(2008-3#1)(2008-9#1)
for completeness##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
for completion of the##2##4##(1995-6#1)(2007-9#1)
for completion of##3##3##(1995-6#1)(1997-3#1)(2007-9#1)
for complex (re-) coarctation and##2##5##(2007-8#2)
for complex diseases##3##3##(2008-4#1)(2010-12#1)(2011-3#1)
for complex samples##2##3##(2008-10#2)
for complex systems##2##3##(2007-12#1)(2008-10#1)
for complex##33##2##(1995-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-7#1)
for complexation of##2##3##(2008-10#2)
for complexation##3##2##(2008-10#3)
for complexes of propidium with RNA and DNA and for##2##10##(1992-3#2)
for complexes of##3##3##(1992-3#2)(2008-10#1)
for complexes##4##2##(1992-3#2)(2008-10#2)
for compliance with##2##3##(1994-3#1)(2008-11#1)
for compliance##4##2##(1994-3#1)(2006-5#1)(2008-10#1)(2008-11#1)
for complicated##5##2##(1997-3#1)(2007-11#1)(2008-7#1)(2009-4#1)(2012-12#1)
for complications##5##2##(1990-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
for components##5##2##(1994-8#1)(2008-10#2)(2008-3#2)
for composite##4##2##(2007-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
for compound##5##2##(1994-6#1)(1995-3#1)(1997-7#2)(2008-10#1)
for compound-specific stable carbon isotope analysis##2##6##(2008-10#2)
for compounds containing##2##3##(2008-10#2)
for compounds that##2##3##(2008-4#1)(2010-10#1)
for compounds##10##2##(1991-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-10#1)(2012-2#1)
for comprehensive analysis of##3##4##(1992-1#1)(1995-8#1)(1996-8#1)
for comprehensive##10##2##(1992-1#1)(1994-2#1)(1995-8#1)(1996-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-7#1)(2013-1#1)
for compression##2##2##(2007-11#1)(2008-6#1)
for computation of the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
for computational##3##2##(2008-6#1)(2009-12#1)(2012-3#1)
for computer##3##2##(1991-8#1)(1992-12#1)(2007-10#1)
for computing the##13##3##(1990-2#1)(1992-9#1)(2008-2#2)(2008-3#5)(2008-6#1)(2009-3#1)(2009-9#1)(2012-3#1)
for computing##20##2##(1990-2#1)(1992-9#1)(2007-12#1)(2008-2#3)(2008-3#8)(2008-6#1)(2009-12#1)(2009-3#1)(2009-9#1)(2012-3#1)(2013-1#1)
for concentrated##3##2##(1990-8#1)(2008-10#2)
for concentrating##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
for concentration levels##2##3##(2008-10#2)
for concentration##8##2##(1997-2#1)(2008-10#4)(2008-11#1)(2010-11#1)(2010-4#1)
for concentrations of##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
for concentrations##5##2##(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)
for conceptual competency##2##3##(2008-1#2)
for concern##7##2##(1992-3#1)(1997-5#1)(2008-10#2)(2010-3#1)(2011-2#1)(2013-8#1)
for concomitant##2##2##(2007-8#2)
for concurrent##2##2##(1991-1#1)(1994-1#1)
for conditional gene expression##2##4##(2008-10#1)(2008-11#1)
for conditional##4##2##(1995-2#1)(2008-10#1)(2008-11#2)
for conditioning and germination##2##4##(2008-10#2)
for conditioning##5##2##(2008-10#2)(2008-5#2)(2009-6#1)
for conditions with##2##3##(2008-3#2)
for conditions##4##2##(2008-3#4)
for conducting##16##2##(1992-1#1)(1992-2#1)(1995-5#1)(2008-10#2)(2008-4#2)(2009-4#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
for conferring##2##2##(1996-2#1)(2008-10#1)
for confining##2##2##(2008-3#1)(2008-5#1)
for confirmation##3##2##(2008-1#1)(2008-10#1)(2008-12#1)
for confirmatory##2##2##(2009-3#1)(2012-2#1)
for confirming filariasis elimination##2##4##(2008-1#2)
for confirming##5##2##(2008-1#4)(2008-8#1)
for confocal##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)
for confounders is##2##3##(2008-8#2)
for confounders##6##2##(2008-8#2)(2009-4#1)(2010-6#1)(2012-2#1)(2012-5#1)
for confounding factors##3##3##(2010-1#1)(2011-1#1)(2012-12#1)
for confounding##7##2##(1992-9#1)(2008-8#2)(2010-1#1)(2010-2#1)(2011-1#1)(2012-12#1)
for congenital heart disease##2##4##(2010-9#1)(2012-3#1)
for congenital kyphosis##2##3##(2012-12#2)
for congenital malformations##3##3##(1990-5#2)(2008-11#1)
for congenital##21##2##(1990-5#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#3)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#1)
for conidia##4##2##(2008-10#3)(2008-6#1)
for conidial germination##2##3##(2008-10#2)
for conjugation##2##2##(2008-10#1)(2008-4#1)
for consensus##2##2##(1996-3#1)(1996-6#1)
for conservation and management of##2##5##(2007-5#1)(2013-7#1)
for conservation and management##3##4##(2007-5#1)(2008-8#1)(2013-7#1)
for conservation and##4##3##(2007-5#1)(2008-8#2)(2013-7#1)
for conservation of##2##3##(2008-5#1)(2008-8#1)
for conservation##7##2##(2007-5#1)(2008-5#1)(2008-6#1)(2008-8#3)(2013-7#1)
for conservative management of##2##4##(2011-2#1)(2013-1#1)
for conservative##6##2##(1990-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
for conserved##2##2##(1994-8#1)(2008-10#1)
for considerable morbidity##3##3##(2007-12#2)(2008-7#1)
for considerable##8##2##(1993-11#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#1)
for consideration for##2##3##(2008-11#1)(2011-2#1)
for consideration of##2##3##(1997-2#1)(2008-3#1)
for consideration##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
for considering the##2##3##(2008-3#1)(2011-1#1)
for considering##6##2##(1990-8#1)(1997-6#1)(2008-3#1)(2010-10#1)(2010-8#1)(2011-1#1)
for consistent##3##2##(2008-10#2)(2008-9#1)
for constant##2##2##(2008-3#2)
for constitutive##3##2##(1996-5#1)(2008-11#2)
for constructing a##4##3##(2008-4#1)(2008-8#1)(2010-8#1)(2012-3#1)
for constructing the##2##3##(2008-10#1)(2009-10#1)
for constructing##21##2##(1990-5#2)(1993-2#1)(1993-9#1)(1997-6#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#1)
for construction of the##2##4##(2008-10#1)(2012-3#1)
for construction of##9##3##(1990-11#1)(1993-2#1)(1995-6#1)(2008-10#3)(2008-8#1)(2010-4#1)(2012-3#1)
for construction##11##2##(1990-11#1)(1993-2#1)(1995-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-3#1)
for consultation##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
for consumer##5##2##(1993-1#1)(1996-3#1)(2008-8#2)(2008-9#1)
for consumers##5##2##(1997-3#1)(2007-6#1)(2008-12#1)(2011-2#1)(2013-1#1)
for consumption##2##2##(2008-8#1)(2013-1#1)
for contact##3##2##(2008-10#1)(2008-3#1)(2009-7#1)
for contaminated##2##2##(1997-5#1)(2008-10#1)
for contamination of##2##3##(2007-6#1)(2008-10#1)
for contamination##6##2##(2007-6#1)(2008-10#2)(2008-11#2)(2012-2#1)
for contemporary##5##2##(2008-12#2)(2008-7#1)(2010-1#2)
for content##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
for continued##10##2##(1995-3#1)(2008-4#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)
for continuing education##5##3##(1993-1#1)(1994-1#1)(1994-12#1)(2008-1#1)(2013-1#1)
for continuing##11##2##(1991-1#1)(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
for continuity of##2##3##(2007-12#1)(2010-8#1)
for continuous flow##2##3##(2008-10#2)
for continuous long-term##2##3##(2008-11#2)
for continuous measurements##2##3##(2008-10#2)
for continuous monitoring of##4##4##(2008-10#2)(2011-1#1)(2013-8#1)
for continuous operation##2##3##(2008-10#1)(2013-1#1)
for continuous variables##2##3##(2012-12#1)(2013-1#1)
for continuous##35##2##(1991-11#1)(1992-5#2)(1996-2#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#2)
for continuously##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
for contraceptives##2##2##(1996-6#1)(2011-3#1)
for contraction##2##2##(1990-12#1)(2008-3#1)
for contrast##3##2##(2008-3#2)(2008-9#1)
for control and##2##3##(1995-11#1)(2008-5#1)
for control of the##2##4##(2008-8#1)(2008-9#1)
for control of this##2##4##(2007-6#1)(2009-4#1)
for control of##26##3##(1993-3#1)(1994-11#1)(1994-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
for control##51##2##(1990-6#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
for controlled##5##2##(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-6#1)
for controlling expenditures##2##3##(1992-2#1)(1994-3#1)
for controlling the##12##3##(1991-12#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)
for controlling##37##2##(1991-12#2)(1991-2#1)(1992-2#1)(1992-9#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#2)(2011-1#1)(2011-2#3)(2013-1#1)
for controls##5##2##(1997-2#1)(2008-12#1)(2008-7#1)(2013-1#2)
for conventional##11##2##(1992-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#2)(2009-10#1)(2012-2#1)
for converging research using##2##4##(2011-2#2)
for conversion of##6##3##(2007-12#2)(2008-10#2)(2008-2#1)(2008-7#1)
for conversion##7##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
for converting the##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
for converting##8##2##(2007-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)
for convex##2##2##(2008-3#2)
for cooking##2##2##(1990-8#1)(2010-4#1)
for cooperation##2##2##(1994-3#1)(2010-10#1)
for cooperative##2##2##(1990-8#1)(1995-2#1)
for coordinated##2##2##(1996-2#1)(2011-2#1)
for coordinating services##2##3##(1992-1#1)(1997-2#1)
for coordinating##3##2##(1992-1#1)(1997-2#1)(2008-10#1)
for coordination##2##2##(2008-4#1)(2011-1#1)
for coping with##3##3##(1991-2#1)(1996-9#1)(2009-7#1)
for coping##4##2##(1991-2#1)(1996-9#1)(2009-7#1)(2012-1#1)
for copper and mercury ions##2##5##(2008-10#2)
for copper and zinc and##2##5##(1992-3#1)(2008-10#1)
for copper and zinc##5##4##(1992-3#1)(2008-10#4)
for copper and##15##3##(1992-3#1)(1995-2#1)(2008-10#13)
for copper concentrations##2##3##(2008-10#2)
for copper determination by##2##4##(2008-10#2)
for copper determination in##5##4##(2008-10#5)
for copper determination##10##3##(2008-10#10)
for copper in##2##3##(2008-10#2)
for copper resistance##2##3##(2008-10#2)
for copper##49##2##(1992-3#1)(1995-2#1)(2008-10#46)(2012-2#1)
for copper(II) and cadmium(II) was##2##5##(2008-10#2)
for copper(II)##8##2##(2008-10#7)(2008-12#1)
for core##2##2##(1992-1#1)(2008-2#1)
for coronal##2##2##(2013-1#2)
for coronary angiography##4##3##(2008-7#1)(2010-8#1)(2011-2#2)
for coronary artery bypass grafting##6##5##(1993-12#1)(2007-8#4)(2011-2#1)
for coronary artery disease (CAD)##4##5##(1993-12#1)(1997-8#1)(2008-7#1)(2010-8#1)
for coronary artery disease##10##4##(1993-12#3)(1993-2#1)(1994-11#1)(1995-6#1)(1997-8#1)(2007-8#1)(2008-7#1)(2010-8#1)
for coronary artery##19##3##(1993-12#4)(1993-2#1)(1994-11#1)(1995-6#1)(1997-8#1)(2007-8#6)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
for coronary disease##2##3##(1996-11#1)(2007-8#1)
for coronary heart disease##5##4##(1990-3#1)(2008-12#2)(2008-6#1)(2010-4#1)
for coronary procedures##2##3##(2011-2#2)
for coronary revascularization##3##3##(1996-9#1)(2007-8#1)(2008-10#1)
for coronary##44##2##(1990-3#1)(1992-4#1)(1993-12#4)(1993-2#1)(1994-11#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-8#1)(2007-8#11)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#5)(2013-1#1)(2013-8#1)
for correct##13##2##(1990-8#2)(1997-4#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#2)(2011-2#2)(2012-2#1)
for correcting the wavelength misalignment in measured##2##7##(2008-3#2)
for correcting the##5##3##(2008-2#1)(2008-3#4)
for correcting##8##2##(2008-10#1)(2008-2#1)(2008-3#6)
for correction of pectus##3##4##(2007-8#3)
for correction of##5##3##(2007-11#1)(2007-8#3)(2012-2#1)
for correction##6##2##(2007-11#1)(2007-8#3)(2012-2#2)
for correctly##2##2##(2008-9#1)(2011-2#1)
for correlated##2##2##(1995-9#1)(2013-8#1)
for correlation##2##2##(2008-10#1)(2011-1#1)
for correlations between##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
for corresponding##5##2##(1991-5#1)(1992-8#1)(2007-8#1)(2008-11#1)(2008-3#1)
for cortical bone##3##3##(1993-11#1)(1996-3#1)(2009-7#1)
for cortical thickness of 4##2##5##(2013-1#2)
for cortical thickness##3##3##(2013-1#3)
for cortical##12##2##(1993-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#2)(2009-7#1)(2012-2#1)(2013-1#3)
for cosmetic and##3##3##(2008-3#1)(2008-5#2)
for cosmetic use##3##3##(2008-5#3)
for cosmetic##12##2##(2008-3#1)(2008-5#10)(2013-1#1)
for cosmetics##3##2##(2008-5#3)
for cost containment##3##3##(1990-11#1)(1995-1#1)(1995-2#1)
for cost control##3##3##(1993-3#1)(1994-2#1)(2008-7#1)
for cost##9##2##(1990-11#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
for cost-effectiveness##2##2##(2008-2#1)(2011-2#1)
for costing##2##2##(1996-9#2)
for costs##2##2##(1995-12#1)(1995-3#1)
for counseling##3##2##(1993-2#1)(2009-7#1)(2010-8#1)
for counterbalance order II (p &lt##2##6##(2013-8#2)
for counterbalance order##4##3##(2013-8#4)
for counting##2##2##(2008-12#1)(2008-9#1)
for countries where##2##3##(2010-5#1)(2012-2#1)
for couple##2##2##(2008-10#1)(2012-2#1)
for coupling to the##2##4##(2008-10#1)(2008-3#1)
for coupling to##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
for coupling##13##2##(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
for covalent immobilization of a##2##5##(2008-10#2)
for covalent##3##2##(1997-2#1)(2008-10#2)
for covariates##2##2##(1994-11#1)(2013-1#1)
for coverage of##2##3##(2008-9#1)(2010-11#1)
for coverage##4##2##(1996-3#1)(2008-9#1)(2010-11#1)(2011-2#1)
for covering##2##2##(2008-10#1)(2012-3#1)
for cows in##2##3##(2008-12#1)(2012-3#1)
for crack##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
for cranial##3##2##(2007-12#1)(2011-2#2)
for creating a##6##3##(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
for creating functional##2##3##(2008-7#1)(2013-8#1)
for creating the##3##3##(1996-4#1)(2008-8#1)(2009-7#1)
for creating##25##2##(1990-11#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#2)(2009-8#1)(2011-2#1)(2013-8#1)
for creatinine and##4##3##(1991-12#1)(1992-11#1)(2008-10#1)(2011-2#1)
for creatinine determination##2##3##(2008-10#2)
for creatinine##9##2##(1991-12#1)(1992-11#1)(2008-10#6)(2011-2#1)
for creation of##2##3##(2007-11#1)(2008-11#1)
for creative##3##2##(1995-1#2)(2008-11#1)
for crisis management##2##3##(2008-12#1)(2008-7#1)
for criteria##2##2##(2008-11#1)(2012-3#1)
for critical care##4##3##(2007-11#3)(2011-2#1)
for critical##14##2##(1994-3#1)(2007-11#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
for crop##2##2##(2012-12#1)(2013-8#1)
for cross##3##2##(2008-10#2)(2008-3#1)
for cross-disciplinary##2##2##(2012-2#1)(2013-8#1)
for crossed focused##2##3##(2008-3#2)
for crown rust resistance##2##4##(2008-10#2)
for crown rust##3##3##(2008-10#3)
for crude##2##2##(1993-9#1)(2008-10#1)
for cryogenic##2##2##(2008-10#1)(2008-3#1)
for crystal##4##2##(1992-8#1)(1994-5#1)(2008-11#1)(2013-1#1)
for crystallization##2##2##(1990-8#1)(2008-3#1)
for crystals##4##2##(2006-10#1)(2008-2#1)(2008-3#2)
for cubic third-harmonic generation that is phase matched##2##8##(2007-12#2)
for cubic##3##2##(2007-12#2)(2008-3#1)
for cubital tunnel syndrome##4##4##(2008-12#1)(2008-9#3)
for cultivars##2##2##(2008-10#2)
for cultivation and##2##3##(2008-11#2)
for cultivation of##3##3##(2008-10#1)(2008-11#2)
for cultivation##5##2##(2008-10#1)(2008-11#4)
for cultural##2##2##(2008-10#1)(2013-8#1)
for culturally##3##2##(1992-2#1)(2010-3#1)(2011-2#1)
for culture##5##2##(2007-12#1)(2007-8#1)(2008-11#2)(2010-8#1)
for cultured##3##2##(1990-12#1)(1997-2#1)(2008-1#1)
for cultures##3##2##(2008-11#1)(2008-7#2)
for culturing human##2##3##(1991-12#1)(2008-9#1)
for culturing##5##2##(1991-12#1)(2008-9#3)(2010-6#1)
for cumulative lesions##2##3##(2010-8#2)
for cumulative##4##2##(1997-4#1)(2008-10#1)(2010-8#2)
for cure##3##2##(2010-11#1)(2011-1#1)(2012-12#1)
for curing##2##2##(2010-11#1)(2012-12#1)
for current##14##2##(1992-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-5#1)(2012-1#3)(2012-2#1)(2013-1#1)
for currently##4##2##(1997-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
for custom##3##2##(2007-12#1)(2008-2#2)
for cutaneous##4##2##(2007-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
for cutting paddy stem##2##4##(2008-12#2)
for cutting##4##2##(1992-2#1)(1996-5#1)(2008-12#2)
for cw and pulsed##2##4##(2008-3#2)
for cw##3##2##(2007-11#1)(2008-3#2)
for cyanide##7##2##(1990-12#1)(2008-10#6)
for cylinders##3##2##(2008-2#1)(2008-3#2)
for cyst and egg##3##4##(2008-10#3)
for cyst##6##2##(2008-10#6)
for cysteine and##2##3##(2008-10#2)
for cysteine##6##2##(2008-1#1)(2008-10#4)(2012-2#1)
for cystic fibrosis##5##3##(1990-8#1)(1991-2#1)(1994-2#1)(2007-8#1)(2011-3#1)
for cystic##7##2##(1990-8#1)(1991-2#1)(1994-2#1)(2007-8#1)(2010-11#1)(2011-2#1)(2011-3#1)
for cystine##2##2##(2008-10#1)(2008-11#1)
for cystocoele##2##2##(2011-2#2)
for cytidine##2##2##(2008-10#2)
for cytochrome c##5##3##(1990-3#1)(1991-6#1)(1993-6#1)(1997-2#1)(2008-10#1)
for cytochrome oxidase##3##3##(1990-12#1)(1993-2#1)(2008-6#1)
for cytochrome##10##2##(1990-12#1)(1990-3#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
for cytogenetic##5##2##(1996-2#2)(1997-4#1)(2008-11#1)(2010-1#1)
for cytokeratin##7##2##(1991-12#1)(1994-8#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
for cytokeratins and##2##3##(1993-9#1)(2010-12#1)
for cytokeratins##3##2##(1993-9#1)(1994-8#1)(2010-12#1)
for cytokines##5##2##(2008-10#1)(2008-9#1)(2011-2#2)(2012-12#1)
for cytokinesis##2##2##(2009-10#1)(2009-8#1)
for cytotoxicity##3##2##(1993-9#1)(1996-2#1)(2008-11#1)
for d-lactic acid analysis##3##4##(2008-10#3)
for dTTP)##2##2##(1993-3#2)
for daily death counts##2##4##(2011-1#2)
for daily##10##2##(1992-4#1)(1995-5#1)(1997-3#1)(2008-3#3)(2008-4#1)(2011-1#2)(2012-2#1)
for dairy##2##2##(2008-12#1)(2012-2#1)
for damping-off##2##2##(2008-10#2)
for dark##4##2##(2008-10#1)(2008-2#2)(2012-3#1)
for data acquisition and##2##4##(2008-10#1)(2008-3#1)
for data acquisition##5##3##(2008-10#3)(2008-3#2)
for data analysis and##2##4##(1991-12#1)(2008-10#1)
for data analysis in##2##4##(2008-11#1)(2008-2#1)
for data analysis##14##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#2)
for data collection and##4##4##(1992-12#1)(1994-12#1)(2009-11#1)(2011-2#1)
for data collection##15##3##(1992-12#1)(1993-2#1)(1994-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
for data obtained##2##3##(2008-2#1)(2008-3#1)
for data on##2##3##(2008-11#1)(2010-8#1)
for data processing##2##3##(2007-11#1)(2008-3#1)
for data with##2##3##(1994-2#1)(2013-1#1)
for data##59##2##(1990-8#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-9#2)(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for data-based##4##2##(1997-1#4)
for day surgery##3##3##(1995-1#2)(1995-2#1)
for day##4##2##(1995-1#2)(1995-2#1)(2008-10#1)
for days##6##2##(1990-12#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
for daytime operation##2##3##(2008-2#1)(2008-3#1)
for daytime##3##2##(2008-2#1)(2008-3#2)
for dc##2##2##(2008-2#1)(2008-3#1)
for de novo##3##3##(2010-10#1)(2011-2#1)(2012-12#1)
for deactivation in##2##3##(1992-11#1)(2010-8#1)
for deaf##2##2##(2011-2#2)
for dealing with##8##3##(1996-9#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-5#1)(2012-12#1)
for dealing##9##2##(1996-2#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-5#1)(2012-12#1)
for death##4##2##(1990-3#1)(1994-1#1)(2007-10#1)(2008-6#1)
for decades##18##2##(1994-5#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for decentralized##2##2##(1994-3#1)(2008-10#1)
for deciding##6##2##(1994-2#1)(1996-1#1)(2007-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
for decision makers##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
for decision making in crop loss assessment and pest management##2##10##(2008-10#2)
for decision making##5##3##(1994-3#1)(2008-10#3)(2011-2#1)
for decision support##2##3##(1993-2#1)(2008-3#1)
for decision##10##2##(1993-2#1)(1994-3#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
for decision-making##6##2##(1997-1#2)(2007-12#1)(2010-2#1)(2011-7#1)(2013-1#1)
for decompression##2##2##(2007-8#1)(2013-8#1)
for decreased TdO and PEPCK##2##5##(1995-3#2)
for decreased##7##2##(1995-3#2)(1995-5#1)(1996-7#1)(2008-11#1)(2011-2#1)(2012-3#1)
for decreasing of##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
for decreasing##9##2##(1992-6#1)(2008-10#6)(2008-12#1)(2012-3#1)
for deep##3##2##(2007-10#1)(2008-3#1)(2012-2#1)
for defects##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
for defense against##2##3##(2008-10#2)
for defense and##2##3##(1997-5#1)(2009-8#1)
for defense##4##2##(1997-5#1)(2008-10#2)(2009-8#1)
for defiance##2##2##(2008-12#2)
for defining and##2##3##(1992-3#1)(1993-9#1)
for defining the##4##3##(1994-2#1)(1996-7#1)(2008-3#1)(2011-1#1)
for defining##18##2##(1991-8#1)(1992-3#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-7#1)(2008-10#4)(2008-3#1)(2010-11#1)(2011-1#2)(2011-2#2)
for definition##3##2##(1995-2#1)(2008-3#1)(2010-7#1)
for definitive diagnosis##2##3##(2008-5#1)(2008-7#1)
for definitive##7##2##(1990-12#1)(1991-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
for deformation##2##2##(2008-3#1)(2009-7#1)
for degenerative disc disease##4##4##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
for degenerative##6##2##(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
for degradation of##5##3##(1992-12#1)(1994-5#1)(2008-11#2)(2011-1#1)
for degradation##9##2##(1990-11#1)(1992-12#1)(1994-5#1)(2008-11#2)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
for degree of sensitivity to##2##5##(2008-10#2)
for degree of##4##3##(2008-10#2)(2008-9#1)(2009-7#1)
for delayed dispersal##2##3##(2008-8#2)
for delayed##6##2##(1996-12#1)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#1)
for delineating the##2##3##(2012-3#1)(2013-1#1)
for delineating##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
for delineation of##2##3##(2012-2#1)(2012-3#1)
for delivering the##2##3##(2008-4#1)(2010-11#1)
for delivering##12##2##(1992-2#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-8#1)
for delivery and##3##3##(1996-11#2)(2013-1#1)
for delivery of the##2##4##(1993-6#1)(2008-1#1)
for delivery of##10##3##(1991-9#1)(1993-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-2#1)
for delivery##18##2##(1991-9#1)(1993-10#1)(1993-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-2#1)(2013-1#2)
for dementia in##2##3##(2008-7#2)
for dementia patients##2##3##(2008-6#2)
for dementia##9##2##(2008-3#1)(2008-6#3)(2008-7#4)(2013-1#1)
for demographic and##2##3##(1993-9#1)(2010-6#1)
for demographic variables##2##3##(2008-7#1)(2012-3#1)
for demographic##9##2##(1993-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#3)
for demographics##2##2##(1997-2#1)(2012-1#1)
for demonstrating##5##2##(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
for demonstration of##2##3##(2007-7#1)(2008-9#1)
for demonstrations##2##2##(1994-12#1)(2008-12#1)
for dendritic##2##2##(2008-4#1)(2008-7#1)
for denial of##2##3##(1992-3#1)(2008-4#1)
for denial##3##2##(1992-3#1)(2008-4#2)
for dense wavelength-division##2##3##(2008-2#2)
for dense##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
for density##2##2##(2008-10#1)(2008-9#1)
for dental and##2##3##(2011-2#1)(2013-1#1)
for dental hygienists##2##3##(1993-1#2)
for dental services##3##3##(1993-12#1)(1994-3#1)(1996-3#1)
for dental##14##2##(1993-1#3)(1993-12#1)(1994-3#2)(1994-6#1)(1996-3#1)(2008-1#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-1#2)
for dentoalveolar##2##2##(2007-12#2)
for dependent##2##2##(1994-11#1)(2009-5#1)
for dephosphorylation of##2##3##(1994-6#1)(2012-2#1)
for depigmentation##2##2##(2012-3#2)
for deployment##2##2##(2008-10#2)
for deposition##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)
for depressed##4##2##(1991-2#1)(1993-2#1)(2008-4#1)(2008-6#1)
for depression and##3##3##(2007-10#1)(2011-3#1)(2013-1#1)
for depression for##2##3##(2013-1#1)(2013-8#1)
for depression in##3##3##(2008-1#1)(2012-2#2)
for depression##25##2##(1991-10#1)(1996-7#1)(2006-10#4)(2007-10#2)(2008-1#2)(2010-10#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-2#4)(2013-1#5)(2013-8#2)
for depressive##2##2##(2008-7#1)(2009-7#1)
for depth and##2##3##(2008-3#2)
for depth##6##2##(2008-10#1)(2008-3#4)(2008-9#1)
for depths##2##2##(2008-3#2)
for derivatization of##4##3##(1990-8#1)(2008-10#3)
for deriving##6##2##(2008-10#2)(2008-2#3)(2009-3#1)
for dermal##2##2##(2008-5#2)
for dermatological##2##2##(2007-7#1)(2008-8#1)
for describing the##5##3##(2008-3#3)(2008-7#1)(2008-8#1)
for describing##15##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
for descriptive##2##2##(2008-10#1)(2011-2#1)
for design and##4##3##(1997-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
for design of##4##3##(1995-12#1)(2008-2#2)(2008-3#1)
for design##12##2##(1992-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#4)(2012-2#1)(2013-1#1)
for designing a##6##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-12#1)
for designing and##6##3##(1994-3#1)(2008-2#1)(2008-3#3)(2008-4#1)
for designing diffractive##2##3##(2007-11#1)(2008-3#1)
for designing effective##2##3##(2008-6#1)(2012-2#1)
for designing novel##2##3##(2013-1#1)(2013-7#1)
for designing optical##2##3##(2008-2#1)(2008-3#1)
for designing the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
for designing these##2##3##(2008-2#1)(2008-6#1)
for designing##46##2##(1993-11#1)(1993-8#1)(1994-3#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
for desmin##2##2##(1991-6#1)(2010-6#1)
for desorption of the##2##4##(2008-10#2)
for desorption of##3##3##(2008-10#3)
for desorption##5##2##(2008-10#5)
for detailed analysis of##2##4##(1993-2#1)(2008-4#1)
for detailed##5##2##(1993-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)
for detecting DNA##2##3##(2008-10#2)
for detecting HPV DNA##2##4##(1994-1#2)
for detecting HPV##3##3##(1992-3#1)(1994-1#2)
for detecting a##6##3##(1995-2#2)(2008-10#2)(2008-3#1)(2008-4#1)
for detecting and enumerating##2##4##(2008-9#2)
for detecting and##8##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#2)(2013-1#1)
for detecting association##2##3##(2012-3#2)
for detecting explosives##2##3##(2008-10#2)
for detecting human##2##3##(1990-2#1)(1995-11#1)
for detecting small##3##3##(2008-10#1)(2009-5#1)(2010-12#1)
for detecting the##9##3##(1994-2#1)(1994-7#1)(1995-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#1)
for detecting##123##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#2)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1996-10#1)(1996-8#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#37)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#10)(2008-7#5)(2008-8#1)(2008-9#6)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-8#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
for detection and characterization of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
for detection and quantification of##5##5##(2008-10#4)(2010-7#1)
for detection and quantification##6##4##(2008-10#5)(2010-7#1)
for detection and quantitation of##3##5##(1992-8#1)(2008-4#1)(2013-8#1)
for detection and##16##3##(1992-8#1)(2008-10#8)(2008-2#1)(2008-4#2)(2009-6#1)(2010-7#1)(2012-2#1)(2013-8#1)
for detection of C##2##4##(2007-7#1)(2008-12#1)
for detection of E##2##4##(2008-10#1)(2008-9#1)
for detection of P##3##4##(1991-2#1)(2007-7#1)(2008-10#1)
for detection of a##3##4##(1992-8#1)(2008-10#1)(2008-3#1)
for detection of paraoxon##2##4##(2008-10#2)
for detection of surface##2##4##(1990-12#1)(2008-3#1)
for detection of the##7##4##(2008-1#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
for detection of##112##3##(1990-12#1)(1991-1#1)(1991-2#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-12#2)(1997-3#2)(1997-4#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#41)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#2)(2008-9#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#3)(2012-3#5)(2013-8#3)
for detection##145##2##(1990-12#1)(1991-1#1)(1991-2#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1995-2#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#3)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#57)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#4)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#4)(2012-3#5)(2013-8#4)
for determinants##2##2##(2010-8#1)(2013-1#1)
for determination by##2##3##(2008-10#2)
for determination of Ag(I)##2##4##(2008-10#2)
for determination of COD##2##4##(2008-10#2)
for determination of GSH##2##4##(2008-10#2)
for determination of acid##3##4##(2008-10#3)
for determination of aluminium##2##4##(2008-10#2)
for determination of ascorbic acid##4##5##(2008-10#4)
for determination of both##2##4##(2008-10#2)
for determination of cobalt##2##4##(2008-10#2)
for determination of copper and##2##5##(2008-10#2)
for determination of copper in##2##5##(2008-10#2)
for determination of copper##7##4##(2008-10#7)
for determination of copper(II)##2##4##(2008-10#2)
for determination of different##3##4##(1993-8#2)(2008-10#1)
for determination of elemental##2##4##(2008-10#2)
for determination of glucose in##2##5##(2008-10#2)
for determination of glucose##4##4##(2008-10#4)
for determination of iodate##2##4##(2008-10#2)
for determination of iron##2##4##(2008-10#2)
for determination of lead##2##4##(2008-10#2)
for determination of low##2##4##(2008-10#2)
for determination of magnesium##2##4##(2008-10#2)
for determination of manganese##2##4##(2008-10#2)
for determination of metoclopramide##2##4##(2008-10#2)
for determination of nickel in##2##5##(2008-10#2)
for determination of nickel##3##4##(2008-10#3)
for determination of nitrite##2##4##(2008-10#2)
for determination of phenols and pesticides##2##6##(2008-10#2)
for determination of sulfonamides in##2##5##(2008-10#2)
for determination of the existence of##2##6##(1990-8#1)(2008-9#1)
for determination of the##22##4##(1990-7#1)(1990-8#2)(2007-11#1)(2008-10#7)(2008-2#3)(2008-3#6)(2008-8#1)(2008-9#1)
for determination of tin in##2##5##(2008-10#2)
for determination of total##4##4##(1995-2#1)(2008-10#3)
for determination of trace amounts of##4##6##(2008-10#4)
for determination of trace elements##2##5##(2008-10#2)
for determination of trace##10##4##(2008-10#10)
for determination of transferrin##2##4##(2008-10#2)
for determination of ultra-trace##2##4##(2008-10#2)
for determination of urinary##2##4##(1992-11#1)(1992-3#1)
for determination of##265##3##(1990-7#1)(1990-8#3)(1991-5#1)(1992-11#2)(1992-3#1)(1993-2#1)(1993-8#2)(1993-9#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#225)(2008-2#4)(2008-3#8)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#2)(2012-12#2)(2013-1#1)(2013-8#1)
for determination the optimum therapeutic parameters##2##6##(2010-8#2)
for determination##278##2##(1990-7#1)(1990-8#3)(1991-5#1)(1992-11#2)(1992-3#1)(1993-2#1)(1993-8#2)(1993-9#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#235)(2008-2#4)(2008-3#8)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#4)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
for determinations of##2##3##(2008-10#2)
for determinations##5##2##(2008-10#5)
for determining andrographolide##2##3##(2008-10#2)
for determining caffeine##2##3##(2008-10#2)
for determining cell##4##3##(1993-6#1)(2008-11#2)(2008-9#1)
for determining iron(III)##2##3##(2008-10#2)
for determining reducing sugars##2##4##(2008-10#2)
for determining the optical properties of##2##6##(2008-3#2)
for determining the optical##4##4##(2008-3#4)
for determining the precise##2##4##(2008-7#1)(2011-2#1)
for determining the relative##2##4##(2008-10#2)
for determining the##74##3##(1990-11#1)(1990-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-7#1)(2006-4#1)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-2#7)(2008-3#27)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2011-2#2)(2013-8#2)
for determining when##2##3##(2007-11#1)(2008-9#1)
for determining whether##4##3##(1996-4#1)(2008-4#1)(2008-7#1)(2012-12#1)
for determining##183##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-4#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#63)(2008-11#5)(2008-2#10)(2008-3#35)(2008-4#11)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-8#5)
for deterministic##3##2##(2007-12#2)(2012-2#1)
for developing T2D##2##3##(2009-3#2)
for developing a##10##3##(1992-3#1)(1992-8#1)(1995-1#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
for developing an##5##3##(1995-1#1)(1997-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
for developing breast cancer##3##4##(1993-1#1)(2012-3#2)
for developing more##2##3##(2007-7#1)(2008-12#1)
for developing new##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
for developing the##2##3##(1997-3#1)(2009-3#1)
for developing##98##2##(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-5#1)(1996-3#1)(1997-1#2)(1997-3#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#3)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#2)
for development and##3##3##(2008-10#1)(2009-4#1)(2010-5#1)
for development in##2##3##(2012-3#2)
for development of a##2##4##(2008-11#1)(2013-1#1)
for development of new##2##4##(2008-8#1)(2009-8#1)
for development of##32##3##(1993-3#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#2)(2007-10#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-3#1)(2011-1#2)(2011-2#3)(2013-1#2)
for development##45##2##(1993-3#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#2)(2007-10#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#2)
for developmental dysplasia of##2##4##(2007-8#1)(2013-7#1)
for developmental##12##2##(1991-12#1)(1992-12#2)(1996-5#2)(2007-8#1)(2008-10#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-7#1)
for deviations##2##2##(2008-8#1)(2011-1#1)
for device##5##2##(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#2)
for devices##4##2##(1994-6#1)(2007-11#1)(2008-7#1)(2012-12#1)
for devising strategies##2##3##(1991-1#1)(2010-9#1)
for devising##3##2##(1991-1#1)(2010-9#1)(2013-1#1)
for diabetes mellitus##6##3##(1990-9#1)(1993-2#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
for diabetes##23##2##(1990-9#1)(1993-2#1)(2008-1#3)(2008-3#3)(2008-5#1)(2008-7#3)(2009-11#2)(2009-5#1)(2010-11#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
for diabetic##12##2##(1993-8#1)(1995-9#1)(2007-8#1)(2008-1#4)(2008-10#3)(2010-10#1)(2012-1#1)
for diagnoses##3##2##(1990-12#1)(1994-2#1)(2013-8#1)
for diagnosing cirrhosis in##2##4##(2010-8#2)
for diagnosing latent##2##3##(1993-2#1)(2010-5#1)
for diagnosing##25##2##(1991-6#1)(1992-5#1)(1993-2#1)(1993-9#1)(1994-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-5#2)(2010-8#2)(2011-2#5)(2012-2#2)
for diagnosis and management##3##4##(1993-6#1)(1997-3#1)(2011-2#1)
for diagnosis and therapy##3##4##(1990-9#1)(2011-2#1)(2013-1#1)
for diagnosis and treatment in patients##2##6##(1990-3#1)(1996-8#1)
for diagnosis and treatment in##3##5##(1990-3#1)(1996-8#1)(2011-1#1)
for diagnosis and treatment of##5##5##(1990-9#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
for diagnosis and treatment##15##4##(1990-3#1)(1990-9#1)(1994-9#1)(1996-8#1)(2006-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
for diagnosis and##30##3##(1990-3#1)(1990-9#2)(1991-6#1)(1993-6#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-3#2)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)
for diagnosis are##4##3##(1994-3#1)(1997-4#1)(2008-6#1)(2013-1#1)
for diagnosis of carpal tunnel syndrome##2##6##(2010-8#2)
for diagnosis of the##2##4##(2008-9#1)(2011-2#1)
for diagnosis of##33##3##(1991-12#1)(1991-2#1)(1994-11#1)(1995-1#1)(1996-12#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
for diagnosis##93##2##(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#2)(1996-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#2)
for diagnostic and therapeutic##3##4##(2010-5#1)(2012-12#1)(2012-2#1)
for diagnostic and##6##3##(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
for diagnostic imaging##2##3##(1992-1#1)(1992-2#1)
for diagnostic or##2##3##(2008-9#1)(2010-6#1)
for diagnostic purposes##3##3##(1996-12#1)(2008-1#1)(2013-7#1)
for diagnostic##25##2##(1990-10#1)(1992-1#1)(1992-2#1)(1993-12#2)(1996-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
for dialysis##2##2##(1993-12#1)(2007-12#1)
for diastolic##2##2##(1992-6#1)(2012-12#1)
for diazepam and prazepam respectively##2##5##(2008-10#2)
for diazepam and##3##3##(2008-10#3)
for diazinon##2##2##(2008-10#2)
for dichlorvos##5##2##(2008-10#5)
for diclofenac##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
for dielectric##7##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2011-1#1)
for dietary changes##3##3##(1990-6#3)
for dietary##8##2##(1990-6#3)(2008-5#2)(2010-4#1)(2010-6#1)(2012-2#1)
for dietitians in##2##3##(1993-12#1)(1993-2#1)
for dietitians##4##2##(1993-12#2)(1993-2#1)(1995-12#1)
for differences between##2##3##(2008-3#1)(2008-9#1)
for differences in##17##3##(1990-9#1)(1991-3#1)(1994-1#2)(1994-2#1)(1995-11#1)(1995-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)
for differences##21##2##(1990-9#1)(1991-3#1)(1994-1#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#3)(2011-2#1)(2012-2#1)
for different applications##5##3##(2008-3#1)(2008-4#2)(2008-9#1)(2013-8#1)
for different components##2##3##(2008-10#1)(2008-2#1)
for different concentration##2##3##(2008-10#2)
for different concentrations of##2##4##(1996-12#1)(2012-3#1)
for different hybridoma cell lines##2##5##(1994-5#1)(2008-11#1)
for different incident##2##3##(2008-2#1)(2008-3#1)
for different individuals##2##3##(2008-11#1)(2008-9#1)
for different particle##2##3##(2008-2#1)(2008-3#1)
for different people##2##3##(1994-12#1)(2010-2#1)
for different periods of time##2##5##(2008-10#1)(2008-3#1)
for different periods of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
for different periods##7##3##(2008-10#5)(2008-3#1)(2012-3#1)
for different polarizations of##2##4##(2007-12#1)(2008-3#1)
for different polarizations##3##3##(2007-12#1)(2008-3#2)
for different positions of the##2##5##(2008-2#1)(2008-3#1)
for different purposes##2##3##(2010-11#1)(2013-1#1)
for different reasons##3##3##(1994-5#1)(2007-12#1)(2011-2#1)
for different temperature and pressure##2##5##(2008-2#2)
for different temperature##3##3##(2008-10#1)(2008-2#2)
for different time periods##2##4##(2008-10#1)(2010-11#1)
for different types of##8##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)
for different types##9##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)
for different wavelengths##2##3##(2008-3#1)(2013-8#1)
for different##167##2##(1990-2#2)(1990-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1996-12#2)(1997-3#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#31)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#3)(2013-8#5)
for different-sized##2##2##(2008-2#1)(2008-8#1)
for differential absorption lidar applications##2##5##(2008-2#2)
for differential absorption lidar##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
for differential diagnosis of##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
for differential diagnosis##8##3##(1993-2#1)(1994-12#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
for differential phase##2##3##(2007-12#1)(2008-2#1)
for differential pulse and square wave voltammetric techniques##2##8##(2008-10#2)
for differential##28##2##(1991-11#1)(1993-2#1)(1994-12#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
for differentially##2##2##(1996-9#1)(2009-8#1)
for differentiating##5##2##(2008-10#5)
for differentiation between##2##3##(1995-2#1)(2008-10#1)
for differentiation into##2##3##(1994-8#1)(2010-6#1)
for differentiation of##5##3##(2008-10#3)(2008-5#1)(2009-6#1)
for differentiation##12##2##(1994-8#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-6#1)(2010-6#1)
for difficult##5##2##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
for difficulties##2##2##(1996-1#1)(2008-4#1)
for diffraction##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
for diffraction-limited performance##2##3##(2008-2#1)(2008-3#1)
for diffraction-limited##3##2##(2008-2#2)(2008-3#1)
for diffractive##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
for diffuse light##2##3##(2007-12#2)
for diffuse##7##2##(1991-9#1)(2007-12#3)(2008-2#2)(2008-9#1)
for diffusion##2##2##(2008-10#2)
for digested##2##2##(2008-10#1)(2008-12#1)
for digestion of##2##3##(1997-3#1)(2008-10#1)
for digestion##5##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-4#1)
for digital holography##2##3##(2007-11#1)(2007-12#1)
for digital image##2##3##(2008-3#1)(2008-9#1)
for digital revascularization##2##3##(2008-9#2)
for digital##13##2##(2007-11#2)(2007-12#3)(2008-3#2)(2008-4#1)(2008-9#3)(2010-8#1)(2011-1#1)
for dilute##3##2##(1992-3#1)(2007-12#1)(2008-1#1)
for dimer formation##2##3##(1992-3#1)(2012-2#1)
for diode##2##2##(2008-3#2)
for diospyrin determination in nanomolar concentrations##2##6##(2008-10#2)
for dioxin##3##2##(2008-10#3)
for dioxins and PCBs##2##4##(2008-10#2)
for dioxins and dioxin-like PCBs##2##5##(2008-10#2)
for dioxins and##5##3##(2008-10#4)(2008-7#1)
for dioxins##6##2##(2008-10#5)(2008-7#1)
for dioxygen##2##2##(1991-3#1)(2008-10#1)
for dipeptides##5##2##(1990-11#4)(1995-6#1)
for direct analysis of##2##4##(1997-2#1)(2008-10#1)
for direct and indirect##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
for direct and##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
for direct detection Doppler wind lidar from##2##7##(2008-3#2)
for direct detection of##2##4##(2008-10#1)(2008-3#1)
for direct detection##7##3##(2008-10#2)(2008-2#2)(2008-3#3)
for direct determination of bending strains##2##6##(2008-3#2)
for direct determination of the##3##5##(2008-10#2)(2008-3#1)
for direct determination of##13##4##(2008-10#10)(2008-3#3)
for direct determination##14##3##(2008-10#11)(2008-3#3)
for direct measurement of##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
for direct measurement##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
for direct measurements##2##3##(2008-10#2)
for direct solid sampling##2##4##(2008-10#2)
for direct##82##2##(1991-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#7)(2008-10#29)(2008-2#5)(2008-3#15)(2008-4#6)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)
for directing the##2##3##(1993-3#1)(2008-10#1)
for directing##3##2##(1993-3#1)(2008-10#1)(2009-4#1)
for direction of##2##3##(1994-8#2)
for direction##4##2##(1990-12#1)(1993-1#1)(1994-8#2)
for directly observed therapy##2##4##(1996-3#2)
for directly##7##2##(1990-11#1)(1996-3#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#1)
for disability benefits##2##3##(1997-5#2)
for disability pension##3##3##(1993-6#1)(1997-6#2)
for disability##8##2##(1993-6#1)(1995-12#1)(1995-5#1)(1997-5#2)(1997-6#2)(2007-10#1)
for disabled##3##2##(1992-2#1)(2008-8#1)(2012-12#1)
for disaster##2##2##(2008-1#1)(2013-8#1)
for discharge##2##2##(2011-2#1)(2012-2#1)
for discontinuation##3##2##(2007-10#1)(2008-11#1)(2008-3#1)
for discontinuous##3##2##(1995-1#1)(2008-10#1)(2008-2#1)
for discovering and testing##2##4##(2009-3#1)(2012-3#1)
for discovering##8##2##(1994-6#1)(1996-10#1)(2008-4#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
for discovery of##3##3##(2008-2#1)(2008-8#1)(2012-3#1)
for discrete##5##2##(1994-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
for discriminating between alternant versus nonalternant polycyclic aromatic hydrocarbons##3##9##(2008-10#3)
for discriminating between##4##3##(2008-10#3)(2008-3#1)
for discriminating##7##2##(2008-10#3)(2008-3#1)(2009-6#1)(2009-8#1)(2011-2#1)
for discrimination between closely similar DNA sequences in situ##2##9##(2008-4#1)(2008-9#1)
for discrimination between##5##3##(1996-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
for discrimination##8##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)
for discussing##3##2##(1994-1#1)(1996-1#1)(1997-3#1)
for discussion##10##2##(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
for discussions##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
for disease activity##2##3##(2008-10#1)(2011-2#1)
for disease and##4##3##(1995-6#1)(2008-10#1)(2013-1#2)
for disease control##8##3##(1990-12#1)(2008-10#6)(2009-10#1)
for disease development##8##3##(2008-10#8)
for disease incidence##3##3##(2008-10#3)
for disease management##4##3##(2008-10#4)
for disease modeling and##2##4##(2013-1#2)
for disease prevention##2##3##(1996-3#1)(2013-8#1)
for disease progression##4##3##(1991-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
for disease resistance##3##3##(2008-10#2)(2009-10#1)
for disease severity##4##3##(1997-5#1)(2008-10#3)
for disease spread##2##3##(2008-1#1)(2008-10#1)
for disease suppression##4##3##(2008-10#4)
for disease##71##2##(1990-12#1)(1991-4#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#45)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#2)(2010-11#1)(2011-2#3)(2013-1#5)(2013-8#1)
for disease-specific##2##2##(2008-6#1)(2013-8#1)
for diseases of the female##2##5##(1992-4#2)
for diseases of the##3##4##(1992-4#2)(2013-8#1)
for diseases of##4##3##(1992-4#2)(1995-9#1)(2013-8#1)
for diseases##9##2##(1991-2#1)(1992-4#2)(1995-9#1)(1997-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
for disgust##2##2##(2010-7#1)(2013-8#1)
for disinfection##2##2##(2007-7#1)(2008-10#1)
for disk##2##2##(2007-7#1)(2008-2#1)
for disorders of##2##3##(1991-5#1)(2008-5#1)
for disorders##4##2##(1991-5#1)(2008-11#1)(2008-5#1)(2012-2#1)
for dispersal of##2##3##(2010-6#2)
for dispersal##6##2##(2008-5#1)(2008-9#1)(2010-6#2)(2013-1#2)
for dispersing##2##2##(2008-10#1)(2008-8#1)
for dispersion compensation##3##3##(2007-11#1)(2008-3#2)
for dispersion##7##2##(2007-11#1)(2008-10#1)(2008-3#5)
for displacing##2##2##(1997-4#1)(2008-3#1)
for display purposes##2##3##(2008-2#1)(2008-3#1)
for display##5##2##(2008-2#1)(2008-3#3)(2008-9#1)
for displaying##4##2##(2007-11#2)(2008-2#2)
for dissecting##3##2##(2009-12#1)(2010-12#1)(2011-2#1)
for dissection of##2##3##(1990-3#1)(2008-7#1)
for dissection##3##2##(1990-3#1)(2008-7#1)(2010-10#1)
for disseminating##2##2##(1996-1#1)(2013-1#1)
for dissemination##2##2##(1992-9#1)(1993-12#1)
for dissociation##2##2##(1993-8#1)(1996-7#1)
for dissolution of##2##3##(2008-10#2)
for dissolution##4##2##(2008-10#3)(2009-7#1)
for distal hypospadias repair##2##4##(2008-10#1)(2009-5#1)
for distal hypospadias##4##3##(2008-10#1)(2009-5#3)
for distal##7##2##(1997-3#1)(2008-10#1)(2008-9#2)(2009-5#3)
for distance to##2##3##(2008-10#1)(2009-7#1)
for distance##5##2##(1996-1#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-1#1)
for distant metastases##2##3##(2008-5#1)(2008-6#1)
for distant##3##2##(1997-7#1)(2008-5#1)(2008-6#1)
for distinct##5##2##(1994-11#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
for distinguishing between##5##3##(1990-2#1)(1991-1#1)(2008-4#1)(2008-9#1)(2012-3#1)
for distinguishing##16##2##(1990-2#1)(1991-1#1)(1996-6#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-9#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
for distraction##2##2##(2007-12#1)(2011-1#1)
for distributed##3##2##(2008-11#1)(2010-8#2)
for distribution##3##2##(2007-11#1)(2008-4#1)(2011-1#1)
for disulfide conjugation##3##3##(2008-4#3)
for disulphide##2##2##(1993-2#1)(1993-9#1)
for diuron and atrazine##2##4##(2008-10#2)
for divalent##3##2##(1995-11#1)(2008-10#2)
for diverse##6##2##(1994-3#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)
for diversity##2##2##(1996-1#1)(2008-10#1)
for diverticular disease##3##3##(2010-8#3)
for diving##2##2##(1991-6#1)(1997-1#1)
for doctors from##3##3##(1992-2#2)(1992-5#1)
for doctors in##2##3##(1993-3#1)(2008-7#1)
for doctors##8##2##(1992-2#2)(1992-5#1)(1993-3#1)(1997-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
for documenting##2##2##(2008-8#1)(2008-9#1)
for doing so##3##3##(1996-12#1)(2010-11#1)(2011-1#1)
for doing this##2##3##(1997-4#1)(2008-11#1)
for doing##6##2##(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-1#1)
for dominant##4##2##(2008-8#1)(2010-4#1)(2012-3#2)
for donation##5##2##(1991-3#1)(2008-10#1)(2011-2#3)
for donor##2##2##(1991-3#1)(2011-2#1)
for donors##3##2##(1994-9#1)(2008-12#1)(2011-2#1)
for dopamine and##2##3##(2008-10#2)
for dopamine in##2##3##(1993-8#1)(2008-10#1)
for dopamine##9##2##(1993-8#2)(2008-10#5)(2008-7#1)(2013-1#1)
for doping##2##2##(2007-12#1)(2008-10#1)
for dormancy release in apricot##2##5##(2012-8#2)
for dosage##2##2##(2008-1#1)(2008-4#1)
for dose##6##2##(1992-9#1)(2006-10#1)(2007-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
for double-focusing sector field ICP-MS##2##5##(2008-10#2)
for downstream##3##2##(2008-2#1)(2010-6#1)(2011-2#1)
for doxazosin##3##2##(1995-12#3)
for doxycycline##2##2##(1994-11#1)(2008-10#1)
for drift noise##2##3##(2008-2#2)
for drinking water treatment##2##4##(2013-1#2)
for drinking water##4##3##(2008-10#2)(2013-1#2)
for driving the##3##3##(2008-11#1)(2008-3#1)(2010-3#1)
for driving##7##2##(1992-9#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
for drug abuse##3##3##(1995-5#1)(2008-4#1)(2008-6#1)
for drug and##2##3##(1991-1#1)(2009-8#1)
for drug delivery##7##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)(2013-1#1)
for drug development##5##3##(1992-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)
for drug discovery and##2##4##(2008-4#1)(2011-3#1)
for drug discovery applications##2##4##(2008-11#2)
for drug discovery##13##3##(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#2)(2011-3#1)
for drug misusers##3##3##(1992-5#2)(1996-3#1)
for drug therapy##2##3##(2008-1#1)(2010-12#1)
for drug treatment##2##3##(2011-1#1)(2011-10#1)
for drug##62##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#5)(2010-12#1)(2010-5#2)(2011-1#3)(2011-10#1)(2011-3#2)(2013-1#1)
for drug-induced##3##2##(1996-11#1)(2007-10#1)(2008-10#1)
for drugs and##2##3##(2008-5#1)(2010-6#1)
for drugs with##3##3##(1994-9#1)(2008-7#1)(2012-3#1)
for drugs##11##2##(1992-2#1)(1994-9#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2012-3#1)
for drunken driving##2##3##(1994-2#2)
for dry matter##2##3##(2008-11#1)(2009-4#1)
for dry##3##2##(2008-10#1)(2008-11#1)(2009-4#1)
for drying##2##2##(2008-10#1)(2008-6#1)
for dsRNA##2##2##(2008-10#2)
for dual##8##2##(1995-2#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)
for dual-wavelength operation##2##3##(2008-2#2)
for dually entitled##2##3##(1995-3#2)
for ductal carcinoma in situ##2##5##(1994-8#2)
for duodenal##2##2##(1990-6#1)(2006-10#1)
for durable resistance##3##3##(2008-10#3)
for durable##4##2##(2008-10#3)(2011-2#1)
for dyads by##2##3##(2009-11#2)
for dye##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
for dynamic and static##2##4##(2012-1#1)(2012-2#1)
for dynamic phase##2##3##(2007-11#1)(2008-3#1)
for dynamic pressure##2##3##(2008-2#1)(2008-3#1)
for dynamic##21##2##(1994-8#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#8)(2009-12#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-2#1)
for dysfunctional uterine bleeding##2##4##(2008-10#1)(2009-5#1)
for dysfunctional##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
for dysphagia##3##2##(1993-2#1)(2007-10#1)(2011-1#1)
for e##2##2##(2008-10#2)
for each SQG approach were##2##5##(2012-1#2)
for each additional##2##3##(2008-10#1)(2011-2#1)
for each alternative##2##3##(1992-12#2)
for each analyte##4##3##(2008-10#4)
for each assay##3##3##(1990-12#1)(1996-12#2)
for each attribute##2##3##(2008-5#2)
for each case##3##3##(2009-9#1)(2013-1#2)
for each cell##4##3##(1997-3#1)(1997-4#1)(2008-11#1)(2008-7#1)
for each channel##2##3##(1995-3#1)(2008-2#1)
for each chemical##2##3##(2008-10#2)
for each child##3##3##(1992-11#1)(2008-11#1)(2008-9#1)
for each clinical##3##3##(1992-3#1)(2010-8#1)(2013-8#1)
for each comparison##2##3##(1997-7#1)(2010-9#1)
for each complex##2##3##(2008-10#1)(2008-7#1)
for each compound and##2##4##(2008-10#2)
for each compound##8##3##(1993-12#1)(2008-10#7)
for each cultivar and experiment##2##5##(2008-10#2)
for each cultivar and##3##4##(2008-10#2)(2011-10#1)
for each cultivar##6##3##(2008-10#3)(2008-12#1)(2011-10#1)(2011-2#1)
for each drug##6##3##(1991-5#1)(1993-8#1)(2008-10#3)(2008-11#1)
for each element##4##3##(2008-10#4)
for each enantiomer##2##3##(2008-10#2)
for each experiment##3##3##(2008-10#3)
for each gene##6##3##(2008-10#1)(2008-11#1)(2008-4#2)(2009-9#1)(2012-3#1)
for each genotype##2##3##(2008-10#2)
for each group was##2##4##(2008-12#1)(2011-2#1)
for each group##8##3##(2008-1#1)(2008-12#2)(2008-3#1)(2011-2#2)(2012-2#2)
for each individual patient##2##4##(1990-9#1)(2012-12#1)
for each individual##14##3##(1990-9#1)(1994-3#1)(2007-11#1)(2008-10#5)(2008-3#2)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
for each inoculation##2##3##(2008-10#2)
for each isolate##4##3##(2008-10#4)
for each item##2##3##(1996-1#1)(2012-3#1)
for each kind of##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
for each measurement##3##3##(2008-10#3)
for each metal ion##3##4##(2008-10#3)
for each metal##6##3##(2008-10#6)
for each method##6##3##(1992-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)
for each model##5##3##(1992-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
for each month##2##3##(2008-10#1)(2011-1#1)
for each mutant##2##3##(1995-5#1)(2008-4#1)
for each of the seven##2##5##(2008-10#1)(2008-5#1)
for each of the three##5##5##(1995-12#1)(2007-5#1)(2008-10#2)(2012-2#1)
for each of the##35##4##(1991-12#1)(1991-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
for each of these##10##4##(1993-11#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-7#1)
for each of three##3##4##(1992-3#1)(2008-3#1)(2013-1#1)
for each of##53##3##(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-3#2)(1997-5#1)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
for each one##4##3##(1993-12#1)(2008-10#2)(2013-8#1)
for each particular##2##3##(2008-10#1)(2012-3#1)
for each patient##17##3##(1992-4#1)(1992-9#1)(1993-9#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
for each pixel##3##3##(2008-2#2)(2008-3#1)
for each procedure##2##3##(1993-12#1)(2008-10#1)
for each projection##2##3##(2011-1#1)(2012-1#1)
for each question##2##3##(2008-7#1)(2010-11#1)
for each reagent##2##3##(2008-10#2)
for each receptor##2##3##(1994-6#1)(1997-2#1)
for each region##2##3##(2008-10#1)(2012-12#1)
for each sample##7##3##(2008-10#5)(2008-12#1)(2009-11#1)
for each sensor may be realized##3##6##(2008-3#3)
for each sensor##4##3##(2008-10#1)(2008-3#3)
for each service##2##3##(1994-1#1)(1995-1#1)
for each sex##3##3##(2008-8#2)(2013-7#1)
for each site##2##3##(2007-12#1)(2013-7#1)
for each spatial##2##3##(2008-2#1)(2013-7#1)
for each species and##2##4##(2008-10#2)
for each species of bacterium##2##5##(2011-2#2)
for each species##15##3##(1996-5#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)
for each specific##2##3##(2008-10#1)(2011-2#1)
for each specified##2##3##(1993-9#1)(2011-2#1)
for each specimen##2##3##(2008-8#1)(2013-8#1)
for each stage##3##3##(2007-8#1)(2009-3#1)(2010-12#1)
for each study##4##3##(1997-3#1)(2008-10#1)(2009-8#1)(2012-3#1)
for each subject##5##3##(1997-4#1)(2008-10#2)(2008-11#1)(2010-8#1)
for each system##2##3##(2008-10#2)
for each test##5##3##(2008-10#2)(2008-3#2)(2010-2#1)
for each tooth##2##3##(2010-3#1)(2011-2#1)
for each topic##2##3##(1994-9#1)(2008-10#1)
for each treatment group##2##4##(1994-9#1)(2013-1#1)
for each treatment##7##3##(1994-8#1)(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
for each type of##8##4##(1990-5#1)(1997-4#1)(2008-10#4)(2008-9#1)(2010-8#1)
for each virus##2##3##(2008-10#1)(2008-5#1)
for each vitamin##2##3##(2008-10#1)(2008-5#1)
for each year##4##3##(1992-12#1)(1993-12#1)(2007-2#1)(2008-10#1)
for each##542##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#4)(1992-4#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#8)(1993-3#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#2)(2006-12#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#172)(2008-11#10)(2008-12#7)(2008-2#13)(2008-3#36)(2008-4#12)(2008-5#12)(2008-6#2)(2008-7#12)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#17)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#8)(2012-3#8)(2012-5#2)(2013-1#19)(2013-7#5)(2013-8#5)
for each)##2##2##(1994-11#1)(2008-7#1)
for ear rot##3##3##(2008-10#3)
for ear##4##2##(2008-10#3)(2013-8#1)
for earlier##3##2##(2009-10#1)(2012-12#1)(2012-2#1)
for early breast cancer##2##4##(1994-12#1)(2011-2#1)
for early breast##3##3##(1994-12#1)(1995-11#1)(2011-2#1)
for early detection and##2##4##(2007-8#1)(2010-8#1)
for early detection of##7##4##(1990-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2013-1#1)
for early detection##13##3##(1990-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#2)(2013-1#1)
for early diagnosis and##5##4##(1992-3#1)(1993-6#1)(2008-5#1)(2011-2#1)(2013-8#1)
for early diagnosis of##3##4##(1992-5#1)(2010-3#1)(2012-2#1)
for early diagnosis##10##3##(1992-3#1)(1992-5#1)(1993-6#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
for early intervention services##2##4##(1994-1#2)
for early intervention##5##3##(1994-1#2)(2009-8#1)(2010-9#1)(2012-2#1)
for early psychosis in##2##4##(2008-1#2)
for early screening##2##3##(2008-10#1)(2008-12#1)
for early stage##2##3##(1995-9#1)(2008-11#1)
for early syphilis##2##3##(1997-5#1)(1997-7#1)
for early##70##2##(1990-2#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-1#2)(1994-12#2)(1995-11#1)(1995-2#1)(1995-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#2)
for earthquake prediction##3##3##(1996-4#3)
for easy access to##2##4##(2008-7#1)(2012-2#1)
for easy and##2##3##(2008-10#1)(2008-2#1)
for easy##12##2##(1990-2#1)(1994-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
for eating disorders##3##3##(2007-7#1)(2008-8#1)(2010-11#1)
for eating##5##2##(2007-7#1)(2008-8#1)(2010-11#1)(2013-8#2)
for echinococcosis##3##2##(1993-6#1)(2012-3#2)
for ecological##2##2##(2008-8#1)(2013-7#1)
for economic##3##2##(1994-2#1)(2009-10#1)(2012-1#1)
for ectopic##3##2##(1993-12#1)(2013-1#2)
for edge##3##2##(2008-2#1)(2008-3#2)
for educating##2##2##(1991-2#1)(2007-4#1)
for education in##3##3##(1993-3#2)(2012-3#1)
for education of##2##3##(1993-3#1)(2011-1#1)
for education##14##2##(1993-12#1)(1993-3#4)(1996-7#1)(2008-1#1)(2008-11#1)(2009-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
for educational##7##2##(1990-2#1)(1991-2#1)(1992-1#1)(1993-1#1)(1996-1#1)(2008-10#1)(2008-11#1)
for educators to##2##3##(2008-12#2)
for educators##9##2##(1993-1#1)(1996-2#1)(2008-12#5)(2009-12#1)(2013-8#1)
for effect##2##2##(1994-6#1)(2013-8#1)
for effecting##2##2##(1994-9#1)(2008-4#1)
for effective collaboration##2##3##(2008-12#2)
for effective prevention##2##3##(2009-4#1)(2013-1#1)
for effective urban air quality management##2##6##(2008-11#2)
for effective##43##2##(1992-1#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
for effectively##6##2##(1997-6#1)(2008-10#1)(2008-4#1)(2010-3#1)(2010-4#1)(2010-8#1)
for effectiveness in##2##3##(2008-1#1)(2011-2#1)
for effectiveness##5##2##(1996-3#1)(2008-1#2)(2011-2#1)(2012-12#1)
for effects of##2##3##(2007-7#1)(2008-3#1)
for effects on##3##3##(1993-8#1)(2008-10#2)
for effects##5##2##(1993-8#1)(2007-7#1)(2008-10#2)(2008-3#1)
for efficacious##2##2##(1996-12#1)(2013-1#1)
for efficacy of##3##3##(2011-2#1)(2012-1#1)(2013-8#1)
for efficacy##10##2##(1991-3#1)(1994-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
for efficient coupling##2##3##(2007-11#1)(2008-2#1)
for efficient expression##3##3##(1990-5#1)(1997-6#1)(2008-11#1)
for efficient production of##2##4##(2008-6#1)(2011-3#1)
for efficient production##3##3##(2008-11#1)(2008-6#1)(2011-3#1)
for efficient secretion##2##3##(1991-9#1)(2008-11#1)
for efficient##59##2##(1990-5#2)(1991-9#1)(1994-5#1)(1995-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#10)(2008-2#7)(2008-3#4)(2008-4#2)(2008-6#1)(2009-5#2)(2010-8#1)(2011-1#6)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
for efficiently##4##2##(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
for effluent##2##2##(2008-10#1)(2008-6#1)
for egg##2##2##(2008-12#1)(2008-9#1)
for eight determinations of##2##4##(2008-10#2)
for eight replicate measurements##3##4##(2008-10#3)
for eight replicate##5##3##(2008-10#5)
for eight weeks##3##3##(2012-12#1)(2013-1#2)
for eight years##2##3##(2008-1#1)(2013-1#1)
for eight##28##2##(1993-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-1#2)(2008-10#13)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#3)
for either genus##2##3##(2008-10#2)
for either the##2##3##(1997-4#1)(2008-7#1)
for either##46##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
for elaboration##2##2##(2009-5#1)(2009-6#1)
for elaidic acid##2##3##(2008-10#2)
for elastic##2##2##(2007-12#1)(2009-5#1)
for elderly and##2##3##(1994-1#1)(1995-3#1)
for elderly institutionalised adults##2##4##(2011-2#2)
for elderly patients##3##3##(1992-1#1)(2008-8#1)(2012-12#1)
for elderly##16##2##(1992-1#1)(1992-6#1)(1993-12#1)(1994-1#2)(1994-6#1)(1995-3#1)(1997-8#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#1)
for elective surgery##7##3##(1995-1#1)(1996-9#1)(2006-12#1)(2008-7#1)(2010-7#2)(2010-8#1)
for elective##16##2##(1990-6#1)(1993-10#1)(1995-1#1)(1996-3#1)(1996-9#2)(2006-12#1)(2007-8#1)(2008-7#1)(2010-7#2)(2010-8#2)(2011-2#2)(2013-1#1)
for electrical stimulation of##2##4##(1993-12#1)(2009-9#1)
for electrical stimulation##4##3##(1993-12#1)(2008-9#1)(2009-9#1)(2012-2#1)
for electrical##10##2##(1993-12#1)(1994-5#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-9#2)(2012-2#2)
for electrically addressed##2##3##(2008-3#2)
for electro-optic##3##2##(2007-11#1)(2007-12#2)
for electroanalytical applications##2##3##(2008-10#2)
for electroanalytical##4##2##(2008-10#4)
for electrocatalytic oxidation of nitrite ion##2##6##(2008-10#2)
for electrochemical##8##2##(2008-10#4)(2010-11#1)(2012-2#1)(2013-1#2)
for electroconvulsive therapy##2##3##(2008-7#1)(2011-1#1)
for electrode types [I] and [II]##2##6##(2008-10#2)
for electrode##5##2##(2008-10#4)(2008-9#1)
for electromagnetic scattering##3##3##(2008-2#1)(2008-3#2)
for electromagnetic##5##2##(2008-2#1)(2008-3#4)
for electron beams##3##3##(2009-11#2)(2012-1#1)
for electron transfer##2##3##(1990-5#1)(1993-11#1)
for electron##10##2##(1990-5#1)(1993-11#1)(1995-9#1)(1997-7#1)(2007-10#1)(2007-7#1)(2009-11#2)(2010-4#1)(2012-1#1)
for electronic##7##2##(1994-3#1)(1994-5#1)(1996-3#1)(2008-11#2)(2010-8#1)(2012-3#1)
for electrothermal atomic absorption spectrometric##2##5##(2008-10#2)
for electrothermal atomic absorption spectrometry##3##5##(2008-10#3)
for electrothermal atomic absorption##5##4##(2008-10#5)
for electrothermal##6##2##(2008-10#6)
for element-dependent signal##2##3##(2008-10#2)
for elemental analysis of##2##4##(2008-10#2)
for elemental analysis##3##3##(2008-10#3)
for elemental##5##2##(2008-10#5)
for elements of##2##3##(1993-6#1)(2008-9#1)
for elements##5##2##(1993-6#1)(2008-10#3)(2008-9#1)
for elevated##2##2##(1992-6#1)(2007-7#1)
for elevation of##2##3##(1993-6#1)(1997-4#1)
for eleven##2##2##(2008-10#2)
for elicitation##2##2##(2008-10#1)(2008-4#1)
for eliciting##5##2##(1995-2#1)(1996-12#1)(2007-6#1)(2008-10#1)(2013-1#1)
for eligibility##2##2##(1993-6#1)(2012-3#1)
for eligible individuals aged##2##4##(2011-2#2)
for eliminating the##2##3##(2008-10#1)(2008-4#1)
for eliminating##6##2##(1992-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-4#1)
for elimination of##3##3##(2008-10#2)(2013-1#1)
for elimination##4##2##(2008-10#3)(2013-1#1)
for elliptical##2##2##(2008-3#2)
for elucidating the##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)
for elucidating##9##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)
for elucidation of##2##3##(1996-10#1)(2012-2#1)
for elution of##4##3##(2008-10#4)
for elution##9##2##(1990-8#1)(2008-10#6)(2008-4#2)
for embedding in##2##3##(2008-7#2)
for embedding##3##2##(2008-7#2)(2013-1#1)
for embolization##2##2##(2007-10#1)(2012-12#1)
for embryo##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
for emergency services##3##3##(1996-4#1)(2008-11#1)(2012-3#1)
for emergency##19##2##(1990-4#1)(1991-2#1)(1995-2#1)(1996-4#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
for emerging##7##2##(1995-1#1)(2010-8#5)(2011-1#1)
for emission##2##2##(2008-3#2)
for emotional distress##3##3##(1991-1#1)(1992-1#1)(1997-5#1)
for emotional##5##2##(1991-1#1)(1992-1#1)(1995-2#1)(1997-5#1)(2008-11#1)
for empirical##4##2##(1995-1#1)(2009-4#1)(2011-2#1)(2012-3#1)
for employees##5##2##(1991-3#1)(1994-1#1)(1995-6#1)(1996-3#1)(2008-12#1)
for employment##3##2##(1996-2#1)(1997-5#1)(2008-11#1)
for enabling##2##2##(1994-3#1)(2008-10#1)
for enantioselective##2##2##(2008-10#1)(2008-7#1)
for encapsulation##3##2##(1994-12#1)(1996-5#1)(2008-11#1)
for encoding and decoding##2##4##(2008-2#1)(2008-3#1)
for encoding the##2##3##(2007-12#1)(2008-3#1)
for encoding##8##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)
for end stage renal disease##3##5##(1995-12#1)(1997-1#1)(2010-7#1)
for end stage##4##3##(1995-12#1)(1997-1#1)(2010-7#1)(2011-2#1)
for end##6##2##(1991-3#1)(1993-3#1)(1995-12#1)(1997-1#1)(2010-7#1)(2011-2#1)
for end-point##2##2##(2008-10#1)(2008-11#1)
for end-stage liver disease##2##4##(2010-6#1)(2011-2#1)
for end-stage renal disease (ESRD)##2##5##(1996-2#1)(2008-1#1)
for end-stage renal disease##3##4##(1994-5#1)(1996-2#1)(2008-1#1)
for end-stage renal##4##3##(1994-5#1)(1996-2#1)(2008-1#1)(2011-2#1)
for end-stage##8##2##(1994-5#1)(1996-2#1)(2008-1#1)(2008-2#1)(2010-6#1)(2011-2#2)(2011-3#1)
for endemic##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
for endocytosis##2##2##(1990-11#2)
for endogenous##5##2##(1993-9#1)(1994-5#1)(2008-5#1)(2008-7#1)(2010-8#1)
for endometrial cancer##3##3##(1992-12#2)(1994-9#1)
for endometrial sampling##2##3##(2012-2#2)
for endometrial##8##2##(1992-12#2)(1994-9#1)(2011-2#3)(2012-2#2)
for endoscopic##9##2##(1991-9#1)(2006-12#1)(2008-10#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
for endovascular##2##2##(2007-8#1)(2010-8#1)
for energy##4##2##(2008-6#1)(2009-8#1)(2012-2#1)(2013-1#1)
for engaging in##3##3##(2008-11#1)(2012-1#1)(2012-12#1)
for engaging##5##2##(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
for engineering##6##2##(2007-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)
for enhanced second-harmonic generation##2##4##(2007-11#2)
for enhanced##24##2##(1992-12#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
for enhancement##2##2##(2007-11#1)(2007-12#1)
for enhancing the effectiveness of##2##5##(2009-6#1)(2012-2#1)
for enhancing the fluorescence##2##4##(2008-10#1)(2009-5#1)
for enhancing the##16##3##(1994-12#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-6#1)(2012-2#1)
for enhancing##33##2##(1991-3#1)(1994-12#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-1#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#1)
for enriching##2##2##(2010-4#1)(2012-2#1)
for enrichment of##9##3##(2008-10#7)(2013-7#2)
for enrichment##10##2##(2008-10#8)(2013-7#2)
for enrolled nurses##2##3##(2007-10#2)
for enrolling##4##2##(1994-3#1)(1995-12#1)(1996-1#1)(2010-11#1)
for ensuring##7##2##(1990-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-3#1)
for entering##2##2##(1993-3#1)(2008-7#1)
for entertainment##2##2##(2008-11#1)(2013-8#1)
for entries that##2##3##(2008-10#2)
for entries##3##2##(2008-10#3)
for entry into##2##3##(1997-7#1)(2012-12#1)
for entry##4##2##(1997-7#1)(2008-10#1)(2012-12#1)(2012-2#1)
for enumerating##2##2##(2008-9#1)(2012-2#1)
for enuresis##2##2##(1991-3#1)(2007-7#1)
for environmental analysis##2##3##(1994-9#1)(2008-10#1)
for environmental and biological samples##2##5##(2008-10#2)
for environmental and##3##3##(2008-10#3)
for environmental monitoring of##2##4##(2008-10#2)
for environmental monitoring purposes##2##4##(2008-10#2)
for environmental monitoring##9##3##(2008-10#9)
for environmental risk assessment##4##4##(2008-10#1)(2008-11#2)(2011-2#1)
for environmental##31##2##(1994-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-5#1)(2011-2#1)
for environmentally##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
for enzymatic activity##3##3##(1990-5#1)(1993-9#1)(1995-2#1)
for enzymatic reaction##2##3##(2008-10#2)
for enzymatic##17##2##(1990-5#2)(1993-12#1)(1993-9#1)(1995-2#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
for enzyme activity##4##3##(1994-6#1)(1997-4#1)(2008-6#1)(2011-2#1)
for enzyme##12##2##(1992-6#1)(1993-8#1)(1994-6#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
for enzymes##2##2##(2008-10#2)
for epidemics##3##2##(2008-10#3)
for epidemiological studies and##2##4##(2008-10#1)(2011-2#1)
for epidemiological studies##3##3##(2008-10#2)(2011-2#1)
for epidemiological##9##2##(1991-2#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-8#1)
for epidural##2##2##(2007-2#1)(2010-7#1)
for epigenetic##2##2##(2007-11#1)(2010-12#1)
for epilepsy##3##2##(2008-5#2)(2010-8#1)
for epinephrine##2##2##(2008-10#2)
for epithelial##3##2##(2006-12#1)(2011-2#1)(2013-8#1)
for epitope##2##2##(1995-12#1)(2012-12#1)
for epoxidation##2##2##(2007-11#2)
for equal##2##2##(1990-8#1)(2008-2#1)
for equilibrium constants in##2##4##(2008-10#2)
for equilibrium##4##2##(2008-10#3)(2008-9#1)
for equipment acquisition##2##3##(1994-3#1)(1996-1#1)
for equipment##3##2##(1994-3#1)(1996-1#1)(1996-12#1)
for equity##2##2##(1992-12#1)(1995-1#1)
for equivalence##2##2##(1994-9#1)(2008-10#1)
for equivalent##2##2##(2008-10#1)(2008-2#1)
for eradication of##2##3##(2010-12#1)(2011-2#1)
for erbium##2##2##(2008-10#1)(2008-3#1)
for erbium-doped##2##2##(2008-3#2)
for error##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
for erythrocyte glutathione##3##3##(1996-12#3)
for erythromycin##2##2##(1991-8#1)(2010-8#1)
for esophageal cancer##3##3##(1992-9#1)(2010-8#2)
for esophageal##4##2##(1992-9#1)(2010-8#3)
for esophagoscopic removal was##2##4##(2007-8#2)
for essential##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
for established##2##2##(1992-3#1)(2008-3#1)
for establishing DNA binding selectivity##2##5##(2008-4#2)
for establishing a##11##3##(1990-2#1)(1993-1#1)(1994-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#1)
for establishing and##2##3##(2008-2#1)(2012-12#1)
for establishing the##3##3##(1991-2#1)(2008-11#1)(2009-8#1)
for establishing this##2##3##(1995-12#1)(1996-1#1)
for establishing##38##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-4#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
for establishment of##2##3##(2008-10#1)(2009-11#1)
for establishment##3##2##(2008-10#1)(2009-11#1)(2012-3#1)
for esthetic##2##2##(1990-9#1)(2011-1#1)
for estimating a wide range of proteins##2##7##(1996-12#2)
for estimating a##4##3##(1994-3#1)(1996-12#2)(2008-2#1)
for estimating energy##2##3##(2008-11#1)(2013-1#1)
for estimating level and net severity of##2##7##(1992-6#2)
for estimating maximum permissible load##2##5##(2013-1#2)
for estimating sample size and##2##5##(1994-2#1)(2007-7#1)
for estimating the absorption##4##4##(2008-2#2)(2008-3#2)
for estimating the motion of##2##5##(2008-3#2)
for estimating the##32##3##(1992-9#1)(1993-3#1)(1994-7#1)(1995-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#1)
for estimating total##2##3##(2008-3#1)(2008-4#1)
for estimating##78##2##(1992-3#1)(1992-6#3)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-12#3)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#6)(2013-3#1)
for estimation of blood##2##4##(2008-10#2)
for estimation of the two drugs##2##6##(2010-3#1)(2012-2#1)
for estimation of the##8##4##(1990-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-2#1)
for estimation of##23##3##(1990-7#1)(1997-3#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)
for estimation was##2##3##(2008-10#1)(2011-1#1)
for estimation##27##2##(1990-7#1)(1997-3#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
for estradiol and##2##3##(2008-10#1)(2008-12#1)
for estrogen receptor##3##3##(1994-7#1)(1995-4#2)
for estrogen##5##2##(1991-12#1)(1993-11#1)(1994-7#1)(1995-4#2)
for estrone##4##2##(2008-10#4)
for ethanol and##4##3##(1991-5#2)(2008-10#2)
for ethanol is##2##3##(2008-10#1)(2008-6#1)
for ethanol##15##2##(1991-5#3)(1997-7#4)(2008-10#6)(2008-6#2)
for ethical reasons##2##3##(2008-11#2)
for ethical##7##2##(1995-5#2)(1997-2#1)(2008-11#2)(2008-4#1)(2012-2#1)
for ethics##3##2##(1997-3#1)(2008-11#1)(2013-8#1)
for ethnic groups##3##3##(1995-2#1)(2008-5#1)(2012-12#1)
for ethnic##6##2##(1990-6#1)(1995-2#1)(2007-12#1)(2008-5#1)(2009-7#1)(2012-12#1)
for euthanasia##2##2##(1994-1#1)(2008-4#1)
for evacuation is##2##3##(2013-1#2)
for evaluating an##2##3##(2008-3#1)(2011-2#1)
for evaluating and##4##3##(2008-10#2)(2008-11#2)
for evaluating bone toxicity##2##4##(2012-1#2)
for evaluating cost-effectiveness in primary health care centers##2##8##(2011-2#2)
for evaluating managed care##2##4##(1992-2#1)(1996-3#1)
for evaluating skin##2##3##(2008-5#2)
for evaluating the effects of##2##5##(1996-2#1)(2008-4#1)
for evaluating the efficacy of##3##5##(2008-1#1)(2008-8#1)(2012-12#1)
for evaluating the measurement##2##4##(2008-10#1)(2008-9#1)
for evaluating the performance of##4##5##(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
for evaluating the potential##2##4##(2008-10#2)
for evaluating the uncertainty##2##4##(2008-10#2)
for evaluating the validity##2##4##(1995-6#1)(2008-10#1)
for evaluating the##46##3##(1990-12#1)(1990-2#1)(1991-1#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
for evaluating##119##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-8#4)(2008-1#2)(2008-10#21)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#6)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)
for evaluation and treatment##3##4##(1991-1#1)(1993-1#1)(2010-12#1)
for evaluation and##7##3##(1991-1#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-2#1)
for evaluation of an abnormal##2##5##(1994-1#1)(2008-1#1)
for evaluation of an##3##4##(1994-1#1)(2008-1#1)(2008-10#1)
for evaluation of different##2##4##(2008-11#1)(2008-9#1)
for evaluation of the##12##4##(1997-8#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)
for evaluation of##50##3##(1991-11#1)(1992-1#1)(1993-1#1)(1994-1#1)(1994-3#1)(1997-8#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-8#1)
for evaluation##82##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-1#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#2)(2006-5#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-4#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
for evanescent##2##2##(2008-10#1)(2008-3#1)
for even the##3##3##(1992-1#1)(1992-3#1)(2010-11#1)
for even##4##2##(1991-12#1)(1992-1#1)(1992-3#1)(2010-11#1)
for every 1##2##3##(1990-3#1)(2013-1#1)
for every other##2##3##(2007-10#2)
for every patient##2##3##(1993-12#1)(1993-5#1)
for every##41##2##(1990-3#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-1#1)(1995-5#1)(1996-6#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
for everyday##3##2##(1995-5#1)(2007-8#1)(2008-12#1)
for everyone##7##2##(1992-12#1)(1993-1#1)(1994-12#1)(1996-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
for evidence of##7##3##(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
for evidence##9##2##(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-7#1)(2011-2#1)
for evidence-based##3##2##(2008-11#1)(2008-12#1)(2010-6#1)
for evolution##3##2##(1992-6#1)(2008-8#2)
for evolutionarily##3##2##(1995-2#1)(2008-8#1)(2012-3#1)
for evolutionary##8##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#1)
for ewes##2##2##(2008-9#2)
for ex vivo##3##3##(1997-4#1)(2008-4#1)(2012-3#1)
for exact##3##2##(1992-3#1)(2008-3#2)
for examination of the##2##4##(2008-9#1)(2012-12#1)
for examination of##6##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-12#1)
for examination##10##2##(1991-12#1)(1995-12#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-12#1)
for examining the##11##3##(1995-11#1)(1995-2#2)(2008-1#1)(2008-11#1)(2008-4#3)(2008-9#2)(2012-2#1)
for examining##24##2##(1992-2#1)(1993-9#1)(1995-11#1)(1995-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-7#1)(2008-9#5)(2010-10#1)(2012-1#1)(2012-2#1)(2012-3#1)
for example by##4##3##(1991-2#1)(1995-5#1)(2008-10#1)(2008-7#1)
for example in the##2##4##(1994-11#1)(2008-7#1)
for example in##3##3##(1994-11#1)(2008-11#1)(2008-7#1)
for example the##6##3##(1993-2#1)(2007-11#1)(2008-10#2)(2010-7#1)(2011-2#1)
for example to##3##3##(1994-6#1)(2008-1#1)(2008-10#1)
for example when##3##3##(1996-11#1)(2010-11#1)(2013-8#1)
for example##133##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#8)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#4)
for example)##4##2##(2007-12#2)(2008-2#1)(2012-2#1)
for excellence in##3##3##(1992-3#1)(1996-8#1)(2012-12#1)
for excess##3##2##(1993-12#1)(2008-3#1)(2013-1#1)
for exchange##3##2##(1990-8#2)(1991-12#1)
for exchanging##2##2##(2010-10#1)(2010-8#1)
for excision of##3##3##(2011-2#2)(2012-12#1)
for excision##4##2##(2008-10#1)(2011-2#2)(2012-12#1)
for excitation of##3##3##(2007-11#2)(2007-12#1)
for excitation##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)
for excluding##2##2##(1995-6#1)(2008-2#1)
for exclusion##2##2##(1990-12#1)(1991-12#1)
for executive##2##2##(1993-2#1)(1996-2#1)
for exercise##2##2##(1996-11#1)(2013-1#1)
for existence of##2##3##(2008-10#1)(2008-8#1)
for existing##3##2##(2007-7#1)(2008-8#1)(2012-2#1)
for exogenous##3##2##(2008-11#1)(2008-7#2)
for exon##2##2##(1995-12#1)(2008-2#1)
for expanded##4##2##(1991-3#1)(1994-12#1)(1995-1#1)(2007-2#1)
for expanding the##2##3##(1993-12#1)(2008-4#1)
for expanding##5##2##(1992-2#2)(1993-12#1)(2008-4#1)(2012-3#1)
for expansion##2##2##(2008-11#2)
for expected##2##2##(1997-1#1)(2008-11#1)
for expensive##3##2##(1992-3#1)(1997-1#1)(2010-12#1)
for experienced##2##2##(1992-1#1)(2008-11#1)
for experimental biases##2##3##(2008-2#2)
for experimental research##2##3##(2008-4#1)(2011-2#1)
for experimental##17##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
for experimentation##2##2##(1992-1#1)(2013-8#1)
for experiments in which##2##4##(2008-3#2)
for experiments in##4##3##(2008-11#1)(2008-3#2)(2008-5#1)
for experiments##7##2##(1996-2#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)
for explaining the##2##3##(1990-8#1)(2008-3#1)
for explaining these##2##3##(2008-8#1)(2009-12#1)
for explaining##10##2##(1990-8#1)(1992-12#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-12#1)
for explanation##2##2##(1992-12#1)(2010-10#1)
for exploitation##3##2##(1995-5#1)(2008-10#1)(2009-5#1)
for exploration##2##2##(1992-2#1)(2009-5#1)
for exploratory data analysis##2##4##(2008-8#1)(2011-2#1)
for exploratory##7##2##(1995-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
for exploring the##4##3##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
for exploring##7##2##(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
for explosives detection##2##3##(2008-10#2)
for explosives##6##2##(2008-10#6)
for exposure of##2##3##(2008-10#1)(2012-2#1)
for exposure to##2##3##(2008-9#1)(2012-3#1)
for exposure##5##2##(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#1)
for exposure-based##2##2##(2009-11#1)(2012-2#1)
for expressing the##2##3##(2008-10#1)(2011-2#1)
for expressing##4##2##(1997-4#1)(2008-10#1)(2008-2#1)(2011-2#1)
for expression analysis##2##3##(2008-7#1)(2008-9#1)
for expression and##4##3##(1990-5#1)(1996-12#1)(2008-4#1)(2013-1#1)
for expression in##2##3##(1993-8#1)(1996-5#1)
for expression of the##4##4##(1990-5#1)(1992-4#1)(1995-2#1)(2009-9#1)
for expression of this##2##4##(1993-1#1)(1994-8#1)
for expression of##16##3##(1990-5#1)(1992-4#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-3#1)
for expression##28##2##(1990-5#2)(1992-4#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-8#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
for extended periods##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
for extended##9##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)
for extending##2##2##(2008-10#1)(2008-7#1)
for extension##2##2##(1990-5#1)(2008-10#1)
for extensive##8##2##(1991-5#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#3)
for external##12##2##(1992-12#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
for extinction##3##2##(2008-3#3)
for extra##2##2##(2008-3#1)(2008-5#1)
for extracellular##6##2##(1993-5#1)(1993-9#3)(2008-10#1)(2008-8#1)
for extracorporeal circulation##2##3##(1996-11#1)(2010-8#1)
for extracorporeal##4##2##(1995-1#1)(1996-11#1)(2010-8#2)
for extracting the##6##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
for extracting##17##2##(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#2)(2010-7#1)
for extraction and##3##3##(2008-10#3)
for extraction of the##3##4##(2008-10#2)(2008-2#1)
for extraction of these##2##4##(2008-10#2)
for extraction of##13##3##(2008-10#7)(2008-2#3)(2008-7#1)(2010-8#1)(2012-2#1)
for extraction##30##2##(2008-10#22)(2008-11#1)(2008-2#3)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
for extractive concentration of##2##4##(2008-10#2)
for extractive##3##2##(2008-10#3)
for extraneous risk##3##3##(2012-12#3)
for extraneous##5##2##(1991-12#1)(2008-11#1)(2012-12#3)
for extrapleural pneumonectomy##3##3##(2007-8#3)
for extraskeletal osteosarcoma##2##3##(2008-6#2)
for extreme ultraviolet lithography##3##4##(2008-2#2)(2008-3#1)
for extreme##6##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)
for extreme-ultraviolet lithography##5##3##(2008-3#5)
for extreme-ultraviolet##7##2##(2007-11#1)(2008-3#6)
for extremely low birth weight##2##5##(2008-11#1)(2012-2#1)
for extremely##5##2##(1992-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
for eye##2##2##(2008-11#1)(2008-2#1)
for fabricating an##2##3##(2008-10#1)(2010-8#1)
for fabricating##14##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#5)(2009-11#2)(2010-8#1)
for fabrication of mouthguards and interocclusal splints##2##7##(2008-11#2)
for fabrication of three-dimensional photonic crystals##2##6##(2007-11#2)
for fabrication of##17##3##(2007-11#4)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2013-1#1)
for fabrication##18##2##(2007-11#5)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2013-1#1)
for faces##2##2##(2007-8#2)
for facial expression animation##2##4##(2008-6#2)
for facial##8##2##(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
for facilitated##2##2##(1994-11#1)(2008-10#1)
for facilitating##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)
for factor##3##2##(1991-9#1)(2008-11#1)(2010-6#1)
for factors##2##2##(2008-10#1)(2012-12#1)
for faculty development in##3##4##(1996-2#1)(2012-3#1)(2013-1#1)
for faculty development##4##3##(1993-2#1)(1996-2#1)(2012-3#1)(2013-1#1)
for faculty members##3##3##(1992-1#1)(1996-3#1)(2008-5#1)
for faculty##12##2##(1992-1#1)(1993-1#1)(1993-2#2)(1994-9#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-5#1)(2012-3#1)(2013-1#1)
for faecal##3##2##(1993-8#2)(2011-1#1)
for failure of##4##3##(1993-2#1)(2007-8#1)(2008-7#1)(2012-12#1)
for failure to##3##3##(1993-12#1)(1994-12#1)(2008-12#1)
for failure##9##2##(1993-12#1)(1993-2#1)(1994-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#2)
for falciparum malaria##3##3##(2007-2#3)
for falls among##2##3##(2008-7#2)
for falls##6##2##(2007-11#1)(2008-7#3)(2010-11#1)(2011-2#1)
for familial##11##2##(1990-3#2)(1991-6#1)(1992-11#1)(1992-12#1)(1997-5#3)(2007-10#1)(2007-7#1)(2011-2#1)
for families and##3##3##(1995-1#1)(2008-7#1)(2011-2#1)
for families with##2##3##(1997-2#1)(2011-1#1)
for families##8##2##(1995-1#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
for family members##3##3##(2007-11#1)(2009-5#1)(2011-2#1)
for family planning##2##3##(2008-7#1)(2010-7#1)
for family##12##2##(1994-1#1)(1996-11#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
for family-centered##2##2##(1993-12#1)(2013-7#1)
for far-infrared##4##2##(2007-12#2)(2008-3#2)
for farm##3##2##(1990-6#1)(1994-5#1)(2008-12#1)
for fascial closure##5##3##(1991-1#2)(1991-2#2)(1992-1#1)
for fascial##6##2##(1991-1#2)(1991-2#2)(1992-1#1)(2013-1#1)
for fast and##4##3##(1995-1#1)(2008-2#1)(2009-12#1)(2013-1#1)
for fast frequency##2##3##(2007-12#2)
for fast response##2##3##(2008-10#2)
for fast##22##2##(1995-1#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#2)(2009-8#1)(2013-1#2)
for faster##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
for fatty acid##4##3##(1990-8#1)(1992-6#1)(1993-9#1)(1996-12#1)
for fatty acids and##2##4##(1995-3#1)(2008-1#1)
for fatty##6##2##(1990-8#1)(1992-6#1)(1993-9#1)(1995-3#1)(1996-12#1)(2008-1#1)
for favorable##2##2##(2007-7#1)(2009-3#1)
for fear of##2##3##(2008-8#1)(2011-1#1)
for fear##3##2##(2008-8#1)(2011-1#1)(2013-8#1)
for feature##2##2##(2008-10#1)(2008-2#1)
for febrile neutropenia##2##3##(2008-7#2)
for fed-batch##2##2##(2008-11#1)(2008-7#1)
for feeding##6##2##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#1)
for feline##2##2##(2012-3#2)
for female##7##2##(1996-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
for females and males##2##4##(2008-5#1)(2013-7#1)
for females and##5##3##(2008-5#1)(2012-12#1)(2013-7#3)
for females##27##2##(1991-6#2)(1993-9#1)(1995-2#1)(1997-4#3)(2008-10#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-7#4)
for femtosecond##6##2##(2007-11#1)(2007-12#2)(2008-3#1)(2011-1#2)
for femur##2##2##(1997-4#2)
for fenbendazole and mebendazole was 1##2##6##(2008-10#2)
for fermentation##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
for fertility##3##2##(1993-3#1)(1995-6#1)(2008-9#1)
for fetal anomalies##2##3##(2008-11#2)
for fetal distress##3##3##(1990-9#1)(1994-3#1)(2012-12#1)
for fetal##13##2##(1990-9#1)(1993-12#1)(1994-3#1)(1996-12#4)(2008-11#3)(2010-2#1)(2012-12#1)(2012-2#1)
for fever##3##2##(2007-7#1)(2007-8#1)(2010-12#1)
for fiber Bragg gratings##2##4##(2007-11#1)(2008-3#1)
for fiber Bragg##3##3##(2007-11#1)(2008-3#2)
for fiber##8##2##(1991-12#1)(2007-11#2)(2008-2#1)(2008-3#3)(2013-1#1)
for fiber-optic##2##2##(2007-11#1)(2007-12#1)
for fibers with##2##3##(2007-11#1)(2008-3#1)
for fibrinogen##2##2##(2006-6#1)(2008-10#1)
for fibroblasts##2##2##(2008-9#1)(2010-3#1)
for field analysis##2##3##(2008-10#2)
for field applications##2##3##(2008-10#2)
for field monitoring of##2##4##(2008-10#2)
for field resistance##2##3##(2008-10#2)
for field screening of##2##4##(2008-10#2)
for field##28##2##(1990-9#1)(2007-11#1)(2008-10#20)(2008-3#2)(2008-8#1)(2009-2#1)(2011-1#2)
for fields##4##2##(2007-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
for fighting##3##2##(2008-12#1)(2008-7#1)(2013-8#1)
for filling##3##2##(2008-4#2)(2009-7#1)
for filter applications##2##3##(2007-12#1)(2008-2#1)
for filtering noise##2##3##(2008-3#2)
for filters##2##2##(1993-3#1)(2008-7#1)
for final##5##2##(1992-1#1)(1994-6#1)(2008-10#2)(2008-11#1)
for financial##2##2##(1991-12#1)(2009-7#1)
for financing health care##2##4##(1993-3#1)(2008-1#1)
for financing##7##2##(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-7#1)
for finding the##2##3##(2008-3#1)(2008-6#1)
for finding##13##2##(1994-12#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2010-5#1)(2011-2#2)(2012-2#1)
for fine##3##2##(1996-5#1)(2008-2#1)(2009-10#1)
for fine-tuning##3##2##(1992-3#1)(1995-9#1)(2011-2#1)
for finished##2##2##(2008-3#1)(2008-5#1)
for finite cylinders##2##3##(2008-2#2)
for finite##4##2##(2008-2#4)
for fire blight##3##3##(2008-10#3)
for first and##2##3##(2008-10#2)
for first##7##2##(1996-8#1)(2008-10#3)(2008-12#1)(2009-3#1)(2011-2#1)
for fiscal year##4##3##(1992-1#1)(1993-12#1)(1995-6#1)(1997-2#1)
for fiscal##8##2##(1992-1#1)(1993-12#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#1)
for fish sperm DNA (fsDNA)##2##5##(2008-10#2)
for fish sperm DNA##8##4##(2008-10#8)
for fish##18##2##(2007-5#1)(2008-10#11)(2008-12#1)(2010-8#2)(2011-2#1)(2013-7#2)
for fission##2##2##(1992-8#1)(2008-7#1)
for fistula creation##2##3##(2007-7#2)
for fistula##3##2##(1993-2#1)(2007-7#2)
for fitness##3##2##(1997-7#1)(2008-8#2)
for fitting##6##2##(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)
for five 1##2##3##(2008-10#2)
for five days##2##3##(1992-8#1)(2008-11#1)
for five determinations of##2##4##(2008-10#2)
for five different##4##3##(1995-5#1)(2008-10#3)
for five measurements##3##3##(2008-10#3)
for five of the##2##4##(1991-6#1)(2008-10#1)
for five replicate##3##3##(2008-10#3)
for five weeks##2##3##(1990-3#1)(1992-4#1)
for five years##5##3##(1990-5#1)(1994-12#1)(2007-7#1)(2008-12#1)(2008-9#1)
for five##41##2##(1990-3#1)(1990-5#2)(1991-6#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-12#2)(1995-5#1)(1996-3#1)(2007-7#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#2)(2012-9#1)
for fixation of##2##3##(2008-10#1)(2008-7#1)
for fixation##5##2##(2008-10#2)(2008-7#1)(2009-3#1)(2012-12#1)
for fixed and##2##3##(2008-6#1)(2012-2#1)
for fixed##5##2##(1994-3#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
for fixing##2##2##(2007-11#1)(2008-9#1)
for flame atomic absorption##3##4##(2008-10#3)
for flap##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
for flat##2##2##(2008-3#2)
for flavonoids##2##2##(2008-10#1)(2012-12#1)
for flexible##3##2##(1993-1#1)(2008-7#1)(2009-4#1)
for flexion##2##2##(2008-8#1)(2012-2#1)
for flow analysis##4##3##(2008-10#4)
for flow cytometric analysis of##2##5##(2008-10#1)(2008-4#1)
for flow cytometric analysis##5##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)
for flow cytometric##11##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#8)
for flow cytometry##9##3##(2008-4#2)(2008-9#7)
for flow injection analysis of##5##5##(2008-10#5)
for flow injection analysis##10##4##(2008-10#10)
for flow injection##16##3##(2007-12#1)(2008-10#15)
for flow rates##2##3##(2008-10#1)(2008-11#1)
for flow##47##2##(2007-12#1)(2008-10#22)(2008-11#1)(2008-4#3)(2008-5#2)(2008-9#17)(2012-2#1)
for flow-injection##3##2##(1992-11#1)(2008-10#2)
for flower##2##2##(2007-12#1)(2009-6#1)
for flows in##2##3##(2008-7#2)
for fluconazole##3##2##(2008-5#3)
for fluid##3##2##(1992-11#1)(2008-3#2)
for fluorescein##4##2##(1991-8#1)(2008-10#3)
for fluorescence detection##2##3##(2008-10#2)
for fluorescence microscopy##2##3##(1996-5#1)(2008-4#1)
for fluorescence##16##2##(1995-5#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#3)(2010-5#1)(2011-1#1)(2011-2#1)
for fluorescent##3##2##(2007-12#1)(2008-10#2)
for fluoride and##2##3##(2008-10#2)
for fluoride##5##2##(2008-10#5)
for fluoxetine and##2##3##(2008-10#1)(2012-2#1)
for fluoxetine##4##2##(2008-10#1)(2012-2#3)
for focal##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
for focus-error sensing in optical data storage##2##7##(2008-2#2)
for focused##2##2##(2008-2#1)(2009-3#1)
for focusing##2##2##(2007-11#1)(2008-3#1)
for foetal##2##2##(2008-4#1)(2012-2#1)
for folate##2##2##(1997-5#1)(2013-8#1)
for folding##2##2##(2008-3#1)(2008-7#1)
for foliar##2##2##(2008-10#2)
for follow-up##9##2##(1991-12#1)(1994-11#1)(1995-2#2)(1996-2#1)(1996-9#1)(2008-11#1)(2009-10#1)(2013-1#1)
for following the##2##3##(1991-5#1)(2013-1#1)
for following##6##2##(1991-5#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
for food analysis##2##3##(2008-10#1)(2011-1#1)
for food and##2##3##(1993-5#1)(2010-9#1)
for food safety##3##3##(1990-3#1)(2008-11#1)(2012-2#1)
for food with##2##3##(1992-11#1)(2007-10#1)
for food##27##2##(1990-2#1)(1990-3#1)(1992-10#1)(1992-11#1)(1993-5#1)(1993-6#2)(1994-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-6#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
for foraging##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
for force##2##2##(2009-5#1)(2013-1#1)
for forensic identification##2##3##(2008-12#2)
for forensic investigations##2##3##(1995-11#1)(2012-3#1)
for forensic##6##2##(1995-11#1)(2008-10#1)(2008-12#3)(2012-3#1)
for forest##2##2##(2008-10#2)
for form##2##2##(1994-8#1)(2008-3#1)
for formal##6##2##(1991-1#1)(1992-1#1)(1994-12#1)(1995-3#1)(2008-7#1)(2010-12#1)
for formaldehyde determination##2##3##(2008-10#2)
for formaldehyde##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
for formation of the##5##4##(1990-5#1)(1992-6#1)(1994-8#1)(2008-10#1)(2008-2#1)
for formation of##7##3##(1990-5#1)(1992-6#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
for formation##8##2##(1990-5#1)(1992-6#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)
for formic##3##2##(2008-10#3)
for forming##7##2##(1991-3#1)(1992-11#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)
for formulating##2##2##(2007-2#1)(2008-12#1)
for fossil##2##2##(2008-10#1)(2008-6#1)
for four days##4##3##(1991-2#1)(1993-2#1)(2008-10#1)(2013-1#1)
for four dimensions##2##3##(2008-6#1)(2011-2#1)
for four hours##3##3##(2008-12#1)(2008-4#1)(2012-12#1)
for four months##5##3##(1994-6#2)(1997-6#1)(2010-11#1)(2013-1#1)
for four weeks##6##3##(1991-6#1)(2007-7#1)(2008-5#3)(2010-3#1)
for four years##4##3##(1992-5#1)(1997-8#1)(2007-7#1)(2011-1#1)
for four##61##2##(1990-11#2)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-9#2)(1994-6#2)(1995-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#3)(2008-10#10)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#5)
for fractionation of##2##3##(2008-10#2)
for fracture neck##2##3##(2012-2#2)
for fracture##3##2##(2008-5#1)(2012-2#2)
for fractures of the##2##4##(2007-11#2)
for fractures##5##2##(1993-11#1)(2007-11#2)(2007-8#2)
for fragments##4##2##(1997-6#1)(2008-10#1)(2008-2#2)
for free and##2##3##(1996-3#1)(1997-7#1)
for free radical scavenging##2##4##(2008-5#1)(2012-2#1)
for free##20##2##(1990-8#1)(1991-2#1)(1993-12#1)(1996-3#1)(1997-7#3)(2007-12#1)(2007-4#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#2)(2012-2#1)
for free-space optical interconnects##2##4##(2008-2#2)
for free-space optical##3##3##(2008-2#3)
for free-space optoelectronic##2##3##(2008-2#1)(2008-3#1)
for free-space##6##2##(2008-2#5)(2008-3#1)
for frequencies##2##2##(2007-12#1)(2009-11#1)
for frequency##7##2##(2007-11#2)(2007-12#3)(2008-3#1)(2008-9#1)
for fresh water##2##3##(2008-10#2)
for fresh##4##2##(1996-12#1)(2008-10#2)(2010-2#1)
for freshly prepared##2##3##(2008-10#2)
for fringe##4##2##(2008-2#2)(2008-3#2)
for from##3##2##(1990-9#1)(1991-8#1)(2007-8#1)
for frozen DS##2##3##(2011-2#2)
for frozen storage##2##3##(1990-12#1)(2011-2#1)
for frozen##5##2##(1990-12#1)(1991-2#1)(2011-2#3)
for fructose##3##2##(1993-12#1)(1994-8#1)(2008-6#1)
for fruit infection##2##3##(2008-10#2)
for fruit juices and##2##4##(2008-10#2)
for fruit##8##2##(2008-10#8)
for fuel##2##2##(2010-4#2)
for fuels##2##2##(2008-10#2)
for full activity##2##3##(1993-8#1)(2007-11#1)
for full face##2##3##(2013-1#2)
for full##16##2##(1990-8#1)(1991-5#1)(1992-3#1)(1993-8#1)(1995-12#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#1)(2013-1#2)
for fully##7##2##(1990-7#1)(2007-12#1)(2008-2#3)(2008-3#2)
for fumaric acid##3##3##(2008-10#3)
for function##4##2##(1994-5#1)(1995-5#1)(1995-8#1)(2008-8#1)
for functional genomics##3##3##(2008-7#2)(2009-10#1)
for functional##20##2##(1991-6#1)(1992-11#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2009-10#3)(2009-5#2)(2012-2#1)(2012-3#1)(2013-8#1)
for fundamental##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
for funding purposes##2##3##(1991-12#1)(1995-6#1)
for funding##6##2##(1991-12#2)(1993-12#1)(1995-6#1)(1996-1#1)(2012-2#1)
for fungal growth##2##3##(2008-10#2)
for fungal##13##2##(1997-4#1)(2008-10#11)(2010-4#1)
for fungi was##2##3##(2008-5#1)(2013-8#1)
for fungi##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
for further advances##2##3##(1990-11#1)(2009-5#1)
for further analyses##4##3##(2008-10#1)(2008-7#1)(2008-9#2)
for further analysis##10##3##(1991-12#1)(1993-11#1)(1994-12#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-9#1)
for further detailed##2##3##(1992-5#1)(1992-9#1)
for further development as a##2##5##(2009-11#1)(2010-5#1)
for further development of##3##4##(1996-4#1)(2010-7#1)(2012-2#1)
for further development##12##3##(1992-8#1)(1996-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)
for further developments##2##3##(2008-10#2)
for further evaluation##4##3##(1990-6#1)(1991-5#1)(2008-10#2)
for further exploration##2##3##(2008-10#1)(2010-10#1)
for further improvement of##2##4##(2008-7#2)
for further improvement##6##3##(1995-3#1)(1996-3#1)(2007-11#2)(2008-7#2)
for further investigation of the##2##5##(2008-4#1)(2012-12#1)
for further investigation of##5##4##(2008-12#1)(2008-4#2)(2011-2#1)(2012-12#1)
for further investigation##6##3##(1997-8#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-12#1)
for further investigations##4##3##(1990-11#1)(1994-12#1)(2010-10#1)(2013-1#1)
for further optimization##2##3##(2013-1#2)
for further processing##2##3##(1995-2#1)(2008-6#1)
for further research and development##2##5##(2012-1#1)(2013-1#1)
for further research are##2##4##(2008-11#1)(2011-2#1)
for further research on##4##4##(1994-6#1)(2009-6#1)(2013-1#2)
for further research that##2##4##(2008-11#1)(2008-12#1)
for further research##24##3##(1990-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#2)(2009-6#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-8#1)(2013-1#4)
for further studies##9##3##(1993-1#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)
for further study in this##2##5##(2008-3#1)(2013-8#1)
for further study in##5##4##(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
for further study on##2##4##(1994-5#1)(1995-8#1)
for further study##15##3##(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
for further treatment##3##3##(1992-11#1)(1995-5#1)(2008-10#1)
for further understanding of##2##4##(1996-12#1)(2008-7#1)
for further understanding##3##3##(1996-12#1)(2008-7#1)(2013-1#1)
for further use##2##3##(2008-11#1)(2010-1#1)
for further##170##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#5)(2012-8#1)(2013-1#9)(2013-8#2)
for future applications of##2##4##(1994-8#1)(2012-2#1)
for future applications##4##3##(1994-8#1)(2008-11#1)(2012-2#2)
for future clinical practice and##2##5##(2010-12#1)(2011-2#1)
for future clinical use##2##4##(2010-11#1)(2011-1#1)
for future clinical##5##3##(2007-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
for future comparison##2##3##(1997-4#1)(2011-2#1)
for future development##5##3##(1991-1#1)(2008-12#1)(2008-2#2)(2012-2#1)
for future developments##2##3##(2008-7#1)(2012-12#1)
for future directions##2##3##(1996-12#1)(2010-9#1)
for future experimental##2##3##(2008-12#1)(2010-5#1)
for future experiments##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
for future functional##2##3##(2010-4#1)(2012-2#1)
for future generations##2##3##(2008-11#1)(2008-9#1)
for future investigation##2##3##(1992-3#1)(2008-10#1)
for future investigations##2##3##(2010-12#1)(2012-12#1)
for future practice##3##3##(2008-11#2)(2012-12#1)
for future research and clinical practice are##2##7##(1994-12#1)(2010-9#1)
for future research and clinical##3##5##(1994-12#1)(2008-11#1)(2010-9#1)
for future research and##8##4##(1992-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)
for future research are discussed##3##5##(2007-12#1)(2008-12#1)(2012-12#1)
for future research are##10##4##(1995-2#1)(1996-2#1)(2007-12#1)(2008-12#2)(2008-4#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-12#1)
for future research in##2##4##(2008-5#1)(2013-1#1)
for future research on##2##4##(1996-3#1)(2012-2#1)
for future research##49##3##(1991-9#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
for future studies are##2##4##(1993-12#1)(2011-2#1)
for future studies of##2##4##(1995-5#1)(2010-5#1)
for future studies##14##3##(1992-2#1)(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
for future study##4##3##(2008-10#1)(2008-3#1)(2010-9#1)(2012-3#1)
for future therapeutic##2##3##(2008-10#1)(2008-11#1)
for future use##4##3##(1994-2#1)(2006-10#1)(2008-11#1)(2013-7#1)
for future work##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2012-1#1)
for future##184##2##(1991-1#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#12)(2008-11#13)(2008-12#14)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#4)(2011-2#9)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#8)(2012-4#1)(2012-9#1)(2013-1#8)(2013-7#1)
for g##2##2##(2008-10#1)(2008-3#1)
for gain##3##2##(2008-3#1)(2008-9#2)
for gaining##3##2##(2008-7#1)(2008-8#2)
for gallbladder cancer##2##3##(2010-12#2)
for gallium and##2##3##(2008-10#2)
for gallium-APDC complex was##2##4##(2008-10#2)
for gallium-PCV complex was##2##4##(2008-10#2)
for gamma##2##2##(1993-8#1)(2009-11#1)
for gamma-cyhalothrin##2##2##(2011-2#2)
for gas##12##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2011-2#1)
for gas-phase##2##2##(2008-10#1)(2008-3#1)
for gaseous##3##2##(2008-10#3)
for gastric cancer##5##3##(1990-9#1)(1992-8#2)(1997-1#1)(2011-2#1)
for gastric##9##2##(1990-9#1)(1992-8#2)(1997-1#1)(2006-10#1)(2011-2#1)(2013-1#3)
for gastroduodenal##2##2##(1997-1#1)(2012-2#1)
for gastroesophageal##2##2##(2008-11#1)(2011-2#1)
for gastrointestinal##7##2##(1992-8#1)(1996-8#1)(2006-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)
for gastroschisis##2##2##(1997-3#1)(2008-11#1)
for gelatin and##2##3##(1995-5#1)(2010-5#1)
for gelatin##3##2##(1995-5#2)(2010-5#1)
for gender and##3##3##(1990-3#1)(2008-7#1)(2013-8#1)
for gender##8##2##(1990-3#1)(1993-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2013-8#1)
for gene delivery to##2##4##(2008-2#1)(2008-4#1)
for gene delivery##4##3##(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
for gene expression in mammalian cells##2##6##(1993-6#2)
for gene expression##8##3##(1993-6#2)(1996-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
for gene regulation##2##3##(1991-5#1)(2009-5#1)
for gene therapy and##3##4##(2008-11#2)(2011-2#1)
for gene therapy of##2##4##(1997-1#1)(2008-8#1)
for gene therapy##19##3##(1994-5#2)(1997-1#2)(1997-3#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
for gene##51##2##(1991-5#1)(1993-6#2)(1994-5#2)(1995-2#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-11#9)(2008-2#2)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
for gene-expression##2##2##(2008-1#1)(2008-4#1)
for general practice##3##3##(1994-12#1)(1996-8#1)(2011-2#1)
for general practitioners to##2##4##(1992-4#1)(1997-4#1)
for general public##2##3##(2012-2#1)(2013-1#1)
for general##40##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-4#3)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-5#1)(2008-6#2)(2008-8#2)(2009-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
for generating a##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
for generating and##4##3##(2008-2#1)(2008-4#3)
for generating optical##2##3##(2007-11#1)(2007-12#1)
for generating the##4##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
for generating##49##2##(1990-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(2007-11#6)(2007-12#2)(2008-10#4)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-5#1)(2012-12#1)
for generation of##16##3##(1992-3#1)(2007-11#8)(2007-12#3)(2008-1#1)(2008-11#1)(2008-4#2)
for generation##18##2##(1992-3#1)(2007-11#8)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)
for genes that##2##3##(1991-5#1)(2008-10#1)
for genes with##2##3##(2008-7#1)(2012-3#1)
for genes##14##2##(1991-5#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-8#1)(2008-10#4)(2008-4#1)(2008-7#3)(2012-3#1)
for genetic analyses##2##3##(2008-11#1)(2008-4#1)
for genetic analysis of##2##4##(2008-9#1)(2012-3#1)
for genetic analysis##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
for genetic counseling##3##3##(1997-3#1)(2008-7#1)(2013-1#1)
for genetic differentiation##2##3##(2008-10#2)
for genetic manipulation##2##3##(1993-12#1)(1997-4#1)
for genetic research##2##3##(2007-10#1)(2008-4#1)
for genetic studies##5##3##(1997-7#1)(2008-10#2)(2008-12#1)(2013-8#1)
for genetic variation##2##3##(2008-10#2)
for genetic##49##2##(1993-12#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-12#1)(2007-10#4)(2007-6#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
for genetically##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
for genetics##2##2##(1995-9#1)(1997-3#1)
for geniposidic##2##2##(2008-10#2)
for genital##2##2##(2007-12#1)(2008-10#1)
for genome analysis##4##3##(1996-12#1)(2008-10#2)(2008-7#1)
for genome##11##2##(1990-11#1)(1991-11#1)(1996-12#1)(2008-10#2)(2008-4#2)(2008-7#2)(2010-3#1)(2012-2#1)
for genome-wide analysis of##2##4##(2007-12#2)
for genome-wide association studies##2##4##(2012-3#2)
for genome-wide association##3##3##(2012-3#3)
for genome-wide##6##2##(2007-12#2)(2008-9#1)(2012-3#3)
for genomic data##2##3##(2010-3#1)(2011-3#1)
for genomic sequencing that##2##4##(2008-10#2)
for genomic sequencing##7##3##(2008-10#6)(2008-2#1)
for genomic##16##2##(1995-12#1)(2008-10#8)(2008-2#2)(2008-4#3)(2010-3#1)(2011-3#1)
for genomics##4##2##(2008-11#1)(2008-7#2)(2009-5#1)
for genotoxic##3##2##(1990-8#1)(1997-4#1)(2008-9#1)
for genotype##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
for genotypic##2##2##(2008-9#1)(2012-3#1)
for genotyping##6##2##(1997-5#1)(2008-10#2)(2008-11#1)(2008-4#2)
for gentamicin##2##2##(2007-7#1)(2010-3#1)
for geographic##2##2##(1991-2#1)(1992-2#1)
for geometric##2##2##(2008-3#1)(2009-2#1)
for geriatric patients##2##3##(2008-4#1)(2013-1#1)
for geriatric##3##2##(2008-4#1)(2008-7#1)(2013-1#1)
for germ##2##2##(1992-12#1)(2009-7#1)
for germanium##2##2##(2008-10#2)
for germination and apothecium##2##4##(2008-10#2)
for germination##7##2##(2008-10#4)(2008-12#2)(2011-2#1)
for gestational age##9##3##(1990-12#2)(1991-6#1)(1994-3#1)(2011-1#4)(2013-1#1)
for gestational diabetes mellitus##2##4##(2008-10#1)(2011-2#1)
for gestational##11##2##(1990-12#2)(1991-6#1)(1994-3#1)(2008-10#1)(2011-1#4)(2011-2#1)(2013-1#1)
for getting##2##2##(2008-10#1)(2010-8#1)
for giant keratoacanthomas##3##3##(2010-8#3)
for giant##7##2##(1993-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-8#3)
for girls and boys##2##4##(2007-12#1)(2010-4#1)
for girls and##5##3##(1990-9#1)(2007-12#1)(2009-7#2)(2010-4#1)
for girls##19##2##(1990-9#1)(1993-8#1)(2007-12#4)(2008-7#1)(2008-9#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-4#1)(2013-1#4)
for given##2##2##(2008-10#1)(2008-3#1)
for giving##3##2##(1996-9#1)(1997-5#1)(2007-2#1)
for glass electrode##2##3##(2008-10#2)
for glass##6##2##(1995-3#1)(2008-10#3)(2008-2#1)(2008-3#1)
for glaucoma and##2##3##(2011-1#2)
for glaucoma##9##2##(1996-10#1)(2008-1#1)(2009-3#1)(2011-1#5)(2011-7#1)
for glial##4##2##(1994-2#1)(1996-5#1)(2007-10#1)(2008-2#1)
for glioblastoma multiforme##2##3##(1994-2#1)(2008-11#1)
for glioblastoma##3##2##(1994-2#1)(1995-9#1)(2008-11#1)
for global##10##2##(1994-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2009-8#1)(2012-2#1)
for glucagon##2##2##(1991-12#2)
for glucose and urea##2##4##(2008-3#2)
for glucose and##8##3##(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#1)
for glucose determination in##3##4##(2008-10#3)
for glucose determination##7##3##(2008-10#7)
for glucose in##2##3##(2008-10#2)
for glucose uptake##2##3##(2008-5#1)(2008-7#1)
for glucose##42##2##(1990-11#2)(1990-7#1)(1991-5#1)(1993-6#2)(1995-8#1)(1996-5#1)(2008-10#18)(2008-11#2)(2008-3#4)(2008-5#2)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#1)(2012-3#1)(2012-7#1)(2013-1#1)
for glutamate##3##2##(1995-5#1)(1997-3#1)(2008-7#1)
for glutamine##3##2##(1995-12#1)(2008-11#1)(2008-7#1)
for glutathione##5##2##(1995-12#1)(1996-12#1)(2008-10#3)
for glycerol##3##2##(2008-10#2)(2008-5#1)
for glycine and##2##3##(2008-10#1)(2008-7#1)
for glycine##6##2##(1996-5#2)(1997-2#2)(2008-10#1)(2008-7#1)
for glycitein##2##2##(2008-10#2)
for glycogen##4##2##(1990-2#1)(1994-8#1)(2008-10#1)(2009-7#1)
for glycoprotein analysis##2##3##(1992-6#2)
for glycoprotein##4##2##(1990-5#2)(1992-6#2)
for glycosaminoglycans##2##2##(1990-5#1)(1991-1#1)
for gold##5##2##(1993-3#1)(1995-3#1)(2008-2#1)(2008-3#1)(2009-4#1)
for good performance of the vertebrae and pedicle screw unit##2##10##(2007-11#2)
for good performance##3##3##(1996-12#1)(2007-11#2)
for good##16##2##(1990-11#1)(1992-9#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-3#1)
for government##4##2##(1990-4#1)(1992-2#1)(1994-2#1)(2008-6#1)
for grading##2##2##(2008-7#1)(2012-2#1)
for graduate##3##2##(1991-2#1)(1996-1#1)(2013-1#1)
for graduates##2##2##(1994-12#1)(1996-3#1)
for grafting the##2##3##(2007-8#1)(2008-11#1)
for grafting##5##2##(1993-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)
for granting##2##2##(1991-9#1)(1995-5#1)
for grapevine##2##2##(2008-10#2)
for graphite##2##2##(1991-5#1)(2008-10#1)
for grass##2##2##(1991-2#1)(2011-2#1)
for grating##2##2##(2007-11#1)(2008-2#1)
for gratings recorded##2##3##(2007-11#1)(2007-12#1)
for gratings##5##2##(2007-11#2)(2007-12#3)
for gravitational-wave##3##2##(2007-12#1)(2008-3#2)
for gray leaf spot of maize##2##6##(2008-10#2)
for gray leaf spot##6##4##(2008-10#6)
for gray##7##2##(1996-3#1)(2008-10#6)
for grazing-incidence##2##2##(2008-3#2)
for greater than##5##3##(1990-5#1)(1994-8#1)(2008-7#1)(2009-4#1)(2012-2#1)
for greater##21##2##(1990-5#1)(1994-1#2)(1994-12#1)(1994-8#1)(1996-1#2)(1997-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-4#1)(2011-1#2)(2012-2#3)
for greenhouse##4##2##(2008-3#3)(2011-2#1)
for grey matter##2##3##(2012-1#1)(2012-12#1)
for grey##3##2##(2011-1#1)(2012-1#1)(2012-12#1)
for ground##2##2##(2008-2#1)(2011-2#1)
for ground-based##4##2##(2008-2#1)(2008-3#3)
for group I##2##3##(1995-12#1)(2008-10#1)
for group practices##2##3##(1993-1#1)(1997-3#1)
for group##14##2##(1990-8#1)(1992-1#1)(1993-1#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-8#1)
for grouping##3##2##(2008-10#3)
for groups with##2##3##(1994-9#1)(2008-9#1)
for groups##7##2##(1993-12#1)(1994-9#1)(2008-10#2)(2008-12#2)(2008-9#1)
for growing##12##2##(1996-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-9#1)(2010-2#1)
for growth and methane utilization##2##5##(2008-6#2)
for growth and##10##3##(1994-2#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#1)
for growth hormone##3##3##(1990-3#1)(1992-9#1)(2012-3#1)
for growth hormone-releasing hormone 1-44 NH2##2##6##(1992-9#2)
for growth in##6##3##(1992-3#1)(1996-8#1)(2008-10#2)(2012-3#1)(2013-7#1)
for growth inhibition##2##3##(1997-4#1)(2011-2#1)
for growth of##7##3##(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-3#1)
for growth on##2##3##(1995-8#1)(2008-7#1)
for growth under##3##3##(2008-7#1)(2011-2#2)
for growth##59##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#3)(1994-12#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-4#4)(2007-12#1)(2008-10#8)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-3#2)(2013-7#1)
for guanine##2##2##(2008-10#1)(2010-11#1)
for guaranteeing##2##2##(2008-10#1)(2008-11#1)
for guidance on##3##3##(1993-1#1)(1994-12#1)(2012-12#1)
for guidance##6##2##(1993-1#1)(1994-12#1)(2007-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
for guided-wave optical interconnections##2##4##(2008-2#2)
for guided-wave##3##2##(2007-12#1)(2008-2#2)
for guiding the##2##3##(1993-1#1)(2011-2#1)
for guiding##5##2##(1993-1#1)(2008-6#1)(2009-10#1)(2010-6#1)(2011-2#1)
for haematological##2##2##(2008-6#1)(2008-7#1)
for haemorrhage##2##2##(2008-10#2)
for hair 'handle'##2##3##(2008-5#2)
for hair##9##2##(2008-10#1)(2008-5#5)(2012-2#1)(2013-1#1)(2013-7#1)
for half-maximal##4##2##(1990-5#1)(1995-2#2)(1995-6#1)
for halo##3##2##(2008-2#2)(2011-2#1)
for halting##2##2##(2008-7#1)(2008-8#1)
for hand##5##2##(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
for hand-infesting cornstalks with European corn borer##2##7##(2011-2#2)
for handling the##2##3##(2008-3#1)(2008-4#1)
for handling##12##2##(1991-1#1)(1991-12#1)(1993-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-9#1)
for hardness##4##2##(2010-3#2)(2010-4#1)(2012-2#1)
for harmonic generation##2##3##(2007-12#1)(2008-2#1)
for harnessing##2##2##(2008-10#1)(2012-12#1)
for harsh##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
for harvesting##4##2##(2007-8#1)(2008-4#1)(2008-9#1)(2010-8#1)
for having##6##2##(1994-12#1)(1997-5#1)(2007-10#1)(2012-12#1)(2012-2#2)
for hazard identification##3##3##(2008-10#3)
for hazardous drinking##2##3##(2008-12#2)
for hazardous##4##2##(1993-3#1)(2008-12#2)(2009-10#1)
for he##2##2##(2008-10#1)(2008-7#1)
for head and neck cancer##4##5##(1991-4#1)(1995-9#1)(2008-4#1)(2013-1#1)
for head and neck##6##4##(1991-4#1)(1995-9#1)(2007-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
for head movement##2##3##(1990-5#1)(1995-5#1)
for head##9##2##(1990-5#1)(1991-4#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
for headache##2##2##(2008-12#1)(2008-7#1)
for headspace solid-phase microextraction (HS-SPME)##2##5##(2008-10#1)(2012-1#1)
for headspace solid-phase microextraction##3##4##(2008-10#1)(2012-1#2)
for headspace##4##2##(2008-10#2)(2012-1#2)
for healing##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
for health administration education##2##4##(1992-2#1)(1995-12#1)
for health administration##5##3##(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-12#1)
for health administrators##2##3##(1994-2#1)(2008-12#1)
for health and social care##3##5##(1992-11#1)(2008-11#2)
for health and##7##3##(1991-12#1)(1991-3#1)(1992-11#1)(1994-7#1)(2008-10#1)(2008-11#2)
for health care CQI##2##4##(1994-2#1)(1994-3#1)
for health care administrators##3##4##(1995-12#1)(1997-3#1)(2009-8#1)
for health care and##3##4##(1993-3#1)(1995-9#1)(2008-7#1)
for health care expenditures##2##4##(1993-2#1)(1993-3#1)
for health care financing##2##4##(1993-3#1)(1994-2#1)
for health care in the year##2##6##(1992-3#1)(1996-2#1)
for health care in the##3##5##(1992-3#1)(1996-2#1)(2008-7#1)
for health care in##4##4##(1992-3#1)(1995-3#1)(1996-2#1)(2008-7#1)
for health care information##2##4##(1993-1#1)(1993-3#1)
for health care institutions##3##4##(1992-1#1)(1994-12#1)(1995-1#1)
for health care is##3##4##(1991-3#1)(1993-3#1)(1997-8#1)
for health care leaders##2##4##(1994-2#1)(2008-1#1)
for health care management##2##4##(1991-12#1)(2008-7#1)
for health care organizations##6##4##(1992-3#1)(1994-12#2)(1997-3#1)(2008-12#1)(2011-2#1)
for health care planners##2##4##(1992-3#1)(1996-3#1)
for health care professionals to##2##5##(1993-2#1)(2007-4#1)
for health care professionals##5##4##(1993-2#1)(1995-1#1)(2007-4#1)(2008-10#1)(2008-4#1)
for health care providers and##2##5##(1994-2#1)(2008-11#1)
for health care providers to##3##5##(1991-2#1)(1996-3#1)(2009-5#1)
for health care providers##9##4##(1991-2#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-2#1)
for health care reform##12##4##(1993-3#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-7#1)
for health care systems##2##4##(1994-1#1)(2008-7#1)
for health care workers##2##4##(1997-3#1)(2007-12#1)
for health care##106##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#8)(1994-1#2)(1994-12#9)(1994-2#6)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#5)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#1)(1997-2#1)(1997-3#4)(1997-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#5)(2009-1#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
for health education##3##3##(1994-6#1)(1995-12#1)(2008-9#1)
for health information##6##3##(1996-6#1)(2010-8#1)(2012-12#3)(2012-3#1)
for health management##2##3##(1992-12#1)(1996-3#1)
for health plan##2##3##(1997-1#1)(1997-3#1)
for health plans##3##3##(1996-2#1)(2008-6#2)
for health policy##4##3##(1992-12#1)(2012-12#3)
for health professionals##5##3##(1993-12#1)(2008-11#1)(2008-12#2)(2013-8#1)
for health promotion##5##3##(1994-3#1)(2007-2#1)(2008-12#2)(2008-7#1)
for health reform##3##3##(1994-3#1)(1996-1#1)(2010-9#1)
for health sciences librarians##3##4##(1991-3#1)(1992-2#1)(1996-12#1)
for health sciences##5##3##(1991-3#1)(1992-2#1)(1996-12#1)(2008-1#1)(2008-11#1)
for health sector##2##3##(1997-1#1)(2012-3#1)
for health service managers##3##4##(1992-1#2)(1994-12#1)
for health service##7##3##(1992-1#2)(1993-12#1)(1994-12#1)(1995-1#1)(1997-1#1)(2012-12#1)
for health services administration##2##4##(1994-3#1)(1996-3#1)
for health services##13##3##(1991-2#1)(1991-3#1)(1992-3#1)(1994-1#2)(1994-2#1)(1994-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2012-3#1)
for health system reform##3##4##(1993-3#1)(1996-1#1)(1996-12#1)
for health system##4##3##(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#1)
for health technology##2##3##(2008-2#1)(2011-2#1)
for health##226##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#4)(1991-6#1)(1992-1#4)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#7)(1992-5#1)(1993-1#3)(1993-12#4)(1993-2#4)(1993-3#10)(1994-1#4)(1994-12#11)(1994-2#9)(1994-3#5)(1994-6#1)(1994-7#1)(1995-1#4)(1995-12#4)(1995-2#4)(1995-3#5)(1995-9#1)(1996-1#6)(1996-12#4)(1996-2#7)(1996-3#6)(1996-6#1)(1997-1#7)(1997-2#2)(1997-3#5)(1997-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#7)(2008-9#1)(2009-1#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#10)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#1)
for health-related##3##2##(1994-3#1)(2011-1#1)(2012-3#1)
for healthcare##17##2##(1992-1#1)(1992-2#2)(1993-1#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-9#1)(2008-12#1)(2008-9#1)(2012-12#2)(2013-8#2)
for healthy##7##2##(1994-12#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
for hearing impairment##2##3##(1991-2#1)(2013-1#1)
for hearing##3##2##(1991-2#1)(2013-1#2)
for heart attack##2##3##(2008-2#1)(2011-2#1)
for heart failure##9##3##(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#3)(2012-2#1)
for heart##19##2##(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#7)(2011-2#4)(2012-2#1)
for heat##5##2##(1990-11#1)(2007-12#1)(2008-2#1)(2009-8#1)(2012-2#1)
for heating and##3##3##(2008-10#2)(2010-5#1)
for heating##4##2##(1997-4#1)(2008-10#2)(2010-5#1)
for heavy metal removal##2##4##(2008-10#2)
for heavy metal##4##3##(2008-10#3)(2013-1#1)
for heavy metals##4##3##(2008-10#3)(2011-2#1)
for heavy##10##2##(1997-9#1)(2008-10#6)(2008-9#1)(2011-2#1)(2013-1#1)
for height##5##2##(1991-12#1)(1993-2#1)(2008-12#1)(2008-8#1)(2013-7#1)
for help##5##2##(1992-1#1)(1992-12#1)(1993-12#1)(1996-1#1)(2010-11#1)
for helping##5##2##(1992-12#1)(1992-4#1)(1997-1#1)(2008-6#1)(2009-11#1)
for hematologic##2##2##(2008-10#1)(2008-7#1)
for hematology##2##2##(2007-7#2)
for hematopoietic progenitor##2##3##(2008-11#1)(2008-7#1)
for hematopoietic stem##2##3##(2008-7#1)(2008-9#1)
for hematopoietic##5##2##(1993-8#1)(2008-11#1)(2008-7#2)(2008-9#1)
for hematuria##3##2##(1996-12#2)(2008-10#1)
for heme O##2##3##(1992-12#2)
for heme##7##2##(1990-8#1)(1992-12#2)(1994-8#4)
for hemodialysis (HD)##2##3##(2007-7#2)
for hemodialysis patients in##2##4##(2007-7#2)
for hemodialysis vascular access##2##4##(2007-7#2)
for hemodialysis##27##2##(1991-6#1)(2007-10#1)(2007-7#15)(2008-1#3)(2008-10#5)(2008-4#1)(2011-3#1)
for hemoglobin (Hb)##2##3##(1990-8#1)(2008-10#1)
for hemoglobin##5##2##(1990-8#1)(2008-10#3)(2012-12#1)
for hemophilia B##3##3##(2008-8#1)(2008-9#2)
for heparin##3##2##(1995-2#3)
for hepatic##10##2##(1990-11#1)(1991-12#1)(1991-8#1)(1993-9#1)(1995-11#1)(1997-8#1)(2008-10#1)(2011-2#2)(2013-8#1)
for hepatitis A##2##3##(1997-3#1)(2007-7#1)
for hepatitis B surface antigen##2##5##(2007-12#1)(2008-12#1)
for hepatitis B virus (HBV)##2##5##(2006-10#1)(2008-1#1)
for hepatitis B virus##4##4##(2006-10#2)(2008-1#1)(2008-12#1)
for hepatitis B##8##3##(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-9#1)
for hepatitis C virus##4##4##(2006-10#2)(2008-1#1)(2013-8#1)
for hepatitis C##7##3##(2006-10#2)(2008-1#2)(2009-8#1)(2013-8#2)
for hepatitis##18##2##(1997-3#1)(2006-10#4)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#2)
for hepatocellular carcinoma (HCC)##2##4##(1992-3#1)(2010-12#1)
for hepatocellular carcinoma in##2##4##(2013-8#2)
for hepatocellular carcinoma##9##3##(1992-3#1)(2008-1#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-7#1)(2013-8#3)
for hepatocyte##3##2##(1992-3#1)(1995-2#1)(2008-6#1)
for her##6##2##(1993-9#1)(1994-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for herbivore##2##2##(2008-8#2)
for hereditary##5##2##(1994-6#1)(1996-11#1)(1997-8#1)(2011-2#2)
for heterogeneity##4##2##(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#1)
for heterologous##4##2##(1995-5#1)(2008-11#1)(2008-7#1)(2008-8#1)
for heterosexual##3##2##(1994-7#1)(1997-6#1)(2013-1#1)
for heterozygotes##2##2##(2008-10#2)
for hexagonal columns##2##3##(2008-3#2)
for hexagonal##4##2##(2008-2#1)(2008-3#3)
for high affinity##2##3##(1991-5#1)(2010-11#1)
for high efficiency##2##3##(1990-11#1)(2008-11#1)
for high energy##2##3##(2007-8#1)(2008-11#1)
for high expression##2##3##(1997-8#1)(2008-11#1)
for high grade##2##3##(2008-6#1)(2011-2#1)
for high performance liquid chromatographic##2##5##(2008-10#2)
for high performance liquid chromatography (HPLC)##2##6##(2008-10#2)
for high performance liquid##4##4##(2008-10#4)
for high performance##5##3##(2008-10#4)(2011-1#1)
for high pump##2##3##(2008-3#2)
for high risk patients##2##4##(2007-7#1)(2010-3#1)
for high speed##2##3##(2008-10#1)(2010-5#1)
for high throughput screening##4##4##(2008-10#3)(2010-12#1)
for high throughput##7##3##(2008-10#4)(2009-9#1)(2010-12#2)
for high##77##2##(1990-11#1)(1991-1#1)(1991-5#1)(1992-6#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#5)(2008-2#6)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#3)
for high-accuracy##2##2##(2008-2#1)(2008-3#1)
for high-affinity##3##2##(1991-6#1)(1992-6#1)(1997-4#1)
for high-bandwidth##2##2##(2008-3#2)
for high-density near-field optical storage##2##5##(2008-3#2)
for high-density near-field##3##3##(2008-3#3)
for high-density##6##2##(1994-5#1)(2008-2#1)(2008-3#4)
for high-dose##2##2##(1997-3#1)(2008-7#1)
for high-efficiency##3##2##(1991-6#1)(2007-11#1)(2008-10#1)
for high-fidelity##2##2##(2007-11#1)(2008-3#1)
for high-frequency##3##2##(2008-3#1)(2009-5#1)(2010-12#1)
for high-grade##2##2##(2008-6#1)(2011-2#1)
for high-level expression of##3##4##(1996-3#1)(1997-4#1)(2008-9#1)
for high-level expression##4##3##(1994-12#1)(1996-3#1)(1997-4#1)(2008-9#1)
for high-level##5##2##(1994-12#1)(1996-3#1)(1997-4#1)(2008-2#1)(2008-9#1)
for high-power laser##2##3##(2007-11#1)(2008-2#1)
for high-power##7##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)
for high-precision##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
for high-quality##5##2##(2008-10#1)(2008-11#2)(2013-1#2)
for high-resolution spectroscopy##3##3##(2007-11#2)(2007-12#1)
for high-resolution##19##2##(2007-11#4)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-8#1)(2012-2#1)
for high-risk patients##6##3##(1995-2#1)(2007-8#2)(2008-11#1)(2012-12#2)
for high-risk##11##2##(1995-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2011-2#3)(2012-12#3)
for high-sensitivity##3##2##(2007-12#1)(2008-3#2)
for high-speed##3##2##(2007-11#1)(2008-3#2)
for high-throughput screening##2##3##(2008-10#2)
for high-throughput##16##2##(1994-3#1)(2008-10#5)(2008-3#2)(2008-4#4)(2008-7#1)(2010-11#1)(2010-7#1)(2011-1#1)
for higher##19##2##(1991-6#1)(1993-12#1)(1995-5#1)(2006-10#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#3)(2011-2#2)(2013-8#2)
for highly accurate##2##3##(2008-3#1)(2011-1#1)
for highly efficient##4##3##(2007-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
for highly rural##3##3##(2012-1#3)
for highly sensitive##4##3##(2007-11#1)(2008-3#3)
for highly##30##2##(1995-11#1)(1995-3#1)(2007-11#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)
for him##2##2##(1992-3#2)
for himself##2##2##(1990-11#1)(1993-11#1)
for hip##6##2##(1996-8#1)(2007-8#1)(2008-10#1)(2008-8#2)(2009-8#1)
for his or her##2##4##(1992-2#1)(1997-8#1)
for his scientific##3##3##(2007-5#1)(2010-1#1)(2012-1#1)
for his##19##2##(1990-2#1)(1991-6#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-5#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-4#1)(2012-1#1)
for histamine##8##2##(1991-9#1)(1992-11#1)(1996-5#2)(2008-10#3)(2008-11#1)
for histidase##2##2##(1994-5#2)
for histidine##2##2##(1995-8#1)(2008-10#1)
for histologic##2##2##(1991-12#1)(1992-12#1)
for histological##4##2##(1996-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
for histology##3##2##(1996-6#1)(2008-1#1)(2008-7#1)
for histone##3##2##(1992-8#2)(2009-12#1)
for holistic##2##2##(2008-1#1)(2011-2#1)
for hologram formation##3##3##(2008-2#2)(2008-3#1)
for hologram##5##2##(2008-2#2)(2008-3#3)
for holographic recording##2##3##(2007-12#1)(2008-2#1)
for holographic##10##2##(2007-12#2)(2008-2#2)(2008-3#6)
for home IV therapy##2##4##(2012-2#2)
for home care##5##3##(1995-3#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
for home health care##2##4##(1991-2#1)(1993-12#1)
for home health##4##3##(1991-2#1)(1993-12#1)(1995-3#1)(1997-2#1)
for home##13##2##(1991-2#1)(1992-2#1)(1993-12#1)(1995-3#2)(1997-2#2)(1997-4#1)(2008-10#1)(2011-2#1)(2012-2#3)
for homeostasis##2##2##(2008-9#1)(2011-1#1)
for homocysteine##4##2##(2007-10#2)(2008-10#2)
for homogeneous##9##2##(1993-11#1)(2008-10#1)(2008-2#3)(2008-3#4)
for homology##2##2##(1991-2#1)(2010-11#1)
for honokiol and##2##3##(2008-10#2)
for horizontal##3##2##(1991-5#1)(2008-3#1)(2008-9#1)
for horizontally##3##2##(2008-2#1)(2008-3#2)
for hormone##3##2##(1993-8#1)(1996-3#1)(2010-10#1)
for hospice##2##2##(1991-2#1)(1996-3#1)
for hospital administrators##2##3##(1993-1#1)(2008-12#1)
for hospital admission##2##3##(2008-1#1)(2013-1#1)
for hospital and##2##3##(2007-10#1)(2012-1#1)
for hospital care##6##3##(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#1)(2010-10#1)
for hospital inpatient services##2##4##(1994-12#1)(2008-11#1)
for hospital security##4##3##(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)
for hospital workers##2##3##(1991-3#1)(1991-6#1)
for hospital##36##2##(1991-12#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#6)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1997-2#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-1#1)(2013-1#1)
for hospitalization and##2##3##(1995-12#1)(2008-6#1)
for hospitalization##5##2##(1993-2#1)(1995-12#1)(2008-6#1)(2013-1#2)
for hospitalized children##2##3##(2008-11#2)
for hospitalized patients##3##3##(2009-7#1)(2012-3#1)(2013-1#1)
for hospitalized##6##2##(1993-1#1)(2008-11#2)(2009-7#1)(2012-3#1)(2013-1#1)
for hospitals and##3##3##(1992-12#1)(1993-12#1)(1993-2#1)
for hospitals that##2##3##(1992-2#1)(2013-1#1)
for hospitals to##4##3##(1992-1#1)(2008-11#1)(2010-9#1)(2012-2#1)
for hospitals##27##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#2)(2007-9#1)(2008-11#1)(2009-11#1)(2010-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
for host##8##2##(1994-11#1)(2008-10#3)(2008-8#2)(2008-9#1)(2013-1#1)
for hosts##2##2##(1997-7#1)(2008-8#1)
for hours##3##2##(1997-1#1)(2008-3#1)(2008-5#1)
for household##3##2##(2007-7#1)(2013-1#1)(2013-8#1)
for how the##2##3##(2008-9#1)(2010-3#1)
for how to##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
for how##18##2##(1991-2#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
for human IgG##2##3##(2008-10#2)
for human T##2##3##(1992-6#1)(2008-4#1)
for human and animal##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
for human and##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
for human brain##2##3##(1991-9#1)(2008-5#1)
for human consumption##6##3##(1997-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-7#2)
for human disease##3##3##(2007-12#1)(2008-4#1)(2012-2#1)
for human diseases##3##3##(1994-5#1)(2008-2#1)(2008-4#1)
for human embryonic stem##2##4##(2008-9#2)
for human exposure##2##3##(1990-8#1)(2008-9#1)
for human gene##2##3##(2008-9#1)(2011-2#1)
for human health##3##3##(2008-11#1)(2012-3#1)(2013-7#1)
for human hemoglobin##5##3##(1990-8#4)(1991-6#1)
for human identification##2##3##(1993-2#1)(2008-12#1)
for human immunodeficiency virus (HIV)##3##5##(1990-6#1)(1997-3#1)(2007-7#1)
for human immunodeficiency virus##4##4##(1990-6#1)(1997-3#1)(2007-7#2)
for human immunodeficiency##5##3##(1990-6#1)(1997-3#1)(2007-7#2)(2012-1#1)
for human islet##2##3##(2010-11#2)
for human placenta DNA##2##4##(2008-10#2)
for human placenta##3##3##(1992-10#1)(2008-10#2)
for human serum albumin (HSA)##2##5##(2008-10#2)
for human serum##5##3##(2008-10#4)(2008-4#1)
for human type I##2##4##(1990-2#1)(1995-3#1)
for human type##3##3##(1990-2#1)(1995-3#2)
for human use##2##3##(2010-6#1)(2011-2#1)
for human##146##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-6#1)(1990-8#7)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#6)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-7#3)(2013-8#2)
for humans and##2##3##(2008-10#1)(2013-8#1)
for humans##17##2##(1990-11#1)(1992-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-12#3)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
for hundreds##2##2##(1996-9#1)(2008-7#1)
for hybrid##2##2##(1995-5#1)(2008-3#1)
for hybridization with##2##3##(2008-10#1)(2012-3#1)
for hybridization##6##2##(2008-10#3)(2008-2#1)(2008-5#1)(2012-3#1)
for hydrazine and phenylhydrazine##2##4##(2008-10#2)
for hydrazine and##3##3##(2008-10#3)
for hydrazine is##2##3##(2008-10#2)
for hydrazine##7##2##(2008-10#7)
for hydrocephalus##4##2##(2008-7#1)(2012-12#2)(2012-2#1)
for hydrodynamic##2##2##(2008-10#1)(2008-12#1)
for hydrogen peroxide##13##3##(1990-5#1)(2008-10#10)(2008-5#1)(2012-2#1)
for hydrogen sulfide determination##2##4##(2008-10#2)
for hydrogen sulfide##3##3##(2008-10#3)
for hydrogen##26##2##(1990-5#1)(1991-3#1)(1996-5#1)(2008-10#18)(2008-2#1)(2008-5#2)(2008-7#1)(2012-2#1)
for hydrolysis of##2##3##(1995-2#1)(2008-11#1)
for hydrophobic##7##2##(1994-9#1)(1995-12#1)(2007-11#1)(2008-10#4)
for hydroquinone##6##2##(2008-10#6)
for hydroxyl##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
for hygroscopic##2##2##(1996-12#2)
for hyperglycemia##2##2##(1991-7#1)(2009-11#1)
for hypertension and##3##3##(1994-6#1)(2007-8#1)(2008-10#1)
for hypertension in##4##3##(1993-9#3)(1994-6#1)
for hypertension##14##2##(1992-8#1)(1993-9#3)(1994-6#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2010-5#1)
for hyphal##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
for hypospadias repair##2##3##(2008-10#1)(2009-5#1)
for hypospadias##3##2##(2008-10#2)(2009-5#1)
for hypothesis testing and##2##4##(2008-10#2)
for hypothetical##2##2##(2008-2#1)(2009-4#1)
for hysterectomy##3##2##(1991-1#1)(1994-2#1)(2010-3#1)
for i##3##2##(1993-8#1)(2008-1#1)(2008-2#1)
for ibuprofen##2##2##(2008-10#2)
for ice crystal##2##3##(2008-2#1)(2008-3#1)
for ice##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
for identical twin boys with childhood apraxia of speech (CAS)##2##10##(2011-1#2)
for identical##3##2##(2008-7#1)(2011-1#2)
for identification and differentiation of##2##5##(2007-7#1)(2008-10#1)
for identification and##11##3##(1995-12#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
for identification of the##3##4##(1995-3#1)(2008-3#1)(2011-2#1)
for identification of##29##3##(1995-12#1)(1995-3#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
for identification##47##2##(1995-12#2)(1995-3#1)(1996-6#1)(1997-1#1)(1997-7#2)(2007-7#2)(2008-1#2)(2008-10#13)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
for identifying a##2##3##(2008-11#1)(2008-4#1)
for identifying and##8##3##(1994-2#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-7#1)(2013-8#1)
for identifying functional##2##3##(2008-4#2)
for identifying novel##2##3##(2008-9#1)(2013-8#1)
for identifying potential##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
for identifying proteins##2##3##(1993-8#1)(2008-4#1)
for identifying the genes##2##4##(1997-4#1)(2009-10#1)
for identifying the##9##3##(1995-12#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
for identifying women##2##3##(1993-11#1)(2009-3#1)
for identifying##86##2##(1991-12#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1997-2#2)(1997-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#7)(2008-4#7)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
for idiopathic scoliosis##2##3##(2007-8#1)(2008-11#1)
for idiopathic##7##2##(1997-3#1)(2007-8#1)(2008-11#1)(2008-7#2)(2012-12#1)(2012-3#1)
for ifosfamide##3##2##(1996-8#1)(2008-6#2)
for illicit##2##2##(2008-10#2)
for illuminating##3##2##(2007-11#1)(2008-2#2)
for illumination and##3##3##(2008-3#2)(2008-9#1)
for illumination##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
for illustration##2##2##(1997-2#1)(2011-1#1)
for illustrative purposes##5##3##(1992-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2010-7#1)
for image capture##2##3##(2008-1#1)(2008-4#1)
for image reconstruction##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
for image##24##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
for image-processing applications##2##3##(2008-2#1)(2008-3#1)
for images##2##2##(2008-2#1)(2012-2#1)
for imaging and##2##3##(1995-1#1)(2008-7#1)
for imaging in turbid media##2##5##(2007-12#2)
for imaging in##4##3##(1990-11#1)(2007-12#2)(2008-9#1)
for imaging objects##2##3##(2007-12#1)(2008-3#1)
for imaging of##5##3##(1990-11#1)(2007-11#1)(2010-12#1)(2010-2#1)(2011-7#1)
for imaging services##3##3##(1993-2#2)(1995-12#1)
for imaging spectrometers##2##3##(2008-2#1)(2008-3#1)
for imaging surface acoustic##2##4##(2007-11#1)(2007-12#1)
for imaging the anterior segment of the eye##2##8##(2011-7#2)
for imaging the##7##3##(2007-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-7#2)
for imaging through scattering media##3##5##(2007-12#2)(2008-2#1)
for imaging through##6##3##(2007-12#4)(2008-2#2)
for imaging with##2##3##(2007-12#1)(2008-3#1)
for imaging##66##2##(1990-11#2)(1993-2#2)(1995-1#1)(1995-12#1)(1996-2#1)(1997-8#1)(2007-11#5)(2007-12#10)(2008-2#9)(2008-3#12)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-7#3)(2012-2#2)
for immediate and delayed##2##4##(1992-9#1)(2008-6#1)
for immediate hemodialysis##2##3##(2007-7#2)
for immediate##19##2##(1992-9#1)(2007-6#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#2)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#1)
for immobilization of##2##3##(2008-10#2)
for immobilization##3##2##(2008-10#3)
for immobilizing##5##2##(1991-5#1)(2008-10#4)
for immortalization and##2##3##(2008-11#1)(2008-6#1)
for immortalization##3##2##(1994-8#1)(2008-11#1)(2008-6#1)
for immune competence##2##3##(2009-2#2)
for immune##6##2##(2008-1#1)(2008-10#2)(2008-4#1)(2009-2#2)
for immunization##4##2##(1997-8#1)(2008-10#2)(2008-4#1)
for immunoassay##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
for immunoassays##5##2##(2008-10#5)
for immunofluorescence##2##2##(1990-11#1)(2008-9#1)
for immunoglobulin##2##2##(2008-7#1)(2009-8#1)
for immunolocalization of##2##3##(1994-2#1)(2008-9#1)
for immunolocalization##3##2##(1994-2#1)(2008-11#1)(2008-9#1)
for immunologic##2##2##(1990-12#1)(2011-2#1)
for immunological studies##2##3##(1994-3#1)(2010-2#1)
for immunological##3##2##(1993-12#1)(1994-3#1)(2010-2#1)
for immunomodulating##2##2##(1991-6#1)(2008-10#1)
for immunotherapy##5##2##(2008-6#1)(2009-2#1)(2010-12#1)(2010-3#1)(2013-8#1)
for immunotoxic potential##2##3##(2008-10#2)
for immunotoxicity##3##2##(2008-10#3)
for immunotoxicology evaluation##2##3##(2008-10#2)
for impact##4##2##(1997-5#1)(2008-4#2)(2013-8#1)
for impaction and##2##3##(2008-11#1)(2013-8#1)
for impaired##6##2##(2008-11#2)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#1)
for implant placement##3##3##(2007-12#1)(2013-1#2)
for implant site development##2##4##(2007-12#2)
for implant##8##2##(2007-12#3)(2010-12#1)(2012-2#2)(2013-1#2)
for implantable biosensors##2##3##(2009-11#2)
for implantable devices##2##3##(2009-11#1)(2010-8#1)
for implantable##7##2##(2008-7#1)(2009-10#1)(2009-11#4)(2010-8#1)
for implantation##3##2##(1995-11#1)(2009-11#1)(2010-12#1)
for implementation in##4##3##(2007-11#1)(2008-3#1)(2010-5#2)
for implementation of the##4##4##(1992-3#1)(1996-2#1)(2007-12#1)(2008-11#1)
for implementation of##8##3##(1992-3#1)(1996-2#1)(2007-12#2)(2008-11#3)(2008-7#1)
for implementation##20##2##(1992-3#1)(1993-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#2)(2010-5#2)(2010-8#1)
for implementing the##7##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#1)
for implementing##26##2##(1991-2#1)(1992-2#1)(1994-1#2)(1994-2#1)(1996-2#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
for important##7##2##(1991-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2012-3#1)
for improved access##2##3##(2009-3#1)(2012-1#1)
for improved data##2##3##(1994-3#1)(2008-10#1)
for improved patient##2##3##(1992-12#1)(2008-9#1)
for improved##35##2##(1992-12#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-4#1)(2008-8#2)(2008-9#3)(2009-3#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
for improvement are##2##3##(2008-3#1)(2010-12#1)
for improvement in the management of##2##6##(2008-3#1)(2010-12#1)
for improvement in the##5##4##(1996-2#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-12#1)
for improvement in##8##3##(1996-2#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-12#1)(2012-12#1)
for improvement of medical##2##4##(1997-4#1)(2010-4#1)
for improvement of the##2##4##(1996-8#1)(2008-10#1)
for improvement of##13##3##(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
for improvement##49##2##(1991-1#1)(1994-12#2)(1994-2#2)(1995-3#1)(1996-2#3)(1996-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
for improvements in##3##3##(1994-1#1)(2008-5#1)(2012-12#1)
for improvements##4##2##(1994-1#1)(2008-5#1)(2008-7#1)(2012-12#1)
for improving both##2##3##(1991-3#1)(1997-2#1)
for improving cognitive##2##3##(1994-6#1)(2012-2#1)
for improving health care##2##4##(1996-1#1)(2009-5#1)
for improving health##5##3##(1996-1#1)(1996-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
for improving human##3##3##(1993-12#1)(1995-2#1)(2012-2#1)
for improving library services##2##4##(1996-2#2)
for improving pathogen##2##3##(2008-10#2)
for improving performance##2##3##(1995-2#1)(1996-11#1)
for improving prevention and##2##4##(2008-10#1)(2012-3#1)
for improving quality##2##3##(1993-12#1)(2008-1#1)
for improving the efficiency of##2##5##(1994-12#1)(2008-12#1)
for improving the quality of##2##5##(1996-9#1)(2010-2#1)
for improving the quality##3##4##(1996-9#1)(2010-2#1)(2013-1#1)
for improving the##34##3##(1991-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-11#2)(2007-3#1)(2008-10#4)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
for improving##111##2##(1991-1#1)(1991-3#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#3)(2007-11#5)(2007-3#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
for in a##8##3##(1992-12#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
for in planta##2##3##(2008-10#2)
for in situ and##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
for in situ gas sampling##2##5##(2012-2#2)
for in situ measurements of##3##5##(2008-2#1)(2008-3#2)
for in situ measurements##4##4##(2008-2#2)(2008-3#2)
for in situ monitoring of##2##5##(2008-2#1)(2008-3#1)
for in situ monitoring##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
for in situ##31##3##(1996-12#1)(2008-10#11)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#2)
for in the##10##3##(1991-11#1)(1992-3#1)(1996-7#1)(1997-3#1)(2007-11#2)(2008-2#1)(2008-3#2)(2009-5#1)
for in vitro and in vivo##4##6##(1996-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
for in vitro drug release##3##5##(2010-3#2)(2011-1#1)
for in vitro fertilisation##2##4##(1990-2#1)(1996-8#1)
for in vitro production of##2##5##(1994-12#1)(2008-11#1)
for in vitro selection##4##4##(1997-6#1)(2008-4#3)
for in vitro studies##4##4##(1997-1#1)(2008-10#1)(2008-11#2)
for in vitro susceptibility##2##4##(2008-5#1)(2011-2#1)
for in vitro testing##2##4##(1994-2#1)(2008-5#1)
for in vitro##43##3##(1990-12#1)(1990-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-6#2)(2007-11#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#5)(2008-5#6)(2008-7#3)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-6#1)
for in vivo applications##2##4##(1997-4#1)(2007-11#1)
for in vivo cloning##3##4##(1994-12#3)
for in vivo gene transfer##2##5##(1994-5#2)
for in vivo imaging##4##4##(2007-12#3)(2009-5#1)
for in vivo##26##3##(1992-6#1)(1993-8#1)(1994-12#3)(1994-5#2)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-4#3)(2009-3#1)(2009-5#1)(2010-6#2)(2011-7#1)(2012-2#2)(2013-1#1)
for in##129##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-12#4)(1994-2#1)(1994-5#2)(1994-9#1)(1995-5#1)(1996-12#4)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#5)(2007-12#3)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#10)(2008-5#7)(2008-7#5)(2008-8#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#3)(2011-1#4)(2011-2#2)(2011-7#1)(2012-2#4)(2012-6#1)(2013-1#1)
for in-depth##2##2##(2008-9#1)(2013-8#1)
for in-hospital##2##2##(1996-2#1)(2011-2#1)
for in-line##3##2##(2008-10#3)
for in-orbit##2##2##(2008-2#2)
for inactivation of##2##3##(2008-4#1)(2009-7#1)
for inactivation##3##2##(1995-6#1)(2008-4#1)(2009-7#1)
for inbreeding avoidance##3##3##(2008-9#3)
for incapacitation##2##2##(1996-12#2)
for incidence of##3##3##(2008-10#2)(2008-7#1)
for incidence##7##2##(2007-11#1)(2008-10#5)(2008-7#1)
for incident angles##2##3##(2007-11#1)(2008-3#1)
for incident##7##2##(1997-3#1)(2007-11#2)(2008-2#2)(2008-3#1)(2009-10#1)
for including##2##2##(1996-1#1)(2008-5#1)
for inclusion in a##2##4##(1996-1#1)(2008-2#1)
for inclusion in the study##2##5##(2007-11#1)(2013-1#1)
for inclusion in the##3##4##(2007-11#1)(2009-5#1)(2013-1#1)
for inclusion in##8##3##(1996-1#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
for inclusion of##2##3##(1995-5#1)(2008-9#1)
for inclusion production##2##3##(2008-10#2)
for inclusion##21##2##(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#5)
for incoherent##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
for income##2##2##(2007-12#1)(2011-1#1)
for incomplete##2##2##(1996-12#1)(2010-8#1)
for incontinence##2##2##(1997-7#1)(2008-10#1)
for incorporating##10##2##(1994-12#1)(1995-12#2)(1996-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-7#1)(2013-1#1)
for incorporation into##2##3##(2007-11#1)(2008-10#1)
for incorporation of##2##3##(2008-10#1)(2008-4#1)
for incorporation##5##2##(1996-2#1)(2007-11#1)(2008-10#2)(2008-4#1)
for increase##3##2##(1997-4#1)(2008-12#1)(2008-3#1)
for increased##39##2##(1992-12#1)(1993-3#1)(1995-11#2)(1996-12#1)(1997-4#1)(2007-11#1)(2007-3#1)(2008-10#7)(2008-12#1)(2008-3#6)(2008-8#4)(2010-10#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
for increases in##2##3##(2008-9#1)(2009-5#1)
for increasing categories of##2##4##(1992-10#2)
for increasing the##18##3##(1991-3#1)(1992-2#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-3#1)(2012-4#1)(2013-1#1)
for increasing##44##2##(1991-3#1)(1992-10#2)(1992-2#1)(1992-6#1)(1994-6#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#2)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#5)
for incubation##2##2##(1992-3#1)(2008-10#1)
for independent##3##2##(2008-10#2)(2008-3#1)
for indicators##2##2##(2008-12#1)(2012-12#1)
for indirect determination of##3##4##(2008-10#3)
for indirect monitoring of the##2##5##(2008-10#2)
for indirect##9##2##(1991-12#1)(2008-10#6)(2012-3#1)(2013-8#1)
for indium##4##2##(2008-10#4)
for individual based##2##3##(1997-6#2)
for individual clinical##2##3##(1996-2#1)(2008-10#1)
for individual patients##6##3##(1993-11#1)(2007-5#1)(2008-7#1)(2010-5#1)(2013-1#2)
for individual services##2##3##(1995-12#1)(1997-3#1)
for individual##45##2##(1991-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-6#2)(2007-12#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
for individualization##3##2##(1995-6#1)(2008-12#1)(2010-9#1)
for individualized##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
for individuals from##2##3##(1996-12#1)(2008-8#1)
for individuals who##4##3##(1997-3#1)(2009-8#1)(2012-2#1)(2012-3#1)
for individuals with##19##3##(1993-1#1)(1993-3#1)(1994-12#5)(1994-9#1)(2007-7#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-12#1)(2013-8#1)
for individuals##33##2##(1992-1#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#5)(1994-9#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#3)(2010-12#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
for indoor##4##2##(1995-6#1)(2008-3#1)(2008-5#1)(2008-7#1)
for induced##2##2##(2008-10#2)
for inducible##2##2##(2008-2#2)
for inducing the##2##3##(1996-5#1)(2008-10#1)
for inducing##22##2##(1991-12#1)(1991-2#1)(1991-6#1)(1994-6#1)(1995-2#1)(1996-5#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-9#2)(2010-11#1)(2010-8#1)(2012-2#1)
for induction of neoplastic transformation##2##5##(2008-7#2)
for induction of##15##3##(1991-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)
for induction##19##2##(1990-6#1)(1991-3#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
for industrial application##2##3##(1991-5#1)(2008-3#1)
for industrial applications##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
for industrial hygiene and safety in##2##6##(2012-12#2)
for industrial production##2##3##(2008-11#1)(2013-8#1)
for industrial##18##2##(1991-5#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
for industry-sponsored##2##2##(2008-10#1)(2009-11#1)
for indwelling electrodes##3##3##(2012-2#3)
for indwelling##4##2##(2012-2#4)
for inertial confinement fusion (ICF) research have been##2##8##(2008-3#2)
for inertial confinement fusion (ICF)##3##5##(2008-3#3)
for inertial confinement fusion##4##4##(2007-11#1)(2008-3#3)
for infant abduction prevention and response##2##6##(1996-12#2)
for infant##8##2##(1994-3#1)(1995-5#1)(1996-12#2)(2007-2#1)(2008-10#1)(2012-2#1)(2013-8#1)
for infantile##2##2##(2007-7#1)(2010-12#1)
for infants and##3##3##(1992-1#1)(2012-2#1)(2013-8#1)
for infants with##6##3##(1993-3#2)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
for infants##17##2##(1992-1#1)(1993-12#1)(1993-3#2)(1994-9#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-6#2)(2012-2#2)(2013-8#1)
for infected##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
for infecting##2##2##(2008-4#2)
for infection and##3##3##(2008-10#3)
for infection assays##2##3##(2008-9#2)
for infection by##5##3##(2008-10#4)(2008-12#1)
for infection control##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
for infection efficiency##2##3##(2008-10#2)
for infection of##8##3##(2008-10#6)(2008-5#1)(2008-7#1)
for infection to occur##2##4##(2008-10#2)
for infection was##2##3##(2008-10#2)
for infection with##3##3##(2007-6#1)(2008-7#1)(2011-2#1)
for infection##52##2##(1991-7#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
for infections##2##2##(2011-2#1)(2013-1#1)
for infectious diseases##7##3##(1997-3#2)(2008-11#2)(2009-5#1)(2010-6#1)(2012-1#1)
for infectious##10##2##(1997-3#3)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#1)(2010-6#1)(2012-1#1)
for infective endocarditis##2##3##(1992-2#1)(2007-8#1)
for infectivity##2##2##(2008-9#1)(2011-2#1)
for inference##2##2##(2008-7#1)(2009-7#1)
for inferences##2##2##(1997-3#1)(2010-5#1)
for inferring##7##2##(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)
for infertility treatment##2##3##(1994-7#1)(2008-12#1)
for infertility##4##2##(1991-3#1)(1993-3#1)(1994-7#1)(2008-12#1)
for infinite cylinders##2##3##(2008-2#2)
for infinite##3##2##(2008-2#3)
for inflammation and rheumatoid arthritis##2##5##(2008-5#2)
for inflammatory##8##2##(1994-6#1)(1996-2#1)(1997-8#1)(2008-7#1)(2010-5#2)(2012-2#1)(2013-1#1)
for influenza A##2##3##(2007-12#1)(2013-1#1)
for influenza##7##2##(1996-6#1)(2007-12#1)(2008-11#2)(2010-4#1)(2011-2#1)(2013-1#1)
for influx and efflux##2##4##(1994-8#2)
for information and##2##3##(1995-12#1)(2009-5#1)
for information on##2##3##(1991-3#1)(1994-6#1)
for information retrieval##2##3##(1991-8#1)(1996-12#1)
for information systems##3##3##(1992-3#1)(1995-1#2)
for information##25##2##(1991-3#1)(1991-8#1)(1992-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)
for infrared##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
for inhalation##3##2##(1996-3#1)(1997-2#1)(2008-8#1)
for inhaled##3##2##(1992-3#1)(2008-11#1)(2008-8#1)
for inherent##2##2##(1994-11#2)
for inhibiting the##2##3##(2008-10#1)(2008-4#1)
for inhibiting##10##2##(1995-11#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-4#3)(2010-4#1)
for inhibition of pol##2##4##(1995-2#2)
for inhibition of the##2##4##(1997-7#1)(2008-10#1)
for inhibition of##15##3##(1990-5#1)(1992-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-5#1)(1997-7#1)(2008-10#4)(2008-9#1)(2012-2#1)
for inhibition##19##2##(1990-5#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-9#1)(2012-2#1)
for inhibitor##2##2##(2008-10#1)(2012-2#1)
for inhibitors of##6##3##(1991-5#2)(2008-11#1)(2009-6#1)(2013-1#2)
for inhibitors##7##2##(1991-5#2)(2008-11#1)(2009-11#1)(2009-6#1)(2013-1#2)
for initial##17##2##(1991-2#1)(1992-4#1)(1992-6#1)(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
for initiating and terminating##2##4##(2011-1#2)
for initiating and##3##3##(2008-3#1)(2011-1#2)
for initiating##8##2##(1990-5#1)(1992-6#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)
for initiation of##6##3##(1991-1#1)(1991-12#1)(1994-5#1)(2008-1#1)(2008-6#1)(2012-2#1)
for initiation##7##2##(1991-1#1)(1991-12#1)(1994-5#1)(2008-1#1)(2008-6#1)(2012-12#1)(2012-2#1)
for injection##7##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-3#2)(2012-3#1)(2013-1#1)
for injuries##2##2##(1991-7#1)(2007-11#1)
for injury##3##2##(1993-10#1)(1994-2#1)(2008-8#1)
for inner##2##2##(2008-4#1)(2010-9#1)
for innovation##2##2##(2008-11#1)(2010-5#1)
for innovative##4##2##(1993-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
for inoculating##3##2##(2008-2#1)(2008-9#2)
for inoperable##3##2##(1991-2#1)(1993-6#1)(1996-3#1)
for inorganic and organic##2##4##(2008-10#2)
for inorganic and##3##3##(2008-10#3)
for inorganic arsenic##3##3##(2008-10#3)
for inorganic##10##2##(2008-10#10)
for inpatient care##4##3##(1991-1#1)(1991-3#1)(1993-3#1)(2008-7#1)
for inpatient##10##2##(1991-1#1)(1991-3#2)(1993-12#1)(1993-3#1)(1996-3#1)(2008-7#1)(2010-10#2)(2012-2#1)
for input##3##2##(2007-12#1)(2008-3#2)
for insect cell culture##2##4##(2008-11#2)
for insect##7##2##(1995-6#1)(2008-10#2)(2008-11#2)(2009-8#1)(2013-7#1)
for insecticide##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
for insensitivity in the##2##4##(2008-10#2)
for insensitivity to##2##3##(2008-10#2)
for insensitivity##4##2##(2008-10#4)
for inserting##2##2##(1993-12#1)(2008-10#1)
for insertion of##4##3##(2007-7#1)(2008-11#1)(2008-8#1)(2010-7#1)
for insertional mutagenesis##2##3##(2008-10#2)
for insertional##3##2##(2008-10#2)(2010-3#1)
for insomnia##4##2##(2013-1#4)
for inspection of##2##3##(2007-7#1)(2008-3#1)
for inspection##3##2##(1994-3#1)(2007-7#1)(2008-3#1)
for instability##2##2##(2008-3#1)(2013-1#1)
for instance##25##2##(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)
for institutionalization##2##2##(2009-9#2)
for instruction##3##2##(1993-1#1)(1994-2#1)(1994-7#1)
for instrument##2##2##(1997-2#1)(2008-10#1)
for instrumental##2##2##(2008-10#1)(2008-4#1)
for instrumentation##2##2##(2007-8#1)(2012-2#1)
for instruments##2##2##(2008-2#1)(2008-9#1)
for insulin and##2##3##(1995-6#1)(1996-2#1)
for insulin resistance##11##3##(1994-12#1)(1996-2#1)(2008-1#1)(2008-3#3)(2011-1#4)(2013-8#1)
for insulin signaling##4##3##(1995-6#1)(2008-1#1)(2010-11#1)(2012-2#1)
for insulin##30##2##(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-6#3)(1996-2#3)(2008-1#4)(2008-11#1)(2008-3#3)(2008-8#1)(2010-11#2)(2011-1#5)(2012-12#1)(2012-2#1)(2013-8#1)
for insulin-dependent diabetes mellitus##2##4##(1990-5#1)(1997-8#1)
for insulin-like growth factor##2##4##(2008-8#1)(2010-4#1)
for insulin-like growth factor-I##2##4##(1994-2#1)(2008-8#1)
for insulin-like growth##4##3##(1994-2#1)(2008-8#2)(2010-4#1)
for insurance##2##2##(1995-1#1)(1996-2#1)
for intact##4##2##(1995-2#1)(1995-5#1)(1995-6#1)(2013-8#1)
for integrated optical##2##3##(2008-2#1)(2008-3#1)
for integrated##16##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
for integrating the##2##3##(2008-6#1)(2009-11#1)
for integrating these##2##3##(2007-8#1)(2008-10#1)
for integrating##14##2##(1991-12#1)(1992-3#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-7#1)
for integration and##2##3##(2008-3#1)(2008-7#1)
for integration in##2##3##(2008-10#1)(2008-3#1)
for integration into##2##3##(2008-2#1)(2008-7#1)
for integration of##3##3##(2008-2#2)(2008-4#1)
for integration with##2##3##(2008-2#1)(2010-9#1)
for integration##15##2##(1992-6#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#2)(2010-9#1)
for intensity and initial rate measurements##2##6##(2008-10#2)
for intensity##4##2##(2008-10#2)(2008-3#1)(2010-1#1)
for intensive##5##2##(1992-1#1)(1997-2#1)(2007-11#1)(2008-5#1)(2011-2#1)
for interacting with##3##3##(1992-11#1)(2008-4#1)(2010-3#1)
for interacting##4##2##(1992-11#1)(2008-4#1)(2008-8#1)(2010-3#1)
for interaction with the##2##4##(1994-8#1)(2008-3#1)
for interaction with##6##3##(1990-4#1)(1993-11#1)(1994-2#1)(1994-8#1)(2008-3#1)(2010-10#1)
for interaction##10##2##(1990-4#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-11#1)
for interactions##3##2##(1991-7#1)(2012-3#1)(2013-1#1)
for interactive##5##2##(2008-4#1)(2008-6#3)(2008-9#1)
for interchip##2##2##(2008-3#2)
for intercomparison##2##2##(2008-2#1)(2008-3#1)
for interdisciplinary##3##2##(1991-6#1)(1996-1#1)(1996-2#1)
for interference##5##2##(2008-10#3)(2008-2#1)(2012-2#1)
for interferences##2##2##(2008-10#2)
for interfering##2##2##(2008-2#1)(2010-11#1)
for interferometric##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
for interleukin##2##2##(1995-2#1)(2012-2#1)
for intermediate##4##2##(2007-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
for intermittent##3##2##(1993-11#1)(2008-3#1)(2011-2#1)
for internal##9##2##(1990-3#1)(1991-8#1)(1992-12#2)(2007-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
for internalization##2##2##(1990-11#1)(2011-2#1)
for international##10##2##(1993-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)
for interpretation of##5##3##(1991-12#1)(1992-3#1)(2007-8#1)(2008-3#1)(2009-8#1)
for interpretation##9##2##(1991-1#1)(1991-12#1)(1992-3#1)(1992-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)
for interpretations##2##2##(2008-10#1)(2011-1#1)
for interpreting results##2##3##(2008-4#1)(2008-8#1)
for interpreting the##5##3##(1995-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#1)
for interpreting##15##2##(1995-12#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2011-2#2)
for interprofessional education##2##3##(2008-11#2)
for interprofessional##3##2##(2008-11#2)(2012-12#1)
for interrogating##2##2##(2008-3#1)(2010-2#1)
for intervention and##3##3##(2008-1#2)(2012-3#1)
for intervention in##3##3##(1994-6#1)(2007-10#1)(2008-12#1)
for intervention research##2##3##(2008-2#1)(2011-2#1)
for intervention with##2##3##(1992-12#1)(2013-1#1)
for intervention##18##2##(1991-2#1)(1992-12#1)(1994-6#1)(1995-12#1)(2007-10#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for interventional##4##2##(1991-3#1)(2008-3#1)(2008-7#1)(2010-12#1)
for interventions with##2##3##(2009-5#2)
for interventions##6##2##(1994-5#1)(2009-12#1)(2009-5#2)(2011-2#1)(2013-1#1)
for intestinal##5##2##(1992-5#1)(1992-9#1)(1995-12#1)(2008-5#1)(2011-2#1)
for intimate partner violence##3##4##(2010-11#2)(2010-3#1)
for intimate##4##2##(2010-11#2)(2010-3#1)(2012-2#1)
for intra-arterial##2##2##(2008-3#1)(2013-1#1)
for intracavity##2##2##(2007-11#1)(2008-3#1)
for intracellular histamine receptors##2##4##(1991-9#2)
for intracellular processing##3##3##(1993-8#3)
for intracellular##14##2##(1991-9#2)(1993-8#3)(1994-8#1)(2008-11#3)(2008-8#1)(2008-9#1)(2011-1#2)(2012-12#1)
for intracranial##3##2##(2008-7#3)
for intractable##7##2##(2008-10#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#1)(2013-8#1)
for intramolecular##2##2##(1993-2#1)(2009-8#1)
for intraocular retinoblastoma##2##3##(2011-2#2)
for intraocular##6##2##(2008-3#2)(2009-7#1)(2011-2#3)
for intraoperative##4##2##(1992-2#1)(2007-11#1)(2010-8#1)(2013-1#1)
for intravenous (i##2##3##(2007-10#1)(2008-1#1)
for intravenous##9##2##(1993-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-2#1)
for intrinsic##4##2##(1990-11#1)(1997-2#1)(2011-2#1)(2013-1#1)
for introducing##11##2##(1997-1#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-4#3)(2009-11#1)(2010-10#1)(2010-4#1)(2013-1#1)
for introduction##2##2##(2008-9#1)(2010-9#1)
for invasion and##2##3##(2008-10#1)(2011-1#1)
for invasion##4##2##(2008-10#3)(2011-1#1)
for invasive procedures##3##3##(2012-2#2)(2013-1#1)
for invasive##11##2##(1991-2#1)(1992-10#1)(1994-1#1)(2009-3#1)(2009-5#2)(2011-2#1)(2012-2#2)(2013-1#2)
for inversion of##2##3##(2007-12#1)(2008-3#1)
for inverting##2##2##(2008-2#1)(2012-3#1)
for investigating the##14##3##(1992-5#1)(1993-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#4)(2008-6#2)(2010-5#1)(2010-6#1)
for investigating##33##2##(1992-5#2)(1993-8#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-3#1)(2012-2#1)
for investigation of the effect of##2##6##(2008-10#1)(2008-3#1)
for investigation of the##9##4##(1990-5#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)
for investigation of##18##3##(1990-5#1)(1992-11#1)(1995-12#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
for investigation##24##2##(1990-5#1)(1992-11#1)(1994-6#1)(1995-12#2)(1996-1#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-2#1)
for investigations of##3##3##(1993-1#1)(2008-10#1)(2008-4#1)
for investigations##4##2##(1993-1#1)(2008-10#2)(2008-4#1)
for investigators to##2##3##(2008-5#1)(2012-3#1)
for investigators##7##2##(1993-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2012-12#1)(2012-3#1)
for involvement in decisions##2##4##(1993-12#2)
for involvement in##4##3##(1993-12#3)(2010-3#1)
for involvement of the##3##4##(1994-5#1)(2008-4#1)(2008-6#1)
for involvement of##4##3##(1990-11#1)(1994-5#1)(2008-4#1)(2008-6#1)
for involvement##10##2##(1990-11#1)(1993-12#4)(1994-5#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-3#1)
for iodide ion##2##3##(2008-10#2)
for iodide##5##2##(2008-10#5)
for iodine##2##2##(2007-12#1)(2008-10#1)
for ion##5##2##(2008-10#3)(2008-8#1)(2012-7#1)
for ion-exchanged##2##2##(2008-2#2)
for ion-selective electrode##2##3##(2008-10#2)
for ion-selective##4##2##(2008-10#4)
for ionic conduction##2##3##(2010-7#2)
for ionic##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-7#3)(2012-2#1)
for iron and zinc##2##4##(2008-10#2)
for iron and##3##3##(2008-10#3)
for iron determination##2##3##(2008-10#2)
for iron in##2##3##(2008-10#1)(2013-8#1)
for iron##19##2##(2008-10#18)(2013-8#1)
for iron(III)##2##2##(2008-10#2)
for irradiation##3##2##(1994-11#1)(2008-10#2)
for irreversible##3##2##(1991-3#1)(2008-1#1)(2008-5#1)
for irrigation##2##2##(2008-10#2)
for ischaemic stroke##2##3##(2008-7#1)(2012-2#1)
for ischaemic##4##2##(2007-8#1)(2008-7#2)(2012-2#1)
for ischemic stroke##5##3##(2007-10#2)(2008-9#1)(2012-12#2)
for ischemic##8##2##(2007-10#2)(2008-10#3)(2008-9#1)(2012-12#2)
for islet##2##2##(2010-11#2)
for isocitrate##3##2##(2008-10#3)
for isofraxidin and##3##3##(2008-10#3)
for isolate##3##2##(2008-10#3)
for isolated##6##2##(1993-8#2)(1994-8#1)(2008-10#2)(2012-3#1)
for isolates CS-1##3##3##(2008-10#3)
for isolates collected from##4##4##(2008-10#4)
for isolates from##4##3##(2008-10#4)
for isolates##19##2##(2008-10#18)(2008-12#1)
for isolating##19##2##(1990-5#1)(1990-7#1)(1991-5#1)(1993-8#1)(1994-2#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#5)(2008-9#2)(2013-1#1)
for isolation and##3##3##(1997-6#1)(2008-1#1)(2008-9#1)
for isolation of rhein##2##4##(2010-3#2)
for isolation of##17##3##(1990-12#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-9#3)(2010-3#2)(2011-2#1)
for isolation##22##2##(1990-12#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-9#5)(2010-3#2)(2011-2#1)
for isoniazid##4##2##(2008-10#4)
for isotopic analysis##2##3##(2008-10#2)
for isotopic##3##2##(2008-10#2)(2008-4#1)
for it to be##2##4##(1990-2#1)(2008-7#1)
for it to##4##3##(1990-2#1)(1995-5#1)(2008-3#1)(2008-7#1)
for it!##2##2##(1994-12#1)(2008-4#1)
for items with##2##3##(2010-2#1)(2012-2#1)
for items##4##2##(1993-1#1)(2010-2#1)(2012-2#2)
for iterative##2##2##(2008-2#1)(2009-2#1)
for its ability to prevent##2##5##(2007-11#1)(2008-10#1)
for its ability to##12##4##(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)
for its ability##13##3##(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)
for its action##2##3##(1996-5#1)(2008-11#1)
for its activity##3##3##(1993-6#1)(1994-6#1)(1995-2#1)
for its application##2##3##(2008-3#1)(2008-4#1)
for its assembly##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
for its capacity to##3##4##(1995-2#1)(2008-10#2)
for its control##2##3##(2007-12#1)(2008-11#1)
for its design##2##3##(1996-6#1)(2010-8#1)
for its detection##5##3##(2007-7#2)(2008-10#3)
for its determination in##3##4##(2008-10#3)
for its determination##8##3##(1997-2#2)(2008-10#6)
for its development##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
for its efficacy in##2##4##(2008-10#2)
for its extracellular ligand##2##4##(1992-12#2)
for its function##2##3##(1994-8#1)(2009-6#1)
for its interaction with##2##4##(1990-5#1)(1992-5#1)
for its introduction##2##3##(2008-7#1)(2013-1#1)
for its larger##2##3##(2011-2#1)(2012-12#1)
for its members##2##3##(1994-12#1)(2008-4#1)
for its operation##2##3##(2008-2#1)(2008-3#1)
for its patients##2##3##(1992-3#1)(1996-1#1)
for its potential to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
for its potential use##2##4##(1997-4#1)(2012-2#1)
for its potential##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
for its prevention##2##3##(2012-12#1)(2012-2#1)
for its role as a##2##5##(1997-5#1)(2007-11#1)
for its role in##6##4##(1995-2#1)(2008-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
for its role##8##3##(1995-2#1)(1997-5#1)(2007-11#1)(2008-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
for its solution##2##3##(2009-3#1)(2009-7#1)
for its strong##2##3##(2008-9#1)(2010-11#1)
for its structure##2##3##(1993-8#1)(2009-7#1)
for its suitability for##2##4##(1995-2#1)(2008-3#1)
for its treatment##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
for its use in the##4##5##(2008-1#1)(2008-10#2)(2011-2#1)
for its use in##9##4##(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)
for its use##12##3##(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#2)(2010-12#1)(2010-6#2)(2011-2#1)
for its##256##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-6#3)(1994-8#2)(1995-12#4)(1995-2#6)(1995-6#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#58)(2008-11#7)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#9)(2008-7#6)(2008-8#11)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#17)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#6)
for jfm binding##2##3##(1990-2#2)
for jobs##3##2##(1990-2#1)(1993-1#2)
for joint reconstruction##2##3##(2007-8#1)(2010-3#1)
for joint##4##2##(2007-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
for judging##3##2##(1996-5#1)(2008-3#1)(2010-4#1)
for jun-B and c-jun##2##4##(1991-12#1)(1991-2#1)
for just##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
for juvenile myelomonocytic leukemia##2##4##(2013-1#2)
for juvenile##4##2##(2008-11#2)(2013-1#2)
for k##4##2##(1992-9#2)(1996-3#1)(2008-2#1)
for keeping##3##2##(2008-1#1)(2008-5#1)(2010-9#1)
for keratin##4##2##(1991-12#1)(2008-5#2)(2012-1#1)
for key##6##2##(1990-9#1)(1993-12#1)(1995-12#1)(2008-11#1)(2010-6#1)(2010-8#1)
for kidney transplantation (KT)##2##4##(2010-8#1)(2011-2#1)
for kidney transplantation##5##3##(2007-7#1)(2010-8#2)(2011-2#2)
for kidney##16##2##(1994-5#2)(1995-2#1)(1995-9#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-8#2)(2011-2#3)(2012-3#2)
for kinetic analysis of soluble Interleukin-1 receptor I##2##8##(2008-10#2)
for kinetic analysis of##3##4##(2008-10#2)(2008-2#1)
for kinetic##5##2##(2008-10#4)(2008-2#1)
for kinetics of##2##3##(1990-8#1)(1990-9#1)
for knowledge##6##2##(1993-3#1)(1997-5#1)(2008-11#1)(2010-10#1)(2010-9#1)(2012-3#1)
for known##8##2##(1991-6#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
for l-cysteine and glutathione##3##4##(2008-10#3)
for l-cysteine and##4##3##(2008-10#4)
for label-free##5##2##(2008-10#1)(2012-2#1)(2013-1#3)
for labeling##11##2##(2008-1#2)(2008-10#3)(2008-4#4)(2008-9#2)
for labor##3##2##(2010-10#1)(2011-2#1)(2012-3#1)
for laboratories##2##2##(2008-11#1)(2013-1#1)
for laboratory testing##2##3##(1996-6#1)(2008-7#1)
for laboratory##19##2##(1992-10#1)(1992-12#1)(1993-1#1)(1994-12#2)(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
for laboratory-scale##2##2##(2008-4#2)
for lack of##6##3##(1990-2#1)(1993-2#1)(2007-12#1)(2008-10#2)(2012-2#1)
for lactose##2##2##(1990-2#1)(1994-9#1)
for lambda =##3##3##(2008-2#2)(2008-3#1)
for lambda##4##2##(1994-11#1)(2008-2#2)(2008-3#1)
for land##2##2##(2008-8#1)(2012-2#1)
for language##3##2##(1993-9#1)(1996-2#1)(2012-3#1)
for lanthanide##2##2##(2008-10#2)
for lanthanides##2##2##(2008-10#2)
for laparoscopic surgery##4##3##(2010-7#1)(2011-2#2)(2012-3#1)
for laparoscopic##12##2##(1993-12#1)(1993-9#1)(1994-3#1)(2007-7#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
for laparoscopy in##2##3##(1994-3#1)(2010-8#1)
for laparoscopy##3##2##(1991-11#1)(1994-3#1)(2010-8#1)
for laparotomy##2##2##(1990-2#1)(2011-1#1)
for large and##2##3##(2008-7#1)(2011-2#1)
for large birefringence##2##3##(2007-12#1)(2008-3#1)
for large circumferential extremity##2##4##(2011-2#2)
for large circumferential##3##3##(2011-2#3)
for large earthquakes##2##3##(1996-4#2)
for large numbers of##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
for large populations##2##3##(2009-7#1)(2011-1#1)
for large scale##6##3##(2008-10#2)(2008-11#3)(2012-3#1)
for large spatial data sets##2##5##(2009-9#2)
for large##47##2##(1991-1#1)(1992-3#1)(1993-11#1)(1995-1#1)(1996-4#2)(1997-2#2)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-7#1)(2009-9#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
for large-area##2##2##(2007-11#1)(2008-7#1)
for large-core polymer##2##3##(2008-2#2)
for large-core##3##2##(2007-12#1)(2008-2#2)
for large-scale comparative##2##3##(1993-9#1)(2008-7#1)
for large-scale expansion of NSCs##2##5##(2008-11#2)
for large-scale production of##2##4##(1992-11#1)(2008-4#1)
for large-scale production##3##3##(1992-11#1)(2008-4#1)(2011-2#1)
for large-scale##26##2##(1992-11#1)(1993-9#1)(1997-4#1)(1997-5#1)(2008-10#3)(2008-11#4)(2008-4#3)(2008-7#5)(2008-8#2)(2008-9#1)(2011-2#2)(2013-8#2)
for larger##11##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2013-1#1)
for larvae##2##2##(2011-2#2)
for larval##4##2##(1996-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
for laryngeal carcinoma##3##3##(2011-2#3)
for laryngopharyngitis##2##2##(2011-2#2)
for laser beam##3##3##(2007-11#2)(2008-3#1)
for laser fluences##2##3##(2008-2#2)
for laser##25##2##(1996-1#1)(2007-11#5)(2007-12#2)(2008-2#9)(2008-3#6)(2008-9#1)(2010-6#1)
for laser-induced##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for lasers##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
for last##3##2##(2008-7#1)(2009-7#1)(2010-12#1)
for late blight##3##3##(2008-10#3)
for late##9##2##(2007-8#2)(2008-10#4)(2008-11#1)(2008-7#2)
for latent infection##2##3##(2008-10#2)
for latent period##3##3##(2008-10#3)
for latent##6##2##(2008-10#5)(2012-2#1)
for latent-period duration in stem rust##2##6##(2008-10#2)
for later##13##2##(1992-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)
for lateral##2##2##(2007-12#1)(2008-9#1)
for latex beads##2##3##(2008-10#1)(2008-2#1)
for latex##3##2##(1990-12#1)(2008-10#1)(2008-2#1)
for leaching of##2##3##(2008-10#2)
for leaching##4##2##(2008-10#4)
for lead (II)##2##3##(2008-10#2)
for lead and##8##3##(2008-10#8)
for lead concentration of##2##4##(2008-10#2)
for lead determination by##3##4##(2008-10#3)
for lead determination in##2##4##(2008-10#2)
for lead determination using##2##4##(2008-10#2)
for lead determination##8##3##(2008-10#8)
for lead in##2##3##(2008-10#2)
for lead##43##2##(1990-8#1)(1997-4#1)(2008-10#39)(2009-5#1)(2013-8#1)
for lead(II)##2##2##(2008-10#2)
for leadership##3##2##(1991-3#1)(1994-1#1)(2008-1#1)
for leaf infection##2##3##(2008-10#2)
for leaf rust and stripe rust##3##6##(2008-10#3)
for leaf rust resistance and##2##5##(2008-10#2)
for leaf rust resistance##7##4##(2008-10#7)
for leaf rust##11##3##(2008-10#11)
for leaf##19##2##(2008-10#16)(2008-5#1)(2008-8#1)(2009-5#1)
for leaflets and leaves##2##4##(2008-10#2)
for learners##2##2##(2008-12#2)
for learning and memory in##2##5##(2008-10#1)(2009-8#1)
for learning and memory##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
for learning and##7##3##(2008-10#1)(2008-3#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#2)
for learning##16##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
for left ventricular##2##3##(1992-12#1)(2008-12#1)
for left##7##2##(1992-12#1)(1992-5#1)(1994-7#1)(2008-12#1)(2011-2#3)
for legal##2##2##(1992-2#1)(2013-1#1)
for length of##3##3##(1992-1#1)(2008-12#1)(2008-8#1)
for length##4##2##(1992-1#1)(2008-12#1)(2008-3#1)(2008-8#1)
for lens##2##2##(2008-2#1)(2008-3#1)
for lens-free relay##2##3##(2008-2#2)
for leprosy##3##2##(1995-9#1)(2008-8#1)(2012-12#1)
for lesbian and##2##3##(1992-1#1)(2008-12#1)
for lesbians##2##2##(1997-7#2)
for lesion detection##2##3##(1997-8#1)(2007-11#1)
for lesion##5##2##(1997-8#2)(2007-11#1)(2008-10#2)
for lesions##5##2##(1994-12#1)(2007-11#1)(2008-10#2)(2012-2#1)
for less than 1% of##2##5##(2008-3#1)(2013-7#1)
for less than 2% of all##2##6##(2007-5#1)(2013-1#1)
for less than 2% of##3##5##(2007-5#1)(2011-2#1)(2013-1#1)
for less than##15##3##(1990-6#1)(1991-2#1)(1993-2#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
for less##19##2##(1990-6#1)(1991-2#1)(1992-1#1)(1993-2#1)(1996-3#1)(1996-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
for leukemia##2##2##(1991-2#1)(2008-10#1)
for levels of##2##3##(2010-8#1)(2013-8#1)
for levodopa##2##2##(2008-10#1)(2010-12#1)
for liberation of##2##3##(2008-1#1)(2008-10#1)
for librarians##2##2##(1994-2#1)(1995-2#1)
for libraries##2##2##(1993-2#1)(2008-4#1)
for library##2##2##(1992-12#1)(1995-2#1)
for lidar##6##2##(2008-3#6)
for lidocaine##3##2##(1993-1#1)(2008-10#2)
for life##10##2##(1990-2#1)(1991-12#1)(1996-5#1)(2008-10#1)(2008-7#2)(2011-2#1)(2011-3#2)(2012-3#1)
for life-prolonging##2##2##(2009-11#2)
for lifelong##3##2##(1992-12#1)(2008-8#1)(2012-12#1)
for ligand binding##2##3##(1992-9#1)(1994-8#1)
for ligand##6##2##(1992-9#1)(1993-11#1)(1994-8#1)(1995-2#1)(2008-10#2)
for ligands##4##2##(1990-8#1)(1994-6#1)(2008-10#2)
for light delivery##2##3##(2008-2#1)(2008-4#1)
for light incident##3##3##(2008-3#3)
for light microscopy##5##3##(1995-12#1)(2008-1#1)(2008-5#2)(2008-8#1)
for light scattering by a##2##5##(2008-3#2)
for light scattering by##5##4##(2008-3#5)
for light with##2##3##(2007-12#1)(2008-2#1)
for light##33##2##(1995-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)
for light-emitting##2##2##(2008-3#1)(2008-7#1)
for light-scattering##2##2##(2007-11#2)
for limb##2##2##(2008-6#1)(2010-5#1)
for limited##6##2##(1991-7#1)(1995-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
for limiting##3##2##(1992-2#1)(2008-12#1)(2008-8#1)
for linear##10##2##(1993-6#1)(1995-9#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
for linearity##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
for linearly##3##2##(2008-3#3)
for linewidth##2##2##(2007-11#1)(2008-3#1)
for linkage analysis##4##3##(1994-3#1)(2008-4#3)
for linkage to##2##3##(1997-5#1)(2008-5#1)
for linkage##13##2##(1994-3#1)(1997-5#5)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2011-1#1)
for lipid lowering##2##3##(2009-12#1)(2009-6#1)
for lipid##10##2##(1990-5#3)(1992-6#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)
for lipids##2##2##(2008-3#1)(2009-7#1)
for lipoprotein(a)##2##2##(1995-2#1)(1995-6#1)
for liquid chromatographic##2##3##(2008-10#2)
for liquid chromatography##7##3##(1990-8#1)(2008-10#5)(2010-11#1)
for liquid##17##2##(1990-8#1)(1995-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)
for liquid-crystal##2##2##(2008-3#2)
for listening to##2##3##(2008-9#1)(2013-1#1)
for lithium determination in##2##4##(2008-10#2)
for lithium##4##2##(2008-10#3)(2008-3#1)
for liver cancer##3##3##(1990-8#1)(2010-12#1)(2013-1#1)
for liver damage##2##3##(1995-3#2)
for liver imaging##2##3##(2010-12#2)
for liver metastases##2##3##(1990-9#1)(2008-1#1)
for liver total lipids##2##4##(2008-12#2)
for liver toxicity##2##3##(2013-1#2)
for liver##25##2##(1990-8#1)(1990-9#1)(1991-8#1)(1995-10#1)(1995-3#2)(1996-11#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-8#2)(2010-12#3)(2011-2#1)(2013-1#4)(2013-8#1)
for livestock production##2##3##(2011-2#2)
for livestock##3##2##(2010-1#1)(2011-2#2)
for living donor##2##3##(2011-2#2)
for living##5##2##(1992-12#1)(2009-2#1)(2010-10#1)(2011-2#2)
for load##2##2##(1997-7#1)(2009-4#1)
for local control of##2##4##(2008-6#1)(2008-7#1)
for local control##5##3##(2008-6#1)(2008-7#1)(2010-3#3)
for local recurrence##3##3##(1994-8#1)(2008-7#1)(2012-2#1)
for local##25##2##(1992-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#1)(2010-3#4)(2012-2#2)
for localization of##3##3##(1994-11#1)(2008-9#1)(2009-7#1)
for localization##5##2##(1994-11#1)(1996-6#2)(2008-9#1)(2009-7#1)
for localized and##2##3##(2008-10#1)(2009-11#1)
for localized##7##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)
for localizing##3##2##(2008-2#1)(2008-4#2)
for locally advanced##3##3##(1995-10#1)(2007-5#1)(2009-9#1)
for locating the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
for locating##8##2##(1990-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)
for location of##2##3##(2007-12#1)(2008-9#1)
for locations##2##2##(2008-10#2)
for long and##2##3##(2008-11#1)(2011-2#1)
for long enough##2##3##(2008-10#1)(2008-3#1)
for long periods##4##3##(1991-5#1)(1995-5#1)(2008-5#1)(2012-2#1)
for long term##9##3##(1993-2#1)(1993-3#1)(1995-11#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2011-3#1)(2013-7#1)
for long##30##2##(1991-5#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-5#1)(2007-10#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
for long-distance##2##2##(2007-11#1)(2008-10#1)
for long-range##5##2##(2007-11#1)(2008-3#3)(2008-4#1)
for long-term care##7##3##(1992-12#1)(1994-3#1)(1995-3#1)(1997-1#3)(2013-1#1)
for long-term investigations##2##3##(2008-10#1)(2008-7#1)
for long-term maintenance of##2##4##(2008-11#1)(2008-7#1)
for long-term storage of##2##4##(2008-10#1)(2008-9#1)
for long-term storage##4##3##(2007-5#1)(2008-10#1)(2008-9#2)
for long-term survival##2##3##(2008-5#1)(2010-11#1)
for long-term##54##2##(1990-6#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1997-1#4)(1997-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#5)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
for longer periods and##2##4##(1990-11#1)(1993-11#1)
for longer periods of time##3##5##(2007-10#1)(2008-1#1)(2008-10#1)
for longer periods##8##3##(1990-11#1)(1991-9#1)(1993-11#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)
for longer than##5##3##(1990-12#1)(1994-5#1)(2007-12#1)(2008-1#1)(2009-2#1)
for longer time##2##3##(2008-12#1)(2013-8#1)
for longer##20##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1993-11#1)(1994-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
for longitudinal##4##2##(1997-8#1)(2008-3#1)(2010-7#1)(2011-1#1)
for lopinavir##3##2##(2011-3#3)
for loss of##4##3##(1993-9#1)(1996-11#1)(2008-10#1)(2008-2#1)
for lost##2##2##(1995-6#1)(2008-3#1)
for loved ones##2##3##(2009-5#1)(2013-8#1)
for low back pain and##2##5##(2007-8#1)(2012-2#1)
for low back pain##5##4##(1993-6#1)(1994-2#1)(2007-8#1)(2012-2#1)(2012-3#1)
for low concentrations of##2##4##(2008-10#2)
for low concentrations##3##3##(2008-10#3)
for low dose studies##2##4##(2008-7#2)
for low dose##3##3##(2008-7#3)
for low molecular##2##3##(2008-10#2)
for low values of the##2##5##(2007-11#1)(2008-2#1)
for low values of##3##4##(2007-11#1)(2008-2#1)(2008-5#1)
for low##50##2##(1991-5#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#3)(2012-2#1)(2012-3#2)(2013-1#2)
for low-##2##2##(2007-12#1)(2008-7#1)
for low-coherence interferometry##4##3##(2008-3#4)
for low-coherence##6##2##(2008-3#6)
for low-cost##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
for low-dose##2##2##(2008-7#1)(2013-8#1)
for low-income##3##2##(1992-2#1)(1994-2#1)(1995-12#1)
for low-intensity##2##2##(2008-2#1)(2012-1#1)
for low-level##8##2##(2008-10#3)(2008-2#3)(2008-9#1)(2013-7#1)
for low-light recording##2##3##(2007-12#2)
for lower##16##2##(1992-5#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2010-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
for lowering the##3##3##(1997-2#1)(2008-12#1)(2008-8#1)
for lumbar disc##2##3##(2012-12#1)(2013-1#1)
for lumbar stenosis##2##3##(2007-8#1)(2012-3#1)
for lumbar##8##2##(2007-10#1)(2007-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
for luminescence##5##2##(2008-10#3)(2011-1#2)
for luminol##2##2##(2008-10#2)
for lung cancer in##2##4##(1990-2#1)(1990-8#1)
for lung cancer##17##3##(1990-12#1)(1990-2#1)(1990-8#1)(1995-11#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-11#3)(2008-7#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
for lung##24##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-9#1)(1995-11#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-11#3)(2008-6#1)(2008-7#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
for lymph node metastasis in##2##5##(2009-2#1)(2013-1#1)
for lymph node metastasis##5##4##(1990-2#1)(1996-6#1)(2009-2#1)(2010-8#1)(2013-1#1)
for lymph##8##2##(1990-2#1)(1996-6#1)(1997-7#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-8#1)(2013-1#1)
for lymphocytes##3##2##(1990-3#1)(2008-11#1)(2008-4#1)
for lymphoma##2##2##(2007-1#1)(2008-4#1)
for lysosomal exocytosis##2##3##(2012-12#2)
for lysosomal##3##2##(1991-12#1)(2012-12#2)
for lysozyme##5##2##(1997-2#1)(2008-10#2)(2008-7#2)
for m &gt##2##3##(2008-3#1)(2013-1#1)
for m = 3 and 4 is##2##7##(1991-8#2)
for m = 3 and 4##3##6##(1991-8#3)
for m = 5 and 6##3##6##(1991-8#3)
for m =##7##3##(1991-8#6)(2008-10#1)
for m##11##2##(1991-8#6)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
for m-nitroaniline##2##2##(2008-10#2)
for mAb##2##2##(1996-12#1)(2008-11#1)
for mRNA##4##2##(1990-11#1)(1991-9#1)(2010-11#1)(2012-2#1)
for mRNAs##2##2##(1992-6#1)(2012-2#1)
for macromolecular##2##2##(2008-7#1)(2009-8#1)
for macroscopic##2##2##(2008-10#1)(2010-4#1)
for magnesium##6##2##(2008-10#5)(2008-7#1)
for magnetic resonance imaging##4##4##(1992-3#1)(2006-10#1)(2008-8#1)(2011-2#1)
for magnetic resonance##6##3##(1992-3#1)(2006-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
for magnetic##7##2##(1992-3#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)
for magneto-optical##2##2##(2008-3#2)
for magnolol##2##2##(2008-10#1)(2011-2#1)
for maintaining health##2##3##(2008-10#2)
for maintaining the##7##3##(1992-3#1)(1992-8#1)(1996-2#1)(2008-8#2)(2008-9#2)
for maintaining##29##2##(1990-8#1)(1992-3#1)(1992-8#1)(1996-2#1)(2008-10#3)(2008-11#7)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-3#1)
for maintenance and##2##3##(2008-2#1)(2012-3#1)
for maintenance of glucose##2##4##(1991-7#1)(2008-1#1)
for maintenance of##14##3##(1991-7#1)(1992-9#1)(1995-2#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-7#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
for maintenance##21##2##(1991-7#1)(1992-9#1)(1994-7#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
for maize##4##2##(2008-10#3)(2008-12#1)
for major##15##2##(1993-12#1)(1996-4#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
for making a##4##3##(1992-5#1)(1997-8#1)(2008-3#1)(2010-5#1)
for making absolute##2##3##(2008-10#1)(2008-3#1)
for making accurate##2##3##(2008-10#1)(2008-3#1)
for making##29##2##(1991-11#1)(1992-2#1)(1992-5#1)(1994-1#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-5#1)(2012-2#2)(2013-8#1)
for malaria control in##3##4##(2008-8#1)(2012-3#1)(2013-1#1)
for malaria diagnosis##4##3##(2007-2#3)(2012-12#1)
for malaria in##2##3##(1994-11#1)(2012-12#1)
for malaria##18##2##(1990-3#1)(1994-11#1)(1997-7#1)(2007-2#3)(2008-8#4)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)
for male fertility##2##3##(2008-9#1)(2012-2#1)
for male##14##2##(2007-12#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
for males and females##3##4##(2008-4#1)(2008-5#1)(2008-7#1)
for males and##9##3##(1991-6#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2013-1#1)(2013-7#1)
for males than##2##3##(2008-8#1)(2008-9#1)
for males##25##2##(1991-6#2)(1993-9#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#4)
for malformations##2##2##(2008-10#1)(2011-2#1)
for malignancy##2##2##(1994-5#1)(2011-2#1)
for malignant disease##3##3##(2012-2#2)(2013-1#1)
for malignant melanoma##3##3##(1993-5#1)(2007-5#1)(2008-5#1)
for malignant transformation##2##3##(1990-5#1)(1990-8#1)
for malignant##22##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1992-11#1)(1993-5#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-2#3)(2013-1#2)(2013-8#1)
for malpractice##7##2##(1991-12#1)(1992-2#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-3#1)(2008-3#1)
for mammalian cell##4##3##(2008-11#2)(2008-4#1)(2008-9#1)
for mammalian cells##6##3##(1993-12#1)(2008-11#3)(2008-2#1)(2008-7#1)
for mammalian##17##2##(1993-12#1)(1995-3#1)(2008-11#7)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-9#1)(2012-2#1)
for managed care companies##3##4##(1994-12#1)(1995-1#1)(1996-3#1)
for managed care plans##3##4##(1994-2#1)(1997-1#1)(1997-3#1)
for managed care##21##3##(1992-3#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#3)(1995-12#1)(1996-12#2)(1996-3#4)(1997-1#1)(1997-3#1)(2008-6#1)
for managed competition##2##3##(1994-3#1)(1995-3#1)
for managed##24##2##(1992-3#2)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#4)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#4)(1997-1#1)(1997-3#1)(2008-6#1)
for management and##3##3##(1992-11#1)(2008-10#1)(2008-4#1)
for management development##2##3##(1994-1#1)(1995-3#1)
for management of acute##2##4##(1997-8#1)(2008-3#1)
for management of lesser mealworm##2##5##(2011-2#2)
for management of##31##3##(1990-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)
for management##53##2##(1990-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-1#1)(1994-1#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)
for managers##7##2##(1991-1#2)(1991-12#1)(1993-1#1)(1994-2#2)(1995-12#1)
for managing cultural##2##3##(1993-2#1)(2012-3#1)
for managing patients##2##3##(1995-6#1)(2008-8#1)
for managing##24##2##(1991-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
for mandatory##3##2##(1990-3#1)(2008-7#1)(2013-8#1)
for manganese and##3##3##(2008-10#3)
for manganese##8##2##(2008-10#8)
for manganese(II)##2##2##(2008-10#2)
for manipulating##6##2##(1995-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2009-5#1)(2011-1#1)
for manipulation and##2##3##(2007-11#1)(2008-4#1)
for manipulation##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
for manual##4##2##(2008-10#2)(2008-4#1)(2010-9#1)
for manufacturing##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
for many applications##7##3##(2007-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)
for many clinical##2##3##(1996-2#1)(1997-8#1)
for many decades##2##3##(2008-2#1)(2012-1#1)
for many different purposes##2##4##(2008-5#1)(2008-7#1)
for many different##4##3##(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
for many health care##2##4##(1994-2#1)(2008-11#1)
for many months##3##3##(1996-6#1)(2008-10#1)(2008-9#1)
for many more##2##3##(2008-3#1)(2012-2#1)
for many of the##4##4##(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#1)
for many of these##4##4##(1996-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
for many of##9##3##(1994-2#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)
for many organisms##2##3##(2008-8#1)(2008-9#1)
for many other applications##2##4##(1997-7#1)(2012-2#1)
for many other##5##3##(1997-7#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
for many patients##6##3##(1992-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-4#1)(2012-2#1)
for many people##3##3##(1997-4#1)(2008-12#1)(2010-8#1)
for many researchers##2##3##(2008-7#1)(2012-2#1)
for many species##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
for many women##2##3##(2008-5#2)
for many years and##2##4##(1991-12#1)(2007-12#1)
for many years in##2##4##(2008-5#1)(2010-4#1)
for many years##27##3##(1991-12#1)(1993-3#1)(1994-5#1)(1997-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-7#1)(2012-12#1)(2012-2#1)
for many##153##2##(1991-12#2)(1991-5#1)(1992-2#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#9)(2009-10#2)(2009-4#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#2)
for mapping the##2##3##(2008-3#2)
for mapping##16##2##(1994-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
for marine water##2##3##(2008-10#2)
for marine##9##2##(1996-2#1)(2007-5#1)(2008-10#4)(2008-2#1)(2009-2#1)(2012-12#1)
for marker-assisted selection of##2##4##(2008-10#2)
for marker-assisted selection##7##3##(2008-10#7)
for marker-assisted##8##2##(2008-10#8)
for marketing##4##2##(1991-12#1)(2008-5#1)(2012-2#2)
for mass production of##2##4##(2008-11#2)
for mass production##6##3##(2008-10#2)(2008-11#2)(2008-3#2)
for mass screening##2##3##(1995-4#1)(2008-4#1)
for mass##20##2##(1990-8#1)(1995-4#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#3)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
for massive##4##2##(1992-9#1)(2008-5#1)(2008-7#1)(2012-3#1)
for massively parallel##5##3##(2007-11#1)(2008-2#3)(2009-5#1)
for mast cells##2##3##(2008-4#1)(2008-7#1)
for mast##4##2##(1995-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
for mate##2##2##(1995-6#1)(2008-8#1)
for material##4##2##(2008-11#1)(2008-2#2)(2010-8#1)
for materials##9##2##(1996-12#3)(2007-11#1)(2008-3#2)(2008-7#2)(2012-2#1)
for maternal age##4##3##(1992-2#1)(1995-6#1)(2008-10#1)(2010-6#1)
for maternal and##2##3##(1991-6#1)(2010-5#1)
for maternal##10##2##(1991-6#1)(1992-2#1)(1992-5#1)(1995-6#1)(1996-12#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
for mating type and##3##4##(2008-10#3)
for mating type##8##3##(2008-10#8)
for mating##13##2##(1995-12#1)(2008-10#9)(2008-8#2)(2008-9#1)
for matrix##3##2##(2008-10#1)(2009-3#1)(2010-7#1)
for mature##2##2##(1996-5#1)(2008-9#1)
for maxillary##2##2##(2008-7#1)(2011-2#1)
for maxillofacial surgery##2##3##(1993-1#1)(2012-3#1)
for maxillofacial##3##2##(1993-1#1)(2012-3#1)(2013-1#1)
for maximal enzyme##2##3##(1993-8#1)(2008-4#1)
for maximal##14##2##(1991-5#1)(1992-12#1)(1993-3#1)(1993-8#1)(1997-3#2)(1997-7#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
for maximizing##6##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-2#1)
for maximum protection##2##3##(1992-9#1)(2011-2#1)
for maximum##21##2##(1992-12#1)(1992-9#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#4)
for mean##4##2##(1991-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
for meaningful##3##2##(1993-2#1)(1996-12#1)(2008-8#1)
for measles##2##2##(2011-2#1)(2012-12#1)
for measured##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
for measurement of dissolved##2##4##(2008-10#2)
for measurement of oropharyngeal clearance in##2##6##(1996-2#2)
for measurement of the##12##4##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#4)(2011-2#1)(2013-8#1)
for measurement of##60##3##(1994-1#2)(1995-12#1)(1996-2#2)(2007-11#7)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#3)(2008-6#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
for measurement##67##2##(1994-1#2)(1995-12#1)(1996-2#2)(2007-11#7)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#15)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
for measurements at##2##3##(2008-3#2)
for measurements in##2##3##(2008-3#2)
for measurements of##12##3##(2008-10#3)(2008-2#3)(2008-3#5)(2010-11#1)
for measurements##23##2##(2008-10#5)(2008-2#3)(2008-3#11)(2008-5#1)(2009-9#1)(2010-11#1)(2010-4#1)
for measures##2##2##(1995-2#1)(2008-10#1)
for measuring DPOAEs##2##3##(2008-4#2)
for measuring aberrations##2##3##(2008-3#2)
for measuring and##2##3##(1992-1#1)(2008-3#1)
for measuring birefringence##2##3##(2007-11#1)(2008-3#1)
for measuring chlorine dioxide in##2##5##(2008-10#2)
for measuring clinical##2##3##(1996-3#1)(2010-2#1)
for measuring large-object##2##3##(2008-2#2)
for measuring phase##3##3##(2008-3#3)
for measuring prescribing volume##2##4##(2008-11#2)
for measuring skin hydration##2##4##(2008-5#2)
for measuring the capacity of##2##5##(2008-4#2)
for measuring the concentration of##4##5##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
for measuring the degree of##3##5##(2008-2#1)(2008-3#1)(2012-3#1)
for measuring the diffusion coefficient of homogeneous and layered media##2##10##(2007-12#2)
for measuring the diffusion##3##4##(2007-12#2)(2012-2#1)
for measuring the focal length of a microlens##2##8##(2008-3#2)
for measuring the phase##2##4##(2007-12#1)(2008-3#1)
for measuring the##92##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-6#1)(2007-11#4)(2007-12#10)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#11)(2008-3#30)(2008-4#6)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
for measuring total scattering##2##4##(2008-2#1)(2008-3#1)
for measuring total##3##3##(1995-2#1)(2008-2#1)(2008-3#1)
for measuring##226##2##(1990-11#2)(1990-12#2)(1990-5#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(2007-11#10)(2007-12#11)(2008-1#4)(2008-10#23)(2008-11#5)(2008-2#22)(2008-3#66)(2008-4#19)(2008-5#8)(2008-7#2)(2008-8#3)(2008-9#5)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)
for meat##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
for mechanical loads##2##3##(2008-7#2)
for mechanical ventilation##2##3##(1994-6#1)(2008-11#1)
for mechanical##8##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-6#1)(2013-8#1)
for mechanism-based##3##2##(1993-11#1)(2008-9#1)(2009-9#1)
for medical and social##2##4##(1992-5#1)(1996-3#1)
for medical and##6##3##(1992-5#1)(1993-12#1)(1994-12#1)(1996-3#1)(2008-10#1)(2008-4#1)
for medical applications##2##3##(2009-12#1)(2010-4#1)
for medical appointments##2##3##(2013-8#2)
for medical care##6##3##(1991-12#2)(1993-12#1)(1994-3#1)(1995-2#1)(2008-3#1)
for medical group##5##3##(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#2)
for medical manpower##3##3##(1990-6#3)
for medical personnel##2##3##(2008-10#1)(2013-1#1)
for medical practitioners##2##3##(2009-10#1)(2013-8#1)
for medical staff##4##3##(1992-2#1)(1993-1#1)(1993-12#1)(2012-2#1)
for medical treatment##5##3##(1992-3#1)(2008-1#1)(2008-8#1)(2010-9#1)(2011-2#1)
for medical ultrasound transducers##2##4##(2010-8#2)
for medical##87##2##(1990-3#1)(1990-6#3)(1991-12#4)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#3)(1993-12#4)(1993-6#1)(1994-1#4)(1994-12#2)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#6)
for medically##5##2##(1993-1#2)(2007-2#1)(2008-10#2)
for medication##3##2##(2007-10#1)(2011-1#1)(2011-2#1)
for medications##3##2##(2008-11#1)(2009-6#1)(2013-1#1)
for medicinal##5##2##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
for medicine in the##2##4##(1991-11#1)(2008-7#1)
for medicine##4##2##(1991-11#1)(1992-3#1)(2008-7#1)(2011-2#1)
for medium optimization##2##3##(2008-11#2)
for medium##5##2##(1991-9#1)(2008-11#4)
for medulloblastoma##4##2##(1991-4#1)(1997-3#2)(2008-7#1)
for meeting the##3##3##(1994-2#1)(1997-3#1)(2008-3#1)
for meeting##9##2##(1994-2#2)(1996-9#1)(1997-3#1)(2008-12#1)(2008-3#1)(2010-3#1)(2010-8#1)(2013-1#1)
for meiosis##2##2##(1992-11#1)(2012-2#1)
for meiotic##4##2##(1994-8#1)(2008-7#1)(2008-9#1)(2012-3#1)
for melanoma##10##2##(1992-3#1)(1994-5#1)(1997-7#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for members of the##4##4##(1996-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
for membrane protein##2##3##(2008-7#1)(2011-1#1)
for membrane##8##2##(1990-5#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-1#1)
for membranes containing##2##3##(1996-8#1)(2008-10#1)
for memory##7##2##(1990-3#1)(1993-12#2)(1995-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
for men and women##6##4##(1990-11#1)(1991-11#1)(1997-2#1)(2008-9#1)(2012-12#2)
for men and##7##3##(1990-11#1)(1991-11#1)(1997-2#2)(2008-9#1)(2012-12#2)
for men in Okinawa##2##4##(2008-10#2)
for men in##3##3##(1997-4#1)(2008-10#2)
for men than##2##3##(1991-6#1)(2012-12#1)
for men with prostate cancer##2##5##(2008-7#1)(2009-5#1)
for men with##5##3##(1991-7#1)(2008-7#2)(2009-5#1)(2010-12#1)
for men##35##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-7#1)(1994-5#1)(1996-3#2)(1997-2#2)(1997-4#1)(1997-6#1)(2006-8#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#3)(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#3)
for meningitis##3##2##(2007-8#2)(2008-9#1)
for mental disorders##2##3##(1997-3#1)(2008-1#1)
for mental health nurses##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
for mental health professionals to##2##5##(2009-9#2)
for mental health professionals##4##4##(2008-11#1)(2008-3#1)(2009-9#2)
for mental health##16##3##(1992-12#1)(1992-2#1)(1993-12#1)(2008-11#3)(2008-12#2)(2008-3#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
for mental##22##2##(1992-12#1)(1992-2#1)(1993-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
for mentally retarded##2##3##(1991-6#1)(1997-8#1)
for mequitazine##2##2##(2008-10#2)
for mercuric ion##2##3##(2008-10#2)
for mercury (II)##2##3##(2008-10#2)
for mercury ions were##2##4##(2008-10#2)
for mercury ions##3##3##(2008-10#3)
for mercury speciation##5##3##(2008-10#5)
for mercury##22##2##(1995-3#1)(2008-10#20)(2008-6#1)
for mercury(II) chloride##2##3##(2008-10#2)
for mercury(II)##6##2##(2008-10#6)
for mesh##2##2##(2011-2#1)(2012-12#1)
for mesna and##2##3##(2008-10#2)
for mesothelioma##2##2##(1991-12#2)
for meta-analysis##6##2##(1995-12#1)(1995-2#1)(1997-8#2)(2008-10#1)(2008-9#1)
for metabolic syndrome##3##3##(2008-3#1)(2009-2#1)(2012-12#1)
for metabolic##13##2##(1994-6#1)(1995-8#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-8#2)(2009-2#1)(2012-12#1)
for metal analysis##2##3##(2008-10#2)
for metal binding##2##3##(2008-10#1)(2009-7#1)
for metal ion##4##3##(2008-10#4)
for metal ions##8##3##(2008-10#8)
for metal##27##2##(2008-10#23)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)
for metals##3##2##(2008-10#2)(2009-8#1)
for metastases##3##2##(1992-2#1)(2007-11#1)(2008-6#1)
for metastasis##4##2##(2007-11#1)(2008-1#1)(2008-4#1)(2008-6#1)
for metastatic breast##2##3##(1994-2#1)(1994-8#1)
for metastatic disease##4##3##(2007-11#3)(2013-1#1)
for metastatic renal cell carcinoma##3##5##(1991-8#2)(1993-12#1)
for metastatic##16##2##(1991-8#2)(1993-12#1)(1994-2#1)(1994-8#1)(2007-11#4)(2007-7#1)(2010-12#2)(2011-2#2)(2011-3#1)(2013-1#1)
for metered dose inhalers##2##4##(1996-1#2)
for metformin##2##2##(2010-5#1)(2012-2#1)
for methane##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)
for methanol and##2##3##(2008-10#2)
for methanol##6##2##(1991-5#2)(2008-10#4)
for methanotrophic##2##2##(2008-6#1)(2008-7#1)
for methicillin-resistant##2##2##(2010-6#1)(2012-2#1)
for method##2##2##(2008-10#1)(2010-11#1)
for methods A and B##3##5##(2008-10#3)
for methyl##5##2##(1992-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
for methylamine##2##2##(2008-10#2)
for methylated##4##2##(1993-11#1)(1994-12#1)(2008-10#1)(2009-6#1)
for methyldopa##2##2##(2008-10#2)
for methylene##2##2##(2008-10#2)
for metric##2##2##(1992-6#1)(1995-6#1)
for metronidazole##2##2##(2008-10#1)(2011-2#1)
for mice##6##2##(1991-8#1)(1995-11#1)(2008-4#2)(2008-5#1)(2008-8#1)
for micro amounts of nucleic acids##2##6##(2008-10#2)
for micro##3##2##(2008-10#2)(2013-1#1)
for microarray##4##2##(2008-7#1)(2008-8#2)(2009-8#1)
for microbial##5##2##(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
for microbiological##3##2##(2008-5#1)(2010-4#1)(2012-2#1)
for microchip##3##2##(2008-10#3)
for microcystin-LR##2##2##(2008-10#2)
for microfluidic##2##2##(2008-10#2)
for microinjection##2##2##(2008-2#1)(2008-4#1)
for micromolar concentrations of the##2##5##(2008-10#1)(2008-3#1)
for microorganisms##2##2##(2008-5#1)(2008-6#1)
for microscale analytical systems##2##4##(2008-10#2)
for microscopic##6##2##(2008-3#3)(2008-4#1)(2008-9#1)(2013-8#1)
for microscopy##5##2##(2007-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-7#1)
for microsomal samples##2##3##(1990-8#2)
for microsomal##3##2##(1990-8#2)(1997-8#1)
for microsurgery##2##2##(1996-2#2)
for microtubule association##2##3##(1995-2#2)
for microwave##6##2##(2007-12#2)(2008-10#3)(2008-2#1)
for middle##5##2##(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2009-10#1)
for midwives##3##2##(2008-11#1)(2012-12#1)(2012-3#1)
for migraine##3##2##(2008-6#1)(2008-9#2)
for migration time and##3##4##(2008-10#3)
for migration time##5##3##(2008-10#5)
for migration times##2##3##(2008-10#2)
for migration##13##2##(1994-8#1)(1995-8#3)(2008-10#7)(2008-7#2)
for mild##12##2##(1992-6#1)(1993-1#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#2)
for milk##5##2##(1995-8#1)(2008-10#1)(2012-2#1)(2013-1#2)
for mineral##4##2##(2008-10#3)(2008-6#1)
for mineralization##2##2##(2008-10#1)(2008-7#1)
for mineralogical##2##2##(2008-10#2)
for minicircle##2##2##(2010-2#2)
for minimal##4##2##(2008-2#2)(2010-11#1)(2012-2#1)
for minimally invasive##3##3##(2007-8#1)(2009-12#1)(2011-1#1)
for minimally##4##2##(2007-8#1)(2008-10#1)(2009-12#1)(2011-1#1)
for minimising##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
for minimization of##2##3##(1993-2#1)(2008-10#1)
for minimizing##7##2##(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#2)
for mining##2##2##(2008-4#2)
for minor##2##2##(2008-10#1)(2008-7#1)
for minorities##2##2##(1993-12#1)(1994-12#1)
for minority##2##2##(1997-2#1)(2010-11#1)
for minors##2##2##(1994-2#1)(1996-5#1)
for misalignment##2##2##(2008-3#2)
for mission##2##2##(1992-2#2)
for mitochondrial DNA (mtDNA)##2##4##(2008-10#2)
for mitochondrial DNA##4##3##(2008-10#3)(2009-2#1)
for mitochondrial diseases##2##3##(2008-11#1)(2012-3#1)
for mitochondrial function##2##3##(2007-12#1)(2013-1#1)
for mitochondrial##10##2##(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-2#1)(2012-3#1)(2013-1#1)
for mitomycin C##2##3##(1995-5#2)
for mitral cell##2##3##(2013-1#2)
for mitral valve repair##4##4##(2008-10#1)(2009-7#1)(2011-2#2)
for mitral valve##6##3##(2008-10#1)(2009-7#1)(2011-2#3)(2013-1#1)
for mitral##11##2##(1990-3#1)(2008-10#2)(2009-7#1)(2011-2#4)(2013-1#3)
for mixed##5##2##(1990-8#1)(1997-6#1)(2008-10#2)(2009-7#1)
for mixed-phase and ice##2##4##(2008-2#2)
for mixing##3##2##(2008-10#2)(2008-12#1)
for mixture##2##2##(2008-10#2)
for mixtures##2##2##(2008-10#2)
for mobile facilities##3##3##(1992-5#3)
for mobile##8##2##(1992-5#3)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
for mobilization##2##2##(1992-6#1)(2013-8#1)
for mode##5##2##(2007-11#2)(2008-3#2)(2011-1#1)
for mode-locked operation was##2##4##(2007-12#1)(2008-2#1)
for model selection##2##3##(2009-12#1)(2011-1#1)
for model##6##2##(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)
for modeling a##2##3##(2008-3#1)(2009-11#1)
for modeling of##2##3##(2007-12#1)(2008-11#1)
for modeling the##10##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-3#1)(2013-1#1)
for modeling##35##2##(2007-11#4)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#7)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#2)(2009-4#1)(2010-3#1)(2010-8#1)(2013-1#2)(2013-8#1)
for modelling the##2##3##(1993-9#1)(2010-8#1)
for modelling##9##2##(1993-9#1)(1994-2#1)(1997-7#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-3#2)(2012-3#1)
for models I and II##2##5##(2008-10#2)
for models##6##2##(1991-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
for moderate or severe hypothermia##2##5##(2011-2#2)
for moderate to severe##2##4##(2008-6#1)(2013-1#1)
for moderate##11##2##(1992-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
for modern##10##2##(1993-12#1)(1994-3#2)(1995-5#1)(1997-5#1)(2008-2#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
for modification##4##2##(1992-5#1)(1993-3#1)(2008-4#1)(2009-10#1)
for modifications to##2##3##(2008-12#1)(2008-3#1)
for modified##2##2##(1993-8#1)(2008-10#1)
for modifying##6##2##(1991-3#1)(1996-1#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#1)
for modulating##2##2##(2008-5#1)(2008-7#1)
for modulation amplitudes##2##3##(2008-3#2)
for modulation##3##2##(1997-4#1)(2008-3#2)
for moisture##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
for molecular analysis##2##3##(1994-8#1)(2010-9#1)
for molecular biology##2##3##(2008-8#1)(2008-9#1)
for molecular characterization##2##3##(1990-11#1)(1995-11#1)
for molecular cytogenetics##2##3##(2008-9#2)
for molecular diagnostics##2##3##(2009-12#1)(2011-2#1)
for molecular dynamics simulations of various physical systems##2##8##(2013-1#2)
for molecular dynamics simulations of##3##5##(1992-6#1)(2013-1#2)
for molecular genetic##2##3##(2008-10#1)(2008-4#1)
for molecular imaging##2##3##(2010-6#1)(2010-9#1)
for molecular spectroscopy##2##3##(2008-10#1)(2008-3#1)
for molecular##38##2##(1990-11#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
for molecules##8##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#1)(2012-12#2)
for molybdenum##6##2##(2008-10#6)
for money##4##2##(1993-2#1)(1994-2#1)(1997-5#1)(2008-9#1)
for monitoring and analysing##2##4##(1994-9#2)
for monitoring and##6##3##(1994-9#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)
for monitoring dedifferentiation##2##3##(2008-11#2)
for monitoring diseases##2##3##(2008-10#1)(2009-12#1)
for monitoring environmental##3##3##(2008-10#3)
for monitoring formaldehyde##3##3##(2008-10#3)
for monitoring in##2##3##(2006-6#1)(2008-3#1)
for monitoring metal##2##3##(1994-11#2)
for monitoring of##11##3##(1992-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
for monitoring the index of refraction##2##6##(2008-3#2)
for monitoring the progress of##2##5##(2008-10#1)(2013-8#1)
for monitoring the response of##2##5##(2006-6#1)(2013-7#1)
for monitoring the response##4##4##(2006-6#1)(2012-2#1)(2012-3#1)(2013-7#1)
for monitoring the service condition of diesel-engine lubricating oils##2##9##(2008-10#2)
for monitoring the##36##3##(1991-2#1)(1996-12#1)(1997-3#1)(2006-6#1)(2007-8#1)(2008-10#17)(2008-3#5)(2008-4#2)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
for monitoring their##2##3##(1994-12#1)(2008-11#1)
for monitoring trace##3##3##(2008-10#3)
for monitoring##133##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-9#2)(1995-2#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#53)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
for mono- and##2##3##(1991-7#1)(2008-10#1)
for mono-##5##2##(1991-7#1)(2008-10#4)
for monodisperse##2##2##(2008-10#1)(2008-3#1)
for monolithic##2##2##(2008-10#2)
for monosaccharide##2##2##(1997-2#1)(2008-10#1)
for monovalent cations##2##3##(2008-10#2)
for monovalent##4##2##(1992-6#1)(2008-10#3)
for months##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
for mood disorders##2##3##(1996-7#1)(2008-7#1)
for mood##3##2##(1996-7#1)(2008-7#1)(2012-2#1)
for moral##2##2##(2008-5#1)(2013-8#1)
for morbidity##3##2##(2007-8#1)(2012-1#1)(2012-3#1)
for more accurate##5##3##(1992-9#1)(2008-10#1)(2008-3#1)(2009-6#1)(2013-1#1)
for more aggressive isolates##2##4##(2008-10#2)
for more appropriate##2##3##(1994-1#1)(1994-2#1)
for more complex##2##3##(2008-3#1)(2008-9#1)
for more comprehensive##4##3##(1995-2#1)(2006-10#1)(2008-4#2)
for more detailed##2##3##(1995-12#2)
for more effective##4##3##(1990-12#1)(2008-10#2)(2008-4#1)
for more information##3##3##(1996-3#1)(2008-4#1)(2008-9#1)
for more intensive##2##3##(2008-8#2)
for more patients##2##3##(1994-12#1)(2011-2#1)
for more precise##2##3##(2008-11#1)(2008-4#1)
for more research##3##3##(1995-11#1)(2008-4#1)(2010-3#1)
for more sensitive and##2##4##(1992-6#1)(2011-2#1)
for more than 1 year##3##5##(2008-10#1)(2008-7#1)(2009-12#1)
for more than 1##10##4##(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#3)(2011-2#2)(2013-8#1)
for more than 10 years##2##5##(1990-9#1)(2008-11#1)
for more than 10##4##4##(1990-9#1)(2008-11#2)(2008-9#1)
for more than 100##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
for more than 12 days##2##5##(2008-11#2)
for more than 12 months##2##5##(1991-11#1)(1996-6#1)
for more than 12##6##4##(1990-12#1)(1991-11#1)(1996-6#1)(2008-11#2)(2012-2#1)
for more than 15 years##2##5##(2008-10#1)(2013-1#1)
for more than 15##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
for more than 16##3##4##(2012-3#1)(2013-1#2)
for more than 2 months##2##5##(2008-10#2)
for more than 2 weeks##2##5##(2008-10#1)(2011-2#1)
for more than 2##5##4##(2008-10#3)(2008-11#1)(2011-2#1)
for more than 20 years##4##5##(1993-3#1)(2008-7#1)(2011-2#2)
for more than 22##2##4##(1994-2#1)(2011-2#1)
for more than 24##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
for more than 3 months##3##5##(2008-10#3)
for more than 30 years##2##5##(2008-6#1)(2010-10#1)
for more than 4##5##4##(2007-7#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)
for more than 5##2##4##(1991-8#1)(2008-10#1)
for more than 50##3##4##(1996-3#1)(2008-10#2)
for more than 50% of##2##5##(2011-2#2)
for more than 6 months##2##5##(1991-2#1)(2008-10#1)
for more than 80 years##2##5##(1995-11#1)(2012-2#1)
for more than 80##3##4##(1995-11#1)(2008-10#1)(2012-2#1)
for more than a century##5##5##(1992-5#1)(1994-3#2)(2008-8#1)(2013-8#1)
for more than a decade##3##5##(1994-12#1)(1996-5#1)(2009-5#1)
for more than a##9##4##(1992-5#1)(1994-12#1)(1994-3#2)(1996-5#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-8#1)
for more than four decades##2##5##(2011-2#1)(2012-3#1)
for more than four##4##4##(1992-4#1)(2008-10#1)(2011-2#1)(2012-3#1)
for more than one week##2##5##(1992-1#1)(1994-12#1)
for more than one##6##4##(1992-1#1)(1993-3#1)(1994-12#1)(2008-10#1)(2009-12#1)(2011-2#1)
for more than six months##2##5##(2008-1#1)(2008-7#1)
for more than three months##5##5##(1990-12#2)(1996-3#2)(2012-3#1)
for more than three##7##4##(1990-12#2)(1996-3#2)(2006-6#1)(2012-3#2)
for more than two weeks##2##5##(1991-9#1)(2009-2#1)
for more than two##4##4##(1990-6#1)(1991-9#1)(2008-10#1)(2009-2#1)
for more than##125##3##(1990-12#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-3#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-12#4)(2009-2#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#6)(2013-8#2)
for more##209##2##(1990-11#1)(1990-12#5)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-1#3)(2008-10#38)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#7)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#15)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#9)(2013-8#3)
for morphine##3##2##(2007-11#1)(2008-10#2)
for morphological index##2##3##(2008-8#2)
for morphological##9##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-8#1)
for mortality and morbidity##2##4##(1992-2#1)(2011-3#1)
for mortality and##3##3##(1992-2#1)(2008-3#1)(2011-3#1)
for mortality in##2##3##(2008-2#1)(2011-2#1)
for mortality##7##2##(1992-2#1)(1995-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2011-3#1)
for most applications##2##3##(2008-3#1)(2008-9#1)
for most combinations of##2##4##(2008-10#1)(2008-8#1)
for most elements##3##3##(2008-10#3)
for most locations##2##3##(2008-10#1)(2008-5#1)
for most of the analytes##3##5##(2008-10#3)
for most of the compounds##2##5##(2008-10#2)
for most of the elements##3##5##(2008-10#3)
for most of the##35##4##(1991-9#1)(1994-12#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
for most of these##3##4##(2008-10#3)
for most of##45##3##(1991-1#1)(1991-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
for most patients with##4##4##(1991-6#1)(2011-1#1)(2013-1#2)
for most patients##6##3##(1991-6#1)(1994-5#1)(2007-8#1)(2011-1#1)(2013-1#2)
for most procedures##2##3##(1993-12#1)(2012-2#1)
for most##120##2##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
for mother and foetus##2##4##(1992-5#1)(2007-2#1)
for mother and##3##3##(1992-5#1)(2007-2#1)(2008-7#1)
for mothers in##2##3##(1994-2#1)(1994-3#1)
for mothers##10##2##(1990-10#1)(1991-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(2007-2#1)(2008-10#1)(2013-1#2)
for motion##2##2##(2008-10#1)(2008-6#1)
for motor##4##2##(1991-2#1)(2008-7#1)(2010-12#1)(2013-8#1)
for mouse##8##2##(1993-8#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
for mouth##3##2##(1990-8#2)(1991-2#1)
for movement##3##2##(1991-5#1)(1993-9#1)(2008-10#1)
for moving the##2##3##(2007-12#1)(2008-7#1)
for moving##6##2##(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-9#1)
for mtDNA##3##2##(2008-10#2)(2008-8#1)
for mu##2##2##(1993-12#1)(1995-6#1)
for mu(a) and mu(s)'##2##4##(2008-3#2)
for much of the##6##4##(1993-11#1)(1993-12#1)(1995-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
for much of their##2##4##(1994-2#1)(2008-10#1)
for much of##8##3##(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
for much##12##2##(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-1#1)
for mucormycosis##3##2##(2011-2#3)
for multi-element analysis##2##3##(2008-10#2)
for multi-element##4##2##(2007-12#1)(2008-10#3)
for multianalyte detection##2##3##(2008-10#2)
for multianalyte##4##2##(2008-10#3)(2008-7#1)
for multicellular##2##2##(2008-11#1)(2010-3#1)
for multichannel##3##2##(2007-12#1)(2008-3#2)
for multicolor flow##2##3##(2008-9#2)
for multicomponent##3##2##(1991-9#1)(2008-10#1)(2012-3#1)
for multidimensional##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
for multidisciplinary##2##2##(2008-3#1)(2013-8#1)
for multidrug resistance##5##3##(1991-12#2)(2008-11#1)(2013-1#2)
for multilayer interference coatings##2##4##(2008-3#2)
for multilayer##6##2##(2007-12#1)(2008-3#4)(2011-2#1)
for multilevel##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
for multiparameter##2##2##(2008-11#1)(2008-9#1)
for multiphoton##2##2##(2007-12#1)(2012-2#1)
for multiple comparisons##3##3##(2008-11#2)(2013-8#1)
for multiple diseases##2##3##(2008-10#1)(2008-7#1)
for multiple failure time data##2##5##(1997-4#2)
for multiple generations##2##3##(2008-10#1)(2011-2#1)
for multiple injuries##2##3##(1990-2#2)
for multiple levels of##2##4##(2007-11#1)(2012-1#1)
for multiple markers##2##3##(2007-7#1)(2008-10#1)
for multiple passages##2##3##(2008-11#2)
for multiple scattering##3##3##(2008-3#3)
for multiple sclerosis (MS)##3##4##(1995-12#1)(2007-11#1)(2010-12#1)
for multiple sclerosis##7##3##(1995-12#1)(2007-11#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-8#1)
for multiple wavelengths##2##3##(2008-2#2)
for multiple##70##2##(1990-2#2)(1990-9#1)(1991-12#1)(1991-6#2)(1993-2#1)(1994-8#2)(1995-12#1)(1997-4#3)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
for multiplex##3##2##(2008-10#2)(2008-3#1)
for multiplexed##2##2##(2008-9#2)
for multiplexing##3##2##(2007-12#1)(2008-3#2)
for multivariate##6##2##(1992-6#1)(2008-10#4)(2008-6#1)
for multivessel##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
for multiwavelength##2##2##(2008-3#2)
for murine##4##2##(1993-8#1)(1997-4#1)(2008-11#1)(2008-4#1)
for muscarinic##5##2##(1990-5#1)(1992-10#1)(1995-12#1)(1997-7#1)(2010-5#1)
for muscle##6##2##(1990-5#1)(1995-8#1)(2008-11#2)(2012-12#1)(2013-1#1)
for muscularity##2##2##(2007-12#2)
for musculoskeletal##6##2##(2007-11#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
for music##2##2##(2008-9#2)
for musical##2##2##(2008-7#1)(2013-1#1)
for mutant##2##2##(2008-8#1)(2008-9#1)
for mutation##2##2##(2008-4#1)(2008-7#1)
for mutations in the##2##4##(1991-12#1)(2008-3#1)
for mutations in##4##3##(1991-12#1)(1994-11#1)(2008-3#1)(2008-4#1)
for mutations that##2##3##(2008-4#1)(2008-9#1)
for mutations##7##2##(1991-12#1)(1993-9#1)(1994-11#1)(2008-3#1)(2008-4#2)(2008-9#1)
for mutual##2##2##(2009-9#1)(2011-2#1)
for mycelial##2##2##(2008-10#2)
for myeloid##3##2##(2008-4#1)(2012-2#1)(2013-1#1)
for myocardial infarction##5##3##(1991-6#1)(1992-12#1)(2008-10#1)(2009-9#1)(2013-1#1)
for myocardial protection##2##3##(1991-3#1)(1996-9#1)
for myocardial regeneration##3##3##(2010-10#1)(2010-6#2)
for myocardial##14##2##(1991-3#1)(1991-6#1)(1992-12#1)(1996-9#2)(2006-10#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
for myoglobin##2##2##(2008-10#2)
for myosin##2##2##(1990-11#1)(1991-2#1)
for nadir##2##2##(2008-2#1)(2008-3#1)
for nanoparticles functionalized with##2##4##(2008-4#2)
for nanoparticles##3##2##(2008-4#2)(2010-12#1)
for nanosecond laser##2##3##(2007-11#1)(2008-3#1)
for nanosecond##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
for nanotechnology##2##2##(2008-11#1)(2010-12#1)
for naphazoline##2##2##(2008-10#2)
for naproxen##3##2##(2008-10#2)(2010-5#1)
for narrow-band##3##2##(2007-11#2)(2008-3#1)
for nasal##2##2##(2011-1#1)(2011-2#1)
for nasopharyngeal carcinoma##4##3##(1991-2#2)(1991-8#1)(2008-9#1)
for national health##2##3##(1992-3#1)(2012-12#1)
for national##8##2##(1992-12#1)(1992-3#1)(2007-6#1)(2007-7#2)(2008-11#1)(2011-1#1)(2012-12#1)
for native##7##2##(1990-5#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
for natural##14##2##(1991-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
for near-field optical##2##3##(2008-3#2)
for near-field##4##2##(2008-2#1)(2008-3#2)(2010-10#1)
for nearly 30 years##2##4##(1995-1#1)(1996-3#1)
for nearly a##2##3##(1997-7#1)(2011-2#1)
for nearly all##2##3##(2008-10#1)(2008-7#1)
for nearly##21##2##(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#1)(1996-11#1)(1996-3#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
for necropsy##2##2##(2008-5#1)(2010-7#1)
for necrotrophic##2##2##(2008-10#2)
for needle##2##2##(2008-8#1)(2009-12#1)
for negative##6##2##(1990-8#1)(1997-5#1)(2008-11#2)(2008-2#1)(2008-6#1)
for negligent##2##2##(1991-12#1)(1993-12#1)
for neonatal##4##2##(1991-11#1)(1991-2#2)(2008-11#1)
for neoplastic##5##2##(1992-5#1)(1993-3#1)(1994-5#1)(2007-11#1)(2010-3#1)
for nephrectomy in##2##3##(2008-10#2)
for nephrectomy##3##2##(2007-7#1)(2008-10#2)
for nephrotoxicity##2##2##(1994-5#1)(1995-3#1)
for nerve##5##2##(1993-1#1)(1995-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
for nervous system##3##3##(2008-7#2)(2009-8#1)
for network##2##2##(1992-3#1)(2010-1#1)
for neural##5##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
for neurobiological studies##2##3##(1992-10#1)(1997-6#1)
for neurobiological##3##2##(1992-10#1)(1994-6#1)(1997-6#1)
for neurodegenerative diseases##2##3##(2012-2#1)(2013-1#1)
for neurodegenerative##4##2##(2008-7#1)(2012-2#2)(2013-1#1)
for neurogenic##2##2##(2008-10#1)(2008-9#1)
for neurological##2##2##(1991-6#1)(2011-2#1)
for neuron-glial##2##2##(2008-7#1)(2009-3#1)
for neuron-specific enolase##2##3##(1991-8#1)(1992-2#1)
for neuronal##9##2##(1995-12#1)(1995-8#1)(2007-12#2)(2008-7#4)(2012-2#1)
for neurons##3##2##(1996-12#1)(2009-3#1)(2009-5#1)
for neuropathic pain based on recent clinical trials##2##8##(2008-9#2)
for neuropathic pain##8##3##(1997-3#1)(2008-9#6)(2012-12#1)
for neuropsychiatric##2##2##(2011-1#1)(2012-3#1)
for neuroscience##4##2##(1995-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
for neurotransmitters##3##2##(1993-3#1)(2008-4#1)(2012-1#1)
for neurotrophins in##3##3##(1995-8#1)(1996-12#2)
for neutral##3##2##(1991-7#2)(2013-1#1)
for neutron capture therapy##2##4##(1994-3#2)
for neutrophil##2##2##(2008-11#1)(2008-7#1)
for new and##2##3##(2008-10#1)(2008-6#1)
for new antibiotics##2##3##(2008-10#1)(2010-12#1)
for new applications##2##3##(1991-2#1)(2008-10#1)
for new biological##2##3##(2008-10#1)(2008-4#1)
for new drug##2##3##(2008-4#1)(2008-5#1)
for new graduates##2##3##(1993-11#1)(1995-1#1)
for new health##2##3##(1995-12#1)(1996-2#1)
for new mothers##2##3##(2007-2#1)(2012-12#1)
for new parents##2##3##(1995-1#1)(2008-11#1)
for new strategies##2##3##(2008-8#1)(2011-2#1)
for new therapeutic##2##3##(2008-5#1)(2013-1#1)
for new therapies##2##3##(2008-3#1)(2011-2#1)
for new treatments for##2##4##(2010-7#1)(2012-1#1)
for new##80##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-3#2)(1996-2#3)(1997-1#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#4)
for newborn##4##2##(1990-11#1)(1995-5#1)(2007-2#1)(2010-8#1)
for newborns##2##2##(1991-12#1)(1991-3#1)
for newer##3##2##(1991-12#1)(1993-11#1)(2008-7#1)
for newly admitted patients##2##4##(1991-1#2)
for newly##5##2##(1990-6#1)(1991-1#2)(2008-9#1)(2010-3#1)
for next year##2##3##(2009-9#1)(2011-2#1)
for next##5##2##(2008-12#1)(2009-9#1)(2011-2#2)(2012-1#1)
for next-generation##4##2##(2008-3#1)(2008-7#2)(2009-5#1)
for nicarbazin##2##2##(2007-6#2)
for nickel determination in food samples##2##6##(2008-10#2)
for nickel determination in##4##4##(2008-10#4)
for nickel determination##5##3##(2008-10#5)
for nickel in##2##3##(2008-10#2)
for nickel##16##2##(2008-10#16)
for nine months##3##3##(2007-2#1)(2008-5#1)(2010-11#1)
for nine replicate##2##3##(2008-10#2)
for nine##17##2##(1991-12#1)(1991-6#1)(1992-5#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-11#1)(2012-3#1)
for nitrate and##3##3##(2008-10#1)(2008-2#2)
for nitrate determination##2##3##(2008-10#2)
for nitrate##10##2##(2008-10#8)(2008-2#2)
for nitric oxide (NO)##2##4##(1997-2#1)(2008-3#1)
for nitric oxide##4##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)
for nitric##5##2##(1991-3#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)
for nitrite and nitrate##2##4##(2008-10#2)
for nitrite and##6##3##(2008-10#6)
for nitrite based on##2##4##(2008-10#2)
for nitrite determination in##2##4##(2008-10#2)
for nitrite determination##3##3##(2008-10#3)
for nitrite##18##2##(2008-10#18)
for nitrogen and phosphorus##2##4##(2008-10#2)
for nitrogen determination in##2##4##(2008-10#2)
for nitrogen dioxide##2##3##(2008-10#2)
for nitrogen##6##2##(2008-10#6)
for no obvious reason##2##4##(2008-11#1)(2010-12#1)
for no##6##2##(2007-6#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-12#1)
for nodal##2##2##(1990-8#1)(2008-2#1)
for nodes##2##2##(1990-12#1)(2008-6#1)
for noise and##2##3##(2008-2#1)(2012-1#1)
for noise reduction##2##3##(2008-10#1)(2008-2#1)
for noise suppression##2##3##(2008-3#2)
for noise##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)
for noiseless##2##2##(2008-3#2)
for noisy##2##2##(2008-2#2)
for non##6##2##(1992-5#1)(1995-11#2)(2008-1#1)(2008-3#1)(2008-4#1)
for non-addictive psychoactive drug##2##4##(2012-3#2)
for non-biological##2##2##(1997-3#1)(2008-5#1)
for non-invasive##5##2##(1993-3#1)(2007-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
for non-linear##2##2##(2008-10#2)
for non-proteolytic C##2##3##(2011-2#2)
for non-small cell lung##2##4##(2008-2#1)(2008-4#1)
for non-smokers##2##2##(2008-12#2)
for non-specific##2##2##(2008-10#1)(2011-1#1)
for non-vitality##2##2##(1994-7#2)
for noncardiac##3##2##(1992-6#1)(2006-10#1)(2011-2#1)
for nondestructive evaluation of##3##4##(2007-12#2)(2008-2#1)
for nondestructive##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
for nondisplaced scaphoid##2##3##(2008-9#2)
for nonintrusive##2##2##(2008-2#2)
for noninvasive##6##2##(1995-12#1)(2007-11#1)(2007-4#1)(2008-3#2)(2008-7#1)
for nonlinear optical##3##3##(2007-12#2)(2008-2#1)
for nonlinear##13##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#4)
for nonoverlapping noise##2##3##(2008-2#2)
for nonprofit hospitals##4##3##(1993-1#2)(1993-2#1)(1996-2#1)
for nonprofit managers##2##3##(1994-12#2)
for nonprofit organizations##2##3##(1992-3#1)(1995-3#1)
for nonprofit##9##2##(1992-3#2)(1993-1#2)(1993-2#1)(1994-12#2)(1995-3#1)(1996-2#1)
for nonrandom##2##2##(2008-10#1)(2011-1#1)
for nonspecific##3##2##(2008-10#1)(2008-4#1)(2010-1#1)
for nonspherical particles##4##3##(2008-2#2)(2008-3#2)
for nonspherical##5##2##(2008-2#3)(2008-3#2)
for nonunion##2##2##(2008-8#1)(2011-2#1)
for nonvolatile##2##2##(2008-2#1)(2008-3#1)
for noradrenaline and##2##3##(1990-8#1)(2008-10#1)
for noradrenaline##3##2##(1990-8#1)(2008-10#2)
for norfloxacin##5##2##(2008-10#2)(2010-5#1)(2012-2#2)
for normal FIA and reversed FIA respectively##2##7##(2008-10#2)
for normal embryo development##2##4##(2009-8#2)
for normal growth and##2##4##(2008-11#1)(2009-10#1)
for normal mouse##2##3##(1992-10#1)(1995-2#1)
for normal##35##2##(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#3)
for normalization##2##2##(2008-2#1)(2012-2#1)
for normalizing##2##2##(2008-10#1)(2009-10#1)
for normally distributed data and##2##5##(1994-2#1)(2013-1#1)
for normally incident##3##3##(2008-2#2)(2008-3#1)
for normally##7##2##(1994-2#1)(2007-12#2)(2008-2#2)(2008-3#1)(2013-1#1)
for norovirus##2##2##(2009-3#1)(2013-8#1)
for not only the##2##4##(1992-2#1)(2008-3#1)
for not only##4##3##(1992-2#1)(1995-2#1)(1995-5#1)(2008-3#1)
for not using##2##3##(2007-10#1)(2011-2#1)
for not##15##2##(1992-2#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-10#2)(2008-1#1)(2008-3#1)(2011-2#3)(2013-7#1)
for novel therapies##2##3##(2008-4#1)(2008-7#1)
for novel##23##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
for now##4##2##(1996-3#1)(2008-10#2)(2011-2#1)
for nuclear factor kappa B##2##5##(1992-12#1)(2013-1#1)
for nuclear transport##3##3##(1991-2#2)(2011-2#1)
for nuclear##23##2##(1991-2#2)(1991-5#1)(1992-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#5)(2011-2#1)(2013-1#3)
for nucleic acid##3##3##(2008-4#1)(2008-5#1)(2009-6#1)
for nucleic acids is##2##4##(2008-10#1)(2010-10#1)
for nucleic acids##4##3##(1991-6#1)(1997-6#1)(2008-10#1)(2010-10#1)
for nucleic##8##2##(1991-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-2#1)
for nucleotide##5##2##(1991-5#1)(1994-12#1)(2008-4#2)(2008-9#1)
for number of##2##3##(2013-1#1)(2013-8#1)
for number##5##2##(2008-2#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
for numerical reconstruction##2##3##(2008-3#2)
for numerical##11##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2012-3#1)
for numerous##4##2##(2007-11#1)(2008-10#2)(2012-2#1)
for nurse educators##2##3##(2008-11#2)
for nurse##5##2##(2008-11#4)(2010-4#1)
for nurses and##4##3##(1997-7#1)(2008-11#1)(2008-12#2)
for nurses in##4##3##(2008-11#2)(2008-12#1)(2010-10#1)
for nurses to##3##3##(2008-11#1)(2010-11#1)(2011-1#1)
for nurses working in##2##4##(2008-11#1)(2013-8#1)
for nurses##36##2##(1992-1#1)(1993-1#1)(1995-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-11#12)(2008-12#7)(2008-9#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-8#3)
for nursing and medical students##2##5##(2008-11#1)(2008-12#1)
for nursing education##4##3##(1996-3#1)(2008-11#1)(2008-12#2)
for nursing home care##3##4##(1992-3#1)(1993-3#1)(1996-3#1)
for nursing home##9##3##(1990-5#1)(1991-2#1)(1992-3#1)(1993-3#2)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
for nursing leadership##2##3##(2008-1#1)(2008-12#1)
for nursing practice##2##3##(2008-11#2)
for nursing research##5##3##(1996-3#1)(2007-10#2)(2013-1#2)
for nursing students and##2##4##(2008-11#1)(2008-12#1)
for nursing students##3##3##(2008-11#2)(2008-12#1)
for nursing##43##2##(1990-12#1)(1990-5#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-2#1)(1996-2#1)(1996-3#4)(1997-1#1)(1997-7#1)(2007-10#3)(2008-1#1)(2008-11#8)(2008-12#6)(2012-3#3)(2013-1#4)
for nutrient immobilization##2##3##(2013-1#2)
for nutrient##5##2##(2008-10#1)(2008-12#1)(2009-8#1)(2013-1#2)
for nutrients##7##2##(2007-12#1)(2008-10#6)
for nutrition and##2##3##(1997-1#1)(2008-10#1)
for nutrition##5##2##(1991-3#1)(1997-1#1)(2007-8#1)(2008-10#1)(2011-2#1)
for obese##2##2##(2011-2#1)(2012-12#1)
for obesity##6##2##(2008-1#1)(2008-11#1)(2008-4#2)(2010-8#1)(2011-2#1)
for object diameters &gt##2##4##(2012-1#2)
for object##5##2##(1996-2#1)(2008-2#1)(2008-3#1)(2012-1#2)
for objective##3##2##(2008-3#1)(2008-5#2)
for objects or##2##3##(1993-2#1)(2007-12#1)
for objects that##2##3##(2007-12#1)(2008-3#1)
for objects##11##2##(1993-2#1)(1996-2#1)(2007-12#3)(2008-2#1)(2008-3#5)
for observation of the Earth##2##5##(2008-3#2)
for observation of##3##3##(2008-10#1)(2008-3#2)
for observation##7##2##(1992-2#1)(2006-5#1)(2008-10#2)(2008-3#2)(2012-12#1)
for observed##2##2##(1996-5#1)(2013-1#1)
for observing the##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
for observing##8##2##(2008-1#1)(2008-2#1)(2008-3#3)(2008-8#1)(2011-2#1)(2013-8#1)
for obstetrical##2##2##(1994-1#2)
for obstructive sleep apnea syndrome##4##5##(2007-12#2)(2010-5#2)
for obstructive sleep apnea##7##4##(2007-12#4)(2010-5#2)(2013-7#1)
for obstructive##8##2##(2007-12#4)(2008-12#1)(2010-5#2)(2013-7#1)
for obtaining a##13##3##(1994-12#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)
for obtaining accurate##2##3##(2008-10#1)(2013-1#1)
for obtaining an##3##3##(2008-10#1)(2008-7#1)(2012-5#1)
for obtaining gas concentration##2##4##(2008-2#2)
for obtaining good##2##3##(2008-10#1)(2011-1#1)
for obtaining reliable##2##3##(1996-3#1)(2008-10#1)
for obtaining the##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2013-8#1)
for obtaining##69##2##(1990-12#1)(1990-2#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-6#1)(2007-12#5)(2008-10#11)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#8)(2008-7#1)(2008-9#4)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
for occult fecal blood##2##4##(1991-6#1)(1993-3#1)
for occult##4##2##(1991-6#2)(1993-3#1)(2008-5#1)
for occupational exposure##2##3##(1994-12#1)(2008-10#1)
for occupational health##3##3##(1996-3#1)(2012-12#1)(2012-2#1)
for occupational##6##2##(1993-12#1)(1994-12#1)(1996-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
for occurrence of##2##3##(1993-9#1)(2013-1#1)
for ocean##2##2##(2008-2#1)(2008-3#1)
for octopole collision cell ICP-MS##2##5##(2008-10#2)
for odour##3##2##(1997-4#1)(2008-7#2)
for oesophageal cancer##2##3##(1990-9#2)
for of##2##2##(2008-3#1)(2011-2#1)
for off-axis beams##2##3##(2008-2#1)(2008-3#1)
for off-axis##6##2##(2008-2#1)(2008-3#5)
for off-line##4##2##(1990-8#1)(1997-3#1)(2008-10#1)(2009-6#1)
for offering##2##2##(1997-3#1)(2010-5#1)
for official##2##2##(1997-6#2)
for ofloxacin##6##2##(2008-10#6)
for old##4##2##(1990-3#1)(1991-11#1)(2008-7#1)(2012-1#1)
for older adults##7##3##(1992-1#3)(2008-3#1)(2010-4#1)(2013-1#2)
for older children##2##3##(1992-3#1)(1995-12#1)
for older patients with##2##4##(2007-8#1)(2011-2#1)
for older people and their families##2##6##(1997-3#1)(2010-10#1)
for older people in##3##4##(1991-2#1)(2009-3#1)(2010-10#1)
for older people##20##3##(1991-2#1)(1996-11#4)(1997-3#1)(2008-1#1)(2008-3#1)(2009-3#2)(2010-10#9)(2013-8#1)
for older persons##3##3##(1994-2#1)(2011-1#1)(2011-2#1)
for older##39##2##(1991-2#1)(1992-1#3)(1992-3#1)(1994-2#1)(1995-12#1)(1996-11#4)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#4)(2009-3#2)(2010-10#9)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
for olfactory groove meningiomas##2##4##(2006-12#2)
for olfactory##4##2##(1991-2#2)(2006-12#2)
for oligonucleotide##6##2##(2008-10#1)(2008-4#5)
for oligosaccharide##2##2##(1993-8#1)(2009-8#1)
for olive oil authentication##2##4##(2008-10#2)
for on##3##2##(1994-12#1)(2008-11#1)(2010-6#1)
for on-line determination of##2##4##(2008-10#1)(2010-5#1)
for on-line determination##3##3##(2008-10#2)(2010-5#1)
for on-line monitoring of##4##4##(2008-10#2)(2008-2#1)(2008-7#1)
for on-line preconcentration and determination of copper##2##7##(2008-10#2)
for on-line preconcentration and determination of##5##6##(2008-10#5)
for on-line preconcentration of##2##4##(2008-10#2)
for on-line preconcentration##7##3##(2008-10#7)
for on-line sample##3##3##(2008-10#3)
for on-line##40##2##(2008-10#33)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-5#1)
for on-site##7##2##(2008-10#5)(2008-3#1)(2013-8#1)
for onchocerciasis##2##2##(1991-9#1)(2011-2#1)
for one day##3##3##(1993-2#1)(2008-11#1)(2011-2#1)
for one field##2##3##(2008-10#2)
for one generation##2##3##(2009-9#1)(2011-2#1)
for one hour##3##3##(1992-6#1)(2008-12#1)(2011-1#1)
for one month##5##3##(1990-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2013-8#1)
for one of the##8##4##(1990-8#1)(1991-2#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-11#1)(2011-2#1)
for one of these##2##4##(1997-2#1)(2008-11#1)
for one of##12##3##(1990-8#1)(1991-2#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#3)(2009-11#1)(2010-11#1)(2011-2#1)
for one or more##4##4##(1991-9#1)(1992-6#1)(2007-7#1)(2008-3#1)
for one or##6##3##(1991-9#1)(1992-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-8#1)
for one particular##2##3##(1991-2#1)(2008-3#1)
for one sample##4##3##(2008-10#3)(2011-1#1)
for one to##5##3##(1992-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
for one type of##3##4##(1992-12#1)(1992-6#1)(2008-10#1)
for one wavelength##2##3##(2007-12#1)(2008-3#1)
for one week##5##3##(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)
for one year after##3##4##(1996-6#1)(1997-6#1)(2010-8#1)
for one year and##3##4##(1990-9#1)(1994-7#1)(2013-1#1)
for one year with##2##4##(1994-3#1)(2011-1#1)
for one year##17##3##(1990-9#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-7#1)(1996-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
for one##113##2##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1993-12#2)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#19)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#2)
for one- and two-dimensional##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
for one-dimensional##4##2##(2008-10#1)(2008-11#1)(2008-2#2)
for ongoing##7##2##(1996-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2013-1#1)
for online##3##2##(1995-3#1)(2007-12#1)(2008-10#1)
for only 2% of##2##4##(2010-5#1)(2012-3#1)
for only a few##5##4##(1991-12#1)(1992-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
for only a##7##3##(1991-11#1)(1991-12#1)(1992-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
for only one##2##3##(1995-12#1)(2008-11#1)
for only##33##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-7#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
for open fractures##2##3##(1991-6#1)(2007-8#1)
for open ocean water##2##4##(2008-2#1)(2008-3#1)
for open##10##2##(1991-6#1)(1992-2#1)(1996-1#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)(2013-8#1)
for openness and transparency##2##4##(2008-7#1)(2013-8#1)
for operating##4##2##(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
for operation in##2##3##(2007-12#1)(2008-10#1)
for operation##8##2##(2007-12#2)(2008-10#3)(2008-3#2)(2010-4#1)
for operative laparoscopy##3##3##(1995-2#3)
for operative##6##2##(1991-3#2)(1995-2#3)(2007-11#1)
for operators##2##2##(2008-11#1)(2008-9#1)
for ophthalmic##2##2##(2008-10#1)(2011-3#1)
for opiate receptors##2##3##(1991-1#1)(1994-2#1)
for opiate##3##2##(1991-1#2)(1994-2#1)
for opioid##5##2##(1991-1#1)(1996-12#1)(2008-6#1)(2008-7#1)(2009-9#1)
for opportunistic and##2##3##(2008-1#1)(2012-3#1)
for optic neuropathy in Graves' eye disease##2##7##(2008-7#2)
for optical coherence tomography##4##4##(2007-11#3)(2007-12#1)
for optical data storage##3##4##(2008-2#1)(2008-3#2)
for optical glass##2##3##(2008-2#1)(2008-3#1)
for optical isolation##2##3##(2008-3#2)
for optical limiting##2##3##(2008-3#2)
for optical mammography##2##3##(2008-2#1)(2008-3#1)
for optical network applications##2##4##(2008-2#2)
for optical network##3##3##(2008-2#3)
for optical path##4##3##(2008-2#1)(2008-3#2)(2013-8#1)
for optical pattern recognition##2##4##(2008-3#2)
for optical properties##3##3##(2008-2#1)(2008-3#2)
for optical pulses in##2##4##(2007-11#2)
for optical recording##3##3##(2008-2#2)(2008-3#1)
for optical switching##2##3##(1995-6#1)(2008-3#1)
for optical tomography##2##3##(2007-11#1)(2008-2#1)
for optical waveguide design##2##4##(2008-3#2)
for optical waveguide##4##3##(2007-11#1)(2008-3#3)
for optical waveguiding by##2##4##(2007-11#2)
for optical##88##2##(1995-6#1)(2007-11#11)(2007-12#5)(2008-10#3)(2008-2#22)(2008-3#43)(2008-6#1)(2011-1#1)(2013-8#1)
for optically thick##2##3##(2008-2#2)
for optically##3##2##(2008-2#2)(2008-3#1)
for optics##2##2##(2008-3#2)
for optimal feature##2##3##(2008-6#2)
for optimal growth##2##3##(2008-11#1)(2008-9#1)
for optimal##46##2##(1991-12#1)(1991-8#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
for optimisation##2##2##(1997-6#1)(2008-10#1)
for optimization of the##2##4##(2008-10#1)(2008-2#1)
for optimization of##15##3##(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-7#2)(2009-11#1)
for optimization##21##2##(1995-12#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#2)(2009-11#1)(2009-2#1)
for optimizing the design##2##4##(2008-2#1)(2008-3#1)
for optimizing the##13##3##(1996-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#5)(2010-8#1)
for optimizing##23##2##(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
for optimum resolution##2##3##(2008-10#1)(2008-3#1)
for optimum##14##2##(1993-3#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-7#1)
for optoelectronic##4##2##(2008-2#1)(2008-3#3)
for or against##2##3##(2008-9#1)(2012-3#1)
for or##7##2##(1990-4#1)(1992-2#2)(2007-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
for oral and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
for oral health##3##3##(1991-6#1)(2008-1#1)(2013-1#1)
for oral squamous cell carcinoma##2##5##(2013-1#2)
for oral##21##2##(1991-6#1)(1992-5#1)(1993-1#1)(1994-5#1)(1997-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#4)
for ordering##2##2##(2008-7#1)(2013-1#1)
for ordinary##2##2##(2008-2#1)(2008-3#1)
for organ allocation##2##3##(2008-9#1)(2010-6#1)
for organ donation##2##3##(1991-3#1)(2008-12#1)
for organ##7##2##(1991-3#1)(1996-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)
for organic##11##2##(1992-11#1)(1996-5#1)(2008-10#6)(2008-3#1)(2008-5#1)(2010-4#1)
for organization##2##2##(1991-9#1)(1994-2#1)
for organizational##5##2##(1992-1#1)(1992-12#1)(1994-12#2)(2012-3#1)
for organizing##3##2##(2008-10#1)(2008-12#1)(2010-11#1)
for organs##2##2##(2008-12#2)
for orientation and##3##3##(1996-2#1)(2009-8#1)(2010-10#1)
for orientation##6##2##(1995-3#1)(1996-2#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-10#1)
for orlistat##2##2##(2008-5#2)
for oropharyngeal##2##2##(2011-2#2)
for orthogonal polarizations##2##3##(2007-11#1)(2008-3#1)
for orthopaedic##2##2##(2008-12#1)(2012-4#1)
for orthopedic##2##2##(2009-6#1)(2012-3#1)
for orthophosphate##5##2##(2008-10#5)
for oscillations##2##2##(1990-8#1)(2008-7#1)
for osmotic##2##2##(2008-11#1)(2008-12#1)
for osteoarthritis##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
for osteogenic differentiation##3##3##(2008-11#2)(2012-1#1)
for osteogenic##4##2##(1994-6#1)(2008-11#2)(2012-1#1)
for osteoporosis is##2##3##(2008-7#1)(2008-8#1)
for osteoporosis##8##2##(1990-9#1)(1991-3#1)(2007-8#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
for osteosarcoma patients##2##3##(2010-3#2)
for osteosarcoma##9##2##(2008-6#2)(2010-3#7)
for other applications##4##3##(2008-11#1)(2008-2#2)(2008-9#1)
for other countries##2##3##(2008-8#1)(2012-12#1)
for other forms of##2##4##(2008-1#1)(2010-12#1)
for other members of the##2##5##(1991-11#1)(2012-12#1)
for other members of##3##4##(1990-7#1)(1991-11#1)(2012-12#1)
for other pathologies##2##3##(1993-3#1)(2007-8#1)
for other poorly##2##3##(2008-7#1)(2012-2#1)
for other significant##2##3##(2010-12#1)(2011-2#1)
for other species of##2##4##(2008-10#1)(2008-5#1)
for other species##6##3##(1994-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
for other studies##2##3##(1994-9#1)(2012-2#1)
for other techniques##2##3##(2008-2#1)(2008-9#1)
for other types of##4##4##(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
for other##145##2##(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-8#3)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#3)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#6)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
for others to##2##3##(1995-1#1)(1995-12#1)
for others##14##2##(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-4#1)
for our experimental##2##3##(2007-12#1)(2008-2#1)
for our study##2##3##(2008-10#1)(2013-1#1)
for our understanding of the##4##5##(1994-5#1)(2008-10#1)(2010-6#1)(2013-1#1)
for our understanding of##7##4##(1994-5#1)(1994-9#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
for our understanding##8##3##(1994-5#1)(1994-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
for our##46##2##(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-9#1)(1996-2#1)(1996-7#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
for outbreak##3##2##(1996-1#1)(2013-1#2)
for outcomes##9##2##(1993-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-4#1)(2012-12#3)(2012-2#1)
for outdoor##2##2##(2008-3#2)
for outpatient services##3##3##(1994-2#1)(1996-1#1)(2010-6#1)
for outpatient surgical##2##3##(1995-12#1)(1995-2#1)
for outpatient##13##2##(1993-1#1)(1993-2#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2006-5#1)(2008-3#1)(2010-2#2)(2010-6#1)
for ovarian cancer##9##3##(1992-9#1)(1993-9#3)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
for ovarian tumor##2##3##(1994-7#1)(2007-12#1)
for ovarian##17##2##(1991-9#1)(1992-9#1)(1993-9#3)(1994-7#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
for over 1##2##3##(2008-10#1)(2008-11#1)
for over 20 years##3##4##(1992-1#1)(2008-10#1)(2008-8#1)
for over 3##2##3##(1994-2#1)(1996-5#1)
for over 300##2##3##(2008-11#1)(2012-2#1)
for over a century##2##4##(2007-12#1)(2009-12#1)
for over a decade##3##4##(1994-2#1)(1995-1#1)(2012-3#1)
for over a year##3##4##(1993-9#1)(2008-10#1)(2012-12#1)
for over a##9##3##(1993-9#1)(1994-2#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)(2012-3#1)
for over three##2##3##(2008-10#1)(2010-12#1)
for over##46##2##(1992-1#1)(1993-1#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
for overall##11##2##(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-2#1)
for overcoming the##4##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
for overcoming##11##2##(1991-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-8#1)(2011-2#1)(2012-12#1)
for overexpression of##2##3##(2008-1#1)(2008-10#1)
for overexpression##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
for overhead drilling##2##3##(2008-12#2)
for overlapping##2##2##(2008-10#1)(2008-7#1)
for overproducing##2##2##(2008-2#2)
for overweight and obesity##2##4##(2007-12#1)(2011-2#1)
for overweight##5##2##(2007-12#1)(2008-1#1)(2009-8#1)(2011-2#2)
for overwintering##3##2##(2008-8#1)(2008-9#2)
for ovine##2##2##(1992-3#1)(2013-8#1)
for oviposition##2##2##(2007-12#1)(2008-9#1)
for ovulation induction##2##3##(2007-7#1)(2011-1#1)
for ox liver##2##3##(1994-8#2)
for oxidation of##4##3##(1992-9#1)(2008-10#3)
for oxidation##5##2##(1992-9#1)(1995-12#1)(2008-10#3)
for oxidative stress##2##3##(1992-9#1)(2008-10#1)
for oxidative##4##2##(1990-5#1)(1992-9#1)(2008-10#1)(2013-1#1)
for oxybenzone##2##2##(2008-5#2)
for oxygen in the##2##4##(2007-10#1)(2008-7#1)
for oxygen##18##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)
for ozone monitoring##2##3##(2008-10#2)
for ozone##8##2##(1991-5#1)(2008-10#4)(2008-2#2)(2008-3#1)
for p &lt##2##3##(2011-2#2)
for p = 0##3##4##(2011-2#3)
for p##7##2##(2008-11#1)(2008-3#1)(2011-2#5)
for p-aminobenzoate##2##2##(2008-10#2)
for p53##3##2##(1992-12#1)(1995-6#1)(2009-9#1)
for pH values##2##3##(2008-10#2)
for pH##9##2##(2008-10#6)(2008-11#1)(2008-7#1)(2010-5#1)
for pK(a(1)) and 7##2##4##(2008-10#2)
for packaging##2##2##(1990-11#1)(1993-6#1)
for paediatric cochlear implantation##2##4##(2008-9#2)
for paediatric##10##2##(1997-8#1)(2008-11#4)(2008-7#1)(2008-9#2)(2009-5#1)(2013-8#1)
for pain and disability##2##4##(2007-11#2)
for pain and##6##3##(1997-5#1)(2007-11#2)(2011-1#1)(2011-2#1)(2012-2#1)
for pain are##2##3##(2008-11#2)
for pain assessment in the##2##5##(2008-11#1)(2009-3#1)
for pain assessment##4##3##(2008-11#1)(2008-7#1)(2009-3#1)(2012-2#1)
for pain control##4##3##(1990-10#1)(2008-3#1)(2009-5#1)(2010-11#1)
for pain management##5##3##(2006-12#2)(2008-7#1)(2009-5#1)(2013-1#1)
for pain relief##2##3##(2008-7#2)
for pain treatment##2##3##(1997-3#1)(2007-8#1)
for pain##43##2##(1990-10#1)(1996-3#1)(1997-3#1)(1997-5#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#5)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2013-1#2)(2013-8#1)
for painful##3##2##(1991-6#1)(2008-6#1)(2008-7#1)
for paired##3##2##(1990-6#1)(1991-9#1)(1992-6#1)
for pairs of##3##3##(2007-11#2)(2008-7#1)
for palladium##6##2##(2008-10#6)
for palliation of malignant gastric outlet obstruction##2##7##(2012-2#2)
for palliation##4##2##(1991-12#1)(2008-1#1)(2012-2#2)
for palliative treatment of##2##4##(2010-5#1)(2013-1#1)
for palliative##5##2##(2008-2#1)(2008-6#1)(2010-5#1)(2010-8#1)(2013-1#1)
for pancreatic cancer was##2##4##(2011-2#2)
for pancreatic cancer##6##3##(1990-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
for pancreatic##10##2##(1990-9#2)(2008-3#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
for pancreatitis##2##2##(2008-12#1)(2013-1#1)
for panic disorder##2##3##(2008-4#1)(2012-2#1)
for panoramic##3##2##(2008-2#1)(2008-3#1)(2010-3#1)
for para-aortic##2##2##(2008-2#1)(2009-11#1)
for paracetamol##7##2##(1990-2#1)(1990-3#1)(2008-10#4)(2010-3#1)
for parallel##11##2##(2007-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2010-7#1)
for parameter##2##2##(2008-6#1)(2011-1#1)
for parameters##2##2##(2008-11#1)(2008-3#1)
for parametric##2##2##(2007-11#1)(2007-12#1)
for paraneoplasic neurological syndromes##2##4##(1996-11#2)
for parasite control##2##3##(1997-7#1)(2008-9#1)
for parasite##3##2##(1997-7#1)(2008-8#1)(2008-9#1)
for parasites##2##2##(2007-7#1)(2009-10#1)
for parasitic##2##2##(1997-7#1)(2011-2#1)
for parental##7##2##(1994-2#1)(1995-1#1)(2008-9#3)(2009-7#1)(2010-6#1)
for parents and##3##3##(2008-10#1)(2008-6#1)(2009-11#1)
for parents in##2##3##(2010-5#1)(2011-2#1)
for parents of children with##2##5##(1991-8#1)(1993-1#1)
for parents of##3##3##(1991-8#1)(1993-1#1)(1995-2#1)
for parents to learn about prior to##2##7##(1994-2#2)
for parents to##5##3##(1994-2#2)(2008-9#1)(2012-12#2)
for parents##19##2##(1991-8#2)(1992-1#1)(1992-2#1)(1993-1#1)(1994-2#2)(1995-1#1)(1995-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#2)
for parking##2##2##(1992-12#1)(2008-10#1)
for partial field resistance in the United States##2##8##(2008-10#2)
for partial least squares##3##4##(2008-10#3)
for partial or##2##3##(1997-8#1)(2011-7#1)
for partial resistance##3##3##(2008-10#3)
for partial##19##2##(1991-1#1)(1991-2#1)(1992-1#1)(1995-2#1)(1997-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-7#1)
for partially coherent##5##3##(2007-11#3)(2008-3#2)
for partially polarized##2##3##(2007-12#2)
for partially##10##2##(1990-8#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)(2008-9#1)
for participants to##3##3##(1992-1#1)(2010-11#1)(2012-12#1)
for participants##5##2##(1992-1#1)(2010-11#1)(2010-7#1)(2012-12#1)(2013-1#1)
for participation in##2##3##(2008-8#1)(2013-1#1)
for participation##8##2##(1996-1#1)(1997-1#1)(2007-10#2)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
for particle sizing##5##3##(2008-2#2)(2008-3#3)
for particle##15##2##(2008-10#2)(2008-2#5)(2008-3#8)
for particle-size##2##2##(2008-3#2)
for particles with##3##3##(2008-3#2)(2010-4#1)
for particles##7##2##(2007-12#1)(2008-11#2)(2008-3#3)(2010-4#1)
for particular##10##2##(1990-11#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-2#1)(2012-3#1)
for partitioning##2##2##(1990-5#1)(2009-8#1)
for partners##2##2##(2009-5#1)(2009-9#1)
for parts##2##2##(1995-2#1)(2008-2#1)
for passengers##2##2##(1996-12#1)(2007-2#1)
for passive Q switching##2##4##(2007-11#1)(2008-3#1)
for passive mode locking##2##4##(2007-11#1)(2007-12#1)
for passive##10##2##(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
for passively##2##2##(2007-11#1)(2008-3#1)
for past##5##2##(2008-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
for patents##2##2##(1995-11#1)(2008-5#1)
for path difference##2##3##(2007-12#1)(2008-3#1)
for pathogen detection##2##3##(2008-10#1)(2011-2#1)
for pathogen##8##2##(2008-10#6)(2011-2#1)(2012-2#1)
for pathogenicity on strawberry##2##4##(2008-10#2)
for pathogenicity on##7##3##(2008-10#7)
for pathogenicity or##2##3##(2008-10#1)(2011-2#1)
for pathogenicity to##2##3##(2008-10#2)
for pathogenicity##15##2##(2008-10#14)(2011-2#1)
for pathogens##2##2##(1997-4#1)(2008-10#1)
for pathologic##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
for pathological##5##2##(1995-5#1)(1997-3#1)(2007-11#1)(2008-9#1)(2010-1#1)
for pathotype##2##2##(2008-10#2)
for pathway##2##2##(2009-6#1)(2012-3#1)
for patient age##2##3##(1996-3#1)(2012-3#1)
for patient care and##2##4##(1990-3#1)(1995-3#1)
for patient care##6##3##(1990-3#1)(1995-3#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-9#1)
for patient focused##2##3##(1993-12#1)(1993-3#1)
for patient safety##3##3##(1992-3#1)(2008-10#1)(2010-11#1)
for patient selection##2##3##(1991-2#1)(2011-2#1)
for patient##42##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#2)(1993-3#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)
for patient-friendly##2##2##(2010-11#2)
for patients admitted to##2##4##(2008-3#2)
for patients admitted##3##3##(2008-3#3)
for patients affected by##2##4##(2009-8#1)(2011-2#1)
for patients and family members##2##5##(1992-12#1)(2008-6#1)
for patients and their families##3##5##(1994-1#1)(1994-12#1)(2012-3#1)
for patients and their##4##4##(1994-1#1)(1994-12#1)(2010-12#1)(2012-3#1)
for patients and##17##3##(1992-12#1)(1994-1#1)(1994-12#2)(1996-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
for patients at the##2##4##(2011-2#1)(2012-12#1)
for patients at##7##3##(1990-5#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for patients being##2##3##(1995-3#1)(2007-7#1)
for patients from##2##3##(2007-8#1)(2010-8#1)
for patients having##2##3##(2007-8#1)(2008-10#1)
for patients in the##3##4##(1990-8#1)(1991-2#1)(2008-7#1)
for patients in whom##3##4##(1991-9#1)(2007-10#1)(2011-2#1)
for patients in##14##3##(1990-8#1)(1991-2#1)(1991-9#1)(1995-3#1)(1997-1#1)(2007-10#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#2)
for patients not##4##3##(2007-8#1)(2008-3#1)(2010-11#1)(2011-2#1)
for patients of##3##3##(1996-2#1)(2011-1#2)
for patients presenting with##2##4##(2007-7#1)(2008-6#1)
for patients receiving##7##3##(1992-3#1)(1995-1#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-12#1)
for patients requiring##2##3##(2008-6#1)(2011-2#1)
for patients scheduled for##2##4##(2008-7#1)(2008-8#1)
for patients suffering from##3##4##(1991-11#1)(2006-7#1)(2011-2#1)
for patients to be##3##4##(1997-8#1)(2008-8#1)(2012-3#1)
for patients to##6##3##(1997-8#1)(2007-12#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-8#1)
for patients treated with##6##4##(2006-10#1)(2008-6#2)(2011-2#1)(2013-1#2)
for patients treated##11##3##(1990-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#2)(2011-2#2)(2013-1#2)
for patients undergoing##9##3##(1991-11#1)(1992-3#1)(2007-11#1)(2007-8#2)(2008-5#1)(2011-2#1)(2012-12#2)
for patients who are##5##4##(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
for patients who had##5##4##(1997-7#1)(2008-11#1)(2010-3#2)(2012-3#1)
for patients who present with##3##5##(2008-3#2)(2011-2#1)
for patients who present##4##4##(2008-1#1)(2008-3#2)(2011-2#1)
for patients who##19##3##(1993-1#1)(1993-12#1)(1997-7#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2010-3#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for patients with Alzheimer's disease##2##5##(1996-9#1)(2009-3#1)
for patients with CD##2##4##(2008-2#2)
for patients with Dukes'##2##4##(1992-8#2)
for patients with Treacher Collins syndrome##2##6##(2007-12#2)
for patients with a##7##4##(1990-12#1)(1994-12#1)(2007-8#1)(2008-11#2)(2010-5#1)(2011-2#1)
for patients with acute coronary syndromes##2##6##(2008-3#2)
for patients with acute myocardial infarction##2##6##(2008-3#1)(2010-11#1)
for patients with acute myocardial##3##5##(2008-3#2)(2010-11#1)
for patients with acute##8##4##(2008-3#4)(2009-11#1)(2010-11#1)(2010-12#1)(2012-12#1)
for patients with advanced##6##4##(2007-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
for patients with an##3##4##(2008-11#2)(2011-2#1)
for patients with bipolar##2##4##(2011-1#1)(2012-12#1)
for patients with cancer##3##4##(2008-7#1)(2010-11#1)(2010-9#1)
for patients with chronic heart failure##2##6##(2008-7#1)(2008-8#1)
for patients with chronic hepatitis B##2##6##(2009-8#1)(2011-2#1)
for patients with chronic##8##4##(2008-1#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
for patients with coexisting##2##4##(2008-10#1)(2013-1#1)
for patients with diabetes##2##4##(2007-8#1)(2009-11#1)
for patients with early##2##4##(1997-7#1)(2010-8#1)
for patients with end-stage##2##4##(2011-3#1)(2013-8#1)
for patients with limited English proficiency##2##6##(2010-8#2)
for patients with liver##3##4##(1995-4#1)(2010-12#1)(2013-1#1)
for patients with localized##3##4##(2008-7#1)(2010-3#1)(2012-12#1)
for patients with locally advanced##3##5##(2008-7#1)(2009-9#1)(2012-2#1)
for patients with low back pain##2##6##(2008-12#2)
for patients with lung##2##4##(2009-11#1)(2012-2#1)
for patients with malignant##2##4##(2008-3#1)(2013-8#1)
for patients with metastatic##3##4##(1992-10#1)(2008-11#1)(2012-2#1)
for patients with multiple##2##4##(2007-11#1)(2011-1#1)
for patients with myeloma##2##4##(2008-9#1)(2009-4#1)
for patients with nonmetastatic disease##2##5##(2010-3#2)
for patients with osteosarcoma##3##4##(2010-3#3)
for patients with panic disorder##3##5##(1990-11#1)(1993-12#2)
for patients with relapsed and refractory##2##6##(2010-4#2)
for patients with severe disease and##2##6##(2011-2#1)(2013-1#1)
for patients with severe##4##4##(2011-2#2)(2012-12#1)(2013-1#1)
for patients with spinal cord##2##5##(1991-6#1)(2007-11#1)
for patients with stage##2##4##(2007-8#1)(2011-2#1)
for patients with stroke##3##4##(2007-10#2)(2008-2#1)
for patients with suspected##2##4##(2008-12#2)
for patients with these##2##4##(2008-3#1)(2008-6#1)
for patients with this##2##4##(2009-4#1)(2013-8#1)
for patients with##215##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-6#2)(1992-10#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-5#1)(1994-12#2)(1994-9#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-7#3)(2007-8#7)(2008-1#3)(2008-10#6)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#12)(2008-4#1)(2008-6#9)(2008-7#9)(2008-8#3)(2008-9#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#6)(2010-3#7)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#12)(2013-1#13)(2013-7#1)(2013-8#8)
for patients without##2##3##(1992-5#1)(2010-3#1)
for patients younger than 54 years of age##2##8##(2008-9#2)
for patients##390##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#3)(1991-2#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#2)(2006-10#2)(2006-7#1)(2007-10#9)(2007-11#6)(2007-12#5)(2007-7#7)(2007-8#15)(2007-9#1)(2008-1#9)(2008-10#12)(2008-11#10)(2008-12#8)(2008-2#3)(2008-3#20)(2008-4#3)(2008-5#1)(2008-6#17)(2008-7#15)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#8)(2010-3#11)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#25)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#8)(2012-3#16)(2013-1#22)(2013-7#1)(2013-8#13)
for patients'##6##2##(1994-1#2)(1994-3#1)(2007-10#1)(2008-11#1)(2010-8#1)
for pattern recognition##2##3##(2008-3#1)(2013-8#1)
for patterning##3##2##(2008-7#1)(2009-2#1)(2010-12#1)
for patterns of##5##3##(2007-12#1)(2008-10#2)(2008-8#2)
for patterns##6##2##(2007-12#1)(2008-10#2)(2008-8#2)(2011-2#1)
for paying##2##2##(1992-12#1)(1992-2#1)
for payment##3##2##(1991-1#1)(1992-12#1)(1993-12#1)
for peak area and peak height##3##6##(2008-10#3)
for peak area##6##3##(2008-10#6)
for peak height##2##3##(2008-10#2)
for peak##14##2##(2007-11#1)(2008-10#12)(2008-3#1)
for peanut##2##2##(1994-8#1)(2008-10#1)
for pediatric nurse practitioners to understand##2##6##(2009-9#1)(2010-10#1)
for pediatric nurses##3##3##(2011-1#3)
for pediatric oncology patients##2##4##(1992-12#1)(1994-12#1)
for pediatric patients##2##3##(2008-10#1)(2009-9#1)
for pediatric##17##2##(1992-12#1)(1994-12#1)(1995-3#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#1)
for pediatrics##2##2##(2007-12#1)(2013-1#1)
for peer##2##2##(1994-1#1)(2009-7#1)
for pelvi-ureteric junction obstruction in children##2##6##(2008-10#2)
for pelvic##5##2##(1990-6#1)(2008-1#1)(2008-12#1)(2012-2#1)(2013-1#1)
for pendimethalin##2##2##(2008-11#2)
for penetration##2##2##(1996-5#1)(2008-5#1)
for penicillin##2##2##(1990-12#1)(2008-12#1)
for pentaerythritol triacrylate##2##3##(2008-9#2)
for people in##2##3##(2008-1#1)(2008-11#1)
for people living with##2##4##(2011-2#1)(2012-12#1)
for people who##5##3##(1993-3#1)(1994-1#2)(2008-7#1)(2013-8#1)
for people with dementia##2##4##(2011-1#1)(2013-8#1)
for people with mental health problems##5##6##(1993-1#3)(2008-11#2)
for people with mental retardation##2##5##(1993-3#1)(1997-8#1)
for people with mental##8##4##(1993-1#3)(1993-3#1)(1997-8#1)(2008-11#2)(2011-1#1)
for people with severe##2##4##(1997-1#2)
for people with##28##3##(1991-1#1)(1992-12#1)(1993-1#3)(1993-3#2)(1995-12#2)(1996-1#1)(1997-1#3)(1997-8#1)(2007-2#1)(2008-11#2)(2008-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-8#1)
for people##43##2##(1991-1#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-3#3)(1994-1#2)(1995-12#2)(1995-5#1)(1996-1#1)(1997-1#3)(1997-8#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-7#2)(2009-3#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#2)
for peptide mapping##2##3##(1996-5#1)(2008-10#1)
for peptide##4##2##(1996-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
for perceived##4##2##(1991-12#1)(1996-3#1)(2008-11#1)(2008-3#1)
for percent##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
for perchlorate determination in##2##4##(2008-10#2)
for perchlorate determination##3##3##(2008-10#3)
for perchlorate##4##2##(2008-10#4)
for percussion drilling##2##3##(2008-3#2)
for percutaneous coronary procedures##2##4##(2011-2#2)
for percutaneous coronary##4##3##(2011-2#3)(2013-1#1)
for percutaneous##9##2##(1990-8#1)(2008-11#1)(2010-12#1)(2011-2#5)(2013-1#1)
for perennial ryegrass##5##3##(2008-10#5)
for performance measurement of health care networks and health plans##2##10##(1996-2#2)
for performance measurement##3##3##(1996-2#3)
for performance of##2##3##(1992-1#1)(2008-3#1)
for performance##19##2##(1992-1#1)(1996-12#1)(1996-2#4)(1996-3#4)(2008-3#2)(2008-4#2)(2008-6#3)(2008-9#1)(2010-7#1)
for performing a##4##3##(2007-11#1)(2008-3#2)(2012-2#1)
for performing accurate##2##3##(2007-11#1)(2008-2#1)
for performing the##2##3##(2008-10#1)(2008-4#1)
for performing##37##2##(1993-11#1)(1995-2#1)(1997-6#1)(2007-11#4)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-9#2)(2009-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
for perfusion##4##2##(2008-11#2)(2008-4#1)(2010-8#1)
for periodic##3##2##(1990-8#1)(1995-3#1)(2008-10#1)
for periodical cicadas##3##3##(2008-9#3)
for periodically poled##2##3##(2007-11#1)(2008-2#1)
for periodically##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
for periodontal diseases##2##3##(2008-12#1)(2012-3#1)
for periodontal##4##2##(1995-2#1)(2008-12#1)(2012-2#1)(2012-3#1)
for periods longer than##2##4##(2008-3#1)(2012-3#1)
for periods of 1##2##4##(1992-8#1)(2010-6#1)
for periods of up to##3##5##(1996-12#1)(2008-10#1)(2008-2#1)
for periods of##9##3##(1992-8#1)(1994-1#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-2#2)(2010-6#1)
for periods up to##3##4##(1996-12#1)(2008-10#2)
for periods##17##2##(1992-8#1)(1994-1#1)(1995-6#1)(1995-8#1)(1996-12#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2010-6#1)(2012-3#1)
for perioperative##3##2##(1990-11#1)(2008-3#1)(2010-12#1)
for peripheral vascular disease##2##4##(2007-12#1)(2008-5#1)
for peripheral##10##2##(1996-6#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#2)(2013-7#1)
for peritoneal dialysis##2##3##(2008-1#1)(2008-5#1)
for peritoneal##3##2##(2008-1#1)(2008-5#1)(2011-2#1)
for permanent modification##2##3##(2008-10#2)
for permanent teeth##2##3##(2008-9#2)
for permanent##7##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#3)
for peroxidase##3##2##(1996-12#1)(2008-10#2)
for peroxide##2##2##(2008-10#2)
for peroxisomal targeting##3##3##(1991-12#2)(2009-10#1)
for peroxisomal##4##2##(1991-12#2)(2008-1#1)(2009-10#1)
for persistence of##2##3##(2008-10#1)(2013-1#1)
for persistence##8##2##(2008-10#2)(2008-3#2)(2008-8#2)(2009-5#1)(2013-1#1)
for persistent##7##2##(2007-12#1)(2008-11#3)(2008-7#1)(2011-1#1)(2013-1#1)
for personal and##2##3##(1997-1#1)(2008-9#1)
for personal##14##2##(1991-1#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)
for personalized##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
for persons who##2##3##(1991-6#1)(1995-2#1)
for persons with chronic##2##4##(1993-3#1)(2009-4#1)
for persons with special health care needs##2##7##(1997-2#2)
for persons with##18##3##(1991-12#2)(1993-1#1)(1993-3#1)(1995-3#1)(1996-1#1)(1997-2#3)(1997-3#1)(2009-4#1)(2009-6#2)(2012-3#1)(2013-1#2)(2013-7#2)
for persons##28##2##(1991-12#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-2#3)(1997-3#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-6#3)(2010-10#1)(2012-3#1)(2013-1#2)(2013-7#2)
for pertussis##2##2##(1993-6#1)(1993-8#1)
for pest##3##2##(1997-7#1)(2008-9#1)(2011-2#1)
for pesticide##4##2##(2008-10#4)
for pesticides##4##2##(1990-9#1)(2008-10#2)(2008-11#1)
for phage##2##2##(1994-12#1)(2008-7#1)
for pharmaceutical analysis##2##3##(2008-10#2)
for pharmaceutical use##2##3##(1992-3#1)(1994-5#1)
for pharmaceutical##11##2##(1992-3#1)(1993-12#1)(1994-5#1)(1996-1#1)(2008-10#3)(2008-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
for pharmaceuticals##3##2##(1993-3#1)(1996-1#1)(2008-10#1)
for pharmacists##3##2##(2008-3#1)(2011-1#1)(2013-1#1)
for pharmacokinetic studies##3##3##(2008-10#2)(2009-5#1)
for pharmacokinetic##4##2##(2008-10#3)(2009-5#1)
for pharmacologic##2##2##(2008-2#2)
for pharmacological##4##2##(2007-11#1)(2009-12#1)(2010-3#1)(2011-2#1)
for pharmacy##2##2##(1995-1#1)(2010-3#1)
for phase control##3##3##(2007-11#1)(2008-3#2)
for phase retrieval in##2##4##(2008-2#1)(2008-3#1)
for phase retrieval##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
for phase separation##2##3##(1992-6#1)(2008-10#1)
for phase unwrapping##3##3##(2008-2#2)(2008-3#1)
for phase##26##2##(1992-6#1)(1992-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#10)(2008-5#1)(2008-8#1)(2010-7#1)(2012-3#1)
for phase-change##2##2##(2008-2#1)(2008-3#1)
for phase-encoded images##3##3##(2008-2#3)
for phase-shifting interferometry##3##3##(2008-3#3)
for phase-shifting##4##2##(2008-3#4)
for phased arrays##2##3##(2008-3#2)
for phased##3##2##(2008-2#1)(2008-3#2)
for phased-array antenna##2##3##(2008-3#2)
for phased-array##3##2##(2008-3#3)
for phasing##3##2##(2008-2#2)(2008-3#1)
for phenanthrene##2##2##(2008-10#2)
for phenol and intermediate products in##2##6##(2008-3#2)
for phenol and##4##3##(2008-10#1)(2008-3#2)(2012-1#1)
for phenol##11##2##(2008-10#7)(2008-3#2)(2008-8#1)(2012-1#1)
for phenolic##2##2##(2008-10#1)(2008-11#1)
for phenols determination##2##3##(2008-10#2)
for phenols##4##2##(2008-10#4)
for phenotypic##4##2##(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
for phenyl valerate esterase##2##4##(1996-12#2)
for phenyl##3##2##(1996-12#2)(2008-10#1)
for phenylalanine##3##2##(1992-9#1)(1994-6#1)(2008-10#1)
for phi##4##2##(1991-5#1)(1996-12#3)
for phosphate sensing##2##3##(2008-10#2)
for phosphate##5##2##(2008-10#5)
for phosphate/thiophosphate protection in oligodeoxyribonucleotide synthesis##2##6##(2008-4#2)
for phosphatidylinositol phosphates##2##3##(1994-8#2)
for phosphatidylinositol##5##2##(1991-8#2)(1994-8#2)(1997-8#1)
for phospholipid##3##2##(1992-11#1)(1992-6#1)(1993-6#1)
for phosphorus##7##2##(2008-10#5)(2008-12#1)(2008-8#1)
for phosphorylation by##2##3##(1990-8#1)(1997-4#1)
for phosphorylation##7##2##(1990-8#1)(1991-2#2)(1995-12#1)(1995-6#2)(1997-4#1)
for photoconversion##2##2##(2011-1#2)
for photodynamic therapy##3##3##(1992-1#1)(2012-3#2)
for photoelastic##2##2##(2008-3#2)
for photon beams##3##3##(1993-9#1)(2012-1#2)
for photon counting##2##3##(2007-11#1)(2008-3#1)
for photon transport##2##3##(2008-3#2)
for photon##11##2##(1993-9#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#5)(2012-1#2)
for photonic##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
for photonics applications##2##3##(2008-3#1)(2008-7#1)
for photophosphorylation##2##2##(1992-3#2)
for photorefractive##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for photosynthesis##3##2##(1995-6#1)(2008-8#1)(2009-6#1)
for phylogenetic analysis##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
for phylogenetic##8##2##(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#1)
for phylogeny##2##2##(2008-7#1)(2008-9#1)
for physical activity##5##3##(2008-4#3)(2013-1#2)
for physical mapping##2##3##(1996-12#1)(2010-3#1)
for physical##23##2##(1992-3#1)(1992-6#1)(1995-1#1)(1996-12#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#5)(2008-5#1)(2009-7#1)(2010-3#2)(2011-2#3)(2013-1#2)
for physician and supplier services##2##5##(1992-1#2)
for physician and##4##3##(1992-1#2)(2008-4#1)(2008-6#1)
for physician services##6##3##(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1994-3#1)
for physician##18##2##(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#1)(1993-12#1)(1994-3#2)(1995-2#1)(1997-2#1)(1997-3#1)(2008-4#2)(2008-6#1)(2013-1#1)
for physicians and##6##3##(1991-1#1)(1991-2#2)(1991-3#1)(1997-1#1)(2012-12#1)
for physicians in##4##3##(1990-6#1)(1993-12#1)(1996-2#1)(2006-10#1)
for physicians should be##2##4##(1990-6#1)(1991-3#1)
for physicians to##3##3##(1996-1#1)(2011-1#1)(2012-2#1)
for physicians who##2##3##(1991-2#1)(2008-11#1)
for physicians##41##2##(1990-6#2)(1991-1#3)(1991-2#6)(1991-3#3)(1992-12#2)(1992-2#2)(1992-3#2)(1993-12#2)(1994-12#1)(1995-3#1)(1996-1#3)(1996-2#1)(1997-1#1)(2006-10#1)(2007-5#2)(2008-11#3)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
for physicians' services##2##3##(1991-2#1)(1993-2#1)
for physicians'##3##2##(1991-12#1)(1991-2#1)(1993-2#1)
for physiological##8##2##(1992-9#1)(1993-9#1)(2008-11#1)(2008-4#1)(2010-2#2)(2012-6#1)(2013-7#1)
for physiotherapy##2##2##(1993-2#1)(2012-1#1)
for pig##2##2##(1990-11#1)(2008-10#1)
for pigment##4##2##(2007-7#1)(2008-10#2)(2008-7#1)
for placement of##2##3##(2008-10#1)(2010-12#1)
for placement##3##2##(2007-7#1)(2008-10#1)(2010-12#1)
for placing##2##2##(2008-1#1)(2008-6#1)
for plan##2##2##(1995-12#1)(1996-12#1)
for planar##4##2##(2007-12#1)(2008-3#2)(2008-6#1)
for planning and##4##3##(1994-6#1)(1995-12#1)(1997-1#1)(2013-7#1)
for planning##20##2##(1990-12#1)(1991-3#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-7#1)
for plant disease##3##3##(2008-10#3)
for plant diseases##3##3##(2008-10#3)
for plant height##2##3##(2008-10#1)(2008-9#1)
for plant##36##2##(1994-11#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
for plants##11##2##(2008-10#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)
for plaque##2##2##(2008-1#1)(2010-9#1)
for plasma fibrinogen measurement##2##4##(2008-10#2)
for plasma fibrinogen##3##3##(2008-10#3)
for plasma formation##3##3##(2007-12#2)(2008-3#1)
for plasma membrane##3##3##(1992-12#1)(1995-12#1)(2009-9#1)
for plasma membranes##2##3##(1990-11#1)(1992-3#1)
for plasma##17##2##(1990-11#1)(1990-6#1)(1992-12#1)(1992-3#2)(1995-12#1)(2007-12#2)(2008-10#5)(2008-3#1)(2009-9#1)(2013-1#1)(2013-8#1)
for plasmid DNA##2##3##(2010-8#1)(2013-1#1)
for plasmid##7##2##(1990-11#2)(1994-8#2)(2008-10#1)(2010-8#1)(2013-1#1)
for plasminogen and##2##3##(1992-3#1)(1994-11#1)
for plasminogen##4##2##(1990-11#1)(1992-3#2)(1994-11#1)
for plastic##2##2##(1992-2#1)(2008-10#1)
for platelet aggregation##2##3##(2006-6#1)(2007-12#1)
for platelet##4##2##(1992-6#1)(2006-6#2)(2007-12#1)
for platinum and##2##3##(2008-10#2)
for platinum determination##2##3##(2008-10#2)
for platinum##7##2##(2008-10#6)(2008-3#1)
for pneumonia##2##2##(2008-9#1)(2013-1#1)
for point##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)
for points##2##2##(1996-11#1)(2013-1#1)
for polarity##2##2##(2009-10#1)(2009-8#1)
for polarization mode dispersion emulators with rotators##2##7##(2007-11#2)
for polarization mode dispersion##3##4##(2007-11#3)
for polarization##6##2##(2007-11#3)(2007-12#1)(2008-2#2)
for policies to##3##3##(1993-2#1)(2008-11#1)(2011-2#1)
for policies##4##2##(1991-5#1)(1993-2#1)(2008-11#1)(2011-2#1)
for policy and##2##3##(1993-9#1)(1994-2#1)
for policy development##3##3##(1994-1#1)(1996-3#1)(2007-12#1)
for policy makers##2##3##(1992-12#1)(2008-7#1)
for policy##11##2##(1992-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
for political##3##2##(1997-5#1)(2011-2#1)(2012-2#1)
for pollen tube##2##3##(2008-10#1)(2009-8#1)
for pollen##8##2##(2008-10#1)(2008-9#1)(2009-10#3)(2009-8#1)(2011-2#1)(2013-1#1)
for pollution##2##2##(2008-10#1)(2008-2#1)
for poly-drug users##2##3##(2013-8#2)
for polymer##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
for polymerase chain reaction (PCR)##5##5##(2008-10#5)
for polymerase chain reaction##6##4##(2008-10#6)
for polymerase##7##2##(2008-10#6)(2008-4#1)
for polymeric membrane##2##3##(2008-10#2)
for polymerization##2##2##(2012-12#1)(2012-2#1)
for polymorphisms##4##2##(2008-10#3)(2008-7#1)
for poor##10##2##(1995-12#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#2)
for poorer##2##2##(2008-10#1)(2011-2#1)
for population growth##2##3##(1994-2#1)(2008-10#1)
for population##14##2##(1991-3#1)(1994-2#1)(1995-5#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)
for population-based##3##2##(1997-8#1)(2007-12#1)(2012-12#1)
for populations of##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
for populations##11##2##(1995-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#2)
for porcine pancreatic elastase (PPE) and##2##6##(2008-5#2)
for porcine##5##2##(1994-11#2)(2008-5#2)(2011-1#1)
for positional cloning of the##2##5##(2008-10#2)
for positional cloning of##3##4##(2008-1#1)(2008-10#2)
for positional##5##2##(2008-1#1)(2008-10#3)(2012-3#1)
for positioning##2##2##(2008-4#1)(2012-12#1)
for positions##2##2##(1990-2#2)
for positive##14##2##(1990-8#1)(1992-3#1)(1993-2#1)(1994-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
for positively##2##2##(1990-11#1)(2008-10#1)
for possible application##2##3##(2007-12#1)(2008-3#1)
for possible drug##2##3##(1992-8#1)(2008-5#1)
for possible use##2##3##(2008-11#1)(2008-5#1)
for possible##27##2##(1992-8#1)(1994-7#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
for post partum##2##3##(2011-2#1)(2013-1#1)
for post##5##2##(2010-10#1)(2011-2#3)(2013-1#1)
for post-acute##2##2##(1992-3#1)(1994-12#1)
for post-market##2##2##(2011-2#2)
for post-marketing##2##2##(1990-9#1)(2008-8#1)
for post-registration##2##2##(2008-11#2)
for post-treatment##2##2##(2009-5#1)(2009-9#1)
for posterior##5##2##(2008-10#1)(2009-2#1)(2010-9#1)(2012-3#1)(2013-1#1)
for postharvest##2##2##(2008-10#2)
for postoperative##14##2##(1990-9#1)(1991-3#1)(1993-1#2)(1995-9#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
for postsynaptic##3##2##(1997-2#1)(1997-3#1)(2009-8#1)
for posttraumatic##2##2##(2009-3#1)(2012-1#1)
for potassium##3##2##(2007-11#2)(2008-10#1)
for potent##2##2##(1995-12#1)(2011-2#1)
for potential adverse effects##3##4##(1994-6#1)(2008-10#1)(2009-5#1)
for potential adverse##4##3##(1994-6#2)(2008-10#1)(2009-5#1)
for potential application in##2##4##(2011-1#1)(2012-2#1)
for potential applications in##3##4##(1997-4#1)(2007-12#1)(2010-4#1)
for potential clinical##2##3##(2010-8#1)(2013-1#1)
for potential confounders##4##3##(2009-3#1)(2011-1#1)(2013-1#2)
for potential confounding factors##2##4##(2010-1#1)(2010-11#1)
for potential confounding##3##3##(2008-4#1)(2010-1#1)(2010-11#1)
for potential therapeutic##3##3##(2008-4#1)(2009-4#1)(2010-5#1)
for potential use in human##2##5##(1993-2#1)(2008-5#1)
for potential use in##3##4##(1993-2#1)(2008-10#1)(2008-5#1)
for potential use##4##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-5#1)
for potential##48##2##(1990-7#1)(1991-1#1)(1993-2#1)(1994-6#2)(1995-12#1)(1996-11#1)(1996-6#1)(1997-4#1)(2007-12#2)(2008-10#5)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#5)
for potentially##4##2##(1992-2#1)(1994-1#1)(1996-12#1)(2008-5#1)
for potentiometric determination of chloride##2##5##(2008-10#2)
for potentiometric determination of##3##4##(2008-10#3)
for potentiometric##10##2##(2008-10#10)
for powdery mildew resistance in##2##5##(2008-10#2)
for powdery mildew resistance##3##4##(2008-10#3)
for power##3##2##(1993-2#1)(2008-3#2)
for practical application##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-3#1)
for practical applications##5##3##(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
for practical implementation##2##3##(2008-2#1)(2013-1#1)
for practical purposes##2##3##(2008-10#1)(2008-3#1)
for practical use##2##3##(2008-10#2)
for practical##23##2##(1995-1#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
for practice and##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
for practice expense##2##3##(1994-1#2)
for practice in##2##3##(2007-2#1)(2011-1#1)
for practice##25##2##(1994-1#2)(1997-2#1)(2007-2#1)(2008-1#2)(2008-11#9)(2008-12#1)(2008-3#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
for practice'##2##2##(2008-11#2)
for practitioners and##2##3##(2008-2#1)(2012-12#1)
for practitioners##5##2##(1996-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-12#1)
for prazosin)##2##2##(1991-6#2)
for pre- and##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)
for pre-clinical##3##2##(2008-10#1)(2008-11#1)(2009-9#1)
for pre-concentrating and##2##3##(2008-10#2)
for pre-registration nursing##2##3##(2008-11#2)
for pre-registration##3##2##(2008-11#3)
for precipitating##2##2##(2008-4#1)(2008-6#1)
for precise and##3##3##(2008-10#2)(2008-3#1)
for precise determination of##2##4##(2007-11#1)(2008-2#1)
for precise diagnosis##2##3##(2007-7#1)(2009-5#1)
for precise measurement of the##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
for precise##22##2##(1993-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-7#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
for precision small-angle measurement##2##4##(2008-3#2)
for precision##13##2##(2008-10#4)(2008-2#3)(2008-3#5)(2013-8#1)
for preclinical##4##2##(1994-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
for preconcentrating##6##2##(2008-10#6)
for preconcentration and determination of copper##2##6##(2008-10#2)
for preconcentration and determination of lead##2##6##(2008-10#2)
for preconcentration and determination of##6##5##(2008-10#6)
for preconcentration and determination##7##4##(2008-10#7)
for preconcentration and separation of##2##5##(2008-10#2)
for preconcentration and##15##3##(2008-10#15)
for preconcentration of metal ions##2##5##(2008-10#2)
for preconcentration of metal##3##4##(2008-10#3)
for preconcentration of trace##3##4##(2008-10#3)
for preconcentration of##21##3##(2008-10#21)
for preconcentration##41##2##(2008-10#41)
for predicted##2##2##(2008-10#1)(2013-1#1)
for predicting RNA##2##3##(2008-4#1)(2011-3#1)
for predicting how##2##3##(2008-8#1)(2009-2#1)
for predicting linear##2##3##(2008-10#2)
for predicting the behaviour of##2##5##(1990-9#1)(2008-10#1)
for predicting the risk of##2##5##(2011-2#1)(2012-12#1)
for predicting the##21##3##(1990-9#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
for predicting##64##2##(1990-9#1)(1992-3#1)(1992-9#1)(1994-9#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-6#3)(2008-8#3)(2008-9#2)(2009-2#2)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
for prediction of the##3##4##(1997-6#1)(2008-2#1)(2008-4#1)
for prediction of##16##3##(1990-3#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
for prediction##19##2##(1990-3#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
for predictions of##2##3##(2008-10#1)(2008-9#1)
for predictive##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
for pregnancy termination##2##3##(2011-2#1)(2013-1#1)
for pregnancy##4##2##(2008-5#1)(2011-2#1)(2013-1#2)
for pregnant women##6##3##(1992-4#1)(1995-12#1)(2007-2#1)(2008-1#1)(2010-6#1)(2011-1#1)
for pregnant##8##2##(1992-4#1)(1995-12#1)(1995-6#1)(2007-2#2)(2008-1#1)(2010-6#1)(2011-1#1)
for preliminary evaluation of the correlation time of local dynamics##2##10##(2008-10#2)
for preliminary##4##2##(2008-10#3)(2008-3#1)
for prelingually##2##2##(2008-9#2)
for premature##4##2##(1995-8#1)(2008-1#1)(2011-3#1)(2012-3#1)
for premedication##2##2##(2012-2#1)(2012-3#1)
for prenatal and postnatal##2##4##(2008-4#2)
for prenatal diagnosis of##2##4##(1996-12#1)(2008-4#1)
for prenatal diagnosis##6##3##(1992-6#1)(1996-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
for prenatal##12##2##(1992-6#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-7#1)(2008-4#3)(2011-2#1)(2012-3#1)(2013-1#1)
for preoperative disinfection of##2##4##(1994-11#2)
for preoperative##6##2##(1994-11#2)(2007-8#1)(2008-12#1)(2013-1#2)
for preparation and transfection##3##4##(2008-1#1)(2008-2#1)(2008-9#1)
for preparation and##5##3##(2008-1#1)(2008-2#1)(2008-9#3)
for preparation of a##4##4##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
for preparation of##28##3##(1992-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#9)(2008-9#5)(2009-9#1)(2011-2#1)(2012-1#1)
for preparation##35##2##(1992-5#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#9)(2008-9#8)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
for preparative##2##2##(2008-10#1)(2011-1#1)
for preparing MAP systems##3##4##(2008-4#3)
for preparing a##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
for preparing and##2##3##(2008-4#1)(2008-9#1)
for preparing the##7##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)
for preparing##41##2##(1990-11#1)(1990-12#1)(1994-11#1)(2008-1#1)(2008-10#6)(2008-2#5)(2008-4#16)(2008-5#4)(2008-7#1)(2008-9#4)(2012-2#1)
for prescribing##2##2##(2009-3#1)(2013-8#1)
for prescription drugs##6##3##(1993-1#2)(1993-3#1)(1997-1#2)(2008-12#1)
for prescription##11##2##(1993-1#2)(1993-3#1)(1996-1#1)(1997-1#2)(2007-11#1)(2008-12#1)(2008-3#1)(2012-1#1)(2013-1#1)
for presence of##3##3##(2009-8#1)(2011-2#1)(2012-12#1)
for presence##5##2##(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)
for presentation of##2##3##(1990-5#1)(1995-12#1)
for presentation##5##2##(1990-5#1)(1995-12#1)(2008-1#1)(2008-12#1)(2012-2#1)
for presenting the##2##3##(1995-12#1)(2007-4#1)
for presenting##4##2##(1995-12#1)(2007-4#1)(2008-10#1)(2008-4#1)
for preservation of the##2##4##(1990-5#1)(2008-3#1)
for preservation of##7##3##(1990-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
for preserving the##2##3##(1997-6#1)(2008-11#1)
for preserving##7##2##(1992-12#1)(1995-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
for pressures##2##2##(2008-3#2)
for presynaptic##2##2##(1994-8#1)(1997-7#1)
for preterm##2##2##(2008-11#1)(2010-5#1)
for pretreatment##2##2##(2008-10#1)(2013-1#1)
for preventing and treating##2##4##(2008-5#1)(2013-1#1)
for preventing and##6##3##(1994-2#1)(2008-5#3)(2013-1#1)(2013-7#1)
for preventing the##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)
for preventing##38##2##(1991-5#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
for prevention and control of##3##5##(2008-7#1)(2010-4#1)(2011-2#1)
for prevention and control##4##4##(2008-7#1)(2010-4#1)(2010-5#1)(2011-2#1)
for prevention and intervention##2##4##(2009-11#1)(2009-7#1)
for prevention and treatment of osteoporosis##3##6##(1993-11#2)(2008-7#1)
for prevention and treatment of##7##5##(1993-11#2)(1997-2#1)(2007-11#1)(2008-1#1)(2008-7#2)
for prevention and treatment##10##4##(1990-12#1)(1993-11#2)(1997-2#1)(2007-11#1)(2008-1#1)(2008-7#3)(2009-11#1)
for prevention and##21##3##(1990-12#1)(1993-11#3)(1995-3#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)
for prevention of HO##2##4##(2007-11#2)
for prevention of cardiovascular##2##4##(1990-2#1)(2011-1#1)
for prevention of heterotopic ossification##2##5##(1994-8#2)
for prevention of mother-to-child transmission of HIV##2##7##(2009-4#2)
for prevention of##25##3##(1990-2#1)(1994-8#2)(1995-3#1)(1995-8#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-4#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
for prevention##58##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-11#3)(1994-8#2)(1994-9#1)(1995-3#2)(1995-8#1)(1996-11#1)(1997-2#2)(1997-3#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
for preventive care##3##3##(1996-1#1)(1996-12#1)(1996-3#1)
for preventive health##4##3##(1994-2#1)(1995-12#1)(1997-1#1)(2010-8#1)
for preventive intervention##2##3##(2008-1#1)(2008-12#1)
for preventive measures##2##3##(1992-9#1)(2009-10#1)
for preventive services##3##3##(1994-2#3)
for preventive##19##2##(1990-6#1)(1992-3#1)(1992-5#2)(1992-9#1)(1994-2#4)(1994-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-8#1)
for previously##5##2##(1990-6#1)(1992-5#1)(1997-3#1)(2007-12#1)(2008-8#1)
for primary and secondary alcohols##2##5##(1990-8#1)(2007-12#1)
for primary and secondary prevention##2##5##(2011-1#1)(2011-2#1)
for primary and secondary##5##4##(1990-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
for primary and##7##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
for primary breast cancer##4##4##(1991-12#1)(1992-10#1)(1992-12#1)(1994-7#1)
for primary care##4##3##(1995-2#1)(2008-12#1)(2008-6#1)(2011-1#1)
for primary hyperparathyroidism##2##3##(2008-10#2)
for primary prevention of cardiovascular disease##2##6##(2009-4#1)(2011-2#1)
for primary prevention of stroke##3##5##(1995-5#1)(2007-10#2)
for primary prevention of thromboembolism##2##5##(2007-8#2)
for primary prevention of##7##4##(1995-5#1)(2007-10#2)(2007-8#2)(2009-4#1)(2011-2#1)
for primary##59##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
for primary-care##2##2##(1992-8#1)(1996-3#1)
for prime##4##2##(2009-4#1)(2010-4#1)(2010-5#1)(2013-8#1)
for priming##2##2##(1992-3#1)(2008-7#1)
for prior##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2010-6#1)
for prioritizing##2##2##(2010-2#1)(2011-2#1)
for private##5##2##(1992-12#1)(1993-2#1)(1996-3#1)(1997-2#1)(2013-8#1)
for proactive##2##2##(1994-2#1)(2008-11#1)
for probe##3##2##(2008-4#1)(2008-9#2)
for probes of##2##3##(2008-9#1)(2009-5#1)
for probing single##2##3##(2008-2#1)(2012-2#1)
for probing the##3##3##(1990-8#1)(1993-6#1)(2007-12#1)
for probing##8##2##(1990-8#1)(1993-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
for problem##2##2##(1994-2#1)(2008-11#1)
for problems##2##2##(1995-9#1)(2008-6#1)
for procaine##2##2##(2008-10#2)
for procedural##2##2##(2008-10#1)(2011-2#1)
for procedures##6##2##(1996-1#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
for process control##2##3##(1996-5#1)(2008-10#1)
for process monitoring##2##3##(1994-9#1)(2008-11#1)
for process##9##2##(1994-3#1)(1994-5#1)(1994-9#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#1)
for processing and##2##3##(2008-10#1)(2008-4#1)
for processing animate stimuli##2##4##(2008-11#2)
for processing fringe-pattern images##3##4##(2008-2#3)
for processing of the##2##4##(1992-12#2)
for processing the##4##3##(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
for processing##28##2##(1992-12#2)(1992-6#1)(1995-5#1)(2008-10#3)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#2)(2010-8#1)(2013-1#1)
for procolipase##2##2##(1995-5#2)
for producing a##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
for producing human##2##3##(2008-11#2)
for producing the##2##3##(2008-10#1)(2008-9#1)
for producing##37##2##(1990-8#1)(1991-12#1)(1993-1#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
for product##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
for production of a##2##4##(1997-7#1)(2008-4#1)
for production of antibodies that##4##5##(1995-11#1)(2008-2#1)(2008-4#2)
for production of##26##3##(1995-11#1)(1995-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
for production##31##2##(1995-11#1)(1995-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
for products##3##2##(2008-5#1)(2008-6#1)(2008-7#1)
for professional##14##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
for professionals from##2##3##(1995-3#1)(2008-12#1)
for professionals##9##2##(1991-2#1)(1992-3#1)(1993-1#1)(1994-12#1)(1995-3#1)(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
for profiling##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
for profit##2##2##(2008-1#2)
for prognosis and treatment##2##4##(2006-12#1)(2012-2#1)
for prognosis and##3##3##(2006-12#1)(2012-2#1)(2013-1#1)
for prognosis##8##2##(1992-10#1)(1997-7#1)(2006-12#1)(2008-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
for prognostic##3##2##(1990-6#1)(2010-11#1)(2011-2#1)
for program evaluation##2##3##(1992-1#1)(2008-12#1)
for program##8##2##(1992-1#2)(1994-2#1)(1995-12#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-12#1)
for programming##6##2##(1990-3#1)(2007-11#1)(2008-9#3)(2011-3#1)
for programs that##2##3##(2010-4#1)(2012-3#1)
for programs##5##2##(1992-3#1)(1996-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
for progress##4##2##(2008-10#1)(2008-6#2)(2012-3#1)
for progression of##2##3##(1992-12#1)(2009-8#1)
for progression through##2##3##(1993-8#1)(2011-1#1)
for progression to##2##3##(1994-5#1)(2013-1#1)
for progression##7##2##(1992-12#1)(1993-8#1)(1994-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
for projection moiré interferometry##2##4##(2008-3#2)
for projection##4##2##(2008-2#1)(2008-3#3)
for proliferating##2##2##(2012-1#1)(2013-1#1)
for proliferation##2##2##(1993-9#1)(2013-8#1)
for proliferative##4##2##(1993-5#1)(2006-10#1)(2008-9#1)(2011-1#1)
for proline##3##2##(1994-8#1)(2008-10#2)
for prolonged periods of time##3##5##(2008-11#1)(2008-7#1)(2009-2#1)
for prolonged periods##10##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
for prolonged##15##2##(1993-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
for promoting the##2##3##(2008-7#1)(2008-9#1)
for promoting##15##2##(1992-3#1)(1993-2#1)(1995-12#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2011-1#2)(2012-1#1)
for promotion##4##2##(1992-3#1)(1992-5#1)(2012-3#2)
for prompt##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
for propagating electromagnetic##2##3##(2008-3#2)
for propagating mCMV##2##3##(2008-4#2)
for propagating##5##2##(2008-3#2)(2008-4#2)(2008-9#1)
for propagation and##3##3##(2008-2#2)(2008-9#1)
for propagation in##2##3##(2008-3#2)
for propagation of##2##3##(2007-12#1)(2008-12#1)
for propagation##7##2##(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)
for proper##21##2##(1993-3#1)(1995-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
for properly##2##2##(2007-12#1)(2008-2#1)
for prophylactic intervention##2##3##(2008-1#1)(2011-2#1)
for prophylactic treatment##2##3##(1990-3#1)(2011-1#1)
for prophylactic##5##2##(1990-2#1)(1990-3#1)(2008-1#1)(2011-1#1)(2011-2#1)
for prophylaxis after##3##3##(1990-2#1)(1990-9#1)(2008-7#1)
for prophylaxis and treatment##2##4##(1992-2#1)(2013-1#1)
for prophylaxis and##3##3##(1992-2#1)(2008-5#1)(2013-1#1)
for prophylaxis of##2##3##(2009-12#1)(2010-3#1)
for prophylaxis##10##2##(1990-2#1)(1990-9#2)(1992-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
for prospective##5##2##(1992-12#1)(1992-3#1)(2008-10#1)(2008-7#1)(2013-8#1)
for prostaglandin##2##2##(1992-3#1)(1993-11#1)
for prostate cancer and##2##4##(2008-2#1)(2008-5#1)
for prostate cancer diagnosis##2##4##(2008-10#1)(2011-2#1)
for prostate cancer in the##2##5##(2009-5#2)
for prostate cancer in##3##4##(2008-8#1)(2009-5#2)
for prostate cancer##25##3##(1995-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#3)(2010-10#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
for prostate##29##2##(1991-8#1)(1993-9#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#3)(2010-10#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
for prostatic cancer##3##3##(1991-7#2)(1993-8#1)
for prostatic##6##2##(1990-9#1)(1991-7#2)(1993-8#2)(2008-5#1)
for prosthetic##2##2##(2006-10#1)(2007-7#1)
for protease##2##2##(2011-2#1)(2013-1#1)
for proteases##2##2##(1992-6#1)(1996-12#1)
for protecting and##2##3##(2008-9#2)
for protecting the##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
for protecting##9##2##(1993-12#1)(1994-8#1)(2008-1#1)(2008-5#1)(2008-9#2)(2009-2#1)(2011-2#1)(2013-1#1)
for protection against##4##3##(2008-10#1)(2008-2#1)(2008-5#2)
for protection of##5##3##(1991-3#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
for protection##14##2##(1991-3#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
for protein analysis##2##3##(2008-10#1)(2008-4#1)
for protein determination##2##3##(2007-2#1)(2008-10#1)
for protein expression##2##3##(2008-11#1)(2008-4#1)
for protein folding##2##3##(2008-8#1)(2009-9#1)
for protein interactions##2##3##(1997-2#1)(2008-4#1)
for protein isoprenylation##2##3##(1994-11#2)
for protein kinase A##3##4##(1991-2#1)(1994-9#1)(2011-2#1)
for protein kinase C##4##4##(1990-8#2)(1992-6#1)(1994-11#1)
for protein kinase##9##3##(1990-8#2)(1991-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(2011-2#1)
for protein production##4##3##(1997-4#1)(2008-11#2)(2008-4#1)
for protein structure##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
for protein synthesis##5##3##(1990-12#1)(1993-12#1)(1996-2#1)(2008-7#1)(2012-1#1)
for protein tyrosine##2##3##(1994-6#1)(1995-11#1)
for protein##76##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-12#2)(1994-11#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-2#1)(2007-5#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#9)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-6#1)(2013-8#1)
for protein-protein interactions using##2##4##(2008-4#2)
for protein-protein interactions##4##3##(2008-4#3)(2008-7#1)
for protein-protein##5##2##(2008-4#4)(2008-7#1)
for proteinase##2##2##(2008-4#1)(2008-5#1)
for proteins of##3##3##(2007-10#1)(2008-10#2)
for proteins##16##2##(1997-4#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
for proteolytic##2##2##(1991-9#1)(2008-4#1)
for proteome##2##2##(2008-4#1)(2008-7#1)
for proteomic##2##2##(2008-4#1)(2013-8#1)
for proteomics##4##2##(2008-7#3)(2009-6#1)
for proton##3##2##(1990-11#1)(1995-2#1)(2008-6#1)
for protoporphyrinogen oxidase and ferrochelatase in human leucocytes##2##8##(1991-5#2)
for protoporphyrinogen##3##2##(1991-5#3)
for provider##3##2##(1995-2#1)(1996-12#1)(2010-12#1)
for providers and##2##3##(1995-1#2)
for providers to##2##3##(1995-3#1)(2010-8#1)
for providers##7##2##(1992-12#1)(1994-1#1)(1995-1#2)(1995-3#1)(2010-10#1)(2010-8#1)
for providing a##2##3##(2008-3#1)(2010-4#1)
for providing family-centered services in neonatal intensive care##2##8##(1991-12#2)
for providing quality##2##3##(1991-1#1)(2012-12#1)
for providing the##3##3##(2008-2#1)(2010-7#1)(2012-12#1)
for providing##35##2##(1991-1#1)(1991-12#2)(1991-2#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-12#1)(1997-3#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)
for provision of##6##3##(1992-12#1)(1997-5#1)(2008-10#1)(2008-5#2)(2008-8#1)
for proximal##5##2##(1990-9#1)(1997-3#1)(2007-8#1)(2012-12#1)(2013-8#1)
for pseudothecia##2##2##(2008-10#2)
for psilocin##2##2##(2008-10#2)
for psoriasis##3##2##(1993-11#2)(2007-11#1)
for psychiatric disorders##5##3##(2008-1#3)(2010-7#1)(2011-2#1)
for psychiatric##16##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-1#1)(2007-1#1)(2008-1#3)(2008-11#2)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
for psychosocial##4##2##(1991-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
for pubertal stage##2##3##(2011-2#2)
for public and##3##3##(1993-1#1)(1994-12#1)(2008-10#1)
for public health agencies##2##4##(1995-12#2)
for public health practitioners##2##4##(1997-2#2)
for public health surveillance##5##4##(1997-3#5)
for public health##35##3##(1991-12#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#5)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#6)(2008-7#1)(2009-9#1)(2010-8#2)(2011-2#1)(2012-12#3)(2012-2#1)
for public policy##2##3##(1991-2#1)(1997-5#1)
for public##49##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(1994-2#3)(1995-12#5)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#6)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-5#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-8#2)(2011-2#1)(2012-12#3)(2012-2#1)
for publication in##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
for publication##9##2##(1991-6#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-4#1)
for publications##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
for pulmonary artery##2##3##(2007-8#1)(2010-10#1)
for pulmonary endarterectomy##2##3##(2010-10#1)(2010-6#1)
for pulmonary tuberculosis##2##3##(2008-12#1)(2008-7#1)
for pulmonary##19##2##(1991-12#1)(1992-3#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-10#3)(2010-6#2)(2011-2#2)(2013-1#1)
for pulp##2##2##(1990-9#1)(2008-6#1)
for pulse durations##2##3##(2007-11#1)(2008-3#1)
for pulse##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
for pulsed##5##2##(2007-12#3)(2008-3#2)
for pulses##2##2##(2007-12#2)
for purchasers##2##2##(1991-3#1)(1993-12#1)
for purchasing##2##2##(1996-2#2)
for pure stands##2##3##(2008-10#2)
for pure water##2##3##(2008-2#1)(2010-4#1)
for pure##14##2##(1992-3#1)(1995-5#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2010-4#1)(2013-1#1)
for purification and##3##3##(2008-10#1)(2008-4#2)
for purification of DNA from##2##5##(2008-10#1)(2008-2#1)
for purification of the##3##4##(1990-7#1)(1991-12#1)(1991-5#1)
for purification of##11##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)
for purification##17##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#4)(2008-8#1)
for purifying RNA##2##3##(2008-2#1)(2008-4#1)
for purifying##5##2##(1991-8#1)(2008-2#1)(2008-4#3)
for purpose##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
for purposes of##11##3##(1991-2#1)(1991-6#1)(1992-3#1)(1994-6#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-11#1)(2011-2#1)
for putative##2##2##(1990-7#1)(2008-1#1)
for putrescine##2##2##(2008-10#2)
for pyrocatechol##2##2##(2008-10#2)
for pyrolysis and atomization##4##4##(2008-10#4)
for pyrolysis and##5##3##(2008-10#5)
for pyromania##2##2##(2008-6#2)
for pyruvate##4##2##(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
for qualitative and quantitative analysis of##2##6##(2008-5#1)(2012-3#1)
for qualitative and quantitative analysis##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
for qualitative and quantitative##4##4##(2008-10#2)(2008-5#1)(2012-3#1)
for qualitative##11##2##(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#1)
for quality aging##2##3##(2011-2#2)
for quality and##4##3##(1991-2#1)(1992-2#1)(2008-10#1)(2009-6#1)
for quality assessment and##2##4##(1993-3#1)(2008-10#1)
for quality assurance##9##3##(1991-12#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(2008-12#2)(2008-3#1)
for quality control of##2##4##(2008-9#1)(2011-3#1)
for quality control##6##3##(1992-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-3#1)
for quality improvement##6##3##(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(2012-2#1)
for quality in##2##3##(1996-3#1)(2008-11#1)
for quality management##4##3##(1994-12#1)(1995-3#1)(2008-3#1)(2008-4#1)
for quality measurement##2##3##(1996-12#1)(2008-4#1)
for quality of care##3##4##(1991-12#1)(1996-12#1)(1996-2#1)
for quality of##4##3##(1991-12#1)(1996-12#1)(1996-2#1)(2008-10#1)
for quality##65##2##(1991-12#2)(1991-2#3)(1991-3#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1997-1#1)(1997-5#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
for quantification of the##4##4##(2008-10#2)(2008-9#2)
for quantification of##16##3##(2007-11#1)(2008-10#11)(2008-11#1)(2008-9#2)(2009-6#1)
for quantification phenoxyl##2##3##(2008-10#2)
for quantification##25##2##(2007-11#1)(2008-10#16)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-5#1)
for quantifying the##10##3##(1994-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
for quantifying##24##2##(1994-11#1)(1997-6#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
for quantitating the##3##3##(1990-12#1)(1990-7#1)(2008-4#1)
for quantitating##9##2##(1990-12#1)(1990-7#1)(2008-10#3)(2008-4#3)(2012-2#1)
for quantitation of##4##3##(1992-12#1)(1993-3#1)(2007-10#1)(2008-10#1)
for quantitation##7##2##(1992-12#1)(1993-3#1)(2007-10#1)(2008-10#3)(2008-9#1)
for quantitative analysis of octahydro-1##2##5##(2008-10#2)
for quantitative analysis of##10##4##(2008-10#10)
for quantitative analysis##20##3##(2007-12#1)(2008-10#18)(2008-5#1)
for quantitative and qualitative##2##4##(2008-10#1)(2008-12#1)
for quantitative and##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
for quantitative concentration measurements##2##4##(2008-3#2)
for quantitative determination of the##2##5##(2008-10#2)
for quantitative determination of##14##4##(1991-5#1)(1996-5#1)(2008-10#11)(2008-2#1)
for quantitative determination##18##3##(1991-5#1)(1996-5#1)(2008-10#15)(2008-2#1)
for quantitative estimation##2##3##(2010-5#2)
for quantitative evaluation of##4##4##(2007-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
for quantitative extraction##2##3##(2008-10#2)
for quantitative measurement of the##2##5##(2008-3#2)
for quantitative measurement##7##3##(2008-10#4)(2008-3#3)
for quantitative measurements of##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
for quantitative measurements##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
for quantitative protein profiling##2##4##(2008-4#2)
for quantitative recovery is 5##2##5##(2008-10#2)
for quantitative recovery##3##3##(2008-10#3)
for quantitative resistance to Sclerotinia trifoliorum##4##6##(2008-10#4)
for quantitative resistance to##5##4##(2008-10#5)
for quantitative sorption of##2##4##(2008-10#2)
for quantitative sorption##6##3##(2008-10#6)
for quantitative two-dimensional##2##3##(2008-2#1)(2008-4#1)
for quantitative##106##2##(1991-5#1)(1995-3#1)(1996-5#1)(2007-11#2)(2007-12#3)(2008-10#66)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#3)(2008-9#4)(2010-5#3)(2010-7#1)(2011-2#1)(2013-1#1)
for quantitatively##3##2##(2007-10#1)(2008-9#1)(2010-5#1)
for quantum##6##2##(2007-12#4)(2013-1#2)
for quaternary##4##2##(1990-8#1)(2008-10#2)(2013-8#1)
for question##3##2##(2008-12#1)(2013-1#2)
for questions that are##2##4##(2008-7#2)
for questions##3##2##(2008-7#2)(2009-2#1)
for quick and##2##3##(2008-4#1)(2010-8#1)
for quick##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
for r##2##2##(2008-10#2)
for rAAV production##2##3##(2008-8#2)
for rAAV##4##2##(2008-8#3)(2008-9#1)
for rHBsAg##2##2##(2008-8#2)
for rabbit##2##2##(1992-11#1)(2008-10#1)
for race##2##2##(2008-10#2)
for radial##7##2##(2008-2#2)(2008-9#1)(2011-2#4)
for radiation hormesis##2##3##(2008-7#1)(2013-1#1)
for radiation protection##2##3##(2008-7#1)(2013-1#1)
for radiation therapy##2##3##(1994-3#1)(1994-8#1)
for radiation##18##2##(1994-3#2)(1994-8#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#6)(2009-11#1)(2013-1#4)
for radiative transfer##3##3##(2008-3#3)
for radiative##4##2##(2007-11#1)(2008-3#3)
for radical surgery of##2##4##(1990-6#1)(1990-9#1)
for radical surgery##4##3##(1990-6#1)(1990-9#1)(2008-10#1)(2012-2#1)
for radical##8##2##(1990-3#1)(1990-6#1)(1990-9#1)(1997-4#1)(2007-8#1)(2008-10#2)(2012-2#1)
for radiographers##3##2##(1991-2#1)(1996-1#1)(2008-10#1)
for radiographic##2##2##(2007-11#1)(2008-3#1)
for radioiodination of##2##3##(2008-1#2)
for radiological##2##2##(1996-6#1)(2012-2#1)
for radiologists##2##2##(2008-7#1)(2010-9#1)
for radiology administrators##3##3##(1991-12#1)(1995-12#1)(1996-2#1)
for radiology managers##4##3##(1991-1#1)(1993-2#1)(1993-3#1)(1994-1#1)
for radiology##13##2##(1991-1#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#3)(2007-4#1)
for radiotherapy in##3##3##(1994-8#3)
for radiotherapy##7##2##(1994-8#3)(2007-10#1)(2008-2#3)
for rainwater##2##2##(2008-10#2)
for raising##5##2##(1991-9#1)(2008-11#1)(2008-5#1)(2008-6#2)
for ramipril and telmisartan##2##4##(2010-3#2)
for ramipril##3##2##(2010-3#3)
for random##2##2##(1990-9#1)(2012-3#1)
for randomized trials##2##3##(1993-12#1)(2008-10#1)
for randomized##4##2##(1993-12#1)(1995-2#2)(2008-10#1)
for randomly##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
for ranitidine##2##2##(2008-10#1)(2008-11#1)
for rapid and accurate##3##4##(2008-10#2)(2008-5#1)
for rapid and direct##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
for rapid and efficient##2##4##(2007-7#1)(2008-10#1)
for rapid and selective extraction##3##5##(2008-10#3)
for rapid and sensitive##2##4##(1990-12#1)(2013-1#1)
for rapid and simultaneous determination of##2##6##(2008-10#1)(2008-5#1)
for rapid and##23##3##(1990-12#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
for rapid determination of##3##4##(2008-10#3)
for rapid diagnosis of##4##4##(2007-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
for rapid growth##3##3##(1990-5#1)(2008-9#1)(2010-7#1)
for rapid identification of##5##4##(2007-7#1)(2008-10#2)(2010-4#2)
for rapid identification##6##3##(2007-7#1)(2008-10#2)(2008-12#1)(2010-4#2)
for rapid production of##2##4##(1995-8#1)(2008-11#1)
for rapid sample##2##3##(2008-10#2)
for rapid screening of##2##4##(2007-11#1)(2008-4#1)
for rapid screening##4##3##(2007-11#1)(2008-10#2)(2008-4#1)
for rapid separation and##2##4##(1997-2#1)(2008-10#1)
for rapid separation##3##3##(1997-2#1)(2008-10#2)
for rapid surgical##2##3##(2007-8#1)(2011-2#1)
for rapid##97##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#38)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#1)
for rapidly##2##2##(1992-10#1)(2008-11#1)
for rare diseases##2##3##(2013-1#2)
for rare##5##2##(2008-10#1)(2008-2#1)(2010-3#1)(2013-1#2)
for rat liver##2##3##(1994-8#1)(2008-4#1)
for rat pancreatic##2##3##(2008-11#2)
for rat##18##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#1)
for rates of##2##3##(2008-10#1)(2008-3#1)
for rating##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
for ratio##2##2##(1994-11#2)
for rational use of##2##4##(2007-7#2)
for rational##8##2##(1990-6#1)(1991-11#1)(2007-11#1)(2007-7#2)(2008-5#1)(2010-10#1)(2012-12#1)
for rats and##3##3##(1990-11#1)(1995-11#1)(2008-4#1)
for rats##5##2##(1990-11#1)(1991-12#1)(1995-11#1)(2008-4#2)
for reaching##8##2##(1994-1#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-2#1)
for reaction of##2##3##(1990-7#1)(1996-5#1)
for reaction to##2##3##(2008-10#2)
for reaction##8##2##(1990-7#1)(1992-11#1)(1996-5#1)(2008-10#4)(2008-4#1)
for reactions##2##2##(1997-2#1)(1997-7#1)
for reactivation##2##2##(1995-6#1)(2013-8#1)
for readers##4##2##(2007-5#2)(2008-2#1)(2008-4#1)
for reading##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
for readmissions##2##2##(1990-12#1)(2011-2#1)
for real sample analysis##2##4##(2008-10#2)
for real samples##3##3##(2008-10#3)
for real time##2##3##(2008-10#2)
for real##18##2##(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#12)(2008-2#1)(2008-3#1)(2013-8#1)
for real-life##2##2##(2007-9#1)(2008-10#1)
for real-time detection of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
for real-time holography##2##3##(2008-2#1)(2008-3#1)
for real-time hyperspectral image processing##2##5##(2008-3#2)
for real-time monitoring of##6##4##(2007-12#1)(2008-10#2)(2008-3#1)(2010-5#1)(2013-8#1)
for real-time##40##2##(2007-11#4)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
for real-world##2##2##(2008-3#1)(2012-2#1)
for realistic##8##2##(1995-2#1)(2007-11#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-9#1)
for realization of##2##3##(1996-5#1)(2008-10#1)
for reasoning##2##2##(1995-8#1)(2008-7#1)
for reasons of##2##3##(2008-10#1)(2008-7#1)
for reasons that##2##3##(2010-12#1)(2013-1#1)
for reasons##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2013-1#1)
for reassortants##2##2##(2012-12#2)
for receiving##4##2##(1992-2#1)(2008-2#2)(2011-2#1)
for recent##3##2##(1990-3#1)(2008-7#1)(2011-1#1)
for recently##2##2##(2008-2#1)(2013-8#1)
for receptor##9##2##(1990-4#1)(1992-9#1)(1993-12#1)(1994-5#2)(1994-9#1)(2008-8#1)(2011-2#2)
for receptors##2##2##(1994-2#1)(2009-8#1)
for recipients##6##2##(1994-9#5)(2011-2#1)
for recognition and##2##3##(1991-9#1)(2008-6#1)
for recognition of##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
for recognition##11##2##(1991-9#1)(1993-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#1)
for recognizing a##3##3##(2007-12#2)(2008-3#1)
for recognizing the##2##3##(2008-7#1)(2008-9#1)
for recognizing##12##2##(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
for recombinant protein production##3##4##(2008-11#2)(2011-1#1)
for recombinant protein##4##3##(2008-11#2)(2008-4#1)(2011-1#1)
for recombinant proteins##3##3##(1995-5#1)(2008-11#1)(2008-4#1)
for recombinant therapeutic##2##3##(2008-10#1)(2008-11#1)
for recombinant##19##2##(1991-9#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)
for recombination##3##2##(1995-8#1)(2008-10#1)(2008-12#1)
for recommending##2##2##(1992-12#1)(2011-2#1)
for reconstitution of##2##3##(1992-8#1)(2010-11#1)
for reconstitution##3##2##(1992-12#1)(1992-8#1)(2010-11#1)
for reconstructing the index##2##4##(2008-3#2)
for reconstructing the##3##3##(2008-3#3)
for reconstructing##18##2##(1995-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
for reconstruction of the##5##4##(2007-11#1)(2007-12#1)(2008-6#1)(2013-8#2)
for reconstruction of##13##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#2)(2013-8#3)
for reconstruction##18##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
for reconstructive##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
for recording and##3##3##(1994-2#1)(2007-12#1)(2008-2#1)
for recording##14##2##(1994-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)
for recovering##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
for recovery in##2##3##(2009-11#1)(2012-3#1)
for recovery is##3##3##(2007-10#1)(2008-6#1)(2011-2#1)
for recovery of##6##3##(1992-3#1)(2008-10#3)(2008-7#2)
for recovery##18##2##(1992-3#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
for recruiting##2##2##(1996-3#1)(2011-1#1)
for recruitment and retention##2##4##(1994-3#1)(2012-3#1)
for recruitment##4##2##(1994-3#1)(2010-10#1)(2012-3#1)(2013-1#1)
for rectal cancer is##2##4##(2008-10#1)(2011-2#1)
for rectal cancer##9##3##(1990-9#2)(1993-9#1)(1997-7#3)(2008-10#1)(2011-2#2)
for rectal##11##2##(1990-9#2)(1993-9#1)(1997-7#3)(2008-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
for recurrence and##2##3##(1996-11#1)(2012-12#1)
for recurrence of##3##3##(2007-12#1)(2008-7#1)(2010-8#1)
for recurrence##8##2##(1996-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)
for recurrent disease##2##3##(1997-4#1)(2011-1#1)
for recurrent event data##2##4##(1997-4#2)
for recurrent##18##2##(1991-3#1)(1991-8#1)(1992-5#1)(1992-9#1)(1994-1#1)(1997-4#3)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
for recurring##2##2##(1993-9#1)(2008-12#1)
for red wines##4##3##(2008-10#4)
for red##9##2##(1993-12#1)(2008-10#6)(2008-12#1)(2008-4#1)
for reduced##12##2##(1990-5#1)(1992-6#1)(2008-10#7)(2008-3#1)(2012-2#1)(2013-1#1)
for reducing health##2##3##(2008-4#1)(2008-6#1)
for reducing the reconstruction##2##4##(2008-2#1)(2008-3#1)
for reducing the##12##3##(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-5#1)
for reducing##51##2##(1991-11#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)
for reduction in##2##3##(1993-12#1)(2008-5#1)
for reduction of##6##3##(1990-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
for reduction##10##2##(1990-11#1)(1992-6#1)(1993-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2013-1#1)
for reductive##3##2##(2008-10#3)
for reference materials##2##3##(2008-10#2)
for reference##7##2##(1997-3#1)(2008-10#3)(2011-2#3)
for referral##2##2##(1993-12#1)(2006-5#1)
for refining the##2##3##(1993-11#1)(2011-2#1)
for refining##8##2##(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(2010-3#1)(2010-7#1)(2011-2#1)
for reflection and##4##3##(2008-2#3)(2013-1#1)
for reflection##10##2##(1992-11#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#2)(2013-1#1)
for reflective practice in##2##4##(2008-11#2)
for reflective##5##2##(2008-11#2)(2008-3#3)
for reflux esophagitis##3##3##(1996-2#2)(2008-12#1)
for reform is##2##3##(1994-12#1)(1996-1#1)
for reform##12##2##(1991-12#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-12#4)(1995-1#1)(1996-1#1)(1997-3#1)(2008-10#1)
for reform?##2##2##(1995-2#1)(1997-2#1)
for reforming##2##2##(1994-3#1)(2008-11#1)
for refraction##2##2##(2008-2#2)
for refractive##5##2##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
for refractive-index##2##2##(2008-2#1)(2008-3#1)
for refractory##8##2##(2006-10#1)(2008-7#3)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
for regaining##2##2##(2007-8#1)(2012-7#1)
for regeneration of##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
for regeneration##5##2##(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
for regenerative medicine##2##3##(2008-9#1)(2009-12#1)
for regional##4##2##(1993-12#1)(1997-2#1)(2011-2#1)(2012-12#1)
for regions of##2##3##(1990-4#1)(2012-1#1)
for regions##4##2##(1990-4#1)(1993-2#1)(2008-10#1)(2012-1#1)
for registered nurses##4##3##(2007-10#1)(2008-11#2)(2008-12#1)
for registration of##3##3##(1991-11#1)(2008-10#1)(2008-3#1)
for registration##6##2##(1991-11#1)(2008-10#1)(2008-11#3)(2008-3#1)
for regression##5##2##(1996-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-1#1)
for regular use##2##3##(1992-10#1)(2011-2#1)
for regular##6##2##(1992-10#1)(1995-11#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
for regulated##3##2##(1993-9#1)(2008-4#1)(2012-2#1)
for regulating##10##2##(1992-6#1)(1995-8#1)(2008-11#4)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
for regulation of cell##2##4##(2008-4#1)(2012-3#1)
for regulation of##11##3##(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1996-5#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-2#1)(2012-3#1)
for regulation##13##2##(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1996-5#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-2#1)(2010-12#1)(2012-3#1)
for regulatory compliance##2##3##(2008-10#2)
for regulatory purposes##3##3##(1991-12#1)(2008-11#2)
for regulatory##11##2##(1991-12#1)(1991-5#1)(2008-10#2)(2008-11#4)(2009-6#1)(2011-1#1)(2012-3#1)
for rehabilitation of##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
for rehabilitation services##2##3##(1995-12#1)(2006-5#1)
for rehabilitation##13##2##(1991-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-7#2)(2009-8#1)(2011-1#1)(2013-1#2)
for reimbursement of##3##3##(1992-1#1)(1995-1#1)(2008-12#1)
for reimbursement##4##2##(1992-1#1)(1995-1#1)(2008-12#1)(2011-2#1)
for reinforcement##2##2##(1994-2#1)(2009-10#1)
for rejection of##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2009-8#1)
for relapse##3##2##(1997-5#1)(2007-5#2)
for relapsed##2##2##(2009-4#1)(2010-12#1)
for relapsed/refractory Hodgkin's disease##2##4##(1994-12#1)(1995-9#1)
for related##5##2##(1995-11#1)(1995-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
for relational##2##2##(2008-12#1)(2010-8#1)
for relationships##2##2##(2010-4#1)(2013-8#1)
for relative risk##2##3##(1995-9#1)(2012-12#1)
for relative##12##2##(1992-12#1)(1994-12#1)(1994-9#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-6#1)
for relatively##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)
for relaxation##3##2##(1995-12#1)(2007-6#2)
for releasing##4##2##(2008-10#1)(2008-4#2)(2009-8#1)
for relevance##3##2##(1991-6#1)(2007-2#1)(2007-7#1)
for relevant##10##2##(1991-8#1)(2007-4#1)(2007-7#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
for reliability##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
for reliable and##2##3##(1995-1#1)(2008-10#1)
for reliable##19##2##(1993-12#1)(1993-2#1)(1995-1#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
for relief of##2##3##(1993-10#1)(2006-10#1)
for religious##2##2##(1990-10#1)(2008-10#1)
for remission##2##2##(2008-6#1)(2012-12#1)
for remote detection##2##3##(2008-3#2)
for remote sensing of##2##4##(2007-12#1)(2008-3#1)
for remote sensing##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
for remote##16##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-9#1)(2009-6#1)
for removal of##16##3##(1991-12#1)(1994-3#2)(2007-12#1)(2007-8#2)(2008-10#5)(2008-6#1)(2010-12#2)(2012-3#1)(2013-1#1)
for removal##18##2##(1991-12#1)(1994-3#2)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-6#1)(2010-12#2)(2012-3#1)(2013-1#1)
for removing the##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
for removing##16##2##(1990-5#1)(1991-3#1)(1994-11#1)(2007-11#1)(2008-10#9)(2008-2#1)(2008-3#1)(2010-3#1)
for renal cell carcinoma (RCC)##2##5##(2008-1#1)(2013-1#1)
for renal cell carcinoma##4##4##(1995-12#1)(2008-1#1)(2009-5#1)(2013-1#1)
for renal disease##2##3##(2007-7#1)(2011-2#1)
for renal transplantation##3##3##(1991-9#1)(2007-7#1)(2009-10#1)
for renal##26##2##(1991-12#1)(1991-9#1)(1993-12#1)(1995-12#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-7#4)(2008-1#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
for renewable##2##2##(2008-10#1)(2008-6#1)
for renewing##2##2##(2008-11#1)(2008-8#1)
for renovascular hypertension##2##3##(1994-9#1)(2010-4#1)
for reoperation##2##2##(2007-11#1)(2011-2#1)
for repair of##2##3##(2008-8#1)(2011-2#1)
for repair##7##2##(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#4)
for repairing##3##2##(2011-2#2)(2013-8#1)
for repeatability and##2##3##(2008-5#1)(2009-11#1)
for repeatability##5##2##(2008-10#3)(2008-5#1)(2009-11#1)
for repeated measurements##2##3##(2008-10#1)(2013-1#1)
for repeated use##2##3##(2008-10#2)
for repeated##15##2##(1992-12#1)(1994-7#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
for replacement of##2##3##(1990-8#1)(2011-3#1)
for replacement##3##2##(1990-8#1)(2011-1#1)(2011-3#1)
for replacing##2##2##(1992-12#1)(2008-10#1)
for replicate##2##2##(2008-10#2)
for replication and##3##3##(2008-10#2)(2008-11#1)
for replication in##2##3##(1991-12#1)(1997-3#1)
for replication##7##2##(1991-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-9#1)
for reporting##10##2##(1990-6#1)(1991-2#1)(1994-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#2)
for reports##2##2##(2007-2#1)(2012-12#1)
for representing##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
for reproducibility##3##2##(2008-10#3)
for reproducible##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
for reproduction##6##2##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#2)
for reproductive##3##2##(1992-3#1)(2009-7#1)(2012-2#1)
for requiring##2##2##(1995-6#1)(2012-12#1)
for research and the##2##4##(1995-1#1)(2011-7#1)
for research and##15##3##(1991-12#1)(1995-1#1)(1996-12#1)(1997-7#1)(2007-10#1)(2008-11#2)(2008-9#2)(2009-5#1)(2011-1#2)(2011-2#2)(2011-7#1)
for research in##2##3##(1996-2#1)(2008-11#1)
for research into the##5##4##(2007-10#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#1)
for research into##11##3##(1994-1#1)(1996-11#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-6#1)(2009-7#1)(2010-12#1)(2013-1#2)
for research on the##2##4##(2008-10#1)(2008-12#1)
for research on##7##3##(2008-10#2)(2008-12#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
for research purposes##4##3##(1993-1#1)(2008-11#1)(2011-1#1)(2013-1#1)
for research##61##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-7#2)(2007-10#2)(2008-10#6)(2008-11#7)(2008-12#3)(2008-4#2)(2008-6#1)(2008-9#4)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#4)
for research-based##2##2##(2007-11#1)(2008-11#1)
for researchers and##4##3##(2007-11#1)(2007-12#2)(2010-8#1)
for researchers in##2##3##(2008-9#1)(2010-7#1)
for researchers is##2##3##(2008-4#1)(2011-2#1)
for researchers to##3##3##(1992-3#1)(1994-3#1)(2009-8#1)
for researchers##18##2##(1992-3#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-11#3)(2008-4#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
for researching##2##2##(1994-2#1)(2010-5#1)
for resection of a##2##4##(2008-10#1)(2011-2#1)
for resection of##6##3##(2007-8#1)(2008-10#1)(2011-2#4)
for resection##9##2##(2007-8#1)(2008-10#1)(2011-2#4)(2012-12#1)(2013-1#2)
for residency program##2##3##(2007-4#1)(2012-3#1)
for residents##4##2##(1993-3#1)(1995-2#1)(2011-1#1)(2012-12#1)
for residual chlorine##2##3##(2008-10#2)
for residual##5##2##(2008-10#2)(2009-11#1)(2010-12#1)(2011-2#1)
for residue##3##2##(1992-3#1)(1995-5#1)(2008-10#1)
for residues##4##2##(2008-10#3)(2009-7#1)
for resin coated with##2##4##(2008-10#2)
for resin##3##2##(2008-10#2)(2008-4#1)
for resistance against##2##3##(2008-10#1)(2009-6#1)
for resistance and##2##3##(2008-10#2)
for resistance genes##2##3##(2008-10#2)
for resistance in the##2##4##(2008-10#2)
for resistance in##13##3##(2008-10#13)
for resistance is##2##3##(2008-10#2)
for resistance to FHB##2##4##(2008-10#2)
for resistance to M##2##4##(2008-10#2)
for resistance to P##4##4##(2008-10#4)
for resistance to STB##3##4##(2008-10#3)
for resistance to aflatoxin production##2##5##(2008-10#2)
for resistance to bacterial blight##2##5##(2008-10#2)
for resistance to leaf rust and##2##6##(2008-10#2)
for resistance to leaf rust##3##5##(2008-10#3)
for resistance to races##2##4##(2008-10#2)
for resistance to southern leaf blight##5##6##(2008-10#5)
for resistance to the##2##4##(2008-10#2)
for resistance to these##2##4##(2008-10#2)
for resistance to white pine blister rust##5##7##(2008-10#5)
for resistance to white pine blister##6##6##(2008-10#6)
for resistance to##78##3##(2008-10#77)(2008-5#1)
for resistance trained athletes##3##4##(2008-5#3)
for resistance was##3##3##(2008-10#3)
for resistance##128##2##(2008-10#121)(2008-5#4)(2008-8#2)(2009-6#1)
for resistant##5##2##(2008-10#2)(2009-11#1)(2009-4#1)(2013-8#1)
for resisting##3##2##(1991-12#1)(1992-3#1)(2009-2#1)
for resolution of##2##3##(2008-10#2)
for resolution##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
for resolving chemical##2##3##(2008-10#2)
for resolving ternary mixtures of##2##5##(2008-10#2)
for resolving the##2##3##(2008-1#1)(2011-2#1)
for resolving##13##2##(2008-1#1)(2008-10#8)(2008-12#1)(2011-2#3)
for resonant##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
for resorcinol and##3##3##(2008-10#3)
for resorcinol##4##2##(2008-10#4)
for resource##2##2##(1995-1#1)(2008-8#1)
for resources and##2##3##(2008-10#1)(2008-11#1)
for resources##9##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
for respiratory##5##2##(1991-2#1)(1997-7#1)(2008-12#1)(2010-6#1)(2010-8#1)
for respondents##2##2##(1997-2#1)(2011-2#1)
for responders and##2##3##(1994-8#1)(2007-10#1)
for response to##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)
for response##15##2##(1990-2#2)(1991-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-4#1)(2010-12#1)
for restenosis##2##2##(1996-6#1)(2008-5#1)
for restoration of##11##3##(1990-5#2)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#2)
for restoration##12##2##(1990-5#2)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#2)
for restoring##2##2##(1990-5#1)(2009-2#1)
for restriction fragment length polymorphisms##2##5##(1996-12#1)(2008-10#1)
for restriction fragment length##3##4##(1996-12#1)(2008-10#2)
for restriction fragment##4##3##(1996-12#1)(2008-10#3)
for restriction##5##2##(1994-8#1)(1996-12#1)(2008-10#3)
for restrictive##2##2##(1993-1#1)(2012-3#1)
for restructuring##4##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)
for resurfacing the##2##3##(2011-2#2)
for retaining and recruiting##2##4##(1994-1#2)
for retaining##5##2##(1994-1#2)(2007-7#1)(2008-10#1)(2011-2#1)
for retention and##2##3##(1993-1#1)(2008-10#1)
for retention modeling in##2##4##(2008-10#2)
for retention of##5##3##(1992-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
for retention##12##2##(1992-11#1)(1993-1#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2012-2#1)
for retinal prosthesis##2##3##(2009-12#2)
for retinal##3##2##(2009-12#2)(2013-1#1)
for retirement##2##2##(2008-1#1)(2010-3#1)
for retrieval of the##4##4##(1993-12#1)(2008-3#3)
for retrieval of##13##3##(1993-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)(2008-6#1)
for retrieval##14##2##(1993-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#6)(2008-6#1)
for retrievals##2##2##(2008-3#2)
for retrieving the##5##3##(2008-2#1)(2008-3#4)
for retrieving##10##2##(2008-2#3)(2008-3#6)(2008-6#1)
for retrospective##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
for retroviral##3##2##(1990-2#1)(2008-11#1)(2011-3#1)
for return##3##2##(2008-9#1)(2009-3#1)(2013-1#1)
for reuse##2##2##(2008-1#1)(2010-4#1)
for revascularization of##2##3##(2010-8#2)
for revascularization##3##2##(2008-5#1)(2010-8#2)
for reverse##4##2##(1992-6#1)(2008-10#1)(2008-9#1)(2009-2#1)
for reversed##2##2##(2008-10#1)(2011-1#1)
for review##3##2##(1995-6#1)(2008-6#1)(2013-8#1)
for reviewing##3##2##(1995-12#1)(2012-12#1)(2013-1#1)
for revision surgery##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
for revision##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#1)(2013-1#2)
for revisions##2##2##(1995-1#1)(1995-3#1)
for rhEPO##2##2##(2008-8#2)
for rheumatic fever##2##3##(1996-12#1)(2008-7#1)
for rheumatic##4##2##(1996-12#1)(2006-10#1)(2007-8#1)(2008-7#1)
for rheumatoid arthritis##9##3##(1997-5#1)(2006-10#1)(2007-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
for rhinoplasty##2##2##(2010-8#2)
for rhodium##2##2##(2008-10#2)
for ribose##2##2##(1996-5#1)(2011-1#1)
for ribosomal##2##2##(1997-2#1)(2008-5#1)
for rice##11##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)
for rifampicin##2##2##(2007-7#1)(2008-10#1)
for right##8##2##(1997-8#1)(2007-8#3)(2008-8#1)(2011-2#2)(2012-3#1)
for rigorous##2##2##(2011-2#1)(2012-2#1)
for risk assessment##8##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)
for risk control with health and safety protection and promotion##2##10##(2008-9#2)
for risk factors##3##3##(1994-2#1)(1997-3#1)(2007-10#1)
for risk management##4##3##(1990-11#1)(1992-3#1)(1993-2#1)(2008-8#1)
for risk managers##2##3##(1992-2#1)(1996-12#1)
for risk of##2##3##(1992-9#1)(2008-10#1)
for risk reduction##2##3##(2008-12#1)(2011-2#1)
for risk stratification##4##3##(2010-9#1)(2012-2#1)(2012-3#2)
for risk##33##2##(1990-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#4)(1993-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#2)
for risk-selection in##3##3##(2008-7#3)
for risk-selection##4##2##(2008-7#4)
for river water samples##2##4##(2008-10#2)
for river water##3##3##(2008-10#3)
for river##5##2##(2008-10#5)
for road##3##2##(2008-10#1)(2009-10#1)(2010-8#1)
for robot##2##2##(2008-6#2)
for robust and reliable##2##4##(2013-1#1)(2013-8#1)
for robust##7##2##(2007-12#1)(2008-3#2)(2009-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
for root canal##2##3##(1991-3#1)(2008-11#1)
for root##7##2##(1991-3#1)(2008-10#4)(2008-11#1)(2013-1#1)
for rotational##3##2##(1996-5#1)(1997-6#1)(2008-11#1)
for rough##2##2##(2008-3#2)
for roughly##2##2##(1997-2#1)(2007-11#1)
for roughness values##2##3##(2008-3#2)
for roughness##3##2##(2008-3#3)
for routine analyses of##2##4##(2008-10#1)(2008-5#1)
for routine analyses##3##3##(2008-10#1)(2008-5#2)
for routine analysis of##6##4##(2008-10#6)
for routine analysis##10##3##(2008-10#10)
for routine clinical use##2##4##(1997-7#1)(2008-10#1)
for routine clinical##3##3##(1997-7#1)(2008-10#2)
for routine determination of##2##4##(2008-10#2)
for routine identification are presented##2##5##(2008-10#2)
for routine laboratory##2##3##(2008-10#1)(2008-9#1)
for routine monitoring##2##3##(2008-10#2)
for routine screening##3##3##(1991-7#1)(2007-10#1)(2008-4#1)
for routine testing##3##3##(2012-2#3)
for routine use##5##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-9#2)
for routine##71##2##(1991-6#1)(1991-7#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#38)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-9#8)(2009-11#1)(2012-2#4)(2013-8#1)
for running##3##2##(2008-4#2)(2010-8#1)
for rural health##3##3##(1992-12#1)(1996-2#1)(1996-3#1)
for rural##14##2##(1992-12#2)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#2)(2008-12#2)(2013-1#2)
for rust##6##2##(2008-10#6)
for safe and##3##3##(1992-6#1)(1993-3#1)(2011-2#1)
for safe##7##2##(1992-6#1)(1993-3#1)(1994-3#1)(2007-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
for safety and efficacy##2##4##(2008-5#1)(2011-2#1)
for safety and##4##3##(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
for safety assessment##2##3##(2010-11#1)(2010-6#1)
for safety##9##2##(2008-11#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
for salbutamol##2##2##(2008-10#2)
for salicylate##6##2##(2008-10#6)
for salicylate-selective##2##2##(2008-10#2)
for salicylic acid##2##3##(2008-10#2)
for salinomycin (1/4)##2##3##(2007-6#2)
for salivary##2##2##(2011-2#1)(2013-8#1)
for salt##3##2##(1997-8#1)(2008-12#1)(2012-2#1)
for salvage##3##2##(2009-1#1)(2013-1#2)
for sample and reagent##2##4##(2008-10#2)
for sample clean-up##2##3##(1996-5#1)(2008-10#1)
for sample dissolution##2##3##(2008-5#1)(2012-2#1)
for sample injection##2##3##(2008-10#2)
for sample pre-treatment##2##3##(2008-10#2)
for sample preconcentration##2##3##(2008-10#2)
for sample preparation and##3##4##(2008-10#1)(2008-9#2)
for sample preparation##8##3##(2008-10#3)(2008-4#2)(2008-9#2)(2013-1#1)
for sample size calculation##2##4##(1992-6#1)(2013-1#1)
for sample size##3##3##(1992-6#1)(2012-3#1)(2013-1#1)
for sample treatment##3##3##(2008-10#3)
for sample##46##2##(1992-6#1)(1996-5#1)(2008-10#33)(2008-4#4)(2008-5#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#2)
for samples collected in##2##4##(2008-3#1)(2012-3#1)
for samples from##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
for samples of##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)
for samples spiked with single species##3##6##(2008-10#3)
for samples spiked with##4##4##(2008-10#4)
for samples##24##2##(1992-11#2)(1995-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-3#1)
for sampling and##4##3##(2008-10#2)(2010-12#1)(2011-1#1)
for sampling the##2##3##(2008-2#1)(2008-9#1)
for sampling##19##2##(2007-6#1)(2008-10#11)(2008-2#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)
for sanitation##3##2##(2008-10#3)
for satellite##5##2##(2008-2#1)(2008-3#2)(2009-3#1)(2013-8#1)
for saturable##2##2##(1992-3#1)(1992-9#1)
for saturated##2##2##(2008-3#1)(2010-4#1)
for saturation##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
for savings##2##2##(1992-2#1)(2010-8#1)
for scab resistance##2##3##(2008-10#2)
for scab##4##2##(2008-10#4)
for scale-up##3##2##(2008-11#2)(2008-6#1)
for scanning near-field optical microscopy##2##5##(2008-2#1)(2008-3#1)
for scanning##6##2##(2007-11#2)(2008-2#1)(2008-3#2)(2008-5#1)
for scar##2##2##(2008-9#2)
for scattering from an optically##2##5##(2008-2#2)
for scattering from##3##3##(2008-2#2)(2008-3#1)
for scattering of##2##3##(2008-2#2)
for scattering##14##2##(2008-2#9)(2008-3#5)
for scheduled##2##2##(2011-2#1)(2013-1#1)
for schistosomiasis japonica control in different environmental settings##2##8##(2008-8#2)
for schistosomiasis japonica##3##3##(2008-8#2)(2012-3#1)
for schistosomiasis##5##2##(2008-8#3)(2012-3#2)
for schizophrenia and##3##3##(1995-11#1)(1997-5#1)(2013-8#1)
for schizophrenia in##3##3##(1994-12#1)(1997-5#1)(1997-8#1)
for schizophrenia##15##2##(1994-12#1)(1995-11#2)(1995-8#1)(1997-5#4)(1997-8#1)(2007-10#1)(2010-1#2)(2011-1#1)(2013-1#1)(2013-8#1)
for school##4##2##(1994-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
for school-aged##2##2##(1992-12#1)(1992-2#1)
for schools##2##2##(2008-7#1)(2010-5#1)
for scientific and##2##3##(2008-10#1)(2008-2#1)
for scientific##9##2##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2010-3#1)(2012-12#1)(2012-3#1)
for scientists##2##2##(2008-11#1)(2010-8#1)
for scintillations##2##2##(2008-3#2)
for scoliosis##2##2##(2008-11#1)(2012-12#1)
for screening and##8##3##(1994-3#1)(2008-10#3)(2008-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
for screening for##2##3##(2008-10#1)(2008-8#1)
for screening hepatitis B in blood donors##2##7##(2011-2#2)
for screening hepatitis B##3##4##(2011-2#3)
for screening large numbers of##3##5##(2008-10#2)(2008-9#1)
for screening of##9##3##(1992-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2012-2#1)(2012-3#1)
for screening polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
for screening potato##2##3##(2008-10#2)
for screening purposes##11##3##(1990-6#2)(1995-12#1)(1997-1#1)(2008-10#7)
for screening the##3##3##(2008-9#1)(2010-8#1)(2013-1#1)
for screening##84##2##(1990-6#3)(1992-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-9#2)(1996-12#1)(1996-8#1)(1997-1#2)(2007-7#1)(2007-8#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)
for search and rescue##2##4##(2008-3#2)
for search and##3##3##(2008-11#1)(2008-3#2)
for search##4##2##(1993-3#1)(2008-11#1)(2008-3#2)
for searching with short peptides and oligonucleotides##2##7##(2008-4#2)
for searching##8##2##(1992-1#1)(1995-6#1)(2008-4#4)(2008-9#1)(2013-7#1)
for seasonal allergic rhinitis##2##4##(2007-11#1)(2012-12#1)
for seasonal##7##2##(1997-6#1)(2007-11#1)(2008-5#3)(2011-2#1)(2012-12#1)
for second-##2##2##(2007-11#1)(2008-3#1)
for second-harmonic generation at##2##4##(2007-12#1)(2008-3#1)
for second-harmonic generation##9##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)
for second-order##3##2##(1997-7#1)(2007-12#1)(2008-3#1)
for secondary prevention of ischemic heart##2##6##(1995-11#1)(2011-2#1)
for secondary prevention of##3##4##(1995-11#2)(2011-2#1)
for secondary prevention##7##3##(1990-2#1)(1995-11#2)(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#1)
for secondary##21##2##(1990-2#1)(1990-7#1)(1990-9#1)(1995-11#2)(1997-7#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)
for secretion of soluble RGP and cell surface expression of full-length RGP##2##12##(1995-2#2)
for secretion of##4##3##(1993-9#1)(1995-2#2)(2008-10#1)
for secretion##7##2##(1991-6#1)(1993-9#1)(1995-2#3)(2008-10#1)(2009-9#1)
for sectioning##3##2##(2008-4#2)(2008-9#1)
for secure communications##2##3##(2007-11#2)
for secure real-time display##2##4##(2007-11#2)
for secure##5##2##(2007-11#4)(2010-8#1)
for securing##3##2##(1991-3#1)(2008-11#1)(2012-3#1)
for security applications##2##3##(2008-2#1)(2008-3#1)
for security verification##2##3##(2008-2#2)
for security##10##2##(1991-1#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2010-8#1)
for sedation and analgesia##3##4##(2008-8#2)(2011-2#1)
for sedation##7##2##(2008-8#5)(2010-7#1)(2011-2#1)
for sediments##2##2##(2008-10#2)
for seed coat##3##3##(2013-8#3)
for seed transmission of##2##4##(2008-10#2)
for seed##11##2##(2008-10#4)(2008-9#2)(2009-10#1)(2012-3#1)(2013-8#3)
for seeding##3##2##(2007-12#1)(2008-11#1)(2012-1#1)
for seeking##3##2##(2008-2#1)(2008-4#1)(2011-1#1)
for segmentation and##2##3##(2011-7#2)
for segmentation of##5##3##(2008-3#2)(2008-7#1)(2010-8#2)
for segmentation##7##2##(2008-3#2)(2008-7#1)(2010-8#2)(2011-7#2)
for segmented##2##2##(2008-3#2)
for seizure generation##2##3##(1990-5#1)(2009-8#1)
for seizure##3##2##(1990-5#1)(2008-7#1)(2009-8#1)
for seizures##3##2##(1995-12#1)(2011-1#2)
for select##6##2##(1991-1#1)(1993-3#1)(2008-10#1)(2011-2#2)(2012-3#1)
for selected patients##3##3##(1992-6#1)(2008-9#1)(2010-10#1)
for selected##22##2##(1991-2#1)(1992-6#1)(1994-6#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)
for selecting a##5##3##(2008-9#1)(2009-12#1)(2010-7#1)(2012-1#1)(2012-5#1)
for selecting an appropriate##2##4##(2008-9#1)(2011-2#1)
for selecting and##2##3##(1996-12#1)(2008-4#1)
for selecting the##12##3##(1990-5#1)(1995-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2009-11#1)(2009-12#1)(2010-11#1)
for selecting##37##2##(1990-5#1)(1992-11#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-4#1)(2010-11#3)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2012-5#1)
for selection based on disease progression##2##6##(2008-10#2)
for selection based on maximal disease##2##6##(2008-10#2)
for selection based on##4##4##(2008-10#4)
for selection of stable##2##4##(1993-12#1)(2008-11#1)
for selection of##17##3##(1992-3#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
for selection on##4##3##(2008-8#4)
for selection via##2##3##(1995-2#1)(2008-8#1)
for selection##30##2##(1992-3#1)(1993-12#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#6)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
for selective detection of##2##4##(2008-10#2)
for selective detection##3##3##(2008-10#3)
for selective determination of##3##4##(2008-10#3)
for selective extraction of mercury(II)##2##5##(2008-10#2)
for selective extraction##3##3##(2008-10#3)
for selective##26##2##(2007-12#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
for selectivity##3##2##(2008-10#1)(2009-2#1)(2011-2#1)
for selenite##2##2##(2008-10#2)
for selenium determination in##2##4##(2008-10#2)
for selenium in the##2##4##(2008-10#2)
for selenium##12##2##(2008-10#11)(2009-10#1)
for self-evaluation##2##2##(1990-2#1)(1994-6#1)
for self-focusing##5##2##(2007-12#5)
for self-help groups and##2##4##(1994-1#1)(2008-4#1)
for self-referenced oxygen sensing##2##4##(2008-10#2)
for seminal##2##2##(1995-11#1)(2011-1#1)
for senior##4##2##(1993-12#1)(1996-3#1)(1997-3#1)(2008-11#1)
for sensing applications##3##3##(2008-2#2)(2008-7#1)
for sensing is##2##3##(2008-10#1)(2012-2#1)
for sensing##14##2##(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-7#1)(2012-2#1)
for sensitive and##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2009-3#1)
for sensitive detection##2##3##(2008-10#2)
for sensitive##14##2##(1992-11#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-9#1)(2009-3#1)
for sensitivity and##2##3##(2008-10#2)
for sensitivity enhancement##2##3##(2007-12#1)(2008-10#1)
for sensitivity to the##2##4##(2008-10#2)
for sensitivity to##6##3##(1997-4#1)(2008-10#4)(2008-7#1)
for sensitivity##18##2##(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
for sensitization in##2##3##(2008-10#2)
for sensitization##4##2##(2007-12#2)(2008-10#2)
for sensor 1##2##3##(2008-10#2)
for sensor applications##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
for sensor##11##2##(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)
for sensorimotor##2##2##(1995-5#1)(1996-2#1)
for sensory##4##2##(1996-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
for sentinel lymph nodes mapping##2##5##(2012-12#2)
for sentinel##3##2##(2012-12#2)(2013-1#1)
for separate##4##2##(1995-8#1)(1996-5#1)(2008-10#1)(2008-5#1)
for separating and##4##3##(2008-10#4)
for separating##18##2##(1992-6#1)(1994-12#1)(1994-9#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#3)(2008-9#1)(2009-11#1)
for separation and detection##2##4##(2008-10#2)
for separation and determination of##4##5##(2008-10#3)(2009-8#1)
for separation and preconcentration of nickel##2##6##(2008-10#2)
for separation and preconcentration of trace amounts of##2##8##(2008-10#2)
for separation and preconcentration of##6##5##(2008-10#6)
for separation and preconcentration##7##4##(2008-10#7)
for separation and##17##3##(2008-10#15)(2008-6#1)(2009-8#1)
for separation of##24##3##(1995-11#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#2)(2013-1#1)
for separation##54##2##(1995-11#1)(1997-2#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#2)(2009-8#1)(2010-7#1)(2013-1#1)
for sepsis##5##2##(2007-12#1)(2011-2#3)(2012-3#1)
for septic##2##2##(2007-8#1)(2008-10#1)
for sequence##5##2##(1993-6#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-2#1)
for sequences##4##2##(1994-12#1)(2008-10#1)(2008-9#2)
for sequencing##7##2##(1990-5#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
for sequential determination of##3##4##(2008-10#3)
for sequential implantation (P &lt##2##4##(2012-2#2)
for sequential implantation##3##3##(2012-2#3)
for sequential injection##3##3##(2008-10#3)
for sequential##20##2##(1994-11#1)(2008-10#12)(2008-3#1)(2009-9#2)(2012-2#3)(2013-1#1)
for serial##3##2##(2008-10#1)(2008-7#1)(2012-5#1)
for serine binding##2##3##(1994-5#2)
for serine##5##2##(1994-5#3)(1997-1#1)(2008-10#1)
for serious##7##2##(1994-3#1)(1996-6#1)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#2)
for seriously ill##2##3##(1992-5#1)(2012-12#1)
for seriously##3##2##(1992-5#1)(1996-8#1)(2012-12#1)
for serological##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)
for serotonin##2##2##(2008-2#1)(2008-7#1)
for serum concentrations##2##3##(1990-11#1)(1993-8#1)
for serum cortisol##3##3##(1992-6#1)(2011-2#1)(2013-1#1)
for serum p53 Abs##2##4##(2011-2#2)
for serum samples##3##3##(1990-8#1)(2008-10#2)
for serum##22##2##(1990-11#1)(1990-2#1)(1990-8#2)(1992-6#1)(1993-8#1)(1996-7#1)(2008-10#4)(2008-11#1)(2011-1#1)(2011-2#7)(2013-1#2)
for serum-free##3##2##(2008-11#3)
for service improvement and##2##4##(1993-12#1)(1994-3#1)
for service##21##2##(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-5#1)(2006-10#1)(2008-11#1)(2009-6#1)(2013-8#10)
for service&quot##2##2##(1990-9#1)(1992-3#1)
for services with##2##3##(1993-3#1)(1997-1#1)
for services##10##2##(1991-3#1)(1992-2#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-12#1)
for serving##2##2##(1997-6#1)(2008-10#1)
for setting up more##2##4##(1990-10#1)(2008-9#1)
for setting up##5##3##(1990-10#1)(2008-4#2)(2008-9#2)
for setting##13##2##(1990-10#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-4#2)(2008-9#3)(2012-2#1)
for seven consecutive##2##3##(2008-10#2)
for seven days##5##3##(1994-5#1)(1997-2#1)(2008-8#1)(2009-4#1)(2013-1#1)
for seven of##2##3##(1991-2#1)(1994-9#1)
for seven replicate determinations##2##4##(2008-10#2)
for seven##24##2##(1990-3#1)(1991-2#1)(1994-5#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#3)(2013-8#1)
for several days on##2##4##(2007-12#2)
for several days##7##3##(1991-3#1)(2007-12#2)(2008-10#2)(2008-7#1)(2011-1#1)
for several decades##4##3##(2008-1#1)(2008-10#2)(2012-2#1)
for several different##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
for several diseases##2##3##(2008-7#1)(2012-2#1)
for several hours##6##3##(1997-4#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
for several minutes##2##3##(1992-8#1)(2008-8#1)
for several months##9##3##(1990-6#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-12#2)(2012-2#2)
for several neuropsychiatric disorders##2##4##(1997-5#1)(2012-12#1)
for several of the##2##4##(1995-6#1)(2008-4#1)
for several of##4##3##(1995-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
for several reasons##5##3##(1996-3#1)(2008-10#2)(2009-6#1)(2013-1#1)
for several samples##2##3##(2008-10#1)(2008-7#1)
for several tissues##2##3##(2008-5#1)(2008-7#1)
for several weeks##3##3##(2008-10#2)(2008-11#1)
for several years##10##3##(1991-12#1)(1993-11#1)(1994-12#2)(2007-2#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-3#1)(2013-1#1)
for several##133##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#3)(1994-11#1)(1994-12#4)(1995-2#2)(1995-6#2)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-11#2)(2007-12#5)(2007-2#1)(2008-1#2)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-6#4)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#2)
for severe acute##2##3##(2008-8#1)(2013-1#1)
for severe malaria##3##3##(1996-8#1)(2012-12#2)
for severe##33##2##(1990-3#2)(1990-8#1)(1991-11#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#3)(2013-1#3)(2013-8#5)
for severely##3##2##(1997-2#1)(1997-3#1)(2013-1#1)
for severity of##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
for severity##7##2##(2008-10#4)(2012-12#1)(2012-2#1)(2013-1#1)
for sex##11##2##(1991-8#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-5#1)(2010-8#1)
for sexual abuse##2##3##(1993-12#1)(2009-9#1)
for sexual reproduction##2##3##(2008-10#2)
for sexual selection##5##3##(1995-2#1)(2008-8#4)
for sexual##16##2##(1991-6#1)(1993-12#1)(1995-2#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-8#4)(2009-9#1)(2012-1#1)(2012-3#2)
for sexually transmitted infections##2##4##(2008-11#1)(2011-2#1)
for sexually transmitted##6##3##(1996-6#1)(1997-3#1)(2007-7#2)(2008-11#1)(2011-2#1)
for sexually##8##2##(1995-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-7#2)(2008-11#1)(2011-2#1)
for shallow##3##2##(2008-2#1)(2008-3#2)
for shared##4##2##(1992-2#1)(2008-1#1)(2008-12#1)(2008-3#1)
for sharing##2##2##(1995-12#1)(2008-12#1)
for shear rupture##4##3##(1996-4#4)
for shiga toxin##2##3##(2008-8#2)
for short and long##2##4##(2008-10#1)(2008-3#1)
for short and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
for short periods##2##3##(1996-3#1)(2011-2#1)
for short##18##2##(1992-8#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#1)
for short- and##2##3##(1993-12#2)
for short-term##4##2##(1992-9#1)(2008-11#1)(2008-9#1)(2010-8#1)
for shorter duration##2##3##(2008-5#2)
for shorter##5##2##(2008-10#1)(2008-5#2)(2009-3#1)(2013-1#1)
for shoulder##3##2##(2007-11#2)(2012-1#1)
for showing the##2##3##(1996-6#1)(2008-12#1)
for showing##3##2##(1993-2#1)(1996-6#1)(2008-12#1)
for sigma##3##2##(1990-7#1)(1992-12#1)(1996-3#1)
for sigmoid colon cancer##2##4##(2008-10#1)(2012-12#1)
for sigmoid##3##2##(1993-5#1)(2008-10#1)(2012-12#1)
for signal and##2##3##(2008-2#1)(2008-3#1)
for signal processing##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
for signal transduction##3##3##(1995-2#1)(1997-3#1)(2009-8#1)
for signal##17##2##(1995-2#1)(1996-2#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#4)(2008-9#1)(2009-8#1)
for signal-to-noise##2##2##(2008-10#1)(2008-8#1)
for signaling##2##2##(2007-12#1)(2010-8#1)
for signals##2##2##(2008-10#1)(2008-2#1)
for significance##2##2##(2008-10#1)(2012-2#1)
for significant##23##2##(1991-12#1)(1994-2#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-7#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
for signs##2##2##(1997-3#1)(2010-12#1)
for silencing##2##2##(2008-9#1)(2011-2#1)
for silica##2##2##(2008-2#1)(2008-5#1)
for silicon and phosphorous##2##4##(2008-11#2)
for silicon##5##2##(2008-11#2)(2008-2#3)
for silver##8##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-4#1)
for similar conditions##2##3##(2008-10#1)(2010-12#1)
for similar##13##2##(1991-8#1)(1993-11#1)(1996-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-3#1)
for simple and complex##2##4##(2010-12#1)(2011-2#1)
for simple and##3##3##(1997-4#1)(2010-12#1)(2011-2#1)
for simple##18##2##(1990-12#1)(1994-9#1)(1995-5#1)(1997-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-2#1)
for simplified##2##2##(2008-10#1)(2011-2#1)
for simulating light transport##2##4##(2011-1#2)
for simulating##11##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#2)
for simulation of##2##3##(2008-3#2)
for simulation##7##2##(1993-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-9#1)
for simultaneous analysis of##6##4##(2008-10#5)(2008-9#1)
for simultaneous detection##4##3##(2008-10#1)(2008-9#1)(2009-11#1)(2010-6#1)
for simultaneous determination of Fe(II) and Fe(III)##2##7##(2008-10#2)
for simultaneous determination of Fe(II)##3##5##(2008-10#3)
for simultaneous determination of ammonium##2##5##(2008-10#2)
for simultaneous determination of some metals##2##6##(2008-10#2)
for simultaneous determination of some##3##5##(2008-10#3)
for simultaneous determination of the##2##5##(2008-10#2)
for simultaneous determination of uric acid##3##6##(2008-10#3)
for simultaneous determination of##50##4##(2008-10#44)(2008-5#2)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
for simultaneous determination##51##3##(2008-10#45)(2008-5#2)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
for simultaneous electrochemical determination of ascorbic acid##2##7##(2008-10#2)
for simultaneous implantation##3##3##(2012-2#3)
for simultaneous measurement of temperature and##2##6##(2007-11#2)
for simultaneous measurement of temperature##3##5##(2007-11#2)(2007-12#1)
for simultaneous measurement of##9##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2008-4#1)
for simultaneous measurements of##4##4##(2008-10#3)(2008-2#1)
for simultaneous quantification of##5##4##(2008-10#1)(2008-11#1)(2010-12#2)(2011-3#1)
for simultaneous separation and##2##4##(2008-10#2)
for simultaneous separation of##2##4##(2008-10#2)
for simultaneous separation##4##3##(2008-10#4)
for simultaneous spectrophotometric determination of##3##5##(2008-10#3)
for simultaneous spectrophotometric##4##3##(2008-10#4)
for simultaneous velocity##2##3##(2008-2#1)(2008-3#1)
for simultaneous##130##2##(1991-6#1)(2007-11#4)(2007-12#7)(2008-10#78)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#2)(2010-12#2)(2010-6#1)(2011-1#2)(2011-3#3)(2012-2#4)(2012-3#1)(2013-8#1)
for simultaneously determining##2##3##(2008-10#2)
for simultaneously##5##2##(2008-10#2)(2008-3#2)(2009-12#1)
for single layers##2##3##(2008-2#1)(2008-3#1)
for single nucleotide##2##3##(1997-9#1)(2008-4#1)
for single scattering##2##3##(2008-3#1)(2009-11#1)
for single##28##2##(1990-5#1)(1990-7#1)(1993-2#1)(1997-9#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-8#1)
for single-beam##2##2##(2008-2#1)(2008-3#1)
for single-mode##5##2##(2008-2#1)(2008-3#4)
for single-molecule##3##2##(2009-4#2)(2010-2#1)
for single-photon##2##2##(2008-3#1)(2008-4#1)
for single-shot measurement of the##2##5##(2007-11#1)(2007-12#1)
for single-shot measurement##3##3##(2007-11#1)(2007-12#2)
for single-shot measurements##2##3##(2007-12#1)(2008-3#1)
for single-shot##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
for single-stranded##2##2##(1994-12#1)(1997-2#1)
for sinonasal##2##2##(2008-3#1)(2012-1#1)
for sinusitis##4##2##(1993-2#2)(1996-1#1)(1997-3#1)
for sinusoidal##3##2##(2008-2#1)(2008-3#2)
for site##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
for sites##4##2##(2008-10#2)(2009-10#1)(2012-3#1)
for situations where##4##3##(1997-5#1)(2008-10#1)(2008-4#1)(2010-3#1)
for situations##7##2##(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)
for six measurements##2##3##(2008-10#2)
for six months##12##3##(1990-2#1)(1990-5#2)(1993-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#2)
for six replicate determinations##2##4##(2008-10#2)
for six replicate##3##3##(2008-10#3)
for six replicates##2##3##(2008-10#2)
for six times##2##3##(2008-10#2)
for six weeks##3##3##(1991-3#1)(1991-6#1)(2011-2#1)
for six##43##2##(1990-2#1)(1990-5#2)(1991-11#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-7#1)(1993-2#2)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
for size based iron speciation of particles##2##7##(2008-10#2)
for size parameters##2##3##(2008-3#2)
for size##10##2##(2007-12#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-8#1)
for sizing##2##2##(2008-3#2)
for skeletal metastases from soft tissue sarcomas##3##7##(2008-6#3)
for skeletal metastases##4##3##(2008-1#1)(2008-6#3)
for skill development##2##3##(1994-2#1)(2012-12#1)
for skin hydration##2##3##(2008-5#2)
for skin##19##2##(1991-12#1)(1995-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#9)(2008-8#1)(2011-2#2)(2013-1#2)
for skull base surgery##2##4##(2011-2#1)(2012-3#1)
for skull base##4##3##(2011-2#3)(2012-3#1)
for skull##5##2##(1995-6#1)(2011-2#3)(2012-3#1)
for sky##2##2##(2008-2#2)
for slab##3##2##(2008-10#2)(2008-3#1)
for sleeping##2##2##(1992-11#1)(2010-1#1)
for slope##2##2##(2008-10#1)(2008-2#1)
for slow##2##2##(2007-7#1)(2008-10#1)
for slurry##2##2##(2008-10#2)
for small bowel##2##3##(2010-12#2)
for small molecules##3##3##(2008-4#2)(2012-1#1)
for small##37##2##(1991-5#1)(1991-6#2)(1994-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
for small-angle##3##2##(2008-2#2)(2008-3#1)
for small-cell lung cancer##2##4##(1996-8#2)
for small-scale##2##2##(2007-12#1)(2008-11#1)
for smaller##7##2##(1992-4#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
for smart cannula##2##3##(2007-8#2)
for smokers##2##2##(1995-12#1)(2008-12#1)
for smoking cessation in##3##4##(2009-7#1)(2011-1#1)(2011-2#1)
for smoking cessation##9##3##(2007-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)
for smoking##12##2##(1995-6#1)(2007-12#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#4)
for smooth##4##2##(1997-1#1)(2008-6#3)
for smoothing##2##2##(2007-11#1)(2008-3#1)
for snail##2##2##(2008-8#1)(2012-3#1)
for snook##2##2##(2013-7#2)
for so many##2##3##(1994-12#1)(2012-12#1)
for so##3##2##(1994-12#1)(2008-10#1)(2012-12#1)
for so-called##2##2##(1990-11#1)(1992-5#1)
for social cognition##2##3##(2008-11#1)(2009-9#1)
for social phobia##3##3##(2008-4#3)
for social##18##2##(1992-8#1)(1996-1#1)(1996-8#1)(2007-12#1)(2008-11#4)(2008-4#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
for society##2##2##(2008-6#1)(2010-4#1)
for socioeconomic##2##2##(2009-11#1)(2012-12#1)
for sodium and potassium##3##4##(2008-10#3)
for sodium channel##2##3##(1996-12#1)(2008-8#1)
for sodium##16##2##(1990-7#1)(1993-12#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-8#1)
for soft tissue reconstruction##2##4##(2010-11#1)(2012-8#1)
for soft tissue sarcoma##2##4##(2008-6#2)
for soft tissue##8##3##(2008-5#1)(2008-6#3)(2008-9#1)(2010-11#1)(2012-8#1)(2013-1#1)
for soft##11##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-11#1)(2012-8#1)(2013-1#1)
for software##2##2##(2008-11#1)(2008-9#1)
for soil##4##2##(2008-10#3)(2008-6#1)
for soilborne##4##2##(2008-10#4)
for soils##3##2##(2008-10#3)
for solar zenith angles##2##4##(2008-2#2)
for solar##8##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
for solid phase##8##3##(1990-12#1)(1993-2#1)(2008-10#6)
for solid tumors##2##3##(2008-4#1)(2013-1#1)
for solid##22##2##(1990-12#1)(1992-3#1)(1993-2#1)(1995-3#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#2)
for solid-phase extraction of##2##4##(2008-10#2)
for solid-phase synthesis of##2##4##(1997-4#1)(2008-4#1)
for solid-phase synthesis##3##3##(1997-4#2)(2008-4#1)
for solid-phase##6##2##(1997-4#2)(2008-10#3)(2008-4#1)
for solid-state dye lasers##3##4##(2008-2#2)(2008-3#1)
for solid-state##5##2##(2008-2#4)(2008-3#1)
for soliton##2##2##(2007-11#2)
for solubilization##3##2##(1994-12#2)(1994-6#1)
for soluble##2##2##(2008-10#1)(2008-11#1)
for solute##2##2##(2008-10#1)(2013-1#1)
for solution of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
for solution of##5##3##(1994-9#1)(2008-10#1)(2008-2#1)(2008-3#2)
for solution##8##2##(1992-8#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#2)
for solutions containing##3##3##(2008-10#3)
for solutions of##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
for solutions to##2##3##(1997-7#1)(2012-3#1)
for solutions##13##2##(1992-8#1)(1994-3#1)(1997-7#1)(2008-10#7)(2008-3#1)(2012-2#1)(2012-3#1)
for solvent extraction##3##3##(2008-10#3)
for solvent##5##2##(2008-10#5)
for solving the##7##3##(2007-5#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2012-1#1)
for solving this##2##3##(2009-3#1)(2011-2#1)
for solving##20##2##(1993-5#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-6#3)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-1#2)
for somatic gene therapy##2##4##(2008-5#1)(2008-8#1)
for somatic##5##2##(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)
for some common##3##3##(2008-10#2)(2008-4#1)
for some drugs##4##3##(1997-4#1)(2008-10#1)(2008-7#1)(2013-1#1)
for some hospital##2##3##(2011-1#1)(2012-2#1)
for some metal ions##3##4##(2008-10#3)
for some of the above##2##5##(1990-9#1)(2012-2#1)
for some of the##15##4##(1990-5#1)(1990-9#1)(1992-3#1)(1992-4#1)(1994-5#1)(1995-12#1)(1996-6#1)(2007-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2012-12#1)(2012-2#1)
for some of these##5##4##(1994-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)
for some of this##2##4##(1991-12#1)(2013-1#1)
for some of##23##3##(1990-5#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-4#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
for some patients##3##3##(1996-2#1)(2007-9#1)(2008-10#1)
for some species##3##3##(1995-3#2)(2008-5#1)
for some specific##2##3##(2008-10#1)(2008-6#1)
for some time in##2##4##(1992-3#1)(2010-1#1)
for some time to##3##4##(1995-12#1)(2007-8#1)(2009-6#1)
for some time##11##3##(1992-3#1)(1993-2#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-2#1)
for some types of##2##4##(2008-4#1)(2009-10#1)
for some typical##2##3##(2007-11#1)(2008-10#1)
for some##149##2##(1990-3#1)(1990-5#2)(1990-9#1)(1991-12#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#34)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
for soot##3##2##(2008-3#3)
for sorbic acid##2##3##(2008-10#2)
for sorption##2##2##(2008-10#2)
for sorting##2##2##(2008-9#1)(2011-2#1)
for sound##3##2##(1992-1#1)(2007-12#1)(2012-2#1)
for source##3##2##(2008-10#2)(2008-2#1)
for soybean rust##2##3##(2008-10#2)
for soybean##5##2##(2008-10#3)(2012-2#2)
for space##10##2##(1990-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)
for space-based##2##2##(2008-3#2)
for spatial learning##4##3##(1993-3#2)(1996-2#1)(2008-9#1)
for spatial pattern##2##3##(2008-10#1)(2008-8#1)
for spatial phase##2##3##(2007-12#1)(2008-3#1)
for spatial##25##2##(1990-3#1)(1993-3#3)(1994-3#2)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-9#2)(2011-2#3)(2012-3#1)
for spatially resolved##2##3##(2008-2#1)(2008-3#1)
for spatially##5##2##(2008-2#2)(2008-3#2)(2008-8#1)
for spawning##2##2##(2010-8#2)
for special##11##2##(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
for specialists in##2##3##(1997-8#1)(2009-5#1)
for specialty##2##2##(1997-1#1)(2009-10#1)
for speciation analysis##3##3##(2008-10#2)(2009-6#1)
for speciation of Al-citrate and other negatively charged Al complexes##2##10##(2008-10#2)
for speciation of chromium##2##4##(2008-10#2)
for speciation of##13##3##(2008-10#13)
for speciation##19##2##(2008-10#18)(2009-6#1)
for species identification##4##3##(2008-10#1)(2008-9#1)(2010-3#1)(2013-7#1)
for species##20##2##(1996-4#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#4)(2010-3#1)(2012-3#2)(2013-1#1)(2013-7#1)
for species-specific##2##2##(2008-10#1)(2012-3#1)
for specific and##2##3##(2008-4#2)
for specific applications##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
for specific binding sites##2##4##(1990-5#2)
for specific binding##3##3##(1990-5#2)(1991-2#1)
for specific categories##2##3##(1992-8#1)(1993-1#1)
for specific determination of##2##4##(2008-10#2)
for specific procedures##2##3##(1993-2#1)(2009-5#1)
for specific regions of##2##4##(2008-9#1)(2012-1#1)
for specific##73##2##(1990-5#2)(1991-2#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
for specificity##8##2##(2008-1#1)(2008-10#5)(2008-2#1)(2008-9#1)
for specified##2##2##(1996-4#1)(2008-2#1)
for specifying##2##2##(1991-9#1)(1995-2#1)
for spectra##2##2##(2008-2#1)(2008-3#1)
for spectral##11##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-8#1)
for spectrophotometric and##2##3##(2008-10#2)
for spectrophotometric detection##2##3##(2008-10#2)
for spectrophotometric determination of boron in plants##2##7##(2008-10#2)
for spectrophotometric determination of boron##3##5##(2008-10#3)
for spectrophotometric determination of##17##4##(2008-10#17)
for spectrophotometric determination##18##3##(2008-10#18)
for spectrophotometric determinations of##2##4##(2008-10#2)
for spectrophotometric##28##2##(2007-2#1)(2008-10#27)
for spectroscopic applications##2##3##(2007-11#1)(2007-12#1)
for spectroscopic ellipsometry of thick transparent films##2##7##(2008-2#2)
for spectroscopic ellipsometry of##3##4##(2008-2#2)(2008-3#1)
for spectroscopic##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
for speech therapy##2##3##(1995-1#1)(2011-2#1)
for speech##6##2##(1995-1#1)(2008-9#3)(2011-1#1)(2011-2#1)
for sperm##8##2##(1993-6#1)(1994-5#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
for spermatozoa##2##2##(2008-5#1)(2008-7#1)
for spermine##2##2##(1995-2#1)(2008-8#1)
for spheres##5##2##(2008-2#2)(2008-3#3)
for spherical##2##2##(2007-12#1)(2008-3#1)
for spiked##5##2##(2008-10#5)
for spinal cord##2##3##(2008-1#1)(2012-2#1)
for spinal##14##2##(1995-11#1)(2007-11#3)(2007-8#1)(2008-1#1)(2009-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
for spine##2##2##(2007-8#1)(2008-8#1)
for spiritual##2##2##(2009-11#1)(2010-11#1)
for spirituality in##2##3##(2013-1#1)(2013-8#1)
for spironolactone determination##2##3##(2008-10#2)
for splash dispersal##2##3##(2008-10#2)
for splitting##3##2##(2007-11#1)(2008-5#1)(2013-8#1)
for spontaneous pneumothorax##2##3##(1991-6#1)(2010-8#1)
for spontaneous##7##2##(1991-6#1)(1992-6#1)(1996-11#1)(2007-10#1)(2010-3#1)(2010-8#1)(2013-1#1)
for spore##8##2##(2007-7#2)(2008-10#5)(2010-10#1)
for spore-forming##2##2##(2011-2#2)
for sports##3##2##(1993-3#1)(2008-11#1)(2013-1#1)
for sporulation##3##2##(1995-9#2)(2008-10#1)
for spot##2##2##(2008-10#1)(2008-2#1)
for spread##2##2##(2008-8#1)(2008-9#1)
for spreading##3##2##(2008-5#1)(2009-10#1)(2013-8#1)
for squamous cell carcinoma of the esophagus##2##7##(2013-8#2)
for squamous cell carcinoma of the##3##6##(1993-9#1)(2013-8#2)
for square-wave##3##2##(2008-10#2)(2008-3#1)
for ss-DNA##3##2##(1997-2#3)
for stabilisation of##2##3##(1991-2#2)
for stability##4##2##(1991-8#1)(1995-5#1)(2008-2#1)(2008-9#1)
for stabilization of##2##3##(2007-8#1)(2008-9#1)
for stabilizing the##3##3##(2007-11#1)(2008-4#1)(2010-4#1)
for stabilizing##7##2##(1995-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-4#1)(2013-1#1)
for stable gene##2##3##(2008-4#2)
for stable##21##2##(1990-7#1)(1991-8#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-8#1)(2012-2#1)
for staff##9##2##(1994-1#1)(1995-3#4)(1995-8#1)(2008-1#1)(2008-11#2)
for stage I##6##3##(1990-2#2)(1990-6#1)(2007-8#2)(2013-1#1)
for stage II##2##3##(1990-6#1)(1997-7#1)
for stage III and##2##4##(1990-6#1)(1997-3#1)
for stage III##3##3##(1990-6#1)(1997-3#1)(2012-3#1)
for stage IIIA##3##3##(1992-12#1)(1992-6#1)(2008-10#1)
for stage##23##2##(1990-2#2)(1990-6#4)(1992-12#2)(1992-6#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
for staging##3##2##(2008-2#1)(2010-8#1)(2012-2#1)
for staining cell colonies##2##4##(2008-11#2)
for staining##5##2##(2008-11#3)(2008-4#1)(2008-9#1)
for standard addition##2##3##(2008-10#2)
for standard setting##2##3##(2011-2#1)(2012-2#1)
for standard##16##2##(2007-8#1)(2008-10#4)(2008-2#1)(2008-9#2)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
for standardisation##2##2##(1990-3#1)(2008-10#1)
for standardization##2##2##(2008-10#1)(2008-8#1)
for standardized##2##2##(1995-3#1)(2008-1#1)
for standards and##2##3##(1992-11#2)
for standards##4##2##(1992-11#2)(1996-2#1)(2013-8#1)
for starting##2##2##(2008-10#1)(2008-4#1)
for state health agencies##2##4##(1995-12#1)(1997-1#1)
for state health##3##3##(1995-12#1)(1996-3#1)(1997-1#1)
for state##5##2##(1994-8#1)(1995-12#2)(1996-3#1)(1997-1#1)
for states##2##2##(1991-2#1)(1993-12#1)
for static##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
for statistical analysis##9##3##(1994-9#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
for statistical##17##2##(1994-9#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#2)(2010-11#1)(2012-3#1)
for statistically##2##2##(2008-11#1)(2013-1#1)
for stem cell research##2##4##(2008-10#1)(2009-3#1)
for stem cell##5##3##(2008-10#1)(2008-11#2)(2009-3#1)(2009-8#1)
for stem cells##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
for stem##14##2##(2008-10#5)(2008-11#2)(2008-4#1)(2009-3#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#2)
for stenosis in##2##3##(1993-8#1)(2007-8#1)
for stenosis##3##2##(1993-8#1)(2007-8#1)(2010-12#1)
for stereotactic radiotherapy##2##3##(1994-3#1)(2008-3#1)
for stereotactic##5##2##(1994-3#1)(1995-9#1)(2008-3#1)(2008-7#1)(2013-1#1)
for sterilization##2##2##(1994-3#1)(2011-2#1)
for steroid##4##2##(1994-6#1)(1996-5#1)(2010-6#1)(2011-1#1)
for steroids##3##2##(2008-10#2)(2013-1#1)
for stigmatization of##3##3##(2008-9#2)(2011-2#1)
for stimulated Raman scattering##2##4##(2007-11#1)(2010-7#1)
for stimulated##4##2##(2007-11#2)(2008-3#1)(2010-7#1)
for stimulating the##2##3##(1992-10#1)(2008-11#1)
for stimulating##3##2##(1992-10#1)(2008-11#1)(2010-5#1)
for stimulation of##5##3##(1994-11#1)(1995-8#1)(1997-7#1)(2008-11#2)
for stimulation##6##2##(1994-11#1)(1995-3#1)(1995-8#1)(1997-7#1)(2008-11#2)
for stimuli##3##2##(1991-5#1)(1996-2#1)(2011-2#1)
for stochastic##3##2##(1996-6#1)(2008-12#1)(2008-7#1)
for stoichiometry##2##2##(2008-10#1)(2010-5#1)
for stomach##4##2##(1990-8#1)(1993-9#1)(1996-12#1)(2008-5#1)
for stopping##2##2##(1995-2#1)(2008-3#1)
for storage of##3##3##(1994-3#2)(2008-7#1)
for storage##6##2##(1991-5#1)(1994-3#2)(2008-3#1)(2008-7#1)(2012-12#1)
for storing##6##2##(1994-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)
for strain measurement##2##3##(2008-3#1)(2013-8#1)
for strain##7##2##(2008-10#4)(2008-3#2)(2013-8#1)
for strains of##2##3##(2007-7#1)(2008-5#1)
for strains##7##2##(2007-7#1)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)
for strategic##4##2##(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#1)
for stratification##2##2##(1991-6#1)(2008-10#1)
for strength##2##2##(1994-8#1)(2008-5#1)
for strengthening and##2##3##(1996-2#1)(2013-1#1)
for strengthening##8##2##(1991-3#1)(1996-2#1)(2007-2#1)(2008-12#1)(2009-5#1)(2012-12#2)(2013-1#1)
for streptavidin##2##2##(1990-2#1)(2008-10#1)
for stress##7##2##(1991-3#1)(1994-8#1)(2007-6#1)(2008-3#1)(2010-7#1)(2011-2#2)
for striatal##2##2##(1995-5#1)(2013-8#1)
for stripe rust##2##3##(2008-10#2)
for stripping##3##2##(2008-10#2)(2008-4#1)
for stroke and##3##3##(2007-10#1)(2008-2#1)(2008-8#1)
for stroke in##3##3##(2007-10#1)(2008-8#2)
for stroke or##2##3##(1993-12#1)(2008-8#1)
for stroke prevention##2##3##(2007-10#1)(2008-8#1)
for stroke research##4##3##(2008-8#3)(2013-1#1)
for stroke##34##2##(1993-12#1)(2007-10#12)(2007-9#1)(2008-2#2)(2008-8#16)(2011-2#1)(2013-1#1)
for strong##9##2##(1990-5#1)(1994-3#1)(2007-11#1)(2008-3#5)(2008-8#1)
for stronger##2##2##(2008-3#1)(2008-9#1)
for strongly##3##2##(2007-11#1)(2008-3#2)
for structural and functional analysis##2##5##(1993-6#1)(2008-9#1)
for structural and functional##4##4##(1993-6#1)(1995-12#1)(2007-12#1)(2008-9#1)
for structural proteomics##2##3##(2008-7#2)
for structural studies##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
for structural##16##2##(1991-5#1)(1993-6#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#4)(2008-9#1)(2012-2#2)
for structure##3##2##(1994-8#1)(2008-9#1)(2009-11#1)
for structure-function studies of##2##4##(1991-12#1)(2008-11#1)
for structure-function##3##2##(1991-12#1)(1991-2#1)(2008-11#1)
for structures##2##2##(1997-5#1)(2012-2#1)
for student learning##3##3##(2008-11#1)(2008-12#1)(2012-1#1)
for student nurse learning##2##4##(2008-11#2)
for student nurses##6##3##(2008-11#5)(2008-12#1)
for student##13##2##(1991-1#1)(2008-11#8)(2008-12#3)(2012-1#1)
for students and##2##3##(2008-11#1)(2008-7#1)
for students from##2##3##(2008-12#2)
for students in##2##3##(2008-11#1)(2011-1#1)
for students to##7##3##(1992-3#1)(1993-1#1)(1996-1#1)(2008-11#2)(2008-12#1)(2013-1#1)
for students who##2##3##(2008-10#1)(2008-12#1)
for students with dyslexia##2##4##(2008-12#2)
for students##27##2##(1992-3#1)(1993-1#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#7)(2008-12#8)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
for studies of gene expression in##2##6##(2008-7#2)
for studies of##22##3##(1992-11#1)(1992-8#1)(1993-11#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#2)(2008-7#3)(2008-8#2)(2010-12#1)(2012-2#1)
for studies on the##5##4##(1995-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
for studies on##8##3##(1995-12#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
for studies that##2##3##(2008-7#1)(2008-8#1)
for studies with##2##3##(2010-7#1)(2011-2#1)
for studies##45##2##(1992-11#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-12#3)(1995-8#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
for study of the##5##4##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
for study of##12##3##(1995-11#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)
for study question##2##3##(2012-12#2)
for study##27##2##(1991-3#1)(1995-11#2)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#1)(2010-11#1)(2012-12#2)
for studying RNA##3##3##(2008-4#1)(2009-11#2)
for studying dynamic##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
for studying gene function##2##4##(1993-9#1)(2008-7#1)
for studying genetic##2##3##(2008-10#1)(2008-12#1)
for studying human##2##3##(1993-6#1)(2008-7#1)
for studying mechanisms of##3##4##(1995-3#1)(2008-11#1)(2008-4#1)
for studying membrane transport of Fe(II)##2##6##(1996-2#2)
for studying protein##2##3##(2008-10#1)(2008-9#1)
for studying proteins##2##3##(2008-1#1)(2010-11#1)
for studying the biological##2##4##(2008-4#1)(2008-9#1)
for studying the effects of##2##5##(1994-11#1)(1995-2#1)
for studying the evolution of##2##5##(2008-8#1)(2009-2#1)
for studying the formation##2##4##(1993-8#1)(2009-5#1)
for studying the in##2##4##(1991-5#1)(1995-2#1)
for studying the molecular##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
for studying the process of##2##5##(2008-1#1)(2009-12#1)
for studying the##57##3##(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#2)(1996-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
for studying##150##2##(1990-5#3)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#7)(1995-3#2)(1996-12#2)(1996-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#4)(2008-1#6)(2008-10#20)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#13)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#10)(2009-11#3)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)
for sub-100-fs##2##2##(2007-11#1)(2007-12#1)
for subcutaneous##3##2##(1990-3#1)(1994-3#1)(2012-2#1)
for subjective##2##2##(2008-5#1)(2013-1#1)
for subjects##4##2##(1995-5#1)(2008-9#1)(2013-1#2)
for subpopulations##2##2##(2008-10#1)(2011-2#1)
for subsequent analysis##6##3##(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)
for subsequent detection##2##3##(2008-10#1)(2008-3#1)
for subsequent treatment##2##3##(1992-12#1)(2010-6#1)
for subsequent##42##2##(1992-10#1)(1992-12#1)(1992-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-7#3)(2008-9#5)(2010-6#1)(2011-1#2)(2012-2#1)
for substance abuse problems##2##4##(1993-2#1)(2008-4#1)
for substance abuse##7##3##(1993-2#1)(2008-4#2)(2008-6#2)(2009-9#1)(2012-12#1)
for substance##9##2##(1993-2#1)(1994-2#1)(2008-4#2)(2008-6#2)(2009-7#1)(2009-9#1)(2012-12#1)
for substances##3##2##(2008-10#2)(2008-12#1)
for substrate inhibition##2##3##(1992-3#1)(1997-2#1)
for substrate##6##2##(1992-3#1)(1993-11#1)(1997-2#1)(2008-11#1)(2011-1#1)(2012-3#1)
for substrates##3##2##(1990-10#1)(1995-8#1)(2008-10#1)
for subunit##4##2##(1991-6#2)(1997-3#1)(2008-9#1)
for success in##2##3##(1995-2#1)(2013-1#1)
for success with##2##3##(1996-2#1)(2013-1#1)
for successful management##2##3##(2008-7#1)(2011-2#1)
for successful therapy##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
for successful totally endoscopic##2##4##(2007-8#2)
for successful treatment of##4##4##(1993-5#1)(2008-1#1)(2009-7#1)(2013-8#1)
for successful treatment##6##3##(1993-5#1)(1995-5#1)(2008-1#1)(2009-7#1)(2013-1#1)(2013-8#1)
for successful##57##2##(1991-1#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-5#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
for successfully##5##2##(1991-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2009-11#1)
for successive##6##2##(2008-10#2)(2011-1#1)(2011-2#2)(2013-1#1)
for such a purpose##2##4##(2008-10#1)(2008-9#1)
for such a system##2##4##(2007-12#1)(2008-3#1)
for such a##13##3##(1990-12#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
for such an##4##3##(1994-3#1)(2008-7#1)(2009-3#1)(2009-8#1)
for such analysis##2##3##(1995-5#1)(2011-3#1)
for such measurements##2##3##(2008-10#2)
for such models##2##3##(1994-3#1)(2010-1#1)
for such patients##6##3##(2007-8#2)(2008-10#1)(2008-7#1)(2012-12#2)
for such programs##2##3##(1994-2#1)(1997-5#1)
for such purposes##2##3##(2008-10#1)(2008-2#1)
for such##102##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#2)(1996-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#15)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#3)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#3)
for sucrose##4##2##(1997-2#1)(2008-10#3)
for sudden infant##2##3##(1991-9#1)(2011-1#1)
for sudden sensorineural hearing loss##2##5##(2008-4#2)
for sudden##4##2##(1991-9#1)(2008-4#2)(2011-1#1)
for sufficiently##2##2##(2007-12#2)
for sugar cane##2##3##(2008-10#1)(2008-6#1)
for sugar##5##2##(1993-9#2)(2008-10#2)(2008-6#1)
for suicidal behavior##2##3##(2013-1#2)
for suicidal ideation##2##3##(2008-11#1)(2013-1#1)
for suicidal##5##2##(2008-11#1)(2009-3#1)(2013-1#3)
for suitable##3##2##(1995-11#1)(2008-10#1)(2011-1#1)
for sulfaguanidine and sulfamerazine and between##3##6##(2008-10#3)
for sulfaguanidine##4##2##(2008-10#4)
for sulfate##2##2##(2008-10#2)
for sulfide##5##2##(2008-10#5)
for sulfur dioxide in##2##4##(2008-10#2)
for sulfur dioxide##3##3##(2008-10#3)
for sulfur##5##2##(2008-10#4)(2008-11#1)
for sulisobenzone##2##2##(2008-5#2)
for sulphate determination in automotive fuel##2##6##(2008-10#2)
for sulphate##5##2##(1997-7#1)(2008-10#4)
for sulphide##2##2##(2008-10#2)
for sum-frequency##2##2##(2007-12#1)(2008-3#1)
for summation##2##2##(2008-10#2)
for sunscreen##4##2##(2008-4#1)(2008-5#3)
for supercritical fluid extraction##2##4##(2008-10#2)
for supercritical##3##2##(2008-10#3)
for superficial esophageal carcinoma##2##4##(2008-5#2)
for superior##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
for supernatant##3##2##(2008-10#3)
for superoxide##2##2##(1994-8#1)(2008-10#1)
for supervision##2##2##(1996-7#1)(2008-7#1)
for support##5##2##(1992-12#1)(1994-1#2)(1996-11#1)(2011-1#1)
for supporting##2##2##(1992-3#1)(2009-3#1)
for supportive cancer therapy##2##4##(2008-7#2)
for suppressing the##3##3##(2007-11#2)(2007-12#1)
for suppressing##5##2##(2007-11#3)(2007-12#1)(2008-10#1)
for suppression of the##2##4##(1995-2#1)(2008-10#1)
for suppression of##15##3##(1995-12#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-9#1)(2009-6#1)
for suppression##16##2##(1995-12#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-7#1)(2008-9#1)(2009-6#1)
for surface and##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
for surface display##3##3##(1997-4#3)
for surface electrodes and##2##4##(2012-2#2)
for surface electrodes##3##3##(2012-2#3)
for surface enhanced##2##3##(2008-10#1)(2013-8#1)
for surface mapping of phosphate in##2##6##(2008-10#2)
for surface metrology##2##3##(2008-3#2)
for surface reconstruction##2##3##(2008-6#2)
for surface scattering##2##3##(2007-12#1)(2008-3#1)
for surface##30##2##(1997-4#3)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#11)(2008-6#2)(2008-9#2)(2012-2#3)(2013-8#1)
for surface-enhanced Raman scattering##4##4##(2007-12#3)(2008-10#1)
for surgeons##6##2##(2007-8#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
for surgery and the##2##4##(1997-3#1)(2007-11#1)
for surgery and##4##3##(1990-8#1)(1990-9#1)(1997-3#1)(2007-11#1)
for surgery are##3##3##(1991-5#1)(2007-11#1)(2008-7#1)
for surgery in##2##3##(1992-9#1)(2011-2#1)
for surgery of##2##3##(2007-8#1)(2008-9#1)
for surgery were##4##3##(1990-6#1)(1992-9#1)(2007-8#1)(2008-7#1)
for surgery##37##2##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-9#3)(1993-9#1)(1994-1#1)(1996-6#1)(1997-2#2)(1997-3#1)(2007-11#5)(2007-8#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
for surgical correction##2##3##(2007-12#1)(2007-8#1)
for surgical crown lengthening##2##4##(2012-3#2)
for surgical drainage##2##3##(2008-7#1)(2011-2#1)
for surgical excision of##2##4##(2010-8#1)(2011-2#1)
for surgical patients##2##3##(2010-12#2)
for surgical procedures##4##3##(1991-1#1)(1994-12#1)(2008-8#1)(2009-6#1)
for surgical treatment of spinal metastases##2##6##(2007-11#2)
for surgical treatment of this##2##5##(2007-8#1)(2010-6#1)
for surgical treatment of##8##4##(1990-9#1)(1993-3#1)(1996-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2010-6#1)
for surgical treatment##14##3##(1990-6#1)(1990-8#1)(1990-9#1)(1993-3#1)(1994-9#1)(1996-9#1)(2007-11#4)(2007-8#2)(2008-10#1)(2010-6#1)
for surgical##46##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#3)(1993-12#1)(1993-3#1)(1994-12#2)(1994-9#1)(1996-9#1)(2006-12#1)(2007-11#5)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)
for surveillance and##3##3##(2008-10#1)(2009-12#1)(2009-5#1)
for surveillance of##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
for surveillance##8##2##(2008-1#2)(2008-10#1)(2009-12#1)(2009-5#1)(2011-2#1)(2011-9#1)(2012-12#1)
for survey##2##2##(2007-12#1)(2011-1#1)
for survival and##3##3##(2008-4#1)(2010-11#1)(2010-3#1)
for survival in##2##3##(2008-7#1)(2009-1#1)
for survival were##3##3##(1996-12#1)(2006-10#1)(2010-3#1)
for survival##30##2##(1991-12#1)(1992-9#1)(1994-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-1#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#5)(2010-7#1)(2011-2#1)(2012-3#3)
for survivors of##2##3##(2008-11#1)(2008-6#1)
for susceptibility##3##2##(2008-10#2)(2011-2#1)
for susceptible##2##2##(2008-10#1)(2011-10#1)
for suspected##9##2##(1990-6#1)(1991-11#1)(1991-6#1)(1997-6#1)(2007-12#1)(2007-7#1)(2011-1#1)(2011-2#2)
for sustainable##5##2##(2008-11#1)(2011-1#1)(2012-9#1)(2013-1#1)(2013-8#1)
for sustained##4##2##(1995-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
for sustaining##2##2##(1996-1#1)(2013-1#1)
for swimming##2##2##(1994-8#1)(2008-8#1)
for switching from##2##3##(2008-10#2)
for switching the##2##3##(2008-3#2)
for switching##6##2##(2007-12#2)(2008-10#2)(2008-3#2)
for symptom management##2##3##(2010-11#1)(2011-1#1)
for symptom severity##2##3##(2008-10#1)(2008-9#1)
for symptom##5##2##(2008-10#2)(2008-9#1)(2010-11#1)(2011-1#1)
for symptomatic ASD##2##3##(1996-6#1)(2012-12#1)
for symptomatic##20##2##(1993-3#1)(1993-9#1)(1994-11#1)(1996-6#1)(2008-10#1)(2008-7#5)(2008-8#2)(2009-3#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
for symptoms of##2##3##(1994-6#1)(2011-2#1)
for symptoms##4##2##(1994-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
for synaptic plasticity##3##3##(1997-7#1)(2008-11#1)(2009-8#1)
for synaptic##6##2##(1995-2#1)(1997-7#1)(2008-11#1)(2009-3#1)(2009-8#1)(2012-3#1)
for synaptophysin##2##2##(1991-6#1)(1991-8#1)
for synchronous##4##2##(2007-12#1)(2007-8#1)(2008-3#1)(2009-11#1)
for synchrotron radiation##2##3##(2008-10#1)(2008-3#1)
for synergistic##2##2##(2008-10#1)(2013-8#1)
for synergy##2##2##(2008-10#2)
for synthesis of the##2##4##(1994-12#1)(2008-11#1)
for synthesis of##9##3##(1993-11#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)
for synthesis##11##2##(1992-6#1)(1993-11#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)
for synthesizing a##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
for synthesizing high-molecular-weight##2##3##(1994-11#2)
for synthesizing##12##2##(1994-11#2)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#2)(2008-8#1)(2010-6#1)
for synthetic##4##2##(1996-5#1)(2008-10#1)(2011-1#1)(2012-2#1)
for syphilis##4##2##(1991-6#1)(1997-5#1)(2011-2#1)(2013-1#1)
for system##10##2##(1996-12#1)(1996-2#1)(2008-10#3)(2008-3#5)
for systematic##4##2##(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#1)
for systemic infection##2##3##(2009-11#1)(2013-1#1)
for systemic lupus erythematosus##4##4##(1992-2#1)(2007-12#1)(2009-3#1)(2010-12#1)
for systemic##14##2##(1992-2#1)(1995-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2013-1#1)
for systems biology##2##3##(2008-11#1)(2008-9#1)
for systems with##3##3##(2007-12#1)(2008-8#1)(2010-10#1)
for systems##9##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
for systolic##3##2##(1991-12#1)(1992-6#1)(1993-1#1)
for tRNAa and##2##3##(2008-8#2)
for tRNAb##2##2##(2008-8#2)
for tagging##4##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
for tail##2##2##(1993-1#1)(2008-9#1)
for tailored##2##2##(2007-5#1)(2012-12#1)
for tailoring##4##2##(2007-12#1)(2009-5#1)(2010-2#1)(2012-3#1)
for taking##2##2##(1992-4#1)(1995-12#1)
for talking##2##2##(1992-3#1)(2012-12#1)
for tan spot##3##3##(2008-10#3)
for tandem mass##2##3##(2008-10#1)(2011-2#1)
for tandem##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
for tap water##2##3##(2008-10#2)
for tap##3##2##(2008-10#3)
for target lesions and##2##4##(2010-8#2)
for target recognition##2##3##(2007-11#1)(2008-6#1)
for target selective SPECT/CT imaging and##2##6##(2012-12#2)
for target selective##3##3##(2012-12#3)
for target##18##2##(1997-3#1)(2007-11#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-12#3)(2012-2#1)
for targeted##17##2##(1997-3#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-2#1)(2010-4#2)(2012-3#1)(2013-1#3)
for targeting of##2##3##(1990-12#1)(2008-6#1)
for targeting the##3##3##(1990-5#1)(1994-11#1)(2008-6#1)
for targeting##15##2##(1990-12#1)(1990-5#2)(1994-11#1)(1995-2#1)(1995-5#1)(2007-10#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
for targets##2##2##(2007-12#1)(2013-8#1)
for tartaric acid##2##3##(2008-10#2)
for tasks##3##2##(2008-2#1)(2008-4#1)(2009-7#1)
for taxonomic assignment of##2##4##(2011-2#2)
for taxonomic differentiation of##2##4##(2008-10#1)(2008-12#1)
for taxonomic differentiation##3##3##(2008-10#2)(2008-12#1)
for taxonomic##8##2##(2008-10#2)(2008-12#1)(2011-2#5)
for teachers##2##2##(2008-12#1)(2012-1#1)
for teaching and##3##3##(1992-12#1)(2008-11#1)(2008-12#1)
for teaching computer literacy##3##4##(1996-1#3)
for teaching##16##2##(1992-12#1)(1995-1#3)(1996-1#4)(1997-2#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-2#1)
for technical and medical##2##4##(1997-6#1)(2008-3#1)
for technical##3##2##(1997-6#1)(2008-3#1)(2009-7#1)
for technologists##3##2##(1994-1#1)(1994-2#1)(1996-3#1)
for technology##2##2##(1996-2#1)(2008-7#1)
for teenagers##4##2##(2008-9#2)(2013-1#2)
for telomere##4##2##(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
for temazepam##2##2##(1995-2#2)
for temperature and##6##3##(2008-10#4)(2008-2#2)
for temperature measurements##3##3##(2007-11#2)(2008-2#1)
for temperature##17##2##(2007-11#2)(2008-10#6)(2008-2#4)(2008-3#5)
for temperatures##2##2##(1995-3#1)(2008-10#1)
for temporal##6##2##(1997-8#1)(2008-2#2)(2008-3#2)(2010-11#1)
for ten days##3##3##(1991-12#1)(1991-5#1)(2008-10#1)
for ten determinations of 0##2##5##(2008-10#2)
for ten determinations of##4##4##(2008-10#4)
for ten different##2##3##(2008-10#1)(2010-7#1)
for ten independent analyses of 100 ng ml(-1)##2##8##(2008-10#2)
for ten independent##3##3##(2008-10#3)
for ten replicate##3##3##(2008-10#3)
for ten##29##2##(1990-5#1)(1991-12#2)(1991-5#1)(1994-9#1)(1995-2#1)(2008-10#18)(2008-11#1)(2008-3#1)(2010-7#1)(2012-2#2)
for terahertz##4##2##(2007-11#1)(2007-12#1)(2012-12#1)(2013-8#1)
for terminal##4##2##(1992-9#1)(1993-3#2)(2008-10#1)
for terminating##2##2##(1994-11#1)(1996-6#1)
for termination of##2##3##(1992-12#1)(2013-8#1)
for termination##4##2##(1992-12#1)(1996-6#1)(1997-8#1)(2013-8#1)
for ternary##2##2##(2008-10#1)(2013-8#1)
for terrestrial taxa##2##3##(2008-8#2)
for territories##3##2##(2008-8#3)
for tertiary##2##2##(1992-12#1)(1993-11#1)
for testicular cancer##3##3##(1992-6#1)(1996-5#1)(2007-5#1)
for testing and##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
for testing in the##2##4##(1997-3#1)(2008-9#1)
for testing multiple##2##3##(1994-12#1)(2010-1#1)
for testing new##2##3##(1996-6#1)(2008-10#1)
for testing of##3##3##(1995-11#1)(2008-3#1)(2008-5#1)
for testing the##14##3##(1994-6#1)(1996-3#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
for testing this##3##3##(1991-2#1)(1993-9#1)(1997-8#1)
for testing##63##2##(1991-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#5)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
for testosterone##2##2##(1990-11#1)(2008-10#1)
for tetracycline and##2##3##(2008-10#1)(2008-12#1)
for tetracycline##5##2##(2008-10#4)(2008-12#1)
for tetrahedral##3##2##(1992-3#1)(1993-11#1)(2011-2#1)
for texture discrimination##2##3##(2008-2#2)
for thalassemia##2##2##(2008-10#2)
for thallium##2##2##(2008-10#2)
for that of##3##3##(1992-3#1)(2008-10#2)
for that##18##2##(1991-12#1)(1991-7#1)(1992-3#1)(1993-11#1)(1995-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
for the &quot##3##3##(1997-4#1)(2008-1#1)(2010-8#1)
for the '90s##2##3##(1991-3#1)(1992-3#1)
for the -1##2##3##(2008-3#1)(2013-1#1)
for the 0##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
for the 1##9##3##(1990-7#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#3)
for the 10-day reading##2##4##(2008-10#2)
for the 12##2##3##(2012-3#1)(2013-8#1)
for the 16S##2##3##(2012-3#1)(2013-1#1)
for the 1990s##8##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1993-12#1)(1997-3#1)
for the 2##5##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-1#1)
for the 21st century##14##4##(1991-1#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-12#1)
for the 21st century?##2##4##(1994-3#1)(2012-3#1)
for the 21st##19##3##(1991-1#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-1#3)(2008-12#1)(2012-3#1)
for the 3##2##3##(1992-3#1)(2009-2#1)
for the 36##2##3##(2007-8#1)(2008-5#1)
for the 4##3##3##(1996-2#1)(1997-2#1)(2008-10#1)
for the 5'##3##3##(1992-3#1)(1997-8#1)(2008-10#1)
for the 50##2##3##(2008-10#1)(2008-8#1)
for the A##4##3##(1995-12#1)(1995-2#1)(2008-10#2)
for the A(3)##2##3##(2008-4#2)
for the AAA sequence##3##4##(2012-12#3)
for the ACE and CIS speech-processing strategies in the Nucleus 24 cochlear implant system##2##14##(2008-9#2)
for the AF4Q initiative##2##4##(2013-1#2)
for the AIDS##3##3##(1990-3#2)(1997-5#1)
for the ANN##2##3##(2008-10#2)
for the AR##2##3##(1990-11#1)(2010-1#1)
for the American population##2##4##(2008-10#1)(2012-3#1)
for the American##4##3##(2008-10#1)(2010-5#1)(2010-6#1)(2012-3#1)
for the Analysis of##2##4##(2008-2#1)(2009-8#1)
for the Asian patient##2##4##(2010-8#2)
for the Asian##4##3##(2010-8#4)
for the Athens##2##3##(2008-2#2)
for the BM/Hitachi 917##2##4##(2008-10#2)
for the BOD sensing film##2##5##(2008-10#2)
for the BOD##3##3##(2008-10#3)
for the Bahia##2##3##(2008-5#2)
for the Bessel-Gauss##2##3##(2007-11#2)
for the Birefringence##2##3##(2008-2#2)
for the CAF+FT group and##3##5##(1997-7#3)
for the CAF+FT+TAM group##2##4##(1997-7#2)
for the California##3##3##(2008-10#2)(2011-2#1)
for the Care of##3##4##(1992-3#1)(1994-3#1)(2012-12#1)
for the Cerro Negro##2##4##(2008-10#2)
for the Chikungunya##2##3##(2013-8#2)
for the Commission##2##3##(2008-2#1)(2008-7#1)
for the Cr(VI)##2##3##(2008-10#2)
for the DAPI-RNA complex##2##4##(1992-3#2)
for the Department of##2##4##(1992-3#1)(1996-5#1)
for the Detection of##2##4##(2008-10#1)(2008-3#1)
for the Detection##3##3##(2008-10#2)(2008-3#1)
for the Development##2##3##(1997-6#1)(2007-12#1)
for the Diagnosis of##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
for the District of Columbia##4##5##(1996-12#4)
for the Donnan effect during##2##5##(2011-2#2)
for the EC at 0##2##5##(2011-2#2)
for the ELISA##5##3##(1992-5#4)(2008-10#1)
for the ESLI##2##3##(2008-3#2)
for the Elderly (PACE)##3##4##(1992-1#1)(1994-2#1)(1995-1#1)
for the Elderly##5##3##(1992-1#1)(1994-2#1)(1995-1#1)(2008-4#1)(2013-1#1)
for the Ethylene-Forming Enzyme##2##4##(2008-10#2)
for the European##2##3##(2008-10#1)(2008-2#1)
for the Evaluation of##2##4##(2008-11#1)(2013-8#1)
for the FIA##2##3##(2008-10#2)
for the FIQ##2##3##(1996-3#2)
for the Fresnel##2##3##(2008-3#2)
for the Gulf##2##3##(2008-5#1)(2010-11#1)
for the HPLC determination of##2##5##(2008-10#2)
for the Health Care Financing Administration##2##6##(1992-1#1)(1997-2#1)
for the Health Care##3##4##(1992-1#1)(1997-2#1)(2008-11#1)
for the Health##5##3##(1991-12#1)(1992-1#1)(1997-2#1)(2008-11#1)(2011-2#1)
for the I and bc-1(2) alleles##2##6##(2008-10#2)
for the I##3##3##(2008-10#3)
for the Identification##2##3##(2008-10#2)
for the International Conference on##2##5##(2008-10#2)
for the International##4##3##(1991-9#1)(2008-10#2)(2012-2#1)
for the Large##2##3##(2007-11#1)(2008-3#1)
for the Laser Interferometer##2##4##(2008-3#2)
for the Lyme disease spirochetes##2##5##(1997-4#2)
for the Lyme disease##3##4##(1997-4#2)(2010-6#1)
for the MS##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
for the MVB group##2##4##(2007-7#2)
for the Management of##4##4##(2008-3#2)(2008-6#1)(2011-2#1)
for the Measurement of Atmospheric##2##5##(2008-3#2)
for the Measurement of##4##4##(2006-12#1)(2008-3#2)(2010-3#1)
for the Medicaid program##2##4##(1996-1#2)
for the Medicare##2##3##(1996-3#1)(1997-1#1)
for the N-terminal##2##3##(2008-10#1)(2009-7#1)
for the NHS##9##3##(1997-5#5)(2008-11#1)(2008-12#1)(2008-7#2)
for the National##2##3##(1994-11#1)(2008-3#1)
for the New York##2##4##(1996-3#1)(1996-5#1)
for the Organization for Economic Cooperation and Development##2##8##(1993-3#2)
for the PD##3##3##(2012-3#1)(2013-1#2)
for the PTH level##2##4##(1997-7#2)
for the Pacific##3##3##(2008-1#1)(2008-5#1)(2012-12#1)
for the Preparation of##3##4##(1996-5#2)(2008-11#1)
for the Raman##2##3##(1996-2#1)(2011-1#1)
for the Rippey##2##3##(2008-3#2)
for the SM group were significantly##2##6##(2012-3#2)
for the SPE##2##3##(2008-10#2)
for the Simultaneous##4##3##(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)
for the State of##2##4##(2008-6#1)(2008-8#1)
for the State##3##3##(1990-12#1)(2008-6#1)(2008-8#1)
for the Study of##5##4##(1992-2#1)(1995-11#1)(2008-5#1)(2010-4#1)(2013-1#1)
for the TPF##2##3##(2008-10#1)(2008-3#1)
for the TSH##2##3##(1994-11#1)(1996-5#1)
for the Treatment of##7##4##(2008-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
for the U##4##3##(1991-9#1)(1995-6#1)(2008-10#1)(2011-1#1)
for the UV##2##3##(1991-12#1)(2013-7#1)
for the United States##4##4##(1993-2#1)(1995-3#1)(1997-1#1)(1997-3#1)
for the VDCC beta 3 was##2##6##(1997-4#2)
for the Western##2##3##(1995-6#1)(2009-12#1)
for the ability of##3##4##(1992-10#1)(2007-10#1)(2012-2#1)
for the ability to reduce##2##5##(2008-10#2)
for the ability to##11##4##(1990-2#1)(1991-11#1)(1991-8#1)(1994-5#1)(1997-3#1)(2008-10#6)
for the ability##14##3##(1990-2#1)(1991-11#1)(1991-8#1)(1992-10#1)(1994-5#1)(1997-3#1)(2007-10#1)(2008-10#6)(2012-2#1)
for the above##6##3##(1990-7#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-7#1)
for the absence of##7##4##(1990-10#1)(1997-3#1)(2008-10#3)(2008-8#1)(2011-2#1)
for the absolute##2##3##(1992-12#1)(2008-3#1)
for the absorption coefficient and##2##5##(2008-3#2)
for the absorption##7##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)
for the accumulation of##2##4##(1997-2#1)(2008-10#1)
for the accumulation##3##3##(1997-2#1)(2008-10#2)
for the accurate and##4##4##(2008-10#4)
for the accurate determination of##2##5##(2008-10#2)
for the accurate##10##3##(2008-10#6)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)
for the achievement of a##2##5##(1996-2#1)(2007-5#1)
for the achievement of##3##4##(1996-2#1)(2007-11#1)(2007-5#1)
for the acquisition of##3##4##(1991-2#1)(2008-3#1)(2010-12#1)
for the acquisition##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
for the activated carbon and##3##5##(2008-10#3)
for the activated carbon##5##4##(2008-10#5)
for the activated##7##3##(1995-2#1)(2008-10#6)
for the activation of##10##4##(1992-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
for the activation##13##3##(1992-6#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
for the active##5##3##(1994-5#1)(1995-5#1)(2008-10#2)(2013-1#1)
for the activity of##6##4##(1990-5#1)(1994-6#2)(1995-12#1)(2008-1#1)(2012-3#1)
for the activity##11##3##(1990-5#1)(1990-7#1)(1991-5#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#1)(1997-7#1)(2008-1#1)(2012-3#1)
for the actual##4##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
for the acute##2##3##(1995-12#1)(2008-10#1)
for the adaptive##2##3##(2008-3#1)(2009-8#1)
for the addition of the##3##5##(1990-8#2)(2008-10#1)
for the addition of##5##4##(1990-8#2)(1992-10#1)(2008-10#1)(2009-8#1)
for the addition##6##3##(1990-8#2)(1992-10#1)(2008-10#1)(2008-2#1)(2009-8#1)
for the additional##3##3##(1991-3#1)(1992-9#1)(2011-2#1)
for the adequacy of##2##4##(2008-11#2)
for the administration of##2##4##(1996-8#1)(2013-8#1)
for the administration##3##3##(1996-8#1)(2012-2#1)(2013-8#1)
for the administrative and clinical systems##3##6##(2013-8#3)
for the administrative##6##3##(2013-8#6)
for the adsorption of##5##4##(2008-10#5)
for the adsorption##8##3##(2008-10#8)
for the advancement of##2##4##(2008-11#1)(2011-2#1)
for the aerosol##4##3##(2008-2#2)(2008-3#2)
for the affinity##3##3##(1990-2#1)(1990-8#1)(2008-7#1)
for the age of the##3##5##(1990-10#1)(1997-6#2)
for the age of##4##4##(1990-10#1)(1997-6#2)(2008-9#1)
for the age##6##3##(1990-10#1)(1991-12#1)(1997-6#2)(2008-9#1)(2011-1#1)
for the aged##3##3##(1994-1#1)(1995-1#1)(2009-5#1)
for the algorithm##2##3##(2008-12#1)(2008-3#1)
for the allosteric##2##3##(1995-2#1)(1995-5#1)
for the alpha 5##2##4##(1993-9#1)(1995-11#1)
for the alpha 7##2##4##(1996-12#1)(2010-8#1)
for the alpha##8##3##(1992-8#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-11#1)(1996-12#1)(2010-8#1)
for the altered##2##3##(1993-6#1)(2009-1#1)
for the ambulatory##3##3##(1991-1#1)(1991-11#1)(2013-1#1)
for the amino acid sequence##2##5##(1990-12#1)(1992-8#1)
for the amino acid##4##4##(1990-12#1)(1992-8#1)(1995-12#1)(2008-10#1)
for the amount of##2##4##(2008-10#2)
for the amperometric detection of##6##5##(2008-10#6)
for the amperometric##8##3##(1992-11#1)(2008-10#7)
for the amplification of##6##4##(1993-2#1)(2008-10#4)(2008-11#1)
for the analyses of##3##4##(2008-10#3)
for the analyses##5##3##(1997-7#1)(2008-10#4)
for the analysis and##5##4##(2008-10#2)(2008-4#2)(2010-4#1)
for the analysis are##2##4##(2008-10#1)(2008-3#1)
for the analysis of a##3##5##(1996-2#1)(1997-4#1)(2008-4#1)
for the analysis of binary##2##5##(2008-10#2)
for the analysis of complex##3##5##(1997-2#1)(2008-10#2)
for the analysis of different##2##5##(2008-10#2)
for the analysis of dynamic##2##5##(2008-3#2)
for the analysis of each##2##5##(1992-3#1)(2008-10#1)
for the analysis of glass##3##5##(2008-10#3)
for the analysis of human disease##3##6##(2008-4#3)
for the analysis of nitrite##2##5##(2008-10#2)
for the analysis of organophosphorus pesticides##3##6##(2008-10#3)
for the analysis of parabens##2##5##(2008-10#2)
for the analysis of polycyclic aromatic hydrocarbons (PAHs)##4##8##(2008-10#4)
for the analysis of polycyclic aromatic hydrocarbons in water samples##2##10##(2008-10#2)
for the analysis of polycyclic aromatic hydrocarbons in##3##8##(2008-10#3)
for the analysis of polycyclic aromatic hydrocarbons##8##7##(2008-10#8)
for the analysis of protein##2##5##(2008-10#1)(2010-4#1)
for the analysis of reactive##2##5##(2007-12#1)(2008-10#1)
for the analysis of real##2##5##(2008-10#2)
for the analysis of selected##2##5##(2008-10#2)
for the analysis of sodium##2##5##(2008-10#2)
for the analysis of some##4##5##(2008-10#4)
for the analysis of such##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
for the analysis of synthetic##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
for the analysis of the##15##5##(1992-3#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-9#1)
for the analysis of these##2##5##(2008-10#2)
for the analysis of this##3##5##(2008-10#3)
for the analysis of total##2##5##(2008-10#1)(2012-2#1)
for the analysis of trace##4##5##(2008-10#4)
for the analysis of##207##4##(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#139)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#12)(2008-7#3)(2008-9#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
for the analysis##223##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#146)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#14)(2008-7#4)(2008-9#3)(2010-11#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)
for the analyte##6##3##(2008-10#6)
for the analytes are in the range of##2##8##(2008-10#2)
for the analytes##9##3##(2008-10#8)(2010-5#1)
for the analytical##7##3##(1990-8#1)(2008-10#4)(2008-2#1)(2008-3#1)
for the angular distribution of the##2##6##(2007-11#1)(2008-3#1)
for the angular##3##3##(2007-11#1)(2008-3#2)
for the anther-specific expression of the##2##6##(1997-2#2)
for the antigen##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
for the antioxidant##2##3##(2008-10#1)(2009-6#1)
for the apparent##7##3##(1990-8#1)(2008-10#5)(2008-3#1)
for the appearance of##4##4##(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)
for the application of the##2##5##(2008-10#1)(2009-9#1)
for the application of##15##4##(1993-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)
for the application##17##3##(1993-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)
for the applied##2##3##(1994-9#1)(2008-2#1)
for the appropriate##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)
for the aryl hydrocarbon receptor (AhR)##2##6##(2008-10#2)
for the assay of D-Mtx##2##5##(2008-10#2)
for the assay of R-baclofen##2##5##(2008-10#2)
for the assay of l-carnitine##2##5##(2008-10#2)
for the assay of perphenazine in drug##2##7##(2008-10#2)
for the assay of perphenazine##4##5##(2008-10#4)
for the assay of the##2##5##(2008-10#1)(2008-4#1)
for the assay of three##2##5##(2008-10#2)
for the assay of##53##4##(1990-2#1)(1995-2#1)(2008-10#48)(2008-4#2)(2008-6#1)
for the assay##58##3##(1990-2#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-12#1)(2008-10#49)(2008-11#1)(2008-4#2)(2008-6#1)
for the assays of##2##4##(2008-10#2)
for the assays##3##3##(2008-10#3)
for the assembly of##4##4##(1990-11#1)(1997-4#1)(2008-10#1)(2008-8#1)
for the assembly##5##3##(1990-11#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)
for the assessment of left##2##5##(2008-12#1)(2011-2#1)
for the assessment of patients##2##5##(2007-8#1)(2012-12#1)
for the assessment of the efficacy##2##6##(2008-5#2)
for the assessment of the##9##5##(2008-10#2)(2008-4#1)(2008-5#3)(2012-12#1)(2012-3#1)(2013-8#1)
for the assessment of their##3##5##(2008-10#1)(2008-4#1)(2008-7#1)
for the assessment of unwanted immunogenicity##2##6##(2008-10#2)
for the assessment of##58##4##(1990-12#1)(1991-1#1)(1996-12#3)(1996-6#1)(1997-7#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
for the associated##5##3##(1991-3#1)(2008-10#2)(2008-12#1)(2010-8#1)
for the association between##2##4##(2011-1#1)(2012-3#1)
for the association of##2##4##(1995-2#1)(2008-10#1)
for the association##10##3##(1991-8#1)(1995-2#2)(1997-5#2)(2008-10#2)(2009-8#1)(2011-1#1)(2012-3#1)
for the asymmetric synthesis of##2##5##(2007-11#1)(2008-11#1)
for the attachment of##6##4##(1990-12#1)(1994-12#1)(2008-10#1)(2008-4#2)(2010-12#1)
for the auditory evaluation of the hearing impaired##2##8##(2008-9#2)
for the autocrine##2##3##(1993-9#1)(2008-4#1)
for the automated##7##3##(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)
for the automatic##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
for the automation of analytical procedures##2##6##(2008-10#2)
for the automation of##3##4##(2008-10#3)
for the average##4##3##(1991-1#1)(1996-3#1)(2008-3#2)
for the backbone##2##3##(1994-5#1)(2009-7#1)
for the bacterial##2##3##(2008-10#1)(2011-2#1)
for the bacterium##2##3##(2008-10#1)(2008-5#1)
for the basal##2##3##(1992-9#1)(1997-7#1)
for the baseline##2##3##(2008-10#1)(2008-3#1)
for the batch method##2##4##(2008-10#2)
for the beam##2##3##(2008-3#2)
for the behavior of##2##4##(2008-9#1)(2013-8#1)
for the benefit of the virus##2##6##(2013-1#2)
for the benefit of##6##4##(1995-5#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
for the benefit##7##3##(1995-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
for the best choice of##2##5##(2008-3#2)
for the best##18##3##(1995-12#1)(1996-2#1)(1996-8#1)(2008-10#7)(2008-3#3)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
for the beta 3-adrenoceptor##2##4##(1995-11#2)
for the beta##4##3##(1990-7#1)(1992-9#1)(1995-11#2)
for the better health##2##4##(1994-3#1)(1997-2#1)
for the better##3##3##(1994-3#1)(1997-2#1)(2010-8#1)
for the bifurcated##2##3##(2008-10#2)
for the binary complex of Cd2(111mCd)Cd2LADH with##2##7##(1995-5#2)
for the binary##4##3##(1995-5#2)(2008-10#2)
for the binding of##10##4##(1991-2#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-10#3)(2008-8#1)
for the binding##16##3##(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)
for the biochemical##3##3##(2008-4#1)(2008-9#1)(2012-3#1)
for the biological activity of##3##5##(1990-12#1)(1992-8#1)(2008-10#1)
for the biological activity##5##4##(1990-12#1)(1992-8#2)(2008-10#1)(2010-12#1)
for the biological control of##7##5##(2008-10#6)(2008-8#1)
for the biological control##8##4##(2008-10#6)(2008-8#1)(2011-2#1)
for the biological##15##3##(1990-12#1)(1992-8#2)(2007-10#1)(2008-10#7)(2008-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
for the biomedical##2##3##(2008-7#1)(2009-12#1)
for the biosynthesis of the##2##5##(2008-7#1)(2011-2#1)
for the biosynthesis of##4##4##(1993-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
for the biotechnological##2##3##(2008-6#1)(2011-1#1)
for the biovolume##2##3##(2008-11#2)
for the blind##4##3##(2008-2#1)(2008-7#2)(2009-12#1)
for the blood##2##3##(2008-12#1)(2008-5#1)
for the body##2##3##(2007-12#1)(2008-5#1)
for the bond##2##3##(2008-9#2)
for the bone##2##3##(1995-6#1)(2012-2#1)
for the bovine##3##3##(1994-8#2)(2012-3#1)
for the brain##7##3##(1994-12#1)(1996-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
for the breast cancer##2##4##(1993-11#1)(2012-3#1)
for the bulk##2##3##(2008-3#1)(2008-7#1)
for the bystander effect##2##4##(2008-7#2)
for the calcium##2##3##(1997-7#1)(2008-10#1)
for the calculation of the##2##5##(2008-2#1)(2008-3#1)
for the calculation of##12##4##(1997-3#1)(2008-10#2)(2008-2#4)(2008-3#4)(2010-8#1)
for the calculations##3##3##(2008-10#3)
for the calibration of##5##4##(2008-10#3)(2008-3#2)
for the calibration##9##3##(2008-10#7)(2008-3#2)
for the canine larynx##2##4##(1996-5#2)
for the capacity to##2##4##(2008-5#1)(2009-3#1)
for the capacity##3##3##(2008-3#1)(2008-5#1)(2009-3#1)
for the capillary##2##3##(1994-12#1)(2008-10#1)
for the carbohydrate##2##3##(1990-5#2)
for the carbons of the##2##5##(1995-11#2)
for the carcinogenicity of##2##4##(1990-8#1)(1991-6#1)
for the cardiovascular##2##3##(1995-12#1)(2011-1#1)
for the care of the aged##2##6##(1991-11#2)
for the care of the##3##5##(1991-11#2)(1992-1#1)
for the care of##13##4##(1991-11#2)(1992-1#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#2)(2010-10#1)(2012-3#1)(2013-1#1)
for the carrier##2##3##(2007-11#2)
for the case in which the##2##6##(2008-3#2)
for the case of a##6##5##(2008-10#1)(2008-2#1)(2008-3#4)
for the case of an##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
for the case of##22##4##(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#10)(2008-8#1)
for the case##25##3##(1995-2#2)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#12)(2008-8#1)
for the cases##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
for the catalysis of##3##4##(1990-12#1)(2008-10#2)
for the catalysis##5##3##(1990-12#1)(1993-11#1)(2008-10#2)(2008-11#1)
for the catalytic zinc##2##4##(1992-3#1)(1995-5#1)
for the catalytic##4##3##(1992-3#1)(1992-6#1)(1995-5#1)(2008-10#1)
for the cationic##2##3##(2008-10#1)(2008-5#1)
for the cations##2##3##(2008-10#2)
for the cause of##3##4##(1996-8#1)(2008-11#1)(2010-3#1)
for the cell##7##3##(1995-2#1)(1996-7#1)(2008-4#2)(2008-9#1)(2011-2#2)
for the cellular##2##3##(1997-2#1)(2008-9#1)
for the central##5##3##(1994-5#1)(1994-8#1)(2007-12#1)(2008-8#1)(2012-2#1)
for the change of##2##4##(2008-12#1)(2013-8#1)
for the change##6##3##(1994-2#1)(1995-11#1)(1995-3#1)(2008-12#1)(2008-2#1)(2013-8#1)
for the changes in##4##4##(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
for the changes##6##3##(1994-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
for the characterisation of##6##4##(2008-10#4)(2008-11#1)(2012-2#1)
for the characterisation##7##3##(2008-10#5)(2008-11#1)(2012-2#1)
for the characteristic##4##3##(1992-8#1)(1994-11#1)(2008-4#1)(2008-5#1)
for the characterization and##2##4##(2008-10#1)(2008-3#1)
for the characterization of sub-10-fs##2##5##(2007-12#2)
for the characterization of the##3##5##(1992-2#1)(2007-12#1)(2008-10#1)
for the characterization of##28##4##(1991-12#1)(1992-2#1)(1994-12#1)(1996-5#1)(2007-12#4)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-6#1)
for the characterization##30##3##(1991-12#1)(1992-2#1)(1994-12#1)(1996-5#1)(2007-12#4)(2008-10#7)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-6#1)
for the chemical analysis of##2##5##(2008-10#2)
for the chemical reaction##2##4##(2008-10#2)
for the chemical##9##3##(1993-11#1)(2008-10#8)
for the chemiluminescence##2##3##(2008-10#2)
for the chemiluminescent##3##3##(2008-10#3)
for the chemiluminometric determination of##2##5##(2008-10#2)
for the chicken brain receptor##2##5##(1995-3#2)
for the chicken##3##3##(1995-3#2)(1997-9#1)
for the child##4##3##(2008-11#2)(2010-9#1)(2011-1#1)
for the children who##2##4##(1994-6#1)(2011-1#1)
for the children's##2##3##(1990-2#1)(2008-11#1)
for the choice of the##2##5##(1990-2#1)(2008-3#1)
for the choice of##3##4##(1990-2#1)(2007-8#1)(2008-3#1)
for the choice##4##3##(1990-2#1)(2007-8#1)(2008-3#1)(2013-1#1)
for the chromatographic##3##3##(2008-10#3)
for the chronic##3##3##(2007-8#1)(2008-5#1)(2012-3#1)
for the chronically ill##2##4##(1995-2#1)(2008-1#1)
for the chronically##3##3##(1995-2#1)(1997-2#1)(2008-1#1)
for the class of##3##4##(1991-6#1)(2011-1#1)(2011-2#1)
for the classical##2##3##(1990-12#1)(2012-12#1)
for the classification and##2##4##(2007-11#1)(2008-10#1)
for the classification of the##3##5##(1990-6#2)(2008-12#1)
for the classification of##9##4##(1990-6#2)(2008-10#2)(2008-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2013-8#1)
for the classification##13##3##(1990-6#2)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-8#1)
for the clean-up of##2##4##(2008-10#1)(2008-11#1)
for the client##3##3##(1994-2#1)(2008-11#1)(2013-8#1)
for the clinical application##2##4##(1990-2#1)(2008-11#1)
for the clinical data specialist##3##5##(2007-12#3)
for the clinical development of the##2##6##(2008-5#1)(2009-4#1)
for the clinical management of##2##5##(2009-12#1)(2009-5#1)
for the clinical use of##2##5##(1992-3#1)(2008-6#1)
for the clinical##25##3##(1990-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(2007-12#3)(2007-8#1)(2008-11#4)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
for the clinician##5##3##(1990-9#1)(2008-1#1)(2008-12#1)(2009-9#1)(2012-2#1)
for the cloning and##2##4##(1997-4#1)(2008-4#1)
for the cloning##3##3##(1990-5#1)(1997-4#1)(2008-4#1)
for the coastal##2##3##(2008-10#1)(2008-8#1)
for the coated##2##3##(2008-10#1)(2008-2#1)
for the cohered structure##2##4##(1991-7#2)
for the coherent##2##3##(2008-2#1)(2008-3#1)
for the collaborative##2##3##(2008-11#1)(2012-2#1)
for the collection of##3##4##(1997-3#1)(2008-10#1)(2008-5#1)
for the collection##5##3##(1994-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)
for the colony-stimulating##2##3##(1991-6#1)(1992-10#1)
for the colorimetric determination##2##4##(2008-10#2)
for the column##2##3##(1992-11#1)(2008-10#1)
for the combination of##2##4##(1990-2#1)(2007-11#1)
for the combined##4##3##(1995-3#1)(1996-3#1)(2008-10#1)(2008-2#1)
for the common##6##3##(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
for the community##6##3##(1991-1#1)(1995-9#1)(1997-3#1)(2008-8#2)(2013-1#1)
for the comparison of##4##4##(1994-9#1)(2007-8#1)(2008-10#2)
for the comparison##6##3##(1994-9#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-12#1)
for the compensation##2##3##(1991-2#1)(2008-10#1)
for the competitive##3##3##(1993-6#1)(2008-10#2)
for the complete##2##3##(2008-10#1)(2011-2#1)
for the completion of##2##4##(2007-12#1)(2008-6#1)
for the complex formation##2##4##(1997-6#1)(2008-10#1)
for the complex##5##3##(1992-4#1)(1993-8#1)(1997-6#1)(2008-10#1)(2012-2#1)
for the complexation of the##2##5##(2008-10#2)
for the complexation##4##3##(2008-10#4)
for the complexes of##2##4##(1993-11#1)(2008-10#1)
for the complexes##3##3##(1993-11#1)(2008-10#2)
for the complexity of##4##4##(1993-2#1)(1997-6#1)(2010-7#1)(2012-12#1)
for the compounds were##3##4##(1993-1#1)(2008-10#2)
for the compounds##6##3##(1993-1#1)(1997-2#1)(1997-7#1)(2008-10#2)(2009-8#1)
for the computation of##2##4##(2008-10#2)
for the concentration of##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
for the concentration##4##3##(2008-10#2)(2008-12#1)(2008-4#1)
for the concentrations of##3##4##(1990-8#1)(2008-10#1)(2008-2#1)
for the concept of a##2##5##(1991-1#1)(1995-12#1)
for the concept##3##3##(1991-1#1)(1995-12#1)(1995-2#1)
for the conditional##2##3##(1993-8#1)(2008-10#1)
for the confirmation of##2##4##(2008-10#1)(2011-2#1)
for the conidial germination assays##2##5##(2008-10#2)
for the conidial germination##3##4##(2008-10#3)
for the conscious##2##3##(2010-4#2)
for the consecutive##2##3##(2008-10#2)
for the constitutive##2##3##(1991-9#1)(1995-12#1)
for the construction and##2##4##(1995-2#1)(2008-10#1)
for the construction of a##7##5##(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2010-5#1)
for the construction of##28##4##(1991-5#1)(1993-2#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#2)
for the construction##31##3##(1991-5#1)(1993-2#1)(1994-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#2)(2012-3#1)
for the continued##3##3##(2008-1#1)(2010-11#1)(2013-1#1)
for the continuing##2##3##(1993-3#1)(1997-8#1)
for the continuous monitoring of##2##5##(2008-10#1)(2008-2#1)
for the continuous production of##3##5##(2008-6#1)(2008-7#2)
for the continuous##17##3##(1993-12#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#3)(2010-12#1)
for the contrast##4##3##(1997-4#1)(2008-3#3)
for the control and##2##4##(2008-7#2)
for the control group##3##4##(2008-12#1)(2009-1#1)(2011-2#1)
for the control of avian influenza##2##6##(2007-6#2)
for the control of common waterhemp##2##6##(2008-10#2)
for the control of movement##2##5##(2007-12#1)(2007-8#1)
for the control of the##3##5##(1993-6#1)(1996-12#1)(2008-10#1)
for the control of this##2##5##(2008-10#1)(2008-6#1)
for the control of##48##4##(1990-6#1)(1991-12#1)(1992-12#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-4#1)(1997-6#1)(2007-12#2)(2007-5#1)(2007-6#3)(2007-8#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-2#1)
for the control##60##3##(1990-6#1)(1991-12#1)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-6#3)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-1#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)
for the controlled release of##2##5##(2008-10#1)(2012-6#1)
for the controlled##4##3##(1993-11#1)(1995-3#1)(2008-10#1)(2012-6#1)
for the convenient##2##3##(2008-10#1)(2008-9#1)
for the conventional##7##3##(1994-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
for the conversion of##8##4##(1992-12#1)(1993-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-12#1)(2010-12#1)
for the copper complex##2##4##(1996-2#2)
for the copper##3##3##(1996-2#2)(2008-10#1)
for the correct##7##3##(1993-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
for the correction of the##2##5##(2008-3#1)(2013-1#1)
for the correction of##10##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2009-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
for the correlation between the##2##5##(2012-3#1)(2013-1#1)
for the correlation between##4##4##(1991-9#1)(1996-3#1)(2012-3#1)(2013-1#1)
for the correlation##5##3##(1991-9#1)(1996-3#1)(2008-3#1)(2012-3#1)(2013-1#1)
for the correlations##2##3##(2008-12#1)(2013-7#1)
for the corresponding##9##3##(1990-12#1)(1990-5#1)(1995-11#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)
for the cosmetic industry##3##4##(2008-5#3)
for the cost of##2##4##(1993-1#1)(1997-5#1)
for the coupling of##2##4##(2008-2#1)(2008-4#1)
for the coupling##6##3##(1990-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)
for the covalent immobilization of##2##5##(2008-10#1)(2013-8#1)
for the covalent##3##3##(1995-6#1)(2008-10#1)(2013-8#1)
for the creation of##12##4##(1990-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-2#1)
for the cross-spectral density of partially coherent##2##7##(2007-11#2)
for the crystal structure of##2##5##(1994-5#1)(2013-7#1)
for the crystal##3##3##(1993-12#1)(1994-5#1)(2013-7#1)
for the cultivation of human##2##5##(2008-11#1)(2012-3#1)
for the cultivation of##7##4##(2008-11#3)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#1)
for the culture of##6##4##(1994-2#1)(2008-11#3)(2008-5#1)(2008-9#1)
for the culture##7##3##(1994-2#1)(2008-11#3)(2008-5#1)(2008-9#2)
for the curing of##2##4##(2008-8#2)
for the current study##2##4##(2010-3#1)(2013-8#1)
for the current##9##3##(1995-12#1)(1996-6#1)(2007-12#2)(2008-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
for the curvature##2##3##(2007-12#1)(2010-2#1)
for the dRTA##2##3##(2008-1#2)
for the data##2##3##(2008-8#1)(2011-2#1)
for the daughter##2##3##(1995-9#1)(2008-3#1)
for the day##2##3##(1993-1#1)(2011-2#1)
for the decision to##2##4##(1997-4#1)(2008-9#1)
for the decision##4##3##(1997-4#1)(1997-8#1)(2008-9#1)(2013-1#1)
for the decomposition of##2##4##(2008-10#1)(2009-11#1)
for the decreased##2##3##(2011-1#1)(2013-1#1)
for the definitive##4##3##(1996-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the degradation of##9##4##(1994-8#1)(1995-6#1)(1995-8#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
for the degree of##5##4##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
for the delivery of therapeutic##2##5##(2008-5#2)
for the delivery of##16##4##(1991-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(2008-3#2)(2008-5#3)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)
for the delivery##17##3##(1991-3#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(2008-3#2)(2008-5#3)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)
for the departure##2##3##(2008-3#2)
for the dependence of##2##4##(2007-10#1)(2008-3#1)
for the deposition of##4##4##(1994-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
for the derivation of##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)
for the derivation##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
for the description of the##3##5##(2007-11#2)(2008-3#1)
for the description of##7##4##(1990-8#1)(2007-11#2)(2008-3#2)(2008-4#1)(2008-9#1)
for the description##8##3##(1990-8#1)(2007-11#2)(2008-3#3)(2008-4#1)(2008-9#1)
for the design and##5##4##(1994-3#1)(2008-3#3)(2010-4#1)
for the design of a##3##5##(2007-12#1)(2008-3#2)
for the design of an##2##5##(2008-11#1)(2008-3#1)
for the design of diffractive optical##2##6##(2008-2#1)(2008-3#1)
for the design of diffractive##4##5##(2007-11#2)(2008-2#1)(2008-3#1)
for the design of new##4##5##(2008-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
for the design of synthetic##2##5##(2008-10#1)(2008-2#1)
for the design of##39##4##(1992-12#1)(1993-11#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for the design tolerances##2##4##(2008-3#2)
for the design##51##3##(1992-12#1)(1993-11#1)(1994-3#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for the designed##2##3##(2008-10#1)(2008-3#1)
for the detected##2##3##(2008-10#1)(2008-3#1)
for the detection and determination of##3##6##(2008-10#1)(2008-11#2)
for the detection and identification of##3##6##(2008-10#3)
for the detection and treatment of##2##6##(2007-10#1)(2012-2#1)
for the detection and##18##4##(1990-12#1)(2007-10#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
for the detection of DNA##4##5##(1995-12#1)(2008-10#3)
for the detection of Escherichia coli O157##2##7##(2008-10#2)
for the detection of IgM antibodies to either one of two##2##11##(1990-12#2)
for the detection of NO##4##5##(2008-10#1)(2008-3#2)(2010-7#1)
for the detection of P##2##5##(2008-10#2)
for the detection of Phytophthora ramorum##2##6##(2008-10#2)
for the detection of Salmonella##2##5##(1990-12#1)(2008-10#1)
for the detection of Schistosoma japonicum antibody##2##7##(2008-10#2)
for the detection of a##3##5##(2008-10#2)(2009-3#1)
for the detection of aflatoxin##2##5##(2008-12#1)(2010-5#1)
for the detection of anti-West Nile virus IgG##2##8##(2008-10#2)
for the detection of antibodies to##5##6##(1990-12#2)(1991-3#2)(1992-6#1)
for the detection of antibodies##7##5##(1990-12#3)(1991-3#2)(1992-6#1)(1997-6#1)
for the detection of antigens##2##5##(1993-2#1)(2008-10#1)
for the detection of begomoviruses##2##5##(2008-10#2)
for the detection of cancer##3##5##(1990-6#1)(1992-9#1)(2008-11#1)
for the detection of hantavirus##2##5##(2008-10#2)
for the detection of hydrogen peroxide##2##6##(2008-10#2)
for the detection of hydrogen##3##5##(2008-10#3)
for the detection of mercury(II)##2##5##(2008-10#2)
for the detection of nitric oxide##2##6##(2008-10#2)
for the detection of peroxynitrite##2##5##(2008-10#2)
for the detection of pesticides in##2##6##(2008-10#2)
for the detection of plant viruses##2##6##(2008-10#2)
for the detection of rabbit IgG##2##6##(2008-10#2)
for the detection of rare##2##5##(1991-3#1)(2008-9#1)
for the detection of retroviruses##2##5##(2008-11#2)
for the detection of several##2##5##(2008-10#1)(2009-3#1)
for the detection of the novel##2##6##(2011-1#2)
for the detection of the##15##5##(1990-12#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-9#1)(2011-1#4)(2013-8#1)
for the detection of these##2##5##(2008-10#2)
for the detection of toxicants in water##3##7##(2008-10#3)
for the detection of trace levels of##2##7##(2008-10#2)
for the detection of trace##6##5##(2008-10#6)
for the detection of##218##4##(1990-12#9)(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#3)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#111)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
for the detection##240##3##(1990-12#10)(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#3)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#3)(1993-5#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#123)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#4)
for the determination and speciation of arsenic##2##7##(2008-10#2)
for the determination and speciation##3##5##(2008-10#3)
for the determination and##5##4##(2008-10#4)(2010-11#1)
for the determination of 0##2##5##(2008-10#2)
for the determination of 1##2##5##(2008-10#2)
for the determination of 10##2##5##(2008-10#1)(2011-1#1)
for the determination of 2##2##5##(2008-10#2)
for the determination of 2-acetyl-1-pyrroline in##2##6##(2011-1#2)
for the determination of 2-phenylethylamine##2##5##(1996-5#2)
for the determination of 4-aminophenol##2##5##(2008-10#2)
for the determination of 50##3##5##(2008-10#3)
for the determination of 6-mercaptopurine##2##5##(2008-10#2)
for the determination of Aflatoxin B(1)##2##6##(2008-10#2)
for the determination of Ag##3##5##(2008-10#3)
for the determination of As and Sb##2##7##(2008-10#2)
for the determination of As##4##5##(2008-10#4)
for the determination of As(III)##4##5##(2008-10#4)
for the determination of Bi##2##5##(2008-10#2)
for the determination of Ca##2##5##(2008-10#2)
for the determination of Cd and Pb##2##7##(2008-10#2)
for the determination of Cd in acid-digested solutions of##2##9##(2008-10#2)
for the determination of Cd in##3##6##(2008-10#3)
for the determination of Cd##7##5##(2008-10#7)
for the determination of Co##2##5##(2008-10#2)
for the determination of Cu and##2##6##(2008-10#2)
for the determination of Cu##6##5##(2008-10#6)
for the determination of Cu(II) in##3##6##(2008-10#3)
for the determination of Cu(II)##5##5##(2008-10#5)
for the determination of DMA in##2##6##(2008-10#2)
for the determination of Hg(II)##3##5##(2008-10#3)
for the determination of Mg(2+)##2##5##(2008-10#2)
for the determination of Mo##2##5##(2008-10#2)
for the determination of N-nitrosodiethanolamine##2##5##(2008-5#2)
for the determination of NO##2##5##(2008-10#2)
for the determination of Ni(II) and Co(II)##2##7##(2008-10#2)
for the determination of OTA in##2##6##(2008-10#2)
for the determination of PA##2##5##(2008-10#2)
for the determination of Pb(II) at trace##2##7##(2008-10#2)
for the determination of Sb(V) in##2##6##(2008-10#2)
for the determination of Se compounds in##2##7##(2008-10#2)
for the determination of Se in##2##6##(2008-10#2)
for the determination of Se##6##5##(2008-10#6)
for the determination of VB(2)##2##5##(2008-10#2)
for the determination of VHCs##2##5##(2009-8#2)
for the determination of Vitamin##2##5##(2008-10#2)
for the determination of Zn(2+)##2##5##(2008-10#2)
for the determination of a##3##5##(2008-10#3)
for the determination of acetylcholine##3##5##(2008-10#3)
for the determination of alendronate##2##5##(2008-10#2)
for the determination of aliphatic##2##5##(2008-10#2)
for the determination of alkylating agents in complex##2##8##(2008-10#2)
for the determination of aluminium##4##5##(2008-10#4)
for the determination of amines##2##5##(2008-10#2)
for the determination of aminomethylbenzoic acid##2##6##(2008-10#2)
for the determination of ammonium##3##5##(2008-10#3)
for the determination of anionic surfactants in##2##7##(2008-10#2)
for the determination of anionic##3##5##(2008-10#3)
for the determination of antimony in pharmaceuticals##2##7##(2008-10#2)
for the determination of antimony##4##5##(2008-10#4)
for the determination of antithyroid drugs##2##6##(2008-10#2)
for the determination of arsenic in environmental samples##2##8##(2008-10#2)
for the determination of arsenic in##5##6##(2008-10#5)
for the determination of arsenic##8##5##(2008-10#8)
for the determination of ascorbic acid in##2##7##(2008-10#2)
for the determination of ascorbic acid##8##6##(2008-10#8)
for the determination of atmospheric##2##5##(2008-10#2)
for the determination of atropine and pethidine##2##7##(2008-10#2)
for the determination of benzo[a]pyrene in##2##6##(2008-10#2)
for the determination of benzoic acid in##2##7##(2008-10#2)
for the determination of boron##2##5##(2008-10#2)
for the determination of both##2##5##(2008-10#2)
for the determination of bromide in seawater##2##7##(2008-10#2)
for the determination of bromide##4##5##(2008-10#4)
for the determination of cadmium and##2##6##(2008-10#2)
for the determination of cadmium by graphite furnace atomic absorption spectrometry##2##11##(2008-10#2)
for the determination of cadmium in##4##6##(2008-10#4)
for the determination of cadmium##11##5##(2008-10#11)
for the determination of calcium##3##5##(2008-10#3)
for the determination of carbon dioxide##3##6##(2008-10#3)
for the determination of carbon in##2##6##(2008-10#1)(2008-3#1)
for the determination of carbon##5##5##(2008-10#4)(2008-3#1)
for the determination of carbonyl compounds##2##6##(2008-10#2)
for the determination of cardiac troponin I##2##7##(2008-10#2)
for the determination of cationic##2##5##(2008-10#2)
for the determination of cetylpyridinium##2##5##(2008-10#2)
for the determination of chloride in##2##6##(2008-10#2)
for the determination of chloride ion in##2##7##(2008-10#2)
for the determination of chloride##5##5##(2008-10#5)
for the determination of chromium##6##5##(2008-10#6)
for the determination of ciprofloxacin in drug formulations##2##8##(2008-10#2)
for the determination of ciprofloxacin##3##5##(2008-10#3)
for the determination of cobalt in##3##6##(2008-10#3)
for the determination of cobalt##7##5##(2008-10#7)
for the determination of copper by##2##6##(2008-10#2)
for the determination of copper in the##2##7##(2008-10#2)
for the determination of copper in##5##6##(2008-10#5)
for the determination of copper##13##5##(2008-10#13)
for the determination of copper(II) based on##2##7##(2008-10#2)
for the determination of copper(II)##4##5##(2008-10#4)
for the determination of cyanide##3##5##(2008-10#3)
for the determination of cysteine##6##5##(2008-10#6)
for the determination of d-serine in neural samples##2##8##(2008-10#2)
for the determination of dissolved oxygen##2##6##(2008-10#2)
for the determination of dissolved##7##5##(2008-10#7)
for the determination of dithiocarbamate##2##5##(2008-10#2)
for the determination of dopamine##3##5##(2008-10#3)
for the determination of drug in##2##6##(2008-10#2)
for the determination of drug##3##5##(2008-10#3)
for the determination of eight##2##5##(2008-10#2)
for the determination of enoxacin##2##5##(2010-4#2)
for the determination of ethanol and##2##6##(1991-5#1)(2008-10#1)
for the determination of ethanol in##4##6##(2008-10#4)
for the determination of ethanol##7##5##(1991-5#1)(2008-10#6)
for the determination of famotidine##2##5##(2008-10#2)
for the determination of fish freshness##4##6##(2008-10#4)
for the determination of five-part##2##5##(2008-10#2)
for the determination of fluoride ion in##2##7##(2008-10#2)
for the determination of fluoride ion##3##6##(2008-10#3)
for the determination of fluoride##4##5##(2008-10#4)
for the determination of gallium##2##5##(2008-10#2)
for the determination of glucose in animal blood serum##2##9##(2008-10#2)
for the determination of glucose in##4##6##(2008-10#4)
for the determination of glucose##5##5##(2008-10#5)
for the determination of glutamine in##2##6##(1993-9#2)
for the determination of glutathione##2##5##(2008-10#2)
for the determination of hemoglobin##2##5##(2008-10#2)
for the determination of hydrazine##3##5##(2008-10#3)
for the determination of hydrogen peroxide in rainwater##2##8##(2008-10#2)
for the determination of hydrogen peroxide in##4##7##(2008-10#4)
for the determination of hydrogen peroxide##9##6##(2008-10#9)
for the determination of hydrogen##10##5##(2008-10#10)
for the determination of hydroquinone in##2##6##(2008-10#2)
for the determination of inorganic##5##5##(1993-12#1)(2008-10#4)
for the determination of iodate and##2##6##(2008-10#2)
for the determination of iodate##3##5##(2008-10#3)
for the determination of iodide##2##5##(2008-10#2)
for the determination of ion exchange equilibrium constants##2##8##(2008-10#2)
for the determination of iron (II)##2##6##(2008-10#2)
for the determination of iron in##3##6##(2008-10#3)
for the determination of iron##8##5##(2008-10#8)
for the determination of isoniazid##2##5##(2008-10#2)
for the determination of keratan sulphate peptides in biological fluids##2##10##(1990-12#2)
for the determination of l- and d-enantiomers of methotrexate##2##9##(2008-10#2)
for the determination of lead and##2##6##(2008-10#2)
for the determination of lead in##7##6##(2008-10#7)
for the determination of lead##14##5##(2008-1#1)(2008-10#13)
for the determination of lead(II)##3##5##(2008-10#3)
for the determination of linezolid in the presence of its alkaline-induced degradation products##2##13##(2008-10#2)
for the determination of lithium##2##5##(2008-10#2)
for the determination of low##3##5##(2008-10#3)
for the determination of manganese##3##5##(2008-10#3)
for the determination of manganese(II)##3##5##(2008-10#3)
for the determination of mercury by##3##6##(2008-10#3)
for the determination of mercury##7##5##(2008-10#7)
for the determination of metal##3##5##(2008-10#2)(2010-11#1)
for the determination of metals in##5##6##(2008-10#5)
for the determination of metronidazole##3##5##(2008-10#3)
for the determination of molybdenum##4##5##(2008-10#4)
for the determination of morphine##2##5##(2008-10#2)
for the determination of nanogram##2##5##(2008-10#2)
for the determination of naproxen##2##5##(2008-10#2)
for the determination of nickel in##2##6##(2008-10#2)
for the determination of nickel##3##5##(2008-10#3)
for the determination of nitrate in##3##6##(2008-10#3)
for the determination of nitrite in##2##6##(2008-10#2)
for the determination of nitrite##9##5##(2008-10#9)
for the determination of nitrogen##2##5##(2008-10#2)
for the determination of o-xylene##2##5##(2008-10#2)
for the determination of organophosphorous pesticides##2##6##(2008-10#2)
for the determination of orthophosphate##2##5##(2008-10#2)
for the determination of ozone##2##5##(2008-10#2)
for the determination of panaxynol in##2##6##(2008-10#2)
for the determination of papaverine##2##5##(2008-10#2)
for the determination of paracetamol in##2##6##(2008-10#2)
for the determination of paracetamol##3##5##(2008-10#3)
for the determination of paraquat##3##5##(2008-10#3)
for the determination of pentoxyverine##2##5##(2008-10#2)
for the determination of perphenazine##2##5##(2008-10#2)
for the determination of phenolic##2##5##(2008-10#2)
for the determination of phenylephrine hydrochloride in pharmaceutical##2##8##(2008-10#2)
for the determination of phosphorus species in##2##7##(2008-10#2)
for the determination of phosphorus##7##5##(2008-10#7)
for the determination of piroxicam##2##5##(2008-10#2)
for the determination of platinum in##2##6##(2008-10#2)
for the determination of platinum##3##5##(2008-10#3)
for the determination of polycyclic aromatic hydrocarbons (PAHs) in##2##9##(2008-10#2)
for the determination of polycyclic aromatic hydrocarbons##3##7##(2008-10#3)
for the determination of potentiometric selectivity coefficients of##2##8##(2008-10#2)
for the determination of prenalterol##2##5##(2008-10#2)
for the determination of protein##4##5##(1990-12#1)(2008-10#2)(2008-4#1)
for the determination of proteins with##2##6##(2008-10#2)
for the determination of proteins##5##5##(2008-10#5)
for the determination of pyrimethamine##3##5##(2008-10#3)
for the determination of rare earth##2##6##(2008-10#2)
for the determination of reductive sulphur##2##6##(2008-10#2)
for the determination of retinyl acetate##2##6##(2008-10#2)
for the determination of rhodium##3##5##(2008-10#3)
for the determination of ruthenium##3##5##(2008-10#3)
for the determination of salsalate##2##5##(2008-10#2)
for the determination of selenium##2##5##(2008-10#2)
for the determination of several##2##5##(2008-10#2)
for the determination of silver##2##5##(2008-10#2)
for the determination of soluble##2##5##(1994-2#1)(2008-10#1)
for the determination of some##7##5##(2008-10#6)(2008-2#1)
for the determination of stability constants of##2##7##(2008-10#2)
for the determination of sulfate##2##5##(2008-10#2)
for the determination of sulfide##2##5##(2008-10#2)
for the determination of sulfite in##2##6##(2008-10#2)
for the determination of sulfite##4##5##(2008-10#4)
for the determination of sulphur##2##5##(2008-10#2)
for the determination of thallium##3##5##(1991-12#1)(2008-10#2)
for the determination of the above##2##6##(2008-10#2)
for the determination of the analyte##2##6##(2008-10#2)
for the determination of the concentration of##4##7##(2008-10#3)(2008-11#1)
for the determination of the drug in##2##7##(2008-10#2)
for the determination of the drug##3##6##(2008-10#3)
for the determination of the four##2##6##(2008-10#2)
for the determination of the herbicide##3##6##(2008-10#3)
for the determination of the refractive index##2##7##(2008-3#2)
for the determination of the stability##2##6##(2008-10#2)
for the determination of the studied drugs in their pharmaceutical##2##10##(2008-10#2)
for the determination of the total amount of##2##8##(2008-10#2)
for the determination of the widely used herbicide##2##8##(2008-10#2)
for the determination of the##81##5##(1990-12#2)(1991-5#2)(1991-7#1)(1993-11#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#61)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)
for the determination of these##6##5##(2008-10#6)
for the determination of this##3##5##(2008-10#3)
for the determination of three##3##5##(2008-10#3)
for the determination of tin##2##5##(2008-10#2)
for the determination of total arsenic##2##6##(2008-10#2)
for the determination of total mercury##4##6##(2008-10#4)
for the determination of total phosphorus in##2##7##(2008-10#2)
for the determination of total sulfur##2##6##(2008-10#2)
for the determination of total sulphur##3##6##(2008-10#3)
for the determination of total##22##5##(2008-10#22)
for the determination of trace amount of indium in##2##9##(2008-10#2)
for the determination of trace amount of##7##7##(2008-10#7)
for the determination of trace amounts of bromide##2##8##(2008-10#2)
for the determination of trace amounts of nitrite##2##8##(2008-10#2)
for the determination of trace amounts of##25##7##(2008-10#25)
for the determination of trace elements in##4##7##(2008-10#3)(2011-2#1)
for the determination of trace elements##6##6##(2008-10#5)(2011-2#1)
for the determination of trace lead##2##6##(2008-10#1)(2013-8#1)
for the determination of trace levels of##7##7##(1990-8#1)(2008-10#6)
for the determination of trace mercury##3##6##(2008-10#3)
for the determination of trace metal##2##6##(2008-10#2)
for the determination of trace metals by##2##7##(2008-10#2)
for the determination of trace metals##4##6##(2008-10#4)
for the determination of trace silver(I)##2##6##(2008-10#2)
for the determination of trace##79##5##(1990-8#1)(2008-10#76)(2011-2#1)(2013-8#1)
for the determination of traces of##4##6##(2008-10#4)
for the determination of transparent exopolymer particles (TEP) in freshwater##2##10##(2008-10#2)
for the determination of triazines##2##5##(2008-10#2)
for the determination of tungsten in##2##6##(2008-10#2)
for the determination of tungsten##3##5##(2008-10#3)
for the determination of two##3##5##(2008-10#3)
for the determination of ultra trace##2##6##(2008-10#2)
for the determination of ultra-trace##3##5##(2008-10#3)
for the determination of uranium in##2##6##(2008-10#2)
for the determination of uranium##4##5##(2008-10#4)
for the determination of uric acid##3##6##(2008-10#3)
for the determination of vanadium in##2##6##(2008-10#2)
for the determination of vanadium##6##5##(2008-10#6)
for the determination of very low##2##6##(1990-12#1)(2008-10#1)
for the determination of volatile##4##5##(2008-10#4)
for the determination of zinc##4##5##(2008-10#4)
for the determination of##1182##4##(1990-12#7)(1990-2#4)(1990-8#6)(1991-12#1)(1991-5#6)(1991-7#1)(1992-11#3)(1992-3#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#6)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1073)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#4)(2008-7#1)(2009-8#4)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#10)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
for the determination##1193##3##(1990-12#7)(1990-2#4)(1990-8#6)(1991-12#1)(1991-5#6)(1991-7#1)(1992-11#3)(1992-3#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#6)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1083)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#4)(2008-7#1)(2009-8#4)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#10)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
for the determinations of##4##4##(2008-10#4)
for the developed##3##3##(2007-12#1)(2008-10#2)
for the developing##2##3##(1996-5#1)(2007-7#1)
for the development and##5##4##(1993-3#1)(2007-5#1)(2008-4#1)(2008-9#1)(2012-2#1)
for the development of a new##4##6##(1995-2#1)(2008-10#3)
for the development of a##20##5##(1990-10#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
for the development of an##4##5##(2006-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
for the development of atherosclerosis##2##5##(1995-8#1)(2012-3#1)
for the development of cardiovascular disease##2##6##(2008-1#1)(2011-1#1)
for the development of chest pain centers##2##7##(2008-3#2)
for the development of clinical##2##5##(1993-12#1)(1996-1#1)
for the development of early##2##5##(1990-2#1)(1992-12#1)
for the development of future##3##5##(2007-11#1)(2011-1#1)(2011-2#1)
for the development of mental health##2##6##(1994-1#1)(2009-6#1)
for the development of new##8##5##(1994-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-12#1)(2013-1#1)
for the development of novel##6##5##(1994-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
for the development of robust##2##5##(2008-10#1)(2008-7#1)
for the development of the##8##5##(1996-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)
for the development of##139##4##(1990-10#1)(1990-12#1)(1990-2#2)(1990-8#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-9#1)(2007-11#4)(2008-1#3)(2008-10#22)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
for the development##149##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-8#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-2#3)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-9#1)(2007-11#4)(2007-5#1)(2008-1#3)(2008-10#22)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
for the device##4##3##(2008-2#2)(2008-3#2)
for the diagnosis and prognosis of##3##6##(2007-7#1)(2008-4#2)
for the diagnosis and the##2##5##(1993-6#1)(2010-12#1)
for the diagnosis and treatment of##3##6##(1991-1#1)(2009-4#1)(2013-1#1)
for the diagnosis and##16##4##(1991-1#1)(1993-2#1)(1993-6#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-4#2)(2008-7#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
for the diagnosis of Cushing's disease##2##6##(2011-2#2)
for the diagnosis of acute myocardial infarction##3##7##(1997-2#1)(2008-3#2)
for the diagnosis of acute##5##5##(1997-2#1)(2007-2#1)(2008-3#3)
for the diagnosis of cardiovascular autonomic##2##6##(1990-9#2)
for the diagnosis of parasitic diseases##2##6##(2011-2#2)
for the diagnosis of the##2##5##(2007-8#1)(2008-3#1)
for the diagnosis of##72##4##(1990-2#1)(1990-8#2)(1990-9#3)(1991-12#1)(1991-3#1)(1994-6#1)(1996-11#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2006-8#1)(2007-10#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
for the diagnosis##95##3##(1990-11#1)(1990-2#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-12#1)(1991-3#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-11#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
for the diagnostic##2##3##(2012-1#1)(2012-12#1)
for the difference between##2##4##(1996-12#1)(2008-2#1)
for the difference in##2##4##(1993-12#1)(2008-10#1)
for the difference##4##3##(1993-12#1)(1996-12#1)(2008-10#1)(2008-2#1)
for the differences in##5##4##(1992-3#1)(1994-5#1)(2007-7#1)(2008-10#1)(2008-11#1)
for the differences##7##3##(1992-3#1)(1994-5#1)(1997-9#1)(2007-7#1)(2008-10#2)(2008-11#1)
for the different species##3##4##(2008-10#2)(2008-8#1)
for the different##35##3##(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#13)(2008-2#2)(2008-3#3)(2008-8#2)(2008-9#2)(2010-4#1)(2012-3#1)(2012-8#1)(2013-1#4)
for the differential diagnosis of##5##5##(1990-2#1)(1991-10#1)(1996-11#1)(2008-1#1)(2012-12#1)
for the differential##7##3##(1990-2#1)(1991-10#1)(1996-11#1)(1997-7#1)(2008-1#1)(2008-10#1)(2012-12#1)
for the differentiation and##2##4##(1990-9#1)(2008-10#1)
for the differentiation of##6##4##(2008-10#2)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#1)
for the differentiation##8##3##(1990-9#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#1)
for the diffraction of##2##4##(2008-2#1)(2009-5#1)
for the diffraction##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
for the diffuse##3##3##(2008-2#2)(2008-3#1)
for the diffusion of##2##4##(1993-11#2)
for the diffusion##5##3##(1993-11#2)(2008-10#1)(2008-3#2)
for the digestion of##4##4##(2008-10#2)(2008-4#1)(2010-8#1)
for the digestion##5##3##(2008-10#3)(2008-4#1)(2010-8#1)
for the dioxin##3##3##(2008-10#3)
for the direct analysis of##4##5##(1997-2#1)(2008-10#3)
for the direct and##2##4##(2008-10#2)
for the direct detection of##2##5##(2008-10#1)(2008-4#1)
for the direct detection##3##4##(2008-10#2)(2008-4#1)
for the direct determination of copper##2##6##(2008-10#2)
for the direct determination of the##2##6##(2008-10#2)
for the direct determination of##27##5##(2008-10#26)(2008-3#1)
for the direct##56##3##(1990-5#1)(1997-2#2)(2007-11#1)(2008-10#46)(2008-2#3)(2008-3#1)(2008-4#1)(2011-2#1)
for the disabled##4##3##(1992-12#1)(1992-3#1)(2008-8#1)(2009-6#1)
for the discovery and##2##4##(2007-2#1)(2010-11#1)
for the discovery of novel##2##5##(2008-9#1)(2011-2#1)
for the discovery of##9##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
for the discovery##12##3##(1997-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
for the discrete##2##3##(1995-3#1)(2008-3#1)
for the discrimination of##5##4##(2008-10#3)(2008-12#1)(2010-8#1)
for the discriminative##3##3##(1992-11#2)(1997-7#1)
for the disease##15##3##(1991-5#1)(1994-9#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
for the dispersion of the refractive index##2##7##(2008-2#2)
for the dissociation of##2##4##(1992-3#1)(1994-2#1)
for the dissociation##3##3##(1992-3#1)(1994-2#1)(2008-10#1)
for the dissolution of##3##4##(2008-10#3)
for the dissolution##4##3##(2008-10#4)
for the dissolved##2##3##(2008-10#1)(2008-7#1)
for the distinctiveness of##2##4##(1996-6#1)(2008-6#1)
for the distribution of##3##4##(2008-12#1)(2008-3#1)(2011-2#1)
for the distribution##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
for the diversity of##2##4##(1997-5#1)(2008-4#1)
for the diversity##3##3##(1997-2#1)(1997-5#1)(2008-4#1)
for the doctor##2##3##(1990-5#1)(1993-3#1)
for the domains##2##3##(2010-11#1)(2012-12#1)
for the donor##2##3##(2011-2#2)
for the dopamine##2##3##(1991-1#1)(1993-1#1)
for the dose-response##2##3##(1992-9#1)(2009-5#1)
for the double-edge Doppler analyzer##2##5##(2008-2#1)(2008-3#1)
for the downstream rivers##2##4##(2008-10#2)
for the drug accumulation and##2##5##(2008-10#2)
for the drug##11##3##(1993-12#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
for the drugs##2##3##(2008-10#1)(2011-2#1)
for the duration of the experiment##2##6##(2008-10#2)
for the duration of the##8##5##(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)
for the duration of##11##4##(1996-9#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)
for the duration##12##3##(1996-9#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-1#1)
for the dye##2##3##(2008-3#2)
for the dynamic##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
for the dynamics of##2##4##(1995-5#1)(2008-8#1)
for the dynamics##3##3##(1995-5#1)(2008-8#1)(2010-10#1)
for the ear##2##3##(2008-10#1)(2008-7#1)
for the early detection of breast cancer##2##7##(2009-7#1)(2010-9#1)
for the early detection of##7##5##(1990-10#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-9#1)
for the early stages of##4##5##(2008-4#2)(2010-8#2)
for the early##19##3##(1990-10#1)(1991-2#1)(1992-2#1)(1992-8#1)(1996-9#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2009-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)
for the easy construction of##2##5##(1990-5#1)(2013-8#1)
for the edge##3##3##(2008-2#1)(2008-3#1)(2009-7#1)
for the education##2##3##(1992-4#1)(2008-11#1)
for the effect of##10##4##(1996-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
for the effect on##2##4##(2008-11#1)(2009-2#1)
for the effect##12##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
for the effective##14##3##(1995-2#1)(2006-6#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-8#1)(2010-6#1)
for the effectiveness of##6##4##(1992-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
for the effects of##15##4##(1991-5#2)(1993-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2012-2#1)(2013-8#1)
for the efficacy and##2##4##(2008-10#1)(2013-1#1)
for the efficacy of##2##4##(2008-10#1)(2010-8#1)
for the efficacy##5##3##(1997-4#1)(2008-10#2)(2010-8#1)(2013-1#1)
for the efficiency of##3##4##(2008-12#1)(2012-12#1)(2013-7#1)
for the efficient and##2##4##(2011-2#1)(2013-1#1)
for the efficient##5##3##(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#1)
for the eight##3##3##(1993-6#1)(1997-3#1)(2009-10#1)
for the elaboration of##3##4##(1996-2#1)(2008-10#2)
for the elaboration##4##3##(1996-2#1)(2008-10#2)(2008-9#1)
for the elderly and##2##4##(1992-3#1)(2008-7#1)
for the elderly are discussed##2##5##(1994-12#1)(1995-2#1)
for the elderly are##3##4##(1994-1#1)(1994-12#1)(1995-2#1)
for the elderly in##3##4##(1991-2#1)(2011-1#2)
for the elderly##22##3##(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-1#1)(1994-12#3)(1995-2#1)(1995-3#1)(2008-11#1)(2008-7#2)(2011-1#2)
for the electrocatalytic##3##3##(2008-10#3)
for the electrochemical determination of sulphur-containing compounds##2##7##(2008-10#2)
for the electrochemical determination of##4##5##(2008-10#4)
for the electrochemical##6##3##(2008-10#6)
for the electrode##5##3##(2008-10#5)
for the electron##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
for the electrothermal atomic absorption##2##5##(2008-10#2)
for the elemental analysis##2##4##(2008-10#2)
for the elemental##3##3##(2008-10#3)
for the elements##4##3##(2008-10#4)
for the elevation of##2##4##(1995-6#1)(2009-1#1)
for the elicitation of##2##4##(2008-4#1)(2008-8#1)
for the elimination of distal periodontal pockets adjacent to edentulous areas##2##11##(2012-12#2)
for the elimination of##7##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#3)
for the elucidation of the##2##5##(2010-1#1)(2013-8#1)
for the elution of##2##4##(2008-10#2)
for the emergence of a##2##5##(1994-1#1)(2007-2#1)
for the emergence of##6##4##(1993-8#1)(1994-1#1)(2007-2#1)(2008-8#1)(2009-6#1)(2010-5#1)
for the empirical treatment##2##4##(1994-3#1)(2007-12#1)
for the empirical##4##3##(1994-3#1)(2007-12#1)(2008-2#1)(2010-1#1)
for the enantiomers of##2##4##(2008-10#2)
for the enantioselective##4##3##(2008-10#4)
for the encapsulation of##2##4##(2008-10#1)(2008-7#1)
for the end##2##3##(2008-10#2)
for the endodontic therapy##2##4##(2012-3#1)(2013-1#1)
for the energy##2##3##(2008-10#1)(2013-1#1)
for the enhanced ECL##2##4##(2008-10#2)
for the enhanced##5##3##(1992-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
for the enhancement of the##2##5##(2008-10#2)
for the enhancement of##6##4##(1996-2#1)(2008-10#3)(2008-9#1)(2012-6#1)
for the enhancement##9##3##(1990-6#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-9#1)(2012-6#1)
for the enhancer##2##3##(1991-11#1)(1991-5#1)
for the enlargement of##2##4##(2008-10#1)(2008-3#1)
for the enrichment of##4##4##(2008-10#4)
for the enrichment##5##3##(2008-10#5)
for the entire group##2##4##(1991-12#1)(1992-10#1)
for the entire##23##3##(1991-12#2)(1992-1#1)(1992-10#1)(1992-9#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
for the environmental monitoring of##2##5##(2008-10#1)(2013-8#1)
for the environmental##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-8#1)
for the enzymatic determination of cholesterol is reported##2##8##(2008-10#2)
for the enzymatic determination of##4##5##(2008-10#4)
for the enzymatic##7##3##(2008-10#4)(2008-6#1)(2008-7#1)(2009-2#1)
for the enzyme from##4##4##(1992-12#1)(1993-6#1)(1994-11#1)(1996-2#1)
for the enzyme##17##3##(1991-5#1)(1991-8#1)(1992-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-6#1)(2010-4#1)(2011-2#1)
for the enzyme-catalyzed##2##3##(1993-8#1)(2008-7#1)
for the epidemic in##2##4##(1992-5#1)(1996-11#1)
for the epidemiology##2##3##(2008-10#2)
for the eradication of##3##4##(2007-12#1)(2010-4#1)(2012-1#1)
for the error##3##3##(2008-2#1)(2008-3#2)
for the establishment of the##2##5##(1992-6#1)(2009-8#1)
for the establishment of viral latency##2##6##(2012-2#2)
for the establishment of##9##4##(1992-6#1)(1994-8#1)(2008-10#2)(2009-8#1)(2012-2#3)(2013-1#1)
for the establishment##10##3##(1992-6#1)(1994-8#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
for the estimated fringe##2##4##(2008-3#2)
for the estimated##4##3##(2008-10#1)(2008-3#3)
for the estimation of binding parameters##2##6##(2008-10#2)
for the estimation of ritodrine hydrochloride##2##6##(2008-10#2)
for the estimation of the##8##5##(2008-10#4)(2008-2#1)(2008-3#1)(2009-10#1)(2013-1#1)
for the estimation of##32##4##(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-3#1)(2010-5#2)(2013-1#1)(2013-7#1)
for the estrogen receptor##2##4##(2008-11#2)
for the ethical##2##3##(2008-1#1)(2008-10#1)
for the etiology of##4##4##(1991-9#1)(1995-12#1)(2008-12#1)(2008-2#1)
for the evaluation and##6##4##(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
for the evaluation of coronary artery##2##6##(2010-11#1)(2011-2#1)
for the evaluation of public##2##5##(2008-7#1)(2010-5#1)
for the evaluation of the effects of##2##7##(2008-10#1)(2013-1#1)
for the evaluation of the##14##5##(1994-5#1)(1997-3#1)(2008-10#6)(2008-2#2)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
for the evaluation of treatment effects##2##6##(2008-7#1)(2009-8#1)
for the evaluation of##69##4##(1990-11#2)(1990-12#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#9)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#1)
for the evaluation##77##3##(1990-11#2)(1990-12#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#19)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#1)
for the evidence##2##3##(2007-11#1)(2008-5#1)
for the evolution of sexual dimorphism##2##6##(2008-8#2)
for the evolution of the##4##5##(1996-5#1)(2007-11#1)(2010-7#2)
for the evolution of##25##4##(1995-5#1)(1996-5#1)(2007-11#2)(2008-10#2)(2008-8#8)(2008-9#3)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#3)(2012-1#1)(2013-8#1)
for the evolution##26##3##(1995-5#1)(1996-5#1)(2007-11#2)(2008-10#2)(2008-8#9)(2008-9#3)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#3)(2012-1#1)(2013-8#1)
for the exact##3##3##(1996-3#1)(2007-8#1)(2008-3#1)
for the examined##2##3##(2008-10#1)(2008-5#1)
for the excess##3##3##(1990-8#1)(1995-2#1)(1997-7#1)
for the exchange of##3##4##(2008-7#1)(2011-2#2)
for the exchange##5##3##(1997-7#1)(2008-7#1)(2010-8#1)(2011-2#2)
for the excitation##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
for the exclusion##2##3##(1993-2#1)(2012-2#1)
for the exclusive##2##3##(1993-6#1)(1996-5#1)
for the exercise##3##3##(1991-8#1)(2008-10#2)
for the existence of a##5##5##(1990-5#1)(1992-11#1)(1993-8#1)(1994-12#1)(2008-7#1)
for the existence of the##2##5##(1990-7#1)(2008-3#1)
for the existence of##25##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1991-8#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-6#1)(1997-7#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-3#1)(2012-3#1)
for the exogenous##2##3##(2008-7#2)
for the expansion of##2##4##(2008-11#1)(2008-4#1)
for the expectation##2##3##(1997-1#1)(2008-12#1)
for the expected##3##3##(1994-11#1)(2008-2#1)(2008-9#1)
for the experiment##2##3##(2008-3#1)(2008-4#1)
for the experimental group##2##4##(1991-12#1)(2008-12#1)
for the experimental##8##3##(1991-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
for the experiments##4##3##(2008-11#2)(2008-2#1)(2008-5#1)
for the exploration of##2##4##(2008-5#1)(2011-2#1)
for the exponential band model##2##5##(2008-3#2)
for the expression of both##2##5##(1993-12#1)(2008-10#1)
for the expression of recombinant##2##5##(2008-11#2)
for the expression of the##3##5##(1997-2#1)(1997-8#1)(2013-8#1)
for the expression of these##2##5##(1990-8#1)(2008-1#1)
for the expression of##28##4##(1990-5#1)(1990-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#3)(2009-3#1)(2010-3#1)(2011-1#1)(2013-8#2)
for the expression##31##3##(1990-5#1)(1990-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2013-8#2)
for the extinction##3##3##(2008-10#1)(2008-3#2)
for the extracellular##2##3##(1994-11#1)(2008-4#1)
for the extractable##2##3##(2008-10#2)
for the extraction and##6##4##(2008-10#6)
for the extraction of Hg##2##5##(2008-10#2)
for the extraction of a##2##5##(2008-10#2)
for the extraction of metals##2##5##(2008-10#1)(2011-2#1)
for the extraction of soluble and##2##6##(2008-10#1)(2011-2#1)
for the extraction of soluble##4##5##(2008-10#3)(2011-2#1)
for the extraction of the##2##5##(2008-10#2)
for the extraction of##33##4##(2008-10#26)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-1#1)
for the extraction##44##3##(2008-10#37)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-1#1)
for the extractive##4##3##(2008-10#3)(2011-2#1)
for the extreme##2##3##(2008-3#1)(2008-5#1)
for the fabrication of a multilevel##2##6##(2008-3#2)
for the fabrication of a##4##5##(2008-10#2)(2008-3#2)
for the fabrication of the##2##5##(2008-10#1)(2008-3#1)
for the fabrication of##13##4##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2009-11#1)(2010-2#1)
for the fabrication##14##3##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)(2009-11#1)(2010-2#1)
for the family##4##3##(1995-1#1)(1995-3#1)(2008-10#1)(2008-5#1)
for the far-field##2##3##(2008-3#2)
for the fast##6##3##(2008-10#3)(2008-3#2)(2011-2#1)
for the features of the##2##5##(2008-3#2)
for the female##2##3##(1993-2#1)(2008-10#1)
for the fetus##3##3##(1996-11#1)(2008-3#1)(2013-1#1)
for the fiber##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)
for the field##7##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-12#1)
for the filter##2##3##(2008-2#2)
for the final##7##3##(1992-5#2)(1996-5#1)(2008-10#1)(2008-3#2)(2012-3#1)
for the findings##2##3##(1996-2#1)(2009-2#1)
for the first 2 months##2##5##(2006-10#1)(2007-7#1)
for the first 2##4##4##(2006-10#1)(2007-7#1)(2010-4#1)(2013-1#1)
for the first 7 days##2##5##(2007-7#1)(2007-8#1)
for the first and second##3##5##(1997-2#1)(2008-10#2)
for the first and the second##2##6##(2008-10#2)
for the first and##6##4##(1997-2#1)(2008-10#5)
for the first derivative##2##4##(2008-10#1)(2008-2#1)
for the first dose##3##4##(2012-12#3)
for the first hyperpolarizability##2##4##(2007-12#2)
for the first of##3##4##(2011-1#1)(2012-12#2)
for the first time a##5##5##(2007-5#1)(2008-10#1)(2008-6#1)(2009-8#1)(2012-2#1)
for the first time and##2##5##(2008-10#1)(2008-11#1)
for the first time as##3##5##(2008-10#3)
for the first time at##3##5##(1990-4#1)(2007-11#1)(2008-10#1)
for the first time by##5##5##(1996-5#1)(2008-10#3)(2009-11#1)
for the first time for##2##5##(2010-4#1)(2010-9#1)
for the first time from the##4##6##(2007-11#1)(2010-3#1)(2013-1#2)
for the first time from##9##5##(1990-5#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-3#1)(2013-1#3)
for the first time in the##5##6##(1990-5#1)(2007-7#1)(2008-10#1)(2008-9#1)(2013-1#1)
for the first time in this##2##6##(2008-10#1)(2009-9#1)
for the first time in##27##5##(1990-12#1)(1990-5#1)(1991-2#1)(1993-2#1)(1994-11#2)(1995-12#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-1#2)
for the first time of##2##5##(2008-10#1)(2008-3#1)
for the first time on##5##5##(1996-3#1)(2008-12#1)(2008-5#2)(2009-2#1)
for the first time that the##6##6##(1995-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
for the first time that##20##5##(1992-12#1)(1992-8#1)(1995-6#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-9#3)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#1)
for the first time the##16##5##(1992-3#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
for the first time to directly##2##6##(1992-9#1)(2013-8#1)
for the first time to our knowledge in##2##8##(2007-11#1)(2008-3#1)
for the first time to our knowledge##37##7##(2007-11#8)(2007-12#9)(2008-2#6)(2008-3#14)
for the first time to the authors' knowledge##9##8##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
for the first time to the##11##6##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)
for the first time to##57##5##(1992-9#1)(1994-3#1)(2007-11#10)(2007-12#12)(2008-10#4)(2008-2#10)(2008-3#16)(2009-7#1)(2011-1#1)(2013-8#1)
for the first time used##2##5##(2008-10#2)
for the first time using##2##5##(2008-10#1)(2008-11#1)
for the first time were##2##5##(1993-12#1)(1994-3#1)
for the first time with the##2##6##(2008-11#1)(2008-6#1)
for the first time with##5##5##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
for the first time##311##4##(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#3)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-11#2)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-4#1)(2007-1#1)(2007-11#13)(2007-12#16)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#80)(2008-11#5)(2008-12#2)(2008-2#18)(2008-3#24)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#3)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#3)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#19)(2013-8#4)
for the first two##4##4##(1990-8#1)(1993-8#1)(2008-10#2)
for the first##377##3##(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#3)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#2)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#13)(2007-12#19)(2007-5#1)(2007-7#4)(2007-8#3)(2008-10#93)(2008-11#6)(2008-12#4)(2008-2#21)(2008-3#25)(2008-4#1)(2008-5#6)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2011-3#3)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#21)(2013-8#5)
for the five##8##3##(2008-10#7)(2008-2#1)
for the flame atomic absorption spectrometric##2##6##(2008-10#2)
for the flame atomic absorption##3##5##(2008-10#3)
for the flow injection##4##4##(2008-10#4)
for the flow of##2##4##(2008-10#1)(2010-8#1)
for the flow##9##3##(2008-10#7)(2008-9#1)(2010-8#1)
for the flow-injection determination of##2##5##(2008-10#2)
for the flow-injection##3##3##(2008-10#3)
for the fluorescence##5##3##(2007-12#1)(2008-10#3)(2013-8#1)
for the fluorimetric determination of##5##5##(2008-10#5)
for the fluorimetric##6##3##(2008-10#6)
for the fluorometric determination of##4##5##(2008-10#4)
for the fluoroquinolones##2##3##(2008-10#1)(2012-2#1)
for the focus of##2##4##(2008-5#1)(2009-6#1)
for the focusing of electromagnetic waves through a plane interface##2##10##(2008-3#2)
for the foetus##2##3##(1992-4#1)(2008-5#1)
for the folded##2##3##(1993-11#2)
for the folding##2##3##(1995-3#1)(2008-1#1)
for the follow-up of##2##4##(1997-4#1)(2011-2#1)
for the follow-up##3##3##(1997-4#1)(2007-7#1)(2011-2#1)
for the following three##2##4##(2008-1#1)(2008-9#1)
for the following##15##3##(1992-11#1)(1994-12#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#3)(2010-5#1)(2011-2#1)(2012-2#1)
for the forensic analysis of##2##5##(2008-10#2)
for the formation of a##4##5##(1991-5#1)(1992-5#1)(2007-11#1)(2008-10#1)
for the formation of an##2##5##(1994-5#1)(2008-3#1)
for the formation of the##11##5##(1990-5#1)(1993-2#1)(2008-10#5)(2008-2#1)(2008-5#3)
for the formation of##57##4##(1990-5#1)(1991-5#2)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#21)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-2#5)(2012-2#2)(2013-1#1)
for the formation##58##3##(1990-5#1)(1991-5#2)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#21)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#5)(2012-2#2)(2013-1#1)
for the former and##3##4##(1995-6#1)(2007-8#1)(2008-10#1)
for the former##7##3##(1995-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2012-1#1)
for the formulation of##7##4##(1993-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)
for the formulation##8##3##(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)
for the four analytes##2##4##(2008-10#2)
for the four##12##3##(1997-2#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-8#1)(2013-1#1)
for the fractionation of##4##4##(2008-10#4)
for the fractionation##5##3##(2008-10#4)(2008-2#1)
for the frail elderly##7##4##(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#3)
for the free energy##3##4##(1995-2#1)(2013-1#2)
for the free##4##3##(1995-2#1)(2008-6#1)(2013-1#2)
for the frequency of a low level of fitness##2##9##(2008-3#2)
for the frequency of##3##4##(2008-3#2)(2012-3#1)
for the frequency##7##3##(2007-11#2)(2008-2#1)(2008-3#2)(2009-5#1)(2012-3#1)
for the fruit##2##3##(1993-3#1)(2008-10#1)
for the full range of##2##5##(1997-4#1)(2008-7#1)
for the full##9##3##(1990-2#1)(1997-4#1)(2007-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-10#1)(2012-2#1)
for the function of##5##4##(1993-12#2)(1995-6#1)(2008-11#1)(2009-8#1)
for the functional##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
for the fundamental wavelength##2##4##(2007-11#1)(2007-12#1)
for the fundamental##8##3##(1991-3#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
for the fungal##2##3##(2008-10#1)(2009-8#1)
for the fungicide##2##3##(2008-10#2)
for the further development of##3##5##(2008-12#1)(2010-11#1)(2013-8#1)
for the further##9##3##(1994-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#2)
for the fusion##3##3##(1994-12#1)(2008-9#1)(2013-1#1)
for the future is to##2##5##(1993-11#1)(2008-10#1)
for the future is##3##4##(1993-11#1)(2008-10#1)(2008-7#1)
for the future of health care##2##6##(1991-3#1)(1996-3#1)
for the future of##10##4##(1991-3#1)(1995-12#2)(1996-3#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
for the future##64##3##(1990-10#1)(1990-3#1)(1990-9#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1995-12#3)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-7#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#2)
for the gas chromatographic (GC)##2##5##(2008-10#2)
for the gas chromatographic##3##4##(2008-10#3)
for the gene##9##3##(1995-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)
for the gene-for-gene relationship in the##2##6##(2008-10#2)
for the general case of##2##5##(2008-2#1)(2008-9#1)
for the general population##2##4##(1997-8#1)(2013-8#1)
for the general##13##3##(1990-2#1)(1994-3#1)(1996-11#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-7#1)(2011-2#1)(2013-8#1)
for the generation and##2##4##(2008-3#1)(2009-6#1)
for the generation of the##2##5##(2008-11#1)(2012-3#1)
for the generation of##29##4##(1990-5#1)(1993-8#1)(1997-1#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#2)(2009-3#1)(2009-5#1)(2012-3#1)(2012-4#1)
for the generation##31##3##(1990-5#1)(1993-8#1)(1997-1#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#6)(2008-4#2)(2009-3#1)(2009-5#1)(2009-6#1)(2012-3#1)(2012-4#1)
for the genes##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
for the genetic##10##3##(1990-11#1)(1997-4#1)(1997-5#1)(2008-7#1)(2008-9#3)(2010-2#1)(2012-2#1)(2013-1#1)
for the genus##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
for the given##4##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
for the global##4##3##(1991-6#1)(2007-12#1)(2008-7#1)(2010-8#1)
for the glutamate##2##3##(1996-5#1)(2008-7#1)
for the good##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
for the goodness of##2##4##(2008-10#1)(2013-8#1)
for the great##2##3##(2008-10#1)(2013-8#1)
for the greater##3##3##(1992-8#1)(2008-10#2)
for the greatest proportion of##2##5##(2007-12#1)(2008-2#1)
for the green##2##3##(2008-11#1)(2008-6#1)
for the group with##2##4##(1992-2#1)(1995-2#1)
for the group##11##3##(1992-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#4)
for the growth and differentiation of##2##6##(1991-6#1)(2008-5#1)
for the growth and##4##4##(1991-6#1)(1997-4#1)(2008-11#1)(2008-5#1)
for the growth of M##2##5##(2008-6#1)(2013-1#1)
for the growth of##10##4##(1990-5#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-8#1)(2013-1#2)(2013-8#1)
for the growth##17##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1997-4#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-8#1)(2013-1#2)(2013-8#1)
for the health care industry##5##5##(1993-12#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)
for the health care##11##4##(1991-1#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2010-4#1)
for the health of##3##4##(1996-3#1)(2008-9#2)
for the health sciences##2##4##(1994-12#1)(1994-3#1)
for the health##21##3##(1991-1#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-3#1)(2008-9#2)(2010-4#1)(2010-7#1)
for the healthy##3##3##(1993-5#1)(2007-8#1)(2013-7#1)
for the heart##3##3##(2010-7#1)(2010-8#1)(2012-1#1)
for the heat##2##3##(1990-8#1)(2008-2#1)
for the heaviest##2##3##(1992-10#1)(2008-10#1)
for the helix##2##3##(2008-2#1)(2010-7#1)
for the high quality##2##4##(2008-10#1)(2011-2#1)
for the high resistance to##2##5##(2007-10#1)(2008-10#1)
for the high susceptibility of##2##5##(2008-8#1)(2012-1#1)
for the high##14##3##(1995-11#2)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-2#1)(2012-1#1)
for the high-affinity##2##3##(1994-3#1)(1994-5#1)
for the higher##4##3##(1991-9#1)(2008-5#2)(2008-7#1)
for the higher-order##2##3##(2007-12#1)(2008-2#1)
for the highest##4##3##(1990-8#1)(2008-10#1)(2008-6#1)(2013-8#1)
for the highly conserved##2##4##(1992-2#1)(1997-3#1)
for the highly sensitive##2##4##(2008-10#2)
for the highly##8##3##(1992-2#1)(1997-3#1)(2008-10#5)(2012-2#1)
for the historical##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
for the holistic##2##3##(2008-1#1)(2013-1#1)
for the homologous##2##3##(1994-6#1)(2007-12#1)
for the hospital security##2##4##(1995-2#1)(1997-2#1)
for the hospital##7##3##(1992-1#1)(1995-2#1)(1997-2#2)(2007-10#1)(2013-8#2)
for the host##3##3##(2008-8#3)
for the human genome##3##4##(1995-8#1)(2008-4#1)(2008-7#1)
for the human##25##3##(1991-5#1)(1991-6#2)(1991-9#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-9#1)(2008-4#3)(2008-7#1)(2009-5#1)(2009-7#2)(2012-3#1)(2013-1#1)
for the hydride forming elements##2##5##(2008-10#2)
for the hydrogen##2##3##(1995-2#1)(2010-12#1)
for the hydrolysis and##2##4##(2008-10#2)
for the hydrolysis of the##3##5##(1991-8#1)(1994-5#2)
for the hydrolysis of##10##4##(1990-8#1)(1991-8#1)(1993-8#1)(1994-5#4)(2008-10#1)(2008-7#1)(2011-2#1)
for the hydrolysis##12##3##(1990-8#1)(1991-8#1)(1993-8#1)(1994-5#4)(2008-10#3)(2008-7#1)(2011-2#1)
for the hydrolytic##2##3##(1990-7#1)(2008-12#1)
for the hypothesis that##4##4##(1994-8#1)(2008-12#1)(2011-2#1)(2013-8#1)
for the hypothesis##7##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
for the hypothetical##2##3##(1993-12#1)(1994-5#1)
for the idea##2##3##(2008-11#1)(2011-2#1)
for the ideal##5##3##(1994-3#1)(1996-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
for the identification and determination of##2##6##(2008-10#2)
for the identification and determination##3##5##(2008-10#2)(2013-1#1)
for the identification and quantification of##2##6##(2008-10#2)
for the identification and##14##4##(2008-1#1)(2008-10#8)(2008-4#1)(2008-9#1)(2011-2#2)(2013-1#1)
for the identification of functional interfaces##2##6##(2008-7#2)
for the identification of macrokinetic models##2##6##(2008-7#2)
for the identification of novel##2##5##(2008-10#1)(2013-1#1)
for the identification of proteins##2##5##(1997-2#1)(2008-1#1)
for the identification of the##5##5##(2008-10#4)(2011-2#1)
for the identification of##48##4##(1990-3#1)(1997-2#2)(2007-10#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
for the identification##66##3##(1990-3#1)(1997-2#2)(2007-10#1)(2008-1#2)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#5)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#3)(2013-8#1)
for the imaging of##4##4##(2008-2#2)(2008-8#1)(2012-2#1)
for the immature and mature seed oils##2##7##(2008-11#2)
for the immature##3##3##(2008-11#2)(2008-6#1)
for the immobilisation##2##3##(2008-10#2)
for the immobilization of the##2##5##(2008-10#1)(2010-5#1)
for the immobilization of##10##4##(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)
for the immobilization##11##3##(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)
for the immobilized##2##3##(2008-7#1)(2009-10#1)
for the immunosuppressive##3##3##(1991-9#1)(1993-8#1)(2011-2#1)
for the impact of##4##4##(1995-12#1)(2007-8#1)(2008-11#1)(2009-12#1)
for the implantation of##2##4##(2010-6#1)(2012-12#1)
for the implementation of##13##4##(1991-12#1)(1994-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
for the importance of##2##4##(2008-9#1)(2010-3#1)
for the improved##2##3##(2008-10#1)(2013-1#1)
for the improvement of##3##4##(1992-1#1)(2008-11#1)(2011-1#1)
for the improvement##6##3##(1992-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-1#1)
for the in situ##7##4##(1993-6#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
for the in vitro study of##2##6##(2008-11#1)(2008-4#1)
for the in vitro##8##4##(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)
for the in vivo##6##4##(1991-9#1)(1992-3#1)(2008-10#1)(2008-4#1)(2008-5#2)
for the in##22##3##(1991-9#1)(1992-3#1)(1993-6#1)(2006-4#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)
for the in-line##3##3##(2008-10#2)(2008-2#1)
for the in-row rotary cultivator##2##5##(2008-10#2)
for the in-vitro##2##3##(1990-12#1)(2008-9#1)
for the inactivation of##4##4##(1993-8#1)(1995-5#1)(2009-8#1)(2012-2#1)
for the incidence of##4##4##(2008-10#4)
for the incidence rate##2##4##(2008-11#1)(2008-12#1)
for the incidence##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
for the inclusion##2##3##(2008-10#1)(2008-5#1)
for the incoming##2##3##(2008-10#1)(2010-7#1)
for the increase in##5##4##(1990-5#1)(2008-12#2)(2008-4#1)(2008-5#1)
for the increase of##2##4##(2008-3#1)(2008-4#1)
for the increase##10##3##(1990-5#1)(1994-6#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)
for the increased##11##3##(1990-5#1)(1990-8#1)(1991-11#1)(1994-6#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)
for the increasing##2##3##(1997-2#1)(2010-12#1)
for the independent calibration of Raman backscatter water-vapor lidar systems##2##10##(2008-3#2)
for the independent##3##3##(2008-3#2)(2010-5#1)
for the indigent##2##3##(2008-11#1)(2010-2#1)
for the indirect determination of##3##5##(2008-10#3)
for the indirect##5##3##(2008-10#5)
for the individual patient##2##4##(2009-9#1)(2013-8#1)
for the individual##15##3##(1992-12#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
for the induced##2##3##(2007-12#1)(2008-5#1)
for the induction of##16##4##(1991-12#1)(1991-9#2)(1992-10#1)(1993-9#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-11#1)(2011-2#1)
for the induction##17##3##(1991-12#1)(1991-9#2)(1992-10#1)(1993-9#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
for the infant##3##3##(1994-3#1)(2009-9#1)(2012-2#1)
for the infection of##2##4##(2008-4#2)
for the infection##4##3##(2008-10#1)(2008-4#2)(2013-1#1)
for the influence of##4##4##(1993-2#1)(1997-4#1)(2008-10#1)(2011-2#1)
for the information##7##3##(1994-1#2)(1996-3#1)(2007-4#1)(2008-1#1)(2008-3#2)
for the infrared##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
for the inhibition of protein phosphatase##2##6##(1995-8#2)
for the inhibition of##14##4##(1991-2#1)(1992-3#1)(1995-11#1)(1995-3#2)(1995-8#3)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2012-3#1)
for the inhibition##15##3##(1991-2#1)(1992-3#1)(1993-8#1)(1995-11#1)(1995-3#2)(1995-8#3)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2012-3#1)
for the initial attachment of##2##5##(1992-12#1)(1994-9#1)
for the initial##10##3##(1991-7#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-11#2)
for the initiation and##3##4##(1993-12#1)(2008-8#1)(2009-5#1)
for the initiation of##5##4##(1990-5#1)(1994-11#1)(2008-10#1)(2008-7#1)(2009-8#1)
for the initiation##9##3##(1990-5#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)
for the inorganic species##2##4##(2008-10#2)
for the inorganic##5##3##(2008-10#4)(2008-7#1)
for the input##4##3##(2008-2#2)(2008-3#1)(2008-6#1)
for the insertion of##2##4##(1991-6#1)(1993-10#1)
for the institution of##2##4##(1997-2#1)(2011-2#1)
for the institution##3##3##(1993-1#1)(1997-2#1)(2011-2#1)
for the instrument##2##3##(2008-10#1)(2008-3#1)
for the insulin##3##3##(1995-11#1)(1996-5#1)(2010-11#1)
for the integral##2##3##(2008-3#1)(2012-12#1)
for the integrated intensity##2##4##(2008-3#2)
for the integration of chemical and##2##6##(2008-10#2)
for the integration of##7##4##(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
for the integrity of##2##4##(2009-7#1)(2012-2#1)
for the intensity distribution##2##4##(2008-10#1)(2008-3#1)
for the intensity of##2##4##(2007-11#1)(2010-11#1)
for the intensity##6##3##(2007-11#1)(2008-10#1)(2008-3#3)(2010-11#1)
for the interaction of##13##4##(1990-8#2)(1991-1#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-2#1)(2008-10#5)
for the interaction##17##3##(1990-8#2)(1991-1#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-2#1)(2008-10#7)(2011-2#2)
for the interactions##3##3##(1995-6#1)(2008-10#1)(2013-8#1)
for the internal##3##3##(1996-5#1)(1997-7#1)(2008-10#1)
for the international##2##3##(1994-8#1)(2008-10#1)
for the interpretation of##7##4##(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2013-1#2)
for the interpretation##8##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2013-1#2)
for the intervention##2##3##(2011-9#1)(2012-12#1)
for the interventions##2##3##(2009-7#1)(2013-1#1)
for the intracavity##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
for the intraoperative##2##3##(2011-2#1)(2013-1#1)
for the introduction of##9##4##(1990-12#1)(1993-9#3)(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)
for the introduction##10##3##(1990-12#1)(1990-3#1)(1993-9#3)(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)
for the invasion and##2##4##(1990-11#1)(2008-10#1)
for the invasion##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
for the investigated compounds##2##4##(2008-10#2)
for the investigation of sex##2##5##(2008-10#2)
for the investigation of the##5##5##(1991-5#1)(2008-10#2)(2008-4#1)(2010-12#1)
for the investigation of##17##4##(1991-5#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)
for the investigation##21##3##(1991-3#1)(1991-5#1)(1997-6#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2012-2#1)
for the involvement of G proteins in##2##7##(1991-9#1)(1993-3#1)
for the involvement of##11##4##(1990-11#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
for the ion exchange resin##2##5##(2008-10#2)
for the ion##4##3##(2008-10#4)
for the iron##2##3##(2008-10#1)(2009-6#1)
for the isolated##4##3##(1992-6#1)(1993-8#1)(1996-2#1)(2007-8#1)
for the isolates##2##3##(2008-10#1)(2008-5#1)
for the isolation and##6##4##(1991-8#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
for the isolation of nuclei##2##5##(2008-1#1)(2008-4#1)
for the isolation of the##2##5##(1996-5#1)(2008-2#1)
for the isolation of##18##4##(1991-8#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#2)
for the isolation##25##3##(1991-8#2)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-12#1)(2010-3#1)(2011-1#3)
for the isoproteins##2##3##(1991-8#2)
for the job##2##3##(1990-2#1)(2010-3#1)
for the kappa##2##3##(1991-1#1)(1995-2#1)
for the key##3##3##(2008-11#1)(2013-1#2)
for the kinetic determination of##2##5##(2008-10#2)
for the kinetic##3##3##(1991-9#1)(2008-10#2)
for the knowledge##3##3##(2008-10#2)(2012-3#1)
for the known##3##3##(1990-11#1)(2008-8#1)(2013-8#1)
for the laboratory##2##3##(1993-1#1)(2008-9#1)
for the lack of##7##4##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
for the lactose carrier of Citrobacter freundii##2##7##(1994-9#2)
for the large scale production##2##5##(2008-11#2)
for the large scale##3##4##(2008-11#3)
for the large##7##3##(1990-3#1)(1990-9#1)(2008-10#1)(2008-11#3)(2008-3#1)
for the large-scale production of##2##5##(1997-4#1)(2008-11#1)
for the large-scale##3##3##(1995-6#1)(1997-4#1)(2008-11#1)
for the largest##8##3##(1997-6#1)(1997-7#1)(2008-10#3)(2009-4#1)(2010-8#1)(2013-1#1)
for the last 15 years##2##5##(1991-11#1)(2010-3#1)
for the last 15##3##4##(1991-11#1)(2010-3#1)(2012-2#1)
for the last ten years##3##5##(1991-9#1)(1996-11#1)(2007-11#1)
for the last two##2##4##(1990-8#1)(2010-2#1)
for the last##22##3##(1990-8#1)(1991-11#1)(1991-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2012-2#2)
for the later##3##3##(2007-8#1)(2008-6#1)(2013-8#1)
for the lateral##2##3##(2007-11#1)(2007-8#1)
for the latter group##2##4##(1991-12#1)(2008-5#1)
for the latter##15##3##(1991-12#1)(1991-6#2)(1995-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)
for the lead##3##3##(1995-12#1)(2008-10#1)(2012-2#1)
for the lecture##2##3##(1994-9#2)
for the left##2##3##(2009-12#1)(2010-7#1)
for the less##3##3##(1997-2#1)(2008-11#2)
for the level of##3##4##(1995-8#2)(2008-10#1)
for the lidar##2##3##(2008-2#1)(2008-3#1)
for the light##2##3##(2008-3#2)
for the limited##3##3##(1995-12#1)(2008-10#2)
for the limiting case##2##4##(2008-3#2)
for the limiting##4##3##(2008-3#4)
for the line strength##2##4##(2008-3#2)
for the line##4##3##(2008-3#3)(2009-12#1)
for the linear##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
for the lipid##2##3##(1990-7#1)(2008-4#1)
for the liquid##2##3##(2008-10#1)(2008-3#1)
for the liquid-liquid extraction##2##4##(2008-10#2)
for the local and##2##4##(2010-7#1)(2011-2#1)
for the local##8##3##(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
for the localization of##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-7#1)
for the localization##6##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-9#1)
for the location of the##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
for the location of##5##4##(2007-11#2)(2008-11#1)(2008-3#1)(2008-8#1)
for the logistic##2##3##(1991-12#1)(2007-8#1)
for the long##3##3##(2008-5#1)(2008-7#1)(2013-7#1)
for the long-term treatment##2##4##(1990-2#1)(2013-1#1)
for the long-term##11##3##(1990-2#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-5#1)(2010-2#1)(2013-1#1)
for the loss of##6##4##(1993-6#1)(1994-8#1)(1995-5#1)(1997-7#1)(2008-3#1)(2009-12#1)
for the loss##7##3##(1993-6#1)(1994-8#1)(1995-5#1)(1997-7#1)(2008-3#2)(2009-12#1)
for the low##9##3##(1991-9#1)(1993-3#1)(1994-7#1)(1994-9#1)(1996-12#1)(1997-7#1)(2008-7#1)(2011-2#1)(2013-1#1)
for the lower##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
for the lumbar##4##3##(2008-12#1)(2010-3#2)(2012-2#1)
for the lung##4##3##(1996-3#1)(2008-8#1)(2010-7#1)(2012-2#1)
for the magnetic resonance##2##4##(2008-3#1)(2010-8#1)
for the magnitude of##2##4##(1993-12#1)(2008-3#1)
for the main##6##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2013-1#1)
for the maintenance of the##4##5##(1996-12#1)(2008-10#1)(2008-6#1)(2012-1#1)
for the maintenance of##15##4##(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2012-1#1)
for the maintenance##18##3##(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
for the major part of the##2##6##(1997-8#1)(2013-1#1)
for the major##11##3##(1990-12#1)(1994-5#1)(1995-1#1)(1995-9#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#2)
for the majority of patients with##2##6##(1996-2#1)(2008-6#1)
for the majority of the##2##5##(1992-11#1)(2010-3#1)
for the majority of##25##4##(1991-1#1)(1992-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
for the majority##26##3##(1991-1#1)(1992-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
for the managed care##2##4##(1996-3#1)(1997-3#1)
for the management of ACS##2##5##(2008-3#2)
for the management of acute##4##5##(2008-3#2)(2008-4#1)(2008-7#1)
for the management of asthma##2##5##(2010-5#2)
for the management of bone##2##5##(2008-7#2)
for the management of cervical##2##5##(2007-8#1)(2008-7#1)
for the management of chronic##3##5##(1997-1#1)(2009-12#1)(2013-1#1)
for the management of metastatic##2##5##(2008-10#1)(2012-2#1)
for the management of patients with##4##6##(2007-7#1)(2008-12#1)(2008-3#2)
for the management of sorghum##2##5##(2008-10#2)
for the management of the disease##2##6##(2008-10#2)
for the management of the##6##5##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-7#1)
for the management of this disease##2##6##(1991-2#1)(2011-2#1)
for the management of this##4##5##(1991-2#1)(2010-12#1)(2010-4#1)(2011-2#1)
for the management of##92##4##(1991-1#1)(1991-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1997-1#1)(1997-8#1)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-6#2)(2008-7#11)(2008-9#4)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
for the management##94##3##(1991-1#1)(1991-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1997-1#1)(1997-8#1)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-6#2)(2008-7#11)(2008-9#4)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
for the manganese##2##3##(2008-10#2)
for the manifestation of##2##4##(2007-5#1)(2008-11#1)
for the manipulation of##4##4##(2008-11#2)(2009-8#1)(2011-2#1)
for the manipulation##5##3##(1995-5#1)(2008-11#2)(2009-8#1)(2011-2#1)
for the manufacture of##3##4##(2008-5#1)(2008-6#1)(2011-1#1)
for the manufacturing of##2##4##(2008-11#2)
for the many##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
for the marginal##2##3##(1997-3#1)(2008-7#1)
for the marine##2##3##(2007-5#1)(2008-11#1)
for the market##2##3##(1996-1#1)(2012-2#1)
for the mass##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
for the material##2##3##(2008-10#1)(2013-1#1)
for the mature##4##3##(1991-6#1)(1995-8#2)(2009-7#1)
for the maximal##2##3##(2008-7#2)
for the maximum##9##3##(1997-3#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)
for the mean##8##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-8#1)
for the measurement of NO##2##5##(2008-10#1)(2008-7#1)
for the measurement of human##2##5##(1992-11#1)(2008-4#1)
for the measurement of in-plane##2##5##(2007-11#1)(2008-3#1)
for the measurement of optical##2##5##(2008-10#1)(2008-3#1)
for the measurement of small rotation angles##2##7##(2008-3#2)
for the measurement of small##3##5##(2008-2#1)(2008-3#2)
for the measurement of the##6##5##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)
for the measurement of##69##4##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(2007-11#4)(2008-10#20)(2008-11#3)(2008-2#6)(2008-3#13)(2008-4#6)(2008-5#2)(2008-7#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-12#3)
for the measurement##77##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(2007-11#5)(2008-10#26)(2008-11#3)(2008-2#7)(2008-3#13)(2008-4#6)(2008-5#2)(2008-7#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-12#3)
for the measurements##5##3##(2008-1#1)(2008-3#4)
for the mechanical##2##3##(2007-8#1)(2008-7#1)
for the mechanics of embryonic epithelia##2##6##(2008-7#2)
for the mechanics of##3##4##(2007-12#1)(2008-7#2)
for the mechanism of##3##4##(1994-8#1)(1996-12#1)(2012-12#1)
for the medial##2##3##(1994-3#1)(1996-5#1)
for the medical##8##3##(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(2009-11#1)(2010-8#1)(2012-2#1)
for the medium-scale distribution##2##4##(2008-10#2)
for the membrane##8##3##(1994-5#1)(1997-1#1)(1997-7#1)(2008-10#3)(2009-8#1)(2012-2#1)
for the mental##2##3##(1993-12#1)(2008-11#1)
for the mentally retarded##4##4##(1991-1#2)(1997-8#2)
for the mentally##5##3##(1991-1#2)(1992-1#1)(1997-8#2)
for the metabolic syndrome##2##4##(2008-3#2)
for the metabolic##5##3##(2008-11#1)(2008-3#3)(2008-8#1)
for the metabolism of##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
for the metabolism##4##3##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
for the metal ions##3##4##(2008-10#3)
for the metal##7##3##(2008-10#6)(2010-11#1)
for the metals##2##3##(2008-10#2)
for the method##3##3##(1992-6#1)(2008-10#1)(2009-3#1)
for the methodology##2##3##(2008-10#2)
for the methyltransferase##2##3##(1993-9#1)(1994-12#1)
for the micro determination of##2##5##(2008-10#2)
for the microsatellites containing##2##4##(2008-10#2)
for the microwave##2##3##(2008-10#1)(2008-2#1)
for the mid-infrared region##2##4##(2008-2#1)(2008-3#1)
for the mid-infrared##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
for the migration time and##2##5##(1996-5#1)(2008-10#1)
for the minimum number of##3##5##(1992-9#1)(2008-7#1)(2008-8#1)
for the minimum##5##3##(1992-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
for the missing##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
for the mitochondrial##3##3##(1991-11#1)(1991-5#1)(1992-10#1)
for the mixture of##2##4##(2008-10#1)(2008-3#1)
for the mode##2##3##(2007-11#1)(2007-6#1)
for the model parameters##2##4##(2008-3#1)(2008-7#1)
for the model##9##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2011-2#1)(2012-1#1)(2012-12#1)
for the modeling of##2##4##(2008-3#1)(2009-10#1)
for the modification of##6##4##(1993-11#1)(1996-5#1)(2008-10#4)
for the modification##7##3##(1993-11#1)(1996-5#1)(2008-10#5)
for the modified##2##3##(1995-2#1)(2008-10#1)
for the modular##2##3##(2008-9#1)(2009-5#1)
for the modulation of##2##4##(2008-7#1)(2009-3#1)
for the modulation##3##3##(2008-3#1)(2008-7#1)(2009-3#1)
for the molecular diagnosis of##2##5##(1997-4#1)(2013-8#1)
for the molecular##7##3##(1991-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2012-2#2)(2013-8#1)
for the monitoring of the##4##5##(1992-5#1)(2008-10#2)(2013-8#1)
for the monitoring of##13##4##(1991-5#1)(1992-5#1)(2008-10#8)(2008-11#1)(2012-2#1)(2013-8#1)
for the monitoring##16##3##(1991-5#1)(1992-5#1)(2008-10#9)(2008-11#2)(2011-1#1)(2012-2#1)(2013-8#1)
for the more##9##3##(1991-3#1)(1992-6#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-8#1)
for the most accurate determination of##2##6##(2008-3#2)
for the most accurate##3##4##(2008-3#3)
for the most common##2##4##(1990-8#1)(2008-2#1)
for the most commonly used##2##5##(1994-12#1)(2008-4#1)
for the most part in##2##5##(1991-3#1)(1997-8#1)
for the most part the##2##5##(1991-3#1)(2010-4#1)
for the most part##18##4##(1990-6#1)(1991-1#1)(1991-3#2)(1992-1#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)
for the most##39##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-3#2)(1992-1#1)(1992-6#1)(1994-12#2)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-4#2)(2011-2#1)
for the mother##3##3##(1990-10#1)(1992-10#1)(2008-2#1)
for the mouse##3##3##(1991-9#1)(1995-8#1)(2008-4#1)
for the multi-element determination##2##4##(2008-10#2)
for the multi-element##3##3##(2008-10#3)
for the multilayer##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for the multiple##2##3##(1996-3#1)(2008-2#1)
for the murine##5##3##(1990-5#1)(1993-2#1)(1994-11#1)(1995-2#1)(2008-9#1)
for the mutant##6##3##(1990-12#2)(1991-5#1)(1994-8#1)(1995-6#1)(1996-2#1)
for the mutation##3##3##(1996-5#2)(2008-12#1)
for the mycelial growth assays and##2##6##(2008-10#2)
for the national##3##3##(1992-11#1)(1994-1#1)(2008-3#1)
for the native protein##2##4##(1994-11#1)(2008-10#1)
for the native##6##3##(1990-8#1)(1994-11#2)(1994-8#1)(2008-10#1)(2009-8#1)
for the natural##4##3##(1995-2#1)(2008-11#1)(2008-5#1)(2010-2#1)
for the nature of the##3##5##(1990-3#1)(1991-5#1)(1997-8#1)
for the nature of##4##4##(1990-3#1)(1991-5#1)(1997-8#1)(2012-1#1)
for the nature##5##3##(1990-3#1)(1991-5#1)(1997-8#1)(2010-5#1)(2012-1#1)
for the near future##2##4##(2007-2#1)(2010-4#1)
for the near##3##3##(2007-11#1)(2007-2#1)(2010-4#1)
for the nebulizers FISO Neb##2##5##(1993-2#2)
for the need##2##3##(2008-1#1)(2008-7#1)
for the needs of##2##4##(2007-11#1)(2008-5#1)
for the needs##3##3##(2007-11#1)(2008-5#1)(2011-1#1)
for the neuroprotective effect##2##4##(1994-11#1)(2009-12#1)
for the neurotransmitter##2##3##(1993-8#1)(1996-5#1)
for the new technique##2##4##(2008-3#2)
for the new##13##3##(1991-9#1)(1992-2#1)(2008-10#5)(2008-2#1)(2008-3#2)(2009-11#1)(2010-12#1)(2011-2#1)
for the next 10##2##4##(1994-11#1)(1997-3#1)
for the next decade##3##4##(1994-3#1)(1997-1#1)(2011-1#1)
for the next few years##2##5##(2010-5#1)(2011-1#1)
for the next four##2##4##(2008-5#1)(2011-2#1)
for the next generation of##4##5##(2008-11#2)(2012-2#1)(2013-1#1)
for the next generation##5##4##(1992-3#1)(2008-11#2)(2012-2#1)(2013-1#1)
for the next##29##3##(1991-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
for the nitrate##2##3##(2008-10#2)
for the nitrite##3##3##(2008-10#3)
for the noninvasive##3##3##(2008-2#1)(2010-9#1)(2012-2#1)
for the nonlinear##4##3##(2007-11#2)(2007-12#2)
for the normal allele##2##4##(1994-11#2)
for the normal##12##3##(1991-5#1)(1994-11#2)(1994-8#2)(2007-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
for the normalized##3##3##(2008-2#1)(2008-3#2)
for the nos promoter##2##4##(1997-2#2)
for the novice##2##3##(1991-1#1)(2008-11#1)
for the nuclear##6##3##(1992-11#1)(1993-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)
for the number of##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
for the numerical analysis of##2##5##(2007-12#2)
for the numerical##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
for the nurse##2##3##(1994-3#1)(2013-8#1)
for the objective##2##3##(2008-10#2)
for the observation of##2##4##(2008-10#1)(2008-3#1)
for the observation##5##3##(1992-5#1)(2008-10#2)(2008-3#2)
for the observed behavior##2##4##(2008-3#1)(2010-6#1)
for the observed effect##2##4##(1992-2#1)(2008-3#1)
for the observed##24##3##(1990-5#1)(1991-12#1)(1992-10#1)(1992-2#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2009-8#2)(2010-6#1)(2011-2#1)(2013-1#1)
for the occurrence of two##2##5##(1992-6#1)(2008-8#1)
for the occurrence of##14##4##(1992-1#1)(1992-6#1)(1993-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#3)(2011-2#1)(2013-8#1)
for the older##2##3##(2010-10#2)
for the oldest##4##3##(1994-5#1)(1996-2#1)(2012-3#2)
for the on##2##3##(2008-10#2)
for the on-line determination of palladium(II) and platinum(IV)##2##8##(2008-10#2)
for the on-line determination of##8##5##(2008-10#8)
for the on-line preconcentration of##3##5##(2008-10#3)
for the on-line##21##3##(2008-10#21)
for the onset and##2##4##(2007-11#1)(2008-7#1)
for the onset of##5##4##(1991-5#1)(2008-11#1)(2008-3#1)(2010-6#1)(2010-7#1)
for the onset##9##3##(1991-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-6#1)(2010-7#1)
for the operating##2##3##(1992-12#1)(2011-1#1)
for the operation of the##2##5##(2008-2#1)(2008-3#1)
for the operation of##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
for the operation##4##3##(1994-3#1)(2008-2#1)(2008-3#1)(2008-4#1)
for the operative treatment of##3##5##(1992-2#2)(2013-1#1)
for the optical constants##2##4##(2008-2#1)(2008-3#1)
for the optical properties##3##4##(2008-2#2)(2008-3#1)
for the optical##20##3##(2007-11#1)(2008-2#8)(2008-3#10)(2010-7#1)
for the optimal##5##3##(1997-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
for the optimisation of the##2##5##(2008-10#2)
for the optimisation of##3##4##(2008-10#3)
for the optimization of the##3##5##(1997-2#1)(2008-10#2)
for the optimization of##17##4##(1997-2#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)
for the optimization##18##3##(1997-2#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)
for the optimum##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
for the oral delivery of##2##5##(2008-5#1)(2008-8#1)
for the oral##3##3##(1994-2#1)(2008-5#1)(2008-8#1)
for the organism##4##3##(1991-6#1)(2008-7#1)(2010-2#2)
for the organization and##2##4##(1993-12#1)(2008-12#1)
for the organization##6##3##(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(2008-12#1)(2008-9#1)
for the origin of the##3##5##(2008-12#1)(2008-2#1)(2010-12#1)
for the origin of##9##4##(1995-11#1)(1996-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-6#1)(2010-12#1)
for the original data##2##4##(2008-10#2)
for the original##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
for the other two##3##4##(1993-2#1)(2008-10#2)
for the other##40##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-11#1)(1997-3#1)(2007-11#1)(2007-6#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#2)
for the outcomes##3##3##(1992-12#1)(1997-1#1)(2013-1#1)
for the outer##2##3##(1996-5#1)(2009-2#1)
for the overall##10##3##(1995-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2013-1#1)
for the overexpression of##3##4##(1991-2#1)(2008-11#2)
for the overexpression##4##3##(1991-2#1)(2008-11#2)(2011-2#1)
for the oxidation of NADH##4##5##(2008-10#3)(2008-6#1)
for the oxidation of luminol with hydrogen peroxide catalyzed by microperoxidase 8##2##12##(2008-10#2)
for the oxidation of##20##4##(1993-9#1)(2007-11#2)(2008-10#14)(2008-11#1)(2008-6#1)(2009-5#1)
for the oxidation##22##3##(1993-9#1)(2007-11#2)(2008-10#15)(2008-11#1)(2008-6#1)(2009-5#1)(2009-6#1)
for the oxidative##4##3##(1990-5#1)(2007-11#1)(2008-10#2)
for the oxidized##2##3##(2008-10#2)
for the pH##2##3##(2011-2#2)
for the paediatric##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
for the parameters of##2##4##(1994-9#1)(2007-12#1)
for the parameters##5##3##(1994-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
for the parametric##2##3##(2009-10#1)(2010-5#1)
for the parasites##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
for the participants##2##3##(2008-10#1)(2009-10#1)
for the particles##2##3##(2008-3#2)
for the particular##7##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-3#1)
for the past 2##2##4##(2011-1#1)(2013-8#1)
for the past five years##2##5##(1995-5#1)(2007-9#1)
for the past two##2##4##(2007-2#1)(2013-1#1)
for the past##16##3##(1991-12#1)(1995-5#1)(1997-5#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#2)(2012-3#2)(2013-1#1)(2013-8#1)
for the pathogen and##2##4##(2008-10#2)
for the pathogen##4##3##(2008-10#4)
for the pathogenesis of##5##4##(1992-2#1)(2008-6#1)(2010-4#1)(2013-1#1)(2013-8#1)
for the pathogenesis##6##3##(1990-11#1)(1992-2#1)(2008-6#1)(2010-4#1)(2013-1#1)(2013-8#1)
for the patient and##5##4##(1992-2#1)(1992-3#1)(2007-12#1)(2008-1#2)
for the patient in##2##4##(2008-11#1)(2008-12#1)
for the patient with##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
for the patient##26##3##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
for the patient's symptoms##2##4##(2008-9#1)(2010-1#1)
for the patient's##4##3##(1994-11#1)(2007-8#1)(2008-9#1)(2010-1#1)
for the patient?]##2##3##(1991-11#1)(1993-3#1)
for the patients and##2##4##(1991-9#1)(2008-7#1)
for the patients in##3##4##(1993-11#1)(2007-11#1)(2008-10#1)
for the patients of##2##4##(2011-1#2)
for the patients who##2##4##(1995-3#1)(1997-4#1)
for the patients with##4##4##(2006-10#1)(2008-11#1)(2011-3#1)(2013-1#1)
for the patients##22##3##(1991-2#1)(1991-9#1)(1993-11#1)(1995-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-1#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#1)
for the peak height##2##4##(1996-5#1)(2008-10#1)
for the peak##5##3##(1996-5#1)(2008-10#4)
for the people##2##3##(1992-12#1)(1996-5#1)
for the peptide##3##3##(1991-12#1)(1992-11#1)(2008-10#1)
for the perchlorate system##2##4##(2008-10#2)
for the perchlorate##3##3##(2008-10#3)
for the percutaneous##2##3##(2008-9#1)(2010-5#1)
for the performance of##7##4##(1992-1#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-9#1)
for the performance##8##3##(1992-1#1)(1994-12#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-9#1)
for the period between growth stages##2##6##(2008-10#2)
for the period between##3##4##(2008-10#2)(2008-9#1)
for the period extending from 2001 to 2004##2##8##(2008-10#2)
for the period from##5##4##(2007-2#1)(2008-2#2)(2008-3#1)(2008-8#1)
for the period of 20 years##2##6##(2008-7#2)
for the period of##5##4##(2008-7#2)(2009-11#1)(2012-3#1)(2013-1#1)
for the period##31##3##(1990-2#1)(1990-6#1)(1991-2#1)(1992-1#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#1)(1997-4#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
for the persistence of##2##4##(2008-8#1)(2011-3#1)
for the pharmaceutical##2##3##(2008-10#1)(2012-2#1)
for the pharmacokinetic study##2##4##(2008-10#1)(2008-5#1)
for the pharmacological management of##2##5##(2008-3#1)(2008-7#1)
for the pharmacological##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
for the phase of the##2##5##(2008-3#2)
for the phase##9##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2010-12#2)
for the phenotypic##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
for the photorefractive##2##3##(2007-11#1)(2007-12#1)
for the phylogenetic##2##3##(2007-12#1)(2010-8#1)
for the physical##3##3##(2007-4#1)(2008-12#1)(2008-7#1)
for the physician##4##3##(1992-4#1)(1994-2#1)(1997-7#1)(2013-8#1)
for the physiological electron##2##4##(1992-6#1)(1995-2#1)
for the physiological##4##3##(1992-6#1)(1995-2#1)(2008-11#1)(2011-1#1)
for the picrate##3##3##(2008-10#3)
for the placement of##3##4##(2008-1#1)(2008-2#1)(2012-12#1)
for the placement##4##3##(2008-1#1)(2008-12#1)(2008-2#1)(2012-12#1)
for the planning##2##3##(1993-6#1)(2008-4#1)
for the plant##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
for the plastic##2##3##(2008-7#1)(2012-2#1)
for the point##2##3##(2008-10#1)(2008-2#1)
for the polarization##2##3##(2007-12#1)(2008-3#1)
for the polarized##3##3##(2008-2#2)(2008-3#1)
for the polymer##2##3##(2008-10#2)
for the polymeric##2##3##(2008-10#2)
for the pooled##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
for the poor insane as##2##5##(2008-7#2)
for the poor##4##3##(1994-2#2)(2008-7#2)
for the population of##2##4##(2011-1#1)(2013-8#1)
for the population##9##3##(1991-12#1)(1992-2#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
for the populations##3##3##(2008-10#2)(2012-3#1)
for the positive##5##3##(2007-11#1)(2008-5#2)(2008-9#1)(2013-8#1)
for the possibility of##5##4##(1991-5#1)(1995-3#1)(2008-10#1)(2009-7#1)(2012-2#1)
for the possibility that##2##4##(1994-5#1)(2008-8#1)
for the possibility##7##3##(1991-5#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)
for the possible##7##3##(1992-3#1)(1992-9#1)(1993-9#1)(2008-10#2)(2008-8#1)(2009-12#1)
for the posterior##2##3##(1994-3#1)(2009-4#1)
for the postoperative##2##3##(2007-12#1)(2007-8#1)
for the potential treatment of##8##5##(2008-5#7)(2008-8#1)
for the potential treatment##9##4##(2008-5#8)(2008-8#1)
for the potential use##2##4##(2008-5#2)
for the potential##17##3##(1992-6#1)(1994-5#1)(2008-10#2)(2008-2#1)(2008-5#10)(2008-8#1)(2012-3#1)
for the potentiometric determination of##3##5##(2008-10#3)
for the potentiometric selectivity of##2##5##(2008-10#2)
for the potentiometric titration of##3##5##(2008-10#3)
for the potentiometric##12##3##(2008-10#12)
for the power##2##3##(1995-3#1)(2010-3#1)
for the practical##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
for the practice of##3##4##(1992-2#1)(1996-2#1)(2008-1#1)
for the practice##4##3##(1992-2#1)(1996-2#1)(2008-1#1)(2008-10#1)
for the practicing##3##3##(2008-7#1)(2010-12#1)(2010-6#1)
for the pre-analysis sample stabilization##2##5##(2008-10#2)
for the pre-concentration of##2##4##(2008-10#2)
for the precise##4##3##(1990-8#1)(1991-8#1)(1993-2#1)(2009-8#1)
for the preclinical##2##3##(1991-9#1)(2008-9#1)
for the preconcentration and determination of##2##6##(2008-10#2)
for the preconcentration and separation of trace##2##7##(2008-10#2)
for the preconcentration and separation of##4##6##(2008-10#4)
for the preconcentration and speciation of##2##6##(2008-10#2)
for the preconcentration and##11##4##(2008-10#11)
for the preconcentration of trace metals##2##6##(2008-10#2)
for the preconcentration of trace##5##5##(2008-10#5)
for the preconcentration of##18##4##(2008-10#18)
for the preconcentration##32##3##(2008-10#32)
for the precursor##2##3##(1990-12#1)(1995-2#1)
for the prediction of reaction rate constants of volatile unsaturated hydrocarbons##2##11##(2007-11#2)
for the prediction of retention##2##5##(2008-10#2)
for the prediction of the##4##5##(2007-12#1)(2008-10#2)(2008-3#1)
for the prediction of##27##4##(1990-5#1)(1995-5#1)(1996-12#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#9)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-3#1)(2012-2#1)
for the prediction##29##3##(1990-5#1)(1995-5#1)(1996-12#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-3#1)(2012-2#1)
for the preparation of a##2##5##(2008-4#1)(2011-1#1)
for the preparation of bifunctional##2##5##(2012-3#2)
for the preparation of polyacrylamide gradient gel-filled capillaries with low UV detection background##2##13##(2008-10#2)
for the preparation of##52##4##(1990-12#1)(1992-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-2#3)(2011-1#2)(2012-3#2)(2013-7#1)
for the preparation##54##3##(1990-12#1)(1992-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#2)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-2#3)(2011-1#2)(2012-3#2)(2013-7#1)
for the presence and##3##4##(1991-8#1)(1992-12#1)(2013-1#1)
for the presence of a##2##5##(1995-2#1)(2008-4#1)
for the presence of oesophageal varices##2##6##(2009-8#2)
for the presence of the##8##5##(1990-11#1)(1994-5#1)(2008-10#5)(2013-8#1)
for the presence of##85##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#2)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
for the presence or absence of##3##6##(1995-6#1)(1997-8#1)(2008-10#1)
for the presence##92##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#2)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
for the present study##3##4##(1992-1#1)(2008-6#1)(2011-2#1)
for the present##11##3##(1992-1#1)(1992-3#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2011-2#1)
for the presentation of##2##4##(1993-12#1)(2008-11#1)
for the presentation##3##3##(1993-12#1)(1995-11#1)(2008-11#1)
for the preservation of##2##4##(1992-8#1)(2008-11#1)
for the pretreatment of##6##4##(2008-1#1)(2008-10#4)(2013-1#1)
for the prevention and control of##3##6##(2008-9#1)(2011-2#1)(2013-8#1)
for the prevention and treatment of##3##6##(2007-7#1)(2008-7#1)(2013-1#1)
for the prevention and##9##4##(1990-2#1)(1993-11#1)(1995-6#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
for the prevention of complications##2##5##(2007-10#1)(2007-8#1)
for the prevention of gastrointestinal##2##5##(2011-1#1)(2012-3#1)
for the prevention of obesity in rats##2##7##(2011-2#2)
for the prevention of obesity##3##5##(2008-10#1)(2011-2#2)
for the prevention of postoperative##2##5##(2007-12#1)(2010-7#1)
for the prevention of skin##2##5##(1997-4#1)(2008-5#1)
for the prevention of##34##4##(1990-12#1)(1995-2#1)(1996-3#1)(1997-4#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#2)(2009-4#1)(2009-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-3#1)
for the prevention or treatment of##2##6##(2008-7#1)(2010-2#1)
for the prevention or##3##4##(1991-9#1)(2008-7#1)(2010-2#1)
for the prevention##48##3##(1990-12#1)(1990-2#1)(1991-9#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
for the previously described##2##4##(1991-5#1)(1995-11#1)
for the previously reported##2##4##(1992-3#1)(2008-5#1)
for the previously##10##3##(1991-5#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
for the primary tumor##2##4##(2010-3#1)(2011-2#1)
for the primary##13##3##(1995-6#1)(2008-11#2)(2008-12#2)(2008-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
for the principal refractive indices and##2##6##(2008-2#2)
for the principle of##3##4##(1996-3#1)(2008-1#1)(2008-11#1)
for the probability##2##3##(1997-3#1)(2008-7#1)
for the probing of##2##4##(2007-11#1)(2008-10#1)
for the procedure##11##3##(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#1)(2012-12#1)
for the procedures are##2##4##(1994-7#1)(2010-6#1)
for the procedures##5##3##(1994-7#1)(1997-2#1)(2008-7#1)(2008-9#1)(2010-6#1)
for the process of##6##4##(1995-6#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-3#2)
for the process##8##3##(1995-6#1)(2007-12#1)(2008-6#2)(2008-8#1)(2011-1#1)(2012-3#2)
for the processing of##3##4##(1990-8#1)(2008-3#1)(2010-8#1)
for the processing##4##3##(1990-8#1)(2008-3#1)(2010-8#1)(2013-1#1)
for the product##2##3##(2012-2#2)
for the production of a##6##5##(1990-7#1)(2007-12#1)(2008-11#3)(2012-3#1)
for the production of antibodies##2##5##(2008-11#1)(2011-2#1)
for the production of biopharmaceuticals##2##5##(2008-11#1)(2011-2#1)
for the production of ethanol##2##5##(2008-7#1)(2008-8#1)
for the production of monoclonal##2##5##(2008-11#2)
for the production of recombinant proteins for##2##7##(2008-11#2)
for the production of recombinant proteins##6##6##(2008-11#6)
for the production of recombinant##9##5##(2008-11#9)
for the production of singlet oxygen (1O2)##2##7##(2008-5#2)
for the production of xylose##2##5##(2008-10#1)(2008-6#1)
for the production of##78##4##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#3)(2007-12#1)(2008-10#6)(2008-11#27)(2008-2#4)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#3)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
for the production##81##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#3)(2007-12#1)(2008-10#6)(2008-11#28)(2008-2#4)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#3)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
for the professional##3##3##(1990-2#1)(1993-3#1)(1994-1#1)
for the prognostication of##2##4##(2011-2#2)
for the program##4##3##(1992-2#1)(1995-12#1)(2008-6#1)(2008-9#1)
for the programs##2##3##(1997-2#1)(2008-9#1)
for the progress##2##3##(2008-10#1)(2008-5#1)
for the project##3##3##(2008-11#2)(2012-1#1)
for the promotion of##2##4##(1996-3#1)(2013-8#1)
for the proper##6##3##(1993-2#1)(2008-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
for the prophylaxis and##2##4##(2007-12#1)(2008-5#1)
for the prophylaxis##3##3##(2007-12#1)(2008-5#1)(2010-11#1)
for the proportion of##2##4##(2008-10#2)
for the proposed method is##3##5##(2008-10#2)(2008-2#1)
for the proposed method##5##4##(2008-10#4)(2008-2#1)
for the proposed##14##3##(1997-7#1)(1997-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2011-1#1)
for the prospective##2##3##(1995-12#1)(2008-8#1)
for the protection of##3##4##(1992-3#1)(2008-11#1)(2009-6#1)
for the protective##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
for the protein is##2##4##(1992-8#1)(2009-5#1)
for the protein##11##3##(1992-8#1)(1994-5#1)(1995-2#1)(2008-10#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-2#1)
for the proteins##4##3##(1990-12#1)(1992-6#1)(1994-5#1)(1997-3#1)
for the proton release##2##4##(1990-8#2)
for the proton##4##3##(1990-8#2)(1995-5#1)(2008-10#1)
for the provision of##5##4##(1993-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(2013-1#1)
for the psychiatrically##2##3##(1993-3#1)(1995-8#1)
for the psychosocial##3##3##(1992-3#1)(1995-5#1)(2007-12#1)
for the public##3##3##(1996-12#1)(1997-3#1)(2008-11#1)
for the pump##2##3##(2008-3#2)
for the pure##3##3##(2008-10#3)
for the purification of the##4##5##(2008-10#1)(2008-11#2)(2008-4#1)
for the purification of##14##4##(1995-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#3)(2009-12#1)(2012-2#1)
for the purification##15##3##(1995-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#3)(2009-12#1)(2012-2#1)
for the purified##2##3##(1992-9#1)(1993-8#1)
for the purpose of characterizing##2##5##(1996-12#1)(2008-3#1)
for the purpose of developing##2##5##(1996-5#1)(2009-1#1)
for the purpose of enhancing##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
for the purpose of person recognition##2##6##(2012-1#2)
for the purpose of person##3##5##(2012-1#3)
for the purpose of this##2##5##(2008-10#1)(2010-12#1)
for the purpose of##49##4##(1991-2#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-5#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-8#1)
for the purpose##53##3##(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-8#1)
for the purposes of##8##4##(1990-3#1)(1991-12#1)(1993-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)
for the putative##5##3##(1995-8#1)(1996-12#3)(2009-12#1)
for the pyralid##2##3##(2008-10#2)
for the qualitative and quantitative analysis of##2##7##(2008-10#2)
for the qualitative and quantitative##5##5##(1994-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
for the qualitative##8##3##(1994-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-9#1)(2012-2#1)
for the quality control analysis of##2##6##(2008-10#2)
for the quality control of##5##5##(2008-10#1)(2011-1#3)(2012-3#1)
for the quality control##8##4##(2008-10#3)(2011-1#4)(2012-3#1)
for the quality of##2##4##(1991-12#1)(2008-11#1)
for the quality##13##3##(1991-12#1)(2008-10#5)(2008-11#1)(2011-1#4)(2012-3#1)(2013-8#1)
for the quantification of beta-cell function and insulin sensitivity##2##9##(1994-12#2)
for the quantification of the##4##5##(2008-10#2)(2009-12#1)(2011-1#1)
for the quantification of these##2##5##(2008-10#1)(2010-1#1)
for the quantification of##32##4##(1990-12#1)(1994-12#2)(2008-1#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-4#3)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#1)
for the quantitation of FB(1)##2##5##(2008-10#2)
for the quantitation of fumonisin B(1)##2##6##(2008-10#2)
for the quantitation of##11##4##(1997-2#2)(2008-10#8)(2008-4#1)
for the quantitative analysis of##10##5##(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)
for the quantitative assessment of##2##5##(1996-12#1)(2008-3#1)
for the quantitative determination of small amounts of pollutants##2##9##(2008-10#2)
for the quantitative determination of##24##5##(1997-2#1)(2008-1#1)(2008-10#19)(2008-12#1)(2011-1#1)(2012-12#1)
for the quantitative evaluation of##4##5##(1991-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
for the quantitative measurement of##2##5##(2008-10#1)(2010-11#1)
for the quantitative##56##3##(1991-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#30)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for the radiative##2##3##(2008-10#1)(2008-2#1)
for the radical##2##3##(1996-5#1)(2007-11#1)
for the radiology manager##3##4##(1991-1#1)(1991-12#1)(1994-12#1)
for the radiology##4##3##(1991-1#1)(1991-12#1)(1992-12#1)(1994-12#1)
for the range of##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
for the range##9##3##(1992-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2010-3#2)(2011-2#1)
for the rapid analysis of##2##5##(2008-10#1)(2010-9#1)
for the rapid and direct##2##5##(2008-10#1)(2012-3#1)
for the rapid and sensitive determination of##3##7##(2008-10#3)
for the rapid and sensitive##4##5##(2008-10#4)
for the rapid and##11##4##(2008-10#8)(2008-7#1)(2008-9#1)(2012-3#1)
for the rapid detection of##4##5##(2007-7#1)(2008-10#1)(2008-11#1)(2009-6#1)
for the rapid detection##5##4##(2007-7#1)(2008-10#2)(2008-11#1)(2009-6#1)
for the rapid determination of immunoglobulin A##2##7##(2008-10#2)
for the rapid determination of##6##5##(2008-10#6)
for the rapid determination##7##4##(2008-10#7)
for the rapid diagnosis##2##4##(2007-7#1)(2012-3#1)
for the rapid identification of##2##5##(2008-9#1)(2010-12#1)
for the rapid screening of##2##5##(2008-10#2)
for the rapid separation and purification of##2##7##(1997-2#1)(2008-10#1)
for the rapid separation and##4##5##(1997-2#1)(2008-10#3)
for the rapid##55##3##(1997-2#1)(1997-6#1)(2007-7#2)(2008-10#34)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-9#2)(2012-2#1)(2012-3#2)(2013-1#2)
for the rarity of##3##4##(2007-10#1)(2008-9#1)(2010-5#1)
for the rat##10##3##(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-7#1)(2008-11#1)(2011-2#1)
for the rate##2##3##(2008-10#2)
for the ratios##2##3##(2008-8#1)(2011-2#1)
for the raw materials##2##4##(2008-10#2)
for the reaction of prostaglandin H##2##6##(1994-5#2)
for the reaction of##8##4##(1990-7#1)(1994-5#2)(2008-10#3)(2008-6#1)(2013-8#1)
for the reaction was##2##4##(2008-10#2)
for the reaction were##2##4##(1994-11#1)(2008-10#1)
for the reaction##21##3##(1990-7#1)(1992-3#1)(1994-11#1)(1994-5#2)(2008-10#14)(2008-6#1)(2013-8#1)
for the reactions##2##3##(1994-5#1)(2009-8#1)
for the real##5##3##(1993-12#1)(2008-10#2)(2008-3#2)
for the real-time monitoring of##2##5##(2007-12#1)(2008-10#1)
for the real-time##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2009-12#1)
for the realization of a##2##5##(2008-3#1)(2008-7#1)
for the receiver##2##3##(2008-3#2)
for the receiver-stimulator package##2##4##(2012-2#2)
for the receptor##2##3##(1992-3#1)(2008-11#1)
for the recipient##2##3##(2011-2#1)(2011-3#1)
for the recognition and##2##4##(2008-10#1)(2008-4#1)
for the recognition of the##2##5##(1993-11#1)(2008-3#1)
for the recognition of##6##4##(1991-8#1)(1993-11#1)(1994-9#1)(2008-3#1)(2010-8#1)(2012-3#1)
for the recognition##8##3##(1991-8#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-3#1)
for the recombinant##3##3##(1994-3#1)(2007-11#1)(2008-4#1)
for the recommended procedure##2##4##(2008-10#2)
for the recommended##3##3##(2008-10#2)(2010-6#1)
for the reconstruction of##7##4##(1993-6#1)(2007-12#2)(2008-3#2)(2012-12#1)(2013-1#1)
for the reconstruction##9##3##(1993-6#1)(2007-12#2)(2008-3#2)(2011-1#2)(2012-12#1)(2013-1#1)
for the recording of##4##4##(1996-6#1)(2008-2#1)(2008-3#2)
for the recovered##3##3##(1996-7#1)(2008-3#1)(2013-8#1)
for the recovery of##7##4##(2007-12#2)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
for the recruitment##3##3##(1993-2#2)(2008-5#1)
for the recycling of##3##4##(1994-11#1)(2008-10#2)
for the red##3##3##(1994-8#1)(2008-10#1)(2008-3#1)
for the reduced scattering coefficient##3##5##(2008-2#1)(2008-3#2)
for the reduced##11##3##(1991-11#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
for the reductase##2##3##(1994-11#1)(2008-11#1)
for the reduction of##16##4##(1990-12#1)(1993-3#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2010-7#1)(2011-2#1)
for the reduction##21##3##(1990-12#1)(1993-3#1)(1994-5#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-7#1)(2010-7#1)(2011-2#2)
for the reductive##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
for the reestablishment of##2##4##(1991-12#1)(1995-2#1)
for the reference##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
for the referred##3##3##(1992-3#1)(2008-12#1)(2008-9#1)
for the reflection##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for the reflectivity of##2##4##(2007-12#1)(2008-3#1)
for the regeneration of##2##4##(2008-11#1)(2008-5#1)
for the region##2##3##(2007-7#1)(2008-10#1)
for the regional##2##3##(2008-10#2)
for the registration of##2##4##(2008-3#1)(2008-5#1)
for the regression##5##3##(1990-3#1)(2008-10#2)(2008-3#1)(2008-6#1)
for the regulation of the##2##5##(1992-12#1)(2008-5#1)
for the regulation of##13##4##(1991-5#1)(1992-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
for the regulatory subunit##2##4##(1995-2#1)(2008-8#1)
for the relationship between##4##4##(1996-3#1)(2008-10#3)
for the relationship##5##3##(1996-3#1)(2008-10#3)(2011-1#1)
for the relative##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
for the relatively low##2##4##(2008-7#1)(2013-1#1)
for the relatively##4##3##(1992-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
for the relaxation time##2##4##(2008-3#2)
for the release of##4##4##(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
for the reliability and validity of the##3##7##(2008-12#1)(2008-6#1)(2011-1#1)
for the reliable detection of##2##5##(2008-10#1)(2008-2#1)
for the reliable##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
for the remainder of the##2##5##(2007-6#1)(2008-10#1)
for the remainder of##3##4##(2007-6#1)(2008-10#1)(2010-3#1)
for the remaining##8##3##(1993-1#1)(1995-6#1)(1996-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
for the removal of heavy metal##2##6##(2008-10#1)(2013-1#1)
for the removal of heavy##3##5##(2008-10#2)(2013-1#1)
for the removal of the##2##5##(2012-12#1)(2013-1#1)
for the removal of##14##4##(1996-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#3)
for the repair of##5##4##(1995-5#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#1)
for the replacement of the##2##5##(2008-3#1)(2008-9#1)
for the replacement of##3##4##(1994-3#1)(2008-3#1)(2008-9#1)
for the repositioning##2##3##(2008-7#1)(2010-7#1)
for the reproductive##3##3##(1991-1#1)(2008-6#1)(2012-3#1)
for the requirement of##2##4##(1992-10#1)(2011-1#1)
for the research of##2##4##(2008-11#1)(2010-12#1)
for the research##6##3##(2008-11#3)(2010-12#1)(2010-3#1)(2013-1#1)
for the resistance to##3##4##(1990-5#1)(1990-8#1)(2008-10#1)
for the resistance##8##3##(1990-5#1)(1990-8#1)(1991-2#1)(2008-10#5)
for the resistant A(549)/DDP cells##2##5##(2008-9#2)
for the resistant allele##2##4##(2008-10#2)
for the resistant##5##3##(2008-10#3)(2008-9#2)
for the resolution of mixtures of##2##6##(2008-10#2)
for the resolution of the##2##5##(2008-10#1)(2008-11#1)
for the resolution of##15##4##(2008-10#11)(2008-11#1)(2008-9#2)(2013-1#1)
for the respective cultivars##2##4##(2008-10#2)
for the respective##4##3##(1995-11#1)(2008-10#2)(2010-12#1)
for the response to##2##4##(2008-8#1)(2010-3#1)
for the response##4##3##(2008-2#2)(2008-8#1)(2010-3#1)
for the rest of the##2##5##(2008-10#1)(2012-9#1)
for the rest of their lives##2##6##(1994-9#1)(1997-8#1)
for the rest of##5##4##(1994-9#1)(1995-2#1)(1997-8#1)(2008-10#1)(2012-9#1)
for the rest##8##3##(1994-9#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-10#2)(2012-12#1)(2012-9#1)
for the restoration of the##3##5##(2008-2#1)(2008-3#1)(2013-1#1)
for the restoration of##8##4##(1990-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#2)
for the restriction endonuclease##2##4##(1993-9#1)(1994-12#1)
for the resulting##2##3##(2012-12#1)(2013-8#1)
for the results obtained##2##4##(2008-10#1)(2008-5#1)
for the retention and##2##4##(2008-10#2)
for the retention of##4##4##(1994-12#1)(2008-10#2)(2009-6#1)
for the retention##7##3##(1994-12#1)(2008-10#5)(2009-6#1)
for the retinal##2##3##(2009-12#2)
for the retrieval of##6##4##(1991-8#1)(2007-12#2)(2008-2#2)(2008-4#1)
for the revelation of##2##4##(2008-5#1)(2012-2#1)
for the reversible##2##3##(1997-2#1)(2008-6#1)
for the revised##2##3##(1992-1#1)(2012-2#1)
for the revision##3##3##(2011-2#2)(2013-1#1)
for the rheumatic##2##3##(1990-12#1)(2008-8#1)
for the rho proteins##3##4##(1991-2#3)
for the right##8##3##(1994-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2010-5#1)(2010-7#1)
for the ring##2##3##(2007-11#1)(2011-1#1)
for the risk assessment of##3##5##(1997-4#1)(2008-11#2)
for the risk of##5##4##(1997-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-6#1)
for the risk##12##3##(1994-1#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-6#1)
for the role of the##2##5##(1991-5#1)(1993-12#1)
for the role of##13##4##(1991-5#1)(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
for the rotation of the##2##5##(1991-5#1)(1996-2#1)
for the rotation##3##3##(1991-5#1)(1996-2#1)(2008-3#1)
for the rotational##2##3##(1993-12#1)(2007-11#1)
for the routine analysis of##4##5##(2008-10#4)
for the routine analysis##5##4##(2008-10#4)(2011-1#1)
for the routine determination of##3##5##(1993-12#1)(2008-10#1)(2010-4#1)
for the routine##14##3##(1993-12#1)(2008-10#9)(2010-4#2)(2010-8#1)(2011-1#1)
for the safe and effective##2##5##(2008-12#1)(2008-9#1)
for the safe##6##3##(1994-12#1)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)
for the safety##2##3##(1996-5#1)(2012-2#1)
for the sake of##4##4##(2008-10#2)(2008-12#1)(2009-6#1)
for the salicylate##2##3##(2008-10#2)
for the salivary##3##3##(2008-11#2)(2011-2#1)
for the same indication##3##4##(1996-11#1)(2008-5#2)
for the same period##3##4##(1990-7#1)(2008-6#1)(2012-12#1)
for the same purpose##3##4##(2007-7#1)(2008-10#1)(2009-8#1)
for the same samples##5##4##(2008-10#4)(2008-3#1)
for the same type of##2##5##(1992-6#1)(1997-6#1)
for the same##62##3##(1990-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#2)
for the sample##12##3##(1995-9#1)(2008-10#9)(2009-11#1)(2012-2#1)
for the samples##7##3##(2008-10#3)(2008-3#1)(2009-4#2)(2012-1#1)
for the saturation##2##3##(2007-12#1)(2008-3#1)
for the scattering properties of##3##5##(2008-2#1)(2008-3#2)
for the scattering##6##3##(2008-2#3)(2008-3#3)
for the screening of##8##4##(1990-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)
for the screening##12##3##(1990-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2013-8#1)
for the search##2##3##(1993-12#1)(2013-7#1)
for the seasonal##2##3##(2008-10#2)
for the second disease##2##4##(2007-7#1)(2011-2#1)
for the second time##2##4##(1991-8#1)(2008-3#1)
for the second##19##3##(1991-8#1)(1992-11#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
for the secondary##3##3##(2008-3#2)(2008-8#1)
for the section##2##3##(1990-5#1)(1996-4#1)
for the segmentation of##3##4##(2007-12#3)
for the segmentation##4##3##(2007-11#1)(2007-12#3)
for the selected##4##3##(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
for the selection of variables##2##5##(2008-10#2)
for the selection of##15##4##(1990-5#2)(1994-2#1)(2007-10#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-2#1)
for the selection##17##3##(1990-5#2)(1994-2#1)(2007-10#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2012-2#1)
for the selective and##2##4##(2008-10#2)
for the selective determination of##4##5##(2008-10#4)
for the selective extraction and##3##5##(2008-10#3)
for the selective extraction of U(VI)##2##6##(2008-10#2)
for the selective extraction of trace##2##6##(2008-10#2)
for the selective extraction of##4##5##(2008-10#4)
for the selective extraction##7##4##(2008-10#7)
for the selective separation and##3##5##(2008-10#3)
for the selective##27##3##(1990-8#1)(1992-12#1)(2008-10#22)(2008-7#1)(2009-8#1)(2011-1#1)
for the selectivity##3##3##(1995-3#1)(2008-10#1)(2012-12#1)
for the sensing##2##3##(2008-10#2)
for the sensitive and selective determination of##2##7##(2008-10#2)
for the sensitive and selective##3##5##(1995-6#1)(2008-10#2)
for the sensitive and##4##4##(1995-6#1)(2008-10#2)(2010-5#1)
for the sensitive detection of##2##5##(2008-10#1)(2010-12#1)
for the sensitive determination of##5##5##(2008-10#5)
for the sensitive##14##3##(1995-6#1)(2008-10#9)(2008-9#2)(2010-12#1)(2010-5#1)
for the sensitivity of the##2##5##(1990-12#1)(2011-1#1)
for the sensitivity of##6##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#1)
for the sensor##6##3##(2008-10#6)
for the sensory##2##3##(1993-12#1)(2013-1#1)
for the separate##2##3##(2008-3#1)(2009-6#1)
for the separation and detection of##3##6##(2008-10#3)
for the separation and determination of##10##6##(2008-10#10)
for the separation and preconcentration of trace##2##7##(2008-10#2)
for the separation and preconcentration of##8##6##(2008-10#8)
for the separation and##29##4##(1996-5#1)(2008-10#27)(2008-2#1)
for the separation of aromatic##2##5##(1990-8#1)(2008-10#1)
for the separation of human##2##5##(1991-5#1)(1997-2#1)
for the separation of the##5##5##(2008-10#5)
for the separation of zinc##2##5##(2008-10#2)
for the separation of##59##4##(1990-8#1)(1991-12#1)(1991-5#2)(1994-9#3)(1995-6#1)(1996-5#2)(1997-2#1)(2008-10#42)(2008-11#1)(2008-2#3)(2008-4#1)(2010-7#1)
for the separation##95##3##(1990-8#1)(1991-12#1)(1991-5#2)(1994-9#3)(1995-6#1)(1996-5#4)(1997-2#1)(2008-10#72)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)
for the sequence##3##3##(1992-11#1)(2008-4#2)
for the sequences##2##3##(1996-6#1)(2008-7#1)
for the sequencing of the##2##5##(1995-12#1)(2008-4#1)
for the sequential determination of##4##5##(2008-10#4)
for the sequential##9##3##(1994-8#1)(2008-10#8)
for the series##2##3##(2010-3#1)(2012-1#1)
for the serodiagnosis of##2##4##(1996-12#1)(2007-7#1)
for the service##2##3##(1996-2#1)(2008-12#1)
for the services##2##3##(1992-11#1)(2007-7#1)
for the seven##2##3##(2008-10#2)
for the severity of##3##4##(2007-10#1)(2008-10#1)(2013-1#1)
for the severity##4##3##(2007-10#1)(2008-10#1)(2009-8#1)(2013-1#1)
for the sexual##2##3##(1994-2#1)(1996-2#1)
for the short-term##2##3##(1996-4#1)(2008-10#1)
for the signal##8##3##(1991-9#1)(1993-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-3#1)(2012-1#1)
for the silicon##2##3##(2008-10#1)(2009-11#1)
for the simple##5##3##(1992-3#1)(2008-10#4)
for the simulation of##2##4##(2008-10#1)(2008-3#1)
for the simulation##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
for the simultaneous analysis of##4##5##(2008-10#4)
for the simultaneous assay of##2##5##(2008-10#2)
for the simultaneous assessment of##2##5##(2008-12#1)(2008-9#1)
for the simultaneous detection and identification of multiple##2##8##(2008-10#2)
for the simultaneous detection of##7##5##(2008-10#4)(2008-2#1)(2008-9#1)(2010-11#1)
for the simultaneous detection##9##4##(2008-10#6)(2008-2#1)(2008-9#1)(2010-11#1)
for the simultaneous determination of As##2##6##(2008-10#2)
for the simultaneous determination of ammonia##2##6##(1995-3#2)
for the simultaneous determination of binary##2##6##(2008-10#2)
for the simultaneous determination of caffeine##2##6##(2008-10#2)
for the simultaneous determination of four##2##6##(2008-10#2)
for the simultaneous determination of lead and##2##7##(2008-10#2)
for the simultaneous determination of nitrite and nitrate in##4##9##(2008-10#4)
for the simultaneous determination of nitrite and nitrate##6##8##(2008-10#6)
for the simultaneous determination of the three##2##7##(2008-10#2)
for the simultaneous determination of the##9##6##(2008-10#8)(2008-2#1)
for the simultaneous determination of trace##4##6##(2008-10#4)
for the simultaneous determination of##97##5##(1990-8#1)(1995-3#2)(2008-10#89)(2008-2#2)(2009-6#1)(2011-1#2)
for the simultaneous determination##98##4##(1990-8#1)(1995-3#2)(2008-10#90)(2008-2#2)(2009-6#1)(2011-1#2)
for the simultaneous estimation of##3##5##(2008-10#2)(2010-3#1)
for the simultaneous separation and pre-concentration of##2##7##(2008-10#2)
for the simultaneous separation##3##4##(2008-10#3)
for the simultaneous spectrophotometric determination of##7##6##(2008-10#7)
for the simultaneous##150##3##(1990-8#1)(1994-5#1)(1995-3#3)(2008-1#1)(2008-10#127)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#2)
for the single##6##3##(1990-7#1)(2008-10#4)(2012-3#1)
for the site##2##3##(2008-10#2)
for the six##4##3##(1993-11#1)(2008-10#3)
for the size fractionation##2##4##(2008-10#2)
for the size##4##3##(1991-2#1)(2008-10#3)
for the slow##4##3##(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
for the small bowel##2##4##(1992-9#1)(2013-1#1)
for the small##4##3##(1992-9#1)(2008-2#1)(2008-3#1)(2013-1#1)
for the small-scale##2##3##(2008-10#2)
for the smallest##2##3##(2007-12#1)(2008-7#1)
for the social##4##3##(1993-1#1)(1994-12#1)(1996-1#1)(1996-8#1)
for the solid phase extraction##2##5##(2008-10#2)
for the solid phase extractive preconcentration##2##6##(2008-10#2)
for the solid phase##4##4##(2008-10#4)
for the solid##6##3##(2008-10#4)(2008-12#1)(2008-3#1)
for the solid-liquid##2##3##(2008-10#2)
for the solid-phase##4##3##(1997-3#1)(1997-4#1)(2008-10#2)
for the solution##6##3##(1994-5#4)(2008-3#2)
for the solvent extraction of##2##5##(2008-10#2)
for the solvent##4##3##(1996-2#1)(2008-10#3)
for the sorption of##2##4##(2008-10#2)
for the sorting##2##3##(1990-5#1)(2008-9#1)
for the source of##2##4##(2008-12#1)(2008-8#1)
for the spatial##3##3##(1996-6#1)(2008-3#2)
for the specialty##2##3##(1992-11#1)(2012-12#1)
for the speciation analysis##2##4##(2008-10#2)
for the speciation and##2##4##(2008-10#2)
for the speciation of arsenic##2##5##(2008-10#2)
for the speciation of chromium in natural water##2##8##(2008-10#2)
for the speciation of chromium##3##5##(2008-10#3)
for the speciation of selenium##2##5##(2008-10#2)
for the speciation of##17##4##(2008-10#17)
for the speciation##23##3##(2008-10#23)
for the species##11##3##(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-8#1)(2010-4#1)
for the specific detection of##4##5##(2008-10#3)(2010-10#1)
for the specific##22##3##(1990-11#1)(1990-3#1)(1991-9#1)(1992-10#1)(1993-3#1)(1994-1#1)(1994-3#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-10#1)
for the specified##2##3##(2008-10#1)(2008-2#1)
for the spectral region near##2##5##(2008-3#2)
for the spectral shape##2##4##(2007-12#1)(2008-3#1)
for the spectral##11##3##(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2013-8#1)
for the spectrometer##3##3##(2008-10#2)(2008-3#1)
for the spectrophotometric determination of copper(II)##2##6##(2008-10#2)
for the spectrophotometric determination of lead in##3##7##(2008-10#3)
for the spectrophotometric determination of lead##4##6##(2008-10#4)
for the spectrophotometric determination of nickel##3##6##(2008-10#3)
for the spectrophotometric determination of##36##5##(2008-10#35)(2010-5#1)
for the spectrophotometric##37##3##(2008-10#36)(2010-5#1)
for the speed of sound and##2##6##(2008-3#2)
for the spiked##3##3##(2008-10#3)
for the spread of##4##4##(1997-3#1)(1997-6#1)(2008-10#1)(2012-2#1)
for the spread##5##3##(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2012-2#1)
for the stability of##2##4##(1993-3#1)(1994-2#1)
for the stability##3##3##(1993-3#1)(1994-2#1)(2008-10#1)
for the standard##6##3##(2008-10#3)(2008-3#3)
for the statistical##4##3##(1997-4#1)(2008-3#1)(2008-7#1)(2009-11#1)
for the status##2##3##(2008-11#1)(2012-12#1)
for the stem cell population##2##5##(2008-11#1)(2010-7#1)
for the stimulation of gene##2##5##(1991-6#1)(1997-6#1)
for the stimulation of##4##4##(1991-6#1)(1996-2#1)(1997-6#1)(2008-9#1)
for the stimulatory##2##3##(1994-3#1)(2008-8#1)
for the strain measurement##2##4##(2013-8#2)
for the strain##3##3##(2008-3#1)(2013-8#2)
for the stripping##2##3##(2008-10#2)
for the strong##2##3##(2008-3#1)(2008-8#1)
for the structural##4##3##(1993-8#1)(1997-2#1)(1997-4#1)(1997-8#1)
for the structure and function of##2##6##(1995-6#1)(2008-5#1)
for the structure of the##2##5##(1990-7#1)(2008-11#1)
for the structure of##3##4##(1990-7#1)(1991-5#1)(2008-11#1)
for the structure##6##3##(1990-7#1)(1991-5#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
for the student##3##3##(2008-11#3)
for the students##3##3##(2008-11#3)
for the studied##7##3##(2007-10#1)(2008-10#5)(2013-1#1)
for the study and##2##4##(2008-3#1)(2011-2#1)
for the study included##2##4##(1996-1#2)
for the study of gastroenteropancreatic neuroendocrine tumors##2##7##(2011-2#2)
for the study of gene expression##2##6##(2008-4#2)
for the study of gene##3##5##(2007-6#1)(2008-4#2)
for the study of human##4##5##(2008-4#2)(2008-7#1)(2012-3#1)
for the study of living##2##5##(2008-1#1)(2008-11#1)
for the study of molecular##2##5##(2008-7#2)
for the study of polymeric acids was used##2##8##(2008-10#2)
for the study of the morphological##2##6##(2008-2#1)(2012-3#1)
for the study of the##16##5##(1991-6#1)(1992-12#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
for the study of##107##4##(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#2)(1997-4#1)(2007-11#4)(2007-12#2)(2007-6#1)(2008-1#5)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#9)(2008-5#1)(2008-7#8)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-6#2)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#2)
for the study period##2##4##(2012-12#2)
for the study to##2##4##(2007-7#1)(2008-11#1)
for the study##134##3##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-1#2)(1996-12#2)(1997-4#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#6)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#3)(2008-7#8)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
for the subsequent##7##3##(1991-12#1)(1993-9#1)(2008-10#3)(2008-8#1)(2013-7#1)
for the substrate##6##3##(1990-11#1)(1992-3#1)(1993-8#1)(1994-3#1)(2008-6#1)(2009-2#1)
for the substrates##2##3##(1990-7#1)(1994-5#1)
for the success of the##2##5##(2012-2#2)
for the success of this##2##5##(2008-8#1)(2009-4#1)
for the success of##8##4##(1992-3#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-8#1)(2012-2#2)
for the successful detection of##2##5##(2010-5#1)(2012-3#1)
for the successful implementation of##3##5##(1994-3#1)(2008-10#1)(2010-3#1)
for the successful##13##3##(1991-3#1)(1994-3#2)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-3#1)(2010-5#1)(2012-3#1)
for the successive determination of##3##5##(2008-10#3)
for the sudden infant death syndrome##2##6##(1993-12#2)
for the sudden##3##3##(1993-12#2)(2008-10#1)
for the sugar##2##3##(1992-12#1)(2013-1#1)
for the sunscreen##3##3##(2008-5#3)
for the suppression of##10##4##(1991-5#1)(1997-8#1)(2008-10#6)(2008-11#1)(2010-2#1)
for the suppression##11##3##(1991-5#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-2#1)
for the surface##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
for the surgeon##7##3##(2007-12#2)(2007-8#2)(2008-10#1)(2008-9#1)(2010-12#1)
for the surgical management of##2##5##(2011-2#1)(2012-12#1)
for the surgical treatment of##2##5##(2008-7#1)(2010-3#1)
for the surgical##8##3##(2007-8#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
for the surveillance of##4##4##(1995-3#1)(2007-7#1)(2008-10#1)(2012-3#1)
for the surveillance##5##3##(1995-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
for the survival and##2##4##(1993-9#1)(2009-3#1)
for the survival of##7##4##(1991-12#1)(1991-6#1)(2008-9#1)(2009-8#1)(2012-5#1)(2013-7#2)
for the survival##11##3##(1991-12#1)(1991-6#1)(1993-9#1)(2007-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2012-5#1)(2013-7#2)
for the susceptibility##2##3##(2008-10#1)(2011-1#1)
for the susceptible##2##3##(2008-10#2)
for the symptoms##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
for the syndrome##2##3##(1993-11#1)(1997-3#1)
for the synthesis and##4##4##(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
for the synthesis of 2##2##5##(1995-2#1)(2007-11#1)
for the synthesis of##53##4##(1990-5#2)(1992-11#2)(1993-8#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-3#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the synthesis##60##3##(1990-5#2)(1992-11#2)(1993-8#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-3#1)(2007-11#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#6)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
for the synthetic and##2##4##(1990-10#1)(2008-3#1)
for the synthetic##5##3##(1990-10#1)(1993-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
for the system##8##3##(1994-2#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2013-8#1)
for the systematic##2##3##(2008-4#1)(2011-1#1)
for the systemic##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
for the target and##2##4##(1995-1#1)(2007-12#1)
for the target##8##3##(1995-1#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
for the task##2##3##(2007-12#1)(2008-2#1)
for the teaching##3##3##(1995-1#1)(2008-11#1)(2008-12#1)
for the techniques##2##3##(1997-4#1)(2008-2#1)
for the temperature##2##3##(2008-10#1)(2008-2#1)
for the temporal order of##2##5##(1992-11#1)(1992-3#1)
for the temporal profile##2##4##(2008-3#2)
for the temporal##6##3##(1992-11#1)(1992-3#1)(2007-11#2)(2008-3#2)
for the temporary##2##3##(2008-11#2)
for the terahertz radiation##2##4##(2007-11#1)(2007-12#1)
for the termination of##2##4##(1995-8#1)(1996-12#1)
for the ternary complexes##2##4##(2008-10#2)
for the ternary##3##3##(2008-10#2)(2008-3#1)
for the test##5##3##(2008-10#3)(2008-12#1)(2012-3#1)
for the testing of##5##4##(1995-9#1)(2008-11#1)(2008-3#1)(2008-5#2)
for the tetrapeptide##2##3##(1993-9#1)(1994-5#1)
for the theoretical##2##3##(2008-12#1)(2012-3#1)
for the therapeutic##3##3##(1991-8#1)(1997-4#1)(2013-1#1)
for the therapy of##7##4##(1994-5#1)(1995-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-1#1)(2013-1#1)
for the thermal##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
for the thermodynamic##2##3##(2008-10#1)(2008-3#1)
for the third dose of##2##5##(1995-3#2)
for the third##9##3##(1995-3#3)(2007-10#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-7#1)
for the three different##2##4##(2008-10#1)(2008-3#1)
for the three##42##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-1#1)(1994-1#1)(1994-8#1)(1995-12#1)(2007-2#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
for the three-dimensional##3##3##(1990-7#1)(2008-3#2)
for the threshold##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
for the time##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-3#1)
for the timely##3##3##(1997-7#1)(2008-10#1)(2011-2#1)
for the titration##3##3##(2008-10#3)
for the titrimetric determination of##2##5##(2008-10#2)
for the topical treatment of##2##5##(1990-6#1)(2010-8#1)
for the total population##2##4##(1996-6#1)(2012-12#1)
for the total removal of##2##5##(2008-7#2)
for the total##18##3##(1991-1#1)(1991-6#1)(1992-12#1)(1995-12#1)(1996-6#1)(1996-7#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-7#2)(2009-1#1)(2010-11#1)(2012-12#1)(2013-1#1)
for the toxic##2##3##(1991-9#1)(2008-10#1)
for the toxicity of##2##4##(2008-7#1)(2011-2#1)
for the toxicity##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
for the trace determination of zinc##2##6##(2008-10#2)
for the trace determination of##3##5##(2008-10#3)
for the trace##11##3##(2008-10#11)
for the training of##2##4##(1992-1#1)(2008-7#1)
for the training##4##3##(1992-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
for the trait##2##3##(2008-10#1)(2012-3#1)
for the transcription of the##2##5##(1997-8#2)
for the transcription##4##3##(1993-6#1)(1997-8#2)(2010-11#1)
for the transcriptional##2##3##(1995-6#1)(1995-8#1)
for the transfer of##2##4##(1992-5#1)(2008-3#1)
for the transfer##3##3##(1992-5#1)(1995-5#1)(2008-3#1)
for the transformation of##2##4##(1992-12#1)(2012-3#1)
for the transformed##2##3##(2008-10#1)(2008-2#1)
for the transient response of##2##5##(2008-2#1)(2008-3#1)
for the transient##7##3##(1992-6#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#2)
for the transition##4##3##(1996-12#1)(1997-2#1)(2008-3#1)(2012-2#1)
for the translation of##3##4##(2008-11#1)(2008-8#1)(2011-1#1)
for the translation##4##3##(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#1)
for the transmission of##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
for the transport of the##2##5##(1994-11#1)(2010-11#1)
for the transport of##3##4##(1994-11#1)(2008-7#1)(2010-11#1)
for the transport##5##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
for the transverse##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
for the treatment and prevention of##3##6##(2007-11#1)(2007-12#1)(2010-5#1)
for the treatment and##6##4##(1992-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-5#1)(2013-8#1)
for the treatment by##2##4##(2007-7#1)(2013-8#1)
for the treatment of Crohn's disease##2##6##(1994-6#1)(2013-1#1)
for the treatment of HIV infection##2##6##(2008-5#2)
for the treatment of HIV##3##5##(1995-3#1)(2008-5#2)
for the treatment of PD##3##5##(2008-7#3)
for the treatment of a##3##5##(2008-5#1)(2011-2#1)(2013-1#1)
for the treatment of acute stroke##2##6##(2007-10#1)(2009-11#1)
for the treatment of acute##6##5##(1995-6#1)(1997-7#1)(2007-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
for the treatment of advanced##3##5##(1994-7#1)(2007-11#1)(2008-4#1)
for the treatment of asthma##2##5##(1996-1#1)(1996-2#1)
for the treatment of benign prostatic hyperplasia##2##7##(1994-11#1)(2008-5#1)
for the treatment of benign##3##5##(1994-11#1)(2008-5#1)(2011-2#1)
for the treatment of brain tumors##3##6##(1995-2#1)(2008-11#1)(2008-5#1)
for the treatment of breast cancer##2##6##(1993-1#1)(2011-1#1)
for the treatment of breast##4##5##(1992-9#1)(1993-1#1)(2008-3#1)(2011-1#1)
for the treatment of cancer##8##5##(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-3#1)
for the treatment of chemotherapy-induced anemia##3##6##(2008-7#2)(2010-11#1)
for the treatment of chemotherapy-induced##4##5##(2008-7#3)(2010-11#1)
for the treatment of childhood##2##5##(2008-11#2)
for the treatment of chronic##8##5##(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-12#1)
for the treatment of degenerative##2##5##(1996-6#1)(2008-7#1)
for the treatment of diabetes##2##5##(2008-4#1)(2010-12#1)
for the treatment of diabetic##2##5##(2008-1#1)(2013-1#1)
for the treatment of different##2##5##(2012-2#1)(2013-1#1)
for the treatment of distal radial osteosarcoma##2##7##(2013-8#2)
for the treatment of essential hypertension##2##6##(1992-8#1)(2008-7#1)
for the treatment of heart failure##3##6##(2008-5#2)(2009-10#1)
for the treatment of hepatocellular carcinoma##2##6##(2008-8#1)(2013-7#1)
for the treatment of hot flashes##3##6##(2008-7#3)
for the treatment of human##3##5##(2010-3#1)(2013-1#1)(2013-7#1)
for the treatment of hypertension##5##5##(1991-5#1)(1992-8#1)(2007-8#1)(2008-8#1)(2011-2#1)
for the treatment of infection##2##5##(2008-5#1)(2008-7#1)
for the treatment of infections##2##5##(2008-5#1)(2013-8#1)
for the treatment of inflammatory diseases##3##6##(1995-12#1)(2011-1#2)
for the treatment of inflammatory##4##5##(1995-12#1)(2010-5#1)(2011-1#2)
for the treatment of localized##2##5##(1995-2#1)(2013-1#1)
for the treatment of malaria##3##5##(2008-10#1)(2009-6#1)(2011-2#1)
for the treatment of neuropathic pain##2##6##(2008-9#2)
for the treatment of obesity##2##5##(2008-3#1)(2008-5#1)
for the treatment of opioid##2##5##(2008-11#1)(2008-6#1)
for the treatment of osteoporosis##4##5##(1993-11#1)(2008-11#1)(2008-6#1)(2012-12#1)
for the treatment of painful##2##5##(2008-7#1)(2013-1#1)
for the treatment of patients with##3##6##(1991-9#1)(2008-1#1)(2012-12#1)
for the treatment of pulmonary##2##5##(1997-1#1)(2008-1#1)
for the treatment of refractory bladder neck##2##7##(2013-8#2)
for the treatment of rheumatoid arthritis##3##6##(1990-6#1)(2006-10#1)(2008-5#1)
for the treatment of schizophrenia and##2##6##(2008-5#1)(2008-6#1)
for the treatment of schizophrenia##7##5##(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#3)
for the treatment of several##3##5##(2008-11#2)(2009-1#1)
for the treatment of severe sepsis##2##6##(2007-12#2)
for the treatment of severe##5##5##(2007-12#2)(2008-5#1)(2008-8#1)(2013-1#1)
for the treatment of some##2##5##(2008-11#1)(2008-9#1)
for the treatment of symptomatic##2##5##(2008-8#1)(2013-7#1)
for the treatment of the##6##5##(1996-2#1)(2007-8#1)(2008-3#1)(2008-5#2)(2011-7#1)
for the treatment of these##2##5##(2010-2#1)(2010-4#1)
for the treatment of this disease##3##6##(1993-6#1)(2007-8#1)(2008-10#1)
for the treatment of this##5##5##(1993-6#1)(2007-8#1)(2008-10#1)(2010-8#1)(2013-1#1)
for the treatment of various inflammatory##2##6##(2010-5#1)(2011-1#1)
for the treatment of various##3##5##(2008-10#1)(2010-5#1)(2011-1#1)
for the treatment of##330##4##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#1)(2006-10#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#10)(2008-1#6)(2008-10#11)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#35)(2008-6#4)(2008-7#26)(2008-8#9)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#4)(2010-8#6)(2010-9#1)(2011-1#11)(2011-10#1)(2011-2#16)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#9)(2012-2#8)(2012-3#6)(2013-1#20)(2013-7#3)(2013-8#7)
for the treatment or##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
for the treatment##353##3##(1990-10#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#1)(2006-10#3)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#12)(2008-1#7)(2008-10#11)(2008-11#13)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#4)(2008-5#35)(2008-6#4)(2008-7#26)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#4)(2010-8#6)(2010-9#1)(2011-1#12)(2011-10#1)(2011-2#18)(2011-3#1)(2011-7#2)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#6)(2013-1#20)(2013-7#3)(2013-8#9)
for the trial##2##3##(1997-7#1)(2008-5#1)
for the true##2##3##(1990-8#1)(1991-5#1)
for the tumor##2##3##(1994-9#1)(2011-1#1)
for the two cyromazine resistance-correlated oligonucleotides##2##6##(2011-2#2)
for the two drugs##2##4##(2008-11#2)
for the two groups##3##4##(1997-7#1)(2008-10#1)(2009-11#1)
for the two most common##2##5##(1991-8#1)(2008-10#1)
for the two soils##2##4##(1993-8#1)(2008-6#1)
for the two systems##2##4##(2008-10#1)(2008-7#1)
for the two types of##2##5##(2008-3#1)(2008-5#1)
for the two##70##3##(1990-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-5#3)(1994-9#1)(1995-2#2)(1995-5#3)(1996-11#1)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
for the type I alpha regulatory subunit##2##7##(1990-2#2)
for the type of##3##4##(1990-12#1)(1996-6#1)(2008-4#1)
for the type##7##3##(1990-12#1)(1990-2#2)(1994-11#1)(1996-6#1)(2007-11#1)(2008-4#1)
for the typical##2##3##(2007-12#1)(2010-9#1)
for the tyrosine##2##3##(1992-3#1)(1996-2#1)
for the tyrosyl##2##3##(1991-12#1)(1997-3#1)
for the understanding of the pathogenesis of##2##7##(2008-3#1)(2008-7#1)
for the understanding of the##4##5##(1990-8#1)(1993-12#1)(2008-3#1)(2008-7#1)
for the understanding of##7##4##(1990-8#1)(1993-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)
for the understanding##8##3##(1990-8#1)(1993-12#1)(1994-5#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)
for the uninsured##4##3##(1992-2#1)(1995-1#1)(1996-1#1)(2008-11#1)
for the unique##3##3##(2008-2#1)(2009-1#1)(2012-3#1)
for the unit on site##2##5##(1996-2#2)
for the universal##2##3##(2011-2#1)(2012-12#1)
for the unprotonated and protonated##2##5##(1991-9#2)
for the unretained##2##3##(2008-10#2)
for the upper and lower##2##5##(2008-12#1)(2008-7#1)
for the upper and##3##4##(2008-12#2)(2008-7#1)
for the upper##5##3##(2008-12#2)(2008-7#1)(2010-12#1)(2012-2#1)
for the uptake of##4##4##(1993-6#1)(1994-12#1)(2008-10#2)
for the upwelling##3##3##(2008-2#3)
for the use in##3##4##(2008-10#2)(2008-11#1)
for the use of a##2##5##(1992-1#1)(2008-10#1)
for the use of contrast agents in##3##7##(2008-7#3)
for the use of contrast##4##5##(2008-7#3)(2008-9#1)
for the use of cortical allograft##3##6##(2011-2#3)
for the use of the##3##5##(2007-11#1)(2008-5#1)(2010-3#1)
for the use of these##5##5##(1991-8#1)(1992-2#1)(2008-10#2)(2010-6#1)
for the use of this##6##5##(1990-9#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
for the use of##71##4##(1990-3#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-8#1)
for the use##74##3##(1990-3#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-8#1)
for the usual##2##3##(1997-4#1)(2007-12#1)
for the utilization of##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
for the validity of##3##4##(1993-3#1)(2008-2#1)(2008-3#1)
for the validity##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
for the value of##3##4##(2007-11#1)(2008-11#1)(2009-4#1)
for the values of##2##4##(2008-3#1)(2012-12#1)
for the vanadium determination##2##4##(2008-10#2)
for the vanadium##4##3##(2008-10#4)
for the variability in##2##4##(2008-8#1)(2010-2#1)
for the variability of##2##4##(1992-3#1)(1992-9#1)
for the variability##4##3##(1992-3#1)(1992-9#1)(2008-8#1)(2010-2#1)
for the variants##2##3##(1995-6#1)(2013-1#1)
for the variation in the##2##5##(1995-11#1)(2008-10#1)
for the variation##3##3##(1994-12#1)(1995-11#1)(2008-10#1)
for the various##15##3##(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#2)(2012-3#1)
for the vascular##2##3##(1990-5#1)(2008-7#1)
for the vector##3##3##(2007-11#1)(2008-8#1)(2011-2#1)
for the velocity##2##3##(2008-11#1)(2008-3#1)
for the very##2##3##(2008-10#1)(2008-3#1)
for the viability##2##3##(1995-12#1)(2008-11#1)
for the viral##2##3##(1992-6#1)(2008-10#1)
for the visible and##2##4##(2008-2#1)(2008-3#1)
for the visible region of the##2##6##(2007-11#1)(2008-2#1)
for the visible##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
for the visual##2##3##(2008-10#1)(2008-8#1)
for the visualization of##3##4##(1997-8#1)(2008-8#1)(2009-6#1)
for the vitality of the##2##5##(1991-5#2)
for the voltammetric detection of##3##5##(2008-10#3)
for the voltammetric determination of##2##5##(2008-10#2)
for the voltammetric##5##3##(2008-10#5)
for the volume##3##3##(1990-2#1)(2008-9#1)(2010-7#1)
for the water content determination of##2##6##(2008-10#2)
for the water##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
for the wave aberration##2##4##(2007-12#2)
for the wave##4##3##(2007-12#2)(2008-3#2)
for the waveguide##2##3##(2007-12#1)(2008-3#1)
for the wavelength##2##3##(2008-10#1)(2008-2#1)
for the wavelengths##3##3##(2007-12#2)(2008-2#1)
for the way in which##2##5##(1993-8#1)(2008-8#1)
for the way##3##3##(1993-8#1)(2008-3#1)(2008-8#1)
for the weak##4##3##(1990-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
for the weight##2##3##(2007-12#1)(2008-5#1)
for the wheat##2##3##(2008-10#2)
for the whole analytical##2##4##(2008-10#2)
for the whole group##3##4##(2008-4#1)(2010-3#2)
for the whole sample##3##4##(2008-10#1)(2010-10#1)(2010-3#1)
for the whole##31##3##(1992-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1996-8#1)(1997-4#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
for the wide range of##2##5##(1996-3#1)(1997-7#1)
for the wide##3##3##(1996-3#1)(1997-7#1)(2008-2#1)
for the wider##3##3##(2010-2#1)(2012-3#1)(2013-1#1)
for the wild-type enzyme##5##4##(1991-5#1)(1992-6#2)(1995-6#2)
for the wild-type##8##3##(1991-5#1)(1992-6#2)(1994-8#1)(1995-6#2)(2008-10#2)
for the work of##3##4##(1996-1#1)(2008-11#1)(2012-2#1)
for the work##4##3##(1996-1#1)(2008-11#2)(2012-2#1)
for the working##3##3##(1995-2#1)(1996-6#1)(2012-2#1)
for the year 2000##3##4##(1991-5#1)(1997-3#1)(2010-5#1)
for the year##9##3##(1991-5#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-5#1)(2011-1#1)(2012-12#1)
for the years##5##3##(1991-3#1)(1994-2#1)(1996-1#1)(1997-7#1)(2013-1#1)
for the zigzag##2##3##(2008-10#1)(2008-3#1)
for the##13243##2##(1990-10#9)(1990-11#31)(1990-12#64)(1990-2#42)(1990-3#17)(1990-4#1)(1990-5#48)(1990-6#13)(1990-7#26)(1990-8#62)(1990-9#16)(1991-1#28)(1991-10#2)(1991-11#14)(1991-12#59)(1991-2#33)(1991-3#32)(1991-4#1)(1991-5#56)(1991-6#27)(1991-7#4)(1991-8#29)(1991-9#42)(1992-1#26)(1992-10#13)(1992-11#38)(1992-12#53)(1992-2#31)(1992-3#71)(1992-4#6)(1992-5#23)(1992-6#41)(1992-7#1)(1992-8#30)(1992-9#32)(1993-1#15)(1993-10#1)(1993-11#42)(1993-12#54)(1993-2#32)(1993-3#50)(1993-5#6)(1993-6#32)(1993-8#45)(1993-9#23)(1994-1#25)(1994-10#1)(1994-11#43)(1994-12#56)(1994-2#56)(1994-3#47)(1994-5#57)(1994-6#26)(1994-7#5)(1994-8#48)(1994-9#33)(1995-1#18)(1995-11#32)(1995-12#67)(1995-2#85)(1995-3#58)(1995-4#1)(1995-5#47)(1995-6#60)(1995-8#30)(1995-9#12)(1996-1#23)(1996-11#13)(1996-12#70)(1996-2#74)(1996-3#44)(1996-4#3)(1996-5#77)(1996-6#16)(1996-7#7)(1996-8#8)(1996-9#9)(1997-1#29)(1997-2#76)(1997-3#48)(1997-4#58)(1997-5#23)(1997-6#25)(1997-7#54)(1997-8#35)(1997-9#5)(2006-10#9)(2006-12#4)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#28)(2007-11#183)(2007-12#228)(2007-2#14)(2007-4#6)(2007-5#15)(2007-6#16)(2007-7#45)(2007-8#66)(2007-9#3)(2008-1#110)(2008-10#4154)(2008-11#452)(2008-12#143)(2008-2#410)(2008-3#779)(2008-4#220)(2008-5#284)(2008-6#113)(2008-7#346)(2008-8#202)(2008-9#215)(2009-1#16)(2009-10#33)(2009-11#39)(2009-12#41)(2009-2#20)(2009-3#24)(2009-4#23)(2009-5#42)(2009-6#29)(2009-7#39)(2009-8#65)(2009-9#27)(2010-1#24)(2010-10#20)(2010-11#47)(2010-12#51)(2010-2#31)(2010-3#56)(2010-4#52)(2010-5#66)(2010-6#37)(2010-7#32)(2010-8#75)(2010-9#21)(2011-1#169)(2011-10#2)(2011-2#327)(2011-3#15)(2011-7#3)(2011-9#1)(2012-1#52)(2012-12#119)(2012-2#182)(2012-3#138)(2012-4#1)(2012-5#3)(2012-6#3)(2012-8#2)(2012-9#1)(2013-1#254)(2013-7#40)(2013-8#144)
for their abilities to inhibit##2##5##(1993-8#1)(2008-10#1)
for their abilities to##4##4##(1993-8#1)(2008-10#2)(2009-12#1)
for their ability to act as##2##6##(1990-11#1)(2008-10#1)
for their ability to act##3##5##(1990-11#1)(2008-10#2)
for their ability to bind to the##2##7##(1994-6#1)(2007-11#1)
for their ability to change##2##5##(2007-11#1)(2009-7#1)
for their ability to degrade##3##5##(2008-10#1)(2011-2#2)
for their ability to form##2##5##(1992-2#1)(2008-10#1)
for their ability to induce##4##5##(2008-10#3)(2008-4#1)
for their ability to inhibit the##2##6##(1995-11#1)(2008-11#1)
for their ability to inhibit##7##5##(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
for their ability to produce##2##5##(1991-2#1)(2008-10#1)
for their ability to transmit##3##5##(2008-10#3)
for their ability to##54##4##(1990-11#1)(1990-5#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1997-3#1)(2007-11#2)(2007-6#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
for their adult##2##3##(2008-11#1)(2010-9#1)
for their age and##2##4##(2012-12#2)
for their age##4##3##(1991-12#1)(2011-2#1)(2012-12#2)
for their antibacterial activities against##2##5##(2010-3#1)(2012-3#1)
for their antibacterial##3##3##(2010-3#1)(2011-1#1)(2012-3#1)
for their antimicrobial##2##3##(2012-12#1)(2012-3#1)
for their apparent##2##3##(1991-8#1)(2008-8#1)
for their applications##2##3##(2007-11#1)(2008-10#1)
for their atomic absorption##2##4##(2008-10#2)
for their binding##3##3##(1995-8#1)(2007-11#1)(2012-2#1)
for their biocontrol activity against##2##5##(2008-10#2)
for their biocontrol potential##2##4##(2008-10#2)
for their biocontrol##4##3##(2008-10#4)
for their capacity to detect##2##5##(2008-5#1)(2012-3#1)
for their capacity to##7##4##(1990-5#1)(1991-11#1)(1991-2#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
for their catalytic##2##3##(1993-6#1)(1997-3#1)
for their child##2##3##(1995-1#1)(1995-12#1)
for their children##10##3##(1991-3#1)(1992-12#1)(1993-1#1)(1993-3#1)(1996-1#2)(2009-7#3)(2012-3#1)
for their children's##6##3##(1995-1#2)(2009-7#3)(2012-12#1)
for their clinical##2##3##(1996-7#1)(2009-1#1)
for their cytotoxic##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
for their detection##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
for their determination in##2##4##(2008-10#2)
for their development##5##3##(1994-2#1)(1996-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
for their discovery##2##3##(2008-7#2)
for their disease##2##3##(2008-7#1)(2012-1#1)
for their effect on the##2##5##(2008-10#1)(2008-7#1)
for their effect on##8##4##(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
for their effect##9##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)
for their effectiveness##2##3##(2008-11#1)(2008-12#1)
for their effects on the##3##5##(1997-7#1)(2008-10#1)(2011-2#1)
for their effects on##9##4##(1991-3#1)(1997-7#1)(2008-10#4)(2011-2#1)(2012-2#1)(2012-3#1)
for their efficacy in##2##4##(2008-10#1)(2009-7#1)
for their efficacy##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
for their employees##2##3##(1993-3#1)(2007-2#1)
for their expression##3##3##(1994-8#1)(1997-2#1)(1997-7#1)
for their first##2##3##(1991-6#1)(2013-1#1)
for their flame atomic absorption spectrometric##2##6##(2008-10#2)
for their future##3##3##(1992-6#1)(1993-3#1)(2013-7#1)
for their growth##2##3##(2008-10#1)(2008-11#1)
for their health and##2##4##(1994-3#1)(2008-12#1)
for their health##4##3##(1994-3#1)(2008-12#1)(2010-10#1)(2011-2#1)
for their identification##5##3##(1992-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-3#1)
for their implementation##2##3##(1994-2#1)(2008-3#1)
for their in vitro##2##4##(2008-10#1)(2011-2#1)
for their inhibitory activity##2##4##(2008-4#1)(2011-1#1)
for their inhibitory##3##3##(1995-3#1)(2008-4#1)(2011-1#1)
for their interaction##2##3##(1992-11#1)(2010-5#1)
for their long-term##2##3##(2008-7#1)(2011-2#1)
for their low##2##3##(2008-5#1)(2010-4#1)
for their management##2##3##(2007-12#1)(2011-2#1)
for their offspring##2##3##(2008-8#2)
for their own health##2##4##(1994-2#1)(2008-6#1)
for their own##5##3##(1994-12#1)(1994-2#1)(2008-11#1)(2008-6#1)(2012-2#1)
for their parents##2##3##(1990-12#1)(2012-2#1)
for their participation##2##3##(1995-12#1)(2009-6#1)
for their pathogenicity on##2##4##(2008-10#2)
for their patients##5##3##(2006-7#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
for their possible##2##3##(2008-12#1)(2008-7#1)
for their potencies##2##3##(1992-3#1)(1993-12#1)
for their potential to##3##4##(1993-9#1)(1996-1#1)(2008-7#1)
for their potential##6##3##(1993-9#1)(1996-1#1)(1996-12#1)(2008-7#2)(2009-5#1)
for their practice##2##3##(2010-3#1)(2011-2#1)
for their present##2##3##(1990-6#1)(1995-3#1)
for their prevention and treatment##2##5##(2008-8#1)(2011-2#1)
for their primary##2##3##(1991-3#1)(2007-12#1)
for their proper##2##3##(2008-1#1)(2011-2#1)
for their reactions##2##3##(1996-2#1)(1996-6#1)
for their research##2##3##(2008-11#1)(2008-12#1)
for their resistance##2##3##(2008-10#1)(2012-3#1)
for their response to##2##4##(2011-2#1)(2012-9#1)
for their role in##3##4##(1994-12#1)(2008-12#1)(2008-7#1)
for their role##5##3##(1994-12#1)(2008-12#2)(2008-7#1)(2008-9#1)
for their roles in##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
for their sensitivity to##3##4##(2008-10#3)
for their sensitivity##4##3##(2008-10#3)(2008-12#1)
for their separation##3##3##(2008-10#3)
for their significance to##2##4##(2008-10#1)(2012-2#1)
for their simultaneous##2##3##(1993-8#1)(2008-10#1)
for their solution##2##3##(1991-3#1)(2007-12#1)
for their specific##2##3##(1991-8#1)(2008-10#1)
for their study##2##3##(2008-10#1)(2008-11#1)
for their subsequent##2##3##(2008-10#1)(2011-1#1)
for their survival##2##3##(2008-10#1)(2012-7#1)
for their tolerance##2##3##(2008-12#1)(2012-5#1)
for their treatment##2##3##(1992-5#1)(2008-1#1)
for their unique##2##3##(1995-5#1)(1996-3#1)
for their use as##2##4##(2007-8#1)(2008-10#1)
for their use##6##3##(1996-11#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-8#1)
for their virulence##2##3##(2008-10#2)
for their work##2##3##(1994-2#1)(1997-1#1)
for their##501##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#5)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-3#7)(1993-6#3)(1993-8#3)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#1)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-7#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#101)(2008-11#18)(2008-12#16)(2008-3#4)(2008-4#11)(2008-5#14)(2008-6#5)(2008-7#17)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#12)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#24)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#14)(2012-3#8)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#13)(2013-7#1)(2013-8#3)
for them to##5##3##(1995-1#1)(1997-2#1)(2008-11#1)(2008-9#1)(2009-10#1)
for them##17##2##(1992-12#1)(1992-3#1)(1993-3#1)(1995-1#1)(1997-1#2)(1997-2#2)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-8#1)
for themselves and their##2##4##(2007-10#1)(2007-2#1)
for themselves and##3##3##(1992-1#1)(2007-10#1)(2007-2#1)
for themselves##10##2##(1990-6#1)(1992-1#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
for theophylline##2##2##(2008-10#2)
for theoretical##2##2##(2012-2#1)(2013-8#1)
for theory##4##2##(2008-11#2)(2008-5#1)(2009-8#1)
for therapeutic and##2##3##(1993-5#1)(2008-10#1)
for therapeutic drug monitoring##2##4##(2008-8#1)(2010-11#1)
for therapeutic efficacy##2##3##(1991-6#1)(2008-10#1)
for therapeutic intervention##9##3##(1991-9#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-3#2)(2011-1#1)
for therapeutic interventions##2##3##(2011-2#2)
for therapeutic purposes##2##3##(1994-8#1)(2008-4#1)
for therapeutic strategies##2##3##(2009-6#1)(2013-1#1)
for therapeutic use##4##3##(1990-3#1)(2007-7#1)(2008-11#1)(2008-5#1)
for therapeutic##43##2##(1990-3#1)(1991-6#1)(1991-9#1)(1993-5#1)(1994-8#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
for therapeutics##2##2##(2008-8#1)(2009-6#1)
for therapy and##3##3##(1992-9#1)(2008-11#2)
for therapy of##3##3##(1994-5#1)(2010-3#1)(2011-3#1)
for therapy that##2##3##(1992-3#1)(1992-8#1)
for therapy##24##2##(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-11#3)(2008-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#5)(2011-3#1)(2012-2#1)
for there to##2##3##(1992-9#1)(2008-10#1)
for thermal fixing of##2##4##(2008-2#1)(2008-3#1)
for thermal stabilization of##2##4##(2008-10#2)
for thermal##14##2##(1993-8#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2011-1#2)
for thermostability##2##2##(1997-4#2)
for these activities##3##3##(1996-2#1)(1997-7#1)(2012-3#1)
for these adjustments##2##3##(1991-1#2)
for these analytes##3##3##(2008-10#3)
for these and other##2##4##(2008-11#1)(2008-8#1)
for these challenges##2##3##(1997-1#1)(2009-10#1)
for these children##5##3##(2007-12#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)
for these complications##2##3##(1993-5#1)(1996-2#1)
for these components##2##3##(2007-1#1)(2008-10#1)
for these compounds was##2##4##(2008-10#2)
for these compounds##6##3##(2008-10#5)(2008-11#1)
for these conditions##2##3##(1997-7#1)(2008-2#1)
for these determinations##2##3##(2008-10#2)
for these devastating##2##3##(2008-5#1)(2011-2#1)
for these differences##4##3##(1993-11#1)(1995-2#1)(2008-1#1)(2008-9#1)
for these disorders##8##3##(1994-10#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-7#1)
for these drugs##2##3##(2006-10#1)(2008-10#1)
for these effects is##2##4##(1994-8#1)(2008-2#1)
for these effects##7##3##(1994-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
for these enzymes##2##3##(1990-3#1)(2006-6#1)
for these estimates##2##3##(2008-12#1)(2008-9#1)
for these factors##2##3##(1991-8#1)(2008-11#1)
for these findings are##2##4##(2009-5#1)(2011-1#1)
for these findings##4##3##(1995-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
for these four##2##3##(2008-10#2)
for these genes##2##3##(1993-6#1)(2008-9#1)
for these goals##2##3##(2008-4#1)(2012-3#1)
for these highly##2##3##(1990-11#1)(1996-2#1)
for these increases##2##3##(2009-11#1)(2011-2#1)
for these individuals##2##3##(2008-11#1)(2008-7#1)
for these interactions##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
for these ions##2##3##(2008-10#2)
for these lesions##4##3##(2006-12#1)(2007-10#1)(2008-7#1)(2011-2#1)
for these less##2##3##(2009-10#1)(2011-2#1)
for these metal ions##2##4##(2008-10#2)
for these models##3##3##(1993-12#1)(2007-11#1)(2012-1#1)
for these new##2##3##(1997-2#1)(1997-9#1)
for these optical##2##3##(2008-3#2)
for these parameters##4##3##(1990-4#1)(2008-10#1)(2012-3#1)(2013-3#1)
for these patients is##3##4##(2008-5#1)(2008-6#1)(2010-12#1)
for these patients##26##3##(1991-2#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#2)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
for these phenomena##2##3##(1993-6#1)(2008-11#1)
for these procedures##7##3##(1994-11#1)(2008-10#2)(2008-4#1)(2010-8#2)(2011-2#1)
for these proteins##4##3##(1991-12#1)(1997-6#1)(2009-8#1)(2012-3#1)
for these purposes##3##3##(2008-10#1)(2009-11#1)(2010-11#1)
for these receptors##2##3##(1993-9#1)(2008-4#1)
for these relationships##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
for these residues##2##3##(1994-5#1)(1996-5#1)
for these results##2##3##(1991-11#1)(2010-1#1)
for these samples##4##3##(2008-10#4)
for these services##2##3##(1992-3#1)(2012-2#1)
for these sites##2##3##(1992-3#1)(1995-12#1)
for these studies##4##3##(1990-8#1)(1991-12#1)(2008-10#1)(2012-12#1)
for these substrates##2##3##(1991-9#1)(1992-3#1)
for these systems##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
for these three##5##3##(2008-10#3)(2008-7#1)(2008-9#1)
for these tumors##2##3##(2008-3#1)(2012-3#1)
for these two##8##3##(1996-3#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2012-2#1)
for these unusual##2##3##(1991-8#1)(2012-2#1)
for these##359##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-12#6)(1995-2#4)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-6#2)(1997-7#5)(1997-8#1)(1997-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#7)(2008-10#59)(2008-11#16)(2008-12#4)(2008-2#7)(2008-3#22)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#11)(2009-10#5)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#13)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#9)(2013-3#1)(2013-8#3)
for theta##4##2##(1996-3#3)(2008-3#1)
for thiabendazole##3##2##(2008-10#3)
for thickness##2##2##(2007-12#1)(2008-3#1)
for thin films##4##3##(2008-3#4)
for thin##12##2##(2008-2#1)(2008-3#9)(2008-9#2)
for thin-film##3##2##(1990-8#1)(2007-11#1)(2008-3#1)
for thiocyanate##2##2##(2008-10#2)
for thiocyanate-selective##2##2##(2008-10#2)
for thiols##2##2##(2008-10#2)
for thiosulfate##2##2##(2008-10#2)
for thiram##3##2##(2008-10#3)
for third##2##2##(2008-11#1)(2008-12#1)
for third-harmonic generation (THG)##2##4##(2007-12#1)(2008-3#1)
for this ROI tracking##2##4##(2010-8#2)
for this action##2##3##(1992-6#1)(2008-5#1)
for this activity##3##3##(1990-2#1)(1992-3#1)(2012-12#1)
for this age group##3##4##(1993-12#1)(1994-5#1)(1997-4#1)
for this agent##2##3##(1991-9#1)(2008-2#1)
for this analysis##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
for this and other##3##4##(1997-7#1)(2008-3#1)(2008-9#1)
for this apparent disparity in##2##5##(2008-1#2)
for this apparent##4##3##(1994-11#1)(2008-1#2)(2012-12#1)
for this application##4##3##(2008-10#2)(2008-3#2)
for this approach to##2##4##(2008-10#1)(2011-2#1)
for this approach##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
for this are discussed##3##4##(1991-4#1)(1994-8#1)(2008-9#1)
for this assay##2##3##(2008-11#2)
for this association##4##3##(2008-12#1)(2008-9#2)(2013-1#1)
for this behavior##2##3##(2007-12#1)(2013-8#1)
for this calibration##2##3##(2008-10#1)(2008-2#1)
for this cancer##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
for this case##3##3##(1995-5#1)(2008-10#1)(2010-2#1)
for this challenging##2##3##(2010-8#1)(2013-1#1)
for this class of##6##4##(1993-11#1)(1993-2#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
for this community##2##3##(2008-11#2)
for this complex##2##3##(1994-5#1)(2009-7#1)
for this compound##2##3##(1990-8#1)(1991-5#1)
for this condition##5##3##(1991-11#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
for this cross-sectional study##2##4##(2011-1#1)(2012-12#1)
for this decrease##2##3##(2008-10#1)(2008-9#1)
for this determination##2##3##(2008-10#2)
for this devastating disease##2##4##(2008-11#1)(2008-7#1)
for this devastating##3##3##(2008-11#1)(2008-7#2)
for this difference##2##3##(2008-10#1)(2012-1#1)
for this disease##13##3##(1995-5#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-3#1)
for this disorder##4##3##(2008-4#2)(2008-7#2)
for this effect is##3##4##(2007-11#1)(2008-10#1)(2012-3#1)
for this effect##10##3##(1992-8#1)(1993-12#1)(1993-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-3#1)
for this enzyme in##3##4##(1994-8#1)(2008-5#1)(2011-3#1)
for this enzyme##6##3##(1990-8#1)(1991-12#1)(1994-8#1)(1997-7#1)(2008-5#1)(2011-3#1)
for this family of##2##4##(1990-5#1)(2010-2#1)
for this finding##2##3##(1992-2#1)(2008-9#1)
for this gene##2##3##(1993-9#1)(2008-10#1)
for this group of patients##2##5##(2007-8#1)(2011-1#1)
for this group of##5##4##(2007-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)
for this group##11##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
for this hypothesis##2##3##(2009-12#1)(2010-4#1)
for this important##4##3##(1995-2#1)(2008-6#1)(2008-8#1)(2008-9#1)
for this indication##6##3##(1992-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)
for this induction of##2##4##(1994-11#1)(2012-12#1)
for this induction##3##3##(1994-11#1)(1994-12#1)(2012-12#1)
for this inhibition##2##3##(1994-11#1)(2008-7#1)
for this is##8##3##(2007-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2009-8#1)(2010-12#2)
for this kind of##5##4##(1991-3#1)(1996-6#1)(2007-8#1)(2008-3#1)(2013-7#1)
for this method##7##3##(1990-2#1)(1995-8#1)(1997-4#1)(2008-10#4)
for this methodology##2##3##(1992-3#1)(2008-4#1)
for this model##2##3##(2008-11#1)(2008-3#1)
for this molecule##2##3##(1991-5#1)(2007-11#1)
for this mutation##2##3##(2006-8#1)(2008-2#1)
for this new member of the genus##2##7##(2008-10#2)
for this new##4##3##(2008-10#3)(2008-5#1)
for this paper##2##3##(2010-10#1)(2012-2#1)
for this particular##3##3##(2007-2#1)(2008-10#1)(2008-3#1)
for this pathogen##5##3##(2008-10#5)
for this patient##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
for this peculiar##2##3##(2008-10#1)(2008-8#1)
for this period##2##3##(1990-6#1)(1997-1#1)
for this phenomenon is##5##4##(1992-9#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
for this phenomenon##9##3##(1990-2#1)(1992-9#1)(1997-6#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)
for this population##11##3##(1991-12#1)(1992-6#1)(2008-10#1)(2009-11#2)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
for this procedure##4##3##(2008-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
for this process##2##3##(1991-3#1)(2008-5#1)
for this protein##6##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-1#1)(1996-2#1)(2008-10#1)
for this purpose and##2##4##(2008-4#1)(2012-2#1)
for this purpose are##3##4##(2008-10#2)(2008-11#1)
for this purpose##56##3##(1991-8#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
for this rare##2##3##(1992-6#1)(2010-3#1)
for this reaction##3##3##(1991-9#1)(1992-6#1)(2008-10#1)
for this reason##4##3##(1991-5#1)(1992-5#1)(2008-10#1)(2008-3#1)
for this reduction##2##3##(1993-11#1)(2008-12#1)
for this result##2##3##(1993-11#1)(2011-2#1)
for this special##2##3##(1996-3#1)(2013-1#1)
for this species##5##3##(2007-12#1)(2008-5#1)(2010-3#2)(2010-8#1)
for this study were##3##4##(1990-10#1)(2007-6#1)(2011-2#1)
for this study##39##3##(1990-10#1)(1990-12#1)(1991-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#3)(2013-1#5)
for this surgery##2##3##(2007-8#1)(2012-12#1)
for this system is##2##4##(2008-10#1)(2008-2#1)
for this system was##2##4##(2008-10#1)(2008-12#1)
for this system##6##3##(2008-10#2)(2008-12#1)(2008-2#2)(2013-1#1)
for this task##6##3##(1996-2#1)(2008-10#2)(2008-2#1)(2008-4#2)
for this technique##2##3##(2007-12#1)(2008-8#1)
for this test##3##3##(1992-11#1)(1997-3#1)(2008-9#1)
for this trait##2##3##(2008-8#1)(2008-9#1)
for this transformation##3##3##(2007-11#1)(2009-5#1)(2012-1#1)
for this treatment##2##3##(2007-11#1)(2008-9#1)
for this trial##2##3##(2007-7#1)(2013-8#1)
for this tumor##3##3##(1992-10#1)(2008-10#2)
for this type of##9##4##(2008-10#1)(2008-3#1)(2008-9#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
for this unusual##2##3##(2007-2#1)(2008-6#1)
for this variation##2##3##(2008-10#2)
for this very##2##3##(1995-3#1)(2010-12#1)
for this young##2##3##(2011-2#1)(2013-1#1)
for this##619##2##(1990-10#1)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#7)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#5)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#3)(2007-6#2)(2007-7#3)(2007-8#6)(2008-1#7)(2008-10#95)(2008-11#22)(2008-12#10)(2008-2#18)(2008-3#29)(2008-4#11)(2008-5#18)(2008-6#4)(2008-7#21)(2008-8#12)(2008-9#18)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#5)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#5)(2011-2#25)(2011-3#2)(2012-1#5)(2012-12#9)(2012-2#10)(2012-3#12)(2013-1#25)(2013-7#3)(2013-8#8)
for thoracic surgeons##2##3##(2007-8#1)(2012-1#1)
for thoracic##8##2##(1993-7#1)(2006-10#1)(2007-8#1)(2010-8#1)(2012-1#1)(2012-12#3)
for thorough##5##2##(1991-12#1)(1991-2#1)(1996-3#1)(2008-4#1)(2008-5#1)
for those adding##3##3##(1993-9#3)
for those in the##2##4##(1993-11#1)(2008-9#1)
for those in##3##3##(1993-11#1)(2008-8#1)(2008-9#1)
for those interested in##2##4##(2008-11#1)(2008-9#1)
for those involved##3##3##(1996-8#1)(2008-10#1)(2012-12#1)
for those not##3##3##(1993-1#2)(1994-9#1)
for those of##2##3##(1995-11#1)(2012-12#1)
for those patients##3##3##(2011-2#3)
for those planning##3##3##(1993-1#1)(1995-1#1)(2012-2#1)
for those receiving##2##3##(1993-9#1)(2011-1#1)
for those seeking to##2##4##(2008-1#1)(2011-2#1)
for those seeking##3##3##(1995-12#1)(2008-1#1)(2011-2#1)
for those that##5##3##(1993-12#1)(1997-4#1)(2008-10#2)(2011-2#1)
for those who are##2##4##(2008-6#1)(2013-8#1)
for those who had##2##4##(2008-11#1)(2010-3#1)
for those who##16##3##(1991-12#1)(1991-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-3#1)(2013-1#1)(2013-8#1)
for those whose##2##3##(2007-2#1)(2008-10#1)
for those wishing to##2##4##(2008-4#1)(2012-12#1)
for those with##20##3##(1994-8#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)
for those without##2##3##(2008-3#1)(2012-2#1)
for those##132##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-6#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-9#5)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2008-1#4)(2008-10#12)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#4)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#5)(2009-11#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#14)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
for thousands of genes##2##4##(2008-10#1)(2008-7#1)
for thousands of years##5##4##(1996-11#1)(2008-4#1)(2008-9#1)(2009-1#1)(2011-2#1)
for thousands of##7##3##(1996-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)
for three cases##2##3##(1995-11#1)(2008-3#1)
for three consecutive days##2##4##(1992-3#1)(1995-3#1)
for three consecutive##6##3##(1991-3#1)(1992-3#1)(1995-3#1)(1996-1#1)(2008-10#2)
for three days##5##3##(1991-5#1)(1994-2#1)(2007-12#1)(2008-5#1)(2013-1#1)
for three different##7##3##(1992-3#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
for three hours##2##3##(2008-4#1)(2008-5#1)
for three independent##2##3##(2008-10#1)(2008-9#1)
for three months##9##3##(1990-5#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
for three of the##4##4##(2008-10#3)(2008-3#1)
for three of##5##3##(1992-3#1)(2008-10#3)(2008-3#1)
for three other##3##3##(1990-12#1)(1993-11#1)(2008-11#1)
for three types of##3##4##(2008-10#1)(2008-2#1)(2009-9#1)
for three weeks##8##3##(1991-6#1)(1994-6#1)(2007-11#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
for three years##4##3##(1995-5#1)(1996-9#1)(2008-1#1)(2008-12#1)
for three##105##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-11#4)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
for three-dimensional (3-D)##2##3##(2008-3#2)
for three-dimensional imaging##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
for three-dimensional object recognition##3##4##(2007-11#2)(2008-3#1)
for three-dimensional##21##2##(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#8)(2008-9#1)(2012-2#1)
for threonine##3##2##(1992-6#1)(1993-8#2)
for thrombin##4##2##(1990-5#1)(1990-7#2)(1992-4#1)
for thrombocytopenia##2##2##(2008-8#2)
for thromboembolic##2##2##(2008-8#1)(2012-2#1)
for thromboembolism##2##2##(2008-7#1)(2012-12#1)
for thrombolysis-eligible patients##2##3##(2008-3#1)(2009-11#1)
for thrombosis##5##2##(1994-6#1)(1997-2#1)(2007-2#1)(2008-5#2)
for thymectomy##3##2##(2007-8#3)
for thymic##2##2##(2008-10#1)(2010-8#1)
for thyroid carcinoma##2##3##(2008-7#1)(2012-3#1)
for thyroid##8##2##(1994-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-3#2)
for tibiocalcaneal fusion##2##3##(2009-3#2)
for tilted and offset planes##2##5##(2008-3#2)
for tilted##4##2##(2008-2#1)(2008-3#2)(2011-7#1)
for time##11##2##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
for time-resolved##9##2##(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)
for timely treatment##2##3##(2009-4#1)(2012-3#1)
for timely##7##2##(1991-12#1)(1993-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
for times##2##2##(1992-9#1)(2007-12#1)
for timing of##2##3##(2008-11#1)(2009-5#1)
for tin##4##2##(2008-10#4)
for tinnitus##2##2##(2013-1#2)
for tissue engineering applications##3##4##(2008-11#1)(2010-10#2)
for tissue engineering##12##3##(2008-11#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-10#4)(2010-9#1)(2011-2#1)(2012-12#1)(2012-5#1)
for tissue regeneration and##2##4##(2012-12#1)(2012-3#1)
for tissue regeneration##7##3##(2009-12#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#2)
for tissue##30##2##(1994-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#7)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#2)
for tissue-specific##2##2##(1990-8#1)(1995-9#1)
for titanium##2##2##(2008-10#2)
for titration##2##2##(2008-10#1)(2008-11#1)
for to##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2011-1#1)
for tobacco dependence##2##3##(2010-11#1)(2013-7#1)
for tobacco##4##2##(2008-7#1)(2008-9#1)(2010-11#1)(2013-7#1)
for today##2##2##(1996-3#1)(2008-12#1)
for today's##6##2##(1992-2#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)
for tolerance to##2##3##(2008-10#1)(2008-3#1)
for tolerance##7##2##(1991-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2011-3#1)
for toluene##2##2##(2008-10#1)(2008-7#1)
for tomato##2##2##(2008-10#2)
for tomographic imaging of##2##4##(2007-12#1)(2008-2#1)
for tomographic imaging##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
for tomographic##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
for tomorrow##2##2##(1995-12#1)(1996-1#1)
for too##2##2##(1994-3#1)(2008-11#1)
for tooth replacement##2##3##(2009-8#2)
for tooth##5##2##(1991-2#1)(2009-8#2)(2010-3#1)(2013-1#1)
for topical treatment##2##3##(1990-6#1)(2008-5#1)
for topical##8##2##(1990-6#1)(1993-11#1)(2007-11#1)(2008-5#2)(2009-6#1)(2010-8#1)(2011-2#1)
for total As##2##3##(2008-10#2)
for total absorption##2##3##(2008-3#2)
for total and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
for total arsenic and##2##4##(2008-10#2)
for total cholesterol##4##3##(1992-11#1)(1994-11#1)(2008-10#1)(2011-2#1)
for total chromium##2##3##(2008-10#2)
for total inorganic##5##3##(2008-10#5)
for total knee arthroplasty##4##4##(2008-8#1)(2013-1#3)
for total knee##5##3##(2007-8#1)(2008-8#1)(2013-1#3)
for total mercury##2##3##(2008-10#2)
for total nucleated cell count##2##5##(2008-10#2)
for total protein##2##3##(2008-10#1)(2008-9#1)
for total removal##2##3##(2008-7#2)
for total thyroidectomy##3##3##(2011-2#3)
for total##82##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#1)(2007-8#1)(2008-10#35)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-5#2)(2011-2#5)(2013-1#5)
for toxic##2##2##(2008-10#2)
for toxicity and##2##3##(2008-9#1)(2012-1#1)
for toxicity testing##4##3##(1992-3#1)(2008-11#1)(2011-1#2)
for toxicity to##2##3##(2008-10#1)(2008-6#1)
for toxicity##13##2##(1990-12#1)(1992-3#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#3)(2012-1#1)
for toxicology and##2##3##(2008-9#1)(2011-2#1)
for toxicology##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
for toxin reaction##3##3##(2008-10#3)
for toxin##6##2##(2008-10#6)
for toxoplasmosis##3##2##(1990-9#2)(1996-11#1)
for trace analysis of##2##4##(2008-10#2)
for trace analysis##4##3##(2008-10#4)
for trace determination of##3##4##(2008-10#3)
for trace element determination##3##4##(2008-10#3)
for trace enrichment of metal ions##3##6##(2008-10#3)
for trace gas analysis and##2##5##(2008-10#2)
for trace gas detection##2##4##(2008-2#1)(2013-8#1)
for trace gas##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
for trace metal##4##3##(2007-5#2)(2008-10#2)
for trace metals in##2##4##(2007-5#1)(2008-10#1)
for trace##39##2##(2007-5#3)(2008-10#30)(2008-2#1)(2008-3#3)(2013-8#2)
for traces of##3##3##(2008-10#3)
for tracheostomy##2##2##(2012-12#1)(2012-2#1)
for tracking and##2##3##(2009-4#1)(2010-5#1)
for tracking the##2##3##(2008-2#1)(2008-3#1)
for tracking##7##2##(1997-1#1)(1997-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-5#1)
for traditional##11##2##(1992-1#1)(1993-12#2)(1996-2#1)(1997-2#2)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
for training and testing##2##4##(2010-8#1)(2011-2#1)
for training and##7##3##(1993-1#1)(2007-5#1)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)
for training in##2##3##(1993-12#1)(2008-11#1)
for training the##2##3##(2008-2#1)(2010-1#1)
for training##27##2##(1991-2#1)(1993-1#2)(1993-12#2)(1994-3#1)(1995-2#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2010-1#2)(2010-8#4)(2011-1#2)(2011-2#1)(2012-3#1)
for traits##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
for tramadol##2##2##(2008-10#2)
for transcranial resection##2##3##(2011-2#2)
for transcranial##3##2##(2010-7#1)(2011-2#2)
for transcription factors##2##3##(1990-5#1)(1993-6#1)
for transcription##12##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
for transcription-coupled##2##2##(1994-8#2)
for transcriptional##4##2##(1991-6#1)(1993-3#1)(1993-8#1)(2008-6#1)
for transduction with##2##3##(1990-11#2)
for transduction##3##2##(1990-11#2)(2008-2#1)
for transfection##4##2##(1991-5#1)(2008-1#1)(2008-11#1)(2011-1#1)
for transfer of##2##3##(1992-12#1)(2007-12#1)
for transfer to the##2##4##(1992-4#1)(2008-9#1)
for transfer to##3##3##(1992-4#1)(2008-9#1)(2010-5#1)
for transfer##11##2##(1992-12#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)
for transferrin##3##2##(2008-10#2)(2013-7#1)
for transferring information about##2##4##(1990-8#1)(2012-2#1)
for transferring information##3##3##(1990-8#1)(2010-12#1)(2012-2#1)
for transferring##4##2##(1990-8#1)(2009-6#1)(2010-12#1)(2012-2#1)
for transformation by##2##3##(1990-8#1)(2008-6#1)
for transformation##14##2##(1990-11#1)(1990-8#1)(1992-12#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-6#2)(2009-12#1)(2012-12#1)
for transforming the##2##3##(2008-2#1)(2008-7#1)
for transforming##4##2##(1992-9#1)(2008-2#2)(2008-7#1)
for transfusion##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
for transgene##5##2##(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#1)(2011-2#1)
for transient expression of##2##4##(2008-4#1)(2008-9#1)
for transient expression##5##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
for transient##15##2##(1996-11#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-1#1)
for transition##2##2##(2008-10#2)
for translating##2##2##(1997-1#1)(2008-10#1)
for translation##4##2##(1997-7#1)(2009-10#1)(2010-4#1)(2013-8#1)
for translational##3##2##(1997-6#1)(2010-9#1)(2013-8#1)
for translocation##2##2##(1991-8#1)(2010-10#1)
for transmembrane signaling##3##3##(1992-8#1)(1993-6#1)(1994-5#1)
for transmission and##2##3##(2008-10#1)(2008-3#1)
for transmission electron microscopy##2##4##(2008-10#1)(2008-5#1)
for transmission of##6##3##(1992-11#1)(1996-3#1)(1997-6#1)(2008-12#1)(2008-5#1)(2008-8#1)
for transmission##19##2##(1992-11#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-8#2)(2009-7#1)
for transmissive##2##2##(2008-3#2)
for transmitting a##2##3##(2008-3#1)(2010-1#1)
for transmitting##6##2##(2008-10#1)(2008-2#3)(2008-3#1)(2010-1#1)
for transparent##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
for transplant##2##2##(2008-1#1)(2011-2#1)
for transplantation of##2##3##(2008-10#1)(2011-2#1)
for transplantation##15##2##(1991-3#1)(1994-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)(2010-12#2)(2011-2#3)
for transport##8##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-8#1)
for transposition##2##2##(1996-11#1)(1997-7#1)
for transradial##2##2##(2011-2#2)
for transverse##4##2##(2007-12#2)(2008-3#1)(2008-9#1)
for trapping##2##2##(2008-10#2)
for trauma##5##2##(1991-12#1)(1992-8#1)(2007-10#1)(2008-6#1)(2012-2#1)
for travel health advice##5##4##(2007-2#5)
for travel##9##2##(2007-2#8)(2008-12#1)
for travelers##5##2##(2007-2#2)(2011-2#3)
for traveling-wave##2##2##(2007-12#2)
for travellers from##2##3##(2007-2#2)
for travellers##7##2##(1995-2#1)(2007-2#5)(2010-5#1)
for trazodone##3##2##(1995-2#2)(2008-10#1)
for treated and##2##3##(1991-11#1)(2008-10#1)
for treated##3##2##(1991-11#1)(2008-10#2)
for treating a number of##2##5##(2007-12#1)(2012-2#1)
for treating a##5##3##(2007-12#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
for treating cancer##2##3##(2011-2#1)(2013-1#1)
for treating cardiac arrhythmias##2##4##(2011-2#2)
for treating diseases##2##3##(2008-10#1)(2009-6#1)
for treating patients with##4##4##(2007-7#1)(2008-3#1)(2010-3#1)(2013-1#1)
for treating patients##5##3##(2007-7#1)(2008-3#1)(2008-8#1)(2010-3#1)(2013-1#1)
for treating some##2##3##(1993-6#1)(2009-6#1)
for treating##71##2##(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
for treatment and the##3##4##(1991-2#1)(1996-12#1)(1997-3#1)
for treatment and##15##3##(1991-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-5#1)(2010-7#1)
for treatment effects##2##3##(2008-7#1)(2012-2#1)
for treatment in the##2##4##(1994-12#1)(1996-3#1)
for treatment in##6##3##(1991-11#1)(1992-12#1)(1993-1#1)(1994-12#1)(1996-3#1)(2010-5#1)
for treatment of a##2##4##(2007-11#1)(2007-7#1)
for treatment of bone##2##4##(2007-11#1)(2011-2#1)
for treatment of depression##2##4##(2008-4#2)
for treatment of diseases##2##4##(1994-9#1)(2011-2#1)
for treatment of human##2##4##(1997-4#1)(2010-2#1)
for treatment of hypertension##2##4##(2009-9#1)(2012-12#1)
for treatment of malignant##2##4##(1992-2#1)(2008-5#1)
for treatment of primary tumors##2##5##(2010-3#2)
for treatment of refractory##2##4##(2011-2#2)
for treatment of the##4##4##(1996-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
for treatment of these##2##4##(2008-7#1)(2013-1#1)
for treatment of##116##3##(1990-11#1)(1990-6#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#12)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)
for treatment planning##2##3##(2010-8#1)(2011-2#1)
for treatment should be based on##2##6##(2008-7#1)(2010-5#1)
for treatment varied##2##3##(2007-10#2)
for treatment with##2##3##(1997-3#1)(2007-7#1)
for treatment##182##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-2#3)(1991-4#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#15)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#1)
for treatment-resistant depression##3##3##(2011-1#2)(2012-12#1)
for trend##3##2##(1993-9#1)(1995-2#1)(2007-10#1)
for triage of suspected scaphoid##2##5##(2008-9#2)
for triage of##3##3##(2008-3#1)(2008-9#2)
for trichlorfon##4##2##(2008-10#4)
for trichothecene##2##2##(2008-10#1)(2008-11#1)
for trigeminal neuralgia##4##3##(2008-7#1)(2011-2#2)(2013-1#1)
for triggering##6##2##(1990-5#1)(1992-11#1)(2008-1#1)(2008-8#2)(2012-2#1)
for triglycerides and##2##3##(1994-11#2)
for triglycerides##3##2##(1992-11#1)(1994-11#2)
for trimipramine##2##2##(1995-2#2)
for triplex formation at low##2##5##(1993-8#2)
for triplex formation##6##3##(1993-8#4)(1995-5#2)
for tropical##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
for tropospheric##8##2##(2008-11#1)(2008-2#5)(2008-3#2)
for true breathing-zone sampling##2##4##(2010-5#2)
for true##4##2##(1997-2#1)(2008-3#1)(2010-5#2)
for trunk##2##2##(2008-12#2)
for trypsin-APC and##2##3##(1997-2#2)
for trypsin-APC##3##2##(1997-2#3)
for trypsin-SAPC##3##2##(1997-2#3)
for tubal##4##2##(1991-3#1)(1993-3#1)(2007-7#1)(2011-1#1)
for tuberculosis (TB)##3##3##(1996-3#1)(2013-1#2)
for tuberculosis##14##2##(1990-6#2)(1995-5#1)(1995-9#1)(1996-3#3)(1997-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2013-1#2)(2013-7#1)
for tubular repair##2##3##(2008-8#1)(2013-1#1)
for tumor cell##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
for tumor formation##3##3##(1991-12#1)(1992-2#1)(2007-10#1)
for tumor immunotherapy##3##3##(1994-5#1)(2008-8#1)(2011-2#1)
for tumor initiation##2##3##(2011-2#1)(2012-12#1)
for tumor therapy##2##3##(1992-9#1)(2013-8#1)
for tumor##30##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2010-6#1)(2011-2#4)(2012-12#1)(2013-8#2)
for tumors with##2##3##(1993-11#1)(2013-1#1)
for tumors##6##2##(1993-11#1)(2006-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
for tumour##6##2##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)
for tunable##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
for tuning the##2##3##(2008-2#2)
for tuning##6##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#2)
for turbid coastal##2##3##(2008-3#2)
for turbid##3##2##(2008-3#3)
for twenty-first century##2##3##(1997-1#2)
for twins##2##2##(1997-7#1)(2008-12#1)
for two and three##2##4##(2008-3#1)(2008-9#1)
for two common##2##3##(2008-10#1)(2008-11#1)
for two consecutive##2##3##(1996-4#1)(2013-1#1)
for two days##2##3##(2008-12#1)(2012-2#1)
for two different##7##3##(1991-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-6#1)
for two distinct##3##3##(1993-11#1)(1996-2#1)(2008-6#1)
for two groups of##2##4##(1997-2#1)(2013-1#1)
for two groups##4##3##(1992-6#1)(1997-2#1)(2012-2#1)(2013-1#1)
for two hours##2##3##(2008-11#1)(2008-12#1)
for two months##6##3##(1994-6#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
for two of these##2##4##(1992-8#1)(2008-2#1)
for two of##3##3##(1992-8#1)(2008-2#1)(2008-8#1)
for two or more##4##4##(1994-9#1)(1995-11#1)(2008-9#2)
for two other##2##3##(1995-6#1)(1997-6#1)
for two patients##2##3##(1990-3#1)(2010-7#1)
for two populations##2##3##(2008-10#1)(2013-8#1)
for two rare variants##2##4##(1990-8#1)(1991-8#1)
for two rare##3##3##(1990-8#1)(1991-8#1)(2012-3#1)
for two samples##2##3##(2008-10#2)
for two species##2##3##(2008-10#1)(2008-8#1)
for two to##2##3##(1992-5#1)(1997-5#1)
for two types of##3##4##(2008-3#2)(2010-3#1)
for two weeks and##2##4##(2008-1#1)(2008-12#1)
for two weeks##10##3##(1992-11#1)(1994-12#1)(2006-11#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-5#1)
for two years in Urbana##2##5##(2008-10#2)
for two years##15##3##(1991-8#1)(1992-4#1)(1997-8#2)(2008-1#1)(2008-10#4)(2008-5#1)(2010-11#1)(2011-2#3)(2013-7#1)
for two##157##2##(1990-3#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#17)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
for two- and three-dimensional##2##4##(2008-3#2)
for two-##3##2##(2008-3#2)(2008-9#1)
for two-channel##2##2##(2008-7#1)(2009-2#1)
for two-dimensional##9##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)(2008-9#1)
for two-photon absorption##2##3##(2007-11#1)(2007-12#1)
for two-photon fluorescence microscopy##2##4##(2008-2#1)(2011-1#1)
for two-photon fluorescence##3##3##(2008-2#1)(2011-1#2)
for two-photon##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#2)
for two-step##2##2##(1990-7#1)(1991-9#1)
for type 1##2##3##(2008-2#1)(2009-3#1)
for type 2 diabetes##4##4##(2008-1#1)(2009-11#1)(2010-12#1)(2012-2#1)
for type 2##5##3##(1993-6#1)(2008-1#1)(2009-11#1)(2010-12#1)(2012-2#1)
for type A##3##3##(2007-8#3)
for type I##5##3##(1996-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-7#1)
for type II##4##3##(1994-11#1)(2007-11#1)(2008-10#1)(2008-7#1)
for type##24##2##(1993-6#1)(1994-11#1)(1996-2#1)(2007-11#5)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2012-2#1)
for typical##9##2##(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)
for typing##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
for tyrosinase immobilisation##2##3##(2008-10#2)
for tyrosinase##4##2##(2007-10#1)(2008-10#2)(2008-5#1)
for tyrosine##4##2##(1992-7#1)(1993-9#1)(2008-10#1)(2012-3#1)
for ulcer##2##2##(2012-2#2)
for ulcerative colitis##6##3##(1991-6#1)(2009-5#3)(2012-12#1)(2013-1#1)
for ultra##2##2##(1992-3#1)(2008-10#1)
for ultra-high##2##2##(2008-11#1)(2011-7#1)
for ultrabrief##2##2##(2012-12#2)
for ultrafast all-optical##2##3##(2007-12#1)(2008-3#1)
for ultrafast##10##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)
for ultrasensitive detection of##3##4##(2008-10#1)(2008-3#1)(2010-5#1)
for ultrasensitive##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
for ultrashort pulses##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
for ultrashort##7##2##(2007-11#4)(2007-12#2)(2008-3#1)
for ultrasonic##2##2##(1991-1#1)(2009-5#1)
for ultrasound##4##2##(1993-1#1)(2008-7#1)(2009-7#1)(2010-12#1)
for ultrastructural studies##2##3##(2008-7#2)
for ultrastructural##5##2##(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)
for ultratrace##2##2##(2008-10#2)
for ultraviolet##4##2##(2007-11#1)(2007-12#3)
for unambiguous##2##2##(2008-10#1)(2008-3#1)
for uncertainty##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
for uncovering##3##2##(1995-5#1)(2008-7#2)
for undergraduate education##3##3##(1991-1#1)(1994-2#1)(2013-1#1)
for undergraduate nursing students##5##4##(2008-11#4)(2008-12#1)
for undergraduate##14##2##(1991-1#1)(1994-2#1)(2008-11#6)(2008-12#5)(2013-1#1)
for underserved##3##2##(2011-2#2)(2012-3#1)
for understanding and predicting##2##4##(2007-12#1)(2012-1#1)
for understanding and treating##2##4##(1995-2#1)(2012-12#1)
for understanding and##9##3##(1991-12#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-8#1)(2012-1#1)(2012-12#2)
for understanding of##2##3##(2008-10#1)(2012-3#1)
for understanding the evolution of##3##5##(2008-11#1)(2008-6#1)(2008-8#1)
for understanding the mechanisms##3##4##(1994-8#1)(2008-9#1)(2010-3#1)
for understanding the potential##2##4##(2009-12#1)(2011-2#1)
for understanding the underlying##2##4##(2008-10#1)(2008-2#1)
for understanding the##46##3##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
for understanding why##2##3##(2008-10#1)(2010-4#1)
for understanding##93##2##(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-3#3)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
for undertaking##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
for underwater##2##2##(2008-3#2)
for uniaxial##3##2##(2006-4#2)(2008-3#1)
for uniform##3##2##(2008-2#1)(2008-3#2)
for uniformity##2##2##(1995-3#1)(2008-10#1)
for uniformly##2##2##(1997-6#1)(2007-12#1)
for uninsured##3##2##(2008-11#3)
for union##2##2##(1996-3#1)(1997-6#1)
for unique##7##2##(1992-11#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-2#2)(2013-1#1)
for uniqueness##2##2##(2010-10#2)
for unit##2##2##(2008-3#2)
for universal##5##2##(1991-2#1)(2007-12#1)(2008-8#1)(2010-3#2)
for university##4##2##(1990-3#1)(2009-7#1)(2012-1#1)(2012-3#1)
for unknown##3##2##(1991-5#1)(2008-10#1)(2012-3#1)
for unrelated##3##2##(1997-8#1)(2012-3#1)(2013-7#1)
for unresectable##5##2##(1993-9#1)(1994-3#1)(2008-6#2)(2013-1#1)
for unresolved##2##2##(2008-9#1)(2013-1#1)
for unstable angina and non-ST elevation myocardial infarction##3##8##(2008-3#3)
for unstable angina and##4##4##(2008-3#3)(2008-5#1)
for unstable angina##5##3##(2008-3#3)(2008-5#2)
for unstable##6##2##(2008-3#4)(2008-5#2)
for untreated and NEM-treated cells##3##5##(1995-8#3)
for untreated populations##2##3##(2008-10#1)(2008-6#1)
for untreated##7##2##(1995-8#3)(2008-10#1)(2008-5#2)(2008-6#1)
for unwanted##2##2##(1995-2#1)(2007-2#1)
for unwrapping the phase##2##4##(2008-2#1)(2008-3#1)
for up to 10 days##2##5##(1996-12#1)(2009-7#1)
for up to 12##2##4##(2008-10#1)(2008-7#1)
for up to 120##2##4##(2008-10#1)(2008-12#1)
for up to 14##2##4##(1997-6#1)(2009-12#1)
for up to 15##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
for up to 168 h##2##5##(1992-8#2)
for up to 2 hours##3##5##(1993-8#1)(1994-3#2)
for up to 2 months##2##5##(1996-12#2)
for up to 2 weeks##2##5##(1990-12#1)(2008-10#1)
for up to 2 years##2##5##(2008-7#1)(2010-8#1)
for up to 2##10##4##(1990-12#1)(1993-8#1)(1994-3#2)(1996-12#2)(1996-5#1)(2008-10#1)(2008-7#1)(2010-8#1)
for up to 20##2##4##(2008-11#1)(2008-9#1)
for up to 3##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
for up to 30##3##4##(1991-5#1)(2008-10#2)
for up to 4 months##2##5##(2008-11#2)
for up to 4##5##4##(1993-3#1)(2008-11#3)(2010-9#1)
for up to 48##2##4##(1994-6#1)(2008-10#1)
for up to 5##4##4##(1994-2#1)(2007-5#1)(2008-8#1)(2011-2#1)
for up to 6 days##2##5##(2008-11#2)
for up to 6 months##2##5##(2008-10#2)
for up to 6 weeks##2##5##(2008-10#2)
for up to 6##7##4##(2008-10#4)(2008-11#2)(2008-8#1)
for up to 7 days##2##5##(2008-7#1)(2009-5#1)
for up to 9##2##4##(1995-11#1)(1995-2#1)
for up to 90##2##4##(1997-4#1)(2008-11#1)
for up to eight##2##4##(2008-10#1)(2010-11#1)
for up to four days##2##5##(1992-9#1)(2008-10#1)
for up to four##3##4##(1992-9#1)(1993-2#1)(2008-10#1)
for up to##93##3##(1990-12#1)(1991-11#1)(1991-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
for up##94##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
for updating##3##2##(1992-12#1)(2008-1#1)(2010-8#1)
for upper tract##2##3##(2008-10#1)(2009-5#1)
for upper##9##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)
for upstream##2##2##(1990-11#1)(2008-11#1)
for uptake##2##2##(1992-3#1)(1995-11#1)
for uranium is##2##3##(2008-10#2)
for uranium##7##2##(2008-10#5)(2013-8#2)
for uranium(VI) and thorium(IV) prior to##2##6##(2008-10#2)
for urate##2##2##(1993-8#1)(2008-10#1)
for urban##7##2##(1994-1#1)(1994-2#1)(2008-12#1)(2010-9#2)(2012-1#2)
for uredinium area##2##3##(2008-10#2)
for ureteral##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
for uric acid and##2##4##(2008-10#2)
for uric acid detection##2##4##(2008-10#2)
for uric acid##6##3##(2008-10#6)
for urinary bladder##2##3##(1992-11#1)(2009-2#1)
for urinary tract##2##3##(1993-2#1)(1997-4#1)
for urinary##6##2##(1992-11#1)(1993-2#1)(1993-8#1)(1997-4#1)(2008-10#1)(2009-2#1)
for urine##3##2##(1990-11#1)(2008-10#2)
for us to##7##3##(1992-1#1)(1995-1#1)(2008-3#1)(2010-6#1)(2010-7#1)(2011-2#2)
for use against##2##3##(1993-2#1)(2008-10#1)
for use as a##12##4##(1994-6#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
for use as an##7##4##(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
for use as biomarkers##2##4##(2010-11#1)(2012-12#1)
for use as templates##2##4##(2008-2#1)(2008-7#1)
for use as##36##3##(1990-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#2)(2008-5#3)(2008-7#2)(2009-11#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
for use at##4##3##(1990-12#2)(2008-2#1)(2008-3#1)
for use by##10##3##(1992-3#1)(1993-12#1)(1996-11#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2009-3#1)(2013-1#1)
for use during##4##3##(1994-3#1)(2007-8#1)(2008-12#1)(2010-8#1)
for use in a new##2##5##(2007-8#1)(2008-10#1)
for use in a##10##4##(1990-2#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-8#1)
for use in allergic##2##4##(2008-10#1)(2008-5#1)
for use in an##3##4##(2007-12#1)(2008-3#2)
for use in evaluating##2##4##(1996-3#1)(2009-10#1)
for use in gene##2##4##(2008-10#1)(2010-1#1)
for use in immunoassays##3##4##(2008-10#3)
for use in nursing##2##4##(2008-11#1)(2010-11#1)
for use in optical##3##4##(2007-11#1)(2008-3#2)
for use in patients with##2##5##(2007-12#1)(2007-7#1)
for use in studies of##2##5##(1993-12#1)(1993-8#1)
for use in the construction of##2##6##(2008-10#1)(2008-9#1)
for use in the##19##4##(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-3#1)(2013-1#1)
for use in this##2##4##(2008-1#1)(2008-8#1)
for use in##176##3##(1990-2#1)(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#3)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-3#1)(1997-6#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#3)(2008-2#9)(2008-3#22)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#2)
for use of the##3##4##(1996-9#1)(2008-7#1)(2009-11#1)
for use of these##2##4##(2007-12#1)(2008-2#1)
for use of##14##3##(1990-3#1)(1993-6#1)(1994-9#1)(1995-1#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
for use on a##3##4##(2007-11#1)(2008-3#1)(2008-4#1)
for use on##6##3##(1991-2#1)(1992-6#1)(2007-11#1)(2008-3#2)(2008-4#1)
for use over##2##3##(2008-3#1)(2008-7#1)
for use with a##2##4##(1997-3#1)(2007-9#1)
for use with children##2##4##(2008-9#1)(2010-5#1)
for use with other##2##4##(1996-2#1)(2008-10#1)
for use with the##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
for use with##32##3##(1996-2#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#3)(2008-4#5)(2008-6#2)(2008-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2012-3#1)(2013-1#1)
for use within##3##3##(2008-10#1)(2008-2#2)
for use##305##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#1)(1997-1#3)(1997-3#2)(1997-6#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#47)(2008-11#11)(2008-12#5)(2008-2#25)(2008-3#33)(2008-4#8)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#6)(2013-8#3)
for user facilities##2##3##(1993-3#2)
for users of##2##3##(1991-3#1)(2008-4#1)
for users##5##2##(1991-3#1)(1994-2#1)(2008-4#1)(2010-5#1)(2011-2#1)
for using a##2##3##(1990-11#1)(2008-2#1)
for using an##2##3##(2007-2#1)(2009-12#1)
for using technology##2##3##(2008-11#1)(2010-3#1)
for using the##6##3##(2007-7#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#1)
for using this##5##3##(1992-5#1)(1996-5#1)(2008-11#2)(2008-5#1)
for using##42##2##(1990-11#1)(1991-1#1)(1992-5#1)(1994-11#1)(1996-3#2)(1996-5#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#1)(2012-5#1)
for uterine##4##2##(2010-12#1)(2012-12#2)(2012-2#1)
for utility##2##2##(2010-8#1)(2013-1#1)
for utilization in##2##3##(2007-11#1)(2009-11#1)
for utilization##5##2##(1993-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-11#1)
for vaccination##5##2##(1996-1#2)(2007-11#1)(2008-4#1)(2011-1#1)
for vaccine##2##2##(1993-3#1)(2008-5#1)
for vaccines##4##2##(1995-5#2)(2008-9#1)(2011-2#1)
for vacuum##2##2##(2008-11#1)(2013-1#1)
for vaginal##7##2##(1991-3#1)(1992-1#1)(1993-1#1)(1993-12#1)(2009-2#2)(2010-7#1)
for validating##3##2##(2008-8#1)(2008-9#1)(2009-4#1)
for validation of##2##3##(2008-10#1)(2008-7#1)
for validation studies##2##3##(2008-10#1)(2008-3#1)
for validation##8##2##(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#2)
for validity##3##2##(1994-12#1)(2008-5#1)(2011-1#1)
for valine##2##2##(1992-8#1)(2008-10#1)
for valsartan##2##2##(2011-1#2)
for values in##2##3##(2008-10#2)
for values##3##2##(2008-10#2)(2008-5#1)
for valve##3##2##(2007-8#3)
for valvular heart surgery##6##4##(2013-1#6)
for valvular heart##7##3##(2007-8#1)(2013-1#6)
for vanadium and 0##2##4##(2008-10#2)
for vanadium and##3##3##(2008-10#3)
for vanadium##9##2##(2008-10#9)
for vanadium(IV) and##2##3##(2008-10#2)
for variability##2##2##(2008-10#1)(2008-4#1)
for variable selection##4##3##(2008-10#2)(2010-1#1)(2012-12#1)
for variable##8##2##(1991-5#1)(1994-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-1#1)(2012-12#1)
for variables##4##2##(1996-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
for variance##3##2##(1994-9#1)(1995-12#1)(2008-9#1)
for variation at 16 putative random amplified polymorphic DNA##2##9##(2008-10#2)
for variation at##3##3##(2008-10#3)
for variation in##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
for variation##10##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
for variations in the##3##4##(2007-11#1)(2008-1#1)(2008-6#1)
for variations in##4##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)
for variations##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
for various biomedical applications##2##4##(2008-5#2)
for various biomedical##3##3##(2008-5#2)(2010-4#1)
for various indications##3##3##(2008-1#1)(2008-11#2)
for various periods of time##3##5##(1990-12#1)(1996-2#1)(1997-7#1)
for various periods##4##3##(1990-12#1)(1996-2#1)(1997-7#1)(2008-10#1)
for various purposes##4##3##(1990-3#1)(2008-1#1)(2010-10#1)(2013-7#1)
for various quadrat sizes suggested##2##5##(2008-10#2)
for various reasons##6##3##(1993-3#1)(1994-5#1)(1995-5#1)(2008-5#1)(2012-12#1)(2013-8#1)
for various refractive indices##2##4##(2007-11#1)(2008-3#1)
for various types of##8##4##(1991-2#1)(1993-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2009-9#1)
for various##119##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#18)(2008-11#5)(2008-2#7)(2008-3#22)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
for varying periods of time##3##5##(1995-2#1)(2008-1#1)(2008-10#1)
for varying times##3##3##(1993-6#1)(1993-8#2)
for varying##15##2##(1991-12#1)(1993-6#1)(1993-8#2)(1995-2#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#1)
for vascular disease##2##3##(2008-1#1)(2010-1#1)
for vascular endothelial##2##3##(1992-9#1)(1994-3#1)
for vascular##15##2##(1991-9#1)(1992-9#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
for vector##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
for vegetative compatibility groups (VCGs)##2##5##(2008-10#2)
for vegetative compatibility##5##3##(2008-10#5)
for vegetative##6##2##(2008-10#6)
for velocity##3##2##(2007-12#1)(2008-3#2)
for venous thromboembolic##2##3##(2007-8#1)(2013-1#1)
for venous thromboembolism##2##3##(1993-5#1)(2007-10#1)
for venous##5##2##(1993-5#1)(2007-10#2)(2007-8#1)(2013-1#1)
for verb##2##2##(2012-1#2)
for verifiable##2##2##(1994-6#2)
for verification of the##2##4##(2008-4#1)(2009-2#1)
for verification of##3##3##(2008-4#1)(2009-2#2)
for vertebral##2##2##(2008-7#2)
for vertebrobasilar##2##2##(2008-12#1)(2008-7#1)
for vertical micromirror##2##3##(2007-11#2)
for vertical##4##2##(2007-11#2)(2008-9#2)
for very##6##2##(1990-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)
for vesicles of##2##3##(1990-2#1)(1994-5#1)
for vesicles##3##2##(1990-2#1)(1994-5#1)(1997-6#1)
for veterans##3##2##(2011-1#1)(2011-2#1)(2012-1#1)
for veterinary and##2##3##(2007-12#1)(2011-2#1)
for veterinary##4##2##(1993-2#1)(1997-7#1)(2007-12#1)(2011-2#1)
for viability##10##2##(1993-9#1)(1994-2#1)(1995-3#1)(1997-3#1)(1997-7#1)(2008-10#3)(2009-2#1)(2011-1#1)
for vibration##2##2##(2008-3#2)
for video-assisted thoracoscopic##2##3##(2007-8#2)
for video-rate##2##2##(2011-1#2)
for viewing##3##2##(2008-3#1)(2008-4#1)(2010-7#1)
for vimentin and##3##3##(2008-11#1)(2010-12#1)(2011-1#1)
for violence##8##2##(1995-2#1)(1996-12#1)(2008-9#1)(2011-1#2)(2013-1#1)(2013-8#2)
for viral and##2##3##(2008-11#1)(2009-4#1)
for viral replication##2##3##(1994-8#1)(1997-3#1)
for viral##20##2##(1990-6#1)(1994-11#1)(1994-8#1)(1995-9#1)(1997-3#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-8#1)(2009-4#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
for virtual##3##2##(2008-3#1)(2008-6#1)(2009-4#1)
for virulence against Mi##2##4##(2008-10#2)
for virulence and##4##3##(2008-10#3)(2011-10#1)
for virulence on##5##3##(2008-10#5)
for virulence phenotypes on##2##4##(2008-10#2)
for virulence to##5##3##(2008-10#5)
for virulence##31##2##(2008-10#27)(2008-8#1)(2008-9#1)(2009-2#1)(2011-10#1)
for virus resistance##4##3##(2008-10#4)
for virus##8##2##(2007-6#1)(2008-10#5)(2008-9#1)(2012-2#1)
for virus-resistant cultivars##2##3##(2008-10#2)
for viruses or##2##3##(1995-2#1)(2008-10#1)
for viruses##5##2##(1995-2#1)(1997-6#1)(2008-10#3)
for visceral leishmaniasis##2##3##(1990-7#1)(2008-8#1)
for visceral##3##2##(1990-7#1)(2008-3#1)(2008-8#1)
for visible imaging polarimetry##2##4##(2008-3#2)
for visible light##3##3##(2007-12#2)(2013-8#1)
for visible##10##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)(2013-8#1)
for vision##4##2##(2007-11#2)(2007-5#1)(2011-2#1)
for visual and quantitative analysis of different tastes using##2##9##(2008-10#2)
for visual perception##2##3##(2008-3#1)(2008-9#1)
for visual##8##2##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)
for visualisation of##3##3##(2008-10#2)(2011-3#1)
for visualisation##4##2##(2008-10#2)(2011-3#2)
for visualization of##7##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)
for visualization##10##2##(2007-11#2)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
for visualizing and##2##3##(2008-4#1)(2012-2#1)
for visualizing##9##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
for vital##2##2##(2011-2#1)(2012-2#1)
for vitamin A##4##3##(1991-8#1)(2007-11#1)(2008-5#1)(2012-1#1)
for vitamin##7##2##(1991-8#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-1#1)
for vitellogenin##2##2##(2008-10#1)(2008-6#1)
for vocational##2##2##(2008-12#1)(2010-9#1)
for voltammetric determination of trace amount of##2##7##(2008-10#2)
for voltammetric##4##2##(2008-10#3)(2010-6#1)
for volume holographic##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for volume##15##2##(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#1)
for volunteer programs##3##3##(1994-2#3)
for volunteer##4##2##(1993-2#1)(1994-2#3)
for vortices##2##2##(2007-11#2)
for vulnerable populations##5##3##(1995-12#2)(1997-2#1)(2011-2#1)(2012-2#1)
for vulnerable##8##2##(1995-12#2)(1997-2#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-8#2)
for waiting##3##2##(1991-11#2)(2008-8#1)
for waiver##2##2##(1993-1#1)(2012-3#1)
for walking##2##2##(2008-8#1)(2012-12#1)
for washing##2##2##(1994-6#1)(2008-10#1)
for waste##4##2##(1990-4#1)(2008-10#1)(2008-12#2)
for wastewater quality monitoring##3##4##(2008-10#3)
for wastewater##4##2##(2008-10#3)(2013-1#1)
for water disinfection##2##3##(2008-10#2)
for water in##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
for water samples##3##3##(2008-10#3)
for water vapor##3##3##(2008-2#1)(2008-3#2)
for water##35##2##(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-8#1)
for water-dissolved oxygen sensing##2##4##(2008-10#2)
for water-leaving##2##2##(2008-3#2)
for water-vapor##4##2##(2008-2#4)
for wave-front##4##2##(2008-2#1)(2008-3#3)
for waveguide##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
for wavelength selection in##2##4##(2008-10#1)(2008-9#1)
for wavelength selection##4##3##(2008-10#2)(2008-9#2)
for wavelength##11##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#2)
for wavelength-division multiplexed##2##3##(2007-12#2)
for wavelength-division multiplexing applications##2##4##(2007-11#1)(2008-3#1)
for wavelength-division multiplexing##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
for wavelength-division##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
for wavelengths from##4##3##(2007-11#2)(2008-3#2)
for wavelengths of##3##3##(2008-2#1)(2008-3#2)
for wavelengths ranging from##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
for wavelengths##14##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#7)
for ways in which##2##4##(2008-2#1)(2008-8#1)
for ways to##4##3##(1990-4#1)(1996-12#1)(1996-3#1)(1997-3#1)
for ways##6##2##(1990-4#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-2#1)(2008-8#1)
for weak##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2009-7#1)
for weakly##2##2##(2007-12#1)(2008-2#1)
for weaning##3##2##(1997-4#3)
for wear##3##2##(2008-8#2)(2013-1#1)
for weeks##2##2##(2007-10#1)(2009-12#1)
for weight loss and##2##4##(2008-3#2)
for weight loss##7##3##(2008-10#1)(2008-3#3)(2008-5#1)(2012-2#1)(2013-8#1)
for weight##12##2##(2008-10#1)(2008-3#4)(2008-5#3)(2009-5#1)(2012-2#2)(2013-8#1)
for well##3##2##(1990-5#1)(1997-4#1)(2008-7#1)
for well-being##2##2##(2008-12#1)(2010-10#1)
for western##2##2##(1991-12#1)(2013-8#1)
for what is believed to be the first time for##2##10##(2007-11#1)(2007-12#1)
for what is believed to be the first time##14##9##(2007-11#10)(2007-12#4)
for what is to our knowledge the first time##6##9##(2007-12#5)(2008-3#1)
for what is to##7##4##(2007-12#5)(2008-2#1)(2008-3#1)
for what is##25##3##(2007-11#10)(2007-12#10)(2008-12#1)(2008-2#2)(2008-3#1)(2010-4#1)
for what it##2##3##(2012-3#2)
for what the##2##3##(1992-6#1)(1994-12#1)
for what they##6##3##(1992-12#3)(1995-1#1)(2009-7#1)(2009-9#1)
for what we believe is the first time##4##8##(2007-12#3)(2008-3#1)
for what we believe to be the first time##2##9##(2007-12#1)(2008-3#1)
for what we believe to be##3##6##(2007-12#1)(2008-3#2)
for what we believe##7##4##(2007-12#4)(2008-3#3)
for what##44##2##(1992-12#3)(1992-6#1)(1994-12#1)(1995-1#1)(2007-11#10)(2007-12#14)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2012-3#2)
for wheat powdery mildew resistance in##2##6##(2008-10#2)
for wheat##12##2##(1997-3#1)(2008-10#10)(2008-5#1)
for which a##13##3##(1995-2#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-7#1)
for which an##3##3##(1997-7#1)(2008-3#2)
for which both##2##3##(1994-8#1)(2008-3#1)
for which data##2##3##(1997-3#1)(2012-12#1)
for which it is##4##4##(1996-5#2)(2008-2#1)(2008-3#1)
for which it##8##3##(1993-2#1)(1996-5#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
for which no##7##3##(1992-5#1)(1994-2#1)(1997-2#1)(2008-10#3)(2008-8#1)
for which only##2##3##(2008-9#1)(2010-11#1)
for which some##2##3##(1994-3#1)(2008-7#1)
for which such##2##3##(2007-11#1)(2008-10#1)
for which sufficient data##2##4##(1992-11#1)(2008-8#1)
for which the maximum##2##4##(2008-2#1)(2008-3#1)
for which the name##7##4##(2008-10#7)
for which the transmission##2##4##(2008-10#1)(2008-3#1)
for which the##52##3##(1991-12#1)(1991-5#1)(1992-8#1)(1996-4#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-2#4)(2008-3#13)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2013-1#2)
for which there are no##3##5##(1995-5#1)(2008-10#2)
for which there are##7##4##(1993-12#1)(1995-5#1)(2006-7#1)(2008-10#2)(2008-3#2)
for which there is a##2##5##(2007-11#1)(2011-1#1)
for which there is no##4##5##(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
for which there is##9##4##(1994-12#1)(1996-9#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
for which there##18##3##(1993-12#1)(1994-12#1)(1995-5#1)(1996-9#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
for which they are##4##4##(1993-1#1)(1996-12#1)(2008-10#1)(2008-9#1)
for which they##8##3##(1993-1#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-9#2)(2010-11#1)(2013-7#1)
for which this##5##3##(1990-6#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
for which treatment##2##3##(2008-6#1)(2013-1#1)
for which we##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
for which##229##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#46)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#32)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#2)(2009-5#3)(2010-10#2)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#4)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#2)
for white crests##2##3##(2008-9#2)
for white lies##2##3##(2008-1#2)
for white wines and 0##2##5##(2008-10#2)
for white wines##4##3##(2008-10#4)
for white##11##2##(2008-1#2)(2008-10#5)(2008-2#1)(2008-9#2)(2013-8#1)
for white-light##2##2##(2008-3#2)
for whites##2##2##(2011-1#1)(2011-2#1)
for whole blood##2##3##(1993-2#1)(2010-4#1)
for whole milk##3##3##(2008-10#2)(2011-1#1)
for whole pelvic lymph node##2##5##(2013-1#2)
for whole pelvic##3##3##(2013-1#3)
for whole##15##2##(1993-2#1)(1996-5#1)(2008-1#2)(2008-10#4)(2008-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
for whom a##2##3##(1995-5#1)(1996-1#1)
for whom follow-up information was available##2##6##(1991-12#1)(2008-7#1)
for whom it##2##3##(2012-3#2)
for whom no##3##3##(1990-2#1)(1992-3#1)(2007-8#1)
for whom the##2##3##(1990-6#1)(2008-7#1)
for whom##32##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-3#3)(1993-11#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
for why##3##2##(2007-4#1)(2008-3#1)(2010-8#1)
for wide##2##2##(2008-10#1)(2008-3#1)
for wideband##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
for widespread##6##2##(1993-8#1)(2008-10#3)(2008-11#1)(2009-5#1)
for wild##2##2##(1991-8#1)(1994-12#1)
for wild-type and##2##3##(2008-10#1)(2008-8#1)
for wild-type##3##2##(2008-10#2)(2008-8#1)
for wind and##2##3##(2008-10#1)(2008-3#1)
for wind measurements##2##3##(2008-3#2)
for wind##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
for winter##2##2##(2008-10#1)(2008-12#1)
for with##5##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)
for within##3##2##(2010-11#1)(2010-12#2)
for within-person variability##3##3##(1992-6#3)
for within-run##2##2##(2008-10#2)
for women aged 50 to 69 years##2##7##(2012-12#2)
for women aged##3##3##(1992-10#1)(2012-12#2)
for women and##8##3##(1990-6#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-4#1)(2007-10#1)(2008-3#1)(2009-7#1)
for women in##3##3##(1996-8#1)(2008-11#1)(2013-1#1)
for women than##2##3##(2010-4#1)(2011-2#1)
for women who are##2##4##(1995-9#1)(1997-1#1)
for women who##3##3##(1995-9#1)(1997-1#1)(2013-1#1)
for women with a##2##4##(1990-9#1)(2008-8#1)
for women with breast cancer##3##5##(1994-3#1)(2008-4#1)(2011-2#1)
for women with##8##3##(1990-9#1)(1994-3#1)(1996-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
for women##63##2##(1990-6#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-12#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#4)(2013-8#1)
for women's##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
for wood##3##2##(2008-3#1)(2008-9#1)(2010-4#1)
for work##5##2##(1995-1#1)(1995-6#1)(2008-4#1)(2010-7#1)(2011-1#1)
for workers##2##2##(2010-4#1)(2011-2#1)
for working with##9##3##(2008-10#1)(2008-4#2)(2008-9#4)(2010-3#1)(2010-8#1)
for working##11##2##(1991-12#1)(2008-10#2)(2008-4#2)(2008-9#4)(2010-3#1)(2010-8#1)
for worsening##2##2##(2012-12#1)(2013-1#1)
for wound closure##2##3##(1992-2#1)(2008-4#1)
for wound healing##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
for wound##9##2##(1992-1#1)(1992-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#3)
for write-once##2##2##(2008-3#2)
for writing and##2##3##(2007-12#1)(2008-3#1)
for writing##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
for x##3##2##(2007-11#2)(2008-2#1)
for x-ray##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
for xylan##2##2##(2011-1#1)(2013-1#1)
for years and##2##3##(1995-2#1)(1995-9#1)
for years in##4##3##(1997-8#1)(2008-7#1)(2011-2#2)
for years that##2##3##(2008-1#1)(2008-11#1)
for years to##2##3##(1993-2#1)(2012-12#1)
for years##27##2##(1991-11#1)(1991-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)
for yeast RNA##6##3##(2008-10#6)
for yeast##18##2##(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1997-3#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-1#1)(2012-3#1)
for yeasts##2##2##(2008-9#2)
for yield and##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
for you##4##2##(1994-3#2)(1996-3#2)
for young children##5##3##(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
for young people in##2##4##(2008-10#1)(2008-7#1)
for young people##5##3##(2008-10#1)(2008-7#3)(2011-2#1)
for young women with breast cancer##2##6##(2013-1#2)
for young women with##3##4##(2008-9#1)(2013-1#2)
for young women##6##3##(1996-12#1)(2008-11#1)(2008-9#1)(2010-3#1)(2013-1#2)
for young##27##2##(1990-3#1)(1991-11#1)(1992-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#3)
for younger##3##2##(1991-5#1)(2008-3#1)(2010-8#1)
for your health care##2##4##(1991-1#1)(1994-3#1)
for your medical##2##3##(1992-1#1)(2013-7#1)
for your organization##2##3##(1996-1#1)(1996-2#1)
for your##27##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-2#2)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1996-1#1)(1996-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2010-9#1)(2011-2#3)(2013-7#1)(2013-8#2)
for youth development##2##3##(2008-7#1)(2009-7#1)
for youth who##2##3##(2009-6#1)(2010-1#1)
for youth with special health care needs##2##7##(2008-11#1)(2011-1#1)
for youth with##5##3##(2008-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
for youth##13##2##(2008-11#2)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
for ytterbium##2##2##(2008-10#2)
for zinc and##2##3##(2008-10#2)
for zinc determination in##4##4##(2008-10#4)
for zinc determination##5##3##(2008-10#5)
for zinc is 0##2##4##(2008-10#2)
for zinc##17##2##(1992-3#1)(2008-10#15)(2010-10#1)
for β-cell##2##2##(2012-12#1)(2012-2#1)
for##67778##1##(1990-10#24)(1990-11#168)(1990-12#229)(1990-2#179)(1990-3#103)(1990-4#15)(1990-5#202)(1990-6#102)(1990-7#91)(1990-8#240)(1990-9#92)(1991-1#148)(1991-10#6)(1991-11#92)(1991-12#301)(1991-2#247)(1991-3#180)(1991-4#14)(1991-5#203)(1991-6#166)(1991-7#29)(1991-8#130)(1991-9#159)(1992-1#140)(1992-10#66)(1992-11#147)(1992-12#293)(1992-2#212)(1992-3#398)(1992-4#44)(1992-5#120)(1992-6#227)(1992-7#8)(1992-8#169)(1992-9#167)(1993-1#160)(1993-10#10)(1993-11#187)(1993-12#362)(1993-2#204)(1993-3#270)(1993-5#33)(1993-6#164)(1993-7#2)(1993-8#191)(1993-9#160)(1994-1#148)(1994-10#2)(1994-11#193)(1994-12#339)(1994-2#302)(1994-3#285)(1994-5#222)(1994-6#167)(1994-7#42)(1994-8#234)(1994-9#157)(1995-1#162)(1995-10#3)(1995-11#161)(1995-12#409)(1995-2#480)(1995-3#276)(1995-4#15)(1995-5#220)(1995-6#261)(1995-8#135)(1995-9#89)(1996-1#186)(1996-10#9)(1996-11#73)(1996-12#410)(1996-2#402)(1996-3#299)(1996-4#44)(1996-5#233)(1996-6#101)(1996-7#39)(1996-8#55)(1996-9#70)(1997-1#204)(1997-2#390)(1997-3#320)(1997-4#285)(1997-5#152)(1997-6#160)(1997-7#263)(1997-8#170)(1997-9#13)(2006-10#85)(2006-11#3)(2006-12#27)(2006-4#14)(2006-5#7)(2006-6#24)(2006-7#8)(2006-8#7)(2006-9#1)(2007-1#11)(2007-10#261)(2007-11#1085)(2007-12#1316)(2007-2#127)(2007-3#12)(2007-4#35)(2007-5#92)(2007-6#63)(2007-7#350)(2007-8#463)(2007-9#33)(2008-1#691)(2008-10#15368)(2008-11#2441)(2008-12#941)(2008-2#2172)(2008-3#4131)(2008-4#1466)(2008-5#1322)(2008-6#684)(2008-7#1911)(2008-8#1238)(2008-9#1584)(2009-1#45)(2009-10#225)(2009-11#229)(2009-12#213)(2009-2#125)(2009-3#162)(2009-4#134)(2009-5#268)(2009-6#166)(2009-7#251)(2009-8#290)(2009-9#201)(2010-1#122)(2010-10#210)(2010-11#275)(2010-12#326)(2010-2#149)(2010-3#321)(2010-4#266)(2010-5#318)(2010-6#194)(2010-7#196)(2010-8#503)(2010-9#123)(2011-1#833)(2011-10#16)(2011-2#2220)(2011-3#105)(2011-7#28)(2011-8#2)(2011-9#5)(2012-1#290)(2012-12#855)(2012-2#1265)(2012-3#915)(2012-4#10)(2012-5#22)(2012-6#14)(2012-7#7)(2012-8#10)(2012-9#6)(2013-1#1812)(2013-3#4)(2013-7#186)(2013-8#854)
for-profit and nonprofit hospitals##2##4##(1995-1#2)
for-profit and##3##2##(1993-2#1)(1995-1#2)
for-profit hospitals##3##2##(1992-12#1)(1995-1#1)(2008-11#1)
for-profit organizations##2##2##(1991-12#1)(1992-3#1)
for-profit##19##1##(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#3)(1993-2#1)(1995-1#3)(1995-2#1)(1996-1#1)(2008-11#3)(2008-12#1)(2008-5#1)
for?##3##1##(1994-2#1)(2007-12#1)(2007-7#1)
forH##4##1##(2008-8#4)
forage and##2##2##(2008-10#1)(2008-9#1)
forage bermudagrass##2##2##(2008-10#2)
forage for##2##2##(2008-6#1)(2008-9#1)
forage legume##2##2##(2008-10#2)
forage yield##2##2##(2008-10#2)
forage##28##1##(2008-10#11)(2008-12#1)(2008-6#1)(2008-9#8)(2009-10#2)(2009-4#2)(2009-8#1)(2010-8#2)
forager distributions##2##2##(2008-9#2)
forager##5##1##(1992-3#1)(2008-9#4)
foragers in##2##2##(2008-9#2)
foragers##22##1##(2007-12#4)(2008-10#1)(2008-8#7)(2008-9#10)
forages##3##1##(2008-6#2)(2008-8#1)
foraging and##2##2##(2008-9#2)
foraging bees##2##2##(2007-12#2)
foraging behavior of##2##3##(2008-8#2)
foraging behavior##3##2##(2008-8#3)
foraging in the##2##3##(2008-8#1)(2009-6#1)
foraging in##6##2##(2008-8#3)(2008-9#2)(2009-6#1)
foraging on a##2##3##(2008-9#2)
foraging performance##3##2##(2008-9#3)
foraging strategies##3##2##(2008-9#3)
foraging theory##3##2##(2008-8#1)(2008-9#2)
foraging##73##1##(1995-2#2)(2007-12#2)(2008-5#2)(2008-7#1)(2008-8#16)(2008-9#36)(2009-6#2)(2009-8#2)(2009-9#1)(2010-8#2)(2011-2#5)(2012-3#1)(2013-8#1)
foramen and##3##2##(2012-3#1)(2013-8#2)
foramen is##2##2##(2007-8#1)(2012-12#1)
foramen magnum##5##2##(1996-9#2)(2008-7#2)(2011-2#1)
foramen ovale and##6##3##(1996-11#2)(1996-3#1)(2007-10#1)(2007-9#1)(2008-7#1)
foramen ovale in##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
foramen ovale##25##2##(1996-11#2)(1996-3#1)(1996-6#2)(2007-10#3)(2007-12#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-7#3)(2009-10#1)(2011-2#6)(2012-2#1)
foramen was##4##2##(2013-8#4)
foramen##58##1##(1996-11#2)(1996-3#1)(1996-6#2)(1996-9#2)(1997-8#2)(2007-10#3)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#7)(2008-9#1)(2009-10#1)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#13)
foramens##2##1##(2007-11#1)(2013-8#1)
foramina##3##1##(2006-12#1)(2013-8#2)
foraminal##3##1##(1997-8#2)(2011-2#1)
forbidden in##2##2##(1991-6#1)(2008-9#1)
forbidden##13##1##(1991-6#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
force a##2##2##(1995-1#1)(2008-10#1)
force acting on a dielectric sphere##2##6##(2008-2#2)
force and the##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
force and torque##3##3##(2008-3#3)
force and##20##2##(1991-3#1)(1993-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-7#1)(2011-2#2)(2013-1#1)
force applied##2##2##(2008-6#1)(2009-4#1)
force as##2##2##(1992-8#1)(1994-2#1)
force at the##2##3##(2009-7#1)(2013-1#1)
force at##3##2##(1991-8#1)(2009-7#1)(2013-1#1)
force balance##4##2##(2007-12#1)(2009-7#3)
force behind##5##2##(1995-12#1)(1995-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
force being##2##2##(1993-12#1)(2009-4#1)
force between the##5##3##(2007-11#1)(2008-10#3)(2008-5#1)
force between##7##2##(2007-11#1)(2008-10#4)(2008-5#2)
force by##3##2##(1997-2#2)(2009-2#1)
force control##5##2##(2007-12#1)(2013-1#4)
force detection##2##2##(2007-12#1)(2008-7#1)
force development##3##2##(1995-12#2)(2008-11#1)
force dissipation and##2##3##(2008-11#2)
force distribution##2##2##(2008-7#2)
force during##2##2##(2008-12#1)(2012-12#1)
force effects##3##2##(2008-10#1)(2008-3#2)
force exerted on##2##3##(2007-11#1)(2008-10#1)
force exerted##5##2##(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#1)
force field and##2##3##(2008-10#1)(2011-2#1)
force field##11##2##(2008-10#2)(2008-11#2)(2008-4#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-2#2)
force fields##3##2##(1996-5#1)(2008-11#1)(2010-2#1)
force for the##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
force for##13##2##(1994-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2013-1#1)(2013-8#2)
force has##2##2##(1991-3#1)(2007-8#1)
force in the evolution of##2##5##(2008-10#1)(2008-9#1)
force in the##7##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-9#2)(2011-1#1)(2012-12#1)
force in this##2##3##(1995-3#1)(2008-5#1)
force in##16##2##(1994-5#1)(1995-12#1)(1995-3#2)(2007-11#3)(2008-10#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
force is##3##2##(1991-2#1)(1995-2#1)(2007-11#1)
force like expression##2##3##(2008-11#2)
force mapping of##2##3##(2009-5#2)
force measurements##4##2##(2008-10#1)(2008-5#2)(2009-12#1)
force microscope has##2##3##(1994-9#1)(2008-4#1)
force microscope##17##2##(1994-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#2)(2013-8#1)
force microscopy (AFM) and##5##4##(2008-10#2)(2009-11#2)(2009-7#1)
force microscopy (AFM)##26##3##(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-7#2)(2012-2#1)
force microscopy and##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2012-2#1)
force microscopy##74##2##(1993-6#1)(1994-9#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#10)(2008-3#6)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#3)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
force of 293 cells##2##4##(2008-11#2)
force of FF units##2##4##(2013-8#2)
force of contraction##3##3##(1992-9#1)(1995-12#1)(1997-7#1)
force of infection was 0##2##5##(2012-12#2)
force of infection##4##3##(1994-9#1)(2012-12#3)
force of the##2##3##(2008-5#1)(2010-5#1)
force of##26##2##(1991-12#1)(1992-9#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#2)(2010-5#1)(2012-12#5)(2012-3#2)(2013-1#1)(2013-8#2)
force on a##2##3##(2008-2#1)(2011-1#1)
force on the##4##3##(2007-12#2)(2008-5#1)(2009-4#1)
force on##9##2##(1994-12#1)(1995-5#1)(2007-12#2)(2008-2#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-1#1)
force planning in the 90s##2##5##(1994-1#1)(1994-2#1)
force planning in##3##3##(1994-1#2)(1994-2#1)
force planning##4##2##(1994-1#2)(1994-2#2)
force plate##5##2##(2008-10#2)(2010-12#1)(2010-3#1)(2010-9#1)
force platform##2##2##(1995-5#1)(2011-2#1)
force produced##2##2##(2009-3#1)(2010-3#1)
force spectroscopy##2##2##(2009-9#2)
force taken by the 0##2##5##(2007-8#2)
force the##2##2##(1997-7#1)(2008-8#1)
force through##3##2##(1991-9#1)(2008-12#2)
force to##6##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
force values##3##2##(2008-12#2)(2010-4#1)
force was##6##2##(1994-1#1)(2008-10#2)(2008-4#1)(2009-9#1)(2010-4#1)
force will##2##2##(1991-1#1)(2008-11#1)
force within##3##2##(1996-9#2)(1997-2#1)
force without##2##2##(2008-10#2)
force##450##1##(1990-2#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-1#6)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#2)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#3)(1997-2#9)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2007-11#10)(2007-12#19)(2007-8#3)(2008-1#3)(2008-10#57)(2008-11#21)(2008-12#5)(2008-2#21)(2008-3#22)(2008-4#4)(2008-5#22)(2008-6#4)(2008-7#17)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#7)(2009-7#8)(2009-9#10)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#6)(2010-3#3)(2010-4#14)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#8)(2012-2#11)(2012-3#4)(2012-7#2)(2013-1#21)(2013-8#6)
force&quot##3##1##(1991-3#1)(1995-5#1)(2008-8#1)
force)##2##1##(1994-8#1)(2008-10#1)
force-frequency##2##1##(2013-8#2)
force/torque measurements##2##2##(2013-1#2)
force/torque##3##1##(2013-1#3)
forced and##2##2##(1995-5#1)(2012-3#1)
forced choice##2##2##(1990-11#1)(2012-1#1)
forced eruption of##2##3##(2007-12#2)
forced eruption##3##2##(2007-12#3)
forced expiratory volume in one second (FEV1)##2##7##(2007-2#1)(2012-3#1)
forced expiratory volume in the first second##3##7##(2007-8#1)(2013-1#2)
forced expiratory volume in##5##4##(2007-2#1)(2007-8#1)(2012-3#1)(2013-1#2)
forced expiratory volume##6##3##(2007-2#1)(2007-8#1)(2008-7#1)(2012-3#1)(2013-1#2)
forced expiratory##12##2##(1991-2#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-7#2)(2012-3#1)(2013-1#2)
forced expression of##5##3##(2008-11#1)(2010-11#2)(2011-2#1)(2012-12#1)
forced into a##2##3##(2008-2#1)(2008-7#1)
forced into##4##2##(1991-8#1)(1996-3#1)(2008-2#1)(2008-7#1)
forced swim stress##3##3##(1995-12#3)
forced swim##7##2##(1995-12#3)(2008-11#4)
forced swimming test##2##3##(1990-5#1)(1991-12#1)
forced swimming##3##2##(1990-5#1)(1991-12#1)(2013-1#1)
forced to##16##2##(1992-1#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)
forced treatment of##2##3##(1990-2#1)(2008-11#1)
forced vital capacity (FVC)##4##4##(1997-3#1)(2007-2#1)(2008-1#1)(2012-2#1)
forced##74##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#3)(1995-5#2)(1996-3#2)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#3)(2007-2#2)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
forced-choice##2##1##(1996-2#1)(2011-2#1)
forceful##7##1##(1992-9#1)(2008-10#3)(2008-12#1)(2010-1#1)(2013-1#1)
forceps##9##1##(1992-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
forces acting on the##3##4##(1997-2#1)(2008-8#1)(2009-10#1)
forces acting on##5##3##(1997-2#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
forces acting##7##2##(1997-2#1)(2007-12#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
forces and hydrogen##2##3##(2007-11#1)(2008-10#1)
forces and##24##2##(1992-9#1)(1994-12#2)(1995-12#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#2)(2011-2#1)(2013-1#1)
forces are##12##2##(1995-2#2)(1997-1#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2013-8#1)
forces as##3##2##(2007-12#2)(2008-7#1)
forces associated with##2##3##(2008-3#1)(2008-5#1)
forces at work##2##3##(1991-1#1)(2008-9#1)
forces at##4##2##(1991-1#1)(1997-3#1)(2008-9#1)(2009-6#1)
forces between##3##2##(1994-9#1)(2008-4#1)(2012-7#1)
forces can be##2##3##(2008-1#1)(2008-11#1)
forces driving##3##2##(1995-1#1)(2010-11#1)(2012-3#1)
forces during##2##2##(2007-12#1)(2010-9#1)
forces exerted on##2##3##(2008-3#2)
forces exerted##3##2##(1997-2#1)(2008-3#2)
forces for##6##2##(2008-1#1)(2008-3#1)(2013-1#4)
forces in a##2##3##(2008-2#1)(2011-1#1)
forces in##7##2##(1992-5#1)(1993-2#1)(2008-2#2)(2008-6#1)(2011-1#1)(2011-2#1)
forces is##5##2##(2007-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
forces of managed care##2##4##(1996-12#1)(1997-2#1)
forces of##10##2##(1992-9#1)(1995-3#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-2#1)
forces on the##2##3##(2007-12#1)(2008-7#1)
forces on##3##2##(1997-3#1)(2007-12#1)(2008-7#1)
forces shaping the##2##3##(2008-8#1)(2009-6#1)
forces shaping##3##2##(1994-12#1)(2008-8#1)(2009-6#1)
forces should##2##2##(2008-10#1)(2012-2#1)
forces that are##2##3##(1996-2#1)(2008-7#1)
forces that drive##2##3##(2010-8#1)(2012-3#1)
forces that have##3##3##(1994-12#1)(2008-8#1)(2012-12#1)
forces that##13##2##(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
forces the##8##2##(1992-11#1)(2007-12#2)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#2)
forces to##10##2##(1995-2#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-5#1)(2012-7#3)
forces with##2##2##(2008-9#1)(2010-8#1)
forces##230##1##(1990-8#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#6)(1997-3#3)(2007-11#2)(2007-12#15)(2007-8#3)(2008-1#4)(2008-10#14)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#7)(2008-8#11)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-3#10)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#6)(2012-7#4)(2013-1#13)(2013-8#4)
forcibly displaced##3##2##(2013-1#3)
forcibly##4##1##(2008-8#1)(2013-1#3)
forcing the##6##2##(1994-5#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-10#2)
forcing##23##1##(1990-2#1)(1992-1#2)(1992-4#1)(1993-2#1)(1994-5#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-2#5)(2008-8#3)(2013-8#1)
fore and##2##2##(2007-12#1)(2008-5#1)
fore femur##2##2##(2008-5#2)
fore##11##1##(2007-12#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)
forearm and##3##2##(2007-7#1)(2008-5#1)(2008-9#1)
forearm flap was used##2##4##(1991-4#1)(2008-9#1)
forearm flap##7##2##(1991-4#2)(2007-12#1)(2008-9#3)(2011-2#1)
forearm free flap##5##3##(2007-12#2)(2011-2#3)
forearm free flaps##2##3##(2008-4#1)(2011-2#1)
forearm free##7##2##(2007-12#2)(2008-4#1)(2011-2#4)
forearm muscles in##2##3##(2008-9#2)
forearm of##2##2##(2008-5#2)
forearm to cigarette smoke##2##4##(2008-5#2)
forearm##69##1##(1991-4#2)(1994-6#1)(2007-12#3)(2007-7#6)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#25)(2008-9#13)(2009-3#1)(2011-2#10)(2012-3#2)(2013-1#1)
forearms##7##1##(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-6#1)
forebrain 5-HT##2##2##(1991-2#2)
forebrain and##3##2##(1994-8#1)(2007-10#1)(2008-7#1)
forebrain bundle##8##2##(1991-2#2)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)
forebrain cholinergic neurons##5##3##(1991-12#2)(1994-8#1)(1996-5#2)
forebrain cholinergic##7##2##(1991-12#2)(1994-8#1)(1996-5#4)
forebrain ischemia in the rat##2##5##(1991-5#1)(1996-12#1)
forebrain ischemia##9##2##(1990-5#2)(1991-5#2)(1995-12#1)(1996-12#3)(2009-12#1)
forebrain nuclei##2##2##(1993-12#1)(1995-12#1)
forebrain regions##2##2##(1993-8#2)
forebrain structures##2##2##(1993-12#1)(1994-3#1)
forebrain##65##1##(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#4)(1991-5#2)(1992-10#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#7)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-8#3)(1995-11#1)(1995-12#5)(1995-3#2)(1995-5#1)(1996-12#3)(1996-2#1)(1996-5#5)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2009-12#1)(2009-3#2)(2009-8#1)(2013-1#1)
forecast for##2##2##(1991-8#1)(2012-12#1)
forecast models##2##2##(2008-10#1)(2008-3#1)
forecast of the##2##3##(1993-2#1)(2008-8#1)
forecast of##3##2##(1993-2#1)(2008-8#1)(2012-3#1)
forecast##22##1##(1991-12#1)(1991-8#1)(1993-2#1)(1996-4#2)(1996-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#4)(2009-8#1)(2012-12#1)(2012-3#1)(2013-8#2)
forecasted##3##1##(1992-3#1)(2008-10#2)
forecasters##3##1##(2008-10#3)
forecasting and##2##2##(1993-3#1)(2008-10#1)
forecasting elemental contents in geological samples##2##6##(2013-8#2)
forecasting model for##2##3##(2008-10#2)
forecasting model##3##2##(2008-10#3)
forecasting system for##4##3##(2008-10#4)
forecasting system##6##2##(2008-10#6)
forecasting systems##2##2##(2008-10#2)
forecasting##28##1##(1993-3#1)(1994-1#1)(1994-12#3)(1994-9#1)(1995-3#1)(2008-10#15)(2008-11#3)(2008-9#1)(2013-8#2)
forecasts of##2##2##(2008-10#1)(2008-11#1)
forecasts the##3##2##(1993-1#1)(2008-11#1)(2009-10#1)
forecasts##11##1##(1993-1#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)
foregoing##5##1##(1990-7#1)(1991-12#1)(1994-8#1)(1994-9#1)(2008-8#1)
foregone##3##1##(1994-1#2)(2008-11#1)
foregut cyst##4##2##(2007-8#1)(2008-5#3)
foregut##17##1##(1991-8#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#2)(2008-5#3)(2008-6#2)(2011-2#2)
forehand##3##1##(2011-2#3)
forehead##16##1##(1992-2#1)(1993-2#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-5#6)(2010-1#1)(2010-6#1)(2012-3#1)(2013-7#1)
foreign DNA into##2##3##(2008-11#1)(2008-8#1)
foreign DNA##8##2##(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#2)
foreign and##2##2##(1994-2#1)(2008-11#1)
foreign antigens##3##2##(1993-3#1)(1994-11#1)(1997-4#1)
foreign bodies and##2##3##(2010-5#1)(2012-2#1)
foreign bodies##17##2##(1995-3#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-12#1)(2010-5#3)(2011-1#5)(2012-2#1)(2013-1#1)
foreign body in the##3##4##(2007-9#1)(2008-12#2)
foreign body in##6##3##(2007-8#1)(2007-9#1)(2008-12#2)(2010-4#1)(2010-5#1)
foreign body response##4##3##(2009-11#4)
foreign body was##2##3##(2007-8#1)(2013-1#1)
foreign body##34##2##(1990-3#3)(1993-6#1)(2007-8#3)(2007-9#1)(2008-12#4)(2008-7#2)(2008-9#1)(2009-11#4)(2009-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#5)
foreign compounds##2##2##(1994-8#1)(2008-10#1)
foreign gene##12##2##(1993-12#1)(1994-12#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#2)
foreign genes in##4##3##(1995-5#1)(1997-4#2)(2008-4#1)
foreign genes into the##2##4##(2008-11#1)(2008-4#1)
foreign genes into##3##3##(1991-6#1)(2008-11#1)(2008-4#1)
foreign genes##13##2##(1991-6#1)(1995-5#1)(1997-4#4)(1997-8#1)(2008-11#2)(2008-4#2)(2008-8#2)
foreign genetic material##2##3##(2011-1#2)
foreign genetic##3##2##(2008-10#1)(2011-1#2)
foreign ions are##2##3##(2008-10#2)
foreign ions have been##4##4##(2008-10#4)
foreign ions have##5##3##(2008-10#5)
foreign ions on the determination of##2##6##(2008-10#2)
foreign ions on the##4##4##(2008-10#4)
foreign ions on##6##3##(2008-10#6)
foreign ions was##2##3##(2008-10#2)
foreign ions were also##2##4##(2008-10#2)
foreign ions were##4##3##(2008-10#4)
foreign ions##36##2##(2008-10#36)
foreign material##4##2##(1991-6#1)(1992-12#1)(2008-11#1)(2008-6#1)
foreign parasites##2##2##(1997-7#2)
foreign protein##2##2##(2008-11#1)(2008-7#1)
foreign sequences as##2##3##(1994-12#1)(1997-4#1)
foreign songs recorded at##4##4##(2008-8#4)
foreign songs##5##2##(2008-8#5)
foreign species##3##2##(2008-10#3)
foreign substances was##2##3##(2008-10#2)
foreign substances##5##2##(2008-10#5)
foreign##213##1##(1990-3#4)(1991-5#1)(1991-6#2)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#10)(1997-6#2)(1997-7#2)(1997-8#2)(2007-12#1)(2007-5#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#54)(2008-11#14)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#13)(2008-9#4)(2009-11#4)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#3)(2010-5#4)(2010-6#1)(2011-1#8)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)
foreign-body response##2##2##(2011-2#2)
foreign-body##3##1##(2011-2#2)(2012-12#1)
foreign-born##8##1##(2009-5#1)(2011-2#6)(2012-12#1)
foreigners and##2##2##(1990-3#1)(2008-12#1)
foreigners##10##1##(1990-3#2)(1993-6#2)(1997-6#1)(2007-2#4)(2008-12#1)
forelegs##5##1##(1990-11#1)(2007-12#4)
forelimb lameness##3##2##(2012-3#1)(2013-8#2)
forelimb response to##2##3##(1997-6#2)
forelimb response##4##2##(1997-6#4)
forelimb##18##1##(1992-11#1)(1992-12#3)(1994-3#1)(1994-8#1)(1997-6#5)(2007-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
forelimbs##7##1##(1992-12#2)(1993-3#1)(1996-6#1)(2011-2#2)(2012-3#1)
foremost##6##1##(1990-11#1)(1995-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-8#1)
forensic DNA##5##2##(1995-11#1)(2008-11#1)(2008-12#3)
forensic STR profiling##2##3##(2008-12#2)
forensic analyses##2##2##(2008-10#1)(2008-6#1)
forensic analysis##5##2##(2008-10#4)(2008-12#1)
forensic and##5##2##(1996-5#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
forensic applications in the##2##4##(2008-10#1)(2008-12#1)
forensic casework##2##2##(2008-10#1)(2008-12#1)
forensic chemistry##3##2##(2008-10#1)(2010-7#2)
forensic chemists##2##2##(2008-10#2)
forensic drug analysis##2##3##(2008-10#2)
forensic interview##2##2##(2011-2#2)
forensic investigations##5##2##(1995-11#1)(2008-10#1)(2008-12#1)(2012-3#2)
forensic laboratories##2##2##(2008-12#2)
forensic medical##2##2##(2011-2#2)
forensic medicine##5##2##(1991-11#1)(1995-6#2)(1997-8#1)(2011-2#1)
forensic organisations##2##2##(2008-12#2)
forensic psychiatry##8##2##(2011-2#7)(2013-8#1)
forensic samples##6##2##(2008-10#3)(2008-12#3)
forensic science##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
forensic sciences##2##2##(2010-4#1)(2011-2#1)
forensic toxicology and##2##3##(2008-10#1)(2010-4#1)
forensic toxicology##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
forensic trace evidence##2##3##(2008-10#2)
forensic##115##1##(1990-7#1)(1991-11#1)(1993-2#1)(1995-11#2)(1995-6#4)(1996-12#1)(1996-5#2)(1997-2#1)(1997-8#1)(2008-10#27)(2008-11#1)(2008-12#33)(2008-6#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#3)(2011-1#1)(2011-2#21)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
forensic-anthropological##2##1##(2011-2#2)
forensics##2##1##(2008-5#1)(2011-1#1)
forepaw##2##1##(2007-10#2)
forequarter amputation##2##2##(2009-3#2)
forerunners of Colombian independence's thoughts##2##5##(2011-2#2)
forerunners of##4##2##(1992-12#1)(2011-2#3)
forerunners##5##1##(1992-12#1)(2011-2#4)
foresee the##3##2##(1990-3#1)(1997-1#1)(2007-8#1)
foresee##11##1##(1990-3#1)(1991-2#1)(1991-6#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
foreseeability##2##1##(1991-1#2)
foreseeable##10##1##(1991-12#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)
foreseen##6##1##(2008-10#2)(2008-5#2)(2012-2#2)
foreshadow the powerful##2##3##(1996-12#1)(1997-2#1)
foreshadow##3##1##(1994-1#1)(1996-12#1)(1997-2#1)
foreshadowed##2##1##(2008-10#1)(2011-2#1)
foreshocks##5##1##(1996-4#5)
foreskin##4##1##(2007-12#1)(2008-10#2)(2008-11#1)
forest and the##2##3##(2008-5#1)(2008-8#1)
forest and##6##2##(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
forest at##2##2##(2008-5#1)(2011-2#1)
forest cover##4##2##(1995-3#2)(2009-8#2)
forest diseases##2##2##(2008-10#2)
forest ecosystem##11##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#7)(2012-5#1)
forest ecosystems##3##2##(2008-10#3)
forest fragmentation##2##2##(1995-3#2)
forest fragments##3##2##(2008-8#1)(2013-7#2)
forest in##3##2##(2008-9#1)(2012-5#1)(2013-7#1)
forest of##6##2##(1995-12#1)(2008-5#4)(2011-2#1)
forest on the##3##3##(2008-5#2)(2012-2#1)
forest pathologists##2##2##(2008-10#2)
forest pathology##7##2##(2008-10#7)
forest restoration##2##2##(2012-2#1)(2013-7#1)
forest soil##3##2##(2008-11#1)(2011-2#1)(2012-9#1)
forest soils##6##2##(2008-10#2)(2008-11#1)(2008-9#2)(2012-6#1)
forest to##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
forest tree##2##2##(2008-5#2)
forest trees##8##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#4)(2010-4#1)
forest understory##2##2##(2008-5#1)(2008-9#1)
forest was##2##2##(2008-10#1)(2008-8#1)
forest with##3##2##(2008-10#1)(2008-5#2)
forest##169##1##(1992-3#1)(1995-12#1)(1995-3#6)(2007-5#3)(2008-10#42)(2008-11#4)(2008-12#2)(2008-5#24)(2008-6#5)(2008-7#1)(2008-8#20)(2008-9#19)(2009-8#5)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#4)(2012-2#5)(2012-3#2)(2012-5#3)(2012-6#1)(2012-9#2)(2013-1#2)(2013-7#10)
forest) were##2##2##(2008-5#1)(2013-7#1)
forest)##3##1##(2008-5#1)(2008-8#1)(2013-7#1)
forested##3##1##(1991-12#1)(2008-10#2)
forestomach squamous cell##2##3##(1992-2#1)(2008-9#1)
forestomach##8##1##(1992-2#2)(2008-9#6)
forestry##8##1##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
forests and##8##2##(2008-10#3)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#2)
forests from##3##2##(2008-7#1)(2012-2#2)
forests in Western##2##3##(2013-7#2)
forests in the##2##3##(2008-10#2)
forests in##9##2##(2008-10#4)(2008-5#1)(2011-2#1)(2012-9#1)(2013-7#2)
forests of the##3##3##(2008-10#1)(2010-4#1)(2013-7#1)
forests of##8##2##(1991-12#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-7#2)
forests with##2##2##(2008-7#2)
forests##61##1##(1990-8#1)(1991-12#1)(1992-5#1)(1994-9#1)(1996-11#1)(2008-10#19)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2010-4#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-9#1)(2013-7#12)
foretell##2##1##(2008-10#2)
forge##5##1##(1993-5#1)(1995-2#1)(2007-2#1)(2008-11#1)(2008-7#1)
forged##2##1##(1996-3#1)(2008-11#1)
forgery##2##1##(1996-5#1)(2008-10#1)
forget##4##1##(1991-2#1)(2008-7#1)(2012-12#1)(2013-8#1)
forgetfulness##2##1##(2008-2#1)(2011-1#1)
forgetting##7##1##(1992-1#1)(1993-2#1)(1997-4#1)(2008-3#1)(2009-10#2)(2013-8#1)
forging##6##1##(1991-3#1)(1992-3#1)(1996-2#1)(2008-1#1)(2008-12#2)
forgotten##17##1##(1991-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
fork##20##1##(1991-12#3)(1992-3#5)(1995-5#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#1)
forked##4##1##(1995-6#2)(2010-8#1)(2011-2#1)
forks and##2##2##(2008-4#1)(2011-2#1)
forks##8##1##(1992-3#1)(2008-4#1)(2011-2#1)(2012-3#5)
form (P##2##2##(2008-10#2)
form (aa##2##2##(1994-12#2)
form 1##2##2##(1996-2#1)(2008-10#1)
form A##2##2##(1997-1#2)
form BTV##2##2##(1997-4#2)
form DNA adducts##2##3##(1994-8#1)(2008-12#1)
form DNA##3##2##(1994-8#1)(1995-3#1)(2008-12#1)
form I plasmid##2##3##(2008-9#2)
form I##5##2##(2008-8#3)(2008-9#2)
form II##3##2##(1992-3#1)(2008-8#2)
form a &quot##3##3##(2008-1#1)(2008-8#1)(2009-10#1)
form a colored complex with##2##5##(2008-10#2)
form a colored complex##4##4##(2008-10#4)
form a colored##9##3##(2008-10#9)
form a compact##2##3##(2008-10#2)
form a complex with##5##4##(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
form a complex##7##3##(1995-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
form a continuum##2##3##(2008-10#1)(2012-12#1)
form a distinct##2##3##(2008-10#2)
form a family of##3##4##(1990-8#1)(1994-6#2)
form a fluorescent##2##3##(2008-10#2)
form a large##3##3##(2008-10#3)
form a long##2##3##(1994-12#1)(2008-5#1)
form a monophyletic clade##2##4##(2008-10#1)(2010-3#1)
form a monophyletic##5##3##(2008-10#2)(2008-7#1)(2010-3#1)(2010-8#1)
form a much##2##3##(1994-3#1)(2008-10#1)
form a set of##2##4##(2008-3#1)(2008-7#1)
form a single##4##3##(1993-11#1)(2008-10#1)(2008-5#1)(2010-10#1)
form a stable complex##2##4##(1994-8#1)(2008-10#1)
form a stable##5##3##(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-4#1)
form a ternary complex with##2##5##(2008-10#2)
form a ternary complex##3##4##(2008-10#2)(2012-12#1)
form a very##2##3##(2007-12#1)(2008-10#1)
form a wide##2##3##(2008-10#1)(2008-7#1)
form a##210##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-5#2)(1992-6#2)(1992-9#1)(1993-11#3)(1993-9#1)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#2)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#9)(2007-7#2)(2008-1#5)(2008-10#82)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#1)(2009-8#3)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)
form aggregates##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
form an important##4##3##(1990-7#1)(2008-11#1)(2008-4#1)(2008-8#1)
form an optical##2##3##(2007-12#1)(2008-3#1)
form an##38##2##(1990-2#1)(1990-7#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-2#2)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2011-2#1)
form and function##4##3##(2008-9#1)(2009-8#1)(2010-6#1)(2012-12#1)
form and is##2##3##(1992-3#1)(1994-11#1)
form and that##3##3##(1994-3#1)(1995-11#1)(2011-1#1)
form and the##9##3##(1991-12#1)(2008-10#4)(2008-3#1)(2011-2#2)(2013-1#1)
form and to##2##3##(1990-11#1)(2008-8#1)
form and##50##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-6#1)(2007-6#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
form any##3##2##(1997-2#1)(2010-2#1)(2013-1#1)
form are##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
form as determined by##2##4##(1990-5#1)(1991-5#1)
form as well##2##3##(2008-10#1)(2008-7#1)
form as##5##2##(1990-5#1)(1991-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
form at##4##2##(1990-2#1)(2006-10#1)(2007-12#1)(2011-2#1)
form birefringence##4##2##(2007-11#1)(2008-3#3)
form but##2##2##(1992-6#1)(2012-1#1)
form by the##2##3##(1992-8#1)(2008-9#1)
form by##12##2##(1990-11#1)(1992-12#2)(1992-8#1)(1993-11#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)
form complexes with##9##3##(1991-2#1)(2008-10#5)(2008-7#1)(2009-8#1)(2010-11#1)
form complexes##10##2##(1991-2#1)(2008-10#6)(2008-7#1)(2009-8#1)(2010-11#1)
form extensive##2##2##(1997-1#1)(2013-1#1)
form extremely##2##2##(2008-8#1)(2010-12#1)
form for each##2##3##(2008-12#1)(2008-5#1)
form for the##7##3##(1990-12#1)(1990-8#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-9#1)
form for##16##2##(1990-12#1)(1990-8#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
form from##4##2##(1994-5#1)(1996-5#1)(2011-2#2)
form groups##2##2##(2013-1#1)(2013-7#1)
form has been##3##3##(1995-5#2)(2012-2#1)
form has##4##2##(1995-2#1)(1995-5#2)(2012-2#1)
form have been##2##3##(1992-12#1)(2008-3#1)
form have##4##2##(1990-2#1)(1991-5#1)(1992-12#1)(2008-3#1)
form highly##3##2##(1997-4#1)(2008-10#1)(2009-11#1)
form in the##15##3##(1990-11#1)(1990-2#1)(1992-6#3)(1994-8#1)(1997-3#2)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
form in##37##2##(1990-11#2)(1990-2#1)(1990-7#1)(1992-3#1)(1992-6#3)(1993-11#1)(1994-8#2)(1997-3#2)(2007-10#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
form indicated##2##2##(1991-9#1)(1992-9#1)
form insoluble##3##2##(1996-12#1)(2008-10#2)
form into##5##2##(1992-3#1)(1995-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
form is more##2##3##(2007-11#1)(2008-10#1)
form is##15##2##(1990-5#1)(1995-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)
form large##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
form liposomes##2##2##(1990-2#2)
form literature##2##2##(2007-11#2)
form lung metastases##3##3##(2010-3#3)
form may##2##2##(1995-2#1)(2007-8#1)
form more##2##2##(2008-10#1)(2008-12#1)
form multinucleated##2##2##(2008-4#2)
form of Al##2##3##(2008-10#2)
form of CGRP##2##3##(1992-6#1)(1993-3#1)
form of DNA##2##3##(1997-7#1)(2008-10#1)
form of G##2##3##(1995-6#1)(2008-8#1)
form of P450cam##2##3##(1994-6#2)
form of PKC##2##3##(1993-9#1)(1995-5#1)
form of RNA polymerase##2##4##(1994-3#1)(2008-9#1)
form of RNA##3##3##(1990-7#1)(1994-3#1)(2008-9#1)
form of Rhizopus##2##3##(2008-6#2)
form of a##40##3##(1991-12#1)(1993-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
form of acute##5##3##(1994-9#2)(2007-7#1)(2008-5#1)(2009-6#1)
form of albuminuria##2##3##(2012-1#2)
form of an##9##3##(1992-6#1)(1994-5#1)(2008-10#3)(2008-11#1)(2010-5#2)(2010-6#1)
form of angioedema of the##2##5##(2013-1#2)
form of angioedema##4##3##(2010-5#1)(2013-1#3)
form of both##2##3##(2007-12#1)(2011-2#1)
form of cell death##6##4##(1992-3#1)(1994-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)
form of chronic##2##3##(2006-10#1)(2011-1#1)
form of congenital##2##3##(2012-2#1)(2012-3#1)
form of contraception##2##3##(1993-2#1)(1996-8#1)
form of cooperative##2##3##(2008-7#1)(2008-9#1)
form of cytochrome##3##3##(1994-6#1)(1996-4#1)(2008-10#1)
form of density dependence##2##4##(2008-8#2)
form of diabetes##2##3##(2008-7#1)(2009-11#1)
form of endothelin receptor in human##2##6##(1990-2#2)
form of endothelin receptor##3##4##(1990-2#3)
form of exercise##2##3##(2008-5#1)(2013-1#1)
form of factor##2##3##(1995-12#1)(2008-11#1)
form of higher##2##3##(1992-12#1)(2011-2#1)
form of human##2##3##(1995-12#1)(2008-3#1)
form of hypertension##3##3##(1990-2#1)(1997-2#1)(1997-3#1)
form of inorganic##2##3##(2008-10#2)
form of managed care##2##4##(1997-1#1)(1997-2#1)
form of mental##2##3##(2012-1#1)(2013-8#1)
form of neurofibromatosis##2##3##(1997-3#2)
form of oxygen##2##3##(2012-3#1)(2013-1#1)
form of protein kinase C##2##5##(1992-9#1)(2013-8#1)
form of pulmonary##2##3##(2010-10#1)(2011-2#1)
form of recombinant##2##3##(1997-8#1)(2007-8#1)
form of surgery##2##3##(1990-9#1)(1993-6#1)
form of synaptic homeostasis##2##4##(2009-9#2)
form of the binary power law with##2##7##(2008-10#2)
form of the disease##4##4##(1991-12#1)(2008-5#1)(2008-7#2)
form of the enzyme##9##4##(1992-11#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-5#1)(1995-8#1)(1997-2#1)(2009-7#1)
form of the fungus##3##4##(2008-10#3)
form of the human##2##4##(1997-2#1)(2008-11#1)
form of the iron cluster##2##5##(1991-5#2)
form of the model##3##4##(2008-3#1)(2008-8#1)(2013-8#1)
form of the protein is##2##5##(1992-3#2)
form of the protein##4##4##(1990-7#1)(1992-3#2)(1995-3#1)
form of the receptor##3##4##(1990-11#1)(1994-8#1)(1995-11#1)
form of the##103##3##(1990-10#1)(1990-11#3)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#4)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-6#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#5)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
form of therapy##5##3##(1992-11#1)(1992-4#1)(1993-12#1)(2007-10#1)(2007-7#1)
form of thymidylate synthase##2##4##(1993-11#2)
form of transforming growth factor-beta 1##2##6##(1990-2#2)
form of treatment for##3##4##(2008-7#1)(2012-12#1)(2013-1#1)
form of treatment is##2##4##(1993-6#1)(1997-2#1)
form of treatment##6##3##(1993-6#1)(1997-2#1)(1997-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
form of vascular##2##3##(2007-10#1)(2007-7#1)
form of vitamin##4##3##(2008-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
form of##702##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#6)(1990-3#2)(1990-5#5)(1990-7#7)(1990-8#1)(1990-9#2)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#6)(1991-5#7)(1991-6#2)(1991-8#1)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#6)(1992-12#15)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#5)(1993-11#5)(1993-12#4)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#8)(1993-9#2)(1994-1#2)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#7)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#9)(1995-5#3)(1995-6#3)(1995-8#4)(1996-11#1)(1996-12#5)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#10)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#2)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#16)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#9)(2008-10#108)(2008-11#26)(2008-12#5)(2008-2#10)(2008-3#17)(2008-4#16)(2008-5#11)(2008-6#9)(2008-7#24)(2008-8#21)(2008-9#18)(2009-1#1)(2009-10#3)(2009-11#2)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#6)(2010-10#2)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#11)(2012-1#5)(2012-12#9)(2012-2#17)(2012-3#10)(2013-1#18)(2013-7#3)(2013-8#15)
form on##4##2##(1994-11#1)(1996-11#1)(2008-7#1)(2010-10#1)
form one of the##2##4##(1995-6#1)(2007-8#1)
form or##6##2##(1996-1#1)(2008-10#3)(2008-7#1)(2009-8#1)
form part of the##2##4##(1991-7#1)(1997-4#1)
form part of##3##3##(1990-11#1)(1991-7#1)(1997-4#1)
form particles that##2##3##(1994-12#2)
form particles##4##2##(1994-12#2)(1994-3#1)(1995-5#1)
form present##2##2##(1990-12#1)(2008-10#1)
form reported##2##2##(2008-9#1)(2010-6#1)
form small##3##2##(1994-5#1)(2008-10#1)(2009-8#1)
form spheroids##3##2##(2008-11#3)
form stable##12##2##(1993-11#1)(1993-6#1)(1995-5#1)(1995-8#1)(2008-10#5)(2008-4#1)(2008-8#1)(2010-11#1)
form synapses with##3##3##(2011-2#3)
form tandem pairs##2##3##(2009-5#2)
form that is##2##3##(1992-8#1)(2008-12#1)
form that##10##2##(1991-5#1)(1992-2#1)(1992-8#1)(1996-12#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-6#1)
form the basis for the##2##5##(1995-2#1)(2012-3#1)
form the basis for##10##4##(1995-2#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
form the basis of the##2##5##(2008-10#1)(2008-5#1)
form the basis of##7##4##(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
form the basis##17##3##(1995-2#1)(1995-5#1)(1996-2#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
form the catalytic triad##2##4##(1992-3#1)(1997-6#1)
form the core of##3##4##(1991-2#1)(1996-12#1)(2012-2#1)
form the core##4##3##(1991-2#1)(1996-12#1)(2011-1#1)(2012-2#1)
form the most##2##3##(2008-10#1)(2009-4#1)
form the##92##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#2)(1995-2#2)(1995-5#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#5)(2008-1#1)(2008-10#22)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#7)(2008-9#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#2)
form their##2##2##(1995-2#1)(2008-10#1)
form this##3##2##(1995-1#1)(2007-12#1)(2008-5#1)
form to##6##2##(1991-12#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)
form two##8##2##(1994-5#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-10#1)
form two-dimensional##2##2##(2008-3#1)(2008-8#1)
form under##2##2##(2008-5#1)(2009-10#1)
form using a##2##3##(1994-11#1)(2008-6#1)
form using##3##2##(1990-2#1)(1994-11#1)(2008-6#1)
form volatile hydrides##2##3##(2008-10#2)
form volatile##3##2##(2008-10#3)
form was also##2##3##(2008-10#1)(2011-1#1)
form was used##2##3##(1992-12#1)(2007-12#1)
form was##18##2##(1990-7#1)(1990-9#1)(1992-12#1)(1995-11#1)(1995-2#1)(1995-8#3)(2007-12#2)(2007-7#1)(2008-10#4)(2008-3#2)(2011-1#1)
form were##5##2##(1990-9#1)(1991-9#1)(2008-10#1)(2008-2#1)(2008-8#1)
form when##2##2##(2008-10#2)
form which##3##2##(1992-6#1)(1995-2#1)(2008-3#1)
form with E(m##2##3##(2008-10#2)
form with a##2##3##(1997-8#1)(2008-10#1)
form with##17##2##(1991-5#1)(1992-5#1)(1992-6#1)(1995-11#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-9#1)(2009-5#1)(2013-1#2)
form within the##2##3##(2008-11#1)(2008-7#1)
form within##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
form##1994##1##(1990-10#1)(1990-11#13)(1990-12#8)(1990-2#17)(1990-3#3)(1990-5#15)(1990-6#1)(1990-7#13)(1990-8#10)(1990-9#5)(1991-1#1)(1991-11#4)(1991-12#11)(1991-2#7)(1991-3#6)(1991-4#1)(1991-5#16)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#11)(1992-1#2)(1992-10#5)(1992-11#8)(1992-12#22)(1992-2#2)(1992-3#13)(1992-4#1)(1992-5#2)(1992-6#21)(1992-8#5)(1992-9#9)(1993-1#2)(1993-11#17)(1993-12#7)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#5)(1993-8#12)(1993-9#3)(1994-1#2)(1994-11#17)(1994-12#13)(1994-2#2)(1994-3#8)(1994-5#15)(1994-6#14)(1994-8#16)(1994-9#3)(1995-1#3)(1995-11#11)(1995-12#7)(1995-2#24)(1995-3#15)(1995-5#19)(1995-6#9)(1995-8#12)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#10)(1996-2#15)(1996-3#3)(1996-4#1)(1996-5#11)(1996-6#3)(1996-7#1)(1996-8#6)(1997-1#10)(1997-2#15)(1997-3#10)(1997-4#9)(1997-6#8)(1997-7#10)(1997-8#5)(2006-10#4)(2007-1#1)(2007-10#6)(2007-11#25)(2007-12#60)(2007-2#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#1)(2008-1#17)(2008-10#418)(2008-11#59)(2008-12#19)(2008-2#34)(2008-3#50)(2008-4#41)(2008-5#46)(2008-6#22)(2008-7#67)(2008-8#51)(2008-9#53)(2009-1#1)(2009-10#12)(2009-11#6)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#11)(2009-6#4)(2009-7#5)(2009-8#14)(2009-9#10)(2010-10#8)(2010-11#7)(2010-12#3)(2010-2#7)(2010-3#9)(2010-4#5)(2010-5#23)(2010-6#5)(2010-7#2)(2010-8#9)(2011-1#16)(2011-2#45)(2011-3#1)(2012-1#7)(2012-12#27)(2012-2#49)(2012-3#17)(2013-1#43)(2013-7#6)(2013-8#23)
form(s) of cytochrome P-450##3##4##(1990-7#3)
form(s) of##4##2##(1990-7#3)(1991-12#1)
form)##8##1##(1990-12#1)(1991-3#1)(1991-6#1)(2008-10#3)(2008-7#1)(2012-12#1)
forma specialis##5##2##(2008-10#5)
formae speciales##9##2##(2008-10#9)
formal and informal##2##3##(1992-12#2)
formal and##6##2##(1992-12#2)(1997-1#1)(1997-6#1)(2008-7#1)(2010-4#1)
formal continuing##2##2##(1994-12#1)(1996-1#1)
formal education##7##2##(1994-3#1)(2007-10#1)(2008-11#1)(2009-12#2)(2011-1#2)
formal educational##2##2##(2008-11#2)
formal evaluation of##3##3##(1991-12#1)(1992-1#1)(1992-2#1)
formal evaluation##4##2##(1991-12#1)(1992-1#1)(1992-2#1)(2008-10#1)
formal genetic##2##2##(2008-12#1)(2008-8#1)
formal knowledge##2##2##(2008-11#1)(2008-7#1)
formal lectures##2##2##(1994-12#2)
formal potential of##6##3##(2008-10#6)
formal potential##14##2##(2008-10#14)
formal potentials##3##2##(2008-10#3)
formal registration##2##2##(1994-12#1)(2012-12#1)
formal screening for##2##3##(2008-7#2)
formal screening##3##2##(2008-7#2)(2011-1#1)
formal training##6##2##(1994-12#1)(1996-4#1)(2008-11#1)(2008-6#1)(2010-11#1)(2011-1#1)
formal##136##1##(1990-12#1)(1991-1#3)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#8)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#5)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-10#4)(2007-7#1)(2008-1#1)(2008-10#25)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#10)(2008-8#2)(2009-12#4)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
formaldehyde and acetaldehyde##4##3##(2008-10#1)(2008-11#3)
formaldehyde and##11##2##(2007-7#1)(2008-10#7)(2008-11#3)
formaldehyde degradation##2##2##(2008-7#2)
formaldehyde in air##6##3##(2008-10#6)
formaldehyde in shiitake mushroom##3##4##(2008-10#3)
formaldehyde in the air##2##4##(2008-10#2)
formaldehyde in the##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
formaldehyde in##28##2##(2008-10#23)(2008-3#2)(2008-7#3)
formaldehyde to##6##2##(2008-10#1)(2008-2#2)(2008-7#3)
formaldehyde was##4##2##(2008-10#3)(2008-7#1)
formaldehyde with##2##2##(2008-10#1)(2008-7#1)
formaldehyde##107##1##(1990-8#1)(1991-3#1)(1992-5#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(2007-7#2)(2008-10#63)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#3)(2008-5#1)(2008-7#15)(2010-12#1)(2011-2#2)(2012-3#1)
formalin and##3##2##(1996-12#1)(2007-7#1)(2008-7#1)
formalin fixation time##2##3##(2012-3#2)
formalin fixation##4##2##(2012-3#4)
formalin fixed##3##2##(1991-2#1)(1991-4#1)(2012-12#1)
formalin or##2##2##(2008-3#1)(2008-5#1)
formalin solution##4##2##(1995-12#1)(1996-12#2)(2008-12#1)
formalin test in##2##3##(1995-12#1)(2013-7#1)
formalin test##4##2##(1995-12#3)(2013-7#1)
formalin##32##1##(1991-2#1)(1991-4#1)(1995-12#5)(1996-12#5)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#5)(2013-7#4)
formalin-fixed brain##2##2##(1997-3#1)(2008-7#1)
formalin-fixed paraffin-embedded##3##2##(1997-7#2)(2008-9#1)
formalin-fixed tissue##2##2##(1994-7#1)(2008-11#1)
formalin-fixed##17##1##(1991-7#1)(1993-12#1)(1994-7#1)(1997-3#3)(1997-7#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
formalin-induced##2##1##(2011-1#1)(2012-3#1)
formalised##2##1##(2012-1#1)(2012-12#1)
formalism and##4##2##(2008-2#1)(2008-3#3)
formalism for WM spectrometry##2##4##(2008-3#2)
formalism for##6##2##(1993-5#1)(2007-11#1)(2008-3#3)(2013-1#1)
formalism is developed to##2##4##(2008-3#2)
formalism is presented##2##3##(2007-11#1)(2008-3#1)
formalism is##9##2##(2007-11#1)(2008-2#1)(2008-3#7)
formalism of##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
formalism##51##1##(1993-5#1)(1997-2#3)(2007-11#3)(2008-1#1)(2008-10#3)(2008-2#6)(2008-3#29)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
formalisms##2##1##(1994-5#1)(2008-3#1)
formalization##2##1##(1997-2#1)(2008-7#1)
formalize##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
formalized and##2##2##(1995-3#1)(2008-3#1)
formalized##10##1##(1991-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#2)(2008-10#1)(2008-3#1)
formally evaluated##2##2##(2008-12#1)(2012-1#1)
formally##26##1##(1992-2#1)(1994-12#1)(1996-6#2)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#4)
formamide (DMF) and##2##3##(2008-10#1)(2013-8#1)
formamide (DMF)##3##2##(2008-10#2)(2013-8#1)
formamide##9##1##(1992-8#1)(2008-10#6)(2008-5#1)(2013-8#1)
formant##3##1##(2010-2#3)
format and the##2##3##(2008-10#1)(2008-9#1)
format and##7##2##(2008-10#3)(2008-11#1)(2008-9#2)(2010-11#1)
format as well as##2##4##(2011-1#1)(2013-1#1)
format as##3##2##(2011-1#1)(2012-2#1)(2013-1#1)
format conversion##2##2##(2008-3#1)(2008-4#1)
format for each##2##3##(2008-1#1)(2008-10#1)
format for##12##2##(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#2)(2011-2#1)
format is##4##2##(2008-10#1)(2008-3#1)(2009-10#1)(2012-3#1)
format of the##2##3##(1995-11#1)(2008-5#1)
format of##7##2##(1990-2#1)(1995-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
format that is##2##3##(2008-10#1)(2008-9#1)
format that##7##2##(1992-12#1)(1993-12#1)(1994-2#1)(2008-10#2)(2008-9#1)(2010-10#1)
format to##2##2##(2008-10#1)(2009-10#1)
format using##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
format was##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
format will##2##2##(2008-12#1)(2008-7#1)
format with a##2##3##(2008-2#1)(2008-4#1)
format with##4##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-4#1)
format##129##1##(1990-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#3)(1995-11#1)(1995-12#5)(1995-2#1)(1996-12#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#36)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#8)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
format)##3##1##(2010-10#1)(2010-8#2)
formate and##4##2##(1992-6#1)(2008-10#1)(2011-1#2)
formate dehydrogenase (FDH)##2##3##(1995-8#1)(2008-7#1)
formate dehydrogenase isoenzyme in Escherichia coli##2##6##(1992-6#2)
formate dehydrogenase##9##2##(1992-6#6)(1995-8#2)(2008-7#1)
formate to##2##2##(1990-12#1)(1992-6#1)
formate##29##1##(1990-12#1)(1992-10#2)(1992-6#9)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#1)(2008-10#5)(2008-6#2)(2008-7#1)(2011-1#3)(2011-2#1)
formate-lyase##2##1##(1995-2#2)
formation along##2##2##(1992-12#1)(2008-5#1)
formation and DNA damage##2##4##(1994-11#2)
formation and development##2##3##(1995-8#1)(2012-2#1)
formation and functional##2##3##(2008-11#1)(2008-9#1)
formation and growth##2##3##(2008-5#1)(2012-2#1)
formation and intimal hyperplasia##2##4##(1996-8#2)
formation and maintenance##5##3##(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)
formation and maturation of##2##4##(2012-1#1)(2012-2#1)
formation and maturation##3##3##(2009-9#1)(2012-1#1)(2012-2#1)
formation and organization##2##3##(2009-12#1)(2010-4#1)
formation and proliferation of##2##4##(1996-3#1)(2013-7#1)
formation and proliferation##3##3##(1996-3#1)(2012-12#1)(2013-7#1)
formation and provides##2##3##(1995-6#1)(2008-9#1)
formation and resorption##2##3##(1990-7#1)(2008-7#1)
formation and rupture of##2##4##(2009-4#1)(2010-9#1)
formation and rupture##4##3##(2006-10#1)(2007-10#1)(2009-4#1)(2010-9#1)
formation and stabilization of##3##4##(1994-5#1)(2008-10#1)(2009-8#1)
formation and stabilization##4##3##(1994-5#1)(2008-10#2)(2009-8#1)
formation and structure of the##2##5##(2008-10#1)(2008-7#1)
formation and subsequent##4##3##(1991-9#1)(2008-10#2)(2012-2#1)
formation and the##9##3##(1994-2#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#3)
formation and to##5##3##(1992-3#1)(2007-11#1)(2008-10#2)(2008-7#1)
formation and##159##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#31)(2008-11#6)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#9)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-4#1)(2010-9#2)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2013-1#5)(2013-7#1)(2013-8#1)
formation and/or##2##2##(2008-5#1)(2008-7#1)
formation are##11##2##(1990-12#1)(1990-7#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)
formation as a##5##3##(1993-6#1)(2008-10#2)(2008-2#1)(2009-6#1)
formation as well as the##2##5##(1995-5#1)(2010-5#1)
formation as well as##4##4##(1992-3#1)(1995-5#1)(2008-7#1)(2010-5#1)
formation as##13##2##(1992-3#1)(1993-6#1)(1994-5#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)
formation associated with##2##3##(1991-9#1)(1994-12#1)
formation at an early stage##2##5##(2008-10#1)(2010-3#1)
formation at the##5##3##(1993-3#1)(1994-3#1)(2008-11#1)(2008-3#1)(2012-12#1)
formation at various##2##3##(2006-6#1)(2011-2#1)
formation at##18##2##(1991-8#1)(1993-3#1)(1993-8#2)(1994-3#1)(2006-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2010-3#1)(2011-2#2)(2012-12#1)
formation because##2##2##(1997-4#1)(2011-2#1)
formation between the##5##3##(1992-2#1)(1996-5#1)(2008-10#1)(2008-8#1)(2012-3#1)
formation between##24##2##(1992-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-6#1)(2008-10#15)(2008-7#1)(2008-8#1)(2012-3#1)
formation but##4##2##(1992-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
formation by a##3##3##(1994-2#1)(2008-3#1)(2010-11#1)
formation by the##3##3##(2008-10#3)
formation by##29##2##(1991-5#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-8#2)(1995-5#1)(1996-2#1)(1997-6#2)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#1)
formation can be##4##3##(1991-5#1)(1997-3#1)(2008-5#1)(2009-8#1)
formation can##5##2##(1991-5#1)(1997-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
formation constant of the##2##4##(2008-10#2)
formation constant of##9##3##(2008-10#9)
formation constant values##2##3##(2008-10#2)
formation constant##17##2##(2008-10#17)
formation constants are##3##3##(2008-10#3)
formation constants of the resulting##3##5##(2008-10#3)
formation constants of the##7##4##(2008-10#7)
formation constants of##19##3##(2008-10#19)
formation constants were##2##3##(2008-10#2)
formation constants##35##2##(2008-10#35)
formation could be##2##3##(1992-9#1)(2013-1#1)
formation due to##2##3##(1997-7#2)
formation during the##2##3##(1995-12#1)(2008-10#1)
formation during##12##2##(1991-5#1)(1995-12#1)(1997-4#1)(2008-10#4)(2008-11#2)(2009-8#2)(2011-2#1)
formation enthalpies##3##2##(2008-10#3)
formation equilibria of some beta-amino-alcohols with lead(II) and cadmium(II)##2##9##(2008-10#2)
formation equilibria##6##2##(2008-10#6)
formation following##5##2##(1991-1#1)(2007-7#1)(2008-11#2)(2012-2#1)
formation for the##2##3##(1992-12#1)(2008-10#1)
formation for##10##2##(1992-12#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2013-1#1)
formation from##12##2##(1992-9#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
formation has been observed##2##4##(2007-11#1)(2009-8#1)
formation has been##6##3##(1990-11#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2009-8#1)
formation has##8##2##(1990-11#1)(1993-9#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2009-8#1)
formation in a##7##3##(1990-7#1)(1994-3#1)(1995-10#1)(2007-12#1)(2008-2#1)(2008-3#2)
formation in an##3##3##(1990-11#1)(1994-5#1)(2007-12#1)
formation in both##2##3##(1992-2#1)(2008-11#1)
formation in different##2##3##(2007-12#1)(2008-10#1)
formation in human##4##3##(1993-8#1)(1994-8#1)(1995-10#1)(2008-10#1)
formation in isolated##2##3##(1991-3#1)(2008-11#1)
formation in mice##2##3##(2007-8#1)(2013-1#1)
formation in phase-shifting digital holography##2##5##(2008-3#2)
formation in pure silica-core fibers##2##5##(2007-11#2)
formation in rat##2##3##(1992-6#1)(2007-10#1)
formation in relation to##2##4##(1990-7#2)
formation in response to##5##4##(1992-8#2)(1993-6#1)(1994-8#1)(2008-10#1)
formation in the presence##2##4##(1990-12#1)(1991-3#1)
formation in the##33##3##(1990-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-9#2)(2010-1#1)(2010-2#1)(2012-2#1)(2013-8#1)
formation in vitro##2##3##(1991-5#1)(1993-8#1)
formation in vivo##3##3##(1993-9#1)(1994-3#1)(2013-1#1)
formation in water##3##3##(1991-5#1)(2008-3#2)
formation in whole blood##4##4##(2006-6#3)(2013-1#1)
formation in winter and spring barley##2##6##(2008-10#2)
formation in##170##2##(1990-11#1)(1990-12#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#5)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#3)(1994-6#1)(1994-8#5)(1995-10#2)(1995-12#4)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-6#4)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#3)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#8)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#4)(2013-8#1)
formation including the##2##3##(1994-8#1)(2008-3#1)
formation independently of##2##3##(1994-3#1)(2006-6#1)
formation induced by##5##3##(1990-12#1)(1991-2#1)(1994-6#1)(2008-4#1)(2013-8#1)
formation into##2##2##(1991-12#1)(2008-10#1)
formation is a##3##3##(1993-8#1)(2010-11#1)(2013-8#1)
formation is also##2##3##(2008-10#1)(2011-2#1)
formation is described##2##3##(2008-10#1)(2008-4#1)
formation is due to##2##4##(1992-9#1)(2011-1#1)
formation is not##2##3##(1995-2#1)(2010-10#1)
formation is unlikely##2##3##(1996-5#1)(2009-7#1)
formation is##45##2##(1990-12#1)(1990-7#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
formation may be##2##3##(1995-5#1)(2012-3#1)
formation mechanism##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
formation occurred##2##2##(1996-6#1)(2008-10#1)
formation of 1##4##3##(1994-3#1)(2008-10#3)
formation of DNA##3##3##(1993-8#1)(2008-11#2)
formation of Fe(III) and Fe(II) chelates with##2##7##(2008-10#2)
formation of GS and##3##4##(2008-10#3)
formation of Z-lumirubin##2##3##(1992-4#2)
formation of a 1##6##4##(1993-11#1)(2007-11#1)(2008-10#4)
formation of a complex##5##4##(1991-2#1)(1995-2#1)(2008-10#2)(2008-4#1)
formation of a high-molecular##2##4##(2008-10#2)
formation of a single##2##4##(2008-10#1)(2011-2#1)
formation of a specified##2##4##(2008-3#2)
formation of a stable##5##4##(1992-12#1)(2007-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
formation of a ternary complex##2##5##(1994-5#1)(2008-10#1)
formation of a##107##3##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1997-2#2)(2007-11#3)(2007-12#6)(2008-1#2)(2008-10#37)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
formation of actin waves during regeneration after axonal lesion##2##9##(2012-2#2)
formation of actin##3##3##(2008-9#1)(2012-2#2)
formation of active##2##3##(1992-9#1)(2013-1#1)
formation of adenosine##2##3##(1994-9#1)(2008-7#1)
formation of all##2##3##(1993-11#1)(2008-7#1)
formation of an##20##3##(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-3#1)(2008-6#1)(2009-11#1)(2009-8#1)
formation of appressoria##2##3##(2008-10#2)
formation of both##9##3##(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(2006-6#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
formation of carcinogenic nitrosamines##2##4##(1992-8#2)
formation of carcinogenic##3##3##(1992-8#2)(1997-7#1)
formation of color centers##2##4##(2007-12#1)(2008-3#1)
formation of color##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
formation of complexes##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
formation of covalent##2##3##(1995-12#1)(1995-6#1)
formation of diacylglycerol##2##3##(1990-12#2)
formation of different##4##3##(2008-10#3)(2008-6#1)
formation of erythroblastic islands de##2##5##(2013-1#2)
formation of gellike##2##3##(2008-11#2)
formation of glycosylated##2##3##(1990-12#1)(1992-12#1)
formation of highly##2##3##(1994-8#1)(2008-4#1)
formation of human##2##3##(1990-2#1)(1995-12#1)
formation of inositol 1##2##4##(1993-6#1)(1995-11#1)
formation of inositol##5##3##(1990-7#2)(1993-6#1)(1993-8#1)(1995-11#1)
formation of intracellular##2##3##(2008-11#1)(2008-7#1)
formation of ion pairs##2##4##(2008-10#2)
formation of ion##3##3##(2008-10#2)(2008-9#1)
formation of iron##2##3##(2008-10#2)
formation of labelled diacylglycerol##2##4##(1990-12#2)
formation of large##2##3##(1994-2#1)(2008-10#1)
formation of lipid##3##3##(2008-7#1)(2013-1#2)
formation of mature##2##3##(2007-11#1)(2008-10#1)
formation of medical groups##2##4##(1992-3#2)
formation of mineralized##2##3##(2008-11#1)(2013-1#1)
formation of mixed##2##3##(2008-10#2)
formation of new##6##3##(1990-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-8#1)
formation of papillae##3##3##(2008-10#3)
formation of primary##2##3##(2008-10#1)(2012-2#1)
formation of protein##3##3##(2009-7#1)(2010-10#1)(2010-9#1)
formation of reactive oxygen species##4##5##(1992-12#1)(2009-8#1)(2010-1#1)(2010-10#1)
formation of reactive##7##3##(1992-12#1)(2008-11#3)(2009-8#1)(2010-1#1)(2010-10#1)
formation of sclerotia##2##3##(2008-10#2)
formation of secondary##6##3##(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
formation of simple##2##3##(2008-3#1)(2010-9#1)
formation of skeletal muscle##2##4##(1993-12#1)(1993-2#1)
formation of spatial##2##3##(2007-12#1)(2012-1#1)
formation of stable##3##3##(1995-2#1)(2007-5#1)(2013-1#1)
formation of superoxide anion##3##4##(1995-6#1)(2008-10#1)(2008-4#1)
formation of the catalytic##2##4##(1997-7#1)(2008-10#1)
formation of the corresponding##2##4##(1996-5#1)(2009-10#1)
formation of the ion association complex##3##6##(2008-10#3)
formation of the ion##4##4##(2008-10#4)
formation of the structure##3##4##(1992-4#1)(2007-11#1)(2008-3#1)
formation of the##137##3##(1990-11#1)(1990-2#2)(1990-5#4)(1990-7#1)(1991-3#2)(1991-5#3)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#4)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#6)(1997-2#3)(1997-4#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#4)(2008-10#39)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#6)(2008-9#1)(2009-10#2)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#1)(2013-7#1)
formation of these##8##3##(1990-12#1)(1991-5#2)(1993-11#1)(1995-2#1)(1996-5#1)(2008-10#2)
formation of this##4##3##(1994-8#1)(2007-12#2)(2008-10#1)
formation of thromboxane by##2##4##(1993-3#2)
formation of thromboxane##3##3##(1993-3#2)(1993-8#1)
formation of transient##2##3##(2007-11#1)(2010-10#1)
formation of tumor##2##3##(1995-12#1)(2008-11#1)
formation of two##5##3##(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#2)
formation of uniform##2##3##(2008-10#1)(2009-12#1)
formation of water-soluble##2##3##(1992-2#1)(1992-4#1)
formation of##928##2##(1990-11#7)(1990-12#11)(1990-2#5)(1990-5#11)(1990-7#8)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#9)(1991-6#1)(1991-9#8)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#10)(1992-4#5)(1992-5#4)(1992-6#7)(1992-8#3)(1992-9#3)(1993-11#20)(1993-12#2)(1993-2#2)(1993-3#8)(1993-5#1)(1993-6#4)(1993-8#11)(1993-9#2)(1994-11#5)(1994-12#5)(1994-2#10)(1994-3#10)(1994-5#5)(1994-6#5)(1994-8#19)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#8)(1995-5#12)(1995-6#6)(1995-8#2)(1995-9#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-5#14)(1997-1#4)(1997-2#8)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#9)(1997-8#3)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#13)(2007-12#26)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#250)(2008-11#31)(2008-12#5)(2008-2#9)(2008-3#18)(2008-4#7)(2008-5#15)(2008-6#10)(2008-7#27)(2008-8#10)(2008-9#11)(2009-10#3)(2009-11#9)(2009-12#3)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#24)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#10)(2012-3#4)(2012-5#1)(2013-1#27)(2013-7#2)(2013-8#2)
formation on the##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
formation on##18##2##(1990-11#1)(1990-9#1)(1991-9#1)(1993-12#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
formation or##13##2##(1990-7#1)(1992-3#2)(1992-9#1)(1993-11#2)(1995-9#1)(2006-6#1)(2007-12#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
formation patterns##2##2##(2008-7#1)(2009-10#1)
formation process##8##2##(1993-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)
formation rate##2##2##(1997-4#1)(2008-10#1)
formation reaction##7##2##(1995-5#1)(2008-10#6)
formation reactions of##2##3##(2008-10#2)
formation reactions##3##2##(2008-10#3)
formation required##2##2##(1995-2#1)(2008-10#1)
formation that##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-9#1)
formation the##3##2##(1997-3#1)(2008-12#1)(2008-2#1)
formation time##2##2##(1997-4#1)(2008-10#1)
formation to be##3##3##(1992-3#1)(2011-1#1)(2013-8#1)
formation to##8##2##(1992-3#1)(2007-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
formation under##2##2##(2007-12#1)(2008-7#1)
formation using##2##2##(2008-10#1)(2011-1#1)
formation was also##2##3##(1994-9#1)(2008-10#1)
formation was examined##2##3##(1994-11#1)(1997-6#1)
formation was found##2##3##(2008-10#1)(2008-2#1)
formation was inhibited by the addition of##2##7##(1993-8#1)(1994-6#1)
formation was inhibited by##4##4##(1990-5#1)(1993-8#1)(1994-6#1)(2008-10#1)
formation was inhibited##5##3##(1990-5#1)(1993-8#1)(1994-6#1)(2008-10#1)(2011-2#1)
formation was investigated##2##3##(1993-8#1)(1994-8#1)
formation was not##3##3##(2008-10#2)(2008-5#1)
formation was observed only##2##4##(2008-10#1)(2008-5#1)
formation was observed##6##3##(1993-11#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
formation was shifted to the##2##5##(1990-12#1)(1995-8#1)
formation was significantly##2##3##(1993-1#1)(1994-9#1)
formation was##57##2##(1990-12#1)(1990-5#2)(1991-3#1)(1991-5#2)(1993-1#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-6#1)(2006-6#2)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
formation were found##2##3##(2008-7#1)(2009-7#1)
formation were##13##2##(1993-9#1)(1994-8#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-7#1)(2010-10#1)
formation when the##2##3##(1995-8#1)(2008-10#1)
formation when##8##2##(1992-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(2008-10#3)(2013-1#1)
formation whereas the##2##3##(2008-10#1)(2010-2#1)
formation whereas##4##2##(2008-10#1)(2010-11#1)(2010-2#1)(2011-1#1)
formation which##2##2##(1994-3#1)(2009-8#1)
formation with the##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2009-7#1)
formation with##25##2##(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#2)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
formation within##2##2##(1995-5#1)(2008-8#1)
formation without##2##2##(1993-6#1)(1997-6#1)
formation##2284##1##(1990-11#12)(1990-12#21)(1990-2#6)(1990-4#1)(1990-5#17)(1990-7#18)(1990-8#6)(1990-9#6)(1991-1#3)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#11)(1991-4#1)(1991-5#27)(1991-6#1)(1991-8#1)(1991-9#14)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#14)(1992-2#6)(1992-3#21)(1992-4#7)(1992-5#6)(1992-6#14)(1992-8#8)(1992-9#16)(1993-1#2)(1993-11#30)(1993-12#7)(1993-2#2)(1993-3#12)(1993-5#1)(1993-6#9)(1993-8#25)(1993-9#8)(1994-1#1)(1994-11#13)(1994-12#8)(1994-2#21)(1994-3#25)(1994-5#14)(1994-6#11)(1994-8#44)(1994-9#7)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#19)(1995-2#18)(1995-3#5)(1995-5#25)(1995-6#21)(1995-8#7)(1995-9#3)(1996-12#10)(1996-2#12)(1996-3#3)(1996-5#23)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#14)(1997-3#8)(1997-4#11)(1997-6#9)(1997-7#13)(1997-8#6)(2006-10#3)(2006-6#23)(2007-10#9)(2007-11#30)(2007-12#53)(2007-5#2)(2007-7#7)(2007-8#10)(2008-1#9)(2008-10#563)(2008-11#77)(2008-12#15)(2008-2#25)(2008-3#52)(2008-4#16)(2008-5#50)(2008-6#21)(2008-7#65)(2008-8#29)(2008-9#39)(2009-10#11)(2009-11#13)(2009-12#12)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#7)(2009-6#9)(2009-7#15)(2009-8#34)(2009-9#5)(2010-1#5)(2010-10#10)(2010-11#15)(2010-12#9)(2010-2#8)(2010-3#6)(2010-4#9)(2010-5#7)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#7)(2011-1#19)(2011-2#69)(2011-3#3)(2012-1#8)(2012-12#20)(2012-2#40)(2012-3#12)(2012-4#1)(2012-5#1)(2013-1#65)(2013-7#3)(2013-8#15)
formation)##6##1##(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
formation-stimulating##2##1##(1993-11#2)
formation]##2##1##(1990-6#1)(2013-1#1)
formations of the##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
formations of##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
formations##14##1##(1990-11#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
formative##8##1##(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#2)
formats and##4##2##(1991-3#1)(2008-10#1)(2008-4#1)(2010-10#1)
formats is##2##2##(2008-10#1)(2008-3#1)
formats of##2##2##(2008-3#1)(2012-12#1)
formats that##2##2##(2008-11#1)(2013-1#1)
formats were##2##2##(2008-10#1)(2012-2#1)
formats##46##1##(1991-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#9)(2008-7#1)(2008-9#3)(2010-10#5)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
formatted##2##1##(2008-10#1)(2009-2#1)
formazan##3##1##(2008-10#1)(2008-11#2)
formed 1##2##2##(2008-10#2)
formed a basis for##2##4##(2008-10#2)
formed a complex##3##3##(1992-12#1)(1997-6#1)(2012-2#1)
formed a gum-like aggregate##2##4##(2008-10#2)
formed a large##2##3##(2008-7#1)(2013-8#1)
formed a strongly supported##2##4##(2008-10#1)(2008-9#1)
formed a well-supported##2##3##(2008-10#2)
formed a##44##2##(1990-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
formed after the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
formed after##10##2##(1991-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-1#1)
formed an##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
formed and the##2##3##(2008-10#1)(2012-2#1)
formed and##18##2##(1990-7#1)(1991-9#1)(1993-1#1)(1993-3#1)(1994-9#1)(1997-7#1)(2008-10#7)(2008-12#1)(2008-3#3)(2012-2#1)
formed appressoria##3##2##(2008-10#3)
formed are##4##2##(1994-8#1)(2008-10#3)
formed as a result of the##2##6##(2008-10#1)(2008-2#1)
formed as a result of##3##5##(2008-10#2)(2008-2#1)
formed as a##5##3##(1990-7#1)(2008-10#3)(2008-2#1)
formed as an##2##3##(2008-4#1)(2011-2#1)
formed as##9##2##(1990-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2011-2#1)
formed at a##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
formed at pH##2##3##(2008-10#2)
formed at the end of##2##5##(1994-9#1)(2008-10#1)
formed at the site of the##2##6##(2008-4#1)(2010-4#1)
formed at the##16##3##(1994-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-4#1)
formed at##35##2##(1992-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-7#1)(2010-11#2)(2010-4#1)(2013-1#1)
formed behind the##2##3##(2008-3#2)
formed between a##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
formed between the##7##3##(1990-7#1)(1994-8#1)(1997-7#1)(2008-10#3)(2008-4#1)
formed between##36##2##(1990-7#1)(1992-3#1)(1994-5#3)(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#23)(2008-2#1)(2008-3#1)(2008-4#2)(2009-8#1)
formed by a##17##3##(1990-11#1)(1997-5#1)(2007-11#5)(2007-12#3)(2008-10#2)(2008-3#3)(2011-2#1)(2013-1#1)
formed by addition of##2##4##(2008-10#2)
formed by alternate##2##3##(1994-2#1)(2007-11#1)
formed by an##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
formed by coupling##2##3##(2008-10#2)
formed by each##2##3##(2008-10#1)(2008-3#1)
formed by incoherent##2##3##(2007-11#1)(2007-12#1)
formed by many##2##3##(1995-3#1)(2008-3#1)
formed by rat hepatic microsomes##2##5##(2011-1#2)
formed by reaction##2##3##(1992-2#1)(2008-10#1)
formed by sodium##2##3##(2008-10#2)
formed by the two##2##4##(2008-3#1)(2008-8#1)
formed by the##51##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-4#2)(1993-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-8#1)
formed by two##6##3##(2007-12#3)(2008-10#2)(2012-2#1)
formed by using##2##3##(2008-10#1)(2008-11#1)
formed by##213##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#3)(1993-11#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-5#1)(2007-11#13)(2007-12#23)(2008-1#2)(2008-10#52)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#23)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#4)(2010-11#1)(2010-2#1)(2010-8#4)(2011-1#2)(2011-2#9)(2012-1#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#1)
formed colonies##2##2##(1993-12#1)(2008-10#1)
formed complex with##2##3##(2008-10#1)(2013-1#1)
formed complex##5##2##(1991-2#2)(2008-10#2)(2013-1#1)
formed complexes were##2##3##(2008-10#2)
formed complexes##5##2##(1990-11#1)(2008-10#4)
formed conidia with##2##3##(2008-10#2)
formed due to##4##3##(1996-5#1)(2007-11#1)(2008-10#2)
formed during an##2##3##(1994-9#1)(2011-1#1)
formed during the##11##3##(1994-11#1)(2007-12#1)(2008-10#4)(2008-9#1)(2010-4#1)(2012-2#1)(2012-5#2)
formed during##20##2##(1990-2#1)(1992-4#1)(1994-11#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#2)(2013-8#1)
formed endogenously##2##2##(2008-8#1)(2013-1#1)
formed exhibits##2##2##(2008-10#2)
formed first##2##2##(1995-6#1)(2007-12#1)
formed from a##3##3##(1991-11#1)(2008-2#1)(2008-6#1)
formed from the decomposition of hydroperoxides of##2##7##(1990-5#2)
formed from the##9##3##(1990-5#2)(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
formed from##37##2##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-5#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
formed immediately##2##2##(2008-10#2)
formed in a##5##3##(1995-6#1)(2008-10#1)(2008-11#2)(2009-12#1)
formed in an##3##3##(1994-2#1)(2007-11#1)(2008-7#1)
formed in cells##2##3##(1993-9#1)(2008-10#1)
formed in response to##2##4##(2008-10#1)(2008-9#1)
formed in solution##5##3##(2008-10#5)
formed in the formulations##2##4##(2008-10#2)
formed in the presence of the##3##6##(1992-3#1)(2008-10#2)
formed in the presence of##6##5##(1992-3#1)(1994-5#1)(1997-4#1)(2008-10#3)
formed in the reaction of##2##5##(2008-10#2)
formed in the same##2##4##(2007-12#1)(2008-10#1)
formed in the sample##2##4##(2008-10#2)
formed in the##42##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#23)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)
formed in these##3##3##(2008-10#2)(2008-11#1)
formed in##100##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#6)(2007-12#3)(2008-10#49)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
formed inside##4##2##(2007-12#2)(2008-10#2)
formed into##3##2##(2008-8#1)(2009-11#1)(2009-5#1)
formed is a##2##3##(2008-10#1)(2008-7#1)
formed is extracted into##3##4##(2008-10#3)
formed is measured at##3##4##(2008-10#3)
formed is##19##2##(2007-11#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-7#1)
formed microsclerotia##2##2##(2008-10#2)
formed no##2##2##(1992-2#1)(2008-10#1)
formed not##2##2##(1995-6#1)(2008-10#1)
formed of##2##2##(1995-1#1)(2008-7#1)
formed on a##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
formed on an##3##3##(2007-12#1)(2008-10#2)
formed on the surface of##3##5##(2008-10#2)(2010-7#1)
formed on the surface##5##4##(2008-10#3)(2008-3#1)(2010-7#1)
formed on the##17##3##(1995-12#1)(1996-10#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-12#1)(2010-7#1)
formed on##40##2##(1990-11#1)(1995-12#1)(1995-6#1)(1996-10#2)(2007-12#2)(2007-7#1)(2008-10#19)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-7#1)(2013-7#1)
formed one##2##2##(2008-10#1)(2012-3#1)
formed over the##2##3##(1994-12#1)(2008-10#1)
formed over##3##2##(1994-12#1)(2008-10#2)
formed per##4##2##(1991-5#3)(2008-10#1)
formed products##2##2##(1991-2#1)(2008-10#1)
formed spheroids##3##2##(2008-11#3)
formed synapses with##2##3##(1997-3#1)(2011-2#1)
formed synapses##3##2##(1997-2#1)(1997-3#1)(2011-2#1)
formed the basis##2##3##(2008-11#1)(2008-12#1)
formed the foundation##2##3##(1992-2#1)(2007-8#1)
formed the##17##2##(1992-2#1)(1995-3#1)(1997-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#2)(2011-1#1)(2012-12#1)(2013-1#1)
formed through the##2##3##(2008-10#1)(2008-4#1)
formed through##3##2##(2008-10#2)(2008-4#1)
formed to##7##2##(1994-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2013-1#1)
formed two##4##2##(2008-10#2)(2011-2#2)
formed under these##2##3##(2008-10#1)(2008-6#1)
formed under##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
formed upon the##2##3##(2008-5#1)(2013-1#1)
formed upon##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
formed using##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
formed via##3##2##(1996-5#1)(2008-10#2)
formed was##7##2##(1990-12#1)(1996-5#1)(1997-1#1)(2008-10#3)(2013-8#1)
formed were##2##2##(2008-10#2)
formed when the##4##3##(1990-7#1)(1994-9#1)(2007-11#1)(2008-10#1)
formed when##7##2##(1990-7#1)(1990-8#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
formed with a##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
formed with an##2##3##(1994-5#1)(2008-7#1)
formed with the##5##3##(1993-11#1)(1997-3#1)(1997-7#1)(2008-3#1)(2008-7#1)
formed with##34##2##(1993-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-3#2)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#3)(2010-5#1)
formed within a##2##3##(2007-12#1)(2008-10#1)
formed within##5##2##(1997-6#1)(2007-12#1)(2008-10#2)(2008-9#1)
formed##987##1##(1990-11#6)(1990-12#2)(1990-2#2)(1990-5#5)(1990-7#8)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#6)(1991-6#2)(1991-9#4)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#4)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#3)(1994-1#2)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#5)(1994-5#5)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#12)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#4)(1996-2#2)(1996-5#13)(1996-6#1)(1997-1#2)(1997-2#6)(1997-3#10)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#1)(2007-11#33)(2007-12#40)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#373)(2008-11#28)(2008-12#8)(2008-2#19)(2008-3#53)(2008-4#8)(2008-5#19)(2008-6#10)(2008-7#22)(2008-8#9)(2008-9#16)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-5#4)(2009-7#6)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#4)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#5)(2011-2#19)(2012-1#6)(2012-12#2)(2012-2#17)(2012-3#4)(2012-5#3)(2013-1#17)(2013-7#1)(2013-8#6)
former East##2##2##(1995-1#1)(2008-11#1)
former German Democratic##3##3##(1992-1#1)(1995-1#1)(2008-10#1)
former ammunition plant##3##3##(2008-11#3)
former and##8##2##(1991-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-7#1)
former are##2##2##(1997-8#1)(2009-8#1)
former group##3##2##(1993-8#1)(1996-2#1)(2008-7#1)
former had##2##2##(2008-9#1)(2012-3#1)
former is##9##2##(1990-12#1)(1993-12#1)(1993-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)
former method##2##2##(1993-3#1)(2009-10#1)
former procedure##2##2##(1990-8#1)(2011-2#1)
former smokers##2##2##(1996-3#1)(2008-10#1)
former strategy##2##2##(2008-2#1)(2010-8#1)
former two##3##2##(1993-11#1)(1993-12#1)(2008-9#1)
former was##4##2##(1991-9#1)(1996-3#1)(2008-10#1)(2010-8#1)
former were##3##2##(1990-8#1)(2008-6#1)(2008-8#1)
former##206##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#3)(2007-11#3)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#27)(2008-11#10)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#6)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
formerly known as the##2##4##(2008-5#1)(2012-2#1)
formerly known as##4##3##(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
formerly##14##1##(1995-12#1)(1995-5#1)(2007-5#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)
formers and##2##2##(1991-12#1)(1995-3#1)
formers##9##1##(1991-12#6)(1995-3#1)(2011-2#2)
formes##2##1##(1995-6#1)(2011-2#1)
formetanate##3##1##(2011-2#3)
formic acid##18##2##(1990-9#1)(1992-5#1)(2008-10#9)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)
formic acid)##2##2##(2008-10#1)(2011-1#1)
formic##25##1##(1990-9#1)(1992-5#1)(1994-9#1)(2008-10#13)(2008-11#1)(2008-4#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
formidable barrier to##2##3##(2008-12#1)(2009-2#1)
formidable##14##1##(1991-2#1)(1995-1#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
forming a &quot##2##3##(2008-4#1)(2011-2#1)
forming a complete##2##3##(2008-2#1)(2008-5#1)
forming a complex with##3##4##(1990-7#1)(1993-3#1)(2008-10#1)
forming a complex##4##3##(1990-7#1)(1993-3#1)(2008-10#2)
forming a##30##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
forming ability of##2##3##(2008-8#1)(2010-2#1)
forming ability##4##2##(2008-8#2)(2010-2#2)
forming an##10##2##(1992-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)
forming and##2##2##(2008-10#1)(2011-2#1)
forming cell##2##2##(2008-10#2)
forming highly##2##2##(1991-9#1)(1994-3#1)
forming in##4##2##(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
forming of the##2##3##(2008-10#1)(2011-2#1)
forming of##5##2##(1991-6#1)(1993-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
forming polymeric formulations##2##3##(2010-5#2)
forming polymeric##3##2##(2010-5#3)
forming reagent##2##2##(2008-10#2)
forming the##21##2##(1990-8#1)(1992-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-7#2)(2011-2#3)(2012-1#1)(2012-3#1)
forming two##2##2##(2007-11#1)(2008-10#1)
forming units of##3##3##(2008-10#3)
forming units##12##2##(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#6)(2008-5#2)(2010-5#1)
forming units-erythroid##3##2##(2008-10#2)(2008-7#1)
forming##233##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#4)(1992-6#2)(1992-8#4)(1993-11#3)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#6)(2007-7#1)(2008-1#3)(2008-10#70)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#5)(2010-7#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
formol ether concentration##2##3##(2013-8#2)
formosa##4##1##(2008-8#2)(2009-2#2)
forms (e##2##2##(2008-4#1)(2008-7#1)
forms (which##2##2##(1997-4#1)(2008-4#1)
forms a 1##3##3##(1995-5#1)(2008-10#2)
forms a complex with##3##4##(1993-3#1)(2008-10#2)
forms a complex##4##3##(1993-3#1)(2008-10#3)
forms a dimer##2##3##(1997-2#1)(2010-12#1)
forms a dimeric##2##3##(1992-3#1)(1996-2#1)
forms a hydrogen bond with##2##5##(1990-8#1)(1992-3#1)
forms a hydrogen bond##3##4##(1990-8#1)(1991-8#1)(1992-3#1)
forms a specialized infection structure##2##5##(2008-10#2)
forms a useful##2##3##(2008-3#1)(2008-7#1)
forms a very stable##2##4##(1991-8#1)(1992-3#1)
forms a very##4##3##(1991-8#1)(1992-3#2)(2008-10#1)
forms a##72##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-3#4)(1993-11#2)(1993-3#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#4)(2008-10#23)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
forms an##11##2##(1992-11#2)(1995-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#1)
forms and in##2##3##(2008-10#1)(2010-3#1)
forms and##31##2##(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-8#1)(2007-7#2)(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
forms are##14##2##(1990-5#1)(1991-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-12#1)(2012-2#1)
forms as well as in##3##5##(2008-10#2)(2008-11#1)
forms as well as##5##4##(1997-7#1)(2008-10#2)(2008-11#1)(2011-1#1)
forms as well##6##3##(1997-7#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-1#1)
forms as##9##2##(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-11#1)(2010-5#1)(2011-1#1)
forms at##2##2##(2008-3#1)(2008-4#1)
forms based on##2##3##(2008-10#1)(2008-5#1)
forms but##2##2##(1994-8#1)(1995-5#1)
forms by means of##2##4##(2008-10#1)(2008-3#1)
forms by the##2##3##(2008-10#1)(2008-8#1)
forms by##10##2##(1990-12#2)(1993-11#1)(1994-5#1)(2008-10#4)(2008-3#1)(2008-8#1)
forms can##2##2##(1996-3#1)(2013-7#1)
forms complexes with##4##3##(1993-8#1)(1995-5#2)(2010-11#1)
forms containing##2##2##(1996-12#1)(2008-10#1)
forms could be##2##3##(1994-9#1)(1995-3#1)
forms for the##2##3##(1990-2#1)(2008-3#1)
forms for##5##2##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
forms from these##2##3##(2008-10#1)(2012-12#1)
forms from##6##2##(1992-9#1)(1994-6#1)(1995-5#1)(2008-10#1)(2012-12#1)(2012-2#1)
forms has##2##2##(2008-10#1)(2008-4#1)
forms have been##3##3##(1990-8#1)(2008-10#1)(2011-3#1)
forms have##5##2##(1990-12#1)(1990-8#1)(1992-5#1)(2008-10#1)(2011-3#1)
forms in chromaffin cells##2##4##(1990-5#2)
forms in the##6##3##(1991-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-5#1)
forms in##20##2##(1990-5#2)(1990-6#1)(1991-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#3)(2009-6#1)(2010-5#1)(2011-2#1)(2012-1#1)
forms into##4##2##(2008-10#2)(2008-11#1)(2010-5#1)
forms is##3##2##(1990-11#1)(2008-1#1)(2008-4#1)
forms may be##2##3##(1990-12#1)(1991-12#1)
forms may##3##2##(1990-12#1)(1991-12#1)(2008-10#1)
forms more stable##3##3##(2008-10#3)
forms more##5##2##(2008-10#4)(2011-1#1)
forms occur##2##2##(1991-12#1)(2007-7#1)
forms of APP##2##3##(1994-11#1)(1994-9#1)
forms of ARM##4##3##(2011-2#4)
forms of Alzheimer##2##3##(1993-8#1)(2008-4#1)
forms of BCG##2##3##(2011-2#2)
forms of Cr##2##3##(2008-10#2)
forms of HLH##2##3##(2011-2#2)
forms of IGF-I##2##3##(2010-5#2)
forms of MS##4##3##(2010-12#2)(2012-3#2)
forms of Myo-D1##2##3##(1993-2#2)
forms of NADPH-cyt##2##3##(1991-5#2)
forms of PAM##3##3##(1994-11#3)
forms of PSA##2##3##(2008-4#1)(2010-12#1)
forms of a##5##3##(1995-5#1)(1997-5#1)(2008-10#2)(2011-2#1)
forms of asthma##2##3##(2010-5#2)
forms of both##3##3##(1992-12#2)(2008-7#1)
forms of brain##2##3##(1991-5#1)(2008-1#1)
forms of cancer##6##3##(1992-5#1)(1997-2#1)(2010-11#1)(2010-7#1)(2011-2#2)
forms of cathepsin##2##3##(1995-6#2)
forms of chromium##2##3##(2008-10#2)
forms of congenital##2##3##(2008-10#1)(2008-4#1)
forms of dementia##2##3##(1990-11#1)(2008-7#1)
forms of depression##2##3##(2008-6#1)(2013-1#1)
forms of developmental##2##3##(2008-3#1)(2010-8#1)
forms of diabetes##2##3##(1992-11#1)(2008-7#1)
forms of diabetic neuropathy##2##4##(2008-1#2)
forms of each##2##3##(1992-6#1)(1993-11#1)
forms of gonadotropin-releasing hormone (GnRH) have been##2##7##(1992-8#1)(1995-11#1)
forms of gonadotropin-releasing##3##3##(1992-8#1)(1994-8#1)(1995-11#1)
forms of growth##2##3##(2008-6#2)
forms of human##9##3##(1990-12#1)(1992-8#3)(1994-12#1)(1994-9#1)(1997-7#2)(2008-2#1)
forms of incomplete resistance##2##4##(2008-10#2)
forms of insurance contract##2##4##(1992-1#2)
forms of intervention##3##3##(1996-1#1)(2013-1#2)
forms of learning##3##3##(1997-7#1)(2008-11#1)(2010-4#1)
forms of male##2##3##(1991-11#1)(2011-1#1)
forms of memory##3##3##(1994-8#2)(2007-8#1)
forms of most##2##3##(1990-12#1)(1994-2#1)
forms of murine##2##3##(1990-12#2)
forms of presentation##2##3##(2010-3#1)(2011-2#1)
forms of protein##2##3##(1995-11#1)(1995-3#1)
forms of short-term memory##2##4##(2007-8#2)
forms of social##2##3##(2008-5#1)(2009-8#1)
forms of stress##2##3##(2012-3#1)(2013-7#1)
forms of synaptic plasticity##2##4##(1993-12#1)(2009-9#1)
forms of synaptic##3##3##(1993-12#1)(2009-9#2)
forms of the G-CSFR##2##4##(1994-11#2)
forms of the disease are##2##5##(2008-11#1)(2008-5#1)
forms of the disease##5##4##(1993-2#1)(2008-11#1)(2008-5#3)
forms of the enzyme##6##4##(1992-12#3)(1997-2#2)(2008-11#1)
forms of the fulgimide##2##4##(2009-9#2)
forms of the pathogen##2##4##(2008-10#2)
forms of the protein##2##4##(1993-11#1)(2008-9#1)
forms of the##41##3##(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1994-11#4)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#3)(2008-9#1)(2009-9#2)
forms of therapy##2##3##(1993-9#1)(2007-12#1)
forms of these##2##3##(2008-11#1)(2013-1#1)
forms of this##4##3##(1991-12#1)(1991-7#1)(2006-6#1)(2013-1#1)
forms of training##2##3##(1994-12#1)(2009-1#1)
forms of treatment##5##3##(1991-6#1)(1994-9#1)(2007-12#1)(2012-3#1)(2013-1#1)
forms of##429##2##(1990-11#1)(1990-12#6)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#7)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#8)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#4)(1992-8#8)(1992-9#4)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#6)(1993-3#2)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#12)(1994-12#3)(1994-2#2)(1994-6#2)(1994-8#5)(1994-9#8)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#7)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#4)(1997-8#1)(1997-9#1)(2006-6#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-8#6)(2008-1#10)(2008-10#43)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#7)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#2)
forms on##4##2##(2008-10#3)(2008-3#1)
forms one##2##2##(1992-6#1)(2013-1#1)
forms or##4##2##(1991-2#1)(1995-5#1)(2008-10#2)
forms part of the##4##4##(1992-6#1)(2008-12#1)(2008-7#1)(2010-10#1)
forms part of##6##3##(1992-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)
forms that##6##2##(1995-5#1)(1997-5#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
forms the basis for##6##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#2)
forms the basis of##4##4##(2008-10#2)(2008-2#1)(2011-2#1)
forms the basis##10##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#2)
forms the core of##2##4##(2007-12#1)(2009-7#1)
forms the first##2##3##(1990-12#1)(1997-4#1)
forms the##28##2##(1990-12#1)(1992-6#1)(1997-4#1)(1997-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#2)(2011-2#1)(2013-8#2)
forms to##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
forms under##2##2##(1990-12#1)(2008-9#1)
forms using packed column supercritical fluid chromatography##2##7##(2008-10#2)
forms using##5##2##(2008-10#4)(2013-1#1)
forms were##18##2##(1990-12#1)(1990-9#1)(1994-11#1)(1994-6#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-7#1)(2011-2#3)(2012-12#1)
forms which have##2##3##(1990-8#1)(1997-5#1)
forms which##3##2##(1990-8#1)(1991-3#1)(1997-5#1)
forms with##7##2##(1990-11#1)(1993-3#1)(1994-12#1)(1995-5#1)(2008-10#3)
forms##1005##1##(1990-10#1)(1990-11#5)(1990-12#18)(1990-2#6)(1990-3#2)(1990-5#13)(1990-6#3)(1990-7#2)(1990-8#8)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#14)(1991-2#7)(1991-3#5)(1991-4#1)(1991-5#10)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#10)(1992-2#2)(1992-3#8)(1992-5#4)(1992-6#10)(1992-8#15)(1992-9#6)(1993-10#1)(1993-11#13)(1993-12#4)(1993-2#8)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#7)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#16)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#4)(1994-8#13)(1994-9#13)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#8)(1995-5#14)(1995-6#11)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#10)(1997-3#4)(1997-4#7)(1997-5#7)(1997-6#1)(1997-7#6)(1997-8#2)(1997-9#2)(2006-6#2)(2007-10#2)(2007-11#8)(2007-12#18)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#15)(2008-10#170)(2008-11#19)(2008-12#13)(2008-2#11)(2008-3#22)(2008-4#16)(2008-5#25)(2008-6#8)(2008-7#32)(2008-8#13)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#5)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#6)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#14)(2010-3#3)(2010-4#1)(2010-5#16)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#14)(2011-2#35)(2011-3#2)(2012-1#4)(2012-12#10)(2012-2#13)(2012-3#9)(2012-6#1)(2013-1#27)(2013-7#3)(2013-8#4)
forms)##2##1##(1993-8#1)(2008-10#1)
forms?##2##1##(1996-1#1)(2006-10#1)
formula and the##2##3##(2007-11#1)(2012-1#1)
formula and##5##2##(1991-12#1)(2007-11#1)(2008-10#1)(2010-10#1)(2012-1#1)
formula for partially coherent##2##4##(2007-11#1)(2008-3#1)
formula for the mean lifetime of metapopulations in heterogeneous landscapes##2##10##(2008-8#2)
formula for the transient##2##4##(2008-2#2)
formula for the##13##3##(1992-9#1)(1995-9#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#2)
formula for##25##2##(1992-9#2)(1993-3#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#3)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-8#2)
formula in the##2##3##(2008-5#1)(2012-1#1)
formula in##4##2##(1994-6#1)(2008-5#1)(2012-1#2)
formula is derived for the##2##5##(2007-11#1)(2008-3#1)
formula is derived for##3##4##(2007-11#1)(2008-3#2)
formula is derived##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
formula is used to##2##4##(1993-3#1)(2008-3#1)
formula is##13##2##(1993-3#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)(2012-2#1)
formula of##4##2##(1992-9#1)(1995-6#1)(2008-10#1)(2008-5#1)
formula that##4##2##(2007-11#1)(2008-3#2)(2008-5#1)
formula to##2##2##(2007-11#2)
formula used##3##2##(1992-12#1)(1994-12#1)(2008-2#1)
formula with##2##2##(2008-3#1)(2008-5#1)
formula##127##1##(1990-8#1)(1991-12#3)(1992-12#2)(1992-9#4)(1993-12#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-6#2)(1995-6#2)(1995-9#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#4)(2007-11#11)(2007-12#3)(2008-10#12)(2008-12#1)(2008-2#8)(2008-3#18)(2008-5#17)(2008-8#7)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#6)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
formula)##2##1##(1994-6#1)(2008-10#1)
formulae are##2##2##(1994-2#1)(2012-3#1)
formulae for##4##2##(1994-2#1)(2008-7#1)(2009-9#1)(2012-3#1)
formulae##21##1##(1994-2#3)(2007-7#1)(2008-10#4)(2008-5#7)(2008-7#1)(2009-9#1)(2012-3#4)
formularies##2##1##(1996-8#1)(2009-6#1)
formulary##5##1##(1994-3#1)(1995-2#2)(2011-1#1)(2011-2#1)
formulas and##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
formulas are##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
formulas derived##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
formulas for the##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
formulas for##20##2##(2007-12#1)(2008-10#1)(2008-2#7)(2008-3#7)(2008-8#1)(2013-1#1)(2013-8#2)
formulas of the##3##3##(2008-3#2)(2008-4#1)
formulas that##4##2##(1991-12#1)(2008-3#3)
formulas to##4##2##(1994-6#1)(2008-3#3)
formulas##73##1##(1991-12#1)(1993-1#1)(1994-6#1)(1997-2#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#17)(2008-3#22)(2008-4#1)(2008-5#4)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
formulate a##6##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)
formulate and analyze a##2##4##(2011-2#1)(2012-2#1)
formulate and##6##2##(1992-12#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
formulate the##5##2##(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)
formulate##44##1##(1992-12#1)(1993-12#1)(1994-2#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-8#1)
formulated ABCD matrix for##2##4##(2008-2#1)(2008-3#1)
formulated a##2##2##(1997-4#1)(2011-1#1)
formulated and the##2##3##(2008-5#1)(2013-8#1)
formulated and##10##2##(1991-1#1)(1996-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2013-8#1)
formulated as an##2##3##(2007-12#1)(2008-5#1)
formulated as assimilative hyphae in##2##5##(2008-10#2)
formulated as##12##2##(1996-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#3)(2011-2#1)
formulated by the##3##3##(1991-9#1)(2008-3#1)(2011-2#1)
formulated by##8##2##(1991-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#2)(2013-8#1)
formulated differently##2##2##(1995-3#1)(1996-1#1)
formulated for the##3##3##(2008-10#1)(2008-2#1)(2012-4#1)
formulated for##4##2##(2008-10#1)(2008-2#2)(2012-4#1)
formulated in a##2##3##(1994-5#1)(2008-3#1)
formulated in the laboratory##2##4##(2008-5#2)
formulated in the##4##3##(2008-3#1)(2008-5#2)(2009-4#1)
formulated in##11##2##(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-3#2)(2008-5#2)(2009-4#1)(2009-5#1)(2012-1#1)
formulated microspheres##2##2##(2010-5#2)
formulated product##3##2##(2008-10#1)(2008-5#2)
formulated to contain##2##3##(1994-12#1)(2008-10#1)
formulated to##7##2##(1992-1#1)(1994-12#1)(2008-10#1)(2008-7#2)(2010-2#1)(2012-2#1)
formulated using##3##2##(2007-9#1)(2008-6#1)(2009-4#1)
formulated with the##3##3##(2008-10#2)(2008-3#1)
formulated with##15##2##(1995-5#1)(1996-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-4#1)(2013-8#1)
formulated##112##1##(1991-1#2)(1991-9#1)(1992-1#1)(1992-3#1)(1994-12#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#17)(2008-11#6)(2008-12#5)(2008-2#6)(2008-3#10)(2008-5#16)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-8#3)
formulating a##4##2##(1991-3#1)(1995-8#1)(2008-10#1)(2008-7#1)
formulating the##2##2##(2008-12#1)(2008-3#1)
formulating##19##1##(1991-3#2)(1992-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
formulation also##2##2##(2007-11#1)(2008-10#1)
formulation and##17##2##(1990-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-3#1)
formulation are##2##2##(2008-11#1)(2008-2#1)
formulation at##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
formulation based on canola meal##2##5##(2008-10#2)
formulation based on##6##3##(2008-10#3)(2008-3#1)(2008-5#2)
formulation by##2##2##(2008-10#2)
formulation containing##5##2##(1995-5#1)(2008-5#4)
formulation development##6##2##(1992-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
formulation for the##3##3##(1996-3#1)(2009-12#1)(2012-2#1)
formulation for##10##2##(1996-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2012-2#1)
formulation from##2##2##(2008-5#1)(2011-3#1)
formulation in a##2##3##(1996-1#1)(2008-5#1)
formulation in##6##2##(1996-1#1)(2008-3#1)(2008-5#2)(2011-3#1)(2012-2#1)
formulation is##9##2##(1997-3#1)(2008-10#2)(2008-3#4)(2008-5#1)(2011-2#1)
formulation of a##8##3##(1992-9#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
formulation of cosmetic products##2##4##(2008-5#2)
formulation of the differential##2##4##(2007-12#1)(2008-2#1)
formulation of the##14##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2010-1#1)(2013-8#1)
formulation of##72##2##(1990-8#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
formulation on##3##2##(2008-3#2)(2008-5#1)
formulation or##2##2##(2007-11#1)(2008-10#1)
formulation that##8##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-10#1)(2012-12#1)(2012-2#1)
formulation to the##2##3##(1996-1#1)(2008-3#1)
formulation to##4##2##(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
formulation type##2##2##(2008-5#1)(2011-2#1)
formulation was found to be##3##5##(2009-10#1)(2012-2#2)
formulation was subjected to##2##4##(2008-10#1)(2011-1#1)
formulation was##13##2##(2008-10#4)(2008-5#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
formulation were compared with##2##4##(2012-2#2)
formulation were##3##2##(1992-8#1)(2012-2#2)
formulation with##6##2##(2008-11#1)(2008-5#5)
formulation##335##1##(1990-8#2)(1990-9#1)(1992-3#1)(1992-8#6)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-1#3)(1996-3#1)(1996-4#3)(1996-9#1)(1997-3#1)(1997-6#1)(2007-11#5)(2007-12#4)(2007-7#1)(2008-10#69)(2008-11#15)(2008-12#4)(2008-2#12)(2008-3#24)(2008-4#1)(2008-5#73)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#3)(2009-10#4)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#8)(2010-4#2)(2010-5#5)(2010-8#1)(2011-1#5)(2011-2#10)(2011-3#4)(2012-1#2)(2012-12#2)(2012-2#16)(2012-6#1)(2013-1#4)(2013-8#1)
formulations and biological samples##2##4##(2008-10#2)
formulations and biological##4##3##(2008-10#4)
formulations and##16##2##(2007-11#1)(2008-10#12)(2008-2#1)(2008-6#1)(2009-7#1)
formulations are##9##2##(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-11#1)(2010-5#1)
formulations as##2##2##(2008-10#2)
formulations at##5##2##(1996-1#1)(2008-10#3)(2010-3#1)
formulations by applying##2##3##(2008-10#2)
formulations by means of the##2##5##(2008-10#1)(2008-5#1)
formulations by using##4##3##(2008-10#4)
formulations by##16##2##(2008-10#14)(2008-5#2)
formulations compared##2##2##(2008-10#1)(2008-5#1)
formulations containing a combination of##2##5##(2008-10#2)
formulations containing##17##2##(2008-10#8)(2008-5#8)(2010-5#1)
formulations for acne##2##3##(2008-5#1)(2012-12#1)
formulations for the##3##3##(1997-1#1)(2008-11#1)(2009-5#1)
formulations for##7##2##(1997-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-5#2)(2012-12#1)
formulations from##2##2##(2008-10#1)(2008-11#1)
formulations have##2##2##(2008-5#1)(2008-7#1)
formulations in the##2##3##(2008-5#2)
formulations in##5##2##(2008-10#2)(2008-11#1)(2008-5#2)
formulations is##9##2##(2008-10#7)(2008-5#1)(2010-10#1)
formulations may##2##2##(2008-11#1)(2011-2#1)
formulations of amphotericin B##2##4##(2008-5#1)(2011-2#1)
formulations of amphotericin##3##3##(2008-5#1)(2011-2#2)
formulations of oxybutynin and tolterodine##2##5##(2008-3#2)
formulations of salbutamol##2##3##(1996-1#2)
formulations of##30##2##(1996-1#3)(1997-7#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#1)
formulations on##2##2##(2008-5#1)(2012-12#1)
formulations showed##2##2##(2008-5#1)(2013-1#1)
formulations tested##2##2##(2008-10#2)
formulations that contained##2##3##(2008-10#1)(2008-5#1)
formulations that##6##2##(2008-10#1)(2008-2#1)(2008-5#3)(2012-2#1)
formulations to##4##2##(2008-5#2)(2011-2#1)(2012-2#1)
formulations used##3##2##(2008-10#1)(2008-5#2)
formulations using the##2##3##(2008-10#2)
formulations using##16##2##(2008-10#15)(2008-5#1)
formulations was developed##3##3##(2008-10#3)
formulations was investigated##2##3##(2008-5#2)
formulations was tested##2##3##(2008-10#2)
formulations was##12##2##(1997-4#1)(2008-10#7)(2008-5#2)(2008-7#1)(2011-2#1)
formulations were tested##3##3##(2008-10#1)(2010-3#2)
formulations were##24##2##(2008-10#11)(2008-5#5)(2008-7#1)(2010-3#2)(2011-1#2)(2012-12#2)(2012-2#1)
formulations will be##2##3##(2008-5#2)
formulations will##4##2##(2008-5#3)(2008-9#1)
formulations with##6##2##(2008-10#4)(2008-5#1)(2012-2#1)
formulations##419##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-5#3)(1996-1#6)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#203)(2008-11#11)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#98)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#8)(2010-4#3)(2010-5#14)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#5)(2012-2#7)(2013-1#4)(2013-8#1)
formulations)##2##1##(1997-3#1)(2008-10#1)
formulator##5##1##(2008-10#1)(2008-5#3)(2011-1#1)
formycin B##3##2##(1994-8#3)
formyl##3##1##(1990-9#1)(1993-6#1)(2009-12#1)
formyl-methionyl-leucyl-phenylalanine##2##1##(1990-7#1)(2008-4#1)
fornix and##2##2##(1993-3#1)(1993-6#1)
fornix lesions##4##2##(1991-5#1)(1993-3#2)(1993-6#1)
fornix##18##1##(1991-5#5)(1991-8#1)(1992-11#2)(1993-3#5)(1993-6#2)(1996-12#1)(2008-10#1)(2011-2#1)
forproducing##2##1##(2008-11#2)
forrecording##2##1##(2008-2#2)
forskohlii##2##1##(2008-11#1)(2008-5#1)
forskolin (10 microM) was##2##4##(1997-2#1)(2009-12#1)
forskolin (10 microM)##4##3##(1997-2#2)(2009-12#2)
forskolin (10##5##2##(1995-11#1)(1997-2#2)(2009-12#2)
forskolin and##6##2##(1991-12#1)(1991-9#1)(1993-3#2)(1994-11#1)(1995-12#1)
forskolin induced##2##2##(1993-3#1)(1997-7#1)
forskolin on##2##2##(1993-3#1)(2009-12#1)
forskolin or##3##2##(1994-11#1)(1995-5#1)(2008-11#1)
forskolin was applied##2##3##(1993-3#1)(2009-12#1)
forskolin was not##2##3##(1993-3#1)(1997-1#1)
forskolin was##7##2##(1993-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#1)(2009-12#1)
forskolin##57##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-6#1)(1993-3#7)(1993-6#1)(1994-11#4)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#5)(1996-5#2)(1997-1#3)(1997-2#10)(1997-7#5)(2008-11#3)(2009-12#6)(2012-12#1)
forskolin-agarose-retained fractions##2##2##(1992-3#2)
forskolin-agarose-retained##3##1##(1992-3#3)
forskolin-induced##2##1##(1995-6#1)(1996-12#1)
forskolin-stimulated adenylyl cyclase##4##3##(1995-11#1)(1995-12#1)(1997-1#2)
forskolin-stimulated cAMP accumulation##2##3##(1993-3#1)(1993-9#1)
forskolin-stimulated cAMP##3##2##(1993-3#1)(1993-9#1)(2008-4#1)
forskolin-stimulated##8##1##(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1997-1#2)(2008-4#1)
forsterite crystal with##2##3##(2008-2#2)
forsterite crystal##3##2##(2008-2#3)
forsterite laser and##2##3##(2007-12#1)(2008-3#1)
forsterite laser at##2##3##(2007-12#1)(2008-2#1)
forsterite laser pumped by a##2##5##(2008-2#2)
forsterite laser with the##2##4##(2007-11#2)
forsterite laser with##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
forsterite laser##26##2##(2007-11#8)(2007-12#6)(2008-2#7)(2008-3#5)
forsterite lasers are##2##3##(2007-12#1)(2008-2#1)
forsterite lasers##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
forsterite regenerative amplifier##3##3##(2007-11#1)(2007-12#2)
forsterite##49##1##(2007-11#12)(2007-12#11)(2008-2#16)(2008-3#10)
forsythus##4##1##(2008-12#4)
forth a##2##2##(2008-11#1)(2012-2#1)
forth by##3##2##(1993-2#1)(1993-3#1)(1995-12#1)
forth in##5##2##(1991-2#1)(1992-12#1)(1997-3#1)(1997-5#1)(2007-12#1)
forth the##3##2##(1994-12#1)(2008-3#1)(2008-7#1)
forth##27##1##(1991-2#2)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1997-3#1)(1997-5#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
forthcoming operation##2##2##(2007-8#2)
forthcoming##11##1##(1994-2#1)(1996-8#1)(1997-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
forthe##4##1##(2008-11#3)(2008-2#1)
forthis##2##1##(2008-11#2)
forties##2##1##(2008-5#2)
fortification levels##2##2##(2008-10#2)
fortification of##5##2##(1997-8#1)(2008-10#2)(2010-1#1)(2012-1#1)
fortification programs##3##2##(2012-1#3)
fortification##16##1##(1997-8#1)(2008-10#6)(2008-11#2)(2010-1#3)(2012-1#4)
fortified at levels##2##3##(2008-10#2)
fortified at##3##2##(2008-10#3)
fortified medium##4##2##(2008-11#4)
fortified with##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
fortified##20##1##(2008-10#10)(2008-11#5)(2008-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)
fortifying##2##1##(2008-10#2)
fortinii##3##1##(2008-10#3)
fortnightly##3##1##(1996-12#1)(2007-7#1)(2008-6#1)
fortran##2##1##(2008-2#2)
fortress##2##1##(2010-1#1)(2011-2#1)
fortuitous ORFs##3##2##(1996-3#3)
fortuitous association?##2##2##(2008-1#1)(2008-8#1)
fortuitous##12##1##(1991-5#1)(1996-3#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
fortuitously##3##1##(1995-8#1)(1997-1#1)(2013-7#1)
fortuitum was##2##2##(2008-11#1)(2011-2#1)
fortuitum##11##1##(2007-12#3)(2007-7#1)(2008-11#2)(2008-8#1)(2011-2#4)
fortunately##2##1##(2007-11#1)(2008-10#1)
forty percent of##2##3##(1995-6#1)(2008-11#1)
forty year old##2##3##(1993-6#1)(2007-7#1)
forty years of##2##3##(1996-9#1)(2012-3#1)
forty years##3##2##(1991-8#1)(1996-9#1)(2012-3#1)
forty##17##1##(1991-8#1)(1993-6#1)(1994-12#1)(1995-6#2)(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
forty-one##2##1##(1991-6#1)(2008-10#1)
forty-three##3##1##(1991-8#1)(2008-10#1)(2010-2#1)
forum for##8##2##(1995-3#1)(1996-1#2)(2007-5#1)(2008-4#1)(2008-5#2)(2010-4#1)
forum on##2##2##(2008-8#1)(2012-2#1)
forum to discuss##2##3##(2008-10#1)(2010-11#1)
forum to##5##2##(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
forum##28##1##(1991-2#1)(1993-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-11#2)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
forums as##2##2##(2011-2#1)(2012-12#1)
forums##6##1##(1994-12#1)(2010-4#1)(2011-2#3)(2012-12#1)
forward BP equations##2##3##(2008-3#2)
forward Raman##2##2##(2007-11#1)(2008-3#1)
forward SRS##2##2##(2008-3#2)
forward and backward anisotropic scattering##2##5##(2008-3#2)
forward and backward##9##3##(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-5#1)(2012-2#1)
forward and reverse##7##3##(1992-3#1)(1992-6#1)(1997-2#1)(2008-10#2)(2009-5#1)(2009-9#1)
forward and##22##2##(1992-3#1)(1992-6#1)(1997-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
forward current##3##2##(2009-11#3)
forward displacement of the##2##4##(2008-10#1)(2013-1#1)
forward electron transfer##3##3##(1992-6#2)(2009-3#1)
forward for##3##2##(1995-3#1)(1996-8#1)(2009-10#1)
forward genetics##2##2##(2007-12#1)(2012-3#1)
forward head posture##3##3##(2010-9#3)
forward in our understanding of##2##5##(2010-12#1)(2012-12#1)
forward in the##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
forward in understanding the##2##4##(2010-11#1)(2011-1#1)
forward in##14##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)
forward light scatter##2##3##(2006-6#1)(2008-9#1)
forward model and##3##3##(2008-3#3)
forward model for##2##3##(2007-12#2)
forward model##9##2##(1995-3#1)(2007-12#2)(2008-3#5)(2010-2#1)
forward models##3##2##(2008-3#1)(2011-1#2)
forward neural networks##2##3##(2008-10#1)(2010-8#1)
forward neural##3##2##(2008-10#2)(2010-8#1)
forward power##2##2##(2007-9#1)(2008-10#1)
forward rate##2##2##(2008-10#2)
forward scattering##5##2##(2008-2#4)(2008-3#1)
forward stepwise##2##2##(2008-10#1)(2008-9#1)
forward the##5##2##(2008-7#1)(2009-7#1)(2009-9#1)(2012-2#1)(2012-3#1)
forward to##5##2##(1995-1#1)(2008-3#1)(2008-7#2)(2010-4#1)
forward with##4##2##(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)
forward##179##1##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#6)(2007-12#7)(2007-9#2)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#22)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#4)(2011-1#6)(2011-2#3)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#3)
forward)##2##1##(2008-5#1)(2011-1#1)
forward-scattered light##3##2##(2008-2#3)
forward-scattered##6##1##(2007-11#2)(2008-2#4)
forward-scattering ratios for diffuse##2##4##(2008-2#2)
forward-scattering##9##1##(2008-2#8)(2008-3#1)
forwards##2##1##(2008-10#1)(2008-9#1)
fos mRNA##3##2##(1992-9#3)
fos##8##1##(1992-9#4)(1994-6#1)(2008-11#2)(2008-9#1)
fos-lacZ##4##1##(1996-5#4)
fosfestrol##3##1##(2008-10#3)
fosfomycin##6##1##(2008-10#4)(2008-7#1)(2011-2#1)
fosmid clones##2##2##(2008-11#1)(2010-3#1)
fosmid##3##1##(2008-11#2)(2010-3#1)
fossa abscess after pelvic floor##2##5##(2012-3#2)
fossa and##5##2##(1996-6#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
fossa arachnoid cyst##2##3##(2008-2#1)(2009-9#1)
fossa is##2##2##(2008-7#1)(2008-8#1)
fossa of the##2##3##(2011-2#2)
fossa ovalis atrial septal defect##2##5##(2008-11#2)
fossa ovalis atrial septal##3##4##(2008-11#3)
fossa was performed##2##3##(1997-8#1)(2009-3#1)
fossa was##3##2##(1997-8#1)(2008-5#1)(2009-3#1)
fossa with##2##2##(2008-7#1)(2008-8#1)
fossa##64##1##(1993-1#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#1)(2006-12#2)(2008-1#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#2)(2009-3#2)(2009-9#2)(2011-1#1)(2011-2#16)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)
fossae##4##1##(2006-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
fossil and##2##2##(2012-9#1)(2013-1#1)
fossil evidence##2##2##(1994-3#1)(2013-1#1)
fossil fuel##3##2##(2008-11#1)(2009-3#1)(2011-2#1)
fossil fuels##2##2##(2008-6#1)(2009-3#1)
fossil##31##1##(1992-7#1)(1994-3#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#2)(2008-8#2)(2009-3#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-9#3)(2013-1#6)(2013-8#1)
fossilized##3##1##(1990-11#1)(1995-3#2)
fossils##6##1##(1991-8#1)(2008-1#1)(2008-9#2)(2013-1#2)
foster care##2##2##(1997-2#1)(2009-9#1)
foster children##3##2##(2008-12#3)
foster our##2##2##(2008-8#1)(2011-1#1)
foster parents##2##2##(1995-5#2)
foster the##3##2##(1993-1#1)(1995-12#1)(2012-12#1)
foster this##2##2##(2008-11#1)(2013-1#1)
foster understanding##2##2##(2007-2#1)(2008-12#1)
foster##45##1##(1990-11#1)(1991-12#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-3#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#8)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
fostered by##2##2##(1992-2#1)(2009-8#1)
fostered the##2##2##(1997-2#1)(2012-12#1)
fostered##13##1##(1992-2#1)(1994-1#1)(1997-2#1)(2008-10#1)(2008-11#4)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)
fostering an##2##2##(2011-3#1)(2012-3#1)
fostering deep learning##2##3##(2008-11#2)
fostering##18##1##(1990-12#6)(1996-3#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)(2011-3#1)(2012-3#2)
fosters##5##1##(1991-12#1)(1992-12#1)(2008-12#1)(2008-3#1)(2012-3#1)
fought##3##1##(1991-3#1)(2011-2#1)(2013-1#1)
foul##6##1##(1990-6#1)(2007-7#1)(2009-10#1)(2013-1#2)(2013-8#1)
fouling and##3##2##(2008-10#3)
fouling processes##2##2##(2008-11#2)
fouling##30##1##(2008-10#10)(2008-11#4)(2008-6#2)(2008-7#7)(2010-5#1)(2010-8#2)(2013-1#4)
found 23##2##2##(2008-12#1)(2013-1#1)
found 30##2##2##(2008-10#2)
found a high##3##3##(1992-9#1)(2008-1#1)(2008-11#1)
found a higher##2##3##(1994-9#1)(2008-1#1)
found a new##3##3##(1991-1#1)(1993-6#1)(2008-2#1)
found a prevalence of##2##4##(2011-1#1)(2013-8#1)
found a significant correlation between##2##5##(2011-1#1)(2013-8#1)
found a significant decrease##2##4##(2008-11#1)(2008-5#1)
found a significant increase in##2##5##(2008-11#1)(2008-7#1)
found a significant##10##3##(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
found a way##2##3##(1991-9#1)(2010-5#1)
found a##67##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#4)(2011-4#1)(2013-1#2)(2013-8#2)
found absent##2##2##(2008-11#1)(2009-7#1)
found according to##2##3##(2008-10#1)(2009-11#1)
found acute##2##2##(2008-1#2)
found after##17##2##(1990-12#1)(1990-6#1)(1991-2#1)(1993-2#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)
found all##2##2##(1996-9#1)(2013-7#1)
found almost##3##2##(1997-7#1)(2008-10#2)
found along the##3##3##(1997-6#1)(2011-2#1)(2012-2#1)
found along##6##2##(1997-6#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
found also that##2##3##(1992-12#1)(2010-4#1)
found among children##2##3##(2012-3#1)(2013-1#1)
found among isolates##2##3##(2008-10#2)
found among some##2##3##(1993-6#1)(2008-10#1)
found among subpopulations of##2##4##(2008-10#1)(2008-4#1)
found among the##22##3##(1993-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#4)(2008-7#2)(2009-5#1)(2009-8#1)(2012-2#1)(2012-5#1)
found among##53##2##(1993-2#1)(1993-6#1)(1994-6#1)(1995-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#3)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#3)
found an##13##2##(1993-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
found and discussed##2##3##(2008-10#1)(2008-3#1)
found and##19##2##(1994-5#1)(1997-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#2)(2011-3#1)(2013-1#3)(2013-8#1)
found application in##2##3##(2007-8#1)(2008-10#1)
found applications in##2##3##(2008-2#1)(2008-5#1)
found are##4##2##(2008-10#2)(2008-4#1)(2012-12#1)
found around the##2##3##(2008-10#1)(2008-9#1)
found around##3##2##(2008-10#2)(2008-9#1)
found as 0##3##3##(2008-10#3)
found as a##4##3##(1996-6#2)(2008-10#1)(2008-3#1)
found as the##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
found as##24##2##(1994-3#1)(1996-6#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
found associated with##6##3##(1990-5#1)(1994-12#1)(2008-10#3)(2008-11#1)
found at a##3##3##(1995-6#1)(2008-1#1)(2008-6#1)
found at depths of##2##4##(2008-10#1)(2012-2#1)
found at high##2##3##(1994-11#1)(2008-5#1)
found at low levels in##2##5##(1994-9#1)(2008-10#1)
found at low##3##3##(1991-9#1)(1994-9#1)(2008-10#1)
found at operation##2##3##(1991-6#1)(2008-10#1)
found at the sites##2##4##(2008-10#1)(2011-1#1)
found at the time of##2##5##(1991-6#1)(2012-12#1)
found at the##25##3##(1991-5#1)(1991-6#1)(1992-5#1)(1995-4#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
found at##73##2##(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)
found bacterial##2##2##(2008-5#1)(2009-6#1)
found beneath the##2##3##(1995-3#1)(2008-10#1)
found beneath##3##2##(1995-3#1)(2008-10#2)
found beneficial in##2##3##(2008-10#1)(2011-2#1)
found between disease##2##3##(2008-10#2)
found between groups in##2##4##(1996-1#1)(2008-12#1)
found between groups##4##3##(1996-1#1)(2008-12#1)(2008-7#1)(2009-2#1)
found between measured##2##3##(2007-12#1)(2008-2#1)
found between results for##2##4##(2008-10#1)(2008-3#1)
found between the child's and##2##5##(1993-2#2)
found between the child's##3##4##(1993-2#2)(2008-11#1)
found between the peak##2##4##(2008-10#2)
found between the results##2##4##(2008-10#1)(2008-3#1)
found between the two groups##3##5##(2008-7#1)(2010-12#1)(2013-1#1)
found between the two##8##4##(1990-6#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
found between the##95##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#3)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
found between these##3##3##(1990-3#1)(2007-10#1)(2008-2#1)
found between##225##2##(1990-12#3)(1990-3#1)(1990-6#2)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#5)(1993-5#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#49)(2008-11#5)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#11)(2011-3#1)(2012-12#4)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#6)(2013-7#2)(2013-8#3)
found both for##2##3##(1993-12#1)(1994-2#1)
found both in##3##3##(1993-12#1)(1995-11#1)(2008-9#1)
found both##8##2##(1993-12#2)(1994-2#1)(1995-11#1)(1995-2#1)(2008-2#1)(2008-9#1)(2010-7#1)
found by PCR##2##3##(1994-8#1)(2008-12#1)
found by an##3##3##(1990-11#1)(2008-10#2)
found by means of##2##4##(1990-6#1)(2008-3#1)
found by other##2##3##(1996-4#1)(2008-5#1)
found by others##2##3##(2008-10#1)(2008-2#1)
found by the##6##3##(1990-9#1)(2008-10#1)(2008-3#1)(2011-1#3)
found by use of##2##4##(2008-3#2)
found by##68##2##(1990-11#1)(1990-6#1)(1990-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#4)(2012-3#1)(2013-7#1)
found commonly##2##2##(2008-10#1)(2010-5#1)
found concerning the##2##3##(2008-10#1)(2013-1#1)
found concerning##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
found correlation between##2##3##(2011-2#2)
found correlation##3##2##(2008-10#1)(2011-2#2)
found dead in##2##3##(1995-3#1)(2012-12#1)
found dead##3##2##(1995-11#1)(1995-3#1)(2012-12#1)
found different##2##2##(2008-1#1)(2012-2#1)
found discrepancies##2##2##(1994-12#1)(2008-2#1)
found during surgery##2##3##(1990-5#1)(1992-6#1)
found during the##5##3##(1990-3#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#1)
found during##16##2##(1990-3#1)(1990-5#2)(1990-6#1)(1992-6#1)(1995-9#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-9#1)(2012-12#1)
found either##4##2##(1990-12#1)(1994-1#1)(2008-9#1)(2012-3#1)
found elevated##2##2##(1993-9#1)(2008-7#1)
found even##2##2##(1992-6#1)(2008-10#1)
found evidence for##4##3##(2008-11#1)(2008-8#2)(2009-8#1)
found evidence of the##2##4##(2008-5#1)(2012-3#1)
found evidence of##4##3##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
found evidence that##4##3##(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
found evidence##13##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
found exclusively in the##2##4##(1992-3#1)(2008-7#1)
found exclusively##4##2##(1992-3#1)(1992-6#1)(2008-5#1)(2008-7#1)
found experimentally##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
found extensive##2##2##(2008-8#1)(2013-1#1)
found following##2##2##(1994-3#1)(2013-1#1)
found for Cu##3##3##(2008-10#3)
found for a##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
found for all##2##3##(1997-1#1)(2008-10#1)
found for both##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
found for each##6##3##(2008-10#3)(2008-3#1)(2008-5#1)(2011-1#1)
found for ethnic##2##3##(2009-7#1)(2012-12#1)
found for some##4##3##(1997-5#1)(2007-12#1)(2008-10#2)
found for the first time##2##5##(2008-3#1)(2008-9#1)
found for the presence of##2##5##(2008-10#2)
found for the##41##3##(1993-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-7#2)(2007-11#1)(2008-10#15)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
found for these##2##3##(1997-1#1)(2008-10#1)
found for this##4##3##(1997-7#1)(2007-10#1)(2008-10#1)(2008-4#1)
found for##154##2##(1990-12#1)(1990-8#1)(1992-11#1)(1992-3#1)(1993-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#2)(1997-1#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-6#6)(2008-10#52)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#2)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
found frequently in##2##3##(2008-10#1)(2011-2#1)
found from the slope##2##4##(2008-10#2)
found from the##7##3##(2008-10#6)(2010-8#1)
found from##15##2##(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-12#1)
found good##5##2##(1992-5#1)(2007-11#1)(2008-3#2)(2011-2#1)
found high##4##2##(1991-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
found in 0##2##3##(1996-12#1)(2013-1#1)
found in 1##2##3##(2007-11#1)(2008-10#1)
found in 11##4##3##(1992-2#1)(2007-11#1)(2008-1#1)(2008-4#1)
found in 11%##2##3##(2008-1#1)(2013-1#1)
found in 12% of the##2##5##(1992-9#1)(2007-8#1)
found in 12%##3##3##(1992-9#1)(2007-8#1)(2008-8#1)
found in 13##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
found in 16##2##3##(2012-12#1)(2013-1#1)
found in 18##2##3##(2007-8#1)(2013-8#1)
found in 20##3##3##(2008-6#1)(2013-1#2)
found in 2010##2##3##(2012-3#2)
found in 22##2##3##(2007-8#1)(2008-4#1)
found in 25##2##3##(1990-6#1)(1996-10#1)
found in 25%##2##3##(1994-2#1)(2011-2#1)
found in 3##3##3##(2007-11#2)(2008-9#1)
found in 30##2##3##(1990-6#1)(1991-9#1)
found in 4##5##3##(1991-12#1)(2007-11#1)(2008-4#1)(2011-2#2)
found in 5##4##3##(1993-2#1)(2007-11#2)(2007-8#1)
found in 50% of##2##4##(2008-1#1)(2008-3#1)
found in 50%##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
found in 6##4##3##(2008-1#2)(2011-1#1)(2012-3#1)
found in 7##3##3##(2007-11#2)(2008-10#1)
found in 8##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
found in 84%##2##3##(2007-7#1)(2008-5#1)
found in 9 of##2##4##(2011-2#1)(2013-1#1)
found in 90% of the##2##5##(1992-4#1)(2008-10#1)
found in 90% of##3##4##(1992-4#1)(2007-8#1)(2008-10#1)
found in Drosophila##2##3##(1995-11#1)(1997-7#1)
found in Europe##2##3##(2008-12#2)
found in P##3##3##(1995-2#1)(2008-12#1)(2008-7#1)
found in RP-HPLC##2##3##(1996-5#1)(2008-10#1)
found in Spanish##2##3##(2008-10#1)(2008-11#1)
found in a number of##4##5##(1993-9#2)(1997-7#1)(2008-10#1)
found in a similar##3##4##(1991-10#1)(1993-6#1)(2008-11#1)
found in a single##2##4##(2008-10#2)
found in a##39##3##(1990-11#2)(1990-3#2)(1991-10#1)(1993-6#1)(1993-9#2)(1994-8#2)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
found in about##2##3##(1996-5#1)(2008-7#1)
found in adult##2##3##(1992-9#1)(2008-7#1)
found in all 5##2##4##(1991-8#1)(1994-11#1)
found in all of the##3##5##(2008-11#1)(2008-5#2)
found in all parts of the##2##6##(1997-8#1)(2008-9#1)
found in all populations##2##4##(2008-10#1)(2013-8#1)
found in all six##2##4##(2008-10#1)(2008-5#1)
found in all the##4##4##(1993-2#1)(2008-10#2)(2008-6#1)
found in all##34##3##(1990-7#1)(1991-8#1)(1993-2#1)(1994-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
found in an earlier study##2##5##(1995-8#1)(2008-10#1)
found in an##11##3##(1990-3#1)(1993-1#1)(1995-11#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-1#1)
found in animals##3##3##(1992-5#1)(2013-1#2)
found in another##2##3##(2008-10#1)(2009-8#1)
found in any of the four groups##2##7##(1991-8#2)
found in any of the##7##5##(1991-8#2)(1992-5#1)(2006-8#1)(2008-7#1)(2008-8#1)(2010-8#1)
found in any##13##3##(1991-4#1)(1991-8#2)(1992-5#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-8#1)
found in approximately##4##3##(1995-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
found in areas##3##3##(2008-10#2)(2013-1#1)
found in association with##6##4##(1995-12#1)(2007-5#2)(2008-7#1)(2008-8#1)(2013-1#1)
found in both the##4##4##(1993-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
found in both##18##3##(1990-12#1)(1991-2#1)(1992-8#1)(1993-2#1)(1994-2#1)(1996-5#2)(1997-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
found in brain##2##3##(1992-12#1)(1996-2#1)
found in cell##3##3##(1990-5#1)(1994-11#1)(2008-7#1)
found in certain##2##3##(2008-10#1)(2011-2#1)
found in children 5 years##2##5##(1997-4#1)(2008-10#1)
found in children##4##3##(1997-4#1)(2008-10#1)(2008-12#1)(2011-2#1)
found in combustion##2##3##(1996-12#1)(2008-2#1)
found in common##2##3##(1996-6#1)(2008-10#1)
found in concentrations##3##3##(2007-1#1)(2008-10#1)(2008-11#1)
found in controls##2##3##(1991-12#1)(1993-12#1)
found in diabetes##2##3##(2008-1#2)
found in diabetic patients##2##4##(2008-1#2)
found in different classes of##2##5##(2008-2#1)(2010-3#1)
found in different##6##3##(1993-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-3#1)
found in differentiating##2##3##(1990-5#1)(1995-12#1)
found in each##5##3##(1991-5#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-12#1)
found in eight##3##3##(1991-12#1)(1992-3#1)(2008-7#1)
found in either##3##3##(1991-9#1)(1995-12#1)(1997-5#1)
found in every##3##3##(1993-3#1)(1997-5#1)(2008-10#1)
found in extrapulmonary##2##3##(1991-12#1)(2008-4#1)
found in ground##2##3##(2008-10#2)
found in houses##2##3##(2011-2#2)
found in human cancers##2##4##(2009-9#2)
found in human liver##2##4##(1993-3#1)(1994-2#1)
found in human##10##3##(1992-8#1)(1993-3#2)(1994-2#1)(2008-10#1)(2008-11#1)(2009-9#3)(2012-2#1)
found in humans##2##3##(1996-5#1)(2008-10#1)
found in infectious##2##3##(1992-6#1)(2008-5#1)
found in isolates##2##3##(2008-10#2)
found in kidney##3##3##(1990-5#1)(1993-11#1)(1995-3#1)
found in large##3##3##(1990-7#1)(1991-5#1)(2008-10#1)
found in leaf##2##3##(2008-10#2)
found in many##10##3##(1990-5#1)(1992-3#1)(1993-2#1)(1995-12#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
found in members of the##2##5##(1991-12#1)(2009-6#1)
found in mixed infections with##2##5##(2008-10#2)
found in most##13##3##(1991-2#1)(1991-9#1)(1992-5#1)(1994-5#1)(1995-1#1)(1997-2#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
found in natural waters##2##4##(2008-10#2)
found in natural##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
found in naturally##2##3##(2008-10#1)(2008-9#1)
found in no##2##3##(2008-1#1)(2008-9#1)
found in normal tissues##2##4##(2008-11#1)(2013-8#1)
found in normal##7##3##(1994-11#1)(1995-8#1)(2008-11#2)(2008-4#1)(2008-9#1)(2013-8#1)
found in older##2##3##(1990-3#1)(2013-1#1)
found in one##4##3##(1995-8#1)(2007-6#1)(2008-10#1)(2008-9#1)
found in only##4##3##(1991-11#1)(1997-3#1)(2008-1#1)(2011-2#1)
found in other##18##3##(1991-2#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
found in our##7##3##(1996-8#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)
found in parts of##2##4##(1995-3#1)(2008-9#1)
found in patients with##7##4##(1990-12#1)(1994-2#1)(1995-12#1)(2008-7#1)(2010-3#1)(2011-2#2)
found in patients##15##3##(1990-12#1)(1994-2#2)(1995-12#1)(1996-5#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-3#1)
found in plant##2##3##(2008-10#1)(2009-10#1)
found in plants and in##2##5##(2008-3#1)(2009-8#1)
found in plants##4##3##(1997-8#1)(2008-10#1)(2008-3#1)(2009-8#1)
found in plasma##2##3##(1991-9#1)(2008-11#1)
found in primary##2##3##(1993-9#1)(2008-4#1)
found in purified##2##3##(1992-8#1)(1997-3#1)
found in rat##4##3##(1990-11#1)(1992-6#1)(1993-12#1)(2011-2#1)
found in regard to##2##4##(1994-5#1)(2008-7#1)
found in resistant##2##3##(2008-10#2)
found in rice##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
found in samples##3##3##(2008-10#2)(2011-2#1)
found in seven##3##3##(1997-3#1)(2008-1#1)(2008-10#1)
found in several##5##3##(1994-11#1)(2008-12#1)(2009-12#1)(2011-2#2)
found in single##2##3##(2008-10#1)(2008-7#1)
found in six##3##3##(1995-11#1)(2008-10#2)
found in some##11##3##(1992-3#1)(1992-9#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-11#1)(2010-8#1)(2013-1#1)
found in studies##3##3##(2008-10#2)(2008-2#1)
found in subjects with##2##4##(1995-8#1)(2008-7#1)
found in subjects##3##3##(1995-8#1)(2008-11#1)(2008-7#1)
found in terms of##2##4##(1990-2#1)(2008-2#1)
found in that##2##3##(2008-10#1)(2013-1#1)
found in the F##2##4##(2008-10#2)
found in the Japanese population##2##5##(1993-3#2)
found in the adult##2##4##(2008-1#1)(2013-7#1)
found in the analysis of##4##5##(2008-10#3)(2013-1#1)
found in the areas##2##4##(1996-2#1)(2008-10#1)
found in the blood##2##4##(1995-2#1)(2008-4#1)
found in the circulation##2##4##(2008-1#1)(2008-4#1)
found in the controls##2##4##(2008-11#1)(2009-6#1)
found in the cytoplasm##2##4##(1994-12#1)(2008-11#1)
found in the cytosol##3##4##(1991-12#1)(1991-2#1)(1992-8#1)
found in the epithelial cells##3##5##(1991-2#1)(2008-12#1)(2008-8#1)
found in the family##2##4##(1992-3#1)(2008-10#1)
found in the female##2##4##(2008-10#1)(2011-2#1)
found in the field##2##4##(2008-10#2)
found in the first##2##4##(1991-2#1)(2008-5#1)
found in the general##2##4##(1996-3#1)(1996-9#1)
found in the group##3##4##(1991-6#1)(1993-8#1)(2013-1#1)
found in the hEp genomic clones##2##6##(1993-12#1)(1993-6#1)
found in the literature##13##4##(1990-12#1)(1990-9#2)(2007-8#1)(2008-10#1)(2008-3#4)(2008-7#2)(2012-2#1)(2012-3#1)
found in the liver##2##4##(2008-12#1)(2008-4#1)
found in the most##2##4##(1997-1#1)(2008-8#1)
found in the patients with##2##5##(1994-2#1)(2008-7#1)
found in the patients##3##4##(1994-2#1)(2008-7#1)(2011-2#1)
found in the present study##2##5##(1994-8#1)(2008-10#1)
found in the present##4##4##(1994-8#1)(1997-3#1)(2008-10#1)(2013-8#1)
found in the range of##2##5##(2008-10#1)(2010-3#1)
found in the range##5##4##(2008-10#3)(2010-3#1)(2011-2#1)
found in the same##2##4##(1991-12#1)(2008-5#1)
found in the study##2##4##(2008-10#1)(2008-5#1)
found in the upper##2##4##(2007-5#1)(2008-10#1)
found in the urine##3##4##(1993-8#1)(1995-3#1)(2008-10#1)
found in the use of##2##5##(2008-10#1)(2008-8#1)
found in the vascular##2##4##(2008-10#2)
found in the##354##3##(1990-11#1)(1990-12#3)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-12#5)(1991-2#7)(1991-5#1)(1991-6#3)(1991-9#4)(1992-12#3)(1992-3#3)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-6#3)(1994-7#1)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-6#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#63)(2008-11#15)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#19)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#5)
found in their##3##3##(2008-10#1)(2010-1#1)(2013-1#1)
found in these##10##3##(1992-2#1)(1992-3#1)(1993-12#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)
found in this study##10##4##(1994-6#1)(2008-10#2)(2008-5#3)(2008-6#1)(2012-2#3)
found in this##18##3##(1991-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-6#1)(1997-6#1)(2008-10#3)(2008-5#3)(2008-6#2)(2012-2#3)(2013-7#1)
found in three##6##3##(1992-6#1)(1997-6#1)(2008-7#2)(2010-4#2)
found in tissues##2##3##(1990-11#1)(2012-3#1)
found in transcriptional##2##3##(1991-5#1)(1995-8#1)
found in two##9##3##(1990-5#1)(1993-12#1)(2007-12#1)(2008-10#5)(2008-5#1)
found in urine##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
found in various##4##3##(1997-2#1)(2007-7#1)(2012-2#2)
found in virtually all##2##4##(1992-3#1)(2008-4#1)
found in women##3##3##(1990-2#1)(2008-4#1)(2008-5#1)
found in##1277##2##(1990-11#7)(1990-12#6)(1990-2#7)(1990-3#9)(1990-5#11)(1990-6#5)(1990-7#3)(1990-8#1)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#14)(1991-2#12)(1991-3#1)(1991-4#2)(1991-5#8)(1991-6#3)(1991-8#4)(1991-9#10)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#2)(1992-3#10)(1992-4#1)(1992-5#3)(1992-6#8)(1992-8#6)(1992-9#8)(1993-1#2)(1993-11#6)(1993-12#18)(1993-2#9)(1993-3#5)(1993-5#1)(1993-6#8)(1993-8#7)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#6)(1994-2#12)(1994-3#1)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#11)(1995-12#9)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#5)(1995-8#9)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#10)(1996-2#8)(1996-3#1)(1996-5#14)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#10)(1997-4#9)(1997-5#3)(1997-6#10)(1997-7#4)(1997-8#4)(1997-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#2)(2007-10#7)(2007-11#21)(2007-12#13)(2007-2#1)(2007-5#5)(2007-6#3)(2007-7#6)(2007-8#17)(2008-1#23)(2008-10#227)(2008-11#46)(2008-12#22)(2008-2#14)(2008-3#21)(2008-4#18)(2008-5#44)(2008-6#15)(2008-7#58)(2008-8#24)(2008-9#30)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#4)(2010-1#5)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#7)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#8)(2011-1#6)(2011-10#1)(2011-2#52)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#23)(2012-3#17)(2013-1#31)(2013-7#9)(2013-8#15)
found incidentally in##2##3##(2009-4#1)(2013-1#1)
found incidentally##4##2##(2009-1#1)(2009-4#1)(2012-3#1)(2013-1#1)
found increased##3##2##(1994-2#1)(1996-3#1)(2011-2#1)
found insufficient evidence to##2##4##(2013-1#2)
found is##3##2##(2007-8#1)(2008-10#2)
found it to be##5##4##(1993-8#1)(1995-2#1)(1997-2#1)(2008-3#1)(2012-2#1)
found it##9##2##(1992-4#1)(1993-8#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
found its##5##2##(1991-9#1)(1994-3#2)(1995-8#1)(2008-11#1)
found lower##2##2##(1996-7#1)(2013-1#1)
found mainly in the##3##4##(1990-9#1)(2008-7#1)(2008-8#1)
found mainly in##6##3##(1990-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
found mainly on##3##3##(2008-5#2)(2013-7#1)
found mainly##11##2##(1990-9#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-7#1)
found many##2##2##(2012-2#1)(2013-8#1)
found more frequently##3##3##(1997-1#1)(2008-7#1)(2012-12#1)
found more often in##3##4##(1992-9#1)(1993-9#1)(1994-6#1)
found more stable##2##3##(2008-10#1)(2008-5#1)
found more##9##2##(1992-9#1)(1993-9#1)(1994-6#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#1)
found most frequently in##2##4##(1991-10#1)(2007-12#1)
found most suitable for##2##4##(2008-10#2)
found most##10##2##(1991-10#1)(1992-3#1)(1996-5#1)(2007-12#1)(2008-10#4)(2012-2#1)(2013-1#1)
found mostly in##2##3##(2008-10#1)(2011-2#1)
found multiple##2##2##(1994-11#1)(2012-3#1)
found neither##2##2##(1991-9#1)(2008-9#1)
found neurons expressing##2##3##(1996-12#2)
found no difference in##2##4##(2009-4#1)(2010-7#1)
found no difference##3##3##(2009-10#1)(2009-4#1)(2010-7#1)
found no differences between##2##4##(1995-2#1)(1995-5#1)
found no differences##4##3##(1995-2#1)(1995-5#1)(2008-8#1)(2013-1#1)
found no evidence for##3##4##(1995-12#1)(2009-8#1)(2011-2#1)
found no evidence of##3##4##(1995-11#1)(2008-3#1)(2008-6#1)
found no evidence that##2##4##(1991-8#1)(2009-9#1)
found no evidence##9##3##(1991-8#1)(1995-11#1)(1995-12#1)(2008-3#1)(2008-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
found no relationship between##4##4##(2008-5#1)(2008-8#2)(2013-1#1)
found no significant##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
found no statistically significant correlation between##2##6##(1994-3#1)(2013-7#1)
found no statistically significant##4##4##(1994-3#1)(2008-4#1)(2011-2#1)(2013-7#1)
found no##50##2##(1991-11#1)(1991-8#1)(1992-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
found not only##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
found not to alter##2##4##(1993-12#1)(2008-10#1)
found not to have##2##4##(1991-2#1)(2008-8#1)
found not to##8##3##(1991-2#1)(1991-3#1)(1993-12#1)(2007-11#1)(2008-10#3)(2008-8#1)
found not##13##2##(1991-2#1)(1991-3#1)(1991-6#1)(1993-12#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-8#2)
found of##4##2##(1990-2#1)(1994-6#1)(1994-8#1)(2007-7#1)
found on a##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
found on both sides##2##4##(2008-5#1)(2013-7#1)
found on both##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
found on different##2##3##(2008-10#2)
found on other##2##3##(2008-10#2)
found on the##21##3##(1991-2#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
found on##70##2##(1990-8#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#25)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#4)(2011-2#3)(2012-2#3)(2013-7#3)(2013-8#1)
found only in one##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
found only in the##5##4##(1997-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
found only in##22##3##(1990-8#1)(1991-2#1)(1991-9#1)(1994-1#1)(1995-11#1)(1996-5#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
found only##33##2##(1990-8#1)(1991-2#1)(1991-9#1)(1994-1#1)(1995-11#1)(1996-5#3)(1997-3#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
found out in##2##3##(2011-1#1)(2012-3#1)
found out that##4##3##(1996-9#1)(2007-11#1)(2008-11#1)(2013-1#1)
found out##8##2##(1996-9#1)(2007-11#1)(2008-11#1)(2011-1#1)(2012-3#3)(2013-1#1)
found over##2##2##(2008-10#2)
found positive##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
found predominantly in##2##3##(1993-9#1)(2013-1#1)
found present in##2##3##(1993-8#1)(2008-10#1)
found previously in##4##3##(1993-3#1)(2007-12#1)(2008-10#2)
found previously##6##2##(1993-3#1)(1994-8#1)(2007-12#1)(2008-10#3)
found ranged from##2##3##(2007-12#1)(2013-1#1)
found relative to##2##3##(1997-4#1)(2009-7#1)
found repeated##2##2##(1995-8#1)(1996-8#1)
found resting##2##2##(2007-10#1)(2012-2#1)
found satisfactory##2##2##(2008-10#1)(2010-8#1)
found several##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
found significant differences between##3##4##(1997-5#1)(2011-1#1)(2012-2#1)
found significant differences##4##3##(1997-5#1)(2011-1#1)(2011-3#1)(2012-2#1)
found significant##12##2##(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
found significantly higher##3##3##(2007-8#1)(2008-12#1)(2012-3#1)
found significantly##8##2##(1994-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
found size and##2##3##(1993-9#1)(2013-7#1)
found some##3##2##(1992-11#1)(2008-8#1)(2011-3#1)
found species##2##2##(2008-10#1)(2013-7#1)
found spinal cord compression symptoms##2##5##(2007-11#2)
found statistically significant##5##3##(1996-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
found statistically##6##2##(1996-3#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
found strong##2##2##(1997-5#1)(2008-2#1)
found substantial differences##2##3##(1995-3#1)(2010-12#1)
found substantial##3##2##(1995-3#1)(2008-12#1)(2010-12#1)
found such##3##2##(1994-8#1)(2008-11#1)(2009-7#1)
found suitable for the##2##4##(2008-10#1)(2008-11#1)
found suitable for##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
found suitable##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
found that 12##2##3##(1992-11#1)(1992-12#1)
found that 41##2##3##(1995-12#1)(2012-2#1)
found that 5##2##3##(1991-11#1)(2012-2#1)
found that a single##2##4##(2008-2#1)(2012-12#1)
found that a##25##3##(1991-11#1)(1992-1#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
found that alcuronium##2##3##(1995-11#2)
found that all the##3##4##(1992-12#1)(2008-10#1)(2008-12#1)
found that all##9##3##(1992-12#1)(1992-5#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-11#1)(2010-4#1)
found that although##3##3##(1997-6#1)(2008-12#1)(2012-12#1)
found that an##5##3##(1997-5#1)(2008-11#1)(2008-2#1)(2009-7#1)(2013-8#1)
found that approximately##2##3##(2008-11#1)(2008-3#1)
found that at least##2##4##(1990-5#1)(2008-10#1)
found that at##7##3##(1990-5#1)(1991-5#1)(1993-11#1)(1994-3#1)(2007-12#1)(2008-10#2)
found that bone##2##3##(1990-6#1)(1991-6#1)
found that both the##4##4##(2008-10#2)(2010-4#1)(2012-2#1)
found that both##10##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
found that by##2##3##(2008-5#1)(2009-12#1)
found that certain##2##3##(2008-10#1)(2008-5#1)
found that curcumin##2##3##(2011-2#1)(2012-3#1)
found that during the##2##4##(2008-2#1)(2008-5#1)
found that during##3##3##(1994-11#1)(2008-2#1)(2008-5#1)
found that early##2##3##(1990-5#1)(2007-2#1)
found that estrogen##2##3##(2008-11#1)(2008-6#1)
found that expression of##2##4##(2008-11#1)(2012-2#1)
found that females##2##3##(2008-4#1)(2008-8#1)
found that for certain##2##4##(2008-3#2)
found that for##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)
found that human##3##3##(1993-3#1)(1995-5#1)(2010-8#1)
found that in the##7##4##(1993-8#2)(1994-8#1)(2008-10#4)
found that in##16##3##(1990-5#1)(1993-1#1)(1993-8#2)(1994-8#2)(1995-6#1)(2008-10#6)(2008-8#2)(2011-1#1)
found that increasing the##2##4##(1995-6#1)(2008-8#1)
found that it is##6##4##(1990-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)
found that it##9##3##(1990-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)
found that local##2##3##(1997-2#1)(2008-7#1)
found that many##4##3##(1995-5#1)(2008-10#1)(2009-8#1)(2012-3#1)
found that mean##2##3##(2008-8#1)(2013-1#1)
found that monoclonal##2##3##(2008-5#1)(2008-8#1)
found that most of the##3##5##(2008-6#1)(2008-7#1)(2011-2#1)
found that most##7##3##(1997-3#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
found that no##2##3##(2008-7#1)(2011-1#1)
found that once##2##3##(1995-2#1)(2013-8#1)
found that one##3##3##(1996-12#1)(2008-3#1)(2012-12#1)
found that only##5##3##(1993-6#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-8#1)
found that participants##2##3##(2008-12#1)(2010-9#1)
found that patients##2##3##(1991-3#1)(2008-11#1)
found that rRNA##2##3##(2008-8#1)(2013-1#1)
found that selenium##2##3##(2008-6#2)
found that serum##2##3##(2008-10#1)(2008-7#1)
found that some##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
found that such##2##3##(1997-1#1)(2008-12#1)
found that sweating was influenced by##2##6##(2008-5#2)
found that the activity##2##4##(1997-6#1)(2008-11#1)
found that the addition of 3##2##6##(2008-10#2)
found that the addition of##3##5##(2008-10#2)(2008-5#1)
found that the amounts of##2##5##(1994-11#1)(2008-10#1)
found that the complexation##2##4##(2008-10#2)
found that the difference##3##4##(2008-11#1)(2008-2#2)
found that the diffraction efficiency##2##5##(2008-3#2)
found that the error##2##4##(2008-2#2)
found that the first##2##4##(1997-4#1)(2008-10#1)
found that the fundamental##2##4##(2008-2#1)(2008-6#1)
found that the greatest##2##4##(2008-7#1)(2008-8#1)
found that the higher##2##4##(2007-10#1)(2008-3#1)
found that the level of##3##5##(1995-8#1)(2007-11#1)(2013-8#1)
found that the lower##3##4##(2007-11#1)(2008-2#1)(2010-4#1)
found that the major##2##4##(2008-10#1)(2008-12#1)
found that the majority of##2##5##(2007-7#1)(2008-11#1)
found that the majority##3##4##(2007-7#1)(2008-11#1)(2009-6#1)
found that the model##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
found that the most##2##4##(2009-8#1)(2012-3#1)
found that the neural##2##4##(2008-10#1)(2008-11#1)
found that the new##2##4##(1992-12#1)(2008-3#1)
found that the number of##2##5##(2008-9#2)
found that the output##2##4##(2007-11#1)(2008-2#1)
found that the overall##2##4##(2008-11#1)(2010-7#1)
found that the peak##3##4##(2008-10#3)
found that the proposed##2##4##(2008-2#1)(2008-8#1)
found that the relative##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
found that the response##2##4##(2008-10#1)(2009-8#1)
found that the sensitivity of##2##5##(1997-4#1)(2008-10#1)
found that the sensitivity##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
found that the spectral##2##4##(1994-11#1)(2007-12#1)
found that the stability of##2##5##(1990-2#1)(1992-6#1)
found that the three##2##4##(2008-10#1)(2009-2#1)
found that the total##3##4##(1994-5#1)(2008-3#2)
found that the use of##3##5##(1993-2#1)(2008-10#1)(2011-2#1)
found that the values of##2##5##(2007-11#1)(2008-10#1)
found that the##352##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-8#6)(1991-1#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#14)(2007-12#10)(2007-7#1)(2008-10#84)(2008-11#16)(2008-12#3)(2008-2#23)(2008-3#34)(2008-4#1)(2008-5#15)(2008-6#2)(2008-7#10)(2008-8#13)(2008-9#8)(2009-11#1)(2009-2#1)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-7#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#6)
found that their##3##3##(2008-10#2)(2011-2#1)
found that there are##5##4##(1994-2#1)(1997-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
found that there is an##2##5##(2008-11#1)(2008-3#1)
found that there is##4##4##(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#1)
found that there was a##2##5##(1996-12#1)(2012-2#1)
found that there was no##2##5##(2008-10#1)(2013-1#1)
found that there was##6##4##(1991-7#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#2)
found that there were##4##4##(1993-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
found that there##20##3##(1991-7#1)(1993-2#1)(1994-2#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
found that these##7##3##(1993-11#1)(1996-2#1)(1996-8#1)(2008-1#1)(2011-2#1)(2013-1#2)
found that they are##2##4##(2007-11#1)(2008-10#1)
found that they can##2##4##(2008-9#1)(2010-1#1)
found that they were##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
found that they##8##3##(1995-12#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
found that this effect##2##4##(2008-3#2)
found that this##17##3##(1990-5#1)(1995-3#1)(1996-8#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-3#4)(2008-8#1)(2009-10#1)(2012-2#2)(2013-1#1)
found that three##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
found that treatment with##3##4##(1994-11#1)(2009-8#1)(2011-2#1)
found that treatment##4##3##(1994-11#1)(2009-8#1)(2010-1#1)(2011-2#1)
found that two##3##3##(2008-5#1)(2009-10#1)(2011-2#1)
found that when the##2##4##(2007-12#1)(2013-8#1)
found that when##3##3##(2007-12#1)(2008-11#1)(2013-8#1)
found that while##4##3##(2008-5#1)(2009-11#1)(2010-2#1)(2013-8#1)
found that with##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
found that##1033##2##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#5)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#5)(1994-10#2)(1994-11#9)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#11)(1994-9#2)(1995-11#7)(1995-12#6)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#8)(1995-8#2)(1996-1#4)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#6)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#2)(2006-6#1)(2007-10#5)(2007-11#25)(2007-12#25)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#185)(2008-11#53)(2008-12#15)(2008-2#40)(2008-3#74)(2008-4#6)(2008-5#36)(2008-6#10)(2008-7#25)(2008-8#47)(2008-9#22)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#10)(2009-8#17)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#9)(2010-3#2)(2010-4#6)(2010-5#5)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#14)(2011-2#18)(2012-1#6)(2012-12#10)(2012-2#23)(2012-3#12)(2013-1#28)(2013-7#3)(2013-8#16)
found the following##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
found the##44##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
found them to##3##3##(1990-8#1)(1995-9#1)(2011-2#1)
found them##4##2##(1990-2#1)(1990-8#1)(1995-9#1)(2011-2#1)
found theoretically##2##2##(2007-12#2)
found this##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
found through##5##2##(1993-12#1)(1994-2#1)(2008-10#2)(2008-7#1)
found throughout the##2##3##(1992-9#1)(2008-10#1)
found till##2##2##(2011-3#1)(2013-1#1)
found to account for##2##4##(1991-12#1)(2007-12#1)
found to account##3##3##(1991-12#1)(2007-12#1)(2008-3#1)
found to accurately##3##3##(2008-2#1)(2013-1#2)
found to affect##8##3##(1992-3#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-3#1)(2010-4#1)
found to agree with##2##4##(2008-11#1)(2008-3#1)
found to agree##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
found to be &gt##4##4##(2007-7#1)(2008-10#3)
found to be &lt##2##4##(2008-10#2)
found to be 0##33##4##(1990-6#1)(1996-2#1)(2008-10#28)(2008-2#1)(2010-3#1)(2011-1#1)
found to be 1##29##4##(1992-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-12#1)(2010-3#1)(2013-1#2)
found to be 100##2##4##(2008-10#1)(2008-4#1)
found to be 16##4##4##(1997-6#1)(2008-10#1)(2012-2#2)
found to be 18##2##4##(2007-7#1)(2013-8#1)
found to be 2##26##4##(1995-2#1)(1996-5#1)(2008-10#21)(2008-2#2)(2008-5#1)
found to be 3 x##2##5##(2008-3#2)
found to be 3##9##4##(1990-12#1)(2008-10#5)(2008-3#2)(2012-2#1)
found to be 4##12##4##(1994-5#1)(1995-12#1)(1996-12#1)(2008-10#8)(2012-3#1)
found to be 5##6##4##(2008-10#5)(2013-1#1)
found to be 6##4##4##(1992-2#1)(2008-10#3)
found to be 60##2##4##(2008-10#2)
found to be 7##4##4##(1991-5#1)(2008-10#3)
found to be 8##3##4##(2008-10#3)
found to be 9##2##4##(1991-5#1)(2008-10#1)
found to be 99##4##4##(2008-10#3)(2013-1#1)
found to be HIV-positive##2##4##(1991-7#1)(1995-6#1)
found to be a fairly##2##5##(1992-12#1)(2008-10#1)
found to be a function of the##2##7##(1991-5#1)(2011-1#1)
found to be a good##2##5##(1994-12#1)(2008-10#1)
found to be a more##3##5##(1994-11#1)(2008-10#2)
found to be a powerful##3##5##(1993-8#1)(2008-11#2)
found to be a significant protective factor in##2##8##(2009-7#2)
found to be a significant##4##5##(1996-3#1)(2008-6#1)(2009-7#2)
found to be a single##2##5##(1990-11#1)(1995-8#1)
found to be a suitable##2##5##(2008-10#1)(2008-11#1)
found to be a##59##4##(1990-11#3)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#3)(1992-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
found to be able to##4##5##(2008-10#3)(2008-2#1)
found to be accurate##6##4##(2008-10#3)(2008-3#1)(2010-11#1)(2012-2#1)
found to be active in##2##5##(1995-3#1)(2010-2#1)
found to be active##6##4##(1995-3#1)(2007-11#1)(2008-11#1)(2010-2#1)(2011-1#2)
found to be altered in##2##5##(1990-6#1)(2008-6#1)
found to be amorphous##3##4##(2007-12#1)(2008-10#2)
found to be an important factor##2##6##(1996-12#1)(2008-6#1)
found to be an##11##4##(1991-12#1)(1992-2#1)(1992-3#1)(1995-4#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
found to be approximately 3##2##5##(2008-2#2)
found to be approximately##8##4##(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)
found to be associated with a variety of##2##8##(2011-2#1)(2012-3#1)
found to be associated with##15##5##(1993-11#1)(1993-3#1)(1994-11#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
found to be associated##17##4##(1993-11#1)(1993-3#1)(1994-11#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
found to be at##4##4##(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
found to be below##2##4##(2008-10#1)(2008-3#1)
found to be better than##6##5##(2008-10#4)(2008-5#1)(2012-1#1)
found to be better##8##4##(2008-10#6)(2008-5#1)(2012-1#1)
found to be between 0##2##5##(2008-10#2)
found to be between 4 and##2##6##(1996-3#1)(2008-10#1)
found to be between##10##4##(1991-9#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-4#1)
found to be bound##2##4##(1990-12#1)(2010-11#1)
found to be cell##2##4##(1993-8#1)(2008-11#1)
found to be close to##7##5##(1992-5#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2012-12#1)
found to be common to##2##5##(1991-7#1)(1994-2#1)
found to be comparable to##4##5##(2008-10#3)(2008-7#1)
found to be comparable with those obtained##2##7##(2007-12#1)(2008-10#1)
found to be comparable with##4##5##(2007-12#1)(2008-10#3)
found to be comparable##9##4##(2007-12#1)(2008-10#7)(2008-7#1)
found to be completely##3##4##(1990-7#1)(1996-5#1)(2008-7#1)
found to be composed##3##4##(1994-6#1)(2007-11#1)(2008-10#1)
found to be consistent with the theoretical##2##7##(2008-2#1)(2008-7#1)
found to be consistent with##8##5##(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)
found to be consistent##9##4##(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)(2009-12#1)
found to be contaminated with##2##5##(1995-11#1)(2008-11#1)
found to be contaminated##3##4##(1994-3#1)(1995-11#1)(2008-11#1)
found to be correlated##2##4##(1991-6#1)(2007-11#1)
found to be covalently##2##4##(1990-2#1)(1992-3#1)
found to be crucial to##2##5##(1997-3#1)(2008-10#1)
found to be dependent on the##4##6##(1991-3#1)(2008-10#2)(2010-5#1)
found to be dependent on##7##5##(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2010-5#1)
found to be dependent upon the##3##6##(2008-10#2)(2008-5#1)
found to be dependent##11##4##(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
found to be different##4##4##(1993-11#1)(1993-12#1)(2008-10#1)(2012-2#1)
found to be difficult##2##4##(2008-11#1)(2008-12#1)
found to be directly proportional to the##2##7##(2008-10#2)
found to be effective and##2##5##(1994-2#1)(2007-8#1)
found to be effective in preventing##3##6##(1992-3#1)(2007-7#1)(2010-7#1)
found to be effective in##9##5##(1990-3#1)(1992-3#1)(1994-3#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-7#1)(2013-1#1)
found to be effective##15##4##(1990-3#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
found to be efficient##2##4##(2008-10#1)(2008-5#1)
found to be either##2##4##(1995-11#1)(1997-1#1)
found to be elevated##2##4##(1992-8#1)(2008-5#1)
found to be enriched##2##4##(1994-11#1)(2008-10#1)
found to be equal to##2##5##(2007-11#1)(2008-10#1)
found to be equally effective##2##5##(1995-3#1)(2010-7#1)
found to be equally##3##4##(1995-3#1)(2007-7#1)(2010-7#1)
found to be essential for##3##5##(1992-12#1)(1995-2#1)(2007-11#1)
found to be excellent##2##4##(1997-2#1)(2008-5#1)
found to be expressed in##2##5##(2008-10#1)(2012-3#1)
found to be expressed##5##4##(1991-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
found to be extracted##4##4##(2008-10#4)
found to be good##3##4##(1996-3#1)(2008-10#2)
found to be greater for the##2##6##(1993-6#1)(2008-2#1)
found to be greater in##3##5##(1996-7#1)(2008-5#1)(2010-3#1)
found to be greater than##4##5##(1990-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
found to be greater##10##4##(1990-12#1)(1993-12#1)(1993-6#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-3#1)
found to be growth associated##2##5##(1994-5#1)(2008-11#1)
found to be growth##3##4##(1994-5#1)(2008-11#2)
found to be high##2##4##(2008-10#1)(2009-9#1)
found to be higher in##4##5##(1990-7#1)(1993-12#1)(2008-4#1)(2009-12#1)
found to be higher than##3##5##(2008-11#2)(2011-2#1)
found to be higher##10##4##(1990-7#1)(1993-12#1)(2007-10#1)(2008-11#4)(2008-4#1)(2009-12#1)(2011-2#1)
found to be highly correlated##3##5##(1997-2#1)(2008-6#1)(2008-7#1)
found to be highly phosphorylated in##2##6##(1995-6#1)(1995-8#1)
found to be highly selective##2##5##(2008-10#2)
found to be highly sensitive##2##5##(1992-12#1)(2008-7#1)
found to be highly##24##4##(1990-11#1)(1992-12#1)(1992-5#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
found to be homologous##2##4##(1996-12#1)(2008-8#1)
found to be identical to that##2##6##(1996-12#1)(2008-10#1)
found to be identical to##4##5##(1994-12#1)(1996-12#1)(2008-10#2)
found to be identical##9##4##(1990-8#1)(1992-11#1)(1994-12#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)
found to be impaired##4##4##(1990-11#1)(1995-5#1)(2008-7#2)
found to be important for##2##5##(1997-6#1)(2008-4#1)
found to be important##7##4##(1993-12#2)(1997-6#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-7#1)
found to be improved##3##4##(2009-3#2)(2012-1#1)
found to be in agreement with##3##6##(2007-12#1)(2008-10#2)
found to be in excellent agreement with the##2##8##(2008-10#1)(2009-9#1)
found to be in excellent agreement with##3##7##(2008-10#1)(2008-2#1)(2009-9#1)
found to be in good agreement with the##5##8##(1992-11#1)(2007-11#1)(2008-10#2)(2008-2#1)
found to be in good agreement with##7##7##(1992-11#1)(2007-11#1)(2008-10#3)(2008-2#2)
found to be in good agreement##8##6##(1992-11#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)
found to be in the range of 5##2##8##(2008-10#2)
found to be in the range of##6##7##(2008-10#6)
found to be in the range##7##6##(2008-10#7)
found to be in the##9##5##(1993-8#1)(2008-10#8)
found to be in##30##4##(1992-11#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-2#3)(2008-3#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
found to be inadequate##2##4##(1995-11#1)(2010-11#1)
found to be independent of the##5##6##(2007-11#1)(2007-12#1)(2008-10#2)(2009-8#1)
found to be independent of##7##5##(2007-11#2)(2007-12#1)(2008-10#2)(2009-8#1)(2012-2#1)
found to be independent##9##4##(1990-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2009-8#1)(2012-2#1)
found to be ineffective in##3##5##(1994-2#1)(1995-12#1)(2013-8#1)
found to be ineffective##4##4##(1994-2#1)(1995-12#1)(1996-2#1)(2013-8#1)
found to be infected##4##4##(1997-4#1)(2008-10#2)(2011-2#1)
found to be influenced by the##2##6##(1994-5#1)(2008-10#1)
found to be influenced by##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
found to be influenced##4##4##(1994-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
found to be involved in##3##5##(1992-8#1)(2008-10#1)(2010-4#1)
found to be less sensitive to##2##6##(1996-5#1)(2008-10#1)
found to be less than##7##5##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
found to be less##12##4##(1994-6#1)(1996-5#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
found to be limited by##2##5##(2008-2#1)(2008-3#1)
found to be limited##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
found to be linear in the range of##3##8##(2008-10#3)
found to be linear over the##2##6##(2008-10#2)
found to be linear##12##4##(1992-5#1)(2008-10#9)(2008-11#1)(2012-2#1)
found to be linearly proportional to the absorption##2##8##(2008-10#1)(2008-3#1)
found to be linearly proportional##3##5##(1995-3#1)(2008-10#1)(2008-3#1)
found to be linearly##5##4##(1995-3#1)(2008-10#2)(2008-3#1)(2008-7#1)
found to be linked to##2##5##(2008-10#2)
found to be localized##2##4##(2008-5#1)(2009-10#1)
found to be located in the##3##6##(1990-5#1)(2008-8#1)(2009-5#1)
found to be located##7##4##(1990-11#1)(1990-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
found to be low in##2##5##(2008-12#1)(2008-7#1)
found to be low##3##4##(2008-12#1)(2008-7#1)(2010-5#1)
found to be mainly##4##4##(1990-12#1)(2008-4#1)(2008-5#2)
found to be mediated by##4##5##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
found to be mediated through##2##5##(1992-6#2)
found to be mediated##6##4##(1992-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
found to be more effective##5##5##(1992-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
found to be more frequent##2##5##(2008-9#1)(2010-3#1)
found to be more likely to##2##6##(1993-12#1)(2008-8#1)
found to be more potent##2##5##(1991-9#1)(1995-3#1)
found to be more sensitive than##3##6##(1990-12#1)(2008-10#1)(2012-1#1)
found to be more sensitive##4##5##(1990-12#2)(2008-10#1)(2012-1#1)
found to be more stable than##2##6##(1992-11#1)(2008-5#1)
found to be more than##2##5##(2008-10#1)(2008-3#1)
found to be more##34##4##(1990-12#2)(1990-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-3#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)
found to be most##4##4##(2008-10#2)(2009-5#1)(2013-8#1)
found to be much lower##2##5##(1995-3#1)(2008-10#1)
found to be much##7##4##(1991-9#1)(1995-3#1)(2008-10#3)(2008-7#1)(2009-7#1)
found to be nearly identical##3##5##(1991-12#1)(1995-11#1)(1996-8#1)
found to be nearly##5##4##(1991-12#1)(1995-11#1)(1996-8#1)(2008-2#2)
found to be necessary for##3##5##(1990-8#1)(2009-1#1)(2011-2#1)
found to be necessary to##2##5##(2008-10#2)
found to be necessary##6##4##(1990-8#1)(2008-10#3)(2009-1#1)(2011-2#1)
found to be negative for##2##5##(2007-10#1)(2013-1#1)
found to be negative##3##4##(2007-10#1)(2007-11#1)(2013-1#1)
found to be negligible##4##4##(2008-10#2)(2008-2#2)
found to be neither##2##4##(1992-11#1)(1995-12#1)
found to be of##3##4##(1994-2#1)(1996-9#1)(2008-10#1)
found to be positive for##4##5##(2007-7#2)(2013-1#1)(2013-8#1)
found to be positive##7##4##(2007-7#3)(2008-1#1)(2010-8#1)(2013-1#1)(2013-8#1)
found to be positively##2##4##(2009-11#1)(2009-7#1)
found to be predominant##2##4##(1990-6#1)(2008-10#1)
found to be present in##6##5##(1995-8#1)(2008-1#1)(2008-10#2)(2008-12#2)
found to be present##7##4##(1995-8#1)(2008-1#1)(2008-10#3)(2008-12#2)
found to be proportional to the##2##6##(2008-10#1)(2008-3#1)
found to be quite##4##4##(2008-10#3)(2008-3#1)
found to be rapid and##2##5##(2008-10#2)
found to be rather##3##4##(1990-7#1)(2008-10#2)
found to be related to the##4##6##(1995-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
found to be related to##12##5##(1992-9#1)(1993-12#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-7#2)(2012-3#1)
found to be relatively##7##4##(2008-10#4)(2008-11#1)(2008-2#1)(2010-7#1)
found to be remarkably##2##4##(1990-7#1)(2008-10#1)
found to be resistant to##2##5##(1992-9#1)(2008-10#1)
found to be reversible##2##4##(2008-10#1)(2008-5#1)
found to be rich in neutral lipids##2##7##(2008-11#2)
found to be rich in##3##5##(1995-11#1)(2008-11#2)
found to be satisfactory##2##4##(2007-11#1)(2008-10#1)
found to be sensitive to the##3##6##(1995-11#1)(2008-3#1)(2008-8#1)
found to be sensitive to##6##5##(1995-11#1)(1997-2#1)(1997-4#1)(2008-3#1)(2008-8#1)(2010-8#1)
found to be sensitive##8##4##(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)
found to be significant##5##4##(1993-9#1)(1997-2#1)(2008-10#2)(2008-9#1)
found to be significantly associated with the##2##7##(2008-8#1)(2012-2#1)
found to be significantly associated with##6##6##(2007-12#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#2)
found to be significantly associated##7##5##(2007-12#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#3)
found to be significantly correlated##3##5##(1992-12#1)(1994-3#1)(2008-5#1)
found to be significantly different##3##5##(2007-12#1)(2008-2#1)(2011-2#1)
found to be significantly greater##2##5##(1997-4#1)(2009-2#1)
found to be significantly higher in##2##6##(2008-10#1)(2011-1#1)
found to be significantly higher##5##5##(1994-8#1)(1996-1#1)(2008-10#1)(2008-4#1)(2011-1#1)
found to be significantly increased in the##2##7##(1996-12#1)(1997-3#1)
found to be significantly increased in##3##6##(1996-12#1)(1997-3#1)(2008-11#1)
found to be significantly lower in##3##6##(2008-10#1)(2008-3#1)(2013-7#1)
found to be significantly lower##4##5##(2008-10#1)(2008-3#1)(2013-7#1)(2013-8#1)
found to be significantly##39##4##(1992-11#1)(1992-12#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#2)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-7#1)(2013-8#1)
found to be similar to##5##5##(1990-2#1)(1993-9#1)(2008-10#2)(2008-3#1)
found to be similar##8##4##(1990-2#1)(1993-3#1)(1993-9#1)(2008-10#3)(2008-3#2)
found to be slightly more##2##5##(1990-12#1)(1993-12#1)
found to be slightly##3##4##(1990-12#1)(1993-12#1)(1993-2#1)
found to be stable##5##4##(1990-7#1)(1992-6#1)(1996-2#1)(2007-11#1)(2008-10#1)
found to be statistically significant##3##5##(1990-2#2)(1997-4#1)
found to be statistically##7##4##(1990-2#2)(1997-4#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
found to be strongly dependent on##3##6##(2008-2#1)(2008-7#1)(2013-1#1)
found to be strongly##7##4##(1991-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#1)
found to be suitable for##6##5##(2008-10#4)(2008-7#1)(2011-1#1)
found to be suitable##9##4##(1991-9#1)(2008-10#6)(2008-7#1)(2011-1#1)
found to be superior##5##4##(1995-3#1)(1996-2#1)(2008-10#2)(2010-8#1)
found to be susceptible to##2##5##(2008-10#2)
found to be the best##7##5##(1990-9#1)(2008-10#3)(2008-7#1)(2009-7#1)(2011-2#1)
found to be the main##4##5##(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
found to be the most useful##2##6##(1991-6#1)(1992-1#1)
found to be the most##22##5##(1991-6#1)(1992-1#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
found to be the same as that of##2##8##(2008-8#2)
found to be the same as that##3##7##(2008-3#1)(2008-8#2)
found to be the same##4##5##(2008-3#1)(2008-7#1)(2008-8#2)
found to be the##53##4##(1990-9#1)(1991-6#2)(1992-1#1)(1994-3#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#2)
found to be unrelated to##2##5##(1996-12#1)(2007-11#1)
found to be useful for##2##5##(2008-10#1)(2008-11#1)
found to be useful in##3##5##(1996-6#1)(2008-10#1)(2008-9#1)
found to be useful##7##4##(1996-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)
found to be variable##2##4##(1993-12#1)(2013-8#1)
found to be very effective##2##5##(2007-7#1)(2013-1#1)
found to be very##17##4##(1990-5#1)(1991-9#1)(1992-12#1)(1993-9#1)(1997-4#1)(1997-8#1)(2007-7#2)(2008-10#4)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
found to be well##2##4##(2008-10#1)(2008-3#1)
found to be##1265##3##(1990-11#9)(1990-12#10)(1990-2#7)(1990-3#1)(1990-5#6)(1990-6#4)(1990-7#8)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#7)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#1)(1992-11#5)(1992-12#6)(1992-2#3)(1992-3#7)(1992-5#5)(1992-6#3)(1992-8#6)(1992-9#4)(1993-11#5)(1993-12#11)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#6)(1994-11#3)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#1)(1995-11#7)(1995-12#7)(1995-2#6)(1995-3#8)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#6)(1996-1#1)(1996-12#8)(1996-2#8)(1996-3#4)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#14)(1997-5#1)(1997-6#8)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#28)(2007-12#16)(2007-7#13)(2007-8#4)(2008-1#6)(2008-10#442)(2008-11#48)(2008-12#13)(2008-2#39)(2008-3#42)(2008-4#7)(2008-5#23)(2008-6#7)(2008-7#33)(2008-8#21)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#6)(2009-3#4)(2009-5#5)(2009-6#1)(2009-7#12)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#10)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#4)(2011-1#13)(2011-2#22)(2012-1#3)(2012-12#9)(2012-2#21)(2012-3#12)(2013-1#23)(2013-7#3)(2013-8#9)
found to bind the##2##4##(1995-5#1)(2008-10#1)
found to bind##8##3##(1990-11#1)(1992-11#1)(1992-9#1)(1995-5#1)(1995-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
found to carry##3##3##(1993-6#1)(1994-9#1)(1995-9#1)
found to catalyze the##2##4##(1990-12#1)(2009-12#1)
found to cause##5##3##(1993-2#1)(2008-10#2)(2009-12#1)(2012-3#1)
found to change dramatically##2##4##(1995-12#1)(2008-11#1)
found to coincide with##2##4##(1993-11#1)(2008-11#1)
found to consist of##4##4##(1991-10#1)(1993-6#1)(2008-10#1)(2008-3#1)
found to contain the##2##4##(1993-6#1)(2008-10#1)
found to contain two##2##4##(1990-5#1)(1995-6#1)
found to contain##27##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-8#1)(1992-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
found to correlate with##7##4##(1992-6#1)(1994-2#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2013-7#1)
found to correlate##9##3##(1992-2#1)(1992-6#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-7#1)
found to correspond to known##2##5##(2008-10#1)(2008-11#1)
found to correspond to##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
found to decrease the##7##4##(1990-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
found to decrease with##4##4##(1996-3#1)(2008-10#2)(2008-3#1)
found to decrease##20##3##(1990-2#1)(1990-5#3)(1994-5#1)(1994-8#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
found to depend on the##4##5##(1991-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
found to depend on##5##4##(1991-1#1)(2008-10#2)(2008-7#1)(2011-1#1)
found to depend strongly on the##3##6##(2007-12#1)(2008-3#2)
found to depend strongly on##5##5##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)
found to depend##13##3##(1991-1#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#1)
found to differ##3##3##(1990-7#1)(1992-11#1)(2009-12#1)
found to display a##2##4##(1990-8#1)(2012-2#1)
found to display unique photophysical properties in the presence of##2##10##(2008-10#2)
found to display##6##3##(1990-12#1)(1990-8#1)(2008-10#2)(2008-7#1)(2012-2#1)
found to effectively##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
found to elicit##3##3##(1992-9#1)(1995-5#1)(2012-1#1)
found to emit##2##3##(2008-2#1)(2012-2#1)
found to encode a##2##4##(1993-12#1)(1997-7#1)
found to encode##4##3##(1992-10#1)(1993-12#1)(1994-12#1)(1997-7#1)
found to enhance the acetylcholinesterase (AChE) activity of the rat neuronal cell line PC12 at##2##15##(2008-11#2)
found to enhance the##9##4##(1993-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-11#1)(2012-2#1)
found to enhance##10##3##(1991-2#1)(1993-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-11#1)(2012-2#1)
found to exhibit a##4##4##(2008-10#4)
found to exhibit##9##3##(2008-10#5)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
found to exist##7##3##(1992-3#1)(1996-12#1)(2008-10#4)(2008-2#1)
found to express##4##3##(1994-9#1)(1995-11#1)(1996-12#1)(2008-5#1)
found to fall into##2##4##(1994-12#1)(2008-10#1)
found to fall##3##3##(1994-12#1)(2008-10#2)
found to follow the##5##4##(1994-12#1)(1994-6#1)(1997-2#1)(2008-3#1)(2008-4#1)
found to follow##7##3##(1994-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
found to form##4##3##(1994-3#1)(1995-8#1)(2008-5#1)(2009-11#1)
found to generate##2##3##(1990-12#1)(2008-10#1)
found to give the##3##4##(2008-10#2)(2008-11#1)
found to give##18##3##(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)
found to have a high##4##5##(2008-1#1)(2008-10#1)(2008-3#1)(2013-7#1)
found to have a significant effect on the##2##8##(2008-2#1)(2008-3#1)
found to have a significant##4##5##(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
found to have a##43##4##(1991-12#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
found to have an##13##4##(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-7#3)(2009-7#1)(2010-5#1)
found to have approximately##2##4##(1992-6#1)(2009-3#1)
found to have good##2##4##(2008-6#1)(2012-2#1)
found to have high##2##4##(2008-10#1)(2008-7#1)
found to have increased##3##4##(1992-9#1)(2008-2#1)(2009-11#1)
found to have more##2##4##(2007-12#1)(2012-2#1)
found to have no##4##4##(1992-12#1)(1995-2#1)(2011-1#1)(2012-2#1)
found to have severe##2##4##(2008-8#1)(2011-2#1)
found to have significant##6##4##(1993-2#1)(2008-1#1)(2008-10#4)
found to have significantly##3##4##(1995-12#1)(2008-2#1)(2008-3#1)
found to have the greatest##2##5##(2008-10#1)(2012-3#1)
found to have the##10##4##(1991-12#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)(2012-3#1)
found to have two##3##4##(1997-6#1)(2008-12#1)(2008-7#1)
found to have##163##3##(1990-6#1)(1991-12#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#2)(2006-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#26)(2008-11#6)(2008-12#7)(2008-2#9)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#5)(2009-11#2)(2009-3#3)(2009-7#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2011-3#2)(2012-2#7)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
found to hold##2##3##(2008-9#1)(2011-2#1)
found to improve##2##3##(2008-3#1)(2013-1#1)
found to include##2##3##(1993-2#1)(2009-7#1)
found to increase both##2##4##(2008-7#1)(2009-3#1)
found to increase slightly with increasing##2##6##(1996-5#1)(2008-10#1)
found to increase with the number of##2##7##(2008-10#1)(2009-11#1)
found to increase with the##3##5##(2008-10#1)(2008-8#1)(2009-11#1)
found to increase with##5##4##(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)
found to increase##23##3##(1992-11#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)
found to induce apoptosis##2##4##(1994-9#1)(2008-10#1)
found to induce##13##3##(1990-5#1)(1991-2#2)(1991-9#1)(1993-6#2)(1994-9#1)(1995-12#1)(2008-10#3)(2009-12#1)(2012-2#1)
found to influence the##2##4##(1992-10#1)(2009-7#1)
found to influence##5##3##(1992-10#1)(2009-7#1)(2009-9#1)(2010-8#1)(2013-7#1)
found to inhibit the growth of##2##6##(2008-10#2)
found to inhibit the##4##4##(1990-7#1)(1994-5#1)(2008-10#2)
found to inhibit##18##3##(1990-7#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#1)
found to lie in the##2##5##(1996-2#1)(2008-10#1)
found to lie##3##3##(1996-2#1)(2008-10#2)
found to limit the##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
found to live##2##3##(1997-2#1)(2008-8#1)
found to mediate##3##3##(1992-3#1)(2008-6#1)(2009-10#1)
found to mimic##2##3##(1990-12#1)(2012-3#1)
found to modulate##2##3##(2008-10#1)(2008-11#1)
found to occur##7##3##(1990-11#2)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
found to possess##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2009-11#1)
found to produce a##3##4##(2008-10#3)
found to produce##10##3##(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-2#1)
found to promote##2##3##(1992-5#1)(2008-11#1)
found to provide a##3##4##(1994-12#1)(2008-10#1)(2008-2#1)
found to provide the best##2##5##(2008-10#2)
found to provide##8##3##(1994-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
found to range from##4##4##(1994-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
found to react##3##3##(1991-7#1)(2008-10#2)
found to reduce##6##3##(1990-7#1)(1993-2#1)(1995-5#1)(2008-10#2)(2008-2#1)
found to relate to##3##4##(1994-1#1)(2008-11#1)(2012-12#1)
found to relate##4##3##(1994-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
found to release##2##3##(1997-1#1)(2008-5#1)
found to respond##2##3##(1990-12#1)(2008-11#1)
found to result in##2##4##(1992-3#1)(2011-2#1)
found to result##6##3##(1990-2#1)(1991-9#1)(1992-3#1)(1995-6#1)(2008-7#1)(2011-2#1)
found to reverse the##2##4##(1992-9#1)(2011-1#1)
found to selectively##2##3##(1992-6#1)(2008-10#1)
found to share significant homology##2##5##(1993-12#1)(1995-2#1)
found to share##5##3##(1993-12#1)(1995-2#1)(1995-6#1)(1997-6#1)(2012-2#1)
found to show an##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
found to show##6##3##(1996-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
found to significantly##8##3##(1990-12#1)(1991-12#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
found to stimulate##4##3##(1990-10#1)(1992-3#1)(1994-9#1)(1995-2#1)
found to strongly##4##3##(1990-11#1)(1995-6#1)(2008-10#2)
found to substantially##2##3##(2008-10#2)
found to suppress##2##3##(2008-11#1)(2011-1#1)
found to synthesize##2##3##(1992-8#1)(1992-9#1)
found to undergo##2##3##(1996-5#1)(2008-10#1)
found to vary##13##3##(1992-11#1)(1992-3#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#2)
found to yield a better##2##5##(2008-11#1)(2008-2#1)
found to yield a##3##4##(2008-11#1)(2008-2#2)
found to yield##4##3##(1997-3#1)(2008-11#1)(2008-2#2)
found to##1983##2##(1990-10#1)(1990-11#14)(1990-12#18)(1990-2#10)(1990-3#1)(1990-5#13)(1990-6#5)(1990-7#12)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#11)(1991-2#5)(1991-3#1)(1991-5#7)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#11)(1992-1#1)(1992-10#2)(1992-11#10)(1992-12#8)(1992-2#5)(1992-3#14)(1992-5#7)(1992-6#8)(1992-8#13)(1992-9#12)(1993-1#1)(1993-11#9)(1993-12#20)(1993-2#8)(1993-3#6)(1993-6#12)(1993-8#6)(1993-9#7)(1994-1#1)(1994-11#5)(1994-12#12)(1994-2#9)(1994-3#10)(1994-5#10)(1994-6#10)(1994-7#1)(1994-8#10)(1994-9#5)(1995-11#10)(1995-12#12)(1995-2#14)(1995-3#11)(1995-4#1)(1995-5#6)(1995-6#13)(1995-8#7)(1995-9#1)(1996-1#1)(1996-12#11)(1996-2#11)(1996-3#7)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#13)(1997-3#9)(1997-4#14)(1997-5#1)(1997-6#11)(1997-7#4)(1997-8#3)(2006-10#2)(2006-4#1)(2007-1#1)(2007-10#5)(2007-11#37)(2007-12#28)(2007-6#1)(2007-7#15)(2007-8#7)(2008-1#13)(2008-10#603)(2008-11#88)(2008-12#26)(2008-2#59)(2008-3#68)(2008-4#14)(2008-5#34)(2008-6#13)(2008-7#54)(2008-8#30)(2008-9#19)(2009-1#1)(2009-10#6)(2009-11#13)(2009-12#8)(2009-2#7)(2009-3#8)(2009-5#6)(2009-6#2)(2009-7#19)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#3)(2010-2#4)(2010-3#14)(2010-4#7)(2010-5#7)(2010-6#2)(2010-7#5)(2010-8#6)(2011-1#28)(2011-2#30)(2011-3#3)(2012-1#4)(2012-12#12)(2012-2#39)(2012-3#17)(2013-1#34)(2013-7#8)(2013-8#16)
found two##6##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-2#1)
found under##4##2##(1994-10#1)(2007-7#1)(2008-10#1)(2013-7#1)
found upstream of##2##3##(1997-3#1)(2008-10#1)
found upstream##3##2##(1994-12#1)(1997-3#1)(2008-10#1)
found use in the##2##4##(2008-1#1)(2010-7#1)
found useful for##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
found useful##4##2##(2008-10#1)(2008-2#2)(2012-12#1)
found using the##8##3##(2007-8#5)(2008-7#1)(2008-8#1)(2013-8#1)
found using##13##2##(1992-5#1)(2007-8#5)(2008-7#1)(2008-8#2)(2009-8#1)(2013-1#2)(2013-8#1)
found values##4##2##(2008-10#4)
found very##3##2##(1991-9#1)(2008-10#1)(2013-8#1)
found was##5##2##(1995-11#1)(1996-5#1)(2008-10#1)(2012-12#1)(2013-1#1)
found were##13##2##(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#8)(2012-12#2)
found when a##4##3##(1997-8#1)(2008-10#1)(2008-2#1)(2009-10#1)
found when the##6##3##(1994-3#2)(2007-12#1)(2008-10#2)(2008-3#1)
found when##25##2##(1994-3#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2011-3#1)(2013-7#1)
found which##7##2##(1990-11#1)(1990-12#1)(2008-10#2)(2011-2#2)(2012-12#1)
found with conventional##2##3##(2008-3#1)(2011-2#1)
found with high##2##3##(2008-10#1)(2008-7#1)
found with increasing##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
found with results##2##3##(2008-2#1)(2008-3#1)
found with the##12##3##(1990-9#1)(1992-2#1)(1993-9#1)(2007-7#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
found with##71##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-6#2)(1993-9#2)(1994-5#2)(1996-2#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-10#13)(2008-12#3)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#6)(2009-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
found within a##4##3##(1992-9#1)(1996-6#1)(2008-10#2)
found within the##9##3##(1991-9#1)(1993-12#1)(1994-3#1)(2008-10#2)(2008-5#4)
found within this##2##3##(1997-7#1)(2009-10#1)
found within##28##2##(1991-11#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-6#1)(1997-7#1)(2006-6#1)(2008-10#11)(2008-5#5)(2008-7#2)(2009-10#1)
found without##4##2##(1991-11#1)(1991-12#1)(2008-4#1)(2008-7#1)
found worldwide##2##2##(2008-10#1)(2010-3#1)
found##6456##1##(1990-10#2)(1990-11#30)(1990-12#44)(1990-2#26)(1990-3#19)(1990-5#38)(1990-6#20)(1990-7#16)(1990-8#21)(1990-9#16)(1991-1#7)(1991-10#4)(1991-11#12)(1991-12#35)(1991-2#28)(1991-3#9)(1991-4#3)(1991-5#24)(1991-6#15)(1991-7#7)(1991-8#10)(1991-9#33)(1992-1#4)(1992-10#4)(1992-11#23)(1992-12#28)(1992-2#13)(1992-3#34)(1992-4#3)(1992-5#16)(1992-6#29)(1992-8#25)(1992-9#31)(1993-1#8)(1993-10#1)(1993-11#26)(1993-12#57)(1993-2#28)(1993-3#19)(1993-5#2)(1993-6#32)(1993-8#23)(1993-9#25)(1994-1#4)(1994-10#4)(1994-11#27)(1994-12#30)(1994-2#29)(1994-3#28)(1994-5#24)(1994-6#30)(1994-7#6)(1994-8#39)(1994-9#14)(1995-1#3)(1995-11#38)(1995-12#34)(1995-2#37)(1995-3#26)(1995-4#3)(1995-5#15)(1995-6#30)(1995-8#24)(1995-9#4)(1996-1#8)(1996-10#2)(1996-11#2)(1996-12#41)(1996-2#32)(1996-3#16)(1996-4#3)(1996-5#46)(1996-6#14)(1996-7#6)(1996-8#8)(1996-9#11)(1997-1#13)(1997-2#25)(1997-3#38)(1997-4#39)(1997-5#13)(1997-6#31)(1997-7#23)(1997-8#19)(1997-9#2)(2006-10#5)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#4)(2007-10#27)(2007-11#118)(2007-12#107)(2007-2#7)(2007-5#7)(2007-6#12)(2007-7#35)(2007-8#46)(2007-9#1)(2008-1#59)(2008-10#1510)(2008-11#237)(2008-12#110)(2008-2#164)(2008-3#238)(2008-4#57)(2008-5#184)(2008-6#57)(2008-7#216)(2008-8#145)(2008-9#109)(2009-1#5)(2009-10#25)(2009-11#27)(2009-12#19)(2009-2#17)(2009-3#14)(2009-4#10)(2009-5#17)(2009-6#13)(2009-7#43)(2009-8#38)(2009-9#17)(2010-1#11)(2010-10#6)(2010-11#13)(2010-12#18)(2010-2#19)(2010-3#29)(2010-4#25)(2010-5#26)(2010-6#5)(2010-7#14)(2010-8#25)(2010-9#7)(2011-1#85)(2011-10#1)(2011-2#205)(2011-3#11)(2011-4#1)(2012-1#18)(2012-12#61)(2012-2#114)(2012-3#74)(2012-4#1)(2012-5#3)(2012-6#1)(2013-1#159)(2013-7#42)(2013-8#86)
foundation and##5##2##(2008-10#2)(2010-1#1)(2010-3#1)(2013-1#1)
foundation for a##8##3##(1992-12#1)(1995-1#1)(1996-1#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-9#1)(2012-12#1)
foundation for further##4##3##(2008-10#1)(2010-10#1)(2013-1#1)(2013-8#1)
foundation for future##5##3##(1997-4#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
foundation for the development of##2##5##(2008-10#1)(2008-9#1)
foundation for the development##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
foundation for the##9##3##(1995-1#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-5#1)(2013-8#2)
foundation for##61##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-3#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
foundation in##2##2##(1993-11#1)(2008-12#1)
foundation of our##2##3##(2008-4#1)(2008-5#1)
foundation of##10##2##(1992-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
foundation to##5##2##(1994-2#1)(1995-3#1)(2007-12#1)(2010-10#1)(2013-1#1)
foundation with##2##2##(1993-12#1)(2008-5#1)
foundation##117##1##(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-4#6)(2008-5#10)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#2)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#5)(2013-8#3)
foundational##5##1##(2008-11#1)(2008-12#1)(2010-9#1)(2012-3#1)(2013-1#1)
foundations and##2##2##(1991-1#1)(2007-11#1)
foundations for##5##2##(1995-2#1)(1996-12#1)(2007-5#1)(2008-11#1)(2011-2#1)
foundations of the##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
foundations of this##2##3##(2012-12#1)(2013-1#1)
foundations of##12##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
foundations##32##1##(1991-1#1)(1992-12#2)(1993-12#2)(1994-1#1)(1995-2#2)(1996-1#1)(1996-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
founded and##3##2##(1993-6#1)(2010-1#1)(2011-4#1)
founded by##4##2##(1993-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
founded in##11##2##(1991-6#1)(1992-1#1)(1993-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)
founded on the##2##3##(2008-2#1)(2013-1#1)
founded on##6##2##(1993-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
founded##35##1##(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#2)(2011-4#2)(2012-1#1)(2012-3#2)(2013-1#2)
founder effect##6##2##(1996-6#2)(2008-10#3)(2008-5#1)
founder effects##3##2##(1996-6#1)(2010-8#1)(2011-2#1)
founder of the##2##3##(2008-10#1)(2008-8#1)
founder of##3##2##(2007-10#1)(2008-10#1)(2008-8#1)
founder populations##2##2##(1996-4#1)(2008-10#1)
founder##25##1##(1993-2#1)(1996-4#1)(1996-6#5)(2007-10#1)(2008-10#6)(2008-5#1)(2008-8#3)(2008-9#4)(2009-6#1)(2010-8#1)(2011-2#1)
founders##8##1##(1996-6#1)(2008-1#1)(2009-5#1)(2011-2#4)(2013-1#1)
founding members##2##2##(2008-8#1)(2012-1#1)
founding of##5##2##(1994-3#1)(1997-2#1)(2008-1#1)(2008-7#1)(2011-2#1)
founding##16##1##(1991-1#1)(1991-3#1)(1993-6#1)(1994-3#2)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
foundresses##2##1##(2008-8#2)
foundry##2##1##(2008-10#1)(2008-2#1)
fountain##5##1##(2007-12#1)(2008-10#3)(2011-2#1)
four E##4##2##(1995-3#1)(1995-6#2)(2011-2#1)
four European##2##2##(2008-10#2)
four Fusarium spp##2##3##(2008-10#2)
four QTL##2##2##(2008-10#1)(2012-3#1)
four S compounds##3##3##(2008-10#3)
four S##4##2##(2008-10#4)
four Stokes parameters##2##3##(2007-12#1)(2008-3#1)
four Stokes##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
four Venezuelan##3##2##(2008-10#1)(2011-2#2)
four Western##2##2##(1993-2#1)(2010-2#1)
four acids##2##2##(2008-10#1)(2012-3#1)
four additional##4##2##(1991-8#1)(1995-6#1)(2008-10#2)
four amino acid##2##3##(2008-10#1)(2013-1#1)
four amino##4##2##(1992-9#1)(1994-8#1)(2008-10#1)(2013-1#1)
four analytes##3##2##(2008-10#3)
four and a half##2##4##(1992-4#1)(1992-5#1)
four and five##3##3##(2008-10#1)(2012-2#2)
four and##11##2##(1992-4#1)(1992-5#1)(1996-9#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-2#2)
four animals##2##2##(2008-5#1)(2008-7#1)
four anions##3##2##(2008-10#2)(2012-1#1)
four aortic##2##2##(2013-3#2)
four apple cultivars##2##3##(2008-10#2)
four are##2##2##(2007-8#1)(2010-3#1)
four areas##10##2##(1993-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)(2012-12#1)(2013-7#1)
four arsenic species in##2##4##(2008-10#2)
four arsenic species##3##3##(2008-10#3)
four articles describing##2##3##(1997-1#1)(2012-12#1)
four atmospheric##2##2##(2013-8#2)
four bands##3##2##(2008-10#2)(2008-9#1)
four bases##2##2##(1992-3#1)(2008-2#1)
four basic operations##2##3##(2008-10#2)
four basic##7##2##(1992-1#1)(1992-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)
four beaches##3##2##(2008-5#3)
four beams is##2##3##(2007-11#1)(2008-3#1)
four beams##4##2##(2007-11#1)(2008-3#3)
four candidate##2##2##(2008-11#1)(2008-7#1)
four cases of##16##3##(1991-12#1)(1991-2#1)(1994-12#1)(1996-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#1)
four cases with##2##3##(1994-12#1)(1994-6#1)
four cases##46##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-12#2)(1991-2#1)(1994-12#3)(1994-6#2)(1995-3#2)(1996-12#2)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#5)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#2)(2012-2#2)
four categories of##6##3##(1994-12#2)(1995-4#1)(2007-9#1)(2012-1#1)(2013-1#1)
four categories##16##2##(1992-3#1)(1994-12#2)(1995-3#1)(1995-4#1)(1997-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
four cell lines##3##3##(1992-2#1)(1993-3#1)(1993-6#1)
four cell##5##2##(1990-2#1)(1992-2#1)(1993-3#1)(1993-6#1)(2008-10#1)
four channels##2##2##(2008-3#2)
four characteristics##2##2##(1996-11#1)(2013-7#1)
four chemicals##2##2##(2008-5#2)
four children##2##2##(1992-5#1)(2008-9#1)
four circular##2##2##(2011-2#1)(2012-1#1)
four cities##3##2##(1996-1#1)(2007-12#1)(2013-1#1)
four classes of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
four classes##5##2##(1990-3#1)(2008-10#1)(2011-2#2)(2013-1#1)
four clinical##3##2##(1997-5#1)(2008-7#1)(2012-3#1)
four closely related##2##3##(2012-3#1)(2012-5#1)
four closely##3##2##(2008-12#1)(2012-3#1)(2012-5#1)
four clusters of##2##3##(1992-2#1)(2008-10#1)
four clusters##6##2##(1992-2#1)(2008-10#5)
four cohort studies##2##3##(1994-2#2)
four combinations of##2##3##(2008-10#1)(2008-9#1)
four commercial##2##2##(2008-10#2)
four common##4##2##(1991-5#1)(2008-10#2)(2010-9#1)
four components##3##2##(1995-3#1)(2006-12#1)(2008-10#1)
four compounds##5##2##(1992-3#1)(2008-10#3)(2008-9#1)
four consecutive##8##2##(1994-2#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#2)(2013-1#2)
four control##2##2##(1993-12#1)(1996-12#1)
four cortical##2##2##(1996-5#1)(2012-2#1)
four countries##6##2##(1990-11#1)(1991-11#1)(2009-3#2)(2012-12#1)(2012-3#1)
four cultivars were##2##3##(2008-10#1)(2011-10#1)
four cultivars##5##2##(2008-10#4)(2011-10#1)
four cycles of##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
four cycles##4##2##(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
four cysteine residues##2##3##(1991-12#1)(1993-8#1)
four days after##2##3##(2007-12#1)(2008-11#1)
four days before##2##3##(2008-10#1)(2008-11#1)
four days of##4##3##(1991-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
four days##18##2##(1991-2#1)(1992-9#1)(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
four decades##11##2##(1994-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
four different genotypes##2##3##(2008-10#2)
four different nursing homes in##2##5##(2010-10#2)
four different protocols##2##3##(2007-8#1)(2008-4#1)
four different temperatures##3##3##(2008-10#2)(2008-5#1)
four different##86##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#41)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#2)(2013-1#3)(2013-8#1)
four dimensions of OCE##2##4##(2011-2#2)
four dimensions of##4##3##(2011-2#4)
four dimensions##10##2##(1992-3#1)(2008-6#1)(2009-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
four directions##3##2##(2008-10#3)
four distinct##18##2##(1992-6#1)(1992-8#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
four domains##3##2##(1992-4#2)(2007-12#1)
four drug##3##2##(1994-2#1)(1997-5#1)(2008-10#1)
four eastern##2##2##(2008-10#2)
four elements##2##2##(2008-10#1)(2008-6#1)
four enzymes##3##2##(1995-5#1)(2008-10#2)
four episodes of##2##3##(2008-1#1)(2012-12#1)
four episodes##3##2##(2008-1#1)(2012-12#2)
four exons interrupted by three introns##2##6##(1993-3#1)(1994-12#1)
four exons of##2##3##(1994-11#1)(1994-12#1)
four exons##10##2##(1990-5#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)
four experimental##3##2##(1996-2#1)(2008-4#1)(2012-2#1)
four experiments##3##2##(2008-6#1)(2011-1#1)(2013-8#1)
four factors##5##2##(2008-10#3)(2008-11#1)(2010-10#1)
four families##2##2##(1992-7#1)(2013-8#1)
four farms##2##2##(2008-10#1)(2008-5#1)
four females##2##2##(1992-9#1)(2008-5#1)
four field experiments##3##3##(2008-10#3)
four field##6##2##(2008-10#5)(2011-2#1)
four fields##5##2##(1993-12#1)(2008-10#2)(2013-1#1)(2013-7#1)
four fish##2##2##(2009-5#1)(2013-7#1)
four flavonoids##3##2##(2008-10#3)
four fluorescence##2##2##(2008-4#1)(2008-9#1)
four fluoroquinolones##3##2##(2008-10#1)(2008-7#2)
four fractions##2##2##(2008-10#1)(2013-1#1)
four from the##2##3##(2008-9#2)
four from##5##2##(1992-3#1)(1994-2#1)(2007-6#1)(2008-9#2)
four functional##2##2##(1991-6#1)(2008-11#1)
four genera##2##2##(2007-5#1)(2008-10#1)
four general##2##2##(1993-12#1)(2008-5#1)
four genes##12##2##(1993-12#1)(1993-6#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
four genotypes##2##2##(2008-10#2)
four goals##2##2##(1996-1#1)(1996-3#1)
four groups based on##3##4##(2008-9#1)(2010-8#1)(2011-2#1)
four groups had##2##3##(2007-11#1)(2008-5#1)
four groups of##8##3##(1990-11#1)(1991-7#1)(1991-8#2)(1992-2#1)(2012-12#1)(2013-1#2)
four groups were##3##3##(1993-3#1)(2008-10#1)(2008-12#1)
four groups##55##2##(1990-11#1)(1991-2#1)(1991-7#1)(1991-8#3)(1992-1#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1996-7#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#5)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2013-1#7)(2013-8#1)
four growing##2##2##(2008-10#1)(2013-1#1)
four had a##2##3##(2008-12#1)(2008-9#1)
four had##4##2##(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
four health##3##2##(1993-3#1)(2007-12#1)(2008-12#1)
four healthy subjects##2##3##(2012-2#1)(2013-8#1)
four high##2##2##(1990-12#1)(2009-7#1)
four high-speed##2##2##(2008-3#2)
four highly##2##2##(1997-1#1)(2008-10#1)
four hormones##2##2##(1995-11#1)(2013-7#1)
four hospitals in##2##3##(1992-5#1)(1994-1#1)
four hospitals##4##2##(1992-5#1)(1994-1#1)(1994-3#1)(2008-1#1)
four hours after the##2##4##(2008-12#1)(2008-7#1)
four hours after##3##3##(2008-12#1)(2008-7#1)(2012-12#1)
four hours##7##2##(1990-2#1)(2008-12#2)(2008-4#1)(2008-7#1)(2012-12#2)
four human transformed epithelial cell lines##2##6##(1992-2#2)
four human##4##2##(1990-6#1)(1992-2#2)(2008-4#1)
four identical##5##2##(2007-11#1)(2008-3#3)(2008-7#1)
four impurities##3##2##(2008-10#3)
four in##4##2##(1994-11#1)(2008-10#3)
four independent##3##2##(1990-8#1)(2007-12#1)(2010-4#1)
four input polarization states##2##4##(2007-12#2)
four isolated##2##2##(2007-11#1)(2008-10#1)
four isolates of BSV##2##4##(2008-10#2)
four isolates of##6##3##(2007-6#1)(2008-10#5)
four isolates##10##2##(2007-6#1)(2008-10#9)
four key##7##2##(1995-3#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-9#1)(2012-12#1)
four kindergartens##2##2##(2011-2#1)(2013-1#1)
four kinds of##9##3##(1990-12#1)(1995-3#1)(2008-10#5)(2008-5#1)(2013-8#1)
four known##3##2##(1994-8#1)(1995-8#1)(2010-3#1)
four leaves##2##2##(2008-10#1)(2008-12#1)
four lesions##3##2##(2008-6#2)(2009-3#1)
four levels of##4##3##(2008-10#2)(2008-7#1)(2013-3#1)
four levels##6##2##(2008-10#3)(2008-7#1)(2008-9#1)(2013-3#1)
four lineages##2##2##(2008-10#2)
four lines of##2##3##(1990-11#1)(2008-5#1)
four locations##7##2##(2008-10#5)(2008-3#1)(2010-12#1)
four loci##2##2##(1991-5#1)(2008-10#1)
four main themes##2##3##(2009-5#1)(2011-1#1)
four main##11##2##(1990-11#1)(1990-5#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
four major taxa##2##3##(2008-10#1)(2008-9#1)
four major##18##2##(1991-2#1)(1994-2#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#1)(2012-3#2)
four male##3##2##(2007-8#1)(2008-6#1)(2012-7#1)
four mammalian##5##2##(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#1)
four markers (Kmy1##2##3##(1997-8#2)
four markers##4##2##(1997-8#2)(2007-7#1)(2008-10#1)
four measurements##2##2##(2008-2#1)(2008-3#1)
four measures of##2##3##(2011-2#1)(2013-7#1)
four medical##3##2##(1990-10#1)(1991-6#1)(2012-3#1)
four members of##2##3##(1995-6#1)(1997-6#1)
four metabolites##2##2##(2008-10#1)(2008-11#1)
four methods of##2##3##(2008-3#1)(2008-7#1)
four methods##11##2##(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-7#1)(2013-8#1)
four microsatellite loci##2##3##(2008-10#2)
four microsatellite##3##2##(2008-10#3)
four million##2##2##(1992-9#1)(1995-11#1)
four mixed##2##2##(2008-10#1)(2008-8#1)
four mixtures##2##2##(2008-10#2)
four models##3##2##(1995-3#1)(2008-11#1)(2010-4#1)
four modifiable risk factors##2##4##(2008-1#2)
four months after##2##3##(1993-8#1)(2007-7#1)
four months and##2##3##(1992-4#1)(2008-6#1)
four months to##2##3##(2008-5#1)(2013-1#1)
four months was##2##3##(1992-11#1)(2008-10#1)
four months##23##2##(1990-9#1)(1992-11#1)(1992-4#1)(1993-2#1)(1993-8#2)(1994-6#2)(1997-5#1)(1997-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
four more##2##2##(1997-3#1)(2008-6#1)
four most##3##2##(2008-10#2)(2010-8#1)
four multivariate methods##2##3##(2008-10#2)
four municipalities##2##2##(1994-6#2)
four mutants##3##2##(1990-11#1)(1994-5#1)(1997-2#1)
four new##7##2##(1997-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)
four novel##4##2##(1991-5#2)(2007-7#1)(2008-10#1)
four nucleotide##2##2##(1991-6#1)(2009-7#1)
four of five##4##3##(1990-11#1)(1997-4#2)(2008-10#1)
four of seven##3##3##(2008-10#3)
four of six##6##3##(1994-5#1)(2008-10#2)(2008-5#2)(2008-7#1)
four of the five##6##4##(1991-6#1)(1995-5#1)(1997-8#1)(2008-10#3)
four of the six##3##4##(1990-5#1)(2008-8#1)(2013-8#1)
four of the##22##3##(1990-5#1)(1991-6#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-2#1)(2010-2#1)(2013-8#2)
four of them##3##3##(1993-2#1)(1995-3#1)(2011-2#1)
four of these##9##3##(1992-2#1)(1994-2#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)
four of which##2##3##(1991-8#1)(1996-3#1)
four of##59##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#2)(2013-8#2)
four oligopeptide substrates##2##3##(1991-9#2)
four open reading frames (ORFs)##2##5##(1995-6#1)(1997-3#1)
four open reading frames##8##4##(1995-6#2)(1997-3#2)(2008-10#3)(2008-8#1)
four or more##4##3##(1995-5#1)(1997-7#1)(2010-6#1)(2012-2#1)
four or##6##2##(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-6#1)(2012-2#1)
four orders of magnitude with##2##5##(2008-10#1)(2009-11#1)
four orders of magnitude##6##4##(2008-10#4)(2009-11#1)(2012-2#1)
four orders of##9##3##(2008-1#1)(2008-10#6)(2009-11#1)(2012-2#1)
four orders##10##2##(2008-1#1)(2008-10#6)(2008-5#1)(2009-11#1)(2012-2#1)
four other cases##3##3##(2006-6#1)(2008-1#1)(2011-2#1)
four other##17##2##(1991-2#1)(1992-3#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
four out of five##4##4##(1991-9#1)(1993-8#1)(2008-10#1)(2010-3#1)
four out of the##3##4##(1996-5#1)(2008-5#1)(2009-11#1)
four out of##9##3##(1991-9#1)(1993-8#1)(1996-5#1)(2008-10#2)(2008-5#2)(2009-11#1)(2010-3#1)
four outcomes##2##2##(2008-7#1)(2008-8#1)
four pH values##2##3##(2008-10#1)(2008-5#1)
four pairs of##5##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)
four parameters##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
four parts##2##2##(1995-6#1)(2008-6#1)
four patients are##2##3##(1990-9#1)(2008-6#1)
four patients under##2##3##(1996-2#1)(2007-11#1)
four patients were##3##3##(1990-2#1)(1992-9#1)(2008-7#1)
four patients who underwent##2##4##(2008-6#1)(2011-2#1)
four patients who##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
four patients with##12##3##(1990-8#1)(1993-2#1)(1994-12#1)(1996-9#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-8#1)(2013-8#1)
four patients##64##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-5#1)(1991-8#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-5#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-8#2)(2007-11#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#2)(2008-12#3)(2008-5#3)(2008-6#3)(2008-7#8)(2008-9#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
four peaks##4##2##(2008-10#1)(2008-8#3)
four pear##2##2##(2008-10#2)
four percent##3##2##(2007-2#1)(2013-1#1)(2013-8#1)
four phase-shifted images##2##3##(2008-3#2)
four phases##4##2##(1990-3#2)(1996-1#1)(1996-2#1)
four phenotypes##2##2##(2008-10#2)
four plants##2##2##(2008-10#2)
four points##4##2##(1995-1#1)(2008-12#1)(2009-2#1)(2010-5#1)
four polypeptides##2##2##(1990-7#2)
four populations collected from##2##4##(2008-10#2)
four populations of##3##3##(2008-10#2)(2011-2#1)
four populations##8##2##(2008-10#5)(2009-9#2)(2011-2#1)
four positions##2##2##(2007-2#1)(2008-8#1)
four positive##2##2##(2008-5#1)(2013-1#1)
four possible##4##2##(1990-7#1)(1991-5#1)(2008-8#1)(2008-9#1)
four potential polyadenylation##2##3##(1994-11#1)(2010-4#1)
four potential##4##2##(1993-8#1)(1994-11#1)(2008-3#1)(2010-4#1)
four predictors##2##2##(1992-3#1)(2011-2#1)
four previously##3##2##(2008-10#2)(2013-8#1)
four primary##6##2##(1990-12#2)(1994-2#1)(1995-12#1)(2008-7#1)(2012-12#1)
four principal##3##2##(1991-3#1)(1997-3#1)(2008-5#1)
four procedures##5##2##(1995-2#1)(2007-7#1)(2008-10#2)(2008-4#1)
four proteins##2##2##(1995-5#1)(2012-2#1)
four putative##3##2##(1993-6#1)(1995-9#1)(2008-10#1)
four quadrants of##2##3##(2009-7#2)
four randomized##2##2##(2010-12#1)(2012-3#1)
four regions of##5##3##(1993-8#1)(2007-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
four regions##8##2##(1993-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
four replicate##3##2##(2008-10#2)(2008-8#1)
four replications##9##2##(2008-10#4)(2008-12#5)
four residues##2##2##(1991-2#1)(1993-11#1)
four restriction enzymes##3##3##(1997-2#1)(2008-10#2)
four restriction fragment length##2##4##(1997-5#1)(2008-10#1)
four restriction##6##2##(1992-11#1)(1997-2#1)(1997-5#1)(2008-10#3)
four risk factors##2##3##(2008-1#1)(2009-7#1)
four rounds of##2##3##(2008-10#2)
four sample##2##2##(2007-5#1)(2010-10#1)
four sampled##2##2##(2013-8#2)
four samples of##2##3##(2008-3#1)(2010-10#1)
four samples##5##2##(2008-10#2)(2008-3#1)(2010-10#1)(2011-2#1)
four sampling##3##2##(2007-5#1)(2008-10#2)
four seasons of##2##3##(2008-12#1)(2013-8#1)
four seasons##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
four sections##4##2##(2008-10#2)(2010-6#1)(2012-2#1)
four selected##5##2##(1990-3#1)(2008-5#1)(2008-8#1)(2011-3#1)(2013-8#1)
four separate##5##2##(1994-2#1)(2008-10#2)(2008-2#1)(2012-2#1)
four sequential##2##2##(1990-8#1)(2008-10#1)
four serogroups##2##2##(2008-10#2)
four sessions of##2##3##(2008-10#2)
four sessions##3##2##(2008-10#2)(2011-2#1)
four sets of##2##3##(2008-10#1)(2008-9#1)
four showed##2##2##(1996-3#1)(2007-7#1)
four siblings##2##2##(2011-1#2)
four signs##2##2##(2010-4#2)
four sites were##2##3##(1993-12#1)(2008-11#1)
four sites##8##2##(1991-3#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)(2013-7#2)
four six-month##2##2##(2007-5#2)
four smaller##2##2##(1991-5#1)(2008-10#1)
four social health maintenance##2##4##(1991-3#1)(1992-1#1)
four sociologists##2##2##(2008-12#2)
four soil##2##2##(2008-12#1)(2013-8#1)
four solar radiometers##2##3##(2008-3#2)
four species belonging to the##2##5##(2007-12#1)(2008-5#1)
four species of##13##3##(1990-7#1)(1994-8#1)(2007-12#2)(2008-10#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
four species##28##2##(1990-7#1)(1994-8#1)(2007-12#4)(2008-10#6)(2008-5#6)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-5#2)(2013-8#1)
four spherical mirrors##2##3##(2008-3#2)
four stages of##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
four stages##6##2##(1991-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
four standard reference materials##2##4##(2008-10#2)
four standard##3##2##(2008-10#3)
four states##3##2##(2008-10#3)
four stationary phases##2##3##(2008-10#2)
four step##2##2##(1992-12#1)(2008-10#1)
four step-to-step transition types##2##4##(2012-12#2)
four steps##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
four strains and##2##3##(2008-10#2)
four strains of X##3##4##(2008-10#3)
four strains of##5##3##(1990-5#1)(2008-10#3)(2013-1#1)
four strains were##2##3##(2008-10#1)(2008-6#1)
four strains##13##2##(1990-5#1)(2008-10#10)(2008-6#1)(2013-1#1)
four strategies##2##2##(1995-2#1)(1997-8#1)
four studies##9##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
four study##2##2##(1996-3#1)(2008-10#1)
four subgroups##6##2##(1990-8#1)(1997-6#1)(2008-10#3)(2009-8#1)
four subpopulations##5##2##(2008-10#3)(2008-11#1)(2008-9#1)
four subtropical##2##2##(2008-8#2)
four subtypes##2##2##(2008-3#1)(2008-7#1)
four subunits##2##2##(1990-7#1)(2012-2#1)
four successive##4##2##(2007-11#1)(2008-10#2)(2008-8#1)
four such##2##2##(2008-10#1)(2008-5#1)
four surface##2##2##(2008-10#1)(2008-5#1)
four taxa##2##2##(2008-11#1)(2008-12#1)
four techniques##2##2##(1990-8#1)(2008-10#1)
four temperatures##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
four time##3##2##(1997-6#1)(2007-12#1)(2008-4#1)
four times a##2##3##(1994-2#1)(2009-1#1)
four times at##2##3##(2008-10#1)(2008-2#1)
four times daily##2##3##(1992-8#1)(2008-3#1)
four times during##2##3##(1995-8#1)(2007-2#1)
four times each##2##3##(2008-10#1)(2008-5#1)
four times more##3##3##(1992-9#1)(1994-7#1)(2008-3#1)
four times per day##2##4##(1992-3#1)(2008-12#1)
four times##36##2##(1990-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-7#1)(1995-8#1)(1997-6#1)(2007-12#2)(2007-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2009-1#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
four to eight##2##3##(2008-11#1)(2009-10#1)
four to five##6##3##(1993-1#1)(1995-3#1)(2008-10#2)(2008-5#2)
four to##13##2##(1992-11#1)(1993-1#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-10#1)(2013-7#1)
four traditional##3##2##(2008-8#1)(2010-8#1)(2011-2#1)
four traits##2##2##(2008-10#1)(2008-9#1)
four treatment regimens##2##3##(1995-2#1)(2008-10#1)
four treatment##5##2##(1993-9#2)(1995-2#1)(2008-10#1)(2009-8#1)
four treatments##4##2##(2008-10#1)(2008-12#1)(2012-6#1)(2012-9#1)
four types of phase code##2##5##(2008-3#2)
four types of##15##3##(1990-2#1)(1991-2#1)(1992-3#1)(1994-3#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-2#1)
four types##17##2##(1990-2#1)(1991-2#1)(1992-3#1)(1994-3#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-2#1)
four unbranched##2##2##(2007-12#2)
four units of##2##3##(1994-12#1)(1994-9#1)
four units##4##2##(1994-12#1)(1994-9#1)(2008-4#2)
four unrelated##2##2##(1994-8#1)(1997-7#1)
four valve##2##2##(2007-8#1)(2008-4#1)
four variables##5##2##(2007-11#1)(2008-10#2)(2011-2#1)(2013-1#1)
four videos##2##2##(2008-11#1)(2008-9#1)
four water##2##2##(2008-10#1)(2010-8#1)
four wave mixing##2##3##(2009-7#2)
four wavelengths##2##2##(2008-3#2)
four weeks of##4##3##(2008-5#1)(2011-1#1)(2013-1#2)
four weeks##31##2##(1990-6#1)(1991-12#1)(1991-6#3)(1992-4#1)(1992-9#1)(1995-12#1)(2007-7#3)(2008-5#9)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#1)
four were##9##2##(1993-6#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-3#1)(2010-1#1)(2012-3#1)
four who##2##2##(1990-11#1)(2008-1#1)
four with##3##2##(2008-10#1)(2008-6#1)(2012-1#1)
four women##3##2##(2010-3#2)(2012-3#1)
four year##5##2##(1995-5#1)(1996-9#1)(1997-8#1)(2008-11#1)(2008-5#1)
four years after##2##3##(2007-7#1)(2011-1#1)
four years as##2##3##(1995-1#1)(1996-12#1)
four years in##2##3##(1990-12#1)(1993-6#1)
four years later##2##3##(1996-3#1)(2008-7#1)
four years of this##2##4##(2008-1#1)(2008-5#1)
four years of##7##3##(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-9#1)
four years##41##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#3)(1997-8#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#3)(2011-2#2)
four##2236##1##(1990-10#1)(1990-11#10)(1990-12#6)(1990-2#5)(1990-3#6)(1990-5#9)(1990-6#2)(1990-7#6)(1990-8#12)(1990-9#4)(1991-11#3)(1991-12#9)(1991-2#11)(1991-3#4)(1991-4#1)(1991-5#9)(1991-6#10)(1991-7#2)(1991-8#11)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#8)(1992-12#2)(1992-2#9)(1992-3#17)(1992-4#9)(1992-5#5)(1992-6#7)(1992-7#1)(1992-8#6)(1992-9#9)(1993-1#3)(1993-11#6)(1993-12#11)(1993-2#13)(1993-3#9)(1993-5#3)(1993-6#10)(1993-8#10)(1993-9#4)(1994-1#1)(1994-11#9)(1994-12#12)(1994-2#14)(1994-3#6)(1994-5#4)(1994-6#10)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#7)(1995-2#12)(1995-3#14)(1995-4#3)(1995-5#9)(1995-6#20)(1995-8#4)(1995-9#6)(1996-1#8)(1996-11#1)(1996-12#9)(1996-2#7)(1996-3#8)(1996-5#7)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#7)(1997-1#3)(1997-2#9)(1997-3#19)(1997-4#8)(1997-5#7)(1997-6#8)(1997-7#15)(1997-8#13)(1997-9#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#24)(2007-12#39)(2007-2#6)(2007-5#7)(2007-6#4)(2007-7#26)(2007-8#20)(2007-9#1)(2008-1#29)(2008-10#568)(2008-11#59)(2008-12#55)(2008-2#23)(2008-3#70)(2008-4#24)(2008-5#103)(2008-6#33)(2008-7#61)(2008-8#41)(2008-9#43)(2009-1#2)(2009-10#3)(2009-11#6)(2009-12#1)(2009-2#6)(2009-3#7)(2009-4#2)(2009-5#9)(2009-6#3)(2009-7#11)(2009-8#9)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#12)(2010-4#9)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#19)(2010-9#2)(2011-1#21)(2011-10#2)(2011-2#82)(2011-3#2)(2012-1#5)(2012-12#18)(2012-2#25)(2012-3#29)(2012-5#3)(2012-6#1)(2012-7#1)(2012-9#2)(2013-1#58)(2013-3#3)(2013-7#15)(2013-8#29)
four)##3##1##(1995-12#1)(2008-10#1)(2012-2#1)
four- and##3##2##(2008-10#2)(2011-1#1)
four- or##2##2##(1997-3#1)(2008-9#1)
four-##8##1##(1992-1#1)(1997-3#1)(2008-10#4)(2008-9#1)(2011-1#1)
four-base-pair##2##1##(2013-1#2)
four-channel##12##1##(1996-1#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2011-2#1)
four-color##5##1##(2008-4#1)(2008-9#4)
four-coordinated##2##1##(1995-2#2)
four-corner##2##1##(2008-9#2)
four-day##3##1##(1996-4#1)(2008-5#1)(2013-8#1)
four-descriptors##2##1##(2007-11#2)
four-dimensional##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
four-factor model##2##2##(2009-7#2)
four-five years##2##2##(1991-5#2)
four-flux radiative transfer model##3##4##(2008-2#2)(2008-3#1)
four-flux radiative transfer##4##3##(2008-2#3)(2008-3#1)
four-flux##8##1##(2008-2#5)(2008-3#3)
four-fold##5##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#2)
four-frame##2##1##(2008-3#2)
four-helix bundle##3##2##(1992-8#1)(1995-5#2)
four-helix##5##1##(1990-5#1)(1992-8#1)(1994-3#1)(1995-5#2)
four-leaf##3##1##(2008-10#2)(2012-3#1)
four-level grating##2##2##(2007-12#1)(2008-3#1)
four-level##7##1##(2007-11#2)(2007-12#1)(2008-3#3)(2010-10#1)
four-month##2##1##(2008-10#1)(2013-1#1)
four-part##6##1##(1993-2#1)(2007-8#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-8#1)
four-pass amplifier##2##2##(2007-11#1)(2008-2#1)
four-pass dye laser amplifier##3##4##(2008-2#3)
four-pass##7##1##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
four-point bending##3##2##(2008-8#3)
four-point##5##1##(2008-2#1)(2008-8#3)(2011-2#1)
four-port##3##1##(2007-11#1)(2007-9#1)(2008-2#1)
four-stage##2##1##(2008-2#2)
four-step procedure##2##2##(2008-4#1)(2011-2#1)
four-step##6##1##(1990-8#1)(1992-11#1)(1994-11#1)(2008-4#2)(2011-2#1)
four-wave mixing (FWM)##2##3##(2007-11#1)(2007-12#1)
four-wave mixing and##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
four-wave mixing as a##2##4##(2007-11#1)(2008-3#1)
four-wave mixing between pulses in##2##5##(2007-11#2)
four-wave mixing efficiency##2##3##(2007-11#2)
four-wave mixing for##3##3##(2007-12#1)(2008-3#2)
four-wave mixing in a##8##4##(2007-11#2)(2007-12#6)
four-wave mixing in an optical##2##5##(2007-11#1)(2007-12#1)
four-wave mixing in an##4##4##(2007-11#1)(2007-12#3)
four-wave mixing in##19##3##(2007-11#7)(2007-12#10)(2008-3#2)
four-wave mixing is##2##3##(2007-12#1)(2008-2#1)
four-wave mixing process##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
four-wave mixing scheme##2##3##(2007-12#1)(2008-3#1)
four-wave mixing with extraordinary writing beams and an ordinary reading beam##2##11##(2008-2#2)
four-wave mixing with##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
four-wave mixing##72##2##(1991-9#1)(2007-11#24)(2007-12#26)(2008-2#7)(2008-3#14)
four-wave rectification##2##2##(2007-12#2)
four-wave##77##1##(1991-9#1)(2007-11#26)(2007-12#29)(2008-2#7)(2008-3#14)
four-wave-mixing##7##1##(2007-11#1)(2007-12#6)
four-way junction DNA##3##3##(1994-9#2)(1996-2#1)
four-way junctions##2##2##(1994-9#1)(1995-8#1)
four-way##7##1##(1990-8#1)(1994-9#3)(1995-8#1)(1996-2#1)(2009-9#1)
four-week##5##1##(1992-9#1)(2008-5#2)(2008-7#1)(2011-3#1)
four-zone##2##1##(2008-3#2)
fourfold and##2##2##(2008-10#1)(2008-6#1)
fourfold##21##1##(1992-11#1)(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)
fourier analysis##2##2##(2008-3#1)(2013-7#1)
fourier polarimetry##2##2##(2008-3#2)
fourier transform spectroscopy##2##3##(2008-2#1)(2011-1#1)
fourier transform##11##2##(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2011-1#1)
fourier##24##1##(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#14)(2011-1#1)(2013-7#1)
fourier-transform infrared##3##2##(2008-2#1)(2008-3#2)
fourier-transform method##2##2##(2008-2#1)(2008-3#1)
fourier-transform spectrometers##3##2##(2008-2#1)(2008-3#2)
fourier-transform##13##1##(2008-2#3)(2008-3#10)
fourteen##24##1##(1991-5#2)(1992-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-1#3)(2008-4#1)(2008-5#4)(2008-7#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-3#2)
fourth and fifth##12##3##(1997-3#2)(2007-12#1)(2008-10#3)(2008-9#1)(2010-11#2)(2010-3#2)(2012-3#1)
fourth and##14##2##(1997-3#2)(2007-12#1)(2008-10#3)(2008-9#1)(2010-11#2)(2010-3#2)(2012-3#2)(2012-9#1)
fourth derivative spectrophotometry##2##3##(2008-10#2)
fourth derivative##4##2##(2008-10#4)
fourth dimension##2##2##(2007-8#1)(2012-2#1)
fourth ed##2##2##(2008-11#2)
fourth generation##2##2##(2008-10#1)(2011-1#1)
fourth month##2##2##(1990-9#1)(2007-8#1)
fourth of##4##2##(1990-12#1)(2007-10#1)(2008-10#1)(2010-4#1)
fourth step##2##2##(1990-8#1)(2008-10#1)
fourth study##4##2##(1994-2#3)(2008-11#1)
fourth ventricle##9##2##(1996-5#1)(2008-7#3)(2010-11#1)(2011-2#1)(2013-1#3)
fourth week##2##2##(1997-2#1)(2007-11#1)
fourth year of##2##3##(1994-12#1)(2008-2#1)
fourth year##5##2##(1992-12#2)(1994-12#1)(2008-10#1)(2008-2#1)
fourth##169##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1995-2#2)(1995-6#2)(1995-8#1)(1996-5#1)(1997-2#4)(1997-3#4)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#6)
fourth- and##2##2##(2007-12#1)(2008-2#1)
fourth-##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
fourth-harmonic generation in##2##3##(2007-11#1)(2008-3#1)
fourth-harmonic generation##4##2##(2007-11#3)(2008-3#1)
fourth-harmonic##6##1##(2007-11#4)(2008-3#2)
fourth-order dispersion##3##2##(2007-11#2)(2007-12#1)
fourth-order theory##2##2##(2008-3#2)
fourth-order##14##1##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#5)(2008-6#2)(2010-12#1)
fourth-stage juveniles##2##2##(2008-10#2)
fovea##2##1##(2007-11#1)(2011-2#1)
foveal##5##1##(2008-2#1)(2011-7#1)(2013-1#3)
foveolar##2##1##(2012-1#1)(2013-8#1)
foveolata##3##1##(2008-8#3)
fowl##3##1##(1997-3#1)(1997-6#2)
fox##6##1##(1991-9#1)(1994-8#3)(1996-12#2)
foxes##4##1##(1995-3#1)(1996-12#2)(2008-12#1)
foxtail millet##4##2##(2008-10#4)
foxtail##7##1##(2008-10#7)
fr##3##1##(2008-10#2)(2008-11#1)
fra-1##2##1##(1993-6#2)
fractal aggregate of particles##2##4##(2008-2#2)
fractal aggregate##3##2##(2008-2#3)
fractal aggregates##2##2##(2008-2#1)(2008-3#1)
fractal clusters##3##2##(2008-2#1)(2012-2#2)
fractal design##2##2##(2008-10#2)
fractal dimension of##2##3##(2008-2#1)(2012-2#1)
fractal dimension##7##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
fractal geometry##4##2##(2008-8#2)(2011-2#2)
fractal patterns##2##2##(2008-3#2)
fractal##38##1##(2006-10#1)(2008-10#4)(2008-2#12)(2008-3#9)(2008-8#6)(2011-2#3)(2012-2#3)
fractal-based##2##1##(2008-10#1)(2009-12#1)
fractal-like##3##1##(2008-10#1)(2012-2#2)
fraction (66%)##2##2##(1992-11#1)(2008-8#1)
fraction 9##3##2##(1992-12#3)
fraction B##2##2##(1990-5#2)
fraction F1##4##2##(2008-11#4)
fraction also##2##2##(1990-5#1)(1992-3#1)
fraction and a##2##3##(2007-11#1)(2008-7#1)
fraction and the##11##3##(1991-2#1)(1991-8#1)(1993-2#2)(2008-10#2)(2008-2#2)(2008-6#1)(2008-9#1)(2009-3#1)
fraction and##34##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-2#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)
fraction are##2##2##(1994-8#1)(2012-12#1)
fraction as##2##2##(1991-9#1)(1994-11#1)
fraction at##6##2##(1992-6#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-5#1)
fraction bound##3##2##(1995-6#1)(2008-10#2)
fraction by##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
fraction caused##2##2##(1991-2#1)(2008-10#1)
fraction cells##3##2##(2012-1#2)(2012-12#1)
fraction containing##5##2##(1990-7#1)(1993-6#2)(1997-2#1)(2008-10#1)
fraction during##2##2##(1992-12#1)(2008-5#1)
fraction for##5##2##(1992-6#1)(2008-10#2)(2008-3#1)(2011-2#1)
fraction from an##2##3##(1996-2#1)(1997-7#1)
fraction from the##3##3##(1990-2#1)(1990-7#1)(1991-9#1)
fraction from##12##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-9#1)(1994-11#1)(1996-2#2)(1997-2#1)(1997-7#1)(2007-8#1)(2012-2#1)
fraction had##2##2##(1996-2#1)(1997-4#1)
fraction has been##2##3##(1997-4#1)(2008-9#1)
fraction in the##8##3##(1990-8#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#1)
fraction in##15##2##(1990-8#1)(1991-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-2#1)
fraction increased##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
fraction increases##2##2##(1990-2#1)(1991-5#1)
fraction may be##2##3##(1994-11#1)(2008-10#1)
fraction may##3##2##(1994-11#1)(2008-10#2)
fraction obtained by##2##3##(1995-5#1)(2008-10#1)
fraction obtained##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
fraction of 0##3##3##(2008-10#2)(2008-3#1)
fraction of a##6##3##(1995-9#1)(1997-6#1)(2007-11#1)(2008-2#1)(2008-3#2)
fraction of arsenic##2##3##(2008-10#2)
fraction of both##3##3##(1990-11#1)(2008-10#2)
fraction of cells##5##3##(1997-1#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-9#1)
fraction of cellular##2##3##(1992-5#1)(1996-12#1)
fraction of damage was##2##4##(1994-5#2)
fraction of each##2##3##(2008-10#1)(2008-3#1)
fraction of individuals##2##3##(2008-8#1)(2008-9#1)
fraction of metals##3##3##(2008-10#3)
fraction of organic##2##3##(1995-3#1)(2008-10#1)
fraction of patients with##2##4##(1995-3#1)(2008-3#1)
fraction of patients##3##3##(1995-2#1)(1995-3#1)(2008-3#1)
fraction of smoking mothers##2##4##(1991-11#2)
fraction of that##2##3##(1995-5#1)(2008-3#1)
fraction of the cells##3##4##(1992-3#1)(1995-2#1)(2008-11#1)
fraction of the total##4##4##(1990-4#1)(1992-2#1)(2008-7#2)
fraction of the##52##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
fraction of these##2##3##(2008-11#1)(2013-1#1)
fraction of total cells that##2##5##(2008-7#2)
fraction of total##4##3##(2008-10#2)(2008-7#2)
fraction of##216##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#3)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#5)(1996-4#1)(1996-5#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#48)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#11)(2008-5#4)(2008-6#6)(2008-7#18)(2008-8#7)(2008-9#3)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
fraction on##2##2##(2008-10#1)(2008-12#1)
fraction or##2##2##(2007-8#1)(2008-10#1)
fraction recovered##2##2##(1997-2#1)(2008-6#1)
fraction revealed##2##2##(1990-7#1)(2008-10#1)
fraction size##2##2##(1992-10#1)(2007-4#1)
fraction to##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
fraction was observed##2##3##(1995-2#1)(2008-10#1)
fraction was then##2##3##(1992-5#1)(2008-10#1)
fraction was##29##2##(1990-11#1)(1990-5#3)(1991-5#1)(1992-2#1)(1992-5#1)(1992-8#1)(1995-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-6#2)(2009-7#1)(2011-2#1)(2013-8#1)
fraction were##7##2##(1995-4#1)(2008-10#2)(2008-11#3)(2013-7#1)
fraction with a##3##3##(1992-11#1)(1995-2#1)(2008-10#1)
fraction with##10##2##(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#2)(1995-2#1)(1997-2#1)(2008-10#3)
fraction##638##1##(1990-11#8)(1990-2#6)(1990-4#1)(1990-5#11)(1990-6#1)(1990-7#6)(1990-8#6)(1990-9#2)(1991-11#5)(1991-12#9)(1991-2#4)(1991-5#6)(1991-7#1)(1991-8#2)(1991-9#5)(1992-10#2)(1992-11#6)(1992-12#7)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#6)(1993-9#3)(1994-11#14)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#3)(1995-11#4)(1995-2#9)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#6)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#12)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#3)(2006-4#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#141)(2008-11#35)(2008-12#7)(2008-2#16)(2008-3#29)(2008-4#2)(2008-5#7)(2008-6#14)(2008-7#29)(2008-8#12)(2008-9#7)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#2)(2011-1#3)(2011-2#15)(2011-3#2)(2012-1#4)(2012-12#4)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#4)(2013-8#8)
fraction) of##2##2##(2008-11#1)(2013-1#1)
fraction)##14##1##(1991-2#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
fractional Fourier transform and##2##4##(2008-2#2)
fractional Fourier transform is##2##4##(2008-2#1)(2008-3#1)
fractional Fourier transform##16##3##(2007-11#1)(2007-12#4)(2008-2#10)(2008-3#1)
fractional Fourier##20##2##(2007-11#1)(2007-12#6)(2008-2#11)(2008-3#2)
fractional Hilbert transform##6##3##(2008-2#5)(2008-3#1)
fractional Talbot effect##3##3##(2007-11#3)
fractional Talbot##4##2##(2007-11#4)
fractional correlation##7##2##(2008-2#4)(2008-3#3)
fractional crystallization of##2##3##(1996-2#2)
fractional derivative##2##2##(2008-3#2)
fractional distribution##2##2##(2008-10#2)
fractional factorial design##8##3##(2008-10#7)(2013-1#1)
fractional factorial##10##2##(2008-10#9)(2013-1#1)
fractional fiber shortening is##2##4##(2012-2#2)
fractional fiber shortening##4##3##(2012-2#4)
fractional fourier transform##2##3##(2008-2#2)
fractional fourier##3##2##(2008-2#2)(2008-3#1)
fractional frequency##2##2##(2007-12#1)(2008-3#1)
fractional interception##2##2##(2008-10#2)
fractional saturation##2##2##(1990-8#1)(1994-5#1)
fractional##114##1##(1990-4#1)(1990-8#1)(1992-3#1)(1993-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#2)(1996-4#1)(1997-8#1)(2007-11#7)(2007-12#7)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#31)(2008-3#25)(2008-7#3)(2009-12#1)(2009-4#1)(2010-3#1)(2011-1#2)(2012-2#4)(2012-3#1)(2013-1#1)
fractional-power##2##1##(2008-3#2)
fractionate##7##1##(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)
fractionated by##9##2##(1990-2#1)(1990-8#1)(1991-12#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-5#1)
fractionated doses of the same type of radiation##2##8##(2008-12#2)
fractionated doses of##3##3##(1993-9#1)(2008-12#2)
fractionated into##3##2##(1993-8#1)(2008-10#2)
fractionated on a##2##3##(1990-5#1)(1993-2#1)
fractionated on##9##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
fractionated radiotherapy##3##2##(1995-9#1)(1997-4#1)(2008-10#1)
fractionated with##2##2##(2008-10#1)(2008-12#1)
fractionated##51##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-10#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#2)
fractionation and##8##2##(1994-6#1)(2008-10#3)(2008-4#2)(2011-2#1)(2012-2#1)
fractionation channel is##2##3##(2008-10#2)
fractionation channel##3##2##(2008-10#3)
fractionation data##2##2##(2008-10#2)
fractionation in the##2##3##(2007-10#1)(2008-4#1)
fractionation in##9##2##(1995-6#1)(2007-10#1)(2008-10#6)(2008-4#1)
fractionation is##5##2##(2008-10#2)(2008-4#3)
fractionation method##2##2##(2008-10#1)(2008-11#1)
fractionation of arsenic in soils##2##5##(2008-10#2)
fractionation of arsenic in##3##4##(2008-10#3)
fractionation of arsenic##4##3##(2008-10#4)
fractionation of metals##2##3##(2008-10#2)
fractionation of the extract##2##4##(1992-3#1)(2008-11#1)
fractionation of the##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
fractionation of tissue culture cells##3##5##(2008-4#3)
fractionation of trace##2##3##(2008-10#2)
fractionation of##45##2##(1990-4#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-4#5)(2008-5#1)(2008-6#1)(2009-10#1)
fractionation on##2##2##(2008-10#1)(2008-5#1)
fractionation procedures##2##2##(2008-11#1)(2008-4#1)
fractionation process##4##2##(2008-6#2)(2008-7#2)
fractionation schedule##2##2##(2007-4#2)
fractionation schedules##2##2##(1992-10#1)(2007-4#1)
fractionation scheme##2##2##(2008-10#2)
fractionation studies##6##2##(1994-10#2)(1995-6#2)(2008-10#1)(2009-10#1)
fractionation techniques##4##2##(1995-6#1)(2008-4#3)
fractionation using##3##2##(2008-4#1)(2008-8#2)
fractionation with##2##2##(2008-10#2)
fractionation##146##1##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-5#1)(1992-10#5)(1992-3#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#4)(1995-9#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-4#4)(2008-1#1)(2008-10#61)(2008-11#10)(2008-2#1)(2008-4#17)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2009-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)
fractionations of##2##2##(1992-10#1)(2008-11#1)
fractionations##6##1##(1992-10#2)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)
fractions A and B##2##4##(1990-5#2)
fractions and their##2##3##(1994-11#1)(2012-2#1)
fractions and##13##2##(1993-11#1)(1993-6#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
fractions are##5##2##(1990-12#1)(1991-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
fractions at##3##2##(2008-10#2)(2008-7#1)
fractions by##5##2##(1993-11#1)(2008-10#4)
fractions collected from##2##3##(2008-10#1)(2012-2#1)
fractions contained##2##2##(1996-2#1)(2008-10#1)
fractions containing##5##2##(1990-8#1)(1993-6#1)(1997-3#1)(2008-10#2)
fractions demonstrated##2##2##(1996-2#1)(2008-11#1)
fractions enriched with##2##3##(1996-5#2)
fractions for##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
fractions from##7##2##(1990-5#1)(1991-5#1)(1996-2#1)(2008-10#3)(2008-11#1)
fractions had##3##2##(1990-11#1)(1996-2#1)(2008-11#1)
fractions in a##2##3##(1996-2#1)(2008-10#1)
fractions in the##4##3##(1991-12#1)(1997-2#1)(2007-7#1)(2008-3#1)
fractions in##15##2##(1991-12#2)(1996-2#2)(1996-5#1)(1997-2#2)(2007-7#1)(2008-10#5)(2008-3#1)(2012-2#1)
fractions increased##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
fractions obtained by##2##3##(2008-10#1)(2008-5#1)
fractions obtained##3##2##(1990-7#1)(2008-10#1)(2008-5#1)
fractions of all##2##3##(1993-8#1)(2008-2#1)
fractions of both##2##3##(1990-11#1)(1994-11#1)
fractions of high##2##3##(1990-5#1)(2008-10#1)
fractions of natural##2##3##(2008-10#1)(2011-2#1)
fractions of the##13##3##(1990-5#1)(1991-6#1)(1992-3#1)(1994-11#1)(1995-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
fractions of these##2##3##(1992-6#1)(2008-10#1)
fractions of##71##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#22)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
fractions on##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
fractions over##3##2##(2008-6#1)(2011-2#2)
fractions per week)##2##3##(1992-10#1)(2008-10#1)
fractions prepared##2##2##(1990-8#1)(1996-2#1)
fractions showed that the##3##4##(1995-8#1)(2008-10#2)
fractions showed##4##2##(1994-11#1)(1995-8#1)(2008-10#2)
fractions that##5##2##(1990-12#1)(2008-1#1)(2008-10#2)(2008-11#1)
fractions was##11##2##(1991-12#1)(1992-3#1)(1994-8#2)(1997-2#1)(2008-10#5)(2013-8#1)
fractions were also##2##3##(2008-7#1)(2013-8#1)
fractions were analyzed##2##3##(1990-7#1)(1992-10#1)
fractions were assayed for##2##4##(1990-2#1)(1990-5#1)
fractions were detected##2##3##(2008-5#1)(2010-2#1)
fractions were measured##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
fractions were used to##2##4##(2008-3#1)(2011-1#1)
fractions were used##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
fractions were##31##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-10#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#2)
fractions whereas##2##2##(1990-12#1)(1993-8#1)
fractions which##2##2##(1990-5#1)(1992-3#1)
fractions with a##2##3##(1992-3#1)(1993-8#1)
fractions with##11##2##(1992-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-11#1)(2010-2#1)
fractions##391##1##(1990-11#6)(1990-12#7)(1990-2#2)(1990-5#13)(1990-7#3)(1990-8#5)(1991-11#1)(1991-12#4)(1991-2#4)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#9)(1992-6#3)(1992-9#1)(1993-11#5)(1993-12#4)(1993-6#5)(1993-8#7)(1994-11#8)(1994-3#4)(1994-6#5)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#9)(1996-5#9)(1996-8#1)(1997-1#2)(1997-2#9)(1997-3#1)(1997-4#3)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#122)(2008-11#27)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#5)(2008-5#4)(2008-6#10)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#4)
fractions)##3##1##(1997-7#1)(2008-10#2)
fractions/##2##1##(2008-10#2)
fracture after##2##2##(2007-8#1)(2011-2#1)
fracture and a##2##3##(1991-11#1)(2009-3#1)
fracture and##20##2##(1991-11#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
fracture are##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
fracture as##2##2##(2009-1#1)(2013-1#1)
fracture associated with##3##3##(2009-3#1)(2010-5#1)(2012-12#1)
fracture at##2##2##(2008-11#1)(2013-1#1)
fracture but##2##2##(2008-12#1)(2009-4#1)
fracture by##2##2##(2012-2#1)(2013-1#1)
fracture cases##3##2##(2008-11#1)(2011-2#2)
fracture dislocation of##4##3##(2008-9#1)(2012-2#3)
fracture dislocation##5##2##(2008-9#1)(2012-2#4)
fracture displacement##2##2##(2008-9#2)
fracture energy##8##2##(1996-4#1)(2008-7#5)(2009-7#2)
fracture fixation##4##2##(2008-9#2)(2009-3#1)(2013-1#1)
fracture for##2##2##(2007-8#1)(2013-1#1)
fracture fragments##3##2##(1991-6#1)(2008-12#2)
fracture gap##3##2##(2009-3#2)(2012-2#1)
fracture healing##4##2##(2007-11#2)(2008-8#1)(2010-12#1)
fracture in the##4##3##(1991-11#1)(1996-4#1)(2008-8#1)(2012-12#1)
fracture in##14##2##(1990-9#1)(1991-11#1)(1991-8#1)(1993-2#1)(1996-4#1)(2007-11#3)(2008-12#1)(2008-6#1)(2008-8#2)(2012-12#1)(2013-1#1)
fracture increases the risk of##2##5##(1992-6#1)(2007-11#1)
fracture is the most##3##4##(1996-6#1)(2008-7#1)(2013-1#1)
fracture is##10##2##(1996-6#1)(2008-7#3)(2011-2#1)(2012-2#2)(2013-1#3)
fracture line orientation##2##3##(2013-1#2)
fracture line##4##2##(2011-2#1)(2013-1#3)
fracture occurs##2##2##(2007-11#2)
fracture of human##2##3##(2008-5#1)(2013-8#1)
fracture of humerus##2##3##(2007-11#1)(2010-11#1)
fracture of the distal radius##2##5##(2009-3#2)
fracture of the distal##4##4##(2008-9#1)(2009-3#2)(2013-1#1)
fracture of the femoral neck##2##5##(2006-10#2)
fracture of the humerus##2##4##(2008-7#1)(2013-1#1)
fracture of the proximal##2##4##(2007-11#1)(2009-1#1)
fracture of the##19##3##(2006-10#2)(2007-11#1)(2007-7#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#2)(2009-5#1)(2013-1#4)
fracture of##39##2##(1991-11#1)(2006-10#2)(2007-11#7)(2007-7#1)(2007-8#1)(2008-12#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
fracture or##7##2##(2007-11#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
fracture properties##2##2##(2008-7#2)
fracture reduction##2##2##(2007-8#1)(2012-2#1)
fracture resistance##5##2##(2011-2#1)(2013-1#4)
fracture risk assessment##2##3##(2008-6#1)(2012-12#1)
fracture risk##19##2##(1993-11#6)(2007-11#3)(2008-6#1)(2008-8#2)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#2)
fracture shaft of##2##3##(2008-7#1)(2012-2#1)
fracture site##3##2##(2008-9#2)(2011-2#1)
fracture strain##2##2##(2009-7#2)
fracture strength##3##2##(2008-2#1)(2012-2#2)
fracture threshold&quot##3##2##(1991-11#3)
fracture toughness of dental nanocomposites by##2##6##(2008-8#2)
fracture toughness of dental nanocomposites##3##5##(2008-8#3)
fracture toughness of##5##3##(2008-8#5)
fracture toughness##11##2##(2008-8#6)(2009-6#2)(2009-7#3)
fracture treatment##4##2##(2007-11#2)(2007-8#2)
fracture type##3##2##(2007-11#1)(2011-2#1)(2012-2#1)
fracture types##2##2##(2012-2#1)(2013-1#1)
fracture was##9##2##(1991-6#1)(2007-11#2)(2008-11#1)(2008-9#2)(2009-3#1)(2010-5#1)(2012-2#1)
fracture were##2##2##(2008-8#1)(2013-1#1)
fracture with##9##2##(2007-8#2)(2008-10#1)(2009-1#1)(2009-3#2)(2009-4#1)(2010-3#1)(2012-12#1)
fracture would##2##2##(2008-7#1)(2013-1#1)
fracture##406##1##(1990-9#1)(1991-11#11)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#14)(1993-2#1)(1996-4#3)(1996-6#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-11#46)(2007-12#1)(2007-7#3)(2007-8#20)(2008-10#4)(2008-11#9)(2008-12#13)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#28)(2008-8#33)(2008-9#18)(2009-1#8)(2009-11#1)(2009-2#1)(2009-3#17)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#13)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#4)(2011-1#3)(2011-2#27)(2012-12#9)(2012-2#31)(2012-3#2)(2013-1#42)(2013-8#3)
fracture)##3##1##(2010-12#1)(2011-2#1)(2013-1#1)
fracture-planes of membrane##2##3##(1992-6#2)
fracture]##2##1##(1992-5#1)(1997-4#1)
fractured bones##3##2##(2007-11#1)(2007-8#1)(2013-8#1)
fractured##18##1##(1990-3#1)(1991-11#2)(2007-11#4)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2013-1#3)(2013-8#1)
fractures after##2##2##(2012-12#1)(2012-2#1)
fractures and a##2##3##(2007-11#1)(2009-4#1)
fractures and osteoporosis##2##3##(2007-11#1)(2011-2#1)
fractures and the##3##3##(1993-11#1)(2007-8#1)(2009-3#1)
fractures and##26##2##(1991-11#1)(1993-11#3)(2007-11#7)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#2)(2009-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
fractures are a##3##3##(1993-11#1)(2012-12#1)(2013-1#1)
fractures are common injuries##3##4##(2008-9#1)(2010-12#1)(2013-1#1)
fractures are the##2##3##(2007-11#1)(2007-8#1)
fractures are##17##2##(1993-11#1)(2007-11#3)(2007-8#5)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
fractures associated with##2##3##(2007-11#1)(2008-8#1)
fractures at##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
fractures by##2##2##(2010-12#1)(2012-2#1)
fractures due to##2##3##(1991-11#1)(2007-11#1)
fractures during the##2##3##(2010-3#1)(2013-1#1)
fractures during##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
fractures had##2##2##(2007-8#1)(2012-2#1)
fractures have been##2##3##(2011-2#1)(2012-12#1)
fractures have##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
fractures in children##6##3##(2009-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
fractures in elderly##2##3##(1993-11#1)(2007-11#1)
fractures in osteoporosis##2##3##(2007-11#1)(2007-8#1)
fractures in patients##3##3##(1993-11#1)(2007-11#1)(2008-8#1)
fractures in the course of neoplastic disease##2##7##(2007-11#2)
fractures in the elderly##3##4##(2008-8#3)
fractures in the##14##3##(1991-11#1)(1993-11#1)(2007-11#5)(2008-11#1)(2008-8#3)(2013-1#2)(2013-8#1)
fractures in##55##2##(1990-2#1)(1991-11#1)(1991-6#1)(1993-11#5)(1995-11#1)(2007-11#13)(2007-12#2)(2007-8#1)(2008-11#2)(2008-8#4)(2009-3#7)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#1)
fractures is a##3##3##(1991-9#1)(2007-11#1)(2007-8#1)
fractures is##8##2##(1991-9#1)(2007-11#2)(2007-8#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
fractures of distal third##2##4##(2010-11#1)(2012-2#1)
fractures of distal##3##3##(2010-11#1)(2012-2#2)
fractures of long bones##5##4##(2007-11#2)(2007-2#1)(2007-8#1)(2008-7#1)
fractures of proximal humerus##2##4##(2007-8#2)
fractures of the calcaneus##2##4##(2007-11#2)
fractures of the distal radius##3##5##(2008-9#2)(2013-1#1)
fractures of the distal##8##4##(2007-8#3)(2008-9#2)(2012-2#2)(2013-1#1)
fractures of the femoral neck##4##5##(2007-11#1)(2007-8#1)(2009-3#2)
fractures of the femur##3##4##(2007-8#3)
fractures of the hip##4##4##(2007-8#2)(2008-4#1)(2013-1#1)
fractures of the humerus##2##4##(2007-11#1)(2008-7#1)
fractures of the lower limbs##2##5##(1991-11#1)(2007-11#1)
fractures of the lower##3##4##(1991-11#1)(2007-11#1)(2009-8#1)
fractures of the proximal epiphysis of the##2##7##(2007-11#2)
fractures of the proximal femur##2##5##(2007-11#2)
fractures of the proximal##5##4##(2007-11#5)
fractures of the spine##2##4##(2007-8#1)(2008-8#1)
fractures of the##46##3##(1991-11#3)(1997-4#1)(2007-11#13)(2007-8#11)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#2)(2009-8#1)(2012-2#3)(2013-1#3)(2013-8#2)
fractures of##65##2##(1991-11#3)(1997-4#1)(2007-11#16)(2007-2#1)(2007-8#17)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-3#2)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#5)(2013-1#3)(2013-8#3)
fractures on##3##2##(1996-4#1)(2011-2#1)(2013-1#1)
fractures or##3##2##(2007-8#2)(2008-7#1)
fractures resulting##2##2##(2007-11#1)(2012-2#1)
fractures treated by##3##3##(2007-8#1)(2008-12#1)(2008-9#1)
fractures treated##4##2##(2007-8#2)(2008-12#1)(2008-9#1)
fractures treatment##5##2##(2007-11#3)(2007-8#2)
fractures using##3##2##(2007-8#1)(2008-9#1)(2013-1#1)
fractures were fixed with##2##4##(2012-2#2)
fractures were included##2##3##(2011-2#1)(2012-2#1)
fractures were treated with##2##4##(2007-11#1)(2013-1#1)
fractures were treated##5##3##(2007-11#1)(2009-4#1)(2011-2#1)(2013-1#2)
fractures were##20##2##(1991-9#1)(2007-11#3)(2007-8#4)(2008-9#2)(2009-3#2)(2009-4#1)(2011-2#2)(2012-2#3)(2013-1#2)
fractures with the##2##3##(2007-11#1)(2009-3#1)
fractures with use of##2##4##(2007-11#2)
fractures with##12##2##(2007-11#3)(2007-8#3)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)
fractures within##2##2##(1991-9#1)(2007-11#1)
fractures without##2##2##(2007-8#1)(2008-8#1)
fractures##434##1##(1990-2#1)(1990-6#1)(1991-11#12)(1991-6#2)(1991-8#1)(1991-9#8)(1993-11#19)(1995-11#1)(1995-2#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-4#1)(1997-6#1)(2007-11#81)(2007-12#7)(2007-2#1)(2007-7#3)(2007-8#75)(2008-11#9)(2008-12#8)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#16)(2008-8#16)(2008-9#27)(2009-1#2)(2009-3#24)(2009-4#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#20)(2012-12#6)(2012-2#24)(2012-3#1)(2013-1#30)(2013-8#6)
fractures)##5##1##(2007-11#3)(2008-11#1)(2009-12#1)
fractures]##2##1##(2011-2#1)(2013-1#1)
fracturing##2##1##(1995-6#1)(2008-7#1)
fragariae to##2##2##(2008-10#2)
fragariae was##3##2##(2008-10#3)
fragariae##16##1##(2008-10#16)
fragariae&quot##5##1##(2008-10#5)
fragariae)##2##1##(2008-10#2)
fragile X syndrome and##2##4##(1997-8#1)(2011-2#1)
fragile X syndrome##7##3##(1997-8#1)(2007-2#1)(2008-4#3)(2011-2#2)
fragile X##10##2##(1991-2#1)(1997-8#1)(2007-2#1)(2008-4#5)(2011-2#2)
fragile and##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
fragile infants##4##2##(1991-3#1)(1992-3#1)(2008-10#2)
fragile site##3##2##(2009-5#1)(2011-2#2)
fragile sites in cancer##3##4##(2011-2#3)
fragile sites in##4##3##(2009-3#1)(2011-2#3)
fragile sites##12##2##(1997-5#3)(2009-3#1)(2011-2#8)
fragile##60##1##(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#2)(1994-11#1)(1995-1#1)(1995-3#3)(1996-3#1)(1997-5#3)(1997-8#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-4#5)(2008-5#3)(2008-7#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#12)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
fragilis##6##1##(1993-2#1)(1997-2#3)(2007-7#2)
fragility and##2##2##(2008-10#1)(2011-1#1)
fragility fractures and##2##3##(2008-4#1)(2008-8#1)
fragility fractures##6##2##(2008-4#2)(2008-8#4)
fragility of the##4##3##(1991-11#1)(1995-3#1)(2007-8#1)(2007-9#1)
fragility of##5##2##(1991-11#1)(1992-6#1)(1995-3#1)(2007-8#1)(2007-9#1)
fragility##23##1##(1991-11#1)(1991-12#1)(1992-6#1)(1993-11#1)(1995-3#2)(1997-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2011-1#1)(2012-12#2)
fragment (scFv)##4##2##(2008-10#2)(2008-8#1)(2009-2#1)
fragment 13##3##2##(1997-6#3)
fragment 32##3##2##(1997-6#3)
fragment analysis##2##2##(2008-10#2)
fragment and##6##2##(1990-11#1)(1990-12#1)(1991-10#1)(1993-12#1)(1993-9#1)(1997-6#1)
fragment as a probe##3##4##(1993-12#1)(1995-8#1)(2008-8#1)
fragment as probe##3##3##(1990-12#1)(1991-5#1)(2008-8#1)
fragment as##9##2##(1990-12#1)(1991-10#1)(1991-5#1)(1993-12#1)(1994-12#1)(1995-8#1)(2008-8#2)(2009-2#1)
fragment at the##2##3##(1995-2#1)(2013-1#1)
fragment between##2##2##(1997-6#1)(2008-12#1)
fragment by##5##2##(1991-5#1)(1991-6#1)(1995-2#1)(2008-3#1)(2008-8#1)
fragment can be##2##3##(1994-12#1)(2007-8#1)
fragment carrying the##2##3##(2008-10#2)
fragment carrying##3##2##(1991-6#1)(2008-10#2)
fragment confirmed##2##2##(2008-9#1)(2011-2#1)
fragment contained##3##2##(1991-6#1)(1996-8#1)(2008-8#1)
fragment containing the##10##3##(1993-12#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-2#1)
fragment containing##14##2##(1990-5#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
fragment contains one complete open reading frame##2##7##(2008-8#2)
fragment contains one complete##3##4##(2008-8#2)(2008-9#1)
fragment contains##6##2##(1990-11#1)(1991-9#1)(2008-8#3)(2008-9#1)
fragment encoding a##2##3##(1990-12#1)(1997-7#1)
fragment encoding the##2##3##(1994-8#1)(2008-10#1)
fragment encoding##5##2##(1990-12#1)(1994-8#1)(1997-7#2)(2008-10#1)
fragment formation##2##2##(1993-11#2)
fragment from DNA of##2##4##(2008-10#2)
fragment from a##3##3##(1991-2#1)(1994-12#1)(2008-10#1)
fragment from the C-terminus of beta-amyloid##2##6##(1992-6#2)
fragment from the left arm of chromosome##2##7##(1995-6#1)(1995-9#1)
fragment from the left arm of##3##6##(1995-6#1)(1995-9#1)(1996-3#1)
fragment from the##14##3##(1992-6#2)(1993-9#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-3#2)(1997-7#1)(2008-10#3)(2008-9#1)
fragment from##27##2##(1990-5#1)(1991-2#1)(1992-6#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-3#2)(1997-3#2)(1997-6#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-8#1)(2008-9#1)
fragment has##2##2##(1990-5#1)(2011-2#1)
fragment in the##3##3##(1997-4#1)(2008-10#1)(2013-7#1)
fragment in##12##2##(1994-12#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#4)(2013-1#1)(2013-7#1)
fragment into##2##2##(1993-8#1)(1997-2#1)
fragment ions##6##2##(1994-3#1)(2008-10#5)
fragment is##8##2##(1990-12#1)(1992-12#1)(1992-6#3)(1995-6#1)(1995-8#1)(1997-4#1)
fragment length polymorphism (AFLP) and##9##5##(2008-10#8)(2008-7#1)
fragment length polymorphism (AFLP) marker##2##5##(2008-10#2)
fragment length polymorphism (AFLP) markers were##2##6##(2008-10#2)
fragment length polymorphism (AFLP) markers##10##5##(2008-10#9)(2008-7#1)
fragment length polymorphism (AFLP)##44##4##(2008-10#42)(2008-7#2)
fragment length polymorphism (PCR-RFLP)##4##4##(1997-8#1)(2008-10#3)
fragment length polymorphism (RFLP) analysis of##6##6##(1995-12#1)(2008-10#5)
fragment length polymorphism (RFLP) analysis##11##5##(1995-12#1)(2008-10#8)(2008-5#1)(2012-3#1)
fragment length polymorphism (RFLP) markers were##4##6##(2008-10#3)(2008-9#1)
fragment length polymorphism (RFLP) markers##11##5##(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#7)(2008-9#1)
fragment length polymorphism (RFLP)##42##4##(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#31)(2008-4#1)(2008-5#1)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
fragment length polymorphism [RFLP]##2##4##(2008-10#2)
fragment length polymorphism among the##2##5##(2008-10#2)
fragment length polymorphism among##3##4##(1996-8#1)(2008-10#2)
fragment length polymorphism analyses of the##2##6##(2008-10#2)
fragment length polymorphism analyses##4##4##(2008-10#4)
fragment length polymorphism analysis of the##4##6##(2008-10#4)
fragment length polymorphism analysis of##9##5##(2008-10#9)
fragment length polymorphism analysis##22##4##(2008-10#19)(2008-11#1)(2008-4#1)(2008-5#1)
fragment length polymorphism and random amplified polymorphic DNA##2##8##(2008-10#2)
fragment length polymorphism and##6##4##(2008-10#6)
fragment length polymorphism linkage##3##4##(1996-10#1)(2008-10#2)
fragment length polymorphism loci##3##4##(2008-10#3)
fragment length polymorphism marker##6##4##(2008-10#6)
fragment length polymorphism markers##12##4##(2008-10#12)
fragment length polymorphism##196##3##(1990-3#1)(1992-3#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-8#1)(2008-10#168)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-6#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
fragment length polymorphisms (AFLPs)##4##4##(2008-10#3)(2008-9#1)
fragment length polymorphisms (RFLPs) and##3##5##(2008-10#2)(2008-5#1)
fragment length polymorphisms (RFLPs)##10##4##(2008-10#9)(2008-5#1)
fragment length polymorphisms with##2##4##(1996-12#1)(2008-10#1)
fragment length polymorphisms##39##3##(1991-8#1)(1994-11#1)(1996-12#2)(1996-5#1)(1997-5#1)(2008-10#26)(2008-12#1)(2008-5#2)(2008-9#1)(2011-1#3)
fragment length##238##2##(1990-3#1)(1991-8#1)(1992-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#3)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-8#1)(2008-10#195)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#4)(2009-6#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#2)
fragment lengths##5##2##(2008-10#4)(2008-7#1)
fragment located on the##2##4##(1995-9#1)(1997-3#1)
fragment located##3##2##(1995-9#1)(1997-3#1)(2008-8#1)
fragment of E##2##3##(2008-10#1)(2008-4#1)
fragment of LIR was##2##4##(2008-9#2)
fragment of Saccharomyces cerevisiae chromosome VII##2##6##(1996-6#1)(1997-3#1)
fragment of anti-nerve growth##2##4##(1991-2#2)
fragment of chromosome 13##2##4##(2013-1#2)
fragment of chromosome##3##3##(2008-10#1)(2013-1#2)
fragment of genomic DNA##3##4##(1990-5#1)(1992-3#1)(2008-10#1)
fragment of human parathyroid hormone##2##5##(1991-6#2)
fragment of human##3##3##(1991-6#2)(2008-5#1)
fragment of the##19##3##(1990-12#1)(1991-6#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-6#1)(2008-10#3)(2008-12#1)(2010-8#1)(2011-1#1)
fragment of##83##2##(1990-12#6)(1990-5#3)(1991-12#1)(1991-2#3)(1991-6#4)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1995-11#5)(1995-5#2)(1995-6#3)(1995-8#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#4)(1997-7#1)(2007-6#1)(2007-7#1)(2008-10#10)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
fragment patterns##2##2##(2008-1#1)(2008-10#1)
fragment revealed that##2##3##(1990-12#1)(1991-2#1)
fragment revealed##5##2##(1990-12#1)(1991-2#1)(1991-9#1)(1993-8#1)(2008-8#1)
fragment signals##2##2##(2008-10#2)
fragment size##5##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-8#1)
fragment sizes##2##2##(1991-9#1)(2008-10#1)
fragment that contained##2##3##(1990-5#1)(1991-5#1)
fragment that##9##2##(1990-5#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-6#1)(1997-2#1)(2008-5#1)(2013-1#2)
fragment to##7##2##(1992-3#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-8#3)
fragment used##2##2##(1991-5#1)(2008-10#1)
fragment was amplified from##2##4##(1995-8#1)(2008-10#1)
fragment was amplified##3##3##(1995-8#1)(2008-10#2)
fragment was cloned##4##3##(1995-8#1)(1997-4#1)(2008-8#2)
fragment was identified to be##2##5##(1993-8#2)
fragment was observed##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
fragment was##38##2##(1990-11#2)(1990-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#3)(1994-11#1)(1995-8#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#7)(2010-1#1)(2010-6#1)(2011-2#2)(2013-1#3)
fragment were##4##2##(1997-6#1)(2008-10#3)
fragment which begins at residue##2##5##(1995-6#2)
fragment which can##2##3##(2008-8#1)(2008-9#1)
fragment which##6##2##(1995-12#1)(1995-6#2)(1997-2#1)(2008-8#1)(2008-9#1)
fragment with##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
fragment within the##4##3##(2008-10#4)
fragment within##5##2##(2008-10#4)(2013-1#1)
fragment##721##1##(1990-11#5)(1990-12#13)(1990-3#2)(1990-5#12)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#6)(1991-6#10)(1991-8#3)(1991-9#8)(1992-11#1)(1992-12#3)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#8)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#10)(1993-9#2)(1994-11#7)(1994-12#10)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-11#8)(1995-12#2)(1995-2#7)(1995-3#2)(1995-5#8)(1995-6#9)(1995-8#8)(1995-9#3)(1996-10#2)(1996-12#6)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#4)(1996-8#4)(1997-1#1)(1997-2#8)(1997-3#10)(1997-4#11)(1997-5#1)(1997-6#13)(1997-7#7)(1997-8#3)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#272)(2008-11#6)(2008-12#8)(2008-2#8)(2008-3#4)(2008-4#5)(2008-5#13)(2008-7#10)(2008-8#44)(2008-9#17)(2009-11#1)(2009-2#2)(2009-6#2)(2010-1#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#1)
fragment)##6##1##(1990-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)
fragment-length##2##1##(2008-10#2)
fragmentary##9##1##(1990-6#1)(1992-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
fragmentation and the##3##3##(1992-9#1)(1995-3#1)(2012-3#1)
fragmentation and##12##2##(1992-9#1)(1993-8#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#2)
fragmentation during##2##2##(2008-10#1)(2009-5#1)
fragmentation in##6##2##(1993-8#1)(1995-2#1)(1995-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
fragmentation of DNA##3##3##(1991-12#1)(1992-3#1)(1994-10#1)
fragmentation of care and##2##4##(2012-3#1)(2013-8#1)
fragmentation of care##3##3##(2012-3#2)(2013-8#1)
fragmentation of the primary ozonides##2##5##(1996-5#2)
fragmentation of the##9##3##(1990-12#1)(1992-4#1)(1995-2#1)(1996-5#2)(2008-10#3)(2008-5#1)
fragmentation of##33##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-10#1)(1995-2#1)(1996-12#1)(1996-5#3)(1997-8#5)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#4)(2013-8#1)
fragmentation pattern##2##2##(1990-12#1)(1991-9#1)
fragmentation process and##2##3##(1990-4#1)(2008-7#1)
fragmentation to##3##2##(1991-9#1)(1995-8#1)(2008-10#1)
fragmentation typical of apoptosis##2##4##(1992-3#2)
fragmentation vectors##2##2##(1991-9#2)
fragmentation was##2##2##(1992-3#1)(1997-8#1)
fragmentation##128##1##(1990-12#2)(1990-4#1)(1991-12#2)(1991-3#1)(1991-9#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-8#1)(1992-9#4)(1993-3#1)(1993-8#7)(1994-10#2)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-8#1)(1996-12#3)(1996-5#4)(1997-4#2)(1997-8#7)(2007-12#1)(2008-1#7)(2008-10#11)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#10)(2013-1#2)(2013-8#2)
fragmentation)##2##1##(2008-4#1)(2011-2#1)
fragmented DNA##2##2##(1996-12#1)(1997-4#1)
fragmented and##6##2##(1993-8#1)(1997-3#1)(2008-10#1)(2008-8#2)(2013-1#1)
fragmented by##2##2##(1991-9#1)(1993-8#1)
fragmented cancer care##2##3##(2012-3#2)
fragmented landscapes##7##2##(1995-3#1)(2008-8#4)(2008-9#2)
fragmented systems##3##2##(2008-9#3)
fragmented##47##1##(1991-9#1)(1992-12#1)(1993-8#3)(1995-3#3)(1995-6#1)(1996-12#1)(1997-3#2)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#8)(2008-9#7)(2009-9#1)(2010-4#1)(2012-3#5)(2013-1#1)(2013-7#3)
fragments &lt##2##2##(2008-10#1)(2008-2#1)
fragments after##3##2##(1991-2#1)(1993-6#1)(2008-10#1)
fragments amplified by##3##3##(2008-10#2)(2008-5#1)
fragments amplified##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
fragments and##22##2##(1991-2#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-2#2)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-7#1)
fragments are##6##2##(1991-7#1)(1991-9#1)(1993-3#1)(1995-8#3)
fragments as##4##2##(1990-12#1)(1992-6#1)(1996-10#1)(2010-5#1)
fragments associated with##4##3##(1995-6#1)(2008-10#2)(2008-5#1)
fragments but##2##2##(1997-1#1)(2008-8#1)
fragments by##8##2##(1990-5#1)(1992-12#1)(1993-6#1)(1994-5#1)(2008-10#3)(2008-2#1)
fragments can be accurately sized based on relative electrophoretic mobility##2##10##(2008-2#1)(2008-4#1)
fragments can be##3##3##(2008-2#1)(2008-4#2)
fragments can##4##2##(2008-2#1)(2008-4#2)(2010-9#1)
fragments coding##2##2##(2008-5#1)(2008-8#1)
fragments comprising##2##2##(1990-5#1)(2008-10#1)
fragments contained##2##2##(1993-5#1)(2008-8#1)
fragments containing the##7##3##(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1995-5#2)(2008-10#1)
fragments containing##14##2##(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-5#1)(1995-5#2)(1996-10#1)(2008-10#2)(2008-5#2)(2008-8#2)
fragments could##4##2##(1993-8#1)(1995-11#1)(1997-2#1)(2008-9#1)
fragments derived from##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
fragments did not##3##3##(1990-5#1)(1992-3#1)(2008-8#1)
fragments encoding##3##2##(1997-4#2)(2008-6#1)
fragments for##3##2##(1992-7#1)(1993-6#1)(1997-4#1)
fragments from human##2##3##(1990-5#1)(1997-1#1)
fragments from the##8##3##(1992-3#1)(1993-2#2)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
fragments from##26##2##(1990-5#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1995-5#2)(1995-6#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-7#1)(2012-3#1)
fragments generated by##2##3##(1992-6#1)(2008-10#1)
fragments have been##2##3##(1995-12#1)(2008-8#1)
fragments in a##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
fragments in both##2##3##(1992-11#1)(1994-12#1)
fragments in the##6##3##(2008-10#4)(2008-3#1)(2013-7#1)
fragments in##25##2##(1992-11#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
fragments into##3##2##(1990-2#1)(1995-2#1)(1996-2#1)
fragments located##2##2##(2008-8#2)
fragments obtained from##2##3##(1990-5#1)(2008-10#1)
fragments obtained were##2##3##(1991-12#1)(2008-10#1)
fragments obtained##5##2##(1990-5#1)(1991-12#1)(1992-6#1)(2008-10#2)
fragments of DNA##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
fragments of PKC alpha##2##4##(1995-11#2)
fragments of PKC##3##3##(1995-11#2)(1995-2#1)
fragments of a##2##3##(1995-2#1)(2008-4#1)
fragments of all##2##3##(2008-12#1)(2008-2#1)
fragments of genes##2##3##(2008-7#1)(2013-8#1)
fragments of the##15##3##(1992-3#1)(1992-6#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-6#1)(2008-1#1)(2008-10#3)(2011-1#2)
fragments of this##2##3##(1992-4#1)(1993-6#1)
fragments of##85##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-5#1)(1993-6#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1996-2#3)(1996-5#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#4)
fragments on the surface of##2##5##(1993-8#1)(2012-2#1)
fragments on the##4##3##(1993-5#1)(1993-8#1)(2012-2#1)(2013-1#1)
fragments on##6##2##(1993-5#1)(1993-8#1)(1995-12#1)(1996-12#1)(2012-2#1)(2013-1#1)
fragments or##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
fragments originating from##2##3##(2008-10#2)
fragments present##2##2##(1990-12#1)(1991-12#1)
fragments produced by##2##3##(1990-5#1)(1992-12#1)
fragments produced##3##2##(1990-5#1)(1990-7#1)(1992-12#1)
fragments showed that##2##3##(1993-11#1)(2008-10#1)
fragments showed##3##2##(1993-11#1)(1993-6#1)(2008-10#1)
fragments specific##2##2##(2008-10#2)
fragments that##5##2##(1991-5#1)(1992-12#1)(1992-9#1)(2008-10#1)(2008-2#1)
fragments thereof##2##2##(1992-12#1)(1992-3#1)
fragments to##10##2##(1992-6#1)(1993-11#1)(1995-5#1)(1996-6#1)(2008-10#2)(2008-4#2)(2008-7#1)(2013-1#1)
fragments was determined by##2##4##(1990-7#2)
fragments was##7##2##(1990-7#2)(1992-3#1)(1994-8#2)(2008-9#1)(2012-2#1)
fragments were amplified##2##3##(2008-8#2)
fragments were analyzed##2##3##(1993-8#1)(1995-2#1)
fragments were cloned and sequenced##2##5##(2008-10#1)(2008-8#1)
fragments were cloned and##3##4##(2008-10#2)(2008-8#1)
fragments were cloned##6##3##(2008-10#3)(2008-8#2)(2010-6#1)
fragments were detected##2##3##(1995-6#1)(2010-5#1)
fragments were fixed##2##3##(2008-7#2)
fragments were sequenced##2##3##(1992-3#1)(2008-8#1)
fragments were##38##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#2)(1995-2#1)(1995-6#2)(1996-5#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#12)(2008-9#3)(2010-5#1)(2010-6#1)
fragments which##4##2##(1993-8#1)(1995-12#1)(2008-10#1)(2008-6#1)
fragments with molecular##2##3##(1992-12#1)(1993-8#1)
fragments with##13##2##(1991-12#1)(1992-12#1)(1993-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
fragments within##2##2##(1992-12#1)(2011-2#1)
fragments##518##1##(1990-11#3)(1990-12#10)(1990-2#1)(1990-5#10)(1990-6#1)(1990-7#5)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#10)(1992-4#1)(1992-6#14)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-2#5)(1993-3#1)(1993-5#4)(1993-6#9)(1993-8#9)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#4)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#8)(1995-11#6)(1995-12#5)(1995-2#7)(1995-3#2)(1995-5#7)(1995-6#15)(1995-8#4)(1996-10#2)(1996-12#2)(1996-2#7)(1996-5#2)(1996-6#2)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#5)(2008-10#97)(2008-11#6)(2008-12#3)(2008-2#19)(2008-3#6)(2008-4#16)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#42)(2008-9#11)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#8)(2013-8#5)
fragrance components##2##2##(2008-5#2)
fragrance compounds in##2##3##(2008-5#2)
fragrance compounds##3##2##(2008-5#3)
fragrance evaporation##2##2##(2008-5#2)
fragrance ingredient##2##2##(2008-5#2)
fragrance materials##3##2##(2008-5#3)
fragrance molecules##2##2##(2008-5#2)
fragrance##26##1##(2007-7#1)(2008-5#25)
fragrances and##2##2##(2008-5#2)
fragrances##5##1##(2008-5#5)
fragrant##2##1##(1996-2#1)(2008-5#1)
frail elderly##16##2##(1991-12#2)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#5)(1995-2#2)
frail patient##2##2##(1992-3#1)(2013-8#1)
frail##24##1##(1991-12#2)(1992-3#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#2)(1995-1#7)(1995-2#2)(1996-12#1)(2010-6#1)(2013-8#1)
frailty##5##1##(1995-2#1)(1997-7#1)(2008-7#1)(2010-10#2)
frame (ORF) encoding##6##3##(1993-12#1)(1993-6#1)(1994-11#1)(1995-6#1)(1997-7#1)(2010-5#1)
frame (ORF)##39##2##(1990-11#2)(1991-9#1)(1993-12#4)(1993-6#1)(1994-11#1)(1994-12#6)(1995-6#1)(1995-8#4)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2008-10#4)(2008-7#2)(2008-8#3)(2008-9#1)(2010-5#1)(2013-1#1)
frame analysis##2##2##(2007-12#1)(2008-8#1)
frame and##5##2##(1990-11#1)(1991-2#1)(1992-3#1)(1996-3#1)(2012-3#1)
frame as##2##2##(2008-4#1)(2008-9#1)
frame by frame##2##3##(1993-3#1)(2007-12#1)
frame by##3##2##(1993-3#1)(1995-9#1)(2007-12#1)
frame error##2##2##(1995-1#2)
frame for the##2##3##(1996-1#1)(1997-2#1)
frame for##5##2##(1996-1#2)(1997-2#2)(2008-7#1)
frame in the##2##3##(1994-11#1)(1995-8#1)
frame in##4##2##(1994-11#1)(1995-8#1)(1995-9#1)(2010-1#1)
frame into##2##2##(1995-8#1)(1997-3#1)
frame is##7##2##(1993-6#1)(1995-8#1)(1996-10#1)(2008-2#2)(2008-6#1)(2011-1#1)
frame of reference for the##2##5##(1990-12#1)(1995-3#1)
frame of reference to##2##4##(1992-2#1)(1996-1#1)
frame of reference##8##3##(1990-12#1)(1990-2#1)(1992-2#1)(1995-3#2)(1996-1#1)(2008-10#1)(2008-7#1)
frame of the##10##3##(1990-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-3#3)
frame of##67##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#4)(1991-1#1)(1991-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-6#2)(1997-9#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#2)
frame on##2##2##(2008-10#1)(2008-11#1)
frame rate##3##2##(2008-3#3)
frame rates##6##2##(2008-11#1)(2008-3#2)(2009-6#2)(2012-2#1)
frame shifts##2##2##(1993-2#1)(2008-4#1)
frame to##4##2##(1996-3#1)(2008-3#1)(2008-7#1)(2011-1#1)
frame was##11##2##(1990-12#1)(1992-9#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#2)(2011-2#1)(2013-1#2)
frame with##5##2##(1992-12#1)(1993-11#1)(1995-1#1)(2008-10#1)(2009-5#1)
frame##289##1##(1990-11#7)(1990-12#3)(1990-2#2)(1990-5#6)(1990-7#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#3)(1993-6#5)(1993-8#1)(1994-11#5)(1994-12#11)(1994-6#4)(1994-8#2)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#5)(1995-8#12)(1995-9#3)(1996-1#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-2#7)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#3)(1997-9#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#27)(2008-11#3)(2008-2#5)(2008-3#20)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#12)(2008-9#6)(2009-5#2)(2009-6#2)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-2#7)(2012-3#5)(2013-1#7)(2013-8#2)
frame-shifting##2##1##(1990-7#1)(1992-8#1)
framed as##2##2##(2010-12#1)(2012-3#1)
framed in##2##2##(2008-1#1)(2011-1#1)
framed##8##1##(1990-7#1)(1995-1#1)(2008-1#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#1)
frameless stereotaxy##2##2##(2008-7#1)(2008-9#1)
frameless##6##1##(2006-12#1)(2007-11#1)(2008-7#3)(2008-9#1)
frames 6##2##2##(2011-1#2)
frames and##5##2##(1996-3#1)(1997-3#2)(2008-2#1)(2012-3#1)
frames are##2##2##(1990-5#1)(2011-1#1)
frames by##2##2##(2008-11#1)(2008-2#1)
frames for##3##2##(1993-1#1)(1997-3#1)(2008-3#1)
frames in##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
frames of the##2##3##(2008-10#1)(2008-2#1)
frames of##7##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2012-3#1)
frames per second##3##3##(2007-11#1)(2008-2#1)(2008-6#1)
frames to##2##2##(2008-2#1)(2008-8#1)
frames were also##2##3##(1997-3#1)(2011-1#1)
frames were##6##2##(1997-3#1)(2011-1#5)
frames with##2##2##(2008-2#1)(2012-3#1)
frames##148##1##(1990-11#2)(1990-5#2)(1991-7#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#4)(1995-1#1)(1995-12#2)(1995-6#4)(1995-8#1)(1995-9#6)(1996-12#2)(1996-3#8)(1996-6#8)(1997-3#14)(1997-6#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-10#24)(2008-11#4)(2008-2#14)(2008-3#12)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2011-1#10)(2012-2#1)(2012-3#3)
frames/s##2##1##(2007-12#1)(2008-3#1)
frameshift mutation##2##2##(1993-9#1)(1997-4#1)
frameshift mutations##3##2##(1993-8#1)(2008-4#1)(2012-3#1)
frameshift##9##1##(1993-6#1)(1993-8#1)(1993-9#1)(1997-4#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
frameshifting in##2##2##(1995-9#2)
frameshifting##6##1##(1995-9#6)
framework allows##2##2##(1994-2#1)(2008-7#1)
framework and##12##2##(1992-3#1)(1993-2#2)(1997-2#1)(2007-12#1)(2008-12#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#3)
framework as##4##2##(1990-8#1)(1992-12#1)(2008-11#1)(2009-6#1)
framework based on##2##3##(2008-6#1)(2012-3#1)
framework can##4##2##(1997-2#1)(2008-8#1)(2010-6#1)(2013-8#1)
framework for a##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
framework for achieving##2##3##(2008-9#1)(2012-12#1)
framework for analysis##2##3##(1993-1#1)(2008-11#1)
framework for assessing##2##3##(2008-11#1)(2008-7#1)
framework for describing##3##3##(2008-7#2)(2009-5#1)
framework for developing##3##3##(1993-12#1)(1997-1#1)(2008-12#1)
framework for exploring##2##3##(2009-5#1)(2011-2#1)
framework for future##2##3##(1994-11#1)(2011-2#1)
framework for implementing##2##3##(1992-2#1)(2010-8#1)
framework for studying the##2##4##(2008-11#1)(2008-8#1)
framework for studying##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
framework for systematically##2##3##(1991-1#1)(2008-2#1)
framework for the development of##2##5##(1993-12#1)(1994-2#1)
framework for the##20##3##(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1996-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-6#1)(2012-12#2)(2013-1#1)
framework for understanding the##2##4##(2007-4#1)(2007-8#1)
framework for understanding##4##3##(2007-4#1)(2007-8#1)(2008-12#1)(2010-4#1)
framework for##136##2##(1991-1#1)(1991-12#2)(1992-12#1)(1992-2#3)(1992-6#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#13)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#5)
framework from##2##2##(2008-1#1)(2012-1#1)
framework in the##2##3##(1993-2#1)(2008-4#1)
framework in which##2##3##(1994-3#1)(2012-2#1)
framework in##12##2##(1992-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
framework is a##2##3##(2008-9#1)(2009-12#1)
framework is an##2##3##(2007-12#1)(2013-1#1)
framework is proposed##2##3##(1994-3#1)(2008-4#1)
framework is##16##2##(1992-12#1)(1993-12#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-9#1)(2013-1#2)
framework of the##23##3##(1990-6#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2011-2#1)(2013-1#1)
framework of##78##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
framework originally##2##2##(2011-1#1)(2012-12#1)
framework presented##2##2##(1996-2#1)(2008-7#1)
framework provides##2##2##(2008-7#1)(2013-1#1)
framework that can be used to##3##6##(2008-4#1)(2008-8#1)(2012-12#1)
framework that can be##4##4##(1996-1#1)(2008-4#1)(2008-8#1)(2012-12#1)
framework that can##5##3##(1996-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-12#1)
framework that##15##2##(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#2)(2012-12#1)(2013-1#1)
framework to assess##2##3##(2007-9#1)(2008-7#1)
framework to assist##2##3##(2008-10#1)(2008-12#1)
framework to evaluate the##2##4##(2008-8#1)(2011-2#1)
framework to explain the##2##4##(2010-3#1)(2012-2#1)
framework to explain##3##3##(2010-3#1)(2012-12#1)(2012-2#1)
framework to guide the##3##4##(2008-11#3)
framework to guide##4##3##(2008-11#3)(2012-3#1)
framework to integrate##2##3##(2008-12#1)(2008-7#1)
framework to##38##2##(1992-3#2)(1995-2#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
framework under which##2##3##(2009-9#1)(2012-2#1)
framework using##2##2##(2010-8#1)(2013-7#1)
framework was developed to##2##4##(1992-9#1)(2012-2#1)
framework was developed##3##3##(1992-9#1)(2008-10#1)(2012-2#1)
framework was##8##2##(1992-9#1)(1994-3#1)(2007-12#1)(2008-10#1)(2010-10#1)(2012-2#3)
framework with which to##3##4##(1994-3#1)(2008-5#1)(2013-8#1)
framework with which##4##3##(1992-2#1)(1994-3#1)(2008-5#1)(2013-8#1)
framework with##5##2##(1992-2#1)(1994-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
framework within which to##2##4##(2008-7#1)(2012-12#1)
framework within which##4##3##(1993-2#1)(1994-2#1)(2008-7#1)(2012-12#1)
framework##485##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#3)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#4)(1992-2#4)(1992-3#8)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#5)(1993-3#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#9)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#7)(1995-5#3)(1995-6#3)(1996-1#3)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#5)(1997-2#5)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#19)(2008-11#25)(2008-12#18)(2008-2#8)(2008-3#16)(2008-4#11)(2008-5#4)(2008-6#10)(2008-7#24)(2008-8#20)(2008-9#5)(2009-1#4)(2009-11#3)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#3)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#11)(2011-2#9)(2012-1#3)(2012-12#17)(2012-2#20)(2012-3#18)(2013-1#25)(2013-7#1)(2013-8#8)
frameworks for##3##2##(1996-2#1)(2008-9#1)(2009-7#1)
frameworks in##2##2##(1996-2#1)(2007-12#1)
frameworks of##3##2##(1992-11#1)(1996-12#1)(2009-6#1)
frameworks that##2##2##(2008-7#1)(2010-12#1)
frameworks##35##1##(1992-11#2)(1996-12#1)(1996-2#2)(1996-6#1)(2007-12#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#2)(2009-6#2)(2009-7#2)(2010-12#6)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
framing camera##2##2##(2008-2#1)(2008-3#1)
framing of##4##2##(2008-1#1)(2008-11#1)(2008-4#2)
framing##10##1##(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2010-2#1)
franciscana##6##1##(1994-8#1)(2008-5#2)(2008-8#1)(2013-1#2)
francophone##2##1##(1991-3#1)(1996-2#1)
frank##6##1##(1992-3#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#1)
frankfurters##3##1##(2008-10#1)(2010-4#2)
françai##4##1##(2008-10#4)
frass##2##1##(2008-10#1)(2013-8#1)
fraterculus##3##1##(2008-6#3)
fraud alerts##2##2##(1993-12#1)(1994-2#1)
fraud and abuse##14##3##(1991-1#3)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-2#1)(2007-9#1)
fraud and##16##2##(1991-1#3)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-2#1)(1996-12#1)(2007-9#1)
fraud prevention##2##2##(1994-2#2)
fraud##39##1##(1991-1#3)(1991-12#2)(1991-2#3)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#6)(1993-2#2)(1993-3#2)(1994-2#8)(1995-12#1)(1996-12#3)(1996-5#1)(1997-3#1)(2007-9#1)(2009-11#1)(2009-6#1)
fraudulent##4##1##(1992-2#1)(1995-12#1)(1996-12#2)
fraught with##8##2##(1994-2#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-11#1)
fraxini##3##1##(2008-10#3)
freckling##2##1##(1991-3#1)(2012-3#1)
free ADP##5##2##(1992-3#3)(1994-8#2)
free Ca(2+) concentration##2##3##(2008-11#1)(2008-9#1)
free Ca(2+)##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)
free Ca2+ concentration via##2##4##(1993-12#1)(1995-5#1)
free Ca2+ concentration##9##3##(1990-12#1)(1990-2#1)(1990-7#1)(1993-12#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)
free Ca2+##17##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-7#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1997-1#1)(2008-9#1)
free Cd2+ concentration##2##3##(1994-8#2)
free Cd2+##3##2##(1994-8#3)
free DAPI##5##2##(2008-2#5)
free FA##2##2##(2009-3#2)
free Mg2+ concentration##2##3##(1990-7#1)(1992-3#1)
free Mg2+ or ADP is required##2##6##(1992-3#2)
free Mg2+##9##2##(1990-7#4)(1992-3#4)(1994-6#1)
free N-acetylneuraminic acid##2##3##(1995-12#2)
free NA##4##2##(1997-7#4)
free NIR##2##2##(2012-2#2)
free OH##2##2##(2007-12#2)
free T(4)##2##2##(2008-4#1)(2008-7#1)
free T3##3##2##(2008-7#1)(2011-1#1)(2012-3#1)
free T4 levels##3##3##(1993-12#3)
free T4 measurements##2##3##(1993-12#2)
free T4##14##2##(1993-12#9)(1994-6#2)(2008-6#1)(2008-7#1)(2012-3#1)
free Zn##2##2##(2012-12#1)(2013-7#1)
free access to the##2##4##(1992-12#1)(2010-2#1)
free access to##4##3##(1992-12#1)(2008-11#1)(2010-2#1)(2012-12#1)
free access##5##2##(1992-12#1)(2008-11#1)(2010-2#1)(2012-12#2)
free acid forms of##2##4##(1992-12#1)(2008-10#1)
free acid##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
free acids##2##2##(1994-8#1)(1995-5#1)
free air##4##2##(1993-3#1)(1993-6#1)(2010-4#1)(2011-2#1)
free amino acid content##2##4##(2008-12#1)(2008-5#1)
free amino acid##4##3##(1990-12#1)(2008-12#1)(2008-5#2)
free amino acids##8##3##(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2010-6#1)
free amino##15##2##(1990-12#1)(1990-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#2)(2010-6#1)
free and DOM-bound##2##3##(2008-11#2)
free and conjugated bile acids in serum##2##7##(1993-2#2)
free and conjugated##3##3##(1993-2#2)(2008-10#1)
free and covalently bound lipids##2##5##(2008-5#2)
free and esterified cholesterol##2##4##(1990-7#2)
free and immobilized##3##3##(2008-6#2)(2008-7#1)
free and protein-bound Gla##2##4##(1991-12#2)
free and sulphate conjugated##3##4##(1997-7#3)
free and sulphate##5##3##(1997-7#5)
free and total##9##3##(1991-2#1)(2008-10#4)(2008-5#1)(2008-7#3)
free and##55##2##(1990-12#1)(1990-7#2)(1991-12#2)(1991-2#1)(1992-6#1)(1993-2#2)(1994-3#1)(1996-3#1)(1997-3#1)(1997-7#5)(2007-8#1)(2008-10#16)(2008-11#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#6)(2008-9#1)(2009-7#1)(2013-1#1)
free androgen index##2##3##(1990-11#2)
free available chlorine##3##3##(2008-10#3)
free available##6##2##(2008-10#6)
free base##2##2##(2008-10#1)(2009-12#1)
free binding##2##2##(2008-10#1)(2012-2#1)
free bisphenol S##2##3##(2013-1#2)
free caged activity##2##3##(2009-3#2)
free calcium concentration ([Ca2+]i)##2##4##(1992-6#2)
free calcium concentration in##3##4##(1992-6#1)(1993-3#1)(2008-10#1)
free calcium concentration##7##3##(1991-12#1)(1992-6#3)(1993-3#1)(2008-10#1)(2008-7#1)
free calcium in##3##3##(1992-6#1)(1993-12#1)(1995-11#1)
free calcium##20##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#5)(1993-11#2)(1993-12#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-7#1)
free carboxyl groups##2##3##(1992-12#1)(2008-10#1)
free carboxyl##4##2##(1992-12#1)(2008-10#2)(2008-5#1)
free carnitine##3##2##(1991-2#1)(1995-12#1)(2008-7#1)
free carrier##2##2##(1990-11#1)(2007-12#1)
free carriers##4##2##(2007-12#1)(2008-3#3)
free catecholamines##3##2##(1990-8#2)(2011-2#1)
free cells##2##2##(2008-6#1)(2008-7#1)
free ceramides##2##2##(2008-5#2)
free chains are##2##3##(1991-9#2)
free chains##7##2##(1991-9#7)
free chlorine##5##2##(2008-10#5)
free choice##4##2##(1992-12#1)(2008-12#3)
free cholesterol and##3##3##(1990-8#2)(1991-12#1)
free cholesterol##10##2##(1990-8#5)(1991-12#1)(1991-2#1)(2008-10#2)(2008-7#1)
free chromatin from cultured##2##4##(2008-4#2)
free chromatin##4##2##(2008-4#4)
free conditions##4##2##(1990-5#1)(1992-11#1)(2008-11#2)
free consent to##2##3##(2011-2#2)
free consent##3##2##(2011-2#3)
free copper##2##2##(1997-8#1)(2008-10#1)
free cyanide##4##2##(2008-10#4)
free cytosolic##2##2##(1990-5#1)(1994-12#1)
free diffusion##2##2##(2008-11#1)(2008-8#1)
free disc##2##2##(2011-2#2)
free electron##3##2##(1993-8#1)(2010-8#1)(2012-2#1)
free energies of dimer-tetramer assembly##3##5##(1990-8#3)
free energies of linkage##2##4##(1990-8#2)
free energies of##10##3##(1990-8#6)(1997-2#1)(2008-10#1)(2009-9#1)(2010-2#1)
free energies##17##2##(1990-8#7)(1997-2#3)(2008-10#1)(2009-9#1)(2010-2#5)
free energy (E) of##2##4##(2008-10#2)
free energy contribution##3##3##(2008-4#1)(2013-1#2)
free energy contributions##4##3##(2013-1#4)
free energy levels##2##3##(1990-8#1)(1997-2#1)
free energy of binding##3##4##(1990-11#1)(1992-6#1)(2013-7#1)
free energy of stabilization##2##4##(1990-8#1)(1995-5#1)
free energy of the##2##4##(1992-6#1)(2008-10#1)
free energy of unfolding##3##4##(1991-6#1)(1993-11#1)(1995-5#1)
free energy of##16##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-3#2)(1992-6#2)(1993-11#1)(1995-2#1)(1995-5#2)(1996-6#1)(1997-2#1)(2008-10#1)(2013-7#1)
free energy on##2##3##(1997-2#2)
free energy value##4##3##(1990-8#3)(2008-10#1)
free energy##65##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#9)(1991-6#1)(1992-3#2)(1992-6#3)(1993-11#2)(1995-2#2)(1995-5#2)(1996-6#1)(1997-2#6)(2008-10#12)(2008-2#1)(2008-4#3)(2008-5#1)(2009-11#1)(2010-2#4)(2010-7#3)(2011-1#1)(2012-2#1)(2013-1#6)(2013-7#1)
free enzyme was##2##3##(2008-6#1)(2008-7#1)
free enzyme##7##2##(1993-8#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
free fall##2##2##(2008-2#2)
free fat transplantation##2##3##(1997-3#2)
free fat##4##2##(1997-3#3)(2011-2#1)
free fatty acid and##2##4##(2008-4#1)(2010-11#1)
free fatty acid##10##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#1)
free fatty acids##16##3##(1990-7#1)(1990-8#3)(1992-12#1)(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)
free fatty##26##2##(1990-7#1)(1990-8#3)(1992-12#1)(1994-5#1)(1994-8#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2012-2#1)
free filamentous mycelia##2##3##(2008-7#2)
free flap##11##2##(2007-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#4)(2012-12#2)
free flap)##2##2##(1993-11#1)(2012-3#1)
free flaps and##3##3##(2007-12#1)(2011-2#2)
free flaps##10##2##(2007-12#1)(2008-4#2)(2011-2#3)(2012-12#2)(2012-2#2)
free floating##2##2##(2007-8#1)(2008-7#1)
free flow##2##2##(1996-11#1)(2007-8#1)
free forearm flap##2##3##(1991-4#2)
free form##2##2##(2008-10#2)
free forms##2##2##(2008-10#1)(2010-11#1)
free from any##5##3##(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
free from interference##5##3##(2008-1#1)(2008-10#4)
free from interferences##3##3##(2008-10#3)
free from the interference of##4##5##(2008-10#4)
free from the measurement-volume effect##2##5##(2008-3#2)
free from the##9##3##(1990-12#1)(2007-12#1)(2008-10#4)(2008-3#2)(2010-11#1)
free from##56##2##(1990-12#1)(1990-6#1)(1991-12#2)(1992-1#1)(1992-6#1)(1994-3#1)(1997-2#1)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
free glucose was##2##3##(1995-6#1)(2008-10#1)
free glucose##4##2##(1995-6#1)(2008-10#2)(2008-11#1)
free graft##2##2##(1990-3#1)(2008-10#1)
free hemoglobin##2##2##(1994-11#1)(2013-1#1)
free hydroxy##2##2##(1996-5#1)(2008-10#1)
free in solution##2##3##(2008-10#2)
free in the##3##3##(1993-6#1)(1997-3#1)(2007-12#1)
free in##7##2##(1993-6#1)(1997-3#1)(2007-12#1)(2008-10#4)
free interval##2##2##(1990-10#1)(2013-1#1)
free iodine##2##2##(2008-10#2)
free ions##2##2##(2008-10#1)(2008-4#1)
free iron##4##2##(1996-2#1)(2008-10#3)
free ligand and##2##3##(1993-11#1)(2008-10#1)
free ligand##4##2##(1993-11#1)(2008-10#3)
free magnesium concentration##5##3##(1993-11#1)(2008-7#4)
free magnesium##9##2##(1990-7#1)(1993-11#2)(2008-7#6)
free market##5##2##(1991-3#1)(1994-2#1)(1995-1#1)(1997-1#1)(2008-7#1)
free medium##9##2##(2008-11#8)(2009-6#1)
free metal ions##2##3##(2008-10#2)
free metal##6##2##(1994-8#1)(2008-10#5)
free moisture##6##2##(1997-6#3)(2008-10#3)
free molecules##2##2##(2007-12#1)(2008-9#1)
free muscle##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
free of any MS criteria##2##5##(2013-1#2)
free of any##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
free of complications##2##3##(1992-9#1)(2011-2#1)
free of contaminating##2##3##(1993-8#1)(2008-4#1)
free of disease at##3##4##(1993-11#2)(2009-1#1)
free of disease##8##3##(1991-2#1)(1993-11#2)(2008-6#2)(2009-1#1)(2010-3#1)(2013-7#1)
free of pain##2##3##(2011-2#2)
free of serum##2##3##(2008-11#1)(2008-7#1)
free of the disease##2##4##(2010-11#1)(2011-2#1)
free of the pathogen##2##4##(2008-10#2)
free of the##8##3##(1996-12#1)(2007-8#1)(2008-10#4)(2010-11#1)(2011-2#1)
free of##99##2##(1990-12#3)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#8)(2012-2#6)(2012-6#1)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#1)
free on##2##2##(2008-10#1)(2010-5#1)
free or##2##2##(1996-12#1)(2008-5#1)
free oxidized##3##2##(1995-12#1)(2009-10#2)
free parameters##8##2##(1997-2#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2012-2#1)
free phosphate##2##2##(2008-10#2)
free polar##2##2##(2008-5#2)
free radical damage##2##3##(1994-6#1)(2008-10#1)
free radical formation##3##3##(1995-3#1)(2008-11#1)(2013-8#1)
free radical generating##2##3##(1994-6#1)(2008-5#1)
free radical generation and to##2##5##(1994-11#1)(2009-9#1)
free radical generation and##3##4##(1994-11#1)(2009-5#1)(2009-9#1)
free radical generation in##2##4##(1994-11#1)(2008-11#1)
free radical generation##8##3##(1991-9#1)(1994-11#2)(1996-2#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-9#1)
free radical processes##2##3##(2011-1#2)
free radical production##3##3##(1990-12#1)(2008-5#2)
free radical reaction and lipid peroxidation##2##6##(1996-2#2)
free radical reaction##5##3##(1996-2#4)(2007-11#1)
free radical reactions##2##3##(1996-5#1)(2008-10#1)
free radical scavenger##15##3##(1991-9#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-8#3)(2008-11#1)(2008-5#2)(2009-8#1)(2012-2#2)
free radical scavengers##11##3##(1991-9#3)(1994-6#1)(1996-2#1)(2008-11#1)(2008-5#3)(2011-2#2)
free radical scavenging activities##2##4##(2008-12#1)(2009-3#1)
free radical scavenging activity##6##4##(2008-10#1)(2008-11#1)(2008-5#3)(2009-6#1)
free radical scavenging##20##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
free radical theory of aging##4##5##(2009-12#1)(2013-8#3)
free radical##99##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-9#7)(1993-11#1)(1994-11#2)(1994-5#2)(1994-6#5)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-2#6)(1996-5#1)(1996-9#1)(2007-11#3)(2008-10#10)(2008-11#5)(2008-12#2)(2008-5#16)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#5)(2013-1#1)(2013-8#4)
free radical-mediated##2##2##(1991-9#1)(2012-2#1)
free radical-scavenging##2##2##(1992-5#1)(2008-12#1)
free radicals and other##3##4##(1994-6#1)(2008-10#1)(2008-5#1)
free radicals and##15##3##(1991-12#1)(1991-2#1)(1991-9#1)(1994-6#1)(1995-6#1)(1995-8#2)(1996-2#1)(2008-10#2)(2008-5#4)(2013-8#1)
free radicals are##3##3##(2008-5#1)(2010-10#2)
free radicals generated##3##3##(1993-3#1)(1995-5#1)(1995-8#1)
free radicals in a##2##4##(1990-12#1)(2008-10#1)
free radicals in##6##3##(1990-12#1)(1991-2#1)(1992-12#1)(1996-9#1)(2008-10#1)(2008-5#1)
free radicals play a major role##2##6##(1991-9#1)(1995-12#1)
free radicals play##3##3##(1991-9#1)(1995-12#1)(1995-8#1)
free radicals that##3##3##(2007-8#1)(2009-10#1)(2009-8#1)
free radicals##83##2##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-9#4)(1992-12#2)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-6#2)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#4)(1996-2#2)(1996-5#1)(1996-9#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#9)(2008-7#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-3#3)(2010-8#1)(2013-8#2)
free range##3##2##(2008-10#3)
free resection##2##2##(1990-9#1)(2007-8#1)
free software##2##2##(2008-4#1)(2010-9#1)
free space and##2##3##(2008-3#2)
free space##9##2##(2007-11#2)(2007-12#1)(2008-3#4)(2011-1#2)
free spectral range (FSR)##3##4##(2007-12#1)(2008-3#1)(2013-8#1)
free spectral range of##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
free spectral range##12##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#4)(2013-8#1)
free spectral##13##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#4)(2013-8#1)
free standing##4##2##(2007-8#1)(2008-10#2)(2012-2#1)
free substrate##2##2##(1994-5#2)
free sugars##3##2##(2008-10#3)
free sulfhydryl group##2##3##(1995-6#1)(2008-10#1)
free sulfhydryl##8##2##(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-9#1)
free sulfide and##2##3##(2008-10#2)
free survival (DFS)##4##3##(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)
free survival was##2##3##(2008-10#1)(2010-3#1)
free survival##13##2##(1993-2#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#2)(2012-2#1)
free suspension##2##2##(2008-11#2)
free testosterone levels##3##3##(1990-5#1)(2011-2#2)
free testosterone##5##2##(1990-5#1)(2008-5#1)(2011-2#2)(2012-12#1)
free text sign-out##2##3##(2011-1#2)
free text##5##2##(1992-4#1)(2011-1#4)
free thiol groups##3##3##(1991-12#1)(2008-10#1)(2010-11#1)
free thiol##4##2##(1991-12#1)(2008-10#1)(2008-2#1)(2010-11#1)
free thyroxine##4##2##(2007-5#1)(2008-6#1)(2012-3#1)(2013-8#1)
free time##4##2##(2009-7#1)(2011-2#2)(2013-1#1)
free tissue transfer is##2##4##(2008-4#1)(2011-2#1)
free tissue transfer##4##3##(2008-4#1)(2011-2#2)(2012-12#1)
free tissue##5##2##(2008-4#1)(2011-2#3)(2012-12#1)
free to##5##2##(1992-3#1)(2007-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
free trade##3##2##(2008-1#2)(2008-7#1)
free triiodothyronine##3##2##(2007-5#1)(2012-12#1)(2012-2#1)
free troposphere##2##2##(2008-3#2)
free up##2##2##(1994-2#1)(1995-12#1)
free wall rupture##5##3##(1997-3#1)(2007-8#3)(2011-2#1)
free wall##11##2##(1997-3#1)(2007-8#4)(2008-7#4)(2010-10#1)(2011-2#1)
free water##5##2##(2008-10#2)(2008-5#2)(2009-12#1)
free will##4##2##(2008-8#1)(2010-12#3)
free with##2##2##(2008-6#1)(2008-8#1)
free zinc##3##2##(1994-6#1)(2013-7#2)
free##1330##1##(1990-10#2)(1990-11#4)(1990-12#13)(1990-2#7)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#10)(1990-8#30)(1990-9#1)(1991-11#2)(1991-12#11)(1991-2#12)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#21)(1992-1#1)(1992-11#5)(1992-12#10)(1992-2#1)(1992-3#15)(1992-4#1)(1992-5#3)(1992-6#14)(1992-9#6)(1993-1#1)(1993-11#15)(1993-12#13)(1993-2#6)(1993-3#4)(1993-6#6)(1993-8#8)(1993-9#2)(1994-1#1)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#8)(1994-5#6)(1994-6#12)(1994-8#10)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#11)(1995-2#9)(1995-3#3)(1995-5#11)(1995-6#6)(1995-8#9)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#12)(1996-3#3)(1996-5#3)(1996-6#1)(1996-9#3)(1997-1#4)(1997-2#14)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#14)(1997-8#3)(2006-12#2)(2007-11#18)(2007-12#30)(2007-2#2)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#16)(2008-1#6)(2008-10#247)(2008-11#48)(2008-12#13)(2008-2#21)(2008-3#49)(2008-4#23)(2008-5#58)(2008-6#20)(2008-7#51)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#4)(2010-10#4)(2010-11#6)(2010-12#5)(2010-2#14)(2010-3#6)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#17)(2011-2#49)(2011-3#1)(2012-12#13)(2012-2#34)(2012-3#8)(2012-6#1)(2013-1#27)(2013-3#1)(2013-7#5)(2013-8#17)
free-electron laser##4##2##(1993-5#1)(2008-3#2)(2012-2#1)
free-electron##8##1##(1991-9#1)(1993-5#1)(2008-3#2)(2011-1#3)(2012-2#1)
free-energy##4##1##(1996-6#1)(2008-3#1)(2008-4#1)(2010-2#1)
free-flight##2##1##(2008-9#2)
free-flow##3##1##(2008-1#2)(2008-4#1)
free-form##2##1##(2008-10#2)
free-lead gasoline and gas oil##2##5##(2008-10#2)
free-living and##2##2##(1997-6#1)(2011-2#1)
free-living animals##6##2##(2008-10#1)(2008-9#5)
free-living##32##1##(1992-9#1)(1994-12#1)(1995-5#1)(1997-6#3)(2008-10#3)(2008-3#1)(2008-5#4)(2008-7#4)(2008-9#5)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#1)
free-path-length distribution##2##2##(2008-2#2)
free-radical polymerization##2##2##(2007-11#1)(2010-2#1)
free-radical scavengers##4##2##(2008-6#2)(2008-7#1)(2009-6#1)
free-radical##14##1##(1992-9#1)(1993-6#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-1#2)
free-range##2##1##(1995-3#1)(2011-1#1)
free-ranging argali##2##2##(2009-4#2)
free-ranging females##2##2##(2008-8#2)
free-ranging owl monkeys (Aotus azarai azarai) from Formosa##2##8##(2013-1#2)
free-ranging primates##2##2##(2013-1#2)
free-ranging##10##1##(2008-8#3)(2009-10#1)(2009-4#2)(2013-1#4)
free-running and##3##2##(2008-2#1)(2008-3#2)
free-running##22##1##(1990-5#1)(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#11)
free-space add-drop##2##2##(2008-3#2)
free-space and##6##2##(2008-2#1)(2008-3#4)(2013-8#1)
free-space components##2##2##(2008-3#2)
free-space interconnect##2##2##(2008-2#2)
free-space interconnections##2##2##(2008-3#2)
free-space interference patterns##2##3##(2008-3#2)
free-space optical and electrical##2##4##(2008-2#2)
free-space optical computing architectures##2##4##(2008-2#2)
free-space optical interconnect system##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnect systems##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnect##11##3##(2008-2#4)(2008-3#7)
free-space optical interconnection system##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnection##6##3##(2008-2#2)(2008-3#4)
free-space optical interconnections##2##3##(2008-2#2)
free-space optical interconnects are##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnects##8##3##(2008-2#3)(2008-3#5)
free-space optical system##2##3##(2008-3#2)
free-space optical systems##3##3##(2008-3#3)
free-space optical##43##2##(2008-2#19)(2008-3#24)
free-space optics##5##2##(2008-2#1)(2008-3#4)
free-space optoelectronic interconnects##2##3##(2008-3#2)
free-space optoelectronic##5##2##(2008-2#3)(2008-3#2)
free-space photonic##2##2##(2008-2#1)(2008-3#1)
free-space polarization-controlled##2##2##(2008-2#2)
free-space satellite##2##2##(2008-2#2)
free-space##96##1##(2007-11#1)(2007-12#5)(2008-2#38)(2008-3#49)(2009-5#1)(2011-1#1)(2013-8#1)
free-spawning marine##2##2##(2008-8#1)(2008-9#1)
free-spawning##3##1##(2008-8#2)(2008-9#1)
free-stall##2##1##(2012-3#2)
free-standing##8##1##(1993-12#1)(1994-9#1)(1996-3#1)(2007-12#1)(2008-10#1)(2010-10#1)(2012-2#2)
freed from##2##2##(1990-7#1)(2008-10#1)
freedom and##3##2##(1994-2#1)(2007-12#1)(2008-5#1)
freedom from##10##2##(1992-5#1)(1993-9#1)(1995-3#1)(2007-11#1)(2007-8#3)(2008-2#1)(2011-2#1)(2012-3#1)
freedom in the##2##3##(2007-11#1)(2008-7#1)
freedom in##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
freedom of choice##3##3##(1995-1#2)(1996-11#1)
freedom of movement##3##3##(1993-2#1)(1993-3#1)(2008-7#1)
freedom of the##3##3##(1995-11#1)(2008-3#1)(2008-6#1)
freedom of##11##2##(1993-2#1)(1993-3#1)(1995-1#2)(1995-11#1)(1996-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)
freedom that##2##2##(2007-11#1)(2008-3#1)
freedom to##6##2##(1997-2#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-12#1)
freedom##64##1##(1990-8#1)(1991-5#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-3#2)(1996-11#1)(1997-2#1)(1997-3#2)(2007-11#3)(2007-12#4)(2007-8#3)(2008-10#2)(2008-11#4)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)
freefall##2##1##(2009-9#2)
freeing##3##1##(2008-10#2)(2009-11#1)
freely across the##2##3##(1990-2#1)(2008-7#1)
freely available for##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
freely available online##2##3##(2009-2#1)(2010-12#1)
freely available##12##2##(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
freely behaving##3##2##(1991-2#2)(2009-8#1)
freely moving cats##2##3##(1990-7#1)(1993-9#1)
freely moving rats##9##3##(1990-7#1)(1992-3#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#2)
freely moving##13##2##(1990-7#2)(1992-3#1)(1993-9#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-4#2)
freely propagating##5##2##(2007-11#2)(2007-12#3)
freely soluble##3##2##(2008-10#2)(2010-5#1)
freely suspended cells##2##3##(1994-3#1)(2008-11#1)
freely suspended##5##2##(1994-3#1)(2008-10#2)(2008-11#2)
freely##71##1##(1990-2#1)(1990-7#2)(1991-2#2)(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#7)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
freestanding centers##2##2##(1991-1#1)(1993-2#1)
freestanding diagnostic imaging centers##2##4##(1991-1#2)
freestanding facilities##2##2##(1995-2#1)(1996-3#1)
freestanding renal##2##2##(1995-12#2)
freestanding##15##1##(1991-1#4)(1992-1#1)(1993-2#1)(1995-12#2)(1995-2#1)(1996-3#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#1)
freeware##4##1##(2008-2#3)(2010-8#1)
freeway##3##1##(1996-3#2)(2008-5#1)
freeze and##2##2##(2011-1#1)(2011-2#1)
freeze drying##2##2##(2012-12#2)
freeze fixation##2##2##(2008-7#2)
freeze fracture##2##2##(2012-12#2)
freeze or##2##2##(1993-3#1)(2008-8#1)
freeze tolerance##2##2##(2011-1#2)
freeze##21##1##(1993-11#1)(1993-3#1)(2008-1#2)(2008-10#1)(2008-7#4)(2008-8#2)(2011-1#3)(2011-2#2)(2012-12#5)
freeze-avoidance##2##1##(2008-8#2)
freeze-dried antigen for the##2##4##(1996-12#2)
freeze-dried apple##2##2##(2008-10#2)
freeze-dried iohexol##2##2##(2008-7#2)
freeze-dried powder for injection##2##4##(2011-3#2)
freeze-dried powder##3##2##(2011-2#1)(2011-3#2)
freeze-dried##17##1##(1996-12#2)(2008-10#7)(2008-6#1)(2008-7#2)(2011-2#1)(2011-3#2)(2012-12#2)
freeze-drying##6##1##(2008-10#4)(2008-11#1)(2012-12#1)
freeze-fracture electron microscopy##4##3##(1990-12#1)(1991-5#1)(1992-6#1)(1997-2#1)
freeze-fracture##6##1##(1990-12#1)(1991-5#1)(1992-6#3)(1997-2#1)
freeze-thaw##2##1##(2009-11#1)(2009-12#1)
freeze-tolerance##2##1##(2008-8#2)
freezer##3##1##(2008-11#1)(2008-3#1)(2008-8#1)
freezes##2##1##(2008-3#1)(2008-8#1)
freezing and thawing cells##2##4##(2008-4#1)(2008-9#1)
freezing and thawing##12##3##(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)
freezing and##14##2##(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2010-3#1)
freezing at##2##2##(1997-8#1)(2008-10#1)
freezing in##2##2##(1992-11#1)(2008-7#1)
freezing media##2##2##(2008-8#2)
freezing of##3##2##(1992-9#1)(1993-5#1)(2008-2#1)
freezing or##4##2##(2008-10#1)(2008-9#1)(2012-3#1)(2013-7#1)
freezing point##2##2##(2008-10#1)(2009-2#1)
freezing resistance##3##2##(2009-2#3)
freezing temperatures##4##2##(2008-10#2)(2008-3#1)(2010-7#1)
freezing tolerance##4##2##(2009-2#1)(2009-8#3)
freezing##62##1##(1992-11#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#6)(2009-8#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-7#1)
freezing-thawing##5##1##(2008-10#4)(2011-2#1)
frenatus##2##1##(2010-8#2)
frequencies (0##2##2##(2008-10#1)(2012-7#1)
frequencies above##2##2##(2007-12#1)(2009-5#1)
frequencies and modulation##2##3##(2008-2#1)(2008-3#1)
frequencies and the##3##3##(2008-4#2)(2008-8#1)
frequencies and##21##2##(1991-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-8#1)(2011-2#3)
frequencies are##8##2##(1995-5#3)(2007-11#2)(2008-10#1)(2008-3#2)
frequencies as high as 1##2##5##(2007-11#1)(2008-3#1)
frequencies as high as##4##4##(2007-11#2)(2008-3#2)
frequencies as low as##2##4##(1996-12#1)(2008-3#1)
frequencies as##7##2##(1996-12#1)(2007-11#2)(2008-3#3)(2009-5#1)
frequencies at##2##2##(1994-3#1)(2008-9#1)
frequencies between##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
frequencies by means of##2##4##(2007-12#1)(2008-3#1)
frequencies by##3##2##(2007-12#2)(2008-3#1)
frequencies did not##2##3##(1996-12#1)(2008-10#1)
frequencies for the##2##3##(1997-5#1)(2012-12#1)
frequencies for##12##2##(1990-7#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-12#4)(2008-3#3)(2012-12#1)
frequencies from##4##2##(2008-10#1)(2008-12#2)(2008-2#1)
frequencies higher than##2##3##(2007-12#1)(2008-3#1)
frequencies in the##8##3##(1994-11#1)(1994-2#1)(2008-10#1)(2008-3#3)(2008-9#1)(2012-2#1)
frequencies in this##2##3##(1995-12#1)(2007-12#1)
frequencies in##23##2##(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#6)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2012-12#1)(2012-2#1)
frequencies indicate##2##2##(2008-10#1)(2008-5#1)
frequencies is##5##2##(2007-11#1)(2008-11#1)(2008-3#3)
frequencies near##2##2##(2007-11#1)(2008-2#1)
frequencies of 3##2##3##(2013-1#2)
frequencies of CIITA G-944C##2##4##(2011-1#2)
frequencies of Cr2##2##3##(2008-10#2)
frequencies of a##2##3##(2007-11#1)(2007-12#1)
frequencies of alleles##3##3##(1997-5#2)(2008-10#1)
frequencies of occurrence##2##3##(2008-10#2)
frequencies of some##2##3##(1997-7#1)(2009-8#1)
frequencies of the##18##3##(1990-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#2)(2011-2#2)(2012-12#1)
frequencies of##101##2##(1990-2#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#3)(2008-10#26)(2008-12#4)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#8)(2012-12#2)(2012-3#1)(2013-1#4)
frequencies on the##2##3##(2008-10#1)(2010-7#1)
frequencies ranging from 0##3##4##(2007-12#1)(2008-3#1)(2009-11#1)
frequencies ranging from##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)
frequencies reported##2##2##(1990-3#1)(2010-8#1)
frequencies that are##2##3##(2008-3#2)
frequencies that##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
frequencies to##6##2##(2007-12#1)(2008-3#3)(2008-4#1)(2009-12#1)
frequencies up to##6##3##(2007-11#1)(2007-12#3)(2008-2#2)
frequencies was##3##2##(2008-10#2)(2013-1#1)
frequencies were determined##2##3##(2008-10#1)(2008-7#1)
frequencies were estimated##2##3##(2008-10#1)(2008-5#1)
frequencies were measured##2##3##(2008-5#1)(2013-8#1)
frequencies were significantly different##2##4##(2008-10#2)
frequencies were##29##2##(1990-5#1)(1993-8#1)(2007-12#2)(2008-10#10)(2008-12#1)(2008-5#3)(2008-7#2)(2011-1#8)(2013-8#1)
frequencies with##4##2##(1997-7#1)(2008-10#2)(2008-3#1)
frequencies within the##3##3##(2008-10#2)(2008-3#1)
frequencies within##4##2##(2008-10#2)(2008-3#1)(2012-3#1)
frequencies##410##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1993-12#3)(1993-3#2)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1995-12#1)(1995-5#5)(1996-12#6)(1996-2#5)(1996-6#1)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#4)(2006-12#1)(2007-11#20)(2007-12#27)(2007-7#1)(2008-1#2)(2008-10#87)(2008-11#3)(2008-12#17)(2008-2#23)(2008-3#49)(2008-4#6)(2008-5#12)(2008-7#7)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-2#2)(2010-4#3)(2010-7#2)(2010-8#2)(2011-1#22)(2011-2#12)(2012-12#5)(2012-2#9)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#6)
frequency after a##2##3##(2008-10#1)(2008-8#1)
frequency after##3##2##(2008-10#2)(2008-8#1)
frequency among##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)
frequency analysis of the##2##4##(2008-2#1)(2008-9#1)
frequency analysis of##4##3##(2008-2#2)(2008-9#1)(2011-2#1)
frequency analysis##10##2##(2007-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
frequency and a##3##3##(2008-7#1)(2010-4#1)(2012-3#1)
frequency and amplitude##5##3##(1995-12#1)(2007-12#1)(2008-2#1)(2012-2#2)
frequency and difficulty##2##3##(1996-1#2)
frequency and duration of##2##4##(1995-5#1)(2008-10#1)
frequency and duration##3##3##(1995-5#1)(2008-10#1)(2013-8#1)
frequency and intensity of##4##4##(1995-12#1)(2007-8#1)(2010-11#1)(2011-2#1)
frequency and levels##2##3##(2008-10#2)
frequency and severity of##4##4##(1991-12#1)(1992-11#1)(2012-2#1)(2012-3#1)
frequency and severity##8##3##(1991-12#1)(1992-11#1)(1995-5#1)(2008-10#1)(2008-6#2)(2012-2#1)(2012-3#1)
frequency and the##16##3##(1992-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)
frequency and timing noise##2##4##(2007-11#2)
frequency and timing##5##3##(2007-11#5)
frequency and##124##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-5#2)(1996-1#2)(1996-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#8)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#5)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
frequency are##4##2##(2008-1#1)(2008-3#2)(2008-9#1)
frequency as a##3##3##(1991-2#1)(2007-12#1)(2008-7#1)
frequency as##6##2##(1991-2#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-7#1)
frequency at the##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
frequency at which##2##3##(1993-9#1)(2008-2#1)
frequency at##7##2##(1993-9#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)
frequency bands##2##2##(1991-10#1)(1996-5#1)
frequency bandwidth##2##2##(2008-2#1)(2008-7#1)
frequency but also##2##3##(2007-12#1)(2008-2#1)
frequency but##4##2##(1993-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
frequency by an##2##3##(2007-12#1)(2008-1#1)
frequency by the##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
frequency by##10##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
frequency can be##5##3##(2007-11#1)(2007-12#2)(2008-4#1)(2012-2#1)
frequency changes##7##2##(2007-12#1)(2008-10#4)(2009-5#1)(2013-1#1)
frequency chirp##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
frequency comb generated by a##2##5##(2007-12#2)
frequency comb generation##2##3##(2007-12#2)
frequency comb generator##2##3##(2007-12#1)(2008-3#1)
frequency comb is##3##3##(2007-12#3)
frequency comb##15##2##(2007-11#2)(2007-12#11)(2008-3#2)
frequency combs##3##2##(2007-11#2)(2007-12#1)
frequency compared to##2##3##(1993-9#1)(2009-8#1)
frequency compared with##2##3##(2008-10#2)
frequency compared##4##2##(1993-9#1)(2008-10#2)(2009-8#1)
frequency components of##2##3##(2007-12#2)
frequency components##7##2##(2007-11#1)(2007-12#5)(2008-8#1)
frequency content of##2##3##(1994-8#1)(2012-2#1)
frequency control of##3##3##(2007-12#3)
frequency control##4##2##(2007-12#3)(2008-2#1)
frequency conversion by##2##3##(2007-12#2)
frequency conversion in##2##3##(2007-12#2)
frequency conversion of##4##3##(2007-12#2)(2008-3#2)
frequency conversion##15##2##(2007-11#2)(2007-12#8)(2008-3#5)
frequency converter##2##2##(2007-12#1)(2008-2#1)
frequency data##4##2##(1995-2#1)(2008-12#2)(2008-8#1)
frequency dependence and##2##3##(2008-2#1)(2008-8#1)
frequency dependence of dynamic compliance##2##5##(2013-7#2)
frequency dependence of dynamic##3##4##(2013-7#3)
frequency dependence of##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#3)
frequency dependence##12##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#3)(2013-7#3)
frequency dependent##3##2##(1995-5#1)(2008-10#1)(2008-9#1)
frequency derived##2##2##(2007-12#2)
frequency detection time##2##3##(2008-10#2)
frequency detuning##4##2##(2007-11#4)
frequency difference##2##2##(2007-12#1)(2008-3#1)
frequency differences among populations##2##4##(2008-10#1)(2009-5#1)
frequency differences between##2##3##(2007-12#1)(2008-12#1)
frequency differences##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2013-1#1)
frequency distribution of##6##3##(2008-10#2)(2008-7#3)(2010-4#1)
frequency distribution was##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
frequency distribution##13##2##(2008-10#5)(2008-6#1)(2008-7#5)(2008-9#1)(2010-4#1)
frequency distributions of##5##3##(1996-7#1)(2008-10#3)(2008-3#1)
frequency distributions##10##2##(1994-3#1)(1996-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2009-5#1)
frequency domain##17##2##(1995-11#1)(1995-6#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2011-1#2)
frequency doubled in a##2##4##(2007-12#1)(2008-2#1)
frequency doubled in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
frequency doubled to##2##3##(2008-2#1)(2008-3#1)
frequency doubled##9##2##(1992-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
frequency doublers##3##2##(2007-12#2)(2008-2#1)
frequency doubling and tripling with##2##5##(2008-3#2)
frequency doubling and tripling##4##4##(2008-2#1)(2008-3#3)
frequency doubling and##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
frequency doubling in##3##3##(2007-11#2)(2007-12#1)
frequency doubling of a diode-pumped##2##5##(2007-12#2)
frequency doubling of a##11##4##(2007-11#1)(2007-12#7)(2008-2#1)(2008-3#2)
frequency doubling of an##2##4##(2007-11#1)(2007-12#1)
frequency doubling of the output of a##2##7##(2007-11#1)(2007-12#1)
frequency doubling of the output of##4##6##(2007-11#1)(2007-12#3)
frequency doubling of the##5##4##(2007-11#2)(2007-12#3)
frequency doubling of##22##3##(2007-11#4)(2007-12#15)(2008-2#1)(2008-3#2)
frequency doubling with##3##3##(2007-11#2)(2007-12#1)
frequency doubling##45##2##(2007-11#11)(2007-12#20)(2008-2#6)(2008-3#8)
frequency drift of##2##3##(2007-12#2)
frequency drift##4##2##(2007-12#3)(2008-3#1)
frequency during the##3##3##(1992-5#1)(2008-10#1)(2008-8#1)
frequency f(l)##2##2##(2007-12#2)
frequency factor##2##2##(1996-7#1)(2008-3#1)
frequency filtering with##2##3##(2007-11#1)(2008-3#1)
frequency filtering##3##2##(2007-11#1)(2008-3#2)
frequency fluctuations of the##2##4##(2007-12#2)
frequency fluctuations of##4##3##(2007-11#1)(2007-12#3)
frequency fluctuations##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
frequency for the##2##3##(2008-3#1)(2011-2#1)
frequency for##10##2##(1993-11#1)(1996-4#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2011-2#1)(2013-8#1)
frequency found##2##2##(2007-7#1)(2008-1#1)
frequency from##6##2##(1995-2#1)(2007-11#1)(2008-10#3)(2008-8#1)
frequency gap##2##2##(2007-12#2)
frequency generation in##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
frequency generation of##2##3##(2007-11#2)
frequency generation##12##2##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#2)(2009-7#1)
frequency have been characterized##2##4##(2007-11#1)(2008-4#1)
frequency have been##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
frequency have##5##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
frequency impulse activity##2##3##(2008-5#2)
frequency in a##3##3##(2007-11#2)(2008-2#1)
frequency in patients##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
frequency in the##9##3##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)
frequency in this##2##3##(2008-10#1)(2011-2#1)
frequency in##30##2##(1993-8#1)(1995-8#1)(1996-9#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
frequency increased##2##2##(2009-8#1)(2012-1#1)
frequency is##22##2##(1991-6#1)(1995-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#2)(2012-2#2)(2012-3#1)(2012-7#1)
frequency jitter##2##2##(2007-11#1)(2008-3#1)
frequency locking of a diode laser##2##6##(2007-11#1)(2008-3#1)
frequency measurement##5##2##(2007-12#4)(2008-3#1)
frequency measurements for##2##3##(2008-2#2)
frequency measurements##6##2##(1994-3#2)(2007-11#1)(2008-2#3)
frequency mixing##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
frequency modulation of##3##3##(2008-3#2)(2012-2#1)
frequency modulation spectroscopy##2##3##(2008-2#1)(2008-3#1)
frequency modulation##17##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#9)(2012-2#1)
frequency noise##9##2##(2007-11#5)(2007-12#2)(2008-3#1)(2010-8#1)
frequency of 0##7##3##(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#2)(2013-1#1)
frequency of 1##5##3##(2008-11#1)(2008-3#2)(2008-9#1)(2012-3#1)
frequency of 100##2##3##(2008-10#1)(2012-2#1)
frequency of 110##2##3##(2007-12#1)(2008-10#1)
frequency of 120 Hz##2##4##(2008-10#1)(2008-3#1)
frequency of 12h(-1)##2##3##(2008-10#2)
frequency of 20 samples per hour##2##6##(2008-10#2)
frequency of 20##4##3##(2008-10#3)(2008-9#1)
frequency of 24h(-1)##2##3##(2008-10#2)
frequency of 250##2##3##(2007-11#1)(2008-10#1)
frequency of 27##3##3##(2008-10#3)
frequency of 28##2##3##(2008-10#2)
frequency of 30 samples per##2##5##(2008-10#2)
frequency of 30##4##3##(2008-10#4)
frequency of 40##3##3##(2008-10#3)
frequency of 60 h(-1)##3##4##(2008-10#3)
frequency of 60##5##3##(2008-10#3)(2008-6#1)(2008-7#1)
frequency of 7##2##3##(2008-10#1)(2008-11#1)
frequency of 90 h(-1)##2##4##(2008-10#2)
frequency of 90##3##3##(2008-10#3)
frequency of HLA-B27##2##3##(2012-12#2)
frequency of P##5##3##(2008-10#5)
frequency of R##2##3##(2008-10#2)
frequency of a##7##3##(1991-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
frequency of about##3##3##(1997-8#1)(2008-8#1)(2009-12#1)
frequency of acute##2##3##(1996-3#1)(2007-2#1)
frequency of administration##2##3##(2011-2#1)(2012-12#1)
frequency of adverse##2##3##(1997-5#1)(2010-5#1)
frequency of antigen##2##3##(2008-10#1)(2008-11#1)
frequency of approximately##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
frequency of autoimmune##2##3##(1994-12#1)(1996-11#1)
frequency of bone##2##3##(2007-11#1)(2011-2#1)
frequency of cankered trees in infected stands##2##7##(2008-10#2)
frequency of cervical##3##3##(1990-12#1)(2006-10#2)
frequency of complications##2##3##(2006-10#1)(2010-12#1)
frequency of contraceptive use##2##4##(2012-12#2)
frequency of dermatoses in##2##4##(2011-2#2)
frequency of dose##2##3##(1991-12#1)(2008-7#1)
frequency of either##2##3##(1994-11#1)(2012-3#1)
frequency of family dinners##4##4##(2013-1#4)
frequency of females is##2##4##(2008-9#2)
frequency of females##4##3##(1991-5#1)(2008-9#3)
frequency of finger use##2##4##(2013-8#2)
frequency of hepatitis##2##3##(1994-7#1)(2008-12#1)
frequency of hypotensive episodes##2##4##(2008-1#2)
frequency of involvement of the##2##5##(1997-8#2)
frequency of isolation of##2##4##(2008-10#2)
frequency of methylation of##2##4##(2008-7#2)
frequency of micronucleated erythrocytes in##3##5##(2008-8#1)(2008-9#2)
frequency of micronucleated erythrocytes##7##4##(2008-8#1)(2008-9#6)
frequency of micronucleated##9##3##(1996-12#1)(2008-8#1)(2008-9#7)
frequency of multiple##2##3##(2008-5#1)(2008-9#1)
frequency of mutations##2##3##(1997-3#1)(2013-1#1)
frequency of occurrence among##2##4##(2008-10#1)(2008-5#1)
frequency of occurrence of##3##4##(1996-4#1)(2012-3#1)(2013-1#1)
frequency of occurrence##8##3##(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-3#1)(2013-1#1)(2013-7#1)
frequency of perceived##2##3##(1995-12#1)(2008-10#1)
frequency of positive##2##3##(2011-2#2)
frequency of reported##2##3##(1993-2#1)(2008-11#1)
frequency of resistance##2##3##(1993-8#1)(2008-10#1)
frequency of restenosis##3##3##(1994-11#1)(1994-9#2)
frequency of serious clinical incidents##2##5##(2008-6#2)
frequency of severe##2##3##(1995-5#1)(2007-7#1)
frequency of sex##3##3##(2008-10#1)(2012-3#2)
frequency of sexual reproduction##2##4##(2008-10#1)(2012-3#1)
frequency of sexual##3##3##(2008-10#1)(2012-3#2)
frequency of side effects##2##4##(1993-2#1)(1997-1#1)
frequency of social##3##3##(2009-5#1)(2009-7#2)
frequency of spontaneously contracting##2##4##(2010-3#2)
frequency of spontaneously##3##3##(2007-12#1)(2010-3#2)
frequency of such##2##3##(1992-6#1)(1996-6#1)
frequency of the AA genotype##3##5##(2011-2#3)
frequency of the In(+)##2##4##(2007-12#2)
frequency of the##63##3##(1990-3#1)(1990-8#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-11#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#6)(2008-3#7)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#1)
frequency of these##4##3##(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
frequency of this##2##3##(1991-8#1)(1997-3#1)
frequency of twin births##2##4##(1990-6#2)
frequency of two##2##3##(2008-10#1)(2009-8#1)
frequency of type##2##3##(2007-5#1)(2008-3#1)
frequency of use of##2##4##(1990-8#1)(2013-1#1)
frequency of use##4##3##(1990-8#1)(2012-2#2)(2013-1#1)
frequency of virulence##2##3##(2008-10#2)
frequency of visits to##2##4##(1990-9#1)(1992-5#1)
frequency of which##2##3##(1997-7#1)(2008-7#1)
frequency of##599##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#4)(1990-9#3)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#5)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#6)(1993-3#2)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#4)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#8)(1997-9#1)(2006-10#5)(2006-6#2)(2007-10#5)(2007-11#11)(2007-12#20)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#133)(2008-11#15)(2008-12#12)(2008-2#12)(2008-3#20)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#16)(2008-8#17)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#34)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#14)(2012-5#1)(2013-1#21)(2013-7#3)(2013-8#7)
frequency on the##2##3##(1993-8#1)(2007-11#1)
frequency on##14##2##(1990-8#1)(1993-8#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-2#1)
frequency or##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
frequency over##2##2##(2007-12#1)(2008-3#1)
frequency quadrupled##2##2##(2008-2#2)
frequency questionnaire##4##2##(1993-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
frequency range from 0##2##4##(2007-11#2)
frequency range from##3##3##(2007-11#2)(2008-3#1)
frequency range of 0##3##4##(1996-5#1)(1997-2#1)(2008-10#1)
frequency range of the##2##4##(2007-12#2)
frequency range of##12##3##(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)
frequency range##31##2##(1996-5#1)(1996-7#1)(1997-2#1)(2007-11#7)(2007-12#4)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2010-8#3)(2012-2#1)
frequency ranges##2##2##(2008-11#1)(2010-5#1)
frequency related##2##2##(2008-10#1)(2010-4#1)
frequency relative to##2##3##(2008-10#1)(2008-2#1)
frequency resolution##2##2##(2007-11#2)
frequency response is##2##3##(2007-11#1)(2010-5#1)
frequency response of a moving grating##2##6##(2007-12#2)
frequency response of a##3##4##(2007-12#2)(2009-5#1)
frequency response of##6##3##(2007-12#2)(2008-3#3)(2009-5#1)
frequency response##17##2##(2007-11#3)(2007-12#4)(2008-10#2)(2008-3#4)(2009-5#2)(2009-9#1)(2010-5#1)
frequency scanned##2##2##(2008-3#2)
frequency scanning##2##2##(2008-3#2)
frequency shift curves##2##3##(2008-10#2)
frequency shift in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
frequency shift of##5##3##(2008-2#1)(2008-3#1)(2009-5#3)
frequency shift was##3##3##(2007-11#1)(2008-10#1)(2009-5#1)
frequency shift##28##2##(1997-7#1)(2007-11#4)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#6)(2009-5#4)(2012-2#1)
frequency shifting##2##2##(2007-12#1)(2008-3#1)
frequency shifts of##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
frequency shifts##9##2##(1997-7#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
frequency span##2##2##(2007-12#2)
frequency spectrum##3##2##(2007-12#1)(2008-3#2)
frequency splitting##2##2##(2008-2#1)(2012-2#1)
frequency stability of better than##2##5##(2007-12#1)(2008-3#1)
frequency stability of##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
frequency stability##9##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)
frequency stabilization is##2##3##(2008-3#2)
frequency stabilization of a##3##4##(2007-12#2)(2008-3#1)
frequency stabilization of##4##3##(2007-12#2)(2008-3#2)
frequency stabilization##9##2##(2007-11#2)(2007-12#2)(2008-3#5)
frequency standard##7##2##(2007-11#3)(2007-12#2)(2008-2#2)
frequency standards##7##2##(2007-11#1)(2007-12#6)
frequency stimulation##2##2##(1993-12#1)(2009-9#1)
frequency sweep##2##2##(2008-3#2)
frequency than##3##2##(1993-2#1)(1995-8#1)(2008-5#1)
frequency that is##2##3##(2007-12#1)(2008-3#1)
frequency that##3##2##(1994-3#1)(2007-12#1)(2008-3#1)
frequency to the##3##3##(2007-11#1)(2007-9#1)(2009-12#1)
frequency to##12##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#1)(2009-12#1)
frequency tuning of##2##3##(2007-11#1)(2007-12#1)
frequency tuning##6##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2011-1#2)
frequency upconversion of##2##3##(2007-12#1)(2008-3#1)
frequency upconversion##3##2##(2007-12#2)(2008-3#1)
frequency was 50##2##3##(1990-3#1)(2008-4#1)
frequency was 70##2##3##(2008-10#2)
frequency was found##2##3##(2008-11#1)(2008-3#1)
frequency was not##2##3##(1994-6#1)(1995-12#1)
frequency was significantly##2##3##(2010-4#1)(2013-1#1)
frequency was stabilized##2##3##(2008-2#1)(2008-3#1)
frequency was##41##2##(1990-3#1)(1990-5#1)(1992-11#1)(1994-6#1)(1995-12#1)(2007-12#2)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
frequency were##11##2##(1990-8#1)(1991-12#1)(1992-8#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-1#1)(2013-7#1)
frequency when##2##2##(1994-2#1)(2008-2#1)
frequency with##11##2##(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)
frequency##1834##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#2)(1990-6#8)(1990-8#9)(1990-9#3)(1991-10#3)(1991-11#3)(1991-12#10)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#4)(1991-8#4)(1991-9#6)(1992-1#2)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#3)(1992-8#7)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#7)(1993-3#2)(1993-6#1)(1993-8#9)(1993-9#10)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#9)(1994-7#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#11)(1995-2#3)(1995-3#2)(1995-5#8)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#15)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#7)(1997-8#9)(1997-9#1)(2006-10#7)(2006-6#2)(2007-10#6)(2007-11#124)(2007-12#202)(2007-2#1)(2007-5#2)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#14)(2008-10#285)(2008-11#41)(2008-12#30)(2008-2#113)(2008-3#195)(2008-4#13)(2008-5#31)(2008-6#11)(2008-7#46)(2008-8#45)(2008-9#44)(2009-10#4)(2009-11#3)(2009-12#5)(2009-2#4)(2009-3#1)(2009-5#18)(2009-6#2)(2009-7#6)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#6)(2010-4#11)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#16)(2011-2#50)(2012-1#6)(2012-12#16)(2012-2#24)(2012-3#22)(2012-5#1)(2012-7#2)(2013-1#39)(2013-7#12)(2013-8#16)
frequency) and##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
frequency)##4##1##(1996-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
frequency- and##2##2##(2007-11#1)(2008-8#1)
frequency-##3##1##(2007-11#1)(2008-2#1)(2008-8#1)
frequency-chirped response of##2##3##(2008-3#2)
frequency-chirped##6##1##(2007-11#2)(2007-12#1)(2008-3#3)
frequency-conversion devices##3##2##(2007-11#1)(2007-12#2)
frequency-conversion##8##1##(2007-11#1)(2007-12#6)(2008-2#1)
frequency-dependent selection##6##2##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-2#1)
frequency-dependent##16##1##(1995-2#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#3)(2009-2#1)
frequency-domain (FD)##3##2##(2008-2#1)(2008-3#2)
frequency-domain analysis##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
frequency-domain measurements of##2##3##(2008-3#2)
frequency-domain measurements##3##2##(2007-11#1)(2008-3#2)
frequency-domain method is##2##3##(2008-2#1)(2008-3#1)
frequency-domain optical delay line##2##4##(2007-11#2)
frequency-domain optical##3##2##(2007-11#2)(2007-12#1)
frequency-domain photon migration##6##3##(2008-3#6)
frequency-domain pump-probe##2##2##(2008-3#1)(2010-7#1)
frequency-domain##40##1##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#26)(2010-7#1)(2012-1#1)(2013-1#1)
frequency-doubled Nd##10##2##(1992-1#1)(2007-12#4)(2008-2#4)(2008-3#1)
frequency-doubled diode##2##2##(2008-2#1)(2008-3#1)
frequency-doubled femtosecond##2##2##(2008-2#1)(2008-3#1)
frequency-doubled output##2##2##(2008-2#2)
frequency-doubled##44##1##(1992-1#1)(2007-11#6)(2007-12#14)(2008-2#11)(2008-3#12)
frequency-doubling crystal##3##2##(2007-11#1)(2007-12#2)
frequency-doubling##7##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
frequency-mixing##2##1##(2007-12#2)
frequency-modulated (FM)##2##2##(2007-11#2)
frequency-modulated lasers##2##2##(2008-3#2)
frequency-modulated##19##1##(2007-11#7)(2007-12#1)(2008-2#2)(2008-3#9)
frequency-modulation spectroscopy##5##2##(2007-11#2)(2008-3#3)
frequency-modulation##7##1##(2007-11#2)(2008-3#5)
frequency-noise##2##1##(2007-12#2)
frequency-offset##2##1##(2007-11#1)(2007-12#1)
frequency-plane##2##1##(2007-12#1)(2008-2#1)
frequency-quadrupled solid-state laser##2##3##(2007-12#2)
frequency-quadrupled##4##1##(2007-12#3)(2008-2#1)
frequency-resolved optical gating (FROG)##6##4##(2007-11#1)(2007-12#4)(2008-3#1)
frequency-resolved optical gating technique##3##4##(2007-11#1)(2007-12#2)
frequency-resolved optical gating techniques##2##4##(2007-12#1)(2008-2#1)
frequency-resolved optical gating##22##3##(2007-11#6)(2007-12#12)(2008-2#1)(2008-3#3)
frequency-resolved##24##1##(2007-11#7)(2007-12#12)(2008-2#1)(2008-3#4)
frequency-selective components##3##2##(2007-12#1)(2008-3#2)
frequency-selective surfaces##4##2##(2008-3#4)
frequency-selective##11##1##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#7)
frequency-shifted feedback##5##2##(2007-11#3)(2008-2#2)
frequency-shifted##8##1##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#1)
frequency-stabilization##2##1##(2007-12#1)(2008-3#1)
frequency-stabilized##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
frequency-swept##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
frequency-translated holographic##2##2##(2007-11#2)
frequency-tripled Nd##2##2##(2007-12#1)(2008-2#1)
frequency]##2##1##(1993-5#1)(1995-8#1)
frequeney##2##1##(2013-8#2)
frequent 100 percent juice##2##4##(2012-2#2)
frequent among##8##2##(1995-12#1)(1997-3#1)(2008-9#2)(2009-5#1)(2010-11#1)(2012-6#1)(2013-8#1)
frequent and that##2##3##(2008-10#2)
frequent and##15##2##(1993-12#1)(1993-3#1)(1994-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
frequent as##3##2##(1990-12#1)(1990-8#1)(1997-3#1)
frequent association with##2##3##(1996-11#1)(2012-2#1)
frequent cause of death##3##4##(1992-4#1)(2011-2#1)(2012-12#1)
frequent cause of##15##3##(1990-9#1)(1991-8#1)(1992-4#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
frequent causes of##7##3##(1990-6#1)(1992-5#1)(1993-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
frequent causes##9##2##(1990-6#1)(1992-5#1)(1993-6#1)(1997-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
frequent changes in##3##3##(1992-3#1)(2008-9#1)(2009-8#1)
frequent clinical##4##2##(1990-8#1)(2007-7#1)(2013-1#1)(2013-8#1)
frequent complaints##2##2##(1994-6#1)(2008-7#1)
frequent complication in##4##3##(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
frequent complication of##4##3##(2008-1#1)(2009-9#1)(2011-2#1)(2013-1#1)
frequent complication##11##2##(2008-1#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
frequent complications##3##2##(1994-5#1)(2007-7#1)(2008-1#1)
frequent daily spiritual experience##2##4##(2009-11#2)
frequent daily##4##2##(2007-8#1)(2009-11#3)
frequent disease in##2##3##(1997-3#1)(2011-1#1)
frequent disease##6##2##(1993-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-3#1)
frequent due to##2##3##(1990-6#1)(1992-9#1)
frequent exposure to##2##3##(2009-7#1)(2013-1#1)
frequent genera##2##2##(2008-5#1)(2008-6#1)
frequent genetic##2##2##(2008-1#1)(2013-1#1)
frequent in gastric##2##3##(2011-2#2)
frequent in patients with##4##4##(1990-2#1)(2008-1#1)(2011-2#1)(2013-8#1)
frequent in patients##5##3##(1990-2#1)(2008-1#1)(2010-3#1)(2011-2#1)(2013-8#1)
frequent in the##9##3##(1991-3#1)(1993-12#1)(1996-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
frequent in these##2##3##(1991-12#1)(2009-10#1)
frequent in women##4##3##(1990-8#1)(1992-5#1)(2009-8#1)(2013-1#1)
frequent in##51##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-6#1)(1994-7#1)(1996-12#2)(1996-3#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#3)(2013-1#7)(2013-8#2)
frequent is##2##2##(1994-11#1)(2009-1#1)
frequent mixed infections##2##3##(2013-1#2)
frequent occurrence of##7##3##(2008-10#2)(2008-11#1)(2008-6#1)(2010-11#1)(2012-3#1)(2013-1#1)
frequent of##3##2##(1993-9#1)(2008-10#1)(2013-1#1)
frequent ones##2##2##(2011-1#1)(2011-2#1)
frequent primary##2##2##(2008-10#1)(2010-3#1)
frequent recombination##2##2##(2008-10#2)
frequent shaving##2##2##(2008-5#2)
frequent site of##2##3##(2008-5#1)(2008-6#1)
frequent site##3##2##(2007-7#1)(2008-5#1)(2008-6#1)
frequent source of##3##3##(1990-8#2)(1991-3#1)
frequent target##3##2##(2008-11#1)(2008-9#1)(2009-5#1)
frequent than##18##2##(1990-6#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#2)(2012-2#2)
frequent travel##2##2##(2007-12#1)(2011-2#1)
frequent use of##8##3##(1992-11#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
frequent##471##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#6)(1990-8#6)(1990-9#3)(1991-12#4)(1991-3#3)(1991-4#2)(1991-6#4)(1991-8#3)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-11#2)(1996-12#2)(1996-3#4)(1996-6#4)(1996-8#1)(1996-9#3)(1997-3#9)(1997-6#2)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#10)(2007-8#13)(2008-1#12)(2008-10#28)(2008-11#9)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#17)(2008-6#7)(2008-7#14)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#3)(2009-2#2)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#15)(2011-2#41)(2011-3#4)(2012-12#13)(2012-2#16)(2012-3#9)(2012-6#1)(2013-1#37)(2013-8#12)
frequentist##7##1##(1994-11#2)(1995-2#1)(1997-8#2)(2010-5#1)(2011-1#1)
frequently (RR =##2##3##(1992-5#2)
frequently a##2##2##(1995-12#1)(2008-10#1)
frequently acquired##2##2##(2007-12#1)(2008-5#1)
frequently affect##2##2##(2012-2#1)(2013-7#1)
frequently amplified##2##2##(2008-7#1)(2011-2#1)
frequently analyzed##2##2##(2008-2#1)(2010-11#1)
frequently and the##2##3##(1997-3#1)(2008-10#1)
frequently and##8##2##(1990-12#1)(1992-9#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-8#1)
frequently applied##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
frequently are##5##2##(1996-3#1)(1997-8#1)(2008-10#1)(2012-2#1)(2013-7#1)
frequently as an##2##3##(1996-12#1)(2013-1#1)
frequently as##9##2##(1996-12#1)(1996-6#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
frequently associated with##26##3##(1990-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#2)
frequently associated##27##2##(1990-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-7#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#2)
frequently at##2##2##(2008-10#1)(2008-8#1)
frequently been found##2##3##(1993-9#1)(2010-1#1)
frequently been##7##2##(1992-9#1)(1993-9#1)(2006-12#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)
frequently but##3##2##(2008-10#1)(2008-6#2)
frequently by##3##2##(1992-8#1)(1996-6#1)(2010-8#1)
frequently caused by##2##3##(1994-3#1)(2011-2#1)
frequently caused##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
frequently cited as##2##3##(2008-11#1)(2008-12#1)
frequently cited##4##2##(1993-1#1)(1995-12#1)(2008-11#1)(2008-12#1)
frequently coexisting##2##2##(1994-5#1)(2012-2#1)
frequently complete##2##2##(1990-11#1)(2010-6#1)
frequently complicated by##3##3##(2007-12#1)(2007-7#1)(2010-6#1)
frequently described in##3##3##(1992-5#1)(1992-8#1)(2008-9#1)
frequently detected in##5##3##(1996-12#1)(2008-10#1)(2009-8#1)(2010-5#1)(2013-1#1)
frequently detected##13##2##(1996-12#1)(2008-10#6)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
frequently diagnosed##4##2##(2007-7#1)(2010-6#1)(2011-1#1)(2012-12#1)
frequently done##2##2##(2008-11#1)(2008-3#1)
frequently during##3##2##(1996-6#1)(2008-10#1)(2012-3#1)
frequently employed##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
frequently encountered in##3##3##(1997-8#1)(2011-2#2)
frequently encountered##13##2##(1993-12#1)(1997-3#1)(1997-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
frequently fail to##2##3##(2007-4#1)(2008-10#1)
frequently followed by##2##3##(1991-2#1)(2008-7#1)
frequently follows##2##2##(2008-1#1)(2008-7#1)
frequently formed##2##2##(2008-10#2)
frequently found in the##3##4##(1997-6#1)(2008-7#1)(2011-2#1)
frequently found in##6##3##(1991-5#1)(1997-6#1)(2008-10#2)(2008-7#1)(2011-2#1)
frequently found##13##2##(1991-5#1)(1994-3#1)(1996-8#2)(1997-6#1)(2008-10#4)(2008-2#1)(2008-7#2)(2011-2#1)
frequently from##4##2##(1991-4#1)(2008-10#2)(2008-5#1)
frequently give rise to##2##4##(2009-5#1)(2010-6#1)
frequently had##2##2##(2008-10#1)(2010-5#1)
frequently has##3##2##(1992-11#1)(2007-7#1)(2011-2#1)
frequently have##7##2##(1993-2#1)(1995-11#1)(2006-10#1)(2011-2#2)(2012-1#1)(2013-1#1)
frequently identified##4##2##(2007-10#1)(2009-7#1)(2009-8#1)(2012-12#1)
frequently in male##2##3##(2007-10#1)(2011-2#1)
frequently in older##2##3##(2007-12#1)(2011-2#1)
frequently in the##11##3##(1991-10#1)(1993-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
frequently in##33##2##(1991-10#1)(1993-6#1)(1994-11#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#1)
frequently involved in the##2##4##(1993-9#1)(2009-5#1)
frequently involved in##5##3##(1993-9#1)(2006-7#1)(2008-5#1)(2009-5#1)(2013-1#1)
frequently involved##7##2##(1993-9#1)(2006-7#1)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#2)
frequently is##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
frequently isolated from##2##3##(2008-10#1)(2011-2#1)
frequently isolated##7##2##(1991-11#1)(1997-3#1)(2007-7#2)(2008-10#2)(2011-2#1)
frequently lead to##2##3##(1990-3#1)(2008-9#1)
frequently leads to##4##3##(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)
frequently mentioned##5##2##(1991-8#1)(2007-2#1)(2008-12#1)(2008-5#1)(2011-1#1)
frequently misunderstood##2##2##(1993-1#1)(2009-6#1)
frequently not##2##2##(1995-1#1)(2008-9#1)
frequently noted##2##2##(2008-1#1)(2008-7#1)
frequently observed in the##2##4##(2007-12#1)(2011-1#1)
frequently observed in##10##3##(1990-5#1)(1994-12#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2011-1#1)(2013-1#2)
frequently observed##30##2##(1990-5#1)(1991-4#1)(1992-6#1)(1994-12#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
frequently occurring##6##2##(1994-5#1)(1995-2#1)(2007-7#1)(2008-12#1)(2011-2#1)(2012-12#1)
frequently occurs in##2##3##(2008-3#1)(2008-6#1)
frequently occurs##4##2##(2007-8#1)(2008-3#1)(2008-6#1)(2009-12#1)
frequently of##2##2##(2008-10#1)(2008-9#1)
frequently overlooked##2##2##(2008-10#1)(2008-9#1)
frequently performed in##2##3##(2008-7#1)(2013-8#1)
frequently performed##9##2##(1990-9#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
frequently present in##2##3##(2009-10#1)(2012-12#1)
frequently present##5##2##(1994-12#1)(2007-5#1)(2009-10#1)(2009-9#1)(2012-12#1)
frequently presents##2##2##(2007-12#1)(2008-10#1)
frequently produces##2##2##(1990-5#1)(2008-10#1)
frequently provided##2##2##(1992-12#1)(1992-5#1)
frequently reported in association with##2##5##(2008-7#1)(2011-2#1)
frequently reported in##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
frequently reported##9##2##(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
frequently required##2##2##(1994-12#1)(2013-1#1)
frequently requires##2##2##(2008-2#1)(2008-7#1)
frequently result in##2##3##(2008-11#1)(2011-2#1)
frequently results##2##2##(2008-9#1)(2013-1#1)
frequently sampled##2##2##(2008-4#1)(2012-7#1)
frequently screened##3##2##(1990-12#2)(1992-10#1)
frequently seen in##5##3##(1993-11#1)(1994-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
frequently seen##10##2##(1993-11#1)(1993-8#1)(1994-11#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
frequently studied in the##2##4##(2008-7#1)(2012-7#1)
frequently studied in##3##3##(2008-7#1)(2012-7#1)(2013-7#1)
frequently studied##5##2##(2008-7#1)(2009-3#1)(2011-1#1)(2012-7#1)(2013-7#1)
frequently than the##2##3##(2008-10#1)(2013-1#1)
frequently than##18##2##(1990-6#1)(1993-11#1)(1994-5#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
frequently the##6##2##(1997-2#1)(1997-8#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-3#1)
frequently to##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
frequently treated by##3##3##(1995-9#1)(2006-10#1)(2009-10#1)
frequently treated##6##2##(1995-9#1)(2006-10#1)(2007-11#1)(2008-6#1)(2009-10#1)(2009-3#1)
frequently use##4##2##(1994-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
frequently used and##2##3##(2008-10#1)(2010-8#1)
frequently used drugs##2##3##(1994-6#1)(1997-6#1)
frequently used in the##5##4##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)
frequently used in##16##3##(1992-5#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#2)(2012-2#2)
frequently used methods##2##3##(2008-4#1)(2011-2#1)
frequently used modalities##2##3##(1995-12#1)(2012-2#1)
frequently used to assess##2##4##(2008-4#1)(2013-8#1)
frequently used to##8##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
frequently used treatment##2##3##(1994-2#1)(2011-2#1)
frequently used##63##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-5#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-3#2)(1997-6#1)(2006-10#1)(2007-11#4)(2007-8#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#2)
frequently were##3##2##(2008-10#2)(2012-2#1)
frequently with##4##2##(1997-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
frequently##691##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#5)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-6#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#5)(1995-5#3)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#6)(1996-6#5)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-6#2)(1997-7#4)(1997-8#3)(2006-10#5)(2006-12#1)(2006-7#1)(2007-10#4)(2007-11#11)(2007-12#10)(2007-2#3)(2007-4#3)(2007-5#1)(2007-7#8)(2007-8#5)(2008-1#10)(2008-10#80)(2008-11#26)(2008-12#12)(2008-2#7)(2008-3#16)(2008-4#7)(2008-5#23)(2008-6#12)(2008-7#30)(2008-8#9)(2008-9#18)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#7)(2010-6#8)(2010-7#1)(2010-8#5)(2011-1#9)(2011-2#51)(2011-3#2)(2012-1#2)(2012-12#15)(2012-2#21)(2012-3#8)(2012-7#2)(2013-1#30)(2013-7#5)(2013-8#13)
fresh AMI##2##2##(1995-2#2)
fresh CAPD fluids##2##3##(2008-10#2)
fresh air##2##2##(1993-2#1)(1996-12#1)
fresh and immortalised##2##3##(2008-11#2)
fresh and marine##3##3##(2008-10#2)(2008-9#1)
fresh and saline water##2##4##(2008-10#1)(2012-5#1)
fresh and stored seeds##2##4##(2008-5#2)
fresh and##19##2##(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-9#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-5#1)
fresh axilla secretions##2##3##(2008-5#2)
fresh blood in the##2##4##(2011-2#1)(2013-8#1)
fresh blood##3##2##(1993-9#1)(2011-2#1)(2013-8#1)
fresh broccoli##2##2##(2008-10#2)
fresh enzyme##2##2##(1992-11#1)(2008-7#1)
fresh fish (p = 0##2##5##(2011-2#2)
fresh fish##8##2##(1990-8#1)(2008-1#5)(2011-2#2)
fresh frozen plasma and##3##4##(1994-9#1)(2008-4#1)(2008-7#1)
fresh frozen plasma##5##3##(1990-2#1)(1994-9#1)(2008-4#1)(2008-7#1)(2013-8#1)
fresh frozen##9##2##(1990-2#1)(1991-4#1)(1993-6#1)(1994-9#1)(2008-4#1)(2008-7#1)(2008-9#2)(2013-8#1)
fresh fruit##2##2##(1990-8#1)(2008-10#1)
fresh ginseng##3##2##(2008-11#1)(2012-3#2)
fresh leaf juice##3##3##(2008-10#3)
fresh leaves##2##2##(2008-10#1)(2013-7#1)
fresh material##3##2##(2008-10#2)(2013-7#1)
fresh meat##4##2##(2008-10#1)(2010-2#2)(2011-1#1)
fresh medium##8##2##(1990-11#1)(2008-11#7)
fresh or##3##2##(1990-12#1)(2008-10#1)(2012-5#1)
fresh osteochondral allograft##2##3##(2012-3#2)
fresh osteochondral allografts##2##3##(2012-3#2)
fresh osteochondral##4##2##(2012-3#4)
fresh plasma##3##2##(1995-3#3)
fresh root##2##2##(2008-10#2)
fresh samples##2##2##(2008-5#1)(2012-2#1)
fresh surface ready##2##3##(2008-10#2)
fresh tissue##6##2##(1996-12#3)(2008-10#2)(2008-9#1)
fresh vegetable##2##2##(2008-10#2)
fresh water by##2##3##(2008-10#2)
fresh water crab##3##3##(2008-5#1)(2008-7#2)
fresh water samples##2##3##(2008-10#2)
fresh water##22##2##(1995-2#1)(2008-10#12)(2008-5#2)(2008-6#2)(2008-7#2)(2010-8#1)(2011-2#1)(2012-5#1)
fresh waters##5##2##(2008-10#5)
fresh weight of##3##3##(2008-12#3)
fresh weight##17##2##(2008-10#9)(2008-12#3)(2009-6#3)(2013-7#2)
fresh##237##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#6)(1994-6#2)(1994-9#1)(1995-2#3)(1995-3#3)(1996-12#7)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#10)(2008-10#75)(2008-11#15)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#9)(2009-4#1)(2009-6#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#8)(2012-5#3)(2012-7#1)(2013-1#2)(2013-7#5)(2013-8#3)
fresh-keeping##2##1##(2010-7#2)
fresh-water##2##1##(2008-6#2)
freshly added##2##2##(2008-11#1)(2011-2#1)
freshly isolated cells##2##3##(1995-11#2)
freshly isolated from##2##3##(1994-11#1)(1997-4#1)
freshly isolated human##2##3##(1990-12#1)(1995-8#1)
freshly isolated rat renal proximal tubules##2##6##(1997-1#2)
freshly isolated##15##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-11#2)(1995-8#1)(1997-1#2)(1997-4#1)(2007-8#1)(2008-11#1)(2008-4#2)(2011-2#1)
freshly mixed##2##2##(1990-12#1)(2008-10#1)
freshly prepared##4##2##(2008-10#3)(2008-7#1)
freshly procured##2##2##(2008-7#2)
freshly##43##1##(1990-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-8#2)(1997-1#2)(1997-4#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#1)
freshmen##2##1##(2013-8#2)
freshness was##2##2##(2008-10#2)
freshness##13##1##(2008-10#13)
freshwater fish##9##2##(2008-10#3)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-7#2)
freshwater fishes with enriched stable isotopes##2##6##(2010-8#2)
freshwater fishes##4##2##(2008-8#2)(2010-8#2)
freshwater habitats##3##2##(2010-8#2)(2013-7#1)
freshwater samples##5##2##(2008-10#5)
freshwater snail##4##2##(2008-8#4)
freshwater snails##2##2##(2008-12#1)(2011-2#1)
freshwater systems##6##2##(2008-11#1)(2008-12#3)(2012-12#1)(2012-5#1)
freshwater##83##1##(1991-8#1)(2007-12#1)(2008-10#20)(2008-11#3)(2008-12#6)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#1)(2009-5#1)(2010-6#1)(2010-8#8)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#4)(2013-8#1)
freshwaters##6##1##(2008-10#1)(2008-11#1)(2008-5#3)(2013-1#1)
freundii##9##1##(1993-11#3)(1994-9#3)(2010-6#2)(2011-2#1)
friability##3##1##(2010-3#2)(2012-2#1)
fricatives##3##1##(2009-12#3)
friction and the##2##3##(1996-4#1)(1997-3#1)
friction and##6##2##(1996-4#2)(1997-3#1)(2008-10#1)(2008-5#1)(2009-9#1)
friction behavior##5##2##(2008-5#2)(2010-10#3)
friction between##7##2##(1990-6#2)(1994-9#1)(1997-3#1)(2008-3#1)(2008-5#1)(2010-10#1)
friction coefficient##3##2##(2008-5#2)(2010-4#1)
friction couple##2##2##(2008-5#2)
friction force##2##2##(2008-10#1)(2008-5#1)
friction images##2##2##(1994-9#2)
friction laws##3##2##(1996-4#3)
friction of##2##2##(1996-4#1)(2008-5#1)
friction was##2##2##(1997-3#1)(2008-5#1)
friction##62##1##(1990-6#2)(1994-9#4)(1996-4#16)(1997-3#4)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#17)(2008-7#2)(2008-9#1)(2009-9#3)(2010-10#4)(2010-4#2)(2012-2#2)
frictional force##4##2##(2008-5#4)
frictional properties##2##2##(2008-5#1)(2010-4#1)
frictional##14##1##(2007-12#1)(2008-10#1)(2008-5#6)(2010-10#2)(2010-4#2)(2011-2#1)(2012-2#1)
fried##2##1##(1997-3#1)(2008-10#1)
friend in##2##2##(1996-12#1)(2010-5#1)
friend or foe?##2##3##(1991-12#1)(1996-3#1)
friend##24##1##(1991-12#1)(1996-12#1)(1996-3#1)(2007-12#4)(2008-2#1)(2008-7#1)(2009-7#7)(2010-1#1)(2010-5#2)(2013-1#4)(2013-8#1)
friend's##3##1##(2010-5#2)(2013-8#1)
friendly and##4##2##(1992-12#1)(1996-3#1)(1996-8#1)(2011-2#1)
friendly method##3##2##(2008-10#3)
friendly##23##1##(1992-12#1)(1992-2#1)(1992-3#1)(1996-3#1)(1996-8#1)(2008-10#10)(2008-3#2)(2009-7#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
friends (who##2##2##(2009-7#2)
friends and family##5##3##(1994-1#1)(1995-3#1)(1997-2#1)(2008-6#1)(2010-8#1)
friends and the##2##3##(2009-7#1)(2011-2#1)
friends and##12##2##(1994-1#1)(1995-1#1)(1995-3#1)(1997-2#1)(2008-6#1)(2009-5#1)(2009-7#3)(2010-8#2)(2011-2#1)
friends as##2##2##(2011-1#2)
friends in##2##2##(2009-7#2)
friends or relatives##3##3##(1997-6#1)(2008-12#1)(2008-7#1)
friends showed##2##2##(2009-7#2)
friends than##3##2##(2009-7#2)(2010-5#1)
friends were the##2##3##(1993-3#1)(2007-12#1)
friends were##4##2##(1993-3#1)(2007-12#1)(2009-7#2)
friends##67##1##(1992-12#2)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-6#1)(2007-12#2)(2007-4#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#30)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#2)
friends'##3##1##(2009-7#3)
friendship and##3##2##(2010-2#2)(2013-1#1)
friendship##12##1##(2008-4#2)(2009-7#2)(2010-2#4)(2010-5#2)(2013-1#2)
friendships##5##1##(2009-11#1)(2009-7#3)(2010-5#1)
fries##2##1##(2008-12#1)(2012-2#1)
frightened##2##1##(1992-3#1)(2009-10#1)
frightening##2##1##(1994-1#1)(2008-7#1)
frigid mutant##3##2##(1991-2#3)
frigida##3##1##(2013-1#3)
fringe analysis##5##2##(2008-2#3)(2008-3#2)
fringe analyzer##2##2##(2008-2#2)
fringe contrast##4##2##(2007-12#1)(2008-3#3)
fringe cuts##2##2##(2008-2#2)
fringe density##2##2##(2008-3#2)
fringe frequency##2##2##(2008-3#2)
fringe images##2##2##(2007-12#2)
fringe imaging##4##2##(2008-2#2)(2008-3#2)
fringe intensity##3##2##(2008-3#3)
fringe locking##2##2##(2007-12#1)(2008-3#1)
fringe modulation##6##2##(2007-12#1)(2008-3#5)
fringe motion##2##2##(2008-3#2)
fringe order of##2##3##(2008-2#1)(2008-3#1)
fringe order##9##2##(2008-2#2)(2008-3#7)
fringe orders##3##2##(2008-2#2)(2008-3#1)
fringe orientation in##2##3##(2008-2#2)
fringe pattern in the##2##4##(2008-2#2)
fringe pattern in##3##3##(2008-2#2)(2008-3#1)
fringe pattern is##2##3##(2008-3#2)
fringe pattern##23##2##(2007-11#1)(2008-2#12)(2008-3#10)
fringe patterns and##2##3##(2008-2#1)(2008-3#1)
fringe patterns are##3##3##(2008-2#1)(2008-3#2)
fringe patterns for##2##3##(2008-3#2)
fringe patterns is presented##2##4##(2008-3#2)
fringe patterns is##3##3##(2008-3#3)
fringe patterns obtained##2##3##(2008-2#2)
fringe patterns##35##2##(2007-11#1)(2008-2#16)(2008-3#18)
fringe phase##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
fringe projection##6##2##(2008-2#1)(2008-3#5)
fringe spacing##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
fringe technique##4##2##(2007-12#1)(2008-3#3)
fringe visibility##11##2##(2007-12#1)(2008-2#2)(2008-3#8)
fringe##187##1##(1996-3#1)(2007-11#4)(2007-12#12)(2008-2#59)(2008-3#109)(2011-2#1)(2013-8#1)
fringe-adjusted##2##1##(2008-3#2)
fringe-contrast##2##1##(2008-2#1)(2008-3#1)
fringe-order##2##1##(2008-2#1)(2008-3#1)
fringe-projection method##2##2##(2008-3#2)
fringe-projection##6##1##(2008-3#6)
fringes and##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
fringes are obtained##2##3##(2008-2#1)(2008-3#1)
fringes are##12##2##(2008-2#3)(2008-3#9)
fringes by##2##2##(2007-11#1)(2007-12#1)
fringes can be##2##3##(2008-3#2)
fringes for##2##2##(2008-3#2)
fringes formed by a##2##4##(2007-11#1)(2008-3#1)
fringes formed by##3##3##(2007-11#2)(2008-3#1)
fringes formed##4##2##(2007-11#3)(2008-3#1)
fringes from##2##2##(2008-2#1)(2008-3#1)
fringes in both##2##3##(2007-12#1)(2008-3#1)
fringes in the##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
fringes in##19##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#14)
fringes is##4##2##(2008-3#4)
fringes observed##2##2##(2008-3#2)
fringes or##2##2##(2008-2#2)
fringes produced by the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
fringes that are##4##3##(2007-12#1)(2008-3#3)
fringes that##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
fringes to be##2##3##(2008-3#2)
fringes to##4##2##(2008-2#1)(2008-3#3)
fringes when##2##2##(2008-3#2)
fringes with##3##2##(2008-2#1)(2008-3#2)
fringes##117##1##(2007-11#9)(2007-12#5)(2007-5#1)(2008-2#23)(2008-3#78)(2013-8#1)
fritillary##3##1##(2008-8#2)(2012-3#1)
frizzled naked neck and##2##4##(2008-5#2)
frizzled naked neck##3##3##(2008-5#3)
frm2##3##1##(1996-3#3)
frog (Rana catesbeiana) brain and intestine##2##6##(1991-5#2)
frog (Rana##3##2##(1991-5#2)(2012-3#1)
frog Physalaemus biligonigerus##2##3##(2008-7#2)
frog Rana##5##2##(1993-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
frog and##2##2##(2008-10#1)(2010-3#1)
frog lens##2##2##(1993-2#2)
frog pituitary melanotrophs##3##3##(1993-5#3)
frog pituitary##4##2##(1993-5#4)
frog skin##4##2##(1993-3#1)(1994-5#1)(2008-5#1)(2008-7#1)
frog##51##1##(1990-5#4)(1991-5#2)(1993-2#2)(1993-3#4)(1993-5#5)(1993-8#1)(1994-11#2)(1994-5#2)(1996-2#2)(1996-5#4)(1996-6#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#4)
frog-turtle clade##2##2##(2010-3#2)
frogs (Rana##2##2##(2008-8#1)(2008-9#1)
frogs and##3##2##(2008-12#3)
frogs##17##1##(1991-1#1)(1992-11#1)(1995-2#3)(1996-6#2)(2008-12#3)(2008-8#3)(2008-9#3)(2013-7#1)
frogs) by##2##2##(2008-12#1)(2008-5#1)
froid##4##1##(2008-5#3)(2011-2#1)
from $1##2##2##(1992-2#1)(1993-3#1)
from &gt##4##2##(1997-7#1)(2008-2#1)(2008-4#1)(2010-6#1)
from &lt##9##2##(1995-6#1)(2008-10#6)(2008-7#1)(2010-3#1)
from &quot##16##2##(1991-12#1)(1992-8#1)(1995-1#1)(1995-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-1#1)
from (0##2##2##(2008-10#1)(2008-6#1)
from (1)##2##2##(2009-11#1)(2012-3#1)
from +0##3##2##(2008-10#3)
from -0##6##2##(2008-10#6)
from -1##3##2##(2008-10#3)
from -20##3##2##(2008-10#1)(2008-3#2)
from -5 to##2##3##(2008-10#1)(2008-3#1)
from -5##3##2##(2008-10#2)(2008-3#1)
from 0 to 0##6##4##(2008-10#2)(2008-11#1)(2009-6#1)(2010-4#1)(2011-1#1)
from 0 to 1##7##4##(2008-10#4)(2008-5#1)(2009-6#1)(2011-2#1)
from 0 to 100##4##4##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
from 0 to 100% of##2##5##(1993-8#1)(2008-9#1)
from 0 to 100%##4##4##(1993-8#1)(1994-3#1)(2008-9#2)
from 0 to 3##3##4##(2007-11#1)(2008-10#1)(2008-8#1)
from 0 to 30##2##4##(2007-8#1)(2013-1#1)
from 0 to 5##2##4##(2008-10#2)
from 0 to 50%##2##4##(1993-12#1)(2008-10#1)
from 0 to 6##2##4##(1991-9#1)(2008-10#1)
from 0 to##66##3##(1991-2#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#29)(2008-11#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-6#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-8#1)(2013-1#2)(2013-8#1)
from 0##461##2##(1990-11#3)(1990-12#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#8)(2007-12#5)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#230)(2008-11#9)(2008-12#4)(2008-2#9)(2008-3#24)(2008-5#13)(2008-7#6)(2008-8#5)(2008-9#5)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#2)(2009-7#5)(2009-8#1)(2010-10#2)(2010-11#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#13)(2011-2#16)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#13)(2013-7#3)(2013-8#5)
from 0% in##4##3##(1995-1#1)(2008-10#1)(2010-8#1)(2013-8#1)
from 0% to##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
from 0%##7##2##(1995-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
from 1 month to##2##4##(2007-8#1)(2011-2#1)
from 1 to &gt##2##4##(1997-3#1)(2008-10#1)
from 1 to 10 kHz##2##5##(2007-11#2)
from 1 to 10##5##4##(2007-11#2)(2008-10#1)(2008-7#1)(2010-8#1)
from 1 to 100##2##4##(2008-10#1)(2008-11#1)
from 1 to 13##2##4##(2008-10#2)
from 1 to 2##6##4##(1990-12#1)(1993-9#1)(1995-5#1)(2007-11#2)(2008-11#1)
from 1 to 3##2##4##(1997-6#1)(2007-10#1)
from 1 to 4##6##4##(2008-10#2)(2008-3#2)(2011-2#1)(2013-1#1)
from 1 to 5##4##4##(1992-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
from 1 to 6##3##4##(2008-10#2)(2013-1#1)
from 1 to##52##3##(1990-12#1)(1992-3#1)(1993-11#1)(1993-9#1)(1995-5#1)(1997-3#2)(1997-6#1)(2007-10#2)(2007-11#5)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
from 1 year to##2##4##(1995-6#1)(2008-10#1)
from 1##215##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#11)(2007-12#6)(2007-8#2)(2008-1#2)(2008-10#89)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#9)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#5)
from 1% to##3##3##(1993-8#1)(1994-12#1)(2012-12#1)
from 10 ml of##2##4##(2008-10#2)
from 10 patients##2##3##(2008-5#1)(2013-1#1)
from 10 to 100##2##4##(2008-10#1)(2008-4#1)
from 10 to 12##3##4##(1997-2#1)(2008-2#1)(2011-2#1)
from 10 to 20##2##4##(2008-10#1)(2008-3#1)
from 10 to 200##2##4##(1990-8#1)(2011-2#1)
from 10 to 30##5##4##(1994-11#1)(2008-10#2)(2008-3#1)(2009-7#1)
from 10 to 60##2##4##(2008-10#2)
from 10 to##44##3##(1990-2#1)(1990-8#1)(1994-11#1)(1994-3#1)(1997-2#1)(2008-10#24)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2011-2#3)(2013-1#1)
from 10##99##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-10#1)(1993-1#1)(1994-11#1)(1994-3#2)(1996-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
from 10% to##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
from 10%##5##2##(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
from 10(-1) to##3##3##(2008-10#3)
from 10(-3) to##3##3##(2008-10#3)
from 10(-5)##2##2##(2008-10#2)
from 10(3) to 10(5)##2##4##(2008-10#1)(2008-2#1)
from 10(3) to##3##3##(2008-10#2)(2008-2#1)
from 10(4) to##2##3##(2008-10#2)
from 10-1000##2##2##(1991-2#1)(2008-10#1)
from 100 000##2##3##(2008-10#2)
from 100 to 1##2##4##(2008-10#1)(2013-1#1)
from 100 to##14##3##(2007-12#3)(2008-10#7)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
from 100##25##2##(1990-5#1)(1993-12#1)(2007-12#3)(2008-10#13)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
from 100%##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
from 1000##2##2##(2007-11#1)(2008-2#1)
from 101 to 103%##2##4##(2008-10#2)
from 101 to##4##3##(1997-6#1)(2008-10#3)
from 103##3##2##(2008-10#2)(2011-2#1)
from 1032 to##2##3##(2007-11#1)(2007-12#1)
from 104##2##2##(1991-6#1)(2008-10#1)
from 105##2##2##(1990-2#1)(2010-6#1)
from 11 patients##2##3##(1994-7#1)(1996-5#1)
from 11 to##8##3##(1990-7#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)
from 11##31##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-3#1)(1994-7#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-5#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#2)
from 110##2##2##(1997-2#1)(2008-10#1)
from 112##3##2##(2008-10#1)(2008-4#1)(2009-9#1)
from 113##2##2##(2007-12#1)(2013-1#1)
from 115##2##2##(1996-11#1)(2008-10#1)
from 117##3##2##(2008-10#2)(2010-1#1)
from 118##2##2##(2008-12#1)(2011-1#1)
from 12 patients##2##3##(2008-12#1)(2012-5#1)
from 12 to 18##3##4##(1993-11#2)(2013-1#1)
from 12 to 24##2##4##(2008-10#2)
from 12 to 32 degrees C##2##6##(2008-10#2)
from 12 to##23##3##(1993-11#2)(1994-9#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
from 12##51##2##(1990-2#1)(1992-12#1)(1993-11#2)(1994-9#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#2)
from 12%##2##2##(2008-10#1)(2008-5#1)
from 120 to##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
from 120##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)
from 124##2##2##(1992-5#1)(1994-12#1)
from 129##3##2##(1994-9#1)(2008-10#1)(2008-5#1)
from 13##11##2##(1990-7#1)(1991-12#1)(1995-8#1)(1997-4#1)(2007-10#1)(2008-2#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
from 13% to##2##3##(2008-10#1)(2013-8#1)
from 134##3##2##(1991-6#1)(2011-2#2)
from 14 to 18##2##4##(2007-12#1)(2008-10#1)
from 14 to 28##2##4##(2008-10#1)(2009-12#1)
from 14 to##9##3##(1993-12#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#2)(2009-12#1)
from 14##18##2##(1993-10#1)(1993-12#1)(1995-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-12#1)
from 144##2##2##(1996-2#1)(2010-8#1)
from 146##2##2##(1995-3#1)(2008-8#1)
from 148##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
from 149##3##2##(1993-8#1)(1997-8#1)(2009-5#1)
from 15 days to##2##4##(1996-5#1)(2008-10#1)
from 15 degrees to##2##4##(2008-2#2)
from 15 different##2##3##(2008-10#2)
from 15 patients##2##3##(1997-1#1)(2008-6#1)
from 15 to 30##3##4##(2008-10#2)(2008-2#1)
from 15 to##8##3##(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#1)(2011-1#1)(2013-1#1)
from 15##41##2##(1991-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#12)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
from 150##5##2##(1995-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
from 1515##2##2##(2007-11#1)(2011-1#1)
from 152##2##2##(2008-10#1)(2012-2#1)
from 158##2##2##(1990-11#1)(1995-6#1)
from 159##2##2##(1993-12#1)(2008-8#1)
from 16 to##2##3##(2008-3#1)(2013-8#1)
from 16##14##2##(1994-12#1)(1995-12#1)(1995-8#1)(2006-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
from 16%##2##2##(1995-8#1)(2011-2#1)
from 160##2##2##(1997-6#1)(2011-2#1)
from 17 to##2##3##(2007-7#1)(2008-11#1)
from 17##13##2##(1990-3#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-7#1)(2008-10#6)(2008-11#1)(2011-2#1)
from 170 to##3##3##(1991-2#1)(2008-10#2)
from 170##4##2##(1991-2#1)(2008-10#3)
from 18 months##2##3##(1994-6#1)(2007-8#1)
from 18 to##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
from 18##23##2##(1992-11#1)(1992-6#1)(1994-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
from 18%##2##2##(2008-10#1)(2013-1#1)
from 18-month-old residues that were##2##5##(2008-10#2)
from 180##4##2##(1991-6#1)(2008-10#1)(2009-10#1)(2009-9#1)
from 1860 to 2090 nm##2##5##(2007-11#2)
from 19 patients##2##3##(1993-2#1)(2008-5#1)
from 19 to##6##3##(1990-3#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
from 19##12##2##(1990-3#2)(1991-4#1)(1993-2#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
from 19%##2##2##(2008-11#1)(2011-2#1)
from 190##2##2##(1996-5#1)(2008-12#1)
from 1920 to##2##3##(2008-2#1)(2008-8#1)
from 1932##2##2##(1993-6#1)(2007-6#1)
from 1950##3##2##(1991-3#1)(1993-6#1)(2011-1#1)
from 1960 to##7##3##(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2013-1#1)
from 1964 to##2##3##(1991-5#1)(2008-10#1)
from 1966 to##3##3##(1992-10#1)(2008-7#1)(2008-8#1)
from 1966##4##2##(1992-10#1)(2007-11#1)(2008-7#1)(2008-8#1)
from 1970 through##3##3##(1990-6#1)(1991-2#1)(1992-1#1)
from 1970 to##3##3##(1991-2#1)(2008-12#1)(2008-2#1)
from 1970##6##2##(1990-6#1)(1991-2#2)(1992-1#1)(2008-12#1)(2008-2#1)
from 1972 to##2##3##(1990-6#1)(1992-9#1)
from 1974 to the present##2##5##(1990-6#1)(1994-2#1)
from 1974 to##6##3##(1990-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#1)
from 1974##7##2##(1990-5#1)(1990-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#1)
from 1975 to##3##3##(1991-9#2)(2012-2#1)
from 1975##4##2##(1991-9#2)(2008-10#1)(2012-2#1)
from 1976 to##2##3##(2009-7#1)(2011-2#1)
from 1979 through##2##3##(1993-12#1)(2008-9#1)
from 1979 to 2008##2##4##(2012-12#2)
from 1979 to##4##3##(1996-4#1)(2012-12#2)(2012-3#1)
from 1979##6##2##(1993-12#1)(1996-4#1)(2008-9#1)(2012-12#2)(2012-3#1)
from 1980 through##3##3##(1991-3#1)(2008-7#1)(2008-8#1)
from 1980 to##8##3##(1990-3#1)(1996-9#1)(2008-10#1)(2009-5#1)(2012-2#4)
from 1980##13##2##(1990-3#1)(1991-3#1)(1996-7#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#4)
from 1981 to##2##3##(1990-12#1)(2008-10#1)
from 1982 to 1987##2##4##(1991-4#1)(1992-1#1)
from 1982 to##4##3##(1991-4#1)(1992-1#1)(1994-7#1)(1995-3#1)
from 1982##5##2##(1991-4#1)(1992-1#1)(1994-7#1)(1995-3#1)(2010-3#1)
from 1983 to##2##3##(1991-9#1)(1994-2#1)
from 1983 until##2##3##(1996-11#1)(2008-10#1)
from 1983##7##2##(1990-11#1)(1991-12#1)(1991-9#1)(1994-2#2)(1996-11#1)(2008-10#1)
from 1984 through##3##3##(1996-1#1)(2008-8#2)
from 1984 to##7##3##(1991-12#1)(1994-2#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)
from 1984##10##2##(1991-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)
from 1985 through 1987##2##4##(1991-12#1)(1993-12#1)
from 1985 through##3##3##(1991-12#1)(1992-12#1)(1993-12#1)
from 1985 to 1998##2##4##(2007-12#1)(2008-1#1)
from 1985 to##8##3##(1992-1#1)(1993-3#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
from 1985##11##2##(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
from 1986 to##6##3##(1990-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
from 1986##8##2##(1990-12#1)(1993-11#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
from 1987 to##2##3##(1992-5#1)(1994-3#1)
from 1987##4##2##(1992-5#1)(1994-2#1)(1994-3#1)(1997-6#1)
from 1988 to 1998##2##4##(2008-9#2)
from 1988 to##5##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#2)
from 1988##7##2##(1994-6#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#2)
from 1989 through##2##3##(1995-1#1)(2008-10#1)
from 1989 to 1999##2##4##(2008-1#1)(2008-9#1)
from 1989 to##4##3##(1993-9#1)(2008-1#2)(2008-9#1)
from 1989##8##2##(1993-9#1)(1995-1#1)(1996-1#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-9#1)
from 1990 to 1993##2##4##(1996-3#1)(1996-6#1)
from 1990 to 1998##2##4##(2007-12#1)(2011-2#1)
from 1990 to 1999##2##4##(2008-10#1)(2012-2#1)
from 1990 to##14##3##(1991-11#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
from 1990##16##2##(1991-11#1)(1994-6#1)(1995-6#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
from 1991 to 1993##2##4##(1995-12#1)(1995-3#1)
from 1991 to##5##3##(1995-12#1)(1995-3#1)(2007-8#1)(2012-3#1)(2013-1#1)
from 1991##6##2##(1993-8#1)(1995-12#1)(1995-3#1)(2007-8#1)(2012-3#1)(2013-1#1)
from 1992 to 1996##2##4##(1996-9#1)(2008-10#1)
from 1992 to##7##3##(1996-9#1)(2008-10#3)(2008-5#1)(2010-8#1)(2012-3#1)
from 1992##9##2##(1996-9#1)(2008-10#4)(2008-5#1)(2010-4#1)(2010-8#1)(2012-3#1)
from 1993 to 1998##2##4##(2008-1#1)(2008-10#1)
from 1993 to##6##3##(2007-4#1)(2008-1#1)(2008-10#4)
from 1993##8##2##(1997-1#1)(2007-4#1)(2008-1#1)(2008-10#5)
from 1994 through 1996##2##4##(2008-10#2)
from 1994 to 1996##3##4##(1997-6#1)(2008-10#2)
from 1994 to 1997##2##4##(2008-10#2)
from 1994 to 2005##2##4##(2009-5#1)(2011-2#1)
from 1994 to##10##3##(1997-6#1)(2008-10#4)(2008-9#1)(2009-5#1)(2011-2#2)(2012-3#1)
from 1994##14##2##(1997-3#1)(1997-6#2)(2008-10#6)(2008-9#1)(2009-5#1)(2011-2#2)(2012-3#1)
from 1995 to 1997##3##4##(2008-10#3)
from 1995 to 1998##2##4##(2008-10#1)(2008-11#1)
from 1995 to##10##3##(2008-10#5)(2008-11#1)(2008-12#1)(2010-12#1)(2012-1#1)(2012-12#1)
from 1995##12##2##(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
from 1996 to 1998##2##4##(2008-10#2)
from 1996 to##3##3##(2008-10#2)(2013-1#1)
from 1996##9##2##(2007-6#3)(2008-10#4)(2012-2#1)(2013-1#1)
from 1997 to##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
from 1997##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2013-8#1)
from 1998 to 2000##2##4##(2008-10#2)
from 1998 to##5##3##(2007-8#1)(2008-10#3)(2011-2#1)
from 1998##9##2##(2007-6#1)(2007-8#1)(2008-10#6)(2011-2#1)
from 1999 and##2##3##(2007-6#1)(2009-6#1)
from 1999 to##5##3##(2008-11#1)(2010-8#1)(2012-1#2)(2013-8#1)
from 1999##8##2##(2007-6#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-1#2)(2013-8#1)
from 1x10(-3) to##2##3##(2008-10#2)
from 1x10(-7) to##2##3##(2008-10#2)
from 2 days to##2##4##(2013-1#2)
from 2 months##2##3##(1996-12#1)(2008-4#1)
from 2 to 10 in##2##5##(2007-11#1)(2008-10#1)
from 2 to 10##4##4##(2007-11#1)(2008-10#2)(2008-11#1)
from 2 to 15##2##4##(1996-5#1)(2008-10#1)
from 2 to 4##2##4##(2008-10#1)(2012-2#1)
from 2 to 5##2##4##(1992-11#1)(2010-5#1)
from 2 to 6##3##4##(1991-8#1)(1992-12#1)(1996-5#1)
from 2 to 8##3##4##(1994-3#1)(2008-10#1)(2012-1#1)
from 2 to##33##3##(1990-2#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-2#1)(1996-5#2)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-6#1)(2010-5#1)(2012-1#1)(2012-2#2)
from 2 weeks to##2##4##(2007-7#1)(2008-10#1)
from 2##141##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-7#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#9)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#52)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#6)
from 2% to 7%##2##4##(2008-2#1)(2012-12#1)
from 2% to##4##3##(1991-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
from 2%##5##2##(1991-11#1)(2008-10#1)(2008-2#1)(2009-4#1)(2012-12#1)
from 2(2+) and##2##3##(1996-2#2)
from 2-adamantanone##2##2##(2008-5#2)
from 20 patients##2##3##(2011-2#1)(2013-8#1)
from 20 to 30 degrees C##2##6##(2008-10#2)
from 20 to 30##3##4##(2008-10#2)(2012-12#1)
from 20 to 300##2##4##(2008-10#2)
from 20 to 60##2##4##(2008-1#1)(2008-10#1)
from 20 to 70##2##4##(2008-10#2)
from 20 to##30##3##(1990-8#1)(1992-11#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
from 20##57##2##(1990-8#2)(1991-2#1)(1992-11#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#2)(1997-3#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#21)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
from 20% to##2##3##(2008-7#1)(2010-4#1)
from 20%##4##2##(1997-4#1)(2008-7#2)(2010-4#1)
from 20-##2##2##(2008-10#1)(2008-8#1)
from 200 to##5##3##(1990-2#1)(1991-12#1)(2007-11#1)(2008-10#2)
from 200##9##2##(1990-2#1)(1991-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2011-1#1)(2011-2#1)
from 2000 to 2003##2##4##(2007-11#1)(2008-9#1)
from 2000 to 2005##3##4##(2008-10#1)(2008-11#2)
from 2000 to##10##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#2)
from 2000##13##2##(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-3#1)
from 2001 to 2004##4##4##(2008-10#2)(2008-8#1)(2011-2#1)
from 2001 to 2005##3##4##(2008-12#1)(2010-8#1)(2011-2#1)
from 2001 to##13##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-8#1)
from 2001##16##2##(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-8#1)
from 2002 to 2004##2##4##(2008-10#2)
from 2002 to##5##3##(2008-10#2)(2010-8#1)(2011-2#1)(2012-3#1)
from 2002##6##2##(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
from 2003 to##4##3##(2009-12#1)(2010-8#1)(2011-2#2)
from 2003##7##2##(2008-10#2)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#2)
from 2004 to 2009##2##4##(2011-2#2)
from 2004 to##5##3##(2007-12#1)(2009-3#1)(2011-2#2)(2012-3#1)
from 2004##10##2##(2007-12#1)(2008-1#1)(2008-10#3)(2009-2#1)(2009-3#1)(2011-2#2)(2012-3#1)
from 2005 to 2009##2##4##(2012-3#2)
from 2005 to 2010##2##4##(2012-3#2)
from 2005 to 2011##2##4##(2012-12#1)(2013-8#1)
from 2005 to##9##3##(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#2)
from 2006 to 2010##2##4##(2013-1#1)(2013-8#1)
from 2006 to##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
from 2006##4##2##(2011-1#1)(2013-1#2)(2013-8#1)
from 2008 to##3##3##(2011-7#1)(2012-3#2)
from 2009 to##2##3##(2012-3#2)
from 2009##3##2##(2011-2#1)(2012-3#2)
from 201##2##2##(2011-2#1)(2012-1#1)
from 21 to##4##3##(1990-11#1)(1994-6#1)(2007-7#1)(2008-10#1)
from 21##14##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-3#1)(1994-6#1)(1994-7#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)
from 22 countries##2##3##(1991-4#1)(2008-10#1)
from 22 to##6##3##(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
from 22##17##2##(1990-9#1)(1991-4#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#2)
from 23 to##3##3##(1990-2#1)(1995-3#1)(2009-3#1)
from 23##11##2##(1990-2#1)(1992-12#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
from 23%##2##2##(2008-10#1)(2010-5#1)
from 24 patients##2##3##(2007-11#1)(2012-3#1)
from 24 to##6##3##(1993-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)
from 24##19##2##(1993-12#1)(1997-3#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2009-11#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-7#1)
from 240 to##3##3##(2008-10#2)(2008-2#1)
from 240##5##2##(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#1)
from 25 patients##2##3##(1992-3#1)(2008-7#1)
from 25 primary health care centers##2##6##(2011-2#2)
from 25 to 50 degrees C##2##6##(2008-10#1)(2008-3#1)
from 25 to##18##3##(1993-3#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-7#1)(2009-12#1)(2011-1#1)
from 25##33##2##(1991-2#1)(1992-3#1)(1993-3#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)
from 250 to##5##3##(2008-10#3)(2008-2#2)
from 250##7##2##(1993-12#1)(2008-10#4)(2008-2#2)
from 253##2##2##(2008-10#1)(2013-1#1)
from 257##2##2##(2008-7#1)(2011-2#1)
from 26##7##2##(1991-3#1)(1992-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)
from 27##12##2##(1990-12#1)(1991-7#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-12#1)
from 28##9##2##(1990-12#1)(1991-11#1)(1993-9#1)(1996-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
from 28% in##2##3##(2008-10#1)(2013-8#1)
from 28%##4##2##(1995-3#1)(2008-10#2)(2013-8#1)
from 29 to##5##3##(1990-8#1)(1993-12#1)(2006-5#1)(2007-8#1)(2008-10#1)
from 29##9##2##(1990-8#1)(1993-12#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)
from 290 to##2##3##(2008-3#1)(2008-5#1)
from 290##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
from 296##2##2##(2008-10#1)(2008-3#1)
from 3 different##2##3##(1991-2#1)(2011-1#1)
from 3 months##3##3##(1992-5#1)(2007-8#1)(2008-4#1)
from 3 to 10##2##4##(2008-10#1)(2010-5#1)
from 3 to 5##2##4##(2008-12#1)(2011-2#1)
from 3 to 8##3##4##(2007-12#1)(2010-11#1)(2011-2#1)
from 3 to##26##3##(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
from 3##102##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#3)(2007-8#3)(2008-1#1)(2008-10#36)(2008-11#2)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-8#2)
from 3%##2##2##(1994-12#1)(2008-10#1)
from 3(2+)##2##2##(1996-2#2)
from 3-D##2##2##(2008-11#1)(2008-3#1)
from 30 to 15##2##4##(2008-10#1)(2010-8#1)
from 30 to 37##2##4##(1996-12#1)(2008-7#1)
from 30 to 50##2##4##(2008-6#1)(2008-7#1)
from 30 to 60##2##4##(1993-1#1)(2008-10#1)
from 30 to##24##3##(1991-9#1)(1993-1#1)(1996-12#1)(1997-8#1)(2008-10#10)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2010-8#1)(2011-2#1)
from 30##32##2##(1990-6#1)(1991-9#2)(1993-1#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#11)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)
from 300 mOsmol kg-1 to##3##5##(2008-11#3)
from 300 to 1000 nm##2##5##(2007-12#1)(2008-3#1)
from 300 to 1000##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
from 300 to##10##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)
from 300##18##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#5)(2008-2#3)(2008-3#4)
from 31 to##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
from 31##8##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#1)
from 313##2##2##(2008-8#1)(2009-5#1)
from 32 to##2##3##(2008-11#1)(2008-3#1)
from 32##8##2##(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-1#1)(2013-1#1)
from 32P-labeled##2##2##(1990-11#1)(1995-2#1)
from 33##9##2##(1990-2#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-9#1)
from 34##7##2##(1994-6#1)(2008-10#3)(2008-12#1)(2009-10#1)(2010-8#1)
from 35 to##4##3##(2008-10#2)(2008-6#1)(2009-7#1)
from 35##11##2##(1991-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)
from 350 to##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#1)
from 355##2##2##(2008-10#1)(2009-2#1)
from 36 to##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
from 36##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
from 37 degrees C to##3##5##(2007-10#1)(2008-11#2)
from 37 patients##2##3##(2007-7#1)(2008-10#1)
from 37 to##5##3##(1992-9#1)(1997-7#1)(2007-12#1)(2008-11#2)
from 37##12##2##(1992-9#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)
from 38##4##2##(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
from 38%##2##2##(2009-4#1)(2010-8#1)
from 380 to##2##3##(1991-2#1)(2008-2#1)
from 39 to##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
from 39##5##2##(1995-3#1)(2007-8#1)(2008-10#2)(2012-1#1)
from 3D##3##2##(2008-2#1)(2009-7#1)(2011-2#1)
from 3x10(-9) to##2##3##(2008-10#2)
from 4 degrees C cultures##2##5##(2008-10#2)
from 4 different##2##3##(1997-3#1)(2013-8#1)
from 4 months to##2##4##(1997-3#1)(2008-9#1)
from 4 to 10##2##4##(2008-10#1)(2008-11#1)
from 4 to 11##2##4##(2008-10#2)
from 4 to 14##2##4##(2007-11#1)(2008-10#1)
from 4 to 6##2##4##(2008-10#1)(2008-12#1)
from 4 to##18##3##(1997-7#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2013-8#1)
from 4##74##2##(1990-11#1)(1991-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#3)(1997-3#2)(1997-7#2)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#3)(2010-10#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-8#3)
from 4%##2##2##(1997-3#1)(2008-10#1)
from 4-week-old plants##2##3##(2008-10#2)
from 40 to 400##2##4##(2008-10#2)
from 40 to##11##3##(1993-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)
from 40##17##2##(1991-8#1)(1993-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-12#1)(2011-2#1)(2012-12#1)
from 400 to##11##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)
from 400##13##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#4)
from 41##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2012-12#1)
from 42##7##2##(1991-9#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
from 43##6##2##(1991-5#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
from 430##2##2##(2007-11#1)(2008-9#1)
from 45 to 65##2##4##(2010-7#1)(2013-8#1)
from 45 to##6##3##(2008-10#2)(2009-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
from 45##12##2##(1990-8#1)(1993-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
from 450 to##3##3##(2008-10#2)(2008-12#1)
from 46##4##2##(1990-2#1)(1997-3#1)(2008-10#2)
from 47 to##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
from 47##5##2##(1993-12#1)(1997-8#1)(2008-10#1)(2012-12#1)(2013-1#1)
from 48 to##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
from 48##14##2##(1991-11#1)(1992-12#1)(1993-8#1)(1994-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
from 49 to##2##3##(2008-3#1)(2011-2#1)
from 49##6##2##(1992-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
from 495##2##2##(2008-12#1)(2012-2#1)
from 5 different##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
from 5 to 15##4##4##(2008-10#3)(2008-6#1)
from 5 to 200muM and##2##5##(2008-10#2)
from 5 to 25 degrees C##3##6##(2008-10#3)
from 5 to 30##2##4##(2008-2#1)(2008-3#1)
from 5 to 8##2##4##(2008-10#1)(2009-7#1)
from 5 to 80##2##4##(2008-3#2)
from 5 to##45##3##(1990-6#1)(1991-2#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-9#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
from 5 x##4##3##(1997-4#1)(2008-10#2)(2009-3#1)
from 5##125##2##(1990-11#2)(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#52)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
from 5% in##2##3##(1994-3#1)(2008-10#1)
from 5% to 10%##3##4##(2008-3#2)(2008-9#1)
from 5% to##4##3##(2008-3#2)(2008-9#1)(2013-1#1)
from 5%##8##2##(1994-3#1)(1996-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2013-1#1)
from 5-day-old##2##2##(2011-2#2)
from 5-fold##2##2##(1993-3#1)(2009-10#1)
from 50 to 600##2##4##(2008-10#1)(2008-3#1)
from 50 to##19##3##(1990-2#1)(1992-12#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-5#2)
from 50##32##2##(1990-2#1)(1992-12#1)(1993-1#1)(1994-2#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#1)
from 50% of the##2##4##(2008-10#1)(2008-11#1)
from 50% of##3##3##(2008-10#2)(2008-11#1)
from 50%##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)
from 500 to##2##3##(2007-11#1)(2008-3#1)
from 500##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
from 51##4##2##(1995-12#1)(2008-12#1)(2011-2#1)(2013-1#1)
from 52 to##2##3##(1995-5#1)(2008-10#1)
from 52##10##2##(1990-2#1)(1993-2#1)(1993-9#1)(1995-3#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
from 53 patients##2##3##(1990-3#1)(2012-5#1)
from 53 to##2##3##(2008-10#1)(2011-2#1)
from 53##7##2##(1990-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)(2012-5#1)
from 54 to##4##3##(1995-3#1)(2008-10#2)(2008-2#1)
from 54##8##2##(1995-3#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-1#1)
from 540##2##2##(2008-10#1)(2008-8#1)
from 55 to##2##3##(2008-10#1)(2013-1#1)
from 55##5##2##(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
from 55% to##2##3##(2008-11#1)(2010-1#1)
from 56 CA patients##2##4##(2011-1#2)
from 56##5##2##(1993-1#1)(2009-7#1)(2010-8#1)(2011-1#2)
from 57##3##2##(2008-2#1)(2010-12#1)(2013-1#1)
from 58##6##2##(1994-6#1)(2008-10#2)(2008-12#1)(2009-11#1)(2010-11#1)
from 59##2##2##(1993-3#1)(2008-1#1)
from 597##2##2##(2007-11#1)(2008-10#1)
from 5x10(-10) to##2##3##(2008-10#2)
from 5x10(-4) to##2##3##(2008-10#2)
from 6 months to##2##4##(2007-8#1)(2013-1#1)
from 6 to 0##2##4##(2008-10#2)
from 6 to 12##2##4##(1994-9#1)(2007-8#1)
from 6 to 16##2##4##(2007-12#1)(2007-8#1)
from 6 to 18##3##4##(1990-7#1)(2007-8#1)(2008-10#1)
from 6 to##20##3##(1990-7#1)(1994-9#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#8)(2008-12#1)(2008-5#1)(2010-4#2)
from 6 weeks##2##3##(2007-11#1)(2013-1#1)
from 6##61##2##(1990-7#2)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-8#4)(2008-10#17)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#2)(2009-3#1)(2010-4#2)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
from 6% to##2##3##(2007-11#1)(2011-2#1)
from 6%##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
from 6-##2##2##(1993-12#1)(2008-3#1)
from 60 to##8##3##(1991-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
from 60##11##2##(1991-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2012-12#2)(2013-8#1)
from 600 to##3##3##(1991-5#1)(2007-11#1)(2008-10#1)
from 600##4##2##(1990-12#1)(1991-5#1)(2007-11#1)(2008-10#1)
from 61 to##2##3##(1996-12#1)(2009-3#1)
from 61##7##2##(1995-11#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-12#2)(2009-3#1)
from 62 to##2##3##(2008-10#2)
from 62##4##2##(2008-10#3)(2011-1#1)
from 63##3##2##(1994-6#1)(1995-3#1)(2012-12#1)
from 64##6##2##(1991-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
from 65 to##2##3##(2008-10#2)
from 65##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-5#1)
from 66 to##2##3##(2008-10#1)(2009-8#1)
from 66##3##2##(2008-10#2)(2009-8#1)
from 68 to##3##3##(1995-6#1)(2008-10#2)
from 68##6##2##(1992-6#1)(1995-6#1)(2008-10#3)(2012-3#1)
from 680 to##2##3##(1997-7#1)(2012-6#1)
from 69##3##2##(1997-7#1)(2007-8#1)(2013-1#1)
from 6th##2##2##(2013-7#2)
from 7 to 19##2##4##(2007-8#1)(2008-10#1)
from 7 to##11##3##(1991-8#1)(2007-8#2)(2008-10#7)(2013-1#1)
from 7##36##2##(1991-2#1)(1991-8#3)(1993-6#1)(1993-8#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
from 70 to##3##3##(1992-2#1)(1992-8#1)(2009-9#1)
from 70##9##2##(1992-2#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-9#1)(2013-1#1)
from 71##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)
from 72##5##2##(2008-10#2)(2008-7#1)(2011-1#2)
from 73##5##2##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
from 75 to##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
from 75##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
from 76##4##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-6#1)
from 77 to##3##3##(1994-3#1)(2008-10#2)
from 77##4##2##(1994-3#1)(2008-10#3)
from 78 to##3##3##(2008-10#1)(2008-2#1)(2010-9#1)
from 78##5##2##(2008-10#2)(2008-2#1)(2008-6#1)(2010-9#1)
from 79##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
from 79% to##2##3##(2007-10#1)(2011-1#1)
from 8 to 12##3##4##(1994-8#1)(2007-12#1)(2009-9#1)
from 8 to##9##3##(1994-8#2)(2007-12#1)(2008-1#1)(2008-10#3)(2009-11#1)(2009-9#1)
from 8##37##2##(1990-6#1)(1990-8#1)(1991-5#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-9#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2012-3#1)(2013-8#1)
from 80 to 104%##2##4##(2008-10#2)
from 80 to##7##3##(2008-10#6)(2008-3#1)
from 80##12##2##(1992-3#1)(1993-8#1)(2007-11#1)(2008-10#7)(2008-3#1)(2010-8#1)
from 80% to##2##3##(2011-2#1)(2013-8#1)
from 800 to 936 nm##2##5##(2008-2#2)
from 800 to##6##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
from 81 to##3##3##(1993-6#1)(2008-10#2)
from 81##6##2##(1993-6#1)(1994-3#1)(1996-12#1)(2008-10#3)
from 82 to##3##3##(2008-10#3)
from 83##2##2##(1997-2#1)(2008-10#1)
from 84##4##2##(1991-9#1)(2008-10#2)(2011-1#1)
from 85% to##2##3##(1992-3#1)(2013-1#1)
from 85%##3##2##(1992-3#1)(1994-9#1)(2013-1#1)
from 86 to##3##3##(2008-10#3)
from 86##6##2##(1997-5#1)(2007-7#1)(2008-10#4)
from 87##2##2##(1995-8#1)(2011-1#1)
from 88 to##4##3##(2008-10#3)(2008-8#1)
from 88##6##2##(1990-3#1)(2008-10#4)(2008-8#1)
from 9 to##7##3##(2008-10#4)(2008-7#1)(2010-4#1)(2012-2#1)
from 9##24##2##(1995-3#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#2)
from 90 to##5##3##(2008-10#5)
from 90##11##2##(2008-10#5)(2009-3#1)(2011-1#2)(2013-1#2)(2013-8#1)
from 91 to##7##3##(2008-10#7)
from 91##9##2##(2008-10#8)(2009-4#1)
from 92 to##3##3##(2008-10#3)
from 92##7##2##(2008-10#6)(2009-8#1)
from 93 to##3##3##(2008-10#3)
from 93##6##2##(2008-10#6)
from 94 to##2##3##(2008-10#2)
from 94##4##2##(1993-12#1)(2008-10#3)
from 95 to##3##3##(2008-10#3)
from 95##15##2##(1990-3#1)(2008-10#13)(2012-12#1)
from 95%##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
from 96 to 104%##2##4##(2008-10#2)
from 96 to##6##3##(2008-10#6)
from 96##12##2##(1991-8#1)(2008-10#8)(2008-4#1)(2010-4#1)(2013-8#1)
from 97 families##4##3##(1997-5#4)
from 97 to##3##3##(2008-10#3)
from 97##19##2##(1992-11#1)(1992-2#1)(1997-5#4)(2008-1#1)(2008-10#9)(2008-12#3)
from 98 to##3##3##(2008-10#2)(2008-6#1)
from 98##8##2##(1992-11#1)(2008-10#5)(2008-6#1)(2010-10#1)
from 99 to##5##3##(2008-10#5)
from 99##14##2##(1990-11#1)(1992-11#1)(2008-10#10)(2008-12#1)(2010-3#1)
from A##25##2##(1994-12#1)(1994-3#1)(1996-2#1)(1997-6#3)(2008-1#1)(2008-10#12)(2008-5#3)(2008-6#1)(2008-9#1)(2010-2#1)
from A431##2##2##(1992-7#1)(1992-8#1)
from AB##2##2##(1996-7#2)
from AG-1-IA##2##2##(2008-10#2)
from AIDS patients##2##3##(1996-11#1)(2008-5#1)
from AIDS##7##2##(1995-2#1)(1996-11#4)(1997-6#1)(2008-5#1)
from AR patients (luminol CL##2##5##(1991-9#2)
from AR##3##2##(1991-9#2)(2012-12#1)
from ARDS and##2##3##(1991-9#1)(2008-8#1)
from ARDS##4##2##(1991-9#3)(2008-8#1)
from ATP and##2##3##(1993-11#1)(2008-7#1)
from ATP##4##2##(1993-11#1)(2008-7#1)(2013-1#2)
from ATs by +0##2##4##(2010-5#2)
from Acinetobacter sp##2##3##(1997-6#2)
from Aedes albopictus##2##3##(1992-8#2)
from Africa and the##2##4##(1994-3#1)(2008-10#1)
from Africa and##5##3##(1993-6#1)(1994-3#1)(2008-10#2)(2012-12#1)
from Africa##10##2##(1993-11#1)(1993-6#1)(1994-3#1)(2008-1#1)(2008-10#5)(2012-12#1)
from African cultivated rice##2##4##(2009-10#2)
from African green monkeys##3##4##(1995-2#3)
from African##10##2##(1992-8#1)(1993-6#1)(1994-12#1)(1995-2#3)(2008-10#1)(2008-12#1)(2009-10#2)
from Agricultural##2##2##(1995-3#1)(2008-10#1)
from Agrobacterium radiobacter##2##3##(2008-10#2)
from Ala##2##2##(1990-11#1)(2008-10#1)
from Andean##2##2##(2008-10#2)
from Antarctic##2##2##(1990-12#2)
from Antioquia##2##2##(2012-12#2)
from April 2000 to##2##4##(2008-10#1)(2013-7#1)
from April to##4##3##(2008-10#2)(2008-12#1)(2010-2#1)
from April##17##2##(1994-6#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#3)
from Arabidopsis thaliana##11##3##(1992-3#1)(1993-2#1)(1996-10#1)(1997-2#1)(2008-10#3)(2008-4#1)(2009-10#1)(2012-1#1)(2012-3#1)
from Arabidopsis##13##2##(1992-3#1)(1993-2#1)(1996-10#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#2)(2012-1#1)(2012-3#1)
from Areca catechu##2##3##(2008-5#2)
from Argentina##9##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2013-1#1)
from Arkansas##2##2##(2008-10#2)
from Arthrobacter sp##2##3##(1995-3#1)(2009-9#1)
from Asia##4##2##(2007-2#1)(2007-5#1)(2008-10#1)(2009-8#1)
from Aspergillus nidulans##3##3##(1997-4#3)
from Aspergillus niger##7##3##(1991-9#1)(1993-8#1)(1994-12#2)(1997-2#2)(2008-10#1)
from Aspergillus##14##2##(1991-9#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1996-6#1)(1997-2#2)(1997-4#3)(2008-10#2)
from Atlantic##2##2##(2008-7#1)(2012-3#1)
from August to##2##3##(2008-10#1)(2013-7#1)
from August##7##2##(1990-3#1)(1994-7#1)(2008-10#2)(2012-2#2)(2013-7#1)
from Australia##11##2##(1992-11#1)(2007-2#3)(2008-10#6)(2008-8#1)
from Australian##5##2##(2007-10#1)(2008-10#3)(2010-10#1)
from Azotobacter vinelandii##3##3##(1990-11#1)(1992-3#1)(2009-7#1)
from B cells##2##3##(1991-2#1)(2008-7#1)
from B##19##2##(1991-2#1)(1992-3#5)(1997-4#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-7#1)(2012-2#1)
from B1##2##2##(1990-2#1)(2008-11#1)
from BALB/c mice##4##3##(1996-12#2)(2008-11#1)(2012-3#1)
from BALB/c##6##2##(1996-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
from Bacillus amyloliquefaciens##3##3##(1990-11#2)(1991-6#1)
from Bacillus cereus##3##3##(2010-12#2)(2011-1#1)
from Bacillus stearothermophilus was##2##4##(1992-3#1)(1993-11#1)
from Bacillus stearothermophilus##6##3##(1990-11#1)(1990-7#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-5#1)
from Bacillus subtilis##6##3##(1991-6#2)(1992-3#1)(2009-7#1)(2011-1#2)
from Bacillus thuringiensis##2##3##(1993-12#1)(1993-8#1)
from Bacillus##27##2##(1990-11#3)(1990-7#1)(1991-6#3)(1992-3#2)(1993-11#1)(1993-12#1)(1993-8#1)(1995-2#1)(1995-5#1)(1997-4#5)(2009-7#1)(2010-12#2)(2011-1#4)(2011-2#1)
from Bahia##2##2##(2008-5#1)(2010-8#1)
from Baja California##2##3##(2008-8#1)(2008-9#1)
from Bajo Pepito##2##3##(2008-5#2)
from Bangalore##2##2##(2008-10#2)
from Barcelona harbour##2##3##(2008-10#2)
from Barcelona)##2##2##(1996-5#2)
from Beijing##3##2##(2011-1#2)(2013-8#1)
from Bombyx mori##4##3##(1997-4#1)(1997-7#1)(2008-11#2)
from Bos taurus##4##3##(1993-12#1)(1993-2#3)
from Botryotinia fuckeliana##2##3##(1997-4#2)
from Botrytis cinerea##2##3##(2008-10#2)
from Brassica##2##2##(2008-10#2)
from Brazil##10##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)
from Brazilian##7##2##(2008-10#1)(2008-6#5)(2013-1#1)
from British##3##2##(1993-1#1)(1997-8#1)(2008-8#1)
from Bryonia dioica Jacq##2##4##(1992-3#2)
from Burkina Faso##2##3##(2008-12#2)
from C##16##2##(1992-3#1)(1993-9#1)(1996-3#1)(2008-10#9)(2008-5#3)(2013-1#1)
from C57BL/6 mice were##2##4##(2008-10#1)(2012-3#1)
from C57BL/6##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
from CAN to##2##3##(2009-7#2)
from CBCT##2##2##(2012-3#1)(2013-1#1)
from CC##2##2##(2008-10#2)
from CHO##2##2##(1993-9#1)(2008-11#1)
from CO2##2##2##(2008-6#2)
from CTP##2##2##(1992-11#2)
from California and##2##3##(2008-10#1)(2008-8#1)
from California##14##2##(1996-4#1)(2007-2#1)(2008-10#11)(2008-8#1)
from Calycotome villosa Subsp##2##4##(2007-11#2)
from Camellia sinensis##2##3##(2008-7#2)
from Cameroon##2##2##(2013-1#2)
from Canada and##2##3##(2008-10#2)
from Canada##4##2##(1994-1#1)(2008-10#3)
from Canadian##4##2##(2008-10#3)(2013-1#1)
from Candida albicans##2##3##(1997-4#2)
from Candida boidinii##2##3##(1991-5#1)(1995-8#1)
from Candida parapsilosis##3##3##(1997-2#3)
from Candida tropicalis##2##3##(1990-5#1)(1991-9#1)
from Candida##16##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1995-3#1)(1995-8#2)(1996-3#2)(1997-2#4)(1997-4#2)(2008-7#1)
from Cd-MT##2##2##(1995-3#2)
from CdCl2 was##2##3##(1995-3#2)
from CdCl2##3##2##(1995-3#3)
from Cellulomonas##2##2##(1991-9#1)(1995-5#1)
from Central Asia and the Caucasus were##2##7##(2008-10#2)
from Central##4##2##(1997-3#1)(2008-10#3)
from Chenopodium##2##2##(2008-10#1)(2008-11#1)
from Chiapas##2##2##(2008-10#2)
from China are##2##3##(2013-8#2)
from China was##3##3##(2008-10#2)(2008-5#1)
from China##19##2##(1997-3#2)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2013-8#4)
from Chinese cabbage (Brassica campestris L##2##6##(1997-2#2)
from Chinese herbs##4##3##(2008-5#3)(2011-3#1)
from Chinese##11##2##(1995-6#1)(1997-2#2)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#2)(2011-3#1)
from Citrus tristeza virus##2##4##(2008-10#2)
from Citrus##4##2##(2008-10#4)
from Clostridium##3##2##(1991-5#1)(2007-7#1)(2009-7#1)
from Cm##2##2##(1995-8#2)
from Cochliobolus##2##2##(2008-10#2)
from Coiba National Park##2##4##(2008-5#2)
from Coiba##3##2##(2008-5#3)
from Colombia##2##2##(2008-10#1)(2008-5#1)
from Colorado##3##2##(1997-1#1)(2008-10#2)
from Conus##3##2##(1993-11#1)(2008-8#2)
from Costa Rica##8##3##(2008-10#8)
from Cr(III)##5##2##(2008-10#5)
from Crikvenica##3##2##(2011-2#3)
from Cultivated##2##2##(2008-10#2)
from D##7##2##(1991-5#1)(1992-6#1)(1993-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
from D-R isotherm##2##3##(2008-10#2)
from DNA and##3##3##(2008-11#1)(2008-4#1)(2009-5#1)
from DNA by##2##3##(1991-8#1)(2008-10#1)
from DNA isolated##2##3##(1997-4#1)(2008-2#1)
from DNA microarray experiments##2##4##(2008-4#1)(2013-8#1)
from DNA of##3##3##(1993-8#1)(2008-10#2)
from DNA sequence##2##3##(1994-8#1)(2008-10#1)
from DNA sequences of##2##4##(1997-2#1)(2008-10#1)
from DNA sequences##4##3##(1997-2#1)(2008-10#1)(2008-8#1)(2011-1#1)
from DNA##28##2##(1991-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
from DPP##2##2##(2008-10#2)
from Day##2##2##(1994-1#1)(2008-10#1)
from December##7##2##(1991-8#1)(1997-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-7#1)
from Department of##2##3##(2013-1#2)
from Descemet's membrane##2##3##(1990-8#2)
from Dictyostelium##2##2##(1994-12#1)(1994-8#1)
from Different##2##2##(2008-10#1)(2013-1#1)
from Diseased##2##2##(2008-10#2)
from Drosophila melanogaster##5##3##(2007-12#1)(2008-11#1)(2009-7#2)(2012-3#1)
from Drosophila##8##2##(1990-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#2)(2009-8#1)(2012-3#1)
from E##26##2##(1990-8#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-7#1)(2010-3#1)
from EC##2##2##(1994-2#2)
from ECV to ECII##2##4##(2008-11#2)
from ELISA##2##2##(2008-10#1)(2011-1#1)
from ES cells##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
from ES##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)
from East##7##2##(2008-10#3)(2008-12#2)(2009-5#1)(2010-8#1)
from Eastern##2##2##(1996-8#1)(2008-10#1)
from Ectothiorhodospira vacuolata##2##3##(1993-11#2)
from Ecuador##3##2##(2008-10#3)
from Egypt##3##2##(2008-10#3)
from Eisenia fetida##2##3##(2008-9#2)
from English##2##2##(1995-12#1)(2006-10#1)
from Er##2##2##(1991-9#2)
from Erwinia carotovora##2##3##(1990-5#1)(2010-11#1)
from Erwinia##4##2##(1990-5#1)(2008-10#2)(2010-11#1)
from Escherichia coli and##2##4##(2009-5#1)(2011-1#1)
from Escherichia coli by##2##4##(1993-11#1)(1995-5#1)
from Escherichia coli with##2##4##(1990-11#1)(1994-6#1)
from Escherichia coli##40##3##(1990-11#2)(1990-7#3)(1991-5#2)(1992-6#2)(1992-8#1)(1993-11#7)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-5#3)(1995-8#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-4#3)(2008-9#1)(2009-5#1)(2011-1#1)
from Ethiopia##5##2##(2008-10#5)
from Europe and North America##3##5##(2008-10#1)(2011-2#2)
from Europe and##6##3##(2008-10#4)(2011-2#2)
from Europe were##2##3##(2008-10#2)
from Europe##19##2##(1995-12#1)(2007-2#1)(2007-7#1)(2008-10#13)(2011-2#2)(2013-8#1)
from European countries##2##3##(2008-8#1)(2013-1#1)
from F##5##2##(2008-10#5)
from Fe(III)##2##2##(2008-10#2)
from February 1992 to##2##4##(2008-2#1)(2008-5#1)
from February 1998 to February 1999##2##6##(2007-5#2)
from February 1998 to##3##4##(2007-5#2)(2008-11#1)
from February to##2##3##(2008-10#1)(2008-11#1)
from February##13##2##(1997-7#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2009-2#1)(2011-1#1)
from Florida##7##2##(2008-10#6)(2011-2#1)
from FnR-deficient##2##2##(1993-9#2)
from Fourier transform##2##3##(2008-7#1)(2010-4#1)
from France##3##2##(2008-10#3)
from French##2##2##(2008-10#1)(2008-9#1)
from Fukushima##2##2##(2012-2#1)(2013-1#1)
from Fusarium oxysporum##3##3##(2008-10#3)
from Fusarium solani##2##3##(1995-3#1)(2008-10#1)
from Fusarium verticillioides##2##3##(2008-10#2)
from Fusarium##8##2##(1995-3#1)(2008-10#7)
from G in the codon for##2##6##(2008-10#2)
from G##4##2##(2008-10#2)(2013-1#2)
from G0 + G1 to S##2##6##(1990-11#2)
from G0##3##2##(1990-11#2)(1995-2#1)
from G1 to S##2##4##(1994-5#1)(1997-7#1)
from G1 to##3##3##(1994-5#1)(1997-7#1)(2008-11#1)
from G1##4##2##(1994-5#1)(1996-3#1)(1997-7#1)(2008-11#1)
from GC##2##2##(2008-10#2)
from GSR##2##2##(2012-2#2)
from Galicia##2##2##(2008-10#2)
from GenBank##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
from Germany##2##2##(1992-12#1)(2011-2#1)
from Great Britain##2##3##(1992-11#1)(2008-10#1)
from Guadeloupe##2##2##(2008-10#2)
from Guatemala##2##2##(2008-10#2)
from Guinea-Bissau##2##2##(1990-8#1)(2011-1#1)
from H =##2##3##(1997-7#1)(2008-10#1)
from H##12##2##(1997-7#1)(2008-10#6)(2009-3#1)(2013-7#4)
from H(2)SO(4)-HF##2##2##(2008-10#2)
from H2O2##2##2##(1991-9#1)(2008-6#1)
from HC##2##2##(2008-10#1)(2008-11#1)
from HEK293##2##2##(2008-8#2)
from HIV##8##2##(1990-2#1)(1995-1#1)(2007-7#2)(2008-5#1)(2011-1#2)(2012-12#1)
from HIV-1 infected##2##3##(1997-3#1)(2011-3#1)
from HIV-1##4##2##(1992-6#1)(1997-3#1)(2008-4#1)(2011-3#1)
from HIV-infected patients with##2##4##(2008-5#2)
from HIV-infected patients##3##3##(2008-5#3)
from HIV-infected##5##2##(1997-4#1)(2008-5#4)
from HL-60##2##2##(1991-2#1)(2008-9#1)
from HPLC##2##2##(2008-10#2)
from Hahella##2##2##(2009-7#2)
from Halobacterium halobium##2##3##(1990-2#1)(1993-11#1)
from HeLa cells##6##3##(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-2#1)
from Health##2##2##(1991-3#1)(2012-12#1)
from Helianthus##2##2##(1991-5#1)(2008-10#1)
from Helicobacter pylori##2##3##(1996-12#2)
from Honduras##2##2##(2008-10#1)(2008-5#1)
from I##3##2##(2008-10#3)
from IECs##4##2##(2008-11#4)
from Ilyobacter tartaricus##2##3##(1993-12#2)
from India and##4##3##(1996-4#1)(2008-10#2)(2011-1#1)
from India in##2##3##(1994-9#1)(2011-1#1)
from India##16##2##(1994-9#1)(1996-4#1)(1996-9#1)(2007-2#1)(2008-10#4)(2009-2#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
from Indian##6##2##(1996-8#1)(2008-10#1)(2010-10#1)(2010-3#2)(2013-1#1)
from Indiana##2##2##(2008-10#2)
from Indonesia##2##2##(2008-10#2)
from Indonesian women##3##3##(2008-11#3)
from Iquitos##2##2##(2007-6#2)
from Iran and##2##3##(2008-12#2)
from Iran##7##2##(2007-9#1)(2008-10#2)(2008-12#3)(2012-2#1)
from Israel and##2##3##(2008-10#2)
from Israel than##2##3##(2008-10#2)
from Israel##13##2##(2008-10#13)
from Italian ryegrass##2##3##(2008-10#1)(2012-2#1)
from Italy and##3##3##(2008-10#3)
from Italy##10##2##(1991-2#1)(2008-10#7)(2008-12#1)(2008-8#1)
from Jannaschia sp##2##3##(2010-10#2)
from January 1##2##3##(2007-8#1)(2013-1#1)
from January 1985 to##2##4##(1994-1#1)(2012-2#1)
from January 1997##2##3##(2008-10#1)(2013-1#1)
from January 2001##2##3##(2007-11#1)(2007-8#1)
from January 2003##3##3##(2008-7#1)(2010-6#1)(2013-1#1)
from January 2004 to December##2##5##(2008-8#1)(2013-8#1)
from January 2006 to December##2##5##(2011-2#1)(2013-1#1)
from January 2006 to##3##4##(2011-2#2)(2013-1#1)
from January 2008 to##2##4##(2011-2#2)
from January to April##2##4##(2009-8#1)(2013-7#1)
from January to##5##3##(1993-12#1)(2009-8#1)(2013-7#3)
from January##35##2##(1990-9#1)(1991-12#1)(1993-12#1)(1993-5#1)(1994-1#1)(1996-2#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-6#1)(2011-2#6)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#1)
from Japan and##4##3##(2008-10#4)
from Japan##18##2##(2006-10#1)(2008-10#13)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
from Jordan##2##2##(2008-10#1)(2012-2#1)
from July to##3##3##(1995-12#1)(2007-11#1)(2007-2#1)
from July##13##2##(1990-2#1)(1991-2#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-7#1)
from June to September##4##4##(2008-10#1)(2012-2#2)(2013-7#1)
from June to##5##3##(2008-10#2)(2012-2#2)(2013-7#1)
from June##12##2##(1991-8#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-7#2)
from Jurkat cells##3##3##(1992-11#1)(1992-6#1)(1994-6#1)
from K##2##2##(1993-5#1)(2012-2#1)
from KG-1 leukemic cells##2##4##(1993-12#2)
from KG-1##4##2##(1993-12#3)(1996-10#1)
from Kaneka##2##2##(2008-5#2)
from Kentucky##4##2##(2008-10#4)
from Khotang##2##2##(2008-7#2)
from Kjeldahl and 0##2##4##(2008-10#2)
from Klebsiella pneumoniae##4##3##(1997-7#2)(2008-9#1)(2010-10#1)
from Klebsiella##7##2##(1993-12#1)(1995-11#2)(1997-7#2)(2008-9#1)(2010-10#1)
from Kluyveromyces##3##2##(1995-6#2)(1995-8#1)
from Kostrena##4##2##(2011-2#4)
from L##2##2##(2008-10#2)
from L-arginine##4##2##(1992-12#1)(2008-5#1)(2008-8#1)(2009-9#1)
from LSP##2##2##(2006-8#2)
from La##5##2##(2008-10#2)(2008-5#3)
from Lake##2##2##(1996-6#1)(2010-8#1)
from Lambertian##3##2##(2008-2#2)(2008-3#1)
from Latin America##5##3##(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
from Latin##6##2##(1990-6#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
from Lettuce##2##2##(2008-10#2)
from LiNbO(3) optical parametric oscillators##2##5##(2007-12#2)
from Listeria monocytogenes##2##3##(1994-12#2)
from Lycopersicon hirsutum##3##3##(2008-10#3)
from M##14##2##(1991-12#1)(1993-11#3)(2008-10#6)(2008-6#1)(2010-4#2)(2011-10#1)
from MCN1##2##2##(1995-11#2)
from MRI##2##2##(2008-10#1)(2013-1#1)
from MRL(+/+) mice##2##3##(2008-10#2)
from Macedonia##2##2##(2008-12#2)
from Malawi##2##2##(2008-10#1)(2009-6#1)
from Malus##3##2##(2008-10#3)
from Manitoba##2##2##(2007-12#2)
from March 1994 to##2##4##(2007-8#1)(2008-7#1)
from March 2003 to February 2004##2##6##(2008-5#1)(2010-8#1)
from March through##2##3##(1994-9#2)
from March to July##2##4##(2012-6#2)
from March##17##2##(1990-10#1)(1991-12#1)(1994-9#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#2)(2012-6#2)
from May to November##3##4##(1996-12#1)(2011-2#1)(2013-7#1)
from May to October##3##4##(2008-10#1)(2008-12#1)(2013-8#1)
from May to September##2##4##(1996-12#1)(1997-6#1)
from May to##10##3##(1996-12#2)(1997-6#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
from May##16##2##(1991-2#1)(1996-12#2)(1997-6#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
from Medicaid##2##2##(1992-2#1)(2009-6#1)
from Medicare##4##2##(1992-3#1)(1993-12#1)(1993-2#1)(1995-2#1)
from Mexico City##4##3##(2008-12#4)
from Mexico and##3##3##(1996-12#1)(2008-5#1)(2009-8#1)
from Mexico##13##2##(1996-12#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-5#1)(2009-8#1)
from Michigan##5##2##(2008-10#5)
from Mie theory##5##3##(2008-2#1)(2008-3#4)
from Mie##7##2##(2008-2#2)(2008-3#5)
from Mississippi)##2##2##(2008-10#2)
from Monosiga brevicollis and other choanoflagellates##3##6##(2010-2#3)
from Monte Carlo simulations##3##4##(2008-3#2)(2013-1#1)
from Monte Carlo##4##3##(2008-3#3)(2013-1#1)
from Morelos##2##2##(2008-5#2)
from Mucor##2##2##(1997-3#1)(2008-6#1)
from Mycobacterium tuberculosis##5##3##(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#2)
from Mycobacterium##8##2##(1993-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#2)(2012-2#1)
from N##6##2##(1991-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2009-9#1)
from NBL##2##2##(2011-2#2)
from NIST##4##2##(2008-10#2)(2008-3#2)
from NMR and##2##3##(1993-11#1)(2013-1#1)
from Na(+)##2##2##(2008-10#2)
from National##2##2##(2008-10#1)(2009-4#1)
from Natronobacterium pharaonis##3##3##(1993-11#1)(1994-5#2)
from Nd##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
from Nebraska##3##2##(2008-10#1)(2008-8#2)
from Neisseria##3##2##(2009-7#2)(2010-10#1)
from Nepal##2##2##(2011-2#2)
from Neurospora crassa##5##3##(1995-2#3)(1997-4#1)(2008-10#1)
from Neurospora##6##2##(1995-2#3)(1997-4#1)(2008-10#1)(2013-1#1)
from New Jersey##3##3##(2008-10#2)(2008-8#1)
from New Mexico##2##3##(2008-10#1)(2008-3#1)
from New World##2##3##(2008-10#1)(2012-2#1)
from New York State##3##4##(1992-1#1)(1993-1#1)(1996-1#1)
from New York##5##3##(1992-1#1)(1993-1#1)(1996-1#1)(2007-4#1)(2008-10#1)
from New Zealand and##2##4##(2008-10#2)
from New Zealand##3##3##(2008-10#3)
from New##16##2##(1992-1#1)(1993-1#1)(1996-1#1)(2007-4#1)(2008-10#9)(2008-3#1)(2008-8#1)(2012-2#1)
from Ni(II)##2##2##(2008-10#2)
from Nicotiana##2##2##(2008-10#2)
from Nigeria##2##2##(1990-3#1)(2008-10#1)
from North America and##3##4##(2008-5#1)(2011-10#1)(2013-8#1)
from North America##10##3##(2008-10#6)(2008-5#1)(2011-10#1)(2012-3#1)(2013-8#1)
from North##14##2##(1992-2#1)(2008-10#8)(2008-5#1)(2009-10#1)(2011-10#1)(2012-3#1)(2013-8#1)
from Northern##3##2##(2008-3#1)(2009-2#1)(2009-4#1)
from Norwegian##3##2##(1991-2#1)(2008-7#1)(2011-2#1)
from November 1991 to##2##4##(2008-2#2)
from November 1998 to##2##4##(2008-10#1)(2008-3#1)
from November 2007 to December##2##5##(2011-2#1)(2013-1#1)
from November##15##2##(1993-12#1)(1996-1#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
from Novosibirsk##3##2##(2013-1#3)
from O##2##2##(1991-3#1)(2008-10#1)
from ODN-chain##2##2##(2008-10#2)
from October 2000 to##2##4##(2008-5#1)(2011-3#1)
from October to December##2##4##(2007-5#1)(2010-3#1)
from October to##4##3##(2007-5#1)(2008-10#1)(2010-3#1)(2013-7#1)
from October##10##2##(1995-3#1)(1995-5#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-3#1)(2013-7#2)
from Okinawa##3##2##(2008-2#1)(2008-5#1)(2010-8#1)
from Oslo##2##2##(1995-6#1)(1995-8#1)
from Other##2##2##(2008-10#2)
from P##26##2##(1990-12#1)(1993-2#1)(1993-9#1)(1995-5#1)(2008-10#17)(2008-12#1)(2008-5#2)(2011-2#1)(2012-2#1)
from PAP##2##2##(1995-11#1)(2010-7#1)
from PC12 cells##5##3##(1990-8#1)(1996-12#2)(1997-2#1)(2008-10#1)
from PC12 pheochromocytoma cells##2##4##(1994-6#1)(2008-11#1)
from PC12##7##2##(1990-8#1)(1994-6#1)(1996-12#2)(1997-2#1)(2008-10#1)(2008-11#1)
from PCR amplified real samples##2##5##(2008-10#2)
from PD##4##2##(2008-10#3)(2008-7#1)
from PDT##2##2##(1992-9#1)(2009-4#1)
from PMNs##2##2##(1992-5#2)
from PSV##2##2##(2008-10#2)
from PVC##2##2##(2008-10#2)
from Pacific##2##2##(2008-10#1)(2012-12#1)
from Pakistan##2##2##(2012-2#2)
from Palau##4##2##(2008-1#3)(2008-10#1)
from Palinurus versicolor##2##3##(2008-9#2)
from Panax ginseng##2##3##(1995-8#2)
from Paracoccus denitrificans##2##3##(1992-3#2)
from Part I##3##3##(2009-2#3)
from Penicillium##2##2##(2008-6#2)
from Pennsylvania##2##2##(2008-10#2)
from Peru##2##2##(2008-10#2)
from Phanerochaete chrysosporium##5##3##(1990-12#1)(1991-11#1)(1993-3#1)(2008-6#2)
from Phytophthora##2##2##(2008-10#2)
from Pinus##2##2##(2008-10#2)
from Pistachio and Other##2##4##(2008-10#2)
from Plasmodium falciparum##2##3##(1990-12#1)(1994-12#1)
from Pm##3##2##(2011-1#3)
from Portugal##3##2##(2008-10#2)(2008-12#1)
from Potato##3##2##(2008-10#3)
from Prunus spp##2##3##(2008-10#2)
from Prunus##3##2##(2008-10#3)
from Pseudomonas aeruginosa##3##3##(2009-11#2)(2010-10#1)
from Pseudomonas putida 86##2##4##(1993-11#2)
from Pseudomonas putida##5##3##(1991-5#1)(1993-11#2)(1994-12#1)(1994-5#1)
from Pseudomonas##15##2##(1991-5#1)(1993-11#2)(1994-12#2)(1994-5#2)(2008-10#2)(2008-7#2)(2009-11#2)(2009-2#1)(2010-10#1)
from Puerto Rico##4##3##(2008-10#3)(2008-11#1)
from Pyrenophora tritici-repentis##2##3##(2008-10#2)
from Pyrenophora##3##2##(2008-10#3)
from R##9##2##(1995-12#2)(2008-10#5)(2008-12#1)(2010-4#1)
from RBC's##2##2##(2008-3#2)
from RFLP marker##2##3##(2008-10#2)
from RFLP##3##2##(2008-10#3)
from RNA##7##2##(1995-2#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
from Raman scattering##2##3##(2008-3#2)
from Raman spectra##2##3##(2008-10#1)(2008-2#1)
from Raman##5##2##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
from Rattus norvegicus##2##3##(1994-12#2)
from Rayleigh##2##2##(2008-3#2)
from Rhizoctonia solani##3##3##(2008-10#2)(2010-10#1)
from Rhodobacter sphaeroides##4##3##(1992-6#1)(2008-9#2)(2010-2#1)
from Rhodobacter##5##2##(1992-6#1)(1993-11#1)(2008-9#2)(2010-2#1)
from Rio##2##2##(2008-10#1)(2012-3#1)
from Roma##2##2##(2008-10#1)(2011-3#1)
from Roman##2##2##(2008-10#2)
from Romania##2##2##(2008-10#1)(2010-4#1)
from Ría de Arousa estuary (Galicia##2##6##(2008-10#1)(2010-5#1)
from S##22##2##(1990-2#1)(1990-5#2)(1992-8#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-9#1)(1997-3#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)
from SHR##3##2##(2006-8#3)
from SIV##2##2##(2010-10#2)
from SJL/J and##2##3##(1993-2#2)
from SPD##2##2##(2008-7#1)(2012-1#1)
from Saccharomyces cerevisiae by##2##4##(1991-8#1)(1993-9#1)
from Saccharomyces cerevisiae has##2##4##(1996-6#1)(1997-4#1)
from Saccharomyces cerevisiae was##2##4##(1996-3#1)(1997-8#1)
from Saccharomyces cerevisiae##23##3##(1991-5#1)(1991-8#2)(1993-12#1)(1993-9#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2008-4#2)(2009-7#2)(2013-1#1)
from Salvia miltiorrhiza##3##3##(2008-10#3)
from Salvia splendens##2##3##(2009-12#2)
from Salvia##5##2##(2008-10#3)(2009-12#2)
from Sclerotinia##2##2##(2008-10#2)
from September##9##2##(1990-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2011-2#1)(2013-8#2)
from Serranía de Los Paraguas##2##5##(2008-5#2)
from Sf9 cells##2##3##(1992-3#1)(2008-1#1)
from Sf9##3##2##(1992-3#1)(1993-8#1)(2008-1#1)
from Si##2##2##(1994-2#1)(2008-10#1)
from SiGe##2##2##(2008-10#2)
from Sm10T##2##2##(2008-10#2)
from Small##2##2##(2008-10#2)
from South Africa and##2##4##(2008-10#1)(2011-2#1)
from South Africa##6##3##(2008-10#1)(2008-12#2)(2010-1#2)(2011-2#1)
from South America and##4##4##(2008-10#4)
from South America##7##3##(2008-10#7)
from South##16##2##(2008-10#9)(2008-12#2)(2008-3#1)(2010-1#2)(2011-2#1)(2013-8#1)
from Southern##3##2##(2008-11#1)(2013-7#2)
from Soybean##2##2##(2008-10#2)
from Spain and Israel##2##4##(2008-10#2)
from Spain and##4##3##(2008-10#3)(2013-8#1)
from Spain##7##2##(2008-10#5)(2008-7#1)(2013-8#1)
from Spanish##5##2##(2008-10#4)(2008-5#1)
from Sphingomonas paucimobilus##2##3##(1994-6#2)
from Ss275##2##2##(2008-10#2)
from Staphylococcus aureus##5##3##(1990-11#1)(1990-12#1)(1991-9#1)(1994-3#1)(1996-12#1)
from Strawberry and##2##3##(2008-10#2)
from Strawberry##3##2##(2008-10#3)
from Streptococcus equisimilis##2##3##(1991-9#2)
from Streptococcus mutans##2##3##(1992-9#2)
from Streptococcus##6##2##(1991-9#2)(1992-9#2)(2009-6#2)
from Streptomyces cattleya##2##3##(2008-8#2)
from Streptomyces coelicolor##3##3##(1995-8#1)(2008-8#1)(2011-2#1)
from Streptomyces sp##2##3##(2009-2#1)(2009-6#1)
from Streptomyces##14##2##(1994-12#1)(1994-3#1)(1995-8#1)(2008-10#1)(2008-8#6)(2009-2#2)(2009-6#1)(2011-2#1)
from Sudan##3##2##(1996-12#1)(2007-10#1)(2008-10#1)
from Sulfolobus##2##2##(1990-2#1)(2008-9#1)
from Surinam##2##2##(1990-9#1)(1994-12#1)
from Switzerland##2##2##(1991-11#1)(2008-10#1)
from Synechococcus PCC7002##2##3##(1997-4#2)
from Syria##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
from São Paulo##5##3##(2008-10#4)(2008-12#1)
from T cell##2##3##(2008-11#2)
from T cells##2##3##(2008-4#1)(2008-7#1)
from T##18##2##(1994-12#3)(1996-12#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-6#3)(2008-7#1)
from T3##3##2##(1997-2#1)(2008-10#2)
from T50 to##2##3##(2013-8#2)
from TA 870##2##3##(2008-10#2)
from TNT##2##2##(1995-6#1)(2008-10#1)
from Tagetes mendocina##2##3##(2008-11#2)
from Taiwan##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
from Tanzania##2##2##(2008-11#2)
from Tex6##2##2##(2008-10#2)
from Texas##3##2##(1996-12#1)(2008-10#2)
from Th##2##2##(2008-9#2)
from The##5##2##(1992-5#1)(2007-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
from Thermotoga maritima##2##3##(2010-10#2)
from Thermus##5##2##(1990-7#1)(1994-12#1)(1997-4#1)(1997-6#1)(1997-8#1)
from Thinopyrum intermedium##2##3##(2008-5#1)(2008-8#1)
from Thinopyrum##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
from Three##2##2##(2008-10#2)
from Tomato and Potato in##2##5##(2008-10#2)
from Tomato##5##2##(2008-10#5)
from Toxoplasma##2##2##(2008-10#1)(2009-7#1)
from Trichoderma reesei##2##3##(2008-9#2)
from Trichoderma##4##2##(2008-10#2)(2008-9#2)
from Triticum##2##2##(2008-10#1)(2008-8#1)
from Trypanosoma brucei##3##3##(1994-12#1)(2009-7#2)
from Tumaco##2##2##(2012-12#2)
from Turkey##2##2##(2008-10#1)(2008-12#1)
from U##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
from UV##2##2##(2008-10#1)(2008-5#1)
from Uganda##3##2##(1993-6#1)(2008-10#1)(2008-8#1)
from United##2##2##(1990-12#1)(1995-12#1)
from V##3##2##(1997-8#1)(2008-10#2)
from Varian (Australia)##2##3##(2008-10#2)
from Venezuela##3##2##(2008-10#3)
from Venturia inaequalis and##2##4##(2008-10#2)
from Verticillium##2##2##(2008-10#2)
from Vicia faba##3##3##(2008-10#2)(2008-8#1)
from Victoria Harbor##2##3##(2010-5#2)
from Vitis vinifera##3##3##(2008-10#1)(2008-5#2)
from WHO##4##2##(1996-3#1)(2008-3#1)(2010-5#1)(2012-12#1)
from West Africa##2##3##(2008-1#1)(2008-10#1)
from West##4##2##(2008-1#1)(2008-10#1)(2009-10#1)(2010-10#1)
from Western countries##2##3##(1990-6#1)(2009-3#1)
from Western##7##2##(1990-6#1)(1991-6#1)(1994-8#1)(2008-10#1)(2008-12#1)(2009-3#1)(2013-7#1)
from Wheat##4##2##(2008-10#4)
from Wistar-Kyoto##2##2##(1994-2#1)(2008-2#1)
from Wolinella succinogenes##3##3##(1992-8#2)(1994-11#1)
from Würzburg##2##2##(1996-5#2)
from X##3##2##(2008-10#3)
from X-ray##4##2##(1992-6#1)(1997-7#2)(2007-6#1)
from Xenopus laevis##5##3##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(2008-11#1)
from Xenopus##7##2##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-2#1)(2008-11#1)(2008-5#1)
from Yunnan##3##2##(2008-8#1)(2013-8#2)
from Zymomonas mobilis##3##3##(1995-3#1)(2008-6#2)
from a &quot##3##3##(1990-6#1)(1994-12#1)(2013-1#1)
from a 0##2##3##(2008-10#1)(2012-2#1)
from a 2##3##3##(1991-2#1)(2007-12#1)(2008-2#1)
from a 4##2##3##(2008-3#1)(2009-12#1)
from a Cr(4+)##2##3##(2007-11#1)(2008-2#1)
from a Dutch##2##3##(2009-12#1)(2011-2#1)
from a Friedlander condensation##2##4##(1995-3#2)
from a Gaussian##2##3##(2008-3#2)
from a He-Ne laser##2##4##(2008-3#2)
from a Japanese##2##3##(2008-10#1)(2008-6#1)
from a Kerr-lens mode-locked Ti##4##5##(2007-11#1)(2007-12#3)
from a Kerr-lens mode-locked##5##4##(2007-11#2)(2007-12#3)
from a Nd##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
from a Ti##10##3##(2007-11#3)(2007-12#5)(2008-3#2)
from a balloon##2##3##(2008-2#1)(2008-3#1)
from a biological and##2##4##(2008-7#1)(2010-10#1)
from a biological##4##3##(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)
from a biphasic##2##3##(2008-7#2)
from a blood##2##3##(2009-3#1)(2011-2#1)
from a bovine##2##3##(1991-5#1)(1992-3#1)
from a broad##4##3##(2008-10#2)(2008-7#1)(2009-4#1)
from a broadband##2##3##(2007-11#1)(2008-3#1)
from a cDNA library of##2##5##(1992-9#1)(1995-8#1)
from a cDNA library##6##4##(1990-11#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(2011-2#1)
from a cDNA##7##3##(1990-11#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(1997-7#1)(2011-2#1)
from a calibration curve##2##4##(2008-10#2)
from a calibration##3##3##(2008-10#3)
from a careful##2##3##(1994-3#1)(2013-1#1)
from a case##3##3##(1991-12#1)(1997-1#1)(2007-7#1)
from a cell##4##3##(2008-11#2)(2008-3#1)(2008-4#1)
from a central##3##3##(2008-10#2)(2011-1#1)
from a cervical##2##3##(1993-12#1)(1997-6#1)
from a change##2##3##(2008-5#1)(2011-2#1)
from a chemical##3##3##(1991-9#1)(2008-10#1)(2008-2#1)
from a chicken hybridoma##2##4##(2008-11#2)
from a circular##2##3##(2008-10#1)(2008-2#1)
from a class##2##3##(1990-12#1)(2008-3#1)
from a classic##3##3##(1991-6#1)(1996-12#1)(2008-8#1)
from a clinical trial of##3##5##(1994-9#1)(2008-5#1)(2009-4#1)
from a clinical trial##4##4##(1994-2#1)(1994-9#1)(2008-5#1)(2009-4#1)
from a clinical##7##3##(1994-2#1)(1994-9#1)(1995-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2013-1#1)
from a close##2##3##(1993-2#1)(2008-10#1)
from a cohort of##3##4##(1997-3#1)(1997-7#1)(2010-10#1)
from a cohort##5##3##(1997-3#1)(1997-7#1)(2008-12#1)(2010-10#1)(2011-1#1)
from a collection##4##3##(2008-10#3)(2012-3#1)
from a combination of##6##4##(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
from a combinatorial cDNA library by complementation of##2##8##(1994-8#2)
from a combinatorial##3##3##(1994-8#2)(2008-9#1)
from a commercial##8##3##(2007-11#1)(2008-10#4)(2008-7#1)(2012-2#2)
from a commercially available##2##4##(2008-2#1)(2008-4#1)
from a common ancestor##2##4##(1997-4#1)(2012-3#1)
from a common ancestral##2##4##(1997-9#1)(2008-10#1)
from a common##12##3##(1990-5#1)(1993-5#1)(1994-12#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2012-3#1)
from a community##5##3##(1996-12#1)(2008-7#1)(2009-11#1)(2010-10#1)(2012-12#1)
from a community-based study##2##4##(2007-12#1)(2008-7#1)
from a community-based##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
from a comparative##2##3##(2009-8#1)(2010-8#1)
from a complex mixture##3##4##(1992-6#1)(2008-4#2)
from a complex##7##3##(1992-6#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#1)
from a composite##2##3##(2008-10#2)
from a comprehensive##2##3##(1994-3#1)(1997-6#1)
from a contaminated##3##3##(2008-10#2)(2012-3#1)
from a continuous##2##3##(1996-12#1)(2013-1#1)
from a conventional##2##3##(2008-10#1)(2008-2#1)
from a copper-vapor laser##2##4##(2007-12#1)(2008-2#1)
from a cross between a resistant##2##6##(2008-10#2)
from a cross between a##4##5##(2008-10#3)(2012-3#1)
from a cross between the inbred##2##6##(2008-10#2)
from a cross between the resistant##3##6##(2008-10#3)
from a cross between the##8##5##(2008-10#8)
from a cross between two##3##5##(2008-10#2)(2008-5#1)
from a cross between##25##4##(2008-10#21)(2008-5#2)(2008-9#1)(2012-3#1)
from a cross of##4##4##(2008-10#4)
from a cross##31##3##(2008-10#26)(2008-3#1)(2008-5#2)(2008-9#1)(2012-3#1)
from a crude##4##3##(2008-10#1)(2008-6#1)(2008-7#2)
from a current##2##3##(1996-12#1)(2008-9#1)
from a cw##2##3##(2007-11#2)
from a data##3##3##(2008-10#2)(2008-8#1)
from a defect in the##2##5##(1994-11#1)(2008-1#1)
from a department of pulmonary medicine##2##6##(1992-11#1)(1995-2#1)
from a diagnostic##2##3##(1996-5#1)(2008-12#1)
from a different##6##3##(1992-11#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-4#2)
from a diffuse##3##3##(1995-11#1)(2008-2#1)(2008-3#1)
from a diode-pumped Kerr-lens mode-locked Cr##2##6##(2007-12#2)
from a diode-pumped Yb##2##4##(2007-11#1)(2007-12#1)
from a diode-pumped##7##3##(2007-11#1)(2007-12#5)(2008-2#1)
from a direct##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
from a disease##2##3##(2008-10#1)(2008-11#1)
from a distance of##2##4##(2008-10#2)
from a diverse set of##2##5##(2008-10#1)(2012-4#1)
from a diverse##4##3##(2008-10#1)(2010-8#1)(2012-3#1)(2012-4#1)
from a donor##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
from a dye##2##3##(2008-10#1)(2008-2#1)
from a eubacterium##2##3##(2009-8#2)
from a family##3##3##(1994-12#1)(1997-5#1)(2008-10#1)
from a few##11##3##(1997-6#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
from a fiber-coupled##2##3##(2007-12#1)(2008-3#1)
from a field##7##3##(2008-10#4)(2008-9#1)(2011-2#2)
from a first##3##3##(2008-10#2)(2008-11#1)
from a first-order##2##3##(2007-12#1)(2008-3#1)
from a fixed##5##3##(1993-12#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-3#1)
from a flow##2##3##(2008-10#1)(2008-3#1)
from a flowing##2##3##(2008-10#2)
from a frequency-doubled##2##3##(2007-12#1)(2008-3#1)
from a frozen##2##3##(2008-3#1)(2008-8#1)
from a full-length##2##3##(1991-7#1)(2008-10#1)
from a gas##2##3##(2008-10#1)(2008-2#1)
from a gender##2##3##(2009-10#1)(2010-12#1)
from a gene##2##3##(1997-3#1)(2010-10#1)
from a general##2##3##(2007-12#1)(2008-10#1)
from a generalized##2##3##(2007-12#1)(2008-11#1)
from a genome##2##3##(1997-5#1)(1997-8#1)
from a genomic library of##4##5##(1990-5#1)(1994-12#1)(2008-10#2)
from a genomic library##8##4##(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(2008-10#3)
from a genomic##10##3##(1990-12#1)(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1997-5#1)(2008-10#3)
from a given##7##3##(1994-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-8#1)
from a global##3##3##(2008-6#1)(2009-4#1)(2009-5#1)
from a greater##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
from a ground-based##2##3##(2008-3#2)
from a group of##9##4##(1990-12#1)(1994-11#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-8#1)
from a group##12##3##(1990-12#1)(1992-12#2)(1994-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)
from a growing##2##3##(1995-2#1)(2007-11#1)
from a health##5##3##(1994-2#1)(1996-12#1)(1997-2#1)(2008-7#1)(2010-4#1)
from a heated metal##5##4##(2007-11#2)(2007-12#3)
from a heated##6##3##(2007-11#3)(2007-12#3)
from a height of##2##4##(2008-10#1)(2008-3#1)
from a heterogeneous##2##3##(1996-4#1)(2008-4#1)
from a higher##2##3##(1994-2#1)(2008-11#1)
from a highly##6##3##(1993-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#1)(2011-2#1)
from a historical##3##3##(1994-12#1)(2012-12#1)(2013-1#1)
from a human brain cDNA library##3##6##(1992-3#1)(1993-8#2)
from a human genomic DNA library##2##6##(1994-9#1)(1997-4#1)
from a human liver##3##4##(1992-8#1)(1993-3#1)(1994-11#1)
from a human lung cDNA library##2##6##(1991-5#1)(1997-2#1)
from a human lung##3##4##(1991-5#1)(1993-11#1)(1997-2#1)
from a human##31##3##(1990-7#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-8#1)(2008-9#1)(2010-7#1)
from a hydrochloric acid production plant##2##6##(2008-10#2)
from a judicious mix of##2##5##(1996-2#1)(2009-8#1)
from a kidney transplant##2##4##(1997-4#1)(2010-12#1)
from a kidney##3##3##(1997-4#1)(2008-1#1)(2010-12#1)
from a laboratory##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
from a lack of##2##4##(1991-12#1)(2008-10#1)
from a lambda##6##3##(1991-12#1)(1991-6#1)(1993-2#1)(1994-8#1)(1997-7#1)(2008-11#1)
from a large number of##3##5##(1990-7#1)(2008-10#1)(2008-3#1)
from a large volume of aqueous##2##6##(2008-10#2)
from a large volume##3##4##(2008-10#3)
from a large##24##3##(1990-7#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-9#1)(1995-9#1)(1997-8#1)(2008-10#5)(2008-3#3)(2008-5#1)(2009-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
from a large-scale##2##3##(2009-12#1)(2012-2#1)
from a larger##3##3##(2008-12#1)(2008-9#1)(2010-7#1)
from a laser diode##2##4##(2008-2#2)
from a laser##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
from a layer##2##3##(2008-10#1)(2008-3#1)
from a library of##3##4##(1990-5#1)(1995-6#1)(2008-10#1)
from a limited number of##2##5##(2008-10#1)(2008-8#1)
from a limited##6##3##(1994-8#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-11#1)
from a line##2##3##(1993-6#1)(2008-3#1)
from a linear##2##3##(2008-10#1)(2008-7#1)
from a liquid##2##3##(2008-10#1)(2008-2#1)
from a list of##2##4##(2008-7#1)(2011-1#1)
from a literature##2##3##(1995-2#1)(2008-7#1)
from a local##5##3##(1994-2#1)(2008-10#1)(2008-12#1)(2011-2#2)
from a long##2##3##(1995-11#1)(2007-12#1)
from a long-term##2##3##(1992-9#1)(2011-1#1)
from a longitudinal study##4##4##(2008-11#2)(2009-8#1)(2012-12#1)
from a longitudinal##6##3##(2008-11#2)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
from a low level##2##4##(2008-10#2)
from a low##7##3##(1993-6#1)(1996-9#1)(2008-10#4)(2008-2#1)
from a major##3##3##(2007-2#1)(2008-3#1)(2011-2#1)
from a male##3##3##(1991-6#1)(2008-5#1)(2012-12#1)
from a marine##2##3##(2008-11#1)(2008-9#1)
from a material##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
from a mathematical##2##3##(2008-9#1)(2011-3#1)
from a maximum of##2##4##(2008-7#1)(2013-7#1)
from a mean of##3##4##(2008-1#2)(2008-5#1)
from a mean##5##3##(2008-1#3)(2008-5#1)(2013-1#1)
from a measurement of##2##4##(2007-11#1)(2007-12#1)
from a medical##3##3##(1991-11#1)(2011-2#1)(2012-12#1)
from a member of the family##6##6##(2011-2#6)
from a member of the##10##5##(2011-2#10)
from a mild##3##3##(1990-9#1)(2008-2#1)(2011-2#1)
from a minimal##2##3##(2008-6#2)
from a mixture of##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
from a mixture##7##3##(2008-10#4)(2008-7#1)(2008-8#1)(2009-11#1)
from a mode-locked laser##2##4##(2007-11#1)(2007-12#1)
from a mode-locked##11##3##(2007-11#5)(2007-12#6)
from a molecular##2##3##(2008-10#1)(2010-12#1)
from a more##2##3##(1993-2#1)(2007-12#1)
from a mouse##5##3##(1993-3#1)(1995-12#2)(1995-2#1)(1995-6#1)
from a moving##4##3##(2008-2#2)(2008-3#2)
from a multidisciplinary##2##3##(1993-1#1)(1996-3#1)
from a multiple-scattering##2##3##(2008-2#1)(2008-3#1)
from a myocardial infarction##2##4##(2007-10#1)(2013-1#1)
from a national survey of##2##5##(1992-1#1)(1994-2#1)
from a national survey##4##4##(1992-1#1)(1994-2#1)(2011-2#1)(2012-2#1)
from a national##8##3##(1992-1#1)(1994-2#1)(1997-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
from a nationwide##2##3##(2012-12#1)(2012-3#1)
from a natural##4##3##(1994-11#1)(1997-3#1)(2008-9#1)(2013-1#1)
from a new##3##3##(2008-3#1)(2013-1#1)(2013-7#1)
from a newborn##2##3##(1993-2#1)(2009-12#1)
from a nonlinear##2##3##(1990-8#1)(2007-12#1)
from a novel##4##3##(1990-8#1)(1996-5#1)(2007-11#1)(2008-4#1)
from a number of different##4##5##(2008-10#3)(2008-12#1)
from a number of##15##4##(1993-12#1)(1993-2#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)
from a pair of##3##4##(2008-10#1)(2008-3#2)
from a partial##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
from a particular##2##3##(2008-10#1)(2008-11#1)
from a passive##2##3##(2008-11#2)
from a passively mode-locked##4##4##(2007-11#3)(2008-3#1)
from a patient who##2##4##(2008-11#1)(2011-1#1)
from a patient with##6##4##(1990-12#2)(1991-12#1)(1993-11#1)(1994-11#1)(2007-10#1)
from a patient##14##3##(1990-12#2)(1991-12#1)(1992-11#1)(1993-11#1)(1994-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-8#1)
from a patient's consent##2##4##(1994-1#2)
from a patient's perspective##2##4##(2010-8#2)
from a patient's##4##3##(1994-1#2)(2010-8#2)
from a pediatric##2##3##(1991-9#1)(2010-5#1)
from a pharmacological##2##3##(1990-9#1)(1993-6#1)
from a phase##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
from a pig##4##3##(1993-6#1)(1996-2#1)(2008-3#1)(2011-2#1)
from a pilot##2##3##(1996-2#1)(2008-12#1)
from a plant##3##3##(2008-10#3)
from a plasmid##2##3##(1994-12#1)(1995-8#1)
from a point source##5##4##(2008-10#3)(2008-3#2)
from a pool of##2##4##(1990-11#1)(1992-11#1)
from a population of##5##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
from a population##8##3##(1993-11#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)
from a population-based##2##3##(1994-3#1)(2012-2#1)
from a posterior##2##3##(1991-6#1)(2008-12#1)
from a pre-existing##3##3##(1992-12#2)(1997-8#1)
from a preliminary##3##3##(2008-10#2)(2008-12#1)
from a previous study##2##4##(1991-2#1)(2008-10#1)
from a previous##8##3##(1991-2#2)(2008-1#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
from a previously reported##2##4##(1994-11#1)(2012-2#1)
from a previously##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
from a primary tumor##2##4##(1992-9#1)(2010-8#1)
from a primary##6##3##(1992-9#1)(1993-2#1)(1994-11#1)(2009-6#1)(2010-2#1)(2010-8#1)
from a promoter##2##3##(1997-3#1)(2007-12#1)
from a prospective study##2##4##(2008-11#1)(2008-6#1)
from a prospective##5##3##(2007-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
from a public##2##3##(2008-7#1)(2012-3#1)
from a pure##4##3##(2007-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
from a putative##3##3##(1994-12#1)(2008-10#1)(2008-6#1)
from a qualitative perspective##2##4##(2011-2#1)(2013-8#1)
from a qualitative study##2##4##(1995-6#1)(2013-8#1)
from a qualitative##4##3##(1995-6#1)(2011-2#1)(2013-8#2)
from a quantitative##2##3##(2006-6#1)(2012-3#1)
from a radical##2##3##(2007-11#1)(2010-7#1)
from a random sample of##2##5##(1996-2#1)(2012-3#1)
from a random sample##3##4##(1993-12#1)(1996-2#1)(2012-3#1)
from a random##7##3##(1993-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
from a randomized clinical trial##2##5##(1994-2#1)(1996-6#1)
from a randomized controlled trial##3##5##(1997-2#1)(2008-8#1)(2013-7#1)
from a randomized##6##3##(1994-2#1)(1994-8#1)(1996-6#1)(1997-2#1)(2008-8#1)(2013-7#1)
from a range of##8##4##(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)(2010-10#1)(2012-1#1)
from a rat genomic library##2##5##(1993-3#1)(1993-8#1)
from a rat liver##2##4##(1991-12#1)(1995-2#1)
from a rat##11##3##(1991-12#3)(1992-10#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)
from a real##3##3##(1997-4#1)(2007-12#1)(2011-1#1)
from a recent##5##3##(1995-1#1)(1996-2#1)(2006-12#1)(2008-7#1)(2008-8#1)
from a recently##2##3##(1993-2#1)(2008-3#1)
from a reference##2##3##(2008-3#1)(2013-1#1)
from a refuge##2##3##(2009-5#2)
from a region##3##3##(1993-9#1)(2008-1#1)(2008-10#1)
from a remote##2##3##(2008-10#1)(2008-3#1)
from a report by the NCRP##2##6##(1994-12#1)(1995-1#1)
from a report by the##4##5##(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)
from a rotating##2##3##(2007-12#1)(2008-10#1)
from a rough surface##2##4##(2008-2#1)(2008-3#1)
from a rough##4##3##(2008-2#1)(2008-3#3)
from a sample of##14##4##(1993-12#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#4)(2009-7#1)(2009-8#1)(2012-3#2)
from a sample##21##3##(1993-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#4)(2009-7#1)(2009-8#1)(2012-3#2)
from a second##2##3##(2008-10#1)(2008-3#1)
from a separate##2##3##(1991-12#1)(1991-8#1)
from a sequence of##2##4##(2008-2#1)(2008-3#1)
from a series of overlapping##2##5##(1992-12#1)(2008-10#1)
from a series of##15##4##(1990-8#1)(1992-12#1)(1992-9#1)(1993-5#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-11#1)
from a set of##5##4##(1992-9#1)(1993-12#1)(2008-10#1)(2008-3#1)(2009-7#1)
from a ship in the Southern California Bight##2##8##(2008-2#2)
from a similar survey##2##4##(1994-2#1)(1994-3#1)
from a similar##5##3##(1993-6#1)(1994-2#1)(1994-3#1)(2007-10#1)(2012-12#1)
from a simple##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-2#1)
from a single gene##2##4##(1994-9#1)(1996-2#1)
from a single institution##2##4##(2007-8#1)(2011-2#1)
from a single sample##3##4##(2008-10#3)
from a single species##2##4##(1993-12#1)(2011-2#1)
from a single##65##3##(1990-8#1)(1992-11#1)(1993-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#5)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
from a site##2##3##(2008-10#1)(2013-1#1)
from a skin##2##3##(2007-7#1)(2008-4#1)
from a slightly##3##3##(2008-11#1)(2010-3#1)(2011-2#1)
from a small##10##3##(1990-11#1)(1991-9#1)(1992-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-6#2)(2012-3#1)
from a solid##4##3##(2008-10#3)(2010-3#1)
from a solution containing##2##4##(2008-10#2)
from a solution##4##3##(1990-5#1)(1996-2#1)(2008-10#2)
from a source of##2##4##(2008-10#1)(2008-3#1)
from a source##3##3##(2008-10#2)(2008-3#1)
from a spatially##2##3##(2008-10#1)(2008-3#1)
from a specific##2##3##(1995-2#1)(2008-3#1)
from a spherical##2##3##(2008-10#1)(2012-2#1)
from a squash##2##3##(2008-10#2)
from a stable##2##3##(1993-9#1)(2007-12#1)
from a standard##3##3##(2008-3#1)(2012-1#2)
from a standardized##2##3##(1993-12#1)(2013-1#1)
from a state##2##3##(2010-8#1)(2012-2#1)
from a statistical##2##3##(1994-11#1)(2007-11#1)
from a strangulating fallopian tube##2##5##(2012-3#2)
from a stratospheric balloon##2##4##(2008-3#2)
from a strong##4##3##(1991-9#1)(2007-11#1)(2008-10#2)
from a structure##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
from a study of##10##4##(1992-11#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-3#1)
from a study on##2##4##(1993-12#1)(1993-9#1)
from a study that##2##4##(1994-3#1)(2009-5#1)
from a study##20##3##(1990-11#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
from a subgroup I strain##2##5##(2008-10#2)
from a subgroup##3##3##(2008-10#3)
from a suitable##2##3##(1990-12#1)(2008-10#1)
from a superficial##2##3##(2008-10#1)(2008-3#1)
from a survey of 200##2##5##(1997-2#1)(2008-12#1)
from a survey of nurses##2##5##(2008-12#1)(2010-10#1)
from a survey of##7##4##(1993-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-12#2)(2010-10#1)
from a survey##8##3##(1993-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-12#2)(2010-10#1)
from a susceptible##2##3##(2008-10#2)
from a synthetic phage display library##2##6##(2008-10#2)
from a synthetic phage display##3##5##(2008-10#3)
from a synthetic##6##3##(1991-11#1)(1991-5#1)(2008-10#4)
from a system##3##3##(2008-3#2)(2009-3#1)
from a tertiary care##3##4##(2008-1#1)(2010-5#1)(2013-1#1)
from a tertiary##4##3##(2008-1#1)(2010-5#1)(2013-1#2)
from a theoretical point of view##2##6##(2008-2#2)
from a theoretical##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)
from a thermal##2##3##(2007-11#1)(2008-10#1)
from a thin##5##3##(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)
from a third##2##3##(1990-11#1)(1995-11#1)
from a total of##10##4##(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2013-8#1)
from a total quality##2##4##(1995-3#1)(2007-8#1)
from a total##15##3##(1994-12#1)(1995-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
from a tunable##3##3##(2007-12#2)(2008-3#1)
from a turbid medium##3##4##(2008-2#1)(2008-3#2)
from a two-dimensional##3##3##(2008-3#3)
from a two-wavelength##2##3##(2008-2#1)(2008-3#1)
from a type##2##3##(1992-3#1)(1993-12#1)
from a unified##2##3##(2007-11#1)(2008-2#1)
from a variety of medical##4##5##(2007-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
from a variety of other##3##5##(1994-9#1)(2008-10#1)(2012-2#1)
from a variety of sources##5##5##(1992-6#1)(1995-1#1)(1997-4#1)(2010-10#1)(2012-3#1)
from a variety of##35##4##(1992-6#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-1#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#2)(2010-6#1)(2011-1#1)(2011-2#4)(2011-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
from a very##2##3##(2008-11#1)(2013-8#1)
from a viewpoint##2##3##(2009-7#1)(2013-1#1)
from a weakly acidic solution##2##5##(2008-10#2)
from a weakly##4##3##(2007-11#1)(2008-10#2)(2009-5#1)
from a wide range of host species##2##7##(2008-10#2)
from a wide range of host##3##6##(2008-10#3)
from a wide range of##6##5##(1995-2#1)(2008-10#4)(2008-11#1)
from a wide variety of##2##5##(2008-2#1)(2013-8#1)
from a wide##12##3##(1995-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
from a worldwide##2##3##(2008-10#1)(2012-2#1)
from a yeast##2##3##(1990-5#1)(1993-9#1)
from a##2002##2##(1990-11#11)(1990-12#10)(1990-2#2)(1990-3#1)(1990-5#8)(1990-6#2)(1990-7#5)(1990-8#10)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#14)(1991-2#6)(1991-5#7)(1991-6#6)(1991-7#1)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#7)(1992-12#14)(1992-2#2)(1992-3#9)(1992-4#1)(1992-6#3)(1992-8#7)(1992-9#7)(1993-1#2)(1993-11#5)(1993-12#22)(1993-2#14)(1993-3#10)(1993-5#4)(1993-6#12)(1993-8#4)(1993-9#9)(1994-1#3)(1994-11#23)(1994-12#17)(1994-2#12)(1994-3#11)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#10)(1994-9#6)(1995-1#5)(1995-11#8)(1995-12#8)(1995-2#17)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#9)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#14)(1996-2#19)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#12)(1997-3#9)(1997-4#10)(1997-5#3)(1997-6#5)(1997-7#9)(1997-8#5)(1997-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#8)(2007-11#76)(2007-12#99)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#18)(2008-10#343)(2008-11#62)(2008-12#29)(2008-2#90)(2008-3#177)(2008-4#24)(2008-5#41)(2008-6#22)(2008-7#45)(2008-8#41)(2008-9#31)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#6)(2009-3#4)(2009-4#6)(2009-5#6)(2009-6#6)(2009-7#9)(2009-8#10)(2009-9#1)(2010-10#9)(2010-11#7)(2010-12#7)(2010-2#2)(2010-3#4)(2010-4#7)(2010-5#5)(2010-6#5)(2010-7#3)(2010-8#12)(2010-9#1)(2011-1#14)(2011-2#71)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#9)(2012-12#26)(2012-2#27)(2012-3#31)(2012-4#1)(2012-7#1)(2013-1#40)(2013-7#5)(2013-8#19)
from abdominal##3##2##(1990-8#1)(2007-2#1)(2010-4#1)
from abnormal##3##2##(2007-12#1)(2009-4#1)(2012-2#1)
from about##13##2##(1990-2#1)(1990-8#1)(1992-6#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-5#1)(2008-7#1)(2009-4#1)
from above##2##2##(2008-2#1)(2008-3#1)
from above-surface##2##2##(2008-3#2)
from abroad##4##2##(1991-2#1)(2007-12#1)(2007-2#1)(2008-3#1)
from absorption##6##2##(1992-12#1)(1997-1#1)(2007-12#1)(2008-2#2)(2008-3#1)
from academia and the pharmaceutical industry##2##6##(2008-5#2)
from academia and the pharmaceutical##3##5##(2008-5#3)
from academia and##5##3##(2008-5#5)
from academia##9##2##(2008-5#7)(2008-7#1)(2009-11#1)
from accessing##2##2##(1996-5#1)(2012-12#1)
from accidental##4##2##(1995-3#1)(1996-8#1)(2007-12#1)(2008-10#1)
from acid##5##2##(1996-12#1)(2008-10#3)(2013-1#1)
from acidic waste streams##2##4##(2008-10#2)
from acidic waste##3##3##(2008-10#3)
from acidic##13##2##(2008-10#11)(2010-4#2)
from acidified##2##2##(2008-10#2)
from acquired##2##2##(2008-9#1)(2011-2#1)
from across##2##2##(2008-7#1)(2011-9#1)
from activated##10##2##(1992-6#1)(1994-8#1)(1996-2#1)(1997-1#1)(2008-11#1)(2009-10#1)(2010-3#2)(2010-8#1)(2011-2#1)
from activating the##2##3##(2008-11#1)(2009-10#1)
from activating##3##2##(2008-11#1)(2008-8#1)(2009-10#1)
from activation of the##2##4##(1991-9#1)(1996-5#1)
from activation of##3##3##(1991-9#1)(1996-5#2)
from activation##4##2##(1991-9#1)(1996-5#2)(2013-1#1)
from active##5##2##(1995-3#1)(2007-12#1)(2008-1#1)(2010-11#1)(2013-8#1)
from activities##2##2##(1991-12#1)(1995-3#1)
from actual##3##2##(2008-2#1)(2008-6#1)(2008-7#1)
from acute challenge with noradrenaline##2##5##(1996-2#2)
from acute##23##2##(1990-5#1)(1990-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1996-2#3)(2006-7#1)(2008-3#1)(2008-7#3)(2009-3#2)(2010-1#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
from additional##2##2##(2008-11#1)(2008-3#1)
from additivity##3##2##(1992-12#2)(2008-10#1)
from adherent##2##2##(2008-11#1)(2008-4#1)
from adipose tissue##2##3##(2008-6#1)(2013-1#1)
from adipose##3##2##(1990-12#1)(2008-6#1)(2013-1#1)
from adjacent##4##2##(2008-3#1)(2008-9#1)(2012-3#1)(2013-8#1)
from adjuvant##3##2##(1993-1#1)(1995-4#1)(2011-2#1)
from admission to##2##3##(2006-8#1)(2007-8#1)
from adult rat##2##3##(1996-12#1)(2008-1#1)
from adult##17##2##(1994-9#1)(1996-12#1)(1996-2#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2012-3#1)
from adults##4##2##(2008-11#1)(2008-9#1)(2010-5#1)(2010-6#1)
from advances in##2##3##(1993-1#1)(2010-7#1)
from aerial parts of##2##4##(2008-10#2)
from aerial##3##2##(2008-10#2)(2010-5#1)
from aerobic##2##2##(1994-8#1)(2013-1#1)
from aerosols##2##2##(1996-1#1)(2008-3#1)
from age 20 to 40##3##5##(2009-9#3)
from age##7##2##(1993-1#1)(2008-7#1)(2009-8#1)(2009-9#3)(2011-1#1)
from age-related macular degeneration##3##4##(2007-11#2)(2013-1#1)
from aged##4##2##(1990-3#1)(1997-6#1)(2008-7#1)(2012-2#1)
from ages##2##2##(2009-7#2)
from agricultural##2##2##(2008-10#2)
from air##6##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
from airborne##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
from alcohol##2##2##(1994-2#1)(2008-2#1)
from alfalfa##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
from alginate##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
from alkali##2##2##(2008-10#2)
from alkaline##3##2##(1990-8#1)(1997-2#1)(2008-10#1)
from all five##3##3##(2008-10#2)(2008-11#1)
from all four##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
from all geographic##2##3##(2008-10#1)(2011-10#1)
from all isolates of##3##4##(2008-10#3)
from all isolates##5##3##(2008-10#5)
from all levels of the organization##2##6##(1992-9#1)(1996-3#1)
from all locations##2##3##(2008-10#2)
from all of the##7##4##(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
from all other strains##2##4##(2008-10#2)
from all other##14##3##(1997-1#1)(2008-10#10)(2010-8#1)(2011-2#2)
from all over##2##3##(1994-9#1)(2008-10#1)
from all participants##2##3##(2012-12#1)(2013-1#1)
from all sites##3##3##(2008-1#1)(2008-10#2)
from all the other##3##4##(2008-10#2)(2009-8#1)
from all the provenances##2##4##(2011-10#2)
from all the##14##3##(1990-3#1)(1993-12#1)(1996-12#1)(2007-12#2)(2008-10#4)(2009-8#1)(2010-1#1)(2011-10#2)(2011-2#1)
from all three##10##3##(2008-10#7)(2008-12#1)(2010-5#1)(2011-3#1)
from all##137##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#65)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#3)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#3)(2011-10#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
from alloxan-induced cell damage##2##4##(2008-11#2)
from almond and##2##3##(2008-10#2)
from almond##9##2##(2008-10#9)
from almost##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
from alternative##5##2##(1992-5#1)(1995-6#1)(2008-10#2)(2008-8#1)
from amalgam fillings in##2##4##(1995-6#2)
from amalgam fillings##4##3##(1995-6#4)
from amalgam##5##2##(1995-3#1)(1995-6#4)
from amino acid##4##3##(1992-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
from amino acids##4##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
from amino##8##2##(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
from ammonia##3##2##(1991-9#1)(2008-10#2)
from amniotic fluid and##2##4##(2008-9#1)(2012-2#1)
from amniotic fluid##3##3##(2008-9#1)(2012-2#2)
from among the##2##3##(2008-12#1)(2008-7#1)
from among##8##2##(1990-11#1)(1995-12#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
from amphibians of the##2##4##(2013-1#2)
from amplified fragment length##2##4##(2008-10#2)
from amplified##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
from amyotrophic lateral sclerosis##2##4##(1993-9#1)(2009-12#1)
from an AIDS##2##3##(1997-4#1)(2009-12#1)
from an F(2) population##2##4##(2008-10#1)(2008-8#1)
from an F(2)##3##3##(2008-10#1)(2008-8#2)
from an Indian##3##3##(1997-4#1)(2008-5#1)(2009-11#1)
from an MDI##2##3##(1996-1#1)(1997-1#1)
from an abandoned##2##3##(2008-10#1)(2013-1#1)
from an actual##2##3##(2008-3#1)(2012-1#1)
from an adult##5##3##(1997-7#1)(1997-8#1)(2008-9#3)
from an airborne##2##3##(2008-2#1)(2008-3#1)
from an amino##2##3##(1992-6#1)(2008-12#1)
from an analysis of##2##4##(2008-12#1)(2008-2#1)
from an analytical##2##3##(2008-3#2)
from an ancestral##4##3##(1990-7#1)(1992-3#1)(1994-8#1)(2008-11#1)
from an ancient##2##3##(1994-2#1)(2008-10#1)
from an animal##2##3##(2008-10#1)(2008-6#1)
from an aqueous solution of##3##5##(1995-2#1)(2008-10#2)
from an aqueous solution onto##2##5##(2008-10#1)(2008-11#1)
from an aqueous solution##9##4##(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#1)
from an aqueous##12##3##(1995-2#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-5#1)
from an area of##2##4##(2008-3#1)(2013-1#1)
from an area##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
from an average of##4##4##(1994-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
from an early stage##3##4##(1992-6#1)(2007-12#1)(2008-10#1)
from an early##4##3##(1991-11#1)(1992-6#1)(2007-12#1)(2008-10#1)
from an electro-optic modulator##2##4##(2007-12#1)(2008-3#1)
from an emergency##2##3##(2008-8#1)(2010-11#1)
from an empirical study##3##4##(1992-3#1)(2008-12#1)(2009-8#1)
from an emulsion##3##3##(2008-10#1)(2009-11#2)
from an environmental##2##3##(2008-10#2)
from an enzymic##2##3##(1991-5#1)(1992-12#1)
from an epidemiological##2##3##(1992-9#1)(2008-11#1)
from an ethical##3##3##(1994-11#1)(2007-6#1)(2010-11#1)
from an evolutionary##2##3##(2009-2#1)(2012-3#1)
from an existing##2##3##(2008-11#1)(2012-2#1)
from an expanded##2##3##(2008-7#1)(2011-2#1)
from an experiment##3##3##(1994-6#1)(2008-1#1)(2008-4#1)
from an external##2##3##(2008-3#1)(2008-7#1)
from an image##2##3##(2008-3#1)(2009-6#1)
from an in vitro##3##4##(1994-11#1)(2008-10#1)(2012-3#1)
from an in##5##3##(1994-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
from an increased##2##3##(1990-5#1)(1995-2#1)
from an independent##2##3##(2008-6#1)(2011-2#1)
from an infected##3##3##(2008-10#2)(2008-9#1)
from an infinite##3##3##(2008-2#2)(2012-3#1)
from an initial##5##3##(1991-1#1)(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
from an initially##2##3##(2008-2#1)(2008-8#1)
from an inoculum source##3##4##(2008-10#3)
from an international perspective##2##4##(2008-11#1)(2009-12#1)
from an international##4##3##(2008-10#1)(2008-11#2)(2009-12#1)
from an invertebrate##2##3##(1990-5#1)(2008-8#1)
from an isotropic point source##2##5##(2008-3#2)
from an object##2##3##(2007-12#1)(2008-3#1)
from an ongoing##2##3##(2008-11#1)(2008-6#1)
from an online survey##2##4##(2010-8#1)(2010-9#1)
from an optical##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
from an optically active sphere##3##5##(2008-2#3)
from an optically##5##3##(2008-2#4)(2008-3#1)
from an orchard##2##3##(2008-10#2)
from an urban##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
from an##382##2##(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#11)(2007-12#14)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#76)(2008-11#17)(2008-12#4)(2008-2#27)(2008-3#36)(2008-4#9)(2008-5#9)(2008-6#6)(2008-7#4)(2008-8#7)(2008-9#8)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#11)(2013-1#7)(2013-8#1)
from analyses of##3##3##(2008-10#1)(2008-7#1)(2010-3#1)
from analyses##4##2##(1996-3#1)(2008-10#1)(2008-7#1)(2010-3#1)
from analysis of##3##3##(2007-11#1)(2010-3#1)(2012-2#1)
from analysis##5##2##(1991-8#1)(2007-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
from analyte##2##2##(2008-10#2)
from ancient##4##2##(1991-2#1)(2007-11#1)(2012-2#2)
from and how##2##3##(2011-2#1)(2013-1#1)
from and the##2##3##(1991-2#1)(2008-3#1)
from and##14##2##(1991-2#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
from androgens##2##2##(1994-2#1)(2010-2#1)
from anemone##2##2##(2008-10#2)
from angular static light-scattering measurements##2##5##(2008-3#2)
from angular##5##2##(2008-3#5)
from animal models##2##3##(2008-5#1)(2010-6#1)
from animal##12##2##(1994-3#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
from animals treated with##2##4##(1992-9#1)(1995-11#1)
from animals##8##2##(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-11#2)(1997-4#1)(2008-5#1)
from anionic##2##2##(2008-10#1)(2009-9#1)
from another population##2##3##(2008-9#2)
from another##19##2##(1990-7#1)(1993-12#1)(1994-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)
from anoxia##2##2##(1990-7#2)
from antenatal##2##2##(2007-7#1)(2013-1#1)
from antennal##2##2##(2007-12#2)
from anterior##2##2##(2008-10#1)(2008-8#1)
from anthropogenic##4##2##(2007-5#1)(2008-10#1)(2008-5#1)(2013-7#1)
from antibiosis##2##2##(2008-10#2)
from antibody##2##2##(2008-11#1)(2008-4#1)
from antimesenteric##2##2##(1996-2#2)
from any adverse##2##3##(1994-3#1)(2012-2#1)
from any of##2##3##(2008-10#1)(2008-4#1)
from any other##4##3##(1990-8#1)(2008-10#3)
from any##35##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#4)(2009-2#1)(2009-3#1)(2009-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
from apo##2##2##(1994-6#2)
from apoptosis##8##2##(1993-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
from apple roots##2##3##(2008-10#2)
from apple##7##2##(2008-10#6)(2008-8#1)
from application of the##2##4##(2007-12#1)(2009-12#1)
from applying a##2##3##(2008-10#2)
from applying##3##2##(2008-10#2)(2008-5#1)
from appressoria##3##2##(2008-10#3)
from approx##4##2##(1997-1#1)(2008-11#1)(2008-6#2)
from approximately 0##9##3##(1991-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-5#1)
from approximately 1 to##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
from approximately 1##6##3##(1992-8#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
from approximately 2##2##3##(2008-10#2)
from approximately 8##2##3##(2008-2#1)(2008-3#1)
from approximately##38##2##(1990-12#1)(1991-11#1)(1991-9#2)(1992-8#1)(1994-5#1)(1995-6#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-2#6)(2008-3#8)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
from aquatic environments were##2##4##(2008-5#2)
from aqueous media containing##2##4##(2008-10#2)
from aqueous media##4##3##(2008-10#4)
from aqueous medium using##2##4##(2008-10#2)
from aqueous medium##3##3##(2008-10#3)
from aqueous phase##3##3##(2008-10#3)
from aqueous sample##2##3##(2008-10#2)
from aqueous samples##6##3##(2008-10#5)(2012-1#1)
from aqueous solution by##3##4##(2008-10#3)
from aqueous solution with##2##4##(2008-10#2)
from aqueous solution##12##3##(1990-5#1)(1991-12#1)(2008-10#8)(2008-5#1)(2013-8#1)
from aqueous solutions by##2##4##(2008-10#2)
from aqueous solutions containing##4##4##(2008-10#4)
from aqueous solutions into##2##4##(2008-10#2)
from aqueous solutions onto loaded##2##5##(2008-10#2)
from aqueous solutions was studied##2##5##(2008-10#1)(2008-6#1)
from aqueous solutions was##3##4##(2008-10#2)(2008-6#1)
from aqueous solutions##23##3##(2008-10#18)(2008-2#2)(2008-6#2)(2010-11#1)
from aqueous##61##2##(1990-5#1)(1991-12#1)(2008-10#51)(2008-2#2)(2008-5#1)(2008-6#2)(2010-11#1)(2012-1#1)(2013-8#1)
from archaeological##3##2##(1991-2#1)(2008-10#2)
from areas of##3##3##(1991-8#1)(2007-5#1)(2008-9#1)
from areas##6##2##(1991-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
from around the world##5##4##(2008-1#1)(2008-5#1)(2009-6#1)(2010-5#1)(2013-8#1)
from around the##6##3##(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-5#1)(2013-8#1)
from around##9##2##(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-5#1)(2013-8#1)
from arterial##2##2##(2008-1#1)(2010-5#1)
from arthroscopic##2##2##(2008-8#1)(2011-2#1)
from artificial##5##2##(1995-5#1)(2007-11#1)(2008-10#2)(2008-5#1)
from artificially infected##2##3##(2008-10#2)
from as early as##2##4##(1997-2#1)(2012-3#1)
from as low as##3##4##(1993-12#1)(2008-10#1)(2012-2#1)
from as##8##2##(1992-12#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2012-2#1)(2012-3#1)
from ascitic fluid##2##3##(1992-2#1)(2009-8#1)
from ascorbate and##2##3##(1992-6#1)(1995-2#1)
from ascorbic acid##2##3##(2008-10#2)
from ascospores##4##2##(2008-10#4)
from asphyxia##2##2##(1993-3#1)(1996-12#1)
from assessing the##2##3##(2008-10#1)(2008-11#1)
from assessing##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
from asthmatic individuals##2##3##(1992-3#2)
from asymmetric##2##2##(2008-8#1)(2009-10#1)
from asymptomatic##4##2##(2007-2#1)(2008-10#2)(2012-2#1)
from at least one##2##4##(2008-5#1)(2008-6#1)
from at least two##2##4##(1994-9#1)(2008-5#1)
from at least##7##3##(1994-9#1)(1996-7#1)(2008-10#2)(2008-5#2)(2008-6#1)
from atmospheric##7##2##(2008-10#2)(2008-2#2)(2008-3#3)
from atomic force microscopy##2##4##(2008-2#1)(2011-2#1)
from atomic##4##2##(1996-6#1)(2008-10#1)(2008-2#1)(2011-2#1)
from attacks##2##2##(2008-8#1)(2011-2#1)
from autochthonous##2##2##(2008-9#1)(2013-1#1)
from autologous bone marrow##3##4##(2008-11#1)(2012-1#2)
from autologous##4##2##(2008-11#1)(2012-1#2)(2012-12#1)
from autopsies##2##2##(1993-2#1)(2012-2#1)
from available##2##2##(2008-7#1)(2011-2#1)
from average##2##2##(2007-11#1)(2007-8#1)
from axonal##2##2##(2008-7#1)(2013-1#1)
from baboon##2##2##(1993-6#1)(1994-12#1)
from backscatter and extinction coefficients at multiple wavelengths##2##8##(2008-3#2)
from backscatter lidar##2##3##(2008-2#2)
from backscatter##4##2##(2008-2#2)(2008-3#2)
from bacteria##5##2##(1995-8#1)(1997-4#1)(2008-2#1)(2008-7#1)(2008-9#1)
from bacterial##8##2##(1991-9#1)(1992-6#1)(2008-10#3)(2008-8#1)(2010-7#1)(2011-2#1)
from baculovirus##2##2##(1997-4#1)(2008-11#1)
from banana##3##2##(2008-10#3)
from band##5##2##(2008-10#1)(2008-2#1)(2013-8#3)
from bark##2##2##(2008-10#2)
from barley##9##2##(1994-6#1)(2008-10#6)(2008-5#2)
from basal##4##2##(1994-6#1)(2008-10#1)(2009-3#1)(2010-8#1)
from baseline after 12 weeks of##2##6##(1992-11#1)(2008-7#1)
from baseline after##4##3##(1992-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
from baseline and##2##3##(1997-1#1)(2008-10#1)
from baseline at##2##3##(2011-1#1)(2013-1#1)
from baseline in##5##3##(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
from baseline of##2##3##(2008-1#1)(2013-1#1)
from baseline to##6##3##(2008-7#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
from baseline was##3##3##(2013-1#3)
from baseline##35##2##(1992-11#1)(1993-1#1)(1996-7#1)(1997-1#1)(2007-10#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)
from baseline) in##2##3##(1993-1#1)(2008-10#1)
from basic research##2##3##(1991-9#1)(2008-2#1)
from basic##5##2##(1991-6#1)(1991-9#1)(1997-3#1)(2008-2#1)(2010-4#1)
from bats##2##2##(2008-12#1)(2013-1#1)
from beam##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
from bean##4##2##(2008-10#4)
from becoming##2##2##(2008-11#1)(2011-2#1)
from bed##2##2##(2007-8#1)(2008-7#1)
from beef##2##2##(1992-11#1)(2010-4#1)
from before##2##2##(1994-12#1)(2007-8#1)
from behavioral##2##2##(1993-3#1)(1996-1#1)
from behavioural##2##2##(2007-12#1)(2008-11#1)
from being a##2##3##(1996-2#1)(2008-3#1)
from being##24##2##(1992-6#1)(1994-2#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-3#1)(2012-12#1)(2013-8#1)
from bell pepper##3##3##(2008-10#3)
from below##4##2##(1991-2#2)(2008-10#1)(2011-2#1)
from bench to##2##3##(2008-8#1)(2012-12#1)
from benefiting from##2##3##(1996-12#1)(2008-9#1)
from benign##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
from beryllium##2##2##(2007-11#2)
from biased##2##2##(2007-12#2)
from bilateral##5##2##(2008-9#1)(2009-4#1)(2010-9#1)(2011-3#1)(2012-2#1)
from binary##4##2##(2008-10#4)
from binding media##2##3##(2008-10#2)
from binding##6##2##(1992-3#1)(2008-10#4)(2008-9#1)
from bioinformatics##2##2##(2010-11#2)
from biological samples##2##3##(2008-10#2)
from biological##13##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-12#1)
from biomass##6##2##(2008-11#1)(2008-6#4)(2011-2#1)
from biopsy specimens##2##3##(1997-8#1)(2008-12#1)
from biose to decaose##2##4##(2008-10#2)
from biose to##3##3##(1991-12#1)(2008-10#2)
from biotic and abiotic##2##4##(2008-10#1)(2008-8#1)
from bipolar##3##2##(1996-7#1)(2008-6#2)
from bird##2##2##(2008-3#1)(2008-5#1)
from birds and##2##3##(1997-4#1)(2008-3#1)
from birds##8##2##(1997-3#2)(1997-4#1)(1997-6#1)(2007-12#1)(2008-3#1)(2008-5#2)
from birth to one month of age##2##7##(2012-2#2)
from birth to##7##3##(1994-7#1)(1996-12#1)(1996-5#1)(2007-2#1)(2008-1#1)(2012-2#2)
from birth##10##2##(1994-7#2)(1996-12#1)(1996-5#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-11#1)(2012-2#2)
from bladder to##2##3##(2012-12#1)(2012-3#1)
from bladder##3##2##(1997-4#1)(2012-12#1)(2012-3#1)
from blood specimen collection##2##4##(2010-6#2)
from blood stains##2##3##(1990-7#2)
from blood to##2##3##(1990-11#1)(1993-12#1)
from blood##21##2##(1990-11#1)(1990-7#2)(1993-11#1)(1993-12#1)(1994-9#1)(1995-3#1)(2008-1#2)(2008-11#2)(2008-7#2)(2008-9#1)(2010-6#2)(2011-2#2)(2013-8#3)
from bloom until##2##3##(2008-10#2)
from body weight##2##3##(2008-1#1)(2008-3#1)
from body##6##2##(1996-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
from bone marrow and##3##4##(2008-4#1)(2010-7#1)(2012-3#1)
from bone marrow##10##3##(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
from bone metastases##2##3##(2007-11#1)(2008-10#1)
from bone##17##2##(1991-12#1)(1992-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#2)(2009-4#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
from both P##2##3##(2008-10#2)
from both a##3##3##(1991-2#1)(1994-12#1)(2008-10#1)
from both human and##2##4##(2007-4#1)(2008-12#1)
from both inpatient and##2##4##(1997-1#1)(2013-1#1)
from both instruments##2##3##(2008-3#2)
from both methods##3##3##(2008-10#2)(2012-3#1)
from both neighbours and professionals##2##5##(1992-3#2)
from both practical and##2##4##(2008-3#1)(2008-5#1)
from both sides of the##2##5##(1993-3#1)(2008-2#1)
from both species##4##3##(1990-2#1)(1992-10#1)(1995-5#1)(2008-10#1)
from both states##2##3##(2008-5#2)
from both strains##2##3##(1991-8#1)(1993-11#1)
from both the##23##3##(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-9#1)(2009-8#2)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
from both types of##2##4##(2008-12#1)(2012-3#1)
from both young##2##3##(1994-8#1)(1997-6#1)
from both##188##2##(1990-2#1)(1990-5#1)(1990-8#3)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1994-12#4)(1994-2#2)(1994-5#2)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-12#2)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#6)(2008-12#4)(2008-2#8)(2008-3#17)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#7)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
from bovine adrenal cortex##2##4##(1993-8#2)
from bovine adrenal##3##3##(1990-2#1)(1993-8#2)
from bovine brain##4##3##(1991-2#1)(1991-5#1)(1992-11#1)(1994-6#1)
from bovine neutrophils##2##3##(1992-8#1)(1993-8#1)
from bovine pituitaries##2##3##(1990-12#1)(2008-4#1)
from bovine serum##3##3##(1991-8#1)(1992-9#1)(2008-11#1)
from bovine##34##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
from boxing##2##2##(1992-2#1)(2008-7#1)
from brain and##2##3##(1995-6#1)(2008-12#1)
from brain##13##2##(1992-8#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-8#2)
from brains##2##2##(1994-8#1)(2009-12#1)
from bran##2##2##(1992-8#2)
from breakdown##2##2##(1995-12#1)(2008-11#1)
from breast cancer has##2##4##(1997-7#2)
from breast cancer in##2##4##(1997-7#1)(2008-7#1)
from breast cancer were##3##4##(1990-12#1)(1991-12#1)(1995-4#1)
from breast cancer##15##3##(1990-12#1)(1991-12#2)(1995-4#2)(1997-7#5)(2007-11#1)(2008-4#1)(2008-7#2)(2010-9#1)
from breast##21##2##(1990-12#1)(1990-8#1)(1991-12#3)(1993-1#1)(1993-11#1)(1995-4#2)(1997-7#5)(2007-11#2)(2008-4#1)(2008-7#3)(2010-9#1)
from breeding to helping##2##4##(2008-8#2)
from bright##2##2##(2007-12#1)(2008-3#1)
from broilers and the hatchery##2##5##(1997-3#2)
from bronchial##4##2##(1992-3#1)(2008-5#2)(2013-1#1)
from bronchoalveolar lavage##2##3##(2008-12#1)(2008-5#1)
from brown spot lesions on##2##5##(2008-10#2)
from brown spot lesions##3##4##(2008-10#3)
from brown##4##2##(2008-10#4)
from buffer##2##2##(2008-10#2)
from bulk##2##2##(2008-11#1)(2008-2#1)
from burn##2##2##(1990-2#1)(2008-12#1)
from c-Myc##2##2##(1996-12#1)(2013-1#1)
from cAMP##3##2##(1994-8#1)(2008-11#2)
from cDNA and##2##3##(1991-9#1)(1995-2#1)
from cDNA clones##4##3##(2008-10#4)
from cDNA##11##2##(1991-6#1)(1991-9#1)(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-9#1)
from cDNAs##2##2##(1991-6#1)(2008-10#1)
from ca##2##2##(2008-5#1)(2012-9#1)
from cacao##3##2##(2008-10#3)
from cadmium##2##2##(2008-10#2)
from calcium##2##2##(1993-6#1)(2008-10#1)
from calf thymus##2##3##(1990-8#1)(1995-6#1)
from calf##3##2##(1990-12#1)(1990-8#1)(1995-6#1)
from calibration##2##2##(2007-12#1)(2008-3#1)
from california##2##2##(2008-10#2)
from cancer cells##3##3##(1991-2#1)(1992-2#1)(1992-8#1)
from cancer patients were##2##4##(1994-3#1)(2008-10#1)
from cancer patients##7##3##(1993-9#2)(1994-3#3)(2008-10#1)(2008-4#1)
from cancer##21##2##(1991-2#1)(1992-2#1)(1992-8#1)(1993-9#2)(1994-11#1)(1994-3#3)(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
from canine tracheal##2##3##(1994-11#1)(1997-7#1)
from canine##4##2##(1994-11#1)(1997-7#1)(2008-8#1)(2013-1#1)
from cankers##4##2##(2008-10#4)
from canopy##2##2##(2008-10#2)
from cantaloupe##3##2##(2008-10#3)
from capsaicin-sensitive##2##2##(1992-6#1)(1997-4#1)
from carbohydrate##3##2##(2008-3#3)
from carbon##3##2##(1991-9#1)(2008-10#2)
from carcinoma of gall bladder##2##5##(2010-11#2)
from carcinoma of the cervix##2##5##(1990-8#2)
from carcinoma of the##5##4##(1990-8#2)(1994-7#1)(1995-8#2)
from carcinoma of##8##3##(1990-8#2)(1994-7#1)(1995-8#3)(2010-11#2)
from carcinoma##10##2##(1990-7#1)(1990-8#2)(1992-2#1)(1994-7#1)(1995-8#3)(2010-11#2)
from cardiac arrest##2##3##(2008-10#1)(2012-2#1)
from cardiac##4##2##(1996-9#1)(2008-10#1)(2010-4#1)(2012-2#1)
from cardiopulmonary bypass##3##3##(1996-9#1)(2007-8#2)
from cardiovascular and##2##3##(1990-5#1)(2011-1#1)
from cardiovascular disease##4##3##(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)
from cardiovascular diseases and##2##4##(2008-2#1)(2011-1#1)
from cardiovascular##13##2##(1990-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
from caring##2##2##(2008-1#1)(2008-12#1)
from case##5##2##(1996-11#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
from case-control studies##2##3##(1990-6#1)(1990-8#1)
from case-control##3##2##(1990-6#1)(1990-8#1)(2008-9#1)
from casein##2##2##(2007-11#1)(2008-6#1)
from cases of##8##3##(1992-5#1)(1993-2#2)(2007-7#3)(2008-12#1)(2008-7#1)
from cases##9##2##(1992-5#1)(1993-2#2)(2007-7#3)(2008-12#1)(2008-6#1)(2008-7#1)
from cat##3##2##(2007-12#1)(2008-8#2)
from caterpillar##2##2##(2008-5#2)
from catheter##2##2##(2010-3#1)(2011-2#1)
from cattle##8##2##(1990-3#2)(2010-4#2)(2011-2#2)(2012-2#1)(2013-1#1)
from causes##2##2##(1994-2#1)(2006-10#1)
from cell cultures##2##3##(2008-11#1)(2009-6#1)
from cell death##3##3##(1995-5#1)(2008-11#2)
from cell surface receptors to##2##5##(1996-2#1)(1997-7#1)
from cell suspensions##3##3##(2008-1#1)(2008-3#1)(2008-9#1)
from cell##24##2##(1990-12#1)(1995-5#1)(1996-10#1)(1996-2#2)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-9#4)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
from cells and##2##3##(1990-2#1)(2012-12#1)
from cells in##3##3##(2008-4#2)(2012-2#1)
from cells that##4##3##(1994-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
from cells transfected with##3##4##(1992-12#2)(1993-11#1)
from cells##26##2##(1990-2#1)(1992-12#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-8#2)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#1)(2012-12#1)(2012-2#1)
from central and##2##3##(2008-10#1)(2010-8#1)
from central##12##2##(1992-6#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-7#1)
from centralized##2##2##(1994-12#1)(1994-2#1)
from cereal##2##2##(2008-10#2)
from cerebral##4##2##(1993-8#1)(1996-3#1)(2007-10#1)(2009-8#1)
from cerebrospinal fluid##3##3##(1995-3#2)(2009-3#1)
from cerebrovascular disease##2##3##(1996-2#1)(2011-1#1)
from certain##3##2##(1995-2#1)(2008-11#1)(2011-1#1)
from certified##2##2##(2008-10#2)
from cervical cancer##2##3##(2013-1#1)(2013-7#1)
from cervical##7##2##(1992-8#1)(2007-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
from changes in the##4##4##(1994-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
from changes in##9##3##(1990-8#1)(1992-5#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
from chemical analysis##2##3##(2008-10#2)
from chemical and##2##3##(1995-11#1)(1997-2#1)
from chemical##9##2##(1994-6#1)(1995-11#1)(1997-2#3)(2008-10#2)(2008-4#1)(2010-7#1)
from chemically##2##2##(1993-11#1)(2008-10#1)
from chest##3##2##(2008-7#1)(2010-8#1)(2012-2#1)
from chick##4##2##(1990-8#1)(1995-11#1)(1995-5#1)(2008-1#1)
from chicken gizzard##4##3##(1991-2#1)(1993-6#1)(1993-8#2)
from chicken##14##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#1)(1993-6#1)(1993-8#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-2#1)
from chickens and##2##3##(1997-3#2)
from chickens##4##2##(1997-3#2)(1997-6#1)(2008-5#1)
from childhood to##2##3##(2012-3#2)
from childhood##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-3#2)
from children with##5##3##(2007-10#1)(2007-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
from children##9##2##(1990-8#1)(1992-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
from chloride media##2##3##(2008-10#2)
from chloride##4##2##(2008-10#4)
from chromaffin granule membranes##3##4##(1990-11#3)
from chromaffin##4##2##(1990-11#3)(1996-5#1)
from chromaticity coordinates##2##3##(2008-2#1)(2008-3#1)
from chromosome X##2##3##(1995-9#2)
from chromosome##5##2##(1993-9#1)(1995-9#2)(1996-3#1)(2009-10#1)
from chromosomes##3##2##(1996-12#1)(1997-5#1)(2008-5#1)
from chronic diseases##2##3##(1994-3#1)(2008-11#1)
from chronic renal disease##2##4##(2008-10#2)
from chronic renal##4##3##(1993-3#1)(2008-10#2)(2013-1#1)
from chronic##31##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
from chronically##2##2##(1994-6#1)(1996-1#1)
from cigarette##2##2##(2008-10#1)(2008-5#1)
from citrus and papaya##3##4##(2008-10#3)
from citrus and##4##3##(2008-10#4)
from citrus##12##2##(2008-10#12)
from claims##2##2##(1996-3#1)(2011-2#1)
from classic##2##2##(2008-9#1)(2013-1#1)
from classical bacterial genetics##2##4##(2008-2#2)
from classical##6##2##(1995-8#1)(2008-10#1)(2008-2#2)(2008-9#1)(2010-8#1)
from clear##2##2##(2008-10#1)(2008-11#1)
from cleavage##2##2##(1994-3#1)(1995-6#1)
from clinical cases##4##3##(1993-2#1)(1996-8#1)(2013-8#2)
from clinical practice and##2##4##(2008-12#1)(2008-9#1)
from clinical samples##4##3##(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
from clinical specimens of##2##4##(2007-12#1)(2008-12#1)
from clinical specimens##5##3##(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
from clinical studies##4##3##(2008-10#1)(2013-8#3)
from clinical trials##9##3##(1992-9#1)(1995-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
from clinical##41##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-2#1)(1995-5#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
from clinically##4##2##(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
from clinicians##2##2##(2011-2#1)(2012-2#1)
from cloned##6##2##(2007-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
from close contact##2##3##(2008-12#1)(2008-8#1)
from close##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
from closed##2##2##(2010-2#1)(2012-2#1)
from clotting##3##2##(1996-5#1)(1997-5#1)(2008-10#1)
from clouds##4##2##(2008-10#1)(2008-3#3)
from clusters of##2##3##(2008-3#2)
from clusters##4##2##(2008-10#2)(2008-3#2)
from coal##6##2##(2008-10#2)(2008-6#4)
from coastal##2##2##(2008-2#1)(2012-1#1)
from cobalt##3##2##(2008-10#3)
from cocaine##3##2##(1991-1#1)(1992-11#1)(2008-6#1)
from cochlear##3##2##(2008-9#2)(2012-2#1)
from coffee##5##2##(1995-11#2)(2008-10#3)
from cognitive##2##2##(2008-2#2)
from coherent##2##2##(2007-11#1)(2008-2#1)
from cohort studies##2##3##(1991-12#1)(1996-3#1)
from cold##4##2##(2008-1#1)(2008-2#1)(2009-3#1)(2012-7#1)
from cold-treated##2##2##(2011-2#2)
from collagen##4##2##(1995-3#1)(1997-7#1)(2010-2#1)(2012-3#1)
from colon##4##2##(1992-8#1)(2008-11#2)(2011-2#1)
from colonies##3##2##(2008-10#2)(2011-2#1)
from color##2##2##(2008-10#1)(2008-5#1)
from colorectal cancer##4##3##(1993-9#1)(1994-6#1)(1995-9#1)(2009-12#1)
from colorectal##5##2##(1991-6#1)(1993-9#1)(1994-6#1)(1995-9#1)(2009-12#1)
from column##2##2##(2008-10#1)(2008-4#1)
from combinations of##2##3##(2008-5#1)(2010-7#1)
from combinations##3##2##(1995-5#1)(2008-5#1)(2010-7#1)
from combined##3##2##(1990-8#1)(2008-3#1)(2013-1#1)
from combustion)##2##2##(2008-10#2)
from commensal##3##2##(2008-12#2)(2008-7#1)
from commercial potato##3##3##(2008-10#3)
from commercial##19##2##(1991-9#1)(1997-4#1)(2008-10#13)(2008-4#1)(2008-8#1)(2011-2#1)(2013-7#1)
from commercially available##2##3##(2008-10#1)(2010-2#1)
from common bean##2##3##(2008-10#2)
from common wheat from##2##4##(2008-10#2)
from common wheat had##2##4##(2008-10#2)
from common wheat##6##3##(2008-10#6)
from common##26##2##(1994-11#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-10#16)(2008-11#1)(2008-12#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
from commonly##4##2##(2008-10#3)(2008-12#1)
from community groups##2##3##(1996-1#1)(2011-2#1)
from community##8##2##(1996-1#1)(2008-1#1)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
from comparative##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
from competition between##2##3##(1990-7#1)(2008-8#1)
from competition##3##2##(1990-7#1)(2008-10#1)(2008-8#1)
from complementary foods##2##3##(2010-6#2)
from complementary##3##2##(2008-10#1)(2010-6#2)
from complete##5##2##(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-3#1)
from complex matrices##2##3##(2008-10#2)
from complex mixtures##2##3##(2008-10#1)(2009-7#1)
from complex##14##2##(1993-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(2008-10#7)(2008-3#1)(2009-7#1)(2010-11#1)
from computational##2##2##(2007-8#1)(2008-11#1)
from computed tomography##2##3##(1995-9#1)(2008-9#1)
from computer modeling##2##3##(1995-2#1)(2008-2#1)
from computer##4##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
from computer-generated holograms##3##3##(2007-11#1)(2008-3#2)
from computer-generated##4##2##(2007-11#1)(2008-3#3)
from computerized medical records##2##4##(1996-9#1)(1997-2#1)
from concept to action##2##4##(1993-12#2)
from concept to##4##3##(1993-12#2)(1995-12#1)(2010-10#1)
from conception##2##2##(2008-10#1)(2012-2#1)
from conditioned##2##2##(1992-8#1)(1994-11#1)
from conditions##2##2##(2008-10#1)(2008-7#1)
from conidia or##2##3##(2008-10#2)
from conidia##4##2##(2008-10#4)
from consanguineous##2##2##(2011-1#1)(2012-2#1)
from conserved regions of##3##4##(1994-12#1)(2008-10#2)
from conserved sequences##2##3##(1994-11#1)(1994-12#1)
from conserved##6##2##(1994-11#1)(1994-12#2)(1997-6#1)(2008-10#2)
from considering##4##2##(1995-5#1)(2008-11#1)(2008-9#2)
from consumers##3##2##(1992-11#2)(2008-11#1)
from consumption##3##2##(1994-2#1)(2007-12#1)(2008-5#1)
from contact##2##2##(1991-12#1)(2007-12#1)
from contaminated##4##2##(1992-12#1)(1997-5#1)(2008-6#1)(2010-4#1)
from contaminating##4##2##(2008-10#3)(2011-2#1)
from content##2##2##(2008-10#1)(2012-12#1)
from continuous##8##2##(1992-11#1)(1992-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-5#1)
from continuum##2##2##(2009-12#1)(2009-7#1)
from contributing##2##2##(2008-9#1)(2012-12#1)
from control and##5##3##(1990-12#1)(1993-6#1)(1994-5#1)(2008-5#1)(2008-7#1)
from control rats##3##3##(1991-12#1)(1993-6#1)(1997-1#1)
from control subjects##3##3##(1990-12#1)(1990-8#1)(2013-1#1)
from control values##2##3##(1992-3#1)(1995-12#1)
from control##24##2##(1990-12#3)(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#2)(1993-6#2)(1994-5#1)(1995-12#2)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#1)
from controls##13##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-8#1)(1996-7#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
from conventional##17##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2010-3#1)(2012-8#1)(2013-1#1)
from copper##2##2##(2008-10#2)
from cord blood and to determine their potential for osteogenic differentiation##2##11##(2008-11#2)
from cord blood and##3##4##(2008-11#2)(2008-9#1)
from cord blood##6##3##(2008-11#4)(2008-9#2)
from corn##3##2##(1995-3#1)(2008-10#2)
from corneal##2##2##(2007-11#1)(2010-1#1)
from coronary##7##2##(1991-12#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-3#1)
from correlation##2##2##(2007-12#1)(2008-3#1)
from corresponding##3##2##(1996-2#1)(2008-10#2)
from cosmetic##2##2##(2008-5#2)
from cotton and##2##3##(2008-10#2)
from cotton soil##2##3##(2008-10#2)
from cotton##9##2##(2008-10#8)(2008-9#1)
from counting fingers at##2##4##(2011-1#2)
from countries##4##2##(1997-8#1)(2008-1#1)(2008-10#2)
from country to country and##2##5##(1993-2#1)(2008-7#1)
from country to country##3##4##(1993-2#1)(1994-1#1)(2008-7#1)
from couples##2##2##(2007-7#2)
from cows and##2##3##(2007-2#1)(2013-1#1)
from cows##6##2##(1991-8#1)(2007-2#1)(2012-3#1)(2013-1#3)
from crime scene##2##3##(2008-12#2)
from crime scenes##2##3##(2008-10#2)
from crime##4##2##(2008-10#2)(2008-12#2)
from cross##3##2##(2007-11#1)(2008-10#1)(2009-10#1)
from crosses between##9##3##(2008-10#6)(2008-5#1)(2008-8#1)(2012-3#1)
from crosses of##4##3##(2008-10#4)
from crosses##14##2##(2008-10#11)(2008-5#1)(2008-8#1)(2012-3#1)
from crossing##3##2##(2008-10#2)(2012-12#1)
from crown-6##2##2##(2008-10#2)
from crowns##3##2##(2008-10#3)
from cruciferous hosts##2##3##(2008-10#2)
from cruciferous##4##2##(2008-10#4)
from crude##6##2##(1990-2#1)(1990-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-3#1)
from cucumber and spinach##2##4##(2008-4#2)
from cucumber##5##2##(2008-10#3)(2008-4#2)
from cucurbit hosts##2##3##(2008-10#2)
from cucurbit##4##2##(2008-10#4)
from cucurbits##2##2##(2008-10#2)
from cultivated and wild##2##4##(2008-10#1)(2012-3#1)
from cultivated potatoes and wild Solanum##2##6##(2008-10#2)
from cultivated potatoes and##3##4##(2008-10#3)
from cultivated potatoes##4##3##(2008-10#4)
from cultivated##10##2##(2008-10#9)(2012-3#1)
from culture filtrates of##4##4##(2008-10#3)(2008-11#1)
from culture##10##2##(1990-12#1)(1991-11#1)(1997-2#1)(2007-7#1)(2008-10#5)(2008-11#1)
from cultured bovine aortic endothelial cells##2##6##(1990-2#1)(1991-5#1)
from cultured cells##6##3##(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
from cultured mouse##2##3##(1995-11#1)(2008-11#1)
from cultured neonatal##2##3##(1993-6#1)(1995-11#1)
from cultured rat##2##3##(1994-12#1)(2008-10#1)
from cultured##31##2##(1990-2#2)(1991-5#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-11#3)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
from cultures of##4##3##(1992-9#1)(1996-5#1)(2008-10#1)(2012-2#1)
from cultures that##2##3##(2008-10#1)(2012-12#1)
from cultures##10##2##(1992-9#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#1)
from current##4##2##(1992-2#1)(1993-12#1)(2011-1#1)(2013-1#1)
from cv##4##2##(2008-10#4)
from cyanide##2##2##(2008-10#2)
from cysts##2##2##(2008-10#2)
from cytochrome##4##2##(1990-5#1)(1994-5#1)(2008-5#2)
from cytoplasm to nucleus##2##4##(1991-2#2)
from cytoplasm##3##2##(1991-2#2)(1997-8#1)
from cytoplasmic##6##2##(1990-7#1)(1995-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
from cytosol to##2##3##(1990-7#1)(2008-8#1)
from cytosolic##2##2##(1990-5#1)(1997-4#1)
from daily##3##2##(1992-3#1)(2008-7#1)(2013-8#1)
from dairy##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
from damage##2##2##(2008-5#1)(2008-6#1)
from damaged cells and##2##4##(2008-10#1)(2008-4#1)
from damaged cells##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
from damaged##8##2##(1990-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2010-8#1)
from dark##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
from data acquired##2##3##(2008-3#1)(2012-7#1)
from data collected in##2##4##(2007-12#1)(2010-3#1)
from data##16##2##(1995-3#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2010-3#1)(2012-7#1)(2013-1#2)
from date##2##2##(1994-12#1)(2008-12#1)
from day 0 to day 4##2##6##(2010-7#2)
from day 1##3##3##(1991-8#1)(1997-3#1)(1997-6#1)
from day 2 to day##2##5##(2008-8#1)(2010-7#1)
from day 2##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
from day 5 to day##2##5##(1995-2#1)(2010-7#1)
from day to day##2##4##(1993-12#1)(2012-3#1)
from day##21##2##(1991-8#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-7#4)(2011-2#1)(2012-3#3)
from days##5##2##(1993-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-3#1)
from db/db mice##2##3##(2012-12#1)(2012-3#1)
from de##2##2##(1992-12#1)(2008-5#1)
from dead##4##2##(1996-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
from dead-in-shell turkey embryos##2##4##(2008-5#2)
from death certificates##2##3##(2012-12#1)(2013-8#1)
from death##6##2##(1994-10#1)(2008-11#2)(2008-9#1)(2012-12#1)(2013-8#1)
from decayed##2##2##(2008-10#2)
from deceased donors##2##3##(2011-2#2)
from deceased##3##2##(1997-3#1)(2011-2#2)
from decision##2##2##(1994-3#1)(2010-8#1)
from decreased##2##2##(2008-10#1)(2008-7#1)
from deep##3##2##(2007-7#1)(2008-5#1)(2008-9#1)
from deficient##3##2##(1990-11#1)(1993-6#1)(2012-2#1)
from degradation##3##2##(2008-10#2)(2010-4#1)
from delayed##2##2##(2008-8#1)(2012-2#1)
from deleterious##2##2##(1995-2#1)(2008-7#1)
from demes of##2##3##(2008-9#2)
from dental amalgam##2##3##(1995-3#1)(2008-10#1)
from dental##10##2##(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
from depression##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
from depths of##2##3##(2008-10#2)
from destruction##2##2##(1993-5#1)(2012-12#1)
from deterministic effects##2##3##(2008-7#2)
from developed countries##3##3##(2009-5#1)(2009-6#2)
from developing countries##3##3##(1992-2#2)(1997-8#1)
from developing##9##2##(1992-2#2)(1993-11#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-8#1)
from development##2##2##(1997-3#1)(2012-2#1)
from developmental##2##2##(2009-3#1)(2011-2#1)
from diabetes mellitus##2##3##(2008-1#1)(2011-2#1)
from diabetes##5##2##(2008-1#1)(2008-7#2)(2010-8#1)(2011-2#1)
from diabetic patients##5##3##(1991-12#1)(1993-8#3)(2008-10#1)
from diabetic##7##2##(1991-12#1)(1993-8#4)(2008-10#1)(2012-2#1)
from diagnostic##3##2##(1997-8#1)(2008-2#1)(2008-9#1)
from diarrhoeal##2##2##(2007-7#1)(2008-10#1)
from dielectric##3##2##(2007-11#2)(2008-3#1)
from diet-induced##2##2##(1995-2#1)(2008-1#1)
from dietary##2##2##(1991-12#1)(2011-1#1)
from differences in##6##3##(1992-5#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
from different angles##3##3##(1995-6#2)(2010-10#1)
from different areas of the##2##5##(2010-9#1)(2012-12#1)
from different areas of##3##4##(2008-10#1)(2010-9#1)(2012-12#1)
from different cellular##2##3##(2008-9#1)(2009-8#1)
from different centers##2##3##(2008-1#1)(2008-2#1)
from different classes##2##3##(2008-1#1)(2008-10#1)
from different countries##3##3##(2008-11#2)(2011-1#1)
from different dates##2##3##(2007-5#1)(2008-10#1)
from different experimental##3##3##(2008-10#2)(2008-7#1)
from different genetic backgrounds##2##4##(2008-10#1)(2012-3#1)
from different geographic locations##2##4##(2008-10#1)(2009-2#1)
from different geographic##5##3##(2008-10#3)(2008-5#1)(2009-2#1)
from different geographical locations##2##4##(2008-10#1)(2011-2#1)
from different geographical regions##2##4##(2008-10#2)
from different geographical##5##3##(2008-10#4)(2011-2#1)
from different host##3##3##(2008-10#3)
from different hosts and##3##4##(2008-10#2)(2012-2#1)
from different hosts##4##3##(2008-10#3)(2012-2#1)
from different laboratories##2##3##(2011-2#1)(2012-3#1)
from different localities##2##3##(2008-10#1)(2013-1#1)
from different locations in##2##4##(2008-10#2)
from different locations##10##3##(1994-12#1)(2008-10#7)(2012-3#2)
from different models##2##3##(1996-11#1)(2010-12#1)
from different organs##2##3##(2008-10#1)(2008-9#1)
from different origins##3##3##(2008-10#3)
from different parts of the##4##5##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
from different parts of##5##4##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
from different places of##2##4##(2008-10#2)
from different places##4##3##(2008-10#4)
from different points##2##3##(2008-3#1)(2013-8#1)
from different regions in##2##4##(1991-11#1)(2011-1#1)
from different regions of the##2##5##(2008-10#1)(2009-2#1)
from different regions of##6##4##(1990-3#1)(2008-1#1)(2008-10#3)(2009-2#1)
from different regions##12##3##(1990-3#1)(1991-11#2)(2008-1#1)(2008-10#6)(2009-2#1)(2011-1#1)
from different rice##2##3##(2008-9#2)
from different samples##2##3##(1993-11#1)(2008-10#1)
from different sampling##2##3##(1997-4#1)(2008-10#1)
from different sectors##2##3##(1992-4#1)(2010-12#1)
from different sites##2##3##(2008-10#1)(2008-5#1)
from different sources##9##3##(1990-5#1)(1992-12#1)(2008-10#5)(2008-7#1)(2011-1#1)
from different species##5##3##(1990-5#1)(1993-6#1)(1997-6#1)(2008-8#1)(2009-5#1)
from different strains##2##3##(2008-7#1)(2010-4#1)
from different studies##4##3##(2008-1#1)(2008-10#3)
from different tissue##3##3##(1995-11#1)(2008-1#1)(2008-8#1)
from different tissues and##2##4##(1995-2#1)(1997-3#1)
from different tissues##5##3##(1995-11#1)(1995-2#1)(1997-3#1)(2008-11#1)(2009-8#1)
from different types of##4##4##(1997-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
from different##239##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-12#2)(1991-6#1)(1992-12#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#3)(1995-6#3)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#7)(2008-10#96)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#8)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#8)(2012-7#1)(2013-1#7)(2013-8#2)
from differential##5##2##(1990-12#1)(2008-10#1)(2008-6#3)
from differentiated##2##2##(1993-8#1)(2013-1#1)
from difficulties in##2##3##(1993-12#1)(2011-1#1)
from difficulties##3##2##(1993-12#1)(2009-10#1)(2011-1#1)
from diffuse##4##2##(1992-6#2)(2008-1#1)(2008-2#1)
from diffusion##4##2##(2008-10#1)(2008-2#1)(2012-2#1)(2013-1#1)
from digital##4##2##(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)
from dilute aqueous solutions##4##4##(2008-10#4)
from dilute##5##2##(2008-10#4)(2008-2#1)
from diluted##3##2##(2008-10#2)(2008-2#1)
from diploid##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
from direct##14##2##(1990-5#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#2)
from discovery##2##2##(2010-5#1)(2013-8#1)
from disease##6##2##(1990-6#1)(1993-12#1)(2008-10#1)(2011-1#1)(2012-2#2)
from diseased lettuce and tomato plants##3##6##(2008-10#3)
from diseased roots##3##3##(2008-10#3)
from diseased soybean##2##3##(2008-10#2)
from diseased strawberry##2##3##(2008-10#2)
from diseased tissue##3##3##(2008-10#3)
from diseased tissues##2##3##(2008-10#2)
from diseased##38##2##(2008-10#37)(2011-2#1)
from disks##2##2##(2008-10#2)
from distinct##3##2##(1997-6#1)(2007-8#1)(2008-5#1)
from diverse cultural##2##3##(2012-2#2)
from diverse##18##2##(1993-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
from dog##5##2##(1991-11#1)(1991-6#1)(1993-3#2)(1995-12#1)
from dogs at##2##3##(2011-1#1)(2012-3#1)
from dogs##9##2##(2008-10#1)(2008-11#1)(2010-12#2)(2011-1#4)(2012-3#1)
from doing##2##2##(2008-9#1)(2010-1#1)
from domestic##2##2##(1996-12#1)(2012-2#1)
from donor to recipient##2##4##(2008-11#1)(2008-12#1)
from donor##6##2##(1992-3#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
from donors and##2##3##(2008-11#1)(2008-12#1)
from dopamine##3##2##(1995-2#2)(1995-8#1)
from dormant##2##2##(2008-10#2)
from dorsal##4##2##(1990-5#1)(1993-3#1)(1994-12#1)(1996-6#1)
from drier habitats##2##3##(2012-9#2)
from drinking water##2##3##(2008-10#1)(2008-11#1)
from drinking##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
from driver##2##2##(2008-2#2)
from droplets##2##2##(2007-12#1)(2008-3#1)
from drug therapy##2##3##(1991-5#1)(2008-7#1)
from drug##11##2##(1991-5#1)(1991-8#1)(1994-3#1)(1994-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-7#1)
from drugs and##2##3##(1992-12#1)(2009-9#1)
from drugs##3##2##(1992-12#1)(1996-6#1)(2009-9#1)
from dry##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
from dsRNA isolated from##2##4##(2008-10#2)
from dsRNA##3##2##(2008-10#2)(2008-2#1)
from duodenal varices##2##3##(2011-2#2)
from duodenal##4##2##(1997-1#1)(2007-8#1)(2011-2#2)
from durum and bread##2##4##(2008-10#2)
from durum wheat from Argentina##2##5##(2008-10#2)
from durum wheat from##4##4##(2008-10#4)
from durum wheat in##2##4##(2008-10#1)(2008-8#1)
from durum wheat##12##3##(2008-10#11)(2008-8#1)
from durum##14##2##(2008-10#13)(2008-8#1)
from dye##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
from dying##4##2##(1992-12#1)(1996-12#1)(2008-10#2)
from dynamic##3##2##(2008-3#2)(2008-8#1)
from dynamical##2##2##(1994-8#1)(2008-11#1)
from dysphagia##2##2##(2007-8#1)(2011-2#1)
from dystrophic##2##2##(2010-12#1)(2012-2#1)
from each class##2##3##(2007-11#1)(2010-2#1)
from each domain##2##3##(1993-12#2)
from each group were##6##4##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
from each group##7##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
from each of the three##3##5##(1991-2#1)(1995-11#1)(2008-10#1)
from each of the##10##4##(1991-2#1)(1994-3#1)(1995-11#1)(2008-10#4)(2008-12#1)(2009-7#1)(2013-7#1)
from each of three##3##4##(1991-2#1)(2008-10#1)(2009-12#1)
from each of two##4##4##(2008-10#3)(2008-4#1)
from each of##21##3##(1991-2#2)(1994-3#1)(1995-11#1)(1995-5#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-7#1)
from each other (P &lt##2##5##(2008-10#2)
from each other and also##2##5##(2008-10#2)
from each other and from other##2##6##(2008-10#1)(2010-10#1)
from each other and from##6##5##(1991-5#1)(2008-10#3)(2008-11#1)(2010-10#1)
from each other and##11##4##(1991-5#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2010-10#1)
from each other by##5##4##(1992-6#1)(2008-10#3)(2008-4#1)
from each other in the##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
from each other in##10##4##(1990-11#1)(1992-12#1)(1997-7#1)(2008-10#3)(2008-8#1)(2009-8#1)(2009-9#1)(2013-1#1)
from each other##54##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-9#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2013-1#1)
from each site##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
from each species##3##3##(2008-10#1)(2011-2#2)
from each tree##3##3##(2008-10#3)
from each type##2##3##(2008-10#1)(2008-5#1)
from each##172##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-3#3)(1997-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#63)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
from earlier##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
from early to late##3##4##(1991-2#1)(1992-6#1)(2009-7#1)
from early to##4##3##(1991-2#1)(1992-6#1)(2009-7#2)
from early##21##2##(1991-2#1)(1992-6#3)(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
from easily##2##2##(2008-10#1)(2013-8#1)
from eastern and western North America##2##6##(2008-10#2)
from eastern##5##2##(2008-10#4)(2012-9#1)
from effects on##2##3##(1994-5#1)(2008-1#1)
from effects##3##2##(1994-5#1)(2008-1#1)(2008-10#1)
from egg white##2##3##(2008-10#1)(2008-7#1)
from egg##4##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
from eggs and##3##3##(2008-10#2)(2008-11#1)
from eggs##8##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
from eight different##2##3##(2008-10#2)
from eight##19##2##(1993-6#1)(2008-1#1)(2008-10#10)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2012-3#1)(2013-7#1)
from either an##2##3##(2007-12#1)(2008-11#1)
from either the##12##3##(1994-8#1)(1995-3#1)(1996-5#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-5#1)(2012-12#1)
from either##30##2##(1991-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-5#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
from elective##2##2##(1990-2#1)(1997-2#1)
from electroactive species##2##3##(2008-10#2)
from electrochemical##2##2##(2008-10#2)
from electronic##5##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
from electroplating##2##2##(2008-10#2)
from electrotechnical applications##2##3##(2008-10#2)
from elements##2##2##(1991-5#1)(2012-2#1)
from elevated##3##2##(1992-9#1)(2012-7#1)(2013-1#1)
from eleven##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
from elite##2##2##(2008-9#1)(2009-7#1)
from embryogenic calli##2##3##(2008-9#2)
from embryonic and neonatal##3##4##(1996-5#3)
from embryonic day (E)##2##4##(1996-5#1)(2013-1#1)
from embryonic day##8##3##(1993-3#1)(1994-2#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
from embryonic stem cells##4##4##(2008-11#1)(2008-9#2)(2010-10#1)
from embryonic stem##5##3##(2008-11#2)(2008-9#2)(2010-10#1)
from embryonic##24##2##(1993-3#1)(1994-2#1)(1996-5#6)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2013-1#1)
from embryos##3##2##(1997-9#1)(2008-11#1)(2008-4#1)
from emergency##2##2##(1994-1#1)(2008-12#1)
from empirical##4##2##(1992-12#1)(2008-11#1)(2010-10#1)(2011-3#1)
from encircling lymphovasculogenesis rather than##2##5##(2011-2#2)
from end-stage##3##2##(2010-12#1)(2010-8#1)(2012-1#1)
from endemic areas of##2##4##(2007-12#1)(2013-1#1)
from endemic areas##8##3##(1990-9#1)(1991-11#1)(1993-3#1)(2006-10#1)(2007-12#2)(2007-2#1)(2013-1#1)
from endemic##10##2##(1990-9#1)(1991-11#1)(1993-3#1)(1996-6#1)(2006-10#1)(2007-12#2)(2007-2#1)(2011-2#1)(2013-1#1)
from endodontic infections to##2##4##(2008-12#2)
from endogenous##5##2##(1990-2#1)(2008-10#2)(2009-3#1)(2012-3#1)
from endoscopically##2##2##(2012-2#1)(2013-1#1)
from endosomes into the##2##4##(1995-5#1)(2009-2#1)
from endosomes##4##2##(1992-6#1)(1995-5#1)(2009-10#1)(2009-2#1)
from endothelial cell##2##3##(1993-6#1)(1995-2#1)
from endothelial cells##4##3##(1991-5#1)(1995-11#1)(1995-12#1)(2008-9#1)
from endothelial##6##2##(1991-5#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-9#1)
from enrichment cultures##2##3##(2011-1#1)(2012-2#1)
from environmental samples##5##3##(2008-10#4)(2012-1#1)
from environmental water samples##3##4##(2008-10#3)
from environmental##19##2##(1994-3#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-1#1)
from enzymatic reactions##2##3##(2008-10#1)(2010-5#1)
from enzymatic##3##2##(1994-12#1)(2008-10#1)(2010-5#1)
from epidemiologic studies##2##3##(1997-1#1)(2008-7#1)
from epidemiologic##5##2##(1994-3#1)(1997-1#1)(2008-7#1)(2008-8#1)(2010-5#1)
from epidemiological##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
from epilepsy##3##2##(1995-12#1)(2009-8#1)(2013-1#1)
from episodes of##2##3##(2009-8#1)(2012-3#1)
from equilibrium##4##2##(1993-11#1)(2010-7#1)(2012-3#2)
from ergonomics##2##2##(2013-1#2)
from error##2##2##(2008-3#1)(2011-2#1)
from erythrocytes##3##2##(1990-2#1)(1992-12#1)(1996-12#1)
from esophageal adenocarcinoma##2##3##(2009-4#1)(2010-6#1)
from esophageal##4##2##(2009-4#1)(2010-6#3)
from established##2##2##(2006-10#1)(2007-7#1)
from estuarine and##2##3##(2013-7#2)
from ethanol##2##2##(2008-10#1)(2012-3#1)
from ethanol-water mixtures##2##3##(2011-2#2)
from ethanolic##3##2##(1990-12#1)(2008-12#2)
from ethnocultural communities##2##3##(1995-1#2)
from eukaryotes##3##2##(1995-6#1)(1997-4#1)(2008-11#1)
from every##4##2##(2008-9#2)(2013-1#2)
from excipients##5##2##(2008-10#5)
from excited-state##2##2##(1991-5#1)(2008-3#1)
from exercise##4##2##(1993-1#1)(2012-3#1)(2013-8#2)
from existing##11##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
from exiting##2##2##(1996-5#1)(2008-2#1)
from exogenous sources##3##3##(2008-10#3)
from exogenous##7##2##(1994-8#1)(2008-1#1)(2008-10#4)(2008-7#1)
from exon##3##2##(1991-1#1)(1997-8#1)(2008-12#1)
from expectations##2##2##(2008-10#1)(2008-7#1)
from experience##5##2##(1990-6#1)(1991-1#1)(2008-1#1)(2008-4#1)(2013-8#1)
from experiences##2##2##(1992-2#1)(2008-10#1)
from experimental and clinical##2##4##(2007-4#1)(2008-7#1)
from experimental and##3##3##(2007-4#1)(2008-7#1)(2009-7#1)
from experimental data##7##3##(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
from experimental results##2##3##(2008-3#1)(2008-7#1)
from experimental studies##2##3##(2008-10#1)(2008-9#1)
from experimental##25##2##(2007-12#2)(2007-4#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#3)(2008-9#2)(2009-7#1)(2012-12#1)
from experimentally##2##2##(1991-5#1)(1996-12#1)
from experiments in##2##3##(2008-10#1)(2008-7#1)
from experiments on##2##3##(2007-12#1)(2008-3#1)
from experiments##14##2##(1994-9#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#1)
from exploitation##2##2##(1995-3#1)(2009-6#1)
from exploratory##2##2##(1993-6#1)(2008-10#1)
from exposed##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
from exposure to##8##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1996-6#1)(1997-8#1)(2008-7#2)
from expression##2##2##(1994-12#1)(2008-6#1)
from extensive##2##2##(2008-10#1)(2013-1#1)
from external##4##2##(1996-6#1)(2008-3#3)
from extinction##6##2##(2008-3#4)(2008-8#1)(2013-1#1)
from extracts of##3##3##(1995-2#1)(2008-10#2)
from extracts##4##2##(1995-2#1)(2008-10#3)
from fabrics##2##2##(2008-10#2)
from facilities##2##2##(1995-12#1)(2012-1#1)
from failure##2##2##(2008-6#1)(2012-3#1)
from fairly##3##2##(2008-2#1)(2008-7#1)(2009-7#1)
from fall##2##2##(2008-10#1)(2008-12#1)
from falling##2##2##(2008-7#1)(2010-11#1)
from familial##3##2##(1990-5#1)(1993-12#1)(2007-4#1)
from family members##2##3##(2008-6#1)(2011-2#1)
from family##10##2##(1990-3#1)(1994-11#1)(1995-5#1)(1996-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
from farms##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
from fast##2##2##(2008-7#1)(2012-2#1)
from fasted rats##2##3##(1993-6#1)(1993-8#1)
from fasted##6##2##(1993-6#1)(1993-8#1)(1994-8#3)(1995-6#1)
from fat##3##2##(2008-3#2)(2013-1#1)
from fatigue##2##2##(1992-2#1)(2010-8#1)
from feces##2##2##(2008-5#1)(2012-2#1)
from fed rats##3##3##(1993-8#1)(1994-8#1)(1997-2#1)
from fed##5##2##(1993-8#1)(1994-8#2)(1996-5#1)(1997-2#1)
from female DES(prenatal)/DES(adult)##2##3##(2008-10#2)
from female rat##2##3##(1990-11#1)(1996-5#1)
from female##8##2##(1990-11#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-9#1)
from females##2##2##(1991-5#1)(2008-7#1)
from femtosecond##2##2##(2007-11#1)(2007-12#1)
from feral##2##2##(2008-10#1)(2008-9#1)
from fertile##2##2##(1997-4#1)(2008-12#1)
from fertilized eggs##2##3##(2008-11#1)(2008-5#1)
from fertilized##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
from fetal life##2##3##(2012-2#1)(2013-1#1)
from fetal rat##3##3##(1990-12#1)(1994-11#1)(1995-5#1)
from fetal##10##2##(1990-12#1)(1994-11#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-8#1)(2012-2#1)(2013-1#1)
from few##2##2##(2008-10#2)
from fiber##2##2##(2007-12#2)
from field samples##4##3##(2008-10#2)(2010-2#1)(2013-7#1)
from field trials##3##3##(2008-10#3)
from field##16##2##(2008-10#11)(2008-8#2)(2008-9#1)(2010-2#1)(2013-7#1)
from fields##6##2##(2008-10#4)(2010-10#1)(2011-2#1)
from fifteen##2##2##(1992-3#2)
from fifth instar##2##3##(1995-11#1)(2008-7#1)
from fifty##2##2##(1994-11#1)(2012-3#1)
from filter##4##2##(2007-5#1)(2008-10#2)(2008-3#1)
from fine##2##2##(2008-5#1)(2010-3#1)
from fire##2##2##(1996-12#1)(2008-10#1)
from first principles##2##3##(1992-3#1)(2013-1#1)
from first##6##2##(1992-3#1)(1994-9#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
from fish calcified tissues##2##4##(2008-11#2)
from fish to##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
from fish##12##2##(1990-2#1)(1991-12#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#2)(2009-6#1)(2012-3#1)
from five different##6##3##(2008-10#6)
from five sites##2##3##(2008-10#1)(2008-5#1)
from five##47##2##(1994-3#1)(1995-2#1)(1997-3#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#28)(2008-11#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#1)
from fixed##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
from flock A##3##3##(1997-3#3)
from flock##4##2##(1997-3#4)
from flow injection##2##3##(2008-10#2)
from flow##4##2##(1994-12#1)(2008-10#2)(2008-9#1)
from flowers##2##2##(2008-10#1)(2008-12#1)
from fluorescence spectroscopy##2##3##(1990-11#1)(2009-12#1)
from fluorescence##5##2##(1990-11#1)(1995-6#1)(2009-12#1)(2011-1#1)(2012-2#1)
from fluorinated polyimides##4##3##(2008-2#4)
from focus groups##4##3##(2008-11#1)(2008-12#1)(2009-5#1)(2012-12#1)
from follow-up##2##2##(1992-6#1)(2008-8#1)
from food and##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
from food##13##2##(1992-12#4)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-5#1)(2011-2#1)(2013-1#1)
from foreign##6##2##(1994-11#1)(2007-5#1)(2008-10#2)(2012-3#2)
from fossil##2##2##(2008-11#1)(2008-8#1)
from four consecutive##2##3##(2008-10#1)(2010-3#1)
from four different##10##3##(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
from four distinct##2##3##(1997-6#1)(2008-10#1)
from four field##2##3##(2008-10#1)(2011-2#1)
from four non-fluorescent##2##3##(2008-10#2)
from four of##2##3##(1997-5#1)(2008-10#1)
from four other##2##3##(2008-10#2)
from four patients with##3##4##(1990-8#1)(1994-12#1)(2008-6#1)
from four patients##5##3##(1990-8#1)(1994-12#1)(1996-2#1)(2008-6#1)(2010-8#1)
from four regions of##2##4##(2008-11#1)(2013-1#1)
from four##78##2##(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-12#2)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
from frame to frame##2##4##(2008-3#1)(2011-1#1)
from free##9##2##(1990-8#1)(1992-6#1)(1995-11#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-3#1)
from frequency-domain measurements##2##3##(2007-11#1)(2008-3#1)
from fresh water##2##3##(2008-10#2)
from fresh##10##2##(1991-4#1)(1992-6#1)(2008-10#4)(2008-9#2)(2010-8#1)(2013-1#1)
from freshwater##2##2##(2008-8#1)(2011-2#1)
from friends##4##2##(1994-1#1)(1997-6#1)(2008-6#1)(2011-2#1)
from frog skin##2##3##(1993-3#1)(1994-5#1)
from frog##5##2##(1991-5#1)(1993-3#1)(1993-5#1)(1994-5#1)(1996-2#1)
from frontal##3##2##(1995-6#1)(2008-8#1)(2012-12#1)
from fruit and##2##3##(2008-10#2)
from fruit##6##2##(2008-10#6)
from fruits of##2##3##(2008-12#1)(2008-4#1)
from fruits##5##2##(2008-10#2)(2008-12#1)(2008-4#1)(2012-12#1)
from fullerene soot##2##3##(2008-10#2)
from fumaric acid##2##3##(2008-6#2)
from functional##6##2##(1995-2#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
from fundamental##2##2##(2012-2#1)(2013-1#1)
from fungal##3##2##(2008-10#3)
from further##4##2##(1997-7#1)(2008-5#1)(2008-7#1)(2010-7#1)
from galls##2##2##(2008-10#2)
from garlic##3##2##(2008-10#2)(2008-9#1)
from gas##2##2##(2008-10#1)(2008-11#1)
from gastric##5##2##(1992-6#1)(1993-12#1)(2008-12#2)(2008-5#1)
from gastrointestinal##2##2##(2008-10#1)(2008-4#1)
from gavage to nipple feeding##2##5##(2010-5#2)
from gel##2##2##(1990-12#1)(2008-9#1)
from gene##4##2##(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
from genera##2##2##(2008-10#1)(2008-12#1)
from general population##2##3##(2008-12#1)(2008-7#1)
from general practice##2##3##(1994-6#1)(2011-1#1)
from general##8##2##(1994-3#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
from genes##2##2##(1997-8#1)(2009-6#1)
from genetic##8##2##(1994-12#1)(2008-10#2)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
from genetically##5##2##(2008-10#2)(2008-5#1)(2011-2#2)
from genome##2##2##(2010-11#1)(2011-10#1)
from genomic DNA and##2##4##(1992-8#1)(2008-10#1)
from genomic DNA by##2##4##(1991-7#1)(1994-12#1)
from genomic DNA##5##3##(1991-7#1)(1992-8#1)(1994-12#1)(2008-10#1)(2008-4#1)
from genomic##6##2##(1991-7#1)(1992-8#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
from genotypes##2##2##(2008-10#2)
from geodetic##2##2##(1990-11#1)(2008-3#1)
from geographically##4##2##(2008-10#1)(2009-9#1)(2012-3#1)(2013-1#1)
from geological##5##2##(2008-10#4)(2008-11#1)
from germ##2##2##(1991-6#1)(2008-10#1)
from germ-free##2##2##(2008-11#2)
from germinated conidia##2##3##(2008-10#2)
from germinating soybean##2##3##(1990-5#2)
from germinating##7##2##(1990-5#4)(2008-10#3)
from gestational##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
from ginger##6##2##(2008-10#6)
from giving##3##2##(1992-11#1)(1994-3#1)(1996-9#1)
from glass##6##2##(2007-12#1)(2008-10#3)(2009-7#2)
from glaucoma##2##2##(2011-1#1)(2011-2#1)
from global##5##2##(1997-2#1)(2008-10#1)(2008-2#1)(2010-1#1)(2011-1#1)
from glomerular##2##2##(1997-3#1)(2008-4#1)
from glucose was##2##3##(1990-11#1)(1995-8#1)
from glucose##9##2##(1990-11#2)(1995-3#1)(1995-8#1)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
from glutamine##5##2##(1990-11#1)(2008-11#4)
from glycerol esterification##2##3##(2013-1#2)
from glycoproteins##2##2##(1994-9#1)(1997-2#1)
from glycosylated##2##2##(1992-8#1)(1997-8#1)
from government##5##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
from granitic rocks##2##3##(2008-10#2)
from grape##11##2##(2008-10#9)(2008-5#1)(2013-1#1)
from grapefruit##2##2##(2008-10#2)
from grapevine##4##2##(2008-10#4)
from grapevines##2##2##(2008-10#2)
from graphite cathode##2##3##(2008-10#2)
from graphite##3##2##(2008-10#3)
from grass pea##3##3##(2011-2#3)
from grass##5##2##(2010-4#2)(2011-2#3)
from greater##4##2##(1992-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
from green tea##2##3##(2008-10#1)(2008-11#1)
from green to##2##3##(1993-11#1)(2008-2#1)
from green##9##2##(1993-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-2#2)
from ground-based multispectral measurements##2##4##(2008-2#2)
from ground-based##7##2##(2008-2#2)(2008-3#4)(2013-8#1)
from groundwater##4##2##(2013-1#3)(2013-8#1)
from group##10##2##(1990-12#1)(1996-3#2)(1997-3#1)(2007-11#1)(2008-3#2)(2008-5#1)(2013-8#2)
from groups of 10- to 19-day-old piglets##2##7##(1996-12#2)
from groups of##7##3##(1991-3#1)(1996-12#4)(2008-10#1)(2008-2#1)
from groups##10##2##(1990-2#1)(1991-3#1)(1995-1#1)(1996-12#4)(2008-10#1)(2008-2#1)(2008-3#1)
from growth##7##2##(1991-2#1)(1995-12#1)(1995-2#1)(2008-7#2)(2011-2#1)(2012-12#1)
from guanine##2##2##(1992-11#1)(1993-11#1)
from guinea pig liver##2##4##(1992-11#2)
from guinea pig##10##3##(1991-2#1)(1992-11#2)(1994-8#3)(1995-12#1)(1995-8#3)
from hair##3##2##(2008-5#2)(2012-3#1)
from hairy root##3##3##(1992-12#2)(2008-8#1)
from having##4##2##(1993-1#1)(2008-10#1)(2008-4#1)(2010-12#1)
from hazardous##2##2##(2008-10#1)(2012-2#1)
from hazelnut##4##2##(2008-10#4)
from head to##2##3##(2008-5#1)(2011-1#1)
from head##5##2##(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
from health care##7##3##(1991-1#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)
from health services and##2##4##(2008-1#1)(2009-3#1)
from health##13##2##(1991-1#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2009-3#1)(2011-2#1)
from healthy donors##5##3##(1994-12#1)(1994-3#1)(2008-11#2)(2008-4#1)
from healthy individuals##3##3##(2008-10#1)(2010-12#2)
from healthy or##2##3##(2008-10#1)(2013-7#1)
from healthy persons##2##3##(1992-11#1)(2008-12#1)
from healthy subjects##3##3##(1993-8#1)(1994-6#1)(2008-10#1)
from healthy volunteers##4##3##(1992-3#1)(1993-9#1)(2008-10#1)(2011-2#1)
from healthy##42##2##(1991-12#1)(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
from heart and##2##3##(1996-12#1)(2008-5#1)
from heart##4##2##(1991-12#1)(1996-12#1)(2008-5#1)(2011-1#1)
from heat##5##2##(1993-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-3#1)
from heated##2##2##(1994-8#1)(2007-12#1)
from heavy##6##2##(2008-10#4)(2008-8#1)(2012-12#1)
from hematopoietic##2##2##(2008-4#1)(2012-3#1)
from heparinized##2##2##(2011-2#2)
from hepatic##2##2##(1993-6#1)(2007-12#1)
from hepatocytes##3##2##(1993-11#2)(1994-6#1)
from her birth##2##3##(1995-4#1)(2007-7#1)
from her##6##2##(1993-12#1)(1995-12#1)(1995-4#1)(2007-7#2)(2009-2#1)
from herbicides##2##2##(2008-11#2)
from here##2##2##(2012-2#2)
from herpes##2##2##(1991-6#1)(2007-2#1)
from heterologous##2##2##(2008-10#2)
from hibernating##2##2##(1996-5#2)
from high blood pressure##2##4##(1997-2#1)(1997-3#1)
from high levels of##2##4##(2008-10#1)(2008-7#1)
from high potency##2##3##(2009-10#2)
from high to low population size##2##6##(2008-9#2)
from high##21##2##(1993-8#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2011-2#1)(2013-1#2)
from high-income##2##2##(2012-12#1)(2012-2#1)
from high-precision##2##2##(1992-7#1)(2008-10#1)
from high-predation environments have##2##4##(2008-8#2)
from high-predation environments##3##3##(2008-8#3)
from high-predation##4##2##(2008-8#4)
from high-resolution##2##2##(1997-2#1)(2006-4#1)
from high-throughput##2##2##(2008-7#1)(2008-8#1)
from higher plant##2##3##(1997-6#1)(2008-8#1)
from higher##8##2##(1991-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
from highest to lowest##2##4##(2008-10#1)(2008-5#1)
from highest##3##2##(2008-10#2)(2008-5#1)
from highly mineralised water##3##4##(2008-10#3)
from highly##12##2##(2007-11#1)(2008-10#7)(2008-2#2)(2010-4#1)(2013-1#1)
from his own##2##3##(1992-2#1)(1994-12#1)
from his##13##2##(1990-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-2#1)(2008-12#1)(2008-4#1)(2010-9#1)(2011-3#1)
from historical##4##2##(1992-3#1)(2008-10#2)(2008-4#1)
from holocycly to anholocycly##2##4##(2008-9#2)
from home to##2##3##(1994-3#1)(2012-2#1)
from home##5##2##(1994-2#1)(1994-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
from homogenates of##2##3##(1991-5#1)(1996-2#1)
from homogeneous##3##2##(2008-2#1)(2008-3#2)
from homosexual men##2##3##(1992-2#2)
from horse##7##2##(1990-8#1)(2008-10#4)(2008-11#1)(2011-2#1)
from horses##2##2##(1996-6#1)(2013-1#1)
from hospital records##3##3##(1990-9#1)(2008-12#1)(2008-7#1)
from hospital to home##3##4##(1991-12#2)(2011-2#1)
from hospital to##5##3##(1991-12#2)(2011-2#1)(2012-12#2)
from hospital##19##2##(1990-2#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-1#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#2)
from hospitals and##2##3##(1993-2#1)(1995-3#1)
from hospitals to##2##3##(1991-11#1)(1996-2#1)
from hospitals##4##2##(1991-11#1)(1993-2#1)(1995-3#1)(1996-2#1)
from host plant##2##3##(2008-10#1)(2008-5#1)
from host##5##2##(2008-10#3)(2008-5#1)(2012-12#1)
from hot##2##2##(2007-12#1)(2008-10#1)
from human adrenal##2##3##(1990-11#1)(1992-8#1)
from human and##5##3##(1991-12#1)(1991-5#1)(1991-6#1)(1995-6#1)(2012-12#1)
from human blood##2##3##(2008-10#1)(2008-4#1)
from human brain##5##3##(1991-6#1)(1993-3#1)(1996-10#1)(1996-8#1)(2008-7#1)
from human breast##2##3##(1993-1#2)
from human cell##4##3##(1995-8#1)(1996-2#2)(2008-11#1)
from human cells##2##3##(1993-3#2)
from human colon##2##3##(1995-2#1)(1997-4#1)
from human cord blood##4##4##(2008-8#1)(2008-9#3)
from human erythrocytes##2##3##(1994-8#2)
from human fetal##2##3##(1995-6#1)(2010-11#1)
from human genetics##2##3##(2009-5#1)(2009-6#1)
from human genomic##3##3##(1991-2#1)(1994-6#1)(2008-7#1)
from human immunodeficiency virus##2##4##(1990-2#1)(1992-6#1)
from human kidney##3##3##(1990-8#1)(1991-5#1)(1994-12#1)
from human liver and##2##4##(1991-12#1)(1994-8#1)
from human liver microsomes##3##4##(1990-5#1)(1991-5#1)(2011-3#1)
from human liver##12##3##(1990-12#2)(1990-5#2)(1991-12#1)(1991-5#1)(1992-8#2)(1993-3#1)(1994-8#2)(2011-3#1)
from human lung cell line (WI-38) cDNA library##2##8##(2008-8#1)(2008-9#1)
from human lung##3##3##(1991-5#1)(2008-8#1)(2008-9#1)
from human macrophages##2##3##(1994-6#1)(1994-8#1)
from human medullary thyroid##2##4##(1992-6#2)
from human mononuclear leukocytes##2##4##(1992-12#2)
from human neutrophils##4##3##(1991-12#1)(1992-12#1)(1992-5#2)
from human patients##2##3##(2011-2#1)(2012-12#1)
from human peripheral##2##3##(1990-12#1)(2008-11#1)
from human placenta was##2##4##(1993-3#1)(1997-1#1)
from human placenta##12##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#1)(1992-12#1)(1993-3#1)(1993-8#1)(1997-1#2)(2008-8#2)
from human placental##2##3##(1994-6#1)(2008-8#1)
from human plasma samples##3##4##(2008-10#3)
from human plasma using##2##4##(2008-10#2)
from human plasma##6##3##(2008-10#5)(2012-1#1)
from human plasminogen##2##3##(1990-5#2)
from human platelets##3##3##(1990-2#1)(1994-12#2)
from human prostate##2##3##(1994-11#2)
from human skin##4##3##(1991-12#1)(1992-6#1)(1994-6#1)(2008-5#1)
from human spleen##2##3##(1990-7#2)
from human term##3##3##(1994-9#1)(1995-11#1)(2008-9#1)
from human umbilical veins##2##4##(1993-3#1)(2008-9#1)
from human umbilical##4##3##(1993-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
from human urine##7##3##(1990-12#1)(1990-7#2)(1990-8#1)(1994-3#1)(2008-10#2)
from human##179##2##(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#4)(1990-7#5)(1990-8#2)(1991-12#6)(1991-2#1)(1991-5#4)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#4)(1992-8#3)(1993-1#2)(1993-11#1)(1993-3#6)(1993-8#3)(1994-11#4)(1994-12#4)(1994-3#1)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#3)(1996-12#1)(1996-2#4)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2008-10#11)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#8)(2008-9#6)(2009-5#2)(2009-6#1)(2010-11#2)(2010-3#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
from humans##3##2##(1997-7#1)(2008-4#1)(2009-2#1)
from hyaluronic acid##2##3##(1992-12#1)(1994-5#1)
from hybrid##2##2##(2009-9#1)(2013-1#1)
from hybridoma##3##2##(2008-11#2)(2008-7#1)
from hydrochloric acid media##3##4##(2008-10#3)
from hydrochloric acid medium##2##4##(2008-10#2)
from hydrochloric acid##6##3##(2008-10#6)
from hydrogen##5##2##(1995-3#1)(2007-11#1)(2008-10#3)
from hypertensive##2##2##(1992-8#1)(2011-2#1)
from hyperthermophilic##2##2##(1995-5#1)(2008-9#1)
from hypertrophic chondrocytes##3##3##(2012-12#3)
from hyphae##2##2##(2008-10#1)(2010-2#1)
from hypothalamic##2##2##(1993-12#1)(1993-5#1)
from hypoxic##3##2##(1994-5#2)(1995-2#1)
from ideal bond##3##3##(1993-8#1)(1997-4#2)
from ideal##9##2##(1993-8#1)(1997-4#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-12#1)
from ideality is##2##3##(1992-4#1)(2008-10#1)
from idiopathic polymyositis##2##3##(2008-7#2)
from idiopathic##4##2##(2007-8#1)(2008-7#3)
from illicit drugs##2##3##(2010-4#1)(2012-12#1)
from illicit##3##2##(2010-4#2)(2012-12#1)
from image analysis##2##3##(2008-10#2)
from image##3##2##(2008-10#2)(2008-3#1)
from images##3##2##(2008-3#2)(2008-5#1)
from immature##3##2##(1997-4#1)(2008-6#1)(2008-9#1)
from immigrant##2##2##(2008-10#1)(2013-8#1)
from immigrants##2##2##(1992-5#2)
from immunized##2##2##(2008-10#1)(2008-9#1)
from impaired##5##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)
from important##2##2##(2008-3#1)(2013-8#1)
from imported##2##2##(2007-12#1)(2012-2#1)
from improved##3##2##(2008-12#2)(2012-2#1)
from in situ data##2##4##(2007-5#1)(2008-3#1)
from in situ hybridization##3##4##(1990-11#1)(1996-12#1)(2008-4#1)
from in situ##7##3##(1990-11#1)(1996-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)
from in vitro and##2##4##(1992-11#1)(2008-10#1)
from in vitro studies##3##4##(1996-2#1)(2012-2#2)
from in vitro##9##3##(1992-11#1)(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#2)
from in vivo studies##2##4##(2008-11#1)(2008-5#1)
from in vivo##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
from in##24##2##(1990-11#1)(1992-11#1)(1992-9#1)(1993-12#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)(2012-2#3)
from in-water##3##2##(2008-3#3)
from inactivation##2##2##(1993-6#1)(2008-11#1)
from inactive##3##2##(1994-3#2)(2008-10#1)
from inadequate##2##2##(1994-3#1)(2008-10#1)
from inception##2##2##(2008-11#1)(2011-2#1)
from inclusion bodies##2##3##(1997-4#1)(2008-4#1)
from inclusion##3##2##(1997-4#1)(2007-12#1)(2008-4#1)
from incompletely##2##2##(1992-12#1)(2012-3#1)
from increased##8##2##(1993-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#3)
from increasing the##2##3##(1995-6#2)
from increasing##5##2##(1993-12#1)(1995-6#2)(1997-3#1)(2010-8#1)
from increasingly##2##2##(2008-10#1)(2012-2#1)
from incubation##2##2##(1991-12#1)(2008-10#1)
from independent##7##2##(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-9#1)(2013-8#1)
from indica##2##2##(2008-10#2)
from indigenous##4##2##(2008-10#3)(2009-6#1)
from individual cells##2##3##(1995-5#1)(2009-9#1)
from individual mice##2##3##(1995-12#1)(1997-4#1)
from individual spores##2##3##(2011-2#2)
from individual##26##2##(1993-8#1)(1995-12#2)(1995-5#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
from individuals##7##2##(1992-3#1)(1993-12#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-5#1)
from indoor##2##2##(2008-10#1)(2008-11#1)
from industrial##3##2##(1993-3#1)(2008-3#2)
from industry##7##2##(1991-3#1)(1991-6#1)(1993-12#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-12#1)
from infants##3##2##(1992-3#1)(2008-4#1)(2011-1#1)
from infected fruit##2##3##(2008-10#2)
from infected pineapple##2##3##(2008-10#2)
from infected plants##8##3##(2008-10#8)
from infected roots##2##3##(2008-10#2)
from infected seed##2##3##(2008-10#2)
from infected tobacco##2##3##(2008-10#2)
from infected tomato plants##3##4##(2008-10#3)
from infected trees##2##3##(2008-10#2)
from infected##56##2##(1990-2#1)(1991-3#1)(2007-12#1)(2008-10#49)(2008-12#1)(2008-9#2)(2009-6#1)
from infection by##2##3##(2011-2#1)(2012-12#1)
from infection to##2##3##(1992-6#1)(2008-10#1)
from infection##9##2##(1992-12#1)(1992-6#1)(2008-10#3)(2011-2#2)(2012-12#1)(2013-1#1)
from infections##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
from infectious diseases##2##3##(1992-3#1)(1996-1#1)
from infectious##5##2##(1992-3#1)(1996-1#1)(2008-10#3)
from infertile patients and##2##4##(2008-12#2)
from infested##2##2##(2008-10#1)(2008-12#1)
from inflammation##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
from information technology##2##3##(1994-12#1)(2008-7#1)
from information##3##2##(1993-12#1)(1994-12#1)(2008-7#1)
from informed consent##2##3##(2009-4#2)
from infrared##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
from inhibition##3##2##(1992-3#1)(1992-6#1)(1997-2#1)
from initial##6##2##(2008-10#2)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#1)
from initiation of the##2##4##(2008-10#2)
from initiation of##3##3##(2008-10#2)(2009-1#1)
from initiation##4##2##(2008-10#2)(2008-7#1)(2009-1#1)
from injured##2##2##(1996-5#1)(2009-6#1)
from injury##3##2##(1995-12#1)(2008-12#1)(2010-7#1)
from inner##2##2##(2011-2#2)
from inoculated plants##2##3##(2008-10#2)
from inoculated trees##2##3##(2008-10#2)
from inoculated##10##2##(2008-10#10)
from inoculation##6##2##(2008-10#6)
from inoculum sources##2##3##(2008-10#2)
from inoculum##4##2##(2008-10#4)
from inorganic##3##2##(2008-10#3)
from inpatient to outpatient care##2##5##(1991-1#1)(1993-12#1)
from inpatient to outpatient##6##4##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(2008-3#1)
from insects##5##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
from inside##2##2##(2008-10#2)
from insoluble##2##2##(1994-11#1)(2008-10#1)
from inspection of##2##3##(1995-3#1)(2008-2#1)
from institutional##2##2##(1991-1#1)(1995-1#1)
from instrumental##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
from insulin##2##2##(1992-11#1)(2008-1#1)
from insulin-treated cells##2##3##(1997-6#2)
from intact##4##2##(1991-12#1)(1995-2#1)(2008-10#1)(2008-9#1)
from integrating sphere measurements on##2##5##(2008-3#2)
from integrating sphere measurements##3##4##(2008-3#3)
from integrating##4##2##(1994-3#1)(2008-3#3)
from intensity##3##2##(1993-11#1)(2008-2#1)(2008-3#1)
from intensive care##3##3##(1995-3#1)(2007-7#1)(2008-11#1)
from intensive##4##2##(1995-3#1)(2007-10#1)(2007-7#1)(2008-11#1)
from intentional##2##2##(1994-1#1)(2008-10#1)
from interference of##2##3##(2008-10#1)(2008-3#1)
from interference##7##2##(2008-1#1)(2008-10#5)(2008-3#1)
from interfering species##2##3##(2008-10#1)(2008-3#1)
from interfering##6##2##(2008-10#4)(2008-3#2)
from internal##7##2##(1990-8#1)(1993-12#1)(2007-11#1)(2008-12#1)(2010-11#1)(2010-6#1)(2013-1#1)
from international##2##2##(2007-2#1)(2010-3#1)
from interspecific##3##2##(2008-10#2)(2008-8#1)
from interventions##3##2##(1995-2#1)(2007-12#1)(2008-12#1)
from interviews with##3##3##(1990-12#1)(1993-1#1)(2008-9#1)
from interviews##7##2##(1990-12#1)(1993-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-11#1)
from intestinal epithelial cells (IECs)##2##5##(2008-11#2)
from intestinal epithelial cells##3##4##(2008-11#3)
from intestinal##7##2##(1990-12#1)(1993-2#1)(2008-11#3)(2008-4#1)(2011-2#1)
from intracellular pools to the plasma membrane##2##7##(1994-11#2)
from intracellular storage##2##3##(1991-12#1)(2007-12#1)
from intracellular stores##9##3##(1990-12#2)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(2008-7#1)(2012-2#1)
from intracellular##18##2##(1990-12#2)(1991-12#2)(1992-9#1)(1993-11#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-7#1)(2012-2#1)
from intramolecular##3##2##(2008-10#3)
from inulin##2##2##(2011-1#2)
from invasive##4##2##(1997-3#1)(2008-5#1)(2009-5#1)(2013-8#1)
from investigation of##2##3##(2009-8#2)
from investigations of the##2##4##(1997-4#1)(2008-10#1)
from investigations of##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
from investigations##4##2##(1997-4#1)(2006-12#1)(2008-10#1)(2008-3#1)
from investigators of##2##3##(2008-12#1)(2008-4#1)
from investigators##4##2##(1993-12#1)(2008-12#1)(2008-4#2)
from involvement of##2##3##(2007-7#1)(2009-3#1)
from involvement##3##2##(2007-7#1)(2009-3#1)(2010-10#1)
from iron##2##2##(2008-10#2)
from iron(III)##2##2##(2008-10#2)
from irradiance##2##2##(2008-3#2)
from irrigation##3##2##(2008-10#3)
from ischemia##2##2##(2007-10#1)(2010-11#1)
from ischemic damage##3##3##(1996-9#1)(2008-11#2)
from ischemic heart disease in Chile##3##6##(2011-2#3)
from ischemic heart disease##7##4##(1996-3#1)(2007-8#1)(2008-7#1)(2011-2#4)
from ischemic##14##2##(1996-3#1)(1996-9#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#5)
from isolate##6##2##(1995-2#1)(2008-10#5)
from isolated rat##4##3##(1991-2#1)(1991-8#1)(1994-12#1)(1996-5#1)
from isolated##21##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2010-11#2)(2012-2#1)(2012-3#1)
from isolates of##7##3##(2008-10#6)(2008-5#1)
from isolates within##2##3##(2008-10#2)
from isolates##13##2##(2008-10#12)(2008-5#1)
from isotropic##2##2##(2008-10#1)(2008-2#1)
from it by##4##3##(2008-10#2)(2008-5#2)
from it##11##2##(1990-12#1)(1992-12#1)(2007-12#1)(2008-10#3)(2008-5#2)(2009-10#2)(2011-2#1)
from its Fourier##2##3##(2008-3#2)
from its HSA binding site by DHEA##2##7##(2008-10#2)
from its affinity##2##3##(1995-11#1)(2008-11#1)
from its application##2##3##(1997-7#1)(2008-10#1)
from its binding site in the##2##6##(1992-3#1)(2008-10#1)
from its cDNA##2##3##(1996-2#1)(2008-8#1)
from its degradation products##3##4##(2008-10#2)(2011-1#1)
from its first##3##3##(1991-1#1)(1991-12#1)(1992-2#1)
from its implementation##2##3##(1995-2#1)(1996-12#1)
from its initial location##2##4##(2008-10#1)(2010-4#1)
from its origin##2##3##(2008-8#1)(2013-1#1)
from its own##2##3##(1995-1#1)(2011-1#1)
from its##113##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-2#1)(1992-3#2)(1993-3#1)(1994-11#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-3#10)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
from joint##2##2##(2008-11#1)(2010-11#1)
from just##2##2##(1995-2#1)(1996-6#1)
from juvenile##2##2##(2008-11#1)(2008-8#1)
from kidney##6##2##(1992-12#1)(1992-3#1)(1994-12#1)(2008-10#1)(2010-4#1)(2013-1#1)
from known##8##2##(1996-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-1#1)
from labeled##2##2##(1993-11#1)(2008-10#1)
from laboratories##2##2##(2008-11#1)(2010-10#1)
from laboratory and clinical studies##2##5##(2008-1#1)(2009-7#1)
from laboratory and##3##3##(2008-1#1)(2008-10#1)(2009-7#1)
from laboratory##13##2##(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
from lack of##2##3##(1995-12#1)(2008-4#1)
from lactate##4##2##(1991-3#1)(1991-9#1)(1994-8#1)(2011-2#1)
from lactating rats##2##3##(1990-11#1)(1994-6#1)
from lambda##4##2##(1992-6#1)(1993-9#1)(1994-11#1)(2008-2#1)
from large amounts of cadmium##2##5##(2008-10#2)
from large amounts of##7##4##(2008-10#6)(2008-11#1)
from large volume##2##3##(2008-10#2)
from large volumes of seawater##3##5##(2008-10#3)
from large volumes of##4##4##(2008-10#4)
from large##23##2##(1991-8#1)(1995-12#1)(2008-10#15)(2008-11#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
from large-scale##4##2##(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)
from larger##5##2##(1997-4#2)(2008-10#1)(2008-2#1)(2010-7#1)
from laser##3##2##(1990-7#1)(2007-11#1)(2008-3#1)
from laser-heated##2##2##(2008-10#2)
from laser-induced breakdown##2##3##(2008-2#1)(2008-3#1)
from laser-induced##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
from late June##2##3##(1994-7#1)(2008-12#1)
from late March##2##3##(2008-10#2)
from late##9##2##(1993-6#1)(1994-7#1)(1996-8#1)(2008-10#5)(2008-12#1)
from lateral##3##2##(2008-3#1)(2009-11#1)(2013-1#1)
from lawsuits##2##2##(1993-12#1)(2008-4#1)
from layer##2##2##(2008-11#1)(2008-7#1)
from leaching##2##2##(2008-10#1)(2008-7#1)
from leaf spectra##4##3##(2008-10#4)
from leaf##11##2##(2008-10#8)(2008-11#1)(2008-12#1)(2010-9#1)
from least-squares fits of##2##4##(2008-2#1)(2008-3#1)
from leaves of##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#2)
from leaves##14##2##(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#2)
from leek plants##2##3##(2008-10#2)
from leek##4##2##(2008-10#4)
from left to right##2##4##(2008-7#1)(2013-8#1)
from left##5##2##(2007-10#1)(2007-8#1)(2008-7#1)(2010-5#1)(2013-8#1)
from lentil##2##2##(2008-10#2)
from lesion expansion##4##3##(2008-10#4)
from lesion##5##2##(2008-10#4)(2008-11#1)
from lesioned##2##2##(1997-2#1)(2008-1#1)
from lesions on##3##3##(2008-10#3)
from lesions##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
from less than 1##3##4##(1997-4#1)(2007-12#1)(2008-10#1)
from less than 4%##2##4##(2008-1#1)(2008-10#1)
from less than##10##3##(1990-12#1)(1994-9#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)
from less##11##2##(1990-12#1)(1994-9#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2013-1#1)
from lettuce to##2##3##(2008-10#2)
from lettuce##7##2##(2008-10#7)
from leukocytes##6##2##(1990-12#1)(1992-12#2)(1997-3#1)(2008-10#1)(2012-2#1)
from libraries##2##2##(1997-4#1)(2008-1#1)
from lidar##4##2##(2008-2#1)(2008-3#3)
from light##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
from lignocellulosic hydrolysates##2##3##(2011-1#1)(2013-1#1)
from lignocellulosic##4##2##(2008-6#1)(2011-1#2)(2013-1#1)
from limb##2##2##(1991-8#1)(2010-8#1)
from limited proteolysis##2##3##(1990-12#1)(2012-12#1)
from limited resource settings##3##4##(2009-6#3)
from limited resource##4##3##(2009-6#4)
from limited transmitted field data sets##2##6##(2008-3#2)
from limited##9##2##(1990-12#1)(2008-3#2)(2008-8#1)(2009-6#4)(2012-12#1)
from linear##6##2##(2007-12#1)(2008-10#3)(2008-3#1)(2011-1#1)
from linearity at##2##3##(2008-10#1)(2008-5#1)
from linearity##3##2##(2008-10#2)(2008-5#1)
from linkage to BAD##2##4##(1997-5#2)
from lipid##3##2##(1991-12#1)(1994-11#1)(2013-8#1)
from liquid##4##2##(2008-10#1)(2008-3#3)
from literature##9##2##(1996-1#1)(2008-10#4)(2008-7#1)(2010-3#1)(2012-12#1)(2012-3#1)
from live##3##2##(1992-3#1)(2008-7#1)(2009-10#1)
from liver and brain##2##4##(1990-11#1)(2008-4#1)
from liver and##3##3##(1990-11#1)(1993-12#1)(2008-4#1)
from liver##11##2##(1990-11#1)(1990-12#1)(1991-5#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-4#1)(2012-3#1)
from living##7##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
from local##17##2##(1991-2#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-8#2)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
from log##2##2##(2008-10#1)(2009-6#1)
from long term##2##3##(2008-10#1)(2008-8#1)
from long##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
from long-term##8##2##(1994-6#1)(1997-3#1)(2007-8#3)(2008-5#1)(2009-8#1)(2013-1#1)
from longitudinal##2##2##(1993-12#1)(2011-2#1)
from loss of##5##3##(1994-3#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-9#1)
from loss##6##2##(1993-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-9#1)
from low density lipoproteins##2##4##(1995-5#2)
from low dose##2##3##(2008-7#1)(2013-1#1)
from low##18##2##(1990-2#1)(1995-5#2)(1996-12#2)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-7#2)(2009-9#1)(2012-2#1)(2013-1#2)
from low-dose##2##2##(2008-10#1)(2008-7#1)
from low-income families##3##3##(2007-9#1)(2008-11#2)
from lower##3##2##(2008-10#1)(2008-7#1)(2009-2#1)
from luminol##2##2##(1995-3#1)(2008-10#1)
from lung cancer##7##3##(1990-12#1)(1992-6#2)(2007-6#1)(2008-1#1)(2008-11#2)
from lung##15##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#2)(1993-3#1)(1993-8#1)(1995-12#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-5#2)(2012-12#1)
from lymphocytes##5##2##(1992-3#1)(1992-8#1)(1997-4#1)(2008-11#1)(2008-9#1)
from mRNA##3##2##(1991-6#1)(1992-9#1)(2008-9#1)
from mRNAs##2##2##(1993-3#1)(1997-2#1)
from machining##2##2##(2008-10#1)(2008-2#1)
from macrophages##4##2##(1994-6#1)(2008-11#3)
from magnetic##2##2##(2008-7#2)
from main##3##2##(2008-10#2)(2008-12#1)
from mainland##2##2##(2008-10#1)(2013-8#1)
from maize was##2##3##(1995-2#1)(2008-10#1)
from maize##15##2##(1994-6#1)(1995-2#3)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#2)
from major##3##2##(2007-10#1)(2008-10#1)(2009-12#1)
from malaria##2##2##(2007-2#1)(2010-1#1)
from male rats##2##3##(1997-4#1)(1997-6#1)
from male to female##2##4##(2008-5#2)
from male##14##2##(1990-3#1)(1990-7#1)(1991-12#1)(1994-2#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-5#3)(2008-9#1)(2010-4#1)
from malignant##13##2##(1990-2#1)(1990-6#1)(1996-6#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-6#2)(2009-1#1)
from mammalian cells##8##3##(1995-2#1)(2008-2#4)(2008-4#1)(2009-12#1)(2012-3#1)
from mammalian##14##2##(1991-8#1)(1993-6#1)(1995-2#2)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#1)(2009-12#1)(2012-3#1)
from mammals##2##2##(1994-11#2)
from mammary##2##2##(1990-11#1)(1997-6#1)
from managed care##4##3##(1991-3#1)(1993-12#1)(1993-2#1)(1997-2#1)
from managed##5##2##(1991-3#1)(1993-12#1)(1993-2#1)(1995-1#1)(1997-2#1)
from mango##2##2##(2008-10#2)
from manual##3##2##(2008-10#1)(2012-2#2)
from manufacturing##2##2##(1995-1#1)(2011-2#1)
from many of the##3##4##(1995-9#1)(2008-11#1)(2008-8#1)
from many parts of##2##4##(1990-6#1)(2013-8#1)
from many sources##3##3##(1994-2#1)(2008-5#1)(2008-9#1)
from many species##2##3##(1990-2#1)(2008-8#1)
from many##29##2##(1990-2#1)(1990-6#1)(1991-12#1)(1994-2#1)(1994-9#1)(1995-9#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
from map##2##2##(1995-8#1)(1996-6#1)
from marinas##2##2##(2007-5#1)(2008-10#1)
from marine sediments##2##3##(2008-10#2)
from marine to freshwater habitats##2##5##(2010-8#2)
from marine##15##2##(2008-10#4)(2008-11#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)
from mass spectrometry##2##3##(2008-4#1)(2010-2#1)
from mass##3##2##(2008-4#1)(2008-9#1)(2010-2#1)
from materials##3##2##(2007-12#1)(2008-11#1)(2010-3#1)
from maternal blood##2##3##(1996-12#2)
from maternal##7##2##(1995-8#1)(1996-12#2)(2007-2#1)(2008-10#2)(2008-7#1)
from matrix##6##2##(2008-10#6)
from mature##7##2##(1990-7#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)
from maxillary##2##2##(2007-12#1)(2008-8#1)
from maximum##2##2##(1995-2#1)(2008-10#1)
from measured##3##2##(1993-9#1)(2008-10#1)(2008-2#1)
from measurement of the##2##4##(2008-2#2)
from measurement of##3##3##(2007-11#1)(2008-2#2)
from measurement##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
from measurements at##2##3##(2008-3#2)
from measurements of the##5##4##(2008-2#1)(2008-3#4)
from measurements of##7##3##(2008-2#1)(2008-3#6)
from measurements##16##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#11)
from mechanical and##2##3##(2007-12#1)(2011-2#1)
from mechanical ventilation##3##3##(2007-6#3)
from mechanical##9##2##(2007-12#1)(2007-6#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
from medial##4##2##(1991-12#1)(2007-10#1)(2008-7#1)(2013-1#1)
from medical gas##2##3##(2011-2#2)
from medical records##2##3##(1993-12#1)(2007-10#1)
from medical##17##2##(1990-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-1#2)(2007-10#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-2#2)(2011-2#2)
from medicinal##2##2##(1996-11#1)(2008-10#1)
from medium##4##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
from melanocytes to keratinocytes##5##4##(2008-8#5)
from melanocytes##6##2##(2008-8#6)
from melanoma patients##2##3##(1994-5#1)(2007-10#1)
from melanoma##4##2##(1992-9#1)(1994-5#1)(2007-10#1)(2008-10#1)
from members of the genus Thermus##2##6##(2011-2#2)
from members of the##3##4##(2008-10#1)(2011-2#2)
from members of##5##3##(1997-7#1)(1997-9#1)(2008-10#1)(2011-2#2)
from members##6##2##(1997-7#1)(1997-9#1)(2008-10#1)(2011-2#2)(2013-7#1)
from membrane phospholipids##4##3##(1994-3#3)(2012-1#1)
from membrane##6##2##(1994-3#3)(1994-5#1)(2009-3#1)(2012-1#1)
from membranes##4##2##(1993-11#1)(1994-6#1)(1995-2#1)(2008-5#1)
from meningioma##2##2##(2008-6#1)(2008-7#1)
from mental health##3##3##(1996-1#2)(2012-12#1)
from mental##5##2##(1996-1#2)(2008-5#1)(2008-7#1)(2012-12#1)
from menthofuran##2##2##(1991-5#2)
from mesenteric##2##2##(1992-3#1)(2008-11#1)
from metal ions##3##3##(2008-10#3)
from metal##6##2##(2008-10#4)(2008-3#1)(2008-6#1)
from metastatic##5##2##(1991-9#1)(2008-6#1)(2010-7#3)
from methanol##2##2##(2010-12#1)(2010-4#1)
from mice with##3##3##(2008-11#2)(2011-3#1)
from mice##13##2##(1990-7#1)(1994-8#1)(1995-9#1)(2008-10#2)(2008-11#5)(2008-8#1)(2008-9#1)(2011-3#1)
from microarray analysis##2##3##(2010-6#1)(2011-2#1)
from microarray experiments##2##3##(2008-4#1)(2008-7#1)
from microarray##4##2##(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)
from microbiological##2##2##(2008-5#1)(2013-8#1)
from microorganisms##2##2##(1993-2#1)(2011-2#1)
from microroughness-induced scattering##2##3##(2008-2#2)
from middle##2##2##(2007-10#1)(2009-7#1)
from migraine##2##2##(1994-11#1)(2008-7#1)
from mild##9##2##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
from milk##3##2##(2008-10#2)(2008-8#1)
from millimeters to##2##3##(2008-10#1)(2008-3#1)
from mines]##2##2##(1992-6#2)
from miniature##2##2##(2007-11#1)(2008-10#1)
from minor to##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
from minor##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
from mismatched##2##2##(2007-12#1)(2008-10#1)
from mitochondria in##2##3##(1991-3#1)(2008-11#1)
from mitochondria##5##2##(1991-2#1)(1991-3#1)(1993-12#1)(2008-11#1)(2008-9#1)
from mitochondrial and nuclear##2##4##(2010-4#1)(2013-8#1)
from mitochondrial##7##2##(1994-11#1)(2006-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-6#1)(2013-8#1)
from mixed or##2##3##(2008-9#1)(2010-6#1)
from mixed##6##2##(2008-10#3)(2008-6#1)(2008-9#1)(2010-6#1)
from mixtures of##3##3##(1992-6#1)(1997-3#1)(2008-10#1)
from mixtures##5##2##(1992-6#1)(1997-3#1)(2008-10#3)
from model##4##2##(1993-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
from modeling by##2##3##(2008-3#1)(2013-8#1)
from modeling##5##2##(1994-12#1)(2008-3#3)(2013-8#1)
from moderate##3##2##(1991-11#1)(2008-12#1)(2008-3#1)
from modified##2##2##(2008-10#2)
from molecular and##2##3##(2008-5#1)(2010-4#1)
from molecular biology##2##3##(2008-10#1)(2008-4#1)
from molecular nitrogen##2##3##(2008-3#2)
from molecular##14##2##(1992-11#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2010-4#1)(2013-7#1)
from molecules to##2##3##(2008-7#1)(2009-3#1)
from molecules##4##2##(1997-6#1)(2008-2#1)(2008-7#1)(2009-3#1)
from monkey##2##2##(1997-2#1)(2008-5#1)
from monkeys##2##2##(1990-2#1)(1990-5#1)
from monocytes by##2##3##(2008-4#2)
from mononuclear##2##2##(1991-11#1)(2008-4#1)
from moor frog Rana arvalis##2##5##(2011-2#2)
from more basal to more modern##2##6##(2008-8#2)
from more than one##5##4##(2007-12#1)(2008-10#3)(2009-11#1)
from more than##10##3##(1993-5#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#1)
from more##23##2##(1993-5#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#4)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
from morphological##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
from most of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
from most##11##2##(1990-8#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#2)
from mother to##2##3##(1990-9#1)(1992-6#1)
from mouse brain##3##3##(1990-11#2)(1992-11#1)
from mouse embryonic stem cells##2##5##(2008-11#1)(2008-9#1)
from mouse embryonic stem##3##4##(2008-11#2)(2008-9#1)
from mouse lung##2##3##(1991-8#1)(1994-8#1)
from mouse small intestines##3##4##(1993-11#1)(1993-9#2)
from mouse thymus##2##3##(1997-4#2)
from mouse##35##2##(1990-11#2)(1991-2#1)(1991-8#1)(1992-11#2)(1993-11#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-9#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)
from moving##4##2##(2007-11#1)(2008-7#1)(2009-12#1)(2011-2#1)
from multicopy##2##2##(1991-12#2)
from multiple directional derivatives##2##4##(2007-12#2)
from multiple gene##2##3##(2008-8#1)(2010-4#1)
from multiple locations##3##3##(2008-10#3)
from multiple reflections##2##3##(2008-2#1)(2008-3#1)
from multiple sources##5##3##(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)
from multiple##42##2##(1992-1#1)(1993-2#1)(1994-12#1)(1997-2#2)(1997-5#1)(2007-12#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
from multivariate##2##2##(2008-10#1)(2012-2#1)
from mummies##2##2##(2008-10#2)
from municipal##2##2##(1995-11#1)(2008-10#1)
from murine##10##2##(1990-8#1)(1992-12#1)(1993-2#1)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-7#1)
from muscle##3##2##(2006-10#1)(2007-12#1)(2008-7#1)
from muscles##2##2##(2008-3#1)(2010-4#1)
from muscular##3##2##(1995-12#1)(1996-6#1)(2007-12#1)
from mutant##2##2##(1997-7#1)(2008-10#1)
from mutation of the##2##4##(1993-11#1)(2007-7#1)
from myocardial infarction##2##3##(1991-4#1)(2008-10#1)
from nadir##2##2##(2008-3#2)
from naive CD4(+) T cells##3##5##(2008-11#3)
from naive##5##2##(2008-10#1)(2008-11#4)
from narrow##2##2##(2007-12#1)(2008-3#1)
from national##6##2##(1992-6#1)(1993-12#1)(1994-12#1)(2008-1#1)(2008-8#1)(2012-12#1)
from native##5##2##(1994-8#1)(2008-1#1)(2008-10#3)
from natural origin##2##3##(2008-10#1)(2011-2#1)
from natural populations in##2##4##(2008-10#1)(2008-3#1)
from natural populations##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
from natural sources##5##3##(1996-6#2)(2007-11#1)(2008-10#1)(2008-5#1)
from natural water samples##2##4##(2008-10#2)
from natural water##3##3##(2008-10#3)
from natural##31##2##(1996-6#2)(2006-12#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
from naturally infected plant##2##4##(2008-10#2)
from naturally infected##10##3##(1992-8#1)(2008-10#9)
from naturally occurring##4##3##(1992-8#1)(2008-10#1)(2008-4#1)(2010-7#1)
from naturally##16##2##(1992-8#2)(1996-12#1)(2008-10#11)(2008-4#1)(2010-7#1)
from nature##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
from naïve##3##2##(2008-1#1)(2008-11#1)(2010-10#1)
from near neutral##2##3##(2008-10#2)
from near##5##2##(2008-10#3)(2008-3#1)(2008-6#1)
from near-field##2##2##(2007-12#1)(2008-3#1)
from nearby##7##2##(1995-5#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-2#1)(2012-2#1)
from nearly##4##2##(1993-11#1)(2008-2#1)(2008-4#1)(2010-3#1)
from needle procedures##2##3##(2008-11#2)
from needles##3##2##(2008-10#1)(2008-7#2)
from negligible##2##2##(1990-9#1)(2008-11#1)
from neighboring##3##2##(1995-8#1)(2008-2#1)(2010-11#1)
from neighbouring cells##2##3##(2008-4#1)(2008-5#1)
from neighbouring##5##2##(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
from neonatal##7##2##(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-5#1)(2012-2#1)(2013-1#1)
from neonates##2##2##(1994-9#1)(2011-1#1)
from neoplastic##2##2##(2007-11#1)(2011-2#1)
from nerve terminals##2##3##(1995-11#1)(1995-5#1)
from nerve##4##2##(1992-9#1)(1995-11#1)(1995-5#1)(2008-5#1)
from neural stem cells##2##4##(2008-11#1)(2011-2#1)
from neural##7##2##(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
from neurological disorders##2##3##(1992-5#2)
from neurological##4##2##(1992-5#2)(2008-12#1)(2010-12#1)
from neuronal##3##2##(2008-4#3)
from neurons in##2##3##(2008-4#1)(2008-8#1)
from neurons##4##2##(1992-3#1)(2008-4#1)(2008-5#1)(2008-8#1)
from neutral##6##2##(1990-8#1)(1994-8#1)(1995-5#1)(2007-4#1)(2008-10#1)(2012-3#1)
from neutrality##2##2##(2012-3#1)(2013-8#1)
from neutrophil##2##2##(1992-5#1)(1994-11#1)
from new##4##2##(1995-12#1)(1995-6#1)(2009-10#1)(2013-1#1)
from newly##2##2##(1990-9#1)(2008-11#1)
from nine hospitals in##2##4##(1993-2#1)(2011-2#1)
from nine patients with##2##4##(1996-9#1)(2010-12#1)
from nine##13##2##(1993-2#1)(1996-9#1)(2006-6#1)(2008-10#6)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
from nitric acid medium##3##4##(2008-10#3)
from nitric acid##5##3##(2008-10#5)
from nitrogen and##2##3##(2007-12#1)(2008-2#1)
from no##3##2##(2008-10#2)(2010-6#1)
from noise and##2##3##(2008-2#1)(2008-3#1)
from noise##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
from noisy##5##2##(2007-12#2)(2008-3#1)(2008-4#1)(2010-8#1)
from non##4##2##(2007-6#1)(2008-11#1)(2008-3#1)(2010-12#1)
from non-pregnant##2##2##(1990-11#1)(1994-8#1)
from non-probabilistic examples##2##3##(2009-11#2)
from non-treated##3##2##(1996-2#1)(2008-10#2)
from non-vaccinated poults##2##3##(1997-6#2)
from non-vaccinated##4##2##(1997-3#1)(1997-6#2)(2008-5#1)
from noncruciferous hosts##3##3##(2008-10#3)
from noncultivated hosts##5##3##(2008-10#5)
from noncultivated##6##2##(2008-10#6)
from none##2##2##(2008-9#1)(2010-12#1)
from noninoculated##2##2##(2008-10#2)
from nonlinear##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
from nonprecooled donor cells##2##4##(2008-9#2)
from nonvector##2##2##(2008-10#2)
from normal and##2##3##(1991-4#1)(1997-7#1)
from normal human##5##3##(1992-11#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
from normal individuals##3##3##(1991-9#1)(1992-3#1)(1992-9#1)
from normal tissues##2##3##(1990-5#1)(2013-1#1)
from normal to##5##3##(1994-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2013-8#1)
from normal##45##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
from normally##2##2##(1992-6#1)(2008-11#1)
from north##2##2##(2007-7#1)(2008-12#1)
from northeast##2##2##(2008-10#2)
from northeastern##2##2##(2008-10#1)(2008-5#1)
from northern##5##2##(2007-1#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
from northwest of##2##3##(2008-12#1)(2008-9#1)
from northwestern Europe##2##3##(2008-10#2)
from northwestern##3##2##(2008-10#2)(2012-12#1)
from not##2##2##(2008-10#2)
from novice to##2##3##(2008-12#2)
from now##3##2##(2007-6#1)(2008-1#1)(2008-3#1)
from nuclear##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2009-2#1)
from nuclei##2##2##(1994-8#1)(1996-2#1)
from nucleic##2##2##(1997-6#1)(2008-10#1)
from nucleotide##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
from numerical##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
from numerous##9##2##(1995-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-8#1)(2013-8#1)
from nursing and##2##3##(1996-12#1)(2008-11#1)
from nursing##6##2##(1991-2#1)(1994-1#1)(1996-12#1)(2008-1#1)(2008-11#1)(2013-1#1)
from obese##4##2##(1994-11#1)(1996-12#1)(2013-1#2)
from objects##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
from observational studies##4##3##(2007-12#1)(2008-11#2)(2010-6#1)
from observational##5##2##(2007-12#1)(2008-11#2)(2010-6#1)(2013-8#1)
from observations of##3##3##(2008-9#1)(2010-10#1)(2012-2#1)
from observations##4##2##(2008-2#1)(2008-9#1)(2010-10#1)(2012-2#1)
from observed##5##2##(2008-1#1)(2008-10#4)
from occupational##3##2##(1994-6#1)(2008-12#1)(2013-7#1)
from occurring##2##2##(2008-8#1)(2013-8#1)
from of##3##2##(2009-7#1)(2011-2#1)(2011-3#1)
from officially##2##2##(1996-3#1)(2010-4#1)
from offshore petroleum exploration##2##4##(2008-10#2)
from old##2##2##(1994-6#1)(2008-9#1)
from older##3##2##(2008-2#1)(2008-7#1)(2009-10#1)
from olfactory##2##2##(1993-6#1)(2008-7#1)
from olive oil##2##3##(1994-2#1)(2008-10#1)
from olive trees##2##3##(2008-10#2)
from olive##6##2##(1994-2#1)(2008-10#5)
from one DNA##2##3##(1990-5#1)(2008-10#1)
from one another##11##3##(1992-3#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-3#1)
from one climatic##2##3##(2008-10#1)(2013-1#1)
from one neuron##2##3##(1990-5#1)(1997-3#1)
from one of the##4##4##(2008-3#1)(2008-8#3)
from one of##10##3##(1991-3#1)(1994-9#1)(1995-6#1)(2007-10#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-10#1)
from one or more##2##4##(1992-4#1)(2011-2#1)
from one or##3##3##(1992-4#1)(2008-12#1)(2011-2#1)
from one replication and##2##4##(2008-10#2)
from one sample##2##3##(1994-2#1)(2007-12#1)
from one site##2##3##(1990-5#1)(2008-10#1)
from one species to##3##4##(1992-11#1)(2008-8#1)(2012-2#1)
from one specific##2##3##(2008-1#1)(2010-4#1)
from one subunit##2##3##(1990-8#1)(1991-12#1)
from one to##3##3##(1993-12#1)(2008-10#2)
from one week##2##3##(2007-2#1)(2008-8#1)
from one woman##2##3##(1990-6#1)(1995-1#1)
from one##127##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-3#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-1#3)(2008-10#33)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#1)
from one's##2##2##(1991-2#1)(2012-2#1)
from ongoing##2##2##(2008-10#1)(2011-8#1)
from onion##4##2##(2008-10#4)
from only a single##2##4##(2008-10#1)(2008-3#1)
from only a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
from only one##2##3##(2008-3#1)(2009-10#1)
from only##9##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#1)
from onset of##5##3##(1991-12#1)(1996-9#1)(2008-3#1)(2013-1#2)
from onset##6##2##(1991-12#1)(1996-6#1)(1996-9#1)(2008-3#1)(2013-1#2)
from op/op##2##2##(1990-5#2)
from open##3##2##(1991-3#1)(1997-3#1)(2010-3#1)
from operating##2##2##(1994-2#1)(2008-9#1)
from optical disks##2##3##(2008-2#2)
from optical##13##2##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#4)
from optimal##2##2##(2008-11#1)(2008-8#1)
from or##2##2##(1992-6#1)(1994-12#1)
from oral##2##2##(2008-12#1)(2012-7#1)
from orchards##2##2##(2008-10#2)
from ordinary##4##2##(1993-12#1)(2008-2#1)(2010-5#1)(2013-8#1)
from organic phase##3##3##(2008-10#3)
from organic##11##2##(1991-9#1)(2006-12#1)(2008-10#6)(2008-3#2)(2010-12#1)
from organisms##2##2##(1994-12#1)(2013-1#1)
from ornamental asparagus##3##3##(2008-10#3)
from ornamental##7##2##(2008-10#6)(2011-2#1)
from other areas##4##3##(1990-6#1)(2008-10#1)(2008-4#1)(2010-9#1)
from other bacterial##2##3##(2008-10#1)(2011-2#1)
from other causes##4##3##(2008-1#1)(2008-12#1)(2008-6#1)(2011-1#1)
from other continents##3##3##(2008-10#2)(2010-5#1)
from other countries##12##3##(1990-6#1)(1992-1#1)(1993-2#1)(1995-8#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
from other diseases##2##3##(1992-6#1)(2010-12#1)
from other eukaryotes##3##3##(1992-8#1)(1994-12#1)(1996-3#1)
from other fungi##3##3##(1994-3#1)(2008-10#2)
from other hospitals##2##3##(1990-9#1)(1992-12#1)
from other host species##2##4##(2008-10#2)
from other hosts##8##3##(2008-10#8)
from other known##2##3##(1990-8#1)(2008-8#1)
from other laboratories##2##3##(1990-8#1)(2008-2#1)
from other locations##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
from other metal ions##2##4##(2008-10#2)
from other methods##2##3##(2007-11#1)(2008-7#1)
from other organisms##8##3##(1990-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-9#1)(1996-3#1)(1997-6#1)(2010-3#1)
from other plant##3##3##(2008-10#2)(2008-11#1)
from other plants##2##3##(2008-10#1)(2009-8#1)
from other populations##2##3##(2009-9#1)(2013-7#1)
from other regions of the##3##5##(1995-3#1)(2009-12#1)(2012-3#1)
from other regions##5##3##(1995-3#1)(2008-10#1)(2009-12#1)(2009-5#1)(2012-3#1)
from other related##2##3##(2008-10#2)
from other sources##6##3##(1996-2#1)(2008-11#2)(2008-8#1)(2009-5#1)(2012-12#1)
from other species##14##3##(1990-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#1)(2012-1#1)
from other strains of the##2##5##(2008-10#1)(2008-7#1)
from other strains##4##3##(2008-10#3)(2008-7#1)
from other substances##2##3##(2008-10#2)
from other types of##2##4##(1990-3#1)(2008-2#1)
from other types##4##3##(1990-3#1)(2008-2#1)(2008-3#1)(2008-9#1)
from other vertebrates##2##3##(1993-6#1)(1995-2#1)
from other viruses##2##3##(2007-12#1)(2008-10#1)
from other##277##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-2#4)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#3)(2008-1#4)(2008-10#84)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#5)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#2)
from others##9##2##(2008-11#2)(2008-2#2)(2008-3#1)(2009-2#1)(2009-9#1)(2010-10#1)(2013-8#1)
from our data##4##3##(1994-11#1)(2008-11#1)(2008-8#1)(2010-6#1)
from our group##4##3##(1995-5#1)(2008-1#1)(2008-7#1)(2013-1#1)
from our laboratories##3##3##(1991-12#1)(2008-4#1)(2012-2#1)
from our laboratory have shown##2##5##(2008-10#1)(2008-7#1)
from our laboratory have##3##4##(1993-6#1)(2008-10#1)(2008-7#1)
from our laboratory##4##3##(1993-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
from our recent##2##3##(1996-4#1)(2009-8#1)
from our results that##2##4##(1996-5#1)(2008-3#1)
from our results##3##3##(1996-5#1)(2008-3#1)(2008-7#1)
from our studies##2##3##(1995-4#1)(2008-7#1)
from our study##3##3##(2010-2#1)(2011-2#1)(2012-12#1)
from our##59##2##(1991-12#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#8)(2008-8#5)(2009-10#1)(2009-8#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)
from outpatients##2##2##(2011-2#2)
from outside sources##2##3##(1992-3#1)(2011-2#1)
from outside the##7##3##(1991-5#1)(1995-9#1)(2007-12#1)(2008-10#2)(2009-5#1)(2011-2#1)
from outside##11##2##(1991-5#1)(1992-3#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-5#1)(2011-2#2)
from ovarian##3##2##(1990-2#1)(1994-7#1)(2010-3#1)
from over 30##2##3##(2008-10#1)(2008-9#1)
from over##9##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-9#1)(2009-9#1)(2010-3#1)
from ovine hypothalamic##2##3##(1990-7#1)(1992-9#1)
from own##2##2##(2007-11#1)(2008-10#1)
from oxidation of##2##3##(1991-3#1)(2008-7#1)
from oxidation##4##2##(1991-3#1)(2008-11#1)(2008-7#1)(2013-8#1)
from oxidative damage##2##3##(1992-12#1)(2009-12#1)
from oxidative##10##2##(1991-2#1)(1992-12#1)(1994-2#2)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
from oxygen atoms##2##3##(2013-8#2)
from oxygen##3##2##(2013-8#3)
from ozonation##2##2##(1992-5#2)
from pH 3##2##3##(2008-10#2)
from pH 4##3##3##(2008-10#2)(2008-5#1)
from pH 6##2##3##(2008-10#1)(2008-6#1)
from pH##10##2##(2008-10#8)(2008-5#1)(2008-6#1)
from pain##3##2##(1992-5#1)(1996-8#1)(2008-7#1)
from paintings##2##2##(2008-10#2)
from pairs of##2##3##(2007-11#1)(2008-10#1)
from palm##2##2##(2008-6#1)(2013-1#1)
from pancreatic##4##2##(2010-11#3)(2013-7#1)
from panelists##2##2##(2008-5#1)(2008-7#1)
from parasites##2##2##(2008-8#2)
from parent##5##2##(2008-10#5)
from parental##4##2##(2008-10#1)(2008-11#2)(2008-8#1)
from parents##5##2##(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
from partial##3##2##(1992-3#1)(1996-8#1)(2008-10#1)
from partially##3##2##(1993-11#1)(2007-11#2)
from participants##3##2##(1993-2#1)(2010-5#1)(2012-3#1)
from participation##2##2##(2009-4#1)(2013-1#1)
from particles##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
from particulate##3##2##(2008-2#2)(2008-3#1)
from passiflora##2##2##(2008-10#2)
from past##9##2##(1991-3#1)(1993-3#1)(1994-3#1)(2008-10#1)(2009-12#1)(2011-2#3)(2012-7#1)
from paternity casework##3##3##(2008-12#3)
from pathogenic##4##2##(2008-4#2)(2008-7#2)
from pathogens##2##2##(2008-6#1)(2013-1#1)
from pathology##3##2##(2009-10#1)(2009-2#1)(2011-2#1)
from patient and##2##3##(1994-8#1)(2008-11#1)
from patient to patient##2##4##(1993-11#1)(2008-7#1)
from patient##10##2##(1993-11#1)(1994-8#2)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
from patients about their##2##4##(1992-12#1)(1995-12#1)
from patients and##2##3##(2008-11#1)(2013-8#1)
from patients at##3##3##(2012-2#2)(2013-1#1)
from patients in Ontario##2##4##(2007-12#2)
from patients in##5##3##(1991-11#1)(1991-12#1)(2007-12#2)(2008-5#1)
from patients of the##2##4##(2008-10#1)(2012-3#1)
from patients to##4##3##(1992-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
from patients who had##2##4##(2007-7#1)(2009-11#1)
from patients who##6##3##(1991-7#1)(1993-9#1)(1994-5#1)(2007-7#1)(2009-11#1)(2010-11#1)
from patients with Graves' disease##2##5##(1990-7#1)(1991-12#1)
from patients with a##2##4##(1994-8#1)(2008-6#1)
from patients with cancer of##2##5##(1991-12#1)(2008-7#1)
from patients with cancer##3##4##(1991-12#1)(2008-7#1)(2012-1#1)
from patients with chronic##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
from patients with disseminated neoplasm##2##5##(1996-12#2)
from patients with schizophrenia##2##4##(1995-12#1)(2011-1#1)
from patients with the##2##4##(1992-12#1)(2008-9#1)
from patients with uncomplicated##2##4##(1992-2#2)
from patients with##74##3##(1990-2#6)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-2#4)(1993-11#2)(1993-2#2)(1993-8#4)(1993-9#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-9#1)(2007-12#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#3)(2012-2#2)(2012-3#1)
from patients without##2##3##(1995-12#1)(2007-10#1)
from patients##127##2##(1990-2#6)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1993-11#2)(1993-2#2)(1993-8#5)(1993-9#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#4)(1995-2#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-8#1)(1997-9#1)(2007-10#1)(2007-12#3)(2007-7#5)(2008-10#6)(2008-11#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-11#4)(2009-4#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
from patterns of##5##3##(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)
from pea##5##2##(2008-1#1)(2008-10#3)(2008-8#1)
from peak##2##2##(1991-2#1)(2007-12#1)
from pear##2##2##(2008-10#2)
from pediatric##2##2##(2008-11#1)(2010-3#1)
from pellets##2##2##(2008-7#2)
from penetrating##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
from people##2##2##(1993-3#1)(2011-2#1)
from pepper##2##2##(2008-10#2)
from peptides##2##2##(1996-12#1)(2008-7#1)
from perennial##2##2##(2008-10#1)(2012-2#1)
from peripheral blood mononuclear cells of##2##6##(1993-3#1)(2011-1#1)
from peripheral blood mononuclear cells##3##5##(1993-3#1)(2008-11#1)(2011-1#1)
from peripheral blood mononuclear##4##4##(1993-3#1)(1997-4#1)(2008-11#1)(2011-1#1)
from peripheral blood##12##3##(1990-8#1)(1993-3#1)(1993-6#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)(2011-1#1)
from peripheral##17##2##(1990-8#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-11#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)
from peritoneal dialysis##2##3##(2007-12#1)(2011-2#1)
from peritoneal##3##2##(2007-12#1)(2011-2#1)(2013-8#1)
from permeabilized##2##2##(1991-8#1)(1992-12#1)
from persistent##2##2##(2007-11#1)(2008-9#1)
from person to person##5##4##(1990-6#1)(1992-6#1)(1994-6#1)(2007-12#2)
from personal##2##2##(2008-4#1)(2008-5#1)
from persons with##2##3##(1994-2#1)(1994-9#1)
from persons##5##2##(1994-2#1)(1994-9#1)(1995-6#1)(1996-11#1)(2008-10#1)
from petroleum##2##2##(2008-12#1)(2013-1#1)
from phage display libraries##2##4##(2008-10#1)(2008-9#1)
from pharmaceutical##5##2##(2008-10#5)
from pharmacists##2##2##(2008-3#1)(2008-8#1)
from pharmacological##2##2##(2008-2#1)(2008-7#1)
from phase II##2##3##(2008-8#2)
from phase##8##2##(1992-6#1)(1995-12#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#2)
from phorbol ester-activated human neutrophils##2##5##(1991-12#1)(1991-9#1)
from phorbol##3##2##(1991-12#1)(1991-9#1)(1993-2#1)
from phosphate##2##2##(1994-11#1)(2008-10#1)
from phosphatidylcholine##4##2##(1990-12#1)(1992-8#1)(1992-9#1)(1993-11#1)
from phosphatidylinositol##2##2##(1997-8#1)(2008-11#1)
from phospholipase C##2##3##(1993-6#1)(1995-8#1)
from phospholipids##2##2##(1997-2#1)(2008-11#1)
from phylogenetic##3##2##(2008-10#1)(2011-1#2)
from physical##5##2##(1990-9#1)(1991-6#1)(1997-2#1)(2008-10#1)(2008-12#1)
from physician##2##2##(1992-1#1)(1997-1#1)
from physicians##2##2##(1991-3#1)(1995-1#1)
from pig##6##2##(1995-6#1)(1996-11#1)(2007-11#1)(2008-11#2)(2008-12#1)
from pigeons##2##2##(1997-3#1)(2012-12#1)
from pigs##2##2##(1996-3#1)(1997-6#1)
from pinwheel centers##2##3##(2008-11#1)(2012-2#1)
from pistachio in##2##3##(2008-10#2)
from pistachio##6##2##(2008-10#6)
from place to place##2##4##(2007-8#1)(2008-1#1)
from planar##4##2##(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
from planning##4##2##(1996-1#1)(2009-11#2)(2013-1#1)
from plant and soil samples##2##5##(2008-10#2)
from plant material##2##3##(2008-10#2)
from plant tissues##4##3##(1990-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
from plant to plant##2##4##(2008-10#1)(2012-2#1)
from plant##21##2##(1990-5#1)(2008-10#13)(2008-4#1)(2008-8#1)(2008-9#4)(2012-2#1)
from plants have been##2##4##(2008-11#1)(2009-10#1)
from plants in##2##3##(2008-10#2)
from plants to animals##2##4##(2008-7#1)(2008-9#1)
from plants##24##2##(2008-10#14)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)
from plasma and##2##3##(2008-10#1)(2008-8#1)
from plasma by a##2##4##(1992-10#1)(2011-3#1)
from plasma samples##2##3##(1991-9#1)(2013-8#1)
from plasma##14##2##(1990-11#1)(1991-9#1)(1992-10#1)(1996-5#1)(1997-2#1)(2008-10#6)(2008-8#1)(2011-3#1)(2013-8#1)
from plasmid##2##2##(1995-8#1)(2008-8#1)
from plasmids##2##2##(1993-2#1)(1996-12#1)
from plate-oriented pyramidal crystals##2##4##(2008-2#2)
from platelet##3##2##(1990-2#1)(1997-7#1)(2010-3#1)
from platelets##2##2##(1992-11#1)(1994-5#1)
from pleural effusion##2##3##(1992-2#1)(2008-5#1)
from plots##3##2##(2008-10#3)
from pluripotent##2##2##(2008-11#1)(2009-3#1)
from pneumococcal##2##2##(1994-9#2)
from point##2##2##(1992-6#1)(2008-11#1)
from polar##3##2##(2008-3#1)(2009-12#1)(2009-6#1)
from polarization##2##2##(2008-10#1)(2008-3#1)
from polarized##3##2##(1990-11#1)(2008-2#1)(2008-3#1)
from pollinator##2##2##(2008-10#1)(2008-8#1)
from polluted waters##2##3##(2008-10#2)
from polymer##5##2##(2007-12#1)(2008-10#3)(2008-12#1)
from polysomes##2##2##(2012-2#2)
from pond water##2##3##(2008-10#1)(2012-2#1)
from pond##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
from pooled##4##2##(1990-8#1)(1991-12#1)(2012-2#1)(2013-8#1)
from poor##4##2##(1995-12#1)(1997-5#1)(2008-5#1)(2012-2#1)
from poplar##3##2##(2008-10#2)(2013-1#1)
from population##4##2##(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#1)
from population-based##2##2##(1992-2#1)(2013-1#1)
from populations##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
from porcine brain##2##3##(1994-5#1)(1996-5#1)
from porcine kidney and##2##4##(1992-11#1)(2008-10#1)
from porcine kidney##3##3##(1992-11#1)(2008-10#2)
from porcine##16##2##(1991-8#1)(1992-11#1)(1993-3#1)(1994-11#4)(1994-5#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)
from positive##3##2##(1996-2#2)(2011-2#1)
from possible##3##2##(1995-5#1)(2007-5#1)(2008-3#1)
from postheparin##3##2##(1991-12#1)(1993-3#1)(1994-11#1)
from postnatal##2##2##(1991-6#1)(2008-10#1)
from potassium##2##2##(2008-10#2)
from potato and tomato##2##4##(2008-10#2)
from potato and##6##3##(2008-10#6)
from potato tubers##4##3##(1992-12#2)(2008-10#1)(2008-12#1)
from potato##19##2##(1992-12#2)(2008-10#16)(2008-12#1)
from potential##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
from poultry##2##2##(2008-5#1)(2011-2#1)
from powdered##2##2##(2008-10#2)
from pre- to##3##3##(1992-12#1)(2008-12#1)(2012-2#1)
from pre-clinical##2##2##(2008-10#1)(2013-8#1)
from pre-existing##2##2##(2011-1#1)(2013-8#1)
from pre-to posttest and##2##4##(2012-2#2)
from pre-to##3##2##(2012-2#3)
from prebloom##2##2##(2008-10#2)
from predominantly##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
from pregnant women##4##3##(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#1)
from pregnant##6##2##(1990-11#2)(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#1)
from preliminary##3##2##(2008-2#1)(2008-3#2)
from prescription data##2##3##(2008-11#1)(2008-8#1)
from present and##2##3##(1996-5#1)(2008-9#1)
from pressure##2##2##(2007-8#1)(2008-3#1)
from pretest to##2##3##(2010-10#2)
from pretreatment##2##2##(1992-11#1)(2013-1#1)
from preventable##2##2##(1990-2#1)(2011-1#1)
from previous experience##2##3##(1996-2#1)(2011-1#1)
from previous research##2##3##(2008-12#1)(2010-4#1)
from previous studies##9##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
from previous surveys##3##3##(1992-2#1)(2008-10#2)
from previous##35##2##(1992-10#1)(1992-2#1)(1995-12#1)(1996-2#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
from previously described##2##3##(1990-12#1)(2008-10#1)
from previously published##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
from previously reported##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
from previously##11##2##(1990-12#1)(1991-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
from primary care##2##3##(2008-7#1)(2012-2#1)
from primary##24##2##(1990-11#2)(1990-5#1)(1990-8#1)(1992-2#3)(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
from primary-cultured murine##2##3##(2008-11#2)
from primitive##2##2##(2009-10#1)(2010-3#1)
from prior##3##2##(2006-10#1)(2007-10#1)(2012-3#1)
from prison##3##2##(2009-11#3)
from private##2##2##(1990-6#1)(2011-1#1)
from probabilistic examples##2##3##(2009-11#2)
from production##4##2##(2007-12#1)(2008-10#1)(2008-11#2)
from productive##2##2##(2008-11#1)(2008-9#1)
from products preserved with##2##4##(2008-5#2)
from professional##3##2##(1991-3#1)(2008-2#1)(2008-9#1)
from progeny##3##2##(1997-3#1)(2008-5#1)(2009-12#1)
from programs##2##2##(1993-1#1)(2008-6#1)
from progression##2##2##(2007-8#1)(2013-8#1)
from progressive##3##2##(2010-6#1)(2012-2#1)(2013-7#1)
from proliferating##2##2##(1992-6#1)(1992-9#1)
from prolonged##3##2##(2008-7#1)(2013-1#2)
from prosody##3##2##(2009-10#3)
from prospective##6##2##(1990-4#1)(1994-2#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
from prostate##2##2##(2008-7#1)(2008-9#1)
from protein and##2##3##(2008-11#1)(2008-3#1)
from protein##11##2##(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#2)
from proteins##6##2##(1992-12#1)(2008-10#3)(2008-7#2)
from providing##2##2##(1997-2#1)(2008-7#1)
from proximal##3##2##(1995-6#1)(2008-11#1)(2008-7#1)
from pseudosclerotia buried##2##3##(2008-10#2)
from psychiatric##2##2##(1993-12#1)(2012-12#1)
from psychiatrists##2##2##(2008-11#1)(2010-12#1)
from psychotic##3##2##(1993-8#2)(1995-1#1)
from pth##2##2##(1994-12#2)
from public and private##2##4##(2008-12#1)(2011-2#1)
from public health##5##3##(1994-3#1)(1996-11#1)(1997-3#1)(2011-2#1)(2012-2#1)
from public##12##2##(1990-6#1)(1994-3#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-2#1)
from published literature and##2##4##(2008-10#1)(2010-8#1)
from published##7##2##(1993-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-8#1)(2011-2#1)
from pulmonary##4##2##(1996-3#1)(2007-8#1)(2010-10#1)(2011-2#1)
from pulse##3##2##(1997-8#1)(2007-12#1)(2008-10#1)
from pumpkin leaves##2##3##(1997-4#2)
from pupils##2##2##(2009-10#2)
from pure##10##2##(1992-5#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-8#1)(2010-4#1)
from purified human##2##3##(1991-5#1)(2008-10#1)
from purified trypanosomes and T##2##5##(2013-1#2)
from purified##16##2##(1990-8#1)(1991-5#2)(1993-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(2008-10#6)(2008-4#1)(2013-1#2)
from putative##2##2##(2007-12#1)(2008-10#1)
from pyramidal##2##2##(2008-2#2)
from pyridine##2##2##(2008-3#2)
from pyrolysis##2##2##(2008-10#2)
from pyruvate##2##2##(1991-3#1)(1995-5#1)
from quality assurance to continuous quality improvement##3##7##(1993-3#1)(1994-2#1)(1994-3#1)
from quality assurance to##4##4##(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)
from quality##5##2##(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)
from quantitative##2##2##(1993-2#1)(2007-12#1)
from rabbit muscle enhanced IgM production##2##6##(2008-11#2)
from rabbit muscle##4##3##(2008-11#4)
from rabbit skeletal muscle##2##4##(1995-2#1)(1997-7#1)
from rabbit small##2##3##(1990-11#2)
from rabbit##24##2##(1990-11#2)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#2)(1995-5#2)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-9#1)
from rabbits fed##2##3##(1991-2#2)
from rabbits##3##2##(1991-2#2)(1995-11#1)
from race 1 isolates##2##4##(2008-10#2)
from race 1##3##3##(2008-10#3)
from race##5##2##(1991-9#1)(2008-10#4)
from radiation##4##2##(2007-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
from radiative transfer theory##2##4##(2008-2#1)(2008-3#1)
from radiological##2##2##(1992-9#1)(2012-2#1)
from radiotherapy##2##2##(2008-2#1)(2013-1#1)
from rainbow trout##5##3##(1994-11#1)(1994-5#1)(1997-9#1)(2009-5#1)(2009-6#1)
from rainbow##7##2##(1994-11#1)(1994-5#1)(1997-9#1)(2008-11#1)(2008-2#1)(2009-5#1)(2009-6#1)
from random amplified polymorphic DNA##2##5##(2008-10#2)
from random##11##2##(1993-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-3#1)
from randomised controlled trials##2##4##(2007-6#1)(2012-12#1)
from randomized controlled trials##3##4##(1993-12#1)(2011-2#2)
from randomized##5##2##(1993-12#2)(1997-3#1)(2011-2#2)
from randomly selected##4##3##(2008-10#2)(2008-6#1)(2013-1#1)
from randomly##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
from rapid##2##2##(2008-11#1)(2008-7#1)
from rat adipose##2##3##(2008-11#2)
from rat and##5##3##(1990-11#1)(1991-8#1)(1994-6#1)(1996-12#1)(1996-6#1)
from rat bone marrow##3##4##(1990-12#1)(1995-11#1)(2012-2#1)
from rat brain##8##3##(1990-7#1)(1991-5#1)(1994-8#2)(1996-2#2)(2008-4#1)(2008-7#1)
from rat brains##2##3##(1991-5#1)(2008-8#1)
from rat cerebellum##2##3##(1991-12#1)(1992-3#1)
from rat heart##4##3##(1991-12#1)(1992-11#2)(1993-6#1)
from rat hypothalamic slices##2##4##(1992-3#2)
from rat intestinal##2##3##(1993-8#1)(1994-8#1)
from rat liver and##4##4##(1990-5#1)(1992-6#2)(1995-6#1)
from rat liver cytosol##2##4##(1993-8#1)(1996-5#1)
from rat liver microsomes##3##4##(1990-11#2)(1993-11#1)
from rat liver was##2##4##(1992-6#1)(1994-11#1)
from rat liver##21##3##(1990-11#2)(1990-12#1)(1990-5#2)(1991-12#1)(1992-11#1)(1992-6#3)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#1)
from rat neostriatum in##2##4##(1992-3#2)
from rat pancreatic##2##3##(1990-12#1)(1991-8#1)
from rat peritoneal mast cells##3##5##(1991-12#2)(1992-3#1)
from rat peritoneal##5##3##(1991-12#2)(1992-3#1)(2008-11#2)
from rat platelets##2##3##(1990-8#2)
from rat skeletal muscle##3##4##(1995-8#2)(2008-2#1)
from rat spinal cord##2##4##(1992-11#1)(2008-11#1)
from rat##105##2##(1990-11#3)(1990-12#5)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#7)(1991-5#3)(1991-8#2)(1991-9#1)(1992-11#4)(1992-3#7)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#4)(1994-11#1)(1994-12#1)(1994-6#3)(1994-8#4)(1995-11#5)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#3)(1996-2#3)(1996-5#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-4#1)
from rats at days 1##2##5##(2010-6#2)
from rats fed##4##3##(1991-12#2)(1994-5#2)
from rats of different##2##4##(1990-2#1)(1995-6#1)
from rats orally given##2##4##(2008-11#2)
from rats treated with##5##4##(1990-12#1)(1990-8#1)(1991-5#1)(1994-5#1)(1997-1#1)
from rats##24##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-8#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-5#3)(1995-5#1)(1995-6#1)(1997-1#1)(2008-11#3)(2008-8#1)(2010-6#2)
from raw pork meat##2##4##(1997-4#2)
from raw##3##2##(1997-4#2)(2008-10#1)
from reaching the##3##3##(2009-12#1)(2009-2#1)(2010-1#1)
from reaching##4##2##(2009-12#1)(2009-2#1)(2010-1#1)(2012-2#1)
from reaction##3##2##(1993-11#1)(2008-10#2)
from reactive##3##2##(2007-11#1)(2008-1#1)(2008-5#1)
from readily available##2##3##(2008-10#2)
from real##9##2##(2008-10#5)(2008-3#2)(2009-6#1)(2012-1#1)
from recent outbreaks in Taiwan##2##5##(2007-6#2)
from recent##11##2##(1994-2#1)(1994-6#1)(2007-6#2)(2008-10#1)(2008-6#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
from recently##2##2##(1993-2#1)(2008-11#1)
from receptor##2##2##(1992-9#1)(1995-6#1)
from reciprocal##2##2##(2007-11#1)(2009-12#1)
from recombinant DNA##2##3##(2012-2#1)(2013-1#1)
from recombinant##9##2##(1990-8#1)(1997-4#1)(2008-11#3)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
from recombination##2##2##(2008-10#1)(2008-7#1)
from recordable##2##2##(2008-10#2)
from recovered trees##2##3##(2008-10#2)
from recovery assays##2##3##(2008-10#2)
from rectal##4##2##(2007-10#2)(2008-10#1)(2010-12#1)
from recurrent##5##2##(1992-11#1)(1996-3#1)(2008-12#1)(2008-9#1)(2010-6#1)
from red blood cells (RBCs)##2##5##(1994-12#1)(1994-3#1)
from red blood cells##7##4##(1992-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(2008-8#1)(2012-2#1)
from red##12##2##(1992-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(2008-7#1)(2008-8#3)(2011-10#1)(2012-2#1)(2013-8#1)
from reduced##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
from reflected##2##2##(2008-2#1)(2008-3#1)
from reflection and transmission##2##4##(2008-3#2)
from reflectivity##2##2##(2007-12#2)
from refractoriness##4##2##(1991-2#4)
from refractory##2##2##(2008-5#1)(2010-5#1)
from region to region##2##4##(1992-2#1)(2008-7#1)
from regional##4##2##(2008-11#1)(2011-2#1)(2012-12#2)
from regions of##2##3##(1991-12#1)(2008-10#1)
from regions within##2##3##(1992-6#1)(2013-1#1)
from regions##8##2##(1991-12#1)(1992-12#1)(1992-6#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
from regulation##2##2##(1991-3#1)(2010-2#1)
from regulatory##2##2##(2008-10#2)
from rehabilitation##3##2##(1996-2#1)(2007-10#1)(2008-10#1)
from rehydrated French beans##2##4##(2008-10#2)
from related##4##2##(1992-12#1)(2008-10#3)
from relevant##3##2##(1991-6#1)(2009-11#1)(2011-2#1)
from remote experience##2##3##(2007-8#2)
from remote sensing##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
from remote##10##2##(1996-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
from renal failure##4##3##(1995-12#2)(2007-7#1)(2008-10#1)
from renal##9##2##(1990-11#1)(1992-12#1)(1993-9#1)(1995-12#2)(2007-7#1)(2008-10#1)(2008-6#1)(2012-1#1)
from replant##2##2##(2008-10#2)
from representative##4##2##(1991-9#1)(2008-10#2)(2008-11#1)
from reproductive##2##2##(1995-3#1)(1996-12#1)
from reptiles##2##2##(2010-3#2)
from research##10##2##(1992-11#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2011-1#1)(2013-1#1)
from residues##3##2##(1990-10#1)(1990-12#1)(2008-10#1)
from resistant cultivars##2##3##(2008-10#2)
from resistant##6##2##(2008-10#6)
from resonance##2##2##(2007-11#1)(2007-12#1)
from respiration##2##2##(2008-10#1)(2008-7#1)
from respiratory distress syndrome##2##4##(1990-11#1)(2012-3#1)
from respiratory tract##2##3##(1991-4#1)(2009-3#1)
from respiratory##7##2##(1990-11#1)(1991-11#1)(1991-4#1)(1997-2#1)(2007-11#1)(2009-3#1)(2012-3#1)
from response surfaces##2##3##(2008-10#2)
from resting##5##2##(1992-6#1)(1993-11#2)(1994-6#1)(1995-12#1)
from restructuring##2##2##(1991-3#1)(1994-3#1)
from retention of##2##3##(2007-12#1)(2011-2#1)
from retroperitoneal##2##2##(2008-5#1)(2009-9#1)
from retrospective studies##2##3##(1991-11#2)
from retrospective##4##2##(1991-11#2)(1991-3#1)(2010-8#1)
from return signals##2##3##(2008-3#2)
from rhenium##2##2##(1996-2#2)
from rhizomes of##2##3##(2008-12#1)(2013-1#1)
from rice (Oryza sativa L##2##5##(1997-4#2)
from rice in##3##3##(2008-10#2)(2013-8#1)
from rice##27##2##(1995-3#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#6)(2009-10#1)(2013-1#1)(2013-8#1)
from right##5##2##(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
from risk factors to##2##4##(2008-4#1)(2009-12#1)
from risk##7##2##(1994-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-2#1)(2012-3#1)
from rodent##2##2##(1994-8#1)(2008-4#1)
from rodents##2##2##(1996-12#1)(1997-6#1)
from room temperature to##3##4##(2008-2#1)(2008-3#2)
from room temperature##5##3##(2008-2#1)(2008-3#3)(2011-2#1)
from root canal walls##2##4##(2008-11#2)
from root to shoot competition##2##5##(2008-9#2)
from root to##4##3##(2008-10#1)(2008-9#2)(2012-2#1)
from root##10##2##(2008-10#2)(2008-11#2)(2008-12#2)(2008-9#2)(2011-2#1)(2012-2#1)
from roots and##2##3##(1992-3#1)(2008-10#1)
from roots of##6##3##(1991-7#1)(2008-10#5)
from roots to##3##3##(2008-11#1)(2008-9#1)(2010-5#1)
from roots##15##2##(1990-11#1)(1991-7#1)(1992-3#1)(2008-10#9)(2008-11#1)(2008-9#1)(2010-5#1)
from rough surfaces##3##3##(2007-11#1)(2008-3#2)
from rough##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
from routine##5##2##(1997-3#1)(2011-2#1)(2012-2#3)
from ruminants##2##2##(1993-2#2)
from rural areas##4##3##(1993-6#1)(1994-9#1)(2009-5#1)(2011-1#1)
from rural##9##2##(1993-12#1)(1993-6#1)(1994-9#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#3)
from rye and##2##3##(1991-12#1)(2008-8#1)
from rye##3##2##(1991-12#1)(2008-5#1)(2008-8#1)
from s##2##2##(1992-6#1)(2007-11#1)
from salicylate media##2##3##(2008-10#2)
from saline using##2##3##(1991-12#1)(1993-12#1)
from saline##3##2##(1991-12#1)(1993-12#1)(1995-12#1)
from saliva##2##2##(1996-5#1)(2010-5#1)
from salivary##2##2##(2008-10#1)(2008-4#1)
from sample matrix##2##3##(2008-10#2)
from sample preparation##2##3##(2008-10#2)
from sample solution##2##3##(2008-10#2)
from sample to sample##3##4##(1994-2#1)(2008-10#2)
from sample##14##2##(1994-2#1)(2008-10#10)(2009-12#1)(2011-2#1)(2012-1#1)
from samples in##2##3##(2008-10#1)(2010-4#1)
from samples of##6##3##(1996-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
from samples##20##2##(1996-6#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-5#1)(2010-4#1)
from sampling##2##2##(2008-10#2)
from satellite sounder##2##3##(2008-2#2)
from satellite##3##2##(2008-2#2)(2008-3#1)
from satellites##2##2##(2008-3#1)(2008-8#1)
from scalp##2##2##(2007-12#1)(2008-5#1)
from scanning electron microscopy##2##4##(2008-2#1)(2010-11#1)
from scattered##2##2##(2007-12#1)(2008-7#1)
from scattering##7##2##(2008-2#6)(2008-3#1)
from schistosomiasis endemic areas##3##4##(2012-3#3)
from schizophrenia##2##2##(2008-7#1)(2011-2#1)
from schizophrenic patients##2##3##(1996-7#2)
from schizophrenic##3##2##(1996-5#1)(1996-7#2)
from schools of##2##3##(1991-8#1)(2008-12#1)
from schools##3##2##(1991-8#1)(2008-12#1)(2009-7#1)
from sciatic##2##2##(1994-12#1)(1996-5#1)
from screening for##2##3##(2008-10#1)(2011-1#1)
from screening##3##2##(1990-3#1)(2008-10#1)(2011-1#1)
from sea water##3##3##(2008-10#3)
from sea##8##2##(1994-9#1)(1995-3#1)(2008-10#4)(2008-2#1)(2010-8#1)
from seawater##4##2##(2008-10#3)(2011-2#1)
from second-order##2##2##(1996-2#1)(2007-11#1)
from secondary##6##2##(1992-2#1)(1992-8#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-4#1)
from secretory##2##2##(2008-4#1)(2012-1#1)
from sediments##2##2##(2008-10#2)
from seed of##3##3##(2008-10#2)(2013-8#1)
from seed##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2013-8#1)
from seedling roots##2##3##(2008-10#2)
from seedling to##2##3##(2008-10#1)(2009-8#1)
from seedling##5##2##(2008-10#3)(2008-12#1)(2009-8#1)
from seedlings##6##2##(2008-10#4)(2008-8#1)(2011-10#1)
from seeds of##2##3##(1995-6#1)(2008-10#1)
from seeds ofPhytolacca americana##2##4##(2008-8#2)
from seeds##7##2##(1995-6#1)(2008-10#3)(2008-8#2)(2013-1#1)
from selected##6##2##(1994-5#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
from selection##3##2##(1992-2#1)(2008-10#1)(2009-8#1)
from selective##4##2##(1990-5#1)(1996-2#1)(2008-7#1)(2011-2#1)
from semiconductor##2##2##(2007-11#1)(2007-12#1)
from sensitive##3##2##(2008-10#3)
from sensory neurons##2##3##(1992-6#1)(2008-8#1)
from sensory##3##2##(1992-6#1)(2008-8#1)(2009-9#1)
from sepsis##3##2##(1996-9#1)(2007-7#1)(2011-2#1)
from septic shock##2##3##(1996-3#1)(2010-5#1)
from septic##4##2##(1996-3#1)(2007-5#1)(2008-9#1)(2010-5#1)
from sequence information##3##3##(1997-8#1)(2008-2#1)(2008-4#1)
from sequence##9##2##(1994-8#1)(1997-2#1)(1997-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-6#1)(2011-2#1)
from sequences##2##2##(2008-10#1)(2013-1#1)
from sequential##3##2##(1990-12#1)(2008-10#1)(2010-3#1)
from serial##2##2##(1997-3#1)(2009-5#1)
from serogroup Y##2##3##(2007-12#2)
from serogroups B##2##3##(2007-12#2)
from serous##4##2##(1992-2#1)(1993-6#1)(1993-9#1)(2013-1#1)
from serum was##3##3##(2008-10#3)
from serum##10##2##(1990-12#1)(1993-2#1)(1997-4#1)(2008-10#6)(2008-11#1)
from service##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
from seven different##3##3##(1997-6#1)(2008-10#1)(2013-7#1)
from seven locations in##2##4##(2008-10#1)(2010-8#1)
from seven##23##2##(1991-12#1)(1992-6#1)(1993-3#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-8#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-7#1)
from several European##2##3##(1993-3#1)(1997-4#1)
from several different##5##3##(1991-6#1)(1992-3#1)(2008-10#2)(2008-2#1)
from several directions##2##3##(2008-2#1)(2008-3#1)
from several hosts##3##3##(2008-10#3)
from several perspectives##2##3##(1996-12#1)(2008-9#1)
from several studies##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
from several##68##2##(1991-6#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#27)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#1)(2011-2#3)(2013-8#1)
from severe##10##2##(1991-2#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-8#1)
from sex##4##2##(1991-1#1)(1994-7#1)(2008-12#1)(2008-7#1)
from sexual##7##2##(2008-10#1)(2008-8#3)(2008-9#1)(2010-3#2)
from sheep##5##2##(1991-8#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-12#1)
from shifts in##2##3##(2008-3#1)(2008-8#1)
from ships##2##2##(2008-11#1)(2011-2#1)
from shoot tip##2##3##(2008-12#1)(2008-9#1)
from short##8##2##(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#3)
from side##2##2##(2008-10#1)(2008-8#1)
from sign##2##2##(2008-9#1)(2010-5#1)
from signals##3##2##(1992-6#1)(2008-11#1)(2009-6#1)
from significant##3##2##(2008-7#1)(2010-2#1)(2012-1#1)
from silica and##2##3##(2007-12#1)(2008-3#1)
from silica##4##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
from silver##2##2##(1992-12#1)(2008-10#1)
from similar##4##2##(1992-4#1)(2008-10#1)(2008-2#1)(2010-3#1)
from simple##13##2##(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#2)
from simply##2##2##(1996-5#1)(2010-4#1)
from simulated data##2##3##(2008-10#1)(2008-7#1)
from simulated##11##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-7#1)
from simulations of##2##3##(1995-5#1)(2008-3#1)
from simulations##6##2##(1992-3#1)(1995-5#1)(2008-3#3)(2010-3#1)
from simultaneous measurements of##2##4##(2008-2#1)(2008-3#1)
from simultaneous measurements##3##3##(2008-2#2)(2008-3#1)
from simultaneous##4##2##(2008-2#3)(2008-3#1)
from simultaneously acquired##2##3##(2007-12#1)(2008-3#1)
from simultaneously##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
from single cells##4##3##(2008-4#3)(2008-7#1)
from single institutions##2##3##(1996-12#1)(2008-6#1)
from single##26##2##(1996-12#3)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
from single-crystal##2##2##(2007-12#1)(2008-3#1)
from site to site##2##4##(2008-10#2)
from site##3##2##(2008-10#2)(2010-4#1)
from sites with##3##3##(2008-10#3)
from sites##5##2##(1994-5#1)(2008-10#3)(2013-1#1)
from six indigenous communities residing in##2##6##(2012-12#2)
from six months##2##3##(1991-6#1)(2008-1#1)
from six states##2##3##(2008-10#2)
from six studies##2##3##(1995-5#1)(2008-6#1)
from six##26##2##(1991-2#1)(1991-6#2)(1995-12#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#3)
from skeletal muscle##2##3##(1991-2#1)(2008-1#1)
from skeletal##4##2##(1991-2#1)(1996-8#1)(2008-1#1)(2008-7#1)
from skin##15##2##(1992-2#1)(1994-8#1)(1995-12#1)(2008-2#1)(2008-5#7)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
from slingshot metal darts##2##4##(2008-1#2)
from slow##2##2##(1990-7#1)(2008-9#1)
from small studies##2##3##(2008-6#1)(2013-8#1)
from small water droplets##2##4##(2007-11#1)(2008-2#1)
from small##22##2##(1993-12#2)(1995-3#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-12#1)(2013-8#1)
from small-scale##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
from smokers##2##2##(2008-10#1)(2010-2#1)
from smoking##2##2##(1992-4#1)(1992-6#1)
from smooth muscle##3##3##(1991-5#1)(1993-6#1)(1993-8#1)
from smooth##4##2##(1991-5#1)(1993-6#1)(1993-8#1)(1996-12#1)
from snake##2##2##(1995-5#1)(2008-8#1)
from social##3##2##(2008-11#1)(2011-2#1)(2012-1#1)
from sodium chloride##2##3##(2008-10#1)(2008-12#1)
from sodium##4##2##(1993-11#1)(2008-10#2)(2008-12#1)
from soft tissue sarcoma##4##4##(2008-6#4)
from soft tissue sarcomas##5##4##(2008-6#5)
from soft tissue##10##3##(2008-6#9)(2013-8#1)
from soil and##6##3##(1993-11#1)(2008-10#4)(2013-1#1)
from soil samples with##2##4##(1994-3#1)(2008-10#1)
from soil samples##13##3##(1994-3#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#1)
from soil##43##2##(1993-11#1)(1994-3#1)(1994-9#1)(2008-10#33)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
from soils and##3##3##(2008-10#2)(2013-8#1)
from soils in##3##3##(2008-10#3)
from soils##18##2##(2008-10#16)(2013-8#2)
from solar##2##2##(2008-3#1)(2008-5#1)
from solid matrices##3##3##(2008-10#3)
from solid samples##4##3##(2008-10#3)(2012-1#1)
from solid tumors##2##3##(2008-7#1)(2008-9#1)
from solid##15##2##(1996-3#1)(2008-10#9)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-7#1)
from solid-state##2##2##(2008-10#2)
from solubilized##2##2##(1990-11#1)(2008-11#1)
from solution samples##5##3##(2008-10#5)
from solution##11##2##(1990-2#1)(2008-10#8)(2009-11#1)(2010-12#1)
from solutions containing##3##3##(1992-8#1)(2008-10#2)
from solutions of##2##3##(2008-10#2)
from solutions##8##2##(1992-8#1)(2008-10#6)(2009-11#1)
from solvent##3##2##(2008-4#1)(2013-1#2)
from somatic mutations##2##3##(2008-10#2)
from somatic##5##2##(1997-7#1)(2008-10#3)(2008-11#1)
from some of the##2##4##(2008-1#1)(2008-10#1)
from some of these##2##4##(1990-3#1)(2008-10#1)
from some of##4##3##(1990-3#1)(2008-1#1)(2008-10#2)
from some other##2##3##(2008-10#1)(2008-11#1)
from some##31##2##(1990-3#1)(1991-8#1)(1992-11#1)(1993-3#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#2)(2008-8#1)(2012-3#1)(2013-8#1)
from sorghum and millet##2##4##(2008-10#2)
from source##4##2##(2008-10#3)(2008-8#1)
from sources located##2##3##(2007-12#1)(2008-3#1)
from sources##6##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
from south India##2##3##(2008-3#1)(2012-2#1)
from south to north##2##4##(2008-10#1)(2008-9#1)
from south##5##2##(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
from southern##4##2##(2008-10#2)(2008-11#1)(2012-1#1)
from soybean (Glycine max)##2##4##(2013-1#2)
from soybean hypocotyls##2##3##(1997-6#2)
from soybean plants##3##3##(2008-10#3)
from soybean##24##2##(1990-5#1)(1991-12#1)(1997-6#3)(2008-10#15)(2008-8#1)(2013-1#3)
from space##8##2##(2008-2#1)(2008-3#7)
from space-based##2##2##(2008-2#1)(2008-3#1)
from spatially resolved##2##3##(2008-3#2)
from spatially##3##2##(2008-3#2)(2008-8#1)
from speakers who##4##3##(2008-4#4)
from speakers##5##2##(2008-2#1)(2008-4#4)
from specialist##3##2##(1997-8#1)(2008-8#1)(2011-1#1)
from species and##2##3##(2008-8#1)(2011-2#1)
from species##6##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
from specific##7##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
from specimens##3##2##(2008-3#1)(2008-6#1)(2011-1#1)
from speckle##4##2##(2008-2#2)(2008-3#2)
from spectra##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
from spectral data##2##3##(2008-10#2)
from spectral##9##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)
from spectrophotometric data##2##3##(2008-10#2)
from spectrophotometric measurements##3##3##(2008-10#1)(2008-2#2)
from spectrophotometric##6##2##(2008-10#4)(2008-2#2)
from spermidine##2##2##(2013-8#2)
from spherical##4##2##(2008-3#4)
from spheroids disaggregated immediately after treatment##2##6##(1992-9#2)
from spheroids disaggregated##3##3##(1992-9#3)
from spiked matrices##2##3##(2008-10#2)
from spiked plasma samples were##2##5##(2008-10#2)
from spiked plasma samples##3##4##(2008-10#3)
from spiked samples##2##3##(2008-10#2)
from spiked##15##2##(2008-10#14)(2009-8#1)
from spinach leaves##2##3##(1990-5#1)(2008-10#1)
from spinach##4##2##(1990-5#1)(1991-9#1)(1997-7#1)(2008-10#1)
from spinal cord synaptosomes##3##4##(1996-2#3)
from spinal cord##4##3##(1995-11#1)(1996-2#3)
from spinal##7##2##(1994-7#1)(1995-11#1)(1996-2#3)(2006-12#1)(2007-11#1)
from splash##2##2##(2008-10#2)
from spleen##2##2##(1994-2#1)(2008-10#1)
from spontaneous##5##2##(1992-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
from spontaneously hypertensive rats##2##4##(1995-11#2)
from sporadic##2##2##(2008-10#1)(2009-11#1)
from spray inoculation##2##3##(2008-10#2)
from spruce##2##2##(2008-10#1)(2013-1#1)
from sputum##3##2##(2008-1#1)(2008-5#2)
from squamous cell carcinoma of the##2##6##(1993-8#2)
from squamous cell carcinoma##4##4##(1993-8#2)(2009-6#1)(2010-8#1)
from squamous##5##2##(1993-8#2)(2009-6#1)(2010-8#1)(2011-2#1)
from staff and##2##3##(2007-11#1)(2011-1#1)
from staff nurse to nurse consultant##2##6##(2013-8#2)
from staff##4##2##(2007-11#1)(2011-1#1)(2013-8#2)
from stage 0-##2##3##(2008-10#2)
from stage III to stage##2##5##(1991-8#1)(2008-7#1)
from stage##7##2##(1991-8#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-7#1)
from standard solutions##2##3##(2008-1#1)(2008-10#1)
from standard##14##2##(1992-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
from standardized##2##2##(1996-2#1)(2008-9#1)
from start of##2##3##(1992-5#1)(2011-2#1)
from start##4##2##(1991-6#1)(1992-5#1)(2008-10#1)(2011-2#1)
from stationary##2##2##(2008-3#1)(2011-2#1)
from stem##2##2##(2007-12#1)(2008-10#1)
from stems##4##2##(2008-10#3)(2008-7#1)
from stepwise##2##2##(2008-10#1)(2008-11#1)
from stimulated##5##2##(1992-6#1)(1993-11#1)(1994-11#1)(2008-10#1)(2008-2#1)
from stimulation of the##3##4##(1990-5#2)(1993-12#1)
from stimulation of##5##3##(1990-5#3)(1993-12#1)(1995-8#1)
from stimulation##10##2##(1990-5#3)(1993-12#1)(1995-8#1)(1996-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
from stock F##2##3##(2007-6#2)
from stomach##2##2##(1990-12#1)(2008-4#1)
from stool##2##2##(2007-7#1)(2008-10#1)
from storage and##2##3##(2008-10#1)(2008-3#1)
from storage##3##2##(2008-10#2)(2008-3#1)
from stored##3##2##(1992-3#1)(2008-1#1)(2008-10#1)
from strain##16##2##(1991-8#2)(1993-9#1)(2008-10#10)(2008-3#1)(2008-8#1)(2012-2#1)
from strains##8##2##(2008-10#7)(2012-3#1)
from strawberry and##5##3##(2008-10#5)
from strawberry##17##2##(2008-10#17)
from strawberry)##2##2##(2008-10#2)
from street##2##2##(2008-10#1)(2012-3#1)
from strength##2##2##(2007-12#1)(2008-7#1)
from stress and##2##3##(2007-5#1)(2012-2#1)
from stress##4##2##(1996-4#1)(2007-5#1)(2008-7#1)(2012-2#1)
from stroke##5##2##(1993-2#1)(1995-5#1)(2008-2#1)(2008-8#1)(2013-1#1)
from strong to##2##3##(2008-10#1)(2011-2#1)
from strong##9##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2011-2#1)
from structural analysis##2##3##(2008-10#1)(2010-7#1)
from structural equation modeling##2##4##(2009-7#1)(2010-2#1)
from structural##10##2##(1995-5#1)(1995-6#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-3#1)
from students and##2##3##(2008-11#2)
from students##5##2##(2008-11#3)(2009-6#1)(2012-1#1)
from studies for other clinical indications##2##6##(2011-2#2)
from studies for##3##3##(2011-2#3)
from studies of the##3##4##(1993-11#1)(2009-11#1)(2009-8#1)
from studies of##12##3##(1991-9#1)(1993-11#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
from studies on##5##3##(1992-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)
from studies with##4##3##(1991-1#1)(1997-9#1)(2008-10#1)(2008-4#1)
from studies##34##2##(1991-1#1)(1991-9#1)(1992-3#1)(1993-11#1)(1997-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#4)(2008-8#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#1)
from study##4##2##(1997-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
from subcellular##2##2##(1995-6#1)(2010-9#1)
from subcutaneous fat##2##3##(2008-7#1)(2012-4#1)
from subcutaneous##3##2##(1997-3#1)(2008-7#1)(2012-4#1)
from subgroup##2##2##(2008-5#1)(2011-2#1)
from subjects##4##2##(1991-8#1)(1995-12#1)(1996-5#1)(2008-7#1)
from subpopulations##2##2##(1990-12#1)(2008-10#1)
from subsequent##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
from substrate##3##2##(2008-7#2)(2009-11#1)
from successful##4##2##(2007-11#3)(2008-1#1)
from such a##5##3##(1990-6#1)(1992-8#1)(1997-4#1)(2008-10#2)
from such##28##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-8#2)(1993-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#1)
from sugarcane bagasse##2##3##(2008-6#1)(2013-1#1)
from sulfate##3##2##(2008-10#2)(2011-2#1)
from sunset##2##2##(2008-10#1)(2008-2#1)
from supernatant##2##2##(2008-11#1)(2013-1#1)
from surface contamination##2##3##(2008-10#2)
from surface to##2##3##(2008-3#1)(2013-8#1)
from surface water##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
from surface##16##2##(1994-12#1)(2007-12#1)(2008-10#7)(2008-3#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
from surfaces of##2##3##(2008-2#2)
from surfaces##4##2##(2008-12#2)(2008-2#2)
from surgery##2##2##(1997-2#1)(2012-12#1)
from surgical treatment##2##3##(2009-3#1)(2013-1#1)
from surgical##10##2##(1990-5#1)(1991-3#1)(2008-4#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
from surrounding##6##2##(1990-2#1)(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#2)
from survey##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
from susceptible##9##2##(1994-8#1)(2008-10#8)
from suspected##3##2##(1990-7#1)(2012-3#1)(2013-8#1)
from suspension##5##2##(2008-11#2)(2008-4#2)(2008-8#1)
from sweet##3##2##(2008-10#2)(2008-6#1)
from symmetric and##2##3##(2008-8#2)
from symptomatic plants##2##3##(2008-10#2)
from symptomatic##9##2##(1991-3#1)(2008-10#8)
from symptomless##3##2##(2008-10#3)
from symptoms##3##2##(1996-6#1)(2007-8#1)(2011-3#1)
from synchrotron##2##2##(2006-4#2)
from synthesis##2##2##(1997-2#1)(2008-3#1)
from synthetic and##2##3##(2008-10#2)
from synthetic##7##2##(2008-10#5)(2008-2#1)(2011-3#1)
from systemic lupus erythematosus (SLE)##2##5##(1994-6#1)(2008-10#1)
from systemic##4##2##(1994-6#1)(2006-10#1)(2008-10#2)
from systemically infected##4##3##(2008-10#4)
from systems##2##2##(2007-12#1)(2011-2#1)
from tablet was##2##3##(2008-10#1)(2010-5#1)
from tablet##5##2##(2008-10#2)(2010-5#3)
from tablets##5##2##(2008-10#4)(2010-5#1)
from taking##2##2##(2011-2#1)(2012-12#1)
from tall fescue##3##3##(2008-10#3)
from tamarillo##3##2##(2008-10#3)
from tankships##2##2##(2008-11#2)
from target##2##2##(2008-4#1)(2008-5#1)
from targets##2##2##(2008-3#1)(2010-10#1)
from technical##2##2##(1993-2#1)(2008-3#1)
from technologies##2##2##(2008-10#1)(2008-4#1)
from temperate##2##2##(2011-2#1)(2012-2#1)
from ten##9##2##(1991-6#1)(1995-12#1)(1996-9#1)(2008-10#2)(2010-4#1)(2012-2#2)(2013-7#1)
from tens of##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
from term deliveries##2##3##(2007-11#2)
from term##3##2##(1995-11#1)(2007-11#2)
from terrestrial##2##2##(2008-9#1)(2011-2#1)
from tester##2##2##(2008-2#2)
from tests##3##2##(2008-12#1)(2008-2#1)(2012-3#1)
from thapsigargin-sensitive intracellular stores##2##4##(2008-4#2)
from that for##9##3##(1990-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
from that found in the##2##5##(1996-9#1)(2006-10#1)
from that found in##5##4##(1995-12#1)(1996-9#1)(2006-10#1)(2008-5#1)(2008-7#1)
from that in the##9##4##(1994-5#1)(1995-2#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-5#2)(2008-6#1)(2013-1#1)
from that in##21##3##(1990-11#1)(1990-2#1)(1992-5#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-2#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#1)
from that observed##6##3##(1993-6#1)(1994-3#1)(1996-5#1)(2008-10#1)(2008-8#1)(2011-1#1)
from that of a##7##4##(1990-6#1)(1991-3#1)(2007-11#1)(2007-12#1)(2008-3#3)
from that of all other##2##5##(2007-12#1)(2008-5#1)
from that of all##3##4##(2007-12#1)(2008-5#1)(2011-3#1)
from that of compound##2##4##(1994-6#1)(1995-3#1)
from that of other##4##4##(1993-2#1)(2008-10#2)(2008-9#1)
from that of synthetic rat##2##5##(1994-6#1)(1994-8#1)
from that of the original##2##5##(2008-10#2)
from that of the traditional##2##5##(1994-2#1)(1996-5#1)
from that of the##37##4##(1990-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2012-3#1)
from that of##114##3##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2010-12#2)(2011-10#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
from that on##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
from that previously##3##3##(1991-9#1)(1993-1#1)(1993-11#1)
from that##195##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#8)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(2006-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#30)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#13)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#2)(2009-10#3)(2009-12#2)(2009-3#1)(2010-12#2)(2011-1#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
from the &quot##6##3##(1990-6#1)(1991-5#1)(2008-10#2)(2009-6#1)(2011-1#1)
from the 1##3##3##(1995-5#1)(1996-2#1)(2008-10#1)
from the 10##4##3##(1990-7#1)(1992-11#1)(1997-2#1)(2008-10#1)
from the 12 mg/kg group##2##5##(2008-9#2)
from the 12##3##3##(2008-10#1)(2008-9#2)
from the 1930s##2##3##(2007-12#1)(2010-1#1)
from the 1940s to the##2##5##(2009-7#1)(2012-3#1)
from the 1970s##2##3##(2008-7#1)(2011-2#1)
from the 1990##3##3##(1992-12#1)(2008-8#1)(2010-7#1)
from the 1990s##2##3##(2007-12#1)(2012-3#1)
from the 1991##2##3##(1997-1#1)(1997-4#1)
from the 1st##3##3##(1990-12#1)(2007-8#1)(2008-7#1)
from the 2##3##3##(1990-7#1)(2008-10#1)(2008-7#1)
from the 2000##2##3##(2008-8#1)(2011-2#1)
from the 2001##2##3##(2007-6#1)(2008-11#1)
from the 2005##2##3##(2009-5#1)(2012-12#1)
from the 2D##2##3##(1996-2#1)(2013-1#1)
from the 3 mg/kg group##2##5##(2008-9#2)
from the 3##4##3##(1997-4#1)(2008-9#2)(2013-1#1)
from the 3' end of the completed Okazaki fragment##2##9##(1992-3#2)
from the 3' end of the##3##6##(1992-3#2)(2008-10#1)
from the 3'##4##3##(1992-3#2)(2008-10#2)
from the 30##2##3##(1992-12#1)(2008-10#1)
from the 5##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
from the 5'##3##3##(1992-3#1)(1992-6#1)(2008-10#1)
from the 6 mg/kg group##2##5##(2008-9#2)
from the 6th##2##3##(1993-6#1)(1997-6#1)
from the 9##2##3##(2008-10#1)(2008-2#1)
from the American##5##3##(1996-2#1)(1997-8#1)(2008-5#1)(2011-2#1)(2013-8#1)
from the Arabidopsis##2##3##(1994-12#1)(2009-10#1)
from the B genome##2##4##(2008-10#2)
from the B##3##3##(2008-10#3)
from the Brazilian##2##3##(2008-11#1)(2013-8#1)
from the British##2##3##(1992-2#1)(2012-12#1)
from the C##2##3##(1992-6#1)(1995-2#1)
from the C-terminus of##3##4##(1992-6#2)(1993-11#1)
from the C-terminus##5##3##(1992-6#2)(1993-11#1)(1994-11#1)(1995-2#1)
from the CA##2##3##(2008-10#1)(2011-1#1)
from the CA1##2##3##(1995-12#1)(1995-5#1)
from the Cambridge##2##3##(2008-10#1)(2009-7#1)
from the Canadian##5##3##(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)
from the Caribbean coast##2##4##(2008-5#2)
from the Caribbean region##3##4##(2008-10#2)(2012-12#1)
from the Caribbean##10##3##(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#4)(2012-12#1)
from the Chernobyl##4##3##(2008-10#2)(2008-4#1)(2010-4#1)
from the China##2##3##(2011-2#2)
from the Chinese##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
from the Colombian##2##3##(2008-5#1)(2013-7#1)
from the Community##2##3##(1992-12#1)(1992-5#1)
from the Copenhagen Male Study##2##5##(2008-3#2)
from the Coronary##2##3##(1991-8#1)(2011-2#1)
from the Croatian##2##3##(2011-2#2)
from the Current##2##3##(1993-3#1)(2011-2#1)
from the DNA##8##3##(1991-5#1)(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
from the DRR of the##2##5##(2009-11#2)
from the DRR##3##3##(2009-11#2)(2009-2#1)
from the DZ##2##3##(2009-7#2)
from the Department of##8##4##(1991-9#1)(1993-3#2)(1996-3#1)(2007-11#1)(2007-2#1)(2008-11#1)(2012-3#1)
from the Doppler shift##2##4##(2008-2#2)
from the Doppler##3##3##(2008-2#2)(2008-3#1)
from the Drosophila##3##3##(1995-8#1)(1997-4#1)(2009-3#1)
from the Dutch##2##3##(1992-6#1)(2008-5#1)
from the E##2##3##(1990-11#1)(2009-7#1)
from the ER##3##3##(1993-12#1)(2010-11#1)(2012-2#1)
from the EU##3##3##(2008-10#2)(2013-1#1)
from the East##2##3##(2008-11#1)(2010-8#1)
from the European##8##3##(1990-11#1)(1994-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-3#1)(2012-2#1)
from the FDPM data##2##4##(2008-3#2)
from the Federal##2##3##(1993-1#1)(1996-1#1)
from the Fiji##2##3##(2008-1#2)
from the Food and Drug Administration##2##6##(1996-5#1)(2008-7#1)
from the Fourier intensities of the##2##6##(2007-11#2)
from the Fourier##4##3##(1991-5#1)(2007-11#2)(2008-3#1)
from the GC-HRMS##2##3##(2008-10#2)
from the Gaussian##3##3##(2008-2#2)(2008-3#1)
from the German##2##3##(2008-10#1)(2011-2#1)
from the Gibbs##2##3##(2008-10#1)(2011-2#1)
from the Global##3##3##(2008-3#1)(2011-2#2)
from the Golgi apparatus##2##4##(1990-7#1)(2012-2#1)
from the Golgi##4##3##(1990-7#1)(1994-12#1)(2008-11#1)(2012-2#1)
from the Gulf of##2##4##(2008-5#1)(2011-2#1)
from the H##2##3##(1994-8#1)(2008-11#1)
from the H-2Kb-tsA58 transgenic mouse##3##5##(1995-11#3)
from the HPLC column##2##4##(1995-3#1)(2008-10#1)
from the Health##3##3##(1996-8#1)(2009-7#1)(2010-2#1)
from the ICU##2##3##(2007-8#1)(2013-8#1)
from the Indian Ocean##2##4##(2008-11#2)
from the Indian##3##3##(2008-11#2)(2011-2#1)
from the International##5##3##(1994-9#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-2#1)
from the Italian##2##3##(2010-11#1)(2011-2#1)
from the Ivory Coast were##2##5##(2008-10#2)
from the Japanese##4##3##(2008-10#2)(2010-8#1)(2012-1#1)
from the Leaves of##2##4##(2013-1#2)
from the Lyon area##2##4##(2008-10#2)
from the MCBS (Medicare Current Beneficiary Survey)##2##7##(1996-2#1)(1997-1#1)
from the MX line##2##4##(2008-10#2)
from the Medicare Current Beneficiary Survey (MCBS) and##2##8##(1994-1#1)(1995-12#1)
from the Medicare Current Beneficiary Survey (MCBS)##4##7##(1994-1#1)(1995-12#2)(1997-2#1)
from the Medicare##8##3##(1993-1#1)(1993-3#2)(1994-1#1)(1995-12#2)(1995-2#1)(1997-2#1)
from the Middle East##2##4##(2007-8#1)(2008-10#1)
from the Middle Volga region##2##5##(2013-1#2)
from the Middle##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2013-1#2)
from the N terminus##2##4##(1994-8#1)(2008-6#1)
from the N-terminal##5##3##(1990-2#2)(1991-11#1)(1995-12#1)(1995-5#1)
from the N-terminus##2##3##(1990-2#1)(1990-7#1)
from the NH(4)VO(3) solution##3##4##(2008-10#3)
from the National Cancer##2##4##(1997-3#1)(2013-8#1)
from the National Health##4##4##(1995-12#1)(1996-5#1)(2010-12#1)(2013-8#1)
from the National Institute of Standards##2##6##(2008-10#1)(2013-8#1)
from the National Institute of##4##5##(2008-10#1)(2008-5#2)(2013-8#1)
from the National Insurance Scheme##2##5##(1991-8#2)
from the National Insurance##3##4##(1991-8#2)(1995-2#1)
from the National Survey of##2##5##(2009-5#1)(2010-10#1)
from the National##30##3##(1990-6#1)(1991-2#1)(1991-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-5#3)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-1#2)(2013-8#4)
from the New##2##3##(1996-3#1)(2008-10#1)
from the North American##2##4##(2008-10#2)
from the North Carolina sample##2##5##(2008-10#2)
from the North##9##3##(1992-5#1)(1992-8#1)(2008-10#4)(2008-6#1)(2008-9#1)(2011-2#1)
from the Northern##5##3##(2008-5#1)(2011-1#3)(2013-1#1)
from the Northwest##2##3##(2008-12#1)(2008-8#1)
from the Norwegian##2##3##(1991-11#1)(1997-8#1)
from the Ontario##2##3##(1991-2#1)(2008-6#1)
from the P##2##3##(2008-10#2)
from the PDL##2##3##(2008-11#2)
from the Pacific Coast of##3##5##(2008-5#1)(2013-7#2)
from the Pacific Northwest of the United States and##2##9##(2008-10#2)
from the Pacific##9##3##(2008-10#2)(2008-5#5)(2013-7#2)
from the Pantanal##3##3##(2013-7#3)
from the Parana River basin##2##5##(2008-12#2)
from the Pimentel Barbosa##2##4##(1991-12#2)
from the Quebec##2##3##(1991-12#1)(2008-3#1)
from the R to the T##2##6##(1990-8#2)
from the REE##2##3##(2008-10#2)
from the RPP##2##3##(2007-12#2)
from the SH group##2##4##(1996-5#2)
from the SPE cartridge##2##4##(1997-2#2)
from the SPME##2##3##(2008-10#2)
from the School of##2##4##(2008-10#1)(2012-3#1)
from the South##6##3##(1992-5#1)(1997-4#1)(2008-8#1)(2010-3#1)(2010-8#2)
from the Southern##2##3##(2008-10#1)(2013-7#1)
from the Sudan and##2##4##(2008-10#2)
from the Sun##3##3##(2008-2#2)(2008-3#1)
from the T cell line transfected with##2##7##(2008-11#2)
from the T##3##3##(2008-11#2)(2011-2#1)
from the Telembi River drainage##2##5##(2013-7#2)
from the U##5##3##(1993-2#1)(1994-1#1)(2008-10#3)
from the US##5##3##(1993-6#1)(2008-1#1)(2008-5#1)(2010-10#1)(2013-8#1)
from the UV##3##3##(2007-12#1)(2008-10#2)
from the United Kingdom##3##4##(1991-3#1)(2008-3#1)(2008-8#1)
from the United States and France##2##6##(2008-10#2)
from the United States and##8##5##(2007-12#1)(2008-10#6)(2009-11#1)
from the United States were##4##5##(2008-10#4)
from the United States##29##4##(2007-12#1)(2007-7#1)(2008-10#24)(2009-11#2)(2011-2#1)
from the United##33##3##(1991-3#1)(2007-12#1)(2007-7#1)(2008-10#25)(2008-3#1)(2008-8#1)(2009-11#2)(2011-2#1)
from the University of##3##4##(1991-1#1)(1995-3#1)(2009-8#1)
from the University##4##3##(1991-1#1)(1995-3#1)(2008-11#1)(2009-8#1)
from the Upper##2##3##(1991-12#1)(2007-12#1)
from the VOCl(2) solution##2##4##(2008-10#2)
from the Vf cultivar##2##4##(2008-10#2)
from the WHO##2##3##(2008-10#1)(2013-8#1)
from the WWTP##2##3##(2008-10#1)(2013-1#1)
from the Web##2##3##(2008-6#1)(2011-2#1)
from the Western Hemisphere##2##4##(2008-10#2)
from the Western diamondback rattlesnake##2##5##(1992-8#1)(1994-6#1)
from the Western##6##3##(1992-8#1)(1994-6#1)(2008-10#3)(2009-4#1)
from the World##2##3##(1990-3#1)(2010-12#1)
from the X chromosome##2##4##(2008-11#2)
from the X##3##3##(2008-10#1)(2008-11#2)
from the abdominal##2##3##(1991-2#1)(2012-2#1)
from the ability to##3##4##(1996-12#1)(2008-11#1)(2008-9#1)
from the absence of##4##4##(1990-5#1)(1990-8#2)(2009-10#1)
from the absorption spectra by##2##5##(2008-3#2)
from the absorption##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
from the academic##4##3##(1991-8#1)(2008-12#1)(2012-1#1)(2012-3#1)
from the accepted##2##3##(1991-6#1)(1997-8#1)
from the acidic##2##3##(2008-10#1)(2008-5#1)
from the acquired##2##3##(1993-12#1)(2009-8#1)
from the activated macrophages##2##4##(2008-11#2)
from the active##2##3##(1995-3#1)(2008-5#1)
from the activity of a##2##5##(1995-2#1)(2013-8#1)
from the activity of##3##4##(1995-2#1)(2009-3#1)(2013-8#1)
from the actual##2##3##(2008-10#2)
from the acute care##3##4##(2008-3#1)(2013-1#2)
from the addition of##2##4##(1997-8#1)(2008-3#1)
from the adipose##2##3##(2008-10#2)
from the adult mouse##2##4##(2008-11#2)
from the aerial parts of##3##5##(2007-11#1)(2008-11#1)(2013-1#1)
from the aerial##4##3##(2007-11#1)(2008-11#2)(2013-1#1)
from the affected##3##3##(1994-12#1)(2007-6#1)(2008-12#1)
from the age of 17##2##5##(1992-4#1)(1997-3#1)
from the age of##4##4##(1992-4#1)(1995-12#1)(1997-3#1)(2007-12#1)
from the age##5##3##(1992-4#1)(1995-12#1)(1997-3#1)(2007-12#1)(2012-3#1)
from the air##6##3##(1994-3#1)(1997-2#1)(2008-10#2)(2008-3#2)
from the airway##4##3##(1992-2#2)(1995-12#1)(1997-1#1)
from the airways##3##3##(1997-1#3)
from the alcohol or aldehyde oxidation level##2##7##(2010-7#2)
from the alcohol##4##3##(2009-8#1)(2010-7#2)(2013-8#1)
from the alpha and beta##2##5##(1992-6#1)(2008-10#1)
from the alternative##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
from the ambient##2##3##(2008-11#1)(2008-3#1)
from the amino acid sequences of##2##6##(1993-6#1)(2008-10#1)
from the amino acid##4##4##(1993-6#1)(1994-8#1)(2008-10#2)
from the amino terminus of##2##5##(1992-5#1)(1992-8#1)
from the amino terminus##3##4##(1992-5#1)(1992-8#2)
from the amino##9##3##(1992-5#1)(1992-8#2)(1993-6#1)(1994-6#1)(1994-8#1)(2008-10#2)(2008-11#1)
from the amygdala##2##3##(1993-6#1)(1994-2#1)
from the anaerobic##2##3##(1990-12#1)(1991-12#1)
from the analyses##2##3##(2008-10#2)
from the analysis of##8##4##(2008-10#4)(2010-2#1)(2010-3#1)(2011-8#1)(2013-1#1)
from the analysis were##2##4##(2008-11#2)
from the analysis##16##3##(1993-12#1)(1996-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-8#1)(2013-1#2)
from the analyte solution##2##4##(2008-10#2)
from the analytical##4##3##(2008-10#3)(2010-1#1)
from the aneurysm##2##3##(2008-12#1)(2008-7#1)
from the animal##2##3##(1994-2#1)(1995-8#1)
from the animals##4##3##(1990-12#1)(1990-5#1)(1996-12#1)(2013-1#1)
from the antenna##2##3##(2007-12#2)
from the anterior##7##3##(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
from the aorta##3##3##(1997-1#1)(2007-12#1)(2012-2#1)
from the application of##8##4##(1992-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#2)
from the application##10##3##(1992-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#2)
from the appropriate##2##3##(1996-5#1)(2008-7#1)
from the aquatic##3##3##(2008-10#2)(2010-6#1)
from the aqueous phase##3##4##(2008-10#2)(2008-7#1)
from the aqueous##10##3##(1991-5#1)(2008-10#8)(2008-7#1)
from the area##2##3##(1995-3#1)(2008-11#1)
from the aspect of##3##4##(2008-10#2)(2013-7#1)
from the assumptions of##2##4##(2008-10#1)(2008-9#1)
from the assumptions##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
from the atmosphere##2##3##(2008-2#2)
from the atmospheric##2##3##(2008-2#1)(2008-3#1)
from the atomic##2##3##(1997-2#1)(2007-12#1)
from the author's##5##3##(1992-2#1)(2008-10#1)(2010-3#1)(2012-2#1)(2012-3#1)
from the authors'##5##3##(1992-1#1)(2007-12#1)(2008-10#1)(2008-7#2)
from the available data##3##4##(2007-11#1)(2008-1#1)(2008-11#1)
from the available##6##3##(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
from the axial##2##3##(2008-3#1)(2011-2#1)
from the back##2##3##(2007-12#1)(2008-3#1)
from the background##2##3##(1997-5#1)(2008-9#1)
from the bacterium Cellulomonas fimi##2##5##(1992-11#1)(1995-5#1)
from the bacterium##5##3##(1992-11#1)(1993-9#1)(1995-5#1)(2008-10#1)(2013-1#1)
from the base to the tip of##2##7##(1991-12#1)(2008-10#1)
from the base##4##3##(1991-12#1)(1993-11#1)(2007-11#1)(2008-10#1)
from the baseline##7##3##(1994-6#1)(2007-9#1)(2008-10#1)(2008-7#2)(2010-7#1)(2013-1#1)
from the basement membrane##2##4##(2013-8#2)
from the basic##2##3##(1996-1#1)(1997-2#1)
from the basidiomycete Phanerochaete chrysosporium##2##5##(1991-11#1)(1994-11#1)
from the basidiomycete##3##3##(1991-11#1)(1993-12#1)(1994-11#1)
from the beads##2##3##(2008-10#1)(2008-6#1)
from the beginning of the##4##5##(1997-8#1)(2007-5#1)(2010-10#1)(2010-2#1)
from the beginning of##9##4##(1997-8#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-2#1)(2013-1#1)
from the beginning to the##2##5##(2007-8#1)(2010-1#1)
from the beginning##13##3##(1997-8#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2013-1#1)
from the best##2##3##(2008-10#1)(2008-3#1)
from the beta##2##3##(1991-6#1)(2007-11#1)
from the biliary##2##3##(1992-2#1)(2008-11#1)
from the binary power##2##4##(2008-10#2)
from the binding##2##3##(1990-2#1)(1993-8#1)
from the biocontrol##2##3##(2008-10#2)
from the biological matrix##2##4##(2008-10#1)(2011-2#1)
from the biological##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
from the bioreactor##4##3##(2008-11#3)(2008-7#1)
from the blastocyst##2##3##(2008-10#1)(2008-9#1)
from the blood of##3##4##(1993-12#1)(2011-1#2)
from the blood##13##3##(1990-7#1)(1991-2#1)(1993-12#2)(1993-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
from the body into the brain##2##6##(2009-8#2)
from the body##9##3##(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#2)
from the bond##2##3##(1996-2#1)(1997-7#1)
from the bone##2##3##(2008-11#1)(2010-6#1)
from the bones##2##3##(1995-3#2)
from the border##2##3##(2007-12#1)(2012-2#1)
from the bottom of##2##4##(2008-10#1)(2008-3#1)
from the bottom##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
from the bound##3##3##(1994-8#1)(2008-10#2)
from the brachiopod Lingula reevii##2##5##(1991-10#2)
from the brachiopod Lingula##3##4##(1991-10#3)
from the brain of the##2##5##(1993-5#1)(1996-12#1)
from the brain of##4##4##(1993-5#1)(1995-12#1)(1996-12#1)(1997-3#1)
from the brain##7##3##(1990-12#1)(1993-5#1)(1995-12#1)(1996-12#2)(1997-3#1)(2008-5#1)
from the brush border##2##4##(1990-11#1)(1990-12#1)
from the budding yeast##3##4##(1993-8#2)(1996-6#1)
from the bulk##5##3##(2008-10#2)(2008-6#1)(2008-7#1)(2010-4#1)
from the cDNA##4##3##(1991-2#1)(1991-5#1)(1992-10#1)(1992-8#1)
from the calcium##2##3##(1991-11#1)(2008-9#1)
from the calibration##2##3##(2008-10#2)
from the canopy##2##3##(2008-10#2)
from the case##2##3##(2008-3#1)(2008-6#1)
from the catalytic##3##3##(1992-12#1)(1992-3#1)(2009-7#1)
from the cattle##2##3##(1994-3#1)(2010-4#1)
from the cell body##2##4##(1994-6#1)(2008-11#1)
from the cell membrane##4##4##(1990-11#1)(1990-12#2)(2008-12#1)
from the cell surface##2##4##(1990-12#1)(1994-9#1)
from the cell wall##2##4##(2008-10#1)(2008-5#1)
from the cell##17##3##(1990-11#1)(1990-12#3)(1992-8#1)(1994-6#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-10#1)
from the cell-free##3##3##(1994-6#1)(2008-10#1)(2011-2#1)
from the cells and##2##4##(1994-11#1)(1994-3#1)
from the cells of##2##4##(2008-11#1)(2012-3#1)
from the cells##17##3##(1990-5#1)(1990-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-11#5)(2008-8#1)(2012-3#1)
from the center of##3##4##(2011-2#2)(2013-8#1)
from the center##8##3##(1994-3#1)(1997-3#1)(1997-5#1)(2008-3#1)(2009-6#1)(2011-2#2)(2013-8#1)
from the central Coastal Bend region##2##6##(2008-10#2)
from the central nervous system (CNS)##2##6##(1991-12#1)(2012-3#1)
from the central nervous system##3##5##(1991-12#1)(2008-5#1)(2012-3#1)
from the central##13##3##(1991-12#1)(1994-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
from the centromere##2##3##(1997-3#1)(2008-8#1)
from the cervical##2##3##(2010-8#1)(2011-2#1)
from the cervix##3##3##(1994-2#1)(1996-12#2)
from the chamber##3##3##(2008-10#2)(2008-7#1)
from the changes##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
from the channel walls##2##4##(2008-12#2)
from the characteristics of the##2##5##(1992-5#1)(2008-3#1)
from the chemical##2##3##(2008-10#1)(2013-1#1)
from the chicken##3##3##(1990-8#1)(1991-6#1)(2008-5#1)
from the children##2##3##(1994-6#1)(2008-9#1)
from the chloroplast##3##3##(1990-7#1)(1994-11#1)(2010-6#1)
from the choice of##2##4##(1991-2#1)(2008-3#1)
from the circulation##2##3##(1992-11#1)(2009-12#1)
from the city of##2##4##(1993-3#1)(2008-11#1)
from the classical##5##3##(1990-2#1)(1991-1#1)(1997-8#1)(2008-10#1)(2008-8#1)
from the clinic##2##3##(2008-10#1)(2011-2#1)
from the clinical and##2##4##(1991-6#1)(1991-8#1)
from the clinical##11##3##(1991-6#1)(1991-8#1)(1994-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
from the clinician##2##3##(2008-6#1)(2009-4#1)
from the closely related##3##4##(1991-5#1)(1992-8#1)(2008-5#1)
from the coding##2##3##(1997-4#1)(2013-1#1)
from the coelomic##2##3##(1990-5#1)(2007-6#1)
from the coherent##2##3##(2008-2#1)(2009-5#1)
from the collections##2##3##(2008-10#1)(2008-5#1)
from the column with##4##4##(1990-12#1)(2008-10#3)
from the column##14##3##(1990-12#1)(2008-10#11)(2008-6#2)
from the combination of##3##4##(1997-4#1)(2008-2#1)(2008-3#1)
from the combination##4##3##(1997-4#1)(2008-2#1)(2008-3#1)(2012-3#1)
from the commercial##3##3##(2008-10#2)(2013-7#1)
from the common##8##3##(1991-3#1)(1993-6#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
from the community##2##3##(1992-1#1)(2009-5#1)
from the complete##3##3##(1994-6#1)(1995-2#1)(1997-4#1)
from the complex##6##3##(1993-11#2)(1994-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
from the component##2##3##(1992-6#1)(2008-3#1)
from the concept##3##3##(2012-3#1)(2013-1#2)
from the configuration##2##3##(2007-8#1)(2009-9#1)
from the conjugate##2##3##(2008-7#1)(2010-6#1)
from the consensus##2##3##(1990-5#1)(1991-9#1)
from the contaminated##2##3##(2008-10#1)(2012-3#1)
from the continuous##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
from the contralateral##4##3##(1990-5#1)(1993-12#1)(1996-5#1)(2009-4#1)
from the control group##5##4##(2007-10#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#1)
from the control site##4##4##(2008-7#4)
from the control##13##3##(1992-12#1)(1993-1#1)(1993-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2009-6#1)(2011-2#1)
from the controls##2##3##(1995-12#1)(2008-10#1)
from the conventional##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
from the core to##2##4##(2008-2#1)(2008-8#1)
from the core##4##3##(1997-1#1)(2008-2#1)(2008-8#1)(2011-1#1)
from the coronary##2##3##(1994-11#1)(2008-8#1)
from the correlation time function##2##5##(2008-3#2)
from the correlation##3##3##(2008-10#1)(2008-3#2)
from the corresponding##14##3##(1990-12#1)(1991-9#1)(1994-3#1)(1995-3#1)(2007-11#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
from the cross between##6##4##(2008-10#5)(2012-3#1)
from the cross of the##2##5##(2008-10#2)
from the cross of##6##4##(2008-10#6)
from the cross##30##3##(2007-12#1)(2008-10#25)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
from the crowns of##2##4##(2008-10#1)(2013-1#1)
from the crude##4##3##(1990-2#1)(2008-11#2)(2009-12#1)
from the crystal##2##3##(1992-8#1)(2007-12#1)
from the culture broth of##2##5##(2008-11#1)(2008-12#1)
from the culture medium##6##4##(1993-6#1)(1993-9#1)(1994-6#1)(2008-11#3)
from the culture##14##3##(1990-8#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2010-6#1)
from the cultures##3##3##(2008-10#2)(2008-11#1)
from the current study##3##4##(2007-4#1)(2008-10#1)(2012-2#1)
from the current##10##3##(1995-1#1)(1996-5#1)(2007-4#1)(2008-10#2)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
from the cytosol to the membrane##2##6##(1992-12#1)(1995-11#1)
from the cytosol to the##3##5##(1992-12#1)(1995-11#1)(1997-1#1)
from the cytosol to##5##4##(1992-12#1)(1992-6#1)(1995-11#1)(1997-1#1)(2011-2#1)
from the cytosol##9##3##(1991-12#1)(1992-12#1)(1992-6#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-1#1)(2008-7#1)(2011-2#1)
from the data of the##2##5##(2008-10#1)(2008-3#1)
from the data of##5##4##(1990-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
from the data on##2##4##(1996-4#1)(2007-11#1)
from the data##24##3##(1990-11#1)(1990-8#1)(1991-2#1)(1992-6#1)(1996-3#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-12#3)
from the date of##4##4##(1990-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
from the decay##2##3##(2008-3#1)(2009-8#1)
from the deep##2##3##(1995-3#1)(2008-1#1)
from the deeper##4##3##(2008-3#1)(2008-5#3)
from the deleterious effects of##2##5##(1994-11#2)
from the demodulated##2##3##(2007-12#1)(2008-3#1)
from the demographic##2##3##(1992-5#1)(2010-3#1)
from the dependence of the##2##5##(2008-10#2)
from the desert##2##3##(2008-10#1)(2013-1#1)
from the detailed##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
from the detection##2##3##(2008-10#2)
from the detector##3##3##(2008-2#2)(2008-3#1)
from the developed##2##3##(2008-5#1)(2010-10#1)
from the developing##2##3##(2008-4#1)(2008-7#1)
from the development of##6##4##(1996-6#1)(2008-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2011-1#1)
from the developmental##2##3##(2007-8#1)(2008-3#1)
from the device##3##3##(1997-2#1)(2007-7#1)(2008-9#1)
from the diagnostic##2##3##(1997-8#1)(2011-3#1)
from the difference between the##3##5##(2008-10#2)(2008-9#1)
from the difference in##2##4##(1995-5#1)(2008-2#1)
from the difference##8##3##(1995-5#1)(2008-10#5)(2008-2#1)(2008-9#1)
from the different##11##3##(1990-12#2)(1995-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2013-1#3)
from the digestive##2##3##(2008-10#1)(2008-5#1)
from the dimer##2##3##(1994-8#1)(1995-5#1)
from the dimorphic##2##3##(1991-9#1)(1996-6#1)
from the direct##4##3##(1990-11#1)(1993-12#1)(1994-5#1)(2008-9#1)
from the direction of the##2##5##(2008-3#1)(2009-7#1)
from the direction##3##3##(2008-3#1)(2009-7#1)(2013-8#1)
from the disease##10##3##(1992-6#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)
from the diseased##2##3##(2008-10#2)
from the disk##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
from the distal##4##3##(2007-8#1)(2008-11#1)(2008-6#1)(2008-9#1)
from the distance##2##3##(1996-6#1)(2007-11#1)
from the distinct##2##3##(1995-12#1)(2008-10#1)
from the donor##4##3##(1992-6#1)(1994-5#1)(2008-10#2)
from the dorsal fin##2##4##(2010-8#1)(2013-7#1)
from the dorsal##6##3##(1997-3#1)(2007-12#1)(2008-9#1)(2010-8#1)(2013-7#1)(2013-8#1)
from the drop##2##3##(1991-5#1)(2008-10#1)
from the duodenum to##2##4##(1994-12#1)(2013-1#1)
from the duodenum##3##3##(1994-12#1)(1996-8#1)(2013-1#1)
from the earliest stages of##2##5##(2008-10#1)(2008-7#1)
from the early##6##3##(1990-6#1)(1997-8#2)(2008-11#1)(2008-4#1)(2010-6#1)
from the earthworm##2##3##(2008-5#1)(2011-1#1)
from the east##5##3##(2008-10#2)(2009-12#1)(2009-7#1)(2010-8#1)
from the eastern##3##3##(2008-10#3)
from the edge of the##2##5##(2008-10#1)(2008-5#1)
from the edge of##3##4##(2008-10#2)(2008-5#1)
from the edge##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
from the effect of##4##4##(1990-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
from the effects of##9##4##(1995-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-12#1)
from the egg jelly##2##4##(1992-8#1)(1994-11#1)
from the egg##4##3##(1992-8#1)(1994-11#1)(2007-12#1)(2008-9#1)
from the electric field##2##4##(2007-12#1)(2008-10#1)
from the electrode surface##2##4##(2008-10#2)
from the electrode##5##3##(2008-10#4)(2008-3#1)
from the eluent##2##3##(2008-10#2)
from the embargo##2##3##(1996-11#2)
from the embryo##2##3##(2008-10#1)(2008-11#1)
from the embryonic##2##3##(2008-10#1)(2008-8#1)
from the emergency##3##3##(2007-5#2)(2011-2#1)
from the emission##2##3##(1991-5#1)(2008-3#1)
from the emulsion##2##3##(2008-11#1)(2009-11#1)
from the end of the##3##5##(1992-6#1)(2012-2#2)
from the end of treatment##2##5##(1991-2#1)(2007-8#1)
from the end of##10##4##(1991-2#1)(1992-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#2)
from the end##11##3##(1991-2#1)(1992-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)
from the endogenous##5##3##(1992-9#1)(1996-6#1)(1997-7#1)(1997-8#1)(2010-11#1)
from the endoplasmic reticulum to##2##5##(2008-1#1)(2010-8#1)
from the endoplasmic reticulum##4##4##(2008-1#1)(2009-8#1)(2010-8#1)(2013-1#1)
from the endothelial cell##2##4##(1990-4#1)(1993-6#1)
from the energy##2##3##(1997-7#1)(2008-2#1)
from the entire##4##3##(1993-9#1)(1995-6#1)(2008-10#1)(2010-3#1)
from the environment##9##3##(1994-3#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)
from the enzymatic##3##3##(2008-10#2)(2013-1#1)
from the enzyme##9##3##(1992-11#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#2)
from the epithelium of the##2##5##(2006-12#1)(2007-12#1)
from the epithelium##5##3##(2006-12#1)(2007-12#2)(2008-7#1)(2012-2#1)
from the esophagus##2##3##(2008-5#1)(2010-8#1)
from the estrogen##2##3##(1991-2#1)(2008-11#1)
from the ethanol##2##3##(1993-11#1)(2010-5#1)
from the excipients##4##3##(2008-10#3)(2010-5#1)
from the existing##2##3##(2007-11#1)(2011-1#1)
from the expected##2##3##(2008-10#1)(2008-11#1)
from the experiences of colleagues##2##5##(1990-6#1)(1995-3#1)
from the experiences of##3##4##(1990-6#1)(1991-2#1)(1995-3#1)
from the experiment##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
from the experimental data##2##4##(2007-12#1)(2008-10#1)
from the experimental results##2##4##(2008-10#1)(2010-8#1)
from the experimental##11##3##(2007-12#2)(2008-10#5)(2008-3#2)(2010-8#2)
from the experts##2##3##(2008-4#1)(2010-12#1)
from the exponential##2##3##(2008-7#1)(2011-2#1)
from the exposed##3##3##(2008-12#1)(2008-3#1)(2009-12#1)
from the exposure of##2##4##(1996-12#1)(2008-11#1)
from the external carotid artery##2##5##(2006-12#1)(2008-7#1)
from the external##7##3##(1997-2#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-7#2)
from the extracellular##5##3##(1990-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)
from the extraction##3##3##(1991-12#1)(2008-10#2)
from the extremely##2##3##(1990-7#1)(1993-2#1)
from the eye##2##3##(2007-12#1)(2011-2#1)
from the fact that the##5##5##(1993-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-3#1)
from the fact that##10##4##(1993-6#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2011-3#1)(2012-2#2)
from the family##6##3##(1992-2#1)(2008-10#2)(2011-2#3)
from the federal government##2##4##(1991-1#1)(1992-1#1)
from the federal##3##3##(1991-1#1)(1992-1#1)(2008-10#1)
from the female##4##3##(2008-10#3)(2010-3#1)
from the femoral##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
from the femur##3##3##(1995-6#1)(2008-6#1)(2009-4#1)
from the fermentation broth##2##4##(2008-6#1)(2012-2#1)
from the fern Pteris cretica##2##5##(1994-11#2)
from the fiber##10##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)
from the field of##6##4##(1994-2#1)(1995-1#1)(1997-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
from the field##21##3##(1994-2#1)(1995-1#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
from the fields of public##2##5##(1996-3#1)(2009-5#1)
from the fields of##3##4##(1996-3#1)(2006-4#1)(2009-5#1)
from the filamentous##2##3##(1992-12#1)(1995-6#1)
from the files of the##2##5##(1990-2#1)(2008-12#1)
from the files of##3##4##(1990-2#1)(1997-8#1)(2008-12#1)
from the filtrate ranged from##2##5##(2008-10#2)
from the final##2##3##(1994-6#1)(2010-10#1)
from the findings##2##3##(1995-1#1)(2008-10#1)
from the fingernails of##2##4##(2010-5#2)
from the first day of##2##5##(1992-5#1)(1993-12#1)
from the first round##2##4##(1991-6#2)
from the first to the second##3##6##(1990-8#1)(1991-6#1)(2010-3#1)
from the first to the##4##5##(1990-8#1)(1991-6#1)(2008-12#1)(2010-3#1)
from the first two##2##4##(2008-10#2)
from the first##31##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-6#4)(1992-5#1)(1992-6#2)(1993-12#1)(1994-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
from the first-order##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
from the fission yeast Schizosaccharomyces pombe##2##6##(1995-2#1)(1995-8#1)
from the five##3##3##(2008-10#2)(2008-11#1)
from the floor##4##3##(1997-2#3)(2008-7#1)
from the flow##4##3##(1995-3#1)(2008-10#3)
from the fluorescence quenching##2##4##(2008-10#1)(2008-8#1)
from the fluorescence##3##3##(1994-8#1)(2008-10#1)(2008-8#1)
from the flux##2##3##(1997-5#1)(2008-10#1)
from the foam##2##3##(2007-12#1)(2008-6#1)
from the focus##4##3##(2008-10#3)(2012-3#1)
from the forearm##2##3##(2008-9#1)(2011-2#1)
from the forehead##2##3##(2007-12#1)(2008-5#1)
from the forelimbs##2##3##(2011-2#2)
from the forest##2##3##(2008-11#1)(2008-6#1)
from the formation of##2##4##(1991-12#1)(1996-12#1)
from the former##5##3##(1993-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2011-2#1)
from the four##8##3##(1991-6#1)(1992-1#1)(2008-10#5)(2008-11#1)
from the frequency##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
from the fringe##3##3##(2008-2#1)(2008-3#2)
from the front lines##2##4##(1994-1#1)(1996-12#1)
from the front##3##3##(1994-1#1)(1996-12#1)(1997-4#1)
from the fruit of Gardenia jasminoides##2##6##(2013-1#2)
from the fruit of##3##4##(2008-9#1)(2013-1#2)
from the fruit##5##3##(2008-10#1)(2008-9#1)(2013-1#3)
from the fruits of##3##4##(2008-11#1)(2010-3#1)(2012-3#1)
from the fruits##5##3##(2008-11#3)(2010-3#1)(2012-3#1)
from the full##2##3##(2008-10#1)(2008-3#1)
from the fungal##2##3##(2008-10#1)(2008-4#1)
from the future##3##3##(1996-2#1)(2008-7#1)(2012-2#1)
from the ganglia of##2##4##(1990-2#1)(1991-5#1)
from the gastrointestinal tract##2##4##(2011-1#1)(2012-2#1)
from the gastrointestinal##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
from the gel##2##3##(2008-10#1)(2008-11#1)
from the gene family##2##4##(2008-8#1)(2010-6#1)
from the gene##9##3##(1992-9#1)(1993-2#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-6#1)
from the general population##3##4##(1992-2#1)(2008-3#1)(2008-7#1)
from the general##12##3##(1990-11#1)(1991-12#1)(1992-2#1)(1995-5#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)
from the generation of the##2##5##(2007-12#1)(2011-2#1)
from the generation of##3##4##(1991-2#1)(2007-12#1)(2011-2#1)
from the genetic##5##3##(2008-10#3)(2008-5#1)(2008-6#1)
from the genome of##2##4##(1994-12#1)(2009-3#1)
from the genomic##3##3##(1991-9#1)(1996-6#1)(1997-7#1)
from the genomics##2##3##(2008-10#1)(2010-12#1)
from the genus##6##3##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
from the geometric##3##3##(2008-3#2)(2008-6#1)
from the global##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
from the government##2##3##(1996-2#1)(2008-11#1)
from the grating##4##3##(2007-11#1)(2008-3#3)
from the green##3##3##(1996-2#2)(2008-10#1)
from the ground to##2##4##(2008-3#2)
from the ground##7##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)
from the group of##3##4##(1994-5#1)(2008-10#1)(2012-3#1)
from the groups##2##3##(1994-3#1)(2012-12#1)
from the growth medium##2##4##(1990-6#1)(2008-10#1)
from the growth##5##3##(1990-6#1)(1995-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
from the gut and##2##4##(2008-10#1)(2008-5#1)
from the gut##6##3##(2007-12#2)(2008-10#3)(2008-5#1)
from the hair##3##3##(2008-5#3)
from the hands##2##3##(1997-5#1)(2008-5#1)
from the head to the tail##2##6##(2011-1#2)
from the head##4##3##(2008-7#1)(2011-1#2)(2012-2#1)
from the heads##2##3##(2008-3#1)(2008-5#1)
from the health authorities##2##4##(1994-6#1)(2012-12#1)
from the health care##3##4##(1995-12#1)(1996-12#1)(2010-10#1)
from the health##8##3##(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-11#1)(2010-10#1)(2012-12#1)(2013-1#1)
from the healthy##2##3##(1994-5#1)(2013-1#1)
from the heart##8##3##(1990-12#1)(2007-10#2)(2007-12#1)(2008-12#1)(2009-3#1)(2011-1#1)(2013-1#1)
from the hemolymph of coleopteran##2##5##(1997-2#2)
from the hemolymph of##3##4##(1990-5#1)(1997-2#2)
from the hemolymph##7##3##(1990-5#1)(1997-2#2)(2007-12#1)(2008-6#1)(2008-7#2)
from the high##9##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
from the higher##2##3##(2008-2#1)(2011-2#1)
from the highly##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
from the hippocampus##2##3##(1992-7#1)(2008-11#1)
from the historical##2##3##(2008-6#1)(2012-3#1)
from the honeybee##2##3##(2008-7#1)(2008-8#1)
from the horizontal##2##3##(1993-1#1)(2008-5#1)
from the hospital##14##3##(1991-12#1)(1991-3#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#1)(2008-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#2)
from the host cell##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#2)
from the host##14##3##(1997-4#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#2)(2013-1#1)
from the human##17##3##(1991-9#3)(1992-11#1)(1993-6#1)(1994-8#1)(1995-2#2)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
from the hybrid##3##3##(2007-11#1)(2008-10#2)
from the hybrids##2##3##(2008-10#1)(2008-9#1)
from the hydrolysis of##2##4##(1992-12#1)(2009-12#1)
from the hyperthermophilic##4##3##(1993-9#1)(1994-12#2)(2008-9#1)
from the hypothalamus##2##3##(1993-12#1)(1997-2#1)
from the ideal##6##3##(2008-10#1)(2008-2#3)(2008-3#1)(2009-11#1)
from the image data##2##4##(2011-2#1)(2012-3#1)
from the image##5##3##(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
from the imaging##2##3##(2008-3#1)(2012-2#1)
from the immobilized##2##3##(2008-10#1)(2008-11#1)
from the immune##4##3##(1993-3#1)(1997-8#1)(2008-3#1)(2008-4#1)
from the immunized mice##2##4##(2008-11#1)(2008-9#1)
from the immunized##3##3##(2008-11#1)(2008-9#2)
from the implementation of##3##4##(1991-3#1)(1995-3#1)(2008-12#1)
from the implementation##4##3##(1991-3#1)(1995-3#1)(1997-2#1)(2008-12#1)
from the in situ##3##4##(2007-5#1)(2008-10#1)(2008-3#1)
from the in vitro##3##4##(1993-9#1)(2008-11#2)
from the in##7##3##(1993-9#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
from the inability to##2##4##(2008-6#1)(2008-7#1)
from the inclusion##2##3##(2008-10#1)(2008-9#1)
from the increase in##2##4##(1990-11#1)(1991-5#1)
from the increased##2##3##(1995-6#1)(2007-11#1)
from the incubation medium##2##4##(1995-11#2)
from the incubation##4##3##(1991-3#1)(1994-6#1)(1995-11#2)
from the index##2##3##(2008-6#1)(2008-7#1)
from the individual##5##3##(1991-12#1)(2007-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
from the induced grating##2##4##(2007-11#2)
from the induction of##2##4##(1993-9#1)(1995-3#1)
from the infected##2##3##(2008-10#2)
from the inferior##5##3##(2007-8#1)(2008-11#3)(2013-1#1)
from the inhibition of##2##4##(1995-12#1)(2008-10#1)
from the initial isolates##2##4##(2008-10#2)
from the initial##8##3##(1993-12#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
from the initiation of##5##4##(2008-10#1)(2008-5#2)(2010-8#1)(2011-2#1)
from the initiation##6##3##(2008-10#1)(2008-11#1)(2008-5#2)(2010-8#1)(2011-2#1)
from the injected##2##3##(2008-10#2)
from the injection site##2##4##(1996-12#1)(2008-8#1)
from the injection##5##3##(1990-7#1)(1996-12#1)(1997-2#1)(2008-8#1)(2008-9#1)
from the inner walls of##2##5##(2008-10#2)
from the inner##9##3##(1990-11#1)(1991-5#1)(2008-10#4)(2008-5#2)(2008-9#1)
from the inoculated leaf##2##4##(2008-10#2)
from the inoculated##6##3##(2008-10#5)(2008-5#1)
from the inoculation site##2##4##(2008-10#2)
from the inoculation##3##3##(2008-10#3)
from the inoculum source##3##4##(2008-10#3)
from the inside##3##3##(1996-2#1)(2008-8#1)(2013-7#1)
from the insoluble##2##3##(1994-11#1)(1997-4#1)
from the instrument##2##3##(2008-3#2)
from the intact##3##3##(1991-5#1)(1992-3#1)(2008-9#1)
from the integration##2##3##(1997-1#1)(2008-4#1)
from the intensity##2##3##(2008-2#1)(2008-3#1)
from the interaction of genetic##2##5##(2009-10#1)(2013-1#1)
from the interaction of##8##4##(1992-8#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
from the interaction##10##3##(1992-8#1)(1994-3#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
from the interference of##6##4##(2008-10#5)(2008-3#1)
from the interference##9##3##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)
from the intermediate##4##3##(1993-5#2)(2008-10#1)(2010-10#1)
from the internal transcribed spacer##3##5##(2008-10#3)
from the internal##4##3##(2008-10#3)(2008-8#1)
from the international##2##3##(2007-12#1)(2010-10#1)
from the interplay between##3##4##(2007-12#1)(2008-6#1)(2011-1#1)
from the interstitial##2##3##(1997-3#1)(2008-6#1)
from the interview##3##3##(2006-10#1)(2007-10#1)(2011-1#1)
from the interviews were##2##4##(2008-12#1)(2011-1#1)
from the interviews##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
from the intestinal##2##3##(2011-2#2)
from the ipsilateral##5##3##(1993-12#1)(1995-12#1)(2006-12#1)(2010-3#1)(2013-8#1)
from the iron##3##3##(1990-3#2)(1994-5#1)
from the isolated##5##3##(1990-12#1)(1991-2#1)(2008-11#1)(2008-2#1)(2012-12#1)
from the isolates##2##3##(2008-5#1)(2011-1#1)
from the jellyfish Aequorea victoria##2##5##(1996-6#1)(2008-10#1)
from the kidney and##2##4##(1994-5#1)(2008-7#1)
from the kidney##5##3##(1992-3#1)(1994-5#1)(2008-7#1)(2011-2#2)
from the kidneys##2##3##(1997-1#1)(1997-6#1)
from the known##5##3##(1992-8#1)(1993-6#1)(1993-8#1)(2008-3#1)(2008-7#1)
from the laboratory and##2##4##(2008-10#1)(2008-2#1)
from the laboratory##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
from the labral##2##3##(2007-12#2)
from the lack of##2##4##(2011-2#2)
from the lag##2##3##(1990-7#1)(2011-2#1)
from the lamellar##2##3##(1990-12#1)(2012-2#1)
from the lamp##2##3##(2008-11#1)(2008-2#1)
from the large volume of##2##5##(2008-10#2)
from the large##6##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)
from the larger##2##3##(1991-6#1)(2008-11#1)
from the largest##3##3##(1993-9#1)(1994-11#1)(2007-12#1)
from the laser crystal##2##4##(2008-3#2)
from the laser##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
from the laser-heated##2##3##(2008-2#1)(2008-3#1)
from the last##3##3##(1992-6#1)(1997-6#1)(2008-10#1)
from the lateral##5##3##(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
from the latter##2##3##(2007-11#1)(2012-2#1)
from the law##2##3##(1990-7#1)(1996-3#1)
from the leading##2##3##(2008-4#1)(2009-6#1)
from the leaf##6##3##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
from the leaves of Morus alba##2##6##(2011-3#2)
from the leaves of##12##4##(1990-11#2)(2008-11#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#2)
from the left arm of yeast chromosome##2##7##(1996-3#1)(1996-6#1)
from the left arm of##5##5##(1995-6#1)(1995-9#1)(1996-3#2)(1996-6#1)
from the left sinus of Valsalva##2##6##(2007-8#2)
from the left ventricle##2##4##(2007-7#1)(2010-6#1)
from the left##25##3##(1990-5#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-6#1)(2007-7#2)(2007-8#3)(2008-3#2)(2008-6#3)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-2#1)
from the lens##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
from the lessons##2##3##(2007-5#1)(2008-12#1)
from the levels##2##3##(1993-6#1)(2011-2#1)
from the library##2##3##(1994-8#1)(2008-10#1)
from the lidar data##2##4##(2008-3#2)
from the lidar##6##3##(2008-2#1)(2008-3#5)
from the light source##3##4##(1993-3#1)(2008-2#1)(2008-3#1)
from the liquid##4##3##(2008-10#3)(2008-11#1)
from the literature and##3##4##(2008-10#1)(2009-5#1)(2012-3#1)
from the literature are##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
from the literature for##2##4##(1992-12#1)(2008-3#1)
from the literature on##3##4##(1991-2#1)(2008-9#1)(2009-5#1)
from the literature to##2##4##(2008-11#2)
from the literature##43##3##(1990-6#1)(1991-12#2)(1991-2#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1997-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2012-1#1)(2012-3#2)
from the liver and##2##4##(1991-12#1)(1995-9#1)
from the liver to##2##4##(2008-5#1)(2010-11#1)
from the liver##12##3##(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1995-9#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-5#1)
from the loading##2##3##(2008-10#2)
from the local population##3##4##(2008-10#2)(2008-7#1)
from the local##5##3##(2008-10#3)(2008-7#1)(2008-8#1)
from the locus##2##3##(2008-10#1)(2008-7#1)
from the logarithm##2##3##(2007-12#1)(2008-3#1)
from the logistic regression##2##4##(2008-10#1)(2013-1#1)
from the logistic##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
from the loss of##3##4##(1990-8#1)(1994-3#1)(2008-3#1)
from the lower##10##3##(1992-12#1)(1996-12#1)(1996-4#1)(2008-3#2)(2008-6#1)(2008-7#3)(2013-8#1)
from the lumbar##2##3##(2008-7#1)(2011-2#1)
from the lumen##2##3##(1997-1#1)(2007-12#1)
from the luminescent##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
from the lung##4##3##(1991-12#2)(2010-3#2)
from the lungs##3##3##(1991-8#1)(1997-1#1)(2008-10#1)
from the lymphocytes##2##3##(2008-10#1)(2011-2#1)
from the lysate##2##3##(1997-1#1)(2008-4#1)
from the main##10##3##(1991-6#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)
from the major##2##3##(2008-10#1)(2009-3#1)
from the male##4##3##(2008-10#2)(2008-7#2)
from the mammary##2##3##(1990-11#1)(2008-10#1)
from the many##2##3##(2008-11#1)(2010-10#1)
from the marine environment##2##4##(1994-9#1)(2008-10#1)
from the marine##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
from the marine-derived Pichia guilliermondii##2##5##(2011-1#2)
from the mass##2##3##(1995-11#1)(2010-5#1)
from the maternal##2##3##(1992-4#1)(2008-10#1)
from the matrix and##2##4##(2008-10#2)
from the matrix##8##3##(2008-10#5)(2010-5#1)(2013-1#1)(2013-7#1)
from the mature##3##3##(1990-12#1)(1991-10#1)(2008-5#1)
from the mean##7##3##(1991-5#1)(1995-8#1)(1996-7#1)(2007-7#2)(2008-10#1)(2009-11#1)
from the measured data##2##4##(2008-10#1)(2008-3#1)
from the measured##18##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#9)(2008-5#1)
from the measurement of##3##4##(2008-10#2)(2008-3#1)
from the measurement##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
from the measurements##3##3##(2008-3#3)
from the mechanisms##2##3##(2009-8#2)
from the medial border of##2##5##(2007-10#1)(2012-12#1)
from the medial superior olivary nucleus##2##6##(1997-3#2)
from the medial##9##3##(1994-3#1)(1995-12#1)(1997-3#2)(2007-10#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
from the medical##7##3##(1992-4#2)(1996-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
from the medium##5##3##(1992-11#1)(1992-5#1)(2008-10#1)(2008-6#2)
from the membrane by##2##4##(1993-11#1)(1994-8#1)
from the membrane##10##3##(1991-5#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
from the mental##2##3##(1995-5#1)(2012-12#1)
from the mesenchyme##2##3##(1993-3#1)(1995-8#1)
from the mesenteric##3##3##(1992-3#2)(2008-5#1)
from the metabolic##2##3##(1994-8#1)(2008-7#1)
from the mid point of the humerus##2##7##(2013-8#2)
from the middle##7##3##(2007-5#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#3)
from the migration##2##3##(2008-10#1)(2008-5#1)
from the minicolumn##3##3##(2008-10#3)
from the minute##2##3##(2007-12#1)(2008-3#1)
from the mitochondrial##2##3##(2007-12#1)(2008-6#1)
from the mixed##2##3##(1994-12#1)(2011-1#1)
from the mixing##2##3##(2007-11#1)(2008-3#1)
from the mixture##3##3##(1990-5#1)(2008-10#2)
from the model##16##3##(1990-8#1)(1994-7#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-7#1)(2008-8#1)(2012-3#1)
from the molecular##7##3##(1992-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2012-2#1)
from the monitoring##2##3##(2008-10#1)(2008-7#1)
from the monolayer##2##3##(1994-6#1)(2008-10#1)
from the monomeric##2##3##(1990-2#1)(2009-12#1)
from the more common##3##4##(1992-5#1)(1997-8#1)(2010-1#1)
from the more##11##3##(1992-5#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-2#3)(2010-1#1)(2010-3#1)(2013-8#1)
from the moss Physcomitrella patens##2##5##(2010-2#2)
from the most recent##2##4##(1991-12#1)(2008-8#1)
from the most##14##3##(1991-12#1)(1992-2#1)(1996-3#1)(1996-6#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
from the mouse##9##3##(1991-12#1)(1991-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(2008-2#1)(2008-4#1)(2010-11#1)
from the mtDNA##2##3##(1997-2#1)(2010-8#1)
from the municipal##2##3##(1993-3#1)(2008-10#1)
from the mycelial##2##3##(2008-10#1)(2008-5#1)
from the myocardium##2##3##(1996-9#1)(2008-7#1)
from the national##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
from the native##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2009-8#1)
from the nearest##2##3##(2008-10#1)(2011-1#1)
from the need for##2##4##(2008-2#1)(2009-11#1)
from the need##3##3##(1995-2#1)(2008-2#1)(2009-11#1)
from the neighboring##2##3##(2008-8#1)(2009-7#1)
from the nematode##2##3##(1992-9#1)(1996-6#1)
from the neural##2##3##(1994-12#1)(2008-11#1)
from the neutral##2##3##(2008-10#2)
from the new##5##3##(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)
from the nine-banded armadillo##2##4##(2008-5#2)
from the nonreducing terminal##2##4##(1994-5#2)
from the normal##11##3##(1990-7#1)(1993-11#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)
from the north##3##3##(2008-10#2)(2008-7#1)
from the northern##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
from the nuclear##5##3##(1997-7#1)(2008-10#2)(2008-11#1)(2010-6#1)
from the nucleation##2##3##(1996-4#1)(2008-3#1)
from the nucleotide sequence data##5##5##(1992-3#1)(1997-6#4)
from the nucleotide sequence of the##6##6##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1991-9#1)(1994-12#1)
from the nucleotide sequence of##7##5##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-9#1)
from the nucleotide sequence##14##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#4)
from the nucleotide sequences##2##4##(1990-5#1)(1996-8#1)
from the nucleotide##16##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-9#1)(1996-8#1)(1997-4#1)(1997-6#4)
from the nucleus in##2##4##(2008-7#1)(2011-2#1)
from the nucleus to the cytoplasm##3##6##(1992-3#1)(1993-9#1)(2011-2#1)
from the nucleus to the##4##5##(1992-3#1)(1993-9#1)(2009-10#1)(2011-2#1)
from the nucleus##8##3##(1992-3#1)(1993-9#1)(1995-12#1)(2007-8#1)(2008-7#1)(2009-10#1)(2011-2#2)
from the null##2##3##(2008-10#1)(2008-8#1)
from the number of##4##4##(1990-5#1)(1990-8#1)(1990-9#1)(2011-2#1)
from the number##5##3##(1990-5#1)(1990-8#1)(1990-9#1)(2008-3#1)(2011-2#1)
from the nurse cells to the oocyte##2##7##(2007-12#1)(2008-10#1)
from the nursing##2##3##(2007-10#1)(2008-12#1)
from the object##2##3##(2008-2#1)(2008-3#1)
from the observed##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
from the occiput to C2##2##5##(2012-3#2)
from the occurrence of##2##4##(2007-12#1)(2008-8#1)
from the ocean##4##3##(1996-4#1)(2008-2#1)(2008-3#2)
from the oil##2##3##(2008-10#2)
from the old##3##3##(1994-5#1)(1995-2#1)(2007-12#1)
from the olfactory nerve##2##4##(1995-12#1)(2008-5#1)
from the on-line##2##3##(2008-11#2)
from the one##2##3##(2008-10#1)(2011-2#1)
from the ones##4##3##(2008-10#2)(2010-8#1)(2011-2#1)
from the ongoing##3##3##(1996-2#1)(2008-5#1)(2012-2#1)
from the onset of##5##4##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
from the onset##6##3##(1990-12#1)(1994-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
from the open##2##3##(2008-11#1)(2008-5#1)
from the opening of##2##4##(2008-1#1)(2008-6#1)
from the operating##2##3##(2008-6#1)(2008-9#1)
from the operation##3##3##(1993-9#1)(2007-11#2)
from the operative field##2##4##(1995-1#1)(2007-8#1)
from the operative##3##3##(1995-1#1)(2007-8#2)
from the optical##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
from the optimum##2##3##(2008-3#1)(2008-8#1)
from the oral cavity##3##4##(2008-5#1)(2012-1#2)
from the oral##6##3##(1997-4#1)(2008-5#1)(2012-1#2)(2012-12#2)
from the orchard##2##3##(2008-10#2)
from the organic phase was stripped with##2##7##(2008-10#2)
from the organic phase##4##4##(2008-10#4)
from the organic##5##3##(2008-10#5)
from the organism##2##3##(1995-5#1)(2008-11#1)
from the original##6##3##(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#3)
from the other species##2##4##(2008-10#1)(2008-6#1)
from the other##32##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-5#1)(1994-5#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
from the others##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
from the outer to the inner mitochondrial membrane##2##8##(1996-2#1)(2012-2#1)
from the outer##11##3##(1991-2#1)(1992-6#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
from the outpatient department of##2##5##(1996-12#1)(1997-3#1)
from the output##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
from the outset##3##3##(1993-1#1)(2008-10#1)(2010-2#1)
from the outside##2##3##(2008-10#2)
from the ovary##2##3##(2010-5#1)(2012-1#1)
from the oxidation of luminol##2##5##(2008-10#2)
from the oxidation of##8##4##(1995-2#1)(2008-10#6)(2008-5#1)
from the oxidative burst##2##4##(1995-6#2)
from the oxidative##3##3##(1995-6#2)(2008-10#1)
from the pancreatic##2##3##(1991-12#1)(2009-7#1)
from the parental##4##3##(1991-4#1)(1991-6#1)(2008-10#1)(2008-9#1)
from the parents##3##3##(2008-10#2)(2008-9#1)
from the parietal##2##3##(2007-5#1)(2008-5#1)
from the partial##2##3##(2008-10#2)
from the participating##2##3##(2008-10#1)(2008-12#1)
from the past for##2##4##(2008-10#1)(2008-12#1)
from the past##11##3##(1992-5#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2012-3#1)
from the pathogenic##2##3##(2008-10#2)
from the pathologist's perspective##2##4##(2010-3#2)
from the patient##15##3##(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
from the patient's perspective##2##4##(2008-12#1)(2012-3#1)
from the patient's##9##3##(1990-12#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
from the patients##5##3##(1992-11#1)(1993-12#1)(1994-11#1)(2008-10#1)(2013-8#1)
from the peak of##2##4##(1990-11#1)(2007-8#1)
from the peak##6##3##(1990-11#1)(2007-8#1)(2008-10#3)(2008-3#1)
from the perception of##2##4##(2011-2#1)(2012-2#1)
from the perception##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
from the perfused##2##3##(1990-11#1)(1991-5#1)
from the perfusion##2##3##(2008-11#1)(2008-6#1)
from the period##3##3##(1993-6#1)(2007-11#1)(2008-1#1)
from the peripheral blood of##3##5##(1996-12#2)(2011-1#1)
from the peripheral##6##3##(1990-11#1)(1993-6#1)(1996-12#2)(2011-1#1)(2012-2#1)
from the periphery to the##2##5##(1990-2#1)(2008-7#1)
from the periphery##6##3##(1990-2#1)(1991-11#1)(2008-7#4)
from the permanent##2##3##(1996-12#1)(2009-8#1)
from the perspective of a##3##5##(1994-1#1)(1994-12#1)(2008-1#1)
from the perspective of both##2##5##(1996-3#1)(2007-11#1)
from the perspective of the##6##5##(1993-12#1)(2007-11#1)(2008-11#2)(2008-7#1)(2012-3#1)
from the perspective of##33##4##(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2007-11#2)(2007-8#1)(2008-1#5)(2008-11#4)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#3)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
from the perspectives of##4##4##(2008-12#2)(2008-3#1)(2013-8#1)
from the pharmaceutical##3##3##(2008-10#2)(2008-5#1)
from the phase diagram##2##4##(2008-5#2)
from the phase of##2##4##(2008-2#1)(2008-3#1)
from the phase##8##3##(2007-11#1)(2008-2#2)(2008-3#3)(2008-5#2)
from the phosphopeptidomannan of##2##4##(1991-12#2)
from the phosphor##2##3##(2008-10#1)(2008-3#1)
from the phylum##2##3##(1992-6#1)(2011-2#1)
from the physical##2##3##(2008-3#1)(2012-2#1)
from the physician##2##3##(1991-6#1)(1994-1#1)
from the pilot study##2##4##(2007-8#1)(2012-2#1)
from the pilot##3##3##(1994-5#1)(2007-8#1)(2012-2#1)
from the plant##6##3##(1993-3#1)(1997-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
from the plants##2##3##(2008-10#2)
from the plasma membrane to the##2##6##(1990-11#1)(2009-2#1)
from the plasma membrane##5##4##(1990-11#1)(1990-12#1)(1992-3#1)(1995-2#1)(2009-2#1)
from the plasma##7##3##(1990-11#2)(1990-12#1)(1992-3#1)(1995-2#1)(2009-2#1)(2012-2#1)
from the plate##2##3##(2008-10#1)(2008-8#1)
from the point of view of the##5##7##(1992-11#1)(1992-3#1)(1994-2#1)(1995-11#1)(2008-7#1)
from the point of view of their##2##7##(1994-3#1)(2008-10#1)
from the point of view of##20##6##(1990-3#1)(1991-2#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-7#1)(2009-12#1)(2009-9#1)(2013-8#2)
from the point of##22##4##(1990-3#1)(1991-2#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-7#1)(2009-12#1)(2009-9#1)(2013-8#2)
from the point##24##3##(1990-3#1)(1991-2#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-7#2)(2009-12#1)(2009-9#1)(2013-8#2)
from the pollen##2##3##(1996-5#1)(2008-9#1)
from the polymer matrix and##2##5##(2007-12#1)(2009-12#1)
from the population##9##3##(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
from the porcine##3##3##(1990-12#1)(1990-2#1)(2009-7#1)
from the portion of##2##4##(1997-6#1)(2008-7#1)
from the position##2##3##(1994-12#1)(2008-3#1)
from the positive##2##3##(1992-6#1)(2011-1#1)
from the possibility of##2##4##(2008-10#1)(2011-2#1)
from the posterior##5##3##(1991-6#1)(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
from the potential##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
from the power##2##3##(2007-12#1)(2012-2#1)
from the prefrontal##2##3##(2008-10#1)(2008-11#1)
from the presence of the##2##5##(2008-10#1)(2008-3#1)
from the presence of##6##4##(1991-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
from the present study##3##4##(1992-8#1)(2008-10#1)(2008-12#1)
from the present##7##3##(1990-10#1)(1992-7#1)(1992-8#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
from the previous##13##3##(1994-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
from the previously described##2##4##(2008-10#2)
from the previously##5##3##(2007-11#1)(2008-10#4)
from the primary care perspective]##2##5##(1990-9#1)(1995-11#1)
from the primary care##3##4##(1990-9#1)(1993-6#1)(1995-11#1)
from the primary tumor##2##4##(2012-12#1)(2013-1#1)
from the primary##14##3##(1990-9#1)(1993-6#1)(1994-8#1)(1995-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
from the primate##2##3##(1995-5#2)
from the probe##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
from the procedure##5##3##(2007-7#1)(2007-8#1)(2008-10#3)
from the production of##2##4##(2008-10#1)(2008-12#1)
from the production##4##3##(2008-10#2)(2008-12#1)(2008-4#1)
from the products##3##3##(1991-9#1)(1994-12#1)(2010-12#1)
from the program##2##3##(1991-1#1)(2008-11#1)
from the promoter##2##3##(1990-5#1)(1997-4#1)
from the proposed##2##3##(2008-10#2)
from the prospective payment system##2##5##(1992-2#1)(2008-11#1)
from the protein##6##3##(1990-5#1)(1990-8#2)(1992-8#1)(1994-8#1)(1997-2#1)
from the protozoan##3##3##(1993-9#2)(2009-7#1)
from the proximal##2##3##(1997-8#1)(2008-5#1)
from the public health##2##4##(2008-7#1)(2010-12#1)
from the public##5##3##(1997-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
from the published literature##3##4##(1996-2#1)(2010-12#2)
from the published##5##3##(1994-12#2)(1996-2#1)(2010-12#2)
from the pulmonary artery##2##4##(2008-12#1)(2010-5#1)
from the pulmonary##3##3##(2008-12#1)(2010-5#1)(2013-8#1)
from the pure drug##2##4##(2008-10#2)
from the purified##6##3##(1994-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
from the purple##3##3##(1993-8#1)(2009-9#1)(2011-2#1)
from the putative##4##3##(1992-12#1)(1993-12#1)(1994-11#1)(2008-10#1)
from the quantitative##4##3##(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
from the quantum##2##3##(2007-12#1)(2009-6#1)
from the random##2##3##(1997-6#1)(2008-3#1)
from the rank##2##3##(1993-2#1)(2009-4#1)
from the rat##8##3##(1991-9#1)(1993-6#1)(1996-5#1)(1997-2#1)(2008-8#3)(2008-9#1)
from the rattlesnake##2##3##(1992-8#1)(1994-6#1)
from the raw##2##3##(1994-3#1)(2011-2#1)
from the reaction between##4##4##(1990-5#1)(2008-10#3)
from the reaction mixture##2##4##(2008-10#1)(2008-8#1)
from the reaction of##8##4##(1996-5#1)(2007-11#1)(2008-10#5)(2013-1#1)
from the reaction##16##3##(1990-5#1)(1996-5#1)(2007-11#1)(2008-10#10)(2008-7#1)(2008-8#1)(2013-1#1)
from the rear surface##2##4##(2007-12#2)
from the rear##3##3##(2007-12#3)
from the recent##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
from the recently##2##3##(1997-7#1)(2008-10#1)
from the receptor##3##3##(1995-11#1)(1996-5#1)(2008-4#1)
from the record of##2##4##(1995-3#1)(2007-11#1)
from the recorded##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
from the red alga##2##4##(2008-10#1)(2008-11#1)
from the reduced##2##3##(1995-2#1)(1995-5#1)
from the reduction##2##3##(1991-5#1)(1992-5#1)
from the reference##6##3##(1993-2#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#2)
from the referral##2##3##(1995-10#1)(2007-8#1)
from the reflected##2##3##(2007-12#1)(2008-3#1)
from the reflection##2##3##(2007-12#1)(2008-3#1)
from the refractive-index##2##3##(2008-3#2)
from the region to##2##4##(2008-4#1)(2008-8#1)
from the region##6##3##(1991-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-1#1)
from the related##2##3##(1994-6#1)(2008-10#1)
from the relationship between the##2##5##(2008-10#1)(2010-4#1)
from the remaining##4##3##(2008-10#4)
from the removal of nonpolar and polar surface from water##2##10##(1992-5#2)
from the renal##2##3##(1990-11#1)(2008-1#1)
from the reported##2##3##(1997-7#1)(2008-10#1)
from the requirement##2##3##(1997-8#1)(2008-3#1)
from the research##7##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-12#1)(2012-12#1)
from the resin column##2##4##(2008-10#2)
from the resin##6##3##(2008-10#6)
from the resistance##2##3##(2011-2#1)(2012-3#1)
from the resistant##4##3##(2008-10#4)
from the respiratory tract##2##4##(2007-7#1)(2011-1#1)
from the rest of the##6##5##(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
from the result of##2##4##(2008-5#1)(2009-12#1)
from the result##4##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)
from the resulting##2##3##(1991-9#1)(2008-8#1)
from the results obtained##5##4##(2007-11#1)(2008-10#2)(2008-5#2)
from the results of##9##4##(1990-11#1)(1993-3#1)(1994-5#1)(2008-10#2)(2008-2#2)(2008-4#2)
from the results##17##3##(1990-11#1)(1993-3#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-5#3)(2010-2#1)
from the retina##5##3##(1993-9#1)(1994-5#1)(2008-3#1)(2008-5#1)(2011-1#1)
from the retinal##2##3##(1993-12#1)(2011-2#1)
from the rhizosphere of wheat##2##5##(2008-10#2)
from the rhizosphere of##3##4##(2008-10#3)
from the rhizosphere##4##3##(2008-10#4)
from the rice##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
from the right aortic sinus of valsalva##2##7##(2007-8#2)
from the right arm of Saccharomyces cerevisiae chromosome VII##2##9##(1996-3#1)(1997-3#1)
from the right arm of Saccharomyces cerevisiae chromosome##3##8##(1996-3#1)(1997-3#2)
from the right arm of##4##5##(1996-3#2)(1997-3#2)
from the right##16##3##(1990-5#1)(1996-3#2)(1996-9#2)(1997-3#3)(2007-8#3)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)(2013-8#1)
from the river Danube in Hungary##2##6##(2008-10#2)
from the river##5##3##(2008-10#4)(2010-8#1)
from the root canal##2##4##(2008-7#1)(2013-1#1)
from the root to the distal end##2##7##(2008-5#2)
from the root to##3##4##(2008-5#3)
from the root##9##3##(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#1)(2013-1#1)(2013-8#1)
from the roots of Derris by high-speed counter-current##2##8##(2011-1#2)
from the roots of##8##4##(1990-11#2)(2008-10#3)(2010-6#1)(2011-1#2)
from the roots##10##3##(1990-11#2)(2008-10#4)(2008-11#1)(2010-6#1)(2011-1#2)
from the rough##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
from the saline##2##3##(2008-10#1)(2013-8#1)
from the same area##2##4##(2007-12#1)(2008-5#1)
from the same gene##3##4##(1990-2#1)(1993-12#1)(2007-12#1)
from the same location##3##4##(2008-10#3)
from the same organism##2##4##(1993-6#1)(1997-6#1)
from the same patient##3##4##(1992-3#1)(2008-7#1)(2008-8#1)
from the same pool##2##4##(2008-10#1)(2008-5#1)
from the same population##2##4##(1994-5#1)(2008-10#1)
from the same site##2##4##(2008-10#1)(2011-2#1)
from the same source##3##4##(2008-3#1)(2011-2#1)(2013-8#1)
from the same tissue##2##4##(1992-3#1)(2009-4#1)
from the same##100##3##(1990-2#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#37)(2008-11#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
from the sample matrix##5##4##(2008-10#4)(2008-5#1)
from the sample surface##2##4##(2007-12#1)(2008-3#1)
from the sample using##2##4##(2008-10#2)
from the sample##23##3##(1997-3#1)(2007-12#1)(2008-10#15)(2008-12#1)(2008-3#3)(2008-5#1)(2013-1#1)
from the samples##7##3##(2008-10#6)(2008-3#1)
from the scanning##2##3##(2008-2#1)(2008-3#1)
from the scattered##2##3##(2011-2#1)(2012-2#1)
from the scattering##5##3##(2008-10#1)(2008-3#4)
from the scene of##2##4##(1995-11#1)(2008-10#1)
from the school##2##3##(2013-1#1)(2013-7#1)
from the scientific##2##3##(2008-4#1)(2011-2#1)
from the second##9##3##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-3#1)
from the seed##2##3##(2007-11#1)(2008-10#1)
from the seeds of##4##4##(1990-11#1)(2011-1#3)
from the seeds##5##3##(1990-11#1)(2008-5#1)(2011-1#3)
from the seminiferous epithelium##3##4##(2009-10#1)(2012-2#2)
from the sense##2##3##(2008-1#1)(2008-6#1)
from the sensors##2##3##(2008-10#1)(2008-3#1)
from the separation##2##3##(2008-10#1)(2010-7#1)
from the sequence of a##2##5##(1991-9#1)(1993-6#1)
from the sequence of the##2##5##(2008-10#2)
from the sequence of##7##4##(1991-9#1)(1992-8#1)(1993-11#1)(1993-6#1)(1997-6#1)(2008-10#2)
from the sequence##8##3##(1991-9#1)(1992-8#1)(1993-11#1)(1993-6#1)(1997-6#1)(2008-10#3)
from the sequential##2##3##(1997-3#1)(2007-11#1)
from the shore##2##3##(2008-5#2)
from the side of the##2##5##(1995-11#1)(2008-10#1)
from the side##4##3##(1992-4#1)(1995-11#1)(2008-10#1)(2008-3#1)
from the silkworm##3##3##(1990-12#1)(2008-10#2)
from the simultaneous##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
from the single##2##3##(2008-10#1)(2009-5#1)
from the site of the##2##5##(1993-8#1)(1994-8#1)
from the site of##4##4##(1993-8#1)(1994-8#1)(2008-10#1)(2008-5#1)
from the site##8##3##(1992-3#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
from the six##2##3##(1992-1#1)(2008-1#1)
from the size##2##3##(2008-2#1)(2008-3#1)
from the skin of a Korean frog##2##7##(1994-11#2)
from the skin of##5##4##(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)
from the skin surface##3##4##(2008-5#3)
from the skin##13##3##(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2008-5#8)
from the slope of the calibration curve##2##7##(2008-10#2)
from the slope of the calibration##3##6##(2008-10#3)
from the slope of the##4##5##(2008-10#4)
from the slope of##5##4##(1991-5#1)(2008-10#4)
from the slope##6##3##(1991-5#1)(2008-10#5)
from the small##3##3##(1997-3#1)(2008-4#1)(2008-5#1)
from the social##2##3##(1991-6#1)(2009-12#1)
from the soil samples##3##4##(2008-10#2)(2013-7#1)
from the soil##9##3##(2008-10#7)(2011-2#1)(2013-7#1)
from the solid##2##3##(2008-10#2)
from the solution and##2##4##(2008-10#2)
from the solution##7##3##(2008-10#7)
from the source##14##3##(1993-3#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)
from the south of Spain##2##5##(2008-10#2)
from the south##3##3##(1992-8#1)(2008-10#2)
from the southeastern Gulf of California##2##6##(2008-5#2)
from the southeastern United States##2##5##(2011-2#2)
from the southeastern##4##3##(2008-5#2)(2011-2#2)
from the southern##4##3##(2008-10#3)(2008-5#1)
from the southwestern##2##3##(2008-10#2)
from the spatial##2##3##(2008-2#1)(2008-3#1)
from the specific##3##3##(1993-12#1)(2007-7#1)(2009-4#1)
from the spectral##9##3##(2007-11#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2013-8#1)
from the spectrum##3##3##(1994-12#1)(2008-1#1)(2008-3#1)
from the spermatheca##2##3##(2008-6#1)(2012-12#1)
from the spherical##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
from the spider##2##3##(1990-5#1)(2007-12#1)
from the spinal root of the##2##6##(2008-7#2)
from the spinal##4##3##(1996-2#2)(2008-7#2)
from the spontaneous##2##3##(2008-1#1)(2008-4#1)
from the standard##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
from the standpoint of##6##4##(1995-12#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
from the start##8##3##(1991-5#1)(1991-6#2)(1997-6#1)(2008-10#1)(2008-6#2)(2010-5#1)
from the state of##4##4##(1991-12#1)(2008-10#1)(2009-6#1)(2011-2#1)
from the state##5##3##(1991-12#1)(2008-10#1)(2009-11#1)(2009-6#1)(2011-2#1)
from the states of##2##4##(2008-5#1)(2010-3#1)
from the states##4##3##(1995-2#1)(2007-7#1)(2008-5#1)(2010-3#1)
from the statistical##2##3##(2008-9#1)(2013-8#1)
from the stimulation##2##3##(1996-5#1)(2010-8#1)
from the stomach##2##3##(1992-9#1)(2012-2#1)
from the stone part to the keel##2##7##(1997-4#2)
from the stop codon of##2##5##(1994-12#1)(1997-7#1)
from the striatum##2##3##(1992-7#2)
from the structure##4##3##(1990-7#1)(1994-3#1)(1995-3#1)(2010-11#1)
from the students##3##3##(2008-11#3)
from the studies##2##3##(2008-10#1)(2009-2#1)
from the study of##4##4##(1994-8#1)(2008-1#1)(2008-6#1)(2008-7#1)
from the study##18##3##(1991-12#1)(1994-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#2)(2013-1#2)(2013-7#1)
from the subject's##2##3##(1992-1#1)(2007-6#1)
from the subsequent##2##3##(2008-7#1)(2011-1#1)
from the substantia nigra##2##4##(1992-10#1)(1993-12#1)
from the substrate##4##3##(1990-8#1)(1992-6#1)(2008-2#1)(2008-3#1)
from the sum##2##3##(2008-3#1)(2008-8#1)
from the superior vena cava##2##5##(2007-8#2)
from the superior##5##3##(1991-5#1)(1994-5#1)(2007-8#2)(2008-7#1)
from the supernatant of##3##4##(1994-2#1)(2008-2#1)(2013-1#1)
from the supernatant##4##3##(1994-2#2)(2008-2#1)(2013-1#1)
from the surface of the##5##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-6#1)
from the surface of##12##4##(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)
from the surface##22##3##(1996-4#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-6#1)(2013-8#1)
from the surgical##3##3##(1995-5#1)(2007-3#1)(2007-8#1)
from the surrounding##5##3##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
from the survey is##2##4##(1995-1#1)(2008-11#1)
from the survey##8##3##(1994-3#1)(1995-1#1)(1996-1#2)(2008-11#1)(2008-12#2)(2011-2#1)
from the susceptible##2##3##(2008-10#2)
from the system##6##3##(1995-3#1)(1997-7#1)(2008-2#1)(2008-3#2)(2010-6#1)
from the target##7##3##(2008-10#3)(2008-3#1)(2009-6#1)(2010-10#1)(2011-2#1)
from the targets##2##3##(2007-8#1)(2008-11#1)
from the teacher's perspective##2##4##(2008-11#2)
from the temperature##3##3##(1990-7#1)(2008-10#2)
from the temporal decay of##2##5##(2007-11#1)(2008-3#1)
from the temporal##4##3##(1996-7#1)(2007-11#1)(2008-2#1)(2008-3#1)
from the test##3##3##(1997-5#1)(2008-10#2)
from the tested##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
from the tests##2##3##(2008-10#1)(2011-1#1)
from the theoretical##2##3##(1995-3#1)(2008-2#1)
from the theory##2##3##(2008-10#1)(2009-8#1)
from the third cycle onwards##2##5##(2012-12#2)
from the third##10##3##(1997-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-9#1)(2012-12#2)(2013-1#1)
from the thoracic aorta to the##2##6##(2008-7#2)
from the thoracic##3##3##(2008-7#2)(2008-8#1)
from the three##13##3##(1991-7#1)(1993-9#1)(1995-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-7#1)
from the time of injury##2##5##(2008-9#2)
from the time of##8##4##(1991-5#1)(1994-3#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#1)
from the time##11##3##(1991-5#1)(1994-3#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#1)
from the tip of a microsyringe##2##6##(2008-10#2)
from the tip of a##3##5##(2008-10#3)
from the tip of the##2##5##(2007-11#1)(2007-12#1)
from the tip of##5##4##(2007-11#1)(2007-12#1)(2008-10#3)
from the tip##6##3##(2007-11#2)(2007-12#1)(2008-10#3)
from the tissue##3##3##(2008-10#1)(2008-4#1)(2010-12#1)
from the top##2##3##(2008-10#1)(2010-6#1)
from the total RNA extracted from##2##6##(2008-10#2)
from the total##13##3##(1992-3#1)(1997-4#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)
from the toxic effects of##5##5##(1991-9#1)(1993-9#2)(1994-5#1)(2008-10#1)
from the toxic##6##3##(1991-9#1)(1993-9#2)(1994-5#1)(2008-10#1)(2010-2#1)
from the traditional##4##3##(1991-12#1)(2008-6#1)(2009-9#1)(2011-1#1)
from the training##2##3##(2010-5#1)(2011-2#1)
from the trans-Golgi network##2##4##(2008-1#2)
from the transcription start point##2##5##(1993-6#1)(1997-4#1)
from the translation##5##3##(1990-11#1)(1992-11#1)(1993-3#1)(1997-2#1)(1997-6#1)
from the translational##2##3##(1992-10#1)(1994-11#1)
from the treated##2##3##(2008-10#1)(2008-4#1)
from the treatment of##4##4##(1996-11#1)(2006-10#1)(2011-1#1)(2012-2#1)
from the treatment##5##3##(1996-11#1)(2006-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
from the tree canopy##2##4##(2008-10#2)
from the trend##2##3##(1996-2#1)(2010-2#1)
from the tropical##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
from the tumor##3##3##(2007-8#1)(2013-1#2)
from the tumour##2##3##(1990-5#1)(2008-7#1)
from the two different##2##4##(1995-3#1)(2008-5#1)
from the two droplets##2##4##(2008-3#2)
from the two independent##2##4##(2007-11#1)(2008-3#1)
from the two strains##2##4##(1993-11#1)(2013-1#1)
from the two##25##3##(1990-3#1)(1993-11#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-3#6)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
from the typical##2##3##(2008-8#1)(2010-6#1)
from the ultrasonic##2##3##(1993-2#1)(2008-2#1)
from the ultraviolet to the far infrared##2##7##(2008-3#2)
from the ultraviolet to the##3##5##(2007-11#1)(2008-3#2)
from the ultraviolet##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
from the uninsured population##2##4##(2008-11#2)
from the uninsured##5##3##(2008-11#5)
from the unique##2##3##(1992-12#1)(2007-11#1)
from the untreated control##2##4##(2008-10#1)(2008-11#1)
from the untreated##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
from the upper surface of##2##5##(2008-10#1)(2008-3#1)
from the upper##6##3##(1995-11#1)(2007-5#1)(2008-10#2)(2008-3#1)(2010-9#1)
from the urinary##2##3##(2008-10#1)(2011-2#1)
from the urine samples##2##4##(1996-2#1)(2008-10#1)
from the urine##4##3##(1991-12#1)(1996-2#1)(2008-10#2)
from the use of a##4##5##(2008-10#3)(2011-2#1)
from the use of the##2##5##(2008-10#2)
from the use of two##2##5##(2008-2#1)(2010-5#1)
from the use of##19##4##(1992-2#1)(1994-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)
from the usual##3##3##(1992-11#1)(1997-8#1)(2012-2#1)
from the vagina##2##3##(1991-12#2)
from the values##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
from the variation##2##3##(1991-11#1)(2008-3#1)
from the varieties##2##3##(2008-10#1)(2008-12#1)
from the various##5##3##(1990-5#1)(1990-7#1)(2008-5#2)(2010-12#1)
from the vector##2##3##(1993-2#1)(2008-2#1)
from the vehicle##2##3##(2008-3#1)(2008-9#1)
from the venom glands##2##4##(1993-6#1)(1997-7#1)
from the venom of the##3##5##(1990-5#1)(1994-8#1)(1995-5#1)
from the venom of##7##4##(1990-5#1)(1994-11#1)(1994-8#1)(1995-5#2)(1995-8#1)(2008-8#1)
from the venom##9##3##(1990-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#2)(1995-8#1)(1997-7#1)(2008-8#1)
from the venoms of##2##4##(1990-5#2)
from the ventral##4##3##(1996-5#1)(2008-5#1)(2009-12#1)(2011-2#1)
from the very##3##3##(2007-11#1)(2008-9#2)
from the vesicles##2##3##(1992-6#1)(2008-10#1)
from the vicinity of##2##4##(2008-10#2)
from the viewpoint of the##2##5##(1990-6#1)(2013-8#1)
from the viewpoint of##11##4##(1990-6#1)(1991-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
from the viewpoints of##2##4##(2007-6#1)(2008-3#1)
from the village##2##3##(2008-10#1)(2013-8#1)
from the villages##2##3##(1991-12#1)(2012-12#1)
from the viral##4##3##(1993-6#1)(2008-10#1)(2012-12#1)(2013-1#1)
from the visible##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
from the visual ganglia of the##2##6##(2010-9#2)
from the visual##4##3##(1995-12#1)(2008-10#1)(2010-9#2)
from the water##7##3##(1990-11#1)(2008-10#4)(2008-2#1)(2012-12#1)
from the well##2##3##(1994-12#1)(2008-10#1)
from the west##4##3##(1995-10#1)(2008-10#1)(2010-8#1)(2013-8#1)
from the wheat##2##3##(2008-10#2)
from the whole##3##3##(2007-1#1)(2008-10#2)
from the wide##2##3##(2007-12#1)(2008-3#1)
from the wild##4##3##(2008-10#3)(2009-4#1)
from the wild-type##5##3##(1991-9#1)(1993-8#1)(1994-6#1)(1995-6#1)(2011-2#1)
from the wipes##2##3##(2008-5#2)
from the workpiece##2##3##(2008-3#2)
from the world##2##3##(1994-9#1)(2013-8#1)
from the year##2##3##(1996-11#1)(2008-12#1)
from the yeast Candida##2##4##(1991-9#1)(1997-2#1)
from the yeast Saccharomyces cerevisiae##4##5##(1990-7#1)(1991-12#1)(1994-3#1)(1997-7#1)
from the yeast##10##3##(1990-7#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)
from the##6513##2##(1990-10#2)(1990-11#41)(1990-12#31)(1990-2#18)(1990-3#7)(1990-4#1)(1990-5#38)(1990-6#7)(1990-7#22)(1990-8#27)(1990-9#3)(1991-1#8)(1991-10#5)(1991-11#12)(1991-12#48)(1991-2#21)(1991-3#11)(1991-4#1)(1991-5#31)(1991-6#24)(1991-7#3)(1991-8#10)(1991-9#28)(1992-1#12)(1992-10#5)(1992-11#22)(1992-12#31)(1992-2#16)(1992-3#38)(1992-4#8)(1992-5#19)(1992-6#34)(1992-7#6)(1992-8#31)(1992-9#14)(1993-1#11)(1993-10#2)(1993-11#21)(1993-12#30)(1993-2#16)(1993-3#33)(1993-5#3)(1993-6#33)(1993-8#20)(1993-9#28)(1994-1#10)(1994-11#34)(1994-12#44)(1994-2#20)(1994-3#33)(1994-5#27)(1994-6#32)(1994-7#2)(1994-8#32)(1994-9#19)(1995-1#7)(1995-10#2)(1995-11#22)(1995-12#41)(1995-2#38)(1995-3#31)(1995-4#1)(1995-5#26)(1995-6#32)(1995-8#14)(1995-9#6)(1996-1#8)(1996-10#1)(1996-11#8)(1996-12#38)(1996-2#41)(1996-3#21)(1996-4#11)(1996-5#35)(1996-6#19)(1996-7#4)(1996-8#8)(1996-9#4)(1997-1#15)(1997-2#42)(1997-3#44)(1997-4#33)(1997-5#13)(1997-6#34)(1997-7#27)(1997-8#25)(2006-10#4)(2006-12#7)(2006-4#3)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#14)(2007-11#99)(2007-12#174)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#16)(2007-6#7)(2007-7#23)(2007-8#47)(2007-9#7)(2008-1#52)(2008-10#1288)(2008-11#262)(2008-12#88)(2008-2#184)(2008-3#393)(2008-4#63)(2008-5#230)(2008-6#87)(2008-7#200)(2008-8#125)(2008-9#102)(2009-1#5)(2009-10#20)(2009-11#16)(2009-12#27)(2009-2#11)(2009-3#20)(2009-4#16)(2009-5#22)(2009-6#21)(2009-7#33)(2009-8#33)(2009-9#13)(2010-1#8)(2010-10#26)(2010-11#18)(2010-12#30)(2010-2#20)(2010-3#32)(2010-4#21)(2010-5#27)(2010-6#21)(2010-7#12)(2010-8#35)(2010-9#6)(2011-1#68)(2011-2#197)(2011-3#7)(2011-8#1)(2012-1#13)(2012-12#55)(2012-2#87)(2012-3#75)(2012-7#5)(2012-9#1)(2013-1#150)(2013-2#1)(2013-3#1)(2013-7#26)(2013-8#111)
from their ability to##2##4##(2008-7#1)(2009-4#1)
from their aqueous##2##3##(2008-10#2)
from their clinical##2##3##(2007-10#1)(2012-3#1)
from their disease##2##3##(2008-4#1)(2010-12#1)
from their home##2##3##(2008-11#1)(2008-12#1)
from their homes##2##3##(2009-9#1)(2013-1#1)
from their normal##2##3##(1997-4#1)(2008-9#1)
from their own##4##3##(1992-2#1)(2008-10#1)(2010-12#1)(2012-12#1)
from their parents in##2##4##(2007-7#1)(2008-12#1)
from their parents##3##3##(2007-7#1)(2008-12#1)(2012-2#1)
from their respective##4##3##(1991-7#1)(1993-12#1)(1994-8#1)(2008-10#1)
from their social##2##3##(1995-1#1)(1997-2#1)
from their##121##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-7#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
from them##17##2##(1991-9#1)(1993-2#1)(1995-12#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-4#1)(2012-1#1)
from theoretical and##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
from theoretical##8##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2013-1#2)
from theoretically##2##2##(2007-12#1)(2008-2#1)
from theory to clinical practice##2##5##(1993-3#2)
from theory to practice]##2##4##(1997-3#1)(2008-9#1)
from theory to##4##3##(1993-3#2)(1997-3#1)(2008-9#1)
from theory##7##2##(1993-3#2)(1997-3#1)(2008-2#1)(2008-9#2)(2012-3#1)
from therapy##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
from there##2##2##(2008-10#1)(2008-7#1)
from thermal decomposition##2##3##(2007-11#1)(2008-10#1)
from thermal##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
from thermally induced##4##3##(2007-12#2)(2008-3#2)
from thermally##5##2##(2007-12#2)(2008-3#3)
from these and##2##3##(2008-10#1)(2011-2#1)
from these cells##7##3##(1990-8#1)(1991-2#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-2#1)
from these components##2##3##(2007-12#1)(2008-3#1)
from these data that##3##4##(1990-5#1)(2008-10#1)(2011-2#1)
from these data##11##3##(1990-5#1)(1990-7#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2010-9#1)(2011-2#1)(2012-12#1)
from these diseases##3##3##(1990-6#1)(2008-11#1)(2011-2#1)
from these experiments##3##3##(1992-10#1)(2008-10#1)(2011-3#1)
from these findings##3##3##(1991-2#1)(2008-11#2)
from these four##4##3##(1993-6#1)(2008-10#2)(2008-7#1)
from these genes##2##3##(1992-6#1)(2008-10#1)
from these interactions##2##3##(2008-2#1)(2008-8#1)
from these issues##2##3##(1994-2#1)(2012-12#1)
from these measurements##4##3##(1993-12#1)(2008-2#1)(2008-3#2)
from these methods##2##3##(2008-10#1)(2008-5#1)
from these mice##2##3##(2008-2#1)(2013-1#1)
from these plants##2##3##(2008-10#2)
from these plots##2##3##(2008-10#2)
from these resonances##2##3##(2007-11#1)(2008-3#1)
from these samples##5##3##(2008-10#3)(2008-7#1)(2013-8#1)
from these species##2##3##(2008-10#1)(2008-5#1)
from these studies##8##3##(1992-3#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-3#1)(2011-2#1)
from these tests##2##3##(2008-10#2)
from these three##3##3##(2008-10#2)(2011-1#1)
from these tissues##2##3##(1990-12#1)(2008-10#1)
from these two sources##3##4##(1991-12#2)(2008-9#1)
from these two##6##3##(1990-8#1)(1991-12#2)(1994-5#1)(1996-1#1)(2008-9#1)
from these##186##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-2#5)(1995-5#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#48)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#9)(2008-5#7)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#3)(2012-8#1)(2013-1#2)(2013-8#1)
from thin##3##2##(1992-5#1)(1995-2#1)(2008-10#1)
from thiocyanate##4##2##(2007-12#1)(2008-10#3)
from third##2##2##(1996-12#1)(2012-12#1)
from this analysis##3##3##(2008-7#1)(2009-12#1)(2013-7#1)
from this and##3##3##(2008-8#1)(2010-10#1)(2010-6#1)
from this approach##5##3##(1993-2#1)(2008-10#2)(2012-1#1)(2013-8#1)
from this area##2##3##(2011-2#1)(2012-2#1)
from this cause##2##3##(2011-2#1)(2013-1#1)
from this disorder##2##3##(2008-7#1)(2013-8#1)
from this experience##2##3##(2008-11#2)
from this experiment##2##3##(2008-2#1)(2012-1#1)
from this group##3##3##(2008-11#1)(2008-12#1)(2013-7#1)
from this knowledge##2##3##(1997-6#1)(2009-6#1)
from this laboratory##6##3##(1990-11#1)(1991-3#1)(1992-8#1)(1995-12#1)(2008-10#2)
from this laser##3##3##(2008-2#2)(2008-3#1)
from this model##4##3##(1990-8#1)(2007-12#1)(2008-3#1)(2012-2#1)
from this new##3##3##(1994-11#1)(2008-3#2)
from this part of the##2##5##(2007-7#1)(2008-1#1)
from this part of##3##4##(2007-7#1)(2008-1#1)(2008-10#1)
from this pathology##2##3##(1990-6#1)(2011-2#1)
from this pattern##2##3##(2008-3#1)(2008-7#1)
from this preliminary##2##3##(1995-2#1)(2008-7#1)
from this process##3##3##(1993-12#1)(2008-9#1)(2012-2#1)
from this project##3##3##(1995-3#1)(2008-12#1)(2012-1#1)
from this promoter##6##3##(1990-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1996-6#1)(2008-10#1)
from this region##7##3##(1991-12#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#2)
from this research##3##3##(2007-12#1)(2008-10#1)(2009-6#1)
from this strain##3##3##(1995-6#1)(2008-12#1)(2012-2#1)
from this study could##2##4##(2008-10#1)(2013-8#1)
from this study have##2##4##(1991-1#1)(2011-2#1)
from this study indicate##2##4##(2008-11#1)(2011-1#1)
from this study is##4##4##(1995-11#1)(2008-10#1)(2008-12#1)(2012-3#1)
from this study show that the##2##6##(2007-10#1)(2010-8#1)
from this study show that##5##5##(2007-10#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-1#1)
from this study suggest that##5##5##(2008-10#3)(2009-3#1)(2011-2#1)
from this study##48##3##(1991-1#1)(1995-11#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
from this survey were##2##4##(1992-1#1)(1994-2#1)
from this survey##3##3##(1992-1#1)(1992-12#1)(1994-2#1)
from this technique##3##3##(2008-12#1)(2008-3#1)(2010-7#1)
from this technology##2##3##(1992-12#1)(2008-5#1)
from this tissue##3##3##(1990-8#1)(1992-3#1)(2008-7#1)
from this type of##3##4##(2007-12#1)(2007-5#1)(2008-4#1)
from this##241##2##(1990-11#3)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#5)(1992-3#3)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#2)(1997-6#1)(1997-8#1)(2006-4#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#43)(2008-11#9)(2008-12#6)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
from thoracic##2##2##(2008-12#1)(2011-2#1)
from those affected##2##3##(1993-2#1)(2011-1#1)
from those currently##2##3##(1994-1#1)(2008-10#1)
from those for##4##3##(1995-6#2)(2008-7#1)(2010-3#1)
from those found##2##3##(2008-10#1)(2008-5#1)
from those identified##2##3##(1991-2#1)(1992-12#1)
from those in the##6##4##(1995-11#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)
from those in##14##3##(1991-11#1)(1994-2#1)(1995-11#2)(1996-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#2)
from those obtained by##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
from those obtained with##2##4##(1997-7#1)(2008-7#1)
from those obtained##7##3##(1997-7#1)(2008-10#2)(2008-5#2)(2008-7#2)
from those of a##5##4##(1990-12#1)(1992-3#1)(1995-1#1)(2008-10#2)
from those of healthy##2##4##(1995-11#1)(2009-8#1)
from those of other##4##4##(1995-5#1)(2008-11#1)(2008-8#1)(2011-2#1)
from those of the other##2##5##(2008-10#1)(2008-9#1)
from those of the##11##4##(1997-6#2)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-8#1)
from those of##50##3##(1990-12#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-6#2)(2007-12#2)(2008-10#14)(2008-11#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
from those on##2##3##(1996-6#1)(2008-3#1)
from those reported##4##3##(1993-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
from those that are##3##4##(1996-3#1)(2008-2#1)(2009-4#1)
from those that##7##3##(1996-3#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-4#1)(2012-2#2)
from those used in##2##4##(2008-2#1)(2008-4#1)
from those using##2##3##(1993-2#1)(1997-3#1)
from those who##3##3##(1996-2#1)(2008-8#1)(2009-6#1)
from those with##5##3##(1991-12#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-8#1)
from those without##2##3##(2008-7#1)(2013-1#1)
from those##152##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#1)(1996-7#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#9)(2008-8#9)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#3)(2013-8#2)
from three cities##2##3##(2008-10#1)(2012-2#1)
from three commercial##2##3##(2008-10#2)
from three different environments##2##4##(2008-10#1)(2008-5#1)
from three different##19##3##(1991-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2010-3#2)(2012-2#2)(2013-8#1)
from three groups of##2##4##(2008-10#1)(2011-1#1)
from three populations##2##3##(2010-8#1)(2012-7#1)
from three primary schools in##2##5##(2007-7#1)(2008-10#1)
from three randomized controlled trials##2##5##(2012-12#2)
from three samples##2##3##(2008-10#2)
from three separate##2##3##(2008-12#1)(2008-8#1)
from three sources were determined##2##5##(2008-10#2)
from three to##6##3##(1990-2#1)(1992-8#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-7#1)
from three##107##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#34)(2008-11#1)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2012-9#1)(2013-8#4)
from three-dimensional##5##2##(1995-2#2)(2008-10#1)(2008-8#1)(2010-2#1)
from threshold to##2##3##(2008-3#2)
from thymus##2##2##(1992-8#1)(2008-7#1)
from thyroid##3##2##(2008-7#1)(2012-1#1)(2013-7#1)
from time to time##5##4##(1997-7#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
from time##6##2##(1997-7#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
from time-resolved measurements##2##3##(2008-3#2)
from time-resolved##3##2##(2008-3#2)(2008-8#1)
from tissue culture##2##3##(2008-10#1)(2008-2#1)
from tissue##11##2##(2008-10#2)(2008-2#3)(2008-5#2)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#1)
from tissue-simulating##2##2##(2008-2#1)(2008-3#1)
from tissues and##2##3##(2008-9#1)(2013-1#1)
from tissues##12##2##(1990-11#1)(1997-3#1)(2008-3#1)(2008-4#3)(2008-9#3)(2010-6#1)(2012-3#1)(2013-1#1)
from tobacco and##2##3##(1994-8#1)(2008-10#1)
from tobacco##16##2##(1992-6#2)(1994-8#1)(1997-3#1)(1997-4#2)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
from tomato leaves##2##3##(2008-10#2)
from tomato plants displaying##2##4##(2008-10#2)
from tomato plants##3##3##(2008-10#3)
from tomato were compared##2##4##(2008-10#2)
from tomato were more##2##4##(2008-10#2)
from tomato were##4##3##(2008-10#4)
from tomato##21##2##(1995-2#1)(2008-10#20)
from tomatoes##3##2##(1997-4#1)(2008-10#2)
from tonsillar tissue##2##3##(2008-4#2)
from top to bottom##2##4##(1995-1#1)(2008-10#1)
from total RNA##4##3##(2008-2#2)(2008-4#1)(2008-9#1)
from total##13##2##(1994-3#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2012-2#1)
from toxic##3##2##(1996-12#1)(1996-5#1)(2008-11#1)
from traditional Chinese medicines with potent anti-HIV activities##2##8##(2011-3#2)
from traditional Chinese medicines##3##4##(2011-3#3)
from traditional Chinese##5##3##(2008-9#1)(2011-3#4)
from traditional##17##2##(1993-12#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#4)
from transcription##3##2##(2008-1#1)(2008-6#1)(2011-1#1)
from transfected##4##2##(1992-11#1)(1995-2#1)(1996-12#1)(2008-10#1)
from transferrin##3##2##(1992-6#1)(2008-5#2)
from transformed##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
from transgenic animals##2##3##(1994-5#2)
from transgenic##7##2##(1994-3#1)(1994-5#2)(1994-8#1)(1996-2#1)(1997-4#1)(2008-10#1)
from transient##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
from transition##3##2##(2008-10#3)
from transitional cell carcinoma of urinary bladder##2##7##(2012-1#2)
from transitional cell carcinoma##3##4##(2012-1#3)
from transmission##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
from transplant##2##2##(1995-12#1)(2008-10#1)
from trauma##2##2##(2007-11#1)(2008-7#1)
from traumatic brain##2##3##(1994-12#1)(2012-2#1)
from treated##9##2##(1991-5#1)(1992-9#1)(1993-12#1)(2008-10#5)(2012-2#1)
from treatment with##6##3##(1996-9#1)(2008-5#2)(2009-4#1)(2010-5#1)(2013-8#1)
from treatment##13##2##(1991-8#1)(1996-9#1)(2007-11#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
from trees##2##2##(2008-10#2)
from trials##3##2##(1994-11#1)(1996-6#1)(2009-11#1)
from tryptophan##2##2##(1993-11#1)(2008-3#1)
from tumor cells##5##3##(2008-11#1)(2008-9#3)(2011-1#1)
from tumor##10##2##(1990-5#1)(1992-7#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#3)(2011-1#1)
from tumors##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
from tumour##2##2##(2008-10#1)(2008-7#1)
from tungsten##2##2##(2008-10#1)(2009-11#1)
from turbid media##3##3##(2008-2#1)(2008-3#2)
from turbid##4##2##(2008-2#1)(2008-3#3)
from turfgrasses##2##2##(2008-10#2)
from turkey##2##2##(1992-6#1)(2008-5#1)
from two areas##2##3##(2008-10#2)
from two cell lines##2##4##(1993-3#1)(2008-11#1)
from two commercial##2##3##(2008-10#2)
from two different populations##2##4##(2008-3#1)(2009-2#1)
from two different##22##3##(1992-2#1)(1994-11#1)(1994-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
from two distinct##2##3##(2008-10#1)(2008-9#1)
from two districts##2##3##(1994-6#1)(2010-3#1)
from two intensities##2##3##(2008-2#2)
from two kinds##2##3##(2008-9#1)(2013-8#1)
from two medical centers##2##4##(1995-11#1)(2011-1#1)
from two medical##3##3##(1995-11#1)(2011-1#1)(2013-1#1)
from two of four##2##4##(2008-10#2)
from two of the##3##4##(1991-6#1)(1996-3#1)(2008-10#1)
from two of##5##3##(1991-6#1)(1996-3#1)(2008-10#3)
from two or more##3##4##(1993-2#1)(2008-10#2)
from two overlapping##2##3##(1992-6#1)(1996-6#1)
from two patients##3##3##(1990-8#1)(1994-11#1)(1996-5#1)
from two populations##2##3##(1992-6#1)(2008-10#1)
from two samples ranged from##2##5##(2008-10#2)
from two samples##3##3##(2008-10#3)
from two separate##2##3##(2008-11#1)(2009-11#1)
from two sets of##2##4##(2008-8#1)(2009-10#1)
from two sites##3##3##(1990-5#1)(2008-5#1)(2013-7#1)
from two sources##3##3##(2009-5#1)(2012-2#1)(2013-1#1)
from two species of##2##4##(2008-10#1)(2013-1#1)
from two studies in##2##4##(2008-10#1)(2009-9#1)
from two studies##4##3##(1995-1#1)(2008-10#1)(2008-5#1)(2009-9#1)
from two to five##2##4##(1992-11#1)(2012-2#1)
from two to seven##2##4##(2008-11#1)(2008-5#1)
from two to##7##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)
from two urban##2##3##(2008-9#1)(2010-1#1)
from two##180##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-6#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#35)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#12)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
from two-dimensional##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
from type 1##2##3##(2012-2#2)
from type 2##2##3##(2008-1#1)(2012-2#1)
from type##6##2##(1990-7#1)(2007-11#1)(2008-1#1)(2012-2#3)
from typical##4##2##(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
from umbilical cord blood##2##4##(2008-11#2)
from umbilical veins##2##3##(1992-2#1)(1994-6#1)
from umbilical##4##2##(1992-2#1)(1994-6#1)(2008-11#2)
from uncertainties##2##2##(2008-10#1)(2013-8#1)
from unconjugated Fib75##2##3##(1990-12#2)
from underlying##2##2##(1997-2#1)(2012-2#1)
from understanding the##2##3##(2010-10#1)(2013-8#1)
from understanding##5##2##(2008-8#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
from undetectable##2##2##(1994-3#1)(1997-2#1)
from unexposed##2##2##(1990-7#2)
from unrelated##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
from unresolved##2##2##(2007-11#1)(2008-10#1)
from unsprayed##2##2##(2008-10#2)
from untreated controls##2##3##(1995-12#1)(2008-11#1)
from untreated##6##2##(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-6#1)
from upper##6##2##(2006-10#1)(2008-10#3)(2008-11#1)(2013-8#1)
from upstream##2##2##(1997-4#1)(2008-11#1)
from urine##13##2##(1990-7#2)(1991-12#1)(1996-5#1)(2007-7#2)(2008-10#6)(2008-12#1)
from urologic##2##2##(1997-7#1)(2008-7#1)
from use of the##2##4##(2008-10#1)(2008-3#1)
from use of this##2##4##(2007-12#1)(2008-2#1)
from use of##10##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-2#1)(2012-12#1)
from use##11##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
from users and##2##3##(1992-2#1)(2008-3#1)
from using a##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
from using the##3##3##(2008-10#3)
from using##10##2##(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
from usual##2##2##(2007-4#1)(2008-2#1)
from vaccinated chickens##2##3##(1996-11#1)(2008-5#1)
from vaccinated poults##2##3##(1997-6#2)
from vaccinated##5##2##(1996-11#1)(1997-6#2)(2008-5#2)
from vaccination##2##2##(2007-2#1)(2008-10#1)
from vaginal##2##2##(1991-11#1)(2010-5#1)
from validation data##4##3##(2008-10#4)
from values##4##2##(1990-5#1)(2008-10#2)(2008-5#1)
from vanilla fragans##2##3##(2008-10#2)
from various clinical samples##2##4##(2007-7#2)
from various clinical##3##3##(2007-7#3)
from various countries##3##3##(1993-3#1)(2009-4#1)(2013-8#1)
from various cultural##2##3##(2009-6#1)(2011-2#1)
from various genetic##2##3##(2008-9#1)(2011-2#1)
from various geographic##2##3##(2008-10#2)
from various host plants##2##4##(2008-10#2)
from various hosts##3##3##(2008-10#3)
from various human##2##3##(1991-5#1)(2008-9#1)
from various mouse tissues##2##4##(1994-12#1)(2008-11#1)
from various other##3##3##(1992-6#1)(1997-3#1)(2011-2#1)
from various parts of Sweden##2##5##(2011-2#2)
from various parts of##5##4##(2008-10#2)(2008-12#1)(2011-2#2)
from various sources##3##3##(1993-8#1)(2008-4#1)(2008-9#1)
from various species##4##3##(1990-5#1)(1993-2#1)(1997-7#1)(2010-3#1)
from various types of##3##4##(2008-4#2)(2008-7#1)
from various##101##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-7#3)(2008-10#28)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#3)(2010-3#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#2)(2013-8#3)
from vascular endothelial cells##2##4##(2008-8#1)(2009-10#1)
from vascular smooth muscle cells##2##5##(1991-12#1)(1993-2#1)
from vascular smooth muscle##3##4##(1990-8#1)(1991-12#1)(1993-2#1)
from vascular##8##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-2#1)(2007-7#1)(2008-8#1)(2009-10#1)
from vegetative cells##2##3##(1997-3#1)(2008-11#1)
from vehicle controls##2##3##(1993-3#1)(2008-9#1)
from vehicle##4##2##(1993-3#1)(1997-7#2)(2008-9#1)
from venom of##2##3##(1993-11#1)(2008-8#1)
from vertebrate##4##2##(1991-5#1)(1993-11#3)
from vertebrates##2##2##(1996-2#1)(2011-2#1)
from very low##5##3##(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
from very##8##2##(1993-8#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2010-11#1)(2012-2#1)
from vesicles##2##2##(1997-7#1)(2008-7#1)
from viable##2##2##(2008-10#1)(2008-9#1)
from vibrating##2##2##(2007-12#1)(2008-3#1)
from villages##2##2##(1996-12#1)(2008-12#1)
from violent##2##2##(1995-2#2)
from viral##3##2##(2007-7#1)(2008-9#1)(2010-7#1)
from virus-infected##2##2##(2008-10#2)
from viruses in##2##3##(2008-10#2)
from viruses##3##2##(2008-10#3)
from visible##2##2##(1992-2#1)(2010-2#1)
from visual##4##2##(1994-3#1)(1994-8#1)(2008-11#1)(2008-6#1)
from vitamin##6##2##(1991-5#1)(1994-5#3)(1995-11#1)(2007-11#1)
from waste water##2##3##(2008-10#2)
from waste##4##2##(2008-10#3)(2008-6#1)
from wastewater##4##2##(2008-10#3)(2012-2#1)
from water and##4##3##(2008-10#3)(2012-2#1)
from water by##2##3##(2008-10#1)(2011-2#1)
from water into benzene##3##4##(2008-10#3)
from water into##4##3##(2008-10#4)
from water samples with##2##4##(2008-10#2)
from water samples##7##3##(2008-10#7)
from water stress##2##3##(2008-10#1)(2008-8#1)
from water to the##4##4##(1992-5#1)(1994-12#1)(2008-10#2)
from water##49##2##(1992-5#3)(1994-12#1)(1995-2#1)(1997-7#1)(2008-10#30)(2008-3#5)(2008-8#1)(2010-4#1)(2011-2#4)(2012-2#2)
from watermelon##3##2##(2008-10#3)
from wave-front##2##2##(2007-12#2)
from wavelet##2##2##(2008-6#1)(2010-4#1)
from weakening##2##2##(2008-5#1)(2013-1#1)
from weaning##3##2##(1991-12#1)(2010-4#2)
from week 1##3##3##(2008-3#1)(2008-7#2)
from week##8##2##(1992-11#1)(1992-3#1)(1996-7#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)
from well##4##2##(1993-3#1)(1997-6#1)(2008-2#1)(2008-5#1)
from well-known##2##2##(1996-4#1)(2008-3#1)
from west##2##2##(2008-12#1)(2013-8#1)
from western Canada##2##3##(2008-10#2)
from western##8##2##(2007-2#1)(2008-10#6)(2008-5#1)
from what is##2##3##(2008-10#1)(2012-3#1)
from what it is today##2##5##(2008-1#2)
from what##5##2##(2008-1#2)(2008-10#1)(2012-12#1)(2012-3#1)
from wheat and##3##3##(1992-8#1)(2008-10#1)(2008-8#1)
from wheat bran##2##3##(1993-11#1)(2008-10#1)
from wheat##16##2##(1992-8#1)(1993-11#1)(2008-10#9)(2008-8#2)(2008-9#1)(2011-2#2)
from when##2##2##(1997-8#1)(2008-3#1)
from where it##2##3##(1994-9#1)(2008-10#1)
from where they##2##3##(1996-1#1)(2008-7#1)
from where##6##2##(1994-9#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-7#2)
from whey##2##2##(2008-6#2)
from which DNA was extracted##2##5##(2008-10#1)(2009-4#1)
from which DNA##4##3##(2008-10#3)(2009-4#1)
from which a##5##3##(1995-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-7#1)
from which infectious RNA##2##4##(2008-10#1)(2008-9#1)
from which it could be eluted##3##6##(2008-10#3)
from which it was##2##4##(1991-5#1)(2012-3#1)
from which it##9##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-5#1)(2008-10#3)(2008-9#1)(2012-3#1)
from which one##3##3##(1992-6#1)(1996-9#1)(1997-3#1)
from which the samples##2##4##(2008-10#1)(2011-2#1)
from which the##29##3##(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
from which their##2##3##(2008-3#1)(2010-8#1)
from which these##5##3##(1991-12#1)(1994-3#2)(2008-10#1)(2008-3#1)
from which they are##2##4##(2008-8#1)(2012-12#1)
from which they can generally be distinguished by their slightly lower temperature optima##2##13##(2011-2#2)
from which they originated##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
from which they were derived##2##5##(2008-4#1)(2008-7#1)
from which they were isolated##2##5##(2008-10#2)
from which they were##5##4##(2008-10#3)(2008-4#1)(2008-7#1)
from which they##16##3##(1990-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
from which to##6##3##(1992-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
from which we##4##3##(1992-8#1)(2007-11#1)(2008-2#1)(2008-9#1)
from which##135##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-9#1)(1997-3#4)(1997-5#1)(1997-6#1)(2007-11#4)(2007-12#3)(2008-1#3)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#1)
from whispering-gallery modes##2##3##(2007-12#2)
from white##3##2##(2008-10#2)(2008-7#1)
from whole blood##2##3##(2007-11#1)(2008-11#1)
from whole##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#2)
from whole-cell extracts##3##3##(1992-3#1)(2008-4#2)
from whole-cell##5##2##(1992-3#1)(2008-4#4)
from whom##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
from wild and cultivated sorghum##2##5##(2008-10#2)
from wild and##3##3##(2008-10#2)(2012-2#1)
from wild einkorn wheat##3##4##(2008-10#3)
from wild type##2##3##(1990-8#1)(2013-1#1)
from wild##17##2##(1990-8#1)(1997-2#1)(2008-10#12)(2008-8#1)(2012-2#1)(2013-1#1)
from wild-type and##2##3##(1995-12#1)(2008-2#1)
from wild-type##10##2##(1990-7#1)(1991-7#1)(1993-12#1)(1993-9#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-2#1)
from within the##5##3##(1992-12#1)(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
from within##9##2##(1992-12#1)(1995-1#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#1)
from women with##3##3##(1992-2#1)(1994-3#1)(1995-12#1)
from women##7##2##(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(2007-10#1)(2009-7#1)
from work##3##2##(1991-9#1)(2012-1#1)(2013-1#1)
from world literature##2##3##(2007-8#1)(2008-10#1)
from world##3##2##(2007-8#2)(2008-10#1)
from worldwide locations##2##3##(2008-10#2)
from year to year and##3##5##(2008-10#2)(2013-1#1)
from year to year##10##4##(2008-10#3)(2008-12#1)(2008-8#3)(2011-2#2)(2013-1#1)
from year##11##2##(2008-10#4)(2008-12#1)(2008-8#3)(2011-2#2)(2013-1#1)
from yeast to man##2##4##(1995-2#1)(1995-6#1)
from yeast to##3##3##(1995-2#1)(1995-6#1)(2012-1#1)
from yeast##16##2##(1990-2#1)(1990-5#2)(1994-6#1)(1995-2#1)(1995-6#3)(1996-3#1)(2008-11#1)(2008-5#3)(2008-6#1)(2012-1#1)(2012-2#1)
from young adults##2##3##(1997-6#1)(2007-12#1)
from young and old##2##4##(1994-6#1)(1994-8#1)
from young and##4##3##(1994-6#1)(1994-8#2)(2013-7#1)
from young##14##2##(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#2)(1997-6#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-7#1)
from younger to older##2##4##(2008-10#1)(2008-5#1)
from your##2##2##(1996-3#1)(2008-1#1)
from zero to##2##3##(2008-11#1)(2008-7#1)
from zero##13##2##(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
from zinc##2##2##(2008-10#1)(2009-12#1)
from zucchini##4##2##(2008-10#4)
from##30632##1##(1990-10#4)(1990-11#149)(1990-12#144)(1990-2#111)(1990-3#42)(1990-4#4)(1990-5#132)(1990-6#44)(1990-7#84)(1990-8#129)(1990-9#31)(1991-1#31)(1991-10#6)(1991-11#56)(1991-12#200)(1991-2#113)(1991-3#69)(1991-4#9)(1991-5#116)(1991-6#74)(1991-7#14)(1991-8#77)(1991-9#109)(1992-1#27)(1992-10#18)(1992-11#101)(1992-12#152)(1992-2#81)(1992-3#185)(1992-4#20)(1992-5#65)(1992-6#140)(1992-7#11)(1992-8#108)(1992-9#76)(1993-1#51)(1993-10#4)(1993-11#136)(1993-12#208)(1993-2#102)(1993-3#142)(1993-5#24)(1993-6#126)(1993-8#121)(1993-9#91)(1994-1#30)(1994-10#3)(1994-11#159)(1994-12#185)(1994-2#110)(1994-3#137)(1994-5#96)(1994-6#120)(1994-7#22)(1994-8#139)(1994-9#92)(1995-1#44)(1995-10#3)(1995-11#106)(1995-12#159)(1995-2#196)(1995-3#132)(1995-4#7)(1995-5#110)(1995-6#151)(1995-8#96)(1995-9#28)(1996-1#47)(1996-10#12)(1996-11#33)(1996-12#181)(1996-2#169)(1996-3#91)(1996-4#23)(1996-5#143)(1996-6#74)(1996-7#28)(1996-8#26)(1996-9#34)(1997-1#67)(1997-2#156)(1997-3#176)(1997-4#155)(1997-5#46)(1997-6#123)(1997-7#132)(1997-8#89)(1997-9#11)(2006-10#27)(2006-11#1)(2006-12#16)(2006-4#13)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#12)(2007-1#8)(2007-10#85)(2007-11#473)(2007-12#673)(2007-2#50)(2007-3#2)(2007-4#20)(2007-5#65)(2007-6#44)(2007-7#124)(2007-8#165)(2007-9#15)(2008-1#271)(2008-10#7448)(2008-11#1122)(2008-12#484)(2008-2#790)(2008-3#1439)(2008-4#408)(2008-5#837)(2008-6#362)(2008-7#783)(2008-8#663)(2008-9#536)(2009-1#10)(2009-10#105)(2009-11#88)(2009-12#95)(2009-2#51)(2009-3#80)(2009-4#56)(2009-5#91)(2009-6#99)(2009-7#145)(2009-8#132)(2009-9#76)(2010-1#41)(2010-10#103)(2010-11#87)(2010-12#115)(2010-2#78)(2010-3#139)(2010-4#136)(2010-5#116)(2010-6#85)(2010-7#62)(2010-8#169)(2010-9#28)(2011-1#320)(2011-10#10)(2011-2#898)(2011-3#41)(2011-7#3)(2011-8#4)(2011-9#2)(2012-1#111)(2012-12#274)(2012-2#487)(2012-3#371)(2012-4#4)(2012-5#4)(2012-6#4)(2012-7#16)(2012-8#4)(2012-9#10)(2013-1#738)(2013-2#1)(2013-3#1)(2013-7#126)(2013-8#392)
from)##2##1##(2008-10#1)(2008-8#1)
fromCarthamus tinctorius##2##2##(2008-11#2)
fromL##2##1##(2008-11#2)
fromthe##2##1##(2008-11#2)
fronds##2##1##(2008-10#2)
front and rear surfaces##2##4##(2008-3#2)
front and##10##2##(1990-10#1)(1990-12#1)(2007-12#1)(2008-10#2)(2008-3#5)
front end of##2##3##(2008-3#1)(2010-8#1)
front end##7##2##(2008-3#6)(2010-8#1)
front facet##4##2##(2008-3#4)
front in##2##2##(2008-3#1)(2010-8#1)
front line##7##2##(2007-12#1)(2008-11#3)(2008-2#1)(2011-2#2)
front meniscus##3##2##(2009-6#3)
front of a##6##3##(1991-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
front of the##29##3##(1991-2#1)(1992-9#1)(1993-1#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#1)
front of##46##2##(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#1)(1996-5#1)(1997-3#1)(2007-11#5)(2007-12#5)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#9)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#2)
front##173##1##(1990-10#1)(1990-12#1)(1991-2#2)(1991-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-11#7)(2007-12#13)(2008-10#14)(2008-11#8)(2008-2#15)(2008-3#72)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-6#4)(2009-7#2)(2010-11#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
front&quot##3##1##(1991-5#1)(1994-1#2)
front-end##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
front-line staff##2##2##(1994-2#1)(2009-3#1)
front-line##10##1##(1992-11#1)(1994-2#1)(2009-3#3)(2010-1#1)(2012-12#4)
front-surface##3##1##(1991-12#1)(2008-3#2)
frontal and occipital##2##3##(1992-2#1)(1996-12#1)
frontal and parietal cortex##2##4##(1992-8#1)(1996-5#1)
frontal and parietal##5##3##(1992-8#1)(1996-5#1)(2011-1#1)(2012-1#2)
frontal and##15##2##(1992-2#1)(1992-8#1)(1995-2#1)(1996-12#2)(1996-5#2)(1997-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-1#2)
frontal approach##6##2##(2006-12#6)
frontal bone##3##2##(2008-7#1)(2011-2#1)(2012-8#1)
frontal bossing in##2##3##(1997-3#1)(2010-8#1)
frontal bossing##3##2##(1997-3#1)(2010-8#1)(2011-1#1)
frontal cortex and hippocampus##5##4##(1994-6#2)(1995-12#2)(1996-2#1)
frontal cortex and##13##3##(1993-12#1)(1994-2#2)(1994-6#5)(1995-12#2)(1996-12#1)(1996-2#1)(1996-5#1)
frontal cortex of##5##3##(1993-6#1)(1995-2#2)(1995-3#1)(2008-8#1)
frontal cortex##38##2##(1991-5#3)(1993-12#1)(1993-6#1)(1994-2#3)(1994-3#1)(1994-6#5)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-2#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-8#2)(2009-9#1)
frontal cortical 5-HT2 receptors and the##2##6##(1995-12#2)
frontal cortical beta-adrenoceptors##2##3##(1995-12#2)
frontal cortical##9##2##(1990-8#1)(1992-11#2)(1993-6#1)(1995-12#4)(1996-5#1)
frontal cortices##2##2##(1996-12#1)(2012-12#1)
frontal craniotomy##2##2##(2008-1#1)(2008-8#1)
frontal executive dysfunctions##2##3##(2009-6#2)
frontal extradural haematoma##2##3##(2008-8#2)
frontal eye fields##2##3##(2010-5#2)
frontal gyrus##8##2##(1994-8#2)(2008-11#4)(2010-2#1)(2013-1#1)
frontal headaches##2##2##(2008-11#1)(2012-8#1)
frontal lobe seizures##2##3##(2008-4#2)
frontal lobe##18##2##(1996-2#2)(1996-5#1)(1997-2#1)(2007-10#3)(2008-1#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#3)(2011-2#2)
frontal lobectomy##3##2##(2008-7#3)
frontal lobes##8##2##(1994-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-6#1)(2008-7#3)
frontal mucoceles##2##2##(2013-1#2)
frontal part before the cut was##2##6##(2008-5#2)
frontal part##3##2##(2008-5#3)
frontal plane##8##2##(2007-10#4)(2010-8#4)
frontal region##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
frontal regions##2##2##(2007-10#1)(2008-11#1)
frontal sinus is##3##3##(2006-12#1)(2013-1#2)
frontal sinus##16##2##(2006-12#4)(2008-6#1)(2011-2#6)(2012-1#1)(2012-8#1)(2013-1#3)
frontal sinusitis##2##2##(2012-8#2)
frontal##198##1##(1990-8#2)(1991-5#3)(1992-11#2)(1992-2#1)(1992-8#2)(1993-12#1)(1993-6#2)(1994-2#3)(1994-3#2)(1994-6#5)(1994-8#2)(1995-12#8)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#2)(1996-12#6)(1996-2#4)(1996-5#8)(1996-6#1)(1997-2#3)(1997-3#2)(1997-7#1)(1997-8#2)(2006-12#11)(2007-10#8)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-12#2)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#5)(2009-4#1)(2009-6#2)(2009-9#2)(2010-2#1)(2010-5#2)(2010-8#5)(2011-1#2)(2011-2#12)(2012-1#5)(2012-12#4)(2012-2#1)(2012-3#1)(2012-8#5)(2013-1#9)
frontally##3##1##(1992-8#1)(1995-5#1)(2007-12#1)
frontier for##2##2##(1995-1#1)(1997-2#1)
frontier of##3##2##(2008-1#1)(2008-10#1)(2009-9#1)
frontier##17##1##(1992-2#2)(1995-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-9#1)(2010-12#1)(2010-5#2)(2013-1#2)
frontiers in##4##2##(1997-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
frontiers##9##1##(1993-1#1)(1993-2#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
frontline##7##1##(1993-1#1)(2007-5#1)(2008-8#1)(2010-11#1)(2012-3#2)(2013-1#1)
fronto-central##2##1##(2008-8#1)(2013-8#1)
fronto-parietal##2##1##(2008-1#1)(2013-8#1)
fronto-striatal##6##1##(2007-8#2)(2013-1#4)
frontocortico-septal##2##1##(1991-5#2)
frontoparietal##2##1##(1993-12#1)(2007-10#1)
frontotemporal dementia (FTD)##3##3##(2008-4#1)(2008-7#1)(2009-9#1)
frontotemporal dementia##7##2##(2008-4#2)(2008-7#1)(2009-9#2)(2013-1#2)
frontotemporal##12##1##(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-9#2)(2011-2#1)(2013-1#3)
fronts in##2##2##(2007-11#1)(2007-12#1)
fronts of##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
fronts to##2##2##(1997-3#1)(2007-12#1)
fronts with respect to the##2##5##(2007-11#1)(2008-3#1)
fronts with##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
fronts##42##1##(1996-2#1)(1996-8#1)(1997-3#1)(2007-11#7)(2007-12#3)(2008-2#9)(2008-3#20)
frost##2##1##(2008-10#2)
frosts##3##1##(2009-2#3)
frozen and##3##2##(1995-4#1)(2008-10#1)(2011-2#1)
frozen cells##4##2##(1994-6#1)(2008-11#1)(2008-8#1)(2009-2#1)
frozen in liquid nitrogen##2##4##(2008-10#1)(2008-5#1)
frozen in##3##2##(1996-8#1)(2008-10#1)(2008-5#1)
frozen or##2##2##(1995-2#1)(2008-4#1)
frozen section##7##2##(1995-4#4)(2007-8#2)(2013-1#1)
frozen sectioning##2##2##(2008-4#2)
frozen sections##8##2##(1990-10#2)(1995-4#3)(1997-7#1)(2010-8#2)
frozen storage of##2##3##(2010-2#1)(2011-2#1)
frozen storage##4##2##(1990-12#1)(2010-2#1)(2011-2#2)
frozen tissue##2##2##(1991-2#1)(2008-4#1)
frozen##79##1##(1990-10#2)(1990-12#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-11#1)(1993-6#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-4#8)(1996-8#2)(1997-7#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-2#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-8#2)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
frozen-flow hypothesis##2##2##(2007-12#2)
frozen-thawed embryos##2##2##(1996-8#1)(2011-1#1)
frozen-thawed##6##1##(1996-8#3)(2011-1#1)(2012-3#2)
fructicola and##6##2##(2008-10#6)
fructicola at##3##2##(2008-10#3)
fructicola did not##2##3##(2008-10#2)
fructicola in##2##2##(2008-10#2)
fructicola isolates##2##2##(2008-10#2)
fructicola were##3##2##(2008-10#3)
fructicola##44##1##(2008-10#44)
fructooligosaccharides##3##1##(2008-12#1)(2012-2#2)
fructosamine and HbA1##4##3##(1991-5#4)
fructosamine and##6##2##(1991-12#1)(1991-5#4)(2009-3#1)
fructosamine concentration##5##2##(1991-12#1)(1991-5#1)(1992-9#3)
fructosamine levels##3##2##(1991-12#2)(2009-3#1)
fructosamine##19##1##(1991-12#6)(1991-5#5)(1992-9#3)(2009-3#5)
fructose 1##3##2##(1990-12#1)(1994-8#1)(1996-6#1)
fructose 1-phosphate##2##2##(1990-7#2)
fructose 2##5##2##(1990-5#2)(1994-3#1)(1995-2#2)
fructose 6-phosphate and##2##3##(1990-7#1)(1996-6#1)
fructose 6-phosphate##7##2##(1990-7#4)(1995-2#1)(1996-6#1)(2008-7#1)
fructose and glucose##4##3##(2008-10#1)(2008-9#3)
fructose and##6##2##(1995-11#1)(2008-10#1)(2008-7#1)(2008-9#3)
fructose in##3##2##(1990-2#1)(1994-3#1)(2008-10#1)
fructose or##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
fructose to glucose##2##3##(2008-6#2)
fructose##65##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#6)(1990-8#1)(1992-12#1)(1993-12#1)(1994-3#2)(1994-8#3)(1995-11#1)(1995-2#4)(1996-2#2)(1996-5#1)(1996-6#2)(2008-10#13)(2008-11#1)(2008-5#1)(2008-6#6)(2008-7#3)(2008-9#5)(2010-2#1)(2012-1#1)(2012-2#6)
fructose-1##10##1##(1992-8#1)(1995-3#1)(1995-8#1)(2008-9#6)(2010-12#1)
fructose-2##5##1##(1990-5#4)(1992-3#1)
fructose-6-phosphate##2##1##(1995-2#1)(1997-2#1)
fructose-induced##3##1##(1990-8#1)(2012-3#2)
frugiperda##24##1##(1992-3#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#1)(1995-2#1)(1997-4#2)(2008-11#12)(2008-7#4)
frugiperda)##3##1##(1997-4#1)(2008-10#1)(2008-9#1)
fruit abortion##2##2##(2008-8#2)
fruit against##3##2##(2008-10#3)
fruit age##2##2##(1993-3#1)(2008-10#1)
fruit and vegetable consumption##2##4##(2008-7#1)(2009-4#1)
fruit and vegetable intake##2##4##(1992-10#1)(2013-1#1)
fruit and vegetable##8##3##(1992-10#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
fruit and vegetables and##2##4##(1990-8#1)(1994-2#1)
fruit and vegetables##5##3##(1990-8#1)(1994-2#2)(1997-1#1)(2009-3#1)
fruit and was##2##3##(2008-10#2)
fruit and##31##2##(1990-8#1)(1992-10#1)(1994-2#2)(1997-1#1)(2008-10#15)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
fruit are##5##2##(2008-10#5)
fruit become nearly immune to infection##2##6##(2008-10#2)
fruit blotch##3##2##(2008-10#3)
fruit by##5##2##(2008-10#4)(2008-11#1)
fruit clusters##5##2##(2008-10#5)
fruit collection##2##2##(2008-10#2)
fruit crops##2##2##(2008-10#1)(2011-2#1)
fruit decay##2##2##(2008-10#2)
fruit declined##2##2##(2008-10#2)
fruit development##15##2##(2008-10#6)(2008-9#9)
fruit developmental stage##2##3##(2008-10#2)
fruit developmental stages##5##3##(2008-10#5)
fruit developmental##7##2##(2008-10#7)
fruit disease incidence##3##3##(2008-10#3)
fruit disease##5##2##(2008-10#5)
fruit during##5##2##(1993-3#1)(2008-10#3)(2011-2#1)
fruit extract##5##2##(1992-3#1)(2008-11#1)(2008-5#2)(2009-6#1)
fruit flies##6##2##(2008-3#1)(2010-4#1)(2013-8#4)
fruit fly (Ceratitis##2##3##(2008-11#2)
fruit fly population##2##3##(2013-8#2)
fruit fly##18##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-8#4)
fruit from diseased##2##3##(2008-10#2)
fruit from the##3##3##(2008-10#3)
fruit from##6##2##(2008-10#6)
fruit have##2##2##(2008-10#2)
fruit in the tree##3##4##(2008-10#3)
fruit in the##4##3##(2008-10#4)
fruit in##12##2##(2008-10#12)
fruit infection in##2##3##(2008-10#2)
fruit infection##9##2##(2008-10#9)
fruit infections##4##2##(2008-10#4)
fruit juice##9##2##(2008-10#8)(2008-5#1)
fruit juices and##8##3##(2008-10#7)(2009-8#1)
fruit juices##18##2##(2008-10#17)(2009-8#1)
fruit mummies##2##2##(2008-10#2)
fruit numbers##2##2##(2008-10#1)(2008-5#1)
fruit of V##2##3##(2008-10#2)
fruit of##15##2##(2008-10#7)(2008-9#1)(2013-1#3)(2013-7#1)(2013-8#3)
fruit on the ground##2##4##(2008-10#2)
fruit on the##3##3##(2008-10#3)
fruit or##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
fruit prior to shellacking##2##4##(2008-10#2)
fruit production in##2##3##(2008-10#1)(2008-5#1)
fruit production##5##2##(2008-10#2)(2008-5#2)(2011-2#1)
fruit pulp extract##2##3##(2008-5#2)
fruit pulp##4##2##(2008-5#3)(2008-9#1)
fruit resistance##2##2##(2008-10#2)
fruit ripening and quality##2##4##(2011-2#2)
fruit ripening##7##2##(2008-10#1)(2008-12#1)(2011-2#5)
fruit rot##8##2##(2008-10#8)
fruit russet severity##3##3##(2008-10#3)
fruit russet##7##2##(2008-10#7)
fruit samples##4##2##(2008-10#3)(2008-3#1)
fruit scab##5##2##(2008-10#5)
fruit set##6##2##(2008-10#6)
fruit showed that##2##3##(2008-10#1)(2008-9#1)
fruit showed##3##2##(2008-10#2)(2008-9#1)
fruit softening##4##2##(2008-10#2)(2011-2#2)
fruit susceptibility to latent infection##2##5##(2008-10#2)
fruit susceptibility to##3##3##(2008-10#3)
fruit susceptibility##8##2##(2008-10#8)
fruit that##2##2##(2008-10#2)
fruit tissue##5##2##(2008-10#5)
fruit tissues##4##2##(2008-10#4)
fruit to##4##2##(2008-10#3)(2011-2#1)
fruit treated by##2##3##(2008-10#2)
fruit tree##5##2##(2008-10#5)
fruit trees##7##2##(2008-10#7)
fruit was##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
fruit were inoculated with P##2##5##(2008-10#2)
fruit were inoculated with##3##4##(2008-10#3)
fruit were inoculated##5##3##(2008-10#5)
fruit were##13##2##(2008-10#13)
fruit wetness sources##2##3##(2008-10#2)
fruit wetness##3##2##(2008-10#3)
fruit with##11##2##(2008-10#11)
fruit yield##5##2##(2008-10#5)
fruit##525##1##(1990-8#1)(1992-10#1)(1992-3#2)(1993-3#4)(1994-2#2)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-5#2)(2008-10#396)(2008-11#5)(2008-12#6)(2008-3#3)(2008-4#1)(2008-5#13)(2008-7#2)(2008-8#2)(2008-9#18)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#22)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#14)
fruit)##2##1##(2008-10#1)(2012-1#1)
fruit-rotting fungi in##2##3##(2008-10#2)
fruitful##11##1##(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-2#1)
fruiting bodies and##2##3##(2008-10#2)
fruiting bodies from##3##3##(2008-10#2)(2009-8#1)
fruiting bodies were##2##3##(2008-10#2)
fruiting bodies##12##2##(2008-10#10)(2008-8#1)(2009-8#1)
fruiting body##5##2##(2008-10#1)(2008-8#2)(2009-8#1)(2011-2#1)
fruiting of##2##2##(2008-8#1)(2012-4#1)
fruiting##27##1##(2008-10#13)(2008-12#2)(2008-6#2)(2008-8#4)(2008-9#1)(2009-8#2)(2011-2#2)(2012-4#1)
fruition##4##1##(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#1)
fruits and leaves##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
fruits and seeds##2##3##(2008-5#1)(2008-9#1)
fruits and vegetables and##2##4##(2008-10#1)(2011-1#1)
fruits and vegetables which##2##4##(2007-12#1)(2012-2#1)
fruits and vegetables##25##3##(1990-8#2)(1991-2#1)(2007-12#1)(2008-10#1)(2008-4#2)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-2#6)(2013-1#3)(2013-8#1)
fruits and##38##2##(1990-8#2)(1991-2#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-9#2)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#7)(2013-1#3)(2013-8#1)
fruits are##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
fruits by##2##2##(1997-6#1)(2008-3#1)
fruits collected in##2##3##(2012-2#2)
fruits in##4##2##(2008-10#3)(2008-3#1)
fruits is##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
fruits may##2##2##(2008-10#2)
fruits of C##2##3##(2008-10#1)(2013-1#1)
fruits of cv##2##3##(2008-10#2)
fruits of##15##2##(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2010-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
fruits or vegetables##3##3##(1994-2#1)(2010-8#1)(2011-1#1)
fruits or##4##2##(1994-2#1)(2008-10#1)(2010-8#1)(2011-1#1)
fruits to##2##2##(2008-10#1)(2008-5#1)
fruits was##3##2##(1997-6#1)(2008-10#1)(2008-5#1)
fruits were##6##2##(2008-10#2)(2008-12#2)(2013-7#2)
fruits with##5##2##(2008-10#5)
fruits##176##1##(1990-8#2)(1991-2#1)(1992-3#2)(1993-11#1)(1994-2#1)(1997-4#1)(1997-6#6)(2007-12#1)(2008-10#70)(2008-11#8)(2008-12#11)(2008-3#3)(2008-4#5)(2008-5#11)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#4)(2012-12#2)(2012-2#16)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#2)(2013-8#1)
frustrate##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
frustrated total internal reflection##2##4##(2008-3#2)
frustrated##8##1##(1992-11#1)(1997-3#1)(2008-1#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)
frustrating for##2##2##(2008-9#1)(2011-2#1)
frustrating##7##1##(1993-12#1)(1994-1#1)(1994-12#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
frustration and##2##2##(2008-12#1)(2009-10#1)
frustration##16##1##(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2009-10#2)(2009-9#1)(2011-2#1)(2012-3#2)
frustrations##2##1##(1993-2#1)(1993-3#1)
frutescens##5##1##(2008-10#5)
fruticosa##6##1##(2008-10#3)(2008-11#3)
fry were##2##2##(1992-6#2)
fry##13##1##(1992-6#4)(2008-12#1)(2008-6#2)(2010-8#6)
frying or grilling##2##3##(1994-3#1)(1997-2#1)
frying##7##1##(1994-3#1)(1997-2#1)(2008-10#4)(2008-6#1)
fréquente##3##1##(2011-2#1)(2013-1#2)
fs (25##2##2##(2007-12#2)
fs and##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
fs are generated with##2##4##(2007-12#1)(2008-2#1)
fs are##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
fs at a##2##3##(2007-12#2)
fs at##8##2##(2007-11#2)(2007-12#5)(2008-2#1)
fs by##2##2##(2007-11#2)
fs can be##2##3##(2007-11#1)(2007-12#1)
fs for##3##2##(2007-11#2)(2008-3#1)
fs is##2##2##(2007-11#2)
fs pulse##2##2##(2007-12#1)(2012-2#1)
fs were##2##2##(2007-11#1)(2008-3#1)
fs with##3##2##(2007-12#3)
fs##58##1##(2007-11#19)(2007-12#26)(2008-10#1)(2008-2#4)(2008-3#6)(2011-1#1)(2012-2#1)
fs(2) at the##2##3##(2008-2#2)
fs(2)##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
fsDNA over##3##2##(2008-10#3)
fsDNA##4##1##(2008-10#4)
ft above sea level)##2##4##(1990-8#2)
ft above sea##3##3##(1990-8#3)
ft##5##1##(1990-8#3)(2008-10#1)(2008-3#1)
ftz##4##1##(1993-9#4)
fuberidazole and thiabendazole in water##2##5##(2008-10#2)
fuberidazole and thiabendazole##3##3##(2008-10#3)
fuberidazole and##4##2##(2008-10#4)
fuberidazole##8##1##(2008-10#8)
fuckeliana##10##1##(1997-2#3)(1997-4#5)(2008-10#2)
fucoidan extracts on##3##3##(2008-11#3)
fucoidan extracts##10##2##(2008-11#10)
fucoidan##11##1##(2008-11#11)
fucose##12##1##(1990-7#1)(1990-8#5)(1992-8#1)(1994-11#1)(2008-11#3)(2008-5#1)
fucosylated##6##1##(1994-5#1)(2008-11#3)(2008-5#1)(2008-8#1)
fucosyltransferase##4##1##(1992-8#3)(1995-2#1)
fuel alcohol##3##2##(2008-10#3)
fuel ethanol from##2##3##(2008-6#2)
fuel ethanol##6##2##(2008-10#4)(2008-6#2)
fuel for##2##2##(2010-12#1)(2012-3#1)
fuel gas##2##2##(2008-6#2)
fuel in##2##2##(2008-10#2)
fuel oil##2##2##(2008-10#2)
fuel spray##3##2##(2008-3#3)
fuel surface##2##2##(2008-2#1)(2008-3#1)
fuel the##2##2##(2010-4#1)(2011-2#1)
fuel was##2##2##(2008-10#2)
fuel##78##1##(1990-2#1)(1990-8#1)(1992-10#1)(1993-11#1)(1997-6#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-2#4)(2008-3#10)(2008-5#4)(2008-6#6)(2008-7#3)(2009-3#1)(2009-8#2)(2010-12#2)(2010-4#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
fuel-concentration measurement technique##2##3##(2008-2#2)
fuel-like fractions##2##2##(2008-10#2)
fuel-like##3##1##(2008-10#3)
fuel-rich##2##1##(2008-2#1)(2008-3#1)
fuel-vapor concentrations##2##2##(2008-2#2)
fuel-vapor##3##1##(2008-2#2)(2008-3#1)
fueled by##3##2##(1995-2#1)(1997-1#1)(2008-1#1)
fueled##6##1##(1995-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-5#1)
fuelled by##2##2##(2006-10#1)(2011-1#1)
fuelled##4##1##(2006-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
fuels and##5##2##(2008-10#4)(2012-3#1)
fuels##26##1##(2008-10#11)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-3#2)
fugax is##2##2##(2011-2#2)
fugax##3##1##(1992-5#1)(2011-2#2)
fujikuroi##6##1##(2008-10#3)(2008-5#3)
fulfil the requirements##2##3##(2008-10#2)
fulfil the##5##2##(1992-11#1)(1997-2#1)(2008-10#3)
fulfil these##2##2##(1994-7#1)(2008-5#1)
fulfil##15##1##(1991-3#1)(1992-11#1)(1994-7#1)(1995-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-10#1)(2012-2#1)
fulfill a##3##2##(1993-8#1)(2010-1#1)(2010-10#1)
fulfill the criteria##2##3##(1997-8#1)(2009-4#1)
fulfill the requirements for##2##4##(2008-2#2)
fulfill the requirements##3##3##(2008-2#2)(2009-6#1)
fulfill the##7##2##(1997-8#1)(2008-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#1)
fulfill this requirement##2##3##(1996-4#1)(2008-10#1)
fulfill this##3##2##(1996-4#1)(2008-10#2)
fulfill##23##1##(1991-12#1)(1993-8#1)(1994-2#1)(1995-1#2)(1995-11#1)(1996-4#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)
fulfilled in##2##2##(2007-12#1)(2008-12#1)
fulfilled the criteria for##2##4##(2006-8#1)(2008-6#1)
fulfilled the criteria##3##3##(2006-8#1)(2008-6#1)(2009-3#1)
fulfilled the diagnostic criteria for##2##5##(2008-7#1)(2013-1#1)
fulfilled the inclusion criteria##4##4##(2008-1#1)(2008-5#1)(2011-1#2)
fulfilled the inclusion##5##3##(2008-1#1)(2008-5#1)(2011-1#2)(2011-2#1)
fulfilled the##13##2##(2006-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-1#2)(2011-2#2)(2013-1#1)
fulfilled##35##1##(1991-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-6#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
fulfilling the##6##2##(1990-9#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
fulfilling##15##1##(1990-9#1)(1994-3#1)(1995-11#1)(1996-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
fulfillment of##5##2##(1992-3#2)(1995-1#1)(2008-10#1)(2010-8#1)
fulfillment##8##1##(1992-3#2)(1995-1#2)(2008-10#2)(2008-11#1)(2010-8#1)
fulfills all the requirements##2##4##(2008-10#1)(2008-2#1)
fulfills all the##3##3##(2008-10#2)(2008-2#1)
fulfills the##4##2##(2008-11#2)(2008-12#1)(2008-2#1)
fulfills##8##1##(1990-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)
fulfils the##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
fulgidum##2##1##(2008-11#2)
fulgimide##4##1##(2009-9#4)
fulguration##2##1##(1995-1#1)(2008-10#1)
fulica##2##1##(1991-5#2)
full HBV##2##2##(2008-9#2)
full account of##2##3##(2010-7#1)(2013-8#1)
full activity##4##2##(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#1)
full advantage of##7##3##(1994-2#1)(1996-4#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)
full agonist##5##2##(1992-8#1)(1995-11#1)(1995-3#1)(2008-4#1)(2009-8#1)
full agonists##3##2##(1995-11#1)(1995-12#1)(2008-11#1)
full and##5##2##(1994-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
full beam##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
full blood##3##2##(2008-12#1)(2009-10#1)(2011-1#1)
full bloom##6##2##(2008-10#6)
full characterization of##2##3##(2007-12#2)
full clinical##2##2##(2009-8#1)(2013-8#1)
full complement of##4##3##(1992-8#1)(1995-5#1)(2010-8#1)(2011-2#1)
full control of the##2##4##(2008-10#1)(2012-2#1)
full control of##3##3##(2008-10#2)(2012-2#1)
full control##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
full coverage##7##2##(2008-10#6)(2010-12#1)
full details##2##2##(1994-6#1)(2008-9#1)
full diagnostic##2##2##(2010-10#1)(2010-8#1)
full differential amplifier##3##3##(2011-1#3)
full diffraction##2##2##(2008-3#2)
full dynamic range##2##3##(2008-3#2)
full exploitation of##3##3##(2007-11#1)(2008-7#1)(2011-1#1)
full expression of##2##3##(1990-2#1)(1995-12#1)
full face transplantation##2##3##(2013-1#2)
full face##3##2##(2013-1#3)
full facial##2##2##(2008-5#2)
full factorial design##7##3##(2008-10#7)
full factorial##9##2##(2008-10#8)(2008-11#1)
full fixed##2##2##(2011-7#2)
full genome##3##2##(2008-5#1)(2008-8#2)
full hospitalization##2##2##(1991-1#2)
full induction of##2##3##(2008-10#2)
full information##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
full length cDNA encoding##2##4##(1994-6#1)(1997-7#1)
full length cDNA##6##3##(1991-9#2)(1992-8#1)(1994-6#2)(1997-7#1)
full length cDNAs##2##3##(1995-8#1)(2008-8#1)
full length##23##2##(1991-5#2)(1991-9#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#2)(1995-12#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-2#1)
full liver##2##2##(2010-12#1)(2012-2#1)
full measuring range##2##3##(2008-10#1)(2008-11#1)
full model##4##2##(2008-11#1)(2008-3#1)(2011-2#2)
full moon##2##2##(2011-2#1)(2013-1#1)
full of##2##2##(2008-5#1)(2013-8#1)
full or##3##2##(2008-12#1)(2008-8#1)(2009-11#1)
full phase##3##2##(2008-3#2)(2008-8#1)
full potential of##8##3##(1994-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)
full potential##12##2##(1994-3#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)
full range of motion##3##4##(2012-12#1)(2013-1#2)
full range of##15##3##(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#2)
full range##16##2##(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
full recovery and##2##3##(2011-2#1)(2012-12#1)
full recovery of the##2##4##(2007-8#1)(2008-3#1)
full recovery of##4##3##(2007-8#1)(2008-1#1)(2008-3#2)
full recovery##16##2##(1995-12#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
full scale##5##2##(1996-12#1)(2008-1#1)(2008-3#1)(2008-7#2)
full scan##3##2##(2008-10#2)(2008-3#1)
full service##2##2##(1996-2#2)
full set of##5##3##(2008-10#3)(2008-7#1)(2010-8#1)
full siblings##2##2##(1995-6#2)
full spectrum of##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-3#1)
full spectrum##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
full speed##2##2##(1995-5#1)(2009-6#1)
full sunlight##2##2##(2008-8#2)
full term and##2##3##(2007-11#1)(2008-12#1)
full term infants##5##3##(1990-11#2)(2007-11#1)(2011-2#2)
full term##9##2##(1990-11#2)(1990-8#1)(2007-11#2)(2008-12#1)(2011-2#3)
full text screening##2##3##(2013-1#2)
full text##4##2##(2011-2#1)(2013-1#3)
full texts of##2##3##(2009-11#1)(2011-1#1)
full texts##4##2##(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
full thickness skin graft##2##4##(2013-1#2)
full thickness##6##2##(1992-8#1)(2008-5#2)(2010-1#1)(2013-1#2)
full time##4##2##(1992-6#1)(1993-1#1)(2008-10#1)(2012-2#1)
full understanding of the##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
full understanding of##6##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2013-8#1)
full use of the##5##4##(1997-4#1)(2008-2#1)(2008-8#1)(2010-6#1)(2013-8#1)
full use of##7##3##(1997-4#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)(2013-8#1)
full width at half-maximum of the##2##6##(2008-2#1)(2008-3#1)
full width at half-maximum of##5##5##(2008-2#2)(2008-3#2)(2013-8#1)
full width at half-maximum##10##4##(2007-12#1)(2008-2#4)(2008-3#3)(2013-8#2)
full width at##11##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2013-8#2)
full working##2##2##(2007-11#1)(2008-10#1)
full##510##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1995-1#1)(1995-11#3)(1995-12#8)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#21)(2007-12#14)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#70)(2008-11#16)(2008-12#11)(2008-2#18)(2008-3#42)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#20)(2008-8#12)(2008-9#12)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#14)(2011-2#23)(2011-7#2)(2012-12#3)(2012-2#18)(2012-3#10)(2013-1#18)(2013-7#1)(2013-8#12)
full- and##4##2##(2008-10#1)(2008-3#3)
full-aperture##3##1##(2008-3#3)
full-blown PCOS##2##2##(2008-4#2)
full-blown##9##1##(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-4#2)(2009-8#2)
full-color images##2##2##(2007-11#1)(2007-12#1)
full-color##9##1##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)(2008-7#1)
full-field##5##1##(2007-11#2)(2008-9#1)(2009-10#1)(2012-2#1)
full-fledged##2##1##(1996-2#1)(2008-12#1)
full-length LysK##2##2##(2009-6#2)
full-length PCR##2##2##(2008-9#1)(2011-2#1)
full-length RGP##4##2##(1995-2#4)
full-length RNA##3##2##(2008-2#1)(2008-7#1)(2008-9#1)
full-length cDNA clone##7##3##(1991-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1997-3#1)(2008-10#2)
full-length cDNA clones of##3##4##(1995-8#1)(2008-10#2)
full-length cDNA clones##4##3##(1992-10#1)(1995-8#1)(2008-10#2)
full-length cDNA encoding the##2##4##(1993-8#1)(1994-12#1)
full-length cDNA encoding##5##3##(1991-2#1)(1992-9#1)(1993-8#1)(1994-12#2)
full-length cDNA of##6##3##(1997-7#1)(2008-10#1)(2008-8#4)
full-length cDNA sequence##2##3##(1996-2#1)(2008-10#1)
full-length cDNA sequences##2##3##(1993-8#1)(2010-5#1)
full-length cDNA was##4##3##(1990-2#1)(1993-3#1)(1995-12#1)(1997-7#1)
full-length cDNA##43##2##(1990-2#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#1)(1997-7#2)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#7)(2010-5#1)
full-length cDNAs##5##2##(1993-2#1)(1996-10#1)(1997-2#1)(2008-7#1)(2009-10#1)
full-length clone##2##2##(1997-9#1)(2008-9#1)
full-length human apoB mRNA##2##4##(1992-11#2)
full-length human##8##2##(1991-7#1)(1992-11#4)(1994-11#1)(1994-12#1)(1996-12#1)
full-length or##2##2##(1995-2#1)(2011-2#1)
full-length proteins##2##2##(1991-5#1)(2008-1#1)
full-length rat##2##2##(1990-11#1)(1990-8#1)
full-length reCsnSN##2##2##(1994-12#2)
full-length receptor##2##2##(1993-8#2)
full-length recombinant human##2##3##(1995-12#1)(2008-11#1)
full-length sequence##2##2##(2008-10#1)(2008-8#1)
full-length transcripts##3##2##(1996-10#1)(1996-2#1)(1997-2#1)
full-length##152##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#4)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#6)(1994-11#3)(1994-12#6)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#10)(1995-6#3)(1995-8#2)(1996-10#2)(1996-12#4)(1996-2#2)(1996-3#2)(1997-2#6)(1997-3#1)(1997-4#2)(1997-7#3)(1997-9#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#11)(2009-10#1)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
full-mouth rehabilitation##3##2##(2008-7#1)(2009-8#2)
full-mouth##4##1##(2008-7#1)(2009-8#3)
full-parallax##2##1##(2008-2#1)(2008-3#1)
full-range##3##1##(2011-1#3)
full-risk##2##1##(1995-3#1)(1996-1#1)
full-scale fire tests##2##3##(1996-12#2)
full-scale##10##1##(1996-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-10#1)
full-scan##2##1##(2008-3#2)
full-sib families##2##2##(2008-10#1)(2011-2#1)
full-sib##3##1##(2008-10#2)(2011-2#1)
full-size##4##1##(1992-12#1)(1993-6#1)(2008-2#1)(2011-2#1)
full-swing##4##1##(2011-2#4)
full-term infants##3##2##(1995-8#1)(2008-10#1)(2012-2#1)
full-term##10##1##(1994-12#1)(1995-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2011-2#1)(2012-2#1)
full-text access to##2##3##(1991-3#2)
full-text biomedical articles##3##3##(2010-12#3)
full-text biomedical##4##2##(2010-12#4)
full-text##13##1##(1991-2#2)(1991-3#2)(1994-1#2)(1996-12#1)(2010-12#4)(2012-12#2)
full-thickness skin##2##2##(2011-2#1)(2012-3#1)
full-thickness slice ovarian##2##3##(1996-2#2)
full-thickness slice##4##2##(1996-2#4)
full-thickness##9##1##(1996-2#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
full-time employees##2##2##(1991-2#1)(2008-11#1)
full-time equivalent##4##2##(1991-3#1)(1993-1#1)(1993-12#1)(1995-3#1)
full-time staff##2##2##(1991-5#1)(1996-1#1)
full-time use within 12 months##2##5##(2012-2#2)
full-time use within##3##3##(2012-2#3)
full-time##30##1##(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#5)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(2008-1#1)(2008-11#3)(2012-1#1)(2012-2#3)
full-vectorial##3##1##(2007-12#1)(2008-3#2)
full-wave vector##2##2##(2008-2#1)(2008-3#1)
full-wave##3##1##(2008-2#1)(2008-3#1)(2013-8#1)
fuller##3##1##(2008-1#1)(2008-11#1)(2008-8#1)
fullerene in##2##2##(2008-10#1)(2008-12#1)
fullerene soot##3##2##(2008-10#3)
fullerene##10##1##(2008-10#5)(2008-12#2)(2008-7#2)(2008-8#1)
fullerene-like structures##2##2##(2008-10#1)(2008-7#1)
fullerene-like##4##1##(2008-10#1)(2008-7#3)
fullerenes and##3##2##(2008-7#3)
fullerenes##14##1##(2008-10#2)(2008-2#3)(2008-7#6)(2008-8#2)(2012-2#1)
fullness##4##1##(1993-6#1)(2008-5#1)(2011-2#1)(2012-3#1)
fullterm and preterm##2##3##(1990-12#2)
fullterm and##3##2##(1990-12#2)(1993-12#1)
fullterm##4##1##(1990-12#2)(1993-12#2)
fully 3-D##2##2##(2008-3#1)(2009-5#1)
fully activated##2##2##(1995-2#1)(2007-5#1)
fully active##10##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-7#2)(2009-10#1)
fully addressed##2##2##(2010-8#1)(2012-2#1)
fully annotated##3##2##(2010-3#3)
fully appreciate the##2##3##(2008-9#1)(2012-3#1)
fully assembled##2##2##(2008-8#1)(2011-2#1)
fully automated and##3##3##(2008-10#2)(2008-3#1)
fully automated flow##2##3##(2008-10#2)
fully automated system##2##3##(2008-10#1)(2008-3#1)
fully automated##38##2##(1990-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-3#1)(1997-3#1)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2009-11#1)(2010-5#1)(2011-1#1)
fully automatic##3##2##(2006-4#1)(2008-10#1)(2008-2#1)
fully automation##2##2##(2008-10#2)
fully autonomous##2##2##(2008-2#1)(2010-7#1)
fully characterized##10##2##(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2012-3#1)
fully closed##2##2##(1997-4#1)(2012-2#1)
fully comparable with##2##3##(1992-3#1)(2010-12#1)
fully compatible with the##2##4##(1995-12#2)
fully connected##3##2##(2008-2#1)(2008-3#2)
fully consistent##2##2##(2007-11#1)(2008-8#1)
fully continuous##3##2##(2008-2#3)
fully define the##2##3##(2009-7#1)(2011-3#1)
fully defined protein-free medium##2##4##(2008-11#2)
fully defined protein-free##3##3##(2008-11#3)
fully defined##4##2##(1995-2#1)(2008-11#3)
fully determined##4##2##(2007-11#1)(2007-12#1)(2008-8#1)(2008-9#1)
fully developed##10##2##(1991-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#2)(2011-2#1)
fully differentiated##3##2##(1990-11#1)(2008-11#1)(2009-12#1)
fully electronic##2##2##(2007-12#1)(2008-3#1)
fully elucidated and##2##3##(1991-6#1)(2008-5#1)
fully elucidated##11##2##(1990-2#1)(1991-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
fully equipped##2##2##(1990-4#1)(2009-12#1)
fully established##7##2##(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
fully evaluated##3##2##(1994-2#1)(2008-1#1)(2008-10#1)
fully explained by##3##3##(1992-8#1)(1997-3#1)(2010-8#1)
fully explained##5##2##(1992-8#1)(1997-3#1)(2008-11#1)(2009-12#1)(2010-8#1)
fully exploited##5##2##(1994-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)
fully explore##4##2##(2008-10#1)(2010-3#1)(2010-4#1)(2013-1#1)
fully explored##2##2##(2008-7#1)(2009-7#1)
fully expressed##2##2##(2008-11#1)(2012-1#1)
fully functional##3##2##(1992-8#1)(2008-11#1)(2008-3#1)
fully human##2##2##(2008-10#1)(2008-7#1)
fully hydrated##5##2##(1990-2#1)(1990-7#2)(2008-5#2)
fully identified##3##2##(1994-3#1)(1994-6#1)(2008-5#1)
fully immunized##2##2##(1996-3#2)
fully inactivated##2##2##(1993-8#1)(1994-11#1)
fully informed consent##2##3##(1992-3#1)(1995-9#1)
fully informed##3##2##(1992-3#1)(1995-9#1)(2010-3#1)
fully integrated##5##2##(1990-11#1)(1991-12#1)(2007-11#1)(2008-1#1)(2008-4#1)
fully investigated##2##2##(2008-10#1)(2011-2#1)
fully kindled##2##2##(1990-5#1)(1996-12#1)
fully liquid##2##2##(2008-10#2)
fully mature##2##2##(1994-11#1)(2008-10#1)
fully operational##3##2##(1992-3#1)(2007-11#1)(2008-3#1)
fully or partially##2##3##(2008-5#1)(2012-3#1)
fully oxidized##2##2##(1990-8#1)(2008-10#1)
fully oxygenated##2##2##(1990-8#1)(1997-2#1)
fully parallel##2##2##(2008-2#2)
fully phase- and amplitude-based encryption##4##5##(2008-3#4)
fully phase-based##2##2##(2008-3#2)
fully phased-in##2##2##(1996-3#2)
fully protected##2##2##(1994-8#1)(1997-4#1)
fully qualified##2##2##(1992-11#1)(2008-7#1)
fully quantitative and##2##3##(2008-10#2)
fully realized##2##2##(2008-3#1)(2010-12#1)
fully recapitulate##2##2##(2009-3#1)(2011-1#1)
fully recognized##2##2##(2008-10#1)(2013-8#1)
fully recombinant##2##2##(2008-10#2)
fully recovered from##2##3##(2008-12#1)(2008-7#1)
fully recovered##7##2##(2008-12#1)(2008-7#4)(2012-1#1)(2013-1#1)
fully resistant to##2##3##(2008-10#2)
fully resistant##4##2##(2008-10#4)
fully resolved##2##2##(2008-8#1)(2009-6#1)
fully restored##2##2##(1991-9#1)(2009-10#1)
fully reversed by##2##3##(1995-12#1)(2009-9#1)
fully reversible and##3##3##(1992-12#1)(2008-10#2)
fully reversible##8##2##(1992-12#1)(1996-2#1)(2008-10#5)(2008-11#1)
fully saturated##2##2##(2012-2#2)
fully sequenced##5##2##(2008-10#2)(2008-11#1)(2009-10#1)(2010-3#1)
fully spatially coherent##2##3##(2007-12#2)
fully support##3##2##(1992-3#1)(2009-6#1)(2012-12#1)
fully susceptible to##5##3##(2008-10#4)(2011-2#1)
fully susceptible##8##2##(2008-10#6)(2008-8#1)(2011-2#1)
fully the##2##2##(2007-12#1)(2008-7#1)
fully transparent##2##2##(2008-7#2)
fully understand##4##2##(1990-12#1)(1993-3#1)(2012-12#1)(2012-2#1)
fully understood and##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
fully understood##37##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
fully validated and##3##3##(1996-12#1)(2008-10#1)(2011-1#1)
fully validated##6##2##(1996-12#1)(2008-10#4)(2011-1#1)
fully##534##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#7)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#1)(1997-2#6)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#2)(2006-4#1)(2007-11#11)(2007-12#14)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#87)(2008-11#26)(2008-12#8)(2008-2#20)(2008-3#40)(2008-4#12)(2008-5#8)(2008-6#4)(2008-7#26)(2008-8#11)(2008-9#4)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#3)(2010-3#6)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#15)(2011-3#2)(2012-1#3)(2012-12#5)(2012-2#13)(2012-3#8)(2013-1#12)(2013-8#4)
fully-automated##2##1##(2008-10#2)
fully-grown oocytes (phase V oocytes)##2##5##(2008-8#2)
fulminant course##2##2##(2007-5#1)(2008-7#1)
fulminant hepatic failure##3##3##(1991-11#1)(1992-5#1)(2007-7#1)
fulminant hepatitis in##2##3##(1994-8#1)(1996-3#1)
fulminant hepatitis##5##2##(1994-8#1)(1996-3#1)(2007-7#2)(2013-1#1)
fulminant liver failure##2##3##(2008-11#1)(2013-1#1)
fulminant##22##1##(1991-11#1)(1992-5#1)(1993-10#1)(1994-8#1)(1996-3#1)(1997-8#1)(2007-5#1)(2007-7#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#3)(2013-1#3)
fulminating##3##1##(2008-12#1)(2009-4#1)(2011-2#1)
fulvellum##2##1##(2008-10#1)(2008-11#1)
fulvic acid##10##2##(2008-10#10)
fulvic acids (FA)##3##3##(2008-10#3)
fulvic acids##9##2##(2008-10#9)
fulvic and humic acids##4##4##(2008-10#4)
fulvic##25##1##(2008-10#24)(2008-3#1)
fumagillol (TNP-470)##2##2##(1994-12#2)
fumarate reductase##4##2##(1996-8#3)(2008-6#1)
fumarate##9##1##(1993-11#1)(1993-6#1)(1993-8#1)(1996-8#3)(2008-6#1)(2008-7#1)(2013-1#1)
fumaric acid to##2##3##(2008-6#2)
fumaric acid##12##2##(2008-10#5)(2008-6#7)
fumaric##14##1##(1994-9#1)(2008-10#5)(2008-6#8)
fume##13##1##(1991-3#1)(2008-10#12)
fumes##7##1##(1991-4#2)(1992-6#1)(2007-11#1)(2008-10#2)(2013-1#1)
fumigant emissions##2##2##(2008-10#2)
fumigant##7##1##(2008-10#5)(2011-2#2)
fumigants will##2##2##(2008-10#2)
fumigants##12##1##(2008-10#12)
fumigated control##2##2##(2008-10#2)
fumigated field soil##2##3##(2008-10#2)
fumigated field##3##2##(2008-10#3)
fumigated or nonfumigated soil##2##4##(2008-10#2)
fumigated plots##3##2##(2008-10#3)
fumigated poplars##2##2##(2008-11#2)
fumigated soil##2##2##(2008-10#2)
fumigated versus##2##2##(2008-10#2)
fumigated with##2##2##(2008-10#2)
fumigated##21##1##(2008-10#19)(2008-11#2)
fumigation of##2##2##(2008-10#1)(2011-2#1)
fumigation with methyl bromide##4##4##(2008-10#4)
fumigation with##5##2##(2008-10#5)
fumigation##17##1##(1995-3#1)(2008-10#10)(2008-11#1)(2011-2#5)
fumigation-induced nonsuppressive##2##2##(2008-10#2)
fumigatus 2140 and##2##3##(1994-3#2)
fumigatus##15##1##(1990-11#1)(1994-3#3)(1997-3#1)(2008-1#2)(2008-10#3)(2008-9#1)(2009-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
fuming sulphuric acid##2##3##(2008-10#2)
fumonisin B(1)##3##2##(2008-10#3)
fumonisin B(2)##2##2##(2008-10#2)
fumonisin and aflatoxin##2##3##(2008-10#2)
fumonisin and##3##2##(2008-10#3)
fumonisin concentration in grain##2##4##(2008-10#2)
fumonisin concentration##5##2##(2008-10#3)(2013-1#2)
fumonisin contamination##6##2##(2008-10#6)
fumonisin in##2##2##(2008-10#1)(2013-1#1)
fumonisin production##4##2##(2008-10#2)(2013-1#2)
fumonisin##34##1##(1995-3#1)(2008-10#27)(2013-1#6)
fumonisin-producing fungus added##3##3##(2013-1#3)
fumonisin-producing fungus##4##2##(2013-1#4)
fumonisins##7##1##(1995-3#1)(2008-10#5)(2010-7#1)
fun##5##1##(1994-3#1)(1996-12#1)(2009-10#1)(2010-4#1)(2013-1#1)
function (the##2##2##(2007-12#1)(2008-3#1)
function abnormalities##2##2##(2007-10#1)(2008-4#1)
function across##2##2##(2008-7#1)(2012-2#1)
function after##10##2##(1992-12#1)(1993-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
function against##2##2##(2008-10#1)(2008-5#1)
function also##2##2##(2013-1#2)
function alterations##2##2##(2008-7#2)
function among##4##2##(1994-5#1)(2008-10#1)(2008-8#1)(2013-8#1)
function analyses##3##2##(1993-5#1)(2008-7#1)(2012-2#1)
function analysis of##3##3##(1991-1#1)(2008-8#1)(2008-9#1)
function analysis##12##2##(1991-1#1)(1992-11#2)(1994-2#1)(1994-3#1)(1995-6#3)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
function and a##6##3##(2008-10#1)(2008-2#3)(2008-8#1)(2012-12#1)
function and activation##2##3##(1995-8#1)(2011-1#1)
function and an##2##3##(1991-12#1)(2008-10#1)
function and are##2##3##(1994-11#1)(2008-4#1)
function and brain##2##3##(2007-11#1)(2008-7#1)
function and can##2##3##(2008-12#1)(2008-3#1)
function and clinical##2##3##(1995-12#1)(1997-1#1)
function and development##2##3##(2008-9#1)(2010-11#1)
function and differentiation##2##3##(1994-11#1)(2008-5#1)
function and evolutionary##2##3##(2007-12#1)(2009-5#1)
function and formation -##2##4##(2008-5#2)
function and formation##3##3##(2008-5#3)
function and have##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
function and in##2##3##(2007-11#1)(2008-10#1)
function and integrity##2##3##(2011-2#1)(2013-1#1)
function and is##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
function and location##2##3##(1993-6#1)(2011-2#1)
function and may##2##3##(1992-6#1)(2011-2#1)
function and molecular##2##3##(2011-2#1)(2013-1#1)
function and performance##2##3##(2007-12#1)(2011-2#1)
function and platelet##2##3##(2009-5#1)(2012-12#1)
function and possible##2##3##(2008-4#1)(2011-2#1)
function and protein##2##3##(2008-1#1)(2011-2#1)
function and recognition##2##3##(2008-10#1)(2013-1#1)
function and social##5##3##(2009-10#4)(2013-8#1)
function and structure of##4##4##(1991-11#1)(1992-3#1)(1995-3#1)(2008-7#1)
function and structure##5##3##(1991-11#1)(1992-3#1)(1995-3#1)(2008-7#1)(2010-8#1)
function and the production of reactive oxygen##2##7##(1994-5#2)
function and the##22##3##(1992-12#1)(1994-5#2)(1997-8#1)(2007-12#3)(2008-10#3)(2008-3#4)(2008-4#1)(2008-7#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-2#1)
function and to##3##3##(1992-10#1)(1996-5#1)(2008-7#1)
function and will##2##3##(2009-9#1)(2013-1#1)
function and##252##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#4)(1994-5#2)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#5)(2007-12#8)(2007-7#3)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#14)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#5)(2009-12#2)(2009-5#6)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-3#1)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#2)(2013-1#11)(2013-8#5)
function appears##2##2##(1995-6#1)(2008-3#1)
function are associated with##2##4##(1991-10#1)(1993-12#1)
function are discussed##2##3##(2008-3#2)
function are not##2##3##(1993-12#1)(2008-1#1)
function are reviewed##2##3##(1991-1#1)(1991-6#1)
function are##23##2##(1991-1#1)(1991-10#1)(1991-6#1)(1992-12#1)(1993-12#2)(1994-12#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
function as a result of##2##5##(2008-7#1)(2010-6#1)
function as a unit##2##4##(2009-5#1)(2009-9#1)
function as a##28##3##(1991-12#1)(1992-12#1)(1995-11#1)(1995-2#4)(1995-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-3#1)(2013-8#1)
function as an##6##3##(1991-2#1)(1995-3#1)(2007-11#1)(2008-4#1)(2010-10#1)(2012-2#1)
function as antioxidants##2##3##(1992-9#1)(2011-2#1)
function as endogenous antiopiates##2##4##(1991-1#2)
function as receptors for##2##4##(2007-8#1)(2008-4#1)
function as the##3##3##(1991-12#1)(1993-12#1)(2008-5#1)
function as well as the##2##5##(1996-2#1)(2008-9#1)
function as well as##4##4##(1996-2#1)(2008-11#1)(2008-9#1)(2012-1#1)
function as##88##2##(1991-1#2)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1995-11#1)(1995-2#6)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#5)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-6#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
function assays##3##2##(2008-10#2)(2012-12#1)
function assessment in young men after##2##6##(2011-2#2)
function associated with##4##3##(1991-8#1)(2007-12#1)(2008-5#1)(2010-5#1)
function associated##6##2##(1991-8#1)(2007-12#1)(2008-5#2)(2010-5#1)(2013-8#1)
function at a##3##3##(2008-2#1)(2008-3#2)
function at the##5##3##(1997-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
function at##21##2##(1995-6#1)(1996-6#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)
function based on##4##3##(2008-10#1)(2008-2#1)(2011-3#1)(2013-1#1)
function be##2##2##(1992-3#1)(2013-1#1)
function before treatment##2##3##(1991-8#1)(1991-9#1)
function best when##2##3##(1993-12#1)(2008-10#1)
function between##4##2##(1996-5#1)(2007-8#1)(2008-6#1)(2013-1#1)
function both##2##2##(2008-9#1)(2009-9#1)
function but##3##2##(2008-2#1)(2009-6#1)(2011-2#1)
function by an##2##3##(2007-12#1)(2013-1#1)
function by converting##2##3##(2010-8#1)(2012-2#1)
function by means of##2##4##(1995-2#1)(2009-9#1)
function by##40##2##(1990-5#2)(1991-12#1)(1991-5#1)(1992-9#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
function can be##10##3##(1993-9#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-5#1)(2013-1#1)
function can result##2##3##(2008-8#2)
function can##18##2##(1990-6#1)(1993-9#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#3)(2009-3#1)(2009-5#1)(2011-3#1)(2013-1#1)
function cannot be##2##3##(2008-3#1)(2011-2#1)
function characterized the##2##3##(2008-10#2)
function coefficients##4##2##(2008-6#1)(2011-2#3)
function control##2##2##(2008-11#1)(2008-8#1)
function corresponding to##2##3##(2008-2#1)(2011-2#1)
function could be##2##3##(2008-7#1)(2012-3#1)
function could##3##2##(1992-12#1)(2008-7#1)(2012-3#1)
function declines##2##2##(1991-7#1)(2012-1#1)
function deficits##2##2##(2008-2#1)(2013-1#1)
function depending on##2##3##(2011-2#1)(2013-8#1)
function depends on the##2##4##(2008-3#1)(2009-5#1)
function depends on##4##3##(1995-2#1)(2007-11#1)(2008-3#1)(2009-5#1)
function derived from the##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
function derived##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
function describing the##2##3##(2008-10#2)
function deteriorated##2##2##(2007-12#1)(2008-1#1)
function determined by the##2##4##(2008-3#2)
function determined by##3##3##(2007-8#1)(2008-3#2)
function determined##4##2##(2007-8#1)(2008-3#3)
function development##2##2##(1996-1#1)(2008-5#1)
function differences##2##2##(1995-5#1)(2013-8#1)
function due to##2##3##(2007-8#1)(2008-7#1)
function during aging##3##3##(1991-12#1)(1994-5#2)
function during##17##2##(1991-12#1)(1992-6#1)(1993-9#1)(1994-5#2)(1995-6#1)(1996-5#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
function effectively##3##2##(1993-1#1)(2008-11#1)(2008-9#1)
function evaluations##2##2##(2007-9#2)
function following##17##2##(1991-2#3)(1992-3#1)(1993-12#1)(1993-5#1)(1996-6#1)(2007-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#3)(2013-1#2)
function for a##4##3##(1992-12#1)(2008-2#1)(2008-3#1)(2011-3#1)
function for the##14##3##(1990-8#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)
function for these##2##3##(2008-3#1)(2008-4#1)
function for this##2##3##(1991-6#1)(1993-12#1)
function for those##2##3##(1995-3#1)(2008-7#1)
function for##68##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)
function from##7##2##(1992-3#1)(1997-8#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-6#1)
function has already##2##3##(1991-4#1)(2011-2#1)
function has been##7##3##(1991-4#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-1#1)
function has##14##2##(1991-4#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
function have been##4##3##(1994-5#1)(2006-6#1)(2008-1#1)(2010-10#1)
function have##5##2##(1994-5#1)(2006-6#1)(2008-1#1)(2008-2#1)(2010-10#1)
function impairment is##3##3##(1996-5#1)(2008-1#1)(2013-8#1)
function impairment##11##2##(1990-12#1)(1992-9#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#4)
function improved##2##2##(1991-9#1)(1995-3#1)
function in PD##2##3##(2008-7#1)(2011-2#1)
function in a##9##3##(1991-2#1)(1995-1#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-5#2)(2011-1#1)(2013-1#1)
function in adult##3##3##(1992-12#1)(1994-2#1)(2008-10#1)
function in all##2##3##(1996-7#1)(2008-7#1)
function in an##3##3##(1997-4#1)(2008-6#1)(2008-8#1)
function in animals##2##3##(2008-11#1)(2009-8#1)
function in both##4##3##(1993-3#1)(2007-8#1)(2008-5#1)(2012-2#1)
function in children with obesity##2##5##(2008-12#2)
function in cultured##2##3##(2008-2#1)(2008-7#1)
function in different##3##3##(2008-5#1)(2009-10#1)(2010-5#1)
function in early##2##3##(1993-3#1)(2013-8#1)
function in elderly patients with##2##5##(2008-7#2)
function in elderly patients##3##4##(2008-7#3)
function in healthy##2##3##(2008-7#1)(2011-2#1)
function in humans##2##3##(1994-8#1)(2011-2#1)
function in idiopathic##2##3##(1997-8#1)(2008-7#1)
function in mice##4##3##(1994-3#1)(2008-4#2)(2012-2#1)
function in patients who##2##4##(2007-11#1)(2011-2#1)
function in patients with##14##4##(1995-8#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#2)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
function in patients##19##3##(1995-8#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-9#2)(2009-10#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
function in people with##3##4##(2012-3#2)(2013-1#1)
function in rats##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#1)
function in regulating##4##3##(2008-8#2)(2008-9#1)(2012-2#1)
function in subjects with##2##4##(2011-2#1)(2012-2#1)
function in terms of##2##4##(1992-3#1)(2008-3#1)
function in the absence of##2##5##(1996-5#1)(2008-10#1)
function in the brain##5##4##(1995-3#1)(2008-6#1)(2009-5#2)(2012-2#1)
function in the##60##3##(1991-9#1)(1992-3#1)(1992-6#2)(1993-5#1)(1993-9#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
function in these patients##2##4##(2008-1#1)(2011-2#1)
function in these##5##3##(1995-2#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-3#1)
function in this##5##3##(1990-11#1)(1992-11#1)(2009-4#1)(2010-4#1)(2013-1#1)
function in various##2##3##(2008-9#1)(2012-1#1)
function in vivo and##2##4##(1992-3#2)
function in vivo##5##3##(1992-3#2)(1995-6#1)(2008-5#1)(2010-11#1)
function in young##2##3##(1991-12#1)(2008-8#1)
function in##284##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-8#2)(2006-10#3)(2007-10#1)(2007-11#5)(2007-12#4)(2007-8#3)(2008-1#4)(2008-10#18)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#10)(2008-5#11)(2008-6#7)(2008-7#23)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#7)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#14)(2012-1#2)(2012-12#6)(2012-2#17)(2012-3#12)(2013-1#10)(2013-8#4)
function includes##2##2##(1996-7#1)(2010-8#1)
function increases##2##2##(2008-5#1)(2008-9#1)
function independently##2##2##(1994-12#1)(1997-4#1)
function indices##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
function involved in##2##3##(1993-2#1)(2008-3#1)
function is also##5##3##(1997-7#1)(2008-3#2)(2008-9#1)(2009-1#1)
function is calculated##2##3##(2008-3#2)
function is derived##2##3##(2007-11#1)(2008-10#1)
function is determined##2##3##(2008-2#1)(2008-6#1)
function is discussed##3##3##(1992-9#1)(1997-6#1)(2009-8#1)
function is estimated##2##3##(2008-10#1)(2008-3#1)
function is not##8##3##(1993-12#1)(1993-2#1)(1993-8#1)(1994-10#1)(1995-6#1)(2008-2#2)(2008-5#1)
function is now##2##3##(1993-11#1)(2008-6#1)
function is one##2##3##(1996-6#1)(2008-9#1)
function is proposed##3##3##(2007-12#1)(2008-12#1)(2008-3#1)
function is related to##3##4##(2008-2#1)(2008-7#1)(2009-11#1)
function is the##5##3##(2007-12#1)(2008-7#2)(2010-1#1)(2011-3#1)
function is to##6##3##(1997-8#1)(2007-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
function is unknown##2##3##(2008-4#1)(2008-8#1)
function is used as##2##4##(2008-2#2)
function is used##5##3##(2008-2#3)(2008-3#1)(2011-2#1)
function is##117##2##(1990-11#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#24)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#2)
function leading to##2##3##(2011-2#1)(2012-1#1)
function leads to##2##3##(2007-12#1)(2013-1#1)
function may be##8##3##(1991-12#1)(1991-5#1)(1992-12#1)(2007-8#1)(2008-6#1)(2008-7#2)(2012-2#1)
function may##13##2##(1991-12#1)(1991-5#1)(1992-12#1)(1994-2#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-2#2)
function measurement##3##2##(2008-2#1)(2008-3#2)
function method##2##2##(1997-3#1)(2008-3#1)
function might be##2##3##(1997-7#1)(2008-5#1)
function might##3##2##(1997-7#1)(2007-12#1)(2008-5#1)
function monitoring##2##2##(2008-10#1)(2013-8#1)
function must##2##2##(2007-8#1)(2008-3#1)
function near##2##2##(2008-10#1)(2008-2#1)
function not##2##2##(2008-10#1)(2009-4#1)
function of Krüppel homolog 1##2##5##(2012-2#2)
function of NifA central domain##4##5##(2008-9#4)
function of NifA##5##3##(2008-9#5)
function of PurR##2##3##(2008-8#2)
function of T-CD4 T cells##2##5##(2012-12#2)
function of a##24##3##(1993-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-12#1)
function of age##5##3##(1990-3#1)(1995-8#2)(2007-8#1)(2010-3#1)
function of an##5##3##(2008-3#3)(2008-4#1)(2008-9#1)
function of analyte##2##3##(2008-10#2)
function of c-Abl##2##3##(1994-10#1)(1995-8#1)
function of cell##2##3##(1994-5#1)(1994-8#1)
function of different##3##3##(1993-2#1)(2008-3#1)(2013-1#1)
function of disease##3##3##(2008-1#1)(2008-10#2)
function of each##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
function of exposure##4##3##(2007-12#2)(2008-3#1)(2008-7#1)
function of flow##2##3##(1997-2#1)(2007-11#1)
function of human##6##3##(1995-6#2)(2006-6#1)(2008-11#1)(2008-4#1)(2009-4#1)
function of ion##2##3##(2008-10#1)(2008-8#1)
function of its##3##3##(1994-5#1)(2008-3#1)(2013-8#1)
function of kidneys##2##3##(2011-3#1)(2012-3#1)
function of laser##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
function of metallothioneins##2##3##(1990-5#1)(2008-10#1)
function of most##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
function of neural##2##3##(2008-9#1)(2013-8#1)
function of normal##3##3##(1991-12#1)(1995-3#1)(2008-7#1)
function of one##2##3##(2007-11#1)(2011-1#1)
function of pH at##2##4##(2008-10#2)
function of pH##20##3##(1990-5#1)(1990-8#1)(1993-11#1)(1995-5#1)(1996-12#1)(2008-10#14)(2013-1#1)
function of partially coherent##3##4##(2007-12#1)(2008-3#2)
function of particle size##5##4##(2008-10#4)(2008-3#1)
function of particle##6##3##(2008-10#4)(2008-3#2)
function of proteins##7##3##(1997-4#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-7#1)
function of sawB##2##3##(2008-8#2)
function of specific##4##3##(2008-4#2)(2008-6#1)(2008-7#1)
function of susceptible##2##3##(1994-3#1)(1994-5#1)
function of the amount of##2##5##(1996-3#1)(2008-10#1)
function of the biotin transport##2##5##(1992-6#2)
function of the concentration of##4##5##(1996-5#1)(2008-10#2)(2013-8#1)
function of the density of##3##5##(2008-10#2)(2008-8#1)
function of the incident##3##4##(2007-12#1)(2008-3#2)
function of the intensity##2##4##(2008-3#2)
function of the left and right##2##6##(1991-2#1)(2008-10#1)
function of the left ventricle##2##5##(2013-1#1)(2013-8#1)
function of the left##5##4##(1991-2#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
function of the maximum##2##4##(2008-3#1)(2010-9#1)
function of the murine##2##4##(1996-5#2)
function of the nervous system##3##5##(2007-8#1)(2008-7#1)(2011-2#1)
function of the number of##7##5##(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)
function of the optical##6##4##(2008-3#6)
function of the plant##2##4##(2009-8#2)
function of the polarization##4##4##(2007-11#1)(2008-3#3)
function of the protein##3##4##(2008-11#1)(2008-7#1)(2009-11#1)
function of the proteins##2##4##(1997-3#1)(2008-7#1)
function of the region##2##4##(2012-2#2)
function of the scattered light##2##5##(2008-3#2)
function of the stratum corneum##3##5##(2008-5#3)
function of the system##3##4##(2008-2#1)(2008-9#1)(2011-1#1)
function of the time##3##4##(2008-10#2)(2008-11#1)
function of the visual##2##4##(1991-2#1)(2011-2#1)
function of the##333##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#5)(1992-8#2)(1993-12#3)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#4)(1997-1#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#5)(2007-10#1)(2007-11#10)(2007-12#16)(2007-8#4)(2008-1#1)(2008-10#31)(2008-11#9)(2008-2#28)(2008-3#59)(2008-4#5)(2008-5#12)(2008-6#4)(2008-7#15)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#3)
function of their##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
function of these##14##3##(1991-12#1)(1995-2#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-1#1)(2013-8#1)
function of this system is##2##5##(1992-3#1)(2008-2#1)
function of this##11##3##(1992-3#2)(1993-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#2)
function of time##27##3##(1990-8#1)(1991-5#1)(1993-3#1)(1996-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2010-4#1)(2010-7#1)
function of total##2##3##(2008-9#1)(2010-10#1)
function of virus##2##3##(2008-4#1)(2008-9#1)
function of which is##2##4##(1994-12#1)(2010-7#1)
function of which##3##3##(1994-12#1)(2009-5#1)(2010-7#1)
function of##1019##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#5)(1990-7#3)(1990-8#2)(1991-1#3)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#1)(1991-5#5)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-6#10)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#2)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#7)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#7)(1995-8#7)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#9)(1996-3#4)(1996-4#1)(1996-5#5)(1996-7#1)(1997-1#2)(1997-2#11)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#9)(1997-8#2)(2006-10#1)(2006-6#3)(2007-10#1)(2007-11#27)(2007-12#36)(2007-5#1)(2007-8#7)(2008-1#10)(2008-10#131)(2008-11#35)(2008-12#2)(2008-2#64)(2008-3#130)(2008-4#28)(2008-5#30)(2008-6#12)(2008-7#35)(2008-8#40)(2008-9#48)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#14)(2011-3#4)(2012-1#3)(2012-12#7)(2012-2#24)(2012-3#10)(2012-4#1)(2013-1#19)(2013-7#1)(2013-8#12)
function on##7##2##(1994-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)
function only##2##2##(2008-7#1)(2009-3#1)
function optimally##2##2##(1994-2#1)(2011-2#1)
function or##10##2##(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)
function over a##2##3##(2008-6#1)(2008-9#1)
function parameters##5##2##(1992-12#1)(2006-10#1)(2008-7#1)(2009-12#1)(2013-8#1)
function plays a##2##3##(2007-12#1)(2008-3#1)
function produced##2##2##(1995-6#1)(2008-3#1)
function provides##3##2##(2008-1#1)(2009-7#1)(2013-8#1)
function relating##2##2##(1992-12#1)(1993-6#1)
function remained unchanged##2##3##(1996-12#1)(2008-5#1)
function remained##4##2##(1996-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
function remains##4##2##(1997-4#1)(2008-3#1)(2008-4#1)(2010-6#1)
function represents##3##2##(2008-3#1)(2009-3#1)(2011-1#1)
function required##2##2##(1990-5#1)(2008-7#1)
function requires##3##2##(1993-8#1)(2008-4#1)(2010-12#1)
function restriction##2##2##(1990-9#2)
function resulting in##2##3##(2008-1#1)(2009-1#1)
function should be##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#1)
function should##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-8#1)
function specificity##3##2##(2011-2#3)
function status##2##2##(2008-7#1)(2009-8#1)
function strongly##2##2##(2007-11#1)(2008-3#1)
function studies##3##2##(2008-2#1)(2008-9#1)(2011-1#1)
function such as##5##3##(1995-11#2)(2008-5#1)(2010-8#1)(2010-9#1)
function suggests##2##2##(2008-2#1)(2012-12#1)
function suppression##2##2##(1994-2#1)(2008-8#1)
function test##8##2##(1997-2#1)(2007-11#1)(2008-4#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)
function testing in##2##3##(2008-10#1)(2008-4#1)
function testing##9##2##(1991-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
function tests (PFTs)##3##3##(2006-10#1)(2007-2#1)(2008-8#1)
function tests and##5##3##(1996-1#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-7#1)
function tests in##4##3##(1991-1#1)(1996-11#1)(2008-4#1)(2013-1#1)
function tests was##2##3##(1992-6#1)(2013-1#1)
function tests were normal##3##4##(2007-12#1)(2008-7#1)(2012-12#1)
function tests were##4##3##(1992-2#1)(2007-12#1)(2008-7#1)(2012-12#1)
function tests##40##2##(1991-1#1)(1991-12#2)(1991-8#1)(1992-2#1)(1992-6#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-3#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
function than##7##2##(1995-5#1)(1996-3#1)(2008-8#1)(2012-2#1)(2013-1#3)
function that are##2##3##(2008-10#1)(2008-7#1)
function that can##3##3##(2008-2#1)(2008-7#2)
function that is##6##3##(1990-3#1)(1996-4#1)(2008-3#1)(2008-9#1)(2010-10#2)
function that##40##2##(1990-3#1)(1992-3#1)(1994-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#3)(2010-2#1)(2010-5#1)(2013-1#1)(2013-8#2)
function the##2##2##(2008-10#1)(2008-3#1)
function through##5##2##(1992-6#1)(1994-12#1)(2008-3#1)(2010-7#1)(2013-8#1)
function to a##2##3##(2008-2#1)(2013-1#1)
function to facilitate##2##3##(1991-10#1)(2008-3#1)
function to genes##2##3##(2008-4#1)(2012-2#1)
function to the##6##3##(1996-1#1)(2006-10#1)(2008-2#1)(2009-8#1)(2013-8#2)
function to yield##2##3##(2008-10#1)(2008-3#1)
function to##46##2##(1991-10#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#2)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#4)(2008-8#2)(2009-8#2)(2010-8#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
function together##3##2##(1997-4#1)(2007-12#1)(2008-7#1)
function typical of##2##3##(2008-2#1)(2010-4#1)
function under##3##2##(2007-9#1)(2010-10#1)(2013-1#1)
function via##5##2##(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
function was assessed##4##3##(1990-12#1)(2007-9#1)(2008-5#1)(2013-1#1)
function was better##2##3##(1994-3#1)(2011-2#1)
function was determined##2##3##(1992-3#1)(1993-6#1)
function was examined##2##3##(2007-8#1)(2010-8#1)
function was found##3##3##(1990-8#1)(1996-3#1)(2007-11#1)
function was measured##3##3##(1994-7#1)(2007-10#1)(2008-2#1)
function was not##3##3##(1991-9#1)(1994-5#1)(2008-4#1)
function was observed##2##3##(1996-7#1)(2013-1#1)
function was restored##2##3##(2012-12#1)(2012-3#1)
function was##53##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-7#1)(1996-3#1)(1996-7#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
function well with##2##3##(2012-12#2)
function well##4##2##(2008-5#1)(2012-12#2)(2012-2#1)
function were identified##2##3##(2008-7#1)(2010-11#1)
function were##13##2##(1990-6#1)(1994-3#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#2)
function which##5##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
function while##2##2##(1991-6#1)(2010-10#1)
function will##3##2##(1991-2#1)(1992-8#1)(1994-5#1)
function with a##6##3##(1992-3#1)(2007-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
function with an##2##3##(1997-3#1)(2008-7#1)
function with respect to the##2##5##(1990-11#1)(2011-2#1)
function with the##2##3##(2008-3#2)
function with##35##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-2#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
function within an##2##3##(2007-12#1)(2009-8#1)
function within the##3##3##(1995-5#1)(2008-9#1)(2013-1#1)
function within##5##2##(1995-5#1)(2007-12#1)(2008-9#1)(2009-8#1)(2013-1#1)
function without##3##2##(1997-7#1)(2008-3#1)(2013-1#1)
function words that precede##2##4##(2008-2#2)
function words##10##2##(1996-2#1)(2008-10#1)(2008-2#8)
function##3663##1##(1990-10#1)(1990-11#9)(1990-12#8)(1990-2#4)(1990-3#4)(1990-5#15)(1990-6#3)(1990-7#6)(1990-8#5)(1990-9#4)(1991-1#11)(1991-10#3)(1991-11#9)(1991-12#24)(1991-2#15)(1991-3#4)(1991-4#2)(1991-5#13)(1991-6#6)(1991-7#2)(1991-8#4)(1991-9#11)(1992-10#2)(1992-11#7)(1992-12#22)(1992-2#6)(1992-3#24)(1992-5#2)(1992-6#30)(1992-8#6)(1992-9#17)(1993-1#2)(1993-11#8)(1993-12#28)(1993-2#5)(1993-3#10)(1993-5#6)(1993-6#11)(1993-7#1)(1993-8#9)(1993-9#8)(1994-1#1)(1994-10#2)(1994-11#14)(1994-12#21)(1994-2#10)(1994-3#10)(1994-5#29)(1994-6#10)(1994-7#1)(1994-8#11)(1994-9#5)(1995-1#1)(1995-11#17)(1995-12#11)(1995-2#27)(1995-3#15)(1995-5#13)(1995-6#25)(1995-8#16)(1995-9#5)(1996-1#9)(1996-11#3)(1996-12#6)(1996-2#20)(1996-3#16)(1996-4#2)(1996-5#17)(1996-6#8)(1996-7#6)(1996-8#1)(1996-9#6)(1997-1#6)(1997-2#23)(1997-3#14)(1997-4#26)(1997-5#2)(1997-6#5)(1997-7#15)(1997-8#9)(2006-10#20)(2006-12#1)(2006-6#8)(2007-10#17)(2007-11#76)(2007-12#86)(2007-2#2)(2007-5#1)(2007-7#8)(2007-8#39)(2007-9#6)(2008-1#49)(2008-10#290)(2008-11#87)(2008-12#18)(2008-2#203)(2008-3#355)(2008-4#96)(2008-5#102)(2008-6#46)(2008-7#166)(2008-8#112)(2008-9#133)(2009-1#4)(2009-10#29)(2009-11#4)(2009-12#12)(2009-2#1)(2009-3#9)(2009-4#5)(2009-5#29)(2009-6#8)(2009-7#13)(2009-8#29)(2009-9#14)(2010-1#5)(2010-10#26)(2010-11#29)(2010-12#19)(2010-2#10)(2010-3#13)(2010-4#11)(2010-5#15)(2010-6#8)(2010-7#5)(2010-8#17)(2010-9#5)(2011-1#27)(2011-2#150)(2011-3#15)(2011-7#1)(2012-1#17)(2012-12#46)(2012-2#115)(2012-3#52)(2012-4#1)(2012-7#1)(2013-1#120)(2013-7#8)(2013-8#64)
function&quot##4##1##(1995-9#1)(2009-10#1)(2009-5#1)(2013-1#1)
function(s)##2##1##(2009-10#1)(2011-2#1)
function) and##2##2##(2007-8#1)(2008-5#1)
function)##20##1##(1992-2#1)(1993-5#2)(1994-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-1#1)
function-biased##2##1##(2009-11#2)
function-blocking##2##1##(2009-3#1)(2013-1#1)
function?##3##1##(1992-8#1)(2008-5#1)(2009-10#1)
function]##6##1##(1992-9#1)(1993-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2013-8#1)
functional CYP1A1##2##2##(1992-8#2)
functional I factors##2##3##(1995-8#2)
functional I##3##2##(1995-8#3)
functional IgG-binding domains##2##3##(1994-12#2)
functional MR##2##2##(2008-7#1)(2010-7#1)
functional MRI (fMRI)##2##3##(2009-6#1)(2009-9#1)
functional MRI in##2##3##(2008-9#1)(2009-9#1)
functional MRI##6##2##(2008-11#1)(2008-9#1)(2009-6#2)(2009-9#2)
functional RNA##2##2##(2008-1#1)(2008-4#1)
functional RNA-protein complexes##2##3##(2008-2#2)
functional T-cell##2##2##(1995-2#1)(2008-10#1)
functional ability and##2##3##(2009-10#1)(2013-1#1)
functional ability of##4##3##(1994-3#1)(2009-12#1)(2011-1#1)(2013-1#1)
functional ability##11##2##(1994-3#1)(1995-1#1)(2009-10#2)(2009-12#1)(2011-1#1)(2011-2#1)(2011-8#1)(2013-1#3)
functional active##2##2##(1993-11#1)(1994-11#1)
functional activities of##2##3##(2008-1#1)(2012-3#1)
functional activities##6##2##(2008-1#1)(2008-11#2)(2008-5#1)(2012-3#1)(2013-1#1)
functional activity and##2##3##(2008-4#1)(2011-2#1)
functional activity in##3##3##(2008-5#1)(2012-1#1)(2013-1#1)
functional activity of##5##3##(1993-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
functional activity##26##2##(1992-8#1)(1993-6#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
functional adaptations##2##2##(2010-12#1)(2012-2#1)
functional alterations of##3##3##(1997-6#1)(2008-1#1)(2009-6#1)
functional alterations##6##2##(1991-5#1)(1995-2#1)(1997-6#1)(2008-1#1)(2009-6#1)(2012-2#1)
functional analyses##5##2##(1995-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
functional analysis and##2##3##(2008-7#1)(2010-4#1)
functional analysis in##2##3##(1994-12#1)(2011-2#1)
functional analysis of a##4##4##(2008-8#3)(2008-9#1)
functional analysis of the##6##4##(1993-3#1)(2008-10#1)(2008-11#2)(2009-10#1)(2009-9#1)
functional analysis of these##2##4##(2008-10#1)(2008-4#1)
functional analysis of##23##3##(1992-3#1)(1993-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-9#1)(2011-2#1)(2011-3#1)
functional analysis##40##2##(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#2)(2009-9#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#2)
functional anatomy of the##2##4##(2007-12#1)(2012-3#1)
functional anatomy##3##2##(2007-12#1)(2012-2#1)(2012-3#1)
functional and cognitive status and the##2##6##(2008-7#2)
functional and effective##2##3##(2008-12#2)
functional and esthetic##3##3##(2007-12#3)
functional and morphological##2##3##(2008-9#1)(2012-1#1)
functional and structural properties##2##4##(1990-2#1)(1991-6#1)
functional and structural role of##2##5##(1992-3#2)
functional and structural##10##3##(1990-2#1)(1990-8#1)(1991-6#1)(1992-3#2)(1994-8#1)(1996-7#1)(2007-12#1)(2008-7#1)(2012-3#1)
functional and##46##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-3#3)(1993-11#1)(1993-12#1)(1994-8#2)(1995-3#1)(1996-1#1)(1996-7#1)(2007-12#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
functional and/or##2##2##(2008-10#1)(2008-4#1)
functional annotation##4##2##(2008-7#2)(2011-2#2)
functional annotations##2##2##(2008-7#1)(2012-2#1)
functional antagonism##3##2##(1995-12#1)(1995-3#1)(1997-2#1)
functional applications##2##2##(2008-10#1)(2008-9#1)
functional architecture##2##2##(2009-5#2)
functional as##3##2##(1993-9#1)(2007-12#1)(2008-4#1)
functional aspects of##3##3##(1992-9#1)(1995-3#1)(2008-5#1)
functional aspects##4##2##(1992-9#1)(1995-3#1)(2008-11#1)(2008-5#1)
functional assay##3##2##(1994-8#1)(1997-4#2)
functional assays in##2##3##(1991-5#1)(2008-9#1)
functional assays that##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
functional assays##16##2##(1991-5#1)(1993-8#1)(1994-6#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
functional assessment of##5##3##(2007-11#1)(2008-7#1)(2012-3#1)(2013-8#2)
functional assessment##14##2##(1990-8#1)(1997-2#1)(2007-11#3)(2008-7#1)(2010-9#1)(2012-3#2)(2013-1#3)(2013-8#2)
functional assignment##3##2##(2009-8#2)(2010-10#1)
functional associations##2##2##(2008-7#2)
functional attributes##2##2##(1991-5#1)(2008-10#1)
functional behavior##3##2##(1992-12#1)(2008-2#1)(2008-9#1)
functional binding##2##2##(1991-5#2)
functional bladder##3##2##(2008-10#3)
functional bone##2##2##(2009-7#1)(2010-9#1)
functional brain imaging##6##3##(2007-8#1)(2008-11#1)(2009-5#3)(2013-8#1)
functional capabilities##3##2##(2008-9#1)(2011-1#1)(2013-1#1)
functional capacities##2##2##(2008-7#1)(2009-12#1)
functional capacity and##3##3##(2008-9#1)(2010-10#1)(2012-12#1)
functional capacity of##2##3##(2013-7#1)(2013-8#1)
functional capacity##13##2##(2008-7#2)(2008-9#2)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
functional capillary rarefaction##2##3##(2009-5#2)
functional categories##4##2##(2008-10#2)(2008-7#2)
functional cell##2##2##(2008-9#1)(2009-3#1)
functional cells##4##2##(2008-7#1)(2013-1#3)
functional centers##3##2##(2007-12#3)
functional changes in##4##3##(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
functional changes##10##2##(1990-11#1)(1994-12#1)(2008-5#3)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
functional characteristics of##6##3##(1991-3#1)(1991-8#1)(1994-11#1)(1995-3#1)(2008-7#1)(2011-2#1)
functional characteristics##8##2##(1991-3#1)(1991-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
functional characterization of##8##3##(1993-3#1)(1993-5#1)(1995-2#1)(2008-11#3)(2009-6#1)(2012-2#1)
functional characterization##10##2##(1993-3#1)(1993-5#1)(1995-2#1)(2008-11#3)(2008-4#1)(2009-6#1)(2009-9#1)(2012-2#1)
functional class##8##2##(2007-8#2)(2009-10#1)(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
functional classes##2##2##(2008-4#1)(2009-10#1)
functional columns##2##2##(2008-11#1)(2009-5#1)
functional complementation##6##2##(1990-5#1)(1994-8#2)(1995-12#1)(2008-9#1)(2009-10#1)
functional components of##2##3##(2008-10#1)(2008-4#1)
functional components##3##2##(1994-11#1)(2008-10#1)(2008-4#1)
functional connections##2##2##(2008-11#1)(2013-1#1)
functional connectivity##4##2##(2009-12#2)(2013-1#2)
functional consequences of the##2##4##(2008-4#1)(2008-8#1)
functional consequences of##10##3##(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2013-1#1)
functional consequences##13##2##(1993-8#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#2)
functional conservation##3##2##(1993-12#1)(2009-5#2)
functional data##9##2##(2008-11#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-8#5)
functional decline in##2##3##(2008-1#1)(2008-7#1)
functional decline##7##2##(2008-1#1)(2008-5#1)(2008-7#2)(2013-1#3)
functional defects in##2##3##(1991-2#1)(2008-10#1)
functional defects##3##2##(1991-2#1)(2008-10#1)(2008-8#1)
functional deficits##4##2##(2007-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
functional dependence##2##2##(1990-8#1)(2008-2#1)
functional design##2##2##(1997-4#1)(2010-8#1)
functional development##2##2##(2008-4#1)(2013-1#1)
functional differences between the##4##4##(1994-3#1)(1994-5#1)(1997-2#1)(2012-2#1)
functional differences between##7##3##(1994-2#1)(1994-3#1)(1994-5#1)(1997-2#1)(2008-11#1)(2008-8#1)(2012-2#1)
functional differences##11##2##(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
functional differentiation##2##2##(2008-10#2)
functional disability and##2##3##(2008-7#1)(2010-12#1)
functional disability##13##2##(1990-6#1)(1993-3#1)(1995-2#1)(2006-10#1)(2008-7#3)(2009-5#1)(2010-12#2)(2012-1#1)(2013-1#2)
functional disorders##3##2##(1990-11#1)(2008-4#1)(2012-12#1)
functional diversification##2##2##(1997-7#1)(2009-10#1)
functional diversity of##7##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-10#1)(2012-1#1)
functional diversity##11##2##(1991-2#1)(1996-2#1)(1997-9#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-10#1)(2009-8#1)(2012-1#1)
functional domain of##2##3##(2008-9#2)
functional domain##4##2##(1992-8#1)(2008-9#2)(2009-8#1)
functional domains to##2##3##(2009-8#1)(2010-2#1)
functional domains##17##2##(1990-5#1)(1990-7#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-6#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-1#1)
functional effect##2##2##(1994-11#1)(1996-6#1)
functional effects of##5##3##(1992-10#1)(1997-4#3)(2007-12#1)
functional effects##8##2##(1992-10#1)(1995-2#1)(1997-4#3)(2007-12#1)(2012-2#2)
functional endoscopic sinus##2##3##(2012-1#1)(2013-1#1)
functional endpoints##4##2##(2008-10#1)(2008-11#3)
functional entity##2##2##(1995-12#1)(2008-2#1)
functional enzyme##3##2##(1994-8#1)(1997-7#1)(2011-1#1)
functional equivalence##2##2##(1995-6#1)(2008-11#1)
functional evaluation##5##2##(2007-11#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)
functional examination##3##2##(1992-10#1)(2007-8#1)(2009-10#1)
functional expression in##2##3##(1992-9#1)(2008-7#1)
functional expression of a##2##4##(1994-12#1)(1995-6#1)
functional expression of the##3##4##(1993-8#1)(1994-8#1)(2008-6#1)
functional expression of##9##3##(1990-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-4#1)(2008-6#1)(2011-2#1)
functional expression##13##2##(1990-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
functional features of##2##3##(1991-6#1)(1992-12#1)
functional features##4##2##(1990-12#1)(1991-6#1)(1992-12#1)(2010-4#1)
functional food##3##2##(2008-10#1)(2010-1#1)(2012-2#1)
functional foods##2##2##(2008-11#1)(2008-12#1)
functional for##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
functional form of##4##3##(2007-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
functional form##11##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
functional gene##4##2##(1990-8#1)(1995-2#1)(2008-7#1)(2013-8#1)
functional genes##2##2##(1993-12#1)(1994-5#1)
functional genomic##4##2##(2008-2#1)(2009-10#1)(2011-1#2)
functional genomics and##3##3##(2008-7#1)(2009-10#1)(2010-3#1)
functional genomics approaches##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
functional genomics of##2##3##(2008-7#2)
functional genomics##31##2##(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#16)(2009-10#4)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
functional glutamate transporters##3##3##(2008-7#3)
functional group has##2##3##(2008-10#2)
functional group in the##2##4##(2008-10#2)
functional group was##2##3##(2008-10#2)
functional group##31##2##(1992-6#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#6)(2009-12#1)(2010-2#1)(2011-2#2)(2012-2#1)
functional groups and##6##3##(1994-9#1)(1997-6#1)(2008-10#2)(2008-4#1)(2012-2#1)
functional groups are##4##3##(2008-10#2)(2009-12#1)(2010-11#1)
functional groups as##2##3##(2008-10#1)(2008-5#1)
functional groups at##2##3##(1992-11#1)(1992-6#1)
functional groups in##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
functional groups of the##3##4##(2008-10#1)(2009-7#1)(2013-1#1)
functional groups of##11##3##(2008-10#6)(2008-4#1)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#1)
functional groups on the##2##4##(1994-9#1)(2008-10#1)
functional groups present##2##3##(1992-6#1)(2008-10#1)
functional groups such as##3##4##(1996-5#2)(2008-10#1)
functional groups to##2##3##(2008-10#1)(2011-2#1)
functional groups##60##2##(1990-9#1)(1992-11#1)(1992-6#4)(1994-9#4)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#22)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
functional hand##2##2##(2008-6#1)(2013-1#1)
functional human##8##2##(1992-12#2)(1993-8#1)(1994-2#1)(2008-2#1)(2012-2#3)
functional imaging of##2##3##(2007-11#1)(2009-12#1)
functional imaging##14##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#3)(2009-12#2)(2009-2#1)(2009-5#1)(2012-12#1)(2012-2#2)
functional immune##3##2##(1995-6#1)(2008-10#1)(2010-2#1)
functional immunoglobulin##2##2##(1997-7#2)
functional impact of##3##3##(2008-7#2)(2011-8#1)
functional impact##5##2##(2008-7#3)(2009-5#1)(2011-8#1)
functional impairment and##2##3##(1996-6#1)(2008-6#1)
functional impairment##17##2##(1991-6#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
functional impairments##3##2##(2007-12#1)(2009-10#1)(2011-2#1)
functional implication in##2##3##(1996-2#1)(2012-2#1)
functional implications for##2##3##(1996-2#1)(2011-2#1)
functional implications##6##2##(1992-12#1)(1996-2#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
functional importance in##2##3##(2010-5#2)
functional importance of##6##3##(1994-5#1)(1995-6#1)(2009-5#1)(2009-9#1)(2012-6#1)(2013-1#1)
functional importance##13##2##(1991-7#1)(1994-5#1)(1995-6#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-5#2)(2012-3#1)(2012-6#1)(2013-1#2)
functional improvement##3##2##(1990-5#1)(1990-6#1)(2006-10#1)
functional in the##4##3##(1994-8#1)(2008-2#1)(2008-7#1)(2010-2#1)
functional in##15##2##(1991-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-3#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-2#1)
functional indices##3##2##(1991-12#1)(2007-11#1)(2011-1#1)
functional information##9##2##(2007-12#2)(2008-1#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-9#1)(2012-12#1)
functional inhibition##2##2##(2008-9#1)(2013-1#1)
functional integrity of the##3##4##(1996-3#1)(2008-8#1)(2012-12#1)
functional integrity of##5##3##(1990-7#1)(1996-3#1)(1997-4#1)(2008-8#1)(2012-12#1)
functional interaction between##2##3##(2008-7#1)(2012-3#1)
functional interaction##6##2##(2007-10#1)(2008-7#3)(2009-8#1)(2012-3#1)
functional interactions between##3##3##(1993-6#1)(2008-4#1)(2012-3#1)
functional interactions##4##2##(1993-6#1)(2008-4#2)(2012-3#1)
functional interfaces##4##2##(2008-7#4)
functional ion channels##2##3##(2009-12#2)
functional ion##3##2##(2009-12#3)
functional iron deficiency##4##3##(2008-1#1)(2011-1#3)
functional iron##5##2##(1992-8#1)(2008-1#1)(2011-1#3)
functional is##2##2##(2007-12#1)(2008-2#1)
functional level and##2##3##(1991-1#1)(2013-1#1)
functional level##4##2##(1991-1#1)(1995-5#1)(2008-9#1)(2013-1#1)
functional life##3##2##(1994-6#1)(2008-7#2)
functional limitations##3##2##(1996-3#1)(1997-2#1)(2007-11#1)
functional linkage##2##2##(1991-5#1)(2008-7#1)
functional localization##3##2##(1991-9#1)(2008-9#1)(2010-9#1)
functional loss of##2##3##(2008-10#1)(2009-11#1)
functional loss##5##2##(1992-12#1)(2008-10#1)(2009-11#1)(2012-2#2)
functional macrophage##2##2##(1990-5#1)(1992-9#1)
functional magnetic resonance imaging (fMRI) study##2##6##(2008-11#1)(2013-8#1)
functional magnetic resonance imaging (fMRI)##13##5##(2008-11#5)(2009-2#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
functional magnetic resonance imaging and##2##5##(2007-8#1)(2008-6#1)
functional magnetic resonance imaging##25##4##(1994-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#9)(2008-2#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
functional magnetic##26##2##(1994-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#10)(2008-2#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
functional map##2##2##(2008-11#1)(2008-7#1)
functional materials##3##2##(2008-5#1)(2010-12#1)(2010-4#1)
functional maturation of the##3##4##(2008-5#1)(2011-2#2)
functional maturation##5##2##(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)
functional mechanisms##2##2##(2009-5#1)(2011-3#1)
functional methods##3##2##(1991-6#1)(2012-12#2)
functional milestones##3##2##(2012-2#3)
functional mobility assessment tool##3##4##(1993-12#3)
functional mobility##4##2##(1993-12#3)(2010-3#1)
functional molecule##2##2##(1993-6#1)(1994-6#1)
functional monomer and##2##3##(2008-10#2)
functional monomer##6##2##(2008-10#6)
functional monomers##2##2##(2008-10#2)
functional morphology and prey selection##2##5##(2010-8#2)
functional morphology and##3##3##(2007-12#1)(2010-8#2)
functional morphology##6##2##(2007-12#3)(2010-8#3)
functional muscle##3##2##(2007-12#1)(2010-4#1)(2012-7#1)
functional neuroimaging techniques##2##3##(2007-8#1)(2008-4#1)
functional neuroimaging##8##2##(2007-8#2)(2008-11#1)(2008-4#1)(2009-9#2)(2013-8#2)
functional neuromuscular stimulation##2##3##(2013-1#2)
functional neurosurgery##2##2##(2008-7#1)(2010-12#1)
functional noncoding##2##2##(2007-11#1)(2008-7#1)
functional optical coherence tomography##5##4##(2007-11#4)(2007-12#1)
functional or structural##2##3##(2007-12#1)(2008-8#1)
functional or##7##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-12#1)
functional organization of the##2##4##(2008-8#2)
functional organization of##5##3##(1997-6#1)(2008-8#3)(2009-5#1)
functional organization##8##2##(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#3)(2009-5#1)
functional outcome after surgery##2##4##(2008-7#1)(2011-2#1)
functional outcome after##4##3##(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
functional outcome for##2##3##(2007-12#1)(2008-7#1)
functional outcome##28##2##(2007-10#5)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-6#7)(2008-7#2)(2008-9#3)(2009-8#1)(2011-2#2)(2012-3#2)
functional outcomes in##3##3##(2009-10#1)(2012-2#1)(2013-1#1)
functional outcomes of##3##3##(2007-10#1)(2008-6#1)(2013-1#1)
functional outcomes were##2##3##(2008-11#1)(2012-3#1)
functional outcomes##20##2##(2007-10#1)(2008-11#1)(2008-6#2)(2009-10#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
functional parameters of##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
functional parameters##4##2##(2007-12#2)(2008-11#1)(2008-9#1)
functional performance##7##2##(1990-3#1)(2008-9#1)(2009-9#1)(2012-12#2)(2013-1#2)
functional phenomena##2##2##(1990-11#2)
functional plasticity and##2##3##(2008-4#1)(2008-7#1)
functional plasticity##6##2##(2008-1#1)(2008-4#1)(2008-7#2)(2012-12#2)
functional principal component analysis##2##4##(2010-7#2)
functional problems##2##2##(1995-3#1)(2008-7#1)
functional prognosis##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
functional properties and##2##3##(2008-8#1)(2010-8#1)
functional properties of both the##2##5##(2008-4#1)(2008-5#1)
functional properties of the##6##4##(1990-8#1)(1991-2#1)(1991-6#1)(1992-3#1)(2008-5#1)(2008-6#1)
functional properties of these cells##2##5##(2010-12#2)
functional properties of this##2##4##(2008-5#1)(2012-2#1)
functional properties of##25##3##(1990-8#2)(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#2)(2010-4#1)(2012-2#1)
functional properties##35##2##(1990-7#1)(1990-8#2)(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2010-12#2)(2010-4#3)(2010-8#1)(2012-2#2)
functional protein##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
functional receptor##5##2##(1993-2#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-4#1)
functional receptors##4##2##(1991-11#1)(1991-12#1)(2007-2#1)(2008-5#1)
functional reconstitution##3##2##(1991-5#2)(1995-2#1)
functional recovery after hip fracture##2##5##(2008-8#2)
functional recovery after##3##3##(1994-8#1)(2008-8#2)
functional recovery following##2##3##(1996-12#1)(2012-2#1)
functional recovery in##2##3##(2013-1#2)
functional recovery of the##2##4##(2008-5#1)(2008-7#1)
functional recovery of##5##3##(2008-12#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-1#1)
functional recovery##23##2##(1990-5#1)(1994-8#2)(1996-12#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
functional redundancy##4##2##(1994-8#1)(1996-2#1)(2007-11#1)(2012-3#1)
functional regions##3##2##(1990-8#1)(1992-12#1)(2008-11#1)
functional regulation##3##2##(1992-11#1)(1993-6#1)(2009-6#1)
functional rehabilitation##2##2##(1993-6#1)(2012-1#1)
functional relationship between##2##3##(1994-3#1)(2008-2#1)
functional relationship to##2##3##(1994-6#1)(2008-5#1)
functional relationship##6##2##(1994-3#1)(1994-6#1)(1995-9#1)(1996-5#1)(2008-2#1)(2008-5#1)
functional relationships among##2##3##(2008-10#1)(2008-8#1)
functional relationships between##2##3##(2008-6#1)(2012-12#1)
functional relationships of##2##3##(2008-3#1)(2009-5#1)
functional relationships##7##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)
functional relevance of##3##3##(1994-6#1)(1995-2#1)(1996-5#1)
functional requirements##2##2##(1993-8#1)(2009-8#1)
functional reserve##5##2##(1990-11#1)(2008-1#3)(2013-8#1)
functional residual capacity##2##3##(1991-12#1)(1996-5#1)
functional response of##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
functional response##6##2##(1990-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-8#1)
functional responses may##2##3##(2008-8#2)
functional responses of##2##3##(1996-2#1)(2008-8#1)
functional responses##18##2##(1993-11#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-6#1)(2008-8#9)(2008-9#1)(2010-1#1)(2011-1#1)
functional restoration of##2##3##(1995-9#1)(2008-11#1)
functional restoration##3##2##(1995-9#1)(2008-11#1)(2008-4#1)
functional result##4##2##(2007-11#1)(2007-8#1)(2009-4#1)(2013-1#1)
functional results after##2##3##(2008-6#1)(2013-1#1)
functional results and##2##3##(1991-9#1)(2010-6#1)
functional results of##2##3##(1990-6#1)(2007-8#1)
functional results##15##2##(1990-6#1)(1991-9#1)(1994-11#1)(2007-8#3)(2008-10#1)(2008-6#1)(2008-9#2)(2010-6#1)(2013-1#4)
functional role as a##2##4##(2009-12#1)(2011-2#1)
functional role for##5##3##(1990-8#1)(1992-3#1)(1995-11#1)(1996-5#1)(2008-11#1)
functional role in##5##3##(1992-3#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
functional role of CNG channels in##2##6##(2009-10#2)
functional role of the##2##4##(1994-8#1)(2008-11#1)
functional role of##29##3##(1993-3#2)(1993-6#1)(1994-5#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
functional role##46##2##(1990-8#1)(1992-3#2)(1993-3#2)(1993-6#1)(1994-5#1)(1994-8#4)(1995-11#2)(1995-12#3)(1995-6#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-2#2)(2013-1#3)
functional roles of##4##3##(1993-3#1)(1994-5#1)(1997-2#1)(2009-10#1)
functional roles##6##2##(1993-3#1)(1994-5#1)(1997-2#1)(2009-10#1)(2012-2#1)(2012-3#1)
functional scores##3##2##(2008-6#2)(2008-9#1)
functional screen##2##2##(2008-4#1)(2011-1#1)
functional secretory##2##2##(2007-12#1)(2009-7#1)
functional significance of neurogenesis in##2##5##(1996-5#1)(2008-7#1)
functional significance of this##3##4##(1993-12#1)(1995-2#1)(2012-2#1)
functional significance of##16##3##(1993-12#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#2)(2012-3#1)
functional significance##23##2##(1990-11#1)(1993-12#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#3)(2012-3#2)
functional similarities##2##2##(2008-11#1)(2009-3#1)
functional similarity##4##2##(1990-5#1)(1994-12#1)(1994-3#1)(2008-8#1)
functional sites##2##2##(1993-6#1)(2008-9#1)
functional specificity##2##2##(1991-5#1)(2009-5#1)
functional state of##9##3##(1995-12#1)(2008-2#1)(2008-4#1)(2010-8#2)(2011-1#2)(2013-1#2)
functional state##11##2##(1993-12#1)(1995-12#1)(2008-2#1)(2008-4#1)(2010-8#2)(2011-1#3)(2013-1#2)
functional states of##2##3##(1994-9#1)(1995-12#1)
functional states##5##2##(1994-9#1)(1995-12#1)(2008-4#1)(2008-9#2)
functional status and##2##3##(1997-1#1)(2008-11#1)
functional status in##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
functional status of the##4##4##(1997-8#2)(2008-7#1)(2008-9#1)
functional status of##10##3##(1994-12#1)(1995-2#1)(1997-8#2)(2008-1#1)(2008-4#1)(2008-7#3)(2008-9#1)
functional status##33##2##(1992-2#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-1#2)(1997-8#2)(2006-5#1)(2007-11#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#6)(2008-9#3)(2009-10#1)(2010-3#1)(2013-1#1)
functional structure##2##2##(2007-11#1)(2011-2#1)
functional studies are##2##3##(2012-2#1)(2013-1#1)
functional studies on##2##3##(1990-11#1)(2012-12#1)
functional studies suggest##2##3##(1995-2#1)(2008-6#1)
functional studies##25##2##(1990-11#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-2#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-12#3)(2012-12#1)(2012-2#3)(2013-1#1)
functional test##4##2##(1991-3#1)(1997-7#1)(2008-10#2)
functional tests##2##2##(1993-5#1)(2013-8#1)
functional tests)##2##2##(2011-1#1)(2012-1#1)
functional that##2##2##(2008-8#1)(2010-2#1)
functional theory##7##2##(1996-2#1)(2008-10#2)(2010-7#1)(2012-2#1)(2013-8#2)
functional training##4##2##(2007-10#3)(2010-3#1)
functional tumors##4##2##(2008-3#4)
functional type of##2##3##(1993-2#1)(2008-11#1)
functional unit that##2##3##(2009-10#1)(2011-2#1)
functional unit##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
functional use##2##2##(1994-8#1)(2008-4#1)
functional value##2##2##(1996-1#1)(2011-2#1)
functional variants##3##2##(2012-3#3)
functional variations##2##2##(2008-7#2)
functional well-being##2##2##(2008-4#1)(2008-7#1)
functional##1825##1##(1990-11#7)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#6)(1990-6#4)(1990-7#4)(1990-8#11)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#6)(1991-3#4)(1991-5#13)(1991-6#8)(1991-7#4)(1991-8#2)(1991-9#3)(1992-10#3)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#10)(1992-5#3)(1992-6#8)(1992-8#11)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#18)(1993-2#8)(1993-3#9)(1993-5#4)(1993-6#10)(1993-8#6)(1993-9#5)(1994-1#3)(1994-11#6)(1994-12#14)(1994-2#3)(1994-3#7)(1994-5#8)(1994-6#6)(1994-8#24)(1994-9#10)(1995-1#1)(1995-11#6)(1995-12#17)(1995-2#22)(1995-3#14)(1995-5#2)(1995-6#17)(1995-8#9)(1995-9#5)(1996-1#5)(1996-12#2)(1996-2#13)(1996-3#6)(1996-5#9)(1996-6#4)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#3)(1997-4#10)(1997-5#1)(1997-6#4)(1997-7#14)(1997-8#3)(1997-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-10#15)(2007-11#25)(2007-12#43)(2007-2#1)(2007-7#2)(2007-8#21)(2008-1#23)(2008-10#127)(2008-11#81)(2008-12#12)(2008-2#25)(2008-3#14)(2008-4#65)(2008-5#29)(2008-6#37)(2008-7#133)(2008-8#64)(2008-9#59)(2009-1#3)(2009-10#32)(2009-11#8)(2009-12#16)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#28)(2009-6#7)(2009-7#6)(2009-8#15)(2009-9#13)(2010-1#3)(2010-10#11)(2010-11#5)(2010-12#11)(2010-2#7)(2010-3#9)(2010-4#10)(2010-5#4)(2010-6#2)(2010-7#6)(2010-8#10)(2010-9#6)(2011-1#32)(2011-2#52)(2011-3#5)(2011-7#1)(2011-8#2)(2012-1#14)(2012-12#32)(2012-2#70)(2012-3#30)(2012-6#1)(2012-7#1)(2013-1#79)(2013-7#4)(2013-8#28)
functionalis##2##1##(1994-9#2)
functionalised with##4##2##(2008-10#4)
functionalised##11##1##(2007-11#1)(2008-10#9)(2009-10#1)
functionalities and##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
functionalities of##2##2##(2008-2#1)(2009-11#1)
functionalities##16##1##(1992-11#1)(1994-11#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-11#1)(2010-8#1)(2011-2#1)
functionality and early use of speech in a group of##2##10##(2011-1#2)
functionality and##7##2##(2008-3#2)(2008-9#1)(2009-10#1)(2011-1#2)(2013-1#1)
functionality but##2##2##(2011-1#1)(2012-3#1)
functionality can be##2##3##(2009-8#1)(2009-9#1)
functionality for##2##2##(2008-11#1)(2010-4#1)
functionality in##2##2##(1991-3#1)(2007-11#1)
functionality of a##2##3##(2009-7#1)(2013-1#1)
functionality of the##8##3##(1991-9#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-3#1)(2012-6#1)
functionality of##20##2##(1990-5#1)(1991-9#1)(1995-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-5#1)(2012-3#1)(2012-6#1)(2013-1#1)
functionality##82##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1995-12#1)(2007-11#7)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-4#1)(2010-5#3)(2011-1#4)(2011-2#4)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#2)
functionalization and##2##2##(2010-2#1)(2010-5#1)
functionalization of the##2##3##(2008-10#1)(2008-4#1)
functionalization of##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-5#1)
functionalization##15##1##(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#2)
functionalized by coupling it##2##4##(2008-10#2)
functionalized by##4##2##(2008-10#3)(2010-6#1)
functionalized nanoparticles##4##2##(2008-10#2)(2010-12#1)(2011-1#1)
functionalized on##2##2##(2011-2#2)
functionalized polymers##4##2##(2008-10#3)(2008-3#1)
functionalized polypyrrole##2##2##(2008-10#1)(2008-5#1)
functionalized resin##6##2##(2008-10#6)
functionalized terbium fluorescent nanoparticles##2##4##(2008-10#2)
functionalized with a##4##3##(2008-4#2)(2008-7#1)(2010-1#1)
functionalized with carboxylic groups##2##4##(2008-10#2)
functionalized with succinic acid##2##4##(2008-10#2)
functionalized with the##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
functionalized with##27##2##(2008-1#1)(2008-10#16)(2008-4#5)(2008-7#1)(2009-11#1)(2010-1#1)(2010-5#1)(2011-1#1)
functionalized##92##1##(1994-9#1)(1996-5#2)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#53)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#5)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)
functionally active##11##2##(1990-12#1)(1990-5#1)(1992-12#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
functionally altered##2##2##(1990-5#1)(1995-12#1)
functionally and##3##2##(1993-12#1)(1997-8#1)(2011-2#1)
functionally associated proteins##2##3##(2008-7#2)
functionally characterized##3##2##(1992-9#1)(2009-10#1)(2012-2#1)
functionally conserved##2##2##(1993-12#1)(2009-9#1)
functionally critical##2##2##(1993-12#1)(2013-8#1)
functionally debilitating##2##2##(2008-9#2)
functionally defined##2##2##(2008-10#1)(2008-7#1)
functionally dependent##2##2##(1994-1#1)(2008-1#1)
functionally different##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
functionally disabled##2##2##(1995-2#1)(2008-1#1)
functionally distinct apical and basal##2##5##(2007-8#2)
functionally distinct##12##2##(1990-12#1)(1990-5#1)(1991-5#1)(1993-8#1)(1994-3#1)(1997-2#1)(2007-8#2)(2008-4#2)(2008-7#1)(2013-8#1)
functionally diverse##2##2##(2008-11#1)(2012-2#1)
functionally equivalent to##2##3##(2008-2#1)(2011-1#1)
functionally equivalent##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
functionally expressed in##3##3##(1994-8#1)(1995-2#1)(1996-2#1)
functionally graded material##2##3##(2008-5#2)
functionally identified##3##2##(1990-5#1)(1994-12#1)(2008-7#1)
functionally important##11##2##(1990-8#2)(1991-6#1)(1993-8#1)(1997-6#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-9#1)(2012-3#1)
functionally involved in##2##3##(1990-11#1)(2008-8#1)
functionally redundant##7##2##(1993-12#1)(1996-2#1)(2008-11#1)(2009-10#2)(2009-5#1)(2012-2#1)
functionally related to the##2##4##(2007-12#1)(2008-8#1)
functionally related to##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
functionally related##5##2##(1992-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
functionally relevant##3##2##(1992-12#1)(1995-12#1)(2009-5#1)
functionally significant##2##2##(2008-11#1)(2008-7#1)
functionally similar##4##2##(1990-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
functionally to##2##2##(1993-2#1)(2008-9#1)
functionally##167##1##(1990-11#1)(1990-12#2)(1990-5#5)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#5)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#6)(2009-10#4)(2009-12#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#4)
functionals##9##1##(2008-3#2)(2010-7#3)(2012-12#4)
functioned as a##3##3##(1991-10#1)(1994-12#1)(2008-10#1)
functioned as##6##2##(1991-10#1)(1994-12#1)(2008-10#3)(2011-1#1)
functioned##13##1##(1991-10#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-5#1)(2008-1#1)(2008-10#4)(2008-8#1)(2011-1#1)
functioning (e##2##2##(2008-7#1)(2013-1#1)
functioning among##3##2##(2008-7#1)(2009-10#1)(2010-12#1)
functioning and role limitations due to##2##6##(2007-11#2)
functioning and the##2##3##(2009-10#1)(2011-2#1)
functioning and well-being##2##3##(1994-3#1)(2007-10#1)
functioning and##31##2##(1990-3#4)(1991-6#1)(1992-5#1)(1994-3#1)(1995-2#1)(1996-1#2)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-7#5)(2008-9#1)(2009-10#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
functioning as a##2##3##(2008-9#1)(2013-1#1)
functioning as an electronic stethoscope##2##5##(2010-2#2)
functioning as##12##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-2#2)(2011-1#1)(2013-1#2)
functioning at the##2##3##(1997-3#1)(2008-5#1)
functioning at##4##2##(1997-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
functioning for##2##2##(1997-6#1)(2009-11#1)
functioning graft##2##2##(2008-1#1)(2011-2#1)
functioning in the##6##3##(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2012-1#1)(2013-1#1)
functioning in##26##2##(1993-1#1)(1994-2#1)(1995-6#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-7#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#2)
functioning is##7##2##(1995-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-12#2)
functioning kidney##3##2##(1997-1#1)(2008-1#1)(2013-1#1)
functioning may be##2##3##(2008-8#1)(2013-1#1)
functioning of children with##2##4##(1996-1#1)(2008-11#1)
functioning of children##3##3##(1996-1#1)(2008-11#1)(2008-12#1)
functioning of the##16##3##(1991-3#1)(1992-1#1)(1993-6#1)(1997-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2009-9#1)(2012-2#1)(2012-6#1)(2013-1#1)
functioning of##38##2##(1991-3#1)(1992-1#1)(1993-6#1)(1994-2#1)(1996-1#2)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#3)(2009-4#2)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-6#1)(2013-1#2)(2013-8#1)
functioning on##3##2##(1996-1#2)(2008-9#1)
functioning or##2##2##(2008-11#1)(2008-6#1)
functioning primarily by##2##3##(2008-10#2)
functioning was##5##2##(2008-6#1)(2013-1#4)
functioning were##2##2##(2008-7#1)(2009-11#1)
functioning##278##1##(1990-11#2)(1990-3#5)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#3)(1994-3#3)(1994-5#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#13)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-4#1)(2007-8#4)(2008-1#8)(2008-10#11)(2008-11#14)(2008-12#5)(2008-2#9)(2008-3#2)(2008-5#1)(2008-6#7)(2008-7#22)(2008-8#7)(2008-9#7)(2009-10#10)(2009-11#4)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-9#4)(2011-1#5)(2011-2#14)(2012-1#2)(2012-12#11)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#20)(2013-7#3)(2013-8#3)
functions after##3##2##(1990-3#1)(1995-11#1)(2012-2#1)
functions and a##2##3##(2008-3#2)
functions and hence##2##3##(2008-10#1)(2008-3#1)
functions and its##2##3##(2011-2#1)(2012-2#1)
functions and normal##2##3##(2008-1#1)(2009-4#1)
functions and the##7##3##(1990-8#1)(1991-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2013-7#1)
functions and their##4##3##(1995-12#2)(2008-7#1)(2009-4#1)
functions and to##3##3##(2008-10#2)(2008-4#1)
functions and##65##2##(1990-8#1)(1991-9#2)(1992-5#1)(1992-9#2)(1993-5#1)(1993-8#1)(1994-12#1)(1995-12#2)(1995-2#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
functions are derived##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
functions are given##2##3##(2007-12#1)(2008-2#1)
functions are not##3##3##(1994-8#1)(2008-2#1)(2011-2#1)
functions are used##2##3##(2008-2#1)(2009-4#1)
functions are##39##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#7)(2008-3#6)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
functions as a receptor for the##2##6##(1995-2#1)(2008-4#1)
functions as a regulator of##2##5##(1994-12#1)(2008-8#1)
functions as a signal-anchor##2##4##(1991-10#2)
functions as a##33##3##(1990-11#1)(1990-2#1)(1991-10#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-2#2)(1995-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
functions as an##8##3##(1994-12#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-6#1)(2008-11#2)(2008-5#1)
functions as well as##4##4##(2008-2#1)(2009-10#1)(2009-5#1)(2009-6#1)
functions as well##5##3##(2008-1#1)(2008-2#1)(2009-10#1)(2009-5#1)(2009-6#1)
functions as##52##2##(1990-11#2)(1990-2#1)(1991-10#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-12#2)(1994-5#1)(1995-2#3)(1995-9#2)(1996-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
functions associated with##2##3##(2008-10#1)(2009-10#1)
functions at##6##2##(1991-3#1)(1993-12#1)(1997-3#1)(2008-10#1)(2009-8#1)(2010-6#1)
functions based on##3##3##(1993-5#1)(2008-2#1)(2008-3#1)
functions but##3##2##(1994-6#1)(2008-3#1)(2011-2#1)
functions by interacting with##2##4##(2012-1#1)(2013-1#1)
functions by the##2##3##(1997-2#2)
functions by##18##2##(1993-12#1)(1995-2#1)(1997-2#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
functions can be##10##3##(1992-9#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
functions characteristic##2##2##(2008-10#1)(2008-9#1)
functions controlled by##2##3##(2008-8#1)(2012-3#1)
functions could be##2##3##(1991-9#1)(2008-10#1)
functions could##3##2##(1991-9#1)(1996-2#1)(2008-10#1)
functions derived##3##2##(1991-5#1)(2008-3#1)(2010-11#1)
functions during##4##2##(1991-12#1)(1995-12#1)(2008-1#1)(2008-8#1)
functions for the##7##3##(1995-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
functions for ultrafast optical routing by##2##6##(2007-12#2)
functions for##29##2##(1995-12#1)(1995-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
functions from a##2##3##(1992-12#1)(2008-2#1)
functions from##6##2##(1992-1#1)(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
functions has been##3##3##(2007-6#1)(2009-2#1)(2010-12#1)
functions have been##6##3##(1992-9#1)(1993-6#1)(1994-3#1)(1997-7#1)(2008-3#1)(2009-10#1)
functions have##10##2##(1992-9#1)(1993-6#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-3#3)(2009-10#1)(2010-11#1)
functions in a##7##3##(1991-2#1)(1991-5#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)
functions in cell##3##3##(1994-5#1)(2008-5#1)(2008-9#1)
functions in lipid##2##3##(1992-9#1)(1995-6#1)
functions in normal##2##3##(2011-1#1)(2013-1#1)
functions in patients with##3##4##(2010-6#1)(2012-2#1)(2013-8#1)
functions in plants##2##3##(2009-6#1)(2011-2#1)
functions in the##22##3##(1993-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-10#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-2#2)(2012-3#1)
functions in vitro##4##3##(2008-11#3)(2011-2#1)
functions in vivo##2##3##(2008-4#1)(2011-1#1)
functions in##112##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-12#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#3)(1997-4#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#3)(2009-2#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#1)
functions include##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
functions including##6##2##(2007-8#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#1)(2012-2#1)
functions involving##2##2##(1994-12#1)(2013-8#1)
functions is##8##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-8#1)
functions it##2##2##(2007-12#1)(2008-7#1)
functions may be##2##3##(2008-12#1)(2008-7#1)
functions may##7##2##(1992-9#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
functions observed in##2##3##(1994-11#1)(2008-2#1)
functions of a##5##3##(1994-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)
functions of an##2##3##(2008-3#1)(2011-2#1)
functions of both##3##3##(2009-10#1)(2009-8#1)(2013-1#1)
functions of genes##3##3##(1993-9#1)(2010-12#1)(2012-3#1)
functions of particular##2##3##(1992-9#1)(2008-11#1)
functions of proteins##2##3##(2009-11#1)(2010-2#1)
functions of public##5##3##(1995-12#2)(1996-1#1)(1996-3#1)(2008-12#1)
functions of rat##2##3##(1990-3#1)(1991-5#1)
functions of the cerebellum##2##4##(2007-8#2)
functions of the gastrointestinal##2##4##(2012-1#2)
functions of the genes##3##4##(1994-8#1)(1997-8#1)(2008-9#1)
functions of the right hemisphere##2##5##(1990-3#2)
functions of the##65##3##(1990-11#2)(1990-3#2)(1991-12#1)(1992-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-8#1)
functions of their##3##3##(1994-2#1)(2008-9#1)(2009-7#1)
functions of this##3##3##(1990-11#1)(2007-12#1)(2008-6#1)
functions of vitamins##2##3##(1992-9#2)
functions of##228##2##(1990-11#6)(1990-3#3)(1990-8#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#3)(1993-11#1)(1993-12#4)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#8)(2008-12#1)(2008-2#11)(2008-3#27)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#1)(2009-5#2)(2009-7#3)(2009-8#7)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
functions on the##2##3##(2008-1#1)(2008-5#1)
functions on##5##2##(1993-3#1)(1995-8#1)(2008-1#1)(2008-5#1)(2008-6#1)
functions onto a single microchip##2##5##(2007-8#2)
functions onto##3##2##(2007-8#2)(2008-3#1)
functions or##2##2##(2010-4#1)(2012-2#1)
functions other than##2##3##(2008-5#1)(2008-7#1)
functions provides a##2##3##(1995-2#1)(1997-8#1)
functions related to the##2##4##(1992-12#1)(1996-12#1)
functions required##2##2##(2008-4#1)(2009-2#1)
functions such as##9##3##(1995-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-8#1)(2012-2#1)
functions that are##4##3##(1996-2#1)(2007-12#1)(2008-2#1)(2013-1#1)
functions that might be##2##4##(2013-1#1)(2013-8#1)
functions that reflect##2##3##(2008-10#1)(2008-9#1)
functions that##22##2##(1990-8#1)(1994-12#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#3)
functions they##3##2##(1994-9#1)(2008-4#1)(2012-1#1)
functions through##4##2##(2008-9#1)(2011-1#2)(2011-3#1)
functions to##15##2##(1993-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)
functions using##2##2##(2007-10#1)(2008-10#1)
functions via##3##2##(1992-9#1)(2008-4#1)(2009-5#1)
functions was##5##2##(1991-2#1)(1993-12#1)(1994-12#1)(2007-10#1)(2008-11#1)
functions were fitted to##2##4##(2008-10#1)(2008-2#1)
functions were used in the hidden and output layers##4##9##(2008-10#4)
functions were used to##2##4##(2008-10#1)(2008-3#1)
functions were used##6##3##(2008-10#5)(2008-3#1)
functions were##25##2##(1994-8#1)(1995-6#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#2)(2012-2#2)
functions with a##2##3##(2008-10#1)(2008-2#1)
functions with##8##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-8#1)
functions within a##2##3##(1995-12#1)(2010-8#1)
functions within##6##2##(1995-12#1)(1995-3#1)(1996-12#1)(2008-7#1)(2010-5#1)(2010-8#1)
functions##1155##1##(1990-11#10)(1990-12#1)(1990-2#1)(1990-3#6)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-10#2)(1991-12#7)(1991-2#5)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#6)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#5)(1992-6#2)(1992-9#15)(1993-11#3)(1993-12#14)(1993-2#4)(1993-3#4)(1993-5#4)(1993-6#1)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#6)(1994-12#11)(1994-2#4)(1994-3#9)(1994-5#4)(1994-6#5)(1994-8#9)(1994-9#2)(1995-11#1)(1995-12#15)(1995-2#10)(1995-3#4)(1995-5#3)(1995-6#5)(1995-8#7)(1995-9#6)(1996-1#1)(1996-12#7)(1996-2#17)(1996-3#6)(1996-4#1)(1996-5#5)(1996-6#2)(1997-1#2)(1997-2#8)(1997-3#5)(1997-4#3)(1997-6#8)(1997-7#3)(1997-8#3)(2006-12#1)(2006-4#2)(2007-10#6)(2007-11#14)(2007-12#25)(2007-2#1)(2007-4#1)(2007-6#4)(2007-7#2)(2007-8#14)(2008-1#18)(2008-10#71)(2008-11#48)(2008-12#7)(2008-2#61)(2008-3#96)(2008-4#32)(2008-5#23)(2008-6#10)(2008-7#51)(2008-8#20)(2008-9#37)(2009-1#1)(2009-10#17)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#4)(2009-5#9)(2009-6#8)(2009-7#9)(2009-8#15)(2009-9#8)(2010-1#4)(2010-10#8)(2010-11#8)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#8)(2010-9#5)(2011-1#16)(2011-2#35)(2011-3#2)(2012-1#11)(2012-12#12)(2012-2#37)(2012-3#17)(2012-5#1)(2013-1#30)(2013-7#3)(2013-8#19)
functions)##4##1##(2008-10#3)(2008-2#1)
fund development programs##5##3##(1992-1#1)(1995-1#2)(1995-3#2)
fund development##6##2##(1991-9#1)(1992-1#1)(1995-1#2)(1995-3#2)
fund raisers##3##2##(1994-1#1)(1994-3#1)(1995-3#1)
fund raising and##2##3##(1996-1#1)(2008-12#1)
fund raising##9##2##(1991-1#1)(1991-3#1)(1992-1#2)(1992-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-12#1)
fund##33##1##(1991-1#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-3#2)(1995-1#3)(1995-12#1)(1995-3#3)(1996-1#1)(1997-1#3)(1997-3#2)(2008-11#1)(2008-12#1)(2009-5#1)(2012-2#1)
fund-raising program##2##2##(1995-1#1)(1997-1#1)
fund-raising##7##1##(1991-1#1)(1991-2#1)(1991-3#1)(1995-1#1)(1996-8#1)(1997-1#1)(2009-5#1)
fundamental and first-order##2##3##(2007-12#1)(2008-3#1)
fundamental and harmonic##2##3##(2008-3#2)
fundamental and second-harmonic##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
fundamental and the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
fundamental and##26##2##(1995-12#1)(2007-11#3)(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2009-4#1)(2010-4#1)(2013-1#1)(2013-8#1)
fundamental beam##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
fundamental beams##2##2##(2007-12#2)
fundamental biological##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)
fundamental cellular processes##3##3##(2007-11#1)(2008-9#1)(2012-12#1)
fundamental changes in the##3##4##(1994-1#1)(1996-12#1)(1997-5#1)
fundamental changes in##6##3##(1994-1#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-3#1)(2011-2#1)
fundamental characteristic of all##2##4##(2008-12#1)(2008-8#1)
fundamental characteristics of##2##3##(2008-3#1)(2008-9#1)
fundamental component of##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
fundamental component##5##2##(1991-3#1)(2008-10#1)(2008-11#2)(2008-9#1)
fundamental concepts##4##2##(2008-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
fundamental determinants of##2##3##(2007-12#1)(2008-8#1)
fundamental difference##3##2##(2008-4#1)(2010-12#1)(2012-2#1)
fundamental differences between##3##3##(2008-5#1)(2009-8#1)(2013-1#1)
fundamental differences in##2##3##(2008-8#1)(2008-9#1)
fundamental differences##6##2##(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-7#1)(2013-1#1)
fundamental difficulties##2##2##(2008-2#1)(2013-1#1)
fundamental economic##2##2##(1994-12#1)(2008-11#1)
fundamental equilibrium constants##4##3##(2008-10#4)
fundamental for##5##2##(1990-5#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
fundamental frequencies##2##2##(1993-9#1)(2010-2#1)
fundamental frequency and##2##3##(2010-2#1)(2013-8#1)
fundamental frequency##5##2##(2007-11#1)(2007-12#1)(2010-2#2)(2013-8#1)
fundamental functions##2##2##(2007-12#1)(2008-3#1)
fundamental goal##2##2##(2007-11#1)(2008-8#1)
fundamental human##2##2##(2009-6#1)(2012-12#1)
fundamental importance in##5##3##(1990-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)
fundamental importance##13##2##(1990-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)
fundamental in##2##2##(1993-6#1)(2008-11#1)
fundamental influence on##2##3##(2008-11#1)(2008-8#1)
fundamental influence##3##2##(1993-6#1)(2008-11#1)(2008-8#1)
fundamental information##4##2##(1994-2#1)(1996-2#1)(2008-10#1)(2011-2#1)
fundamental insight into##2##3##(2007-12#1)(2008-7#1)
fundamental insights into##3##3##(1994-8#1)(1997-3#1)(2010-3#1)
fundamental interest##3##2##(1995-3#1)(2008-3#1)(2008-8#1)
fundamental laser##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
fundamental level##2##2##(1996-1#1)(2009-6#1)
fundamental light##2##2##(2007-12#1)(2008-3#1)
fundamental limitations##2##2##(2007-12#1)(2008-3#1)
fundamental mechanisms##2##2##(1992-6#1)(2012-3#1)
fundamental mode##12##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#7)
fundamental modes##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
fundamental number##2##2##(2010-3#2)
fundamental power##2##2##(2007-12#1)(2008-3#1)
fundamental principle of##2##3##(2008-10#1)(2008-9#1)
fundamental principles of##3##3##(2008-3#1)(2008-5#1)(2010-6#1)
fundamental principles##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)
fundamental problem##4##2##(1991-3#1)(1997-3#1)(2008-3#1)(2008-6#1)
fundamental process##3##2##(1992-9#1)(2012-2#1)(2013-8#1)
fundamental processes##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-4#1)
fundamental questions about##2##3##(1991-2#1)(2013-1#1)
fundamental questions##4##2##(1991-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
fundamental reasons##2##2##(2008-3#2)
fundamental research##6##2##(1994-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2013-1#2)
fundamental role##5##2##(2008-4#1)(2008-8#2)(2010-4#1)(2013-7#1)
fundamental scientific##3##2##(2010-10#1)(2013-1#1)(2013-7#1)
fundamental step##2##2##(2008-10#1)(2008-4#1)
fundamental studies##3##2##(2008-10#3)
fundamental study##3##2##(2008-10#2)(2008-5#1)
fundamental to the##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)
fundamental to##13##2##(1994-12#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-5#1)
fundamental tool##3##2##(1995-2#1)(2008-4#1)(2011-2#1)
fundamental understanding of##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
fundamental vibrational band##2##3##(2008-3#2)
fundamental wave##8##2##(2007-11#1)(2007-12#6)(2008-2#1)
fundamental wavelength##8##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-3#1)
fundamental wavelengths##2##2##(2007-11#1)(2007-12#1)
fundamental waves##2##2##(2007-12#1)(2008-2#1)
fundamental##431##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#3)(1991-5#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#4)(1997-5#1)(2007-10#3)(2007-11#28)(2007-12#57)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#35)(2008-11#17)(2008-12#5)(2008-2#17)(2008-3#52)(2008-4#7)(2008-5#10)(2008-6#6)(2008-7#10)(2008-8#12)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#12)(2012-1#3)(2012-12#2)(2012-2#11)(2012-3#2)(2012-7#1)(2013-1#11)(2013-7#2)(2013-8#7)
fundamental-mode##2##1##(2008-2#1)(2008-3#1)
fundamentally different##8##2##(1990-5#1)(1993-3#1)(1995-1#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)
fundamentally the##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
fundamentally##33##1##(1990-5#1)(1992-12#1)(1993-3#1)(1994-12#2)(1995-1#2)(1995-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-8#2)(2013-1#2)
fundamentals of##10##2##(1994-12#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-1#1)
fundamentals##12##1##(1994-12#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-1#1)
funded and##2##2##(1993-3#1)(1995-2#1)
funded by the National Institute on##2##6##(1992-3#1)(2009-5#1)
funded by the National Institutes of Health##10##7##(2013-8#10)
funded by the National##12##4##(1992-3#1)(2009-5#1)(2013-8#10)
funded by the##24##3##(1992-3#1)(1995-2#1)(1995-3#3)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
funded by##27##2##(1992-3#1)(1995-2#1)(1995-3#3)(1997-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
funded programs##2##2##(1996-12#1)(2008-6#1)
funded project##2##2##(1996-2#1)(2008-10#1)
funded regional##2##2##(1994-3#1)(2010-3#1)
funded research##5##2##(1995-2#4)(2007-4#1)
funded##72##1##(1990-6#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-2#7)(1995-3#4)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-3#1)(1997-8#1)(2007-4#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-5#2)(2008-6#2)(2008-7#3)(2009-5#1)(2010-10#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#11)
funders##7##1##(1991-12#1)(1994-12#1)(1995-3#1)(1997-5#2)(2009-4#2)
fundic gastric##2##2##(1990-9#1)(2009-3#1)
fundic##4##1##(1990-9#2)(1995-11#1)(2009-3#1)
funding agencies to##2##3##(2009-3#2)
funding agencies##5##2##(2008-10#1)(2008-9#1)(2009-3#2)(2009-4#1)
funding and##10##2##(1992-1#1)(1993-2#1)(1995-1#1)(1996-12#1)(2008-10#1)(2009-4#1)(2010-5#2)(2011-2#1)(2013-8#1)
funding as##2##2##(1997-3#1)(2011-1#1)
funding for stroke research##3##4##(2008-8#3)
funding for stroke##4##3##(2008-8#4)
funding for##20##2##(1993-2#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#4)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
funding from the##4##3##(1991-2#1)(1992-1#1)(2008-5#1)(2010-3#1)
funding from##11##2##(1991-2#1)(1992-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)
funding in##3##2##(1995-2#1)(1995-3#1)(1996-1#1)
funding is##6##2##(1994-2#1)(1995-2#2)(2008-7#2)(2010-10#1)
funding levels for##2##3##(1992-12#1)(2008-8#1)
funding of##10##2##(1994-2#2)(1995-12#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-3#1)
funding opportunities##2##2##(2008-4#1)(2013-1#1)
funding purposes##3##2##(1991-12#2)(1995-6#1)
funding sources##3##2##(1991-12#1)(1993-3#1)(1995-3#1)
funding support##2##2##(1997-5#1)(2008-11#1)
funding system##2##2##(1993-3#1)(1996-1#1)
funding systems##2##2##(1995-12#1)(1995-2#1)
funding the##2##2##(2011-2#1)(2012-12#1)
funding to the##2##3##(1997-2#1)(2012-2#1)
funding to##6##2##(1991-1#1)(1991-12#1)(1992-3#1)(1997-2#1)(2009-4#1)(2012-2#1)
funding was##2##2##(1997-2#1)(2008-12#1)
funding##196##1##(1990-4#2)(1990-5#1)(1991-1#2)(1991-12#15)(1991-2#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#4)(1994-1#2)(1994-2#7)(1994-7#1)(1995-1#3)(1995-12#6)(1995-2#5)(1995-3#11)(1995-6#6)(1996-1#7)(1996-12#2)(1996-2#6)(1996-3#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-4#4)(2008-1#3)(2008-10#8)(2008-11#9)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-11#3)(2009-3#5)(2009-4#3)(2009-5#1)(2009-7#1)(2010-10#2)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
fundoplication##7##1##(2008-12#3)(2011-1#3)(2011-2#1)
fundraising##2##1##(1993-1#1)(1995-3#1)
funds and##3##2##(1993-2#1)(2011-2#1)(2013-1#1)
funds are##3##2##(1992-12#1)(1996-1#1)(2008-11#1)
funds for##4##2##(1993-1#1)(1996-5#1)(2008-10#1)(2008-7#1)
funds to##7##2##(1990-6#1)(1992-12#1)(1992-2#1)(1995-6#1)(1996-2#1)(2008-5#1)(2012-12#1)
funds were##2##2##(1994-12#1)(1996-1#1)
funds will be##2##3##(1997-2#1)(2008-5#1)
funds will##3##2##(1997-2#1)(2008-1#1)(2008-5#1)
funds##57##1##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-6#1)(1996-1#6)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2009-11#2)(2009-5#1)(2011-2#10)(2012-12#1)(2013-1#2)
fundus and##2##2##(1997-1#1)(2010-6#1)
fundus examination##2##2##(2010-8#1)(2013-1#1)
fundus images##3##2##(2007-12#1)(2010-8#1)(2011-1#1)
fundus##17##1##(1990-9#1)(1991-12#1)(1993-1#1)(1993-12#1)(1997-1#2)(2007-12#1)(2008-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2013-1#1)
funeral##7##1##(1997-5#3)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
fungal DNA##7##2##(2008-10#5)(2008-5#1)(2011-2#1)
fungal alpha-amylase##2##2##(2008-10#2)
fungal and bacterial##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
fungal and##7##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-1#1)(2012-2#1)
fungal antagonist##2##2##(2008-10#2)
fungal attack##5##2##(2008-10#5)
fungal biocontrol agent##2##3##(2008-10#2)
fungal biomass##7##2##(2008-10#7)
fungal cell wall components##2##4##(2008-10#1)(2011-2#1)
fungal cell wall##6##3##(2008-10#5)(2011-2#1)
fungal cell walls##3##3##(2008-10#2)(2011-2#1)
fungal cell##11##2##(2008-10#9)(2011-2#2)
fungal cells##2##2##(2008-10#2)
fungal colonization was##3##3##(2008-10#3)
fungal colonization##14##2##(2008-10#11)(2008-12#2)(2013-8#1)
fungal colony##3##2##(2008-10#2)(2008-11#1)
fungal community##4##2##(2008-10#4)
fungal conidia##2##2##(2008-10#1)(2011-1#1)
fungal contamination in##2##3##(2008-12#1)(2012-2#1)
fungal contamination##4##2##(2008-10#1)(2008-12#2)(2012-2#1)
fungal culture##3##2##(2008-10#1)(2009-2#1)(2012-3#1)
fungal cultures##2##2##(2008-10#2)
fungal development##8##2##(2008-10#6)(2009-8#1)(2010-10#1)
fungal disease##8##2##(1990-9#1)(2008-10#3)(2008-8#2)(2011-2#2)
fungal diseases of##2##3##(2008-10#2)
fungal diseases##11##2##(1992-2#1)(1997-1#1)(2008-10#6)(2009-9#2)(2011-10#1)
fungal elements##4##2##(1997-3#3)(2007-7#1)
fungal elicitation##2##2##(1994-11#2)
fungal elicitor##2##2##(1992-12#1)(2008-10#1)
fungal endophytes##4##2##(2008-10#1)(2008-8#1)(2010-6#2)
fungal foliar disease##2##3##(2008-10#1)(2012-3#1)
fungal fruiting##2##2##(2008-10#2)
fungal genes##3##2##(1993-2#1)(1997-2#1)(2008-10#1)
fungal genome sequence##2##3##(2008-11#1)(2008-7#1)
fungal genome##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)
fungal genomic DNA##3##3##(2008-10#3)
fungal genomic##4##2##(2008-10#4)
fungal genotypes##4##2##(2008-10#3)(2008-9#1)
fungal growth and##3##3##(2008-10#2)(2010-7#1)
fungal growth in the##2##4##(2008-10#2)
fungal growth in##6##3##(2008-10#5)(2010-7#1)
fungal growth of##2##3##(1997-4#1)(2008-10#1)
fungal growth was##3##3##(2008-10#2)(2012-2#1)
fungal growth##28##2##(1997-4#1)(2008-10#22)(2010-7#2)(2012-2#2)(2013-8#1)
fungal host##2##2##(2008-10#2)
fungal hyphae##6##2##(2008-10#5)(2008-11#1)
fungal infection of the##2##4##(2008-10#1)(2011-2#1)
fungal infection of##3##3##(2008-10#2)(2011-2#1)
fungal infection##15##2##(2007-12#1)(2007-7#1)(2008-10#6)(2008-5#2)(2011-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
fungal infections are##2##3##(2011-2#1)(2011-3#1)
fungal infections caused by##2##4##(2008-5#1)(2012-3#1)
fungal infections have##2##3##(2008-7#1)(2011-2#1)
fungal infections in patients with hematologic malignancies##2##7##(2008-7#2)
fungal infections in patients with##3##5##(2008-7#2)(2012-2#1)
fungal infections in##4##3##(1997-4#1)(2008-7#2)(2012-2#1)
fungal infections##25##2##(1997-2#1)(1997-4#2)(2007-8#1)(2008-5#2)(2008-7#5)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
fungal infestation levels##3##3##(2008-10#3)
fungal inoculations##2##2##(2008-10#2)
fungal inoculum density##5##3##(2008-10#5)
fungal inoculum##6##2##(2008-10#6)
fungal isolate##4##2##(2008-10#4)
fungal isolates were##6##3##(2008-10#2)(2008-12#1)(2009-2#1)(2011-2#2)
fungal isolates##19##2##(2008-10#14)(2008-12#2)(2009-2#1)(2011-2#2)
fungal keratitis in##2##3##(2010-10#1)(2011-2#1)
fungal laccase##3##2##(2008-10#3)
fungal metabolites##2##2##(2008-10#2)
fungal mitochondrial##3##2##(2008-10#2)(2008-9#1)
fungal morphology##2##2##(2008-7#2)
fungal mycoparasite##2##2##(2008-10#2)
fungal pathogen Candida albicans##2##4##(2008-4#1)(2009-8#1)
fungal pathogen of##2##3##(2008-10#1)(2008-9#1)
fungal pathogen##23##2##(2008-10#17)(2008-4#1)(2008-9#2)(2009-8#1)(2010-10#1)(2011-10#1)
fungal pathogenicity and host resistance##2##5##(2008-10#2)
fungal pathogens and##2##3##(2008-10#2)
fungal pathogens from##2##3##(2008-10#2)
fungal pathogens of##4##3##(2008-10#4)
fungal pathogens were##2##3##(2008-10#2)
fungal pathogens##27##2##(2008-10#20)(2008-5#2)(2009-6#3)(2011-10#1)(2011-2#1)
fungal penetration##6##2##(2008-10#6)
fungal plant pathogens##6##3##(2008-10#6)
fungal plant##7##2##(2008-10#7)
fungal population##4##2##(2008-10#3)(2008-12#1)
fungal populations in##2##3##(2008-10#1)(2008-12#1)
fungal populations on##2##3##(2008-10#2)
fungal populations##9##2##(2008-10#8)(2008-12#1)
fungal proteins##2##2##(2008-10#2)
fungal rDNA##2##2##(2008-10#2)
fungal rhinosinusitis caused by Neosartorya hiratsukae##2##6##(2009-2#2)
fungal rhinosinusitis##4##2##(2009-2#3)(2012-1#1)
fungal sinusitis##3##2##(2011-2#3)
fungal species and##2##3##(2008-10#1)(2012-2#1)
fungal species##15##2##(2008-10#9)(2008-5#1)(2009-8#1)(2012-2#2)(2012-3#1)(2012-6#1)
fungal spore concentrations##2##3##(2008-5#2)
fungal spore##7##2##(2008-10#3)(2008-5#3)(2013-8#1)
fungal spores##9##2##(1994-9#1)(2008-10#5)(2008-5#2)(2010-5#1)
fungal strains##7##2##(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-3#2)
fungal versus bacterial##2##3##(2008-10#2)
fungal wall##2##2##(2008-10#1)(2008-3#1)
fungal##527##1##(1990-12#1)(1990-9#1)(1991-5#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-9#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#4)(1997-6#1)(2007-11#1)(2007-12#3)(2007-7#3)(2007-8#2)(2008-10#317)(2008-11#6)(2008-12#8)(2008-3#3)(2008-4#1)(2008-5#19)(2008-6#2)(2008-7#8)(2008-8#11)(2008-9#6)(2009-10#1)(2009-2#7)(2009-6#5)(2009-8#5)(2009-9#5)(2010-10#4)(2010-4#2)(2010-5#2)(2010-6#6)(2010-7#2)(2011-1#4)(2011-10#5)(2011-2#25)(2011-3#1)(2012-1#3)(2012-2#10)(2012-3#8)(2012-6#1)(2013-1#8)(2013-8#4)
fungal-specific##2##1##(2008-10#1)(2009-5#1)
fungemia##7##1##(2007-12#1)(2008-5#6)
fungi and A##2##3##(2009-8#2)
fungi and Oomycetes##2##3##(2008-10#2)
fungi and bacteria##2##3##(2008-10#1)(2008-5#1)
fungi and oomycetes##4##3##(2008-10#4)
fungi and the predatory stinkbug##2##5##(2008-6#2)
fungi and the##3##3##(2008-6#2)(2011-2#1)
fungi and##32##2##(1991-9#1)(1994-11#1)(1995-8#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-8#3)(2009-9#1)(2010-6#1)(2011-2#2)
fungi are able to##2##4##(2006-6#1)(2008-8#1)
fungi are the##2##3##(2008-10#1)(2012-2#1)
fungi are##12##2##(2006-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)
fungi as well as##2##4##(1991-5#1)(2008-10#1)
fungi as##6##2##(1991-5#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
fungi associated with##7##3##(2008-10#6)(2012-3#1)
fungi at##2##2##(2008-10#1)(2013-1#1)
fungi but##3##2##(1994-2#1)(2008-10#2)
fungi could##2##2##(1997-3#1)(2008-12#1)
fungi examined##2##2##(1996-6#1)(2010-7#1)
fungi from##3##2##(2008-10#2)(2008-12#1)
fungi has been##2##3##(2008-11#1)(2013-7#1)
fungi have been##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
fungi in the##6##3##(2008-10#5)(2012-3#1)
fungi in##16##2##(2008-10#12)(2008-5#1)(2008-6#1)(2010-3#1)(2012-3#1)
fungi including##2##2##(2008-10#2)
fungi infecting##2##2##(2008-10#2)
fungi is##7##2##(2008-10#2)(2008-11#1)(2008-5#2)(2010-7#1)(2011-10#1)
fungi isolated from##2##3##(2008-10#2)
fungi of insects from Argentina (Zygomycetes##2##6##(2008-5#2)
fungi of##7##2##(2008-10#2)(2008-5#2)(2010-7#1)(2011-2#1)(2013-8#1)
fungi on##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
fungi or##2##2##(2008-10#1)(2013-8#1)
fungi such as##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
fungi tested##2##2##(2008-10#2)
fungi that are##2##3##(1994-5#1)(2009-6#1)
fungi that##7##2##(1994-5#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-6#1)(2010-7#1)
fungi to##5##2##(2006-6#1)(2008-10#3)(2008-5#1)
fungi was##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
fungi were isolated from##2##4##(2008-10#2)
fungi were##15##2##(1996-6#1)(2008-10#11)(2008-3#1)(2008-5#1)(2010-3#1)
fungi##361##1##(1990-12#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-8#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#2)(2007-11#1)(2008-1#2)(2008-10#185)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#27)(2008-6#11)(2008-7#6)(2008-8#9)(2008-9#5)(2009-2#1)(2009-6#4)(2009-8#7)(2009-9#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-6#6)(2010-7#9)(2011-1#5)(2011-10#1)(2011-2#9)(2012-2#3)(2012-3#5)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#6)
fungi)##3##1##(1993-12#1)(1995-2#1)(2008-10#1)
fungible##3##1##(1994-12#3)
fungicidal and##2##2##(2007-11#1)(2008-3#1)
fungicidal protection##3##2##(2008-10#3)
fungicidal##13##1##(1992-8#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
fungicide and##4##2##(2008-10#3)(2008-7#1)
fungicide application##4##2##(2008-10#3)(2008-7#1)
fungicide applications##10##2##(2008-10#10)
fungicide chlorothalonil##2##2##(2008-10#2)
fungicide concentration##3##2##(2008-10#3)
fungicide concentrations##2##2##(2008-10#2)
fungicide dose##2##2##(2008-10#2)
fungicide efficacy##2##2##(2008-10#2)
fungicide resistance or##2##3##(2008-10#2)
fungicide resistance##8##2##(2008-10#8)
fungicide seed treatment##2##3##(2008-10#2)
fungicide sensitivity##2##2##(2008-10#2)
fungicide significantly reduced##2##3##(2008-10#2)
fungicide spray heterogeneity and the##2##5##(2008-10#2)
fungicide spray heterogeneity##3##3##(2008-10#3)
fungicide spray##4##2##(2008-10#4)
fungicide treatments##4##2##(2008-10#4)
fungicide trials##2##2##(2008-10#2)
fungicide use##8##2##(2008-10#8)
fungicide was applied##3##3##(2008-10#3)
fungicide was##4##2##(2008-10#4)
fungicide##127##1##(1991-5#2)(1996-8#1)(2008-10#120)(2008-11#2)(2008-7#2)
fungicide-amended medium##3##2##(2008-10#3)
fungicide-amended##4##1##(2008-10#4)
fungicide-resistant##5##1##(2008-10#5)
fungicides and##2##2##(2008-10#2)
fungicides are##3##2##(2008-10#3)
fungicides azoxystrobin##2##2##(2008-10#2)
fungicides chlorothalonyl and##2##3##(2008-6#2)
fungicides in##9##2##(2008-10#9)
fungicides including##2##2##(1997-2#1)(2008-10#1)
fungicides or bactericides##3##3##(2008-10#3)
fungicides or##4##2##(2008-10#4)
fungicides used to##2##3##(2008-10#2)
fungicides was##3##2##(2008-10#3)
fungicides##98##1##(1991-5#1)(1997-2#1)(1997-4#2)(2008-10#89)(2008-12#1)(2008-5#1)(2008-6#2)(2011-2#1)
fungicola var##7##2##(2008-10#7)
fungicola##14##1##(2008-10#14)
fungistatic##4##1##(2008-10#2)(2008-3#1)(2008-5#1)
fungivorous nematodes##2##2##(2008-10#2)
fungivorous##3##1##(2008-10#3)
fungoides##6##1##(1992-5#2)(2010-6#4)
fungus Bipolaris sorokiniana (teleomorph##2##4##(2008-10#2)
fungus Botrytis cinerea and##2##4##(1991-5#1)(2008-10#1)
fungus Botrytis cinerea##3##3##(1991-5#1)(2008-10#1)(2011-10#1)
fungus Candida albicans##2##3##(1991-9#1)(1996-6#1)
fungus Cylindrocarpon destructans##2##3##(2008-10#2)
fungus Fusarium##2##2##(1995-3#1)(2008-10#1)
fungus Melampsora larici-populina on##2##4##(2008-10#2)
fungus Mycosphaerella graminicola##2##3##(2008-10#2)
fungus Oidium neolycopersici##2##3##(2008-10#2)
fungus P##2##2##(1997-6#1)(2008-10#1)
fungus Podosordaria tulasnei##2##3##(2008-11#2)
fungus Puccinia##5##2##(2008-10#5)
fungus Pyrenophora tritici-repentis##3##3##(2008-10#3)
fungus Trichoderma##5##2##(1992-3#1)(2008-10#4)
fungus Ustilago maydis##2##3##(2009-8#2)
fungus Verticillium dahliae##3##3##(2008-10#1)(2011-1#2)
fungus activity##2##2##(2008-10#2)
fungus and##7##2##(2008-10#5)(2008-11#1)(2008-12#1)
fungus ball##2##2##(2008-1#2)
fungus behaves as a##2##4##(2008-10#2)
fungus but##3##2##(2008-10#2)(2008-11#1)
fungus can##2##2##(2008-10#2)
fungus did not##2##3##(2008-10#2)
fungus from##4##2##(2008-10#4)
fungus has been##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
fungus has##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
fungus in different##2##3##(2008-10#2)
fungus in the epidermis and outer cortex tissues##2##8##(2008-10#2)
fungus in the##4##3##(2008-10#4)
fungus in##13##2##(2008-10#13)
fungus infection##2##2##(2008-10#1)(2008-8#1)
fungus is##5##2##(2008-10#4)(2008-8#1)
fungus numbers##2##2##(2008-10#2)
fungus of##3##2##(2008-10#3)
fungus population density##2##3##(2008-10#2)
fungus produced##3##2##(2008-10#3)
fungus resulted in significantly higher##2##5##(2008-10#2)
fungus that##11##2##(2008-10#10)(2008-5#1)
fungus was isolated from##2##4##(2008-10#1)(2008-5#1)
fungus was isolated##3##3##(2008-10#2)(2008-5#1)
fungus was not##2##3##(2008-10#1)(2011-2#1)
fungus was##20##2##(2008-10#16)(2008-5#2)(2009-2#1)(2011-2#1)
fungus were used##2##3##(2008-10#1)(2008-8#1)
fungus were##4##2##(2008-10#3)(2008-8#1)
fungus which##2##2##(2008-5#1)(2008-8#1)
fungus with##4##2##(2008-10#3)(2008-5#1)
fungus##344##1##(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-11#2)(1995-2#1)(1995-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#247)(2008-11#8)(2008-12#11)(2008-5#13)(2008-6#3)(2008-8#10)(2008-9#2)(2009-2#2)(2009-8#2)(2009-9#3)(2010-10#2)(2010-3#1)(2010-7#2)(2011-1#6)(2011-10#1)(2011-2#1)(2012-6#1)(2013-1#6)
fungus) was##2##2##(2008-10#1)(2008-12#1)
fungus)##6##1##(1997-4#2)(2008-10#2)(2008-12#1)(2008-8#1)
fungus-fungicide interactions##3##2##(2008-10#3)
fungus-fungicide##4##1##(2008-10#4)
fungus-growing ant Trachymyrmex septentrionalis##2##4##(2012-2#2)
fungus-growing##3##1##(2008-8#1)(2012-2#2)
funnel warts of##2##3##(2007-12#2)
funnel warts##5##2##(2007-12#5)
funnel##9##1##(1990-5#1)(2007-12#5)(2008-10#3)
funnels that##2##2##(2008-10#2)
funnels##4##1##(2008-10#4)
funny##3##1##(2008-10#2)(2008-8#1)
funtionalised##3##1##(2007-11#2)(2008-10#1)
fur mutant##2##2##(2009-6#2)
fur mutation##3##2##(2009-6#3)
fur##13##1##(1992-8#2)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-6#5)
fura 2##2##2##(1990-8#2)
fura-2 and indo-1##2##3##(1991-5#2)
fura-2 and##3##2##(1991-12#1)(1991-5#2)
fura-2 fluorescence##2##2##(1992-5#1)(2013-1#1)
fura-2 method##2##2##(1994-6#1)(1995-11#1)
fura-2 was##2##2##(1991-5#1)(1992-5#1)
fura-2##24##1##(1991-12#1)(1991-5#3)(1992-5#10)(1992-6#1)(1992-9#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(2008-4#1)(2013-1#2)
fura-2-loaded##2##1##(1990-2#1)(1995-8#1)
fura-2/AM##2##1##(1994-6#2)
fura-2/AM-loaded cells##2##2##(1992-5#2)
fura-red##2##1##(2006-6#2)
furafylline inhibition##3##2##(1994-8#3)
furan and##2##2##(2008-11#1)(2013-1#1)
furan related compounds##2##3##(2008-10#2)
furan##10##1##(1997-4#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
furan-2-carboxaldehydes and furo[b]pyrrole type aldehydes with benzothiazolium salts##2##8##(2007-11#2)
furanocoumarins##4##1##(2008-11#1)(2008-8#2)(2008-9#1)
furanose##4##1##(1990-9#2)(1991-3#2)
furans and##2##2##(2008-10#2)
furans##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
furfur##6##1##(2008-5#5)(2010-6#1)
furfural##9##1##(2008-10#1)(2011-1#3)(2013-1#5)
furfuraldehyde condensed resin was##2##4##(2008-10#2)
furfuraldehyde##3##1##(2008-10#3)
furfuralhydrazone##4##1##(2008-10#4)
furin in##2##2##(1991-9#1)(1992-12#1)
furin##13##1##(1991-9#5)(1992-12#7)(2010-12#1)
furiosus##12##1##(1993-9#4)(1994-12#4)(1995-5#4)
furnace AAS##2##2##(1992-3#1)(2008-10#1)
furnace analysis##3##2##(2008-10#3)
furnace and##3##2##(2008-10#2)(2008-3#1)
furnace atomic absorption spectrometry (GFAAS)##23##5##(2008-10#23)
furnace atomic absorption spectrometry##62##4##(1991-12#1)(1995-6#1)(2008-10#60)
furnace atomic absorption##81##3##(1991-12#1)(1995-6#1)(2008-10#78)(2008-7#1)
furnace atomic##82##2##(1991-12#1)(1995-6#1)(2008-10#79)(2008-7#1)
furnace gas##4##2##(2008-10#4)
furnace##130##1##(1991-12#1)(1992-3#1)(1995-6#1)(2008-10#119)(2008-2#3)(2008-3#2)(2008-7#1)(2013-1#1)(2013-8#1)
furnace-AAS##2##1##(2008-10#2)
furnaces##4##1##(2008-10#2)(2008-2#2)
furnieri in the##2##3##(2010-8#2)
furnieri in##3##2##(2010-8#3)
furnieri##5##1##(2009-7#1)(2010-8#4)
furnish the corresponding##2##3##(1996-5#2)
furnish##11##1##(1991-1#1)(1991-12#1)(1992-12#1)(1994-2#1)(1996-5#2)(1997-3#2)(2008-2#1)(2009-11#1)(2010-7#1)
furnished by##4##2##(1991-1#1)(2008-10#3)
furnished in##2##2##(1991-1#1)(2012-2#1)
furnished to Medicare##2##3##(1991-3#1)(1994-12#1)
furnished with a##2##3##(2008-10#2)
furnished with##4##2##(2008-10#3)(2008-9#1)
furnished##19##1##(1991-1#2)(1991-3#1)(1994-12#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
furnishes##2##1##(2008-10#1)(2008-3#1)
furo[b]pyrrole type aldehydes with benzothiazolium salts##3##6##(2007-11#3)
furoate##3##1##(2007-11#3)
furocoumarins and their analogs##3##4##(2007-11#3)
furosemide and triamterene##3##3##(2008-10#3)
furosemide and##4##2##(1994-8#1)(2008-10#3)
furosemide in##3##2##(2008-10#3)
furosemide on##2##2##(1992-8#1)(2007-10#1)
furosemide treatment on the##2##4##(1992-8#2)
furosemide with##2##2##(1993-2#1)(2008-10#1)
furosemide##38##1##(1991-8#3)(1992-11#1)(1992-8#8)(1992-9#4)(1993-2#1)(1994-8#3)(1997-4#1)(2007-10#1)(2008-10#10)(2012-2#5)(2013-1#1)
furovirus##2##1##(2008-8#2)
furrow and subsurface-drip irrigation##2##4##(2008-10#2)
furrow and##3##2##(2008-10#3)
furrow irrigation##11##2##(2008-10#11)
furrow of##2##2##(2008-10#1)(2009-8#1)
furrow##21##1##(2007-7#1)(2008-10#17)(2009-8#3)
furrows##6##1##(2007-12#1)(2008-5#5)
further addition of##2##3##(1995-3#1)(2008-8#1)
further adjustment##2##2##(2008-2#1)(2008-3#1)
further advance##2##2##(2009-4#1)(2010-3#1)
further advanced##2##2##(2008-10#1)(2011-1#1)
further advances in##3##3##(2007-11#1)(2009-2#1)(2009-5#1)
further advances##6##2##(1990-11#1)(2007-11#1)(2008-11#1)(2009-2#1)(2009-5#1)(2012-2#1)
further analyses##7##2##(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)
further analysis of the##4##4##(1994-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
further analysis of##5##3##(1994-11#1)(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
further analysis##21##2##(1991-12#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)
further analyzed by##2##3##(2008-10#1)(2013-8#1)
further analyzed##7##2##(2008-10#2)(2008-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
further and##6##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
further applications##4##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
further applied to##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
further as##2##2##(2008-5#1)(2010-12#1)
further away from the##2##4##(1994-3#1)(2008-5#1)
further away from##3##3##(1994-3#1)(2008-11#1)(2008-5#1)
further away##5##2##(1992-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
further because##2##2##(2008-10#2)
further benefits##2##2##(2008-8#1)(2012-2#1)
further biological##2##2##(2008-4#1)(2012-1#1)
further by##13##2##(1994-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)
further case of##2##3##(1991-5#1)(2008-7#1)
further case##3##2##(1991-5#1)(2008-11#1)(2008-7#1)
further cell##2##2##(1993-6#1)(2008-10#1)
further changes##2##2##(1991-6#1)(1994-9#1)
further characterization of the##3##4##(1994-8#1)(2008-10#1)(2012-12#1)
further characterization of##8##3##(1993-12#1)(1994-8#1)(2008-10#4)(2009-7#1)(2012-12#1)
further characterization##9##2##(1993-12#1)(1994-8#1)(2008-10#5)(2009-7#1)(2012-12#1)
further characterize the##15##3##(1992-12#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-2#1)(2013-8#1)
further characterize##18##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2009-2#1)(2013-8#1)
further characterized by##6##3##(1990-12#1)(1994-11#1)(1994-5#1)(2008-10#3)
further characterized the##3##3##(1991-2#1)(1992-3#1)(2008-10#1)
further characterized##16##2##(1990-12#1)(1990-5#2)(1991-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(2008-10#5)(2008-11#2)(2011-1#1)(2012-3#1)
further characterizes the##2##3##(1995-5#1)(2013-1#1)
further checked##2##2##(2008-10#1)(2013-7#1)
further chemical##2##2##(2008-10#1)(2008-7#1)
further chemotherapy##2##2##(1992-6#1)(2008-6#1)
further clarification##4##2##(1990-9#1)(1994-2#1)(1995-3#1)(2008-12#1)
further clarified##3##2##(1994-3#1)(2009-3#1)(2013-8#1)
further clarify the##6##3##(1992-2#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-3#1)
further classified##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
further cleavage##2##2##(1991-12#1)(2011-1#1)
further clinical studies##2##3##(2011-2#1)(2012-2#1)
further clinical trials##2##3##(2008-5#1)(2010-8#1)
further clinical##8##2##(1996-1#1)(2007-11#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
further complicate##2##2##(2008-10#1)(2013-1#1)
further complicated by the##3##4##(2008-1#1)(2008-4#1)(2009-5#1)
further complicated by##5##3##(1994-2#1)(1997-1#1)(2008-1#1)(2008-4#1)(2009-5#1)
further complicated##6##2##(1994-2#1)(1997-1#1)(2008-1#1)(2008-4#1)(2009-5#1)(2010-5#1)
further complications##3##2##(2008-1#1)(2012-12#1)(2013-1#1)
further compression##2##2##(2007-8#1)(2013-8#1)
further confirm the##2##3##(2008-10#1)(2010-2#1)
further confirm##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)
further confirmed by the##2##4##(1997-1#1)(2010-8#1)
further confirmed by##7##3##(1990-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-8#1)(2010-8#1)(2011-2#1)
further confirmed in##2##3##(1991-4#1)(2008-7#1)
further confirmed the##2##3##(2009-12#1)(2012-2#1)
further confirmed##14##2##(1990-12#1)(1991-4#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
further confirms the##2##3##(2008-10#1)(2008-8#1)
further confirms##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
further consideration##2##2##(1990-6#1)(2009-3#1)
further conversion##2##2##(1990-10#1)(2008-10#1)
further critical##2##2##(2008-10#1)(2008-11#1)
further damage##2##2##(1995-5#1)(2013-1#1)
further data are##2##3##(2008-1#1)(2012-12#1)
further decrease##6##2##(1991-6#1)(1993-11#1)(1994-3#1)(2008-10#1)(2008-6#1)(2009-3#1)
further define the##4##3##(1996-5#1)(2008-10#1)(2008-8#1)(2009-5#1)
further defined by##2##3##(1995-6#1)(2008-5#1)
further defined##4##2##(1995-6#1)(2008-5#2)(2008-8#1)
further demonstrate that the##3##4##(1990-7#1)(2008-3#1)(2013-8#1)
further demonstrate that##5##3##(1990-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
further demonstrate##7##2##(1990-7#1)(1991-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
further demonstrated that##8##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#2)(2012-12#1)(2012-2#1)
further demonstrated##14##2##(1992-8#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#2)(2012-12#1)(2012-2#1)
further demonstrating##2##2##(1993-11#1)(2012-2#1)
further describes##2##2##(2008-7#1)(2013-8#1)
further detail##3##2##(1997-8#1)(2009-8#1)(2011-1#1)
further detailed##3##2##(1992-5#1)(1992-9#1)(2013-8#1)
further develop##5##2##(2007-12#1)(2008-11#1)(2008-12#1)(2010-10#1)(2012-2#1)
further developed to##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
further developed##5##2##(1994-3#1)(2008-10#1)(2008-2#2)(2011-1#1)
further development and##2##3##(1992-8#1)(2008-10#1)
further development of##23##3##(1991-3#1)(1995-5#1)(1996-4#1)(1997-4#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
further development to##2##3##(1990-10#1)(1996-12#1)
further development##47##2##(1990-10#1)(1991-3#1)(1992-8#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-4#2)(1997-8#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
further developments and##3##3##(2007-11#1)(2008-10#2)
further developments##7##2##(1991-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2012-2#1)
further diagnostic##4##2##(1991-6#1)(1997-2#1)(2008-7#1)(2013-1#1)
further differentiated##2##2##(2008-10#1)(2008-8#1)
further discuss##2##2##(2008-11#1)(2009-8#1)
further discussed##6##2##(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#3)
further discussion##4##2##(1995-5#1)(2008-12#1)(2010-11#1)(2011-2#1)
further dissociation##2##2##(1994-6#1)(2008-10#1)
further divided into two##5##4##(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)(2013-1#1)
further divided into##9##3##(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-2#1)(2013-1#1)
further down the##2##3##(1996-12#1)(1996-6#1)
further downstream##2##2##(2007-12#1)(2008-11#1)
further educational##2##2##(2008-11#1)(2013-1#1)
further elucidate the##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
further elucidate these##2##3##(2008-10#1)(2008-11#1)
further elucidate##7##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)
further elucidated by##2##3##(2008-11#1)(2008-2#1)
further elucidated##3##2##(2008-11#1)(2008-2#1)(2010-10#1)
further elucidation##2##2##(2010-11#1)(2010-3#1)
further emphasized##2##2##(1997-3#1)(2008-10#1)
further enhance the##6##3##(1992-12#1)(1994-3#1)(2007-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
further enhance##12##2##(1992-12#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
further enhanced by##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)
further enhanced the##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
further enhanced##11##2##(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)
further enhancement of##2##3##(2008-3#1)(2011-2#1)
further enhancement##3##2##(2006-6#1)(2008-3#1)(2011-2#1)
further established that##3##3##(2008-10#3)
further established##4##2##(1996-12#1)(2008-10#3)
further evaluate the##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
further evaluate##5##2##(2008-5#1)(2010-8#1)(2011-2#2)(2013-8#1)
further evaluated the##3##3##(1994-9#1)(2012-12#1)(2012-3#1)
further evaluated##10##2##(1992-8#1)(1992-9#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-6#1)(2012-12#2)(2012-3#1)(2013-1#1)
further evaluation##12##2##(1990-6#1)(1991-5#1)(1994-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-10#1)(2013-1#1)
further evidence for the existence of##2##6##(1990-12#1)(1991-8#1)
further evidence for the##5##4##(1990-12#1)(1991-8#1)(2008-10#3)
further evidence for##8##3##(1990-12#1)(1991-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-7#1)
further evidence of a##5##4##(1994-8#1)(2008-10#2)(2008-4#1)(2008-7#1)
further evidence of##9##3##(1994-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)
further evidence that the##2##4##(1993-6#1)(2007-6#1)
further evidence that##10##3##(1990-8#1)(1991-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-6#1)(2008-3#1)(2009-9#1)
further evidence##31##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-12#1)(1996-2#1)(1997-8#1)(2007-12#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#1)
further evolution of##2##3##(2008-12#1)(2010-8#1)
further examination##2##2##(1994-12#1)(2011-2#1)
further examined in##2##3##(2008-10#1)(2009-9#1)
further examined using##3##3##(1993-3#1)(2008-9#1)(2012-3#1)
further examined##8##2##(1993-3#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-9#1)(2009-9#1)(2012-3#1)
further expanded##2##2##(2007-11#1)(2010-10#1)
further experience##3##2##(2006-10#1)(2007-12#1)(2008-10#1)
further experimental results revealed that##2##5##(2008-10#2)
further experimental##4##2##(1997-2#1)(2008-10#2)(2009-8#1)
further experiments##3##2##(1994-2#1)(2008-8#1)(2012-2#1)
further explained by##2##3##(2008-1#1)(2008-3#1)
further explained##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
further exploited##3##2##(2008-10#2)(2012-2#1)
further exploration of the##2##4##(1993-12#1)(2008-10#1)
further exploration##7##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-1#2)
further explore the##5##3##(1993-1#1)(1996-2#1)(2008-5#1)(2011-2#2)
further explore##9##2##(1992-9#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-8#1)
further explored##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
further extend the##3##3##(2008-3#1)(2008-7#1)(2009-4#1)
further extended##2##2##(2008-10#1)(2010-3#1)
further for##2##2##(2008-10#1)(2008-3#1)
further found that##2##3##(2009-9#1)(2010-4#1)
further genetic and molecular##2##4##(2008-10#1)(2012-3#1)
further genetic##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
further growth##4##2##(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#1)
further highlights the##2##3##(2007-8#1)(2008-5#1)
further identified##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
further if##2##2##(2008-7#1)(2010-2#1)
further illustrated the##2##3##(2008-10#1)(2008-9#1)
further illustrated##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
further imaging##2##2##(2010-5#1)(2012-2#1)
further improve the##7##3##(1995-6#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
further improve##14##2##(1995-3#1)(1995-6#1)(2007-12#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#1)
further improved by##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)
further improved the##3##3##(2008-1#1)(2008-10#1)(2010-12#1)
further improved##13##2##(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
further improvement in##4##3##(2007-11#2)(2008-2#1)(2012-3#1)
further improvement of##6##3##(2008-10#1)(2008-3#2)(2008-7#2)(2012-1#1)
further improvement##19##2##(1995-3#1)(1996-3#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#2)
further improvements in##2##3##(2008-1#1)(2010-4#1)
further improvements##4##2##(2008-1#1)(2008-10#1)(2010-3#1)(2010-4#1)
further improving the##2##3##(1992-3#1)(2007-12#1)
further improving##3##2##(1992-3#1)(1997-3#1)(2007-12#1)
further in##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)
further increase in the##4##4##(1992-6#1)(2008-2#1)(2008-6#1)(2008-8#1)
further increase in##12##3##(1992-6#1)(1993-11#1)(1994-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-8#1)
further increase the##2##3##(1991-12#1)(2012-3#1)
further increase##19##2##(1991-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-11#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
further increased in##2##3##(1994-10#1)(2008-11#1)
further increased##9##2##(1994-10#1)(1994-11#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
further increases##2##2##(2008-10#1)(2008-11#1)
further increasing the##3##3##(1991-3#1)(2008-3#1)(2013-8#1)
further increasing##5##2##(1991-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-8#1)
further indicate that##2##3##(1990-12#1)(2008-3#1)
further indicate##3##2##(1990-12#2)(2008-3#1)
further indicated##2##2##(2008-10#1)(2011-1#1)
further inflammation##2##2##(2008-5#1)(2012-3#1)
further information on##3##3##(2008-5#1)(2008-7#2)
further information##9##2##(1994-8#1)(2007-5#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)
further insight into the##7##4##(1993-12#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-11#1)
further insight into##11##3##(1993-12#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-11#3)(2010-10#1)
further insight##15##2##(1990-2#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-10#1)
further insights into the##4##4##(1994-9#1)(2006-10#1)(2008-7#1)(2011-2#1)
further insights into##6##3##(1993-11#1)(1994-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
further interest##2##2##(1997-7#1)(2009-8#1)
further into##6##2##(1994-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-8#1)
further investigate the##5##3##(1995-11#1)(2008-10#2)(2008-9#2)
further investigate##11##2##(1995-11#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)
further investigated by##5##3##(1990-11#1)(1992-6#1)(1995-5#1)(2008-10#1)(2009-9#1)
further investigated##19##2##(1990-11#1)(1990-8#1)(1992-6#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-1#1)
further investigation in##2##3##(2008-8#1)(2013-1#1)
further investigation of the##6##4##(1990-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
further investigation of this##2##4##(1992-2#1)(2011-2#1)
further investigation of##11##3##(1990-9#1)(1992-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2011-2#2)(2012-12#1)(2013-8#1)
further investigation##48##2##(1990-6#1)(1990-9#1)(1992-2#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#3)
further investigations of the##2##4##(1994-11#1)(1995-3#1)
further investigations were##2##3##(1997-7#1)(2007-2#1)
further investigations will be##2##4##(1990-6#2)
further investigations##16##2##(1990-11#1)(1990-6#2)(1991-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
further large##2##2##(2008-10#1)(2011-1#1)
further limit the##2##3##(2008-8#1)(2012-3#1)
further management of##2##3##(2012-2#2)
further management##4##2##(1992-12#1)(2011-1#1)(2012-2#2)
further mass##2##2##(2008-11#1)(2010-4#1)
further model##2##2##(2008-11#2)
further modify##2##2##(2008-7#1)(2010-3#1)
further modulated by##2##3##(2008-8#1)(2010-11#1)
further observed##2##2##(2010-4#1)(2013-1#1)
further on-line##2##2##(2008-10#2)
further optimization##3##2##(2008-11#1)(2013-1#2)
further optimized##2##2##(2008-11#1)(2013-8#1)
further our understanding of the##2##5##(1996-11#1)(2008-7#1)
further our understanding of##4##4##(1996-11#1)(2008-11#1)(2008-7#2)
further our understanding##5##3##(1996-11#1)(2008-11#1)(2008-7#2)(2013-1#1)
further our##6##2##(1994-1#1)(1996-11#1)(2008-11#1)(2008-7#2)(2013-1#1)
further outcome##2##2##(2007-11#1)(2008-11#1)
further population##2##2##(2008-12#1)(2012-2#1)
further potential##2##2##(2008-11#1)(2012-2#1)
further preparation##2##2##(1991-5#1)(2009-6#1)
further processed##3##2##(2007-7#1)(2010-5#1)(2012-2#1)
further processing##3##2##(1995-2#1)(2008-3#1)(2008-6#1)
further professional##2##2##(2008-4#1)(2010-5#1)
further progress in##2##3##(2008-11#1)(2008-5#1)
further progress##6##2##(1995-5#1)(1996-1#1)(1997-7#1)(2008-11#1)(2008-5#1)(2010-1#1)
further prospective studies##2##3##(2007-8#1)(2011-1#1)
further prospective##3##2##(2007-8#1)(2011-1#1)(2012-3#1)
further provide a##2##3##(2008-7#1)(2009-11#1)
further provide##3##2##(2008-7#1)(2009-11#1)(2013-8#1)
further provides##2##2##(1996-3#1)(2011-2#1)
further purification##5##2##(1990-2#1)(2008-10#2)(2008-12#1)(2011-1#1)
further purified by##2##3##(2008-4#1)(2008-5#1)
further purified##5##2##(1992-2#1)(1992-3#1)(2008-1#1)(2008-4#1)(2008-5#1)
further reduce the risk of##2##5##(1990-8#1)(2008-4#1)
further reduce the##9##3##(1990-8#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2012-12#1)
further reduce##10##2##(1990-8#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
further reduced the##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
further reduced##10##2##(1991-5#1)(1992-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
further reduction in##3##3##(1991-5#1)(2008-5#1)(2008-7#1)
further reduction of##3##3##(1992-3#1)(2008-11#1)(2008-6#1)
further reduction##7##2##(1991-5#1)(1992-3#1)(1993-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
further refinement and##2##3##(1996-2#1)(2009-4#1)
further refinement##5##2##(1996-2#1)(2007-11#1)(2008-10#2)(2009-4#1)
further research and development##3##4##(1996-2#1)(2012-1#1)(2013-1#1)
further research and##5##3##(1996-2#1)(2008-7#1)(2012-1#1)(2013-1#2)
further research are##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
further research in##2##3##(2008-11#1)(2013-1#1)
further research into##2##3##(2008-11#1)(2008-8#1)
further research is needed to##5##5##(2007-4#1)(2008-11#2)(2009-5#1)(2009-7#1)
further research is needed##8##4##(2007-4#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)(2011-2#2)
further research is required to##2##5##(2008-11#1)(2011-2#1)
further research is required##3##4##(2008-11#2)(2011-2#1)
further research is##13##3##(2007-4#1)(2008-11#4)(2008-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#3)(2013-7#1)
further research on the##3##4##(2008-11#1)(2009-6#1)(2013-8#1)
further research on this##2##4##(2008-10#1)(2008-8#1)
further research on##12##3##(1992-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2013-1#2)(2013-8#1)
further research with##2##3##(2008-7#1)(2012-2#1)
further research##66##2##(1990-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#1)
further resection##2##2##(2007-8#1)(2008-6#1)
further resolved##2##2##(2008-10#2)
further restrict##2##2##(1996-9#1)(1997-3#1)
further revealed that it##2##4##(1997-2#1)(1997-4#1)
further revealed that##4##3##(1993-6#1)(1997-2#1)(1997-4#1)(2008-11#1)
further revealed the##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
further revealed##9##2##(1993-6#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
further reveals that##2##3##(1992-8#1)(1994-6#1)
further reveals##3##2##(1992-8#1)(1994-6#1)(2011-1#1)
further scientific##2##2##(2008-2#1)(2010-8#1)
further selection pressure##2##3##(2008-10#1)(2010-7#1)
further show that##8##3##(1990-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
further show##9##2##(1990-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-12#1)(2012-12#1)
further showed that the##2##4##(1997-2#1)(2008-8#1)
further showed that##5##3##(1997-2#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
further showed##6##2##(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
further shown that##2##3##(2008-2#1)(2012-2#1)
further shows##2##2##(2008-8#1)(2010-8#1)
further significant##4##2##(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)
further spread of##2##3##(2007-12#1)(2008-10#1)
further spread##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
further step##4##2##(1995-2#1)(1997-3#1)(2008-10#2)
further studied in##2##3##(2008-10#1)(2012-2#1)
further studied##8##2##(1992-5#1)(1994-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-2#1)(2012-3#1)
further studies are required in##2##5##(1992-6#1)(2007-11#1)
further studies are required to##2##5##(1994-9#1)(2011-1#1)
further studies are required##5##4##(1992-6#1)(1994-9#1)(2007-11#1)(2008-5#1)(2011-1#1)
further studies are##7##3##(1992-6#1)(1994-9#1)(2007-11#1)(2008-5#1)(2009-5#1)(2011-1#2)
further studies in##2##3##(2007-10#1)(2008-7#1)
further studies of##2##3##(2008-7#1)(2010-8#1)
further studies on functional##2##4##(1993-1#1)(2009-9#1)
further studies on the##5##4##(1993-8#1)(1996-12#1)(2008-10#2)(2009-8#1)
further studies on##10##3##(1993-1#1)(1993-8#1)(1996-12#1)(1996-5#1)(2008-10#2)(2009-8#1)(2009-9#1)(2012-12#1)(2012-3#1)
further studies that##2##3##(2008-10#1)(2011-2#1)
further studies will be##2##4##(2008-7#1)(2009-8#1)
further studies with##4##3##(1990-12#1)(1993-1#1)(1994-2#1)(2008-4#1)
further studies##45##2##(1990-12#2)(1990-2#1)(1992-6#1)(1993-1#2)(1993-8#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
further study in##6##3##(1991-6#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
further study is##3##3##(2007-12#1)(2007-7#1)(2008-1#1)
further study of##4##3##(1996-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
further study on##3##3##(1994-5#1)(1995-8#1)(2008-10#1)
further study the##5##3##(2008-10#2)(2008-9#2)(2009-12#1)
further study##50##2##(1990-11#1)(1991-6#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
further subcloning##3##2##(1991-12#1)(1997-7#1)(2008-4#1)
further subdivided into##3##3##(1995-12#1)(1995-3#1)(2013-8#1)
further substantiated by##2##3##(1994-11#1)(1995-3#1)
further substantiated##3##2##(1994-11#1)(1995-3#1)(2010-5#1)
further substantiates the##2##3##(1994-12#1)(2008-10#1)
further suggest that##9##3##(1992-12#1)(1992-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#2)
further suggested that the##2##4##(1995-3#1)(1995-8#1)
further suggested that##3##3##(1995-3#1)(1995-8#1)(2008-10#1)
further suggested##4##2##(1995-3#1)(1995-8#1)(2008-10#2)
further suggests that the##2##4##(2008-5#1)(2008-7#1)
further suggests that##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
further support for the##4##4##(1991-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
further support for##8##3##(1990-11#1)(1990-7#1)(1991-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
further support the##6##3##(1993-12#1)(1995-12#1)(1996-5#1)(2008-12#1)(2008-7#1)(2009-4#1)
further support to the##4##4##(1993-9#1)(2008-5#1)(2010-10#1)(2012-2#1)
further support to##5##3##(1991-8#1)(1993-9#1)(2008-5#1)(2010-10#1)(2012-2#1)
further support##21##2##(1990-11#1)(1990-7#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-6#1)(2012-2#1)
further supported by the observation##2##5##(2009-9#1)(2013-1#1)
further supported by the##6##4##(1995-6#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
further supported by##9##3##(1990-7#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
further supported##11##2##(1990-10#1)(1990-7#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
further supports that##2##3##(1993-3#1)(2008-9#1)
further supports the##5##3##(1991-6#1)(1992-8#1)(2008-7#1)(2009-10#1)(2009-5#1)
further supports##7##2##(1991-6#1)(1992-8#1)(1993-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)
further surgery##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
further tested##5##2##(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
further testing##4##2##(1991-3#1)(2007-10#1)(2008-10#1)(2012-12#1)
further tests##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
further that##5##2##(1991-8#1)(1995-6#1)(2007-12#1)(2008-8#1)(2011-2#1)
further the role of##2##4##(1996-2#1)(2011-2#1)
further the##25##2##(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
further to the##2##3##(1994-8#1)(2010-10#1)
further to##7##2##(1993-6#1)(1994-8#1)(2008-1#1)(2008-10#1)(2010-10#2)(2013-1#1)
further training##3##2##(2007-2#1)(2008-1#2)
further treated##3##2##(1996-12#1)(2007-11#1)(2007-2#1)
further treatment##10##2##(1991-6#1)(1992-11#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)
further underscores the##2##3##(2008-10#1)(2010-10#1)
further understand the##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
further understand##10##2##(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-12#1)
further understanding of##6##3##(1991-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
further understanding##8##2##(1991-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
further upstream##2##2##(1990-11#1)(1991-6#1)
further use of##2##3##(2008-11#1)(2008-3#1)
further use##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)
further used to##2##3##(2008-10#1)(2008-7#1)
further used##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
further using##4##2##(1994-12#1)(2008-10#2)(2009-12#1)
further validated##6##2##(2008-10#3)(2008-5#1)(2010-12#1)(2013-1#1)
further validation##2##2##(2008-5#1)(2009-12#1)
further we##2##2##(1993-3#1)(2013-1#1)
further with##2##2##(2008-2#1)(2008-4#1)
further work is required to##2##5##(1996-5#1)(2008-10#1)
further work is##6##3##(1996-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-7#1)
further work##9##2##(1993-12#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-7#1)
further##1879##1##(1990-10#3)(1990-11#9)(1990-12#9)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#5)(1990-7#4)(1990-8#6)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#11)(1991-2#3)(1991-3#7)(1991-4#1)(1991-5#7)(1991-6#10)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#5)(1992-12#9)(1992-2#6)(1992-3#12)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#8)(1992-9#7)(1993-1#6)(1993-11#15)(1993-12#12)(1993-2#2)(1993-3#7)(1993-6#5)(1993-8#4)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#7)(1994-12#10)(1994-2#10)(1994-3#13)(1994-5#3)(1994-6#5)(1994-8#11)(1994-9#7)(1995-1#2)(1995-11#6)(1995-12#10)(1995-2#12)(1995-3#13)(1995-5#9)(1995-6#9)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#14)(1996-2#15)(1996-3#5)(1996-4#1)(1996-5#8)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#7)(1997-3#11)(1997-4#8)(1997-5#4)(1997-6#3)(1997-7#11)(1997-8#5)(1997-9#2)(2006-10#6)(2006-6#3)(2007-10#4)(2007-11#25)(2007-12#30)(2007-2#8)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#15)(2008-1#28)(2008-10#276)(2008-11#105)(2008-12#31)(2008-2#26)(2008-3#46)(2008-4#29)(2008-5#59)(2008-6#23)(2008-7#85)(2008-8#54)(2008-9#47)(2009-10#9)(2009-11#4)(2009-12#8)(2009-2#6)(2009-3#5)(2009-4#6)(2009-5#10)(2009-6#9)(2009-7#6)(2009-8#18)(2009-9#10)(2010-1#4)(2010-10#18)(2010-11#5)(2010-12#19)(2010-2#7)(2010-3#12)(2010-4#8)(2010-5#11)(2010-6#4)(2010-7#3)(2010-8#12)(2010-9#1)(2011-1#34)(2011-2#66)(2011-3#2)(2011-8#1)(2012-1#10)(2012-12#21)(2012-2#48)(2012-3#32)(2012-8#1)(2013-1#67)(2013-7#3)(2013-8#33)
furthered our understanding of##2##4##(2006-10#1)(2011-1#1)
furthered schizophrenia##2##2##(2011-1#2)
furthered##6##1##(2006-10#1)(2008-12#1)(2008-9#1)(2011-1#3)
furthering the##2##2##(2011-2#1)(2012-2#1)
furthering##4##1##(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
furthermore the##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
furthermore##28##1##(1992-4#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
furthers the##2##2##(2013-1#2)
furthers##4##1##(1995-6#1)(2010-7#1)(2013-1#2)
furzeri##9##1##(2012-3#9)
fusarenon-X##3##1##(1997-6#3)
fusaric acid production##2##3##(2008-10#2)
fusaric acid##7##2##(2008-10#7)
fusariosis##2##1##(1997-3#1)(2008-10#1)
fusarium crown and root rot of##2##6##(2008-10#2)
fusarium crown and root rot##3##5##(2008-10#3)
fusarium ear##2##2##(2008-10#2)
fusarium head blight and deoxynivalenol content##2##6##(2008-10#2)
fusarium head blight and deoxynivalenol##3##5##(2008-10#3)
fusarium head blight and##4##4##(2008-10#4)
fusarium head blight##13##3##(2008-10#13)
fusarium wilt##7##2##(2008-10#7)
fusarium##33##1##(2008-10#32)(2008-7#1)
fusca##18##1##(1991-12#2)(2007-12#2)(2008-10#10)(2008-6#2)(2008-8#2)
fusca) and##2##2##(2008-10#2)
fusca)##3##1##(2008-10#2)(2008-8#1)
fuscans strains were##3##3##(2008-10#3)
fuscans strains##6##2##(2008-10#6)
fuscans##12##1##(2008-10#12)
fuscans)##2##1##(2008-10#2)
fuscum##2##1##(2008-9#2)
fuse and##2##2##(2008-7#1)(2011-2#1)
fuse to form##2##3##(2008-11#1)(2008-4#1)
fuse together##2##2##(2007-12#1)(2008-5#1)
fuse with the##3##3##(1992-12#1)(2008-10#1)(2012-12#1)
fuse with##8##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-9#3)(2012-12#1)
fuse##19##1##(1992-12#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
fused C1-C2##2##2##(2013-1#2)
fused biconical##3##2##(2007-11#2)(2008-2#1)
fused by##3##2##(1991-5#1)(1995-5#1)(2008-9#1)
fused coupler and##3##3##(2008-2#3)
fused coupler##4##2##(2008-2#4)
fused genes were##2##3##(1994-6#1)(2008-8#1)
fused in frame##2##3##(1992-12#1)(1996-3#1)
fused or##2##2##(1991-11#1)(1996-11#1)
fused quartz##2##2##(2007-12#1)(2008-3#1)
fused ribs##2##2##(1993-12#2)
fused silica after##2##3##(2007-12#2)
fused silica and are##2##4##(2008-3#2)
fused silica and##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
fused silica by##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
fused silica for##2##3##(2008-2#2)
fused silica is##2##3##(2007-11#2)
fused silica using##2##3##(2008-3#1)(2012-2#1)
fused silica##43##2##(2007-11#8)(2007-12#10)(2008-10#2)(2008-2#9)(2008-3#13)(2012-2#1)
fused to IgG-Fcs##2##3##(2013-1#2)
fused to a##7##3##(1990-11#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-2#1)
fused to form##3##3##(1993-8#1)(2008-6#1)(2008-9#1)
fused to the##16##3##(1991-12#1)(1991-5#1)(1992-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2012-2#1)
fused to##50##2##(1990-11#1)(1991-10#2)(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-12#2)(1994-8#2)(1995-2#1)(1995-6#2)(1996-12#2)(1996-6#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
fused together##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
fused with a##2##3##(1995-11#1)(2008-10#1)
fused with the##9##3##(1992-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)
fused with##23##2##(1992-12#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)
fused##183##1##(1990-11#1)(1991-10#4)(1991-11#2)(1991-12#1)(1991-5#4)(1991-7#1)(1992-12#3)(1993-12#2)(1993-8#1)(1994-12#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#1)(2007-11#10)(2007-12#16)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#15)(2008-3#14)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#7)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#9)(2013-7#2)(2013-8#2)
fused-fiber couplers##2##2##(2008-3#2)
fused-fiber grating##2##2##(2007-11#2)
fused-fiber##5##1##(2007-11#2)(2008-3#3)
fused-image##2##1##(2007-12#2)
fused-silica capillaries##3##2##(2008-10#3)
fused-silica capillary##10##2##(1994-9#2)(1996-5#2)(2008-10#5)(2008-5#1)
fused-silica microspheres##4##2##(2007-12#4)
fused-silica sample##2##2##(2007-11#1)(2008-3#1)
fused-silica substrate##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
fused-silica substrates##4##2##(2008-3#4)
fused-silica##45##1##(1994-9#2)(1996-5#2)(1997-2#1)(2007-11#6)(2007-12#10)(2008-10#8)(2008-2#3)(2008-3#12)(2008-5#1)
fuselage##2##1##(1996-12#2)
fuses##3##1##(1991-9#1)(2008-11#1)(2013-1#1)
fushi tarazu##2##2##(1993-9#2)
fusicoccin receptors##3##2##(1995-2#3)
fusicoccin##10##1##(1995-2#10)
fusiform megalourethra with##2##3##(2008-10#2)
fusiform megalourethra##3##2##(2008-10#3)
fusiform rust##4##2##(2008-10#4)
fusiform##17##1##(1997-8#2)(2007-10#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-7#1)(2009-5#1)(2013-8#2)
fusiforme##4##1##(2008-10#4)
fusiformis##2##1##(2008-10#2)
fusing the##3##2##(2008-10#1)(2008-7#1)(2010-9#1)
fusing with##2##2##(2008-5#1)(2011-3#1)
fusing##15##1##(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-3#1)(2012-2#1)
fusion (hemi-fusion)##2##2##(1991-5#2)
fusion and fixation##2##3##(2011-2#1)(2012-3#1)
fusion and##27##2##(1991-5#1)(1992-3#1)(1994-12#1)(1995-11#1)(1996-9#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#3)(2013-1#2)
fusion as##2##2##(2008-9#1)(2012-12#1)
fusion at the##2##3##(1996-12#1)(2012-3#1)
fusion at##3##2##(1996-12#1)(2012-12#1)(2012-3#1)
fusion between the##3##3##(1990-5#1)(1994-12#1)(2008-11#1)
fusion between##10##2##(1990-11#1)(1990-5#1)(1994-12#3)(2008-11#2)(2008-8#1)(2011-3#1)(2012-3#1)
fusion by##2##2##(1992-3#1)(2009-8#1)
fusion can##3##2##(1994-12#1)(2008-8#1)(2012-3#1)
fusion construct##2##2##(2012-3#2)
fusion does not##2##3##(2008-9#2)
fusion efficiency##2##2##(1994-12#1)(2012-2#1)
fusion event##2##2##(2008-11#1)(2008-7#1)
fusion events##4##2##(1995-2#2)(2008-7#1)(2010-3#1)
fusion extent##2##2##(2012-2#2)
fusion for degenerative disc disease##2##5##(2008-7#1)(2012-12#1)
fusion for##8##2##(1994-3#1)(2008-10#1)(2008-7#2)(2012-12#3)(2012-3#1)
fusion frequency of##2##3##(1990-3#1)(2008-11#1)
fusion from##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
fusion gene in##3##3##(1990-8#1)(2008-10#2)
fusion gene is##2##3##(2008-8#2)
fusion gene transcript##2##3##(2011-2#2)
fusion gene was##2##3##(1997-7#1)(2008-8#1)
fusion gene##23##2##(1990-8#1)(1993-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-8#4)(2008-9#1)(2010-5#1)(2011-2#4)(2013-1#2)
fusion genes carrying the mutations##2##5##(1995-6#2)
fusion genes##6##2##(1991-7#1)(1995-6#2)(2008-8#3)
fusion has been##2##3##(2008-11#2)
fusion has##3##2##(2008-11#2)(2012-12#1)
fusion hybrids##3##2##(2008-5#3)
fusion in a##2##3##(1992-6#1)(2008-10#1)
fusion in the presence of##2##5##(1992-6#1)(2008-10#1)
fusion in the##5##3##(1992-6#1)(2008-10#1)(2012-12#2)(2012-3#1)
fusion in##16##2##(1991-5#1)(1992-6#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-3#4)
fusion inhibitor##2##2##(2008-5#1)(2011-3#1)
fusion inhibitors are##2##3##(2011-3#2)
fusion inhibitors##4##2##(2011-2#1)(2011-3#3)
fusion is##4##2##(2008-10#1)(2008-7#1)(2008-8#2)
fusion kinetics##2##2##(2012-2#2)
fusion laser##3##2##(2008-3#3)
fusion machinery##2##2##(2008-11#1)(2009-8#1)
fusion methods##2##2##(2010-9#1)(2012-3#1)
fusion of a##2##3##(2008-4#1)(2008-7#1)
fusion of rough endoplasmic reticulum##2##5##(1992-6#2)
fusion of rough##3##3##(1992-6#3)
fusion of the two##2##4##(2008-6#1)(2009-12#1)
fusion of the##14##3##(1990-5#1)(1994-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-12#2)(2009-6#1)(2011-1#1)(2013-1#1)
fusion of two##7##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)
fusion of##51##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-5#2)(1992-6#4)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#2)(2009-6#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
fusion operations##2##2##(2012-3#2)
fusion or##2##2##(2008-10#1)(2012-12#1)
fusion partner##4##2##(1995-2#1)(2008-11#1)(2012-12#1)(2012-2#1)
fusion partners##2##2##(2008-6#1)(2011-1#1)
fusion plasmas##2##2##(2008-3#2)
fusion plasmids##2##2##(2008-8#2)
fusion process##2##2##(2008-11#1)(2011-3#1)
fusion product##2##2##(1991-9#1)(2012-12#1)
fusion protein (uPA-IgG)##2##3##(1997-4#2)
fusion protein GST-IE86##3##3##(2008-9#3)
fusion protein and##3##3##(1995-12#1)(2008-8#1)(2009-8#1)
fusion protein can##2##3##(2008-1#1)(2008-11#1)
fusion protein containing a C-terminal##2##5##(1995-12#1)(2009-9#1)
fusion protein containing the##3##4##(1994-12#1)(1997-2#1)(2008-4#1)
fusion protein containing##6##3##(1994-12#1)(1995-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-9#1)
fusion protein expressed##2##3##(1990-8#1)(1996-12#1)
fusion protein has both##2##4##(1990-8#1)(2008-8#1)
fusion protein in Escherichia coli##2##5##(1997-4#1)(1997-6#1)
fusion protein in##5##3##(1997-4#1)(1997-6#1)(2008-11#1)(2008-9#1)(2012-3#1)
fusion protein of##3##3##(1990-8#1)(1996-12#1)(2008-7#1)
fusion protein was purified##2##4##(1994-8#1)(2008-10#1)
fusion protein was##12##3##(1991-10#1)(1994-8#4)(1997-4#2)(1997-6#1)(2008-10#2)(2008-9#1)(2011-1#1)
fusion protein with##3##3##(1990-11#1)(1990-8#2)
fusion protein##91##2##(1990-11#3)(1990-8#5)(1991-10#3)(1991-3#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-8#6)(1995-12#3)(1995-6#2)(1996-12#2)(1997-2#4)(1997-4#7)(1997-6#4)(2007-6#1)(2008-1#3)(2008-10#4)(2008-11#6)(2008-4#3)(2008-7#3)(2008-8#5)(2008-9#6)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#2)(2012-3#1)
fusion proteins can be##2##4##(1995-2#1)(2008-10#1)
fusion proteins containing##2##3##(1995-2#2)
fusion proteins for##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
fusion proteins in##2##3##(1995-11#1)(2008-10#1)
fusion proteins localized##2##3##(2008-7#2)
fusion proteins of##2##3##(1991-12#1)(1995-2#1)
fusion proteins to the##2##4##(1997-4#1)(2008-7#1)
fusion proteins were##6##3##(2008-10#5)(2009-3#1)
fusion proteins with a##2##4##(1994-12#1)(2009-3#1)
fusion proteins with##5##3##(1994-12#1)(1996-3#1)(1997-4#1)(2008-8#1)(2009-3#1)
fusion proteins##56##2##(1990-11#1)(1991-10#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-6#2)(1994-12#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-6#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-7#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#2)(2012-12#1)(2012-2#2)
fusion rate##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)
fusion system##3##2##(2008-7#2)(2008-8#1)
fusion technique##2##2##(2008-7#1)(2008-8#1)
fusion to##3##2##(2008-2#2)(2008-9#1)
fusion transcript was detected by##2##5##(2008-10#2)
fusion using the B-Twin##2##4##(2008-11#2)
fusion using the##3##3##(2008-11#2)(2009-3#1)
fusion using##6##2##(2008-11#2)(2009-3#1)(2010-3#1)(2012-12#1)(2012-3#1)
fusion versus##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
fusion was obtained##2##3##(1992-6#1)(2009-3#1)
fusion was the##2##3##(1995-6#1)(2012-3#1)
fusion was##13##2##(1992-3#1)(1992-6#1)(1993-9#1)(1995-2#2)(1995-6#1)(2008-10#1)(2008-8#2)(2009-3#1)(2012-3#2)(2013-1#1)
fusion were##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)
fusion which##3##2##(1990-7#1)(1991-6#1)(2008-10#1)
fusion with an##2##3##(1995-11#1)(2012-3#1)
fusion with##13##2##(1995-11#2)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#4)(2012-12#1)(2012-3#1)
fusion##618##1##(1990-11#8)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#6)(1991-10#5)(1991-12#1)(1991-3#2)(1991-5#13)(1991-6#1)(1991-7#3)(1991-9#3)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#13)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#23)(1994-2#1)(1994-3#1)(1994-8#7)(1995-11#4)(1995-12#7)(1995-2#13)(1995-3#1)(1995-6#14)(1995-8#4)(1996-12#5)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#10)(1997-6#4)(1997-7#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#4)(2008-1#5)(2008-10#51)(2008-11#47)(2008-12#4)(2008-2#4)(2008-3#11)(2008-4#11)(2008-5#7)(2008-6#6)(2008-7#26)(2008-8#62)(2008-9#15)(2009-10#1)(2009-12#4)(2009-2#4)(2009-3#11)(2009-6#5)(2009-7#2)(2009-8#6)(2009-9#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#6)(2011-2#13)(2011-3#8)(2012-12#30)(2012-2#22)(2012-3#31)(2013-1#9)(2013-8#1)
fusion&quot##2##1##(1990-4#1)(2008-11#1)
fusions and##5##2##(1993-11#1)(1994-12#1)(2008-11#1)(2008-12#1)(2012-12#1)
fusions are##2##2##(1990-5#1)(2007-11#1)
fusions between##2##2##(1990-11#1)(2008-10#1)
fusions have##2##2##(1995-8#1)(1997-7#1)
fusions in##3##2##(1996-12#1)(2008-8#1)(2008-9#1)
fusions of##5##2##(1990-11#1)(1993-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
fusions to##3##2##(1990-5#1)(2011-1#1)(2012-2#1)
fusions were##3##2##(2008-12#1)(2008-8#1)(2012-12#1)
fusions with the##2##3##(1994-12#1)(2008-7#1)
fusions with##5##2##(1994-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
fusions##61##1##(1990-11#2)(1990-5#6)(1991-10#1)(1991-6#1)(1992-11#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-12#2)(1995-2#2)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#3)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2010-3#1)(2011-1#3)(2012-12#5)(2012-2#1)(2012-3#3)
fusogenic##4##1##(1994-12#1)(1995-2#2)(2011-3#1)
futile treatment##2##2##(1991-2#1)(1996-3#1)
futile##7##1##(1991-2#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-4#1)(2010-12#1)(2012-12#1)
future American##2##2##(1996-2#1)(2008-10#1)
future action##3##2##(1996-12#1)(2012-12#2)
future actions##2##2##(2008-1#1)(2008-11#1)
future agents##2##2##(2010-4#1)(2011-2#1)
future analyses##2##2##(2008-3#1)(2011-3#1)
future and##5##2##(1991-1#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
future application##2##2##(1992-2#1)(2008-11#1)
future applications of##3##3##(1994-8#1)(2012-12#1)(2012-2#1)
future applications##8##2##(1994-8#1)(2008-11#2)(2008-3#1)(2012-12#1)(2012-2#3)
future approaches to##2##3##(1997-1#1)(2008-8#1)
future approaches##5##2##(1997-1#1)(2007-4#1)(2008-8#1)(2010-5#1)(2010-8#1)
future are discussed##2##3##(1990-9#1)(1997-1#1)
future are##3##2##(1990-9#1)(1997-1#1)(2012-3#1)
future areas of##2##3##(1997-3#1)(2008-5#1)
future areas##3##2##(1996-2#1)(1997-3#1)(2008-5#1)
future as a##3##3##(1994-1#1)(2008-4#1)(2008-5#1)
future as##6##2##(1994-1#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-11#1)(2012-6#1)
future availability##2##2##(2008-8#1)(2012-2#1)
future blood##2##2##(1991-7#1)(2008-12#1)
future by##2##2##(2009-5#1)(2013-1#1)
future cardiovascular events##2##3##(2012-2#1)(2013-8#1)
future cardiovascular##4##2##(2008-11#1)(2009-12#1)(2012-2#1)(2013-8#1)
future career##2##2##(1992-6#1)(2008-8#1)
future cases##3##2##(2008-1#1)(2010-6#1)(2012-3#1)
future challenge for##2##3##(1996-3#1)(2013-1#1)
future challenge##3##2##(1996-3#1)(2009-10#1)(2013-1#1)
future challenges##6##2##(1995-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2013-1#1)
future changes in##3##3##(1991-5#1)(1996-2#1)(2011-2#1)
future changes##6##2##(1991-5#1)(1992-1#1)(1993-2#1)(1996-2#1)(2010-1#1)(2011-2#1)
future choice##2##2##(1991-6#1)(1995-3#1)
future clinical applications##2##3##(1997-8#1)(2008-9#1)
future clinical##14##2##(1993-9#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
future columns##2##2##(1994-1#1)(1997-2#1)
future complications##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
future demands of##2##3##(2008-10#1)(2010-10#1)
future development in this area##2##5##(2008-10#1)(2008-12#1)
future development of##10##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-7#1)
future development##19##2##(1991-1#1)(1992-2#2)(1992-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-7#1)
future developments in##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
future developments##11##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2011-7#1)(2012-12#1)
future direction for##2##3##(2008-7#1)(2013-8#1)
future direction##7##2##(1995-1#1)(2008-11#1)(2008-7#2)(2011-7#1)(2013-1#1)(2013-8#1)
future directions are discussed##2##4##(2008-11#1)(2012-1#1)
future directions for##8##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#2)
future directions in this##2##4##(1994-2#1)(2009-5#1)
future directions in##7##3##(1992-2#1)(1994-2#1)(1996-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-1#1)
future directions of the##3##4##(1994-1#1)(2009-5#1)(2013-1#1)
future directions of##10##3##(1994-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-1#1)
future directions that##2##3##(2009-3#1)(2010-9#1)
future directions##51##2##(1991-2#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-2#3)(1996-12#2)(1996-3#1)(1997-2#1)(2007-10#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#4)(2012-2#1)(2013-1#2)(2013-8#2)
future discoveries##2##2##(2012-12#1)(2012-2#1)
future education in##2##3##(1993-3#2)
future efforts##2##2##(1996-11#1)(2012-2#1)
future employment##2##2##(1995-1#1)(2013-8#1)
future evaluation of##3##3##(1990-9#1)(2010-8#1)(2012-3#1)
future experimental##3##2##(1992-9#1)(2008-12#1)(2010-5#1)
future experiments##5##2##(1992-3#1)(1994-11#1)(2007-11#1)(2008-10#1)(2012-3#1)
future for the##2##3##(1997-5#1)(2013-1#1)
future for##12##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-3#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2012-2#1)(2013-1#1)
future funding##3##2##(1992-2#1)(1995-3#2)
future generations##3##2##(2008-11#2)(2008-9#1)
future genetic##2##2##(1995-6#1)(1995-8#1)
future growth##3##2##(1992-1#1)(2007-12#1)(2008-9#1)
future health care##2##3##(1996-1#1)(1996-2#1)
future health##8##2##(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2010-2#1)(2012-2#2)
future healthcare##2##2##(2008-9#1)(2009-8#1)
future holds##3##2##(1996-3#1)(1997-1#1)(2008-10#1)
future human##2##2##(2012-2#1)(2012-3#1)
future improvement##2##2##(1997-2#1)(2011-1#1)
future improvements##2##2##(2011-2#1)(2012-12#1)
future in##7##2##(1990-6#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
future intent to##2##3##(1993-12#1)(2008-4#1)
future interventions##2##2##(2008-12#1)(2013-1#1)
future investigations of the##2##4##(2012-12#1)(2013-1#1)
future investigations##8##2##(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
future is##10##2##(1992-11#1)(1993-11#2)(1993-2#1)(1994-1#1)(1996-2#2)(2008-10#1)(2008-7#1)(2008-8#1)
future issues##2##2##(1991-3#1)(2008-7#1)
future it is likely that##2##5##(1997-1#1)(2008-8#1)
future it##3##2##(1997-1#1)(2008-8#1)(2009-8#1)
future library##2##2##(1992-12#1)(2013-1#1)
future measurements##2##2##(2008-10#1)(2008-12#1)
future medical##2##2##(1992-6#1)(1997-1#1)
future missions##3##2##(2008-3#2)(2012-3#1)
future models##2##2##(2007-11#1)(2010-4#1)
future need##2##2##(1996-2#1)(2011-2#1)
future needs##2##2##(1994-2#1)(2009-5#1)
future of general##2##3##(2008-4#1)(2010-8#1)
future of health care##6##4##(1991-3#1)(1994-1#1)(1994-12#1)(1996-2#1)(1996-3#1)(2008-1#1)
future of health##8##3##(1991-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-1#1)
future of healthcare##2##3##(1992-12#1)(1995-1#1)
future of hybrid##2##3##(2012-2#2)
future of nursing education##2##4##(1996-3#1)(2008-11#1)
future of nursing##4##3##(1996-3#1)(2008-1#1)(2008-11#1)(2012-3#1)
future of the profession##2##4##(1995-1#1)(1996-1#1)
future of the##16##3##(1991-1#1)(1991-12#2)(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-7#1)(2012-12#1)(2013-8#1)
future of##96##2##(1991-1#4)(1991-12#3)(1991-3#1)(1992-12#1)(1992-3#2)(1993-1#3)(1993-2#3)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#6)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
future offending##2##2##(2009-7#2)
future on##3##2##(1995-2#1)(2008-1#1)(2008-4#1)
future opportunities##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
future orientation##3##2##(2007-12#3)
future patients##2##2##(1993-3#1)(1996-6#1)
future performance of##2##3##(1991-3#1)(2008-11#1)
future performance##3##2##(1991-3#1)(2008-11#1)(2009-9#1)
future perspective##4##2##(1997-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
future perspectives##10##2##(1994-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-3#3)
future planning##3##2##(1991-11#1)(2008-1#1)(2011-2#1)
future population##4##2##(1992-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
future possibilities##2##2##(1991-3#1)(2012-12#1)
future potential of##2##3##(2007-10#1)(2009-12#1)
future potential therapeutic##2##3##(2011-2#1)(2013-8#1)
future potential##7##2##(1993-12#2)(2007-10#1)(2009-12#1)(2009-3#1)(2011-2#1)(2013-8#1)
future practice##5##2##(1994-2#1)(2008-11#2)(2008-12#1)(2012-12#1)
future production##3##2##(2008-10#2)(2010-5#1)
future prospective studies##2##3##(2007-10#1)(2008-1#1)
future prospective##4##2##(2007-10#1)(2008-1#1)(2010-11#1)(2012-2#1)
future prospects for##6##3##(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
future prospects##15##2##(1997-6#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
future quality##2##2##(2011-1#1)(2012-3#1)
future reproduction##4##2##(2008-8#3)(2008-9#1)
future requirement for##2##3##(1992-3#1)(2008-10#1)
future research and clinical##4##4##(1994-12#1)(2008-11#1)(2008-12#1)(2010-9#1)
future research and development##2##4##(2008-10#1)(2013-8#1)
future research and##12##3##(1992-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
future research are discussed##7##4##(2007-12#2)(2007-7#1)(2008-12#2)(2011-2#1)(2012-12#1)
future research are##14##3##(1995-2#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-12#3)(2008-4#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
future research directions##6##3##(1994-3#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-5#1)(2009-9#1)
future research in this##2##4##(2010-8#1)(2013-1#1)
future research in##4##3##(2008-5#1)(2010-8#1)(2013-1#2)
future research is##3##3##(2010-2#1)(2012-3#1)(2013-1#1)
future research should##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
future research will##2##3##(1992-8#1)(2008-11#1)
future research##94##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#8)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#2)
future risk of##2##3##(2008-1#1)(2008-3#1)
future risk##3##2##(2008-1#1)(2008-3#1)(2008-8#1)
future role of##4##3##(1993-2#1)(2008-1#1)(2008-8#1)(2012-12#1)
future role##7##2##(1993-2#1)(2008-1#2)(2008-11#1)(2008-8#1)(2010-4#1)(2012-12#1)
future roles##3##2##(1993-2#1)(2011-1#2)
future space##2##2##(2008-3#2)
future states##2##2##(2008-11#1)(2010-4#1)
future status##2##2##(2010-8#1)(2011-1#1)
future strategies##3##2##(1994-2#1)(1997-2#1)(2011-2#1)
future studies of##8##3##(1995-5#1)(1995-9#1)(2007-7#1)(2008-10#2)(2008-9#1)(2010-5#1)(2013-1#1)
future studies should##3##3##(2008-8#2)(2012-3#1)
future studies to##2##3##(2008-10#1)(2009-8#1)
future studies will##2##3##(2008-7#2)
future studies##37##2##(1992-2#2)(1992-3#1)(1993-12#2)(1995-5#1)(1995-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
future study##6##2##(2008-10#2)(2008-3#1)(2010-12#1)(2010-9#1)(2012-3#1)
future success of##2##3##(1993-2#1)(1995-1#1)
future success##5##2##(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)
future successful##2##2##(1996-12#1)(2013-1#1)
future survivorship and reproduction##2##4##(2008-9#2)
future technological##2##2##(1994-1#1)(2008-3#1)
future the##2##2##(2007-7#1)(2013-7#1)
future therapeutic##4##2##(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
future therapies##3##2##(2010-11#1)(2013-1#2)
future training##2##2##(1996-2#1)(2008-9#1)
future treatment of##2##3##(1993-2#1)(2008-6#1)
future treatment##4##2##(1993-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
future treatments##2##2##(2008-1#1)(2010-1#1)
future trends in the##2##4##(2008-10#1)(2011-2#1)
future trends in##5##3##(1991-5#1)(1991-6#1)(1994-1#1)(2008-10#1)(2011-2#1)
future trends##7##2##(1991-5#1)(1991-6#1)(1994-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2011-2#1)
future trials##3##2##(1997-8#1)(2007-10#1)(2008-10#1)
future use of##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
future use##12##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
future will##4##2##(1991-6#1)(1992-12#1)(1994-12#1)(1994-2#1)
future with##2##2##(2007-6#1)(2008-12#1)
future work is##2##3##(1997-3#1)(2008-10#1)
future work##11##2##(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-1#2)(2013-1#2)
future years##2##2##(1995-12#1)(2010-6#1)
future##1269##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#12)(1991-11#3)(1991-12#9)(1991-2#3)(1991-3#8)(1991-5#2)(1991-6#6)(1991-7#1)(1991-9#1)(1992-1#6)(1992-11#2)(1992-12#10)(1992-2#12)(1992-3#16)(1992-4#1)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#5)(1993-11#5)(1993-12#11)(1993-2#18)(1993-3#9)(1993-6#1)(1993-9#1)(1994-1#13)(1994-11#2)(1994-12#12)(1994-2#16)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#12)(1995-11#2)(1995-12#10)(1995-2#7)(1995-3#9)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#11)(1996-2#17)(1996-3#16)(1996-4#1)(1996-6#3)(1996-9#1)(1997-1#15)(1997-2#9)(1997-3#11)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#2)(2006-9#2)(2007-1#1)(2007-10#10)(2007-11#6)(2007-12#22)(2007-2#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#3)(2007-9#1)(2008-1#32)(2008-10#80)(2008-11#66)(2008-12#42)(2008-2#12)(2008-3#24)(2008-4#21)(2008-5#20)(2008-6#9)(2008-7#42)(2008-8#34)(2008-9#26)(2009-1#1)(2009-10#5)(2009-11#7)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#9)(2009-5#11)(2009-6#3)(2009-7#12)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#8)(2010-12#12)(2010-2#3)(2010-3#8)(2010-4#10)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#11)(2010-9#3)(2011-1#17)(2011-2#57)(2011-3#3)(2011-7#4)(2012-1#20)(2012-12#21)(2012-2#44)(2012-3#30)(2012-4#2)(2012-5#1)(2012-6#1)(2012-9#2)(2013-1#49)(2013-7#9)(2013-8#16)
future&quot##2##1##(1996-2#1)(2011-2#1)
future'##2##1##(1990-10#1)(2011-2#1)
future?##11##1##(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
future]##2##1##(1991-3#1)(1992-6#1)
futures##3##1##(1991-2#1)(2008-1#1)(2012-12#1)
futuristic##2##1##(1996-2#1)(2011-1#1)
fuzzification##2##1##(2008-10#1)(2010-8#1)
fuzzy C-means##2##2##(2008-10#1)(2009-10#1)
fuzzy associative memory##4##3##(2007-12#4)
fuzzy c-means##2##2##(2009-10#1)(2010-8#1)
fuzzy cognitive##2##2##(2008-7#1)(2011-2#1)
fuzzy control##2##2##(2011-2#2)
fuzzy logic system##2##3##(2008-10#2)
fuzzy logic##11##2##(2008-10#3)(2008-12#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
fuzzy sets##2##2##(2007-12#1)(2008-10#1)
fuzzy##40##1##(1992-12#1)(1996-2#1)(2007-12#7)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-8#4)(2011-2#8)(2013-1#1)(2013-8#1)
fuzzy-logic##4##1##(2008-2#2)(2008-3#2)
fuzzy-logic-based##2##1##(2008-2#2)
fzp is##2##2##(2008-9#2)
fzp(t)##7##1##(2008-9#7)
fémoral est##2##2##(2011-2#2)
für##7##1##(1992-3#1)(2007-11#1)(2008-10#3)(2008-11#2)
fœtal##3##1##(2011-2#1)(2013-1#2)
g (range##3##2##(1996-6#1)(2007-8#1)(2013-1#1)
g = 2##2##3##(1990-5#1)(2007-11#1)
g =##3##2##(1990-5#2)(2007-11#1)
g L(-1)##8##2##(2008-11#3)(2008-7#3)(2011-2#2)
g L(-1))##4##2##(2008-10#1)(2008-11#1)(2008-7#2)
g Quincke##2##2##(2009-7#2)
g SO(4) (2-)/L per day##2##5##(2008-7#2)
g after##2##2##(1993-3#2)
g and##7##2##(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-2#1)
g are##2##2##(1997-7#1)(2008-2#1)
g body##2##2##(1996-5#1)(2011-2#1)
g cm(-3) in##2##3##(2008-12#2)
g cm(-3)##4##2##(2008-10#2)(2008-12#2)
g daily##2##2##(1990-11#1)(2008-12#1)
g daily)##2##2##(1992-10#2)
g dry wt##5##3##(2007-5#5)
g for##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
g in##2##2##(1997-2#1)(2008-8#1)
g kg(-1)##12##2##(2008-10#3)(2008-12#4)(2008-3#4)(2008-7#1)
g kg(-1)) and##2##3##(2008-10#2)
g kg(-1))##14##2##(2008-10#14)
g kg-1##4##2##(1995-12#3)(1997-2#1)
g l(-1) Cr(III))##2##3##(2008-10#2)
g l(-1) Cr(VI) and 1##2##5##(2008-10#2)
g l(-1) Pd##2##3##(2008-10#2)
g l(-1) for##2##3##(2008-10#2)
g l(-1)##19##2##(2008-10#12)(2008-11#7)
g l(-1))##3##2##(2008-10#3)
g liter(-1) for##4##3##(2008-10#4)
g m(-2)##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#4)
g ml(-1)##17##2##(2008-10#14)(2008-11#3)
g mol(-1)##3##2##(2008-10#2)(2008-5#1)
g of Al per gram of peat##2##7##(2008-10#2)
g of Al##3##3##(2008-10#3)
g of Amberlite XAD-2 resin##2##5##(2008-10#2)
g of Amberlite##3##3##(2008-10#3)
g of dry##2##3##(1997-4#1)(2008-10#1)
g of soil##11##3##(2008-10#11)
g of soil)##4##3##(2008-10#4)
g of the##3##3##(2008-10#2)(2010-2#1)
g of##84##2##(1990-9#1)(1991-8#3)(1992-9#1)(1995-2#3)(1996-5#1)(1997-4#4)(2008-10#54)(2008-12#6)(2008-3#1)(2008-5#3)(2008-7#1)(2010-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
g or less##2##3##(1991-6#1)(2013-1#1)
g or##4##2##(1991-6#1)(1994-1#1)(2008-11#1)(2013-1#1)
g per##2##2##(2008-10#2)
g protein##2##2##(1995-12#2)
g protein(-1) (+/-##2##3##(1997-1#2)
g proteins##2##2##(2008-6#1)(2008-7#1)
g sucrose·kg-1·h-1##3##2##(2013-1#3)
g supernatant##3##2##(1992-2#1)(1994-11#1)(1994-8#1)
g u-PA was harvested##2##4##(2008-11#2)
g values##2##2##(1993-8#1)(1997-7#1)
g was##2##2##(2008-3#1)(2008-6#1)
g weight##2##2##(2009-12#1)(2012-12#1)
g were fed##2##3##(2008-7#1)(2011-2#1)
g were##10##2##(2008-10#3)(2008-12#2)(2008-7#2)(2009-5#1)(2011-2#1)(2013-1#1)
g with##2##2##(2008-10#1)(2008-11#1)
g##1150##1##(1990-11#6)(1990-12#2)(1990-2#4)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#7)(1990-9#4)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#3)(1991-6#4)(1991-8#5)(1991-9#1)(1992-10#2)(1992-11#1)(1992-2#5)(1992-3#7)(1992-5#2)(1992-6#1)(1992-8#7)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#14)(1995-2#8)(1995-5#7)(1995-6#2)(1995-8#1)(1996-11#4)(1996-12#6)(1996-2#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#11)(1997-3#2)(1997-4#9)(1997-5#2)(1997-6#2)(1997-7#8)(2006-6#3)(2006-8#1)(2007-10#3)(2007-11#12)(2007-12#19)(2007-2#1)(2007-5#5)(2007-7#3)(2007-8#4)(2008-1#10)(2008-10#268)(2008-11#75)(2008-12#35)(2008-2#24)(2008-3#50)(2008-4#44)(2008-5#50)(2008-6#13)(2008-7#51)(2008-8#31)(2008-9#16)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#13)(2009-9#3)(2010-1#4)(2010-10#4)(2010-11#10)(2010-12#3)(2010-2#12)(2010-3#4)(2010-4#7)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#11)(2011-2#31)(2012-1#6)(2012-12#8)(2012-2#23)(2012-3#10)(2012-7#1)(2013-1#27)(2013-7#2)(2013-8#10)
g(##2##1##(1996-2#1)(2008-10#1)
g(-1) and the##2##3##(2008-10#1)(2008-5#1)
g(-1) and##13##2##(2008-10#9)(2008-5#1)(2010-11#1)(2010-5#2)
g(-1) for Co##2##3##(2008-10#2)
g(-1) for Cu##2##3##(2008-10#2)
g(-1) for Ni##3##3##(2008-10#3)
g(-1) for Pb and##2##4##(2008-10#2)
g(-1) for Pb##3##3##(2008-10#3)
g(-1) for the##4##3##(2008-10#4)
g(-1) for##34##2##(2008-10#34)
g(-1) level##8##2##(2008-10#8)
g(-1) level)##2##2##(2008-10#2)
g(-1) of dry##3##3##(2008-10#2)(2008-12#1)
g(-1) of the resin##2##4##(2008-10#2)
g(-1) of the##3##3##(2008-10#3)
g(-1) of##15##2##(2008-10#11)(2008-11#2)(2008-12#1)(2010-8#1)
g(-1) range were##2##3##(2008-10#2)
g(-1) range##3##2##(2008-10#3)
g(-1)##157##1##(2008-10#135)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2009-11#2)(2009-8#1)(2010-11#4)(2010-5#2)(2010-8#3)(2012-12#1)(2013-8#1)
g(-1)) and##2##2##(2008-10#1)(2008-12#1)
g(-1)) of##2##2##(2008-10#1)(2008-12#1)
g(-1))##17##1##(2008-10#14)(2008-12#2)(2011-2#1)
g(0)##2##1##(2008-2#2)
g) and##4##2##(1990-2#1)(1993-12#1)(1994-11#1)(2009-12#1)
g) for##2##2##(2008-10#1)(2013-8#1)
g) of##2##2##(1990-11#1)(2008-10#1)
g) paw withdrawal##2##3##(1993-12#2)
g) rats##2##2##(1994-11#1)(2009-12#1)
g) was##2##2##(1990-12#1)(1993-12#1)
g) were##6##2##(1994-3#1)(1996-6#1)(2008-10#3)(2009-12#1)
g)##41##1##(1990-11#1)(1990-12#1)(1990-2#3)(1991-11#2)(1993-12#7)(1994-11#3)(1994-3#1)(1995-6#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#3)(2009-9#4)(2013-1#1)(2013-8#2)
g-1##5##1##(1994-3#1)(1995-6#4)
g-1)##2##1##(1992-5#1)(1997-2#1)
g-KGM and g-SA##2##3##(2011-2#2)
g-KGM was##2##2##(2011-2#2)
g-KGM##7##1##(2011-2#7)
g-SA##4##1##(2011-2#4)
g-phase##2##1##(2013-1#2)
g/##2##1##(2011-2#2)
g/100 liter)##2##2##(2011-2#2)
g/100 ml##6##2##(1990-11#1)(1990-2#2)(1992-6#2)(1996-9#1)
g/100##8##1##(1990-11#1)(1990-2#2)(1992-6#2)(1996-9#1)(2011-2#2)
g/L (range##2##2##(2007-7#2)
g/L and##5##2##(2008-6#1)(2008-7#2)(2008-8#2)
g/L glucose after##2##3##(2008-6#2)
g/L glucose##4##2##(2008-6#4)
g/L in##3##2##(2008-11#1)(2008-6#1)(2008-7#1)
g/L of BC##2##3##(2008-6#2)
g/L of##8##2##(2008-11#2)(2008-6#4)(2008-7#2)
g/L xylose##2##2##(2008-6#2)
g/L##59##1##(1994-3#1)(2007-12#2)(2007-7#2)(2008-11#4)(2008-4#1)(2008-6#34)(2008-7#12)(2008-8#2)(2011-1#1)
g/L)##5##1##(2007-7#1)(2008-6#4)
g/L/h##2##1##(2008-6#2)
g/cellxday in##3##2##(2008-11#3)
g/cm(2) (SD 0##2##3##(2010-3#2)
g/cm(2)##3##1##(2010-3#3)
g/cm(2)/day at the##2##3##(2007-5#2)
g/cm2##2##1##(2011-2#2)
g/d##4##1##(2008-5#2)(2013-1#2)
g/d)##2##1##(2013-1#2)
g/dL +/- 0##2##3##(2008-7#2)
g/dL +/-##3##2##(2008-7#3)
g/dL from##2##2##(2008-7#2)
g/dL in##2##2##(2008-7#1)(2009-10#1)
g/dL or##3##2##(2008-7#3)
g/dL to##2##2##(2007-12#1)(2008-7#1)
g/dL ± 0##2##3##(2013-8#2)
g/dL ±##4##2##(2013-8#4)
g/dL##37##1##(2007-12#4)(2008-7#27)(2009-10#1)(2009-8#1)(2013-8#4)
g/dL) and##2##2##(2008-7#1)(2010-2#1)
g/dL)##11##1##(2008-7#7)(2010-2#1)(2011-2#3)
g/day##6##1##(1997-8#1)(2008-1#2)(2008-3#1)(2008-8#1)(2013-8#1)
g/day)##7##1##(1992-11#1)(1994-6#1)(1997-8#1)(2008-3#2)(2008-4#1)(2013-8#1)
g/dl##4##1##(1995-3#1)(1996-12#1)(2009-10#1)(2013-8#1)
g/dl)##2##1##(1990-11#2)
g/g x h)##2##3##(2008-6#2)
g/g##7##1##(2008-10#1)(2008-6#6)
g/g)##2##1##(2011-2#2)
g/g/h at dilution rate##2##4##(2008-6#2)
g/g/h##3##1##(2008-6#3)
g/h/g##2##1##(2008-6#2)
g/kg raw protein)##3##3##(2011-2#3)
g/kg##13##1##(1993-12#1)(1995-11#1)(1995-12#2)(2007-12#1)(2008-10#3)(2010-5#1)(2011-2#4)
g/kg)##2##1##(1995-3#1)(2008-10#1)
g/l in##2##2##(1990-3#1)(2008-10#1)
g/l with##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
g/l##21##1##(1990-12#3)(1990-3#2)(1991-12#1)(1991-6#1)(1997-3#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-5#6)
g/l)##8##1##(1997-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)
g/liter carbon loading##2##3##(2008-10#2)
g/liter carbon##3##2##(2008-10#3)
g/liter##4##1##(2008-10#4)
g/m##2##1##(2008-5#2)
g/m(2))##2##1##(2008-6#2)
g/m(3)##2##1##(2008-2#2)
g/m2 and##2##2##(2011-2#1)(2013-7#1)
g/m2##6##1##(1990-2#1)(1991-11#1)(2008-5#2)(2011-2#1)(2013-7#1)
g/m2)##2##1##(2011-2#2)
g/m2/d)##2##1##(2011-2#2)
g/ml##3##1##(1993-12#1)(2013-1#2)
g/mol##2##1##(2008-10#1)(2011-2#1)
g/mol)##2##1##(2008-10#1)(2011-2#1)
g2##2##1##(1993-5#1)(2013-8#1)
gC1q##2##1##(1997-4#2)
gIIIp##2##1##(1997-4#2)
gPAL1##2##1##(2008-10#2)
gRNA##2##1##(2008-10#2)
gabapentin polymorphs##2##2##(2011-3#2)
gabapentin##11##1##(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#5)(2012-3#1)(2013-1#1)
gadd genes##4##2##(1992-12#4)
gadd##6##1##(1992-12#6)
gadobenate dimeglumine (Gd-BOPTA##2##3##(2008-7#2)
gadobenate dimeglumine##4##2##(2008-7#4)
gadolinium (Gd)##2##2##(1997-8#1)(2012-2#1)
gadolinium chelates##3##2##(2008-1#1)(2008-7#2)
gadolinium oxide##2##2##(2008-10#1)(2008-11#1)
gadolinium##22##1##(1995-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
gadolinium(III)##3##1##(2008-10#2)(2012-3#1)
gadolinium-based contrast##2##2##(2008-7#2)
gadolinium-based##4##1##(1997-7#1)(2008-7#3)
gadolinium-enhanced##3##1##(2008-3#1)(2008-7#1)(2013-1#1)
gaegurins##2##1##(1994-11#2)
gaeumannii colonization##2##2##(2008-10#2)
gaeumannii##9##1##(2008-10#9)
gag gene of##2##3##(1994-8#1)(2007-7#1)
gag##12##1##(1991-11#1)(1991-12#2)(1994-12#4)(1994-8#1)(1997-4#1)(2007-7#1)(2008-11#2)
gag-related##3##1##(1995-8#3)
gage##2##1##(2008-2#1)(2009-7#1)
gages##3##1##(2008-2#3)
gain a better understanding of the##4##6##(1995-12#1)(2008-3#1)(2010-9#1)(2011-1#1)
gain a better understanding of##7##5##(1995-12#1)(2008-3#1)(2010-9#1)(2011-1#2)(2012-3#2)
gain a better understanding##8##4##(1995-12#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-1#2)(2012-3#2)
gain a##25##2##(1993-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2010-4#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
gain access to the##4##4##(2007-12#1)(2008-10#2)(2008-12#1)
gain access to##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
gain an insight into##2##4##(1995-12#1)(2010-3#1)
gain an insight##3##3##(1995-12#1)(2008-11#1)(2010-3#1)
gain an understanding of the##2##5##(1995-3#1)(2009-10#1)
gain an understanding of##3##4##(1995-3#1)(2009-10#1)(2009-6#1)
gain an##7##2##(1995-12#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)
gain and noise##2##3##(2007-12#2)
gain and saturation irradiance##5##4##(2008-2#1)(2008-3#4)
gain and the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
gain and##31##2##(1991-12#1)(1995-10#1)(1996-12#1)(2007-11#3)(2007-12#3)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-7#1)
gain as##2##2##(2007-12#1)(2013-1#1)
gain better##3##2##(2008-10#1)(2010-1#1)(2012-2#1)
gain but##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
gain by##3##2##(1995-1#1)(2008-2#1)(2008-9#1)
gain can be##2##3##(2008-2#1)(2009-9#1)
gain coefficient of##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
gain coefficient was##3##3##(2007-11#2)(2008-3#1)
gain coefficient##14##2##(2007-11#5)(2007-12#1)(2008-2#2)(2008-3#6)
gain control of##4##3##(1994-3#2)(2007-9#1)(2008-3#1)
gain control##7##2##(1994-3#2)(2007-11#2)(2007-9#1)(2008-3#2)
gain coupling##2##2##(2007-11#1)(2008-3#1)
gain curve##2##2##(2007-11#1)(2008-2#1)
gain differences##2##2##(2007-12#2)
gain during##3##2##(1997-7#1)(2008-10#1)(2008-12#1)
gain efficiency##2##2##(1994-12#1)(2012-2#1)
gain entry##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
gain experience##2##2##(2007-8#1)(2008-10#1)
gain from##5##2##(1996-6#1)(2008-10#1)(2008-3#1)(2008-8#2)
gain functions in##2##3##(2008-3#1)(2008-9#1)
gain functions##4##2##(2008-3#1)(2008-9#3)
gain further insight into the##3##5##(1995-11#1)(1997-9#1)(2008-11#1)
gain further insight into##7##4##(1995-11#1)(1996-12#1)(1997-9#1)(2008-11#3)(2010-10#1)
gain in a##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-9#1)
gain in the##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
gain in##28##2##(1991-2#1)(1992-6#1)(1992-9#1)(1996-2#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
gain information on the##2##4##(1993-6#1)(2007-8#1)
gain information on##3##3##(1993-6#1)(2007-8#1)(2012-2#1)
gain insight into the mechanism of##2##6##(2008-10#2)
gain insight into the mechanism##4##5##(1990-5#1)(2008-10#3)
gain insight into the##13##4##(1990-5#1)(1990-7#1)(1992-6#1)(2007-12#1)(2008-10#5)(2008-8#1)(2009-4#1)(2010-12#1)(2012-3#1)
gain insight into their##2##4##(2008-10#1)(2012-3#1)
gain insight into##19##3##(1990-5#1)(1990-7#1)(1992-6#1)(1993-6#1)(2007-12#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-3#2)
gain insight##20##2##(1990-5#1)(1990-7#1)(1992-6#1)(1993-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-3#2)
gain insights into##2##3##(2008-10#2)
gain is##11##2##(2007-12#2)(2008-3#5)(2009-9#1)(2010-5#1)(2013-1#2)
gain margin is maximum##2##4##(2008-3#2)
gain margin of a##2##4##(2008-3#2)
gain margin##6##2##(2008-3#6)
gain margins##2##2##(2008-3#2)
gain materials##2##2##(2008-3#2)
gain measurement##3##2##(2007-12#2)(2008-3#1)
gain media##11##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#6)(2009-5#1)
gain medium above##2##3##(2008-3#2)
gain medium##20##2##(2007-11#3)(2007-12#1)(2008-2#9)(2008-3#7)
gain modulation##3##2##(2008-2#2)(2008-3#1)
gain more insight into the##4##5##(1991-6#1)(1994-8#1)(2008-10#1)(2008-11#1)
gain more##7##2##(1991-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
gain narrowing##3##2##(2007-11#1)(2008-2#2)
gain new##3##2##(2007-7#1)(2008-6#1)(2008-9#1)
gain of function activities##2##4##(2009-5#1)(2011-2#1)
gain of function##4##3##(2008-4#1)(2009-5#2)(2011-2#1)
gain of the##2##3##(2007-11#1)(2008-9#1)
gain of##43##2##(1993-11#1)(1995-9#1)(2007-11#5)(2007-12#7)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-9#5)(2009-5#2)(2009-6#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-8#2)
gain or loss##3##3##(1993-2#1)(2008-11#1)(2008-3#1)
gain or##8##2##(1993-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#1)
gain over##2##2##(2007-11#2)
gain per##2##2##(2008-9#1)(2013-1#1)
gain profile##4##2##(2007-12#3)(2008-3#1)
gain results##2##2##(2007-11#1)(2007-12#1)
gain saturation##4##2##(2008-3#4)
gain spectrum##5##2##(2007-11#5)
gain than##5##2##(2007-12#1)(2008-9#1)(2011-2#1)(2013-1#2)
gain that is##2##3##(2007-11#1)(2007-12#1)
gain that##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#1)
gain this##2##2##(2008-5#1)(2013-8#1)
gain understanding##2##2##(2008-10#1)(2010-10#1)
gain valuable##3##2##(1994-10#1)(1997-8#1)(2008-11#1)
gain variation##2##2##(2007-12#2)
gain was obtained##2##3##(2007-11#1)(2007-12#1)
gain was##10##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
gain with##2##2##(2007-12#2)
gain##556##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2007-11#69)(2007-12#59)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#26)(2008-11#16)(2008-12#13)(2008-2#43)(2008-3#99)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#17)(2008-9#20)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#13)(2012-12#4)(2012-2#8)(2012-3#8)(2013-1#25)(2013-7#4)(2013-8#5)
gain)##5##1##(1992-8#1)(2008-10#1)(2008-12#1)(2011-2#2)
gain-clamped fiber amplifiers##2##3##(2008-3#2)
gain-clamped##3##1##(2008-3#3)
gain-guided##3##1##(2007-11#1)(2008-3#2)
gain-modulated##2##1##(2007-11#1)(2013-1#1)
gain-of-function mutations in##3##3##(2012-2#1)(2012-3#2)
gain-of-function##6##1##(1995-2#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#2)
gain-switched Cr##3##2##(2008-2#1)(2008-3#2)
gain-switched##9##1##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#2)
gained a##7##2##(1991-2#1)(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
gained about##2##2##(2009-5#1)(2013-1#1)
gained an average##2##3##(2008-3#1)(2008-5#1)
gained an##4##2##(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
gained approval##2##2##(2008-9#1)(2012-12#1)
gained by the##2##3##(1990-12#1)(2012-2#1)
gained by##11##2##(1990-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#1)
gained considerable##2##2##(2008-10#1)(2011-2#1)
gained during##3##2##(1991-6#1)(1995-2#1)(2008-6#1)
gained from the##7##3##(1994-3#1)(1994-8#1)(2009-4#1)(2010-5#1)(2011-8#1)(2012-2#2)
gained from##14##2##(1991-5#1)(1994-3#1)(1994-8#1)(1997-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-10#1)(2011-8#1)(2012-2#2)
gained in the##2##3##(1996-3#1)(2008-4#1)
gained in##4##2##(1996-3#1)(2008-12#1)(2008-4#1)(2010-11#1)
gained increasing interest##2##3##(2008-10#1)(2008-7#1)
gained increasing##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
gained into the##2##3##(1992-3#1)(2008-10#1)
gained more##2##2##(1991-12#1)(1992-2#1)
gained on##2##2##(2008-10#1)(2008-6#1)
gained over##2##2##(2008-9#1)(2012-2#1)
gained popularity as##2##3##(2010-12#1)(2012-12#1)
gained popularity##3##2##(1992-12#1)(2010-12#1)(2012-12#1)
gained significant attention##3##3##(2009-7#1)(2010-3#1)(2011-2#1)
gained through##5##2##(1994-12#1)(2007-12#1)(2008-9#1)(2009-10#1)(2009-8#1)
gained was##2##2##(2012-12#2)
gained weight##3##2##(1993-1#1)(1993-2#1)(2010-8#1)
gained wide acceptance##2##3##(2008-10#1)(2008-9#1)
gained with##4##2##(1992-5#1)(2006-10#1)(2008-10#1)(2011-2#1)
gained worldwide##2##2##(2009-5#1)(2011-2#1)
gained##127##1##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#19)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#7)(2011-8#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#5)
gainfully##2##1##(1993-6#1)(2008-12#1)
gaining acceptance in the##2##4##(1993-2#1)(2013-1#1)
gaining acceptance##3##2##(1991-1#1)(1993-2#1)(2013-1#1)
gaining an##2##2##(2012-2#1)(2013-1#1)
gaining ground in##2##3##(1997-1#1)(2008-7#1)
gaining ground##4##2##(1997-1#1)(1997-5#1)(2008-7#1)(2009-12#1)
gaining in##2##2##(2008-12#1)(2010-8#1)
gaining popularity##5##2##(2008-12#1)(2009-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
gaining##45##1##(1991-1#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
gains (p &lt##2##3##(2007-7#1)(2008-12#1)
gains access to##2##3##(1997-6#1)(2008-10#1)
gains and losses and##2##4##(2009-10#2)
gains and losses##5##3##(2008-7#1)(2009-10#2)(2009-6#1)(2011-2#1)
gains and##10##2##(1995-6#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-10#2)(2009-6#1)(2011-2#1)(2011-7#1)(2013-1#1)
gains are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
gains at##2##2##(1990-11#1)(2009-11#1)
gains between##3##2##(2007-12#2)(2008-9#1)
gains from##6##2##(1993-2#1)(1994-3#2)(2008-7#1)(2010-8#1)(2012-3#1)
gains in the##4##3##(1995-12#1)(2008-3#1)(2008-9#1)(2011-1#1)
gains in##16##2##(1992-1#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
gains of more than##2##4##(2007-11#1)(2007-12#1)
gains of the##2##3##(2008-3#1)(2010-3#1)
gains of##11##2##(1993-9#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-9#2)(2009-11#1)(2010-3#1)(2011-2#1)
gains or losses of##3##4##(2008-10#2)(2010-3#1)
gains or losses##4##3##(2008-10#3)(2010-3#1)
gains that##2##2##(1996-5#1)(2009-11#1)
gains to##2##2##(1997-4#1)(2011-2#1)
gains were##6##2##(2007-7#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#1)
gains##115##1##(1990-11#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(2007-11#4)(2007-12#5)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#8)(2009-12#1)(2009-5#1)(2009-6#2)(2010-3#3)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#1)
gainsharing program##3##2##(1996-3#3)
gainsharing##4##1##(1996-3#4)
gaisen##2##1##(2008-10#2)
gait analysis##3##2##(2013-1#3)
gait and balance disorders in##2##5##(2013-1#2)
gait and balance disorders##3##4##(2008-7#1)(2013-1#2)
gait and##8##2##(1992-5#1)(2007-10#1)(2008-7#1)(2009-10#1)(2010-9#2)(2013-1#2)
gait cycle##2##2##(2007-10#1)(2010-3#1)
gait disorders in##2##3##(1992-5#1)(2013-1#1)
gait disorders##6##2##(1992-5#1)(2013-1#5)
gait in##2##2##(2008-12#1)(2013-1#1)
gait instability##2##2##(2011-10#1)(2012-12#1)
gait or##2##2##(1994-8#1)(2008-7#1)
gait performance##4##2##(2012-12#1)(2013-1#3)
gait##72##1##(1992-5#3)(1994-12#1)(1994-3#1)(1994-8#3)(1996-9#1)(1997-5#1)(2007-10#4)(2007-8#1)(2008-12#2)(2008-7#8)(2009-10#3)(2009-3#2)(2009-4#1)(2010-12#1)(2010-3#2)(2010-9#3)(2011-10#1)(2012-12#4)(2012-2#1)(2013-1#27)(2013-7#2)
gaits##2##1##(2007-12#1)(2012-12#1)
gal##5##1##(1990-5#2)(1991-5#3)
gal4##2##1##(1990-5#2)
gal80##2##1##(1990-5#2)
galactography##4##1##(1990-11#4)
galactokinase##2##1##(1992-11#2)
galactolipids##4##1##(1996-5#4)
galactomannan assay in##2##3##(2008-7#1)(2012-2#1)
galactomannan##4##1##(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
galactosamine and##2##2##(1994-11#1)(2008-10#1)
galactosamine labeled with daunomycin##2##4##(2008-10#2)
galactosamine##12##1##(1994-11#2)(1994-6#1)(1994-8#1)(2008-10#8)
galactose and##3##2##(1990-5#1)(1994-11#1)(2008-11#1)
galactose elimination capacity##2##3##(1991-6#2)
galactose in##2##2##(1990-5#1)(1995-8#1)
galactose residues##3##2##(1993-11#1)(2008-10#1)(2008-8#1)
galactose were##3##2##(1994-3#1)(1996-12#1)(2013-1#1)
galactose##48##1##(1990-2#1)(1990-5#9)(1991-6#2)(1991-9#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1997-3#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2012-3#1)(2013-1#3)
galactose-6-sulphate sulphatase activity##3##3##(1990-2#3)
galactose-6-sulphate sulphatase##4##2##(1990-2#4)
galactose-inducible promoter##2##2##(1993-9#1)(1995-6#1)
galactose-inducible##3##1##(1993-9#1)(1995-6#2)
galactosemia in neonate##2##3##(2012-3#2)
galactosemia##3##1##(1995-8#1)(2012-3#2)
galactoside##4##1##(2007-11#1)(2009-8#1)(2011-2#2)
galactosyl##2##1##(1991-12#1)(1995-2#1)
galactosylated##2##1##(1995-11#1)(2008-8#1)
galactosyltransferase (UGT8)##2##2##(2013-8#2)
galactosyltransferase##4##1##(2008-7#1)(2008-9#1)(2013-8#2)
galah##2##1##(2008-5#2)
galanin inhibits insulin##2##3##(1994-8#2)
galanin on##2##2##(1993-3#1)(1994-8#1)
galanin##25##1##(1993-3#13)(1994-8#10)(1996-12#2)
galanin(-7-16)##2##1##(1994-8#2)
galanin(-9-16)##2##1##(1994-8#2)
galantamine##2##1##(2012-2#2)
galantide##4##1##(1993-3#4)
galaxies##3##1##(1990-11#1)(1995-6#1)(2008-3#1)
galaxiid Galaxias##2##2##(2010-8#2)
galea##6##1##(2007-12#3)(2008-9#2)(2010-11#1)
galectin-3##5##1##(1994-6#2)(2009-3#2)(2012-2#1)
galenic##2##1##(1990-8#1)(2008-10#1)
gall bladder##4##2##(1992-6#1)(2008-8#1)(2010-11#2)
gall disease##2##2##(2008-10#2)
gall formation##4##2##(2008-10#2)(2009-8#2)
gall induction##2##2##(2009-8#1)(2011-2#1)
gall of##3##2##(2008-10#3)
gall##35##1##(1992-6#1)(1997-8#1)(2008-10#26)(2008-8#1)(2009-8#3)(2010-11#2)(2011-2#1)
gall-insect species##2##2##(2009-8#2)
gallate and##2##2##(1996-2#1)(2008-11#1)
gallate##14##1##(1992-9#1)(1996-2#1)(2008-10#3)(2008-11#7)(2008-5#1)(2009-8#1)
gallates##2##1##(2008-11#1)(2009-8#1)
gallbladder adenocarcinoma##2##2##(1991-8#2)
gallbladder and##2##2##(1992-9#1)(2010-1#1)
gallbladder cancer##12##2##(2010-12#8)(2013-1#4)
gallbladder carcinoma##2##2##(2008-11#2)
gallbladder containing echogenic bile##2##4##(2013-1#2)
gallbladder containing##3##2##(2013-1#3)
gallbladder disease##4##2##(1991-3#1)(2008-12#1)(2010-8#2)
gallbladder is##4##2##(1991-6#1)(1997-7#1)(2011-2#1)(2013-8#1)
gallbladder size##3##2##(2011-2#3)
gallbladder stones and##2##3##(2008-5#1)(2013-8#1)
gallbladder stones##4##2##(2008-5#3)(2013-8#1)
gallbladder##90##1##(1990-12#1)(1990-6#3)(1990-9#2)(1991-12#3)(1991-3#1)(1991-6#2)(1991-8#3)(1992-6#4)(1992-9#3)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-6#2)(1997-7#6)(1997-8#3)(2008-1#2)(2008-11#4)(2008-12#1)(2008-5#6)(2009-3#4)(2010-1#1)(2010-12#11)(2010-8#2)(2011-2#5)(2012-3#2)(2013-1#8)(2013-8#7)
galled tissue##2##2##(2008-10#2)
gallery modes in##2##3##(2007-12#2)
gallery modes##4##2##(2007-12#3)(2008-3#1)
galli##5##1##(2006-12#2)(2011-1#3)
gallic acid and tannic acid are##2##6##(2008-10#2)
gallic acid and tannic acid##3##5##(2008-10#3)
gallic acid and##6##3##(2008-10#5)(2011-1#1)
gallic acid equivalents##2##3##(2008-10#1)(2009-6#1)
gallic acid##17##2##(2008-10#13)(2008-6#2)(2009-6#1)(2011-1#1)
gallic##19##1##(2008-10#14)(2008-6#2)(2009-6#1)(2011-1#2)
gallinae##2##1##(1997-5#2)
gallinarum and T americana##2##4##(2011-1#2)
gallinarum and T##3##3##(2011-1#3)
gallinarum##5##1##(2011-1#5)
gallisepticum and##2##2##(1993-12#2)
gallisepticum##7##1##(1993-12#2)(1997-3#2)(1997-6#2)(2010-9#1)
gallium and indium##2##3##(2008-10#2)
gallium and##5##2##(2008-10#5)
gallium arsenide##3##2##(1990-12#1)(2008-3#1)(2009-6#1)
gallium phosphide##3##2##(2008-3#3)
gallium##44##1##(1990-12#1)(1990-3#1)(1991-12#1)(1992-11#1)(1993-11#1)(2007-11#3)(2007-12#3)(2008-10#26)(2008-2#1)(2008-3#4)(2009-6#1)(2011-2#1)
gallium(III)##7##1##(2008-10#7)
gallium-phosphide##2##1##(2008-3#2)
galls on##8##2##(2008-10#6)(2009-2#1)(2009-8#1)
galls were##2##2##(2008-10#2)
galls##26##1##(2008-10#24)(2009-2#1)(2009-8#1)
gallstone disease##3##2##(1997-8#2)(2013-1#1)
gallstone ileus##2##2##(2008-12#1)(2012-12#1)
gallstone##12##1##(1990-9#1)(1993-9#1)(1997-8#2)(2008-12#4)(2008-8#1)(2012-12#1)(2013-1#2)
gallstones##3##1##(1991-6#1)(2009-3#1)(2013-1#1)
gallus##2##1##(2008-5#1)(2008-9#1)
galvanic cells##3##2##(2008-10#3)
galvanic detector##3##2##(2008-10#3)
galvanic skin response##2##3##(2012-3#2)
galvanic##16##1##(2008-10#10)(2008-3#1)(2008-5#1)(2010-1#1)(2012-2#1)(2012-3#2)
galvanometer##3##1##(2007-12#2)(2008-3#1)
galvanostatic##6##1##(2008-10#5)(2009-10#1)
gambiae s##4##2##(2008-8#4)
gambiae##7##1##(2007-12#2)(2008-8#5)
gamble##6##1##(1997-6#1)(2008-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
gamblers##8##1##(1997-4#1)(2008-3#5)(2012-12#2)
gambling in##4##2##(2008-11#1)(2012-12#2)(2013-8#1)
gambling problems##2##2##(2008-11#2)
gambling##26##1##(1993-6#1)(2008-10#1)(2008-11#11)(2008-6#1)(2012-12#9)(2013-8#3)
gambusia##3##1##(2011-1#3)
game designed##2##2##(1992-1#1)(2013-1#1)
game genre##2##2##(2013-1#2)
game has been##2##3##(2008-8#1)(2012-12#1)
game meat##3##2##(2013-7#3)
game model of##2##3##(2008-8#1)(2008-9#1)
game playing##2##2##(1993-1#1)(2012-12#1)
game reserves##2##2##(1990-3#2)
game theoretic##2##2##(2008-8#2)
game theoretical##3##2##(2008-9#1)(2009-9#1)(2012-3#1)
game theory##2##2##(2008-8#1)(2012-3#1)
game with##2##2##(2008-11#1)(2012-3#1)
game##50##1##(1990-3#3)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-8#6)(2008-9#8)(2009-9#1)(2010-1#1)(2010-4#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#3)
games and##2##2##(1993-12#1)(1993-3#1)
games played by##2##3##(2012-2#2)
games played##3##2##(2012-2#2)(2013-1#1)
games##18##1##(1992-1#1)(1993-12#1)(1993-3#1)(1996-3#1)(2008-8#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
gamete traits##2##2##(2008-8#1)(2009-2#1)
gamete##7##1##(1991-11#1)(1996-9#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-2#2)
gametes##12##1##(1990-10#1)(1997-7#1)(2008-11#2)(2008-7#3)(2008-8#3)(2009-12#1)(2013-1#1)
gametic disequilibrium##5##2##(2008-10#5)
gametic equilibrium##4##2##(2008-10#4)
gametic fusion##2##2##(1994-12#1)(2008-11#1)
gametic phase disequilibrium##3##3##(2008-10#3)
gametic phase##5##2##(2008-10#4)(2012-3#1)
gametic##20##1##(1994-12#1)(2008-10#13)(2008-11#1)(2008-8#1)(2009-2#2)(2010-5#1)(2012-3#1)
gametogenesis##4##1##(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
gametophytic cytokinesis##3##2##(2009-10#3)
gametophytic##4##1##(2008-4#1)(2009-10#3)
gaming##2##1##(2010-10#1)(2013-1#1)
gamma 2 subunit##6##3##(1995-11#3)(1995-12#3)
gamma 2##14##2##(1994-12#6)(1995-11#5)(1995-12#3)
gamma 2L subunits##3##3##(1995-11#3)
gamma 2L##5##2##(1995-11#5)
gamma 2S and alpha##2##4##(1995-11#2)
gamma 3##6##2##(1995-11#6)
gamma =##11##2##(1992-11#1)(1996-2#3)(1997-7#4)(2007-11#2)(2013-8#1)
gamma GT##2##2##(1991-11#1)(2013-1#1)
gamma H2AX##3##2##(2009-5#3)
gamma II crystallin##3##3##(1992-8#3)
gamma II##4##2##(1992-8#4)
gamma S alone##2##3##(1993-8#1)(1995-3#1)
gamma S binding by##2##4##(1993-8#1)(1996-2#1)
gamma S binding was##3##4##(1996-2#3)
gamma S binding##8##3##(1993-8#2)(1996-2#6)
gamma S##31##2##(1991-2#2)(1991-6#3)(1991-9#1)(1992-11#5)(1992-8#3)(1993-6#1)(1993-8#5)(1995-3#1)(1995-8#4)(1996-2#6)
gamma S)##6##2##(1990-8#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-8#1)
gamma and delta-tocopherols##2##3##(2008-5#2)
gamma and epsilon##2##3##(2008-8#2)
gamma and##9##2##(1995-5#1)(1996-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#3)
gamma are##4##2##(2007-11#1)(2008-6#2)(2008-7#1)
gamma band##2##2##(2012-2#2)
gamma camera techniques##3##3##(2008-1#3)
gamma camera to##2##3##(1996-3#1)(2010-3#1)
gamma camera##17##2##(1994-2#1)(1994-5#2)(1996-2#3)(1996-3#1)(2008-1#5)(2008-7#1)(2009-6#2)(2010-3#1)(2012-12#1)
gamma delta T cells may##2##5##(1993-8#1)(1994-11#1)
gamma delta T cells##4##4##(1993-8#3)(1994-11#1)
gamma delta##5##2##(1993-8#4)(1994-11#1)
gamma from##2##2##(1992-6#1)(2008-2#1)
gamma glutamyl##2##2##(2007-12#1)(2009-6#1)
gamma in##4##2##(1990-4#1)(2008-2#1)(2008-3#1)(2013-8#1)
gamma interferon##5##2##(1990-5#1)(1993-8#1)(2008-10#1)(2010-4#2)
gamma irradiation##4##2##(1994-8#1)(2007-12#1)(2008-7#1)(2010-10#1)
gamma is##6##2##(1993-12#1)(1993-3#1)(1994-12#1)(2008-2#1)(2008-3#2)
gamma knife##4##2##(1997-4#1)(2007-5#1)(2008-1#1)(2008-7#1)
gamma of the##2##3##(2008-3#2)
gamma of##5##2##(1991-3#1)(1992-12#1)(1994-2#1)(2008-3#2)
gamma on##2##2##(1993-9#1)(2007-12#1)
gamma phosphate##3##2##(1997-7#1)(2013-1#2)
gamma radiation##6##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
gamma ray##5##2##(2008-5#2)(2008-8#1)(2009-11#2)
gamma rays##5##2##(1993-9#1)(1994-12#1)(2008-5#1)(2008-7#2)
gamma subunit is##3##3##(2008-8#3)
gamma subunit##7##2##(1993-3#2)(1995-11#1)(2008-8#4)
gamma subunits of##5##3##(1992-9#1)(1993-3#2)(1995-8#1)(2008-8#1)
gamma subunits##8##2##(1992-9#1)(1993-3#2)(1995-11#1)(1995-8#1)(2008-8#3)
gamma##307##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-10#1)(1992-11#7)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#8)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#12)(1993-6#4)(1993-8#12)(1993-9#4)(1994-11#1)(1994-12#20)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#24)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#7)(1996-2#13)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#3)(1997-7#5)(2006-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2008-1#7)(2008-10#3)(2008-11#9)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#12)(2008-8#19)(2008-9#3)(2009-11#2)(2009-5#3)(2009-6#3)(2009-8#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
gamma)##11##1##(1993-12#1)(1993-3#3)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-3#1)
gamma-##4##1##(1992-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
gamma-3 proteobacterium##2##2##(2008-10#2)
gamma-CD##10##1##(1996-5#2)(2008-10#7)(2008-6#1)
gamma-Cry##2##1##(1993-6#2)
gamma-Fe(2)O(3)##5##1##(2008-10#5)
gamma-GT determinations##2##2##(1990-9#2)
gamma-GT##8##1##(1990-3#1)(1990-9#4)(1994-5#3)
gamma-GTP##5##1##(1995-11#5)
gamma-H2AX foci##2##2##(2010-2#2)
gamma-IFN##8##1##(1994-5#7)(2008-11#1)
gamma-IFN--transduced##4##1##(1994-5#4)
gamma-L-glutamyl-L-aspartate##2##1##(1993-5#2)
gamma-LGLA administered##2##2##(1993-5#2)
gamma-LGLA##5##1##(1993-5#5)
gamma-LiAlO(2)##4##1##(2008-10#4)
gamma-MSH##3##1##(1995-12#3)
gamma-alkenyl##2##1##(1996-5#2)
gamma-amino##2##1##(2006-12#1)(2012-12#1)
gamma-aminobutyraldehyde##2##1##(1992-11#2)
gamma-aminobutyric acid (GABA) and##2##4##(1995-12#1)(2008-8#1)
gamma-aminobutyric acid (GABA) in##3##4##(1990-5#1)(1993-12#1)(1996-7#1)
gamma-aminobutyric acid (GABA) on##2##4##(1992-3#1)(2008-9#1)
gamma-aminobutyric acid (GABA)##12##3##(1990-5#1)(1992-3#1)(1993-12#1)(1995-12#2)(1995-2#1)(1996-5#1)(1996-7#1)(2008-7#1)(2008-8#2)(2008-9#1)
gamma-aminobutyric acid (GABA)A receptor complex##2##5##(1995-12#2)
gamma-aminobutyric acid and##4##3##(1992-11#1)(1995-12#1)(1996-7#1)(1997-3#1)
gamma-aminobutyric acid##33##2##(1990-5#2)(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1995-11#3)(1995-12#5)(1995-2#2)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#4)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2013-8#1)
gamma-aminobutyric##34##1##(1990-5#2)(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#2)(1993-12#1)(1995-11#3)(1995-12#5)(1995-2#2)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#4)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2013-8#1)
gamma-camera##2##1##(1996-1#1)(2010-3#1)
gamma-carboxyglutamic acid (Gla) domain##2##4##(1995-2#1)(1995-6#1)
gamma-carboxyglutamic acid (Gla)##3##3##(1991-12#1)(1995-2#1)(1995-6#1)
gamma-carboxyglutamic acid##5##2##(1991-12#2)(1995-2#2)(1995-6#1)
gamma-carboxylate##2##1##(1995-2#1)(1995-6#1)
gamma-carboxylation##5##1##(1992-12#4)(2008-8#1)
gamma-crustacyanin##2##1##(2008-12#2)
gamma-cry##6##1##(1993-6#6)
gamma-cyclodextrin##3##1##(1990-7#1)(2008-10#1)(2008-6#1)
gamma-cyclodextrin-based##2##1##(2008-10#2)
gamma-cyhalothrin LC50##2##2##(2011-2#2)
gamma-cyhalothrin for##2##2##(2011-2#2)
gamma-cyhalothrin was##2##2##(2011-2#2)
gamma-cyhalothrin##12##1##(2011-2#12)
gamma-diketo##2##1##(2011-3#2)
gamma-globin gene##2##2##(1990-8#2)
gamma-globin##4##1##(1990-8#4)
gamma-globulin in##2##2##(2008-10#2)
gamma-globulin##7##1##(1993-11#1)(2008-10#6)
gamma-glutamyl transferase (GGT)##2##3##(2006-6#1)(2010-4#1)
gamma-glutamyl transferase##4##2##(1994-5#1)(2006-6#2)(2010-4#1)
gamma-glutamyl transpeptidase##3##2##(1990-3#1)(1995-11#2)
gamma-glutamyl##8##1##(1990-3#1)(1990-5#1)(1994-5#1)(1995-11#2)(2006-6#2)(2010-4#1)
gamma-glutamylcysteine synthetase##3##2##(1995-9#2)(2008-11#1)
gamma-glutamyltransferase##5##1##(1990-9#2)(1995-11#1)(2008-10#1)(2008-5#1)
gamma-hydroxy##2##1##(2009-8#2)
gamma-hydroxybutyrate##2##1##(1992-3#1)(1997-2#1)
gamma-interferon##5##1##(1996-12#3)(2009-12#1)(2010-4#1)
gamma-irradiated cells##2##2##(1995-8#1)(2008-7#1)
gamma-irradiated##8##1##(1994-5#1)(1995-8#1)(2008-10#4)(2008-7#1)(2013-1#1)
gamma-irradiation of##3##2##(2008-10#3)
gamma-irradiation##8##1##(1996-2#1)(1997-4#1)(2008-10#4)(2008-7#1)(2011-1#1)
gamma-knife and##2##2##(2008-7#2)
gamma-knife##5##1##(2008-7#5)
gamma-lactone##2##1##(1990-5#1)(1996-5#1)
gamma-linolenic acid##2##2##(1997-2#1)(2008-5#1)
gamma-linolenic##3##1##(1990-3#1)(1997-2#1)(2008-5#1)
gamma-melanocyte-stimulating hormone##2##2##(1993-5#2)
gamma-meso axis##3##2##(1990-8#1)(1994-5#2)
gamma-methylene-ATP##3##1##(1995-8#3)
gamma-microglobulin##2##1##(1990-12#2)
gamma-motor activity##2##2##(1996-2#2)
gamma-motor##3##1##(1996-2#3)
gamma-proteobacteria##2##1##(2009-8#2)
gamma-radiation##6##1##(1995-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)
gamma-ray irradiation##2##2##(1994-12#2)
gamma-ray microscope##3##2##(2009-6#3)
gamma-ray##12##1##(1992-9#1)(1994-12#2)(1996-2#1)(2008-10#1)(2008-7#1)(2009-6#4)(2010-3#1)(2012-2#1)
gamma-rays##11##1##(1992-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#3)
gamma-secretase##2##1##(2008-5#1)(2010-3#1)
gamma-subunit##2##1##(1994-12#2)
gamma-sultone##2##1##(2008-10#2)
gamma-terpinene##2##1##(2008-11#1)(2008-12#1)
gamma-theta oscillation##2##2##(2008-11#2)
gamma-tub##2##1##(1993-12#2)
gamma-tubulin is##2##2##(1991-5#2)
gamma-tubulin##7##1##(1991-5#6)(1993-12#1)
gamma1##2##1##(2008-11#2)
gamma2-MSH##4##1##(1995-12#4)
gamma]##2##1##(1990-5#2)
gammadelta variant of##2##3##(2009-8#2)
gammadelta variant##3##2##(2009-8#3)
gammadelta##7##1##(2008-11#1)(2009-8#6)
gammaglobulin##5##1##(1996-1#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
gammaglobulins##2##1##(1996-3#1)(2011-2#1)
gammaproteobacterium##2##1##(2011-2#1)(2012-2#1)
gammopathy##3##1##(1992-12#1)(1993-8#1)(2008-9#1)
gamut of##2##2##(2008-3#1)(2008-8#1)
gamut##5##1##(2008-3#3)(2008-4#1)(2008-8#1)
ganciclovir triphosphate##3##2##(1995-2#3)
ganciclovir##7##1##(1991-8#1)(1995-2#4)(2007-12#1)(2010-12#1)
gang involvement##2##2##(2009-5#2)
gang members##2##2##(2009-5#2)
gang membership##2##2##(2009-5#1)(2013-1#1)
gang##6##1##(2009-5#5)(2013-1#1)
ganglia and the##2##3##(1992-12#1)(2008-5#1)
ganglia and##4##2##(1992-12#1)(1995-5#1)(2008-5#1)(2008-7#1)
ganglia are##5##2##(1996-5#1)(2008-4#1)(2008-7#2)(2008-9#1)
ganglia by##2##2##(1996-12#1)(1996-5#1)
ganglia from##2##2##(1996-6#1)(2008-4#1)
ganglia hemorrhage##2##2##(2013-1#2)
ganglia in the##2##3##(1994-12#1)(1997-6#1)
ganglia in##3##2##(1993-9#1)(1994-12#1)(1997-6#1)
ganglia of the##9##3##(1990-2#1)(1992-3#1)(1994-11#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-9#2)
ganglia of##13##2##(1990-2#1)(1991-5#1)(1992-3#1)(1994-11#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-9#2)
ganglia were NADPH-diaphorase positive##2##4##(1992-12#2)
ganglia were##3##2##(1992-12#2)(2008-7#1)
ganglia##103##1##(1990-2#1)(1991-12#2)(1991-5#1)(1992-12#4)(1992-3#1)(1992-6#1)(1993-5#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#3)(1996-12#4)(1996-5#8)(1996-6#1)(1997-3#6)(1997-6#3)(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#17)(2008-9#4)(2009-10#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
ganglia/cm2)##2##1##(1997-3#2)
ganglion and##5##2##(1993-5#1)(1996-12#1)(1996-2#1)(2008-6#2)
ganglion cell##3##2##(1992-3#1)(2008-4#1)(2008-7#1)
ganglion cells and##3##3##(1993-12#1)(2008-9#1)(2011-2#1)
ganglion cells is##2##3##(1993-12#1)(1997-3#1)
ganglion cells were found##2##4##(1997-3#1)(1997-4#1)
ganglion cells##14##2##(1991-7#1)(1993-12#3)(1997-3#2)(1997-4#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2011-2#1)
ganglion cyst of the##2##4##(2008-9#1)(2009-1#1)
ganglion cyst##5##2##(2008-9#1)(2009-1#1)(2013-8#3)
ganglion following##2##2##(1997-2#1)(2008-9#1)
ganglion for##2##2##(1996-5#1)(2008-7#1)
ganglion is##2##2##(2011-2#2)
ganglion mother cells##3##3##(2007-12#3)
ganglion neurons##17##2##(1990-5#1)(1992-3#2)(1992-9#1)(1994-12#1)(1996-12#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2013-8#1)
ganglion of the##2##3##(1990-5#1)(2008-9#1)
ganglion of##6##2##(1990-5#1)(1993-12#1)(2008-7#1)(2008-8#2)(2008-9#1)
ganglion##125##1##(1990-5#2)(1990-7#1)(1991-7#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-5#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#5)(1996-2#2)(1996-5#7)(1997-2#2)(1997-3#5)(1997-4#1)(2007-12#8)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#21)(2009-1#1)(2009-12#3)(2011-2#10)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#6)
ganglioneuroblastoma##2##1##(1990-6#2)
ganglioneuroma##2##1##(1991-2#2)
ganglioneuromatosis##2##1##(2009-1#2)
ganglionic transmission##2##2##(1992-3#1)(1997-7#1)
ganglionic##6##1##(1990-8#1)(1992-3#1)(1996-5#2)(1997-7#1)(2008-5#1)
ganglions##4##1##(2008-5#2)(2008-9#2)
ganglioside GD2##3##2##(1993-9#3)
ganglioside GM1##2##2##(1990-5#1)(1995-5#1)
ganglioside in##2##2##(2008-7#1)(2012-3#1)
ganglioside is##3##2##(1996-5#3)
ganglioside treatment##2##2##(1993-5#2)
ganglioside##33##1##(1990-5#2)(1990-8#1)(1991-5#2)(1992-9#2)(1993-3#1)(1993-5#3)(1993-9#4)(1994-12#1)(1994-3#4)(1994-9#1)(1995-5#1)(1996-5#9)(2008-7#1)(2012-3#1)
ganglioside)##2##1##(2012-3#2)
ganglioside-containing liposome was##2##3##(1994-9#2)
ganglioside-containing liposome##3##2##(1994-9#3)
ganglioside-protein##2##1##(1990-5#1)(1994-12#1)
gangliosides and##5##2##(1993-3#1)(1994-12#1)(1996-5#3)
gangliosides from resting##2##3##(1993-11#2)
gangliosides of the##2##3##(1990-5#1)(2008-7#1)
gangliosides was##2##2##(1993-11#1)(2008-5#1)
gangliosides##35##1##(1990-11#6)(1990-5#2)(1990-7#1)(1991-2#5)(1991-3#1)(1992-12#1)(1993-11#4)(1993-3#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1996-5#5)(2008-5#1)(2008-7#1)(2012-3#1)
gangrene and##3##2##(2007-7#2)(2008-8#1)
gangrene in##2##2##(1991-6#1)(2013-1#1)
gangrene is##2##2##(2010-12#1)(2011-2#1)
gangrene was##2##2##(1997-8#1)(2010-12#1)
gangrene##23##1##(1991-6#1)(1997-8#2)(2007-7#4)(2008-10#1)(2008-8#2)(2010-12#4)(2011-2#2)(2013-1#7)
gangrenosum##9##1##(1991-3#1)(2006-10#2)(2007-7#1)(2010-12#4)(2013-1#1)
gangrenous##3##1##(2007-7#1)(2008-5#1)(2013-1#1)
ganoderma lucidum and##2##3##(2013-8#2)
ganoderma lucidum##6##2##(2013-8#6)
ganoderma##9##1##(2013-8#9)
gantry##5##1##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#2)
gap and smooth septate junctions##2##5##(2008-7#2)
gap and the##2##3##(2008-10#1)(2008-2#1)
gap and##13##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2010-7#1)
gap at##5##2##(1990-12#1)(1990-7#1)(2008-11#1)(2008-2#2)
gap between the##10##3##(1995-8#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-1#1)
gap between these##2##3##(2007-12#1)(2008-3#1)
gap between##42##2##(1990-2#2)(1991-1#1)(1993-12#2)(1994-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-6#2)(2007-10#2)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
gap by##2##2##(2008-7#1)(2012-2#1)
gap from##2##2##(1993-3#1)(2007-12#1)
gap has##3##2##(2008-11#1)(2008-2#1)(2010-5#1)
gap in a##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
gap in knowledge##2##3##(2010-2#1)(2010-9#1)
gap in our knowledge##2##4##(2008-8#1)(2010-5#1)
gap in the##4##3##(1991-1#1)(2008-2#1)(2008-7#1)(2010-3#1)
gap in this##2##3##(2008-11#1)(2008-4#1)
gap in##21##2##(1991-1#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
gap is##7##2##(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#2)
gap junction area##2##3##(1994-3#2)
gap junction protein##4##3##(2008-7#2)(2008-9#2)
gap junction##20##2##(1994-3#4)(2008-7#7)(2008-9#2)(2009-12#1)(2010-9#1)(2012-2#4)(2013-8#1)
gap junctional communication in##2##4##(2008-7#1)(2008-8#1)
gap junctional communication##3##3##(1994-11#1)(2008-7#1)(2008-8#1)
gap junctional intercellular communication (GJIC)##2##5##(2008-11#1)(2008-8#1)
gap junctional intercellular communication##3##4##(1994-11#1)(2008-11#1)(2008-8#1)
gap junctional##7##2##(1994-11#2)(2008-11#2)(2008-7#1)(2008-8#2)
gap junctions and##2##3##(1994-3#1)(2008-11#1)
gap junctions between##3##3##(2008-7#1)(2012-2#2)
gap junctions##14##2##(1994-3#2)(2008-11#1)(2008-6#1)(2008-7#6)(2009-10#1)(2010-9#1)(2012-2#2)
gap of##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#2)
gap or##2##2##(2007-10#1)(2008-4#1)
gap size##2##2##(2008-10#2)
gap solitons##3##2##(2007-11#2)(2007-12#1)
gap was##3##2##(2007-10#1)(2009-3#2)
gap with##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
gap##230##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#3)(1991-12#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-3#6)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#6)(2007-11#8)(2007-12#8)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#20)(2008-12#6)(2008-2#7)(2008-3#16)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#26)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-9#4)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#15)(2013-1#8)(2013-7#2)(2013-8#5)
gap&quot##4##1##(1995-2#1)(2008-1#1)(2008-10#2)
gap'##2##1##(2011-1#1)(2013-1#1)
gaps and##5##2##(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
gaps between the##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
gaps between##4##2##(2007-12#1)(2008-3#2)(2008-5#1)
gaps for##2##2##(2008-11#1)(2013-8#1)
gaps in knowledge##3##3##(1995-1#1)(2010-3#1)(2012-12#1)
gaps in our knowledge##2##4##(2009-10#1)(2010-12#1)
gaps in our##3##3##(2008-12#1)(2009-10#1)(2010-12#1)
gaps in periodic anisotropic##2##4##(2008-3#2)
gaps in service provision##2##4##(2008-12#1)(2011-1#1)
gaps in the literature##2##4##(2008-6#1)(2012-2#1)
gaps in the system of administrative##10##6##(2013-8#10)
gaps in the##20##3##(1992-2#1)(1992-3#1)(2006-10#1)(2007-12#1)(2008-6#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#10)
gaps in##46##2##(1992-2#1)(1992-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#5)(2008-6#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#11)
gaps of##3##2##(2007-10#1)(2007-11#1)(2008-10#1)
gaps or##2##2##(1993-3#1)(2011-2#1)
gaps remain##2##2##(1992-12#1)(1997-5#1)
gaps that##4##2##(1996-3#1)(1997-1#1)(2008-3#1)(2008-7#1)
gaps were##2##2##(2010-6#1)(2013-1#1)
gaps##91##1##(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-10#1)(2009-11#1)(2009-3#4)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#12)
gaps&quot##2##1##(1993-3#2)
garamycin##2##1##(2007-11#1)(2011-2#1)
garbage dump##3##2##(2011-2#3)
garbage##7##1##(1993-2#2)(2008-10#1)(2011-2#4)
garden##14##1##(1991-3#2)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-7#2)(2010-6#1)(2012-3#1)
gardening##2##1##(2009-8#1)(2010-6#1)
gardens of##2##2##(2008-5#1)(2012-2#1)
gardens##14##1##(1997-3#1)(2008-10#5)(2008-5#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-2#3)
garenoxacin##8##1##(2008-10#6)(2011-2#2)
garlic (Allium sativum) and##2##4##(1992-9#1)(2008-10#1)
garlic and leek##2##3##(2008-10#2)
garlic and##4##2##(2008-10#4)
garlic oil##6##2##(2008-9#5)(2012-2#1)
garlic##23##1##(1992-5#1)(1992-8#2)(1992-9#1)(2007-7#1)(2008-10#6)(2008-7#2)(2008-9#9)(2012-2#1)
garment##8##1##(2008-6#2)(2010-8#6)
garments##3##1##(2008-10#1)(2010-8#1)(2011-2#1)
garnered significant##2##2##(2011-2#1)(2012-2#1)
garnered##3##1##(2010-7#1)(2011-2#1)(2012-2#1)
garnet films##3##2##(2008-3#3)
garnet##11##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)(2010-8#1)
garter snake##2##2##(2008-8#1)(2008-9#1)
garter##3##1##(2008-8#2)(2008-9#1)
gas absorption cell##2##3##(2008-10#1)(2008-3#1)
gas analysis was performed##2##4##(2008-10#1)(2011-2#1)
gas analysis was##4##3##(1996-7#1)(2008-10#2)(2011-2#1)
gas analysis##16##2##(1996-7#1)(1997-3#1)(2008-10#10)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
gas and a##2##3##(2007-12#1)(2008-2#1)
gas and liquid chromatography##2##4##(2008-10#1)(2011-2#1)
gas and liquid##4##3##(2008-10#2)(2008-6#1)(2011-2#1)
gas and the##4##3##(1992-2#1)(2008-10#1)(2008-3#1)(2012-3#1)
gas and##20##2##(1992-2#1)(1994-7#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#2)(2011-2#2)(2012-2#1)(2012-3#1)
gas are##2##2##(2008-10#1)(2012-2#1)
gas at##3##2##(2008-10#2)(2008-2#1)
gas ballooning##2##2##(2008-11#2)
gas bubble##2##2##(1993-5#1)(2008-10#1)
gas bubbles##2##2##(2008-11#1)(2012-2#1)
gas by##6##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
gas cell and##2##3##(2008-10#1)(2008-3#1)
gas cell measurements##3##3##(2008-3#3)
gas cell of##2##3##(2008-10#2)
gas cell##14##2##(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#5)
gas chambers##2##2##(2011-2#2)
gas chromatograph coupled##2##3##(2008-10#2)
gas chromatograph##10##2##(2008-10#7)(2008-11#1)(2011-1#1)(2012-1#1)
gas chromatograph-mass spectrometer##3##3##(2008-10#3)
gas chromatographic (GC) analysis##2##4##(2008-10#1)(2010-5#1)
gas chromatographic (GC) method was##2##5##(2011-1#1)(2012-2#1)
gas chromatographic (GC)##5##3##(2008-10#2)(2010-5#1)(2011-1#1)(2012-2#1)
gas chromatographic analysis of##2##4##(2008-10#2)
gas chromatographic analysis##4##3##(1990-7#1)(2008-10#2)(2010-5#1)
gas chromatographic method##4##3##(1996-12#1)(2008-10#3)
gas chromatographic retention indices of##2##5##(2008-10#2)
gas chromatographic retention indices##3##4##(2008-10#3)
gas chromatographic retention##4##3##(2008-10#4)
gas chromatographic##28##2##(1990-7#1)(1996-12#1)(2008-10#21)(2008-5#1)(2010-5#2)(2011-1#1)(2012-2#1)
gas chromatography (GC) and##2##4##(1993-12#1)(2008-10#1)
gas chromatography (GC) coupled##2##4##(2008-10#2)
gas chromatography (GC) for##2##4##(1994-9#1)(2008-10#1)
gas chromatography (GC) with##3##4##(2008-10#3)
gas chromatography (GC) without##2##4##(2008-10#1)(2008-5#1)
gas chromatography (GC)##23##3##(1993-12#1)(1994-9#1)(2008-10#18)(2008-12#1)(2008-5#1)(2011-1#1)
gas chromatography and##8##3##(1995-2#1)(2008-10#7)
gas chromatography combined with##3##4##(2008-10#2)(2008-11#1)
gas chromatography coupled to mass spectrometry##2##6##(2008-10#2)
gas chromatography coupled to##3##4##(2008-10#3)
gas chromatography coupled with##3##4##(2008-10#2)(2008-5#1)
gas chromatography coupled##6##3##(2008-10#5)(2008-5#1)
gas chromatography in the##2##4##(1994-9#1)(2012-2#1)
gas chromatography in##4##3##(1994-5#1)(1994-9#1)(2008-10#1)(2012-2#1)
gas chromatography mass spectrometry##2##4##(2008-10#2)
gas chromatography mass##3##3##(2008-10#2)(2013-1#1)
gas chromatography of##2##3##(2008-5#1)(2008-7#1)
gas chromatography on##3##3##(1991-12#1)(2008-10#1)(2010-4#1)
gas chromatography using a##2##4##(2008-10#1)(2009-8#1)
gas chromatography using##8##3##(2008-10#7)(2009-8#1)
gas chromatography with an electron capture detector##2##7##(2008-10#2)
gas chromatography with electron capture detection (GC-ECD)##2##7##(2008-10#2)
gas chromatography with electron capture detection##3##6##(2008-10#3)
gas chromatography with electron##5##4##(2008-10#5)
gas chromatography with##21##3##(1997-6#1)(2008-10#19)(2008-5#1)
gas chromatography##126##2##(1990-8#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-2#2)(1997-6#1)(2007-12#1)(2008-10#93)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-8#3)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
gas chromatography-Fourier transform infrared spectroscopy##2##5##(2008-10#2)
gas chromatography-electron capture detector (GC-ECD)##2##5##(2008-10#1)(2011-1#1)
gas chromatography-electron capture##3##3##(2008-10#2)(2011-1#1)
gas chromatography-high resolution mass spectrometry (GC-HRMS)##2##6##(2008-10#2)
gas chromatography-high resolution mass spectrometry##4##5##(2008-10#4)
gas chromatography-ion trap-mass##2##3##(2008-10#2)
gas chromatography-ion##3##2##(2008-10#3)
gas chromatography-mass spectrometry (GC-MS) and##3##5##(1990-5#1)(2008-10#1)(2012-1#1)
gas chromatography-mass spectrometry (GC-MS) has been##2##6##(2008-10#1)(2008-5#1)
gas chromatography-mass spectrometry (GC-MS)##23##4##(1990-5#1)(1992-5#1)(1993-12#1)(1995-2#1)(2008-10#16)(2008-5#1)(2012-1#2)
gas chromatography-mass spectrometry (GC/MS)##2##4##(2008-10#2)
gas chromatography-mass spectrometry in##2##4##(1992-3#1)(2008-10#1)
gas chromatography-mass spectrometry method##2##4##(2007-10#1)(2011-1#1)
gas chromatography-mass spectrometry##56##3##(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(2007-10#1)(2008-10#33)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2013-8#1)
gas chromatography-mass spectrometry]##2##3##(2011-1#2)
gas chromatography-mass spectrum##2##3##(2008-10#2)
gas chromatography-mass##62##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(2007-10#1)(2008-10#37)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-12#1)(2013-8#1)
gas chromatography/mass spectrometry (GC/MS)##4##4##(1995-11#1)(2008-10#2)(2013-1#1)
gas chromatography/mass spectrometry##6##3##(1995-11#1)(2008-10#4)(2013-1#1)
gas chromatography/mass##7##2##(1995-11#1)(2008-10#5)(2013-1#1)
gas chromatography]##4##2##(2011-1#3)(2012-2#1)
gas composition##2##2##(2008-2#1)(2009-11#1)
gas concentration##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
gas concentrations##6##2##(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#2)
gas density##3##2##(1992-12#1)(2008-3#2)
gas detection##9##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)(2013-8#3)
gas diffusion unit##2##3##(2008-10#2)
gas diffusion##7##2##(1992-5#1)(2008-10#6)
gas diffusion-flow injection##4##3##(2008-10#4)
gas during the##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
gas embolism##3##2##(1991-11#1)(2012-2#2)
gas exchange in##2##3##(2010-4#1)(2012-5#1)
gas exchange is##2##3##(1997-1#1)(2007-12#1)
gas exchange patterns##3##3##(2010-4#3)
gas exchange##27##2##(1991-9#1)(1994-11#1)(1994-5#1)(1997-1#3)(2007-12#3)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#6)(2012-3#2)(2012-5#1)
gas exposures##2##2##(1996-12#2)
gas filter##2##2##(2007-12#2)
gas flow rate and##2##4##(2008-10#1)(2013-8#1)
gas flow rate of##5##4##(2008-10#3)(2008-6#1)(2013-8#1)
gas flow rate##19##3##(2008-10#13)(2008-6#1)(2009-11#1)(2013-8#4)
gas flow rates##5##3##(2008-10#5)
gas flow to##2##3##(2011-2#2)
gas flow##38##2##(2008-10#24)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#2)(2011-2#3)(2012-1#2)(2013-8#4)
gas flows##2##2##(2008-2#1)(2008-3#1)
gas formation##2##2##(2008-8#1)(2010-6#1)
gas from##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
gas gangrene##7##2##(2007-7#2)(2011-2#2)(2013-1#3)
gas in the##4##3##(2008-10#2)(2012-12#1)(2012-2#1)
gas in##13##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2010-12#1)(2012-12#2)(2012-2#1)
gas is passed##2##3##(2008-10#2)
gas is##6##2##(2008-10#5)(2008-3#1)
gas jet##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
gas leaks##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
gas mixture##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
gas mixtures containing##2##3##(2008-2#1)(2008-3#1)
gas mixtures##11##2##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)
gas monitoring##2##2##(1990-8#1)(2008-3#1)
gas on the##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
gas or##4##2##(2008-10#2)(2008-3#1)(2008-4#1)
gas permeable membrane##3##3##(2008-10#3)
gas permeable##4##2##(2008-10#3)(2012-12#1)
gas phase and particulates##3##4##(2008-10#3)
gas phase and##5##3##(2008-10#4)(2008-7#1)
gas phase molecular absorption spectrometry##8##5##(2008-10#8)
gas phase molecular absorption##11##4##(2008-10#11)
gas phase##41##2##(1990-8#1)(1992-11#1)(1992-9#1)(1993-3#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-7#1)
gas pressure is##2##3##(2008-10#1)(2008-3#1)
gas pressure##10##2##(1995-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)
gas puff target##3##3##(2007-12#3)
gas recirculation##2##2##(2008-3#1)(2008-6#1)
gas sample##2##2##(2008-10#1)(2008-11#1)
gas sampling##3##2##(1990-8#1)(2012-2#2)
gas sensing##5##2##(2007-12#2)(2008-10#1)(2008-2#2)
gas sensor is##2##3##(2008-10#1)(2008-2#1)
gas sensor##14##2##(2008-10#7)(2008-2#2)(2008-3#5)
gas sensors with a##2##4##(2008-3#2)
gas sensors with##3##3##(2008-10#1)(2008-3#2)
gas sensors##8##2##(2008-10#4)(2008-11#1)(2008-3#3)
gas shielding##3##2##(2008-3#3)
gas temperature##8##2##(2008-2#3)(2008-3#5)
gas temperatures##2##2##(2008-2#2)
gas that##3##2##(2008-2#1)(2011-2#1)(2012-2#1)
gas to##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
gas using##3##2##(2008-10#3)
gas vesicles##5##2##(2008-11#5)
gas was##10##2##(2008-10#6)(2008-2#2)(2008-3#2)
gas with##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
gas##849##1##(1990-5#4)(1990-7#2)(1990-8#5)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#4)(1994-7#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-9#3)(1996-12#13)(1996-2#2)(1996-7#2)(1997-1#5)(1997-2#2)(1997-3#3)(1997-6#4)(1997-7#2)(2007-10#1)(2007-11#7)(2007-12#34)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#401)(2008-11#28)(2008-12#3)(2008-2#43)(2008-3#72)(2008-4#1)(2008-5#9)(2008-6#12)(2008-7#12)(2008-8#3)(2008-9#4)(2009-11#3)(2009-12#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#12)(2011-2#27)(2012-1#6)(2012-12#8)(2012-2#20)(2012-3#4)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#9)
gas-chromatographic analysis of##2##3##(1990-8#1)(2008-10#1)
gas-chromatographic##4##1##(1990-8#1)(2008-10#3)
gas-chromatography##2##1##(1994-6#1)(2008-10#1)
gas-chromatography/mass spectrometry##2##2##(1992-3#1)(2008-4#1)
gas-diffusion (GD)##3##2##(2008-10#3)
gas-diffusion separation##2##2##(2008-10#2)
gas-diffusion##9##1##(2008-10#8)(2010-4#1)
gas-exchange##3##1##(2007-12#1)(2008-10#2)
gas-filled##4##1##(2007-11#3)(2008-3#1)
gas-insulated high-voltage switchgear##2##3##(2008-3#2)
gas-lift reactors##2##2##(2008-7#2)
gas-like##3##1##(2012-2#3)
gas-liquid chromatography##3##2##(1990-2#1)(2008-10#2)
gas-liquid separator and then is swept into a##2##8##(2008-10#2)
gas-liquid separator and##4##3##(2008-10#4)
gas-liquid separator##10##2##(2008-10#10)
gas-liquid##18##1##(1990-2#1)(2008-10#16)(2008-6#1)
gas-mass spectrometry at##2##3##(2008-5#2)
gas-permeable membrane##2##2##(2008-10#2)
gas-permeable##5##1##(2008-10#4)(2008-7#1)
gas-permeation flow-injection##2##2##(2008-10#2)
gas-permeation##3##1##(2008-10#3)
gas-phase sequencing##2##2##(1992-6#1)(1992-8#1)
gas-phase temperatures in flames##2##4##(2008-3#2)
gas-phase##18##1##(1992-6#1)(1992-8#1)(1994-5#1)(2007-12#2)(2008-10#4)(2008-3#5)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#1)
gas-puff target##2##2##(2007-11#2)
gas-related emergencies##2##2##(2011-2#2)
gas-sensing##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
gas/liquid##2##1##(2008-10#2)
gas/solid##2##1##(2008-7#2)
gaseous K(+)##2##2##(2011-1#2)
gaseous SbH(3)##2##2##(2008-10#2)
gaseous mixtures##2##2##(2008-10#2)
gaseous nitric oxide##2##3##(2008-10#2)
gaseous phase is measured at##2##5##(2008-10#2)
gaseous phase is##4##3##(2008-10#4)
gaseous phase##5##2##(2008-10#5)
gaseous pollutants##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
gaseous sample##3##2##(2008-10#3)
gaseous samples##5##2##(2008-10#5)
gaseous selenium in the atmosphere##2##5##(2008-10#2)
gaseous selenium in##3##3##(2008-10#3)
gaseous selenium##4##2##(2008-10#4)
gaseous species##3##2##(2008-10#3)
gaseous##64##1##(1991-9#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#53)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#2)(2012-2#1)
gases and##10##2##(1991-4#1)(1993-2#1)(1996-12#2)(1996-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
gases are##3##2##(1992-3#1)(1996-12#1)(2008-11#1)
gases at##2##2##(1996-1#1)(2008-2#1)
gases by use of a##2##5##(2007-12#1)(2008-2#1)
gases by use of##3##4##(2007-12#1)(2008-2#2)
gases by##4##2##(2007-12#1)(2008-2#3)
gases can be##2##3##(1996-12#1)(2008-10#1)
gases carbon##2##2##(1992-3#1)(1996-12#1)
gases in a##2##3##(2008-10#1)(2008-3#1)
gases in##5##2##(1996-12#1)(2008-10#1)(2008-3#3)
gases is##2##2##(2008-2#1)(2008-3#1)
gases of a##2##3##(2008-2#2)
gases of##3##2##(2008-2#3)
gases such as##5##3##(1992-3#1)(1997-1#1)(2008-10#2)(2009-12#1)
gases that##3##2##(1996-12#1)(2008-3#2)
gases through##2##2##(1993-11#1)(1996-12#1)
gases with##5##2##(1996-12#1)(2008-2#3)(2008-3#1)
gases##117##1##(1991-4#2)(1991-5#1)(1991-6#1)(1992-3#3)(1993-11#1)(1993-2#1)(1993-3#2)(1995-8#1)(1996-1#1)(1996-12#17)(1996-5#1)(1997-1#6)(2007-11#1)(2007-12#6)(2008-10#19)(2008-11#3)(2008-2#21)(2008-3#20)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
gasoline in##3##2##(1997-4#1)(2008-10#2)
gasoline##22##1##(1992-3#4)(1994-3#1)(1997-4#1)(2008-10#14)(2008-2#1)(2008-3#1)
gastrectomy (PPG)##2##2##(2008-12#2)
gastrectomy for##2##2##(2007-4#1)(2011-2#1)
gastrectomy to##2##2##(1990-9#1)(2013-1#1)
gastrectomy##16##1##(1990-6#1)(1990-9#1)(1991-6#1)(1992-9#1)(1993-2#1)(2007-4#1)(2008-12#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#4)
gastric Hodgkin's disease##2##3##(1992-8#2)
gastric MALT lymphoma##2##3##(1997-1#2)
gastric MALT##3##2##(1997-1#3)
gastric T cell lymphoma##3##4##(2009-8#3)
gastric acid secretion and##2##4##(1992-6#1)(1997-1#1)
gastric acid secretion##9##3##(1992-6#2)(1993-12#1)(1994-2#1)(1997-1#4)(1997-6#1)
gastric acid##11##2##(1992-6#2)(1993-12#1)(1993-3#1)(1994-2#1)(1996-11#1)(1997-1#4)(1997-6#1)
gastric adenocarcinoma MGC803 cell##2##4##(2008-9#2)
gastric adenocarcinoma and##3##3##(1990-2#1)(2008-1#1)(2008-12#1)
gastric adenocarcinoma##9##2##(1990-2#1)(1992-2#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-9#3)
gastric adenomas##3##2##(2009-3#1)(2013-8#2)
gastric and duodenal ulcers##3##4##(1995-2#1)(2006-10#1)(2008-12#1)
gastric and##7##2##(1990-7#1)(1992-5#1)(1995-2#1)(2006-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
gastric antrum##2##2##(2008-5#1)(2011-2#1)
gastric banding##4##2##(2012-12#4)
gastric body##3##2##(1997-1#1)(2009-3#2)
gastric bypass surgery##2##3##(2012-2#1)(2012-5#1)
gastric bypass##11##2##(2010-8#3)(2012-2#1)(2012-5#2)(2013-1#5)
gastric cancer and gastric##2##4##(2009-3#1)(2011-1#1)
gastric cancer and##4##3##(2009-3#1)(2011-1#1)(2011-2#2)
gastric cancer cell line##3##4##(2008-11#1)(2008-9#2)
gastric cancer cell lines##2##4##(1992-8#1)(2008-11#1)
gastric cancer cell##6##3##(1992-8#1)(2008-11#2)(2008-9#3)
gastric cancer cells##5##3##(1992-8#1)(2008-11#3)(2008-9#1)
gastric cancer in the##2##4##(2008-12#1)(2011-2#1)
gastric cancer in##9##3##(2008-1#1)(2008-12#4)(2010-12#1)(2011-2#2)(2012-3#1)
gastric cancer is##2##3##(1990-9#1)(1992-8#1)
gastric cancer patients##3##3##(1993-12#1)(2011-2#2)
gastric cancer was##2##3##(2010-12#1)(2011-2#1)
gastric cancer were##3##3##(1990-2#1)(1991-4#1)(2011-2#1)
gastric cancer##72##2##(1990-2#3)(1990-8#1)(1990-9#5)(1991-4#2)(1992-12#1)(1992-8#4)(1992-9#1)(1993-12#2)(1996-5#1)(1997-1#3)(1997-3#1)(2007-11#1)(2008-1#3)(2008-11#5)(2008-12#10)(2008-5#1)(2008-9#4)(2009-3#1)(2010-12#7)(2011-1#1)(2011-2#13)(2012-3#2)
gastric cancer]##4##2##(1990-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
gastric cancers##2##2##(1992-8#1)(2011-2#1)
gastric candidiasis##2##2##(2008-5#2)
gastric carcinoma cell line##3##4##(1992-8#2)(2008-9#1)
gastric carcinoma##19##2##(1991-4#1)(1992-8#2)(1992-9#1)(1994-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-9#2)(2010-12#1)(2011-2#6)(2012-2#2)
gastric contents##4##2##(1992-12#3)(1993-10#1)
gastric diseases##2##2##(1990-9#1)(2011-2#1)
gastric distension##2##2##(2010-12#2)
gastric distention in##2##3##(1997-1#1)(2012-3#1)
gastric electrical##2##2##(2012-3#2)
gastric emptying and intestinal transit##5##5##(2013-1#5)
gastric emptying rate of saline##2##5##(1997-4#2)
gastric emptying rate of##3##4##(1997-4#3)
gastric emptying##20##2##(1990-12#1)(1993-10#1)(1994-2#1)(1994-3#1)(1997-4#6)(2008-3#1)(2012-2#3)(2013-1#6)
gastric epithelial##2##2##(1995-6#1)(2009-3#1)
gastric events##3##2##(2008-11#3)
gastric function##4##2##(1992-6#3)(1997-4#1)
gastric glands contained##2##3##(1990-9#1)(1995-11#1)
gastric glands##5##2##(1990-9#1)(1995-11#1)(1995-12#2)(2009-8#1)
gastric glomus tumors##5##3##(2013-1#5)
gastric inhibitory peptide##2##3##(2008-11#2)
gastric inhibitory##3##2##(1997-4#1)(2008-11#2)
gastric juice and feces##4##4##(1993-2#4)
gastric juice##9##2##(1993-2#4)(2008-10#5)
gastric lavage##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
gastric lesions##5##2##(1997-7#2)(2008-11#1)(2013-8#2)
gastric lymphoma##6##2##(2008-12#2)(2009-5#1)(2011-1#1)(2013-1#2)
gastric marginal zone##2##3##(2009-8#2)
gastric mill##3##2##(1995-11#3)
gastric mucosa of##2##3##(1994-2#1)(2013-8#1)
gastric mucosa##16##2##(1990-2#1)(1990-3#1)(1994-2#5)(1996-3#1)(1997-1#1)(1997-7#2)(2008-1#1)(2013-8#4)
gastric mucosal integrity##2##3##(1997-7#1)(2013-8#1)
gastric mucosal##13##2##(1992-6#1)(1993-11#1)(1995-12#3)(1997-1#2)(1997-7#1)(2012-2#1)(2012-3#3)(2013-8#1)
gastric neoplasm##3##2##(1992-9#1)(2013-1#2)
gastric neuroendocrine tumor is##3##4##(1997-1#3)
gastric neuroendocrine tumor##6##3##(1997-1#6)
gastric neuroendocrine##7##2##(1997-1#7)
gastric outlet obstruction##6##3##(2008-12#2)(2012-2#3)(2013-1#1)
gastric pH##2##2##(1993-12#1)(2011-2#1)
gastric pain##2##2##(1990-6#2)
gastric parietal cell##2##3##(1995-11#1)(1997-1#1)
gastric parietal cells##3##3##(1992-3#1)(1997-1#2)
gastric parietal##5##2##(1992-3#1)(1995-11#1)(1997-1#3)
gastric pull-up##2##2##(2007-8#2)
gastric resection##4##2##(1991-6#3)(2012-3#1)
gastric stump cancer##2##3##(1992-9#2)
gastric stump##3##2##(1991-6#1)(1992-9#2)
gastric surgery for cancer##2##4##(2007-4#2)
gastric trichobezoar in a young female##2##6##(2008-12#2)
gastric tube and##2##3##(1991-11#1)(1991-6#1)
gastric tube placement##3##3##(2010-7#3)
gastric tube##7##2##(1991-11#1)(1991-6#1)(2010-7#3)(2011-2#1)(2012-1#1)
gastric tumors##2##2##(1991-6#1)(1992-9#1)
gastric ulcer =##2##3##(2008-5#2)
gastric ulcer and##3##3##(1992-11#2)(2011-2#1)
gastric ulcer##17##2##(1990-3#2)(1992-11#2)(1992-6#1)(2007-11#1)(2008-11#2)(2008-12#3)(2008-5#3)(2011-2#2)(2012-12#1)
gastric ulcers##8##2##(1990-3#1)(1992-11#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2012-2#1)
gastric varices##3##2##(2013-1#3)
gastric wall##4##2##(1992-9#2)(2009-8#1)(2010-12#1)
gastric##447##1##(1990-12#1)(1990-2#8)(1990-3#4)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#10)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#9)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#12)(1992-8#13)(1992-9#10)(1993-10#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#7)(1994-3#1)(1994-8#4)(1995-11#6)(1995-12#6)(1995-2#3)(1995-6#3)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#2)(1997-1#31)(1997-3#1)(1997-4#9)(1997-6#1)(1997-7#5)(2006-10#3)(2007-10#1)(2007-11#2)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#5)(2008-11#19)(2008-12#30)(2008-3#1)(2008-5#9)(2008-9#9)(2009-3#6)(2009-5#1)(2009-8#8)(2010-12#11)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#33)(2012-1#3)(2012-12#9)(2012-2#15)(2012-3#13)(2012-5#2)(2013-1#33)(2013-8#16)
gastrin mRNA was##3##3##(1990-7#2)(1992-8#1)
gastrin mRNA##6##2##(1990-7#3)(1992-8#3)
gastrin on##5##2##(1992-3#2)(1994-8#3)
gastrin##31##1##(1990-7#4)(1992-3#5)(1992-8#5)(1994-6#1)(1994-8#6)(1997-1#7)(2008-1#1)(2010-6#1)(2011-2#1)
gastrin-releasing peptide##2##2##(1992-6#2)
gastrin-releasing##4##1##(1992-6#2)(1997-1#2)
gastrin/CCK-B receptor##3##2##(1994-6#3)
gastrin/CCK-B##4##1##(1994-6#4)
gastrinoma##3##1##(1991-6#3)
gastrinomas##2##1##(1997-8#1)(2008-2#1)
gastritis are##2##2##(1997-1#2)
gastritis in##4##2##(2007-2#1)(2008-12#1)(2008-5#2)
gastritis is##3##2##(1990-11#2)(2008-12#1)
gastritis or##2##2##(1993-12#1)(1994-2#1)
gastritis was##3##2##(2008-5#3)
gastritis##41##1##(1990-11#2)(1992-5#1)(1993-12#1)(1994-2#1)(1996-6#1)(1997-1#7)(1997-8#2)(2007-2#1)(2008-1#2)(2008-12#4)(2008-5#12)(2008-7#1)(2009-10#1)(2009-8#2)(2010-12#1)(2012-12#2)
gastritis/duodenitis##2##1##(2008-11#2)
gastro intestinal bleeding##2##3##(2007-8#2)
gastro intestinal##3##2##(2007-8#3)
gastro-esophageal reflux##2##2##(1992-11#1)(2009-3#1)
gastro-esophageal##3##1##(1992-11#1)(2009-3#1)(2011-3#1)
gastro-intestinal tract##4##2##(1991-4#1)(1994-2#1)(2008-10#1)(2010-8#1)
gastro-intestinal##11##1##(1991-4#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-8#1)(2011-2#1)
gastro-oesophageal reflux##6##2##(1990-12#1)(1995-10#1)(1996-3#3)(1997-5#1)
gastro-oesophageal##8##1##(1990-12#1)(1995-10#1)(1996-3#3)(1997-5#1)(2007-8#1)(2009-8#1)
gastrocnemius and##2##2##(1993-3#1)(1995-2#1)
gastrocnemius muscle##4##2##(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
gastrocnemius muscles##2##2##(2007-11#1)(2008-3#1)
gastrocnemius tissues##3##2##(2013-1#3)
gastrocnemius were##2##2##(1997-2#1)(2013-1#1)
gastrocnemius##20##1##(1993-12#1)(1993-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#1)
gastroduodenal artery##2##2##(2008-12#1)(2008-7#1)
gastroduodenal diseases##2##2##(2011-1#1)(2012-12#1)
gastroduodenal mucosal##2##2##(1997-1#2)
gastroduodenal peptic##2##2##(1990-5#2)
gastroduodenal ulcer##8##2##(1992-5#1)(1992-6#1)(1993-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
gastroduodenal##22##1##(1990-5#3)(1992-5#1)(1992-6#1)(1993-6#1)(1997-1#3)(1997-4#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
gastroenteric##4##1##(1990-10#1)(1991-8#2)(2011-2#1)
gastroenteritis and##2##2##(1990-6#1)(1991-3#1)
gastroenteritis in##2##2##(2009-3#1)(2011-1#1)
gastroenteritis##24##1##(1990-6#2)(1991-3#1)(1996-2#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-7#3)(2009-12#1)(2009-3#2)(2009-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#4)
gastroenterologic##2##1##(1990-2#1)(1992-4#1)
gastroenterological##3##1##(1992-4#1)(1995-6#1)(2012-2#1)
gastroenterologist##3##1##(2008-9#1)(2010-6#1)(2011-2#1)
gastroenterologists and##2##2##(1992-4#1)(2008-12#1)
gastroenterologists are##2##2##(1990-11#1)(1990-2#1)
gastroenterologists##8##1##(1990-11#1)(1990-2#2)(1992-4#1)(2008-12#2)(2008-9#1)(2013-1#1)
gastroenterology and##3##2##(1995-6#1)(2010-12#1)(2012-2#1)
gastroenterology##10##1##(1990-2#1)(1993-12#1)(1994-3#1)(1995-6#2)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
gastroenteropancreatic neuroendocrine tumors##4##3##(2010-9#2)(2011-2#2)
gastroenteropancreatic neuroendocrine##6##2##(2010-9#4)(2011-2#2)
gastroesophageal adverse effects##2##3##(2008-11#2)
gastroesophageal problems##2##2##(2008-11#2)
gastroesophageal reflux disease (GERD)##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
gastroesophageal reflux disease in##3##4##(2009-1#1)(2011-2#1)(2013-8#1)
gastroesophageal reflux disease##12##3##(2008-3#1)(2008-8#1)(2009-1#1)(2009-11#1)(2011-2#1)(2013-1#3)(2013-8#4)
gastroesophageal reflux##21##2##(1992-11#1)(1992-3#2)(1996-3#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-11#1)(2011-2#1)(2013-1#5)(2013-8#7)
gastroesophageal##28##1##(1992-11#1)(1992-3#2)(1996-3#1)(2008-11#5)(2008-3#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2011-2#1)(2013-1#6)(2013-8#7)
gastrointestinal (GI) bleeding##2##3##(2008-7#1)(2012-2#1)
gastrointestinal (GI) function##2##3##(1991-2#1)(2013-1#1)
gastrointestinal (GI) tract##2##3##(2012-1#1)(2012-12#1)
gastrointestinal (GI)##12##2##(1991-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
gastrointestinal and##7##2##(1992-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-5#1)
gastrointestinal bleeding and##2##3##(2008-11#1)(2013-8#1)
gastrointestinal bleeding in a##2##4##(2010-2#1)(2013-1#1)
gastrointestinal bleeding in patients##2##4##(2006-10#1)(2012-3#1)
gastrointestinal bleeding in##8##3##(1995-9#1)(2006-10#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
gastrointestinal bleeding is##4##3##(2006-10#2)(2011-2#1)(2012-2#1)
gastrointestinal bleeding##36##2##(1995-11#1)(1995-9#1)(2006-10#5)(2008-11#1)(2009-8#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#3)
gastrointestinal blood##2##2##(1992-2#1)(1992-6#1)
gastrointestinal cancer##7##2##(1990-8#1)(1990-9#2)(1991-12#1)(1995-8#1)(2011-2#1)(2012-3#1)
gastrointestinal cancers##3##2##(2008-11#1)(2009-3#1)(2011-1#1)
gastrointestinal complaints##2##2##(2007-12#1)(2008-8#1)
gastrointestinal complications##2##2##(2006-10#1)(2011-2#1)
gastrointestinal contrast##3##2##(2009-4#2)(2011-2#1)
gastrointestinal damage##2##2##(2008-11#1)(2008-5#1)
gastrointestinal disease##2##2##(1993-8#1)(2008-7#1)
gastrointestinal disorders##11##2##(1990-8#1)(1991-3#1)(1993-2#1)(1996-6#1)(2007-2#2)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
gastrointestinal endoscopy##10##2##(1995-10#2)(1996-3#1)(2008-1#1)(2008-5#2)(2010-4#1)(2011-2#2)(2012-2#1)
gastrointestinal events##5##2##(2006-10#1)(2008-11#3)(2011-1#1)
gastrointestinal haemorrhage and##2##3##(2011-2#1)(2013-1#1)
gastrointestinal haemorrhage##6##2##(1990-9#2)(1991-8#1)(1997-8#1)(2011-2#1)(2013-1#1)
gastrointestinal injury in##2##3##(2006-10#2)
gastrointestinal involvement##2##2##(2007-2#1)(2013-1#1)
gastrointestinal lesions##2##2##(2012-12#1)(2012-2#1)
gastrointestinal localization##2##2##(1997-3#1)(2007-7#1)
gastrointestinal malignancies##2##2##(2008-2#1)(2010-5#1)
gastrointestinal motility##2##2##(1992-8#1)(1993-3#1)
gastrointestinal mucosa##4##2##(1996-3#1)(2008-4#1)(2009-12#1)(2012-1#1)
gastrointestinal obstruction##2##2##(1992-5#1)(2008-7#1)
gastrointestinal or##2##2##(1997-3#1)(2012-1#1)
gastrointestinal parasites##3##2##(2011-1#2)(2013-1#1)
gastrointestinal side effects##2##3##(1990-2#1)(1991-6#1)
gastrointestinal side-effects##2##2##(1994-12#1)(2008-8#1)
gastrointestinal stromal tumor##4##3##(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
gastrointestinal stromal tumors##4##3##(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
gastrointestinal stromal tumours (GISTs)##2##4##(2008-6#1)(2013-7#1)
gastrointestinal stromal##11##2##(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
gastrointestinal symptoms##8##2##(1993-12#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-1#1)
gastrointestinal system##3##2##(2007-8#1)(2008-11#1)(2012-2#1)
gastrointestinal tissues##2##2##(1995-11#1)(2011-1#1)
gastrointestinal tract and##5##3##(1994-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)
gastrointestinal tract are##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
gastrointestinal tract of##6##3##(2011-2#2)(2012-2#1)(2013-1#3)
gastrointestinal tract##80##2##(1990-11#2)(1990-8#1)(1991-12#2)(1991-6#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-4#1)(1997-8#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#1)(2011-1#4)(2011-2#6)(2012-1#6)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#3)
gastrointestinal tract]##2##2##(1995-6#1)(2013-7#1)
gastrointestinal tracts in##2##3##(2009-4#1)(2013-1#1)
gastrointestinal tracts##4##2##(2008-11#1)(2009-4#1)(2013-1#2)
gastrointestinal troubles##2##2##(2011-1#2)
gastrointestinal tumors##5##2##(1990-6#2)(1991-3#1)(1992-8#1)(2011-1#1)
gastrointestinal##341##1##(1990-11#2)(1990-2#3)(1990-6#3)(1990-8#3)(1990-9#4)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-5#1)(1995-10#3)(1995-11#4)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#3)(1996-3#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#4)(1997-4#1)(1997-8#5)(2006-10#10)(2007-12#2)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#16)(2008-8#6)(2008-9#4)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#14)(2011-2#33)(2012-1#10)(2012-12#5)(2012-2#18)(2012-3#13)(2013-1#31)(2013-7#4)(2013-8#8)
gastropathy##4##1##(1991-11#1)(1991-8#1)(1992-2#1)(1997-1#1)
gastropod##5##1##(2008-10#2)(2008-12#2)(2008-6#1)
gastropods##5##1##(2008-12#1)(2008-9#1)(2011-2#2)(2013-7#1)
gastroretentive##2##1##(2012-2#2)
gastrorrhaphy##2##1##(2009-8#2)
gastroschisis and congenital diaphragmatic hernia##2##5##(2008-11#2)
gastroschisis##4##1##(1997-3#2)(2008-11#2)
gastroscopy##5##1##(1990-3#1)(1990-9#1)(1991-6#1)(2008-5#1)(2013-1#1)
gastrostomy and##2##2##(1992-5#1)(2008-12#1)
gastrostomy##5##1##(1992-5#2)(1996-3#1)(2007-10#1)(2008-12#1)
gastrovascular##4##1##(2009-8#1)(2010-2#3)
gastrula stage##3##2##(2008-5#2)(2010-5#1)
gastrula##6##1##(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#1)
gastrulation and##2##2##(2008-7#2)
gastrulation##7##1##(2008-7#7)
gate and##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
gate arrays##4##2##(2008-2#2)(2008-3#2)
gate field##3##2##(2009-11#3)
gate of a##2##3##(1991-5#1)(2009-5#1)
gate of##3##2##(1991-5#1)(2008-10#1)(2009-5#1)
gate voltage##3##2##(2008-7#2)(2009-5#1)
gate##54##1##(1991-5#3)(1995-1#1)(2007-11#5)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#10)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#4)(2009-3#1)(2009-5#3)(2009-6#1)(2012-2#3)(2012-3#1)(2013-7#1)
gated by##2##2##(1995-2#1)(2008-7#1)
gated gain amplification##2##3##(2007-11#2)
gated##20##1##(1991-2#1)(1993-12#1)(1995-2#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2012-2#2)
gatekeeper in##2##2##(1994-2#1)(1995-3#1)
gatekeeper##11##1##(1991-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(2008-12#3)(2008-8#1)(2009-10#1)(2012-12#1)(2013-8#1)
gatekeeper]##2##1##(1994-12#2)
gatekeepers to##2##2##(2009-4#1)(2012-2#1)
gatekeepers who##2##2##(1996-1#1)(2009-4#1)
gatekeepers##10##1##(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2009-4#2)(2009-6#1)(2012-2#1)(2013-8#2)
gatekeeping##7##1##(1992-3#1)(1995-11#1)(1995-3#1)(1997-3#2)(2008-12#1)(2012-1#1)
gates and##4##2##(2008-3#1)(2008-7#2)(2010-8#1)
gates are##3##2##(2008-3#2)(2008-7#1)
gates##29##1##(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#13)(2008-7#5)(2008-9#1)(2010-8#1)(2012-2#1)(2013-7#2)(2013-8#1)
gateway##2##1##(2008-4#1)(2013-8#1)
gather data##5##2##(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
gather in##2##2##(2007-11#1)(2008-7#1)
gather##30##1##(1990-3#1)(1991-1#1)(1992-12#1)(1992-2#1)(1996-2#2)(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#1)(2013-1#1)
gathered and analyzed##3##3##(1995-12#1)(1995-2#1)(2013-1#1)
gathered and##5##2##(1992-12#1)(1995-12#1)(1995-2#1)(2012-2#1)(2013-1#1)
gathered data##2##2##(1995-1#1)(2007-11#1)
gathered from##10##2##(1990-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-9#1)(2013-1#1)
gathered in the##3##3##(1997-4#1)(1997-5#1)(2008-10#1)
gathered in##7##2##(1994-3#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-7#1)
gathered information on##2##3##(1991-8#1)(2008-12#1)
gathered on##2##2##(2008-12#1)(2009-12#1)
gathered through a##2##3##(1997-8#1)(2011-2#1)
gathered through##5##2##(1992-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
gathered using##2##2##(1992-1#1)(2008-12#1)
gathered##57##1##(1990-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-9#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-4#1)(1997-5#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
gathering a##2##2##(2009-10#1)(2012-3#1)
gathering information##2##2##(1995-12#1)(2007-12#1)
gathering of##5##2##(1996-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
gathering##23##1##(1994-12#1)(1995-12#2)(1996-6#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
gathers##2##1##(1996-3#1)(1997-7#1)
gating and##4##2##(2007-11#1)(2008-8#2)(2008-9#1)
gating by##2##2##(1993-5#1)(2008-2#1)
gating in the##2##3##(2008-8#1)(2010-11#1)
gating in##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-8#2)(2010-11#1)(2011-1#1)
gating is##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
gating light##4##2##(2007-12#1)(2008-2#3)
gating mechanism##5##2##(1990-5#1)(1996-2#1)(2008-7#1)(2008-8#2)
gating modifier##5##2##(2010-12#5)
gating of a##4##3##(1997-2#2)(2007-12#2)
gating of the##2##3##(1993-3#1)(2008-4#1)
gating of##11##2##(1990-11#1)(1990-8#2)(1993-3#1)(1997-2#2)(2007-12#2)(2008-4#1)(2008-7#1)(2010-12#1)
gating properties##2##2##(1993-12#1)(2008-8#1)
gating ratio##2##2##(2008-2#2)
gating technology has##2##3##(2008-11#2)
gating technology##3##2##(2008-11#3)
gating with##2##2##(2007-11#1)(2008-7#1)
gating##117##1##(1990-11#3)(1990-5#1)(1990-8#2)(1993-12#1)(1993-3#1)(1993-5#2)(1996-2#2)(1997-2#3)(2007-11#12)(2007-12#23)(2008-1#1)(2008-11#3)(2008-2#12)(2008-3#7)(2008-4#2)(2008-7#7)(2008-8#15)(2008-9#11)(2009-11#1)(2010-11#1)(2010-12#6)(2011-1#1)
gating)##2##1##(2008-2#1)(2008-3#1)
gattii and##2##2##(2008-5#2)
gattii infection##2##2##(2008-10#1)(2008-5#1)
gattii isolates##2##2##(2008-5#2)
gattii##16##1##(2008-10#3)(2008-5#13)
gauche##5##1##(2007-12#2)(2008-8#2)(2013-1#1)
gauge blocks##3##2##(2008-3#3)
gauge of##2##2##(1996-3#1)(2008-5#1)
gauge the##6##2##(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#2)
gauge##24##1##(1992-8#1)(1996-12#1)(1996-3#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
gauged by##2##2##(2008-11#1)(2008-6#1)
gauging##2##1##(1995-12#1)(2007-11#1)
gaussian beam##7##2##(2008-2#3)(2008-3#4)
gaussian beams##3##2##(2008-2#1)(2008-3#2)
gaussian##12##1##(2008-2#6)(2008-3#6)
gauze##6##1##(2007-11#1)(2007-7#2)(2008-11#1)(2011-2#1)(2012-3#1)
gavage to##3##2##(2008-8#1)(2010-5#2)
gavage##23##1##(1992-12#1)(2008-10#6)(2008-8#1)(2008-9#10)(2010-1#1)(2010-5#2)(2011-2#1)(2013-8#1)
gave (2R##2##2##(1996-5#2)
gave 1##2##2##(1995-3#1)(1996-5#1)
gave a better##3##3##(2008-10#2)(2008-5#1)
gave a good##3##3##(2008-10#2)(2008-7#1)
gave a high##2##3##(1995-12#1)(2008-10#1)
gave a linear response##3##4##(2008-10#3)
gave a linear##6##3##(1992-11#2)(2008-10#4)
gave a mean absorbance of 0##6##6##(2008-10#6)
gave a mean##8##3##(2008-10#8)
gave a positive##6##3##(1993-9#1)(1997-7#1)(1997-8#1)(2008-10#2)(2010-4#1)
gave a relative##2##3##(1991-12#1)(2008-10#1)
gave a series of lectures##2##5##(1993-11#1)(2012-2#1)
gave a significant##2##3##(1996-6#1)(2008-10#1)
gave a significantly##2##3##(1991-2#1)(2008-7#1)
gave a similar##2##3##(1996-1#1)(2008-10#1)
gave a single band with##2##5##(1990-11#1)(1992-8#1)
gave a single##3##3##(1990-11#1)(1992-8#1)(1994-5#1)
gave a##84##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#2)(1997-8#2)(2007-11#1)(2008-10#36)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
gave acceptable##2##2##(1997-2#1)(2008-10#1)
gave accurate results##2##3##(2008-10#2)
gave an overall##3##3##(1990-9#1)(2008-10#1)(2008-12#1)
gave an##18##2##(1990-11#1)(1990-9#3)(1994-6#1)(1996-5#2)(2007-11#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-12#1)
gave average##2##2##(1994-8#1)(2008-10#1)
gave better results than##2##4##(2008-10#1)(2008-7#1)
gave better##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
gave birth to##5##3##(1996-5#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
gave birth##9##2##(1993-8#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#2)
gave comparable results##3##3##(2008-10#3)
gave complementary##2##2##(1994-12#1)(2008-10#1)
gave correlation coefficients##2##3##(1994-9#1)(2008-5#1)
gave epsilon##3##2##(1990-11#3)
gave evidence that##3##3##(2007-6#2)(2008-11#1)
gave evidence##4##2##(2007-6#2)(2008-11#1)(2008-5#1)
gave for##2##2##(1995-6#1)(2007-5#1)
gave good results in##2##4##(2008-10#1)(2008-6#1)
gave good results##5##3##(2008-10#4)(2008-6#1)
gave good##12##2##(2008-10#10)(2008-6#1)(2009-8#1)
gave greater rib##2##3##(2010-2#2)
gave higher C18##3##3##(2010-2#3)
gave higher##9##2##(1992-3#1)(1993-2#1)(2008-10#2)(2008-7#1)(2010-2#4)
gave lower##2##2##(2010-2#1)(2012-1#1)
gave more##6##2##(2008-10#5)(2010-5#1)
gave much##4##2##(2008-10#2)(2008-6#1)(2012-2#1)
gave negative results##2##3##(1991-6#1)(2008-8#1)
gave negative##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
gave no significant##2##3##(2008-10#1)(2008-12#1)
gave no##5##2##(1990-9#1)(1997-4#1)(2008-10#1)(2008-12#2)
gave positive results in##2##4##(1997-4#1)(2008-5#1)
gave positive##5##2##(1992-3#1)(1997-4#1)(2007-7#1)(2008-5#1)(2010-4#1)
gave quantitative##2##2##(2008-10#2)
gave reason##2##2##(2008-10#1)(2012-3#1)
gave recoveries##2##2##(2008-10#2)
gave relative##2##2##(2008-10#2)
gave results that compare favorably with those obtained by##2##9##(2008-10#2)
gave results that##3##3##(2008-10#3)
gave results##5##2##(2008-10#3)(2011-2#2)
gave rise to a##6##4##(1993-8#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-5#1)
gave rise to neurons##2##4##(2008-11#2)
gave rise to the##7##4##(1991-8#1)(1992-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-8#1)
gave rise to##36##3##(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
gave rise##38##2##(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
gave satisfactory results##5##3##(2008-10#3)(2008-11#1)(2013-1#1)
gave satisfactory##6##2##(2008-10#4)(2008-11#1)(2013-1#1)
gave significant##2##2##(1990-12#1)(2008-10#1)
gave significantly##3##2##(2008-10#2)(2008-12#1)
gave similar results##2##3##(1991-5#1)(1993-9#1)
gave similar##5##2##(1991-5#1)(1993-9#1)(2008-10#3)
gave some##3##2##(1997-5#1)(2007-12#1)(2008-10#1)
gave the best##6##3##(1995-3#1)(2007-12#1)(2008-10#3)(2008-9#1)
gave the corresponded##2##3##(2008-11#2)
gave the final ozonides##2##4##(1996-5#2)
gave the highest##9##3##(1993-2#1)(2008-10#2)(2008-12#2)(2009-2#1)(2011-2#1)(2013-1#2)
gave the most##5##3##(1993-3#1)(2007-8#1)(2008-10#2)(2011-2#1)
gave the same##3##3##(1994-3#2)(1997-2#1)
gave the##58##2##(1990-9#2)(1992-12#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-3#2)(1995-8#1)(1996-5#9)(1997-2#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#4)
gave them##2##2##(2008-8#1)(2012-3#1)
gave three##2##2##(1991-12#1)(2008-10#1)
gave to##2##2##(1996-5#1)(2013-1#1)
gave two##4##2##(1990-5#1)(1995-6#1)(1997-2#1)(2009-2#1)
gave very low##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
gave very##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
gave way to##2##3##(2008-9#1)(2010-3#1)
gave##441##1##(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#7)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#26)(1996-6#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2007-10#1)(2007-11#8)(2007-12#3)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#142)(2008-11#18)(2008-12#9)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#6)(2008-7#18)(2008-8#8)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#7)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#10)(2013-8#1)
gay and lesbian##2##3##(1995-6#1)(2010-8#1)
gay and##5##2##(1995-6#1)(1996-5#1)(2008-12#2)(2010-8#1)
gay bars##2##2##(1990-3#1)(2008-12#1)
gay men and##4##3##(1992-9#1)(1996-5#1)(2008-12#2)
gay men in the##2##4##(2008-10#2)
gay men##10##2##(1992-9#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-12#2)(2009-12#1)(2010-8#2)
gay##44##1##(1990-3#1)(1992-1#2)(1992-9#1)(1995-12#1)(1995-6#2)(1996-11#2)(1996-5#3)(1997-5#1)(2008-10#2)(2008-12#16)(2009-12#1)(2009-5#2)(2009-7#1)(2010-8#5)(2012-2#4)
gaze cues##4##2##(2008-11#1)(2010-10#3)
gaze directions were##2##3##(2008-11#2)
gaze in##2##2##(2007-4#1)(2008-11#1)
gaze palsy##6##2##(2007-10#6)
gaze shift##3##2##(2008-11#3)
gaze shifts##8##2##(2008-11#8)
gaze##56##1##(1990-11#1)(2007-10#8)(2007-4#7)(2007-8#1)(2008-11#28)(2008-6#2)(2010-10#5)(2011-2#1)(2012-12#1)(2013-8#2)
gaze-evoked nystagmus##2##2##(2008-7#2)
gcdA##2##1##(1994-12#2)
gdh##3##1##(1993-9#3)
gear and##2##2##(2008-8#1)(2011-2#1)
gear##9##1##(1990-12#1)(1995-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2011-2#1)
geared to##4##2##(1996-2#1)(2008-10#1)(2009-12#1)(2010-3#1)
geared toward##5##2##(1990-12#1)(1992-1#1)(2010-1#1)(2010-3#1)(2010-7#1)
geared towards##5##2##(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)
geared##15##1##(1990-12#1)(1992-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-12#1)
gears##2##1##(2008-3#1)(2013-7#1)
geckoides##3##1##(2010-3#3)
geckos##2##1##(2010-3#2)
gefitinib##6##1##(2008-5#1)(2010-8#2)(2012-1#2)(2013-1#1)
gel (2%##2##2##(2008-5#1)(2013-1#1)
gel (APSG)##2##2##(2008-10#2)
gel 3013-N##2##2##(1990-8#2)
gel analysis of the##2##4##(1991-2#1)(1993-9#1)
gel analysis of##3##3##(1991-2#1)(1991-9#1)(1993-9#1)
gel and electrophoresed##2##3##(2008-4#2)
gel and##35##2##(1996-12#1)(2006-8#1)(2007-7#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
gel as a##6##3##(2008-10#5)(2008-5#1)
gel as##11##2##(1997-2#1)(2008-10#9)(2008-5#1)
gel at pH##2##3##(1992-12#1)(2008-10#1)
gel at##3##2##(1992-12#1)(2008-10#1)(2008-4#1)
gel beads in##3##3##(2008-10#2)(2008-11#1)
gel beads##9##2##(2008-10#2)(2008-11#1)(2008-7#6)
gel by##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
gel can##2##2##(2008-10#1)(2008-4#1)
gel chemically##3##2##(2008-10#3)
gel chromatography##5##2##(1990-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(2009-12#1)
gel column and##2##3##(1990-8#1)(2008-10#1)
gel column##12##2##(1990-8#3)(1991-5#1)(1994-5#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-5#2)
gel containing##7##2##(1994-11#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-3#2)
gel electropherograms##2##2##(2008-4#1)(2008-6#1)
gel electrophoresis (2-DE)##2##3##(2008-7#1)(2011-3#1)
gel electrophoresis (DIGE)##3##3##(2008-2#2)(2008-4#1)
gel electrophoresis (PAGE)##4##3##(1990-11#1)(1995-12#1)(2008-5#1)(2010-3#1)
gel electrophoresis (PFGE)##6##3##(1992-6#1)(1993-12#2)(2008-10#2)(2008-11#1)
gel electrophoresis (SDS-PAGE)##6##3##(1991-5#1)(1992-12#1)(1994-2#1)(2008-1#1)(2008-8#1)(2012-2#1)
gel electrophoresis analysis of##2##4##(2008-10#1)(2011-2#1)
gel electrophoresis analysis##6##3##(2008-10#4)(2008-5#1)(2011-2#1)
gel electrophoresis and autoradiography##2##4##(1993-11#1)(2008-11#1)
gel electrophoresis and##18##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-6#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-4#3)(2008-8#1)(2012-3#1)(2013-1#1)
gel electrophoresis assay##4##3##(1996-2#2)(1997-4#2)
gel electrophoresis assays##3##3##(1997-4#2)(2008-10#1)
gel electrophoresis followed by##5##4##(1990-11#1)(1990-7#1)(1991-8#1)(1995-8#1)(2008-10#1)
gel electrophoresis for##5##3##(2008-10#2)(2008-2#1)(2008-4#2)
gel electrophoresis from##2##3##(1995-6#1)(2008-4#1)
gel electrophoresis in the##2##4##(1992-12#1)(1993-9#1)
gel electrophoresis in##4##3##(1992-12#1)(1992-3#1)(1993-9#1)(2008-11#1)
gel electrophoresis is##2##3##(2008-4#2)
gel electrophoresis of proteins##3##4##(1996-12#1)(2008-1#1)(2008-2#1)
gel electrophoresis of##18##3##(1990-5#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2010-8#1)(2011-2#1)
gel electrophoresis or##2##3##(2008-11#1)(2008-4#1)
gel electrophoresis showed that##5##4##(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)
gel electrophoresis showed##7##3##(1992-12#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)
gel electrophoresis technique##2##3##(1995-8#1)(2008-10#1)
gel electrophoresis to##3##3##(1991-5#1)(1997-3#1)(2010-12#1)
gel electrophoresis under##2##3##(1995-5#1)(2008-2#1)
gel electrophoresis was used to##3##5##(1994-6#1)(2008-8#1)(2012-3#1)
gel electrophoresis was used##4##4##(1994-6#1)(2008-8#1)(2012-3#2)
gel electrophoresis was##7##3##(1991-12#1)(1994-6#1)(2008-10#1)(2008-8#1)(2012-3#2)(2013-1#1)
gel electrophoresis with##2##3##(1991-12#1)(1992-8#1)
gel electrophoresis##219##2##(1990-10#2)(1990-11#4)(1990-5#3)(1990-7#3)(1991-12#5)(1991-2#1)(1991-5#4)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#4)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-12#4)(1996-2#2)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#7)(2007-6#1)(2008-1#5)(2008-10#47)(2008-11#10)(2008-12#1)(2008-2#9)(2008-3#1)(2008-4#16)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#4)
gel electrophoretic analysis##4##3##(1990-11#1)(1991-12#1)(2008-4#2)
gel electrophoretic##7##2##(1990-11#1)(1991-12#1)(1992-8#1)(1993-3#1)(1995-6#1)(2008-4#2)
gel entrapment carrier##3##3##(2008-7#3)
gel entrapment##4##2##(2008-7#4)
gel films##4##2##(2008-3#4)
gel filtration analysis##2##3##(2008-11#1)(2011-1#1)
gel filtration and##14##3##(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1994-6#2)(1997-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
gel filtration chromatography and##4##4##(1990-2#1)(1994-8#1)(2008-10#2)
gel filtration chromatography##15##3##(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#5)(2008-11#1)(2009-3#1)(2010-2#1)
gel filtration on Sephadex G-50##4##5##(1990-12#2)(1990-2#2)
gel filtration on##6##3##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)
gel filtration##72##2##(1990-12#3)(1990-2#6)(1990-5#1)(1990-7#5)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#4)(1994-8#4)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#4)(2009-3#1)(2010-2#2)(2011-1#1)(2012-2#1)
gel for mercury##2##3##(2008-10#2)
gel for##6##2##(2008-10#5)(2008-5#1)
gel formation##3##2##(1994-3#1)(2011-2#2)
gel from##2##2##(2008-10#2)
gel has##3##2##(2008-10#2)(2010-3#1)
gel in a##2##3##(2008-10#1)(2008-4#1)
gel in##7##2##(2007-7#2)(2008-10#4)(2008-4#1)
gel is##11##2##(1996-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-9#1)
gel materials##2##2##(2008-7#2)
gel matrices##2##2##(2008-10#2)
gel matrix##7##2##(1990-12#2)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
gel microcolumn##2##2##(2011-1#1)(2012-2#1)
gel microdrop secretion assay##2##4##(2008-11#2)
gel mobility shift analysis##3##4##(1993-8#1)(1994-9#1)(2008-9#1)
gel mobility shift##5##3##(1992-12#1)(1993-8#1)(1994-9#1)(2008-8#1)(2008-9#1)
gel modified with##10##3##(2008-10#10)
gel modified##11##2##(2008-10#11)
gel monolithic column polydimethylsiloxane##2##4##(2008-10#2)
gel monolithic column##4##3##(2008-10#4)
gel network phase##3##3##(2008-5#3)
gel network##6##2##(2008-5#6)
gel of##2##2##(2008-10#2)
gel on##2##2##(2008-10#1)(2010-8#1)
gel permeation and reversed-phase HPLC##2##5##(1992-8#1)(1994-6#1)
gel permeation chromatography (GPC)##3##4##(2008-10#1)(2009-2#1)(2011-1#1)
gel permeation chromatography##8##3##(1990-8#1)(1996-12#1)(2008-10#3)(2008-5#1)(2009-2#1)(2011-1#1)
gel permeation##13##2##(1990-8#1)(1992-3#1)(1992-8#1)(1994-6#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-5#1)(2009-2#1)(2011-1#2)
gel phase with##2##3##(2010-5#2)
gel phase##15##2##(1993-8#4)(1994-5#1)(2008-10#4)(2008-8#2)(2010-5#4)
gel phases##6##2##(1993-8#2)(2008-10#4)
gel retardation analysis##2##3##(1990-8#1)(1992-6#1)
gel retardation assays##2##3##(1993-6#1)(1995-6#1)
gel retardation##7##2##(1990-8#1)(1992-11#1)(1992-6#1)(1993-6#1)(1995-6#1)(2008-8#2)
gel shift assay##3##3##(1993-6#1)(1993-8#2)
gel shift##6##2##(1993-6#1)(1993-8#2)(1994-6#1)(1995-2#1)(2008-9#1)
gel showed that##2##3##(2008-11#1)(2010-5#1)
gel showed##4##2##(2008-10#1)(2008-11#1)(2010-5#2)
gel substrata##3##2##(1994-8#3)
gel test##8##2##(2011-1#8)
gel to##6##2##(1990-2#1)(1992-8#1)(2008-10#2)(2008-4#2)
gel under##2##2##(2008-10#1)(2008-4#1)
gel using##4##2##(1993-3#1)(1996-5#1)(2008-1#1)(2010-3#1)
gel was found##2##3##(1994-8#1)(2008-10#1)
gel was measured directly after packing the gel beads in a 1-mm silica cell##2##14##(2008-10#2)
gel was##24##2##(1994-8#2)(2008-10#19)(2008-11#1)(2008-5#1)(2010-3#1)
gel were##2##2##(1993-1#1)(2008-10#1)
gel with##4##2##(2008-10#4)
gel##812##1##(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#7)(1990-5#5)(1990-7#11)(1990-8#10)(1991-12#8)(1991-2#4)(1991-3#1)(1991-5#7)(1991-8#1)(1991-9#6)(1992-11#2)(1992-12#9)(1992-3#4)(1992-6#4)(1992-8#8)(1992-9#2)(1993-1#3)(1993-11#5)(1993-12#3)(1993-3#3)(1993-6#4)(1993-8#14)(1993-9#4)(1994-11#5)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#8)(1994-8#14)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#3)(1996-12#6)(1996-2#2)(1996-5#5)(1996-9#9)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#8)(1997-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#4)(2008-1#8)(2008-10#261)(2008-11#26)(2008-12#1)(2008-2#23)(2008-3#6)(2008-4#53)(2008-5#38)(2008-6#3)(2008-7#22)(2008-8#16)(2008-9#19)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#7)(2010-4#1)(2010-5#11)(2010-6#1)(2010-8#5)(2011-1#14)(2011-2#13)(2011-3#5)(2012-12#1)(2012-2#6)(2012-3#8)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#1)
gel) and##2##2##(2008-11#1)(2008-5#1)
gel)##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
gel-filled capillaries##3##2##(2008-10#3)
gel-filtration chromatography##4##2##(1997-2#1)(2008-4#2)(2010-4#1)
gel-filtration column##2##2##(1990-7#1)(2008-4#1)
gel-filtration##11##1##(1990-12#1)(1990-2#1)(1990-7#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2010-4#1)
gel-immobilized##2##1##(2008-10#2)
gel-purified##2##1##(1997-3#1)(2008-4#1)
gelatin and collagen hydrolysate as##2##5##(2008-5#2)
gelatin and collagen hydrolysate##4##4##(2008-5#4)
gelatin and sodium alginate##2##4##(2010-5#2)
gelatin and##9##2##(1995-5#1)(2008-10#2)(2008-5#4)(2010-5#2)
gelatin binding##2##2##(1995-5#2)
gelatin capsule technique##6##3##(2011-2#6)
gelatin capsules##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
gelatin coating##2##2##(2008-9#1)(2013-1#1)
gelatin emulsions##2##2##(2008-3#2)
gelatin is##2##2##(2008-2#2)
gelatin or collagen##2##3##(1991-8#1)(2012-3#1)
gelatin or##3##2##(1991-8#1)(1995-5#1)(2012-3#1)
gelatin pre-coating##2##2##(2013-1#2)
gelatin with##2##2##(2007-11#1)(2008-2#1)
gelatin##77##1##(1990-2#2)(1991-8#1)(1994-5#1)(1995-5#4)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#5)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#4)(2008-9#1)(2009-11#1)(2009-7#2)(2010-5#3)(2010-8#1)(2011-2#7)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#3)
gelatin-isolated##2##1##(2008-11#2)
gelatinase A##3##2##(1994-5#3)
gelatinase##4##1##(1994-5#4)
gelatinase-associated lipocalin##3##2##(2010-5#2)(2012-2#1)
gelatine##5##1##(2008-10#5)
gelatinosus##3##1##(2008-8#3)
gelatinous clutches##3##2##(2008-9#3)
gelatinous##4##1##(2008-9#3)(2009-8#1)
gelation##11##1##(2008-10#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-3#2)
geldanamycin##4##1##(1994-8#4)
gelding##2##1##(2013-8#2)
gelelectrophoresis##2##1##(1990-11#1)(2008-11#1)
gellan gum##7##2##(2010-3#5)(2010-5#1)(2011-3#1)
gellike##4##1##(2008-11#4)
gelling##9##1##(1993-8#1)(2008-10#1)(2010-3#1)(2011-1#4)(2011-2#2)
gelonin and momordin##4##3##(1990-12#4)
gels and##11##2##(1992-2#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)
gels are##6##2##(2008-10#2)(2008-2#1)(2008-7#1)(2009-9#1)(2010-5#1)
gels based on##2##3##(1990-5#1)(2008-5#1)
gels can be##2##3##(2008-5#1)(2008-9#1)
gels containing##2##2##(1991-7#1)(1997-6#1)
gels is##3##2##(2008-2#1)(2008-4#2)
gels of##3##2##(2008-7#2)(2011-1#1)
gels on##2##2##(2008-10#1)(2012-2#1)
gels to##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
gels using##2##2##(2008-2#1)(2008-4#1)
gels were##5##2##(2008-10#2)(2008-5#2)(2008-9#1)
gels with##3##2##(1990-4#1)(1992-12#1)(2007-12#1)
gels##138##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#3)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#32)(2008-2#16)(2008-3#2)(2008-4#13)(2008-5#11)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#3)(2009-6#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#3)(2011-1#2)(2011-2#3)(2012-2#1)(2012-7#1)
gemcitabine 1000 mg/m2/w for##2##4##(2008-6#2)
gemcitabine and carboplatin##2##3##(2008-10#2)
gemcitabine and cisplatin##2##3##(2013-1#2)
gemcitabine and##4##2##(2008-10#2)(2013-1#2)
gemcitabine for##2##2##(2008-11#1)(2011-2#1)
gemcitabine in##2##2##(2008-6#1)(2013-1#1)
gemcitabine##19##1##(2007-7#1)(2008-10#4)(2008-11#1)(2008-6#4)(2010-8#1)(2011-2#3)(2013-1#5)
gemfibrozil##6##1##(1993-9#1)(2008-10#1)(2011-1#4)
geminate recombination of##3##3##(1990-8#1)(1995-2#1)(2008-3#1)
geminate recombination##6##2##(1990-8#3)(1995-2#2)(2008-3#1)
geminiviral DNA replication##3##3##(2008-10#3)
geminiviral##4##1##(2008-10#4)
geminivirus from##3##2##(2008-10#3)
geminivirus species##2##2##(2008-10#2)
geminivirus that##2##2##(2008-10#2)
geminivirus with##2##2##(2008-10#2)
geminivirus##18##1##(2008-10#16)(2008-8#1)(2008-9#1)
geminiviruses in##3##2##(2008-10#2)(2008-8#1)
geminiviruses##14##1##(2008-10#12)(2008-8#2)
gemtuzumab ozogamicin##2##2##(2008-7#1)(2010-4#1)
gender and age as##2##4##(2008-11#1)(2011-2#1)
gender and age##13##3##(1993-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
gender and ethnic differences##2##4##(2007-12#2)
gender and ethnic##3##3##(2007-12#2)(2008-10#1)
gender and length of##2##4##(1993-12#1)(2010-8#1)
gender and pubertal status##2##4##(2011-1#2)
gender and smoking status##2##4##(2011-2#2)
gender and smoking##3##3##(2011-2#2)(2012-2#1)
gender and socioeconomic status##2##4##(2011-1#2)
gender and the##2##3##(2009-7#1)(2013-8#1)
gender and##70##2##(1990-3#1)(1990-9#1)(1993-12#2)(1996-6#1)(2007-10#3)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#5)(2009-10#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
gender categorization##2##2##(2008-11#2)
gender difference in##4##3##(1996-2#1)(2008-1#1)(2008-11#2)
gender difference##9##2##(1996-2#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-3#1)
gender differences in axillary##2##4##(2008-5#2)
gender differences in health##2##4##(2008-7#2)
gender differences in the relationship between##2##6##(2010-1#1)(2010-7#1)
gender differences in the##6##4##(2008-4#2)(2009-7#1)(2010-1#2)(2010-7#1)
gender differences in##28##3##(1996-3#1)(2007-4#1)(2008-12#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2009-7#2)(2009-8#1)(2010-1#3)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
gender differences##38##2##(1996-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#2)
gender equality##2##2##(2010-12#1)(2011-2#1)
gender gap##3##2##(1995-5#1)(2010-7#2)
gender groups##3##2##(2009-1#1)(2009-7#1)(2011-1#1)
gender identity and##3##3##(2008-1#1)(2008-12#1)(2009-5#1)
gender identity##8##2##(2008-1#1)(2008-12#3)(2009-5#2)(2009-7#1)(2011-2#1)
gender in a##2##3##(1994-3#1)(2008-10#1)
gender in the##2##3##(2009-10#1)(2012-2#1)
gender in##6##2##(1994-3#1)(2008-10#1)(2009-10#2)(2011-2#1)(2012-2#1)
gender is##2##2##(2008-9#2)
gender nonconformity##2##2##(2008-12#2)
gender of the##4##3##(1992-3#1)(2008-2#1)(2009-3#1)(2012-3#1)
gender of##5##2##(1992-3#1)(2008-2#1)(2009-3#1)(2012-3#2)
gender on the##3##3##(2010-4#1)(2012-2#2)
gender on##8##2##(1994-3#1)(2007-10#2)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#2)
gender only##2##2##(1994-3#1)(2010-4#1)
gender or##6##2##(1991-9#1)(1994-6#1)(2007-10#1)(2008-3#2)(2013-1#1)
gender perspective on the extent to which mothers and fathers each take responsibility for##2##14##(2009-5#2)
gender perspective##5##2##(2009-10#3)(2009-5#2)
gender ratio in##2##3##(2008-9#1)(2012-3#1)
gender ratio##4##2##(2008-3#1)(2008-6#1)(2008-9#1)(2012-3#1)
gender relations and##2##3##(2007-7#2)
gender relations##3##2##(2007-7#3)
gender roles in##2##3##(2008-11#1)(2009-4#1)
gender roles##3##2##(2008-11#1)(2009-4#1)(2010-2#1)
gender to##2##2##(1993-8#1)(2009-7#1)
gender using##2##2##(2008-11#1)(2012-2#1)
gender was##3##2##(2008-5#1)(2010-5#1)(2013-1#1)
gender were##2##2##(2007-12#1)(2009-7#1)
gender##384##1##(1990-3#2)(1990-9#3)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-8#2)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#2)(2007-10#10)(2007-11#1)(2007-12#5)(2007-4#2)(2007-7#6)(2008-1#5)(2008-10#8)(2008-11#17)(2008-12#16)(2008-2#2)(2008-3#7)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#16)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#4)(2009-5#9)(2009-7#16)(2009-8#2)(2009-9#1)(2010-1#6)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#9)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#15)(2011-2#33)(2012-1#3)(2012-12#10)(2012-2#13)(2012-3#6)(2012-5#1)(2013-1#25)(2013-8#11)
gender)##2##1##(2010-4#1)(2011-2#1)
gender-based##5##1##(1990-2#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
gender-nonconformity-related##2##1##(2008-12#2)
gender-related differences in the##2##4##(2008-11#1)(2009-11#1)
gender-related differences in##3##3##(2008-11#1)(2009-11#1)(2010-12#1)
gender-related differences##4##2##(2008-11#1)(2008-12#1)(2009-11#1)(2010-12#1)
gender-related##7##1##(2008-11#1)(2008-12#1)(2009-1#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
gender-specific differences in##3##3##(2008-11#1)(2008-9#1)(2011-1#1)
gender-specific differences##4##2##(1996-9#1)(2008-11#1)(2008-9#1)(2011-1#1)
gender-specific patterns##2##2##(2008-11#1)(2009-8#1)
gender-specific##15##1##(1994-2#1)(1996-9#1)(2007-10#1)(2008-11#5)(2008-9#1)(2009-8#2)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#1)
gender]##2##1##(1997-6#1)(2008-11#1)
gendered##6##1##(2007-7#2)(2008-11#2)(2009-7#1)(2011-2#1)
genders##18##1##(1994-2#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#2)(2011-1#2)(2011-2#2)(2013-1#3)
gene (aprV5)##2##2##(1993-12#2)
gene (called##2##2##(1992-4#2)
gene (designated##2##2##(2008-10#2)
gene (encoding the##4##3##(1993-12#1)(1993-9#2)(1994-12#1)
gene (encoding##5##2##(1993-12#1)(1993-9#2)(1994-12#2)
gene (or allele) was##2##4##(2008-10#2)
gene (or allele)##6##3##(2008-10#6)
gene (or##8##2##(1990-5#1)(2008-10#6)(2008-2#1)
gene (pgk1) of Trichoderma reesei##2##5##(1991-9#2)
gene (pth)##2##2##(1994-12#1)(2008-10#1)
gene (rDNA)##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
gene 1##3##2##(1994-11#2)(2008-11#1)
gene 11 (Tex11)##2##3##(2012-2#2)
gene 2##3##2##(1994-12#1)(1996-6#1)(2009-12#1)
gene 30##4##2##(1997-7#4)
gene 33 protein##2##3##(1995-6#2)
gene 49##2##2##(1995-12#2)
gene 5'##3##2##(1992-12#1)(1995-2#1)(2008-9#1)
gene GPR1##2##2##(1994-12#2)
gene Pg10##2##2##(2008-10#2)
gene PvuII polymorphism##2##3##(2011-2#2)
gene TMSG-1##2##2##(2008-9#2)
gene abnormalities##2##2##(1990-8#1)(1991-12#1)
gene action was##3##3##(2008-10#3)
gene action##10##2##(2008-10#8)(2009-10#2)
gene activation##11##2##(1995-2#1)(2007-7#1)(2008-10#4)(2008-4#2)(2008-7#2)(2009-5#1)
gene activity##9##2##(1990-6#1)(1993-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)
gene after##2##2##(1991-6#1)(1995-6#1)
gene against##2##2##(2008-10#1)(2008-8#1)
gene alone##2##2##(2008-4#1)(2010-6#1)
gene als##2##2##(2008-9#2)
gene also##4##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
gene alterations in##2##3##(1992-3#1)(2012-2#1)
gene alterations##4##2##(1992-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
gene among the##2##3##(1993-1#1)(2010-4#1)
gene among##4##2##(1991-3#1)(1993-1#1)(2010-4#1)(2011-1#1)
gene amplification by##2##3##(1991-6#1)(1994-12#1)
gene amplification in##2##3##(1991-4#1)(1994-12#1)
gene amplification##25##2##(1990-2#1)(1991-4#2)(1991-6#2)(1994-10#1)(1994-12#4)(1995-8#1)(1996-12#1)(1997-4#1)(2008-11#7)(2008-2#1)(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#1)
gene analysis##4##2##(2008-1#1)(2009-8#1)(2010-5#1)(2013-1#1)
gene and a##9##3##(1997-5#1)(2008-10#4)(2008-8#2)(2011-2#1)(2012-2#1)
gene and at least##2##4##(1991-5#1)(1997-7#1)
gene and expressed##2##3##(2008-1#1)(2008-8#1)
gene and genome##2##3##(2007-12#1)(2008-7#1)
gene and has##2##3##(1997-9#1)(2008-10#1)
gene and introduced##2##3##(1992-12#1)(1995-8#1)
gene and is##2##3##(1996-6#1)(1997-7#1)
gene and its expression##3##4##(1992-12#1)(2008-8#2)
gene and its##14##3##(1990-5#1)(1991-6#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#4)(2013-1#1)
gene and production of##2##4##(2008-11#1)(2010-5#1)
gene and protein expression##3##4##(2008-10#1)(2010-12#1)(2012-7#1)
gene and protein##5##3##(2008-10#2)(2008-7#1)(2010-12#1)(2012-7#1)
gene and that##2##3##(1990-11#1)(2013-1#1)
gene and the 3'##3##4##(1997-6#2)(2008-9#1)
gene and the##31##3##(1990-11#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-6#2)(1997-8#1)(2008-10#7)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#2)(2011-1#2)(2012-12#1)(2013-1#1)
gene and their##3##3##(1992-9#1)(2008-10#1)(2008-8#1)
gene and##179##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#5)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#4)(1997-9#2)(2006-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#38)(2008-11#4)(2008-12#3)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#13)(2008-9#8)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)
gene and/or##2##2##(1991-7#1)(2008-9#1)
gene appears to be##2##4##(1991-6#1)(1993-8#1)
gene appears to##3##3##(1990-8#1)(1991-6#1)(1993-8#1)
gene are not##2##3##(1991-6#1)(1992-6#1)
gene are##13##2##(1991-11#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
gene arrangement##3##2##(1994-12#1)(2008-10#1)(2008-6#1)
gene array analysis##2##3##(2008-10#2)
gene array##3##2##(2008-10#2)(2008-7#1)
gene as a reporter##4##4##(1992-6#1)(2008-11#2)(2008-9#1)
gene as a##10##3##(1991-9#1)(1992-6#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
gene as an##2##3##(1997-8#1)(2008-7#1)
gene as the probe##2##4##(2008-8#2)
gene as the##6##3##(1990-12#1)(2008-8#2)(2010-10#1)(2011-1#1)(2012-2#1)
gene as well as##2##4##(1993-8#1)(2008-11#1)
gene as##30##2##(1990-12#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-8#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-2#1)
gene assay##5##2##(2010-2#3)(2010-5#1)(2011-2#1)
gene associated with the##2##4##(1997-8#1)(2013-1#1)
gene associated with##7##3##(1996-10#1)(1997-8#1)(2008-12#2)(2008-4#1)(2009-7#1)(2013-1#1)
gene at a##2##3##(2008-10#2)
gene at position##2##3##(2011-1#2)
gene at the##4##3##(1993-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
gene at##12##2##(1990-12#1)(1993-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2011-1#2)
gene based on the##2##4##(2008-10#1)(2008-4#1)
gene based##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
gene being##2##2##(2008-10#1)(2011-2#1)
gene belonging to the##3##4##(1994-12#1)(1997-2#1)(1997-9#1)
gene between##3##2##(1991-5#1)(1997-5#1)(2008-10#1)
gene but not##2##3##(1990-5#1)(1993-3#1)
gene but##5##2##(1990-5#1)(1993-3#1)(1997-8#1)(2008-11#1)(2008-4#1)
gene by a##2##3##(2008-11#1)(2009-10#1)
gene by functional##2##3##(1992-8#1)(1994-8#1)
gene by polymerase chain reaction##3##5##(1990-7#1)(1992-6#1)(2012-12#1)
gene by##31##2##(1990-2#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
gene cDNA##3##2##(1994-2#1)(1997-3#1)(2008-10#1)
gene can be##5##3##(1993-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)
gene can inhibit##2##3##(1994-3#1)(2008-8#1)
gene can##8##2##(1991-7#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-12#1)
gene carrier##3##2##(2008-10#2)(2008-11#1)
gene carriers##3##2##(1995-9#1)(2008-1#1)(2009-7#1)
gene causes##2##2##(1990-12#1)(2009-8#1)
gene causing##2##2##(1991-12#1)(2008-10#1)
gene cloned in a multicopy plasmid is##2##7##(1990-11#1)(1997-3#1)
gene cloned in##3##3##(1990-11#1)(1994-12#1)(1997-3#1)
gene cloned##5##2##(1990-11#1)(1994-12#1)(1997-3#1)(2008-10#1)(2011-1#1)
gene cloning##7##2##(1993-11#2)(1993-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
gene cluster and##3##3##(2008-10#2)(2008-7#1)
gene cluster controlling##2##3##(2008-10#2)
gene cluster in##2##3##(1993-3#1)(2008-8#1)
gene cluster is##2##3##(2008-8#1)(2011-1#1)
gene cluster of##3##3##(1990-5#1)(2008-8#1)(2008-9#1)
gene cluster##30##2##(1990-5#1)(1993-3#2)(1994-6#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-8#1)(2008-10#9)(2008-7#1)(2008-8#6)(2008-9#1)(2011-1#3)(2011-2#1)(2012-2#1)
gene clusters in##2##3##(1996-12#1)(2008-1#1)
gene clusters##11##2##(1994-12#1)(1995-6#2)(1996-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-8#1)(2009-9#1)(2012-3#1)
gene codes for a##2##4##(1997-4#1)(2013-1#1)
gene codes##3##2##(1997-4#1)(2008-8#1)(2013-1#1)
gene coding for an##3##4##(1994-2#1)(1995-11#1)(2008-10#1)
gene coding for the##9##4##(1992-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1997-3#2)(2008-6#1)(2013-7#1)
gene coding for##24##3##(1991-6#1)(1992-3#3)(1992-8#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(2008-10#1)(2008-6#1)(2010-8#1)(2013-7#1)
gene coding sequence##2##3##(1993-12#1)(2012-3#1)
gene coding##27##2##(1991-6#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-7#1)
gene combinations##3##2##(1997-7#1)(2008-10#1)(2012-12#1)
gene complexes##2##2##(1992-3#1)(2010-3#1)
gene conferred resistance##2##3##(2008-10#2)
gene conferred the##2##3##(2008-10#2)
gene conferred##4##2##(2008-10#4)
gene conferring resistance to##3##4##(1994-12#2)(2008-10#1)
gene conferring##5##2##(1994-12#2)(2008-10#3)
gene consists of##4##3##(1991-9#1)(1992-12#1)(1993-8#1)(1995-8#1)
gene construct##6##2##(1991-9#1)(1993-3#1)(1993-8#1)(2008-10#2)(2008-8#1)
gene constructs in##2##3##(1993-8#1)(2008-11#1)
gene constructs of##2##3##(2008-10#1)(2008-11#1)
gene constructs##9##2##(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#2)
gene contain##2##2##(1995-6#1)(2008-8#1)
gene containing a##2##3##(1992-6#1)(1993-6#1)
gene containing the##2##3##(1996-2#2)
gene containing##6##2##(1992-6#1)(1993-6#1)(1995-8#1)(1996-12#1)(1996-2#2)
gene contains a##4##3##(1993-6#2)(1995-6#1)(2008-11#1)
gene contains four exons and##2##5##(1993-2#1)(1994-11#1)
gene contains several##3##3##(1997-3#1)(1997-6#1)(2008-10#1)
gene contains two##2##3##(1992-9#2)
gene contains##19##2##(1990-8#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#2)(1994-11#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
gene content##3##2##(2008-4#1)(2008-7#1)(2010-5#1)
gene control##4##2##(1994-11#1)(2008-10#3)
gene controlled by CaMV35S##2##4##(2008-9#2)
gene controlled##5##2##(2008-10#2)(2008-5#1)(2008-9#2)
gene controlling##5##2##(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)
gene controls resistance to##2##4##(2008-10#2)
gene controls resistance##3##3##(2008-10#3)
gene controls##6##2##(1990-11#1)(2008-10#5)
gene conversion were##2##3##(2008-10#1)(2013-1#1)
gene conversion##6##2##(1990-5#2)(1994-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
gene copies##3##2##(1992-9#1)(1995-8#1)(1997-7#1)
gene copy number##7##3##(1991-9#1)(1996-12#3)(2008-10#1)(2008-4#1)(2010-10#1)
gene copy##8##2##(1990-2#1)(1991-9#1)(1996-12#3)(2008-10#1)(2008-4#1)(2010-10#1)
gene could be##5##3##(2008-10#1)(2008-8#2)(2008-9#2)
gene could##6##2##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)
gene defective in##2##3##(1991-12#1)(2010-2#1)
gene defects##2##2##(2007-10#1)(2008-7#1)
gene deletion mutants##3##3##(2008-4#1)(2008-7#1)(2012-3#1)
gene deletion##10##2##(1997-3#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
gene deletions and##2##3##(2008-1#1)(2012-3#1)
gene deletions##5##2##(2008-1#4)(2012-3#1)
gene delivery into##2##3##(2008-11#1)(2008-4#1)
gene delivery system##9##3##(2008-8#8)(2008-9#1)
gene delivery systems##2##3##(1994-5#1)(2009-10#1)
gene delivery to##8##3##(1994-5#2)(2008-2#1)(2008-4#5)
gene delivery##38##2##(1994-11#1)(1994-5#3)(1995-2#1)(2008-11#4)(2008-2#1)(2008-4#7)(2008-5#1)(2008-8#11)(2008-9#2)(2009-10#2)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
gene demonstrated##2##2##(1996-3#1)(2008-11#1)
gene derived from##2##3##(2008-10#2)
gene designated##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
gene detection##2##2##(2008-4#1)(2008-9#1)
gene did not##2##3##(1991-8#1)(2008-10#1)
gene difference##3##2##(1995-6#1)(2008-10#2)
gene discovery##5##2##(2008-7#3)(2011-2#2)
gene diseases##2##2##(2012-3#2)
gene disorders##3##2##(2008-11#1)(2008-8#2)
gene disruption##8##2##(1995-6#1)(1997-3#1)(2008-4#1)(2008-8#5)
gene diversity analysis##2##3##(2008-10#2)
gene diversity was##6##3##(2008-10#6)
gene diversity##23##2##(2008-10#17)(2008-12#1)(2008-4#1)(2008-8#1)(2012-5#2)(2013-1#1)
gene does not##3##3##(1997-4#1)(2008-7#1)(2013-8#1)
gene dosage##4##2##(1990-5#1)(1995-11#1)(2007-11#2)
gene driven by##5##3##(1997-2#1)(2008-11#2)(2008-8#1)(2009-8#1)
gene duplicates##2##2##(2009-10#1)(2009-6#1)
gene duplication has##2##3##(1997-7#1)(2007-11#1)
gene duplication##6##2##(1993-3#1)(1997-7#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
gene duplications##2##2##(2007-11#1)(2009-10#1)
gene during chick development##2##4##(1997-4#2)
gene during development##3##3##(1995-3#1)(1997-8#1)(2008-8#1)
gene during the##2##3##(1995-5#1)(2008-10#1)
gene during##12##2##(1990-12#1)(1991-5#1)(1992-2#1)(1995-3#1)(1995-5#1)(1997-4#2)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#2)
gene eXpression##3##2##(2008-10#2)(2013-1#1)
gene effects##2##2##(2008-8#1)(2010-4#1)
gene encoded by##2##3##(1997-8#1)(2008-9#1)
gene encodes a novel##2##4##(1990-5#1)(1992-12#1)
gene encodes a polypeptide##2##4##(1990-11#1)(1992-3#1)
gene encodes a protein of##4##5##(1992-8#1)(1992-9#1)(1996-6#1)(2008-9#1)
gene encodes a protein##6##4##(1990-5#1)(1992-8#1)(1992-9#1)(1996-6#2)(2008-9#1)
gene encodes a##20##3##(1990-11#1)(1990-5#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-12#4)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#2)(2008-6#1)(2008-9#2)
gene encodes the##3##3##(1992-9#1)(1993-3#1)(1994-6#1)
gene encodes##27##2##(1990-11#1)(1990-5#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#2)(1994-12#4)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#2)(1997-8#1)(2008-6#1)(2008-7#1)(2008-9#2)
gene encoding a protein##3##4##(1990-5#1)(1993-2#1)(1994-12#1)
gene encoding a putative##3##4##(1994-12#1)(1997-3#1)(1997-8#1)
gene encoding a##19##3##(1990-5#1)(1990-7#1)(1992-9#1)(1993-2#1)(1994-12#4)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#2)(1997-3#2)(1997-7#3)(1997-8#1)
gene encoding an##4##3##(1993-2#1)(1995-2#1)(1995-6#1)(2008-10#1)
gene encoding beta-galactosidase##2##3##(1992-12#1)(2008-8#1)
gene encoding for##3##3##(1992-9#1)(1997-6#1)(2008-12#1)
gene encoding human##6##3##(1991-6#3)(1994-11#1)(1994-12#1)(1997-7#1)
gene encoding the 28-kDa##2##4##(1993-2#2)
gene encoding the brain specific snRNP-associated polypeptide &quot##2##8##(1993-8#2)
gene encoding the major outer membrane protein of the##2##9##(1991-9#2)
gene encoding the##50##3##(1991-2#1)(1991-7#1)(1991-9#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-12#6)(1995-2#2)(1995-6#3)(1996-10#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#3)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-6#1)(2013-1#1)
gene encoding this##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
gene encoding##155##2##(1990-11#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-2#1)(1991-6#6)(1991-7#3)(1991-9#4)(1992-12#3)(1992-3#1)(1992-4#3)(1992-8#1)(1992-9#3)(1993-12#4)(1993-2#11)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#17)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#4)(1995-6#9)(1995-8#4)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-3#7)(1997-4#4)(1997-6#2)(1997-7#6)(1997-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#2)(2013-1#2)
gene engineering##2##2##(2011-2#2)
gene essentiality##3##2##(2012-2#3)
gene evolution##3##2##(1991-6#1)(2008-7#1)(2013-1#1)
gene exhibited##2##2##(1990-7#1)(2008-10#1)
gene existed##2##2##(1992-3#1)(2008-9#1)
gene exists##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
gene expressed in##2##3##(1995-12#1)(1997-7#1)
gene expressed##4##2##(1990-12#1)(1993-3#1)(1995-12#1)(1997-7#1)
gene expression also##2##3##(1995-12#1)(2008-10#1)
gene expression among##2##3##(1992-10#1)(2012-3#1)
gene expression analysis##7##3##(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-6#1)(2012-3#1)
gene expression and genome##2##4##(2007-12#1)(2008-10#1)
gene expression and protein##2##4##(2008-7#1)(2008-9#1)
gene expression and regulation##3##4##(2008-9#1)(2009-11#1)(2012-12#1)
gene expression and signal transduction##2##5##(2008-4#1)(2010-5#1)
gene expression and##43##3##(1990-5#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
gene expression are##8##3##(1992-3#1)(1993-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
gene expression at the##8##4##(1991-12#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
gene expression at transcriptional##2##4##(1992-8#1)(2008-4#1)
gene expression at##11##3##(1991-12#1)(1991-5#1)(1992-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)
gene expression by insulin##6##4##(1995-6#4)(1996-2#2)
gene expression by the##3##4##(1995-6#1)(1997-7#1)(2008-7#1)
gene expression by##32##3##(1991-12#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#6)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2011-2#1)
gene expression can##2##3##(1992-10#1)(2008-7#1)
gene expression changes##3##3##(2008-10#2)(2010-4#1)
gene expression could##2##3##(1994-6#1)(2012-2#1)
gene expression data##15##3##(2008-4#2)(2008-7#3)(2009-10#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#3)(2011-3#1)(2012-3#1)
gene expression during##7##3##(1994-8#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
gene expression for##7##3##(1994-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#2)(2012-3#1)
gene expression in Escherichia coli##2##5##(1991-7#1)(1994-12#1)
gene expression in Nile tilapia Oreochromis niloticus##2##7##(2010-8#2)
gene expression in a##6##4##(1991-2#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(2009-8#1)
gene expression in human##8##4##(1990-5#1)(1991-6#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(2009-4#1)
gene expression in mammalian cells##7##5##(1993-6#2)(1994-8#1)(1997-4#2)(2008-11#2)
gene expression in mammary gland##2##5##(1997-6#1)(2008-8#1)
gene expression in mouse##2##4##(2008-11#1)(2008-9#1)
gene expression in other##2##4##(2008-11#1)(2008-7#1)
gene expression in photosynthetic tissues##2##5##(2008-9#2)
gene expression in rat brain##2##5##(1991-1#1)(1993-5#1)
gene expression in rat##5##4##(1991-1#1)(1991-12#1)(1993-5#1)(1993-8#1)(2008-8#1)
gene expression in response to##3##5##(1996-3#1)(2010-10#1)(2010-6#1)
gene expression in the choroid plexus##2##6##(1996-12#2)
gene expression in the hypothalamic paraventricular nucleus##2##7##(1996-12#2)
gene expression in the rat##2##5##(1992-8#1)(1995-11#1)
gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals##2##15##(2012-2#2)
gene expression in the##27##4##(1992-8#1)(1993-6#1)(1995-11#1)(1996-12#7)(1997-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-2#1)(2009-3#1)(2009-6#2)(2012-2#4)(2013-7#1)
gene expression in transgenic##2##4##(2008-9#1)(2011-10#1)
gene expression in various##2##4##(1995-12#1)(2008-10#1)
gene expression in##142##3##(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#6)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#7)(1995-2#3)(1995-8#1)(1995-9#1)(1996-12#10)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#13)(2008-7#13)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#1)
gene expression is also##2##4##(1990-2#1)(2008-9#1)
gene expression is##12##3##(1990-2#1)(1990-7#1)(1993-5#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-12#1)(2011-1#1)
gene expression level in##2##4##(2008-10#1)(2012-1#1)
gene expression level of##4##4##(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
gene expression level##6##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
gene expression levels and##3##4##(2008-10#2)(2011-1#1)
gene expression levels##7##3##(2008-10#4)(2011-1#1)(2011-2#1)(2012-1#1)
gene expression may be##2##4##(1995-2#2)
gene expression may##3##3##(1995-2#2)(1997-6#1)
gene expression microarrays##2##3##(2008-7#1)(2008-8#1)
gene expression of catecholamine##2##4##(2013-1#2)
gene expression of the##5##4##(1992-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
gene expression of two##2##4##(1995-2#1)(2008-9#1)
gene expression of##37##3##(1991-5#1)(1992-10#1)(1992-6#1)(1993-3#3)(1994-12#2)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
gene expression on##5##3##(1992-10#1)(1993-12#1)(2008-10#1)(2008-11#2)
gene expression or##2##3##(2008-4#1)(2010-11#1)
gene expression pattern##3##3##(2008-8#1)(2010-12#2)
gene expression patterns in##2##4##(2008-10#1)(2008-7#1)
gene expression patterns##11##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#3)(2008-7#2)(2010-1#1)(2012-2#1)
gene expression post-transcriptionally##3##3##(2009-5#1)(2010-7#1)(2011-2#1)
gene expression profile in##2##4##(1997-6#1)(2013-1#1)
gene expression profile of##4##4##(2010-11#1)(2010-6#1)(2011-2#2)
gene expression profile##9##3##(1997-6#1)(2008-7#2)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
gene expression profiles are##2##4##(2008-10#1)(2008-8#1)
gene expression profiles in##3##4##(2008-10#2)(2011-2#1)
gene expression profiles of##6##4##(2008-7#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
gene expression profiles##19##3##(2008-10#6)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
gene expression profiling in##2##4##(2008-10#1)(2008-7#1)
gene expression profiling of##2##4##(2008-6#1)(2008-7#1)
gene expression profiling##13##3##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#5)(2009-4#1)(2009-8#1)(2013-8#2)
gene expression regulation##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
gene expression remain##2##3##(1993-12#1)(2009-10#1)
gene expression showed##2##3##(1995-12#1)(2008-10#1)
gene expression studies in##2##4##(1996-6#1)(2008-4#1)
gene expression studies##7##3##(1996-6#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
gene expression system##2##3##(1993-9#1)(2008-5#1)
gene expression that##4##3##(2007-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
gene expression through##2##3##(2008-9#1)(2010-3#1)
gene expression to estrogen in chick##2##6##(1992-9#2)
gene expression to the##2##4##(1996-12#1)(2008-7#1)
gene expression to##8##3##(1992-9#2)(1993-3#1)(1996-12#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-1#1)
gene expression via the##2##4##(1995-2#1)(2008-11#1)
gene expression via##4##3##(1995-2#1)(2008-11#1)(2009-2#1)(2010-10#1)
gene expression was also##3##4##(1996-5#1)(2008-8#2)
gene expression was found##2##4##(1993-9#1)(2013-8#1)
gene expression was significantly##2##4##(1995-12#1)(2008-10#1)
gene expression was##20##3##(1990-3#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-8#4)(2012-2#1)(2013-8#1)
gene expression were##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
gene expression when##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
gene expression with##4##3##(1993-9#1)(1997-8#1)(2008-10#1)(2010-6#1)
gene expression within##4##3##(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#1)
gene expression##745##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#2)(1991-1#2)(1991-12#6)(1991-2#3)(1991-5#3)(1991-6#2)(1991-7#1)(1992-1#2)(1992-10#6)(1992-11#2)(1992-12#2)(1992-3#5)(1992-5#1)(1992-6#4)(1992-8#9)(1992-9#4)(1993-11#1)(1993-12#5)(1993-3#7)(1993-5#4)(1993-6#6)(1993-8#6)(1993-9#8)(1994-11#4)(1994-12#6)(1994-5#3)(1994-6#7)(1994-8#8)(1994-9#1)(1995-11#4)(1995-12#14)(1995-2#18)(1995-6#10)(1995-8#2)(1995-9#2)(1996-10#1)(1996-12#19)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#2)(1997-3#6)(1997-4#6)(1997-6#4)(1997-7#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#7)(2008-1#7)(2008-10#68)(2008-11#54)(2008-2#6)(2008-3#1)(2008-4#25)(2008-5#4)(2008-6#1)(2008-7#73)(2008-8#25)(2008-9#35)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#6)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#6)(2010-10#6)(2010-11#5)(2010-12#5)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#28)(2011-3#1)(2012-1#4)(2012-12#9)(2012-2#17)(2012-3#19)(2013-1#18)(2013-7#3)(2013-8#9)
gene extends##2##2##(1991-6#1)(1993-2#1)
gene families encoding##2##3##(2009-9#1)(2011-2#1)
gene families##8##2##(2008-7#2)(2008-9#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
gene family and##4##3##(1994-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
gene family encoding the##3##4##(1993-12#2)(2010-6#1)
gene family from##3##3##(1995-6#1)(1997-2#2)
gene family in the##2##4##(1993-12#2)
gene family in##4##3##(1993-12#2)(2008-9#1)(2009-10#1)
gene family members##3##3##(1990-5#1)(2011-1#1)(2012-12#1)
gene family of##5##3##(1991-5#2)(1994-9#1)(2008-8#2)
gene family with##3##3##(1993-12#1)(1993-2#1)(1993-3#1)
gene family##65##2##(1990-5#2)(1991-2#2)(1991-5#2)(1991-6#2)(1992-3#3)(1992-5#1)(1992-6#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-2#3)(1997-8#1)(2008-10#5)(2008-8#7)(2008-9#3)(2009-10#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
gene finders##2##2##(2008-4#1)(2008-9#1)
gene finding##2##2##(2008-4#2)
gene flow among these populations##3##5##(2008-10#2)(2011-2#1)
gene flow among##6##3##(2008-10#4)(2011-2#2)
gene flow and hybridization##2##4##(2011-2#2)
gene flow and migration##2##4##(2013-1#2)
gene flow and the##2##4##(2008-10#1)(2011-2#1)
gene flow and##7##3##(2008-10#2)(2011-2#3)(2013-1#2)
gene flow between species##2##4##(2009-2#1)(2012-3#1)
gene flow between the##2##4##(2008-5#1)(2012-3#1)
gene flow between##14##3##(2008-10#4)(2008-5#1)(2009-2#1)(2011-2#2)(2012-3#4)(2013-1#2)
gene flow occurred##2##3##(2008-10#1)(2008-9#1)
gene flow was##2##3##(2009-2#1)(2012-3#1)
gene flow were inferred##2##4##(2008-10#1)(2010-8#1)
gene flow were##3##3##(2008-10#2)(2010-8#1)
gene flow##64##2##(1994-3#1)(2008-10#22)(2008-5#1)(2008-8#2)(2008-9#5)(2009-2#5)(2010-8#2)(2011-2#10)(2012-3#9)(2013-1#5)(2013-7#2)
gene for a##3##3##(1992-3#1)(1993-3#1)(1994-8#1)
gene for bacterial blight resistance in rice##2##7##(2008-10#2)
gene for hereditary##2##3##(1994-6#1)(2011-2#1)
gene for human##4##3##(1990-8#1)(1992-1#1)(1992-8#1)(1994-11#1)
gene for insensitivity##2##3##(2008-10#2)
gene for leaf rust resistance##2##5##(2008-10#2)
gene for neovascular AMD##2##4##(2010-2#2)
gene for resistance to race 2 which segregates independently of Xa10##2##11##(2008-10#2)
gene for resistance to white pine blister rust in##2##9##(2008-10#2)
gene for resistance to white pine blister rust##3##8##(2008-10#3)
gene for resistance to white pine blister##4##7##(2008-10#4)
gene for resistance to##14##4##(2008-10#13)(2008-5#1)
gene for resistance##17##3##(2008-10#16)(2008-5#1)
gene for the##6##3##(1994-12#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-11#1)(2008-7#1)
gene for type##2##3##(1993-6#1)(1994-11#1)
gene for which##2##3##(1996-12#1)(1997-6#1)
gene for##83##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#4)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#28)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
gene found in##2##3##(1993-3#1)(2008-9#1)
gene fragment was##3##3##(1990-11#1)(2008-8#1)(2010-6#1)
gene fragment##11##2##(1990-11#1)(1994-11#1)(1994-8#1)(1997-2#3)(1997-4#1)(2008-8#1)(2008-9#2)(2010-6#1)
gene fragments from##3##3##(1990-5#1)(1996-2#1)(2008-1#1)
gene fragments in##2##3##(1993-8#1)(1997-4#1)
gene fragments##12##2##(1990-5#1)(1993-8#1)(1996-2#1)(1997-4#2)(2008-1#1)(2008-4#4)(2008-8#1)(2013-8#1)
gene frequencies##4##2##(1991-11#1)(1995-5#1)(2008-10#1)(2008-8#1)
gene frequency##4##2##(1991-11#1)(2008-4#1)(2008-8#1)(2012-3#1)
gene from Arabidopsis thaliana##2##4##(1992-3#1)(2008-10#1)
gene from Bacillus##2##3##(1990-11#1)(1992-3#1)
gene from Streptococcus##2##3##(1991-9#1)(1992-9#1)
gene from Streptomyces coelicolor##2##4##(1995-8#1)(2011-2#1)
gene from Streptomyces##4##3##(1995-8#1)(2008-8#2)(2011-2#1)
gene from Thermus##2##3##(1994-12#1)(1997-4#1)
gene from a##5##3##(1993-3#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-5#1)
gene from genomic DNA##2##4##(1991-7#1)(1992-8#1)
gene from the hyperthermophilic archaeum Pyrococcus furiosus##2##7##(1994-12#2)
gene from the patient revealed a homozygous nucleotide change##3##9##(1993-3#1)(1993-6#1)(1994-11#1)
gene from the##19##3##(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1995-6#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-1#1)
gene from##75##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#8)(1995-12#1)(1995-6#1)(1995-8#4)(1996-6#1)(1997-2#3)(1997-4#2)(1997-7#1)(2008-10#13)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
gene function and##4##3##(2008-2#1)(2008-7#2)(2010-5#1)
gene function by##2##3##(1995-2#1)(2008-8#1)
gene function in##4##3##(1994-3#1)(2008-2#1)(2008-4#1)(2010-6#1)
gene function##29##2##(1990-2#1)(1991-5#1)(1993-9#2)(1994-3#1)(1995-2#2)(1997-8#1)(2008-10#1)(2008-2#3)(2008-4#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-3#1)
gene functions and##3##3##(1991-9#1)(2007-6#1)(2008-4#1)
gene functions in##2##3##(2007-6#1)(2012-3#1)
gene functions##11##2##(1991-9#1)(1993-3#1)(1994-8#2)(2007-6#3)(2008-4#1)(2009-5#1)(2010-5#1)(2012-3#1)
gene fused to##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
gene fusion which##2##3##(1990-7#1)(1991-6#1)
gene fusion##8##2##(1990-7#1)(1991-6#1)(1995-6#2)(2008-7#2)(2008-8#1)(2011-2#1)
gene fusions encoding##2##3##(1991-10#1)(1991-6#1)
gene fusions##11##2##(1990-5#1)(1991-10#1)(1991-6#1)(1997-7#2)(2008-6#1)(2008-8#1)(2008-9#2)(2012-12#2)
gene genealogies##4##2##(2008-10#3)(2009-2#1)
gene had a##2##3##(2008-10#2)
gene had been deleted##2##4##(1990-5#1)(1995-2#1)
gene had been##3##3##(1990-5#1)(1995-2#2)
gene had integrated##2##3##(2008-4#1)(2008-8#1)
gene had##9##2##(1990-5#1)(1995-2#2)(2008-10#3)(2008-4#1)(2008-8#2)
gene has an##4##3##(1992-6#2)(1993-2#1)(1995-9#1)
gene has been cloned##3##4##(1990-5#1)(1995-8#1)(1997-8#1)
gene has been found in##2##5##(1997-7#1)(2008-8#1)
gene has been identified##3##4##(1993-11#1)(2008-7#1)(2008-8#1)
gene has been shown to##2##5##(1994-6#1)(1996-12#1)
gene has been##16##3##(1990-2#1)(1990-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#2)
gene has##30##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)
gene have also##2##3##(1995-11#1)(2008-11#1)
gene have been constructed##2##4##(1990-11#1)(1993-12#1)
gene have been identified##2##4##(1995-6#1)(2008-10#1)
gene have been shown##2##4##(1995-2#1)(2012-2#1)
gene have been suggested##2##4##(2008-12#1)(2008-4#1)
gene have been##10##3##(1990-11#1)(1993-12#2)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-2#1)
gene have##14##2##(1990-11#1)(1993-12#2)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-2#1)
gene homologous##2##2##(2008-10#1)(2008-8#1)
gene homologs##3##2##(1991-12#1)(1997-4#1)(2008-7#1)
gene homologues##2##2##(1997-3#1)(2008-8#1)
gene hph##2##2##(2008-10#2)
gene identification##6##2##(2008-4#2)(2008-7#2)(2009-6#1)(2012-2#1)
gene identified in##2##3##(2008-10#2)
gene identified##8##2##(1994-9#1)(1995-8#1)(2008-10#3)(2008-9#1)(2009-6#1)(2012-2#1)
gene implicated##2##2##(1991-5#1)(1994-11#1)
gene in A##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
gene in Aspergillus##2##3##(1991-9#1)(1997-7#1)
gene in Drosophila melanogaster##2##4##(1993-2#1)(1997-6#1)
gene in Escherichia coli##2##4##(2008-8#1)(2011-1#1)
gene in Korean patients with##2##5##(1997-4#1)(1997-8#1)
gene in S##2##3##(1997-7#1)(2008-8#1)
gene in X##2##3##(2008-10#2)
gene in a patient with##2##5##(1992-8#1)(1993-6#1)
gene in a##16##3##(1990-3#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-3#1)(2012-5#1)
gene in addition to##2##4##(1997-8#1)(2008-9#1)
gene in an##3##3##(1993-2#1)(1997-7#1)(2012-3#1)
gene in bovine##2##3##(1991-8#1)(1992-10#1)
gene in cv##2##3##(2008-10#2)
gene in familial##2##3##(1990-5#1)(2008-4#1)
gene in four##2##3##(1993-3#1)(1994-8#1)
gene in human cancer##2##4##(1993-9#1)(1994-9#1)
gene in human##3##3##(1993-3#1)(1993-9#1)(1994-9#1)
gene in mammalian cells##3##4##(1991-9#1)(1997-7#1)(2008-11#1)
gene in mouse##3##3##(1995-2#1)(1996-5#1)(2008-8#1)
gene in order to##2##4##(1994-5#1)(2008-10#1)
gene in patients with##2##4##(1994-11#1)(2011-1#1)
gene in patients##3##3##(1994-11#1)(1997-5#1)(2011-1#1)
gene in plasmid##2##3##(1991-7#1)(2008-8#1)
gene in purified##2##3##(1991-12#1)(1991-9#1)
gene in rice##5##3##(1995-6#1)(2008-10#1)(2008-8#2)(2009-8#1)
gene in the##38##3##(1990-11#3)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#2)(1993-11#2)(1993-9#1)(1994-12#1)(1995-11#1)(1995-6#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
gene in their##2##3##(2008-2#1)(2008-7#1)
gene in these##2##3##(1991-1#1)(1997-7#1)
gene in this##2##3##(1997-3#1)(2007-10#1)
gene in transfected##2##3##(1992-9#1)(1994-8#1)
gene in transgenic mice##2##4##(1990-8#1)(1994-9#1)
gene in transgenic plants##2##4##(2008-8#2)
gene in transgenic##10##3##(1990-8#1)(1994-9#1)(2008-8#3)(2008-9#5)
gene in vivo##3##3##(1991-9#1)(2008-7#1)(2011-2#1)
gene in##266##2##(1990-11#3)(1990-12#4)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-8#5)(1992-9#3)(1993-11#4)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#4)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#4)(1995-3#2)(1995-6#4)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#5)(2007-10#2)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#45)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#18)(2008-9#9)(2009-10#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-5#2)(2013-1#4)
gene inactivation in##2##3##(2008-12#1)(2012-12#1)
gene inactivation##3##2##(2008-12#1)(2008-5#1)(2012-12#1)
gene inactivations##2##2##(2008-4#2)
gene indicated that the##2##4##(2008-10#1)(2008-8#1)
gene indicated that##3##3##(2008-10#2)(2008-8#1)
gene indicated##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
gene indicates##2##2##(2008-6#1)(2008-7#1)
gene induction##2##2##(1991-5#1)(2011-1#1)
gene information##3##2##(1997-6#1)(1997-8#1)(2008-7#1)
gene insertion##2##2##(1997-3#1)(2008-4#1)
gene interactions in##2##3##(2010-10#2)
gene interactions##6##2##(2008-10#2)(2008-7#1)(2009-5#1)(2010-10#2)
gene into a##3##3##(1990-5#1)(1993-8#1)(1997-8#1)
gene into the##6##3##(1990-11#1)(1992-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
gene into##21##2##(1990-11#1)(1990-5#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-8#3)(2008-9#1)(2013-8#1)
gene involved in##9##3##(1990-5#1)(1993-9#1)(1995-9#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-3#1)
gene is a##12##3##(1992-12#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
gene is about##2##3##(1992-8#1)(1997-8#1)
gene is an important##2##4##(1990-8#1)(2008-10#1)
gene is attached to##2##4##(1996-6#1)(2008-4#1)
gene is composed of 18 exons##3##6##(1991-6#1)(1993-3#1)(1994-11#1)
gene is composed of##7##4##(1990-12#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1997-2#1)(2008-9#1)
gene is designated##5##3##(2008-10#4)(2008-9#1)
gene is encoded by a##2##5##(1994-12#1)(1995-8#1)
gene is essential for##2##4##(1994-8#1)(2008-9#1)
gene is expressed in##6##4##(1991-12#1)(1993-3#1)(1995-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
gene is expressed##9##3##(1991-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-8#1)(2008-9#1)
gene is highly##3##3##(1991-6#1)(1992-12#1)(1993-3#1)
gene is in##2##3##(2008-5#1)(2008-8#1)
gene is induced##3##3##(1995-8#1)(1997-7#1)(2008-10#1)
gene is interrupted by##2##4##(1991-9#1)(1997-6#1)
gene is involved in the##3##5##(1993-8#1)(2008-10#1)(2008-8#1)
gene is involved in##4##4##(1993-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
gene is located on the##2##5##(1995-6#1)(2008-8#1)
gene is located on##3##4##(1991-6#1)(1995-6#1)(2008-8#1)
gene is located##4##3##(1991-6#1)(1995-6#1)(1997-9#1)(2008-8#1)
gene is most##2##3##(1993-12#1)(1993-2#1)
gene is mutated##2##3##(1991-5#1)(1992-9#1)
gene is not essential for##2##5##(1993-9#1)(1995-2#1)
gene is not##7##3##(1990-11#1)(1991-2#1)(1993-9#2)(1994-12#1)(1995-2#1)(1997-7#1)
gene is present in##2##4##(1991-11#1)(2008-10#1)
gene is present##4##3##(1991-11#1)(1991-9#1)(1993-2#1)(2008-10#1)
gene is presented##2##3##(1992-12#1)(2008-4#1)
gene is probably##3##3##(1993-8#1)(2012-1#1)(2012-12#1)
gene is regulated by##3##4##(1990-11#1)(1991-12#1)(1995-8#1)
gene is the##3##3##(1993-2#1)(1996-12#1)(2009-5#1)
gene is transcribed##2##3##(1993-9#1)(1997-2#1)
gene is transcriptionally##2##3##(1990-11#1)(2008-9#1)
gene is used as##2##4##(2008-10#1)(2008-5#1)
gene is##160##2##(1990-11#6)(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#4)(1991-9#2)(1992-11#1)(1992-12#5)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#7)(1993-3#4)(1993-6#1)(1993-8#4)(1993-9#5)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#6)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#6)(1997-8#2)(1997-9#3)(2007-11#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#11)(2008-9#9)(2009-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
gene isolated from##2##3##(1996-3#1)(2008-8#1)
gene itself##4##2##(1990-5#1)(1993-2#1)(1997-7#1)(2008-4#1)
gene knockout mice##2##3##(2008-12#1)(2008-9#1)
gene knockout system for plants##2##5##(2008-7#2)
gene knockout##6##2##(2008-12#1)(2008-7#3)(2008-9#1)(2009-11#1)
gene knockouts##2##2##(2008-4#2)
gene known##2##2##(2008-10#1)(2008-7#1)
gene level##5##2##(2008-10#1)(2008-11#2)(2012-2#1)(2012-3#1)
gene library##5##2##(1992-9#2)(1995-2#1)(2008-10#1)(2008-6#1)
gene lies##2##2##(1990-11#1)(1994-12#1)
gene linked to the chloramphenicol acetyltransferase (CAT)##2##7##(1990-8#1)(1991-2#1)
gene linked to the##4##4##(1990-8#1)(1991-2#1)(1993-8#1)(1994-5#1)
gene linked to##5##3##(1990-8#1)(1991-2#1)(1993-8#1)(1994-12#1)(1994-5#1)
gene list##3##2##(2013-8#3)
gene located at##3##3##(1991-10#1)(1996-10#1)(2008-10#1)
gene located on chromosome##2##4##(1996-3#1)(2008-7#1)
gene located on the long arm of##2##7##(2008-10#1)(2008-9#1)
gene located on the##3##4##(2008-10#1)(2008-9#2)
gene located on##6##3##(1996-3#1)(2008-10#2)(2008-7#1)(2008-9#2)
gene located##11##2##(1991-10#1)(1992-9#1)(1996-10#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-7#1)(2008-9#2)
gene location##2##2##(1993-3#1)(2008-11#1)
gene loci##5##2##(1993-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
gene locus was##2##3##(2008-11#1)(2009-8#1)
gene locus##13##2##(1991-12#1)(1992-8#1)(1994-2#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)
gene loss##3##2##(2008-1#1)(2008-10#1)(2009-5#1)
gene mRNA##2##2##(2008-10#1)(2008-9#1)
gene mapping##5##2##(1995-6#1)(1995-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
gene maps##2##2##(1993-12#1)(1994-12#1)
gene markers##2##2##(1991-5#1)(2008-10#1)
gene may be##7##3##(1991-9#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#2)
gene may have##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
gene may not##2##3##(1991-8#1)(2008-4#1)
gene may play##2##3##(1993-8#1)(2008-10#1)
gene may##21##2##(1991-12#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-12#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#4)
gene microarrays##2##2##(2010-12#1)(2010-6#1)
gene might##3##2##(1997-8#1)(2008-10#1)(2009-7#1)
gene models##7##2##(2008-4#3)(2008-9#1)(2009-10#2)(2012-3#1)
gene modified##2##2##(2008-10#1)(2008-5#1)
gene mutation analysis##2##3##(2008-2#1)(2013-8#1)
gene mutation and##2##3##(1995-10#1)(2007-12#1)
gene mutation##12##2##(1990-8#1)(1993-8#1)(1994-12#1)(1995-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-9#1)(2010-4#1)(2013-8#1)
gene mutations and##3##3##(2009-8#1)(2010-4#1)(2010-8#1)
gene mutations in##2##3##(2008-2#1)(2008-8#1)
gene mutations##14##2##(2007-7#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-12#1)
gene named##2##2##(1995-6#1)(2012-12#1)
gene network##2##2##(2010-10#1)(2013-8#1)
gene networks in##2##3##(2010-5#1)(2013-1#1)
gene networks##14##2##(2008-1#2)(2008-2#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#7)
gene nomenclature##3##2##(2008-4#3)
gene number and##2##3##(2008-1#1)(2008-10#1)
gene number in##3##3##(2008-10#2)(2008-9#1)
gene number##5##2##(2008-1#1)(2008-10#3)(2008-9#1)
gene of B##2##3##(1997-4#1)(2008-10#1)
gene of C##2##3##(1990-5#1)(1995-8#1)
gene of Escherichia coli##4##4##(1990-11#1)(1991-9#1)(1994-12#1)(1997-7#1)
gene of S##2##3##(1997-3#1)(2008-8#1)
gene of Saccharomyces cerevisiae##5##4##(1990-5#2)(1995-2#1)(1995-6#1)(1996-3#1)
gene of Xanthomonas##2##3##(2008-10#2)
gene of a##5##3##(2008-10#4)(2008-8#1)
gene of approximately##2##3##(1992-12#1)(1995-6#1)
gene of human immunodeficiency virus##2##5##(1994-8#1)(1997-3#1)
gene of human influenza A viruses (H1 subtype)##2##8##(1994-8#2)
gene of human influenza A viruses##3##6##(1994-8#3)
gene of human##6##3##(1994-8#4)(1997-3#1)(2008-8#1)
gene of interest and##3##4##(2008-11#2)(2008-2#1)
gene of interest into a##2##5##(2008-2#1)(2008-9#1)
gene of interest##14##3##(1996-6#2)(1997-4#1)(2008-11#4)(2008-2#4)(2008-4#1)(2008-9#2)
gene of the##20##3##(1990-11#4)(1993-9#1)(1995-11#1)(1995-6#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-8#1)(2011-1#1)
gene of##135##2##(1990-11#8)(1990-12#2)(1990-5#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-6#6)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#5)(1997-8#1)(2007-7#1)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#4)(2009-5#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
gene on a##2##3##(2008-10#1)(2008-8#1)
gene on chromosome 1##2##4##(1995-8#2)
gene on chromosome##11##3##(1993-12#1)(1993-2#1)(1995-8#4)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-6#1)
gene on the growth##2##4##(2008-9#1)(2011-2#1)
gene on the long arm of##2##6##(2008-10#2)
gene on the##9##3##(1995-9#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2011-2#3)
gene on##34##2##(1990-5#1)(1991-2#1)(1993-12#1)(1993-2#1)(1995-8#4)(1995-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2010-4#2)(2011-1#1)(2011-2#3)(2013-1#1)
gene ontology##4##2##(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
gene or genes##4##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)
gene or##14##2##(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
gene order of the##2##4##(1996-12#1)(1997-2#1)
gene order##8##2##(1990-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(2009-10#1)(2010-7#1)(2013-8#1)
gene ordering##2##2##(2008-4#1)(2008-8#1)
gene organization of##2##3##(1996-6#1)(1997-7#1)
gene organization##8##2##(1990-5#1)(1992-10#1)(1994-12#2)(1995-11#1)(1996-6#1)(1997-7#2)
gene organizations##2##2##(1995-6#1)(1996-12#1)
gene originating from##2##3##(1990-11#1)(2008-10#1)
gene p53##4##2##(1994-9#1)(2008-10#3)
gene pairs##3##2##(2008-6#1)(2008-7#1)(2011-3#1)
gene pathways##3##2##(2008-7#1)(2012-3#2)
gene polymorphism and the##2##4##(2011-1#1)(2012-2#1)
gene polymorphism and##5##3##(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
gene polymorphism in##4##3##(2010-8#1)(2011-1#2)(2013-1#1)
gene polymorphism##26##2##(1997-5#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2010-10#1)(2010-2#3)(2010-8#1)(2011-1#7)(2012-2#2)(2013-1#3)(2013-8#1)
gene polymorphisms and chronic periodontitis##2##5##(2012-3#1)(2013-1#1)
gene polymorphisms are##2##3##(2012-12#1)(2012-3#1)
gene polymorphisms at position##2##4##(2011-1#2)
gene polymorphisms in##3##3##(2011-2#1)(2012-2#2)
gene polymorphisms were##2##3##(2010-8#2)
gene polymorphisms##22##2##(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)
gene pool##9##2##(1995-11#1)(2007-12#1)(2008-10#4)(2009-10#1)(2010-8#1)(2011-2#1)
gene pools (Andean and##2##4##(2008-10#2)
gene pools##11##2##(2008-10#9)(2008-5#1)(2011-2#1)
gene prediction using GeneMark##2##4##(2008-4#2)
gene present in##3##3##(2008-10#2)(2013-1#1)
gene prioritization##3##2##(2011-2#3)
gene probe##6##2##(1992-2#1)(2008-8#5)
gene probes##2##2##(1992-3#1)(1996-6#1)
gene produces a##2##3##(1994-12#1)(1997-8#1)
gene product and##2##3##(1992-3#1)(1992-9#1)
gene product functions##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
gene product have been##2##4##(1995-6#1)(2008-4#1)
gene product is a##4##4##(1991-2#1)(1991-5#1)(1993-9#1)(2008-11#1)
gene product is##11##3##(1990-5#1)(1991-2#2)(1991-5#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-3#2)(1997-2#1)(2008-11#1)
gene product of##4##3##(1990-5#1)(1992-9#1)(1994-12#1)(1997-4#1)
gene product that##2##3##(1990-5#1)(1991-10#1)
gene product were##3##3##(1994-3#1)(2008-6#2)
gene product##85##2##(1990-11#4)(1990-12#1)(1990-5#5)(1991-10#2)(1991-2#2)(1991-5#3)(1991-9#3)(1992-12#4)(1992-3#3)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#3)(1994-11#4)(1994-12#1)(1994-3#5)(1994-8#1)(1995-2#8)(1995-6#4)(1995-8#1)(1996-3#3)(1997-2#2)(1997-4#1)(1997-7#2)(2008-10#6)(2008-11#2)(2008-4#2)(2008-6#2)(2008-7#1)(2009-9#1)
gene products and the##2##4##(2006-10#1)(2008-7#1)
gene products and##5##3##(1994-12#1)(1997-4#1)(2006-10#1)(2008-7#1)(2010-5#1)
gene products are##2##3##(1994-8#2)
gene products have been##2##4##(1995-2#1)(2008-8#1)
gene products in##2##3##(1993-8#1)(2009-9#1)
gene products involved in##2##4##(1995-9#1)(1996-3#1)
gene products is##3##3##(1994-11#1)(1995-9#1)(2008-7#1)
gene products that may##2##4##(1995-11#1)(1997-4#1)
gene products that##3##3##(1995-11#1)(1997-4#1)(2010-12#1)
gene products##47##2##(1990-11#2)(1990-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-9#3)(1996-3#1)(1997-3#1)(1997-4#3)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-9#2)(2010-12#1)(2010-5#1)(2012-2#1)
gene profiling##4##2##(2008-7#2)(2010-3#1)(2012-3#1)
gene promoter activity##2##3##(1995-6#1)(1995-8#1)
gene promoter and##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
gene promoter has been##3##4##(1991-5#1)(2008-5#1)(2008-9#1)
gene promoter polymorphisms##2##3##(2009-12#1)(2012-12#1)
gene promoter region##2##3##(1990-11#1)(1993-12#1)
gene promoter was##2##3##(1994-6#1)(2010-5#1)
gene promoter##26##2##(1990-11#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#1)
gene promoters in##2##3##(1992-9#1)(2008-4#1)
gene promoters##8##2##(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(2008-4#2)(2008-7#1)(2011-1#1)
gene provides##2##2##(1992-6#1)(2008-10#1)
gene rearrangement##9##2##(1994-11#1)(1994-9#1)(2008-4#1)(2008-6#1)(2009-8#4)(2010-3#1)
gene rearrangements##4##2##(1995-11#1)(2008-6#1)(2009-8#2)
gene recognition##2##2##(2008-7#2)
gene recombination and transposon##2##4##(2009-10#2)
gene recombination##3##2##(2009-10#2)(2009-8#1)
gene redundancy##2##2##(2009-10#1)(2009-6#1)
gene region##10##2##(1992-9#2)(1994-8#1)(1996-5#1)(1996-8#2)(1997-8#1)(2008-6#1)(2008-8#2)
gene regions were##2##3##(2008-10#2)
gene regions##10##2##(1996-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2013-7#1)
gene regulation and##5##3##(1993-8#1)(1995-2#2)(1997-7#1)(2008-9#1)
gene regulation by##3##3##(1995-11#1)(1995-6#1)(2011-2#1)
gene regulation in eukaryotes##2##4##(2008-7#1)(2009-5#1)
gene regulation in##4##3##(2008-7#2)(2009-5#1)(2010-10#1)
gene regulation is##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
gene regulation##40##2##(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#2)(1995-2#4)(1995-6#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#8)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
gene regulatory elements##2##3##(1993-6#1)(2009-5#1)
gene regulatory network##2##3##(2008-7#1)(2010-4#1)
gene regulatory networks is##2##4##(2008-8#1)(2011-2#1)
gene regulatory networks##7##3##(2008-7#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
gene regulatory##13##2##(1993-6#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-4#2)(2011-2#1)(2013-1#2)
gene related peptide##2##3##(1991-3#1)(1992-9#1)
gene related##3##2##(1991-3#1)(1992-9#1)(1997-2#1)
gene repeat##2##2##(1991-8#1)(2013-1#1)
gene replacement##5##2##(1996-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
gene reporter##2##2##(1992-12#1)(2008-9#1)
gene required for##5##3##(1993-2#2)(1993-3#1)(1995-9#1)(2008-10#1)
gene responsible for##7##3##(1990-8#1)(1995-5#1)(2007-7#1)(2008-4#3)(2010-8#1)
gene responsible##8##2##(1990-8#1)(1993-6#1)(1995-5#1)(2007-7#1)(2008-4#3)(2010-8#1)
gene restriction##2##2##(1990-3#1)(2008-10#1)
gene resulted in embryonic##2##4##(2008-8#1)(2008-9#1)
gene resulted in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
gene resulting in##2##3##(1995-2#1)(2008-9#1)
gene results in##5##3##(1994-3#1)(1995-2#1)(2008-11#1)(2008-8#1)(2012-12#1)
gene results##6##2##(1994-3#1)(1995-2#1)(2008-11#2)(2008-8#1)(2012-12#1)
gene revealed a##2##3##(1992-8#1)(2011-1#1)
gene revealed that##3##3##(1995-2#1)(2008-10#2)
gene revealed##7##2##(1992-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#2)(2011-1#1)
gene segment##2##2##(2008-7#1)(2013-8#1)
gene segments##11##2##(1991-2#1)(1991-6#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2012-2#1)(2012-3#2)
gene sequence analyses##2##3##(1997-4#1)(2013-1#1)
gene sequence analysis##2##3##(2008-8#1)(2011-1#1)
gene sequence and##2##3##(2008-8#1)(2009-6#1)
gene sequence##20##2##(1991-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#2)(2009-6#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
gene sequences and##2##3##(1993-9#1)(2008-5#1)
gene sequences available in##2##4##(1994-12#1)(2008-10#1)
gene sequences for##2##3##(2008-10#1)(2008-4#1)
gene sequences of##4##3##(2008-10#2)(2008-12#1)(2011-1#1)
gene sequences that##2##3##(1992-9#1)(1994-8#1)
gene sequences were##2##3##(1997-4#1)(2008-10#1)
gene sequences##36##2##(1991-12#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-10#1)(1997-4#2)(2008-10#10)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
gene sequencing##7##2##(1994-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
gene set##2##2##(1995-3#1)(2009-6#1)
gene sets##5##2##(1992-3#1)(1995-3#1)(2008-4#1)(2008-7#1)(2010-5#1)
gene shares##3##2##(1992-12#1)(1993-8#1)(2008-9#1)
gene showed that##2##3##(2008-10#2)
gene showed##6##2##(1993-3#1)(1997-7#1)(2008-10#2)(2009-8#1)(2011-2#1)
gene silencing (PTGS)##4##3##(2008-10#3)(2008-9#1)
gene silencing in##5##3##(2008-2#2)(2008-9#1)(2011-1#1)(2013-1#1)
gene silencing##18##2##(2007-11#2)(2008-10#5)(2008-2#3)(2008-9#4)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
gene single nucleotide##2##3##(2013-7#1)(2013-8#1)
gene spanned##2##2##(1992-11#1)(1997-7#1)
gene spans##3##2##(1991-5#1)(1993-3#1)(1994-11#1)
gene specific##4##2##(1992-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
gene specifically##2##2##(1995-6#1)(1997-2#1)
gene stability##2##2##(1994-3#1)(2008-6#1)
gene status##3##2##(1997-7#1)(2008-10#1)(2009-7#1)
gene structure and##4##3##(1992-9#1)(1993-6#2)(1995-2#1)
gene structure of##2##3##(1991-5#1)(1992-8#1)
gene structure##10##2##(1991-5#1)(1992-8#1)(1992-9#1)(1993-6#3)(1995-2#1)(1995-8#1)(2008-7#1)(2010-5#1)
gene structures##2##2##(1993-3#1)(2009-10#1)
gene studies##2##2##(2007-10#1)(2010-11#1)
gene system##2##2##(1990-11#1)(2008-10#1)
gene systems##2##2##(2008-8#1)(2008-9#1)
gene targeting in mouse embryonic stem cells##2##7##(1995-2#1)(2008-11#1)
gene targeting in mouse embryonic stem##3##6##(1995-2#1)(2008-11#2)
gene targeting##18##2##(1993-3#1)(1994-8#2)(1995-2#1)(2008-11#4)(2008-2#5)(2008-9#3)(2010-2#2)
gene targets of##2##3##(2007-11#1)(2008-10#1)
gene targets##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
gene technology##5##2##(1991-11#3)(1997-4#1)(2008-5#1)
gene than##2##2##(2008-9#1)(2012-2#1)
gene that causes the disease##2##5##(1994-8#1)(2009-10#1)
gene that confers##2##3##(1995-2#1)(2008-10#1)
gene that contained##2##3##(1993-12#1)(2010-5#1)
gene that encodes a##5##4##(1990-11#1)(1993-2#1)(1994-12#1)(2008-10#2)
gene that encodes the##3##4##(2008-4#1)(2008-9#1)(2013-1#1)
gene that encodes##11##3##(1990-11#1)(1993-2#1)(1994-12#1)(1995-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
gene that is##11##3##(1992-11#1)(1993-12#1)(1994-8#1)(1994-9#1)(2008-10#3)(2011-2#2)(2012-2#2)
gene that results in##2##4##(1994-12#1)(2007-8#1)
gene that specifies##2##3##(1990-11#1)(2008-10#1)
gene that was##2##3##(1993-9#1)(2008-10#1)
gene that##51##2##(1990-11#3)(1990-5#1)(1992-11#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#1)
gene therapy also##2##3##(1995-6#1)(2008-9#1)
gene therapy and##7##3##(1993-6#1)(2008-11#3)(2008-5#2)(2011-2#1)
gene therapy applications##2##3##(2008-11#1)(2008-5#1)
gene therapy approach##2##3##(1994-5#1)(1995-2#1)
gene therapy clinical trial for##3##5##(1994-5#1)(2008-5#2)
gene therapy for the treatment of##2##6##(2008-5#1)(2008-8#1)
gene therapy for the##3##4##(2008-5#2)(2008-8#1)
gene therapy for##12##3##(1994-5#2)(2007-11#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-1#1)(2011-3#2)
gene therapy in##3##3##(2008-4#1)(2011-1#1)(2013-8#1)
gene therapy is##2##3##(2008-5#2)
gene therapy of##7##3##(1994-5#1)(1997-1#1)(2008-8#4)(2013-8#1)
gene therapy protocols##3##3##(1994-5#1)(2008-1#1)(2008-11#1)
gene therapy to##3##3##(1994-5#1)(2008-11#1)(2008-9#1)
gene therapy trials##3##3##(1997-1#1)(2008-8#2)
gene therapy##127##2##(1991-8#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-5#16)(1994-8#1)(1995-2#2)(1995-6#3)(1995-8#3)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#5)(2007-7#1)(2008-1#1)(2008-11#16)(2008-4#4)(2008-5#21)(2008-8#18)(2008-9#6)(2010-1#2)(2010-10#3)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-3#1)(2013-8#5)
gene to a##6##3##(1991-6#1)(1993-2#1)(1996-6#1)(2008-10#2)(2008-8#1)
gene to be##5##3##(1995-11#1)(2008-2#1)(2008-4#2)(2008-7#1)
gene to chromosome##3##3##(1991-9#1)(1994-12#1)(2008-7#1)
gene to enhance##2##3##(2008-10#2)
gene to human chromosome##2##4##(1997-6#1)(1997-8#1)
gene to human##3##3##(1997-6#1)(1997-8#1)(2008-8#1)
gene to the##6##3##(1995-9#1)(1997-8#1)(2008-9#2)(2010-11#1)(2010-5#1)
gene to##47##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#3)(2008-10#9)(2008-12#2)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#2)(2010-11#2)(2010-5#1)
gene transcript##7##2##(2008-7#2)(2008-8#2)(2011-2#2)(2012-2#1)
gene transcription and##7##3##(1994-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-8#1)(2008-9#1)
gene transcription by##5##3##(1990-5#1)(1994-11#1)(1996-2#1)(1997-1#1)(2008-8#1)
gene transcription in##6##3##(1990-11#1)(1993-6#2)(1994-8#1)(1997-1#1)(2008-8#1)
gene transcription##54##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#3)(1992-3#1)(1993-6#4)(1994-11#3)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#4)(1996-3#1)(1997-1#3)(1997-3#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
gene transcripts in##3##3##(1992-8#1)(1997-8#1)(2008-4#1)
gene transcripts was##3##3##(1990-12#2)(2008-10#1)
gene transcripts were##3##3##(2008-5#2)(2011-2#1)
gene transcripts##16##2##(1990-12#2)(1992-8#1)(1996-10#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
gene transfected MSCs were##3##4##(2008-5#3)
gene transfected MSCs##4##3##(2008-5#4)
gene transfected stromal cells##2##4##(2008-8#2)
gene transfected##9##2##(2008-5#5)(2008-8#4)
gene transfection##10##2##(1996-12#5)(1996-2#2)(1996-9#1)(2008-9#2)
gene transfer and bone marrow transplantation##2##6##(2008-11#2)
gene transfer and##13##3##(1994-5#2)(1995-8#1)(2008-11#5)(2008-2#1)(2008-8#1)(2008-9#2)(2012-2#1)
gene transfer approaches##2##3##(2008-9#1)(2009-5#1)
gene transfer can##2##3##(2008-8#1)(2012-3#1)
gene transfer for the##2##4##(1994-5#2)
gene transfer in vivo##2##4##(1995-2#1)(1997-4#1)
gene transfer in##7##3##(1994-5#2)(1995-2#1)(1997-4#1)(2008-4#1)(2011-2#1)(2011-3#1)
gene transfer into mammalian##2##4##(1991-9#1)(2008-8#1)
gene transfer into##12##3##(1991-9#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)
gene transfer is##2##3##(1995-12#1)(2008-10#1)
gene transfer may##2##3##(1994-5#1)(2008-10#1)
gene transfer methods##3##3##(1995-2#1)(2007-11#1)(2008-11#1)
gene transfer of##3##3##(1994-5#1)(2008-8#1)(2010-12#1)
gene transfer technique##2##3##(1995-12#1)(1997-4#1)
gene transfer to##4##3##(1994-11#1)(1994-5#2)(2008-4#1)
gene transfer vector##3##3##(1997-3#2)(2008-8#1)
gene transfer vectors##3##3##(2008-4#2)(2008-5#1)
gene transfer which##3##3##(1996-5#1)(2008-11#1)(2008-8#1)
gene transfer##99##2##(1991-9#2)(1994-11#2)(1994-5#18)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#4)(1995-8#1)(1996-5#1)(1997-3#2)(1997-4#5)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#10)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#10)(2008-9#10)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)
gene transferred##2##2##(2008-10#2)
gene tree topologies##2##3##(2012-3#2)
gene tree##5##2##(1997-5#1)(2010-8#1)(2012-3#3)
gene trees##4##2##(2010-6#2)(2012-3#1)(2013-1#1)
gene under control of the##2##5##(1991-5#1)(2008-10#1)
gene under control of##3##4##(1991-5#1)(1992-3#1)(2008-10#1)
gene under field##2##3##(2008-10#1)(2008-9#1)
gene under the control of the##3##6##(1994-12#1)(1997-4#1)(2008-10#1)
gene under the control of##11##5##(1994-12#1)(1994-5#2)(1995-8#1)(1997-4#2)(2008-10#2)(2008-9#3)
gene under##18##2##(1991-5#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-5#2)(1995-8#1)(1997-4#2)(2008-10#4)(2008-2#1)(2008-9#4)
gene variants in##3##3##(2013-1#3)
gene variants##6##2##(1993-9#1)(2012-3#1)(2013-1#4)
gene vector##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
gene via##3##2##(1992-3#1)(1994-9#2)
gene was also##3##3##(1994-6#1)(2008-10#1)(2013-1#1)
gene was amplified and##2##4##(2008-10#1)(2008-11#1)
gene was amplified by PCR##2##5##(2008-8#1)(2011-1#1)
gene was amplified by##6##4##(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)
gene was amplified##9##3##(2008-10#3)(2008-11#2)(2008-8#2)(2009-5#1)(2011-1#1)
gene was analyzed##3##3##(1992-8#1)(1994-6#1)(2008-8#1)
gene was associated with##2##4##(2008-12#1)(2008-9#1)
gene was cloned by##2##4##(1993-2#1)(2008-8#1)
gene was cloned into a##2##5##(1994-12#1)(2008-10#1)
gene was cloned##5##3##(1991-6#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-8#1)
gene was completely##2##3##(2008-10#2)
gene was confirmed##2##3##(2008-10#2)
gene was constructed##2##3##(1990-11#1)(2008-10#1)
gene was designated as##3##4##(1996-2#1)(2008-8#2)
gene was designated##4##3##(1996-2#1)(2008-10#1)(2008-8#2)
gene was detected by##2##4##(1992-9#1)(2011-2#1)
gene was detected in##7##4##(1991-5#1)(1997-3#1)(2008-10#5)
gene was detected##11##3##(1991-5#1)(1992-9#1)(1997-3#1)(2008-10#6)(2011-1#1)(2011-2#1)
gene was determined by##2##4##(1991-9#1)(1997-8#1)
gene was determined##5##3##(1991-11#1)(1991-9#1)(1997-8#1)(2008-10#1)(2012-12#1)
gene was examined##2##3##(1991-9#1)(1997-2#1)
gene was expressed in##4##4##(1991-9#1)(1997-4#1)(1997-7#1)(2008-9#1)
gene was expressed preferentially in##2##5##(1997-2#1)(2008-8#1)
gene was expressed##10##3##(1990-5#1)(1991-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)
gene was found in##5##4##(1991-8#1)(1992-8#1)(1997-9#1)(2011-2#2)
gene was found to be##2##5##(1990-11#1)(2008-8#1)
gene was found to##4##4##(1990-11#1)(1993-2#1)(1997-7#1)(2008-8#1)
gene was found##11##3##(1990-11#1)(1991-8#1)(1992-8#1)(1993-2#1)(1997-7#2)(1997-9#1)(2008-8#2)(2011-2#2)
gene was identified as##2##4##(1997-2#1)(2008-10#1)
gene was identified##6##3##(1993-9#1)(1995-2#1)(1997-2#1)(2006-8#1)(2008-10#2)
gene was in##2##3##(1997-4#1)(2008-10#1)
gene was inserted##2##3##(1994-2#1)(2008-10#1)
gene was integrated in##2##4##(2008-8#1)(2008-9#1)
gene was integrated##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
gene was introduced into##5##4##(1995-11#1)(1997-2#1)(2008-10#2)(2008-11#1)
gene was isolated and##3##4##(1990-8#1)(1995-2#1)(2008-5#1)
gene was isolated by##2##4##(1996-10#1)(2008-9#1)
gene was isolated from a##3##5##(1990-5#1)(1994-9#1)(1996-8#1)
gene was isolated from##4##4##(1990-5#1)(1994-9#1)(1996-8#1)(2008-8#1)
gene was isolated##10##3##(1990-5#1)(1990-8#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-8#1)(2008-5#1)(2008-8#1)(2008-9#1)
gene was localized to##2##4##(1994-8#1)(1997-7#1)
gene was localized##3##3##(1994-8#1)(1995-6#1)(1997-7#1)
gene was located in##2##4##(1997-6#1)(2008-10#1)
gene was located on chromosome##2##5##(1997-8#1)(2008-10#1)
gene was located on##4##4##(1992-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
gene was located within##2##4##(1997-6#1)(2013-1#1)
gene was located##11##3##(1992-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
gene was mapped in##2##4##(2008-9#1)(2012-3#1)
gene was mapped to##2##4##(1994-9#1)(1997-7#1)
gene was mapped##6##3##(1994-9#1)(1997-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
gene was not affected##2##4##(1994-11#1)(1997-2#1)
gene was not##7##3##(1992-1#1)(1994-11#1)(1997-2#2)(2008-10#2)(2008-8#1)
gene was observed##3##3##(1991-12#1)(1992-9#1)(2008-10#1)
gene was physically mapped##2##4##(1995-6#1)(1997-7#1)
gene was placed downstream##2##4##(1997-4#1)(2008-8#1)
gene was placed##4##3##(1997-4#3)(2008-8#1)
gene was previously##3##3##(1991-11#1)(2008-6#1)(2008-9#1)
gene was screened##2##3##(1995-6#1)(2008-8#1)
gene was sequenced##3##3##(1994-9#1)(2008-10#1)(2008-12#1)
gene was shown to produce a##2##6##(1993-9#1)(1997-7#1)
gene was studied by##2##4##(1992-11#1)(2008-8#1)
gene was studied##4##3##(1992-11#1)(1996-6#1)(2008-8#2)
gene was subcloned##2##3##(1990-5#1)(2008-9#1)
gene was successfully##3##3##(1993-11#1)(1997-8#1)(2008-10#1)
gene was used as a##2##5##(1991-5#1)(1997-7#1)
gene was used to##3##4##(1995-2#1)(2011-2#2)
gene was used##5##3##(1991-5#1)(1995-2#1)(1997-7#1)(2011-2#2)
gene was##220##2##(1990-11#2)(1990-5#4)(1990-8#1)(1991-11#2)(1991-12#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-3#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-2#3)(1993-3#3)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#4)(1995-6#3)(1996-10#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#9)(1997-3#1)(1997-4#8)(1997-6#4)(1997-7#9)(1997-8#6)(1997-9#1)(2006-8#1)(2008-1#1)(2008-10#44)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#25)(2008-9#13)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#4)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
gene were amplified##4##3##(1997-6#1)(2008-10#2)(2013-8#1)
gene were analyzed##2##3##(2008-10#2)
gene were cloned and##2##4##(1992-10#1)(2008-5#1)
gene were constructed##4##3##(1995-11#1)(2008-10#1)(2008-8#2)
gene were detected in##3##4##(1995-6#1)(2008-10#2)
gene were detected##4##3##(1995-6#1)(2008-10#2)(2008-5#1)
gene were identified##2##3##(1991-9#1)(2008-10#1)
gene were isolated and##2##4##(2008-11#1)(2008-8#1)
gene were polymerase chain##2##4##(2008-10#2)
gene were studied##3##3##(1996-5#1)(2008-10#2)
gene were used##2##3##(1993-11#1)(2008-10#1)
gene were##49##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-5#1)(1997-6#3)(1997-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-7#1)(2011-2#1)(2013-8#1)
gene which encodes a##3##4##(1990-6#1)(1992-7#1)(1997-3#1)
gene which encodes##5##3##(1990-6#1)(1992-7#1)(1996-6#1)(1997-3#1)(2008-1#1)
gene which is##5##3##(1997-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-7#1)
gene which was##4##3##(1992-9#1)(1996-2#1)(1996-8#1)(2008-2#1)
gene which##30##2##(1990-6#1)(1991-11#2)(1991-2#1)(1992-7#1)(1992-9#2)(1993-8#1)(1994-12#1)(1995-12#1)(1996-2#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)
gene whose function##2##3##(2008-8#1)(2009-5#1)
gene whose##3##2##(1994-12#1)(2008-8#1)(2009-5#1)
gene with a##5##3##(1991-6#1)(1993-9#1)(1996-12#1)(2008-7#1)(2008-8#1)
gene with other##2##3##(2008-10#2)
gene with the##2##3##(1997-3#1)(2008-10#1)
gene with those of##2##4##(1993-6#1)(2008-10#1)
gene with##33##2##(1990-5#1)(1990-9#1)(1991-6#1)(1993-6#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
gene within the##2##3##(1992-3#1)(2008-10#1)
gene within##3##2##(1992-3#1)(1996-12#1)(2008-10#1)
gene without##2##2##(2008-11#1)(2013-1#1)
gene##6085##1##(1990-11#66)(1990-12#29)(1990-2#7)(1990-3#4)(1990-5#72)(1990-6#2)(1990-7#17)(1990-8#19)(1990-9#1)(1991-1#4)(1991-10#6)(1991-11#15)(1991-12#34)(1991-2#23)(1991-3#3)(1991-4#2)(1991-5#47)(1991-6#46)(1991-7#19)(1991-8#12)(1991-9#62)(1992-1#5)(1992-10#14)(1992-11#10)(1992-12#40)(1992-2#3)(1992-3#49)(1992-4#5)(1992-5#4)(1992-6#22)(1992-7#1)(1992-8#54)(1992-9#49)(1993-1#3)(1993-11#22)(1993-12#67)(1993-2#57)(1993-3#73)(1993-5#6)(1993-6#61)(1993-8#51)(1993-9#50)(1994-10#2)(1994-11#59)(1994-12#135)(1994-2#7)(1994-3#13)(1994-5#59)(1994-6#21)(1994-8#63)(1994-9#32)(1995-10#1)(1995-11#28)(1995-12#36)(1995-2#107)(1995-3#6)(1995-5#9)(1995-6#111)(1995-8#73)(1995-9#25)(1996-10#19)(1996-11#1)(1996-12#62)(1996-2#39)(1996-3#18)(1996-5#17)(1996-6#35)(1996-8#15)(1996-9#1)(1997-1#14)(1997-2#57)(1997-3#71)(1997-4#72)(1997-5#15)(1997-6#41)(1997-7#102)(1997-8#65)(1997-9#16)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#1)(2007-10#5)(2007-11#23)(2007-12#27)(2007-5#1)(2007-6#11)(2007-7#9)(2007-8#5)(2008-1#42)(2008-10#927)(2008-11#217)(2008-12#39)(2008-2#45)(2008-3#5)(2008-4#162)(2008-5#91)(2008-6#42)(2008-7#213)(2008-8#348)(2008-9#264)(2009-10#42)(2009-11#5)(2009-12#6)(2009-2#13)(2009-3#2)(2009-4#5)(2009-5#27)(2009-6#25)(2009-7#12)(2009-8#32)(2009-9#15)(2010-1#15)(2010-10#25)(2010-11#18)(2010-12#14)(2010-2#15)(2010-3#11)(2010-4#25)(2010-5#29)(2010-6#17)(2010-7#4)(2010-8#18)(2010-9#4)(2011-1#86)(2011-10#1)(2011-2#140)(2011-3#16)(2011-8#1)(2012-1#16)(2012-12#42)(2012-2#73)(2012-3#97)(2012-5#4)(2012-7#1)(2013-1#106)(2013-7#9)(2013-8#48)
gene&quot##2##1##(2008-10#1)(2008-4#1)
gene'##3##1##(1995-11#1)(1997-2#1)(2008-5#1)
gene's expression##3##2##(1995-2#1)(2008-8#1)(2012-3#1)
gene's##6##1##(1995-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-3#1)
gene(s) for##2##2##(1995-6#1)(1997-3#1)
gene(s) in target cells##3##4##(1997-8#3)
gene(s) in##5##2##(1997-8#3)(2008-7#1)(2008-8#1)
gene(s)##21##1##(1992-12#1)(1994-12#1)(1995-6#2)(1995-8#1)(1997-3#1)(1997-8#5)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-10#1)
gene) and##2##2##(1995-2#1)(2008-10#1)
gene) of##2##2##(1990-5#1)(2008-11#1)
gene) were##2##2##(2008-10#1)(2008-9#1)
gene)##22##1##(1990-5#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#3)(2009-4#1)(2011-1#1)(2013-1#1)
gene- and##3##2##(2012-2#2)(2013-1#1)
gene-##4##1##(2008-7#1)(2012-2#2)(2013-1#1)
gene-amplified##2##1##(2008-11#2)
gene-based approach##2##2##(2012-3#2)
gene-based##7##1##(1993-12#1)(2007-12#1)(2008-6#1)(2008-8#1)(2012-3#3)
gene-containing##3##1##(2008-5#1)(2008-7#2)
gene-environment interaction##3##2##(1997-3#2)(2011-2#1)
gene-environment interactions##4##2##(2008-1#1)(2008-7#2)(2009-6#1)
gene-environment##7##1##(1997-3#2)(2008-1#1)(2008-7#2)(2009-6#1)(2011-2#1)
gene-expression##9##1##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#3)(2010-5#1)(2011-1#1)(2012-12#1)
gene-finding programs##3##2##(1996-12#2)(2008-4#1)
gene-finding##5##1##(1996-12#3)(1996-8#1)(2008-4#1)
gene-for-gene interaction##7##2##(2008-10#5)(2011-10#2)
gene-for-gene interactions##5##2##(2008-10#5)
gene-for-gene model based on the interaction of##2##7##(2008-10#2)
gene-for-gene model##6##2##(2008-10#6)
gene-for-gene relationship##7##2##(2008-10#7)
gene-for-gene##31##1##(2008-10#27)(2008-8#1)(2008-9#1)(2011-10#2)
gene-gene and gene-environment interactions##2##4##(2008-7#1)(2009-6#1)
gene-gene interaction in linkage analysis##3##5##(2008-4#3)
gene-gene interaction##4##2##(2008-4#3)(2011-2#1)
gene-gene interactions##4##2##(2008-4#4)
gene-gene##10##1##(2008-4#7)(2008-7#1)(2009-6#1)(2011-2#1)
gene-mediated resistance##2##2##(2008-10#1)(2009-6#1)
gene-mediated##3##1##(2008-10#2)(2009-6#1)
gene-modified macrophages##2##2##(2008-8#2)
gene-modified##8##1##(1994-5#1)(2008-8#5)(2012-10#1)(2012-12#1)
gene-product##2##1##(1992-12#1)(1997-3#1)
gene-related peptide (CGRP)##8##3##(1990-7#1)(1993-3#1)(1997-3#2)(1997-4#1)(2007-2#1)(2008-4#2)
gene-related peptide in the##9##4##(1992-6#8)(1993-3#1)
gene-related peptide in##13##3##(1991-1#1)(1992-6#11)(1993-3#1)
gene-related peptide##40##2##(1990-7#2)(1991-1#1)(1992-6#24)(1993-3#2)(1994-8#1)(1997-1#1)(1997-3#3)(1997-4#1)(2007-2#1)(2008-4#2)(2013-1#1)(2013-8#1)
gene-related##44##1##(1990-7#2)(1991-1#1)(1992-6#25)(1992-9#1)(1993-3#2)(1994-8#2)(1997-1#1)(1997-3#4)(1997-4#1)(2007-2#1)(2008-4#2)(2013-1#1)(2013-8#1)
gene-rich region##2##2##(1997-8#1)(2008-10#1)
gene-silencing##3##1##(2008-10#1)(2011-2#2)
gene-specific primer##3##2##(1997-7#2)(2008-2#1)
gene-specific primers##2##2##(1992-3#1)(1994-12#1)
gene-specific##11##1##(1992-3#2)(1994-12#1)(1997-7#2)(2008-10#3)(2008-2#1)(2008-9#1)(2010-4#1)
gene-trap vector##2##2##(1997-8#2)
gene-trap##3##1##(1997-8#3)
gene]##3##1##(2008-10#1)(2011-3#1)(2013-1#1)
genealogical##5##1##(1990-3#1)(2008-12#1)(2010-8#1)(2011-2#2)
genealogies and##2##2##(2008-10#1)(2009-10#1)
genealogies##9##1##(2008-10#4)(2009-10#1)(2009-2#1)(2011-2#3)
genealogy##3##1##(1990-3#1)(1995-5#1)(2008-10#1)
genera and families##2##3##(2012-3#2)
genera and species##2##3##(2008-10#1)(2013-7#1)
genera and##15##2##(2008-10#4)(2008-5#4)(2012-3#2)(2013-1#1)(2013-7#4)
genera are##3##2##(2008-10#2)(2008-5#1)
genera in##2##2##(2008-6#1)(2013-7#1)
genera of##18##2##(1996-6#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-9#1)(2010-10#1)(2012-12#1)(2013-1#1)
genera reported##2##2##(2008-10#1)(2008-5#1)
genera tested##2##2##(2008-10#2)
genera were recorded##2##3##(2008-12#1)(2013-7#1)
genera were##5##2##(2008-10#1)(2008-12#1)(2013-7#3)
genera##118##1##(1995-2#1)(1996-6#2)(1997-4#2)(1997-6#1)(2007-12#2)(2007-5#2)(2008-10#44)(2008-11#2)(2008-12#7)(2008-5#13)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#3)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#10)(2013-8#4)
genera)##3##1##(2008-7#1)(2008-8#1)(2013-7#1)
general &quot##2##2##(1993-12#1)(2009-7#1)
general acceptance that##2##3##(2010-5#1)(2011-3#1)
general acid catalysis##2##3##(1993-8#1)(1994-11#1)
general additive model##2##3##(2011-1#2)
general aging##2##2##(2007-10#1)(2008-6#1)
general agreement between the##2##4##(2008-2#1)(2010-2#1)
general agreement that##5##3##(1994-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)
general agreement##12##2##(1993-8#1)(1994-8#1)(2007-8#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)
general algorithm##2##2##(2008-2#1)(2008-8#1)
general anaesthesia and##2##3##(2008-7#1)(2010-7#1)
general anaesthesia in##2##3##(2008-2#1)(2011-1#1)
general anaesthesia was##2##3##(2010-7#1)(2011-1#1)
general anaesthesia were##2##3##(2008-8#1)(2010-7#1)
general anaesthesia##20##2##(1992-11#2)(1997-6#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-7#6)(2011-1#2)(2012-12#2)(2013-1#1)
general analytical##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
general and abdominal radiologists##2##4##(2012-2#2)
general and local##2##3##(1992-5#1)(2007-8#1)
general and specific##3##3##(2007-12#2)(2009-5#1)
general and##55##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-5#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
general anesthesia and##3##3##(1993-1#1)(2011-2#1)(2013-1#1)
general anesthesia for##4##3##(1993-1#1)(2007-12#1)(2012-12#1)(2012-2#1)
general anesthesia in##2##3##(1993-1#1)(2010-3#1)
general anesthesia is##2##3##(2007-11#1)(2011-2#1)
general anesthesia on##2##3##(1993-1#1)(2012-3#1)
general anesthesia was##2##3##(1990-11#1)(1993-1#1)
general anesthesia##40##2##(1990-11#3)(1991-2#1)(1992-12#2)(1993-1#10)(1994-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-4#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
general anesthetic##4##2##(2007-5#1)(2010-5#1)(2011-2#2)
general anesthetics##2##2##(1990-12#1)(2009-8#1)
general appearance##2##2##(2008-5#1)(2008-7#1)
general applicability for##2##3##(2010-5#1)(2011-1#1)
general applicability##4##2##(2008-10#1)(2008-9#1)(2010-5#1)(2011-1#1)
general applications##2##2##(2008-10#1)(2010-5#1)
general approach based on##2##4##(1994-11#1)(1995-2#1)
general approach to##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
general approach##13##2##(1994-11#1)(1995-2#2)(1995-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-3#1)
general approaches##4##2##(1994-5#1)(2008-4#1)(2011-1#1)(2012-3#1)
general aspects of##4##3##(1993-2#1)(2008-8#1)(2009-11#1)(2013-7#1)
general aspects##5##2##(1993-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2013-7#1)
general assumption##2##2##(2008-10#1)(2008-5#1)
general attachment##2##2##(2007-12#2)
general awareness##2##2##(2007-2#1)(2008-7#1)
general belief##2##2##(2008-10#1)(2008-3#1)
general case of##4##3##(2008-2#2)(2008-3#1)(2008-9#1)
general categories of##2##3##(2008-4#1)(2009-10#1)
general categories##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
general characteristics##5##2##(1990-2#2)(1994-11#1)(2009-3#1)(2010-12#1)
general circulation##2##2##(2008-3#1)(2012-3#1)
general class of##5##3##(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)
general classes##2##2##(1995-5#1)(2009-11#1)
general classification of##2##3##(2008-11#1)(2011-2#1)
general clinical##5##2##(1994-12#1)(1994-2#1)(1996-8#1)(2008-7#1)(2013-1#1)
general cognitive style##4##3##(2010-1#4)
general cognitive##6##2##(2009-2#1)(2010-1#4)(2010-5#1)
general complex##2##2##(2008-3#2)
general complications##3##2##(2007-11#2)(2010-4#1)
general computational##2##2##(2008-3#1)(2012-3#1)
general concept##2##2##(1996-3#1)(1997-6#1)
general conclusion is##2##3##(2010-11#1)(2012-2#1)
general conclusion##4##2##(2008-9#2)(2010-11#1)(2012-2#1)
general condition of the patient##3##5##(2007-11#3)
general condition of the##4##4##(2007-11#3)(2012-3#1)
general condition##10##2##(1990-9#1)(2007-11#6)(2011-2#1)(2012-3#1)(2013-8#1)
general conditions in##2##3##(1990-8#1)(2008-7#1)
general conditions##8##2##(1990-8#1)(1993-3#1)(2007-10#1)(2007-12#1)(2008-7#2)(2008-9#1)(2013-8#1)
general consensus##4##2##(1996-1#1)(2008-3#1)(2008-8#1)(2012-12#1)
general considerations##2##2##(2008-10#1)(2010-3#1)
general context##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
general demographic##2##2##(1995-3#1)(2008-7#1)
general dental practitioner##3##3##(2008-1#2)(2011-2#1)
general dental practitioners##2##3##(2008-1#1)(2011-2#1)
general dental##6##2##(2008-1#3)(2011-2#2)(2013-1#1)
general description of the##2##4##(2008-3#1)(2008-9#1)
general description of##4##3##(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)
general design##2##2##(2008-3#2)
general diagnostic##2##2##(1994-2#1)(2008-9#1)
general economic##2##2##(2008-11#1)(2008-7#1)
general education##2##2##(1993-11#1)(1994-2#1)
general effect##2##2##(1995-11#1)(2008-10#1)
general epidemics##4##2##(2008-10#4)
general expression##2##2##(2007-11#1)(2008-2#1)
general factors##2##2##(2008-10#1)(2009-11#1)
general family of##2##3##(2008-7#1)(2012-3#1)
general family##3##2##(1996-2#1)(2008-7#1)(2012-3#1)
general features of##4##3##(1997-2#1)(2008-2#1)(2009-10#1)(2009-3#1)
general features##7##2##(1994-3#1)(1997-2#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2012-2#1)
general filament light##2##3##(2008-3#2)
general form of##3##3##(2008-8#3)
general form##4##2##(2008-2#1)(2008-8#3)
general formula##5##2##(1997-7#1)(2008-10#2)(2008-3#2)
general framework##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)
general genetic##2##2##(1990-5#1)(2008-4#1)
general government expenditures##2##3##(2013-7#2)
general guidelines for##3##3##(1993-12#1)(1995-2#1)(2008-9#1)
general guidelines##6##2##(1990-3#1)(1993-12#1)(1995-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
general health and##4##3##(2008-11#1)(2008-7#1)(2013-1#2)
general health care##5##3##(1993-3#1)(2008-11#3)(2010-4#1)
general health conditions##2##3##(2008-10#1)(2011-2#1)
general health issues##2##3##(2010-1#2)
general health perception##2##3##(2007-11#2)
general health status and##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
general health status##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
general health##41##2##(1991-6#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-6#1)(1996-7#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#7)(2008-8#1)(2010-1#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
general hospital in##3##3##(1992-2#1)(2007-2#1)(2008-7#1)
general hospital##16##2##(1990-3#1)(1992-11#1)(1992-2#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#2)(2013-1#4)
general hospitals in##4##3##(1991-2#1)(2008-3#1)(2009-12#1)(2011-2#1)
general hospitals##11##2##(1990-6#1)(1991-2#2)(1993-12#1)(1994-1#3)(1997-5#1)(2008-3#1)(2009-12#1)(2011-2#1)
general hospitals]##2##2##(1991-2#1)(2013-8#1)
general host##2##2##(1994-8#1)(2008-11#1)
general importance in##2##3##(1993-11#1)(2008-9#1)
general in##2##2##(1994-11#1)(2008-8#1)
general information about##2##3##(1993-3#1)(1996-11#1)
general information##5##2##(1993-3#1)(1996-11#1)(2008-10#1)(2010-3#1)(2013-8#1)
general intellectual functioning##2##3##(1995-11#2)
general interest##4##2##(1991-2#1)(1991-3#1)(2008-11#1)(2010-11#1)
general introduction##4##2##(1997-3#1)(2008-11#1)(2008-4#2)
general laboratory##2##2##(1994-12#1)(2008-8#1)
general lack of##4##3##(1991-12#1)(1992-2#1)(2008-11#1)(2012-3#1)
general linear model##3##3##(2008-10#1)(2009-6#1)(2013-8#1)
general linear models were##2##4##(2013-1#1)(2013-7#1)
general linear##5##2##(2008-10#1)(2009-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
general malaise##2##2##(1992-12#1)(2012-3#1)
general management of##2##3##(1994-5#1)(1996-3#1)
general management##7##2##(1992-1#1)(1993-12#1)(1994-1#1)(1994-5#1)(1996-3#1)(2008-2#1)(2009-8#1)
general markers of##2##3##(1995-11#1)(2008-5#1)
general markers##3##2##(1995-11#1)(2008-5#1)(2011-2#1)
general mathematical##2##2##(2008-10#1)(2008-7#1)
general means##2##2##(2008-3#1)(2008-4#1)
general mechanism##2##2##(1995-12#1)(2009-12#1)
general medical conditions##2##3##(1991-12#1)(2013-8#1)
general medical##7##2##(1991-12#1)(1995-5#1)(1995-9#1)(1996-9#1)(2010-12#1)(2013-8#2)
general medicine##9##2##(1995-3#1)(1995-6#2)(1996-3#1)(2007-10#2)(2007-7#1)(2009-8#1)(2013-8#1)
general method for##9##3##(1990-11#1)(1994-8#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-3#1)(2012-2#1)
general method of##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
general method##14##2##(1990-11#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#3)(2009-3#1)(2012-2#1)(2013-1#1)
general methodology##4##2##(2008-7#1)(2008-8#2)(2009-10#1)
general mode##2##2##(1994-6#1)(2007-12#1)
general model for##2##3##(1992-1#1)(2013-1#1)
general model of the##2##4##(1990-8#1)(1995-6#1)
general model of##5##3##(1990-8#1)(1995-6#1)(2008-3#1)(2012-3#1)(2013-1#1)
general model##12##2##(1990-8#1)(1992-1#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-8#3)(2012-3#1)(2013-1#2)
general morphology##2##2##(2007-12#1)(2008-8#1)
general non-specific##2##2##(1994-6#1)(2008-10#1)
general nor##2##2##(1990-6#1)(2011-2#1)
general or specific##2##3##(2008-10#1)(2008-9#1)
general or##6##2##(2008-10#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
general organization##4##2##(1991-2#1)(1992-11#1)(1992-2#1)(2008-4#1)
general outcomes##2##2##(2008-4#2)
general pattern##5##2##(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
general patterns##2##2##(2008-10#1)(2012-2#1)
general performance##2##2##(2008-10#1)(2008-12#1)
general phenomena##3##2##(1995-3#1)(2008-4#1)(2008-7#1)
general physicians##2##2##(2008-4#1)(2008-7#1)
general population and##5##3##(1992-2#1)(1997-1#1)(2010-12#1)(2013-1#2)
general population in##2##3##(1995-9#1)(2012-3#1)
general population##108##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-2#3)(1992-9#1)(1993-1#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-8#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-1#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-12#3)(2012-3#3)(2013-1#12)(2013-8#4)
general potentiometric##2##2##(2008-10#2)
general practice and##2##3##(1994-6#1)(2008-6#1)
general practice of##2##3##(2008-9#1)(2011-2#1)
general practice over##2##3##(1990-9#1)(1996-8#1)
general practice staff##2##3##(2007-2#1)(2011-2#1)
general practice##85##2##(1990-2#2)(1990-3#4)(1990-6#2)(1990-9#3)(1991-11#1)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#4)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#5)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-4#2)(1997-5#4)(2007-2#2)(2007-3#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#3)(2011-1#2)(2011-2#8)(2012-3#2)
general practice/family medicine##2##3##(1993-11#1)(1997-5#1)
general practice]##14##2##(1990-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-6#2)(1995-11#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)
general practices in##2##3##(2008-11#1)(2008-3#1)
general practices##4##2##(1993-12#1)(1996-8#1)(2008-11#1)(2008-3#1)
general practitioner (GP)##2##3##(1990-9#1)(2011-1#1)
general practitioner and##3##3##(1995-3#1)(1996-8#1)(1997-4#1)
general practitioner##35##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-3#1)(1992-2#1)(1992-5#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-8#2)(1997-4#2)(2008-11#1)(2009-3#2)(2010-1#1)(2011-1#1)(2012-12#1)
general practitioner's##3##2##(1996-8#1)(1997-4#1)(2008-7#1)
general practitioners (GPs) and##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
general practitioners (GPs)##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
general practitioners and a##2##4##(1997-4#2)
general practitioners and to##3##4##(1993-2#2)(2008-10#1)
general practitioners and##10##3##(1993-11#1)(1993-2#2)(1994-11#1)(1996-6#1)(1997-4#3)(2008-10#1)(2011-2#1)
general practitioners from##2##3##(1993-3#1)(1994-6#1)
general practitioners in the##3##4##(1997-4#1)(2008-11#1)(2013-1#1)
general practitioners in##12##3##(1991-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-8#2)(2013-1#1)
general practitioners to##5##3##(1992-4#1)(1997-4#1)(2007-2#1)(2010-4#1)(2011-2#1)
general practitioners were##2##3##(1993-2#1)(2012-2#1)
general practitioners with##2##3##(2008-10#1)(2011-2#1)
general practitioners'##3##2##(1990-11#1)(1996-9#1)(2008-8#1)
general principle of##3##3##(1993-9#1)(2011-1#1)(2012-3#1)
general principle##6##2##(1993-9#1)(2008-8#1)(2009-8#2)(2011-1#1)(2012-3#1)
general principles and##2##3##(2008-8#1)(2013-1#1)
general principles for##3##3##(2007-11#1)(2007-5#1)(2008-1#1)
general principles of##2##3##(1990-5#1)(2008-4#1)
general principles##13##2##(1990-5#1)(2007-11#2)(2007-5#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
general procedure##5##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-4#2)
general process for##2##3##(1992-11#1)(2010-12#1)
general protocol##2##2##(2008-10#1)(2008-4#1)
general psychiatric##3##2##(1993-2#1)(2008-2#1)(2009-7#1)
general psychological##2##2##(2007-12#1)(2008-2#1)
general public health##2##3##(1997-3#1)(2012-2#1)
general public##20##2##(1991-11#1)(1993-2#1)(1996-3#1)(1997-3#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-11#1)(2008-7#3)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
general purpose##3##2##(1996-2#1)(2008-10#1)(2008-3#1)
general quantitative##3##2##(2009-5#2)(2010-2#1)
general recommendations##2##2##(1990-2#1)(1996-6#1)
general reducing agent##2##3##(1990-9#1)(1996-5#1)
general regression##2##2##(1997-4#1)(2008-10#1)
general relationship between the##2##4##(2008-8#1)(2008-9#1)
general relationship between##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
general relationship##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)
general representation factors##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
general results##3##2##(2007-11#1)(2008-1#1)(2008-9#1)
general risk of infection in a society##2##7##(1992-6#2)
general role for##2##3##(2008-10#1)(2008-7#1)
general rule##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
general rules governing##3##3##(2008-8#3)
general rules##5##2##(1991-12#1)(2008-5#1)(2008-8#3)
general satisfaction in the SG order##2##6##(1993-12#2)
general satisfaction##5##2##(1993-12#5)
general scheme##2##2##(2008-10#1)(2009-5#1)
general screening##2##2##(2008-10#1)(2011-2#1)
general statistical##3##2##(2007-12#1)(2013-1#2)
general step-down multiple testing procedures##2##5##(2009-9#2)
general strategies##3##2##(2008-10#2)(2013-8#1)
general stress response protein##2##4##(1997-7#2)
general stress response##3##3##(1997-7#2)(2011-1#1)
general stress##6##2##(1997-7#2)(2008-7#1)(2009-7#2)(2011-1#1)
general structure##5##2##(1991-12#1)(1995-11#1)(2007-12#1)(2008-5#1)(2013-7#1)
general surgeon##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
general surgeons##3##2##(2008-4#1)(2008-6#1)(2010-8#1)
general surgery##15##2##(1990-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#2)(2010-8#1)(2011-2#1)(2012-3#3)
general surgical##3##2##(1992-1#1)(2007-11#1)(2009-7#1)
general symptoms##4##2##(2008-4#2)(2012-2#2)
general techniques##3##2##(2008-2#2)(2010-12#1)
general tendency##4##2##(2007-12#1)(2008-8#3)
general terms##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
general the##6##2##(1996-9#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)
general theoretical##2##2##(2008-12#1)(2008-3#1)
general theory of##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
general thoracic##3##2##(2007-8#1)(2010-8#2)
general to##2##2##(2008-2#1)(2011-1#1)
general toxicity studies##2##3##(2011-2#2)
general transcription factors##5##3##(1994-3#4)(1997-6#1)
general transcription##6##2##(1994-3#4)(1995-6#1)(1997-6#1)
general treatment strategies##2##3##(1996-6#2)
general trend of##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
general trend##9##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)
general types##2##2##(1992-3#1)(2008-3#1)
general use##4##2##(1992-4#1)(2008-11#1)(2008-8#1)(2010-6#1)
general usefulness of##2##3##(2008-10#1)(2008-11#1)
general validity##3##2##(1990-8#1)(2007-11#1)(2008-11#1)
general versus specific##2##3##(2008-9#1)(2013-1#1)
general way##3##2##(1994-12#1)(2007-12#1)(2008-7#1)
general##1798##1##(1990-11#9)(1990-12#4)(1990-2#9)(1990-3#13)(1990-5#7)(1990-6#8)(1990-7#1)(1990-8#6)(1990-9#8)(1991-1#3)(1991-11#6)(1991-12#10)(1991-2#13)(1991-3#8)(1991-6#10)(1991-8#1)(1991-9#4)(1992-1#6)(1992-11#7)(1992-12#6)(1992-2#11)(1992-3#9)(1992-4#3)(1992-5#12)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#13)(1993-10#1)(1993-11#10)(1993-12#23)(1993-2#26)(1993-3#8)(1993-5#1)(1993-6#6)(1993-8#2)(1993-9#3)(1994-1#10)(1994-11#15)(1994-12#7)(1994-2#11)(1994-3#17)(1994-5#4)(1994-6#16)(1994-8#5)(1994-9#5)(1995-1#5)(1995-11#13)(1995-12#5)(1995-2#8)(1995-3#8)(1995-5#9)(1995-6#7)(1995-8#7)(1995-9#8)(1996-1#6)(1996-11#5)(1996-12#4)(1996-2#5)(1996-3#13)(1996-5#4)(1996-6#9)(1996-7#2)(1996-8#9)(1996-9#9)(1997-1#4)(1997-2#2)(1997-3#14)(1997-4#21)(1997-5#11)(1997-6#9)(1997-7#7)(1997-8#7)(2006-6#1)(2007-1#1)(2007-10#9)(2007-11#30)(2007-12#44)(2007-2#10)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#10)(2007-8#11)(2007-9#1)(2008-1#26)(2008-10#155)(2008-11#68)(2008-12#21)(2008-2#46)(2008-3#90)(2008-4#43)(2008-5#34)(2008-6#17)(2008-7#71)(2008-8#63)(2008-9#39)(2009-10#9)(2009-11#5)(2009-12#4)(2009-2#3)(2009-3#7)(2009-5#9)(2009-6#4)(2009-7#10)(2009-8#12)(2009-9#5)(2010-1#11)(2010-10#1)(2010-11#6)(2010-12#17)(2010-2#3)(2010-3#6)(2010-4#9)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#9)(2011-1#29)(2011-2#68)(2011-3#3)(2012-12#23)(2012-2#32)(2012-3#31)(2012-7#1)(2013-1#55)(2013-7#6)(2013-8#23)
general-purpose##5##1##(1994-8#1)(2008-3#3)(2011-1#1)
general/family##3##1##(1993-11#2)(1997-6#1)
generalisable##2##1##(2008-11#1)(2008-12#1)
generalisation##2##1##(1997-6#1)(2007-11#1)
generalised##12##1##(1990-9#1)(1994-2#1)(2008-10#4)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
generalist can##2##2##(1991-4#1)(1993-2#1)
generalist##22##1##(1991-4#1)(1993-2#2)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-8#3)(2011-10#1)
generalists are##2##2##(1993-2#1)(2008-8#1)
generalists##9##1##(1993-12#1)(1993-2#1)(2008-10#2)(2008-8#1)(2008-9#3)(2010-8#1)
generality and##2##2##(2008-3#1)(2013-1#1)
generality of the##6##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
generality of##9##2##(1993-12#1)(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)(2013-7#1)
generality##12##1##(1993-12#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2013-1#1)(2013-7#1)
generalizability of##5##2##(1993-3#1)(1995-11#1)(1996-3#1)(2013-8#2)
generalizability##7##1##(1993-3#1)(1995-11#1)(1996-3#1)(2008-2#1)(2012-2#1)(2013-8#2)
generalization from##2##2##(2009-12#1)(2009-9#1)
generalization of the##10##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-3#1)(2010-8#1)(2011-1#1)
generalization of##21##2##(1997-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#3)(2009-9#2)(2010-3#1)(2010-8#1)(2011-1#1)
generalization to##2##2##(2008-3#1)(2012-3#1)
generalization##35##1##(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-7#1)
generalizations about the##2##3##(1991-5#1)(2011-2#1)
generalizations about##4##2##(1991-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
generalizations of##2##2##(2008-10#1)(2008-2#1)
generalizations##8##1##(1991-5#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#2)(2011-2#1)
generalize the##7##2##(1996-3#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-12#1)
generalize to other##3##3##(2008-11#1)(2009-10#1)(2013-8#1)
generalize to##6##2##(2007-8#1)(2008-11#1)(2009-10#1)(2009-12#1)(2010-7#1)(2013-8#1)
generalize##19##1##(1995-5#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-7#1)(2012-12#1)(2013-8#1)
generalized Damman gratings##2##3##(2008-3#2)
generalized Lorenz-Mie theory for cylinders##2##5##(2008-3#2)
generalized Lorenz-Mie theory for##3##4##(2008-3#3)
generalized Lorenz-Mie theory that##2##4##(2007-12#1)(2008-2#1)
generalized Lorenz-Mie theory##11##3##(2007-12#1)(2008-2#2)(2008-3#8)
generalized Newtonian mathematical models##2##4##(2013-8#2)
generalized Shwartzman reaction was##2##4##(1996-12#2)
generalized Shwartzman reaction##4##3##(1996-12#4)
generalized absence seizures##2##3##(1992-3#2)
generalized and##2##2##(2008-10#1)(2008-6#1)
generalized anxiety disorder##4##3##(2008-4#1)(2012-2#1)(2013-1#2)
generalized anxiety##5##2##(2008-4#1)(2012-2#1)(2013-1#3)
generalized atherosclerosis##3##2##(2008-1#3)
generalized convulsive status epilepticus##2##4##(2012-2#2)
generalized convulsive##3##2##(2012-2#2)(2013-8#1)
generalized cross-validation##2##2##(2008-10#1)(2008-3#1)
generalized diffraction-filtered resonator##2##3##(2008-2#2)
generalized ellipsometric angles##3##3##(2008-3#3)
generalized ellipsometry##7##2##(2007-11#2)(2008-2#2)(2008-3#3)
generalized estimating equation##4##3##(1994-2#1)(1995-9#1)(2012-12#2)
generalized estimating equations##3##3##(1995-2#1)(1997-8#1)(2008-4#1)
generalized estimating##7##2##(1994-2#1)(1995-2#1)(1995-9#1)(1997-8#1)(2008-4#1)(2012-12#2)
generalized folding##2##2##(2008-2#2)
generalized for##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
generalized from##2##2##(2008-11#1)(2008-3#1)
generalized hypertrichosis##3##2##(2007-7#3)
generalized imaging##2##2##(2008-6#2)
generalized least squares##2##3##(1992-6#2)
generalized linear mixed models##2##4##(2008-10#1)(2012-1#1)
generalized linear model##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
generalized linear models with##2##4##(2011-1#1)(2012-1#1)
generalized linear models##6##3##(2008-10#3)(2010-12#1)(2011-1#1)(2012-1#1)
generalized linear system##2##3##(2011-1#2)
generalized linear##15##2##(1995-12#1)(2008-10#7)(2008-11#1)(2010-12#1)(2011-1#3)(2012-1#2)
generalized lorenz-mie theory##2##3##(2008-2#1)(2008-3#1)
generalized loss of##2##3##(2008-5#1)(2011-1#1)
generalized lymphadenopathy##2##2##(2008-1#1)(2011-1#1)
generalized problem##2##2##(1997-7#1)(2007-12#1)
generalized ray tracing##2##3##(2008-2#2)
generalized reciprocity##3##2##(2012-3#3)
generalized scidar##3##2##(2008-2#2)(2008-3#1)
generalized self-filtering unstable##3##3##(2008-2#2)(2008-3#1)
generalized self-filtering##4##2##(2008-2#2)(2008-3#2)
generalized to##12##2##(1992-9#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-6#1)(2009-11#1)(2009-5#1)
generalized topological distance##2##3##(2007-11#2)
generalized two-dimensional Gaussian model##3##4##(2008-10#3)
generalized version##2##2##(2008-2#1)(2008-9#1)
generalized viscous double-layer##2##3##(2009-10#2)
generalized von Bertalanffy##2##3##(2010-8#2)
generalized weakness##3##2##(2009-3#1)(2010-8#1)(2012-2#1)
generalized##263##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-12#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#12)(2007-12#8)(2007-7#3)(2008-1#6)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#27)(2008-3#37)(2008-4#3)(2008-5#4)(2008-6#10)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#13)(2011-2#4)(2012-1#4)(2012-12#8)(2012-2#6)(2012-3#8)(2013-1#5)(2013-8#5)
generalizes##6##1##(2007-11#1)(2008-3#1)(2009-4#2)(2009-9#1)(2011-2#1)
generalizing the##2##2##(2008-1#1)(2012-1#1)
generalizing##4##1##(2008-1#1)(2008-10#1)(2008-11#1)(2012-1#1)
generally a##8##2##(1991-1#1)(1991-6#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2013-1#1)
generally accepted as##4##3##(1994-12#1)(2007-11#1)(2008-5#1)(2008-9#1)
generally accepted to be##2##4##(1990-12#1)(2008-7#1)
generally accepted##27##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#2)
generally agree##2##2##(1990-6#1)(2008-2#1)
generally agreed##5##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
generally applicable##4##2##(1997-6#1)(1997-7#1)(2008-10#2)
generally are##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
generally as the##2##3##(2007-8#1)(2008-7#1)
generally associated with the##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
generally associated with##10##3##(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)
generally associated##11##2##(1995-12#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)
generally asymptomatic##2##2##(1993-9#1)(2007-8#1)
generally available##2##2##(1995-12#1)(2007-8#1)
generally be##5##2##(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#2)
generally been##6##2##(1990-7#1)(1994-6#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-3#1)
generally being##2##2##(2007-11#1)(2011-2#1)
generally believed that##3##3##(2010-7#1)(2011-10#1)(2012-1#1)
generally believed to be##2##4##(1996-5#1)(2007-2#1)
generally believed to##3##3##(1996-5#1)(2007-2#1)(2008-4#1)
generally believed##8##2##(1990-2#1)(1996-5#1)(2007-2#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-10#1)(2012-1#1)
generally benign##3##2##(1996-8#1)(2011-2#1)(2012-3#1)
generally better##2##2##(2008-10#1)(2008-7#1)
generally carried out##3##3##(1995-9#1)(2008-10#1)(2008-2#1)
generally carried##4##2##(1995-9#1)(2008-10#1)(2008-2#1)(2012-3#1)
generally carry a##2##3##(2008-7#1)(2011-2#1)
generally considered safe##2##3##(2013-1#2)
generally considered to be##2##4##(2008-7#1)(2011-2#1)
generally considered to##4##3##(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
generally considered##16##2##(1996-2#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#2)
generally consistent with the##2##4##(1997-5#1)(2013-8#1)
generally consistent with##3##3##(1997-5#2)(2013-8#1)
generally consistent##4##2##(1997-5#2)(2008-10#1)(2013-8#1)
generally could not be##2##4##(1996-4#1)(2008-10#1)
generally could##4##2##(1996-4#1)(1996-9#1)(2008-10#1)(2011-2#1)
generally decreased##2##2##(2010-7#1)(2013-7#1)
generally did not##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
generally do not##2##3##(2008-3#1)(2009-8#1)
generally effective##2##2##(2008-10#1)(2010-5#1)
generally exhibit##5##2##(1996-12#1)(2008-9#3)(2012-5#1)
generally expected##3##2##(1995-11#1)(2008-2#1)(2008-5#1)
generally found##6##2##(1990-12#1)(1993-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
generally good##5##2##(1991-12#1)(1991-6#1)(1996-5#1)(2008-3#1)(2008-7#1)
generally had##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
generally has##2##2##(1992-3#1)(2008-7#1)
generally have a higher##2##4##(2008-3#1)(2011-2#1)
generally have a##3##3##(2008-3#1)(2010-12#1)(2011-2#1)
generally have##7##2##(2008-12#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
generally high##3##2##(1996-2#1)(2007-10#1)(2008-11#1)
generally higher in##2##3##(1994-9#1)(2013-8#1)
generally higher than##2##3##(2008-10#1)(2008-12#1)
generally higher##5##2##(1994-9#1)(2008-10#2)(2008-12#1)(2013-8#1)
generally in the##2##3##(2008-10#1)(2008-5#1)
generally in##6##2##(2008-10#4)(2008-5#1)(2010-1#1)
generally inadequate##2##2##(2007-2#1)(2008-10#1)
generally include##2##2##(2007-6#1)(2008-10#1)
generally included##2##2##(1997-3#1)(2008-1#1)
generally increased at##2##3##(2008-10#1)(2008-9#1)
generally increased##7##2##(1996-5#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-12#1)
generally indicated##2##2##(2010-10#1)(2011-2#1)
generally involved in##2##3##(1993-8#1)(2008-9#1)
generally involved##3##2##(1993-8#1)(1996-1#1)(2008-9#1)
generally is##4##2##(2008-10#2)(2008-3#1)(2010-6#1)
generally known to##2##3##(2008-4#1)(2009-8#1)
generally known##4##2##(2008-4#2)(2008-5#1)(2009-8#1)
generally leads##2##2##(2009-5#1)(2011-2#1)
generally less than##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
generally less##8##2##(1995-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)
generally locally##2##2##(2008-5#1)(2010-3#1)
generally low##4##2##(1992-3#1)(2008-10#1)(2009-10#1)(2012-2#1)
generally lower than##5##3##(1995-12#1)(1995-2#1)(2008-10#2)(2010-8#1)
generally lower##7##2##(1992-12#1)(1995-12#1)(1995-2#1)(2008-10#3)(2010-8#1)
generally made##2##2##(1990-5#1)(2008-8#1)
generally mild##6##2##(1990-2#1)(1992-8#1)(2007-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
generally more##9##2##(1994-2#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
generally not##14##2##(1992-1#1)(1992-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-11#1)(2012-12#1)
generally observed in##2##3##(2008-5#1)(2009-10#1)
generally observed##6##2##(2008-10#1)(2008-5#2)(2008-7#1)(2009-10#1)(2013-7#1)
generally occurring in##2##3##(2008-4#1)(2008-9#1)
generally only##6##2##(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)
generally outperforms##2##2##(2008-5#1)(2012-3#1)
generally perceived as##2##3##(2008-7#1)(2008-9#1)
generally performed##2##2##(2008-10#1)(2011-2#1)
generally poor##8##2##(1990-11#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#1)
generally positive##3##2##(1993-3#1)(2008-10#2)
generally present in##2##3##(1996-12#1)(2008-8#1)
generally rare##2##2##(1991-11#1)(1996-11#1)
generally recognized as##2##3##(2008-10#1)(2008-7#1)
generally recognized##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
generally reduced##2##2##(2008-9#1)(2009-4#1)
generally referred to as the##2##5##(1996-12#1)(2008-3#1)
generally referred to as##3##4##(1996-12#1)(1997-1#1)(2008-3#1)
generally regarded as##3##3##(2008-10#2)(2008-7#1)
generally regarded##5##2##(1994-9#1)(2007-12#1)(2008-10#2)(2008-7#1)
generally reported##4##2##(1994-3#1)(2007-2#1)(2008-8#1)(2009-4#1)
generally require##2##2##(2008-10#1)(2011-2#1)
generally safe##2##2##(2010-10#1)(2011-2#1)
generally satisfied with their##2##4##(1996-2#2)
generally satisfied with##3##3##(1991-1#1)(1996-2#2)
generally show##2##2##(2008-10#1)(2008-8#1)
generally showed a porous layer##2##5##(2008-10#2)
generally showed a##3##3##(2008-10#2)(2013-1#1)
generally showed##4##2##(2008-10#2)(2010-4#1)(2013-1#1)
generally similar to that##4##4##(2007-12#1)(2008-11#1)(2008-9#2)
generally similar##7##2##(2007-12#1)(2008-11#2)(2008-7#1)(2008-9#2)(2013-1#1)
generally small##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-7#1)
generally supportive##2##2##(1993-10#1)(2008-11#1)
generally the##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
generally to##5##2##(1993-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
generally used for##4##3##(1990-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
generally used to##2##3##(2008-10#1)(2012-2#1)
generally used##11##2##(1990-5#1)(1996-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
generally useful##2##2##(2008-6#1)(2008-9#1)
generally very##3##2##(1995-11#1)(2012-12#1)(2013-1#1)
generally was associated with##2##4##(2008-10#2)
generally was found##3##3##(2009-7#1)(2013-1#2)
generally was##11##2##(2008-10#8)(2009-7#1)(2013-1#2)
generally well tolerated in##3##4##(2008-7#2)(2011-2#1)
generally well tolerated##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
generally were more##2##3##(2008-10#2)
generally were##8##2##(2008-10#7)(2010-3#1)
generally with##3##2##(2007-8#1)(2008-3#1)(2008-8#1)
generally worked##2##2##(2008-10#1)(2008-2#1)
generally##697##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#8)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#9)(1996-3#4)(1996-4#3)(1996-5#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#5)(2007-11#8)(2007-12#8)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#10)(2008-10#127)(2008-11#23)(2008-12#8)(2008-2#21)(2008-3#29)(2008-4#16)(2008-5#18)(2008-6#7)(2008-7#25)(2008-8#27)(2008-9#32)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#6)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#3)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#4)(2011-1#8)(2011-10#1)(2011-2#31)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#5)(2012-2#15)(2012-3#14)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#3)(2013-8#5)
generate NO##2##2##(2008-7#2)
generate a new##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
generate a##61##2##(1990-12#1)(1991-11#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-1#1)(1997-8#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
generate action potentials##2##3##(2008-7#1)(2013-1#1)
generate an##11##2##(1992-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#1)
generate and maintain##2##3##(2009-8#1)(2011-2#1)
generate and##9##2##(1996-2#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
generate different amounts of##2##4##(2007-8#1)(2008-4#1)
generate different##6##2##(1994-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
generate functional##3##2##(2008-10#1)(2009-10#1)(2009-3#1)
generate hypotheses for##2##3##(2012-2#1)(2013-8#1)
generate hypotheses##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
generate knowledge##2##2##(2007-12#1)(2009-7#1)
generate many##2##2##(1995-2#1)(2008-5#1)
generate multiple##4##2##(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
generate nested deletions##2##3##(1994-12#1)(1996-12#1)
generate nitric oxide##2##3##(1992-5#1)(1996-3#1)
generate patterns of##2##3##(2008-9#1)(2009-8#1)
generate persistent##2##2##(2008-11#1)(2008-8#1)
generate positive##2##2##(1997-3#1)(2013-1#1)
generate reactive##2##2##(2008-4#1)(2010-1#1)
generate several##2##2##(1994-6#1)(2008-9#1)
generate the##34##2##(1990-2#2)(1993-8#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-12#2)(1997-7#2)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-5#1)(2012-12#1)
generate their##2##2##(1995-6#1)(2007-11#1)
generate this##2##2##(1994-3#1)(2007-12#1)
generate various##2##2##(2008-3#2)
generate##392##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#4)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#5)(1993-2#1)(1993-8#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#6)(1994-9#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#4)(1997-8#2)(2007-10#1)(2007-11#13)(2007-12#21)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#48)(2008-11#21)(2008-12#1)(2008-2#21)(2008-3#36)(2008-4#13)(2008-5#4)(2008-6#9)(2008-7#11)(2008-8#14)(2008-9#15)(2009-10#4)(2009-11#2)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#4)(2011-1#4)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#5)
generated &gt##2##2##(2008-3#1)(2012-2#1)
generated 1##2##2##(2007-12#1)(2008-2#1)
generated Ru(bpy)(3)(3+)-based chemiluminescence##2##3##(2008-10#2)
generated THG signal is##2##4##(2008-3#2)
generated a great deal of##2##5##(1994-9#1)(2011-1#1)
generated a set of##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
generated a signal##2##3##(2008-3#2)
generated a##20##2##(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
generated across##2##2##(2008-10#1)(2009-3#1)
generated against C##2##3##(2008-5#2)
generated against##7##2##(1990-5#1)(1994-11#1)(1994-6#1)(1995-6#1)(2007-12#1)(2008-5#2)
generated and analyzed##3##3##(2008-12#2)(2012-12#1)
generated and their##2##3##(1993-12#1)(2008-3#1)
generated and##17##2##(1991-8#1)(1993-12#1)(1995-12#2)(1997-9#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
generated approximately##2##2##(1995-5#1)(2008-3#1)
generated as a consequence of##2##5##(1992-6#1)(2008-2#1)
generated as a result of the##2##6##(2007-12#1)(2008-10#1)
generated as a result of##3##5##(2007-12#1)(2008-10#2)
generated as a##6##3##(1992-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
generated at a##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
generated at the##5##3##(2007-11#1)(2007-12#1)(2008-3#2)(2009-5#1)
generated at##22##2##(1994-5#1)(2007-11#3)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#1)
generated blue##2##2##(2007-12#1)(2008-2#1)
generated both##2##2##(1994-11#1)(2008-4#1)
generated by CYP1A1 and P450 reductase##2##6##(1994-8#2)
generated by PCR##2##3##(1990-11#1)(2008-2#1)
generated by a 3D object at##2##6##(2007-12#1)(2008-3#1)
generated by a##27##3##(1990-11#1)(1994-6#1)(1996-3#1)(2007-11#2)(2007-12#6)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#8)(2008-8#1)(2012-2#1)(2013-8#1)
generated by activation of##2##4##(1990-5#2)
generated by alternative splicing##2##4##(1993-8#1)(1993-9#1)
generated by an##11##3##(1990-2#1)(1994-12#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2009-5#1)
generated by digestion##2##3##(1992-6#1)(2008-10#1)
generated by direct##2##3##(2008-10#1)(2010-8#1)
generated by femtosecond terawatt laser pulses##2##6##(2007-11#1)(2007-12#1)
generated by frequency doubling of the output of##3##8##(2007-12#3)
generated by frequency doubling of##4##5##(2007-12#4)
generated by in vitro immunization##3##5##(2008-11#3)
generated by in vitro##4##4##(1992-9#1)(2008-11#3)
generated by means of##2##4##(2007-11#1)(2008-10#1)
generated by random##3##3##(2008-10#2)(2008-9#1)
generated by several##2##3##(2008-3#1)(2009-8#1)
generated by spontaneous parametric downconversion##3##5##(2007-12#3)
generated by such##2##3##(2007-12#1)(2008-3#1)
generated by the cleavage##2##4##(1990-12#1)(1992-6#1)
generated by the induction##2##4##(2008-11#1)(2009-12#1)
generated by the oxidation of##3##5##(2008-10#3)
generated by the oxidation##4##4##(2008-10#4)
generated by the##54##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1995-6#3)(1995-8#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
generated by this##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
generated by ultrashort laser pulses##2##5##(2007-11#1)(2008-3#1)
generated by use of##2##4##(2007-11#1)(2008-3#1)
generated by using##4##3##(2008-10#1)(2008-11#3)
generated by##285##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-9#2)(1992-6#2)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#4)(1995-12#1)(1995-2#2)(1995-6#4)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#3)(2007-11#21)(2007-12#37)(2008-1#1)(2008-10#42)(2008-11#19)(2008-2#15)(2008-3#35)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#6)(2009-10#2)(2009-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
generated data##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
generated directly from##4##3##(2007-11#2)(2007-12#2)
generated droplets (nebulizer##2##3##(1995-3#2)
generated during its reaction with either##2##6##(2008-10#2)
generated during oxidation##2##3##(2008-10#2)
generated during the##6##3##(1995-8#1)(1996-12#1)(1996-9#1)(2008-10#2)(2010-2#1)
generated during##21##2##(1991-5#1)(1992-12#1)(1992-5#2)(1995-8#1)(1996-12#2)(1996-9#1)(1997-4#1)(2008-10#8)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#1)
generated either by##2##3##(1995-5#1)(2008-3#1)
generated enzymatically##2##2##(2008-10#2)
generated following a##2##3##(2009-10#1)(2013-1#1)
generated following##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
generated for each##2##3##(2008-10#1)(2008-9#1)
generated for the##6##3##(1993-2#1)(2008-10#3)(2008-11#1)(2013-7#1)
generated for##17##2##(1993-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
generated fragments##2##2##(1990-7#1)(1995-6#1)
generated from a##8##3##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#1)
generated from human##3##3##(1992-8#1)(2008-11#1)(2008-4#1)
generated from membrane phospholipids##2##4##(1994-3#2)
generated from somatic##2##3##(2008-10#1)(2008-11#1)
generated from the##22##3##(1990-2#1)(1992-9#1)(1995-3#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-4#1)(2007-11#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2011-2#3)
generated from this##5##3##(1995-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
generated from##91##2##(1990-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-11#1)(1994-3#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-9#1)(2007-11#7)(2007-12#3)(2008-10#28)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-8#1)(2011-2#4)
generated higher##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
generated hydrogen peroxide##3##3##(2008-10#3)
generated idler##2##2##(2007-11#1)(2008-2#1)
generated in a cold chamber##2##5##(2007-11#1)(2008-3#1)
generated in a##22##3##(2007-11#4)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#5)(2009-10#1)(2010-4#1)(2013-8#1)
generated in dogs##2##3##(1996-9#1)(2008-10#1)
generated in rabbits using##2##4##(1997-4#1)(2008-10#1)
generated in rabbits##3##3##(1997-4#1)(2008-10#2)
generated in situ at##2##4##(2008-10#2)
generated in situ by KBr/KBrO(3) in HCl medium##2##8##(2008-10#2)
generated in situ by##3##4##(1993-11#1)(2008-10#2)
generated in situ##7##3##(1993-11#1)(1994-11#1)(1996-5#1)(2008-10#4)
generated in the##16##3##(1993-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
generated in these##2##3##(1992-8#1)(2008-11#1)
generated in this way##3##4##(2008-10#2)(2008-3#1)
generated in this##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
generated in##85##2##(1991-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-2#2)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2013-7#1)(2013-8#4)
generated is##5##2##(2008-10#4)(2008-5#1)
generated nickel##2##2##(2008-10#2)
generated on a##2##3##(2008-10#1)(2008-2#1)
generated on the##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
generated on##9##2##(1992-12#1)(1992-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
generated only##4##2##(1994-11#1)(1997-4#1)(2007-12#1)(2008-3#1)
generated or##2##2##(2008-10#1)(2008-12#1)
generated over##2##2##(2007-12#1)(2008-7#1)
generated rains##2##2##(2008-10#2)
generated recombinant##3##2##(1995-8#1)(1997-4#1)(2008-11#1)
generated signal##3##2##(2007-12#2)(2008-3#1)
generated simultaneously##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
generated the##7##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)
generated through a##3##3##(2007-12#1)(2009-8#1)(2012-3#1)
generated through the##2##3##(2008-11#1)(2008-5#1)
generated through##12##2##(1991-12#1)(1991-9#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2012-3#1)
generated to##8##2##(1996-2#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
generated transgenic mice##2##3##(1994-8#1)(1995-2#1)
generated transgenic##6##2##(1993-9#1)(1994-8#1)(1995-2#1)(2008-11#1)(2010-2#1)(2012-12#1)
generated two##2##2##(2008-2#2)
generated under##3##2##(2008-3#1)(2008-5#1)(2010-8#1)
generated upon##2##2##(1993-6#1)(2012-12#1)
generated using a##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
generated using##14##2##(1991-9#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-1#2)
generated via##4##2##(2008-10#2)(2008-3#1)(2008-6#1)
generated was##3##2##(1993-9#1)(2008-10#2)
generated when##2##2##(2008-10#1)(2008-3#1)
generated with a##7##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
generated with an##4##3##(1996-12#1)(2007-12#3)
generated with the##5##3##(1990-5#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
generated with##31##2##(1990-5#1)(1993-6#1)(1995-12#1)(1996-12#2)(2007-11#2)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#5)(2008-8#1)(2009-5#1)
generated##992##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#4)(1990-7#2)(1990-8#1)(1991-12#2)(1991-3#4)(1991-5#3)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#3)(1992-6#7)(1992-8#4)(1992-9#4)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#10)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#2)(1995-12#6)(1995-2#9)(1995-3#8)(1995-5#3)(1995-6#10)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#2)(1997-4#10)(1997-6#3)(1997-8#4)(1997-9#2)(2007-11#57)(2007-12#92)(2008-1#3)(2008-10#201)(2008-11#55)(2008-12#8)(2008-2#55)(2008-3#99)(2008-4#17)(2008-5#14)(2008-6#6)(2008-7#15)(2008-8#14)(2008-9#15)(2009-10#9)(2009-11#4)(2009-12#3)(2009-3#4)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#13)(2011-2#17)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#12)(2012-3#4)(2013-1#18)(2013-7#2)(2013-8#7)
generates 2##2##2##(2007-11#1)(2007-12#1)
generates a##23##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-6#1)
generates an##8##2##(1995-8#1)(1997-3#1)(2008-3#3)(2008-6#2)(2010-2#1)
generates both##2##2##(2008-6#1)(2008-8#1)
generates different##2##2##(2008-2#1)(2008-3#1)
generates high##2##2##(1991-2#1)(2008-6#1)
generates information##2##2##(1993-2#1)(2008-4#1)
generates many##2##2##(2007-11#1)(2007-12#1)
generates the##11##2##(1992-12#1)(1994-5#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
generates##125##1##(1990-11#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#3)(1992-6#1)(1993-11#2)(1993-2#1)(1994-5#2)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#4)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-9#1)(2006-12#1)(2007-11#8)(2007-12#13)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#17)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
generating a new##2##3##(1996-5#1)(2008-11#1)
generating a##16##2##(1990-8#1)(1993-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)
generating an##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
generating and##6##2##(2008-2#1)(2008-4#4)(2008-9#1)
generating large##4##2##(1992-3#1)(1996-12#1)(2008-7#1)(2010-3#1)
generating many##2##2##(2008-7#1)(2009-6#1)
generating more##2##2##(1994-1#1)(2008-2#1)
generating oxidase##2##2##(1991-2#2)
generating pulses##2##2##(2007-11#1)(2007-12#1)
generating results##2##2##(2008-11#1)(2008-12#1)
generating system##4##2##(1992-12#1)(1994-6#1)(1995-6#1)(2008-5#1)
generating the##12##2##(1990-2#1)(1990-5#1)(1995-2#2)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-4#1)
generating transgenic##2##2##(2008-11#2)
generating##195##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-1#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#2)(2007-11#16)(2007-12#13)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#12)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)
generation (DFG) in##2##3##(2008-2#1)(2008-3#1)
generation (HG)##8##2##(2008-10#8)
generation (SHG) and##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
generation (SHG) in##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
generation (SHG) is##2##3##(2007-11#1)(2007-12#1)
generation (SHG)##19##2##(2007-11#6)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
generation after hybridization##2##3##(2008-9#2)
generation and a##2##3##(2008-2#1)(2011-1#1)
generation and analysis##2##3##(2008-2#1)(2008-9#1)
generation and atomic fluorescence##3##4##(2008-10#3)
generation and atomic##4##3##(2008-10#4)
generation and cascaded##2##3##(2008-2#2)
generation and delivery##2##3##(1992-3#2)
generation and pulse##2##3##(2007-11#1)(2007-12#1)
generation and release of##2##4##(2008-4#1)(2010-9#1)
generation and separation properties##2##4##(1995-3#2)
generation and##93##2##(1991-2#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-3#3)(1996-2#1)(1997-1#1)(2007-11#8)(2007-12#7)(2008-1#1)(2008-10#23)(2008-11#2)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
generation are##3##2##(2008-3#2)(2008-9#1)
generation as well as##2##4##(1996-2#1)(2009-2#1)
generation as##3##2##(1996-2#1)(2007-12#1)(2009-2#1)
generation at##10##2##(2007-11#2)(2007-12#5)(2008-3#3)
generation atomic absorption spectrometry##15##4##(2007-12#1)(2008-10#14)
generation atomic absorption##17##3##(2007-12#1)(2008-10#16)
generation atomic fluorescence spectrometry##14##4##(2008-10#14)
generation atomic fluorescence##16##3##(2008-10#16)
generation atomic##34##2##(2007-12#1)(2008-10#33)
generation automation##2##2##(2008-10#2)
generation based on##2##3##(2007-12#1)(2009-6#1)
generation between##2##2##(2007-12#1)(2008-10#1)
generation by a##2##3##(2007-12#2)
generation by use of##4##4##(2007-11#2)(2007-12#2)
generation by##28##2##(1990-12#1)(1991-12#2)(1993-6#1)(1994-11#1)(1994-5#1)(1996-12#1)(2007-11#5)(2007-12#11)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
generation can be##5##3##(2007-12#2)(2008-3#2)(2008-8#1)
generation devices##2##2##(2010-6#2)
generation does##2##2##(2008-10#1)(2009-4#1)
generation efficiency##4##2##(2008-10#2)(2008-2#1)(2013-1#1)
generation experiment##2##2##(2007-12#1)(2008-2#1)
generation following##3##2##(2008-10#3)
generation for the##2##3##(2007-11#1)(2008-10#1)
generation for##5##2##(2007-11#2)(2007-12#1)(2008-10#2)
generation from a##5##3##(2007-11#2)(2007-12#3)
generation from##18##2##(1995-3#1)(2007-11#3)(2007-12#6)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-10#1)
generation has been##3##3##(2007-12#2)(2013-8#1)
generation imaging of laser-induced breakdown in glass##2##7##(2008-3#2)
generation in Ge(20)As(25)S(55) glass##2##4##(2007-12#2)
generation in a periodically poled##3##5##(2007-12#3)
generation in a single##2##4##(2007-11#1)(2008-3#1)
generation in a##19##3##(1994-11#1)(2007-11#4)(2007-12#9)(2008-10#1)(2008-2#1)(2008-3#2)(2010-9#1)
generation in an atomic##2##4##(2007-11#1)(2008-3#1)
generation in an##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
generation in periodically poled LiNbO(3)##2##5##(2007-12#2)
generation in periodically poled##3##4##(2007-12#3)
generation in short##2##3##(2007-12#1)(2008-3#1)
generation in the presence of##2##5##(1993-8#1)(2007-12#1)
generation in the##8##3##(1993-8#1)(2007-12#2)(2008-2#3)(2008-4#1)(2009-9#1)
generation in waveguides induced by photorefractive##2##6##(2007-12#2)
generation in##82##2##(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#3)(1995-8#1)(1996-11#1)(2007-11#17)(2007-12#30)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#7)(2008-4#1)(2009-8#1)(2009-9#1)(2010-9#1)(2012-2#2)
generation inductively coupled plasma##3##4##(2008-10#3)
generation interface##2##2##(2008-10#2)
generation into the##2##3##(2007-12#2)
generation is##19##2##(2007-11#4)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)
generation means##2##2##(2008-10#2)
generation of H(+)##2##3##(2008-10#2)
generation of LAK##2##3##(2008-4#2)
generation of a##25##3##(1992-9#1)(1993-8#1)(1997-8#2)(2007-11#6)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
generation of action potentials##2##4##(1997-6#1)(2009-12#1)
generation of amplitude-squeezed##2##3##(2007-12#2)
generation of an##7##3##(1993-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)
generation of antipsychotics##2##3##(2011-2#2)
generation of arbitrary complex vector wave##2##6##(2007-11#2)
generation of arbitrary complex##3##4##(2007-11#2)(2008-3#1)
generation of cells and##2##4##(2008-7#1)(2009-3#1)
generation of chimeric##2##3##(2008-11#1)(2008-6#1)
generation of coherent##2##3##(2007-11#2)
generation of data##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
generation of defective##2##3##(2008-10#1)(2008-11#1)
generation of femtosecond##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
generation of free radicals##3##4##(2008-5#1)(2009-8#1)(2013-8#1)
generation of free##5##3##(1992-12#1)(2007-12#1)(2008-5#1)(2009-8#1)(2013-8#1)
generation of high quality##2##4##(2007-12#1)(2008-10#1)
generation of high##3##3##(2007-12#1)(2008-10#1)(2009-12#1)
generation of highly##3##3##(2008-2#1)(2009-10#1)(2011-1#1)
generation of human##5##3##(1995-12#1)(2008-11#2)(2008-4#2)
generation of hydroxyl##2##3##(1991-9#1)(1996-2#1)
generation of inositol##2##3##(1993-3#1)(1993-6#1)
generation of large diffraction gratings##2##5##(2008-3#2)
generation of large##3##3##(2008-10#1)(2008-3#2)
generation of mercury vapour##2##4##(2008-10#2)
generation of multiple##4##3##(1991-2#1)(2007-11#1)(2012-2#1)(2013-1#1)
generation of new##6##3##(2007-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-4#1)
generation of oxygen##2##3##(1993-8#1)(2008-10#1)
generation of reactive oxygen species (ROS)##3##6##(2008-10#1)(2008-5#1)(2009-12#1)
generation of reactive oxygen species##8##5##(2008-1#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-2#1)
generation of reactive oxygen##9##4##(1995-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-2#1)
generation of recombinant baculoviruses##2##4##(2008-2#2)
generation of research##2##3##(2011-1#1)(2012-2#1)
generation of second-harmonic##2##3##(2007-11#1)(2007-12#1)
generation of several##2##3##(2007-12#1)(2008-10#1)
generation of superoxide anion##4##4##(1993-6#3)(2008-10#1)
generation of the reactive oxygen species##2##6##(2008-10#1)(2011-2#1)
generation of the##18##3##(1990-5#1)(1995-12#1)(1996-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-3#1)
generation of therapeutic##2##3##(2008-11#1)(2011-9#1)
generation of these##3##3##(1996-4#1)(2007-12#1)(2008-9#1)
generation of transgenic mice##3##4##(2008-4#3)
generation of transgenic##4##3##(2008-11#1)(2008-4#3)
generation of tunable##3##3##(2007-11#2)(2008-2#1)
generation of two##2##3##(2007-11#2)
generation of volatile silicon tetrafluoride##2##5##(2008-10#2)
generation of##411##2##(1990-12#2)(1990-5#2)(1991-12#3)(1991-2#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#5)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-4#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2007-10#2)(2007-11#48)(2007-12#36)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#47)(2008-11#30)(2008-12#1)(2008-2#22)(2008-3#23)(2008-4#18)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#9)(2009-10#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#12)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#5)(2013-8#3)
generation or##6##2##(1993-12#1)(2007-11#1)(2008-10#2)(2008-8#1)(2012-12#1)
generation procedure##3##2##(2008-10#3)
generation process##5##2##(1996-4#1)(2007-12#2)(2008-3#2)
generation pulsatile##2##2##(2010-6#1)(2010-8#1)
generation sequencing##4##2##(2010-10#1)(2012-2#3)
generation system##5##2##(2008-10#4)(2010-11#1)
generation technique##2##2##(2008-10#2)
generation techniques for##2##3##(2008-10#1)(2008-3#1)
generation techniques##5##2##(2008-10#4)(2008-3#1)
generation that is##3##3##(2007-12#3)
generation that##4##2##(2007-11#1)(2007-12#3)
generation time##6##2##(2008-4#1)(2008-8#3)(2011-2#1)(2013-1#1)
generation times##6##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
generation to##3##2##(2007-12#1)(2008-2#1)(2008-9#1)
generation under different##2##3##(2008-10#2)
generation under##3##2##(2008-10#2)(2008-11#1)
generation using##2##2##(1995-3#1)(2007-12#1)
generation was determined##2##3##(1994-5#1)(2008-12#1)
generation was the##2##3##(2007-12#1)(2008-10#1)
generation was used##2##3##(2007-12#1)(2008-10#1)
generation was##20##2##(1990-12#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-11#4)(2007-12#4)(2008-10#4)(2008-12#1)
generation were investigated##3##3##(1997-1#1)(2008-10#2)
generation were##11##2##(1993-6#1)(1995-6#1)(1997-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2011-1#1)
generation when##2##2##(2008-8#1)(2009-9#1)
generation will##2##2##(2008-10#1)(2011-1#1)
generation with a##10##3##(2007-11#3)(2007-12#5)(2008-3#2)
generation with femtosecond##2##3##(2007-12#2)
generation with##20##2##(2007-11#7)(2007-12#10)(2008-3#2)(2008-8#1)
generation youth##4##2##(2009-7#4)
generation##1175##1##(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#5)(1990-7#2)(1991-12#11)(1991-2#4)(1991-3#2)(1991-5#6)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#6)(1992-3#5)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#10)(1993-8#6)(1993-9#1)(1994-11#7)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#7)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#5)(1996-12#5)(1996-2#12)(1996-3#1)(1996-4#5)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(1997-9#1)(2007-1#1)(2007-10#2)(2007-11#138)(2007-12#160)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#246)(2008-11#42)(2008-12#6)(2008-2#54)(2008-3#79)(2008-4#30)(2008-5#17)(2008-6#6)(2008-7#18)(2008-8#18)(2008-9#18)(2009-10#1)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#5)(2009-7#7)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#5)(2010-7#2)(2010-8#5)(2010-9#5)(2011-1#13)(2011-2#26)(2011-3#2)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#20)(2012-3#2)(2012-4#1)(2012-8#1)(2013-1#12)(2013-8#6)
generation&quot##3##1##(1995-11#1)(2008-7#1)(2009-7#1)
generation)##8##1##(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#3)
generation-FTIR##2##1##(2008-10#2)
generation-Fourier transform infrared##2##3##(2008-10#2)
generation-atomic absorption spectrometry##6##3##(1995-11#1)(2008-10#5)
generation-atomic fluorescence spectrometry##7##3##(2008-10#7)
generation-atomic fluorescence##9##2##(2008-10#9)
generation-atomic##15##1##(1995-11#1)(2008-10#14)
generation-gas phase##4##2##(2008-10#4)
generation/atomic absorption spectrometry##2##3##(2008-10#2)
generational##5##1##(1996-2#1)(2008-5#1)(2009-7#1)(2012-12#2)
generations and##3##2##(1997-5#1)(2008-10#1)(2008-9#1)
generations in the##2##3##(1995-2#1)(2008-10#1)
generations in##6##2##(1995-2#1)(2008-10#2)(2008-2#1)(2009-6#1)(2012-2#1)
generations is##2##2##(1996-6#1)(2007-10#1)
generations of the##2##3##(2007-12#1)(2009-12#1)
generations of##21##2##(1993-9#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
generations on##2##2##(2008-10#2)
generations were evaluated##2##3##(2008-10#2)
generations were##6##2##(1994-3#1)(2007-11#1)(2008-10#4)
generations##120##1##(1990-11#1)(1991-6#1)(1992-2#2)(1993-9#1)(1994-11#1)(1994-3#1)(1995-2#3)(1995-8#2)(1996-12#1)(1996-6#1)(1997-5#3)(2006-12#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#8)(2008-9#8)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#1)
generations)##3##1##(1997-6#1)(2008-12#2)
generative##10##1##(2007-12#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-1#1)(2013-8#2)
generator and##6##2##(2008-10#2)(2008-2#2)(2008-3#2)
generator based on##4##3##(2007-12#3)(2008-3#1)
generator for a modulator-based free-space optical interconnect##2##7##(2008-3#2)
generator for##8##2##(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#2)
generator gas##2##2##(1997-6#2)
generator in##2##2##(2007-11#1)(2008-11#1)
generator is##3##2##(2008-10#1)(2008-3#2)
generator of##4##2##(2007-12#2)(2007-8#1)(2008-7#1)
generator settings##2##2##(1992-12#2)
generator to##2##2##(2007-10#1)(2007-12#1)
generator with##2##2##(2008-10#2)
generator##87##1##(1992-12#3)(1992-5#1)(1992-8#2)(1994-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-6#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-8#1)(2008-10#16)(2008-11#4)(2008-2#8)(2008-3#15)(2008-4#2)(2008-6#1)(2008-7#6)(2009-10#2)(2009-6#1)(2010-1#1)(2013-1#1)
generators and##2##2##(2008-10#1)(2008-3#1)
generators in##2##2##(2008-10#1)(2013-1#1)
generators of##2##2##(2007-12#1)(2008-3#1)
generators##28##1##(1996-12#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#9)(2009-5#2)(2013-1#1)
generic Escherichia coli##2##3##(2010-4#2)
generic and patient specific##3##4##(2009-3#3)
generic and##5##2##(2008-10#1)(2009-3#3)(2009-9#1)
generic drugs and##2##3##(2011-3#2)
generic drugs##3##2##(2010-5#1)(2011-3#2)
generic for##2##2##(2008-10#1)(2008-11#1)
generic medicines##10##2##(2011-1#10)
generic methodology##2##2##(2008-6#1)(2008-9#1)
generic model##3##2##(2008-11#2)(2008-6#1)
generic name##4##2##(1990-6#1)(1990-7#1)(2008-10#1)(2008-11#1)
generic stress##2##2##(1990-5#2)
generic term##2##2##(2008-1#1)(2012-2#1)
generic to##2##2##(2007-11#1)(2008-8#1)
generic##103##1##(1990-5#2)(1990-6#1)(1990-7#1)(1992-3#2)(1992-9#2)(1994-12#1)(1994-3#2)(1995-3#2)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-9#2)(2010-10#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#13)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#3)(2013-8#3)
generics##2##1##(1996-11#1)(2008-8#1)
generosity##3##1##(1996-1#1)(1996-2#1)(2008-10#1)
generous##4##1##(1992-2#1)(1994-1#1)(1996-3#1)(2012-3#1)
genes (Rlm1##2##2##(2008-10#2)
genes Lr1##3##2##(2008-10#3)
genes MlRE and Pm4b##2##4##(2008-10#2)
genes across different##2##3##(2008-7#1)(2008-8#1)
genes across##3##2##(2008-7#2)(2008-8#1)
genes affecting##2##2##(2008-6#1)(2008-9#1)
genes also##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
genes among##6##2##(1991-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)
genes analyzed##2##2##(1992-6#1)(2008-8#1)
genes and 13##2##3##(1996-6#2)
genes and DNA##4##3##(2008-10#1)(2008-4#1)(2013-1#2)
genes and a##4##3##(1995-6#1)(1996-12#2)(1996-6#1)
genes and alcoholism##2##3##(1997-5#2)
genes and environmental factors##3##4##(2008-4#2)(2013-7#1)
genes and gene clusters##3##4##(1995-6#2)(1996-12#1)
genes and gene products##3##4##(2008-7#1)(2008-9#1)(2009-9#1)
genes and gene##9##3##(1995-6#2)(1996-12#1)(2008-7#3)(2008-9#1)(2009-9#1)(2012-2#1)
genes and genetic##2##3##(2008-9#1)(2012-3#1)
genes and is##4##3##(2010-3#1)(2011-2#3)
genes and of##3##3##(2008-1#1)(2008-10#2)
genes and one##3##3##(1993-6#1)(2008-9#1)(2009-10#1)
genes and other##2##3##(2008-5#1)(2008-8#1)
genes and proteins##7##3##(1994-8#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-11#1)
genes and provide##3##3##(1994-8#1)(2008-11#1)(2008-4#1)
genes and quantitative##2##3##(2008-5#1)(2008-9#1)
genes and that##2##3##(1991-9#1)(1997-7#1)
genes and the##10##3##(2007-12#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)
genes and their##7##3##(1993-8#1)(1997-4#1)(2008-10#2)(2009-5#1)(2011-2#2)
genes and three##2##3##(2008-11#1)(2013-8#1)
genes and##163##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-6#2)(1993-8#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-6#5)(1996-10#2)(1996-12#4)(1996-3#1)(1996-6#6)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#31)(2008-11#6)(2008-4#8)(2008-5#4)(2008-7#7)(2008-8#7)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-2#14)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
genes and/or gene segments##3##4##(1997-6#2)(1997-8#1)
genes and/or gene##4##3##(1997-6#2)(1997-8#2)
genes and/or##6##2##(1997-6#2)(1997-8#2)(2008-11#1)(2008-5#1)
genes appears to be##2##4##(1992-3#1)(2009-8#1)
genes are associated with##2##4##(1992-12#1)(1995-2#1)
genes are differentially expressed between##2##5##(2008-9#2)
genes are expressed in the##2##5##(2008-8#1)(2010-3#1)
genes are expressed in##5##4##(1996-2#1)(2008-10#1)(2008-8#1)(2010-3#1)(2012-3#1)
genes are expressed##11##3##(1996-2#2)(2008-10#3)(2008-6#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
genes are identical##2##3##(1992-6#1)(2008-9#1)
genes are involved in##4##4##(1997-8#1)(2008-10#2)(2010-10#1)
genes are involved##6##3##(1992-7#1)(1997-8#1)(2008-10#2)(2008-6#1)(2010-10#1)
genes are located in##2##4##(1994-12#1)(2009-9#1)
genes are located##3##3##(1993-6#1)(1994-12#1)(2009-9#1)
genes are present in##3##4##(1993-3#1)(2008-4#2)
genes are present##4##3##(1991-5#1)(1993-3#1)(2008-4#2)
genes are the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
genes are transcribed##4##3##(1990-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
genes are useful##2##3##(1990-2#1)(2009-8#1)
genes are##97##2##(1990-11#1)(1990-2#1)(1990-8#3)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-3#2)(1993-6#2)(1994-11#2)(1994-12#5)(1995-2#1)(1995-6#1)(1996-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#4)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#3)(2013-8#2)
genes as a##2##3##(1993-8#1)(2009-6#1)
genes as well as##4##4##(1994-8#1)(1997-8#1)(2008-10#1)(2008-9#1)
genes as well##5##3##(1994-8#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-9#1)
genes as##17##2##(1991-6#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
genes assigned##2##2##(1995-6#1)(1996-6#1)
genes associated with##8##3##(1992-10#1)(2008-10#3)(2008-7#1)(2009-6#1)(2010-11#1)(2013-1#1)
genes at high##2##3##(2008-11#1)(2008-7#1)
genes at##6##2##(1991-7#1)(1995-2#1)(2008-11#2)(2008-7#1)(2008-9#1)
genes between##2##2##(2008-11#1)(2009-10#1)
genes both##2##2##(2008-11#1)(2012-3#1)
genes but##2##2##(1993-6#1)(2008-10#1)
genes by##17##2##(1991-7#1)(1992-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-8#2)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
genes can be##6##3##(1997-8#2)(2008-11#2)(2008-9#1)(2011-2#1)
genes can##10##2##(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-3#1)
genes carried sequences which show some similarities to known genes##2##10##(1996-10#1)(1996-2#1)
genes carried sequences which##3##4##(1995-8#1)(1996-10#1)(1996-2#1)
genes carried##5##2##(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-4#1)
genes cloned##3##2##(1991-9#2)(1993-9#1)
genes coding for the##3##4##(1994-5#1)(1995-2#1)(1997-8#1)
genes coding for##13##3##(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-9#1)(2012-2#2)
genes coding##15##2##(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#2)
genes commonly##2##2##(2008-10#1)(2011-2#1)
genes conferred##2##2##(2008-10#1)(2008-8#1)
genes conferring resistance to##4##4##(2008-10#4)
genes conferring##7##2##(1994-9#1)(2008-10#6)
genes confirmed the##2##3##(2009-10#1)(2011-2#1)
genes containing##7##2##(1990-5#1)(1992-12#1)(1993-12#1)(1997-4#1)(2008-8#2)(2011-2#1)
genes contribute to##4##3##(1992-6#1)(2008-7#1)(2009-6#1)(2013-1#1)
genes contributing to##5##3##(2008-1#1)(2008-10#2)(2008-4#1)(2012-3#1)
genes control##4##2##(2007-12#1)(2008-10#1)(2009-5#1)(2009-8#1)
genes controlled by the##2##4##(2008-11#1)(2008-7#1)
genes controlling##4##2##(2008-10#2)(2008-7#1)(2009-6#1)
genes could also##2##3##(2008-6#1)(2010-3#1)
genes could be classified##2##4##(2007-11#1)(2009-10#1)
genes could be##4##3##(2007-11#1)(2008-10#2)(2009-10#1)
genes could##8##2##(1993-9#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-10#1)(2010-3#1)
genes derived from##2##3##(2008-10#2)
genes derived##3##2##(1997-9#1)(2008-10#2)
genes did not##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
genes differ##2##2##(2008-4#1)(2008-7#1)
genes differentially expressed##3##3##(2008-8#1)(2010-1#1)(2012-3#1)
genes displaying##2##2##(1997-8#1)(2008-10#1)
genes do not##2##3##(1993-6#1)(2012-2#1)
genes driven##2##2##(1991-7#1)(2009-4#1)
genes during##5##2##(1991-9#1)(1994-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
genes either##2##2##(2008-11#2)
genes encode a family of##2##5##(1993-12#1)(2009-8#1)
genes encode##7##2##(1993-12#2)(1995-6#1)(1997-7#1)(2008-4#1)(2009-8#1)(2011-2#1)
genes encoded##2##2##(2008-1#1)(2008-7#1)
genes encoding enzymes##2##3##(1997-2#1)(2010-7#1)
genes encoding for the##2##4##(2008-10#1)(2009-5#1)
genes encoding for##4##3##(2008-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
genes encoding key##2##3##(2008-8#1)(2009-5#1)
genes encoding proteins with##2##4##(2008-4#1)(2008-7#1)
genes encoding proteins##4##3##(2008-4#1)(2008-7#1)(2009-6#1)(2012-3#1)
genes encoding putative##2##3##(1994-8#1)(1997-4#1)
genes encoding such##2##3##(1996-12#1)(2009-8#1)
genes encoding the enzymes##2##4##(2008-10#1)(2008-3#1)
genes encoding the two##2##4##(1992-9#2)
genes encoding the##20##3##(1991-6#1)(1992-6#1)(1992-9#2)(1993-2#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-7#1)(2013-1#1)
genes encoding##75##2##(1990-5#2)(1991-6#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#5)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
genes examined##3##2##(2008-7#1)(2012-3#2)
genes except##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
genes exhibited##2##2##(1997-8#1)(2008-10#1)
genes exist##2##2##(1995-8#1)(2008-10#1)
genes expressed in##6##3##(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#3)
genes expressed##8##2##(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#3)
genes expression##5##2##(1992-8#2)(2008-7#1)(2008-9#1)(2012-7#1)
genes for biosynthesis of the##2##5##(2008-10#2)
genes for other##2##3##(1994-8#1)(2011-2#1)
genes for parental investment##2##4##(2008-9#2)
genes for resistance to STB##2##5##(2008-10#2)
genes for resistance to##11##4##(2008-10#11)
genes for resistance##14##3##(2008-10#14)
genes for the##8##3##(1993-9#1)(1994-8#1)(1995-6#1)(2008-11#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
genes for virulence##2##3##(2008-10#2)
genes for##87##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#34)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
genes from A##3##3##(2008-10#3)
genes from a##2##3##(2008-7#1)(2012-3#1)
genes from other organisms##3##4##(1994-2#1)(1996-3#1)(1997-6#1)
genes from other##4##3##(1994-2#1)(1996-3#1)(1997-6#1)(2008-10#1)
genes from the##4##3##(1990-11#1)(1997-6#1)(2008-7#1)(2009-10#1)
genes from##43##2##(1990-11#1)(1991-2#2)(1993-9#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#2)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-3#2)(2013-7#1)
genes had##3##2##(2008-7#1)(2008-8#1)(2009-8#1)
genes has been##5##3##(1990-5#1)(1992-3#1)(1997-8#1)(2008-7#1)(2011-2#1)
genes has##8##2##(1990-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1997-8#2)(2008-7#1)(2011-2#1)
genes have been described##2##4##(2011-3#1)(2012-12#1)
genes have been identified that##3##5##(2008-10#1)(2008-4#1)(2009-6#1)
genes have been identified##9##4##(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-6#1)
genes have been shown to##3##5##(1995-6#1)(2009-5#1)(2012-12#1)
genes have been##26##3##(1993-12#1)(1995-6#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)
genes have yet to be identified##2##6##(1997-7#1)(2009-6#1)
genes have yet##3##3##(1991-5#1)(1997-7#1)(2009-6#1)
genes have##47##2##(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
genes identified and##2##3##(1991-11#1)(2008-9#1)
genes identified by##2##3##(1995-12#1)(2008-10#1)
genes identified in##2##3##(2008-10#1)(2008-7#1)
genes identified##10##2##(1991-11#1)(1995-12#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)
genes implicated in##5##3##(2008-4#2)(2008-6#2)(2009-3#1)
genes important for##2##3##(1995-8#1)(2008-10#1)
genes important##3##2##(1995-8#1)(2008-10#2)
genes in Arabidopsis##4##3##(1997-8#1)(2007-12#1)(2008-7#1)(2008-9#1)
genes in Drosophila##2##3##(1993-12#1)(2008-7#1)
genes in P##2##3##(1990-5#1)(2008-10#1)
genes in T##2##3##(1997-2#1)(2008-9#1)
genes in XN4##2##3##(2008-10#2)
genes in a##13##3##(1991-9#1)(1992-3#1)(1995-11#1)(1995-2#1)(1996-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#2)(2012-3#1)
genes in an##2##3##(1994-8#1)(2008-11#1)
genes in both##5##3##(1996-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
genes in cells##2##3##(1990-5#1)(1997-8#1)
genes in cotton##2##3##(2008-10#2)
genes in cultured##2##3##(1996-2#1)(1997-4#1)
genes in databases##2##3##(1996-6#1)(2008-9#1)
genes in eukaryotic##4##3##(2008-4#2)(2008-5#1)(2008-9#1)
genes in human##5##3##(1995-9#1)(2008-2#2)(2008-7#1)(2011-2#1)
genes in insect cells##2##4##(1993-6#1)(1997-4#1)
genes in mammalian cells##2##4##(1996-12#1)(2008-11#1)
genes in mammalian##3##3##(1991-6#1)(1996-12#1)(2008-11#1)
genes in other genomes##2##4##(2008-7#1)(2012-2#1)
genes in other##4##3##(2008-10#1)(2008-7#2)(2012-2#1)
genes in plant development##2##4##(2009-8#2)
genes in rat##3##3##(1997-3#1)(2008-8#1)(2008-9#1)
genes in response to##4##4##(1996-12#1)(2008-10#2)(2012-12#1)
genes in rice##3##3##(2008-9#2)(2011-3#1)
genes in several##2##3##(2008-10#1)(2008-7#1)
genes in the human genome##2##5##(1991-6#1)(2011-2#1)
genes in the human##3##4##(1991-6#1)(1992-3#1)(2011-2#1)
genes in the##45##3##(1990-11#1)(1990-12#1)(1991-6#2)(1992-3#3)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-9#1)(2008-10#11)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
genes in these##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
genes in this region##3##4##(1996-8#1)(1997-3#1)(2008-7#1)
genes in this##6##3##(1992-3#1)(1993-12#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-7#1)
genes in tomato##2##3##(1993-12#1)(2008-10#1)
genes in vitro and in##2##5##(2008-10#1)(2008-4#1)
genes in vitro##3##3##(2008-10#1)(2008-4#2)
genes in vivo##2##3##(1997-8#1)(2008-10#1)
genes in wheat##2##3##(2011-2#2)
genes in##251##2##(1990-11#1)(1990-12#1)(1990-5#4)(1991-5#1)(1991-6#4)(1991-9#2)(1992-3#8)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-12#5)(1996-2#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(1997-9#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#51)(2008-11#8)(2008-2#4)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#19)(2008-8#10)(2008-9#16)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-4#2)(2011-2#10)(2011-3#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
genes including the##2##3##(1997-2#1)(2013-1#1)
genes including##9##2##(1997-2#1)(2008-10#3)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
genes indicated that##2##3##(2008-11#1)(2008-8#1)
genes indicates##2##2##(1991-7#1)(2008-10#1)
genes induced by##2##3##(1992-12#1)(2008-7#1)
genes induced##3##2##(1992-12#1)(2008-7#1)(2012-2#1)
genes influencing##2##2##(2008-8#1)(2009-10#1)
genes into a single##2##4##(2008-10#2)
genes into a##3##3##(2008-10#2)(2012-12#1)
genes into the##5##3##(1994-12#1)(1994-5#1)(2008-11#1)(2008-4#2)
genes into##21##2##(1990-11#1)(1990-5#2)(1991-6#1)(1992-6#1)(1994-12#1)(1994-5#4)(2006-12#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-8#1)(2012-12#1)
genes involved in cancer##2##4##(2008-7#1)(2008-9#1)
genes involved in cell##2##4##(2008-7#1)(2009-8#1)
genes involved in cellular##2##4##(2008-11#1)(2010-7#1)
genes involved in defense response##2##5##(2008-9#2)
genes involved in pathogenicity of##2##5##(2008-10#2)
genes involved in pathogenicity##3##4##(2008-10#3)
genes involved in the##15##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-11#1)(2012-3#1)(2013-1#2)
genes involved in##61##3##(1990-5#2)(1994-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#7)(2008-9#7)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#3)
genes involved##66##2##(1990-5#2)(1994-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#7)(2008-9#8)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
genes is a##23##3##(2008-5#1)(2011-2#22)
genes is associated with##2##4##(1997-3#1)(2008-4#1)
genes is discussed##2##3##(2007-11#1)(2008-9#1)
genes is regulated##2##3##(1997-3#1)(2008-9#1)
genes is##79##2##(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-9#1)(1997-3#2)(1997-7#1)(2007-11#3)(2008-10#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#7)(2009-8#3)(2010-11#1)(2011-2#39)(2012-2#1)(2012-3#1)(2013-1#1)
genes knirps##2##2##(1994-8#2)
genes known as##2##3##(2008-10#1)(2010-4#1)
genes known##4##2##(2008-10#2)(2010-4#1)(2012-3#1)
genes lacking a##2##3##(1997-2#1)(2012-3#1)
genes lacking##3##2##(1997-2#1)(2007-11#1)(2012-3#1)
genes linked##2##2##(2008-4#1)(2013-1#1)
genes located on the left arm of##2##7##(1996-6#2)
genes located on the##3##4##(1996-6#3)
genes located on##5##3##(1996-6#3)(2008-4#1)(2008-7#1)
genes located##7##2##(1996-6#3)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)
genes mapped##2##2##(2008-10#1)(2008-8#1)
genes may be present##2##4##(1997-2#1)(2008-9#1)
genes may be##6##3##(1991-12#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-9#2)
genes may have implications##2##4##(2008-11#1)(2009-4#1)
genes may have##4##3##(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)
genes may##26##2##(1990-3#1)(1991-12#1)(1992-12#1)(1993-3#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-4#1)(2009-6#2)
genes might##3##2##(2008-10#2)(2008-9#1)
genes more##2##2##(1994-11#1)(2008-7#1)
genes must##2##2##(2007-11#1)(2010-3#1)
genes near the##2##3##(2008-10#1)(2008-11#1)
genes not##2##2##(2008-10#1)(2010-4#1)
genes of C##2##3##(1993-9#1)(2008-8#1)
genes of Saccharomyces cerevisiae##2##4##(1994-9#1)(1997-3#1)
genes of X##2##3##(2008-10#2)
genes of a##2##3##(1994-12#2)
genes of both##2##3##(1997-4#1)(2008-10#1)
genes of different##2##3##(1995-12#1)(2008-8#1)
genes of interest##6##3##(1997-4#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)
genes of the##17##3##(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-3#1)
genes of these##2##3##(2008-9#1)(2013-1#1)
genes of two##2##3##(2008-10#2)
genes of##84##2##(1990-7#3)(1990-8#1)(1991-5#1)(1993-8#2)(1993-9#2)(1994-12#5)(1994-8#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(2007-12#1)(2007-6#1)(2008-10#14)(2008-11#2)(2008-4#5)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
genes on chromosome VI of Saccharomyces cerevisiae##2##7##(1997-6#2)
genes on chromosome VI of##3##5##(1997-6#3)
genes on chromosome##10##3##(1996-10#1)(1996-6#1)(1997-6#3)(1997-8#1)(2008-10#3)(2008-8#1)
genes on##18##2##(1996-10#1)(1996-6#2)(1997-6#3)(1997-8#1)(2008-10#5)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)
genes or##19##2##(1995-6#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
genes p21##2##2##(2008-7#2)
genes participating in##3##3##(1996-6#1)(2009-8#1)(2012-3#1)
genes play##3##2##(2008-7#2)(2011-2#1)
genes polymorphisms##2##2##(1997-5#1)(2012-1#1)
genes potentially##2##2##(1994-8#1)(2008-10#1)
genes predisposing to##2##3##(1996-8#1)(2007-7#1)
genes preferentially##2##2##(2009-10#1)(2010-1#1)
genes present in##5##3##(1997-6#1)(2008-10#4)
genes previously##3##2##(1996-8#1)(2008-10#2)
genes produce##2##2##(2008-4#1)(2011-2#1)
genes provides##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
genes rather than##2##3##(2012-3#2)
genes regulate##2##2##(1994-8#1)(2008-10#1)
genes regulated by##3##3##(1990-5#1)(1991-9#1)(2008-7#1)
genes related to Krox-20##2##4##(1991-9#2)
genes related to apoptosis##2##4##(2010-11#2)
genes related to the##4##4##(1991-9#1)(2010-5#2)(2012-3#1)
genes related to##15##3##(1991-9#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
genes relative to##2##3##(2008-1#1)(2008-7#1)
genes relevant to##2##3##(2009-5#1)(2012-3#1)
genes remain##2##2##(2009-6#1)(2011-2#1)
genes required for##6##3##(1993-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
genes respectively##2##2##(2009-12#1)(2012-3#1)
genes responsible for glaucoma##2##4##(2011-1#2)
genes responsible for the##3##4##(1995-6#1)(1996-2#1)(2011-2#1)
genes responsible for##11##3##(1994-9#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-1#2)(2011-10#1)(2011-2#1)
genes result in##2##3##(1993-12#1)(2012-3#1)
genes revealed that##2##3##(1992-3#1)(2007-6#1)
genes revealed##3##2##(1992-3#1)(2007-6#1)(2010-6#1)
genes seem to be##2##4##(2007-11#1)(2009-10#1)
genes seem to##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2009-10#1)
genes segregating##2##2##(2008-10#2)
genes selected##2##2##(2008-10#1)(2011-2#1)
genes share##4##2##(1993-12#1)(1993-6#1)(1997-7#1)(2008-7#1)
genes should##2##2##(1996-6#1)(2008-11#1)
genes show##2##2##(1994-8#1)(2008-10#1)
genes showed that##2##3##(1991-9#1)(2009-6#1)
genes showed##8##2##(1991-9#1)(1997-2#1)(2008-8#1)(2009-6#1)(2010-1#3)(2010-4#1)
genes showing##2##2##(2008-7#1)(2008-9#1)
genes shows##2##2##(1993-6#1)(2008-7#1)
genes specifically expressed in orally tolerized T cells##2##8##(2008-11#2)
genes specifically expressed in##3##4##(2008-11#2)(2008-7#1)
genes specifically##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
genes such as##8##3##(2008-11#2)(2008-4#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-2#1)
genes suggests that the##2##4##(2008-6#1)(2009-5#1)
genes suggests that##4##3##(1991-2#1)(2008-6#1)(2009-5#1)(2009-8#1)
genes suggests##6##2##(1991-2#1)(1992-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)
genes tested##2##2##(2011-2#2)
genes that allow##2##3##(1995-5#1)(2008-7#1)
genes that are associated with##2##5##(2007-11#1)(2009-9#1)
genes that are often##2##4##(2008-6#1)(2009-5#1)
genes that are potentially##2##4##(2011-1#1)(2012-12#1)
genes that are##24##3##(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
genes that can##2##3##(1991-5#1)(1994-12#1)
genes that code for##2##4##(1993-6#1)(2010-10#1)
genes that confer##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
genes that contain##2##3##(1995-2#1)(2012-3#1)
genes that control##2##3##(1997-8#1)(2008-1#1)
genes that could##2##3##(2008-10#2)
genes that encode the##2##4##(1995-6#1)(2008-4#1)
genes that encode##13##3##(1992-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
genes that have##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
genes that influence##4##3##(2007-10#1)(2008-10#2)(2008-9#1)
genes that lead to##3##4##(2008-6#1)(2008-7#2)
genes that may##2##3##(1992-9#1)(2008-10#1)
genes that might##2##3##(2008-10#1)(2008-7#1)
genes that play##2##3##(1996-10#1)(2011-2#1)
genes that were##7##3##(1994-8#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-4#1)(2013-1#1)
genes that##105##2##(1991-5#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#2)
genes through##3##2##(1996-10#1)(2008-7#1)(2011-2#1)
genes to a##2##3##(2008-10#1)(2008-4#1)
genes to be##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)
genes to generate##2##3##(2008-6#1)(2011-2#1)
genes to human##2##3##(1994-5#1)(2008-10#1)
genes to identify##2##3##(2011-3#1)(2012-3#1)
genes to the##2##3##(2008-10#1)(2008-8#1)
genes to##42##2##(1991-5#1)(1992-12#1)(1994-11#1)(1994-5#2)(1996-10#2)(2007-10#1)(2008-10#14)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
genes under different##2##3##(1995-6#1)(2008-10#1)
genes under the control of##2##5##(1992-3#1)(1996-5#1)
genes under##5##2##(1992-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-7#1)
genes upregulated in##2##3##(2008-10#1)(2008-7#1)
genes upregulated##4##2##(2008-10#1)(2008-7#2)(2009-8#1)
genes using##7##2##(1994-6#1)(2008-10#3)(2008-2#1)(2009-10#1)(2010-10#1)
genes was confirmed by##2##4##(2008-1#1)(2011-2#1)
genes was determined##2##3##(1992-3#1)(2008-10#1)
genes was examined##2##3##(1990-12#1)(2008-10#1)
genes was observed##2##3##(1991-6#1)(2010-4#1)
genes was studied##2##3##(1990-11#1)(2008-9#1)
genes was##33##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
genes we##2##2##(2008-7#1)(2009-8#1)
genes were also##4##3##(1997-6#1)(1997-8#2)(2008-11#1)
genes were analyzed in##2##4##(1997-6#1)(2012-2#1)
genes were analyzed##3##3##(1997-6#1)(2010-4#1)(2012-2#1)
genes were assigned to##2##4##(1991-2#1)(2010-4#1)
genes were assigned##3##3##(1991-2#1)(1996-6#1)(2010-4#1)
genes were associated with##3##4##(2010-4#1)(2011-2#1)(2012-2#1)
genes were characterized in##2##4##(2008-10#1)(2013-8#1)
genes were cloned##3##3##(2008-10#2)(2008-9#1)
genes were constructed##2##3##(1994-6#1)(2008-10#1)
genes were detected##5##3##(2008-10#4)(2010-5#1)
genes were down-regulated##2##3##(2008-10#1)(2010-4#1)
genes were examined##2##3##(1991-2#1)(2012-3#1)
genes were expressed at##2##4##(2008-10#1)(2013-7#1)
genes were expressed in a##2##5##(1993-8#1)(1995-8#1)
genes were expressed in##5##4##(1993-8#1)(1995-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
genes were expressed##7##3##(1993-8#1)(1995-8#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-7#1)
genes were first##2##3##(2008-7#1)(2008-8#1)
genes were found to##2##4##(2008-7#2)
genes were found##3##3##(2008-10#1)(2008-7#2)
genes were highly expressed in##2##5##(2008-11#1)(2008-8#1)
genes were highly##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
genes were identified that##2##4##(2008-10#1)(2008-5#1)
genes were identified##9##3##(1995-12#2)(1995-8#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)
genes were introduced##2##3##(2008-6#1)(2008-8#1)
genes were isolated from##2##4##(1990-11#1)(1991-2#1)
genes were isolated##4##3##(1990-11#1)(1991-2#1)(1993-12#1)(2008-8#1)
genes were located##2##3##(2008-8#2)
genes were mapped on the##3##5##(1996-8#1)(1997-8#1)(2013-8#1)
genes were mapped##4##3##(1996-8#1)(1997-8#1)(2008-10#1)(2013-8#1)
genes were more##2##3##(2008-10#1)(2008-8#1)
genes were not##2##3##(2008-10#1)(2008-9#1)
genes were observed##2##3##(2008-10#1)(2008-11#1)
genes were obtained##2##3##(1997-6#1)(2008-8#1)
genes were present##2##3##(1991-6#1)(1997-6#1)
genes were regulated##2##3##(2008-9#1)(2009-8#1)
genes were significantly##2##3##(2008-8#1)(2010-11#1)
genes were subcloned##2##3##(1992-3#1)(1994-5#1)
genes were unrelated to any reported genes##3##7##(1995-8#1)(1996-10#1)(1996-2#1)
genes were up-regulated and##2##4##(2008-10#1)(2008-9#1)
genes were up-regulated##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
genes were used to##2##4##(1994-8#1)(2008-7#1)
genes were used##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
genes were##143##2##(1990-11#1)(1991-2#3)(1991-6#1)(1992-3#2)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#2)(1995-8#3)(1996-10#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-8#6)(2008-10#35)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#15)(2008-9#6)(2009-10#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#7)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#5)
genes when##2##2##(2008-10#2)
genes which are##4##3##(2008-6#1)(2008-8#2)(2011-2#1)
genes which##12##2##(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-6#1)(2008-7#1)(2008-8#4)(2011-2#2)
genes whose expression is##2##4##(1995-11#1)(2009-4#1)
genes whose expression##4##3##(1995-11#1)(2008-10#1)(2009-4#1)(2012-3#1)
genes whose products are##4##4##(1994-9#1)(2007-12#2)(2008-11#1)
genes whose##17##2##(1991-12#1)(1992-12#1)(1994-9#1)(1995-11#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#1)
genes will##3##2##(2008-1#1)(2012-3#1)(2013-8#1)
genes with a##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
genes with multiple##2##3##(2012-3#2)
genes with potential##2##3##(2008-7#1)(2011-1#1)
genes with potentially##2##3##(2008-7#2)
genes with rare##2##3##(2010-5#1)(2012-3#1)
genes with respect to##2##4##(2011-2#2)
genes with the##3##3##(1990-5#1)(1996-12#1)(2008-9#1)
genes with their##2##3##(1991-6#1)(2008-7#1)
genes with unknown function##2##4##(2008-7#1)(2008-9#1)
genes with##47##2##(1990-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-5#1)(1996-12#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#11)(2008-8#2)(2008-9#3)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-3#5)(2013-8#1)
genes within the##2##3##(2008-10#2)
genes within##5##2##(1992-3#1)(1996-6#1)(2008-10#2)(2012-3#1)
genes##3042##1##(1990-11#14)(1990-12#6)(1990-2#3)(1990-3#1)(1990-5#26)(1990-7#4)(1990-8#13)(1991-11#3)(1991-12#7)(1991-2#15)(1991-5#16)(1991-6#24)(1991-7#6)(1991-9#24)(1992-10#2)(1992-11#2)(1992-12#18)(1992-3#27)(1992-4#3)(1992-6#17)(1992-7#3)(1992-8#14)(1992-9#7)(1993-11#2)(1993-12#29)(1993-2#8)(1993-3#9)(1993-5#1)(1993-6#20)(1993-8#12)(1993-9#19)(1994-11#20)(1994-12#36)(1994-2#2)(1994-3#3)(1994-5#19)(1994-6#6)(1994-8#34)(1994-9#13)(1995-11#10)(1995-12#25)(1995-2#12)(1995-3#3)(1995-5#6)(1995-6#39)(1995-8#30)(1995-9#5)(1996-10#20)(1996-12#36)(1996-2#24)(1996-3#10)(1996-5#7)(1996-6#28)(1996-8#9)(1996-9#1)(1997-2#27)(1997-3#24)(1997-4#23)(1997-5#9)(1997-6#34)(1997-7#35)(1997-8#45)(1997-9#5)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#4)(2007-11#20)(2007-12#24)(2007-6#4)(2007-7#3)(2008-1#22)(2008-10#580)(2008-11#83)(2008-12#3)(2008-2#11)(2008-3#4)(2008-4#92)(2008-5#24)(2008-6#44)(2008-7#208)(2008-8#118)(2008-9#131)(2009-10#39)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#9)(2009-5#23)(2009-6#23)(2009-7#1)(2009-8#45)(2009-9#5)(2010-1#12)(2010-10#11)(2010-11#17)(2010-12#3)(2010-3#18)(2010-4#28)(2010-5#12)(2010-6#7)(2010-7#8)(2010-8#3)(2011-1#26)(2011-10#4)(2011-2#156)(2011-3#9)(2012-1#3)(2012-12#25)(2012-2#40)(2012-3#92)(2012-7#1)(2013-1#43)(2013-7#6)(2013-8#24)
genes&quot##4##1##(1995-12#1)(2008-1#2)(2008-6#1)
genes) was##2##2##(2008-10#2)
genes)##18##1##(1993-12#2)(1995-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-9#1)(2010-11#2)(2013-1#2)(2013-7#1)
genes/molecules##2##1##(2008-4#2)
genes/proteins##3##1##(2008-10#1)(2008-11#1)(2009-8#1)
genesis and##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
genesis of the##2##3##(1991-12#1)(2007-8#1)
genesis of##18##2##(1991-12#1)(1991-4#2)(1995-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
genesis##30##1##(1990-9#1)(1991-12#1)(1991-4#3)(1992-5#1)(1995-8#2)(1997-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-8#1)
genetic aberrations##3##2##(2008-9#2)(2010-11#1)
genetic abnormalities##4##2##(1993-12#1)(2007-5#2)(2008-3#1)
genetic abnormality##3##2##(1993-3#1)(2008-8#1)(2013-8#1)
genetic algorithm (GA)##2##3##(2008-3#2)
genetic algorithm for rule-set prediction##2##5##(2008-8#2)
genetic algorithm for##5##3##(2008-10#1)(2008-3#1)(2008-8#2)(2010-8#1)
genetic algorithm##19##2##(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)
genetic algorithms##7##2##(1994-2#1)(2008-10#2)(2008-3#3)(2012-3#1)
genetic alteration of p53##3##4##(1994-12#3)
genetic alteration##4##2##(1994-12#3)(1997-5#1)
genetic alterations and##3##3##(2008-2#1)(2010-3#1)(2011-2#1)
genetic alterations are##2##3##(2009-4#1)(2011-3#1)
genetic alterations##13##2##(1994-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#3)(2011-2#2)(2011-3#1)
genetic analyses are##2##3##(2007-12#1)(2008-12#1)
genetic analyses of##6##3##(2007-8#1)(2008-10#3)(2008-8#1)(2010-3#1)
genetic analyses##20##2##(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#2)(2010-3#1)(2012-3#1)(2013-1#1)
genetic analysis of complex##2##4##(2010-5#1)(2012-3#1)
genetic analysis of the##3##4##(1997-6#1)(2008-10#1)(2011-1#1)
genetic analysis of##27##3##(1990-3#3)(1996-12#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
genetic analysis##43##2##(1990-3#3)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#12)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-1#2)(2010-5#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
genetic and biochemical##5##3##(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
genetic and biological diversity##3##4##(2008-10#3)
genetic and biological##7##3##(1992-11#1)(1997-2#1)(2008-10#5)
genetic and cellular##2##3##(2008-4#1)(2008-9#1)
genetic and environmental factors that##2##5##(2008-11#1)(2008-3#1)
genetic and environmental factors##19##4##(1990-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
genetic and environmental risk factors##2##5##(2007-10#1)(2008-11#1)
genetic and environmental##28##3##(1990-6#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
genetic and epidemiological studies##2##4##(2008-10#1)(2008-7#1)
genetic and epigenetic##8##3##(1992-3#1)(2008-7#2)(2009-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
genetic and genomic##3##3##(2008-4#1)(2009-3#1)(2012-3#1)
genetic and molecular analysis##2##4##(2008-8#1)(2012-3#1)
genetic and molecular##12##3##(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)
genetic and non-genetic##2##3##(1997-5#1)(2008-1#1)
genetic and pathogenic##4##3##(2008-10#4)
genetic and phenotypic diversity within##2##5##(2008-10#2)
genetic and phenotypic##6##3##(2008-10#3)(2010-12#1)(2013-1#2)
genetic and physical mapping##2##4##(1995-6#1)(2008-10#1)
genetic and physical maps##2##4##(1996-10#1)(2008-4#1)
genetic and physical##5##3##(1995-6#1)(1996-10#1)(2008-10#1)(2008-4#1)(2009-10#1)
genetic and physiological##2##3##(1995-6#1)(2011-10#1)
genetic and virulence diversity##2##4##(2008-10#2)
genetic and##121##2##(1990-6#1)(1992-11#1)(1992-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#3)(2010-10#2)(2010-12#2)(2010-3#2)(2011-1#2)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
genetic approach to##3##3##(1993-12#1)(1995-2#1)(2012-3#1)
genetic approach##6##2##(1991-11#1)(1993-12#1)(1995-2#1)(2008-8#2)(2012-3#1)
genetic approaches##7##2##(1991-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-1#1)(2013-1#1)
genetic architecture of##9##3##(2008-10#1)(2008-8#4)(2009-12#1)(2010-12#1)(2011-1#1)(2012-3#1)
genetic architecture##12##2##(2008-10#1)(2008-8#5)(2009-12#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#1)
genetic architectures of##2##3##(2008-8#2)
genetic architectures##3##2##(2008-8#2)(2011-1#1)
genetic as well as##2##4##(1994-2#1)(2010-10#1)
genetic aspects##3##2##(1994-11#1)(2008-11#1)(2008-7#1)
genetic association studies##2##3##(2008-4#1)(2012-3#1)
genetic association##9##2##(1997-5#1)(2007-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#3)
genetic background and##2##3##(2011-2#1)(2012-3#1)
genetic background in##2##3##(2008-1#1)(2008-10#1)
genetic background of##11##3##(2007-10#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-10#1)(2012-3#2)
genetic background##30##2##(1995-12#2)(1996-5#1)(2007-10#3)(2008-1#2)(2008-10#12)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#3)(2013-1#1)
genetic backgrounds##9##2##(1996-8#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-3#2)
genetic base of##2##3##(2008-10#1)(2012-12#1)
genetic basis and##2##3##(2008-5#1)(2008-9#1)
genetic basis for this##2##4##(2008-11#1)(2008-8#1)
genetic basis for##8##3##(1991-8#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-4#1)
genetic basis of glucose homeostasis##3##5##(2008-1#3)
genetic basis of heterosis in rice##3##6##(2008-4#2)(2008-8#1)
genetic basis of heterosis##5##4##(2008-4#3)(2008-8#1)(2009-10#1)
genetic basis of the##3##4##(2008-10#2)(2012-3#1)
genetic basis of##28##3##(1994-9#1)(1995-12#1)(2008-1#3)(2008-10#4)(2008-4#5)(2008-5#2)(2008-8#4)(2009-10#2)(2009-5#1)(2010-5#1)(2011-1#1)(2012-3#3)
genetic basis##46##2##(1991-8#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-10#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#4)
genetic cause of##2##3##(2008-7#1)(2010-4#1)
genetic cause##3##2##(2008-4#1)(2008-7#1)(2010-4#1)
genetic causes of##3##3##(1995-12#1)(1997-7#1)(2008-1#1)
genetic causes##6##2##(1995-12#1)(1997-3#2)(1997-7#1)(2008-1#1)(2009-6#1)
genetic change in##2##3##(1994-12#1)(2008-10#1)
genetic change##4##2##(1992-2#1)(1994-12#1)(2007-6#1)(2008-10#1)
genetic changes during##2##3##(2008-10#2)
genetic changes in##4##3##(1994-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
genetic changes##11##2##(1993-8#1)(1994-12#1)(1994-6#1)(1996-6#1)(2007-10#1)(2008-10#4)(2008-4#1)(2013-1#1)
genetic characteristics of Sasang##2##4##(2012-12#2)
genetic characteristics of the viruses##2##5##(2011-2#2)
genetic characteristics of##9##3##(2008-7#1)(2011-2#3)(2012-12#2)(2013-8#3)
genetic characteristics##14##2##(1994-11#1)(2007-10#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#5)
genetic characteristrics##2##2##(2011-1#2)
genetic characterization of the##2##4##(2008-10#1)(2009-8#1)
genetic characterization of##5##3##(2008-10#2)(2009-5#1)(2009-8#1)(2012-2#1)
genetic characterization##8##2##(2008-10#4)(2008-7#1)(2009-5#1)(2009-8#1)(2012-2#1)
genetic clusters##4##2##(2008-10#2)(2012-1#2)
genetic code##8##2##(1994-5#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#2)
genetic component of##2##3##(2008-7#1)(2012-3#1)
genetic component##7##2##(2008-7#2)(2008-8#2)(2012-2#1)(2012-3#2)
genetic components##4##2##(2008-7#1)(2008-8#1)(2009-6#1)(2010-8#1)
genetic composition of the##3##4##(1996-6#1)(2008-10#2)
genetic composition of##6##3##(1996-6#1)(2008-10#4)(2009-8#1)
genetic composition##9##2##(1996-6#1)(2008-10#5)(2008-12#1)(2009-8#1)(2012-3#1)
genetic condition##2##2##(1991-2#1)(2008-11#1)
genetic connectedness##4##2##(2012-1#4)
genetic content##2##2##(2011-2#1)(2012-12#1)
genetic contribution of##3##3##(2011-2#3)
genetic contribution to##2##3##(2007-10#1)(2008-9#1)
genetic contribution##8##2##(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#3)
genetic contributions##3##2##(1994-2#1)(2007-10#1)(2011-2#1)
genetic control and##2##3##(1991-12#1)(2008-10#1)
genetic control of resistance to necrosis induced by P##2##9##(2008-10#2)
genetic control of resistance to##3##5##(2008-10#3)
genetic control of##9##3##(1993-2#1)(2008-10#3)(2008-8#2)(2009-10#1)(2012-3#1)(2013-8#1)
genetic control##16##2##(1991-12#1)(1993-2#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
genetic correlation between the##3##4##(1991-1#1)(2008-8#1)(2008-9#1)
genetic correlation between##6##3##(1991-1#1)(2008-8#2)(2008-9#3)
genetic correlation##10##2##(1991-1#1)(1994-2#1)(2008-8#3)(2008-9#4)(2013-1#1)
genetic correlations between##4##3##(2008-10#1)(2008-8#3)
genetic correlations##6##2##(2008-10#1)(2008-8#5)
genetic counseling and##3##3##(2008-1#1)(2008-3#1)(2013-1#1)
genetic counseling##13##2##(1997-3#2)(1997-4#2)(2007-7#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
genetic counselling##3##2##(1991-11#1)(1991-3#1)(1997-3#1)
genetic cross##3##2##(1996-12#1)(2008-10#2)
genetic damage##2##2##(2011-2#1)(2013-1#1)
genetic data in##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
genetic data##11##2##(1990-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-3#3)(2013-1#1)
genetic defect##8##2##(1990-11#1)(1990-5#1)(1993-6#1)(1996-12#1)(1996-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
genetic defects in##2##3##(2011-1#2)
genetic defects responsible for##2##4##(1995-8#1)(2011-1#1)
genetic defects##9##2##(1991-3#1)(1993-9#1)(1995-8#1)(2011-1#4)(2011-2#1)(2013-8#1)
genetic deficiency##2##2##(1993-12#1)(2010-5#1)
genetic deletion##2##2##(2010-2#1)(2011-2#1)
genetic determinant##3##2##(2008-10#1)(2009-5#2)
genetic determinants##4##2##(2007-10#1)(2008-10#3)
genetic determination##2##2##(2008-4#1)(2008-8#1)
genetic diagnosis (PGD) is##2##4##(2008-4#1)(2012-3#1)
genetic diagnosis of##4##3##(1994-2#1)(1996-8#1)(2007-7#1)(2008-6#1)
genetic diagnosis##10##2##(1994-2#1)(1996-8#1)(2007-7#1)(2008-4#4)(2008-6#1)(2012-3#2)
genetic difference between##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
genetic difference##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-8#2)
genetic differences among##2##3##(2008-2#1)(2010-4#1)
genetic differences in##2##3##(2008-10#1)(2008-11#1)
genetic differences##10##2##(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-4#2)(2011-2#1)
genetic differentiation (G(ST) = 0##2##5##(2008-10#2)
genetic differentiation among populations##5##4##(2008-10#2)(2008-8#2)(2013-8#1)
genetic differentiation among regions##2##4##(2008-10#2)
genetic differentiation among subpopulations##2##4##(2008-10#2)
genetic differentiation among##15##3##(2008-10#11)(2008-8#2)(2011-2#1)(2013-8#1)
genetic differentiation between##5##3##(2008-10#3)(2012-3#1)(2013-1#1)
genetic differentiation of##5##3##(2008-10#4)(2008-6#1)
genetic differentiation was##3##3##(2008-10#3)
genetic differentiation##46##2##(2008-10#32)(2008-6#1)(2008-8#4)(2011-2#2)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
genetic disease that##2##3##(2008-11#1)(2008-2#1)
genetic disease##11##2##(1990-3#1)(1990-8#1)(1992-3#1)(1994-2#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2009-5#1)
genetic diseases##10##2##(1990-2#1)(1991-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
genetic disorder with##2##3##(2008-4#1)(2008-7#1)
genetic disorder##10##2##(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#2)(2011-3#1)(2013-1#4)
genetic disorders in##2##3##(2008-11#1)(2013-1#1)
genetic disorders##11##2##(1995-1#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#2)
genetic dissection of##4##3##(1994-9#2)(2011-2#1)(2012-3#1)
genetic dissimilarity##2##2##(2008-10#2)
genetic distance among isolates##2##4##(2008-10#2)
genetic distance between the##2##4##(2008-10#1)(2008-6#1)
genetic distance between##5##3##(2008-10#4)(2008-6#1)
genetic distance of##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
genetic distance was found##2##4##(2008-10#2)
genetic distance was##3##3##(2008-10#3)
genetic distance##23##2##(1997-5#1)(2008-10#18)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
genetic distances between##3##3##(2008-10#2)(2011-1#1)
genetic distances were##3##3##(2008-10#2)(2008-6#1)
genetic distances##13##2##(2008-10#8)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#2)
genetic divergence and##2##3##(2008-8#1)(2013-1#1)
genetic divergence between populations##2##4##(2008-8#2)
genetic divergence between##3##3##(2008-8#2)(2009-2#1)
genetic divergence##14##2##(2008-10#1)(2008-8#5)(2008-9#1)(2009-2#2)(2010-10#1)(2012-3#1)(2013-1#2)(2013-7#1)
genetic diversities##2##2##(2008-4#1)(2011-2#1)
genetic diversity (H)##2##3##(2008-10#2)
genetic diversity among X##2##4##(2008-10#2)
genetic diversity among##10##3##(2008-10#9)(2008-8#1)
genetic diversity and population differentiation##2##5##(2008-10#2)
genetic diversity and population structure of##2##6##(2011-2#1)(2013-8#1)
genetic diversity and population structure##3##5##(2008-10#1)(2011-2#1)(2013-8#1)
genetic diversity and population##5##4##(2008-10#3)(2011-2#1)(2013-8#1)
genetic diversity and the##2##4##(2008-10#1)(2009-2#1)
genetic diversity and##17##3##(2008-10#10)(2009-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
genetic diversity between##3##3##(1995-2#1)(2008-7#1)(2011-2#1)
genetic diversity for##2##3##(2008-9#1)(2012-3#1)
genetic diversity found##2##3##(2008-10#2)
genetic diversity in the##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
genetic diversity in##14##3##(1994-11#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-2#2)(2010-10#1)(2010-3#1)(2012-3#1)
genetic diversity of the##9##4##(2008-10#6)(2008-6#1)(2013-8#2)
genetic diversity of##27##3##(2008-10#17)(2008-12#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-7#1)(2012-1#1)(2012-3#1)(2013-8#2)
genetic diversity than##2##3##(2008-10#1)(2013-8#1)
genetic diversity was attributable to##2##5##(2008-10#2)
genetic diversity was observed##2##4##(2008-10#2)
genetic diversity was##11##3##(2008-10#9)(2009-2#1)(2013-8#1)
genetic diversity within a##2##4##(2008-10#2)
genetic diversity within the##4##4##(2008-10#3)(2009-5#1)
genetic diversity within##8##3##(2008-10#7)(2009-5#1)
genetic diversity##130##2##(1994-11#1)(1995-2#1)(1997-3#1)(2008-10#78)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#7)(2009-3#2)(2009-5#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#6)
genetic drift and##2##3##(2008-10#1)(2013-1#1)
genetic drift##15##2##(1996-6#2)(2008-10#6)(2008-11#1)(2012-3#1)(2013-1#5)
genetic effect and the other##2##5##(1994-2#2)
genetic effect in the##2##4##(1994-2#2)
genetic effect in##3##3##(1994-2#3)
genetic effect on##2##3##(2008-10#2)
genetic effect##12##2##(1994-2#8)(2008-10#2)(2009-7#1)(2012-3#1)
genetic effects has##2##3##(2008-11#1)(2010-4#1)
genetic effects in##2##3##(2008-8#2)
genetic effects of a##2##4##(1990-7#1)(2008-9#1)
genetic effects of##3##3##(1990-7#1)(2008-9#1)(2009-7#1)
genetic effects on##3##3##(1994-2#2)(2008-8#1)
genetic effects##18##2##(1990-7#1)(1994-2#2)(2008-11#1)(2008-8#8)(2008-9#1)(2009-7#1)(2010-4#2)(2012-3#2)
genetic element##3##2##(1995-8#1)(1996-6#1)(2013-1#1)
genetic elements that##2##3##(2012-3#2)
genetic elements##6##2##(2008-10#1)(2008-11#2)(2009-3#1)(2012-3#2)
genetic engineering and##2##3##(2008-10#1)(2009-3#1)
genetic engineering of##2##3##(2012-2#1)(2013-1#1)
genetic engineering##15##2##(1990-11#1)(1992-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
genetic epidemiology studies##3##3##(1996-2#1)(2008-7#1)(2011-2#1)
genetic epidemiology##6##2##(1996-2#1)(2008-7#3)(2009-10#1)(2011-2#1)
genetic etiology##2##2##(2007-12#1)(2008-1#1)
genetic evaluation of##2##3##(2008-12#1)(2010-6#1)
genetic evaluation##3##2##(2008-12#1)(2010-6#1)(2011-2#1)
genetic events##6##2##(1993-2#1)(1994-12#1)(1995-12#1)(2008-8#1)(2009-8#1)(2010-3#1)
genetic evidence of##2##3##(2008-10#1)(2010-11#1)
genetic evidence##15##2##(1994-9#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
genetic evolution##3##2##(1994-12#1)(2009-9#1)(2013-8#1)
genetic exchange between##2##3##(2008-10#1)(2008-5#1)
genetic exchange in##2##3##(2008-10#1)(2008-8#1)
genetic exchange##10##2##(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
genetic expression##2##2##(2008-5#1)(2008-9#1)
genetic factor##2##2##(1994-2#1)(2009-10#1)
genetic factors and##2##3##(1997-8#1)(2007-6#1)
genetic factors are##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
genetic factors contributing to##2##4##(2007-10#1)(2009-6#1)
genetic factors involved in human susceptibility to infection by schistosomiasis##2##10##(2009-5#2)
genetic factors involved in the pathogenesis of##2##7##(1997-8#2)
genetic factors involved in##4##4##(1997-8#2)(2009-5#2)
genetic factors that##5##3##(1993-12#1)(1993-8#1)(1996-5#1)(2008-10#1)(2008-4#1)
genetic factors##46##2##(1990-12#1)(1990-2#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#2)(1996-5#1)(1997-5#2)(1997-8#3)(2007-10#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
genetic family##2##2##(2007-7#1)(2012-1#1)
genetic features##3##2##(2008-8#1)(2010-6#1)(2013-1#1)
genetic form##2##2##(2011-2#2)
genetic framework##2##2##(2008-10#1)(2011-1#1)
genetic groups##6##2##(2008-10#4)(2010-10#1)(2013-1#1)
genetic heterogeneity of##4##3##(1993-11#1)(1997-3#1)(1997-5#1)(2011-1#1)
genetic heterogeneity##9##2##(1993-11#1)(1997-3#3)(1997-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2011-1#1)
genetic homogeneity of##2##3##(1995-12#1)(2008-10#1)
genetic homogeneity##5##2##(1995-12#1)(2008-10#2)(2008-9#1)(2013-8#1)
genetic homology##2##2##(2008-8#1)(2011-2#1)
genetic identification##2##2##(2008-10#1)(2008-12#1)
genetic identity and##2##3##(2008-10#2)
genetic identity between##2##3##(2008-10#2)
genetic identity##6##2##(2008-10#6)
genetic improvement##2##2##(2008-10#1)(2009-10#1)
genetic influences on the##2##4##(2009-12#1)(2010-4#1)
genetic influences on##3##3##(2008-8#1)(2009-12#1)(2010-4#1)
genetic influences##8##2##(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-4#1)
genetic information##20##2##(1993-1#1)(1995-4#1)(1996-10#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#1)(2012-2#1)
genetic inheritance of##2##3##(2008-10#1)(2010-4#1)
genetic instability and##2##3##(2013-1#2)
genetic instability in##3##3##(2008-4#2)(2012-2#1)
genetic instability##14##2##(1994-12#1)(1994-6#2)(2008-4#6)(2012-2#1)(2012-3#1)(2013-1#3)
genetic integrity##2##2##(2008-11#1)(2009-9#1)
genetic interactions##3##2##(1991-2#1)(2009-3#1)(2012-3#1)
genetic interval##2##2##(2008-10#2)
genetic inversion##3##2##(2008-3#3)
genetic investigations##2##2##(2008-10#1)(2008-12#1)
genetic isolation by distance##2##4##(2008-9#2)
genetic isolation##6##2##(2008-10#3)(2008-5#1)(2008-9#2)
genetic knowledge##2##2##(2008-12#1)(2013-1#1)
genetic lesion##2##2##(1990-5#1)(1994-12#1)
genetic lesions##2##2##(1997-4#1)(2011-1#1)
genetic level##4##2##(1997-6#1)(2007-10#1)(2012-2#1)(2012-3#1)
genetic lineage##2##2##(2008-9#1)(2010-3#1)
genetic lineages##2##2##(2008-10#2)
genetic lines of broilers##2##4##(1997-3#1)(1997-6#1)
genetic lines of##3##3##(1997-3#1)(1997-6#2)
genetic link##2##2##(1990-3#1)(2008-7#1)
genetic linkage analysis##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
genetic linkage and##2##3##(1997-5#1)(2008-4#1)
genetic linkage map and##2##4##(2008-7#1)(2012-3#1)
genetic linkage map of the##2##5##(1996-8#1)(2008-10#1)
genetic linkage map of##4##4##(1996-8#1)(2008-10#2)(2013-8#1)
genetic linkage map were##2##4##(2008-9#1)(2013-8#1)
genetic linkage map##13##3##(1996-8#1)(2008-10#5)(2008-7#2)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
genetic linkage maps##3##3##(2008-10#2)(2008-7#1)
genetic linkage of##2##3##(1995-3#1)(2008-11#1)
genetic linkage##27##2##(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-7#3)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
genetic load##2##2##(1992-10#1)(2008-10#1)
genetic loci by##2##3##(1997-4#1)(2008-10#1)
genetic loci##14##2##(1994-8#1)(1995-3#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-5#1)(2012-3#3)
genetic locus##6##2##(1990-8#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-5#1)
genetic make-up##2##2##(2008-10#1)(2013-8#1)
genetic makeup of##2##3##(2008-9#1)(2012-2#1)
genetic makeup##3##2##(1996-3#1)(2008-9#1)(2012-2#1)
genetic male##3##2##(2007-10#1)(2008-2#2)
genetic manipulation of these##2##4##(1993-12#1)(2008-11#1)
genetic manipulation of##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
genetic manipulation##13##2##(1993-12#1)(1993-3#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#3)(2009-3#1)
genetic manipulations of##2##3##(2008-6#1)(2008-9#1)
genetic manipulations##7##2##(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)
genetic map is##2##3##(1996-6#1)(2008-7#1)
genetic map of##7##3##(1996-12#2)(2008-10#5)
genetic map##30##2##(1992-4#1)(1994-9#2)(1995-8#1)(1996-10#1)(1996-12#3)(1996-6#1)(2008-10#15)(2008-5#3)(2008-7#1)(2008-8#1)(2012-3#1)
genetic map)##3##2##(1992-9#2)(1997-7#1)
genetic mapping##8##2##(1994-9#1)(1995-6#2)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#2)
genetic maps of##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
genetic maps##6##2##(1994-9#1)(1995-6#1)(2008-10#1)(2008-5#2)(2008-7#1)
genetic marker##7##2##(1993-8#1)(1994-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)
genetic markers and##4##3##(2008-10#2)(2012-3#2)
genetic markers associated with##2##4##(2008-10#2)
genetic markers for##4##3##(2008-10#2)(2008-8#1)(2011-3#1)
genetic markers that##2##3##(2008-10#1)(2008-7#1)
genetic markers to##2##3##(2008-10#2)
genetic markers##28##2##(1994-12#1)(1997-3#1)(2008-10#9)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-3#2)(2012-3#4)(2013-1#2)(2013-8#1)
genetic material into##3##3##(2008-1#1)(2008-5#1)(2011-1#1)
genetic material to##2##3##(2008-2#1)(2011-1#1)
genetic material within##2##3##(2008-10#1)(2011-2#1)
genetic material##13##2##(1994-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
genetic mechanism##3##2##(2008-10#3)
genetic mechanisms of##3##3##(2008-10#2)(2013-8#1)
genetic mechanisms that##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
genetic mechanisms underlying##2##3##(2008-7#1)(2008-9#1)
genetic mechanisms##11##2##(1994-11#1)(1994-12#1)(2008-10#3)(2008-7#1)(2008-9#2)(2012-3#2)(2013-8#1)
genetic methods are##2##3##(2007-7#1)(2013-1#1)
genetic methods##3##2##(2007-7#1)(2011-3#1)(2013-1#1)
genetic model for##2##3##(2008-10#1)(2008-8#1)
genetic model is##2##3##(2008-4#1)(2008-8#1)
genetic model of##3##3##(1997-5#1)(1997-8#1)(2008-8#1)
genetic model##10##2##(1997-5#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#4)
genetic models##5##2##(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)
genetic modification of##5##3##(1996-6#1)(2008-11#2)(2008-7#1)(2012-2#1)
genetic modification##7##2##(1996-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-8#1)
genetic modifications##2##2##(2008-7#1)(2011-1#1)
genetic mouse##2##2##(2011-2#1)(2012-2#1)
genetic mutation##3##2##(2007-2#1)(2010-4#1)(2011-2#1)
genetic mutations##4##2##(1995-12#1)(2008-10#1)(2013-1#2)
genetic network##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
genetic networks##2##2##(2008-7#1)(2012-2#1)
genetic optimization##2##2##(2011-1#1)(2012-2#1)
genetic or##2##2##(2008-10#1)(2008-3#1)
genetic organization##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
genetic origin##4##2##(1990-2#1)(1995-11#1)(2009-8#1)(2013-1#1)
genetic parameters##2##2##(2008-12#2)
genetic pathway##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
genetic pathways##5##2##(2007-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)
genetic patterns##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
genetic polymorphism and##2##3##(2008-10#2)
genetic polymorphism between##2##3##(2007-10#1)(2011-1#1)
genetic polymorphism in##4##3##(1996-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
genetic polymorphism of##2##3##(1992-3#1)(2008-8#1)
genetic polymorphism with##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
genetic polymorphism##17##2##(1992-3#1)(1996-6#1)(2006-6#1)(2007-10#1)(2008-10#4)(2008-8#3)(2008-9#4)(2011-1#1)(2012-3#1)
genetic polymorphisms in##2##3##(1992-3#1)(2013-8#1)
genetic polymorphisms##12##2##(1992-3#1)(1997-7#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
genetic potential##4##2##(1994-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
genetic predisposition and environmental##2##4##(2008-10#1)(2008-3#1)
genetic predisposition and##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
genetic predisposition to##5##3##(2007-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
genetic predisposition##17##2##(1994-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
genetic processes##2##2##(2008-10#1)(2008-8#1)
genetic profiles for##3##3##(2008-11#2)(2010-7#1)
genetic profiles##6##2##(2007-3#1)(2008-10#1)(2008-11#2)(2010-7#1)(2011-2#1)
genetic program##2##2##(2007-12#1)(2012-12#1)
genetic reassortment##3##2##(2007-12#1)(2011-2#1)(2013-8#1)
genetic recombination and##2##3##(1995-3#1)(2010-4#1)
genetic recombination##8##2##(1990-5#1)(1995-3#1)(2008-10#4)(2010-4#2)
genetic regulation of##2##3##(2008-11#1)(2011-2#1)
genetic regulation##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
genetic relatedness##3##2##(2008-10#1)(2008-5#2)
genetic relationship between##3##3##(2007-2#1)(2008-10#1)(2008-9#1)
genetic relationship##7##2##(2007-2#1)(2008-10#4)(2008-12#1)(2008-9#1)
genetic relationships among##7##3##(2008-10#6)(2008-5#1)
genetic relationships between##3##3##(2008-10#2)(2008-6#1)
genetic relationships in##2##3##(2008-10#1)(2008-5#1)
genetic relationships##14##2##(2008-10#10)(2008-5#2)(2008-6#1)(2011-2#1)
genetic research##15##2##(1994-2#1)(1995-6#1)(2007-10#2)(2007-3#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2013-7#1)
genetic resistance to##2##3##(2008-10#1)(2011-2#1)
genetic resistance##8##2##(1997-7#1)(2008-10#4)(2008-5#1)(2011-2#2)
genetic risk assessment##2##3##(2008-3#1)(2008-7#1)
genetic risk factors##4##3##(2007-10#2)(2008-6#1)(2008-8#1)
genetic risk for##4##3##(1995-9#1)(2008-7#2)(2012-2#1)
genetic risk##18##2##(1994-2#1)(1995-9#1)(2007-10#2)(2008-1#3)(2008-3#3)(2008-6#1)(2008-7#5)(2008-8#1)(2012-2#1)
genetic screen##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
genetic screening##5##2##(1990-5#1)(1995-12#1)(2008-4#1)(2009-7#1)(2012-3#1)
genetic selection in##2##3##(1991-5#1)(1995-5#1)
genetic selection##3##2##(1991-5#1)(1994-3#1)(1995-5#1)
genetic sequences were##2##3##(2012-2#2)
genetic sequences##3##2##(2012-2#3)
genetic services in##2##3##(2013-1#2)
genetic services##5##2##(2013-1#5)
genetic similarity among##2##3##(2008-10#1)(2008-8#1)
genetic similarity##7##2##(2008-10#4)(2008-8#1)(2013-7#1)(2013-8#1)
genetic spectrum of##2##3##(1994-3#1)(2008-8#1)
genetic structure and##6##3##(1993-2#1)(2008-10#2)(2010-8#3)
genetic structure of A##2##4##(2011-2#1)(2013-8#1)
genetic structure of M##4##4##(2008-10#4)
genetic structure of S##2##4##(2008-10#2)
genetic structure of a##2##4##(2008-10#2)
genetic structure of field populations of##4##6##(2008-10#4)
genetic structure of the##5##4##(2008-10#3)(2012-1#1)(2013-8#1)
genetic structure of##44##3##(2008-10#32)(2008-8#3)(2008-9#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-8#2)
genetic structure##71##2##(1993-2#1)(2008-10#46)(2008-8#7)(2008-9#1)(2010-8#4)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#3)
genetic structures##2##2##(2008-10#1)(2008-8#1)
genetic studies are##2##3##(2008-9#1)(2010-5#1)
genetic studies have##4##3##(1995-8#1)(2007-12#1)(2008-5#1)(2013-7#1)
genetic studies in##3##3##(2008-12#1)(2012-1#1)(2013-8#1)
genetic studies of##6##3##(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#2)(2012-3#1)
genetic studies on##2##3##(2008-10#1)(2008-7#1)
genetic studies##36##2##(1995-11#1)(1995-8#2)(1997-5#1)(1997-7#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
genetic study of##2##3##(1997-5#1)(2008-10#1)
genetic study##7##2##(1990-3#1)(1997-5#2)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
genetic susceptibility to##3##3##(1994-11#1)(1995-12#1)(2008-9#1)
genetic susceptibility##10##2##(1994-11#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
genetic syndrome associated with##2##4##(2010-7#1)(2012-12#1)
genetic syndrome##3##2##(2010-7#1)(2012-12#2)
genetic syndromes##2##2##(2008-11#2)
genetic system##3##2##(1990-11#1)(2008-9#1)(2009-5#1)
genetic systems##5##2##(1995-11#1)(2008-7#2)(2008-8#1)(2008-9#1)
genetic techniques##8##2##(1997-4#1)(2007-2#1)(2007-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
genetic technologies##2##2##(1997-4#1)(2008-5#1)
genetic test##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
genetic testing and##4##3##(1995-9#1)(2007-3#1)(2010-8#1)(2013-1#1)
genetic testing of##3##3##(2007-7#1)(2011-2#2)
genetic testing##21##2##(1991-11#2)(1995-9#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-3#1)(2013-1#1)
genetic tests and##2##3##(2008-10#1)(2011-3#1)
genetic tests##7##2##(2008-10#3)(2008-7#1)(2011-3#1)(2012-3#1)(2013-1#1)
genetic tools##6##2##(2008-2#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
genetic toxicity of##2##3##(1997-4#2)
genetic toxicology##3##2##(1996-12#3)
genetic trade-offs in performance##2##4##(2008-8#1)(2008-9#1)
genetic trade-offs##3##2##(2008-8#2)(2008-9#1)
genetic transcription levels##2##3##(2008-10#2)
genetic transcription##3##2##(2008-10#2)(2008-6#1)
genetic transformation##3##2##(2006-12#2)(2008-8#1)
genetic transmission##2##2##(2008-2#1)(2008-9#1)
genetic tumour growth##2##3##(2008-7#2)
genetic tumours##7##2##(2008-7#7)
genetic uniformity##2##2##(2008-10#2)
genetic variability and##2##3##(2010-3#1)(2010-8#1)
genetic variability between##2##3##(2007-10#1)(2008-10#1)
genetic variability in wild populations##2##5##(2009-2#2)
genetic variability in##6##3##(1996-6#1)(2008-10#2)(2008-7#1)(2009-2#2)
genetic variability of the pathogen##2##5##(2008-10#2)
genetic variability of##3##3##(2008-10#3)
genetic variability was distributed##2##4##(2008-10#2)
genetic variability was##3##3##(2008-10#3)
genetic variability with##2##3##(2008-9#1)(2013-1#1)
genetic variability##39##2##(1996-6#1)(2006-8#1)(2007-10#1)(2008-10#19)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
genetic variance##8##2##(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#1)
genetic variant-phenotype association##2##3##(2011-2#2)
genetic variants in##2##3##(2009-12#1)(2013-1#1)
genetic variants of##2##3##(1991-8#1)(1996-8#1)
genetic variants that contribute to##2##5##(2012-3#2)
genetic variants that##3##3##(2009-5#1)(2012-3#2)
genetic variants##14##2##(1991-12#1)(1991-8#1)(1996-8#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-2#2)(2012-3#5)(2013-1#1)
genetic variation among##5##3##(2008-10#4)(2008-12#1)
genetic variation and##7##3##(1995-2#1)(2008-10#3)(2008-11#1)(2010-1#1)(2013-8#1)
genetic variation by##2##3##(1996-6#1)(2008-10#1)
genetic variation for##5##3##(2008-10#2)(2008-9#3)
genetic variation has been##2##4##(2008-10#1)(2012-2#1)
genetic variation in the##2##4##(2009-9#1)(2010-4#1)
genetic variation in##13##3##(2008-10#6)(2008-12#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-4#1)
genetic variation of##7##3##(2008-10#3)(2008-7#1)(2011-10#1)(2012-2#1)(2013-1#1)
genetic variation was distributed among##2##5##(2008-10#2)
genetic variation was distributed within##2##5##(2008-10#2)
genetic variation was distributed##4##4##(2008-10#4)
genetic variation was found in the##2##6##(2007-1#1)(2012-3#1)
genetic variation was##8##3##(2007-1#1)(2008-10#4)(2008-12#1)(2009-5#1)(2012-3#1)
genetic variation within##6##3##(2008-10#4)(2008-12#2)
genetic variation##97##2##(1991-2#1)(1995-2#2)(1996-6#4)(2007-1#2)(2008-10#36)(2008-11#1)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#8)(2009-10#1)(2009-2#5)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#4)(2010-5#2)(2011-10#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
genetic variations and##2##3##(2008-3#1)(2008-8#1)
genetic variations##9##2##(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#3)
genetic##2191##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#6)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#7)(1994-12#14)(1994-2#23)(1994-3#2)(1994-5#5)(1994-6#4)(1994-8#1)(1994-9#8)(1995-1#1)(1995-11#3)(1995-12#11)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#10)(1995-8#7)(1995-9#2)(1996-10#3)(1996-12#11)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#15)(1996-8#6)(1997-2#3)(1997-3#14)(1997-4#10)(1997-5#16)(1997-6#8)(1997-7#8)(1997-8#6)(2006-10#5)(2006-12#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#25)(2007-11#3)(2007-12#17)(2007-2#3)(2007-3#5)(2007-5#3)(2007-6#3)(2007-7#18)(2007-8#2)(2007-9#1)(2008-1#31)(2008-10#555)(2008-11#50)(2008-12#36)(2008-2#21)(2008-3#29)(2008-4#70)(2008-5#47)(2008-6#18)(2008-7#103)(2008-8#141)(2008-9#93)(2009-10#14)(2009-11#1)(2009-12#5)(2009-2#19)(2009-3#11)(2009-4#7)(2009-5#19)(2009-6#8)(2009-7#4)(2009-8#11)(2009-9#3)(2010-1#3)(2010-10#9)(2010-11#2)(2010-12#5)(2010-2#7)(2010-3#15)(2010-4#19)(2010-5#12)(2010-6#3)(2010-7#5)(2010-8#13)(2011-1#34)(2011-10#2)(2011-2#92)(2011-3#8)(2012-1#16)(2012-12#15)(2012-2#38)(2012-3#86)(2012-5#1)(2013-1#79)(2013-7#7)(2013-8#38)
genetic)##2##1##(1994-5#1)(2008-8#1)
genetical##4##1##(1990-12#1)(2008-10#2)(2008-4#1)
genetically altered##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
genetically and##8##2##(2008-10#5)(2010-10#1)(2011-2#1)(2013-1#1)
genetically based##2##2##(2007-10#1)(2008-11#1)
genetically characterized##4##2##(2007-11#1)(2008-10#3)
genetically close##3##2##(2007-10#1)(2008-1#1)(2008-8#1)
genetically conditioned##2##2##(2010-6#1)(2012-12#1)
genetically controlled##4##2##(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#1)
genetically defined##3##2##(1991-8#1)(2013-1#2)
genetically determined and##2##3##(2008-8#1)(2008-9#1)
genetically determined##18##2##(1990-2#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-3#3)
genetically different from the##2##4##(1991-11#1)(2008-10#1)
genetically different##4##2##(1991-11#1)(2007-6#1)(2008-10#2)
genetically differentiated populations##2##3##(2008-10#1)(2008-12#1)
genetically differentiated##4##2##(2008-10#3)(2008-12#1)
genetically dissimilar##2##2##(1994-9#1)(2008-10#1)
genetically distinct from isolates##2##4##(2008-10#2)
genetically distinct from##7##3##(2008-10#7)
genetically distinct groups##2##3##(2008-10#1)(2008-6#1)
genetically distinct##23##2##(1995-6#1)(2008-10#18)(2008-6#1)(2008-8#2)(2012-5#1)
genetically diverse##13##2##(2008-10#11)(2012-3#1)(2013-1#1)
genetically engineered mouse##3##3##(2008-4#2)(2013-1#1)
genetically engineered to secrete##3##4##(1997-4#2)(2008-5#1)
genetically engineered to##6##3##(1997-4#2)(2008-10#2)(2008-4#1)(2008-5#1)
genetically engineered##31##2##(1995-11#1)(1995-2#3)(1997-2#1)(1997-4#2)(2008-10#4)(2008-11#4)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
genetically epilepsy-prone rat (GEPR)##2##4##(1996-12#2)
genetically heterogeneous##5##2##(1995-5#1)(2008-3#1)(2009-10#1)(2013-1#2)
genetically homogeneous##4##2##(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
genetically identical##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
genetically influenced##2##2##(2012-2#1)(2012-3#1)
genetically inherited##3##2##(1995-8#1)(2008-4#1)(2009-2#1)
genetically isolated from##2##3##(2008-10#1)(2009-2#1)
genetically isolated##4##2##(2008-10#3)(2009-2#1)
genetically linked to##4##3##(1991-12#1)(1992-3#1)(1995-6#1)(1997-3#1)
genetically linked##7##2##(1991-12#1)(1992-3#1)(1995-6#1)(1997-3#1)(2008-10#2)(2012-2#1)
genetically mapped##3##2##(2008-9#2)(2012-3#1)
genetically modified (FVB Tg##9##4##(2008-8#1)(2008-9#8)
genetically modified mice##4##3##(2008-4#1)(2012-1#1)(2012-3#2)
genetically modified strains##2##3##(2007-10#1)(2011-2#1)
genetically modified to##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
genetically modified##40##2##(1994-11#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#15)(2009-5#1)(2011-2#5)(2012-1#1)(2012-3#2)
genetically normal##3##2##(2008-7#3)
genetically predetermined type of biotransformation by acetylation##2##7##(2008-10#2)
genetically programmed##2##2##(2008-11#1)(2008-5#1)
genetically related##4##2##(2008-10#3)(2012-3#1)
genetically similar to##4##3##(1991-11#2)(2008-10#2)
genetically similar##7##2##(1991-11#2)(1997-8#1)(2008-10#4)
genetically stable##3##2##(2008-10#2)(2008-9#1)
genetically susceptible##4##2##(1995-12#1)(2008-3#1)(2013-7#1)(2013-8#1)
genetically to##3##2##(2008-10#3)
genetically transformed##2##2##(1994-11#1)(2008-10#1)
genetically transmitted##2##2##(1990-2#2)
genetically uniform##2##2##(2008-10#2)
genetically very##2##2##(2008-10#2)
genetically with##2##2##(2008-11#1)(2009-8#1)
genetically##297##1##(1990-2#3)(1991-11#3)(1991-12#2)(1991-5#1)(1991-8#2)(1992-3#1)(1992-5#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#86)(2008-11#13)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#18)(2008-9#27)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#11)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#1)
geneticists##8##1##(1996-3#1)(2008-10#2)(2009-5#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
genetics and evolution##3##3##(2008-10#1)(2008-8#1)(2010-1#1)
genetics and##18##2##(1997-4#1)(2008-10#4)(2008-7#2)(2008-8#3)(2009-5#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
genetics for##2##2##(2008-7#1)(2008-8#1)
genetics governing##2##2##(2009-3#2)
genetics has been##2##3##(2012-3#2)
genetics has##3##2##(2009-2#1)(2012-3#2)
genetics in order to##3##4##(1991-11#1)(2008-12#1)(2008-8#1)
genetics in##10##2##(1991-11#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-12#1)
genetics into a full##2##4##(2008-12#2)
genetics into##4##2##(2008-12#3)(2008-8#1)
genetics is a##2##3##(2008-8#1)(2009-10#1)
genetics is##4##2##(2008-4#2)(2008-8#1)(2009-10#1)
genetics of reproductive isolation##3##4##(2008-8#3)
genetics of the##5##3##(2008-10#2)(2008-4#1)(2012-2#1)(2013-1#1)
genetics of##47##2##(1994-2#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-10#4)(2007-7#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-9#1)(2010-8#1)(2011-10#1)(2012-2#3)(2012-3#3)(2013-1#1)
genetics research##6##2##(1997-3#1)(2009-6#4)(2010-1#1)
genetics studies##2##2##(2009-2#1)(2009-6#1)
genetics study##2##2##(2008-10#1)(2008-12#1)
genetics to the study of##2##5##(1990-3#1)(2008-2#1)
genetics to##3##2##(1990-3#1)(2008-10#1)(2008-2#1)
genetics##190##1##(1990-12#1)(1990-3#1)(1991-11#2)(1991-2#1)(1994-2#1)(1994-9#1)(1995-8#1)(1995-9#3)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#8)(1997-7#1)(2007-10#5)(2007-12#2)(2007-6#2)(2007-7#2)(2008-1#3)(2008-10#23)(2008-11#1)(2008-12#8)(2008-2#3)(2008-3#1)(2008-4#9)(2008-6#1)(2008-7#10)(2008-8#25)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#7)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#12)(2013-1#9)(2013-8#1)
genets##2##1##(2008-9#2)
genic##5##1##(2008-7#2)(2008-8#2)(2010-3#1)
geniculate ganglion##4##2##(2011-2#4)
geniculate neurons##2##2##(1997-7#2)
geniculate nucleus##5##2##(1992-10#1)(1993-12#2)(1997-7#1)(2008-1#1)
geniculate##15##1##(1992-10#1)(1993-12#2)(1997-7#4)(2008-1#1)(2008-11#1)(2011-2#5)(2013-8#1)
geniculo-cortical##2##1##(1992-10#2)
geniculocortical and##2##2##(2008-1#2)
geniculocortical##3##1##(2008-1#3)
genipin##2##1##(2013-1#2)
geniposidic and chlorogenic##2##3##(2008-10#2)
geniposidic##3##1##(2008-10#3)
genistein and daidzin enhance##2##4##(2008-11#2)
genistein and daidzin##4##3##(2008-11#4)
genistein and##7##2##(1993-3#1)(2008-10#1)(2008-11#4)(2010-3#1)
genistein or##3##2##(2008-10#2)(2008-11#1)
genistein##46##1##(1992-12#2)(1992-3#1)(1992-8#4)(1993-12#2)(1993-3#2)(1993-8#1)(1997-4#1)(1997-7#4)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#8)(2010-1#2)(2010-10#2)(2010-3#2)(2012-2#4)
genital anomaly in##2##3##(2008-10#2)
genital anomaly##3##2##(2008-10#3)
genital appendages##3##2##(2008-8#3)
genital area##2##2##(1992-1#1)(2009-10#1)
genital chlamydial##2##2##(2007-12#2)
genital edema##2##2##(2008-10#2)
genital features##2##2##(2013-8#2)
genital herpes is##2##3##(2007-12#1)(2008-10#1)
genital herpes##13##2##(2007-12#3)(2008-10#8)(2008-12#1)(2008-8#1)
genital infection##5##2##(1995-6#1)(2008-8#1)(2013-1#3)
genital injuries##3##2##(2013-8#3)
genital lesions and##2##3##(1996-12#1)(2007-8#1)
genital lesions##3##2##(1996-12#1)(2007-8#1)(2008-10#1)
genital organs##3##2##(1993-3#1)(1996-12#1)(2008-10#1)
genital pathology##4##2##(1991-11#1)(1996-12#3)
genital region##2##2##(2011-1#1)(2012-1#1)
genital schistosomiasis (FGS)##5##3##(1996-12#5)
genital schistosomiasis##10##2##(1996-12#10)
genital system##3##2##(1993-3#1)(1995-9#1)(2007-12#1)
genital tissue##4##2##(1996-12#4)
genital tract and##3##3##(1991-2#1)(2011-2#1)(2012-1#1)
genital tract##26##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#2)(1992-3#2)(1994-1#2)(1996-12#2)(2007-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-8#1)
genital tracts##5##2##(2008-7#5)
genital trauma##2##2##(2013-8#2)
genital ulcer##2##2##(2011-2#1)(2012-2#1)
genital##144##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1992-1#1)(1992-2#1)(1992-3#2)(1993-3#3)(1994-1#2)(1994-2#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#25)(1997-8#1)(2007-12#10)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2009-10#2)(2009-2#1)(2009-5#2)(2010-12#1)(2011-1#3)(2011-2#11)(2012-1#2)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#8)
genitalia and##3##2##(2008-1#1)(2010-12#1)(2010-4#1)
genitalia are##2##2##(2008-10#1)(2008-5#1)
genitalia is##2##2##(2007-12#1)(2008-8#1)
genitalia size##2##2##(2008-8#2)
genitalia##29##1##(1997-3#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#2)(2012-3#1)(2013-1#1)
genitalia)##2##1##(2008-6#1)(2012-3#1)
genitalic##2##1##(2008-5#1)(2008-8#1)
genitalium is##3##2##(2011-2#3)
genitalium##4##1##(2011-2#4)
genitourinary anomaly in##2##3##(2008-10#2)
genitourinary complications##2##2##(2007-7#1)(2008-10#1)
genitourinary malignancies##4##2##(1995-12#3)(2008-7#1)
genitourinary system##2##2##(2013-8#2)
genitourinary tract##2##2##(2007-12#2)
genitourinary##22##1##(1990-6#2)(1995-12#3)(1997-8#1)(2007-12#4)(2007-7#1)(2008-10#4)(2008-7#1)(2009-5#1)(2010-8#1)(2013-8#4)
genomagnetic##2##1##(2008-10#2)
genome (5##2##2##(2008-10#1)(2010-3#1)
genome DNA##2##2##(2008-8#2)
genome RNA##2##2##(2008-10#1)(2008-11#1)
genome addition##3##2##(2008-9#3)
genome also##2##2##(2008-10#2)
genome amplification##4##2##(2008-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
genome analyses of##2##3##(2008-8#1)(2011-1#1)
genome analysis##12##2##(1993-9#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-7#3)(2009-10#1)(2012-3#1)
genome and is##3##3##(1992-3#1)(1993-9#1)(1995-8#1)
genome and the##6##3##(1990-5#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-1#1)
genome and##36##2##(1990-5#1)(1992-3#1)(1993-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
genome annotation##5##2##(2008-4#2)(2008-7#1)(2011-2#2)
genome approach##2##2##(1995-2#1)(2008-7#1)
genome approaches##2##2##(2008-7#2)
genome are##6##2##(1995-2#1)(2008-10#2)(2008-7#2)(2012-2#1)
genome as##3##2##(2008-11#2)(2008-4#1)
genome assembly##4##2##(2007-11#1)(2011-2#2)(2012-3#1)
genome at##2##2##(1990-7#1)(2009-5#1)
genome by##11##2##(1993-11#1)(1995-6#1)(1996-6#1)(2008-11#1)(2008-4#2)(2008-8#2)(2009-10#1)(2012-3#2)
genome can##2##2##(2008-4#1)(2011-1#1)
genome complexity##2##2##(2010-3#2)
genome components were##2##3##(2008-10#2)
genome comprising##2##2##(2011-2#2)
genome consisting of##2##3##(2008-10#2)
genome containing##2##2##(1996-8#1)(2008-10#1)
genome contains two##2##3##(1993-3#1)(1996-6#1)
genome contains##12##2##(1991-9#1)(1993-3#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#3)
genome data##4##2##(1991-11#1)(1997-7#1)(2008-4#1)(2008-7#1)
genome database##7##2##(2008-11#1)(2008-7#6)
genome duplication##4##2##(2007-12#2)(2008-1#1)(2012-3#1)
genome encodes##4##2##(2007-12#2)(2011-1#1)(2011-10#1)
genome equivalents##3##2##(1996-10#1)(1996-12#1)(2008-8#1)
genome evolution and##2##3##(2008-7#1)(2010-3#1)
genome evolution##7##2##(2008-7#3)(2009-5#1)(2010-3#2)(2012-3#1)
genome for##2##2##(2008-12#1)(2008-8#1)
genome fragments##2##2##(2008-10#1)(2008-11#1)
genome from a member of the##2##6##(2011-2#2)
genome from a##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
genome from the##3##3##(2011-2#3)
genome from##9##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#5)(2012-2#1)
genome functional##2##2##(2008-7#2)
genome has been##3##3##(1996-8#1)(2008-7#2)
genome has##8##2##(1991-6#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-7#3)(2011-1#1)
genome in the##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
genome in##11##2##(1990-7#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
genome instability##4##2##(1992-5#1)(2010-2#1)(2011-1#1)(2011-2#1)
genome integration and genetic instability in##2##6##(2008-4#2)
genome integration##4##2##(2008-4#4)
genome is##10##2##(1991-12#1)(1993-11#1)(1995-8#1)(2007-12#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-10#1)(2012-3#1)
genome level##2##2##(1995-5#1)(2008-7#1)
genome mapping##2##2##(2008-9#1)(2010-3#1)
genome may be##2##3##(2007-11#1)(2008-7#1)
genome mining##2##2##(2011-1#1)(2011-2#1)
genome nucleotide sequences##2##3##(2008-8#1)(2012-12#1)
genome of C##2##3##(2008-7#1)(2011-2#1)
genome of Enterovirus 71 China strain##2##6##(2008-8#2)
genome of PcMV##2##3##(2008-10#2)
genome of S##3##3##(1992-6#2)(2008-9#1)
genome of Tomato##2##3##(2008-10#2)
genome of a##5##3##(2008-10#1)(2008-4#2)(2008-7#1)(2009-5#1)
genome of an##3##3##(1990-7#1)(2008-10#2)
genome of the##21##3##(1990-5#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#3)(1997-3#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
genome of this##2##3##(2008-12#1)(2009-3#1)
genome of##88##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-6#2)(1993-11#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-6#3)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(2007-6#1)(2008-10#20)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
genome or##4##2##(2008-2#1)(2008-4#2)(2012-3#1)
genome organization and##2##3##(2007-12#1)(2008-10#1)
genome organization of##4##3##(1995-6#1)(2008-10#2)(2008-8#1)
genome organization typical##2##3##(2008-10#2)
genome organization was##2##3##(2008-10#1)(2008-9#1)
genome organization##16##2##(1995-6#1)(2007-12#1)(2008-10#9)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#2)
genome origin##2##2##(2008-10#2)
genome project##4##2##(1994-3#1)(1995-8#1)(2008-11#1)(2008-12#1)
genome projects##2##2##(1995-2#1)(1997-7#1)
genome regions##2##2##(2009-5#1)(2010-3#1)
genome replication##4##2##(2008-10#1)(2009-11#1)(2011-1#1)(2012-12#1)
genome research##4##2##(2008-7#4)
genome restructuring##3##2##(2012-3#3)
genome scan##4##2##(1997-5#4)
genome screen of##2##3##(1997-5#2)
genome screen##5##2##(1997-5#4)(2007-6#1)
genome sequence and##15##3##(2008-7#1)(2011-2#14)
genome sequence data##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
genome sequence for##3##3##(2011-10#1)(2011-2#2)
genome sequence from a member of the genus##3##8##(2011-2#3)
genome sequence from a member of the##4##7##(2011-2#4)
genome sequence from##6##3##(2008-4#1)(2011-2#5)
genome sequence in the family##4##5##(2011-2#4)
genome sequence in the##5##4##(2011-2#5)
genome sequence information for##2##4##(2008-10#1)(2008-9#1)
genome sequence of a member of the family##7##8##(2011-2#7)
genome sequence of a member of the genus##6##8##(2011-2#6)
genome sequence of a member of the##16##7##(2011-2#16)
genome sequence of a member##17##5##(2011-2#17)
genome sequence of a type##2##5##(2011-2#2)
genome sequence of a##20##4##(2008-7#1)(2011-2#19)
genome sequence of the genus##5##5##(2011-2#5)
genome sequence of the##15##4##(2008-7#2)(2008-9#1)(2011-2#12)
genome sequence of##88##3##(1996-8#1)(2008-10#1)(2008-7#3)(2008-9#2)(2011-2#79)(2013-7#1)(2013-8#1)
genome sequence submission##2##3##(2011-2#2)
genome sequence##150##2##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#5)(2008-9#3)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#125)(2012-3#1)(2013-7#1)(2013-8#3)
genome sequences and##2##3##(2008-10#1)(2010-8#1)
genome sequences has##2##3##(2008-7#2)
genome sequences is##2##3##(2009-5#1)(2010-3#1)
genome sequences of##5##3##(2008-10#4)(2011-2#1)
genome sequences##24##2##(2008-10#6)(2008-4#4)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
genome sequencing and##2##3##(2011-2#1)(2013-8#1)
genome sequencing projects##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
genome sequencing##13##2##(1990-11#1)(1995-2#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-3#2)(2013-8#1)
genome sites##2##2##(2008-9#1)(2012-3#1)
genome size and##3##3##(1997-6#1)(2008-8#2)
genome size##16##2##(1997-2#2)(1997-6#1)(2008-10#2)(2008-7#1)(2008-8#6)(2008-9#1)(2010-3#1)(2011-2#2)
genome sizes in birds##2##4##(2008-8#2)
genome sizes##4##2##(1997-2#1)(2008-10#1)(2008-8#2)
genome species group##2##3##(2008-5#2)
genome stability and##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
genome stability##4##2##(1993-9#1)(2008-7#1)(2012-2#1)(2013-1#1)
genome structure of##2##3##(1996-12#1)(1997-2#1)
genome structure##6##2##(1996-10#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-7#1)
genome that may##2##3##(2008-1#1)(2008-4#1)
genome that was##2##3##(1997-3#1)(2008-9#1)
genome that##9##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)
genome to##7##2##(1995-4#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)
genome using##3##2##(1997-2#1)(2008-4#1)(2009-10#1)
genome variation##3##2##(2008-7#3)
genome variations##2##2##(2008-7#2)
genome was found##2##3##(2008-10#1)(2011-2#1)
genome was used##2##3##(2008-10#2)
genome was##16##2##(1996-6#1)(1997-3#1)(2008-10#12)(2008-7#1)(2011-2#1)
genome were confirmed##2##3##(1990-11#1)(2008-8#1)
genome were##5##2##(1990-11#1)(2008-10#3)(2008-8#1)
genome wide##3##2##(2008-1#1)(2009-12#1)(2010-3#1)
genome with its 1##7##4##(2011-2#7)
genome with its 3##11##4##(2011-2#11)
genome with its 7##2##4##(2011-2#2)
genome with its##37##3##(2011-2#37)
genome with##44##2##(1991-6#1)(1993-8#1)(1994-8#1)(2008-2#1)(2008-8#1)(2011-2#38)(2012-3#1)
genome##978##1##(1990-11#3)(1990-12#2)(1990-5#3)(1990-7#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#6)(1991-9#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#5)(1994-3#1)(1994-8#6)(1995-11#3)(1995-12#4)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#9)(1995-8#9)(1995-9#1)(1996-10#4)(1996-12#13)(1996-2#2)(1996-3#1)(1996-6#20)(1996-8#8)(1997-2#9)(1997-3#9)(1997-4#4)(1997-5#8)(1997-6#6)(1997-7#4)(1997-8#3)(2007-11#4)(2007-12#8)(2007-6#5)(2008-1#4)(2008-10#133)(2008-11#18)(2008-12#8)(2008-2#9)(2008-4#38)(2008-5#16)(2008-6#1)(2008-7#88)(2008-8#42)(2008-9#33)(2009-10#12)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#8)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#20)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#15)(2011-10#3)(2011-2#213)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#37)(2013-1#8)(2013-7#1)(2013-8#9)
genome) and B##2##3##(2008-10#2)
genome) and##4##2##(2008-10#3)(2011-1#1)
genome)##16##1##(1990-5#1)(1993-12#1)(1994-12#1)(2008-10#11)(2009-5#1)(2011-1#1)
genome-transgene##2##1##(1993-6#2)
genome-wide analysis of##3##3##(2007-12#2)(2010-5#1)
genome-wide approaches##3##2##(2007-11#1)(2009-5#1)(2010-2#1)
genome-wide association studies using##2##4##(2009-8#1)(2012-3#1)
genome-wide association studies##12##3##(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#6)
genome-wide association study##2##3##(2009-8#1)(2012-3#1)
genome-wide association##17##2##(2009-5#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#10)
genome-wide copy number analysis##2##4##(2011-2#2)
genome-wide data##3##2##(2009-4#1)(2009-5#1)(2010-3#1)
genome-wide expression##3##2##(2010-5#1)(2011-2#2)
genome-wide linkage##2##2##(2008-1#1)(2009-6#1)
genome-wide screening##2##2##(2008-9#1)(2012-12#1)
genome-wide selection##2##2##(2012-3#2)
genome-wide studies##2##2##(2008-7#1)(2008-9#1)
genome-wide##71##1##(1996-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#5)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#10)(2012-12#1)(2012-3#21)(2013-1#2)
genomes and##6##2##(1990-5#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
genomes are##5##2##(1994-12#1)(1995-2#1)(2008-4#2)(2010-5#1)
genomes by##2##2##(1993-11#1)(1995-2#1)
genomes can##2##2##(2008-4#1)(2010-7#1)
genomes contain##2##2##(2009-5#1)(2010-3#1)
genomes have##6##2##(2008-5#1)(2009-10#1)(2010-3#3)(2013-8#1)
genomes in##8##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#2)(2013-8#1)
genomes into##2##2##(1997-2#1)(2008-7#1)
genomes is##4##2##(1991-6#1)(1997-2#1)(2008-7#1)(2011-2#1)
genomes may##2##2##(2008-8#1)(2011-2#1)
genomes of fungal pathogens##3##4##(2009-6#3)
genomes of the##3##3##(2008-10#2)(2008-5#1)
genomes of##34##2##(1991-6#1)(1991-8#1)(1994-12#1)(1995-11#1)(1997-6#2)(2006-12#1)(2008-10#10)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-5#1)(2009-6#4)(2010-3#2)(2011-1#1)(2012-2#1)
genomes suggests that##2##3##(1997-2#1)(2009-6#1)
genomes that##2##2##(1997-3#1)(2010-3#1)
genomes to understand##2##3##(2008-10#1)(2013-8#1)
genomes to##5##2##(2008-10#2)(2008-7#1)(2008-9#1)(2013-8#1)
genomes was##2##2##(2008-10#1)(2008-8#1)
genomes were##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
genomes with##2##2##(1997-3#1)(2008-9#1)
genomes##203##1##(1990-5#2)(1991-6#4)(1991-8#1)(1992-10#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-6#3)(2006-12#1)(2008-10#27)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#8)(2008-5#4)(2008-7#20)(2008-8#9)(2008-9#15)(2009-10#4)(2009-12#1)(2009-3#1)(2009-5#4)(2009-6#7)(2010-10#1)(2010-3#18)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#4)(2013-8#5)
genomic DNA (gDNA)##2##3##(1997-7#1)(2013-1#1)
genomic DNA and##13##3##(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-10#1)
genomic DNA as a##2##4##(2008-5#1)(2008-8#1)
genomic DNA as##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
genomic DNA by##5##3##(1991-7#1)(1994-12#1)(2008-10#1)(2008-4#2)
genomic DNA clones##2##3##(1992-11#1)(1996-8#1)
genomic DNA fragment##5##3##(1990-12#3)(1991-5#1)(2008-9#1)
genomic DNA from Monosiga brevicollis and other choanoflagellates##2##8##(2010-2#2)
genomic DNA from a##2##4##(1993-2#1)(1997-7#1)
genomic DNA from the##2##4##(1996-6#1)(2008-9#1)
genomic DNA from##20##3##(1992-10#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1996-6#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-9#1)(2010-2#2)
genomic DNA in##3##3##(1997-7#1)(2008-1#1)(2008-8#1)
genomic DNA indicated that the##2##5##(1990-12#1)(1992-11#1)
genomic DNA isolated from##2##4##(1993-12#1)(1994-12#1)
genomic DNA library of##3##4##(1993-2#1)(1994-9#1)(1997-2#1)
genomic DNA library using##3##4##(1992-11#1)(1994-12#1)(1997-4#1)
genomic DNA library##12##3##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-5#1)
genomic DNA of##10##3##(1992-6#1)(1993-12#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
genomic DNA revealed##2##3##(2008-10#1)(2008-9#1)
genomic DNA sequences of##2##4##(1993-8#1)(2008-4#1)
genomic DNA sequences##9##3##(1991-9#1)(1993-2#1)(1993-8#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
genomic DNA was##7##3##(1990-5#1)(1991-7#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)
genomic DNA with##3##3##(1993-2#1)(2008-10#1)(2008-7#1)
genomic DNA##180##2##(1990-12#6)(1990-5#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#4)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-12#6)(1993-2#6)(1993-3#1)(1993-6#5)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#5)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-4#3)(1997-6#5)(1997-7#6)(1997-8#1)(2008-1#3)(2008-10#31)(2008-11#6)(2008-12#1)(2008-2#6)(2008-4#13)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#1)(2010-2#3)(2010-7#2)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
genomic DNAs from##2##3##(1992-3#1)(2008-10#1)
genomic DNAs##5##2##(1991-6#1)(1992-3#1)(1994-12#1)(2008-10#2)
genomic RNA of##5##3##(1997-3#2)(2008-10#3)
genomic RNA##18##2##(1992-6#1)(1997-3#5)(2008-10#9)(2008-11#1)(2008-8#1)(2013-1#1)
genomic RNAs of##2##3##(2008-10#2)
genomic RNAs##8##2##(1997-3#1)(2008-10#6)(2008-8#1)
genomic Southern##4##2##(1993-2#2)(1993-8#1)(1994-12#1)
genomic actions of##2##3##(1994-8#1)(2008-7#1)
genomic alterations##4##2##(1993-8#1)(2010-2#1)(2012-2#2)
genomic analyses##5##2##(2008-4#2)(2008-9#1)(2009-7#1)(2010-3#1)
genomic analysis of##3##3##(2008-10#1)(2008-7#2)
genomic analysis##9##2##(2008-10#2)(2008-4#1)(2008-7#4)(2009-10#1)(2011-2#1)
genomic and cDNA phage##2##4##(2008-7#2)
genomic and cDNA##6##3##(1992-3#1)(1994-12#1)(1997-4#1)(2008-7#3)
genomic and proteomic##2##3##(2008-10#1)(2008-11#1)
genomic and##17##2##(1992-3#1)(1994-12#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-3#2)(2011-2#1)
genomic approach##5##2##(2008-10#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
genomic approaches##5##2##(2008-7#2)(2009-3#1)(2010-11#1)(2011-1#1)
genomic basis##2##2##(2008-8#1)(2011-2#1)
genomic characteristics##2##2##(2010-3#2)
genomic clone containing the##2##4##(1994-12#1)(1996-8#1)
genomic clone containing##3##3##(1993-12#1)(1994-12#1)(1996-8#1)
genomic clone of the##3##4##(1992-8#1)(1993-6#1)(1997-4#1)
genomic clone of##4##3##(1992-8#1)(1993-6#1)(1996-6#1)(1997-4#1)
genomic clone##21##2##(1990-12#2)(1991-5#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1994-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)
genomic clones of##4##3##(1993-6#1)(1994-12#1)(1997-8#1)(2008-10#1)
genomic clones##21##2##(1990-11#1)(1990-12#1)(1990-8#3)(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2010-5#1)
genomic context##2##2##(2008-7#1)(2010-3#1)
genomic copy number##2##3##(2008-7#2)
genomic copy##3##2##(1993-2#1)(2008-7#2)
genomic data from##2##3##(2008-11#1)(2010-3#1)
genomic data##14##2##(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-3#2)(2011-2#1)(2011-3#3)(2012-12#1)(2013-8#1)
genomic disorders##4##2##(2009-5#4)
genomic distribution##3##2##(2008-5#1)(2009-10#1)(2011-2#1)
genomic diversity and##2##3##(2008-10#1)(2009-6#1)
genomic diversity in##2##3##(2008-10#1)(2008-7#1)
genomic diversity##8##2##(2008-10#3)(2008-7#3)(2009-6#1)(2011-1#1)
genomic effects##3##2##(2008-4#2)(2008-7#1)
genomic element##2##2##(1991-6#2)
genomic era and##2##3##(2009-5#2)
genomic era##3##2##(2009-5#2)(2010-5#1)
genomic fingerprint profiles##2##3##(2008-10#2)
genomic fingerprinting##5##2##(2008-10#5)
genomic fingerprints##4##2##(2008-10#4)
genomic fragment##3##2##(1996-6#1)(1997-7#1)(2008-10#1)
genomic fragments##6##2##(1990-5#1)(1991-6#1)(1991-7#1)(1996-6#1)(1997-4#1)(2008-10#1)
genomic functional elements##2##3##(2008-7#2)
genomic functions##2##2##(2008-10#1)(2008-4#1)
genomic gene##2##2##(1990-7#1)(1995-8#1)
genomic hybridization##10##2##(1992-3#1)(2008-4#2)(2008-9#2)(2009-5#1)(2012-1#1)(2012-3#3)
genomic imprinting and##2##3##(1994-11#1)(2010-3#1)
genomic imprinting##3##2##(1994-11#1)(1996-10#1)(2010-3#1)
genomic in situ hybridization##2##4##(2008-5#1)(2008-8#1)
genomic in situ##3##3##(2008-5#1)(2008-8#1)(2010-3#1)
genomic in-situ hybridization##2##3##(2008-8#2)
genomic information##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
genomic instability and##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
genomic instability##9##2##(1995-6#1)(2008-11#1)(2009-6#1)(2010-2#2)(2011-2#2)(2012-3#1)(2013-1#1)
genomic level##7##2##(1991-12#1)(1991-6#1)(1992-3#1)(2008-10#2)(2009-10#1)(2011-2#1)
genomic libraries##3##2##(1990-5#1)(1997-4#1)(2008-10#1)
genomic library and sequenced##2##4##(1994-11#1)(1996-10#1)
genomic library and##5##3##(1993-3#1)(1993-6#1)(1994-11#1)(1996-10#1)(1996-3#1)
genomic library constructed##3##3##(1990-5#1)(1997-4#1)(1997-8#1)
genomic library for##2##3##(1994-6#1)(2008-5#1)
genomic library of##8##3##(1990-5#1)(1991-9#1)(1994-12#1)(1997-6#1)(2008-10#3)(2008-8#1)
genomic library was##2##3##(1992-3#1)(1996-12#1)
genomic library with a##2##4##(1992-8#1)(2008-8#1)
genomic library with##4##3##(1991-6#1)(1992-8#1)(1993-12#1)(2008-8#1)
genomic library##39##2##(1990-5#2)(1991-6#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#5)(2008-9#3)(2013-8#1)
genomic location of##5##3##(2008-10#3)(2008-4#1)(2008-9#1)
genomic location##9##2##(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
genomic loci##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
genomic mechanism of action##2##4##(2008-4#2)
genomic organization of the##2##4##(1992-3#1)(1997-6#1)
genomic organization of##3##3##(1992-3#2)(1997-6#1)
genomic organization##7##2##(1992-3#2)(1993-12#1)(1997-6#1)(2008-10#1)(2012-2#2)
genomic pectin##2##2##(1991-9#2)
genomic phage##2##2##(1991-6#1)(1991-9#1)
genomic probes##2##2##(1996-12#1)(2008-5#1)
genomic region on##2##3##(1997-2#1)(2008-9#1)
genomic region##15##2##(1990-5#1)(1992-10#1)(1995-6#1)(1996-10#1)(1997-2#3)(2008-10#3)(2008-2#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)
genomic regions in##2##3##(2008-2#1)(2008-7#1)
genomic regions of##4##3##(2008-10#2)(2012-3#2)
genomic regions on##2##3##(2007-11#1)(2008-10#1)
genomic regions##29##2##(1993-8#1)(1996-12#1)(2007-11#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#4)(2009-10#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-8#1)
genomic regulatory##2##2##(2008-11#1)(2008-7#1)
genomic research##6##2##(2008-2#1)(2008-7#4)(2012-2#1)
genomic resources##7##2##(2008-11#3)(2008-7#2)(2010-10#2)
genomic response to##2##3##(1997-3#1)(2008-7#1)
genomic responses##3##2##(2008-7#3)
genomic scale##2##2##(2008-7#1)(2010-7#1)
genomic scan of##3##3##(1997-5#3)
genomic segments##3##2##(1992-6#1)(2008-7#1)(2010-4#1)
genomic sequence and##2##3##(1993-3#1)(2008-11#1)
genomic sequence data of Synechocystis##2##5##(1995-12#2)
genomic sequence data##4##3##(1995-12#2)(2008-1#1)(2008-7#1)
genomic sequence information##2##3##(2008-11#1)(2008-9#1)
genomic sequence of##7##3##(1990-12#1)(1996-12#1)(2008-10#3)(2008-8#1)(2008-9#1)
genomic sequence respectively##2##3##(2010-7#2)
genomic sequence was##2##3##(2008-10#1)(2008-9#1)
genomic sequence##38##2##(1990-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-12#2)(1996-12#1)(1997-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-5#1)(2010-7#3)(2012-2#1)
genomic sequences and##3##3##(1993-8#1)(2008-4#2)
genomic sequences from##3##3##(1995-6#1)(2008-11#1)(2009-10#1)
genomic sequences in##2##3##(2008-2#1)(2008-7#1)
genomic sequences of##3##3##(1994-8#1)(2008-5#1)(2008-9#1)
genomic sequences##21##2##(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-2#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)
genomic sequencing and##3##3##(2008-2#2)(2013-8#1)
genomic sequencing##12##2##(2008-10#7)(2008-2#2)(2008-7#1)(2011-2#1)(2013-8#1)
genomic signature##2##2##(2013-8#2)
genomic sites##2##2##(1993-9#1)(2011-1#1)
genomic stability##2##2##(2010-2#1)(2011-2#1)
genomic structure and function##3##4##(2008-5#1)(2008-7#1)(2010-3#1)
genomic structure and the##2##4##(1997-7#1)(2008-8#1)
genomic structure and##6##3##(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#2)
genomic structure of##3##3##(1993-11#1)(1993-12#1)(2008-4#1)
genomic structure##10##2##(1993-11#1)(1993-12#2)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#2)
genomic studies##2##2##(2007-12#1)(2010-2#1)
genomic targets##2##2##(1995-2#1)(2008-11#1)
genomic techniques##2##2##(2008-11#1)(2009-8#1)
genomic tools##4##2##(2008-11#1)(2008-8#1)(2010-10#1)(2011-1#1)
genomic variation##2##2##(2008-10#1)(2010-3#1)
genomic##751##1##(1990-11#2)(1990-12#11)(1990-5#7)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#12)(1991-7#3)(1991-9#10)(1992-10#2)(1992-11#3)(1992-12#3)(1992-3#10)(1992-6#4)(1992-8#5)(1993-11#2)(1993-12#16)(1993-2#14)(1993-3#5)(1993-6#16)(1993-8#9)(1993-9#6)(1994-11#5)(1994-12#14)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-5#1)(1995-6#5)(1995-8#4)(1996-10#4)(1996-12#6)(1996-3#1)(1996-5#1)(1996-6#6)(1996-8#3)(1997-2#7)(1997-3#7)(1997-4#9)(1997-5#4)(1997-6#8)(1997-7#12)(1997-8#4)(1997-9#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#134)(2008-11#28)(2008-12#2)(2008-2#14)(2008-4#36)(2008-5#12)(2008-6#1)(2008-7#61)(2008-8#26)(2008-9#27)(2009-10#8)(2009-2#2)(2009-3#1)(2009-5#12)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#8)(2010-3#20)(2010-4#3)(2010-5#3)(2010-7#6)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#14)(2011-3#3)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#9)(2013-1#5)(2013-8#7)
genomically compromised##2##2##(2008-7#2)
genomically##7##1##(2008-7#3)(2010-7#1)(2011-2#2)(2012-2#1)
genomics and proteomics##3##3##(2008-11#2)(2011-3#1)
genomics and##20##2##(2008-10#2)(2008-11#2)(2008-7#6)(2009-10#1)(2009-5#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
genomics approaches##4##2##(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
genomics as##2##2##(2008-10#1)(2008-7#1)
genomics for##2##2##(2008-10#1)(2008-7#1)
genomics in##2##2##(2009-10#1)(2009-5#1)
genomics initiative (PGI)##2##3##(2010-10#2)
genomics is a##2##3##(2008-11#1)(2009-10#1)
genomics is##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
genomics of##5##2##(2008-7#4)(2008-9#1)
genomics projects##2##2##(2008-7#2)
genomics technologies##2##2##(2008-7#1)(2010-12#1)
genomics to##2##2##(2012-3#1)(2013-8#1)
genomics tools##2##2##(2008-10#1)(2008-5#1)
genomics##143##1##(2006-10#1)(2008-10#9)(2008-11#6)(2008-2#2)(2008-4#4)(2008-5#2)(2008-7#59)(2008-8#3)(2008-9#2)(2009-10#5)(2009-3#1)(2009-4#1)(2009-5#16)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
genomics-assisted breeding##2##2##(2010-10#2)
genomovar III and##2##3##(2007-12#1)(2008-10#1)
genomovar III##3##2##(2007-12#2)(2008-10#1)
genomovar##4##1##(2007-12#2)(2008-10#2)
genomovars##2##1##(2007-12#2)
genotoxic activity##2##2##(1997-4#1)(2008-9#1)
genotoxic agents##2##2##(1993-3#1)(1995-2#1)
genotoxic and##3##2##(1997-4#1)(2008-11#1)(2011-2#1)
genotoxic chemicals##2##2##(1990-8#1)(1997-3#1)
genotoxic effects of##5##3##(1993-11#1)(1997-4#1)(2008-8#1)(2010-1#1)(2010-5#1)
genotoxic effects##8##2##(1993-11#1)(1997-4#1)(2008-8#1)(2010-1#1)(2010-5#1)(2013-1#3)
genotoxic in human colon cells##2##5##(1997-4#2)
genotoxic in human##3##3##(1997-4#3)
genotoxic in##4##2##(1997-4#4)
genotoxic##35##1##(1990-8#1)(1992-5#1)(1993-11#3)(1993-3#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-4#10)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
genotoxicity and##2##2##(1996-1#1)(2013-1#1)
genotoxicity of##4##2##(1996-12#2)(1996-2#1)(1997-4#1)
genotoxicity test##2##2##(1996-2#1)(2008-11#1)
genotoxicity testing##2##2##(1996-2#1)(2011-1#1)
genotoxicity##19##1##(1991-9#1)(1992-6#1)(1996-1#1)(1996-12#2)(1996-2#4)(1997-4#1)(2008-11#1)(2008-4#1)(2011-1#5)(2013-1#2)
genotoxin treatment##3##2##(2010-3#3)
genotoxin-induced##2##1##(2010-3#2)
genotoxins##3##1##(1990-8#1)(1997-4#1)(2010-3#1)
genotype (OR##2##2##(2008-7#1)(2011-2#1)
genotype (named &quot##2##3##(2012-2#2)
genotype 1 HCV##2##3##(2012-12#2)
genotype 1##5##2##(2009-4#2)(2012-12#2)(2013-1#1)
genotype A##2##2##(2008-10#1)(2009-3#1)
genotype B##4##2##(2008-10#2)(2012-12#2)
genotype C##2##2##(2008-10#1)(2013-8#1)
genotype GG##3##2##(2008-7#1)(2011-1#2)
genotype Hawaii##2##2##(2008-10#2)
genotype I##2##2##(2008-10#2)
genotype ND##2##2##(2008-10#2)
genotype analysis##3##2##(2008-10#1)(2009-5#1)(2013-8#1)
genotype and in##2##3##(2008-10#1)(2008-8#1)
genotype and phenotype##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
genotype and##28##2##(1995-9#1)(1996-12#2)(1997-8#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#5)(2011-1#4)(2011-2#1)(2012-3#1)(2013-1#2)
genotype as a##2##3##(1994-5#1)(2008-10#1)
genotype as##4##2##(1990-3#1)(1994-5#1)(2008-10#2)
genotype at##4##2##(2008-10#2)(2008-4#1)(2011-1#1)
genotype by##4##2##(2008-10#2)(2010-11#1)(2013-1#1)
genotype calls##3##2##(2009-7#1)(2009-8#2)
genotype correlated with##2##3##(2008-10#2)
genotype data##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
genotype distribution##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
genotype diversity##5##2##(2008-10#5)
genotype for##3##2##(1997-7#1)(2008-10#2)
genotype frequencies of A/A homozygotes##2##5##(2011-1#2)
genotype frequencies of A/A##3##4##(2011-1#3)
genotype frequencies of##5##3##(2008-10#1)(2011-1#4)
genotype frequencies##7##2##(1997-5#1)(2008-10#2)(2011-1#4)
genotype frequency of Br polymorphism##2##5##(2006-6#2)
genotype frequency of##3##3##(2006-6#2)(2011-1#1)
genotype frequency##7##2##(2006-6#2)(2008-10#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
genotype groups##5##2##(2008-10#3)(2009-9#1)(2012-2#1)
genotype had##2##2##(2008-12#1)(2013-1#1)
genotype identification##2##2##(2008-5#2)
genotype in the##3##3##(2008-10#2)(2012-2#1)
genotype in##15##2##(1995-12#1)(2008-10#7)(2008-7#1)(2009-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
genotype is associated with##3##4##(2008-4#1)(2011-2#2)
genotype is##7##2##(1996-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#2)
genotype isolate##2##2##(2008-10#2)
genotype may be##2##3##(1990-3#1)(2008-7#1)
genotype mixtures##4##2##(2008-10#4)
genotype of C##2##3##(2008-10#2)
genotype of the##8##3##(1997-7#1)(2008-10#4)(2008-4#2)(2008-5#1)
genotype of##19##2##(1997-7#1)(2008-10#8)(2008-4#3)(2008-5#1)(2008-8#2)(2011-1#1)(2013-1#2)(2013-8#1)
genotype on##5##2##(2008-10#2)(2008-4#1)(2011-1#1)(2013-8#1)
genotype resistance and chemical control##2##5##(2008-10#2)
genotype resistance and##3##3##(2008-10#3)
genotype resistance##5##2##(2008-10#5)
genotype showed##2##2##(1997-7#1)(2008-10#1)
genotype specific##2##2##(2008-10#1)(2011-10#1)
genotype than##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
genotype to phenotype##2##3##(2008-7#1)(2012-2#1)
genotype to the##2##3##(2008-10#1)(2011-1#1)
genotype to##5##2##(2008-10#2)(2008-7#1)(2011-1#1)(2012-2#1)
genotype unit##2##2##(2008-10#2)
genotype was associated with##3##4##(1997-5#1)(2008-12#1)(2011-2#1)
genotype was detected##2##3##(2008-10#2)
genotype was found to be##2##5##(2008-10#2)
genotype was significantly higher in##3##5##(2011-2#1)(2012-1#1)(2013-1#1)
genotype was significantly##4##3##(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
genotype was##25##2##(1995-12#1)(1997-5#1)(1997-7#1)(2008-10#10)(2008-12#2)(2008-4#1)(2008-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
genotype were##6##2##(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)
genotype with##3##2##(1997-3#1)(2011-2#1)(2012-2#1)
genotype x##2##2##(2008-10#2)
genotype##400##1##(1990-3#3)(1994-5#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#4)(1997-3#2)(1997-5#3)(1997-7#4)(1997-8#2)(2006-6#2)(2008-1#1)(2008-10#188)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#6)(2008-7#8)(2008-8#20)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#26)(2011-10#1)(2011-2#14)(2012-1#1)(2012-12#9)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#19)(2013-8#14)
genotype)##5##1##(2008-10#4)(2008-9#1)
genotype-by-environment interactions##3##2##(2008-8#2)(2013-1#1)
genotype-phenotype##4##1##(1997-3#1)(1997-6#1)(2008-8#1)(2012-3#1)
genotype-specific##7##1##(2007-7#1)(2008-10#3)(2009-5#1)(2012-5#2)
genotype-trait associations##2##2##(2012-3#2)
genotype/phenotype##3##1##(2008-9#1)(2009-12#1)(2009-8#1)
genotyped at##4##2##(2008-10#4)
genotyped by##4##2##(2008-10#2)(2012-12#1)(2013-8#1)
genotyped for##8##2##(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
genotyped using##2##2##(2008-10#1)(2013-1#1)
genotyped##30##1##(1996-12#1)(1997-5#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#2)
genotypes (A##3##2##(2008-10#2)(2008-12#1)
genotypes A and B##3##4##(2008-10#3)
genotypes A##5##2##(2008-10#4)(2009-3#1)
genotypes C/C and##2##3##(2012-12#2)
genotypes F##2##2##(2008-10#1)(2013-1#1)
genotypes PI##3##2##(2008-10#3)
genotypes among##4##2##(2008-10#3)(2013-1#1)
genotypes and allele frequencies##4##4##(2011-1#4)
genotypes and phenotypes##5##3##(2008-4#2)(2009-10#1)(2010-4#2)
genotypes and the##2##3##(2008-9#1)(2012-1#1)
genotypes and##30##2##(2008-10#10)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
genotypes are resistant to P##2##5##(2008-10#2)
genotypes are##8##2##(2008-10#5)(2008-11#1)(2008-12#1)(2010-4#1)
genotypes at NBS1##2##3##(2011-1#2)
genotypes at this##2##3##(2008-12#2)
genotypes at##6##2##(1995-2#1)(1997-7#1)(2008-12#2)(2011-1#2)
genotypes but##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
genotypes by##2##2##(2008-10#1)(2012-1#1)
genotypes can##2##2##(2008-8#1)(2010-10#1)
genotypes carrying different resistance##2##4##(2008-10#2)
genotypes carrying##5##2##(2008-10#5)
genotypes differ in##2##3##(2008-10#1)(2008-9#1)
genotypes differ##3##2##(2008-10#1)(2008-9#2)
genotypes exhibited##2##2##(2008-10#2)
genotypes for##4##2##(2008-10#2)(2008-12#2)
genotypes from the##2##3##(2008-10#2)
genotypes from##5##2##(2008-10#5)
genotypes had##8##2##(2008-10#7)(2011-1#1)
genotypes have been##4##3##(2008-10#4)
genotypes have##8##2##(2008-10#6)(2008-12#1)(2008-8#1)
genotypes having##2##2##(2008-10#1)(2008-12#1)
genotypes highly##2##2##(2008-10#2)
genotypes identified##3##2##(2008-10#3)
genotypes in a##2##3##(2008-10#1)(2012-3#1)
genotypes in the##2##3##(2008-10#1)(2008-7#1)
genotypes in##15##2##(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2011-2#2)(2012-3#1)
genotypes including##2##2##(2008-10#2)
genotypes indicated##2##2##(2008-10#2)
genotypes infected with the##2##4##(2008-10#2)
genotypes into##3##2##(1997-6#1)(2008-10#2)
genotypes may be##2##3##(2008-10#2)
genotypes of C##4##3##(2008-10#3)(2013-1#1)
genotypes of P##6##3##(2008-10#6)
genotypes of a##2##3##(2008-10#1)(2008-5#1)
genotypes of the##4##3##(2008-10#4)
genotypes of##34##2##(1995-6#1)(2008-10#18)(2008-12#4)(2008-4#2)(2008-5#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2012-3#2)(2013-1#1)
genotypes on##4##2##(2008-10#3)(2008-8#1)
genotypes or##5##2##(2008-10#4)(2011-1#1)
genotypes per day##2##3##(2008-7#2)
genotypes present in##2##3##(2008-10#1)(2008-8#1)
genotypes representing##2##2##(2008-10#2)
genotypes resistant or susceptible to##2##5##(2008-10#2)
genotypes resistant##3##2##(2008-10#2)(2010-7#1)
genotypes tested##2##2##(2008-10#2)
genotypes than in##2##3##(2008-10#2)
genotypes than##3##2##(2008-10#2)(2008-11#1)
genotypes that exhibited##2##3##(2008-10#2)
genotypes that##13##2##(2008-10#11)(2008-9#1)(2011-2#1)
genotypes to##10##2##(2008-10#7)(2008-12#2)(2011-1#1)
genotypes using##3##2##(2008-10#2)(2008-12#1)
genotypes was##7##2##(2008-10#6)(2008-12#1)
genotypes were also found##2##4##(2008-10#1)(2008-12#1)
genotypes were also##5##3##(2008-10#2)(2008-12#3)
genotypes were analyzed##2##3##(2008-10#2)
genotypes were detected##2##3##(2008-10#2)
genotypes were determined in##2##4##(2008-7#1)(2009-3#1)
genotypes were found within##2##4##(2008-10#2)
genotypes were found##3##3##(2008-10#3)
genotypes were identified among the##2##5##(2008-10#2)
genotypes were identified##7##3##(2007-7#1)(2008-10#6)
genotypes were not##2##3##(2008-10#1)(2008-11#1)
genotypes were present##2##3##(2008-10#2)
genotypes were##46##2##(2007-7#1)(2008-10#34)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-5#1)
genotypes when used##2##3##(2008-10#2)
genotypes when##3##2##(2008-10#3)
genotypes with a##2##3##(2008-10#2)
genotypes with complete resistance to Fusarium wilt##2##7##(2008-10#2)
genotypes with specific virulence to##2##5##(2008-10#2)
genotypes with##19##2##(2008-10#15)(2008-8#1)(2008-9#2)(2012-2#1)
genotypes within##3##2##(2008-10#3)
genotypes##538##1##(1992-3#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#352)(2008-11#6)(2008-12#40)(2008-2#1)(2008-4#5)(2008-5#8)(2008-7#4)(2008-8#16)(2008-9#13)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#5)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#13)(2011-2#12)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#11)(2012-5#1)(2013-1#6)(2013-8#6)
genotypes)##6##1##(1997-5#1)(2008-10#4)(2008-3#1)
genotypic and phenotypic information##2##4##(2008-10#1)(2012-3#1)
genotypic and phenotypic##7##3##(1991-6#1)(2008-10#2)(2011-2#1)(2012-3#3)
genotypic cluster##4##2##(2012-3#4)
genotypic composition of populations##2##4##(2008-10#1)(2008-8#1)
genotypic composition of##4##3##(2008-10#3)(2008-8#1)
genotypic composition##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
genotypic differences were##2##3##(2008-10#1)(2012-4#1)
genotypic differences##4##2##(2008-10#2)(2012-3#1)(2012-4#1)
genotypic differentiation##2##2##(2008-10#1)(2012-3#1)
genotypic diversity was high##2##4##(2008-10#2)
genotypic diversity was##5##3##(2008-10#5)
genotypic diversity##25##2##(2008-10#25)
genotypic frequency##2##2##(2008-10#1)(2008-9#1)
genotypic information of##2##3##(2008-8#2)
genotypic information##3##2##(2008-12#1)(2008-8#2)
genotypic resistance##2##2##(1996-11#1)(2008-10#1)
genotypic sex determination##5##3##(2010-3#5)
genotypic specialization##2##2##(2008-8#2)
genotypic variability##3##2##(2008-10#2)(2009-2#1)
genotypic variation##4##2##(1997-3#1)(2008-10#2)(2008-7#1)
genotypic##99##1##(1990-3#1)(1991-6#1)(1993-6#1)(1996-11#1)(1997-3#1)(2008-10#51)(2008-12#5)(2008-4#1)(2008-7#3)(2008-8#7)(2008-9#3)(2009-2#1)(2010-3#5)(2011-2#2)(2012-2#1)(2012-3#12)(2012-4#1)(2012-5#2)
genotypically distinct strains##2##3##(2008-10#2)
genotypically distinct##5##2##(2008-10#5)
genotypically diverse##2##2##(2008-10#2)
genotypically##12##1##(1991-6#1)(2008-10#8)(2008-12#2)(2012-3#1)
genotyping and##5##2##(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#2)
genotyping are##2##2##(2008-11#1)(2008-4#1)
genotyping in##4##2##(1997-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
genotyping methods##4##2##(2008-12#2)(2011-1#1)(2012-12#1)
genotyping of the##2##3##(2008-10#1)(2010-8#1)
genotyping of##4##2##(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
genotyping platform##2##2##(2008-7#1)(2010-10#1)
genotyping platforms##3##2##(2008-7#3)
genotyping strategies##2##2##(2008-2#1)(2008-4#1)
genotyping using polymerase chain##2##4##(1990-2#1)(1997-8#1)
genotyping using##4##2##(1990-2#1)(1997-8#1)(2008-9#2)
genotyping was##2##2##(2008-10#1)(2012-2#1)
genotyping with##3##2##(2008-1#1)(2008-4#2)
genotyping##80##1##(1990-2#1)(1997-5#3)(1997-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#5)(2008-2#2)(2008-4#8)(2008-5#2)(2008-7#12)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#2)
genre##6##1##(2007-6#2)(2009-10#1)(2011-2#1)(2013-1#2)
gentamicin 2##3##2##(2010-3#3)
gentamicin and##4##2##(2010-3#3)(2011-1#1)
gentamicin##26##1##(1990-6#1)(2007-7#5)(2008-10#4)(2009-12#1)(2009-5#1)(2010-3#8)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
gentamycin is##3##2##(2008-10#2)(2010-8#1)
gentamycin##17##1##(2007-12#2)(2008-10#7)(2008-12#3)(2008-9#1)(2010-8#2)(2013-8#2)
gentian##2##1##(1994-5#1)(2008-10#1)
gentiobioside##3##1##(2008-11#2)(2013-1#1)
gentisic acid##3##2##(2008-10#3)
gentle but##2##2##(1991-3#1)(1997-6#1)
gentle method##2##2##(2008-10#1)(2008-9#1)
gentle##20##1##(1991-3#1)(1992-7#2)(1995-6#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-5#1)(2011-2#1)(2013-7#1)
gentleman with##4##2##(2007-8#1)(2008-12#1)(2008-8#1)(2011-2#1)
gentleman##11##1##(2007-8#1)(2008-12#2)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
gently##9##1##(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#1)
genuine##22##1##(1992-10#1)(1993-8#1)(1994-3#2)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
genuinely##2##1##(1993-3#1)(2009-11#1)
genus Byssochlamys##2##2##(2010-3#2)
genus Cercospora##2##2##(2008-10#2)
genus Chitinophaga##2##2##(2011-2#2)
genus Ignisphaera##2##2##(2011-2#2)
genus Janolus##2##2##(2008-5#2)
genus Malassezia##3##2##(2007-7#1)(2008-5#2)
genus Microsomacanthus##5##2##(2011-2#5)
genus Phytophthora##2##2##(2008-10#1)(2009-2#1)
genus Platycopia##2##2##(2008-5#2)
genus Potyvirus##11##2##(2008-10#11)
genus Sceloporus##2##2##(2010-3#2)
genus Thermus##3##2##(1997-4#1)(2011-2#2)
genus Vulcanisaeta##2##2##(2011-2#2)
genus Xanthomonas##2##2##(2008-10#2)
genus and species##2##3##(2008-10#1)(2011-2#1)
genus and##5##2##(1991-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
genus from##3##2##(2008-10#1)(2013-1#2)
genus in the##2##3##(2008-10#1)(2011-2#1)
genus in##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
genus is of##5##3##(2011-2#5)
genus is##6##2##(2010-10#1)(2011-2#5)
genus level##2##2##(2008-5#1)(2013-7#1)
genus of plant##2##3##(2008-10#2)
genus of the family##4##4##(2008-10#1)(2011-2#3)
genus of##12##2##(1996-4#1)(2008-10#5)(2008-3#1)(2008-9#1)(2010-10#1)(2011-2#3)
genus with##2##2##(1995-12#1)(2008-10#1)
genus##349##1##(1991-12#1)(1991-3#1)(1995-12#2)(1996-4#1)(1997-2#1)(1997-4#10)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-10#105)(2008-11#1)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#36)(2008-6#13)(2008-7#1)(2008-8#8)(2008-9#7)(2009-2#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#8)(2010-2#3)(2010-3#13)(2010-4#2)(2010-8#4)(2011-2#86)(2012-2#1)(2012-3#4)(2013-1#11)(2013-7#5)(2013-8#5)
genus-specific amplicon##3##2##(2008-10#3)
genus-specific primer pair##4##3##(1995-12#1)(2008-10#3)
genus-specific##11##1##(1995-12#1)(1996-11#2)(2008-10#7)(2011-2#1)
geochemical and##2##2##(1996-4#1)(2008-10#1)
geochemical##12##1##(1996-4#1)(1997-5#2)(2007-5#2)(2008-10#5)(2008-11#1)(2011-2#1)
geochemistry##3##1##(1997-5#1)(2008-11#2)
geocoded##2##1##(2009-9#1)(2013-1#1)
geodetic##3##1##(1990-11#1)(2008-3#2)
geographic adjustment##3##2##(1991-3#2)(1992-2#1)
geographic and##4##2##(1992-1#1)(1994-2#1)(2007-12#1)(2007-2#1)
geographic area and##3##3##(1994-6#1)(2008-10#1)(2010-8#1)
geographic area of##2##3##(2008-10#2)
geographic area##9##2##(1991-3#1)(1994-6#1)(1997-3#1)(2008-10#4)(2010-8#1)(2011-2#1)
geographic areas and##2##3##(1992-9#1)(2012-3#1)
geographic areas of##2##3##(1993-2#1)(2008-10#1)
geographic areas##21##2##(1991-3#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#6)(2008-3#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-3#1)
geographic data to##2##3##(2008-10#2)
geographic data##3##2##(2008-10#2)(2010-2#1)
geographic differences in##2##3##(1992-2#1)(1996-3#1)
geographic distance##8##2##(2008-10#6)(2008-8#2)
geographic distances among##2##3##(2008-10#2)
geographic distances##4##2##(2008-10#4)
geographic distribution and##2##3##(1995-12#1)(2008-10#1)
geographic distribution of##8##3##(1991-12#1)(1996-12#1)(2008-10#3)(2010-3#1)(2011-2#1)(2012-12#1)
geographic distribution##14##2##(1991-12#1)(1995-12#1)(1996-12#1)(2008-10#6)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
geographic information system (GIS)##2##4##(2007-5#1)(2008-8#1)
geographic information system##3##3##(2007-5#1)(2008-8#2)
geographic information systems##5##3##(1997-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
geographic information##9##2##(1992-1#1)(1997-1#1)(2007-5#1)(2008-10#2)(2008-8#3)(2011-2#1)
geographic isolation##3##2##(2008-1#1)(2008-10#1)(2010-8#1)
geographic location##6##2##(1994-1#1)(1997-1#1)(2008-10#3)(2008-11#1)
geographic locations in##2##3##(2008-10#2)
geographic locations##18##2##(2008-10#15)(2008-8#1)(2008-9#1)(2009-2#1)
geographic origin and##2##3##(1990-3#1)(2012-2#1)
geographic origin##11##2##(1990-3#1)(1994-3#1)(2008-10#7)(2011-2#1)(2012-2#1)
geographic patterns##4##2##(1994-3#1)(2008-10#1)(2008-9#1)(2013-7#1)
geographic populations##9##2##(2008-10#8)(2013-1#1)
geographic range##10##2##(2007-1#1)(2008-10#3)(2008-5#3)(2008-8#1)(2010-10#1)(2013-7#1)
geographic ranges##2##2##(2008-10#1)(2008-6#1)
geographic region##11##2##(1994-6#1)(2007-2#1)(2008-10#6)(2008-5#1)(2008-8#1)(2013-8#1)
geographic regions of the##2##4##(2008-10#2)
geographic regions were##2##3##(2008-10#1)(2008-3#1)
geographic regions##17##2##(1992-8#1)(1993-12#1)(2008-10#9)(2008-3#1)(2008-8#1)(2011-10#1)(2012-3#1)(2013-8#2)
geographic separation of##2##3##(2008-10#1)(2011-2#1)
geographic separation##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
geographic source##2##2##(2008-10#2)
geographic variation in##6##3##(1991-2#1)(2008-10#1)(2008-8#3)(2010-8#1)
geographic variation##9##2##(1991-2#1)(1994-3#1)(2008-10#1)(2008-8#3)(2010-8#2)(2013-7#1)
geographic##238##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#6)(1992-1#2)(1992-12#2)(1992-2#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#2)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-3#1)(2007-1#1)(2007-12#1)(2007-2#4)(2007-5#1)(2008-1#2)(2008-10#97)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#13)(2008-9#6)(2009-2#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#7)(2011-10#1)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#8)
geographical and##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-5#1)
geographical area##8##2##(1991-6#1)(1994-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
geographical areas##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
geographical distance##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
geographical distribution and##4##3##(2008-6#1)(2012-3#1)(2013-7#2)
geographical distribution of the##3##4##(1997-7#1)(2010-8#1)(2013-8#1)
geographical distribution of##5##3##(1997-7#1)(2008-10#2)(2010-8#1)(2013-8#1)
geographical distribution##19##2##(1990-9#1)(1996-1#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
geographical factors##2##2##(2011-2#2)
geographical information system##2##3##(2008-10#2)
geographical information systems (GIS)##2##4##(2008-10#1)(2008-8#1)
geographical information systems and##2##4##(2008-10#1)(2008-8#1)
geographical information systems##8##3##(2008-10#5)(2008-8#3)
geographical information##10##2##(2008-10#7)(2008-8#3)
geographical isolation##3##2##(2008-10#2)(2008-8#1)
geographical location##7##2##(1993-2#1)(2008-10#1)(2009-2#1)(2009-6#1)(2011-2#2)(2012-2#1)
geographical locations##5##2##(1991-11#1)(2008-10#3)(2011-2#1)
geographical or temporal##2##3##(1992-8#1)(2008-10#1)
geographical or##3##2##(1992-8#1)(1997-6#1)(2008-10#1)
geographical origin##8##2##(2008-10#6)(2011-1#1)(2011-2#1)
geographical origins##2##2##(2008-10#1)(2008-12#1)
geographical populations##2##2##(2008-10#1)(2008-12#1)
geographical range of##2##3##(2008-8#2)
geographical region of origin##2##4##(2008-10#2)
geographical region##11##2##(1993-1#1)(1993-11#1)(2008-1#1)(2008-10#6)(2011-2#1)(2012-3#1)
geographical regions in##2##3##(2008-10#2)
geographical regions of##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
geographical regions##15##2##(2008-1#2)(2008-10#9)(2012-3#1)(2013-7#2)(2013-8#1)
geographical scale##2##2##(2008-9#1)(2012-3#1)
geographical variations##3##2##(1990-8#2)(2010-8#1)
geographical##142##1##(1990-8#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#2)(2008-1#4)(2008-10#51)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#13)(2008-9#3)(2009-2#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#11)(2012-2#1)(2012-3#5)(2012-5#2)(2013-1#2)(2013-7#8)(2013-8#3)
geographically and##3##2##(1995-12#1)(2007-7#1)(2012-3#1)
geographically dispersed##4##2##(2008-10#3)(2008-11#1)
geographically distant##2##2##(2008-10#1)(2013-1#1)
geographically distinct##2##2##(2008-10#2)
geographically diverse##5##2##(2008-10#4)(2010-5#1)
geographically isolated populations of##2##4##(2008-8#1)(2008-9#1)
geographically isolated populations##3##3##(2008-8#1)(2008-9#2)
geographically isolated##5##2##(1997-5#1)(2008-8#1)(2008-9#2)(2009-9#1)
geographically linked regional health networks that are##2##7##(1996-12#1)(1997-2#1)
geographically separated##4##2##(1995-11#1)(2008-10#3)
geographically##52##1##(1992-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
geography and##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
geography##9##1##(1991-2#1)(1991-9#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)
geologic##5##1##(1990-11#1)(1997-5#3)(2008-10#1)
geological and##2##2##(2008-10#2)
geological materials##6##2##(2008-10#6)
geological reference##2##2##(2008-10#2)
geological samples by electrothermal##2##4##(2008-10#2)
geological samples by##6##3##(2008-10#6)
geological samples##22##2##(2008-10#19)(2013-8#3)
geological##45##1##(1996-4#1)(1996-6#2)(1997-5#1)(2008-10#33)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#5)
geology##2##1##(2008-12#1)(2008-5#1)
geometric and optical properties##2##4##(2008-3#2)
geometric and##7##2##(1993-8#1)(2008-3#5)(2009-2#1)
geometric birefringence##2##2##(2007-11#1)(2008-2#1)
geometric effects##2##2##(2008-3#2)
geometric features##2##2##(2008-3#1)(2008-6#1)
geometric form##3##2##(2008-2#1)(2008-3#2)
geometric incompatibility##3##2##(1996-4#3)
geometric isomers of carotenoids##5##4##(2010-2#5)
geometric isomers of##8##3##(1994-6#1)(2010-2#7)
geometric isomers##10##2##(1994-6#1)(2010-2#9)
geometric layout##2##2##(2008-3#2)
geometric means##3##2##(1993-12#1)(2010-3#1)(2012-3#1)
geometric model##2##2##(1995-5#1)(2008-2#1)
geometric parameters##4##2##(2008-3#3)(2010-2#1)
geometric properties of the##2##4##(2006-10#1)(2008-6#1)
geometric properties of##5##3##(2006-10#1)(2008-3#2)(2008-6#2)
geometric shapes##3##2##(2007-12#1)(2008-7#1)(2010-9#1)
geometric thickness##2##2##(2008-2#1)(2008-3#1)
geometric##121##1##(1991-5#3)(1993-12#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-4#3)(2006-10#1)(2007-11#6)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#14)(2008-3#43)(2008-5#1)(2008-6#6)(2008-7#3)(2008-8#1)(2009-2#2)(2009-8#1)(2010-2#10)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
geometrical analysis##2##2##(2007-11#1)(2008-11#1)
geometrical and##3##2##(2008-2#1)(2012-2#1)(2012-3#1)
geometrical deformations##2##2##(2008-3#1)(2009-9#1)
geometrical effects##2##2##(2008-3#2)
geometrical method##2##2##(2007-12#1)(2008-3#1)
geometrical model##3##2##(2008-3#2)(2009-4#1)
geometrical optics and##2##3##(2008-2#1)(2008-3#1)
geometrical optics approximation##4##3##(2008-2#2)(2008-3#2)
geometrical optics to##2##3##(2008-2#1)(2008-3#1)
geometrical optics##16##2##(2007-11#1)(2008-2#7)(2008-3#8)
geometrical parameters of##3##3##(2007-11#2)(2008-3#1)
geometrical parameters##5##2##(1997-7#1)(2007-11#2)(2008-3#1)(2011-2#1)
geometrical patterns were##2##3##(2008-10#2)
geometrical properties##2##2##(2007-8#1)(2008-7#1)
geometrical structure of##2##3##(1993-8#1)(2008-3#1)
geometrical structure##3##2##(1993-8#1)(2008-3#1)(2012-2#1)
geometrical##78##1##(1993-8#1)(1995-5#1)(1996-2#1)(1996-4#2)(1997-4#1)(1997-7#1)(2007-11#7)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#9)(2008-3#27)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
geometrical-optics approximation and##2##3##(2008-3#2)
geometrical-optics approximation##4##2##(2008-2#1)(2008-3#3)
geometrical-optics##8##1##(2008-2#2)(2008-3#6)
geometrically##11##1##(1992-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-12#2)(2013-1#1)
geometries and##6##2##(1996-2#1)(2008-2#2)(2008-3#1)(2010-3#1)(2010-8#1)
geometries are##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#2)
geometries can be##3##3##(1997-6#1)(2007-12#1)(2008-7#1)
geometries for##3##2##(1996-5#1)(2008-2#1)(2008-3#1)
geometries in##4##2##(2007-11#1)(2007-12#2)(2008-6#1)
geometries is##2##2##(2008-2#1)(2008-3#1)
geometries of the##2##3##(2008-2#1)(2012-2#1)
geometries of##6##2##(1997-6#1)(2008-2#2)(2008-6#1)(2012-2#1)(2013-8#1)
geometries on the##2##3##(2008-3#2)
geometries to##2##2##(2009-12#1)(2010-10#1)
geometries with##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
geometries##82##1##(1990-8#1)(1991-3#2)(1996-2#1)(1996-5#1)(1997-6#2)(2007-11#5)(2007-12#6)(2008-10#3)(2008-2#20)(2008-3#20)(2008-6#2)(2008-7#4)(2009-12#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-2#3)(2013-8#2)
geometry allows for##2##3##(2008-10#1)(2008-3#1)
geometry allows##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
geometry and measures##2##3##(2008-12#1)(2008-3#1)
geometry and size##2##3##(2008-10#2)
geometry and the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
geometry and##29##2##(1991-3#1)(1991-8#2)(1995-5#1)(1996-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#9)(2008-7#2)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#2)
geometry are##5##2##(2008-2#1)(2008-3#4)
geometry around the##3##3##(1996-2#2)(2008-5#1)
geometry as##3##2##(2008-2#2)(2011-2#1)
geometry for the##2##3##(2007-12#1)(2008-3#1)
geometry for##8##2##(1996-2#1)(2007-12#3)(2008-2#1)(2008-3#3)
geometry in##8##2##(1992-8#1)(1996-2#1)(2007-12#2)(2008-2#1)(2009-11#1)(2010-9#1)(2011-1#1)
geometry is a##2##3##(1997-6#1)(2008-2#1)
geometry is##9##2##(1997-6#1)(2008-10#1)(2008-2#4)(2008-3#3)
geometry of a##5##3##(1996-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
geometry of an##2##3##(2006-4#1)(2008-3#1)
geometry of the spectrometric microtitration chamber##2##6##(2008-10#2)
geometry of the##28##3##(1990-12#1)(1990-5#1)(1991-12#1)(1995-5#1)(1996-2#1)(2007-12#3)(2007-5#1)(2008-10#6)(2008-2#2)(2008-3#6)(2008-7#3)(2009-12#1)(2009-9#1)
geometry of##49##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-5#2)(1995-5#1)(1996-2#1)(1996-4#1)(2006-4#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#10)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)
geometry on the##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
geometry on##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
geometry provides##2##2##(2008-3#2)
geometry results in##2##3##(2007-11#1)(2008-2#1)
geometry results##3##2##(2007-11#1)(2008-2#2)
geometry structure##2##2##(2013-8#2)
geometry that is##3##3##(1995-12#1)(2007-11#1)(2007-12#1)
geometry that##9##2##(1995-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)(2013-1#1)
geometry the##2##2##(2008-2#1)(2012-2#1)
geometry to##4##2##(1997-6#1)(2008-3#1)(2009-5#1)(2011-2#1)
geometry was##2##2##(2008-11#1)(2009-9#1)
geometry with##5##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
geometry##277##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-5#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-5#2)(1996-2#6)(1996-4#2)(1997-6#4)(1997-7#4)(2006-4#1)(2007-11#15)(2007-12#19)(2007-5#1)(2007-7#2)(2008-10#19)(2008-11#8)(2008-12#1)(2008-2#36)(2008-3#76)(2008-5#1)(2008-6#7)(2008-7#10)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#2)
geometry-based##2##1##(2008-6#2)
geophysical parameters from##4##3##(2008-2#2)(2008-3#2)
geophysical parameters##7##2##(2008-2#2)(2008-3#5)
geophysical##9##1##(1996-4#1)(1997-5#1)(2008-2#2)(2008-3#5)
georeferenced##2##1##(2008-12#1)(2010-5#1)
geospatial data##5##2##(2008-8#5)
geospatial##7##1##(2008-8#6)(2010-2#1)
geostatistical analysis##2##2##(2008-10#2)
geostatistical##8##1##(2008-10#4)(2008-11#1)(2008-8#3)
gepirone##4##1##(1992-3#4)
geraniol and##2##2##(2007-11#1)(2008-10#1)
geraniol##7##1##(2007-11#4)(2008-10#2)(2008-5#1)
geraniol)##2##1##(2008-10#2)
geranium plants were##2##3##(2008-10#1)(2008-5#1)
geranium plants##5##2##(2008-10#4)(2008-5#1)
geranium seedlings##4##2##(2008-10#4)
geranium##17##1##(2008-10#15)(2008-5#2)
geranylgeranyl pyrophosphate##2##2##(1994-11#1)(2008-8#1)
geranylgeranyl##3##1##(1993-3#1)(1994-11#1)(2008-8#1)
geranylgeranyltransferase type I##2##3##(1995-2#2)
gerbil##8##1##(1990-7#1)(1992-11#2)(1992-12#3)(2008-1#1)(2008-8#1)
gerbillid##2##1##(2008-8#2)
gerbils##3##1##(1990-7#1)(1995-12#1)(2010-11#1)
geriatric assessment unit##9##3##(1990-5#6)(1992-12#1)(1992-2#1)(2008-7#1)
geriatric assessment##10##2##(1990-5#6)(1992-12#1)(1992-2#1)(1997-8#1)(2008-7#1)
geriatric care management##2##3##(1996-1#2)
geriatric care##7##2##(1992-1#1)(1993-3#2)(1996-1#2)(1997-4#1)(2008-7#1)
geriatric health care##2##3##(1991-11#1)(1995-3#1)
geriatric medicine##3##2##(1996-3#2)(1997-4#1)
geriatric mental health##3##3##(1992-1#2)(2009-5#1)
geriatric nurse practitioners##2##3##(1991-1#2)
geriatric patient##4##2##(1990-9#1)(1991-2#1)(2013-8#2)
geriatric patients with##3##3##(2008-4#1)(2013-8#2)
geriatric patients##9##2##(1990-11#2)(1992-9#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#3)
geriatric population##5##2##(1990-3#1)(1993-5#1)(1996-3#1)(2007-8#1)(2009-8#1)
geriatric rehabilitation##2##2##(1990-5#1)(2008-7#1)
geriatric services##2##2##(1991-2#2)
geriatric unit##2##2##(2008-7#2)
geriatric##79##1##(1990-11#2)(1990-3#3)(1990-5#7)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1992-1#3)(1992-12#3)(1992-2#1)(1992-9#2)(1993-3#2)(1993-5#1)(1994-3#3)(1994-6#1)(1995-3#1)(1996-1#2)(1996-3#3)(1996-6#1)(1997-4#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-4#4)(2008-7#8)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#6)
geriatrics##6##1##(1991-6#1)(1993-12#1)(1994-2#1)(1994-6#1)(2008-7#1)(2010-6#1)
germ agglutinin##12##2##(1991-12#2)(1992-6#3)(1993-6#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-7#2)
germ cell alkaline phosphatase##2##4##(1992-3#2)
germ cell development in##2##4##(2009-7#2)
germ cell development##9##3##(2009-10#1)(2009-3#2)(2009-7#2)(2012-2#4)
germ cell loss from the seminiferous epithelium##2##7##(2009-10#1)(2012-2#1)
germ cell movement##3##3##(2009-10#3)
germ cell tumor##5##3##(1991-6#1)(2008-1#1)(2008-10#1)(2008-6#2)
germ cell tumors##5##3##(2007-10#1)(2008-10#3)(2008-6#1)
germ cell##40##2##(1991-6#1)(1992-3#2)(1994-7#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#3)(2009-10#8)(2009-3#3)(2009-7#2)(2012-2#9)
germ cell-free##2##2##(2008-4#2)
germ cells and##4##3##(2009-10#1)(2009-3#1)(2010-5#1)(2012-12#1)
germ cells are the##2##4##(2012-2#2)
germ cells express##2##3##(2009-3#1)(2012-2#1)
germ cells from##3##3##(2009-10#1)(2009-3#1)(2012-2#1)
germ cells in the cysts##2##5##(2008-7#2)
germ cells in the testis##4##5##(2008-4#1)(2008-7#2)(2009-10#1)
germ cells in the##7##4##(2008-4#1)(2008-7#4)(2009-10#1)(2012-2#1)
germ cells in##8##3##(2008-4#1)(2008-7#4)(2009-10#2)(2012-2#1)
germ cells##47##2##(1990-9#1)(1992-12#1)(1994-11#3)(1997-3#1)(2007-12#1)(2008-11#4)(2008-4#2)(2008-7#6)(2009-10#8)(2009-3#5)(2010-5#5)(2012-12#1)(2012-2#8)(2013-8#1)
germ layer##2##2##(2007-12#1)(2008-9#1)
germ layers##6##2##(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2012-12#1)
germ line##16##2##(1990-12#1)(1993-3#1)(1994-12#2)(1995-2#2)(2007-12#1)(2008-11#1)(2009-3#7)(2012-2#1)
germ plasm groups were##2##4##(2008-10#2)
germ plasm groups##3##3##(2008-10#3)
germ plasm line##2##3##(2008-10#2)
germ plasm lines##2##3##(2008-10#2)
germ plasm of##2##3##(2008-10#2)
germ plasm with##2##3##(2008-10#2)
germ plasm##28##2##(2008-10#27)(2009-3#1)
germ tube growth of##6##4##(2008-10#6)
germ tube growth##9##3##(2008-10#9)
germ tube length##2##3##(2008-10#2)
germ tube##18##2##(2008-10#17)(2008-5#1)
germ tubes and##3##3##(2008-10#2)(2008-7#1)
germ tubes increased##2##3##(2008-10#2)
germ tubes of##2##3##(2008-10#2)
germ tubes were##2##3##(2008-10#2)
germ tubes##31##2##(2008-10#29)(2008-7#2)
germ##222##1##(1990-11#1)(1990-12#2)(1990-9#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#2)(1994-7#1)(1995-2#2)(1997-3#2)(2007-10#1)(2007-12#5)(2008-1#2)(2008-10#83)(2008-11#10)(2008-12#3)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#4)(2009-10#17)(2009-3#17)(2009-7#2)(2010-3#1)(2010-5#5)(2012-12#3)(2012-2#18)(2013-1#1)(2013-8#1)
germ-cell tumors##3##2##(2007-10#2)(2010-11#1)
germ-cell##5##1##(2007-10#2)(2008-10#1)(2010-11#2)
germ-free##4##1##(2008-11#3)(2012-3#1)
germ-line##12##1##(1995-6#1)(1997-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#6)(2010-8#1)
germ-tube##2##1##(2008-10#1)(2008-5#1)
germanica##3##1##(2011-2#1)(2012-2#2)
germanium and molybdenum##2##3##(2008-10#2)
germanium and##3##2##(2008-10#3)
germanium were##3##2##(2007-12#1)(2008-10#2)
germanium##26##1##(1992-11#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-2#5)(2008-3#1)(2010-5#2)
germanium(IV)##2##1##(2008-10#2)
germanium-doped optical fibers##2##3##(2007-12#2)
germanium-doped##3##1##(2007-12#3)
germanosilicate fiber##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
germanosilicate fibers and##2##3##(2007-12#2)
germanosilicate fibers##4##2##(2007-12#4)
germanosilicate##11##1##(2007-12#7)(2008-2#2)(2008-3#2)
germanus##2##1##(2011-2#2)
germicidal##2##1##(1990-6#1)(1996-3#1)
germicides##2##1##(2007-12#1)(2008-1#1)
germinability##3##1##(2008-10#3)
germinal centers##2##2##(2008-10#1)(2010-11#1)
germinal epithelium degeneration##2##3##(2008-9#2)
germinal vesicle breakdown (GVBD)##2##4##(1992-11#1)(1995-2#1)
germinal vesicle##5##2##(1992-11#1)(1995-2#1)(2007-12#1)(2008-7#1)(2013-1#1)
germinal##15##1##(1992-11#1)(1995-2#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
germinans (Avicenniaceae)##2##2##(2008-5#2)
germinans##3##1##(2008-5#3)
germinant receptors##2##2##(2011-2#2)
germinate and grow out##2##4##(2011-2#2)
germinate and##5##2##(2008-10#3)(2011-2#2)
germinate on##2##2##(2008-10#1)(2010-10#1)
germinate##19##1##(2008-10#12)(2008-12#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#3)
germinated after##2##2##(2008-10#2)
germinated and produced apothecia##2##4##(2008-10#2)
germinated and##3##2##(2008-10#3)
germinated at 0 to##2##4##(2008-10#2)
germinated at##4##2##(2008-10#4)
germinated by##2##2##(2008-10#2)
germinated conidia##9##2##(2008-10#9)
germinated from 12 to##2##4##(2008-10#2)
germinated in##3##2##(2006-11#1)(2008-10#2)
germinated more##3##2##(2008-10#2)(2011-2#1)
germinated on##3##2##(2008-10#3)
germinated seeds extract##4##3##(2008-5#4)
germinated seeds##5##2##(2008-5#5)
germinated spores##2##2##(2008-9#1)(2011-2#1)
germinated within##2##2##(2008-10#2)
germinated##60##1##(1997-2#1)(2006-11#1)(2008-10#46)(2008-12#1)(2008-5#7)(2008-9#1)(2009-10#1)(2011-2#2)
germinating F(1) teliospores##2##3##(2008-10#2)
germinating Lupinus luteus L##3##4##(1990-5#3)
germinating conidia of the##2##4##(2008-10#2)
germinating conidia of##3##3##(2008-10#3)
germinating conidia##10##2##(2008-10#10)
germinating maize##2##2##(2009-8#2)
germinating seeds##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
germinating##36##1##(1990-5#6)(1993-6#1)(2008-10#20)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#3)
germination and appressorium formation##5##4##(2008-10#5)
germination and appressorium##6##3##(2008-10#5)(2009-8#1)
germination and early seedling growth##3##5##(2008-12#3)
germination and germ tube growth of##3##6##(2008-10#3)
germination and growth##2##3##(2008-10#1)(2011-2#1)
germination and hyphal growth##4##4##(1997-6#1)(2008-10#3)
germination and outgrowth processes##3##4##(2011-2#3)
germination and outgrowth##9##3##(2011-2#9)
germination and seedling growth of the Mexican sunflower Tithonia diversifolia##2##10##(2008-5#2)
germination and seedling growth of##8##5##(2008-12#6)(2008-5#2)
germination and seedling growth##9##4##(2008-12#7)(2008-5#2)
germination and sporulation of##2##4##(2008-10#2)
germination and subsequent##2##3##(2008-10#2)
germination and##62##2##(1997-6#1)(2007-5#1)(2008-10#29)(2008-12#11)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#2)(2011-2#11)
germination at##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
germination fluid##4##2##(2008-10#4)
germination for sclerotia##2##3##(2008-10#2)
germination for##3##2##(2008-10#3)
germination frequency##3##2##(2008-10#3)
germination in P##2##3##(2008-10#1)(2013-7#1)
germination in the##3##3##(2008-10#3)
germination in##20##2##(2006-11#2)(2008-10#14)(2008-5#1)(2009-8#1)(2011-2#1)(2013-7#1)
germination inhibition##2##2##(2008-10#1)(2008-9#1)
germination is##4##2##(2008-10#1)(2009-8#2)(2011-2#1)
germination model##2##2##(2008-10#1)(2011-2#1)
germination occurred at##5##3##(2008-10#5)
germination occurred##8##2##(2008-10#8)
germination of B##3##3##(2008-10#3)
germination of P##6##3##(2008-10#6)
germination of S##3##3##(2008-10#3)
germination of sclerotia##7##3##(2008-10#7)
germination of seeds##3##3##(2008-12#3)
germination of sporangia##2##3##(2008-10#2)
germination of spores##3##3##(2007-5#1)(2009-8#1)(2011-2#1)
germination of the##3##3##(2008-10#3)
germination of##57##2##(1993-3#1)(2006-11#1)(2007-5#1)(2008-10#44)(2008-12#4)(2008-5#2)(2009-8#1)(2011-1#1)(2011-2#2)
germination on##7##2##(2008-10#6)(2011-2#1)
germination or##2##2##(2008-10#2)
germination peaks##2##2##(2008-10#2)
germination percentage and seedling growth of V##2##7##(2008-12#2)
germination percentage of##5##3##(2008-10#3)(2008-5#1)(2013-7#1)
germination percentage was##3##3##(2008-10#2)(2008-12#1)
germination percentage##11##2##(2008-10#5)(2008-12#3)(2008-5#2)(2013-7#1)
germination percents##3##2##(2008-10#3)
germination proteins##2##2##(1997-7#2)
germination rate##3##2##(2008-10#2)(2008-12#1)
germination rates##2##2##(2008-10#2)
germination remained##2##2##(2008-10#2)
germination responses##3##2##(2008-10#2)(2009-8#1)
germination stimulants##2##2##(2008-10#2)
germination time##3##2##(2008-10#1)(2008-12#2)
germination to##2##2##(2008-10#2)
germination was strongly##2##3##(2008-10#2)
germination was##13##2##(2008-10#12)(2011-2#1)
germination were##3##2##(2008-10#3)
germination##341##1##(1993-3#1)(1995-6#1)(1997-6#1)(1997-7#2)(2006-11#4)(2007-5#2)(2008-10#217)(2008-12#40)(2008-5#11)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#5)(2009-8#11)(2010-10#1)(2011-1#1)(2011-2#28)(2012-3#1)(2013-7#2)
germinative##3##1##(2008-12#2)(2008-5#1)
germinoma 14 years after##2##4##(2008-7#2)
germinoma##8##1##(2008-7#8)
germline gene##2##2##(2007-12#2)
germline mutation##6##2##(2008-6#1)(2009-12#1)(2009-8#1)(2010-3#1)(2012-3#2)
germline mutations##2##2##(2008-10#1)(2013-1#1)
germline sequences##2##2##(1996-12#2)
germline transmission##2##2##(2008-2#1)(2012-3#1)
germline##39##1##(1992-10#1)(1995-8#4)(1996-12#2)(2007-12#6)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#4)
germlings##2##1##(2008-10#2)
germplasm and##2##2##(2008-7#1)(2009-6#1)
germplasm##15##1##(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-10#1)(2012-4#1)
germplasms##4##1##(2008-10#2)(2008-7#1)(2008-8#1)
germs##9##1##(1992-5#1)(1997-3#1)(2007-8#1)(2008-5#1)(2009-3#2)(2010-4#2)(2013-1#1)
gerontologic##3##1##(1992-11#1)(1993-2#1)(1994-5#1)
gerontological##6##1##(1993-12#1)(2008-11#1)(2012-12#4)
gerontology and##2##2##(1992-1#1)(1994-5#1)
gerontology##9##1##(1991-12#1)(1992-1#1)(1994-1#1)(1994-5#1)(1995-12#1)(2008-7#3)(2012-3#1)
geropsychiatric services that##2##3##(1992-1#2)
gesneriana##4##1##(2009-12#4)
gesnerioides parasitic on##2##3##(2008-10#2)
gesnerioides##8##1##(2008-10#8)
gestation and##6##2##(1993-12#3)(1996-5#1)(2007-11#1)(2008-5#1)
gestation at##2##2##(1990-2#1)(2007-11#1)
gestation day##2##2##(1996-5#1)(2008-10#1)
gestation days##2##2##(1991-5#1)(2008-10#1)
gestation for##2##2##(1994-12#1)(2008-10#1)
gestation from##2##2##(1990-5#1)(1996-11#1)
gestation have##2##2##(2012-2#1)(2013-1#1)
gestation in a##2##3##(2011-1#1)(2013-1#1)
gestation in##7##2##(1992-5#1)(1994-3#1)(1995-8#1)(2008-11#1)(2011-1#1)(2013-1#2)
gestation is##6##2##(1995-8#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
gestation on##2##2##(2009-6#1)(2010-2#1)
gestation to##4##2##(1990-5#2)(1995-8#1)(2013-8#1)
gestation until the end of pregnancy##2##6##(2008-12#1)(2011-2#1)
gestation with##6##2##(1991-3#1)(2007-10#1)(2007-7#1)(2008-7#1)(2013-1#2)
gestation##116##1##(1990-11#1)(1990-2#2)(1990-5#5)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#8)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-11#2)(1996-12#1)(1996-5#3)(1996-6#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-2#3)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#8)(2013-8#1)
gestation)##8##1##(1990-5#1)(1993-6#1)(1995-4#1)(1996-5#1)(2007-10#1)(2008-11#2)(2012-2#1)
gestational age and##3##3##(1990-12#1)(2008-11#1)(2011-1#1)
gestational age at diagnosis##2##4##(2007-8#1)(2013-1#1)
gestational age at##3##3##(1992-6#1)(2007-8#1)(2013-1#1)
gestational age##39##2##(1990-12#2)(1990-8#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#2)(1994-3#1)(1994-9#2)(1995-8#1)(1996-11#1)(1996-12#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-12#1)(2013-1#2)
gestational ages##6##2##(1990-8#1)(1992-2#1)(1992-6#2)(2008-11#1)(2011-1#1)
gestational and##2##2##(1993-6#1)(2012-2#1)
gestational day##2##2##(1995-2#1)(1995-8#1)
gestational days##2##2##(1995-11#1)(1996-5#1)
gestational diabetes mellitus (GDM)##2##4##(2010-8#1)(2011-2#1)
gestational diabetes mellitus was##2##4##(1992-12#1)(2008-10#1)
gestational diabetes mellitus##16##3##(1992-12#5)(1996-2#3)(2008-1#1)(2008-10#4)(2010-8#1)(2011-2#2)
gestational diabetes##24##2##(1992-12#5)(1996-11#3)(1996-2#3)(2008-1#1)(2008-10#5)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
gestational period##3##2##(1996-5#1)(2008-11#1)(2008-7#1)
gestational stress##5##2##(2008-11#5)
gestational week##2##2##(1997-8#2)
gestational weeks##3##2##(1990-9#1)(2011-1#1)(2011-2#1)
gestational##104##1##(1990-11#1)(1990-12#2)(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-6#4)(1993-6#2)(1994-3#2)(1994-9#3)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-5#2)(1997-8#2)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#11)(2008-12#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#9)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
gestations##3##1##(2008-11#1)(2012-3#2)
gesticulation of motion events##2##4##(2008-4#2)
gestodene (EE+G)##2##2##(1994-5#2)
gestodene##9##1##(1994-5#3)(2011-3#6)
gestural##2##1##(2010-5#2)
gesture with their##2##3##(2010-5#2)
gesture##6##1##(2007-12#1)(2008-4#2)(2009-12#1)(2010-5#2)
gestures and##7##2##(1990-3#1)(2008-11#4)(2008-4#1)(2010-5#1)
gestures##15##1##(1990-3#1)(1997-5#1)(2008-11#5)(2008-4#3)(2010-5#4)(2010-6#1)
get a better##4##3##(1994-1#1)(2008-10#1)(2008-3#2)
get a higher##2##3##(2007-12#1)(2008-2#1)
get a##19##2##(1994-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2013-8#4)
get an inside##2##3##(1994-12#1)(1995-2#1)
get an##11##2##(1994-12#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
get back##2##2##(2008-2#1)(2010-10#1)
get from##2##2##(1996-1#1)(1996-3#1)
get in##2##2##(1994-5#1)(2008-11#1)
get into the##3##3##(1996-4#1)(2008-5#1)(2010-4#1)
get involved##4##2##(1990-11#1)(1995-1#1)(2008-4#2)
get it##2##2##(2011-2#1)(2013-8#1)
get more insight##2##3##(2008-10#1)(2009-4#1)
get more##6##2##(1994-1#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
get the best##2##3##(2008-10#1)(2008-7#1)
get the most##2##3##(1994-3#1)(2008-7#1)
get the##21##2##(1993-1#1)(1993-2#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#2)(2013-8#1)
get their##3##2##(1995-12#1)(1996-7#1)(2009-5#1)
get to##3##2##(1992-12#1)(1992-8#1)(2008-11#1)
get you started##3##3##(1995-12#1)(1995-2#1)(2012-12#1)
get##158##1##(1990-11#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#3)(1996-1#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#9)
gets a##2##2##(1990-8#1)(2012-2#1)
gets the##2##2##(1996-2#1)(2008-10#1)
gets##21##1##(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
getting a##3##2##(2008-9#1)(2010-6#1)(2010-8#1)
getting in the##2##3##(2010-5#1)(2011-1#1)
getting in##4##2##(1993-6#1)(2008-10#1)(2010-5#1)(2011-1#1)
getting started##3##2##(1994-1#1)(2008-11#1)(2009-11#1)
getting the evidence straight##2##4##(1993-12#2)
getting the##4##2##(1992-1#1)(1993-12#2)(2013-8#1)
getting there##2##2##(1994-1#1)(1994-3#1)
getting##50##1##(1991-1#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-3#1)(1996-1#2)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-9#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
gfg transcripts##3##2##(1994-11#3)
gfg##5##1##(1994-11#5)
gfp##6##1##(1996-6#2)(1997-4#3)(2008-10#1)
ghana##5##1##(2011-2#4)(2013-1#1)
ghost pulse energy##2##3##(2007-11#2)
ghost pulse##7##2##(2007-11#6)(2007-12#1)
ghost talk in##2##3##(2008-3#2)
ghost talk##4##2##(2008-3#4)
ghost##18##1##(1990-11#1)(1994-5#1)(2007-11#7)(2007-12#2)(2008-10#1)(2008-3#5)(2008-9#1)
ghostlike&quot##2##1##(2008-12#2)
ghosts##7##1##(1993-11#4)(1994-2#1)(2008-10#1)(2009-8#1)
ghrelin and##2##2##(2008-3#1)(2011-2#1)
ghrelin in##3##2##(2011-1#1)(2011-2#2)
ghrelin is##2##2##(2008-3#1)(2013-8#1)
ghrelin levels were##2##3##(2011-1#2)
ghrelin levels##10##2##(2011-1#9)(2013-8#1)
ghrelin may##3##2##(2011-1#1)(2011-2#2)
ghrelin##44##1##(2007-7#1)(2008-3#10)(2010-11#1)(2011-1#13)(2011-2#10)(2012-3#3)(2013-8#6)
giant aneurysm##2##2##(2008-12#1)(2011-2#1)
giant back mass##2##3##(2011-2#2)
giant cell reparative granuloma of the skull base and##2##9##(2006-12#2)
giant cell reparative granuloma##3##4##(2006-12#3)
giant cell reparative##4##3##(2006-12#4)
giant cell rich malignant fibrous histiocytoma##2##6##(2008-6#2)
giant cell tumor of the##2##5##(2009-3#2)
giant cell tumor##4##3##(2009-3#2)(2010-12#1)(2012-3#1)
giant cell##15##2##(1997-8#1)(2006-12#5)(2008-10#2)(2008-5#1)(2008-6#2)(2009-3#2)(2010-12#1)(2012-3#1)
giant cells and##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
giant cells in the##3##4##(1993-8#1)(2008-10#2)
giant cells in##5##3##(1993-8#1)(2007-12#1)(2008-10#3)
giant cells##20##2##(1991-11#1)(1991-12#1)(1993-8#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#2)
giant condyloma acuminatum##2##3##(2007-8#2)
giant condyloma##4##2##(2007-8#2)(2011-1#1)(2012-12#1)
giant cracks##2##2##(1991-8#2)
giant cystic craniopharyngiomas##2##3##(2008-7#2)
giant grouper##5##2##(2010-5#5)
giant hiatal##2##2##(2011-2#2)
giant intracranial##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
giant middle cerebral##3##3##(2008-7#1)(2011-2#2)
giant neck and back masses##2##5##(2011-2#2)
giant neurons in##3##3##(2007-12#3)
giant neurons##8##2##(1997-6#1)(2007-12#7)
giant olfactory groove meningioma##2##4##(2006-12#2)
giant panda##7##2##(2008-8#4)(2008-9#3)
giant porokeratosis##2##2##(2007-7#2)
giant posterior circulation aneurysms##2##4##(2008-7#2)
giant posterior##4##2##(2008-7#2)(2011-2#1)(2013-1#1)
giant refraction and##2##3##(2007-11#2)
giant right##2##2##(2007-8#2)
giant saccular aneurysm##2##3##(2008-7#2)
giant schwannoma##2##2##(2012-12#2)
giant unilamellar vesicles##3##3##(2012-2#2)(2013-7#1)
giant##169##1##(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-8#2)(1992-11#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#3)(2006-12#7)(2007-11#2)(2007-12#14)(2007-7#3)(2007-8#6)(2008-10#13)(2008-12#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#16)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#3)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-8#5)(2011-1#1)(2011-2#12)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#3)
giant-cell##4##1##(2007-11#3)(2010-9#1)
giants##2##1##(2007-4#1)(2013-1#1)
gibberella ear rot##2##3##(2008-10#2)
gibberellin (GA)##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
gibberellin signaling##2##2##(2009-8#2)
gibberellin##7##1##(1994-8#2)(2008-10#1)(2008-8#1)(2009-8#3)
gibberellins (GAs)##2##2##(1994-8#1)(2009-8#1)
gibberellins##5##1##(1994-8#1)(2008-10#1)(2009-8#3)
gibbon##6##1##(1993-8#5)(2012-12#1)
gibbosa##3##1##(2008-12#3)
gicerin expression##3##2##(1997-6#3)
gicerin##6##1##(1997-6#6)
gift shop##2##2##(1994-3#1)(1997-1#1)
gift##6##1##(1994-12#1)(1994-3#1)(1995-1#1)(1997-1#1)(2007-12#1)(2008-1#1)
gifted##2##1##(1995-1#1)(2011-2#1)
gifts from##2##2##(1994-7#1)(2008-12#1)
gifts to##2##2##(1992-3#1)(1993-5#1)
gifts##12##1##(1991-1#1)(1992-1#1)(1992-3#2)(1993-5#1)(1994-7#1)(1996-1#1)(1997-4#1)(2008-11#3)(2008-12#1)
gigabit optical link designer##2##4##(2008-2#2)
gigabit##3##1##(2007-11#1)(2008-2#2)
gigabits per second##2##3##(2007-12#1)(2008-2#1)
gigahertz optical pulse##2##3##(2007-12#2)
gigahertz##6##1##(1995-3#1)(2007-12#3)(2008-2#1)(2008-3#1)
giganteus##7##1##(1991-9#2)(1993-2#2)(1997-4#1)(2008-10#2)
gigantic##5##1##(1997-7#1)(2009-10#1)(2013-1#3)
gigantocellularis##3##1##(1990-9#2)(1997-2#1)
gill and kidney##2##3##(2008-10#1)(2008-7#1)
gill and##3##2##(2008-10#1)(2008-7#2)
gill arrangements##2##2##(2010-10#2)
gill##22##1##(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#10)(2009-7#1)(2010-10#3)(2011-2#1)
gills and##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
gills of the##4##3##(2008-7#4)
gills of##6##2##(2008-7#5)(2010-8#1)
gills was##2##2##(2008-7#2)
gills##29##1##(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#14)(2010-10#7)(2010-8#1)(2012-3#1)
gilthead sea bream##4##3##(2008-7#1)(2009-5#1)(2010-8#2)
gilthead##5##1##(2008-11#1)(2008-7#1)(2009-5#1)(2010-8#2)
gilts##5##1##(1996-8#1)(2010-2#1)(2013-1#3)
ginbuna##4##1##(2008-5#4)
ginger extract##4##2##(2008-11#4)
ginger##14##1##(2008-10#10)(2008-11#4)
gingiva increased the pain thresholds##2##5##(1993-1#2)
gingiva##13##1##(1993-1#3)(2009-8#1)(2012-12#1)(2012-3#4)(2013-1#4)
gingival bleeding index##2##3##(2008-12#2)
gingival bleeding##3##2##(2008-12#2)(2013-1#1)
gingival enlargement##3##2##(2012-12#3)
gingival fibromatosis##3##2##(2007-12#1)(2012-3#2)
gingival hyperplasia##2##2##(1990-10#1)(2008-1#1)
gingival index##2##2##(2008-12#2)
gingival mass##2##2##(2012-12#1)(2012-3#1)
gingival overgrowth##3##2##(2012-3#3)
gingival recession##7##2##(2008-1#1)(2008-12#2)(2009-8#1)(2012-3#3)
gingival swelling##2##2##(2007-12#1)(2013-1#1)
gingival##50##1##(1990-10#2)(2007-10#1)(2007-12#2)(2008-1#2)(2008-12#6)(2008-5#1)(2009-8#1)(2010-12#2)(2011-2#4)(2012-12#4)(2012-3#18)(2013-1#7)
gingivalis and##4##2##(2008-12#3)(2013-1#1)
gingivalis was##2##2##(1990-11#1)(2008-12#1)
gingivalis##16##1##(1990-11#3)(2007-7#1)(2008-12#5)(2008-9#5)(2013-1#2)
gingivitis##6##1##(1990-10#1)(2007-7#3)(2012-12#1)(2012-3#1)
gingivo-buccal complex##2##2##(2010-12#2)
ginkgo##4##1##(2008-10#3)(2010-5#1)
ginseng (Panax quinquefolius)##3##3##(2008-10#3)
ginseng (Panax##5##2##(1997-2#2)(2008-10#3)
ginseng and##4##2##(2008-10#1)(2009-12#1)(2012-3#1)(2013-8#1)
ginseng cpDNA##2##2##(1997-2#2)
ginseng leaflets##2##2##(2008-10#2)
ginseng on##2##2##(1995-8#2)
ginseng plants##2##2##(2008-10#2)
ginseng production##2##2##(2008-10#2)
ginseng roots was##2##3##(2008-10#2)
ginseng roots were##2##3##(2008-10#2)
ginseng roots##5##2##(2008-10#5)
ginseng was##2##2##(1997-2#1)(2008-10#1)
ginseng##51##1##(1995-8#3)(1997-2#8)(2008-10#26)(2008-11#4)(2009-12#1)(2009-9#1)(2012-3#6)(2013-8#2)
ginseng-induced##2##1##(2012-3#2)
ginsenoside Rg1##2##2##(2008-11#1)(2012-3#1)
ginsenoside##4##1##(2008-11#2)(2012-3#1)(2013-1#1)
ginsenosides was##2##2##(2008-11#2)
ginsenosides##3##1##(2008-11#3)
girdle relaxation##8##2##(1990-6#7)(1991-2#1)
girdle##24##1##(1990-6#9)(1991-2#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-6#3)(2008-7#2)(2011-2#3)(2012-2#2)
girdling##3##1##(2008-10#3)
girl had##2##2##(2007-7#1)(2012-12#1)
girl is reported##2##3##(2008-10#1)(2009-5#1)
girl is##4##2##(1994-2#1)(2008-10#1)(2009-5#1)(2011-2#1)
girl presented with recurrent##3##4##(2008-10#2)(2010-6#1)
girl presented with##4##3##(2007-8#1)(2008-10#2)(2010-6#1)
girl presented##5##2##(2007-8#1)(2008-10#2)(2008-8#1)(2010-6#1)
girl underwent##2##2##(2008-10#1)(2012-2#1)
girl was##5##2##(1997-3#1)(2011-1#1)(2012-12#2)(2012-3#1)
girl who had##2##3##(1996-6#1)(2008-7#1)
girl who presented with##4##4##(2008-10#1)(2008-11#1)(2009-3#1)(2010-5#1)
girl who presented##6##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-5#1)
girl who##9##2##(1996-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2010-5#1)(2011-2#1)
girl with a history of##2##5##(2011-1#1)(2013-8#1)
girl with a##3##3##(1995-4#1)(2011-1#1)(2013-8#1)
girl with bilateral##2##3##(2012-2#1)(2013-1#1)
girl with congenital##2##3##(2007-12#1)(2008-9#1)
girl with##23##2##(1995-4#1)(1995-8#2)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-1#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
girl##89##1##(1991-2#1)(1991-6#1)(1992-3#1)(1994-2#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-6#1)(1997-3#4)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#2)(2009-5#3)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#7)(2011-2#4)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
girlfriends and boyfriends##2##3##(2008-9#2)
girlfriends##3##1##(2008-9#2)(2011-2#1)
girls aged##3##2##(1996-3#1)(2007-8#1)(2008-1#1)
girls and boys##4##3##(2007-12#1)(2010-10#1)(2010-4#1)(2011-1#1)
girls and women##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
girls and young women##2##4##(2011-2#1)(2013-1#1)
girls and##25##2##(1990-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-6#1)(2009-7#3)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#4)(2013-1#3)(2013-8#1)
girls at##2##2##(2013-1#2)
girls by##2##2##(2007-12#2)
girls can##2##2##(1995-6#1)(2013-1#1)
girls had##4##2##(2009-7#1)(2011-1#2)(2012-2#1)
girls in the##2##3##(1996-6#1)(2013-1#1)
girls in##8##2##(1996-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#2)
girls is##2##2##(2011-1#1)(2013-1#1)
girls receiving the##2##3##(2013-1#2)
girls reported##5##2##(1991-9#2)(1994-2#1)(1996-6#1)(2008-10#1)
girls than##3##2##(1990-2#1)(1994-12#1)(2007-12#1)
girls were##6##2##(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
girls with eating##3##3##(2008-11#3)
girls with premature adrenarche##2##4##(2008-4#2)
girls with strong##3##3##(2013-1#3)
girls with##16##2##(1994-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#3)(2011-1#1)(2011-2#1)(2013-1#3)
girls##181##1##(1990-11#1)(1990-2#5)(1990-6#1)(1990-9#1)(1991-11#1)(1991-9#2)(1993-8#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#3)(1996-9#2)(2007-11#2)(2007-12#16)(2007-8#4)(2008-1#5)(2008-10#8)(2008-11#5)(2008-12#8)(2008-4#6)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#3)(2009-5#1)(2009-7#8)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#4)(2010-7#4)(2011-1#16)(2011-2#9)(2012-2#5)(2012-3#2)(2013-1#29)(2013-8#1)
girls' body##3##2##(2007-12#2)(2010-10#1)
girls' drinking##2##2##(2010-7#2)
girls' psychological well-being##2##3##(2010-7#2)
girls' violence##2##2##(2013-1#2)
girls'##19##1##(2007-12#3)(2008-11#1)(2008-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-7#6)(2013-1#4)
girls) aged##3##2##(1991-6#1)(2009-7#1)(2010-7#1)
girls) were##2##2##(1996-6#1)(2012-2#1)
girls) with a##2##3##(2008-1#1)(2011-2#1)
girls) with##4##2##(1990-12#1)(1993-2#1)(2008-1#1)(2011-2#1)
girls)##18##1##(1990-12#1)(1991-6#1)(1991-9#2)(1993-2#1)(1996-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-7#2)(2009-8#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
girth as predictors##2##3##(1996-8#1)(2008-11#1)
girth##4##1##(1996-8#2)(2008-11#1)(2008-12#1)
give a better##3##3##(1997-3#1)(1997-7#1)(2007-11#1)
give a brief overview of##2##5##(1995-2#1)(2009-8#1)
give a brief##5##3##(1990-8#1)(1995-2#1)(1996-8#1)(2009-8#1)(2013-8#1)
give a detailed##3##3##(1992-2#1)(2008-3#1)(2009-11#1)
give a direct##2##3##(2007-12#1)(2008-11#1)
give a full##2##3##(1995-12#1)(2008-10#1)
give a high##2##3##(2008-2#1)(2008-3#1)
give a qualitative##2##3##(2008-3#2)
give a total##2##3##(2008-10#2)
give a##77##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-8#2)(2009-9#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
give acceptable##2##2##(1993-12#1)(2008-10#1)
give access to##2##3##(1994-8#1)(2012-2#1)
give an additional##2##3##(1995-11#1)(2008-10#1)
give an efficient##2##3##(2008-2#2)
give an overview of the##2##5##(2010-9#1)(2011-2#1)
give an overview of##5##4##(2008-11#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)
give an overview##7##3##(2008-11#1)(2008-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)
give an##32##2##(1991-6#1)(1995-11#1)(1996-2#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-4#2)(2008-5#3)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
give better##2##2##(2008-10#1)(2013-8#1)
give birth to##2##3##(1990-9#1)(2007-12#1)
give birth##5##2##(1990-9#1)(2007-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
give clues as to the##2##5##(2008-11#1)(2013-8#1)
give clues##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
give different results##2##3##(2007-12#1)(2008-10#1)
give different##3##2##(2007-12#1)(2008-10#2)
give evidence##3##2##(2008-10#2)(2009-10#1)
give examples##2##2##(1997-7#1)(2008-3#1)
give further##2##2##(1990-2#1)(1991-8#1)
give good##2##2##(2007-11#1)(2008-10#1)
give high yields##2##3##(2008-4#1)(2012-1#1)
give high##4##2##(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)
give information about the##2##4##(1991-5#1)(2008-3#1)
give information about##4##3##(1991-5#1)(2008-3#1)(2008-4#1)(2010-8#1)
give information on the##4##4##(1994-11#1)(2008-10#2)(2008-5#1)
give information on##5##3##(1994-11#1)(2007-2#1)(2008-10#2)(2008-5#1)
give information##10##2##(1991-5#1)(1994-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
give insight into the##2##4##(1995-3#1)(2008-10#1)
give insights##3##2##(2008-11#1)(2010-7#1)(2012-3#1)
give it a##2##3##(2008-7#1)(2013-1#1)
give more accurate##2##3##(2008-10#1)(2011-1#1)
give more##10##2##(1994-11#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
give much##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
give new insight into the##2##5##(1997-3#1)(2008-3#1)
give new##3##2##(1997-3#1)(2008-11#1)(2008-3#1)
give priority to the##2##4##(2009-3#1)(2013-7#1)
give results##3##2##(2008-10#1)(2012-12#2)
give rise to a##6##4##(1991-9#1)(2006-12#1)(2008-3#2)(2009-3#1)(2009-5#1)
give rise to an##2##4##(2008-2#1)(2008-7#1)
give rise to the##6##4##(2007-11#2)(2012-12#2)(2012-2#1)(2013-1#1)
give rise to##66##3##(1990-8#1)(1991-3#1)(1991-9#2)(1992-4#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
give rise##69##2##(1990-8#1)(1991-3#1)(1991-9#2)(1992-4#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-9#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
give satisfactory results##7##3##(1992-9#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#1)
give satisfactory##9##2##(1992-9#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-3#1)
give several examples##2##3##(2012-2#1)(2013-8#1)
give significant##4##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-2#1)
give similar results in the##2##5##(2008-10#1)(2008-2#1)
give similar results in##3##4##(1996-2#1)(2008-10#1)(2008-2#1)
give similar results##4##3##(1996-2#1)(1996-3#1)(2008-10#1)(2008-2#1)
give similar##5##2##(1996-2#1)(1996-3#1)(2008-10#1)(2008-2#1)(2010-4#1)
give some##5##2##(1992-9#1)(1996-4#1)(1997-4#1)(2007-12#1)(2009-10#1)
give strong##2##2##(1991-6#1)(2008-10#1)
give support to##3##3##(1990-10#1)(1995-12#1)(2010-5#1)
give support##4##2##(1990-10#1)(1994-1#1)(1995-12#1)(2010-5#1)
give the best results##2##4##(1994-2#1)(2008-10#1)
give the best##9##3##(1992-12#1)(1994-2#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#2)
give the most##2##3##(2008-10#1)(2008-7#1)
give the opportunity##2##3##(2007-11#1)(2013-8#1)
give the same##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
give the##69##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(2007-10#1)(2007-11#6)(2007-12#1)(2008-10#10)(2008-11#7)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#3)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
give their##6##2##(1990-3#1)(1992-1#1)(1992-4#1)(2008-3#1)(2011-2#1)(2013-8#1)
give them##3##2##(1995-1#1)(2008-1#1)(2008-10#1)
give this##2##2##(1993-6#1)(2008-5#1)
give three##2##2##(2008-10#1)(2010-11#1)
give to##3##2##(1995-1#1)(1995-3#1)(2008-7#1)
give us a##2##3##(2008-8#1)(2010-10#1)
give us##8##2##(2007-11#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-10#1)(2012-2#2)
give useful##3##2##(1990-8#1)(1990-9#1)(2008-5#1)
give valuable##2##2##(2008-5#1)(2009-5#1)
give very##2##2##(2008-10#2)
give##536##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-6#2)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#8)(1996-3#3)(1996-4#3)(1996-5#9)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(1997-9#1)(2006-12#1)(2007-10#2)(2007-11#29)(2007-12#13)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#85)(2008-11#26)(2008-12#2)(2008-2#22)(2008-3#30)(2008-4#11)(2008-5#19)(2008-6#4)(2008-7#16)(2008-8#9)(2008-9#4)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#5)(2009-5#7)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#10)
given 5##4##2##(1992-5#1)(1997-7#2)(2008-10#1)
given 6##3##2##(1994-5#2)(1995-3#1)
given a diagnosis of##2##4##(1997-3#1)(2012-3#1)
given a general##2##3##(1996-11#1)(2008-3#1)
given a large##2##3##(1991-6#1)(2008-11#1)
given a single dose of##2##5##(2008-1#1)(2013-1#1)
given a single intramuscular injection of KLH at 10 mg/animal##2##10##(2008-10#2)
given a single##4##3##(2008-1#1)(2008-10#2)(2013-1#1)
given a##47##2##(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1994-8#1)(1994-9#1)(1996-11#2)(1996-5#1)(1997-3#1)(1997-8#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
given access to##2##3##(2008-7#1)(2013-1#1)
given accuracy##2##2##(2008-3#2)
given acquisition access periods (AAPs) ranging from##2##7##(2008-10#2)
given after##3##2##(1992-5#1)(2008-10#1)(2008-7#1)
given alone##2##2##(1995-12#1)(2009-2#1)
given an appropriate##2##3##(2008-3#1)(2011-1#1)
given an##16##2##(1990-5#1)(1994-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
given and##8##2##(1990-9#1)(1991-12#1)(2008-10#5)(2011-1#1)
given as a##9##3##(1991-6#1)(1992-12#1)(1992-9#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)
given as bolus injection at 3-week intervals##2##7##(2008-6#2)
given as the##2##3##(2008-10#1)(2013-1#1)
given as##25##2##(1991-6#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1995-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
given at 2##2##3##(1992-2#1)(1995-5#1)
given at birth##2##3##(1995-5#1)(2007-11#1)
given at the time of##2##5##(1997-7#1)(2012-3#1)
given at the##6##3##(1994-9#1)(1997-7#1)(2008-12#1)(2011-2#1)(2012-3#2)
given at##24##2##(1992-2#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-5#3)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
given azoxymethane##2##2##(1992-3#1)(1992-9#1)
given before##2##2##(2010-8#1)(2011-2#1)
given bilateral##3##2##(1993-3#1)(1993-6#1)(1994-3#1)
given both##2##2##(2008-10#1)(2008-9#1)
given by an##2##3##(2008-10#1)(2008-2#1)
given by general practitioners##2##4##(2007-2#2)
given by mouth##2##3##(1991-9#1)(1997-1#1)
given by the##31##3##(1993-2#1)(1994-9#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#7)(2008-6#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)
given by##69##2##(1990-8#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-9#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-8#2)(2007-11#4)(2007-12#5)(2007-2#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#6)(2008-3#13)(2008-5#1)(2008-6#2)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
given concerning##2##2##(1996-3#1)(2008-9#1)
given daily##2##2##(2007-10#1)(2008-7#1)
given day##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
given diethylnitrosamine##2##2##(1991-6#2)
given difference##2##2##(1992-12#1)(2008-3#1)
given direction##4##2##(2007-11#1)(2008-10#3)
given during the##2##3##(2008-1#1)(2010-3#1)
given during##5##2##(1992-5#1)(1992-9#1)(2008-1#1)(2010-3#1)(2011-2#1)
given either##4##2##(1990-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
given every 2 weeks##2##4##(2008-6#1)(2010-3#1)
given every##5##2##(1990-12#1)(2008-6#2)(2010-3#2)
given experimental##2##2##(2007-8#1)(2008-10#1)
given for a##6##3##(1992-10#1)(2008-2#3)(2008-3#1)(2008-6#1)
given for each##3##3##(1997-4#1)(2008-10#1)(2013-1#1)
given for the first##2##4##(2007-12#1)(2007-8#1)
given for the##22##3##(1994-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)
given for##81##2##(1990-2#1)(1990-5#1)(1991-11#1)(1992-10#1)(1994-11#2)(1995-12#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#13)(2008-3#16)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
given genomic sequence##2##3##(2008-7#2)
given genomic##3##2##(2008-7#3)
given greater##2##2##(1992-6#1)(2008-10#1)
given here##5##2##(2008-10#2)(2008-11#1)(2008-3#2)
given host##4##2##(2008-10#4)
given i##7##2##(1990-12#1)(1992-3#5)(2008-7#1)
given immediately after##2##3##(1990-12#1)(2012-2#1)
given in a##6##3##(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
given in combination##2##3##(1993-6#1)(1994-2#1)
given in detail##2##3##(2008-3#2)
given in doses of##2##4##(1991-6#1)(2007-6#1)
given in doses##3##3##(1991-6#1)(2007-11#1)(2007-6#1)
given in the same##2##4##(1994-8#1)(1997-7#1)
given in the##13##3##(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)
given in this paper##4##4##(2008-10#3)(2008-2#1)
given in this##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
given in which##3##3##(2008-3#2)(2008-4#1)
given in##48##2##(1990-10#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-2#2)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-4#2)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-8#1)
given intravenously##4##2##(1991-6#1)(1996-12#1)(2007-7#1)(2012-2#1)
given is##4##2##(1992-9#1)(2008-3#1)(2008-4#1)(2010-10#1)
given its##9##2##(1990-11#1)(1991-1#1)(1995-11#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
given little##2##2##(1994-2#1)(1997-2#1)
given membrane##2##2##(2008-10#1)(2008-7#1)
given of the##10##3##(1992-1#1)(1996-12#1)(1997-7#1)(2006-4#2)(2007-2#1)(2008-2#4)
given of##16##2##(1992-1#1)(1992-6#1)(1996-12#1)(1997-7#1)(2006-4#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)
given on how##2##3##(2008-4#1)(2010-5#1)
given on the##6##3##(1990-10#1)(1991-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-1#1)
given on##17##2##(1990-10#1)(1991-5#2)(1997-2#1)(2006-6#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-1#1)
given only##3##2##(1992-5#1)(1996-12#1)(1997-3#1)
given or##2##2##(1994-2#1)(2006-10#1)
given orally##11##2##(1991-9#1)(1992-12#1)(1993-12#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-5#2)(2012-12#1)(2012-2#1)(2013-1#1)
given patient##8##2##(1992-8#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-1#1)
given placebo##4##2##(1995-2#1)(2007-7#1)(2008-3#1)(2008-7#1)
given point##6##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-2#1)
given population##3##2##(2008-9#1)(2011-3#1)(2012-3#1)
given positive##2##2##(2008-5#1)(2012-2#1)
given prior to##2##3##(1997-2#1)(1997-4#1)
given prior##3##2##(1997-2#1)(1997-4#1)(2010-3#1)
given protein##9##2##(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2009-12#1)
given regarding##2##2##(2008-4#2)
given repeated##2##2##(1992-7#1)(2008-10#1)
given rise to a##3##4##(2008-1#1)(2009-8#1)(2013-8#1)
given rise to##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-7#1)(2013-8#1)
given size##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
given small##2##2##(2012-1#1)(2013-1#1)
given species##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)
given specificity##2##2##(2008-2#1)(2011-1#1)
given task##2##2##(2008-10#1)(2008-9#1)
given technique##2##2##(2008-3#1)(2009-5#1)
given temperature##3##2##(2008-10#3)
given that it##2##3##(2008-1#1)(2008-10#1)
given that the##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
given that##25##2##(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#4)
given the current##3##3##(1997-1#1)(2008-11#1)(2008-4#1)
given the lack of##2##4##(2008-6#1)(2008-9#1)
given the limited##2##3##(1996-2#1)(1996-3#1)
given the opportunity to##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
given the potential##2##3##(2008-9#1)(2013-8#1)
given the responsibility##2##3##(1992-1#1)(1994-3#1)
given the same##3##3##(2008-5#1)(2009-11#1)(2012-3#1)
given the##88##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
given their##6##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)
given this##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
given time and##2##3##(2008-4#1)(2008-9#1)
given time##4##2##(1995-3#1)(2008-3#1)(2008-4#1)(2008-9#1)
given to a##2##3##(2008-5#1)(2008-8#1)
given to children##2##3##(2010-10#1)(2010-3#1)
given to different##2##3##(2008-8#1)(2009-11#1)
given to groups of##2##4##(1996-12#1)(2007-6#1)
given to illustrate the##2##4##(2008-10#1)(2008-11#1)
given to illustrate##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
given to increasing##2##3##(2008-11#1)(2010-5#1)
given to patients with##3##4##(1991-8#1)(1993-11#1)(2007-8#1)
given to the patient##3##4##(1990-10#1)(1991-8#1)(2013-1#1)
given to the use of##2##5##(2008-12#1)(2012-2#1)
given to the##45##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
given to these##2##3##(1994-6#1)(2011-1#1)
given to##133##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
given tumor##2##2##(2007-10#1)(2010-12#1)
given twice##2##2##(2007-11#1)(2008-6#1)
given using##2##2##(2008-4#1)(2008-5#1)
given wavelength##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
given when##2##2##(2008-11#1)(2009-10#1)
given with##5##2##(1995-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
given year##5##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
given##1422##1##(1990-10#4)(1990-11#9)(1990-12#5)(1990-2#4)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-11#3)(1991-12#6)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#10)(1991-8#4)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#11)(1992-2#4)(1992-3#16)(1992-4#2)(1992-5#6)(1992-6#9)(1992-7#2)(1992-8#1)(1992-9#9)(1993-1#2)(1993-11#6)(1993-12#10)(1993-2#7)(1993-3#7)(1993-6#8)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#8)(1994-3#5)(1994-5#7)(1994-6#2)(1994-7#2)(1994-8#4)(1994-9#6)(1995-1#2)(1995-11#5)(1995-12#8)(1995-2#3)(1995-3#7)(1995-5#8)(1995-6#3)(1995-9#1)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#4)(1996-9#4)(1997-1#5)(1997-2#9)(1997-3#5)(1997-4#9)(1997-5#4)(1997-6#6)(1997-7#8)(1997-8#9)(1997-9#1)(2006-10#3)(2006-12#2)(2006-4#2)(2006-6#1)(2007-10#5)(2007-11#33)(2007-12#23)(2007-2#8)(2007-4#1)(2007-5#1)(2007-6#6)(2007-7#15)(2007-8#13)(2008-1#18)(2008-10#187)(2008-11#54)(2008-12#11)(2008-2#84)(2008-3#152)(2008-4#35)(2008-5#30)(2008-6#24)(2008-7#32)(2008-8#26)(2008-9#42)(2009-10#3)(2009-11#5)(2009-12#6)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#7)(2009-6#7)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#10)(2010-2#6)(2010-3#9)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#13)(2011-2#28)(2011-3#2)(2012-1#4)(2012-12#7)(2012-2#18)(2012-3#20)(2012-7#1)(2013-1#45)(2013-7#3)(2013-8#13)
givers##4##1##(1990-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
gives a brief overview##4##4##(1994-12#1)(2008-10#2)(2011-2#1)
gives a brief##6##3##(1994-12#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
gives a good##4##3##(2008-10#4)
gives a new##2##3##(1997-2#1)(2008-3#1)
gives a useful##2##3##(1992-11#1)(2008-10#1)
gives a value of##2##4##(1990-12#1)(2008-2#1)
gives a##63##2##(1990-12#1)(1991-11#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-8#1)(1997-2#1)(2006-6#1)(2007-11#3)(2008-10#24)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
gives access to the##2##4##(2006-12#1)(2007-12#1)
gives access to##4##3##(2006-12#1)(2007-12#2)(2008-3#1)
gives additional##2##2##(1992-7#1)(2008-5#1)
gives an insight into the##2##5##(2008-10#1)(2010-6#1)
gives an overview of the##5##5##(1997-2#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-11#1)
gives an overview of##10##4##(1990-6#1)(1994-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#2)(2010-11#1)
gives an overview on##2##4##(2008-10#2)
gives an overview##13##3##(1990-6#1)(1994-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-9#2)(2010-11#1)(2013-1#1)
gives an##33##2##(1990-6#1)(1992-6#1)(1994-1#1)(1996-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#3)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2013-1#1)
gives excellent agreement##2##3##(2007-12#1)(2008-3#1)
gives excellent##3##2##(1991-9#1)(2007-12#1)(2008-3#1)
gives fast##3##2##(2007-11#1)(2007-8#1)(2009-10#1)
gives further##2##2##(1997-3#1)(2008-10#1)
gives good results##2##3##(2008-10#1)(2013-1#1)
gives good##7##2##(1993-11#1)(2008-10#1)(2008-3#3)(2013-1#2)
gives high##2##2##(2007-11#1)(2012-2#1)
gives higher##3##2##(2008-10#2)(2008-6#1)
gives improved##2##2##(2007-11#1)(2008-8#1)
gives information##2##2##(1991-5#1)(2008-9#1)
gives insight into the##2##4##(2009-8#1)(2012-2#1)
gives more##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
gives much##2##2##(2008-10#2)
gives results with##2##3##(2008-10#2)
gives results##3##2##(1994-9#1)(2008-10#2)
gives rise to a high##2##5##(1991-9#1)(1992-3#1)
gives rise to a##13##4##(1990-11#1)(1991-9#1)(1992-3#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-8#1)
gives rise to an##4##4##(1994-8#1)(2008-10#2)(2010-11#1)
gives rise to many##2##4##(1992-3#1)(2008-5#1)
gives rise to the##7##4##(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#1)(2011-2#1)
gives rise to##49##3##(1990-11#1)(1991-9#1)(1992-3#2)(1994-8#2)(1995-6#2)(1996-3#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#4)
gives satisfactory##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
gives some##2##2##(1992-2#1)(2008-9#1)
gives the best##2##3##(2008-10#1)(2008-2#1)
gives the highest##2##3##(2008-10#2)
gives the minimum error##2##4##(2008-3#2)
gives the minimum##3##3##(2008-2#1)(2008-3#2)
gives the possibility##2##3##(2007-11#1)(2008-10#1)
gives the potential for##2##4##(2008-3#2)
gives the results##2##3##(1995-2#1)(2008-10#1)
gives the same results as##2##5##(2008-11#1)(2008-2#1)
gives the same##4##3##(1994-9#1)(1996-5#1)(2008-11#1)(2008-2#1)
gives the##42##2##(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#5)(2008-3#7)(2008-6#2)(2009-8#1)(2010-4#1)
gives us a##2##3##(1997-1#1)(2008-11#1)
gives very good results##2##4##(1996-11#1)(2011-3#1)
gives##332##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-11#12)(2007-12#10)(2007-6#1)(2007-8#5)(2008-1#1)(2008-10#81)(2008-11#13)(2008-12#2)(2008-2#17)(2008-3#33)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#5)(2008-9#10)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#5)(2013-8#5)
giving a signal equal to three##4##6##(2008-10#4)
giving a##28##2##(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2010-1#1)(2010-11#1)(2012-12#1)
giving an##8##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-11#1)(2012-1#1)
giving birth during the##2##4##(2011-1#2)
giving birth##6##2##(1990-6#1)(2009-10#1)(2010-12#2)(2011-1#2)
giving excellent##2##2##(2008-7#1)(2011-2#1)
giving feedback##2##2##(2012-3#2)
giving good results##2##3##(2008-10#2)
giving it##2##2##(2009-7#1)(2012-12#1)
giving low##2##2##(1993-11#1)(2008-10#1)
giving new##2##2##(2008-10#1)(2008-3#1)
giving rise to a new##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
giving rise to a##7##4##(2007-11#1)(2008-10#4)(2008-2#1)(2009-4#1)
giving rise to an##2##4##(1990-11#1)(2008-12#1)
giving rise to new##2##4##(2009-12#1)(2009-8#1)
giving rise to the##5##4##(1995-11#1)(1997-8#1)(2008-11#1)(2010-2#1)(2012-12#1)
giving rise to##37##3##(1990-11#1)(1991-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
giving the##23##2##(1990-5#1)(1992-11#1)(1992-4#1)(1995-2#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)
giving to the##2##3##(1992-1#1)(2009-4#1)
giving travel##2##2##(2007-2#2)
giving up##2##2##(1990-10#1)(2010-2#1)
giving us a##2##3##(2008-11#1)(2012-2#1)
giving values##2##2##(2007-11#1)(2008-10#1)
giving##205##1##(1990-10#1)(1990-11#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#6)(1996-9#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#5)(2007-12#4)(2007-2#6)(2007-7#1)(2008-1#3)(2008-10#42)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
gizzard actin [(beta)##2##3##(1990-5#2)
gizzard##12##1##(1990-5#2)(1991-2#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#4)(2008-12#1)
gl(-1)##3##1##(2008-10#3)
glaA##4##1##(2008-8#1)(2008-9#3)
glabellar frowns##3##2##(2008-5#3)
glabellar##5##1##(2008-5#5)
glaberrima##2##1##(2009-10#2)
glabra##4##1##(2008-10#3)(2008-5#1)
glabrata and##2##2##(2008-10#1)(2008-5#1)
glabrata isolates##3##2##(2008-5#3)
glabrata snail and##2##3##(2008-12#2)
glabrata were##3##2##(1993-6#1)(2008-12#1)(2008-5#1)
glabrata##24##1##(1993-6#4)(2008-10#3)(2008-11#2)(2008-12#5)(2008-5#10)
glabrescens Boiss##2##2##(2008-11#2)
glabripennis and A##2##3##(2013-8#2)
glabripennis##4##1##(2013-8#4)
glacial acetic acid##5##3##(1994-3#1)(2008-10#3)(2011-1#1)
glacial##6##1##(1994-3#1)(2008-10#3)(2008-9#1)(2011-1#1)
gladioli##4##1##(2008-10#4)
glance##10##1##(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-11#1)(2009-6#1)(2012-1#1)(2013-8#1)
gland ACC##2##2##(1991-6#1)(2013-8#1)
gland adenoma##2##2##(1990-3#1)(2013-8#1)
gland and kidney##2##3##(1991-2#1)(2008-9#1)
gland and the##4##3##(2008-10#1)(2008-4#1)(2012-3#1)(2013-7#1)
gland and##29##2##(1990-11#1)(1990-5#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-5#2)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
gland are##6##2##(1991-6#1)(2007-12#1)(2008-6#1)(2012-2#2)(2013-1#1)
gland as##2##2##(1993-11#1)(2009-12#1)
gland at##4##2##(1997-6#1)(2008-7#2)(2011-2#1)
gland by##4##2##(1995-11#1)(1995-3#1)(2008-5#1)(2009-12#1)
gland carcinoma##2##2##(2012-3#1)(2013-1#1)
gland cell##5##2##(2007-12#4)(2008-9#1)
gland cells and##2##3##(2008-7#1)(2013-8#1)
gland cells##17##2##(1990-5#1)(2007-12#5)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-1#1)(2013-8#1)
gland development and##2##3##(2008-5#2)
gland development##3##2##(2008-5#2)(2011-1#1)
gland diseases##3##2##(2013-1#3)
gland during##2##2##(2011-1#1)(2012-1#1)
gland follicular cell hypertrophy##2##4##(2008-9#2)
gland from##2##2##(1993-5#1)(2012-12#1)
gland growth##2##2##(1995-11#1)(2007-12#1)
gland has##2##2##(2008-6#1)(2012-1#1)
gland in a##2##3##(1997-5#1)(2008-6#1)
gland in the##5##3##(1990-5#2)(1994-5#1)(2007-12#1)(2012-12#1)
gland in##11##2##(1990-5#2)(1994-5#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#1)
gland is a##2##3##(2007-5#1)(2013-1#1)
gland is the##2##3##(1994-7#1)(2008-11#1)
gland is##12##2##(1993-3#1)(1994-7#1)(1996-11#1)(2007-12#2)(2007-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-2#1)(2013-1#1)
gland of the##12##3##(1990-5#1)(1997-2#1)(2007-12#3)(2008-4#3)(2008-6#1)(2008-8#1)(2013-1#2)
gland of##23##2##(1990-5#1)(1992-3#1)(1994-5#1)(1995-11#1)(1997-2#1)(2007-12#4)(2008-11#4)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2013-1#2)
gland origin##2##2##(1991-6#1)(2011-2#1)
gland secretion##4##2##(2007-12#3)(2008-7#1)
gland showed##2##2##(1993-3#1)(2012-1#1)
gland structure##2##2##(2009-10#2)
gland that##3##2##(1990-5#1)(2009-12#1)(2009-3#1)
gland tumorigenesis##2##2##(1992-9#1)(1994-7#1)
gland tumors##2##2##(1993-9#1)(2007-5#1)
gland tumours##6##2##(2012-2#6)
gland using##2##2##(1992-6#1)(1996-12#1)
gland was##8##2##(1992-3#1)(2007-12#1)(2008-12#2)(2008-5#1)(2011-1#3)
gland were##5##2##(2008-5#2)(2008-7#1)(2009-12#1)(2012-3#1)
gland with##2##2##(2011-1#1)(2013-1#1)
gland##384##1##(1990-11#4)(1990-12#2)(1990-3#2)(1990-5#10)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#6)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#6)(1992-4#1)(1992-6#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#9)(1993-5#3)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#2)(1994-5#9)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#9)(1995-12#4)(1995-3#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#3)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#37)(2007-5#4)(2008-1#2)(2008-10#15)(2008-11#11)(2008-12#10)(2008-4#8)(2008-5#18)(2008-6#10)(2008-7#16)(2008-8#9)(2008-9#18)(2009-1#1)(2009-10#2)(2009-12#7)(2009-3#3)(2011-1#10)(2011-2#17)(2012-1#8)(2012-12#2)(2012-2#13)(2012-3#8)(2013-1#17)(2013-7#3)(2013-8#12)
gland)##2##1##(2008-4#1)(2009-3#1)
glands after##2##2##(2007-12#1)(2008-10#1)
glands and the##3##3##(1992-5#1)(2007-12#1)(2011-2#1)
glands and##14##2##(1992-5#1)(1994-7#1)(1994-9#1)(2007-12#3)(2008-10#3)(2008-5#1)(2011-2#3)(2012-3#1)
glands are##8##2##(1995-11#1)(2007-12#5)(2008-7#1)(2013-8#1)
glands in the##6##3##(2007-12#4)(2008-7#1)(2009-7#1)
glands in##19##2##(1994-2#1)(1996-6#1)(1997-1#1)(2007-12#10)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2013-1#1)
glands is a##2##3##(2008-4#1)(2009-3#1)
glands is##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#1)
glands of Cercaria baushii 6 (Xiphidiocercariae##2##6##(2013-1#2)
glands of males##2##3##(2007-12#1)(2008-10#1)
glands of the##5##3##(1991-11#1)(1995-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
glands of##34##2##(1990-11#4)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#2)(1992-12#1)(1993-12#1)(1995-12#1)(2007-12#9)(2008-10#6)(2008-4#1)(2008-8#2)(2011-2#1)(2013-1#3)
glands that##4##2##(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
glands to##3##2##(2008-6#1)(2012-12#2)
glands tumors##2##2##(1990-6#1)(2011-2#1)
glands was##4##2##(1993-3#1)(2007-7#1)(2011-2#1)(2013-1#1)
glands were##8##2##(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)
glands with##5##2##(1995-11#1)(1997-6#1)(2007-12#1)(2011-2#2)
glands##221##1##(1990-11#5)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#4)(1990-9#2)(1991-11#2)(1991-12#3)(1991-6#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-7#5)(1994-9#1)(1995-11#5)(1995-12#4)(1996-1#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-12#42)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#27)(2008-11#4)(2008-4#5)(2008-5#13)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#1)(2009-2#2)(2009-3#3)(2009-7#2)(2009-8#2)(2010-12#1)(2011-1#5)(2011-2#19)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
glandular and##4##2##(1993-11#1)(2007-12#2)(2012-1#1)
glandular epithelium##6##2##(1990-12#1)(1995-6#1)(2007-12#4)
glandular restructuring##2##2##(2008-5#2)
glandular tissues##2##2##(2008-4#2)
glandular trichomes of##2##3##(1997-6#2)
glandular units##2##2##(2007-12#2)
glandular##44##1##(1990-12#1)(1990-2#1)(1992-12#1)(1993-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-6#2)(2007-12#13)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#2)(2009-3#1)(2011-2#5)(2012-1#1)(2012-3#1)
glans penis##5##2##(2007-10#1)(2007-7#3)(2007-8#1)
glans##8##1##(1991-2#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#2)
glanular##2##1##(2008-10#2)
glare##13##1##(1991-8#1)(2007-11#1)(2008-2#4)(2008-3#7)
glass (CPG)##3##2##(2008-10#3)
glass and polyimide##2##3##(2009-7#2)
glass and polypropylene##2##3##(2008-4#2)
glass and##26##2##(2007-12#4)(2008-10#9)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2009-4#1)(2009-7#4)
glass are##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2009-7#1)
glass as a##4##3##(2007-12#1)(2008-3#2)(2009-7#1)
glass as an##2##3##(2008-10#1)(2008-3#1)
glass as##8##2##(2007-12#1)(2008-10#3)(2008-3#3)(2009-7#1)
glass base substrate and##2##4##(2010-2#2)
glass beads and##2##3##(2008-2#1)(2008-5#1)
glass beads with##2##3##(2008-10#1)(2009-5#1)
glass beads##15##2##(2008-10#8)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)
glass by focused##2##3##(2007-11#1)(2008-3#1)
glass by poling with ArF-laser excitation##2##6##(2007-12#2)
glass by use of##2##4##(2008-2#1)(2008-3#1)
glass by##13##2##(1991-5#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2009-7#1)
glass capillary##7##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)
glass cell##2##2##(2008-10#2)
glass ceramic##3##2##(2008-3#2)(2013-8#1)
glass ceramics##2##2##(2007-11#2)
glass containers##3##2##(2008-10#3)
glass electrode calibration##2##3##(2008-10#2)
glass electrode##24##2##(2008-10#24)
glass electrodes##6##2##(2008-10#6)
glass electrophoresis##2##2##(2008-10#2)
glass extraction##2##2##(2008-10#2)
glass fiber and##2##3##(2007-11#2)
glass fiber filter##4##3##(2007-5#1)(2008-10#3)
glass fiber filters##4##3##(2008-10#4)
glass fiber laser##3##3##(1997-6#1)(2007-12#2)
glass fiber##17##2##(1997-6#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#7)(2008-3#2)
glass fibers for##2##3##(2008-3#2)
glass fibers##16##2##(2007-12#2)(2008-2#1)(2008-3#8)(2009-7#5)
glass formation##2##2##(1995-3#2)
glass fragments##6##2##(2008-10#6)
glass have##2##2##(2007-12#1)(2008-3#1)
glass in a##2##3##(2007-12#1)(2008-10#1)
glass ionomer cement and##2##4##(2010-3#1)(2013-1#1)
glass ionomer cement##5##3##(2008-12#2)(2010-3#1)(2013-1#2)
glass ionomer cements##2##3##(2008-10#1)(2012-2#1)
glass ionomer##9##2##(1990-2#1)(2008-10#1)(2008-12#2)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#2)
glass irradiated by an electron beam##2##6##(2007-12#2)
glass is##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
glass laser system##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
glass laser with##2##3##(2007-12#1)(2008-3#1)
glass laser##11##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#5)
glass lasers##4##2##(2008-3#4)
glass layers##2##2##(2008-3#2)
glass material by##2##3##(2008-2#1)(2008-3#1)
glass material##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
glass matrix##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)
glass membrane##3##2##(2008-10#3)
glass microchip laser##3##3##(2007-11#2)(2007-12#1)
glass microchip##5##2##(2007-11#2)(2007-12#1)(2008-10#2)
glass microscope slides##2##3##(2008-4#1)(2009-12#1)
glass of##2##2##(2008-10#1)(2008-5#1)
glass particles##4##2##(2008-3#1)(2008-5#2)(2008-7#1)
glass plate is##2##3##(2008-2#1)(2008-3#1)
glass plate was##2##3##(2007-11#1)(2008-2#1)
glass plate##13##2##(2007-11#2)(2008-10#3)(2008-2#4)(2008-3#4)
glass plates##9##2##(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#5)
glass rod##3##2##(2008-2#3)
glass sample##6##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)
glass samples##6##2##(2007-12#1)(2008-10#3)(2008-3#2)
glass slide##6##2##(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#1)
glass slides##10##2##(1996-12#1)(2008-10#5)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
glass specimens##2##2##(2008-10#2)
glass structure##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
glass substrate##9##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-4#1)
glass substrates and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
glass substrates were##2##3##(2007-11#1)(2008-10#1)
glass substrates##19##2##(2007-11#4)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#6)(2009-5#1)(2010-12#1)
glass surface##5##2##(1991-5#2)(2008-10#1)(2008-3#1)(2013-1#1)
glass surfaces##7##2##(2007-12#1)(2008-10#6)
glass to##3##2##(2007-12#1)(2008-10#2)
glass transition temperature of the polymer##2##6##(2008-3#1)(2010-5#1)
glass transition temperature of the##4##5##(2008-3#3)(2010-5#1)
glass transition temperature##8##3##(1995-3#2)(2008-3#4)(2010-4#1)(2010-5#1)
glass transition temperatures (T(g))##2##4##(2008-9#1)(2009-7#1)
glass transition temperatures##4##3##(1995-3#1)(2008-9#1)(2009-7#1)(2010-4#1)
glass transition##17##2##(1995-3#5)(2008-2#1)(2008-3#4)(2008-9#1)(2009-7#1)(2010-4#2)(2010-5#1)(2012-2#2)
glass tube##7##2##(2008-10#5)(2008-2#2)
glass tubes##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
glass wafer##2##2##(2008-10#1)(2009-7#1)
glass was found to##2##4##(2008-2#1)(2008-3#1)
glass was used##2##3##(2008-10#1)(2008-3#1)
glass was##13##2##(1990-8#1)(1991-5#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)
glass waveguide gratings##3##3##(2008-3#3)
glass waveguide laser##3##3##(2008-3#3)
glass waveguide##8##2##(2007-11#1)(2008-3#7)
glass waveguides##7##2##(2007-11#1)(2008-2#4)(2008-3#2)
glass were##6##2##(2007-12#2)(2008-10#2)(2008-2#1)(2009-4#1)
glass window##2##2##(2008-2#1)(2009-7#1)
glass with a##2##3##(2007-11#1)(2008-3#1)
glass with##7##2##(2007-11#4)(2007-12#2)(2008-3#1)
glass wool##2##2##(2008-10#1)(2013-1#1)
glass##615##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#7)(1992-8#1)(1995-12#1)(1995-3#10)(1996-12#1)(1997-6#1)(2007-11#42)(2007-12#73)(2007-5#2)(2008-10#207)(2008-11#2)(2008-12#4)(2008-2#49)(2008-3#121)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#4)(2009-7#24)(2009-8#5)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#2)
glass)##3##1##(2008-10#1)(2008-2#1)(2009-11#1)
glass-ceramic fiber laser and##2##4##(2007-11#2)
glass-ceramic materials##2##2##(2007-11#1)(2009-7#1)
glass-ceramic##9##1##(2007-11#3)(2008-10#2)(2008-8#1)(2009-7#3)
glass-ceramics##6##1##(2009-7#6)
glass-forming##3##1##(1995-3#2)(2008-10#1)
glass-infiltrated##3##1##(2009-8#3)
glass-ionomer powder##2##2##(2009-7#2)
glass-ionomer restorative material##3##3##(2009-7#3)
glass-ionomer##8##1##(2009-7#7)(2013-1#1)
glasses and silicas##2##3##(1990-8#2)
glasses and##4##2##(1990-8#2)(2008-10#1)(2012-2#1)
glasses are##2##2##(1991-6#1)(2008-3#1)
glasses by##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
glasses in the spectral range from 2##2##7##(2007-12#2)
glasses in the##3##3##(1991-5#1)(2007-12#2)
glasses is##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
glasses was##2##2##(2007-12#1)(2008-10#1)
glasses were##2##2##(2008-2#1)(2008-5#1)
glasses with##3##2##(2007-12#1)(2008-2#2)
glasses##88##1##(1990-8#3)(1991-1#1)(1991-5#1)(1991-6#2)(1993-11#1)(1993-9#1)(1995-3#6)(2007-11#10)(2007-12#23)(2008-10#6)(2008-12#1)(2008-2#9)(2008-3#19)(2008-5#1)(2010-8#2)(2011-7#1)(2012-2#1)
glasshouse##9##1##(2008-10#9)
glasshouse-grown##2##1##(2008-10#2)
glassware and##2##2##(2008-10#2)
glassware##4##1##(2008-10#4)
glassy carbon (GC) electrode was##2##5##(2008-10#2)
glassy carbon (GC) electrode##8##4##(2008-10#8)
glassy carbon (GC)##12##3##(2008-10#12)
glassy carbon and##4##3##(2008-10#4)
glassy carbon disk electrode##2##4##(2008-10#2)
glassy carbon disk##3##3##(2008-10#3)
glassy carbon electrode (GCE) and##2##5##(2008-10#2)
glassy carbon electrode (GCE)##14##4##(2008-10#14)
glassy carbon electrode and##5##4##(2008-10#4)(2013-1#1)
glassy carbon electrode by##4##4##(2008-10#4)
glassy carbon electrode in the presence of##2##7##(2008-10#2)
glassy carbon electrode in the presence##3##6##(2008-10#3)
glassy carbon electrode in##5##4##(2008-10#5)
glassy carbon electrode is##3##4##(1990-12#1)(2008-10#2)
glassy carbon electrode modified by##2##5##(2008-10#2)
glassy carbon electrode modified with##6##5##(2008-10#6)
glassy carbon electrode modified##8##4##(2008-10#8)
glassy carbon electrode surface at##3##5##(2008-10#3)
glassy carbon electrode surface##7##4##(2008-10#7)
glassy carbon electrode using cyclic##2##5##(2008-10#2)
glassy carbon electrode was##5##4##(2008-10#5)
glassy carbon electrode were##2##4##(2008-10#2)
glassy carbon electrode##110##3##(1990-12#1)(1995-6#1)(2008-10#107)(2013-1#1)
glassy carbon electrodes modified with##3##5##(2008-10#3)
glassy carbon electrodes##13##3##(2008-10#12)(2013-1#1)
glassy carbon##155##2##(1990-12#1)(1995-6#1)(2008-10#151)(2013-1#2)
glassy polymer##2##2##(1995-3#1)(2010-4#1)
glassy wax tests##2##3##(2007-12#2)
glassy##165##1##(1990-12#1)(1995-3#2)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#154)(2010-4#2)(2013-1#2)
glatiramer acetate##2##2##(2010-12#1)(2012-3#1)
glauca##3##1##(2008-10#1)(2008-11#1)(2010-2#1)
glaucoma and##6##2##(2010-8#1)(2011-1#3)(2011-2#2)
glaucoma associated with##2##3##(2011-1#1)(2011-2#1)
glaucoma in##10##2##(1991-6#1)(1996-10#1)(1997-3#1)(2008-7#2)(2010-8#1)(2011-2#3)(2012-2#1)
glaucoma is##2##2##(2011-1#1)(2011-2#1)
glaucoma patients##4##2##(2009-9#1)(2011-2#3)
glaucoma progression##2##2##(2011-7#2)
glaucoma##67##1##(1990-11#3)(1991-6#2)(1996-10#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-7#3)(2009-3#1)(2009-9#1)(2010-8#4)(2011-1#12)(2011-2#29)(2011-7#3)(2012-2#1)(2013-1#1)
glaucomas##2##1##(2011-2#2)
glaucomatous damage##2##2##(2011-7#2)
glaucomatous##3##1##(2011-2#1)(2011-7#2)
glaze##2##1##(2008-10#2)
glazed##3##1##(2008-10#3)
glazes##4##1##(2008-10#4)
gld##2##1##(1997-8#2)
gleaned from##6##2##(1996-3#1)(2007-6#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-2#1)
gleaner##2##1##(2008-8#2)
glenohumeral##2##1##(2007-11#1)(2008-7#1)
glenoid fossa##2##2##(2011-2#2)
glenoid##5##1##(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#2)
glia and neurons##4##3##(2008-2#1)(2008-5#1)(2008-7#2)
glia and##6##2##(1995-5#1)(1996-5#1)(2008-2#1)(2008-5#1)(2008-7#2)
glia are##4##2##(1996-5#1)(2008-7#3)
glia at##2##2##(2008-7#1)(2009-11#1)
glia cells##2##2##(2008-7#1)(2008-8#1)
glia in the##2##3##(2008-7#2)
glia in##4##2##(1995-12#1)(2008-7#3)
glia signaling is##2##3##(2008-5#1)(2008-7#1)
glia that do not##2##4##(2008-7#1)(2009-8#1)
glia##44##1##(1995-12#2)(1995-5#1)(1996-5#2)(2007-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#28)(2008-8#1)(2009-11#1)(2009-8#2)(2009-9#1)(2013-7#1)
gliadin##4##1##(1991-11#1)(1991-12#1)(1992-12#2)
glial amino acid transporters##3##4##(2008-7#3)
glial and neuronal immunoreactivity in##2##5##(1991-6#1)(1996-6#1)
glial antioxidant network##2##3##(2008-2#2)
glial cell development##2##3##(2008-7#1)(2009-3#1)
glial cell line-derived neurotrophic factor (GDNF)##3##6##(1995-12#1)(1996-5#1)(2012-2#1)
glial cell migration##4##3##(2008-7#4)
glial cell##16##2##(1990-7#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-8#3)(2012-2#1)
glial cells and##3##3##(1996-6#1)(2008-12#1)(2013-8#1)
glial cells are##4##3##(1994-11#1)(2008-11#1)(2008-7#2)
glial cells in the brain##2##5##(2008-4#1)(2012-2#1)
glial cells in the##7##4##(1994-2#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-3#1)(2012-2#1)
glial cells in##11##3##(1994-2#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-3#1)(2012-2#1)
glial cells of the central and peripheral nervous system##2##9##(2008-7#2)
glial cells of the central##3##5##(2008-2#1)(2008-7#2)
glial cells of the##6##4##(1990-7#1)(2008-2#1)(2008-7#4)
glial cells were##3##3##(1994-11#1)(1996-5#2)
glial cells##61##2##(1990-11#1)(1990-7#5)(1993-12#2)(1994-11#3)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-5#2)(1996-6#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#19)(2008-8#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
glial development##2##2##(2008-7#1)(2009-3#1)
glial fibrillary acidic protein (GFAP)##6##5##(1990-7#1)(1994-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#1)
glial fibrillary acidic protein##11##4##(1990-7#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-7#2)(2009-1#1)
glial neoplasms##2##2##(2008-9#1)(2012-2#1)
glial precursors##2##2##(2008-7#2)
glial processes##2##2##(2008-7#2)
glial system##2##2##(2008-7#2)
glial##140##1##(1990-11#1)(1990-7#7)(1991-6#2)(1993-12#2)(1993-6#1)(1994-11#3)(1994-2#3)(1994-6#1)(1995-12#4)(1995-2#3)(1995-5#4)(1996-5#6)(1996-6#3)(1997-2#3)(1997-3#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#4)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#51)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#3)(2009-8#3)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
glial-precursor##2##1##(2008-7#1)(2013-1#1)
glibenclamide uptake was##2##3##(1992-3#2)
glibenclamide uptake##4##2##(1992-3#4)
glibenclamide was not##2##3##(1992-3#2)
glibenclamide was##3##2##(1992-3#3)
glibenclamide##25##1##(1992-3#13)(1994-11#1)(1994-8#7)(1996-9#2)(1997-7#1)(2008-8#1)
gliding##3##1##(2008-11#1)(2008-9#1)(2013-1#1)
glimepiride and glibenclamide##4##3##(1994-8#4)
glimepiride##8##1##(1994-8#6)(2011-1#2)
glimepride##12##1##(1994-8#1)(2011-1#11)
glimpse into the##4##3##(2008-1#1)(2010-12#1)(2010-3#2)
glimpse into##5##2##(2008-1#1)(2008-2#1)(2010-12#1)(2010-3#2)
glimpse of the##2##3##(1994-12#1)(1994-3#1)
glimpse of##3##2##(1994-12#1)(1994-3#1)(1995-6#1)
glimpse##9##1##(1994-12#1)(1994-3#1)(1995-6#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-3#2)
glint##12##1##(2008-3#12)
glioblastoma cell lines##3##3##(1990-6#3)
glioblastoma cells in brain##2##4##(2008-7#2)
glioblastoma cells##6##2##(2008-7#4)(2013-1#2)
glioblastoma in a##2##3##(2012-3#1)(2013-1#1)
glioblastoma in##4##2##(2011-2#2)(2012-3#1)(2013-1#1)
glioblastoma multiforme##9##2##(1994-2#1)(1995-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#2)(2011-3#1)
glioblastoma##46##1##(1990-6#3)(1994-2#1)(1995-12#1)(1995-9#2)(2008-11#2)(2008-12#1)(2008-7#9)(2009-1#1)(2010-4#1)(2011-2#11)(2011-3#2)(2012-3#6)(2013-1#6)
glioblastomas##7##1##(1993-3#1)(1995-12#2)(1996-5#2)(1997-7#1)(2013-1#1)
glioblastomatous##3##1##(2009-1#3)
glioma C6 cells##2##3##(2008-4#2)
glioma and##2##2##(1994-3#1)(2008-11#1)
glioma cell line##7##3##(1991-12#1)(1992-9#1)(1994-11#4)(1997-7#1)
glioma cell lines##3##3##(1992-6#2)(1995-2#1)
glioma cell##13##2##(1991-12#1)(1992-6#3)(1992-9#1)(1994-11#4)(1995-2#1)(1997-7#1)(2011-2#1)(2013-1#1)
glioma cells##11##2##(1992-6#1)(1992-9#1)(1993-3#2)(1994-11#1)(1995-12#1)(1995-2#1)(1997-7#2)(2008-4#1)(2012-2#1)
glioma patients##2##2##(2011-2#2)
glioma##80##1##(1991-12#1)(1992-6#4)(1992-9#2)(1993-3#2)(1993-9#1)(1994-11#12)(1994-3#2)(1995-12#1)(1995-2#4)(1995-9#2)(1997-7#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#2)(2011-2#9)(2012-12#3)(2012-2#1)(2013-1#11)(2013-8#2)
gliomas and##2##2##(2008-12#1)(2013-1#1)
gliomas are the most##2##4##(2013-1#2)
gliomas are##3##2##(2013-1#2)(2013-8#1)
gliomas in##2##2##(2008-9#1)(2012-2#1)
gliomas##29##1##(1993-9#1)(1994-6#1)(1995-2#1)(1995-9#1)(1997-7#1)(2008-12#4)(2008-5#1)(2008-7#7)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#2)
gliosis and##2##2##(1996-12#1)(2008-7#1)
gliosis##14##1##(1990-7#1)(1995-5#1)(1996-12#1)(1996-5#3)(2007-10#2)(2008-4#1)(2008-7#4)(2013-7#1)
glisoxepide and glibenclamide##2##3##(1992-3#2)
glisoxepide and##3##2##(1992-3#3)
glisoxepide##11##1##(1992-3#11)
glistening##5##1##(2008-2#5)
glnA##4##1##(1992-12#4)
global AIDS##2##2##(1990-12#2)
global UV##2##2##(2008-2#1)(2008-3#1)
global agenda##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
global analysis and distribution analysis##2##5##(2008-10#2)
global analysis of##4##3##(2008-7#2)(2008-9#1)(2010-5#1)
global analysis##8##2##(1994-11#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)
global and local##6##3##(1996-5#3)(2007-11#1)(2008-5#1)(2011-1#1)
global and regional##3##3##(2008-3#1)(2012-2#1)(2013-3#1)
global and specific memory strength##2##5##(2009-8#2)
global and##17##2##(1996-5#3)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-3#1)
global approach to##4##3##(1996-3#1)(2007-11#2)(2007-6#1)
global approach##6##2##(1996-3#1)(1996-4#1)(2007-11#2)(2007-6#1)(2008-8#1)
global assessment of dry##2##4##(2006-10#2)
global assessment of##4##3##(2006-10#2)(2008-7#2)
global assessment##6##2##(2006-10#2)(2007-12#1)(2008-7#2)(2013-1#1)
global biogeochemical##2##2##(2011-2#1)(2012-3#1)
global budget##6##2##(1993-3#1)(1994-12#1)(1995-2#1)(2008-11#3)
global budgeting##13##2##(1992-1#1)(1993-1#3)(1993-2#2)(1994-1#1)(1994-2#5)(1996-12#1)
global budgets##9##2##(1991-12#1)(1994-1#2)(1994-12#2)(2008-11#4)
global changes in##3##3##(2008-4#1)(2008-7#1)(2009-9#1)
global changes##4##2##(2008-4#2)(2008-7#1)(2009-9#1)
global climate change##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
global clinical##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
global cognitive efficiency##2##3##(2013-1#2)
global collaboration##3##2##(2007-7#1)(2008-9#1)(2010-12#1)
global conformational##2##2##(1990-8#1)(1994-5#1)
global data##2##2##(2008-3#1)(2012-7#1)
global distribution of##5##3##(2008-10#2)(2008-2#1)(2009-8#1)(2012-12#1)
global distribution##6##2##(2008-10#2)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#1)
global economic##2##2##(1993-12#1)(2013-1#1)
global elimination##3##2##(2008-1#2)(2008-4#1)
global energy##2##2##(2008-2#1)(2013-1#1)
global environment##2##2##(2010-7#1)(2012-7#1)
global environmental##3##2##(2010-1#1)(2011-1#2)
global estimates of##2##3##(2008-12#1)(2013-3#1)
global evaluation of efficacy##2##4##(1990-9#2)
global evaluation of##3##3##(1990-6#1)(1990-9#2)
global extinction##2##2##(1997-5#1)(2008-8#1)
global fold of##2##3##(1992-8#1)(1994-5#1)
global functioning##3##2##(2010-6#1)(2011-2#1)(2012-3#1)
global gene expression in##2##4##(2008-7#1)(2009-12#1)
global gene expression profiling##2##4##(2008-11#1)(2008-7#1)
global gene expression##8##3##(2008-11#1)(2008-7#3)(2009-12#1)(2010-4#1)(2011-2#2)
global gene##10##2##(2008-10#1)(2008-11#1)(2008-7#3)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#2)
global genetic##2##2##(2008-10#2)
global health problem##4##3##(2008-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
global health problems##2##3##(2011-1#1)(2012-3#1)
global health##20##2##(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-6#2)(2011-1#4)(2011-3#1)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#1)
global heterozygosity##2##2##(2009-2#2)
global impact of##2##3##(1991-12#1)(2008-11#1)
global improvement index##2##3##(2010-8#2)
global information##2##2##(2007-2#1)(2010-8#1)
global interconnection##2##2##(2008-2#1)(2008-3#1)
global irradiance##2##2##(2008-3#2)
global irradiances##3##2##(2008-2#1)(2008-3#2)
global ischemia##2##2##(1996-5#1)(1996-9#1)
global level of##2##3##(2009-10#1)(2011-2#1)
global level##7##2##(2007-12#1)(2008-10#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
global longitudinal##2##2##(2013-7#2)
global market##2##2##(2008-10#1)(2011-1#1)
global markets##2##2##(2007-5#1)(2008-5#1)
global mortality##3##2##(1993-9#1)(2011-1#1)(2012-12#1)
global network##2##2##(1995-6#1)(2009-4#1)
global objects##3##2##(2008-9#3)
global optical##2##2##(2008-2#1)(2008-3#1)
global optimisation##2##2##(2008-10#2)
global optimization##2##2##(2007-12#1)(2007-9#1)
global ozone monitoring##2##3##(2008-2#1)(2008-3#1)
global ozone##3##2##(2008-2#2)(2008-3#1)
global pain##2##2##(2008-7#2)
global pattern##2##2##(2010-6#1)(2012-1#1)
global patterns##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
global perspective##6##2##(1993-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
global physical and general##2##4##(2009-7#2)
global population##4##2##(2007-12#1)(2008-8#2)(2011-1#1)
global positioning system (GPS)##2##4##(2008-8#1)(2011-2#1)
global positioning system##5##3##(2008-10#1)(2008-8#2)(2009-10#1)(2011-2#1)
global positioning##6##2##(2008-10#2)(2008-8#2)(2009-10#1)(2011-2#1)
global primary##2##2##(2009-6#1)(2012-2#1)
global problem##2##2##(2010-12#1)(2011-1#1)
global proteome##2##2##(2008-4#1)(2010-7#1)
global public health##6##3##(2008-1#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-8#1)
global rating and##2##3##(1996-7#1)(2008-10#1)
global regulator H-NS of Escherichia coli##2##6##(2011-1#2)
global regulator##3##2##(1995-8#1)(2011-1#2)
global resonance##2##2##(2007-9#2)
global responses##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
global scale##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
global scouting##2##2##(2011-2#2)
global search##2##2##(2007-9#2)
global solar##4##2##(2008-2#2)(2008-3#1)(2010-1#1)
global stability constant##2##3##(2008-10#2)
global stability##3##2##(1997-2#1)(2008-10#2)
global trade##3##2##(1996-12#1)(2007-5#2)
global trend##2##2##(2008-10#1)(2010-8#1)
global unfolding##2##2##(1997-2#2)
global value##2##2##(2008-9#2)
global view of gene##2##4##(2010-1#1)(2010-5#1)
global view of##5##3##(2008-2#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-5#1)
global warming potentials##2##3##(1992-3#2)
global warming##12##2##(1992-3#3)(1996-1#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-5#2)(2012-6#1)(2012-8#1)
global world##2##2##(2008-11#1)(2008-3#1)
global##569##1##(1990-11#1)(1990-12#3)(1990-6#1)(1990-8#3)(1990-9#3)(1991-12#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#9)(1996-7#2)(1996-9#3)(1997-2#6)(1997-3#1)(1997-5#1)(1997-7#2)(2006-10#3)(2006-6#1)(2007-11#8)(2007-12#6)(2007-2#3)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#5)(2008-1#5)(2008-10#51)(2008-11#25)(2008-12#8)(2008-2#20)(2008-3#34)(2008-4#13)(2008-5#7)(2008-6#6)(2008-7#30)(2008-8#18)(2008-9#16)(2009-10#4)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#7)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#5)(2010-12#11)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#23)(2011-2#31)(2011-3#2)(2012-1#4)(2012-12#14)(2012-2#10)(2012-3#5)(2012-5#2)(2012-6#1)(2012-7#3)(2012-8#1)(2013-1#15)(2013-3#2)(2013-7#6)(2013-8#8)
global-local task##2##2##(2008-11#2)
global/local##3##1##(1996-5#3)
globalisation##2##1##(2008-12#2)
globalization and##3##2##(2009-8#1)(2011-1#1)(2013-1#1)
globalization of the##2##3##(2007-12#1)(2008-11#1)
globalization of##6##2##(1996-12#2)(2007-12#1)(2008-11#1)(2008-7#2)
globalization##13##1##(1996-12#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-8#2)(2011-1#2)(2013-1#1)
globalized##2##1##(2011-1#1)(2013-1#1)
globally and##2##2##(2008-10#1)(2009-9#1)
globally distributed##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
globally##42##1##(1990-7#1)(1990-8#1)(1994-3#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
globe is##2##2##(2008-7#1)(2011-2#1)
globe##15##1##(1990-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
globin chains##2##2##(1990-8#1)(2008-10#1)
globin expression##2##2##(1994-8#1)(2008-8#1)
globin gene##8##2##(1990-8#1)(1991-5#3)(2008-8#2)(2008-9#2)
globin##25##1##(1990-8#4)(1991-5#4)(1994-8#2)(1995-3#1)(2008-10#2)(2008-11#2)(2008-8#5)(2008-9#2)(2009-4#1)(2012-12#2)
globisporus C1027##2##2##(2008-9#2)
globosa was##2##2##(2008-5#2)
globosa##5##1##(2008-5#5)
globose##3##1##(2008-10#3)
globosum and##2##2##(2008-5#1)(2013-1#1)
globosum##6##1##(2008-5#1)(2013-1#5)
globotriaosylceramide (Gb3)##2##2##(2011-1#1)(2013-1#1)
globular domain##3##2##(1997-4#3)
globular embryos##2##2##(2008-12#1)(2011-2#1)
globular protein is##2##3##(1997-2#1)(2008-7#1)
globular protein##5##2##(1994-5#1)(1995-5#1)(1997-2#2)(2008-7#1)
globular proteins and##2##3##(2009-5#1)(2011-2#1)
globular proteins##4##2##(1992-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
globular state (diameter about##2##4##(2008-8#2)
globular tetrameric form##2##3##(1995-12#2)
globular##34##1##(1992-5#1)(1994-5#1)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#1)(1997-2#2)(1997-4#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#4)(2008-8#2)(2009-12#2)(2009-5#1)(2009-7#1)(2011-2#4)
globule##13##1##(1993-11#2)(1995-5#1)(1997-4#1)(2008-10#8)(2008-5#1)
globules##4##1##(2008-10#3)(2008-5#1)
globulin (SHBG)##4##2##(1990-11#1)(1990-2#1)(2008-3#1)(2011-2#1)
globulin (TBG)##3##2##(1990-2#3)
globulin and##2##2##(1997-6#1)(2008-10#1)
globulin##32##1##(1990-11#1)(1990-2#6)(1990-3#2)(1990-9#1)(1991-3#3)(1992-12#1)(1994-6#3)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
globulins and##2##2##(2008-12#2)
globulins in##2##2##(1990-2#1)(2008-12#1)
globulins##11##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1997-8#1)(2008-10#1)(2008-12#3)(2008-5#1)(2010-4#1)
globulus and E##3##3##(2008-10#3)
globulus and##4##2##(2008-10#3)(2008-5#1)
globulus##8##1##(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#2)
globus pallidus##6##2##(1992-10#1)(1993-12#1)(1996-12#1)(2008-7#2)(2012-2#1)
globus##8##1##(1992-10#1)(1993-12#1)(1995-5#1)(1996-12#1)(2008-7#2)(2010-12#1)(2012-2#1)
gloeosporioides and##5##2##(2008-10#5)
gloeosporioides from citrus##2##3##(2008-10#2)
gloeosporioides from crowns##2##3##(2008-10#2)
gloeosporioides from##12##2##(2008-10#12)
gloeosporioides isolates from##2##3##(2008-10#2)
gloeosporioides isolates##4##2##(2008-10#4)
gloeosporioides or C##2##3##(2008-10#2)
gloeosporioides pathogenic on red pepper##2##5##(2008-10#2)
gloeosporioides subgroup that##2##3##(2008-10#2)
gloeosporioides were##3##2##(2008-10#3)
gloeosporioides##73##1##(1997-6#1)(2008-10#72)
gloeosporioides-specific primers##2##2##(2008-10#2)
gloeosporioides-specific##3##1##(2008-10#3)
glomerata##5##1##(1996-5#1)(2010-4#4)
glomerular and tubular##2##3##(1993-12#2)
glomerular and##4##2##(1993-12#2)(1997-7#1)(2007-12#1)
glomerular basement membrane##5##3##(1992-12#1)(1993-2#1)(1994-8#1)(2007-7#1)(2008-1#1)
glomerular basement##6##2##(1992-12#1)(1993-2#1)(1994-8#1)(2007-7#1)(2008-1#1)(2012-3#1)
glomerular capillary##3##2##(1996-6#1)(2007-7#1)(2008-1#1)
glomerular disease##11##2##(2007-7#5)(2008-1#5)(2008-8#1)
glomerular diseases##12##2##(2007-7#1)(2008-1#9)(2012-2#2)
glomerular filtration rate (GFR)##4##4##(2008-1#1)(2010-4#1)(2011-2#1)(2012-3#1)
glomerular filtration rate and##4##4##(1995-12#2)(1996-6#2)
glomerular filtration rate##18##3##(1995-12#3)(1996-6#4)(2008-1#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
glomerular filtration##20##2##(1995-12#3)(1996-6#4)(2008-1#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
glomerular lesions##3##2##(1993-2#2)(1997-8#1)
glomerular mesangial cells##4##3##(1993-8#1)(2008-1#1)(2008-4#2)
glomerular permeability##3##2##(1996-6#1)(2008-1#1)(2008-9#1)
glomerular##85##1##(1991-3#1)(1992-12#1)(1993-12#2)(1993-2#4)(1993-8#1)(1994-8#1)(1995-12#3)(1996-6#9)(1997-3#1)(1997-7#2)(1997-8#2)(2007-12#2)(2007-7#8)(2008-1#25)(2008-4#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#7)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
glomeruli##8##1##(1993-2#1)(2007-12#2)(2007-7#1)(2008-9#1)(2009-6#1)(2013-7#2)
glomerulonephritidis##3##1##(2007-7#1)(2008-1#2)
glomerulonephritis (GN) were##2##3##(2008-1#1)(2011-1#1)
glomerulonephritis (GN)##9##2##(1997-8#1)(2007-7#1)(2008-1#5)(2008-10#1)(2011-1#1)
glomerulonephritis (MCGN)##3##2##(1996-6#1)(2008-1#2)
glomerulonephritis (MPGN)##5##2##(2007-7#1)(2008-1#3)(2013-1#1)
glomerulonephritis and amyloidosis##3##3##(1997-5#1)(1997-8#1)(2012-2#1)
glomerulonephritis and##6##2##(1997-5#1)(1997-8#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
glomerulonephritis as##2##2##(1993-2#1)(2007-7#1)
glomerulonephritis in##12##2##(1993-2#1)(2007-7#3)(2007-8#1)(2008-1#7)
glomerulonephritis is##2##2##(1993-2#1)(2007-7#1)
glomerulonephritis was##2##2##(2008-1#1)(2008-4#1)
glomerulonephritis##84##1##(1993-2#8)(1996-3#1)(1996-6#2)(1997-5#1)(1997-8#2)(2007-2#1)(2007-7#23)(2007-8#1)(2008-1#28)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#2)(2013-8#2)
glomerulonephritis]##4##1##(1991-2#1)(1994-3#1)(1996-6#1)(2011-1#1)
glomerulopathies and##2##2##(2013-1#1)(2013-8#1)
glomerulopathies##4##1##(2012-2#2)(2013-1#1)(2013-8#1)
glomerulopathy and##3##2##(2007-7#1)(2008-4#1)(2013-8#1)
glomerulopathy in##2##2##(2008-1#2)
glomerulopathy##15##1##(1992-6#1)(1993-2#1)(1996-6#1)(2007-7#2)(2008-1#5)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#2)
glomerulosa##6##1##(1990-5#1)(1991-12#1)(1996-5#1)(2008-4#3)
glomerulosclerosis##20##1##(1992-8#1)(2007-7#5)(2007-8#1)(2008-1#11)(2012-2#1)(2013-1#1)
glomerulus##3##1##(2007-12#1)(2007-7#1)(2008-1#1)
glomus tumors##7##2##(1997-2#1)(2013-1#6)
glomus##10##1##(1996-5#1)(1996-8#1)(1997-2#1)(2013-1#7)
glory and##2##2##(2007-11#1)(2010-8#1)
glory##13##1##(2007-11#3)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#4)(2010-8#1)
gloss uniformity##4##2##(2008-3#4)
gloss##7##1##(2008-3#6)(2008-5#1)
gloss-imaging instrument##2##2##(2008-3#2)
glossitis##3##1##(2011-1#1)(2013-1#1)(2013-7#1)
glossopharyngeal##4##1##(1996-5#1)(2011-2#3)
glottic##3##1##(1991-4#1)(1993-9#1)(2013-1#1)
glove integrity test procedures and their ability to detect leaking gloves##2##11##(2012-2#2)
glove powder##2##2##(1995-3#2)
glove powder-treated HL-60##3##3##(1995-3#3)
glove powders##2##2##(1995-3#2)
glove##12##1##(1993-6#1)(1995-3#7)(2008-11#1)(2012-2#3)
gloves are##3##2##(1995-6#1)(2008-4#2)
gloves for##2##2##(2012-12#1)(2012-2#1)
gloves##24##1##(1995-6#7)(1996-11#1)(2008-12#2)(2008-4#2)(2009-5#1)(2012-12#2)(2012-2#9)
glow discharge##5##2##(2007-11#1)(2008-10#2)(2010-5#2)
glow##8##1##(1997-4#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-5#2)
glu##2##1##(1996-5#1)(2008-10#1)
gluA##2##1##(2008-10#2)
gluB##2##1##(2008-10#2)
glucagon and##3##2##(1990-8#1)(2011-2#2)
glucagon gene##2##2##(2008-8#1)(2010-11#1)
glucagon in##4##2##(1991-12#2)(1996-2#1)(2008-3#1)
glucagon levels##2##2##(1992-9#1)(2010-11#1)
glucagon on##2##2##(1994-8#1)(1996-2#1)
glucagon or##3##2##(1990-7#2)(1991-3#1)
glucagon receptor expression##3##3##(1994-11#3)
glucagon receptor##10##2##(1994-11#5)(1995-11#3)(2008-11#2)
glucagon receptors##3##2##(1994-11#1)(1995-11#2)
glucagon release##3##2##(1994-11#3)
glucagon secretion and##2##3##(2010-11#2)
glucagon secretion in rats##2##4##(1994-11#2)
glucagon secretion in##3##3##(1994-11#2)(2010-11#1)
glucagon secretion##10##2##(1991-7#1)(1994-11#3)(2010-11#6)
glucagon was##6##2##(1991-12#1)(1996-2#1)(2008-11#1)(2008-8#3)
glucagon##88##1##(1990-7#3)(1990-8#3)(1991-12#6)(1991-3#2)(1991-7#2)(1991-8#1)(1992-9#1)(1994-11#12)(1994-8#3)(1995-11#6)(1995-6#4)(1995-8#1)(1996-2#7)(1997-2#1)(2008-11#4)(2008-3#3)(2008-8#7)(2010-11#13)(2011-2#4)(2012-1#3)(2012-2#1)(2012-3#1)
glucagon)##4##1##(1991-12#1)(2008-1#1)(2008-11#1)(2008-8#1)
glucagon-37##4##1##(1997-6#4)
glucagon-degrading activity##2##2##(1995-6#2)
glucagon-induced##4##1##(1994-8#1)(1996-2#3)
glucagon-like peptide 1##2##3##(1994-11#1)(2012-3#1)
glucagon-like peptide-1 (GLP-1)##2##3##(1995-8#1)(1996-2#1)
glucagon-like peptide-1##7##2##(1994-8#1)(1995-8#1)(1996-2#2)(2009-9#1)(2011-2#2)
glucagon-like##9##1##(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#2)(2009-9#1)(2011-2#2)(2012-3#1)
glucagonoma##3##1##(2013-7#3)
glucan from##2##2##(2008-5#2)
glucan##8##1##(1990-9#1)(1995-11#1)(2008-5#4)(2008-6#2)
glucanase##4##1##(2008-10#4)
glucanases##2##1##(2008-10#2)
glucanohydrolase##2##1##(1990-5#1)(2008-7#1)
glucoamylase gene##2##2##(2008-5#1)(2008-9#1)
glucoamylase were##3##2##(2008-6#1)(2008-8#2)
glucoamylase##16##1##(1991-5#1)(1992-11#1)(1995-6#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)
glucoamylase-encoding##2##1##(1995-6#2)
glucoamylases##2##1##(1995-6#1)(2008-6#1)
glucocerebrosidase##5##1##(1991-9#1)(1994-5#1)(1997-7#3)
glucocorticoid (GC)##2##2##(1995-12#1)(1995-3#1)
glucocorticoid and mineralocorticoid##2##3##(1993-8#1)(1997-1#1)
glucocorticoid and##4##2##(1993-8#1)(1997-1#1)(2008-4#1)(2008-7#1)
glucocorticoid deficiency##5##2##(1993-11#2)(2011-1#3)
glucocorticoid excess##2##2##(1991-5#1)(2008-7#1)
glucocorticoid feedback##2##2##(1995-11#1)(2008-11#1)
glucocorticoid induced##2##2##(1992-12#1)(1994-6#1)
glucocorticoid induction##2##2##(1992-12#1)(1997-4#1)
glucocorticoid receptor gene##2##3##(1994-5#1)(2008-11#1)
glucocorticoid receptor immunoreactivity##2##3##(1993-12#2)
glucocorticoid receptor##23##2##(1990-11#6)(1991-12#1)(1993-12#2)(1993-5#1)(1993-8#2)(1994-5#1)(1995-12#1)(1995-2#2)(1996-12#4)(2008-11#2)(2013-1#1)
glucocorticoid receptors are##2##3##(1991-12#1)(2008-4#1)
glucocorticoid receptors##12##2##(1991-12#2)(1992-5#1)(1994-2#2)(1994-9#1)(1995-12#3)(2008-4#1)(2008-6#1)(2009-6#1)
glucocorticoid signal transduction##2##3##(1997-4#2)
glucocorticoid stress##2##2##(1994-10#2)
glucocorticoid therapy##5##2##(1995-11#1)(2012-12#2)(2012-2#2)
glucocorticoid treatment##4##2##(1992-2#1)(1994-9#1)(1996-5#1)(2008-1#1)
glucocorticoid##87##1##(1990-11#6)(1991-12#4)(1991-5#2)(1992-12#4)(1992-2#2)(1992-5#1)(1993-11#2)(1993-12#3)(1993-5#2)(1993-8#3)(1994-10#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#4)(1996-5#1)(1997-1#2)(1997-4#3)(1997-7#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
glucocorticoid-receptor translocation promoter##2##3##(1993-6#2)
glucocorticoid-receptor##3##1##(1993-6#3)
glucocorticoids (GC)##2##2##(2008-7#1)(2013-1#1)
glucocorticoids (GCs)##4##2##(2008-11#1)(2008-7#2)(2009-4#1)
glucocorticoids and cyclic adenosine 3'##2##5##(1994-9#2)
glucocorticoids and##6##2##(1994-5#1)(1994-9#3)(2012-1#1)(2012-3#1)
glucocorticoids are##4##2##(1996-12#1)(1996-5#1)(1997-1#1)(2008-7#1)
glucocorticoids decreased##2##2##(1994-9#1)(1995-12#1)
glucocorticoids in the##5##3##(1992-12#1)(1993-5#1)(2008-11#2)(2012-12#1)
glucocorticoids in##6##2##(1992-12#1)(1993-5#1)(2008-11#2)(2008-8#1)(2012-12#1)
glucocorticoids or##2##2##(1993-12#1)(2009-6#1)
glucocorticoids##56##1##(1990-11#1)(1992-12#1)(1993-12#1)(1993-5#2)(1993-8#1)(1994-5#1)(1994-6#1)(1994-9#8)(1995-12#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#4)(1997-1#1)(2008-1#1)(2008-11#5)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
glucocorticosteroids##2##1##(1992-6#1)(1996-7#1)
glucokinase and hexokinase##2##3##(1990-11#2)
glucokinase by##2##2##(1990-11#1)(1990-7#1)
glucokinase##19##1##(1990-11#5)(1990-7#10)(2008-1#2)(2008-11#1)(2008-7#1)
glucomannan##5##1##(2008-10#3)(2011-2#2)
gluconate##8##1##(1990-11#1)(2007-7#1)(2010-4#2)(2012-3#2)(2013-1#2)
gluconeogenesis by##2##2##(1991-9#1)(1994-8#1)
gluconeogenesis in##3##2##(1991-3#1)(1994-8#2)
gluconeogenesis is##3##2##(1994-8#2)(2010-11#1)
gluconeogenesis##23##1##(1991-3#4)(1991-9#1)(1994-5#2)(1994-8#8)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-3#1)(2010-11#1)(2012-2#1)
gluconeogenic and##2##2##(1994-8#1)(2008-11#1)
gluconeogenic enzymes##2##2##(1994-8#2)
gluconeogenic flux##2##2##(1995-8#2)
gluconeogenic##11##1##(1991-3#2)(1994-8#3)(1995-8#2)(2008-11#1)(2010-11#2)(2011-1#1)
gluconic acid##14##2##(1996-5#1)(2008-10#7)(2008-6#5)(2010-4#1)
gluconic##16##1##(1996-5#1)(2008-10#9)(2008-6#5)(2010-4#1)
glucosamine and##2##2##(1992-3#1)(1994-8#1)
glucosamine##8##1##(1990-7#1)(1991-3#1)(1992-3#1)(1994-8#1)(1995-2#1)(2008-2#1)(2010-9#1)(2011-2#1)
glucosaminidase##2##1##(1993-12#1)(2012-2#1)
glucose &gt##2##2##(1993-12#1)(2012-5#1)
glucose &lt##3##2##(2008-1#1)(2010-2#1)(2012-5#1)
glucose (0##2##2##(1990-5#1)(2008-10#1)
glucose (1##2##2##(2008-11#2)
glucose (P##2##2##(2008-10#1)(2010-2#1)
glucose (S/N=3)##2##2##(2008-10#2)
glucose 6-phosphate##2##2##(1996-6#1)(2008-10#1)
glucose absorption in##2##3##(1997-6#2)
glucose absorption##4##2##(1997-6#4)
glucose administration##3##2##(1994-12#1)(2007-11#1)(2007-8#1)
glucose after##4##2##(1994-5#1)(2008-5#1)(2008-6#2)
glucose agar##3##2##(2008-10#1)(2008-5#2)
glucose alone##2##2##(1990-12#1)(2008-7#1)
glucose and ATP##2##3##(1991-5#1)(2008-10#1)
glucose and GLP##2##3##(1995-8#2)
glucose and H(2)O(2)##2##3##(2008-10#2)
glucose and ascorbic acid##2##4##(2008-10#2)
glucose and blood##2##3##(1995-3#1)(2008-2#1)
glucose and ethanol##5##3##(2008-10#5)
glucose and fatty acid##2##4##(2008-1#1)(2012-2#1)
glucose and fructosamine##4##3##(2009-3#4)
glucose and fructose in the##2##5##(1990-2#1)(2008-10#1)
glucose and fructose##9##3##(1990-2#1)(2008-10#4)(2008-6#3)(2010-2#1)
glucose and galactose were##2##4##(1994-3#1)(2013-1#1)
glucose and galactose##6##3##(1994-12#1)(1994-3#1)(2008-10#1)(2013-1#3)
glucose and glucagon##2##3##(1994-8#2)
glucose and glutamine at##2##4##(1994-5#1)(2008-7#1)
glucose and glutamine concentrations##2##4##(2008-11#2)
glucose and glutamine metabolism##4##4##(2008-11#4)
glucose and glutamine##16##3##(1994-5#1)(2008-11#12)(2008-7#3)
glucose and insulin concentrations were##2##5##(2010-8#2)
glucose and insulin concentrations##3##4##(2010-10#1)(2010-8#2)
glucose and insulin levels in##2##5##(2010-8#1)(2012-3#1)
glucose and insulin levels##3##4##(2008-1#1)(2010-8#1)(2012-3#1)
glucose and insulin were##2##4##(1991-2#1)(2010-8#1)
glucose and insulin##9##3##(1991-2#1)(2008-1#1)(2010-10#1)(2010-8#4)(2012-3#1)(2012-5#1)
glucose and its##2##3##(1990-7#1)(1993-3#1)
glucose and lactate##2##3##(2009-3#1)(2011-2#1)
glucose and lipid homeostasis##2##4##(2008-5#1)(2010-10#1)
glucose and lipid metabolism##6##4##(1994-12#1)(2008-3#3)(2008-7#1)(2012-1#1)
glucose and lipid##9##3##(1994-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-10#1)(2012-1#1)
glucose and oxygen##2##3##(2008-11#1)(2009-11#1)
glucose and sucrose##3##3##(2008-6#1)(2008-9#1)(2010-11#1)
glucose and the##5##3##(1994-5#1)(2008-10#2)(2008-3#1)(2012-1#1)
glucose and urea##8##3##(2008-11#3)(2008-3#5)
glucose and xylose##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
glucose and##160##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-12#5)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#2)(1995-3#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-4#1)(2008-1#4)(2008-10#30)(2008-11#21)(2008-2#1)(2008-3#10)(2008-5#4)(2008-6#8)(2008-7#11)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#5)(2010-10#2)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#7)(2013-8#1)
glucose as well as with##2##5##(2008-10#1)(2011-1#1)
glucose as well as##4##4##(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
glucose as##8##2##(1995-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
glucose assay##2##2##(2008-10#2)
glucose at##5##2##(1994-8#1)(2008-10#3)(2012-7#1)
glucose biosensor based on##3##4##(2008-10#3)
glucose biosensor was##3##3##(2008-10#2)(2010-5#1)
glucose biosensor with##2##3##(2008-10#2)
glucose biosensor##20##2##(2008-10#17)(2009-10#1)(2010-5#2)
glucose biosensors based on##2##4##(2008-10#2)
glucose biosensors##8##2##(2008-10#8)
glucose but##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
glucose by the##3##3##(1994-6#1)(2008-10#2)
glucose by##11##2##(1992-6#1)(1993-8#1)(1994-6#1)(2008-10#4)(2008-5#1)(2008-6#2)(2011-1#1)
glucose concentration at##2##3##(1991-7#1)(1993-1#1)
glucose concentration in sows##2##4##(2010-2#2)
glucose concentration in the##2##4##(1992-9#1)(2008-10#1)
glucose concentration in##8##3##(1991-12#1)(1992-9#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-2#1)(2010-2#2)
glucose concentration of##3##3##(2008-10#2)(2008-5#1)
glucose concentration on the##2##4##(1992-6#1)(2008-6#1)
glucose concentration on##3##3##(1992-6#1)(1994-2#1)(2008-6#1)
glucose concentration range of##2##4##(2008-10#1)(2008-11#1)
glucose concentration up to##2##4##(1992-12#1)(2008-10#1)
glucose concentration was##3##3##(2008-10#2)(2008-11#1)
glucose concentration##56##2##(1990-6#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-8#1)(2007-11#4)(2008-10#13)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#5)
glucose concentrations in##3##3##(1994-8#1)(2008-1#1)(2010-10#1)
glucose concentrations were##2##3##(1993-1#1)(1996-2#1)
glucose concentrations##15##2##(1990-12#1)(1990-5#1)(1991-9#1)(1993-1#2)(1994-11#1)(1994-12#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-11#1)(2013-8#1)
glucose consumption and lactate production were##2##6##(2008-11#1)(2008-7#1)
glucose consumption and lactate production##3##5##(2008-11#2)(2008-7#1)
glucose consumption rate##5##3##(2008-11#5)
glucose consumption##14##2##(1994-5#1)(2008-11#11)(2008-7#1)(2009-4#1)
glucose content##4##2##(1992-9#1)(2008-10#3)
glucose control in##4##3##(1991-2#1)(2010-12#1)(2011-2#1)(2012-5#1)
glucose control over##2##3##(1990-6#2)
glucose control##12##2##(1990-6#2)(1990-8#1)(1991-2#1)(1993-12#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-5#1)
glucose could be##2##3##(2008-10#2)
glucose could##3##2##(1992-8#1)(2008-10#2)
glucose degradation products (GDPs)##3##4##(2011-2#3)
glucose degradation products##5##3##(2011-2#5)
glucose dehydrogenase##5##2##(1990-11#2)(2008-10#3)
glucose depletion##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
glucose detection##3##2##(2008-10#3)
glucose determination in drinks##2##4##(2008-10#2)
glucose determination in##6##3##(2008-10#6)
glucose determination##11##2##(1995-3#1)(2008-10#10)
glucose determinations##2##2##(2008-1#2)
glucose diet##2##2##(2010-2#2)
glucose diets##2##2##(2010-2#2)
glucose disposal##3##2##(1992-6#1)(2008-3#2)
glucose during##3##2##(1990-2#1)(2010-2#2)
glucose effectiveness##3##2##(2008-1#1)(2012-7#2)
glucose enzyme biosensors##2##3##(2008-10#2)
glucose enzyme##3##2##(2008-10#3)
glucose feeding##3##2##(2008-6#2)(2012-2#1)
glucose fluctuations##3##2##(2009-11#2)(2009-9#1)
glucose for##9##2##(1990-8#1)(1992-8#1)(1994-6#1)(1995-8#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-10#1)
glucose from##6##2##(1990-11#1)(1991-9#1)(1994-6#1)(1997-7#1)(2008-7#1)(2009-10#1)
glucose grown cells##2##3##(1990-11#2)
glucose has been##2##3##(1994-12#1)(2008-10#1)
glucose homeostasis and##2##3##(2008-1#1)(2008-4#1)
glucose homeostasis in##3##3##(2007-5#1)(2010-12#1)(2012-2#1)
glucose homeostasis phenotypes##2##3##(2008-1#2)
glucose homeostasis##21##2##(1991-7#1)(2007-11#1)(2007-5#2)(2008-1#8)(2008-3#2)(2008-4#3)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
glucose in a##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
glucose in blood##2##3##(2008-10#2)
glucose in human##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
glucose in the presence of##4##5##(1990-8#1)(2008-10#2)(2008-7#1)
glucose in the##12##3##(1990-8#1)(1991-10#1)(1994-8#1)(2007-8#1)(2008-10#7)(2008-7#1)
glucose in##41##2##(1990-3#1)(1990-8#1)(1991-10#1)(1994-12#1)(1994-8#4)(1995-8#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
glucose incorporation##2##2##(2008-9#1)(2009-10#1)
glucose increased##2##2##(2008-11#1)(2010-2#1)
glucose induced##2##2##(2008-9#1)(2010-11#1)
glucose into the##2##3##(1995-5#1)(2010-8#1)
glucose into##4##2##(1990-11#1)(1995-5#1)(1997-7#1)(2010-8#1)
glucose intolerance and##3##3##(1991-5#1)(2010-11#1)(2012-2#1)
glucose intolerance##12##2##(1991-5#1)(2008-3#4)(2008-4#1)(2009-3#1)(2010-11#2)(2010-4#1)(2012-2#2)
glucose is##6##2##(1990-5#2)(1991-7#1)(2008-10#1)(2010-5#1)(2011-1#1)
glucose kinase##2##2##(1995-8#2)
glucose level and##2##3##(2008-5#1)(2011-1#1)
glucose level was##3##3##(2008-1#1)(2008-7#1)(2010-4#1)
glucose level##24##2##(1991-2#1)(1993-11#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-4#6)(2011-1#3)(2011-3#1)(2012-2#3)
glucose levels are##2##3##(2007-8#1)(2009-3#1)
glucose levels at##2##3##(2008-3#1)(2012-3#1)
glucose levels can##2##3##(2008-11#1)(2012-5#1)
glucose levels during##2##3##(2008-5#1)(2011-2#1)
glucose levels in##6##3##(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)
glucose levels of##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
glucose levels were##7##3##(2007-12#1)(2008-10#3)(2008-7#1)(2009-4#1)(2012-3#1)
glucose levels##54##2##(1990-5#1)(1991-12#1)(1991-7#2)(1994-12#2)(1997-2#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#3)(2009-11#1)(2009-3#2)(2009-4#1)(2010-11#6)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#3)(2012-5#2)
glucose load##3##2##(2007-7#1)(2008-5#1)(2008-7#1)
glucose loading##3##2##(1990-12#1)(2011-1#1)(2012-2#1)
glucose lowering##2##2##(2008-12#1)(2010-7#1)
glucose measurements##2##2##(2008-10#1)(2009-11#1)
glucose media##2##2##(2012-5#2)
glucose metabolism and##2##3##(1994-6#1)(2008-8#1)
glucose metabolism in rat##2##4##(1993-11#1)(1994-3#1)
glucose metabolism in##10##3##(1990-11#1)(1993-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1996-5#2)(2008-7#1)(2013-8#1)
glucose metabolism##34##2##(1990-11#1)(1991-12#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#3)(1996-2#2)(1996-5#3)(2008-1#2)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#2)(2013-7#1)(2013-8#1)
glucose monitoring and##2##3##(2009-11#1)(2010-2#1)
glucose monitoring in##4##3##(1996-2#3)(2008-2#1)
glucose monitoring systems##2##3##(2008-1#1)(2009-11#1)
glucose monitoring##17##2##(1996-2#3)(2007-10#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-11#4)(2010-2#2)(2012-4#2)(2012-5#1)
glucose of##3##2##(2010-2#2)(2012-2#1)
glucose on##7##2##(1992-9#1)(1994-8#1)(2007-7#1)(2008-7#1)(2010-11#2)(2011-2#1)
glucose or glutamine##2##3##(2008-11#1)(2008-7#1)
glucose or mannose##2##3##(1995-6#1)(2008-6#1)
glucose or##13##2##(1990-8#1)(1991-12#2)(1993-2#1)(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-5#1)
glucose output in##4##3##(1994-6#4)
glucose output##6##2##(1991-7#1)(1994-6#5)
glucose oxidase (GOD)##4##3##(2008-10#4)
glucose oxidase (GOx) and##3##4##(2008-10#2)(2010-5#1)
glucose oxidase (GOx)##6##3##(2008-10#5)(2010-5#1)
glucose oxidase immobilized on##4##4##(2008-10#4)
glucose oxidase in##2##3##(2008-10#2)
glucose oxidase was immobilized##2##4##(2008-10#2)
glucose oxidase was##4##3##(2008-10#4)
glucose oxidase##52##2##(1990-12#1)(1995-5#1)(2008-10#46)(2008-6#2)(2009-10#1)(2010-5#1)
glucose oxidation and##2##3##(1990-7#1)(2008-10#1)
glucose oxidation##3##2##(1990-7#2)(2008-10#1)
glucose phosphate isomerase##2##3##(1997-6#2)
glucose phosphorylation##2##2##(1990-11#2)
glucose production by##3##3##(1994-11#1)(1994-8#2)
glucose production##11##2##(1991-7#2)(1993-8#2)(1994-11#1)(1994-8#2)(2008-1#2)(2008-3#1)(2012-2#1)
glucose profile##2##2##(1991-8#1)(2012-4#1)
glucose pulses##2##2##(2008-6#2)
glucose reduced##3##2##(2010-11#1)(2012-4#2)
glucose regulation##9##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)
glucose release by##2##3##(1991-7#1)(1994-6#1)
glucose response##2##2##(2008-10#1)(2008-11#1)
glucose sensing##6##2##(2008-10#2)(2008-11#2)(2009-11#2)
glucose sensor##5##2##(2008-10#5)
glucose sensors##5##2##(2008-10#3)(2009-11#2)
glucose solution##2##2##(2008-10#2)
glucose solutions##2##2##(1995-3#1)(2008-3#1)
glucose starvation##11##2##(2008-11#5)(2008-7#5)(2010-10#1)
glucose to##9##2##(1991-7#1)(1995-8#4)(2008-10#2)(2008-12#1)(2010-2#1)
glucose tolerance in##2##3##(1995-11#1)(2008-1#1)
glucose tolerance test##16##3##(1990-8#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2012-7#3)
glucose tolerance##53##2##(1990-8#1)(1994-12#4)(1995-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-1#7)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#6)(2009-3#1)(2010-10#2)(2010-4#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#5)(2013-8#1)
glucose transfer in the rat jejunum##2##6##(1991-5#2)
glucose transfer##4##2##(1991-5#4)
glucose transport and##2##3##(1997-1#1)(2010-4#1)
glucose transport by##2##3##(1992-11#2)
glucose transport in##4##3##(1991-12#1)(1994-12#1)(2008-1#1)(2008-7#1)
glucose transport into L6 myotubes##2##5##(1994-11#2)
glucose transport into L6##3##4##(1994-11#3)
glucose transport into skeletal muscle##2##5##(2008-1#1)(2008-3#1)
glucose transport into##6##3##(1994-11#3)(2008-1#2)(2008-3#1)
glucose transport to the same extent as insulin##2##8##(1992-11#2)
glucose transport was##2##3##(1994-11#1)(1997-6#1)
glucose transport##30##2##(1990-11#2)(1991-12#1)(1992-11#8)(1994-11#4)(1994-12#3)(1994-6#1)(1995-6#1)(1997-1#1)(1997-6#1)(2008-1#3)(2008-3#2)(2008-7#1)(2009-9#1)(2010-4#1)
glucose transporter (GLUT4)##3##3##(1990-8#1)(1994-11#2)
glucose transporter 1##2##3##(1993-8#2)
glucose transporter family##2##3##(1993-6#1)(2008-7#1)
glucose transporter gene##2##3##(1991-12#1)(1993-8#1)
glucose transporter is##3##3##(1990-11#3)
glucose transporter isoforms##2##3##(1993-6#1)(1994-12#1)
glucose transporter protein##2##3##(1990-8#1)(1993-6#1)
glucose transporter##29##2##(1990-11#3)(1990-8#3)(1991-12#5)(1993-6#7)(1993-8#4)(1994-11#2)(1994-12#1)(1994-2#1)(2008-11#2)(2008-7#1)
glucose transporters in##3##3##(1990-11#1)(1994-12#2)
glucose transporters##9##2##(1990-11#2)(1993-6#1)(1994-12#3)(1994-2#1)(2008-7#2)
glucose under##2##2##(1990-12#1)(2008-10#1)
glucose uptake and##7##3##(1994-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-2#1)
glucose uptake by##3##3##(1990-8#1)(1991-7#1)(2008-10#1)
glucose uptake in skeletal muscle##3##5##(1990-8#1)(2008-11#1)(2008-3#1)
glucose uptake in the##2##4##(2008-3#1)(2008-8#1)
glucose uptake in##9##3##(1990-8#1)(1993-8#1)(2008-11#3)(2008-3#2)(2008-8#2)
glucose uptake rates##2##3##(1994-5#1)(2008-7#1)
glucose uptake was##2##3##(1994-12#1)(2008-11#1)
glucose uptake##45##2##(1990-8#5)(1991-7#1)(1993-8#1)(1994-12#2)(1994-5#6)(1994-6#1)(2008-1#2)(2008-10#1)(2008-11#14)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#3)(2010-12#1)(2010-2#1)
glucose used##2##2##(1994-5#1)(2008-12#1)
glucose utilization by##2##3##(1990-11#1)(1994-8#1)
glucose utilization in##6##3##(1990-11#2)(1990-7#2)(1994-8#2)
glucose utilization rate##2##3##(2008-11#1)(2008-7#1)
glucose utilization##16##2##(1990-11#3)(1990-7#3)(1990-8#1)(1991-7#2)(1994-8#5)(2008-11#1)(2008-7#1)
glucose value##2##2##(2008-1#1)(2009-11#1)
glucose variability##5##2##(2012-4#4)(2012-5#1)
glucose was released##2##3##(1994-6#1)(2008-10#1)
glucose was##21##2##(1990-11#2)(1991-9#1)(1993-1#1)(1994-6#1)(1995-6#1)(1995-8#1)(2008-10#8)(2008-11#3)(2008-6#2)(2009-11#1)
glucose were significantly##2##3##(1992-8#1)(2010-11#1)
glucose were##3##2##(1992-8#1)(2008-6#1)(2010-11#1)
glucose with##5##2##(1992-6#1)(1994-12#1)(2008-10#3)
glucose##1396##1##(1990-11#25)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#10)(1990-6#4)(1990-7#8)(1990-8#16)(1991-10#1)(1991-12#13)(1991-2#5)(1991-5#8)(1991-7#13)(1991-8#3)(1991-9#4)(1992-11#8)(1992-12#5)(1992-6#8)(1992-8#10)(1992-9#8)(1993-1#5)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#13)(1993-8#10)(1994-11#10)(1994-12#33)(1994-2#7)(1994-3#2)(1994-5#18)(1994-6#19)(1994-8#24)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#28)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#1)(1996-5#7)(1996-6#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-6#7)(1997-7#4)(2007-10#2)(2007-11#8)(2007-12#2)(2007-5#2)(2007-7#2)(2007-8#8)(2008-1#53)(2008-10#300)(2008-11#95)(2008-12#7)(2008-2#6)(2008-3#49)(2008-4#9)(2008-5#26)(2008-6#46)(2008-7#68)(2008-8#9)(2008-9#6)(2009-10#5)(2009-11#24)(2009-3#10)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#6)(2010-10#11)(2010-11#26)(2010-12#5)(2010-2#29)(2010-3#1)(2010-4#11)(2010-5#8)(2010-7#2)(2010-8#6)(2011-1#19)(2011-2#28)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#19)(2012-3#13)(2012-4#15)(2012-5#11)(2012-7#10)(2013-1#25)(2013-7#2)(2013-8#5)
glucose)##8##1##(1991-5#1)(1992-9#1)(2008-10#2)(2008-6#2)(2008-7#1)(2010-2#1)
glucose-6-P##2##1##(1991-5#1)(2013-1#1)
glucose-6-phosphatase activity and##2##3##(1994-11#2)
glucose-6-phosphatase activity in##2##3##(1993-8#1)(1994-11#1)
glucose-6-phosphatase activity##10##2##(1993-8#3)(1994-11#6)(1997-7#1)
glucose-6-phosphatase and##2##2##(1993-8#1)(2008-7#1)
glucose-6-phosphatase mRNA##3##2##(1994-11#2)(1997-7#1)
glucose-6-phosphatase##21##1##(1993-8#5)(1994-11#9)(1997-7#6)(2008-7#1)
glucose-6-phosphate dehydrogenase and the##2##4##(1991-5#1)(2008-10#1)
glucose-6-phosphate dehydrogenase and##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
glucose-6-phosphate dehydrogenase deficiency##3##3##(1990-2#1)(2007-12#1)(2008-8#1)
glucose-6-phosphate dehydrogenase##11##2##(1990-2#1)(1990-3#1)(1991-5#2)(1995-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
glucose-6-phosphate isomerase and peptidase##3##4##(2008-10#3)
glucose-6-phosphate isomerase##6##2##(2008-10#6)
glucose-6-phosphate##23##1##(1990-2#1)(1990-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1995-6#1)(1997-6#1)(1997-7#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-8#1)(2013-1#1)
glucose-free buffer##2##2##(1995-8#2)
glucose-free##7##1##(1995-8#7)
glucose-fructose oxidoreductase##2##2##(2008-6#2)
glucose-glucose oxidase##2##2##(1990-5#1)(1993-11#1)
glucose-induced insulin release##2##3##(1990-12#1)(1990-8#1)
glucose-induced##10##1##(1990-12#1)(1990-8#1)(1994-8#1)(2008-1#3)(2011-2#1)(2012-4#3)
glucose-limited##2##1##(1994-3#1)(2008-6#1)
glucose-oxidase##2##1##(2008-10#2)
glucose-starved##3##1##(2008-11#2)(2010-10#1)
glucose-stimulated insulin release##2##3##(1994-11#1)(2008-11#1)
glucose-stimulated insulin secretion from##3##4##(1990-12#1)(2008-1#1)(2010-11#1)
glucose-stimulated insulin secretion##8##3##(1990-12#1)(1997-4#1)(2008-1#2)(2008-11#1)(2010-11#3)
glucose-stimulated insulin##10##2##(1990-12#1)(1994-11#1)(1997-4#1)(2008-1#2)(2008-11#2)(2010-11#3)
glucose-stimulated##13##1##(1990-12#1)(1990-5#1)(1994-11#1)(1997-4#1)(2008-1#2)(2008-11#3)(2010-11#4)
glucose-to-cell yield increased and##2##4##(2008-11#2)
glucose-to-lactate yield decreased##2##3##(2008-11#2)
glucose/insulin ratio and##3##3##(1992-6#1)(2008-3#2)
glucosidase##6##1##(1993-8#1)(1995-5#2)(2008-10#2)(2013-1#1)
glucoside was##3##2##(1994-11#1)(2008-11#2)
glucoside##12##1##(1990-11#1)(1990-2#1)(1992-12#2)(1994-11#1)(2007-11#2)(2008-11#4)(2008-5#1)
glucosides##2##1##(2007-11#1)(2008-10#1)
glucosidic##2##1##(1990-7#2)
glucosinolate containing##2##2##(2008-10#2)
glucosinolate content##2##2##(2008-10#2)
glucosinolate##9##1##(2008-10#8)(2008-9#1)
glucosuria##2##1##(1994-5#1)(2008-1#1)
glucosyl##3##1##(1990-7#1)(1995-5#1)(2008-10#1)
glucosyl-3-phosphoglycerate phosphatase##2##2##(2012-2#2)
glucosyl-3-phosphoglycerate##5##1##(2012-2#5)
glucosylceramide and##2##2##(1990-5#1)(2008-5#1)
glucosylceramide##4##1##(1990-5#1)(1994-3#1)(2008-5#2)
glucosylceramides##2##1##(2008-5#2)
glucosyltransferase##7##1##(1990-5#4)(1992-9#2)(2009-10#1)
glucosyltransferases##3##1##(2008-10#1)(2009-10#2)
glucuronic acid##5##2##(1990-7#1)(1991-2#1)(2008-10#2)(2011-1#1)
glucuronic-acid-containing##2##1##(1990-7#2)
glucuronidation activity##2##2##(1990-12#1)(2008-11#1)
glucuronidation of##3##2##(1992-8#1)(2008-11#2)
glucuronidation##11##1##(1990-12#1)(1991-5#1)(1992-8#3)(2008-11#5)(2013-8#1)
glucuronide##10##1##(1990-11#3)(1991-5#3)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
glucuronides and##2##2##(2008-11#1)(2010-6#1)
glucuronides##5##1##(1990-8#2)(2008-11#1)(2010-6#2)
glue for##2##2##(2008-9#1)(2012-12#1)
glue is##2##2##(2010-2#1)(2012-2#1)
glue was##2##2##(1992-3#1)(2008-10#1)
glue##29##1##(1992-3#2)(1992-5#1)(1996-3#1)(1997-3#5)(1997-6#2)(2006-12#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-2#2)(2012-12#1)(2012-2#8)
glue)##2##1##(2012-2#2)
glued##3##1##(1997-3#2)(2007-12#1)
glues and##3##2##(2008-9#1)(2013-1#2)
glues##9##1##(2008-10#2)(2008-9#2)(2012-2#2)(2012-3#1)(2013-1#2)
gluing##3##1##(1997-3#1)(2007-8#1)(2010-10#1)
glume blotch##2##2##(2008-10#2)
glume##5##1##(2008-10#5)
glutamate (mGlu)##3##2##(1995-12#1)(2008-11#1)(2008-7#1)
glutamate and lysine##2##3##(1993-11#1)(2008-7#1)
glutamate and nitric oxide (NO)##2##5##(2008-6#1)(2008-7#1)
glutamate and##16##2##(1991-12#1)(1993-11#1)(1995-12#1)(2008-11#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-6#1)(2012-1#1)
glutamate antagonist##2##2##(1996-5#1)(2008-7#1)
glutamate as a##2##3##(1991-5#1)(2008-7#1)
glutamate as##3##2##(1991-5#1)(2008-11#1)(2008-7#1)
glutamate concentrations##2##2##(1994-2#1)(2008-7#1)
glutamate decarboxylase##4##2##(1996-12#2)(1996-5#2)
glutamate dehydrogenase (GDH)##3##3##(1995-5#1)(2008-1#1)(2008-11#1)
glutamate dehydrogenase and##3##3##(1992-11#1)(2008-11#1)(2013-1#1)
glutamate dehydrogenase##23##2##(1990-7#4)(1992-11#2)(1993-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-8#1)(2013-1#1)
glutamate in the##5##3##(1992-11#1)(1994-2#1)(1995-12#1)(2008-7#2)
glutamate in##9##2##(1992-11#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#3)(2012-12#1)
glutamate levels##6##2##(1997-6#4)(2008-11#2)
glutamate neurotoxicity##5##2##(2008-7#5)
glutamate oxidase##4##2##(1992-11#2)(2008-10#1)(2009-11#1)
glutamate pyruvate transaminase##3##3##(2012-2#2)(2013-1#1)
glutamate racemase##3##2##(1995-2#3)
glutamate receptor agonists in##2##4##(1996-5#1)(1997-7#1)
glutamate receptor agonists##4##3##(1995-12#1)(1996-5#2)(1997-7#1)
glutamate receptor antagonist##4##3##(1994-8#1)(2008-11#2)(2012-12#1)
glutamate receptor subunit##2##3##(1990-8#1)(1996-5#1)
glutamate receptor subunits##3##3##(1993-9#1)(1995-5#2)
glutamate receptor##44##2##(1990-8#1)(1991-2#2)(1992-11#1)(1993-8#4)(1993-9#3)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#4)(1996-5#5)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2008-11#3)(2008-7#1)(2008-8#1)(2012-12#2)(2012-2#1)
glutamate receptors and##2##3##(1996-12#1)(2008-7#1)
glutamate receptors in the##2##4##(1995-5#1)(1996-12#1)
glutamate receptors in##3##3##(1995-5#1)(1996-12#1)(2008-4#1)
glutamate receptors##33##2##(1990-8#1)(1994-8#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-5#2)(1996-12#3)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-4#2)(2008-7#3)(2009-3#1)(2009-7#1)(2012-12#2)(2012-2#2)
glutamate release in##3##3##(1995-12#2)(2008-7#1)
glutamate release##9##2##(1993-9#1)(1994-8#2)(1995-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
glutamate residue##2##2##(1997-7#1)(2011-1#1)
glutamate synthase##4##2##(1997-1#2)(2008-8#2)
glutamate to##2##2##(1997-6#1)(2008-7#1)
glutamate toxicity against dopaminergic neurons##2##5##(2008-7#2)
glutamate toxicity against##3##3##(2008-7#3)
glutamate toxicity##5##2##(2008-7#5)
glutamate transporter##7##2##(1993-3#1)(1995-11#1)(1996-2#3)(2008-7#1)(2009-8#1)
glutamate transporters##7##2##(2008-7#6)(2008-8#1)
glutamate uptake##4##2##(1991-5#3)(2008-11#1)
glutamate was##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
glutamate with##2##2##(1997-1#1)(2008-7#1)
glutamate##287##1##(1990-11#2)(1990-7#5)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#4)(1992-11#6)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#6)(1993-9#5)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#8)(1995-11#8)(1995-12#15)(1995-2#10)(1995-3#1)(1995-5#14)(1996-12#7)(1996-2#4)(1996-5#8)(1996-6#2)(1997-1#6)(1997-2#3)(1997-3#3)(1997-6#8)(1997-7#3)(2008-1#1)(2008-10#9)(2008-11#21)(2008-2#1)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#51)(2008-8#8)(2009-11#3)(2009-12#2)(2009-3#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#3)
glutamate-free medium##2##2##(2008-11#2)
glutamate-induced##8##1##(1995-12#4)(2008-11#2)(2008-6#1)(2008-7#1)
glutamate-mediated##3##1##(2008-7#3)
glutamatergic axon terminals##2##3##(2008-7#2)
glutamatergic inputs##2##2##(2012-2#2)
glutamatergic neurons##3##2##(2008-7#1)(2009-8#2)
glutamatergic neurotransmission##2##2##(1993-12#1)(2011-1#1)
glutamatergic synapses##2##2##(1997-7#1)(2012-2#1)
glutamatergic transmission##2##2##(2008-7#2)
glutamatergic##39##1##(1990-8#1)(1991-5#2)(1993-12#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#15)(2009-12#1)(2009-8#3)(2011-1#1)(2012-12#1)(2012-2#4)
glutamic acid (GAG)##2##3##(1990-8#1)(1991-8#1)
glutamic acid and##5##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
glutamic acid at##3##3##(1991-8#1)(1993-11#1)(2008-10#1)
glutamic acid by##3##3##(1990-10#1)(2008-10#2)
glutamic acid decarboxylase##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
glutamic acid on##3##3##(1990-10#1)(2008-10#2)
glutamic acid residue##2##3##(1994-5#1)(2009-2#1)
glutamic acid##41##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2011-2#1)(2013-8#1)
glutamic oxaloacetic transaminase##3##3##(1995-6#1)(2008-7#1)(2010-6#1)
glutamic pyruvic transaminase (GPT)##2##4##(2008-11#1)(2008-7#1)
glutamic pyruvic transaminase##3##3##(1995-6#1)(2008-11#1)(2008-7#1)
glutamic##51##1##(1990-10#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-5#1)(1995-6#4)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
glutamic-pyruvic##2##1##(1994-5#1)(1995-2#1)
glutamicum to##2##2##(2008-7#2)
glutamicum##9##1##(1994-6#4)(2008-7#5)
glutaminase##3##1##(1990-7#1)(2008-11#2)
glutamine (CAG)##2##2##(1990-12#1)(1991-8#1)
glutamine and serine##3##3##(2008-11#3)
glutamine and##13##2##(1993-8#1)(1994-8#1)(1995-5#1)(2008-11#10)
glutamine at##3##2##(1992-3#1)(1994-5#1)(2008-7#1)
glutamine concentration##3##2##(2008-11#3)
glutamine consumption##5##2##(2008-11#5)
glutamine depletion##3##2##(2008-11#1)(2008-7#2)
glutamine in the##2##3##(2008-11#2)
glutamine in##6##2##(1993-9#3)(1995-3#1)(2008-11#2)
glutamine levels##2##2##(1997-6#1)(2008-11#1)
glutamine metabolism##6##2##(2008-11#6)
glutamine residue in##2##3##(1991-2#1)(2008-5#1)
glutamine synthetase (GS)##5##3##(2008-11#2)(2008-2#1)(2008-7#2)
glutamine synthetase expression##2##3##(1996-12#2)
glutamine synthetase gene##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
glutamine synthetase in the##2##4##(1992-12#1)(1996-12#1)
glutamine synthetase in##4##3##(1992-12#2)(1996-12#1)(2008-11#1)
glutamine synthetase##22##2##(1992-12#2)(1996-12#6)(1997-1#2)(2008-10#1)(2008-11#7)(2008-2#1)(2008-7#2)(2009-8#1)
glutamine to##3##2##(1993-8#1)(1996-5#1)(2008-10#1)
glutamine utilization##2##2##(2008-7#2)
glutamine was##4##2##(1993-9#1)(1994-5#1)(1997-6#1)(2008-11#1)
glutamine##144##1##(1990-11#1)(1990-12#1)(1990-7#3)(1991-12#1)(1991-2#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-3#2)(1993-8#5)(1993-9#4)(1994-5#5)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-12#6)(1996-5#2)(1997-1#3)(1997-6#2)(2008-10#4)(2008-11#75)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#9)(2009-2#1)(2009-8#1)(2013-8#1)
glutamine) was##2##2##(2008-1#1)(2008-11#1)
glutamine)##4##1##(2008-1#1)(2008-11#3)
glutamine-free##3##1##(2008-11#2)(2008-7#1)
glutamines##2##1##(1992-6#1)(1997-7#1)
glutaminesynthetase##2##1##(2008-11#2)
glutaminyl##2##1##(1993-8#1)(1994-8#1)
glutaminyl-tRNA synthetase##3##2##(1993-8#2)(1994-8#1)
glutamyl##5##1##(1990-2#1)(1992-6#1)(1995-6#1)(2007-12#1)(2009-6#1)
glutaraldehyde (0##2##2##(1990-12#1)(2008-10#1)
glutaraldehyde (GA) vapour##2##3##(2008-10#2)
glutaraldehyde (GA)##4##2##(2008-10#3)(2008-5#1)
glutaraldehyde and fixed on a pretreated teflon membrane##2##8##(2008-10#2)
glutaraldehyde and fixed on a pretreated##3##6##(2008-10#3)
glutaraldehyde and fixed on##4##4##(2008-10#4)
glutaraldehyde and##11##2##(1990-8#1)(1991-5#2)(2008-10#7)(2008-11#1)
glutaraldehyde in##3##2##(2008-10#2)(2009-10#1)
glutaraldehyde on##2##2##(2008-10#2)
glutaraldehyde solution##2##2##(2008-10#1)(2010-8#1)
glutaraldehyde vapours##2##2##(2008-10#2)
glutaraldehyde##64##1##(1990-12#2)(1990-8#1)(1991-5#2)(1992-12#1)(1993-8#1)(1997-2#1)(2007-8#1)(2008-10#42)(2008-11#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)
glutaredoxin##2##1##(2008-7#1)(2009-12#1)
glutaredoxins##6##1##(2008-7#6)
glutaric dialdehyde##2##2##(1993-8#1)(2008-10#1)
glutaric##5##1##(1993-8#1)(2008-10#3)(2008-5#1)
glutathione (GSH) and glutathione disulfide##2##5##(2008-10#1)(2008-11#1)
glutathione (GSH) and##5##3##(1991-9#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
glutathione (GSH) or##2##3##(1992-9#1)(2008-10#1)
glutathione (GSH)##32##2##(1990-12#1)(1990-2#2)(1991-9#3)(1992-9#1)(1993-8#1)(1994-2#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)
glutathione S-conjugate##2##2##(1995-2#1)(2008-11#1)
glutathione S-transferase (GST) in##2##4##(1997-7#1)(2010-5#1)
glutathione S-transferase (GST)##6##3##(1991-12#1)(1993-2#1)(1994-12#1)(1997-7#1)(2008-4#1)(2010-5#1)
glutathione S-transferase T1##2##3##(2008-12#2)
glutathione S-transferase activity##2##3##(1995-6#1)(2008-8#1)
glutathione S-transferase fusion protein##2##4##(1994-12#1)(1995-6#1)
glutathione S-transferase fusion##3##3##(1994-12#1)(1995-6#2)
glutathione S-transferase##26##2##(1991-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#2)(1994-12#2)(1995-2#1)(1995-6#4)(1995-8#1)(1996-12#1)(1997-7#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-8#1)(2010-5#1)(2013-1#1)
glutathione S-transferases##4##2##(1990-2#2)(2006-10#1)(2008-7#1)
glutathione administration##2##2##(2012-2#2)
glutathione and glutathione disulfide in##3##5##(2008-10#3)
glutathione and##18##2##(1991-12#1)(1991-9#1)(1992-8#2)(1993-6#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)
glutathione at##2##2##(2008-10#2)
glutathione content##4##2##(1991-9#1)(2008-10#2)(2008-8#1)
glutathione derivatives are##2##3##(1994-9#2)
glutathione derivatives##4##2##(1994-9#4)
glutathione determination##3##2##(1996-12#1)(2008-10#2)
glutathione disulfide (GSSG)##2##3##(2008-10#1)(2008-11#1)
glutathione disulfide##6##2##(2008-10#5)(2008-11#1)
glutathione in the##2##3##(2008-5#1)(2013-1#1)
glutathione in##8##2##(1992-8#1)(2008-10#5)(2008-5#1)(2013-1#1)
glutathione level##2##2##(2008-7#1)(2012-2#1)
glutathione levels##5##2##(1991-9#1)(2008-4#2)(2008-7#2)
glutathione metabolism##2##2##(1990-3#1)(1994-6#1)
glutathione on##4##2##(1991-9#1)(2007-4#1)(2008-11#1)(2012-2#1)
glutathione peroxidase (GPx)##2##3##(2011-2#1)(2013-1#1)
glutathione peroxidase activity##2##3##(1990-3#1)(1993-8#1)
glutathione peroxidase and catalase##2##4##(1991-12#2)
glutathione peroxidase and##6##3##(1991-12#3)(1994-9#1)(2008-4#1)(2011-2#1)
glutathione peroxidase in##3##3##(1994-6#2)(2008-7#1)
glutathione peroxidase mRNA levels were##3##5##(1993-6#3)
glutathione peroxidase mRNA##4##3##(1990-3#1)(1993-6#3)
glutathione peroxidase##41##2##(1990-3#4)(1991-12#9)(1991-9#2)(1992-9#1)(1993-6#6)(1993-8#3)(1994-6#2)(1994-9#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-7#3)(2009-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
glutathione reductase (GR)##4##3##(2008-4#1)(2011-2#2)(2013-1#1)
glutathione reductase and##2##3##(1992-1#1)(1993-3#1)
glutathione reductase##18##2##(1990-3#1)(1992-1#3)(1993-3#1)(1994-9#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2010-5#1)(2011-2#2)(2013-1#1)
glutathione synthesis##2##2##(1992-11#1)(1995-11#1)
glutathione was##2##2##(1992-2#1)(1996-12#1)
glutathione##280##1##(1990-12#4)(1990-2#6)(1990-3#6)(1990-5#2)(1991-12#12)(1991-6#1)(1991-9#14)(1992-1#3)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#5)(1992-9#2)(1993-2#3)(1993-3#2)(1993-6#7)(1993-8#4)(1994-12#2)(1994-2#1)(1994-6#3)(1994-9#8)(1995-11#3)(1995-12#4)(1995-2#5)(1995-6#6)(1995-8#2)(1995-9#1)(1996-12#7)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-4#1)(2008-10#51)(2008-11#18)(2008-12#3)(2008-2#1)(2008-4#11)(2008-5#7)(2008-7#14)(2008-8#4)(2009-10#2)(2009-7#2)(2009-8#1)(2010-11#3)(2010-5#4)(2011-2#8)(2012-2#12)(2013-1#9)
glutathione-S-transferase (GST)##3##2##(2008-7#1)(2011-10#1)(2013-7#1)
glutathione-S-transferase##9##1##(1990-3#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-10#1)(2013-7#2)
glutathione-related##2##1##(2008-4#2)
glutathione-s-transferase (GST)##2##2##(2011-2#1)(2013-1#1)
glutathionylcobalamin##3##1##(2008-10#3)
gluteal muscle weakness##4##3##(2012-2#4)
gluteal muscle##9##2##(2009-9#1)(2012-2#7)(2013-8#1)
gluteal region##5##2##(1992-2#1)(2009-9#1)(2010-8#1)(2011-2#2)
gluteal weakness##2##2##(2012-2#2)
gluteal##21##1##(1992-2#1)(2007-7#1)(2008-12#1)(2009-9#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#9)(2013-1#1)(2013-8#1)
gluten and##2##2##(1991-2#1)(2007-5#1)
gluten proteins and##2##3##(1991-12#1)(2011-2#1)
gluten re-exposure##2##2##(2007-5#2)
gluten##13##1##(1991-12#1)(1991-2#1)(2007-5#7)(2008-10#2)(2008-11#1)(2011-2#1)
gluten-free diet##8##2##(1991-2#4)(2007-5#2)(2011-2#2)
gluten-free##9##1##(1991-2#4)(2007-5#3)(2011-2#2)
glutenin##2##1##(1991-12#2)
gluteraldehyde##2##1##(2009-12#2)
gluteus##3##1##(1990-8#1)(2006-10#1)(2009-3#1)
glutinis PM4##5##2##(2008-10#5)
glutinis##12##1##(2008-10#12)
glutinosa##8##1##(2008-10#8)
glutinous cultivars##3##2##(2008-10#3)
glutinous##7##1##(2008-10#7)
glyburide##2##1##(1990-7#1)(1991-12#1)
glycaemia##5##1##(1991-5#1)(1993-9#1)(2008-7#2)(2012-3#1)
glycaemic control##10##2##(1991-5#1)(1992-9#3)(1993-2#1)(1995-2#1)(2008-1#2)(2008-7#1)(2013-1#1)
glycaemic##12##1##(1991-5#1)(1992-9#3)(1993-2#1)(1995-2#1)(2008-1#2)(2008-7#3)(2013-1#1)
glycan chains##4##2##(1990-7#1)(1994-5#3)
glycan moiety##2##2##(1991-12#1)(1994-8#1)
glycan structures##2##2##(1992-9#1)(2008-11#1)
glycan units##2##2##(1994-5#2)
glycan##23##1##(1990-7#2)(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-5#6)(1994-8#1)(2008-11#2)(2008-4#2)(2008-7#1)(2009-8#1)(2010-11#3)
glycans and##2##2##(2010-11#1)(2012-3#1)
glycans are##2##2##(1991-9#1)(2008-1#1)
glycans in##3##2##(1991-12#1)(2008-5#1)(2010-11#1)
glycans##16##1##(1990-5#1)(1991-12#4)(1991-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-11#3)(2010-4#2)(2012-3#1)
glycated albumin##5##2##(1993-6#4)(2009-11#1)
glycated##15##1##(1990-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1993-6#8)(2009-11#1)(2011-2#1)
glycation and##2##2##(2008-1#1)(2009-11#1)
glycation end products (AGEs)##4##4##(1994-6#1)(2008-1#2)(2011-1#1)
glycation end products and##2##4##(2008-1#1)(2008-7#1)
glycation end products##13##3##(1993-6#1)(1994-6#2)(2008-1#3)(2008-7#2)(2010-10#1)(2011-1#2)(2012-2#2)
glycation end##14##2##(1993-6#1)(1994-6#2)(2008-1#4)(2008-7#2)(2010-10#1)(2011-1#2)(2012-2#2)
glycation endproducts##2##2##(1996-12#1)(2011-2#1)
glycation of human apolipoprotein##2##4##(1991-12#1)(1993-8#1)
glycation of proteins##2##3##(1990-12#1)(2008-5#1)
glycation of##6##2##(1990-12#2)(1991-12#1)(1991-5#1)(1993-8#1)(2008-5#1)
glycation products##2##2##(1990-12#2)
glycation##31##1##(1990-12#4)(1991-12#1)(1991-5#1)(1992-12#2)(1993-6#1)(1993-8#1)(1994-6#2)(1996-12#1)(2008-1#5)(2008-5#1)(2008-7#2)(2009-11#2)(2010-10#1)(2011-1#2)(2011-2#3)(2012-2#2)
glycemia within##2##2##(2008-1#1)(2008-10#1)
glycemia##9##1##(2008-1#3)(2008-10#2)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)
glycemic and##2##2##(2010-10#1)(2010-8#1)
glycemic control and##8##3##(2008-1#2)(2008-3#4)(2009-11#1)(2012-2#1)
glycemic control in##4##3##(2008-1#1)(2009-11#1)(2009-3#1)(2009-5#1)
glycemic control##29##2##(2007-7#1)(2008-1#7)(2008-3#8)(2008-7#1)(2009-11#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-4#1)(2012-5#1)(2013-7#1)
glycemic index and##3##3##(2008-1#2)(2013-8#1)
glycemic index##6##2##(2008-1#4)(2012-2#1)(2013-8#1)
glycemic load##4##2##(2008-1#3)(2013-8#1)
glycemic potential##2##2##(2008-10#2)
glycemic status##6##2##(2008-1#1)(2011-2#1)(2012-2#4)
glycemic variability##7##2##(2009-11#4)(2012-5#3)
glycemic##60##1##(2007-7#1)(2008-1#15)(2008-10#2)(2008-3#8)(2008-7#1)(2009-11#8)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#6)(2012-4#1)(2012-5#6)(2013-7#1)(2013-8#2)
glyceollin##2##1##(2008-10#2)
glyceraldehyde 3-phosphate dehydrogenase##3##3##(1994-8#1)(1996-12#1)(2008-10#1)
glyceraldehyde 3-phosphate##4##2##(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)
glyceraldehyde##8##1##(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-7#3)(2012-2#1)
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and##2##4##(1990-7#1)(2009-10#1)
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)##5##3##(1990-7#1)(1992-6#1)(1994-5#1)(1995-6#1)(2009-10#1)
glyceraldehyde-3-phosphate dehydrogenase##13##2##(1990-7#1)(1992-6#2)(1994-5#2)(1995-11#1)(1995-6#2)(2008-10#2)(2008-7#1)(2009-10#1)(2010-9#1)
glyceraldehyde-3-phosphate dehydrogenase-encoding gene##2##3##(1993-6#2)
glyceraldehyde-3-phosphate dehydrogenases##3##2##(1990-7#1)(1991-12#2)
glyceraldehyde-3-phosphate##18##1##(1990-7#2)(1991-12#2)(1992-6#2)(1993-6#2)(1994-5#2)(1995-11#1)(1995-6#2)(2008-10#2)(2008-7#1)(2009-10#1)(2010-9#1)
glyceride##2##1##(1994-3#1)(2013-1#1)
glycerin and##2##2##(2008-2#1)(2008-5#1)
glycerin##9##1##(2008-2#1)(2008-5#7)(2008-6#1)
glycerinated##3##1##(1991-12#2)(2008-6#1)
glycerine##4##1##(2008-10#2)(2008-5#2)
glycerol and##4##2##(1990-5#1)(2008-10#1)(2008-5#2)
glycerol as the##2##3##(1995-8#1)(2013-1#1)
glycerol as##5##2##(1995-8#1)(2008-6#2)(2008-7#1)(2013-1#1)
glycerol gradient##2##2##(1990-2#1)(1991-8#1)
glycerol in##6##2##(1990-5#1)(1993-3#1)(2008-10#2)(2013-1#2)
glycerol is##3##2##(2008-10#2)(2008-11#1)
glycerol or##5##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
glycerol was##3##2##(2008-11#1)(2008-6#1)(2008-7#1)
glycerol##90##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#3)(1990-7#1)(1991-1#1)(1991-3#1)(1991-8#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-8#1)(1996-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#8)(2008-2#3)(2008-5#10)(2008-6#8)(2008-7#6)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#8)
glycerol-3-phosphate##3##1##(1993-6#1)(2008-10#1)(2008-5#1)
glycerolipid##2##1##(1993-6#2)
glycerophosphate dehydrogenase##2##2##(1992-9#1)(2008-11#1)
glycerophosphate##4##1##(1991-2#2)(1992-9#1)(2008-11#1)
glycerophosphoinositol##5##1##(1990-8#2)(2012-12#1)(2013-8#2)
glyceryl trinitrate (GTN)##3##3##(1995-11#1)(2007-10#1)(2009-5#1)
glyceryl trinitrate##7##2##(1995-11#1)(2007-10#2)(2007-8#2)(2008-8#1)(2009-5#1)
glyceryl##11##1##(1995-11#1)(2007-10#2)(2007-8#2)(2008-5#1)(2008-8#1)(2009-5#2)(2013-1#2)
glycidyl ether##2##2##(2012-12#2)
glycidyl methacrylate (GMA) and ethylene##2##5##(2008-10#2)
glycidyl##6##1##(2008-10#2)(2012-12#2)(2012-2#2)
glycinal diethylacetal##5##2##(1990-12#5)
glycinal##6##1##(1990-12#6)
glycinamide ribonucleotide synthetase##2##3##(1993-12#2)
glycinamide ribonucleotide##3##2##(1993-12#3)
glycinamide##5##1##(1993-12#3)(1994-8#2)
glycine (F3MBAG)##2##2##(1994-8#2)
glycine (Gly) and##2##3##(1995-5#1)(2008-10#1)
glycine (Gly)##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
glycine 212##3##2##(1995-2#3)
glycine alone##3##2##(1997-1#1)(1997-2#1)(1997-3#1)
glycine and GABA##4##3##(1995-2#1)(1997-2#3)
glycine and arginine##2##3##(2008-10#2)
glycine and glutamate##3##3##(1997-3#1)(2008-7#2)
glycine and glutamine##2##3##(1993-3#1)(1996-5#1)
glycine and lysine##2##3##(1996-2#1)(2008-12#1)
glycine and##24##2##(1990-8#2)(1992-10#1)(1993-3#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)
glycine at##5##2##(1991-12#1)(2008-8#3)(2011-1#1)
glycine decarboxylase cDNA##2##3##(1990-12#2)
glycine decarboxylase##4##2##(1990-12#4)
glycine in##2##2##(1996-5#1)(2008-5#1)
glycine of the##2##3##(2008-8#1)(2009-6#1)
glycine precipitation##2##2##(2008-10#2)
glycine receptor##7##2##(1992-11#3)(1996-2#3)(1997-7#1)
glycine receptors##4##2##(1992-11#1)(1995-11#3)
glycine residue in##2##3##(1994-5#1)(1995-2#1)
glycine residue##3##2##(1991-2#1)(1994-5#1)(1995-2#1)
glycine synthesis##2##2##(1992-10#2)
glycine was the##2##3##(1997-1#2)
glycine##136##1##(1990-12#4)(1990-2#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1992-10#4)(1992-11#4)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#5)(1995-2#6)(1995-5#2)(1996-2#5)(1996-5#6)(1997-1#13)(1997-2#8)(1997-3#4)(1997-7#1)(1997-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#7)(2009-6#1)(2010-1#1)(2011-1#4)
glycine(463 and 701)##2##3##(1996-2#2)
glycine)##4##1##(2008-10#3)(2011-1#1)
glycine- and##2##2##(1997-2#1)(2010-5#1)
glycine-rich##6##1##(1992-8#1)(1995-6#1)(1997-7#2)(2008-10#1)(2012-2#1)
glycine-serine interconversion##2##2##(1997-1#2)
glycinea MAFF301683##2##2##(2008-10#2)
glycinea and phaseolicola##2##3##(2008-10#2)
glycinea##13##1##(2008-10#13)
glycinebetaine##7##1##(1997-4#4)(2008-4#3)
glycinergic##3##1##(1995-11#1)(1995-2#1)(1997-2#1)
glycines and F##2##3##(2008-10#2)
glycines and Heterodera glycines in##2##5##(2008-10#2)
glycines and##8##2##(2008-10#8)
glycines did not##2##3##(2008-10#2)
glycines in vitro##2##3##(2008-10#2)
glycines in##6##2##(2008-10#6)
glycines is##2##2##(2008-10#2)
glycines populations##4##2##(2008-10#4)
glycines was##2##2##(2008-10#2)
glycines were determined from##2##4##(2008-10#2)
glycines were##8##2##(2008-10#8)
glycines##78##1##(1992-6#1)(1997-6#4)(2008-10#73)
glycitein##5##1##(1993-12#1)(2008-10#2)(2010-1#2)
glyco-protein##2##1##(1991-8#1)(1997-3#1)
glycoalkaloids##8##1##(2008-10#7)(2008-9#1)
glycoamidases##2##1##(2008-4#2)
glycobiosyl##3##1##(1992-12#3)
glycocalyx resistance##2##2##(2008-12#2)
glycocalyx##4##1##(1994-9#1)(2008-12#3)
glycoconjugate##7##1##(1991-9#1)(1992-11#1)(2007-12#1)(2008-4#1)(2010-11#1)(2011-2#2)
glycoconjugates in##2##2##(1994-12#1)(2011-2#1)
glycoconjugates##15##1##(1990-7#1)(1994-12#1)(1995-2#2)(2008-10#1)(2008-4#7)(2010-11#1)(2011-2#2)
glycoform distribution##2##2##(2008-7#2)
glycoform##6##1##(2008-7#5)(2011-2#1)
glycoforms were##2##2##(2008-11#1)(2009-8#1)
glycoforms##6##1##(2008-11#2)(2008-7#2)(2009-8#2)
glycogen and##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
glycogen by light scattering technique##2##5##(2008-10#2)
glycogen by##3##2##(1993-8#1)(2008-10#2)
glycogen content##2##2##(1993-8#2)
glycogen depletion##2##2##(2008-5#1)(2013-8#1)
glycogen in##3##2##(1995-8#2)(2008-10#1)
glycogen loading##2##2##(2008-5#2)
glycogen phosphorylase##5##2##(1991-11#4)(1996-2#1)
glycogen storage disease##3##3##(2008-7#2)(2012-2#1)
glycogen storage diseases##2##3##(2008-11#1)(2012-2#1)
glycogen storage##5##2##(2008-11#1)(2008-7#2)(2012-2#2)
glycogen synthase##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
glycogen synthesis##5##2##(1992-6#1)(1994-8#1)(1995-6#1)(2010-4#1)(2012-2#1)
glycogen##65##1##(1990-2#3)(1990-8#1)(1991-11#4)(1992-6#1)(1993-8#7)(1994-3#1)(1994-8#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#2)(1997-4#1)(2007-12#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#4)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2012-2#6)(2013-1#2)(2013-8#1)
glycogen)##2##1##(1990-2#1)(1994-3#1)
glycogenolysis##2##1##(1995-11#1)(1996-2#1)
glycoinositol phospholipid##2##2##(1992-3#2)
glycol (PG)##2##2##(2008-11#1)(2008-5#1)
glycol and##8##2##(1991-5#2)(2008-10#2)(2008-11#3)(2011-2#1)
glycol chitosan##2##2##(2008-10#2)
glycol derivative##2##2##(1993-11#1)(2008-10#1)
glycol dimethacrylate (EGDMA)##3##3##(2008-10#3)
glycol dimethacrylate##6##2##(2008-10#5)(2013-1#1)
glycol donor##2##2##(2008-4#2)
glycol##90##1##(1990-12#2)(1991-5#6)(1992-11#1)(1992-6#1)(1993-11#2)(1994-3#3)(1995-3#1)(1997-5#1)(2007-7#1)(2008-10#30)(2008-11#5)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#11)(2008-7#3)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
glycol)##24##1##(1993-6#1)(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-1#6)
glycol)s##3##1##(2008-10#3)
glycolate oxidase##2##2##(1997-7#1)(2008-8#1)
glycolate##5##1##(1997-7#2)(2008-8#1)(2010-3#2)
glycolic acid in##3##3##(2007-7#1)(2008-5#2)
glycolic acid##7##2##(2007-12#1)(2007-7#2)(2008-5#4)
glycolic##12##1##(2007-12#1)(2007-7#2)(2008-10#4)(2008-5#5)
glycolipid##11##1##(1990-5#2)(1990-7#1)(1990-9#1)(1993-9#1)(1994-12#1)(2008-11#1)(2009-10#1)(2010-10#3)
glycolipids##9##1##(1994-12#2)(1994-9#1)(2008-11#5)(2012-2#1)
glycols)##2##1##(2008-10#2)
glycolysis and kreb cycle##3##4##(2010-7#3)
glycolysis and##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-7#3)
glycolysis##24##1##(1992-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-6#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#3)(2012-1#1)(2013-1#1)(2013-8#1)
glycolytic activity##3##2##(1992-9#1)(2008-11#1)(2013-1#1)
glycolytic enzyme##2##2##(1993-6#1)(2009-12#1)
glycolytic enzymes in##2##3##(1994-8#1)(2010-12#1)
glycolytic enzymes##6##2##(1994-8#2)(1996-3#2)(1997-2#1)(2010-12#1)
glycolytic flux##3##2##(1992-3#1)(2008-6#1)(2008-7#1)
glycolytic intermediates##4##2##(1996-6#1)(1997-1#3)
glycolytic oscillations##2##2##(1990-8#1)(1996-6#1)
glycolytic pathway##8##2##(1990-11#1)(1991-9#1)(1996-6#1)(2008-11#2)(2008-7#2)(2012-2#1)
glycolytic##39##1##(1990-11#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-8#3)(1996-3#2)(1996-6#6)(1997-1#3)(1997-2#1)(2008-11#3)(2008-6#1)(2008-7#3)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#2)
glyconanoparticles with##2##2##(2008-8#2)
glyconanoparticles##4##1##(2008-8#4)
glycopeptide##10##1##(1990-5#4)(1990-8#3)(2008-10#2)(2008-8#1)
glycopeptides and##2##2##(1990-7#1)(2007-12#1)
glycopeptides##11##1##(1990-12#3)(1990-5#1)(1990-7#1)(1991-9#1)(1992-6#1)(2007-12#1)(2008-4#1)(2010-11#1)(2011-2#1)
glycophorin A##4##2##(1991-5#2)(1993-12#1)(1994-5#1)
glycophorin C##3##2##(1992-6#3)
glycophorin alpha##4##2##(1992-11#4)
glycophorin##17##1##(1991-5#4)(1992-11#4)(1992-6#3)(1993-12#2)(1994-12#1)(1994-5#1)(2008-9#2)
glycopolypeptides##6##1##(2009-2#6)
glycoprotein (HPRG)##2##2##(1995-2#1)(1997-2#1)
glycoprotein E##2##2##(2011-2#2)
glycoprotein IIb-IIIa complex##2##3##(1990-5#2)
glycoprotein IIb-IIIa##5##2##(1990-5#4)(2006-6#1)
glycoprotein IIb/IIIa##4##2##(2008-3#3)(2009-12#1)
glycoprotein Ib##2##2##(1994-11#2)
glycoprotein and##5##2##(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(2013-8#1)
glycoprotein can##3##2##(1992-8#1)(2008-7#2)
glycoprotein elicitor##2##2##(2008-10#2)
glycoprotein glycans##2##2##(2008-1#1)(2010-11#1)
glycoprotein hormones##3##2##(1990-4#1)(1991-3#1)(1995-8#1)
glycoprotein in##3##2##(1991-12#1)(1997-4#1)(2008-11#1)
glycoprotein is##2##2##(1992-6#1)(1994-8#1)
glycoprotein of##6##2##(1991-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#1)
glycoprotein produced##2##2##(2008-11#2)
glycoprotein synthesis##2##2##(1993-6#1)(1996-12#1)
glycoprotein that is important in##2##5##(1995-2#1)(2013-1#1)
glycoprotein that is##4##3##(1990-11#1)(1995-2#1)(2009-4#1)(2013-1#1)
glycoprotein that##6##2##(1990-11#1)(1995-2#1)(2008-4#2)(2009-4#1)(2013-1#1)
glycoprotein was cloned##2##3##(1994-3#1)(1995-11#1)
glycoprotein was##4##2##(1994-3#1)(1995-11#1)(2007-8#1)(2008-10#1)
glycoprotein with##5##2##(1990-5#1)(1992-8#1)(1993-3#1)(1995-2#1)(2008-4#1)
glycoprotein##153##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#6)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-8#1)(1991-9#3)(1992-12#3)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#2)(1993-3#5)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#5)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-7#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#10)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#7)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2011-2#5)(2013-1#3)(2013-8#3)
glycoproteins and##2##2##(1990-12#1)(2008-4#1)
glycoproteins by##3##2##(1990-5#1)(1991-5#1)(1994-9#1)
glycoproteins containing##4##2##(1990-12#2)(2008-4#1)(2010-12#1)
glycoproteins during meiotic maturation##2##4##(2013-1#2)
glycoproteins from##2##2##(1993-11#1)(2008-11#1)
glycoproteins in the##2##3##(1990-11#1)(2008-5#1)
glycoproteins in##7##2##(1990-11#1)(1990-12#1)(2008-1#2)(2008-11#1)(2008-5#1)(2010-12#1)
glycoproteins occurred during meiotic maturation and##2##6##(2013-1#2)
glycoproteins of##3##2##(1994-6#1)(2008-10#1)(2008-5#1)
glycoproteins or##3##2##(1996-12#1)(1997-2#1)(2011-2#1)
glycoproteins were##2##2##(1992-8#1)(1994-9#1)
glycoproteins with##5##2##(1990-5#1)(1996-12#1)(2008-1#1)(2008-7#1)(2009-8#1)
glycoproteins##88##1##(1990-11#4)(1990-12#6)(1990-2#1)(1990-5#4)(1990-7#2)(1991-5#3)(1992-10#4)(1992-8#5)(1993-11#1)(1993-6#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#5)(2008-10#5)(2008-11#6)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#2)(2009-8#1)(2010-12#2)(2011-2#2)(2012-1#1)(2013-1#4)
glycoproteomic##3##1##(2010-12#3)
glycosaminoglycan (GAG)##2##2##(1992-9#1)(2012-3#1)
glycosaminoglycan free chains##3##3##(1991-9#3)
glycosaminoglycan free##4##2##(1991-9#4)
glycosaminoglycan heparin##2##2##(1995-2#2)
glycosaminoglycan side##2##2##(1991-9#1)(1993-2#1)
glycosaminoglycan synthesis##3##2##(1992-9#2)(2008-5#1)
glycosaminoglycan##21##1##(1990-5#2)(1991-9#6)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-2#1)(1995-2#3)(2008-5#1)(2011-1#1)(2012-3#1)
glycosaminoglycans (GAGs)##2##2##(1990-2#1)(1993-12#1)
glycosaminoglycans and##2##2##(1991-1#1)(1992-3#1)
glycosaminoglycans in##2##2##(1990-5#1)(2011-2#1)
glycosaminoglycans##17##1##(1990-2#1)(1990-5#1)(1991-1#1)(1992-3#4)(1993-12#3)(1995-2#1)(2008-5#3)(2008-9#1)(2010-11#1)(2011-2#1)
glycosidase##7##1##(1991-9#1)(1992-10#3)(2008-8#2)(2009-9#1)
glycosidases##5##1##(1992-10#1)(2008-10#1)(2008-11#3)
glycoside and##3##2##(1997-4#1)(2007-11#1)(2008-9#1)
glycoside from the##3##3##(1994-11#1)(2008-11#2)
glycoside##27##1##(1991-8#1)(1994-11#2)(1995-11#4)(1997-4#2)(2007-11#3)(2008-10#1)(2008-11#5)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#1)(2010-6#2)(2012-2#1)
glycosides and##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
glycosides from##2##2##(2007-11#1)(2010-6#1)
glycosides were##3##2##(2008-11#2)(2009-8#1)
glycosides##27##1##(1992-12#3)(1995-11#1)(2007-11#2)(2008-10#2)(2008-11#7)(2008-12#3)(2008-8#1)(2009-8#1)(2010-6#2)(2013-1#3)(2013-7#2)
glycosidic bonds##2##2##(1992-12#1)(2009-10#1)
glycosidic linkage##5##2##(1990-5#1)(1992-3#1)(1993-11#2)(2010-5#1)
glycosidic##13##1##(1990-12#1)(1990-5#1)(1991-7#1)(1992-12#2)(1992-3#1)(1993-11#4)(1993-3#1)(2009-10#1)(2010-5#1)
glycosphingolipid##5##1##(1994-3#2)(1995-12#1)(2007-7#1)(2011-1#1)
glycosphingolipids##5##1##(1990-7#2)(1993-3#1)(1994-3#1)(2010-11#1)
glycosyl donors##2##2##(2008-12#2)
glycosyl hydrolase family##3##3##(1995-6#1)(2009-10#1)(2013-1#1)
glycosyl hydrolases##2##2##(2008-10#1)(2009-3#1)
glycosyl##15##1##(1991-3#1)(1992-12#2)(1994-5#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2013-1#1)
glycosylase##3##1##(1994-5#1)(1996-8#1)(1997-4#1)
glycosylasparaginase##8##1##(1991-7#6)(1993-11#2)
glycosylated and##8##2##(1990-5#1)(1991-9#1)(1992-8#2)(1994-3#2)(1994-9#1)(1997-4#1)
glycosylated forms of##2##3##(1990-12#1)(1993-8#1)
glycosylated forms##3##2##(1990-12#1)(1993-8#1)(1997-4#1)
glycosylated haemoglobin##4##2##(1993-12#1)(1993-2#1)(1996-12#1)(2008-10#1)
glycosylated hemoglobin##7##2##(1990-6#2)(1991-2#3)(2008-3#1)(2012-12#1)
glycosylated protein##2##2##(1993-6#1)(2010-11#1)
glycosylated##54##1##(1990-12#3)(1990-5#1)(1990-6#2)(1991-2#4)(1991-9#1)(1992-10#3)(1992-12#5)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-9#1)(1996-12#1)(1997-4#2)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
glycosylation and##8##2##(1990-12#1)(1992-6#1)(1992-9#1)(1996-12#1)(2008-11#2)(2010-11#1)(2010-12#1)
glycosylation are##2##2##(1991-9#1)(2013-8#1)
glycosylation as##2##2##(1993-6#1)(2008-11#1)
glycosylation at##5##2##(1990-12#1)(1991-9#2)(1992-12#1)(1993-8#1)
glycosylation by##2##2##(1994-11#1)(2008-11#1)
glycosylation for##2##2##(1995-2#1)(2008-11#1)
glycosylation in the##2##3##(1992-12#1)(2008-8#1)
glycosylation in##7##2##(1992-12#1)(1992-6#1)(1993-1#1)(1993-6#1)(1995-2#1)(2008-8#1)(2010-11#1)
glycosylation is##5##2##(1994-11#1)(1995-2#3)(2008-11#1)
glycosylation mutants##2##2##(1992-3#1)(1995-2#1)
glycosylation of proteins in##2##4##(2008-4#1)(2011-2#1)
glycosylation of recombinant##2##3##(2008-8#1)(2011-2#1)
glycosylation of the##6##3##(1992-12#2)(1992-5#1)(1993-1#1)(1994-11#1)(1994-8#1)
glycosylation of##27##2##(1990-12#1)(1992-12#4)(1992-5#2)(1993-1#1)(1994-11#4)(1994-8#2)(1995-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#3)(2010-5#1)(2011-2#3)
glycosylation patterns##3##2##(2008-11#2)(2013-8#1)
glycosylation process##3##2##(1991-9#1)(2008-11#1)(2008-7#1)
glycosylation profile##2##2##(2008-11#2)
glycosylation reactions##2##2##(1992-12#1)(2008-5#1)
glycosylation site##7##2##(1990-5#2)(1992-10#1)(1992-12#1)(1994-11#2)(2008-4#1)
glycosylation sites at##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
glycosylation sites##17##2##(1990-5#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2013-8#1)
glycosylation was##5##2##(1991-9#1)(1994-11#1)(1995-2#1)(2008-11#2)
glycosylation##150##1##(1990-12#3)(1990-5#3)(1991-9#5)(1992-10#2)(1992-12#12)(1992-3#4)(1992-5#4)(1992-6#7)(1992-9#2)(1993-1#2)(1993-2#1)(1993-6#5)(1993-8#1)(1994-11#11)(1994-3#1)(1994-8#4)(1995-2#10)(1995-3#1)(1996-12#1)(2008-11#28)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2010-11#8)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#3)
glycosylphosphatidylinositol (GPI)##3##2##(1996-3#1)(2008-9#1)(2012-2#1)
glycosylphosphatidylinositol##6##1##(1995-2#1)(1996-3#2)(2008-11#1)(2008-9#1)(2012-2#1)
glycosylphosphatidylinositol-anchored##2##1##(1995-2#1)(2008-11#1)
glycosyltransferase##2##1##(2009-10#2)
glycosyltransferases##5##1##(1990-5#1)(1990-7#2)(1996-6#1)(2009-10#1)
glycuronic acids##4##2##(1991-7#4)
glycyl radical##3##2##(1995-2#3)
glycyl##7##1##(1990-12#1)(1990-2#1)(1990-7#1)(1995-2#3)(2006-6#1)
glycylglycine##2##1##(1990-8#1)(2008-10#1)
glycyrrhetic acid##2##2##(2008-9#2)
glycyrrhetinic acid##2##2##(2012-3#2)
glycyrrhetinic##3##1##(2012-3#3)
glyoxal##5##1##(1992-5#1)(2008-10#3)(2008-5#1)
glyoxalase I##6##2##(1991-12#1)(1991-5#3)(2008-10#2)
glyoxalase##7##1##(1991-12#1)(1991-5#3)(2008-10#2)(2008-11#1)
glyoxime##3##1##(2008-10#3)
glyoxylate aminotransferase (AGT)##2##3##(1992-6#1)(1995-12#1)
glyoxylate aminotransferase activity in human liver##2##6##(1992-6#1)(1993-9#1)
glyoxylate aminotransferase##6##2##(1992-6#2)(1993-9#1)(1995-12#3)
glyoxylate##11##1##(1992-6#2)(1993-9#2)(1995-12#4)(1997-7#1)(2008-10#1)(2008-7#1)
glyoxylic acid##5##2##(1990-11#3)(1992-5#1)(1997-7#1)
glyphosate and##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
glyphosate were##2##2##(2010-1#2)
glyphosate##18##1##(2008-10#6)(2008-7#1)(2008-9#1)(2010-1#5)(2011-1#2)(2011-2#3)
glyphosate-tolerant##3##1##(2008-10#1)(2011-2#2)
glyptosternoid fishes##2##2##(2008-9#2)
gm/m(2) given##2##2##(2008-6#2)
gm/m(2)##3##1##(2008-6#3)
gml(-1) vanadium##2##2##(2008-10#2)
gml(-1)##6##1##(2008-10#6)
gna##3##1##(2006-12#3)
gnotobiotic##9##1##(1991-8#1)(2008-10#4)(2008-12#2)(2008-5#2)
go a long way to##3##5##(1991-2#1)(1995-12#1)(2010-3#1)
go a long way##5##4##(1991-2#1)(1995-12#1)(1996-1#1)(2010-3#1)(2010-7#1)
go a##6##2##(1991-2#1)(1994-2#1)(1995-12#1)(1996-1#1)(2010-3#1)(2010-7#1)
go about their daily##2##4##(2008-9#1)(2010-5#1)
go about##5##2##(1992-1#1)(2008-11#1)(2008-9#2)(2010-5#1)
go away##2##2##(1993-12#1)(1993-2#1)
go back to the##2##4##(2009-10#1)(2010-6#1)
go back to##3##3##(2009-10#1)(2010-1#1)(2010-6#1)
go back##4##2##(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)
go beyond the##2##3##(2008-10#1)(2012-3#1)
go beyond##7##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
go for##2##2##(1994-12#1)(1995-9#1)
go hand in hand##2##4##(2009-7#1)(2012-2#1)
go home##4##2##(1993-1#1)(1997-3#2)(1997-7#1)
go in##3##2##(1991-12#1)(1994-7#1)(2008-7#1)
go into##4##2##(1990-8#1)(2007-8#1)(2008-5#1)(2008-7#1)
go on to##2##3##(1994-1#1)(2007-2#1)
go on##3##2##(1994-1#1)(2007-2#1)(2011-2#1)
go signal-related neurons##2##3##(1991-6#2)
go through the##2##3##(2007-5#1)(2012-2#1)
go through##4##2##(1992-11#1)(1995-12#1)(2007-5#1)(2012-2#1)
go to the##3##3##(1992-12#1)(1993-2#1)(1995-6#1)
go to##10##2##(1990-5#1)(1992-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-6#1)(2007-2#1)(2011-2#1)(2012-2#1)
go undetected##2##2##(2007-12#1)(2008-5#1)
go unrecognised##2##2##(2007-6#1)(2010-12#1)
go##105##1##(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-7#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#5)
go&quot##3##1##(2008-3#1)(2012-12#1)(2013-8#1)
go?##5##1##(1996-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
goal attainment##3##2##(2008-3#2)(2010-2#1)
goal disengagement and re-engagement##2##4##(2010-2#2)
goal disengagement##3##2##(2010-2#3)
goal for the##4##3##(1992-3#1)(2007-12#1)(2008-11#1)(2008-3#1)
goal for##9##2##(1991-2#1)(1992-3#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
goal in the treatment of##3##5##(2007-11#1)(2007-12#1)(2008-11#1)
goal in the##6##3##(1991-6#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-4#1)
goal in this##2##3##(2008-3#1)(2012-2#1)
goal in##20##2##(1991-6#1)(1993-2#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
goal is the##2##3##(1997-3#1)(2008-7#1)
goal is to create##2##4##(2007-12#1)(2008-6#1)
goal is to improve##2##4##(2008-11#1)(2012-3#1)
goal is to provide##2##4##(1995-3#1)(2008-5#1)
goal is to understand##2##4##(2008-2#1)(2009-12#1)
goal is to##23##3##(1992-2#1)(1993-2#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2012-1#1)(2012-3#1)
goal is##31##2##(1992-1#1)(1992-2#1)(1993-2#1)(1994-11#1)(1995-3#2)(1996-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-3#1)
goal of a##2##3##(1994-1#1)(2008-4#1)
goal of achieving##2##3##(2007-7#1)(2009-7#1)
goal of determining##4##3##(1992-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
goal of health##2##3##(1991-2#1)(1994-2#1)
goal of improving##2##3##(1997-1#1)(2011-2#1)
goal of our##5##3##(1997-8#1)(2007-8#2)(2011-2#1)(2012-3#1)
goal of such##2##3##(2008-2#1)(2010-12#1)
goal of surgery##2##3##(2007-11#2)
goal of the##23##3##(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
goal of these##2##3##(2008-11#1)(2009-6#1)
goal of this article is to##2##6##(2013-1#2)
goal of this article is##4##5##(2008-10#1)(2011-2#1)(2013-1#2)
goal of this article##5##4##(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
goal of this paper##2##4##(1996-3#1)(2008-10#1)
goal of this project was to##2##6##(2007-11#1)(2013-1#1)
goal of this review is to##6##6##(2008-11#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-3#1)
goal of this study was to##28##6##(1992-8#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-7#2)(2010-8#1)(2011-1#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#2)
goal of this study##35##4##(1992-8#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#3)
goal of this##74##3##(1992-8#1)(1994-2#1)(1994-8#1)(1996-3#2)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#5)(2012-4#1)(2013-1#5)(2013-8#3)
goal of##199##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#7)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#7)(2008-5#1)(2008-6#6)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#11)(2011-3#1)(2011-8#1)(2012-12#4)(2012-2#12)(2012-3#5)(2012-4#1)(2013-1#9)(2013-8#4)
goal or##2##2##(1996-2#1)(2012-2#1)
goal setting##2##2##(1997-2#1)(2009-10#1)
goal should be##3##3##(1993-12#1)(2007-7#1)(2011-2#1)
goal to##6##2##(1994-3#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-9#1)
goal was to establish##2##4##(1997-4#1)(2011-2#1)
goal was to identify##2##4##(1996-12#1)(2007-12#1)
goal was to##13##3##(1992-1#1)(1996-12#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2011-2#1)(2012-3#1)
goal was##15##2##(1992-1#1)(1993-3#1)(1996-12#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
goal will##3##2##(1994-7#1)(2008-10#1)(2010-3#1)
goal##375##1##(1990-5#1)(1991-2#2)(1991-3#2)(1991-6#2)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#2)(1992-8#2)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#7)(1994-1#1)(1994-11#3)(1994-2#4)(1994-3#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#10)(2007-12#12)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#23)(2008-11#26)(2008-12#5)(2008-2#6)(2008-3#14)(2008-4#11)(2008-5#2)(2008-6#12)(2008-7#11)(2008-8#6)(2008-9#10)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#4)(2010-11#2)(2010-12#4)(2010-2#7)(2010-3#5)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#3)(2011-2#16)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#1)(2012-12#6)(2012-2#16)(2012-3#9)(2012-4#1)(2013-1#11)(2013-8#5)
goal-directed behavior##2##2##(2008-11#1)(2008-4#1)
goal-directed behaviors##2##2##(2007-8#2)
goal-directed##8##1##(2007-8#2)(2008-11#1)(2008-4#1)(2010-10#1)(2013-1#1)(2013-8#2)
goal-driven##2##1##(2012-3#2)
goal-oriented##2##1##(1994-3#1)(2010-10#1)
goals and objectives##7##3##(1991-12#1)(1994-12#2)(1996-3#1)(2007-4#1)(2008-12#1)(2011-2#1)
goals and priorities##2##3##(1996-1#2)
goals and##32##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-3#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
goals are to##5##3##(1993-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
goals are##8##2##(1993-1#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
goals at##2##2##(2008-6#1)(2011-1#1)
goals by##2##2##(1995-12#1)(2007-10#1)
goals for##11##2##(1991-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-8#3)(2011-2#1)(2012-12#2)
goals has##2##2##(2012-3#1)(2013-1#1)
goals in this##2##3##(2008-10#1)(2009-8#1)
goals in##10##2##(1995-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
goals may##2##2##(2008-12#1)(2009-7#1)
goals of our##4##3##(2008-3#1)(2012-3#1)(2013-1#2)
goals of reconstruction##2##3##(2010-6#1)(2011-2#1)
goals of the project##2##4##(1995-3#1)(1996-1#1)
goals of the##17##3##(1991-12#1)(1994-9#1)(1995-3#2)(1996-1#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#2)(2013-1#1)
goals of therapy##3##3##(1994-7#1)(2010-6#2)
goals of this##5##3##(1994-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
goals of treatment of##2##4##(2008-3#1)(2008-9#1)
goals of treatment##4##3##(1996-7#1)(2007-12#1)(2008-3#1)(2008-9#1)
goals of##70##2##(1991-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-1#1)(1995-3#3)(1996-1#4)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
goals should be##2##3##(2008-6#1)(2008-7#1)
goals than##2##2##(2007-2#1)(2012-5#1)
goals that##4##2##(1996-2#1)(2006-5#1)(2009-12#1)(2010-3#1)
goals to be##2##3##(2008-12#1)(2008-7#1)
goals to##3##2##(1996-3#1)(2008-12#1)(2008-7#1)
goals were to##4##3##(1993-1#1)(2008-8#1)(2013-1#1)(2013-8#1)
goals were##7##2##(1991-1#1)(1993-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
goals##266##1##(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#4)(1994-12#6)(1994-2#3)(1994-3#9)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#4)(1995-12#2)(1995-2#3)(1995-3#6)(1995-5#1)(1996-1#13)(1996-12#2)(1996-2#4)(1996-3#12)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#3)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#10)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#3)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#8)(2011-2#9)(2012-12#8)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#10)(2013-8#3)
goat Mb has##2##3##(2010-4#2)
goat Mb##5##2##(2010-4#5)
goat and rat gastrointestinal tracts##2##5##(2013-1#2)
goat and##6##2##(1991-8#1)(2008-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
goat anti-human IgG##2##3##(1990-12#1)(2008-10#1)
goat anti-mouse IgG##2##3##(1995-2#1)(2008-10#1)
goat anti-rabbit IgG##3##3##(2008-10#3)
goat anti-rabbit IgG)##2##3##(2008-4#2)
goat anti-rabbit##6##2##(2008-10#4)(2008-4#2)
goat in##2##2##(1997-7#1)(2013-1#1)
goat##47##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-8#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#2)(2010-2#1)(2010-4#11)(2011-1#2)(2011-2#2)(2013-1#4)
goats against##2##2##(1996-12#2)
goats and sheep##3##3##(2008-12#2)(2011-2#1)
goats and##5##2##(1996-12#1)(2008-12#2)(2008-8#1)(2011-2#1)
goats in##2##2##(2008-12#1)(2011-2#1)
goats was##3##2##(2008-12#1)(2008-8#1)(2008-9#1)
goats were##5##2##(2008-12#2)(2010-2#3)
goats##45##1##(1992-3#1)(1996-12#11)(1996-5#1)(1997-7#1)(1997-8#3)(2008-12#9)(2008-5#1)(2008-8#3)(2008-9#2)(2010-2#5)(2010-4#2)(2011-1#1)(2011-2#3)(2013-1#2)
goblet cell carcinoids##2##3##(2013-1#2)
goblet cell##7##2##(1994-11#2)(1996-7#1)(2013-1#3)(2013-8#1)
goblet cells##5##2##(1990-2#1)(1994-11#2)(1997-7#1)(2008-5#1)
goblet##12##1##(1990-2#1)(1994-11#4)(1996-7#1)(1997-7#1)(2008-5#1)(2013-1#3)(2013-8#1)
goby##3##1##(2010-8#3)
goes along with##2##3##(2011-2#2)
goes beyond the##4##3##(2008-2#1)(2008-7#1)(2011-2#2)
goes beyond##5##2##(1997-3#1)(2008-2#1)(2008-7#1)(2011-2#2)
goes both ways##2##3##(1995-12#1)(2008-7#1)
goes on to##5##3##(1993-2#1)(1994-3#1)(2008-12#1)(2008-9#1)(2013-7#1)
goes on##6##2##(1990-3#1)(1993-2#1)(1994-3#1)(2008-12#1)(2008-9#1)(2013-7#1)
goes through a##2##3##(2010-9#1)(2011-3#1)
goes through##5##2##(1992-11#1)(2008-10#1)(2010-9#1)(2011-3#1)(2013-7#1)
goes to the##3##3##(1990-11#1)(1996-5#1)(2008-7#1)
goes to##6##2##(1990-11#1)(1996-5#2)(1997-5#1)(2008-3#1)(2008-7#1)
goes##38##1##(1990-11#2)(1990-3#1)(1992-11#2)(1993-12#1)(1993-2#2)(1994-3#1)(1995-12#1)(1996-5#2)(1997-3#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#2)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#5)(2011-3#1)(2013-7#2)
goggle objectives##2##2##(2008-2#2)
going beyond##2##2##(1993-12#1)(2010-8#1)
going from the##4##3##(1992-8#1)(1997-7#1)(2008-10#1)(2008-5#1)
going from##7##2##(1992-8#1)(1996-11#1)(1997-7#1)(2008-10#3)(2008-5#1)
going in##2##2##(2008-1#1)(2013-1#1)
going into the##2##3##(2008-3#1)(2011-1#1)
going into##5##2##(2007-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)
going through##6##2##(1991-12#1)(1996-2#1)(2008-2#1)(2008-8#1)(2013-1#2)
going to be##11##3##(1990-11#1)(1991-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2010-4#1)(2011-3#1)
going to have##3##3##(1990-2#1)(2013-1#2)
going to##27##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
going##65##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-5#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#5)
goiter in##2##2##(1990-6#1)(2007-8#1)
goiter is##2##2##(2013-1#2)
goiter##23##1##(1990-6#1)(1992-5#1)(2007-8#6)(2008-4#1)(2010-7#1)(2011-1#5)(2012-3#1)(2013-1#5)(2013-8#2)
goiters##4##1##(2008-4#1)(2013-1#3)
goitre and##3##2##(1990-8#1)(1990-9#1)(1993-5#1)
goitre##15##1##(1990-8#1)(1990-9#3)(1992-2#1)(1993-5#7)(1993-6#2)(1994-6#1)
goitrogens##2##1##(1990-8#1)(1996-5#1)
goitrous hypothyroidism##2##2##(2011-1#2)
gold (Au)##2##2##(2008-10#2)
gold and silver##3##3##(2008-10#3)
gold and##11##2##(2008-10#7)(2008-3#2)(2008-5#1)(2010-5#1)
gold colloid monolayers##3##3##(2007-12#3)
gold colloid##5##2##(2007-12#5)
gold concentration##3##2##(1994-5#1)(1995-3#1)(2008-10#1)
gold cytochemistry##2##2##(2008-10#2)
gold disk##2##2##(2008-10#2)
gold electrode and##2##3##(2008-10#2)
gold electrode modified with##8##4##(2008-10#8)
gold electrode surface##4##3##(2008-10#4)
gold electrode was##2##3##(2008-10#2)
gold electrode##41##2##(2008-10#41)
gold electrodes##18##2##(1990-5#2)(2008-10#15)(2008-7#1)
gold filament##2##2##(2010-5#2)
gold film##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
gold films##4##2##(2008-10#1)(2008-3#3)
gold from##3##2##(1994-5#1)(2007-12#1)(2008-9#1)
gold in##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
gold island films##3##3##(2008-10#1)(2013-8#2)
gold layer##2##2##(2007-12#1)(2008-10#1)
gold microelectrode##3##2##(2008-10#3)
gold nanoparticle solution##2##3##(2008-10#2)
gold nanoparticle##6##2##(2008-10#5)(2010-5#1)
gold nanoparticles are##2##3##(2008-10#1)(2008-4#1)
gold nanoparticles for##2##3##(2008-10#2)
gold nanoparticles loaded with##2##4##(2008-10#2)
gold nanoparticles##23##2##(2008-10#14)(2008-11#2)(2008-4#1)(2008-7#3)(2009-7#1)(2010-12#1)(2013-8#1)
gold nanoplate##5##2##(2013-1#5)
gold nanorods (GNRs)##2##3##(2010-1#1)(2012-12#1)
gold nanorods##3##2##(2010-1#1)(2012-12#1)(2013-1#1)
gold or silver##2##3##(2008-10#2)
gold or##3##2##(2008-10#3)
gold particle##4##2##(2007-12#4)
gold particles##13##2##(1992-12#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)
gold shell##2##2##(2008-10#1)(2010-6#1)
gold sodium thiomalate (AuTM) in##2##5##(1994-5#1)(1995-3#1)
gold sodium thiomalate##4##3##(1994-5#2)(1995-3#2)
gold sol##2##2##(2008-10#2)
gold standard diagnostic##2##3##(2011-2#1)(2011-3#1)
gold standard for the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
gold standard for##10##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
gold standard in##6##3##(2007-8#1)(2008-1#1)(2011-2#2)(2011-3#1)(2012-12#1)
gold standard is##2##3##(1997-8#1)(2013-1#1)
gold standard test##2##3##(2008-12#1)(2012-3#1)
gold standard##52##2##(1994-1#1)(1996-6#1)(1997-8#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
gold standard&quot##14##2##(1992-3#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-4#1)
gold substrates##2##2##(2008-10#1)(2010-4#1)
gold surface and##2##3##(2008-10#2)
gold surface was##2##3##(2008-10#1)(2013-8#1)
gold surface##11##2##(2008-10#9)(2013-8#2)
gold surfaces##4##2##(2008-10#4)
gold thin film##2##3##(2009-4#2)
gold toxicity##2##2##(1994-5#1)(1995-3#1)
gold were##3##2##(1994-5#1)(2008-10#2)
gold working electrode##3##3##(1991-7#1)(2008-10#2)
gold##373##1##(1990-5#2)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-5#10)(1994-7#1)(1995-3#4)(1995-5#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#3)(2007-10#1)(2007-11#4)(2007-12#21)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#180)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#11)(2008-9#7)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#2)(2012-12#6)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#9)(2013-7#2)(2013-8#6)
gold(I)##2##1##(2008-10#1)(2010-3#1)
gold(III)##2##1##(2008-10#2)
gold-coated##4##1##(2007-11#1)(2008-10#2)(2008-3#1)
gold-complexed##2##1##(2008-10#2)
gold-cyanide ion from##2##3##(2008-6#2)
gold-cyanide ion##5##2##(2008-6#5)
gold-island films##2##2##(2008-2#2)
gold-labeled##3##1##(2008-10#2)(2008-5#1)
gold-plated##2##1##(2008-10#2)
golden age of##2##3##(1993-2#1)(2010-1#1)
golden hamster##5##2##(1990-6#2)(1995-3#3)
golden mosaic virus##8##3##(2008-10#8)
golden mosaic##11##2##(2008-10#11)
golden##30##1##(1990-6#2)(1993-2#1)(1993-9#1)(1995-3#3)(2007-11#1)(2008-10#15)(2008-11#2)(2008-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
goldeneye##2##1##(2008-9#2)
goldenrod (Solidago altissima)##2##3##(2009-2#1)(2009-8#1)
goldfish (Carassius auratus)##2##3##(2008-5#1)(2008-6#1)
goldfish Carassius auratus morphotypes##2##4##(2010-8#2)
goldfish Carassius auratus##3##3##(2008-1#1)(2010-8#2)
goldfish##31##1##(1991-2#6)(1994-11#3)(1994-8#6)(1997-7#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-6#4)(2010-8#2)(2011-2#5)
golf courses in Wisconsin##2##4##(2008-10#2)
golf courses in##3##3##(2008-10#3)
golf##7##1##(2008-10#5)(2011-2#2)
gomphocephala##2##1##(2010-3#2)
gonad and##4##2##(1994-11#1)(2007-12#1)(2010-5#1)(2012-12#1)
gonad development##2##2##(2008-7#1)(2010-5#1)
gonad doses##2##2##(2009-11#2)
gonad maturation##2##2##(2008-12#2)
gonad##22##1##(1994-11#1)(1994-12#1)(2007-12#3)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#3)(2009-11#2)(2010-5#3)(2011-2#1)(2012-1#2)(2012-12#2)
gonadal development##3##2##(2008-11#1)(2010-8#1)(2012-2#1)
gonadal dysfunction##2##2##(2011-2#1)(2012-3#1)
gonadal hormones##2##2##(1991-1#1)(1993-8#1)
gonadal recrudescence##2##2##(2008-5#2)
gonadal secretions##3##2##(2008-11#3)
gonadal sex##4##2##(2008-5#4)
gonadal steroid environment##3##3##(2008-11#3)
gonadal steroid##4##2##(2008-11#4)
gonadal steroids##4##2##(1994-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
gonadal##42##1##(1991-1#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-11#11)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
gonadic##2##1##(2008-5#1)(2013-7#1)
gonadosomatic index##3##2##(2008-5#1)(2008-7#1)(2009-7#1)
gonadotropes##7##1##(1993-11#4)(1995-2#1)(1997-2#2)
gonadotroph##2##1##(1991-2#1)(2008-3#1)
gonadotrophins##2##1##(2010-8#1)(2011-1#1)
gonadotropic hormones##2##2##(1990-9#1)(2009-7#1)
gonadotropic##3##1##(1990-9#1)(1993-3#1)(2009-7#1)
gonadotropin alpha subunit##2##3##(1995-8#2)
gonadotropin##31##1##(1990-9#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-5#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#4)(1997-1#1)(1997-4#1)(2007-7#3)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#3)(2010-5#1)(2011-1#2)(2013-1#1)
gonadotropin-II##2##1##(1994-8#2)
gonadotropin-releasing hormone (GnRH)##6##3##(1992-8#1)(1993-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-5#1)
gonadotropin-releasing hormone receptor##3##3##(1992-12#3)
gonadotropin-releasing hormone##13##2##(1990-9#1)(1992-12#3)(1992-8#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-11#2)(1996-2#1)(2008-5#1)(2008-8#1)
gonadotropin-releasing hormones##2##2##(1992-8#1)(1994-8#1)
gonadotropin-releasing##16##1##(1990-9#1)(1992-12#3)(1992-8#2)(1993-11#1)(1994-8#2)(1994-9#1)(1995-11#2)(1996-2#2)(2008-5#1)(2008-8#1)
gonadotropins and##3##2##(1990-9#1)(1994-9#1)(2012-2#1)
gonadotropins##5##1##(1990-9#1)(1994-9#1)(2008-8#1)(2010-5#1)(2012-2#1)
gonads and##2##2##(2008-7#1)(2011-2#1)
gonads is##3##2##(2008-4#1)(2009-11#1)(2009-7#1)
gonads of##2##2##(2008-11#1)(2008-12#1)
gonads were##3##2##(2008-11#1)(2008-5#1)(2009-11#1)
gonads##27##1##(1993-11#1)(1994-5#1)(2007-12#1)(2008-11#8)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#4)(2009-2#1)(2009-7#1)(2010-5#2)(2011-2#3)
gonarthrosis##4##1##(2007-8#4)
gondii antibodies##3##2##(2008-5#3)
gondii##24##1##(1990-9#1)(1991-11#1)(1992-8#4)(1993-9#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-5#3)(2009-6#3)(2009-7#2)(2012-2#2)(2012-3#2)
gone before##2##2##(2008-8#1)(2012-3#1)
gone into##2##2##(1997-7#1)(2008-10#1)
gone through##2##2##(1996-3#1)(2009-10#1)
gone##13##1##(1991-12#1)(1993-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-10#1)(2012-12#1)(2012-3#1)
gone?##2##1##(1992-7#1)(2012-2#1)
gonial##2##1##(2012-12#1)(2012-2#1)
goniometer##6##1##(2006-4#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-1#1)
goniometry##2##1##(2012-12#2)
gonion##2##1##(2008-7#2)
gonioreflectometer is##2##2##(2008-2#2)
gonioreflectometer##3##1##(2008-2#2)(2008-3#1)
gono-carp##2##1##(2008-7#2)
gonococcal urethritis##4##2##(2007-7#3)(2007-8#1)
gonococcal##10##1##(1993-12#1)(1994-2#2)(1995-12#1)(1996-6#1)(2007-7#3)(2007-8#1)(2011-2#1)
gonocytes##2##1##(2012-2#2)
gonoduct##2##1##(1992-9#1)(2011-2#1)
gonorrhea##5##1##(1990-3#1)(1991-6#1)(1994-3#1)(1996-6#1)(2013-1#1)
gonorrhoea has been##2##3##(1990-3#2)
gonorrhoea##9##1##(1990-3#6)(1995-3#1)(1996-6#1)(2007-7#1)
gonorrhoeae##11##1##(1993-12#1)(1993-9#2)(1995-6#1)(1996-6#1)(2007-7#1)(2007-8#3)(2010-10#1)(2010-11#1)
good -##2##2##(2007-11#1)(2007-8#1)
good Nernstian##2##2##(2008-10#2)
good accordance with the##2##4##(1995-11#1)(2008-2#1)
good accordance with##3##3##(1995-11#1)(2008-10#1)(2008-2#1)
good accuracy and precision##5##4##(2008-10#4)(2008-3#1)
good accuracy and##7##3##(2007-11#1)(2008-10#4)(2008-3#2)
good accuracy##22##2##(2007-11#2)(2007-12#1)(2008-10#14)(2008-3#3)(2012-1#1)(2013-8#1)
good activity##3##2##(1992-12#1)(2008-10#2)
good affinity##5##2##(1993-8#1)(2008-10#1)(2008-4#3)
good agreement and##3##3##(2008-10#1)(2008-3#2)
good agreement between the predicted##2##5##(2008-10#2)
good agreement between the proposed method and##2##7##(2008-10#2)
good agreement between the results##2##5##(2008-10#2)
good agreement between the##14##4##(1996-12#1)(2008-10#11)(2008-3#1)(2010-2#1)
good agreement between theoretical and experimental results##2##7##(2007-12#1)(2008-2#1)
good agreement between theory and experiment##3##6##(1992-5#1)(2008-3#1)(2008-5#1)
good agreement between##29##3##(1992-5#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-2#1)
good agreement for##5##3##(2007-12#1)(2008-2#3)(2008-7#1)
good agreement in##2##3##(2008-3#2)
good agreement is demonstrated##2##4##(2008-2#2)
good agreement is obtained##2##4##(2008-10#1)(2008-3#1)
good agreement is##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
good agreement of results##2##4##(2008-10#2)
good agreement of##4##3##(2008-10#3)(2008-3#1)
good agreement was found between##2##5##(2008-2#1)(2008-3#1)
good agreement was found##3##4##(2008-2#2)(2008-3#1)
good agreement was observed between##2##5##(2008-10#2)
good agreement was obtained between##2##5##(2008-10#2)
good agreement was obtained##4##4##(2008-10#4)
good agreement was##11##3##(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#1)
good agreement with certified values##5##5##(2008-10#5)
good agreement with certified##6##4##(2008-10#6)
good agreement with direct##2##4##(1992-12#1)(2008-3#1)
good agreement with experimental results##3##5##(2008-2#1)(2008-3#1)(2010-2#1)
good agreement with experimental##4##4##(2008-2#1)(2008-3#2)(2010-2#1)
good agreement with predictions##2##4##(2008-2#2)
good agreement with previous##2##4##(2008-10#1)(2008-3#1)
good agreement with reference values##2##5##(2008-10#2)
good agreement with the certified value##6##6##(2008-10#6)
good agreement with the certified values##12##6##(2008-10#12)
good agreement with the certified##19##5##(2008-10#19)
good agreement with the data##2##5##(2008-10#1)(2008-3#1)
good agreement with the experiment##2##5##(2007-11#1)(2008-3#1)
good agreement with the experimental data##3##6##(2008-10#1)(2008-3#1)(2009-6#1)
good agreement with the experimental results##5##6##(2007-11#1)(2007-12#1)(2008-2#2)(2011-2#1)
good agreement with the experimental##9##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-6#1)(2011-2#1)
good agreement with the measured##5##5##(1996-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
good agreement with the measurements##2##5##(2008-3#1)(2008-7#1)
good agreement with the reference##2##5##(2008-10#2)
good agreement with the results obtained##2##6##(2008-10#2)
good agreement with the results##4##5##(2007-12#1)(2008-10#2)(2013-8#1)
good agreement with the theory##2##5##(2007-11#1)(2008-3#1)
good agreement with the##88##4##(1991-11#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(2007-11#8)(2007-12#3)(2008-10#36)(2008-11#1)(2008-2#9)(2008-3#17)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
good agreement with theoretical##7##4##(2007-11#3)(2007-12#2)(2008-2#1)(2011-1#1)
good agreement with those obtained by an##3##7##(2008-10#3)
good agreement with those obtained by##18##6##(2008-10#18)
good agreement with those obtained using##2##6##(2008-10#2)
good agreement with those obtained##23##5##(2008-10#22)(2008-3#1)
good agreement with those of##6##5##(2008-10#3)(2008-2#1)(2008-3#2)
good agreement with those##39##4##(2008-10#32)(2008-2#2)(2008-3#4)(2012-8#1)
good agreement with##198##3##(1991-11#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#14)(2007-12#11)(2008-10#87)(2008-11#1)(2008-2#21)(2008-3#38)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-8#1)
good agreement##303##2##(1991-11#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-7#1)(2007-11#16)(2007-12#14)(2008-10#134)(2008-11#3)(2008-2#36)(2008-3#61)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-8#2)
good agricultural practice##2##3##(2013-1#2)
good alignment and##2##3##(2009-3#1)(2013-1#1)
good alternative for the##3##4##(2007-8#1)(2008-10#2)
good alternative for##5##3##(2007-8#1)(2008-10#2)(2009-8#1)(2013-7#1)
good alternative method in##2##4##(2012-2#1)(2013-1#1)
good alternative to##8##3##(1994-9#1)(1995-6#1)(2008-10#3)(2010-4#1)(2013-1#2)
good alternative##16##2##(1994-9#1)(1995-6#1)(2007-8#1)(2008-10#5)(2009-8#1)(2010-4#2)(2012-2#1)(2013-1#3)(2013-7#1)
good analgesic##2##2##(2012-2#1)(2013-7#1)
good analytical performance##2##3##(2008-10#2)
good analytical precision##2##3##(2008-10#1)(2009-8#1)
good analytical##4##2##(2008-10#3)(2009-8#1)
good and bad care##2##4##(2010-10#2)
good and lasting##2##3##(1990-5#1)(2007-11#1)
good and poor##2##3##(2010-3#1)(2013-1#1)
good and the##3##3##(1994-8#1)(2008-10#1)(2012-3#1)
good and very good results in##2##6##(2007-11#2)
good and very good results##3##5##(2007-11#2)(2013-1#1)
good and##38##2##(1990-3#1)(1990-5#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(2007-11#9)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-10#2)(2010-3#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
good application##2##2##(2008-9#1)(2013-8#1)
good as##19##2##(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
good assessment of the##2##4##(2008-10#1)(2011-2#1)
good assessment##3##2##(2008-10#1)(2011-2#2)
good at##2##2##(2008-3#1)(2009-9#1)
good business##2##2##(1992-12#1)(2008-11#1)
good by##3##2##(1996-9#1)(2012-1#2)
good caliber##2##2##(2008-9#2)
good candidates for the##2##4##(1993-11#1)(2008-2#1)
good candidates for##6##3##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
good candidates##8##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
good care##3##2##(2007-10#1)(2010-10#1)(2013-8#1)
good catalytic activity##2##3##(2008-10#2)
good catalytic##3##2##(2008-10#3)
good characteristics##3##2##(2008-10#2)(2008-5#1)
good chromatographic##2##2##(2008-10#1)(2011-1#1)
good classification##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
good clinical outcome##4##3##(2007-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
good clinical##15##2##(1997-6#1)(2007-8#2)(2008-6#1)(2008-7#3)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
good color##2##2##(2007-12#1)(2008-3#1)
good communication and good patient care##2##6##(1994-1#2)
good communication and good##3##4##(1994-1#2)(2010-10#1)
good communication##4##2##(1994-1#2)(2009-4#1)(2010-10#1)
good compatibility##2##2##(2008-5#1)(2010-12#1)
good compliance##3##2##(1991-11#1)(2010-4#1)(2013-1#1)
good condition##4##2##(2008-12#1)(2010-12#1)(2010-8#1)(2011-3#1)
good consistency##2##2##(2008-10#1)(2013-8#1)
good continuity##2##2##(1993-1#1)(2008-11#1)
good contrast##2##2##(2008-2#1)(2008-3#1)
good control##4##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
good correlation (r=0##3##3##(2008-10#3)
good correlation between##17##3##(1990-7#2)(1992-3#1)(1994-6#1)(1995-12#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#2)
good correlation was found between the##5##6##(1996-11#1)(1997-6#1)(2007-12#1)(2008-10#2)
good correlation was observed between the##3##6##(1994-6#1)(2008-10#1)(2008-7#1)
good correlation was observed##5##4##(1994-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
good correlation was##11##3##(1994-6#1)(1996-11#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-7#1)
good correlation with data obtained by##2##6##(2008-10#2)
good correlation with the##3##4##(1990-12#1)(2007-12#1)(2008-10#1)
good correlation with##8##3##(1990-12#1)(1992-11#1)(2007-12#2)(2007-2#1)(2008-10#3)
good correlation##54##2##(1990-12#1)(1990-7#2)(1990-8#1)(1992-11#1)(1992-3#1)(1994-6#2)(1995-12#2)(1996-11#1)(1997-6#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#29)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)
good correlations##2##2##(2008-10#1)(2011-2#1)
good cosmetic result##3##3##(1991-8#1)(2009-5#1)(2013-8#1)
good cosmetic##8##2##(1991-8#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#2)(2013-8#1)
good coverage##2##2##(2007-8#1)(2008-9#1)
good deal of##3##3##(1994-3#1)(2008-5#1)(2011-2#1)
good degree##2##2##(2008-3#1)(2008-7#1)
good diagnostic##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
good discriminating ability towards##5##4##(2008-10#5)
good discrimination between##2##3##(2008-10#1)(2011-2#1)
good discrimination##7##2##(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)
good distribution ratio values##2##4##(2008-10#2)
good early##2##2##(2007-8#1)(2008-3#1)
good effect in##3##3##(1992-6#1)(2008-1#1)(2008-11#1)
good effect on##3##3##(2008-7#2)(2008-9#1)
good effect##8##2##(1992-6#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-9#1)(2012-3#1)
good efficacy##2##2##(1990-6#1)(2007-11#1)
good electrocatalytic activity##2##3##(2008-10#2)
good electrochemical##3##2##(2008-10#3)
good encounters##2##2##(2010-10#2)
good enough##2##2##(1992-11#1)(1994-1#1)
good esthetic##2##2##(1990-9#1)(1993-11#1)
good estimates of##3##3##(1992-12#1)(2008-3#2)
good estimation of##3##3##(1995-9#1)(2008-10#2)
good evidence for##3##3##(1994-12#1)(1997-6#1)(2008-7#1)
good evidence##7##2##(1994-12#1)(1996-12#1)(1997-6#1)(2008-7#2)(2009-6#1)(2010-12#1)
good evolution##3##2##(2009-1#1)(2013-1#2)
good example of##4##3##(2008-2#1)(2009-3#1)(2009-5#1)(2011-10#1)
good experimental##2##2##(1995-11#1)(2008-7#1)
good family##2##2##(2007-8#1)(2010-12#1)
good fit for the##2##4##(2008-3#2)
good fit##9##2##(1993-1#1)(1994-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-3#1)
good for the##2##3##(2008-8#1)(2013-1#1)
good for##9##2##(1996-7#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
good function and independence in daily activities##2##7##(2007-11#2)
good function of##2##3##(2007-11#2)
good function##4##2##(2007-11#4)
good functional results##2##3##(2010-6#1)(2013-1#1)
good functional##8##2##(2007-8#2)(2008-7#2)(2009-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
good general health##3##3##(1995-8#1)(2008-1#1)(2013-8#1)
good general##7##2##(1995-8#1)(1996-12#1)(1996-6#1)(2008-1#1)(2010-2#1)(2013-8#2)
good genes benefits##2##3##(2013-1#2)
good genes##4##2##(2008-8#1)(2013-1#3)
good growth##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2010-4#1)
good health and##4##3##(1997-5#1)(2008-5#1)(2011-2#1)(2012-1#1)
good health##18##2##(1991-6#1)(1993-6#1)(1996-1#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#2)(2012-12#1)
good identification of the substances present in##2##7##(2008-10#2)
good if##5##2##(1996-8#1)(1996-9#1)(2007-11#1)(2008-3#1)(2008-4#1)
good imaging##2##2##(2008-3#1)(2013-8#1)
good in 30##2##3##(2007-11#1)(2013-8#1)
good in all cases##2##4##(1994-9#1)(2008-10#1)
good in all##3##3##(1994-9#1)(1996-6#1)(2008-10#1)
good in vitro model##4##4##(1993-8#1)(1994-8#1)(1994-9#1)(2008-5#1)
good in vitro##6##3##(1993-8#1)(1994-8#1)(1994-9#1)(1997-1#1)(2008-5#1)(2012-2#1)
good in##29##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-6#1)(1996-9#2)(1997-1#1)(2007-11#6)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
good indicators##2##2##(2007-2#1)(2013-1#1)
good information##3##2##(1991-11#1)(1993-3#1)(2008-2#1)
good internal##2##2##(2007-11#1)(2013-1#1)
good knowledge##2##2##(2011-2#1)(2013-1#1)
good linear relation##2##3##(2008-10#2)
good linear relationship between the##2##5##(2008-10#1)(2011-1#1)
good linear relationship with##4##4##(2008-10#4)
good linear relationship##7##3##(2008-10#6)(2011-1#1)
good linear response##3##3##(2008-10#3)
good linear##21##2##(1994-12#2)(2008-10#15)(2008-3#1)(2011-1#3)
good linearity and##4##3##(1993-8#1)(2008-10#3)
good linearity between##2##3##(2008-10#1)(2008-11#1)
good linearity in the##5##4##(2008-10#4)(2011-1#1)
good linearity in##6##3##(2008-10#4)(2011-1#1)(2011-3#1)
good linearity##28##2##(1993-8#1)(1996-5#1)(2008-10#19)(2008-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)
good long-term stability##3##3##(2008-10#3)
good long-term##6##2##(1990-6#1)(2007-7#1)(2008-10#3)(2013-1#1)
good match between##2##3##(2007-12#1)(2008-3#1)
good match##5##2##(2007-12#1)(2008-3#2)(2012-2#1)(2013-8#1)
good measurement##2##2##(2008-2#1)(2008-3#1)
good mechanical and chemical stability##2##5##(2008-10#1)(2008-5#1)
good mechanical##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
good medical##3##2##(1992-9#1)(1994-9#1)(1997-4#1)
good mental health##2##3##(2008-11#1)(2013-1#1)
good method##3##2##(2007-11#1)(2008-4#1)(2013-1#1)
good model of##3##3##(1997-1#1)(2008-6#1)(2010-4#1)
good model##11##2##(1991-12#1)(1993-11#1)(1994-5#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-4#1)
good nursing##2##2##(1994-9#1)(2011-2#1)
good nutrition and##2##3##(2008-12#1)(2012-12#1)
good nutrition##4##2##(1993-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
good of##2##2##(1993-12#1)(2008-5#1)
good old##2##2##(1991-1#1)(2008-10#1)
good operational##3##2##(2008-10#3)
good or##8##2##(1990-6#1)(1991-3#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-7#2)
good oral##4##2##(1992-5#1)(2007-12#1)(2008-5#1)(2011-1#1)
good outcome##7##2##(1996-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-12#1)(2013-8#1)
good outcomes##4##2##(1994-12#1)(2007-11#1)(2011-2#1)(2013-1#1)
good over a##2##3##(1994-2#1)(2008-3#1)
good overall##4##2##(1996-5#1)(2008-10#1)(2009-5#1)(2010-4#1)
good patency##2##2##(2007-8#1)(2008-1#1)
good patient care##3##3##(1994-1#2)(1996-2#1)
good patient##4##2##(1994-1#2)(1994-12#1)(1996-2#1)
good performance characteristics##4##3##(2008-10#4)
good performance in##2##3##(2008-10#1)(2008-3#1)
good performance of the##3##4##(2007-11#2)(2008-10#1)
good performance of##4##3##(2007-11#2)(2008-10#2)
good performance##24##2##(1996-12#1)(2007-11#3)(2008-10#12)(2008-2#2)(2008-3#3)(2010-3#1)(2010-8#1)(2013-1#1)
good physical##5##2##(2008-5#2)(2010-5#1)(2011-2#1)(2012-12#1)
good postoperative##3##2##(1990-9#1)(2009-5#1)(2010-5#1)
good potential##6##2##(2008-10#3)(2008-3#1)(2011-2#1)(2011-3#1)
good power for##2##3##(1995-2#1)(1997-3#1)
good practice recommendations##2##3##(2007-6#1)(2011-2#1)
good practice##7##2##(1994-3#1)(1996-8#1)(1997-5#1)(2007-6#1)(2008-12#1)(2011-2#1)(2012-12#1)
good precision (R##3##3##(2008-10#3)
good precision (RSD##3##3##(2008-10#3)
good precision and accuracy##4##4##(2008-10#4)
good precision and##5##3##(2008-10#5)
good precision##20##2##(2008-10#19)(2011-2#1)
good predictive##4##2##(2008-10#2)(2012-3#1)(2013-8#1)
good professional##2##2##(1993-6#1)(2012-1#1)
good prognosis##18##2##(1991-8#1)(1992-5#2)(1995-11#1)(1995-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
good protection##3##2##(1997-8#1)(2008-10#1)(2008-12#1)
good psychometric##2##2##(2008-7#1)(2012-3#1)
good qualitative agreement with the##2##5##(2008-2#1)(2013-8#1)
good qualitative agreement with##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
good qualitative agreement##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
good quality and##3##3##(2008-10#2)(2008-8#1)
good quality of life##5##4##(1991-6#1)(1992-11#1)(1996-3#1)(2011-3#1)(2012-3#1)
good quality of##7##3##(1991-6#1)(1992-11#1)(1996-3#1)(2006-4#1)(2010-10#1)(2011-3#1)(2012-3#1)
good quality##19##2##(1991-6#1)(1992-11#1)(1993-1#1)(1996-3#1)(2006-4#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#2)
good quantitative##2##2##(2008-2#1)(2008-7#1)
good reasons##2##2##(1994-8#1)(2013-1#1)
good reconstruction##2##2##(2008-2#1)(2008-3#1)
good recoveries of##2##3##(2008-10#2)
good recoveries##9##2##(2008-10#8)(2012-1#1)
good recovery and##2##3##(2008-10#1)(2008-7#1)
good recovery##10##2##(1992-11#1)(1997-3#1)(2008-10#6)(2008-7#1)(2010-12#1)
good relationship##2##2##(2010-10#1)(2011-1#1)
good reliability and##2##3##(2008-10#1)(2011-1#1)
good reliability of the determination was proved##2##7##(2008-10#2)
good reliability##5##2##(2008-10#3)(2010-2#1)(2011-1#1)
good repeatability (RSD##2##3##(2008-10#2)
good repeatability and##4##3##(2008-10#3)(2009-4#1)
good repeatability##16##2##(2008-10#15)(2009-4#1)
good reproducibility and##5##3##(2008-10#3)(2008-11#1)(2012-3#1)
good reproducibility of the method##2##5##(2008-10#2)
good reproducibility of the##3##4##(2008-10#2)(2009-11#1)
good reproducibility of##4##3##(2008-10#3)(2009-11#1)
good reproducibility with##2##3##(2008-10#2)
good reproducibility##42##2##(1996-6#1)(2008-10#36)(2008-11#1)(2009-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
good resistance to##3##3##(2008-10#2)(2013-1#1)
good resolution and##2##3##(2007-12#1)(2009-8#1)
good resolution of the##2##4##(2008-10#2)
good resolution of##3##3##(2008-10#2)(2008-7#1)
good resolution##9##2##(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#4)(2008-7#1)(2009-8#1)
good respiratory##2##2##(2008-5#1)(2013-1#1)
good response for##4##3##(2008-10#4)
good response in##5##3##(1992-6#1)(2007-11#1)(2008-10#1)(2011-2#2)
good response to therapy##2##4##(2007-7#1)(2009-2#1)
good response to##9##3##(1992-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
good response##28##2##(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)
good result in##3##3##(1996-9#1)(2007-11#2)
good result was##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
good result##8##2##(1996-9#1)(2007-11#3)(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
good results and##3##3##(1993-3#1)(2008-10#1)(2012-3#1)
good results for##3##3##(1991-9#1)(2008-6#1)(2013-1#1)
good results in the##2##4##(2008-10#1)(2011-3#1)
good results in##12##3##(1990-12#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2011-3#1)
good results of##2##3##(1990-9#1)(2008-10#1)
good results were obtained with##2##5##(2007-8#1)(2008-10#1)
good results were obtained##6##4##(2007-8#1)(2008-10#5)
good results were##8##3##(1990-5#1)(2007-11#1)(2007-8#1)(2008-10#5)
good results when##2##3##(2008-10#2)
good results with a##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
good results with##7##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
good results##78##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-3#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-9#1)(1996-11#1)(1996-6#1)(2007-11#8)(2007-12#1)(2007-8#4)(2008-10#28)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
good safety##3##2##(2008-7#1)(2008-9#1)(2009-9#1)
good selectivities for##4##3##(2008-10#4)
good selectivities##7##2##(2008-10#7)
good selectivity and sensitivity##2##4##(2008-10#2)
good selectivity and##4##3##(2008-10#4)
good selectivity for VO(2+) over##2##5##(2008-10#2)
good selectivity for the##2##4##(2008-10#1)(2009-11#1)
good selectivity for##25##3##(2008-10#24)(2009-11#1)
good selectivity over##2##3##(2008-10#2)
good selectivity##39##2##(2008-10#37)(2009-11#1)(2010-11#1)
good sensitivity and stability##2##4##(2008-10#2)
good sensitivity and##7##3##(2008-10#5)(2008-9#1)(2011-2#1)
good sensitivity##18##2##(2008-10#14)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
good separation of the##4##4##(2008-10#3)(2009-8#1)
good separation of##8##3##(2008-10#6)(2009-8#1)(2012-1#1)
good separation##12##2##(2008-10#10)(2009-8#1)(2012-1#1)
good separations##2##2##(2008-10#1)(2008-4#1)
good signal-to-noise ratio##2##3##(2007-12#1)(2008-3#1)
good signal-to-noise##3##2##(2007-12#2)(2008-3#1)
good solubility##2##2##(2008-4#1)(2010-4#1)
good specificity##2##2##(2009-1#1)(2012-2#1)
good stability and##6##3##(2008-10#5)(2013-8#1)
good stability for at least##2##5##(1992-5#1)(2008-10#1)
good stability for##3##3##(1992-5#1)(2008-10#2)
good stability over##2##3##(2008-10#1)(2013-1#1)
good stability##22##2##(1992-5#1)(2007-11#1)(2008-10#15)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
good statistical##3##2##(2008-10#2)(2008-3#1)
good storage stability##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
good substrates for##2##3##(1994-8#1)(2008-10#1)
good substrates##5##2##(1992-11#1)(1994-8#1)(1994-9#1)(2008-10#1)(2009-2#1)
good surface##2##2##(2008-10#1)(2013-8#1)
good surgical outcome##2##3##(2007-8#1)(2009-5#1)
good surgical##5##2##(1991-2#1)(2007-11#2)(2007-8#1)(2009-5#1)
good symptomatic##2##2##(1992-4#1)(2008-11#1)
good that##2##2##(1992-3#1)(2008-3#1)
good thermal##2##2##(2008-10#1)(2008-3#1)
good tissue##2##2##(2012-12#1)(2012-3#1)
good to excellent##4##3##(2010-7#2)(2010-8#1)(2012-12#1)
good to very good##2##4##(1990-9#1)(1991-3#1)
good to##13##2##(1990-9#1)(1991-3#1)(1992-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2009-12#1)(2009-4#1)(2010-7#2)(2010-8#1)(2012-12#1)(2013-8#1)
good tolerability and##2##3##(1991-3#1)(2010-11#1)
good tolerability##5##2##(1990-2#1)(1991-3#1)(2008-5#1)(2010-11#1)(2013-8#1)
good tolerance##2##2##(1990-3#1)(2008-10#1)
good treatment##4##2##(1994-12#1)(2007-8#1)(2011-2#2)
good understanding of the##3##4##(2008-2#1)(2013-1#2)
good understanding of##7##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2013-1#2)
good uptake##2##2##(1990-10#1)(2010-2#1)
good vaccine##2##2##(2008-11#1)(2009-5#1)
good values##2##2##(2008-10#1)(2008-6#1)
good way##3##2##(1993-2#1)(2008-9#1)(2013-8#1)
good with##2##2##(1994-9#1)(2008-10#1)
good working##2##2##(2008-12#1)(2008-4#1)
good yield##10##2##(1996-5#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2010-3#1)(2010-7#1)
good yields##14##2##(1996-5#2)(2007-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2010-6#1)(2012-3#1)(2013-7#1)
good##1968##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#9)(1990-7#2)(1990-8#1)(1990-9#6)(1991-1#3)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#10)(1991-4#1)(1991-5#2)(1991-6#7)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#10)(1992-12#5)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#7)(1992-6#7)(1992-8#1)(1992-9#3)(1993-1#5)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#6)(1993-6#4)(1993-8#4)(1993-9#3)(1994-1#6)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#11)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#8)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#10)(1996-2#4)(1996-3#5)(1996-5#8)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#4)(1997-5#3)(1997-6#8)(1997-7#1)(1997-8#5)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#2)(2007-10#7)(2007-11#91)(2007-12#32)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#33)(2008-1#16)(2008-10#641)(2008-11#49)(2008-12#16)(2008-2#71)(2008-3#129)(2008-4#20)(2008-5#44)(2008-6#15)(2008-7#56)(2008-8#14)(2008-9#25)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#5)(2009-3#5)(2009-4#8)(2009-5#8)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#2)(2010-10#11)(2010-11#4)(2010-12#7)(2010-2#7)(2010-3#9)(2010-4#12)(2010-5#8)(2010-6#2)(2010-7#8)(2010-8#7)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#47)(2011-3#9)(2012-1#10)(2012-12#16)(2012-2#23)(2012-3#34)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#58)(2013-7#5)(2013-8#34)
good&quot##10##1##(2007-10#1)(2007-11#3)(2008-11#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
good)##4##1##(2007-8#2)(2012-2#1)(2013-1#1)
good-quality##3##1##(2008-3#1)(2008-4#1)(2013-8#1)
goodness of##6##2##(1990-5#1)(2008-10#4)(2013-8#1)
goodness-of-fit test##2##2##(1995-2#1)(2008-10#1)
goodness-of-fit tests for##2##3##(1995-2#2)
goodness-of-fit tests##4##2##(1995-2#2)(2008-10#1)(2009-9#1)
goodness-of-fit##13##1##(1995-2#3)(2008-10#3)(2008-3#1)(2008-8#2)(2009-9#1)(2011-1#2)(2011-2#1)
goods and services##5##3##(1991-2#1)(1991-3#1)(1994-2#1)(2008-11#1)(2012-12#1)
goods and the##2##3##(2008-10#2)
goods and##8##2##(1991-2#1)(1991-3#1)(1994-2#1)(2008-10#2)(2008-11#2)(2012-12#1)
goods games##5##2##(2012-3#5)
goods is##2##2##(2008-10#2)
goods##32##1##(1991-12#2)(1991-2#1)(1991-3#1)(1994-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2009-10#4)(2011-2#1)(2012-12#1)(2012-3#6)(2013-8#1)
gordonae 989##2##2##(1993-11#2)
gordonae##7##1##(1993-11#7)
gorging one##2##2##(2008-12#2)
gorging##5##1##(2008-12#5)
gorilla##3##1##(1993-8#1)(1995-2#1)(1997-6#1)
goserelin##3##1##(1994-2#1)(1996-2#1)(1997-7#1)
gossypii on##2##2##(2008-6#2)
gossypii##16##1##(2008-10#6)(2008-6#7)(2012-3#3)
gossypol##10##1##(1990-11#5)(2008-10#1)(2008-8#4)
got the##4##2##(1993-8#1)(1997-3#1)(2010-7#1)(2013-8#1)
got##16##1##(1992-3#1)(1993-8#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2010-7#1)(2013-1#1)(2013-8#2)
gouldii##3##1##(1992-8#3)
gourd##7##1##(2008-10#1)(2013-8#6)
gout##18##1##(1990-11#1)(1991-8#1)(2006-10#9)(2007-7#1)(2009-10#2)(2010-8#2)(2011-2#2)
gouty##2##1##(1990-11#1)(2006-10#1)
govern the##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
govern##18##1##(1990-9#1)(1993-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
governance and##5##2##(1993-12#1)(2008-11#1)(2012-12#1)(2012-2#2)
governance in##4##2##(1995-12#1)(1996-1#1)(2008-7#1)(2012-3#1)
governance of##2##2##(1996-1#1)(2008-7#1)
governance structures##2##2##(2008-11#1)(2010-10#1)
governance##48##1##(1991-1#7)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#7)(1996-3#1)(2008-1#1)(2008-11#3)(2008-7#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-7#1)(2013-8#1)
governates in##2##2##(2008-10#2)
governed and##2##2##(1995-1#1)(1997-2#1)
governed by a single##3##4##(1990-7#1)(2008-10#2)
governed by a##6##3##(1990-7#1)(2008-10#4)(2008-5#1)
governed by the##13##3##(1990-9#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-3#1)
governed by##30##2##(1990-7#1)(1990-9#1)(1992-3#1)(1994-12#1)(2007-11#2)(2008-10#13)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-3#3)(2013-1#1)
governed##34##1##(1990-7#1)(1990-9#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-2#1)(2007-11#2)(2008-10#13)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-3#3)(2013-1#1)
governing board##2##2##(1993-1#1)(2008-11#1)
governing boards##6##2##(1991-1#4)(1991-12#1)(1992-1#1)
governing bodies##2##2##(1991-2#2)
governing expression of the##2##4##(1993-5#1)(2013-8#1)
governing stem cell fate decisions##2##5##(2008-11#2)
governing the##14##2##(1990-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)
governing this##2##2##(2008-9#1)(2009-10#1)
governing##67##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#4)(1991-12#2)(1991-2#4)(1992-1#1)(1993-1#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#2)(2009-3#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#2)
government actions##2##2##(1992-2#1)(1993-3#1)
government agencies##4##2##(1996-1#1)(1996-2#1)(1997-4#1)(2010-12#1)
government and##19##2##(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#1)
government as##3##2##(1993-1#1)(1995-1#1)(2013-1#1)
government decisions##2##2##(1992-5#1)(1997-1#1)
government effort to##2##3##(1991-2#1)(1992-1#1)
government employees##2##2##(1994-2#1)(2012-12#1)
government expenditures##3##2##(2010-12#1)(2013-7#2)
government has##6##2##(1992-12#1)(1992-2#1)(1995-3#1)(1997-6#1)(2008-8#1)(2013-1#1)
government health clinics##3##3##(2008-8#3)
government health##9##2##(1994-1#1)(1995-3#1)(2007-7#1)(2008-7#1)(2008-8#3)(2012-12#1)(2013-8#1)
government hospitals##4##2##(1992-12#1)(1992-3#1)(2009-6#1)(2011-1#1)
government in the##2##3##(1996-3#1)(2008-12#1)
government in##6##2##(1990-3#1)(1996-12#1)(1996-3#1)(2008-12#1)(2012-2#1)(2013-1#1)
government intervention##2##2##(1994-3#1)(1995-1#1)
government is##8##2##(1995-3#1)(1997-1#1)(1997-2#1)(1997-6#2)(2007-12#1)(2007-9#1)(2008-6#1)
government of##5##2##(1994-9#2)(2008-10#1)(2008-7#1)(2010-4#1)
government officials##6##2##(1994-12#1)(1994-3#1)(1995-6#1)(2008-11#1)(2011-2#1)(2013-7#1)
government organizations##2##2##(1993-1#1)(1996-4#1)
government policies##2##2##(2008-11#1)(2011-2#1)
government policy##4##2##(1992-1#1)(2007-12#1)(2008-11#1)(2010-10#1)
government regulation in##2##3##(1995-3#1)(1997-1#1)
government regulation##4##2##(1995-3#2)(1997-1#1)(2008-11#1)
government regulations##2##2##(1993-3#1)(2008-11#1)
government reports##2##2##(1996-7#1)(2008-3#1)
government support##2##2##(2008-11#1)(2010-3#1)
government to##9##2##(1991-1#1)(1994-1#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
government was##2##2##(2006-10#1)(2008-10#1)
government will##2##2##(1997-3#1)(2008-11#1)
government##232##1##(1990-2#1)(1990-3#2)(1990-4#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#1)(1992-1#4)(1992-12#3)(1992-2#6)(1992-3#1)(1992-4#1)(1992-5#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#5)(1994-1#2)(1994-12#6)(1994-2#7)(1994-3#3)(1994-7#2)(1994-9#3)(1995-1#5)(1995-12#3)(1995-2#6)(1995-3#11)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#1)(2006-10#1)(2007-12#3)(2007-7#5)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#22)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#2)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#1)
government's##25##1##(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(2007-9#1)(2008-11#7)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2012-3#2)(2013-1#1)
government-owned##3##1##(1992-12#1)(1994-12#1)(1995-2#1)
government-sponsored##4##1##(1991-5#1)(1995-12#1)(1995-3#1)(2007-12#1)
governmental agencies##3##2##(1991-3#1)(1992-12#1)(1993-3#1)
governmental and nongovernmental##2##3##(1996-1#1)(2009-12#1)
governmental and##6##2##(1996-1#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-11#1)
governmental policy##2##2##(1993-3#1)(1997-3#1)
governmental##39##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1995-1#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#2)
governments and##5##2##(1993-6#1)(1994-3#1)(1996-1#1)(1997-1#1)(2008-11#1)
governments are now##2##3##(1995-1#1)(2008-11#1)
governments are##4##2##(1992-1#1)(1995-1#1)(2008-11#2)
governments in##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
governments of##2##2##(1991-2#1)(2012-12#1)
governments to##4##2##(1995-3#1)(2007-11#1)(2007-12#1)(2012-12#1)
governments##52##1##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-5#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-7#1)(2009-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#2)
governor##3##1##(1990-3#1)(1991-8#1)(1993-5#1)
governs the##8##2##(1994-6#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-11#1)(2009-11#1)(2010-8#1)(2011-2#1)
governs##14##1##(1994-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#2)(2011-2#1)(2012-12#1)
gox2 transcripts##2##2##(2008-10#2)
gox2##3##1##(2008-10#3)
gp##4##1##(1991-5#3)(1996-2#1)
gp120 of##4##2##(1993-3#2)(2008-12#2)
gp120 were##2##2##(2008-12#2)
gp120##22##1##(1990-2#1)(1992-5#1)(1993-3#4)(1994-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-12#4)(2008-4#1)(2013-1#5)(2013-8#2)
gp130-Related cytokines as well as their receptors are expressed in the pituitary##2##12##(2008-4#2)
gp130-Related cytokines such as interleukin-6 and leukemia-inhibitory factor (LIF) act on the adenohypophysis in a paracrine manner##2##17##(2008-4#2)
gp130-Related cytokines##5##2##(2008-4#5)
gp130-Related##6##1##(2008-4#6)
gp160##2##1##(1994-12#1)(1995-2#1)
gp19##2##1##(1994-12#2)
gp32##4##1##(1994-12#1)(1997-3#3)
gp41##5##1##(2011-3#3)(2013-8#2)
gp58##3##1##(1994-12#1)(1996-12#2)
gp60##2##1##(2013-1#2)
gp64 promoter##3##2##(2008-11#3)
gp64##4##1##(2008-11#4)
gp70##2##1##(1992-9#2)
gp75##2##1##(1994-12#2)
grabbing of##3##2##(2007-8#3)
grabbing##5##1##(2007-8#3)(2008-3#1)(2008-5#1)
gracilis##6##1##(1996-2#2)(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)
graciloplasty##2##1##(2008-12#1)(2011-1#1)
grade 1 in##2##3##(2008-6#1)(2008-7#1)
grade 1##10##2##(1994-2#1)(1996-6#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
grade 2 in##3##3##(2008-6#2)(2008-7#1)
grade 2 or##2##3##(1991-3#1)(2008-5#1)
grade 2##11##2##(1991-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2012-2#1)(2013-1#2)(2013-8#1)
grade 3 and 4##2##4##(2008-10#2)
grade 3 and##4##3##(2008-10#2)(2010-7#1)(2013-8#1)
grade 3##20##2##(1991-8#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#2)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
grade 4 neutropenia##3##3##(2008-6#1)(2008-7#2)
grade 4##8##2##(1991-8#2)(1992-8#1)(2008-6#1)(2008-7#3)(2009-7#1)
grade C##4##2##(2008-7#1)(2012-3#3)
grade CIN##2##2##(2011-1#2)
grade I in##2##3##(2008-8#2)
grade I##15##2##(1990-3#1)(1991-2#1)(1991-6#1)(1997-7#1)(2007-11#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#2)
grade II in##2##3##(2008-8#2)
grade II##15##2##(1990-12#1)(1990-3#1)(1991-2#1)(1997-7#1)(2007-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#2)
grade III##17##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-8#1)(1995-11#1)(1997-7#2)(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#3)
grade IV and##2##3##(2008-7#1)(2012-3#1)
grade IV##11##2##(2007-10#1)(2007-11#2)(2008-12#3)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
grade V##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
grade and ploidy##2##3##(2008-6#2)
grade and##7##2##(1990-12#1)(1992-10#1)(2008-10#1)(2008-6#2)(2011-1#1)(2011-2#1)
grade by##2##2##(2008-10#1)(2008-8#1)
grade dysplasia##2##2##(1994-2#1)(2008-5#1)
grade gliomas##2##2##(2011-2#1)(2013-1#1)
grade level##4##2##(2010-5#1)(2011-1#2)(2013-1#1)
grade levels##3##2##(2012-12#2)(2013-8#1)
grade malignancy##3##2##(1993-8#1)(2007-8#1)(2008-4#1)
grade malignant##3##2##(1997-3#1)(2008-5#1)(2010-3#1)
grade of malignancy##2##3##(2011-1#1)(2012-2#1)
grade of##19##2##(1990-12#2)(1993-6#1)(1996-1#1)(1997-7#1)(2007-11#1)(2008-10#5)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
grade on##2##2##(2008-12#1)(2008-7#1)
grade or##5##2##(1994-9#1)(2006-8#1)(2011-1#1)(2011-2#2)
grade retention##3##2##(2008-12#3)
grade students##5##2##(1991-9#1)(1994-5#1)(2008-12#2)(2009-7#1)
grade to##2##2##(2010-4#1)(2013-8#1)
grade was associated with a nodal metastasis##2##7##(2013-8#2)
grade was##4##2##(1993-9#1)(2012-2#1)(2013-8#2)
grade##315##1##(1990-12#5)(1990-3#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#6)(1992-1#2)(1992-10#1)(1992-4#1)(1992-8#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#3)(1994-5#1)(1994-9#3)(1995-11#2)(1996-1#1)(1996-6#2)(1997-3#1)(1997-7#5)(2006-8#1)(2007-10#4)(2007-11#11)(2007-8#1)(2008-10#23)(2008-11#4)(2008-12#22)(2008-4#1)(2008-5#5)(2008-6#21)(2008-7#28)(2008-8#7)(2008-9#6)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2011-1#10)(2011-2#22)(2011-3#1)(2012-12#5)(2012-2#10)(2012-3#9)(2013-1#18)(2013-7#2)(2013-8#26)
grade)##5##1##(2008-6#1)(2008-9#2)(2009-4#1)(2011-2#1)
graded according to the##2##4##(2008-4#1)(2013-1#1)
graded according to##4##3##(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
graded as##5##2##(1990-5#1)(1997-3#1)(2010-7#1)(2012-2#1)(2013-8#1)
graded doses of##3##3##(1992-11#1)(1992-9#1)(2012-2#1)
graded exercise##2##2##(2008-5#1)(2013-8#1)
graded levels of dietary phosphorus##2##5##(2008-10#2)
graded refractive-index profiles##2##3##(2008-3#2)
graded##59##1##(1990-11#1)(1990-3#1)(1990-5#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#2)(1995-12#1)(1996-6#2)(1997-3#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#2)
graded-index POF's##3##2##(2008-3#3)
graded-index multimode fiber##3##3##(2008-3#3)
graded-index multimode##4##2##(2008-3#4)
graded-index##12##1##(2007-12#3)(2008-2#1)(2008-3#8)
graders from##2##2##(2009-11#1)(2010-1#1)
graders##4##1##(2008-5#1)(2009-11#1)(2010-1#1)(2013-1#1)
grades 1##2##2##(1990-6#1)(1997-3#1)
grades 7 and 8##2##4##(2007-12#2)
grades in##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
grades of gastric carcinoma##2##4##(2011-2#2)
grades of##14##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#2)
grades##59##1##(1990-12#1)(1990-6#1)(1991-8#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#4)(2008-3#2)(2008-7#2)(2008-8#1)(2009-7#6)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#10)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
gradient across the##3##3##(1990-2#1)(1993-8#1)(2010-4#1)
gradient along##4##2##(1993-5#1)(2007-11#1)(2013-1#1)(2013-7#1)
gradient analysis##3##2##(1990-11#2)(1993-11#1)
gradient and##7##2##(1996-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#1)
gradient at a##2##3##(2008-10#2)
gradient at the##2##3##(2008-3#1)(2011-2#1)
gradient at##5##2##(2008-10#2)(2008-3#1)(2011-2#2)
gradient between##4##2##(2008-10#2)(2008-3#1)(2010-10#1)
gradient by##2##2##(1990-2#1)(1991-5#1)
gradient centrifugation of##2##3##(1997-3#1)(2008-9#1)
gradient centrifugation##23##2##(1991-11#1)(1991-8#1)(1993-8#3)(1994-8#2)(1995-12#2)(1997-3#2)(2008-1#2)(2008-10#1)(2008-4#4)(2008-9#4)(2011-2#1)
gradient chamber and##2##3##(2008-10#2)
gradient chamber##3##2##(2008-10#2)(2008-6#1)
gradient descent technique##2##3##(2007-11#1)(2008-3#1)
gradient descent##4##2##(2007-11#1)(2008-3#3)
gradient dilution##3##2##(2008-10#3)
gradient echo##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
gradient elution using##2##3##(2011-1#2)
gradient elution was##3##3##(2008-10#3)
gradient elution with the mobile##2##5##(2011-1#2)
gradient elution with##8##3##(1990-8#1)(2008-10#2)(2011-1#4)(2013-1#1)
gradient elution##31##2##(1990-8#2)(1994-12#1)(2008-10#20)(2008-5#1)(2011-1#6)(2013-1#1)
gradient enrichment##3##2##(1996-12#2)(1997-3#1)
gradient field##2##2##(2008-2#2)
gradient flow##5##2##(2008-10#3)(2008-4#1)(2010-8#1)
gradient for##2##2##(2008-10#1)(2008-8#1)
gradient force##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
gradient fractionation of##2##3##(1993-8#1)(2008-11#1)
gradient from##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
gradient gel electrophoresis (DGGE)##6##4##(2008-10#3)(2008-9#2)(2010-6#1)
gradient gel electrophoresis of##2##4##(1990-5#1)(2008-10#1)
gradient gel electrophoresis##11##3##(1990-5#1)(1991-12#1)(1994-8#1)(2008-10#4)(2008-3#1)(2008-9#2)(2010-6#1)
gradient gels##2##2##(2008-10#1)(2008-2#1)
gradient in a##2##3##(2008-9#1)(2011-2#1)
gradient in the direction##2##4##(2008-10#2)
gradient in the##5##3##(1993-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
gradient in##18##2##(1993-8#1)(2008-10#4)(2008-3#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
gradient is##6##2##(1990-2#2)(1994-8#1)(2008-10#1)(2008-2#2)
gradient liquid chromatographic system##2##4##(2008-5#1)(2013-1#1)
gradient liquid chromatographic##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
gradient liquid##4##2##(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
gradient model##2##2##(2012-2#2)
gradient of increasing##2##3##(2008-10#1)(2008-4#1)
gradient of the##6##3##(1990-7#1)(1991-5#1)(1994-6#1)(2008-2#1)(2008-6#1)(2008-8#1)
gradient of##27##2##(1990-7#1)(1991-5#1)(1992-12#3)(1994-6#1)(1995-3#1)(1995-6#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2011-2#1)(2013-8#2)
gradient on##6##2##(1993-2#1)(2008-10#3)(2008-2#1)(2011-2#1)
gradient or##2##2##(2009-2#1)(2009-6#1)
gradient revealed##2##2##(1990-8#1)(2008-10#1)
gradient sedimentation##2##2##(1994-6#1)(1995-6#1)
gradient similarity criterion##2##3##(2008-3#2)
gradient system##2##2##(1997-2#1)(2008-7#1)
gradient technique##2##2##(2008-10#1)(2008-2#1)
gradient that##3##2##(2008-10#2)(2008-3#1)
gradient was observed for##2##4##(2008-10#1)(2011-2#1)
gradient was##7##2##(2008-10#5)(2008-5#1)(2011-2#1)
gradient with a##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
gradient with##4##2##(2008-10#2)(2008-3#1)(2009-2#1)
gradient##379##1##(1990-11#4)(1990-2#6)(1990-5#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#1)(1991-5#3)(1991-8#1)(1992-12#3)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#6)(1993-9#1)(1994-12#2)(1994-6#6)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(2007-11#5)(2007-12#8)(2007-8#4)(2008-1#3)(2008-10#103)(2008-11#6)(2008-12#3)(2008-2#22)(2008-3#30)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#15)(2008-9#16)(2009-10#1)(2009-12#3)(2009-2#2)(2009-6#2)(2009-8#4)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#8)(2011-2#12)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#2)
gradient-echo##2##1##(1997-8#1)(2012-2#1)
gradient-enriched##3##1##(1997-3#3)
gradient-force##2##1##(2007-11#1)(2008-2#1)
gradient-index axicon##2##2##(2008-3#2)
gradient-index lens##6##2##(2007-11#2)(2008-2#1)(2008-3#3)
gradient-index lenses##4##2##(2007-11#1)(2008-3#3)
gradient-index rod lenses##4##3##(2008-3#4)
gradient-index rod##5##2##(2008-3#5)
gradient-index##22##1##(2007-11#3)(2008-2#3)(2008-3#16)
gradient-recalled-echo MRI##2##2##(1997-8#2)
gradient-recalled-echo##3##1##(1997-8#3)
gradients and##9##2##(1990-11#1)(1994-8#1)(1995-6#2)(1995-8#1)(2008-8#1)(2010-3#2)(2012-6#1)
gradients are##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2010-3#1)
gradients as##2##2##(2008-3#2)
gradients by##2##2##(1992-8#1)(2008-3#1)
gradients can be##2##3##(2007-11#1)(2008-2#1)
gradients in a##2##3##(1997-3#1)(2008-7#1)
gradients in the##2##3##(2008-3#1)(2009-12#1)
gradients in##11##2##(1995-3#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-7#1)
gradients of##12##2##(1996-5#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#2)(2013-8#1)
gradients or##4##2##(1995-2#1)(2008-2#1)(2008-4#1)(2008-8#1)
gradients to##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
gradients were##5##2##(2008-10#4)(2008-7#1)
gradients with##2##2##(1995-6#1)(2013-1#1)
gradients within the central nervous system##2##6##(2008-7#2)
gradients within the##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
gradients within##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)
gradients##126##1##(1990-11#2)(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#29)(2008-11#2)(2008-2#5)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#15)(2008-9#3)(2009-12#2)(2009-6#1)(2009-7#1)(2010-3#7)(2011-1#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
grading and staging##2##3##(1990-6#1)(2006-10#1)
grading and typing##3##3##(2013-8#3)
grading and##8##2##(1990-6#1)(2006-10#1)(2008-6#1)(2011-2#2)(2013-8#3)
grading is##3##2##(2008-6#1)(2012-2#1)(2013-8#1)
grading of malignant##2##3##(1996-9#1)(2013-8#1)
grading of##8##2##(1995-9#1)(1996-9#2)(2008-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
grading scale##2##2##(2012-3#2)
grading scales##2##2##(2008-5#1)(2008-7#1)
grading system##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
grading systems were##3##3##(2011-2#3)
grading was done by##2##4##(2013-8#2)
grading##59##1##(1990-10#1)(1990-6#1)(1994-10#1)(1995-3#1)(1995-9#1)(1996-9#2)(1997-3#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2010-1#1)(2010-3#1)(2010-8#3)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#11)
gradings##2##1##(2007-10#1)(2008-6#1)
gradual and##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
gradual change##4##2##(1995-5#1)(2008-2#1)(2008-8#1)(2010-5#1)
gradual clinical improvement##2##3##(2013-1#1)(2013-8#1)
gradual clinical##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
gradual decrease in##8##3##(1990-11#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
gradual decrease##10##2##(1990-11#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
gradual evolution of##2##3##(2008-7#1)(2008-8#1)
gradual growth##2##2##(2008-12#1)(2008-3#1)
gradual increase in the##3##4##(1994-8#1)(2008-10#1)(2011-2#1)
gradual increase in##8##3##(1994-11#1)(1994-8#1)(1996-5#1)(2008-10#3)(2008-5#1)(2011-2#1)
gradual increase of osmotic pressure##4##5##(2008-11#4)
gradual increase##14##2##(1994-11#1)(1994-8#1)(1996-5#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#1)(2011-2#2)
gradual loss of##2##3##(1990-5#1)(2009-5#1)
gradual reduction in##2##3##(1995-12#1)(2009-8#1)
gradual reduction##3##2##(1995-12#1)(2009-8#1)(2012-2#1)
gradual rise in##2##3##(2009-7#1)(2010-4#1)
gradual sample addition to##2##4##(2008-10#2)
gradual##101##1##(1990-11#1)(1990-5#1)(1991-11#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-5#1)(2008-10#16)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
gradually after##3##2##(2008-10#2)(2008-11#1)
gradually and##7##2##(1991-12#1)(2008-12#2)(2008-9#1)(2010-10#1)(2010-8#1)(2013-8#1)
gradually as the##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
gradually became##4##2##(1997-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
gradually become##4##2##(1997-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
gradually change the##2##3##(2008-6#1)(2013-1#1)
gradually change##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
gradually combined##2##2##(2013-1#2)
gradually declined##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
gradually decreased to##2##3##(2008-7#1)(2011-2#1)
gradually decreased##14##2##(1990-6#1)(1990-7#1)(1991-8#1)(1994-11#1)(1997-6#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
gradually diminished##3##2##(1994-9#2)(2008-11#1)
gradually during the##3##3##(1994-3#1)(2008-2#1)(2008-7#1)
gradually during##4##2##(1994-3#1)(2008-12#1)(2008-2#1)(2008-7#1)
gradually enlarged##2##2##(1995-4#1)(2008-11#1)
gradually from##8##2##(1996-3#1)(1997-4#2)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
gradually in the##4##3##(1990-12#1)(2008-1#1)(2008-2#1)(2013-8#1)
gradually in##6##2##(1990-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
gradually increased during the##2##4##(2008-10#1)(2013-1#1)
gradually increased##14##2##(1995-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
gradually increasing##6##2##(1995-12#1)(1997-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-1#1)
gradually over##4##2##(2007-7#1)(2008-10#1)(2011-1#1)(2012-12#1)
gradually to a##2##3##(1997-6#1)(2013-8#1)
gradually to##3##2##(1990-11#1)(1997-6#1)(2013-8#1)
gradually with the##2##3##(2008-9#1)(2013-8#1)
gradually with##5##2##(1995-8#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
gradually##180##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-8#3)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#7)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#9)(2008-7#8)(2008-8#4)(2008-9#6)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#14)
graduate and undergraduate##2##3##(1991-1#1)(2008-12#1)
graduate degree##2##2##(1993-1#1)(1997-2#1)
graduate dietetic internship##2##3##(1992-2#2)
graduate education##5##2##(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(2011-1#1)
graduate educational##2##2##(1992-1#1)(2008-1#1)
graduate health administration##4##3##(1991-2#1)(1995-1#1)(1996-1#2)
graduate health##5##2##(1991-12#1)(1991-2#1)(1995-1#1)(1996-1#2)
graduate level##2##2##(1993-12#1)(2008-12#1)
graduate medical education##12##3##(1991-8#4)(2007-4#2)(2008-11#5)(2013-8#1)
graduate medical##13##2##(1991-8#4)(2007-4#2)(2008-1#1)(2008-11#5)(2013-8#1)
graduate nurse program##2##3##(2008-11#2)
graduate nurse##4##2##(2008-11#4)
graduate nursing students##2##3##(2010-10#1)(2010-3#1)
graduate nursing workforce##2##3##(2012-3#2)
graduate nursing##6##2##(2008-11#1)(2010-10#1)(2010-3#1)(2012-2#1)(2012-3#2)
graduate programs in health administration##2##5##(1995-1#1)(1996-1#1)
graduate programs in health##4##4##(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)
graduate programs in##5##3##(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)
graduate programs##6##2##(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-4#1)
graduate student##8##2##(1996-1#1)(2008-10#2)(2008-9#2)(2010-6#2)(2012-3#1)
graduate students and##2##3##(1996-2#1)(2010-9#1)
graduate students who##2##3##(2008-9#1)(2011-2#1)
graduate students##8##2##(1991-1#1)(1996-1#2)(1996-2#1)(2008-9#2)(2010-9#1)(2011-2#1)
graduate year 1##2##3##(1991-8#2)
graduate year##3##2##(1991-8#2)(2008-11#1)
graduate##99##1##(1991-1#2)(1991-12#2)(1991-2#1)(1991-8#6)(1992-1#1)(1992-2#4)(1993-1#2)(1993-12#2)(1993-2#1)(1994-12#4)(1995-1#3)(1995-2#3)(1996-1#6)(1996-2#2)(1996-3#1)(1997-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#4)(2008-1#2)(2008-10#2)(2008-11#12)(2008-12#3)(2008-9#5)(2010-10#1)(2010-3#3)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#5)(2013-8#1)
graduated from##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
graduated in##2##2##(1993-6#1)(1994-12#1)
graduated##11##1##(1991-2#1)(1993-6#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)
graduates and##2##2##(1993-3#1)(1996-3#1)
graduates are##2##2##(1992-8#1)(2012-3#1)
graduates at the##2##3##(2013-8#2)
graduates from the##2##3##(1991-6#1)(1993-3#1)
graduates from##5##2##(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(2013-1#1)
graduates in##5##2##(1991-8#1)(1995-2#2)(1996-3#1)(2012-3#1)
graduates of##7##2##(1991-2#1)(1995-1#1)(2007-11#2)(2008-11#1)(2011-2#1)(2013-1#1)
graduates to##4##2##(1993-11#1)(1996-3#1)(2011-2#1)(2012-3#1)
graduates was##2##2##(1994-12#1)(1996-1#1)
graduates with##3##2##(1993-3#1)(1994-12#1)(2012-2#1)
graduates##69##1##(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-8#1)(1993-11#1)(1993-2#3)(1993-3#3)(1994-12#8)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#3)(1996-1#2)(1996-3#3)(1997-2#1)(2007-11#2)(2008-11#8)(2009-10#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#9)(2013-1#4)(2013-8#2)
graduates'##4##1##(2007-11#3)(2013-1#1)
graduating in 2005##2##3##(2013-1#2)
graduating in##3##2##(2012-3#1)(2013-1#2)
graduating##6##1##(2007-4#1)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
graduation of##2##2##(1990-5#1)(1994-12#1)
graduation##8##1##(1990-5#1)(1994-12#2)(1995-2#1)(2008-12#2)(2008-9#1)(2012-3#1)
graellsii##3##1##(2012-3#3)
graft acceptance##2##2##(2011-2#1)(2012-3#1)
graft allocation##2##2##(2011-3#2)
graft anastomoses during coronary artery bypass grafting##2##7##(2007-8#2)
graft anastomoses##4##2##(2007-7#1)(2007-8#3)
graft and the patient##2##4##(2007-11#1)(2007-7#1)
graft and the##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2012-3#1)
graft and##9##2##(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-2#2)(2012-3#1)
graft between the##2##3##(1990-3#1)(2007-8#1)
graft composed of##2##3##(2008-5#1)(2008-9#1)
graft contracture##2##2##(2008-9#1)(2009-5#1)
graft diameter##2##2##(2013-1#2)
graft failure##5##2##(2006-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
graft failures##2##2##(1997-1#1)(2007-7#1)
graft for##7##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
graft from the##3##3##(1995-12#1)(2008-7#2)
graft from##4##2##(1995-12#2)(2008-7#2)
graft function##8##2##(1991-11#1)(1991-9#1)(1994-5#1)(2007-10#1)(2008-8#1)(2011-2#1)(2013-1#2)
graft had##2##2##(2007-7#1)(2013-1#1)
graft has##2##2##(2007-11#1)(2008-5#1)
graft healing##2##2##(2008-9#1)(2012-12#1)
graft implant##2##2##(2007-7#2)
graft in a##2##3##(2007-11#1)(2008-7#1)
graft in the treatment of##2##5##(2007-9#1)(2012-3#1)
graft in the##5##3##(2007-7#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
graft in##18##2##(1994-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-8#1)(2013-8#1)
graft infection##3##2##(2007-10#1)(2011-3#2)
graft inoculation methods##2##3##(2008-10#2)
graft inoculation##4##2##(2008-10#4)
graft interposition##2##2##(2008-1#2)
graft is##3##2##(2007-7#1)(2008-9#1)(2011-3#1)
graft loss due to##2##4##(2008-8#1)(2013-1#1)
graft loss##6##2##(2008-1#1)(2008-8#3)(2008-9#1)(2013-1#1)
graft material##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
graft materials##5##2##(2007-12#1)(2009-11#1)(2011-3#1)(2012-12#1)(2012-8#1)
graft occlusion##2##2##(2007-8#1)(2011-3#1)
graft on##2##2##(1993-1#1)(1996-3#1)
graft patency in##3##3##(2007-7#1)(2007-8#2)
graft patency was 96##3##4##(2007-8#3)
graft patency was##5##3##(2007-8#5)
graft patency##12##2##(2007-7#3)(2007-8#9)
graft polymerization of 2-methacryloyloxyethyl phosphorylcholine##2##5##(2010-4#2)
graft polymerization##4##2##(2008-10#1)(2010-4#3)
graft pseudoaneurysm##2##2##(2007-8#2)
graft recipients with other etiologies of renal failure##2##8##(2013-1#2)
graft recipients##4##2##(2007-7#1)(2008-1#1)(2013-1#2)
graft rejection##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
graft repair##3##2##(2009-5#1)(2010-12#2)
graft replacement of##2##3##(2007-8#1)(2012-2#1)
graft replacement##3##2##(2007-8#2)(2012-2#1)
graft stenosis##3##2##(1996-2#2)(2007-8#1)
graft surgery##14##2##(1993-12#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-11#1)(2009-6#1)(2012-12#1)(2013-8#1)
graft survival and##2##3##(1991-11#1)(2011-2#1)
graft survival in##2##3##(2011-2#1)(2013-1#1)
graft survival is##2##3##(1995-9#1)(2008-4#1)
graft survival was##3##3##(2008-1#3)
graft survival##21##2##(1990-10#1)(1990-11#1)(1991-11#3)(1995-2#1)(1995-9#2)(2007-8#1)(2008-1#4)(2008-4#1)(2011-2#6)(2013-1#1)
graft survivals##2##2##(2008-8#2)
graft thrombosis##4##2##(2007-7#1)(2011-2#3)
graft to the##2##3##(2007-8#1)(2008-6#1)
graft to##6##2##(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-6#1)
graft versus host disease##3##4##(2007-4#1)(2008-5#1)(2008-7#1)
graft was##8##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
graft with##6##2##(1996-2#1)(2007-8#1)(2009-10#2)(2009-5#1)(2013-1#1)
graft##373##1##(1990-10#1)(1990-11#1)(1990-3#3)(1990-9#1)(1991-11#5)(1991-9#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#3)(1995-2#4)(1995-9#2)(1996-2#5)(1996-3#3)(1997-1#1)(1997-3#2)(1997-8#3)(2006-12#1)(2006-6#2)(2007-10#4)(2007-11#10)(2007-12#2)(2007-4#1)(2007-7#21)(2007-8#55)(2007-9#1)(2008-1#17)(2008-10#14)(2008-11#9)(2008-12#4)(2008-4#3)(2008-5#4)(2008-6#7)(2008-7#9)(2008-8#16)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#2)(2009-3#2)(2009-5#8)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-8#1)(2011-2#38)(2011-3#16)(2011-7#1)(2012-12#7)(2012-2#5)(2012-3#7)(2012-8#2)(2013-1#24)(2013-8#5)
graft)##2##1##(1993-3#1)(2011-2#1)
graft-inoculated with##2##2##(2008-10#2)
graft-inoculated##4##1##(2008-10#4)
graft-inoculation##2##1##(2008-10#2)
graft-transmissible##2##1##(2008-10#2)
graft-versus-host disease (GVHD)##2##3##(2006-10#1)(2009-10#1)
graft-versus-host disease after bone marrow transplantation##2##6##(1991-2#1)(1997-7#1)
graft-versus-host disease and##2##3##(1997-8#1)(2008-5#1)
graft-versus-host disease##12##2##(1991-2#1)(1997-7#2)(1997-8#1)(2006-10#1)(2008-5#1)(2009-10#2)(2010-11#1)(2012-2#2)(2013-8#1)
graft-versus-host reaction##3##2##(1991-5#1)(1997-8#2)
graft-versus-host##16##1##(1991-2#1)(1991-5#1)(1997-7#2)(1997-8#3)(2006-10#1)(2008-5#1)(2009-10#2)(2010-11#1)(2012-2#3)(2013-8#1)
graftectomy##3##1##(2011-3#3)
grafted BSA protein##2##3##(2008-10#2)
grafted and##2##2##(2008-10#2)
grafted cellulose membrane##4##3##(2008-10#4)
grafted methacrylate groups and##2##4##(2013-1#2)
grafted on silica##2##3##(2008-10#2)
grafted on##7##2##(2008-10#7)
grafted polymer is##2##3##(2008-10#2)
grafted polymer##8##2##(2008-10#6)(2009-10#1)(2009-5#1)
grafted to##2##2##(1993-12#1)(2008-10#1)
grafted with poly(ethylene glycol)##2##4##(2008-8#1)(2010-6#1)
grafted with##8##2##(1991-2#1)(1995-2#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-6#1)
grafted##60##1##(1990-7#2)(1991-2#1)(1993-12#1)(1995-2#1)(1996-2#1)(1997-5#1)(2008-10#37)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-7#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#4)
grafting (CABG) and##2##3##(2007-8#1)(2013-1#1)
grafting (CABG)##9##2##(2006-8#1)(2007-8#6)(2010-8#1)(2013-1#1)
grafting after##2##2##(2012-1#1)(2012-12#1)
grafting and##7##2##(2007-12#2)(2007-8#2)(2008-10#1)(2008-3#1)(2013-8#1)
grafting experiments##3##2##(1993-12#1)(2008-10#2)
grafting for##2##2##(2007-8#2)
grafting in the##2##3##(2007-12#2)
grafting in##4##2##(1993-12#1)(2007-12#2)(2007-8#1)
grafting into the##2##3##(1994-5#1)(2006-10#1)
grafting is##4##2##(2008-9#1)(2009-1#1)(2010-3#1)(2013-1#1)
grafting of the##4##3##(2007-8#2)(2008-4#1)(2013-8#1)
grafting of##9##2##(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
grafting on the arrested heart##2##5##(2007-8#2)
grafting on the arrested##3##4##(2007-8#3)
grafting on the##4##3##(2007-8#3)(2008-3#1)
grafting on##8##2##(1997-3#1)(2007-8#4)(2008-10#1)(2008-3#2)
grafting procedures##3##2##(2007-12#1)(2007-8#1)(2010-3#1)
grafting process##4##2##(2008-10#4)
grafting techniques##2##2##(2007-12#1)(2013-8#1)
grafting the##4##2##(2007-12#1)(2007-8#2)(2008-11#1)
grafting through a##2##3##(2007-8#1)(2011-2#1)
grafting through##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
grafting to the##2##3##(2008-5#1)(2013-1#1)
grafting to##5##2##(1991-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
grafting using##2##2##(2007-8#1)(2008-9#1)
grafting with##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
grafting##182##1##(1991-2#1)(1991-9#1)(1993-12#3)(1994-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#12)(2007-7#2)(2007-8#56)(2007-9#2)(2008-10#23)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#7)(2009-1#1)(2009-12#1)(2010-3#2)(2010-6#1)(2010-8#3)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#11)(2013-8#5)
grafts (3##2##2##(2007-7#1)(2007-8#1)
grafts after##2##2##(2008-1#1)(2011-2#1)
grafts and long-term##2##3##(2007-7#1)(2010-11#1)
grafts and##11##2##(1996-2#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2009-10#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
grafts are##4##2##(2007-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
grafts by##2##2##(2010-11#1)(2012-2#1)
grafts can##2##2##(1993-12#1)(2010-8#1)
grafts for##6##2##(2007-7#1)(2007-8#1)(2010-10#1)(2010-8#3)
grafts from##2##2##(1997-8#1)(2010-11#1)
grafts has##2##2##(2008-9#1)(2009-4#1)
grafts have been##5##3##(1991-3#1)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#1)
grafts have##6##2##(1991-3#1)(2007-8#1)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#1)
grafts in the##3##3##(1990-5#1)(1991-2#1)(1993-12#1)
grafts in##13##2##(1990-5#1)(1991-2#1)(1993-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-5#2)(2010-12#1)(2010-8#1)(2011-3#1)
grafts of##3##2##(1993-12#1)(1995-2#2)
grafts that##3##2##(2008-5#1)(2010-8#1)(2012-3#1)
grafts to the##2##3##(1992-4#1)(1993-12#1)
grafts to##7##2##(1992-4#1)(1993-12#1)(1994-11#2)(2008-11#1)(2008-5#2)
grafts used in##2##3##(2007-7#1)(2007-8#1)
grafts used##3##2##(2007-7#1)(2007-8#2)
grafts using a##2##3##(1997-2#1)(2012-3#1)
grafts were constructed##2##3##(1996-9#1)(2007-7#1)
grafts were implanted in##2##4##(2007-7#2)
grafts were used##3##3##(1995-2#1)(2008-1#1)(2008-8#1)
grafts were##22##2##(1995-2#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#2)(2011-2#2)
grafts when##2##2##(1997-8#1)(2008-11#1)
grafts with a branch##2##4##(2010-8#2)
grafts with##5##2##(2007-7#1)(2008-11#1)(2009-10#1)(2010-8#2)
grafts##206##1##(1990-5#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-4#1)(1993-12#9)(1993-5#1)(1994-11#2)(1994-8#1)(1995-2#3)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-8#3)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-7#30)(2007-8#22)(2007-9#1)(2008-1#10)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#6)(2009-5#5)(2010-10#1)(2010-11#5)(2010-12#3)(2010-6#3)(2010-8#14)(2011-2#16)(2011-3#6)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
grafts)##3##1##(1991-11#1)(2007-7#1)(2007-8#1)
grain Se concentration was##2##4##(2012-2#2)
grain and Fusarium##2##3##(2008-10#2)
grain and soil surveys##2##4##(2012-2#2)
grain and##13##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#1)(2012-2#2)
grain by##3##2##(2008-10#3)
grain density##4##2##(1991-12#1)(1996-5#2)(2008-10#1)
grain filling##5##2##(2008-9#4)(2011-2#1)
grain growth##2##2##(2008-12#1)(2009-7#1)
grain in##2##2##(2008-10#2)
grain incubated in vitro##3##4##(2008-10#3)
grain intake##2##2##(2010-1#2)
grain number##2##2##(2008-10#1)(2008-12#1)
grain protein##2##2##(1991-12#1)(2008-12#1)
grain quality##3##2##(2008-5#1)(2008-8#2)
grain size and##2##3##(2008-3#1)(2012-2#1)
grain size distributions##2##3##(2008-2#2)
grain size##8##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)
grain sizes##3##2##(2008-10#3)
grain sorghum##2##2##(2008-10#2)
grain was##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
grain weight##5##2##(2008-10#1)(2008-12#3)(2011-2#1)
grain were##2##2##(2008-10#2)
grain yield in##2##3##(2008-10#2)
grain yield##17##2##(2008-10#5)(2008-12#9)(2008-8#1)(2011-2#1)(2012-2#1)
grain##150##1##(1990-6#1)(1991-12#2)(1991-9#1)(1995-2#1)(1996-2#1)(1996-5#3)(2007-11#2)(2008-10#63)(2008-11#8)(2008-12#17)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#6)(2008-9#4)(2009-7#5)(2010-1#6)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#5)
grains and##9##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)
grains are##2##2##(2008-10#1)(2010-1#1)
grains by##4##2##(2008-10#3)(2008-12#1)
grains for##2##2##(1995-3#1)(2008-9#1)
grains in##5##2##(2008-10#1)(2008-2#2)(2012-12#2)
grains is one##2##3##(2008-12#1)(2010-1#1)
grains is##3##2##(2008-12#1)(2010-1#2)
grains of##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2009-10#1)
grains or##2##2##(2008-10#2)
grains was##2##2##(2012-12#1)(2013-1#1)
grains were##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
grains##81##1##(1990-12#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2010-1#9)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#1)(2013-8#1)
gram negative bacteria were##2##4##(2007-7#1)(2008-12#1)
gram negative bacteria##10##3##(1997-8#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)(2013-8#2)
gram negative##18##2##(1991-2#1)(1996-2#2)(1997-8#2)(2007-7#6)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)(2013-8#2)
gram negatives##2##2##(2007-7#2)
gram of a##2##3##(2008-11#2)
gram of##33##2##(1993-11#1)(2008-10#25)(2008-11#4)(2011-1#1)(2011-2#2)
gram positive and gram negative bacteria##3##6##(2007-7#1)(2008-11#1)(2010-3#1)
gram positive bacteria##2##3##(1997-8#1)(2008-12#1)
gram positive cocci##2##3##(2007-7#1)(2013-8#1)
gram positive##10##2##(1997-8#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-8#1)
gram stained urethral smears##2##4##(2007-7#2)
gram##79##1##(1990-8#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-5#1)(1996-2#2)(1997-4#1)(1997-8#3)(2007-7#13)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#3)
gram-negative bacteria##10##2##(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2010-3#2)(2013-1#1)
gram-negative bacterium##2##2##(2011-2#1)(2012-2#1)
gram-negative organisms##3##2##(1991-11#1)(1992-12#1)(2008-9#1)
gram-negative rods##2##2##(2009-8#1)(2012-2#1)
gram-negative##28##1##(1991-11#1)(1992-12#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-3#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
gram-positive and gram-negative bacteria##2##4##(2010-3#2)
gram-positive and gram-negative##3##3##(2007-12#1)(2010-3#2)
gram-positive bacterium##2##2##(2008-10#2)
gram-positive##15##1##(2007-12#2)(2008-1#1)(2008-10#6)(2009-6#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-2#1)
gramicidin in##2##2##(2010-5#2)
gramicidin##7##1##(1994-5#1)(2010-5#6)
graminearum and F##2##3##(2008-10#2)
graminearum and##5##2##(2008-10#3)(2009-6#1)(2010-7#1)
graminearum in##3##2##(2008-10#3)
graminearum infection##2##2##(2008-10#2)
graminearum isolates from##2##3##(2008-10#2)
graminearum isolates##3##2##(2008-10#3)
graminearum treatment##3##2##(2008-10#3)
graminearum##55##1##(2008-10#48)(2008-8#2)(2009-6#1)(2010-7#2)(2011-10#2)
graminearum)##3##1##(2008-10#3)
graminicola and##4##2##(2008-10#3)(2011-10#1)
graminicola ascocarps##2##2##(2008-10#2)
graminicola at##2##2##(2008-10#2)
graminicola from##2##2##(2008-10#2)
graminicola fruiting bodies##2##3##(2008-10#2)
graminicola in wheat##2##3##(2008-10#1)(2011-10#1)
graminicola in##5##2##(2008-10#4)(2011-10#1)
graminicola is##2##2##(2008-10#2)
graminicola isolates##2##2##(2008-10#2)
graminicola populations##5##2##(2008-10#5)
graminicola to##2##2##(2008-10#2)
graminicola was##2##2##(2008-10#2)
graminicola were##3##2##(2008-10#3)
graminicola##82##1##(2008-10#80)(2011-10#2)
graminicola)##3##1##(2008-10#3)
graminis f##28##2##(2008-10#28)
graminis var##10##2##(2008-10#10)
graminis zoospores##2##2##(2008-10#2)
graminis##55##1##(2008-10#54)(2008-7#1)
graminis-infested##2##1##(2008-10#2)
graminum biotypes##3##2##(2008-10#3)
graminum##12##1##(1996-12#2)(2008-10#10)
grammar learning##3##2##(2008-5#2)(2012-12#1)
grammar##6##1##(2008-2#1)(2008-5#4)(2012-12#1)
grammars##3##1##(2008-2#1)(2011-3#2)
grammatical and##2##2##(2008-11#1)(2008-4#1)
grammatical##16##1##(1991-2#2)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#1)(2009-8#2)(2009-9#1)(2012-1#1)(2013-1#1)
grammatical-class##2##1##(1991-2#2)
grammaticality##2##1##(2008-2#1)(2011-1#1)
grammatically##2##1##(2009-9#1)(2012-3#1)
grams average weight##2##3##(2013-1#2)
grams average##3##2##(2013-1#3)
grams of##3##2##(1993-11#1)(1994-5#1)(2011-2#1)
grams##9##1##(1990-8#1)(1993-11#1)(1994-5#1)(2008-10#2)(2011-2#1)(2013-1#3)
grand##4##1##(1993-11#1)(1995-12#1)(1997-3#1)(2011-1#1)
grandchild##4##1##(2007-1#1)(2010-9#3)
grandchild's death##2##2##(2010-9#2)
grande partie##2##2##(2008-11#1)(2008-5#1)
grande##5##1##(2008-11#1)(2008-5#2)(2013-1#2)
grandicollis##4##1##(2011-2#4)
grandiflora##4##1##(2013-7#4)
grandiglumis##4##1##(2008-5#4)
grandis##11##1##(2007-12#1)(2008-10#3)(2008-5#5)(2011-2#1)(2013-8#1)
grandis)##2##1##(2008-10#1)(2008-5#1)
grandmothers##3##1##(2009-12#2)(2011-2#1)
grandparent##4##1##(2008-10#1)(2010-9#3)
grandparents##2##1##(2010-9#2)
granisetron##19##1##(2008-7#1)(2010-12#14)(2010-7#4)
granite##8##1##(2008-1#1)(2008-10#4)(2013-8#3)
granites containing numerous debris of red beds and granites##2##9##(2013-8#2)
granites containing numerous debris of red beds##3##7##(2013-8#3)
granites##7##1##(2008-10#1)(2013-8#6)
granitic rocks##3##2##(2008-10#3)
granitic##5##1##(2008-10#5)
grant from the##2##3##(1996-1#1)(2009-4#1)
grant management##3##2##(2010-7#3)
grant program##3##2##(1992-12#1)(1996-1#1)(1996-2#1)
grant##28##1##(1990-5#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-6#4)(1996-1#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-3#1)(2008-12#2)(2009-11#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#3)(2011-2#1)(2012-12#1)(2013-1#1)
granted a##5##2##(1995-5#2)(1996-12#1)(2008-5#1)(2012-3#1)
granted an injunction##2##3##(1995-6#1)(1997-7#1)
granted an##3##2##(1995-6#1)(1996-1#1)(1997-7#1)
granted that##2##2##(2008-11#1)(2008-9#1)
granted##25##1##(1990-11#1)(1994-3#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2012-12#1)(2012-3#1)(2013-8#1)
grantee##2##1##(1996-3#1)(2012-12#1)
granting the##4##2##(1995-6#2)(1996-12#1)(2009-3#1)
granting##8##1##(1991-9#1)(1993-12#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-3#1)(2009-3#1)
grants and##2##2##(1997-2#1)(2008-12#1)
grants programs##2##2##(2008-10#1)(2008-7#1)
grants which##2##2##(1991-1#1)(2008-1#1)
grants##28##1##(1991-1#1)(1993-3#1)(1996-3#7)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-1#2)
grantwrite##2##1##(1996-1#2)
granular and##2##2##(1995-3#1)(2013-8#1)
granular cell tumor##4##3##(1994-7#1)(2007-12#1)(2009-4#1)(2011-2#1)
granular cell##6##2##(1994-7#1)(1996-5#1)(2007-12#1)(2009-4#1)(2011-2#2)
granular component##2##2##(1995-3#2)
granular endoplasmic reticulum##2##3##(2008-12#1)(2008-7#1)
granular layer##3##2##(1993-12#1)(2008-7#1)(2013-1#1)
granular material##2##2##(2008-10#1)(2008-7#1)
granular materials##3##2##(1992-8#1)(2008-3#2)
granular##60##1##(1990-12#2)(1992-11#2)(1992-5#2)(1992-8#2)(1993-12#1)(1994-7#1)(1995-3#3)(1996-5#1)(2007-12#3)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#9)(2009-4#1)(2009-8#2)(2010-1#2)(2010-11#1)(2011-2#3)(2013-1#4)(2013-8#1)
granularity and##2##2##(2009-12#1)(2012-12#1)
granularity##8##1##(2008-11#2)(2009-12#1)(2010-4#1)(2011-2#3)(2012-12#1)
granulated##6##1##(2007-12#1)(2008-11#2)(2010-1#1)(2011-2#1)(2013-1#1)
granulating##4##1##(1992-2#1)(1995-3#1)(2008-9#1)(2010-5#1)
granulation tissue weight and##2##4##(2008-10#2)
granulation tissue##7##2##(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
granulation##16##1##(2007-11#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
granule and##3##2##(1990-11#1)(1992-6#2)
granule cell degeneration induced by intragyral##2##6##(1994-8#2)
granule cell degeneration induced by##3##5##(1994-8#3)
granule cell degeneration##4##3##(1994-8#4)
granule cell layer##5##3##(1993-9#1)(1995-12#2)(2009-8#1)(2013-8#1)
granule cell##13##2##(1990-7#1)(1993-9#1)(1994-8#5)(1995-12#2)(1996-5#1)(2008-11#1)(2009-8#1)(2013-8#1)
granule cells in##4##3##(1991-12#1)(1994-8#1)(2008-6#1)(2009-8#1)
granule cells##19##2##(1990-5#2)(1990-7#2)(1991-12#2)(1994-2#1)(1994-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(2008-6#1)(2008-9#2)(2009-8#2)(2012-2#1)
granule dynamics##2##2##(2010-11#2)
granule exocytosis##3##2##(1993-6#1)(1996-5#1)(2010-11#1)
granule membranes as##2##3##(1990-11#1)(1992-6#1)
granule membranes##7##2##(1990-11#3)(1991-5#2)(1992-6#2)
granule neurons##6##2##(1991-12#1)(1995-8#2)(2008-6#1)(2009-8#2)
granule##72##1##(1990-11#5)(1990-5#3)(1990-7#4)(1991-12#3)(1991-5#2)(1992-12#1)(1992-5#1)(1992-6#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#6)(1995-12#2)(1995-8#3)(1996-12#3)(1996-5#3)(1996-7#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-9#2)(2009-8#5)(2010-11#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
granules and the##2##3##(2010-5#1)(2013-1#1)
granules and##8##2##(1992-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#2)
granules are##2##2##(2007-12#1)(2008-7#1)
granules as##2##2##(2008-10#1)(2008-4#1)
granules containing##2##2##(1992-12#1)(2008-5#1)
granules during the##2##3##(2007-12#1)(2008-7#1)
granules for##2##2##(2008-4#1)(2011-2#1)
granules in##8##2##(1992-12#1)(1992-3#2)(1997-7#2)(2009-8#1)(2013-1#2)
granules of##5##2##(1991-12#1)(1992-10#1)(1996-5#2)(2008-5#1)
granules were##6##2##(1990-11#1)(2008-10#2)(2008-6#1)(2010-5#1)(2013-8#1)
granules with##4##2##(1992-12#1)(1994-12#1)(2008-7#2)
granules##120##1##(1990-11#1)(1990-5#10)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#6)(1992-2#2)(1992-3#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#3)(1996-5#4)(1997-7#9)(2007-12#11)(2008-1#2)(2008-10#9)(2008-11#1)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#8)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#5)(2010-5#4)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
granulin A##2##2##(1990-12#2)
granulin##6##1##(1990-12#6)
granulins##2##1##(1990-12#2)
granulocyte colony-stimulating factor (G-CSF)##4##4##(1994-11#1)(2006-10#1)(2008-7#2)
granulocyte colony-stimulating factor receptor##2##4##(1994-11#2)
granulocyte colony-stimulating factor##16##3##(1994-11#3)(1994-12#1)(2006-10#1)(2008-11#4)(2008-7#3)(2010-6#1)(2012-3#2)(2013-1#1)
granulocyte count##2##2##(1994-3#2)
granulocyte macrophage colony stimulating factor gene##2##6##(2012-2#2)
granulocyte macrophage colony stimulating factor##4##5##(1992-3#2)(2012-2#2)
granulocyte transfusions##2##2##(2011-2#2)
granulocyte##31##1##(1990-2#1)(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#3)(1994-12#1)(1994-3#2)(2006-10#1)(2008-11#4)(2008-5#1)(2008-7#3)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)
granulocyte-colony stimulating factor (G-CSF)##2##4##(1994-3#1)(1996-5#1)
granulocyte-colony stimulating factor##3##3##(1994-3#1)(1996-5#1)(2008-6#1)
granulocyte-macrophage colony stimulating factor (GM-CSF)##3##5##(1992-3#1)(1992-8#1)(2008-11#1)
granulocyte-macrophage colony-stimulating factor (GM-CSF)##2##4##(1995-6#1)(2008-7#1)
granulocyte-macrophage colony-stimulating factor##7##3##(1991-8#1)(1993-11#1)(1995-6#1)(2008-11#1)(2008-7#1)(2009-7#2)
granulocyte-macrophage##12##1##(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-6#1)(2008-11#2)(2008-7#1)(2009-7#2)
granulocytes and monocytes##2##3##(1990-7#1)(2008-9#1)
granulocytes and##6##2##(1990-7#1)(2006-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
granulocytes from##2##2##(1992-3#1)(1994-2#1)
granulocytes##27##1##(1990-7#2)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-6#2)(2011-2#1)(2013-1#2)
granulocytic anaplasmosis##7##2##(2008-12#2)(2008-9#1)(2013-1#4)
granulocytic ehrlichiosis)##2##2##(2008-12#1)(2008-9#1)
granulocytic sarcoma##2##2##(1993-2#2)
granulocytic##13##1##(1993-2#2)(1994-5#1)(1997-7#1)(2008-12#3)(2008-9#2)(2013-1#4)
granuloma and##4##2##(2009-2#2)(2012-3#2)
granuloma in##4##2##(2008-10#2)(2008-8#1)(2009-2#1)
granuloma with##2##2##(2007-7#1)(2011-2#1)
granuloma##38##1##(1991-11#1)(1991-9#2)(1993-2#1)(2006-12#3)(2007-7#5)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#3)(2010-6#1)(2011-2#2)(2012-12#5)(2012-3#7)
granulomas in the##3##3##(2008-4#1)(2012-3#2)
granulomas##16##1##(1990-5#1)(1990-9#1)(1992-5#1)(1993-6#1)(1997-3#2)(1997-8#1)(2006-12#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-6#1)(2012-3#2)
granulomata##2##1##(2008-1#1)(2008-11#1)
granulomatosis with polyangiitis##4##3##(2012-12#3)(2013-8#1)
granulomatosis##19##1##(1990-8#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-11#3)(2010-6#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
granulomatous areas in##2##3##(2011-2#2)
granulomatous disease is##2##3##(2007-8#1)(2013-1#1)
granulomatous disease##9##2##(1992-5#3)(1993-11#1)(2007-8#1)(2012-12#1)(2013-1#3)
granulomatous diseases##3##2##(1997-8#1)(2008-9#1)(2012-3#1)
granulomatous infections##2##2##(2012-3#1)(2013-1#1)
granulomatous inflammation##5##2##(1990-3#3)(2008-5#1)(2012-2#1)
granulomatous lesions##2##2##(1997-3#1)(2008-5#1)
granulomatous mastitis##4##2##(1997-8#2)(2011-1#2)
granulomatous myositis##2##2##(2008-7#2)
granulomatous prostatitis were##2##3##(2011-1#2)
granulomatous reaction##3##2##(1991-11#1)(2008-5#1)(2011-2#1)
granulomatous vasculitis##2##2##(1990-8#1)(2008-1#1)
granulomatous##57##1##(1990-3#3)(1990-8#2)(1990-9#1)(1991-11#1)(1992-5#3)(1993-11#1)(1993-2#1)(1993-6#1)(1997-3#1)(1997-8#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#9)
granulomatus##2##1##(2008-4#2)
granulometer##2##1##(2008-3#2)
granulosa and theca##2##3##(2008-12#1)(2008-9#1)
granulosa and##5##2##(1992-9#2)(2008-12#2)(2008-9#1)
granulosa cell apoptosis##2##3##(2008-11#2)
granulosa cell tumors of the ovary##2##6##(2007-8#2)
granulosa cell tumors##3##3##(1995-2#1)(2007-8#2)
granulosa cell##9##2##(1992-9#1)(1994-7#1)(1995-12#1)(1995-2#1)(2007-8#2)(2008-11#2)(2008-4#1)
granulosa cells and##3##3##(1992-11#1)(2008-3#1)(2008-8#1)
granulosa cells as##2##3##(1995-12#1)(2008-5#1)
granulosa cells of##5##3##(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)
granulosa cells##28##2##(1992-11#4)(1995-12#4)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#5)(2008-9#1)
granulosa layer##3##2##(2008-12#3)
granulosa##53##1##(1992-11#4)(1992-9#3)(1994-7#1)(1995-12#6)(1995-2#1)(1995-8#2)(2007-8#2)(2008-11#8)(2008-12#11)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#5)(2008-9#2)(2013-8#1)
granulosus##7##1##(1996-12#2)(2010-11#1)(2011-2#3)(2013-1#1)
grape (Vitis##2##2##(2008-10#1)(2013-1#1)
grape and##3##2##(2008-10#3)
grape berries##6##2##(2008-10#6)
grape juice##2##2##(2007-7#1)(2012-3#1)
grape necrosis##2##2##(2008-10#2)
grape powdery mildew##4##3##(2008-10#4)
grape seed##3##2##(2008-10#2)(2013-1#1)
grape skin##3##2##(2008-10#3)
grape strains##2##2##(2008-10#2)
grape varieties##5##2##(2008-10#5)
grape##64##1##(2007-7#1)(2008-10#57)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#3)
grapefruit and##4##2##(2008-10#4)
grapefruit juice##2##2##(2008-10#1)(2008-8#1)
grapefruit were##2##2##(2008-10#1)(2011-2#1)
grapefruit##24##1##(2008-10#19)(2008-8#2)(2011-2#3)
grapes and##3##2##(2008-10#3)
grapes are##2##2##(2008-10#2)
grapes in##4##2##(2008-10#4)
grapes were##3##2##(2008-10#3)
grapes##32##1##(2008-10#29)(2008-11#1)(2012-12#1)(2013-1#1)
grapevine (Vitis vinifera)##2##3##(2008-10#2)
grapevine and##2##2##(2008-10#2)
grapevine downy mildew##3##3##(2008-10#3)
grapevine leaf disks##2##3##(2008-10#2)
grapevine leaf##4##2##(2008-10#4)
grapevine leaves##9##2##(2008-10#9)
grapevine powdery mildew##3##3##(2008-10#3)
grapevine rupestris##2##2##(2008-10#2)
grapevine to##3##2##(2008-10#3)
grapevine viruses##3##2##(2008-10#3)
grapevine##53##1##(2008-10#51)(2009-8#1)(2011-10#1)
grapevines (Vitis vinifera##2##3##(2008-10#2)
grapevines##19##1##(2008-10#19)
graph (in which females are connected to males##2##8##(2008-9#2)
graph for the##3##3##(2008-10#2)(2008-9#1)
graph for##8##2##(2008-10#7)(2008-9#1)
graph in##2##2##(2008-10#2)
graph is linear in the range 0##2##7##(2008-10#2)
graph is linear in the range##6##6##(2008-10#6)
graph is linear##12##3##(2008-10#12)
graph is##19##2##(2008-10#18)(2009-3#1)
graph of##4##2##(2008-10#4)
graph theory##3##2##(1995-6#2)(2008-11#1)
graph was linear in the range##11##6##(2008-10#11)
graph was linear in the##14##5##(2008-10#14)
graph was linear##32##3##(2008-10#32)
graph was obtained for##2##4##(2008-10#1)(2008-12#1)
graph was obtained##16##3##(2008-10#15)(2008-12#1)
graph was##51##2##(2008-10#49)(2008-12#1)(2013-8#1)
graph##127##1##(1995-6#2)(2008-10#103)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#2)(2010-2#3)(2011-2#2)(2011-3#1)(2012-2#4)(2013-8#1)
graphene oxide##3##2##(2012-2#2)(2013-1#1)
graphene sheet##4##2##(2009-11#4)
graphene##15##1##(2008-7#1)(2009-11#4)(2010-7#1)(2012-2#8)(2013-1#1)
graphic analysis of##2##3##(2008-10#1)(2008-5#1)
graphic analysis##4##2##(2007-12#1)(2008-10#1)(2008-5#2)
graphic method are##2##3##(2008-5#2)
graphic method##4##2##(2008-10#1)(2008-5#3)
graphic##18##1##(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#1)(2008-9#2)(2009-11#1)(2010-3#1)
graphical analysis##2##2##(2008-10#2)
graphical and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
graphical method for##2##3##(1995-12#1)(2008-7#1)
graphical method##5##2##(1995-12#1)(2008-10#2)(2008-7#2)
graphical model of##2##3##(2008-9#1)(2012-2#1)
graphical programming language##2##3##(2008-10#1)(2008-3#1)
graphical representation of##2##3##(2008-11#1)(2013-8#1)
graphical user interface##6##3##(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)
graphical user##8##2##(1994-3#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)
graphical##52##1##(1992-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-8#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-7#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#2)(2013-8#1)
graphically##4##1##(2008-10#1)(2008-3#2)(2010-3#1)
graphics for##2##2##(2008-6#2)
graphics processing unit (GPU)##2##4##(2009-6#1)(2011-1#1)
graphics processing unit##3##3##(2009-6#1)(2011-1#2)
graphics##19##1##(1991-8#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-6#8)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#3)(2012-3#1)
graphite (EG) as##2##3##(2008-10#2)
graphite and##5##2##(1991-5#1)(2008-1#1)(2008-10#2)(2008-3#1)
graphite as##2##2##(2008-1#1)(2008-10#1)
graphite atomizer (THGA)##3##3##(2008-10#3)
graphite atomizer##10##2##(2008-10#10)
graphite carbon electrode##2##3##(2008-10#2)
graphite cathode##3##2##(2008-10#3)
graphite coated##2##2##(2008-10#2)
graphite composite##3##2##(2008-10#3)
graphite electrode##8##2##(2008-10#8)
graphite electrodes##5##2##(2008-10#5)
graphite furnace atomic absorption spectrometer##5##5##(2008-10#5)
graphite furnace atomic absorption spectrometric (GFAAS)##2##6##(2008-10#2)
graphite furnace atomic absorption spectrometric##5##5##(2008-10#5)
graphite furnace atomic absorption spectrometry (GFAAS) is##2##7##(2008-10#2)
graphite furnace atomic absorption spectrometry (GFAAS)##22##6##(2008-10#22)
graphite furnace atomic absorption spectrometry using##2##6##(2008-10#2)
graphite furnace atomic absorption spectrometry##57##5##(1991-12#1)(1995-6#1)(2008-10#55)
graphite furnace atomic absorption spectroscopy##5##5##(2008-10#4)(2008-7#1)
graphite furnace atomic absorption##76##4##(1991-12#1)(1995-6#1)(2008-10#73)(2008-7#1)
graphite furnace atomic##77##3##(1991-12#1)(1995-6#1)(2008-10#74)(2008-7#1)
graphite furnace##95##2##(1991-12#1)(1992-3#1)(1995-6#1)(2008-10#91)(2008-7#1)
graphite inks##2##2##(2008-10#2)
graphite morphology##2##2##(2008-10#2)
graphite paste##4##2##(2008-10#4)
graphite powder##2##2##(2008-10#2)
graphite tube atomizer##3##3##(2008-10#3)
graphite tube##21##2##(2008-10#20)(2008-2#1)
graphite tubes (GTs)##2##3##(2008-10#2)
graphite tubes##6##2##(2007-12#1)(2008-10#5)
graphite##220##1##(1990-4#1)(1991-12#1)(1991-5#2)(1992-3#1)(1995-6#1)(2007-12#4)(2008-1#3)(2008-10#193)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#4)
graphite-based inks##2##2##(2008-10#2)
graphite-castor oil polyurethane composite electrode##2##5##(2008-10#2)
graphite-epoxy ion-selective electrode for the determination of##2##7##(2008-10#2)
graphite-epoxy ion-selective electrode for##3##4##(2008-10#3)
graphite-epoxy##4##1##(2008-10#4)
graphite/polyester composite electrodes##2##3##(2008-10#2)
graphitic##7##1##(1990-8#2)(1995-6#1)(2008-10#2)(2008-7#1)(2013-1#1)
graphitized carbon##5##2##(1990-8#1)(1996-5#2)(2008-10#1)(2010-11#1)
graphs are linear over the##2##5##(2008-10#2)
graphs are linear##4##3##(2008-10#4)
graphs are##5##2##(2008-10#5)
graphs for the##2##3##(2008-10#2)
graphs for##6##2##(2008-10#6)
graphs obtained by##2##3##(2008-10#2)
graphs obtained##3##2##(2008-10#3)
graphs of##6##2##(1990-11#1)(1995-3#1)(2007-11#1)(2008-10#3)
graphs were linear from##2##4##(2008-10#2)
graphs were linear over the range 0##2##7##(2008-10#2)
graphs were linear over the##3##5##(2008-10#3)
graphs were linear##14##3##(2008-10#14)
graphs were obtained for##4##4##(2008-10#4)
graphs were obtained##11##3##(2008-10#11)
graphs were##38##2##(1993-2#1)(2008-10#37)
graphs##85##1##(1990-11#1)(1993-2#1)(1995-3#1)(2007-11#2)(2008-10#77)(2008-4#1)(2010-10#1)(2013-1#1)
grapple##2##1##(1993-12#1)(2008-12#1)
grappled with##2##2##(2008-12#1)(2008-5#1)
grasp of the##2##3##(2007-12#1)(2011-2#1)
grasp##12##1##(1992-12#1)(1996-2#3)(2007-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
grasping movements##2##2##(1996-2#1)(2012-2#1)
grasping the##2##2##(2007-12#1)(2013-1#1)
grasping##13##1##(1994-3#1)(1996-2#5)(2007-12#2)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
grass Distichlis spicata##2##3##(2008-9#2)
grass and##8##2##(2008-10#3)(2008-12#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
grass cover##2##2##(2008-3#1)(2012-12#1)
grass pea (Lathyrus##2##3##(2008-7#1)(2011-2#1)
grass pea seedlings##2##3##(2011-2#2)
grass pea##5##2##(2008-7#1)(2011-2#4)
grass pollen allergens##2##3##(2011-2#2)
grass pollen##9##2##(1992-3#2)(2011-2#3)(2012-2#3)(2013-8#1)
grass samples##3##2##(1996-12#1)(2008-10#2)
grass shrimp Palaemonetes pugio exposed to##3##6##(2010-4#3)
grass shrimp##7##2##(2010-4#7)
grass species##3##2##(2008-10#3)
grass##76##1##(1991-2#1)(1992-11#1)(1992-3#2)(1996-12#2)(2008-10#24)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2010-4#7)(2011-2#8)(2012-12#3)(2012-2#5)(2013-1#2)(2013-8#2)
grass-infecting##3##1##(2008-10#3)
grasses and woody##2##3##(2008-8#1)(2008-9#1)
grasses and##7##2##(2008-10#2)(2008-8#3)(2008-9#2)
grasses##30##1##(1991-12#1)(2008-10#12)(2008-5#1)(2008-8#8)(2008-9#5)(2009-10#1)(2012-3#1)(2013-1#1)
grasshopper communities##2##2##(2013-7#2)
grasshopper species##2##2##(2008-9#2)
grasshopper##15##1##(1993-12#1)(2007-12#7)(2008-5#2)(2008-9#3)(2013-7#2)
grasshoppers##7##1##(2008-9#1)(2013-7#6)
grassland##10##1##(2008-5#1)(2008-9#5)(2010-6#2)(2013-7#1)(2013-8#1)
grasslands and##2##2##(2008-5#1)(2013-7#1)
grasslands of the##3##3##(2013-7#3)
grasslands of##5##2##(2011-2#1)(2013-7#4)
grasslands##16##1##(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#11)
grassroots##6##1##(1992-1#1)(1993-3#1)(1996-3#1)(2008-6#1)(2012-2#1)(2013-1#1)
grateful##2##1##(2008-12#2)
gratification##2##1##(1992-3#1)(2008-9#1)
grating about the axis##3##4##(2008-3#3)
grating about the##4##3##(2008-3#4)
grating amplitude##4##2##(2008-3#4)
grating and a##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
grating and an##4##3##(2007-11#1)(2008-3#3)
grating and its##2##3##(2007-11#1)(2008-3#1)
grating and##31##2##(2007-11#6)(2007-12#6)(2008-2#2)(2008-3#17)
grating are##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
grating array##2##2##(2008-2#1)(2008-3#1)
grating as a##3##3##(2007-12#2)(2008-3#1)
grating as the##2##3##(2008-2#2)
grating as##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
grating at##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
grating based on##2##3##(2008-2#1)(2008-3#1)
grating beams##2##2##(2008-2#2)
grating buildup##2##2##(2007-11#1)(2008-2#1)
grating by##4##2##(2008-3#4)
grating can be##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
grating constant##2##2##(2007-11#2)
grating coupler with a##2##4##(2007-12#1)(2008-3#1)
grating coupler##14##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#7)
grating couplers##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
grating decay##3##2##(2007-11#1)(2008-2#2)
grating design##2##2##(2007-12#2)
grating designed to##2##3##(2008-2#2)
grating devices##2##2##(2008-3#2)
grating diffraction efficiency##3##3##(2008-2#2)(2008-3#1)
grating diffraction method##2##3##(2008-3#2)
grating diffraction##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
grating efficiency##4##2##(2008-2#2)(2008-3#2)
grating embedded in##2##3##(2007-11#1)(2008-3#1)
grating fabricated##2##2##(2008-3#2)
grating fabrication##2##2##(2007-12#1)(2008-3#1)
grating filter##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
grating filters##2##2##(2008-3#2)
grating for a##2##3##(2008-3#2)
grating for simultaneous##2##3##(2007-11#1)(2007-12#1)
grating for##13##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#7)
grating formation##6##2##(2007-11#2)(2008-2#2)(2008-3#2)
grating frequency##2##2##(2008-3#2)
grating from##2##2##(2007-12#1)(2008-3#1)
grating generation##2##2##(2008-2#2)
grating grooves##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
grating had a##2##3##(2007-12#1)(2008-3#1)
grating has been##3##3##(2007-12#1)(2008-3#2)
grating has##4##2##(2007-12#1)(2008-3#3)
grating in a##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
grating in the##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
grating in transmission##2##3##(2008-2#2)
grating in##19##2##(2007-11#5)(2007-12#5)(2008-2#4)(2008-3#5)
grating inside a##3##3##(2007-12#1)(2008-3#2)
grating inside##4##2##(2007-12#1)(2008-3#3)
grating interferometer##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
grating into a##2##3##(2008-3#2)
grating into the##2##3##(2007-11#2)
grating into##4##2##(2007-11#2)(2008-3#2)
grating is presented##2##3##(2007-12#1)(2008-3#1)
grating is projected onto##4##4##(2008-3#4)
grating is rotated##2##3##(2007-11#1)(2008-3#1)
grating is used##2##3##(2008-2#1)(2008-3#1)
grating is written##2##3##(2007-11#2)
grating is##36##2##(1995-11#1)(2007-11#8)(2007-12#6)(2008-2#4)(2008-3#17)
grating lens##4##2##(2008-3#4)
grating method##2##2##(2008-3#1)(2008-5#1)
grating mirror##3##2##(2007-11#3)
grating of##2##2##(2008-2#1)(2008-3#1)
grating pair##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
grating parameters##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
grating pattern##3##2##(2008-3#3)
grating patterns##4##2##(2007-11#1)(2008-3#3)
grating period##8##2##(2008-2#2)(2008-3#6)
grating periods##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
grating planes##8##2##(2008-3#8)
grating profiles##3##2##(2007-12#1)(2008-2#2)
grating projection profilometry based on##2##5##(2008-3#2)
grating projection profilometry##4##3##(2008-3#4)
grating recording##2##2##(2007-12#1)(2008-3#1)
grating reflectivity##5##2##(2007-11#2)(2008-3#3)
grating regions##2##2##(2007-12#1)(2008-3#1)
grating scale##3##2##(2008-3#3)
grating sensor##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
grating sensors##10##2##(2008-10#1)(2008-2#3)(2008-3#6)
grating size##2##2##(2008-2#1)(2008-3#1)
grating solid-state dye laser oscillator##2##5##(2008-3#2)
grating spectrometer with##3##3##(2008-3#3)
grating spectrometer##8##2##(2008-10#1)(2008-3#6)(2013-8#1)
grating strain sensor##2##3##(2008-3#2)
grating strength##3##2##(2007-11#3)
grating structure is##2##3##(2008-3#2)
grating structure##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
grating structures with##2##3##(2008-2#2)
grating structures##5##2##(2007-12#2)(2008-2#3)
grating substrate had##2##3##(2007-11#1)(2008-2#1)
grating substrate##3##2##(2007-11#1)(2008-2#2)
grating substrates##2##2##(2008-3#2)
grating that is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
grating that##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
grating thus##2##2##(2007-11#1)(2008-3#1)
grating tilt##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
grating to##5##2##(2007-11#3)(2008-3#2)
grating type##2##2##(2007-11#2)
grating used##2##2##(2007-12#1)(2008-3#1)
grating vector direction##3##3##(2008-2#3)
grating was obtained##2##3##(2007-12#1)(2008-2#1)
grating was##9##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
grating waveguide##4##2##(2008-3#4)
grating with a##14##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#7)
grating with an##3##3##(2007-12#1)(2008-3#2)
grating with respect to##2##4##(2007-11#1)(2008-3#1)
grating with##27##2##(2007-11#4)(2007-12#3)(2008-2#8)(2008-3#11)(2013-8#1)
grating within the##2##3##(2007-11#1)(2007-12#1)
grating within##3##2##(2007-11#1)(2007-12#2)
grating written in##3##3##(2007-11#1)(2008-3#2)
grating written##4##2##(2007-11#1)(2008-3#3)
grating##715##1##(1995-11#1)(2007-11#115)(2007-12#117)(2008-10#6)(2008-11#1)(2008-2#113)(2008-3#355)(2008-5#2)(2013-8#5)
grating's##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
grating-assisted codirectional coupler##2##3##(2008-3#2)
grating-assisted output couplers##3##3##(2007-12#3)
grating-assisted##10##1##(2007-12#3)(2008-3#7)
grating-based##8##1##(2007-11#2)(2007-12#2)(2008-3#4)
grating-coupler sampled-reflector laser was used to##2##6##(2008-2#2)
grating-frustrated coupler##2##2##(2007-12#2)
grating-stabilized external-cavity diode##2##3##(2007-12#1)(2008-2#1)
grating-stabilized##4##1##(2007-11#1)(2007-12#1)(2008-2#2)
grating-tuned##3##1##(2007-12#3)
gratinglike##2##1##(2008-3#2)
gratings (eta &gt##2##3##(2008-3#2)
gratings allow for##2##3##(2007-11#1)(2008-3#1)
gratings and a##2##3##(2008-3#2)
gratings and##20##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#15)
gratings are discussed##3##3##(2007-11#1)(2008-3#2)
gratings are fabricated##2##3##(2008-3#2)
gratings are found to be##2##5##(2008-2#1)(2008-3#1)
gratings are used##4##3##(2007-11#1)(2008-3#3)
gratings are##30##2##(2007-11#4)(2007-12#1)(2008-2#4)(2008-3#20)(2008-7#1)
gratings as##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
gratings at large##2##3##(2007-12#1)(2008-3#1)
gratings at##4##2##(2007-12#1)(2008-3#3)
gratings by a##2##3##(2008-2#1)(2008-3#1)
gratings by use of a novel##2##6##(2007-12#1)(2008-3#1)
gratings by use of##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
gratings by##14##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#6)(2013-8#1)
gratings can be used##2##4##(2008-3#2)
gratings can be##7##3##(2007-11#2)(2008-3#5)
gratings could##2##2##(2007-12#1)(2008-3#1)
gratings during##2##2##(2007-12#2)
gratings fabricated in##2##3##(2008-3#2)
gratings fabricated##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
gratings for a##2##3##(2008-3#2)
gratings for beam##2##3##(2008-2#1)(2008-3#1)
gratings for##18##2##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#8)(2008-7#1)
gratings from##3##2##(2008-3#1)(2013-8#2)
gratings have been##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
gratings have##8##2##(2007-11#2)(2007-12#4)(2008-3#2)
gratings in a##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
gratings in nematic liquid crystals##2##5##(2007-11#1)(2007-12#1)
gratings in the compressor##2##4##(2008-2#2)
gratings in the resonance domain##2##5##(2007-12#2)
gratings in the##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
gratings in##44##2##(2007-11#15)(2007-12#14)(2008-2#6)(2008-3#8)(2013-8#1)
gratings induced in##2##3##(2007-11#2)
gratings inscribed##2##2##(2007-11#1)(2007-12#1)
gratings is presented##4##3##(2007-11#2)(2008-3#2)
gratings is proposed##2##3##(2008-3#2)
gratings is##14##2##(2007-11#2)(2008-2#1)(2008-3#9)(2013-8#2)
gratings made by##3##3##(2007-12#1)(2008-3#2)
gratings of##9##2##(1995-11#1)(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#4)
gratings on the##3##3##(2008-3#3)
gratings on##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
gratings operating##2##2##(2008-3#2)
gratings presented in the##2##4##(1996-5#2)
gratings printed##2##2##(2007-11#1)(2008-2#1)
gratings produced##2##2##(2008-3#2)
gratings recorded in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
gratings recorded with a##2##4##(2008-2#2)
gratings recorded##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
gratings than##2##2##(2007-11#1)(2008-3#1)
gratings that are##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
gratings that##7##2##(2007-11#1)(2007-12#2)(2008-3#4)
gratings the##2##2##(2008-3#1)(2008-8#1)
gratings to##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
gratings used for##2##3##(2008-3#2)
gratings was##5##2##(2007-11#1)(2008-3#4)
gratings were fabricated and##2##4##(2008-3#2)
gratings were fabricated##5##3##(2007-11#2)(2008-3#2)(2013-8#1)
gratings were induced by##2##4##(2007-11#1)(2007-12#1)
gratings were recorded##2##3##(2008-2#1)(2008-3#1)
gratings were studied in cells of##2##6##(2007-11#1)(2007-12#1)
gratings were written##2##3##(2007-12#1)(2008-2#1)
gratings were##17##2##(2007-11#5)(2007-12#3)(2008-2#3)(2008-3#5)(2013-8#1)
gratings with a##4##3##(2007-12#2)(2008-3#2)
gratings with high##2##3##(2007-11#1)(2008-3#1)
gratings with periods##2##3##(2007-12#2)
gratings with##27##2##(2007-11#4)(2007-12#6)(2008-2#5)(2008-3#12)
gratings written in specially designed few-mode fibers##2##7##(2007-11#2)
gratings written in##7##3##(2007-11#4)(2007-12#3)
gratings written through##2##3##(2008-3#2)
gratings written##13##2##(2007-11#4)(2007-12#5)(2008-3#4)
gratings##488##1##(1995-11#1)(1996-2#2)(1996-5#2)(2007-11#83)(2007-12#96)(2008-10#1)(2008-2#59)(2008-3#228)(2008-7#3)(2008-8#4)(2013-8#9)
gratitude and##2##2##(2008-12#2)
gratitude##6##1##(2008-12#6)
grave##13##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-2#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-6#1)(2009-10#1)(2013-1#2)(2013-8#1)
graveolens##3##1##(2008-10#3)
gravid##6##1##(2008-10#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
gravida##4##1##(1992-9#1)(1994-12#1)(2007-7#1)(2008-7#1)
gravidity##4##1##(1996-3#1)(2008-1#1)(2011-1#1)(2013-1#1)
gravimetric analysis##4##2##(2008-10#4)
gravimetric and volumetric dilution procedures##2##5##(2008-10#2)
gravimetric and##3##2##(1994-3#1)(2008-10#2)
gravimetric determination of##2##3##(2008-10#2)
gravimetric estimation of intraoperative blood loss##2##6##(1994-3#2)
gravimetric method##5##2##(1994-3#2)(2008-10#2)(2011-2#1)
gravimetric##22##1##(1993-2#1)(1994-3#5)(2008-10#13)(2008-11#1)(2008-5#1)(2011-2#1)
gravimetry and##2##2##(2008-10#2)
gravimetry##4##1##(2008-10#3)(2008-5#1)
gravis and##5##2##(1997-8#1)(2008-5#1)(2009-11#1)(2010-11#1)(2013-1#1)
gravis##30##1##(1991-11#1)(1991-2#1)(1996-12#1)(1996-3#1)(1997-5#3)(1997-8#1)(2007-8#7)(2008-5#2)(2009-11#1)(2010-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#1)
gravitation##3##1##(2008-10#2)(2008-7#1)
gravitational field-flow fractionation##2##3##(2008-10#2)
gravitational wave antenna##2##3##(2008-3#2)
gravitational wave##4##2##(2008-3#4)
gravitational##19##1##(1991-9#1)(1995-12#2)(1996-2#1)(2006-10#2)(2008-10#4)(2008-2#1)(2008-3#7)(2008-5#1)
gravitational-wave antenna##2##2##(2008-3#2)
gravitational-wave detector##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
gravitational-wave detectors##8##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)
gravitational-wave##21##1##(2007-11#4)(2007-12#3)(2008-2#4)(2008-3#10)
gravitropic##3##1##(2009-8#2)(2011-1#1)
gravitropism##2##1##(2008-9#1)(2009-8#1)
gravity and the##2##3##(1991-1#1)(2008-10#1)
gravity and##5##2##(1991-1#1)(2007-12#1)(2008-10#1)(2008-4#2)
gravity levels##2##2##(2008-7#2)
gravity of##2##2##(1990-3#1)(1991-12#1)
gravity waves##4##2##(2008-3#4)
gravity##45##1##(1990-3#1)(1991-1#2)(1991-12#1)(1997-5#2)(2006-10#1)(2007-12#3)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#9)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-9#1)(2013-8#1)
gravity-based##3##1##(2011-2#3)
gray MTA##2##2##(2013-1#2)
gray MTA+5%CaO##2##2##(2013-1#2)
gray area##2##2##(1993-12#1)(1997-8#1)
gray leaf spot in##2##4##(2008-10#2)
gray leaf spot of maize##7##5##(2008-10#7)
gray leaf spot of##11##4##(2008-10#11)
gray leaf spot on##2##4##(2008-10#2)
gray leaf spot severity##4##4##(2008-10#4)
gray leaf spot##36##3##(2008-10#36)
gray level##2##2##(2008-6#1)(2010-8#1)
gray levels##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
gray marketers##2##2##(1996-3#2)
gray matter##3##2##(1993-12#1)(2008-3#1)(2008-5#1)
gray mold##8##2##(1997-4#1)(2008-10#7)
gray pineapple##2##2##(2008-10#2)
gray value-based symmetry##2##3##(2008-6#2)
gray values##2##2##(2008-10#1)(2008-3#1)
gray##103##1##(1990-9#1)(1991-5#1)(1993-12#4)(1995-6#2)(1996-3#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-3#1)(2008-10#49)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#3)(2008-7#3)(2009-9#1)(2010-6#4)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#7)
gray-code##3##1##(2008-3#3)
gray-level mask##2##2##(2008-2#2)
gray-level##8##1##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
gray-scale images##2##2##(2008-3#2)
gray-scale modulation##2##2##(2007-11#1)(2008-3#1)
gray-scale photolithography##2##2##(2007-11#2)
gray-scale##19##1##(2007-11#4)(2008-2#1)(2008-3#10)(2012-2#4)
gray-tone##3##1##(2008-3#3)
grazed on##3##2##(2010-2#1)(2011-1#1)(2012-12#1)
grazed##10##1##(1996-12#2)(2008-8#3)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
grazer##2##1##(2008-8#1)(2009-8#1)
grazers##4##1##(2008-8#3)(2009-8#1)
grazing and##4##2##(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)
grazing angle##3##2##(2008-2#2)(2008-7#1)
grazing angles##4##2##(2007-11#4)
grazing in areas below 1000 m##2##6##(1996-12#2)
grazing in areas##3##3##(1996-12#3)
grazing in##6##2##(1996-12#3)(2008-8#2)(2008-9#1)
grazing on##4##2##(2008-12#2)(2012-2#2)
grazing period##4##2##(1996-12#3)(2010-2#1)
grazing periods##2##2##(2010-2#2)
grazing season##10##2##(1991-8#1)(1996-12#2)(2008-12#1)(2010-2#3)(2012-2#3)
grazing systems##4##2##(2008-8#2)(2010-4#2)
grazing##64##1##(1991-12#1)(1991-8#1)(1993-8#1)(1996-12#10)(1997-7#1)(2007-11#4)(2008-12#7)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2010-2#8)(2010-4#4)(2012-2#8)(2013-7#2)
grazing-incidence flat-field##3##2##(2008-3#3)
grazing-incidence x-ray reflectivity##2##3##(2007-11#1)(2007-12#1)
grazing-incidence x-ray##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
grazing-incidence##18##1##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#13)
grease##4##1##(2008-10#1)(2008-5#1)(2013-1#2)
greasy##3##1##(2008-10#1)(2008-5#1)(2013-1#1)
great amount of##8##3##(2008-10#3)(2008-12#2)(2008-7#1)(2009-8#1)(2013-8#1)
great and##2##2##(2008-10#1)(2008-11#1)
great ape species##3##3##(1994-3#1)(1997-6#2)
great apes##2##2##(1997-6#1)(2007-12#1)
great as##29##2##(1992-11#1)(1992-5#1)(1995-12#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#12)(2008-5#1)(2012-2#1)
great attention##4##2##(2008-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
great cardiac vein##2##3##(2013-2#2)
great care should be##2##4##(1991-6#1)(2011-2#1)
great care##3##2##(1991-6#1)(2011-2#1)(2012-12#1)
great caution##2##2##(1994-8#1)(1995-5#1)
great challenge##6##2##(1990-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
great changes##2##2##(1991-6#1)(2008-7#1)
great concern##8##2##(1994-1#1)(2008-10#4)(2008-9#1)(2010-8#1)(2012-2#1)
great deal better&quot##2##3##(2008-12#2)
great deal of##31##3##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
great deal##43##2##(1991-1#2)(1991-12#2)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
great detail##4##2##(2008-9#1)(2009-2#1)(2012-1#1)(2013-7#1)
great difference in##3##3##(1995-3#1)(2006-8#1)(2008-10#1)
great differences##2##2##(1995-11#1)(2008-2#1)
great diversity in##2##3##(1994-11#1)(1994-12#1)
great diversity of##4##3##(2008-5#2)(2009-10#1)(2009-7#1)
great diversity##7##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-7#1)
great extent##14##2##(1990-12#2)(1992-3#1)(1992-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#2)
great impact##3##2##(2008-1#1)(2011-2#1)(2012-12#1)
great importance for##8##3##(1991-2#1)(1992-12#1)(2006-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
great importance in##8##3##(1991-9#1)(1997-1#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#2)
great importance to##3##3##(1996-1#1)(2008-9#1)(2009-1#1)
great importance##34##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-1#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)
great improvements##2##2##(2009-3#1)(2013-1#1)
great in##2##2##(2008-4#1)(2008-5#1)
great increase##2##2##(2008-10#1)(2008-11#1)
great influence on the##3##4##(1992-6#1)(1996-5#1)(2010-11#1)
great influence on##5##3##(1992-6#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-11#1)
great influence##6##2##(1992-6#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
great interest and##2##3##(1997-1#1)(2008-5#1)
great interest for##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#2)
great interest in the##3##4##(2008-10#2)(2012-2#1)
great interest in##8##3##(1995-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-5#1)(2009-7#1)(2012-2#1)
great interest##29##2##(1992-6#1)(1993-12#1)(1995-5#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
great majority of patients##2##4##(2008-1#1)(2010-12#1)
great majority of##7##3##(1991-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
great majority##11##2##(1991-6#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-12#1)
great mean##3##2##(2008-10#3)
great need to monitor##2##4##(2008-10#1)(2009-11#1)
great need to##4##3##(2008-10#2)(2008-6#1)(2009-11#1)
great need##8##2##(1990-12#1)(1994-9#1)(2008-10#3)(2008-6#1)(2009-11#1)(2013-1#1)
great number of##10##3##(1994-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
great opportunity##3##2##(2008-8#1)(2010-11#1)(2012-3#1)
great part##4##2##(2008-6#2)(2011-2#2)
great potential as a##3##4##(1997-4#1)(2008-10#1)(2008-6#1)
great potential as##4##3##(1997-4#1)(2008-10#2)(2008-6#1)
great potential for improving##2##4##(1995-1#1)(2012-1#1)
great potential for##12##3##(1992-12#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
great potential in##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2013-8#1)
great potential to##2##3##(2009-3#1)(2010-9#1)
great potential##31##2##(1992-12#1)(1993-12#1)(1994-1#1)(1995-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
great progress has been##2##4##(2009-2#1)(2010-5#1)
great progress in the development of##2##6##(2008-10#2)
great progress##5##2##(2008-10#2)(2008-11#1)(2009-2#1)(2010-5#1)
great promise as##2##3##(1995-3#1)(2008-7#1)
great promise for##15##3##(1997-1#1)(1997-4#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
great promise in the treatment##2##5##(2008-8#1)(2010-6#1)
great promise in##4##3##(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
great promise##22##2##(1995-3#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
great role in##2##3##(2008-12#1)(2010-8#1)
great sensitivity##6##2##(1990-12#1)(2008-10#2)(2008-3#2)(2008-4#1)
great significance in the##2##4##(2007-11#1)(2008-10#1)
great significance in##3##3##(2007-11#1)(2008-10#1)(2010-7#1)
great significance##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-7#1)
great social##2##2##(1991-5#1)(2010-11#1)
great strides in##2##3##(2008-10#1)(2008-7#1)
great strides##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-3#1)
great success##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
great tits##3##2##(2008-5#1)(2008-8#2)
great toe##5##2##(2010-11#2)(2010-5#2)(2010-6#1)
great toes##2##2##(2007-7#1)(2012-12#1)
great value in##5##3##(1991-6#1)(2009-8#1)(2013-1#2)(2013-8#1)
great value##8##2##(1991-6#1)(1992-8#1)(1996-11#1)(2009-8#1)(2010-8#1)(2013-1#2)(2013-8#1)
great variability##5##2##(1994-3#1)(1997-4#2)(2008-11#1)(2011-1#1)
great variation in##3##3##(2009-6#1)(2009-7#1)(2010-3#1)
great variation##5##2##(1997-3#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-3#1)
great variety of##9##3##(1992-5#1)(1993-11#1)(1997-6#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
great##549##1##(1990-11#3)(1990-12#5)(1990-6#2)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#7)(1997-7#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#95)(2008-11#19)(2008-12#12)(2008-2#12)(2008-3#23)(2008-4#3)(2008-5#14)(2008-6#7)(2008-7#18)(2008-8#15)(2008-9#16)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#4)(2010-10#1)(2010-11#7)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#10)(2011-2#18)(2011-3#1)(2012-1#4)(2012-12#10)(2012-2#13)(2012-3#7)(2013-1#17)(2013-2#2)(2013-7#1)(2013-8#5)
greater (P &lt##4##3##(2008-10#4)
greater (P##6##2##(2008-10#5)(2010-12#1)
greater (P&lt##6##2##(2009-4#6)
greater PI##2##2##(2011-2#2)
greater ability to##2##3##(1995-2#1)(2008-10#1)
greater ability##3##2##(1995-2#1)(2008-10#1)(2012-12#1)
greater abundance##3##2##(2008-5#1)(2012-2#1)(2013-7#1)
greater access to##2##3##(2008-11#1)(2011-1#1)
greater accuracy in##2##3##(2008-10#1)(2008-6#1)
greater accuracy than##3##3##(1992-11#1)(2008-10#2)
greater accuracy##5##2##(1992-11#1)(2008-10#3)(2008-6#1)
greater activation in the##3##4##(2008-11#3)
greater activation in##5##3##(2008-11#5)
greater activation##6##2##(2008-11#6)
greater activity##4##2##(1992-9#1)(2008-6#3)
greater affinity for##2##3##(1995-2#1)(1995-3#1)
greater affinity##4##2##(1990-5#1)(1995-2#1)(1995-3#1)(1995-6#1)
greater after##3##2##(1992-9#1)(1996-2#1)(2008-5#1)
greater agreement##2##2##(2008-11#1)(2010-11#1)
greater among##4##2##(1995-1#2)(2008-9#1)(2012-3#1)
greater amount of##2##3##(2008-10#1)(2008-12#1)
greater amounts of##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
greater amounts##4##2##(2008-10#2)(2010-8#1)(2013-1#1)
greater amygdala activity##2##3##(2008-11#2)
greater and more##2##3##(1994-8#1)(2008-3#1)
greater and##6##2##(1994-8#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-3#1)
greater as##2##2##(2008-10#1)(2008-3#1)
greater at 25 degrees C##2##5##(1991-5#1)(2008-10#1)
greater at##13##2##(1991-5#1)(1992-8#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
greater attention##5##2##(1995-1#1)(1995-3#1)(1997-8#1)(2007-8#1)(2011-1#1)
greater availability of##4##3##(1997-1#1)(2008-10#1)(2008-8#1)(2010-11#1)
greater awareness of##4##3##(1991-1#1)(1992-9#1)(1995-8#1)(2008-5#1)
greater awareness##5##2##(1991-1#1)(1992-9#1)(1995-8#1)(2008-12#1)(2008-5#1)
greater behavioral##2##2##(1996-5#1)(2012-3#1)
greater benefits##3##2##(2008-5#1)(2009-4#1)(2009-8#1)
greater body weight and##2##4##(2008-10#1)(2008-7#1)
greater body##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
greater cell##3##2##(1995-8#1)(2008-10#1)(2009-6#1)
greater change##2##2##(2008-5#2)
greater clarity##2##2##(1997-1#1)(2010-12#1)
greater clinical##2##2##(2007-9#1)(2008-5#1)
greater collaboration and##3##3##(1996-1#1)(2008-11#1)(2009-3#1)
greater comfort##2##2##(2007-7#1)(2008-12#1)
greater concentration of##3##3##(1992-2#1)(1994-1#1)(2008-10#1)
greater concentrations##2##2##(2008-5#1)(2013-1#1)
greater confidence in##2##3##(2008-9#1)(2012-1#1)
greater confidence##4##2##(2008-2#1)(2008-9#2)(2012-1#1)
greater consideration##2##2##(2011-1#1)(2012-2#1)
greater control of##2##3##(2010-3#1)(2012-12#1)
greater control over##4##3##(1994-2#1)(2007-12#1)(2008-11#1)(2009-10#1)
greater control##7##2##(1994-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-12#1)
greater cost##2##2##(1995-2#1)(1997-2#1)
greater coverage##3##2##(1994-3#1)(2007-11#1)(2013-1#1)
greater damage##2##2##(2008-3#1)(2011-2#1)
greater decrease in##3##3##(1992-6#1)(2008-4#1)(2008-7#1)
greater decrease##4##2##(1992-6#1)(2008-4#1)(2008-5#1)(2008-7#1)
greater degree of##8##3##(1991-2#1)(1994-11#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#2)
greater degree than##5##3##(1991-6#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-4#1)
greater degree##17##2##(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#2)(2011-1#1)
greater demands##2##2##(1994-1#1)(1996-2#1)
greater density of##2##3##(1993-5#1)(2008-8#1)
greater density##3##2##(1993-5#1)(2008-8#1)(2012-12#1)
greater depressive##5##2##(2010-4#4)(2013-8#1)
greater depth##5##2##(1992-5#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-3#1)
greater differences were##2##3##(2008-10#1)(2008-3#1)
greater differences##4##2##(1991-6#1)(1995-5#1)(2008-10#1)(2008-3#1)
greater differentiation##2##2##(2008-10#1)(2008-11#1)
greater difficulty##3##2##(2008-5#2)(2013-1#1)
greater distances##2##2##(2008-4#1)(2009-8#1)
greater diversity##6##2##(1997-7#1)(2008-10#3)(2008-7#1)(2008-8#1)
greater dose##2##2##(2011-2#1)(2012-12#1)
greater ease##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
greater effect##4##2##(1992-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
greater effects##3##2##(1997-6#1)(2008-10#1)(2009-7#1)
greater efficacy and##2##3##(1996-2#1)(2013-1#1)
greater efficacy##4##2##(1996-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
greater efficiency##5##2##(1991-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-4#1)
greater emphasis on##9##3##(1991-12#1)(1993-11#1)(1994-2#2)(1996-3#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-3#1)
greater emphasis should be##2##4##(2008-10#1)(2008-11#1)
greater emphasis##15##2##(1991-12#1)(1993-11#1)(1994-2#2)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-5#1)(2012-3#1)(2013-1#2)
greater energy##2##2##(2008-5#1)(2009-8#1)
greater equity##2##2##(1993-1#1)(2012-2#1)
greater exposure to##2##3##(2007-7#1)(2012-3#1)
greater exposure##3##2##(2007-7#1)(2012-12#1)(2012-3#1)
greater extent##17##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-9#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2013-1#1)
greater flexibility and##2##3##(1994-2#1)(2008-7#1)
greater flexibility in##3##3##(2007-11#1)(2009-5#1)(2011-2#1)
greater flexibility##7##2##(1992-3#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
greater flow##2##2##(2008-10#2)
greater for females##2##3##(1993-9#1)(2012-12#1)
greater for the##7##3##(1993-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
greater for those##2##3##(1996-8#1)(2008-2#1)
greater for##37##2##(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#5)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
greater frequency of##4##3##(1990-9#1)(2008-10#1)(2008-5#1)(2010-11#1)
greater from##2##2##(2008-10#1)(2008-9#1)
greater genetic##2##2##(2010-8#1)(2012-3#1)
greater germination##2##2##(2006-11#1)(2008-10#1)
greater gingival##2##2##(2008-12#2)
greater growth##4##2##(1992-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
greater health##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
greater height##2##2##(2008-10#1)(2011-1#1)
greater heterogeneity##2##2##(2008-10#1)(2008-9#1)
greater impact on##5##3##(1992-1#1)(2008-10#1)(2012-5#1)(2013-1#2)
greater impact##7##2##(1992-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-5#1)(2013-1#2)
greater importance##4##2##(1990-2#1)(1997-1#1)(2008-4#1)(2008-8#1)
greater improvement in##4##3##(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)
greater improvement##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)
greater improvements in##2##3##(2008-12#1)(2012-12#1)
greater improvements##5##2##(2008-12#1)(2008-3#2)(2008-8#1)(2012-12#1)
greater in obese than in lean rats##2##7##(1995-5#2)
greater in organic than in conventional plots##3##7##(2008-10#3)
greater in the 5##2##4##(1991-5#1)(2008-5#1)
greater in the cancer group than in the control##2##9##(1997-4#2)
greater in the former##2##4##(1997-7#1)(2011-2#1)
greater in the##31##3##(1990-8#1)(1991-5#1)(1992-6#2)(1995-12#1)(1995-6#1)(1996-5#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2010-8#1)(2011-2#3)(2013-1#1)
greater in these##2##3##(2008-10#1)(2013-1#1)
greater in##98##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-12#2)(1992-6#2)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#4)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#33)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#3)
greater incidence of##5##3##(1990-6#2)(2007-7#1)(2008-10#1)(2012-3#1)
greater incidence##6##2##(1990-6#2)(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
greater incorporation of##2##3##(1994-3#1)(2008-8#1)
greater increase in##11##3##(1991-3#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-6#1)(2008-12#2)(2008-3#1)(2009-11#1)(2010-10#1)(2011-10#1)
greater increases in##6##3##(1990-2#1)(2008-10#1)(2008-12#2)(2010-1#1)(2013-7#1)
greater increases##7##2##(1990-2#1)(1992-10#1)(2008-10#1)(2008-12#2)(2010-1#1)(2013-7#1)
greater inhibition##2##2##(1995-11#1)(2008-10#1)
greater inhibitory##4##2##(1990-7#1)(1992-2#1)(2008-10#1)(2013-1#1)
greater initial fear levels during repeated exposure##2##7##(2012-2#2)
greater initial##3##2##(2010-3#1)(2012-2#2)
greater insight into the##3##4##(2008-10#1)(2008-11#1)(2010-6#1)
greater insight into##4##3##(2008-10#1)(2008-11#1)(2009-4#1)(2010-6#1)
greater interaction between##2##3##(1991-9#1)(1997-1#1)
greater interest##3##2##(1996-3#1)(1996-7#1)(2008-4#1)
greater knowledge of##2##3##(1995-1#2)
greater knowledge##3##2##(1995-1#2)(2008-4#1)
greater levels of##5##3##(1995-12#1)(1996-12#1)(2008-8#1)(2009-5#2)
greater likelihood of##4##3##(1995-2#1)(2008-12#1)(2008-8#1)(2012-12#1)
greater log/(log##2##2##(2008-10#2)
greater losses##2##2##(2008-10#2)
greater males and##4##3##(2008-9#4)
greater mean##2##2##(2007-11#1)(2008-5#1)
greater mortality in wave##2##4##(2011-2#2)
greater mortality##5##2##(2008-1#1)(2010-6#1)(2011-2#2)(2013-7#1)
greater need for##2##3##(1991-12#1)(2010-3#1)
greater number of individuals##2##4##(2008-8#2)
greater number of##22##3##(1992-9#1)(1993-12#1)(1996-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)
greater number##23##2##(1992-9#1)(1993-12#1)(1996-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#1)
greater numbers of##4##3##(1997-4#1)(2008-10#2)(2013-1#1)
greater numbers##6##2##(1997-2#1)(1997-4#1)(2008-10#2)(2008-8#1)(2013-1#1)
greater on the##5##3##(2007-10#2)(2007-11#1)(2008-10#1)(2011-2#1)
greater on##9##2##(1997-6#1)(2007-10#2)(2007-11#1)(2008-10#4)(2011-2#1)
greater or lesser##2##3##(2007-11#1)(2008-6#1)
greater or##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
greater participation##2##2##(2007-6#1)(2008-12#1)
greater past month use##2##4##(2010-9#2)
greater peak knee##2##3##(2011-2#2)
greater peak##3##2##(2011-2#3)
greater perceived##2##2##(2007-12#1)(2009-5#1)
greater percent of##2##3##(2008-3#1)(2011-2#1)
greater percentage of##4##3##(1993-8#1)(1995-3#1)(1996-2#1)(2008-10#1)
greater percentage##5##2##(1990-8#1)(1993-8#1)(1995-3#1)(1996-2#1)(2008-10#1)
greater potency in##2##3##(1990-5#1)(1995-3#1)
greater potency##4##2##(1990-5#1)(1993-9#1)(1995-3#1)(2012-12#1)
greater precision##5##2##(2007-8#1)(2008-10#2)(2008-3#1)(2010-4#1)
greater presence##2##2##(2008-5#1)(2009-10#1)
greater proportion of##11##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
greater protection##2##2##(1997-4#1)(2008-10#1)
greater range##3##2##(1991-12#1)(2008-8#1)(2008-9#1)
greater rate of##4##3##(2008-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
greater recovery##3##2##(2008-10#3)
greater reduction in pain##2##4##(1994-3#1)(2007-11#1)
greater reduction in##6##3##(1994-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-3#1)(2010-4#1)
greater reduction##7##2##(1994-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
greater relative##2##2##(2008-8#1)(2013-7#1)
greater relevance##3##2##(2008-10#2)(2008-5#1)
greater resolution than##2##3##(1997-4#1)(2008-4#1)
greater responses##2##2##(2007-6#1)(2008-9#1)
greater responsibility##2##2##(1992-6#1)(2008-10#1)
greater rheas##4##2##(2013-1#4)
greater risk because##2##3##(2008-7#1)(2012-1#1)
greater risk for adjustment problems##2##5##(2009-8#2)
greater risk for##7##3##(2007-10#1)(2008-11#2)(2009-8#2)(2010-6#1)(2012-12#1)
greater risk of complications##2##4##(1991-6#1)(2013-1#1)
greater risk of relapse##2##4##(1990-11#1)(2011-2#1)
greater risk of##11##3##(1990-11#1)(1991-6#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
greater risk##24##2##(1990-11#1)(1991-6#1)(1995-2#1)(1996-11#2)(2007-10#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
greater satisfaction##2##2##(2007-12#1)(2008-8#1)
greater sensitivity and##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
greater sensitivity than the##2##4##(1992-5#1)(2007-12#1)
greater sensitivity than##3##3##(1992-5#1)(2007-12#1)(2011-2#1)
greater sensitivity##10##2##(1990-7#1)(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
greater severity##2##2##(1997-3#1)(1997-7#1)
greater significance##2##2##(1994-2#1)(2008-6#1)
greater skin##2##2##(1995-3#1)(2008-5#1)
greater spatial##2##2##(2008-10#1)(2008-3#1)
greater specificity##4##2##(1991-12#1)(2008-10#1)(2009-7#1)(2012-3#1)
greater spending and##2##3##(1996-1#1)(2012-3#1)
greater spending##3##2##(1996-1#1)(2012-3#2)
greater spore##2##2##(2008-10#2)
greater stability##4##2##(2007-11#1)(2008-10#3)
greater success as##2##3##(1994-2#1)(2008-8#1)
greater success##6##2##(1994-1#2)(1994-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
greater superficial petrosal nerve##2##4##(2006-12#2)
greater suppression##3##2##(2008-10#3)
greater susceptibility##2##2##(2008-9#1)(2012-2#1)
greater symptom burden##2##3##(2008-7#2)
greater tendency to##3##3##(1992-5#1)(2008-9#1)(2009-12#1)
greater than 0##21##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-8#1)(2007-11#1)(2008-10#10)(2008-2#2)(2008-3#1)(2009-11#1)(2011-1#1)(2012-12#1)
greater than 1##14##3##(1990-5#1)(1992-3#1)(1993-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#2)
greater than 10 units/ml##2##4##(2008-10#2)
greater than 10##13##3##(1990-5#1)(1990-9#1)(1991-5#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-7#1)
greater than 10% of##2##4##(1992-3#1)(2010-11#1)
greater than 10%##4##3##(1992-3#1)(2008-10#1)(2010-11#1)(2010-6#1)
greater than 100##9##3##(1990-8#1)(1991-12#1)(1991-9#1)(1995-6#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
greater than 12##3##3##(2008-3#1)(2008-8#1)(2010-7#1)
greater than 15 mm##3##4##(1995-12#2)(2011-2#1)
greater than 15##5##3##(1991-10#1)(1994-12#1)(1995-12#2)(2011-2#1)
greater than 1 cm##2##3##(2012-2#1)(2013-8#1)
greater than 2 mg##2##4##(2008-10#1)(2008-3#1)
greater than 2 microM##2##4##(1990-7#1)(1997-4#1)
greater than 2##14##3##(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-2#1)(1997-4#1)(2008-10#1)(2008-3#4)(2010-6#1)(2012-12#1)(2013-1#1)
greater than 20##7##3##(1990-12#1)(1992-3#1)(1992-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)
greater than 20%##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
greater than 200 nM##2##4##(1997-4#1)(1997-6#1)
greater than 200##5##3##(1991-8#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-3#1)
greater than 3##8##3##(1991-12#1)(1991-5#1)(1992-3#1)(1997-3#1)(2008-10#2)(2008-3#1)(2012-3#1)
greater than 30##3##3##(1990-11#1)(1997-4#1)(2008-1#1)
greater than 35##2##3##(1991-4#1)(2008-6#1)
greater than 4##2##3##(1990-9#1)(1991-4#1)
greater than 40##2##3##(1991-2#1)(2008-7#1)
greater than 40%##2##3##(2008-3#2)
greater than 5##4##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
greater than 50##2##3##(1997-4#1)(2008-3#1)
greater than 50% of##4##4##(1990-2#1)(1992-8#1)(1997-1#1)(2009-10#1)
greater than 50%##8##3##(1990-2#1)(1992-8#1)(1997-1#1)(2007-12#2)(2008-9#1)(2009-10#1)(2012-2#1)
greater than 6##4##3##(1990-6#1)(2007-10#1)(2008-10#1)(2010-6#1)
greater than 60##2##3##(2008-7#1)(2009-4#1)
greater than 60%##2##3##(2007-11#1)(2010-3#1)
greater than 70%##2##3##(1992-10#1)(2011-2#1)
greater than 8##2##3##(2007-11#1)(2008-10#1)
greater than 80% of##2##4##(1995-6#1)(2008-7#1)
greater than 80%##8##3##(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
greater than 85%##2##3##(2008-10#1)(2008-6#1)
greater than 90##2##3##(2008-3#2)
greater than 90%##9##3##(1991-11#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
greater than 93%##3##3##(1990-12#1)(2008-10#2)
greater than 94%##2##3##(2008-10#1)(2008-3#1)
greater than 95% of##3##4##(1990-12#1)(1990-8#1)(1994-8#1)
greater than 95%##12##3##(1990-11#1)(1990-12#1)(1990-8#1)(1994-8#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)
greater than 97%##5##3##(2008-10#3)(2008-2#1)(2013-8#1)
greater than 98%##3##3##(1990-7#1)(2008-10#2)
greater than 99 percent##2##4##(1992-12#1)(1997-2#1)
greater than 99##5##3##(1992-12#1)(1997-2#1)(2007-12#2)(2008-10#1)
greater than 99%##8##3##(1990-11#1)(2008-10#4)(2008-3#1)(2012-3#1)(2013-1#1)
greater than Phe psi##4##4##(1992-8#4)
greater than a##2##3##(1997-7#1)(2007-11#1)
greater than additive effects on##2##5##(2008-10#2)
greater than additive##5##3##(2008-10#5)
greater than approximately 0##2##4##(2008-3#2)
greater than approximately##3##3##(2008-3#3)
greater than ever##2##3##(1991-3#1)(2007-4#1)
greater than expected##2##3##(2008-8#1)(2013-7#1)
greater than for##4##3##(1995-3#1)(2008-10#2)(2013-1#1)
greater than in the##6##4##(1995-5#1)(1996-2#1)(2008-11#1)(2008-7#2)(2009-2#1)
greater than in##13##3##(1990-3#1)(1990-5#1)(1992-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-4#1)
greater than is##2##3##(1994-3#1)(2008-11#1)
greater than its##2##3##(2008-8#2)
greater than or equal to 50 mg M/kg##2##8##(2008-5#2)
greater than or equal to 50##3##6##(2008-5#3)
greater than or equal to 8##2##6##(1991-6#1)(1992-6#1)
greater than or equal to##26##5##(1990-11#2)(1990-2#2)(1991-5#1)(1991-6#1)(1991-8#9)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(2008-10#2)(2008-5#3)
greater than that for##2##4##(1995-3#1)(2008-2#1)
greater than that from##2##4##(1991-9#1)(2008-8#1)
greater than that in the##5##5##(2008-5#1)(2008-9#4)
greater than that in##10##4##(1994-2#1)(1994-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#4)
greater than that observed##2##4##(1993-8#2)
greater than that obtained##2##4##(1990-12#1)(2008-4#1)
greater than that of the wild type##2##7##(2008-10#1)(2008-8#1)
greater than that of the##12##5##(1990-10#1)(1992-12#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)
greater than that of##33##4##(1990-10#1)(1990-8#1)(1992-12#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)
greater than that to##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
greater than that##66##3##(1990-10#1)(1990-12#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)
greater than the cost of##2##5##(1995-1#1)(2011-1#1)
greater than the##45##3##(1990-12#1)(1991-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
greater than their##2##3##(1992-2#1)(2008-3#1)
greater than those of the vehicle controls at the end of the study##2##13##(2008-9#2)
greater than those of the vehicle controls##6##7##(2008-9#6)
greater than those of the##9##5##(2008-5#1)(2008-8#1)(2008-9#7)
greater than those of##12##4##(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#7)(2010-4#1)
greater than those##19##3##(1993-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#11)(2010-4#1)(2011-2#1)
greater than when##2##3##(1995-12#1)(2008-3#1)
greater than with a##2##4##(2007-11#1)(2007-12#1)
greater than##550##2##(1990-10#2)(1990-11#12)(1990-12#8)(1990-2#3)(1990-3#1)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#8)(1990-9#15)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#9)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#1)(1991-8#13)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#9)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#9)(1992-9#1)(1993-1#3)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#3)(1996-12#1)(1996-2#4)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#12)(1997-6#3)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#14)(2007-12#18)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#5)(2008-10#97)(2008-11#11)(2008-12#1)(2008-2#11)(2008-3#46)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#13)(2008-8#12)(2008-9#20)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#6)(2013-7#3)(2013-8#4)
greater therapeutic##2##2##(1994-6#1)(2011-2#1)
greater to##2##2##(1997-2#1)(2009-8#1)
greater tolerance to##2##3##(2008-10#1)(2012-7#1)
greater tolerance##4##2##(2008-10#3)(2012-7#1)
greater total##7##2##(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#1)
greater understanding of the##12##4##(1994-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-1#2)
greater understanding of##18##3##(1994-2#2)(1995-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)
greater understanding##19##2##(1994-2#2)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)
greater use of##7##3##(2006-8#2)(2008-6#2)(2008-9#1)(2010-4#1)(2012-2#1)
greater value##4##2##(2008-10#1)(2008-2#1)(2010-4#1)(2012-3#1)
greater variation##3##2##(1996-6#1)(2008-5#1)(2009-7#1)
greater variety of##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#1)
greater vulnerability to##2##3##(1995-11#1)(2009-4#1)
greater weight loss per calorie##2##5##(2008-3#2)
greater weight##4##2##(2008-3#2)(2012-12#1)(2013-7#1)
greater when the##3##3##(2008-10#2)(2008-3#1)
greater when##12##2##(1993-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2010-2#1)(2013-1#1)
greater with the supplement than placebo##2##6##(2013-8#2)
greater with##9##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
greater yield##4##2##(2008-10#1)(2008-8#1)(2009-7#2)
greater##1761##1##(1990-10#3)(1990-11#14)(1990-12#9)(1990-2#6)(1990-3#2)(1990-5#12)(1990-6#5)(1990-7#5)(1990-8#11)(1990-9#18)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#13)(1991-2#12)(1991-3#4)(1991-4#4)(1991-5#9)(1991-6#8)(1991-8#15)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#14)(1992-4#1)(1992-5#7)(1992-6#10)(1992-8#12)(1992-9#6)(1993-1#7)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-1#9)(1994-11#5)(1994-12#5)(1994-2#14)(1994-3#9)(1994-5#5)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#9)(1995-11#6)(1995-12#10)(1995-2#9)(1995-3#12)(1995-5#8)(1995-6#6)(1995-8#6)(1996-1#5)(1996-11#2)(1996-12#11)(1996-2#9)(1996-3#5)(1996-5#4)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#3)(1997-1#10)(1997-2#11)(1997-3#8)(1997-4#21)(1997-5#3)(1997-6#10)(1997-7#6)(1997-8#2)(1997-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#2)(2007-10#12)(2007-11#29)(2007-12#32)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#12)(2008-10#294)(2008-11#62)(2008-12#30)(2008-2#27)(2008-3#80)(2008-4#20)(2008-5#53)(2008-6#22)(2008-7#55)(2008-8#48)(2008-9#69)(2009-10#5)(2009-11#8)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#14)(2009-5#9)(2009-6#6)(2009-7#13)(2009-8#12)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#6)(2010-2#5)(2010-3#9)(2010-4#15)(2010-5#4)(2010-6#10)(2010-7#3)(2010-8#4)(2010-9#6)(2011-1#16)(2011-10#1)(2011-2#50)(2011-3#1)(2012-1#8)(2012-12#26)(2012-2#28)(2012-3#24)(2012-4#1)(2012-5#1)(2012-7#1)(2013-1#54)(2013-7#12)(2013-8#14)
greater)##3##1##(2007-11#1)(2008-3#1)(2011-2#1)
greatest activity##3##2##(1994-9#1)(2007-11#1)(2008-10#1)
greatest at##5##2##(2007-8#1)(2008-10#3)(2008-12#1)
greatest between##4##2##(1992-4#1)(2008-10#3)
greatest challenge##3##2##(1994-2#1)(2008-10#1)(2008-2#1)
greatest challenges##2##2##(2008-11#1)(2008-4#1)
greatest concern##2##2##(2008-2#1)(2012-2#1)
greatest decrease##4##2##(1995-9#1)(2007-10#1)(2008-10#2)
greatest difficulty##2##2##(2008-4#1)(2009-9#1)
greatest for##9##2##(1990-5#1)(2008-10#5)(2008-5#1)(2009-7#1)(2013-1#1)
greatest genetic distance##3##3##(2008-10#3)
greatest genetic##4##2##(2008-10#4)
greatest in the##8##3##(1991-12#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-1#1)(2013-8#1)
greatest in##17##2##(1991-12#1)(1993-9#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
greatest need##2##2##(2010-12#2)
greatest number of##10##3##(1990-12#1)(1992-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
greatest percentage##2##2##(2007-10#1)(2008-12#1)
greatest potential##3##2##(1993-11#1)(1996-3#1)(2008-7#1)
greatest preference##2##2##(1992-3#1)(2007-2#1)
greatest proportion of##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
greatest reduction in##4##3##(2008-10#2)(2008-3#2)
greatest reduction##5##2##(1995-11#1)(2008-10#2)(2008-3#2)
greatest risk for##2##3##(2011-2#1)(2012-3#1)
greatest risk##10##2##(1992-6#1)(1997-3#1)(2007-7#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
greatest sensitivity##3##2##(2008-10#3)
greatest similarities##2##2##(1992-8#1)(2008-10#1)
greatest when##6##2##(1990-9#1)(2008-10#4)(2008-9#1)
greatest with##2##2##(1995-2#1)(2013-1#1)
greatest##262##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-2#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#89)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#4)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#5)
greatly advanced##3##2##(1992-9#1)(2008-2#1)(2010-4#1)
greatly affect the##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
greatly affect##4##2##(1992-9#1)(2008-11#1)(2008-8#1)(2011-2#1)
greatly affected by detuning the##2##5##(2008-3#2)
greatly affected by##7##3##(1990-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
greatly affected##8##2##(1990-12#1)(2008-10#3)(2008-3#2)(2008-7#1)(2011-2#1)
greatly affects the##2##3##(2008-8#1)(2011-2#1)
greatly affects##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
greatly alter the##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
greatly amplified##2##2##(2008-10#1)(2008-2#1)
greatly assist##2##2##(1997-7#1)(2012-3#1)
greatly at##2##2##(2008-10#2)
greatly benefited##2##2##(1990-5#1)(2008-10#1)
greatly between##2##2##(1995-2#1)(1995-5#1)
greatly by the##2##3##(2008-10#1)(2011-3#1)
greatly by##4##2##(2008-10#2)(2008-3#1)(2011-3#1)
greatly decreased in##2##3##(1996-5#1)(2008-11#1)
greatly decreased##5##2##(1992-3#1)(1995-8#1)(1996-5#1)(2008-11#2)
greatly depending on the##2##4##(1994-6#1)(2013-1#1)
greatly depends##2##2##(2008-10#1)(2008-11#1)
greatly diminished##5##2##(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1996-5#1)
greatly enhance our understanding of##2##5##(2008-10#1)(2009-8#1)
greatly enhance our##3##3##(2008-10#1)(2009-2#1)(2009-8#1)
greatly enhance the##8##3##(1994-2#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-8#1)
greatly enhance##11##2##(1994-2#1)(2006-10#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-8#1)
greatly enhanced by the##4##4##(1997-8#1)(2008-10#2)(2010-3#1)
greatly enhanced by##19##3##(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-9#1)(2010-3#1)(2013-1#1)
greatly enhanced in##2##3##(2008-10#2)
greatly enhanced our##2##3##(2008-10#1)(2011-2#1)
greatly enhanced the##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
greatly enhanced##43##2##(1991-12#1)(1994-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#25)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
greatly enhances the##4##3##(1995-2#1)(2007-12#2)(2008-10#1)
greatly exceed those##2##3##(1996-12#1)(2008-9#1)
greatly exceeds##2##2##(1991-11#1)(1992-12#1)
greatly expanded##4##2##(1991-12#2)(2008-9#2)
greatly extended##2##2##(2007-11#1)(2008-4#1)
greatly facilitate the##4##3##(1996-8#2)(2008-3#1)(2009-10#1)
greatly facilitate##6##2##(1996-8#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
greatly facilitated in##2##3##(2008-10#1)(2013-1#1)
greatly facilitated##6##2##(1993-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)
greatly facilitates##6##2##(1996-9#1)(2007-11#1)(2007-12#1)(2008-7#2)(2010-1#1)
greatly from##2##2##(2008-10#1)(2008-3#1)
greatly improve the##9##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-6#1)(2009-9#1)(2010-8#1)(2012-2#1)
greatly improve##10##2##(1994-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2009-9#1)(2010-8#1)(2012-2#1)
greatly improved by##2##3##(2008-3#2)
greatly improved the##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
greatly improved##20##2##(2006-4#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#5)(2009-11#1)(2009-5#1)(2009-9#1)(2010-3#1)
greatly improves the##4##3##(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
greatly improves##6##2##(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
greatly in the##4##3##(1991-12#1)(1992-12#1)(2010-8#1)(2012-3#1)
greatly in##7##2##(1991-12#1)(1992-12#1)(1997-3#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-3#1)
greatly increase the##2##3##(1997-4#1)(2007-10#1)
greatly increase##3##2##(1997-4#1)(2007-10#1)(2008-8#1)
greatly increased the##3##3##(1996-2#1)(2008-10#1)(2008-9#1)
greatly increased##21##2##(1990-2#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#2)
greatly increases the##5##3##(2007-7#1)(2008-10#4)
greatly increases##6##2##(2007-7#1)(2008-10#4)(2008-8#1)
greatly influenced by the##3##4##(1993-6#1)(2008-10#1)(2009-5#1)
greatly influenced by##7##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-3#1)
greatly influenced##9##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-3#1)
greatly inhibited##3##2##(1990-12#1)(1993-12#1)(2008-10#1)
greatly on the##3##3##(2008-10#1)(2008-2#2)
greatly reduce the##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
greatly reduced and the##2##4##(2007-12#1)(2008-5#1)
greatly reduced at##2##3##(1996-12#1)(2012-12#1)
greatly reduced in##4##3##(1990-11#1)(2008-7#2)(2008-9#1)
greatly reduced levels of##2##4##(1990-8#1)(1994-9#1)
greatly reduced##34##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-5#2)(1992-5#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)
greatly reduces the##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
greatly reduces##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
greatly restricted##2##2##(1994-8#1)(2013-1#1)
greatly simplified##2##2##(2008-3#2)
greatly simplifies the##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
greatly simplify##2##2##(1990-8#1)(2008-5#1)
greatly simplifying##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
greatly stimulated##2##2##(1992-11#1)(2010-1#1)
greatly suppressed##2##2##(2007-12#1)(2008-10#1)
greatly the##2##2##(1990-5#1)(2008-8#1)
greatly to the##2##3##(2011-2#1)(2012-3#1)
greatly to##8##2##(1997-1#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-6#2)(2011-2#1)(2012-3#1)
greatly varies##2##2##(2007-12#1)(2012-3#1)
greatly##383##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#4)(1990-8#2)(1991-11#1)(1991-12#5)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#7)(2007-12#14)(2007-7#1)(2008-1#3)(2008-10#94)(2008-11#12)(2008-12#2)(2008-2#12)(2008-3#24)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#17)(2008-9#14)(2009-10#1)(2009-11#3)(2009-2#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#11)(2013-1#8)(2013-8#1)
green alga##8##2##(1991-12#1)(1994-11#3)(2008-11#1)(2008-6#1)(2010-10#1)(2012-3#1)
green algae##5##2##(2008-10#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-1#1)
green analytical procedure for##2##4##(2008-10#2)
green analytical procedure##3##3##(2008-10#2)(2008-5#1)
green and blue##2##3##(2007-11#1)(2008-3#1)
green and red emission##2##4##(2007-12#1)(2008-10#1)
green and roasted coffee##2##4##(2008-10#2)
green and roasted##3##3##(2008-10#3)
green and yellow vegetables##2##4##(2008-10#2)
green and yellow##3##3##(2008-10#2)(2008-3#1)
green and##18##2##(1996-10#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-12#1)(2008-3#2)(2009-8#2)
green area##2##2##(2008-10#2)
green areas##2##2##(2008-10#2)
green bean##4##2##(2008-10#2)(2011-2#2)
green beans##2##2##(2011-2#2)
green chromatographic##2##2##(2008-10#2)
green coffee beans and##2##4##(2008-10#2)
green coffee beans##5##3##(2008-10#5)
green coffee##8##2##(2008-10#8)
green dye##2##2##(2008-10#2)
green emission##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
green fluorescence protein##3##3##(2008-9#1)(2009-10#1)(2011-2#1)
green fluorescence was##3##3##(2008-9#3)
green fluorescence##10##2##(2008-11#1)(2008-9#6)(2009-10#1)(2011-2#1)(2013-8#1)
green fluorescent protein (GFP) as##3##5##(2008-1#1)(2008-7#1)(2011-3#1)
green fluorescent protein (GFP) baculovirus##2##5##(1997-4#1)(2008-11#1)
green fluorescent protein (GFP) from##2##5##(1996-6#1)(2008-10#1)
green fluorescent protein (GFP) gene##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
green fluorescent protein (GFP)##22##4##(1996-6#1)(1997-4#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2011-3#1)
green fluorescent protein and##2##4##(2008-1#1)(2008-10#1)
green fluorescent protein in##2##4##(2008-11#1)(2008-7#1)
green fluorescent protein##53##3##(1996-6#1)(1997-4#1)(1997-8#1)(2008-1#3)(2008-10#12)(2008-11#13)(2008-4#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-6#1)(2009-8#1)(2009-9#1)(2011-3#1)(2012-3#1)
green fluorescent##55##2##(1996-6#1)(1997-4#1)(1997-8#1)(2008-1#3)(2008-10#13)(2008-11#13)(2008-4#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-3#1)(2012-3#1)
green grass##2##2##(2012-12#2)
green in##2##2##(1992-2#1)(2008-10#1)
green is##2##2##(2008-10#1)(2008-3#1)
green lacewing Chrysoperla externa (Hagen)##2##5##(2008-6#2)
green laser##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
green leaf odours##2##3##(2008-10#2)
green leaf volatiles##2##3##(2011-10#1)(2011-2#1)
green leaf##9##2##(2008-10#6)(2011-10#1)(2011-2#2)
green leaves##2##2##(2008-10#1)(2008-11#1)
green light is##2##3##(2008-2#2)
green light was##2##3##(2007-12#1)(2008-7#1)
green light##9##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#2)
green manure##4##2##(2008-10#4)
green mold disease##2##3##(2008-10#2)
green mold epidemics##2##3##(2008-10#2)
green mold##6##2##(2008-10#6)
green mottle mosaic virus##6##4##(2008-10#6)
green mussel##3##2##(2013-7#3)
green on black##2##3##(2008-10#2)
green on##3##2##(2008-10#2)(2010-5#1)
green or##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
green output##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
green plants##2##2##(2008-9#2)
green synthesis##2##2##(2011-2#1)(2012-3#1)
green tea catechins##3##3##(2008-10#1)(2008-11#2)
green tea extract##5##3##(1994-2#1)(2009-11#3)(2009-5#1)
green tea was##2##3##(2008-11#1)(2009-8#1)
green tea##24##2##(1994-2#1)(1995-9#1)(2008-10#5)(2008-11#8)(2009-11#5)(2009-5#3)(2009-8#1)
green to##3##2##(1993-11#1)(2008-10#1)(2008-2#1)
green upconversion lasing of Er(3+)##2##5##(2007-11#2)
green##353##1##(1990-6#2)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-2#1)(1995-2#3)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#8)(2007-12#14)(2007-2#1)(2008-1#3)(2008-10#128)(2008-11#31)(2008-12#4)(2008-2#10)(2008-3#18)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#12)(2008-8#6)(2008-9#16)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-5#3)(2010-6#2)(2011-10#1)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#5)
green-emitting CdTe quantum dots##2##4##(2008-10#2)
green-fluorescence##2##1##(2011-1#2)
green-fluorescent##3##1##(1992-10#1)(2008-11#2)
green-light##3##1##(2007-12#2)(2008-2#1)
green-sensitive##2##1##(2008-8#2)
green-yellow##5##1##(2008-2#1)(2011-2#4)
greener##3##1##(2008-10#2)(2011-1#1)
greenhouse and field studies##2##4##(2008-10#2)
greenhouse and field##4##3##(2008-10#3)(2008-12#1)
greenhouse and growth chamber experiments##2##5##(2008-10#2)
greenhouse and##17##2##(2008-10#16)(2008-12#1)
greenhouse conditions##19##2##(2008-10#19)
greenhouse effect##8##2##(1991-6#5)(1992-3#2)(2008-10#1)
greenhouse experiment##5##2##(2008-10#5)
greenhouse experiments and##2##3##(2008-10#1)(2008-8#1)
greenhouse experiments##22##2##(2008-10#21)(2008-8#1)
greenhouse for##6##2##(2008-10#6)
greenhouse gas##2##2##(2012-2#1)(2013-8#1)
greenhouse gases##6##2##(1992-3#1)(2008-3#3)(2012-2#2)
greenhouse isolates##6##2##(2008-10#6)
greenhouse or field##2##3##(2008-10#1)(2011-2#1)
greenhouse or in##2##3##(2008-10#2)
greenhouse or##6##2##(2008-10#5)(2011-2#1)
greenhouse seedling resistance##2##3##(2008-10#2)
greenhouse seedling##5##2##(2008-10#5)
greenhouse studies with##3##3##(2008-10#3)
greenhouse studies##10##2##(2008-10#9)(2013-8#1)
greenhouse tests##7##2##(2008-10#7)
greenhouse to##2##2##(2008-10#1)(2011-2#1)
greenhouse with##3##2##(2008-10#3)
greenhouse##210##1##(1991-6#5)(1992-3#4)(2008-10#181)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#8)(2012-2#3)(2013-8#2)
greenhouse-grown plants##4##2##(2008-10#3)(2008-8#1)
greenhouse-grown##10##1##(2008-10#9)(2008-8#1)
greenhouses in##3##2##(2008-10#3)
greenhouses##12##1##(2008-10#9)(2008-6#1)(2011-2#2)
greening of##2##2##(1992-8#1)(2008-11#1)
greening##6##1##(1992-8#4)(2008-11#1)(2013-8#1)
greenish orange##2##2##(1993-11#2)
greenish##4##1##(1993-11#2)(2008-10#2)
greens##2##1##(2008-10#1)(2009-5#1)
gregaria##11##1##(2007-12#7)(2008-12#1)(2012-12#3)
gregarious clutches##2##2##(2008-9#2)
gregarious##7##1##(2007-12#2)(2008-9#4)(2011-2#1)
gregata f##3##2##(2008-10#3)
gregata##8##1##(2008-10#8)
gregata)##3##1##(2008-10#3)
grew actively##2##2##(2008-10#2)
grew and##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
grew as##3##2##(1991-6#1)(2008-11#1)(2008-6#1)
grew at##7##2##(1995-2#1)(1996-1#1)(2008-10#3)(2010-4#1)(2012-2#1)
grew faster##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
grew from##4##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
grew in##11##2##(1991-6#2)(1993-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)
grew more rapidly##3##3##(1993-3#1)(1996-12#1)(2008-10#1)
grew more slowly than##2##4##(1993-3#1)(2008-8#1)
grew more slowly##4##3##(1993-3#1)(2008-10#2)(2008-8#1)
grew more##7##2##(1993-3#2)(1996-12#1)(2008-10#3)(2008-8#1)
grew on##3##2##(2008-10#2)(2008-7#1)
grew out of##3##3##(1995-3#1)(2008-10#1)(2008-4#1)
grew out##4##2##(1993-9#1)(1995-3#1)(2008-10#1)(2008-4#1)
grew significantly##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
grew slightly##2##2##(1993-6#1)(2008-10#1)
grew through##3##2##(2008-10#3)
grew to a##2##3##(1994-5#1)(2008-11#1)
grew to##4##2##(1994-5#1)(1995-2#1)(1996-2#1)(2008-11#1)
grew up##3##2##(1992-3#1)(2008-8#1)(2008-9#1)
grew well##3##2##(2008-10#2)(2008-11#1)
grew with an average specific growth rate of 0##2##9##(2008-11#2)
grew with##3##2##(2008-11#3)
grew##115##1##(1990-11#1)(1991-6#3)(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-7#1)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#39)(2008-11#12)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
grey and white##2##3##(1995-6#1)(1995-8#1)
grey area##2##2##(1992-8#1)(1997-4#1)
grey hair##3##2##(2009-12#1)(2011-1#2)
grey matter atrophy##3##3##(2013-1#3)
grey matter##11##2##(1995-8#3)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#4)
grey treefrogs##3##2##(2009-5#2)(2009-9#1)
grey##45##1##(1990-5#1)(1992-6#1)(1992-8#3)(1994-6#1)(1995-6#2)(1995-8#4)(1996-11#1)(1997-4#1)(2008-10#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#3)(2009-9#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#4)(2013-8#1)
grey-scale ultrasound##2##2##(2008-7#2)
grey-scale##3##1##(1997-8#1)(2008-7#2)
greywater##3##1##(2008-10#3)
grid cells is##2##3##(2008-10#2)
grid cells##3##2##(2008-10#3)
grid in a##2##3##(2008-10#1)(2008-3#1)
grid in##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
grid of##4##2##(2008-10#2)(2008-3#2)
grid points##4##2##(2008-2#2)(2009-12#1)(2012-2#1)
grid search##2##2##(2012-2#2)
grid size##3##2##(1996-4#2)(2011-2#1)
grid was##2##2##(1996-1#1)(2008-10#1)
grid##80##1##(1993-12#1)(1995-6#2)(1996-1#1)(1996-4#2)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#14)(2008-11#1)(2008-2#6)(2008-3#16)(2008-4#1)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#4)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#6)(2013-1#7)
grid&quot##2##1##(2008-6#1)(2013-1#1)
gridded##3##1##(1996-8#1)(2008-6#1)(2012-3#1)
grids in##2##2##(2013-1#2)
grids##6##1##(2008-11#1)(2009-11#2)(2012-2#1)(2013-1#2)
grief and coping##2##3##(1990-10#2)
grief and##7##2##(1990-10#4)(1993-3#1)(2008-12#1)(2010-2#1)
grief##21##1##(1990-10#6)(1992-3#1)(1993-3#2)(1993-6#2)(2007-11#1)(2008-11#1)(2008-12#2)(2010-2#4)(2011-1#1)(2013-7#1)
grievance##2##1##(1990-5#1)(2008-11#1)
grieving##4##1##(2008-12#1)(2010-9#3)
grinding and polishing##2##3##(2008-3#2)
grinding oil##2##2##(2008-10#2)
grinding##15##1##(1990-5#1)(2008-10#7)(2008-3#5)(2009-12#1)(2010-12#1)
grip and hold strengths##2##4##(2008-6#2)
grip and hold##4##3##(2008-6#4)
grip force control##4##3##(2013-1#4)
grip preference##3##2##(2007-12#3)
grip strength after diagnostic##2##4##(2008-9#2)
grip strength after##5##3##(2008-9#5)
grip strength##15##2##(2008-9#15)
grip##34##1##(1996-2#2)(2007-12#5)(2008-6#5)(2008-9#17)(2013-1#5)
gripping##7##1##(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)
grisea Isolates##2##2##(2008-10#2)
grisea and##6##2##(2008-10#6)
grisea by##2##2##(2008-10#2)
grisea collected from##3##3##(2008-10#3)
grisea in Korea##2##3##(2008-10#2)
grisea in##7##2##(2008-10#7)
grisea infection##2##2##(2008-10#2)
grisea isolates##4##2##(2008-10#4)
grisea lineages##2##2##(2008-10#2)
grisea populations##4##2##(2008-10#4)
grisea strains##3##2##(2008-10#3)
grisea toward foxtail millet##2##4##(2008-10#2)
grisea##101##1##(1997-4#1)(1997-6#1)(2008-10#93)(2008-9#1)(2009-10#2)(2010-7#3)
grisea)##2##1##(2008-10#2)
griseofulvin##2##1##(2008-10#1)(2008-3#1)
griseola isolates##2##2##(2008-10#2)
griseola##7##1##(2008-10#7)
griseus##8##1##(2008-10#2)(2008-11#1)(2009-2#1)(2010-8#4)
grism##2##1##(2008-2#2)
grisms##2##1##(2008-2#2)
groE##3##1##(1996-12#1)(2008-10#2)
groEL##3##1##(1996-12#2)(2008-10#1)
grocery##2##1##(1990-3#1)(2010-9#1)
groin area##3##2##(2008-7#2)(2011-2#1)
groin##15##1##(1992-5#2)(1996-12#2)(1996-9#1)(2007-7#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
grooming and vacuous chewing movements##2##5##(1996-2#2)
grooming behavior##2##2##(1994-8#2)
grooming responses##2##2##(1993-12#2)
grooming##19##1##(1991-3#1)(1993-12#5)(1994-8#5)(1995-9#1)(1996-2#4)(2008-5#1)(2008-8#1)(2011-2#1)
groove and##3##2##(1990-7#1)(1995-8#1)(2008-5#1)
groove densities##2##2##(2008-2#1)(2008-3#1)
groove density##2##2##(2007-11#1)(2008-3#1)
groove depth##6##2##(2008-2#2)(2008-3#4)
groove efficiencies##2##2##(2008-2#1)(2008-3#1)
groove efficiency of a##2##4##(2008-3#2)
groove efficiency of##3##3##(2008-3#3)
groove efficiency##6##2##(2008-3#6)
groove of DNA##4##3##(1994-6#1)(1996-3#1)(2008-4#2)
groove of the DNA##2##4##(1991-2#1)(1996-2#1)
groove of the##6##3##(1991-2#1)(1993-1#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-2#1)
groove of##14##2##(1991-2#1)(1992-3#2)(1993-1#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-4#3)
groove profile of##2##3##(2008-2#1)(2008-3#1)
groove profile with##3##3##(2007-11#1)(2008-3#2)
groove profile##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
groove profiles##3##2##(2008-2#3)
groove width##2##2##(2008-2#2)
groove##99##1##(1990-7#1)(1991-11#1)(1991-2#1)(1992-3#3)(1992-4#2)(1992-6#1)(1993-1#2)(1993-3#1)(1993-8#1)(1994-5#3)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-2#1)(1996-3#3)(2006-12#6)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#13)(2008-3#29)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#2)(2011-2#1)(2012-2#1)
groove)##3##1##(1994-5#1)(2008-3#1)(2008-5#1)
groove-binding##3##1##(1992-3#2)(2008-12#1)
grooved##6##1##(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)
grooved-peg##2##1##(2007-12#2)
grooves is##2##2##(1993-8#1)(2008-3#1)
grooves on##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
grooves##29##1##(1991-2#1)(1993-8#1)(1993-9#1)(1995-8#2)(2007-12#5)(2008-10#2)(2008-2#4)(2008-3#9)(2008-5#1)(2008-8#1)(2010-5#2)
grooves/mm##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
grooves/mm) grating##3##2##(2007-12#2)(2008-3#1)
grooves/mm)##4##1##(2007-12#2)(2008-3#2)
groping along&quot##3##2##(1991-1#2)(1993-2#1)
groping##4##1##(1991-1#3)(1993-2#1)
gross anatomical##2##2##(2008-10#1)(2008-4#1)
gross and microscopic##4##3##(2008-10#2)(2008-5#2)
gross and##8##2##(2008-10#3)(2008-5#4)(2011-2#1)
gross appearance##2##2##(1990-8#2)
gross cystic disease##3##3##(1993-1#1)(1994-7#2)
gross domestic product (GDP)##3##4##(1991-2#1)(1993-3#1)(1996-2#1)
gross domestic product##7##3##(1991-2#1)(1992-12#1)(1993-3#2)(1996-2#1)(2010-12#1)(2012-12#1)
gross energy##2##2##(2010-2#2)
gross examination##3##2##(1992-8#1)(2008-11#1)(2010-6#1)
gross hematuria is##2##3##(2008-11#2)
gross hematuria##13##2##(2008-1#1)(2008-10#7)(2008-11#4)(2011-2#1)
gross instability##3##2##(2012-3#3)
gross lesion scores##2##3##(2008-5#2)
gross lesions##6##2##(2008-5#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
gross morphology##2##2##(1990-8#1)(2007-12#1)
gross national product##5##3##(1991-12#1)(1992-3#2)(1993-1#1)(2007-7#1)
gross national##6##2##(1991-12#1)(1992-3#2)(1993-1#1)(2007-7#1)(2013-7#1)
gross structural##2##2##(1994-5#1)(2008-1#1)
gross total##2##2##(2008-12#1)(2008-8#1)
gross tumor volume##2##3##(2009-2#2)
gross tumour##4##2##(2008-2#3)(2008-7#1)
gross tumours##2##2##(2008-5#2)
gross##116##1##(1990-12#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-5#1)(1994-7#2)(1995-12#1)(1995-5#3)(1996-2#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#12)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#1)
gross-exposure##3##1##(2012-12#1)(2013-1#2)
grossesse##10##1##(2011-2#2)(2013-1#8)
grossly##11##1##(1990-8#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-11#1)(2009-3#1)(2010-5#1)(2013-1#1)
ground albedo##4##2##(2008-2#4)
ground and excited states##2##4##(2008-10#1)(2008-3#1)
ground and##15##2##(1997-7#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2013-7#1)
ground beef##4##2##(2008-9#1)(2010-4#3)
ground crickets##2##2##(2008-8#2)
ground for##4##2##(1995-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
ground glass##2##2##(2008-3#1)(2010-12#1)
ground in##5##2##(1997-1#1)(2008-10#3)(2008-7#1)
ground level##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
ground of##3##2##(2008-10#1)(2008-8#1)(2009-6#1)
ground or##3##2##(1993-3#1)(2008-10#1)(2009-4#1)
ground pattern of##2##3##(2007-12#2)
ground pattern##3##2##(2007-12#3)
ground reaction forces##2##3##(2010-3#1)(2013-1#1)
ground reflectance##2##2##(2008-3#2)
ground samples##2##2##(2008-10#2)
ground spraying##2##2##(2011-2#2)
ground squirrel##12##2##(1990-5#3)(2008-8#9)
ground squirrels##4##2##(1995-12#2)(2008-8#2)
ground state and##2##3##(1996-2#1)(2008-2#1)
ground state##18##2##(1991-5#1)(1991-9#1)(1996-2#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-9#1)(2012-2#3)(2013-1#1)
ground states##4##2##(1993-5#1)(2007-11#1)(2008-3#2)
ground substance##2##2##(2008-7#1)(2009-7#1)
ground surface##2##2##(2008-3#2)
ground surfaces##2##2##(2008-11#1)(2008-3#1)
ground to##4##2##(1990-8#1)(2008-10#1)(2008-3#2)
ground water samples##3##3##(2008-10#3)
ground water##15##2##(2008-10#15)
ground##194##1##(1990-5#3)(1990-8#2)(1991-5#1)(1991-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-5#2)(1997-7#2)(2006-10#1)(2007-1#1)(2007-11#4)(2007-12#7)(2008-1#3)(2008-10#52)(2008-11#1)(2008-2#9)(2008-3#39)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#15)(2008-9#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#5)(2011-2#2)(2012-12#2)(2012-2#6)(2013-1#3)(2013-7#1)
ground-based backscatter lidar measurements##2##4##(2008-3#2)
ground-based measurements of direct##2##4##(2008-2#1)(2008-3#1)
ground-based measurements##4##2##(2008-2#2)(2008-3#2)
ground-based multispectral measurements of direct solar##2##6##(2008-2#2)
ground-based multispectral measurements##4##3##(2008-2#4)
ground-based passive##2##2##(2008-3#2)
ground-based remote##2##2##(2008-3#2)
ground-based stellar##2##2##(2007-11#1)(2008-3#1)
ground-based##46##1##(2007-11#1)(2008-10#3)(2008-2#13)(2008-3#27)(2013-8#2)
ground-breaking##2##1##(1991-12#1)(1994-2#1)
ground-glass##4##1##(2007-12#1)(2008-1#1)(2010-10#1)(2013-1#1)
ground-level##3##1##(2008-2#1)(2008-3#1)(2008-5#1)
ground-state absorption cross##2##3##(2008-3#2)
ground-state absorption##3##2##(2008-3#3)
ground-state and##2##2##(1993-11#1)(2008-3#1)
ground-state levels##2##2##(2008-3#2)
ground-state problems##2##2##(2012-2#2)
ground-state##22##1##(1993-11#1)(2007-1#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#10)(2012-2#4)
ground-truth##3##1##(2007-5#1)(2008-6#1)(2010-12#1)
groundbreaking##2##1##(2008-11#1)(2011-1#1)
grounded in a##2##3##(2008-11#1)(2008-12#1)
grounded in the##4##3##(1993-1#1)(2008-11#1)(2010-12#1)(2011-2#1)
grounded in##18##2##(1993-1#1)(1994-12#2)(1995-1#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)
grounded on the##2##3##(2008-9#1)(2012-3#1)
grounded on##4##2##(2008-9#2)(2012-3#2)
grounded theory approach##6##3##(2008-11#1)(2008-12#1)(2009-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
grounded theory method##3##3##(2007-10#1)(2008-11#1)(2013-8#1)
grounded theory methodology##4##3##(2008-12#2)(2011-2#2)
grounded theory study##3##3##(2007-10#2)(2008-12#1)
grounded theory##21##2##(2007-10#3)(2008-11#3)(2008-12#5)(2009-11#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
grounded##48##1##(1993-1#1)(1994-12#2)(1995-1#1)(1997-5#2)(2007-10#3)(2008-1#3)(2008-11#6)(2008-12#6)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
grounded-theory study##2##2##(2008-11#2)
grounding in##2##2##(2008-12#1)(2012-12#1)
grounding##4##1##(2008-12#1)(2012-12#1)(2012-2#2)
groundnut rosette disease agents##2##4##(2008-10#2)
groundnut rosette disease##6##3##(2008-10#6)
groundnut rosette##8##2##(2008-10#8)
groundnut##16##1##(2008-10#16)
grounds for##5##2##(1992-3#1)(2008-10#3)(2008-12#1)
grounds of##3##2##(1991-9#1)(2008-5#1)(2011-1#1)
grounds##28##1##(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-5#1)(1994-7#1)(1995-12#2)(1997-1#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
groundwater and##2##2##(2008-8#1)(2013-8#1)
groundwater contamination##2##2##(2008-10#2)
groundwater samples##9##2##(2008-10#4)(2013-1#5)
groundwater##45##1##(1996-4#2)(2008-10#26)(2008-2#1)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#8)(2013-8#3)
groundwork##4##1##(1997-1#1)(2008-12#1)(2008-7#1)(2012-2#1)
group &quot##5##2##(2009-10#3)(2009-5#1)(2012-2#1)
group (0##6##2##(2008-10#1)(2008-12#2)(2008-7#3)
group (1##4##2##(2007-8#1)(2008-12#2)(2013-1#1)
group (1%)##2##2##(1991-8#1)(2012-1#1)
group (10 women)##2##3##(2010-9#2)
group (10##3##2##(2010-9#2)(2011-2#1)
group (130##2##2##(2008-6#1)(2011-2#1)
group (15##2##2##(2013-1#1)(2013-8#1)
group (2##3##2##(2007-8#1)(2008-12#1)(2008-5#1)
group (20##2##2##(2008-1#1)(2008-10#1)
group (31##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
group (8##3##2##(2007-10#1)(2007-8#1)(2008-7#1)
group (9##3##2##(2007-8#2)(2013-1#1)
group (A)##2##2##(2013-1#2)
group (Group##4##2##(1992-11#2)(2007-9#2)
group (IV)##2##2##(2010-6#2)
group (N =##2##3##(2008-10#1)(2011-2#1)
group (P &lt##13##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-7#5)(2010-2#1)(2011-1#1)(2011-3#2)(2012-3#1)
group (P = 0##11##4##(1994-2#1)(1995-12#1)(2008-3#1)(2008-7#4)(2011-1#2)(2012-2#1)(2012-3#1)
group (P =##12##3##(1994-2#1)(1995-12#1)(2008-3#1)(2008-7#4)(2009-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
group (P##26##2##(1994-2#1)(1994-3#1)(1995-12#2)(2008-10#1)(2008-3#1)(2008-7#10)(2009-8#1)(2010-2#1)(2011-1#3)(2011-3#2)(2012-2#1)(2012-3#2)
group (P&lt##3##2##(2006-10#1)(2007-8#1)(2008-3#1)
group (P=0##3##2##(2007-8#2)(2008-12#1)
group (P = 0##2##2##(2012-2#2)
group (grade##2##2##(2008-12#2)
group (graduation classes for years##2##5##(2012-3#2)
group (group##6##2##(2008-1#4)(2008-10#1)(2011-2#1)
group (mean##2##2##(1991-5#1)(2007-5#1)
group (n = 10)##3##4##(1995-2#1)(2007-10#1)(2008-9#1)
group (n = 12)##2##4##(1991-5#2)
group (n =##25##3##(1991-2#2)(1991-5#2)(1993-2#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-8#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-4#3)(2012-3#3)(2013-1#1)
group (n=##4##2##(2012-12#1)(2013-1#3)
group (n=26)##2##2##(2007-11#2)
group (p &gt##2##3##(2011-2#1)(2012-2#1)
group (p &lt##8##3##(2007-10#1)(2008-4#1)(2009-12#1)(2011-1#2)(2011-2#3)
group (p = 0##6##4##(1991-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
group (p##17##2##(1991-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#3)(2011-2#6)(2012-2#1)
group (p&lt##11##2##(1994-12#1)(1995-4#2)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
group (p = 0##2##2##(2013-8#2)
group 0##2##2##(1994-9#1)(2008-5#1)
group 1 and##5##3##(1992-6#1)(1992-9#1)(2008-10#1)(2009-6#1)(2011-2#1)
group 1 had##2##3##(2008-3#2)
group 1 were##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
group 1##42##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-6#1)(1992-9#2)(2008-1#5)(2008-10#12)(2008-11#2)(2008-3#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#4)
group 11##2##2##(2007-8#1)(2008-10#1)
group 13##2##2##(2008-10#1)(2010-5#1)
group 14##2##2##(2009-3#1)(2010-5#1)
group 2 and##3##3##(2008-1#2)(2008-9#1)
group 2##31##2##(1991-3#1)(1992-6#1)(1992-9#1)(1995-2#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#6)
group 3##19##2##(1992-6#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-7#4)(2008-9#1)(2010-10#2)(2010-3#1)(2010-5#2)(2011-2#1)
group 4##7##2##(1992-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)
group 5##3##2##(2008-10#3)
group 7 chromosome##3##3##(2008-10#1)(2008-5#2)
group 7##9##2##(2008-10#2)(2008-5#5)(2008-8#1)(2011-2#1)
group 9##3##2##(2007-11#1)(2008-10#2)
group A and##2##3##(1990-7#1)(2012-2#1)
group A patients##3##3##(2008-1#3)
group A strains##2##3##(2008-10#2)
group A streptococcal##4##3##(1991-8#1)(1995-6#1)(2007-12#2)
group A was##2##3##(2007-8#1)(2013-8#1)
group A##49##2##(1990-6#1)(1990-7#3)(1991-8#1)(1992-12#2)(1993-12#1)(1994-12#3)(1994-9#1)(1995-12#2)(1995-6#1)(1996-6#2)(2007-12#2)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#2)(2008-5#1)(2009-9#1)(2010-12#1)(2010-7#4)(2011-2#3)(2012-2#2)(2013-8#1)
group B Streptococcus##3##3##(1995-6#2)(2006-5#1)
group B strains were##2##4##(2008-10#2)
group B strains##3##3##(2008-10#3)
group B streptococcus and##2##4##(1995-5#1)(2007-12#1)
group B was##2##3##(2008-1#1)(2011-2#1)
group B##35##2##(1990-6#2)(1993-10#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-6#2)(2006-5#1)(2007-12#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2010-1#2)(2011-2#2)(2012-2#1)
group C was##2##3##(2010-7#1)(2011-2#1)
group C##11##2##(1990-12#1)(2008-12#2)(2010-7#3)(2011-2#2)(2012-2#3)
group D##11##2##(1996-1#1)(2007-8#1)(2008-12#6)(2010-4#1)(2011-2#1)(2013-1#1)
group E##3##2##(2007-11#1)(2008-12#1)(2011-2#1)
group F##7##2##(1995-8#1)(2008-10#5)(2008-12#1)
group I and##6##3##(1995-12#1)(2007-8#3)(2008-10#1)(2011-2#1)
group I intron##4##3##(1993-1#1)(1995-6#2)(2008-10#1)
group I isolates formed##2##4##(2008-10#2)
group I isolates were##2##4##(2008-10#2)
group I isolates##5##3##(2008-10#5)
group I metabotropic glutamate receptors##4##5##(1996-12#2)(2008-4#1)(2009-3#1)
group I metabotropic##5##3##(1996-12#2)(2008-4#1)(2009-3#2)
group I were##2##3##(2008-10#1)(2013-1#1)
group I##52##2##(1991-3#1)(1993-1#1)(1994-11#1)(1995-12#3)(1995-6#3)(1996-12#2)(2006-12#1)(2006-6#2)(2007-11#2)(2007-7#3)(2007-8#3)(2008-10#14)(2008-4#3)(2008-7#1)(2009-10#1)(2009-3#4)(2009-8#1)(2010-1#2)(2011-2#1)(2013-1#3)
group II and##2##3##(2006-6#2)
group II isolates##4##3##(2008-10#4)
group II receptor##2##3##(1995-12#2)
group II receptors##3##3##(1995-12#3)
group II##40##2##(1991-3#1)(1994-11#1)(1995-12#6)(1997-3#3)(2006-12#1)(2006-6#4)(2007-7#3)(2007-8#3)(2008-10#11)(2008-9#1)(2009-8#1)(2010-1#2)(2011-2#1)(2013-1#2)
group III was##2##3##(2006-6#1)(2011-2#1)
group III##19##2##(1995-12#2)(2006-6#2)(2007-7#3)(2008-10#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)
group IV##4##2##(2007-11#1)(2008-10#3)
group L##11##2##(1996-3#11)
group M##2##2##(1996-3#1)(2013-1#1)
group N##9##2##(2007-8#3)(2008-10#1)(2013-1#5)
group O##6##2##(1992-9#1)(1993-12#1)(1994-12#2)(1996-3#1)(2008-10#1)
group S##11##2##(1996-3#7)(2007-8#4)
group a##5##2##(1990-5#1)(1993-8#1)(1996-9#1)(2008-10#1)(2009-8#1)
group after##3##2##(2010-4#1)(2011-2#2)
group against##2##2##(2011-1#1)(2011-2#1)
group also showed##2##3##(2009-11#1)(2013-1#1)
group also##9##2##(1992-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2013-1#1)
group analyses##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
group analysis##3##2##(2008-10#2)(2012-2#1)
group and 0##3##3##(1995-12#1)(2012-12#1)(2013-1#1)
group and 1##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
group and 2##2##3##(2011-2#1)(2013-1#1)
group and 5##2##3##(2008-12#1)(2009-3#1)
group and 7##2##3##(2008-1#1)(2011-2#1)
group and a control group##2##5##(1995-2#1)(2008-2#1)
group and a discrete phenon##2##5##(2008-10#2)
group and a##7##3##(1991-12#1)(1992-6#1)(1995-2#1)(2008-10#3)(2008-2#1)
group and control group##2##4##(2007-8#1)(2013-1#1)
group and control##3##3##(2007-8#1)(2009-8#1)(2013-1#1)
group and for##2##3##(2008-10#1)(2008-4#1)
group and from 7##3##4##(2008-11#1)(2008-7#2)
group and groups with##2##4##(2008-7#1)(2012-2#1)
group and in the##2##4##(2007-8#1)(2010-8#1)
group and in##8##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
group and individual##3##3##(1991-1#1)(2008-11#2)
group and its##3##3##(1992-10#1)(2008-10#1)(2012-1#1)
group and may##2##3##(2008-10#1)(2013-1#1)
group and no##2##3##(2013-1#2)
group and one##2##3##(1996-2#1)(1997-6#1)
group and that##2##3##(2008-11#1)(2008-9#1)
group and the other##2##4##(2008-12#1)(2008-7#1)
group and the##28##3##(1991-12#1)(1992-6#1)(1993-3#1)(1994-5#2)(1997-7#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#2)(2012-2#2)
group and to##3##3##(1993-12#1)(2011-2#2)
group and two##2##3##(1993-12#1)(2007-8#1)
group and##189##2##(1990-2#3)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-7#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#4)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#24)(2008-11#6)(2008-12#10)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#11)(2013-8#1)
group animals##2##2##(2008-10#2)
group antigens##10##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-8#2)(1994-9#1)(1995-6#1)(2012-2#1)
group approach##4##2##(1997-2#1)(2008-11#1)(2012-12#2)
group are subjected to##2##4##(2012-3#2)
group are##12##2##(1990-12#1)(1995-1#1)(2007-12#1)(2008-10#4)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
group as a whole##4##4##(1996-1#1)(1997-3#1)(2008-6#1)(2008-7#1)
group as a##6##3##(1996-1#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-9#1)
group as##15##2##(1996-1#1)(1996-5#2)(1997-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#2)
group associated with##2##3##(2008-12#1)(2010-12#1)
group at risk##2##3##(1993-2#1)(2007-12#1)
group at the##12##3##(1991-12#1)(1991-3#1)(1992-4#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)
group at##37##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-2#1)(1993-8#2)(1995-3#2)(1995-5#1)(1996-5#3)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#1)
group attached to##2##3##(1991-12#1)(1991-5#1)
group attended a##2##3##(1995-1#1)(2007-10#1)
group based on##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
group because##2##2##(2008-8#1)(2011-1#1)
group being##2##2##(2008-7#1)(2012-12#1)
group but not in the##2##5##(2011-1#1)(2011-2#1)
group but##9##2##(2008-1#1)(2008-10#4)(2011-1#1)(2011-2#2)(2012-3#1)
group by the##2##3##(2008-10#1)(2013-7#1)
group by##10##2##(1991-5#1)(1994-8#1)(1997-4#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
group came from the##2##4##(2008-10#1)(2008-8#1)
group came##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
group can be##4##3##(1995-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
group can##5##2##(1993-12#1)(1995-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
group carrying##2##2##(1991-8#1)(2008-8#1)
group children exhibited##2##3##(2008-12#2)
group classification##2##2##(2008-8#1)(2011-2#1)
group cohesion##3##2##(2008-9#1)(2010-8#1)(2013-1#1)
group compared to the##2##4##(1994-12#1)(2009-7#1)
group compared to##6##3##(1990-11#1)(1994-12#1)(1994-8#1)(2009-7#1)(2010-6#1)(2012-2#1)
group compared with the placebo group##3##6##(2008-11#2)(2009-8#1)
group compared with the##9##4##(1996-6#1)(2008-11#2)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#1)
group compared with##14##3##(1996-6#1)(1997-7#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#2)(2012-3#2)
group compared##20##2##(1990-11#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-7#1)(2008-11#2)(2008-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)
group comprised##12##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
group comprises##2##2##(2008-12#1)(2008-3#1)
group comprising##2##2##(2009-12#1)(2010-10#1)
group consisted of 32##2##4##(2007-8#1)(2013-8#1)
group consisted of##25##3##(1990-2#1)(1994-2#2)(1994-3#2)(2007-7#1)(2007-8#5)(2008-10#2)(2008-7#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
group consisting of##5##3##(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
group consists of##3##3##(2008-10#2)(2008-8#1)
group contained##4##2##(2007-11#1)(2008-10#2)(2011-3#1)
group containing##5##2##(2008-10#5)
group content##2##2##(2008-10#2)
group control##4##2##(2009-8#4)
group corresponded to##2##3##(2008-10#1)(2008-11#1)
group could be##3##3##(2008-10#2)(2008-5#1)
group could##5##2##(1993-1#1)(2008-10#2)(2008-5#1)(2010-4#1)
group covalently linked to##2##4##(1991-12#1)(2008-10#1)
group data##2##2##(2008-4#1)(2009-5#1)
group decision##2##2##(1992-1#1)(1993-2#1)
group decreased##2##2##(1995-3#1)(2008-5#1)
group defined by##2##3##(2008-10#1)(2012-3#1)
group delay as##2##3##(2007-11#1)(2008-3#1)
group delay dispersion##2##3##(2008-2#1)(2008-3#1)
group delay of##4##3##(2007-11#2)(2007-12#2)
group delay##21##2##(2007-11#6)(2007-12#9)(2008-2#1)(2008-3#5)
group delays##3##2##(2008-1#2)(2008-3#1)
group demonstrated a##2##3##(2008-12#2)
group demonstrated significantly##2##3##(2008-10#1)(2013-1#1)
group demonstrated##7##2##(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-5#1)(2013-1#1)
group design##4##2##(1996-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
group developed##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
group did not differ from##3##5##(2007-5#1)(2008-10#1)(2008-7#1)
group did not differ##4##4##(2007-5#1)(2008-10#1)(2008-7#1)(2009-4#1)
group did not receive##2##4##(1995-1#1)(2007-10#1)
group did not##12##3##(1994-12#1)(1995-1#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-4#1)(2011-1#1)(2013-1#1)
group died##2##2##(1990-5#1)(2011-2#1)
group difference##4##2##(1992-6#1)(1997-3#1)(2010-10#1)(2010-2#1)
group differences in the##3##4##(1993-3#1)(1994-8#1)(2009-3#1)
group differences in##6##3##(1993-3#1)(1994-8#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#1)
group differences over##2##3##(1992-6#1)(2008-5#1)
group differences were##4##3##(1993-9#1)(2008-2#1)(2008-6#2)
group differences##23##2##(1992-12#1)(1992-6#4)(1993-3#1)(1993-9#1)(1994-8#1)(1997-3#2)(2007-12#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2009-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
group discussion##5##2##(1991-6#1)(1996-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
group discussions were held##2##4##(2008-7#1)(2010-3#1)
group discussions##19##2##(1994-3#1)(1994-6#1)(2007-7#2)(2008-11#3)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-3#2)(2010-4#1)(2012-2#1)(2013-1#1)
group displayed a##2##3##(2012-7#1)(2013-1#1)
group displayed##4##2##(1995-1#1)(2007-8#1)(2012-7#1)(2013-1#1)
group does not##2##3##(1994-3#1)(2010-8#1)
group during the##5##3##(1993-12#1)(1997-3#1)(2008-11#1)(2008-5#1)(2011-1#1)
group dynamics##2##2##(1993-12#1)(1994-2#1)
group elements##12##2##(2008-10#9)(2008-11#2)(2009-12#1)
group examined##2##2##(2008-11#1)(2008-7#1)
group exhibited##6##2##(1990-3#1)(1997-6#2)(2008-10#2)(2012-2#1)
group experienced##4##2##(1993-1#1)(1995-8#1)(2007-7#1)(2008-7#1)
group exposed to##2##3##(1994-5#1)(2008-12#1)
group exposed##3##2##(1994-5#1)(2008-12#2)
group fMRI data##3##3##(2008-11#3)
group fission##2##2##(2010-4#2)
group focused on##2##3##(1993-6#1)(2008-8#1)
group for a##2##3##(1990-8#1)(2008-4#1)
group for the##8##3##(2008-10#2)(2008-11#1)(2008-4#2)(2009-5#1)(2010-2#1)(2010-6#1)
group for##43##2##(1990-8#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-11#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#5)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
group format##2##2##(2009-5#1)(2012-2#1)
group formation##4##2##(1992-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
group from the##6##3##(1993-11#2)(1996-5#1)(2008-10#2)(2008-2#1)
group from##14##2##(1993-11#3)(1996-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#2)(2011-2#1)
group functionalized##2##2##(2008-10#1)(2011-2#1)
group had a greater##2##4##(2008-11#1)(2008-3#1)
group had a mean age of##2##6##(2013-8#2)
group had a significantly##4##4##(1996-2#1)(2008-3#1)(2011-1#2)
group had a##18##3##(1990-5#2)(1991-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-3#2)(2009-8#1)(2011-1#2)(2011-2#1)(2013-8#2)
group had better##2##3##(2011-2#2)
group had significant##3##3##(2008-5#1)(2009-4#1)(2012-3#1)
group had significantly lower levels of##2##6##(2008-10#1)(2013-8#1)
group had significantly lower##4##4##(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
group had significantly##5##3##(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
group had##51##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-1#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-9#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-3#3)(2013-1#4)(2013-8#3)
group has a##5##3##(1994-12#1)(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
group has been##3##3##(1990-3#1)(2008-10#1)(2009-10#1)
group has##17##2##(1990-3#1)(1994-12#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2010-3#2)
group have been##3##3##(2008-10#2)(2010-2#1)
group have##10##2##(1991-12#1)(1992-6#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-7#1)(2010-2#1)(2011-1#1)
group having##2##2##(1993-6#1)(2008-5#1)
group health##2##2##(1991-9#1)(2008-11#1)
group home##3##2##(1995-12#1)(2010-8#2)
group improved##2##2##(1995-11#1)(2007-10#1)
group in 4##2##3##(2007-11#1)(2008-11#1)
group in a##2##3##(2008-10#1)(2008-4#1)
group in all##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
group in aqueous solution##2##4##(1997-2#2)
group in both##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
group in comparison to##2##4##(2008-5#1)(2010-6#1)
group in terms of##2##4##(2010-12#1)(2012-1#1)
group in the##22##3##(1990-11#2)(1991-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-2#1)(1997-2#2)(2008-10#8)(2008-4#1)(2008-5#1)(2010-1#1)(2013-1#2)
group in this area##2##4##(2008-10#1)(2013-7#1)
group in western##2##3##(2008-10#1)(2013-7#1)
group in##83##2##(1990-11#2)(1990-5#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#5)(2008-10#19)(2008-11#4)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
group included 40 patients##2##4##(2011-2#2)
group included 50 patients (N = 100 eyes) who underwent##2##10##(2011-2#2)
group included those diagnosed with##2##5##(2011-2#2)
group included##20##2##(1990-2#1)(1996-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#6)(2012-1#1)(2013-1#1)
group includes isolates of races##2##5##(2008-10#2)
group includes isolates of##3##4##(2008-10#3)
group includes##4##2##(2008-10#3)(2011-2#1)
group increased##2##2##(1995-3#1)(1996-5#1)
group increases##2##2##(2007-12#1)(2008-10#1)
group index of##3##3##(2007-12#1)(2008-3#2)
group index##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
group indicate that##2##3##(1990-12#1)(2011-2#1)
group intervention##2##2##(2008-9#1)(2013-1#1)
group interview##4##2##(1992-2#2)(2008-11#2)
group interviews were conducted##3##4##(2008-11#2)(2012-3#1)
group interviews were##5##3##(2007-10#1)(2008-11#3)(2012-3#1)
group interviews with##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
group interviews##18##2##(2007-10#1)(2008-11#6)(2008-12#2)(2009-11#1)(2010-10#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
group into a##2##3##(1994-9#1)(2008-10#1)
group into the##3##3##(1995-2#1)(1997-4#2)
group into##6##2##(1994-9#1)(1995-2#1)(1997-4#2)(2008-10#1)(2008-11#1)
group is a##3##3##(1993-12#1)(2008-4#2)
group is not##4##3##(1990-5#1)(2007-8#1)(2008-7#1)(2010-12#1)
group is rare##2##3##(2008-10#1)(2012-12#1)
group is the##2##3##(1992-12#1)(2011-1#1)
group is##50##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-12#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
group it was##2##3##(1997-6#1)(2008-11#1)
group it##3##2##(1997-6#1)(2007-7#1)(2008-11#1)
group lessons)##2##2##(2008-3#2)
group level##6##2##(2008-1#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
group living and##2##3##(2008-8#1)(2008-9#1)
group living##3##2##(2008-8#1)(2008-9#2)
group lost a mean of##2##5##(2008-3#2)
group management##2##2##(1991-3#1)(1996-2#1)
group managers##3##2##(1991-3#1)(1994-1#2)
group may be##3##3##(1992-12#1)(1994-6#1)(2008-5#1)
group may##7##2##(1992-12#1)(1994-2#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
group mean##11##2##(1991-11#1)(1991-12#1)(1991-3#1)(1997-4#1)(2008-1#1)(2011-2#6)
group medical practices##6##3##(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)
group medical##9##2##(1993-12#3)(1993-2#2)(1993-3#2)(1994-1#2)
group meetings##2##2##(1994-2#1)(2009-6#1)
group member##2##2##(2007-4#1)(2008-9#1)
group members in##2##3##(1996-2#1)(2008-10#1)
group members##17##2##(1996-2#2)(1996-3#1)(2008-10#2)(2008-8#2)(2008-9#8)(2010-1#1)(2011-2#1)
group membership##2##2##(2010-2#1)(2010-4#1)
group methodology was##2##3##(2008-4#1)(2008-9#1)
group of 10##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)
group of 100##2##3##(2008-7#1)(2012-12#1)
group of 102##2##3##(2008-10#1)(2008-9#1)
group of 12 patients##2##4##(2011-2#1)(2011-3#1)
group of 12##5##3##(2008-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
group of 14##2##3##(1992-2#1)(1996-3#1)
group of 15##2##3##(1996-3#1)(2008-10#1)
group of 19 patients##2##4##(2012-3#2)
group of 20 patients##3##4##(1990-6#1)(1994-12#1)(1996-9#1)
group of 21##2##3##(1990-2#1)(2008-11#1)
group of 22##2##3##(2008-9#1)(2012-3#1)
group of 25##2##3##(1990-9#1)(2013-1#1)
group of 29##2##3##(1996-9#1)(2010-12#1)
group of 30##2##3##(2008-7#1)(2011-2#1)
group of 35##2##3##(1991-4#1)(2007-11#1)
group of 40##2##3##(1990-10#1)(1990-2#1)
group of 46##2##3##(1990-2#1)(2008-3#1)
group of 7##3##3##(1994-2#1)(2007-11#1)(2011-2#1)
group of 80##2##3##(2007-11#1)(2007-8#1)
group of a##2##3##(2008-10#2)
group of adult##4##3##(1994-2#1)(2008-10#1)(2008-9#2)
group of animals##2##3##(1993-3#1)(2008-11#1)
group of cells were##2##4##(1992-8#2)
group of cells##4##3##(1992-8#2)(2008-10#1)(2010-6#1)
group of chronic##2##3##(1995-5#1)(2011-2#1)
group of compounds##2##3##(1992-11#1)(2011-2#1)
group of control##3##3##(1993-8#1)(1996-7#1)(2012-12#1)
group of diseases that##3##4##(2009-10#1)(2010-4#1)(2012-3#1)
group of diseases##7##3##(2007-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
group of disorders##4##3##(2008-7#2)(2012-2#2)
group of doctors##2##3##(1993-2#1)(1995-5#1)
group of drugs for##2##4##(1991-6#1)(2011-2#1)
group of drugs##3##3##(1991-6#1)(2011-2#2)
group of elderly##3##3##(1993-1#1)(1994-3#1)(2011-2#1)
group of enzymes that##2##4##(1993-6#1)(2009-10#1)
group of five##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
group of four##2##3##(1993-6#1)(2008-12#1)
group of fungi##2##3##(2008-5#1)(2011-1#1)
group of genetic##3##3##(2008-7#1)(2010-2#1)(2011-2#1)
group of health##2##3##(1992-2#1)(2008-7#1)
group of healthy##4##3##(1990-2#1)(1996-1#1)(2010-12#1)(2011-2#1)
group of high##2##3##(2009-5#1)(2010-4#1)
group of high-risk##2##3##(1995-1#1)(2010-10#1)
group of highly##2##3##(1991-2#1)(1991-5#1)
group of individual##2##3##(2008-5#1)(2013-1#1)
group of individuals##3##3##(1997-8#2)(2011-2#1)
group of infants##3##3##(1994-6#1)(2009-5#2)
group of inherited##2##3##(1991-11#1)(2007-7#1)
group of isolates from##2##4##(2008-10#2)
group of isolates##4##3##(2008-10#4)
group of leaders in radiology administration regarding the##2##8##(1995-2#2)
group of lesions##2##3##(2008-6#1)(2012-2#1)
group of mainly##2##3##(1996-9#1)(2008-9#1)
group of mammals##2##3##(2010-3#1)(2013-1#1)
group of men##2##3##(1993-9#1)(2011-2#1)
group of neoplasms##2##3##(2011-2#2)
group of nine##2##3##(2008-5#1)(2009-11#1)
group of pathologies##2##3##(2012-3#1)(2013-1#1)
group of patient##2##3##(2012-3#2)
group of patients and##2##4##(2011-1#1)(2013-1#1)
group of patients of all ages##2##6##(1995-3#1)(2006-10#1)
group of patients treated surgically for##2##6##(2007-8#2)
group of patients treated with##3##5##(1990-3#1)(1996-9#1)(2007-11#1)
group of patients treated##6##4##(1990-3#1)(1991-9#1)(1996-9#1)(2007-11#1)(2007-8#2)
group of patients under##2##4##(1990-5#1)(1996-9#1)
group of patients were##2##4##(1990-2#1)(2012-3#1)
group of patients whose cerebellar symptoms##2##6##(2011-2#2)
group of patients whose##3##4##(2008-4#1)(2011-2#2)
group of patients with chronic##2##5##(2008-7#1)(2010-12#1)
group of patients with##17##4##(1990-10#1)(1992-12#1)(1995-6#1)(2008-1#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
group of patients##81##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#2)(2006-10#1)(2007-11#5)(2007-7#2)(2007-8#6)(2008-1#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#10)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#6)
group of people##2##3##(2008-12#1)(2012-1#1)
group of plants##3##3##(2008-11#1)(2009-8#1)(2013-7#1)
group of proteins that##3##4##(2008-10#2)(2011-2#1)
group of proteins##4##3##(1994-12#1)(2008-10#2)(2011-2#1)
group of psychotic patients##2##4##(1993-8#1)(2011-2#1)
group of rats (n = 10) received##2##7##(2007-10#2)
group of rats was used to evaluate##2##7##(1991-12#2)
group of rats##9##3##(1991-12#2)(1993-12#1)(1993-8#1)(1994-8#1)(2007-10#2)(2008-10#1)(2009-11#1)
group of related##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
group of scientists##2##3##(1993-12#1)(2008-9#1)
group of seven patients##2##4##(1993-3#1)(2007-7#1)
group of seven##4##3##(1993-3#1)(2007-7#1)(2008-11#1)(2008-5#1)
group of six##2##3##(1996-12#1)(2008-7#1)
group of stable##2##3##(2008-1#1)(2012-3#1)
group of stromal cells that##2##5##(1994-9#2)
group of students##3##3##(1996-2#1)(2008-11#2)
group of subjects with##5##4##(2008-10#1)(2008-7#3)(2011-2#1)
group of teaching hospitals##2##4##(1992-12#1)(1997-1#1)
group of techniques##2##3##(1992-6#1)(2008-6#1)
group of the##24##3##(1990-5#3)(1992-3#1)(1992-6#2)(1993-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#4)(2009-11#1)(2010-2#1)
group of these##2##3##(1992-10#1)(2008-11#1)
group of three##3##3##(1997-4#1)(2007-12#1)(2010-2#1)
group of tumors##3##3##(1991-12#1)(2010-12#1)(2011-2#1)
group of tumours##2##3##(2008-8#1)(2009-8#1)
group of users##2##3##(2008-11#1)(2012-3#1)
group of vertebrates##2##3##(2008-7#1)(2010-3#1)
group of women##3##3##(1992-3#1)(1995-11#1)(2012-3#1)
group of##694##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#7)(1990-3#3)(1990-5#8)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#7)(1992-5#6)(1992-6#6)(1992-8#3)(1993-1#2)(1993-11#5)(1993-12#4)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#6)(1995-5#9)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-9#6)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#5)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#24)(2007-12#9)(2007-2#1)(2007-7#9)(2007-8#15)(2008-1#5)(2008-10#57)(2008-11#23)(2008-12#17)(2008-3#7)(2008-4#2)(2008-5#19)(2008-6#12)(2008-7#32)(2008-8#7)(2008-9#16)(2009-10#4)(2009-11#4)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#10)(2011-10#1)(2011-2#45)(2011-3#3)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#17)(2012-3#22)(2013-1#31)(2013-7#4)(2013-8#6)
group on a##2##3##(2007-11#1)(2008-10#1)
group on corms of##2##4##(2008-10#2)
group on the##15##3##(1991-12#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-3#1)(2008-10#5)(2011-2#1)
group on##27##2##(1990-5#1)(1991-12#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#2)(1994-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-12#1)(2009-12#1)(2011-2#2)
group one##3##2##(2013-8#3)
group only##2##2##(2008-4#1)(2008-9#1)
group onto the##2##3##(1997-7#1)(2013-8#1)
group onto##3##2##(1997-7#1)(2013-8#2)
group oocytes##3##2##(2013-1#3)
group or a##2##3##(2008-10#1)(2010-11#1)
group or##12##2##(1992-12#1)(1993-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
group parameters##4##2##(1996-3#1)(2008-10#3)
group patients##6##2##(1994-3#1)(1995-12#2)(2007-9#1)(2010-12#1)(2010-8#1)
group performance##2##2##(1993-3#1)(2008-7#1)
group performed##2##2##(2007-8#1)(2008-10#1)
group practice model##3##3##(1991-1#3)
group practice setting##4##3##(1994-3#2)(1996-1#1)(1996-3#1)
group practice##24##2##(1991-1#4)(1991-3#3)(1992-1#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#3)(1995-1#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-4#1)(2013-7#1)
group practices##6##2##(1991-3#1)(1992-3#1)(1993-1#1)(1995-1#1)(1997-1#1)(1997-3#1)
group presented##2##2##(2010-4#1)(2010-9#1)
group process and##2##3##(1994-3#1)(2008-12#1)
group process##3##2##(1994-3#1)(2008-12#2)
group processes##4##2##(2008-11#2)(2009-8#2)
group proteins##3##2##(1994-9#1)(2012-3#2)
group provides##2##2##(2008-10#1)(2008-9#1)
group purchasing##3##2##(1992-1#1)(1992-2#1)(2007-9#1)
group received a##2##3##(2007-11#1)(2007-7#1)
group received an##4##3##(1994-6#1)(2007-11#1)(2007-8#1)(2008-12#1)
group received routine##2##3##(2009-12#1)(2010-12#1)
group received##21##2##(1994-6#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#1)(2009-12#2)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
group receiving single##2##3##(2008-10#2)
group receiving##10##2##(1991-1#3)(1991-2#1)(1997-3#1)(2007-12#1)(2008-10#4)
group reform##2##2##(1994-12#2)
group refractive index by##2##4##(2008-3#2)
group refractive index of##2##4##(2008-3#2)
group refractive index##7##3##(2008-2#2)(2008-3#5)
group reported that they would##4##5##(2010-4#4)
group reported##8##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#4)(2011-2#1)
group reproductive##2##2##(2008-8#2)
group scored significantly higher than##2##5##(2010-8#2)
group scores##2##2##(1992-2#1)(2008-2#1)
group seeks to##2##3##(1992-11#2)
group seems##2##2##(1990-5#1)(2012-3#1)
group selected##3##2##(1994-5#1)(2013-1#2)
group selection##5##2##(2008-8#1)(2008-9#1)(2010-4#3)
group sequential analyses##2##3##(1997-3#2)
group sequential design for a##2##5##(1995-2#2)
group sequential##8##2##(1994-9#2)(1995-2#3)(1997-3#3)
group sessions##5##2##(1994-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-12#1)
group should be##4##3##(1992-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
group should##5##2##(1991-1#1)(1992-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
group showed a significant##2##4##(1995-11#1)(2011-2#1)
group showed a##9##3##(1990-2#1)(1991-11#1)(1995-11#1)(2007-10#1)(2007-11#1)(2009-3#1)(2011-2#2)(2012-12#1)
group showed higher percentage of##2##5##(2013-8#2)
group showed lower##2##3##(1990-12#1)(2008-10#1)
group showed significant##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
group showed significantly##4##3##(1990-12#1)(1991-12#1)(2008-8#1)(2009-12#1)
group showed that##2##3##(2008-12#1)(2008-3#1)
group showed the##2##3##(2008-5#1)(2011-1#1)
group showed##35##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#2)
group size and##5##3##(1994-3#2)(2008-8#3)
group size is##5##3##(2008-8#3)(2009-8#1)(2012-3#1)
group size##28##2##(1994-3#2)(2008-8#13)(2008-9#2)(2009-8#5)(2012-2#3)(2012-3#2)(2013-1#1)
group sizes##4##2##(2008-8#2)(2012-3#2)
group studied##12##2##(2007-8#11)(2011-2#1)
group study##6##2##(1990-3#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
group submitted to##5##3##(2013-1#2)(2013-8#3)
group support##2##2##(2008-6#1)(2011-2#1)
group sustainability##2##2##(2009-5#2)
group system##8##2##(1991-3#1)(1992-12#2)(1994-12#1)(2012-2#2)(2013-1#2)
group tested positive##2##3##(2008-1#2)
group testing##3##2##(2008-10#3)
group than in the CAF+FT##2##5##(1997-7#2)
group than in the control group##6##6##(1992-4#1)(1997-4#1)(2007-10#2)(2010-2#1)(2011-1#1)
group than in the control##7##5##(1992-4#1)(1997-4#2)(2007-10#2)(2010-2#1)(2011-1#1)
group than in the normal##3##5##(1995-11#1)(1996-7#2)
group than in the##25##4##(1991-5#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-8#1)(1995-11#1)(1996-7#2)(1997-4#2)(1997-7#2)(2007-10#2)(2008-10#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-1#1)(2011-2#4)(2013-1#1)
group than in##26##3##(1991-5#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-8#1)(1995-11#1)(1996-7#2)(1997-4#2)(1997-7#2)(2007-10#2)(2008-10#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-1#2)(2011-2#4)(2013-1#1)
group than##32##2##(1990-6#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-11#1)(1996-6#1)(1996-7#2)(1997-4#2)(1997-7#2)(2007-10#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#2)(2011-2#4)(2013-1#1)
group that has##3##3##(1991-12#1)(1996-4#1)(2012-1#1)
group that received##4##3##(1990-5#1)(1993-1#1)(2008-12#1)(2008-3#1)
group that was##3##3##(2008-10#1)(2013-1#2)
group that##24##2##(1990-5#1)(1991-12#1)(1993-1#1)(1994-3#2)(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2012-1#2)(2013-1#3)
group the##15##2##(1990-11#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-3#1)
group therapy##5##2##(2008-11#3)(2008-4#1)(2013-1#1)
group there are##2##3##(2008-1#1)(2013-1#1)
group there was##2##3##(1994-8#1)(2007-11#1)
group there##6##2##(1991-12#1)(1992-2#1)(1994-8#1)(2007-11#1)(2008-1#1)(2013-1#1)
group to a##2##3##(2008-10#2)
group to produce##3##3##(1996-5#2)(2008-9#1)
group to the##4##3##(1990-5#1)(1995-2#1)(2008-10#1)(2008-4#1)
group to which##2##3##(1991-8#1)(2010-4#1)
group to##35##2##(1990-11#1)(1990-5#1)(1991-8#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-4#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-4#2)(2011-1#1)(2013-8#1)
group together##2##2##(1996-11#1)(2008-11#1)
group treated with##10##3##(1990-6#1)(1991-2#1)(1993-2#1)(1993-9#1)(1995-12#1)(2007-11#1)(2008-8#2)(2013-1#2)
group treated##12##2##(1990-6#1)(1991-2#1)(1993-2#1)(1993-9#1)(1995-12#1)(2007-11#2)(2008-8#2)(2011-2#1)(2013-1#2)
group treatment##4##2##(2008-11#1)(2009-11#3)
group two##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
group under##3##2##(1990-12#2)(2011-1#1)
group underwent an##2##3##(2008-11#2)
group underwent the procedure##2##4##(2008-8#2)
group underwent##6##2##(2008-1#1)(2008-11#2)(2008-8#2)(2012-3#1)
group using##2##2##(2008-10#2)
group velocities##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
group velocity are##2##3##(2008-3#2)
group velocity of##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
group velocity##9##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#2)
group versus the##2##3##(2008-7#1)(2012-12#1)
group versus##4##2##(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
group was (0##2##3##(2008-8#2)
group was 27##2##3##(2008-1#2)
group was 5##2##3##(2007-7#1)(2009-3#1)
group was better than##2##4##(1993-3#1)(2008-10#1)
group was characterized by##2##4##(2008-10#2)
group was determined##2##3##(2007-8#1)(2013-1#1)
group was found to be##2##5##(1993-12#1)(2013-1#1)
group was found to##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
group was found##6##3##(1993-12#1)(2008-10#3)(2008-9#1)(2013-1#1)
group was further divided into two##2##6##(2010-2#1)(2013-1#1)
group was given##2##3##(2008-12#1)(2010-12#1)
group was greater##3##3##(2008-10#2)(2008-11#1)
group was higher than##4##4##(1990-12#2)(2008-10#1)(2008-12#1)
group was injected with##3##4##(1994-5#1)(2008-12#1)(2011-2#1)
group was injected##4##3##(1994-5#1)(2008-12#1)(2008-9#1)(2011-2#1)
group was lower##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
group was more##5##3##(1990-12#1)(1997-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
group was positive##2##3##(2008-1#1)(2008-6#1)
group was prepared##2##3##(1996-5#1)(2008-5#1)
group was significantly higher than that in##2##7##(2007-10#1)(2011-1#1)
group was significantly higher than that of##2##7##(2011-2#1)(2011-3#1)
group was significantly higher than that##5##6##(1997-7#1)(2007-10#1)(2011-1#1)(2011-2#1)(2011-3#1)
group was significantly higher than##6##5##(1997-7#1)(2007-10#1)(2011-1#2)(2011-2#1)(2011-3#1)
group was significantly lower than##2##5##(1995-4#1)(2011-2#1)
group was significantly lower##3##4##(1995-4#1)(2011-2#1)(2013-1#1)
group was significantly##10##3##(1995-4#1)(1997-7#1)(2007-10#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
group was similar to##2##4##(1991-11#1)(2008-9#1)
group was treated with##5##4##(1990-2#1)(2008-12#2)(2013-1#2)
group was used to##2##4##(2008-1#1)(2012-3#1)
group was used##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
group was##133##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-9#2)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#17)(2008-11#9)(2008-12#7)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#8)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#3)
group we##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
group were compared##2##3##(2008-12#1)(2008-7#1)
group were decreased##2##3##(1992-5#1)(2008-10#1)
group were found##2##3##(2008-10#2)
group were higher than that##2##5##(2011-1#2)
group were higher than##3##4##(2011-1#2)(2013-8#1)
group were housed in##2##4##(1992-3#2)
group were identified##2##3##(2008-10#2)
group were in the##2##4##(2008-10#2)
group were injected i##2##4##(2010-1#2)
group were lower than##2##4##(2007-7#1)(2008-10#1)
group were matched for age##2##5##(1996-3#1)(2008-8#1)
group were significantly higher than those##2##6##(2011-2#1)(2012-3#1)
group were significantly higher than##3##5##(2011-2#2)(2012-3#1)
group were significantly##6##3##(2008-12#1)(2011-2#2)(2012-3#3)
group were the##2##3##(2007-8#1)(2008-11#1)
group were treated##3##3##(1991-8#1)(1994-6#1)(2013-1#1)
group were used##2##3##(1996-9#1)(2013-1#1)
group were##73##2##(1991-8#1)(1992-3#2)(1992-5#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-12#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-8#3)(2008-10#11)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#2)
group when compared with predialysis##2##5##(2008-12#2)
group when compared with the##2##5##(2010-1#1)(2010-12#1)
group when compared with##5##4##(2008-12#2)(2010-1#1)(2010-12#1)(2011-2#1)
group when##10##2##(1993-8#1)(2007-10#1)(2008-10#1)(2008-12#2)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
group where##2##2##(2010-3#1)(2012-3#1)
group which##10##2##(1991-2#2)(1991-8#1)(1994-3#1)(1995-4#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
group while##4##2##(2008-12#1)(2009-3#2)(2013-1#1)
group who did not feel that there was##2##8##(2008-5#2)
group who did not##3##4##(1995-4#1)(2008-5#2)
group who had##2##3##(1997-3#1)(2013-8#1)
group who##9##2##(1991-6#1)(1995-4#1)(1997-3#1)(2007-6#1)(2008-5#3)(2012-2#1)(2013-8#1)
group whose survival##2##3##(1993-1#1)(2008-9#1)
group whose##3##2##(1993-1#1)(2008-5#1)(2008-9#1)
group will##3##2##(1997-1#1)(1997-6#1)(2012-3#1)
group with a##8##3##(1993-8#1)(1994-6#1)(1995-2#1)(2008-2#1)(2008-3#1)(2010-11#1)(2013-1#2)
group with no HMEs##2##4##(1992-2#2)
group with the##9##3##(1990-2#1)(1991-12#1)(1992-12#1)(1995-2#2)(1996-5#1)(2010-3#1)(2012-12#2)
group with##77##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#4)(1995-5#1)(1995-8#2)(1996-5#1)(1996-9#2)(1997-5#1)(1997-8#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
group within the##2##3##(2011-2#1)(2013-7#1)
group within##4##2##(2008-10#1)(2009-7#1)(2011-2#1)(2013-7#1)
group without##10##2##(1992-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(2007-8#1)(2008-3#1)(2011-1#1)(2013-1#1)(2013-7#1)
group##4816##1##(1990-10#4)(1990-11#12)(1990-12#23)(1990-2#21)(1990-3#13)(1990-5#25)(1990-6#15)(1990-7#7)(1990-8#8)(1990-9#5)(1991-1#18)(1991-11#10)(1991-12#40)(1991-2#20)(1991-3#18)(1991-4#5)(1991-5#15)(1991-6#9)(1991-7#2)(1991-8#16)(1991-9#5)(1992-1#9)(1992-10#3)(1992-11#12)(1992-12#26)(1992-2#18)(1992-3#19)(1992-4#4)(1992-5#16)(1992-6#35)(1992-8#13)(1992-9#15)(1993-1#20)(1993-10#1)(1993-11#15)(1993-12#46)(1993-2#16)(1993-3#29)(1993-5#1)(1993-6#9)(1993-8#25)(1993-9#6)(1994-1#9)(1994-11#13)(1994-12#30)(1994-2#18)(1994-3#43)(1994-5#20)(1994-6#15)(1994-7#11)(1994-8#20)(1994-9#18)(1995-1#10)(1995-11#15)(1995-12#42)(1995-2#33)(1995-3#31)(1995-4#5)(1995-5#17)(1995-6#20)(1995-8#8)(1995-9#2)(1996-1#17)(1996-11#7)(1996-12#15)(1996-2#40)(1996-3#34)(1996-4#2)(1996-5#29)(1996-6#15)(1996-7#13)(1996-9#15)(1997-1#14)(1997-2#16)(1997-3#26)(1997-4#14)(1997-5#9)(1997-6#18)(1997-7#34)(1997-8#7)(2006-10#6)(2006-12#2)(2006-5#1)(2006-6#10)(2007-1#1)(2007-10#34)(2007-11#88)(2007-12#54)(2007-2#4)(2007-4#2)(2007-5#4)(2007-6#7)(2007-7#74)(2007-8#121)(2007-9#16)(2008-1#72)(2008-10#576)(2008-11#142)(2008-12#146)(2008-2#23)(2008-3#64)(2008-4#50)(2008-5#108)(2008-6#45)(2008-7#156)(2008-8#88)(2008-9#112)(2009-1#2)(2009-10#26)(2009-11#17)(2009-12#20)(2009-2#10)(2009-3#38)(2009-4#8)(2009-5#22)(2009-6#17)(2009-7#16)(2009-8#43)(2009-9#9)(2010-1#20)(2010-10#12)(2010-11#8)(2010-12#24)(2010-2#22)(2010-3#27)(2010-4#52)(2010-5#18)(2010-6#17)(2010-7#14)(2010-8#23)(2010-9#5)(2011-1#112)(2011-10#1)(2011-2#290)(2011-3#20)(2011-7#1)(2012-1#24)(2012-12#43)(2012-2#104)(2012-3#92)(2012-7#2)(2013-1#226)(2013-7#24)(2013-8#67)
group&quot##4##1##(2008-10#1)(2008-6#2)(2008-8#1)
group's average##2##2##(2008-5#1)(2010-6#1)
group's performance##3##2##(1991-3#1)(1994-3#2)
group's##20##1##(1991-1#1)(1991-3#1)(1993-1#2)(1993-3#2)(1994-1#1)(1994-3#2)(1995-3#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-12#2)
group) and the##2##3##(1991-5#1)(2007-2#1)
group) and##9##2##(1991-5#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
group) or##6##2##(1993-6#1)(2008-12#1)(2011-2#2)(2013-7#2)
group) showed a##2##3##(1991-8#1)(2012-3#1)
group) was##3##2##(2007-8#1)(2008-10#1)(2013-7#1)
group) were##2##2##(2007-10#1)(2013-1#1)
group)##77##1##(1991-5#1)(1991-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#2)(1996-9#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#4)(2008-10#4)(2008-11#2)(2008-12#6)(2008-3#1)(2008-5#6)(2008-7#1)(2009-1#1)(2009-8#1)(2010-6#3)(2011-1#3)(2011-2#10)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#4)
group-based##4##1##(2008-12#2)(2009-8#1)(2013-1#1)
group-delay dispersion##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
group-delay ripple##3##2##(2008-3#3)
group-delay ripples##4##2##(2007-11#4)
group-delay##14##1##(2007-11#6)(2007-12#1)(2008-3#7)
group-size distributions##2##2##(2012-3#2)
group-size##3##1##(2012-3#3)
group-specific##5##1##(1992-6#1)(1995-2#1)(2008-10#2)(2010-4#1)
group-velocity dispersion and##2##3##(2007-12#2)
group-velocity dispersion in##3##3##(2007-12#2)(2008-3#1)
group-velocity dispersion is##2##3##(2007-11#1)(2007-12#1)
group-velocity dispersion##14##2##(2007-11#6)(2007-12#6)(2008-3#2)
group-velocity mismatch##3##2##(2007-11#2)(2007-12#1)
group-velocity walk-off##2##2##(2007-11#2)
group-velocity##23##1##(2007-11#12)(2007-12#8)(2008-2#1)(2008-3#2)
group?##2##1##(1992-1#1)(2008-11#1)
group]##2##1##(1994-3#1)(2013-8#1)
grouped according to##5##3##(1997-8#1)(2008-1#1)(2008-10#2)(2011-2#1)
grouped all##2##2##(2008-10#2)
grouped as##5##2##(1994-6#1)(2008-10#2)(2012-2#1)(2013-1#1)
grouped by##11##2##(1990-2#1)(1994-3#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
grouped data##2##2##(1993-1#1)(2008-12#1)
grouped in two##5##3##(1992-11#1)(1993-11#1)(1996-3#1)(2008-10#2)
grouped in##14##2##(1992-11#1)(1993-11#1)(1996-3#1)(2008-10#7)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
grouped into a##2##3##(2008-10#2)
grouped into five##2##3##(1995-3#1)(2008-10#1)
grouped into six##3##3##(2008-10#2)(2012-12#1)
grouped into the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
grouped into three##6##3##(1991-2#1)(1991-5#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-1#1)
grouped into two##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
grouped into##35##2##(1991-2#1)(1991-5#1)(1995-3#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
grouped on the##2##3##(2008-10#2)
grouped the##7##2##(2008-10#5)(2009-10#1)(2009-5#1)
grouped together and##2##3##(2008-10#2)
grouped together##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
grouped under the##4##3##(1996-3#1)(2008-1#1)(2009-10#1)(2011-2#1)
grouped with other##2##3##(2008-10#2)
grouped with##3##2##(2008-10#3)
grouped##124##1##(1990-2#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-6#2)(1995-3#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#57)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#2)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)
grouper##16##1##(2009-5#1)(2010-5#15)
groupers##5##1##(2007-5#1)(2010-5#4)
grouping and##7##2##(1992-12#1)(1992-6#1)(1994-6#1)(1995-3#1)(2008-12#1)(2008-4#1)(2009-10#1)
grouping at##2##2##(2008-11#1)(2011-2#1)
grouping based on##2##3##(2008-10#2)
grouping by##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)
grouping in##2##2##(2008-9#1)(2009-9#1)
grouping of isolates##2##3##(2008-10#2)
grouping of patients' samples##2##4##(1994-6#2)
grouping of the##5##3##(1994-11#1)(2008-10#2)(2010-8#1)(2013-8#1)
grouping of##20##2##(1994-11#1)(1994-6#2)(1997-3#1)(2008-10#7)(2008-5#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
grouping the##2##2##(2008-7#1)(2013-1#1)
grouping time##3##2##(1997-3#3)
grouping was##4##2##(2008-10#2)(2008-5#2)
grouping##88##1##(1991-12#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#4)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#5)(1997-4#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#6)(2008-7#2)(2008-9#4)(2009-10#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
groupings based##2##2##(2008-10#2)
groupings that##2##2##(1993-3#1)(2008-10#1)
groupings##14##1##(1993-3#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#6)(2009-4#1)
groups (P &gt##2##3##(1994-2#1)(2011-3#1)
groups (P &lt##5##3##(1996-12#1)(2007-10#1)(2011-3#2)(2012-3#1)
groups (P##7##2##(1994-2#1)(1996-12#1)(2007-10#1)(2011-3#3)(2012-3#1)
groups (e##2##2##(2008-10#1)(2008-8#1)
groups (group##2##2##(2008-7#2)
groups (n =##4##3##(1995-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
groups (n=10)##4##2##(2008-12#2)(2013-1#2)
groups (one##2##2##(2009-3#1)(2013-1#1)
groups (p &lt##6##3##(2008-10#1)(2008-6#1)(2011-1#2)(2013-1#1)(2013-8#1)
groups (p = 0##5##4##(2010-8#1)(2011-2#4)
groups (p##13##2##(1991-2#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2013-1#1)(2013-8#1)
groups (with##2##2##(2009-7#1)(2010-8#1)
groups 1##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-4#1)
groups 2##2##2##(2008-10#1)(2010-4#1)
groups 2-6##2##2##(2010-4#2)
groups 3 and 4##2##4##(2008-11#1)(2011-1#1)
groups 3##3##2##(2008-11#1)(2009-6#1)(2011-1#1)
groups 4##2##2##(1990-2#1)(2010-5#1)
groups A and B##4##4##(2007-8#3)(2008-1#1)
groups A##9##2##(2007-8#3)(2008-1#1)(2008-10#2)(2010-12#2)(2010-7#1)
groups B and##2##3##(2011-2#1)(2013-1#1)
groups I and II##6##4##(2007-8#1)(2008-10#4)(2013-1#1)
groups I##9##2##(1995-12#1)(2007-8#1)(2008-10#5)(2011-2#1)(2013-1#1)
groups II and III##2##4##(2007-11#1)(2009-3#1)
groups II##3##2##(2007-11#1)(2009-3#1)(2010-1#1)
groups M and##2##3##(2007-8#1)(2013-1#1)
groups about##2##2##(2007-11#1)(2008-11#1)
groups according to the##14##4##(1992-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-6#1)(2008-10#4)(2008-12#1)(2011-1#1)(2011-2#2)
groups according to their##3##4##(2008-12#1)(2008-3#1)(2011-2#1)
groups according to##22##3##(1992-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-6#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#5)(2012-12#1)
groups according##23##2##(1992-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-6#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)
groups administered##2##2##(2008-9#2)
groups after##4##2##(2008-4#1)(2009-11#1)(2009-12#1)(2011-2#1)
groups along##2##2##(1993-3#1)(2013-7#1)
groups also##5##2##(1990-8#1)(1995-2#1)(2007-8#1)(2008-9#1)(2009-8#1)
groups and a##6##3##(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
groups and ammonium##2##3##(2008-10#2)
groups and among##2##3##(2008-12#1)(2013-1#1)
groups and by##2##3##(2008-10#1)(2009-7#1)
groups and different##2##3##(1990-12#1)(2008-10#1)
groups and in##3##3##(1994-2#1)(2008-1#1)(2008-5#1)
groups and individuals##2##3##(1991-2#1)(1997-8#1)
groups and one##2##3##(2010-10#1)(2013-8#1)
groups and subgroups##2##3##(1993-2#1)(2008-10#1)
groups and that##2##3##(2008-5#1)(2008-8#1)
groups and the##13##3##(1991-1#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-7#1)(2012-3#1)
groups and their##4##3##(1994-9#1)(1997-4#1)(2007-4#2)
groups and there was##2##4##(2008-6#1)(2009-3#1)
groups and to##3##3##(1995-6#1)(2008-10#1)(2010-5#1)
groups and treated##2##3##(1992-2#1)(2011-1#1)
groups and##149##2##(1990-12#1)(1991-1#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#3)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#6)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#4)
groups are currently##2##3##(2006-6#1)(2008-7#1)
groups are discussed##2##3##(1993-1#1)(2008-5#1)
groups are located##2##3##(1992-6#1)(1996-2#1)
groups are not##2##3##(1991-5#1)(1994-3#1)
groups are often##2##3##(1995-1#1)(2008-8#1)
groups are present##2##3##(2008-1#1)(2009-10#1)
groups are the##2##3##(1992-6#1)(2008-4#1)
groups are##45##2##(1991-11#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2012-2#1)
groups as a##3##3##(1992-4#1)(2008-10#1)(2008-5#1)
groups as compared##3##3##(2008-10#1)(2013-8#2)
groups as well as##3##4##(2008-10#1)(2009-11#1)(2013-1#1)
groups as##20##2##(1990-9#1)(1992-4#1)(1993-12#1)(1994-9#1)(1995-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#2)
groups associated with##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
groups associated##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
groups at both##2##3##(1991-12#1)(1991-9#1)
groups at risk##2##3##(1991-12#1)(2008-4#1)
groups at the##12##3##(1992-6#1)(1992-8#1)(1994-12#1)(1996-5#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
groups at##29##2##(1991-12#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1994-12#1)(1996-5#2)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#2)(2013-1#3)
groups based on the##2##4##(2008-10#2)
groups based on their##6##4##(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
groups based on##20##3##(1997-6#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#3)
groups based##22##2##(1991-3#2)(1997-6#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#3)
groups because##2##2##(2008-10#1)(2010-12#1)
groups being##2##2##(2007-7#1)(2008-11#1)
groups but the##2##3##(2008-5#1)(2008-7#1)
groups but##7##2##(1993-2#1)(2007-6#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)
groups by a##2##3##(1995-12#1)(2013-7#1)
groups by##14##2##(1990-12#1)(1992-12#1)(1994-12#1)(1995-12#1)(2008-10#6)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
groups can be##3##3##(1995-12#1)(2008-10#2)
groups can##8##2##(1990-9#1)(1991-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#1)
groups combined##4##2##(1992-12#1)(1994-2#1)(2008-12#1)(2009-2#1)
groups compared to##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
groups compared with##4##3##(1990-7#1)(1995-5#1)(2008-11#1)(2008-7#1)
groups compared##8##2##(1990-7#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
groups consider##2##2##(1991-12#2)
groups containing##2##2##(2008-10#1)(2008-12#1)
groups contributed##2##2##(2008-1#1)(2013-1#1)
groups correspond to##2##3##(2008-10#2)
groups corresponding to the##2##4##(2008-10#2)
groups corresponding to##3##3##(2008-10#2)(2008-9#1)
groups could be##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
groups demonstrate##2##2##(2008-11#1)(2013-1#1)
groups demonstrated##7##2##(1993-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
groups depending on the presence of##2##6##(1991-9#1)(2011-2#1)
groups depending on the##5##4##(1991-9#1)(2007-8#1)(2008-7#1)(2010-1#1)(2011-2#1)
groups depending on##6##3##(1991-9#1)(2007-8#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
groups depending##7##2##(1991-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
groups designated##2##2##(1996-3#1)(2008-10#1)
groups despite##2##2##(1993-12#1)(2008-11#1)
groups did not differ in##2##5##(2007-12#1)(2009-9#1)
groups did not differ on##2##5##(1995-11#1)(2010-4#1)
groups did not differ significantly##3##5##(2010-7#1)(2011-1#1)(2013-1#1)
groups did not differ with respect to##2##7##(2007-8#1)(2008-7#1)
groups did not differ##11##4##(1991-3#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
groups did not show##2##4##(2008-12#1)(2008-5#1)
groups did not##16##3##(1991-2#1)(1991-3#1)(1995-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
groups differed in their##2##4##(2008-10#1)(2010-5#1)
groups different##2##2##(2008-10#1)(2008-4#1)
groups displayed##2##2##(2008-10#1)(2009-10#1)
groups do##3##2##(1993-1#1)(1996-12#1)(2009-5#1)
groups during the##4##3##(1997-4#2)(2007-7#1)(2009-3#1)
groups during##7##2##(1996-5#1)(1997-4#2)(2007-7#1)(2008-9#2)(2009-3#1)
groups each##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
groups except##6##2##(2008-5#1)(2008-7#1)(2008-9#3)(2009-7#1)
groups exhibited##2##2##(2008-10#1)(2013-1#1)
groups experienced##2##2##(1992-2#1)(2008-7#1)
groups fed##2##2##(2008-12#1)(2013-1#1)
groups for children with##2##4##(1992-12#1)(2010-5#1)
groups for patients##2##3##(1990-11#1)(1992-12#1)
groups for the##6##3##(1990-12#1)(1993-11#1)(1996-6#1)(1997-8#1)(2008-2#1)(2013-1#1)
groups for##39##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-3#2)(1993-11#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-6#2)(1997-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
groups formed##2##2##(2011-1#1)(2012-3#1)
groups found in##2##3##(2008-10#1)(2008-9#1)
groups found##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
groups from a##2##3##(1997-2#1)(2008-1#1)
groups from the##7##3##(1992-6#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)
groups from##18##2##(1992-6#1)(1993-1#1)(1994-3#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#3)(2011-1#1)(2012-12#1)(2013-8#1)
groups generally##4##2##(2008-1#1)(2008-9#1)(2009-4#1)(2010-10#1)
groups had a##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
groups had significantly higher##2##4##(2008-7#1)(2010-4#1)
groups had significantly##4##3##(1996-5#1)(1996-7#1)(2008-7#1)(2010-4#1)
groups had##15##2##(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
groups has been##2##3##(2008-10#1)(2009-10#1)
groups have a##3##3##(1994-3#2)(2008-1#1)
groups have been##3##3##(1991-11#1)(1997-2#1)(2008-11#1)
groups have demonstrated that##2##4##(1992-1#1)(2006-6#1)
groups have##24##2##(1991-11#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#3)(1995-1#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-7#1)
groups i##2##2##(1990-6#1)(2007-7#1)
groups identified##3##2##(1991-3#1)(2008-10#1)(2008-7#1)
groups in BSA##2##3##(1991-5#1)(1993-11#1)
groups in a##8##3##(1992-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2013-7#1)
groups in both##6##3##(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#3)
groups in comparison with##3##4##(2008-10#1)(2008-12#1)(2012-1#1)
groups in comparison##4##3##(2008-10#2)(2008-12#1)(2012-1#1)
groups in order to##2##4##(2008-10#1)(2008-12#1)
groups in the molecule##2##4##(2008-11#1)(2008-5#1)
groups in the##41##3##(1990-2#1)(1990-5#1)(1991-5#1)(1992-6#3)(1994-12#2)(1994-3#1)(1994-9#1)(1995-4#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
groups in their##2##3##(1993-12#1)(2012-12#1)
groups in these##2##3##(2008-10#2)
groups in which##3##3##(1997-3#1)(2007-10#1)(2008-8#1)
groups in##144##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#3)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#3)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#32)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#5)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
groups including the##2##3##(1997-8#1)(2010-8#1)
groups including##7##2##(1997-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
groups increased##2##2##(2008-12#1)(2010-11#1)
groups indicate that##2##3##(1993-12#1)(2008-10#1)
groups involved and##2##3##(1994-3#1)(2013-1#1)
groups involved##5##2##(1990-8#1)(1994-3#1)(2009-5#1)(2010-7#1)(2013-1#1)
groups is##10##2##(1992-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-3#1)(2013-1#1)(2013-8#1)
groups may##6##2##(1991-12#1)(1993-1#1)(1993-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
groups more##3##2##(1991-12#1)(2008-1#1)(2010-8#1)
groups named##2##2##(1993-8#1)(2008-10#1)
groups necessary##2##2##(2008-11#1)(2008-7#1)
groups not##3##2##(2008-5#1)(2009-12#1)(2013-7#1)
groups occurred##2##2##(2008-12#1)(2012-2#1)
groups of 10 male and 10 female Tg##3##8##(2008-9#3)
groups of 10 male and 10 female##5##7##(2008-9#5)
groups of 10 specimens##2##4##(2008-12#1)(2009-4#1)
groups of 10##11##3##(1991-3#1)(2008-12#1)(2008-9#8)(2009-4#1)
groups of 20##2##3##(2008-10#1)(2008-5#1)
groups of 21##2##3##(2007-9#1)(2008-5#1)
groups of C##2##3##(2008-10#2)
groups of F##4##3##(2008-10#1)(2008-12#3)
groups of P##3##3##(1993-11#1)(2008-10#2)
groups of age-matched##2##3##(1997-6#1)(2008-5#1)
groups of animals were##5##4##(1991-12#1)(1991-2#2)(2006-6#1)(2008-11#1)
groups of animals##8##3##(1991-12#1)(1991-2#2)(1992-11#1)(2006-6#1)(2008-11#1)(2008-5#1)(2009-12#1)
groups of birds##2##3##(2008-5#1)(2009-2#1)
groups of cells##3##3##(1993-8#1)(2007-12#1)(2008-7#1)
groups of cochlear implant##2##4##(2008-9#2)
groups of compounds##2##3##(2008-10#1)(2009-4#1)
groups of doctors##2##3##(1993-2#1)(1995-5#1)
groups of families##2##3##(1992-1#1)(1995-1#1)
groups of female##3##3##(1995-12#1)(2007-12#1)(2008-5#1)
groups of females##4##3##(2008-11#1)(2008-9#3)
groups of five##2##3##(2008-5#1)(2008-6#1)
groups of four##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2012-1#1)
groups of genes##5##3##(2008-2#1)(2008-7#1)(2010-4#1)(2013-1#2)
groups of highly##2##3##(1997-7#1)(2008-3#1)
groups of individuals in##2##4##(1991-2#1)(2011-2#1)
groups of individuals##5##3##(1991-2#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
groups of isolates##7##3##(2008-10#6)(2011-2#1)
groups of male##2##3##(2010-1#1)(2010-5#1)
groups of males and##3##4##(2008-9#3)
groups of males at##2##4##(2008-9#2)
groups of males##8##3##(2008-11#1)(2008-9#7)
groups of men##2##3##(1997-4#1)(2010-8#1)
groups of mice##10##3##(1990-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#4)
groups of mothers and##2##4##(2009-11#2)
groups of organisms##5##3##(1997-4#1)(2008-10#2)(2008-6#1)(2008-9#1)
groups of participants##2##3##(2008-11#1)(2012-12#1)
groups of patients and##2##4##(1996-7#1)(2011-2#1)
groups of patients in##2##4##(2008-11#1)(2013-1#1)
groups of patients to##2##4##(2010-12#1)(2013-1#1)
groups of patients treated##2##4##(2007-11#1)(2013-1#1)
groups of patients were studied##2##5##(1991-3#1)(1992-2#1)
groups of patients were##4##4##(1991-3#1)(1992-2#1)(1995-6#1)(2007-8#1)
groups of patients with##5##4##(1991-2#1)(1993-9#1)(2007-11#2)(2012-2#1)
groups of patients##38##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(2007-11#4)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
groups of people##2##3##(1994-2#1)(2008-1#1)
groups of proteins##6##3##(1990-11#1)(1990-12#1)(1993-6#1)(2008-10#1)(2008-7#2)
groups of rats were##3##4##(1990-5#1)(1991-12#1)(2011-1#1)
groups of rats##18##3##(1990-5#1)(1991-12#1)(1994-11#1)(1994-7#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#2)
groups of species##2##3##(2008-8#1)(2008-9#1)
groups of strains##3##3##(2008-10#3)
groups of students##4##3##(1997-2#1)(2008-11#2)(2008-12#1)
groups of subjects##5##3##(1994-11#1)(1995-12#1)(2008-7#1)(2009-9#1)(2012-2#1)
groups of ten##2##3##(1996-12#1)(2008-7#1)
groups of the##26##3##(1992-6#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-8#2)(2008-9#1)(2009-7#1)(2013-1#1)
groups of these##4##3##(1993-12#1)(2008-10#1)(2008-12#1)(2009-8#1)
groups of vinca site agents##3##5##(1995-5#3)
groups of women##3##3##(1992-2#1)(1996-11#1)(2013-1#1)
groups of##453##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#5)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#5)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#11)(1996-2#3)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#74)(2008-11#18)(2008-12#9)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#19)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#36)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#3)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#4)
groups on a 7-deoxycholic amide##2##5##(2008-10#2)
groups on a##5##3##(1992-11#1)(2008-10#3)(2008-12#1)
groups on the basis of##2##5##(2008-10#1)(2008-3#1)
groups on the biomass##2##4##(2008-10#2)
groups on the##17##3##(1994-5#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#1)(2011-2#1)
groups on##35##2##(1992-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#2)(1996-7#1)(2007-11#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
groups or##10##2##(1990-12#1)(1990-3#1)(1991-9#1)(1995-1#1)(1996-1#1)(2008-1#2)(2008-10#2)(2012-2#1)
groups over the##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
groups over##6##2##(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-1#1)
groups per molecule##2##3##(1991-5#1)(1995-5#1)
groups per##5##2##(1990-8#1)(1991-5#1)(1995-5#1)(2006-12#1)(2008-10#1)
groups performed##3##2##(1995-3#1)(2007-7#1)(2008-5#1)
groups present in##2##3##(2008-10#1)(2008-5#1)
groups present##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
groups provided##3##2##(1996-3#1)(2008-12#1)(2010-10#1)
groups received##7##2##(1993-5#1)(1993-6#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
groups receiving##3##2##(1993-6#1)(1996-12#1)(2008-5#1)
groups reported##5##2##(1996-6#1)(2008-10#1)(2008-8#2)(2012-12#1)
groups revealed##2##2##(2008-11#1)(2009-11#1)
groups seemed to##2##3##(2008-10#1)(2008-11#1)
groups should##3##2##(1991-3#1)(2008-10#1)(2009-9#1)
groups showed a##5##3##(1990-12#1)(1994-3#1)(1994-8#1)(2008-9#1)(2010-5#1)
groups showed no##2##3##(2008-7#1)(2009-7#1)
groups showed similar##2##3##(1997-1#1)(2009-6#1)
groups showed##15##2##(1990-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)
groups such as the##2##4##(2012-2#1)(2013-1#1)
groups such as##8##3##(1992-1#1)(1996-5#2)(1997-5#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
groups suggesting##2##2##(2008-5#1)(2013-8#1)
groups tested##2##2##(2008-2#1)(2008-7#1)
groups than in the##3##4##(1990-3#1)(2008-7#1)(2011-2#1)
groups than##6##2##(1990-3#1)(1996-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
groups that are##3##3##(1991-9#1)(2008-10#2)
groups that corresponded to##2##4##(2008-10#2)
groups that corresponded##3##3##(2008-10#3)
groups that differed significantly##2##4##(2008-10#2)
groups that differed##4##3##(2008-10#3)(2008-5#1)
groups that elicit##2##3##(2008-11#2)
groups that have##5##3##(1993-12#1)(1996-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
groups that received##3##3##(1993-12#1)(2011-2#1)(2013-1#1)
groups that were##3##3##(2008-10#2)(2011-1#1)
groups that##48##2##(1990-3#1)(1991-2#1)(1991-9#1)(1993-12#3)(1993-3#1)(1994-1#6)(1994-12#1)(1995-11#1)(1996-2#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-5#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
groups the levels were##3##4##(1993-3#1)(2007-7#2)
groups the##7##2##(1991-11#1)(1991-12#1)(1993-3#1)(2007-7#2)(2011-2#2)
groups throughout the study##5##4##(2007-8#1)(2008-8#2)(2008-9#2)
groups throughout the##6##3##(1995-1#1)(2007-8#1)(2008-8#2)(2008-9#2)
groups throughout##10##2##(1993-12#1)(1995-1#1)(2007-8#1)(2008-8#2)(2008-9#5)
groups to form##3##3##(2008-10#2)(2011-2#1)
groups to receive##2##3##(2010-7#1)(2013-7#1)
groups to the##5##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
groups to##37##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#3)(1994-12#2)(1994-2#1)(1994-6#1)(1995-3#1)(1996-5#1)(1997-3#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
groups under the##2##3##(2008-11#1)(2010-10#1)
groups under##3##2##(2008-11#1)(2010-10#1)(2011-2#1)
groups underwent##2##2##(2007-11#1)(2009-6#1)
groups using a##2##3##(1996-2#1)(2008-7#1)
groups using the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
groups using##10##2##(1991-3#1)(1996-2#1)(2008-10#3)(2008-7#2)(2008-8#1)(2012-2#2)
groups utilizing##2##2##(1990-8#1)(1996-5#1)
groups varied##3##2##(1996-12#1)(2008-1#1)(2008-5#1)
groups versus##3##2##(1993-12#1)(2007-6#1)(2011-2#1)
groups was 2##2##3##(1990-3#1)(2008-5#1)
groups was carried out in##2##5##(2008-3#1)(2013-1#1)
groups was conducted##2##3##(2008-10#1)(2008-12#1)
groups was estimated##2##3##(1994-2#1)(2008-10#1)
groups was followed by##2##4##(2008-10#1)(2010-2#1)
groups was found##3##3##(1990-3#1)(1991-9#1)(1996-5#1)
groups was not##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
groups was observed##2##3##(2008-7#1)(2013-8#1)
groups was obtained by##2##4##(2008-10#1)(2011-2#1)
groups was significantly lower than that in the##2##8##(1995-8#1)(2012-2#1)
groups was significantly##6##3##(1994-12#1)(1995-8#1)(1997-4#1)(2011-1#1)(2012-2#2)
groups was similar to that of##5##6##(2008-8#1)(2008-9#4)
groups was similar to that##9##5##(2008-8#3)(2008-9#6)
groups was similar##11##3##(1996-12#1)(2008-8#3)(2008-9#6)(2009-12#1)
groups was statistically significant##2##4##(2007-8#1)(2008-12#1)
groups was studied##2##3##(1993-5#1)(2008-10#1)
groups was##69##2##(1990-3#2)(1991-11#1)(1991-3#1)(1991-9#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
groups were all##2##3##(2008-10#2)
groups were almost##2##3##(1991-8#1)(2012-3#1)
groups were also##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
groups were calculated##2##3##(2008-3#1)(2013-8#1)
groups were combined##2##3##(1992-11#1)(2012-3#1)
groups were comparable in##2##4##(1997-7#1)(2009-11#1)
groups were comparable##7##3##(1992-3#1)(1992-5#1)(1997-7#1)(2007-7#1)(2008-6#1)(2009-11#1)(2011-2#1)
groups were compared##6##3##(2008-11#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)
groups were conducted in##2##4##(2008-4#1)(2011-2#1)
groups were conducted##3##3##(1996-1#1)(2008-4#1)(2011-2#1)
groups were detected##2##3##(2008-10#1)(2008-5#1)
groups were divided##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
groups were formed##5##3##(2008-11#1)(2008-5#1)(2010-4#1)(2012-5#1)(2013-1#1)
groups were found in##4##4##(1990-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
groups were found to be##7##5##(1991-9#1)(1993-12#2)(2008-10#1)(2009-12#1)(2013-1#2)
groups were found to##9##4##(1991-9#1)(1993-12#2)(1994-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#2)
groups were found##13##3##(1990-2#1)(1991-9#1)(1993-12#2)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)(2013-1#2)
groups were higher than##2##4##(2008-10#1)(2008-4#1)
groups were less##3##3##(1992-8#1)(2008-8#1)(2009-11#1)
groups were matched for##2##4##(1991-12#1)(2008-3#1)
groups were not significant##2##4##(2008-10#1)(2008-12#1)
groups were not significantly different##2##5##(2008-5#1)(2012-3#1)
groups were not##6##3##(1992-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
groups were observed##5##3##(1992-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
groups were significantly less##2##4##(1991-1#1)(2008-9#1)
groups were significantly##5##3##(1991-1#1)(1993-3#1)(2007-8#1)(2008-12#1)(2008-9#1)
groups were similar with respect to##2##6##(1991-2#1)(2007-8#1)
groups were similar##10##3##(1990-5#1)(1991-2#1)(2007-8#1)(2008-11#1)(2008-9#5)(2011-2#1)
groups were studied##5##3##(1994-6#1)(1994-7#1)(2007-8#1)(2008-10#1)(2012-3#1)
groups were synthesized##2##3##(2007-11#1)(2008-10#1)
groups were tested##2##3##(1993-12#1)(2008-10#1)
groups were then##2##3##(1991-1#1)(2007-8#1)
groups were used to explore##2##5##(1997-3#1)(2009-5#1)
groups were used to##3##4##(1997-3#1)(2008-11#1)(2009-5#1)
groups were used##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
groups were##180##2##(1990-2#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#3)(1993-5#2)(1994-3#2)(1994-6#1)(1994-7#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#4)(1997-3#2)(1997-7#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#9)(2008-12#10)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-8#4)(2008-9#8)(2009-11#2)(2009-12#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#8)(2012-5#1)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#4)
groups when##2##2##(2008-10#1)(2010-7#1)
groups where##3##2##(1991-6#1)(1997-3#1)(2008-10#1)
groups which##6##2##(1991-5#1)(1995-1#1)(1997-7#1)(2008-1#1)(2008-5#1)(2011-2#1)
groups who##4##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-7#1)
groups whose##2##2##(1996-2#1)(2008-10#1)
groups will be##2##3##(2007-8#1)(2008-10#1)
groups will##5##2##(1991-3#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
groups with a##4##3##(1994-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
groups with and without##3##4##(2008-7#1)(2009-10#1)(2013-8#1)
groups with different##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
groups with high##2##3##(2008-10#1)(2008-5#1)
groups with higher##2##3##(2008-6#1)(2008-8#1)
groups with respect to##2##4##(2009-12#1)(2013-1#1)
groups with the exception of##2##5##(2008-5#1)(2013-1#1)
groups with the##3##3##(1992-12#1)(2008-5#1)(2013-1#1)
groups with##55##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-3#1)(1994-7#1)(1994-9#1)(1995-4#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#2)(2013-8#1)
groups within the##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
groups within##7##2##(2008-10#3)(2008-8#1)(2010-10#1)(2010-8#2)
groups without##4##2##(1993-12#1)(1997-4#1)(2008-10#1)(2013-1#1)
groups##3280##1##(1990-11#6)(1990-12#12)(1990-2#7)(1990-3#11)(1990-5#8)(1990-6#11)(1990-7#4)(1990-8#8)(1990-9#6)(1991-1#9)(1991-11#14)(1991-12#31)(1991-2#17)(1991-3#20)(1991-5#11)(1991-6#7)(1991-7#1)(1991-8#6)(1991-9#13)(1992-1#10)(1992-10#1)(1992-11#11)(1992-12#15)(1992-2#19)(1992-3#17)(1992-4#1)(1992-5#6)(1992-6#23)(1992-8#7)(1992-9#12)(1993-1#12)(1993-10#1)(1993-11#10)(1993-12#34)(1993-2#9)(1993-3#13)(1993-5#6)(1993-6#11)(1993-8#10)(1993-9#6)(1994-1#13)(1994-11#8)(1994-12#19)(1994-2#17)(1994-3#25)(1994-5#7)(1994-6#10)(1994-7#6)(1994-8#9)(1994-9#16)(1995-1#16)(1995-11#10)(1995-12#27)(1995-2#10)(1995-3#16)(1995-4#4)(1995-5#13)(1995-6#9)(1995-8#6)(1996-1#12)(1996-11#5)(1996-12#27)(1996-2#17)(1996-3#16)(1996-5#30)(1996-6#10)(1996-7#10)(1996-8#1)(1996-9#7)(1997-1#8)(1997-2#14)(1997-3#20)(1997-4#16)(1997-5#4)(1997-6#13)(1997-7#17)(1997-8#9)(1997-9#1)(2006-10#1)(2006-12#1)(2006-6#4)(2007-10#16)(2007-11#26)(2007-12#25)(2007-2#5)(2007-4#4)(2007-6#9)(2007-7#21)(2007-8#54)(2007-9#5)(2008-1#38)(2008-10#534)(2008-11#96)(2008-12#108)(2008-2#16)(2008-3#22)(2008-4#39)(2008-5#111)(2008-6#32)(2008-7#107)(2008-8#58)(2008-9#130)(2009-1#4)(2009-10#21)(2009-11#20)(2009-12#19)(2009-2#4)(2009-3#14)(2009-4#4)(2009-5#13)(2009-6#6)(2009-7#19)(2009-8#16)(2009-9#8)(2010-1#9)(2010-10#13)(2010-11#7)(2010-12#15)(2010-2#10)(2010-3#12)(2010-4#36)(2010-5#12)(2010-6#6)(2010-7#13)(2010-8#24)(2010-9#1)(2011-1#56)(2011-2#156)(2011-3#9)(2011-7#1)(2012-1#13)(2012-12#34)(2012-2#65)(2012-3#46)(2012-4#1)(2012-5#4)(2012-7#1)(2013-1#136)(2013-7#24)(2013-8#52)
groups'##7##1##(1994-1#1)(1996-1#1)(2007-2#1)(2008-2#1)(2010-10#1)(2010-12#1)(2011-2#1)
groups) were##4##2##(2008-10#1)(2008-12#1)(2009-11#1)(2012-3#1)
groups)##22##1##(1990-5#1)(1994-7#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2009-1#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
groups]##5##1##(1990-11#1)(1990-2#1)(1996-9#1)(2010-12#1)(2013-1#1)
groupwise##3##1##(2011-2#3)
grove plots##2##2##(2011-2#2)
grove##8##1##(2008-10#5)(2011-2#2)(2013-8#1)
groves are##2##2##(2011-2#2)
groves in##2##2##(2008-10#2)
groves##16##1##(2008-10#6)(2011-2#9)(2013-8#1)
grow and the##2##3##(1993-2#1)(2011-1#1)
grow and##16##2##(1992-5#1)(1993-1#1)(1993-2#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
grow as##5##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
grow at a##3##3##(1992-12#1)(2008-11#1)(2012-2#1)
grow at temperatures##2##3##(2008-10#2)
grow at##9##2##(1991-12#1)(1992-12#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-2#1)
grow either##2##2##(2008-11#1)(2009-6#1)
grow faster than the##2##4##(1996-2#1)(1997-1#1)
grow faster than##3##3##(1996-2#1)(1997-1#1)(2010-8#1)
grow faster##5##2##(1996-2#1)(1997-1#1)(2008-3#1)(2008-8#1)(2010-8#1)
grow in a##2##3##(1993-6#1)(2008-10#1)
grow in suspension##2##3##(2008-1#1)(2008-11#1)
grow in the##7##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)(2013-7#1)
grow in##29##2##(1991-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(2008-1#2)(2008-10#3)(2008-11#10)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2013-7#1)
grow larger##2##2##(2008-8#1)(2008-9#1)
grow more##2##2##(1993-6#1)(2013-1#1)
grow normally##2##2##(1994-12#1)(2008-9#1)
grow on the##5##3##(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#1)
grow on##21##2##(1990-5#1)(1991-7#1)(1997-3#2)(2007-11#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
grow rapidly##2##2##(2009-8#2)
grow through a##2##3##(1996-5#1)(2008-10#1)
grow through##3##2##(1996-5#1)(2008-10#2)
grow to##5##2##(2008-11#2)(2012-2#1)(2013-1#2)
grow under##3##2##(2008-10#1)(2008-11#2)
grow well at 37 degrees C##2##6##(1991-2#1)(2008-11#1)
grow well at##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
grow well##6##2##(1991-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2013-7#1)
grow with##3##2##(1995-9#1)(2008-6#1)(2009-8#1)
grow##172##1##(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-3#2)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#23)(2008-11#27)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#6)(2013-7#3)
grow-out tests##2##2##(2008-10#2)
grower effect##2##2##(2008-10#2)
grower##6##1##(2008-10#4)(2008-12#1)(2011-2#1)
growers in##3##2##(2008-10#3)
growers##14##1##(2008-10#13)(2011-2#1)
growing Saccharomyces cerevisiae##2##3##(1995-9#1)(2012-3#1)
growing amount of##2##3##(2008-1#1)(2010-12#1)
growing and finishing##4##3##(2010-2#4)
growing and##9##2##(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#1)(2010-2#4)(2013-7#1)
growing area of##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
growing area##5##2##(2006-10#1)(2008-10#2)(2008-12#1)(2011-1#1)
growing areas##3##2##(2008-10#3)
growing as##2##2##(2008-11#1)(2008-5#1)
growing at a##2##3##(1991-3#1)(1995-11#1)
growing at##3##2##(1991-3#1)(1995-11#1)(2008-8#1)
growing awareness of the##3##4##(1991-6#1)(2010-1#1)(2011-2#1)
growing body of data suggests that##2##6##(2008-11#1)(2008-8#1)
growing body of data##3##4##(2008-11#1)(2008-7#1)(2008-8#1)
growing body of evidence##7##4##(1990-9#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
growing body of literature##4##4##(2008-12#1)(2008-5#1)(2009-4#1)(2012-3#1)
growing body of research##3##4##(1993-1#1)(2009-5#1)(2013-8#1)
growing body of##20##3##(1990-9#1)(1993-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
growing cells and##2##3##(1995-2#2)
growing cells in##2##3##(2008-11#1)(2008-8#1)
growing cells##11##2##(1991-2#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-2#2)(1997-6#1)(2008-11#2)(2008-8#1)(2013-8#1)
growing concern among##2##3##(1997-3#1)(2010-4#1)
growing concern##7##2##(1997-3#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-4#1)
growing concerns about the##2##4##(1993-3#1)(2008-12#1)
growing consensus##2##2##(2008-10#1)(2008-7#1)
growing context-sensitive##2##2##(2009-12#2)
growing crisis##3##2##(2008-6#2)(2012-12#1)
growing degree##3##2##(2008-10#1)(2008-8#2)
growing demand for##4##3##(1995-1#1)(2008-10#1)(2010-12#1)(2013-1#1)
growing diet##2##2##(2010-2#1)(2010-4#1)
growing evidence for##2##3##(2008-7#1)(2012-1#1)
growing evidence has##2##3##(2009-8#1)(2011-2#1)
growing evidence to support##2##4##(2006-10#1)(2008-7#1)
growing evidence to##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
growing evidence##17##2##(1991-12#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
growing faster than##3##3##(1994-3#2)(2008-1#1)
growing field of##2##3##(2008-5#1)(2009-10#1)
growing field##4##2##(2008-5#1)(2009-10#1)(2010-5#1)(2010-6#1)
growing from##2##2##(2007-5#1)(2013-7#1)
growing importance of##2##3##(2007-7#1)(2013-1#1)
growing importance##5##2##(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
growing in a##5##3##(1995-6#1)(2008-10#2)(2008-11#1)(2009-12#1)
growing in importance##2##3##(2007-12#1)(2012-3#1)
growing in popularity##2##3##(1992-11#1)(2008-9#1)
growing in the##8##3##(1991-12#1)(1991-3#1)(2008-10#4)(2008-8#1)(2008-9#1)
growing in##48##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-6#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
growing interest in the development of##2##6##(2008-11#1)(2009-7#1)
growing interest in the##8##4##(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#1)
growing interest in##22##3##(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
growing interest##26##2##(1995-2#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#2)
growing interfaces##3##2##(1992-11#1)(2012-2#2)
growing international##2##2##(1995-2#1)(1996-12#1)
growing knowledge##2##2##(2007-8#1)(2011-2#1)
growing larvae##2##2##(2007-5#2)
growing list of##2##3##(2008-11#1)(2008-4#1)
growing mass##2##2##(2013-8#2)
growing need for##4##3##(1991-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
growing need##5##2##(1991-10#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
growing number of reports##2##4##(2010-5#1)(2011-2#1)
growing number of studies##5##4##(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
growing number of##32##3##(1991-1#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
growing on the##2##3##(2008-10#2)
growing on##11##2##(2008-10#6)(2008-11#1)(2011-2#2)(2012-6#1)(2013-7#1)
growing pains##2##2##(2008-8#1)(2009-12#1)
growing pigs##8##2##(2008-9#1)(2010-2#6)(2013-1#1)
growing plants in##2##3##(2008-10#2)
growing points##3##2##(2008-10#3)
growing population of##4##3##(1994-12#1)(1997-6#1)(2007-12#1)(2011-2#1)
growing population##6##2##(1994-12#1)(1997-6#2)(2007-12#1)(2008-9#1)(2011-2#1)
growing practice##2##2##(1996-1#2)
growing pressure##3##2##(1997-1#1)(2008-11#1)(2008-12#1)
growing rapidly##6##2##(1992-12#1)(1995-3#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-9#1)
growing recognition in the##2##4##(1993-1#1)(2008-7#1)
growing recognition of the##4##4##(1993-1#1)(1996-7#1)(2007-12#1)(2011-1#1)
growing recognition##6##2##(1993-1#2)(1996-7#1)(2007-12#1)(2008-7#1)(2011-1#1)
growing regions##5##2##(2008-10#4)(2010-10#1)
growing season and##2##3##(2009-2#1)(2012-7#1)
growing season in##4##3##(2008-10#3)(2008-12#1)
growing season##53##2##(2008-10#38)(2008-12#1)(2009-2#7)(2009-8#1)(2010-8#1)(2011-2#2)(2012-5#2)(2012-7#1)
growing seasons in##3##3##(2008-10#3)
growing seasons##14##2##(2008-10#13)(2008-12#1)
growing trend##4##2##(1994-1#1)(1994-3#2)(1996-1#1)
growing tumor##7##2##(1992-8#2)(2008-1#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
growing under##3##2##(2011-2#1)(2012-7#1)(2013-8#1)
growing up##2##2##(2008-11#1)(2009-5#1)
growing use of##4##3##(1996-12#1)(1996-2#1)(2008-3#1)(2009-11#1)
growing use##5##2##(1996-12#1)(1996-2#1)(2008-3#1)(2009-10#1)(2009-11#1)
growing yeast##2##2##(1995-9#1)(2008-8#1)
growing##604##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-6#3)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-8#5)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#6)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#6)(1997-7#1)(2006-10#2)(2006-6#1)(2007-11#4)(2007-12#10)(2007-5#3)(2007-7#2)(2007-8#4)(2008-1#9)(2008-10#125)(2008-11#32)(2008-12#20)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#8)(2008-6#4)(2008-7#18)(2008-8#10)(2008-9#12)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#9)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#13)(2010-3#5)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#5)(2011-2#28)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#13)(2012-3#6)(2012-5#4)(2012-6#1)(2012-7#2)(2013-1#18)(2013-7#4)(2013-8#19)
grown as##3##2##(2008-10#2)(2008-11#1)
grown at 0##3##3##(1991-11#2)(1994-3#1)
grown at 37 and 43 degrees C##2##7##(2008-12#2)
grown at 37##4##3##(1995-8#1)(2008-12#2)(2008-5#1)
grown at low##3##3##(2007-12#1)(2008-5#2)
grown at##24##2##(1990-5#1)(1991-11#3)(1992-2#2)(1994-3#2)(1995-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#4)
grown by a##2##3##(2007-11#1)(2008-7#1)
grown by molecular beam epitaxy##3##5##(1995-3#1)(2007-12#1)(2009-11#1)
grown by pulsed laser deposition##2##5##(2007-11#2)
grown by the##2##3##(2007-12#1)(2008-2#1)
grown by##14##2##(1995-3#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#2)(2013-1#1)
grown cells##3##2##(1990-11#3)
grown directly##2##2##(1996-11#1)(2008-2#1)
grown dramatically##2##2##(1991-3#1)(2008-11#1)
grown during##3##2##(1996-1#1)(2008-10#2)
grown exponentially##2##2##(1996-12#1)(2008-7#1)
grown for 48 h##2##4##(1993-8#1)(2008-10#1)
grown for 48##3##3##(1993-8#1)(2008-10#2)
grown for##11##2##(1993-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-6#1)
grown from the##2##3##(2008-10#1)(2008-2#1)
grown from##8##2##(1992-8#1)(1996-2#1)(2008-10#4)(2008-2#1)(2008-8#1)
grown in 10%##2##3##(1994-2#1)(1996-5#1)
grown in a##9##3##(1992-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2012-2#1)
grown in both##3##3##(2008-10#2)(2008-7#1)
grown in continuous##2##3##(1996-10#1)(2008-12#1)
grown in culture##6##3##(1990-7#1)(1993-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
grown in different##2##3##(1994-3#1)(2008-10#1)
grown in glucose##2##3##(1996-12#1)(2008-10#1)
grown in growth chambers##2##4##(2008-10#1)(2012-5#1)
grown in high##3##3##(2008-11#1)(2008-12#1)(2012-7#1)
grown in liquid##2##3##(1994-6#1)(2011-2#1)
grown in media##3##3##(2008-11#1)(2008-7#1)(2012-7#1)
grown in medium##3##3##(1991-11#2)(2008-10#1)
grown in monolayer##2##3##(1990-12#1)(2008-11#1)
grown in noncultivated##2##3##(2008-10#2)
grown in nonfumigated##2##3##(2008-10#2)
grown in nutrient##2##3##(2008-10#1)(2008-11#1)
grown in potting mix##2##4##(2008-10#2)
grown in serum-free##7##3##(2008-11#7)
grown in soil from##2##4##(2008-10#1)(2008-5#1)
grown in soil##10##3##(2008-10#8)(2008-5#1)(2010-11#1)
grown in the United States##6##5##(2008-10#6)
grown in the absence of##2##5##(2008-10#2)
grown in the absence##3##4##(1994-11#1)(2008-10#2)
grown in the peat mix##3##5##(2008-10#3)
grown in the presence of##13##5##(1990-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-3#1)(2008-10#6)(2011-1#1)
grown in the##40##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(2008-10#28)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
grown in these##4##3##(2008-10#3)(2008-9#1)
grown in vitro##5##3##(1990-6#1)(2008-10#1)(2008-5#2)(2013-1#1)
grown in vivo##2##3##(1991-6#1)(2009-12#1)
grown in##209##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-2#1)(1996-10#1)(1996-12#2)(1996-5#2)(1997-3#1)(2008-1#1)(2008-10#107)(2008-11#27)(2008-12#6)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-5#2)(2012-7#3)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
grown on a##6##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-7#2)
grown on basal medium containing##2##5##(2008-6#2)
grown on basal medium##3##4##(2008-6#3)
grown on carbon monoxide##2##4##(1997-6#2)
grown on galactose##2##3##(1990-5#1)(2008-4#1)
grown on microcarriers##3##3##(2008-11#3)
grown on oleic acid##3##4##(1990-5#1)(1993-6#2)
grown on palmitoleic acid##2##4##(1993-6#2)
grown on plastic and##2##4##(2008-11#2)
grown on plastic##3##3##(2008-11#3)
grown on the##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
grown on##63##2##(1990-5#2)(1990-8#1)(1991-9#1)(1992-12#1)(1993-6#4)(1994-3#1)(1995-11#2)(1995-8#1)(1995-9#1)(1997-6#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#10)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#3)(2008-9#2)(2009-11#1)(2012-2#1)(2013-1#3)
grown over the##3##3##(2008-7#1)(2009-7#1)(2011-2#1)
grown over##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
grown separately##3##2##(2008-10#3)
grown to##5##2##(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
grown together##2##2##(2008-10#2)
grown under a##2##3##(2008-10#1)(2008-11#1)
grown under elevated CO(2) concentration##2##5##(2008-10#2)
grown under##17##2##(1992-12#1)(1997-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
grown with##7##2##(1992-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
grown##448##1##(1990-11#3)(1990-12#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#6)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#4)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#4)(2007-11#5)(2007-12#7)(2008-1#2)(2008-10#176)(2008-11#49)(2008-12#11)(2008-2#6)(2008-3#3)(2008-4#5)(2008-5#13)(2008-6#8)(2008-7#17)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-5#2)(2012-6#1)(2012-7#3)(2012-9#1)(2013-1#10)(2013-7#1)(2013-8#2)
grows and##2##2##(1992-12#1)(2008-10#1)
grows as##2##2##(2007-11#1)(2008-8#1)
grows slowly on##2##3##(1991-11#1)(2008-10#1)
grows to##2##2##(1991-12#1)(2008-9#1)
grows##36##1##(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-3#2)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#2)
growth acceleration and##2##3##(2007-7#2)
growth advantage##6##2##(1991-4#1)(1992-8#1)(1994-12#1)(1994-8#2)(2008-6#1)
growth after##5##2##(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-9#1)
growth and DNA synthesis##3##4##(1990-5#1)(1995-12#2)
growth and antibody production in##2##5##(2008-11#2)
growth and antibody production##5##4##(1994-2#1)(2008-11#4)
growth and cell##4##3##(1995-8#1)(2009-8#2)(2012-3#1)
growth and change##2##3##(1994-12#1)(1995-3#1)
growth and circumnutation##3##3##(2009-6#3)
growth and death##3##3##(1997-7#1)(2008-11#1)(2011-2#1)
growth and detachment##2##3##(2008-11#1)(2008-7#1)
growth and development and##2##4##(1994-3#1)(2009-6#1)
growth and development of##11##4##(1994-1#1)(1996-3#1)(2007-12#1)(2008-12#3)(2008-4#3)(2008-8#1)(2009-8#1)
growth and development##39##3##(1990-6#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-11#5)(2008-12#3)(2008-4#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#3)(2010-5#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)
growth and differentiation factors##2##4##(1994-12#1)(2008-4#1)
growth and differentiation in##2##4##(1993-11#1)(2008-10#1)
growth and differentiation of##13##4##(1990-12#1)(1991-6#1)(1993-5#1)(1993-9#1)(1995-5#1)(1997-2#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-6#1)
growth and differentiation##27##3##(1990-12#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-2#2)(2008-10#1)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2010-7#1)
growth and disease development##2##4##(2008-10#2)
growth and enterotoxin production##2##4##(1997-4#2)
growth and in##2##3##(2008-7#1)(2011-1#1)
growth and induced##5##3##(1990-2#1)(2008-11#1)(2010-1#1)(2012-5#1)(2013-1#1)
growth and its##2##3##(2008-8#1)(2013-8#1)
growth and metabolism of##4##4##(1993-5#1)(2008-11#3)
growth and metabolism##5##3##(1993-5#1)(2008-11#3)(2009-8#1)
growth and metabolite##2##3##(2012-5#2)
growth and metastasis of##2##4##(1994-12#1)(2013-1#1)
growth and metastasis##13##3##(1992-2#1)(1994-12#3)(2008-8#1)(2009-3#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
growth and methane utilization##3##4##(2008-6#3)
growth and methane##4##3##(2008-6#4)
growth and monoclonal antibody production##2##5##(2008-11#1)(2011-2#1)
growth and monoclonal antibody##3##4##(2008-11#2)(2011-2#1)
growth and monoclonal##4##3##(1994-2#1)(2008-11#2)(2011-2#1)
growth and morphology##2##3##(2008-8#1)(2013-1#1)
growth and production of##2##4##(2008-11#2)
growth and production##3##3##(2008-11#3)
growth and productivity of##4##4##(2008-11#2)(2008-12#2)
growth and productivity##7##3##(2008-11#4)(2008-12#2)(2011-2#1)
growth and proliferation and##2##4##(2008-11#1)(2011-2#1)
growth and proliferation##7##3##(1992-8#1)(1996-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
growth and protein##2##3##(2008-11#2)
growth and recombinant protein production##4##5##(2008-11#4)
growth and reduced##2##3##(2008-10#1)(2008-5#1)
growth and remodeling##2##3##(2008-11#1)(2009-7#1)
growth and reproduction##4##3##(2008-5#2)(2008-8#1)(2008-9#1)
growth and sporulation##2##3##(2008-6#2)
growth and structural##2##3##(1994-6#1)(2008-9#1)
growth and subsequent##2##3##(2008-10#1)(2012-2#1)
growth and survival of the##3##5##(1994-10#1)(2008-11#1)(2011-2#1)
growth and survival##8##3##(1994-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2011-2#2)
growth and that##2##3##(1994-6#1)(2008-2#1)
growth and the##7##3##(1994-3#1)(1995-12#1)(2007-11#1)(2007-8#1)(2009-4#1)(2013-1#2)
growth and tissue##3##3##(1990-11#1)(1993-12#1)(2012-2#1)
growth and to##2##3##(1995-2#1)(2013-1#1)
growth and transport##2##3##(2013-1#1)(2013-8#1)
growth and viability of##2##4##(2008-11#1)(2012-2#1)
growth and viability##5##3##(1995-9#1)(2007-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
growth and wall##2##3##(2009-10#2)
growth and yield of##2##4##(2008-10#1)(2008-12#1)
growth and yield##4##3##(2008-10#2)(2008-12#2)
growth and##390##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#4)(1994-6#3)(1994-8#2)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#35)(2008-11#62)(2008-12#12)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#12)(2008-6#8)(2008-7#16)(2008-8#19)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#8)(2010-1#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#9)(2011-2#16)(2012-12#2)(2012-2#6)(2012-3#5)(2012-5#4)(2012-8#1)(2013-1#17)(2013-7#2)(2013-8#8)
growth and/or##2##2##(1994-12#1)(2011-2#1)
growth are##6##2##(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
growth arrest and DNA damage##2##5##(2008-7#1)(2009-7#1)
growth arrest and apoptosis##2##4##(2007-10#1)(2008-11#1)
growth arrest and##9##3##(1992-12#1)(1994-10#1)(2007-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#1)
growth arrest or##2##3##(1992-2#1)(2008-7#1)
growth arrest##25##2##(1992-12#3)(1992-2#1)(1994-10#1)(1995-2#1)(1997-3#1)(1997-7#2)(2007-10#2)(2008-11#4)(2008-4#1)(2008-7#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
growth arrested##3##2##(1990-12#1)(1992-3#1)(1996-12#1)
growth as well as##5##4##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
growth as##9##2##(1994-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-2#1)(2011-2#1)(2013-8#2)
growth associated production##6##3##(2008-11#6)
growth associated##12##2##(1994-5#1)(2008-11#11)
growth at 0##3##3##(2008-10#3)
growth at 37##2##3##(2008-7#1)(2009-2#1)
growth at a##2##3##(1994-8#1)(2008-11#1)
growth at pH##2##3##(1997-4#1)(2010-4#1)
growth at##26##2##(1990-11#2)(1990-4#1)(1993-9#2)(1994-8#1)(1997-4#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#2)
growth behavior##5##2##(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)
growth but also##2##3##(2008-4#1)(2011-2#1)
growth but##9##2##(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
growth by##20##2##(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2011-1#1)(2012-1#1)
growth cabinets##4##2##(2008-10#3)(2008-11#1)
growth can##2##2##(1994-12#1)(2008-7#1)
growth capability##3##2##(2009-6#3)
growth capacity##2##2##(1991-12#1)(2008-8#1)
growth cartilage##2##2##(2007-11#2)
growth cartilages##3##2##(2007-11#3)
growth chamber and##3##3##(2008-10#3)
growth chamber experiments##7##3##(2008-10#7)
growth chamber with##2##3##(2008-10#2)
growth chamber##28##2##(2006-11#1)(2008-10#26)(2011-2#1)
growth chambers##9##2##(2008-10#8)(2012-5#1)
growth characteristics of skin fibroblasts##2##5##(1990-3#2)
growth characteristics of##8##3##(1990-3#2)(1992-2#1)(1993-11#1)(2008-11#4)
growth characteristics were##2##3##(1990-3#1)(2010-11#1)
growth characteristics##14##2##(1990-3#3)(1992-2#1)(1993-11#1)(2008-11#5)(2008-8#1)(2009-10#1)(2010-11#1)(2013-7#1)
growth charts##4##2##(1991-2#1)(2010-7#1)(2011-2#2)
growth compared to##2##3##(2012-12#2)
growth compared with##2##3##(1997-7#1)(2010-8#1)
growth compared##4##2##(1997-7#1)(2010-8#1)(2012-12#2)
growth condition##2##2##(2010-11#1)(2013-1#1)
growth conditions and##3##3##(2008-10#2)(2008-8#1)
growth conditions##32##2##(1990-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-3#1)
growth cone##3##2##(1993-12#1)(2008-7#1)(2008-9#1)
growth cones of##3##3##(1995-12#3)
growth cones##6##2##(1993-12#1)(1995-12#5)
growth control of##2##3##(1995-12#1)(2008-11#1)
growth control##7##2##(1992-8#1)(1995-12#1)(1997-4#1)(2007-10#1)(2008-11#1)(2011-2#2)
growth costs of reproduction##2##4##(2008-9#2)
growth curve analyses##3##3##(2009-7#1)(2012-12#1)(2013-7#1)
growth curve##11##2##(1992-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-7#1)
growth curves obtained##2##3##(2011-2#2)
growth curves##5##2##(1992-9#1)(2009-7#1)(2011-2#2)(2013-7#1)
growth cycle##4##2##(1991-9#1)(2008-11#1)(2008-5#2)
growth data##3##2##(1991-6#1)(2010-7#1)(2013-8#1)
growth defects##3##2##(1996-6#1)(2011-2#2)
growth delay##3##2##(1996-6#1)(1997-3#1)(2011-1#1)
growth during the##2##3##(2009-8#1)(2011-2#1)
growth during##7##2##(1993-5#1)(2007-12#1)(2008-7#2)(2009-8#2)(2011-2#1)
growth dynamics##3##2##(1991-3#1)(2013-8#2)
growth effects of##2##3##(2008-5#1)(2013-7#1)
growth effects##3##2##(1992-8#1)(2008-5#1)(2013-7#1)
growth environment##2##2##(2008-6#1)(2009-11#1)
growth even##2##2##(2008-10#1)(2008-7#1)
growth factor (10##2##3##(2008-11#2)
growth factor (EGF) and##4##4##(1990-12#1)(1995-11#1)(2008-4#1)(2008-8#1)
growth factor (EGF)##29##3##(1990-12#2)(1991-12#3)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-7#1)
growth factor (HB-EGF) is a recently identified potent##2##8##(1993-11#1)(1997-1#1)
growth factor (HB-EGF)##3##3##(1993-11#1)(1997-1#1)(2013-8#1)
growth factor (HGF)##5##3##(1992-12#1)(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
growth factor (IGF-1)##2##3##(2007-11#1)(2011-2#1)
growth factor (NGF)##24##3##(1991-12#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-11#3)(2008-4#1)(2008-5#4)(2010-8#2)
growth factor (PDGF) and##3##4##(1991-12#1)(1994-9#1)(1997-6#1)
growth factor (PDGF)##7##3##(1991-12#1)(1993-8#1)(1994-9#1)(1995-11#2)(1997-6#1)(2008-11#1)
growth factor (VEGF)##25##3##(1992-3#1)(1992-9#1)(1994-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
growth factor 1##6##3##(2008-4#1)(2008-9#3)(2010-10#1)(2010-8#1)
growth factor 2##2##3##(2010-4#1)(2010-6#1)
growth factor I (IGF-I) axis##2##5##(2007-7#1)(2008-4#1)
growth factor I (IGF-I) receptors and##2##6##(1991-5#2)
growth factor I (IGF-I)##6##4##(1991-5#2)(2007-7#1)(2008-11#1)(2008-4#1)(2012-12#1)
growth factor I##8##3##(1991-5#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
growth factor II##5##3##(1990-11#1)(1992-3#2)(1992-9#1)(1996-10#1)
growth factor administration##2##3##(1997-1#1)(2008-7#1)
growth factor and its receptor in##2##6##(1991-7#1)(2009-5#1)
growth factor and its receptor##3##5##(1991-7#1)(2008-9#1)(2009-5#1)
growth factor and##18##3##(1990-12#1)(1990-7#3)(1990-9#1)(1991-7#2)(1992-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-1#2)(2013-1#1)
growth factor beta (TGF beta)##3##5##(1991-12#1)(1992-8#1)(1992-9#1)
growth factor beta (TGF-beta)##7##4##(1993-12#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-12#1)
growth factor beta 1##4##4##(1990-8#2)(1993-9#1)(2011-2#1)
growth factor beta receptor##3##4##(1995-12#1)(1995-2#1)(1997-7#1)
growth factor beta##24##3##(1990-5#1)(1990-8#2)(1991-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#2)(1993-9#1)(1995-12#1)(1995-2#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2011-2#2)(2012-2#1)
growth factor beta1##2##3##(2008-10#1)(2008-8#1)
growth factor binding and##2##4##(1990-12#1)(1993-3#1)
growth factor binding proteins (IGFBPs)##2##5##(1993-3#1)(2008-4#1)
growth factor binding proteins##3##4##(1992-4#1)(1993-3#1)(2008-4#1)
growth factor binding##9##3##(1990-12#2)(1992-4#1)(1993-3#3)(1993-8#1)(2008-4#1)(2011-1#1)
growth factor bound##2##3##(1993-3#1)(2008-7#1)
growth factor by##2##3##(1991-2#1)(1992-12#1)
growth factor delivery##2##3##(2010-10#2)
growth factor domain##2##3##(1990-12#1)(1990-8#1)
growth factor expression in##2##4##(2011-2#1)(2012-3#1)
growth factor expression##3##3##(1997-1#1)(2011-2#1)(2012-3#1)
growth factor for##3##3##(1994-11#1)(1994-3#1)(1994-6#1)
growth factor from##4##3##(1990-7#1)(1994-6#2)(2008-8#1)
growth factor gene##4##3##(1993-8#1)(2008-11#1)(2008-5#1)(2010-12#1)
growth factor genes##4##3##(1992-9#1)(1994-8#1)(2008-9#1)(2013-7#1)
growth factor has##2##3##(2008-8#2)
growth factor in cancer##2##4##(1993-9#1)(2008-7#1)
growth factor in rat##2##4##(1997-6#1)(2008-9#1)
growth factor in the##3##4##(1993-12#1)(1993-9#1)(2013-8#1)
growth factor in##15##3##(1990-5#2)(1990-7#2)(1992-3#1)(1993-12#1)(1993-9#2)(1995-12#1)(1997-6#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#2)
growth factor induced##2##3##(1993-3#1)(1995-12#1)
growth factor into cells##2##4##(1997-7#2)
growth factor is##7##3##(1991-2#1)(1992-12#1)(1993-8#1)(1994-6#1)(1995-12#1)(2008-8#1)(2008-9#1)
growth factor mRNA##3##3##(1993-11#1)(1997-6#1)(2008-9#1)
growth factor messenger##2##3##(1991-12#1)(1995-12#1)
growth factor on##6##3##(1990-11#1)(1990-2#1)(1992-3#1)(1994-8#1)(1995-11#1)(1997-1#1)
growth factor receptor (EGF-R)##2##4##(1994-9#1)(1995-6#1)
growth factor receptor (EGFR)##13##4##(1992-8#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#3)(2012-1#3)(2012-3#1)(2013-1#1)
growth factor receptor and##5##4##(1991-11#1)(1992-8#1)(1994-2#1)(2008-11#1)(2011-2#1)
growth factor receptor expression##2##4##(1994-9#1)(2012-3#1)
growth factor receptor##50##3##(1990-12#2)(1991-11#1)(1991-7#2)(1992-8#2)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#1)(2011-2#3)(2012-1#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
growth factor receptors##12##3##(1991-7#1)(1992-8#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-12#2)
growth factor related##2##3##(1991-2#1)(1997-7#1)
growth factor signaling pathways##2##4##(2008-12#1)(2008-4#1)
growth factor signaling##3##3##(1994-6#1)(2008-12#1)(2008-4#1)
growth factor support was##2##4##(2008-7#2)
growth factor type##3##3##(1990-8#1)(2009-9#1)(2013-1#1)
growth factor was##4##3##(1994-8#1)(2008-11#1)(2008-9#1)(2010-1#1)
growth factor##494##2##(1990-11#4)(1990-12#9)(1990-2#1)(1990-5#4)(1990-7#10)(1990-8#8)(1990-9#1)(1991-11#1)(1991-12#11)(1991-2#11)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#5)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#10)(1992-4#1)(1992-8#8)(1992-9#15)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#12)(1993-5#1)(1993-6#3)(1993-8#8)(1993-9#7)(1994-10#1)(1994-11#9)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#7)(1994-8#11)(1994-9#5)(1995-11#11)(1995-12#12)(1995-2#8)(1995-5#1)(1995-6#3)(1995-8#5)(1995-9#1)(1996-10#1)(1996-12#6)(1996-2#1)(1996-5#4)(1997-1#5)(1997-2#3)(1997-4#2)(1997-6#6)(1997-7#7)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#6)(2008-11#35)(2008-12#2)(2008-3#3)(2008-4#13)(2008-5#17)(2008-6#3)(2008-7#17)(2008-8#16)(2008-9#14)(2009-11#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#17)(2012-1#11)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#7)
growth factor) and##2##3##(1997-7#1)(2008-5#1)
growth factor)##6##2##(1991-9#1)(1997-7#1)(2008-11#2)(2008-5#1)(2008-9#1)
growth factor- and##2##3##(1991-5#1)(1995-6#1)
growth factor-1 (IGF-1)##4##3##(1990-12#1)(1992-12#1)(2007-7#1)(2011-1#1)
growth factor-1##7##2##(1990-12#1)(1992-12#1)(1997-4#1)(2007-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
growth factor-A##2##2##(1995-11#1)(2008-10#1)
growth factor-I (IGF-I) and##2##4##(2008-11#2)
growth factor-I (IGF-I)##10##3##(1991-12#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-11#3)(2010-8#1)
growth factor-I##18##2##(1991-12#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-11#3)(2008-8#2)(2010-8#2)
growth factor-beta##22##2##(1990-2#3)(1991-12#1)(1992-2#1)(1992-3#2)(1993-3#2)(1993-6#1)(1994-11#2)(1995-11#1)(1996-5#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-3#1)(2013-1#2)
growth factor-binding##5##2##(1991-12#1)(1993-2#2)(2008-4#2)
growth factor-induced##4##2##(1992-10#1)(1994-8#1)(1995-2#1)(1997-1#1)
growth factor-like##6##2##(1990-12#1)(1992-12#1)(1993-11#2)(1993-8#1)(1995-6#1)
growth factors (IGF-I and##2##4##(2008-4#1)(2008-5#1)
growth factors and cytokines##4##4##(1994-3#1)(1994-9#1)(2008-9#1)(2012-12#1)
growth factors and other##2##4##(2008-5#1)(2009-8#1)
growth factors and##14##3##(1990-5#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-12#2)
growth factors are##3##3##(1995-12#1)(2008-8#1)(2013-1#1)
growth factors in##8##3##(1990-12#2)(1991-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(2007-12#1)(2008-5#1)
growth factors may##2##3##(2008-12#1)(2008-5#1)
growth factors or##2##3##(1990-5#1)(1991-12#1)
growth factors such as##3##4##(1995-11#1)(2008-11#2)
growth factors that##3##3##(1994-5#1)(2008-5#1)(2008-6#1)
growth factors to##3##3##(1995-2#1)(2007-12#1)(2008-11#1)
growth factors which##2##3##(1991-6#1)(1994-11#1)
growth factors with##2##3##(1992-12#1)(1997-7#1)
growth factors##141##2##(1990-12#5)(1990-5#3)(1991-12#4)(1991-3#5)(1991-5#2)(1991-6#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#4)(1993-8#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#5)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#10)(2008-12#3)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#3)
growth factors)##2##2##(1995-11#1)(2008-4#1)
growth failure##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
growth following##2##2##(2008-6#1)(2010-2#1)
growth for##6##2##(1994-1#1)(1994-2#1)(2008-10#2)(2009-8#1)(2011-1#1)
growth forms##2##2##(1996-6#1)(2012-6#1)
growth fostering##5##2##(1990-12#5)
growth from the##3##3##(1990-7#1)(2008-10#1)(2008-7#1)
growth from##7##2##(1990-7#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
growth functions##2##2##(2008-10#2)
growth habit##4##2##(2008-10#1)(2012-3#3)
growth has been##3##3##(1991-3#1)(2008-11#1)(2008-12#1)
growth has##8##2##(1991-3#1)(1994-7#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#2)
growth have##3##2##(1994-9#1)(2008-1#1)(2008-4#1)
growth hormone (GH) and##2##4##(2008-4#1)(2008-7#1)
growth hormone (GH) deficiency##3##4##(2008-3#1)(2008-4#1)(2011-1#1)
growth hormone (GH)##20##3##(1990-12#2)(1991-12#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
growth hormone (GH)/insulin-like growth factor##2##5##(2007-7#1)(2010-8#1)
growth hormone and##6##3##(1993-2#2)(1996-2#1)(1997-2#1)(2008-7#1)(2009-2#1)
growth hormone cDNA##2##3##(1990-12#2)
growth hormone deficiency are##2##4##(1997-8#1)(2011-1#1)
growth hormone deficiency##10##3##(1997-8#2)(2008-5#1)(2011-1#2)(2012-3#4)(2013-1#1)
growth hormone in##7##3##(1990-12#1)(1994-2#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#2)
growth hormone receptor (GHR)##3##4##(2008-4#1)(2008-9#1)(2010-5#1)
growth hormone receptor gene##2##4##(2008-1#1)(2010-5#1)
growth hormone receptor##10##3##(1990-12#1)(1993-2#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-5#2)
growth hormone release##2##3##(1994-8#1)(2008-3#1)
growth hormone releasing hormone##4##4##(1990-12#1)(1992-6#1)(1992-9#1)(2007-7#1)
growth hormone secretion##2##3##(1990-2#1)(1991-9#1)
growth hormone treatment##3##3##(1990-3#1)(1993-6#1)(2007-11#1)
growth hormone##103##2##(1990-12#13)(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#4)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-8#4)(2007-11#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#6)(2013-1#7)(2013-7#3)
growth hormone-releasing factor##4##3##(1990-2#2)(1991-9#2)
growth hormone-releasing hormone 1-44 NH2 and 1-40 OH##3##8##(1992-9#3)
growth hormone-releasing hormone 1-44 NH2##5##5##(1992-9#5)
growth hormone-releasing hormone##6##3##(1992-9#6)
growth hormone-releasing##10##2##(1990-2#2)(1991-9#2)(1992-9#6)
growth in Medicaid##2##3##(1992-12#1)(1995-6#1)
growth in S##3##3##(1996-2#1)(1996-6#1)(1997-3#1)
growth in a##18##3##(1990-11#1)(1990-8#1)(2008-11#7)(2008-2#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-4#1)(2013-8#1)
growth in all##2##3##(1994-1#1)(2008-10#1)
growth in both##2##3##(2008-9#1)(2011-2#1)
growth in children##4##3##(1993-2#1)(1996-6#1)(2007-11#1)(2010-7#1)
growth in food##2##3##(2010-7#1)(2011-2#1)
growth in hospital##3##3##(1992-1#1)(1992-2#1)(1993-1#1)
growth in liquid media##2##4##(2008-10#1)(2008-8#1)
growth in normal##2##3##(2007-11#1)(2008-11#1)
growth in response to##2##4##(1992-8#1)(2008-11#1)
growth in serum-free##3##3##(2008-11#3)
growth in the host##2##4##(2008-10#2)
growth in the presence of##3##5##(1993-8#1)(2008-10#2)
growth in the##43##3##(1990-7#1)(1992-12#2)(1992-2#2)(1993-8#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#2)
growth in these##2##3##(2008-11#1)(2011-1#1)
growth in vitro and##2##4##(2008-5#1)(2013-1#1)
growth in vitro##7##3##(1992-2#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
growth in##212##2##(1990-11#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-4#1)(1992-1#2)(1992-12#4)(1992-2#5)(1992-3#4)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#3)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#26)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#10)(2011-7#1)(2012-12#2)(2012-3#3)(2013-1#8)(2013-7#7)(2013-8#1)
growth increment and the##2##4##(2008-9#2)
growth increment and##3##3##(2008-9#3)
growth increment##4##2##(2008-9#4)
growth indices##5##2##(2008-12#5)
growth inhibition activity##2##3##(1994-5#1)(2009-6#1)
growth inhibition and apoptosis##3##4##(2011-2#2)(2013-1#1)
growth inhibition and differentiation##2##4##(1997-7#2)
growth inhibition and##7##3##(1997-7#2)(2010-2#1)(2011-2#2)(2012-7#1)(2013-1#1)
growth inhibition by##7##3##(1990-8#2)(1993-3#1)(2008-11#2)(2008-8#1)(2011-2#1)
growth inhibition effects##4##3##(2008-11#4)
growth inhibition in##3##3##(1991-12#1)(1993-11#1)(1994-8#1)
growth inhibition of human##2##4##(2010-6#1)(2013-7#1)
growth inhibition of##9##3##(1990-12#2)(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2013-7#1)
growth inhibition were##2##3##(2008-3#1)(2008-5#1)
growth inhibition##55##2##(1990-12#2)(1990-2#1)(1990-8#2)(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-4#2)(1997-7#2)(2008-10#3)(2008-11#13)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-2#6)(2012-7#1)(2013-1#2)(2013-7#1)
growth inhibitor and##2##3##(1993-8#1)(2010-6#1)
growth inhibitor##3##2##(1990-2#1)(1993-8#1)(2010-6#1)
growth inhibitors##3##2##(1995-11#2)(2012-3#1)
growth inhibitory activity of##3##4##(1990-12#1)(1992-3#2)
growth inhibitory activity##4##3##(1990-12#1)(1992-3#3)
growth inhibitory effect of##3##4##(1995-2#1)(2008-11#1)(2008-12#1)
growth inhibitory effect##4##3##(1993-1#1)(1995-2#1)(2008-11#1)(2008-12#1)
growth inhibitory effects of##4##4##(1991-12#2)(1997-3#1)(2008-11#1)
growth inhibitory effects##7##3##(1991-12#2)(1997-3#1)(2008-11#4)
growth inhibitory factor##9##3##(1992-9#6)(1996-2#3)
growth inhibitory response##2##3##(1992-2#1)(2008-6#1)
growth inhibitory##31##2##(1990-12#1)(1991-12#2)(1992-2#1)(1992-3#4)(1992-9#6)(1993-1#1)(1995-11#1)(1995-2#2)(1996-2#3)(1997-3#1)(2008-11#7)(2008-12#1)(2008-6#1)
growth inside##2##2##(2008-11#1)(2008-9#1)
growth is determined by##2##4##(1994-8#1)(2008-7#1)
growth is regulated by##3##4##(1994-8#1)(2007-10#1)(2009-8#1)
growth is the##2##3##(2008-1#1)(2012-12#1)
growth is##28##2##(1991-9#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-8#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
growth kinetics of##2##3##(2008-11#2)
growth kinetics##12##2##(2007-11#1)(2007-5#1)(2008-11#8)(2008-7#1)(2008-9#1)
growth may be##2##3##(1991-6#1)(2008-1#1)
growth may##3##2##(1991-6#1)(2008-1#1)(2009-2#1)
growth mechanism##3##2##(2008-10#2)(2008-7#1)
growth media evaluated##2##3##(2008-10#2)
growth media using##2##3##(2008-10#2)
growth media##14##2##(2008-10#10)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
growth medium##25##2##(1990-6#1)(1991-10#1)(1991-11#3)(1994-12#2)(1994-2#1)(1995-2#1)(1996-6#1)(1997-6#1)(2008-10#7)(2008-11#4)(2008-6#1)(2011-2#1)(2012-4#1)
growth method##2##2##(2007-12#1)(2008-2#1)
growth mode##2##2##(2009-11#1)(2010-8#1)
growth model based on##2##4##(2010-7#1)(2010-8#1)
growth model was##2##3##(1995-8#1)(2008-10#1)
growth model##17##2##(1991-6#2)(1995-8#1)(2008-10#3)(2008-9#3)(2009-8#1)(2010-7#1)(2010-8#2)(2013-8#4)
growth models were##2##3##(2010-8#2)
growth models##7##2##(2008-1#1)(2008-12#1)(2009-8#2)(2010-8#2)(2012-3#1)
growth nor##2##2##(1995-3#1)(2008-5#1)
growth observed##2##2##(2010-8#1)(2011-2#1)
growth occurred at##2##3##(1995-6#1)(2008-10#1)
growth occurred when##2##3##(2008-10#1)(2010-11#1)
growth occurred##7##2##(1995-6#1)(1996-5#1)(2008-10#3)(2010-11#1)(2010-8#1)
growth occurs in##2##3##(1996-5#1)(2012-2#1)
growth of A##11##3##(2008-10#8)(2010-8#1)(2011-2#2)
growth of B##6##3##(2008-10#2)(2011-2#4)
growth of C##4##3##(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
growth of CHO cells##3##4##(2008-11#2)(2011-2#1)
growth of Candida##2##3##(2007-12#1)(2008-5#1)
growth of Chinese##2##3##(2008-11#1)(2008-8#1)
growth of E##5##3##(2008-10#1)(2008-7#2)(2013-1#2)
growth of Escherichia coli K12##2##5##(2008-7#2)
growth of Escherichia coli##3##4##(2008-7#3)
growth of Escherichia##4##3##(2008-10#1)(2008-7#3)
growth of Fusarium spp##2##4##(2008-10#2)
growth of Fusarium##3##3##(1997-4#1)(2008-10#2)
growth of L##2##3##(1996-12#2)
growth of M##5##3##(1995-2#1)(2008-10#1)(2008-6#2)(2013-1#1)
growth of NB1-RGB cells on the##2##6##(2008-11#2)
growth of NRK##2##3##(1991-12#2)
growth of Nf-1 was##2##4##(1991-12#2)
growth of P##5##3##(2008-10#5)
growth of Phytophthora##4##3##(2008-10#4)
growth of R##9##3##(2008-10#9)
growth of S##2##3##(2008-10#2)
growth of a##9##3##(1990-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2012-3#1)
growth of aligned##2##3##(2008-7#2)
growth of and##2##3##(1992-9#1)(2008-10#1)
growth of apple in replant soils##2##6##(2008-10#2)
growth of apple in##4##4##(2008-10#4)
growth of apple trees in##2##5##(2008-10#2)
growth of apple##10##3##(2008-10#10)
growth of bacteria##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
growth of both cell lines##2##5##(1994-8#1)(1997-1#1)
growth of both##8##3##(1994-8#1)(1997-1#2)(2008-10#3)(2008-5#1)(2008-9#1)
growth of breast cancer##2##4##(2008-4#1)(2012-3#1)
growth of breast##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
growth of cancer cell##2##4##(2008-9#1)(2013-8#1)
growth of cancer##4##3##(1994-11#1)(2008-9#1)(2009-9#1)(2013-8#1)
growth of cells##6##3##(1995-2#1)(1995-9#2)(2008-10#1)(2008-11#2)
growth of certain##2##3##(2008-4#2)
growth of different##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
growth of four##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
growth of human##15##3##(1990-7#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-11#5)(2008-8#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
growth of insect##2##3##(2008-11#2)
growth of larval Japanese anchovy Engraulis japonicus##2##7##(2010-8#2)
growth of larval##3##3##(2010-8#3)
growth of malignant tumour##2##4##(2008-9#2)
growth of mycelia##2##3##(2008-10#2)
growth of mycelium##2##3##(2008-10#2)
growth of neural stem cells##2##5##(1994-11#1)(2008-10#1)
growth of new##3##3##(1994-12#1)(2012-1#1)(2012-3#1)
growth of normal cells##2##4##(2008-11#2)
growth of normal rat kidney##2##5##(1991-12#1)(1991-2#1)
growth of normal##6##3##(1991-12#1)(1991-2#1)(2008-11#3)(2011-2#1)
growth of public##4##3##(1994-2#3)(2012-1#1)
growth of rats##2##3##(1993-11#1)(1993-12#1)
growth of several##2##3##(2008-10#2)
growth of single##2##3##(1995-9#1)(2007-11#1)
growth of the aorta##2##4##(1991-9#1)(2008-3#1)
growth of the arterial##2##4##(1995-8#1)(2009-1#1)
growth of the cells##4##4##(1993-9#1)(1995-9#1)(2008-10#1)(2008-11#1)
growth of the child##2##4##(2007-12#1)(2011-2#1)
growth of the fungus in the##2##6##(2008-10#2)
growth of the fungus##3##4##(2008-10#2)(2009-2#1)
growth of the human##4##4##(1992-8#1)(1995-8#1)(2008-11#1)(2013-1#1)
growth of the pathogen##4##4##(2008-10#4)
growth of the##76##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#2)(1995-9#3)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-1#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
growth of these cell##2##4##(1993-9#1)(2010-3#1)
growth of these cells##3##4##(1993-6#1)(1993-9#1)(2008-1#1)
growth of these##13##3##(1990-11#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#2)(2010-3#1)
growth of this##5##3##(1992-8#1)(1992-9#1)(2008-12#1)(2008-5#1)(2008-7#1)
growth of tumor cells##3##4##(2008-4#1)(2008-9#1)(2012-3#1)
growth of tumor##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
growth of tumors##4##3##(2010-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
growth of two##2##3##(2008-10#1)(2008-5#1)
growth of vascular smooth muscle cells##2##6##(1994-11#1)(2008-1#1)
growth of vascular##3##3##(1993-3#1)(1994-11#1)(2008-1#1)
growth of viruses##2##3##(1994-8#1)(2008-11#1)
growth of which is##2##4##(1994-8#2)
growth of##542##2##(1990-11#5)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#6)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#7)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#2)(1995-9#6)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1997-1#4)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#129)(2008-11#46)(2008-12#18)(2008-2#4)(2008-3#4)(2008-4#9)(2008-5#16)(2008-6#8)(2008-7#25)(2008-8#16)(2008-9#16)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#9)(2011-1#5)(2011-2#24)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#9)(2012-8#1)(2013-1#12)(2013-7#2)(2013-8#6)
growth on acetate##2##3##(2008-7#2)
growth on mixtures##2##3##(2008-7#2)
growth on##27##2##(1991-7#1)(1991-9#1)(1993-9#1)(1995-8#1)(1997-4#1)(2007-5#1)(2008-10#7)(2008-6#2)(2008-7#7)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
growth opportunities##4##2##(1994-1#1)(2007-9#1)(2010-8#1)(2012-2#1)
growth or morphology##2##3##(1995-6#2)
growth or##24##2##(1992-3#1)(1995-6#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
growth over##3##2##(2008-9#1)(2012-12#1)(2012-2#1)
growth parameters such as##2##4##(2008-10#1)(2008-12#1)
growth parameters were##2##3##(2008-10#2)
growth parameters##19##2##(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#1)(2011-1#2)(2012-9#1)(2013-7#1)
growth pattern and##2##3##(1992-2#1)(2013-1#1)
growth pattern of##2##3##(2007-7#1)(2012-1#1)
growth pattern##15##2##(1992-2#1)(1994-11#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-11#1)(2012-1#1)(2013-1#3)
growth patterns of##4##3##(1992-8#1)(2010-7#1)(2013-7#2)
growth patterns##10##2##(1991-12#1)(1992-8#1)(1994-9#1)(2007-5#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-7#1)(2013-7#2)
growth performance and##3##3##(2010-2#2)(2013-1#1)
growth performance##13##2##(2008-12#2)(2010-2#6)(2012-2#3)(2013-1#2)
growth period##7##2##(1992-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2010-11#1)
growth phase and##5##3##(2008-11#3)(2008-7#1)(2013-1#1)
growth phase in##2##3##(2008-11#2)
growth phase##25##2##(1995-8#1)(1996-7#2)(2008-10#1)(2008-11#13)(2008-7#4)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
growth phases##6##2##(1991-8#1)(1996-7#1)(2008-11#2)(2008-7#1)(2012-3#1)
growth phenomenon##3##2##(2008-1#1)(2008-7#2)
growth phenotype##5##2##(2008-11#1)(2010-2#4)
growth plate and its damage##2##5##(2007-11#2)
growth plate and##3##3##(1991-9#1)(2007-11#2)
growth plate cartilage##6##3##(1991-9#1)(1992-8#1)(2012-12#4)
growth plate in##4##3##(2007-11#3)(2012-1#1)
growth plate was##5##3##(2007-11#4)(2012-1#1)
growth plate##30##2##(1991-9#3)(1992-8#2)(1997-3#1)(2007-11#18)(2012-1#2)(2012-12#4)
growth plates is##2##3##(2007-11#1)(2011-1#1)
growth plates##5##2##(1997-3#1)(2007-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
growth potential is##2##3##(2007-8#1)(2010-8#1)
growth potential##6##2##(1990-3#2)(1991-12#1)(2007-8#1)(2010-8#1)(2012-3#1)
growth process##2##2##(2008-7#1)(2009-11#1)
growth processes##2##2##(1991-12#1)(2013-8#1)
growth promoting activities##3##3##(2008-11#2)(2008-9#1)
growth promoting##7##2##(1994-2#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-5#1)
growth promotion##11##2##(2008-10#5)(2008-11#3)(2013-8#3)
growth properties of skin##2##4##(1990-3#2)
growth properties##3##2##(1990-3#2)(1992-9#1)
growth rate and a##2##4##(1990-8#1)(1992-8#1)
growth rate and environmental##2##4##(1994-3#1)(2008-9#1)
growth rate and nutrient##2##4##(2008-12#1)(2008-7#1)
growth rate and the##3##4##(1996-3#1)(2008-3#1)(2008-6#1)
growth rate and##28##3##(1990-8#1)(1992-8#1)(1994-3#2)(1996-3#2)(2008-11#8)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-8#2)(2013-1#1)
growth rate at##3##3##(2008-10#2)(2008-11#1)
growth rate in##4##3##(1991-12#1)(1993-11#1)(2008-10#1)(2008-11#1)
growth rate increases##2##3##(2008-11#1)(2008-9#1)
growth rate of a##2##4##(2008-8#2)
growth rate of cells##3##4##(1992-3#1)(1995-2#1)(2008-11#1)
growth rate of the isolates##2##5##(2008-12#2)
growth rate of the##7##4##(1995-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)
growth rate of##45##3##(1990-6#1)(1992-2#2)(1992-3#1)(1993-9#2)(1995-2#1)(1995-9#1)(2007-11#1)(2008-10#2)(2008-11#7)(2008-12#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
growth rate on##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
growth rate per##2##3##(2008-8#2)
growth rate than##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
growth rate was observed##2##4##(2008-11#2)
growth rate was##10##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-1#2)
growth rate were##3##3##(1993-11#1)(2008-7#1)(2012-3#1)
growth rate when##2##3##(1997-6#1)(2007-11#1)
growth rate with##2##3##(2008-7#1)(2009-10#1)
growth rate##197##2##(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1992-2#3)(1992-3#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-9#2)(1994-3#4)(1994-5#1)(1994-8#1)(1995-2#1)(1995-9#2)(1996-3#2)(1997-6#1)(2007-11#9)(2007-12#1)(2007-9#1)(2008-10#21)(2008-11#38)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#19)(2008-8#13)(2008-9#10)(2009-10#3)(2009-11#1)(2009-6#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#9)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#5)
growth rate)##2##2##(1991-6#1)(2008-11#1)
growth rates and##10##3##(1992-2#1)(1993-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-1#1)
growth rates at##2##3##(2008-10#1)(2008-8#1)
growth rates in##5##3##(2007-5#1)(2008-10#1)(2008-11#2)(2008-8#1)
growth rates of the##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
growth rates of##17##3##(2008-10#5)(2008-11#4)(2008-5#1)(2008-8#4)(2008-9#2)(2011-1#1)
growth rates on##2##3##(2010-3#1)(2012-2#1)
growth rates through the stylar canal##2##6##(2008-10#2)
growth rates were found##2##4##(1993-12#1)(2008-6#1)
growth rates were##9##3##(1993-12#1)(2008-10#3)(2008-11#3)(2008-6#1)(2011-1#1)
growth rates##86##2##(1991-12#1)(1992-2#1)(1993-12#3)(1994-2#1)(1996-12#1)(2007-5#4)(2008-10#16)(2008-11#15)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#20)(2008-9#4)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
growth reaction##2##2##(2008-11#1)(2008-7#1)
growth reduction##3##2##(2008-10#2)(2012-5#1)
growth regulation##2##2##(1990-5#1)(2012-3#1)
growth regulator in##2##3##(1994-11#1)(2008-10#1)
growth regulator##7##2##(1994-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
growth regulators##6##2##(2008-10#4)(2008-12#1)(2011-2#1)
growth response of##2##3##(1994-12#1)(2008-10#1)
growth response##9##2##(1992-9#1)(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#5)
growth response-1##2##2##(1990-11#1)(2012-2#1)
growth responses to##2##3##(2008-10#2)
growth responses##7##2##(1992-12#2)(2008-10#3)(2008-4#1)(2012-5#1)
growth restriction##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
growth retardation and##5##3##(1995-2#1)(2008-10#1)(2012-2#1)(2013-1#2)
growth retardation##18##2##(1994-3#1)(1995-2#1)(1995-8#4)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
growth room##3##2##(2008-10#3)
growth signal was observed in##2##5##(2008-11#2)
growth signal##5##2##(1991-12#2)(2008-11#3)
growth signaling##2##2##(2008-11#1)(2008-4#1)
growth slowed##2##2##(2008-10#1)(2010-1#1)
growth spurt##3##2##(2008-10#1)(2010-3#2)
growth stage and##2##3##(2008-10#1)(2008-6#1)
growth stage##19##2##(1997-6#1)(2008-10#12)(2008-12#1)(2008-6#1)(2010-3#1)(2011-2#3)
growth stages of##2##3##(2008-10#2)
growth stages##23##2##(2008-10#19)(2008-12#1)(2011-2#3)
growth standards##2##2##(1996-8#1)(2011-1#1)
growth state##2##2##(2008-9#1)(2011-2#1)
growth status##2##2##(2008-10#1)(2009-8#1)
growth stimulation in##3##3##(1992-9#2)(2008-10#1)
growth stimulation of##2##3##(1993-9#1)(2008-6#1)
growth stimulation##12##2##(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#3)(1993-9#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-6#1)
growth stimulatory##2##2##(1992-4#1)(2008-6#1)
growth stimulus of the secondary root##2##6##(2008-5#2)
growth stopped##2##2##(2008-10#1)(2008-11#1)
growth substrate##7##2##(1994-12#1)(2007-11#1)(2008-7#5)
growth substrates##3##2##(2008-2#1)(2008-7#1)(2012-2#1)
growth such as##2##3##(2008-1#1)(2008-10#1)
growth suppression and##2##3##(1995-2#2)
growth suppression of##2##3##(1995-2#1)(2008-10#1)
growth suppression##12##2##(1994-9#1)(1995-2#5)(1996-2#1)(2007-11#3)(2008-10#1)(2012-12#1)
growth suppressor##3##2##(1991-5#1)(1995-2#1)(2008-9#1)
growth temperature##6##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#3)
growth temperatures##2##2##(2008-5#2)
growth than##2##2##(2008-5#1)(2008-6#1)
growth that##3##2##(1993-11#1)(2012-12#1)(2013-1#1)
growth the##2##2##(2007-12#1)(2008-10#1)
growth through##5##2##(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)
growth to the##3##3##(2008-10#2)(2008-7#1)
growth to##17##2##(1994-11#1)(1994-9#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)
growth trajectory##2##2##(2009-7#1)(2011-2#1)
growth under##10##2##(1993-3#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#3)
growth using a##3##3##(1994-6#1)(2008-2#1)(2008-9#1)
growth using##7##2##(1994-6#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
growth velocity##4##2##(2007-11#2)(2007-12#1)(2008-1#1)
growth was achieved##2##3##(2008-10#1)(2012-3#1)
growth was evaluated##2##3##(1995-2#1)(2008-11#1)
growth was examined##2##3##(2008-10#1)(2008-7#1)
growth was inhibited at##2##4##(2008-10#1)(2008-6#1)
growth was inhibited##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
growth was not inhibited##2##4##(1992-9#1)(2008-10#1)
growth was not##4##3##(1991-12#1)(1992-9#1)(2008-10#1)(2008-8#1)
growth was observed when##2##4##(2008-10#1)(2008-11#1)
growth was observed##8##3##(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2010-2#1)
growth was obtained when the initial pH##2##7##(2008-6#2)
growth was reduced##2##3##(2008-5#1)(2010-1#1)
growth was restricted to the epidermis and##2##7##(2008-10#2)
growth was restricted##4##3##(2008-10#4)
growth was##59##2##(1991-12#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-12#1)(2008-10#15)(2008-11#10)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2010-1#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
growth were assessed##2##3##(2008-12#1)(2013-7#1)
growth were not##2##3##(1992-5#1)(2008-10#1)
growth were observed##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
growth were##16##2##(1992-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#3)(2010-8#2)(2012-3#2)(2013-7#1)
growth when##5##2##(1995-3#1)(2008-10#2)(2008-6#1)(2008-9#1)
growth which##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
growth while##3##2##(2008-11#1)(2009-8#1)(2012-1#1)
growth with the##2##3##(2008-11#1)(2008-5#1)
growth with##10##2##(2008-11#4)(2008-5#1)(2008-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
growth within the##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
growth within##6##2##(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2013-1#1)
growth without##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
growth##4121##1##(1990-11#17)(1990-12#41)(1990-2#10)(1990-3#9)(1990-4#2)(1990-5#16)(1990-6#7)(1990-7#17)(1990-8#18)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#43)(1991-2#17)(1991-3#14)(1991-4#2)(1991-5#10)(1991-6#14)(1991-7#6)(1991-8#2)(1991-9#16)(1992-1#6)(1992-10#3)(1992-11#6)(1992-12#24)(1992-2#20)(1992-3#31)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#30)(1992-9#51)(1993-1#11)(1993-11#17)(1993-12#22)(1993-2#10)(1993-3#27)(1993-5#9)(1993-6#12)(1993-8#16)(1993-9#33)(1994-1#6)(1994-10#5)(1994-11#33)(1994-12#24)(1994-2#24)(1994-3#21)(1994-5#14)(1994-6#17)(1994-7#4)(1994-8#43)(1994-9#16)(1995-1#5)(1995-11#31)(1995-12#28)(1995-2#41)(1995-3#10)(1995-5#2)(1995-6#15)(1995-8#24)(1995-9#12)(1996-1#5)(1996-10#1)(1996-11#8)(1996-12#15)(1996-2#18)(1996-3#10)(1996-5#16)(1996-6#10)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#20)(1997-2#16)(1997-3#19)(1997-4#22)(1997-6#12)(1997-7#21)(1997-8#7)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#6)(2007-11#64)(2007-12#36)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#10)(2007-7#11)(2007-8#13)(2007-9#2)(2008-1#29)(2008-10#555)(2008-11#466)(2008-12#84)(2008-2#16)(2008-3#23)(2008-4#62)(2008-5#107)(2008-6#67)(2008-7#179)(2008-8#132)(2008-9#121)(2009-1#1)(2009-10#17)(2009-11#15)(2009-12#7)(2009-2#7)(2009-3#11)(2009-4#6)(2009-5#7)(2009-6#20)(2009-7#12)(2009-8#49)(2009-9#8)(2010-1#10)(2010-10#11)(2010-11#10)(2010-12#8)(2010-2#19)(2010-3#10)(2010-4#15)(2010-5#13)(2010-6#8)(2010-7#12)(2010-8#52)(2010-9#3)(2011-1#56)(2011-10#1)(2011-2#162)(2011-7#1)(2012-1#21)(2012-12#37)(2012-2#50)(2012-3#52)(2012-4#1)(2012-5#10)(2012-6#2)(2012-7#2)(2012-8#3)(2012-9#1)(2013-1#116)(2013-7#40)(2013-8#55)
growth)##4##1##(1990-7#1)(1995-9#1)(2008-11#1)(2013-8#1)
growth-arrest and##2##2##(1997-7#2)
growth-arrest genes##3##2##(1992-12#3)
growth-arrest##6##1##(1992-12#4)(1997-7#2)
growth-arrested##3##1##(1993-9#1)(1997-1#1)(2008-7#1)
growth-associated protein##2##2##(2008-7#2)
growth-associated##7##1##(1990-9#1)(1993-12#1)(2008-11#2)(2008-6#1)(2008-7#2)
growth-chamber studies##2##2##(2008-10#2)
growth-chamber##4##1##(2008-10#4)
growth-factor##3##1##(1992-9#1)(1996-10#1)(2008-4#1)
growth-inhibitory##3##1##(1992-9#2)(2013-1#1)
growth-phase-dependent protein regulation##2##3##(2009-6#2)
growth-phase-dependent##3##1##(2009-6#3)
growth-promoting rhizobacteria (PGPR)##3##3##(2008-10#3)
growth-promoting rhizobacteria##6##2##(2008-10#6)
growth-promoting##18##1##(1993-9#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#7)(2008-11#2)(2009-8#2)(2011-1#1)(2012-3#1)
growth-related##4##1##(1992-8#1)(1995-2#1)(2009-9#1)(2010-8#1)
growth-room assay##2##2##(2008-10#2)
growth-room##3##1##(2008-10#3)
growth-stimulating activity##2##2##(1995-8#2)
growth-stimulating effect of##2##3##(1995-8#1)(1996-11#1)
growth-stimulating effect##3##2##(1995-8#2)(1996-11#1)
growth-stimulating##6##1##(1995-2#1)(1995-8#4)(1996-11#1)
growth-stimulatory effect on##2##3##(1992-9#2)
growth-stimulatory factor##2##2##(1992-9#2)
growth-stimulatory##4##1##(1992-9#4)
growtharrest##2##1##(2008-11#2)
growthfactor##3##1##(2008-10#1)(2008-11#2)
growthrate##3##1##(2008-11#3)
growths##2##1##(2012-1#1)(2013-1#1)
grubs##3##1##(2011-2#2)(2013-1#1)
gs##3##1##(2008-5#3)
gsa-1 gene##4##2##(1997-7#4)
guaiac test##3##2##(1991-6#1)(1993-3#2)
guaiphenesin##2##1##(2008-10#2)
guajava##3##1##(2013-1#3)
guanabenz##6##1##(1991-5#1)(2008-5#5)
guanethidine##5##1##(1990-5#1)(1995-12#1)(1997-4#3)
guanidine HCl##2##2##(1992-3#1)(1992-6#1)
guanidine hydrochloride denaturation##3##3##(1995-5#2)(1997-2#1)
guanidine hydrochloride##18##2##(1990-2#1)(1992-6#2)(1993-3#4)(1993-6#1)(1995-5#6)(1997-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
guanidine thiocyanate##2##2##(1990-12#1)(2008-10#1)
guanidine x HCl##3##3##(2008-4#3)
guanidine##35##1##(1990-12#1)(1990-2#1)(1990-5#3)(1992-3#2)(1992-6#3)(1993-3#5)(1993-6#2)(1995-5#7)(1997-2#1)(2008-10#4)(2008-4#3)(2008-5#1)(2011-1#1)(2012-2#1)
guanidine-HCl##3##1##(1997-2#3)
guanidinium group##2##2##(1995-11#1)(1995-5#1)
guanidinium hydrochloride##2##2##(1994-6#1)(2009-9#1)
guanidinium##10##1##(1990-8#2)(1992-6#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-2#1)(2008-2#1)(2009-9#1)
guanine and##6##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2010-11#1)
guanine at##2##2##(1993-8#1)(2008-10#1)
guanine base##2##2##(1992-8#1)(2008-10#1)
guanine bases in DNA##2##4##(1990-5#2)
guanine bases in##3##3##(1990-5#2)(1994-5#1)
guanine bases##5##2##(1990-5#3)(1994-5#1)(2008-10#1)
guanine nucleotide binding protein##4##4##(1991-2#2)(1992-3#1)(1994-2#1)
guanine nucleotide binding##5##3##(1991-2#2)(1992-3#2)(1994-2#1)
guanine nucleotide exchange factor##6##4##(1991-12#1)(1994-8#3)(1995-2#1)(2010-11#1)
guanine nucleotide exchange factors##2##4##(1994-8#1)(1995-2#1)
guanine nucleotide exchange on##2##4##(1994-12#1)(1996-2#1)
guanine nucleotide exchange##10##3##(1991-12#1)(1994-12#1)(1994-8#4)(1995-2#2)(1996-2#1)(2010-11#1)
guanine nucleotide##22##2##(1991-12#1)(1991-2#3)(1992-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#4)(1995-11#1)(1995-2#3)(1996-2#1)(2010-11#1)
guanine nucleotide-binding protein##3##3##(1992-8#2)(1992-9#1)
guanine nucleotide-binding##4##2##(1992-8#2)(1992-9#1)(1997-7#1)
guanine nucleotide-exchange factor##2##3##(1994-12#1)(2011-2#1)
guanine nucleotide-exchange##3##2##(1994-12#2)(2011-2#1)
guanine nucleotides##8##2##(1991-5#1)(1992-11#2)(1993-6#3)(1995-5#2)
guanine residues##3##2##(1993-3#1)(1993-8#1)(2008-10#1)
guanine was##3##2##(1990-5#1)(1995-5#1)(2008-10#1)
guanine##79##1##(1990-5#4)(1991-12#2)(1991-2#3)(1991-5#2)(1992-11#3)(1992-3#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#6)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#4)(1996-2#1)(1997-7#1)(2008-10#18)(2008-11#2)(2010-11#2)(2010-12#1)(2011-2#1)
guanines in the##2##3##(1992-3#1)(1994-8#1)
guanines##6##1##(1992-3#2)(1993-8#2)(1994-8#2)
guanines)##2##1##(1992-4#2)
guanosine 3'##4##2##(1995-2#1)(1995-8#2)(2008-4#1)
guanosine 5'-0-(3-thiotriphosphate) (GTP gamma##2##4##(1991-6#1)(1995-8#1)
guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S)##2##5##(1993-8#1)(1994-3#1)
guanosine 5'-O-(3-thiotriphosphate)##3##2##(1993-8#2)(1994-3#1)
guanosine and##3##2##(1995-12#1)(2009-12#1)(2011-1#1)
guanosine enhances NGF-dependent neurite outgrowth##2##5##(2008-4#2)
guanosine##49##1##(1990-8#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-3#2)(1992-6#1)(1992-8#2)(1993-8#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#3)(1996-5#1)(1997-2#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-4#13)(2008-7#1)(2009-12#4)(2011-1#1)(2012-2#1)
guanosine-5'-triphosphate##2##1##(1996-5#1)(2011-1#1)
guanylate cyclase##6##2##(1991-9#2)(1994-12#1)(1995-2#1)(2008-4#1)(2008-6#1)
guanylate##8##1##(1991-9#2)(1994-12#1)(1995-2#1)(1996-5#1)(2008-4#1)(2008-6#1)(2008-8#1)
guanylin in##2##2##(1994-12#2)
guanylin molecule in human intestine and plasma##2##7##(1994-12#2)
guanylin##9##1##(1994-12#8)(2009-9#1)
guanylyl cyclase in##2##3##(1995-2#1)(2008-3#1)
guanylyl cyclase##9##2##(1994-8#1)(1995-2#1)(2008-3#3)(2008-4#3)(2009-9#1)
guanylyl##11##1##(1992-3#1)(1994-8#1)(1995-2#1)(2008-3#3)(2008-4#3)(2009-10#1)(2009-9#1)
guarantee a##2##2##(2008-3#1)(2008-7#1)
guarantee an##2##2##(2008-12#1)(2008-7#1)
guarantee good##2##2##(2008-11#1)(2008-3#1)
guarantee of the##2##3##(1993-3#1)(2010-8#1)
guarantee that##4##2##(2008-12#1)(2009-2#1)(2011-1#1)(2012-12#1)
guarantee the##6##2##(1995-3#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
guarantee##39##1##(1991-3#1)(1992-6#1)(1993-1#1)(1993-3#2)(1995-3#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-7#4)(2008-9#1)(2009-2#1)(2009-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
guaranteed by the##2##3##(1993-9#1)(2008-10#1)
guaranteed by##3##2##(1993-9#1)(1996-6#1)(2008-10#1)
guaranteed in##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
guaranteed the##2##2##(1992-2#1)(2008-3#1)
guaranteed##19##1##(1990-9#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-6#1)(1996-8#1)(2007-7#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
guaranteeing the##2##2##(1995-1#1)(2008-11#1)
guaranteeing##8##1##(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
guarantees a##2##2##(2008-10#1)(2008-3#1)
guarantees that##3##2##(1993-3#1)(1994-11#1)(2008-2#1)
guarantees the##2##2##(1991-2#1)(2012-12#1)
guarantees##24##1##(1991-2#1)(1993-1#2)(1993-3#3)(1994-11#1)(1994-2#1)(1995-6#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#1)
guard against##3##2##(1994-2#1)(1997-7#1)(2009-1#1)
guard cell protoplasts##5##3##(2008-8#5)
guard cell##6##2##(2008-10#1)(2008-8#5)
guard cells and##2##3##(2008-10#1)(2008-8#1)
guard cells##3##2##(2008-10#2)(2008-8#1)
guard##18##1##(1991-3#1)(1994-2#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#5)(2008-8#6)(2009-1#1)(2009-3#1)
guarded prognosis##3##2##(2010-7#1)(2011-1#1)(2012-3#1)
guarded##7##1##(1990-11#1)(2007-11#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
guardian with##2##2##(1994-12#2)
guardian##9##1##(1990-11#1)(1992-12#2)(1994-12#2)(1995-2#1)(2008-5#1)(2009-7#1)(2011-2#1)
guardians of##3##2##(1992-12#1)(1995-3#1)(1996-8#1)
guardians##8##1##(1991-12#1)(1992-12#1)(1995-3#1)(1996-8#1)(2008-11#2)(2008-9#1)(2011-1#1)
guardianship##2##1##(1994-1#2)
guarding##6##1##(1996-2#1)(2008-9#2)(2009-10#1)(2010-8#1)(2012-12#1)
guards##9##1##(1995-6#6)(1996-12#1)(2008-12#1)(2008-9#1)
guatemalensis##3##1##(2013-7#3)
guava##4##1##(1997-6#1)(2008-10#1)(2012-12#2)
guavas##3##1##(1997-6#3)
guess of the##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
guess##7##1##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#4)
guesses##2##1##(1996-2#1)(2008-10#1)
guest editors##2##2##(2012-2#1)(2013-8#1)
guest metal cations##2##3##(2008-10#2)
guest molecules##7##2##(2008-10#4)(2008-2#2)(2010-12#1)
guest residue##3##2##(1993-11#3)
guest salts##2##2##(2008-10#2)
guest species##2##2##(1997-7#1)(2010-12#1)
guest##33##1##(1993-11#4)(1995-1#3)(1997-7#3)(2008-10#14)(2008-2#2)(2008-3#2)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
guest-host system##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
guest-host##7##1##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)
guests and##2##2##(2010-12#1)(2010-5#1)
guests##10##1##(1995-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2012-3#1)
guevarai##3##1##(2008-12#3)
guianensis##3##1##(2008-10#1)(2012-2#2)
guidance and support##2##3##(1996-3#1)(2008-12#1)
guidance and##12##2##(1990-12#1)(1994-3#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
guidance cues##3##2##(2008-5#1)(2008-7#2)
guidance document##2##2##(2008-10#1)(2011-2#1)
guidance documents##2##2##(2008-10#1)(2012-12#1)
guidance during##2##2##(2008-3#1)(2011-1#1)
guidance for a##2##3##(2007-3#1)(2008-7#1)
guidance for future##2##3##(2008-9#1)(2013-1#1)
guidance for the procedure##2##4##(2008-1#1)(2012-12#1)
guidance for the##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2012-12#2)
guidance for##32##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-9#1)(1996-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#4)(2013-1#2)(2013-8#1)
guidance from##2##2##(2008-11#1)(2008-6#1)
guidance has##2##2##(2008-7#1)(2012-2#1)
guidance in the##2##3##(1993-3#1)(2007-11#1)
guidance in##9##2##(1993-3#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
guidance is##3##2##(1997-8#1)(2007-12#1)(2011-2#1)
guidance of a##4##3##(2007-12#1)(2008-11#1)(2008-3#2)
guidance of##18##2##(1993-1#1)(1993-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2009-3#1)(2009-8#1)(2011-2#3)
guidance on the##4##3##(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)
guidance on##12##2##(1993-1#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-12#1)
guidance speeds##2##2##(2009-5#2)
guidance system##3##2##(2008-3#1)(2011-2#2)
guidance to the##2##3##(1995-12#1)(2008-3#1)
guidance to##9##2##(1993-1#1)(1993-12#1)(1995-12#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2012-12#1)
guidance##179##1##(1990-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#2)(1997-2#1)(1997-8#2)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#5)(2008-1#6)(2008-10#8)(2008-11#14)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#2)(2009-5#3)(2009-8#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#3)
guide a##3##2##(1996-2#1)(2010-8#1)(2012-2#1)
guide and##3##2##(1995-12#1)(2008-10#1)(2010-5#1)
guide catheter##2##2##(2011-2#2)
guide clinicians in the##2##4##(2008-5#1)(2008-7#1)
guide for selecting##2##3##(1995-12#1)(2012-5#1)
guide for the##6##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)
guide for##31##2##(1991-12#1)(1991-2#2)(1993-12#1)(1993-6#1)(1995-12#2)(1996-2#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-5#1)
guide future research##2##3##(1996-12#1)(2012-3#1)
guide future##4##2##(1996-12#2)(2012-3#1)(2013-1#1)
guide health##3##2##(1994-3#2)(1997-2#1)
guide in the##3##3##(1990-9#1)(2008-3#1)(2011-1#1)
guide in##7##2##(1990-9#1)(1992-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
guide is a##2##3##(1996-2#1)(2011-2#1)
guide is##5##2##(1996-2#1)(1997-3#1)(2011-2#2)(2013-1#1)
guide management##2##2##(2008-12#1)(2009-4#1)
guide of##4##2##(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#1)
guide on##3##2##(1996-2#2)(2008-7#1)
guide star##9##2##(2007-12#3)(2008-2#3)(2008-3#3)
guide stars##2##2##(2008-2#1)(2008-3#1)
guide the choice##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
guide the development of##2##4##(1994-3#1)(2008-4#1)
guide the##33##2##(1994-1#1)(1994-3#2)(1995-3#2)(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
guide their##3##2##(1993-12#1)(2007-10#1)(2008-11#1)
guide to health##2##3##(1995-2#1)(2008-11#1)
guide to management##2##3##(2011-1#1)(2012-12#1)
guide to the##9##3##(1992-9#1)(1993-3#1)(1994-3#2)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)
guide to##38##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(2007-11#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
guide tube##2##2##(2008-10#2)
guide was##2##2##(1996-2#1)(2008-4#1)
guide with##2##2##(2007-11#1)(2009-5#1)
guide##285##1##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#9)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#4)(1996-12#3)(1996-2#12)(1996-3#2)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#4)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#18)(2008-11#17)(2008-12#6)(2008-2#6)(2008-3#20)(2008-4#9)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#18)(2012-1#2)(2012-12#6)(2012-2#9)(2012-3#5)(2012-5#1)(2013-1#9)(2013-8#1)
guidebook##3##1##(1994-2#1)(2008-3#2)
guided along a##2##3##(2007-12#1)(2012-12#1)
guided biopsy of##2##3##(2007-8#1)(2013-1#1)
guided biopsy##4##2##(2007-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
guided bone regeneration##2##3##(2007-12#1)(2012-12#1)
guided bone##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
guided by a##4##3##(1993-9#1)(2007-12#1)(2007-5#1)(2010-11#1)
guided by an##2##3##(2008-1#1)(2010-9#1)
guided by the##9##3##(1992-4#1)(1993-12#1)(2007-4#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#2)
guided by##44##2##(1990-10#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1997-7#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-5#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
guided in##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
guided modes in##2##3##(2007-11#1)(2007-12#1)
guided modes##13##2##(2007-11#3)(2007-12#8)(2008-3#2)
guided percutaneous##4##2##(1991-2#1)(2007-8#2)(2009-7#1)
guided streams of##2##3##(2008-2#2)
guided the research##2##3##(2008-10#1)(2010-3#1)
guided the##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2012-12#1)(2012-3#1)
guided this##2##2##(2008-11#1)(2013-1#1)
guided tissue regeneration##2##3##(1990-9#1)(2012-3#1)
guided wave##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
guided waves to##2##3##(2007-12#2)
guided waves##6##2##(1996-4#1)(2007-12#2)(2008-2#1)(2008-3#2)
guided##156##1##(1990-10#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-1#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#8)(2007-12#20)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#2)
guided-mode resonance##3##2##(2008-3#3)
guided-mode resonant filter##2##3##(2008-3#2)
guided-mode##7##1##(2007-12#2)(2008-3#5)
guided-wave optical interconnections##4##3##(2008-2#2)(2008-3#2)
guided-wave optical interconnects for##2##4##(2008-2#1)(2008-3#1)
guided-wave optical##6##2##(2008-2#3)(2008-3#3)
guided-wave optics##2##2##(2007-12#1)(2008-3#1)
guided-wave##19##1##(2007-11#1)(2007-12#4)(2008-2#6)(2008-3#8)
guideline and##2##2##(1991-2#1)(2008-12#1)
guideline development and##2##3##(1996-1#1)(2008-8#1)
guideline development##7##2##(1996-1#1)(2008-7#1)(2008-8#3)(2012-2#2)
guideline for the##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)(2012-3#1)
guideline for##14##2##(1990-11#1)(1993-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2010-5#1)(2010-9#2)(2012-3#1)(2013-8#1)
guideline implementation##4##2##(1996-12#1)(2008-3#1)(2013-1#2)
guideline is##2##2##(1996-1#1)(2008-10#1)
guideline on the##2##3##(2008-10#1)(2010-10#1)
guideline recommendations##2##2##(2008-3#1)(2013-1#1)
guideline values for recreational##2##4##(2008-10#2)
guideline values for##4##3##(2008-10#4)
guideline##73##1##(1990-11#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-6#2)(1996-1#3)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#5)(2008-6#7)(2008-7#1)(2008-8#4)(2009-7#1)(2010-10#3)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#2)
guidelines aimed##2##2##(2008-9#1)(2013-1#1)
guidelines and policies##2##3##(1992-2#1)(2007-2#1)
guidelines and regulations##4##3##(1995-3#1)(2008-4#1)(2008-9#2)
guidelines and training##2##3##(1993-1#1)(2008-1#1)
guidelines and##35##2##(1990-9#1)(1992-2#1)(1993-1#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)
guidelines are presented##2##3##(2008-4#1)(2009-7#1)
guidelines are##10##2##(1993-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
guidelines as##3##2##(1991-12#1)(1993-12#1)(1994-3#1)
guidelines by##2##2##(2008-12#1)(2009-11#1)
guidelines can##2##2##(1994-3#1)(2011-1#1)
guidelines concerning##2##2##(1996-4#1)(2008-11#1)
guidelines define##2##2##(2008-7#1)(2013-1#1)
guidelines exist##2##2##(1991-3#1)(2008-12#1)
guidelines for clinical research##2##4##(2010-9#1)(2012-2#1)
guidelines for clinical##4##3##(1993-12#1)(1996-9#1)(2010-9#1)(2012-2#1)
guidelines for defining##2##3##(1991-8#1)(1992-3#1)
guidelines for developing##2##3##(1992-12#1)(2012-2#1)
guidelines for diagnosis##2##3##(1997-3#1)(2013-1#1)
guidelines for diagnostic##2##3##(1993-12#1)(2013-1#1)
guidelines for evaluating the##2##4##(1991-1#1)(2008-10#1)
guidelines for evaluating##5##3##(1991-1#1)(1997-7#1)(2008-10#1)(2008-7#2)
guidelines for infant##2##3##(1996-12#1)(2012-2#1)
guidelines for its##2##3##(1993-12#1)(2010-12#1)
guidelines for occupational##2##3##(1993-12#1)(1994-12#1)
guidelines for patients with##2##4##(2008-3#2)
guidelines for patients##3##3##(2008-3#2)(2008-8#1)
guidelines for selecting##2##3##(2008-9#1)(2009-4#1)
guidelines for the clinical##2##4##(1992-3#1)(2012-12#1)
guidelines for the management of patients with##2##7##(2008-3#2)
guidelines for the management of##8##5##(2007-12#1)(2008-3#3)(2008-9#1)(2010-12#1)(2012-12#2)
guidelines for the treatment of##5##5##(1995-12#1)(2008-11#1)(2008-9#2)(2012-3#1)
guidelines for the use of contrast agents in liver ultrasound##2##10##(2008-7#2)
guidelines for the use of##5##5##(2007-11#1)(2007-2#1)(2008-7#2)(2010-8#1)
guidelines for the##33##3##(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#3)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
guidelines for treatment of##2##4##(2008-10#1)(2008-6#1)
guidelines for universal precautions##2##4##(2010-3#2)
guidelines for working with pathogenic and infectious microorganisms##2##8##(2008-4#1)(2008-9#1)
guidelines for##142##2##(1990-2#1)(1990-6#1)(1991-1#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-12#4)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#4)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#6)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#1)
guidelines from##2##2##(2008-11#1)(2008-3#1)
guidelines has##3##2##(1993-12#1)(2008-10#1)(2009-4#1)
guidelines have been##3##3##(1995-11#1)(2008-11#1)(2008-3#1)
guidelines have##9##2##(1995-11#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-3#2)(2010-5#1)(2010-9#1)(2011-1#1)
guidelines in a##2##3##(1995-2#1)(2012-12#1)
guidelines in the##3##3##(1991-12#1)(1994-3#1)(2012-2#1)
guidelines in##19##2##(1991-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#1)
guidelines is##3##2##(1994-3#1)(2008-1#1)(2013-1#1)
guidelines issued by##2##3##(1996-9#1)(2008-7#1)
guidelines of the##5##3##(1991-4#1)(1994-6#1)(1997-2#1)(2008-10#1)(2012-2#1)
guidelines of##10##2##(1990-3#1)(1991-3#1)(1991-4#1)(1993-2#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
guidelines on clinical##2##3##(2008-11#1)(2012-2#1)
guidelines on the management of##2##5##(2008-3#2)
guidelines on the use of##2##5##(1993-2#1)(2008-10#1)
guidelines on the##6##3##(1993-2#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
guidelines on##19##2##(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#2)
guidelines or##2##2##(1996-12#1)(1996-8#1)
guidelines provide##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
guidelines recommend##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2009-1#1)(2013-1#1)
guidelines regarding the##2##3##(2009-6#1)(2012-12#1)
guidelines regarding##4##2##(2008-1#1)(2009-6#1)(2011-2#1)(2012-12#1)
guidelines represent##3##2##(1994-1#1)(2007-12#1)(2013-7#1)
guidelines should##4##2##(1990-6#1)(1996-1#1)(1996-3#1)(2010-8#1)
guidelines that##8##2##(1993-12#1)(1993-2#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-5#1)(2012-2#1)
guidelines to assist##2##3##(1992-3#1)(2008-10#1)
guidelines to##17##2##(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
guidelines was##3##2##(1996-3#1)(2012-2#1)(2013-8#1)
guidelines were##8##2##(1990-6#2)(2008-1#1)(2010-3#1)(2010-9#1)(2013-1#2)(2013-8#1)
guidelines which##2##2##(1996-12#1)(2010-6#1)
guidelines will##3##2##(2008-3#1)(2008-8#1)(2013-7#1)
guidelines with##3##2##(1997-1#1)(2007-12#1)(2012-12#1)
guidelines##508##1##(1990-2#1)(1990-3#2)(1990-6#7)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#3)(1992-12#3)(1992-2#3)(1992-3#4)(1992-6#1)(1992-8#4)(1993-1#1)(1993-12#14)(1993-2#4)(1993-3#2)(1994-1#2)(1994-12#5)(1994-2#6)(1994-3#11)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#5)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#2)(1996-6#1)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#5)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#13)(2008-10#22)(2008-11#25)(2008-12#15)(2008-2#1)(2008-3#25)(2008-4#8)(2008-5#4)(2008-6#7)(2008-7#20)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#3)(2009-4#6)(2009-5#3)(2009-6#6)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#5)(2010-4#1)(2010-5#11)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#10)(2011-1#5)(2011-10#1)(2011-2#19)(2011-3#1)(2012-1#4)(2012-12#15)(2012-2#18)(2012-3#9)(2013-1#19)(2013-7#3)(2013-8#8)
guidelines)##2##1##(2008-10#1)(2008-4#1)
guidelines?##4##1##(1994-3#1)(2008-3#1)(2012-12#1)(2012-3#1)
guidelines]##4##1##(1990-2#1)(1997-4#1)(2008-10#1)(2011-3#1)
guides and##2##2##(1991-3#1)(2011-2#1)
guides are##2##2##(2008-3#1)(2011-2#1)
guides the##7##2##(1993-3#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
guides to##2##2##(1994-3#1)(1996-2#1)
guides##31##1##(1991-3#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
guidewire##7##1##(1997-3#1)(1997-6#1)(2010-12#4)(2013-7#1)
guidewires##3##1##(1997-3#2)(2013-1#1)
guiding catheters##2##2##(2011-2#2)
guiding filters##3##2##(2007-12#3)
guiding in##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
guiding percutaneous##2##2##(2010-12#1)(2011-2#1)
guiding principle for##2##3##(1994-12#1)(2008-2#1)
guiding principle##4##2##(1994-12#1)(1994-6#1)(2007-11#1)(2008-2#1)
guiding principles for complementary feeding##2##5##(2010-6#2)
guiding principles for##3##3##(1994-3#1)(2010-6#2)
guiding principles##8##2##(1994-3#1)(1995-3#1)(1997-1#1)(2008-11#1)(2010-6#2)(2011-1#2)
guiding questions##2##2##(2008-11#1)(2012-3#1)
guiding the development of##2##4##(1993-1#1)(2008-9#1)
guiding the##13##2##(1990-2#1)(1993-1#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-8#1)
guiding##70##1##(1990-10#1)(1990-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-7#1)(2007-11#8)(2007-12#9)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#6)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#1)(2010-12#2)(2010-6#3)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-8#1)
guild structure##2##2##(2010-8#1)(2012-2#1)
guild##5##1##(2008-8#1)(2010-8#2)(2012-2#1)(2012-3#1)
guilds of##2##2##(2008-8#1)(2008-9#1)
guilds##18##1##(1993-1#1)(1997-5#1)(2008-6#2)(2008-8#6)(2008-9#3)(2010-8#4)(2013-7#1)
guilliermondii##4##1##(2008-5#2)(2011-1#2)
guilt##12##1##(1990-6#1)(1992-2#1)(1996-11#1)(1997-7#1)(2007-7#1)(2009-10#2)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)
guilt-proneness##2##1##(2009-11#2)
guilty of##4##2##(1993-2#1)(1993-3#1)(1994-12#1)(2012-2#1)
guilty##10##1##(1993-2#1)(1993-3#1)(1994-12#1)(1996-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
guinea pig and##3##3##(1990-2#2)(1994-12#1)
guinea pig chief cells by##2##5##(1995-8#2)
guinea pig chief cells##5##4##(1995-8#5)
guinea pig hearts##3##3##(1992-6#1)(1995-12#1)(1996-9#1)
guinea pig hippocampal slices##2##4##(1990-7#1)(1991-12#1)
guinea pig ileum longitudinal muscle/myenteric plexus##2##6##(1995-12#2)
guinea pig ileum##11##3##(1991-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#4)(1995-3#1)(2008-7#2)
guinea pig liver transglutaminase##3##4##(1992-8#3)
guinea pig liver##5##3##(1992-11#2)(1992-8#3)
guinea pig lung membrane##2##4##(1992-12#2)
guinea pig tissues##3##3##(1992-3#1)(1992-9#1)(2013-1#1)
guinea pig##78##2##(1990-2#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#3)(1992-12#3)(1992-3#5)(1992-6#4)(1992-8#4)(1992-9#3)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#3)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-8#5)(1996-5#2)(1996-9#2)(1997-3#3)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-9#1)(2013-1#1)
guinea pigs##28##2##(1990-11#1)(1991-12#1)(1992-3#3)(1992-8#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#8)(1996-8#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-9#2)(2011-1#1)(2013-1#1)
guinea##108##1##(1990-11#1)(1990-2#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#3)(1992-12#3)(1992-3#8)(1992-6#4)(1992-8#5)(1992-9#3)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#13)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#5)(1996-5#2)(1996-8#1)(1996-9#2)(1997-3#3)(1997-7#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-9#1)(2011-1#1)(2013-1#2)
guinea-pig DDC##3##2##(1990-12#3)
guinea-pig brain tissue##2##3##(2008-2#2)
guinea-pig brain##3##2##(2008-2#3)
guinea-pig colon##2##2##(1997-4#2)
guinea-pig gallbladder##4##2##(1997-7#4)
guinea-pig ileum and##2##3##(1995-12#1)(1997-7#1)
guinea-pig ileum##3##2##(1990-5#1)(1995-12#1)(1997-7#1)
guinea-pig lung##2##2##(1990-5#2)
guinea-pig papillary muscles##2##3##(1995-12#2)
guinea-pig##42##1##(1990-12#5)(1990-5#4)(1994-11#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#8)(1997-4#3)(1997-7#8)(2008-2#5)(2008-9#1)(2009-12#2)
guinea-pigs##8##1##(1993-9#1)(1994-11#2)(1995-12#3)(2008-5#1)(2010-4#1)
guldehnes##4##1##(2008-3#4)
gulf between##3##2##(2008-5#1)(2010-4#1)(2011-3#1)
gulf##4##1##(1991-8#1)(2008-5#1)(2010-4#1)(2011-3#1)
gum and##3##2##(2008-5#2)(2010-3#1)
gum disease##2##2##(2010-9#2)
gum gel##2##2##(2008-7#1)(2010-3#1)
gum of acacia##4##3##(2008-5#4)
gum to##2##2##(1994-12#1)(2011-3#1)
gum xanthan##2##2##(2008-10#2)
gum##32##1##(1990-3#1)(1994-12#1)(2008-10#4)(2008-5#6)(2008-6#1)(2008-7#2)(2009-11#1)(2010-3#5)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#4)
gumming##3##1##(2008-10#3)
gummy smile##2##2##(2012-3#2)
gummy##3##1##(2008-10#1)(2012-3#2)
gums##2##1##(2011-2#1)(2012-3#1)
gun##11##1##(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#3)(2011-2#3)(2013-1#1)
guns##3##1##(1996-1#1)(1997-2#1)(1997-3#1)
gunshot##5##1##(1995-11#1)(2008-9#1)(2010-12#1)(2012-2#2)
guppies from high-predation environments##2##4##(2008-8#2)
guppies from##4##2##(2008-8#3)(2012-3#1)
guppies in##2##2##(2008-8#2)
guppies##13##1##(2008-8#11)(2012-3#2)
guppy populations##2##2##(2008-8#2)
guppy##8##1##(1991-9#1)(2008-8#6)(2012-3#1)
gurken##2##1##(2008-10#2)
gustatory and##3##2##(1993-12#3)
gustatory cortex##2##2##(1996-5#1)(2008-11#1)
gustatory neurons in the##2##4##(2009-10#2)
gustatory neurons##5##2##(2009-10#5)
gustatory##19##1##(1992-11#4)(1993-12#6)(1996-5#1)(2008-11#2)(2008-2#1)(2009-10#5)
gut and##8##2##(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)
gut bacteria##3##2##(2011-1#1)(2011-2#2)
gut barrier##3##2##(2008-10#3)
gut commensal microflora##2##3##(2011-2#2)
gut commensal##3##2##(2011-2#3)
gut contents of##2##3##(2008-5#2)
gut flora##2##2##(2010-10#1)(2012-2#1)
gut microbiota##6##2##(2011-2#4)(2012-1#1)(2012-2#1)
gut or##2##2##(2008-10#2)
gut retention time##2##3##(2008-9#2)
gut##100##1##(1990-12#1)(1990-5#1)(1991-8#1)(1992-6#3)(1993-6#3)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#3)(1997-1#1)(2007-12#7)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#4)(2008-8#1)(2008-9#2)(2009-1#1)(2010-1#2)(2010-10#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#18)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
gut-associated##3##1##(2012-2#3)
gutD##2##1##(2008-8#2)
guts and##2##2##(2008-5#1)(2008-6#1)
guts##4##1##(2008-5#1)(2008-6#2)(2008-7#1)
gutta-percha##3##1##(1991-3#1)(2009-8#1)(2013-1#1)
guttation fluid##4##2##(2008-10#4)
guttation##9##1##(2008-10#9)
gymnasium##2##1##(1997-6#1)(2012-12#1)
gymnastics##3##1##(2011-2#1)(2012-12#2)
gymnasts##3##1##(2011-2#2)(2012-12#1)
gymnasts'##2##1##(2011-2#2)
gymnosperm##2##1##(2008-7#2)
gymnotiform fish##2##2##(1995-12#1)(1996-5#1)
gymnotiform##3##1##(1995-12#2)(1996-5#1)
gynaecological and urological wards##2##4##(2008-10#2)
gynaecological and##3##2##(2008-10#2)(2012-2#1)
gynaecological surgery##2##2##(2011-2#1)(2012-2#1)
gynaecological##9##1##(1995-6#1)(1996-12#1)(2008-10#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
gynaecologists##2##1##(1996-6#1)(2012-2#1)
gynaecology##4##1##(2007-7#1)(2008-12#1)(2010-8#2)
gynaecomastia##5##1##(2008-10#1)(2012-1#4)
gynecologic cancer##2##2##(1991-3#1)(2007-8#1)
gynecologic examination##2##2##(1990-2#2)
gynecologic malignancies##2##2##(1993-6#1)(2012-3#1)
gynecologic malignancy##4##2##(1991-3#2)(2010-7#1)(2013-8#1)
gynecologic##25##1##(1990-2#2)(1991-3#4)(1992-1#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1995-12#1)(1996-3#1)(2007-8#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-8#1)
gynecological and##2##2##(1990-2#1)(1996-12#1)
gynecological examination##2##2##(1991-2#1)(1996-12#1)
gynecological##20##1##(1990-10#1)(1990-2#1)(1991-2#1)(1993-3#1)(1996-12#2)(1996-3#1)(1996-9#1)(2008-1#2)(2008-12#2)(2009-3#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
gynecologist##3##1##(1991-6#1)(1992-2#1)(2011-2#1)
gynecologist's office##2##2##(1991-6#1)(2007-10#1)
gynecologists##5##1##(1991-3#1)(1991-6#1)(1992-2#1)(2011-2#1)(2012-3#1)
gynecology##8##1##(1992-12#1)(1993-12#1)(1994-3#2)(1996-2#2)(2008-4#1)(2012-12#1)
gynecology]##4##1##(1991-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
gyno-carp##3##1##(2008-7#3)
gynodioecious##3##1##(2008-9#3)
gynoecial##2##1##(2008-10#2)
gynogenesis##3##1##(2008-9#3)
gynogenetic trait and##2##3##(2008-9#2)
gynogenetic##8##1##(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-8#1)
gypseum##4##1##(2012-3#4)
gypsum application##4##2##(2008-12#4)
gypsum##13##1##(2008-10#1)(2008-12#10)(2013-1#2)
gypsy moth##2##2##(2008-9#2)
gypsy moths##2##2##(2008-9#2)
gypsy##4##1##(2008-9#4)
gyrA gene##2##2##(1994-12#2)
gyrA##7##1##(1994-12#6)(1995-8#1)
gyrB gene##2##2##(1994-12#2)
gyrB##5##1##(1994-12#3)(1996-12#1)(2011-1#1)
gyrase##6##1##(1994-12#3)(1995-6#1)(1995-8#2)
gyration##6##1##(2008-2#2)(2008-3#2)(2012-2#2)
gyri##3##1##(2007-8#1)(2008-9#1)(2013-7#1)
gyro##7##1##(2007-11#1)(2007-12#6)
gyroscope##6##1##(2007-12#2)(2008-2#2)(2008-3#2)
gyroscopes##4##1##(2008-3#4)
gyrotron beam##2##2##(2007-9#2)
gyrotron##10##1##(2007-9#5)(2011-1#5)
gyrotropic crystals##2##2##(2006-4#2)
gyrotropic##3##1##(2006-4#2)(2008-3#1)
gyrus and the##2##3##(1996-2#1)(1996-5#1)
gyrus and##9##2##(1991-2#1)(1994-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(2008-11#2)(2009-8#1)
gyrus of the##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
gyrus of##8##2##(1994-8#2)(1995-12#2)(1996-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
gyrus##82##1##(1990-5#2)(1990-7#5)(1991-2#2)(1991-5#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#5)(1995-12#13)(1995-8#1)(1996-12#6)(1996-2#5)(1996-5#2)(1996-7#3)(1997-2#1)(1997-6#3)(2008-11#14)(2008-12#1)(2008-7#2)(2009-2#2)(2009-8#3)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
gz = 2##3##3##(1993-8#3)
gz = 3##4##3##(1993-8#4)
gz =##7##2##(1993-8#7)
généralement##2##1##(2011-2#1)(2013-1#1)
h BDL##2##2##(1995-11#2)
h DNA-unwinding time##2##3##(1997-4#2)
h PI##3##2##(2008-10#3)
h a##2##2##(1995-11#1)(2008-9#1)
h after CCl4##3##3##(1994-5#3)
h after UV-C treatment##2##4##(2008-10#2)
h after a single##4##4##(1995-12#3)(1995-3#1)
h after a##5##3##(1995-12#3)(1995-3#1)(2008-10#1)
h after administration##2##3##(1995-3#1)(1995-5#1)
h after an##2##3##(1997-2#1)(2012-3#1)
h after application##3##3##(2008-10#2)(2008-5#1)
h after birth##2##3##(2008-10#2)
h after drug##2##3##(1994-2#2)
h after feeding)##2##3##(2010-2#2)
h after injection##3##3##(1990-5#1)(1995-5#1)(2010-5#1)
h after injury##3##3##(2008-7#3)
h after inoculation and incubation at 20 degrees C##2##9##(2008-10#2)
h after inoculation and##5##4##(2008-10#5)
h after inoculation were##2##4##(2008-10#1)(2008-5#1)
h after inoculation##35##3##(2008-10#32)(2008-11#1)(2008-5#2)
h after operation##2##3##(2007-8#1)(2008-12#1)
h after oral##2##3##(1992-11#1)(2008-11#1)
h after pretreatment##2##3##(1991-2#1)(2008-10#1)
h after serum stimulation##2##4##(1997-1#2)
h after the beginning of##2##5##(2008-10#2)
h after the incubation##2##4##(2008-11#2)
h after the onset of##2##5##(2008-10#1)(2010-10#1)
h after the operation##2##4##(1992-12#1)(2008-7#1)
h after the##28##3##(1990-5#1)(1992-10#1)(1992-12#2)(1992-3#1)(1994-5#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-7#2)(2008-10#7)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
h after treatment##10##3##(1990-10#1)(1990-2#2)(1992-8#1)(2008-10#5)(2012-3#1)
h after wounding##2##3##(1997-2#1)(2008-7#1)
h after##183##2##(1990-10#1)(1990-2#2)(1990-5#2)(1990-6#1)(1991-2#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-3#2)(1993-8#1)(1994-2#3)(1994-5#5)(1994-6#1)(1995-11#5)(1995-12#8)(1995-3#7)(1995-5#3)(1995-8#1)(1996-12#3)(1996-2#1)(1997-1#2)(1997-2#4)(1997-7#3)(2007-8#3)(2008-10#67)(2008-11#9)(2008-12#2)(2008-3#2)(2008-5#7)(2008-7#8)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-2#4)(2012-1#1)(2012-3#3)(2013-1#1)
h and 3##2##3##(2008-10#1)(2008-12#1)
h and 6##2##3##(1995-5#1)(2008-10#1)
h and is##2##3##(2008-11#1)(2012-12#1)
h and the R##2##4##(2008-10#2)
h and the##5##3##(2008-10#5)
h and then##6##3##(1992-8#1)(1997-2#2)(2008-10#1)(2008-7#1)(2008-8#1)
h and##70##2##(1990-5#1)(1990-7#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-8#2)(1994-2#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#2)(1996-12#2)(1996-2#1)(1997-2#3)(1997-4#1)(2007-2#1)(2008-10#23)(2008-11#2)(2008-12#5)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-6#1)(2010-5#1)(2012-12#1)(2012-2#1)
h as compared##2##3##(1992-11#1)(1995-3#1)
h at 20 degrees C##3##5##(2008-10#3)
h at 25##2##3##(2008-10#1)(2008-5#1)
h at 37 degrees C##3##5##(1990-12#1)(1992-6#1)(2010-3#1)
h at 37 degrees##4##4##(1990-12#2)(1992-6#1)(2010-3#1)
h at all##2##3##(2008-10#2)
h at the##2##3##(1993-12#1)(1997-2#1)
h at##39##2##(1990-12#2)(1990-5#1)(1992-6#1)(1993-12#2)(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-3#1)(2011-2#1)(2013-1#3)
h before inoculation with R##2##5##(2008-10#2)
h before inoculation with##3##4##(2008-10#3)
h before inoculation##4##3##(2008-10#4)
h before the##7##3##(1992-8#1)(1995-3#1)(1995-5#1)(1996-5#2)(2007-11#1)(2008-7#1)
h before##27##2##(1991-2#1)(1992-8#1)(1993-3#1)(1995-3#2)(1995-5#2)(1996-5#2)(1996-7#1)(2007-11#1)(2008-10#7)(2008-12#2)(2008-5#2)(2008-7#2)(2010-8#2)(2012-2#1)
h but not##2##3##(1994-5#1)(1997-1#1)
h but##4##2##(1990-12#1)(1994-5#1)(1997-1#1)(2008-7#1)
h by a##2##3##(1993-1#1)(1997-4#1)
h by##8##2##(1993-1#1)(1997-4#1)(1997-6#1)(2008-10#3)(2009-6#1)(2010-5#1)
h cold storage in Bretschneider's##2##5##(2007-8#2)
h compared to##3##3##(1992-11#1)(2008-10#1)(2008-5#1)
h compared with##2##3##(2008-10#1)(2012-2#1)
h compared##5##2##(1992-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
h cultures##5##2##(1993-6#1)(2008-12#1)(2013-1#3)
h dark##2##2##(2008-10#1)(2008-11#1)
h exposure to##4##3##(1997-7#1)(2008-11#1)(2010-4#1)(2013-1#1)
h exposure##8##2##(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-4#1)(2013-1#1)
h following HI##2##3##(1996-12#2)
h following antigen##3##3##(1992-3#3)
h following inoculation##4##3##(2008-10#4)
h following the##3##3##(1992-8#1)(2008-7#2)
h following##21##2##(1992-3#4)(1992-8#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-2#1)(2008-10#6)(2008-7#3)(2009-8#1)(2010-8#1)
h for a##2##3##(1994-2#1)(2008-10#1)
h for both##2##3##(1995-12#1)(2011-2#1)
h for##22##2##(1992-3#1)(1992-8#1)(1994-2#1)(1995-12#4)(1995-5#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
h from##3##2##(2008-10#2)(2010-8#1)
h groups##2##2##(2008-9#2)
h in a flow-injection system##2##5##(2008-10#2)
h in a##5##3##(1993-6#1)(2008-10#2)(2008-8#1)(2012-3#1)
h in culture##2##3##(1990-5#1)(1994-3#1)
h in duration##2##3##(2008-10#2)
h in the absence of##2##5##(2008-10#1)(2008-6#1)
h in the presence of##6##5##(1992-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)
h in the##13##3##(1992-8#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)
h in vitro##2##3##(1995-11#2)
h in##43##2##(1990-5#1)(1991-2#1)(1992-8#2)(1993-6#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#2)(2007-8#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
h incubation##7##2##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)
h intervals##3##2##(1995-5#1)(2008-12#2)
h is##4##2##(1994-12#1)(2008-10#1)(2008-3#2)
h later##10##2##(1990-3#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-2#1)(1996-5#1)(2008-11#2)(2013-7#1)
h light##3##2##(2008-11#1)(2009-6#1)(2010-8#1)
h of a##2##3##(2007-12#1)(2007-2#1)
h of air drying##2##4##(2008-10#2)
h of continuous##3##3##(1997-6#1)(2008-10#2)
h of cultivation##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
h of culture##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)
h of darkness##2##3##(1995-12#1)(2008-10#1)
h of exposure to##6##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
h of exposure##12##3##(1995-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)
h of humidity##2##3##(2008-10#1)(2008-2#1)
h of hypoxia##2##3##(1994-2#1)(1996-12#1)
h of incubation with##2##4##(2008-10#1)(2008-11#1)
h of incubation##12##3##(1992-8#2)(1994-8#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2012-2#1)
h of inoculation##5##3##(2008-10#5)
h of leaf wetness##2##4##(2008-10#2)
h of light exposure##2##4##(2008-5#2)
h of light##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#2)
h of reperfusion##2##3##(1995-12#1)(1996-12#1)
h of storage##2##3##(2008-10#2)
h of the##5##3##(1992-6#1)(1993-3#1)(2007-8#1)(2008-10#2)
h of treatment with 50##2##5##(1995-8#2)
h of treatment with##4##4##(1992-11#1)(1995-8#2)(2007-12#1)
h of treatment##5##3##(1992-11#1)(1995-8#3)(2007-12#1)
h of wetness for##2##4##(2008-10#2)
h of wetness##6##3##(2008-10#6)
h of##128##2##(1990-10#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#4)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#6)(1995-3#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-6#2)(2007-12#3)(2007-2#2)(2007-8#2)(2008-10#35)(2008-11#11)(2008-12#2)(2008-2#4)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
h on##5##2##(1993-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
h or greater##2##3##(2008-10#2)
h or more before##2##4##(2008-10#2)
h or##12##2##(1990-12#1)(1995-11#1)(1995-12#2)(2008-10#5)(2008-11#1)(2008-2#2)
h p##2##2##(2007-6#2)
h per day##3##3##(2008-10#3)
h per##4##2##(1991-5#1)(2008-10#3)
h period##7##2##(1990-2#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
h post administration##2##3##(2008-10#2)
h post infection and##2##4##(1997-4#1)(2008-11#1)
h post infection##4##3##(1997-4#2)(2008-11#2)
h post##8##2##(1997-4#2)(2008-10#2)(2008-11#2)(2008-12#2)
h post-antigen)##2##2##(1992-3#2)
h post-infection in##3##3##(1996-12#3)
h post-infection##9##2##(1996-12#4)(1997-4#2)(2007-6#1)(2008-11#2)
h post-mortem##6##2##(2008-7#6)
h post-treatment##2##2##(2009-12#1)(2011-2#1)
h postinoculation (hpi)##2##3##(2008-10#2)
h postinoculation##6##2##(2008-10#6)
h prior to##10##3##(1992-8#1)(1995-12#1)(2008-10#6)(2008-7#1)(2011-2#1)
h prior##11##2##(1992-8#1)(1995-12#1)(2008-10#7)(2008-7#1)(2011-2#1)
h reperfusion##2##2##(1995-12#1)(2013-1#1)
h reperfusion)##2##2##(1995-12#1)(2012-2#1)
h respectively##2##2##(1996-2#1)(2008-9#1)
h resulted in##3##3##(1997-4#1)(2008-10#1)(2008-7#1)
h show little##2##3##(1995-11#2)
h significantly##3##2##(2008-10#3)
h than did##2##3##(2008-10#2)
h than##3##2##(1996-2#1)(2008-10#2)
h to determine##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
h to##16##2##(1993-12#1)(1993-5#1)(1993-9#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
h treatment##2##2##(1994-2#1)(2008-12#1)
h under##5##2##(1993-6#1)(1994-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
h using##2##2##(2008-5#1)(2013-1#1)
h was##10##2##(1990-2#1)(2008-10#6)(2008-7#1)(2010-3#1)(2012-2#1)
h were##4##2##(2008-10#2)(2008-7#1)(2010-5#1)
h when a##3##3##(2008-10#2)(2008-11#1)
h when the##2##3##(2008-10#1)(2008-6#1)
h when##5##2##(2008-10#3)(2008-11#1)(2008-6#1)
h whereas##2##2##(2007-12#1)(2008-4#1)
h which##2##2##(1995-11#1)(2008-10#1)
h with a##4##3##(2008-10#3)(2008-6#1)
h with the##3##3##(2008-6#1)(2008-7#2)
h with various##2##3##(1993-11#1)(2008-11#1)
h with##20##2##(1993-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(2008-10#5)(2008-11#3)(2008-6#2)(2008-7#4)
h without##4##2##(1994-3#1)(1996-2#1)(1996-5#1)(2008-10#1)
h##1270##1##(1990-10#2)(1990-11#1)(1990-12#10)(1990-2#4)(1990-3#4)(1990-5#5)(1990-6#2)(1990-7#4)(1991-12#1)(1991-2#8)(1991-3#3)(1991-5#3)(1991-8#1)(1991-9#5)(1992-10#2)(1992-11#9)(1992-12#4)(1992-3#13)(1992-6#5)(1992-8#20)(1993-1#1)(1993-11#3)(1993-12#18)(1993-3#5)(1993-5#4)(1993-6#3)(1993-8#7)(1993-9#2)(1994-12#4)(1994-2#11)(1994-3#6)(1994-5#12)(1994-6#3)(1994-8#7)(1994-9#1)(1995-11#23)(1995-12#34)(1995-2#3)(1995-3#20)(1995-5#13)(1995-6#3)(1995-8#8)(1995-9#1)(1996-12#21)(1996-2#20)(1996-5#10)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#15)(1997-4#17)(1997-6#5)(1997-7#7)(2007-11#4)(2007-12#12)(2007-2#4)(2007-5#1)(2007-6#3)(2007-8#16)(2008-10#387)(2008-11#67)(2008-12#36)(2008-2#12)(2008-3#10)(2008-4#4)(2008-5#44)(2008-6#24)(2008-7#64)(2008-8#24)(2008-9#24)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#5)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-2#5)(2010-3#8)(2010-4#1)(2010-5#9)(2010-6#3)(2010-8#8)(2011-1#7)(2011-2#22)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#5)(2013-1#27)(2013-7#1)(2013-8#6)
h(-1) and a relative standard deviation of less than 0##2##10##(2008-10#2)
h(-1) and a relative standard deviation of##3##7##(2008-10#3)
h(-1) and a##4##3##(2008-10#4)
h(-1) and##10##2##(2008-10#9)(2008-7#1)
h(-1) at##2##2##(2008-10#1)(2011-2#1)
h(-1) can be##3##3##(2008-10#3)
h(-1) for##6##2##(2008-10#6)
h(-1) in##2##2##(2008-11#1)(2008-12#1)
h(-1) was achieved##2##3##(2008-10#2)
h(-1) was##5##2##(2008-10#5)
h(-1) were achieved##4##3##(2008-10#4)
h(-1) were##6##2##(2008-10#6)
h(-1) with##4##2##(2008-10#4)
h(-1) without##2##2##(2008-10#1)(2011-2#1)
h(-1)##140##1##(2008-10#123)(2008-11#5)(2008-12#4)(2008-7#5)(2011-2#2)(2011-3#1)
h(-1)) and##3##2##(2008-10#2)(2008-6#1)
h(-1))##12##1##(2008-10#8)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
h(0)##2##1##(2011-2#2)
h(1)/t(1)##2##1##(2008-10#2)
h(3)/h(1)##2##1##(2008-10#2)
h(4)/h(1)##2##1##(2008-10#2)
h(5)/h(1)##2##1##(2008-10#2)
h(i)##2##1##(2008-10#1)(2012-2#1)
h) after the##2##3##(1997-7#1)(2010-2#1)
h) and##9##2##(1994-3#1)(1996-2#1)(2008-10#4)(2008-5#1)(2011-3#1)(2012-2#1)
h) exposure of at least##3##5##(2008-9#3)
h) exposure to 1 microM RO 11-2933##2##7##(1990-2#2)
h) exposure##5##2##(1990-2#2)(2008-9#3)
h) for##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
h) in##3##2##(1991-8#1)(1994-2#1)(2008-10#1)
h) is##2##2##(1997-1#1)(2008-10#1)
h) of##3##2##(1995-11#1)(2008-4#1)(2009-6#1)
h) than##2##2##(2008-10#1)(2008-6#1)
h) to##2##2##(1993-12#1)(1994-6#1)
h) was##3##2##(1993-12#1)(1993-6#2)
h) which##2##2##(1992-3#1)(1995-3#1)
h) with##4##2##(1994-8#1)(1995-2#1)(2008-10#1)(2011-2#1)
h)##88##1##(1990-12#1)(1990-2#2)(1991-3#3)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-6#2)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-4#3)(1997-7#1)(2007-8#2)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#3)(2009-3#1)(2009-6#2)(2010-10#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
h)anthracene##2##1##(2008-10#2)
h*##5##1##(1996-4#5)
h- and l-CaDs##2##3##(1993-11#2)
h-1 (mu_max = 0##2##4##(2008-11#2)
h-1 and 0##3##3##(2008-11#3)
h-1 in##2##2##(1994-3#1)(2008-11#1)
h-1##11##1##(1994-3#3)(2008-11#8)
h-1)##6##1##(1995-12#4)(2008-11#2)
h-CaD##2##1##(1993-11#2)
h-GH##3##1##(2013-1#3)
h-TR beta 1 was##2##4##(1993-8#2)
h-TR beta 1##7##3##(1991-2#2)(1993-8#5)
h-lysozyme##2##1##(1990-12#2)
h/72##2##1##(1996-12#2)
h/d(s)##3##1##(2008-3#3)
h/day##2##1##(2008-10#1)(2010-2#1)
hALR##3##1##(2008-8#3)
hASCs##6##1##(2012-5#3)(2012-6#3)
hAT2R cDNA##2##2##(1994-11#2)
hAT2R##5##1##(1994-11#5)
hB(1)-bradykinin##2##1##(2008-4#2)
hBD-2 mRNA induction##2##3##(2008-11#2)
hBD-2 mRNA##4##2##(2008-11#4)
hBD-2##5##1##(2008-11#5)
hBD2 and hBD3##2##3##(2008-5#2)
hBD2##3##1##(2008-5#3)
hBD3##3##1##(2008-5#3)
hBM-MSCs##3##1##(2009-12#3)
hCG and##4##2##(1993-6#1)(1994-3#1)(1996-12#1)(1996-5#1)
hCG injection##2##2##(1994-9#1)(2008-9#1)
hCG levels##3##2##(1994-3#1)(2011-1#2)
hCG##29##1##(1990-5#1)(1992-8#1)(1993-6#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#2)(1996-5#4)(1997-1#3)(1997-4#4)(2008-5#2)(2008-6#1)(2008-9#1)(2011-1#2)
hCGalpha cDNA##2##2##(1995-8#2)
hCMV##2##1##(2008-11#1)(2008-9#1)
hCNTF##3##1##(1991-6#3)
hCaT1 in the CHO cells##2##5##(2008-11#2)
hCaT1 was##3##2##(2008-11#3)
hCaT1##10##1##(2008-11#10)
hCo4##3##1##(2008-8#3)
hCtr1##2##1##(2010-11#2)
hEPO##3##1##(2008-8#3)
hER##3##1##(1995-11#3)
hERO##3##1##(1993-6#3)
hESC developmental potential are##2##4##(2008-9#2)
hESC lines##5##2##(2008-11#3)(2008-9#2)
hESC##16##1##(2008-11#5)(2008-9#9)(2009-3#2)
hESCs##3##1##(2009-3#2)(2012-5#1)
hEp cDNA##2##2##(1993-6#2)
hEp genomic##3##2##(1993-12#1)(1993-6#2)
hEp##13##1##(1993-12#4)(1993-6#9)
hFGF-10##5##1##(2011-3#5)
hFIX and##2##2##(2008-8#1)(2008-9#1)
hFIX expression##3##2##(2008-8#3)
hFIX minigene##3##2##(2008-8#3)
hFIX##18##1##(2008-8#13)(2008-9#5)
hFIXR338A##6##1##(2008-9#6)
hFSH-beta-(33-53)##2##1##(1990-4#2)
hGH##6##1##(1995-11#2)(2008-11#1)(2010-4#1)(2013-1#2)
hIAPP islets##2##2##(1994-8#2)
hIAPP##5##1##(1994-8#5)
hIK1##7##1##(2008-8#7)
hIL-6 R##2##2##(2008-8#2)
hIL-6 and hIL-6R is##2##4##(2008-8#2)
hIL-6 and hIL-6R##3##3##(2008-8#3)
hIL-6 and##5##2##(2008-8#5)
hIL-6 gene##4##2##(2008-11#4)
hIL-6 production##2##2##(2008-11#2)
hIL-6 protein##2##2##(2008-11#2)
hIL-6##28##1##(1992-8#2)(2008-11#17)(2008-8#9)
hIL-6R##9##1##(2008-8#9)
hKGF##4##1##(1994-11#4)
hL-31##2##1##(1994-6#2)
hMPV##5##1##(2011-2#5)
hMSC##3##1##(2008-11#1)(2010-8#2)
hMSCs were##2##2##(2008-11#2)
hMSCs##14##1##(2008-11#7)(2010-8#5)(2012-7#2)
hMab##4##1##(2008-11#4)
hNE-Na##3##1##(1996-12#2)(2009-12#1)
hNa(v)1##7##1##(2008-8#7)
hOB cells##2##2##(1994-2#2)
hPC##2##1##(2008-12#2)
hPGC##2##1##(1995-3#2)
hPRL##3##1##(2008-11#3)
hPa##3##1##(2008-10#3)
hR##6##1##(1994-5#6)
hR)##3##1##(1994-5#1)(2008-12#2)
hRNA##2##1##(2008-9#2)
hSIM2##5##1##(1996-6#5)
hSTa##2##1##(1992-8#2)
hTERT alone##2##2##(2008-11#2)
hTERT as##2##2##(2008-11#2)
hTERT mRNA and##3##3##(2008-11#3)
hTERT to immortalize##2##3##(2008-11#2)
hTERT##20##1##(2008-11#20)
hTGF alpha##6##2##(1995-2#6)
hTNF cDNA##2##2##(2008-8#2)
hTNF##3##1##(2008-8#3)
hTPO##2##1##(1990-7#2)
hTR##3##1##(1991-6#2)(2008-9#1)
hTREK1##2##1##(2012-2#2)
hVDR protein##2##2##(1992-12#2)
hVDR##4##1##(1992-12#3)(1995-8#1)
hVEGF(165)##4##1##(2008-8#4)
hVN1R1##3##1##(2012-2#3)
hZIP4##2##1##(2008-10#2)
ha in##2##2##(2008-5#1)(2008-9#1)
ha of##3##2##(2008-10#3)
ha##13##1##(1996-5#1)(2007-5#1)(2008-10#7)(2008-5#2)(2008-9#1)(2010-2#1)
ha(-1) N##2##2##(2008-12#2)
ha(-1) with##2##2##(2008-12#2)
ha(-1)##24##1##(2008-12#24)
ha(-1)) and##3##2##(2008-12#3)
ha(-1)) were##2##2##(2008-12#2)
ha(-1))##7##1##(2008-12#7)
ha)##2##1##(2008-10#2)
habenula##3##1##(1991-5#1)(1996-12#2)
habenular##2##1##(1993-3#1)(1997-4#1)
habit formation##2##2##(2009-7#2)
habit in##4##2##(1991-6#1)(1993-9#1)(1994-8#1)(2012-3#1)
habit of##8##2##(1991-9#2)(1995-6#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)
habit##36##1##(1991-12#1)(1991-6#1)(1991-9#3)(1993-6#2)(1993-9#1)(1994-8#1)(1995-12#1)(1995-6#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2011-1#1)(2012-3#6)(2013-1#1)
habitat amount##3##2##(2008-8#3)
habitat and##4##2##(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)
habitat arrangement##2##2##(2008-8#2)
habitat but##2##2##(2008-5#1)(2008-8#1)
habitat choice##3##2##(2008-10#1)(2008-8#2)
habitat destruction##4##2##(2008-8#1)(2008-9#1)(2009-8#2)
habitat for##8##2##(2008-10#3)(2008-5#1)(2008-8#1)(2013-7#3)
habitat heterogeneity##3##2##(2008-8#2)(2013-7#1)
habitat in the##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
habitat in##6##2##(2008-10#1)(2008-8#2)(2008-9#3)
habitat is##5##2##(2008-10#2)(2008-9#2)(2013-7#1)
habitat loss##7##2##(2008-8#1)(2008-9#3)(2009-8#2)(2013-7#1)
habitat maps##4##2##(2007-5#4)
habitat networks##2##2##(2008-8#2)
habitat of##4##2##(2008-11#1)(2008-5#2)(2013-1#1)
habitat patch network##2##3##(2008-8#2)
habitat patch##5##2##(2008-8#5)
habitat patches##13##2##(2008-8#9)(2008-9#4)
habitat preference##2##2##(2008-8#2)
habitat preferences of##2##3##(2007-5#1)(2008-8#1)
habitat preferences##3##2##(2007-5#1)(2008-8#2)
habitat quality##8##2##(2008-5#1)(2008-8#5)(2008-9#2)
habitat saturation##5##2##(2008-8#5)
habitat selection behavior##2##3##(2008-8#2)
habitat selection by##2##3##(2010-8#2)
habitat selection##9##2##(2008-8#5)(2008-9#2)(2010-8#2)
habitat specialization##2##2##(2008-8#2)
habitat structure##5##2##(2008-8#1)(2013-7#4)
habitat suitability and##2##3##(2008-5#1)(2008-8#1)
habitat suitability##7##2##(2008-5#2)(2008-8#5)
habitat use and##2##3##(2010-8#2)
habitat use##3##2##(2010-8#3)
habitat variables##2##2##(2008-5#2)
habitat was##2##2##(2010-8#1)(2013-1#1)
habitat##207##1##(1992-1#1)(1993-12#1)(1995-3#1)(2007-5#6)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#93)(2008-9#25)(2009-2#2)(2009-5#2)(2009-8#6)(2010-6#1)(2010-8#10)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#15)
habitation of##3##2##(2008-10#1)(2011-2#2)
habitats and##6##2##(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-9#1)(2013-7#1)
habitats are##2##2##(2008-8#1)(2010-6#1)
habitats by##2##2##(2008-8#1)(2013-8#1)
habitats during the##3##3##(2008-8#3)
habitats for many##2##3##(2008-8#1)(2011-2#1)
habitats for##11##2##(1992-6#1)(2008-6#1)(2008-8#4)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
habitats have##2##2##(2008-8#1)(2013-7#1)
habitats in the##2##3##(2008-8#1)(2010-8#1)
habitats in##6##2##(2008-5#1)(2008-8#3)(2010-8#1)(2011-1#1)
habitats may be##2##3##(2008-11#1)(2008-8#1)
habitats of the##3##3##(2008-5#2)(2013-7#1)
habitats of##7##2##(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)(2013-7#1)
habitats that##2##2##(2007-12#1)(2013-1#1)
habitats to##2##2##(2008-5#1)(2008-8#1)
habitats used by Aedes aegypti in##2##6##(2007-10#2)
habitats were##6##2##(2007-10#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-9#1)
habitats where##2##2##(2008-8#1)(2012-2#1)
habitats with##3##2##(2008-10#2)(2010-8#1)
habitats##118##1##(1992-6#1)(1996-4#1)(2007-10#3)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#38)(2008-9#7)(2009-10#1)(2009-6#1)(2010-3#1)(2010-6#4)(2010-8#6)(2011-1#3)(2011-2#6)(2012-2#5)(2012-9#2)(2013-1#2)(2013-7#8)(2013-8#1)
habits among the##2##3##(1992-8#1)(1995-6#1)
habits among##3##2##(1992-8#1)(1993-2#1)(1995-6#1)
habits and##16##2##(1992-3#1)(1994-6#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#2)(2010-7#1)(2012-12#2)(2012-2#2)(2013-1#1)
habits are##7##2##(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-6#1)(2013-7#1)
habits as##2##2##(1991-2#1)(1996-3#1)
habits in the##2##3##(1995-5#1)(1997-4#1)
habits in##10##2##(1990-8#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-5#1)(2008-9#1)
habits of four species of mesopelagic fishes from##2##8##(2008-5#2)
habits of the##7##3##(1990-8#1)(1995-2#1)(2008-5#2)(2010-1#1)(2011-1#1)(2013-7#1)
habits of##19##2##(1990-2#1)(1990-8#1)(1995-2#1)(2008-1#1)(2008-5#5)(2009-5#2)(2010-1#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-7#2)
habits or##2##2##(1990-12#1)(1994-11#1)
habits were##2##2##(1990-2#1)(1991-2#1)
habits##121##1##(1990-11#1)(1990-12#1)(1990-2#8)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#4)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#4)(2009-7#1)(2010-1#5)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#1)
habitual##5##1##(1996-8#1)(2008-11#2)(2010-4#1)(2012-12#1)
habitually##5##1##(1992-2#1)(2007-12#1)(2008-10#2)(2008-11#1)
habituate##2##1##(1993-12#1)(2009-8#1)
habituated##5##1##(1992-2#1)(1993-12#1)(2007-11#1)(2008-6#1)(2009-8#1)
habituation of##4##2##(1994-2#1)(2009-8#3)
habituation to the##2##3##(2008-11#1)(2008-6#1)
habituation to##6##2##(1993-5#1)(1994-2#1)(1994-3#1)(2008-11#1)(2008-6#1)(2009-8#1)
habituation##26##1##(1993-5#2)(1994-2#2)(1994-3#4)(1997-2#3)(2007-8#2)(2008-11#1)(2008-4#3)(2008-6#1)(2009-8#7)(2012-2#1)
habitus##2##1##(2008-1#1)(2008-7#1)
had &gt##3##2##(2008-10#2)(2012-3#1)
had &quot##4##2##(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
had (1)##2##2##(2008-12#1)(2013-1#1)
had 1##4##2##(1992-8#1)(1993-9#1)(2009-7#1)(2011-2#1)
had 2##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
had 4##3##2##(1993-8#1)(1993-9#1)(2008-10#1)
had 40##2##2##(1993-2#1)(2007-11#1)
had 5##2##2##(1995-9#1)(2008-1#1)
had AIDS##3##2##(1993-11#1)(1995-12#1)(1995-6#1)
had Alport syndrome##2##3##(2011-2#2)
had CIN##4##2##(1994-2#1)(2011-2#3)
had CT##2##2##(2007-11#2)
had DD and PD##6##4##(2008-12#6)
had FMH##3##2##(2011-2#3)
had G at##2##3##(1990-12#2)
had HCV##2##2##(2007-7#1)(2008-4#1)
had I-shared with a##2##4##(2009-11#2)
had IAA##2##2##(1994-12#2)
had MIC##3##2##(2007-7#3)
had MICs##2##2##(2008-5#2)
had PSA greater than##2##4##(1990-9#2)
had RD##2##2##(2008-7#2)
had SAH##2##2##(2012-3#1)(2013-8#1)
had TBII##2##2##(1991-12#1)(1991-5#1)
had Vmax values##3##3##(1996-7#3)
had a 1##3##3##(2008-10#1)(2009-3#1)(2012-3#1)
had a 30%##2##3##(2008-8#1)(2012-12#1)
had a BMI of##2##4##(2006-8#1)(2008-3#1)
had a LOD of##2##4##(2008-10#2)
had a beneficial effect on##2##5##(2009-7#1)(2011-2#1)
had a beneficial##3##3##(2008-11#1)(2009-7#1)(2011-2#1)
had a blazed groove profile with 2400 grooves/mm and a##2##10##(2007-11#1)(2008-3#1)
had a budget##2##3##(1991-1#1)(2012-3#1)
had a buoyant density##2##4##(2008-10#2)
had a complete resection##2##4##(1990-8#1)(1992-12#1)
had a complete##4##3##(1990-8#1)(1992-12#1)(2009-10#1)(2013-1#1)
had a correct##2##3##(1990-10#1)(2010-3#1)
had a decrease in##2##4##(2008-7#1)(2013-8#1)
had a detection limit of##2##5##(2008-10#2)
had a detection##3##3##(2008-10#2)(2008-3#1)
had a detrimental effect on##3##5##(2008-10#1)(2008-3#1)(2010-1#1)
had a detrimental##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2010-1#1)
had a diagnosis of##3##4##(1993-12#1)(1996-7#1)(2012-12#1)
had a diagnosis##4##3##(1993-12#1)(1996-7#1)(2008-7#1)(2012-12#1)
had a different##6##3##(1997-4#1)(1997-7#1)(2007-5#1)(2008-10#2)(2009-9#1)
had a duration##2##3##(1993-1#1)(2012-2#1)
had a family history of##2##5##(2010-6#1)(2011-2#1)
had a faster##2##3##(1993-2#1)(1994-2#1)
had a full skeletal survey##2##5##(2011-1#2)
had a full##3##3##(2008-11#1)(2011-1#2)
had a good##8##3##(1991-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#2)
had a great##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
had a greater effect##2##4##(2008-10#1)(2008-7#1)
had a greater inhibitory effect than##2##6##(1992-2#1)(2013-1#1)
had a greater##13##3##(1992-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-4#1)(2013-1#1)(2013-7#1)
had a heterozygote frequency of##2##5##(1991-12#2)
had a high affinity##2##4##(1995-12#1)(2008-10#1)
had a high##23##3##(1990-6#1)(1990-8#1)(1991-5#1)(1992-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-3#1)(2013-1#1)
had a higher frequency of##3##5##(2008-7#1)(2009-8#1)(2013-7#1)
had a higher mortality rate##2##5##(2006-10#1)(2011-2#1)
had a higher mortality##5##4##(2006-10#1)(2008-1#1)(2008-7#1)(2011-2#2)
had a higher prevalence of##2##5##(2008-3#1)(2011-2#1)
had a higher rate of##2##5##(2011-2#1)(2012-2#1)
had a higher risk of##2##5##(1995-2#1)(2012-1#1)
had a higher risk##3##4##(1995-2#1)(2012-1#2)
had a higher sensitivity in the##2##6##(2011-2#2)
had a higher##48##3##(1990-11#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-2#1)(2010-4#1)(2011-2#8)(2012-1#2)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#2)
had a history of depression##2##5##(2010-4#1)(2013-1#1)
had a history of##15##4##(1992-9#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-4#2)(2010-1#1)(2010-4#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#3)
had a homogeneous##2##3##(2008-10#1)(2012-2#1)
had a kcat##2##3##(1995-5#2)
had a large##4##3##(1995-6#1)(2008-12#1)(2008-2#1)(2012-3#1)
had a larger##2##3##(1994-2#1)(2008-10#1)
had a limited##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
had a linear##4##3##(2008-10#3)(2008-8#1)
had a long##2##3##(1990-5#1)(1991-8#1)
had a longer##4##3##(1991-6#1)(2008-4#1)(2011-2#2)
had a loss##2##3##(2008-10#1)(2013-1#1)
had a low level of##2##5##(1995-5#1)(2008-10#1)
had a low##12##3##(1990-11#1)(1990-3#1)(1993-5#1)(1995-5#1)(1996-2#1)(2008-10#4)(2009-3#1)(2010-6#1)(2013-1#1)
had a lower##15##3##(1994-7#1)(1996-3#1)(1996-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2010-11#2)(2012-2#1)(2013-1#2)
had a major impact on the##2##6##(1993-12#1)(2008-11#1)
had a major impact on##5##5##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
had a mammography##2##3##(1990-6#2)
had a marked##3##3##(1992-5#1)(1995-3#1)(2013-1#1)
had a maximum average of##2##5##(1996-12#2)
had a maximum##5##3##(1990-10#1)(1996-12#2)(2007-12#1)(2009-10#1)
had a mean QTc##2##4##(2008-8#2)
had a mean age of##4##5##(1994-12#1)(2008-1#1)(2013-8#2)
had a mean of##2##4##(2008-5#1)(2010-11#1)
had a mean##18##3##(1990-2#1)(1994-12#1)(1995-3#1)(1997-3#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-11#1)(2013-8#3)
had a mild##2##3##(2007-2#1)(2010-12#1)
had a minor effect##2##4##(1997-7#1)(2009-8#1)
had a minor##4##3##(1990-2#1)(1997-7#1)(2007-10#1)(2009-8#1)
had a mobile facility on loan##2##6##(1992-5#2)
had a molecular mass of##6##5##(1995-6#1)(2008-10#4)(2013-1#1)
had a molecular weight of##3##5##(1997-2#1)(2008-10#1)(2010-2#1)
had a molecular##9##3##(1995-6#1)(1997-2#1)(2008-10#5)(2010-2#1)(2013-1#1)
had a more##6##3##(1995-3#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-4#1)
had a much##3##3##(1992-8#1)(2008-10#2)
had a negative effect on##5##5##(1991-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
had a negative effect##7##4##(1991-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
had a negative impact on##2##5##(2008-11#1)(2008-12#1)
had a negative##12##3##(1991-2#1)(1996-6#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2013-1#1)
had a normal karyotype##2##4##(1992-10#2)
had a normal plasma##2##4##(1992-9#2)
had a normal##10##3##(1992-10#2)(1992-9#2)(1996-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
had a pH##2##3##(2007-10#1)(2009-4#1)
had a partial##2##3##(1990-12#1)(1991-6#1)
had a past history of##2##5##(2006-10#1)(2011-2#1)
had a past##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
had a persistent##2##3##(1991-5#1)(2008-10#1)
had a poor##2##3##(1990-8#1)(2012-12#1)
had a positive effect on##6##5##(1990-9#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
had a positive impact on the##2##6##(2008-11#1)(2008-12#1)
had a positive impact on##3##5##(2008-11#1)(2008-12#1)(2011-2#1)
had a positive##18##3##(1990-9#1)(1996-6#1)(1997-2#1)(2008-11#3)(2008-12#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-7#1)
had a potent inhibitory effect on##2##6##(1997-7#1)(2008-4#1)
had a potent##4##3##(1997-7#1)(2008-4#2)(2008-8#1)
had a previous##2##3##(2013-1#1)(2013-8#1)
had a profound influence on##2##5##(2008-11#2)
had a profound##4##3##(1997-2#1)(2008-11#2)(2011-1#1)
had a rapid##2##3##(1991-1#1)(2008-11#1)
had a recent##2##3##(2009-4#1)(2013-8#1)
had a recurrence##2##3##(2006-10#2)
had a reduced##2##3##(1993-6#1)(2012-2#1)
had a reduction##2##3##(1996-12#1)(1996-2#1)
had a relative risk of##3##5##(1990-5#1)(1993-9#2)
had a relative standard deviation##2##5##(2008-10#2)
had a relative##7##3##(1990-5#1)(1993-9#2)(2008-10#2)(2008-5#1)(2008-9#1)
had a relatively high##2##4##(1991-8#1)(2008-10#1)
had a remarkable##2##3##(1992-9#1)(2008-12#1)
had a satisfactory##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
had a score##2##3##(1997-3#1)(2013-1#1)
had a sensitivity of 0##2##5##(1993-2#2)
had a sensitivity of##6##4##(1990-8#1)(1993-2#2)(1997-8#2)(2013-1#1)
had a sensitivity##9##3##(1990-8#1)(1993-2#2)(1997-8#2)(2008-12#1)(2013-1#3)
had a severe##3##3##(1992-5#1)(1993-6#1)(2007-8#1)
had a shorter##2##3##(2008-8#2)
had a significant effect on the##8##6##(1991-6#1)(1993-12#1)(1996-2#1)(2008-10#2)(2008-6#1)(2011-2#2)
had a significant effect on##16##5##(1990-6#1)(1991-6#1)(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#7)(2008-6#1)(2008-7#1)(2011-2#2)
had a significant effect##21##4##(1990-6#1)(1991-6#1)(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#11)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)
had a significant impact on the##3##6##(2007-12#1)(2008-7#1)(2013-1#1)
had a significant impact on##4##5##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
had a significant impact##5##4##(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
had a significant influence on##4##5##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
had a significant positive effect on##2##6##(2008-10#1)(2011-1#1)
had a significant reduction##2##4##(2008-6#1)(2011-10#1)
had a significant##48##3##(1990-6#1)(1991-11#1)(1991-6#1)(1993-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#4)(2009-7#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
had a significantly better##3##4##(1991-4#1)(2008-10#1)(2012-1#1)
had a significantly greater##4##4##(1994-6#1)(2008-12#1)(2008-2#1)(2011-2#1)
had a significantly higher frequency of the AA genotype##2##9##(2011-2#2)
had a significantly higher frequency of the##3##7##(2011-2#3)
had a significantly higher percentage of stomata##2##7##(2008-10#2)
had a significantly higher##16##4##(1990-2#1)(1996-8#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
had a significantly larger##3##4##(1994-3#1)(2009-5#1)(2012-3#1)
had a significantly lower##5##4##(1992-6#1)(1994-6#1)(2008-10#2)(2008-3#1)
had a significantly##35##3##(1990-12#1)(1990-2#1)(1991-4#1)(1992-6#1)(1994-3#1)(1994-6#2)(1996-2#1)(1996-8#1)(2007-10#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
had a similar effect as##2##5##(1992-6#1)(2008-10#1)
had a similar effect##5##4##(1992-6#1)(1995-5#1)(2008-10#1)(2008-5#1)(2011-1#1)
had a similar##13##3##(1991-5#1)(1992-6#1)(1995-2#2)(1995-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#2)
had a single evolutionary origin##2##5##(2008-10#1)(2011-3#1)
had a single##5##3##(1990-5#1)(2008-10#3)(2011-3#1)
had a slightly higher##2##4##(1991-12#1)(2008-8#1)
had a slightly##4##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
had a small##3##3##(2008-10#1)(2013-7#1)(2013-8#1)
had a smaller##2##3##(2008-10#1)(2008-7#1)
had a smooth##2##3##(2008-7#1)(2012-2#1)
had a spontaneous##4##3##(1991-12#1)(1991-2#1)(2007-9#1)(2010-11#1)
had a stable##2##3##(1990-2#1)(2008-12#1)
had a statistically significant effect on##2##6##(2008-7#1)(2009-8#1)
had a statistically significant##7##4##(2008-10#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-2#2)(2013-1#1)
had a statistically##10##3##(1993-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#2)(2013-1#2)
had a strong effect on##2##5##(2007-5#1)(2008-10#1)
had a strong influence on##2##5##(2008-10#2)
had a strong negative##2##4##(1994-12#1)(2009-8#1)
had a strong##14##3##(1994-11#1)(1994-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-8#3)(2009-8#1)(2010-5#1)(2010-8#1)
had a stronger##2##3##(2008-8#1)(2010-2#1)
had a substantial##2##3##(2008-5#1)(2008-6#1)
had a successful result##4##4##(2009-3#4)
had a successful##6##3##(2009-3#4)(2011-1#1)(2013-1#1)
had a total of##2##4##(1995-3#1)(2013-7#1)
had a total##4##3##(1992-11#1)(1995-3#1)(2010-7#1)(2013-7#1)
had a unique##3##3##(1992-5#1)(1996-12#1)(2008-10#1)
had a very similar##2##4##(2008-10#1)(2008-11#1)
had a very##11##3##(1993-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-4#1)(2013-1#1)
had a weak##5##3##(1995-12#1)(1996-2#2)(2008-8#1)(2013-8#1)
had a well##2##3##(2009-1#1)(2011-1#1)
had a worse prognosis##2##4##(1991-8#1)(2010-3#1)
had a worsening of##2##4##(1996-9#1)(2013-1#1)
had a##870##2##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#3)(1990-5#5)(1990-6#6)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#3)(1991-11#4)(1991-12#8)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#7)(1991-7#1)(1991-8#5)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#5)(1992-4#2)(1992-5#11)(1992-6#4)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#5)(1993-5#4)(1993-6#8)(1993-8#4)(1993-9#4)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#3)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#2)(1996-12#6)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#4)(1997-2#5)(1997-3#6)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#6)(2006-10#5)(2006-8#2)(2007-10#12)(2007-11#5)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#14)(2007-9#2)(2008-1#10)(2008-10#130)(2008-11#36)(2008-12#23)(2008-2#10)(2008-3#23)(2008-4#10)(2008-5#12)(2008-6#11)(2008-7#29)(2008-8#19)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#1)(2009-2#1)(2009-3#9)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#9)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#3)(2011-1#20)(2011-10#1)(2011-2#40)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#12)(2012-3#9)(2012-4#1)(2012-6#1)(2013-1#48)(2013-7#7)(2013-8#16)
had abnormal##9##2##(1991-12#1)(1994-12#2)(1996-5#1)(2008-11#2)(2008-4#1)(2008-6#1)(2013-1#1)
had acceptable##3##2##(2008-10#1)(2011-1#2)
had access to##5##3##(1992-3#1)(1993-3#1)(2008-11#1)(2009-5#1)(2010-4#1)
had accumulated##4##2##(1993-8#1)(1994-3#1)(2008-10#1)(2008-12#1)
had achieved##3##2##(1991-8#2)(1995-3#1)
had acquired the##2##3##(1996-11#1)(2008-10#1)
had acquired##6##2##(1993-1#1)(1993-9#1)(1996-11#2)(2008-10#1)(2011-2#1)
had activity##2##2##(1991-12#1)(1995-3#1)
had acute##6##2##(2007-12#1)(2007-7#1)(2008-4#1)(2012-2#2)(2012-3#1)
had additional##2##2##(1997-8#1)(2008-6#1)
had adequate##4##2##(1993-2#1)(2008-1#1)(2008-7#1)(2013-1#1)
had advanced##3##2##(2006-10#1)(2007-7#1)(2012-3#1)
had advantages##2##2##(2008-5#2)
had agreed to##3##3##(1995-6#1)(1996-3#1)(2011-1#1)
had all##2##2##(1990-8#1)(2007-7#1)
had allergic##2##2##(2008-10#1)(2008-3#1)
had almost##2##2##(1990-11#1)(2012-1#1)
had already been##7##3##(1995-8#1)(1997-4#1)(2008-12#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
had already##19##2##(1992-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
had also##4##2##(1992-8#1)(2008-1#1)(2008-5#1)(2008-7#1)
had altered expression##2##3##(2008-10#1)(2008-7#1)
had altered##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
had amino acid##2##3##(2011-3#1)(2013-8#1)
had an N-terminal amino acid sequence##2##6##(1995-8#1)(1996-10#1)
had an abnormal##2##3##(1993-11#1)(2008-12#1)
had an acute##2##3##(2007-10#1)(2012-2#1)
had an additional##2##3##(2010-1#1)(2010-2#1)
had an allocatable##2##3##(2008-8#2)
had an apparent molecular mass##3##5##(1993-6#1)(1993-8#1)(2008-10#1)
had an apparent molecular##4##4##(1993-6#1)(1993-8#1)(1994-9#1)(2008-10#1)
had an average similarity in virulence of##2##7##(2008-10#2)
had an average##6##3##(1990-8#2)(1995-3#2)(2008-10#2)
had an effect on the##3##5##(2008-10#1)(2008-8#1)(2010-4#1)
had an effect on##9##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)
had an effect##10##3##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)
had an emergency##2##3##(1996-6#1)(2011-2#1)
had an identical##3##3##(1994-9#1)(2008-10#2)
had an impact on the##3##5##(1995-2#1)(2008-10#1)(2008-7#1)
had an impact on##6##4##(1995-2#1)(2008-10#3)(2008-7#1)(2013-1#1)
had an improved##2##3##(2008-6#1)(2009-11#1)
had an incidence of##2##4##(1993-9#2)
had an increased risk##3##4##(2011-1#2)(2011-2#1)
had an increased##10##3##(1992-5#1)(1995-5#1)(2008-8#1)(2011-1#2)(2011-2#4)(2013-1#1)
had an influence on the##2##5##(1991-1#1)(2009-1#1)
had an influence on##4##4##(1991-1#1)(2008-12#1)(2008-4#1)(2009-1#1)
had an inhibitory##2##3##(1995-12#1)(2008-5#1)
had an intermediate##2##3##(2008-10#1)(2011-2#1)
had an intraparenchymal##2##3##(2012-3#2)
had an intrinsic##2##3##(1995-12#1)(1995-6#1)
had an open reading frame##3##5##(1991-12#1)(1997-2#1)(2008-10#1)
had an open##4##3##(1991-12#1)(1992-6#1)(1997-2#1)(2008-10#1)
had an uneventful recovery and was##2##6##(2010-12#1)(2013-1#1)
had an uneventful recovery##8##4##(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
had an uneventful##9##3##(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
had an##184##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-2#1)(1994-9#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-10#4)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#9)
had anemia##3##2##(2008-7#1)(2013-1#2)
had another##2##2##(2008-7#1)(2013-8#1)
had anterior##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
had antibodies to##2##3##(1992-8#1)(2007-12#1)
had antibodies##3##2##(1992-8#1)(1997-5#1)(2007-12#1)
had any complications##3##3##(2008-9#1)(2010-7#1)(2012-2#1)
had any effect on the##6##5##(1991-3#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
had any effect on##9##4##(1991-3#1)(1994-12#1)(1995-5#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
had any effect##10##3##(1990-11#1)(1991-3#1)(1994-12#1)(1995-5#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
had any##26##2##(1990-11#1)(1991-3#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#2)(2013-8#1)
had apical##2##2##(2008-10#1)(2012-12#1)
had appeared##3##2##(1992-11#1)(2008-10#1)(2008-7#1)
had applied##3##2##(1992-5#1)(2008-12#2)
had approximately##3##2##(1994-2#1)(2008-11#1)(2009-7#1)
had arteriovenous fistulae##2##3##(2008-7#2)
had associated##6##2##(1995-10#1)(2008-1#4)(2008-8#1)
had at least one viable egg##2##6##(2012-12#2)
had at least one##16##4##(1990-6#1)(1990-8#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2012-12#3)(2012-3#1)
had at least two##4##4##(1997-5#1)(2008-4#1)(2011-1#1)(2012-12#1)
had at least##28##3##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#4)(2012-3#1)
had at##29##2##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#4)(2012-3#1)
had attempted suicide##2##3##(1992-1#1)(2007-8#1)
had attempted##3##2##(1992-1#1)(2007-8#1)(2008-11#1)
had basic##2##2##(2008-10#1)(2012-12#1)
had become##14##2##(1991-6#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#1)
had been a##3##3##(1991-5#1)(1995-9#1)(2008-10#1)
had been achieved##2##3##(1991-2#1)(2011-4#1)
had been added##2##3##(1996-2#1)(2008-10#1)
had been admitted##3##3##(1990-12#1)(2008-1#1)(2012-12#1)
had been applied to the determination of trace##3##8##(2008-10#3)
had been applied to the determination of##4##7##(2008-10#4)
had been applied to the##5##5##(2008-10#5)
had been applied to##6##4##(1995-12#1)(2008-10#5)
had been applied##9##3##(1995-12#1)(2008-10#6)(2008-5#2)
had been assessed by##2##4##(1994-3#1)(2008-11#1)
had been assessed##4##3##(1994-12#1)(1994-3#1)(2008-11#1)(2008-7#1)
had been attained##3##3##(1995-6#2)(1996-2#1)
had been carried out##2##4##(2008-10#1)(2012-3#1)
had been coated with##3##4##(1990-12#1)(1995-12#1)(2008-10#1)
had been collected##2##3##(1991-7#1)(2008-10#1)
had been completed##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
had been confirmed##2##3##(1997-3#1)(2013-1#1)
had been damaged##2##3##(2008-8#1)(2008-9#1)
had been deleted##3##3##(1990-5#1)(1995-2#2)
had been demonstrated##2##3##(2008-3#1)(2011-2#1)
had been described##2##3##(1994-2#1)(2012-3#1)
had been detected##3##3##(1996-12#1)(1997-6#1)(2008-10#1)
had been developed##2##3##(1994-12#1)(2008-12#1)
had been diagnosed as##2##4##(1991-9#1)(1995-3#1)
had been diagnosed at##2##4##(1994-12#1)(2008-9#1)
had been diagnosed with##4##4##(2010-10#1)(2011-2#1)(2013-1#2)
had been diagnosed##11##3##(1990-3#1)(1991-9#1)(1994-12#1)(1995-3#1)(2007-10#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
had been done##3##3##(1990-12#1)(2007-11#1)(2011-2#1)
had been employed in##2##4##(1991-12#1)(1993-1#1)
had been employed##3##3##(1991-12#1)(1993-1#1)(2008-11#1)
had been established##4##3##(2008-10#1)(2010-1#1)(2011-3#2)
had been exposed to##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
had been extracted##2##3##(1993-9#1)(2008-10#1)
had been followed up##2##4##(1995-4#1)(2009-3#1)
had been found##5##3##(1990-3#1)(1997-4#1)(2008-10#2)(2011-2#1)
had been generated##3##3##(1992-3#1)(1994-11#1)(2008-11#1)
had been given##2##3##(1993-6#1)(2011-1#1)
had been granted a disability pension##2##6##(1995-5#2)
had been hospitalized##2##3##(1994-6#1)(2007-12#1)
had been identified##6##3##(1990-11#1)(1991-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
had been implanted##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
had been in##2##3##(1995-11#1)(2008-5#1)
had been included in##2##4##(1991-8#1)(2008-2#1)
had been induced##4##3##(1993-6#1)(1994-8#1)(1995-12#1)(2008-11#1)
had been infected with##2##4##(1996-11#1)(1997-4#1)
had been infected##4##3##(1995-9#1)(1996-11#1)(1997-4#1)(2008-1#1)
had been initially##2##3##(1996-12#1)(2008-6#1)
had been introduced##2##3##(1990-8#1)(2008-11#1)
had been isolated from##2##4##(1993-11#1)(2012-12#1)
had been isolated##3##3##(1993-11#1)(1993-2#1)(2012-12#1)
had been left##2##3##(1995-3#1)(2011-2#1)
had been made##4##3##(1993-1#1)(1995-3#1)(2008-10#2)
had been met##2##3##(1995-2#1)(1996-1#1)
had been notified to the##2##5##(1992-11#1)(2008-11#1)
had been observed in##2##4##(2008-10#1)(2008-6#1)
had been observed##3##3##(2008-10#1)(2008-6#1)(2009-9#1)
had been obtained from##2##4##(2008-1#1)(2008-10#1)
had been obtained##3##3##(1995-3#1)(2008-1#1)(2008-10#1)
had been on##4##3##(2008-1#1)(2008-7#1)(2010-11#1)(2013-8#1)
had been passed##2##3##(1990-5#1)(1997-2#1)
had been planted##2##3##(2008-10#1)(2011-2#1)
had been prepared##2##3##(1992-2#1)(1995-2#1)
had been previously treated with chemotherapy##2##6##(1991-6#1)(1992-8#1)
had been previously treated with##4##5##(1991-6#1)(1992-8#1)(2008-10#1)(2012-3#1)
had been previously##15##3##(1990-10#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-6#1)(2008-10#5)(2012-3#1)(2013-8#1)
had been reared##2##3##(2008-10#1)(2009-9#1)
had been recognized##2##3##(1990-9#1)(1993-3#1)
had been recommended for##2##4##(1992-8#2)
had been referred from##2##4##(2008-9#1)(2012-12#1)
had been removed##3##3##(1997-3#1)(1997-8#1)(2008-4#1)
had been reported as having##2##5##(1996-11#2)
had been reported as##3##4##(1996-11#3)
had been reported in##2##4##(2012-2#1)(2013-1#1)
had been reported##8##3##(1993-8#1)(1996-11#3)(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
had been seen in##2##4##(1995-2#1)(2013-1#1)
had been shown to have##3##5##(1992-12#1)(1993-8#1)(1997-1#1)
had been shown to##6##4##(1992-12#1)(1992-2#1)(1993-8#1)(1997-1#1)(2008-10#1)(2010-3#1)
had been shown##7##3##(1992-10#1)(1992-12#1)(1992-2#1)(1993-8#1)(1997-1#1)(2008-10#1)(2010-3#1)
had been stable for##2##4##(1997-6#1)(2008-6#1)
had been subjected to##2##4##(1990-2#1)(2012-12#1)
had been successful##2##3##(1997-3#1)(2008-10#1)
had been successfully applied##3##4##(2008-10#3)
had been successfully##5##3##(1996-6#1)(2008-10#4)
had been suffering##2##3##(2008-11#1)(2013-8#1)
had been symptomatic for##2##4##(1992-5#1)(2010-3#1)
had been the##3##3##(1991-12#1)(1994-6#1)(2008-8#1)
had been thought to be##2##5##(1996-12#1)(2008-6#1)
had been told##2##3##(2008-9#1)(2011-1#1)
had been treated with wide spectrum antibiotics##2##7##(2008-5#2)
had been treated with##10##4##(1994-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)
had been treated##19##3##(1994-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)
had been used to##2##4##(2008-10#2)
had been used##3##3##(1992-8#1)(2008-10#2)
had been vaccinated##2##3##(1995-9#1)(2007-2#1)
had been visualized by##2##4##(1995-12#1)(2008-9#1)
had been well##2##3##(1994-12#1)(2007-12#1)
had been##433##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#3)(1990-8#2)(1990-9#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#6)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-6#4)(1994-8#4)(1994-9#3)(1995-11#2)(1995-12#5)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#6)(1995-9#4)(1996-1#4)(1996-11#6)(1996-12#7)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#3)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#75)(2008-11#17)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#13)(2008-6#9)(2008-7#12)(2008-8#8)(2008-9#10)(2009-10#1)(2009-3#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#5)(2010-4#1)(2010-8#3)(2011-1#7)(2011-2#11)(2011-3#3)(2011-4#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#6)(2012-7#1)(2013-1#6)(2013-8#5)
had begun to##2##3##(2010-10#1)(2012-12#1)
had begun##4##2##(1991-12#1)(1993-6#1)(2010-10#1)(2012-12#1)
had benign##3##2##(1992-11#1)(1994-12#2)
had better adherence##2##3##(2008-3#1)(2010-9#1)
had better long-term##2##3##(2007-11#2)
had better##19##2##(1992-1#1)(1994-12#2)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-9#1)(2011-2#5)(2012-2#1)
had bilateral##4##2##(2007-10#1)(2008-10#1)(2008-7#1)(2010-3#1)
had biopsies##2##2##(1990-12#1)(1994-12#1)
had bone##3##2##(1991-5#1)(1991-8#1)(1997-7#1)
had both##13##2##(1992-1#1)(1993-12#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2012-5#1)(2013-1#2)
had breast cancer##2##3##(2008-7#1)(2011-2#1)
had breast##3##2##(1993-11#1)(2008-7#1)(2011-2#1)
had by##2##2##(1990-5#1)(2010-11#1)
had cancer##2##2##(1993-9#1)(1996-3#1)
had caused##2##2##(1997-2#1)(2007-2#1)
had ceased##2##2##(1993-2#1)(1996-9#1)
had cerebral##3##2##(1996-6#1)(2007-10#1)(2012-3#1)
had cesarean##2##2##(2010-7#1)(2011-2#1)
had changed their diet##2##4##(1990-6#2)
had changed##4##2##(1990-6#2)(1991-5#1)(1992-4#1)
had chest##2##2##(2007-8#1)(2008-1#1)
had children##2##2##(1994-1#1)(1996-12#1)
had chronic##5##2##(1990-9#1)(1994-6#1)(2006-10#1)(2007-7#1)(2008-8#1)
had clear##2##2##(2008-6#1)(2009-2#1)
had clinical evidence of##2##4##(1991-2#1)(2008-10#1)
had clinical##8##2##(1990-10#1)(1990-5#1)(1991-2#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
had clinically##3##2##(1990-2#1)(2011-2#1)(2013-1#1)
had closed##2##2##(2012-2#1)(2013-7#1)
had colonized##3##2##(1997-3#1)(2008-10#2)
had come##2##2##(2007-12#1)(2008-1#1)
had complete remission##2##3##(1990-8#1)(2007-7#1)
had complete responses##2##3##(2007-10#2)
had complete##19##2##(1990-12#1)(1990-8#1)(1992-2#1)(1995-2#1)(1995-8#1)(2007-10#2)(2007-7#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-5#1)(2011-3#1)(2012-3#1)(2013-1#1)
had completed a##2##3##(1993-1#1)(1993-2#1)
had completed the##2##3##(2008-10#1)(2010-8#1)
had completed##4##2##(1993-1#1)(1993-2#1)(2008-10#1)(2010-8#1)
had completely recovered##2##3##(2013-8#2)
had complications##2##2##(2012-2#1)(2012-3#1)
had concomitant##2##2##(2008-3#1)(2011-2#1)
had concurrent##2##2##(1994-11#1)(2008-7#1)
had considerable##2##2##(2008-9#1)(2012-3#1)
had consulted the##2##3##(1994-11#1)(1996-6#1)
had consulted##3##2##(1994-11#1)(1996-6#1)(1997-6#1)
had contact##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
had coronary heart disease##2##4##(1992-6#1)(2008-7#1)
had dark##2##2##(1995-11#1)(2010-6#1)
had data for##2##3##(1992-6#2)
had data##3##2##(1992-6#2)(2013-1#1)
had decided##2##2##(1994-3#1)(1996-3#1)
had declined##3##2##(1996-5#1)(2008-10#1)(2009-4#1)
had decreased and##2##3##(2010-7#1)(2012-2#1)
had decreased by##2##3##(1991-6#1)(1995-3#1)
had decreased##9##2##(1991-6#1)(1994-12#1)(1995-3#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
had delayed union##2##3##(2012-2#2)
had delayed##3##2##(2012-2#2)(2012-3#1)
had delirium##2##2##(2007-7#1)(2013-1#1)
had demonstrated##2##2##(2008-10#1)(2013-1#1)
had detectable##2##2##(1995-9#1)(2007-7#1)
had deteriorated##2##2##(2007-2#1)(2008-1#1)
had developed a##5##3##(1990-9#1)(1993-1#1)(2007-7#1)(2008-5#1)(2008-9#1)
had developed in the##2##4##(1992-8#1)(2007-8#1)
had developed in##3##3##(1992-8#1)(2007-8#1)(2008-10#1)
had developed##19##2##(1990-9#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-11#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#1)
had diabetes##4##2##(1991-3#1)(2013-8#3)
had died at the age of##2##6##(1997-3#1)(2013-1#1)
had died at the##3##4##(1997-3#1)(2011-2#1)(2013-1#1)
had died from AIDS##3##4##(1996-11#3)
had died##11##2##(1990-10#1)(1992-6#1)(1996-11#3)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
had different##17##2##(1992-2#1)(1993-8#1)(1995-2#1)(2008-10#5)(2008-8#2)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
had difficulties##3##2##(1994-8#1)(2009-5#1)(2012-1#1)
had difficulty##4##2##(1993-6#1)(2008-11#1)(2009-6#1)(2010-4#1)
had diffuse##3##2##(1994-12#1)(2008-8#1)(2013-1#1)
had dilated##2##2##(1992-6#1)(2012-1#1)
had diminished##2##2##(1994-3#1)(2007-12#1)
had direct contact with##2##4##(2008-10#1)(2008-12#1)
had direct##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
had disappeared and##2##3##(2012-2#1)(2013-1#1)
had disappeared##5##2##(1993-11#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
had disclosed##2##2##(1996-5#1)(2008-9#1)
had disease 6-15 mm in##2##5##(1995-12#2)
had disease##4##2##(1995-12#4)
had distant##2##2##(1992-12#1)(2008-10#1)
had distinct##6##2##(1991-12#1)(2008-10#2)(2008-8#1)(2013-1#2)
had dramatic effects on##2##4##(2008-11#1)(2008-8#1)
had dramatic##4##2##(1991-4#1)(2007-11#1)(2008-11#1)(2008-8#1)
had earlier##2##2##(1997-4#1)(2013-7#1)
had early sexual debut##2##4##(2011-1#2)
had early##6##2##(2008-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)
had effects##2##2##(1994-8#1)(2009-7#1)
had either a##2##3##(1994-11#1)(2008-7#1)
had either##8##2##(1994-11#1)(2007-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
had elevated levels of##3##4##(1991-12#1)(1992-3#1)(2009-10#1)
had elevated##13##2##(1990-2#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)
had encountered##3##2##(1991-8#2)(1995-8#1)
had enlarged##2##2##(2008-7#1)(2011-1#1)
had entered##4##2##(2008-10#1)(2008-5#2)(2013-1#1)
had epidermal hyperplasia##3##3##(2008-9#3)
had equal##4##2##(2008-8#3)(2012-3#1)
had esophageal##2##2##(1990-3#1)(2013-8#1)
had eutectic phase behavior##2##4##(1993-8#2)
had ever been diagnosed##2##4##(2008-12#1)(2008-4#1)
had ever##7##2##(1993-2#1)(2008-11#1)(2008-12#3)(2008-4#1)(2009-4#1)
had evidence of##6##3##(1990-11#1)(1997-3#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
had evolved##3##2##(2007-6#1)(2008-10#1)(2008-12#1)
had excellent##9##2##(1990-12#1)(1990-6#1)(1994-12#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
had experienced a##3##3##(2007-4#1)(2011-2#2)
had experienced myocardial infarction##2##4##(1994-11#1)(2010-7#1)
had experienced##20##2##(1992-1#3)(1992-2#1)(1994-11#1)(1994-6#2)(1996-9#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2013-1#1)
had failed to##5##3##(1990-3#1)(1991-4#1)(2007-11#1)(2008-10#2)
had failed##13##2##(1990-3#1)(1990-6#1)(1991-4#1)(1993-2#1)(1994-6#1)(1997-8#1)(2007-11#2)(2008-10#2)(2008-4#1)(2012-12#1)(2013-1#1)
had fairly##2##2##(2008-10#1)(2008-7#1)
had fallen to##2##3##(1995-12#1)(2008-2#1)
had fallen##3##2##(1995-12#1)(2008-2#2)
had favorable##2##2##(1995-4#1)(2008-9#1)
had features##3##2##(1991-12#1)(2011-1#1)(2012-2#1)
had fever##2##2##(1994-12#1)(2012-3#1)
had few##4##2##(1997-6#1)(2008-10#3)
had fewer##8##2##(1994-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#1)
had filed##2##2##(1995-6#1)(1997-5#1)
had findings of##2##3##(2008-12#1)(2008-7#1)
had first##2##2##(2008-7#1)(2010-6#1)
had follow-up##2##2##(2008-3#1)(2008-7#1)
had food##2##2##(2012-12#2)
had formed##4##2##(2008-1#1)(2008-10#2)(2008-11#1)
had four##5##2##(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)
had fracture##2##2##(2012-2#2)
had frequent##2##2##(1994-6#1)(2011-2#1)
had from##2##2##(1994-2#1)(1996-8#1)
had general##2##2##(1992-1#1)(1994-3#1)
had given##4##2##(2008-1#1)(2008-5#1)(2009-6#1)(2010-12#1)
had gone##3##2##(1993-2#1)(1997-7#1)(2009-10#1)
had good##11##2##(1990-6#1)(1992-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2010-10#1)(2010-2#1)(2012-3#1)
had grade##2##2##(2008-10#1)(2011-2#1)
had gradually##2##2##(1995-4#1)(2013-8#1)
had graft##3##2##(1991-11#1)(2008-8#2)
had great##5##2##(1991-9#1)(1997-6#1)(2008-10#3)
had greater odds of a positive discography##2##7##(2012-12#2)
had greater##24##2##(1990-6#1)(1993-9#1)(1994-1#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-7#1)(2013-7#1)
had greatly##2##2##(1993-8#1)(2010-4#1)
had grown into##2##3##(2008-10#1)(2010-6#1)
had had a##7##3##(1990-2#1)(1990-6#3)(1991-6#1)(1992-5#1)(1992-8#1)
had had at least one##3##5##(1990-6#1)(1990-8#1)(1992-8#1)
had had at least##4##4##(1990-6#2)(1990-8#1)(1992-8#1)
had had positive##2##3##(1993-2#1)(2008-6#1)
had had their##2##3##(1990-6#1)(2008-11#1)
had had##34##2##(1990-2#1)(1990-6#7)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-2#1)(1995-9#1)(1996-6#2)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#1)
had healthy##2##2##(1996-3#1)(2008-5#1)
had heard about the study##2##5##(2013-1#2)
had heard about##3##3##(2013-1#3)
had heavier##2##2##(2008-9#1)(2012-2#1)
had high EI scores##2##4##(2013-1#2)
had high levels of##2##4##(2012-1#1)(2013-1#1)
had high##33##2##(1992-9#1)(1994-12#1)(1996-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#4)(2009-11#1)(2010-6#1)(2012-1#2)(2012-3#1)(2013-1#4)(2013-8#1)
had higher HbA1c##2##3##(1994-6#2)
had higher body mass index##2##5##(2010-4#1)(2012-1#1)
had higher body mass##3##4##(2010-4#1)(2012-1#1)(2012-2#1)
had higher levels of##5##4##(1990-12#1)(1994-5#1)(2013-1#3)
had higher median##2##3##(1991-12#1)(2006-10#1)
had higher percentage##2##3##(2008-7#1)(2011-1#1)
had higher rates##2##3##(1990-2#1)(2011-1#1)
had higher sCysC (1##2##4##(2013-1#2)
had higher scores##2##3##(2011-2#1)(2013-1#1)
had higher sensitivity##2##3##(2008-10#1)(2013-8#1)
had higher total##3##3##(1992-8#1)(2013-1#2)
had higher##92##2##(1990-12#1)(1990-2#1)(1991-12#2)(1992-1#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-10#12)(2008-11#3)(2008-12#7)(2008-3#4)(2008-6#1)(2008-7#4)(2008-9#5)(2009-4#1)(2010-4#4)(2010-5#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#14)(2013-7#2)(2013-8#2)
had his##2##2##(1991-7#1)(2008-10#1)
had histories of##3##3##(1993-2#1)(1993-3#1)(2008-7#1)
had history of omphalitis##2##4##(2011-2#2)
had history of##12##3##(2007-7#1)(2011-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
had hoped##2##2##(1995-2#1)(2011-2#1)
had hypothyroidism##2##2##(2011-2#1)(2013-1#1)
had hysterectomy##2##2##(2008-7#1)(2009-1#1)
had identical##4##2##(2008-10#2)(2008-5#2)
had immediate##2##2##(2008-6#1)(2013-1#1)
had impaired##2##2##(2007-8#1)(2008-7#1)
had important effects on##2##4##(1992-1#1)(2008-10#1)
had important effects##3##3##(1992-1#1)(2008-10#1)(2009-7#1)
had improved##11##2##(1996-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#2)(2013-1#1)
had in##4##2##(1995-1#1)(1995-12#1)(2010-1#1)(2012-3#1)
had increased in##3##3##(1996-5#1)(2008-12#1)(2008-5#1)
had increased odds of##2##4##(2011-2#1)(2013-1#1)
had increased to##2##3##(2008-2#1)(2012-1#1)
had increased##22##2##(1993-8#1)(1996-5#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-3#1)(2012-7#1)(2013-1#1)
had incurred##2##2##(2007-8#1)(2008-7#1)
had indicated that##3##3##(1993-1#1)(2008-1#1)(2008-10#1)
had inhibitory##2##2##(2008-10#1)(2008-12#1)
had initial##2##2##(2008-1#2)
had initially##3##2##(2008-8#1)(2010-6#1)(2011-2#1)
had integrated##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
had intercourse##2##2##(1996-6#1)(2011-2#1)
had intermediate##3##2##(2008-10#1)(2011-2#2)
had invaded the##3##3##(2009-8#1)(2012-1#1)(2013-8#1)
had invasive##2##2##(2008-5#1)(2013-8#1)
had irritation at the site of application##2##7##(2008-9#2)
had isolated##2##2##(1990-9#1)(2008-10#1)
had its origin##2##3##(1992-12#1)(2013-1#1)
had its##9##2##(1992-12#1)(1993-12#1)(1993-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#1)(2013-1#1)
had just completed a##2##4##(2008-11#2)
had just completed##3##3##(2008-11#3)
had just##4##2##(1996-5#1)(2008-11#3)
had kept##2##2##(1995-3#1)(2011-1#1)
had knowledge on##4##3##(2013-8#4)
had knowledge##6##2##(1993-2#1)(2011-2#1)(2013-8#4)
had known##2##2##(1992-11#1)(2008-6#1)
had large##5##2##(1992-10#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
had largely##3##2##(1995-12#1)(2008-1#1)(2008-7#1)
had larger tumors##2##3##(1994-12#1)(2013-1#1)
had larger##8##2##(1994-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#2)
had learned##3##2##(1992-6#1)(1993-12#1)(1997-6#1)
had led to##3##3##(1997-8#1)(2008-1#1)(2012-2#1)
had led##4##2##(1993-3#1)(1997-8#1)(2008-1#1)(2012-2#1)
had left##6##2##(1991-12#1)(1995-5#1)(1996-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
had less influence on##2##4##(1991-6#1)(1992-12#1)
had less post-cessation weight gain than##2##6##(2013-1#2)
had less than##2##3##(1994-11#1)(2010-12#1)
had less##16##2##(1991-6#1)(1992-12#1)(1994-11#1)(1995-3#1)(1996-2#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#2)(2011-2#1)(2013-1#2)
had levels##2##2##(2008-10#1)(2012-12#1)
had limb##2##2##(2008-6#1)(2010-3#1)
had limited effect##2##3##(1994-12#1)(2008-1#1)
had limited##8##2##(1992-10#1)(1992-3#1)(1994-12#1)(1996-1#1)(1997-5#1)(2008-1#1)(2008-8#1)(2013-1#1)
had linear##3##2##(2008-10#3)
had little effect on the##10##5##(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1995-6#1)(1996-2#1)(1997-2#2)(2008-10#1)(2011-2#1)
had little effect on##18##4##(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-10#2)(2008-7#1)(2011-2#1)(2012-5#1)
had little effect upon##2##4##(1992-12#1)(2008-10#1)
had little effect##24##3##(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-4#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-5#1)
had little impact on##2##4##(1993-11#1)(1997-5#1)
had little influence on the##4##5##(1997-8#1)(2008-10#1)(2010-4#2)
had little influence on##6##4##(1997-8#1)(2008-10#2)(2009-7#1)(2010-4#2)
had little or no effect on##3##6##(1994-6#1)(2008-10#2)
had little or no##6##4##(1991-6#1)(1994-6#1)(1994-8#1)(1997-2#1)(2008-10#2)
had little##53##2##(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-5#1)
had local##3##2##(1991-2#1)(2008-6#1)(2013-1#1)
had localized haemorrhage in the##2##5##(2008-7#2)
had localized##3##2##(2008-7#2)(2008-8#1)
had longer LTFs##2##3##(1991-5#2)
had longer##6##2##(1991-5#2)(1993-12#1)(1994-7#1)(2011-2#1)(2012-3#1)
had lost the ability to##2##5##(1994-12#1)(2008-10#1)
had lost##7##2##(1991-11#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-12#1)
had low levels of##2##4##(2007-10#1)(2011-2#1)
had low vision##2##3##(2010-8#2)
had low##18##2##(1992-9#1)(1994-12#1)(1996-6#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#2)(2011-2#2)
had lower absorption##2##3##(2008-3#2)
had lower rates of##3##4##(2007-2#1)(2008-8#1)(2009-3#1)
had lower values of##3##4##(1996-3#1)(2010-4#1)(2011-2#1)
had lower##41##2##(1992-10#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2010-4#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
had lowest##2##2##(1991-6#1)(2013-1#1)
had lymph node metastasis##2##4##(2011-2#2)
had made a##2##3##(1997-3#1)(2008-7#1)
had made##5##2##(1995-6#1)(1996-6#1)(1997-3#1)(2008-7#1)(2013-1#1)
had maintained##2##2##(1990-11#1)(2012-12#1)
had major##5##2##(1992-1#1)(1992-6#1)(2007-7#1)(2008-7#1)(2008-9#1)
had many##3##2##(2008-10#2)(2008-4#1)
had marked##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
had markedly##3##2##(1990-6#1)(1994-3#1)(2013-8#1)
had masses of##2##3##(1992-3#2)
had massive##3##2##(1992-9#1)(1994-12#1)(2008-7#1)
had mated and##2##3##(2008-5#1)(2008-8#1)
had mean##4##2##(1993-2#1)(1995-2#1)(2008-10#1)(2012-2#1)
had measurable##2##2##(2013-1#2)
had median##2##2##(2011-1#1)(2013-1#1)
had medium##3##2##(2007-10#1)(2008-5#1)(2011-2#1)
had mental retardation##2##3##(1997-3#1)(2011-1#1)
had metastases to##2##3##(1991-4#1)(2008-6#1)
had migrated##2##2##(1993-8#1)(2010-8#1)
had migration of the##2##4##(2007-7#1)(2008-7#1)
had mild##2##2##(2008-12#1)(2012-3#1)
had minimal effect on##2##4##(1994-6#1)(2008-6#1)
had minimal##7##2##(1994-6#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
had minor##2##2##(1994-2#1)(2013-1#1)
had miscellaneous##2##2##(1995-2#1)(2008-1#1)
had mixed##2##2##(2008-12#1)(2013-1#1)
had moderate to severe##2##4##(2007-10#1)(2012-3#1)
had moderate##7##2##(1995-12#1)(2007-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
had more severe##2##3##(1997-3#1)(2008-10#1)
had more than##6##3##(1990-6#1)(1991-11#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
had more##41##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-3#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
had much lower##2##3##(2012-3#2)
had much more##2##3##(1993-8#1)(1995-5#1)
had much##5##2##(1993-8#1)(1995-5#1)(2008-10#1)(2012-3#2)
had multiple##11##2##(1991-11#1)(1993-12#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
had negative##9##2##(1994-12#3)(1995-4#1)(2007-2#1)(2008-10#2)(2009-2#1)(2012-3#1)
had neurological##2##2##(2008-4#2)
had never been##4##3##(1990-2#1)(2008-10#3)
had never had##2##3##(1990-6#1)(1993-9#1)
had never##17##2##(1990-2#1)(1990-6#2)(1992-1#1)(1993-9#1)(1997-3#1)(2008-10#4)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#3)(2013-8#1)
had no activity##2##3##(1992-1#1)(2008-11#1)
had no adverse effect on##2##5##(2008-10#1)(2013-1#1)
had no apparent##4##3##(1994-9#1)(1996-6#1)(2008-10#1)(2010-2#1)
had no common##2##3##(2008-10#1)(2008-6#1)
had no complications##4##3##(1996-3#1)(2007-8#1)(2012-12#1)(2013-7#1)
had no demonstrable##2##3##(1991-3#1)(1996-6#1)
had no detectable effect on##2##5##(2007-5#1)(2008-8#1)
had no detectable##5##3##(1992-6#1)(1995-6#1)(2007-5#1)(2008-8#1)(2012-2#1)
had no effect at all in##2##6##(1995-12#1)(2008-2#1)
had no effect at##4##4##(1993-12#1)(1995-12#1)(2008-10#1)(2008-2#1)
had no effect in##6##4##(1995-12#2)(1996-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
had no effect on either##2##5##(1993-6#1)(2008-7#1)
had no effect on fungal##2##5##(2008-10#2)
had no effect on glucose##2##5##(1992-11#1)(1994-6#1)
had no effect on growth of##2##6##(1995-2#1)(2008-10#1)
had no effect on induction of##2##6##(1993-12#1)(2008-10#1)
had no effect on lesion##2##5##(1995-12#1)(2008-10#1)
had no effect on platelet##2##5##(1992-4#1)(2008-8#1)
had no effect on recovery##2##5##(1990-7#2)
had no effect on survival or mean body weights##3##9##(2008-8#1)(2008-9#2)
had no effect on survival##4##5##(2008-8#2)(2008-9#2)
had no effect on the recovery of##2##7##(2008-10#2)
had no effect on the release of##3##7##(1990-2#1)(1995-11#1)(2006-6#1)
had no effect on the##39##5##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-6#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2012-12#1)(2013-8#1)
had no effect on their##2##5##(2008-10#1)(2009-4#1)
had no effect on uptake##2##5##(1995-11#2)
had no effect on##137##4##(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-11#6)(1995-12#4)(1995-2#7)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-6#2)(2007-10#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
had no effect upon##2##4##(1993-6#1)(2008-5#1)
had no effect##181##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#1)(1995-11#8)(1995-12#8)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#6)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(2006-6#2)(2007-10#1)(2008-1#1)(2008-10#25)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-4#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
had no effects on the sexual behavior##2##7##(1991-2#2)
had no effects on the##3##5##(1991-2#2)(2008-9#1)
had no effects on##7##4##(1991-2#2)(1996-5#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-4#1)
had no effects##8##3##(1991-2#2)(1996-5#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-3#1)(2012-4#1)
had no further##3##3##(1991-6#1)(2008-5#1)(2011-2#1)
had no history of##5##4##(2006-10#1)(2007-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
had no idea##2##3##(2007-7#1)(2008-1#1)
had no impact on the##2##5##(2008-9#1)(2011-10#1)
had no impact on##3##4##(2008-4#1)(2008-9#1)(2011-10#1)
had no influence on survival##2##5##(1995-2#2)
had no influence on the##3##5##(1992-3#1)(1993-9#1)(1994-3#1)
had no influence on##8##4##(1992-3#1)(1993-9#1)(1994-3#1)(1995-2#2)(2008-11#2)(2008-4#1)
had no inhibitory effect on##4##5##(1991-12#1)(1992-8#1)(1994-8#1)(2008-4#1)
had no inhibitory##5##3##(1991-12#1)(1992-8#1)(1994-8#2)(2008-4#1)
had no intrinsic##3##3##(1991-9#1)(1995-11#1)(1995-12#1)
had no measurable effect on##3##5##(1992-12#1)(1993-3#1)(2008-10#1)
had no measurable##4##3##(1992-12#1)(1993-3#1)(1995-5#1)(2008-10#1)
had no obvious##3##3##(1995-2#1)(2008-8#1)(2008-9#1)
had no other##2##3##(2007-12#1)(2008-9#1)
had no predictive value##2##4##(1991-12#1)(2009-4#1)
had no previous history##2##4##(2007-12#1)(2008-1#1)
had no previous##4##3##(1992-10#1)(2007-12#1)(2008-1#1)(2008-12#1)
had no prior##3##3##(1990-8#1)(1992-10#1)(2012-3#1)
had no relationship##2##3##(2008-9#1)(2011-2#1)
had no risk factors for##2##5##(1991-7#1)(2007-12#1)
had no risk##3##3##(1991-7#1)(2007-12#1)(2008-12#1)
had no significant effect on the rate of##2##8##(1995-3#1)(2008-10#1)
had no significant effect on the##9##6##(1990-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(2008-10#3)(2008-7#1)(2011-3#1)
had no significant effect on##20##5##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-5#1)(1995-3#1)(1996-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
had no significant effect##27##4##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#1)
had no significant effects on##2##5##(2007-3#1)(2008-10#1)
had no significant impact on##2##5##(1994-12#1)(2013-1#1)
had no significant influence on the##3##6##(1990-2#1)(1997-7#1)(2011-2#1)
had no significant influence on##4##5##(1990-2#1)(1997-7#1)(2008-10#1)(2011-2#1)
had no significant inhibitory##2##4##(1994-11#1)(1994-8#1)
had no significant##45##3##(1990-2#1)(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-3#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)
had no statistically significant##3##4##(1997-2#1)(2011-2#1)(2013-1#1)
had no such effect##2##4##(1992-9#1)(2008-9#1)
had no such##3##3##(1992-9#1)(1995-12#1)(2008-9#1)
had no symptoms##2##3##(2008-7#1)(2008-9#1)
had no visible##2##3##(2008-10#2)
had no##408##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#7)(1994-9#2)(1995-11#10)(1995-12#13)(1995-2#10)(1995-3#4)(1995-5#5)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#8)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#47)(2008-11#15)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#13)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#10)(2008-9#12)(2009-10#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#17)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#5)(2012-4#1)(2013-1#9)(2013-7#2)(2013-8#3)
had nonsuccessively borne litters in four of five or three of six rounds##2##13##(1997-4#2)
had nonsuccessively borne##3##3##(1997-4#3)
had normal serum creatinine##2##4##(2008-8#2)
had normal serum##3##3##(1993-6#1)(2008-8#2)
had normal vitD levels##2##4##(2011-1#2)
had normal##26##2##(1990-2#1)(1990-3#1)(1991-8#1)(1992-3#1)(1993-6#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-8#2)(2009-10#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
had normalized##2##2##(1993-12#1)(2008-7#1)
had not been established and##2##5##(2010-3#1)(2012-2#1)
had not been established##3##4##(2008-10#1)(2010-3#1)(2012-2#1)
had not been reported##2##4##(2008-10#1)(2011-3#1)
had not been subjected to##2##5##(2008-11#2)
had not been validated##3##4##(2011-2#1)(2013-1#2)
had not been##31##3##(1995-5#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#4)
had not changed##2##3##(1991-6#1)(2011-2#1)
had not had##3##3##(1991-2#1)(2009-1#1)(2010-3#1)
had not passed##2##3##(2008-12#1)(2008-5#1)
had not previously been##2##4##(2008-10#1)(2013-1#1)
had not previously##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
had not received##6##3##(1990-2#1)(1991-4#1)(1992-10#1)(2006-10#1)(2007-8#1)(2008-7#1)
had not taken##3##3##(1996-5#1)(2011-1#1)(2013-1#1)
had not undergone##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
had not worn a seat belt##2##6##(1997-6#2)
had not yet been##3##4##(1990-11#1)(2008-10#1)(2011-2#1)
had not yet##4##3##(1990-11#1)(2008-10#1)(2010-1#1)(2011-2#1)
had not##83##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-10#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#3)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
had numerous##2##2##(1995-12#1)(2009-7#1)
had oICH of##2##3##(2012-3#2)
had occurred in the##2##4##(1990-9#1)(2008-8#1)
had occurred in##3##3##(1990-9#1)(1996-1#1)(2008-8#1)
had occurred##20##2##(1990-6#1)(1990-9#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-3#2)(1995-8#1)(1996-1#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-10#4)(2008-8#3)(2013-1#1)
had often##2##2##(2007-10#1)(2012-2#1)
had on average##3##3##(1996-9#1)(2011-1#1)(2011-2#1)
had on##9##2##(1996-9#1)(2008-10#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
had one or more##6##4##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
had one or##7##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
had one##15##2##(1992-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
had only 0##2##3##(1990-10#1)(2008-10#1)
had only a few##2##4##(2007-12#1)(2008-5#1)
had only a marginal##2##4##(1990-2#1)(1990-6#1)
had only a minor##3##4##(1995-11#1)(2008-10#2)
had only a weak##2##4##(1991-12#1)(2008-6#1)
had only a##16##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1995-11#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-6#1)(2013-1#1)
had only minor effects##2##4##(2008-10#2)
had only minor##4##3##(1995-6#1)(2008-10#3)
had only weak##2##3##(1991-2#1)(1995-12#1)
had only##36##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-4#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-1#1)(2011-2#1)(2013-1#1)
had opacities and##2##3##(2008-12#2)
had opposite##2##2##(1995-12#1)(1996-4#1)
had optimal##2##2##(2008-7#1)(2008-8#1)
had oral##2##2##(1990-3#1)(2007-8#1)
had other##2##2##(2008-5#1)(2011-2#1)
had pain##2##2##(1991-9#1)(2007-11#1)
had partial##5##2##(1990-2#1)(2007-10#2)(2009-1#1)(2012-12#1)
had participated##4##2##(1991-12#1)(2009-6#2)(2013-1#1)
had passed through##2##3##(2007-12#1)(2008-7#1)
had passed##3##2##(2007-12#1)(2008-7#1)(2008-8#1)
had pathological##2##2##(2008-11#1)(2013-8#1)
had penetrated the##2##3##(1991-12#1)(2008-10#1)
had penetrating##2##2##(1992-6#1)(2008-1#1)
had persistent##8##2##(1993-1#1)(1993-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-1#1)
had placed a##2##3##(2013-1#2)
had plasma##2##2##(1996-7#1)(2008-5#1)
had poor##5##2##(1994-6#1)(2007-11#1)(2008-7#2)(2013-1#1)
had poorer##3##2##(1991-11#1)(1991-12#1)(2011-2#1)
had positive##16##2##(1993-2#2)(1994-12#2)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#2)
had postoperative complications##2##3##(2008-3#1)(2011-2#1)
had postoperative##3##2##(1996-3#1)(2008-3#1)(2011-2#1)
had presented##3##2##(1997-2#1)(2008-12#1)(2010-5#1)
had preterm##2##2##(2011-2#2)
had prevented##2##2##(2008-11#1)(2010-12#1)
had previous##5##2##(1994-9#1)(1995-3#1)(1996-9#1)(2010-8#1)(2013-1#1)
had previously been shown to##2##5##(1990-5#1)(2013-1#1)
had previously been##17##3##(1990-5#2)(1993-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
had previously undergone##3##3##(1997-7#1)(2007-5#1)(2008-9#1)
had previously##33##2##(1990-5#2)(1993-8#1)(1994-8#2)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
had primary##2##2##(2008-1#1)(2008-7#1)
had prior##3##2##(2008-4#1)(2011-1#1)(2012-3#1)
had progressive##3##2##(1994-12#1)(2007-10#1)(2008-7#1)
had prolonged##2##2##(1996-3#1)(2007-12#1)
had prominent##2##2##(1991-12#1)(2008-3#1)
had protective effects##2##3##(2008-11#1)(2009-7#1)
had protective##4##2##(2008-11#1)(2008-12#2)(2009-7#1)
had pulmonary##2##2##(1991-11#1)(1997-8#1)
had radiological##2##2##(1992-5#1)(1997-4#1)
had rapidly##2##2##(2008-1#1)(2010-8#1)
had reached##7##2##(1990-12#1)(1994-7#1)(1996-2#1)(1997-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
had reactions##2##2##(2008-11#1)(2012-12#1)
had received a##3##3##(2008-9#1)(2010-10#1)(2012-12#1)
had received blood##2##3##(1991-7#1)(2007-7#1)
had received cisplatin##3##3##(2008-6#3)
had received previous##2##3##(1992-8#1)(2008-6#1)
had received the##2##3##(1990-2#1)(1997-6#1)
had received##45##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-3#2)(1991-7#1)(1992-6#1)(1992-8#1)(1993-10#1)(1994-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
had recently##7##2##(1995-3#1)(1995-6#2)(1997-3#1)(2007-12#1)(2008-12#1)(2009-8#1)
had recovered from##3##3##(1990-5#1)(2008-10#1)(2012-3#1)
had recovered##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
had recurrent##7##2##(1992-6#1)(1994-3#1)(1997-5#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
had reduced their##2##3##(1990-6#1)(2008-6#1)
had reduced##18##2##(1990-11#1)(1990-12#1)(1990-6#1)(1994-12#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
had reductions##3##2##(1991-2#1)(2008-3#2)
had reflux##2##2##(2008-10#2)
had relatively##5##2##(1995-8#1)(2008-10#1)(2009-7#1)(2010-8#1)(2011-2#1)
had renal##5##2##(1991-11#1)(2008-1#1)(2008-4#2)(2012-3#1)
had repeat##2##2##(1995-12#1)(2012-3#1)
had reported##2##2##(1992-9#1)(1997-6#1)
had residues##2##2##(2013-8#2)
had resolved and##2##3##(2009-6#1)(2011-2#1)
had resolved##3##2##(2008-1#1)(2009-6#1)(2011-2#1)
had retained all##2##3##(2008-5#1)(2008-8#1)
had returned to control levels##2##5##(1996-12#2)
had returned to control##3##4##(1994-5#1)(1996-12#2)
had returned to the##2##4##(2008-6#1)(2008-8#1)
had returned to##7##3##(1990-11#1)(1994-5#1)(1996-12#2)(2008-6#1)(2008-8#1)(2009-3#1)
had returned##8##2##(1990-11#1)(1994-5#1)(1996-12#2)(2007-2#1)(2008-6#1)(2008-8#1)(2009-3#1)
had revealed##3##2##(1994-9#1)(1996-11#1)(2008-11#1)
had risk factors##2##3##(1992-1#1)(2012-2#1)
had seedling genes##2##3##(2008-10#2)
had seizures##2##2##(1997-3#1)(2008-7#1)
had serious##3##2##(1991-11#1)(1994-9#1)(2012-3#1)
had serum##4##2##(1991-4#1)(1992-12#1)(2008-1#2)
had several##9##2##(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)(2013-8#2)
had severe pain##2##3##(2008-7#1)(2010-12#1)
had severe##15##2##(1991-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
had sexual intercourse##2##3##(2011-1#1)(2011-2#1)
had short##3##2##(2008-12#1)(2011-1#1)(2013-8#1)
had shown a##2##3##(1994-2#2)
had shown that##2##3##(1996-5#1)(2013-8#1)
had shown##11##2##(1990-5#1)(1992-6#1)(1994-2#2)(1996-5#1)(1997-5#1)(2008-10#1)(2008-12#1)(2013-1#2)(2013-8#1)
had significant effect on##2##4##(2008-12#2)
had significant effects on the expression##2##6##(1993-6#1)(2013-8#1)
had significant effects on the##3##5##(1991-9#1)(1993-6#1)(2013-8#1)
had significant effects on##7##4##(1991-9#1)(1993-6#1)(2008-10#3)(2008-5#1)(2013-8#1)
had significant impact on##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
had significant##35##2##(1991-12#1)(1991-9#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-6#1)(2007-10#2)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
had significantly (P &lt##2##4##(2008-10#1)(2012-3#1)
had significantly decreased##2##3##(1996-12#1)(2009-6#1)
had significantly elevated##5##3##(2008-12#3)(2008-7#1)(2011-1#1)
had significantly fewer##4##3##(1995-12#1)(1995-5#1)(2008-10#2)
had significantly greater##6##3##(1996-7#1)(1997-3#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
had significantly higher levels##2##4##(2010-4#1)(2010-7#1)
had significantly higher scores##2##4##(2008-6#1)(2013-1#1)
had significantly higher##30##3##(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-7#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#3)
had significantly increased incidences of squamous cell##2##7##(2008-9#2)
had significantly increased incidences##3##4##(2008-9#3)
had significantly increased##6##3##(2008-9#4)(2012-2#1)(2013-1#1)
had significantly less disease##3##4##(2008-10#3)
had significantly less##6##3##(1994-9#1)(1996-5#1)(2008-10#4)
had significantly lower Verticillium wilt##2##5##(2008-10#2)
had significantly lower adiponectin levels##2##5##(2011-1#1)(2013-1#1)
had significantly lower incidence##2##4##(1992-9#1)(2008-10#1)
had significantly lower levels of##4##5##(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
had significantly lower##30##3##(1990-2#1)(1992-9#1)(1993-12#2)(2008-10#9)(2008-5#1)(2008-7#4)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
had significantly more concerns##2##4##(1993-3#2)
had significantly more##17##3##(1990-5#2)(1993-3#2)(1994-7#1)(1995-4#1)(1996-12#1)(2007-10#1)(2008-10#4)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#2)
had significantly poorer##2##3##(2007-8#1)(2013-1#1)
had significantly reduced##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
had significantly shorter##2##3##(2008-4#1)(2010-7#1)
had significantly smaller##2##3##(1996-5#1)(2008-10#1)
had significantly##127##2##(1990-2#1)(1990-5#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#2)(1996-5#2)(1996-7#3)(1997-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-9#5)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#1)
had signs of##3##3##(1997-3#1)(2006-10#1)(2012-1#1)
had similar amounts of##2##4##(2008-11#2)
had similar effects on##3##4##(1996-2#1)(2008-8#1)(2011-2#1)
had similar or##2##3##(2006-11#1)(2010-8#1)
had similar topologies##2##3##(2008-10#2)
had similar##34##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-3#1)(1993-11#1)(1995-12#1)(1996-1#1)(1996-2#2)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#3)(2008-8#3)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
had similarly##2##2##(1992-8#1)(2012-3#1)
had skeletal##3##2##(1997-3#1)(2007-7#1)(2009-7#1)
had slight##3##2##(1991-6#1)(2008-7#1)(2008-9#1)
had slightly improved##2##3##(1995-9#1)(2009-5#1)
had slightly##3##2##(1995-9#1)(2009-5#1)(2009-9#1)
had small bowel##2##3##(1995-10#1)(1995-12#1)
had small##4##2##(1992-11#1)(1995-10#1)(1995-12#1)(1997-8#1)
had smaller##2##2##(1993-3#1)(2008-10#1)
had smoked##2##2##(1991-11#2)
had some detrimental effect on##2##5##(2011-2#2)
had some type of##2##4##(2008-12#1)(2013-1#1)
had some##15##2##(1991-1#1)(1991-12#1)(1992-10#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
had sought##2##2##(2007-2#1)(2011-1#1)
had spent##2##2##(1991-12#1)(1993-6#1)
had spontaneous##3##2##(2007-7#1)(2011-1#1)(2012-12#1)
had spread##2##2##(2007-8#1)(2008-10#1)
had squamous cell##3##3##(2008-9#3)
had stable disease and##3##4##(1991-6#1)(1992-12#1)(2008-10#1)
had stable##4##2##(1991-6#1)(1992-12#1)(2008-10#1)(2013-8#1)
had stage##2##2##(1995-12#2)
had started##6##2##(1997-6#1)(2007-12#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
had statistically significant##2##3##(2011-2#1)(2013-1#1)
had statistically##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
had steady##2##2##(1995-2#1)(2012-3#1)
had still##2##2##(1996-3#1)(2011-2#1)
had strong##4##2##(1994-12#1)(2007-12#1)(2008-8#1)(2013-1#1)
had subcortical##2##2##(2008-7#2)
had substantial##4##2##(1990-11#1)(1991-3#1)(2008-10#1)(2008-9#1)
had successful##2##2##(1995-8#1)(2010-5#1)
had successively borne litters in##3##5##(1997-4#3)
had successively borne litters##5##4##(1997-4#5)
had suffered a##4##3##(1997-3#1)(2007-10#1)(2008-7#1)(2010-7#1)
had suffered from##2##3##(2012-3#1)(2013-1#1)
had suffered##10##2##(1990-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
had suggested##2##2##(1993-12#1)(2010-11#1)
had surgery##2##2##(2007-11#1)(2008-8#1)
had surgical##2##2##(1992-9#1)(2008-7#1)
had sustained##5##2##(1995-8#1)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
had symptoms of##5##3##(1991-2#1)(2008-6#1)(2009-4#1)(2010-12#1)(2013-1#1)
had symptoms##8##2##(1991-11#1)(1991-2#1)(1991-3#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-12#1)(2013-1#1)
had taken##4##2##(1991-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
had the ability to##4##4##(1993-8#1)(2008-10#2)(2012-12#1)
had the activity##2##3##(2008-10#1)(2008-8#1)
had the best clinical##2##4##(2008-7#1)(2013-1#1)
had the best##6##3##(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#1)
had the chance to##2##4##(1993-5#1)(2010-6#1)
had the characteristic##2##3##(1990-6#1)(2013-1#1)
had the effect of##2##4##(2008-5#1)(2008-8#1)
had the following##3##3##(1994-3#1)(2008-10#1)(2012-12#1)
had the greatest effect##2##4##(2008-10#2)
had the greatest##7##3##(1993-12#1)(2008-10#4)(2008-12#1)(2008-3#1)
had the higher##2##3##(2008-8#1)(2011-1#1)
had the highest mean score for the##2##7##(1990-2#2)
had the highest number of##2##5##(2011-2#2)
had the highest##43##3##(1990-2#2)(1991-2#1)(1993-11#1)(1996-1#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
had the largest effect##2##4##(2008-10#2)
had the largest##4##3##(2008-10#3)(2012-2#1)
had the least##5##3##(1991-11#1)(2008-10#2)(2008-12#1)(2008-5#1)
had the longest##2##3##(2008-10#1)(2008-6#1)
had the lowest##11##3##(1990-6#1)(1996-12#1)(2008-10#6)(2011-1#1)(2011-2#1)(2013-1#1)
had the mat1-1##2##3##(2008-10#2)
had the mat1-2 allele##2##4##(2008-10#2)
had the more##2##3##(2008-10#1)(2008-11#1)
had the most and##2##4##(2008-12#2)
had the most##10##3##(2008-10#2)(2008-12#3)(2008-5#2)(2009-11#1)(2010-4#1)(2013-1#1)
had the opportunity to study##2##5##(1993-11#1)(2009-8#1)
had the opportunity to##4##4##(1993-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
had the opposite##2##3##(2007-6#1)(2010-1#1)
had the potential to##2##4##(2008-11#1)(2008-8#1)
had the same effect##2##4##(1995-12#2)
had the same##21##3##(1990-6#1)(1993-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)
had the strongest##2##3##(2008-10#2)
had the typical##2##3##(2007-4#1)(2008-11#1)
had the##200##2##(1990-2#2)(1990-6#4)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#1)(1992-8#1)(1993-11#4)(1993-12#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#61)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#5)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-11#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
had their growth unaffected by##2##5##(2008-11#2)
had their##13##2##(1990-6#1)(1994-2#1)(1996-1#1)(2008-11#4)(2008-6#1)(2009-5#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-8#1)
had thin##2##2##(2008-10#1)(2012-2#1)
had this##6##2##(1994-12#1)(1997-6#1)(2008-2#1)(2008-6#1)(2009-3#1)(2010-6#1)
had three##9##2##(1991-12#1)(1994-11#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
had time to##3##3##(1996-4#1)(2008-8#1)(2013-1#1)
had titre##3##2##(2007-7#3)
had to be removed##7##4##(1990-8#2)(1991-6#1)(2008-10#1)(2011-2#3)
had to be used##2##4##(1990-5#1)(2008-5#1)
had to be##42##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-8#1)(1994-8#1)(1996-1#1)(1996-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#3)
had to deal with##2##4##(1997-3#1)(2009-6#1)
had to have##2##3##(1994-2#1)(2011-3#1)
had to leave##2##3##(1993-5#1)(2013-1#1)
had to undergo##2##3##(1991-6#1)(1994-12#1)
had to##72##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#3)(1991-7#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)
had total abdominal hysterectomy##2##4##(2013-1#1)(2013-8#1)
had total hip##2##3##(2007-11#1)(2010-10#1)
had total##8##2##(1994-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
had traveled to##3##3##(1993-8#1)(2008-1#1)(2012-12#1)
had treated##2##2##(1993-2#1)(1996-9#1)
had treatment failure##2##3##(2008-10#1)(2013-8#1)
had treatment##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
had tremor##2##2##(2008-7#2)
had tried##2##2##(1991-9#2)
had two or more##3##4##(1991-2#1)(2010-8#1)(2011-1#1)
had two##20##2##(1991-2#1)(1991-4#1)(1992-1#1)(1993-12#1)(1994-12#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)
had type 1##2##3##(2012-4#1)(2013-1#1)
had type 2 diabetes##3##4##(2008-3#1)(2012-4#2)
had type##6##2##(1997-8#1)(2008-3#1)(2012-4#3)(2013-1#1)
had typical features of##2##4##(1991-3#1)(2012-2#1)
had typical##3##2##(1991-3#1)(2008-1#1)(2012-2#1)
had unacceptable##2##2##(1995-6#1)(2008-3#1)
had unaltered free T4 levels##2##5##(1993-12#2)
had undergone a##9##3##(1990-11#1)(1994-7#2)(1996-5#1)(2008-10#1)(2008-12#1)(2008-9#2)(2013-8#1)
had undergone multiple##2##3##(2008-7#1)(2012-2#1)
had undergone surgery##2##3##(1992-10#1)(1997-2#1)
had undergone##56##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#4)(1994-7#2)(1995-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(2006-8#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-9#1)(2010-10#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
had unique##5##2##(2008-10#5)
had urinary##2##2##(1996-12#1)(2008-10#1)
had used the##3##3##(2007-11#1)(2008-10#2)
had used##6##2##(2007-11#1)(2008-10#2)(2011-10#1)(2012-12#1)(2013-8#1)
had values##2##2##(1996-3#1)(2008-10#1)
had various##2##2##(1994-3#1)(2008-9#1)
had very high##2##3##(1990-5#1)(2013-1#1)
had very low##2##3##(1992-6#1)(1994-12#1)
had very##8##2##(1990-5#1)(1992-6#1)(1994-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-9#1)(2013-1#1)
had visited##5##2##(1993-9#1)(1997-6#1)(2007-2#1)(2012-12#1)(2013-8#1)
had weak##3##2##(1992-8#1)(1994-12#1)(2010-5#1)
had weight loss##2##3##(1992-12#1)(2008-3#1)
had worked in##2##3##(1991-12#1)(1993-1#1)
had worked##7##2##(1991-12#1)(1991-2#1)(1993-1#1)(1995-8#1)(1997-5#1)(2012-12#1)(2012-2#1)
had worse outcome compared with##2##5##(2009-2#2)
had worse##4##2##(2008-7#2)(2009-2#2)
had##5465##1##(1990-10#8)(1990-11#27)(1990-12#27)(1990-2#30)(1990-3#16)(1990-5#29)(1990-6#44)(1990-7#4)(1990-8#19)(1990-9#22)(1991-1#7)(1991-10#1)(1991-11#25)(1991-12#51)(1991-2#29)(1991-3#19)(1991-4#14)(1991-5#18)(1991-6#25)(1991-7#8)(1991-8#20)(1991-9#18)(1992-1#19)(1992-10#13)(1992-11#19)(1992-12#18)(1992-2#18)(1992-3#16)(1992-4#9)(1992-5#26)(1992-6#37)(1992-8#28)(1992-9#28)(1993-1#17)(1993-10#5)(1993-11#23)(1993-12#36)(1993-2#27)(1993-3#25)(1993-5#8)(1993-6#31)(1993-8#30)(1993-9#21)(1994-1#4)(1994-11#18)(1994-12#62)(1994-2#24)(1994-3#34)(1994-5#5)(1994-6#23)(1994-7#8)(1994-8#25)(1994-9#17)(1995-1#5)(1995-10#6)(1995-11#23)(1995-12#54)(1995-2#43)(1995-3#30)(1995-4#7)(1995-5#23)(1995-6#36)(1995-8#22)(1995-9#12)(1996-1#17)(1996-10#3)(1996-11#17)(1996-12#30)(1996-2#29)(1996-3#21)(1996-4#2)(1996-5#20)(1996-6#30)(1996-7#9)(1996-8#10)(1996-9#12)(1997-1#2)(1997-2#23)(1997-3#48)(1997-4#27)(1997-5#14)(1997-6#34)(1997-7#21)(1997-8#27)(1997-9#1)(2006-10#22)(2006-11#1)(2006-12#3)(2006-6#4)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#60)(2007-11#40)(2007-12#37)(2007-2#14)(2007-3#1)(2007-4#5)(2007-5#6)(2007-6#3)(2007-7#76)(2007-8#64)(2007-9#4)(2008-1#94)(2008-10#708)(2008-11#177)(2008-12#133)(2008-2#34)(2008-3#81)(2008-4#50)(2008-5#111)(2008-6#73)(2008-7#200)(2008-8#113)(2008-9#108)(2009-1#10)(2009-10#19)(2009-11#8)(2009-12#1)(2009-2#9)(2009-3#24)(2009-4#19)(2009-5#17)(2009-6#13)(2009-7#24)(2009-8#14)(2009-9#6)(2010-1#21)(2010-10#14)(2010-11#11)(2010-12#15)(2010-2#8)(2010-3#30)(2010-4#36)(2010-5#15)(2010-6#19)(2010-7#11)(2010-8#27)(2010-9#4)(2011-1#91)(2011-10#3)(2011-2#271)(2011-3#11)(2011-4#1)(2012-1#23)(2012-12#82)(2012-2#85)(2012-3#103)(2012-4#5)(2012-5#2)(2012-6#1)(2012-7#4)(2012-9#1)(2013-1#257)(2013-7#24)(2013-8#103)
hadlop##4##1##(2008-2#4)
haem a and##2##3##(1997-7#2)
haem a##3##2##(1997-7#3)
haem##6##1##(1990-2#1)(1994-3#1)(1997-7#4)
haemagglutinating##2##1##(2008-10#1)(2010-4#1)
haemagglutination inhibition (HI)##2##3##(1997-3#1)(1997-6#1)
haemagglutination inhibition##4##2##(1997-3#1)(1997-6#2)(2008-5#1)
haemagglutination##9##1##(1992-5#1)(1997-3#1)(1997-6#2)(2007-7#1)(2008-5#3)(2008-7#1)
haemagglutinin##7##1##(1992-2#1)(1997-6#2)(2007-11#2)(2008-11#1)(2008-8#1)
haemagglutinin-neuraminidase (HN)##3##2##(2007-6#2)(2008-11#1)
haemagglutinin-neuraminidase##4##1##(2007-6#3)(2008-11#1)
haemangioblastoma and##2##2##(2008-7#2)
haemangioma in##2##2##(2010-5#1)(2011-1#1)
haemangioma of##3##2##(2010-5#3)
haemangioma##13##1##(1993-2#1)(1997-6#1)(2008-7#2)(2010-5#4)(2011-1#3)(2013-1#2)
haemangiomas of##2##2##(2011-2#2)
haemangiomas##10##1##(2008-5#3)(2008-7#1)(2011-2#4)(2013-1#2)
haemangiopericytoma of the##2##3##(1997-6#1)(2008-7#1)
haemangiopericytoma##5##1##(1997-6#2)(2008-7#2)(2010-11#1)
haematemesis and##2##2##(2008-7#1)(2011-2#1)
haematemesis##4##1##(1995-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
haematobium ova##3##2##(1996-12#3)
haematobium were##2##2##(1996-12#2)
haematobium##12##1##(1996-12#12)
haematococca##3##1##(2008-10#3)
haematocrit##7##1##(1990-3#1)(1993-3#1)(1997-3#2)(2007-8#1)(2008-5#1)(2008-7#1)
haematogenous spread##2##2##(2008-1#1)(2008-5#1)
haematogenous##3##1##(2008-1#1)(2008-5#1)(2012-2#1)
haematologic##3##1##(2008-8#1)(2011-2#1)(2012-2#1)
haematological and biochemical##2##3##(2008-7#2)
haematological and##4##2##(2008-5#1)(2008-7#3)
haematological disorders##2##2##(1990-10#1)(2013-8#1)
haematological malignancies##5##2##(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#2)
haematological malignancy##3##2##(2009-3#1)(2010-10#1)(2013-8#1)
haematological parameters##4##2##(2008-7#2)(2010-4#1)(2013-8#1)
haematological##33##1##(1990-10#1)(1995-3#1)(1997-6#1)(2006-6#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#2)(2009-3#1)(2010-10#1)(2010-4#2)(2011-1#1)(2013-1#2)(2013-8#5)
haematology analyser and##2##3##(2008-10#1)(2011-1#1)
haematology analyser##10##2##(2008-10#9)(2011-1#1)
haematology##15##1##(1994-12#2)(2008-10#12)(2011-1#1)
haematoma after##2##2##(1997-3#1)(2008-7#1)
haematoma in##3##2##(2008-7#2)(2008-8#1)
haematoma is##2##2##(2008-7#2)
haematoma of the##2##3##(2008-7#2)
haematoma was performed##2##3##(2008-7#2)
haematoma was##4##2##(2008-7#3)(2008-8#1)
haematoma##30##1##(1995-11#1)(1997-3#2)(2007-11#1)(2008-7#20)(2008-8#4)(2011-2#1)(2013-1#1)
haematomas##3##1##(1995-3#1)(1997-6#1)(2008-7#1)
haematopoietic cells##2##2##(1994-10#1)(2012-4#1)
haematopoietic stem cell##3##3##(2008-7#1)(2010-8#1)(2012-2#1)
haematopoietic##10##1##(1990-5#2)(1994-10#1)(1995-11#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-4#1)(2013-8#2)
haematoporphyrin##2##1##(1990-6#2)
haematoxylin-eosin##2##1##(2008-5#1)(2008-7#1)
haematuria in##2##2##(1991-3#1)(1995-5#1)
haematuria was##3##2##(1991-3#3)
haematuria##17##1##(1991-3#4)(1995-5#5)(1996-6#1)(2008-10#3)(2008-8#1)(2009-1#1)(2011-2#1)(2013-8#1)
haemochromatosis##6##1##(1997-7#1)(2007-1#1)(2008-5#3)(2013-8#1)
haemocoel##2##1##(2007-12#2)
haemodialysis patients##7##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-6#2)(2008-12#2)
haemodialysis##15##1##(1990-2#1)(1990-3#2)(1991-11#2)(1991-6#3)(1996-3#1)(2008-10#2)(2008-12#3)(2011-1#1)
haemodialyzed patients were##2##3##(2008-12#2)
haemodialyzed patients##3##2##(2008-12#3)
haemodialyzed##4##1##(2008-12#4)
haemodynamic changes##3##2##(1991-3#1)(1993-10#1)(1993-5#1)
haemodynamic instability##2##2##(2008-3#1)(2008-8#1)
haemodynamic parameters##3##2##(2007-8#1)(2010-7#1)(2011-2#1)
haemodynamic response to surgical##2##4##(2011-2#2)
haemodynamic response##4##2##(1995-12#1)(2011-2#2)(2012-2#1)
haemodynamic responses##2##2##(2009-5#1)(2011-2#1)
haemodynamic##25##1##(1991-2#1)(1991-3#1)(1993-10#1)(1993-5#1)(1995-12#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#1)
haemodynamics and##5##2##(1995-12#1)(2006-10#1)(2010-10#2)(2010-7#1)
haemodynamics##10##1##(1991-5#1)(1995-12#2)(2006-10#1)(2010-10#2)(2010-7#1)(2013-1#3)
haemoglobin and##2##2##(1993-8#1)(2008-7#1)
haemoglobin concentration##2##2##(1990-3#1)(2008-10#1)
haemoglobin level##2##2##(1990-3#1)(2009-10#1)
haemoglobin levels##2##2##(2008-1#2)
haemoglobin of the##2##3##(1994-6#1)(1996-9#1)
haemoglobin was##2##2##(2009-10#1)(2009-3#1)
haemoglobin##42##1##(1990-2#1)(1990-3#2)(1990-8#1)(1991-5#1)(1993-12#1)(1993-2#2)(1993-8#3)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-9#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-7#1)(2008-8#1)(2009-10#3)(2009-3#2)(2009-4#3)(2009-5#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
haemoglobinuria##3##1##(1990-6#1)(1996-8#1)(2007-2#1)
haemolymph of##2##2##(1991-5#1)(1997-8#1)
haemolymph##7##1##(1991-5#4)(1995-12#1)(1997-8#1)(2008-6#1)
haemolysans##3##1##(2012-12#3)
haemolysis and##3##2##(1990-6#1)(1994-8#2)
haemolysis in##2##2##(1991-12#1)(2008-10#1)
haemolysis##16##1##(1990-6#1)(1991-12#3)(1994-8#3)(2008-10#4)(2009-10#1)(2009-4#3)(2013-1#1)
haemolytic uraemic syndrome##2##3##(1991-8#1)(1997-2#1)
haemolytic##12##1##(1991-8#1)(1993-10#1)(1995-12#1)(1995-3#1)(1997-2#1)(2009-5#1)(2011-2#3)(2013-1#3)
haemolyticus##2##1##(2008-7#2)
haemophilia B##3##2##(1990-5#3)
haemophilia##7##1##(1990-5#3)(2009-3#3)(2013-1#1)
haemophiliacs##2##1##(1990-6#1)(1994-9#1)
haemophilic##2##1##(1991-11#1)(2011-2#1)
haemopoiesis##2##1##(2008-11#1)(2010-8#1)
haemopoietic cells##4##2##(1991-5#1)(1994-12#1)(2008-11#2)
haemopoietic progenitor##2##2##(1990-12#1)(1990-5#1)
haemopoietic stem cells##2##3##(2008-11#2)
haemopoietic stem##3##2##(2008-11#3)
haemopoietic##10##1##(1990-12#1)(1990-5#1)(1991-5#1)(1994-12#1)(2008-11#5)(2010-11#1)
haemoptysis##10##1##(1992-9#8)(2008-4#1)(2010-2#1)
haemorrhage (10 10 )##2##4##(2008-7#2)
haemorrhage after##2##2##(1990-9#1)(2008-7#1)
haemorrhage and was##2##3##(2008-7#2)
haemorrhage and##18##2##(1991-11#1)(1992-6#3)(1996-9#1)(2008-7#8)(2008-8#1)(2011-2#2)(2013-1#2)
haemorrhage due to a##2##4##(1997-3#1)(2008-7#1)
haemorrhage during##2##2##(1991-8#1)(2008-7#1)
haemorrhage from##2##2##(2008-10#1)(2010-10#1)
haemorrhage in the basal cisterns##2##5##(2008-7#2)
haemorrhage in the##5##3##(2008-7#4)(2010-11#1)
haemorrhage in##9##2##(1997-8#1)(2008-7#6)(2010-11#1)(2012-12#1)
haemorrhage is##2##2##(2008-10#1)(2008-7#1)
haemorrhage on##3##2##(2008-7#3)
haemorrhage to##2##2##(1992-6#1)(2011-2#1)
haemorrhage was##2##2##(1996-6#1)(2007-10#1)
haemorrhage with mass effect and oedema##2##6##(1996-6#2)
haemorrhage##120##1##(1990-9#3)(1991-11#2)(1991-8#1)(1992-6#6)(1992-9#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-6#6)(1996-9#4)(1997-3#3)(1997-6#2)(1997-8#1)(2007-10#2)(2008-10#6)(2008-2#1)(2008-7#56)(2008-8#5)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#4)
haemorrhages in##2##2##(1991-6#1)(1997-5#1)
haemorrhages##9##1##(1990-9#2)(1991-6#1)(1995-3#1)(1996-6#1)(1997-5#1)(2008-7#2)(2008-8#1)
haemorrhagic fever##6##2##(1990-3#1)(1991-3#1)(1992-6#2)(2007-2#1)(2011-2#1)
haemorrhagic stroke##2##2##(1992-2#1)(2008-8#1)
haemorrhagic##27##1##(1990-3#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#2)(1993-5#1)(1996-9#2)(1997-6#1)(1997-8#1)(2007-2#1)(2008-7#9)(2008-8#1)(2011-2#5)
haemorrhoidal##2##1##(2013-1#2)
haemorrhoidalis##8##1##(2008-8#8)
haemorrhoidectomy##2##1##(1990-3#2)
haemosiderin##2##1##(2008-7#1)(2010-3#1)
haemostasis and##3##2##(2007-9#1)(2008-10#1)(2011-2#1)
haemostasis##6##1##(1995-5#1)(1996-2#1)(2007-9#2)(2008-10#1)(2011-2#1)
haemostatic##6##1##(1990-9#1)(1993-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)
haemothorax in Von Recklinghausen's disease##2##5##(2007-8#2)
haemothorax in##3##2##(2007-8#3)
haemothorax##8##1##(2007-8#4)(2011-2#3)(2013-7#1)
haemotoxicity##2##1##(2007-11#2)
haems##2##1##(1994-3#2)
hafnia-silica multilayer coatings##3##3##(2008-3#3)
hafnium##7##1##(2008-10#4)(2008-3#1)(2010-12#2)
hagfish##3##1##(2008-5#2)(2012-2#1)
hagfishes##3##1##(2012-2#3)
hair 'handle' and 'feel'##2##4##(2008-5#2)
hair 'handle'##3##2##(2008-5#3)
hair after##2##2##(2008-5#2)
hair and blood##4##3##(2008-10#4)
hair and nails##2##3##(2008-5#2)
hair and skin##2##3##(2008-5#2)
hair and the##3##3##(2008-10#1)(2008-5#2)
hair and##31##2##(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-5#10)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
hair at##2##2##(2008-5#2)
hair breakage##3##2##(2008-5#3)
hair by##5##2##(2008-10#3)(2008-5#2)
hair care products##4##3##(2008-10#1)(2008-5#3)
hair care##6##2##(2008-10#1)(2008-5#5)
hair cell##2##2##(2009-8#1)(2012-2#1)
hair cells across their apical membranes##2##6##(2009-8#1)(2012-2#1)
hair cells are##2##3##(1993-9#1)(2009-8#1)
hair cells##18##2##(1993-9#5)(2008-4#1)(2008-9#1)(2009-8#3)(2009-9#2)(2012-2#4)(2013-1#2)
hair color##2##2##(2008-5#2)
hair colour##4##2##(2008-5#4)
hair conditioners##2##2##(2008-10#2)
hair cycle##5##2##(2008-5#5)
hair dye##5##2##(2008-10#1)(2010-5#2)(2012-3#2)
hair dyeing##4##2##(1993-9#1)(2011-1#3)
hair dyes##6##2##(2007-7#1)(2008-10#2)(2008-5#2)(2012-3#1)
hair eclipse phenomenon##4##3##(2008-5#4)
hair fiber##3##2##(2008-2#1)(2008-5#2)
hair fibers##2##2##(2008-5#2)
hair fibre##5##2##(2008-10#1)(2008-5#4)
hair follicle##14##2##(1990-3#2)(2008-5#7)(2008-8#1)(2012-2#3)(2013-8#1)
hair follicles##4##2##(1992-9#1)(2008-5#2)(2008-9#1)
hair from##3##2##(2008-5#2)(2008-7#1)
hair growth and##3##3##(2008-5#3)
hair growth or##2##3##(2008-8#1)(2009-7#1)
hair growth##7##2##(2008-5#5)(2008-8#1)(2009-7#1)
hair have##2##2##(2008-5#2)
hair in##5##2##(2007-7#1)(2008-10#1)(2008-5#2)(2009-7#1)
hair is##6##2##(2008-5#5)(2010-6#1)
hair keratin homologs##3##3##(2011-2#3)
hair keratin research##2##3##(2008-5#2)
hair keratin##6##2##(2008-5#3)(2011-2#3)
hair keratins and##2##3##(2008-5#2)
hair keratins##8##2##(2008-5#6)(2011-2#2)
hair loss and##2##3##(2008-5#2)
hair loss is##3##3##(2008-5#2)(2008-8#1)
hair loss##21##2##(2007-12#1)(2008-5#9)(2008-8#5)(2010-6#2)(2012-2#1)(2012-3#3)
hair of##4##2##(1990-8#1)(2007-8#1)(2008-5#1)(2013-1#1)
hair on the##2##3##(2008-7#1)(2010-6#1)
hair on##3##2##(2008-5#1)(2008-7#1)(2010-6#1)
hair plucking##3##2##(2008-5#3)
hair properties##2##2##(2008-5#2)
hair reference##2##2##(2008-10#2)
hair removal##3##2##(2008-5#1)(2010-8#1)(2013-8#1)
hair root##2##2##(2013-8#2)
hair samples by##2##3##(2008-10#2)
hair samples from##2##3##(2008-10#1)(2013-1#1)
hair samples was##3##3##(2008-10#3)
hair samples##22##2##(1993-6#2)(2008-10#14)(2008-5#5)(2013-1#1)
hair sensilla##3##2##(2007-12#3)
hair shaft diameter##2##3##(2008-5#2)
hair shaft##6##2##(2008-12#1)(2008-5#5)
hair shafts##3##2##(2008-5#3)
hair shedding##4##2##(2008-5#4)
hair styling products##2##3##(2008-5#2)
hair styling##3##2##(2008-5#3)
hair surface##2##2##(2008-5#2)
hair thinning##2##2##(2008-5#1)(2012-3#1)
hair transplantation##4##2##(2007-7#1)(2012-3#2)(2013-7#1)
hair transverse sections##2##3##(2008-5#2)
hair transverse##3##2##(2008-5#3)
hair types were##2##3##(2008-5#2)
hair types##3##2##(2008-5#3)
hair undergoing##2##2##(2008-5#2)
hair using##2##2##(2008-10#1)(2008-5#1)
hair was##4##2##(2008-5#1)(2012-3#3)
hair were##2##2##(2008-9#1)(2012-3#1)
hair with##4##2##(2008-10#2)(2008-5#1)(2012-3#1)
hair zinc##2##2##(2012-2#2)
hair##417##1##(1990-3#2)(1990-8#4)(1992-9#1)(1993-6#2)(1993-9#8)(1995-6#1)(1996-8#1)(2007-12#5)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#51)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#230)(2008-7#4)(2008-8#9)(2008-9#6)(2009-12#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#7)(2010-8#1)(2011-1#6)(2011-2#7)(2012-2#16)(2012-3#19)(2013-1#5)(2013-7#2)(2013-8#5)
hair)##2##1##(2008-10#1)(2008-12#1)
hair-care products##2##2##(2008-10#2)
hair-care##4##1##(2008-10#3)(2008-5#1)
hairiness##2##1##(2008-8#2)
hairless mice##4##2##(1994-6#2)(2012-2#2)
hairless##9##1##(1992-8#1)(1994-6#2)(2008-5#3)(2012-2#3)
hairpin RNA##3##2##(2011-2#1)(2013-1#2)
hairpin and##4##2##(1994-8#1)(1997-2#2)(2008-10#1)
hairpin formation##2##2##(1991-5#2)
hairpin loops##2##2##(1993-12#1)(1994-8#1)
hairpin secondary structure##2##3##(1994-2#1)(2008-11#1)
hairpin##34##1##(1991-5#2)(1992-3#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#9)(1997-2#3)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-11#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
hairpins varied in loop sequence##2##5##(1992-3#2)
hairpins##7##1##(1992-3#4)(2008-10#2)(2008-4#1)
hairs##21##1##(2008-10#7)(2008-2#1)(2008-5#5)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
hairy length##3##2##(2008-7#3)
hairy root culture was##2##4##(1994-11#2)
hairy root culture##3##3##(1994-11#2)(2008-10#1)
hairy root cultures of##4##4##(1992-12#2)(1994-11#2)
hairy root cultures##6##3##(1992-12#2)(1994-11#4)
hairy root##10##2##(1992-12#2)(1994-11#6)(2008-10#1)(2008-8#1)
hairy roots of##2##3##(2008-10#1)(2008-6#1)
hairy roots##8##2##(2008-10#6)(2008-6#1)(2008-8#1)
hairy##31##1##(1990-7#1)(1990-9#2)(1992-12#2)(1994-11#6)(2007-1#1)(2008-10#10)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2011-2#1)(2013-1#1)
hake##3##1##(2010-8#2)(2011-2#1)
half (50##2##2##(1996-3#1)(2007-12#1)
half a century##2##3##(1993-6#1)(2012-3#1)
half a year##2##3##(2008-10#2)
half a##10##2##(1993-6#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
half also##2##2##(2007-12#1)(2010-8#1)
half an hour##2##3##(2008-10#1)(2012-12#1)
half and##3##2##(1992-9#1)(2008-10#1)(2009-10#1)
half are##2##2##(2008-10#1)(2010-4#1)
half as much##2##3##(1996-12#1)(2008-5#1)
half as##3##2##(1996-12#1)(2008-5#2)
half century##4##2##(1993-2#1)(1994-1#1)(1997-1#1)(2009-5#1)
half days##2##2##(2008-7#1)(2010-11#1)
half had##4##2##(1991-9#1)(2007-10#1)(2008-7#1)(2011-2#1)
half hour##2##2##(2008-10#1)(2011-1#1)
half its##4##2##(2007-11#1)(2008-3#2)(2008-5#1)
half life of##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
half life##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
half maximal##3##2##(1990-7#2)(1992-8#1)
half million##4##2##(1995-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
half molecule##3##2##(2008-8#3)
half of France##2##3##(2008-10#1)(2010-1#1)
half of a##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
half of all##6##3##(1992-12#1)(2008-1#1)(2008-10#1)(2009-9#1)(2012-2#1)(2013-7#1)
half of cases##2##3##(2007-10#1)(2011-2#1)
half of each##2##3##(2008-5#1)(2009-12#1)
half of patients##4##3##(1996-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
half of the N-terminal##2##4##(1992-9#1)(2008-7#1)
half of the RTD##3##4##(2008-10#3)
half of the cases##2##4##(1991-11#1)(1995-12#1)
half of the cell##2##4##(2007-12#1)(2008-7#1)
half of the century##2##4##(2008-10#1)(2009-10#1)
half of the females began a breeding regimen of six consecutive##2##11##(1997-4#2)
half of the molecule##3##4##(1992-8#1)(1994-2#1)(1997-8#1)
half of the mothers##2##4##(1993-12#1)(2008-1#1)
half of the nineteenth century##2##5##(2010-1#1)(2011-2#1)
half of the patients were##2##5##(1990-9#1)(2007-7#1)
half of the patients##9##4##(1990-9#1)(1992-6#1)(1995-11#1)(2007-12#1)(2007-7#1)(2008-11#2)(2011-2#1)(2012-3#1)
half of the protein##2##4##(1994-5#1)(2011-1#1)
half of the subjects##2##4##(2008-7#1)(2012-1#1)
half of the total##2##4##(2008-5#1)(2011-2#1)
half of the women##2##4##(2009-4#1)(2010-3#1)
half of the##142##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-5#2)(1996-9#1)(1997-4#3)(1997-7#2)(1997-8#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-11#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
half of them had##2##4##(2011-2#1)(2013-7#1)
half of them##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
half of these patients required##2##5##(1992-2#1)(2007-7#1)
half of these##6##3##(1992-2#1)(1997-2#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-2#1)
half of this##3##3##(2008-11#1)(2008-4#2)
half of treatment##2##3##(2008-1#2)
half of##215##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#3)(1991-11#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#4)(1997-7#2)(1997-8#3)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#4)(2010-11#1)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
half or##2##2##(1993-6#1)(2008-3#1)
half reported##3##2##(2010-9#1)(2012-12#1)(2013-8#1)
half that##3##2##(1992-6#1)(1993-11#1)(2008-2#1)
half the battle##2##3##(1996-2#1)(2007-11#1)
half the cases##2##3##(1997-3#1)(2008-9#1)
half the patients##5##3##(1990-11#1)(2008-6#1)(2008-7#1)(2012-2#2)
half the regions##2##3##(1992-11#2)
half the size and##2##4##(2008-2#1)(2009-10#1)
half the##50##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
half time##4##2##(1996-1#1)(2008-10#3)
half to##2##2##(2008-10#1)(2008-3#1)
half was##2##2##(1997-8#1)(2009-8#1)
half were to##2##3##(1996-3#1)(2007-12#1)
half were##4##2##(1993-12#1)(1996-1#1)(1996-3#1)(2007-12#1)
half year old child##2##4##(2007-7#1)(2010-5#1)
half year##5##2##(1990-9#1)(1992-5#1)(1992-6#1)(2007-7#1)(2010-5#1)
half years##8##2##(1992-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#2)
half##431##1##(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#4)(1991-11#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#6)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#4)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#4)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#11)(2007-2#2)(2007-5#1)(2007-7#6)(2007-8#4)(2008-1#9)(2008-10#44)(2008-11#16)(2008-12#7)(2008-2#11)(2008-3#16)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#6)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#4)(2010-11#5)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#19)(2011-3#3)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#5)
half&quot##2##1##(2008-8#2)
half)##3##1##(1990-8#1)(1997-7#1)(2008-10#1)
half-Cauchy##3##1##(2008-10#3)
half-beam blocks##2##2##(2007-10#2)
half-beam##5##1##(2007-10#5)
half-chair##2##1##(1995-2#1)(2008-5#1)
half-coupler##7##1##(2008-2#4)(2008-3#3)
half-cycle##3##1##(1994-8#1)(2007-11#1)(2008-5#1)
half-hour##2##1##(2008-10#1)(2008-9#1)
half-life and##6##2##(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2011-3#1)
half-life is##2##2##(2008-10#1)(2010-10#1)
half-life of the##6##3##(1990-7#1)(2008-11#4)(2008-8#1)
half-life of##17##2##(1990-7#1)(1991-3#1)(1993-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
half-life##57##1##(1990-7#1)(1991-12#2)(1991-3#2)(1991-8#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2010-10#2)(2010-11#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)
half-lives of growth factors##2##4##(2008-5#1)(2010-10#1)
half-lives of##9##2##(1992-12#1)(1996-5#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2011-1#1)
half-lives##19##1##(1992-12#1)(1995-2#1)(1996-5#2)(2007-11#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
half-maximal concentration of##3##3##(1991-2#1)(1992-11#1)(2008-8#1)
half-maximal concentration##4##2##(1991-2#1)(1991-8#1)(1992-11#1)(2008-8#1)
half-maximal dose##2##2##(1991-8#1)(1992-11#1)
half-maximal effect##4##2##(1990-5#1)(1994-6#1)(1994-8#1)(2008-4#1)
half-maximal inhibition##3##2##(1990-5#2)(1995-6#1)
half-maximal##21##1##(1990-12#1)(1990-5#3)(1991-2#1)(1991-8#2)(1992-11#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(2008-4#1)(2008-6#1)(2008-8#1)
half-maximally##3##1##(1990-7#1)(1993-3#1)(1994-12#1)
half-maximum##13##1##(1990-5#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2013-8#2)
half-mustard##2##1##(1995-3#2)
half-neutralization##2##1##(2007-11#1)(2008-10#1)
half-peak##2##1##(1996-2#1)(2008-9#1)
half-power diameter##3##2##(2008-2#1)(2008-3#2)
half-resonator##2##1##(2008-3#2)
half-sib families of##2##3##(2008-8#1)(2011-10#1)
half-sib families##3##2##(2007-1#1)(2008-8#1)(2011-10#1)
half-sib##4##1##(2007-1#1)(2008-8#1)(2011-10#1)(2012-2#1)
half-site saturation##2##2##(1994-5#2)
half-site##3##1##(1993-6#1)(1994-5#2)
half-spaces##2##1##(2007-11#1)(2012-1#1)
half-time of##4##2##(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)
half-time##6##1##(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1995-5#1)
half-times for##2##2##(1992-6#1)(1994-5#1)
half-visor##6##1##(2010-1#6)
half-visors##4##1##(2010-1#4)
half-wave method##2##2##(2008-3#2)
half-wave potential##2##2##(2008-10#2)
half-wave voltage##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
half-wave##13##1##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#5)
half-width and##2##2##(2008-3#2)
half-width##5##1##(2007-11#1)(2008-2#2)(2008-3#2)
halftone##6##1##(2008-3#6)
halftoning##2##1##(2008-3#2)
halfway between the##2##3##(2007-12#1)(2008-2#1)
halide sensitized gelatin##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
halide##29##1##(1994-5#2)(2007-11#1)(2007-12#2)(2008-10#10)(2008-2#2)(2008-3#8)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)
halides in##2##2##(2008-10#1)(2009-5#1)
halides##17##1##(1997-7#2)(2007-11#2)(2008-10#5)(2009-11#2)(2009-5#1)(2010-5#1)(2011-1#3)(2012-2#1)
halitosis##3##1##(1997-4#1)(2008-10#2)
hallmark of B16 2F2##2##4##(2008-11#2)
hallmark of apoptosis##3##3##(1993-8#1)(2008-1#1)(2008-9#1)
hallmark of cancer##2##3##(2008-11#1)(2013-1#1)
hallmark of the disease##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
hallmark of the##6##3##(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
hallmark of##32##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-8#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-11#6)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)
hallmark##38##1##(1991-2#1)(1992-12#1)(1992-2#1)(1993-8#2)(1996-6#1)(2007-7#1)(2008-1#1)(2008-11#8)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-8#2)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
hallmarks of Alzheimer's disease##2##4##(1992-8#1)(1996-5#1)
hallmarks of##15##2##(1991-6#1)(1992-8#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
hallmarks##16##1##(1991-6#1)(1992-8#1)(1995-1#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
hallucinations and delusions##2##3##(2012-2#1)(2013-8#1)
hallucinations and##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
hallucinations are##2##2##(2008-2#2)
hallucinations in patients##2##3##(2012-3#1)(2013-8#1)
hallucinations in##4##2##(2008-2#2)(2012-3#1)(2013-8#1)
hallucinations##27##1##(1995-11#1)(1995-2#1)(2007-4#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#3)
hallucinogenic##9##1##(1991-1#1)(2008-10#2)(2008-12#2)(2009-12#1)(2011-2#2)(2013-8#1)
hallucinogens##3##1##(1991-1#1)(2008-10#2)
hallucis tendon##3##2##(2009-10#3)
hallucis##8##1##(2009-10#4)(2010-3#1)(2010-7#2)(2012-2#1)
hallux distal phalanx and##2##4##(2009-10#2)
hallux rigidus##3##2##(2010-3#1)(2012-2#1)(2012-3#1)
hallux valgus deformity##6##3##(2009-10#1)(2010-11#1)(2012-2#4)
hallux valgus##11##2##(2009-10#2)(2010-11#1)(2010-3#1)(2012-2#7)
hallux##18##1##(2009-10#6)(2010-11#1)(2010-3#2)(2012-2#8)(2012-3#1)
halo arcs##3##2##(2008-2#2)(2008-3#1)
halo effect##3##2##(2011-1#1)(2012-2#2)
halo function of partially coherent speckle photography##2##7##(2008-3#2)
halo in the##2##3##(2008-2#1)(2008-6#1)
halo is##2##2##(2008-2#1)(2012-2#1)
halo naevus##3##2##(2007-7#3)
halo nevi are##2##3##(2011-2#2)
halo nevi##5##2##(2011-2#5)
halo of##3##2##(1995-5#1)(2006-10#2)
halo phenomena##4##2##(2008-2#3)(2008-3#1)
halo##47##1##(1995-3#1)(1995-5#1)(2006-10#2)(2007-7#3)(2008-10#1)(2008-2#16)(2008-3#9)(2008-6#1)(2011-1#1)(2011-2#7)(2012-2#4)(2013-1#1)
haloacetic acids##5##2##(2008-10#4)(2008-9#1)
haloacetic##6##1##(2008-10#5)(2008-9#1)
haloacetonitriles##2##1##(2008-10#2)
haloalkane##2##1##(2008-10#1)(2011-1#1)
halobenzenes and some deactivated arenes##2##5##(2007-11#2)
halobium##9##1##(1990-11#2)(1990-2#3)(1990-5#3)(1993-11#1)
halocarbon module##2##2##(1992-3#2)
halocarbons##2##1##(1992-3#1)(1994-3#1)
halocyanin##3##1##(1993-11#3)
halofuginone##4##1##(2007-6#4)
halogen lamp##2##2##(2008-12#2)
halogen or##2##2##(2006-12#1)(2008-4#1)
halogen##13##1##(1991-9#1)(1996-2#1)(2006-12#1)(2008-10#3)(2008-12#3)(2008-4#2)(2008-9#1)(2011-2#1)
halogenated acetates##2##2##(2008-4#2)
halogenated aliphatic hydrocarbons in anaerobic##2##5##(2008-11#2)
halogenated compounds##3##2##(2009-8#3)
halogenated fatty##2##2##(2008-11#2)
halogenated hydrocarbons##2##2##(1993-12#1)(2008-7#1)
halogenated monoterpenes##2##2##(2008-11#2)
halogenated organic##3##2##(2008-10#3)
halogenated pyrimidines##2##2##(2008-9#2)
halogenated##31##1##(1993-12#1)(1996-12#1)(2008-10#11)(2008-11#8)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#3)(2010-2#1)(2011-1#1)
halogenation of##2##2##(2010-12#2)
halogenation##3##1##(2010-12#3)
halogens##4##1##(1995-3#1)(1996-1#1)(2008-10#2)
haloperidol and droperidol##2##3##(2008-10#2)
haloperidol and pimozide##2##3##(1995-12#2)
haloperidol and##5##2##(1993-5#1)(1995-12#2)(2008-10#2)
haloperidol decreased the##2##3##(1993-5#1)(1995-12#1)
haloperidol in##3##2##(1995-12#1)(2008-7#1)(2012-2#1)
haloperidol on##4##2##(1995-12#1)(1997-7#3)
haloperidol treatment##5##2##(1995-12#1)(1996-7#2)(1997-7#2)
haloperidol withdrawal##2##2##(1996-7#2)
haloperidol##39##1##(1992-5#2)(1993-5#3)(1995-12#11)(1995-2#1)(1996-12#1)(1996-7#5)(1997-7#7)(2008-10#3)(2008-6#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-2#2)
haloperidol-induced catalepsy##2##2##(2012-2#2)
haloperidol-induced##4##1##(1995-12#1)(1995-2#1)(2012-2#2)
halophilic proteins##3##2##(2011-2#3)
halophilic##6##1##(1990-5#1)(2011-2#4)(2013-1#1)
halophilous grasslands##3##2##(2013-7#3)
halorhodopsin##2##1##(1994-5#2)
halos and##2##2##(2008-10#1)(2008-3#1)
halos are##2##2##(2008-2#2)
halos arising in##2##3##(2008-2#2)
halos arising##3##2##(2008-2#3)
halos in##2##2##(2008-2#2)
halos that##2##2##(2008-2#2)
halos with beta-CD complexing dyes##2##5##(2008-6#2)
halos##28##1##(2008-10#1)(2008-2#18)(2008-3#7)(2008-6#2)
halothane and enflurane##2##3##(1990-2#2)
halothane and##3##2##(1990-2#2)(2009-12#1)
halothane hepatitis##5##2##(1995-3#5)
halothane##16##1##(1990-2#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-3#7)(1996-5#1)(2009-12#1)
halstedii##3##1##(2008-10#3)
halt the progression##2##3##(2011-2#1)(2012-1#1)
halt the##3##2##(2007-12#1)(2011-2#1)(2012-1#1)
halt##10##1##(1995-6#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
halted by##2##2##(2008-10#1)(2008-7#1)
halted##13##1##(1996-3#1)(1996-8#1)(2008-10#7)(2008-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
haltere##2##1##(2012-2#2)
halting##4##1##(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)
halts##3##1##(2008-10#2)(2008-8#1)
halved the##2##2##(1994-11#1)(2008-9#1)
halved##4##1##(1994-11#1)(2007-7#1)(2008-9#1)(2009-6#1)
halves and##2##2##(2008-10#1)(2008-11#1)
halves of the##3##3##(1990-11#1)(1994-5#1)(2008-11#1)
halves of##5##2##(1990-11#1)(1990-8#1)(1994-5#1)(2008-11#1)(2011-3#1)
halves the##3##2##(1997-7#1)(2007-12#1)(2008-3#1)
halves##18##1##(1990-11#1)(1990-7#1)(1990-8#1)(1992-9#1)(1994-5#1)(1997-7#2)(2007-12#2)(2008-10#1)(2008-11#4)(2008-3#1)(2011-3#1)(2012-3#2)
halving##2##1##(2007-2#2)
ham##8##1##(1997-4#1)(2008-10#2)(2010-4#3)(2013-1#2)
hamartoma is a rare benign##2##5##(2008-7#1)(2013-8#1)
hamartoma is##3##2##(2008-7#2)(2013-8#1)
hamartoma of##3##2##(2008-2#2)(2009-5#1)
hamartoma##19##1##(2008-2#3)(2008-7#5)(2008-9#2)(2009-11#1)(2009-5#1)(2013-1#4)(2013-8#3)
hamartomas##7##1##(1997-3#1)(2008-2#1)(2008-7#1)(2013-1#4)
hamartomatous##3##1##(1990-10#1)(2009-12#1)(2013-1#1)
hamatum 382 consistently##2##3##(2008-10#2)
hamatum 382##8##2##(2008-10#8)
hamatum GD12##3##2##(2013-8#3)
hamatum##15##1##(2008-10#10)(2013-8#5)
hamburgers##5##1##(2010-4#5)
hammerhead ribozyme##2##2##(2008-9#2)
hammerhead##3##1##(2008-9#3)
hampei##4##1##(2008-6#4)
hamper the##5##2##(1993-8#1)(1995-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
hamper##8##1##(1993-8#1)(1995-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
hampered by a shortage of##2##5##(1993-2#1)(2009-3#1)
hampered by a##4##3##(1993-2#1)(2008-7#2)(2009-3#1)
hampered by the lack of##6##5##(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2013-1#1)
hampered by the##12##3##(1990-12#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
hampered by##33##2##(1990-12#1)(1990-2#1)(1992-9#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
hampered the##3##2##(2008-10#1)(2010-10#1)(2011-1#1)
hampered##45##1##(1990-12#1)(1990-2#1)(1992-9#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#1)
hampering##7##1##(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-12#1)
hampers the##2##2##(1995-12#1)(2010-11#1)
hampers##4##1##(1995-12#1)(2010-11#1)(2010-8#1)(2012-2#1)
hams##3##1##(2010-4#3)
hamster and rat##2##3##(1993-6#1)(1994-8#1)
hamster and##4##2##(1991-9#1)(1993-6#1)(1994-8#1)(1995-6#1)
hamster cardiomyopathy##2##2##(1996-8#2)
hamster cell line##2##3##(1990-7#1)(1997-4#1)
hamster hypothalamus##3##2##(1990-7#3)
hamster liver S9##3##3##(2008-8#1)(2008-9#2)
hamster liver##5##2##(1992-9#1)(1996-2#1)(2008-8#1)(2008-9#2)
hamster livers##3##2##(1996-2#3)
hamster lung##4##2##(1990-6#1)(1992-3#1)(1997-3#1)(2008-10#1)
hamster ovary (CHO) cells##28##4##(1990-12#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#12)(2008-4#1)(2008-7#5)
hamster ovary (CHO)##38##3##(1990-12#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#18)(2008-4#1)(2008-7#7)
hamster ovary cell##11##3##(1991-9#1)(2008-11#9)(2008-7#1)
hamster ovary cells##31##3##(1990-12#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(2008-11#11)(2008-7#1)(2008-8#1)(2011-2#1)
hamster ovary##89##2##(1990-12#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#4)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#45)(2008-4#1)(2008-7#9)(2008-8#1)(2011-2#1)
hamster##169##1##(1990-12#2)(1990-6#3)(1990-7#7)(1990-8#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#1)(1996-12#1)(1996-2#7)(1996-5#3)(1996-8#5)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(2008-10#2)(2008-11#49)(2008-4#7)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#6)(2011-1#1)(2011-2#1)(2011-3#1)
hamsters were##3##2##(1992-5#1)(1993-11#1)(1996-2#1)
hamsters with tumors)##4##3##(1992-5#4)
hamsters##26##1##(1992-10#2)(1992-5#12)(1993-11#1)(1994-2#2)(1996-2#2)(1996-5#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)
hamstring extensibility##7##2##(2007-11#7)
hamstring graft##2##2##(2008-11#1)(2013-1#1)
hamstring injuries##5##2##(2011-1#5)
hamstring muscle length##5##3##(2012-2#5)
hamstring muscle##7##2##(2012-2#7)
hamstring tightness##2##2##(2012-2#1)(2013-7#1)
hamstring##28##1##(2007-11#9)(2008-11#2)(2011-1#6)(2012-2#9)(2013-1#1)(2013-7#1)
hamstrings##5##1##(2013-1#5)
hancocki##2##1##(2008-5#2)
hand OA##3##2##(2013-1#3)
hand abnormalities##4##2##(1997-3#4)
hand and upper-extremity injuries##2##4##(2011-2#2)
hand and wrist##4##3##(2012-2#3)(2013-1#1)
hand and##34##2##(1991-6#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#4)(2013-1#3)
hand as a##2##3##(1997-4#2)
hand at##2##2##(1997-6#1)(2012-3#1)
hand by##2##2##(1990-12#1)(1995-11#1)
hand eczema##2##2##(2013-1#2)
hand for##3##2##(1997-1#1)(2008-3#1)(2008-9#1)
hand function and##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
hand function##8##2##(2007-10#1)(2007-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
hand functions##2##2##(2007-10#2)
hand gestures and object-directed hand movements##3##6##(2008-11#3)
hand gestures and##4##3##(2008-11#4)
hand gestures##6##2##(1997-5#1)(2008-11#5)
hand hygiene compliance##3##3##(2008-12#2)(2010-4#1)
hand hygiene guidelines and protocols##3##5##(2011-2#3)
hand hygiene##17##2##(2007-12#1)(2008-12#5)(2009-5#2)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#3)
hand illnesses##4##2##(2008-9#4)
hand in hand with##2##4##(2006-8#1)(2012-12#1)
hand in hand##4##3##(2006-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
hand in##7##2##(2006-8#1)(2008-10#2)(2008-6#1)(2009-7#1)(2012-12#1)(2012-2#1)
hand intercourse (median =##2##4##(2011-1#2)
hand is##6##2##(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
hand motor##2##2##(2009-6#2)
hand movement##2##2##(2008-6#1)(2011-2#1)
hand movements activated the##2##4##(2008-11#2)
hand movements to##2##3##(2008-11#2)
hand movements##11##2##(2008-11#9)(2008-6#1)(2011-2#1)
hand of the##2##3##(2007-10#1)(2008-9#1)
hand or##2##2##(1990-8#1)(2008-9#1)
hand pain##2##2##(2010-3#1)(2011-2#1)
hand perfusion##2##2##(2007-8#2)
hand preference##2##2##(2007-12#2)
hand preferences##3##2##(2007-12#3)
hand prostheses##2##2##(2007-11#2)
hand surgeon##3##2##(2008-9#1)(2011-2#2)
hand surgeons to##2##3##(2008-9#1)(2011-2#1)
hand surgeons##6##2##(2008-9#4)(2011-2#2)
hand surgery and##2##3##(2007-8#1)(2011-2#1)
hand surgery in##2##3##(2007-8#1)(2008-9#1)
hand surgery##6##2##(2007-8#3)(2008-9#2)(2011-2#1)
hand that##2##2##(2008-11#1)(2008-3#1)
hand the##6##2##(1991-11#1)(1992-12#1)(2008-11#1)(2008-3#1)(2011-2#1)(2011-7#1)
hand trauma##2##2##(2008-9#2)
hand use and##3##3##(2007-12#1)(2008-9#2)
hand use in##4##3##(2007-12#3)(2008-9#1)
hand use##9##2##(2007-12#4)(2008-9#5)
hand was##2##2##(2008-9#1)(2012-12#1)
hand washing##4##2##(1997-4#1)(2008-5#2)(2013-8#1)
hand with a##3##3##(1994-11#1)(1994-9#1)(2011-2#1)
hand with##7##2##(1991-6#1)(1994-11#1)(1994-9#1)(2006-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
hand##671##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#4)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#3)(1993-12#4)(1993-2#2)(1993-6#2)(1993-8#5)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#7)(1994-5#3)(1994-7#1)(1994-8#3)(1994-9#5)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#6)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#4)(2006-8#2)(2007-10#6)(2007-11#9)(2007-12#13)(2007-4#1)(2007-7#5)(2007-8#10)(2008-1#3)(2008-10#63)(2008-11#50)(2008-12#20)(2008-2#7)(2008-3#15)(2008-4#4)(2008-5#23)(2008-6#24)(2008-7#22)(2008-8#4)(2008-9#60)(2009-10#5)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#33)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#10)
hand-crafted##2##1##(2008-7#2)
hand-foot syndrome##4##2##(1991-3#1)(2008-7#3)
hand-foot##5##1##(1991-3#1)(2008-7#3)(2008-8#1)
hand-foot-and-mouth disease##2##2##(2011-1#2)
hand-held##12##1##(2008-10#5)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
hand-hygiene compliance##2##2##(2013-8#2)
hand-hygiene##3##1##(2013-8#3)
handball##3##1##(1990-6#2)(2009-1#1)
handcycling##3##1##(2013-1#3)
handed##4##1##(1997-1#1)(2008-12#1)(2008-9#1)(2010-9#1)
handedness in##2##2##(2007-12#2)
handedness of##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
handedness##14##1##(1994-8#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-9#1)(2010-12#1)(2013-1#1)
handful of##6##2##(1994-1#1)(2007-10#1)(2007-5#1)(2010-7#1)(2011-3#1)(2013-1#1)
handgrip##3##1##(1994-3#1)(2008-5#1)(2013-8#1)
handheld SD-OCT##2##2##(2011-7#2)
handheld based system##2##3##(2009-10#2)
handheld computer##2##2##(2009-10#2)
handheld##16##1##(2008-10#3)(2008-3#1)(2009-10#5)(2011-7#3)(2012-12#2)(2012-3#1)(2013-1#1)
handicap or##2##2##(1996-6#1)(2011-3#1)
handicap##13##1##(1994-1#1)(1996-6#1)(2007-10#1)(2007-6#2)(2007-8#1)(2008-8#5)(2008-9#1)(2011-3#1)
handicapped patients##2##2##(1991-2#1)(1992-2#1)
handicapped##14##1##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#3)(1995-5#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-7#1)
handicapping##2##1##(2008-8#1)(2009-7#1)
handicaps of##2##2##(2008-9#2)
handicaps##10##1##(1990-9#1)(1991-6#1)(1993-11#1)(1994-9#1)(2008-7#1)(2008-9#5)
handing##2##1##(2007-2#1)(2008-9#1)
handle a##5##2##(2008-10#1)(2008-11#2)(2012-2#2)
handle part##3##2##(2008-6#3)
handle the##4##2##(2008-1#1)(2008-11#1)(2010-9#1)(2011-3#1)
handle##62##1##(1990-6#1)(1990-8#1)(1991-1#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#5)(2008-9#1)(2009-12#3)(2009-5#1)(2010-9#1)(2011-3#1)(2012-2#4)(2012-3#1)(2013-8#2)
handled by##2##2##(1994-2#1)(2008-2#1)
handled in##4##2##(1990-2#1)(1995-11#1)(2008-11#1)(2008-3#1)
handled with##3##2##(1995-3#1)(2008-1#1)(2008-10#1)
handled##24##1##(1990-2#1)(1992-11#1)(1992-7#1)(1994-1#1)(1994-2#1)(1995-11#1)(1995-3#3)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
handles##8##1##(2007-12#1)(2008-10#6)(2009-12#1)
handling a##2##2##(1993-12#1)(2008-3#1)
handling and investigation of surgical##2##5##(2008-10#2)
handling and investigation of##3##4##(2008-10#3)
handling and plus-maze experience##2##4##(1992-7#2)
handling and preparation##2##3##(2007-12#1)(2008-3#1)
handling and##31##2##(1992-7#3)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
handling as##2##2##(1996-1#1)(2008-10#1)
handling at##2##2##(2007-12#1)(2008-3#1)
handling by##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
handling in##6##2##(1997-6#1)(1997-7#1)(2008-10#2)(2008-9#1)(2010-8#1)
handling of the##4##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
handling of##30##2##(1990-2#1)(1992-11#1)(1993-2#1)(1994-6#1)(1996-12#1)(2006-10#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-4#3)(2008-9#3)(2009-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)
handling than the##2##3##(2008-10#2)
handling the##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
handling was##3##2##(1992-2#1)(2008-10#1)(2010-9#1)
handling##166##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-7#5)(1993-1#1)(1993-12#1)(1993-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#3)(2006-10#2)(2007-12#3)(2007-8#2)(2008-1#3)(2008-10#46)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#15)(2008-7#1)(2008-8#1)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#3)(2013-8#1)
handover##2##1##(2012-12#1)(2012-3#1)
handrails##4##1##(2008-6#4)
hands and feet##6##3##(1994-8#1)(2007-7#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
hands and for##2##3##(1994-6#1)(2007-12#1)
hands and the##2##3##(1994-11#1)(2010-6#1)
hands and##20##2##(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-10#1)(2007-12#2)(2007-7#3)(2008-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
hands to##2##2##(1997-4#1)(2010-5#1)
hands with##2##2##(2008-9#1)(2011-1#1)
hands##70##1##(1993-12#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(2006-10#1)(2007-10#3)(2007-12#3)(2007-7#4)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
hands-on##10##1##(1991-3#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-1#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-8#1)
handwashing##4##1##(2007-10#1)(2008-12#2)(2009-6#1)
handwritten##4##1##(2008-10#1)(2008-6#3)
hang##4##1##(1996-5#1)(2008-10#2)(2008-12#1)
hanging drop cultures##2##3##(2008-11#2)
hanging drop technique for stem cell differentiation and cytotoxicity##2##9##(2008-11#2)
hanging drop##5##2##(2008-10#1)(2008-11#4)
hanging mercury drop electrode (HMDE) in##2##6##(2008-10#2)
hanging mercury drop electrode (HMDE)##14##5##(2008-10#14)
hanging mercury drop electrode in##2##5##(2008-10#2)
hanging mercury drop electrode##45##4##(2008-10#45)
hanging##60##1##(2008-10#48)(2008-11#5)(2008-2#1)(2008-8#1)(2009-7#2)(2010-7#2)(2013-1#1)
hantavirus disease##2##2##(1991-11#2)
hantavirus infection##2##2##(2008-10#2)
hantavirus##9##1##(1991-11#2)(1996-6#1)(2008-10#4)(2011-2#2)
hap##2##1##(2008-9#2)
haphazard##2##1##(2010-3#2)
hapla race A##2##3##(2008-10#2)
hapla race##3##2##(2008-10#3)
hapla##16##1##(2008-10#16)
haplodiploid##2##1##(2008-9#2)
haplogroup##3##1##(2008-12#3)
haplogroups##2##1##(2008-12#2)
haploid genome##4##2##(1990-12#1)(1996-10#1)(1996-12#1)(2008-8#1)
haploid strains##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
haploid##47##1##(1990-12#1)(1991-12#1)(1994-11#1)(1994-6#1)(1995-6#3)(1996-10#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-10#21)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#2)
haploid)##2##1##(2008-10#1)(2009-10#1)
haploids##12##1##(1995-9#1)(2008-10#9)(2008-11#2)
haploinsufficiency of##4##2##(1997-3#1)(2009-5#1)(2012-12#2)
haploinsufficiency##10##1##(1997-3#1)(2008-7#1)(2009-5#3)(2011-2#1)(2012-12#2)(2013-1#2)
haplotype analysis##2##2##(1994-2#2)
haplotype and##6##2##(1997-9#2)(2008-10#1)(2009-5#1)(2011-1#1)(2012-3#1)
haplotype diversity##2##2##(2008-12#1)(2010-8#1)
haplotype frequencies##4##2##(1997-5#1)(2008-10#2)(2008-12#1)
haplotype in##2##2##(2012-3#1)(2013-1#1)
haplotype network##2##2##(2011-2#2)
haplotype of##2##2##(1997-8#1)(2008-10#1)
haplotype was##2##2##(2008-10#2)
haplotype were##2##2##(2008-10#1)(2013-1#1)
haplotype##71##1##(1992-9#2)(1994-2#3)(1995-12#3)(1997-5#2)(1997-8#1)(1997-9#3)(2007-7#1)(2008-10#34)(2008-11#1)(2008-12#5)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#2)
haplotypes and##8##2##(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#1)
haplotypes associated with##2##3##(2012-12#2)
haplotypes at the##2##3##(1997-5#1)(2008-12#1)
haplotypes found##2##2##(2008-10#1)(2012-12#1)
haplotypes from##2##2##(2008-10#2)
haplotypes identified##3##2##(2008-10#3)
haplotypes in the##2##3##(2008-10#1)(2010-5#1)
haplotypes in##7##2##(2008-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)
haplotypes of##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
haplotypes that##4##2##(2008-10#2)(2012-12#1)(2012-3#1)
haplotypes were determined##2##3##(2008-10#1)(2012-12#1)
haplotypes were found among the##2##5##(2008-10#2)
haplotypes were found among##3##4##(2008-10#3)
haplotypes were found##7##3##(2008-10#5)(2008-12#1)(2010-8#1)
haplotypes were geographically dispersed##2##4##(2008-10#2)
haplotypes were identified##5##3##(2008-10#4)(2008-12#1)
haplotypes were not##2##3##(2008-10#2)
haplotypes were observed##2##3##(2008-10#2)
haplotypes were##28##2##(1997-5#1)(2008-10#21)(2008-12#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
haplotypes##124##1##(1994-2#1)(1997-5#3)(1997-9#1)(2008-10#66)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#2)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#6)(2011-2#3)(2012-12#12)(2012-3#5)(2013-1#1)(2013-8#2)
haplotypes)##4##1##(2008-10#3)(2008-12#1)
haplotypic diversity##4##2##(2008-10#3)(2008-12#1)
haplotypic##6##1##(2008-10#3)(2008-12#2)(2008-9#1)
haplotyping##5##1##(2008-12#2)(2008-7#1)(2012-3#2)
happen in the##2##3##(2008-10#2)
happen in##4##2##(1995-12#1)(2008-10#2)(2008-9#1)
happen to be##2##3##(2008-1#1)(2008-2#1)
happen to##3##2##(1995-12#1)(2008-1#1)(2008-2#1)
happen##23##1##(1990-2#1)(1991-12#1)(1991-2#3)(1992-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-4#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
happened in the##2##3##(2008-1#1)(2010-8#1)
happened in##4##2##(2008-1#1)(2009-7#1)(2010-8#1)(2011-1#1)
happened to##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
happened##16##1##(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
happening in the##2##3##(1997-2#1)(2013-1#1)
happening##3##1##(1997-2#1)(2008-4#1)(2013-1#1)
happens in##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
happens to##3##2##(1995-5#1)(2008-12#1)(2010-1#1)
happens with##2##2##(2007-12#1)(2008-6#1)
happens##26##1##(1991-3#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-5#1)(1997-5#5)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
happiness##3##1##(1993-3#1)(2008-11#1)(2013-1#1)
happy end&quot##2##2##(2008-12#2)
happy puppet&quot##2##2##(1990-9#2)
happy##13##1##(1990-9#2)(1996-9#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-7#2)(2010-4#1)(2010-8#1)
happy&quot##2##1##(2008-2#2)
hapten and##3##2##(2008-10#1)(2008-11#2)
hapten##25##1##(1990-12#2)(1992-12#4)(1993-8#3)(1994-8#3)(1995-5#1)(2008-10#6)(2008-11#6)
haptenic##2##1##(1991-8#1)(1995-3#1)
haptens##7##1##(1995-2#1)(2008-10#6)
haptoglobin##8##1##(1993-8#2)(1994-12#1)(1995-3#1)(1996-12#2)(2008-1#1)(2009-3#1)
haptotactic##2##1##(1990-5#2)
haptotyla##3##1##(2008-10#3)
harassed##2##1##(2011-1#1)(2011-2#1)
harassers of##2##2##(2011-1#2)
harassment among nursing professionals##2##4##(1996-3#2)
harassment and discrimination##3##3##(1996-3#2)(2008-12#1)
harassment and violence##2##3##(2011-2#2)
harassment and##8##2##(1996-3#2)(2007-12#3)(2008-12#1)(2011-2#2)
harassment##20##1##(1992-12#2)(1993-2#1)(1996-2#2)(1996-3#6)(1996-5#1)(2007-12#3)(2008-12#2)(2008-9#1)(2011-2#2)
harbor a##5##2##(2008-10#1)(2009-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
harbor the##2##2##(1993-11#1)(2008-10#1)
harbor##28##1##(1991-12#1)(1992-12#1)(1993-1#2)(1993-11#1)(1994-12#1)(2008-10#6)(2008-4#2)(2008-6#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-6#1)(2012-2#1)(2012-3#4)(2013-1#2)
harbored a##2##2##(2008-12#1)(2012-2#1)
harbored the##2##2##(1992-9#1)(2013-1#1)
harbored##13##1##(1992-9#1)(1994-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-2#1)(2012-2#2)(2013-1#2)
harboring a##6##2##(1993-9#1)(1995-2#1)(1996-12#1)(2008-10#3)
harboring the##8##2##(1995-12#1)(1997-4#1)(1997-6#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-6#1)
harboring##40##1##(1990-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#2)(1997-6#3)(1997-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-6#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#3)
harbors a##6##2##(1994-8#1)(1997-8#1)(2008-10#1)(2009-5#1)(2012-3#1)(2013-8#1)
harbors##23##1##(1991-1#1)(1991-2#1)(1992-12#2)(1992-3#2)(1993-1#3)(1994-8#1)(1996-10#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
harbour a##2##2##(1997-4#1)(2011-1#1)
harbour##9##1##(1991-2#1)(1996-6#1)(1997-4#1)(2007-2#1)(2008-10#3)(2011-1#2)
harboured##4##1##(1993-9#1)(1997-3#1)(2011-2#2)
harbouring##13##1##(1996-2#1)(1997-6#1)(2006-12#1)(2008-11#3)(2008-7#1)(2009-2#1)(2011-1#3)(2011-2#1)(2013-1#1)
harbours a##3##2##(1997-3#1)(2008-8#1)(2013-1#1)
harbours##7##1##(1995-5#2)(1997-3#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
hard and soft tissue##3##4##(2007-12#2)(2008-2#1)
hard and soft tissues##3##4##(2007-12#3)
hard and soft##11##3##(1991-2#1)(1993-11#1)(2007-12#5)(2008-10#3)(2008-2#1)
hard and##14##2##(1991-2#1)(1993-11#1)(2007-12#5)(2008-10#4)(2008-2#1)(2008-3#1)(2010-11#1)
hard coal##2##2##(2008-10#2)
hard disk##2##2##(2008-2#1)(2008-3#1)
hard exudates##2##2##(2010-8#2)
hard mass##2##2##(1994-7#1)(2010-6#1)
hard modeling##3##2##(2007-12#3)
hard of hearing##9##3##(2011-2#9)
hard part##2##2##(1995-2#1)(2007-9#1)
hard red spring wheat##3##4##(2008-10#3)
hard red##4##2##(2008-10#4)
hard rock and rap music were played##2##7##(1993-1#2)
hard rock and rap music were##3##6##(1993-1#3)
hard rock and##4##3##(1993-1#4)
hard target##3##2##(2008-2#2)(2008-3#1)
hard tissue##6##2##(2007-12#2)(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
hard tissues##5##2##(1990-10#1)(2008-5#1)(2008-7#1)(2011-1#2)
hard to be##2##3##(2008-4#1)(2010-8#1)
hard to control##2##3##(2008-12#1)(2008-6#1)
hard to##24##2##(1990-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-2#1)
hard with the##2##3##(2008-5#1)(2008-9#1)
hard x rays##3##3##(2008-3#3)
hard x-ray##2##2##(2007-11#2)
hard##145##1##(1990-10#1)(1990-3#1)(1990-4#1)(1991-11#3)(1991-2#1)(1993-1#5)(1993-11#2)(1993-3#1)(1994-12#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-4#1)(2006-4#1)(2007-11#2)(2007-12#13)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#1)(2008-12#7)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#17)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#1)
hard)##2##1##(1995-3#1)(2008-9#1)
hard-edge##3##1##(2008-3#3)
hard-sphere crystals##2##2##(2008-3#2)
hard-sphere##5##1##(1990-5#1)(2008-3#4)
hard-target##2##1##(2008-2#1)(2008-3#1)
hard-tissue##3##1##(2008-7#3)
hard-to-reach populations in##2##3##(2012-2#2)
hard-to-reach populations##3##2##(2012-2#2)(2013-1#1)
hard-x-ray and##2##2##(2007-11#1)(2008-3#1)
hard-x-ray##6##1##(2007-11#1)(2008-2#4)(2008-3#1)
hardened##2##1##(1995-6#1)(2013-1#1)
hardening process##2##2##(2008-10#1)(2008-3#1)
hardening with##2##2##(2008-10#2)
hardening##21##1##(1993-2#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-7#2)(2012-1#3)
harder to##7##2##(1994-9#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-3#1)
harder##15##1##(1994-9#1)(1995-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#2)(2012-1#1)(2012-3#1)
hardjo##3##1##(1991-8#3)
hardly affected by##2##3##(1993-6#1)(2012-2#1)
hardly any##3##2##(1990-10#1)(1992-11#1)(2013-1#1)
hardly be##6##2##(1993-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-10#1)
hardly detectable##3##2##(1990-12#1)(1991-2#1)(1993-11#1)
hardly extracted##4##2##(2008-10#4)
hardly influenced##3##2##(1992-8#1)(1995-11#1)(2008-5#1)
hardly##51##1##(1990-10#1)(1990-12#2)(1990-6#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1995-11#2)(1997-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
hardness and##5##2##(2008-10#2)(2008-5#1)(2010-10#1)(2013-1#1)
hardness of the##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
hardness of##10##2##(2007-12#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-5#1)(2010-10#1)
hardness values##2##2##(2008-12#1)(2010-4#1)
hardness was##2##2##(2008-12#1)(2012-2#1)
hardness were##2##2##(2008-5#1)(2010-4#1)
hardness##48##1##(1997-4#1)(2007-12#3)(2008-10#7)(2008-12#13)(2008-3#2)(2008-5#4)(2009-7#2)(2010-10#2)(2010-3#2)(2010-4#4)(2011-2#2)(2012-2#3)(2013-1#3)
hardship##3##1##(1996-5#1)(1997-2#1)(2008-10#1)
hardware and software##11##3##(1993-5#1)(1994-2#1)(1996-12#2)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
hardware and##20##2##(1992-1#1)(1993-5#1)(1994-2#1)(1996-12#2)(2007-12#3)(2008-11#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
hardware for##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
hardware is##3##2##(2008-12#1)(2008-2#1)(2008-6#1)
hardware of##2##2##(1997-6#1)(2008-3#1)
hardware to##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
hardware##68##1##(1992-1#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-12#2)(1997-6#3)(2007-12#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#12)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2010-12#1)(2010-3#2)(2010-9#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
hardware-based##2##1##(2008-2#1)(2008-3#1)
hardwood##8##1##(2008-10#1)(2008-2#1)(2008-6#3)(2013-1#2)(2013-8#1)
hardy C57BL/6ByJ##2##2##(2008-11#2)
hare density##2##2##(2013-1#2)
hare##5##1##(2013-1#5)
hares##4##1##(2013-1#4)
harm reduction##5##2##(1997-5#1)(2008-7#2)(2009-7#2)
harm the##3##2##(1996-9#1)(2008-10#1)(2008-9#1)
harm to##3##2##(1993-1#1)(1994-1#1)(2008-12#1)
harm##34##1##(1993-1#1)(1993-12#2)(1994-1#2)(1995-12#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-2#1)
harmane and harmine with beta-cyclodextrin##2##5##(2008-10#2)
harmane or harmine##2##3##(2008-10#2)
harmane##5##1##(2008-10#5)
harmful components##2##2##(1997-4#1)(2012-3#1)
harmful effect##2##2##(2008-5#1)(2009-12#1)
harmful effects of##5##3##(1991-6#1)(1992-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
harmful effects on##2##3##(1991-6#1)(2008-10#1)
harmful effects##10##2##(1991-6#2)(1992-3#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
harmful environmental factors##2##3##(2008-12#1)(2011-2#1)
harmful environmental##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
harmful for human##2##3##(2008-10#1)(2012-3#1)
harmful for the##2##3##(2011-2#1)(2012-3#1)
harmful for##4##2##(2008-10#1)(2011-2#1)(2012-3#2)
harmful influence of##2##3##(2011-2#2)
harmful influences##2##2##(1990-8#2)
harmful to the##2##3##(1990-11#1)(2008-11#1)
harmful to##8##2##(1990-11#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)
harmful##78##1##(1990-11#1)(1990-3#1)(1990-8#2)(1991-6#3)(1992-3#1)(1993-11#1)(1994-11#2)(1994-2#1)(1994-3#2)(1996-9#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
harmine##6##1##(2008-10#6)
harming##2##1##(1997-2#1)(2008-7#1)
harmless to##2##2##(1996-9#1)(2007-12#1)
harmless##11##1##(1996-9#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2012-3#1)
harmonic US##3##2##(2010-12#3)
harmonic and##3##2##(2007-11#1)(2008-8#1)(2009-7#1)
harmonic components of the##2##4##(2007-12#1)(2008-2#1)
harmonic components of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
harmonic components##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
harmonic emission##3##2##(2007-12#2)(2008-7#1)
harmonic excitation##2##2##(2007-11#2)
harmonic field##2##2##(2007-12#2)
harmonic generation##10##2##(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#3)
harmonic is##2##2##(2007-11#2)
harmonic of a Nd##6##4##(2007-11#1)(2008-2#2)(2008-3#3)
harmonic of a femtosecond##2##4##(2007-11#1)(2008-3#1)
harmonic of a##11##3##(2007-11#4)(2008-2#3)(2008-3#4)
harmonic of the##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
harmonic of##17##2##(2007-11#6)(2007-12#1)(2008-2#5)(2008-3#5)
harmonic pulses for high spectral resolution in the extreme ultraviolet##2##10##(2007-11#1)(2007-12#1)
harmonic pulses##4##2##(2007-11#3)(2007-12#1)
harmonic##98##1##(2007-11#25)(2007-12#21)(2008-10#4)(2008-2#11)(2008-3#23)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#5)(2012-2#2)(2013-1#4)
harmonically mode-locked fiber laser##2##4##(2007-11#2)
harmonically mode-locked fiber##3##3##(2007-11#2)(2007-12#1)
harmonically mode-locked##4##2##(2007-11#3)(2007-12#1)
harmonically##6##1##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
harmonics in the moiré profile##2##5##(2008-3#2)
harmonics in the##3##3##(2008-3#3)
harmonics in##4##2##(2008-3#4)
harmonics of the##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
harmonics of##11##2##(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)
harmonics##33##1##(1993-12#1)(2007-11#4)(2007-12#6)(2008-10#2)(2008-2#5)(2008-3#14)(2008-8#1)
harmonisation##2##1##(1991-3#1)(2008-10#1)
harmonization of##2##2##(2008-10#1)(2010-8#1)
harmonization##4##1##(2008-10#3)(2010-8#1)
harmonizing##2##1##(2008-10#1)(2013-1#1)
harmony pattern##2##2##(2012-12#2)
harmony source triggers were##2##4##(2012-12#2)
harmony source triggers)##2##3##(2012-12#2)
harmony source##4##2##(2012-12#4)
harmony##22##1##(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#5)(2012-12#11)(2012-3#1)
harms##5##1##(1992-12#1)(2008-11#1)(2010-12#1)(2010-3#1)(2012-3#1)
harness##19##1##(2007-8#10)(2008-10#1)(2008-11#1)(2008-7#2)(2010-9#1)(2011-1#2)(2012-3#2)
harnessed to##4##2##(1995-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
harnessed##10##1##(1995-1#1)(1995-12#1)(1995-9#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
harnessing the##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)
harnessing##8##1##(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2010-3#1)(2012-12#1)
harpin group of proteins that##2##5##(2008-10#2)
harpin protein gene##4##3##(2008-8#4)
harpin protein##5##2##(2008-8#5)
harpin##11##1##(2008-10#6)(2008-8#5)
harpin(Xoo)##3##1##(2008-10#3)
harpins##2##1##(2008-10#2)
harpoon over left##4##3##(2008-10#4)
harsh and fluctuating conditions##2##4##(2008-9#2)
harsh conditions##4##2##(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
harsh discipline##4##2##(2009-7#2)(2009-9#1)(2010-11#1)
harsh environments##2##2##(2008-10#1)(2008-2#1)
harsh##17##1##(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#2)(2011-2#1)(2012-3#1)
harshness##3##1##(2008-9#3)
hartmann test##3##2##(2008-3#3)
hartmann##5##1##(2008-3#5)
harvest (greater than##2##3##(2008-10#2)
harvest and##8##2##(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)
harvest date##3##2##(2008-10#3)
harvest fields##4##2##(2008-10#4)
harvest for##5##2##(2007-8#3)(2008-10#1)(2011-2#1)
harvest in##5##2##(2007-8#1)(2007-9#1)(2008-10#3)
harvest process##5##2##(2008-11#5)
harvest scab##2##2##(2008-10#2)
harvest the##2##2##(2008-10#1)(2008-12#1)
harvest time for##2##3##(2007-8#1)(2008-11#1)
harvest time##7##2##(2007-8#1)(2008-11#4)(2008-7#2)
harvest to##2##2##(2008-11#1)(2008-8#1)
harvest was##4##2##(2007-9#1)(2008-10#2)(2008-11#1)
harvest were##3##2##(2008-10#2)(2011-2#1)
harvest with##2##2##(2008-11#1)(2009-7#1)
harvest##113##1##(2007-12#1)(2007-8#8)(2007-9#2)(2008-10#64)(2008-11#17)(2008-12#1)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
harvested after##5##2##(2008-10#1)(2008-11#2)(2009-7#1)(2012-2#1)
harvested and the##2##3##(1997-5#1)(2008-10#1)
harvested and##9##2##(1990-8#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
harvested at 72 h##2##4##(2008-10#2)
harvested at the##2##3##(2011-2#1)(2013-1#1)
harvested at##11##2##(2008-10#4)(2008-11#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
harvested by##3##2##(1990-10#1)(2008-5#1)(2010-11#1)
harvested during##3##2##(1997-6#1)(2008-10#1)(2009-6#1)
harvested for##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
harvested from SDCL C/N 9##2##5##(2008-10#2)
harvested from the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
harvested from##15##2##(1994-5#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-5#2)(2008-9#2)(2010-12#1)
harvested grain##3##2##(2008-10#3)
harvested in##4##2##(2007-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
harvested wheat grain##3##3##(2008-10#3)
harvested within##2##2##(2008-10#1)(2012-3#1)
harvested##106##1##(1990-10#1)(1990-8#1)(1992-6#1)(1993-3#1)(1994-5#3)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-7#1)(2007-8#3)(2008-10#41)(2008-11#16)(2008-12#6)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#5)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
harvesting and##2##2##(2008-4#1)(2011-2#1)
harvesting in##3##2##(1992-6#1)(2008-8#2)
harvesting of##3##2##(1994-2#1)(2008-10#1)(2008-4#1)
harvesting on the##2##3##(2008-5#1)(2008-8#1)
harvesting technique##2##2##(2007-7#1)(2008-11#1)
harvesting the##2##2##(2008-12#1)(2009-10#1)
harvesting was##3##2##(2007-8#2)(2013-1#1)
harvesting##44##1##(1992-6#1)(1994-2#1)(1997-6#1)(2007-12#1)(2007-7#4)(2007-8#7)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
harvestmen##6##1##(2007-12#5)(2008-5#1)
harvests##4##1##(2008-10#3)(2008-11#1)
harzianum P1 conidia##3##3##(2008-10#3)
harzianum and##3##2##(2008-10#2)(2008-5#1)
harzianum##35##1##(2008-10#34)(2008-5#1)
has 2##3##2##(2009-8#1)(2010-8#2)
has 3##2##2##(1993-3#1)(2008-8#1)
has Ala153 (GCC) and##2##4##(1997-8#2)
has a &quot##2##3##(1992-12#1)(1993-2#1)
has a 50%##2##3##(1990-7#1)(2008-10#1)
has a background##2##3##(2008-10#1)(2008-3#1)
has a bandpass of##2##4##(2008-3#2)
has a beneficial effect on##2##5##(2008-11#1)(2013-8#1)
has a beneficial effect##3##4##(2008-11#1)(2013-1#1)(2013-8#1)
has a better##3##3##(2007-12#1)(2008-12#1)(2008-2#1)
has a bipartite genome##2##4##(2008-10#2)
has a bipartite##3##3##(1993-2#1)(2008-10#2)
has a broad##2##3##(2008-10#1)(2008-9#1)
has a central role##2##4##(2008-9#1)(2009-8#1)
has a central##3##3##(2008-9#1)(2009-8#1)(2011-2#1)
has a certain##2##3##(2008-11#1)(2008-9#1)
has a characteristic##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)
has a clear##6##3##(1990-2#1)(1993-8#1)(1996-7#1)(1997-3#1)(2008-12#1)(2008-7#1)
has a close relationship with##2##5##(2008-10#1)(2011-2#1)
has a close##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
has a closer relationship with##2##5##(2008-8#2)
has a complex##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
has a consistent##2##3##(2008-10#1)(2008-5#1)
has a critical role in the##2##6##(1992-8#1)(2012-3#1)
has a critical role in##3##5##(1992-8#1)(2008-11#1)(2012-3#1)
has a detection limit of 0##4##6##(2008-10#4)
has a detection limit of##8##5##(2008-10#7)(2008-2#1)
has a detection limit##9##4##(2008-10#8)(2008-2#1)
has a detection##10##3##(1992-12#1)(2008-10#8)(2008-2#1)
has a different##11##3##(1992-12#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
has a direct impact on##2##5##(1993-2#1)(2008-7#1)
has a direct##9##3##(1992-3#1)(1993-11#1)(1993-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
has a dominant##2##3##(2008-10#2)
has a fast response time of about##4##7##(2008-10#4)
has a fast response time of##8##6##(2008-10#8)
has a fast##9##3##(2008-10#8)(2008-7#1)
has a function in##2##4##(1995-8#1)(2012-2#1)
has a function##3##3##(1995-8#1)(2010-8#1)(2012-2#1)
has a functional role##2##4##(1992-3#1)(2009-1#1)
has a functional##5##3##(1992-3#1)(2008-10#1)(2008-6#1)(2009-1#1)(2009-5#1)
has a good prognosis##3##4##(1992-5#1)(1997-6#1)(2008-10#1)
has a good##10##3##(1992-5#1)(1997-6#1)(2008-10#5)(2008-9#1)(2010-7#1)(2012-2#1)
has a great influence on##2##5##(2008-10#1)(2008-3#1)
has a great##6##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)
has a greater##6##3##(1991-8#1)(1992-6#1)(2008-1#1)(2008-8#1)(2008-9#1)(2013-8#1)
has a high affinity for##3##5##(1996-2#1)(2008-10#1)(2008-6#1)
has a high degree of sequence identity##2##7##(1992-8#1)(1994-12#1)
has a high degree of##7##5##(1992-12#1)(1992-8#2)(1994-12#1)(1997-5#1)(2007-12#1)(2008-10#1)
has a high potential to##2##5##(2007-11#1)(2012-3#1)
has a high##39##3##(1992-12#1)(1992-8#2)(1994-12#2)(1996-10#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
has a higher##8##3##(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-1#1)
has a highly##2##3##(2007-11#1)(2011-2#1)
has a history of##2##4##(2008-10#1)(2012-3#1)
has a history##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
has a key role in##2##5##(1993-1#1)(2008-3#1)
has a key role##3##4##(1993-1#1)(2008-3#1)(2013-7#1)
has a key##4##3##(1993-1#1)(2008-3#1)(2009-8#1)(2013-7#1)
has a large impact on##2##5##(1991-3#1)(2009-7#1)
has a large##11##3##(1991-3#1)(1992-3#1)(1995-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)(2009-1#1)(2009-7#1)
has a larger##2##3##(2007-12#1)(2008-7#1)
has a later age of onset##2##6##(1995-8#1)(2008-2#1)
has a learning curve##2##4##(2008-9#1)(2009-5#1)
has a limited##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
has a limiting##2##3##(2008-2#1)(2008-3#1)
has a linear dynamic range##3##5##(2008-10#3)
has a linear range##2##4##(1991-2#1)(2008-10#1)
has a linear##12##3##(1991-2#1)(2007-11#1)(2008-10#8)(2008-3#2)
has a linearity interval between 0##3##6##(2008-10#3)
has a long history of##2##5##(1997-1#1)(2007-10#1)
has a long history##5##4##(1997-1#1)(2007-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
has a long##12##3##(1993-12#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
has a longer##2##3##(2008-5#1)(2008-8#1)
has a lot##2##3##(1994-3#1)(2012-2#1)
has a low complication rate##2##5##(1993-12#1)(2007-7#1)
has a low incidence of##2##5##(1993-11#1)(1995-5#1)
has a low##14##3##(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(2007-12#1)(2007-7#1)(2008-10#4)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
has a lower##7##3##(1991-5#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
has a major impact on##3##5##(1996-1#1)(2007-8#1)(2008-1#1)
has a major impact##4##4##(1996-1#1)(2007-10#1)(2007-8#1)(2008-1#1)
has a major##9##3##(1992-6#1)(1995-2#1)(1996-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)
has a marked##2##3##(1993-11#1)(2012-12#1)
has a maximum##3##3##(2008-10#2)(2008-3#1)
has a minor##2##3##(1992-10#1)(2008-3#1)
has a molecular mass of##2##5##(1991-8#1)(2009-2#1)
has a molecular weight of##4##5##(1992-8#1)(2008-8#1)(2010-3#1)(2011-2#1)
has a molecular##6##3##(1991-8#1)(1992-8#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)
has a more complex##2##4##(2008-10#1)(2008-11#1)
has a more##4##3##(2008-10#3)(2008-11#1)
has a much higher##2##4##(2008-3#1)(2008-9#1)
has a much##6##3##(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
has a narrow##2##3##(2008-3#1)(2008-8#1)
has a nearly##2##3##(2008-2#2)
has a negative impact on##2##5##(2011-2#1)(2011-7#1)
has a negative##4##3##(2007-12#1)(2008-11#1)(2011-2#1)(2011-7#1)
has a negligible effect on##2##5##(2008-3#1)(2009-7#1)
has a new##2##3##(1991-12#1)(2008-10#1)
has a number of##16##4##(1991-3#1)(1992-9#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#3)(2009-8#1)(2011-2#1)(2013-1#1)
has a partial##2##3##(1992-11#1)(2011-2#1)
has a particular##2##3##(1990-8#1)(1994-3#1)
has a physiological role##2##4##(1997-4#1)(2008-5#1)
has a positive effect on##2##5##(1995-6#1)(2009-10#1)
has a positive effect##4##4##(1993-3#1)(1995-6#1)(2009-10#1)(2011-2#1)
has a positive influence on##2##5##(2008-7#2)
has a positive##10##3##(1993-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
has a potential role in##2##5##(1995-12#1)(2009-6#1)
has a potential to##3##4##(2008-8#1)(2008-9#1)(2013-8#1)
has a potential##8##3##(1995-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-8#1)
has a practical##2##3##(2008-5#1)(2009-3#1)
has a predicted##2##3##(1992-8#1)(2011-2#1)
has a predictive##2##3##(2007-10#1)(2008-3#1)
has a predilection for##2##4##(2008-7#1)(2012-12#1)
has a profound effect on the##2##6##(2008-10#1)(2008-9#1)
has a profound##4##3##(2008-10#1)(2008-9#1)(2010-11#1)(2013-7#1)
has a pronounced effect on the##2##6##(2008-5#1)(2008-7#1)
has a protective effect##2##4##(1993-2#1)(1995-11#1)
has a protective##3##3##(1993-2#1)(1995-11#1)(2009-6#1)
has a pure##2##3##(1996-3#1)(2008-10#1)
has a putative##2##3##(1991-7#1)(2008-10#1)
has a reduced##3##3##(1993-8#1)(1997-2#1)(2008-5#1)
has a relative##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
has a relatively fast response time and can be used for##2##11##(2008-10#2)
has a relatively##5##3##(1993-2#1)(2008-10#4)
has a relevant role in##2##5##(2008-10#1)(2011-2#1)
has a response time of##7##5##(2007-11#2)(2008-10#5)
has a role in the##5##5##(1990-5#2)(1993-12#1)(1996-2#1)(2013-1#1)
has a role in##14##4##(1990-5#2)(1993-12#1)(1995-3#1)(1996-2#2)(2008-10#3)(2008-2#1)(2008-8#1)(2011-2#2)(2013-1#1)
has a role##15##3##(1990-5#2)(1993-12#1)(1995-3#1)(1995-9#1)(1996-2#2)(2008-10#3)(2008-2#1)(2008-8#1)(2011-2#2)(2013-1#1)
has a sample frequency of##2##5##(2008-10#2)
has a secondary##2##3##(2008-2#1)(2012-2#1)
has a sensitive##2##3##(2008-10#2)
has a sensitivity of##3##4##(2008-1#2)(2008-10#1)
has a sequence##2##3##(1991-5#1)(1993-8#1)
has a series of##2##4##(1991-9#1)(2008-10#1)
has a serious##3##3##(2007-11#1)(2008-8#1)(2012-12#1)
has a short##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
has a shorter##2##3##(2008-6#1)(2010-11#1)
has a significant effect on the##4##6##(2008-10#3)(2008-11#1)
has a significant impact on the##3##6##(2007-8#1)(2011-2#1)(2013-1#1)
has a significant impact on##7##5##(2007-12#1)(2007-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
has a significant##20##3##(1990-5#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
has a significantly##6##3##(1992-3#1)(2007-12#1)(2008-3#2)(2008-4#1)(2011-2#1)
has a similar##3##3##(2008-5#1)(2012-3#1)(2013-7#1)
has a simple##4##3##(2008-2#1)(2008-3#1)(2008-7#2)
has a single##6##3##(1990-7#1)(1992-8#1)(1995-8#1)(1996-9#1)(2008-10#1)(2008-3#1)
has a size of##2##4##(1994-2#1)(2008-10#1)
has a small##5##3##(1995-3#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-3#1)
has a smaller##2##3##(1995-12#1)(2008-3#1)
has a special##2##3##(2008-9#1)(2009-3#1)
has a specific##2##3##(2007-10#1)(2011-2#1)
has a striking##2##3##(1991-5#1)(1996-6#1)
has a strong influence on the##2##6##(2008-10#1)(2012-8#1)
has a strong influence on##3##5##(2008-10#1)(2011-2#1)(2012-8#1)
has a strong##16##3##(1990-11#1)(1991-6#1)(1994-12#1)(1995-2#1)(1997-4#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-8#1)
has a structure##2##3##(1990-11#1)(1996-2#1)
has a substantial##2##3##(1992-11#1)(1997-4#1)
has a suppressive effect on##2##5##(1996-5#1)(2008-11#1)
has a tendency to##2##4##(2008-5#1)(2010-12#1)
has a time##2##3##(2008-11#1)(2008-3#1)
has a timing window of approximately 5##2##7##(2008-3#2)
has a two-dimensional##2##3##(1996-5#1)(2008-2#1)
has a unique##10##3##(1991-2#1)(1993-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
has a value##2##3##(1991-5#1)(2009-12#1)
has a very good##3##4##(2008-1#1)(2008-10#1)(2011-3#1)
has a very high##5##4##(2007-12#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
has a very low##3##4##(2008-10#1)(2010-3#1)(2011-2#1)
has a very##20##3##(1991-11#1)(1992-12#1)(1996-6#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
has a well-defined##2##3##(2008-10#1)(2008-5#1)
has a well-established##2##3##(2013-1#1)(2013-8#1)
has a wide range of##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
has a wide##12##3##(1996-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
has a wider##3##3##(2008-3#1)(2009-8#1)(2011-1#1)
has a##817##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#6)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#2)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#5)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2007-10#4)(2007-11#17)(2007-12#27)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#11)(2008-10#156)(2008-11#20)(2008-12#3)(2008-2#24)(2008-3#64)(2008-4#6)(2008-5#26)(2008-6#9)(2008-7#22)(2008-8#18)(2008-9#23)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#11)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#7)(2011-2#31)(2011-3#3)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#16)(2012-3#13)(2012-8#1)(2013-1#22)(2013-7#4)(2013-8#20)
has about##2##2##(1995-5#1)(2008-1#1)
has accelerated##2##2##(2008-1#1)(2013-1#1)
has accepted##2##2##(1994-2#1)(1995-2#1)
has accomplished##2##2##(1992-2#1)(2006-4#1)
has accumulated which##2##3##(2008-5#1)(2012-2#1)
has accumulated##9##2##(1992-3#1)(1993-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
has achieved its##2##3##(1995-2#1)(2010-1#1)
has achieved##6##2##(1994-3#1)(1995-12#1)(1995-2#1)(2010-1#1)(2010-7#1)(2012-3#1)
has acquired##3##2##(1992-2#1)(2009-2#1)(2011-2#1)
has acted##2##2##(1994-3#1)(2012-3#1)
has adapted##2##2##(1997-1#1)(2008-5#1)
has added##2##2##(2007-2#1)(2008-11#1)
has addressed##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
has adopted##4##2##(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#1)
has advanced our knowledge##2##4##(2008-10#1)(2008-11#1)
has advanced##8##2##(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2013-8#1)
has advantages in##2##3##(2008-10#1)(2008-11#1)
has advantages of being##2##4##(2008-10#2)
has advantages of##3##3##(2008-10#3)
has advantages##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2010-11#1)(2011-2#1)
has affected##5##2##(1991-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
has aimed to##2##3##(2012-12#1)(2013-1#1)
has all the##2##3##(2009-5#1)(2012-2#1)
has all##3##2##(2009-5#1)(2011-1#1)(2012-2#1)
has allowed a##2##3##(2008-1#1)(2008-5#1)
has allowed the##10##3##(1993-12#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-4#1)(2010-12#1)(2010-3#1)(2011-2#1)
has allowed to document##2##4##(2008-2#2)
has allowed to##8##3##(2008-10#2)(2008-11#1)(2008-2#4)(2010-12#1)
has allowed us to##7##4##(1993-11#1)(1997-7#1)(2008-10#2)(2010-4#1)(2010-7#1)(2012-12#1)
has allowed##41##2##(1993-11#1)(1993-12#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
has almost##4##2##(1993-3#1)(2008-4#2)(2008-7#1)
has already been published##9##4##(2007-5#1)(2008-11#6)(2008-7#1)(2012-3#1)
has already been reported##2##4##(1991-12#1)(2013-8#1)
has already been##21##3##(1991-12#1)(1994-8#1)(1996-3#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
has already proven to be##2##5##(2008-4#1)(2009-10#1)
has already##34##2##(1991-12#1)(1991-4#1)(1994-2#1)(1994-8#1)(1996-3#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#7)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
has also been associated with##5##5##(2008-9#1)(2010-3#2)(2012-12#1)(2012-2#1)
has also been criticized##2##4##(1996-2#1)(2013-1#1)
has also been demonstrated##5##4##(2007-11#1)(2007-7#1)(2008-5#1)(2011-2#2)
has also been determined##3##4##(1992-6#1)(2008-10#1)(2009-8#1)
has also been developed##4##4##(1993-3#1)(1994-7#1)(2008-10#2)
has also been discussed##4##4##(2008-10#4)
has also been found to be##2##6##(2008-12#1)(2009-5#1)
has also been found##4##4##(1997-5#1)(2008-10#1)(2008-12#1)(2009-5#1)
has also been identified##4##4##(1992-8#1)(1993-8#1)(2008-11#1)(2012-2#1)
has also been implicated in##4##5##(1992-9#1)(2008-5#1)(2009-8#1)(2010-11#1)
has also been implicated##5##4##(1992-9#1)(2008-5#1)(2009-8#1)(2010-11#1)(2012-2#1)
has also been investigated##6##4##(1990-7#1)(2008-10#3)(2008-3#1)(2011-2#1)
has also been made##3##4##(2008-10#3)
has also been observed in##2##5##(2008-10#1)(2009-12#1)
has also been observed##8##4##(1992-3#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
has also been obtained##2##4##(2007-11#1)(2008-10#1)
has also been possible to##2##5##(2006-12#1)(2008-10#1)
has also been presented##2##4##(2008-12#1)(2008-2#1)
has also been proposed##4##4##(2008-1#1)(2008-11#1)(2010-3#1)(2013-8#1)
has also been reported in##3##5##(1994-11#1)(2007-8#1)(2010-6#1)
has also been reported to##2##5##(2012-12#1)(2013-8#1)
has also been reported##8##4##(1994-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-8#1)
has also been shown to be##3##6##(2008-10#1)(2008-3#1)(2012-12#1)
has also been shown to increase##2##6##(1990-8#1)(2008-1#1)
has also been shown to##14##5##(1990-8#1)(1993-8#1)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#1)
has also been shown##20##4##(1990-8#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#1)
has also been studied##7##4##(1990-8#1)(2007-12#1)(2008-10#4)(2008-4#1)
has also been successfully##3##4##(2008-10#2)(2010-8#1)
has also been suggested##3##4##(2006-12#1)(2008-7#1)(2008-8#1)
has also been tested##2##4##(2007-12#1)(2008-10#1)
has also been used as##2##5##(2008-10#1)(2008-3#1)
has also been used for##2##5##(2008-3#1)(2008-4#1)
has also been used##8##4##(1994-6#1)(2008-10#2)(2008-3#2)(2008-4#1)(2012-3#1)(2013-1#1)
has also been validated##2##4##(2008-10#1)(2008-2#1)
has also been verified##2##4##(1994-2#1)(2008-2#1)
has also been##162##3##(1990-7#1)(1990-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-6#2)(1994-7#2)(1994-8#1)(1995-5#1)(1996-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-9#1)(2006-12#2)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#38)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#2)
has also increased##4##3##(2007-12#1)(2008-11#1)(2009-11#1)(2013-1#1)
has also recently been##2##4##(2006-10#1)(2009-11#1)
has also shown##3##3##(1995-6#1)(2010-1#1)(2010-4#1)
has also##209##2##(1990-6#1)(1990-7#1)(1990-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-6#2)(1994-7#2)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-9#1)(2006-10#1)(2006-12#2)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#42)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#12)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#3)(2010-1#3)(2010-11#2)(2010-12#2)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#7)(2013-8#2)
has altered##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
has always been a##4##4##(1994-5#1)(2008-10#1)(2008-5#1)(2009-12#1)
has always been##17##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)(2012-7#1)
has always##22##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#1)
has an ORF##2##3##(1993-2#1)(2008-7#1)
has an absorbance##2##3##(1992-8#1)(2008-10#1)
has an accuracy of##2##4##(2008-3#1)(2008-5#1)
has an accuracy##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
has an additional##4##3##(1991-6#1)(1994-11#1)(2008-10#1)(2008-2#1)
has an advantage in##2##4##(2007-8#1)(2008-3#1)
has an advantage##5##3##(2007-8#1)(2008-10#2)(2008-3#2)
has an affinity for the##2##5##(2009-7#1)(2010-10#1)
has an aggressive##2##3##(1990-8#1)(1994-9#1)
has an anabolic effect on##2##5##(1997-7#1)(2013-1#1)
has an angular##2##3##(2008-2#2)
has an aperture##2##3##(2008-3#2)
has an arbitrary angle with respect to the line direction of the grating##2##13##(2008-3#2)
has an arbitrary angle##3##4##(2008-3#3)
has an average##3##3##(1990-6#1)(2010-10#1)(2013-1#1)
has an effect on the##3##5##(1992-9#1)(2008-10#1)(2008-3#1)
has an effect on##4##4##(1992-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
has an effect##5##3##(1992-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
has an established##2##3##(2007-4#1)(2009-1#1)
has an excellent##4##3##(1990-10#1)(1997-1#1)(2008-10#2)
has an extensive##2##3##(2008-10#1)(2008-7#1)
has an extremely##2##3##(2008-9#1)(2009-4#1)
has an identical##2##3##(1993-8#1)(2010-11#1)
has an impact on the##2##5##(2007-8#1)(2013-1#1)
has an impact on##4##4##(1996-6#1)(2007-8#1)(2008-8#1)(2013-1#1)
has an impact##5##3##(1990-11#1)(1996-6#1)(2007-8#1)(2008-8#1)(2013-1#1)
has an important impact##2##4##(2010-2#1)(2013-8#1)
has an important influence on##2##5##(1990-12#1)(2008-5#1)
has an important role in the##2##6##(2008-6#1)(2009-11#1)
has an important role##3##4##(1993-12#1)(2008-6#1)(2009-11#1)
has an important##11##3##(1990-12#1)(1993-12#1)(1996-3#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
has an incidence of##2##4##(2010-7#1)(2011-2#1)
has an increased##2##3##(1990-7#1)(1994-2#1)
has an increasing##2##3##(1990-2#1)(2010-12#1)
has an influence on##2##4##(1993-12#1)(2008-7#1)
has an influence##3##3##(1993-12#1)(2007-11#1)(2008-7#1)
has an inhibitory##2##3##(1993-12#1)(2013-1#1)
has an intensity##2##3##(2007-11#1)(2007-12#1)
has an intrinsic##4##3##(1990-11#1)(1992-6#1)(1994-5#1)(2007-11#1)
has an intuitive##2##3##(2011-2#1)(2013-1#1)
has an open reading frame of##3##6##(1995-9#1)(1997-6#1)(2008-4#1)
has an opposite effect on##2##5##(1990-12#1)(2008-10#1)
has an optimal pH##2##4##(1990-2#1)(2008-10#1)
has an overall##4##3##(1992-6#1)(1994-2#1)(2008-10#1)(2008-6#1)
has an unusually##2##3##(1993-2#1)(1997-7#1)
has an##176##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-9#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-9#1)(2006-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#29)(2008-11#3)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#3)
has anti-inflammatory##2##2##(2008-12#1)(2008-3#1)
has antioxidant##2##2##(2011-2#1)(2012-2#1)
has any effect##2##3##(1994-6#1)(1997-4#1)
has any##4##2##(1994-6#1)(1997-4#1)(2007-11#1)(2009-1#1)
has apparently##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
has appeared as a##2##4##(1994-2#1)(2012-3#1)
has appeared as##3##3##(1994-2#1)(2012-12#1)(2012-3#1)
has appeared##4##2##(1990-2#1)(1994-2#1)(2012-12#1)(2012-3#1)
has application in the##2##4##(1995-6#1)(2009-6#1)
has application##3##2##(1995-6#1)(2008-3#1)(2009-6#1)
has applications in the##2##4##(1997-4#1)(2008-4#1)
has applications in##3##3##(1997-4#1)(2008-3#1)(2008-4#1)
has approximately doubled##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
has approximately##6##2##(1992-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
has argued that##2##3##(1995-6#1)(1997-8#1)
has argued##3##2##(1995-6#1)(1997-8#1)(2009-10#1)
has arisen in##2##3##(2008-3#1)(2008-8#1)
has arisen##6##2##(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)(2009-8#1)
has around##2##2##(2008-7#1)(2010-8#1)
has as its##4##3##(1991-3#1)(1994-2#1)(1994-5#1)(2013-8#1)
has as##7##2##(1991-3#1)(1994-2#1)(1994-5#1)(2008-10#2)(2011-1#1)(2013-8#1)
has associated##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
has at least##6##3##(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)
has attempted to##3##3##(1991-1#1)(2008-1#1)(2008-10#1)
has attracted considerable attention##2##4##(1991-2#1)(2008-3#1)
has attracted considerable##3##3##(1991-2#1)(2008-3#1)(2008-8#1)
has attracted##6##2##(1991-2#1)(1996-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
has averaged##3##2##(1991-12#1)(2008-6#1)(2008-8#1)
has banned##2##2##(1991-12#1)(1993-3#1)
has become a frequently used##2##5##(2008-5#1)(2012-12#1)
has become a major##8##4##(1991-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-11#1)
has become a more##2##4##(2008-2#1)(2011-2#1)
has become a much more versatile and environmentally attractive technology that can handle a variety of complicated problems in pharmaceuticals##2##20##(2012-2#2)
has become a popular##4##4##(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)
has become a powerful analytical tool##3##6##(2008-10#2)(2008-7#1)
has become a powerful##4##4##(2008-10#2)(2008-4#1)(2008-7#1)
has become a standard##3##4##(2007-11#1)(2007-8#1)(2012-3#1)
has become a valuable##2##4##(2008-1#1)(2008-4#1)
has become a viable##2##4##(2008-4#1)(2009-12#1)
has become a##66##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-12#1)(1995-1#1)(1995-6#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
has become an essential part of##2##6##(1992-1#1)(2011-1#1)
has become an essential tool##2##5##(2008-2#1)(2010-8#1)
has become an essential##5##4##(1992-1#1)(2007-2#1)(2008-2#1)(2010-8#1)(2011-1#1)
has become an established##2##4##(2008-8#1)(2011-3#1)
has become an important issue##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
has become an important part of##3##6##(2006-10#1)(2007-12#1)(2011-3#1)
has become an important procedure in the restoration of function in patients with irreparable preganglionic lesions##2##16##(2008-9#2)
has become an important technique##2##5##(2009-11#1)(2009-5#1)
has become an important tool for##3##6##(1997-4#1)(2010-12#1)(2012-3#1)
has become an important tool##4##5##(1997-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
has become an important##18##4##(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
has become an increasingly important##2##5##(1991-1#1)(2008-10#1)
has become an increasingly##3##4##(1991-1#1)(2008-10#1)(2012-2#1)
has become an indispensable##2##4##(1994-2#1)(2012-3#1)
has become an##36##3##(1991-1#1)(1992-1#1)(1992-5#1)(1994-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-2#2)(2012-3#2)
has become apparent that##5##4##(1995-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
has become apparent##6##3##(1995-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
has become available##2##3##(2008-7#1)(2010-8#1)
has become common##2##3##(2008-10#1)(2011-2#1)
has become established as##2##4##(2008-2#1)(2009-5#1)
has become increasingly apparent##2##4##(2008-9#1)(2012-3#1)
has become increasingly blurred##2##4##(1996-3#1)(2008-4#1)
has become increasingly difficult over the##2##6##(1997-1#1)(2008-10#1)
has become increasingly important##3##4##(1995-1#1)(2008-10#1)(2010-12#1)
has become increasingly##18##3##(1993-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2010-12#1)(2011-1#1)(2012-3#1)
has become less##2##3##(1990-11#1)(1990-5#1)
has become more complex##2##4##(1992-3#1)(1996-1#1)
has become more##14##3##(1992-3#1)(1995-12#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
has become of##2##3##(1992-3#1)(2008-7#1)
has become one of the leading##2##6##(2008-11#1)(2011-2#1)
has become one of the most##4##6##(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
has become one of the##8##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#2)
has become one##9##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-2#2)
has become routine##2##3##(2008-12#1)(2008-9#1)
has become so##3##3##(1992-3#1)(2009-9#1)(2011-2#1)
has become such a##2##4##(2008-3#1)(2008-7#1)
has become the major##3##4##(2008-10#2)(2008-7#1)
has become the most##3##4##(2008-10#2)(2011-2#1)
has become the standard method##2##5##(2008-4#1)(2011-2#1)
has become the standard##4##4##(1996-12#1)(2007-12#1)(2008-4#1)(2011-2#1)
has become the##31##3##(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1996-1#1)(1996-12#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#1)
has become widely used##2##4##(2008-11#1)(2013-1#1)
has become##238##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#3)(1996-3#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#26)(2008-11#9)(2008-12#7)(2008-2#4)(2008-3#3)(2008-4#14)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-9#2)(2010-12#6)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#16)(2011-3#3)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
has becoming##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
has been a fundamental##2##4##(1995-12#1)(2008-8#1)
has been a great deal of##3##6##(1992-9#1)(1997-7#1)(2008-10#1)
has been a large increase in##2##6##(1990-11#1)(2010-8#1)
has been a large##3##4##(1990-11#1)(2008-3#1)(2010-8#1)
has been a long-standing##3##4##(2008-4#1)(2012-2#1)(2013-8#1)
has been a longstanding##2##4##(1995-1#1)(2012-2#1)
has been a major##7##4##(1992-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)
has been a problem##2##4##(1993-3#1)(2008-9#1)
has been a shift##2##4##(2007-12#1)(2013-7#1)
has been a significant##3##4##(1995-1#1)(2008-12#1)(2011-2#1)
has been a source of##2##5##(2008-12#2)
has been a subject of##2##5##(2010-3#1)(2012-2#1)
has been a topic of##3##5##(1995-3#1)(1996-12#1)(2009-10#1)
has been a##129##3##(1990-11#1)(1990-6#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#10)(2008-12#4)(2008-3#6)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2011-4#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#8)
has been able to##7##4##(1992-9#1)(1996-11#1)(1996-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)
has been accepted as a##2##5##(2008-9#1)(2013-8#1)
has been accepted##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#1)
has been accompanied by a##2##5##(2008-10#1)(2012-3#1)
has been accompanied by##8##4##(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-3#1)
has been accomplished by using partial##2##6##(2008-10#2)
has been accomplished by##8##4##(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2012-3#1)
has been accomplished using##2##4##(2008-10#2)
has been accomplished##14##3##(1991-6#1)(1994-12#1)(1994-5#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-4#1)(2012-3#1)
has been accumulated##2##3##(1994-5#1)(2008-1#1)
has been achieved and##2##4##(2008-10#2)
has been achieved by use of##2##6##(2007-11#1)(2007-12#1)
has been achieved by##5##4##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
has been achieved for the##2##5##(2007-8#1)(2008-10#1)
has been achieved for##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
has been achieved in##8##4##(1996-5#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-3#1)
has been achieved on##2##4##(2008-10#1)(2012-12#1)
has been achieved using##4##4##(2008-10#3)(2008-11#1)
has been achieved with a##2##5##(2008-10#1)(2008-3#1)
has been achieved with##3##4##(2008-10#1)(2008-3#1)(2009-6#1)
has been achieved##54##3##(1992-9#1)(1995-5#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-3#1)
has been acknowledged##2##3##(2008-11#2)
has been adapted in the##2##5##(2008-10#1)(2009-6#1)
has been adapted to##2##4##(2008-12#1)(2012-12#1)
has been adapted##4##3##(2008-10#1)(2008-12#1)(2009-6#1)(2012-12#1)
has been added##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
has been addressed by##4##4##(2007-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
has been addressed##6##3##(2007-8#1)(2008-10#1)(2008-9#2)(2009-5#1)(2012-2#1)
has been adequately##2##3##(1997-8#1)(2008-2#1)
has been administered##3##3##(1990-9#1)(1995-5#1)(2010-8#1)
has been adopted as##2##4##(2008-2#1)(2012-3#1)
has been adopted##5##3##(1994-9#1)(2007-11#1)(2008-2#1)(2010-8#1)(2012-3#1)
has been advanced##2##3##(1990-3#1)(2011-1#1)
has been advocated as a##2##5##(2009-6#1)(2010-2#1)
has been advocated as##3##4##(2008-11#1)(2009-6#1)(2010-2#1)
has been advocated##7##3##(1991-6#1)(1996-3#2)(2008-11#2)(2009-6#1)(2010-2#1)
has been aimed at##2##4##(1996-8#1)(2008-3#1)
has been aimed##3##3##(1996-8#1)(2008-3#1)(2013-1#1)
has been almost##2##3##(2008-5#1)(2009-2#1)
has been also applied##2##4##(2008-10#2)
has been also found##3##4##(2008-10#2)(2008-5#1)
has been also investigated##2##4##(2008-10#2)
has been also##14##3##(1994-12#1)(1997-7#1)(2008-10#8)(2008-5#2)(2008-8#1)(2013-1#1)
has been altered##2##3##(1992-1#1)(2012-2#1)
has been always##3##3##(1990-6#1)(1990-9#1)(2008-11#1)
has been amply##2##3##(1994-11#1)(1997-2#1)
has been an important##2##4##(2010-7#1)(2012-2#1)
has been an increase##5##4##(2008-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
has been an increased##3##4##(1996-1#1)(2012-3#1)(2013-1#1)
has been an increasing##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
has been an integral part of##2##6##(1992-1#1)(2008-1#1)
has been an ongoing##3##4##(1996-3#1)(2008-11#1)(2012-12#1)
has been an##29##3##(1992-1#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#6)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
has been analysed in##2##4##(1991-5#1)(2007-11#1)
has been analysed##5##3##(1991-5#2)(2007-11#1)(2008-10#1)(2008-3#1)
has been analyzed by##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
has been analyzed in##4##4##(1994-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
has been analyzed##17##3##(1994-12#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2011-1#1)
has been and##2##3##(1996-3#1)(2008-3#1)
has been applied for analysis of##2##6##(2008-10#2)
has been applied for the determination of##3##7##(2008-10#3)
has been applied for the##6##5##(2008-10#6)
has been applied for##16##4##(2007-12#1)(2008-10#13)(2008-3#1)(2012-3#1)
has been applied in##8##4##(2008-10#6)(2008-11#1)(2013-8#1)
has been applied satisfactorily to##4##5##(2008-10#4)
has been applied satisfactorily##5##4##(2008-10#5)
has been applied successfully to the analysis of##2##8##(2008-10#2)
has been applied successfully to the determination of##4##8##(2008-10#4)
has been applied successfully to the##7##6##(2008-10#7)
has been applied successfully to##10##5##(2008-10#9)(2008-2#1)
has been applied successfully##12##4##(2008-10#11)(2008-2#1)
has been applied to a##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
has been applied to determine the##3##6##(1996-12#1)(2008-10#2)
has been applied to determine##9##5##(1996-12#1)(2008-10#8)
has been applied to several##2##5##(1990-5#1)(2008-10#1)
has been applied to the analysis of##9##7##(2008-10#9)
has been applied to the determination of these##3##8##(2008-10#3)
has been applied to the determination of total##4##8##(2008-10#4)
has been applied to the determination of##47##7##(2008-10#47)
has been applied to the direct determination of##2##8##(2008-10#2)
has been applied to the investigation of##2##7##(1991-2#1)(2008-10#1)
has been applied to the simultaneous determination of##2##8##(2008-10#2)
has been applied to the spectrophotometric determination of##2##8##(2008-10#2)
has been applied to the##82##5##(1991-2#1)(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#74)(2008-3#1)(2009-5#1)(2010-7#1)(2011-1#1)
has been applied to three##2##5##(2008-10#2)
has been applied to two##2##5##(2008-10#1)(2008-3#1)
has been applied to##134##4##(1990-5#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-12#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-12#2)(2008-10#105)(2008-2#3)(2008-3#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)
has been applied##185##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#144)(2008-11#1)(2008-2#4)(2008-3#7)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
has been approved for##3##4##(1993-11#1)(2008-7#1)(2013-1#1)
has been approved##6##3##(1993-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
has been argued##3##3##(2008-8#1)(2008-9#1)(2009-11#1)
has been ascribed to##2##4##(2008-3#1)(2012-2#1)
has been assayed by##2##4##(1992-8#1)(2010-5#1)
has been assembled##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
has been assessed with##2##4##(2008-10#2)
has been assessed##8##3##(1995-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-11#1)(2013-1#1)
has been assigned to##2##4##(1995-6#1)(2008-10#1)
has been assigned##4##3##(1995-6#1)(2008-10#1)(2010-6#1)(2011-2#1)
has been associated with a number of##2##7##(2008-6#1)(2012-1#1)
has been associated with a significant increase##2##7##(2008-3#1)(2008-8#1)
has been associated with a##12##5##(1991-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
has been associated with an increased##2##6##(2007-10#1)(2012-5#1)
has been associated with an##5##5##(1994-5#1)(2007-10#1)(2008-5#1)(2012-5#1)(2013-1#1)
has been associated with higher##2##5##(1994-3#1)(2008-11#1)
has been associated with poor##2##5##(2009-11#1)(2009-5#1)
has been associated with the development of##2##7##(1997-1#1)(2012-12#1)
has been associated with the##7##5##(1995-5#1)(1997-1#1)(2008-10#1)(2010-5#1)(2012-12#2)(2013-8#1)
has been associated with##62##4##(1990-6#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-10#1)(1997-1#1)(2007-10#2)(2007-11#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-5#1)(2013-1#4)(2013-8#4)
has been associated##64##3##(1990-6#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-1#1)(2007-10#2)(2007-11#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-5#1)(2013-1#4)(2013-8#4)
has been assumed that the##2##5##(2008-10#1)(2008-11#1)
has been assumed that##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
has been assumed to##2##4##(1993-3#1)(2008-2#1)
has been assumed##6##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#3)
has been attempted##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
has been attributed to a##2##5##(2008-5#1)(2008-7#1)
has been attributed to the##3##5##(2008-10#2)(2008-8#1)
has been attributed to##14##4##(1991-2#1)(1994-5#1)(1995-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2012-2#1)
has been attributed##17##3##(1991-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)
has been available for##2##4##(2008-10#1)(2008-6#1)
has been available##6##3##(1996-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)
has been based on##2##4##(1996-1#1)(1997-6#1)
has been based##3##3##(1996-1#1)(1997-6#1)(2008-1#1)
has been believed##2##3##(1991-3#1)(2008-5#1)
has been briefly##2##3##(2008-10#2)
has been built and##2##4##(2008-3#2)
has been built##8##3##(2008-2#1)(2008-3#5)(2008-8#1)(2012-12#1)
has been calculated by##2##4##(2008-10#1)(2008-3#1)
has been calculated##9##3##(1993-2#1)(1994-5#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-3#1)(2013-1#1)
has been called##3##3##(1990-5#1)(1994-1#1)(2008-3#1)
has been carried out by the##3##6##(1990-3#1)(2008-10#2)
has been carried out by##14##5##(1990-3#1)(2007-11#2)(2008-10#10)(2012-3#1)
has been carried out for##3##5##(2008-10#2)(2008-3#1)
has been carried out in order to##2##7##(2008-10#1)(2013-1#1)
has been carried out in##9##5##(1990-2#1)(1997-5#1)(2008-10#5)(2008-11#1)(2013-1#1)
has been carried out on##5##5##(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)
has been carried out to##3##5##(1992-10#1)(2008-10#1)(2008-5#1)
has been carried out using##6##5##(2008-10#3)(2009-3#1)(2010-8#2)
has been carried out with##3##5##(1990-7#1)(2008-10#1)(2008-3#1)
has been carried out within##2##5##(2008-3#1)(2010-7#1)
has been carried out##63##4##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1992-10#1)(1997-5#1)(2007-11#2)(2008-10#30)(2008-11#1)(2008-3#5)(2008-5#3)(2008-6#1)(2009-3#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
has been changed##3##3##(1995-5#2)(2008-11#1)
has been changing##2##3##(1990-9#1)(2007-12#1)
has been characterised##2##3##(2008-10#1)(2011-2#1)
has been characterized as a##2##5##(1995-2#1)(2013-1#1)
has been characterized as##5##4##(1992-12#1)(1992-6#1)(1995-2#1)(2009-10#1)(2013-1#1)
has been characterized at##2##4##(1991-12#1)(1994-5#1)
has been characterized by##11##4##(1993-1#1)(1994-12#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-2#1)
has been characterized in##3##4##(1990-11#1)(1991-7#1)(2009-8#1)
has been characterized using##2##4##(2008-10#2)
has been characterized##28##3##(1990-11#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
has been checked##2##3##(2008-10#1)(2008-5#1)
has been chosen##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
has been claimed##3##3##(1991-4#1)(1992-10#1)(1997-4#1)
has been classified as##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
has been classified##4##3##(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
has been clearly##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
has been clinically##2##3##(2007-12#1)(2011-3#1)
has been cloned and expressed in##2##6##(1993-3#1)(1997-6#1)
has been cloned and sequenced##5##5##(1995-12#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-5#1)
has been cloned and##12##4##(1990-5#1)(1991-2#1)(1992-10#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
has been cloned by screening##2##5##(1997-4#1)(1997-8#1)
has been cloned from##5##4##(1994-11#1)(1995-8#1)(2008-9#3)
has been cloned recently##2##4##(1994-12#1)(1995-6#1)
has been cloned##24##3##(1990-5#1)(1991-2#1)(1992-10#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#2)(1995-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-12#1)
has been collected##7##3##(1992-8#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2013-1#1)
has been combined with##2##4##(2008-10#2)
has been combined##3##3##(2008-10#3)
has been compared to##3##4##(1993-9#1)(1995-2#1)(2008-11#1)
has been compared with that of a##2##7##(1996-2#1)(2008-10#1)
has been compared with that of##4##6##(1996-2#1)(2007-11#1)(2008-10#2)
has been compared with that##5##5##(1990-2#1)(1996-2#1)(2007-11#1)(2008-10#2)
has been compared with##10##4##(1990-2#1)(1990-9#1)(1996-2#1)(2007-11#1)(2008-10#5)(2010-8#1)
has been compared##15##3##(1990-2#1)(1990-9#1)(1992-3#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2010-8#1)
has been compiled##3##3##(2008-10#2)(2008-2#1)
has been completed##12##3##(1991-2#1)(1995-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
has been concluded that##4##4##(1990-9#1)(2008-10#3)
has been conducted on##5##4##(2007-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
has been conducted to##5##4##(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)
has been conducted##20##3##(1996-2#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
has been confirmed by the##2##5##(2008-10#1)(2008-8#1)
has been confirmed by##7##4##(1990-9#1)(1994-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-4#1)
has been confirmed experimentally##2##4##(2007-12#1)(2008-2#1)
has been confirmed in##2##4##(2008-10#1)(2008-12#1)
has been confirmed that the##2##5##(1996-2#1)(2008-10#1)
has been confirmed that##5##4##(1995-8#1)(1996-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
has been confirmed##23##3##(1990-9#1)(1992-8#1)(1994-12#2)(1995-8#1)(1996-2#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
has been conserved in##2##4##(2009-6#1)(2012-2#1)
has been considerable##6##3##(1991-9#1)(1992-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-1#1)
has been considered a##4##4##(2008-10#2)(2008-7#2)
has been considered as##2##4##(2008-12#1)(2010-6#1)
has been considered the##2##4##(2008-10#1)(2008-2#1)
has been considered to be##2##5##(2007-10#1)(2008-11#1)
has been considered##19##3##(1994-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#2)(2010-6#1)
has been consistently##2##3##(2011-2#1)(2013-7#1)
has been constructed and used##2##5##(2008-3#2)
has been constructed and##4##4##(2007-9#1)(2008-3#2)(2008-9#1)
has been constructed by##2##4##(1996-3#1)(2009-10#1)
has been constructed that##4##4##(1997-4#1)(2008-3#1)(2011-2#1)(2012-12#1)
has been constructed##22##3##(1990-5#1)(1991-6#1)(1996-3#1)(1997-4#1)(2007-9#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
has been continued##2##3##(1990-11#1)(2013-1#1)
has been controlled by##2##4##(2008-10#1)(2008-7#1)
has been controlled##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
has been controversial##2##3##(1990-5#1)(2010-6#1)
has been converted to##2##4##(1992-8#1)(2008-3#1)
has been converted##3##3##(1992-8#1)(2008-3#1)(2008-8#1)
has been correlated with##4##4##(1997-2#1)(2008-10#2)(2009-5#1)
has been coupled to##3##4##(1992-9#1)(2008-10#2)
has been created##5##3##(1991-6#1)(2008-4#1)(2008-7#2)(2012-12#1)
has been critically##3##3##(2008-10#2)(2011-3#1)
has been crucial in##2##4##(2008-11#1)(2008-4#1)
has been crystallized in##3##4##(2008-4#1)(2008-8#1)(2008-9#1)
has been debated##2##3##(1991-9#1)(2008-7#1)
has been decided##2##3##(1993-1#1)(2011-3#1)
has been decreasing in##2##4##(1990-3#1)(1992-2#1)
has been deduced##3##3##(1990-12#1)(1992-10#1)(1995-8#1)
has been defined as the##2##5##(2011-2#1)(2013-1#1)
has been defined as##4##4##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
has been defined by##2##4##(1996-2#1)(2008-5#1)
has been defined##14##3##(1992-12#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
has been deleted##2##3##(1990-12#1)(1995-2#1)
has been delivered##2##3##(2008-11#1)(2008-7#1)
has been demonstrated as##2##4##(1990-8#1)(2008-10#1)
has been demonstrated at##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
has been demonstrated by the##2##5##(1993-6#1)(2008-8#1)
has been demonstrated by use of##3##6##(2007-11#2)(2007-12#1)
has been demonstrated by##14##4##(1993-6#1)(1995-12#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)
has been demonstrated for the first time##3##7##(2008-10#1)(2008-2#2)
has been demonstrated for the##4##5##(2008-10#2)(2008-2#2)
has been demonstrated for what is believed to be the first time##2##12##(2007-11#1)(2007-12#1)
has been demonstrated for##12##4##(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)
has been demonstrated in a##2##5##(2007-12#1)(2008-4#1)
has been demonstrated in several##2##5##(1992-12#1)(2010-5#1)
has been demonstrated in the##3##5##(2008-4#2)(2011-1#1)
has been demonstrated in##29##4##(1990-6#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-8#1)(1995-12#2)(1997-3#1)(2007-10#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
has been demonstrated that the##3##5##(2008-11#1)(2008-12#1)(2008-7#1)
has been demonstrated that this##2##5##(1997-2#1)(2008-9#1)
has been demonstrated that##25##4##(1991-1#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-7#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2013-1#1)
has been demonstrated to be a##3##6##(2008-10#2)(2008-11#1)
has been demonstrated to be##10##5##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
has been demonstrated to have##2##5##(2010-6#1)(2013-7#1)
has been demonstrated to##21##4##(1990-12#1)(1991-9#1)(1992-5#1)(1995-3#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
has been demonstrated up to##2##5##(2008-11#1)(2008-2#1)
has been demonstrated using##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
has been demonstrated with a##2##5##(2007-12#1)(2008-3#1)
has been demonstrated with##8##4##(1997-4#2)(2007-12#1)(2008-10#1)(2008-3#2)(2009-8#1)(2011-1#1)
has been demonstrated##159##3##(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-12#2)(1992-5#1)(1992-8#2)(1993-6#2)(1994-11#1)(1994-7#1)(1994-8#1)(1995-12#3)(1995-3#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#7)(2007-12#14)(2008-10#24)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#13)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#5)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
has been derived from the##2##5##(1994-11#1)(2009-7#1)
has been derived from##3##4##(1994-11#1)(2008-3#1)(2009-7#1)
has been derived##8##3##(1994-11#1)(1994-5#1)(2008-2#3)(2008-3#2)(2009-7#1)
has been described as a##3##5##(1992-2#1)(2008-10#1)(2008-5#1)
has been described as being##2##5##(1997-7#1)(2008-1#1)
has been described as##10##4##(1992-2#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)
has been described by##2##4##(2008-3#1)(2010-12#1)
has been described for the direct determination of##3##8##(2008-10#3)
has been described for the direct##4##6##(2008-10#4)
has been described for the##8##5##(1996-5#1)(2008-10#6)(2008-11#1)
has been described for##13##4##(1996-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
has been described in a##3##5##(2008-10#2)(2008-6#1)
has been described in the literature##2##6##(2008-10#1)(2009-5#1)
has been described in##19##4##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-6#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
has been described that##2##4##(1994-5#1)(2008-12#1)
has been described##78##3##(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#2)(1994-2#1)(1994-5#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
has been designed and built##2##5##(2008-3#2)
has been designed and fabricated##3##5##(2008-2#1)(2008-3#1)(2008-5#1)
has been designed and##10##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)
has been designed for##5##4##(1995-3#1)(2008-10#1)(2008-3#2)(2008-7#1)
has been designed to##9##4##(1992-2#1)(1993-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
has been designed##32##3##(1990-7#1)(1992-2#1)(1993-3#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-11#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
has been detected at##2##4##(2008-7#1)(2010-5#1)
has been detected in several##3##5##(1993-9#1)(1994-2#1)(2013-1#1)
has been detected in the##2##5##(2008-10#1)(2011-2#1)
has been detected in##13##4##(1991-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
has been detected##25##3##(1990-11#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
has been determined and##5##4##(1991-5#1)(1993-3#1)(1996-3#1)(2008-10#1)(2010-10#1)
has been determined at 2##2##5##(1993-8#1)(1994-12#1)
has been determined at##4##4##(1993-8#1)(1994-12#1)(2008-10#2)
has been determined by X-ray##2##5##(1996-2#1)(1997-7#1)
has been determined by the##2##5##(1990-11#1)(1997-4#1)
has been determined by using##2##5##(2006-4#1)(2011-1#1)
has been determined by##13##4##(1990-11#1)(1990-8#1)(1993-2#1)(1994-5#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#3)(2011-1#1)
has been determined for the##2##5##(1993-3#1)(2008-3#1)
has been determined for##4##4##(1993-3#1)(1994-12#1)(1994-5#1)(2008-3#1)
has been determined in the##2##5##(2008-10#2)
has been determined in##12##4##(1991-5#1)(1992-6#1)(1995-5#1)(1996-5#1)(2008-10#8)
has been determined that##3##4##(1992-11#1)(2008-10#1)(2010-10#1)
has been determined to##2##4##(1994-8#1)(2008-9#1)
has been determined using##4##4##(1991-8#1)(1992-7#1)(1994-5#2)
has been determined##77##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-5#4)(1994-8#2)(1995-5#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#2)
has been developed and applied for the determination of##2##9##(2008-10#2)
has been developed and applied##3##5##(1994-12#1)(2008-10#2)
has been developed and evaluated##3##5##(2008-10#2)(2008-3#1)
has been developed and shown to be##2##7##(1993-11#1)(2008-11#1)
has been developed and tested##3##5##(1996-1#1)(2008-10#2)
has been developed and used to##3##6##(2008-10#1)(2008-11#1)(2008-3#1)
has been developed and used##4##5##(2008-10#2)(2008-11#1)(2008-3#1)
has been developed and validated##7##5##(2008-10#2)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
has been developed and##31##4##(1992-1#1)(1993-11#1)(1994-12#1)(1996-1#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-3#3)(2008-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
has been developed as an alternative to##2##7##(2008-5#1)(2012-12#1)
has been developed as an##4##5##(2008-3#2)(2008-5#1)(2012-12#1)
has been developed as##5##4##(2008-10#1)(2008-3#2)(2008-5#1)(2012-12#1)
has been developed based on the##3##6##(2007-11#1)(2008-10#2)
has been developed based on##7##5##(2007-11#2)(2008-10#5)
has been developed by a##2##5##(2008-10#2)
has been developed by the##3##5##(1995-12#1)(2008-10#1)(2013-1#1)
has been developed by using##3##5##(1993-11#1)(2008-10#2)
has been developed by##15##4##(1993-11#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#10)(2013-1#1)
has been developed for a##2##5##(2008-3#1)(2012-3#1)
has been developed for analysis of##2##6##(2008-10#1)(2008-3#1)
has been developed for determination of##6##6##(2008-10#5)(2008-2#1)
has been developed for measuring##2##5##(2008-10#1)(2008-2#1)
has been developed for preconcentration of##2##6##(2008-10#2)
has been developed for preconcentration##3##5##(2008-10#3)
has been developed for quantitative##2##5##(2008-10#1)(2010-5#1)
has been developed for simultaneous##3##5##(2008-10#2)(2008-4#1)
has been developed for the analysis of##3##7##(1996-5#1)(2008-10#1)(2008-3#1)
has been developed for the detection##2##6##(2008-10#2)
has been developed for the determination of As##2##8##(2008-10#2)
has been developed for the determination of the##2##8##(1991-5#1)(2008-10#1)
has been developed for the determination of trace amounts of##2##10##(2008-10#2)
has been developed for the determination of trace##8##8##(2008-10#8)
has been developed for the determination of##39##7##(1991-5#1)(2008-10#36)(2008-3#1)(2011-1#1)
has been developed for the determination##40##6##(1991-5#1)(2008-10#37)(2008-3#1)(2011-1#1)
has been developed for the direct determination of##5##8##(2008-10#5)
has been developed for the direct##7##6##(2008-10#7)
has been developed for the on-line##2##6##(2008-10#2)
has been developed for the purpose of##2##7##(2008-10#2)
has been developed for the quantitative determination of##4##8##(2008-10#3)(2012-12#1)
has been developed for the rapid and##2##7##(2008-10#2)
has been developed for the rapid##3##6##(2008-10#3)
has been developed for the separation and##3##7##(2008-10#3)
has been developed for the separation##4##6##(2008-10#4)
has been developed for the simultaneous determination of##9##8##(1990-8#1)(2008-10#8)
has been developed for the simultaneous##13##6##(1990-8#1)(2008-10#10)(2008-5#1)(2010-3#1)
has been developed for the study##2##6##(2008-10#1)(2008-3#1)
has been developed for the treatment of##2##7##(1992-8#1)(2008-10#1)
has been developed for the##111##5##(1990-8#1)(1991-5#1)(1992-8#1)(1994-2#2)(1996-5#1)(2008-10#91)(2008-11#2)(2008-3#5)(2008-5#1)(2009-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
has been developed for this##2##5##(2008-3#2)
has been developed for trace##3##5##(2008-10#3)
has been developed for##175##4##(1990-8#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#2)(1995-8#1)(1996-5#1)(2007-12#2)(2008-10#126)(2008-11#3)(2008-2#6)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
has been developed in order to##4##6##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
has been developed in our laboratory##2##6##(1997-6#1)(2008-10#1)
has been developed in this study##2##6##(2008-10#2)
has been developed in this work##3##6##(2008-10#3)
has been developed in this##5##5##(2008-10#5)
has been developed in##14##4##(1997-6#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)
has been developed in-house##2##4##(2008-10#1)(2008-3#1)
has been developed on the basis of##2##7##(2008-10#1)(2008-3#1)
has been developed on##3##4##(2008-10#2)(2008-3#1)
has been developed that can##2##5##(2008-2#2)
has been developed that permits##2##5##(2007-12#2)
has been developed that##9##4##(1997-3#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)(2010-4#1)
has been developed to detect##2##5##(1995-11#1)(2008-10#1)
has been developed to determine##4##5##(2008-10#3)(2011-2#1)
has been developed to measure##2##5##(1996-12#1)(2008-3#1)
has been developed to provide a##2##6##(2008-10#1)(2008-3#1)
has been developed to separate##2##5##(2008-10#2)
has been developed to simulate the##2##6##(2008-10#1)(2008-3#1)
has been developed to simulate##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
has been developed to study the##3##6##(2008-11#1)(2008-2#1)(2011-2#1)
has been developed to study##6##5##(2008-11#1)(2008-2#2)(2008-7#2)(2011-2#1)
has been developed to##49##4##(1991-9#1)(1992-12#1)(1992-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#6)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
has been developed using a##3##5##(2007-8#2)(2008-10#1)
has been developed using##12##4##(1996-2#1)(2007-8#2)(2008-10#9)
has been developed which##4##4##(2008-10#4)
has been developed with a##2##5##(2008-10#1)(2008-11#1)
has been developed with the##3##5##(1990-2#1)(1994-12#1)(2008-10#1)
has been developed with##9##4##(1990-2#1)(1994-12#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
has been developed##522##3##(1990-12#1)(1990-2#1)(1990-8#2)(1991-5#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-11#7)(2007-12#11)(2007-8#3)(2008-1#2)(2008-10#320)(2008-11#9)(2008-2#20)(2008-3#46)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#2)(2011-1#3)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#5)
has been devised##4##3##(2007-11#1)(2008-10#1)(2010-3#1)(2010-8#1)
has been devoted to improving##2##5##(1993-3#1)(2008-9#1)
has been devoted to##7##4##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)
has been difficult to##8##4##(1992-1#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
has been difficult##12##3##(1992-1#1)(1993-11#1)(1993-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-7#1)(2013-8#1)
has been directed to##3##4##(1993-12#1)(2008-1#1)(2008-11#1)
has been directed##6##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
has been discovered in the##2##5##(1991-7#1)(2009-3#1)
has been discovered in##4##4##(1991-7#1)(2008-10#1)(2009-3#1)(2010-7#1)
has been discovered##9##3##(1990-7#1)(1991-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-7#1)
has been discussed in the##3##5##(2008-10#1)(2008-3#1)(2011-3#1)
has been discussed in##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)
has been discussed##15##3##(1990-2#1)(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2011-3#1)(2013-1#1)
has been divided into##2##4##(2006-10#1)(2011-2#1)
has been documented in##4##4##(2008-8#1)(2012-2#3)
has been documented##11##3##(1997-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#4)(2013-1#1)
has been done and##3##4##(2008-7#1)(2009-12#1)(2012-2#1)
has been done in##6##4##(1991-3#1)(1997-7#1)(2009-2#1)(2013-1#3)
has been done on##2##4##(1991-3#1)(2008-10#1)
has been done to##3##4##(1994-3#1)(1996-1#1)(2013-1#1)
has been done with##4##4##(1997-4#1)(2008-10#1)(2008-3#2)
has been done##24##3##(1991-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-3#2)(2008-7#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#4)
has been dramatically##2##3##(2010-7#1)(2013-8#1)
has been drastically reduced##2##4##(1991-3#1)(2008-10#1)
has been driven by##2##4##(2008-5#1)(2013-1#1)
has been easily##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
has been effectively##2##3##(2008-10#1)(2012-3#1)
has been elaborated##3##3##(2008-10#2)(2010-3#1)
has been eliminated##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
has been elucidated in##2##4##(1996-5#1)(2007-12#1)
has been elucidated##6##3##(1995-5#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-7#1)
has been emphasized##5##3##(2007-10#1)(2007-7#1)(2008-10#2)(2012-2#1)
has been employed as##2##4##(2008-10#2)
has been employed for the##2##5##(2008-10#1)(2013-1#1)
has been employed for##6##4##(1990-12#1)(1992-12#1)(2008-10#3)(2013-1#1)
has been employed in##2##4##(2008-7#1)(2011-2#1)
has been employed to determine SjAb in serum samples##2##9##(2008-10#2)
has been employed to determine##3##5##(1993-8#1)(2008-10#2)
has been employed to##11##4##(1993-8#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#6)(2010-8#1)
has been employed with##2##4##(2008-10#1)(2008-12#1)
has been employed##28##3##(1990-12#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
has been endorsed##2##3##(2008-1#1)(2013-8#1)
has been engineered##2##3##(1997-3#1)(2007-12#1)
has been enhanced by the##2##5##(2008-10#1)(2008-3#1)
has been established and##2##4##(2008-10#1)(2010-6#1)
has been established as a##3##5##(1993-9#1)(1994-8#1)(2010-12#1)
has been established as##4##4##(1993-9#1)(1994-8#1)(2008-5#1)(2010-12#1)
has been established at##2##4##(2008-1#2)
has been established by##2##4##(2008-10#2)
has been established for the##3##5##(1990-11#1)(1990-5#1)(2008-10#1)
has been established for##5##4##(1990-11#1)(1990-5#1)(1993-1#1)(2008-10#1)(2011-3#1)
has been established in##4##4##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)
has been established that the##4##5##(1990-8#1)(1993-6#1)(1996-5#1)(2011-2#1)
has been established that##13##4##(1990-5#1)(1990-8#1)(1993-6#1)(1996-5#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#3)
has been established to##3##4##(1997-4#1)(2008-5#1)(2009-11#1)
has been established##51##3##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#2)(2010-6#1)(2011-2#4)(2011-3#1)(2012-3#1)
has been estimated for the##2##5##(1991-2#1)(2007-12#1)
has been estimated that##5##4##(1994-2#1)(2007-2#1)(2008-11#1)(2009-5#1)(2011-2#1)
has been estimated to##2##4##(1995-5#1)(2007-11#1)
has been estimated##15##3##(1991-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-11#1)(2011-2#1)
has been evaluated by##7##4##(2007-11#1)(2008-10#4)(2009-7#1)(2013-1#1)
has been evaluated for determination of##2##6##(2008-10#2)
has been evaluated for the measurement##2##6##(2008-10#2)
has been evaluated for the##4##5##(1994-6#1)(2008-10#3)
has been evaluated for##9##4##(1994-6#1)(2008-10#7)(2008-5#1)
has been evaluated in a##2##5##(2008-11#1)(2010-1#1)
has been evaluated in##6##4##(1990-12#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-1#1)
has been evaluated through##2##4##(1996-8#1)(2008-10#1)
has been evaluated using##4##4##(1990-12#1)(2008-10#2)(2008-9#1)
has been evaluated##42##3##(1990-12#2)(1991-3#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-4#1)(2007-11#2)(2008-10#22)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
has been evidenced in the##2##5##(1994-3#1)(1996-1#1)
has been evidenced in##3##4##(1994-3#1)(1996-1#1)(2012-3#1)
has been evolutionarily conserved##2##4##(1993-6#1)(1993-8#1)
has been examined as a##2##5##(2008-10#2)
has been examined by##4##4##(1995-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
has been examined for##2##4##(1990-2#1)(2008-3#1)
has been examined in##5##4##(1990-5#1)(1992-12#1)(2008-10#2)(2010-1#1)
has been examined##33##3##(1990-2#1)(1990-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
has been expanded to##2##4##(1990-6#1)(1995-2#1)
has been expanded##3##3##(1990-6#1)(1991-11#1)(1995-2#1)
has been experimentally observed##2##4##(2007-11#1)(2007-12#1)
has been experimentally##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
has been explained by the##2##5##(2008-11#1)(2012-2#1)
has been explained by##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
has been explained##5##3##(2008-11#2)(2008-2#1)(2008-7#1)(2012-2#1)
has been exploited for##2##4##(2008-10#1)(2009-12#1)
has been exploited to##2##4##(2008-4#1)(2008-7#1)
has been exploited##6##3##(1990-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)
has been explored for##3##4##(2008-10#3)
has been explored in##2##4##(2007-8#1)(2008-3#1)
has been explored##10##3##(1990-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-9#1)
has been expressed in Escherichia coli##2##6##(1991-3#1)(1995-2#1)
has been expressed in##5##4##(1990-12#1)(1991-3#1)(1992-8#1)(1995-2#1)(2008-3#1)
has been expressed##7##3##(1990-12#1)(1991-3#1)(1992-8#1)(1995-2#1)(1997-2#1)(2008-3#1)(2012-2#1)
has been extended for##2##4##(2008-3#2)
has been extended to##6##4##(1992-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
has been extended##10##3##(1992-3#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)
has been extensively studied in relation to##2##7##(2008-10#1)(2012-1#1)
has been extensively studied in##3##5##(2008-10#1)(2008-8#1)(2012-1#1)
has been extensively studied##8##4##(1991-2#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
has been extensively used##2##4##(1992-11#1)(2008-8#1)
has been extensively##14##3##(1991-2#1)(1992-11#1)(1994-2#1)(1996-4#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
has been extremely difficult##2##4##(2008-10#1)(2008-11#1)
has been extremely##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2010-10#1)
has been fabricated##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
has been focused on the##2##5##(2008-7#1)(2011-2#1)
has been focused on##8##4##(1992-2#1)(1993-1#1)(1994-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
has been focused##9##3##(1992-2#1)(1993-1#1)(1994-2#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
has been followed up for##2##5##(2008-10#1)(2008-6#1)
has been followed##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
has been formed by##2##4##(1996-1#1)(2008-10#1)
has been formed##3##3##(1996-1#1)(2008-10#1)(2008-3#1)
has been found between##3##4##(1990-6#1)(2008-3#1)(2008-7#1)
has been found by##2##4##(2008-10#1)(2012-3#1)
has been found in the##4##5##(1990-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
has been found in various##3##5##(2007-7#1)(2012-2#2)
has been found in##21##4##(1990-5#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2012-2#2)(2013-1#1)
has been found that in##2##5##(2008-10#2)
has been found that the##8##5##(1990-8#1)(2007-12#1)(2008-10#4)(2008-5#1)(2013-8#1)
has been found that##19##4##(1990-8#1)(2007-12#1)(2008-10#8)(2008-3#2)(2008-5#3)(2008-9#1)(2009-11#1)(2010-4#1)(2013-8#1)
has been found to be phase matchable for##2##8##(2008-2#2)
has been found to be significantly associated##2##7##(2012-2#2)
has been found to be##29##5##(1992-5#1)(1992-8#1)(1993-3#1)(2007-11#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#3)(2012-2#3)(2013-8#1)
has been found to follow##2##5##(1997-2#1)(2007-12#1)
has been found to produce##2##5##(1994-3#1)(2008-10#1)
has been found to##46##4##(1990-5#1)(1990-8#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#1)
has been found with##2##4##(2008-10#1)(2008-3#1)
has been found##114##3##(1990-5#2)(1990-6#2)(1990-8#2)(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-7#2)(2007-11#4)(2007-12#2)(2007-7#3)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
has been free of##2##4##(1995-3#1)(2008-7#1)
has been frequently##6##3##(1994-12#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-7#1)
has been fully characterized##2##4##(1997-7#1)(2007-11#1)
has been fully validated and##2##5##(2008-10#1)(2011-1#1)
has been fully validated##4##4##(2008-10#3)(2011-1#1)
has been fully##6##3##(1997-7#1)(2007-11#1)(2008-10#3)(2011-1#1)
has been functionalized with##2##4##(2008-10#2)
has been functionalized##3##3##(2008-10#3)
has been further##8##3##(1990-3#1)(1994-11#1)(1994-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#2)
has been gained##2##3##(2008-10#1)(2009-5#1)
has been gathered##3##3##(2008-2#1)(2009-12#1)(2009-4#1)
has been generated by##3##4##(1996-5#1)(2008-2#1)(2009-10#1)
has been generated##9##3##(1992-9#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2009-10#1)
has been given to the##8##5##(1993-12#1)(1993-2#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)
has been given to##15##4##(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)
has been given##17##3##(1991-9#1)(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)
has been greatly enhanced##2##4##(1997-6#1)(2010-3#1)
has been greatly##6##3##(1994-11#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)
has been growing interest in the##4##6##(2008-10#1)(2008-11#1)(2008-7#2)
has been growing##6##3##(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#2)
has been hampered by the##2##5##(2008-5#1)(2011-2#1)
has been hampered by##6##4##(1994-6#1)(2007-6#1)(2008-11#2)(2008-5#1)(2011-2#1)
has been higher##2##3##(1990-11#1)(1994-3#1)
has been highlighted in the##2##5##(2013-1#2)
has been highlighted##5##3##(1992-12#1)(2008-11#1)(2013-1#3)
has been highly conserved##2##4##(1992-12#1)(1997-9#1)
has been hindered by the##2##5##(1997-7#1)(2010-5#1)
has been hindered##4##3##(1996-3#1)(1997-7#1)(2008-11#1)(2010-5#1)
has been historically##2##3##(2008-8#1)(2009-4#1)
has been hypothesized that the##2##5##(2008-2#1)(2011-2#1)
has been hypothesized that##7##4##(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2011-3#1)
has been hypothesized to be the##2##6##(2008-10#1)(2012-3#1)
has been hypothesized to be##5##5##(2008-10#1)(2008-8#2)(2011-1#1)(2012-3#1)
has been hypothesized to##8##4##(1997-2#1)(2008-10#3)(2008-8#2)(2011-1#1)(2012-3#1)
has been hypothesized##16##3##(1994-11#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-8#3)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
has been identified and##2##4##(1996-12#1)(2008-10#1)
has been identified as a key##3##6##(2008-4#1)(2009-11#1)(2012-12#1)
has been identified as a major##2##6##(2008-11#1)(2012-1#1)
has been identified as a##21##5##(1993-3#1)(1993-6#1)(1993-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
has been identified as an important##2##6##(1994-12#1)(2012-2#1)
has been identified as an##6##5##(1991-3#1)(1994-12#1)(1997-4#1)(2008-2#1)(2010-5#1)(2012-2#1)
has been identified as the##3##5##(1992-8#1)(1994-12#1)(1997-7#1)
has been identified as##34##4##(1991-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
has been identified by##5##4##(1995-11#1)(1995-5#1)(1997-8#1)(2009-6#1)(2012-5#1)
has been identified in a patient##2##6##(1995-6#1)(2012-3#1)
has been identified in a##5##5##(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2012-3#1)
has been identified in the##2##5##(1990-12#1)(2008-11#1)
has been identified in##15##4##(1990-12#1)(1991-12#1)(1991-6#1)(1993-8#1)(1993-9#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
has been identified##80##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-12#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
has been implemented in a##2##5##(2007-12#1)(2012-3#1)
has been implemented in the##2##5##(2008-2#1)(2008-3#1)
has been implemented in##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-3#1)
has been implemented##12##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-8#1)(2012-3#1)
has been implicated as a##7##5##(1991-8#1)(1994-8#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)
has been implicated as##9##4##(1991-8#1)(1994-8#1)(1995-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)
has been implicated in a variety of##3##7##(1994-8#1)(1996-12#1)(2008-4#1)
has been implicated in a##5##5##(1992-11#1)(1994-8#1)(1996-12#1)(2008-4#1)(2012-12#1)
has been implicated in binding to##2##6##(1992-10#1)(1994-5#1)
has been implicated in several##3##5##(2006-10#1)(2008-8#1)(2012-2#1)
has been implicated in the growth of##2##7##(1994-9#1)(2008-4#1)
has been implicated in the pathogenesis of##4##7##(1992-12#1)(1996-7#1)(2008-1#1)(2012-2#1)
has been implicated in the regulation of##2##7##(1992-9#1)(2012-2#1)
has been implicated in the##20##5##(1991-11#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-9#1)(1994-9#1)(1996-12#1)(1996-7#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)
has been implicated in##39##4##(1991-11#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#2)(1996-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-7#1)
has been implicated##50##3##(1991-11#1)(1991-8#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-12#2)(1996-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-7#1)
has been important##2##3##(2007-12#1)(2013-8#1)
has been improved and##2##4##(1992-6#1)(2012-2#1)
has been improved by##6##4##(1997-3#1)(2007-11#1)(2008-10#3)(2008-6#1)
has been improved on##2##4##(2008-10#1)(2008-3#1)
has been improved##14##3##(1992-6#1)(1997-3#1)(2007-11#2)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2012-2#1)
has been in clinical use##2##5##(1996-11#1)(2007-11#1)
has been in effect##2##4##(1993-3#1)(1996-5#1)
has been in operation##2##4##(2008-10#1)(2008-3#1)
has been in place since 2000 to##2##7##(2007-12#1)(2010-4#1)
has been in use##2##4##(2007-8#1)(2012-3#1)
has been in##18##3##(1991-2#1)(1992-1#1)(1993-3#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-3#1)
has been included in the##3##5##(1995-12#1)(2008-11#1)(2008-5#1)
has been included in##4##4##(1995-12#1)(2008-11#1)(2008-5#1)(2012-12#1)
has been included##6##3##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
has been incorporated into a##2##5##(2008-10#1)(2008-5#1)
has been incorporated into##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
has been incorporated##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
has been increased##7##3##(2007-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
has been increasing in##2##4##(2008-10#1)(2011-2#1)
has been increasing##13##3##(1991-2#1)(1991-3#1)(1993-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#1)
has been increasingly used##2##4##(2008-9#1)(2011-2#1)
has been increasingly##7##3##(1992-1#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-7#1)
has been initiated to##2##4##(2010-8#1)(2011-2#1)
has been initiated##7##3##(1992-11#1)(1997-6#1)(2008-7#1)(2010-8#1)(2011-2#3)
has been inserted##2##3##(2008-10#1)(2008-9#1)
has been installed##2##3##(2008-3#2)
has been instrumental in##2##4##(2008-7#1)(2008-9#1)
has been integrated into the##2##5##(1996-12#1)(2008-3#1)
has been integrated##4##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)
has been intensely##2##3##(2008-11#1)(2012-12#1)
has been intensified##2##3##(2008-4#2)
has been intensively studied##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
has been intensively##4##3##(2007-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
has been interpreted as##2##4##(2009-6#1)(2012-3#1)
has been interpreted##4##3##(2008-10#1)(2009-6#2)(2012-3#1)
has been introduced as##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
has been introduced into##4##4##(1990-12#1)(1990-8#1)(1997-6#1)(2008-8#1)
has been introduced to##2##4##(2010-3#1)(2011-2#1)
has been introduced##16##3##(1990-12#1)(1990-8#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-3#1)(2011-2#2)(2012-2#1)
has been investigated and##4##4##(2008-10#3)(2008-7#1)
has been investigated as a function of##2##7##(1995-5#1)(2008-10#1)
has been investigated as a##3##5##(1995-5#1)(2008-10#1)(2009-5#1)
has been investigated as##5##4##(1993-11#1)(1995-5#1)(2008-10#2)(2009-5#1)
has been investigated at##2##4##(2008-10#2)
has been investigated both##2##4##(2007-11#1)(2007-12#1)
has been investigated by means of UV-Vis spectroscopy##2##8##(2008-10#2)
has been investigated by means of##4##6##(1990-12#1)(2008-10#2)(2011-2#1)
has been investigated by measuring the##2##6##(1994-3#1)(2008-10#1)
has been investigated by using##2##5##(1991-9#1)(2008-10#1)
has been investigated by##20##4##(1990-12#1)(1990-5#1)(1991-9#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-5#1)(2008-10#7)(2008-3#2)(2008-5#2)(2009-11#1)(2011-2#1)
has been investigated for##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
has been investigated in detail##6##5##(1994-5#1)(2008-10#5)
has been investigated in the##3##5##(1994-8#1)(2009-10#1)(2009-3#1)
has been investigated in##15##4##(1994-12#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-10#8)(2008-6#1)(2009-10#1)(2009-3#1)
has been investigated on##2##4##(1997-7#1)(2013-1#1)
has been investigated over##2##4##(2008-10#1)(2011-2#1)
has been investigated through##2##4##(2008-10#1)(2011-2#1)
has been investigated using##5##4##(1990-5#1)(2008-10#3)(2009-8#1)
has been investigated with##2##4##(1996-5#1)(1997-7#1)
has been investigated##120##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-5#2)(1996-2#2)(1996-5#1)(1997-7#4)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#56)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#2)
has been isolated and characterized##4##5##(1991-5#1)(1993-8#1)(1994-12#1)(1995-6#1)
has been isolated and sequenced##2##5##(1992-4#1)(1993-2#1)
has been isolated and##9##4##(1991-5#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#1)
has been isolated from a lambda##2##6##(1991-12#1)(1993-2#1)
has been isolated from a##4##5##(1990-11#1)(1991-12#1)(1992-10#1)(1993-2#1)
has been isolated from human##2##5##(1990-7#1)(2011-2#1)
has been isolated from the##6##5##(1990-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(2008-11#1)
has been isolated from##24##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-10#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
has been isolated##39##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#1)(1995-2#2)(1995-6#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-8#1)(2010-5#1)(2011-2#1)
has been known as##3##4##(2008-10#1)(2013-1#2)
has been known for some time##3##6##(2008-3#1)(2009-6#1)(2012-2#1)
has been known for##8##4##(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
has been known to be##3##5##(1997-8#1)(2008-11#1)(2008-12#1)
has been known to##5##4##(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)
has been known##20##3##(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
has been largely ignored##3##4##(1997-8#1)(2008-7#1)(2008-8#1)
has been largely overlooked##2##4##(2008-3#1)(2010-3#1)
has been largely##13##3##(1992-11#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-3#1)(2012-12#1)(2013-7#1)
has been learned in##2##4##(1993-11#1)(2008-2#1)
has been learned##8##3##(1993-11#1)(1993-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)
has been limited by a lack of##2##7##(2008-12#1)(2009-7#1)
has been limited by the##3##5##(2007-6#1)(2008-1#1)(2013-8#1)
has been limited by##8##4##(2007-6#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
has been limited in##2##4##(1996-3#1)(2008-12#1)
has been limited to##4##4##(1994-6#1)(2007-10#1)(2011-7#1)(2013-1#1)
has been limited##26##3##(1992-2#1)(1994-6#1)(1996-3#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been linked to##9##4##(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
has been linked with##2##4##(1990-8#1)(2013-8#1)
has been linked##12##3##(1990-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
has been little##12##3##(1991-4#1)(1992-1#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-3#1)(2012-1#1)(2012-2#1)
has been localized##2##3##(1990-8#1)(1995-2#1)
has been long##2##3##(2008-1#1)(2011-2#1)
has been made by means of##2##6##(2008-10#1)(2010-8#1)
has been made by##4##4##(2008-10#1)(2008-4#1)(2010-8#1)(2011-1#1)
has been made for##2##4##(2008-10#2)
has been made in the##10##5##(1991-12#1)(2007-6#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-7#1)
has been made in understanding the##2##6##(2008-11#1)(2008-5#1)
has been made in understanding##3##5##(2008-11#1)(2008-5#1)(2011-2#1)
has been made in##23##4##(1991-12#1)(1997-1#1)(2007-6#1)(2008-10#2)(2008-11#7)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
has been made of the##3##5##(1992-6#1)(2008-2#1)(2008-4#1)
has been made of##6##4##(1992-3#1)(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
has been made on##2##4##(2007-8#1)(2008-10#1)
has been made to##10##4##(1995-2#1)(2007-2#1)(2008-10#2)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
has been made toward the##3##5##(2008-3#1)(2008-5#1)(2010-9#1)
has been made toward##4##4##(2006-10#1)(2008-3#1)(2008-5#1)(2010-9#1)
has been made with##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
has been made##74##3##(1991-12#2)(1992-3#1)(1992-6#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
has been mainly##4##3##(1990-2#1)(2008-10#1)(2010-5#1)(2013-1#1)
has been maintained##4##3##(1994-9#1)(2008-6#1)(2012-3#1)(2013-1#1)
has been mapped to##2##4##(1991-6#1)(2012-3#1)
has been mapped##7##3##(1990-12#1)(1991-6#1)(1993-6#1)(1993-9#1)(2008-10#1)(2008-3#1)(2012-3#1)
has been markedly##2##3##(1992-1#1)(2009-5#1)
has been measured at##2##4##(2007-12#1)(2008-2#1)
has been measured by##2##4##(1996-2#1)(2008-2#1)
has been measured for##2##4##(2007-12#1)(2008-8#1)
has been measured from##2##4##(2007-12#1)(2008-2#1)
has been measured in the##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
has been measured in##5##4##(2008-10#2)(2008-3#2)(2008-7#1)
has been measured to be 0##2##6##(2007-12#1)(2008-3#1)
has been measured to be##3##5##(2007-12#1)(2008-3#2)
has been measured to##4##4##(2007-12#2)(2008-3#2)
has been measured with a##2##5##(2007-12#1)(2008-3#1)
has been measured with##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
has been measured##32##3##(1996-2#1)(2007-11#2)(2007-12#9)(2008-10#4)(2008-2#3)(2008-3#9)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
has been modified by##5##4##(1995-2#1)(1995-6#1)(2008-10#2)(2008-3#1)
has been modified to##2##4##(2008-3#1)(2008-6#1)
has been modified##12##3##(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)
has been monitored##5##3##(2008-10#4)(2008-3#1)
has been more##6##3##(1991-6#1)(2006-10#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)
has been most##4##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
has been moved to##2##4##(1997-4#1)(2009-4#1)
has been much##10##3##(1990-9#1)(1992-4#1)(2008-3#1)(2008-7#3)(2008-9#2)(2012-12#2)
has been named##4##3##(1996-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
has been naturally##2##3##(2008-10#1)(2013-7#1)
has been neglected##3##3##(1995-9#1)(1996-12#1)(2008-12#1)
has been no recurrence##4##4##(1990-11#1)(2007-11#1)(2008-7#1)(2013-1#1)
has been no report##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
has been no##19##3##(1990-11#1)(1990-6#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#4)(2013-1#2)
has been noted in##3##4##(1991-2#1)(2009-11#1)(2010-8#1)
has been noted##8##3##(1991-2#1)(2008-10#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
has been noticed##2##3##(2008-10#1)(2013-7#1)
has been observed and##2##4##(1991-5#1)(1993-2#1)
has been observed at##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
has been observed by##2##4##(1997-2#1)(2009-1#1)
has been observed experimentally##2##4##(2007-11#1)(2008-2#1)
has been observed for##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
has been observed in a##3##5##(1996-2#1)(2007-12#1)(2008-7#1)
has been observed in patients##2##5##(2008-7#1)(2011-2#1)
has been observed in the##3##5##(1997-6#1)(2007-12#1)(2007-2#1)
has been observed in##20##4##(1990-2#1)(1992-2#1)(1992-6#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-3#3)(2008-7#2)(2011-2#1)(2012-12#1)
has been observed that##8##4##(1991-2#1)(2008-10#6)(2010-1#1)
has been observed to be##4##5##(1993-12#1)(2007-11#1)(2008-5#1)(2012-12#1)
has been observed to##5##4##(1993-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-12#1)
has been observed up to##2##5##(2008-10#1)(2011-2#1)
has been observed with##2##4##(2006-10#1)(2008-10#1)
has been observed##79##3##(1990-2#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-2#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
has been obtained by the##2##5##(1991-6#1)(2008-10#1)
has been obtained by##7##4##(1991-6#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
has been obtained for the##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
has been obtained for##6##4##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
has been obtained from##4##4##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
has been obtained in##4##4##(1994-6#1)(1995-11#1)(2009-3#1)(2012-1#1)
has been obtained##38##3##(1991-6#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(2007-12#4)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#5)(2009-3#1)(2010-4#1)(2010-8#1)(2012-1#1)
has been on the##2##4##(2008-1#1)(2013-1#1)
has been on##8##3##(1993-2#1)(1994-2#1)(1996-2#2)(1996-6#1)(2008-1#1)(2012-12#1)(2013-1#1)
has been one of the most##2##6##(2008-9#1)(2011-1#1)
has been one of the##3##5##(2008-9#1)(2009-2#1)(2011-1#1)
has been one##4##3##(1994-2#1)(2008-9#1)(2009-2#1)(2011-1#1)
has been only##7##3##(1991-3#1)(1992-10#1)(1992-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)
has been optimised to##2##4##(2008-10#2)
has been optimised##4##3##(2008-10#4)
has been optimized and##2##4##(2008-10#1)(2009-8#1)
has been optimized##11##3##(1991-5#1)(1997-4#1)(2006-12#1)(2008-10#6)(2009-6#1)(2009-8#1)
has been organized##2##3##(2008-10#1)(2008-8#1)
has been over##2##3##(2010-4#1)(2012-3#1)
has been paid##20##3##(1990-2#1)(1991-3#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-2#1)
has been partially##2##3##(2008-10#1)(2009-9#1)
has been particularly##4##3##(1990-3#1)(1995-2#1)(2008-10#1)(2012-12#1)
has been partly##2##3##(1993-9#1)(2012-3#1)
has been performed and##3##4##(2009-11#1)(2009-9#1)(2010-6#1)
has been performed by a##2##5##(2008-10#2)
has been performed by##7##4##(2007-8#1)(2008-10#5)(2008-9#1)
has been performed for##2##4##(2007-11#1)(2008-10#1)
has been performed in##9##4##(1990-12#1)(1990-9#1)(1993-6#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
has been performed on the##2##5##(2008-10#1)(2008-2#1)
has been performed on##3##4##(2008-10#1)(2008-2#1)(2009-9#1)
has been performed using##2##4##(1997-4#1)(2008-7#1)
has been performed##49##3##(1990-12#2)(1990-9#1)(1993-6#1)(1997-4#1)(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
has been placed in the##2##5##(2008-10#1)(2010-12#1)
has been placed on the importance of##2##7##(1996-3#1)(2008-12#1)
has been placed on the##3##5##(1996-3#1)(2008-12#1)(2011-1#1)
has been placed on##4##4##(1996-3#1)(2008-12#1)(2011-1#1)(2013-8#1)
has been placed##8##3##(1996-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
has been pointed out##2##4##(2008-10#1)(2008-12#1)
has been poorly studied##2##4##(2013-7#2)
has been poorly##4##3##(1990-3#1)(2008-7#1)(2013-7#2)
has been possible##14##3##(1993-8#1)(1994-6#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-3#1)(2009-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)
has been postulated in##2##4##(1992-11#1)(1996-2#1)
has been postulated that##7##4##(1990-5#1)(1991-2#1)(1994-5#1)(1996-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
has been postulated to##2##4##(1990-5#1)(2012-2#1)
has been postulated##16##3##(1990-5#2)(1991-2#1)(1992-11#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
has been predicted##2##3##(2007-11#1)(2008-7#1)
has been prepared and used##2##5##(1992-3#1)(2008-10#1)
has been prepared and##7##4##(1992-3#1)(2008-10#5)(2008-4#1)
has been prepared by##9##4##(1992-6#1)(1994-9#1)(1996-2#1)(2008-10#4)(2008-8#1)(2013-1#1)
has been prepared##23##3##(1992-3#1)(1992-6#1)(1992-9#1)(1994-9#1)(1996-2#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
has been presented##15##3##(1991-3#1)(1993-3#1)(2007-11#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
has been previously described##2##4##(2008-8#1)(2010-6#1)
has been previously postulated##2##4##(1992-8#1)(2008-7#1)
has been previously reported in##2##5##(2009-1#1)(2009-9#1)
has been previously reported##7##4##(1994-12#1)(1994-2#1)(2008-10#1)(2009-1#1)(2009-9#1)(2012-3#2)
has been previously shown##3##4##(2008-12#1)(2009-7#1)(2012-12#1)
has been previously suggested##2##4##(2008-10#1)(2012-12#1)
has been previously##30##3##(1991-9#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
has been primarily##2##3##(1996-3#1)(2008-3#1)
has been problematic##2##3##(2008-10#1)(2009-3#1)
has been produced in##2##4##(1996-12#1)(2008-11#1)
has been produced##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
has been programmed##2##3##(2008-3#1)(2011-2#1)
has been proposed and its##2##5##(2008-10#2)
has been proposed and##5##4##(1996-5#1)(2007-12#1)(2008-10#2)(2012-3#1)
has been proposed as a marker of##2##7##(1995-2#1)(2008-10#1)
has been proposed as a method##2##6##(1993-11#1)(2008-7#1)
has been proposed as a##10##5##(1990-5#1)(1993-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-7#1)(2012-12#1)
has been proposed as an alternative##2##6##(2008-10#1)(2013-1#1)
has been proposed as an##4##5##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
has been proposed as##16##4##(1990-5#1)(1991-2#1)(1993-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
has been proposed based on the##2##6##(2008-10#2)
has been proposed for the determination of##2##7##(2008-10#2)
has been proposed for the##4##5##(1996-5#1)(2008-10#3)
has been proposed for##7##4##(1996-5#1)(2006-10#1)(2008-10#3)(2009-5#1)(2011-1#1)
has been proposed in the##2##5##(1996-11#1)(2008-3#1)
has been proposed in##3##4##(1996-11#1)(2008-3#2)
has been proposed recently##2##4##(2008-2#1)(2008-7#1)
has been proposed that the##8##5##(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2011-1#1)
has been proposed that##19##4##(1990-12#1)(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2012-3#1)
has been proposed to be##5##5##(1990-12#1)(1993-12#1)(1995-2#1)(2008-6#1)(2008-9#1)
has been proposed to explain##2##5##(2008-10#1)(2008-7#1)
has been proposed to play a critical role in##2##9##(1990-11#1)(2011-2#1)
has been proposed to play a##3##6##(1990-11#1)(2011-2#1)(2013-8#1)
has been proposed to##18##4##(1990-11#1)(1990-12#1)(1992-3#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
has been proposed with##3##4##(2008-10#2)(2011-1#1)
has been proposed##111##3##(1990-11#1)(1990-12#2)(1990-5#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#3)(1996-11#1)(1996-5#3)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
has been proved that##6##4##(1992-5#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
has been proved to be involved in##2##7##(2008-10#1)(2010-12#1)
has been proved to be##6##5##(2008-10#4)(2010-12#1)(2013-8#1)
has been proved##16##3##(1992-5#1)(2008-10#8)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
has been proven that##3##4##(2008-1#1)(2008-11#1)(2010-5#1)
has been proven to be##4##5##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
has been proven to##5##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
has been proven##13##3##(1990-7#1)(1996-10#1)(1996-11#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#1)
has been provided##2##3##(2008-1#1)(2008-3#1)
has been providing##3##3##(1992-2#1)(2008-6#1)(2010-4#1)
has been published on##3##4##(1991-2#1)(2008-10#1)(2008-2#1)
has been published##6##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
has been purified from##2##4##(1992-8#1)(1994-5#1)
has been purified to homogeneity from##3##6##(1990-11#1)(1990-7#1)(2008-8#1)
has been purified to homogeneity##4##5##(1990-11#1)(1990-7#1)(1991-12#1)(2008-8#1)
has been purified to##8##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1994-8#1)(1997-4#1)(2008-8#1)
has been purified##12##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-8#1)
has been put##4##3##(2007-8#1)(2008-11#2)(2008-2#1)
has been questioned because##2##4##(2008-10#2)
has been questioned##7##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
has been rarely##4##3##(2007-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
has been reached##5##3##(1995-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)
has been realized that##2##4##(2007-12#1)(2008-2#1)
has been realized##7##3##(2007-12#3)(2008-2#2)(2008-4#1)(2010-5#1)
has been receiving increasing attention##3##5##(1993-1#1)(2007-10#1)(2013-8#1)
has been receiving##5##3##(1993-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2013-8#1)
has been recent##3##3##(1995-5#1)(1997-8#1)(2010-1#1)
has been recently demonstrated##3##4##(1994-8#1)(2007-8#1)(2011-1#1)
has been recently detected in##2##5##(1990-5#1)(2006-4#1)
has been recently developed##3##4##(2008-11#1)(2008-5#1)(2009-5#1)
has been recently proposed##2##4##(1995-12#1)(2008-10#1)
has been recently shown##2##4##(1994-5#1)(2009-5#1)
has been recently##30##3##(1990-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#5)(2009-5#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
has been recognised as##2##4##(1994-2#1)(2011-1#1)
has been recognised##3##3##(1994-2#1)(2008-10#1)(2011-1#1)
has been recognized as a##4##5##(1997-1#1)(2008-8#1)(2012-2#1)(2012-3#1)
has been recognized as an##2##5##(2007-7#1)(2008-8#1)
has been recognized as the##2##5##(1994-2#1)(2008-3#1)
has been recognized as##9##4##(1994-2#1)(1997-1#1)(2007-7#1)(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#2)
has been recognized in##3##4##(2007-7#1)(2013-1#1)(2013-7#1)
has been recognized that##2##4##(2008-7#2)
has been recognized##15##3##(1994-2#1)(1997-1#1)(2007-7#2)(2008-3#1)(2008-7#2)(2008-8#2)(2010-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
has been recommended by##2##4##(1993-10#1)(2008-8#1)
has been recommended for##2##4##(2008-8#1)(2011-2#1)
has been recommended##14##3##(1991-6#1)(1993-10#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#1)
has been recorded##4##3##(2008-12#1)(2008-3#1)(2009-10#1)(2010-8#1)
has been recovered##3##3##(2008-10#2)(2008-5#1)
has been reduced to##2##4##(1995-5#1)(2008-3#1)
has been reduced##3##3##(1995-5#1)(2008-3#1)(2008-4#1)
has been referred to as the &quot##2##7##(1996-1#1)(2011-2#1)
has been referred##4##3##(1990-12#1)(1990-3#1)(1996-1#1)(2011-2#1)
has been refined##3##3##(1995-3#1)(1997-4#1)(2011-2#1)
has been regarded as##2##4##(1996-2#1)(2012-3#1)
has been registered##2##3##(1990-6#1)(1996-8#1)
has been related to##4##4##(1993-1#1)(1993-9#1)(1994-6#1)(2011-2#1)
has been related##5##3##(1991-6#1)(1993-1#1)(1993-9#1)(1994-6#1)(2011-2#1)
has been relatively##5##3##(1992-8#1)(1993-12#1)(2008-11#1)(2008-5#1)(2009-8#1)
has been released in##2##4##(2008-10#1)(2009-12#1)
has been released##3##3##(2008-10#1)(2009-12#1)(2012-2#1)
has been remarkable##2##3##(2008-11#1)(2011-1#1)
has been remarkably##2##3##(2008-8#1)(2010-6#1)
has been removed##2##3##(1992-9#1)(2008-11#1)
has been repeatedly##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
has been replaced by a##2##5##(1995-8#1)(2010-5#1)
has been replaced by##6##4##(1991-7#1)(1995-8#1)(1996-11#1)(1997-2#1)(2008-3#1)(2010-5#1)
has been replaced##7##3##(1991-7#1)(1992-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(2008-3#1)(2010-5#1)
has been reported as a complication##2##6##(2008-7#1)(2012-1#1)
has been reported by##3##4##(1992-6#1)(2008-10#1)(2012-2#1)
has been reported for the##2##5##(2008-10#2)
has been reported for##3##4##(1990-8#1)(2008-10#2)
has been reported in a##3##5##(2007-10#1)(2009-8#1)(2012-12#1)
has been reported in only##2##5##(1992-8#1)(2007-8#1)
has been reported in patients with##2##6##(2009-4#1)(2012-12#1)
has been reported in several##3##5##(1991-12#1)(2007-10#1)(2011-2#1)
has been reported in the##5##5##(1994-3#1)(1995-12#1)(2009-3#1)(2010-10#1)(2010-7#1)
has been reported in three##2##5##(2008-10#1)(2010-12#1)
has been reported in##40##4##(1990-6#1)(1991-12#2)(1992-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-7#1)(2006-10#2)(2007-10#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
has been reported previously##5##4##(1990-7#1)(1995-6#1)(2008-3#1)(2009-11#1)(2011-1#1)
has been reported so far##2##5##(1992-2#1)(2013-1#1)
has been reported that##16##4##(1991-2#1)(1992-12#1)(1995-11#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2011-2#2)(2013-8#1)
has been reported to be a##2##6##(2008-10#1)(2013-1#1)
has been reported to be decreased##2##6##(1994-6#1)(2013-1#1)
has been reported to be##14##5##(1993-8#2)(1994-6#2)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
has been reported to have a##2##6##(2007-10#1)(2012-3#1)
has been reported to have##3##5##(1994-12#1)(2007-10#1)(2012-3#1)
has been reported to increase##3##5##(2008-10#2)(2008-4#1)
has been reported to inhibit##2##5##(1992-5#1)(1994-8#1)
has been reported to occur in##3##6##(1995-10#1)(2008-1#1)(2011-2#1)
has been reported to occur##5##5##(1995-10#1)(2008-1#1)(2008-11#1)(2009-3#1)(2011-2#1)
has been reported to##45##4##(1991-3#1)(1992-3#1)(1992-5#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
has been reported with##2##4##(2011-2#1)(2013-1#1)
has been reported##159##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#3)(1994-3#3)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#6)(2011-2#13)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
has been resolved##2##3##(2007-11#1)(2012-2#1)
has been responsible for##3##4##(1992-2#1)(2008-10#1)(2013-8#1)
has been restricted##2##3##(2008-11#2)
has been revealed that##4##4##(1991-9#1)(2008-1#1)(2008-8#1)(2008-9#1)
has been revealed##7##3##(1991-9#2)(2008-1#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)
has been reviewed##2##3##(1997-3#1)(2008-7#1)
has been revised##3##3##(2008-11#2)(2012-1#1)
has been running##2##3##(2008-11#1)(2012-3#1)
has been satisfactorily applied for the determination of##2##8##(2008-10#2)
has been satisfactorily applied for the##3##6##(2008-10#3)
has been satisfactorily applied to##13##5##(2008-10#13)
has been satisfactorily applied##16##4##(2008-10#16)
has been satisfactorily##17##3##(2008-10#17)
has been satisfactory##2##3##(1990-5#1)(1993-1#1)
has been seen##8##3##(1994-2#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#1)(2013-1#1)
has been selected for clinical##2##5##(1992-12#1)(1996-9#1)
has been selected for##3##4##(1992-12#1)(1996-9#1)(2008-10#1)
has been selected##5##3##(1992-12#1)(1996-9#1)(2008-10#3)
has been separated from a##2##5##(2008-11#1)(2008-8#1)
has been separated from##4##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
has been separated##6##3##(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
has been sequenced and##2##4##(1990-12#1)(1994-2#1)
has been sequenced##4##3##(1990-12#1)(1994-2#1)(1996-6#1)(1997-3#1)
has been set up at##2##5##(2008-1#1)(2008-2#1)
has been set up##4##4##(1996-6#1)(2008-1#1)(2008-2#1)(2008-7#1)
has been shown by##5##4##(1993-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
has been shown for##2##4##(1994-11#1)(2011-2#1)
has been shown in a##2##5##(2007-10#1)(2007-12#1)
has been shown in the##2##5##(1995-5#1)(2008-10#1)
has been shown in##8##4##(1994-11#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-5#1)
has been shown not to##2##5##(1990-12#1)(1990-2#1)
has been shown not##3##4##(1990-12#1)(1990-2#1)(2012-12#1)
has been shown previously to##4##5##(1990-11#1)(1990-8#1)(1992-12#1)(1993-12#1)
has been shown previously##5##4##(1990-11#1)(1990-8#1)(1992-12#1)(1993-12#1)(2008-2#1)
has been shown that the##13##5##(1990-11#1)(1993-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-4#1)(2013-1#1)(2013-8#1)
has been shown that##38##4##(1990-11#1)(1991-9#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
has been shown to activate the##2##6##(1992-4#1)(2008-11#1)
has been shown to activate##5##5##(1992-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
has been shown to attenuate##2##5##(1990-5#1)(2010-2#1)
has been shown to be a major##2##7##(1990-8#1)(1993-11#1)
has been shown to be a promising##3##7##(1990-11#1)(2008-5#1)(2009-8#1)
has been shown to be a safe##2##7##(2007-10#1)(2011-2#1)
has been shown to be a##17##6##(1990-11#2)(1990-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
has been shown to be activated by##2##7##(1995-6#1)(2013-8#1)
has been shown to be an important##3##7##(1990-2#1)(2008-10#1)(2009-7#1)
has been shown to be an##5##6##(1990-2#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-7#1)
has been shown to be associated with##3##7##(2011-2#1)(2012-1#1)(2012-2#1)
has been shown to be capable of##4##7##(2008-10#2)(2008-11#1)(2008-3#1)
has been shown to be effective in##2##7##(2008-11#1)(2011-2#1)
has been shown to be effective##4##6##(2008-11#2)(2011-2#1)(2013-1#1)
has been shown to be highly##2##6##(1990-2#1)(2007-11#1)
has been shown to be important##2##6##(1995-6#1)(2011-2#1)
has been shown to be involved in##4##7##(1992-11#1)(1994-5#1)(2008-10#1)(2010-8#1)
has been shown to be of##3##6##(1993-2#1)(2008-10#1)(2008-9#1)
has been shown to be sensitive to##2##7##(1994-12#1)(2009-4#1)
has been shown to be suitable for##2##7##(2008-3#2)
has been shown to be the##2##6##(1991-6#1)(2008-11#1)
has been shown to be useful##2##6##(2008-8#1)(2011-1#1)
has been shown to be##96##5##(1990-11#3)(1990-2#3)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#11)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
has been shown to bind to##2##6##(1994-5#1)(2008-5#1)
has been shown to bind##3##5##(1994-5#1)(1994-8#1)(2008-5#1)
has been shown to cause##5##5##(1993-12#1)(1993-6#1)(2008-5#1)(2008-9#1)(2011-2#1)
has been shown to correlate with##2##6##(2009-11#1)(2009-12#1)
has been shown to correlate##3##5##(1993-9#1)(2009-11#1)(2009-12#1)
has been shown to exert##2##5##(2008-7#1)(2010-9#1)
has been shown to function##2##5##(2010-10#1)(2012-1#1)
has been shown to have a##6##6##(1993-3#1)(1994-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
has been shown to have##9##5##(1990-11#1)(1993-3#1)(1994-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-5#1)(2013-1#1)
has been shown to improve the##3##6##(2007-8#1)(2010-12#1)(2011-2#1)
has been shown to improve##6##5##(2007-8#1)(2008-11#2)(2008-9#1)(2010-12#1)(2011-2#1)
has been shown to increase the##2##6##(1996-2#1)(2008-1#1)
has been shown to increase##6##5##(1996-2#1)(1997-1#1)(2008-1#1)(2008-5#2)(2010-9#1)
has been shown to induce##5##5##(1992-8#1)(1996-12#1)(1997-3#1)(2007-2#1)(2008-11#1)
has been shown to influence##2##5##(1991-6#1)(2008-7#1)
has been shown to inhibit##3##5##(1992-5#1)(1995-8#1)(2013-1#1)
has been shown to lower##2##5##(1993-2#1)(2008-6#1)
has been shown to markedly##2##5##(2008-3#1)(2013-8#1)
has been shown to modulate##2##5##(2008-10#1)(2013-8#1)
has been shown to occur##2##5##(2008-11#1)(2009-2#1)
has been shown to play##3##5##(2008-11#1)(2008-7#1)(2008-9#1)
has been shown to promote the##2##6##(1995-8#1)(2013-1#1)
has been shown to promote##3##5##(1995-8#1)(2008-10#1)(2013-1#1)
has been shown to provide a##2##6##(1994-12#1)(2008-10#1)
has been shown to provide##6##5##(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)
has been shown to reduce the##4##6##(1994-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
has been shown to reduce##8##5##(1994-11#1)(1994-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#1)
has been shown to regulate the expression of##2##8##(2010-8#1)(2011-2#1)
has been shown to regulate##6##5##(1995-12#1)(2008-11#1)(2008-9#2)(2010-8#1)(2011-2#1)
has been shown to stimulate##3##5##(1997-1#1)(2008-3#1)(2012-2#1)
has been shown to work well##2##6##(2008-10#1)(2008-3#1)
has been shown to##228##4##(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#16)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#3)
has been shown##302##3##(1990-11#6)(1990-12#2)(1990-2#4)(1990-5#3)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#2)(1992-12#3)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#4)(1994-11#5)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#33)(2008-11#20)(2008-2#2)(2008-3#13)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#15)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#10)(2013-8#5)
has been significantly reduced##2##4##(1994-5#1)(2012-2#1)
has been significantly##3##3##(1994-5#1)(2011-2#1)(2012-2#1)
has been simulated##2##3##(2007-11#1)(2008-3#1)
has been slow in##2##4##(2008-8#1)(2009-11#1)
has been slow##6##3##(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2013-1#2)
has been solved by##2##4##(1992-4#1)(1992-8#1)
has been solved##4##3##(1992-4#1)(1992-8#1)(1995-2#1)(1997-7#1)
has been some##5##3##(1994-2#1)(2008-5#2)(2008-6#1)(2008-8#1)
has been sparse##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
has been specifically designed##2##4##(2008-3#1)(2008-4#1)
has been specifically##3##3##(2008-3#1)(2008-4#2)
has been speculated that##3##4##(2008-10#1)(2008-5#1)(2009-6#1)
has been speculated##4##3##(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)
has been stabilized##5##3##(1991-2#1)(2007-11#2)(2007-12#1)(2008-4#1)
has been stably##2##3##(1992-9#1)(1994-2#1)
has been stated that##3##4##(2008-11#1)(2010-10#1)(2012-12#1)
has been strengthened by the##2##5##(2008-1#1)(2011-1#1)
has been studied and the optimized conditions developed were utilized for##2##11##(2008-10#2)
has been studied and the##3##5##(2008-10#3)
has been studied and##8##4##(2008-10#8)
has been studied as a function of##2##7##(2008-10#2)
has been studied as a##4##5##(2008-10#3)(2008-4#1)
has been studied at pH##2##5##(1995-5#1)(2008-10#1)
has been studied at the##2##5##(2008-10#1)(2011-10#1)
has been studied at##9##4##(1995-5#1)(2008-10#7)(2011-10#1)
has been studied by NMR##2##5##(1992-4#1)(1995-3#1)
has been studied by means of##4##6##(2008-10#3)(2008-5#1)
has been studied by polarography##2##5##(2008-10#2)
has been studied by the##3##5##(1990-5#1)(1995-2#1)(1996-2#1)
has been studied by##28##4##(1990-2#1)(1990-5#1)(1990-8#1)(1992-4#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-8#1)
has been studied extensively##4##4##(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
has been studied for##3##4##(2008-10#3)
has been studied in a##3##5##(2008-10#1)(2008-5#1)(2008-6#1)
has been studied in detail to optimize the conditions for##2##10##(2008-10#2)
has been studied in detail to optimize the conditions##3##9##(2008-10#3)
has been studied in detail##4##5##(2008-10#4)
has been studied in the##2##5##(1992-12#1)(2008-10#1)
has been studied in vitro##2##5##(1992-9#1)(1996-5#1)
has been studied in##18##4##(1992-12#1)(1992-9#1)(1993-2#1)(1996-2#1)(1996-5#1)(2008-10#8)(2008-5#2)(2008-6#1)(2008-8#1)(2010-3#1)
has been studied on##2##4##(2008-10#2)
has been studied to##2##4##(2008-10#2)
has been studied using a##2##5##(2008-10#2)
has been studied using##11##4##(1992-8#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#6)
has been studied with the##2##5##(2008-2#1)(2011-2#1)
has been studied with##4##4##(2008-2#2)(2008-3#1)(2011-2#1)
has been studied##150##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-10#1)(1992-12#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-10#83)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)
has been studying the##2##4##(1992-6#1)(2008-2#1)
has been subdivided into##2##4##(1996-3#1)(2009-2#1)
has been subject to##3##4##(1992-1#1)(2008-11#1)(2012-2#1)
has been subjected to##2##4##(1996-1#1)(2008-11#1)
has been submitted to##4##4##(1997-2#1)(2008-7#1)(2013-1#2)
has been submitted##6##3##(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#3)
has been substituted by##2##4##(1996-9#1)(2008-10#1)
has been substituted##3##3##(1996-9#1)(2008-10#2)
has been successful in the##2##5##(2008-10#1)(2011-2#1)
has been successful in##9##4##(1992-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2007-11#2)(2008-10#1)(2011-2#1)(2013-1#1)
has been successful##11##3##(1992-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2007-11#2)(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
has been successfully applied for the determination of##2##8##(2008-10#2)
has been successfully applied for the##9##6##(2008-10#8)(2009-6#1)
has been successfully applied for##12##5##(2008-10#11)(2009-6#1)
has been successfully applied to the determination of the##2##9##(2008-10#2)
has been successfully applied to the determination of##21##8##(2008-10#21)
has been successfully applied to the##29##6##(1991-12#1)(2008-10#28)
has been successfully applied to##44##5##(1991-12#1)(2008-10#41)(2009-9#1)(2012-12#1)
has been successfully applied##57##4##(1991-12#1)(2008-10#53)(2009-6#1)(2009-9#1)(2012-12#1)
has been successfully demonstrated##2##4##(2007-12#1)(2008-10#1)
has been successfully employed for##4##5##(2008-10#3)(2012-12#1)
has been successfully employed to##2##5##(2008-10#1)(2008-7#1)
has been successfully employed##6##4##(2008-10#4)(2008-7#1)(2012-12#1)
has been successfully performed##2##4##(2008-7#1)(2013-1#1)
has been successfully tested##3##4##(2008-10#2)(2009-2#1)
has been successfully transferred##2##4##(1994-5#1)(2008-10#1)
has been successfully used as##3##5##(1994-2#1)(2008-10#2)
has been successfully used for the##2##6##(2008-10#2)
has been successfully used for##4##5##(2008-10#4)
has been successfully used in the##2##6##(2007-12#1)(2008-10#1)
has been successfully used in##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
has been successfully used to##6##5##(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)
has been successfully used##18##4##(1994-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#2)
has been successfully##104##3##(1991-12#1)(1994-2#1)(1994-5#1)(1996-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#74)(2008-11#3)(2008-3#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
has been suggested as a##3##5##(2008-3#1)(2008-9#1)(2012-2#1)
has been suggested as one##4##5##(1997-2#1)(2008-10#1)(2008-9#1)(2009-8#1)
has been suggested as##10##4##(1995-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#1)
has been suggested by##2##4##(2008-8#2)
has been suggested for##5##4##(1997-8#1)(2008-10#1)(2008-9#1)(2009-9#1)(2011-1#1)
has been suggested in##2##4##(1991-11#1)(2012-2#1)
has been suggested that a##3##5##(1991-2#1)(2010-6#1)(2013-1#1)
has been suggested that the##6##5##(1991-2#1)(1991-9#1)(1997-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
has been suggested that these##3##5##(1994-2#1)(2008-10#1)(2009-10#1)
has been suggested that##49##4##(1990-5#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
has been suggested to be a##2##6##(1995-3#1)(2008-9#1)
has been suggested to be an##2##6##(1994-8#1)(2009-11#1)
has been suggested to be##9##5##(1991-2#1)(1994-8#2)(1995-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)
has been suggested to occur via an associative or dissociative mechanism dependent upon the surrounding environment##2##16##(2013-1#2)
has been suggested to play##2##5##(2008-3#1)(2009-8#1)
has been suggested to##21##4##(1991-2#1)(1994-8#2)(1994-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#3)
has been suggested##99##3##(1990-5#1)(1990-8#1)(1991-11#2)(1991-2#3)(1991-9#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#9)(2013-7#1)(2013-8#1)
has been suspected##5##3##(1991-1#1)(2008-10#1)(2010-1#1)(2010-4#1)(2011-1#1)
has been synthesised##2##3##(2008-10#1)(2008-4#1)
has been synthesized and characterized##3##5##(2008-10#2)(2008-5#1)
has been synthesized and evaluated##2##5##(1995-3#1)(2008-10#1)
has been synthesized and used##2##5##(2008-10#2)
has been synthesized and##9##4##(1995-3#1)(1997-7#1)(2008-10#5)(2008-5#1)(2009-2#1)
has been synthesized by##2##4##(2008-10#2)
has been synthesized for##2##4##(1995-2#1)(1996-5#1)
has been synthesized in a##2##5##(1990-8#1)(2009-10#1)
has been synthesized in##3##4##(1990-8#1)(2008-10#1)(2009-10#1)
has been synthesized##25##3##(1990-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#12)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)
has been taken into account##3##5##(2008-3#2)(2008-7#1)
has been taken to##2##4##(1992-6#1)(2008-10#1)
has been taken##7##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)
has been taking a##2##4##(1993-3#1)(2008-6#1)
has been termed##4##3##(2008-10#2)(2008-11#1)(2010-6#1)
has been tested as a##2##5##(1992-3#1)(2007-11#1)
has been tested by##4##4##(1990-10#1)(2008-10#2)(2008-3#1)
has been tested for##7##4##(1996-2#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-3#1)
has been tested in##4##4##(1993-3#1)(1997-1#1)(2007-11#1)(2008-10#1)
has been tested on a##2##5##(2008-3#1)(2010-8#1)
has been tested on##7##4##(2007-12#1)(2008-10#3)(2008-3#2)(2010-8#1)
has been tested##38##3##(1990-10#1)(1991-3#1)(1992-3#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-12#1)(2010-8#1)(2012-1#1)
has been that##2##3##(2006-10#1)(2008-8#1)
has been the lack of##2##5##(2008-9#1)(2010-12#1)
has been the most##4##4##(1994-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
has been the object of##2##5##(2008-4#1)(2010-11#1)
has been the subject of##5##5##(2007-6#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
has been the topic of##2##5##(2008-1#1)(2008-11#1)
has been the##56##3##(1991-12#1)(1991-3#1)(1992-1#1)(1993-2#1)(1994-2#2)(1994-9#1)(1995-6#1)(1997-2#2)(2006-4#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
has been theoretically##3##3##(1990-12#1)(2008-2#2)
has been thoroughly##3##3##(2008-10#1)(2010-3#1)(2012-2#1)
has been thought##2##3##(2008-5#1)(2012-2#1)
has been to develop##2##4##(2007-7#1)(2010-3#1)
has been to##18##3##(1991-3#1)(1995-8#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
has been traditionally##4##3##(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
has been transferred##2##3##(2008-10#1)(2008-9#1)
has been transformed into##3##4##(1996-5#1)(2008-10#1)(2009-7#1)
has been transformed##5##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
has been translated##2##3##(1993-11#1)(2008-10#1)
has been treated by##2##4##(2007-8#1)(2008-3#1)
has been treated using##2##4##(2007-8#1)(2011-2#1)
has been treated with##4##4##(1991-9#1)(2008-5#1)(2008-8#1)(2012-2#1)
has been treated##10##3##(1991-9#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
has been tried##3##3##(1990-5#1)(2008-10#1)(2010-8#1)
has been unable to##2##4##(1995-3#1)(2013-1#1)
has been unclear whether##2##4##(2008-10#1)(2008-3#1)
has been unclear##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
has been under##2##3##(2008-7#1)(2013-1#1)
has been undergoing a##2##4##(1992-12#1)(2012-3#1)
has been undertaken on##2##4##(1993-11#1)(2010-12#1)
has been undertaken to##4##4##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
has been undertaken##7##3##(1993-11#1)(1994-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#1)
has been unknown##2##3##(1995-2#1)(2011-2#1)
has been unsuccessful##2##3##(1992-9#1)(1995-8#1)
has been updated##2##3##(2008-10#1)(2013-7#1)
has been used as a##15##5##(1992-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)
has been used as an indicator electrode in the potentiometric##2##10##(2008-10#2)
has been used as an##5##5##(2008-10#4)(2008-7#1)
has been used as the##3##5##(1992-4#1)(2008-10#2)
has been used as##33##4##(1992-11#1)(1992-4#1)(1994-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
has been used by##3##4##(2008-11#1)(2008-12#1)(2008-7#1)
has been used extensively in##2##5##(1995-12#1)(2008-3#1)
has been used extensively to##2##5##(2008-10#1)(2008-7#1)
has been used extensively##5##4##(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
has been used for a##2##5##(2008-10#2)
has been used for determination of##2##6##(2008-10#2)
has been used for image##2##5##(2008-10#1)(2011-1#1)
has been used for investigation of##2##6##(2008-10#1)(2008-2#1)
has been used for simultaneous##2##5##(2007-12#1)(2008-10#1)
has been used for the determination of##9##7##(2008-10#9)
has been used for the determination##10##6##(2008-10#10)
has been used for the on-line##2##6##(2008-10#2)
has been used for the##22##5##(2008-10#18)(2008-3#1)(2010-12#1)(2010-8#1)(2012-3#1)
has been used for this##2##5##(2008-1#1)(2008-10#1)
has been used for##66##4##(1992-3#1)(1993-11#1)(1996-9#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been used in a##3##5##(2007-12#1)(2008-2#2)
has been used in the identification of##2##7##(1995-11#1)(2012-2#1)
has been used in the treatment of##2##7##(1994-5#1)(1996-3#1)
has been used in the##11##5##(1994-5#1)(1995-11#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-8#2)(2012-2#1)
has been used in##30##4##(1991-1#1)(1991-11#1)(1992-5#1)(1994-5#1)(1995-11#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2010-12#1)(2010-8#4)(2011-2#1)(2012-2#1)(2012-3#1)
has been used mainly##2##4##(2008-8#1)(2011-2#1)
has been used safely##2##4##(1995-8#1)(2010-6#1)
has been used since 1992 to make##2##7##(2008-2#1)(2008-3#1)
has been used successfully for the##2##6##(1997-2#1)(2008-10#1)
has been used successfully for##4##5##(1997-2#1)(2008-10#3)
has been used successfully in the treatment of##2##8##(2009-10#1)(2009-4#1)
has been used successfully in the##3##6##(2008-4#1)(2009-10#1)(2009-4#1)
has been used successfully in##4##5##(2008-4#1)(2009-10#1)(2009-4#1)(2010-11#1)
has been used successfully to##3##5##(2008-3#1)(2008-4#1)(2010-8#1)
has been used successfully##12##4##(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-8#1)
has been used to assess the##3##6##(2008-10#1)(2008-5#2)
has been used to characterize##2##5##(1992-12#1)(1993-11#1)
has been used to construct##2##5##(2008-10#2)
has been used to detect##4##5##(2008-10#2)(2008-2#1)(2010-5#1)
has been used to determine the##6##6##(1991-2#1)(1992-6#1)(1995-5#1)(2008-10#2)(2008-7#1)
has been used to determine##14##5##(1991-2#1)(1992-6#1)(1995-5#1)(2008-10#10)(2008-7#1)
has been used to develop##2##5##(1994-5#1)(2008-7#1)
has been used to examine the##3##6##(2008-10#1)(2008-5#1)(2008-7#1)
has been used to generate a##2##6##(1994-12#1)(2007-11#1)
has been used to generate##3##5##(1994-12#1)(2007-11#1)(2008-3#1)
has been used to identify the##3##6##(1994-8#1)(2008-10#1)(2012-3#1)
has been used to identify##4##5##(1994-8#1)(1995-12#1)(2008-10#1)(2012-3#1)
has been used to investigate the##3##6##(1990-8#1)(1994-5#1)(2008-4#1)
has been used to investigate##4##5##(1990-8#1)(1994-5#1)(2008-3#1)(2008-4#1)
has been used to map the##2##6##(1990-2#1)(2008-3#1)
has been used to measure##3##5##(1994-9#1)(2008-10#1)(2008-3#1)
has been used to monitor the##2##6##(1992-3#1)(2008-10#1)
has been used to monitor##3##5##(1992-3#1)(2008-10#2)
has been used to obtain##2##5##(2008-3#1)(2009-8#1)
has been used to optimize the##2##6##(1997-2#1)(2008-10#1)
has been used to probe the##2##6##(2008-10#2)
has been used to refer to##2##6##(2011-2#1)(2012-2#1)
has been used to study the##3##6##(1994-5#1)(2007-11#1)(2008-10#1)
has been used to study##7##5##(1991-12#1)(1994-5#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
has been used to synthesize##2##5##(2008-4#1)(2008-7#1)
has been used to##103##4##(1990-11#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#39)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
has been used with##4##4##(1992-11#1)(2008-1#1)(2008-10#1)(2009-5#1)
has been used##277##3##(1990-11#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#5)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#109)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#7)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
has been useful for##2##4##(2007-8#1)(2008-8#1)
has been useful in##2##4##(1991-3#1)(2008-2#1)
has been useful##4##3##(1991-3#1)(2007-8#1)(2008-2#1)(2008-8#1)
has been utilized as a##2##5##(1996-5#1)(2008-11#1)
has been utilized as an##4##5##(2008-10#3)(2012-7#1)
has been utilized as##6##4##(1996-5#1)(2008-10#3)(2008-11#1)(2012-7#1)
has been utilized for##5##4##(1990-12#1)(2007-11#1)(2008-10#3)
has been utilized to##8##4##(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
has been utilized##21##3##(1990-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-7#1)
has been validated by##3##4##(2008-10#3)
has been validated for##2##4##(2008-10#1)(2008-7#1)
has been validated in##3##4##(2008-5#1)(2008-8#1)(2013-1#1)
has been validated##15##3##(1990-2#1)(1994-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
has been verified by on-line interfacing of a rotating biosensor and continuous flow/stopped-flow/continuous-flow processing##2##14##(2008-10#2)
has been verified by on-line interfacing of a rotating##3##9##(2008-10#3)
has been verified by##5##4##(2008-10#5)
has been verified experimentally##2##4##(1997-6#1)(2008-2#1)
has been verified##11##3##(1992-12#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-2#2)
has been very limited##2##4##(2008-9#1)(2012-2#1)
has been very successful##2##4##(1995-9#1)(2008-4#1)
has been very##9##3##(1995-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2012-2#2)
has been virtually##3##3##(1991-2#1)(1994-9#1)(2007-2#1)
has been well characterized##2##4##(1991-12#1)(2009-7#1)
has been well described##2##4##(2007-7#1)(2008-9#1)
has been well documented and##2##5##(1994-12#1)(2008-10#1)
has been well documented##5##4##(1994-12#1)(2007-8#1)(2008-10#2)(2013-1#1)
has been well established##4##4##(1992-9#1)(1994-10#1)(2008-1#1)(2008-10#1)
has been well tolerated##2##4##(1994-2#1)(2008-7#1)
has been well##20##3##(1991-12#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2013-1#1)
has been widely adopted##2##4##(2008-10#1)(2010-5#1)
has been widely disseminated##2##4##(1995-6#1)(1996-1#1)
has been widely documented##2##4##(1990-7#1)(2008-11#1)
has been widely investigated##2##4##(1990-7#1)(2008-7#1)
has been widely studied##2##4##(2008-9#1)(2010-4#1)
has been widely used as a##3##6##(1992-11#1)(2008-10#1)(2012-2#1)
has been widely used as an##2##6##(2008-5#1)(2010-11#1)
has been widely used as##5##5##(1992-11#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)
has been widely used for the##4##6##(1997-8#1)(2008-10#2)(2013-8#1)
has been widely used for##5##5##(1997-8#1)(2008-10#3)(2013-8#1)
has been widely used in##4##5##(2008-1#1)(2008-5#2)(2012-3#1)
has been widely used to##3##5##(1990-8#1)(2012-3#2)
has been widely used##17##4##(1990-8#1)(1992-11#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-5#3)(2010-11#1)(2012-2#1)(2012-3#3)(2013-8#1)
has been widely##40##3##(1990-7#2)(1990-8#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#4)(2013-8#2)
has been withdrawn##7##3##(2007-2#1)(2008-10#1)(2008-11#3)(2013-1#2)
has been witnessed in##2##4##(2011-1#1)(2012-2#1)
has been witnessed##4##3##(1997-2#1)(2008-7#1)(2011-1#1)(2012-2#1)
has been written about the##5##5##(1992-1#1)(1994-8#1)(2007-9#1)(2008-11#1)(2010-10#1)
has been written about##9##4##(1992-1#1)(1994-8#1)(1995-3#1)(2007-9#1)(2008-11#2)(2010-10#1)(2012-2#2)
has been written on the##2##5##(1994-2#1)(2010-2#1)
has been written##13##3##(1992-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-2#1)(2012-2#2)
has been##5877##2##(1990-10#1)(1990-11#23)(1990-12#24)(1990-2#20)(1990-3#10)(1990-5#32)(1990-6#13)(1990-7#9)(1990-8#26)(1990-9#13)(1991-1#5)(1991-10#1)(1991-11#6)(1991-12#25)(1991-2#29)(1991-3#22)(1991-4#3)(1991-5#16)(1991-6#16)(1991-7#5)(1991-8#3)(1991-9#20)(1992-1#15)(1992-10#10)(1992-11#17)(1992-12#27)(1992-2#15)(1992-3#19)(1992-4#9)(1992-5#7)(1992-6#14)(1992-7#1)(1992-8#24)(1992-9#20)(1993-1#7)(1993-10#1)(1993-11#21)(1993-12#18)(1993-2#17)(1993-3#22)(1993-6#16)(1993-8#13)(1993-9#17)(1994-1#6)(1994-10#2)(1994-11#16)(1994-12#46)(1994-2#27)(1994-3#19)(1994-5#33)(1994-6#16)(1994-7#1)(1994-8#26)(1994-9#16)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#22)(1995-2#36)(1995-3#20)(1995-5#19)(1995-6#22)(1995-8#12)(1995-9#3)(1996-1#15)(1996-10#3)(1996-11#8)(1996-12#20)(1996-2#28)(1996-3#26)(1996-4#1)(1996-5#23)(1996-6#9)(1996-7#2)(1996-8#8)(1996-9#6)(1997-1#16)(1997-2#28)(1997-3#16)(1997-4#24)(1997-5#9)(1997-6#23)(1997-7#29)(1997-8#17)(1997-9#1)(2006-10#16)(2006-12#5)(2006-4#6)(2006-5#2)(2006-7#2)(2007-10#23)(2007-11#118)(2007-12#109)(2007-2#12)(2007-4#2)(2007-6#5)(2007-7#21)(2007-8#37)(2007-9#2)(2008-1#66)(2008-10#1627)(2008-11#226)(2008-12#51)(2008-2#134)(2008-3#305)(2008-4#82)(2008-5#130)(2008-6#57)(2008-7#182)(2008-8#111)(2008-9#96)(2009-1#3)(2009-10#25)(2009-11#18)(2009-12#19)(2009-2#10)(2009-3#11)(2009-4#10)(2009-5#33)(2009-6#14)(2009-7#16)(2009-8#25)(2009-9#11)(2010-1#9)(2010-10#17)(2010-11#19)(2010-12#28)(2010-2#8)(2010-3#21)(2010-4#20)(2010-5#30)(2010-6#21)(2010-7#14)(2010-8#44)(2010-9#8)(2011-1#58)(2011-10#1)(2011-2#158)(2011-3#11)(2011-4#1)(2011-7#3)(2012-1#19)(2012-12#66)(2012-2#106)(2012-3#83)(2012-4#1)(2012-5#2)(2012-7#3)(2012-8#1)(2013-1#134)(2013-2#1)(2013-7#19)(2013-8#51)
has begun to##6##3##(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-9#1)
has begun##7##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-9#1)
has benefited from##2##3##(2008-7#1)(2011-2#1)
has better##9##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#2)
has both the##2##3##(1990-8#1)(1997-8#1)
has both##14##2##(1990-8#1)(1992-10#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2013-8#1)
has broad##4##2##(2008-4#2)(2008-5#1)(2010-11#1)
has brought about a##2##4##(2007-11#1)(2008-5#1)
has brought about##3##3##(1997-2#1)(2007-11#1)(2008-5#1)
has brought the##2##3##(2008-1#1)(2008-4#1)
has brought to##2##3##(2008-10#1)(2010-12#1)
has brought##14##2##(1993-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
has called for##2##3##(2008-8#1)(2011-2#1)
has called##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
has caused a##3##3##(2008-8#1)(2012-12#1)(2013-1#1)
has caused##13##2##(1995-3#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
has centered##2##2##(2006-10#1)(2008-7#1)
has certain advantages##2##3##(2007-12#1)(2008-3#1)
has certain##3##2##(2007-12#2)(2008-3#1)
has challenged##2##2##(2008-10#1)(2008-11#1)
has changed considerably##2##3##(1996-7#1)(2011-2#1)
has changed in##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
has changed little in##2##4##(2008-10#1)(2010-3#1)
has changed little##4##3##(1991-9#1)(2007-7#1)(2008-10#1)(2010-3#1)
has changed over the past##2##5##(2010-5#1)(2011-2#1)
has changed over##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
has changed since##2##3##(1996-3#1)(2013-1#1)
has changed the##4##3##(1995-1#1)(1996-1#1)(2009-3#1)(2012-12#1)
has changed##30##2##(1990-3#1)(1990-6#1)(1991-9#2)(1993-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
has characteristic##2##2##(1996-10#1)(2009-11#1)
has characteristics##4##2##(1990-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
has characterized the##2##3##(1995-11#1)(1996-3#1)
has characterized##3##2##(1995-11#1)(1996-3#1)(2008-5#1)
has clearly##5##2##(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
has clinical##2##2##(1991-11#1)(2013-1#1)
has coincided with##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
has colonized##2##2##(2008-9#2)
has come a long way##4##5##(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)
has come a##5##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
has come from##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
has come into the##2##4##(2008-4#1)(2013-1#1)
has come to a##3##4##(1997-5#1)(2008-7#1)(2012-2#1)
has come to##6##3##(1996-3#1)(1997-5#1)(1997-7#1)(2008-7#2)(2012-2#1)
has come##26##2##(1990-4#1)(1991-2#1)(1996-12#1)(1996-3#2)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)(2009-10#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
has commenced##3##2##(2008-5#2)(2008-8#1)
has commonly been##2##3##(2008-5#1)(2008-7#1)
has commonly##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
has compared##2##2##(2008-10#1)(2008-8#1)
has completed##3##2##(1995-12#1)(2008-3#1)(2008-5#1)
has complicated##2##2##(2008-10#1)(2010-6#1)
has concentrated##2##2##(2007-8#1)(2008-10#1)
has concluded that##2##3##(1993-11#1)(2013-1#1)
has conducted##2##2##(1996-12#1)(2007-7#1)
has confirmed the##3##3##(1993-11#1)(2008-3#1)(2008-7#1)
has confirmed##5##2##(1993-11#2)(2008-3#2)(2008-7#1)
has considerable##5##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
has considerably##3##2##(1993-3#1)(2008-5#1)(2012-2#1)
has consisted of##3##3##(1992-3#1)(1993-1#1)(1997-3#1)
has consistently been found to##2##5##(2008-11#1)(2008-6#1)
has consistently been##3##3##(2008-11#2)(2008-6#1)
has consistently##5##2##(2008-11#3)(2008-5#1)(2008-6#1)
has continued to##4##3##(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
has continuously##2##2##(1991-12#1)(2008-7#1)
has contributed to increased##2##4##(1995-2#1)(2009-10#1)
has contributed to the##3##4##(1997-1#1)(2008-5#1)(2012-1#1)
has contributed to##11##3##(1995-2#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-12#1)
has contributed##15##2##(1993-6#1)(1995-2#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)
has created a need for##2##5##(1994-6#1)(2008-9#1)
has created a##8##3##(1994-12#1)(1994-6#1)(1995-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
has created an##4##3##(1995-3#1)(1996-2#1)(2009-11#1)(2010-8#1)
has created the##3##3##(1991-6#1)(1995-6#1)(1997-6#1)
has created##17##2##(1991-2#1)(1991-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-11#1)(2010-8#1)(2012-2#1)
has crucial##2##2##(2011-2#1)(2012-2#1)
has currently not been##2##4##(2011-2#1)(2012-3#1)
has currently##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
has dealt with the##2##4##(1990-3#1)(1995-11#1)
has dealt with##3##3##(1990-3#1)(1995-11#1)(2008-7#1)
has dealt##4##2##(1990-3#1)(1995-11#1)(2008-11#1)(2008-7#1)
has decided to##2##3##(1992-5#1)(2007-7#1)
has declined from##2##3##(1991-2#2)
has declined in##2##3##(1991-11#1)(2008-4#1)
has declined##12##2##(1990-6#1)(1991-11#2)(1991-2#2)(1995-5#2)(1996-2#1)(2007-7#1)(2008-4#1)(2010-8#1)(2011-2#1)
has decreased in the##2##4##(2007-8#1)(2013-7#1)
has decreased in##3##3##(2007-8#1)(2008-11#1)(2013-7#1)
has decreased the##3##3##(1994-5#1)(2008-11#1)(2010-4#1)
has decreased with##2##3##(2008-6#1)(2013-1#1)
has decreased##25##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1993-8#1)(1994-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-7#1)
has definite##2##2##(1991-6#1)(2011-2#1)
has demonstrated a##12##3##(1994-2#1)(1996-12#1)(1997-3#2)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-2#1)(2013-1#1)
has demonstrated efficacy in##2##4##(2008-3#1)(2009-10#1)
has demonstrated good##2##3##(2008-10#1)(2011-2#1)
has demonstrated high##3##3##(2008-5#1)(2010-8#1)(2010-9#1)
has demonstrated that it is##2##5##(2008-5#1)(2012-2#1)
has demonstrated that the##3##4##(2008-10#2)(2011-2#1)
has demonstrated that this##2##4##(2008-11#1)(2010-3#1)
has demonstrated that##17##3##(1993-6#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#1)
has demonstrated the##5##3##(1990-11#1)(1990-8#1)(1997-6#1)(2008-5#1)(2011-2#1)
has demonstrated##56##2##(1990-11#2)(1990-8#1)(1992-12#1)(1993-6#1)(1994-2#1)(1996-12#2)(1997-3#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-3#3)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-2#3)(2013-1#2)
has depended on the##2##4##(2009-6#1)(2010-8#1)
has described the##5##3##(1990-6#1)(1991-3#1)(1992-8#1)(2006-5#1)(2013-1#1)
has described##6##2##(1990-6#1)(1991-3#1)(1992-8#1)(2006-5#1)(2011-2#1)(2013-1#1)
has designed##3##2##(1992-1#1)(2008-3#1)(2011-2#1)
has detected##2##2##(2008-11#1)(2012-2#1)
has detection##2##2##(2008-10#1)(2010-4#1)
has developed a##10##3##(1991-12#1)(1994-7#1)(1995-1#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
has developed and implemented##2##4##(1997-3#1)(2010-5#1)
has developed and##5##3##(1995-12#1)(1996-12#1)(1997-3#1)(2010-5#1)(2013-1#1)
has developed in##3##3##(1991-11#1)(2008-11#1)(2012-12#1)
has developed new##2##3##(2008-3#1)(2008-5#1)
has developed the##2##3##(1996-12#1)(2008-10#1)
has developed to##2##3##(1997-6#1)(2008-3#1)
has developed##41##2##(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-5#1)(1993-12#2)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#2)(1996-12#2)(1997-1#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#3)(2013-7#1)
has differed from##2##3##(1993-6#1)(2012-3#1)
has different##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
has direct##5##2##(1992-8#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
has disappeared##2##2##(1995-2#1)(1997-4#1)
has distinct advantages##2##3##(1994-1#1)(2008-3#1)
has distinct##3##2##(1992-9#1)(1994-1#1)(2008-3#1)
has documented##5##2##(1995-12#2)(2008-12#1)(2008-3#1)(2008-7#1)
has dominated##2##2##(1996-3#1)(2008-7#1)
has dramatically improved the##4##4##(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#1)
has dramatically increased##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
has dramatically##8##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)
has drawbacks##2##2##(2008-10#1)(2008-8#1)
has driven the development of##2##5##(2008-8#1)(2011-2#1)
has driven the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
has driven##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
has dropped##6##2##(1992-2#1)(1994-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
has dual##3##2##(1990-11#1)(1994-3#1)(2008-3#1)
has effectively##2##2##(1994-12#1)(2009-1#1)
has elapsed since the##2##4##(1993-6#1)(2007-5#1)
has elapsed##3##2##(1993-6#1)(2007-5#1)(2010-12#1)
has embarked on a##3##4##(1991-2#1)(1996-2#1)(2008-4#1)
has embarked##4##2##(1991-2#1)(1993-1#1)(1996-2#1)(2008-4#1)
has emerged a##2##3##(1996-2#1)(2008-10#1)
has emerged and##2##3##(1992-2#1)(2009-7#1)
has emerged as a major##3##5##(1994-7#1)(2008-9#1)(2013-1#1)
has emerged as a powerful##2##5##(2008-4#1)(2011-2#1)
has emerged as a promising##3##5##(2008-11#1)(2010-8#1)(2012-2#1)
has emerged as a useful##3##5##(2008-3#1)(2009-4#1)(2011-2#1)
has emerged as a##23##4##(1994-11#1)(1994-7#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
has emerged as an important##6##5##(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2013-3#1)(2013-8#1)
has emerged as an##11##4##(1995-11#1)(1997-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-3#1)(2013-8#1)
has emerged as one of the most##2##7##(2007-11#1)(2008-10#1)
has emerged as one of the##3##6##(2007-11#1)(2008-10#1)(2008-9#1)
has emerged as the##5##4##(1997-1#1)(1997-4#1)(2008-9#1)(2011-7#1)(2013-1#1)
has emerged as##42##3##(1994-11#1)(1994-7#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-3#1)(2013-8#3)
has emerged in recent years##3##5##(1994-12#1)(2010-6#1)(2011-1#1)
has emerged in##4##3##(1994-12#1)(2010-6#1)(2011-1#1)(2012-2#1)
has emerged recently##2##3##(2007-2#1)(2008-7#1)
has emerged##65##2##(1992-2#1)(1994-11#1)(1994-12#2)(1994-7#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-1#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-3#1)(2013-8#3)
has employed##3##2##(1994-3#1)(2008-1#1)(2008-10#1)
has enabled the##9##3##(1990-5#1)(1997-4#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
has enabled us to##5##4##(1996-2#1)(2008-10#2)(2009-11#1)(2010-8#1)
has enabled##21##2##(1990-5#1)(1991-3#1)(1996-2#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
has encouraged the development of##2##5##(2010-11#1)(2010-5#1)
has encouraged the##3##3##(2010-11#1)(2010-4#1)(2010-5#1)
has encouraged##6##2##(1994-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-3#1)(2013-8#1)
has enhanced##2##2##(2008-11#1)(2008-12#1)
has enjoyed##2##2##(1993-2#1)(1996-6#1)
has enough##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
has ensured##2##2##(2008-10#1)(2008-6#1)
has entered##6##2##(1996-3#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)
has established an##4##3##(1996-12#1)(1996-2#1)(2010-3#2)
has established itself##2##3##(2008-10#1)(2011-4#1)
has established the##2##3##(2008-7#1)(2009-6#1)
has established##13##2##(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-3#2)(2011-4#1)(2012-1#1)(2013-1#1)
has estimated##2##2##(1990-3#1)(2008-5#1)
has evaluated the##3##3##(1995-2#1)(2008-10#2)
has evaluated##4##2##(1995-2#1)(2008-10#2)(2011-1#1)
has evolved as##3##3##(2008-8#1)(2009-8#1)(2012-2#1)
has evolved from the##2##4##(2008-9#1)(2011-1#1)
has evolved from##4##3##(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)
has evolved in response to##2##5##(1993-12#1)(2008-10#1)
has evolved in the##2##4##(1991-1#1)(2012-2#1)
has evolved in##6##3##(1991-1#1)(1993-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-2#1)
has evolved into a very##2##5##(2008-4#1)(2008-7#1)
has evolved into a##4##4##(2008-10#2)(2008-4#1)(2008-7#1)
has evolved into##8##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
has evolved over the##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
has evolved over##5##3##(1997-1#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
has evolved significantly##2##3##(2008-8#1)(2013-7#1)
has evolved to##3##3##(1996-3#1)(2009-6#1)(2009-9#1)
has evolved with##2##3##(1996-9#1)(2010-3#1)
has evolved##45##2##(1991-1#1)(1993-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-3#2)(2010-8#4)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
has examined the effects of##2##5##(2008-10#1)(2009-2#1)
has examined the##4##3##(2008-10#1)(2008-11#1)(2009-2#1)(2012-12#1)
has examined whether##2##3##(2008-11#1)(2009-7#1)
has examined##10##2##(1995-1#1)(1995-11#1)(2008-10#1)(2008-11#3)(2009-2#1)(2009-7#1)(2012-12#1)(2013-1#1)
has excellent stability##2##3##(2008-10#1)(2013-1#1)
has excellent##10##2##(2008-10#4)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#2)
has exhibited##2##2##(2008-10#1)(2010-6#1)
has existed##3##2##(1992-1#1)(2007-5#1)(2008-7#1)
has expanded##8##2##(1991-2#1)(1992-3#1)(1994-1#1)(1995-3#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
has experienced##6##2##(1991-6#1)(1997-3#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
has explicitly explored the impact of older parents' chronic pain symptoms on their adult children##2##15##(2013-1#2)
has explored the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
has explored##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
has extended##2##2##(1992-8#1)(2010-10#1)
has extensive##2##2##(2013-8#2)
has faced##2##2##(2008-8#1)(2013-1#1)
has facilitated a##2##3##(2008-10#1)(2008-6#1)
has facilitated the##3##3##(1996-1#1)(2008-10#1)(2010-4#1)
has facilitated##9##2##(1994-5#1)(1996-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
has failed to respond to##3##5##(2007-10#1)(2012-12#1)(2012-2#1)
has failed to##12##3##(1994-2#1)(1995-3#1)(1996-2#1)(2007-10#2)(2008-4#1)(2008-7#2)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
has failed##18##2##(1990-11#1)(1991-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(2007-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
has fallen from##2##3##(1993-6#1)(2008-7#1)
has favorable##2##2##(2007-12#1)(2013-1#1)
has few##3##2##(2008-12#1)(2008-3#1)(2012-12#1)
has fewer##3##2##(2010-10#1)(2012-12#1)(2013-8#1)
has finally##2##2##(2008-2#1)(2010-4#1)
has firstly been##2##3##(2008-10#2)
has five##3##2##(1993-2#1)(2007-12#1)(2009-3#1)
has flexibility##2##2##(2008-6#2)
has flexuous##2##2##(2008-10#2)
has focused on the##14##4##(1993-1#1)(1994-3#1)(1995-1#1)(1997-6#1)(1997-8#1)(2008-2#1)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#3)
has focused on two##2##4##(1993-12#1)(1994-3#1)
has focused on##42##3##(1990-2#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
has focused primarily on##4##4##(1990-12#1)(1995-12#1)(1996-2#1)(2012-2#1)
has focused upon##2##3##(2007-11#1)(2013-1#1)
has focused##50##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
has followed##2##2##(2008-10#1)(2008-11#1)
has for the##2##3##(2009-6#2)
has for##4##2##(1995-5#1)(2007-11#1)(2009-6#2)
has found a##3##3##(1991-9#1)(1996-3#1)(2008-2#1)
has found its way##2##4##(1994-3#1)(1995-8#1)
has found its##3##3##(1994-3#1)(1995-8#1)(2008-11#1)
has found that##2##3##(1995-3#1)(2008-8#1)
has found##16##2##(1991-9#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
has four##5##2##(1990-12#1)(1991-6#1)(1992-9#1)(1996-11#1)(1997-7#1)
has frequently been##3##3##(1992-9#1)(1993-9#1)(2011-2#1)
has frequently##5##2##(1992-9#1)(1993-9#1)(1994-1#1)(2008-9#1)(2011-2#1)
has fuelled##2##2##(2008-11#1)(2008-12#1)
has full##2##2##(1994-5#1)(2013-1#1)
has functional##2##2##(1993-8#1)(2011-2#1)
has further been##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
has further##7##2##(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2012-2#2)
has gained a##2##3##(2009-5#1)(2011-2#1)
has gained increasing##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
has gained significant attention##2##4##(2009-7#1)(2010-3#1)
has gained widespread##2##3##(2009-9#1)(2012-12#1)
has gained##22##2##(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-3#2)(2011-2#4)(2012-12#3)(2013-1#1)
has garnered##2##2##(2010-7#1)(2012-2#1)
has gathered##2##2##(1992-9#1)(2012-12#1)
has generally been##5##3##(1990-7#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-3#1)
has generally##6##2##(1990-7#1)(1996-7#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-3#1)
has generated much##4##3##(1997-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
has generated##16##2##(1992-8#1)(1993-9#1)(1994-1#1)(1997-2#1)(1997-4#1)(2008-3#1)(2009-10#1)(2011-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
has given rise to##2##4##(2008-11#1)(2009-8#1)
has given##11##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#2)(2010-8#1)
has gone##3##2##(1996-3#1)(2008-8#1)(2012-3#1)
has good linearity##2##3##(2008-3#1)(2010-4#1)
has good##12##2##(2008-10#8)(2008-3#1)(2008-9#1)(2010-4#1)(2013-8#1)
has got##2##2##(2008-12#1)(2013-1#1)
has gradually##4##2##(1997-1#1)(2008-5#1)(2012-12#1)(2013-8#1)
has great potential##5##3##(1993-12#1)(1995-1#1)(2007-12#1)(2010-9#1)(2011-1#1)
has great promise for##2##4##(2007-8#1)(2008-3#1)
has great##12##2##(1993-12#1)(1995-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-9#1)(2011-1#1)(2013-1#1)
has greater##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
has greatly contributed to the understanding of##2##7##(1997-8#1)(2012-2#1)
has greatly enhanced##2##3##(2010-12#1)(2011-2#1)
has greatly improved##2##3##(2006-4#1)(2009-5#1)
has greatly increased##3##3##(2008-9#1)(2012-1#1)(2012-12#1)
has greatly reduced##2##3##(1991-5#1)(2008-1#1)
has greatly##18##2##(1990-5#1)(1991-5#1)(1997-8#1)(2006-4#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
has grown among##2##3##(2010-1#1)(2010-8#1)
has grown rapidly##3##3##(1994-1#1)(2008-10#1)(2009-10#1)
has grown##17##2##(1991-8#1)(1992-2#1)(1994-1#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-8#1)
has had a##11##3##(1991-1#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#2)
has had an effect on##2##5##(1995-12#1)(2008-11#1)
has had an impact on##2##5##(1995-2#1)(2013-1#1)
has had an##6##3##(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
has had##35##2##(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-6#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#3)
has hampered##2##2##(2008-10#1)(2008-9#1)
has held##4##2##(1996-5#1)(2008-5#1)(2008-7#1)(2010-5#1)
has helped to shape##2##4##(1991-3#1)(2008-12#1)
has helped to##10##3##(1991-3#1)(1992-2#1)(1996-12#1)(2008-1#1)(2008-12#3)(2010-4#1)(2011-2#1)(2012-3#1)
has helped##14##2##(1991-3#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
has high affinity for##3##4##(1994-8#1)(2011-2#1)(2013-1#1)
has high affinity##4##3##(1990-5#1)(1994-8#1)(2011-2#1)(2013-1#1)
has high sensitivity##3##3##(2008-10#2)(2011-2#1)
has high##30##2##(1990-5#1)(1993-2#1)(1994-8#1)(1996-7#1)(1997-2#1)(2007-2#1)(2008-1#2)(2008-10#9)(2008-3#1)(2008-8#2)(2008-9#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
has higher##10##2##(1997-4#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2013-8#1)
has highlighted the##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
has highlighted##6##2##(1991-3#1)(2008-10#1)(2008-11#1)(2009-8#2)(2013-1#1)
has highly##2##2##(1991-6#1)(2008-2#1)
has hindered##2##2##(2008-9#1)(2012-2#1)
has histamine releasing activity in##2##5##(1992-3#2)
has historically been##2##3##(2006-10#1)(2012-12#1)
has historically##4##2##(1997-1#1)(2006-10#1)(2009-9#1)(2012-12#1)
has hitherto##2##2##(2009-5#1)(2013-1#1)
has homology##2##2##(1991-11#1)(1993-6#1)
has identified a##6##3##(1992-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)
has identified##18##2##(1991-3#1)(1992-11#1)(1992-6#1)(1995-3#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
has illustrated##2##2##(1991-3#1)(2008-10#1)
has implemented a##5##3##(1991-5#1)(1992-2#1)(1995-12#1)(1996-3#1)(2010-9#1)
has implications for the##7##4##(1992-11#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
has implications for##12##3##(1991-2#1)(1992-11#1)(1992-8#1)(2008-11#2)(2008-3#2)(2009-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
has implications##14##2##(1991-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(2008-11#2)(2008-3#2)(2008-8#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
has important clinical##2##3##(2008-3#1)(2013-7#1)
has important implications for the##3##5##(1994-8#1)(2008-11#1)(2008-8#1)
has important implications for##11##4##(1991-3#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
has important implications##14##3##(1991-3#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
has important##28##2##(1991-3#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
has improved considerably##3##3##(1990-3#1)(1997-1#1)(2008-6#1)
has improved dramatically##2##3##(2010-3#1)(2013-1#1)
has improved the prognosis##2##4##(2008-1#1)(2008-6#1)
has improved the treatment results in children with ALL and initial leukocytosis over 50 000/mm3##2##15##(2011-2#2)
has improved the##7##3##(1994-11#1)(2008-1#1)(2008-6#2)(2011-2#2)(2012-2#1)
has improved##27##2##(1990-3#1)(1991-3#1)(1994-11#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-6#3)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)
has in##3##2##(1997-1#1)(2008-11#1)(2008-7#1)
has included##2##2##(1997-8#1)(2010-3#1)
has incorporated##2##2##(1997-3#1)(2009-12#1)
has increased by##8##3##(1990-3#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(2007-12#1)(2008-1#1)
has increased dramatically in the last##2##6##(2008-7#1)(2009-7#1)
has increased dramatically in the##3##5##(2008-7#1)(2009-7#1)(2013-1#1)
has increased dramatically in##4##4##(1997-2#1)(2008-7#1)(2009-7#1)(2013-1#1)
has increased dramatically##9##3##(1995-12#2)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-1#1)
has increased greatly##2##3##(1992-12#1)(2008-5#1)
has increased in the last##2##5##(2008-11#1)(2011-1#1)
has increased in the##3##4##(2008-11#1)(2011-1#1)(2012-2#1)
has increased in##15##3##(1990-11#1)(1991-11#1)(1993-1#1)(2007-12#1)(2007-7#1)(2008-11#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)
has increased interest in##2##4##(2010-11#1)(2013-1#1)
has increased over the last##2##5##(1997-7#1)(2013-1#1)
has increased over the past two decades##2##7##(2009-8#1)(2011-2#1)
has increased over the past##3##5##(2009-7#1)(2009-8#1)(2011-2#1)
has increased over the##5##4##(1997-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
has increased significantly in##2##4##(2008-1#1)(2008-10#1)
has increased significantly##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
has increased substantially##2##3##(1997-8#1)(2008-3#1)
has increased the##8##3##(1992-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
has increased to##2##3##(2008-3#1)(2010-10#1)
has increased##95##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-7#2)(2008-1#4)(2008-10#7)(2008-11#6)(2008-3#3)(2008-5#5)(2008-7#4)(2008-8#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#5)(2013-8#1)
has indicated that the##2##4##(1995-1#1)(2011-2#1)
has indicated that##9##3##(1993-11#1)(1995-1#1)(1996-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
has indicated##13##2##(1993-11#1)(1995-1#1)(1996-1#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
has induced##2##2##(1990-6#1)(1996-3#1)
has inevitably##2##2##(1997-6#1)(2008-12#1)
has influenced the##4##3##(1992-3#2)(2008-12#1)(2010-5#1)
has informed##2##2##(1996-11#1)(2008-12#1)
has inherent##2##2##(2008-1#1)(2008-12#1)
has inhibitory effects##2##3##(1991-12#1)(1997-4#1)
has initiated a##2##3##(1992-12#1)(2011-1#1)
has initiated##4##2##(1992-12#1)(1995-11#1)(2010-7#1)(2011-1#1)
has inspired##2##2##(2008-8#1)(2009-5#1)
has integrated##2##2##(2008-10#1)(2012-2#1)
has intensified##2##2##(1996-2#1)(2013-1#1)
has intrigued##2##2##(2009-6#1)(2009-8#1)
has introduced a##3##3##(1991-12#1)(1995-6#1)(2013-8#1)
has introduced##6##2##(1991-12#1)(1995-6#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-8#1)
has investigated##5##2##(1993-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
has involved##2##2##(1995-12#1)(2008-3#1)
has issued##3##2##(1991-6#1)(1992-8#1)(2008-5#1)
has it##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)
has its advantages and##2##4##(2008-10#1)(2008-9#1)
has its limitations##3##3##(1992-3#1)(2008-11#1)(2008-4#1)
has its origin in##2##4##(1990-2#1)(2007-11#1)
has its own##6##3##(1994-3#1)(1995-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-5#1)
has its roots in the##3##5##(1993-2#1)(1997-2#1)(2008-9#1)
has its roots in##4##4##(1993-2#1)(1997-2#1)(2008-9#1)(2010-3#1)
has its roots##5##3##(1993-2#1)(1997-2#1)(2008-9#1)(2010-3#1)(2013-8#1)
has its##34##2##(1990-2#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
has lacked##2##2##(1997-3#1)(2010-5#1)
has laid##3##2##(2008-9#1)(2009-3#1)(2012-2#1)
has largely been##4##3##(1996-12#1)(2007-8#1)(2008-7#1)(2008-9#1)
has largely focused on##2##4##(2008-10#1)(2012-3#1)
has largely##7##2##(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
has launched a##2##3##(2007-7#1)(2012-12#1)
has launched##3##2##(1990-6#1)(2007-7#1)(2012-12#1)
has lead to a##3##4##(2008-10#1)(2010-1#1)(2011-2#1)
has lead to##6##3##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#2)(2012-12#1)
has learned about##2##3##(1995-1#1)(2012-2#1)
has led researchers to##3##4##(2007-2#1)(2008-11#1)(2011-2#1)
has led the##3##3##(1994-1#1)(2008-12#1)(2009-3#1)
has led to a new##2##5##(2008-2#1)(2008-7#1)
has led to a rise in##2##6##(1994-12#1)(2011-2#1)
has led to a##21##4##(1993-6#1)(1994-12#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#2)
has led to an increase in the##2##7##(2011-2#2)
has led to an increase in##3##6##(2011-2#2)(2011-3#1)
has led to an increase##4##5##(1991-6#1)(2011-2#2)(2011-3#1)
has led to an##7##4##(1991-6#1)(2006-10#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-12#1)
has led to changes in the##2##6##(2008-10#1)(2008-2#1)
has led to increasing##2##4##(1992-5#1)(2011-2#1)
has led to studies investigating##2##5##(2007-10#1)(2010-4#1)
has led to the development of a new##2##8##(2008-10#1)(2012-3#1)
has led to the development of a##3##7##(2008-10#1)(2008-4#1)(2012-3#1)
has led to the development of new##3##7##(2008-2#1)(2010-12#1)(2011-1#1)
has led to the development of##11##6##(1994-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
has led to the discovery of##2##6##(1997-4#1)(2008-4#1)
has led to the hypothesis that##3##6##(2008-6#1)(2010-2#2)
has led to the rapid##2##5##(2008-8#2)
has led to the recognition of##2##6##(2008-4#1)(2008-7#1)
has led to the search for##2##6##(2012-12#1)(2012-3#1)
has led to the##33##4##(1990-5#1)(1994-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#2)
has led to##98##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#2)(1993-6#1)(1994-12#3)(1994-5#1)(1995-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
has led##108##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-5#1)(1995-4#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
has left##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
has less##10##2##(1990-8#1)(1991-8#1)(1992-12#1)(1994-9#1)(2008-10#2)(2011-2#3)(2013-1#1)
has limitations##2##2##(2008-7#1)(2011-2#1)
has limited ability to##2##4##(2011-2#1)(2012-3#1)
has limited sensitivity##2##3##(2008-7#1)(2012-3#1)
has limited the##2##3##(2007-5#1)(2008-3#1)
has limited##15##2##(1995-1#1)(1995-2#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
has linked##4##2##(2008-1#1)(2010-7#1)(2011-2#2)
has little effect on the##2##5##(1990-2#1)(1995-8#1)
has little effect on##4##4##(1990-2#2)(1995-8#1)(2009-5#1)
has little impact on the##2##5##(1996-5#1)(2008-3#1)
has little or no##2##4##(1993-8#1)(2008-5#1)
has little value in##2##4##(1992-3#1)(2013-1#1)
has little##27##2##(1990-2#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
has long been a##4##4##(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
has long been an important##2##5##(2008-8#1)(2008-9#1)
has long been argued##2##4##(2011-1#1)(2012-2#1)
has long been considered a##2##5##(2008-10#1)(2008-4#1)
has long been considered##3##4##(2007-12#1)(2008-10#1)(2008-4#1)
has long been known that##3##5##(2008-7#1)(2008-8#1)(2012-2#1)
has long been known##4##4##(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
has long been observed##2##4##(1995-6#1)(2008-10#1)
has long been recognized as##2##5##(2008-3#1)(2013-1#1)
has long been recognized##7##4##(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
has long been regarded as##3##5##(1995-2#1)(2008-11#1)(2010-5#1)
has long been used to##2##5##(2008-10#1)(2008-8#1)
has long been used##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
has long been##44##3##(1992-2#1)(1993-12#2)(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
has long existed##2##3##(2008-10#1)(2012-12#1)
has long remained##2##3##(2008-3#1)(2010-1#1)
has long##54##2##(1992-2#1)(1993-12#2)(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)
has long-term##2##2##(2008-10#1)(2012-2#1)
has lost its##2##3##(2008-12#1)(2013-8#1)
has lost the##2##3##(2009-6#1)(2010-10#1)
has lost##6##2##(1990-5#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-8#1)(2013-8#1)
has low##11##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
has lower##8##2##(1997-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-2#1)
has made a significant impact on the##2##7##(1992-1#1)(2008-8#1)
has made a significant impact on##3##6##(1992-1#1)(2008-8#1)(2009-6#1)
has made a significant##5##4##(1992-1#1)(2008-8#1)(2009-6#1)(2013-1#2)
has made a##10##3##(1990-11#1)(1992-1#1)(1992-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#2)
has made great strides##2##4##(2009-5#1)(2012-3#1)
has made it possible for##3##5##(1992-3#1)(2007-7#1)(2010-12#1)
has made it possible to place##2##6##(2008-7#1)(2013-1#1)
has made it possible to##11##5##(1992-9#1)(1995-8#1)(1997-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2013-1#1)
has made it possible##14##4##(1992-3#1)(1992-9#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2013-1#1)
has made it##17##3##(1992-3#1)(1992-9#1)(1994-6#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2013-1#1)
has made its##2##3##(2007-8#1)(2010-12#1)
has made much progress##2##4##(1996-11#1)(2008-10#1)
has made significant##2##3##(2008-8#1)(2012-2#1)
has made substantial##2##3##(1995-5#1)(2009-3#1)
has made the##6##3##(1993-3#1)(1995-6#1)(2008-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
has made##63##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
has mainly been##2##3##(1995-8#1)(2012-12#1)
has mainly##4##2##(1994-12#1)(1995-8#1)(2008-5#1)(2012-12#1)
has maintained a##2##3##(2011-2#1)(2012-3#1)
has maintained##3##2##(1996-1#1)(2011-2#1)(2012-3#1)
has major##6##2##(1991-1#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-2#1)
has managed to##2##3##(2008-2#1)(2008-5#1)
has managed##3##2##(2008-2#1)(2008-5#1)(2009-10#1)
has many advantages for##2##4##(1993-1#1)(2012-2#1)
has many characteristics of##2##4##(2008-7#1)(2008-9#1)
has many characteristics##3##3##(2007-4#1)(2008-7#1)(2008-9#1)
has many features that##2##4##(1994-8#1)(1997-2#1)
has many features##3##3##(1994-8#1)(1997-2#1)(2008-8#1)
has many##27##2##(1990-8#1)(1993-1#1)(1994-8#1)(1995-6#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
has marked##4##2##(1993-11#1)(1993-6#1)(2008-10#1)(2008-8#1)
has markedly improved##2##3##(2008-1#1)(2011-2#1)
has markedly##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
has meant##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
has merit##2##2##(1992-8#1)(2008-10#1)
has met##5##2##(1995-3#1)(2008-9#2)(2010-12#1)(2012-3#1)
has minimal##5##2##(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)
has mixed into##2##3##(2008-8#2)
has more recently been##2##4##(1995-2#1)(1997-8#1)
has more than##2##3##(1991-9#1)(2008-9#1)
has more##9##2##(1991-9#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)
has most##3##2##(1994-3#1)(2008-3#1)(2012-12#1)
has mostly##2##2##(2008-8#1)(2010-3#1)
has motivated##2##2##(1996-6#1)(2008-7#1)
has moved##6##2##(1995-6#1)(1996-11#1)(2007-2#1)(2008-10#1)(2009-12#1)(2010-7#1)
has much to offer##2##4##(2008-12#2)
has much to recommend it##2##5##(1992-12#1)(1996-2#1)
has much to##4##3##(1992-12#1)(1996-2#1)(2008-12#2)
has much##14##2##(1990-8#1)(1992-12#1)(1994-11#1)(1996-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
has multiple##2##2##(2008-4#1)(2008-6#1)
has near##2##2##(2008-10#1)(2009-6#1)
has nearly##2##2##(2007-12#1)(2008-7#1)
has negative##2##2##(2008-11#1)(2012-2#1)
has neuroprotective##2##2##(2008-11#1)(2011-2#1)
has neurotoxic##2##2##(1990-3#1)(1994-8#1)
has never been applied to##2##5##(2008-10#2)
has never been examined##2##4##(1992-9#1)(2010-2#1)
has never been explained##2##4##(2007-11#1)(2008-10#1)
has never been published##2##4##(1991-12#1)(1992-12#1)
has never been reported before in the##2##7##(1997-8#1)(2008-11#1)
has never been reported##5##4##(1997-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
has never been##31##3##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-2#1)(2012-12#2)(2012-5#1)(2012-7#1)(2013-8#1)
has never##36##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
has no advantage over those##2##5##(1994-2#2)
has no affinity for##2##4##(1993-6#1)(1995-6#1)
has no detectable##2##3##(1992-12#1)(1995-2#1)
has no effect on the##8##5##(1990-11#1)(1990-12#1)(1990-5#1)(1995-2#1)(2007-8#1)(2008-8#1)(2009-10#1)(2013-8#1)
has no effect on##25##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-8#3)(2009-10#1)(2013-1#1)(2013-8#1)
has no effect##28##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2009-10#1)(2013-1#1)(2013-8#1)
has no health insurance##2##4##(1992-3#1)(1993-12#1)
has no history of##2##4##(1994-12#1)(2012-12#1)
has no known##2##3##(2006-6#1)(2010-6#1)
has no meaning##2##3##(2008-5#1)(2013-1#1)
has no significant effect on##3##5##(1995-6#1)(2007-8#1)(2008-6#1)
has no significant effect##4##4##(1995-6#1)(2007-8#1)(2008-6#1)(2012-12#1)
has no significant##6##3##(1995-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
has no##89##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1996-12#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-7#3)(2006-6#1)(2007-11#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
has normal##5##2##(1993-2#1)(1997-3#1)(2009-5#1)(2010-6#1)(2011-2#1)
has not altered##2##3##(2010-3#2)
has not always been##2##4##(2007-10#1)(2008-1#1)
has not become##2##3##(1990-9#1)(2010-7#1)
has not been accompanied by##2##5##(1994-1#1)(2008-11#1)
has not been achieved##3##4##(1995-3#1)(2008-2#1)(2010-8#1)
has not been addressed##3##4##(2008-11#1)(2008-7#1)(2010-1#1)
has not been adequately##3##4##(1992-6#1)(2009-2#1)(2011-2#1)
has not been assessed##2##4##(2008-10#1)(2012-1#1)
has not been characterized##2##4##(1990-11#1)(2008-9#1)
has not been clearly defined##2##5##(2011-2#2)
has not been clearly##4##4##(2008-10#1)(2008-11#1)(2011-2#2)
has not been cloned##3##4##(1993-12#1)(1995-6#1)(2008-4#1)
has not been conducted##2##4##(2008-12#2)
has not been confirmed in##2##5##(1992-6#1)(2008-9#1)
has not been confirmed##4##4##(1992-6#1)(2007-8#1)(2008-9#1)(2009-5#1)
has not been defined##2##4##(1995-8#1)(2008-6#1)
has not been demonstrated##8##4##(1990-11#2)(1991-10#1)(1992-11#1)(1995-6#1)(2008-10#2)(2009-9#1)
has not been described in##2##5##(2007-12#1)(2012-2#1)
has not been described previously##2##5##(1995-6#1)(2008-10#1)
has not been described##9##4##(1991-6#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-2#1)
has not been detected##2##4##(2006-10#1)(2008-10#1)
has not been determined##8##4##(1992-10#1)(1992-12#1)(1994-12#1)(2008-10#2)(2010-4#1)(2012-1#1)(2012-3#1)
has not been documented##4##4##(1996-5#1)(2008-4#1)(2008-6#1)(2013-7#1)
has not been established##7##4##(1995-12#1)(1996-6#1)(2008-3#1)(2008-4#1)(2010-4#1)(2013-1#2)
has not been evaluated##3##4##(2008-3#1)(2009-11#1)(2013-1#1)
has not been extensive##2##4##(1994-9#1)(2008-10#1)
has not been extensively investigated##2##5##(2007-12#1)(2013-8#1)
has not been extensively studied##2##5##(2008-11#1)(2008-8#1)
has not been extensively##4##4##(2007-12#1)(2008-11#1)(2008-8#1)(2013-8#1)
has not been fully elucidated##2##5##(2007-11#1)(2008-10#1)
has not been fully established##2##5##(2008-7#1)(2010-8#1)
has not been fully##12##4##(1994-12#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2010-8#1)(2012-2#1)
has not been identified##4##4##(1992-6#1)(1995-5#1)(2007-11#1)(2008-6#1)
has not been implemented##2##4##(1994-1#1)(2010-4#1)
has not been investigated##6##4##(1997-2#1)(2008-11#2)(2008-12#1)(2009-10#1)(2011-1#1)
has not been observed in##2##5##(2008-2#1)(2008-7#1)
has not been observed##6##4##(1993-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
has not been performed##2##4##(1994-6#1)(1994-7#1)
has not been previously described##2##5##(2008-7#2)
has not been previously reported in the literature##3##8##(2007-8#1)(2009-7#1)(2010-3#1)
has not been previously reported in the##4##7##(2007-8#1)(2009-7#1)(2010-3#1)(2010-6#1)
has not been previously reported##11##5##(1996-12#1)(2007-8#1)(2008-10#3)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2013-8#1)
has not been previously##20##4##(1996-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-6#1)(2012-3#1)(2013-8#1)
has not been proven##2##4##(1993-2#1)(1993-3#1)
has not been reported for##2##5##(2008-10#2)
has not been reported in any other##2##7##(2008-10#1)(2008-5#1)
has not been reported in the literature##4##7##(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)
has not been reported in##10##5##(1997-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
has not been reported previously##2##5##(1997-3#1)(2008-1#1)
has not been reported##23##4##(1991-11#1)(1997-3#1)(1997-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-6#2)(2011-1#2)(2012-2#3)(2013-1#1)
has not been rigorously##3##4##(1991-8#1)(2008-10#1)(2009-7#1)
has not been shown to##3##5##(1994-6#1)(2008-7#1)(2009-3#1)
has not been studied##6##4##(1996-1#1)(2008-1#1)(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#1)
has not been subjected to rigorous study##2##7##(2012-3#2)
has not been tested##3##4##(2008-8#2)(2013-8#1)
has not been the##2##4##(1995-6#1)(2008-11#1)
has not been treated##2##4##(1995-5#1)(1997-4#1)
has not been well documented##2##5##(2008-12#1)(2012-12#1)
has not been well##8##4##(1991-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-12#1)(2013-1#1)
has not been yet##2##4##(2009-6#1)(2010-12#1)
has not been##245##3##(1990-11#5)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-9#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#31)(2008-11#18)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#13)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#8)(2012-3#5)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#3)
has not changed##4##3##(1996-3#1)(2007-7#1)(2008-1#1)(2012-3#1)
has not declined##2##3##(1994-11#1)(1997-5#1)
has not fully##2##3##(2008-1#1)(2008-11#1)
has not had##3##3##(1992-2#1)(2006-10#1)(2010-6#1)
has not occurred##2##3##(2008-10#2)
has not only been##3##4##(2008-1#1)(2008-7#1)(2010-5#1)
has not only provided##2##4##(2007-8#1)(2013-1#1)
has not only##6##3##(1990-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-5#1)(2013-1#1)
has not previously been described##2##5##(2008-10#1)(2008-12#1)
has not previously been reported##5##5##(1990-7#1)(2007-10#1)(2008-10#1)(2011-1#1)(2013-8#1)
has not previously been##10##4##(1990-7#1)(1994-1#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
has not previously##11##3##(1990-7#1)(1994-1#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
has not provided##2##3##(2008-6#1)(2010-8#1)
has not received##3##3##(1996-6#1)(2008-6#1)(2013-1#1)
has not recurred##2##3##(2007-2#1)(2008-1#1)
has not shown any##2##4##(2012-3#2)
has not shown##3##3##(2012-3#2)(2013-1#1)
has not the##2##3##(1996-7#1)(2008-10#1)
has not undergone##2##3##(1992-2#1)(2012-1#1)
has not yet been achieved##2##5##(2008-11#1)(2008-3#1)
has not yet been described##2##5##(2008-5#1)(2013-7#1)
has not yet been detected##3##5##(1991-12#1)(2008-10#1)(2008-11#1)
has not yet been established##2##5##(1992-5#1)(2008-10#1)
has not yet been identified##3##5##(1990-11#1)(1994-6#1)(2011-2#1)
has not yet been published##2##5##(1990-11#1)(2007-8#1)
has not yet been shown##2##5##(1990-11#1)(1994-3#1)
has not yet been##43##4##(1990-11#3)(1990-6#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-12#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
has not yet##47##3##(1990-11#3)(1990-6#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
has not##377##2##(1990-11#8)(1990-6#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#5)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#8)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-9#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#6)(2008-1#8)(2008-10#45)(2008-11#24)(2008-12#8)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#6)(2008-6#7)(2008-7#17)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#8)(2012-1#6)(2012-12#3)(2012-2#8)(2012-3#10)(2012-7#1)(2013-1#14)(2013-7#3)(2013-8#5)
has nothing##2##2##(2008-10#1)(2012-2#1)
has now become##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
has now been described##2##4##(2006-10#1)(2008-3#1)
has now been established##4##4##(2008-8#1)(2010-12#3)
has now been##14##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#1)
has now gained##2##3##(2008-11#1)(2012-12#1)
has now##27##2##(1992-5#1)(1994-11#1)(2006-10#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
has numerous##2##2##(2008-8#1)(2013-1#1)
has occasionally been##2##3##(1994-12#1)(2010-3#1)
has occurred after##2##3##(1991-6#1)(1995-11#1)
has occurred in many##2##4##(1990-2#1)(2012-12#1)
has occurred in the##2##4##(2007-12#1)(2008-10#1)
has occurred in##8##3##(1990-2#1)(1994-7#1)(2007-12#1)(2008-10#2)(2009-7#1)(2011-1#1)(2012-12#1)
has occurred with the##2##4##(2008-10#1)(2009-7#1)
has occurred##32##2##(1990-2#1)(1991-6#1)(1992-1#1)(1993-5#1)(1994-2#2)(1994-7#1)(1995-11#1)(1997-1#1)(2007-12#2)(2007-5#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2011-1#1)(2012-12#1)
has offered##4##2##(2008-1#1)(2008-2#1)(2010-8#1)(2013-1#1)
has often been##12##3##(1990-2#1)(1992-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
has often##14##2##(1990-2#1)(1992-1#1)(1995-12#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
has on the##3##3##(1994-2#1)(2008-7#1)(2013-1#1)
has on##16##2##(1994-2#1)(1994-3#2)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2012-1#1)(2013-1#1)
has one of the##2##4##(2008-10#1)(2008-11#1)
has one##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
has only a small##2##4##(1990-2#1)(1996-11#1)
has only a##5##3##(1990-2#1)(1995-2#1)(1996-11#1)(1997-6#1)(2008-8#1)
has only been reported##2##4##(2008-9#1)(2013-1#1)
has only been##7##3##(1991-11#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-7#1)(2013-1#2)
has only one##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
has only rarely been##3##4##(1991-3#1)(2006-10#1)(2011-2#1)
has only recently been##4##4##(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)
has only recently##6##3##(1992-1#1)(1993-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)
has only##32##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-12#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
has opened up##2##3##(2008-7#1)(2010-4#1)
has opened##4##2##(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
has optimized the##2##3##(2009-9#1)(2012-3#1)
has over##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
has passed##3##2##(1995-12#1)(2008-10#2)
has performed##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
has permitted the##4##3##(1995-1#1)(1997-2#1)(2007-12#1)(2008-3#1)
has permitted##8##2##(1994-6#1)(1995-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
has played a##3##3##(2008-8#1)(2009-4#1)(2010-3#1)
has played an important role in##2##6##(2007-12#1)(2008-8#1)
has played an##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
has played in##2##3##(1993-6#1)(1995-12#1)
has played##8##2##(1993-6#1)(1995-12#1)(2007-12#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-3#1)
has poor##4##2##(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
has positive##2##2##(2008-3#1)(2008-8#1)
has possible##2##2##(2007-12#1)(2008-1#1)
has potent##5##2##(1992-3#1)(1993-5#1)(1994-2#1)(2008-5#1)(2013-7#1)
has potential applications in##5##4##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
has potential as a biological control agent for##2##8##(2008-10#2)
has potential as a##6##4##(2008-10#4)(2009-5#1)(2010-2#1)
has potential as an##2##4##(2008-10#1)(2008-11#1)
has potential as##8##3##(2008-10#5)(2008-11#1)(2009-5#1)(2010-2#1)
has potential for##2##3##(2008-10#1)(2008-5#1)
has potential in##2##3##(2008-10#1)(2012-2#1)
has potential to become##2##4##(2008-9#1)(2012-12#1)
has potential to##3##3##(2006-12#1)(2008-9#1)(2012-12#1)
has potential use##2##3##(1994-9#1)(2008-11#1)
has potential##29##2##(1994-9#1)(2006-12#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
has practical##3##2##(1997-7#1)(2008-2#1)(2008-7#1)
has precluded##2##2##(2008-10#1)(2010-12#1)
has presented a##3##3##(1993-11#1)(2008-2#1)(2011-1#1)
has presented##9##2##(1991-12#1)(1993-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-12#1)
has prevailed##2##2##(2009-8#1)(2011-2#1)
has prevented##4##2##(1996-2#1)(2008-10#1)(2009-8#1)(2010-12#1)
has previously been described in##2##5##(1992-6#1)(2008-10#1)
has previously been described##3##4##(1990-6#1)(1992-6#1)(2008-10#1)
has previously been proposed##2##4##(1990-8#1)(2012-8#1)
has previously been shown to be a##2##7##(1993-12#1)(2010-2#1)
has previously been shown to be##3##6##(1993-12#1)(2008-6#1)(2010-2#1)
has previously been shown to##9##5##(1990-12#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
has previously been shown##12##4##(1990-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-2#1)(2013-1#1)
has previously been suggested##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
has previously been used to##2##5##(1990-8#1)(2008-10#1)
has previously been##32##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1992-6#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-3#1)(2012-8#1)(2013-1#1)
has previously##36##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-3#1)(2012-8#1)(2013-1#1)
has probably##3##2##(1992-12#1)(2008-5#1)(2010-1#1)
has produced a##4##3##(1996-1#1)(1996-3#1)(2008-7#1)(2011-2#1)
has produced several##2##3##(2008-10#1)(2008-9#1)
has produced##16##2##(1996-1#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
has profound effects on##2##4##(1995-2#1)(2010-8#1)
has profound##3##2##(1995-2#1)(2009-9#1)(2010-8#1)
has progressed##4##2##(1992-3#1)(1995-2#1)(2008-10#1)(2013-1#1)
has progressively##2##2##(1990-9#1)(2011-2#1)
has promoted##3##2##(1994-11#1)(1997-2#1)(2011-2#1)
has prompted a search for##2##5##(2008-5#1)(2013-1#1)
has prompted an##2##3##(2008-7#1)(2009-12#1)
has prompted the##3##3##(1994-12#1)(2008-9#1)(2010-8#1)
has prompted##14##2##(1993-12#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
has pronounced##3##2##(1991-12#1)(1996-12#1)(2010-7#1)
has propelled##2##2##(2012-1#1)(2013-1#1)
has properties similar to those of##2##6##(2007-12#1)(2008-3#1)
has properties##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
has proposed a##2##3##(1995-6#1)(2010-8#1)
has proposed##5##2##(1992-2#1)(1995-2#1)(1995-6#1)(2008-1#1)(2010-8#1)
has protective properties##2##3##(1993-5#1)(2011-2#1)
has protective##3##2##(1993-5#1)(2008-10#1)(2011-2#1)
has proved effective in##2##4##(2008-11#1)(2008-6#1)
has proved its##2##3##(2008-3#1)(2008-9#1)
has proved that##2##3##(2008-10#1)(2011-2#1)
has proved to be a##7##5##(1991-11#1)(1993-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-7#1)
has proved to be an##2##5##(2010-8#1)(2011-2#1)
has proved to be the##3##5##(2008-10#1)(2008-4#1)(2010-8#1)
has proved to be useful##2##5##(2008-10#1)(2011-2#1)
has proved to be##24##4##(1991-11#1)(1993-12#1)(1994-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#2)(2013-1#1)(2013-8#1)
has proved to##25##3##(1991-11#1)(1993-12#1)(1994-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#2)(2013-1#1)(2013-8#1)
has proved##42##2##(1991-11#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-3#1)(1994-6#1)(1997-7#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#2)(2010-8#2)(2011-1#1)(2011-2#5)(2011-7#2)(2012-1#1)(2013-1#1)(2013-8#1)
has proven a##2##3##(2008-11#1)(2008-9#1)
has proven beneficial##2##3##(2008-7#1)(2008-9#1)
has proven effective in##2##4##(1994-10#1)(2008-2#1)
has proven effective##3##3##(1994-10#1)(2008-2#1)(2010-12#1)
has proven the##3##3##(1993-12#1)(2008-10#1)(2011-1#1)
has proven to be a powerful tool in the##2##9##(2008-3#1)(2009-5#1)
has proven to be a powerful tool##3##7##(2008-3#1)(2008-4#1)(2009-5#1)
has proven to be a powerful##4##6##(1994-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
has proven to be a useful tool in##2##8##(1992-1#1)(2008-8#1)
has proven to be a useful##3##6##(1992-1#1)(2008-4#1)(2008-8#1)
has proven to be a##13##5##(1992-1#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-2#1)
has proven to be an##2##5##(1991-5#1)(2011-2#1)
has proven to be applicable##2##5##(2007-12#1)(2009-10#1)
has proven to be more##3##5##(2008-6#1)(2012-2#2)
has proven to be very helpful##2##6##(2008-5#1)(2010-9#1)
has proven to be##30##4##(1991-5#1)(1992-1#1)(1992-6#1)(1994-2#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)
has proven to##31##3##(1991-5#1)(1992-1#1)(1992-6#1)(1994-2#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)
has proven useful in##4##4##(2008-11#1)(2008-2#1)(2008-5#1)(2011-7#1)
has proven very difficult##2##4##(2008-4#1)(2008-9#1)
has proven##54##2##(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-2#1)(1997-2#2)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#3)
has provided a##8##3##(1995-3#1)(1997-2#1)(2007-7#2)(2008-10#1)(2008-2#1)(2010-3#1)(2013-8#1)
has provided an##5##3##(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
has provided evidence##2##3##(2009-11#1)(2009-6#1)
has provided important##2##3##(1991-2#1)(1997-3#1)
has provided insights##2##3##(2007-8#1)(2013-1#1)
has provided new##4##3##(1993-2#1)(1997-8#1)(2008-10#1)(2010-8#1)
has provided several##2##3##(1992-2#1)(2012-12#1)
has provided the##7##3##(1994-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2013-1#1)
has provided us with##2##4##(1995-12#1)(2008-9#1)
has provided valuable information##2##4##(2008-1#1)(2010-4#1)
has provided valuable##3##3##(2007-10#1)(2008-1#1)(2010-4#1)
has provided##58##2##(1991-2#2)(1992-2#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
has provoked##2##2##(1992-1#1)(1996-8#1)
has raised concerns##2##3##(1996-12#1)(2007-12#1)
has raised the##2##3##(1996-3#1)(2008-10#1)
has raised##11##2##(1992-2#1)(1992-9#1)(1996-12#1)(1996-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-3#1)
has rapidly increased in##2##4##(2012-12#1)(2013-8#1)
has rapidly##5##2##(2008-10#2)(2012-12#2)(2013-8#1)
has rarely been reported in##2##5##(2007-7#1)(2010-6#1)
has rarely been reported##7##4##(1991-8#1)(2007-12#1)(2007-7#1)(2009-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
has rarely been##11##3##(1991-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-6#1)(2011-2#2)(2013-8#1)
has reached a##3##3##(1991-3#1)(2008-11#1)(2008-3#1)
has reached an##2##3##(2008-7#1)(2012-2#1)
has reached the##4##3##(2007-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
has reached##16##2##(1991-3#1)(1991-6#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#2)(2013-8#1)
has received attention##2##3##(2012-2#2)
has received considerable attention##2##4##(1997-5#1)(2013-1#1)
has received considerable##3##3##(1997-5#1)(2009-6#1)(2013-1#1)
has received increasing attention##5##4##(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#2)
has received increasing##6##3##(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)
has received less##2##3##(2008-2#1)(2008-9#1)
has received little attention in##3##5##(2008-10#1)(2008-11#1)(2010-3#1)
has received little attention##5##4##(2008-10#1)(2008-11#1)(2009-2#1)(2010-3#1)(2011-2#1)
has received more##2##3##(1992-8#1)(2008-10#1)
has received no##2##3##(1991-5#1)(2013-1#1)
has received relatively little##2##4##(2009-8#1)(2012-12#1)
has received##40##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-8#1)(1995-6#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
has recently become##3##3##(2008-8#1)(2008-9#1)(2010-8#1)
has recently been characterized and##2##5##(1995-6#1)(2009-10#1)
has recently been characterized as a##2##6##(1991-12#1)(1992-11#1)
has recently been characterized##5##4##(1991-12#1)(1992-11#1)(1995-6#1)(2009-10#1)(2011-1#1)
has recently been demonstrated to##2##5##(1991-6#1)(2008-6#1)
has recently been demonstrated##5##4##(1991-11#1)(1991-6#1)(2008-2#1)(2008-6#1)(2012-2#1)
has recently been developed##3##4##(2008-3#2)(2012-2#1)
has recently been found##2##4##(2007-8#1)(2009-4#1)
has recently been identified as a##2##6##(1994-11#1)(1994-12#1)
has recently been identified as the##2##6##(1996-2#1)(2012-1#1)
has recently been identified as##4##5##(1994-11#1)(1994-12#1)(1996-2#1)(2012-1#1)
has recently been identified##5##4##(1990-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(2012-1#1)
has recently been implicated in##3##5##(1994-3#1)(2008-10#1)(2011-2#1)
has recently been proposed##2##4##(2007-12#1)(2013-1#1)
has recently been purified from##3##5##(1991-2#1)(1992-8#1)(1993-3#1)
has recently been questioned##3##4##(1990-8#1)(1992-6#1)(2012-2#1)
has recently been reported##3##4##(1992-8#1)(2009-8#1)(2011-2#1)
has recently been shown that##2##5##(1994-11#1)(2010-11#1)
has recently been shown to be##2##6##(2008-8#1)(2012-2#1)
has recently been shown to stimulate##2##6##(1990-12#1)(2008-3#1)
has recently been shown to##8##5##(1990-12#1)(1993-8#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
has recently been shown##10##4##(1990-12#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-2#1)
has recently been suggested that##2##5##(1990-3#1)(2010-12#1)
has recently been suggested##3##4##(1990-3#1)(2010-12#1)(2013-1#1)
has recently been##78##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-2#2)(1997-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-4#1)(2013-1#3)(2013-7#1)
has recently emerged as a##2##5##(2008-11#1)(2008-3#1)
has recently emerged##4##3##(2008-11#1)(2008-3#1)(2010-3#1)(2012-12#1)
has recently led to##2##4##(1995-5#1)(2007-6#1)
has recently made##2##3##(1992-6#1)(1997-2#1)
has recently published##2##3##(2008-7#1)(2010-8#1)
has recently received##2##3##(2008-11#1)(2010-10#1)
has recently##120##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-4#1)(2013-1#4)(2013-7#1)
has recurred##2##2##(1997-7#1)(2009-3#1)
has reduced the occurrence##2##4##(1996-11#1)(2008-7#1)
has reduced the##8##3##(1990-2#1)(1992-3#1)(1996-11#1)(1997-6#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-2#1)
has reduced##11##2##(1990-2#1)(1992-3#1)(1994-2#1)(1996-11#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
has reinforced##2##2##(1997-8#1)(2008-7#1)
has relatively##5##2##(1991-12#1)(1992-12#1)(1992-6#1)(2008-10#1)(2012-2#1)
has relied upon##2##3##(2008-11#1)(2012-3#1)
has relied##5##2##(1994-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#1)
has remained a matter of##2##5##(2010-12#1)(2013-1#1)
has remained a##4##3##(2010-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
has remained at##2##3##(1996-11#1)(1997-8#1)
has remained constant##2##3##(1992-12#1)(1994-6#1)
has remained elusive##2##3##(2008-10#1)(2008-2#1)
has remained obscure##2##3##(1993-9#1)(2009-10#1)
has remained##30##2##(1991-11#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-11#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#1)
has remarkable##2##2##(2012-12#1)(2013-8#1)
has repeatedly been##3##3##(1993-11#1)(1996-3#1)(2011-2#1)
has replaced##2##2##(1990-12#1)(2010-8#1)
has reported##3##2##(1994-1#1)(1997-6#1)(2010-8#1)
has represented a##2##3##(1992-3#1)(1995-1#1)
has represented##3##2##(1992-3#1)(1995-1#1)(2008-7#1)
has requested that##2##3##(1995-1#1)(1996-11#1)
has required##5##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-6#1)
has resistance to##2##3##(2008-10#2)
has responded to##2##3##(1994-3#1)(2008-8#1)
has responded##3##2##(1994-3#1)(2008-8#1)(2012-3#1)
has restricted##2##2##(1996-11#1)(2008-7#1)
has resulted from##2##3##(2008-7#1)(2009-10#1)
has resulted in a##6##4##(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)
has resulted in increased##2##4##(2006-10#1)(2008-4#1)
has resulted in significant##3##4##(1996-3#1)(1997-4#1)(2009-10#1)
has resulted in the development of##2##6##(2008-11#1)(2011-2#1)
has resulted in the##15##4##(1992-11#1)(1994-11#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
has resulted in##52##3##(1991-12#1)(1991-3#1)(1992-11#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
has resulted##54##2##(1991-12#1)(1991-3#1)(1992-11#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#2)(2009-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
has retained##2##2##(1997-5#1)(2008-5#1)
has returned to##2##3##(2008-12#1)(2009-7#1)
has revealed a##6##3##(1992-6#1)(1994-8#1)(2008-5#1)(2009-3#1)(2009-9#1)(2011-2#1)
has revealed only##2##3##(2008-10#1)(2010-5#1)
has revealed that##9##3##(1993-11#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(2007-6#1)(2008-11#1)(2008-12#1)(2009-3#1)
has revealed the existence of##2##5##(1991-1#1)(1997-3#1)
has revealed the importance of##2##5##(2008-7#1)(2009-3#1)
has revealed the presence of##4##5##(1991-9#1)(1992-8#1)(1997-3#1)(2010-3#1)
has revealed the##12##3##(1991-1#1)(1991-9#1)(1992-8#1)(1997-3#2)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2012-3#1)
has revealed##42##2##(1991-1#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
has reviewed the##2##3##(1995-5#1)(2012-2#1)
has revolutionized the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
has revolutionized##8##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
has risen##6##2##(1995-1#1)(1997-7#1)(2008-12#1)(2008-3#2)(2008-7#1)
has ruled that the##2##4##(1995-12#1)(1995-6#1)
has ruled that##3##3##(1995-12#2)(1995-6#1)
has scarcely been##2##3##(2012-12#1)(2013-1#1)
has seen the##2##3##(1995-12#1)(2008-11#1)
has seen##9##2##(1992-1#1)(1995-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
has serious##4##2##(1991-2#1)(2008-5#1)(2010-7#1)(2013-1#1)
has served as a##2##4##(1997-4#1)(2011-1#1)
has served as##4##3##(1997-4#1)(2008-4#1)(2008-5#1)(2011-1#1)
has set##2##2##(2009-7#1)(2011-2#1)
has several advantages over conventional##3##5##(2008-10#2)(2011-2#1)
has several advantages over##6##4##(1994-9#1)(2008-10#3)(2008-2#1)(2011-2#1)
has several advantages##10##3##(1994-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-10#1)(2011-2#1)
has several characteristics that##3##4##(2008-4#1)(2008-8#1)(2012-3#1)
has several limitations##2##3##(2012-2#1)(2013-1#1)
has several##36##2##(1991-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
has severe##3##2##(1996-5#1)(2008-10#1)(2010-11#1)
has shed##2##2##(2008-11#1)(2012-12#1)
has shifted from##3##3##(1994-3#1)(1995-12#1)(2011-2#1)
has shifted to##4##3##(2007-11#1)(2007-7#1)(2013-1#1)(2013-8#1)
has shifted##9##2##(1994-3#1)(1995-12#2)(2007-11#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
has shown a##10##3##(1991-12#1)(1991-5#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
has shown an##5##3##(1991-5#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
has shown excellent##2##3##(1993-3#1)(2006-10#1)
has shown in his##2##4##(2009-10#1)(2010-7#1)
has shown promise in##3##4##(2006-10#1)(2010-2#1)(2010-4#1)
has shown promising##2##3##(2008-7#1)(2012-3#1)
has shown that a##4##4##(1992-8#1)(1993-11#1)(2008-10#1)(2010-4#1)
has shown that in##2##4##(1997-6#1)(2011-1#1)
has shown that it is##2##5##(2008-11#1)(2008-8#1)
has shown that most##2##4##(1997-4#1)(2012-2#1)
has shown that the##14##4##(1992-2#1)(1995-8#1)(1996-2#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-3#1)
has shown that this##5##4##(1990-10#1)(1991-9#1)(1992-11#1)(1994-11#1)(1995-8#1)
has shown that##76##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-8#3)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
has shown the best##2##4##(2008-10#2)
has shown the##4##3##(2008-10#3)(2011-1#1)
has shown these##2##3##(2008-11#1)(2008-6#1)
has shown to be##2##4##(2009-2#1)(2010-11#1)
has shown to##3##3##(2008-10#1)(2009-2#1)(2010-11#1)
has shown##141##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-11#1)(1994-8#3)(1995-1#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-2#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
has significant impact on the##2##5##(2009-7#1)(2013-1#1)
has significant##21##2##(1992-4#1)(1992-7#1)(1993-9#1)(1994-6#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#2)
has significantly higher##2##3##(2010-6#1)(2011-2#1)
has significantly improved the##2##4##(2008-3#1)(2012-12#1)
has significantly improved##3##3##(2008-3#1)(2012-12#1)(2013-1#1)
has significantly increased##2##3##(2007-6#1)(2008-10#1)
has significantly lower##2##3##(2010-6#1)(2012-2#1)
has significantly##13##2##(2007-6#1)(2008-10#2)(2008-3#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
has similar##4##2##(2008-10#3)(2008-8#1)
has similarities to##2##3##(1990-5#1)(1996-6#1)
has similarities##3##2##(1990-5#1)(1996-2#1)(1996-6#1)
has since been##5##3##(1990-11#1)(1992-2#1)(2008-1#1)(2012-3#1)(2013-8#1)
has since##15##2##(1990-11#1)(1991-2#1)(1992-2#2)(1996-11#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-1#2)(2010-3#1)(2012-3#1)(2013-8#1)
has slowed##3##2##(1994-11#1)(1997-2#1)(2008-12#1)
has so far been##4##4##(1992-2#1)(1993-2#1)(2007-12#1)(2008-1#1)
has so far##5##3##(1992-2#1)(1993-2#1)(2007-12#1)(2008-1#1)(2010-3#1)
has so##6##2##(1992-2#1)(1993-2#1)(2007-12#1)(2008-1#1)(2009-10#1)(2010-3#1)
has solid##2##2##(2008-3#1)(2008-6#1)
has some advantages##2##3##(2008-10#1)(2008-3#1)
has some distinct advantages##2##4##(1992-2#1)(2009-9#1)
has some limitations##3##3##(2012-12#1)(2012-2#2)
has some##19##2##(1992-2#1)(1992-9#1)(1993-3#2)(2007-10#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
has sparked interest##2##3##(1994-11#1)(2009-3#1)
has sparked##4##2##(1993-12#1)(1994-11#1)(1995-1#1)(2009-3#1)
has specific##2##2##(2008-10#1)(2010-4#1)
has specified##2##2##(1995-9#1)(2008-8#1)
has spread##5##2##(1996-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)
has spurred the development of##3##5##(2008-4#1)(2008-6#1)(2012-2#1)
has spurred the##5##3##(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
has spurred##6##2##(1990-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
has started##2##2##(1992-11#1)(2008-5#1)
has stated##2##2##(2008-4#1)(2008-5#1)
has steadily##3##2##(2006-10#1)(2008-1#1)(2012-2#1)
has still##4##2##(2008-11#2)(2010-12#1)(2012-2#1)
has stimulated research##3##3##(1991-12#1)(1994-12#1)(2008-7#1)
has stimulated the development of##2##5##(2008-7#1)(2010-11#1)
has stimulated the##3##3##(2008-7#1)(2010-11#1)(2011-1#1)
has stimulated##8##2##(1991-12#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-11#1)(2011-1#1)
has stressed##2##2##(2008-1#1)(2012-12#1)
has strong implications##2##3##(2010-10#1)(2011-2#1)
has strong influence on##2##4##(2008-10#2)
has strong##11##2##(1991-2#1)(1991-9#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-8#1)(2010-10#2)(2010-4#1)(2011-2#1)
has stronger##4##2##(1997-1#2)(2008-10#1)(2008-2#1)
has structural##2##2##(1990-10#1)(2009-10#1)
has subsequently been##3##3##(1995-8#1)(2010-12#1)(2011-2#1)
has subsequently##6##2##(1995-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
has substantial##6##2##(1994-11#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-10#1)
has succeeded in##2##3##(2008-5#2)
has successfully##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
has suffered from##2##3##(1993-6#1)(1996-3#1)
has suffered##5##2##(1993-6#1)(1996-3#2)(2007-11#1)(2012-3#1)
has sufficient##4##2##(1991-12#1)(2008-3#2)(2010-8#1)
has suggested that the##3##4##(1994-2#1)(2009-7#1)(2011-2#1)
has suggested that##9##3##(1994-2#2)(2008-11#1)(2008-4#1)(2009-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
has suggested the##2##3##(2008-12#1)(2008-6#1)
has suggested##14##2##(1994-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
has summarized the##2##3##(1996-12#1)(2011-1#1)
has superior##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
has supported##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
has survived##3##2##(1990-6#1)(2007-8#1)(2008-10#1)
has taken on##2##3##(1995-2#1)(2008-1#1)
has taken##14##2##(1994-3#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-11#1)(2010-8#2)(2012-12#1)(2013-1#1)
has tended to##3##3##(1995-1#1)(2008-11#1)(2008-12#1)
has that##2##2##(2008-12#1)(2008-2#1)
has the ability to##12##4##(1992-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)
has the ability##14##3##(1992-2#1)(1994-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)(2011-1#1)
has the advantage of a##2##5##(2008-10#1)(2013-1#1)
has the advantage of being##7##5##(1990-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
has the advantage of high##3##5##(2007-12#1)(2008-10#2)
has the advantage of reduced access site complications but is associated with specific technical challenges in comparison with the transfemoral approach##2##21##(2011-2#2)
has the advantage of simplicity##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
has the advantage of##33##4##(1990-6#1)(1991-3#1)(1994-3#1)(1997-3#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#2)(2009-11#1)(2010-3#1)(2011-2#3)(2013-1#1)
has the advantage that it##2##5##(2007-11#1)(2008-3#1)
has the advantage that##5##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)
has the advantage##40##3##(1990-6#1)(1991-3#1)(1994-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-9#3)(2009-11#2)(2010-3#1)(2011-2#3)(2013-1#1)
has the advantages of simple##2##5##(2008-2#1)(2008-3#1)
has the advantages of##17##4##(1990-12#1)(1990-8#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)
has the best##4##3##(1993-1#1)(1997-3#1)(2008-6#1)(2013-8#1)
has the capability to##5##4##(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
has the capacity for##2##4##(2008-10#2)
has the capacity to##3##4##(1997-3#1)(2008-8#1)(2011-2#1)
has the capacity##5##3##(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
has the desired##3##3##(2007-11#1)(2008-2#2)
has the drawback of##2##4##(2007-12#1)(2008-12#1)
has the dual effect of##2##5##(2010-4#1)(2011-2#1)
has the effect of##2##4##(2008-2#1)(2008-3#1)
has the following advantages##2##4##(2008-8#1)(2008-9#1)
has the following##4##3##(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)
has the greatest##3##3##(2008-10#2)(2010-8#1)
has the highest cleavage##2##4##(2008-9#2)
has the highest incidence in Scandinavia##2##6##(1991-11#1)(1992-4#1)
has the highest incidence##3##4##(1991-11#1)(1992-4#1)(1994-9#1)
has the highest sensitivity##2##4##(2008-10#1)(2012-2#1)
has the highest##19##3##(1991-11#1)(1992-10#1)(1992-4#1)(1994-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#4)(2010-8#1)(2012-2#1)(2013-8#1)
has the largest##2##3##(1994-9#1)(2008-8#1)
has the lowest##7##3##(2007-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)
has the most##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
has the possibility of##3##4##(2011-3#1)(2013-1#2)
has the possibility##4##3##(2008-10#1)(2011-3#1)(2013-1#2)
has the potential for##8##4##(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#1)
has the potential of being a##2##6##(2008-10#1)(2008-8#1)
has the potential of##5##4##(2007-12#1)(2008-10#2)(2008-8#1)(2012-2#1)
has the potential to accelerate##2##5##(2008-5#1)(2010-6#1)
has the potential to be a##2##6##(2008-10#1)(2012-2#1)
has the potential to be used for##2##7##(2008-10#1)(2008-2#1)
has the potential to be used##4##6##(1991-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
has the potential to be##12##5##(1991-9#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2012-2#2)
has the potential to become an##2##6##(2011-7#1)(2012-3#1)
has the potential to become##3##5##(2008-10#1)(2011-7#1)(2012-3#1)
has the potential to detect##2##5##(2008-2#1)(2008-7#1)
has the potential to enable##2##5##(2008-11#1)(2008-7#1)
has the potential to enhance##2##5##(2007-10#1)(2011-1#1)
has the potential to function as##2##6##(2007-11#1)(2008-10#1)
has the potential to identify##3##5##(2008-7#1)(2010-9#1)(2013-1#1)
has the potential to improve##2##5##(1994-2#1)(2008-1#1)
has the potential to increase##2##5##(1996-11#1)(2008-3#1)
has the potential to produce##3##5##(1994-11#1)(1996-11#1)(2007-12#1)
has the potential to provide a##2##6##(2011-7#1)(2012-2#1)
has the potential to provide an##2##6##(1996-1#1)(2008-9#1)
has the potential to provide new information##2##7##(2008-2#1)(2012-1#1)
has the potential to provide##8##5##(1996-1#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
has the potential to reduce the##2##6##(2008-3#1)(2010-1#1)
has the potential to reduce##5##5##(2008-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2013-1#1)
has the potential to significantly##2##5##(2008-11#1)(2008-2#1)
has the potential to##89##4##(1991-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#7)(2008-5#2)(2008-7#3)(2008-9#4)(2009-10#1)(2010-1#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-7#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)
has the potential##102##3##(1991-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#3)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#8)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-7#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)
has the power to##2##4##(1997-1#1)(2008-9#1)
has the same spectral characteristics as##2##6##(2008-2#1)(2008-9#1)
has the same structure as##3##5##(2008-2#2)(2009-7#1)
has the same##17##3##(1992-6#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
has the structure##2##3##(1992-12#1)(2008-7#1)
has the unique##4##3##(1995-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
has the##332##2##(1990-11#1)(1990-12#2)(1990-6#3)(1990-7#2)(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#3)(1995-2#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-2#2)(1997-1#1)(1997-3#5)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#53)(2008-11#13)(2008-12#5)(2008-2#29)(2008-3#26)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#22)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#11)(2011-3#1)(2011-7#4)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#4)
has therapeutic##4##2##(2007-5#1)(2008-11#1)(2008-4#1)(2012-2#1)
has therefore been##15##3##(1990-11#1)(1994-3#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-3#1)
has therefore##16##2##(1990-11#1)(1991-12#1)(1994-3#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-3#1)
has this##2##2##(1996-12#1)(2011-2#1)
has three goals##3##3##(1995-12#1)(1996-1#1)(2008-9#1)
has three##17##2##(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#2)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2013-8#1)
has thus been##2##3##(1990-2#1)(2008-2#1)
has thus far##2##3##(2008-9#1)(2010-6#1)
has thus##7##2##(1990-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-6#1)(2012-2#1)
has to be a##2##4##(2008-3#1)(2010-10#1)
has to be applied##2##4##(2010-8#1)(2012-1#1)
has to be considered in##2##5##(2008-11#1)(2008-2#1)
has to be considered##8##4##(1990-6#1)(1992-3#1)(1993-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)
has to be controlled##2##4##(1995-12#1)(2008-10#1)
has to be established##2##4##(1997-8#1)(2008-11#1)
has to be estimated##2##4##(1996-3#1)(2008-11#1)
has to be made##3##4##(1996-3#1)(2009-10#1)(2011-1#1)
has to be overcome##2##4##(1990-6#1)(1997-6#1)
has to be performed##2##4##(2008-12#1)(2012-1#1)
has to be placed##2##4##(2008-11#1)(2008-9#1)
has to be taken into account##3##6##(1994-3#1)(2008-11#1)(2008-5#1)
has to be##85##3##(1990-10#1)(1990-2#1)(1990-6#2)(1990-9#2)(1992-3#1)(1993-11#3)(1994-3#1)(1995-12#1)(1995-5#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#12)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-7#1)(2013-1#3)
has to take##2##3##(1992-6#1)(2008-11#1)
has to##112##2##(1990-10#1)(1990-2#1)(1990-6#2)(1990-9#2)(1991-3#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-9#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-3#2)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#12)(2008-12#3)(2008-2#5)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2010-10#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-7#1)(2013-1#3)(2013-8#1)
has traditionally been a##2##4##(1991-2#1)(1991-3#1)
has traditionally been performed##2##4##(2008-10#1)(2010-8#1)
has traditionally been##15##3##(1991-2#1)(1991-3#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
has traditionally##18##2##(1991-2#1)(1991-3#1)(1994-3#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
has transformed##2##2##(2008-8#1)(2011-7#1)
has turned##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2013-1#1)
has two##33##2##(1991-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)
has uncovered##3##2##(2009-8#1)(2010-5#1)(2012-3#1)
has undergone a##3##3##(1996-3#1)(2008-11#1)(2008-6#1)
has undergone substantial changes##2##4##(1993-3#1)(2007-6#1)
has undergone substantial##3##3##(1993-3#1)(2007-6#1)(2009-9#1)
has undergone##20##2##(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
has undertaken##2##2##(1995-3#1)(2007-10#1)
has undoubtedly##2##2##(2008-12#1)(2008-7#1)
has unique##4##2##(2008-3#1)(2008-9#1)(2009-8#1)(2012-1#1)
has until now been##3##4##(1992-12#1)(2008-2#1)(2012-2#1)
has until now##4##3##(1992-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
has until##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
has used an##2##3##(1997-2#1)(2008-3#1)
has used##11##2##(1993-2#1)(1995-2#1)(1996-1#1)(1997-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
has ushered in a new era##2##6##(1993-6#1)(2008-9#1)
has ushered in##3##3##(1993-6#1)(2008-9#1)(2010-12#1)
has ushered##4##2##(1993-6#1)(2008-3#1)(2008-9#1)(2010-12#1)
has usually been##4##3##(1996-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
has usually##5##2##(1996-11#1)(2007-12#1)(2008-10#2)(2012-3#1)
has utility for##2##3##(2008-10#2)
has utility##3##2##(2008-10#2)(2013-1#1)
has utilized##2##2##(2008-8#1)(2012-12#1)
has validated the##2##3##(2008-10#1)(2008-11#1)
has validated##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
has variable clinical##2##3##(2013-1#1)(2013-8#1)
has variable##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
has various##2##2##(2012-12#1)(2012-2#1)
has very high##2##3##(2008-10#1)(2008-2#1)
has very low##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2012-12#1)
has very##12##2##(1991-9#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
has vital##2##2##(2008-10#1)(2011-2#1)
has weak##2##2##(1995-3#1)(1996-5#1)
has well-documented##2##2##(2008-10#1)(2011-2#1)
has wide##5##2##(2008-12#1)(2008-3#2)(2012-2#1)(2012-3#1)
has widely##2##2##(2009-4#1)(2012-1#1)
has widened##2##2##(2007-7#1)(2008-11#1)
has wider##2##2##(2008-2#1)(2010-4#1)
has widespread##2##2##(2008-3#1)(2011-2#1)
has witnessed##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
has worked with##2##3##(1992-11#1)(2013-1#1)
has worked##5##2##(1992-11#1)(1992-3#1)(1994-1#1)(1996-3#1)(2013-1#1)
has yet been##6##3##(1996-12#1)(2008-1#1)(2008-10#2)(2010-10#1)(2013-8#1)
has yet to be determined##3##5##(1994-8#1)(1995-2#1)(2009-12#1)
has yet to be established##2##5##(2009-5#1)(2012-12#1)
has yet to be fully##3##5##(1994-3#1)(2008-11#1)(2013-1#1)
has yet to be identified##2##5##(1995-2#1)(2011-2#1)
has yet to be proved##2##5##(1990-11#1)(1994-5#1)
has yet to be##25##4##(1990-11#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
has yet to##29##3##(1990-11#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
has yet##36##2##(1990-11#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
has yielded##10##2##(1990-3#1)(1990-8#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-3#1)(2012-2#2)
has##12460##1##(1990-10#7)(1990-11#57)(1990-12#39)(1990-2#40)(1990-3#24)(1990-4#1)(1990-5#52)(1990-6#34)(1990-7#23)(1990-8#43)(1990-9#22)(1991-1#14)(1991-10#2)(1991-11#25)(1991-12#57)(1991-2#53)(1991-3#47)(1991-4#6)(1991-5#35)(1991-6#36)(1991-7#6)(1991-8#11)(1991-9#37)(1992-1#32)(1992-10#15)(1992-11#33)(1992-12#51)(1992-2#39)(1992-3#57)(1992-4#14)(1992-5#20)(1992-6#36)(1992-7#4)(1992-8#52)(1992-9#38)(1993-1#20)(1993-10#1)(1993-11#47)(1993-12#66)(1993-2#40)(1993-3#45)(1993-5#3)(1993-6#35)(1993-8#27)(1993-9#29)(1994-1#20)(1994-10#3)(1994-11#43)(1994-12#85)(1994-2#59)(1994-3#56)(1994-5#52)(1994-6#33)(1994-7#7)(1994-8#45)(1994-9#33)(1995-1#28)(1995-10#2)(1995-11#20)(1995-12#73)(1995-2#73)(1995-3#50)(1995-4#1)(1995-5#42)(1995-6#64)(1995-8#29)(1995-9#10)(1996-1#37)(1996-10#5)(1996-11#27)(1996-12#53)(1996-2#68)(1996-3#68)(1996-4#4)(1996-5#38)(1996-6#27)(1996-7#8)(1996-8#16)(1996-9#14)(1997-1#41)(1997-2#62)(1997-3#60)(1997-4#55)(1997-5#21)(1997-6#47)(1997-7#63)(1997-8#41)(1997-9#4)(2006-10#39)(2006-12#11)(2006-4#8)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#1)(2007-10#39)(2007-11#197)(2007-12#227)(2007-2#26)(2007-3#1)(2007-4#5)(2007-5#9)(2007-6#12)(2007-7#63)(2007-8#86)(2007-9#3)(2008-1#167)(2008-10#2421)(2008-11#509)(2008-12#143)(2008-2#276)(2008-3#577)(2008-4#192)(2008-5#319)(2008-6#139)(2008-7#443)(2008-8#281)(2008-9#272)(2009-1#11)(2009-10#62)(2009-11#46)(2009-12#42)(2009-2#24)(2009-3#33)(2009-4#32)(2009-5#77)(2009-6#37)(2009-7#46)(2009-8#66)(2009-9#35)(2010-1#23)(2010-10#46)(2010-11#45)(2010-12#85)(2010-2#21)(2010-3#83)(2010-4#57)(2010-5#57)(2010-6#48)(2010-7#41)(2010-8#130)(2010-9#19)(2011-1#140)(2011-10#2)(2011-2#437)(2011-3#27)(2011-4#2)(2011-7#15)(2011-9#1)(2012-1#52)(2012-12#164)(2012-2#279)(2012-3#179)(2012-4#2)(2012-5#4)(2012-7#9)(2012-8#3)(2013-1#344)(2013-2#1)(2013-3#1)(2013-7#44)(2013-8#151)
hasbeen##2##1##(2008-11#1)(2008-2#1)
hasn't been##2##2##(1992-5#1)(1996-3#1)
hassles##4##1##(1996-3#1)(2008-12#1)(2009-12#1)(2012-1#1)
hastened the##2##2##(1997-2#1)(2009-8#1)
hastened##4##1##(1995-6#1)(1997-2#1)(2008-10#1)(2009-8#1)
hasty##2##1##(1990-11#1)(2008-10#1)
hat##4##1##(1992-2#1)(1995-2#1)(1996-2#1)(2008-12#1)
hatch after##2##2##(2008-10#1)(2008-5#1)
hatch##12##1##(1991-9#1)(1996-8#1)(1997-6#1)(2008-10#2)(2008-12#3)(2008-5#1)(2008-6#1)(2010-8#2)
hatchability and##2##2##(2008-12#2)
hatched chicks##2##2##(1997-3#1)(2008-6#1)
hatched##17##1##(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-9#1)(2010-8#2)
hatcheries##2##1##(2008-5#1)(2012-1#1)
hatchery was##2##2##(1997-3#1)(2007-5#1)
hatchery##11##1##(1990-3#1)(1997-3#6)(2007-5#2)(2009-6#1)(2010-8#1)
hatches##3##1##(2007-12#1)(2008-12#2)
hatching and##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
hatching competence##2##2##(2010-8#2)
hatching from##2##2##(2008-5#2)
hatching rate of##2##3##(2008-12#1)(2010-8#1)
hatching rate##5##2##(2008-12#1)(2008-5#2)(2010-8#2)
hatching success##2##2##(2008-8#2)
hatching##37##1##(1993-6#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#10)(2008-7#1)(2008-8#5)(2010-8#8)(2013-1#1)
hatchling##3##1##(2008-8#3)
hatchlings##4##1##(2008-8#3)(2009-4#1)
hate##4##1##(1995-1#1)(2008-12#3)
hausmannite##2##1##(2008-10#2)
haustoria##9##1##(2008-10#9)
haustorium##6##1##(2008-10#6)
have 2##2##2##(1991-9#1)(2008-3#1)
have DDD at L1/2 and L5/S1##2##6##(2011-2#2)
have a &quot##2##3##(1995-11#1)(2012-12#1)
have a bad##2##3##(2008-10#1)(2013-1#1)
have a beneficial effect on##3##5##(1991-11#1)(2011-2#1)(2012-3#1)
have a beneficial##5##3##(1991-11#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
have a better prognosis##2##4##(2011-2#1)(2012-3#1)
have a better understanding of the##2##6##(1990-9#1)(2008-10#1)
have a better##10##3##(1990-9#1)(1991-2#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
have a biochemical##2##3##(1997-7#1)(2008-4#1)
have a broad impact on##2##5##(1996-2#1)(2011-2#1)
have a broad range of##2##5##(1996-2#1)(2008-5#1)
have a broad##8##3##(1994-6#1)(1996-2#2)(2008-5#1)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
have a central role##2##4##(1991-5#1)(2010-12#1)
have a clear##2##3##(1997-1#1)(2008-10#1)
have a clinical##2##3##(2007-8#1)(2013-1#1)
have a common##6##3##(1990-7#1)(1991-12#1)(1995-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
have a complex##2##3##(2006-4#1)(2007-12#1)
have a comprehensive##2##3##(1996-8#1)(2012-2#1)
have a defined##3##3##(1996-12#1)(2009-6#1)(2012-2#1)
have a definite##2##3##(2008-10#1)(2013-8#1)
have a detailed##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
have a diameter of##2##4##(2008-10#1)(2008-2#1)
have a different##8##3##(1993-6#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)
have a direct impact on##2##5##(1995-1#1)(2009-10#1)
have a direct##7##3##(1992-11#1)(1995-1#1)(1996-12#1)(1996-8#1)(2008-10#1)(2009-10#1)(2011-2#1)
have a distinct##5##3##(2008-11#2)(2009-12#1)(2011-2#1)(2012-2#1)
have a dominant##2##3##(1996-2#1)(2013-1#1)
have a dramatic##2##3##(2008-3#1)(2008-9#1)
have a fairly##2##3##(1991-6#1)(2011-1#1)
have a fast##2##3##(2008-10#2)
have a favorable##2##3##(1992-11#1)(2013-1#1)
have a favourable effect##2##4##(1990-11#1)(1996-6#1)
have a favourable##3##3##(1990-11#1)(1991-6#1)(1996-6#1)
have a few##2##3##(2010-3#1)(2013-1#1)
have a firm##2##3##(2008-9#1)(2011-2#1)
have a genetic##4##3##(1993-12#1)(1994-11#1)(2008-1#1)(2012-2#1)
have a good##12##3##(1994-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-8#3)
have a great effect on##2##5##(2007-12#1)(2008-10#1)
have a great influence on the##2##6##(1992-6#1)(2010-11#1)
have a great potential##2##4##(2008-11#1)(2011-2#1)
have a great##9##3##(1992-6#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#1)
have a greater influence on##2##5##(2008-3#2)
have a greater##14##3##(1992-5#1)(1992-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2012-2#1)
have a high index of suspicion##3##6##(2008-9#1)(2013-8#2)
have a high risk##2##4##(1992-6#1)(2008-1#1)
have a high##30##3##(1990-3#1)(1992-6#1)(1993-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
have a higher incidence of##3##5##(1992-3#1)(2008-4#1)(2011-1#1)
have a higher incidence##5##4##(1992-3#1)(2007-8#1)(2008-4#1)(2011-1#1)(2011-2#1)
have a higher mortality rate than the##2##7##(1995-3#1)(2008-8#1)
have a higher mortality##3##4##(1995-3#1)(2008-2#1)(2008-8#1)
have a higher prevalence of##3##5##(2011-2#1)(2012-2#2)
have a higher rate of##4##5##(1992-10#1)(1994-2#1)(2007-8#1)(2012-12#1)
have a higher risk of##8##5##(1996-9#1)(2008-12#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2013-1#1)
have a higher##38##3##(1991-6#1)(1992-10#1)(1992-3#1)(1994-11#1)(1994-2#2)(1995-3#1)(1996-9#1)(1997-4#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
have a history of##9##4##(1993-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#2)(2012-12#1)
have a history##10##3##(1993-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#2)(2012-12#1)
have a key role##2##4##(2008-11#1)(2010-11#1)
have a known##2##3##(2008-10#1)(2008-7#1)
have a laminar##2##3##(2008-3#1)(2008-7#1)
have a large impact on##2##5##(1994-12#1)(2008-3#1)
have a large impact##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
have a large##13##3##(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2012-12#1)
have a larger##3##3##(1994-3#1)(2012-12#1)(2012-2#1)
have a left##2##3##(1996-2#1)(2011-2#1)
have a limited role##2##4##(1995-10#1)(2008-10#1)
have a limited##6##3##(1990-7#1)(1992-3#1)(1995-10#1)(2008-10#1)(2008-3#1)(2010-3#1)
have a long history of##2##5##(2008-11#1)(2013-1#1)
have a long##4##3##(1992-12#1)(2008-11#1)(2008-3#1)(2013-1#1)
have a lot of##2##4##(1996-4#1)(2008-11#1)
have a low incidence##2##4##(1997-1#1)(2008-8#1)
have a low##13##3##(1991-11#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
have a lower##5##3##(1991-3#1)(1992-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
have a major impact on##2##5##(2010-4#1)(2013-7#1)
have a major impact##3##4##(2008-7#1)(2010-4#1)(2013-7#1)
have a major role in the##2##6##(1996-12#1)(1997-3#1)
have a major role in##4##5##(1996-12#1)(1997-3#1)(2010-4#1)(2011-3#1)
have a major##9##3##(1996-12#1)(1997-3#1)(1997-8#1)(2008-7#1)(2010-4#2)(2011-3#1)(2013-1#1)(2013-7#1)
have a marked effect on##2##5##(1996-3#1)(2008-5#1)
have a median##2##3##(2008-5#1)(2009-12#1)
have a minor##3##3##(2008-10#2)(2011-1#1)
have a molecular mass##2##4##(1993-6#1)(2011-1#1)
have a moral##2##3##(2008-11#1)(2008-8#1)
have a more specific role##2##5##(2008-6#1)(2008-9#1)
have a more specific##3##4##(1995-6#1)(2008-6#1)(2008-9#1)
have a more##12##3##(1990-2#1)(1994-9#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-5#1)(2013-7#1)
have a much greater##2##4##(1993-8#1)(2012-5#1)
have a much stronger##2##4##(2008-3#1)(2008-8#1)
have a much##8##3##(1992-5#1)(1993-8#1)(1994-6#1)(1997-3#1)(2008-3#1)(2008-8#1)(2012-5#1)(2013-8#1)
have a natural##2##3##(2008-1#1)(2008-7#1)
have a negative effect on##4##5##(1992-5#1)(1993-6#1)(2007-12#1)(2008-10#1)
have a negative influence on##2##5##(2010-8#2)
have a negative##9##3##(1990-11#1)(1992-5#1)(1993-6#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-8#2)
have a normal##2##3##(2009-3#1)(2009-9#1)
have a number of##3##4##(1994-12#1)(2008-6#1)(2012-3#1)
have a particularly##2##3##(1992-2#1)(2012-3#1)
have a peak##2##3##(2008-10#1)(2008-3#1)
have a plan##2##3##(1991-1#1)(1992-1#1)
have a poor prognosis##2##4##(1996-11#1)(2012-12#1)
have a poor##3##3##(1996-1#1)(1996-11#1)(2012-12#1)
have a positive impact on the##3##6##(1995-5#1)(2008-3#1)(2008-4#1)
have a positive impact on##6##5##(1995-5#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
have a positive##15##3##(1992-5#1)(1995-5#1)(1997-1#1)(1997-6#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
have a potential role##2##4##(2011-2#1)(2013-1#1)
have a potential##7##3##(2007-7#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
have a prevalence##2##3##(2008-8#1)(2013-8#1)
have a profound effect on the##2##6##(2008-3#1)(2010-6#1)
have a profound##5##3##(1994-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)
have a prominent##2##3##(1992-6#1)(2007-12#1)
have a protective effect on##3##5##(1992-12#1)(2008-12#1)(2008-7#1)
have a protective effect##6##4##(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-2#1)
have a protective role##2##4##(1997-2#1)(2011-2#1)
have a protective##8##3##(1992-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-2#2)
have a rapid##2##3##(2008-3#1)(2008-6#1)
have a reduced level of##3##5##(2008-5#1)(2010-1#1)(2012-12#1)
have a reduced##6##3##(1996-7#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2012-12#1)
have a relatively##8##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-9#1)
have a relevant##2##3##(1990-8#1)(2008-7#1)
have a residual##3##3##(2008-10#2)(2009-3#1)
have a response##2##3##(2007-12#1)(2008-7#1)
have a right to##3##4##(1994-8#1)(1995-12#1)(2008-12#1)
have a role in mediating##2##5##(1996-2#1)(2009-6#1)
have a role in the##6##5##(1991-9#1)(1992-2#1)(1993-11#1)(1993-9#1)(1996-2#1)(2008-10#1)
have a role in##30##4##(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-2#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-6#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#3)
have a role to play in the##2##7##(2008-4#1)(2008-5#1)
have a role to play in##4##6##(1997-2#1)(2008-4#1)(2008-5#1)(2010-10#1)
have a role to play##5##5##(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)
have a role to##6##4##(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)
have a role##36##3##(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-2#2)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#3)(2009-6#3)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#3)
have a selective##3##3##(1995-6#1)(2008-8#2)
have a significant effect on the##5##6##(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
have a significant effect on##9##5##(1991-8#1)(1992-9#1)(1994-3#1)(1995-12#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
have a significant effect##10##4##(1991-8#1)(1992-9#1)(1994-3#1)(1995-12#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
have a significant impact on the##5##6##(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
have a significant impact on##8##5##(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
have a significant impact##9##4##(1991-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
have a significant influence on the##4##6##(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
have a significant influence on##8##5##(1994-12#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2013-8#1)
have a significant influence##9##4##(1994-12#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
have a significant role in##3##5##(2006-8#1)(2011-1#1)(2013-1#1)
have a significant##43##3##(1991-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1997-2#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#4)(2009-1#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
have a significantly##4##3##(1992-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
have a similar##9##3##(1991-5#1)(1992-6#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)
have a single##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
have a size of##2##4##(2007-11#1)(2008-2#1)
have a slightly##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
have a slower##2##3##(2010-12#1)(2012-12#1)
have a small##8##3##(1991-6#1)(1991-8#1)(1994-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
have a smaller##2##3##(2008-11#1)(2008-9#1)
have a sore throat##2##4##(1995-11#1)(2008-1#1)
have a specific##7##3##(1993-12#1)(1995-3#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-2#1)
have a strong propensity to##2##5##(2008-1#1)(2010-11#1)
have a strong##14##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#3)
have a substantial##2##3##(1994-3#1)(1995-1#1)
have a survival benefit##2##4##(2008-10#1)(2011-3#1)
have a synergistic effect##2##4##(2008-11#2)
have a tendency to##6##4##(1997-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
have a thorough understanding of##4##5##(2008-4#2)(2008-9#1)(2010-8#1)
have a unique##3##3##(1994-11#1)(1994-5#1)(1997-8#1)
have a variety of##8##4##(1991-12#1)(2007-11#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
have a variety##9##3##(1991-12#1)(2007-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
have a varying##2##3##(1993-3#1)(2009-10#1)
have a very##8##3##(1994-11#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2010-12#1)
have a wide range of roles##2##6##(2012-12#1)(2012-3#1)
have a wide##6##3##(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#2)
have a wider##2##3##(2008-3#1)(2012-2#1)
have a worse prognosis##3##4##(2006-10#1)(2008-7#1)(2011-2#1)
have a worse##4##3##(1993-2#1)(2006-10#1)(2008-7#1)(2011-2#1)
have a##888##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#6)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#4)(1992-5#5)(1992-6#7)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#8)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#5)(1994-11#7)(1994-12#7)(1994-2#5)(1994-3#8)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#10)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#6)(1997-2#7)(1997-3#7)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#6)(1997-8#4)(2006-10#1)(2006-4#1)(2006-8#2)(2007-10#6)(2007-11#12)(2007-12#16)(2007-2#1)(2007-7#3)(2007-8#10)(2008-1#15)(2008-10#70)(2008-11#34)(2008-12#15)(2008-2#21)(2008-3#45)(2008-4#15)(2008-5#31)(2008-6#10)(2008-7#36)(2008-8#19)(2008-9#14)(2009-1#1)(2009-10#10)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#10)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#4)(2011-1#10)(2011-2#40)(2011-3#3)(2012-1#1)(2012-12#16)(2012-2#24)(2012-3#21)(2012-5#1)(2013-1#30)(2013-7#4)(2013-8#19)
have abnormal##3##2##(2006-5#1)(2008-9#1)(2011-1#1)
have absorption##2##2##(2008-10#1)(2008-3#1)
have accelerated the##2##3##(2008-10#1)(2008-11#1)
have accelerated##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
have acceptable##3##2##(1994-2#1)(2009-7#1)(2010-7#1)
have accepted##2##2##(1995-6#1)(2008-2#1)
have access to the##5##4##(1994-5#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-8#1)
have access to##17##3##(1991-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-9#1)(2010-8#1)(2012-1#2)
have accounted for##3##3##(1991-12#1)(1991-2#1)(1992-1#1)
have accumulated##6##2##(1992-3#1)(1995-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
have achieved success##2##3##(2008-11#1)(2008-12#1)
have achieved the##2##3##(1995-2#1)(2010-7#1)
have achieved##20##2##(1993-3#1)(1995-2#1)(1996-7#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)
have acquired the##2##3##(2008-10#1)(2010-11#1)
have acquired##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)
have activities##2##2##(1990-8#1)(2008-4#1)
have actually##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
have acute##2##2##(2008-4#1)(2008-7#1)
have adapted##5##2##(1994-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
have added##3##2##(1994-1#1)(1997-1#1)(2008-3#1)
have additional##3##2##(2008-10#2)(2012-3#1)
have addressed the##5##3##(1994-6#1)(1996-2#1)(2008-8#1)(2009-3#1)(2011-2#1)
have addressed##10##2##(1994-6#1)(1995-11#1)(1996-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#2)
have adequate##7##2##(1990-2#1)(1992-2#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-12#1)
have adopted a##2##3##(2008-9#1)(2009-3#1)
have adopted this##2##3##(2008-12#1)(2008-7#1)
have adopted##11##2##(1994-12#1)(1994-3#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)
have advanced to##2##3##(2010-4#1)(2013-8#1)
have advanced##5##2##(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
have advantages##9##2##(1997-3#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-7#1)(2009-1#1)
have adverse effects on##4##4##(1994-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
have adverse effects##6##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
have adverse##9##2##(1992-2#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
have affected the##4##3##(1992-11#1)(1994-5#1)(2007-7#1)(2010-12#1)
have affected##10##2##(1991-3#1)(1992-11#1)(1994-5#1)(2007-7#1)(2008-12#1)(2008-6#1)(2010-12#1)(2012-2#2)(2013-1#1)
have agreed to##3##3##(1990-2#1)(1991-9#1)(2008-7#1)
have agreed##4##2##(1990-2#1)(1991-9#1)(2008-7#1)(2010-4#1)
have aimed##2##2##(2010-11#1)(2013-1#1)
have airway##2##2##(2008-11#1)(2013-8#1)
have alcohol##2##2##(2008-11#1)(2013-8#1)
have all been##10##3##(1990-11#1)(1994-11#1)(1994-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)
have all##17##2##(1990-11#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-3#2)(1997-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
have allowed the##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
have allowed us to##2##4##(2008-4#1)(2008-9#1)
have allowed##16##2##(1991-3#1)(1994-6#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#2)(2012-12#1)
have already been cloned##2##4##(1996-2#1)(2011-1#1)
have already been demonstrated##2##4##(2008-3#1)(2008-7#1)
have already been reported##2##4##(1993-8#1)(1994-11#1)
have already been##19##3##(1990-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-2#2)(1997-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
have already demonstrated##2##3##(2007-7#1)(2008-9#1)
have already established##2##3##(1996-2#1)(2013-7#1)
have already reported##3##3##(1997-4#1)(2008-11#1)(2008-5#1)
have already##39##2##(1990-12#1)(1990-9#1)(1991-11#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#3)(1997-4#2)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-7#1)
have also become##2##3##(1995-6#1)(2008-1#1)
have also been applied##2##4##(2008-10#2)
have also been carried out##2##5##(2008-5#1)(2011-1#1)
have also been compared##2##4##(2008-10#2)
have also been demonstrated##3##4##(1994-5#1)(2007-11#1)(2008-6#1)
have also been described##5##4##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#2)
have also been determined##2##4##(2008-10#2)
have also been developed##2##4##(2008-10#1)(2010-8#1)
have also been discussed##2##4##(2008-10#1)(2008-7#1)
have also been evaluated##2##4##(1995-3#1)(2008-10#1)
have also been examined##2##4##(1993-11#1)(1995-5#1)
have also been found in##3##5##(2008-11#1)(2008-4#1)(2008-6#1)
have also been found##5##4##(1996-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
have also been identified##5##4##(1991-1#1)(1997-3#1)(2007-11#1)(2008-7#1)(2012-1#1)
have also been implicated in##2##5##(2011-2#1)(2013-8#1)
have also been investigated##5##4##(2007-5#1)(2008-10#2)(2008-3#1)(2010-1#1)
have also been observed in##2##5##(1994-3#1)(2008-11#1)
have also been observed##5##4##(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
have also been obtained##3##4##(1992-8#1)(2008-2#2)
have also been proposed##2##4##(1995-12#1)(2008-7#1)
have also been reported to be##2##6##(1991-1#1)(2007-10#1)
have also been reported to##3##5##(1991-1#1)(2007-10#1)(2008-5#1)
have also been reported##9##4##(1991-1#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-6#1)(2011-1#1)
have also been shown to##7##5##(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-12#1)
have also been studied extensively##2##5##(2010-5#1)(2012-2#1)
have also been studied##7##4##(2008-10#3)(2008-3#1)(2008-6#1)(2010-5#1)(2012-2#1)
have also been used as##3##5##(2008-10#2)(2009-8#1)
have also been used to##3##5##(2008-2#1)(2008-6#1)(2009-10#1)
have also been used##9##4##(2008-10#3)(2008-2#1)(2008-6#2)(2009-10#1)(2009-5#1)(2009-8#1)
have also been##120##3##(1991-1#2)(1991-3#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#25)(2008-11#10)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#7)(2008-9#2)(2009-10#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
have also demonstrated a##2##4##(2008-2#1)(2012-12#1)
have also demonstrated that##5##4##(1994-12#1)(1996-12#1)(2008-10#2)(2008-4#1)
have also demonstrated the##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
have also demonstrated##10##3##(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
have also evolved##2##3##(2008-8#1)(2010-6#1)
have also found##4##3##(1994-6#1)(2008-10#1)(2008-9#1)(2013-8#1)
have also identified##2##3##(1995-2#1)(2008-2#1)
have also observed##3##3##(2008-10#1)(2008-3#1)(2009-1#1)
have also played an important role in##2##7##(2008-1#1)(2012-2#1)
have also shown that the##5##5##(1993-12#1)(1994-11#1)(2008-3#1)(2008-4#1)(2009-11#1)
have also shown that##7##4##(1993-12#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-11#1)
have also shown##10##3##(1993-11#1)(1993-12#1)(1994-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-11#1)(2012-3#1)
have also##205##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#35)(2008-11#12)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#7)(2008-7#9)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
have altered##8##2##(1997-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-8#1)
have always been##4##3##(2007-5#2)(2008-10#1)(2010-12#1)
have always##10##2##(1993-12#1)(1996-3#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-12#1)
have amplified##4##2##(1990-3#1)(1992-8#1)(1995-11#1)(1995-3#1)
have an N-terminal##2##3##(1993-12#1)(1997-4#1)
have an abnormal##2##3##(2008-12#1)(2012-12#1)
have an abundance of##2##4##(1992-7#1)(2008-5#1)
have an active role in##2##5##(2010-11#1)(2013-1#1)
have an additional benefit##2##4##(2008-5#1)(2012-3#1)
have an additional##3##3##(2008-5#1)(2010-3#1)(2012-3#1)
have an advantage##2##3##(2008-11#1)(2008-8#1)
have an adverse effect on the##2##6##(2008-10#1)(2012-2#1)
have an adverse effect on##4##5##(1997-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
have an adverse effect##5##4##(1995-3#1)(1997-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
have an aggressive##2##3##(2008-9#1)(2013-7#1)
have an atypical##2##3##(2008-7#1)(2010-10#1)
have an average##2##3##(1995-5#1)(2012-2#1)
have an effect on the results##2##6##(1996-2#1)(2008-12#1)
have an effect on the underlying##2##6##(1990-2#1)(1997-4#1)
have an effect on the##7##5##(1990-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-12#1)(2008-2#1)(2012-2#1)
have an effect on##14##4##(1990-2#1)(1992-3#1)(1996-11#1)(1996-2#1)(1997-4#2)(2008-11#1)(2008-12#1)(2008-2#2)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
have an effect##16##3##(1990-2#1)(1992-3#1)(1996-11#1)(1996-2#1)(1997-4#2)(1997-6#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
have an enhanced##3##3##(1994-8#1)(2010-8#1)(2013-1#1)
have an enormous##2##3##(2008-1#1)(2012-12#1)
have an established##2##3##(2008-5#1)(2011-2#1)
have an excellent##2##3##(1990-12#1)(2011-2#1)
have an impact on the##8##5##(1992-3#1)(2007-10#1)(2008-11#2)(2008-2#1)(2009-7#1)(2012-2#2)
have an impact on##18##4##(1991-7#1)(1992-3#1)(1994-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#4)
have an important impact on##3##5##(2008-1#1)(2008-3#1)(2008-7#1)
have an important influence on the##2##6##(1996-4#1)(2008-10#1)
have an important role in the##4##6##(1993-2#1)(1993-9#1)(2008-11#1)(2008-7#1)
have an important role in##12##5##(1993-2#1)(1993-9#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2012-3#1)
have an important role to play in the##3##8##(1992-3#1)(2008-11#1)(2012-12#1)
have an important role##17##4##(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2012-12#1)(2012-3#2)
have an important##30##3##(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2010-11#1)(2012-12#1)(2012-3#2)
have an increased incidence of##3##5##(2008-4#1)(2012-2#1)(2013-1#1)
have an increased risk for developing##2##6##(2009-3#1)(2012-3#1)
have an increased risk for##3##5##(2009-3#1)(2012-2#1)(2012-3#1)
have an increased risk of##6##5##(1990-12#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
have an increased risk##10##4##(1990-12#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
have an increased##19##3##(1990-12#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
have an increasing##2##3##(2008-11#1)(2009-12#1)
have an influence on##5##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)
have an inhibitory effect on the##2##6##(1992-2#1)(2008-10#1)
have an inhibitory effect on##3##5##(1992-2#1)(1994-8#1)(2008-10#1)
have an interfering effect##2##4##(2008-10#2)
have an unusual##2##3##(1995-6#1)(2008-7#1)
have an upper##2##3##(1991-5#1)(2010-8#1)
have an##222##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#3)(1994-5#1)(1994-8#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#5)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#14)(2008-11#16)(2008-12#7)(2008-2#8)(2008-3#5)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#11)(2012-3#9)(2013-1#8)(2013-7#1)
have analysed the##7##3##(1994-12#1)(1995-11#1)(1996-3#1)(1997-7#1)(2008-7#1)(2009-12#1)(2012-1#1)
have analysed##9##2##(1994-12#1)(1995-11#1)(1996-3#1)(1997-7#2)(2008-7#1)(2008-9#1)(2009-12#1)(2012-1#1)
have analyzed the effects of##4##5##(1990-5#1)(2008-11#1)(2008-3#1)(2008-8#1)
have analyzed the##20##3##(1990-5#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1994-11#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-5#1)
have analyzed##30##2##(1990-5#2)(1991-2#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#1)
have and##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
have angina##2##2##(1995-11#1)(2007-8#1)
have antioxidant and##2##3##(2008-5#1)(2012-2#1)
have anxiolytic effects##2##3##(1993-12#1)(2012-2#1)
have any adverse##2##3##(2008-11#2)
have any effect on the##3##5##(1994-5#1)(1994-6#1)(2008-10#1)
have any effect on##6##4##(1992-9#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
have any##32##2##(1990-12#1)(1991-9#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-6#1)(2008-7#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
have apparent##2##2##(1992-6#1)(2008-4#1)
have apparently##2##2##(1993-12#1)(1997-3#1)
have appeared in##2##3##(1994-9#1)(2009-6#1)
have appeared##4##2##(1992-6#1)(1994-9#1)(2008-2#1)(2009-6#1)
have application to##2##3##(2008-10#1)(2008-3#1)
have application##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)
have applications in the##2##4##(2007-12#1)(2013-7#1)
have applications in##7##3##(2007-12#1)(2008-3#2)(2008-9#1)(2011-7#1)(2012-2#1)(2013-7#1)
have applications##8##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-9#1)(2011-7#1)(2012-2#1)(2013-7#1)
have applied the##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2009-3#1)
have applied##15##2##(1990-12#1)(1990-9#1)(1993-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-3#1)(2010-11#1)(2011-2#1)
have approved##2##2##(1990-6#1)(1996-11#1)
have approximately 50%##2##3##(1992-6#1)(1995-2#1)
have approximately##6##2##(1990-11#1)(1992-6#1)(1994-6#1)(1995-2#1)(2008-12#1)(2009-3#1)
have argued that##3##3##(1995-5#2)(2008-11#1)
have argued##4##2##(1995-2#1)(1995-5#2)(2008-11#1)
have arisen from##5##3##(1995-3#1)(2008-10#2)(2010-11#1)(2010-3#1)
have arisen independently##3##3##(1997-7#1)(2008-10#2)
have arisen##14##2##(1994-11#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)
have as##3##2##(2007-12#2)(2008-2#1)
have assayed the##2##3##(1991-12#1)(2008-11#1)
have assayed##3##2##(1990-5#1)(1991-12#1)(2008-11#1)
have assessed the##7##3##(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
have assessed##9##2##(1993-2#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
have associated##2##2##(2008-10#1)(2012-2#1)
have assumed an##2##3##(2008-10#1)(2012-3#1)
have assumed##5##2##(1994-3#1)(1994-9#1)(1997-7#1)(2008-10#1)(2012-3#1)
have asthma##2##2##(2012-12#2)
have at least one##5##4##(1993-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
have at least##13##3##(1992-12#1)(1993-2#1)(1994-12#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-3#2)
have at##15##2##(1990-10#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-3#2)
have attained##2##2##(1992-12#1)(2011-1#1)
have attempted to identify##2##4##(2012-12#1)(2012-3#1)
have attempted to##13##3##(1990-5#1)(1991-12#1)(1991-3#1)(1994-6#1)(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-12#3)(2012-3#1)
have attempted##16##2##(1990-5#1)(1991-12#1)(1991-3#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#3)(2012-3#1)
have attended##2##2##(2013-1#2)
have attracted a great deal of attention##2##7##(2010-9#1)(2012-3#1)
have attracted attention##2##3##(2008-3#1)(2008-8#1)
have attracted##4##2##(2008-3#1)(2008-8#1)(2010-9#1)(2012-3#1)
have attractive##2##2##(2008-10#1)(2012-2#1)
have average##3##2##(1992-12#1)(1996-7#1)(2009-3#1)
have bearing on##2##3##(2011-2#1)(2012-2#1)
have become a major##2##4##(2008-11#1)(2010-7#1)
have become a useful##2##4##(2008-7#1)(2012-2#1)
have become a##14##3##(1994-2#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
have become an important##2##4##(2008-7#1)(2010-4#1)
have become an##3##3##(2008-11#1)(2008-7#1)(2010-4#1)
have become available to##2##4##(2008-11#1)(2010-7#1)
have become available##7##3##(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
have become established in##2##4##(1997-6#1)(2011-2#1)
have become established##4##3##(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
have become increasingly common##2##4##(2007-8#1)(2008-7#1)
have become increasingly important in the##2##6##(2008-4#1)(2010-9#1)
have become increasingly important##3##4##(2008-10#1)(2008-4#1)(2010-9#1)
have become increasingly##13##3##(1992-3#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-2#1)
have become more and more##3##5##(2007-8#1)(2009-12#1)(2011-2#1)
have become more##9##3##(1991-12#1)(1992-12#1)(1996-2#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
have become of##2##3##(2008-11#1)(2011-2#1)
have become popular##2##3##(1993-1#1)(2012-2#1)
have become prime##2##3##(2007-12#1)(2012-12#1)
have become serious##2##3##(1993-3#1)(2008-7#1)
have become the##10##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#2)
have become widely used in##2##5##(1996-1#1)(1997-4#1)
have become widely##3##3##(1996-1#1)(1997-4#1)(2011-2#1)
have become##111##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#2)(2007-12#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
have been a major##3##4##(1990-6#1)(1996-6#1)(2007-11#1)
have been a number of##5##5##(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
have been a##22##3##(1990-6#1)(1992-6#1)(1993-9#1)(1994-3#2)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
have been able to control##2##5##(2008-5#1)(2012-12#1)
have been able to##17##4##(1991-12#1)(1994-9#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
have been accomplished##3##3##(1992-2#1)(2006-10#1)(2009-7#1)
have been achieved by use of##2##6##(2007-12#2)
have been achieved by##3##4##(2007-12#2)(2011-2#1)
have been achieved for##2##4##(2007-12#1)(2008-3#1)
have been achieved in the##3##5##(2008-5#1)(2010-3#1)(2011-2#1)
have been achieved in##4##4##(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
have been achieved through##2##4##(1994-12#1)(2008-11#1)
have been achieved with##2##4##(2007-12#1)(2008-10#1)
have been achieved##29##3##(1993-1#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-3#1)(2007-12#5)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#1)
have been acquired at##2##4##(2008-5#1)(2011-1#1)
have been acquired##8##3##(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2011-1#1)
have been adapted to##3##4##(2008-11#1)(2008-2#1)(2010-7#1)
have been adapted##4##3##(1995-12#1)(2008-11#1)(2008-2#1)(2010-7#1)
have been added to the##2##5##(1993-12#1)(2008-3#1)
have been added to##6##4##(1993-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2013-7#1)
have been addressed##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
have been administered##2##3##(1996-1#1)(2011-3#1)
have been adopted##2##3##(2011-3#1)(2012-1#1)
have been also studied##2##4##(2008-10#1)(2010-7#1)
have been also##8##3##(1990-12#1)(2007-11#1)(2008-10#5)(2010-7#1)
have been an active area of research for##2##8##(2008-3#1)(2010-2#1)
have been an##6##3##(1990-3#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
have been analysed by##3##4##(1990-8#1)(2008-10#2)
have been analysed for##2##4##(2008-10#2)
have been analysed using##2##4##(2008-10#1)(2008-7#1)
have been analysed##14##3##(1990-6#1)(1990-8#1)(2008-10#8)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
have been analyzed by##3##4##(1992-2#1)(1992-9#1)(2008-10#1)
have been analyzed for the##2##5##(2008-10#1)(2012-3#1)
have been analyzed in##6##4##(1991-5#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(2011-1#1)
have been analyzed##26##3##(1990-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
have been applied for##3##4##(2008-10#2)(2008-2#1)
have been applied in the##3##5##(2008-10#3)
have been applied in##7##4##(2008-10#5)(2008-8#1)(2010-12#1)
have been applied to monitor##2##5##(2008-7#1)(2008-8#1)
have been applied to the##10##5##(1992-3#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-1#2)
have been applied to##30##4##(1992-3#2)(1996-5#1)(2007-11#1)(2007-5#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#1)
have been applied##47##3##(1992-3#2)(1996-3#1)(1996-5#1)(2007-11#1)(2007-5#1)(2008-10#22)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)
have been appreciated for##2##4##(2008-8#1)(2008-9#1)
have been appropriately##2##3##(2008-4#1)(2010-12#1)
have been approved by the##2##5##(2011-2#2)
have been approved by##3##4##(2008-1#1)(2011-2#2)
have been approved##8##3##(2007-11#1)(2008-1#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-2#2)
have been assayed##3##3##(1991-5#1)(2008-10#2)
have been assembled##3##3##(1993-6#1)(2008-10#1)(2010-4#1)
have been assessed in##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
have been assessed##12##3##(2007-11#1)(2007-6#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-9#1)(2012-2#1)
have been assigned to the##3##5##(1996-6#1)(2007-12#1)(2008-7#1)
have been assigned to##6##4##(1990-7#1)(1996-6#1)(2007-12#1)(2008-5#2)(2008-7#1)
have been assigned##8##3##(1990-7#1)(1993-8#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)
have been associated with a##2##5##(1992-9#1)(2011-2#1)
have been associated with altered##2##5##(2008-2#1)(2009-9#1)
have been associated with##24##4##(1991-8#1)(1992-9#1)(1994-7#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
have been associated##26##3##(1991-8#1)(1992-9#1)(1994-7#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
have been assumed##2##3##(2008-10#2)
have been at##2##3##(1993-5#1)(2008-11#1)
have been attempted##2##3##(2007-8#1)(2010-7#1)
have been attracting##2##3##(2009-8#1)(2010-7#1)
have been attributed to##10##4##(1991-3#1)(1995-3#1)(1996-5#2)(2008-10#2)(2008-5#1)(2009-3#1)(2012-12#1)(2012-2#1)
have been available for##4##4##(1994-2#1)(1995-11#1)(2008-5#1)(2008-9#1)
have been available##6##3##(1991-12#1)(1994-2#1)(1995-11#1)(2008-5#1)(2008-9#1)(2010-12#1)
have been based on##2##4##(2007-10#1)(2008-8#1)
have been based##3##3##(2007-10#1)(2008-4#1)(2008-8#1)
have been born##3##3##(1991-6#1)(1993-12#1)(2009-4#1)
have been both##2##3##(2008-11#1)(2008-9#1)
have been built and##2##4##(2008-8#1)(2009-8#1)
have been built##5##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
have been calculated and##2##4##(2008-10#1)(2008-3#1)
have been calculated by##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
have been calculated from the##2##5##(2008-10#2)
have been calculated##16##3##(1992-9#1)(1997-4#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#2)
have been called##2##3##(2011-2#1)(2013-1#1)
have been carefully##3##3##(1990-5#1)(1997-3#1)(2008-10#1)
have been carried out at##3##5##(1997-6#1)(2008-10#1)(2008-3#1)
have been carried out by##2##5##(2008-10#1)(2013-1#1)
have been carried out for##2##5##(1997-7#1)(2010-12#1)
have been carried out in the##2##6##(2008-10#1)(2011-2#1)
have been carried out in##6##5##(1992-8#1)(1994-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
have been carried out on the##5##6##(1993-9#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)
have been carried out on##8##5##(1993-9#1)(2007-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
have been carried out to##4##5##(1993-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
have been carried out under##2##5##(2008-10#1)(2008-7#1)
have been carried out using##2##5##(2008-10#1)(2010-7#1)
have been carried out with##3##5##(2008-10#1)(2008-3#1)(2013-7#1)
have been carried out##44##4##(1990-3#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-6#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
have been carried##46##3##(1990-3#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-6#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
have been categorized##2##3##(2008-10#1)(2013-1#1)
have been caused by##5##4##(1993-1#1)(1994-3#1)(2007-6#1)(2007-9#1)(2008-8#1)
have been characterised##3##3##(1996-2#1)(2008-10#2)
have been characterized by##8##4##(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
have been characterized for##3##4##(2008-10#1)(2009-8#1)(2010-4#1)
have been characterized in##3##4##(1993-2#1)(2008-10#1)(2012-2#1)
have been characterized with##2##4##(2008-10#2)
have been characterized##31##3##(1992-3#3)(1993-2#1)(1995-5#1)(1996-2#1)(2007-11#2)(2008-10#8)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#3)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
have been chemically##2##3##(1995-2#1)(1995-5#1)
have been chosen as##2##4##(1991-5#1)(2008-10#1)
have been chosen##5##3##(1991-5#1)(2008-10#2)(2008-3#1)(2010-8#1)
have been cited##2##3##(2008-8#1)(2013-1#1)
have been classically##2##3##(2008-7#1)(2008-8#1)
have been classified##2##3##(2012-3#2)
have been clearly##4##3##(1990-11#1)(2008-10#1)(2009-6#1)(2011-2#1)
have been cloned and sequenced##3##5##(1990-5#1)(1993-12#1)(2008-8#1)
have been cloned and##5##4##(1990-5#1)(1993-12#2)(2008-7#1)(2008-8#1)
have been cloned from##2##4##(1996-2#1)(2008-8#1)
have been cloned##14##3##(1990-5#1)(1993-12#3)(1994-6#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)
have been collected and##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
have been collected during##2##4##(1994-8#1)(2008-12#1)
have been collected##11##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
have been combined##2##3##(2010-12#1)(2012-12#1)
have been commonly##2##3##(2007-5#1)(2012-12#1)
have been compared at the same##2##6##(2008-3#2)
have been compared for##4##4##(1995-11#1)(2008-10#3)
have been compared in##2##4##(1991-12#1)(2008-11#1)
have been compared to##7##4##(1991-5#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#1)
have been compared with those##2##5##(1994-9#1)(2008-10#1)
have been compared with##6##4##(1994-9#1)(2008-10#4)(2008-3#1)
have been compared##26##3##(1990-7#1)(1991-12#1)(1991-5#1)(1994-9#1)(1995-11#1)(1997-5#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#3)
have been complemented by##2##4##(1997-4#1)(2010-12#1)
have been completed in##2##4##(2007-5#1)(2008-10#1)
have been completed on##2##4##(2007-9#1)(2013-7#1)
have been completed##5##3##(1997-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2013-7#1)
have been completely sequenced##2##4##(2009-5#1)(2012-3#1)
have been completely##5##3##(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#2)
have been complicated by the##2##5##(1995-2#1)(1995-5#1)
have been concentrated##2##3##(2008-5#1)(2011-2#1)
have been conclusively##2##3##(2008-1#1)(2008-9#1)
have been conducted by the##2##5##(2008-10#1)(2011-2#1)
have been conducted in##8##4##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#3)
have been conducted on the##3##5##(2008-2#1)(2011-2#1)(2012-12#1)
have been conducted on##4##4##(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
have been conducted over the last##2##6##(1992-10#1)(2008-8#1)
have been conducted to##4##4##(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
have been conducted with the##2##5##(2008-3#1)(2011-1#1)
have been conducted with##3##4##(2008-3#1)(2008-9#1)(2011-1#1)
have been conducted##31##3##(1992-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#5)
have been confirmed by##2##4##(2007-11#1)(2009-12#1)
have been confirmed##4##3##(2007-11#1)(2008-10#2)(2009-12#1)
have been conflicting##2##3##(2009-12#1)(2010-12#1)
have been conserved##2##3##(1997-9#1)(2008-4#1)
have been considered a##2##4##(2011-2#1)(2013-1#1)
have been considered as##4##4##(1992-12#1)(2008-11#1)(2009-6#1)(2010-5#1)
have been considered to be##3##5##(1996-8#1)(2007-10#1)(2010-8#1)
have been considered to##5##4##(1996-8#1)(2007-10#1)(2010-6#1)(2010-8#2)
have been considered##21##3##(1992-12#1)(1992-6#1)(1993-3#1)(1995-2#1)(1996-8#1)(1997-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2013-1#1)
have been constructed for##2##4##(1997-6#1)(2011-2#1)
have been constructed to##3##4##(2008-11#1)(2008-12#1)(2008-8#1)
have been constructed##13##3##(1990-11#1)(1993-12#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
have been controlled##2##3##(2007-10#1)(2013-1#1)
have been correlated with the##2##5##(1997-6#1)(2012-2#1)
have been correlated with##7##4##(1991-6#1)(1997-5#1)(1997-6#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
have been correlated##8##3##(1991-6#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
have been created that##2##4##(2008-11#1)(2010-6#1)
have been created##12##3##(1993-11#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-6#2)(2012-12#1)(2012-2#1)(2013-1#1)
have been criticized by##2##4##(1996-1#1)(2008-3#1)
have been criticized##5##3##(1991-1#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-3#1)
have been debated##2##3##(1996-3#1)(2008-8#1)
have been declining##2##3##(2008-9#1)(2010-3#1)
have been dedicated to##2##4##(2008-3#1)(2013-1#1)
have been deduced by non-linear regression analysis##2##7##(2008-10#2)
have been deduced##4##3##(2008-10#3)(2008-5#1)
have been defined in##2##4##(2012-2#1)(2012-3#1)
have been defined##8##3##(1991-11#1)(2007-12#1)(2008-3#1)(2010-8#2)(2012-2#2)(2012-3#1)
have been demonstrated by##3##4##(1991-3#1)(1994-5#1)(2008-3#1)
have been demonstrated in both##2##5##(1993-11#1)(2007-8#1)
have been demonstrated in##5##4##(1990-6#1)(1991-12#1)(1992-5#1)(1993-11#1)(2007-8#1)
have been demonstrated on a##2##5##(2007-8#1)(2008-3#1)
have been demonstrated to be##6##5##(1995-6#1)(2008-10#2)(2008-8#1)(2010-5#1)(2010-8#1)
have been demonstrated to have##2##5##(2007-8#1)(2009-3#1)
have been demonstrated to##10##4##(1994-5#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-8#1)
have been demonstrated##37##3##(1990-6#1)(1991-12#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-5#2)(1995-6#1)(1997-4#1)(2007-11#1)(2007-8#4)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
have been deposited onto##2##4##(2008-10#1)(2008-3#1)
have been deposited##3##3##(2008-10#1)(2008-3#2)
have been derived from a##2##5##(1993-2#1)(2008-7#1)
have been derived from the##2##5##(1997-2#1)(1997-4#1)
have been derived from##8##4##(1992-12#1)(1993-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-7#1)(2010-8#1)
have been derived##15##3##(1992-12#1)(1993-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-3#1)
have been described [Appl##2##4##(2008-3#2)
have been described and##6##4##(2008-10#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
have been described as##5##4##(1990-11#1)(1990-5#1)(1992-6#1)(2008-4#1)(2013-8#1)
have been described by##3##4##(1996-1#1)(2007-12#1)(2008-10#1)
have been described for the assay of##2##7##(2008-10#2)
have been described for the##8##5##(1990-2#1)(1994-12#1)(1994-9#1)(2008-10#5)
have been described for this##2##5##(2007-8#1)(2013-1#1)
have been described for##17##4##(1990-2#1)(1994-12#1)(1994-9#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#2)(2013-1#2)
have been described in other##2##5##(2008-7#1)(2013-7#1)
have been described in patients with##2##6##(1994-5#1)(2008-1#1)
have been described in patients##3##5##(1994-5#1)(1997-5#1)(2008-1#1)
have been described in plants##2##5##(2009-5#1)(2009-6#1)
have been described in the literature##2##6##(2007-5#1)(2013-1#1)
have been described in the##3##5##(2006-10#1)(2007-5#1)(2013-1#1)
have been described in##20##4##(1990-8#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
have been described so far in the##2##7##(2008-5#1)(2013-1#1)
have been described to##4##4##(1990-8#1)(1993-6#1)(2008-11#1)(2010-8#1)
have been described with##2##4##(1992-5#1)(1997-3#1)
have been described##109##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#3)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#2)
have been designed and##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
have been designed to##3##4##(2008-9#1)(2010-1#1)(2012-2#1)
have been designed##13##3##(1992-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-7#1)
have been detected in many##2##5##(2008-10#1)(2013-1#1)
have been detected in##8##4##(1990-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
have been detected##21##3##(1990-12#1)(1995-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
have been determined and##3##4##(2007-11#1)(2008-10#1)(2009-9#1)
have been determined as##2##4##(1991-11#1)(2008-5#1)
have been determined at 25 degrees C##4##7##(2008-10#4)
have been determined at##9##4##(1995-3#1)(2008-10#6)(2008-3#2)
have been determined by X-ray crystallography##2##6##(1992-8#1)(2008-10#1)
have been determined by means of##2##6##(2008-10#1)(2008-3#1)
have been determined by##20##4##(1991-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2013-1#1)
have been determined for the##2##5##(1990-5#1)(2008-3#1)
have been determined for##3##4##(1990-5#1)(2008-10#1)(2008-3#1)
have been determined in##5##4##(1992-6#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-3#1)
have been determined simultaneously##2##4##(2008-10#2)
have been determined using##5##4##(1990-8#1)(1995-3#1)(2008-10#3)
have been determined with the##2##5##(2008-10#2)
have been determined with##3##4##(2008-10#3)
have been determined##77##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#1)(1994-9#1)(1995-3#3)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#36)(2008-2#3)(2008-3#8)(2008-5#3)(2008-7#1)(2008-8#2)(2009-7#1)(2009-9#1)(2013-1#1)
have been developed and are##2##5##(2008-10#1)(2010-12#1)
have been developed and validated for the##2##7##(2008-10#1)(2011-1#1)
have been developed and##14##4##(1991-2#1)(1994-3#1)(1996-1#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2013-1#1)
have been developed based##2##4##(1992-3#1)(2008-4#1)
have been developed because of difficulty##2##6##(1992-3#1)(2008-10#1)
have been developed for a##2##5##(1996-5#1)(2008-9#1)
have been developed for detection and##2##6##(2008-10#2)
have been developed for quantitative##2##5##(2008-10#1)(2010-5#1)
have been developed for the determination of##4##7##(1996-5#1)(2008-10#3)
have been developed for the##15##5##(1996-12#1)(1996-5#1)(2008-10#8)(2008-11#2)(2010-5#1)(2010-6#2)
have been developed for use in##2##6##(2008-9#1)(2011-1#1)
have been developed for##41##4##(1990-6#1)(1995-11#1)(1996-12#1)(1996-5#2)(2007-12#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
have been developed from##3##4##(2008-4#1)(2008-7#1)(2010-10#1)
have been developed in##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
have been developed over the##2##5##(2008-4#1)(2012-2#1)
have been developed over##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
have been developed that##7##4##(1994-12#1)(1996-4#1)(1997-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
have been developed to allow##2##5##(1992-3#1)(2008-10#1)
have been developed to improve the##2##6##(2008-11#1)(2013-1#1)
have been developed to overcome this##2##6##(1994-6#1)(2008-1#1)
have been developed to reduce##2##5##(2008-11#1)(2011-2#1)
have been developed to##43##4##(1990-7#1)(1991-12#1)(1992-3#1)(1994-12#1)(1994-6#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#2)
have been developed using##2##4##(2008-10#2)
have been developed which##3##4##(1995-2#1)(2009-10#1)(2009-12#1)
have been developed with##3##4##(2009-7#1)(2010-11#1)(2011-2#1)
have been developed##185##3##(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#3)(1993-2#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#3)(2009-12#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#3)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
have been developing##2##3##(2008-10#1)(2010-5#1)
have been devised to##3##4##(1991-5#1)(2008-11#1)(2012-3#1)
have been devised##4##3##(1991-5#1)(1992-11#1)(2008-11#1)(2012-3#1)
have been diagnosed with##3##4##(2006-8#1)(2008-7#1)(2009-10#1)
have been different##2##3##(2008-10#1)(2010-1#1)
have been differentiated##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
have been difficult to##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
have been directed towards##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
have been directed##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2011-2#1)
have been disappointing##2##3##(2008-2#1)(2010-8#1)
have been discovered in##5##4##(1990-11#2)(2008-1#1)(2008-7#1)(2012-1#1)
have been discovered##9##3##(1990-11#2)(1994-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
have been discussed in the##2##5##(2008-10#1)(2011-2#1)
have been discussed in this##2##5##(2008-10#1)(2009-8#1)
have been discussed in##6##4##(2008-10#4)(2009-8#1)(2011-2#1)
have been discussed##19##3##(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)
have been disseminated##2##3##(2008-10#1)(2012-3#1)
have been distinguished##3##3##(1995-5#1)(2008-7#1)(2009-9#1)
have been documented##6##3##(1994-9#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
have been done with respect to##2##6##(2008-11#1)(2013-8#1)
have been done##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
have been dramatic##2##3##(1991-3#1)(2008-11#1)
have been drawn##2##3##(1991-5#1)(2007-11#1)
have been due to##3##4##(2008-1#1)(2008-10#1)(2009-5#1)
have been efficacious##2##3##(2008-2#1)(2008-8#1)
have been elaborated##3##3##(1992-11#1)(2006-10#1)(2008-10#1)
have been elucidated by##2##4##(2008-10#1)(2011-1#1)
have been elucidated##9##3##(1995-12#1)(1995-9#1)(1997-3#1)(2007-7#1)(2008-10#3)(2011-1#1)(2012-2#1)
have been embedded in##2##4##(2008-10#2)
have been employed for##2##4##(2008-9#1)(2012-2#1)
have been employed in the##2##5##(1997-3#1)(2013-1#1)
have been employed in##5##4##(1997-3#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#1)
have been employed to##3##4##(1991-9#1)(2008-9#1)(2012-3#1)
have been employed##13##3##(1991-9#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been encountered in##2##4##(2008-4#1)(2008-8#1)
have been encountered##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
have been engineered to##3##4##(2008-4#1)(2009-2#1)(2010-5#1)
have been engineered##4##3##(2008-4#1)(2009-2#1)(2010-5#1)(2013-8#1)
have been established for##3##4##(1996-12#1)(2008-10#1)(2010-4#1)
have been established to##2##4##(2008-3#1)(2009-11#1)
have been established##28##3##(1994-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-3#3)(2013-7#1)
have been estimated##4##3##(1992-2#1)(1997-7#1)(2008-10#2)
have been evaluated and compared##2##5##(2008-10#2)
have been evaluated and##5##4##(2008-10#5)
have been evaluated as##2##4##(2008-10#1)(2012-3#1)
have been evaluated by##4##4##(1994-3#1)(2008-10#2)(2008-12#1)
have been evaluated for##5##4##(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
have been evaluated in a##2##5##(2008-5#1)(2012-12#1)
have been evaluated in##10##4##(1993-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-1#1)(2009-7#1)(2012-12#1)(2013-1#1)
have been evaluated to##2##4##(1990-6#1)(2011-2#1)
have been evaluated##44##3##(1990-6#1)(1991-4#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2009-1#1)(2009-7#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been evidenced##2##3##(2008-7#1)(2012-5#1)
have been examined and the##2##5##(2008-10#2)
have been examined and##4##4##(2008-10#3)(2008-5#1)
have been examined as##2##4##(1997-7#1)(2008-10#1)
have been examined by##2##4##(1990-6#1)(2008-3#1)
have been examined for their##2##5##(1993-11#1)(1997-7#1)
have been examined for##3##4##(1993-11#1)(1997-7#1)(2008-5#1)
have been examined in##2##4##(1993-3#1)(1995-5#1)
have been examined using##3##4##(1997-6#1)(2008-10#1)(2010-12#1)
have been examined##29##3##(1990-6#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-3#1)(1995-5#2)(1996-12#1)(1997-6#1)(1997-7#3)(2008-10#10)(2008-3#2)(2008-5#2)(2009-8#1)(2010-12#1)(2010-3#1)
have been experimentally##4##3##(2007-12#1)(2008-3#2)(2009-5#1)
have been experimenting with##2##4##(1994-3#1)(2013-1#1)
have been explained##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
have been exploited for##2##4##(2008-10#1)(2009-3#1)
have been exploited to develop##2##5##(2008-1#1)(2008-10#1)
have been exploited##6##3##(2008-1#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-1#1)
have been explored##5##3##(1992-9#1)(2008-10#1)(2008-6#1)(2009-12#1)(2013-1#1)
have been exposed to##5##4##(1991-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
have been exposed##8##3##(1990-9#1)(1991-12#1)(1991-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
have been expressed in##3##4##(1994-6#1)(1995-6#1)(2008-1#1)
have been expressed##6##3##(1994-6#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#1)
have been extended to##4##4##(1995-5#1)(2007-11#1)(2008-3#1)(2008-8#1)
have been extensively investigated to##2##5##(2009-11#2)
have been extensively investigated##4##4##(1997-7#1)(2009-11#2)(2010-12#1)
have been extensively studied for##2##5##(2006-6#1)(2010-12#1)
have been extensively studied##5##4##(2006-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
have been extensively used to study##2##6##(2008-9#2)
have been extensively used to##3##5##(1997-6#1)(2008-9#2)
have been extensively used##5##4##(1997-6#1)(2008-10#1)(2008-9#2)(2012-2#1)
have been extensively##17##3##(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2009-11#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#1)
have been fabricated by##3##4##(2007-11#1)(2008-3#2)
have been fabricated from##2##4##(2008-10#1)(2008-7#1)
have been fabricated in##2##4##(2008-3#2)
have been fabricated##14##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#2)
have been fatal##2##3##(1995-6#1)(2008-10#1)
have been fed##2##3##(1990-11#1)(2011-2#1)
have been few studies##3##4##(1993-12#1)(2008-7#1)(2011-2#1)
have been few##11##3##(1993-12#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#1)
have been focused on##2##4##(2006-10#1)(2008-10#1)
have been focused##6##3##(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
have been followed##4##3##(1996-3#1)(1997-4#1)(1997-8#1)(2011-2#1)
have been formulated##5##3##(1992-1#1)(2007-7#1)(2008-5#2)(2012-1#1)
have been found by##3##4##(1996-4#1)(2008-3#2)
have been found in a##2##5##(1994-8#1)(2007-11#1)
have been found in the##2##5##(2008-10#1)(2008-7#1)
have been found in##17##4##(1994-8#2)(1995-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2012-12#1)(2013-1#1)(2013-7#1)
have been found to be necessary for##2##7##(2009-1#1)(2011-2#1)
have been found to be related to##2##7##(1993-12#1)(2012-3#1)
have been found to be##26##5##(1992-11#1)(1993-12#2)(1994-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
have been found to exhibit##2##5##(2008-10#1)(2009-5#1)
have been found to occur in##2##6##(1996-12#1)(2011-1#1)
have been found to##49##4##(1990-12#1)(1990-7#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)
have been found##85##3##(1990-12#1)(1990-7#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-8#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)
have been fully characterized##2##4##(2008-2#1)(2012-3#1)
have been fully##3##3##(2008-2#1)(2008-5#1)(2012-3#1)
have been fundamental##2##3##(1993-6#1)(2008-11#1)
have been further##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
have been gained##3##3##(2008-10#2)(2013-1#1)
have been gaining##2##3##(2008-10#1)(2010-8#1)
have been generated by##3##4##(1993-6#1)(2007-11#1)(2008-10#1)
have been generated from##3##4##(2007-11#1)(2007-12#1)(2008-12#1)
have been generated##16##3##(1993-12#1)(1993-6#1)(1995-9#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#3)(2010-10#1)(2012-2#1)(2013-7#1)
have been genetically engineered to##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
have been genetically modified##2##4##(2007-12#1)(2008-4#1)
have been genetically##7##3##(2007-12#1)(2008-10#3)(2008-4#2)(2008-5#1)
have been given the##2##4##(1990-7#1)(1992-1#1)
have been given##6##3##(1990-7#1)(1992-1#1)(1996-3#1)(1997-5#1)(2008-4#1)(2012-3#1)
have been greatly##3##3##(2007-11#1)(2008-1#1)(2013-1#1)
have been grouped##2##3##(2008-11#1)(2011-7#1)
have been grown in##2##4##(1992-11#1)(2008-10#1)
have been grown on##2##4##(2008-10#1)(2008-11#1)
have been grown##6##3##(1992-11#1)(1992-8#1)(1995-3#1)(2008-10#2)(2008-11#1)
have been hampered by the lack of##2##7##(2008-10#1)(2008-4#1)
have been hampered##3##3##(2008-10#2)(2008-4#1)
have been held##3##3##(1990-2#1)(2008-4#1)(2008-7#1)
have been highly conserved##2##4##(1993-6#1)(1995-2#1)
have been highly##3##3##(1993-6#1)(1995-2#1)(2007-9#1)
have been hindered by##3##4##(1996-9#1)(2008-11#1)(2008-6#1)
have been identified and are##2##5##(2008-4#1)(2010-11#1)
have been identified and characterized##4##5##(1995-12#1)(2008-5#1)(2008-7#2)
have been identified and##14##4##(1993-11#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#5)(2010-11#1)
have been identified as a##10##5##(2008-2#1)(2013-8#9)
have been identified as important##2##5##(2008-7#1)(2012-2#1)
have been identified as key##2##5##(2008-10#1)(2012-12#1)
have been identified as the##2##5##(1994-12#1)(2013-8#1)
have been identified as##30##4##(1991-9#1)(1994-12#1)(1994-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#10)
have been identified by GC-MS##2##5##(1992-5#1)(2008-10#1)
have been identified by the##2##5##(1996-2#1)(1996-9#1)
have been identified by##11##4##(1992-5#1)(1992-6#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(2008-10#3)(2008-7#1)(2013-1#1)
have been identified for##3##4##(1991-12#1)(2008-8#1)(2011-1#1)
have been identified from##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
have been identified in the##5##5##(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
have been identified in##20##4##(1990-6#1)(1991-9#1)(1992-12#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2010-5#2)(2011-1#2)(2012-3#1)(2013-1#1)
have been identified on##2##4##(2008-4#1)(2009-3#1)
have been identified that##8##4##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)
have been identified to date##2##5##(1992-12#1)(2008-4#1)
have been identified to##7##4##(1991-12#1)(1992-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
have been identified which##2##4##(1991-9#1)(1996-6#1)
have been identified##151##3##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#3)(1991-9#3)(1992-12#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#10)
have been immobilized##2##3##(2008-10#2)
have been implanted##2##3##(2008-7#1)(2008-9#1)
have been implemented and##2##4##(2007-12#1)(2009-8#1)
have been implemented in##4##4##(2008-3#2)(2010-5#1)(2011-2#1)
have been implemented##15##3##(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#4)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
have been implicated as##2##4##(1994-8#1)(2013-1#1)
have been implicated in a number of##2##7##(2009-5#1)(2009-6#1)
have been implicated in a##4##5##(1994-12#1)(1994-6#1)(2009-5#1)(2009-6#1)
have been implicated in its##2##5##(1991-9#1)(2010-10#1)
have been implicated in several##2##5##(2009-12#1)(2012-2#1)
have been implicated in the control of##3##7##(1993-3#1)(1996-5#1)(2008-7#1)
have been implicated in the pathogenesis of##5##7##(1993-12#1)(1996-12#1)(1996-7#1)(2013-8#2)
have been implicated in the##18##5##(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#2)
have been implicated in various##2##5##(2008-4#1)(2013-7#1)
have been implicated in##49##4##(1991-12#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
have been implicated##54##3##(1991-12#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
have been important##2##3##(1992-8#1)(1996-6#1)
have been imposed##2##3##(2007-6#1)(2008-10#1)
have been improved with##2##4##(2008-6#1)(2008-7#1)
have been improved##5##3##(2008-10#2)(2008-6#1)(2008-7#1)(2010-8#1)
have been in the##2##4##(2008-10#1)(2008-11#1)
have been in##5##3##(2008-10#1)(2008-11#1)(2010-5#1)(2010-9#1)(2011-3#1)
have been included in##2##4##(2008-10#2)
have been included##7##3##(2007-5#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
have been inconsistent##5##3##(1996-11#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-8#1)
have been increased##4##3##(2008-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
have been increasing over the past##2##6##(2010-8#1)(2012-2#1)
have been increasing over##3##4##(2010-8#1)(2012-1#1)(2012-2#1)
have been increasing##6##3##(2007-9#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-2#1)
have been increasingly##6##3##(2008-10#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
have been induced##2##3##(2008-11#1)(2008-8#1)
have been infected##2##3##(1993-8#1)(1997-6#1)
have been initiated##4##3##(1996-1#1)(2008-5#1)(2009-12#1)(2012-2#1)
have been instrumental in##4##4##(1995-6#1)(2008-2#1)(2008-4#1)(2012-12#1)
have been integrated in a##2##5##(2008-11#1)(2008-7#1)
have been integrated into##3##4##(2008-11#1)(2011-1#2)
have been integrated##7##3##(1994-2#1)(2008-11#2)(2008-7#1)(2011-1#2)(2012-3#1)
have been intensively##2##3##(2009-8#1)(2010-2#1)
have been interpreted##2##3##(2006-12#1)(2008-10#1)
have been introduced and##2##4##(1992-9#1)(1997-6#1)
have been introduced as a##2##5##(2008-5#1)(2012-2#1)
have been introduced as##3##4##(2008-5#1)(2012-2#1)(2013-8#1)
have been introduced for##2##4##(2008-10#1)(2008-11#1)
have been introduced into##4##4##(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
have been introduced to the##3##5##(1997-8#1)(2009-5#1)(2013-7#1)
have been introduced to##9##4##(1997-8#1)(2008-10#1)(2008-9#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
have been introduced##29##3##(1992-9#1)(1997-6#1)(1997-8#2)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
have been investigated and##9##4##(1990-11#1)(1995-11#1)(2008-10#4)(2008-3#1)(2011-2#1)(2011-3#1)
have been investigated as##8##4##(1997-7#1)(2008-10#3)(2008-11#2)(2009-9#1)(2012-2#1)
have been investigated at##2##4##(1990-5#1)(2008-10#1)
have been investigated by means of##2##6##(2008-10#1)(2008-5#1)
have been investigated by use of##2##6##(2007-11#1)(2007-12#1)
have been investigated by##15##4##(1994-3#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
have been investigated for the##4##5##(2008-10#2)(2008-2#1)(2008-7#1)
have been investigated for##11##4##(2008-10#6)(2008-2#1)(2008-7#2)(2010-12#1)(2011-1#1)
have been investigated in detail##2##5##(2008-10#2)
have been investigated in the##4##5##(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
have been investigated in vitro##2##5##(1997-4#1)(2008-5#1)
have been investigated in##22##4##(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
have been investigated over the##2##5##(2008-10#1)(2008-3#1)
have been investigated theoretically and experimentally##2##6##(2007-11#1)(2008-3#1)
have been investigated through##2##4##(2009-6#1)(2013-8#1)
have been investigated to##2##4##(2008-10#1)(2009-11#1)
have been investigated using##4##4##(1993-6#1)(1996-2#1)(1997-4#1)(2008-10#1)
have been investigated with respect to##2##6##(2007-12#1)(2008-2#1)
have been investigated with##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
have been investigated##136##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-11#3)(1995-2#1)(1996-2#1)(1997-4#3)(1997-7#2)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#63)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#4)(2008-7#8)(2008-8#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
have been involved in the##6##5##(1990-5#1)(1996-6#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#1)
have been involved in##7##4##(1990-5#1)(1995-12#1)(1996-6#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#1)
have been isolated and characterized##4##5##(1991-5#1)(1991-6#1)(1992-3#1)(2008-11#1)
have been isolated and##7##4##(1990-12#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-6#1)(2008-11#1)
have been isolated from a##4##5##(1990-12#1)(1991-6#1)(1995-3#1)(2011-2#1)
have been isolated from this##2##5##(1994-11#1)(1995-6#1)
have been isolated from##14##4##(1990-12#1)(1991-6#1)(1992-8#1)(1994-11#1)(1995-3#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)
have been isolated##30##3##(1990-12#2)(1991-5#1)(1991-6#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-6#2)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
have been known for##3##4##(1991-12#1)(2007-12#1)(2012-2#1)
have been known to##3##4##(1997-3#1)(2008-11#1)(2011-2#1)
have been known##8##3##(1991-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
have been labeled##2##3##(2008-1#1)(2008-4#1)
have been largely##5##3##(1990-9#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-9#1)
have been learned##3##3##(2008-10#1)(2009-6#1)(2010-1#1)
have been limited by##3##4##(2008-7#1)(2008-8#1)(2011-2#1)
have been limited to##7##4##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2011-1#1)
have been limited##11##3##(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
have been linked to##8##4##(2007-12#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
have been linked with##6##4##(2007-12#1)(2008-5#2)(2009-6#1)(2011-2#1)(2013-1#1)
have been linked##14##3##(2007-12#2)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
have been listed##2##3##(2007-11#1)(2008-10#1)
have been little##2##3##(1997-1#1)(2012-1#1)
have been localized to chromosome##2##5##(2007-7#2)
have been localized to##3##4##(2007-7#2)(2008-4#1)
have been located##3##3##(1993-12#1)(2008-4#1)(2008-5#1)
have been lost##4##3##(1996-3#1)(2008-7#2)(2013-1#1)
have been made and##2##4##(1997-4#1)(2008-10#1)
have been made by##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2010-4#1)
have been made in the##8##5##(1990-9#1)(2007-12#1)(2008-3#2)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
have been made in##21##4##(1990-9#1)(1992-12#1)(1992-2#1)(1995-12#1)(2007-12#1)(2008-11#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
have been made on##2##4##(1992-12#1)(2008-11#1)
have been made to adopt##2##5##(2008-10#1)(2013-1#1)
have been made to establish##2##5##(2008-9#1)(2009-11#1)
have been made to##16##4##(1991-1#1)(1991-2#1)(1995-2#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#2)
have been made toward##2##4##(1990-5#1)(2008-10#1)
have been made with##2##4##(2008-2#1)(2009-6#1)
have been made##72##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#3)(1992-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#7)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#6)
have been maintained##2##3##(2008-11#1)(2008-7#1)
have been managed##2##3##(1996-3#1)(2008-9#1)
have been mapped##5##3##(1990-7#1)(1996-8#1)(2008-10#1)(2008-8#2)
have been marketed##2##3##(2007-2#1)(2008-5#1)
have been measured at##2##4##(2008-11#1)(2008-3#1)
have been measured between##2##4##(1994-11#1)(2008-10#1)
have been measured by##2##4##(1996-2#1)(2008-10#1)
have been measured for##2##4##(1997-8#1)(2008-2#1)
have been measured in the##4##5##(2008-10#1)(2008-3#2)(2010-11#1)
have been measured in##11##4##(1994-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
have been measured with##2##4##(2008-3#2)
have been measured##40##3##(1990-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#8)(2008-6#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2013-1#1)
have been missed##2##3##(1994-12#1)(2008-6#1)
have been modified##5##3##(1992-3#1)(2008-10#2)(2010-8#1)(2011-3#1)
have been monitored since 1999##2##5##(2008-5#1)(2011-2#1)
have been more than##2##4##(1990-6#1)(1994-12#1)
have been more##8##3##(1990-11#1)(1990-6#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
have been named##2##3##(1995-12#1)(2008-10#1)
have been no cases of##2##5##(1997-8#1)(2008-7#1)
have been no##24##3##(1994-2#1)(1994-6#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
have been noted in##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
have been noted##9##3##(1991-2#1)(1991-4#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)
have been noticed in##2##4##(2008-1#1)(2013-1#1)
have been numerous##2##3##(2008-7#1)(2012-2#1)
have been objects of##2##4##(2010-1#2)
have been observed and##2##4##(1997-4#1)(2008-2#1)
have been observed as##2##4##(2007-11#1)(2008-7#1)
have been observed by##2##4##(1995-6#1)(2008-4#1)
have been observed for##5##4##(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#2)
have been observed in patients##2##5##(2008-8#1)(2011-1#1)
have been observed in##16##4##(1992-6#1)(1994-5#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)
have been observed to##4##4##(2008-10#1)(2008-11#1)(2008-3#2)
have been observed with##3##4##(2008-2#1)(2008-3#1)(2010-10#1)
have been observed##52##3##(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#2)(2007-11#3)(2007-12#6)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
have been obtained and##2##4##(1997-7#1)(2008-10#1)
have been obtained at##3##4##(1991-5#1)(1997-7#1)(2008-3#1)
have been obtained by##9##4##(1990-9#1)(1991-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
have been obtained for the##2##5##(2008-10#1)(2009-7#1)
have been obtained for##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
have been obtained from##4##4##(1991-5#1)(2007-12#1)(2008-7#1)(2010-4#1)
have been obtained using the##2##5##(2008-10#1)(2008-5#1)
have been obtained using##5##4##(1990-5#1)(2008-10#2)(2008-5#1)(2009-7#1)
have been obtained with##7##4##(1993-11#1)(1997-7#1)(2008-10#1)(2008-2#2)(2012-2#1)(2013-1#1)
have been obtained##61##3##(1990-5#2)(1990-9#1)(1991-2#1)(1991-5#2)(1993-11#1)(1995-3#1)(1997-5#2)(1997-7#3)(2007-11#3)(2007-12#2)(2008-10#15)(2008-2#10)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#2)(2009-7#2)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#1)
have been occurring on##2##4##(2008-10#1)(2008-9#1)
have been of##6##3##(1992-11#1)(1992-6#1)(1994-12#1)(1994-6#1)(2008-4#1)(2008-5#1)
have been offered##3##3##(1994-9#1)(2008-10#2)
have been on the##2##4##(2008-10#1)(2013-8#1)
have been only partially##2##4##(1994-8#1)(2013-8#1)
have been only##7##3##(1992-2#1)(1994-8#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
have been operated on##2##4##(1997-6#1)(2008-10#1)
have been optimised and the##3##5##(2008-10#3)
have been optimised and##4##4##(2008-10#4)
have been optimised##7##3##(2008-10#7)
have been optimized and the##3##5##(2008-10#3)
have been optimized to##5##4##(2008-10#3)(2008-4#1)(2009-9#1)
have been optimized##18##3##(2008-10#15)(2008-4#1)(2009-8#1)(2009-9#1)
have been or are##2##4##(2008-11#1)(2008-5#1)
have been out of##2##4##(2009-10#1)(2011-2#1)
have been outlined##2##3##(2007-2#1)(2008-10#1)
have been overcome##2##3##(2008-10#1)(2008-4#1)
have been paid##2##3##(1990-9#1)(2013-8#1)
have been particularly##2##3##(1995-9#1)(2008-8#1)
have been performed by##3##4##(2008-10#3)
have been performed for##4##4##(2008-2#1)(2008-3#2)(2012-2#1)
have been performed in##9##4##(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
have been performed on##6##4##(1994-6#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)
have been performed to evaluate the##2##6##(2006-10#1)(2008-2#1)
have been performed to evaluate##3##5##(2006-10#1)(2008-11#1)(2008-2#1)
have been performed to##8##4##(2006-10#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)
have been performed using both##2##5##(2008-6#1)(2008-7#1)
have been performed with the##2##5##(2008-10#1)(2012-2#1)
have been performed with##5##4##(1990-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
have been performed##57##3##(1990-8#1)(1992-2#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-5#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#4)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#1)
have been poorly##3##3##(2007-7#1)(2008-5#1)(2013-7#1)
have been postulated to##3##4##(1995-2#1)(1995-5#1)(2008-7#1)
have been postulated##5##3##(1990-3#1)(1995-2#1)(1995-5#1)(2008-7#1)(2008-9#1)
have been predicted by##2##4##(1991-10#1)(2008-10#1)
have been predicted##4##3##(1991-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
have been prepared and explored as##2##6##(2008-10#2)
have been prepared and##7##4##(2008-10#7)
have been prepared by##3##4##(2008-10#2)(2008-5#1)
have been prepared in an##2##5##(1992-3#1)(1997-7#1)
have been prepared in##3##4##(1992-3#1)(1997-7#1)(2007-11#1)
have been prepared that##2##4##(2008-8#1)(2009-12#1)
have been prepared using##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
have been prepared##25##3##(1992-2#1)(1992-3#1)(1997-7#1)(2007-11#1)(2008-10#13)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
have been presented for##2##4##(2008-12#1)(2009-11#1)
have been presented in##4##4##(1991-3#1)(2008-3#1)(2008-9#1)(2012-1#1)
have been presented##11##3##(1991-12#1)(1991-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-1#1)
have been previously identified##2##4##(1993-6#1)(1996-6#1)
have been previously reported in##2##5##(2008-5#1)(2011-2#1)
have been previously reported##3##4##(1991-1#1)(2008-5#1)(2011-2#1)
have been previously##12##3##(1990-12#1)(1991-1#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
have been processed by##3##4##(2007-11#1)(2008-10#2)
have been processed##6##3##(1997-5#1)(2007-11#1)(2008-10#3)(2008-2#1)
have been produced and##4##4##(1995-5#1)(2008-2#1)(2008-5#1)(2011-3#1)
have been produced##11##3##(1995-12#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
have been proposed and##4##4##(2007-11#1)(2009-4#1)(2010-6#1)(2011-1#1)
have been proposed as a##2##5##(2008-10#1)(2008-3#1)
have been proposed as##10##4##(1995-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-2#2)(2013-1#1)
have been proposed for the##4##5##(1990-5#1)(1991-5#1)(1997-3#1)(2008-7#1)
have been proposed for##21##4##(1990-5#1)(1991-5#1)(1993-1#1)(1993-11#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
have been proposed in the literature##3##6##(2008-7#2)(2009-9#1)
have been proposed in the##4##5##(2008-7#2)(2009-9#1)(2011-1#1)
have been proposed in##8##4##(1994-3#1)(1997-8#1)(2008-7#2)(2008-9#2)(2009-9#1)(2011-1#1)
have been proposed to be##2##5##(1992-3#1)(1994-6#1)
have been proposed to explain the##2##6##(2009-12#1)(2012-3#1)
have been proposed to explain##3##5##(2008-9#1)(2009-12#1)(2012-3#1)
have been proposed to##14##4##(1992-3#1)(1993-6#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-7#1)(2012-3#1)
have been proposed##85##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
have been proved to be##2##5##(2008-8#1)(2013-1#1)
have been proved to##3##4##(1990-2#1)(2008-8#1)(2013-1#1)
have been proved##5##3##(1990-2#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
have been proven to be##2##5##(2008-10#1)(2010-5#1)
have been proven to##3##4##(1997-4#1)(2008-10#1)(2010-5#1)
have been provided to##2##4##(1997-1#1)(2009-6#1)
have been provided##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
have been published from the##2##5##(1993-6#1)(2008-4#1)
have been published in the##2##5##(2008-5#2)
have been published in##4##4##(2008-5#2)(2013-1#2)
have been published on the##2##5##(2008-11#1)(2010-12#1)
have been published previously##2##4##(2008-10#1)(2008-7#1)
have been published to date##2##5##(1990-11#1)(2011-2#1)
have been published##33##3##(1990-11#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
have been purified from##2##4##(1992-8#1)(1993-11#1)
have been purified to homogeneity##3##5##(1990-11#1)(1992-6#1)(1993-12#1)
have been purified##6##3##(1990-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(2007-11#1)
have been pursued for##2##4##(2010-1#1)(2010-2#1)
have been pursued##4##3##(2007-11#1)(2008-3#1)(2010-1#1)(2010-2#1)
have been quantified in##2##4##(2008-10#2)
have been quantified##3##3##(2008-10#3)
have been quantitatively##2##3##(2008-10#2)
have been questioned because##2##4##(1994-9#1)(2008-3#1)
have been rarely described##2##4##(2008-7#1)(2012-3#1)
have been rarely##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
have been reached##3##3##(1990-6#1)(2008-5#1)(2008-8#1)
have been realised##2##3##(2007-8#1)(2008-1#1)
have been realized##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
have been recently developed##2##4##(2010-11#1)(2011-3#1)
have been recently reported##2##4##(2008-10#1)(2008-7#1)
have been recently##15##3##(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-3#1)(2013-8#1)
have been recognized as a##2##5##(2008-3#1)(2013-8#1)
have been recognized as##6##4##(1995-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
have been recognized##12##3##(1995-8#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-3#1)(2010-5#1)(2011-1#1)(2013-8#1)
have been recommended##3##3##(2008-1#1)(2008-9#1)(2012-2#1)
have been recorded and##2##4##(1990-7#1)(2008-10#1)
have been recorded by##2##4##(2008-3#1)(2010-8#1)
have been recorded in##4##4##(2007-12#1)(2011-2#2)(2013-8#1)
have been recorded##16##3##(1990-3#1)(1990-7#1)(1991-9#1)(1992-4#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-8#1)(2011-2#2)(2013-8#1)
have been reduced##2##3##(2008-10#1)(2008-5#1)
have been referred to##2##4##(1994-2#1)(1994-5#1)
have been refined to##2##4##(1995-2#1)(2008-10#1)
have been regarded as##4##4##(1993-3#1)(2008-5#1)(2008-9#1)(2010-11#1)
have been registered##3##3##(1995-2#1)(1995-8#1)(1997-2#1)
have been related to##4##4##(2008-10#1)(2008-9#2)(2011-2#1)
have been relatively##3##3##(2008-5#1)(2008-8#1)(2011-1#1)
have been repeatedly##5##3##(1992-8#1)(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
have been replaced with##2##4##(1990-7#1)(2013-8#1)
have been replaced##3##3##(1990-7#1)(1991-2#1)(2013-8#1)
have been reported among##3##4##(1991-12#1)(2008-4#1)(2009-5#1)
have been reported and##2##4##(2008-6#1)(2010-7#1)
have been reported as a##2##5##(1990-8#1)(2013-1#1)
have been reported as##7##4##(1990-8#1)(1996-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
have been reported for the##2##5##(2008-9#1)(2009-11#1)
have been reported for##5##4##(1995-6#1)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)
have been reported from##2##4##(1995-8#1)(2008-5#1)
have been reported in a##2##5##(2012-2#1)(2012-3#1)
have been reported in children##2##5##(2008-10#1)(2009-4#1)
have been reported in patients with##3##6##(1995-11#1)(2007-10#1)(2010-1#1)
have been reported in some##2##5##(2008-1#1)(2011-1#1)
have been reported in the English literature##4##7##(2006-12#1)(2008-2#1)(2010-6#1)(2013-1#1)
have been reported in the literature##14##6##(1990-12#1)(1990-8#1)(1996-11#1)(1996-6#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
have been reported in the##27##5##(1990-12#1)(1990-8#2)(1996-11#1)(1996-6#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
have been reported in##61##4##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1992-6#1)(1995-11#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#3)(2006-12#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
have been reported on##4##4##(1990-11#1)(2008-10#3)
have been reported previously##4##4##(1996-1#1)(2008-10#3)
have been reported since the##2##5##(2008-12#1)(2010-1#1)
have been reported since##3##4##(2008-12#1)(2008-5#1)(2010-1#1)
have been reported so far##5##5##(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
have been reported to be increased##2##6##(1994-12#1)(2008-10#1)
have been reported to be##11##5##(1992-8#1)(1994-12#2)(1994-5#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
have been reported to cause##2##5##(2008-10#2)
have been reported to contain##2##5##(1995-12#1)(2008-10#1)
have been reported to date##5##5##(2008-1#3)(2008-7#1)(2013-1#1)
have been reported to have##4##5##(2008-11#3)(2008-6#1)
have been reported to occur in##2##6##(2007-8#1)(2013-1#1)
have been reported to possess##2##5##(1992-3#1)(2013-1#1)
have been reported to the##3##5##(1991-8#1)(1992-2#1)(2007-7#1)
have been reported to##45##4##(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#3)
have been reported with##8##4##(2008-10#3)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
have been reported worldwide##3##4##(2007-7#1)(2009-8#1)(2013-1#1)
have been reported##220##3##(1990-11#1)(1990-12#2)(1990-5#3)(1990-8#3)(1991-11#2)(1991-12#3)(1991-2#1)(1991-8#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#31)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#11)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#7)
have been reproduced##3##3##(1994-12#1)(2007-11#1)(2012-3#1)
have been researched##2##3##(2008-8#1)(2012-3#1)
have been resolved##8##3##(1990-10#1)(1991-5#1)(1997-7#1)(2008-10#5)
have been restricted##3##3##(2008-7#2)(2012-3#1)
have been revealed##3##3##(2008-3#1)(2010-2#2)
have been reviewed##3##3##(2009-10#1)(2010-1#1)(2012-2#1)
have been saved##2##3##(1993-8#1)(2008-8#1)
have been scaled##2##3##(2008-11#1)(2008-3#1)
have been selected for##3##4##(2008-10#2)(2008-8#1)
have been selected##6##3##(2008-10#3)(2008-7#1)(2008-8#1)(2010-8#1)
have been separated by##2##4##(2008-10#2)
have been separated within 130s at a separation voltage of##2##10##(2008-10#2)
have been separated##7##3##(2008-10#6)(2008-11#1)
have been sequenced##3##3##(2008-10#2)(2008-7#1)
have been several##4##3##(1992-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
have been shown in##3##4##(1991-8#1)(1992-12#1)(2010-8#1)
have been shown to act##2##5##(2008-8#1)(2009-3#1)
have been shown to activate##2##5##(1994-12#1)(2009-6#1)
have been shown to be associated with##5##7##(2008-4#1)(2009-9#1)(2011-1#2)(2012-2#1)
have been shown to be essential for##2##7##(2008-5#2)
have been shown to be important to the##2##8##(2007-2#1)(2012-3#1)
have been shown to be involved in the##2##8##(2007-8#1)(2010-10#1)
have been shown to be more##2##6##(2008-2#1)(2009-8#1)
have been shown to be necessary for##2##7##(1994-6#1)(2008-9#1)
have been shown to be regulated##2##6##(2008-8#2)
have been shown to be safe##2##6##(1995-5#1)(2013-1#1)
have been shown to be##46##5##(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#2)(1996-2#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
have been shown to cause##3##5##(2008-10#2)(2012-12#1)
have been shown to confer##2##5##(1993-11#1)(2011-2#1)
have been shown to contain##2##5##(1995-6#1)(2008-3#1)
have been shown to decrease##5##5##(2008-10#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)
have been shown to exhibit##2##5##(2008-7#2)
have been shown to have beneficial effects on##2##8##(2008-3#1)(2009-3#1)
have been shown to have##13##5##(1990-3#1)(1993-12#1)(1994-3#1)(1997-7#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-4#1)(2012-12#1)
have been shown to improve##4##5##(1994-9#1)(2008-4#1)(2012-2#1)(2013-8#1)
have been shown to induce##4##5##(1992-3#1)(1992-5#1)(1995-5#1)(2013-1#1)
have been shown to influence##2##5##(1997-1#1)(2009-10#1)
have been shown to inhibit##2##5##(1992-11#1)(2010-11#1)
have been shown to interact with##2##6##(1994-5#1)(2013-1#1)
have been shown to interact##3##5##(1994-5#1)(2008-4#1)(2013-1#1)
have been shown to modulate##4##5##(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
have been shown to play a role in##2##8##(2008-4#2)
have been shown to play important roles in##2##8##(2008-11#1)(2009-10#1)
have been shown to play##6##5##(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#2)
have been shown to provide##2##5##(1996-2#1)(2010-10#1)
have been shown to reduce##2##5##(1993-3#1)(2008-2#1)
have been shown to suppress##3##5##(1995-3#1)(2008-10#1)(2008-7#1)
have been shown to##142##4##(1990-3#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#5)(1996-2#3)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
have been shown##151##3##(1990-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#5)(1996-2#3)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#10)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
have been significant##7##3##(1990-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2013-8#1)
have been significantly##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
have been simultaneously determined##2##4##(2008-10#2)
have been simultaneously##3##3##(2007-11#1)(2008-10#2)
have been so##2##3##(2008-10#1)(2008-11#1)
have been specifically designed##2##4##(1996-1#1)(2008-4#1)
have been specifically##4##3##(1996-1#1)(2008-3#1)(2008-4#1)(2010-5#1)
have been steadily##2##3##(1993-12#1)(2011-2#1)
have been structurally characterized##2##4##(1994-5#1)(1997-7#1)
have been structurally##4##3##(1994-5#1)(1997-7#1)(2010-5#1)(2011-2#1)
have been studied and compared with##2##6##(1992-6#1)(2008-3#1)
have been studied and compared##3##5##(1992-6#1)(2008-10#1)(2008-3#1)
have been studied and##5##4##(1990-11#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
have been studied as a function of##2##7##(1990-5#1)(2008-3#1)
have been studied at##2##4##(1990-8#1)(1997-7#1)
have been studied by##12##4##(1990-7#1)(1990-9#1)(1993-8#1)(1994-12#1)(2008-10#5)(2008-2#1)(2008-8#1)(2012-3#1)
have been studied extensively##5##4##(1995-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-2#1)
have been studied for decades##2##5##(2008-10#2)
have been studied for##8##4##(2008-1#1)(2008-10#6)(2008-8#1)
have been studied from##2##4##(2007-12#1)(2013-1#1)
have been studied in detail to optimize the conditions for determination##2##11##(2008-10#2)
have been studied in detail to optimize the conditions for##4##10##(2008-10#4)
have been studied in detail##8##5##(2008-10#8)
have been studied in order to##2##6##(2008-10#1)(2013-1#1)
have been studied in the##2##5##(1997-3#1)(2008-10#1)
have been studied in##25##4##(1990-5#1)(1991-9#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
have been studied to##3##4##(1995-11#1)(2008-10#1)(2010-7#1)
have been studied using##6##4##(1994-11#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-7#1)
have been studied with a##2##5##(1997-4#1)(2008-10#1)
have been studied with##5##4##(1993-6#1)(1997-4#1)(2008-10#2)(2008-3#1)
have been studied##142##3##(1990-11#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#59)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#2)(2013-7#1)
have been studies##2##3##(1994-8#1)(2013-1#1)
have been subjected to##5##4##(2008-10#1)(2009-7#1)(2010-4#1)(2010-7#1)(2012-12#1)
have been successful in##5##4##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
have been successful##6##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#2)
have been successfully applied to the determination of trace amount of##2##11##(2008-10#2)
have been successfully applied to the##3##6##(2008-10#3)
have been successfully applied to##6##5##(2008-10#6)
have been successfully applied##8##4##(2008-10#7)(2011-2#1)
have been successfully tested##2##4##(2008-10#1)(2011-2#1)
have been successfully used for##2##5##(2007-11#1)(2008-2#1)
have been successfully used to##4##5##(1994-3#1)(1996-12#1)(2012-12#1)(2012-2#1)
have been successfully used##6##4##(1994-3#1)(1996-12#1)(2007-11#1)(2008-2#1)(2012-12#1)(2012-2#1)
have been successfully##27##3##(1993-2#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
have been suggested as##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
have been suggested in##2##4##(2008-12#1)(2008-2#1)
have been suggested to be##2##5##(1997-2#1)(2008-12#1)
have been suggested to play##2##5##(1994-12#1)(2008-10#1)
have been suggested to##8##4##(1994-12#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)
have been suggested##29##3##(1990-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-9#1)(1997-2#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
have been summarized##2##3##(2008-10#2)
have been synthesised##2##3##(2008-10#1)(2008-5#1)
have been synthesized and characterized by##4##6##(1996-2#2)(1997-7#1)(2007-11#1)
have been synthesized and characterized##6##5##(1995-3#1)(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#1)
have been synthesized and##12##4##(1995-11#1)(1995-3#2)(1996-2#2)(1997-7#1)(2007-11#2)(2008-10#2)(2010-6#1)(2013-1#1)
have been synthesized as##2##4##(1991-5#1)(1996-5#1)
have been synthesized by##2##4##(2008-10#1)(2011-1#1)
have been synthesized in##5##4##(1995-6#1)(2009-2#1)(2009-7#1)(2012-2#1)(2012-3#1)
have been synthesized##35##3##(1990-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-2#2)(1996-5#2)(1997-7#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-6#2)(2009-2#1)(2009-7#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been systematically investigated##2##4##(2008-10#2)
have been tabulated##2##3##(1991-3#1)(1994-1#1)
have been taken to##3##4##(2008-11#1)(2008-8#1)(2009-11#1)
have been taken##10##3##(1990-8#1)(1993-8#1)(1996-1#1)(2008-11#2)(2008-8#1)(2009-11#1)(2010-8#2)(2012-3#1)
have been termed##2##3##(1993-8#1)(1995-12#1)
have been tested as##3##4##(2008-10#2)(2009-2#1)
have been tested for the##2##5##(2008-10#2)
have been tested for##5##4##(2008-10#3)(2008-6#1)(2009-12#1)
have been tested in##3##4##(1994-6#1)(2008-6#1)(2008-7#1)
have been tested on##3##4##(2008-10#1)(2010-8#1)(2012-1#1)
have been tested using##2##4##(1990-5#1)(1992-9#1)
have been tested with##2##4##(2007-10#1)(2008-10#1)
have been tested##22##3##(1990-5#1)(1992-9#1)(1994-6#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-6#3)(2008-7#1)(2009-12#1)(2009-2#1)(2010-8#1)(2012-1#1)
have been the focus of##3##5##(2008-11#1)(2009-11#1)(2010-9#1)
have been the most important##2##5##(2007-12#1)(2010-11#1)
have been the most widely##2##5##(2008-2#1)(2009-8#1)
have been the most##5##4##(1994-12#1)(2007-12#1)(2008-2#1)(2009-8#1)(2010-11#1)
have been the subject of intense research##2##7##(2008-5#1)(2008-9#1)
have been the subject of##5##5##(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)
have been the##27##3##(1991-12#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-7#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been thought##2##3##(1992-11#1)(1994-8#1)
have been to##3##3##(1995-12#1)(1996-3#1)(2007-12#1)
have been traced##2##3##(2008-10#1)(2008-8#1)
have been trained in##2##4##(1995-1#1)(1996-5#1)
have been trained to##3##4##(2008-10#3)
have been trained##6##3##(1995-1#1)(1996-5#1)(2008-10#3)(2010-11#1)
have been transmitted##3##3##(1990-3#1)(1990-9#1)(2007-12#1)
have been treated by##3##4##(1990-2#1)(2008-10#1)(2008-7#1)
have been treated with##9##4##(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
have been treated##19##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
have been tried##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
have been typed##2##3##(1997-5#1)(2007-12#1)
have been unable to##3##4##(1996-12#1)(2011-2#1)(2012-3#1)
have been under##3##3##(2010-10#1)(2012-2#1)(2013-1#1)
have been underestimated##2##3##(2009-7#1)(2012-2#1)
have been undertaken in##2##4##(2007-8#1)(2012-12#1)
have been undertaken to##4##4##(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
have been undertaken##7##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
have been used as##15##4##(1992-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-8#1)
have been used because##2##4##(1997-1#1)(2008-10#1)
have been used by##2##4##(2008-1#1)(2008-10#1)
have been used during##2##4##(2008-10#1)(2009-5#1)
have been used extensively in##3##5##(2007-9#1)(2008-10#2)
have been used for a long time##2##7##(2008-1#1)(2008-5#1)
have been used for many years##2##6##(2008-5#1)(2009-8#1)
have been used for sodium##2##5##(2008-10#2)
have been used for the determination of##2##7##(2008-10#2)
have been used for the##9##5##(1993-9#1)(2007-7#1)(2008-10#5)(2008-9#1)(2010-5#1)
have been used for this purpose##2##6##(1995-5#1)(2008-10#1)
have been used for this##3##5##(1995-5#1)(2008-10#1)(2008-3#1)
have been used for##34##4##(1990-11#1)(1990-5#1)(1993-9#1)(1994-9#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
have been used in a study##2##6##(2008-2#1)(2008-6#1)
have been used in combination with##2##6##(1996-12#1)(2013-1#1)
have been used in the##4##5##(2008-3#1)(2008-5#2)(2012-12#1)
have been used in##32##4##(1992-2#1)(1992-8#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-4#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-11#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
have been used more##2##4##(2008-5#1)(2010-6#1)
have been used successfully for##2##5##(2008-2#1)(2008-7#1)
have been used successfully##5##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
have been used to calculate the##2##6##(1997-2#1)(2008-10#1)
have been used to characterize the##2##6##(1993-8#1)(2008-3#1)
have been used to characterize##3##5##(1993-8#1)(1994-11#1)(2008-3#1)
have been used to create##2##5##(1996-4#1)(2008-1#1)
have been used to design##2##5##(2007-11#1)(2008-10#1)
have been used to determine the##2##6##(1990-9#1)(1994-5#1)
have been used to determine##4##5##(1990-9#1)(1994-5#1)(2007-11#1)(2008-10#1)
have been used to identify##3##5##(1992-3#1)(2008-6#1)(2012-1#1)
have been used to investigate the##3##6##(1996-5#1)(2008-10#1)(2008-3#1)
have been used to measure##2##5##(2008-3#1)(2008-4#1)
have been used to monitor the##2##6##(1994-5#1)(2008-11#1)
have been used to probe the##2##6##(1995-6#1)(2008-10#1)
have been used to reduce the##2##6##(1996-11#1)(2008-2#1)
have been used to study the##10##6##(1990-11#1)(1991-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#2)
have been used to study##13##5##(1990-11#1)(1991-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#2)
have been used to treat##3##5##(1993-11#1)(1996-11#1)(2008-8#1)
have been used to##82##4##(1990-11#1)(1990-9#1)(1991-8#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#3)(1995-6#1)(1996-11#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
have been used widely to##2##5##(2010-10#1)(2013-8#1)
have been used with##2##4##(2007-11#1)(2008-3#1)
have been used##214##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#3)(1996-12#2)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#2)(2006-10#1)(2006-4#1)(2007-11#10)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#46)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#11)(2008-5#15)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
have been useful##2##3##(2008-10#1)(2008-2#1)
have been using##4##3##(1993-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
have been utilized to##2##4##(1990-5#1)(2008-3#1)
have been utilized##5##3##(1990-5#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)
have been validated by##2##4##(2008-10#2)
have been validated##6##3##(2008-10#2)(2008-7#2)(2010-5#1)(2013-1#1)
have been verified experimentally##2##4##(1997-1#1)(2008-3#1)
have been verified##7##3##(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-4#1)
have been very few##3##4##(2008-7#2)(2009-10#1)
have been very##8##3##(1990-5#1)(1991-9#1)(1994-6#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-10#1)
have been visualized##2##3##(1996-2#1)(2008-11#1)
have been well documented##3##4##(1995-1#1)(2008-10#1)(2008-11#1)
have been well established##5##4##(1994-11#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-6#1)
have been well##18##3##(1994-11#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
have been well-documented##2##3##(1997-1#1)(2010-3#1)
have been widely reported in##2##5##(2008-9#1)(2009-3#1)
have been widely reported##3##4##(2008-9#1)(2009-3#1)(2012-12#1)
have been widely used for the##2##6##(2008-11#1)(2008-2#1)
have been widely used for##5##5##(2008-11#2)(2008-2#2)(2008-3#1)
have been widely used in South East Asia##2##8##(2013-1#2)
have been widely used in##5##5##(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#2)
have been widely used##11##4##(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
have been widely##21##3##(1991-6#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
have been working##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
have been written##4##3##(1991-3#1)(2007-12#2)(2008-11#1)
have been##4340##2##(1990-10#1)(1990-11#16)(1990-12#10)(1990-2#8)(1990-3#10)(1990-5#22)(1990-6#14)(1990-7#10)(1990-8#14)(1990-9#8)(1991-1#4)(1991-10#1)(1991-11#5)(1991-12#22)(1991-2#8)(1991-3#13)(1991-4#4)(1991-5#12)(1991-6#11)(1991-8#6)(1991-9#9)(1992-1#3)(1992-10#3)(1992-11#11)(1992-12#12)(1992-2#13)(1992-3#22)(1992-4#1)(1992-5#6)(1992-6#17)(1992-8#13)(1992-9#13)(1993-1#3)(1993-11#13)(1993-12#20)(1993-2#6)(1993-3#15)(1993-5#1)(1993-6#13)(1993-8#11)(1993-9#4)(1994-1#3)(1994-11#10)(1994-12#24)(1994-2#12)(1994-3#17)(1994-5#21)(1994-6#18)(1994-7#2)(1994-8#17)(1994-9#17)(1995-1#6)(1995-11#17)(1995-12#17)(1995-2#24)(1995-3#15)(1995-5#19)(1995-6#20)(1995-8#7)(1995-9#3)(1996-1#10)(1996-10#1)(1996-11#10)(1996-12#19)(1996-2#25)(1996-3#10)(1996-4#4)(1996-5#16)(1996-6#9)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#15)(1997-2#22)(1997-3#12)(1997-4#29)(1997-5#12)(1997-6#12)(1997-7#31)(1997-8#20)(1997-9#1)(2006-10#14)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#17)(2007-11#77)(2007-12#77)(2007-2#7)(2007-5#11)(2007-6#4)(2007-7#20)(2007-8#26)(2007-9#5)(2008-1#44)(2008-10#885)(2008-11#156)(2008-12#42)(2008-2#107)(2008-3#197)(2008-4#96)(2008-5#132)(2008-6#44)(2008-7#187)(2008-8#100)(2008-9#91)(2009-1#4)(2009-10#15)(2009-11#17)(2009-12#21)(2009-2#7)(2009-3#15)(2009-4#7)(2009-5#26)(2009-6#17)(2009-7#17)(2009-8#30)(2009-9#15)(2010-1#19)(2010-10#21)(2010-11#14)(2010-12#32)(2010-2#12)(2010-3#17)(2010-4#19)(2010-5#28)(2010-6#21)(2010-7#22)(2010-8#42)(2010-9#5)(2011-1#57)(2011-2#122)(2011-3#15)(2011-7#2)(2012-1#14)(2012-12#47)(2012-2#92)(2012-3#66)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#123)(2013-7#20)(2013-8#46)
have begun to be##2##4##(2008-11#1)(2012-2#1)
have begun to investigate##2##4##(2009-3#1)(2010-11#1)
have begun to realize##2##4##(1996-3#1)(2012-2#1)
have begun to reveal##2##4##(1993-5#1)(2008-10#1)
have begun to use##2##4##(1996-12#1)(2007-8#1)
have begun to##26##3##(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)
have begun##30##2##(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)
have beneficial effects in##2##4##(2009-10#1)(2010-5#1)
have beneficial effects on##3##4##(2008-3#1)(2009-3#1)(2010-3#1)
have beneficial effects##7##3##(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-5#1)
have beneficial##11##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-3#2)(2010-3#1)(2010-5#1)
have benefited from the##2##4##(2008-10#1)(2011-2#1)
have benefited from##7##3##(1991-6#1)(1994-9#1)(1997-3#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
have benefited##8##2##(1991-6#1)(1992-5#1)(1994-9#1)(1997-3#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
have better statistical##2##3##(1997-8#1)(2007-11#1)
have better##14##2##(1995-12#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#2)
have biocontrol activity against##2##4##(2008-10#2)
have blood##2##2##(1996-5#1)(2008-1#1)
have both a##2##3##(2007-10#1)(2008-8#1)
have both been##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2013-8#1)
have both##17##2##(1994-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#2)(2013-8#1)
have briefly##2##2##(2008-10#1)(2009-12#1)
have broad##5##2##(2008-10#2)(2008-2#1)(2008-9#1)(2012-3#1)
have broadened##2##2##(2007-11#1)(2008-10#1)
have brought rapid##2##3##(1992-12#1)(2011-2#1)
have brought##6##2##(1992-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(2010-9#1)(2011-2#1)
have calculated the##2##3##(1995-6#1)(2008-3#1)
have calculated##4##2##(1995-6#1)(2006-6#1)(2008-3#2)
have called##2##2##(2008-11#1)(2009-10#1)
have cancer therapeutic##2##3##(2009-11#1)(2009-3#1)
have cancer##6##2##(1992-3#1)(1996-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)
have cardiovascular##2##2##(2008-3#1)(2011-2#1)
have carried out the##2##4##(1997-1#1)(2010-12#1)
have carried out##10##3##(1990-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2010-12#1)(2012-2#1)
have carried##11##2##(1990-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-10#1)(2010-12#1)(2012-2#1)
have cast##2##2##(2008-1#1)(2008-9#1)
have caused the##3##3##(1991-3#1)(2008-11#1)(2008-2#1)
have caused##15##2##(1991-3#1)(1992-2#1)(1992-6#1)(1994-3#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
have cell##2##2##(1992-11#1)(2008-11#1)
have centered on##2##3##(1996-9#1)(2010-7#1)
have centered##3##2##(1996-9#1)(2008-1#1)(2010-7#1)
have certain##8##2##(1991-6#1)(1994-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-3#1)
have challenged##3##2##(1993-12#1)(2008-7#1)(2009-3#1)
have changed very little##2##4##(1992-5#1)(1996-3#1)
have changed##15##2##(1990-6#1)(1991-3#1)(1992-5#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)
have changes##2##2##(2008-9#1)(2011-1#1)
have characteristics of##2##3##(1997-3#1)(2009-10#1)
have characteristics##4##2##(1997-3#1)(2008-10#2)(2009-10#1)
have characterized the##8##3##(1990-2#1)(1993-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2011-1#1)
have characterized##20##2##(1990-2#1)(1991-2#2)(1991-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-2#1)
have children##8##2##(1992-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
have chosen to##5##3##(1994-12#1)(1994-2#1)(2008-10#1)(2008-7#1)(2009-5#1)
have chosen##11##2##(1994-12#2)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-7#2)(2009-5#1)(2009-7#1)
have chronic##4##2##(1997-2#1)(1997-8#1)(2008-4#1)(2013-1#1)
have claimed that##5##3##(1995-11#1)(2007-5#1)(2008-8#1)(2009-2#1)(2010-8#1)
have clear##3##2##(1991-8#1)(2008-5#1)(2009-3#1)
have clearly demonstrated that##2##4##(2008-10#1)(2010-4#1)
have clearly##8##2##(1990-6#1)(1995-12#1)(2007-7#1)(2008-10#2)(2010-4#1)(2010-6#1)(2010-8#1)
have clinical##8##2##(2007-12#1)(2008-1#1)(2008-4#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
have clinically##2##2##(2007-7#1)(2008-1#1)
have cloned and sequenced the##3##5##(1992-12#1)(1993-9#1)(1997-7#1)
have cloned and sequenced##8##4##(1991-6#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1997-7#1)(2008-10#1)
have cloned and##10##3##(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1997-7#1)(2008-10#1)
have cloned two##2##3##(1993-6#1)(1994-9#1)
have cloned##30##2##(1990-11#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#2)(1996-6#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-5#1)
have coevolved with##2##3##(2008-10#1)(2013-1#1)
have combined##7##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-10#1)(2013-1#1)
have come a long way##2##5##(1991-1#1)(2010-12#1)
have come from##3##3##(1993-12#1)(2008-7#1)(2008-9#1)
have come into##3##3##(1990-2#1)(2012-1#1)(2012-12#1)
have come to light##2##4##(2008-6#1)(2009-10#1)
have come to the conclusion that##2##6##(1992-5#1)(2008-3#1)
have come to##7##3##(1991-1#1)(1992-5#1)(1993-6#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)
have come##21##2##(1990-2#1)(1991-1#3)(1992-5#1)(1993-12#1)(1993-6#1)(1996-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)
have commenced##2##2##(2008-5#2)
have communication related impairments##2##4##(2011-1#2)
have comparable##3##2##(2007-12#1)(2008-8#1)(2010-2#1)
have compared a##2##3##(1993-12#1)(1995-11#1)
have compared different##2##3##(2008-3#1)(2011-1#1)
have compared the results of##3##5##(1997-2#1)(2012-3#1)(2013-1#1)
have compared the results##4##4##(1997-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
have compared the##14##3##(1993-11#1)(1995-2#2)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
have compared##28##2##(1991-3#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-2#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
have completed##7##2##(1990-7#1)(1996-12#1)(1996-3#2)(1997-2#1)(2008-12#1)(2013-1#1)
have completely sequenced##2##3##(1997-7#1)(2008-2#1)
have completely##3##2##(1997-7#1)(2008-2#1)(2009-4#1)
have complex##6##2##(1994-8#1)(1995-5#1)(2007-12#1)(2008-11#2)(2008-2#1)
have computed##3##2##(1994-3#1)(2008-3#1)(2012-2#1)
have concerns##3##2##(1993-1#1)(1996-1#1)(2010-4#1)
have concluded that##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
have conducted a##5##3##(1991-12#1)(1994-2#1)(2009-10#1)(2010-11#1)(2011-2#1)
have conducted##9##2##(1991-12#1)(1994-2#1)(2007-7#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#1)
have confirmed that##8##3##(1995-11#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)
have confirmed the hypothesis##2##4##(1994-2#1)(2008-10#1)
have confirmed the##11##3##(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
have confirmed this##2##3##(2008-12#1)(2008-8#1)
have confirmed##28##2##(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2013-8#1)
have consequences##5##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
have considerable impact on##3##4##(1993-6#1)(2008-9#1)(2012-5#1)
have considerable##11##2##(1990-3#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-5#1)
have considered as##2##3##(2008-10#1)(2011-2#1)
have considered##7##2##(1990-7#1)(1994-3#1)(2007-12#1)(2008-10#1)(2009-2#1)(2011-2#1)(2013-7#1)
have consistently shown##2##3##(2008-3#2)
have consistently##6##2##(2008-3#3)(2008-6#1)(2008-7#1)(2009-7#1)
have constructed a series of##2##5##(1994-12#1)(2008-11#1)
have constructed a##20##3##(1992-2#1)(1994-12#1)(1995-6#1)(1996-10#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-11#4)(2008-3#5)(2008-9#1)(2010-10#1)(2012-2#1)
have constructed an##5##3##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
have constructed##44##2##(1990-5#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#4)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-2#2)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#9)(2008-7#1)(2008-9#2)(2010-10#1)(2012-2#1)
have contact##2##2##(1991-8#1)(2012-2#1)
have continued to make##2##4##(1993-12#1)(2008-7#1)
have continued to##5##3##(1993-12#1)(1996-3#2)(2008-11#1)(2008-7#1)
have continued##7##2##(1993-12#1)(1996-3#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
have continuously##2##2##(2008-2#1)(2011-2#1)
have contributed significantly##2##3##(1997-2#1)(2012-2#1)
have contributed to a##2##4##(2012-2#1)(2012-3#1)
have contributed to control##2##4##(1996-11#1)(2008-10#1)
have contributed to the development of##2##6##(2010-4#1)(2011-10#1)
have contributed to the increase in##2##6##(2010-8#1)(2012-2#1)
have contributed to the increased##2##5##(2008-10#1)(2008-6#1)
have contributed to the success of##2##6##(2010-7#1)(2010-8#1)
have contributed to the##23##4##(1991-2#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-2#1)(2012-7#1)
have contributed to##40##3##(1991-2#1)(1992-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)
have contributed##44##2##(1991-2#1)(1992-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#1)
have converged##3##2##(1995-11#1)(1997-8#1)(2008-10#1)
have convincingly demonstrated##2##3##(2010-11#1)(2011-1#1)
have correspondence##2##2##(2008-5#1)(2008-9#1)
have created a##4##3##(1993-12#1)(2007-11#1)(2007-12#1)(2010-12#1)
have created##14##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-1#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
have critical##2##2##(1991-1#1)(2010-1#1)
have cytotoxic##2##2##(1992-9#1)(1993-3#1)
have dealt with##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
have decided##2##2##(1990-6#1)(1997-3#1)
have declined##3##2##(1994-12#1)(1995-5#1)(2008-7#1)
have decreased the##2##3##(2008-11#1)(2012-2#1)
have decreased##9##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
have deduced##2##2##(1991-9#1)(2008-10#1)
have defined##5##2##(1991-11#1)(1991-9#1)(1993-6#1)(2008-10#1)(2008-9#1)
have deleterious effects on##2##4##(1995-3#1)(2008-7#1)
have deleterious##3##2##(1995-3#1)(1996-11#1)(2008-7#1)
have demonstrated a high##3##4##(2007-12#1)(2008-3#1)(2012-3#1)
have demonstrated a positive##2##4##(2008-10#1)(2008-7#1)
have demonstrated a##20##3##(1994-3#1)(1994-8#1)(1995-12#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
have demonstrated how##2##3##(2008-2#1)(2010-8#1)
have demonstrated in##3##3##(1990-11#1)(1993-8#1)(1994-6#1)
have demonstrated potential##2##3##(2010-6#1)(2013-1#1)
have demonstrated previously that##3##4##(1990-11#1)(2008-4#1)(2008-5#1)
have demonstrated that a##3##4##(1995-2#1)(2008-1#1)(2008-11#1)
have demonstrated that an##2##4##(1995-5#1)(2008-11#1)
have demonstrated that at##2##4##(2008-7#1)(2009-5#1)
have demonstrated that in##3##4##(1994-11#1)(2009-3#1)(2010-1#1)
have demonstrated that the##19##4##(1990-3#1)(1991-2#1)(1992-8#1)(1994-8#3)(1996-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#3)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#1)
have demonstrated that these##2##4##(2008-10#1)(2008-7#1)
have demonstrated that this##4##4##(1996-2#1)(2008-5#1)(2012-2#1)(2012-3#1)
have demonstrated that##83##3##(1990-12#1)(1990-3#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#3)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#3)
have demonstrated the ability##2##4##(2007-11#1)(2008-5#1)
have demonstrated the efficacy of##4##5##(1992-1#1)(2007-11#1)(2008-3#1)(2008-8#1)
have demonstrated the potential##2##4##(2008-2#1)(2010-12#1)
have demonstrated the presence of a##2##6##(1993-6#1)(1995-3#1)
have demonstrated the##31##3##(1990-6#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
have demonstrated their##2##3##(1992-8#1)(2013-1#1)
have demonstrated this##3##3##(1995-11#1)(2007-11#1)(2008-12#1)
have demonstrated##193##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#4)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#3)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#11)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#9)(2013-8#2)
have derived##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
have described a##4##3##(1992-12#1)(1994-5#1)(1997-3#1)(2008-7#1)
have described the##9##3##(1990-3#1)(1994-5#2)(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
have described##24##2##(1990-3#1)(1990-7#1)(1991-3#1)(1992-12#1)(1994-5#3)(1995-12#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
have designated this##2##3##(1990-5#1)(1995-6#1)
have designated##4##2##(1990-5#1)(1991-7#1)(1995-6#1)(2007-11#1)
have designed a##4##3##(1990-12#1)(2007-7#1)(2008-2#2)
have designed and built a##4##5##(2008-3#2)(2009-6#1)(2009-8#1)
have designed and##9##3##(2007-12#1)(2008-2#2)(2008-3#4)(2009-6#1)(2009-8#1)
have designed##19##2##(1990-12#1)(1995-5#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#4)(2008-3#6)(2009-6#1)(2009-8#1)
have detectable##2##2##(2006-10#1)(2008-5#1)
have detected##5##2##(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-9#1)
have determined a##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
have determined that##4##3##(1992-10#1)(1992-8#1)(1996-2#1)(1997-2#1)
have determined the complete nucleotide sequence of##2##7##(1994-12#1)(1995-9#1)
have determined the complete##3##4##(1993-2#1)(1994-12#1)(1995-9#1)
have determined the relative##2##4##(1991-12#1)(1994-8#1)
have determined the##17##3##(1990-5#1)(1991-12#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-9#1)(1997-3#2)(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
have determined##31##2##(1990-5#1)(1991-12#2)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)
have detrimental effects on the##2##5##(1991-3#1)(2013-1#1)
have detrimental effects##3##3##(1991-3#1)(1993-1#1)(2013-1#1)
have detrimental##6##2##(1991-3#1)(1993-1#1)(2008-1#1)(2008-11#1)(2009-9#1)(2013-1#1)
have devastating effects on##2##4##(2007-11#1)(2008-8#1)
have devastating##4##2##(2007-11#1)(2008-8#1)(2011-2#2)
have developed a method to##2##5##(2009-11#1)(2009-12#1)
have developed a method##5##4##(1993-8#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)
have developed a new method for##3##6##(2008-10#2)(2008-2#1)
have developed a new method##5##5##(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
have developed a new##15##4##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
have developed a novel##6##4##(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#2)
have developed a process to##2##5##(2008-5#1)(2008-6#1)
have developed a rapid##2##4##(1990-12#1)(2008-9#1)
have developed a sensitive##4##4##(1992-9#1)(1997-7#1)(2008-10#1)(2008-5#1)
have developed a simple##7##4##(1993-12#1)(1994-11#1)(2007-11#2)(2008-11#2)(2008-3#1)
have developed a unique##2##4##(1991-3#1)(1996-3#1)
have developed a variety of##2##5##(1997-2#1)(2008-6#1)
have developed a##125##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#9)(2007-12#6)(2007-5#1)(2007-6#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#16)(2008-5#7)(2008-6#2)(2008-7#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
have developed an improved##2##4##(1990-12#1)(2008-11#1)
have developed an in vitro##2##5##(1994-12#1)(2008-5#1)
have developed an##23##3##(1990-12#1)(1991-9#1)(1993-8#2)(1994-12#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-1#1)
have developed and implemented a##2##5##(2009-6#1)(2011-1#1)
have developed and##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-1#1)(2013-1#1)
have developed in##2##3##(1995-3#1)(1995-6#1)
have developed methods to##2##4##(1994-6#1)(2008-4#1)
have developed new##2##3##(2008-10#2)
have developed several##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
have developed the##7##3##(1994-6#1)(1996-2#1)(2007-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
have developed to##2##3##(1993-12#1)(2008-6#1)
have developed two##2##3##(1993-6#1)(2008-10#1)
have developed##204##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#11)(2007-12#12)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#23)(2008-11#11)(2008-12#1)(2008-2#8)(2008-3#23)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#3)(2011-1#7)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#1)
have devised an##2##3##(1994-2#1)(1997-4#1)
have devised##7##2##(1992-6#1)(1994-2#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-7#1)
have diabetes##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
have died of##3##3##(1990-6#1)(2007-11#1)(2007-7#1)
have died##15##2##(1990-6#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-7#1)(1995-12#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2012-2#1)
have different affinities for##2##4##(1990-11#1)(1991-11#1)
have different developmental##2##3##(1993-12#1)(2008-12#1)
have different effects on##2##4##(2008-10#1)(2008-8#1)
have different impacts##2##3##(2008-10#1)(2011-2#1)
have different perceptions of##2##4##(2008-8#1)(2011-1#1)
have different phenotypes##2##3##(1996-2#1)(2008-11#1)
have different properties##2##3##(1996-2#1)(2008-3#1)
have different##54##2##(1990-11#1)(1990-12#1)(1991-11#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-11#1)(1996-2#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#1)
have differential effects##2##3##(1992-12#1)(2008-4#1)
have differential##4##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
have difficulties in##2##3##(2008-3#1)(2009-10#1)
have difficulty##5##2##(1996-1#2)(2008-4#1)(2012-12#1)(2012-3#1)
have dire##2##2##(2012-2#2)
have direct##6##2##(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2012-2#1)
have directly measured##2##3##(2008-3#1)(2008-5#1)
have directly##5##2##(1994-8#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-5#1)
have disadvantages##2##2##(1997-7#1)(2008-5#1)
have disastrous consequences##2##3##(2008-1#1)(2008-9#1)
have discovered##6##2##(1991-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
have discussed the##2##3##(1997-7#1)(2010-3#1)
have discussed##6##2##(1991-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2010-3#1)(2012-2#1)
have displayed##2##2##(1995-12#1)(2010-6#1)
have distinct functions in##2##4##(2007-12#1)(2009-10#1)
have distinct functions##3##3##(1994-3#1)(2007-12#1)(2009-10#1)
have distinct roles in##2##4##(2008-5#1)(2013-8#1)
have distinct##16##2##(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-5#1)(2013-8#2)
have documented the##2##3##(2008-11#1)(2013-1#1)
have documented##7##2##(1991-8#1)(1996-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
have dominated the##2##3##(2009-7#1)(2012-3#1)
have dominated##3##2##(2008-4#1)(2009-7#1)(2012-3#1)
have done so##2##3##(1996-2#1)(2012-1#1)
have done##6##2##(1991-11#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-1#1)
have dramatic effects on##2##4##(1994-9#1)(2008-10#1)
have dramatic##3##2##(1994-9#1)(2008-10#1)(2012-1#1)
have dramatically different##2##3##(2008-9#1)(2011-1#1)
have dramatically##6##2##(1993-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#1)
have drawn##2##2##(2008-11#1)(2008-12#1)
have driven##3##2##(2008-8#1)(2009-2#1)(2012-2#1)
have effective##3##2##(1993-12#1)(1994-3#1)(2010-8#1)
have effects on##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2010-3#1)
have effects##7##2##(1990-2#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-3#1)
have efficacy in the##2##4##(1997-7#1)(2010-4#1)
have efficacy##3##2##(1997-7#1)(2008-9#1)(2010-4#1)
have either##8##2##(1991-1#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
have elevated##5##2##(1997-2#1)(1997-3#1)(1997-7#1)(2011-2#1)(2013-1#1)
have eliminated##2##2##(1991-9#1)(2008-10#1)
have elucidated the##2##3##(1993-11#1)(1996-2#1)
have elucidated##6##2##(1993-11#1)(1996-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
have embraced##2##2##(2009-9#1)(2013-1#1)
have emerged as a##6##4##(1993-3#1)(1996-11#1)(2007-11#1)(2007-2#1)(2008-2#1)(2009-8#1)
have emerged as##14##3##(1993-3#1)(1996-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2011-2#2)(2013-8#1)
have emerged in##2##3##(2008-10#1)(2008-5#1)
have emerged over the last##2##5##(2008-4#1)(2013-8#1)
have emerged to##2##3##(2011-2#2)
have emerged##30##2##(1993-3#1)(1996-11#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-8#2)
have emotional##3##2##(2009-10#1)(2009-7#1)(2012-2#1)
have emphasized the importance of##3##5##(2008-11#1)(2008-9#1)(2009-2#1)
have emphasized the##4##3##(2008-11#1)(2008-9#2)(2009-2#1)
have emphasized##8##2##(1990-8#1)(2006-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-2#1)(2013-1#1)
have employed a##2##3##(2008-2#1)(2013-8#1)
have employed the##2##3##(2008-11#1)(2008-9#1)
have employed##9##2##(1990-6#1)(1993-9#1)(1994-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)(2013-8#1)
have enabled the##2##3##(2008-10#1)(2013-8#1)
have enabled##7##2##(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
have encountered##3##2##(2007-7#1)(2008-8#1)(2012-3#1)
have endured##2##2##(2010-2#1)(2011-1#1)
have enhanced##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
have enough##4##2##(2008-10#1)(2008-7#2)(2013-8#1)
have enrolled##2##2##(2007-12#1)(2012-2#1)
have entered a##2##3##(1994-11#1)(2008-6#1)
have entered the##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
have entered##5##2##(1994-11#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
have equal##3##2##(2007-11#1)(2008-3#2)
have equally##2##2##(1997-3#1)(2009-4#1)
have established a##10##3##(1995-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2013-1#1)
have established that##4##3##(1990-2#1)(1995-5#1)(2008-5#1)(2011-2#1)
have established the##4##3##(1997-1#1)(2008-10#1)(2010-1#1)(2011-1#1)
have established two##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
have established##28##2##(1990-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
have estimated##2##2##(2008-11#1)(2009-4#1)
have evaluated the effects of##2##5##(2008-10#1)(2008-11#1)
have evaluated the role of##2##5##(1994-1#1)(2008-5#1)
have evaluated the##19##3##(1990-5#1)(1993-6#1)(1994-1#1)(1995-11#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-3#1)
have evaluated##33##2##(1990-12#2)(1990-5#1)(1992-12#1)(1993-6#1)(1994-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2010-2#1)(2010-3#2)(2010-8#1)(2012-2#1)(2012-3#1)
have even##3##2##(1995-12#1)(1997-3#1)(2008-10#1)
have evidence of##3##3##(1995-3#1)(2006-5#1)(2008-3#1)
have evolved and##2##3##(1994-8#1)(2008-10#1)
have evolved as a result of##2##6##(2008-7#1)(2012-3#1)
have evolved as a##4##4##(1994-8#1)(2008-7#1)(2012-3#1)(2013-7#1)
have evolved as##5##3##(1994-8#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
have evolved from the##4##4##(1995-6#1)(2008-7#1)(2010-3#1)(2012-12#1)
have evolved from##7##3##(1992-3#1)(1995-6#1)(1997-9#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)
have evolved in response to##2##5##(2008-8#1)(2010-5#1)
have evolved in##3##3##(2008-8#1)(2010-3#1)(2010-5#1)
have evolved to##7##3##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
have evolved under##3##3##(1997-9#1)(2007-12#1)(2009-6#1)
have evolved with##2##3##(2008-8#1)(2012-1#1)
have evolved##51##2##(1992-3#1)(1994-1#1)(1994-8#2)(1995-11#1)(1995-6#1)(1997-4#1)(1997-9#2)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-6#3)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
have examined some examples of such language use##2##8##(2013-1#2)
have examined the effect of##8##5##(1992-9#1)(1993-12#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-6#2)
have examined the effects of##4##5##(1990-8#1)(1992-1#1)(1995-5#1)(2008-7#1)
have examined the expression of##2##5##(1992-9#1)(1994-2#1)
have examined the role of##2##5##(1997-7#1)(2007-12#1)
have examined the##46##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-5#3)(1995-6#1)(1996-12#1)(1997-4#4)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#3)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
have examined this##4##3##(1990-5#1)(1992-3#1)(1995-3#1)(2009-6#1)
have examined which##2##3##(1991-12#1)(1995-11#1)
have examined##80##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#4)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#5)(2013-8#1)
have excellent##7##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
have expanded its##2##3##(2008-10#1)(2011-7#1)
have expanded##7##2##(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-7#1)
have expected##2##2##(1990-8#1)(2006-12#1)
have experienced a##2##3##(1991-12#1)(2012-1#1)
have experienced major##2##3##(2008-2#1)(2012-2#1)
have experienced##20##2##(1990-6#1)(1991-12#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-6#1)(2007-7#1)(2008-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
have experimentally demonstrated##2##3##(2008-2#1)(2008-3#1)
have experimentally##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
have exploited##4##2##(1992-4#1)(1994-2#1)(2008-8#1)(2011-1#1)
have explored the role of##2##5##(2008-7#1)(2010-1#1)
have explored the##11##3##(1990-8#1)(1991-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)
have explored##15##2##(1990-8#1)(1991-9#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-1#1)
have expressed the##3##3##(1990-8#1)(1994-8#1)(1997-4#1)
have expressed##11##2##(1990-8#1)(1993-11#1)(1994-11#2)(1994-8#2)(1995-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2009-9#1)
have extended the##4##3##(1995-11#1)(2008-11#1)(2008-2#1)(2010-11#1)
have extended these##3##3##(1990-5#1)(1991-12#1)(2008-11#1)
have extended##10##2##(1990-5#1)(1991-12#1)(1992-2#1)(1995-11#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-11#1)(2011-1#1)
have extensive##4##2##(1991-8#1)(1996-1#2)(2009-2#1)
have extensively##2##2##(2008-11#1)(2008-4#1)
have extremely##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
have faced##2##2##(2012-1#1)(2012-3#1)
have facilitated##3##2##(2008-6#1)(2008-9#1)(2009-6#1)
have failed to identify##2##4##(2008-7#1)(2011-2#1)
have failed to show a##2##5##(1994-2#1)(2008-1#1)
have failed to##13##3##(1993-3#1)(1994-2#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-7#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
have failed##22##2##(1993-3#1)(1994-2#1)(1994-5#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
have fallen short##2##3##(2008-1#1)(2008-7#1)
have fallen##5##2##(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
have features##6##2##(1992-9#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-7#1)(2010-8#1)
have few##3##2##(1991-11#1)(2008-11#1)(2010-8#1)
have fewer##4##2##(1994-3#1)(2008-9#1)(2010-12#1)(2010-5#1)
have finite##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
have focused attention on##2##4##(1992-12#1)(1995-12#1)
have focused on the##12##4##(1994-1#1)(1996-3#1)(1996-4#1)(1997-1#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)
have focused on##31##3##(1991-2#1)(1994-1#1)(1994-7#1)(1996-3#1)(1996-4#1)(1997-1#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
have focused their attention on##2##5##(2008-10#1)(2012-12#1)
have focused##42##2##(1991-2#1)(1992-12#1)(1994-1#1)(1994-7#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-1#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
have followed##7##2##(1993-12#1)(1996-1#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2012-12#1)
have for the##3##3##(1991-1#1)(2008-12#1)(2013-1#1)
have for##8##2##(1991-1#2)(1991-6#1)(1991-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)
have formed a##2##3##(1994-1#1)(2008-12#1)
have formed##8##2##(1992-11#1)(1992-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2008-12#1)(2008-3#1)(2009-5#1)
have found a##4##3##(1992-6#1)(2007-12#1)(2011-1#2)
have found few##2##3##(1996-5#1)(2008-4#1)
have found significant##2##3##(1997-5#1)(2008-7#1)
have found that a##3##4##(1991-11#1)(1995-2#1)(2013-1#1)
have found that the##7##4##(1991-5#1)(1993-3#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-11#1)(2010-11#1)
have found that##48##3##(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-3#2)(2008-5#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#3)(2013-1#1)
have found the##5##3##(1994-2#1)(1995-2#1)(2008-4#1)(2010-8#1)(2012-3#1)
have found##93##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
have frequently been##3##3##(2006-12#1)(2010-1#1)(2010-6#1)
have frequently##6##2##(1991-3#1)(2006-12#1)(2008-11#1)(2009-9#1)(2010-1#1)(2010-6#1)
have fully##2##2##(1995-8#1)(2008-10#1)
have functional##4##2##(1996-2#1)(2007-8#1)(2008-7#1)(2012-12#1)
have functions##2##2##(2008-10#1)(2008-5#1)
have fundamental##2##2##(2007-11#1)(2010-12#1)
have fundamentally##4##2##(1993-3#1)(1995-1#1)(2013-1#2)
have further##5##2##(1991-2#1)(1996-12#1)(2008-1#1)(2008-2#1)(2010-12#1)
have furthered##2##2##(2006-10#1)(2011-1#1)
have future##2##2##(2008-1#1)(2008-11#1)
have gained a new##2##4##(1992-3#1)(1994-2#1)
have gained##8##2##(1992-12#1)(1992-3#1)(1994-2#1)(2008-10#1)(2008-9#2)(2010-12#1)(2011-2#1)
have general##3##2##(1991-2#1)(1993-11#1)(2008-10#1)
have generally##4##2##(1994-6#1)(2010-11#1)(2012-2#2)
have generated a##3##3##(2008-4#1)(2008-7#1)(2011-1#1)
have generated mice##2##3##(1993-12#1)(1995-2#1)
have generated##20##2##(1990-12#1)(1992-3#1)(1993-12#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
have genomic##2##2##(2008-10#1)(2010-3#1)
have given rise to the##2##5##(2008-10#1)(2010-7#1)
have given rise to##3##4##(2008-10#1)(2010-7#1)(2013-8#1)
have given##11##2##(1992-2#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
have goiter##2##2##(2008-4#1)(2011-1#1)
have gone##4##2##(1991-12#1)(2007-11#1)(2008-8#1)(2012-12#1)
have good potential for##2##4##(2008-3#1)(2011-2#1)
have good##12##2##(1994-9#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2011-2#2)(2012-2#1)
have gotten##2##2##(1991-1#1)(1996-3#1)
have gradually##2##2##(2007-12#1)(2008-4#1)
have great potential##4##3##(2008-10#3)(2009-3#1)
have great##14##2##(1996-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
have greater##20##2##(1990-9#1)(1994-6#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#2)
have greatly increased##3##3##(1996-2#1)(2013-1#2)
have greatly##8##2##(1990-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-1#1)(2013-1#2)
have grown##8##2##(1991-3#1)(1992-2#2)(1996-3#1)(1997-2#1)(2007-11#1)(2008-5#1)(2008-9#1)
have had a negative##2##4##(1991-2#1)(2008-12#1)
have had a##16##3##(1991-2#1)(1991-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#4)
have had an##6##3##(1997-5#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
have had both operations##2##4##(2013-1#2)
have had early##2##3##(2008-8#1)(2011-2#1)
have had high##2##3##(2007-8#1)(2012-3#1)
have had limited##3##3##(1992-3#1)(1996-1#1)(2008-1#1)
have had no##3##3##(1992-10#1)(1996-1#1)(2009-10#1)
have had significant##2##3##(1991-12#1)(2008-10#1)
have had to##5##3##(1994-12#1)(1996-1#1)(2008-1#1)(2009-6#1)(2013-1#1)
have had##76##2##(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-3#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#8)
have harnessed the##2##3##(2009-5#1)(2011-2#1)
have helped to reduce the##2##5##(1996-9#1)(2008-10#1)
have helped to##8##3##(1990-12#1)(1992-12#1)(1996-9#2)(1997-6#1)(2008-10#2)(2008-7#1)
have helped##10##2##(1990-12#1)(1992-12#1)(1996-9#2)(1997-6#1)(2008-10#2)(2008-7#1)(2012-2#2)
have high levels of##3##4##(1995-12#1)(2010-8#1)(2013-1#1)
have high sensitivity##2##3##(2007-10#1)(2013-8#1)
have high##38##2##(1991-3#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-6#1)(2007-10#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
have higher levels of##4##4##(1994-2#1)(2008-2#1)(2010-3#1)(2013-1#1)
have higher rates of##4##4##(2008-2#2)(2008-4#1)(2012-12#1)
have higher rates##5##3##(1995-2#1)(2008-2#2)(2008-4#1)(2012-12#1)
have higher##40##2##(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
have highlighted the##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
have highlighted##11##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
have highly##6##2##(1995-1#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
have historically##4##2##(1994-12#1)(1996-1#1)(2008-5#1)(2008-9#1)
have homologues##2##2##(1996-3#1)(1996-6#1)
have hypothesized that##2##3##(2007-10#1)(2009-8#1)
have hypothesized##3##2##(2007-10#1)(2009-8#1)(2011-2#1)
have identical##2##2##(1990-12#1)(2008-10#1)
have identified a##17##3##(1990-5#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1995-5#1)(1995-6#2)(1995-9#1)(2008-7#1)(2010-11#1)(2010-3#1)
have identified an##3##3##(1990-2#1)(1991-5#1)(1996-2#1)
have identified and characterized a##2##5##(1995-2#1)(2008-10#1)
have identified and##6##3##(1990-12#1)(1995-2#2)(2008-10#2)(2013-1#1)
have identified genes##2##3##(2008-10#1)(2011-2#1)
have identified many genes##2##4##(2007-12#1)(2012-3#1)
have identified regions in the##2##5##(2008-1#1)(2009-6#1)
have identified regions##4##3##(1992-8#1)(1995-2#1)(2008-1#1)(2009-6#1)
have identified that##2##3##(2008-3#1)(2010-11#1)
have identified the##19##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)
have identified three##3##3##(1990-11#1)(1991-5#1)(1996-5#1)
have identified two types of##2##5##(1992-6#1)(1994-3#1)
have identified two##5##3##(1992-12#1)(1992-6#1)(1994-3#1)(1994-9#1)(2008-8#1)
have identified##105##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1991-12#3)(1991-5#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-12#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
have illustrated##2##2##(2008-8#1)(2009-10#1)
have impaired##2##2##(2008-7#2)
have implemented a##3##3##(1995-12#1)(2008-3#1)(2008-6#1)
have implemented##13##2##(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-8#1)(2007-12#1)(2008-3#4)(2008-6#1)(2009-6#1)(2012-2#1)
have implicated##10##2##(1991-9#1)(1993-11#1)(1994-3#1)(1997-7#1)(2008-11#2)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
have implication##2##2##(2008-5#1)(2012-3#1)
have implications for the management of##2##6##(2008-9#1)(2013-1#1)
have implications for the##10##4##(1993-2#1)(1995-6#1)(1996-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
have implications for##37##3##(1992-2#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
have implications on##2##3##(2009-4#1)(2011-1#1)
have implications##44##2##(1992-2#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
have important clinical implications##2##4##(2008-1#1)(2010-11#1)
have important clinical##3##3##(2007-10#1)(2008-1#1)(2010-11#1)
have important impacts on##2##4##(2007-3#1)(2012-2#1)
have important implications for the##2##5##(1993-3#1)(2013-7#1)
have important implications for##21##4##(1993-11#1)(1993-3#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-10#1)(2012-1#1)(2013-1#1)(2013-7#1)
have important implications in##4##4##(2007-7#1)(2009-12#1)(2009-8#1)(2012-12#1)
have important implications##29##3##(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
have important policy implications for##2##5##(1993-12#1)(1994-12#1)
have important roles in##3##4##(2008-7#1)(2012-2#1)(2013-8#1)
have important##49##2##(1990-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
have improved the##10##3##(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-8#1)
have improved their##2##3##(1990-11#1)(1997-6#1)
have improved##25##2##(1990-11#1)(1994-6#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
have in common##4##3##(1990-8#1)(1997-3#1)(2008-6#1)(2008-7#1)
have in general##2##3##(2007-2#1)(2010-1#1)
have in the##4##3##(1996-6#1)(2008-1#1)(2008-7#1)(2009-8#1)
have in##23##2##(1990-8#2)(1991-9#1)(1993-12#1)(1993-2#1)(1996-6#1)(1997-3#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#2)(2010-1#1)(2012-12#1)(2013-1#1)
have included the##2##3##(2008-3#1)(2008-9#1)
have included##9##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
have incorporated the##3##3##(2008-3#1)(2008-9#1)(2010-1#1)
have incorporated##8##2##(1995-3#1)(2007-5#1)(2008-3#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)
have increased by##3##3##(1992-3#1)(1997-6#1)(1997-8#1)
have increased from##2##3##(1997-1#1)(2007-2#1)
have increased in##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
have increased our understanding of the##2##6##(1995-5#1)(2008-7#1)
have increased substantially##2##3##(1994-6#1)(2008-7#1)
have increased the need for##2##5##(1994-1#1)(2008-11#1)
have increased the##10##3##(1991-12#1)(1994-1#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)
have increased##49##2##(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#2)(2009-11#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
have increasingly been##2##3##(2011-2#1)(2012-2#1)
have incremental benefit over##2##4##(2008-1#1)(2009-10#1)
have independently##2##2##(2008-11#1)(2011-2#1)
have indicated a##3##3##(1991-4#1)(1994-6#1)(2007-7#1)
have indicated an##2##3##(1994-2#1)(1996-12#1)
have indicated that the##8##4##(1994-8#1)(1995-6#1)(1996-11#1)(2008-10#2)(2008-9#1)(2010-11#1)(2012-2#1)
have indicated that##31##3##(1992-11#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(2008-10#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
have indicated##44##2##(1990-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
have influence on the##2##4##(1990-8#1)(2011-2#1)
have influenced the##6##3##(1990-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
have influenced##9##2##(1990-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
have inherent##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
have initially##2##2##(2008-10#1)(2008-4#1)
have initiated a study of##2##5##(1993-9#1)(1995-11#1)
have initiated a##4##3##(1993-9#1)(1995-11#1)(2007-5#1)(2012-3#1)
have initiated##8##2##(1993-9#1)(1995-11#2)(1996-2#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
have inspired the##2##3##(2007-12#1)(2008-7#1)
have insufficient##2##2##(1995-1#1)(2008-1#1)
have integrated##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
have interesting##2##2##(2008-5#1)(2010-11#1)
have internal##2##2##(2008-6#2)
have intrinsic##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
have introduced a##4##3##(1993-11#1)(1995-8#1)(1997-2#1)(2010-6#1)
have introduced##8##2##(1993-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-6#1)
have invaded##2##2##(1991-12#1)(2008-8#1)
have invested##2##2##(1993-12#1)(2009-3#1)
have investigated a##2##3##(2008-11#1)(2008-2#1)
have investigated how##5##3##(1994-8#1)(1996-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
have investigated the effect of##8##5##(1992-3#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2013-1#1)
have investigated the influence of##4##5##(2008-10#1)(2008-11#2)(2008-2#1)
have investigated the possible##2##4##(1995-12#1)(2012-2#1)
have investigated the regulation##2##4##(1993-5#1)(2008-11#1)
have investigated the role of##4##5##(1997-2#1)(2008-10#1)(2008-7#2)
have investigated the use of two##2##6##(1991-5#1)(2008-12#1)
have investigated the use of##5##5##(1991-5#1)(2008-10#1)(2008-12#1)(2008-7#2)
have investigated the##68##3##(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#4)(2008-10#7)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#10)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2012-2#2)(2013-1#1)
have investigated whether the##2##4##(1994-2#1)(1994-9#1)
have investigated whether##5##3##(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(2012-2#1)
have investigated##95##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#4)(2007-12#1)(2008-10#7)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#12)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
have irreversible##2##2##(1995-12#1)(2013-1#1)
have isolated a##11##3##(1990-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)
have isolated and characterised##2##4##(1993-2#1)(2008-11#1)
have isolated and characterized##3##4##(1991-6#1)(1992-9#1)(1997-6#1)
have isolated and sequenced##3##4##(1990-7#1)(1991-2#1)(1993-6#1)
have isolated and##11##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-9#1)(1997-6#1)(2008-11#1)
have isolated cDNA clones##2##4##(1993-6#1)(2008-5#1)
have isolated##37##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-6#3)(1993-9#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)
have its##3##2##(1997-6#1)(2008-5#1)(2011-2#1)
have just##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)
have known##2##2##(2008-1#1)(2008-10#1)
have laid##2##2##(1991-6#1)(2008-9#1)
have large##8##2##(1990-11#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-8#1)
have largely been##5##3##(1997-8#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-4#1)
have largely##14##2##(1990-11#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#4)(2009-8#1)(2009-9#1)(2012-2#2)(2012-4#1)
have launched##2##2##(1996-12#1)(2007-12#1)
have lead to the##2##4##(2008-11#1)(2008-5#1)
have lead to##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
have lead##4##2##(1994-2#1)(2008-11#1)(2008-5#1)(2010-8#1)
have learned to##4##3##(1991-12#1)(1996-1#2)(2008-2#1)
have learned##12##2##(1991-12#3)(1993-12#1)(1996-1#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-12#1)
have led to a##11##4##(1993-11#1)(1993-8#1)(2008-3#2)(2008-5#1)(2010-10#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#2)
have led to an increase in the##2##7##(2008-10#1)(2008-11#1)
have led to an##4##4##(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
have led to improved##2##4##(2008-8#1)(2009-6#1)
have led to significant advances in##2##6##(2009-3#1)(2011-1#1)
have led to the conclusion that##2##6##(1995-3#1)(2008-3#1)
have led to the development of##3##6##(2008-5#2)(2010-1#1)
have led to the discovery of the##2##7##(2008-11#1)(2013-8#1)
have led to the discovery of##5##6##(2008-11#1)(2009-5#1)(2012-3#2)(2013-8#1)
have led to the identification of##3##6##(2008-7#2)(2012-3#1)
have led to the recognition of##2##6##(1997-8#1)(2010-4#1)
have led to the##32##4##(1995-3#1)(1996-2#1)(1997-8#1)(2007-5#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
have led to##72##3##(1990-6#1)(1992-2#1)(1993-11#1)(1993-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-5#1)(2007-6#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
have led##77##2##(1990-6#1)(1992-2#1)(1993-11#1)(1993-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
have left##3##2##(1991-2#1)(2010-12#1)(2011-2#1)
have less extensive##2##3##(2007-8#1)(2012-12#1)
have less opportunity to##2##4##(1992-11#1)(2008-1#1)
have less than##2##3##(1997-6#1)(2011-2#1)
have less##12##2##(1992-11#1)(1993-11#1)(1995-1#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)
have limitations##8##2##(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-8#1)(2013-1#1)
have limited sensitivity##2##3##(2008-7#1)(2010-5#1)
have limited the##2##3##(1997-8#1)(2008-8#1)
have limited time##2##3##(2010-12#1)(2012-2#1)
have limited##28##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-8#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)
have little confidence in##2##4##(1992-11#1)(2011-1#1)
have little control over##2##4##(2008-1#2)
have little effect on the##3##5##(1994-6#1)(2008-2#1)(2008-8#1)
have little effect on##4##4##(1993-1#1)(1994-6#1)(2008-2#1)(2008-8#1)
have little effect##5##3##(1993-1#1)(1994-12#1)(1994-6#1)(2008-2#1)(2008-8#1)
have little if any effect##2##5##(1991-7#1)(1993-5#1)
have little or no##4##4##(1995-5#1)(2007-4#1)(2008-10#1)(2012-12#1)
have little##25##2##(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-5#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#1)
have lived##2##2##(2008-11#1)(2008-8#1)
have localized the##2##3##(1991-9#1)(1995-6#1)
have localized##4##2##(1991-9#1)(1993-6#1)(1995-12#1)(1995-6#1)
have locally##2##2##(1992-3#1)(2013-7#1)
have located##3##2##(1992-12#1)(1996-12#1)(2008-2#1)
have long been implicated in##2##5##(2008-11#1)(2009-6#1)
have long been known to##2##5##(2008-9#1)(2010-7#1)
have long been##14##3##(1994-3#1)(1996-12#1)(2008-11#3)(2008-9#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
have long##26##2##(1993-2#1)(1994-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
have long-term##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
have longer##2##2##(1996-2#1)(2008-10#1)
have looked at##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
have lost the##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
have lost##8##2##(1993-2#1)(1994-12#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-6#1)(2011-2#1)
have low genetic##2##3##(2008-10#1)(2013-1#1)
have low##26##2##(1990-5#1)(1993-3#1)(1995-2#2)(1995-6#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
have lower##16##2##(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
have lowered##2##2##(1994-1#1)(2008-5#1)
have made a significant##2##4##(2008-11#1)(2010-12#1)
have made a##4##3##(1990-11#1)(2007-11#1)(2008-11#1)(2010-12#1)
have made an attempt to##2##5##(2008-10#1)(2009-7#1)
have made an##4##3##(2008-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
have made great##2##3##(2008-10#1)(2011-3#1)
have made it easier to##2##5##(1997-5#1)(2011-2#1)
have made it possible to##3##5##(1994-6#1)(2007-12#1)(2008-3#1)
have made it possible##4##4##(1994-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
have made it##7##3##(1994-6#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
have made possible the##2##4##(1991-5#1)(2008-5#1)
have made progress in##2##4##(2009-7#1)(2013-1#1)
have made the##4##3##(1993-12#1)(1994-2#1)(2008-11#1)(2012-3#1)
have made this##2##3##(2008-7#1)(2012-2#1)
have made##48##2##(1990-11#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#3)(2009-8#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#1)
have magnetic##2##2##(1996-2#1)(2008-11#1)
have mainly##2##2##(2008-3#1)(2008-5#1)
have maintained##3##2##(1992-12#1)(2007-12#1)(2010-5#1)
have major roles in##2##4##(2007-12#1)(2008-7#1)
have major##7##2##(1992-6#1)(1996-12#1)(2007-12#1)(2008-7#3)(2008-8#1)
have many advantages##4##3##(1997-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
have many potential applications in nucleic acid biochemistry##2##8##(2008-4#2)
have many potential##3##3##(2008-4#2)(2008-5#1)
have many##17##2##(1991-5#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
have mapped the##4##3##(1990-12#1)(1994-12#1)(2008-11#1)(2008-7#1)
have mapped##5##2##(1990-12#1)(1994-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
have marked##2##2##(2008-4#1)(2008-9#1)
have meant##3##2##(1992-5#1)(1995-12#1)(2009-7#1)
have measured the##15##3##(1991-12#1)(1991-5#1)(1993-9#1)(1995-2#1)(1995-5#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)
have measured##23##2##(1991-12#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-9#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2010-6#1)
have mild##2##2##(2008-7#1)(2010-5#1)
have minimal effects on##2##4##(1996-2#1)(2008-3#1)
have minimal##3##2##(1996-2#1)(2008-3#2)
have missed##2##2##(2012-12#1)(2013-1#1)
have modeled the##3##3##(2008-3#3)
have modeled##6##2##(2008-11#1)(2008-3#4)(2010-4#1)
have moderate##2##2##(2008-1#1)(2008-5#1)
have modified the##5##3##(1995-2#1)(2008-10#1)(2008-11#3)
have modified##6##2##(1995-2#1)(2008-10#1)(2008-11#3)(2008-2#1)
have monitored the##2##3##(2008-3#1)(2008-9#1)
have monitored##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
have more physical##2##3##(2013-8#2)
have more recently##2##3##(2008-11#1)(2008-7#1)
have more severe##2##3##(2012-2#1)(2013-8#1)
have more species##2##3##(2008-9#2)
have more than one##2##4##(1996-2#1)(2008-3#1)
have more than##4##3##(1996-2#1)(2008-10#2)(2008-3#1)
have more##44##2##(1991-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#4)
have most##2##2##(2008-2#1)(2010-7#1)
have mostly##3##2##(2008-11#1)(2008-7#1)(2009-1#1)
have moved##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
have much in common##3##4##(1995-1#1)(1996-1#1)(2008-10#1)
have much to contribute to##2##5##(2008-11#1)(2008-9#1)
have much to offer to##2##5##(2008-7#1)(2009-5#1)
have much to offer##4##4##(1993-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
have much to##7##3##(1993-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
have much##15##2##(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
have multiple causes##2##3##(2010-10#1)(2013-8#1)
have multiple##14##2##(1992-3#1)(1993-3#1)(2008-10#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
have named the##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
have named##7##2##(1991-12#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
have nearly##3##2##(1993-2#1)(2008-3#2)
have necessitated##3##2##(2008-1#1)(2008-2#1)(2009-10#1)
have negative consequences##2##3##(1997-2#1)(2010-3#1)
have negative##6##2##(1997-2#1)(2007-11#1)(2008-11#1)(2010-3#2)(2010-5#1)
have negligible##2##2##(2008-3#1)(2010-6#1)
have never been##10##3##(1993-11#1)(1996-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
have never heard of##2##4##(2009-5#1)(2013-1#1)
have never##17##2##(1993-11#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
have new##3##2##(1994-11#1)(2008-10#2)
have no apparent##3##3##(2008-11#1)(2008-8#1)(2009-9#1)
have no effect on the##6##5##(1994-8#1)(2008-10#4)(2008-3#1)
have no effect on##13##4##(1991-2#1)(1993-12#1)(1994-8#1)(1995-8#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
have no effect##14##3##(1991-2#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-3#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
have no influence on the##2##5##(2008-3#2)
have no influence on##3##4##(2007-8#1)(2008-3#2)
have no known sexual##2##4##(2008-10#2)
have no negative##2##3##(1990-2#1)(1993-2#1)
have no or##2##3##(1997-7#1)(2010-12#1)
have no##64##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-2#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-7#3)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#2)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
have normal##10##2##(1995-8#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
have not always been##2##4##(1993-12#1)(1994-12#1)
have not become##2##3##(2008-10#1)(2009-10#1)
have not been adequately##3##4##(2008-11#1)(2010-5#1)(2013-1#1)
have not been characterized##2##4##(1995-6#1)(2007-11#1)
have not been clearly##2##4##(2011-2#1)(2012-2#1)
have not been completely##2##4##(1997-4#1)(2008-10#1)
have not been conclusively##2##4##(2008-11#1)(2008-8#1)
have not been described previously##2##5##(1997-3#1)(2008-12#1)
have not been described##4##4##(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
have not been detected##2##4##(2008-10#1)(2013-1#1)
have not been determined##4##4##(2007-12#1)(2008-10#1)(2008-7#2)
have not been established##2##4##(2008-10#1)(2009-5#1)
have not been explored##4##4##(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
have not been extensively##2##4##(2008-7#1)(2012-2#1)
have not been found##4##4##(1993-6#1)(1996-4#1)(2008-10#1)(2008-4#1)
have not been fully elucidated##3##5##(1990-2#1)(2008-1#1)(2008-6#1)
have not been fully established##2##5##(2011-2#1)(2013-1#1)
have not been fully##7##4##(1990-2#1)(1993-8#1)(2008-1#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-1#1)
have not been identified##4##4##(2008-10#2)(2008-7#1)(2008-9#1)
have not been investigated##4##4##(1994-12#1)(2007-11#1)(2008-6#1)(2010-8#1)
have not been observed##2##4##(1993-2#1)(2008-10#1)
have not been performed##2##4##(2007-11#1)(2007-12#1)
have not been previously reported##4##5##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
have not been previously##6##4##(2008-3#2)(2008-6#1)(2008-9#1)(2010-1#1)(2011-2#1)
have not been reported before##2##5##(1993-12#1)(2011-2#1)
have not been reported##11##4##(1993-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#1)
have not been shown to##2##5##(2008-10#1)(2012-12#1)
have not been studied in##2##5##(2008-5#1)(2011-1#1)
have not been studied##6##4##(1997-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
have not been tested##2##4##(1990-6#1)(2013-1#1)
have not been used##2##4##(2008-3#1)(2009-10#1)
have not been validated##2##4##(2008-5#1)(2011-2#1)
have not been well studied##2##5##(1997-3#1)(2012-2#1)
have not been well##5##4##(1997-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2012-2#1)
have not been widely##4##4##(1992-1#1)(2009-4#1)(2009-6#1)(2010-6#1)
have not been##133##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1995-2#1)(1995-6#3)(1996-11#1)(1996-4#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#4)
have not found##4##3##(1995-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
have not fully##2##3##(2008-7#1)(2009-10#1)
have not had##3##3##(1995-3#1)(2008-4#1)(2008-6#1)
have not only##3##3##(2008-12#1)(2008-5#1)(2009-3#1)
have not previously been##6##4##(1994-6#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-8#1)
have not provided##3##3##(1990-11#1)(1991-2#1)(1992-3#1)
have not reached##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
have not received##4##3##(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
have not taken##3##3##(1993-3#1)(1994-11#1)(1994-3#1)
have not yet been clearly##2##5##(1990-8#1)(1991-5#1)
have not yet been investigated##2##5##(2007-7#1)(2009-5#1)
have not yet been widely##2##5##(2008-11#1)(2012-2#1)
have not yet been##18##4##(1990-8#1)(1991-5#1)(1993-1#1)(1993-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#2)(2010-12#1)(2012-2#2)(2012-3#1)
have not yet reached##2##4##(1994-3#1)(2012-12#1)
have not yet##28##3##(1990-8#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-5#2)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#1)
have not##245##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#11)(2008-6#7)(2008-7#12)(2008-8#6)(2008-9#8)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#11)(2012-12#5)(2012-2#10)(2012-3#3)(2012-8#1)(2013-1#6)
have noted##4##2##(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
have noticed##2##2##(2009-10#1)(2013-1#1)
have novel##2##2##(1993-6#1)(2008-10#1)
have now been able to##2##5##(1992-12#1)(1997-7#1)
have now been made##2##4##(1994-5#1)(2008-5#1)
have now been shown to##2##5##(1995-6#1)(1995-8#1)
have now been##14##3##(1992-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-5#4)(2011-2#1)(2012-3#1)
have now demonstrated that##4##4##(1997-1#1)(2008-11#1)(2009-2#1)(2009-6#1)
have now identified##2##3##(1993-2#1)(1997-7#1)
have now##41##2##(1990-12#1)(1990-9#1)(1991-11#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
have numerous##2##2##(2007-11#1)(2012-2#1)
have observed a##4##3##(1990-3#1)(1996-3#1)(2007-11#1)(2008-6#1)
have observed an##2##3##(1992-6#1)(1995-8#1)
have observed changes##2##3##(2007-12#1)(2008-7#1)
have observed that the##3##4##(1992-3#1)(2007-11#2)
have observed that##9##3##(1992-3#1)(1995-6#1)(1996-2#1)(2007-11#2)(2008-11#2)(2010-5#1)(2013-1#1)
have observed the##2##3##(2007-12#1)(2008-3#1)
have observed##35##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#4)(2007-12#8)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-5#1)(2013-1#1)
have obtained##22##2##(1990-5#1)(1990-9#1)(1992-10#1)(1992-9#2)(1993-8#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-11#1)
have obvious##2##2##(2008-9#1)(2013-8#1)
have occurred between##2##3##(2008-10#1)(2013-1#1)
have occurred by##2##3##(2010-5#1)(2011-2#1)
have occurred in the##7##4##(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
have occurred in##16##3##(1994-5#1)(1995-2#1)(1996-11#1)(2008-10#6)(2008-11#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
have occurred##44##2##(1991-1#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#1)
have of##3##2##(2008-5#1)(2010-3#2)
have often been##6##3##(1994-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
have often##8##2##(1992-3#1)(1994-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#2)(2013-1#1)
have on the##8##3##(1990-2#1)(1993-12#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
have on##37##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)
have one##5##2##(1991-10#1)(1996-1#1)(2007-12#1)(2008-12#1)(2008-5#1)
have only a minor##2##4##(2008-10#1)(2013-8#1)
have only a##9##3##(1991-5#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
have only been##2##3##(1995-8#1)(2008-5#1)
have only recently begun##2##4##(2008-11#1)(2013-8#1)
have only recently##5##3##(1995-2#1)(2008-11#2)(2009-8#1)(2013-8#1)
have only##30##2##(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#3)
have opened##4##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)
have operational##2##2##(1997-8#1)(2008-7#1)
have optical##2##2##(2008-10#1)(2012-1#1)
have optimal##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
have optimized##5##2##(2008-11#2)(2008-2#1)(2011-2#1)(2012-1#1)
have or##2##2##(1991-1#1)(1992-2#1)
have originated from##3##3##(2007-12#1)(2008-12#1)(2009-2#1)
have originated##7##2##(2007-12#2)(2008-10#2)(2008-12#1)(2008-8#1)(2009-2#1)
have other##11##2##(1992-12#1)(1994-9#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2013-7#1)
have overcome##2##2##(1994-1#1)(1996-12#1)
have overlapping##4##2##(1995-5#1)(2012-3#1)(2013-1#2)
have partially characterized##2##3##(2008-10#1)(2008-4#1)
have partially##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
have participated in the##2##4##(2008-1#1)(2012-2#1)
have participated in##4##3##(1996-12#1)(2008-1#2)(2012-2#1)
have particular##3##2##(2008-8#1)(2010-12#1)(2012-2#1)
have passed##6##2##(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
have patients##2##2##(2007-8#1)(2008-6#1)
have performed a##5##3##(1992-6#1)(2008-7#1)(2012-3#1)(2013-1#2)
have performed an##2##3##(1994-6#1)(2008-2#1)
have performed##18##2##(1990-2#1)(1992-6#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
have permitted a##2##3##(2007-11#1)(2008-11#1)
have permitted the##2##3##(2008-2#1)(2010-2#1)
have permitted##5##2##(2007-11#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-8#1)
have placed##2##2##(1992-12#1)(2013-1#1)
have played a role in the##2##6##(2008-7#1)(2013-1#1)
have played a##6##3##(1990-6#1)(1991-1#1)(2008-7#2)(2008-8#1)(2013-1#1)
have played an important role in##2##6##(1991-6#1)(1993-3#1)
have played an important##3##4##(1991-6#1)(1991-9#1)(1993-3#1)
have played important roles in##2##5##(1995-4#1)(2012-12#1)
have played##13##2##(1990-6#1)(1991-1#1)(1991-6#1)(1991-9#1)(1993-3#1)(1995-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
have policies##2##2##(1994-2#1)(2011-2#1)
have poor##3##2##(1993-12#1)(2007-11#1)(2008-1#1)
have poorer##4##2##(1994-12#1)(2008-1#1)(2008-11#1)(2011-1#1)
have positive##7##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)(2013-1#1)
have postulated##2##2##(2008-7#1)(2012-12#1)
have potential advantages##2##3##(2008-10#1)(2013-1#1)
have potential application in##3##4##(1996-3#1)(2008-3#1)(2013-1#1)
have potential application##4##3##(1996-3#1)(2008-3#1)(2008-9#1)(2013-1#1)
have potential as##2##3##(1997-4#1)(2008-10#1)
have potential for##4##3##(1994-6#1)(2008-10#2)(2013-1#1)
have potential in##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
have potential therapeutic implications##2##4##(1994-6#1)(2012-2#1)
have potential to##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
have potential utility##2##3##(2008-5#1)(2008-6#1)
have potential##33##2##(1994-6#2)(1996-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#5)
have potentially##2##2##(2008-11#2)
have practical implications for##2##4##(2008-8#1)(2010-5#1)
have practical##3##2##(1991-11#1)(2008-8#1)(2010-5#1)
have precisely##2##2##(1997-3#1)(2008-1#1)
have predicted the##2##3##(2008-8#1)(2010-7#1)
have predicted##5##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)
have prepared##6##2##(1991-12#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-9#1)
have presented##10##2##(1991-2#1)(1992-3#1)(1994-5#1)(1997-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-1#3)
have prevalence rates that are intermediate to those of the two corresponding monoracial/ethnic rates##2##14##(2013-8#2)
have previously been described##2##4##(1992-10#1)(2009-3#1)
have previously been found to##2##5##(2008-8#1)(2012-12#1)
have previously been identified##3##4##(1994-12#1)(1996-3#1)(2008-10#1)
have previously been reported##4##4##(1992-5#1)(1993-8#1)(2008-11#1)(2008-7#1)
have previously been shown to be##2##6##(2008-10#1)(2010-8#1)
have previously been shown to##7##5##(1990-7#1)(1993-12#1)(1993-8#1)(2008-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
have previously been used##2##4##(2008-4#1)(2008-6#1)
have previously been##25##3##(1990-7#1)(1991-6#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-5#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
have previously demonstrated that##6##4##(1992-12#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-11#1)(2013-8#1)
have previously demonstrated##8##3##(1992-12#1)(1993-11#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
have previously described##3##3##(1992-3#1)(1992-8#1)(1996-12#1)
have previously identified##3##3##(1994-11#1)(1994-8#1)(2010-11#1)
have previously isolated##2##3##(1997-8#1)(2008-5#1)
have previously reported that##5##4##(1992-8#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-4#1)
have previously reported the##4##4##(1994-8#1)(1997-8#1)(2008-10#1)(2010-3#1)
have previously reported##11##3##(1991-2#1)(1992-8#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-1#1)
have previously shown that##24##4##(1990-12#1)(1991-12#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
have previously shown##28##3##(1990-12#1)(1991-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
have previously##97##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
have primarily##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
have private##3##2##(1991-2#1)(1992-2#1)(1996-3#1)
have problems##4##2##(1992-5#1)(2008-3#1)(2008-6#1)(2008-9#1)
have produced a##5##3##(1994-3#2)(2007-11#1)(2008-11#1)(2010-11#1)
have produced the##2##3##(1990-11#1)(2008-2#1)
have produced##30##2##(1990-11#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-11#1)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#2)(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)
have profound effects on the##3##5##(2008-8#1)(2010-1#1)(2010-3#1)
have profound effects on##6##4##(2008-5#1)(2008-8#3)(2010-1#1)(2010-3#1)
have profound##10##2##(1994-2#1)(1997-2#1)(2008-5#2)(2008-8#4)(2010-1#1)(2010-3#1)
have prognostic value##3##3##(1990-5#1)(2008-3#1)(2010-10#1)
have prognostic##5##2##(1990-5#1)(1997-7#1)(2008-3#1)(2008-9#1)(2010-10#1)
have progressed through##2##3##(1996-3#1)(2008-10#1)
have progressed##7##2##(1991-1#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2010-3#1)(2012-12#1)
have prolonged##2##2##(2008-10#1)(2008-11#1)
have promise##2##2##(1997-1#1)(2009-10#1)
have promoted the##2##3##(2009-4#1)(2013-1#1)
have promoted##4##2##(2008-6#1)(2009-4#1)(2013-1#2)
have prompted the##3##3##(2008-7#1)(2010-3#1)(2012-12#1)
have prompted##7##2##(2008-1#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-3#2)
have proper##3##2##(1994-9#1)(2008-1#1)(2009-12#1)
have properties that##2##3##(1995-3#1)(2008-3#1)
have properties##4##2##(1995-3#1)(2008-3#2)(2008-8#1)
have proposed a##5##3##(1996-5#1)(2007-11#2)(2010-3#1)(2010-8#1)
have proposed that##9##3##(1995-2#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
have proposed##16##2##(1995-2#1)(1996-1#1)(1996-5#1)(1996-9#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
have prospectively studied##2##3##(1997-8#1)(2007-8#1)
have protective effects on##2##4##(2008-5#1)(2011-3#1)
have proved the##2##3##(2008-3#1)(2012-3#1)
have proved to be##7##4##(1991-3#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-3#1)(2010-4#1)
have proved##23##2##(1990-5#1)(1991-3#1)(1992-1#1)(1992-8#1)(1994-2#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
have proven effective##2##3##(1992-6#1)(1993-6#1)
have proven to be effective##2##5##(1996-2#1)(2008-4#1)
have proven to be very##3##5##(2008-10#2)(2008-7#1)
have proven to be##9##4##(1996-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2013-8#1)
have proven to##10##3##(1996-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-8#1)
have proven useful in##2##4##(2008-11#1)(2008-12#1)
have proven useful##3##3##(2008-11#1)(2008-12#1)(2010-7#1)
have proven##25##2##(1992-6#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
have provided a wealth of##2##5##(1997-7#1)(2007-8#1)
have provided a##12##3##(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-11#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#2)(2009-12#1)(2009-9#1)
have provided an alternative##2##4##(2008-12#1)(2008-9#1)
have provided an##5##3##(1997-6#1)(2008-12#1)(2008-9#2)(2012-12#1)
have provided data##2##3##(2008-3#1)(2009-12#1)
have provided evidence for##3##4##(1991-2#1)(1994-5#1)(1996-5#1)
have provided evidence##4##3##(1991-2#1)(1994-5#1)(1996-5#1)(2008-11#1)
have provided experimental##2##3##(2008-3#1)(2008-9#1)
have provided further insights into the##2##6##(2006-10#1)(2011-2#1)
have provided further##3##3##(2006-10#1)(2008-12#1)(2011-2#1)
have provided insight into##2##4##(1995-5#1)(2008-4#1)
have provided insight##3##3##(1995-5#1)(2008-4#1)(2008-9#1)
have provided insights##2##3##(2008-4#1)(2010-1#1)
have provided interesting##2##3##(1990-8#1)(2013-1#1)
have provided new insight into##2##5##(1993-2#1)(2010-4#1)
have provided new insight##3##4##(1993-2#1)(1996-8#1)(2010-4#1)
have provided new insights into the##2##6##(2007-7#1)(2008-10#1)
have provided new insights##3##4##(2007-7#1)(2008-10#1)(2011-2#1)
have provided new##7##3##(1993-2#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)
have provided the first##2##4##(2008-4#1)(2008-8#1)
have provided the##6##3##(1997-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)
have provided valuable##2##3##(2010-2#1)(2011-2#1)
have provided##69##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#2)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
have provoked##2##2##(2010-12#1)(2012-2#1)
have public health implications##2##4##(2009-6#1)(2011-2#1)
have public##3##2##(1993-2#1)(2009-6#1)(2011-2#1)
have pulmonary##4##2##(1991-12#2)(2009-10#1)(2013-8#1)
have purified the##2##3##(1991-2#1)(1994-3#1)
have purified##6##2##(1991-2#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-3#1)(1996-2#1)
have put##2##2##(1994-8#1)(2009-10#1)
have quantified##4##2##(1994-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
have quite different##4##3##(1992-11#1)(1994-2#1)(2008-5#2)
have raised questions##2##3##(2008-9#1)(2013-1#1)
have raised the question of##2##5##(1992-12#1)(2008-7#1)
have raised the##4##3##(1992-12#1)(2008-11#1)(2008-7#1)(2009-4#1)
have raised##12##2##(1991-11#1)(1991-9#1)(1992-12#1)(1994-1#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
have rapidly increased##2##3##(2008-11#1)(2011-2#1)
have rarely been##2##3##(1990-6#1)(2008-7#1)
have reached a plateau##2##4##(2010-3#2)
have reached a##4##3##(1994-2#1)(2008-1#1)(2010-3#2)
have reached an##2##3##(1995-6#1)(2008-12#1)
have reached##12##2##(1992-3#1)(1994-2#1)(1995-6#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#2)
have realized##2##2##(2008-1#1)(2008-3#1)
have received increased attention##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
have received increasing attention##2##4##(1994-2#1)(2008-8#1)
have received increasing##3##3##(1994-2#1)(2008-8#1)(2010-3#1)
have received little attention##5##4##(1995-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)
have received little##6##3##(1995-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)
have received much attention##2##4##(2008-3#1)(2008-5#1)
have received much##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
have received##34##2##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#3)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
have recently been described in##2##5##(1990-5#1)(1992-9#1)
have recently been described##4##4##(1990-5#1)(1992-9#1)(2010-12#1)(2012-3#1)
have recently been developed##6##4##(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#2)
have recently been identified##2##4##(1993-2#1)(2013-1#1)
have recently been proposed as a##2##6##(2008-2#1)(2013-1#1)
have recently been proposed##4##4##(1994-6#1)(1995-12#1)(2008-2#1)(2013-1#1)
have recently been reported##5##4##(1992-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
have recently been shown to##2##5##(2009-5#1)(2012-12#1)
have recently been shown##3##4##(1993-11#1)(2009-5#1)(2012-12#1)
have recently been used##2##4##(2008-7#1)(2009-7#1)
have recently been##41##3##(1990-5#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
have recently characterized##2##3##(2009-8#1)(2011-2#1)
have recently demonstrated##9##3##(1994-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-2#1)
have recently developed##5##3##(1996-7#1)(2008-11#1)(2008-3#2)(2010-8#1)
have recently emerged##2##3##(2010-11#1)(2013-1#1)
have recently found##2##3##(1991-12#1)(2008-11#1)
have recently gained##2##3##(2008-10#2)
have recently identified##3##3##(1990-8#1)(1991-5#1)(2009-8#1)
have recently led to##2##4##(2008-5#1)(2011-2#1)
have recently reported that##4##4##(1995-6#1)(1997-3#1)(2009-8#1)(2012-2#1)
have recently reported##7##3##(1991-2#1)(1991-8#1)(1995-6#1)(1997-3#1)(2008-11#1)(2009-8#1)(2012-2#1)
have recently shown that##16##4##(1990-5#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-8#7)(2011-2#1)
have recently##118##2##(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#8)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#14)(2010-11#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
have recognized the need to##3##5##(1991-3#1)(1996-2#1)(1997-2#1)
have recognized the##4##3##(1991-3#1)(1996-2#1)(1997-2#2)
have recognized##6##2##(1990-6#1)(1991-3#1)(1996-2#1)(1997-2#2)(2008-9#1)
have reduced the##7##3##(1992-8#1)(2008-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
have reduced##16##2##(1991-11#1)(1992-8#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
have reexamined the##2##3##(1993-11#1)(2008-3#1)
have reflected##2##2##(2008-10#1)(2008-8#1)
have regarding##2##2##(2008-12#1)(2011-2#1)
have regularly##2##2##(2009-2#1)(2010-7#1)
have relapsed##2##2##(1994-5#1)(2010-3#1)
have related##3##2##(1990-5#1)(2007-12#1)(2008-10#1)
have relatively short##2##3##(2007-11#1)(2008-5#1)
have relatively##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
have relevance for##2##3##(1995-5#1)(2012-3#1)
have relevance##5##2##(1993-12#1)(1994-8#1)(1995-5#1)(2007-10#1)(2012-3#1)
have relied on##6##3##(1991-3#1)(1995-1#1)(1997-1#1)(2008-9#1)(2011-2#1)(2013-8#1)
have relied##9##2##(1991-3#1)(1994-11#1)(1995-1#2)(1997-1#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
have remained largely##2##3##(1991-8#1)(2008-9#1)
have remained unclear##2##3##(2007-2#1)(2009-6#1)
have remained##14##2##(1991-8#1)(1993-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)
have removed##2##2##(1995-11#1)(2011-2#1)
have renal##2##2##(2008-1#2)
have rendered##2##2##(1994-12#1)(1994-3#1)
have replaced the traditional &quot##2##5##(2007-5#2)
have replaced the##3##3##(2007-5#2)(2008-9#1)
have replaced##5##2##(1993-12#1)(1995-5#1)(2007-5#2)(2008-9#1)
have reported a new##2##4##(2008-10#1)(2012-12#1)
have reported a##9##3##(1992-9#1)(1993-3#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
have reported promising##2##3##(2008-7#1)(2009-9#1)
have reported that the##5##4##(1995-11#1)(2008-11#1)(2008-3#1)(2009-11#1)(2011-2#1)
have reported that##12##3##(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
have reported the##8##3##(1992-8#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#2)(2013-1#1)(2013-8#1)
have reported##57##2##(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-7#1)(2007-10#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#3)(2013-8#1)
have represented the##2##3##(2009-5#1)(2009-6#1)
have represented##4##2##(2008-7#1)(2009-5#1)(2009-6#2)
have required##3##2##(1994-12#1)(1997-3#1)(2008-3#1)
have resolved##3##2##(1997-3#1)(2007-12#1)(2008-3#1)
have responded to this##2##4##(2008-9#1)(2012-2#1)
have responded to##4##3##(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
have responded##6##2##(1997-3#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
have response##2##2##(2008-10#1)(2011-1#1)
have resulted from the##3##4##(1992-9#1)(2008-4#1)(2008-6#1)
have resulted from##11##3##(1992-9#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-7#1)(2010-3#1)
have resulted in a##4##4##(1994-12#2)(2008-10#1)(2012-1#1)
have resulted in an##3##4##(1992-1#1)(1993-6#1)(2008-7#1)
have resulted in improved##5##4##(2008-1#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)
have resulted in the development of##2##6##(2007-11#1)(2008-9#1)
have resulted in the##6##4##(2007-11#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
have resulted in##30##3##(1992-1#1)(1992-11#1)(1993-6#1)(1994-12#2)(1996-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)
have resulted##43##2##(1992-1#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-12#3)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)
have retained##2##2##(2008-11#1)(2009-8#1)
have revealed a##7##3##(1990-12#1)(1993-3#1)(1995-12#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
have revealed additional##2##3##(1993-11#1)(2012-2#1)
have revealed an association##2##4##(2008-8#1)(2010-8#1)
have revealed several##3##3##(1995-12#1)(2007-8#1)(2008-9#1)
have revealed that the##3##4##(1990-5#1)(2008-12#1)(2009-9#1)
have revealed that##22##3##(1990-12#1)(1990-5#1)(1992-10#1)(1993-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-9#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
have revealed the existence of##2##5##(2008-10#1)(2010-7#1)
have revealed the##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)
have revealed##56##2##(1990-12#2)(1990-5#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-12#2)(1995-5#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)
have reviewed the literature and##2##5##(1996-6#1)(2012-12#1)
have reviewed the literature##4##4##(1996-6#1)(2008-5#1)(2012-12#1)(2012-2#1)
have reviewed the##11##3##(1990-2#1)(1991-9#1)(1995-12#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-12#1)(2012-2#1)
have reviewed##19##2##(1990-2#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-7#1)(2006-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2012-12#1)(2012-2#1)
have revolutionized the##3##3##(2007-12#1)(2010-5#1)(2012-8#1)
have revolutionized##5##2##(2007-12#1)(2008-5#1)(2010-3#1)(2010-5#1)(2012-8#1)
have risen in##2##3##(1995-3#1)(2007-2#1)
have risen##5##2##(1994-1#1)(1995-3#2)(2007-2#1)(2008-6#1)
have role in##2##3##(2011-2#1)(2013-8#1)
have roles in##2##3##(2009-3#1)(2009-9#1)
have routinely##2##2##(2007-8#1)(2012-3#1)
have screened##4##2##(1990-11#1)(1991-11#1)(1991-9#1)(2012-3#1)
have searched for##2##3##(1991-5#1)(2008-11#1)
have seen a##3##3##(1992-8#1)(2010-11#1)(2012-2#1)
have seen the##3##3##(2008-9#2)(2009-5#1)
have seen##15##2##(1992-8#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#2)
have seldom been##2##3##(2008-5#1)(2008-7#1)
have selected##3##2##(2008-2#1)(2008-4#1)(2013-7#1)
have sequence similarity##2##3##(1992-11#1)(1993-8#1)
have sequenced the##2##3##(1990-5#1)(2011-2#1)
have sequenced##5##2##(1990-5#2)(1995-6#1)(2008-5#1)(2011-2#1)
have sequences##2##2##(1990-5#1)(1994-11#1)
have serious##3##2##(1995-2#1)(2008-7#1)(2013-1#1)
have set##2##2##(1992-5#1)(2008-10#1)
have several advantages##4##3##(2008-3#1)(2008-8#1)(2010-8#1)(2012-3#1)
have several##16##2##(1992-6#1)(1993-1#1)(1995-3#1)(1996-2#1)(1997-6#1)(2007-10#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#2)(2010-8#1)(2012-3#1)
have severe##6##2##(2008-10#1)(2008-2#1)(2008-8#2)(2011-1#1)(2011-2#1)
have sex##18##2##(1996-5#1)(2008-10#1)(2008-11#1)(2009-5#9)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)
have shaped the##3##3##(1993-2#1)(1994-1#1)(2012-12#1)
have shaped##4##2##(1993-2#1)(1994-1#1)(2012-12#1)(2013-1#1)
have shed light on##2##4##(2008-8#1)(2009-7#1)
have shed new##2##3##(2008-7#1)(2012-1#1)
have shed##5##2##(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)
have shifted to##2##3##(2010-7#1)(2011-2#1)
have shifted##5##2##(1992-2#1)(2008-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
have short##4##2##(2008-1#1)(2008-11#2)(2013-7#1)
have shorter##2##2##(1995-11#1)(2012-2#1)
have showed##2##2##(2009-8#1)(2012-2#1)
have shown a positive correlation##2##5##(1995-9#1)(2011-2#1)
have shown a positive##4##4##(1992-4#1)(1993-3#1)(1995-9#1)(2011-2#1)
have shown a significant##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
have shown a substantial##2##4##(1991-3#1)(2012-1#1)
have shown a##19##3##(1991-3#1)(1992-12#1)(1992-4#1)(1993-3#1)(1995-9#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2011-2#2)(2012-1#1)
have shown an##8##3##(1991-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
have shown both##2##3##(2009-5#1)(2010-1#1)
have shown no##3##3##(1992-9#1)(1993-1#1)(2008-11#1)
have shown promise in##2##4##(2008-8#2)
have shown promise##4##3##(2008-10#1)(2008-8#2)(2010-10#1)
have shown promising results in the##2##6##(2010-12#1)(2012-2#1)
have shown promising results in##5##5##(2007-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
have shown promising##7##3##(2007-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
have shown significant##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
have shown some##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
have shown that a##9##4##(1994-8#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#3)
have shown that both##3##4##(1995-8#1)(2008-11#1)(2008-7#1)
have shown that compared##2##4##(1997-1#1)(2008-2#1)
have shown that exposure##2##4##(1991-4#1)(2012-2#1)
have shown that in the##3##5##(2009-9#1)(2012-12#1)(2013-7#1)
have shown that it##2##4##(1997-7#1)(2011-1#1)
have shown that loss of##2##5##(2013-1#1)(2013-7#1)
have shown that the presence of##2##6##(2008-1#1)(2013-1#1)
have shown that the two##2##5##(1993-11#1)(2008-10#1)
have shown that the##50##4##(1990-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-11#3)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#3)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#6)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
have shown that there is a high##2##7##(2008-9#1)(2010-8#1)
have shown that there is##3##5##(1991-3#1)(2008-9#1)(2010-8#1)
have shown that there##4##4##(1991-3#1)(2008-9#1)(2010-8#1)(2011-2#1)
have shown that these##3##4##(1995-2#1)(2006-6#1)(2010-11#1)
have shown that they##2##4##(1992-3#1)(1997-4#1)
have shown that this##11##4##(1993-6#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-2#2)
have shown that##245##3##(1990-11#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-8#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#2)(2007-6#1)(2008-1#7)(2008-10#17)(2008-11#13)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#18)(2008-8#11)(2008-9#5)(2009-10#2)(2009-11#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#15)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#5)
have shown the importance of##2##5##(1990-2#1)(2008-7#1)
have shown the potential##2##4##(2009-11#1)(2010-11#1)
have shown the##19##3##(1990-2#1)(1992-2#1)(1994-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2013-7#1)
have shown to be##4##4##(1992-9#1)(2008-11#1)(2012-2#1)(2013-1#1)
have shown##385##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#4)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#2)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#10)(2008-10#33)(2008-11#21)(2008-12#8)(2008-2#8)(2008-3#14)(2008-4#2)(2008-5#14)(2008-6#3)(2008-7#29)(2008-8#19)(2008-9#5)(2009-10#4)(2009-11#2)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#27)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#7)(2013-1#10)(2013-7#4)(2013-8#8)
have significant effects on##5##4##(1994-6#1)(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)
have significant impacts on##3##4##(1991-12#1)(2008-10#1)(2012-2#1)
have significant implications##2##3##(2008-10#1)(2008-7#1)
have significant influence on##3##4##(1992-8#1)(2008-10#2)
have significant potential##2##3##(2007-12#1)(2008-12#1)
have significant roles in##2##4##(1994-8#1)(2009-8#1)
have significant##44##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#4)(2012-2#2)(2013-1#4)
have significantly higher##3##3##(1991-12#1)(1997-4#1)(2013-7#1)
have significantly improved##2##3##(2008-3#1)(2010-9#1)
have significantly increased##3##3##(1990-12#1)(1993-3#1)(2013-1#1)
have significantly lower##2##3##(1991-12#1)(1996-3#1)
have significantly more##2##3##(1995-1#1)(2008-2#1)
have significantly##19##2##(1990-12#1)(1991-12#3)(1993-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-9#2)(2012-2#1)(2013-1#1)(2013-7#1)
have signs of##2##3##(2008-3#1)(2011-1#1)
have signs##3##2##(1991-8#1)(2008-3#1)(2011-1#1)
have similar precompetitive distributions##2##4##(2008-8#2)
have similar##33##2##(1990-8#1)(1991-2#1)(1992-3#1)(1992-6#4)(1996-5#1)(1996-8#1)(2006-4#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
have similarities with##2##3##(1994-5#1)(1995-9#1)
have since been##3##3##(1996-3#1)(2007-10#1)(2008-9#1)
have since##7##2##(1996-3#1)(1997-1#1)(2007-10#1)(2008-12#2)(2008-9#1)(2011-1#1)
have slightly##2##2##(2008-8#1)(2012-12#1)
have slow##2##2##(2008-3#1)(2012-2#1)
have small##5##2##(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
have smaller##2##2##(1992-12#1)(2010-8#1)
have so far been##11##4##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
have so far##13##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-8#1)(1994-2#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
have so##15##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-8#1)(1994-2#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
have some role in the##2##5##(2008-7#1)(2012-12#1)
have some##25##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
have sought to determine##2##4##(2008-11#1)(2008-8#1)
have sought to##4##3##(1993-12#1)(2008-11#2)(2008-8#1)
have sought##6##2##(1992-2#1)(1993-12#1)(2008-11#2)(2008-8#1)(2013-1#1)
have special needs and##2##4##(1991-3#1)(2008-5#1)
have special##4##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-5#1)
have specialized##2##2##(1991-12#1)(2008-10#1)
have specific relevance##2##3##(2009-6#1)(2013-1#1)
have specific resistance to##2##4##(2008-10#2)
have specific##13##2##(1993-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-8#1)(2009-12#1)(2009-6#1)(2012-3#1)(2013-1#1)
have spread##7##2##(1990-6#1)(1996-1#1)(1997-6#1)(2007-7#2)(2008-10#1)(2008-7#1)
have stabilized##2##2##(2011-1#1)(2013-1#1)
have standardized##2##2##(2008-11#1)(2008-7#1)
have started to##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
have started##5##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
have stimulated##2##2##(1995-3#1)(2013-1#1)
have stressed the##3##3##(1997-6#1)(2008-11#1)(2010-10#1)
have stressed##4##2##(1997-6#1)(2008-11#1)(2008-9#1)(2010-10#1)
have striking##2##2##(1993-6#1)(1994-5#1)
have strong hydrogen bonding##2##4##(1991-8#2)
have strong##13##2##(1991-8#2)(1992-8#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2009-9#1)(2012-12#1)
have structured##3##2##(1994-12#1)(2008-11#2)
have struggled##2##2##(1996-1#1)(2008-10#1)
have studied a##4##3##(1997-3#1)(2008-1#1)(2008-2#1)(2008-8#1)
have studied the effect of##7##5##(1990-2#1)(1993-1#1)(1993-12#1)(1994-11#1)(1995-6#1)(1997-7#1)(2008-12#1)
have studied the effects of the##2##6##(1994-8#1)(2008-3#1)
have studied the effects of##3##5##(1994-8#1)(1995-12#1)(2008-3#1)
have studied the expression of##3##5##(1993-8#1)(2008-7#1)(2008-9#1)
have studied the expression##4##4##(1993-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
have studied the##45##3##(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-1#1)(2012-2#1)
have studied##70##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-11#2)(1991-2#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#2)(2012-2#1)(2012-3#1)
have studies##2##2##(1996-2#1)(2013-1#1)
have substantial##3##2##(1993-11#1)(1993-12#1)(2012-3#1)
have substantially##3##2##(1993-1#1)(1995-2#1)(2008-10#1)
have succeeded in##6##3##(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)
have successfully been##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
have successfully demonstrated the feasibility of##2##6##(2007-11#1)(2008-10#1)
have successfully demonstrated##4##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-7#1)
have successfully##18##2##(1992-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#2)(2009-7#1)(2010-8#1)
have such a##2##3##(2009-11#1)(2009-2#1)
have such##8##2##(1992-8#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-2#1)(2012-2#2)(2013-7#1)
have suffered##6##2##(1995-11#2)(1996-11#1)(2008-12#1)(2008-9#1)(2009-10#1)
have sufficient##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
have sufficiently##2##2##(1993-9#1)(2008-8#1)
have suggested a possible##3##4##(2008-10#1)(2013-1#2)
have suggested a##10##3##(1993-9#1)(1996-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#4)
have suggested that a##2##4##(1992-1#1)(2009-10#1)
have suggested that the##4##4##(1990-11#1)(1992-12#1)(1992-2#1)(2011-1#1)
have suggested that they##2##4##(1996-2#1)(2008-7#1)
have suggested that##33##3##(1990-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#3)(2013-1#2)
have suggested the use of##2##5##(1994-8#1)(2012-3#1)
have suggested the##5##3##(1990-11#1)(1994-8#1)(1995-6#1)(1997-5#1)(2012-3#1)
have suggested##52##2##(1990-11#2)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#6)
have suitably##2##2##(2009-7#1)(2012-12#1)
have summarized##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
have superior##3##2##(1993-6#1)(2007-12#1)(2008-11#1)
have supported the##4##3##(1991-8#1)(2007-12#1)(2008-3#1)(2010-7#1)
have supported##6##2##(1991-8#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-6#1)(2010-7#1)
have surfaced##2##2##(2011-2#2)
have survived##7##2##(1990-5#1)(1991-12#1)(1991-5#1)(2008-10#1)(2008-6#1)(2009-5#1)(2013-1#1)
have sustained##3##2##(1996-2#1)(2010-9#1)(2013-1#1)
have symptoms##2##2##(2010-5#1)(2013-1#1)
have synthesized##8##2##(1991-12#2)(1992-11#1)(1992-6#1)(2008-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
have systematically##3##2##(1995-6#1)(2008-2#1)(2008-9#1)
have taken a##2##3##(1997-3#1)(1997-6#1)
have taken place in##4##4##(1991-2#1)(1991-3#1)(2008-2#1)(2011-1#1)
have taken place##7##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1997-1#1)(2008-2#1)(2011-1#1)
have taken##25##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#2)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#1)
have tended to##3##3##(1992-1#1)(2008-9#1)(2009-9#1)
have tested the##7##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-6#1)(2012-3#1)
have tested##17##2##(1991-9#1)(1992-11#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-9#1)(2009-2#1)(2009-6#1)(2012-3#1)
have the ability to induce##2##5##(2008-10#1)(2011-2#1)
have the ability to##20##4##(1991-12#1)(1993-3#1)(1994-11#1)(1995-5#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
have the ability##21##3##(1991-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-5#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
have the additional##2##3##(1992-12#1)(2008-10#1)
have the advantage of##2##4##(1990-11#1)(2008-11#1)
have the advantage that they can##2##6##(2008-10#1)(2008-7#1)
have the advantage that they##3##5##(1992-3#1)(2008-10#1)(2008-7#1)
have the advantage that##4##4##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
have the advantage##6##3##(1990-11#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
have the best long-term##2##4##(2009-5#1)(2009-8#1)
have the best##7##3##(1995-2#1)(1995-5#1)(2007-2#1)(2008-10#2)(2009-5#1)(2009-8#1)
have the capability##2##3##(1992-12#1)(2008-3#1)
have the capacity to##10##4##(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
have the capacity##11##3##(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
have the disadvantage of being##2##5##(1995-5#1)(2008-11#1)
have the disadvantage##3##3##(1990-2#1)(1995-5#1)(2008-11#1)
have the disease##2##3##(1996-2#2)
have the following##5##3##(1991-12#1)(1993-3#1)(1995-11#2)(2008-3#1)
have the greatest impact##3##4##(2008-8#1)(2009-5#1)(2011-2#1)
have the greatest likelihood of##2##5##(1997-3#1)(2008-8#1)
have the greatest##11##3##(1991-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#2)(2012-3#1)
have the highest##10##3##(1996-2#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#1)
have the knowledge and##2##4##(1995-12#1)(2012-12#1)
have the most empirical support##2##5##(2008-4#1)(2008-9#1)
have the most##7##3##(1994-2#2)(1994-3#1)(2008-4#2)(2008-9#1)(2011-2#1)
have the necessary##2##3##(2007-12#1)(2008-8#1)
have the opportunity to##4##4##(1993-12#1)(1994-1#1)(2008-11#1)(2011-2#1)
have the potential for##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
have the potential of##4##4##(1993-9#1)(2008-2#1)(2010-4#1)(2010-5#1)
have the potential to be##4##5##(1997-7#1)(2008-12#1)(2008-3#1)(2012-2#1)
have the potential to enhance##4##5##(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
have the potential to improve the##2##6##(2008-7#1)(2009-8#1)
have the potential to improve##3##5##(1994-12#1)(2008-7#1)(2009-8#1)
have the potential to induce##2##5##(2008-8#1)(2011-2#1)
have the potential to reduce##3##5##(2008-2#1)(2009-10#1)(2010-5#1)
have the potential to regulate##2##5##(1994-11#1)(2007-2#1)
have the potential to##54##4##(1994-11#1)(1994-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#5)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
have the potential##61##3##(1993-9#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#4)(2008-7#5)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
have the prerogative##2##3##(1994-3#1)(1995-6#1)
have the responsibility##2##3##(1993-11#1)(2012-3#1)
have the right to##2##4##(1992-4#1)(2009-6#1)
have the right##3##3##(1992-4#1)(2008-10#1)(2009-6#1)
have the same basic##2##4##(1994-12#1)(1996-3#1)
have the same effect##2##4##(1995-1#1)(2008-9#1)
have the same genotype##2##4##(2008-10#2)
have the same##40##3##(1990-12#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#2)(1995-1#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-7#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2010-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
have the strongest##2##3##(2008-2#1)(2008-8#1)
have the structure of##2##4##(1990-7#1)(2007-12#1)
have the##298##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#6)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#6)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#2)(1997-2#2)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2007-12#5)(2007-2#2)(2007-7#1)(2008-1#5)(2008-10#27)(2008-11#15)(2008-12#7)(2008-2#7)(2008-3#12)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#14)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#3)(2010-5#4)(2010-8#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#6)(2013-8#3)
have their origins##2##3##(2008-5#1)(2012-2#1)
have their own##13##3##(1992-6#1)(1994-3#1)(1996-12#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
have their##37##2##(1990-2#1)(1992-6#1)(1994-3#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
have theoretically##3##2##(1997-2#1)(1997-3#1)(2007-12#1)
have therapeutic implications##4##3##(1997-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
have therapeutic potential##2##3##(1992-3#1)(1997-1#1)
have therapeutic##12##2##(1992-3#1)(1994-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
have therefore been##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
have therefore##8##2##(1993-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)
have these##2##2##(1991-8#1)(2008-4#1)
have this##4##2##(1992-4#1)(1994-2#1)(2008-10#1)(2008-6#1)
have three##8##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
have thus far##2##3##(2007-7#1)(2011-2#1)
have thus##5##2##(1994-9#1)(1995-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
have time##2##2##(2008-11#1)(2009-10#1)
have to assume##2##3##(1992-12#1)(2010-4#1)
have to be addressed in##2##5##(1994-1#1)(2012-2#1)
have to be addressed##3##4##(1994-1#1)(2008-10#1)(2012-2#1)
have to be analysed##2##4##(2008-11#1)(2011-2#1)
have to be compensated##2##4##(1995-3#1)(2008-10#1)
have to be considered##9##4##(1990-6#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
have to be developed to##2##5##(2008-3#1)(2013-7#1)
have to be developed##4##4##(1997-2#1)(2008-3#1)(2008-4#1)(2013-7#1)
have to be established##3##4##(1992-11#1)(2007-12#1)(2012-2#1)
have to be evaluated##2##4##(1996-5#1)(2008-1#1)
have to be identified##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
have to be managed##2##4##(1997-3#1)(2012-12#1)
have to be met##2##4##(1996-2#1)(2013-8#1)
have to be taken into##2##5##(2012-12#1)(2012-2#1)
have to be taken without the benefit of##2##8##(2010-12#2)
have to be taken##5##4##(2010-12#3)(2012-12#1)(2012-2#1)
have to be used##2##4##(2007-8#1)(2011-2#1)
have to be##106##3##(1990-10#1)(1990-6#2)(1991-2#1)(1991-8#1)(1992-11#2)(1993-3#1)(1994-1#1)(1994-12#3)(1994-5#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
have to do with##2##4##(2007-10#1)(2010-12#1)
have to do##4##3##(1991-1#1)(2007-10#1)(2010-12#1)(2010-8#1)
have to make##5##3##(1991-11#1)(1993-3#1)(1995-2#1)(2007-12#1)(2013-1#1)
have to rely##2##3##(1997-7#1)(2008-12#1)
have to take##3##3##(1995-5#1)(2010-8#1)(2011-1#1)
have to##166##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#6)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#9)(2012-12#2)(2012-2#8)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
have total##3##2##(1990-2#1)(2008-1#1)(2010-4#1)
have traditionally been##7##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
have traditionally relied##2##3##(2008-5#1)(2011-2#1)
have traditionally##12##2##(1994-1#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
have treated##5##2##(1997-2#1)(1997-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
have treatment##2##2##(1997-8#1)(2010-3#1)
have tremendous##3##2##(2008-1#1)(2008-12#1)(2013-1#1)
have tried to##4##3##(1995-3#1)(2006-8#1)(2008-11#1)(2008-8#1)
have tried##6##2##(1992-4#1)(1995-3#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-8#1)
have triggered##2##2##(1997-3#1)(2008-11#1)
have turned##4##2##(1994-7#1)(2008-10#1)(2008-5#1)(2010-3#1)
have two types of##3##4##(1990-11#1)(2008-5#1)(2013-8#1)
have two##19##2##(1990-11#1)(1990-12#1)(1991-12#1)(1994-11#1)(1997-6#2)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-9#1)(2013-8#1)
have uncovered a##2##3##(2008-11#1)(2008-8#1)
have uncovered##5##2##(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-3#1)
have undergone the##2##3##(1995-3#1)(2013-1#1)
have undergone##25##2##(1990-9#1)(1991-3#1)(1992-2#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-3#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
have underlying##2##2##(2008-1#1)(2012-2#1)
have undertaken a##4##3##(1993-3#1)(1997-3#1)(2008-11#1)(2010-9#1)
have undertaken##7##2##(1993-12#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
have undesirable##2##2##(2007-12#1)(2008-7#1)
have uniform##2##2##(2008-10#1)(2008-3#1)
have unique advantages and##2##4##(2011-3#1)(2013-1#1)
have unique##10##2##(1990-8#1)(1992-3#1)(1995-2#1)(2007-2#1)(2008-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-3#1)(2013-1#1)
have until##2##2##(1996-5#1)(2010-7#1)
have unusual##3##2##(1991-3#1)(2008-7#1)(2012-2#1)
have unveiled##2##2##(2010-3#1)(2013-1#1)
have used 13C##2##3##(1992-10#1)(1992-3#1)
have used a##19##3##(1990-11#1)(1990-2#1)(1992-3#1)(1992-8#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2012-2#1)
have used in situ##2##4##(1995-12#1)(1996-12#1)
have used in##3##3##(1995-12#1)(1995-2#1)(1996-12#1)
have used the##18##3##(1991-12#1)(1991-9#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-4#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-9#1)
have used this technique##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
have used this##8##3##(1991-12#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
have used two##2##3##(1995-2#1)(1997-7#1)
have used##115##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#3)(1997-5#2)(1997-7#2)(2006-6#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#7)(2008-9#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#5)
have useful##2##2##(2008-3#1)(2008-7#1)
have utility##2##2##(1995-5#1)(2008-10#1)
have utilized this##2##3##(2008-4#1)(2009-2#1)
have utilized##12##2##(1990-12#1)(1992-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-4#2)(2009-2#1)(2010-5#1)
have validated the##2##3##(2008-3#1)(2013-7#1)
have validated##3##2##(2008-3#1)(2011-2#1)(2013-7#1)
have value##2##2##(1997-3#1)(2011-2#1)
have values of##2##3##(2007-11#1)(2008-5#1)
have values##3##2##(1992-9#1)(2007-11#1)(2008-5#1)
have variable##3##2##(1997-3#1)(2008-11#1)(2009-4#1)
have various##5##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-8#1)
have varying##2##2##(2007-12#1)(2008-4#1)
have verified##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
have very few##2##3##(1994-9#1)(2010-3#1)
have very little##2##3##(1995-2#1)(2008-10#1)
have very low##3##3##(2009-10#1)(2009-3#1)(2010-4#1)
have very similar##2##3##(2007-12#1)(2008-10#1)
have very##17##2##(1994-9#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
have visited##3##2##(2007-2#2)(2008-10#1)
have we learned from##2##4##(2008-7#1)(2009-4#1)
have we learned##3##3##(2007-12#1)(2008-7#1)(2009-4#1)
have we learnt##2##3##(2008-8#1)(2010-5#1)
have we##9##2##(1995-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-5#1)(2012-2#1)
have weak ties to both##2##5##(2008-2#2)
have weak ties to##3##4##(2008-2#3)
have weak##4##2##(1991-9#1)(2008-2#3)
have well##2##2##(2008-1#1)(2010-7#1)
have well-established##2##2##(1991-1#1)(2013-1#1)
have witnessed##8##2##(1996-1#1)(2007-8#1)(2009-12#1)(2009-7#1)(2010-10#2)(2012-1#1)(2013-8#1)
have worked##6##2##(1994-12#1)(1995-3#1)(2008-1#2)(2008-10#2)
have worse##2##2##(1991-11#1)(2011-2#1)
have written##2##2##(2008-1#1)(2011-2#1)
have yet been##3##3##(1991-5#1)(2008-5#1)(2011-2#1)
have yet to be elucidated##3##5##(1993-5#1)(1995-6#1)(2013-1#1)
have yet to be fully##2##5##(2008-10#1)(2008-8#1)
have yet to be identified##3##5##(1994-12#1)(1997-7#1)(2009-6#1)
have yet to be##17##4##(1991-2#1)(1991-7#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-7#1)(2013-1#1)
have yet to##18##3##(1991-2#1)(1991-7#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-7#1)(2013-1#1)
have yet##21##2##(1991-2#1)(1991-5#1)(1991-7#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
have yielded a##3##3##(1990-8#1)(1994-5#1)(2008-6#1)
have yielded increasing##2##3##(2007-2#1)(2013-1#1)
have yielded##16##2##(1990-8#1)(1994-5#1)(2007-11#1)(2007-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
have zero##2##2##(2007-12#1)(2008-9#1)
have##14026##1##(1990-10#7)(1990-11#54)(1990-12#42)(1990-2#40)(1990-3#22)(1990-5#62)(1990-6#39)(1990-7#30)(1990-8#41)(1990-9#17)(1991-1#27)(1991-10#2)(1991-11#25)(1991-12#104)(1991-2#52)(1991-3#55)(1991-4#7)(1991-5#39)(1991-6#39)(1991-7#6)(1991-8#25)(1991-9#49)(1992-1#22)(1992-10#11)(1992-11#41)(1992-12#66)(1992-2#53)(1992-3#87)(1992-4#8)(1992-5#23)(1992-6#55)(1992-7#3)(1992-8#54)(1992-9#52)(1993-1#18)(1993-10#1)(1993-11#64)(1993-12#100)(1993-2#42)(1993-3#77)(1993-5#7)(1993-6#54)(1993-8#43)(1993-9#29)(1994-1#23)(1994-11#58)(1994-12#107)(1994-2#72)(1994-3#73)(1994-5#57)(1994-6#62)(1994-7#9)(1994-8#58)(1994-9#45)(1995-1#26)(1995-10#1)(1995-11#69)(1995-12#73)(1995-2#105)(1995-3#64)(1995-4#4)(1995-5#63)(1995-6#77)(1995-8#33)(1995-9#15)(1996-1#41)(1996-10#2)(1996-11#28)(1996-12#77)(1996-2#106)(1996-3#63)(1996-4#13)(1996-5#47)(1996-6#21)(1996-7#10)(1996-8#15)(1996-9#18)(1997-1#65)(1997-2#92)(1997-3#88)(1997-4#73)(1997-5#36)(1997-6#47)(1997-7#87)(1997-8#56)(1997-9#4)(2006-10#39)(2006-12#6)(2006-4#3)(2006-5#3)(2006-6#9)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#55)(2007-11#231)(2007-12#275)(2007-2#30)(2007-3#2)(2007-4#5)(2007-5#32)(2007-6#12)(2007-7#74)(2007-8#89)(2007-9#14)(2008-1#198)(2008-10#1680)(2008-11#620)(2008-12#198)(2008-2#298)(2008-3#601)(2008-4#249)(2008-5#390)(2008-6#149)(2008-7#613)(2008-8#342)(2008-9#318)(2009-1#11)(2009-10#84)(2009-11#43)(2009-12#51)(2009-2#30)(2009-3#56)(2009-4#37)(2009-5#92)(2009-6#67)(2009-7#64)(2009-8#102)(2009-9#49)(2010-1#47)(2010-10#64)(2010-11#77)(2010-12#111)(2010-2#22)(2010-3#94)(2010-4#64)(2010-5#89)(2010-6#58)(2010-7#55)(2010-8#120)(2010-9#30)(2011-1#205)(2011-10#2)(2011-2#484)(2011-3#35)(2011-7#5)(2012-1#63)(2012-12#196)(2012-2#345)(2012-3#218)(2012-4#1)(2012-5#3)(2012-6#4)(2012-7#1)(2012-8#4)(2012-9#1)(2013-1#407)(2013-7#52)(2013-8#165)
have?##3##1##(1994-1#1)(1997-3#1)(2009-5#1)
haven't##3##1##(1990-4#1)(1996-1#1)(2010-5#1)
having HIV infection##2##3##(1996-11#1)(2010-12#1)
having HIV##3##2##(1996-11#1)(2009-7#1)(2010-12#1)
having I##2##2##(2008-10#2)
having M(n) (NMR) =##2##4##(2008-12#2)
having a C20 ketone##2##4##(1997-1#2)
having a different##2##3##(1995-12#1)(2008-7#1)
having a diffuse humeral spot##2##5##(2013-7#2)
having a finite##2##3##(2008-3#2)
having a greater##2##3##(1990-7#1)(2012-1#1)
having a high##6##3##(1991-5#1)(2010-11#2)(2010-12#1)(2010-8#1)(2013-7#1)
having a low##2##3##(1990-9#1)(1991-5#1)
having a mean##2##3##(2008-10#2)
having a mentor##3##3##(2008-11#3)
having a molecular##2##3##(1990-11#1)(2008-10#1)
having a more##3##3##(1997-7#1)(2008-11#1)(2008-5#1)
having a negative##3##3##(1992-1#2)(2010-12#1)
having a pI value in the##2##6##(2010-8#2)
having a role in##2##4##(1992-7#1)(1995-6#1)
having a sensitive absorption peak at##2##6##(2008-10#2)
having a single##5##3##(1995-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
having a stroke##2##3##(2007-10#1)(2008-8#1)
having a usual source of health care##2##7##(2008-10#2)
having a usual source of##3##5##(1995-12#1)(2008-10#2)
having a very##3##3##(1996-9#1)(2008-10#1)(2012-3#1)
having a##164##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#2)(1992-1#3)(1992-11#1)(1992-3#1)(1992-7#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#20)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#2)
having about##2##2##(1990-8#1)(2012-2#1)
having access to a##2##4##(2008-12#2)
having access to##4##3##(1990-9#1)(2008-12#2)(2012-12#1)
having adequate##2##2##(2008-1#1)(2008-10#1)
having all##2##2##(1993-12#1)(2008-7#1)
having an earlier##2##3##(2008-11#1)(2008-6#1)
having an impact on the##2##5##(1991-3#1)(2008-10#1)
having an##37##2##(1990-11#1)(1991-3#1)(1992-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#2)(1996-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#1)
having analysed the##2##3##(1990-12#1)(1990-3#1)
having at least##5##3##(1993-1#1)(1994-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
having been##16##2##(1990-5#1)(1991-12#1)(1991-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
having both a##2##3##(1991-5#1)(1994-2#1)
having chelating functionalities##2##3##(2008-10#2)
having children##2##2##(2009-12#1)(2009-4#1)
having complex##2##2##(2011-1#1)(2011-2#1)
having conversations##3##2##(2012-3#3)
having dengue##2##2##(2011-1#2)
having different##13##2##(1995-11#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-8#1)
having either##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
having entered##2##2##(2010-4#1)(2011-2#1)
having family##2##2##(2010-8#1)(2013-8#1)
having good##2##2##(2008-10#1)(2009-4#1)
having greater##2##2##(1995-2#1)(2009-4#1)
having had##6##2##(1991-11#1)(1991-12#1)(2007-12#1)(2008-1#1)(2010-8#1)(2013-1#1)
having high##5##2##(1993-1#1)(2007-11#1)(2008-3#1)(2009-5#1)(2013-1#1)
having higher##9##2##(1993-12#1)(1994-9#1)(1995-8#1)(2008-5#2)(2009-11#1)(2011-2#1)(2013-1#2)
having identical##3##2##(1997-7#1)(2008-10#2)
having its##3##2##(1996-2#1)(2008-2#1)(2010-8#1)
having little##2##2##(1995-1#1)(2007-11#1)
having low##7##2##(1991-12#1)(1996-12#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-8#1)
having lower##5##2##(1991-11#1)(2007-12#1)(2008-8#1)(2011-1#1)(2013-8#1)
having maximum##2##2##(2008-10#1)(2008-5#1)
having molar absorptivity##2##3##(2008-10#2)
having more than one##3##4##(1992-9#1)(1997-2#1)(2011-2#1)
having more than##4##3##(1992-9#1)(1997-2#1)(2007-7#1)(2011-2#1)
having more##10##2##(1992-9#1)(1993-5#1)(1993-9#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
having multiple sex partners##2##4##(2007-12#1)(2011-2#1)
having multiple##6##2##(2007-12#1)(2007-7#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
having no##8##2##(1992-3#1)(1992-4#1)(1995-11#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-9#1)
having one or##3##3##(1993-3#1)(2007-12#1)(2007-7#1)
having one##5##2##(1993-3#1)(1995-1#1)(2007-12#1)(2007-7#1)(2009-9#1)
having only a##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
having only##6##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
having poor##2##2##(1996-6#1)(2011-2#1)
having positive##2##2##(2008-11#1)(2011-2#1)
having private##2##2##(1992-2#1)(1995-12#1)
having received##5##2##(1997-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)
having secondary##2##2##(2010-9#1)(2011-2#1)
having severe##2##2##(1991-11#1)(2007-7#1)
having sex while##2##3##(1997-5#1)(2012-1#1)
having sex with##3##3##(2011-1#2)(2013-1#1)
having sex##7##2##(1997-5#1)(2007-12#1)(2011-1#2)(2012-1#1)(2013-1#2)
having short##2##2##(2008-10#1)(2011-1#1)
having similar##5##2##(1992-5#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
having strong##2##2##(1991-9#1)(2011-1#1)
having the highest##6##3##(1993-9#1)(1995-2#1)(1996-12#1)(2008-10#2)(2011-2#1)
having the limited##2##3##(1995-11#1)(2013-1#1)
having the most##2##3##(2008-10#2)
having the same##5##3##(1991-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2013-1#1)
having the##47##2##(1991-10#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-11#3)(1995-2#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-1#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
having their own##2##3##(1991-12#1)(2011-2#1)
having their##6##2##(1991-12#1)(1994-2#1)(1995-11#1)(2007-12#1)(2009-6#1)(2011-2#1)
having three##3##2##(1990-8#1)(1997-2#1)(2008-7#1)
having to##21##2##(1992-12#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-8#1)(1997-5#1)(2007-2#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)
having two##2##2##(2008-7#1)(2012-1#1)
having undergone##3##2##(1994-9#1)(1995-12#1)(2008-7#1)
having used##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
having various##2##2##(2010-8#1)(2012-2#1)
having very##2##2##(1994-11#1)(2011-2#1)
having##802##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#5)(1991-10#1)(1991-11#5)(1991-12#7)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#4)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#7)(1994-2#8)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#4)(1995-11#8)(1995-12#9)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#6)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#9)(2007-12#18)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#17)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#91)(2008-11#29)(2008-12#17)(2008-2#14)(2008-3#26)(2008-4#12)(2008-5#19)(2008-6#7)(2008-7#28)(2008-8#18)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#12)(2010-9#4)(2011-1#13)(2011-2#45)(2012-1#5)(2012-12#17)(2012-2#21)(2012-3#15)(2012-8#1)(2013-1#24)(2013-7#5)(2013-8#10)
hawkmoth##2##1##(2008-8#1)(2009-8#1)
hawkmoths##3##1##(2009-6#1)(2009-8#2)
hay fever##4##2##(1992-3#3)(2008-12#1)
hay##8##1##(1992-3#3)(2008-10#1)(2008-12#1)(2009-4#1)(2010-4#1)(2012-2#1)
hazard assessment##2##2##(1996-12#2)
hazard evaluation##2##2##(2008-11#2)
hazard for##3##2##(1992-9#1)(2010-8#1)(2012-12#1)
hazard function##4##2##(1992-9#1)(2007-8#1)(2008-10#2)
hazard functions##3##2##(1992-9#1)(1997-4#2)
hazard identification and/or risk assessment##2##5##(2008-10#2)
hazard identification##7##2##(2008-10#5)(2008-9#1)(2011-2#1)
hazard in a##2##3##(1996-12#1)(2009-10#1)
hazard in##5##2##(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
hazard models##2##2##(2011-2#2)
hazard of##6##2##(1993-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)
hazard posed##2##2##(1995-11#1)(2008-12#1)
hazard rates##2##2##(1997-7#1)(2008-7#1)
hazard ratio (HR) of##2##4##(2013-1#2)
hazard ratio##6##2##(1993-9#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#2)
hazard ratios##3##2##(2008-7#1)(2009-3#1)(2011-2#1)
hazard to the##3##3##(1992-4#1)(2007-2#1)(2011-2#1)
hazard to##6##2##(1992-4#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-5#1)(2011-2#1)
hazard##93##1##(1990-9#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-12#6)(1996-4#2)(1997-3#5)(1997-4#3)(1997-7#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#4)
hazard-control##2##1##(1992-2#2)
hazardous and##2##2##(2008-10#1)(2008-11#1)
hazardous chemicals in##2##3##(1993-3#1)(2010-7#1)
hazardous chemicals##8##2##(1992-1#1)(1993-3#2)(2008-2#3)(2008-9#1)(2010-7#1)
hazardous materials##5##2##(1995-12#1)(2008-10#1)(2009-10#3)
hazardous than##3##2##(1995-5#1)(1997-6#1)(2008-12#1)
hazardous to##4##2##(1992-5#1)(1997-3#1)(2008-10#1)(2008-11#1)
hazardous waste sites##3##3##(2008-10#2)(2008-11#1)
hazardous##51##1##(1992-1#1)(1992-5#1)(1993-3#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#4)(2010-7#1)(2012-2#3)(2012-3#1)(2013-8#1)
hazards and the##2##3##(1995-9#1)(1997-3#1)
hazards and##4##2##(1995-9#1)(1997-3#1)(2008-9#2)
hazards are##3##2##(1992-3#1)(2008-11#1)(2008-5#1)
hazards associated with##3##3##(1992-3#1)(2008-3#1)(2013-1#1)
hazards for##5##2##(1991-3#1)(1997-7#1)(2008-11#1)(2010-4#1)(2011-2#1)
hazards in##2##2##(2009-12#1)(2012-3#1)
hazards of smoking##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
hazards of##22##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#2)
hazards regression##3##2##(1997-8#1)(2011-2#1)(2013-1#1)
hazards that arise from non-proteolytic Clostridium botulinum##2##7##(2011-2#2)
hazards that##3##2##(2011-2#2)(2013-8#1)
hazards to human health##2##4##(2008-10#1)(2008-11#1)
hazards to human##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
hazards to##5##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
hazards##100##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#6)(1992-8#1)(1993-12#1)(1994-2#2)(1995-11#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#2)(1997-3#9)(1997-4#2)(1997-7#2)(1997-8#5)(2008-10#5)(2008-11#8)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
haze##5##1##(2008-3#5)
hazelnut (Corylus avellana)##2##3##(2008-10#2)
hazelnut orchards##3##2##(2008-10#3)
hazelnut##16##1##(2008-10#16)
hazmat##4##1##(2009-10#4)
hck tyrosine kinase##2##3##(1991-12#2)
hck##3##1##(1991-12#3)
hcp##3##1##(1990-12#1)(1990-4#1)(1995-3#1)
hdf##2##1##(2008-11#2)
he appeared##2##2##(1990-6#1)(2013-1#1)
he became##5##2##(2007-5#2)(2008-12#1)(2012-2#1)(2012-3#1)
he believes##2##2##(1997-2#1)(2008-6#1)
he cannot##2##2##(1990-11#1)(1990-8#1)
he carried out##2##3##(2007-4#2)
he complained of##2##3##(2007-8#1)(2008-12#1)
he could not be##2##4##(1996-5#1)(1997-5#1)
he could not##4##3##(1995-6#1)(1996-5#1)(1997-5#1)(2013-1#1)
he described##2##2##(1995-6#1)(2011-2#1)
he describes##2##2##(1993-3#1)(1995-5#1)
he developed a##5##3##(1995-1#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
he developed low##2##3##(2007-7#1)(2013-1#1)
he developed severe##2##3##(2007-12#1)(2007-8#1)
he developed##13##2##(1991-1#1)(1995-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
he did not##5##3##(1995-12#1)(1996-5#1)(2008-12#1)(2008-7#1)(2012-12#1)
he does not##2##3##(1991-6#1)(1996-5#1)
he does##3##2##(1991-6#1)(1996-5#1)(2007-2#1)
he experienced##2##2##(2011-2#1)(2012-3#1)
he felt##2##2##(2008-1#1)(2008-9#1)
he first##3##2##(2008-7#2)(2010-8#1)
he founded##2##2##(1997-4#1)(2012-3#1)
he had a##4##3##(1991-6#1)(2006-10#1)(2008-12#1)(2010-5#1)
he had been##2##3##(1995-6#1)(2008-11#1)
he had no##2##3##(1991-7#1)(2011-2#1)
he had to##2##3##(1993-11#1)(1996-2#1)
he had undergone##2##3##(2007-5#1)(2008-7#1)
he had##29##2##(1991-11#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
he has##6##2##(1992-11#1)(1993-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
he is still##2##3##(1993-11#1)(2008-4#1)
he is##11##2##(1990-11#1)(1993-11#2)(1996-5#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
he or she must##3##4##(1993-6#1)(2008-8#1)(2011-2#1)
he or she##7##3##(1993-6#1)(1994-12#1)(1996-1#1)(1997-1#1)(2008-4#1)(2008-8#1)(2011-2#1)
he presented a##2##3##(2007-8#1)(2013-1#1)
he presented with a##2##4##(2008-12#1)(2008-6#1)
he presented with##4##3##(2008-12#1)(2008-4#1)(2008-6#1)(2011-2#1)
he presented##9##2##(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
he received##3##2##(1994-3#1)(2008-6#1)(2013-1#1)
he reported##5##2##(2007-2#1)(2008-10#1)(2008-12#2)(2008-7#1)
he says##7##2##(1993-12#1)(1993-2#2)(1994-2#1)(1996-12#2)(1997-2#1)
he showed##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
he stopped##2##2##(1997-3#1)(2012-2#1)
he suffered##2##2##(2013-1#2)
he took##4##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)
he turned##2##2##(2007-7#1)(2010-5#1)
he underwent an##2##3##(2007-8#1)(2013-1#1)
he underwent##7##2##(2007-8#1)(2008-12#1)(2008-6#1)(2011-2#2)(2013-1#2)
he used##2##2##(1991-6#1)(1993-3#1)
he visited##2##2##(1997-4#1)(2009-7#1)
he was HIV-positive##2##3##(1996-5#1)(1997-5#1)
he was a##2##3##(1993-12#1)(2007-12#1)
he was able to##3##4##(1996-12#1)(2009-1#1)(2013-1#1)
he was awake##2##3##(2012-2#1)(2013-8#1)
he was diagnosed with##7##4##(1997-3#1)(1997-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#2)
he was diagnosed##8##3##(1997-3#1)(1997-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#3)
he was elected to##2##4##(1995-1#2)
he was found to be##2##5##(2009-7#1)(2013-1#1)
he was found to##3##4##(2009-11#1)(2009-7#1)(2013-1#1)
he was in remission##2##4##(1994-12#2)
he was not##2##3##(1992-3#1)(1995-6#1)
he was taking##2##3##(1995-6#2)
he was unable to take##2##5##(1993-3#1)(1995-6#1)
he was##61##2##(1990-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#2)(1995-1#2)(1995-3#1)(1995-6#4)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#4)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-12#1)(2009-1#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#9)(2013-8#3)
he will##2##2##(1990-11#1)(1996-5#1)
he would##6##2##(1995-12#2)(1995-6#2)(2008-4#1)(2008-5#1)
he##319##1##(1990-11#7)(1990-4#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#6)(1993-5#1)(1993-6#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#4)(1995-11#1)(1995-12#5)(1995-3#2)(1995-5#1)(1995-6#11)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-5#10)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#6)(2006-10#2)(2007-10#1)(2007-12#8)(2007-2#4)(2007-4#3)(2007-5#10)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#10)(2008-11#4)(2008-12#16)(2008-4#4)(2008-5#2)(2008-6#7)(2008-7#10)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#7)(2009-9#1)(2010-1#5)(2010-12#1)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#12)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#25)(2013-8#5)
he/she was##2##2##(2012-2#1)(2012-3#1)
he/she##9##1##(1992-5#1)(2007-11#1)(2008-7#1)(2010-3#1)(2012-2#3)(2012-3#2)
head and body##2##3##(2008-5#1)(2009-5#1)
head and is##2##3##(2007-12#1)(2008-2#1)
head and neck (SCCHN)##2##4##(2007-11#1)(2012-12#1)
head and neck and##2##4##(2008-6#1)(2008-7#1)
head and neck area##2##4##(2011-2#2)
head and neck cancer cell lines##2##6##(2008-2#2)
head and neck cancer patients##5##5##(1990-12#2)(2008-5#3)
head and neck cancer##33##4##(1990-12#2)(1990-6#2)(1991-4#1)(1992-10#1)(1993-9#2)(1994-10#1)(1995-8#1)(1995-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2010-4#2)(2012-2#1)(2013-1#3)
head and neck carcinoma##4##4##(1990-12#2)(1990-6#1)(1995-8#1)
head and neck carcinomas##2##4##(2011-2#2)
head and neck contrast-enhanced CT##3##5##(2013-1#3)
head and neck contrast-enhanced##4##4##(2013-1#4)
head and neck infections##2##4##(2007-12#2)
head and neck lesions of##2##5##(2013-8#2)
head and neck lesions##6##4##(2013-8#6)
head and neck malignancies##2##4##(1995-9#1)(2008-1#1)
head and neck reconstruction##3##4##(2007-12#1)(2007-5#1)(2008-4#1)
head and neck region##11##4##(1992-5#1)(1992-9#1)(1997-6#1)(2007-12#2)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
head and neck squamous cell carcinoma##3##6##(2008-2#2)(2013-8#1)
head and neck surgery##2##4##(1991-4#1)(2008-12#1)
head and neck tumors##4##4##(1990-12#1)(1991-3#1)(2009-11#1)(2011-2#1)
head and neck##117##3##(1990-12#5)(1990-6#5)(1991-3#1)(1991-4#2)(1992-10#2)(1992-5#1)(1992-9#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-6#1)(1995-8#4)(1995-9#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2010-4#3)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#2)(2013-1#11)(2013-8#10)
head and the##7##3##(1990-9#1)(1995-12#1)(2008-10#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)
head and##151##2##(1990-12#5)(1990-6#5)(1990-9#1)(1991-3#1)(1991-4#2)(1992-10#2)(1992-5#1)(1992-9#2)(1993-8#1)(1993-9#4)(1994-10#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#4)(1995-9#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#13)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-12#2)(2008-2#10)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#12)(2013-8#10)
head blight and deoxynivalenol##4##4##(2008-10#4)
head blight and##6##3##(2008-10#6)
head blight epidemics##2##3##(2008-10#2)
head blight in##2##3##(2008-10#2)
head blight intensity and##2##4##(2008-10#2)
head blight of wheat##5##4##(2008-10#5)
head blight of##6##3##(2008-10#6)
head blight##49##2##(2008-10#48)(2011-10#1)
head breadth##2##2##(1995-6#1)(2008-7#1)
head by the##2##3##(1990-5#1)(2007-8#1)
head by##4##2##(1990-5#1)(2007-12#1)(2007-8#1)(2008-3#1)
head can be##2##3##(2008-5#1)(2008-8#1)
head can##3##2##(1991-5#1)(2008-5#1)(2008-8#1)
head center##2##2##(2011-2#2)
head circumference##8##2##(2008-11#1)(2008-12#2)(2008-2#1)(2011-1#4)
head circumference)##2##2##(2008-12#1)(2012-12#1)
head contains a##2##3##(1993-9#1)(2007-12#1)
head contains##4##2##(1993-9#1)(2007-12#1)(2008-2#1)(2008-7#1)
head diameter##2##2##(1995-6#1)(2007-11#1)
head direction##3##2##(2007-8#1)(2013-8#2)
head group region##2##3##(1994-3#1)(2008-10#1)
head group spacing##3##3##(1992-6#1)(2008-8#2)
head group##10##2##(1990-5#1)(1992-6#1)(1994-3#4)(1995-2#1)(2008-10#1)(2008-8#2)
head groups##6##2##(1992-6#1)(1992-9#2)(1994-3#1)(2008-11#1)(2009-2#1)
head impact##3##2##(2008-7#3)
head injuries##14##2##(1990-3#1)(1990-6#1)(1992-6#1)(1996-8#2)(2007-11#1)(2008-11#3)(2008-7#5)
head injury (GCS##3##3##(2008-7#3)
head injury and##3##3##(1995-5#1)(2008-7#1)(2010-4#1)
head injury complicated by##3##4##(2008-9#3)
head injury in##3##3##(2008-7#1)(2012-3#2)
head injury##48##2##(1991-12#1)(1991-3#1)(1992-6#4)(1995-5#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-7#19)(2008-8#2)(2008-9#3)(2010-4#1)(2010-8#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#4)
head is##4##2##(2007-11#1)(2009-10#1)(2009-3#2)
head kidney##2##2##(2010-5#2)
head length##3##2##(1995-6#1)(2008-5#2)
head magnetic stimulation was##2##4##(2008-7#2)
head magnetic stimulation##4##3##(2008-7#4)
head model##2##2##(1990-5#2)
head movement in##2##3##(1990-5#1)(2009-4#1)
head movement##5##2##(1990-5#2)(1995-5#1)(2008-9#1)(2009-4#1)
head movements in##3##3##(1993-12#3)
head movements##8##2##(1993-12#7)(2008-9#1)
head necrosis##4##2##(1992-11#1)(1994-7#2)(2009-3#1)
head of the pancreas##4##4##(1990-9#1)(1991-3#1)(1994-3#1)(2013-1#1)
head of the##25##3##(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-6#1)(2008-9#2)(2009-4#1)(2012-2#2)(2013-1#1)
head of##32##2##(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-6#1)(2008-9#2)(2009-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
head or neck##2##3##(1995-8#1)(2012-2#1)
head or##6##2##(1995-8#1)(2008-10#2)(2008-11#1)(2009-11#1)(2012-2#1)
head penetration rates##2##3##(2008-8#2)
head posture##4##2##(2010-9#4)
head rot in##2##3##(2008-10#2)
head rot##9##2##(2008-10#9)
head shape##5##2##(1992-5#4)(2007-12#1)
head space gas##2##3##(2008-5#1)(2012-2#1)
head space##4##2##(2008-10#1)(2008-5#2)(2012-2#1)
head specimen##2##2##(2012-3#2)
head structures##2##2##(1994-8#1)(2007-12#1)
head syndrome##2##2##(1997-3#2)
head that##2##2##(2008-3#2)
head to##7##2##(2008-11#2)(2008-5#1)(2010-6#1)(2011-1#3)
head trauma##17##2##(2007-10#1)(2007-11#1)(2008-12#1)(2008-7#4)(2008-9#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
head was##4##2##(1992-9#1)(2008-10#1)(2009-4#2)
head weight##3##2##(2008-10#3)
head widths##3##2##(2007-12#1)(2009-5#2)
head with a##3##3##(2008-3#1)(2008-5#1)(2008-8#1)
head with##5##2##(1991-5#1)(2008-3#2)(2008-5#1)(2008-8#1)
head##638##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#6)(1990-6#6)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#2)(1991-5#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-5#5)(1992-6#10)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#8)(1993-3#2)(1993-8#1)(1993-9#5)(1994-10#1)(1994-12#2)(1994-3#6)(1994-6#3)(1994-7#2)(1994-8#3)(1995-11#8)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#5)(1995-9#3)(1996-12#1)(1996-5#2)(1996-8#2)(1997-3#3)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#10)(2007-12#37)(2007-5#1)(2007-7#1)(2007-8#7)(2008-1#6)(2008-10#92)(2008-11#13)(2008-12#11)(2008-2#18)(2008-3#20)(2008-4#5)(2008-5#23)(2008-6#8)(2008-7#48)(2008-8#17)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#11)(2009-4#11)(2009-5#4)(2009-6#1)(2009-7#1)(2010-1#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#7)(2011-1#14)(2011-10#1)(2011-2#22)(2012-12#4)(2012-2#15)(2012-3#7)(2013-1#20)(2013-7#6)(2013-8#21)
head-and-neck cancer##2##2##(2009-2#2)
head-and-neck##3##1##(2009-2#3)
head-down tilt position##2##3##(1993-1#2)
head-down tilt##5##2##(1993-1#5)
head-mounted displays##2##2##(2008-3#2)
head-mounted##5##1##(2008-3#5)
head-neck##4##1##(2007-10#1)(2011-2#1)(2013-1#2)
head-space method##2##2##(2008-5#2)
head-space##3##1##(2008-5#3)
head-to-tail##4##1##(1992-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
head/neck##5##1##(1995-11#1)(2011-1#1)(2011-3#1)(2012-3#2)
headache and##14##2##(1992-2#1)(1995-12#1)(2007-8#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#2)(2012-3#3)(2013-8#1)
headache in##4##2##(1993-10#2)(2008-7#1)(2013-8#1)
headache of##2##2##(1992-2#1)(2010-12#1)
headache pain intensity##2##3##(2008-12#2)
headache pain##3##2##(2008-12#2)(2008-9#1)
headache with##2##2##(2008-12#1)(2009-6#1)
headache##111##1##(1990-12#1)(1990-2#1)(1992-12#1)(1992-2#3)(1993-10#5)(1994-6#2)(1994-9#3)(1995-12#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-6#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#17)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#12)(2008-9#5)(2009-3#1)(2009-6#3)(2009-7#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-9#3)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#3)
headache)##2##1##(2008-4#1)(2008-9#1)
headache]##3##1##(1991-8#1)(1992-2#1)(1994-9#1)
headaches and backaches are growing faster than any other occupational injury as a by-product of our computerized work environment##2##19##(1994-3#2)
headaches and##9##2##(1994-3#2)(2006-10#1)(2008-11#1)(2009-1#1)(2009-6#1)(2011-2#1)(2012-8#1)(2013-1#1)
headaches##23##1##(1994-3#2)(2006-10#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-4#6)(2008-6#1)(2008-7#2)(2009-1#1)(2009-6#1)(2011-2#2)(2012-3#1)(2012-8#1)(2013-1#1)
headed by##2##2##(1996-2#1)(2008-8#1)
headed##6##1##(1990-10#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-8#1)
header processor##2##2##(2008-3#2)
header##4##1##(2007-12#1)(2008-3#3)
header-error control##2##2##(2008-3#2)
headgroup and##2##2##(2008-5#1)(2012-12#1)
headgroup are##2##2##(1990-7#1)(1994-5#1)
headgroup structure##2##2##(1994-5#2)
headgroup##16##1##(1990-11#1)(1990-7#4)(1992-6#1)(1994-5#4)(1995-3#1)(2008-10#2)(2008-5#1)(2012-12#2)
headgroups and##2##2##(1991-3#1)(1993-11#1)
headgroups##12##1##(1990-11#1)(1990-7#6)(1991-3#1)(1993-11#1)(2008-5#1)(2009-2#1)(2012-2#1)
heading &quot##3##2##(2007-7#1)(2008-1#1)(2009-10#1)
heading date##6##2##(2008-10#5)(2008-9#1)
heading in##2##2##(2008-4#1)(2008-9#1)
heading of the##2##3##(2007-12#1)(2008-11#1)
heading##29##1##(1991-2#1)(1993-3#1)(1995-1#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#6)(2009-10#1)
heading?##2##1##(1992-12#1)(2013-1#1)
headings of##2##2##(2008-11#1)(2009-5#1)
headings##8##1##(1991-12#1)(1992-12#1)(1996-3#1)(2007-7#1)(2008-11#2)(2009-5#1)(2010-11#1)
headlines##2##1##(2011-2#1)(2013-1#1)
headquarters in##3##2##(1991-5#1)(1994-1#1)(2008-10#1)
headquarters##8##1##(1991-5#1)(1993-8#1)(1994-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-8#1)
heads and##4##2##(1994-5#1)(2007-5#1)(2008-3#2)
heads of##5##2##(1991-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
heads were##5##2##(1991-5#1)(1995-2#1)(2008-10#3)
heads##40##1##(1991-3#1)(1991-5#3)(1992-1#1)(1992-8#1)(1994-5#1)(1995-2#2)(1997-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#13)(2008-3#5)(2008-5#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
headspace (HS)##3##2##(2008-10#3)
headspace SPME##6##2##(2008-10#5)(2012-12#1)
headspace above##3##2##(2008-10#3)
headspace analysis##3##2##(2008-10#2)(2008-5#1)
headspace and dissolved##2##3##(2011-2#2)
headspace and##4##2##(2008-10#2)(2011-2#2)
headspace gas chromatography##2##3##(2008-10#2)
headspace gas chromatography-mass##2##3##(2011-1#2)
headspace gas##6##2##(2008-10#4)(2011-1#2)
headspace liquid-phase microextraction (HS-LPME)##2##4##(2008-10#2)
headspace mode##2##2##(2008-10#2)
headspace or dissolved O(2) levels##2##5##(2011-2#2)
headspace or dissolved O(2)##3##4##(2011-2#3)
headspace samples##2##2##(2008-10#1)(2011-10#1)
headspace solid-phase microextraction (HS-SPME) was##2##5##(2008-10#2)
headspace solid-phase microextraction (HS-SPME)##4##4##(2008-10#3)(2012-1#1)
headspace solid-phase microextraction (SPME)##2##4##(2008-10#2)
headspace solid-phase microextraction##12##3##(2008-10#10)(2012-1#2)
headspace solvent microextraction##4##3##(2008-10#4)
headspace volume##4##2##(2008-10#4)
headspace##79##1##(2008-10#61)(2008-11#2)(2008-5#1)(2009-8#1)(2011-1#4)(2011-10#1)(2011-2#6)(2012-1#2)(2012-12#1)
headstands/pecks in##2##2##(2009-9#2)
headstands/pecks##3##1##(2009-9#3)
heal##12##1##(1993-1#1)(1996-1#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-6#2)(2011-2#1)(2012-2#1)
healed in##4##2##(1992-2#2)(1997-8#1)(2012-2#1)
healed well##2##2##(2011-1#1)(2012-3#1)
healed with##4##2##(2008-8#1)(2008-9#1)(2013-1#2)
healed##29##1##(1990-12#1)(1992-2#2)(1992-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#3)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)
healer and##2##2##(2008-12#1)(2008-4#1)
healer##5##1##(1997-6#1)(2008-12#1)(2008-4#2)(2012-12#1)
healers##8##1##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-12#2)
healing after##5##2##(1996-4#1)(2007-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
healing and##12##2##(1991-9#1)(1993-3#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)
healing by##5##2##(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
healing in the##5##3##(1995-11#1)(2008-12#2)(2008-9#1)(2011-2#1)
healing in##9##2##(1992-6#1)(1995-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
healing is a##2##3##(1995-11#1)(2010-8#1)
healing is##4##2##(1992-3#1)(1995-11#1)(2007-8#1)(2010-8#1)
healing of a##2##3##(2008-5#1)(2008-9#1)
healing of all##3##3##(1994-2#1)(2008-11#1)(2008-9#1)
healing of the##7##3##(1992-3#1)(2007-11#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
healing of##23##2##(1992-3#1)(1994-2#1)(1996-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
healing process##11##2##(1996-12#1)(1996-4#1)(2007-11#1)(2008-5#1)(2008-9#3)(2009-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
healing processes##6##2##(2008-5#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
healing properties of##2##3##(2008-7#1)(2011-2#1)
healing properties##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
healing rate##2##2##(1993-11#1)(2012-2#1)
healing rates##2##2##(1992-11#1)(2012-2#1)
healing tissue##3##2##(2008-6#1)(2008-9#2)
healing was##8##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
healing were##2##2##(1990-3#1)(2013-1#1)
healing with##2##2##(2009-8#1)(2013-1#1)
healing without##2##2##(2012-2#1)(2012-3#1)
healing wounds##2##2##(2008-5#1)(2008-9#1)
healing##190##1##(1990-3#1)(1990-9#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-11#2)(1995-3#1)(1996-12#1)(1996-3#2)(1996-4#3)(1997-3#3)(1997-6#7)(2007-11#7)(2007-12#4)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#9)(2008-11#6)(2008-12#4)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#14)(2009-10#2)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#14)(2011-3#1)(2012-12#7)(2012-2#10)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#3)
healing&quot##3##1##(1990-2#1)(2008-11#2)
health (P = 0##3##4##(2008-7#1)(2008-8#2)
health (e##2##2##(2010-9#1)(2011-1#1)
health -##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
health IT##2##2##(2011-2#1)(2012-3#1)
health access##2##2##(1997-1#1)(2013-8#1)
health accounts##4##2##(1993-2#2)(1997-1#1)(2012-12#1)
health actions##2##2##(1997-3#1)(2010-9#1)
health administration and##3##3##(1991-2#1)(1993-12#1)(1996-3#1)
health administration are##2##3##(1993-2#1)(1995-1#1)
health administration curriculum##7##3##(1991-1#1)(1992-3#1)(1993-1#1)(1995-12#1)(1996-1#1)(1996-2#2)
health administration education for##3##4##(1991-1#1)(1995-1#1)(1996-3#1)
health administration education in##2##4##(1991-1#1)(1997-3#1)
health administration education programs##4##4##(1992-2#1)(1993-2#1)(1995-12#1)(1996-3#1)
health administration education##25##3##(1991-1#4)(1991-12#1)(1991-2#1)(1992-2#2)(1993-12#1)(1993-2#2)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#4)(1997-3#4)(2009-8#1)
health administration program##2##3##(1993-1#1)(1996-1#1)
health administration programs in##2##4##(1993-1#1)(1995-1#1)
health administration programs##13##3##(1991-1#1)(1992-3#1)(1993-1#2)(1993-2#2)(1995-1#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)
health administration students##4##3##(1992-3#1)(1996-1#3)
health administration##90##2##(1991-1#9)(1991-12#2)(1991-2#5)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#6)(1993-12#3)(1993-2#7)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#8)(1995-12#3)(1996-1#11)(1996-12#2)(1996-2#6)(1996-3#7)(1997-2#2)(1997-3#6)(2009-8#1)
health administrators##11##2##(1994-12#1)(1994-2#1)(1995-1#5)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)
health advice and##5##3##(2007-2#4)(2012-3#1)
health advice##15##2##(2007-2#13)(2012-3#2)
health advisors as part of the community health team##2##9##(1997-2#2)
health advocacy##3##2##(2007-5#3)
health advocates##5##2##(1992-2#1)(2007-5#2)(2008-11#1)(2009-7#1)
health after##2##2##(2011-1#1)(2012-3#1)
health agencies and##3##3##(1996-1#1)(1997-3#2)
health agencies in##3##3##(1995-12#2)(1997-3#1)
health agencies to focus##2##4##(1995-12#1)(1997-1#1)
health agencies to##5##3##(1995-12#2)(1997-1#3)
health agencies##31##2##(1991-2#2)(1995-12#6)(1995-3#1)(1996-1#6)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#1)(1997-3#5)(2009-5#1)
health agency##13##2##(1992-3#1)(1993-1#2)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2006-5#1)(2010-8#2)
health agenda##3##2##(1997-1#2)(2008-1#1)
health agents##4##2##(2008-9#1)(2010-9#1)(2011-2#2)
health among##11##2##(1993-6#1)(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-2#1)
health and are##2##3##(1994-3#1)(1996-12#1)
health and behavior##2##3##(1993-3#1)(2008-7#1)
health and cognitive##2##3##(2011-2#1)(2012-2#1)
health and dental##2##3##(2008-5#1)(2008-7#1)
health and development##4##3##(1992-3#1)(2007-2#1)(2008-11#1)(2013-1#1)
health and disease and##3##4##(1993-9#1)(2008-10#1)(2012-2#1)
health and disease in##2##4##(2012-12#1)(2013-1#1)
health and disease##32##3##(1992-5#1)(1993-11#1)(1993-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#8)(2013-1#3)(2013-7#3)(2013-8#1)
health and economic##3##3##(2007-12#1)(2009-8#1)(2013-1#1)
health and environment##2##3##(2010-12#2)
health and environmental##3##3##(2008-10#1)(2009-11#1)(2011-2#1)
health and family##3##3##(1992-3#1)(1994-3#1)(1994-7#1)
health and functional characteristics of##2##5##(1991-3#1)(1995-3#1)
health and functional##5##3##(1991-3#1)(1995-3#2)(1997-1#1)(2013-1#1)
health and functioning after##2##4##(2010-9#2)
health and health care##8##4##(1990-12#1)(1995-12#1)(1997-2#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#1)
health and health equity##2##4##(1996-3#1)(2011-1#1)
health and health##15##3##(1990-12#1)(1991-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
health and how##2##3##(1996-6#1)(2010-12#1)
health and human##2##3##(1991-3#1)(1996-12#1)
health and hygiene##2##3##(2007-12#1)(2007-2#1)
health and illness##3##3##(2010-10#1)(2010-2#1)(2011-2#1)
health and its##4##3##(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
health and longevity##2##3##(2008-10#1)(2012-1#1)
health and medical care##3##4##(1995-2#2)(2013-8#1)
health and medical##5##3##(1990-3#1)(1995-2#3)(2013-8#1)
health and medicine##7##3##(1995-2#5)(2008-12#1)(2009-5#1)
health and mental health services##2##5##(1993-2#1)(2008-12#1)
health and mental health##4##4##(1993-2#1)(1995-2#1)(2006-9#1)(2008-12#1)
health and more##2##3##(2008-8#1)(2012-2#1)
health and nutrition##3##3##(2008-1#1)(2008-7#1)(2010-5#1)
health and other##3##3##(1996-12#1)(1996-3#1)(2008-1#1)
health and quality of life##2##5##(2008-7#1)(2009-12#1)
health and safety experiences##2##4##(2011-2#2)
health and safety issues##2##4##(1993-3#1)(2007-2#1)
health and safety##14##3##(1993-3#1)(1995-3#3)(2007-2#1)(2008-11#1)(2008-12#2)(2008-9#3)(2010-7#1)(2011-2#2)
health and skilled nursing facility##2##5##(1995-3#2)
health and social care professionals##2##5##(2008-11#1)(2008-12#1)
health and social care##13##4##(1992-11#1)(1992-2#1)(2008-11#8)(2008-12#3)
health and social service##2##4##(1995-3#1)(2011-2#1)
health and social services##8##4##(1992-11#1)(1994-1#2)(1996-3#1)(2008-1#1)(2008-11#2)(2008-2#1)
health and social##30##3##(1992-11#2)(1992-2#1)(1992-3#1)(1994-1#2)(1995-3#1)(1996-3#1)(2008-1#2)(2008-11#11)(2008-12#3)(2008-2#1)(2009-9#1)(2011-1#2)(2011-2#2)
health and survival##3##3##(2010-5#2)(2012-2#1)
health and the##5##3##(1991-12#1)(1991-3#1)(2011-2#2)(2013-7#1)
health and welfare##3##3##(1992-3#1)(1996-3#2)
health and well-being##13##3##(1994-2#1)(1997-3#1)(2007-6#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-2#4)
health and wellness##5##3##(1994-12#1)(2008-12#2)(2010-12#1)(2013-7#1)
health and##303##2##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-3#5)(1992-11#2)(1992-2#2)(1992-3#5)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#3)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#9)(1995-3#9)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#6)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-2#6)(2007-6#1)(2008-1#9)(2008-10#11)(2008-11#19)(2008-12#12)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#2)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#5)(2010-9#5)(2011-1#6)(2011-2#20)(2012-1#4)(2012-12#4)(2012-2#14)(2012-3#2)(2013-1#13)(2013-7#5)(2013-8#7)
health approach##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
health approaches to##2##3##(1997-1#1)(2008-11#1)
health approaches##3##2##(1997-1#1)(2007-12#1)(2008-11#1)
health are discussed##2##3##(2009-5#1)(2010-3#1)
health are not only##2##4##(2008-2#1)(2012-12#1)
health are##10##2##(1991-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#1)(2012-12#1)
health area##3##2##(1996-9#1)(1997-3#1)(2008-11#1)
health area]##3##2##(1993-10#1)(1993-5#1)(1996-9#1)
health around##2##2##(2012-1#1)(2013-1#1)
health as##8##2##(1991-6#1)(1995-2#1)(1996-1#1)(1996-6#1)(2007-10#1)(2009-9#1)(2010-2#1)(2011-2#1)
health assessment and improvement initiative##3##5##(1996-2#3)
health assessment and##6##3##(1996-12#1)(1996-2#3)(2009-11#1)(2013-8#1)
health assessment##9##2##(1996-1#2)(1996-12#1)(1996-2#3)(1997-3#1)(2009-11#1)(2013-8#1)
health associated with##2##3##(2008-8#1)(2009-5#1)
health at##5##2##(1995-2#1)(1996-2#1)(1997-6#1)(2008-11#2)
health attitudes##3##2##(2013-7#3)
health audit system##2##3##(2010-8#2)
health authorities and##4##3##(1990-12#1)(1994-3#1)(2008-11#1)(2012-12#1)
health authorities have##2##3##(1992-1#1)(1995-6#1)
health authorities in##2##3##(1992-11#1)(1997-2#1)
health authorities of##3##3##(1990-6#1)(2009-10#1)(2012-12#1)
health authorities should##2##3##(1991-8#1)(1994-2#1)
health authorities##28##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-6#2)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-9#1)(2009-10#1)(2010-5#1)(2012-12#2)(2013-1#1)
health authorities'##2##2##(2012-12#2)
health based on##2##3##(1996-12#1)(2011-1#1)
health behavior change##3##3##(2008-4#2)(2011-1#1)
health behavior##6##2##(2007-4#1)(2008-4#2)(2011-1#3)
health behaviors and##3##3##(2008-11#1)(2010-3#1)(2010-9#1)
health behaviors of##2##3##(2008-11#2)
health behaviors##18##2##(2007-2#1)(2008-11#4)(2008-7#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-9#1)(2013-1#4)
health belief model##2##3##(2011-1#2)
health beliefs##6##2##(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#2)
health benefit##7##2##(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#2)(2011-2#1)(2013-8#1)
health benefits are##2##3##(1995-1#1)(2008-10#1)
health benefits of##4##3##(1994-11#1)(2007-11#1)(2008-7#1)(2010-2#1)
health benefits##22##2##(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#1)(1996-12#2)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-1#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
health burden##4##2##(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)
health but##2##2##(2008-6#1)(2011-1#1)
health by##4##2##(2008-8#2)(2010-12#2)
health campaign##4##2##(1996-3#1)(1996-8#1)(2008-1#2)
health campaigns##3##2##(2008-1#1)(2009-5#1)(2011-2#1)
health can##3##2##(1996-2#1)(2013-1#2)
health capital##2##2##(1992-3#1)(2013-8#1)
health care (+0##2##3##(2013-7#2)
health care a##2##3##(1990-12#1)(2008-10#1)
health care access##9##3##(1992-12#1)(1993-3#1)(1996-1#1)(1996-3#2)(2008-4#1)(2009-5#2)(2010-3#1)
health care across##2##3##(1993-2#1)(1997-3#1)
health care administration and##2##4##(1991-12#1)(1995-1#1)
health care administration##7##3##(1991-12#1)(1994-3#1)(1995-1#3)(1996-2#1)(2008-1#1)
health care administrators and##2##4##(1992-2#2)
health care administrators##13##3##(1992-1#1)(1992-2#4)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2009-8#1)
health care among##3##3##(1996-3#1)(2009-5#2)
health care and education##2##4##(1990-2#1)(1994-12#1)
health care and other##3##4##(1993-1#1)(1995-1#1)(2008-6#1)
health care and the##4##4##(1993-12#1)(1995-3#1)(2008-10#1)(2008-7#1)
health care and##35##3##(1990-2#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#2)(1996-1#1)(1996-11#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-6#2)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#2)
health care are##9##3##(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(2008-11#1)(2009-5#1)(2010-4#1)
health care as##3##3##(1992-1#1)(1994-3#1)(1997-3#1)
health care at##3##3##(1992-1#1)(2008-11#1)(2012-12#1)
health care benefits##3##3##(1994-2#1)(1994-3#1)(1995-12#1)
health care bill##2##3##(1995-3#1)(1997-2#1)
health care budget##2##3##(1994-2#1)(2007-7#1)
health care business##2##3##(1993-2#1)(1996-12#1)
health care can be##3##4##(1994-2#1)(1994-3#1)(1996-3#1)
health care center##4##3##(1991-3#1)(1994-3#1)(2007-8#1)(2008-10#1)
health care centers##9##3##(1993-6#1)(1995-3#1)(1995-8#1)(2007-2#1)(2007-8#1)(2011-2#4)
health care centres in##2##4##(1996-1#1)(2008-7#1)
health care centres##3##3##(1995-1#1)(1996-1#1)(2008-7#1)
health care companies##5##3##(1995-1#3)(2008-11#2)
health care computing##3##3##(1996-2#1)(2010-8#2)
health care consumers##2##3##(1994-12#1)(1996-2#1)
health care cost containment##2##4##(1991-2#1)(1994-1#1)
health care cost##6##3##(1991-2#1)(1994-1#1)(1994-2#1)(2007-10#2)(2008-1#1)
health care costs and the##2##5##(1992-1#1)(2008-11#1)
health care costs and##15##4##(1992-1#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-1#2)(1997-2#1)(2008-11#2)(2013-1#1)
health care costs attributable to##2##5##(2008-11#2)
health care costs from##2##4##(2008-11#2)
health care costs in##2##4##(1993-1#1)(1996-3#1)
health care costs##55##3##(1991-12#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#3)(1996-2#3)(1996-3#2)(1997-1#2)(1997-2#3)(1997-3#1)(2008-1#3)(2008-11#7)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
health care coverage##3##3##(1996-1#1)(2008-1#1)(2008-11#1)
health care crisis and##2##4##(1993-12#1)(1997-3#1)
health care crisis##4##3##(1991-1#1)(1993-12#1)(1997-3#2)
health care data##4##3##(1994-2#3)(1997-2#1)
health care datafiles##2##3##(1995-12#2)
health care decentralization##2##3##(2008-7#2)
health care decision making##2##4##(1993-3#1)(1996-3#1)
health care decisions##4##3##(1992-1#1)(1993-2#1)(2010-10#1)(2010-9#1)
health care delivered##2##3##(1996-2#1)(2010-8#1)
health care delivery and##4##4##(1993-2#1)(1996-3#1)(2008-11#1)(2008-6#1)
health care delivery system##16##4##(1991-1#1)(1993-12#2)(1994-1#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(2011-1#1)(2012-3#1)
health care delivery systems##10##4##(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-3#1)(2008-1#1)
health care delivery##66##3##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1996-1#6)(1996-12#4)(1996-2#2)(1996-3#6)(1997-2#3)(1997-3#1)(2007-7#1)(2008-1#4)(2008-11#2)(2008-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-7#1)
health care do not##2##4##(1993-12#1)(1997-4#1)
health care dollars##3##3##(1993-12#2)(1995-2#1)
health care employees##3##3##(2008-11#3)
health care employment##3##3##(1994-2#1)(1996-2#2)
health care entity##2##3##(1993-12#1)(1997-2#1)
health care environment and##3##4##(1996-2#1)(1996-3#1)(2008-1#1)
health care environment has##2##4##(1991-2#1)(1993-12#1)
health care environment##26##3##(1991-12#1)(1991-2#1)(1991-3#2)(1993-12#1)(1993-3#3)(1994-3#1)(1995-1#4)(1995-3#2)(1996-2#1)(1996-3#3)(1997-3#3)(2008-1#3)(2008-11#1)
health care environments##4##3##(1994-2#1)(2008-11#1)(2011-1#1)(2012-3#1)
health care even##2##3##(2008-1#1)(2008-10#1)
health care executive##2##3##(1995-2#1)(2008-1#1)
health care executives in##4##4##(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)
health care executives##10##3##(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#3)(1996-3#1)
health care expenditure##3##3##(2012-1#1)(2013-7#2)
health care expenditures for##2##4##(1991-2#1)(2009-5#1)
health care expenditures##16##3##(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#2)(2009-5#1)(2013-7#1)
health care experience##2##3##(1995-3#1)(1996-2#1)
health care facilities have been##2##5##(1995-1#1)(1996-3#1)
health care facilities in##4##4##(1997-2#1)(2007-12#3)
health care facilities##28##3##(1990-5#1)(1991-1#3)(1991-12#2)(1992-1#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#7)(2009-6#2)(2012-1#1)(2012-3#1)
health care facility construction##3##4##(1991-2#3)
health care facility##10##3##(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1996-2#2)(2008-12#1)
health care field##9##3##(1993-12#2)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
health care finance##4##3##(1991-2#1)(1994-3#2)(2008-7#1)
health care financial management##3##4##(2008-11#3)
health care financing and delivery##2##5##(1993-2#1)(1996-12#1)
health care financing and##3##4##(1993-2#1)(1994-1#1)(1996-12#1)
health care financing##12##3##(1991-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#2)(2008-7#2)
health care for adolescents##2##4##(1995-12#1)(1996-12#1)
health care for children##5##4##(1991-1#1)(1991-3#1)(1995-2#1)(1996-12#1)(2009-5#1)
health care for the elderly##2##5##(1991-12#1)(1992-2#1)
health care for the##6##4##(1991-12#1)(1992-2#1)(1995-1#1)(1996-12#1)(2008-11#1)(2010-10#1)
health care for##29##3##(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-12#1)(1994-3#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#4)(1996-2#2)(2008-11#1)(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#3)(2012-3#1)
health care fraud and abuse##2##5##(1991-1#2)
health care fraud##5##3##(1991-1#2)(1993-12#2)(1996-12#1)
health care has been##3##4##(1993-12#1)(1995-3#1)(1996-7#1)
health care has##8##3##(1993-12#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-7#1)(2008-1#1)(2008-12#1)
health care have##4##3##(1995-1#1)(1995-12#1)(2010-8#1)(2013-1#1)
health care in Canada##2##4##(1992-1#1)(1997-1#1)
health care in Germany##2##4##(1992-1#1)(1996-3#1)
health care in the United States##6##6##(1995-3#2)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)
health care in the past##3##5##(1992-12#1)(2008-1#1)(2010-4#1)
health care in the year 2004##2##6##(1996-2#2)
health care in the year##3##5##(1992-3#1)(1996-2#2)
health care in the##25##4##(1990-9#1)(1992-12#1)(1992-3#1)(1994-1#1)(1995-2#1)(1995-3#2)(1996-2#3)(1997-3#1)(1997-8#2)(2007-12#1)(2008-1#4)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
health care in##53##3##(1990-9#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#6)(1996-2#3)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-9#1)(2007-12#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
health care industry##29##3##(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#5)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)(2008-1#1)(2008-11#6)(2008-4#1)
health care informatics##2##3##(1994-12#2)
health care information system##4##4##(1996-12#1)(1996-3#2)(1997-3#1)
health care information systems##3##4##(1993-1#1)(1995-1#1)(1996-12#1)
health care information##14##3##(1992-12#1)(1993-1#2)(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-3#1)(2008-1#1)(2008-11#1)
health care institution##3##3##(1992-2#1)(1996-3#1)(2008-7#1)
health care institutions and##2##4##(1993-1#1)(2008-11#1)
health care institutions to##2##4##(1991-2#1)(1994-12#1)
health care institutions##19##3##(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-8#1)
health care insurance##2##3##(1996-5#1)(1997-5#1)
health care interventions##2##3##(1993-12#1)(1993-2#1)
health care into##2##3##(1996-2#1)(1997-2#1)
health care is an##2##4##(1992-3#1)(1996-3#1)
health care is regarded as##2##5##(2008-4#1)(2010-8#1)
health care is##26##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#3)(1993-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
health care issues##2##3##(2008-11#1)(2011-2#1)
health care law##2##3##(1993-1#1)(1994-3#1)
health care leader##2##3##(1996-3#1)(2008-1#1)
health care leaders##9##3##(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-3#1)(1997-1#1)(2008-1#2)
health care leadership##2##3##(1993-1#1)(2008-1#1)
health care management is##2##4##(1994-1#1)(1996-2#1)
health care management##21##3##(1991-12#2)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(2008-1#1)(2008-11#1)(2008-7#1)
health care managers##7##3##(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-7#1)
health care market reform##2##4##(1997-3#2)
health care market##8##3##(1991-1#1)(1994-12#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)
health care marketers##2##3##(1994-3#1)(1996-1#1)
health care marketing##4##3##(1995-1#2)(1996-1#1)(2008-12#1)
health care marketplace##5##3##(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)
health care markets##4##3##(1991-3#1)(1995-2#1)(1996-1#1)(2008-12#1)
health care model are##2##4##(2008-1#1)(2011-2#1)
health care model##6##3##(1994-12#2)(1997-6#1)(2008-1#1)(2011-2#2)
health care needs of##2##4##(1994-2#1)(1995-2#1)
health care needs##26##3##(1991-12#1)(1991-3#2)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#6)(1995-2#1)(1995-3#3)(1997-2#2)(2008-1#1)(2008-11#1)(2010-11#2)(2011-1#1)
health care networks##5##3##(1995-2#2)(1996-2#3)
health care of the##2##4##(1993-12#1)(2007-10#1)
health care of##4##3##(1993-12#1)(1995-3#1)(2007-10#1)(2010-8#1)
health care officials##2##3##(1995-1#2)
health care organization is##2##4##(1994-12#1)(1996-1#1)
health care organization##16##3##(1990-6#1)(1991-2#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1997-1#1)(1997-3#2)(2010-4#1)
health care organization's##2##3##(1994-1#1)(1995-1#1)
health care organizational##2##3##(1994-12#1)(2008-12#1)
health care organizations and##6##4##(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#2)(2008-11#1)
health care organizations are##4##4##(1993-1#1)(1994-12#1)(1995-12#2)
health care organizations compare##2##4##(1993-1#1)(1994-2#1)
health care organizations in##3##4##(1995-3#1)(1996-1#1)(1997-2#1)
health care organizations may##2##4##(1994-12#1)(1995-2#1)
health care organizations must##2##4##(1993-12#1)(1994-12#1)
health care organizations need to##2##5##(1993-3#1)(2010-7#1)
health care organizations to##4##4##(1992-3#1)(1994-12#2)(1994-2#1)
health care organizations will##2##4##(1994-1#1)(1996-3#1)
health care organizations##69##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-1#3)(1994-12#10)(1994-2#4)(1994-3#1)(1995-1#2)(1995-12#4)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#2)(1997-2#4)(1997-3#2)(2008-1#2)(2008-11#6)(2008-12#2)(2010-7#1)(2011-2#2)
health care outcomes##2##3##(1995-3#1)(1996-1#1)
health care personnel##5##3##(1990-2#1)(1991-12#1)(1992-11#1)(2008-7#1)(2013-1#1)
health care physicians##2##3##(1993-6#1)(2011-1#1)
health care plan##3##3##(1992-3#1)(1994-3#1)(1995-12#1)
health care planners##5##3##(1991-1#1)(1992-2#1)(1992-3#1)(1996-3#2)
health care planning##2##3##(1994-3#1)(2008-8#1)
health care plans##3##3##(1994-2#1)(1994-3#1)(1996-3#1)
health care policies##2##3##(1995-2#1)(2011-1#1)
health care policy reform##3##4##(1994-1#1)(1997-2#2)
health care policy##8##3##(1993-12#2)(1994-1#1)(1994-12#1)(1997-2#3)(2008-11#1)
health care practice##2##3##(1994-1#1)(2008-11#1)
health care practices##2##3##(2008-1#1)(2008-11#1)
health care practitioner##2##3##(1992-12#1)(2008-1#1)
health care prices##3##3##(1991-1#1)(1991-2#1)(1993-2#1)
health care priorities##3##3##(1992-2#1)(1995-1#1)(1995-2#1)
health care problems in##3##4##(1991-11#1)(1997-8#1)(2011-2#1)
health care problems##4##3##(1991-11#1)(1997-8#1)(2008-7#1)(2011-2#1)
health care processes##2##3##(1995-1#1)(1996-1#1)
health care professional##3##3##(1993-1#1)(1994-3#1)(2008-7#1)
health care professionals and##3##4##(1994-1#1)(1997-3#1)(2008-11#1)
health care professionals are in##2##5##(1996-1#1)(2008-1#1)
health care professionals are##4##4##(1996-1#1)(2007-2#1)(2008-1#1)(2008-4#1)
health care professionals in Canada today is that they##2##9##(1991-2#2)
health care professionals in##7##4##(1991-2#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)
health care professionals should##2##4##(2008-11#1)(2010-9#1)
health care professionals to##3##4##(1993-2#1)(2007-4#1)(2010-8#1)
health care professionals##46##3##(1991-2#3)(1991-3#1)(1992-12#1)(1992-3#2)(1993-1#2)(1993-2#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-2#1)(2007-4#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#2)(2008-7#2)(2009-5#1)(2010-4#2)(2010-8#1)(2010-9#2)(2012-12#1)(2013-1#2)
health care program##5##3##(1991-12#1)(1995-3#1)(1996-12#2)(1997-2#1)
health care programs##3##3##(1991-12#1)(1993-12#1)(2007-10#1)
health care provided##2##3##(1991-12#1)(2012-1#1)
health care provider to##3##4##(1992-2#1)(2008-11#1)(2013-7#1)
health care provider##15##3##(1992-2#1)(1994-1#3)(1995-12#1)(1996-2#1)(1997-3#1)(2008-11#2)(2008-7#1)(2010-1#1)(2013-1#1)(2013-7#3)
health care provider's##4##3##(1991-12#1)(1992-3#1)(1994-1#1)(2007-2#1)
health care providers and the##2##5##(1996-2#1)(2007-2#1)
health care providers and##8##4##(1992-12#1)(1993-1#1)(1994-2#1)(1996-2#1)(2007-2#1)(2008-11#1)(2010-3#1)(2013-1#1)
health care providers are##6##4##(1994-12#1)(1996-3#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-2#1)
health care providers can##2##4##(1994-12#1)(1996-3#1)
health care providers in a##2##5##(1995-1#1)(1996-3#1)
health care providers in their##2##5##(1995-3#1)(2010-7#1)
health care providers in##9##4##(1992-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-7#1)
health care providers need to##2##5##(2010-4#1)(2012-3#1)
health care providers to##7##4##(1991-2#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-3#1)(2008-8#1)(2009-5#1)
health care providers were##2##4##(1991-3#1)(1996-8#1)
health care providers who##2##4##(1992-2#1)(2008-12#1)
health care providers##88##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#3)(1992-2#3)(1992-3#1)(1993-1#4)(1993-12#3)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#4)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#7)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#3)(2008-11#6)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
health care providers'##2##3##(1994-3#1)(2010-10#1)
health care provision##2##3##(2008-7#1)(2012-1#1)
health care proxies##2##3##(1992-12#2)
health care purchasers##4##3##(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)
health care purchasing decisions##3##4##(1994-3#2)(1997-3#1)
health care purchasing##4##3##(1994-12#1)(1994-3#2)(1997-3#1)
health care quality and##2##4##(1996-3#1)(2009-5#1)
health care quality improvement initiative##2##5##(1994-2#1)(1995-1#1)
health care quality improvement##4##4##(1994-2#1)(1995-1#1)(1995-12#1)(1997-1#1)
health care quality management##2##4##(1993-3#1)(1995-1#1)
health care quality##26##3##(1993-3#5)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#1)(1997-3#1)(2009-5#1)(2010-8#1)
health care rationing##2##3##(1992-12#1)(1993-3#1)
health care reform and##6##4##(1993-12#1)(1994-12#2)(1994-3#1)(1997-3#1)(2010-8#1)
health care reform are##3##4##(1994-12#1)(1994-2#1)(1996-1#1)
health care reform efforts##2##4##(1994-1#1)(1996-1#1)
health care reform have##2##4##(1994-8#1)(1996-3#1)
health care reform in the##2##5##(1995-1#1)(1996-6#1)
health care reform in##5##4##(1995-1#1)(1995-3#1)(1996-6#1)(1997-1#1)(2008-2#1)
health care reform initiatives##3##4##(1994-1#1)(1994-12#1)(1996-1#1)
health care reform is##3##4##(1993-3#1)(1994-2#1)(1995-3#1)
health care reform legislation##2##4##(1994-8#1)(2012-3#1)
health care reform objectives##2##4##(1994-12#1)(1996-12#1)
health care reform##118##3##(1992-2#2)(1993-1#1)(1993-12#6)(1993-3#2)(1993-5#1)(1994-1#3)(1994-12#17)(1994-2#5)(1994-3#4)(1994-8#4)(1995-1#8)(1995-12#14)(1995-2#7)(1995-3#5)(1996-1#15)(1996-12#2)(1996-2#3)(1996-3#6)(1996-6#1)(1997-1#1)(1997-3#2)(2008-2#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#2)
health care reform?##5##3##(1993-3#1)(1995-1#1)(1995-12#2)(1996-2#1)
health care reformers##4##3##(1994-3#1)(1995-2#1)(2009-12#2)
health care reforms##2##3##(1995-3#1)(2008-1#1)
health care reimbursement##3##3##(1991-1#1)(1994-3#1)(1997-1#1)
health care resource##2##3##(2007-10#1)(2008-7#1)
health care resources and##4##4##(1995-12#1)(1996-12#1)(2008-7#2)
health care resources##15##3##(1994-3#1)(1995-12#1)(1995-3#2)(1996-12#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)
health care risk managers##3##4##(1992-2#2)(1994-1#1)
health care risk##5##3##(1992-2#2)(1994-1#2)(1997-2#1)
health care satisfaction##3##3##(1994-3#1)(1995-2#1)(1997-2#1)
health care sector##11##3##(1992-1#1)(1992-12#1)(1992-2#1)(1994-2#1)(1995-1#1)(1996-2#1)(2008-11#2)(2008-12#1)(2010-7#1)(2012-2#1)
health care sectors is##2##4##(1995-2#1)(2008-11#1)
health care seeking behavior##2##4##(2009-9#1)(2011-1#1)
health care seeking##3##3##(2009-5#1)(2009-9#1)(2011-1#1)
health care service##5##3##(1992-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-1#1)
health care services and##3##4##(1994-1#1)(1995-12#1)(2008-11#1)
health care services for##2##4##(1993-3#1)(1997-2#1)
health care services in Ontario##2##5##(1995-2#2)
health care services in the##2##5##(1995-1#2)
health care services in##8##4##(1993-12#1)(1993-6#2)(1995-1#2)(1995-2#2)(2010-3#1)
health care services is##2##4##(1993-3#1)(2008-11#1)
health care services to the##2##5##(2008-1#1)(2008-7#1)
health care services to##3##4##(1995-3#1)(2008-1#1)(2008-7#1)
health care services under##3##4##(1994-12#1)(1996-12#1)(1996-2#1)
health care services were##3##4##(1993-6#1)(2010-3#1)(2010-8#1)
health care services##69##3##(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#5)(1996-3#1)(1997-1#4)(1997-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-3#5)(2010-4#2)(2010-8#1)(2012-2#1)
health care services?]##2##3##(1993-6#1)(1995-8#1)
health care setting##8##3##(1994-1#1)(1994-12#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
health care settings##10##3##(1991-3#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(1996-12#1)(2007-12#1)(2010-4#2)(2010-8#1)
health care spending and##2##4##(1993-3#1)(2008-11#1)
health care spending by##2##4##(1994-1#1)(1997-3#1)
health care spending##14##3##(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-11#2)(2008-7#1)
health care staff##3##3##(2010-10#1)(2011-2#2)
health care standards##2##3##(1996-1#2)
health care studies##2##3##(1991-9#1)(2010-10#1)
health care system and its##2##5##(1993-3#1)(1994-1#1)
health care system and##12##4##(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2010-4#1)(2011-1#1)
health care system are##2##4##(1993-3#1)(1997-2#1)
health care system as##3##4##(1995-12#1)(2008-1#1)(2012-3#1)
health care system has##3##4##(2008-11#2)(2008-12#1)
health care system have##2##4##(1991-2#1)(1996-3#1)
health care system in the new millennium##2##7##(2008-1#2)
health care system in the##4##5##(1992-12#1)(1996-12#1)(2008-1#2)
health care system in##5##4##(1992-12#1)(1992-2#1)(1996-12#1)(2008-1#2)
health care system is##4##4##(1994-2#1)(1996-12#1)(1997-2#1)(2008-6#1)
health care system should##3##4##(1994-3#1)(1996-2#1)(2008-10#1)
health care system that##2##4##(2008-7#1)(2012-3#1)
health care system to##5##4##(1994-1#1)(1994-2#1)(1995-1#1)(2008-8#1)(2013-1#1)
health care system##137##3##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#4)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#6)(1993-6#1)(1993-9#1)(1994-1#9)(1994-12#5)(1994-2#7)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#6)(1995-3#4)(1996-12#8)(1996-2#3)(1996-3#5)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(2007-12#1)(2007-2#2)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
health care system?##2##3##(1994-9#1)(1995-1#1)
health care system]##2##3##(1997-3#1)(2008-10#1)
health care systems are##3##4##(1993-12#1)(1996-1#1)(2008-1#1)
health care systems has##2##4##(1995-1#1)(2008-1#1)
health care systems in the##2##5##(1994-12#1)(1997-2#1)
health care systems in##3##4##(1994-12#1)(1997-2#1)(2013-8#1)
health care systems##37##3##(1992-1#1)(1992-12#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#5)(1997-2#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#3)(2012-2#1)(2012-3#1)(2013-8#1)
health care team##12##3##(1993-12#1)(1994-2#1)(1995-2#2)(1995-3#2)(1996-2#1)(2008-11#2)(2008-7#2)(2010-4#1)
health care teams##3##3##(1993-11#1)(2011-1#1)(2012-3#1)
health care technology##3##3##(1994-1#1)(2008-11#1)(2008-7#1)
health care than##2##3##(1997-2#1)(2013-7#1)
health care through##3##3##(1996-1#1)(1997-6#1)(2008-4#1)
health care to##13##3##(1991-4#1)(1994-3#4)(1995-12#1)(1997-3#1)(2008-11#3)(2008-12#1)(2008-7#2)
health care today##3##3##(1994-1#1)(1994-3#1)(2008-1#1)
health care transition##4##3##(1992-12#1)(1995-2#1)(1996-2#1)(2010-11#1)
health care trends##2##3##(1995-3#1)(1996-3#1)
health care units##2##3##(1997-3#1)(2008-11#1)
health care use##6##3##(1994-1#1)(1995-12#1)(1997-3#1)(2007-10#1)(2013-1#2)
health care utilization##14##3##(1996-2#3)(1997-1#2)(2007-10#3)(2008-11#1)(2009-5#2)(2010-12#1)(2013-1#2)
health care was##2##3##(1994-11#1)(1995-1#1)
health care were##2##3##(1993-3#1)(2008-11#1)
health care when##3##3##(1994-12#1)(1994-6#1)(2012-12#1)
health care will##3##3##(1994-12#1)(2008-10#1)(2008-7#1)
health care work force planning##2##5##(1994-1#1)(1994-2#1)
health care work force##5##4##(1994-1#1)(1994-2#3)(1996-3#1)
health care worker##4##3##(1995-6#1)(2007-12#1)(2007-3#2)
health care workers and##2##4##(1996-3#1)(2013-1#1)
health care workers are##2##4##(1995-2#1)(1995-5#1)
health care workers in##4##4##(1992-2#1)(1993-2#1)(1996-12#1)(2009-7#1)
health care workers may##2##4##(2008-11#1)(2010-9#1)
health care workers of the##2##5##(2013-1#2)
health care workers to##2##4##(2007-12#1)(2010-11#1)
health care workers##29##3##(1991-3#1)(1992-2#2)(1993-1#1)(1993-2#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#3)(2009-7#1)(2010-11#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)
health care workforce##3##3##(2008-1#1)(2008-11#1)(2013-7#1)
health care##2131##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#4)(1990-9#1)(1991-1#19)(1991-11#1)(1991-12#29)(1991-2#24)(1991-3#31)(1991-4#1)(1991-6#6)(1991-8#1)(1991-9#2)(1992-1#24)(1992-11#5)(1992-12#30)(1992-2#37)(1992-3#24)(1992-5#1)(1992-9#1)(1993-1#30)(1993-11#3)(1993-12#72)(1993-2#29)(1993-3#45)(1993-5#1)(1993-6#9)(1993-9#1)(1994-1#67)(1994-11#3)(1994-12#100)(1994-2#72)(1994-3#74)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#76)(1995-11#3)(1995-12#68)(1995-2#77)(1995-3#66)(1995-5#3)(1995-6#4)(1995-8#4)(1995-9#3)(1996-1#58)(1996-11#2)(1996-12#47)(1996-2#80)(1996-3#78)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#13)(1996-9#2)(1997-1#38)(1997-2#53)(1997-3#56)(1997-4#5)(1997-5#6)(1997-6#4)(1997-8#8)(2006-9#1)(2007-10#14)(2007-11#1)(2007-12#16)(2007-2#10)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#67)(2008-10#13)(2008-11#107)(2008-12#27)(2008-2#3)(2008-3#3)(2008-4#14)(2008-6#6)(2008-7#52)(2008-8#10)(2009-1#1)(2009-12#3)(2009-4#2)(2009-5#15)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#10)(2010-11#8)(2010-12#5)(2010-2#1)(2010-3#9)(2010-4#14)(2010-5#1)(2010-7#3)(2010-8#21)(2010-9#6)(2011-1#14)(2011-2#24)(2012-1#4)(2012-12#8)(2012-2#9)(2012-3#26)(2013-1#28)(2013-7#11)(2013-8#17)
health care's##2##2##(1995-3#1)(2007-10#1)
health care-seeking behaviors##3##3##(2008-4#3)
health care?##5##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-2#1)(2012-12#1)
health care]##14##2##(1990-9#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-6#1)(1997-5#1)(1997-8#1)
health center in##7##3##(1994-3#4)(1997-6#1)(2008-1#1)(2011-2#1)
health center##29##2##(1990-2#1)(1990-9#1)(1993-3#1)(1994-3#8)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#1)(2009-10#1)(2010-6#1)(2011-2#3)(2013-1#1)
health center]##15##2##(1991-11#1)(1993-10#1)(1993-3#2)(1994-3#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#3)
health centers and the National Health Service Corps##2##8##(2008-10#2)
health centers and##7##3##(1992-4#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#2)
health centers in##5##3##(2008-10#2)(2010-3#1)(2011-2#2)
health centers of##4##3##(1994-2#1)(1996-2#1)(1997-3#1)(2013-1#1)
health centers##31##2##(1992-4#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-12#2)(1996-1#1)(1996-2#2)(1996-9#1)(1997-2#6)(1997-3#2)(2008-10#4)(2008-11#3)(2008-6#1)(2010-3#1)(2011-2#2)(2013-1#1)
health centre and the##2##4##(1990-2#1)(2013-8#1)
health centre##8##2##(1990-2#1)(1990-9#1)(1991-11#1)(1993-9#1)(1997-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
health centres##5##2##(1990-3#1)(1997-4#1)(2012-12#1)(2013-8#2)
health challenges##8##2##(1991-11#1)(2008-1#4)(2008-11#1)(2008-3#1)(2011-1#1)
health characteristics##3##2##(1991-3#1)(1994-3#1)(2011-2#1)
health claims##2##2##(2009-7#1)(2012-2#1)
health clinic##3##2##(2009-9#1)(2010-2#1)(2012-12#1)
health clinicians##2##2##(2008-11#1)(2010-4#1)
health clinics##5##2##(1995-12#1)(1995-6#1)(2008-8#3)
health clubs##3##2##(1994-3#2)(1996-2#1)
health communication##3##2##(1994-3#1)(2010-12#1)(2010-3#1)
health complaints##3##2##(1997-4#1)(2008-10#1)(2008-6#1)
health concern##9##2##(2007-12#1)(2008-11#2)(2009-6#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
health concerns##15##2##(1995-12#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2009-5#1)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
health condition and##2##3##(1994-6#1)(2013-7#1)
health condition##7##2##(1994-6#2)(2008-1#1)(2008-2#1)(2009-7#1)(2013-7#2)
health conditions of##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
health conditions##16##2##(1990-12#1)(1993-1#1)(1995-2#1)(1997-5#1)(2007-11#2)(2008-10#1)(2010-10#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
health consciousness##2##2##(2008-10#1)(2011-2#1)
health consequences of##5##3##(1990-6#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-12#1)
health consequences##12##2##(1990-6#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
health considerations##2##2##(1991-6#2)
health consultant##2##2##(1992-4#2)
health consultation##3##2##(1994-1#1)(2007-2#1)(2011-2#1)
health consumers##7##2##(1995-1#3)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
health control##4##2##(1991-12#1)(1994-6#1)(2008-10#1)(2011-1#1)
health controls##2##2##(2008-12#1)(2008-7#1)
health cost##2##2##(1995-12#1)(2011-2#1)
health costs of##2##3##(2008-11#1)(2010-1#1)
health costs##5##2##(1995-1#1)(1996-2#1)(2008-11#1)(2010-1#1)(2013-1#1)
health curricula##2##2##(1997-3#1)(2007-12#1)
health curriculum##2##2##(2007-12#2)
health data collection##2##3##(2010-8#2)
health data organizations in##2##4##(1995-2#2)
health data organizations##3##3##(1995-2#3)
health data##17##2##(1992-12#1)(1994-2#1)(1995-2#3)(1996-1#1)(1997-2#1)(1997-3#1)(2008-7#1)(2010-8#3)(2012-12#3)(2013-8#2)
health decision-making##2##2##(2010-8#1)(2012-12#1)
health decisions##2##2##(1997-3#2)
health delivery system##3##3##(1992-1#1)(1995-12#1)(1995-3#1)
health delivery##8##2##(1992-1#2)(1994-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-11#1)(2011-2#1)
health department##11##2##(1995-12#2)(1996-12#5)(1997-2#1)(1997-3#1)(2008-9#1)(2011-9#1)
health departments and##2##3##(1992-1#1)(1994-2#1)
health departments have##3##3##(1996-1#1)(1997-3#1)(2012-12#1)
health departments in##4##3##(1995-3#3)(1996-3#1)
health departments##28##2##(1992-1#1)(1994-2#1)(1995-12#1)(1995-3#3)(1996-1#2)(1996-12#3)(1996-2#5)(1996-3#2)(1997-1#3)(1997-2#2)(1997-3#2)(2011-9#2)(2012-12#1)
health devices achievement award##2##4##(2011-2#2)
health directors to##2##3##(2012-12#2)
health directors##4##2##(2012-12#4)
health disciplines##3##2##(1995-2#1)(2008-11#2)
health disorders##10##2##(2008-11#4)(2011-2#1)(2012-12#1)(2013-8#4)
health disparities in##4##3##(2008-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
health disparities research##3##3##(2011-1#1)(2012-3#2)
health disparities##19##2##(2008-4#3)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)
health disparity##3##2##(2008-4#1)(2011-1#2)
health district##7##2##(1997-6#1)(2007-8#1)(2008-7#1)(2010-3#1)(2013-1#3)
health domain##2##2##(1990-12#1)(2010-8#1)
health domains##2##2##(2008-7#1)(2010-10#1)
health due to##2##3##(2008-10#2)
health economic evaluation##3##3##(2011-2#1)(2013-8#2)
health economic studies##3##3##(2011-2#3)
health economic##9##2##(2007-10#1)(2011-2#5)(2013-8#3)
health economics##5##2##(1996-2#1)(1997-8#1)(2008-6#1)(2009-10#1)(2013-8#1)
health education among##2##3##(1994-6#1)(2012-3#1)
health education and##3##3##(1996-2#1)(1997-6#1)(2013-1#1)
health education has##2##3##(1997-3#1)(2008-1#1)
health education in##2##3##(1996-6#1)(2010-12#1)
health education programs##2##3##(2008-9#2)
health education##31##2##(1990-11#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-2#3)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2012-3#4)(2013-1#2)
health education-based##2##2##(2013-1#2)
health education]##2##2##(1990-11#1)(1996-10#1)
health educator##2##2##(1997-2#2)
health educators##4##2##(1993-3#1)(1994-2#1)(2008-12#1)(2009-5#1)
health effect##2##2##(2008-10#1)(2009-5#1)
health effects have been##2##4##(1992-11#1)(1997-1#1)
health effects of the##2##4##(2008-7#1)(2013-1#1)
health effects of##15##3##(1992-11#1)(1992-9#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
health effects were##2##3##(1992-11#1)(2012-1#1)
health effects##35##2##(1990-12#1)(1992-11#3)(1992-9#1)(1994-9#2)(1995-11#1)(1995-3#1)(1996-12#1)(1997-1#2)(2008-10#3)(2008-11#4)(2008-7#2)(2008-9#3)(2009-11#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
health emergency##14##2##(2008-7#1)(2010-8#3)(2013-8#10)
health equity##7##2##(1996-3#1)(2010-12#1)(2011-1#4)(2012-3#1)
health establishments##2##2##(1996-1#2)
health examination##3##2##(2008-12#1)(2011-1#1)(2013-8#1)
health expenditure and##2##3##(1991-2#1)(1993-12#1)
health expenditure performance##2##3##(1993-2#2)
health expenditure##8##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1996-2#1)(1996-3#1)(2012-1#1)
health expenditures as a share of gross##2##7##(1992-12#1)(1992-3#1)
health expenditures as a share of##3##6##(1992-12#1)(1992-3#1)(1995-3#1)
health expenditures through the year##2##5##(1992-3#1)(1996-2#1)
health expenditures##24##2##(1991-2#3)(1992-12#2)(1992-3#7)(1993-2#1)(1993-3#2)(1994-3#1)(1995-3#3)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)
health facilities##5##2##(1994-3#1)(2008-1#1)(2008-7#2)(2010-8#1)
health facility in##2##3##(1992-2#1)(2012-3#1)
health facility##6##2##(1992-2#1)(1997-3#1)(2007-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
health factors##2##2##(1997-3#1)(2013-1#1)
health fair##2##2##(1991-2#2)
health field##10##2##(1991-2#1)(1994-1#1)(1995-1#1)(1996-12#1)(1997-3#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
health financing##3##2##(1992-12#1)(1995-2#1)(2013-8#1)
health for##12##2##(1990-2#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-6#1)(2008-1#2)(2009-6#2)(2010-1#1)(2013-1#1)
health gains##2##2##(2008-7#1)(2011-1#1)
health goals##5##2##(1991-2#2)(1992-1#1)(1996-2#2)
health had##2##2##(1996-1#1)(2008-7#1)
health has been##4##3##(1992-12#1)(1997-2#1)(2011-2#1)(2012-3#1)
health has##12##2##(1992-12#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
health have##5##2##(1996-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2011-1#1)
health hazard##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
health hazards of smoking##2##4##(1995-6#1)(2008-10#1)
health hazards of##3##3##(1995-6#1)(2008-10#1)(2011-1#1)
health hazards to##2##3##(1996-3#1)(2010-4#1)
health hazards##9##2##(1995-6#2)(1996-3#1)(1997-4#1)(2008-10#1)(2009-12#2)(2010-4#1)(2011-1#1)
health hospital##3##2##(1991-3#1)(1992-2#1)(1993-1#1)
health human resources (HHR)##2##4##(2011-2#1)(2012-2#1)
health human resources##6##3##(1995-2#1)(1996-1#1)(2011-2#3)(2012-2#1)
health impact assessment##3##3##(2012-1#2)(2013-1#1)
health impact##9##2##(1991-3#3)(1993-12#1)(1997-3#1)(2009-5#1)(2012-1#2)(2013-1#1)
health impacts of##2##3##(2008-11#2)
health impacts##3##2##(2008-11#2)(2013-1#1)
health impairments##2##2##(1993-1#1)(1994-3#1)
health implications of##4##3##(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
health implications##11##2##(1996-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
health improvement##2##2##(2010-8#1)(2013-1#1)
health in Brazil##2##3##(1993-6#1)(2013-8#1)
health in Nepal##3##3##(2008-3#1)(2008-7#2)
health in a##5##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
health in an##3##3##(1996-12#1)(1996-3#1)(1997-3#1)
health in older women##2##4##(2012-12#2)
health in older##3##3##(2008-1#1)(2012-12#2)
health in the context of##2##5##(2008-6#1)(2011-1#1)
health in the##10##3##(1991-6#1)(1995-2#1)(2008-1#2)(2008-6#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
health in this##2##3##(1995-12#1)(2008-1#1)
health in##59##2##(1991-6#2)(1993-1#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-1#6)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#7)(2012-3#1)(2013-1#8)(2013-8#1)
health including##2##2##(2008-1#1)(2013-1#1)
health indicators for##2##3##(1991-8#1)(2013-1#1)
health indicators##8##2##(1991-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2013-1#4)
health industry##3##2##(1995-1#1)(1995-3#1)(2008-7#1)
health inequalities among##3##3##(2011-2#1)(2013-1#2)
health inequalities##7##2##(2011-2#1)(2013-1#6)
health inequality##2##2##(2009-6#1)(2013-1#1)
health inequities##4##2##(2009-6#1)(2011-1#3)
health inequity##2##2##(2008-1#1)(2009-7#1)
health information and##4##3##(1995-12#1)(1997-2#1)(1997-3#1)(2008-1#1)
health information by##2##3##(1995-3#1)(2008-12#1)
health information for##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
health information in the##2##4##(1995-12#1)(2012-12#1)
health information infrastructure##3##3##(1994-12#1)(1997-3#2)
health information is##2##3##(1997-3#1)(2009-5#1)
health information management##4##3##(1995-2#1)(2007-12#1)(2008-11#1)(2010-8#1)
health information needs##2##3##(1997-3#1)(2012-12#1)
health information on the Internet##2##5##(2008-11#2)
health information system##7##3##(1995-12#1)(1996-12#1)(2007-12#2)(2011-1#1)(2012-12#2)
health information systems (HIS) in##2##5##(2012-12#2)
health information systems (HIS)##3##4##(1993-12#1)(2012-12#2)
health information systems in the Pacific##2##6##(2012-12#2)
health information systems##21##3##(1993-12#2)(1994-2#1)(1996-3#1)(1997-3#4)(2008-7#1)(2012-12#12)
health information to##2##3##(2008-12#1)(2012-12#1)
health information##94##2##(1990-12#1)(1991-3#1)(1993-1#3)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#10)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#12)(2007-12#6)(2008-1#2)(2008-11#3)(2008-12#2)(2008-7#2)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-12#24)(2012-3#2)(2013-1#2)(2013-7#1)
health infrastructure##4##2##(1995-12#1)(1997-1#1)(2008-11#1)(2012-2#1)
health initiative##2##2##(1995-3#1)(2008-6#1)
health initiatives##8##2##(1995-12#1)(1996-3#3)(1997-2#1)(2008-8#1)(2010-2#1)(2012-12#1)
health input##3##2##(2008-11#2)(2010-12#1)
health institutions##5##2##(1993-3#1)(1995-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
health instruments##2##2##(1991-3#1)(2010-5#1)
health insurance and##3##3##(1992-3#1)(1995-1#1)(1997-3#1)
health insurance coverage for##2##4##(1995-12#1)(1996-12#1)
health insurance coverage to##2##4##(1995-12#1)(2008-11#1)
health insurance coverage##14##3##(1991-2#1)(1993-3#3)(1994-3#1)(1995-12#2)(1996-12#1)(2008-11#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
health insurance files##2##3##(2008-11#2)
health insurance for##4##3##(1991-2#1)(1992-3#1)(2011-2#1)(2013-1#1)
health insurance in##7##3##(1992-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2008-11#1)(2012-12#1)
health insurance markets##3##3##(2008-7#3)
health insurance or##2##3##(1993-12#1)(2012-1#1)
health insurance organization##3##3##(1994-2#2)(2008-11#1)
health insurance programs##2##3##(1993-1#1)(1995-3#1)
health insurance scheme##3##3##(1997-2#1)(2008-7#1)(2013-8#1)
health insurance schemes##2##3##(2008-7#2)
health insurance##116##2##(1991-2#9)(1991-3#3)(1992-12#2)(1992-2#2)(1992-3#5)(1993-1#2)(1993-12#1)(1993-3#7)(1994-12#1)(1994-2#8)(1994-3#2)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-8#1)(2008-1#1)(2008-11#11)(2008-4#2)(2008-7#14)(2009-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#1)(2013-1#9)(2013-8#2)
health insurances##2##2##(1996-8#1)(2011-2#1)
health insurers##2##2##(1993-2#1)(2012-12#1)
health interest##2##2##(2008-10#1)(2008-2#1)
health intervention##3##2##(1994-1#1)(2010-10#1)(2010-9#1)
health interventions##9##2##(1993-12#1)(1996-12#1)(2008-10#1)(2010-10#1)(2010-8#3)(2012-2#1)(2013-1#1)
health interview##2##2##(1992-5#1)(2008-12#1)
health into general health##2##4##(1991-6#1)(2010-4#1)
health into##3##2##(1991-6#1)(1993-2#1)(2010-4#1)
health is a##2##3##(2009-10#1)(2012-3#1)
health is necessary##2##3##(2010-8#1)(2013-1#1)
health is the##2##3##(2008-9#1)(2012-12#1)
health is##25##2##(1992-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
health issue##12##2##(1991-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
health issues in##4##3##(1995-12#1)(2008-12#2)(2013-1#1)
health issues##33##2##(1992-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-11#5)(2008-12#2)(2009-12#1)(2009-4#1)(2009-5#2)(2010-1#4)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#1)
health knowledge in##2##3##(2009-6#1)(2010-12#1)
health knowledge##4##2##(1996-2#1)(2009-5#1)(2009-6#1)(2010-12#1)
health law##4##2##(1992-3#1)(1995-1#1)(2012-3#2)
health leaders##4##2##(1996-3#1)(1997-3#1)(2008-1#1)(2008-12#1)
health leadership##3##2##(2010-8#1)(2012-12#2)
health legislation##4##2##(1990-9#1)(1994-1#2)(1997-8#1)
health literacy and##2##3##(2009-5#1)(2010-9#1)
health literacy levels and their perceived##2##6##(2010-9#2)
health literacy through##2##3##(2009-8#1)(2013-7#1)
health literacy##17##2##(2009-5#1)(2009-8#8)(2010-9#4)(2013-7#3)(2013-8#1)
health literature##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
health maintenance organization (HMO) enrollees##2##5##(1996-2#1)(1997-2#1)
health maintenance organization (HMO) for##2##5##(1993-1#1)(1994-12#1)
health maintenance organization (HMO)##16##4##(1993-1#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)
health maintenance organization##30##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#6)(1994-3#4)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#4)(1997-2#1)
health maintenance organizations (HMOs) and preferred provider organizations##2##8##(1993-12#1)(1994-1#1)
health maintenance organizations (HMOs) have##2##5##(1991-3#1)(1994-12#1)
health maintenance organizations (HMOs)##12##4##(1991-1#1)(1991-3#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-3#1)
health maintenance organizations and##3##4##(1991-3#2)(2008-4#1)
health maintenance organizations##27##3##(1991-1#2)(1991-3#7)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-4#1)(2011-1#1)(2011-2#1)
health maintenance##61##2##(1991-1#2)(1991-2#1)(1991-3#8)(1991-7#1)(1992-1#2)(1992-2#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#7)(1994-2#1)(1994-3#6)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#3)(1997-1#5)(1997-2#2)(1997-3#2)(2008-4#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)
health management and##3##3##(1992-12#1)(1993-1#1)(1996-2#1)
health management education in Canada##2##5##(1994-12#2)
health management education in##3##4##(1994-12#3)
health management education##8##3##(1993-12#1)(1994-12#3)(1995-12#2)(1996-1#2)
health management indicators##3##3##(2012-12#3)
health management##25##2##(1992-12#2)(1993-1#1)(1993-12#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-4#2)(2012-12#3)
health managers in the##2##4##(1994-2#1)(2012-12#1)
health managers##5##2##(1994-2#2)(1996-1#1)(2012-12#2)
health mandate##2##2##(2010-8#1)(2011-2#1)
health marketing research##2##3##(2008-12#2)
health measures##11##2##(1990-6#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#5)
health messages##2##2##(1994-3#1)(2008-4#1)
health ministry##3##2##(1992-1#1)(1993-12#1)(1997-6#1)
health motivation##3##2##(2013-7#3)
health need##2##2##(2009-6#1)(2012-12#1)
health needs and##4##3##(1993-1#1)(2008-11#2)(2008-7#1)
health needs have##3##3##(1992-2#1)(1994-3#2)
health needs of a##2##4##(1996-3#1)(2010-3#1)
health needs of the##3##4##(1993-6#1)(1995-12#1)(2008-11#1)
health needs of##10##3##(1993-6#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2010-10#1)(2010-3#1)(2013-1#1)
health needs##27##2##(1992-2#1)(1993-1#1)(1993-6#1)(1994-3#5)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-1#2)(2008-11#5)(2008-7#2)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
health network##4##2##(1995-1#2)(1996-3#1)(1997-4#1)
health networks##5##2##(1996-12#1)(1996-2#1)(1997-2#2)(2008-10#1)
health nurses and##5##3##(2008-11#1)(2010-9#4)
health nurses##25##2##(1995-3#1)(1996-2#2)(1997-6#1)(2008-1#1)(2008-11#3)(2008-12#3)(2009-6#2)(2010-5#3)(2010-9#6)(2011-1#2)(2011-2#1)
health nursing students##4##3##(2008-11#1)(2008-12#1)(2010-3#2)
health nursing within##2##3##(1996-2#2)
health nursing##24##2##(1990-2#1)(1996-2#6)(1997-6#1)(2008-11#9)(2008-12#3)(2009-6#1)(2010-3#2)(2011-2#1)
health objectives##3##2##(1991-5#1)(1996-9#1)(2013-7#1)
health of all##2##3##(1995-2#1)(1996-2#1)
health of children##6##3##(1995-1#1)(2008-11#2)(2009-5#1)(2012-12#1)(2012-3#1)
health of the nation##3##4##(1991-8#1)(1994-3#1)(2008-11#1)
health of the population##3##4##(1990-6#1)(2008-7#1)(2012-12#1)
health of the##19##3##(1990-6#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
health of these##2##3##(1992-3#1)(2008-5#1)
health of women##2##3##(2008-4#1)(2011-2#1)
health of##86##2##(1990-6#2)(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-3#2)(1995-1#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
health officers##2##2##(1996-12#1)(1997-2#1)
health officials to##3##3##(1996-5#1)(2009-5#1)(2012-12#1)
health officials##15##2##(1993-6#1)(1995-12#3)(1996-1#1)(1996-3#1)(1996-5#2)(1997-6#1)(2008-10#1)(2009-5#2)(2012-12#2)(2013-8#1)
health on the##5##3##(1997-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2011-1#1)
health on##8##2##(1993-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2011-1#1)(2013-1#1)
health operations##2##2##(1991-9#1)(1997-3#1)
health or##6##2##(1992-3#2)(1993-1#1)(2008-11#1)(2011-1#1)(2011-2#1)
health organization##2##2##(1994-1#1)(2008-12#1)
health organizations##7##2##(1996-1#1)(1997-3#1)(2008-12#2)(2009-5#1)(2010-5#1)(2012-3#1)
health outcome##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
health outcomes and##3##3##(2010-10#1)(2012-2#2)
health outcomes are##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
health outcomes for##2##3##(2008-1#1)(2013-1#1)
health outcomes in##5##3##(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)
health outcomes of##2##3##(2007-2#1)(2012-12#1)
health outcomes##62##2##(1991-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-1#5)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
health outreach##2##2##(1997-2#1)(2012-2#1)
health parameters##3##2##(2008-7#1)(2011-2#2)
health patterns##3##2##(2012-12#1)(2013-1#2)
health perception##3##2##(2007-11#2)(2013-1#1)
health personnel##8##2##(1990-6#1)(1993-3#1)(1994-3#1)(1996-9#2)(2008-10#2)(2010-9#1)
health personnel]##2##2##(1992-2#1)(1992-4#1)
health perspective##4##2##(1995-12#1)(2008-6#1)(2008-7#1)(2009-10#1)
health physician##2##2##(1991-12#1)(2008-1#1)
health physicians##2##2##(2011-1#1)(2011-2#1)
health plan performance##5##3##(1993-12#1)(1995-2#1)(1996-3#2)(1997-3#1)
health plan to address##2##4##(2013-8#2)
health plan##31##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#6)(1997-1#3)(1997-2#1)(1997-3#9)(2008-5#1)(2011-2#1)(2013-8#2)
health plan's perspective##2##3##(1995-12#1)(2008-6#1)
health planners##2##2##(1994-3#1)(2011-2#1)
health planning and##2##3##(1990-12#1)(1997-3#1)
health planning##13##2##(1990-12#2)(1991-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-3#1)(2012-12#1)
health plans and insurance companies have##2##6##(1994-3#2)
health plans and providers##2##4##(1996-3#1)(2008-6#1)
health plans and##4##3##(1994-3#2)(1996-3#1)(2008-6#1)
health plans can##3##3##(1997-2#3)
health plans in##2##3##(1996-12#1)(1997-2#1)
health plans must##2##3##(1996-1#1)(1997-1#1)
health plans to##3##3##(1994-2#1)(1997-1#1)(2008-6#1)
health plans##36##2##(1991-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#6)(1997-2#4)(1997-3#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2013-8#1)
health policies##4##2##(1997-1#1)(2009-12#1)(2009-7#1)(2013-1#1)
health policy and planning##2##4##(1994-3#1)(2012-12#1)
health policy and practice##2##4##(2008-1#1)(2011-1#1)
health policy and##11##3##(1992-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-12#2)(2012-2#1)
health policy implications##2##3##(1995-12#1)(2008-7#1)
health policy in##3##3##(1992-1#1)(2008-7#1)(2013-1#1)
health policy is##3##3##(1991-1#1)(1993-12#1)(2012-12#1)
health policy issues##4##3##(1995-1#2)(1996-12#1)(2012-12#1)
health policy makers and##3##4##(1996-2#1)(1997-1#1)(2008-8#1)
health policy makers##4##3##(1996-2#1)(1997-1#1)(2008-8#2)
health policy of Pakistan##2##4##(2012-2#2)
health policy##74##2##(1991-1#2)(1991-12#1)(1992-1#5)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#3)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#5)(1995-12#1)(1995-2#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#6)(1997-1#2)(1997-2#1)(1997-3#3)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#5)(2008-8#2)(2010-9#1)(2011-1#2)(2012-12#7)(2012-2#6)(2013-1#1)
health practice and##2##3##(1996-1#1)(1996-3#1)
health practice in##3##3##(1996-2#1)(1997-3#1)(2008-1#1)
health practice##21##2##(1995-12#1)(1996-1#5)(1996-12#2)(1996-2#3)(1996-3#2)(1997-2#3)(1997-3#2)(2008-1#1)(2012-1#1)(2012-2#1)
health practices##9##2##(1994-3#2)(1996-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#2)(2010-9#1)
health practitioners in##2##3##(2008-1#1)(2013-1#1)
health practitioners##11##2##(1995-12#2)(1997-2#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
health problem and is##2##4##(1993-11#1)(2012-12#1)
health problem and##4##3##(1993-11#1)(2009-5#1)(2011-2#1)(2012-12#1)
health problem for##2##3##(2010-8#1)(2011-1#1)
health problem in endemic areas##2##5##(2007-2#1)(2011-2#1)
health problem in the##9##4##(1997-1#1)(2008-10#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
health problem in##25##3##(1991-6#1)(1992-9#2)(1993-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
health problem of##4##3##(1993-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
health problem that##3##3##(1997-3#1)(2008-3#1)(2012-2#1)
health problem with##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
health problem##76##2##(1991-12#1)(1991-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#5)
health problems among##4##3##(1995-6#1)(1996-1#1)(2012-12#1)(2013-1#1)
health problems and##7##3##(1997-1#1)(2008-8#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
health problems are##3##3##(1990-2#1)(2008-1#1)(2008-7#1)
health problems in addition to##2##5##(2008-9#1)(2009-1#1)
health problems in##14##3##(1992-2#1)(1993-1#1)(1997-5#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)
health problems than##2##3##(1996-6#1)(2008-7#1)
health problems that##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
health problems were##4##3##(1994-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
health problems##97##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#4)(1993-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#2)(2008-1#5)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
health process##2##2##(1997-2#1)(2013-1#1)
health products##2##2##(2008-8#1)(2010-3#1)
health profession##3##2##(1993-3#1)(1993-6#1)(2008-1#1)
health professional to##2##3##(1992-3#1)(2008-3#1)
health professional##9##2##(1992-12#1)(1992-3#1)(1994-3#1)(1996-2#1)(2008-12#3)(2008-3#1)(2011-1#1)
health professionals and the general public##2##6##(1993-2#1)(2010-12#1)
health professionals and the##4##4##(1993-2#1)(2008-2#1)(2010-12#1)(2012-2#1)
health professionals and##15##3##(1991-6#1)(1993-2#1)(1995-5#1)(1997-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)
health professionals has been##3##4##(1995-1#1)(2008-11#2)
health professionals in a rural area##2##6##(1995-3#2)
health professionals in a##3##4##(1995-3#2)(1996-2#1)
health professionals in##5##3##(1993-12#1)(1995-3#2)(1996-2#1)(2013-1#1)
health professionals is##2##3##(1994-1#1)(2013-1#1)
health professionals should##5##3##(1993-12#1)(1997-3#1)(2009-3#1)(2013-1#2)
health professionals to##8##3##(1995-3#1)(2008-11#4)(2008-12#1)(2009-9#2)
health professionals using##2##3##(2010-3#1)(2013-1#1)
health professionals with##2##3##(1991-1#1)(2007-12#1)
health professionals working with##3##4##(1993-12#1)(2008-11#1)(2008-3#1)
health professionals working##4##3##(1993-12#1)(2008-11#1)(2008-3#1)(2011-1#1)
health professionals##97##2##(1990-10#1)(1991-1#1)(1991-6#2)(1992-1#1)(1992-6#1)(1993-12#4)(1993-2#1)(1994-1#4)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-3#4)(1995-5#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#4)
health professions##14##2##(1991-6#2)(1992-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-3#1)(2012-2#1)(2012-3#1)
health program##13##2##(1991-3#1)(1993-3#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-5#2)
health programmes and##2##3##(2010-4#1)(2012-12#1)
health programmes in##2##3##(2010-3#1)(2013-7#1)
health programmes##9##2##(1991-6#2)(1997-7#1)(2008-10#1)(2010-3#2)(2010-4#1)(2012-12#1)(2013-7#1)
health programs and##2##3##(2008-7#1)(2012-12#1)
health programs##17##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
health promotion activities##4##3##(1990-9#1)(2007-10#1)(2007-2#1)(2008-11#1)
health promotion and disease prevention initiative##2##6##(1995-12#1)(2008-7#1)
health promotion and disease prevention##5##5##(1995-12#2)(2008-5#1)(2008-7#1)(2012-12#1)
health promotion and##12##3##(1991-1#1)(1993-12#1)(1995-12#2)(1997-3#1)(2008-12#3)(2008-5#1)(2008-7#2)(2012-12#1)
health promotion are##2##3##(2008-11#1)(2010-2#1)
health promotion have##2##3##(2008-12#1)(2011-1#1)
health promotion in##4##3##(1994-9#1)(2008-11#1)(2008-12#1)(2013-8#1)
health promotion is##2##3##(2011-2#2)
health promotion nursing tutors##2##4##(2008-12#2)
health promotion of##2##3##(2010-10#1)(2010-12#1)
health promotion program##2##3##(1994-3#1)(2008-3#1)
health promotion programs##3##3##(1993-11#1)(1994-2#1)(2008-9#1)
health promotion theory##2##3##(2008-11#1)(2008-12#1)
health promotion##83##2##(1990-9#1)(1991-1#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-12#13)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
health promotion'##2##2##(2008-11#2)
health promotion/education##2##2##(2008-11#2)
health protection##4##2##(1997-2#1)(2008-1#1)(2008-9#1)(2012-12#1)
health protective##2##2##(2008-10#1)(2013-1#1)
health providers and##5##3##(1996-12#1)(1997-2#2)(2010-10#1)(2010-5#1)
health providers##17##2##(1993-12#1)(1994-3#1)(1995-1#2)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(2008-3#1)(2008-6#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#1)
health records##19##2##(1991-12#3)(1992-3#4)(1993-3#1)(2007-12#2)(2008-1#1)(2010-4#2)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
health reform efforts##2##3##(1996-1#1)(1996-2#1)
health reform initiatives##2##3##(1995-1#1)(1997-3#1)
health reform is##2##3##(1995-12#1)(1996-12#1)
health reform##42##2##(1993-3#2)(1994-1#4)(1994-2#2)(1994-3#2)(1995-1#3)(1995-12#3)(1995-2#3)(1995-3#1)(1996-1#6)(1996-12#3)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
health reforms##3##2##(1993-3#1)(1994-2#1)(2013-8#1)
health regions in##2##3##(1996-2#1)(2007-12#1)
health regions##4##2##(1996-2#1)(2007-12#1)(2008-12#1)(2012-2#1)
health regulation##2##2##(1994-1#1)(1995-2#1)
health regulations##3##2##(1995-2#3)
health related quality of life##2##5##(2011-2#2)
health related##6##2##(1995-3#1)(1996-1#1)(2008-10#1)(2011-2#2)(2012-3#1)
health requires##3##2##(2010-8#1)(2011-1#1)(2011-2#1)
health research and##2##3##(2008-12#1)(2008-8#1)
health research##19##2##(1996-9#1)(1997-1#1)(2008-1#1)(2008-12#5)(2008-8#2)(2009-6#4)(2009-9#1)(2011-1#1)(2012-12#2)(2013-7#1)
health resources and##2##3##(1996-1#1)(1997-2#1)
health resources##8##2##(1991-12#1)(1992-3#1)(1996-1#1)(1996-12#2)(1997-2#1)(2008-7#1)(2012-12#1)
health responses to##2##3##(2011-2#1)(2012-12#1)
health responses##5##2##(1997-3#1)(2011-2#3)(2012-12#1)
health risk and##2##3##(1992-12#1)(2009-9#1)
health risk assessment##4##3##(1995-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
health risk due to##2##4##(1991-12#1)(1992-3#1)
health risk to##2##3##(1992-2#1)(2008-12#1)
health risk##23##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-11#1)(1996-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2009-7#1)(2009-9#1)(2011-2#3)(2012-3#1)
health risks and##3##3##(1994-3#1)(2009-9#1)(2012-2#1)
health risks associated with##4##4##(1996-1#1)(2008-7#1)(2009-7#1)(2011-1#1)
health risks in##2##3##(2009-10#1)(2011-1#1)
health risks##22##2##(1994-3#1)(1995-9#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#3)(2012-12#1)(2012-2#1)
health risks?##2##2##(1992-2#1)(2010-2#1)
health savings accounts##2##3##(2008-1#1)(2008-4#1)
health science##7##2##(1994-12#2)(1995-12#1)(1996-1#1)(1997-3#2)(2012-3#1)
health sciences librarians to##2##4##(1991-3#1)(1994-3#1)
health sciences librarians##6##3##(1991-3#2)(1992-2#1)(1994-3#1)(1995-2#1)(1996-12#1)
health sciences libraries##4##3##(1991-12#1)(1992-2#1)(1996-12#1)(1996-3#1)
health sciences library##4##3##(1991-12#1)(1995-1#1)(1996-12#2)
health sciences##25##2##(1991-12#2)(1991-3#2)(1992-2#3)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#2)(1996-12#4)(1996-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#1)(2012-3#1)
health screening##3##2##(1997-1#1)(2008-12#1)(2011-2#1)
health sector decentralization in Nepal##2##5##(2012-3#2)
health sector decentralization in##3##4##(2012-3#3)
health sector decentralization##4##3##(2012-3#4)
health sector##29##2##(1991-2#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-3#1)(1997-1#5)(1997-2#1)(2008-11#1)(2008-7#5)(2008-8#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#5)(2013-8#1)
health sectors##6##2##(1990-12#1)(2008-1#1)(2008-12#2)(2008-7#1)(2012-12#1)
health security##2##2##(1995-2#1)(2010-12#1)
health seeking##3##2##(2008-1#2)(2008-4#1)
health sequelae##2##2##(2008-1#1)(2008-11#1)
health service and the##2##4##(1996-11#1)(1997-8#1)
health service and##6##3##(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-7#1)
health service delivery organisations##3##4##(2010-3#3)
health service delivery systems##2##4##(1995-2#1)(1996-1#1)
health service delivery##15##3##(1992-1#1)(1992-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2010-3#4)(2011-1#1)(2012-2#2)(2013-1#1)
health service extension##2##3##(2008-1#2)
health service for##2##3##(1990-6#1)(2009-12#1)
health service managers##4##3##(1992-1#3)(1994-12#1)
health service needs##2##3##(1997-1#1)(2010-8#1)
health service providers##2##3##(2008-12#1)(2012-2#1)
health service provision for##2##4##(2008-11#1)(2008-7#1)
health service research##3##3##(1997-1#3)
health service use##2##3##(1997-2#1)(2011-1#1)
health service users##2##3##(2008-12#2)
health service##77##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#4)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#4)(1997-2#2)(1997-3#1)(1997-8#1)(2007-10#1)(2008-1#4)(2008-11#6)(2008-12#6)(2008-2#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-3#4)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)
health services administration education##3##4##(1993-1#1)(1993-2#1)(1994-2#1)
health services administration in##2##4##(1996-3#1)(1997-3#1)
health services administration programs##2##4##(1996-3#1)(1997-2#1)
health services administration##13##3##(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)
health services administrators##2##3##(1992-12#1)(1994-2#1)
health services and health##2##4##(1991-2#1)(1996-3#1)
health services and the##5##4##(1992-5#1)(1996-11#1)(1996-9#1)(2008-1#1)(2011-1#1)
health services and##15##3##(1990-8#1)(1991-2#1)(1991-6#1)(1992-5#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#1)
health services are##6##3##(1996-9#1)(1997-1#1)(2008-11#1)(2012-12#1)(2013-8#2)
health services available to the##2##5##(1993-6#1)(1994-2#1)
health services available##3##3##(1993-6#1)(1994-2#1)(2008-1#1)
health services by##3##3##(1992-2#1)(1994-2#1)(1995-3#1)
health services can##2##3##(1990-8#1)(2008-7#1)
health services delivery##5##3##(1992-3#1)(1993-2#1)(1997-1#1)(2007-12#1)(2011-1#1)
health services for the##4##4##(1992-11#1)(1994-1#1)(1994-3#1)(2008-1#1)
health services for##10##3##(1991-3#2)(1992-11#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-6#1)(2008-1#1)
health services have##2##3##(2008-8#1)(2011-2#1)
health services in Norway##2##4##(1990-11#1)(1995-2#1)
health services in the##4##4##(1996-12#1)(1996-9#1)(2010-4#1)(2011-2#1)
health services in##18##3##(1990-11#1)(1991-3#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-3#1)(2008-11#1)(2008-2#1)(2010-4#3)(2011-2#1)(2012-12#1)
health services is one##2##4##(1995-3#1)(2008-11#1)
health services management education##2##4##(1992-1#1)(1992-12#1)
health services management##9##3##(1992-1#4)(1992-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(2012-12#1)
health services managers##2##3##(1992-1#1)(1994-3#1)
health services must##2##3##(2012-12#1)(2013-8#1)
health services on##2##3##(1994-12#1)(2013-1#1)
health services research##14##3##(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-7#1)(2012-2#2)
health services than##2##3##(1993-2#1)(1996-3#1)
health services to##4##3##(1994-1#2)(1996-3#1)(2008-12#1)
health services under##2##3##(1994-2#1)(1995-1#1)
health services utilization##3##3##(1990-12#1)(2008-12#1)(2011-1#1)
health services will##4##3##(1997-1#1)(2008-7#2)(2012-2#1)
health services##276##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#7)(1991-6#6)(1991-9#2)(1992-1#6)(1992-11#5)(1992-12#5)(1992-2#5)(1992-3#3)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#5)(1993-6#7)(1994-1#6)(1994-12#4)(1994-2#8)(1994-3#10)(1994-6#1)(1995-1#5)(1995-12#2)(1995-2#2)(1995-3#7)(1995-6#2)(1996-1#5)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#11)(1996-6#1)(1996-8#2)(1996-9#6)(1997-1#5)(1997-2#10)(1997-3#7)(1997-4#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#7)(2008-11#10)(2008-12#8)(2008-2#4)(2008-7#8)(2008-8#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-5#1)(2011-1#6)(2011-2#5)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
health services]##9##2##(1992-11#2)(1992-5#1)(1993-6#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-9#2)
health settings##5##2##(1995-1#1)(2008-12#1)(2008-6#1)(2010-3#1)(2012-2#1)
health since##2##2##(1991-6#1)(1995-12#1)
health situation of##3##3##(1990-12#1)(1992-5#1)(2013-1#1)
health situation##4##2##(1990-12#1)(1992-5#1)(2011-2#1)(2013-1#1)
health spending##13##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2013-8#1)
health staff and##2##3##(2007-11#1)(2007-12#1)
health staff##11##2##(1996-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2012-12#2)(2012-3#1)(2013-8#2)
health stakeholders##2##2##(2008-11#1)(2012-12#1)
health state##7##2##(1993-2#1)(1995-2#1)(2008-7#2)(2009-10#1)(2011-2#2)
health states##3##2##(2008-1#1)(2009-11#1)(2011-2#1)
health statistics##5##2##(1990-11#1)(1997-3#1)(2008-1#1)(2008-11#2)
health status among##3##3##(1994-2#1)(1996-6#1)(2011-1#1)
health status and health care##2##5##(1996-2#1)(2009-5#1)
health status and the##2##4##(1997-1#1)(2013-1#1)
health status and##20##3##(1994-3#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
health status as##3##3##(1994-12#1)(1995-12#1)(2011-2#1)
health status in the##2##4##(1992-3#1)(2008-10#1)
health status in##4##3##(1992-3#1)(1992-9#1)(2008-10#1)(2012-12#1)
health status information##3##3##(1996-1#2)(2010-3#1)
health status is a##2##4##(2010-10#1)(2010-2#1)
health status is##6##3##(2008-7#2)(2008-8#1)(2010-10#2)(2010-2#1)
health status measures##2##3##(1994-3#2)
health status of older##3##4##(2008-5#1)(2010-10#2)
health status of the population##2##5##(1997-5#1)(2008-1#1)
health status of the##7##4##(1990-6#2)(1995-2#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#1)
health status of##29##3##(1990-6#2)(1991-12#1)(1993-1#1)(1994-9#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#2)
health status than##2##3##(2010-2#1)(2013-8#1)
health status to##2##3##(1994-3#1)(2007-8#1)
health status with##3##3##(1997-2#1)(2008-5#1)(2010-10#1)
health status##136##2##(1990-6#3)(1991-12#1)(1991-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-3#2)(1993-6#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#7)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#7)(1995-2#3)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#8)(2008-10#5)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#4)(2009-7#1)(2010-10#7)(2010-2#7)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
health statutes##2##2##(1994-1#2)
health strategies##2##2##(1995-12#1)(2011-1#1)
health strategy and##2##3##(1991-11#1)(2013-8#1)
health strategy##4##2##(1991-11#1)(1994-12#1)(2012-3#1)(2013-8#1)
health stress##2##2##(2012-1#2)
health study##3##2##(1991-2#1)(2008-12#1)(2009-10#1)
health such as##2##3##(2008-10#1)(2013-7#1)
health surveillance systems##7##3##(1997-3#2)(2008-12#1)(2008-7#4)
health surveillance##30##2##(1992-2#1)(1997-3#18)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#5)(2012-12#1)(2012-2#1)
health survey and##2##3##(1992-5#1)(1997-3#1)
health survey of##4##3##(1992-1#1)(1994-11#1)(2008-1#2)
health survey##13##2##(1992-1#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-11#2)(1997-3#1)(2008-1#4)(2009-10#1)(2011-2#1)
health surveys in##2##3##(1993-6#1)(2011-1#1)
health surveys##8##2##(1993-2#1)(1993-6#4)(1997-3#1)(2011-1#1)(2012-12#1)
health system and##3##3##(1993-6#1)(2011-1#1)(2011-2#1)
health system approach##2##3##(2010-12#2)
health system capacity##2##3##(2011-2#1)(2012-12#1)
health system in##6##3##(1995-12#2)(1996-12#1)(1996-2#1)(1997-2#1)(2010-8#1)
health system is a##2##4##(1994-2#1)(2013-8#1)
health system is##3##3##(1994-2#1)(1994-3#1)(2013-8#1)
health system levels##2##3##(2010-11#1)(2011-2#1)
health system performance##8##3##(1995-12#1)(1996-2#1)(2008-11#1)(2011-2#2)(2012-12#1)(2013-8#2)
health system reform in##3##4##(1996-1#1)(1996-12#1)(2007-5#1)
health system reform##13##3##(1993-12#2)(1993-3#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#2)(2007-5#1)(2012-12#1)
health system review##2##3##(2011-1#1)(2013-8#1)
health system that##3##3##(1996-2#1)(1997-3#1)(2011-1#1)
health system to##4##3##(1992-11#1)(1996-2#1)(2012-12#1)(2013-8#1)
health system##106##2##(1992-1#1)(1992-11#1)(1993-12#3)(1993-3#3)(1993-6#1)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#3)(1996-1#4)(1996-12#4)(1996-2#5)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#4)(2007-10#1)(2007-5#1)(2008-1#6)(2008-11#2)(2008-2#3)(2008-6#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-8#4)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#6)(2013-1#1)(2013-7#1)(2013-8#7)
health system]##2##2##(1993-6#1)(2012-12#1)
health systems and##2##3##(2012-12#1)(2013-8#1)
health systems for##2##3##(1993-6#1)(1997-1#1)
health systems in##2##3##(1993-6#1)(2008-7#1)
health systems management##2##3##(1993-1#2)
health systems that##3##3##(1995-12#1)(2008-7#2)
health systems##50##2##(1991-3#1)(1992-1#1)(1993-1#2)(1993-3#1)(1993-6#2)(1994-3#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#4)(2008-1#2)(2008-11#3)(2008-12#1)(2008-7#5)(2010-8#3)(2011-1#3)(2011-2#1)(2012-12#8)(2012-2#1)(2013-8#2)
health team##5##2##(1991-6#1)(1997-2#2)(2008-12#1)(2012-1#1)
health technologies##3##2##(2010-9#1)(2013-8#2)
health technology assessment##6##3##(2008-2#1)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
health technology##12##2##(2008-2#1)(2009-3#3)(2009-5#1)(2011-2#4)(2012-12#2)(2013-1#1)
health tests##2##2##(2008-10#2)
health than##4##2##(1996-11#1)(1997-5#1)(2013-1#2)
health that##6##2##(2008-1#1)(2008-2#1)(2008-5#1)(2009-6#1)(2013-1#2)
health threat in the##2##4##(2011-2#1)(2013-8#1)
health threat in##4##3##(2007-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
health threat##9##2##(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-8#1)
health threats##2##2##(2007-7#1)(2008-7#1)
health through##3##2##(1996-1#1)(2008-6#1)(2008-9#1)
health throughout##3##2##(2008-4#2)(2011-2#1)
health to##11##2##(1991-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
health training##4##2##(1996-2#1)(1996-3#2)(1997-2#1)
health under##3##2##(1995-12#1)(2008-8#1)(2011-1#1)
health unit##3##2##(1995-1#1)(2010-2#1)(2011-2#1)
health units##4##2##(1991-2#1)(1993-6#1)(2007-12#1)(2011-2#1)
health use##4##2##(1994-2#3)(2007-2#1)
health utility##3##2##(2008-7#2)(2011-2#1)
health utilization##3##2##(1995-1#2)(1995-3#1)
health visit##2##2##(1990-6#1)(1995-3#1)
health visiting##2##2##(2008-11#1)(2008-12#1)
health visitor##2##2##(1993-12#1)(2008-12#1)
health visitors in##2##3##(1992-2#1)(2008-12#1)
health visitors##5##2##(1990-12#1)(1992-11#1)(1992-2#1)(2008-11#1)(2008-12#1)
health was##7##2##(1996-3#1)(1997-2#1)(2008-11#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#1)
health were##5##2##(2007-11#1)(2008-8#1)(2011-1#1)(2012-12#2)
health which##2##2##(1992-1#1)(1996-8#1)
health will##3##2##(1995-2#1)(1996-12#1)(1997-2#1)
health with##4##2##(1996-12#1)(2008-7#1)(2009-7#1)(2011-1#1)
health work##5##2##(1991-6#1)(1995-6#1)(2008-1#2)(2013-1#1)
health worker##6##2##(1997-5#3)(2008-12#1)(2012-12#1)(2012-2#1)
health workers and##2##3##(2008-2#1)(2009-5#1)
health workers in the##2##4##(2010-8#1)(2012-12#1)
health workers in##4##3##(1990-11#1)(1996-2#1)(2010-8#1)(2012-12#1)
health workers##27##2##(1990-11#2)(1992-4#1)(1993-12#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2009-5#1)(2009-6#2)(2010-1#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#2)
health workforce in##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
health workforce##9##2##(1997-3#1)(2008-1#4)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
health##7098##1##(1990-10#1)(1990-11#9)(1990-12#20)(1990-2#9)(1990-3#3)(1990-5#1)(1990-6#17)(1990-8#4)(1990-9#6)(1991-1#37)(1991-11#6)(1991-12#55)(1991-2#71)(1991-3#80)(1991-4#2)(1991-5#1)(1991-6#39)(1991-7#1)(1991-8#5)(1991-9#8)(1992-1#73)(1992-11#24)(1992-12#54)(1992-2#69)(1992-3#79)(1992-4#6)(1992-5#11)(1992-6#1)(1992-8#1)(1992-9#9)(1993-1#70)(1993-10#3)(1993-11#10)(1993-12#116)(1993-2#73)(1993-3#98)(1993-5#2)(1993-6#42)(1993-8#1)(1993-9#5)(1994-1#107)(1994-11#9)(1994-12#138)(1994-2#132)(1994-3#177)(1994-5#2)(1994-6#20)(1994-7#2)(1994-8#7)(1994-9#12)(1995-1#153)(1995-11#7)(1995-12#167)(1995-2#141)(1995-3#135)(1995-5#10)(1995-6#21)(1995-8#7)(1995-9#4)(1996-1#173)(1996-10#2)(1996-11#15)(1996-12#136)(1996-2#181)(1996-3#191)(1996-5#6)(1996-6#19)(1996-7#3)(1996-8#24)(1996-9#23)(1997-1#117)(1997-2#157)(1997-3#203)(1997-4#18)(1997-5#18)(1997-6#18)(1997-7#2)(1997-8#18)(2006-12#1)(2006-5#1)(2006-9#2)(2007-1#2)(2007-10#26)(2007-11#13)(2007-12#57)(2007-2#47)(2007-3#2)(2007-4#3)(2007-5#8)(2007-6#3)(2007-7#15)(2007-8#5)(2007-9#1)(2008-1#220)(2008-10#125)(2008-11#342)(2008-12#158)(2008-2#30)(2008-3#19)(2008-4#55)(2008-5#24)(2008-6#33)(2008-7#222)(2008-8#63)(2008-9#36)(2009-1#3)(2009-10#25)(2009-11#9)(2009-12#15)(2009-2#1)(2009-3#8)(2009-4#6)(2009-5#74)(2009-6#35)(2009-7#26)(2009-8#13)(2009-9#17)(2010-1#22)(2010-10#38)(2010-11#11)(2010-12#42)(2010-2#29)(2010-3#40)(2010-4#46)(2010-5#23)(2010-6#9)(2010-7#14)(2010-8#75)(2010-9#37)(2011-1#153)(2011-2#259)(2011-3#1)(2011-9#3)(2012-1#37)(2012-12#203)(2012-2#110)(2012-3#92)(2013-1#248)(2013-7#41)(2013-8#123)
health&quot##2##1##(2008-12#2)
health's##9##1##(1991-9#3)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#2)
health)##4##1##(2008-4#2)(2008-7#1)(2012-3#1)
health-care professionals##2##2##(2008-7#1)(2009-11#1)
health-care reform##2##2##(1991-8#1)(1993-2#1)
health-care service##2##2##(2011-1#2)
health-care system##6##2##(1996-6#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)
health-care workers##3##2##(1995-6#1)(2012-12#2)
health-care##34##1##(1991-8#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-6#2)(1996-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#4)(2009-11#2)(2011-1#4)(2011-2#1)(2012-12#5)(2012-3#3)(2013-8#1)
health-economic studies##2##2##(2011-2#2)
health-economic##3##1##(2011-2#3)
health-information seeking##3##2##(2009-5#3)
health-information##4##1##(2009-5#4)
health-promoting##3##1##(1990-11#1)(2009-5#1)(2012-12#1)
health-protective##2##1##(1997-6#1)(2013-1#1)
health-related QOL##2##2##(2008-7#1)(2011-2#1)
health-related behavior and health care##2##5##(2009-5#2)
health-related behavior##3##2##(1991-6#1)(2009-5#2)
health-related behaviors##2##2##(2010-8#1)(2010-9#1)
health-related issues##2##2##(2008-11#1)(2008-6#1)
health-related quality of life and##2##5##(1995-2#1)(2010-5#1)
health-related quality of life in patients with##2##7##(2008-7#1)(2013-8#1)
health-related quality of life in##7##5##(2007-11#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
health-related quality of life##23##4##(1995-2#1)(2007-11#1)(2008-1#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#3)(2013-1#1)(2013-8#2)
health-related quality of##24##3##(1995-2#1)(2007-11#1)(2008-1#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#3)(2013-1#1)(2013-8#2)
health-related websites##2##2##(2008-8#1)(2013-1#1)
health-related##63##1##(1991-3#1)(1991-6#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#5)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
health-risk behaviors##3##2##(2010-5#2)(2010-7#1)
health-seeking##3##1##(2009-5#1)(2012-12#2)
health-status measures##3##2##(1997-1#1)(1997-2#2)
health?##6##1##(1994-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-7#1)
health]##12##1##(1990-12#1)(1990-3#1)(1991-6#1)(1992-5#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
healthcare access##3##2##(1994-12#1)(1995-1#1)(1996-2#1)
healthcare administrators##4##2##(1991-9#1)(2007-9#1)(2009-8#2)
healthcare and the##3##3##(1994-2#1)(2009-11#2)
healthcare and##12##2##(1994-2#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2009-11#2)(2009-6#1)(2010-10#1)(2012-12#3)
healthcare at##2##2##(2008-12#1)(2012-1#1)
healthcare community##6##2##(1995-2#3)(2011-2#2)(2012-2#1)
healthcare cost##2##2##(1992-1#1)(2008-11#1)
healthcare costs and##2##3##(1990-4#1)(2010-12#1)
healthcare costs##6##2##(1990-4#1)(1995-12#2)(2008-3#1)(2010-12#1)(2013-7#1)
healthcare data##2##2##(2007-12#1)(2011-2#1)
healthcare delivery##10##2##(1992-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-3#2)(2010-3#1)(2013-1#2)
healthcare education##4##2##(1996-2#1)(2008-12#3)
healthcare enterprise##2##2##(2007-12#2)
healthcare environment and##2##3##(1997-3#1)(2008-3#1)
healthcare environment##9##2##(1993-12#1)(1993-2#2)(1996-2#1)(1997-3#1)(2008-3#3)(2008-9#1)
healthcare expenditures##6##2##(2013-1#6)
healthcare experience##2##2##(2012-2#2)
healthcare facilities in##2##3##(2008-9#1)(2010-5#1)
healthcare facilities to##2##3##(2007-12#1)(2011-2#1)
healthcare facilities##19##2##(1992-12#1)(1992-2#2)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#2)(2013-8#3)
healthcare facility##7##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)
healthcare for##2##2##(1990-4#1)(2008-12#1)
healthcare improvement##2##2##(2013-1#2)
healthcare in##7##2##(1995-1#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-10#1)(2013-1#1)
healthcare industry##11##2##(1991-2#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-12#1)(2009-8#1)(2013-8#1)
healthcare information##5##2##(2007-12#1)(2010-8#3)(2011-2#1)
healthcare institutions##6##2##(1993-2#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(2013-8#1)
healthcare leaders##2##2##(2009-3#1)(2012-1#1)
healthcare management##4##2##(2009-3#1)(2009-8#2)(2012-12#1)
healthcare managers##2##2##(1995-12#1)(2008-12#1)
healthcare market##2##2##(1997-5#1)(1997-6#1)
healthcare more##2##2##(1995-2#1)(2010-10#1)
healthcare needs of##2##3##(2008-4#1)(2010-1#1)
healthcare needs##6##2##(2008-4#2)(2010-1#1)(2010-8#2)(2011-1#1)
healthcare network##2##2##(2008-3#1)(2012-12#1)
healthcare networks##2##2##(1995-3#1)(1996-3#1)
healthcare of##2##2##(2008-12#1)(2011-2#1)
healthcare organization##3##2##(1995-12#1)(1995-2#1)(2007-12#1)
healthcare organizations##13##2##(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-9#2)(2008-12#2)(2009-8#1)(2010-8#1)(2013-1#2)(2013-8#1)
healthcare outcomes##2##2##(2008-3#2)
healthcare paradigm##2##2##(2008-10#2)
healthcare personnel##2##2##(2008-8#1)(2011-2#1)
healthcare policy##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
healthcare practitioners##6##2##(2008-12#2)(2008-9#4)
healthcare professionals in##2##3##(1991-1#1)(2008-4#1)
healthcare professionals##15##2##(1991-1#1)(1991-2#1)(1993-12#1)(2007-2#2)(2008-11#1)(2008-12#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
healthcare professionals' approach towards them##2##5##(2011-2#2)
healthcare programs##2##2##(2013-1#2)
healthcare provider##4##2##(2007-12#1)(2008-1#1)(2009-3#1)(2013-1#1)
healthcare providers to##5##3##(1997-7#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
healthcare providers##21##2##(1991-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#2)
healthcare providers'##2##2##(2010-4#1)(2011-1#1)
healthcare provision##2##2##(1997-7#1)(2013-8#1)
healthcare quality##7##2##(1992-11#1)(2010-4#1)(2013-1#5)
healthcare reform is##2##3##(1994-12#1)(2013-1#1)
healthcare reform proposals##3##3##(1993-12#1)(1995-1#2)
healthcare reform##13##2##(1993-12#5)(1994-12#2)(1995-1#4)(1996-2#1)(2013-1#1)
healthcare resources##6##2##(2007-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
healthcare security management##3##3##(1992-12#1)(1993-2#2)
healthcare security##11##2##(1992-12#4)(1992-2#2)(1993-12#1)(1993-2#2)(1995-12#1)(1996-12#1)
healthcare service##4##2##(1991-3#1)(1992-1#1)(1993-12#1)(2012-3#1)
healthcare services in##2##3##(2011-2#2)
healthcare services utilization##2##3##(2012-3#2)
healthcare services##17##2##(1994-3#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-8#1)
healthcare setting##9##2##(1993-2#1)(1996-12#1)(1996-2#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
healthcare settings##6##2##(1994-3#1)(1995-6#1)(2008-12#2)(2012-12#1)(2013-1#1)
healthcare system is##3##3##(1997-3#1)(2007-12#1)(2013-8#1)
healthcare system##22##2##(1991-3#2)(1992-11#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-12#1)(2007-9#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#4)(2013-8#1)
healthcare systems in##2##3##(2009-3#1)(2013-8#1)
healthcare systems##10##2##(1997-2#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#2)
healthcare teams##4##2##(2008-1#1)(2009-6#2)(2010-1#1)
healthcare training##2##2##(2008-9#1)(2011-2#1)
healthcare with##2##2##(2008-12#1)(2008-7#1)
healthcare workers in Hawassa##3##4##(2012-12#3)
healthcare workers in##11##3##(1996-8#1)(2011-2#2)(2012-12#6)(2013-1#2)
healthcare workers##22##2##(1996-12#1)(1996-8#2)(1997-2#1)(2008-12#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#10)(2013-1#3)
healthcare workers'##4##2##(2011-2#1)(2012-12#3)
healthcare##519##1##(1990-4#2)(1991-1#2)(1991-2#4)(1991-3#4)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#7)(1992-2#7)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#16)(1993-2#13)(1993-3#2)(1993-5#2)(1994-1#1)(1994-12#10)(1994-2#3)(1994-3#4)(1995-1#9)(1995-12#9)(1995-2#12)(1995-3#6)(1995-6#1)(1996-1#1)(1996-12#9)(1996-2#11)(1996-3#7)(1996-8#2)(1997-1#1)(1997-2#6)(1997-3#15)(1997-5#2)(1997-6#1)(1997-7#3)(2006-10#1)(2007-12#20)(2007-2#2)(2007-9#5)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#31)(2008-3#12)(2008-4#4)(2008-7#6)(2008-8#3)(2008-9#15)(2009-11#6)(2009-12#1)(2009-3#8)(2009-6#8)(2009-8#14)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#13)(2011-1#5)(2011-2#32)(2011-7#1)(2012-1#4)(2012-12#28)(2012-2#7)(2012-3#4)(2013-1#50)(2013-7#3)(2013-8#22)
healthier##8##1##(1994-12#1)(1994-2#1)(1995-1#1)(2008-11#1)(2010-9#1)(2013-1#3)
healthy Japanese##4##2##(1997-7#1)(2008-5#3)
healthy Norwegians##3##2##(1990-2#1)(1991-6#1)(1997-6#1)
healthy adult##14##2##(1994-12#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)
healthy adults##14##2##(1993-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
healthy age-matched controls##2##3##(2008-7#2)
healthy ageing##2##2##(1992-11#1)(2010-10#1)
healthy aging##4##2##(2009-5#1)(2012-2#3)
healthy and AYP-infected shoots##2##4##(2008-10#2)
healthy and AYP-infected##3##3##(2008-10#3)
healthy and diseased##3##3##(2008-10#3)
healthy and infected##3##3##(2008-10#3)
healthy and##37##2##(1990-5#1)(1991-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1997-2#1)(2008-10#13)(2008-11#2)(2008-5#3)(2008-7#2)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
healthy antral follicles##2##3##(1995-12#1)(2008-11#1)
healthy at##2##2##(1994-9#1)(2012-3#1)
healthy behavior##2##2##(2010-8#1)(2012-3#1)
healthy behaviors##2##2##(2010-5#1)(2013-1#1)
healthy blood donors##3##3##(1992-3#1)(1996-12#1)(2008-7#1)
healthy blood##4##2##(1992-3#1)(1996-12#1)(2008-7#1)(2010-11#1)
healthy boys##2##2##(2011-2#2)
healthy but##2##2##(2006-10#1)(2008-11#1)
healthy carriers##2##2##(1991-11#1)(1992-6#1)
healthy cats##3##2##(1990-9#1)(1996-6#2)
healthy centenarians##2##2##(2008-7#2)
healthy child##3##2##(2008-10#1)(2008-11#2)
healthy children and##3##3##(2008-12#1)(2010-1#1)(2011-1#1)
healthy children in##2##3##(2011-1#1)(2012-2#1)
healthy children with##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
healthy children##24##2##(1991-6#2)(1993-12#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
healthy communities##4##2##(1995-3#1)(1996-2#1)(1997-3#1)(2008-1#1)
healthy condition##3##2##(1994-9#1)(2011-1#1)(2012-3#1)
healthy control groups##3##3##(2011-1#3)
healthy control persons##2##3##(1990-12#1)(1991-5#1)
healthy control subjects##9##3##(1990-5#1)(1992-3#1)(1993-9#1)(1996-7#1)(2007-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
healthy control##23##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-3#1)(1993-9#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-6#1)(2011-1#7)(2011-2#1)(2013-1#1)
healthy controls (P &lt##2##4##(2010-12#1)(2011-1#1)
healthy controls (n =##2##4##(1990-8#1)(1996-7#1)
healthy controls and##7##3##(1991-12#1)(1992-9#1)(2008-10#4)(2009-6#1)
healthy controls completed##2##3##(1992-12#1)(2012-1#1)
healthy controls from##2##3##(1992-11#1)(1997-8#1)
healthy controls were collected##3##4##(1992-8#1)(2008-12#2)
healthy controls were##6##3##(1992-8#1)(1996-11#1)(2008-12#2)(2009-6#1)(2011-2#1)
healthy controls##73##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#2)(1997-8#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2009-6#2)(2009-8#2)(2010-12#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
healthy development of children##2##4##(2008-11#2)
healthy development##4##2##(2008-11#2)(2011-2#1)(2012-12#1)
healthy diet##5##2##(2008-3#1)(2010-12#1)(2011-1#2)(2011-2#1)
healthy dogs##3##2##(2008-12#1)(2008-6#1)(2013-1#1)
healthy donors and##3##3##(2008-11#2)(2008-4#1)
healthy donors showed##2##3##(2008-11#1)(2008-7#1)
healthy donors were##2##3##(1994-12#1)(2010-12#1)
healthy donors##16##2##(1994-12#1)(1994-3#1)(1996-12#1)(2008-11#7)(2008-4#1)(2008-7#2)(2010-12#1)(2012-2#2)
healthy eating and##2##3##(2009-6#1)(2011-1#1)
healthy eating##8##2##(2007-12#1)(2007-3#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
healthy elderly subjects##2##3##(2008-7#2)
healthy elderly##7##2##(1991-8#1)(1994-12#1)(2007-7#1)(2008-5#1)(2008-7#3)
healthy environments##2##2##(2011-2#2)
healthy female volunteers##2##3##(2008-10#1)(2008-5#1)
healthy female##6##2##(1994-12#1)(1995-11#1)(2008-10#3)(2008-5#1)
healthy first-degree relatives of##2##4##(1991-11#2)
healthy fruit##2##2##(2008-10#1)(2013-8#1)
healthy heart##2##2##(1996-3#1)(2008-10#1)
healthy human skin##2##3##(2008-5#1)(2012-3#1)
healthy human##10##2##(1991-2#2)(1992-3#1)(1992-6#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
healthy humans##3##2##(1993-9#1)(2010-4#1)(2012-2#1)
healthy individual##2##2##(2007-10#1)(2012-3#1)
healthy individuals in a##2##4##(2008-10#1)(2008-5#1)
healthy individuals in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
healthy individuals with##4##3##(2008-3#3)(2010-12#1)
healthy individuals##52##2##(1991-7#1)(1992-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-2#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#2)
healthy infant##2##2##(2007-2#1)(2013-1#1)
healthy infants##3##2##(1990-9#1)(2008-4#1)(2011-1#1)
healthy leaf area##4##3##(2008-10#4)
healthy leaves##3##2##(2008-10#2)(2013-7#1)
healthy life##2##2##(2008-5#1)(2013-1#1)
healthy lifestyle education##2##3##(2009-6#2)
healthy lifestyle##7##2##(2008-12#1)(2008-7#1)(2009-6#2)(2011-1#2)(2013-1#1)
healthy lifestyles##3##2##(1994-12#1)(2008-12#1)(2011-1#1)
healthy longevity##2##2##(2008-7#1)(2013-7#1)
healthy male and##3##3##(2008-10#3)
healthy male controls##2##3##(2008-3#2)
healthy male human volunteers##2##4##(2012-2#2)
healthy male volunteers##4##3##(1996-5#1)(1996-7#1)(2008-5#1)(2009-11#1)
healthy male##14##2##(1991-12#1)(1996-5#1)(1996-7#1)(2008-10#3)(2008-3#2)(2008-5#2)(2009-11#1)(2009-8#1)(2012-2#2)
healthy males##4##2##(1990-3#1)(1992-3#1)(2013-7#1)(2013-8#1)
healthy man##6##2##(1994-11#1)(1994-9#1)(2007-2#1)(2010-1#1)(2013-8#2)
healthy mango##2##2##(2008-10#2)
healthy men and women##2##4##(1996-8#1)(2010-12#1)
healthy men##8##2##(1996-7#1)(1996-8#1)(2008-12#2)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
healthy mice##2##2##(2008-8#2)
healthy newborn infant##2##3##(2008-11#1)(2011-2#1)
healthy newborn##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
healthy newborns and##3##3##(2008-10#2)(2011-1#1)
healthy newborns##5##2##(1990-12#1)(1996-3#1)(2008-10#2)(2011-1#1)
healthy non-pregnant##2##2##(1992-3#1)(2011-2#1)
healthy normal skin##2##3##(2012-3#2)
healthy normal##3##2##(1995-11#1)(2012-3#2)
healthy obese##3##2##(2010-8#1)(2013-1#1)(2013-7#1)
healthy older adults##3##3##(2011-1#2)(2013-1#1)
healthy older##5##2##(2008-3#1)(2011-1#3)(2013-1#1)
healthy ones##3##2##(1993-2#1)(1997-6#1)(2012-3#1)
healthy or APP-infected##2##3##(2008-10#2)
healthy or##5##2##(2008-10#3)(2011-2#1)(2013-7#1)
healthy oral cavity##2##3##(2008-12#2)
healthy oral##3##2##(2008-12#2)(2013-1#1)
healthy participants##5##2##(2007-12#1)(2008-10#1)(2008-11#2)(2010-9#1)
healthy patients##4##2##(1997-3#1)(2007-8#1)(2011-2#1)(2013-1#1)
healthy peach seedlings##3##3##(2008-10#3)
healthy people and##2##3##(2011-2#1)(2013-1#1)
healthy people##9##2##(1991-6#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-6#1)(2011-2#2)(2013-1#2)
healthy periwinkle shoots##2##3##(2008-10#2)
healthy persons with##2##3##(1994-11#1)(2007-7#1)
healthy persons##7##2##(1992-11#1)(1994-11#1)(1995-3#1)(1996-9#2)(2007-7#1)(2008-12#1)
healthy plant extracts##2##3##(2008-10#2)
healthy plant##4##2##(2008-10#4)
healthy plants##4##2##(2008-10#4)
healthy population and##2##3##(1990-3#1)(2008-1#1)
healthy population of##3##3##(2008-5#2)(2008-7#1)
healthy population##15##2##(1990-3#1)(1990-6#1)(2007-10#1)(2008-1#4)(2008-5#5)(2008-7#1)(2010-1#1)(2013-7#1)
healthy populations##2##2##(2008-9#1)(2012-2#1)
healthy pregnant women##2##3##(1992-12#1)(2011-1#1)
healthy pregnant##5##2##(1992-12#1)(1993-10#1)(2011-1#1)(2011-2#2)
healthy public policy##2##3##(1996-1#1)(2008-11#1)
healthy roots##3##2##(2008-10#3)
healthy schoolchildren to##2##3##(1994-12#1)(2011-2#1)
healthy seedling stand##2##3##(2008-10#2)
healthy seedlings##4##2##(2008-10#4)
healthy skin and##2##3##(2008-5#2)
healthy skin##17##2##(2008-5#13)(2012-1#1)(2012-3#3)
healthy state##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
healthy stems##2##2##(2008-10#2)
healthy subject was##2##3##(1990-8#1)(2013-1#1)
healthy subject##5##2##(1990-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
healthy subjects after##2##3##(1996-1#1)(2008-7#1)
healthy subjects and patients with chronic neck pain##2##8##(2010-12#2)
healthy subjects and##13##3##(1994-6#1)(1996-1#2)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#3)(2011-2#1)(2012-3#1)
healthy subjects as well as##3##5##(1992-3#1)(2008-11#1)(2008-3#1)
healthy subjects from##2##3##(2008-7#1)(2013-1#1)
healthy subjects of##2##3##(1990-11#1)(2008-5#1)
healthy subjects to##2##3##(1990-5#1)(2010-2#1)
healthy subjects were enrolled in##2##5##(2010-12#1)(2013-1#1)
healthy subjects were##5##3##(2007-2#1)(2008-12#1)(2010-12#2)(2013-1#1)
healthy subjects##90##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-1#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#3)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#3)
healthy sugarcane##2##2##(2008-10#2)
healthy tissue##5##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
healthy tissues##3##2##(2008-10#2)(2010-6#1)
healthy tits##3##2##(2008-5#3)
healthy trees##4##2##(2008-10#4)
healthy volunteers (4 male and##2##5##(2008-7#2)
healthy volunteers after oral administration of##2##6##(1996-5#1)(2008-10#1)
healthy volunteers after##5##3##(1996-5#1)(2008-10#1)(2008-5#2)(2013-1#1)
healthy volunteers and##4##3##(1991-12#1)(1993-9#1)(2012-2#1)(2013-8#1)
healthy volunteers were studied##2##4##(2006-10#1)(2007-10#1)
healthy volunteers were##7##3##(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-5#2)(2013-1#1)
healthy volunteers with##2##3##(1996-5#1)(2008-5#1)
healthy volunteers##64##2##(1991-12#1)(1991-8#1)(1992-3#1)(1993-9#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-5#3)(1996-7#2)(1997-7#1)(2006-10#1)(2006-12#2)(2007-10#2)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#12)(2008-7#4)(2008-8#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-2#2)(2013-1#4)(2013-8#2)
healthy weights&quot##2##2##(2007-12#2)
healthy white##2##2##(1990-3#1)(2011-2#1)
healthy women and women with##2##5##(1992-9#1)(2010-6#1)
healthy women and##3##3##(1991-8#1)(1992-9#1)(2010-6#1)
healthy women with##2##3##(2008-5#1)(2012-3#1)
healthy women##15##2##(1991-5#1)(1991-8#1)(1992-9#2)(1993-2#2)(2007-7#1)(2008-5#3)(2010-6#1)(2010-9#2)(2012-3#1)(2013-1#1)
healthy worker effect##2##3##(2008-7#1)(2011-2#1)
healthy yaks were##2##3##(2011-2#2)
healthy yaks##4##2##(2011-2#4)
healthy young adults##2##3##(1990-12#1)(2008-7#1)
healthy young##8##2##(1990-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
healthy##976##1##(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#5)(1990-5#4)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#4)(1992-11#3)(1992-12#3)(1992-3#9)(1992-6#2)(1992-8#1)(1992-9#5)(1993-10#4)(1993-12#3)(1993-2#5)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#7)(1994-1#4)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#4)(1996-5#8)(1996-6#2)(1996-7#9)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#5)(1997-7#2)(1997-8#3)(2006-10#6)(2006-12#2)(2006-6#2)(2007-1#1)(2007-10#7)(2007-11#2)(2007-12#7)(2007-2#6)(2007-3#1)(2007-7#6)(2007-8#4)(2008-1#10)(2008-10#135)(2008-11#34)(2008-12#24)(2008-3#21)(2008-4#7)(2008-5#59)(2008-6#5)(2008-7#45)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#9)(2009-7#2)(2009-8#11)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#17)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#4)(2010-8#4)(2010-9#5)(2011-1#42)(2011-2#72)(2012-1#7)(2012-12#14)(2012-2#33)(2012-3#25)(2013-1#53)(2013-3#1)(2013-7#11)(2013-8#23)
healthy&quot##2##1##(1996-3#1)(2013-1#1)
hear the##3##2##(1995-6#1)(1996-5#1)(2012-2#1)
hear##6##1##(1994-2#1)(1995-6#1)(1996-5#1)(2008-2#1)(2009-10#1)(2012-2#1)
heard by##2##2##(1992-3#1)(2012-12#1)
heard of##4##2##(1993-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
heard##19##1##(1992-3#1)(1993-12#1)(1995-12#1)(1996-5#1)(1997-4#2)(1997-8#1)(2008-2#2)(2009-5#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
hearing aid use##2##3##(2007-8#2)
hearing aid##9##2##(2007-8#2)(2008-9#5)(2011-2#1)(2012-2#1)
hearing aids##5##2##(1990-12#1)(2008-9#3)(2012-2#1)
hearing and equilibrium##4##3##(2011-2#4)
hearing and speaking##2##3##(2008-7#1)(2012-12#1)
hearing and##13##2##(1990-12#1)(1996-11#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#5)(2012-12#1)(2012-2#1)
hearing children##6##2##(2008-9#2)(2011-2#4)
hearing history##2##2##(2008-9#2)
hearing impairment and##2##3##(2008-9#2)
hearing impairment in the##2##4##(1991-2#1)(2008-9#1)
hearing impairment in##5##3##(1991-2#1)(2008-9#2)(2011-1#1)(2013-1#1)
hearing impairment##15##2##(1991-2#1)(2008-8#1)(2008-9#7)(2011-1#3)(2013-1#3)
hearing improvement##2##2##(1995-6#1)(2008-4#1)
hearing in noise##2##3##(2008-9#1)(2012-2#1)
hearing in##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
hearing loss and##9##3##(2008-9#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
hearing loss associated with##2##4##(2011-2#1)(2012-2#1)
hearing loss gene##2##3##(2012-12#2)
hearing loss in children##3##4##(2009-5#3)
hearing loss in##12##3##(1994-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#3)(2011-1#1)(2011-2#2)(2012-2#2)
hearing loss is##3##3##(2008-4#1)(2008-9#1)(2013-8#1)
hearing loss seen in CINCA syndrome##2##6##(2012-2#2)
hearing loss with##2##3##(2006-12#1)(2012-2#1)
hearing loss##77##2##(1992-2#2)(1994-9#1)(1995-6#1)(1996-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#10)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#14)(2009-5#5)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#11)(2012-3#1)(2013-1#3)(2013-8#2)
hearing peers##3##2##(2008-9#1)(2012-2#2)
hearing preservation##2##2##(2010-4#2)
hearing sensitivity##2##2##(2007-7#1)(2008-9#1)
hearing students##4##2##(2011-2#4)
hearing threshold of##2##3##(2008-2#1)(2010-4#1)
hearing threshold##3##2##(2008-2#1)(2008-4#1)(2010-4#1)
hearing thresholds##5##2##(2008-9#3)(2013-1#2)
hearing was##3##2##(1995-6#1)(2008-4#1)(2011-2#1)
hearing##214##1##(1990-12#7)(1991-2#1)(1992-12#1)(1992-2#2)(1994-9#4)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#4)(1996-11#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#16)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#59)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-4#4)(2011-1#10)(2011-2#28)(2012-12#3)(2012-2#22)(2012-3#1)(2012-8#1)(2013-1#11)(2013-8#2)
hearing-impaired patients##9##2##(1995-1#4)(2008-2#5)
hearing-impaired##16##1##(1995-1#4)(2007-7#1)(2008-2#6)(2008-9#4)(2013-1#1)
hearings##5##1##(1991-3#1)(1995-12#3)(2012-2#1)
heart (group##2##2##(2007-8#2)
heart also##2##2##(1993-6#1)(2008-11#1)
heart and aorta##2##3##(1994-11#1)(2009-12#1)
heart and brain##6##3##(1990-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(2008-5#1)(2012-3#1)
heart and coronary arteries##2##4##(2008-7#1)(2010-10#1)
heart and kidney##4##3##(1990-11#1)(1997-3#2)(2009-11#1)
heart and liver##3##3##(1994-2#1)(1996-12#1)(2008-10#1)
heart and lung##2##3##(1997-2#1)(2010-8#1)
heart and respiratory##2##3##(2011-2#1)(2012-3#1)
heart and right kidney weights of##2##6##(2008-9#2)
heart and skeletal muscle##3##4##(1995-11#1)(2012-3#1)(2013-1#1)
heart and the##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
heart and##52##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
heart are##6##2##(1990-5#2)(1993-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
heart attack and stroke##2##4##(2008-3#1)(2011-2#1)
heart attack and##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
heart attack is##2##3##(2013-7#2)
heart attack patients##2##3##(2008-3#1)(2008-5#1)
heart attack symptoms##2##3##(2010-12#2)
heart attack##22##2##(1995-2#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#2)(2011-2#2)(2013-7#3)(2013-8#1)
heart attacks##4##2##(2008-11#1)(2008-3#1)(2013-7#2)
heart bc1 complex##2##3##(1990-5#2)
heart block in##2##3##(2008-10#1)(2010-6#1)
heart block##4##2##(1992-5#1)(2007-8#1)(2008-10#1)(2010-6#1)
heart cDNA##3##2##(1991-12#1)(1991-6#1)(1994-11#1)
heart catheterisation##2##2##(2010-10#2)
heart catheterization and##4##3##(1992-6#1)(2006-10#1)(2011-2#2)
heart catheterization##5##2##(1992-6#1)(2006-10#1)(2007-12#1)(2011-2#2)
heart chambers##2##2##(2008-4#1)(2013-1#1)
heart cytochrome c##3##3##(1995-2#2)(2008-7#1)
heart defect##3##2##(2007-8#1)(2012-12#2)
heart defects##4##2##(1997-8#2)(2010-10#1)(2012-2#1)
heart disease (CHD)##15##3##(1990-3#1)(1993-12#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-4#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)
heart disease (IHD)##5##3##(1995-12#1)(2008-3#2)(2012-3#2)
heart disease and cerebrovascular disease##2##5##(2008-10#1)(2008-8#1)
heart disease and one##2##4##(2008-5#1)(2008-7#1)
heart disease and the##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
heart disease and##29##3##(1991-11#1)(1992-9#1)(1993-12#3)(1993-2#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#1)(2013-8#1)
heart disease are##3##3##(2008-7#1)(2009-10#1)(2013-7#1)
heart disease in##20##3##(1990-3#1)(1990-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-8#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2011-2#3)(2012-2#1)(2013-8#1)
heart disease is the##4##4##(2008-4#1)(2009-2#1)(2010-12#1)(2011-2#1)
heart disease is##7##3##(1991-2#1)(1991-6#1)(1993-2#1)(2008-4#1)(2009-2#1)(2010-12#1)(2011-2#1)
heart disease or##5##3##(2007-12#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
heart disease patients##2##3##(2010-12#1)(2010-4#1)
heart disease risk##6##3##(1991-6#2)(2008-1#1)(2008-3#1)(2009-12#1)(2012-2#1)
heart disease was##3##3##(2007-8#1)(2008-4#1)(2008-5#1)
heart disease were##3##3##(2011-2#2)(2012-3#1)
heart disease with##3##3##(1990-8#1)(2008-12#1)(2010-11#1)
heart disease##265##2##(1990-11#1)(1990-3#7)(1990-6#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#5)(1991-8#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#4)(1994-11#1)(1994-3#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#2)(1996-9#7)(1997-1#1)(1997-2#1)(1997-8#5)(2006-10#2)(2007-10#3)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#8)(2008-11#6)(2008-12#12)(2008-3#16)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#6)(2009-10#7)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#5)(2010-4#2)(2010-6#6)(2010-8#3)(2010-9#4)(2011-2#20)(2012-2#9)(2012-3#10)(2013-1#2)(2013-7#2)(2013-8#14)
heart disease]##3##2##(1994-11#1)(1995-11#1)(2012-3#1)
heart diseases and##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
heart diseases are##3##3##(1990-2#1)(2013-1#2)
heart diseases in##3##3##(1990-3#1)(1995-12#1)(2012-2#1)
heart diseases##17##2##(1990-2#1)(1990-3#2)(1993-2#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#5)
heart electrical activity vector##2##4##(2010-8#2)
heart failure (CHF)##7##3##(1995-12#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
heart failure (HF)##7##3##(2008-3#1)(2008-4#1)(2011-2#2)(2012-3#2)(2013-8#1)
heart failure after a##2##4##(2007-8#1)(2008-7#1)
heart failure and are##2##4##(2008-3#1)(2010-8#1)
heart failure and##16##3##(1990-3#1)(1990-9#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#2)
heart failure are##2##3##(1990-3#1)(2008-7#1)
heart failure but##2##3##(2008-3#2)
heart failure due to##2##4##(1995-3#1)(2011-2#1)
heart failure has##2##3##(1996-6#1)(2007-8#1)
heart failure in an##2##4##(2008-3#1)(2012-3#1)
heart failure in the##3##4##(1994-6#1)(2009-10#1)(2010-8#1)
heart failure in##9##3##(1994-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#3)(2012-3#1)
heart failure is##6##3##(1991-3#1)(2007-8#1)(2008-3#1)(2010-3#2)(2010-8#1)
heart failure or##5##3##(1997-5#1)(2008-7#1)(2008-8#1)(2012-3#2)
heart failure patients##4##3##(1995-3#1)(2008-7#1)(2012-2#2)
heart failure symptoms##2##3##(2007-8#2)
heart failure to##2##3##(2010-5#1)(2011-2#1)
heart failure was##4##3##(1991-3#1)(1992-6#1)(2007-8#1)(2008-7#1)
heart failure who##2##3##(2008-3#1)(2010-6#1)
heart failure with##7##3##(2008-3#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
heart failure##235##2##(1990-2#1)(1990-3#4)(1990-9#4)(1991-3#4)(1991-6#1)(1992-6#5)(1992-8#1)(1993-2#1)(1993-5#1)(1994-6#1)(1994-7#3)(1995-12#1)(1995-3#5)(1996-6#2)(1996-8#1)(1996-9#3)(1997-5#1)(1997-8#1)(2007-8#8)(2008-1#5)(2008-10#4)(2008-11#6)(2008-3#38)(2008-4#1)(2008-5#3)(2008-7#29)(2008-8#4)(2009-10#10)(2009-12#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#9)(2010-8#12)(2011-1#2)(2011-2#22)(2012-12#2)(2012-2#6)(2012-3#14)(2013-1#3)(2013-8#4)
heart failure]##11##2##(1990-3#1)(1991-3#1)(1992-6#1)(1992-9#1)(1994-7#1)(1996-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
heart from vertebrate ectotherms##3##4##(1993-11#3)
heart fructose##2##2##(1995-2#2)
heart function in##2##3##(2010-12#1)(2013-1#1)
heart function##7##2##(1995-12#1)(2010-12#1)(2010-6#1)(2013-1#4)
heart in a##2##3##(2007-8#2)
heart in the##5##3##(1993-12#2)(2010-6#2)(2013-1#1)
heart in##10##2##(1992-2#1)(1993-12#2)(2007-8#2)(2010-6#2)(2011-2#1)(2013-1#2)
heart infarction##2##2##(1994-11#2)
heart infusion agar##3##3##(1991-8#1)(2008-10#1)(2008-12#1)
heart infusion##4##2##(1991-8#1)(1993-12#1)(2008-10#1)(2008-12#1)
heart injury##2##2##(2007-8#2)
heart is a##2##3##(2007-8#1)(2008-12#1)
heart is##9##2##(1990-3#1)(1991-3#1)(1994-11#1)(1995-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)
heart meridian##3##2##(2008-9#3)
heart mitochondria##5##2##(1994-5#2)(1994-6#1)(2008-1#1)(2008-8#1)
heart mitochondrial##3##2##(1990-7#1)(1994-5#1)(2008-11#1)
heart model and the##2##4##(1991-9#1)(2011-1#1)
heart model##4##2##(1991-9#2)(1995-3#1)(2011-1#1)
heart monitoring##2##2##(2010-8#2)
heart muscle##5##2##(1990-2#1)(1992-9#1)(1995-12#1)(2008-5#1)(2010-12#1)
heart myoglobin##3##2##(1990-8#2)(1995-2#1)
heart of the##10##3##(1993-11#1)(1994-3#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-3#1)(2013-1#1)
heart of##24##2##(1993-11#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
heart off-pump cardiac repair##2##4##(2007-8#2)
heart operations##2##2##(2007-8#2)
heart or##4##2##(1992-9#1)(1993-1#1)(1995-2#1)(1997-5#1)
heart positioners##2##2##(2010-8#2)
heart problems##3##2##(2007-8#1)(2010-5#1)(2013-7#1)
heart rate (HR) and##2##4##(1992-12#1)(2013-8#1)
heart rate (HR)##14##3##(1990-5#1)(1991-2#1)(1992-12#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#3)
heart rate and##14##3##(1990-9#1)(1993-12#1)(1993-2#2)(1995-12#1)(2007-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
heart rate changes##2##3##(2008-6#1)(2008-7#1)
heart rate in##3##3##(1990-5#1)(1991-2#1)(2008-3#1)
heart rate of##2##3##(1995-12#1)(2010-6#1)
heart rate response##2##3##(2008-5#1)(2008-7#1)
heart rate variability (HRV) in##2##5##(2008-12#1)(2008-6#1)
heart rate variability (HRV)##5##4##(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
heart rate variability and##4##4##(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)
heart rate variability##11##3##(2008-12#3)(2008-6#1)(2008-7#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
heart rate variations##2##3##(2008-7#1)(2012-12#1)
heart rate was##5##3##(1995-12#2)(2008-6#1)(2008-7#1)(2012-1#1)
heart rate were observed##2##4##(2008-5#1)(2012-1#1)
heart rate were##5##3##(1993-10#1)(1994-5#1)(2008-5#1)(2011-2#1)(2012-1#1)
heart rate##105##2##(1990-10#1)(1990-5#2)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#2)(1991-6#2)(1992-12#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#3)(1994-3#2)(1994-5#2)(1995-12#7)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#4)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#5)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#7)
heart rate)##2##2##(1991-8#1)(2008-3#1)
heart rates##4##2##(1991-12#1)(2008-8#1)(2011-2#2)
heart rhythm##2##2##(2008-8#1)(2012-3#1)
heart surgery in##3##3##(1997-8#1)(2013-1#2)
heart surgery##19##2##(1990-2#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#3)(2007-9#2)(2013-1#6)
heart surgery]##3##2##(1990-2#1)(1992-3#1)(2013-1#1)
heart syndrome##3##2##(2007-8#1)(2010-6#1)(2013-1#1)
heart tissue##4##2##(1990-12#1)(1994-5#1)(2008-7#1)(2012-3#1)
heart to##4##2##(1994-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
heart transplant##6##2##(1995-8#1)(1995-9#1)(2007-2#1)(2008-10#2)(2011-2#1)
heart transplantation##5##2##(1994-7#1)(1996-11#1)(2010-8#1)(2011-2#2)
heart valve surgery##3##3##(1993-12#1)(2007-8#2)
heart valve##9##2##(1990-12#2)(1991-2#1)(1993-12#1)(2007-8#2)(2008-8#1)(2010-12#1)(2011-2#1)
heart valves##11##2##(1991-3#1)(1995-11#1)(2006-6#1)(2008-3#2)(2008-8#2)(2009-11#1)(2010-12#2)(2010-6#1)
heart via##2##2##(1997-1#1)(2007-8#1)
heart was##5##2##(1993-12#1)(2009-11#1)(2013-1#3)
heart weight##2##2##(2008-9#1)(2010-12#1)
heart weights##2##2##(2008-5#1)(2008-9#1)
heart with##4##2##(1991-3#1)(2008-7#1)(2009-1#1)(2012-1#1)
heart##1268##1##(1990-10#2)(1990-11#11)(1990-12#6)(1990-2#7)(1990-3#18)(1990-5#14)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#8)(1991-11#4)(1991-12#6)(1991-2#6)(1991-3#12)(1991-5#1)(1991-6#11)(1991-8#4)(1991-9#7)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#4)(1992-6#12)(1992-8#1)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#8)(1993-12#14)(1993-2#11)(1993-3#2)(1993-5#3)(1993-6#4)(1994-11#13)(1994-12#2)(1994-2#4)(1994-3#8)(1994-5#12)(1994-6#2)(1994-7#5)(1994-9#1)(1995-11#9)(1995-12#14)(1995-2#9)(1995-3#10)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#9)(1996-6#6)(1996-8#3)(1996-9#22)(1997-1#3)(1997-2#4)(1997-3#4)(1997-5#2)(1997-7#2)(1997-8#12)(2006-10#4)(2006-6#1)(2007-10#7)(2007-11#1)(2007-12#7)(2007-2#6)(2007-4#1)(2007-7#6)(2007-8#63)(2007-9#3)(2008-1#16)(2008-10#32)(2008-11#22)(2008-12#22)(2008-2#1)(2008-3#74)(2008-4#6)(2008-5#34)(2008-6#9)(2008-7#82)(2008-8#28)(2008-9#12)(2009-1#1)(2009-10#17)(2009-11#4)(2009-12#12)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#9)(2010-11#6)(2010-12#25)(2010-3#6)(2010-4#4)(2010-5#9)(2010-6#23)(2010-7#3)(2010-8#42)(2010-9#6)(2011-1#13)(2011-2#71)(2011-3#1)(2012-1#6)(2012-12#9)(2012-2#28)(2012-3#38)(2013-1#56)(2013-7#10)(2013-8#28)
heart-lung transplantation##4##2##(1992-6#2)(1994-3#1)(2010-10#1)
heart-lung transplantations##2##2##(1997-5#1)(2011-3#1)
heart-lung##7##1##(1990-2#1)(1992-6#2)(1994-3#1)(1997-5#1)(2010-10#1)(2011-3#1)
heart-shaped##3##1##(1991-11#1)(2010-3#1)(2012-12#1)
heart-specific##2##1##(2008-7#2)
heart/lung##2##1##(2008-5#1)(2010-10#1)
heart?##3##1##(2007-2#1)(2013-1#1)(2013-7#1)
heart]##2##1##(1990-5#1)(2012-3#1)
heartbeat dynamics and hemodynamics##2##4##(2009-9#1)(2010-5#1)
heartbeat##8##1##(2008-5#1)(2009-9#2)(2010-5#2)(2010-8#2)(2011-2#1)
heartburn##5##1##(1994-6#1)(2011-2#1)(2013-1#3)
heartjnl##3##1##(2008-7#3)
hearts and##2##2##(1991-3#1)(2010-6#1)
hearts from##3##2##(1993-11#1)(2008-10#1)(2010-12#1)
hearts of vitamin E##2##4##(1994-5#2)
hearts of##6##2##(1994-5#3)(1995-12#1)(2013-7#2)
hearts were subjected to##2##4##(1996-9#1)(2007-8#1)
hearts were##4##2##(1994-12#1)(1996-9#1)(2007-8#1)(2010-7#1)
hearts##70##1##(1990-7#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-6#3)(1994-12#2)(1994-5#7)(1995-12#2)(1995-3#3)(1996-9#9)(1997-6#3)(2007-2#1)(2007-8#5)(2008-10#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-12#1)(2013-7#8)
heartwater##7##1##(1996-12#1)(2010-1#6)
heartwood extract of##2##3##(2008-5#2)
heartwood extract##3##2##(2008-5#3)
heartwood##4##1##(2008-10#1)(2008-5#3)
heat and acid##3##3##(1994-11#2)(1996-2#1)
heat and humidity at the airway##2##6##(1992-2#2)
heat and moisture exchangers##2##4##(1992-2#2)
heat and moisture##3##3##(1992-2#2)(2008-2#1)
heat and pressure##2##3##(1997-7#1)(2008-11#1)
heat and water##2##3##(1996-12#1)(2013-1#1)
heat and##25##2##(1992-2#4)(1994-11#2)(1996-12#3)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#3)
heat are##2##2##(2007-11#1)(2011-2#1)
heat balance##2##2##(2008-3#1)(2008-5#1)
heat capacities of##4##3##(1997-2#4)
heat capacity change##2##3##(1992-5#1)(1997-2#1)
heat capacity changes##4##3##(1994-3#1)(1997-2#3)
heat capacity of the##2##4##(1997-2#1)(2008-3#1)
heat capacity of##4##3##(1997-2#2)(2008-3#2)
heat capacity##15##2##(1992-5#1)(1993-8#1)(1994-3#1)(1995-5#1)(1997-2#7)(2008-3#3)(2013-1#1)
heat conduction##2##2##(2008-2#1)(2008-3#1)
heat conservation##2##2##(1992-2#2)
heat curing##2##2##(2008-10#2)
heat damage##3##2##(2008-10#3)
heat denaturation##2##2##(2008-11#1)(2008-7#1)
heat dissipation##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
heat exchangers##2##2##(1993-12#2)
heat flow##6##2##(1996-4#1)(2008-11#1)(2008-3#4)
heat flux##6##2##(2008-11#5)(2009-11#1)
heat fluxes##2##2##(2008-11#1)(2011-1#1)
heat generation in##2##3##(2008-2#1)(2009-8#1)
heat hyperalgesia##3##2##(1996-5#1)(2008-4#1)(2008-7#1)
heat in##2##2##(2008-7#1)(2013-1#1)
heat inactivation##6##2##(1990-12#1)(1994-11#2)(1995-6#2)(1995-8#1)
heat injury##2##2##(1994-5#2)
heat is##5##2##(1996-12#1)(2009-7#1)(2011-1#2)(2011-2#1)
heat labile##2##2##(1992-6#1)(1995-5#1)
heat loss from the airway##2##5##(1992-2#2)
heat loss from the##3##4##(1992-2#2)(1993-12#1)
heat loss from##5##3##(1992-2#2)(1993-12#2)(2008-3#1)
heat loss##8##2##(1992-2#3)(1992-3#1)(1993-12#2)(2008-3#1)(2008-5#1)
heat of solvation##3##3##(2008-10#3)
heat of##9##2##(1990-8#1)(2008-10#4)(2008-11#1)(2010-4#3)
heat on the##2##3##(1990-12#1)(2008-3#1)
heat on##4##2##(1990-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
heat or##2##2##(2008-10#1)(2008-2#1)
heat production in##2##3##(2009-8#2)
heat production##4##2##(2008-3#1)(2009-8#3)
heat pump##4##2##(2008-10#1)(2011-2#3)
heat removal in##2##3##(2007-12#1)(2008-2#1)
heat removal##3##2##(2007-12#2)(2008-2#1)
heat resistance##4##2##(1994-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
heat resistant and##2##3##(2008-10#1)(2010-3#1)
heat resistant##7##2##(2008-10#2)(2010-3#2)(2011-2#3)
heat sensitivity##2##2##(1990-12#2)
heat shock (HS)##2##3##(1991-9#1)(1994-11#1)
heat shock and##3##3##(1994-11#1)(1997-4#1)(2012-3#1)
heat shock cognate protein##2##4##(1994-11#1)(1995-2#1)
heat shock element##2##3##(1993-8#2)
heat shock factor 1##3##4##(1994-8#3)
heat shock factor##6##3##(1990-11#1)(1994-8#4)(2010-2#1)
heat shock gene##4##3##(1994-8#3)(1995-2#1)
heat shock genes##3##3##(1990-11#1)(1994-8#2)
heat shock in##3##3##(1991-9#1)(1994-8#1)(2008-7#1)
heat shock promoter##2##3##(1990-11#1)(1996-12#1)
heat shock protein 60##2##4##(2008-4#1)(2008-7#1)
heat shock protein 70 (hsp70)##3##5##(1993-11#1)(1994-11#1)(1995-2#1)
heat shock protein 70##10##4##(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2010-12#1)(2012-1#1)(2013-8#1)
heat shock protein 90##2##4##(2012-1#1)(2012-12#1)
heat shock protein hsp90##2##4##(1990-11#1)(1996-12#1)
heat shock protein of##4##4##(1995-6#1)(1996-12#3)
heat shock protein with a molecular weight of 90 kDa##3##10##(2012-1#3)
heat shock protein##48##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-12#1)(1993-11#1)(1993-8#1)(1994-11#4)(1994-8#4)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#4)(1996-9#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#4)(2010-12#1)(2010-2#1)(2012-1#5)(2012-12#1)(2013-1#2)(2013-8#1)
heat shock proteins (HSPs)##2##4##(1991-9#1)(2008-7#1)
heat shock proteins##18##3##(1990-11#1)(1991-9#1)(1993-8#2)(1994-11#7)(1996-9#1)(1997-4#1)(2008-7#2)(2009-5#2)(2012-12#1)
heat shock response is##3##4##(1994-11#1)(1994-8#2)
heat shock response of##2##4##(2008-7#2)
heat shock response##14##3##(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#3)(2008-5#1)(2008-7#3)(2010-2#2)
heat shock transcription factor##6##4##(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(2012-12#1)
heat shock##149##2##(1990-11#6)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#3)(1992-12#2)(1993-11#1)(1993-8#8)(1994-11#24)(1994-6#1)(1994-8#20)(1995-11#4)(1995-2#4)(1995-5#1)(1995-6#2)(1996-12#7)(1996-9#2)(1997-2#1)(1997-4#4)(1997-7#3)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#20)(2009-5#2)(2010-12#1)(2010-2#4)(2012-1#5)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
heat shocked cultures##2##3##(1995-12#2)
heat shocked##4##2##(1995-12#3)(2008-5#1)
heat source##4##2##(1996-5#1)(2007-12#1)(2008-3#2)
heat stability and##2##3##(1990-10#1)(2011-2#1)
heat stability##4##2##(1990-10#1)(1997-4#2)(2011-2#1)
heat stable##8##2##(1992-8#1)(1992-9#1)(1993-6#2)(1997-8#1)(2008-10#2)(2008-11#1)
heat stress in##3##3##(2008-5#1)(2012-2#2)
heat stress##29##2##(1991-12#2)(1991-9#1)(1994-11#2)(1995-5#3)(2008-11#1)(2008-12#6)(2008-5#5)(2008-7#2)(2010-7#1)(2012-2#6)
heat the##2##2##(1997-4#1)(2008-10#1)
heat tolerance of##3##3##(2010-4#3)
heat tolerance##4##2##(2008-10#1)(2010-4#3)
heat transfer of a##2##4##(2008-10#1)(2013-1#1)
heat transfer##10##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
heat treated at##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
heat treated serum##2##3##(1990-12#1)(1993-6#1)
heat treated##5##2##(1990-12#1)(1993-6#1)(2008-2#1)(2008-3#1)(2013-1#1)
heat treatment and##2##3##(2008-10#2)
heat treatment at##2##3##(2010-4#1)(2012-2#1)
heat treatment compared##2##3##(2008-2#1)(2012-2#1)
heat treatment of##3##3##(1992-8#1)(2007-12#1)(2008-10#1)
heat treatment on the##2##4##(2011-2#1)(2012-2#1)
heat treatment on##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
heat treatment##33##2##(1990-11#1)(1992-8#1)(1993-11#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#3)(2010-4#1)(2011-2#3)(2012-2#4)(2013-8#2)
heat treatments##5##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
heat wave lasted for##2##4##(2011-1#2)
heat wave lasted##3##3##(2011-1#3)
heat wave##12##2##(1995-6#2)(2011-1#10)
heat waves##3##2##(2011-1#3)
heat##531##1##(1990-10#1)(1990-11#7)(1990-12#7)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#9)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#4)(1993-6#3)(1993-8#10)(1994-11#30)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#21)(1995-11#4)(1995-12#5)(1995-2#4)(1995-5#6)(1995-6#8)(1995-8#1)(1996-12#19)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#12)(1997-3#1)(1997-4#8)(1997-7#4)(1997-8#1)(2007-11#4)(2007-12#9)(2008-1#2)(2008-10#52)(2008-11#19)(2008-12#8)(2008-2#17)(2008-3#28)(2008-4#4)(2008-5#13)(2008-6#1)(2008-7#31)(2008-8#2)(2008-9#3)(2009-11#2)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#9)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#18)(2011-2#24)(2012-1#6)(2012-12#4)(2012-2#13)(2012-3#2)(2013-1#10)(2013-8#10)
heat- and##3##2##(1992-9#1)(1996-2#1)(2008-7#1)
heat-##5##1##(1992-9#2)(1996-2#1)(2008-10#1)(2008-7#1)
heat-drawn and##2##2##(2008-3#2)
heat-evoked##3##1##(1992-3#2)(1996-5#1)
heat-flow##2##1##(2008-2#1)(2008-3#1)
heat-hyperalgesia##3##1##(2008-9#3)
heat-inactivated##6##1##(1990-12#1)(1991-8#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-5#1)
heat-induced##7##1##(1994-11#2)(1995-6#3)(2008-2#1)(2008-3#1)
heat-inducible##3##1##(1993-9#1)(1994-12#1)(1995-6#1)
heat-killed##5##1##(1997-6#1)(2008-10#2)(2011-1#2)
heat-labile toxin##2##2##(1995-2#2)
heat-labile##7##1##(1990-11#2)(1991-2#1)(1993-3#1)(1995-2#3)
heat-related illness and death##3##4##(1995-6#3)
heat-shock and##2##2##(1993-6#1)(1997-7#1)
heat-shock protein 70##3##3##(1993-9#1)(2010-5#1)(2012-3#1)
heat-shock protein hsp40##2##3##(1993-11#2)
heat-shock protein##14##2##(1990-5#1)(1993-11#3)(1993-6#3)(1993-9#2)(1994-12#2)(2010-5#2)(2012-3#1)
heat-shock proteins##3##2##(1992-5#1)(2008-10#1)(2008-7#1)
heat-shock##28##1##(1990-5#1)(1991-9#1)(1992-5#1)(1993-11#3)(1993-6#5)(1993-9#2)(1994-11#1)(1994-12#2)(1995-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#2)(2010-4#1)(2010-5#2)(2012-3#1)
heat-shocked samples##2##2##(2008-7#2)
heat-stable and##2##2##(2008-10#1)(2008-11#1)
heat-stable growth factor##2##3##(2008-8#2)
heat-stable##7##1##(1990-7#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-8#2)
heat-stress##2##1##(1994-11#1)(2008-10#1)
heat-transfer##3##1##(2008-11#1)(2008-2#1)(2008-3#1)
heat-treated Bp##2##2##(2008-11#2)
heat-treated human bone##2##3##(1995-6#2)
heat-treated##15##1##(1995-6#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2010-4#1)
heated and##3##2##(1990-12#2)(1995-6#1)
heated at##12##2##(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-7#1)(2010-4#2)(2013-1#1)
heated graphite atomizer##5##3##(2008-10#5)
heated graphite##8##2##(2008-10#8)
heated in a##3##3##(2008-10#2)(2008-3#1)
heated metal##6##2##(1992-8#1)(2007-11#2)(2007-12#3)
heated region##2##2##(2007-12#2)
heated to 110 degrees C for##2##6##(2008-10#1)(2010-2#1)
heated to##6##2##(1991-7#1)(2008-10#3)(2010-2#2)
heated up to##2##3##(1990-3#1)(2008-10#1)
heated##83##1##(1990-12#4)(1990-2#1)(1990-3#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#2)(1995-2#1)(1995-6#2)(2007-11#4)(2007-12#7)(2008-10#30)(2008-11#1)(2008-2#7)(2008-3#5)(2008-7#1)(2010-2#2)(2010-4#2)(2010-9#3)(2011-2#4)(2013-1#2)
heated-wire breathing circuits and heated humidifiers##2##6##(2010-9#2)
heater##3##1##(2008-10#2)(2008-2#1)
heaters##3##1##(2008-3#3)
heath##4##1##(2007-8#1)(2008-1#2)(2008-10#1)
heating and cooling##6##3##(1990-7#1)(2007-11#1)(2008-10#3)(2008-3#1)
heating and##18##2##(1990-7#1)(1990-9#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#3)(2010-5#1)
heating at 80 degrees C for##2##6##(2008-10#2)
heating at 80 degrees C##3##5##(2008-10#3)
heating at##11##2##(1993-3#1)(1994-8#1)(2008-10#6)(2008-2#1)(2011-2#2)
heating conditions##3##2##(2008-10#2)(2013-8#1)
heating cycles##6##2##(2008-10#6)
heating for the##2##3##(2008-10#2)
heating for##3##2##(2008-10#3)
heating in H(2)##2##3##(2010-4#2)
heating in a##3##3##(1990-2#1)(2007-11#1)(2008-10#1)
heating in the focus of an optical trap##2##8##(2008-3#2)
heating in the##3##3##(2008-10#1)(2008-3#2)
heating in##10##2##(1990-2#1)(1990-5#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-4#2)
heating is##2##2##(2008-3#1)(2009-8#1)
heating of the sample##2##4##(2008-3#2)
heating of the##9##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-10#1)
heating of##12##2##(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)
heating or##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
heating program##4##2##(2008-10#4)
heating rates##2##2##(2008-10#1)(2008-3#1)
heating temperature##4##2##(2008-2#1)(2009-11#1)(2013-1#2)
heating the##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
heating time##4##2##(2008-10#2)(2008-2#1)(2013-1#1)
heating times##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
heating to##8##2##(1991-5#1)(2007-12#1)(2008-10#6)
heating up##2##2##(2007-12#1)(2008-2#1)
heating was##4##2##(1990-3#1)(2008-10#3)
heating with a##2##3##(2008-10#1)(2008-2#1)
heating with##4##2##(2008-10#2)(2008-2#2)
heating##190##1##(1990-2#6)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(2007-10#4)(2007-11#3)(2007-12#8)(2008-10#82)(2008-11#2)(2008-2#14)(2008-3#19)(2008-5#3)(2008-8#1)(2008-9#2)(2009-11#2)(2009-8#2)(2010-10#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#4)(2013-8#3)
heating-induced##2##1##(2007-10#1)(2010-4#1)
heats of formation##2##3##(2007-11#1)(2008-11#1)
heats of##4##2##(1996-2#1)(2007-11#1)(2008-11#1)(2010-4#1)
heats up##2##2##(1995-3#1)(1996-2#1)
heats##8##1##(1990-8#1)(1995-3#1)(1996-2#2)(2007-11#1)(2008-11#1)(2008-2#1)(2010-4#1)
heatstroke##6##1##(1995-12#6)
heavier and##2##2##(2009-9#1)(2011-2#1)
heavier than##5##2##(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)
heavier##24##1##(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
heavily O-glycosylated##2##2##(1992-12#1)(1994-5#1)
heavily affected##2##2##(1990-3#1)(2008-4#1)
heavily coated with##2##3##(1994-3#2)
heavily contaminated##2##2##(2008-10#2)
heavily dependent upon##2##3##(2008-7#1)(2010-8#1)
heavily dependent##4##2##(2008-10#1)(2008-7#1)(2009-7#1)(2010-8#1)
heavily infected needles##2##3##(2008-10#2)
heavily infected##4##2##(2008-10#4)
heavily infested##3##2##(1996-12#2)(2008-10#1)
heavily involved in##2##3##(1996-12#1)(2008-7#1)
heavily labelled##2##2##(1992-8#1)(1995-12#1)
heavily on the##2##3##(1995-11#1)(2012-12#1)
heavily on##16##2##(1993-3#1)(1995-1#1)(1995-11#1)(1996-1#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
heavily pretreated##3##2##(1992-2#3)
heavily regulated##3##2##(1991-3#1)(2008-11#1)(2008-12#1)
heavily used##2##2##(2008-3#2)
heavily##83##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
heavy and light chain##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
heavy and light chains of factor Va##2##7##(1994-5#2)
heavy and light chains##4##4##(1994-11#1)(1994-5#2)(2011-2#1)
heavy and light##8##3##(1994-11#1)(1994-5#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)
heavy and##13##2##(1994-11#1)(1994-2#1)(1994-5#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
heavy atom derivatives##2##3##(1992-4#1)(2008-9#1)
heavy atom induced##2##3##(2008-10#2)
heavy atom##13##2##(1992-4#2)(1992-8#1)(2008-10#7)(2008-9#3)
heavy atom-induced room temperature##2##4##(2008-10#2)
heavy care##2##2##(1991-2#1)(1993-3#1)
heavy chain (MHC)##2##3##(1991-9#1)(2008-5#1)
heavy chain contact##2##3##(1997-9#2)
heavy chain expression##3##3##(1997-9#2)(2008-5#1)
heavy chain gene expression##5##4##(1992-3#4)(1997-6#1)
heavy chain gene##16##3##(1991-2#2)(1991-9#3)(1992-11#1)(1992-3#5)(1994-9#1)(1995-2#1)(1997-6#1)(2008-11#2)
heavy chain of the##3##4##(1994-5#2)(2008-9#1)
heavy chain of##7##3##(1990-5#1)(1991-9#1)(1994-5#2)(1995-2#1)(2008-4#1)(2008-9#1)
heavy chain variable region##2##4##(2008-8#1)(2012-2#1)
heavy chain##67##2##(1990-5#4)(1991-2#2)(1991-9#8)(1992-11#2)(1992-3#7)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-9#1)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#1)(1996-9#1)(1997-6#4)(1997-9#5)(2008-11#4)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#2)
heavy chains of##3##3##(1990-5#1)(1993-9#1)(2012-2#1)
heavy chains that##2##3##(1993-9#1)(1997-9#1)
heavy chains##14##2##(1990-5#1)(1992-12#1)(1993-8#1)(1993-9#3)(1994-8#1)(1997-9#4)(2008-11#1)(2008-5#1)(2012-2#1)
heavy ewes##2##2##(2008-9#2)
heavy fermion##2##2##(2012-2#2)
heavy fuel##2##2##(2008-10#2)
heavy isotope##3##2##(2008-4#1)(2012-3#2)
heavy lanthanide##3##2##(2008-10#3)
heavy metal cations##2##3##(1995-3#1)(2008-10#1)
heavy metal concentration and##2##4##(2013-8#2)
heavy metal concentration##3##3##(2008-10#1)(2013-8#2)
heavy metal contaminants##2##3##(2008-10#2)
heavy metal contents##2##3##(1997-4#1)(2008-10#1)
heavy metal ions and##4##4##(2008-10#4)
heavy metal ions in##3##4##(2008-10#2)(2010-2#1)
heavy metal ions was##3##4##(2008-10#3)
heavy metal ions##46##3##(1994-6#1)(2008-10#42)(2008-11#1)(2008-4#1)(2010-2#1)
heavy metal pollution in##2##4##(2008-10#1)(2010-11#1)
heavy metal removal##3##3##(2008-10#2)(2008-7#1)
heavy metal##85##2##(1993-12#1)(1994-11#1)(1994-6#1)(1995-3#1)(1997-4#3)(2008-10#56)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-12#2)(2010-11#1)(2010-2#1)(2013-1#4)(2013-8#4)
heavy metals and##3##3##(1994-6#1)(1995-3#1)(2008-10#1)
heavy metals are##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
heavy metals by##3##3##(1995-3#1)(2008-10#2)
heavy metals have been##2##4##(1997-4#1)(2008-5#1)
heavy metals in contaminated##2##4##(2008-10#2)
heavy metals in sediments##2##4##(2008-10#2)
heavy metals in the environment##2##5##(2008-10#1)(2011-2#1)
heavy metals in the##4##4##(1995-3#1)(2008-10#2)(2011-2#1)
heavy metals in##25##3##(1995-3#1)(2008-10#15)(2008-11#2)(2008-12#4)(2010-11#1)(2011-2#1)(2013-8#1)
heavy metals on##3##3##(2008-10#2)(2008-5#1)
heavy metals was##2##3##(2008-10#2)
heavy metals##96##2##(1994-3#1)(1994-6#1)(1995-3#6)(1997-4#2)(2008-10#51)(2008-11#4)(2008-12#8)(2008-5#4)(2008-6#2)(2008-7#1)(2009-12#2)(2010-11#3)(2010-4#1)(2011-2#4)(2013-1#3)(2013-8#3)
heavy or##2##2##(2008-4#1)(2012-12#1)
heavy proteinuria##3##2##(1993-12#1)(2007-7#1)(2008-1#1)
heavy smokers##2##2##(1993-2#1)(1994-6#1)
heavy stillage##2##2##(2011-2#2)
heavy traffic##2##2##(1995-1#1)(2008-10#1)
heavy users of##2##3##(1996-1#1)(1997-1#1)
heavy##390##1##(1990-5#5)(1991-12#1)(1991-2#3)(1991-9#8)(1992-11#2)(1992-12#1)(1992-3#9)(1992-4#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#9)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-1#2)(1997-4#6)(1997-6#5)(1997-7#1)(1997-9#9)(2007-10#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#138)(2008-11#12)(2008-12#12)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#4)(2009-9#1)(2010-11#4)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#11)(2013-8#9)
heavy-chain gene fragment##2##3##(1997-2#2)
heavy-chain gene##4##2##(1997-2#2)(2008-9#1)(2009-8#1)
heavy-chain joining##2##2##(1991-6#2)
heavy-chain##13##1##(1991-2#1)(1991-6#2)(1994-5#1)(1994-8#1)(1995-2#3)(1995-6#1)(1997-2#2)(2008-9#1)(2009-8#1)
heavy-duty##2##1##(1997-6#1)(2008-12#1)
hebraeum##3##1##(1996-12#3)
hederae##3##1##(2008-10#3)
hedgehog (hh)##2##2##(1993-12#1)(1993-2#1)
hedgehog##19##1##(1993-12#9)(1993-2#2)(1994-12#6)(1996-12#1)(2013-1#1)
hedonic scale##2##2##(1995-2#1)(2012-2#1)
hedonic##7##1##(1991-1#1)(1995-2#1)(2008-9#4)(2012-2#1)
heel lifts##3##2##(2010-3#3)
heel of##2##2##(2008-5#1)(2008-8#1)
heel pain##2##2##(2010-3#2)
heel##16##1##(1990-5#3)(1992-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#8)(2012-3#1)
heels##2##1##(2009-9#1)(2010-9#1)
hegemonic masculinity in##2##3##(2009-5#2)
hegemonic masculinity##4##2##(2009-5#4)
hegemonic##8##1##(2008-10#1)(2009-5#7)
heifers did not show a preference##2##6##(2010-2#2)
heifers were##2##2##(1996-12#1)(2010-2#1)
heifers##17##1##(1996-12#3)(2010-2#11)(2010-4#3)
height SDS##3##2##(2011-1#3)
height and head##2##3##(2008-5#1)(2011-1#1)
height and stem##2##3##(2008-10#1)(2013-7#1)
height and the##9##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#2)
height and weight##5##3##(1991-6#1)(1997-8#1)(2008-11#1)(2012-12#1)(2013-7#1)
height and##53##2##(1991-6#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
height as##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
height at##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
height by the##2##3##(2008-10#1)(2008-3#1)
height by##4##2##(2008-10#3)(2008-3#1)
height changes##3##2##(2010-3#2)(2011-2#1)
height decreased##2##2##(1993-8#1)(2008-11#1)
height differences##2##2##(2008-3#1)(2008-8#1)
height equivalent to##2##3##(2008-10#2)
height factor##2##2##(2007-8#2)
height for##6##2##(1991-12#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-1#1)
height from##2##2##(2007-11#1)(2013-1#1)
height in the##2##3##(2008-10#1)(2013-1#1)
height in##7##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#2)(2013-8#1)
height is proportional to##2##4##(2008-10#2)
height is##7##2##(1996-8#1)(2007-12#1)(2008-10#4)(2008-3#1)
height loss##4##2##(2011-2#4)
height measurement##3##2##(2007-11#1)(2008-3#2)
height measurements##2##2##(2007-11#1)(2008-3#1)
height mode##2##2##(2007-12#1)(2008-10#1)
height of 4##2##3##(2008-3#1)(2009-1#1)
height of occipital##2##3##(2013-1#2)
height of the##10##3##(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#3)(2011-2#1)(2012-2#1)
height of##43##2##(1995-1#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#1)(2009-1#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
height on the##2##3##(2008-10#1)(2011-2#1)
height or##4##2##(2007-11#1)(2007-12#1)(2008-9#1)(2013-8#1)
height patterns##2##2##(2011-2#2)
height relative##2##2##(2008-10#2)
height resolution of##2##3##(2008-3#2)
height resolution##3##2##(2008-3#3)
height structure##2##2##(2008-8#2)
height to##2##2##(2008-10#1)(2013-1#1)
height values##3##2##(2008-10#2)(2011-2#1)
height was##10##2##(1995-1#1)(2008-10#4)(2008-12#2)(2009-1#1)(2009-3#1)(2012-2#1)
height were recorded##2##3##(2008-11#1)(2013-1#1)
height were##6##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
height##351##1##(1991-12#2)(1991-6#1)(1993-10#2)(1993-2#1)(1993-8#2)(1995-1#5)(1995-2#4)(1995-3#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2007-11#10)(2007-12#7)(2007-8#4)(2008-1#1)(2008-10#104)(2008-11#6)(2008-12#9)(2008-2#20)(2008-3#33)(2008-4#1)(2008-5#5)(2008-6#9)(2008-7#7)(2008-8#6)(2008-9#6)(2009-1#6)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#4)(2010-3#5)(2011-1#9)(2011-2#22)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#20)(2013-7#8)(2013-8#5)
height) and##4##2##(2007-11#1)(2008-10#2)(2011-2#1)
height) were##2##2##(2008-12#1)(2013-1#1)
height)##8##1##(2007-11#1)(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
height-dependent terms##3##2##(2008-3#3)
height-dependent##4##1##(2008-3#4)
heighten the##3##2##(1995-3#1)(1997-4#1)(2009-11#1)
heighten##6##1##(1992-12#1)(1995-3#1)(1997-4#1)(2008-7#1)(2009-11#1)(2010-9#1)
heightened risk of##4##3##(2007-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
heightened risk##5##2##(2007-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
heightened sensitivity to##2##3##(1995-12#1)(2009-9#1)
heightened sensitivity##3##2##(1995-12#1)(2009-9#2)
heightened##25##1##(1991-3#1)(1994-2#2)(1995-12#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
heights and##3##2##(2008-10#1)(2010-4#1)(2013-7#1)
heights in##3##2##(2008-10#1)(2008-2#2)
heights of##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
heights to##2##2##(2008-2#1)(2008-6#1)
heights with##2##2##(2008-10#2)
heights##42##1##(1993-2#1)(2007-12#1)(2008-10#21)(2008-2#6)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
heilgymnasts##2##1##(2008-12#2)
held a##4##2##(2007-12#1)(2008-6#1)(2008-7#1)(2010-11#1)
held among##2##2##(2012-3#1)(2013-1#1)
held and##2##2##(1995-1#1)(2012-3#1)
held as##2##2##(2008-1#1)(2008-5#1)
held at the Institute##2##4##(2008-7#1)(2011-2#1)
held at the University##2##4##(1996-6#1)(2013-8#1)
held at the##12##3##(1996-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#4)(2013-8#2)
held at##17##2##(1993-2#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-2#4)(2013-8#2)
held beliefs##3##2##(1996-5#1)(2008-11#1)(2009-9#1)
held by the##5##3##(2008-8#3)(2012-12#1)(2012-2#1)
held by##10##2##(1990-12#1)(1992-3#1)(1994-12#1)(2008-8#3)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
held constant##7##2##(1995-12#1)(1996-3#1)(2008-10#3)(2008-6#1)(2008-9#1)
held during##2##2##(2008-8#1)(2009-6#1)
held for##2##2##(1992-11#1)(2008-10#1)
held hostage##2##2##(2013-8#2)
held in a##3##3##(1994-1#1)(2008-10#1)(2008-3#1)
held in an optical##2##4##(2009-5#1)(2012-2#1)
held in an##3##3##(2009-5#1)(2012-2#1)(2013-1#1)
held in the##2##3##(2008-10#1)(2008-7#1)
held in##41##2##(1991-3#1)(1991-5#1)(1994-1#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-5#3)(2011-2#1)(2011-4#2)(2012-2#1)(2013-1#1)
held its##2##2##(2008-10#1)(2008-5#1)
held on the##2##3##(2008-11#1)(2013-1#1)
held on##6##2##(1990-3#1)(1991-11#1)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
held responsible for##3##3##(1996-1#1)(2008-7#1)(2012-3#1)
held responsible##4##2##(1995-6#1)(1996-1#1)(2008-7#1)(2012-3#1)
held similar##2##2##(2008-12#1)(2010-5#1)
held that##6##2##(1991-3#1)(1993-9#1)(1994-1#1)(1994-12#2)(2010-5#1)
held the##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
held to within##2##3##(2007-11#1)(2008-2#1)
held to##6##2##(1995-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2011-2#1)
held together##3##2##(1990-8#1)(1997-7#1)(2008-11#1)
held up##2##2##(2008-10#1)(2008-3#1)
held view that##2##3##(1994-2#1)(1996-2#1)
held with##5##2##(1992-5#1)(1996-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
held##180##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-5#2)(1992-11#1)(1992-3#1)(1992-5#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#6)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#9)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#4)(2010-2#3)(2010-3#3)(2010-5#5)(2010-8#1)(2011-1#1)(2011-2#9)(2011-4#2)(2012-12#1)(2012-2#3)(2012-3#4)(2012-7#1)(2013-1#3)(2013-8#4)
helenium L##6##2##(2008-10#1)(2008-5#5)
helianthi isolates##2##2##(2008-10#2)
helianthi##6##1##(2008-10#6)
helical CT##5##2##(1995-11#1)(2007-5#1)(2008-1#1)(2009-5#1)(2011-2#1)
helical DNA##2##2##(1991-8#1)(2008-10#1)
helical SPECT##4##2##(2009-8#4)
helical and##2##2##(1990-8#1)(1995-3#1)
helical computed tomography##2##3##(2007-5#1)(2009-8#1)
helical computed##3##2##(2007-5#1)(2008-2#1)(2009-8#1)
helical conformation##2##2##(1992-3#1)(2011-2#1)
helical domain##2##2##(1991-2#1)(1997-7#1)
helical filament##2##2##(1991-1#1)(1997-3#1)
helical hairpin##2##2##(1991-5#1)(1994-2#1)
helical region##3##2##(1991-8#1)(1995-5#1)(2007-11#1)
helical sense##2##2##(1995-6#2)
helical structure##4##2##(2008-10#2)(2010-7#1)(2013-1#1)
helical structures##2##2##(1995-6#1)(2008-7#1)
helical##75##1##(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-4#2)(1992-6#4)(1993-11#5)(1993-8#1)(1994-2#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#8)(1997-3#1)(1997-7#1)(2007-11#2)(2007-5#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#6)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
helical-CT##2##1##(2008-1#2)
helically##2##1##(2007-9#1)(2008-10#1)
helicase and##3##2##(1994-8#1)(2010-2#1)(2012-3#1)
helicase consensus motifs##2##3##(1995-6#2)
helicase domain##2##2##(2008-10#2)
helicase required for##2##3##(2012-3#2)
helicase##29##1##(1991-12#3)(1993-12#1)(1994-8#2)(1995-6#4)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2010-2#5)(2011-1#1)(2011-2#1)(2012-3#3)
helicases##2##1##(1994-8#1)(2010-2#1)
helices I and II##2##4##(1995-5#2)
helices I##4##2##(1990-5#1)(1995-5#3)
helices and##2##2##(1991-12#1)(1992-8#1)
helices are##4##2##(1991-5#1)(1994-5#1)(1995-5#1)(2008-4#1)
helices in the##2##3##(1990-7#1)(1993-11#1)
helices of##2##2##(1990-5#1)(1993-8#1)
helices that##2##2##(1991-12#1)(1993-8#1)
helices##39##1##(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-3#3)(1993-8#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#4)(2006-12#3)(2008-10#3)(2008-4#3)
helicity##3##1##(1992-3#1)(1995-11#1)(2007-11#1)
helicobacter##2##1##(2009-12#1)(2010-12#1)
helicoidal fiber##2##2##(2008-2#2)
helicoidal##6##1##(2007-12#1)(2008-2#3)(2008-3#1)(2010-6#1)
heliconia##2##1##(2008-10#2)
helicopter##2##1##(1990-9#1)(2009-10#1)
helium and##2##2##(2008-3#2)
helium droplets##2##2##(2008-7#2)
helium in##3##2##(2008-10#2)(2008-2#1)
helium##18##1##(1993-11#2)(1997-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#6)(2008-8#1)
helium-neon laser##2##2##(2007-12#1)(2008-3#1)
helix (residues##2##2##(1991-5#2)
helix 4##3##2##(2008-9#3)
helix VIII##2##2##(1995-2#2)
helix XI##3##2##(1993-11#3)
helix and##3##2##(1991-6#1)(2008-10#1)(2010-7#1)
helix are##2##2##(2008-11#1)(2008-8#1)
helix formation##6##2##(1992-12#1)(1995-5#3)(2008-10#1)(2010-7#1)
helix in the##2##3##(1995-5#1)(1997-4#1)
helix in##3##2##(1995-5#1)(1997-4#1)(2013-1#1)
helix is##2##2##(1992-6#1)(2013-1#1)
helix of the##4##3##(1994-12#1)(2008-9#1)(2010-8#2)
helix of##9##2##(1990-11#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#2)
helix pomatia agglutinin##2##3##(2011-2#2)
helix strains##2##2##(2008-10#2)
helix to##2##2##(1994-5#1)(2012-2#1)
helix##110##1##(1990-11#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#7)(1993-8#2)(1994-12#1)(1994-5#5)(1994-6#1)(1995-2#6)(1995-5#10)(1995-6#3)(1995-8#2)(1996-2#1)(1997-4#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#10)(2008-9#4)(2009-7#2)(2010-10#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-2#3)(2012-2#2)(2013-1#8)
helix-loop-helix transcription factors##3##3##(1991-11#1)(1996-2#1)(2011-2#1)
helix-loop-helix transcription##5##2##(1991-11#1)(1994-8#1)(1996-2#1)(2010-11#1)(2011-2#1)
helix-loop-helix##7##1##(1991-11#1)(1994-12#1)(1994-8#2)(1996-2#1)(2010-11#1)(2011-2#1)
helix-turn-helix##2##1##(1992-4#1)(2012-2#1)
hello##2##1##(1996-2#1)(2009-1#1)
helmet##4##1##(2007-3#1)(2008-10#1)(2010-4#2)
helminth control##2##2##(1997-7#2)
helminth infections##3##2##(1994-11#1)(2007-12#1)(2012-12#1)
helminth parasites in##2##3##(2011-1#2)
helminth parasites##3##2##(2011-1#3)
helminth species##5##2##(2011-1#4)(2011-2#1)
helminth##17##1##(1994-11#1)(1997-7#2)(2007-12#1)(2009-5#1)(2011-1#7)(2011-2#2)(2012-12#3)
helminth-naive calves##2##2##(1996-12#2)
helminthes##5##1##(2008-12#1)(2011-2#4)
helminthiasis##3##1##(1990-9#1)(2009-5#2)
helminthic infections and##2##3##(1994-11#1)(2009-5#1)
helminthic##3##1##(1994-11#1)(2009-5#1)(2012-3#1)
helminths and##2##2##(2009-10#1)(2012-12#1)
helminths##11##1##(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#5)(2012-3#1)(2013-1#2)
helodermin &gt##2##2##(1994-3#2)
helophoroides parasitized A##2##3##(2013-8#2)
helophoroides##7##1##(2013-8#7)
help a##2##2##(1997-2#1)(2007-12#1)
help address##2##2##(2012-12#1)(2012-2#1)
help allay##2##2##(2008-12#1)(2008-7#1)
help also##2##2##(2008-10#1)(2008-7#1)
help and##4##2##(1997-2#1)(1997-7#1)(2008-2#1)(2009-6#1)
help answer##2##2##(2008-11#1)(2008-2#1)
help as well##2##3##(1990-6#1)(2012-12#1)
help as##3##2##(1990-6#1)(1992-2#1)(2012-12#1)
help avoid##4##2##(1992-1#1)(2008-5#1)(2008-8#1)(2009-6#1)
help clarify##5##2##(2008-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
help clinicians to##2##3##(2008-10#1)(2012-2#1)
help clinicians##7##2##(1992-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
help college##2##2##(2009-11#1)(2013-8#1)
help decide##2##2##(2008-10#1)(2009-12#1)
help define the##3##3##(1991-6#1)(2008-7#1)(2010-1#1)
help define##5##2##(1991-6#2)(1992-11#1)(2008-7#1)(2010-1#1)
help determine the##2##3##(1992-11#1)(1996-6#1)
help determine##6##2##(1992-11#1)(1996-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-5#1)
help develop a##2##3##(2009-10#1)(2013-1#1)
help develop##5##2##(2008-9#1)(2009-10#1)(2009-5#1)(2010-6#1)(2013-1#1)
help discern##3##2##(1996-2#1)(2010-7#1)(2013-1#1)
help distinguish##3##2##(2006-12#1)(2008-1#1)(2008-11#1)
help elucidate how##2##3##(2008-1#1)(2009-6#1)
help elucidate the function of the##2##6##(1997-7#1)(2008-2#1)
help elucidate the##4##3##(1997-7#1)(2008-2#1)(2009-3#1)(2012-2#1)
help elucidate##8##2##(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-6#1)(2012-2#1)
help ensure that##3##3##(1993-1#1)(1996-9#1)(2010-5#1)
help ensure##7##2##(1993-1#1)(1994-12#1)(1996-9#1)(2008-10#2)(2010-5#2)
help evaluate##2##2##(2007-7#1)(2008-11#1)
help explain the##7##3##(1992-2#1)(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)
help explain##12##2##(1992-2#1)(1993-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
help facilitate the##2##3##(1991-12#1)(2010-7#1)
help families##3##2##(2008-6#1)(2011-2#2)
help for##5##2##(1992-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
help from##3##2##(1992-4#1)(2008-7#1)(2012-3#1)
help future##2##2##(2008-1#1)(2008-2#1)
help guide the##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
help guide##7##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#1)
help health##3##2##(1996-1#1)(2008-12#1)(2008-7#1)
help hospital##2##2##(1991-12#1)(1993-2#1)
help hospitals##4##2##(1991-2#1)(1992-3#1)(1995-2#1)(1997-2#1)
help identify potential##2##3##(2011-2#1)(2012-12#1)
help identify##16##2##(1991-2#1)(1992-8#1)(1997-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
help improve the##4##3##(1992-12#1)(2008-2#1)(2008-7#1)(2013-7#1)
help improve##11##2##(1992-12#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
help in deciding##2##3##(1997-8#1)(2008-10#1)
help in differentiating##2##3##(2008-7#1)(2013-1#1)
help in early##2##3##(2009-12#1)(2011-2#1)
help in identifying##4##3##(1997-2#1)(2007-10#1)(2008-7#1)(2012-3#1)
help in improving the##2##4##(2008-3#1)(2009-5#1)
help in improving##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
help in reducing the##2##4##(2009-5#1)(2012-12#1)
help in reducing##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
help in selecting##2##3##(2009-10#1)(2013-1#1)
help in the formulation of##2##5##(1992-8#1)(1996-1#1)
help in the identification of##4##5##(1990-2#1)(1995-2#1)(2008-7#1)(2011-2#1)
help in the search for##2##5##(1995-6#1)(2008-5#1)
help in the##12##3##(1990-2#1)(1992-12#1)(1992-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)
help in##60##2##(1990-2#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2009-10#2)(2009-12#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
help increase##2##2##(2008-11#1)(2010-4#1)
help is##2##2##(2008-2#1)(2012-3#1)
help maintain##2##2##(1996-1#1)(2009-11#1)
help make##2##2##(1992-12#1)(2008-10#1)
help marketers##2##2##(1997-2#1)(2008-12#1)
help mitigate##2##2##(2008-5#1)(2012-3#1)
help nurses##3##2##(1997-7#1)(2008-11#1)(2010-8#1)
help of a##14##3##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
help of##46##2##(1992-2#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-6#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#4)(2008-8#2)(2009-5#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
help or##2##2##(1994-1#1)(1996-12#1)
help others##2##2##(2008-8#1)(2013-1#1)
help overcome##2##2##(2011-1#1)(2013-1#1)
help patients to##3##3##(2011-2#3)
help patients##8##2##(1995-1#1)(1995-3#1)(2007-6#1)(2008-11#1)(2008-6#1)(2011-2#3)
help physicians##5##2##(1993-2#1)(2007-10#1)(2008-11#2)(2008-3#1)
help predict##2##2##(1994-9#1)(2011-2#1)
help prevent##10##2##(1991-7#1)(2007-2#1)(2008-11#1)(2008-12#2)(2010-1#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
help produce##2##2##(2008-12#1)(2008-2#1)
help provide##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
help reduce the##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
help reduce##12##2##(1997-1#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-4#1)(2013-8#1)
help researchers and##2##3##(2010-11#1)(2013-1#1)
help researchers##7##2##(2008-10#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-6#1)(2013-1#1)
help select##2##2##(1995-3#1)(2010-7#1)
help stem##2##2##(1996-3#1)(2009-5#1)
help strengthen##3##2##(1993-6#1)(1997-1#1)(2012-12#1)
help students##3##2##(2008-11#2)(2009-12#1)
help the clinician##4##3##(1991-2#1)(1993-1#1)(2007-4#1)(2008-1#1)
help the search##2##3##(2008-8#2)
help the##37##2##(1990-10#1)(1991-2#2)(1992-2#1)(1993-1#1)(1995-12#2)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-8#2)
help their##5##2##(1992-12#1)(1994-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
help them##14##2##(1990-12#1)(1991-2#1)(1993-2#1)(1994-12#1)(1995-1#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-10#1)(2011-1#1)(2012-12#2)(2013-8#1)
help themselves to##2##3##(1997-1#1)(2008-10#1)
help themselves##3##2##(1994-1#1)(1997-1#1)(2008-10#1)
help these families##2##3##(2008-10#2)
help these##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
help to achieve##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
help to address##2##3##(2012-3#2)
help to avoid##4##3##(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
help to create##2##3##(1995-3#1)(2008-3#1)
help to define##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
help to determine the##2##4##(2008-2#1)(2012-3#1)
help to develop##6##3##(1994-5#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-10#1)
help to discriminate between##2##4##(1996-12#1)(2010-12#1)
help to distinguish##2##3##(2008-7#1)(2011-2#1)
help to elucidate the##2##4##(2008-10#1)(2008-8#1)
help to elucidate##3##3##(2008-10#1)(2008-8#1)(2009-7#1)
help to explain the##3##4##(1994-2#1)(2008-1#1)(2008-2#1)
help to explain##12##3##(1994-2#1)(1994-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#2)(2009-7#1)(2011-2#1)(2012-2#1)
help to further##2##3##(1992-2#1)(2008-9#1)
help to guide##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
help to identify##9##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
help to improve the##3##4##(2008-10#1)(2009-8#1)(2012-8#1)
help to improve##5##3##(2008-10#2)(2009-8#1)(2010-12#1)(2012-8#1)
help to minimize the##2##4##(2008-1#1)(2008-9#1)
help to minimize##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
help to prevent##7##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
help to protect##2##3##(1990-3#1)(2008-5#1)
help to reduce##5##3##(2008-5#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
help to understand the##4##4##(2007-12#1)(2008-11#1)(2008-7#1)(2013-7#1)
help to understand##7##3##(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-7#1)
help to##145##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#3)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#9)(2012-12#4)(2012-2#4)(2012-3#6)(2012-8#1)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#1)
help understand the##4##3##(1996-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
help understand##6##2##(1996-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
help us in##2##3##(2008-12#1)(2011-2#1)
help us to better understand##2##5##(2010-5#1)(2013-1#1)
help us to understand##4##4##(1993-5#1)(1994-11#1)(2008-2#1)(2009-7#1)
help us to##14##3##(1991-6#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
help us understand the##2##4##(2008-1#1)(2009-10#1)
help us understand##3##3##(2008-1#1)(2008-10#1)(2009-10#1)
help us##28##2##(1991-6#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2009-1#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
help with the##2##3##(1995-3#1)(2010-12#1)
help with##8##2##(1992-2#1)(1995-3#1)(1995-9#1)(2007-11#1)(2008-12#1)(2010-12#1)(2010-8#1)(2013-8#1)
help you##9##2##(1992-3#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-2#1)(2011-2#1)
help##805##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#6)(1991-3#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#3)(1992-11#2)(1992-12#7)(1992-2#10)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#3)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#8)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#8)(1995-3#5)(1995-6#2)(1995-9#3)(1996-1#7)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#11)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#7)(1997-2#13)(1997-3#3)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#7)(2007-2#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#20)(2008-10#58)(2008-11#38)(2008-12#19)(2008-2#17)(2008-3#14)(2008-4#11)(2008-5#23)(2008-6#8)(2008-7#31)(2008-8#25)(2008-9#16)(2009-1#1)(2009-10#12)(2009-11#4)(2009-12#8)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#11)(2009-6#4)(2009-7#8)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#7)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#6)(2010-4#2)(2010-5#9)(2010-6#2)(2010-7#7)(2010-8#15)(2010-9#5)(2011-1#11)(2011-10#1)(2011-2#45)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#13)(2012-3#23)(2012-8#1)(2012-9#1)(2013-1#31)(2013-7#3)(2013-8#15)
help'##3##1##(1991-8#1)(2012-3#2)
help-seeking##4##1##(2008-12#1)(2012-3#3)
help?##4##1##(2006-10#1)(2007-12#1)(2010-9#1)(2013-8#1)
help?]##2##1##(1995-11#1)(1997-2#1)
helped by##10##2##(1990-6#1)(1993-2#1)(1995-8#1)(2008-1#2)(2008-7#1)(2008-8#1)(2012-3#2)(2013-8#1)
helped engage##2##2##(1995-1#1)(2008-12#1)
helped in##2##2##(2008-9#1)(2012-2#1)
helped the##3##2##(2010-7#1)(2011-2#1)(2013-8#1)
helped their##2##2##(2007-7#1)(2008-12#1)
helped them##5##2##(1993-3#1)(1995-3#1)(1996-1#1)(2010-3#1)(2011-2#1)
helped to define##2##3##(1990-12#1)(2010-4#1)
helped to identify##4##3##(2008-1#1)(2008-12#2)(2011-2#1)
helped to improve the##2##4##(1996-9#1)(2007-7#1)
helped to reduce the##4##4##(1996-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
helped to shape##3##3##(1991-3#1)(2008-12#2)
helped to strengthen##2##3##(2008-12#1)(2011-2#1)
helped to##41##2##(1990-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1996-12#2)(1996-9#3)(1997-3#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#6)(2008-2#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
helped us to##2##3##(2007-7#1)(2012-2#1)
helped us##4##2##(2007-7#1)(2010-10#1)(2012-2#1)(2013-8#1)
helped with##3##2##(1992-2#1)(2008-10#1)(2012-3#1)
helped##98##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#4)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-9#3)(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#3)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#10)(2008-2#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#1)(2013-8#3)
helper T cell clones##2##4##(2008-4#2)
helper T cell##6##3##(1995-5#1)(1997-4#1)(2008-11#2)(2008-4#2)
helper T cells##5##3##(1990-12#1)(1991-11#1)(1994-11#1)(2008-10#1)(2013-1#1)
helper T##13##2##(1990-12#1)(1991-11#1)(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#2)(2011-2#1)(2012-3#1)(2013-1#1)
helper T-lymphocytes##2##2##(1997-8#1)(2008-11#1)
helper cells##4##2##(1993-8#1)(1995-12#1)(2008-9#1)(2012-3#1)
helper component (HC)##3##3##(2008-10#3)
helper component##6##2##(2008-10#6)
helper component-protease (HC-Pro)##2##3##(2008-10#2)
helper component-proteinase (HC-Pro)##3##3##(2008-10#3)
helper functions##4##2##(2008-4#2)(2008-8#2)
helper phage##2##2##(1990-5#1)(1994-12#1)
helper virus##16##2##(1990-5#1)(2008-10#10)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)
helper viruses##3##2##(2008-10#2)(2008-11#1)
helper##82##1##(1990-12#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2008-10#26)(2008-11#8)(2008-2#1)(2008-4#10)(2008-8#4)(2008-9#3)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#1)
helper-adenovirus##2##1##(2008-9#2)
helper-dependent virus##2##2##(2008-10#2)
helper-dependent##4##1##(2008-10#2)(2008-2#1)(2008-4#1)
helpers in##2##2##(2008-8#1)(2008-9#1)
helpers of the same sex##2##5##(2008-9#2)
helpers##13##1##(1992-3#1)(1996-11#1)(1996-3#1)(2008-8#6)(2008-9#4)
helpful by##2##2##(2008-8#1)(2010-8#1)
helpful for further##2##3##(1996-12#1)(2008-1#1)
helpful for the##2##3##(1990-6#1)(1997-7#1)
helpful for##22##2##(1990-6#1)(1994-12#1)(1996-12#2)(1997-7#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-7#1)(2012-2#3)(2013-8#1)
helpful in determining the##2##4##(2008-5#1)(2008-7#1)
helpful in developing##2##3##(2008-10#1)(2008-2#1)
helpful in identifying##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
helpful in improving##7##3##(2007-7#1)(2008-3#1)(2008-5#4)(2013-7#1)
helpful in making##2##3##(2008-12#1)(2013-1#1)
helpful in the detection and##2##5##(1995-6#1)(2011-2#1)
helpful in the diagnosis of##4##5##(1990-3#1)(1991-12#1)(2009-3#2)
helpful in the diagnosis##7##4##(1990-3#1)(1991-12#1)(1994-9#1)(1997-8#1)(2009-3#2)(2009-4#1)
helpful in the##18##3##(1990-3#1)(1991-12#1)(1991-4#1)(1992-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-4#1)(2011-2#1)
helpful in this##2##3##(2008-8#1)(2010-9#1)
helpful in those##2##3##(2006-12#1)(2012-2#1)
helpful in##65##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1994-9#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
helpful to choose##2##3##(2007-11#2)
helpful to have##2##3##(2008-1#1)(2009-4#1)
helpful to##23##2##(1994-3#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
helpful##143##1##(1990-10#2)(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-6#2)(1996-12#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
helping close##2##2##(2009-5#1)(2009-8#1)
helping families##2##2##(1997-2#1)(2008-6#1)
helping health##2##2##(1997-1#1)(2011-2#1)
helping in##3##2##(2007-4#1)(2008-10#1)(2012-12#1)
helping patients##5##2##(2008-7#2)(2010-11#1)(2010-7#1)(2011-2#1)
helping the##4##2##(1992-3#1)(2008-11#1)(2010-11#1)(2012-2#1)
helping their##2##2##(2008-11#1)(2010-8#1)
helping to maintain##2##3##(2008-11#1)(2010-8#1)
helping to reduce##2##3##(2007-12#1)(2010-5#1)
helping to##13##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
helping us to##2##3##(2008-7#1)(2011-2#1)
helping##79##1##(1991-1#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#2)(1992-4#1)(1993-1#3)(1993-12#2)(1993-2#1)(1994-1#3)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#4)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-2#1)(2008-6#3)(2008-7#5)(2008-8#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
helpless##2##1##(1994-3#1)(2009-10#1)
helplessness##4##1##(1990-6#1)(1996-7#2)(2010-3#1)
helps ensure##2##2##(2007-12#1)(2010-12#1)
helps explain##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
helps identify the##2##3##(1993-1#1)(2007-7#1)
helps identify##3##2##(1993-1#1)(2007-7#1)(2008-11#1)
helps in the##3##3##(1990-6#1)(2008-1#1)(2008-5#1)
helps in##12##2##(1990-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#1)(2012-2#1)(2013-8#2)
helps researchers##3##2##(2008-2#1)(2008-4#2)
helps the department##2##3##(1993-12#2)
helps the##5##2##(1993-12#2)(1996-12#1)(2007-8#1)(2008-11#1)
helps them##2##2##(2010-5#1)(2010-8#1)
helps to evaluate##2##3##(2007-11#2)
helps to explain##2##3##(1992-9#1)(2012-1#1)
helps to identify##2##3##(2007-11#1)(2011-2#1)
helps to reduce the##4##4##(2008-10#1)(2008-3#2)(2009-9#1)
helps to reduce##5##3##(2008-10#2)(2008-3#2)(2009-9#1)
helps to##37##2##(1991-1#2)(1992-9#1)(1997-3#2)(2007-11#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
helps##101##1##(1990-6#1)(1991-1#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#3)(1996-3#1)(1997-2#3)(1997-3#3)(1997-6#1)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
helveticus 130B4##2##2##(2013-1#2)
hemagglutination##9##1##(1990-7#1)(1991-9#1)(1992-6#1)(1992-9#2)(1994-5#1)(1994-6#1)(2008-11#1)(2008-9#1)
hemagglutinin (HA)##5##2##(1990-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
hemagglutinin##16##1##(1990-5#1)(1992-3#1)(1992-9#4)(1994-8#2)(2008-9#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#2)
hemangioblastoma in a##2##3##(2012-3#1)(2013-8#1)
hemangioblastoma##4##1##(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
hemangioblastomas##2##1##(2011-2#1)(2013-8#1)
hemangioendothelioma of##2##2##(2009-5#1)(2009-9#1)
hemangioendothelioma##8##1##(2006-10#1)(2009-5#4)(2009-9#1)(2011-1#2)
hemangioma is a vascular tumor##2##5##(2007-8#1)(2011-1#1)
hemangioma of the##2##3##(2009-1#1)(2013-7#1)
hemangioma##24##1##(1990-9#1)(1992-8#1)(1993-1#2)(1997-8#2)(2007-8#3)(2008-10#1)(2009-1#1)(2009-3#2)(2009-7#1)(2011-1#3)(2011-2#5)(2013-1#1)(2013-7#1)
hemangioma]##3##1##(1993-2#1)(2007-8#1)(2011-2#1)
hemangiomas in##2##2##(2009-3#1)(2011-2#1)
hemangiomas of##2##2##(1995-8#1)(2013-8#1)
hemangiomas##14##1##(1993-1#2)(1993-5#2)(1995-8#1)(2006-12#1)(2009-3#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
hemangiopericytoma##14##1##(1993-6#3)(2008-6#10)(2011-2#1)
hemangiopericytoma-like vascular pattern##2##3##(2010-6#2)
hematein##3##1##(2008-10#3)
hematemesis and hemoptysis##2##3##(2007-8#2)
hematemesis and##3##2##(2007-8#2)(2011-2#1)
hematemesis or##2##2##(2008-7#1)(2013-8#1)
hematemesis##5##1##(2007-8#2)(2008-7#1)(2011-2#1)(2013-8#1)
hematin and##2##2##(1994-3#1)(1995-3#1)
hematite##3##1##(2008-10#2)(2008-2#1)
hematocrit (Hct)##3##2##(1994-12#1)(1994-6#1)(2008-1#1)
hematocrit (r = -0##2##4##(1993-2#2)
hematocrit and hemoglobin##3##3##(2008-9#1)(2013-1#2)
hematocrit and##5##2##(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#2)
hematocrit values##2##2##(2008-4#2)
hematocrit was##4##2##(1990-2#1)(1997-6#1)(2008-1#1)(2008-4#1)
hematocrit##33##1##(1990-2#1)(1993-2#4)(1994-12#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
hematogenous osteomyelitis of the hip##3##5##(2007-8#3)
hematogenous osteomyelitis##5##2##(2007-8#4)(2010-6#1)
hematogenous spread of HCC cells##2##5##(2008-10#2)
hematogenous spread##3##2##(2007-12#1)(2008-10#2)
hematogenous##11##1##(2007-12#1)(2007-8#4)(2008-10#2)(2010-6#2)(2011-2#1)(2012-3#1)
hematologic and##2##2##(2008-7#2)
hematologic disorders##2##2##(1994-12#1)(2008-7#1)
hematologic malignancies and##2##3##(2008-7#1)(2013-1#1)
hematologic malignancies##20##2##(2008-7#15)(2009-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
hematologic malignancy##2##2##(2010-4#1)(2012-2#1)
hematologic response (Hb increase &gt##2##5##(2008-7#2)
hematologic response##7##2##(2008-7#6)(2013-1#1)
hematologic toxicity did not##2##4##(1991-2#2)
hematologic toxicity##4##2##(1991-2#3)(2006-10#1)
hematologic##54##1##(1990-12#1)(1990-8#1)(1991-2#3)(1994-12#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-7#27)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#2)
hematological and##3##2##(1992-9#1)(1993-2#1)(2013-8#1)
hematological changes in methionine-induced##2##4##(2010-5#2)
hematological changes in##3##3##(2010-5#3)
hematological diseases##3##2##(1992-6#1)(1993-3#1)(2007-4#1)
hematological disorder characterized by##2##4##(2007-10#1)(2010-5#1)
hematological disorder##3##2##(2007-10#1)(2008-7#1)(2010-5#1)
hematological malignancies##13##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
hematological parameters##2##2##(2008-1#1)(2012-12#1)
hematological##47##1##(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#2)(2010-5#5)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#3)
hematologists##3##1##(2008-11#1)(2010-11#2)
hematology and immunology##2##3##(1994-12#1)(2008-9#1)
hematology and##3##2##(1994-12#1)(2007-7#1)(2008-9#1)
hematology##12##1##(1994-12#1)(1997-5#1)(2007-7#2)(2008-10#3)(2008-9#3)(2010-2#1)(2011-2#1)
hematoma after##4##2##(2008-12#1)(2012-12#1)(2013-1#2)
hematoma and##5##2##(1990-5#2)(2011-2#1)(2012-3#2)
hematoma enlargement##2##2##(2007-10#2)
hematoma formation##2##2##(1997-8#1)(2011-2#1)
hematoma in the right##3##4##(2007-10#2)(2008-12#1)
hematoma in##6##2##(1991-11#1)(2007-10#2)(2008-12#1)(2012-2#2)
hematoma is##5##2##(2008-11#1)(2009-3#2)(2011-2#1)(2012-2#1)
hematoma of liver##2##3##(2010-11#2)
hematoma of the abdominal##2##4##(1990-5#2)
hematoma of the esophagus##4##4##(2011-2#4)
hematoma of the##7##3##(1990-5#2)(2011-2#5)
hematoma of##10##2##(1990-5#2)(2010-11#2)(2011-2#6)
hematoma was subperiosteal##2##3##(2009-3#2)
hematoma was##9##2##(2008-7#3)(2009-3#2)(2010-11#1)(2011-2#2)(2012-12#1)
hematoma##99##1##(1990-5#4)(1991-11#1)(1991-12#1)(1991-3#1)(1993-8#1)(1995-3#1)(1996-11#1)(1997-8#1)(2007-10#6)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-7#21)(2008-8#1)(2008-9#1)(2009-3#10)(2010-11#4)(2011-2#18)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#3)
hematoma-related##2##1##(2012-3#2)
hematomas##10##1##(1996-11#1)(1996-6#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)
hematopoiesis##14##1##(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#4)(2010-4#1)
hematopoietic and lymphoid##2##3##(2008-7#1)(2008-9#1)
hematopoietic cell proliferation##2##3##(2008-9#2)
hematopoietic cell##10##2##(1994-5#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-11#1)
hematopoietic cells but##2##3##(2008-11#1)(2010-8#1)
hematopoietic cells in##2##3##(2008-11#1)(2008-4#1)
hematopoietic cells##23##2##(1992-8#1)(1993-8#2)(1994-5#1)(1995-2#2)(1996-2#1)(1997-7#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-8#1)(2012-12#1)
hematopoietic culture##2##2##(2008-11#2)
hematopoietic cytokine##2##2##(2008-8#1)(2012-2#1)
hematopoietic differentiation##3##2##(2008-10#1)(2008-11#2)
hematopoietic disorder##5##2##(2008-9#4)(2012-12#1)
hematopoietic growth factors##2##3##(1991-6#1)(2008-7#1)
hematopoietic growth##3##2##(1991-6#1)(2008-11#1)(2008-7#1)
hematopoietic malignancies##3##2##(2008-10#1)(2009-12#1)(2011-1#1)
hematopoietic progenitor cells##8##3##(1997-4#1)(2008-11#5)(2008-7#1)(2010-8#1)
hematopoietic progenitor##11##2##(1997-4#1)(2008-11#7)(2008-7#2)(2010-8#1)
hematopoietic progenitors##7##2##(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#2)(2011-2#1)
hematopoietic regeneration##2##2##(2013-1#2)
hematopoietic stem cell transplant##3##4##(2008-10#1)(2009-10#1)(2012-12#1)
hematopoietic stem cell transplantation (HSCT)##3##5##(2006-10#1)(2010-5#1)(2011-2#1)
hematopoietic stem cell transplantation for##2##5##(2012-2#2)
hematopoietic stem cell transplantation in##2##5##(2010-11#1)(2012-12#1)
hematopoietic stem cell transplantation is##2##5##(1997-8#1)(2012-12#1)
hematopoietic stem cell transplantation##15##4##(1997-8#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-11#2)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
hematopoietic stem cell transplantation]##2##4##(2011-2#1)(2012-2#1)
hematopoietic stem cell##28##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#2)(2010-11#4)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)
hematopoietic stem cells (HSCs)##4##4##(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
hematopoietic stem cells can survive in vitro for several months##2##10##(2009-12#2)
hematopoietic stem cells##32##3##(1991-11#1)(1993-2#2)(1993-8#2)(1994-5#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-5#1)(2008-9#9)(2009-12#5)(2010-2#1)(2012-10#1)
hematopoietic stem##62##2##(1991-11#1)(1993-2#2)(1993-8#2)(1994-5#1)(1997-8#1)(2006-10#1)(2008-10#4)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#10)(2009-10#1)(2009-12#7)(2010-11#5)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-10#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)
hematopoietic system##4##2##(1992-3#1)(1992-9#1)(2011-1#1)(2012-2#1)
hematopoietic##159##1##(1990-5#1)(1991-11#1)(1991-6#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#3)(1993-8#5)(1994-5#3)(1995-2#2)(1996-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2008-10#8)(2008-11#30)(2008-4#9)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#23)(2009-10#1)(2009-12#8)(2009-3#1)(2009-7#1)(2010-11#6)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#5)(2011-1#3)(2011-2#5)(2012-10#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#4)
hematopoietic/lymphoid tissues##2##2##(2008-7#2)
hematoporphyrin derivatives##2##2##(2008-9#2)
hematoporphyrin##7##1##(1991-5#1)(1992-6#1)(2008-10#1)(2008-8#2)(2008-9#2)
hematotoxicity##3##1##(1992-5#1)(2008-10#2)
hematoxylin and eosin and##2##4##(2007-10#1)(2011-2#1)
hematoxylin and eosin##6##3##(2007-10#1)(2010-8#1)(2011-2#3)(2013-1#1)
hematoxylin##8##1##(1991-2#1)(2007-10#1)(2007-12#1)(2010-8#1)(2011-2#3)(2013-1#1)
hematuria and##8##2##(1990-11#2)(2007-7#2)(2008-1#1)(2008-10#2)(2011-2#1)
hematuria in a##2##3##(2008-10#2)
hematuria in##6##2##(1991-3#1)(2008-1#2)(2008-10#3)
hematuria is##3##2##(1993-2#1)(2008-11#2)
hematuria with##2##2##(2008-10#2)
hematuria##56##1##(1990-11#2)(1991-3#1)(1993-2#1)(1994-5#1)(1996-12#4)(1997-7#1)(2006-10#2)(2007-10#1)(2007-7#4)(2008-1#14)(2008-10#13)(2008-11#6)(2011-2#3)(2013-1#2)(2013-8#1)
heme A##2##2##(1994-8#2)
heme IX##2##2##(2007-11#2)
heme O##3##2##(1992-12#3)
heme and##4##2##(1994-8#1)(1994-9#1)(2008-9#2)
heme binding##6##2##(1991-9#1)(1992-12#1)(1994-5#1)(1994-8#3)
heme c##2##2##(1994-11#1)(1995-2#1)
heme domain##3##2##(1994-9#3)
heme groups##3##2##(1990-8#2)(1992-12#1)
heme in the##3##3##(1994-5#1)(1995-2#1)(2009-9#1)
heme ligands##2##2##(1990-8#2)
heme methyl##2##2##(1994-5#2)
heme oxygenase (HO)##2##3##(1994-5#1)(2008-4#1)
heme oxygenase##6##2##(1993-6#1)(1994-5#2)(1995-2#1)(2008-4#2)
heme oxygenase-1##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
heme pocket##3##2##(1990-8#1)(1992-3#1)(1994-5#1)
heme polymerase activity##2##3##(1993-8#2)
heme polymerase##4##2##(1993-8#4)
heme protein subunit##2##3##(1993-8#2)
heme protein##3##2##(1993-8#2)(1995-3#1)
heme reorientation##2##2##(1990-8#2)
heme site##3##2##(1997-2#3)
heme to##2##2##(1990-8#1)(2008-3#1)
heme was##3##2##(1993-11#1)(1994-8#1)(2011-1#1)
heme##117##1##(1990-8#17)(1991-9#2)(1992-12#6)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#12)(1994-11#1)(1994-5#14)(1994-8#13)(1994-9#4)(1995-2#4)(1995-3#2)(1996-3#1)(1997-2#4)(2007-11#3)(2008-10#7)(2008-3#2)(2008-4#2)(2008-8#2)(2008-9#3)(2009-9#5)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#1)
heme-adducted##2##1##(2008-10#2)
heme-binding##2##1##(1994-6#1)(1994-8#1)
heme-containing enzyme##2##2##(1992-10#1)(1995-12#1)
heme-protein##3##1##(2008-10#3)
heme-proximal histidine linkage##2##3##(1990-8#2)
hemeprotein##3##1##(1990-5#2)(2010-12#1)
hemerythrin and myohemerythrin##2##3##(1992-8#2)
hemerythrin by##2##2##(1992-8#2)
hemerythrin##10##1##(1991-10#2)(1992-8#8)
hemes and of##2##3##(1990-8#2)
hemes and##3##2##(1990-8#2)(2008-11#1)
hemes##10##1##(1990-8#5)(1993-8#1)(1997-2#3)(2008-11#1)
hemi##2##1##(2007-8#1)(2011-2#1)
hemi-Fontan##2##1##(2007-8#2)
hemi-castrated##2##1##(2008-5#2)
hemi-diaphragmatic##2##1##(2013-1#2)
hemi-fusion in##4##2##(1991-5#4)
hemi-fusion##10##1##(1991-5#10)
hemianopia and##2##2##(2009-2#2)
hemianopia in##2##2##(2011-2#1)(2013-1#1)
hemianopia on##2##2##(2009-2#2)
hemianopia##10##1##(1996-2#1)(2009-2#6)(2010-2#1)(2011-2#1)(2013-1#1)
hemiarthroplasties##2##1##(2007-8#1)(2013-1#1)
hemiarthroplasty or total hip##2##4##(2007-11#1)(2009-3#1)
hemiballismus following##2##2##(2008-7#2)
hemiballismus##4##1##(2008-7#4)
hemicellulose hydrolysate##5##2##(2008-6#5)
hemicellulose##13##1##(2008-10#2)(2008-6#9)(2011-2#1)(2013-1#1)
hemicellulosic##3##1##(2008-6#3)
hemicolectomy was performed##2##3##(1993-9#2)
hemicolectomy##3##1##(1993-9#2)(2013-1#1)
hemicraniectomy##3##1##(2008-8#1)(2012-3#2)
hemidesmosome##2##1##(2009-10#1)(2012-2#1)
hemidesmosomes##3##1##(2008-12#1)(2008-7#1)(2012-2#1)
hemifield##4##1##(1996-2#1)(1996-5#3)
hemilabyrinthectomy (HL)##2##2##(1991-2#2)
hemimetabolous##3##1##(2012-2#3)
hemimethylated DNA##5##2##(1990-11#3)(1992-3#1)(1994-12#1)
hemimethylated##7##1##(1990-11#5)(1992-3#1)(1994-12#1)
hemin and##4##2##(1991-9#1)(1994-5#1)(2008-10#1)(2008-12#1)
hemin electronic structure##2##3##(1994-5#2)
hemin is##2##2##(2008-10#2)
hemin or podophyllotoxin##2##3##(1991-9#2)
hemin substrate##2##2##(1994-5#2)
hemin was##4##2##(1995-12#1)(2008-10#3)
hemin##39##1##(1991-9#5)(1994-5#18)(1995-12#2)(2008-10#11)(2008-12#1)(2008-8#1)(2008-9#1)
hemineglect##3##1##(1995-12#1)(2013-8#2)
heminephrectomy in##2##2##(2008-10#2)
hemiparesis and##5##2##(2007-8#1)(2008-7#3)(2011-2#1)
hemiparesis following stroke as a model for disuse osteoporosis##2##9##(2008-7#2)
hemiparesis in##3##2##(2008-7#1)(2011-2#2)
hemiparesis with##2##2##(2008-7#1)(2013-8#1)
hemiparesis##27##1##(1991-6#2)(1997-3#1)(2007-10#4)(2007-8#1)(2008-12#2)(2008-7#10)(2010-9#1)(2011-2#3)(2013-8#3)
hemiparetic patients##4##2##(1994-1#2)(2007-11#2)
hemiparetic##8##1##(1994-1#2)(2007-10#1)(2007-11#3)(2008-7#1)(2010-7#1)
hemipelvis##2##1##(2011-2#2)
hemiplegia##5##1##(1997-5#1)(2007-11#1)(2008-1#1)(2013-1#1)(2013-8#1)
hemiplegic##2##1##(1997-3#1)(2010-9#1)
hemipopulation##3##1##(2011-2#3)
hemipteran##8##1##(2007-12#3)(2008-10#4)(2008-5#1)
hemiscrotum##2##1##(2008-6#1)(2012-12#1)
hemisected##2##1##(1990-5#1)(1996-5#1)
hemisphere and##4##2##(2008-3#1)(2008-7#1)(2010-7#1)(2013-8#1)
hemisphere at##2##2##(1997-8#1)(2011-2#1)
hemisphere brain##3##2##(1996-5#1)(2012-3#2)
hemisphere in lobectomized patients##2##4##(2008-11#2)
hemisphere in the##3##3##(1996-2#1)(2008-1#1)(2013-8#1)
hemisphere in##8##2##(1995-12#1)(1996-2#1)(2008-1#1)(2008-11#3)(2008-2#1)(2013-8#1)
hemisphere is specialized for##2##4##(2008-11#2)
hemisphere is##3##2##(2008-11#3)
hemisphere of##3##2##(1993-6#2)(2007-12#1)
hemisphere stroke##3##2##(2008-2#2)(2013-1#1)
hemisphere to##2##2##(1996-2#1)(1997-8#1)
hemisphere was##2##2##(1991-11#1)(2008-11#1)
hemisphere##85##1##(1990-11#1)(1990-3#7)(1991-11#2)(1993-12#1)(1993-6#2)(1994-8#1)(1995-12#1)(1996-12#2)(1996-2#5)(1996-5#5)(1997-8#6)(2007-10#5)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#8)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
hemispheres##17##1##(1996-12#1)(1996-2#1)(1996-5#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#3)(2009-2#1)(2010-7#1)(2011-2#2)(2012-2#1)
hemispheric global##2##2##(1996-5#2)
hemispheric infarction##2##2##(2006-7#1)(2007-10#1)
hemispheric volume##4##2##(1995-8#2)(1996-7#2)
hemispheric##18##1##(1995-12#1)(1995-8#2)(1996-2#1)(1996-5#3)(1996-7#2)(2006-7#1)(2007-10#4)(2008-1#1)(2009-2#2)(2012-2#1)
hemispherical mirror##2##2##(2008-2#2)
hemispherical##13##1##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#6)
hemithorax##6##1##(2007-12#2)(2009-4#1)(2010-12#1)(2013-1#1)(2013-7#1)
hemithyroidectomy was performed##2##3##(2011-1#1)(2012-12#1)
hemithyroidectomy was##3##2##(2011-1#1)(2012-12#2)
hemizygous##62##1##(2008-8#5)(2008-9#55)(2009-5#1)(2009-8#1)
hemo- and##2##2##(1994-5#1)(2010-12#1)
hemobilia and intestinal hemorrhage##2##4##(1997-8#2)
hemocholecyst in##2##2##(2013-1#2)
hemocholecyst##3##1##(2013-1#3)
hemochromatosis and##4##2##(1992-5#1)(2006-10#1)(2008-7#1)(2010-12#1)
hemochromatosis##7##1##(1992-5#4)(2006-10#1)(2008-7#1)(2010-12#1)
hemocoel##2##1##(2008-10#1)(2008-7#1)
hemocompatibility##2##1##(2008-5#2)
hemocyanin##14##1##(1990-8#4)(2008-10#7)(2008-7#1)(2008-9#1)(2010-4#1)
hemocyte adhesion##2##2##(1995-8#2)
hemocyte with##2##2##(2008-5#2)
hemocyte##9##1##(1995-8#2)(2008-5#4)(2008-7#2)(2010-4#1)
hemocytes and##2##2##(2007-12#1)(2008-5#1)
hemocytes in the##3##3##(2008-5#1)(2008-7#2)
hemocytes in##5##2##(2008-5#2)(2008-7#3)
hemocytes##24##1##(1995-8#3)(2007-12#2)(2008-5#8)(2008-6#4)(2008-7#6)(2010-4#1)
hemocytic differentiation in##2##3##(2008-5#2)
hemodiafiltration##4##1##(2007-8#1)(2013-1#2)(2013-8#1)
hemodialysed patients##2##2##(2008-7#2)
hemodialysed##3##1##(2008-4#1)(2008-7#2)
hemodialysis (HD) access##2##3##(2007-7#2)
hemodialysis (HD) and##3##3##(2007-7#1)(2008-4#1)(2011-2#1)
hemodialysis (HD) patients##8##3##(2007-7#2)(2008-1#5)(2012-12#1)
hemodialysis (HD)##26##2##(2007-12#1)(2007-7#9)(2007-8#1)(2008-1#10)(2008-4#1)(2011-2#3)(2012-12#1)
hemodialysis access##9##2##(2007-7#8)(2011-3#1)
hemodialysis and peritoneal dialysis##4##4##(2007-7#1)(2008-10#3)
hemodialysis and##10##2##(2007-7#1)(2008-10#3)(2008-3#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
hemodialysis catheter##2##2##(2008-1#2)
hemodialysis catheters##5##2##(2007-7#3)(2010-3#2)
hemodialysis dialyzer##2##2##(2007-12#2)
hemodialysis for at least##2##4##(2008-1#1)(2010-5#1)
hemodialysis for##5##2##(2008-1#3)(2010-5#1)(2013-8#1)
hemodialysis have##2##2##(2007-7#1)(2013-1#1)
hemodialysis in the##3##3##(2008-1#1)(2013-1#2)
hemodialysis in##7##2##(1991-6#1)(1993-6#1)(2007-7#1)(2008-1#2)(2013-1#2)
hemodialysis is not##2##3##(2008-1#1)(2013-8#1)
hemodialysis is##7##2##(2008-1#3)(2008-10#1)(2009-11#1)(2013-1#1)(2013-8#1)
hemodialysis on##2##2##(2008-1#1)(2011-2#1)
hemodialysis or##2##2##(2008-4#1)(2011-2#1)
hemodialysis patients and##3##3##(2007-7#2)(2013-1#1)
hemodialysis patients in##6##3##(2007-7#5)(2008-1#1)
hemodialysis patients##47##2##(1994-6#1)(1996-2#2)(1997-7#1)(2007-10#2)(2007-2#1)(2007-7#18)(2008-1#11)(2010-5#2)(2011-1#7)(2011-2#1)(2013-1#1)
hemodialysis patients]##3##2##(2009-5#1)(2013-1#1)(2013-8#1)
hemodialysis saline solutions##2##3##(2008-10#2)
hemodialysis solutions##4##2##(2008-10#4)
hemodialysis treatment##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
hemodialysis unit##3##2##(1996-2#1)(2007-7#2)
hemodialysis units##3##2##(2008-1#2)(2010-10#1)
hemodialysis vascular##3##2##(2007-7#2)(2008-1#1)
hemodialysis was##3##2##(2007-7#1)(2008-10#1)(2008-4#1)
hemodialysis with blood flow of##2##5##(2008-4#2)
hemodialysis with##4##2##(2007-8#1)(2008-4#2)(2008-7#1)
hemodialysis##261##1##(1991-11#2)(1991-12#2)(1991-6#3)(1992-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-2#3)(1996-3#1)(1997-7#1)(2007-10#3)(2007-12#4)(2007-2#1)(2007-7#67)(2007-8#4)(2008-1#63)(2008-10#18)(2008-3#1)(2008-4#9)(2008-7#6)(2009-11#3)(2009-3#1)(2009-5#2)(2010-10#1)(2010-3#3)(2010-5#7)(2011-1#9)(2011-2#12)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#9)
hemodialysis-associated amyloidosis##2##2##(1994-6#2)
hemodialyzed##2##1##(2007-7#1)(2012-12#1)
hemodilution and##2##2##(1992-3#2)
hemodilution group##2##2##(1997-6#2)
hemodilution##12##1##(1992-3#3)(1993-5#1)(1995-11#1)(1997-6#6)(2007-10#1)
hemodynamic abnormalities##2##2##(2006-10#1)(2009-1#1)
hemodynamic alterations##3##2##(2010-4#1)(2013-8#2)
hemodynamic and##4##2##(1993-9#1)(1996-2#2)(2012-12#1)
hemodynamic changes during##2##3##(2008-7#1)(2009-6#1)
hemodynamic changes were##2##3##(2008-12#1)(2009-8#1)
hemodynamic changes##6##2##(1990-12#1)(1997-5#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-8#1)
hemodynamic collapse##2##2##(1995-2#1)(2013-1#1)
hemodynamic condition##2##2##(2008-3#1)(2011-2#1)
hemodynamic data and##2##3##(2011-2#2)
hemodynamic data##3##2##(2007-8#1)(2011-2#2)
hemodynamic effect##2##2##(2009-8#1)(2012-3#1)
hemodynamic effects##2##2##(1991-9#1)(1992-3#1)
hemodynamic factors##5##2##(2007-7#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
hemodynamic improvement##2##2##(1996-2#1)(2010-8#1)
hemodynamic instability##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
hemodynamic less than##2##3##(2012-3#2)
hemodynamic less##3##2##(2012-3#3)
hemodynamic management##2##2##(2010-8#1)(2011-2#1)
hemodynamic monitoring##2##2##(2009-1#1)(2011-2#1)
hemodynamic parameters##5##2##(2007-8#1)(2008-8#1)(2013-1#1)(2013-8#2)
hemodynamic profile##2##2##(2007-8#1)(2010-6#1)
hemodynamic responses##2##2##(1991-9#1)(2009-6#1)
hemodynamic stability##3##2##(2010-7#1)(2010-8#1)(2011-2#1)
hemodynamic status##2##2##(2008-5#1)(2008-9#1)
hemodynamic##97##1##(1990-12#1)(1990-8#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-9#1)(1994-3#2)(1995-2#1)(1996-2#5)(1997-5#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#6)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#4)(2009-3#1)(2009-6#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#6)(2010-7#1)(2010-8#3)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#12)(2013-1#6)(2013-8#4)
hemodynamically stable patients##2##3##(2007-8#1)(2011-2#1)
hemodynamically stable##6##2##(2007-8#2)(2008-3#1)(2009-4#1)(2011-2#2)
hemodynamically##9##1##(1993-2#1)(2007-8#2)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#3)
hemodynamics and##4##2##(1996-2#2)(2008-7#1)(2011-2#1)
hemodynamics are##2##2##(1996-2#1)(2011-2#1)
hemodynamics in##4##2##(1991-5#1)(2008-1#1)(2010-3#1)(2012-3#1)
hemodynamics##29##1##(1991-5#1)(1991-6#1)(1992-8#1)(1996-2#3)(1996-3#2)(1997-5#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
hemofiltration (HF)##2##2##(2007-8#1)(2010-5#1)
hemofiltration in##2##2##(1994-6#1)(2008-4#1)
hemofiltration##4##1##(1994-6#1)(2007-8#1)(2008-4#1)(2010-5#1)
hemoglobin (Hb) and##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
hemoglobin (Hb) at##3##3##(1994-12#1)(2007-7#1)(2008-10#1)
hemoglobin (Hb) is##2##3##(1994-5#1)(2008-10#1)
hemoglobin (Hb)##18##2##(1990-7#1)(1990-8#2)(1994-12#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-7#3)(2008-8#1)
hemoglobin A1c##8##2##(2007-10#1)(2008-1#1)(2008-3#1)(2012-5#5)
hemoglobin S and hemoglobin C##3##5##(1994-11#3)
hemoglobin S##6##2##(1994-11#3)(2012-12#3)
hemoglobin and##6##2##(1990-8#1)(2008-1#1)(2008-10#2)(2008-9#2)
hemoglobin as##2##2##(2008-10#2)
hemoglobin at##2##2##(2008-10#1)(2009-3#1)
hemoglobin can be##2##3##(1990-8#2)
hemoglobin chains##2##2##(1993-8#2)
hemoglobin concentration and oxygen saturation##3##5##(2008-3#3)
hemoglobin concentration and the##2##4##(2008-3#2)
hemoglobin concentration and##6##3##(2008-3#6)
hemoglobin concentration values##3##3##(2008-9#3)
hemoglobin concentration##25##2##(1990-8#3)(1991-12#1)(1992-12#2)(1996-9#2)(2008-10#1)(2008-3#10)(2008-9#5)(2013-1#1)
hemoglobin concentrations##2##2##(2008-10#1)(2008-3#1)
hemoglobin content##2##2##(2008-4#1)(2011-1#1)
hemoglobin could##2##2##(1996-9#1)(2013-8#1)
hemoglobin from##4##2##(1990-8#1)(2008-9#2)(2010-11#1)
hemoglobin in a##3##3##(1990-6#1)(1997-6#1)(2008-10#1)
hemoglobin in blood##2##3##(2011-1#1)(2013-1#1)
hemoglobin in the presence of##2##5##(1990-8#2)
hemoglobin in the##3##3##(1990-8#3)
hemoglobin in##14##2##(1990-6#1)(1990-8#4)(1991-2#1)(1994-12#1)(1997-6#1)(2008-10#3)(2008-9#1)(2011-1#1)(2013-1#1)
hemoglobin level##6##2##(1990-11#1)(2007-12#1)(2008-7#2)(2009-8#1)(2013-1#1)
hemoglobin levels and##2##3##(2010-9#1)(2012-12#1)
hemoglobin levels were##2##3##(2008-7#1)(2011-2#1)
hemoglobin levels##10##2##(2008-7#4)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)
hemoglobin measurement##2##2##(1990-6#1)(1994-3#1)
hemoglobin oxygen saturation##3##3##(2008-3#3)
hemoglobin oxygen##5##2##(1990-8#1)(2008-3#3)(2013-8#1)
hemoglobin solution##3##2##(1990-8#1)(1995-5#1)(1997-2#1)
hemoglobin synthesis##2##2##(2008-8#2)
hemoglobin variants##2##2##(1990-7#1)(2008-10#1)
hemoglobin was##8##2##(1990-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
hemoglobin were##7##2##(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
hemoglobin with##7##2##(1990-8#6)(2008-1#1)
hemoglobin##281##1##(1990-11#1)(1990-2#2)(1990-6#2)(1990-7#3)(1990-8#53)(1990-9#2)(1991-12#1)(1991-2#4)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#8)(1994-11#10)(1994-12#3)(1994-3#2)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#5)(1995-5#2)(1996-12#2)(1996-2#2)(1996-9#3)(1997-2#9)(1997-6#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#7)(2008-10#29)(2008-3#21)(2008-4#2)(2008-7#16)(2008-8#4)(2008-9#10)(2009-12#1)(2009-3#4)(2009-8#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#9)(2012-2#2)(2012-5#5)(2013-1#5)(2013-7#1)(2013-8#8)
hemoglobin-containing##2##1##(1994-11#1)(2008-4#1)
hemoglobin]##2##1##(1991-2#1)(2013-8#1)
hemoglobinopathies##4##1##(1990-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
hemoglobinopathy##5##1##(2012-3#1)(2013-8#4)
hemoglobins##12##1##(1990-8#10)(1992-3#1)(2011-2#1)
hemoglobinuria##9##1##(1992-12#2)(1992-3#3)(1994-12#1)(2008-4#2)(2008-9#1)
hemolymph and##4##2##(1995-11#1)(1997-8#1)(2008-10#1)(2008-6#1)
hemolymph by the##2##3##(2008-5#1)(2008-7#1)
hemolymph by##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
hemolymph of the##3##3##(1995-11#1)(2007-12#1)(2008-10#1)
hemolymph of##10##2##(1990-5#2)(1995-11#1)(1997-2#2)(2007-12#1)(2008-10#4)
hemolymph##40##1##(1990-5#2)(1995-11#2)(1997-2#2)(1997-6#1)(1997-8#4)(2007-12#2)(2008-10#14)(2008-11#1)(2008-5#1)(2008-6#6)(2008-7#3)(2012-2#2)
hemolysin##3##1##(1994-2#2)(1996-12#1)
hemolysis and##2##2##(1990-11#1)(2008-10#1)
hemolysis following##3##2##(1992-12#1)(1992-6#1)(1994-12#1)
hemolysis in a##2##3##(2007-12#1)(2008-7#1)
hemolysis in##3##2##(2007-12#1)(2008-7#2)
hemolysis index##2##2##(2013-1#2)
hemolysis model##2##2##(2008-7#2)
hemolysis of##2##2##(2008-10#1)(2013-1#1)
hemolysis that##2##2##(1994-12#1)(2008-7#1)
hemolysis##39##1##(1990-11#1)(1990-3#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#2)(1993-8#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-3#1)(2007-12#2)(2008-10#2)(2008-4#2)(2008-7#9)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#5)
hemolytic activity##2##2##(1992-6#1)(1994-11#1)
hemolytic anemia due to##2##4##(1992-6#1)(1994-6#1)
hemolytic anemia following##2##3##(1990-3#1)(1992-6#1)
hemolytic anemia##20##2##(1990-3#3)(1991-2#1)(1992-6#2)(1992-9#3)(1994-3#1)(1994-6#3)(1996-3#1)(1997-6#4)(2008-10#1)(2010-5#1)
hemolytic disease of the newborn##3##5##(1992-12#1)(1994-12#2)
hemolytic disease of the##4##4##(1992-12#1)(1994-12#2)(2010-11#1)
hemolytic toxin##2##2##(2008-10#1)(2008-8#1)
hemolytic uremic syndrome##6##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
hemolytic##48##1##(1990-3#3)(1991-2#1)(1992-12#1)(1992-6#3)(1992-9#3)(1994-11#3)(1994-12#2)(1994-3#1)(1994-6#3)(1994-9#1)(1995-3#1)(1996-3#1)(1997-6#4)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
hemomicrocirculatory disorders##2##2##(2011-1#2)
hemomicrocirculatory##3##1##(2011-1#3)
hemoperfusion##3##1##(2008-11#1)(2010-5#1)(2011-2#1)
hemoperitoneum##2##1##(2011-1#2)
hemophagocytic lymphohistiocytosis (HLH)##2##3##(2011-2#1)(2012-3#1)
hemophagocytic lymphohistiocytosis##4##2##(2011-2#2)(2012-3#2)
hemophagocytic syndrome##3##2##(2007-12#1)(2011-2#2)
hemophagocytic##7##1##(2007-12#1)(2011-2#4)(2012-3#2)
hemophagocytosis##3##1##(2011-2#3)
hemophilia A##7##2##(2008-12#3)(2012-12#4)
hemophilia B mice##2##3##(2008-9#2)
hemophilia B##8##2##(2008-8#2)(2008-9#6)
hemophilia##22##1##(1996-5#1)(2007-8#1)(2008-11#4)(2008-12#3)(2008-8#2)(2008-9#6)(2009-3#1)(2012-12#4)
hemophiliac patients##2##2##(2008-5#2)
hemophiliac##4##1##(1990-8#1)(2007-8#1)(2008-5#2)
hemophiliacs who contracted HIV from clotting products##2##7##(1996-5#1)(1997-5#1)
hemophiliacs who contracted HIV from##3##5##(1996-5#1)(1997-5#2)
hemophiliacs who##4##2##(1996-5#2)(1997-5#2)
hemophiliacs##14##1##(1993-8#1)(1996-5#7)(1997-5#4)(2008-5#1)(2012-12#1)
hemoplasma##2##1##(2012-3#2)
hemopoietic cells##4##2##(1991-5#1)(1993-3#1)(1997-2#1)(2008-5#1)
hemopoietic progenitor cells##2##3##(1994-5#2)
hemopoietic stem cells##2##3##(1992-5#1)(2013-1#1)
hemopoietic stem##3##2##(1992-5#1)(2013-1#2)
hemopoietic##17##1##(1991-5#2)(1992-12#2)(1992-5#1)(1993-3#1)(1993-9#1)(1994-5#2)(1997-2#2)(2007-4#1)(2008-5#2)(2013-1#3)
hemoproteins##4##1##(1994-5#1)(1995-3#1)(1997-7#1)(2008-6#1)
hemoptysis##8##1##(1997-8#1)(2007-8#3)(2008-5#1)(2012-3#2)(2013-1#1)
hemorheological parameters##2##2##(2008-7#1)(2009-11#1)
hemorheological##5##1##(2008-7#2)(2008-9#1)(2009-11#2)
hemorphins##2##1##(1995-3#2)
hemorrhage (ICH)##4##2##(2007-10#2)(2008-8#1)(2012-3#1)
hemorrhage (IVH)##2##2##(2007-10#1)(2011-2#1)
hemorrhage (SAH) secondary to##2##4##(2007-10#1)(2013-8#1)
hemorrhage (SAH)##8##2##(1995-5#1)(2007-10#3)(2012-2#1)(2012-3#2)(2013-8#1)
hemorrhage after##5##2##(2008-1#1)(2008-12#1)(2013-1#2)(2013-8#1)
hemorrhage and##11##2##(1994-6#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)
hemorrhage are##3##2##(2007-10#1)(2008-9#1)(2010-8#1)
hemorrhage as##3##2##(2010-10#1)(2011-2#2)
hemorrhage associated with livedo racemosa##2##5##(2007-9#2)
hemorrhage associated with##3##3##(1992-12#1)(2007-9#2)
hemorrhage due to##3##3##(1991-6#1)(1995-5#1)(2012-3#1)
hemorrhage during##2##2##(2007-10#1)(2008-7#1)
hemorrhage from the##2##3##(2008-12#1)(2011-2#1)
hemorrhage from##3##2##(2008-12#1)(2009-4#1)(2011-2#1)
hemorrhage had##2##2##(2007-10#1)(2011-2#1)
hemorrhage in the##2##3##(2011-2#1)(2012-12#1)
hemorrhage in##12##2##(1991-11#1)(2007-10#1)(2007-8#2)(2008-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
hemorrhage is##6##2##(1991-11#1)(2006-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
hemorrhage may##2##2##(2006-10#1)(2007-10#1)
hemorrhage of the##3##3##(1992-5#1)(1993-9#1)(1995-3#1)
hemorrhage of##5##2##(1992-2#1)(1992-5#1)(1993-9#1)(1995-3#1)(2013-8#1)
hemorrhage on##4##2##(2007-10#1)(2012-3#2)(2013-1#1)
hemorrhage secondary to##2##3##(1997-8#1)(2012-1#1)
hemorrhage was##4##2##(2007-10#1)(2008-7#2)(2011-2#1)
hemorrhage were##2##2##(1995-11#1)(2007-10#1)
hemorrhage with intraventricular##2##3##(2007-10#2)
hemorrhage with##3##2##(2007-10#2)(2011-2#1)
hemorrhage within the cyst##2##4##(2008-12#2)
hemorrhage##201##1##(1990-2#1)(1990-5#1)(1991-11#2)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#3)(1992-6#3)(1992-9#3)(1993-9#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-3#1)(1995-5#3)(1997-8#2)(2006-10#4)(2007-10#39)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#6)(2008-2#1)(2008-4#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#4)(2011-2#21)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#21)(2013-1#12)(2013-8#6)
hemorrhage]##2##1##(1990-9#1)(1992-6#1)
hemorrhages and##3##2##(1994-9#1)(2008-12#1)(2013-1#1)
hemorrhages were##2##2##(2012-12#1)(2012-3#1)
hemorrhages##17##1##(1994-9#1)(1995-11#1)(1996-6#1)(2007-10#2)(2008-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)
hemorrhagic alveolitis##2##2##(2006-10#2)
hemorrhagic appearance##2##2##(1992-8#1)(1993-9#1)
hemorrhagic colitis caused by Escherichia coli##2##6##(2010-6#2)
hemorrhagic colitis##3##2##(2008-9#1)(2010-6#2)
hemorrhagic complication##2##2##(2007-10#1)(2012-3#1)
hemorrhagic complications##2##2##(1991-5#1)(1991-6#1)
hemorrhagic cystitis##3##2##(2008-10#3)
hemorrhagic fever with renal syndrome##7##5##(2013-1#7)
hemorrhagic fever##12##2##(1992-6#1)(1995-6#3)(2012-2#1)(2013-1#7)
hemorrhagic fevers##2##2##(2011-1#1)(2013-8#1)
hemorrhagic hydrocephalus##3##2##(2011-2#3)
hemorrhagic lesion##2##2##(2007-10#1)(2012-3#1)
hemorrhagic pancreatitis##2##2##(2009-12#2)
hemorrhagic shock##2##2##(2012-3#1)(2013-1#1)
hemorrhagic stroke##5##2##(2007-10#2)(2008-8#1)(2009-9#1)(2012-12#1)
hemorrhagic telangiectasia##7##2##(2007-10#1)(2008-1#1)(2009-10#1)(2010-6#3)(2012-1#1)
hemorrhagic trauma##2##2##(2008-5#2)
hemorrhagic##89##1##(1990-5#1)(1991-11#1)(1991-5#1)(1991-6#3)(1992-2#1)(1992-6#2)(1992-8#2)(1993-9#1)(1994-8#1)(1995-6#5)(1996-12#1)(1996-6#1)(2006-10#2)(2007-10#7)(2007-7#1)(2008-1#2)(2008-10#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-9#2)(2010-5#1)(2010-6#8)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#11)(2013-8#2)
hemorrhoidal artery ligation##2##3##(2009-2#2)
hemorrhoidal lesions of the third##2##5##(1990-3#2)
hemorrhoidal##7##1##(1990-3#2)(2009-2#2)(2013-1#3)
hemorrhoidectomy##7##1##(1990-3#3)(2009-2#4)
hemorrhoidopexy##2##1##(2009-2#2)
hemosiderin deposits##2##2##(2008-12#1)(2013-1#1)
hemosiderin-stained##2##1##(2012-3#2)
hemostasis achieved##2##2##(1994-1#1)(2011-2#1)
hemostasis and##6##2##(1993-12#1)(1994-5#1)(1994-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
hemostasis during##2##2##(1994-9#1)(2010-3#1)
hemostasis impairment and##2##3##(2011-1#2)
hemostasis impairment##4##2##(2011-1#4)
hemostasis is##2##2##(1994-9#1)(2013-1#1)
hemostasis that##2##2##(2007-10#1)(2013-1#1)
hemostasis was##3##2##(1991-6#1)(2012-2#2)
hemostasis##43##1##(1991-6#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-9#4)(1995-2#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-9#1)(2010-3#3)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)
hemostasis]##2##1##(2008-11#1)(2013-1#1)
hemostatic##9##1##(1993-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-2#3)
hemosuccus pancreaticus##2##2##(2011-2#2)
hemothorax##2##1##(2007-8#1)(2010-5#1)
hemotoxicity##2##1##(1992-5#1)(2011-2#1)
hemp##6##1##(2008-10#1)(2008-12#1)(2008-6#4)
hen egg##3##2##(1994-8#1)(1997-2#1)(2008-9#1)
hen egg-white lysozyme (HEL)##2##4##(1990-12#2)
hen egg-white lysozyme crystals##2##4##(2008-4#2)
hen egg-white lysozyme##5##3##(1990-12#2)(1992-8#1)(2008-4#2)
hen##16##1##(1990-12#2)(1991-6#1)(1992-8#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-12#3)(2008-4#2)(2008-5#2)(2008-9#1)(2012-12#1)
hence a##5##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#2)
hence has##2##2##(1996-9#1)(2008-2#1)
hence in##2##2##(1997-4#1)(2007-12#1)
hence it can be used##2##5##(2008-10#1)(2008-2#1)
hence it is##2##3##(1997-1#1)(2008-7#1)
hence it##8##2##(1997-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2012-2#1)
hence the importance of##2##4##(1996-12#1)(2011-1#1)
hence the need for##2##4##(1992-9#1)(2010-10#1)
hence the##27##2##(1991-5#1)(1992-9#1)(1993-11#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-3#1)
hence they##2##2##(1993-8#1)(2013-1#1)
hence##185##1##(1990-12#2)(1990-7#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-5#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-7#1)(1997-9#1)(2007-11#5)(2007-12#6)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#39)(2008-11#4)(2008-12#3)(2008-2#11)(2008-3#18)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#10)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#2)
henceforth##2##1##(1997-7#1)(2008-9#1)
hens and##2##2##(2008-3#1)(2008-5#1)
hens could##2##2##(2008-10#1)(2013-1#1)
hens under heat stress##2##4##(2012-2#2)
hens##22##1##(1991-11#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#4)(2010-2#1)(2012-1#3)(2012-2#4)(2013-1#2)
hentscheli##2##1##(2008-9#2)
hepa 1 cells##5##3##(2008-11#5)
hepa 1##6##2##(2008-11#6)
heparan sulfate proteoglycan##2##3##(1992-11#1)(2008-7#1)
heparan sulfate proteoglycans##2##3##(1995-6#2)
heparan sulfate##10##2##(1992-11#1)(1995-12#3)(1995-6#2)(1997-1#1)(2008-5#1)(2008-7#1)(2013-8#1)
heparan##13##1##(1992-11#1)(1992-9#1)(1995-12#4)(1995-6#2)(1996-8#1)(1997-1#1)(2008-5#1)(2008-7#1)(2013-8#1)
heparanase##3##1##(1992-9#1)(2013-8#2)
heparin (UFH)##3##2##(2007-7#1)(2008-1#1)(2013-8#1)
heparin administration##2##2##(2007-7#1)(2013-1#1)
heparin and chondroitin sulfate##2##4##(2008-10#2)
heparin and non-steroidal anti-inflammatory agents]##2##5##(1995-5#1)(1995-6#1)
heparin and##14##2##(1992-5#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-8#1)
heparin are##2##2##(1995-5#1)(2008-4#1)
heparin as##4##2##(1994-6#1)(2007-10#1)(2008-10#1)(2010-3#1)
heparin binding##4##2##(1992-10#1)(1997-4#3)
heparin by##2##2##(2008-10#2)
heparin concentration##2##2##(1992-10#1)(2008-10#1)
heparin for##6##2##(1996-6#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-1#1)
heparin in the##3##3##(2007-10#1)(2007-8#1)(2008-11#1)
heparin in##13##2##(1992-1#1)(1992-10#2)(1993-8#1)(1994-6#1)(2007-10#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
heparin induced##2##2##(1990-9#1)(2013-1#1)
heparin is##4##2##(1992-1#1)(1995-5#1)(1997-4#1)(2010-8#1)
heparin resulted in##2##3##(1992-1#1)(1994-6#1)
heparin species##2##2##(1995-2#2)
heparin that##3##2##(1995-2#3)
heparin therapy##4##2##(1997-2#1)(2007-10#1)(2007-5#1)(2008-10#1)
heparin to##4##2##(1992-10#1)(1995-2#1)(1997-1#1)(2008-11#1)
heparin use##2##2##(1994-3#1)(2008-3#1)
heparin was##8##2##(1995-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
heparin##178##1##(1990-12#3)(1990-9#1)(1991-2#1)(1991-6#1)(1992-1#5)(1992-10#7)(1992-3#1)(1992-5#3)(1993-12#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#4)(1994-6#7)(1994-8#1)(1995-2#18)(1995-5#3)(1995-6#4)(1996-6#2)(1997-1#5)(1997-2#4)(1997-4#5)(1997-5#2)(1997-8#2)(2007-10#10)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#8)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#19)(2008-11#9)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2010-3#4)(2010-8#1)(2011-2#2)(2013-1#9)(2013-8#4)
heparin-Sepharose##3##1##(1992-11#1)(1994-6#1)(1995-8#1)
heparin-binding EGF-like growth factor##3##4##(1997-1#1)(2013-8#2)
heparin-binding forms by##2##3##(1990-12#2)
heparin-binding peptide##2##2##(2008-7#2)
heparin-binding##13##1##(1990-12#3)(1992-10#1)(1993-11#1)(1995-2#3)(1997-1#1)(2008-7#2)(2013-8#2)
heparin-induced thrombocytopenia (HIT)##2##3##(1997-2#1)(2013-1#1)
heparin-induced thrombocytopenia##5##2##(1997-2#3)(2013-1#2)
heparin-induced##7##1##(1997-2#3)(2011-2#2)(2013-1#2)
heparinase##3##1##(1993-3#1)(1995-3#1)(1995-6#1)
heparinization in##2##2##(2007-7#2)
heparinization##5##1##(2007-7#4)(2013-8#1)
heparinized and ACD blood##4##4##(2011-2#4)
heparinized blood and##2##3##(2011-2#2)
heparinized blood##3##2##(2011-2#3)
heparinized##11##1##(1990-8#1)(1991-9#1)(1996-12#1)(2011-2#8)
heparins##5##1##(1997-2#1)(2007-10#2)(2008-10#1)(2008-3#1)
hepatectomy and##4##2##(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
hepatectomy is##2##2##(1994-11#1)(2013-8#1)
hepatectomy##28##1##(1990-12#4)(1991-6#1)(1993-5#1)(1994-11#3)(1994-6#1)(1995-6#2)(1996-2#1)(2008-10#1)(2008-5#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#7)
hepatic CYP1A##3##2##(1996-12#1)(2008-10#2)
hepatic IGF-I gene expression##2##4##(2010-8#2)
hepatic L-FABP##2##2##(1994-8#2)
hepatic LDL##2##2##(2012-2#2)
hepatic adenoma##2##2##(1993-5#2)
hepatic and renal disorders##2##4##(2008-10#2)
hepatic and renal##7##3##(1995-3#1)(2008-10#4)(2013-1#1)(2013-8#1)
hepatic and splenic##2##3##(1993-9#1)(2012-3#1)
hepatic and##18##2##(1990-11#1)(1990-12#1)(1992-11#1)(1993-9#2)(1994-8#1)(1995-3#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
hepatic antioxidant status##2##3##(2008-10#2)
hepatic antioxidant##4##2##(2008-10#3)(2013-1#1)
hepatic apo B secretion##2##4##(1994-11#2)
hepatic arterial blood flow##2##4##(1990-3#2)
hepatic arterial##6##2##(1990-3#2)(1997-8#1)(2012-2#1)(2013-1#2)
hepatic artery arising from the##2##5##(2012-2#2)
hepatic artery##9##2##(1990-3#1)(1997-8#1)(2012-12#1)(2012-2#5)(2013-1#1)
hepatic biosynthesis of##2##3##(1990-2#2)
hepatic branch##4##2##(1993-12#3)(1996-5#1)
hepatic cell lines##3##3##(1990-12#2)(2008-10#1)
hepatic cell##5##2##(1990-12#2)(1994-11#1)(2008-10#1)(2008-11#1)
hepatic cells was##2##3##(1993-6#1)(2010-11#1)
hepatic cells##11##2##(1993-6#3)(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#2)(2011-1#2)
hepatic cirrhosis##3##2##(2007-12#1)(2009-8#1)(2012-3#1)
hepatic clearance of##2##3##(1991-1#1)(1992-2#1)
hepatic concentrations of CYP1A1##2##4##(1994-6#2)
hepatic concentrations of Cd##3##4##(1997-4#3)
hepatic concentrations of##5##3##(1994-6#2)(1997-4#3)
hepatic cyst##2##2##(1991-5#1)(2013-1#1)
hepatic cytochrome P450##3##3##(1994-6#1)(1996-12#2)
hepatic cytochrome##5##2##(1990-3#1)(1990-7#1)(1994-6#1)(1996-12#2)
hepatic damage##8##2##(1992-12#1)(1995-3#1)(1995-6#4)(2008-9#1)(2011-2#1)
hepatic drug##2##2##(1995-11#1)(2008-3#1)
hepatic dysfunction##8##2##(1995-11#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#3)
hepatic echinococcosis and##2##3##(1993-9#2)
hepatic encephalopathy##3##2##(1991-5#1)(2007-12#1)(2013-1#1)
hepatic endosomes##2##2##(1995-6#2)
hepatic enzymes##4##2##(1990-3#1)(2008-11#1)(2008-7#1)(2010-2#1)
hepatic expression of##3##3##(1995-8#1)(2008-6#1)(2013-8#1)
hepatic expression##5##2##(1995-2#1)(1995-3#1)(1995-8#1)(2008-6#1)(2013-8#1)
hepatic failure##10##2##(1991-11#1)(1992-5#1)(1994-8#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-3#1)
hepatic flexure##2##2##(1993-9#1)(2012-12#1)
hepatic function##2##2##(1994-5#1)(2013-1#1)
hepatic gene therapy##2##3##(1997-4#1)(2008-9#1)
hepatic gene##4##2##(1997-4#2)(2008-10#1)(2008-9#1)
hepatic glucagon receptor##2##3##(1994-11#2)
hepatic glucagon##3##2##(1994-11#3)
hepatic gluconeogenesis##4##2##(1991-3#1)(1994-8#1)(1995-6#1)(1996-2#1)
hepatic glucose production and##2##4##(2008-1#1)(2012-2#1)
hepatic glucose production##8##3##(1991-7#2)(1993-8#2)(2008-1#2)(2008-3#1)(2012-2#1)
hepatic glucose##9##2##(1991-7#3)(1993-8#2)(2008-1#2)(2008-3#1)(2012-2#1)
hepatic hydatid##3##2##(1991-8#1)(2008-10#1)(2013-1#1)
hepatic hydroxyproline##2##2##(2008-8#1)(2013-8#1)
hepatic induction##3##2##(1991-5#1)(2008-6#2)
hepatic injury##4##2##(1993-3#1)(2006-10#2)(2011-2#1)
hepatic insufficiency##3##2##(2006-10#2)(2008-9#1)
hepatic insulin##2##2##(1996-5#1)(2008-3#1)
hepatic involvement##5##2##(1996-11#1)(1997-8#1)(2008-7#1)(2012-3#1)(2013-1#1)
hepatic lesion##5##2##(1991-6#1)(1997-8#3)(2011-2#1)
hepatic lesions##3##2##(1997-8#1)(2008-9#1)(2010-12#1)
hepatic lipase (HL)##2##3##(1994-8#1)(2008-7#1)
hepatic lipase##4##2##(1992-3#1)(1994-8#2)(2008-7#1)
hepatic lipid##3##2##(2008-10#2)(2013-1#1)
hepatic long-chain acyl-CoA concentrations##2##4##(1994-8#2)
hepatic long-chain acyl-CoA levels##2##4##(1994-8#2)
hepatic long-chain acyl-CoA##5##3##(1994-8#5)
hepatic long-chain##6##2##(1994-8#6)
hepatic macrophages##2##2##(1997-4#2)
hepatic malignancies##3##2##(1995-10#1)(1997-8#1)(2013-1#1)
hepatic metabolism##3##2##(1992-8#1)(2008-3#2)
hepatic metastases##5##2##(1992-11#1)(2008-1#1)(2008-7#1)(2011-1#2)
hepatic microsomal cytochrome##2##3##(1992-11#1)(2008-8#1)
hepatic microsomal##10##2##(1992-11#1)(1993-12#2)(1994-11#1)(1994-6#1)(1994-8#1)(2008-8#4)
hepatic microsomes##5##2##(1991-5#1)(1994-6#1)(2011-1#3)
hepatic nuclear##2##2##(1994-11#1)(2008-10#1)
hepatic or##2##2##(1991-8#1)(1993-12#1)
hepatic perfusion##2##2##(1990-11#1)(2007-8#1)
hepatic regeneration##2##2##(1993-8#1)(2012-2#1)
hepatic resection##2##2##(2008-4#1)(2011-2#1)
hepatic reticuloendothelial cells##2##3##(1992-10#2)
hepatic secretion of##2##3##(2008-6#2)
hepatic stellate cells##3##3##(2006-10#1)(2009-7#1)(2013-8#1)
hepatic stellate##4##2##(2006-10#1)(2008-11#1)(2009-7#1)(2013-8#1)
hepatic tissue##3##2##(1994-6#2)(1996-12#1)
hepatic uptake of##3##3##(1992-3#3)
hepatic uptake##4##2##(1992-3#3)(2011-2#1)
hepatic vein##5##2##(1991-5#3)(1991-6#1)(2009-9#1)
hepatic venous blood##2##3##(1994-7#2)
hepatic venous##4##2##(1991-5#2)(1994-7#2)
hepatic zinc##2##2##(1990-5#2)
hepatic##431##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#5)(1990-5#4)(1990-7#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#11)(1991-6#2)(1991-7#4)(1991-8#3)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#5)(1993-8#3)(1993-9#7)(1994-11#10)(1994-2#1)(1994-5#3)(1994-6#9)(1994-7#2)(1994-8#16)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#5)(1995-6#7)(1995-8#2)(1996-11#1)(1996-12#8)(1996-2#2)(1996-5#7)(1997-2#1)(1997-3#2)(1997-4#9)(1997-8#12)(2006-10#7)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#8)(2008-10#25)(2008-11#7)(2008-12#2)(2008-3#13)(2008-4#4)(2008-5#3)(2008-6#9)(2008-7#8)(2008-8#12)(2008-9#12)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-8#3)(2011-1#11)(2011-2#15)(2012-12#2)(2012-2#17)(2012-3#8)(2013-1#26)(2013-7#1)(2013-8#7)
hepatica and##3##2##(1992-6#1)(2013-1#2)
hepatica infection##3##2##(2009-8#3)
hepatica##14##1##(1992-6#1)(1995-5#1)(1997-8#1)(2007-10#2)(2008-12#1)(2008-8#1)(2009-8#5)(2013-1#2)
hepatitis A has##3##3##(1997-3#1)(2007-12#2)
hepatitis A in Canada##2##4##(2007-12#2)
hepatitis A in##5##3##(2007-12#3)(2011-1#2)
hepatitis A incidence##2##3##(2011-1#2)
hepatitis A vaccine##2##3##(2007-2#1)(2008-7#1)
hepatitis A virus (HAV)##4##4##(2008-7#1)(2009-4#1)(2009-5#1)(2012-12#1)
hepatitis A virus infection##2##4##(2008-1#1)(2012-12#1)
hepatitis A virus##8##3##(2007-12#1)(2008-1#1)(2008-7#2)(2009-4#1)(2009-5#1)(2012-12#2)
hepatitis A##28##2##(1995-5#1)(1997-3#1)(2007-12#10)(2007-2#2)(2007-7#1)(2008-1#1)(2008-7#3)(2009-4#1)(2009-5#1)(2011-1#5)(2012-12#2)
hepatitis B and C##6##4##(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2013-1#1)(2013-7#1)
hepatitis B and hepatitis C##2##5##(2007-12#1)(2009-7#1)
hepatitis B and##13##3##(1990-12#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-2#2)(2007-7#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
hepatitis B in##8##3##(1991-6#1)(1993-6#1)(2007-12#2)(2009-8#1)(2010-11#1)(2011-2#2)
hepatitis B infection in##2##4##(1996-3#1)(2007-12#1)
hepatitis B infection##4##3##(1996-3#1)(2007-12#2)(2009-6#1)
hepatitis B stigma##2##3##(2012-1#2)
hepatitis B surface antibody##2##4##(2009-4#2)
hepatitis B surface antigen (HBsAg)##4##5##(1995-2#1)(2013-1#1)(2013-8#2)
hepatitis B surface antigen##15##4##(1994-5#1)(1995-2#1)(1996-11#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2013-1#1)(2013-8#2)
hepatitis B surface##20##3##(1994-11#1)(1994-5#1)(1995-2#2)(1996-11#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#2)(2013-1#1)(2013-8#2)
hepatitis B vaccination responses##3##4##(2008-10#2)(2009-4#1)
hepatitis B vaccination##8##3##(1993-2#1)(1995-2#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-12#1)(2009-4#1)
hepatitis B vaccine in##2##4##(1990-6#1)(2013-1#1)
hepatitis B vaccine##10##3##(1990-6#1)(1995-3#1)(2008-9#3)(2009-12#2)(2012-3#1)(2013-1#2)
hepatitis B virus (HBV) and##2##5##(2008-1#1)(2013-8#1)
hepatitis B virus (HBV) infection is##2##6##(2008-8#1)(2013-8#1)
hepatitis B virus (HBV) infection##8##5##(1997-4#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#2)(2012-12#1)(2013-8#1)
hepatitis B virus (HBV) infections##3##5##(1995-2#1)(2007-12#1)(2013-1#1)
hepatitis B virus (HBV) replication##2##5##(2009-8#1)(2013-8#1)
hepatitis B virus (HBV)##33##4##(1990-8#1)(1991-11#1)(1993-8#1)(1995-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2012-12#2)(2013-1#4)(2013-8#3)
hepatitis B virus DNA##3##4##(1990-8#1)(1997-4#1)(2006-10#1)
hepatitis B virus and##2##4##(2007-7#2)
hepatitis B virus in##3##4##(1993-2#1)(1993-6#1)(2009-3#1)
hepatitis B virus infection##2##4##(2008-10#1)(2012-2#1)
hepatitis B virus markers##2##4##(1996-3#1)(2011-1#1)
hepatitis B virus surface antigen (HBsAg)##3##6##(1994-11#1)(1997-4#1)(2008-8#1)
hepatitis B virus surface antigen##7##5##(1994-11#2)(1997-4#1)(1997-6#1)(2008-8#3)
hepatitis B virus x##2##4##(2008-8#1)(2012-12#1)
hepatitis B virus##82##3##(1990-8#2)(1991-11#1)(1991-6#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-7#1)(1994-8#2)(1995-2#6)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-4#4)(1997-5#1)(1997-6#2)(2006-10#4)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#6)(2013-8#4)
hepatitis B with##2##3##(1995-5#1)(2013-1#1)
hepatitis B##197##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-6#3)(1991-9#1)(1993-2#3)(1993-6#2)(1993-8#2)(1994-11#3)(1994-5#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#7)(1996-8#1)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#7)(2007-12#9)(2007-2#6)(2007-7#5)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#6)(2008-4#2)(2008-7#1)(2008-8#9)(2008-9#6)(2009-12#5)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#14)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#10)
hepatitis B&quot##2##2##(2009-8#1)(2011-2#1)
hepatitis C and##5##3##(2007-12#1)(2010-10#1)(2012-2#1)(2013-8#2)
hepatitis C in##6##3##(1992-12#1)(2007-7#1)(2008-1#1)(2009-7#1)(2010-11#1)(2011-2#1)
hepatitis C infection and its##2##5##(2007-7#1)(2010-6#1)
hepatitis C infection##3##3##(2007-7#1)(2010-6#1)(2012-12#1)
hepatitis C infections##2##3##(2008-1#1)(2009-4#1)
hepatitis C on##3##3##(2006-10#1)(2008-1#2)
hepatitis C or##2##3##(2009-8#1)(2012-12#1)
hepatitis C viral##2##3##(1994-11#1)(2008-1#1)
hepatitis C virus (HCV) infection##8##5##(2006-10#1)(2007-7#1)(2008-1#1)(2009-8#1)(2012-2#1)(2013-1#3)
hepatitis C virus (HCV)##25##4##(1990-3#1)(1994-8#1)(2006-10#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
hepatitis C virus and##2##4##(1991-2#1)(2007-7#1)
hepatitis C virus antibodies in##2##5##(1994-7#2)
hepatitis C virus infection##13##4##(2006-10#3)(2008-1#1)(2008-4#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
hepatitis C virus with##2##4##(2006-10#1)(2008-11#1)
hepatitis C virus##77##3##(1990-3#2)(1991-11#1)(1991-2#3)(1992-12#1)(1994-11#1)(1994-6#1)(1994-7#2)(1994-8#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#7)(2007-12#1)(2007-7#7)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#3)(2008-8#3)(2009-4#1)(2009-7#1)(2009-8#3)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#8)(2013-8#4)
hepatitis C##144##2##(1990-3#2)(1990-9#1)(1991-11#1)(1991-2#3)(1992-12#2)(1992-5#1)(1994-11#2)(1994-6#1)(1994-7#2)(1994-8#3)(1995-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#11)(2007-12#4)(2007-7#9)(2008-1#11)(2008-10#7)(2008-11#3)(2008-12#4)(2008-4#3)(2008-6#2)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#5)(2010-10#1)(2010-11#1)(2010-4#2)(2010-6#2)(2011-2#4)(2012-12#8)(2012-2#5)(2013-1#12)(2013-7#1)(2013-8#14)
hepatitis E infection##5##3##(2007-12#3)(2007-2#1)(2010-8#1)
hepatitis E virus##6##3##(1997-4#2)(2007-2#1)(2008-7#1)(2009-8#1)(2013-7#1)
hepatitis E##16##2##(1997-4#2)(2007-12#3)(2007-2#2)(2007-7#1)(2008-7#4)(2009-8#1)(2010-8#1)(2012-3#1)(2013-7#1)
hepatitis and##10##2##(1990-9#1)(2007-7#3)(2008-6#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
hepatitis as##2##2##(2009-5#1)(2009-8#1)
hepatitis cases##2##2##(1996-3#1)(2008-5#1)
hepatitis delta virus##3##3##(1994-11#2)(2009-8#1)
hepatitis in##13##2##(1994-8#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-3#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-5#1)(2008-7#1)
hepatitis induced by##2##3##(1994-8#1)(2008-10#1)
hepatitis infection##2##2##(2008-6#1)(2009-5#1)
hepatitis is##9##2##(1990-9#1)(1992-5#1)(1995-3#2)(1996-11#1)(1996-3#1)(1997-7#1)(2008-5#2)
hepatitis or##2##2##(2009-4#1)(2013-1#1)
hepatitis patients and##2##3##(2007-7#2)
hepatitis patients##3##2##(1991-8#1)(2007-7#2)
hepatitis type##2##2##(1993-5#1)(2010-4#1)
hepatitis viruses##2##2##(2007-7#2)
hepatitis##526##1##(1990-12#1)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#3)(1991-11#2)(1991-2#3)(1991-6#6)(1991-8#2)(1991-9#1)(1992-12#3)(1992-5#4)(1993-2#3)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#7)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#7)(1995-10#2)(1995-11#1)(1995-2#13)(1995-3#12)(1995-5#4)(1995-6#1)(1995-9#1)(1996-11#6)(1996-12#1)(1996-2#2)(1996-3#21)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#28)(2007-12#33)(2007-2#12)(2007-7#29)(2008-1#18)(2008-10#16)(2008-11#5)(2008-12#10)(2008-4#5)(2008-5#4)(2008-6#6)(2008-7#12)(2008-8#13)(2008-9#7)(2009-10#1)(2009-12#6)(2009-3#7)(2009-4#9)(2009-5#6)(2009-6#2)(2009-7#8)(2009-8#25)(2010-1#1)(2010-10#1)(2010-11#3)(2010-4#3)(2010-6#3)(2010-8#2)(2011-1#9)(2011-2#13)(2012-1#2)(2012-12#15)(2012-2#8)(2012-3#3)(2013-1#28)(2013-7#4)(2013-8#25)
hepatitis]##2##1##(1991-6#1)(1996-11#1)
hepatobiliary infection##2##2##(2006-10#2)
hepatobiliary##10##1##(1990-3#1)(1990-6#1)(1993-9#1)(2006-10#3)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
hepatoblastoma and##2##2##(2011-1#1)(2013-1#1)
hepatoblastoma specimens##2##2##(2013-1#2)
hepatoblastoma##12##1##(2008-11#3)(2011-1#4)(2012-3#1)(2013-1#4)
hepatoblasts##4##1##(2013-1#4)
hepatocarcinogenesis in##3##2##(1990-7#1)(1992-3#2)
hepatocarcinogenesis induced by N-nitrosomorpholine##2##4##(2008-4#2)
hepatocarcinogenesis##13##1##(1990-12#1)(1990-5#2)(1990-7#1)(1992-3#3)(2008-10#1)(2008-4#3)(2011-2#2)
hepatocarcinoma##8##1##(1993-6#1)(2008-9#1)(2010-1#3)(2012-12#1)(2013-1#2)
hepatocellular cancer##2##2##(2007-11#1)(2012-3#1)
hepatocellular carcinoma (HCC) cells##3##4##(2008-10#1)(2008-8#1)(2013-7#1)
hepatocellular carcinoma (HCC) is##4##4##(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
hepatocellular carcinoma (HCC)##19##3##(1991-11#1)(1992-3#1)(1993-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#3)(2010-12#2)(2011-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
hepatocellular carcinoma after##3##3##(1990-2#2)(1991-11#1)
hepatocellular carcinoma and##4##3##(1990-9#1)(2013-7#1)(2013-8#2)
hepatocellular carcinoma from metastatic tumors in the liver##2##8##(2010-7#2)
hepatocellular carcinoma from metastatic##3##4##(2010-7#3)
hepatocellular carcinoma in a##4##4##(1993-2#1)(2011-2#1)(2013-8#2)
hepatocellular carcinoma in##7##3##(1993-2#1)(2008-4#1)(2011-2#1)(2013-8#4)
hepatocellular carcinoma is##2##3##(2008-2#1)(2011-2#1)
hepatocellular carcinoma or##2##3##(2010-12#1)(2010-7#1)
hepatocellular carcinoma##82##2##(1990-2#2)(1990-8#1)(1990-9#1)(1991-11#2)(1992-3#2)(1993-2#2)(1993-8#1)(1994-12#1)(1994-7#1)(1996-8#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#7)(2009-3#1)(2009-8#3)(2009-9#1)(2010-12#4)(2010-3#2)(2010-6#2)(2010-7#5)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#6)(2013-8#16)
hepatocellular carcinomas##2##2##(1990-7#1)(2010-7#1)
hepatocellular degeneration##2##2##(2012-2#2)
hepatocellular necrosis##2##2##(1993-12#1)(2008-9#1)
hepatocellular##99##1##(1990-2#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1992-3#5)(1993-12#1)(1993-2#3)(1993-8#1)(1994-12#1)(1994-7#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#7)(2008-9#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-12#4)(2010-3#2)(2010-6#2)(2010-7#6)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#6)(2013-8#16)
hepatocyte cell lines##4##3##(2008-11#3)(2012-12#1)
hepatocyte cell##7##2##(2006-10#1)(2008-11#5)(2012-12#1)
hepatocyte culture##2##2##(1997-4#1)(2008-11#1)
hepatocyte cultures##5##2##(1990-5#1)(1992-11#1)(1993-3#1)(2008-4#2)
hepatocyte cylindroids##2##2##(2008-11#2)
hepatocyte cytoplasmic vacuolization in##3##4##(2008-9#3)
hepatocyte cytoplasmic vacuolization##5##3##(2008-9#5)
hepatocyte death and##2##3##(1995-2#2)
hepatocyte differentiation##2##2##(2008-6#2)
hepatocyte fatty change in##4##4##(2008-9#4)
hepatocyte fatty change##5##3##(2008-9#5)
hepatocyte growth factor (HGF)##3##4##(2008-11#1)(2008-8#1)(2011-2#1)
hepatocyte growth factor gene##3##4##(1993-8#1)(2008-11#1)(2010-12#1)
hepatocyte growth factor##15##3##(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(2008-1#1)(2008-11#3)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
hepatocyte growth##16##2##(1991-6#2)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(2008-1#1)(2008-11#3)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
hepatocyte plasma##2##2##(2008-7#2)
hepatocyte receptor##2##2##(1993-8#1)(1994-8#1)
hepatocyte specific functions##2##3##(1994-8#2)
hepatocyte spheroids##6##2##(2008-11#6)
hepatocyte##99##1##(1990-12#2)(1990-5#1)(1991-12#3)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#4)(1993-3#4)(1993-6#2)(1993-8#2)(1994-8#5)(1995-11#4)(1995-2#2)(1996-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#27)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#16)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
hepatocyte-like cells##3##2##(2008-9#3)
hepatocyte/Kupffer##2##1##(1992-3#2)
hepatocytes and a human hepatocyte cell line##2##7##(2008-11#2)
hepatocytes and a##3##3##(2008-11#3)
hepatocytes and in##2##3##(1994-6#1)(1996-5#1)
hepatocytes and##17##2##(1990-3#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-6#1)(1994-8#1)(1996-5#1)(2008-11#6)(2008-5#1)(2008-8#1)(2012-12#1)
hepatocytes appeared##2##2##(1992-6#1)(2008-4#1)
hepatocytes are##2##2##(1994-8#1)(2008-11#1)
hepatocytes as##2##2##(1994-6#1)(1995-8#1)
hepatocytes but##3##2##(1994-6#1)(1994-8#2)
hepatocytes by##4##2##(1992-3#1)(1993-11#1)(1993-3#1)(1995-8#1)
hepatocytes can##2##2##(1997-4#1)(2008-11#1)
hepatocytes cultured on##2##3##(1993-3#1)(2008-11#1)
hepatocytes derived from##2##3##(1994-11#2)
hepatocytes following liver injury##2##4##(2013-1#2)
hepatocytes for##2##2##(2008-11#2)
hepatocytes from fed##3##3##(1994-8#2)(1996-5#1)
hepatocytes from##8##2##(1991-12#1)(1994-11#1)(1994-8#3)(1996-2#1)(1996-5#1)(2013-1#1)
hepatocytes have##2##2##(2008-11#1)(2011-2#1)
hepatocytes in culture##2##3##(1990-12#1)(2008-11#1)
hepatocytes in primary culture##2##4##(1993-8#1)(1994-8#1)
hepatocytes in the##3##3##(1993-11#1)(1993-6#1)(1997-4#1)
hepatocytes in##9##2##(1990-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1997-4#1)(2008-11#2)(2012-5#1)
hepatocytes is##2##2##(1990-5#1)(1993-3#1)
hepatocytes isolated from##4##3##(1993-11#1)(1994-6#1)(1994-8#2)
hepatocytes may##2##2##(2008-11#1)(2008-8#1)
hepatocytes of the chronically ethanol fed rats##2##7##(1993-11#2)
hepatocytes of##8##2##(1993-11#2)(1994-6#3)(1995-2#1)(2008-9#2)
hepatocytes on##4##2##(1994-8#1)(2008-11#3)
hepatocytes or##2##2##(1993-6#1)(1997-4#1)
hepatocytes responded##2##2##(1991-12#2)
hepatocytes than in Fao cells##2##5##(2008-4#2)
hepatocytes to##7##2##(1991-12#1)(1993-3#1)(1994-8#1)(1996-2#1)(2008-11#2)(2008-4#1)
hepatocytes using##3##2##(1990-7#1)(1992-3#1)(2008-11#1)
hepatocytes was##11##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-8#1)(2008-11#2)(2008-6#1)(2008-9#1)
hepatocytes were significantly##2##3##(1995-12#1)(2008-8#1)
hepatocytes were##9##2##(1990-12#1)(1990-5#1)(1992-3#1)(1992-5#2)(1993-3#1)(1995-11#1)(1995-12#1)(2008-8#1)
hepatocytes with##11##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-2#2)(2008-10#1)(2008-11#2)(2013-1#1)
hepatocytes##267##1##(1990-11#3)(1990-12#11)(1990-2#3)(1990-3#5)(1990-5#10)(1990-7#2)(1990-8#2)(1991-12#10)(1991-2#1)(1991-9#3)(1992-12#2)(1992-3#12)(1992-5#5)(1992-6#2)(1993-11#7)(1993-12#1)(1993-3#14)(1993-6#3)(1993-8#7)(1994-11#7)(1994-6#10)(1994-8#22)(1995-11#3)(1995-12#1)(1995-2#2)(1995-8#5)(1996-2#6)(1996-5#4)(1997-4#8)(2008-1#2)(2008-10#2)(2008-11#46)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#9)(2012-5#2)(2013-1#9)(2013-7#1)(2013-8#1)
hepatological##2##1##(1996-3#1)(2013-8#1)
hepatology##4##1##(2006-10#2)(2010-6#1)(2012-2#1)
hepatoma 3924A##3##2##(1990-5#2)(1992-8#1)
hepatoma Fao##2##2##(1994-11#1)(2008-4#1)
hepatoma and##4##2##(1990-5#1)(1994-3#1)(2008-11#1)(2008-2#1)
hepatoma cell invasion##3##3##(2008-11#3)
hepatoma cell line of AH109A##4##5##(2008-11#4)
hepatoma cell line##11##3##(1991-12#1)(1997-1#1)(2008-11#6)(2008-8#1)(2012-12#1)(2013-8#1)
hepatoma cell lines##6##3##(1990-8#2)(1992-3#1)(1994-6#1)(2012-12#2)
hepatoma cell##24##2##(1990-8#2)(1991-12#1)(1992-3#1)(1994-6#1)(1997-1#1)(1997-4#1)(2008-11#10)(2008-8#3)(2012-12#3)(2013-8#1)
hepatoma cells and##3##3##(1992-3#1)(2008-11#1)(2012-12#1)
hepatoma cells by##4##3##(1992-3#1)(2008-11#3)
hepatoma cells in vitro##2##4##(1991-5#1)(2008-11#1)
hepatoma cells in##5##3##(1991-5#1)(2008-11#4)
hepatoma cells with##5##3##(1993-8#1)(1995-2#2)(2008-11#1)(2012-12#1)
hepatoma cells##33##2##(1990-5#1)(1991-5#1)(1992-10#2)(1992-3#4)(1993-6#2)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#2)(1997-4#1)(2008-11#12)(2008-8#3)(2012-12#2)
hepatoma##90##1##(1990-12#1)(1990-5#5)(1990-8#2)(1991-12#1)(1991-5#1)(1992-10#2)(1992-3#7)(1992-8#3)(1993-6#2)(1993-8#5)(1994-11#2)(1994-3#1)(1994-6#2)(1995-2#3)(1995-3#1)(1997-1#1)(1997-4#2)(2008-11#29)(2008-2#1)(2008-4#1)(2008-8#7)(2008-9#1)(2012-12#5)(2012-3#3)(2013-8#2)
hepatoma-derived cell##3##2##(1997-1#2)(2010-12#1)
hepatoma-derived cells##3##2##(1991-12#1)(2010-12#2)
hepatoma-derived##8##1##(1991-12#1)(1997-1#3)(2010-12#4)
hepatomas##10##1##(1990-5#5)(1990-6#2)(1993-8#1)(1994-6#1)(2008-4#1)
hepatomegaly##5##1##(1991-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
hepatopancreas##11##1##(1997-4#2)(2008-10#1)(2008-12#2)(2008-6#4)(2008-7#2)
hepatopathy##2##1##(1996-6#1)(2012-3#1)
hepatoportal osmo-receptive##2##2##(1993-12#2)
hepatoprotective action of##2##3##(2013-1#2)
hepatoprotective activity of##2##3##(2010-2#1)(2013-1#1)
hepatoprotective activity##3##2##(2010-2#1)(2013-1#2)
hepatoprotective##7##1##(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#4)
hepatoprotector##2##1##(2011-1#2)
hepatorenal damage##2##2##(1991-9#1)(2011-2#1)
hepatorenal##6##1##(1991-9#2)(1992-8#1)(1993-12#1)(1996-6#1)(2011-2#1)
hepatosplenomegaly##9##1##(1990-5#1)(2006-10#1)(2008-12#1)(2010-1#1)(2011-2#3)(2012-2#2)
hepatotoxic drugs##3##2##(2008-11#2)(2008-7#1)
hepatotoxic##6##1##(1994-5#1)(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#1)
hepatotoxicity and##2##2##(2008-7#1)(2010-12#1)
hepatotoxicity in##8##2##(1994-5#1)(2008-10#1)(2009-8#1)(2010-11#2)(2010-4#1)(2013-1#2)
hepatotoxicity is##2##2##(2008-7#1)(2008-8#1)
hepatotoxicity##33##1##(1990-12#1)(1991-8#1)(1994-5#2)(1995-3#8)(1996-12#1)(2006-10#1)(2008-10#2)(2008-7#5)(2008-8#3)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#2)(2012-3#1)(2013-1#2)
hepatotoxins##2##1##(1990-12#2)
hepcidin##7##1##(2010-12#7)
hepcidin-20##2##1##(2010-12#2)
hephaestin##2##1##(2012-2#2)
heptacarboxylic##2##1##(1991-5#2)
heptad repeat##3##2##(1993-11#2)(2008-7#1)
heptad repeats##3##2##(1990-11#1)(1993-11#1)(1995-6#1)
heptad##7##1##(1990-11#1)(1992-6#1)(1993-11#3)(1995-6#1)(2008-7#1)
heptafluorobutyric anhydride##3##2##(1992-8#1)(2008-10#2)
heptameric rings##3##2##(1994-5#3)
heptameric##4##1##(1994-5#4)
heptamethine dyes##2##2##(2009-12#2)
heptane##7##1##(1996-5#1)(2008-10#3)(2008-2#2)(2012-3#1)
heptapeptide##8##1##(1992-9#2)(1993-11#2)(1994-2#2)(2008-10#1)(2008-9#1)
heptapeptides##3##1##(1994-11#1)(2008-10#2)
heptenophos##2##1##(2008-10#2)
her ability to##3##3##(2008-6#1)(2009-9#1)(2012-12#1)
her body##5##2##(1991-3#1)(1995-3#1)(2007-2#1)(2007-7#1)(2009-3#1)
her brother##2##2##(1994-2#1)(2008-7#1)
her career##2##2##(2008-1#2)
her child##3##2##(2007-2#1)(2008-7#1)(2009-9#1)
her comorbidities##2##2##(2013-1#2)
her condition##3##2##(1995-12#1)(2006-10#1)(2011-2#1)
her conviction##2##2##(1992-9#2)
her current##2##2##(2008-1#1)(2012-12#1)
her death##3##2##(1995-12#1)(2011-2#2)
her discharge##2##2##(1994-6#1)(2013-1#1)
her disease##2##2##(1994-2#1)(1997-3#1)
her face##4##2##(1996-6#1)(2012-3#1)(2013-1#2)
her father##2##2##(2007-7#1)(2013-1#1)
her first##4##2##(1992-4#1)(1995-4#1)(2008-12#1)(2013-8#1)
her giant##2##2##(2011-2#2)
her illness##2##2##(1993-9#1)(2008-1#1)
her institution##2##2##(1994-12#1)(2012-2#1)
her left##5##2##(1996-11#1)(1996-8#1)(2008-12#1)(2010-8#1)(2012-3#1)
her legs##2##2##(1995-3#1)(2012-3#1)
her neck##2##2##(2008-12#2)
her own##6##2##(1993-3#1)(1995-12#2)(2008-2#1)(2008-8#1)(2011-2#1)
her pregnancy##4##2##(1993-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
her previous##2##2##(2007-7#1)(2012-3#1)
her primary##2##2##(1993-12#1)(2008-12#1)
her right foot##2##3##(2010-3#1)(2013-1#1)
her right lower extremity##2##4##(1991-12#1)(2012-3#1)
her right##19##2##(1991-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-7#1)
her role as##2##3##(1995-6#1)(2010-5#1)
her second##2##2##(1994-9#1)(2010-11#1)
her serum##2##2##(1994-12#1)(2007-12#1)
her son##2##2##(1994-12#1)(2008-7#1)
her sons##2##2##(1997-3#1)(2008-7#1)
her symptoms and##2##3##(2006-10#1)(2012-12#1)
her symptoms##7##2##(2006-10#1)(2008-7#2)(2012-12#1)(2013-1#1)(2013-8#2)
her to##5##2##(1992-4#1)(1993-9#1)(2007-2#1)(2007-9#1)(2013-1#1)
her treatment##2##2##(2011-2#1)(2012-12#1)
her upper##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
her work##2##2##(2008-8#1)(2011-2#1)
her##288##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#3)(1992-12#4)(1992-2#1)(1992-4#3)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-9#4)(1994-1#3)(1994-12#7)(1994-2#4)(1994-3#1)(1994-6#2)(1994-7#3)(1994-9#1)(1995-11#2)(1995-12#9)(1995-3#4)(1995-4#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-3#4)(1997-5#2)(1997-8#1)(2006-10#4)(2007-12#3)(2007-2#6)(2007-7#10)(2007-9#2)(2008-1#6)(2008-11#8)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#5)(2009-7#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#29)(2012-1#1)(2012-12#13)(2012-2#2)(2012-3#9)(2013-1#20)(2013-7#2)(2013-8#9)
her-2/neu overexpression##2##2##(2008-10#2)
her-2/neu##7##1##(2008-10#6)(2008-11#1)
herald##2##1##(2011-10#1)(2013-8#1)
heraldoi##4##1##(2008-12#4)
heralds##3##1##(1995-8#1)(2010-6#1)(2011-2#1)
herb and supplement use##3##4##(2008-10#3)
herb##30##1##(1994-11#1)(2007-2#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-9#4)(2009-3#1)(2012-2#1)(2012-3#2)(2013-1#3)
herba##2##1##(2008-10#1)(2012-3#1)
herbaceous hosts and##2##3##(2008-10#2)
herbaceous species##3##2##(2008-8#1)(2009-12#1)(2012-6#1)
herbaceous##9##1##(2008-10#3)(2008-6#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-6#1)(2013-8#1)
herbaceous)##2##1##(2013-7#2)
herbage##4##1##(2010-2#3)(2012-2#1)
herbal and##2##2##(2008-10#1)(2008-8#1)
herbal extract##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
herbal extracts##2##2##(2008-5#1)(2013-1#1)
herbal granules##3##2##(2010-5#3)
herbal ingredients##2##2##(2009-12#2)
herbal medicine in##2##3##(2013-7#1)(2013-8#1)
herbal medicine with effect of strengthening Qi##3##7##(2012-3#3)
herbal medicine##20##2##(2008-10#4)(2008-11#1)(2010-2#1)(2011-2#3)(2012-3#7)(2013-1#1)(2013-7#1)(2013-8#2)
herbal medicines##7##2##(1997-3#1)(2008-10#2)(2008-11#3)(2008-12#1)
herbal product##2##2##(2008-10#2)
herbal products##6##2##(2006-12#1)(2008-10#2)(2008-8#1)(2013-1#2)
herbal shampoos are##2##3##(2008-5#2)
herbal shampoos##6##2##(2008-5#6)
herbal teas##2##2##(2012-2#2)
herbal##87##1##(1994-6#1)(1997-3#1)(2006-12#3)(2008-10#26)(2008-11#6)(2008-12#2)(2008-5#9)(2008-8#4)(2009-12#3)(2009-6#1)(2010-2#1)(2010-5#3)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#8)(2013-1#6)(2013-7#2)(2013-8#3)
herbal)##2##1##(2008-10#2)
herbals##2##1##(2008-5#1)(2009-8#1)
herbaria##2##1##(2008-10#1)(2013-7#1)
herbarium##7##1##(2008-10#5)(2008-9#1)(2013-7#1)
herbicide 2##5##2##(2008-10#4)(2008-11#1)
herbicide and##2##2##(2008-10#2)
herbicide application##3##2##(1996-3#1)(2008-10#2)
herbicide formulations##2##2##(2008-10#1)(2008-5#1)
herbicide glyphosate##2##2##(2008-9#1)(2010-1#1)
herbicide recovery##2##2##(2008-11#2)
herbicide series##2##2##(2008-10#2)
herbicide treatment##2##2##(1997-2#1)(2008-10#1)
herbicide treatments##2##2##(2008-10#2)
herbicide used##2##2##(2008-10#1)(2008-11#1)
herbicide##65##1##(1995-8#1)(1996-3#2)(1997-2#1)(2006-12#1)(2008-10#46)(2008-11#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-1#2)(2011-1#1)(2011-2#1)
herbicide-resistant##3##1##(2008-9#3)
herbicides and##8##2##(1991-11#1)(1996-3#1)(2008-10#5)(2008-7#1)
herbicides are##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
herbicides based on##2##3##(2008-10#2)
herbicides from##7##2##(2008-10#4)(2008-11#3)
herbicides in##9##2##(2008-10#6)(2008-11#2)(2011-2#1)
herbicides on##3##2##(1996-3#1)(2008-10#2)
herbicides using##2##2##(2008-10#2)
herbicides was##3##2##(2008-10#3)
herbicides were##3##2##(2008-10#3)
herbicides##79##1##(1991-11#1)(1996-3#5)(1996-5#1)(2008-10#56)(2008-11#11)(2008-12#1)(2008-7#2)(2011-2#1)(2013-8#1)
herbicola##4##1##(1993-8#1)(2008-10#3)
herbimycin A##6##2##(1993-8#3)(1994-8#3)
herbimycin##7##1##(1993-8#4)(1994-8#3)
herbimycin-A##2##1##(1993-8#2)
herbivore diversity was##2##3##(2008-9#2)
herbivore diversity##3##2##(2008-9#3)
herbivore population dynamics##2##3##(2008-8#2)
herbivore populations##2##2##(2008-8#2)
herbivore species##3##2##(2008-5#1)(2013-7#2)
herbivore##30##1##(2008-5#1)(2008-8#13)(2008-9#11)(2011-2#1)(2013-7#4)
herbivore-induced plant##2##2##(1990-11#1)(2009-8#1)
herbivore-induced##3##1##(1990-11#1)(2008-9#1)(2009-8#1)
herbivores and pathogens##2##3##(2008-8#1)(2008-9#1)
herbivores and predators##2##3##(2008-8#1)(2009-2#1)
herbivores and##8##2##(2008-8#4)(2008-9#2)(2009-2#1)(2009-8#1)
herbivores are##2##2##(2008-9#1)(2010-2#1)
herbivores have##2##2##(2008-8#1)(2008-9#1)
herbivores in##3##2##(2008-5#2)(2008-9#1)
herbivores may##2##2##(2008-9#2)
herbivores##44##1##(1990-11#2)(2008-5#4)(2008-8#15)(2008-9#10)(2009-2#1)(2009-4#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#5)
herbivorous insects##6##2##(2008-8#3)(2008-9#3)
herbivorous species##2##2##(2008-8#1)(2011-2#1)
herbivorous##14##1##(2008-11#1)(2008-5#1)(2008-8#7)(2008-9#3)(2011-2#2)
herbivory by##2##2##(2008-8#1)(2009-8#1)
herbivory has##2##2##(2008-9#2)
herbivory in##2##2##(2008-8#1)(2008-9#1)
herbivory may##2##2##(2008-8#2)
herbivory on maternal plants##2##4##(2008-8#2)
herbivory on##9##2##(2008-8#5)(2008-9#4)
herbivory that##2##2##(2008-8#2)
herbivory##28##1##(2008-5#1)(2008-8#16)(2008-9#8)(2009-6#1)(2009-8#2)
herbs and other##2##3##(2008-10#1)(2008-8#1)
herbs and their##2##3##(2008-10#1)(2009-11#1)
herbs and##7##2##(1994-6#1)(2008-10#4)(2008-8#1)(2009-11#1)
herbs as##2##2##(2008-10#1)(2013-1#1)
herbs for##2##2##(1990-3#1)(2009-6#1)
herbs in##5##2##(2008-10#4)(2011-2#1)
herbs or botanicals##3##3##(2008-5#3)
herbs or##4##2##(2008-10#1)(2008-5#3)
herbs was##2##2##(2008-5#1)(2008-9#1)
herbs##52##1##(1990-3#1)(1992-2#5)(1994-6#1)(1997-6#1)(2006-12#1)(2008-10#20)(2008-5#8)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#3)(2013-7#1)
herd descriptors##2##2##(2012-1#2)
herd diagnosis would be##2##4##(1992-5#2)
herd predictive##2##2##(1992-5#2)
herd sensitivity##2##2##(1992-5#2)
herd specificity##2##2##(1992-5#2)
herd##25##1##(1992-2#1)(1992-5#9)(1993-2#1)(1996-12#6)(1997-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-1#2)
herding communities##2##2##(2009-8#2)
herding##4##1##(2009-8#4)
herdmates and##3##2##(2010-2#3)
herds and##3##2##(1990-6#1)(1992-5#1)(2012-3#1)
herds in the##3##3##(1992-5#1)(1996-8#2)
herds in##6##2##(1992-5#1)(1996-8#2)(2010-4#1)(2012-1#1)(2012-3#1)
herds were##3##2##(1990-6#1)(1992-5#1)(1995-9#1)
herds which##2##2##(1992-2#1)(1997-8#1)
herds with a##3##3##(1992-5#1)(1996-8#2)
herds with##6##2##(1990-6#1)(1992-5#1)(1996-8#2)(2012-1#1)(2013-8#1)
herds##41##1##(1990-6#3)(1992-2#4)(1992-5#6)(1995-9#1)(1996-12#1)(1996-8#4)(1997-8#3)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#5)(2012-3#7)(2013-8#1)
here a case of##11##4##(1992-10#1)(2007-7#6)(2007-8#1)(2009-2#1)(2010-1#1)(2010-6#1)
here a method##2##3##(2008-11#1)(2012-2#1)
here a new technique##2##4##(2007-8#1)(2008-10#1)
here a new##4##3##(1995-11#1)(2007-8#1)(2008-10#2)
here a novel##3##3##(1992-12#1)(2009-11#1)(2009-9#1)
here a simple##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2013-7#1)
here a##47##2##(1992-10#1)(1992-12#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-7#2)(2007-7#7)(2007-8#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
here also apply##2##3##(2007-12#1)(2008-4#1)
here also##5##2##(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)
here an##5##2##(1997-2#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
here and abroad##2##3##(1994-2#1)(2012-12#1)
here and elsewhere##2##3##(1994-2#1)(1996-12#1)
here and##12##2##(1994-2#2)(1995-11#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
here applied##2##2##(2008-10#2)
here are considered##2##3##(2008-10#1)(2008-3#1)
here are in##2##3##(2008-10#1)(2013-8#1)
here are##25##2##(1993-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2010-2#1)(2010-7#1)(2013-8#1)
here as a##7##3##(1990-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-7#1)
here as the##2##3##(1994-2#1)(2013-1#1)
here as##19##2##(1990-2#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
here at##2##2##(2008-10#1)(2012-5#1)
here by##4##2##(1991-9#1)(1997-3#2)(2008-3#1)
here called##3##2##(2008-10#2)(2008-3#1)
here can be used##3##4##(2007-8#1)(2008-7#1)(2013-1#1)
here can be##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
here can##7##2##(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
here compared##2##2##(1997-3#1)(2012-2#1)
here confirm that##2##3##(2008-10#1)(2008-3#1)
here could##2##2##(1993-12#1)(2007-11#1)
here demonstrate##2##2##(1990-5#1)(1994-12#1)
here demonstrates##2##2##(1993-3#1)(2011-2#1)
here described##4##2##(2008-10#4)
here established##2##2##(1995-6#1)(2012-2#1)
here for a##2##3##(2007-12#1)(2012-2#1)
here for assessing##2##3##(2008-1#1)(2008-3#1)
here for the first time##6##5##(2007-11#1)(2008-10#3)(2010-8#1)(2012-12#1)
here for the##8##3##(1993-2#1)(2007-11#1)(2008-10#4)(2010-8#1)(2012-12#1)
here for##23##2##(1990-8#1)(1992-2#1)(1993-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
here from##3##2##(2007-11#1)(2008-7#1)(2013-8#1)
here gives##2##2##(2007-11#1)(2008-10#1)
here has##6##2##(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)
here have##3##2##(1993-11#1)(1993-6#1)(2010-11#1)
here how##3##2##(2009-8#1)(2010-11#1)(2013-8#1)
here illustrates##2##2##(2008-11#1)(2008-3#1)
here in a##2##3##(1993-12#1)(2008-10#1)
here in detail##3##3##(1997-6#1)(2008-5#1)(2008-7#1)
here in terms of##2##4##(1994-5#1)(2008-10#1)
here in the##3##3##(1990-12#1)(2008-3#1)(2012-2#1)
here in##12##2##(1990-11#1)(1990-12#1)(1993-12#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
here include##2##2##(1997-2#1)(2008-3#1)
here is a##11##3##(2008-10#2)(2008-3#2)(2009-12#1)(2010-10#1)(2010-8#3)(2011-2#1)(2012-2#1)
here is also##2##3##(2008-3#1)(2008-4#1)
here is an##3##3##(1995-2#1)(2008-12#1)(2009-11#1)
here is based on##4##4##(1996-3#1)(2008-11#1)(2008-2#2)
here is for##2##3##(2008-4#1)(2008-9#1)
here is not##3##3##(1992-11#1)(2007-12#1)(2008-10#1)
here is of##2##3##(2008-10#1)(2013-1#1)
here is one##2##3##(2010-8#1)(2011-1#1)
here is rapid##2##3##(2008-10#2)
here is simple##2##3##(2008-10#1)(2008-11#1)
here is that##3##3##(1993-3#1)(2008-12#1)(2008-7#1)
here is the first##2##4##(2008-10#1)(2010-5#1)
here is the##4##3##(1992-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
here is to##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
here is useful##2##3##(1995-12#1)(2008-9#1)
here is##56##2##(1991-5#1)(1992-11#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
here lead##2##2##(1992-8#1)(2008-10#1)
here may also##2##3##(1996-2#1)(2012-2#1)
here may be##4##3##(1991-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
here may##8##2##(1991-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
here on the##5##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
here on##14##2##(1993-12#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
here our##4##2##(1990-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
here presented##2##2##(2008-10#2)
here provide an##2##3##(2008-11#1)(2008-4#1)
here provide the##3##3##(2009-10#1)(2009-7#1)(2012-1#1)
here provide##10##2##(1994-11#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
here provides##5##2##(1990-5#1)(1994-8#1)(2008-12#1)(2008-4#1)(2013-8#1)
here report the##4##3##(1991-12#1)(1996-10#1)(2011-2#1)(2013-1#1)
here report##8##2##(1991-12#1)(1996-10#1)(2007-8#2)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
here reported##2##2##(1993-12#1)(1995-3#1)
here represents a##2##3##(2008-10#2)
here requires##3##2##(1991-12#1)(1994-1#1)(1994-2#1)
here results##2##2##(1994-8#1)(2009-3#1)
here reviewed##2##2##(2008-8#1)(2013-8#1)
here should be##3##3##(1997-2#1)(2008-11#1)(2008-5#1)
here should##4##2##(1994-6#1)(1997-2#1)(2008-11#1)(2008-5#1)
here show that##9##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
here show##10##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
here shows##2##2##(2008-3#1)(2012-1#1)
here studied##2##2##(2008-10#2)
here suggest that##6##3##(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
here suggest##8##2##(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
here that a##5##3##(1991-12#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
here that an##2##3##(1990-5#1)(2009-5#1)
here that the##19##3##(1990-5#1)(1991-5#2)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-8#1)(1994-9#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
here that this inhibition is##2##5##(1993-8#1)(1997-3#1)
here that this##8##3##(1993-8#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
here that##81##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-12#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#3)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#4)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#3)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)
here the backbone##2##3##(2009-7#2)
here the case of a##2##5##(2008-10#1)(2013-1#1)
here the expression of##2##4##(1993-6#1)(1995-2#1)
here the first##4##3##(1994-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
here the purification of##2##4##(1992-11#1)(1997-4#1)
here the use of##2##4##(1995-11#1)(2010-8#1)
here the##65##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-11#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-9#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
here to be##3##3##(1993-11#1)(1993-8#1)(2008-10#1)
here to the##2##3##(1994-5#1)(2008-10#1)
here to##23##2##(1990-5#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-8#1)
here used##2##2##(2008-10#1)(2012-3#1)
here using##4##2##(2007-8#1)(2010-3#1)(2010-6#1)(2013-1#1)
here was the##2##3##(1993-1#1)(2008-11#1)
here was to##2##3##(1991-5#1)(2012-3#1)
here was##13##2##(1991-5#1)(1992-8#1)(1993-1#1)(1995-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-7#1)(2012-3#1)
here we describe##2##3##(2008-3#1)(2009-12#1)
here we provide##2##3##(2008-7#1)(2011-2#1)
here we report##2##3##(2010-12#1)(2012-4#1)
here we show that##3##4##(1992-5#1)(2011-2#1)(2012-2#1)
here we show##4##3##(1992-5#1)(2008-3#1)(2011-2#1)(2012-2#1)
here we##16##2##(1992-3#1)(1992-5#1)(2008-11#1)(2008-3#4)(2008-7#1)(2009-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-4#1)
here were to##2##3##(1995-11#1)(2008-5#1)
here were##5##2##(1995-11#1)(1995-2#1)(2008-10#1)(2008-5#2)
here which##3##2##(1997-4#1)(2008-10#2)
here will##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
here with a##2##3##(2008-3#1)(2008-7#1)
here with##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
here##846##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#4)(1991-2#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#8)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#9)(1993-12#6)(1993-2#4)(1993-3#4)(1993-6#7)(1993-8#6)(1993-9#3)(1994-1#2)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#4)(1995-11#9)(1995-12#5)(1995-2#11)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#4)(1997-3#8)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#1)(1997-9#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#2)(2007-7#10)(2007-8#11)(2008-1#7)(2008-10#127)(2008-11#46)(2008-12#12)(2008-2#18)(2008-3#54)(2008-4#36)(2008-5#21)(2008-6#4)(2008-7#32)(2008-8#14)(2008-9#11)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#6)(2011-2#22)(2011-3#1)(2011-8#1)(2012-1#5)(2012-12#9)(2012-2#20)(2012-3#5)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#14)(2013-7#4)(2013-8#14)
here?##3##1##(1991-1#1)(2008-11#1)(2008-8#1)
hereafter##3##1##(1990-11#1)(1996-1#1)(2009-2#1)
hereby presented##2##2##(2008-10#1)(2011-1#1)
hereby report a##3##3##(2007-7#1)(2012-12#1)(2012-2#1)
hereby report##6##2##(2007-7#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
hereby##21##1##(2007-7#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
hereditary angioedema##2##2##(2007-2#1)(2013-1#1)
hereditary breast cancer##2##3##(1993-1#1)(1995-12#1)
hereditary breast##3##2##(1993-1#1)(1995-12#1)(2011-2#1)
hereditary cancer##4##2##(1994-12#1)(2011-2#2)(2012-3#1)
hereditary cardiopathies##2##2##(1996-11#2)
hereditary diffuse gastric cancer##2##4##(2011-2#1)(2012-3#1)
hereditary disease##3##2##(1991-5#1)(1997-4#1)(2008-10#1)
hereditary diseases##2##2##(1990-3#1)(2013-8#1)
hereditary disorder##3##2##(1994-8#1)(2011-2#1)(2013-8#1)
hereditary disorders##3##2##(1994-11#1)(1996-6#1)(2007-10#1)
hereditary exostoses##2##2##(2008-8#1)(2010-3#1)
hereditary haemochromatosis##2##2##(1997-7#1)(2008-5#1)
hereditary hemorrhagic telangiectasia##6##3##(2007-10#1)(2008-1#1)(2009-10#1)(2010-6#2)(2012-1#1)
hereditary hemorrhagic##7##2##(2007-10#1)(2008-1#2)(2009-10#1)(2010-6#2)(2012-1#1)
hereditary melanoma families##2##3##(1997-7#2)
hereditary melanoma kindreds##2##3##(1997-7#2)
hereditary melanoma##4##2##(1997-7#4)
hereditary neuropathy##2##2##(1994-11#1)(1997-3#1)
hereditary nonpolyposis colon cancer##2##4##(2009-12#1)(2011-2#1)
hereditary nonpolyposis colorectal cancer##2##4##(1994-6#1)(2009-12#1)
hereditary nonpolyposis##4##2##(1994-6#1)(2009-12#2)(2011-2#1)
hereditary osteodystrophy##3##2##(2010-6#2)(2011-1#1)
hereditary syndrome##2##2##(1994-12#1)(2011-2#1)
hereditary##107##1##(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#3)(1991-5#1)(1992-3#1)(1992-9#3)(1993-1#2)(1994-11#2)(1994-12#3)(1994-6#3)(1994-8#2)(1994-9#1)(1995-12#1)(1996-11#2)(1996-6#1)(1997-3#4)(1997-4#1)(1997-7#5)(1997-8#2)(2006-6#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-12#6)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#4)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#4)(2013-8#3)
heredity##11##1##(1992-5#1)(1996-8#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-9#2)(2010-1#1)(2011-1#1)
herein allow for the##2##4##(2008-4#1)(2013-8#1)
herein are##4##2##(1990-2#1)(1991-2#1)(2008-9#2)
herein can be##2##3##(2008-10#2)
herein described##2##2##(2008-10#1)(2011-1#1)
herein is##4##2##(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)
herein report##10##2##(1990-6#1)(1992-12#1)(1993-8#1)(1997-2#1)(2009-8#1)(2010-4#1)(2010-6#2)(2012-2#1)(2013-1#1)
herein reported##3##2##(1993-8#1)(2008-5#1)(2008-6#1)
herein that##2##2##(2012-2#1)(2012-3#1)
herein to##2##2##(1996-12#1)(2008-10#1)
herein##104##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
heretofore##6##1##(1990-12#1)(1991-12#1)(1995-8#1)(2008-8#1)(2009-5#1)(2009-6#1)
herewith##5##1##(2007-7#1)(2008-1#2)(2008-10#2)
heritabilities for ear rot and aflatoxin production were##2##8##(2008-10#2)
heritabilities for##4##2##(2008-10#3)(2008-9#1)
heritabilities of apothecia development##2##4##(2008-10#2)
heritabilities of##4##2##(2008-10#3)(2008-8#1)
heritabilities##15##1##(2008-10#8)(2008-8#5)(2008-9#1)(2012-2#1)
heritability and##3##2##(2008-10#1)(2012-3#2)
heritability coefficients##2##2##(2007-1#1)(2008-10#1)
heritability estimates were##2##3##(2008-10#2)
heritability estimates##4##2##(2008-10#4)
heritability for##7##2##(2008-10#5)(2008-8#2)
heritability of resistance to##2##4##(2008-10#2)
heritability of the##2##3##(2008-10#1)(2008-8#1)
heritability of##12##2##(1997-7#1)(2008-10#5)(2008-2#1)(2008-8#3)(2008-9#1)(2012-3#1)
heritability was##4##2##(2008-10#3)(2008-8#1)
heritability were##2##2##(2008-10#2)
heritability##50##1##(1997-7#5)(2007-1#1)(2008-10#24)(2008-2#1)(2008-8#8)(2008-9#3)(2009-4#1)(2010-12#1)(2012-12#1)(2012-3#4)(2013-1#1)
heritable disorders##3##2##(1992-8#1)(2007-10#1)(2009-12#1)
heritable mutations##5##2##(2008-7#5)
heritable##28##1##(1992-8#1)(1994-11#1)(1995-6#1)(2007-10#1)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-4#2)(2012-3#2)(2013-1#1)
heritage of##6##2##(1993-3#1)(1995-5#1)(1997-3#1)(2008-10#2)(2012-2#1)
heritage##15##1##(1991-2#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#1)(2012-2#1)
hermaphrodite##9##1##(1994-12#1)(2007-12#6)(2008-8#1)(2008-9#1)
hermaphrodites##7##1##(2007-12#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-5#1)
hermaphroditic animals##2##2##(2008-8#2)
hermaphroditic gonad##2##2##(2010-5#1)(2011-2#1)
hermaphroditic groupers##2##2##(2010-5#2)
hermaphroditic plant##2##2##(2008-8#1)(2008-9#1)
hermaphroditic##16##1##(2008-10#1)(2008-5#3)(2008-8#4)(2008-9#4)(2010-5#3)(2011-2#1)
hermaphroditism in animals##3##3##(2008-8#3)
hermaphroditism##6##1##(2008-8#5)(2008-9#1)
hermeneutic phenomenological##2##2##(2013-1#2)
hermeneutic##5##1##(2008-11#1)(2009-10#1)(2010-9#1)(2013-1#2)
hermeneutical##3##1##(2009-9#1)(2010-9#1)(2013-1#1)
hermeneutics##2##1##(2012-3#2)
hermetically##2##1##(2008-3#1)(2010-10#1)
hermonthica##13##1##(2008-10#13)
hernia after##3##2##(1990-5#1)(2007-10#1)(2009-7#1)
hernia in##8##2##(1993-9#1)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#2)(2013-1#1)
hernia is a very##2##4##(2008-12#1)(2012-3#1)
hernia is a##5##3##(1990-5#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
hernia is one of the most##2##6##(2008-7#1)(2010-8#1)
hernia is one##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
hernia is##13##2##(1990-5#4)(2008-12#3)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
hernia repair has##2##3##(2011-2#2)
hernia repair is##3##3##(1996-9#1)(2010-4#1)(2011-2#1)
hernia repair##17##2##(1996-9#3)(2010-4#1)(2010-8#1)(2011-2#9)(2012-12#2)(2013-1#1)
hernia repairs##3##2##(2011-2#3)
hernia sac is##2##3##(2012-12#2)
hernia surgery##6##2##(1992-5#1)(1996-3#1)(1996-9#1)(2011-2#3)
hernia was##2##2##(1993-9#1)(2012-12#1)
hernia with##6##2##(2011-2#5)(2012-3#1)
hernia##106##1##(1990-12#1)(1990-5#6)(1992-5#2)(1993-9#6)(1996-3#1)(1996-9#6)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#14)(2008-7#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#29)(2012-1#1)(2012-12#10)(2012-2#3)(2012-3#2)(2013-1#3)
hernia--a##2##1##(2008-12#1)(2012-3#1)
hernial##2##1##(2008-12#1)(2011-1#1)
hernias and##2##2##(1990-9#1)(1996-9#1)
hernias are##6##2##(2008-12#2)(2009-8#1)(2011-2#2)(2012-12#1)
hernias can##2##2##(1993-9#1)(2011-2#1)
hernias in##2##2##(1991-8#1)(1996-9#1)
hernias of the##2##3##(1993-5#1)(1993-9#1)
hernias of##3##2##(1993-5#1)(1993-9#1)(2011-2#1)
hernias##51##1##(1990-5#1)(1990-6#2)(1990-9#2)(1991-8#1)(1992-5#1)(1993-5#1)(1993-9#6)(1996-6#1)(1996-9#6)(2008-12#2)(2009-7#1)(2009-8#1)(2010-8#5)(2011-1#1)(2011-2#17)(2012-12#1)(2012-2#1)(2013-1#1)
herniated intervertebral##2##2##(1996-8#1)(2008-7#1)
herniated through the##2##3##(2008-12#1)(2011-2#1)
herniated##9##1##(1990-5#1)(1990-9#1)(1995-12#1)(1996-8#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
herniation after##3##2##(2007-8#3)
herniation following##3##2##(2007-8#2)(2008-11#1)
herniation of omentum into the pericardial cavity##2##7##(2007-8#2)
herniation of omentum##3##3##(2007-8#3)
herniation of##6##2##(2007-8#4)(2009-4#1)(2011-2#1)
herniation that##3##2##(2007-10#1)(2009-3#1)(2011-2#1)
herniation##45##1##(1992-2#1)(1995-11#1)(1997-2#1)(1997-3#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-8#11)(2008-11#2)(2008-12#5)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
hernioplasties##2##1##(1996-9#2)
hernioplasty##3##1##(1993-9#1)(2012-1#1)(2012-12#1)
herniorrhaphy##5##1##(2011-2#5)
heroes##2##1##(2013-7#1)(2013-8#1)
heroic##2##1##(1995-8#1)(1996-1#1)
heroin addiction##2##2##(2008-6#1)(2012-1#1)
heroin addicts##5##2##(1991-1#1)(1991-12#4)
heroin and##3##2##(1991-1#1)(2009-7#1)(2010-5#1)
heroin##31##1##(1990-3#1)(1991-1#2)(1991-12#4)(1993-3#1)(1996-11#1)(1996-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-5#1)(2011-1#1)(2012-1#3)(2012-2#4)(2013-8#2)
heroin/cocaine##2##1##(2013-8#2)
herpes encephalitis##3##2##(1995-5#2)(1996-3#1)
herpes simplex virus (HSV)##3##4##(1996-12#1)(1996-6#1)(2008-8#1)
herpes simplex virus DNA polymerase##3##5##(1995-2#3)
herpes simplex virus in##2##4##(2009-4#2)
herpes simplex virus type 1 (HSV-1)##2##6##(2007-12#1)(2008-10#1)
herpes simplex virus type 1##5##5##(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#1)
herpes simplex virus type##6##4##(2007-12#2)(2008-10#1)(2008-11#2)(2008-9#1)
herpes simplex virus vectors##2##4##(2008-11#1)(2008-4#1)
herpes simplex virus##20##3##(1995-2#3)(1996-12#2)(1996-6#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-2#1)(2012-2#1)
herpes simplex##27##2##(1994-11#1)(1995-2#5)(1996-12#2)(1996-6#2)(2007-12#2)(2007-2#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#3)(2011-2#1)(2012-2#1)
herpes virus##6##2##(1990-9#1)(2007-2#1)(2008-5#3)(2012-3#1)
herpes zoster in##2##3##(2007-7#2)
herpes zoster##9##2##(1991-6#1)(1994-3#1)(2007-7#2)(2008-4#1)(2008-5#1)(2008-7#3)
herpes##63##1##(1990-9#1)(1991-6#1)(1994-11#1)(1994-3#1)(1995-2#5)(1995-5#2)(1996-12#2)(1996-3#1)(1996-6#2)(2007-1#1)(2007-12#5)(2007-2#4)(2007-7#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
herpesvirus 1##3##2##(2011-2#2)(2012-3#1)
herpesvirus isolates of##2##3##(1997-6#2)
herpesvirus isolates##4##2##(1997-6#4)
herpesvirus of##2##2##(1997-6#1)(2007-6#1)
herpesvirus##21##1##(1991-2#1)(1991-6#1)(1993-11#2)(1997-6#6)(2007-6#1)(2008-4#1)(2008-5#3)(2011-2#2)(2012-3#4)
herpesvirus-1##3##1##(1995-9#1)(2011-1#1)(2013-8#1)
herpesvirus-6 (HHV-6)##2##2##(1992-2#1)(1993-11#1)
herpesviruses were##2##2##(1997-6#1)(2008-5#1)
herpesviruses##9##1##(1992-2#1)(1993-11#1)(1994-6#1)(1995-3#2)(1997-6#1)(2007-6#1)(2008-5#1)(2010-1#1)
herpeticum##2##1##(2007-7#2)
herring##2##1##(2008-11#2)
herself##8##1##(1990-6#1)(1991-6#1)(1996-5#1)(2007-7#3)(2008-1#1)(2008-7#1)
hertz##4##1##(2007-12#1)(2008-3#3)
herzi##6##1##(2010-8#6)
hesitate to##2##2##(2007-10#1)(2009-11#1)
hesitation##2##1##(2010-11#1)(2011-2#1)
het##4##1##(1996-8#1)(2012-12#3)
hetero poly acid##2##3##(2008-10#2)
hetero-##2##1##(2008-5#1)(2011-1#1)
hetero-Diels-Alder##2##1##(2008-7#1)(2010-2#1)
hetero-metal polynuclear hydrolytic species##2##4##(2008-10#2)
hetero-metal species##2##2##(2008-10#2)
hetero-metal##4##1##(2008-10#4)
hetero-sexual transfer of PGCs had abnormal gonads##2##7##(2008-11#2)
hetero-sexual transfer of PGCs##3##4##(2008-11#3)
hetero-sexual transfer##4##2##(2008-11#4)
heteroaryl##4##1##(2008-8#3)(2009-5#1)
heteroatom##3##1##(2006-12#1)(2007-11#2)
heteroatoms##2##1##(2006-12#1)(2007-11#1)
heterochromatic regions##6##2##(2008-12#1)(2009-10#5)
heterochromatic silencing##2##2##(2009-3#2)
heterochromatic##18##1##(1993-9#2)(2008-12#3)(2008-2#1)(2009-10#7)(2009-3#4)(2010-8#1)
heterochromatin formation##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
heterochromatin##23##1##(1991-12#2)(1993-12#1)(2008-12#7)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
heterochrony##2##1##(2008-9#1)(2010-8#1)
heteroclinic connection##2##2##(2007-12#2)
heterocycle##3##1##(1997-3#1)(2007-11#1)(2012-12#1)
heterocycles##5##1##(1995-3#1)(2007-11#2)(2008-11#2)
heterocyclic amine carcinogens##2##3##(1992-6#2)
heterocyclic amines##8##2##(1992-2#1)(1992-6#1)(1997-2#4)(2008-10#2)
heterocyclic aromatic##3##2##(1995-3#1)(1997-2#2)
heterocyclic compounds##2##2##(1995-3#1)(2007-11#1)
heterocyclic radicals##2##2##(2007-11#1)(2008-10#1)
heterocyclic ring##3##2##(1992-3#1)(2008-10#1)(2012-2#1)
heterocyclic system##2##2##(2009-12#2)
heterocyclic systems##2##2##(2007-11#1)(2008-11#1)
heterocyclic##39##1##(1992-2#1)(1992-3#1)(1992-6#3)(1995-2#2)(1995-3#4)(1996-5#1)(1997-2#6)(2007-11#8)(2008-10#5)(2008-11#2)(2008-4#1)(2009-12#2)(2009-5#1)(2012-2#1)(2012-3#1)
heterocyclization##2##1##(2007-11#2)
heterodimer in##2##2##(2008-9#2)
heterodimer with##2##2##(1993-11#1)(2010-6#1)
heterodimer##27##1##(1990-12#2)(1991-6#2)(1993-11#5)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#2)(1997-4#1)(2008-11#2)(2008-9#4)(2010-6#2)(2011-2#1)
heterodimeric enzyme##2##2##(1993-11#1)(1993-9#1)
heterodimeric form of##2##3##(1993-11#2)
heterodimeric##21##1##(1990-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-8#1)(1993-9#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-4#2)(2008-10#1)(2008-11#2)(2010-6#2)(2011-2#1)
heterodimerization##4##1##(1995-2#1)(1995-8#1)(2008-1#1)(2008-11#1)
heterodimers and##2##2##(1996-2#1)(2012-2#1)
heterodimers with##3##2##(1990-4#1)(1995-8#2)
heterodimers##14##1##(1990-4#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-8#3)(1996-2#3)(1997-7#1)(2008-11#1)(2011-1#1)(2012-2#1)
heteroduplex mobility assay (HMA)##2##4##(2008-10#2)
heteroduplex mobility assay##3##3##(2008-10#3)
heteroduplex##8##1##(1992-8#1)(2008-10#4)(2008-4#3)
heteroduplexes##3##1##(2008-10#2)(2008-4#1)
heterodyne beat##2##2##(2007-11#2)
heterodyne detection of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
heterodyne detection to##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
heterodyne detection##17##2##(2007-11#3)(2007-12#6)(2008-2#3)(2008-3#5)
heterodyne detector##2##2##(2008-3#2)
heterodyne holography##2##2##(2007-12#2)
heterodyne imaging##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
heterodyne interferometer nonlinearity##2##3##(2007-11#2)
heterodyne interferometer with##2##3##(2007-12#1)(2008-3#1)
heterodyne interferometer##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
heterodyne interferometry##7##2##(1995-5#2)(2007-11#2)(2008-3#3)
heterodyne laser-induced thermal##2##3##(2007-11#2)
heterodyne lidar##4##2##(2008-2#3)(2008-3#1)
heterodyne method for##2##3##(2007-12#1)(2008-3#1)
heterodyne mixing efficiency##4##3##(2008-2#4)
heterodyne signal##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
heterodyne technique##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
heterodyne##83##1##(1995-5#2)(2007-11#15)(2007-12#17)(2008-2#18)(2008-3#28)(2008-8#1)(2013-8#2)
heterodyned##3##1##(2008-3#3)
heterodyning of##2##2##(2007-11#1)(2007-12#1)
heterodyning##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
heterofermentative##2##1##(1997-4#2)
heterogamety and##3##2##(2010-3#3)
heterogamety##4##1##(2010-3#4)
heterogeneic nature##2##2##(2008-10#1)(2008-9#1)
heterogeneities in##2##2##(1991-6#1)(2010-8#1)
heterogeneities##7##1##(1990-6#1)(1991-6#1)(1992-9#1)(1996-4#1)(2008-9#1)(2010-8#1)(2011-1#1)
heterogeneity among##6##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#2)
heterogeneity and the##5##3##(2008-10#3)(2008-9#1)(2013-1#1)
heterogeneity and##14##2##(1990-8#1)(2008-10#6)(2008-8#2)(2008-9#1)(2010-2#1)(2013-1#3)
heterogeneity between the##2##3##(2008-12#1)(2008-8#1)
heterogeneity between##6##2##(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-11#1)
heterogeneity by##2##2##(2008-11#1)(2011-2#1)
heterogeneity has##2##2##(2013-1#1)(2013-7#1)
heterogeneity in DNA damage##2##4##(1994-8#1)(1997-4#1)
heterogeneity in a##3##3##(2007-4#1)(2008-11#1)(2013-1#1)
heterogeneity in aortic##2##3##(2013-3#2)
heterogeneity in susceptibility##3##3##(2008-9#3)
heterogeneity in the##10##3##(1991-9#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-8#1)(2010-2#1)(2011-2#1)
heterogeneity in##42##2##(1991-9#2)(1992-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-12#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-8#2)(2008-9#7)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-3#2)
heterogeneity is##5##2##(1990-12#1)(1994-5#1)(2008-10#1)(2008-6#1)(2008-8#1)
heterogeneity may##2##2##(1992-9#1)(2008-8#1)
heterogeneity of cell##2##3##(2008-10#1)(2013-8#1)
heterogeneity of disease##4##3##(2008-10#3)(2013-8#1)
heterogeneity of human##2##3##(1993-11#1)(1995-12#1)
heterogeneity of samples##2##3##(2008-4#1)(2012-12#1)
heterogeneity of the disease##2##4##(2010-12#1)(2011-2#1)
heterogeneity of the##24##3##(1991-12#1)(1994-2#1)(1997-4#1)(2007-10#1)(2008-10#9)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
heterogeneity of this##2##3##(1992-10#1)(2011-2#1)
heterogeneity of##84##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
heterogeneity on##2##2##(2008-10#1)(2008-8#1)
heterogeneity that##6##2##(1991-6#1)(1994-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
heterogeneity was##4##2##(1997-4#1)(2008-10#2)(2009-5#1)
heterogeneity within##2##2##(2008-10#1)(2008-7#1)
heterogeneity##247##1##(1990-12#1)(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-2#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#50)(2008-11#9)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#24)(2008-9#24)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#7)(2013-3#2)(2013-7#1)(2013-8#3)
heterogeneous and##9##2##(1997-4#1)(2008-1#1)(2008-2#1)(2008-9#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
heterogeneous catalyst##2##2##(2012-2#1)(2013-1#1)
heterogeneous catalysts##2##2##(2008-10#1)(2010-12#1)
heterogeneous clinical##3##2##(2010-12#1)(2010-3#1)(2012-3#1)
heterogeneous correlation filter##2##3##(2007-12#2)
heterogeneous correlation##3##2##(2007-12#3)
heterogeneous disease##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
heterogeneous electron transfer rate constant k##2##6##(2008-10#2)
heterogeneous electron transfer rate constant##3##5##(2008-10#3)
heterogeneous electron transfer rate##4##4##(2008-10#4)
heterogeneous electron transfer##6##3##(2008-10#6)
heterogeneous environment##3##2##(1995-5#1)(2008-10#1)(2008-4#1)
heterogeneous for##2##2##(2008-7#1)(2008-9#1)
heterogeneous group of diseases that##2##5##(2009-10#1)(2012-3#1)
heterogeneous group of diseases##3##4##(2008-7#1)(2009-10#1)(2012-3#1)
heterogeneous group of disorders##2##4##(2008-7#1)(2012-2#1)
heterogeneous group of##18##3##(1991-11#1)(1994-2#1)(1995-5#1)(1997-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#3)
heterogeneous group##20##2##(1991-11#1)(1994-2#1)(1995-5#1)(1997-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#3)
heterogeneous groups of##2##3##(2010-12#1)(2013-8#1)
heterogeneous immunoassay##3##2##(1990-12#1)(2008-10#2)
heterogeneous in their##2##3##(2008-9#1)(2012-2#1)
heterogeneous in##4##2##(1996-6#1)(2008-9#1)(2010-12#1)(2012-2#1)
heterogeneous mixture of##3##3##(2008-4#1)(2008-5#2)
heterogeneous mixture##4##2##(2008-10#1)(2008-4#1)(2008-5#2)
heterogeneous mixtures of##2##3##(2008-10#1)(2011-2#1)
heterogeneous nature of##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2010-6#1)
heterogeneous nuclear ribonucleoprotein##3##3##(2008-8#2)(2008-9#1)
heterogeneous nuclear##4##2##(2007-12#1)(2008-8#2)(2008-9#1)
heterogeneous population of##5##3##(1991-12#1)(1995-12#2)(2008-1#1)(2008-11#1)
heterogeneous population##9##2##(1991-12#1)(1995-12#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-8#1)
heterogeneous populations of clusters##2##4##(2010-10#2)
heterogeneous populations of##3##3##(2008-10#1)(2010-10#2)
heterogeneous populations##8##2##(2008-10#4)(2008-4#1)(2008-9#1)(2010-10#2)
heterogeneous radio##2##2##(2009-3#2)
heterogeneous response##3##2##(1990-2#1)(2006-6#1)(2012-3#1)
heterogeneous set of##3##3##(1993-3#1)(1997-5#1)(2011-2#1)
heterogeneous systems##7##2##(2008-10#1)(2008-5#2)(2010-12#1)(2010-8#3)
heterogeneous turbid media##2##3##(2007-12#1)(2008-3#1)
heterogeneous with regard to##2##4##(1992-11#1)(2010-4#1)
heterogeneous with##5##2##(1992-11#1)(1997-4#1)(1997-8#1)(2010-4#1)(2011-2#1)
heterogeneous##248##1##(1990-12#3)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#3)(1996-2#2)(1996-4#2)(1996-6#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#7)(2008-10#36)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#14)(2008-9#8)(2009-10#2)(2009-3#4)(2009-5#1)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#9)(2013-1#8)(2013-8#5)
heterogeneously distributed##2##2##(1993-9#1)(1997-2#1)
heterogeneously##6##1##(1990-12#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
heterogenous data##3##2##(2008-7#3)
heterogenous##22##1##(1990-7#1)(1991-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#6)(2008-8#1)(2008-9#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
heterokaryon##4##1##(2008-10#4)
heterokaryons##3##1##(2008-10#3)
heterologous CTV##2##2##(2008-10#2)
heterologous antigen##2##2##(2008-10#1)(2008-5#1)
heterologous antigenic determinants##2##3##(2008-8#2)
heterologous antigens##3##2##(1995-5#2)(2008-10#1)
heterologous expression in##3##3##(1996-3#1)(2008-11#1)(2008-7#1)
heterologous expression of##3##3##(2008-10#1)(2009-9#1)(2011-1#1)
heterologous expression systems##2##3##(1996-12#1)(2008-7#1)
heterologous expression##8##2##(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2011-1#1)
heterologous gene expression##3##3##(1993-9#2)(1994-8#1)
heterologous gene##5##2##(1993-9#2)(1994-8#1)(2008-11#2)
heterologous genes##6##2##(1991-9#1)(1993-12#1)(1994-12#2)(1997-4#1)(2008-5#1)
heterologous probes##3##2##(1997-2#1)(2008-10#2)
heterologous promoter##4##2##(1994-11#1)(1996-12#1)(1997-3#2)
heterologous promoters##4##2##(1990-12#2)(1992-11#1)(1997-4#1)
heterologous protein expression in##2##4##(2008-11#2)
heterologous protein expression##3##3##(2008-11#3)
heterologous protein production##3##3##(2008-11#2)(2008-7#1)
heterologous protein##11##2##(1994-8#1)(1997-4#1)(2008-11#7)(2008-7#2)
heterologous proteins##9##2##(1997-4#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
heterologous strains##3##2##(2008-10#3)
heterologous viral##3##2##(1993-8#1)(1996-12#1)(2008-8#1)
heterologous##121##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#4)(1995-2#1)(1995-5#3)(1995-6#1)(1996-12#3)(1996-3#1)(1997-2#2)(1997-3#5)(1997-4#7)(1997-7#2)(1997-8#1)(1997-9#1)(2008-10#25)(2008-11#16)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#5)
heterologously expressed in##2##3##(2008-5#1)(2009-9#1)
heterologously expressed##7##2##(1996-3#2)(2008-4#2)(2008-5#1)(2009-9#1)(2012-2#1)
heterolysosomes##2##1##(1990-5#2)
heteromeric G-protein##2##2##(1996-2#2)
heteromeric configurations##2##2##(1993-12#1)(1995-11#1)
heteromeric##15##1##(1990-8#1)(1991-5#1)(1993-11#2)(1993-12#1)(1995-11#5)(1995-2#1)(1996-2#3)(2008-9#1)
heteromorphic sex chromosomes##2##3##(2010-3#2)
heteromorphic##6##1##(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#3)
heteromorphisms##2##1##(2010-3#2)
heteronuclear correlation##3##2##(1990-5#1)(2012-2#2)
heteronuclear##10##1##(1990-5#1)(1992-3#1)(1992-4#1)(1993-11#2)(1995-2#1)(2008-4#1)(2009-2#1)(2012-2#2)
heterooligomeric##2##1##(1994-11#1)(2011-2#1)
heterophil numbers##2##2##(1997-6#2)
heterophil##4##1##(1997-6#3)(2007-2#1)
heterophilic##3##1##(1993-8#2)(2008-5#1)
heterophils and##2##2##(2008-5#1)(2013-1#1)
heterophils in##2##2##(1997-6#1)(2007-6#1)
heterophils##5##1##(1997-6#1)(2007-6#1)(2008-5#2)(2013-1#1)
heteroplasmy of##2##2##(2012-3#1)(2013-8#1)
heteroplasmy##8##1##(2012-3#2)(2013-8#6)
heteropoly acid##2##2##(2008-10#2)
heteropoly acids##3##2##(2008-10#3)
heteropoly anions##6##2##(2008-10#6)
heteropoly blue##2##2##(2008-10#2)
heteropoly compounds##3##2##(2008-10#3)
heteropoly##18##1##(2008-10#18)
heteropolytungstate##3##1##(2008-10#2)(2009-11#1)
heteroprotein complex##2##2##(1994-8#2)
heteroreceptors##2##1##(2008-7#2)
heteroscedastic##8##1##(2008-6#5)(2009-9#2)(2012-3#1)
heterosexual African American males who are seropositive##2##7##(2010-7#2)
heterosexual African##3##2##(2010-12#1)(2010-7#2)
heterosexual HIV transmission##2##3##(2013-1#2)
heterosexual HIV##3##2##(1996-11#1)(2013-1#2)
heterosexual contact##2##2##(1992-9#1)(1993-6#1)
heterosexual couples##2##2##(1994-7#1)(2013-8#1)
heterosexual males##3##2##(2009-10#2)(2012-12#1)
heterosexual men with##2##3##(1992-2#1)(2013-8#1)
heterosexual##34##1##(1990-3#1)(1990-9#1)(1992-2#1)(1992-4#1)(1992-9#3)(1993-6#1)(1994-7#1)(1995-12#1)(1996-11#2)(1997-6#1)(2008-12#4)(2009-10#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
heterosexually##5##1##(1993-6#1)(1996-11#3)(1997-6#1)
heterosexuals##5##1##(1990-3#1)(1992-9#1)(2008-5#3)
heterosis and##3##2##(2008-8#2)(2009-10#1)
heterosis in rice##5##3##(2008-4#2)(2008-8#2)(2009-10#1)
heterosis in##6##2##(2008-4#2)(2008-8#2)(2009-10#1)(2012-3#1)
heterosis##21##1##(2008-10#1)(2008-4#3)(2008-8#6)(2009-10#3)(2010-3#1)(2012-3#7)
heterospecific##5##1##(2008-11#1)(2009-2#1)(2009-5#2)(2009-9#1)
heterospheroids##2##1##(2008-11#2)
heterostrophus race O##4##3##(2008-10#4)
heterostrophus##9##1##(2008-10#9)
heterostructure##2##1##(2007-11#2)
heterostructured electrode##2##2##(2012-2#2)
heterostructured##4##1##(2012-2#4)
heterostructures##4##1##(1990-12#1)(2007-12#1)(2008-3#1)(2008-7#1)
heterosynaptic LTD##3##2##(1993-12#2)(2009-8#1)
heterosynaptic##5##1##(1993-12#2)(2009-8#3)
heterotepala##3##1##(2008-10#3)
heterothallic##5##1##(2008-10#5)
heterothallicum##4##1##(2008-10#4)
heterotic crosses##2##2##(2009-10#2)
heterotic gene##3##2##(2009-10#3)
heterotic##5##1##(2009-10#5)
heterotopia in the gallbladder##2##4##(1990-9#1)(2013-8#1)
heterotopia of the##2##3##(2013-7#2)
heterotopia##6##1##(1990-9#1)(1997-8#1)(2013-7#3)(2013-8#1)
heterotopias##4##1##(1995-5#2)(2011-2#1)(2013-7#1)
heterotopic bone##2##2##(2007-11#1)(2013-8#1)
heterotopic ossification##6##2##(1994-8#2)(2007-11#1)(2012-12#3)
heterotopic##18##1##(1994-3#1)(1994-8#2)(1995-12#2)(1997-8#2)(2007-11#2)(2011-1#3)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
heterotrimeric G proteins##9##3##(1995-6#3)(1995-8#1)(2008-4#2)(2008-7#3)
heterotrimeric G-protein##3##2##(1996-2#1)(2008-7#1)(2008-8#1)
heterotrimeric laminins##2##2##(2008-11#2)
heterotrimeric##17##1##(1995-6#3)(1995-8#1)(1996-2#2)(1997-7#1)(2008-11#2)(2008-4#2)(2008-7#4)(2008-8#1)(2010-11#1)
heterotrophic and P solubilizing bacteria##2##5##(2013-7#2)
heterotrophic bacteria##4##2##(2008-3#1)(2008-9#1)(2009-8#1)(2013-7#1)
heterotrophic growth##2##2##(2010-11#2)
heterotrophic##16##1##(2008-3#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#3)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#3)
heterotrophically##3##1##(2009-10#1)(2010-11#1)(2011-2#1)
heterotrophs##2##1##(2008-7#1)(2009-4#1)
heterotropic##5##1##(1990-8#4)(1997-2#1)
heterozygosis##2##1##(2011-2#1)(2012-3#1)
heterozygosities ranged from 0##2##4##(2008-10#1)(2013-8#1)
heterozygosities##6##1##(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
heterozygosity and##3##2##(2008-8#2)(2009-2#1)
heterozygosity in the##2##3##(2008-5#2)
heterozygosity in##5##2##(1993-11#1)(1994-12#1)(2008-5#2)(2009-2#1)
heterozygosity was##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
heterozygosity##41##1##(1993-11#1)(1994-12#2)(1994-6#1)(1995-12#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-2#4)(2009-5#4)(2010-3#1)(2011-1#1)(2012-3#4)(2013-8#2)
heterozygote frequency##3##2##(1991-12#2)(2008-10#1)
heterozygote##16##1##(1990-8#1)(1991-12#2)(1997-7#1)(1997-8#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
heterozygotes for##2##2##(1991-8#1)(2008-6#1)
heterozygotes have##2##2##(1990-8#1)(1994-12#1)
heterozygotes##21##1##(1990-8#3)(1991-8#1)(1993-3#1)(1994-12#1)(1995-2#2)(1996-12#2)(1996-6#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-6#1)(2008-8#1)(2012-3#1)
heterozygous and##4##2##(1995-2#1)(2008-10#1)(2011-1#2)
heterozygous females##2##2##(2009-5#1)(2012-3#1)
heterozygous for a##2##3##(1993-12#1)(2008-1#1)
heterozygous for the##5##3##(1995-2#1)(1996-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
heterozygous for##12##2##(1993-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-12#2)(2013-1#1)
heterozygous individuals##2##2##(1992-6#1)(2008-4#1)
heterozygous mice##2##2##(1995-2#2)
heterozygous##57##1##(1990-12#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-2#5)(1996-5#3)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-5#2)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)
heuristic CPC##2##2##(2008-3#2)
heuristic algorithms have##2##3##(2010-2#2)
heuristic algorithms##7##2##(2010-2#7)
heuristic##24##1##(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#4)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#7)(2012-3#1)(2013-1#1)
heuristics##4##1##(1992-12#1)(1996-12#1)(2008-6#2)
hex2-PhosChol##4##1##(1990-11#4)
hexachlorobenzene (HCB)##2##2##(2008-10#1)(2008-11#1)
hexachlorobenzene##4##1##(2008-10#2)(2008-11#2)
hexachlorocyclohexane##2##1##(2008-7#2)
hexacyanoferrate (III) in##2##3##(2008-10#2)
hexacyanoferrate (III)##3##2##(2008-10#3)
hexacyanoferrate modified##2##2##(2008-10#2)
hexacyanoferrate##19##1##(2008-10#19)
hexacyanoferrate(III) and##2##2##(2008-10#2)
hexacyanoferrate(III) in alkaline##2##3##(2008-10#2)
hexacyanoferrate(III) in##3##2##(2008-10#3)
hexacyanoferrate(III)##16##1##(2008-10#16)
hexacyanoferrate(III)-hexacyanoferrate(II) potential buffer##2##3##(2008-10#2)
hexacyanoferrates##2##1##(2008-10#2)
hexacyanomanganate(IV)##2##1##(2008-10#2)
hexadecanoic acid##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#5)
hexadecyltrimethylammonium bromide##2##2##(2008-10#2)
hexadecyltrimethylammonium##3##1##(2008-10#3)
hexadentate##2##1##(1997-7#1)(2008-10#1)
hexaflumuron##2##1##(2008-10#2)
hexafluorophosphate##9##1##(1995-2#1)(2008-10#8)
hexagon##4##1##(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
hexagonal HII phase##3##3##(1990-2#3)
hexagonal array illumination##3##3##(2007-11#3)
hexagonal array##5##2##(2007-11#4)(2008-3#1)
hexagonal column is##3##3##(2008-3#3)
hexagonal column##10##2##(2008-3#10)
hexagonal columns##5##2##(2008-3#5)
hexagonal ice column##3##3##(2008-3#3)
hexagonal ice columns##4##3##(2007-12#1)(2008-3#3)
hexagonal ice crystals##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
hexagonal ice##11##2##(2007-12#2)(2008-2#2)(2008-3#7)
hexagonal phase##4##2##(1990-12#2)(1994-12#1)(2008-3#1)
hexagonal phases##2##2##(1990-12#2)
hexagonal plates##3##2##(2007-12#1)(2008-3#2)
hexagonal##74##1##(1990-12#4)(1990-2#4)(1991-5#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#2)(2007-11#8)(2007-12#5)(2008-2#9)(2008-3#34)(2008-5#2)(2008-7#1)
hexagonally##4##1##(2007-11#1)(2008-3#2)(2008-6#1)
hexagons##3##1##(2008-2#2)(2008-8#1)
hexahistidine##2##1##(2008-1#1)(2008-11#1)
hexahydro-1##7##1##(2008-10#6)(2008-3#1)
hexakisphosphate##4##1##(1990-7#3)(1992-5#1)
hexamer and##2##2##(1995-11#1)(1997-2#1)
hexamer motif##4##2##(1997-2#4)
hexamer of##2##2##(1993-11#1)(2008-8#1)
hexamer##21##1##(1990-11#1)(1993-11#1)(1994-6#1)(1995-11#5)(1995-8#1)(1997-2#10)(1997-7#1)(2008-8#1)
hexameric enzyme##2##2##(1994-6#1)(1997-7#1)
hexameric##9##1##(1990-11#1)(1994-6#2)(1995-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-8#1)(2012-2#1)
hexamers to##2##2##(1990-11#1)(1990-5#1)
hexamers##3##1##(1990-11#1)(1990-5#2)
hexametaphosphate##2##1##(2008-10#2)
hexamethonium##3##1##(1993-9#1)(1994-9#1)(1996-2#1)
hexamethyldisiloxane##3##1##(2008-10#2)(2008-3#1)
hexamethylenetetramine##2##1##(2013-1#2)
hexanal##3##1##(2008-10#3)
hexandrum##3##1##(2008-11#3)
hexane and acetone##3##3##(2008-10#1)(2013-8#2)
hexane and ethyl##2##3##(1995-2#1)(2008-12#1)
hexane and##9##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2013-8#3)
hexane extraction##5##2##(2008-10#5)
hexane extracts##2##2##(2013-8#2)
hexane sulfonic acid (HSA)##2##4##(1994-9#1)(2008-10#1)
hexane##40##1##(1994-9#1)(1995-2#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-7#3)(2010-2#1)(2010-5#1)(2011-1#1)(2013-8#6)
hexane-acetone##2##1##(2008-10#2)
hexane/acetone (1##2##2##(2008-10#2)
hexane/dichloromethane##2##1##(2008-10#1)(2008-11#1)
hexane/methanol (4##2##2##(2008-10#2)
hexanes##2##1##(2008-10#2)
hexanethiol##2##1##(2008-10#2)
hexanol##4##1##(1990-12#1)(2008-10#3)
hexanucleotide##4##1##(1990-7#2)(1994-11#1)(2008-10#1)
hexapeptide PS-SCL##2##2##(2008-4#2)
hexapeptide with the##2##3##(1991-8#1)(2008-5#1)
hexapeptide##11##1##(1991-8#1)(1992-4#1)(1992-9#1)(2008-10#1)(2008-4#3)(2008-5#4)
hexapeptides##3##1##(1996-5#2)(2008-4#1)
hexaphosphate##4##1##(1990-8#2)(1992-12#1)(1997-7#1)
hexaplex real-time##2##2##(2011-2#2)
hexaploid wheat##7##2##(2008-10#5)(2008-5#1)(2012-3#1)
hexaploid##14##1##(2008-10#8)(2008-5#2)(2010-8#3)(2012-3#1)
hexarelin administration##2##2##(2010-5#2)
hexarelin##3##1##(2010-5#3)
hexasaccharide##4##1##(1990-7#3)(1990-9#1)
hexasaccharides##3##1##(1994-5#3)
hexavalent chromium##11##2##(2008-10#6)(2008-12#2)(2011-2#2)(2013-1#1)
hexavalent##15##1##(2008-10#9)(2008-12#3)(2011-2#2)(2013-1#1)
hexokinase I##3##2##(1991-5#2)(1993-11#1)
hexokinase II##8##2##(1993-11#5)(1994-11#3)
hexokinase activity##2##2##(1990-11#1)(1991-5#1)
hexokinase and##3##2##(1994-8#1)(2008-10#1)(2009-4#1)
hexokinase##26##1##(1990-11#3)(1991-5#6)(1993-11#7)(1994-11#3)(1994-8#2)(2008-10#3)(2009-4#1)(2013-1#1)
hexosamine pathway##2##2##(2008-1#1)(2011-2#1)
hexosaminidase##5##1##(1990-5#1)(1992-3#4)
hexose phosphates##2##2##(1996-6#1)(2012-1#1)
hexose sugars##3##2##(2011-2#2)(2012-3#1)
hexose transporter##4##2##(2010-2#4)
hexose##16##1##(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-6#1)(2008-9#1)(2010-2#6)(2011-2#2)(2012-1#1)(2012-3#1)
hexoses##2##1##(2008-11#1)(2008-6#1)
hexyl##5##1##(2008-10#4)(2010-4#1)
hexyloxy-1##2##1##(1992-10#2)
hfNSCs##5##1##(2009-10#5)
hgiDIIM gene##2##2##(1991-9#2)
hgiDIIM##5##1##(1991-9#5)
hh expression##2##2##(1993-2#2)
hh mRNA was##2##3##(1993-2#2)
hh##6##1##(1993-12#2)(1993-2#4)
hiPS cell lines##3##3##(2013-1#3)
hiPS##5##1##(2013-1#5)
hiatal hernia with nonspecific esophageal motility disorder (NEMD)##2##8##(2011-2#2)
hiatal hernia with##3##3##(2011-2#3)
hiatal hernia##8##2##(1990-12#1)(2008-12#1)(2011-2#4)(2013-1#2)
hiatal hernias##3##2##(2011-2#3)
hiatal##12##1##(1990-12#1)(2008-12#1)(2011-2#8)(2013-1#2)
hibernating phases##3##2##(2008-8#3)
hibernating##8##1##(1996-5#2)(2008-7#3)(2008-8#3)
hibernation and##2##2##(2008-8#1)(2011-2#1)
hibernation##10##1##(1995-12#2)(1996-5#1)(2008-10#1)(2008-8#5)(2011-2#1)
hibernoma##5##1##(2007-8#4)(2012-2#1)
hiccup##2##1##(2011-2#2)
hiccups##2##1##(1990-6#1)(2011-2#1)
hidden Markov method##2##3##(2008-10#2)
hidden Markov model##5##3##(1996-12#2)(1997-2#2)(2008-10#1)
hidden Markov models (HMMs)##2##4##(2008-4#1)(2008-7#1)
hidden Markov models##5##3##(2008-4#1)(2008-7#2)(2009-3#2)
hidden Markov##12##2##(1996-12#2)(1997-2#2)(2008-10#3)(2008-4#1)(2008-7#2)(2009-3#2)
hidden and output##5##3##(2008-10#5)
hidden and##8##2##(2008-10#6)(2010-10#1)(2010-8#1)
hidden behind a##2##3##(2007-12#2)
hidden cases of syphilis##2##4##(2007-7#2)
hidden in a##2##3##(2007-12#1)(2008-3#1)
hidden in##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
hidden layer##9##2##(2008-10#4)(2008-6#1)(2010-8#4)
hidden local##2##2##(2010-8#2)
hidden markov model##3##3##(2008-7#1)(2013-1#2)
hidden phase##4##2##(2008-3#4)
hidden##90##1##(1991-6#1)(1993-2#2)(1994-3#1)(1995-2#1)(1995-5#2)(1996-12#2)(1997-1#1)(1997-2#3)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#2)(2008-1#4)(2008-10#19)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2009-3#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#9)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
hide##3##1##(2008-10#1)(2010-8#1)(2011-1#1)
hides##2##1##(1990-6#1)(2011-2#1)
hiding##2##1##(2008-3#1)(2008-8#1)
hidradenitis suppurativa##5##2##(1993-8#1)(2006-10#4)
hidradenitis##7##1##(1992-6#1)(1993-8#2)(2006-10#4)
hierarchical Bayesian models##2##3##(1994-9#1)(2009-11#1)
hierarchical analysis of##3##3##(1994-9#1)(2008-10#2)
hierarchical analysis##4##2##(1994-9#1)(2008-10#3)
hierarchical and##3##2##(2008-11#1)(2008-5#1)(2010-4#1)
hierarchical arrangement##2##2##(1990-8#1)(2009-7#1)
hierarchical classification##2##2##(2010-7#1)(2013-1#1)
hierarchical cluster analysis##4##3##(2008-10#3)(2013-8#1)
hierarchical cluster##5##2##(2008-10#4)(2013-8#1)
hierarchical clustering and##2##3##(2008-10#2)
hierarchical clustering##5##2##(2008-10#2)(2008-4#1)(2008-7#2)
hierarchical data##3##2##(2008-6#3)
hierarchical levels##2##2##(1997-2#1)(2008-11#1)
hierarchical linear modeling##2##3##(2007-12#1)(2009-8#1)
hierarchical linear##3##2##(2007-12#1)(2009-8#1)(2012-1#1)
hierarchical models##7##2##(1994-9#1)(1997-5#1)(2008-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2012-2#1)
hierarchical multiple regression##2##3##(2008-4#1)(2011-2#1)
hierarchical organization##2##2##(1991-6#1)(2008-7#1)
hierarchical regression analysis##2##3##(2010-8#1)(2011-2#1)
hierarchical regression##5##2##(2008-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
hierarchical sampling##2##2##(2008-10#2)
hierarchical spring systems##2##3##(2012-2#2)
hierarchical spring##3##2##(2012-2#3)
hierarchical structure##2##2##(2009-7#1)(2011-2#1)
hierarchical structures that##2##3##(1995-2#1)(2012-2#1)
hierarchical structures##3##2##(1995-2#1)(2012-2#2)
hierarchical##80##1##(1990-8#1)(1991-6#2)(1992-5#2)(1994-9#4)(1995-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#4)(2008-9#1)(2009-11#3)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#7)(2013-1#3)(2013-8#2)
hierarchically organized##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
hierarchically##13##1##(1992-5#1)(1996-5#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2013-1#1)(2013-8#1)
hierarchies##11##1##(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#2)
hierarchy and##4##2##(1993-2#1)(2008-10#1)(2008-12#1)(2010-1#1)
hierarchy are##3##2##(1995-9#1)(2008-10#2)
hierarchy at##2##2##(1993-2#1)(2012-12#1)
hierarchy of evidence##2##3##(2008-11#1)(2012-12#1)
hierarchy of##17##2##(1990-8#1)(1991-8#1)(1992-4#1)(1996-4#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2012-12#1)(2012-2#2)
hierarchy to##2##2##(2008-10#2)
hierarchy##57##1##(1990-8#1)(1991-8#1)(1992-4#1)(1993-2#3)(1995-2#1)(1995-9#1)(1996-4#2)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2013-1#2)
high (##2##2##(2008-10#1)(2010-11#1)
high (&gt##6##2##(2008-10#3)(2008-5#1)(2013-1#2)
high (0##5##2##(1990-6#1)(2008-10#3)(2009-9#1)
high (1##2##2##(1995-11#1)(2008-10#1)
high (2##2##2##(1996-9#1)(2011-1#1)
high (20##2##2##(2008-11#1)(2010-4#1)
high (25##2##2##(1990-6#1)(1992-6#1)
high (8% w/w) levels of dietary fiber from##2##8##(1993-11#2)
high (96%)##2##2##(1995-3#1)(2008-10#1)
high (beta-)##3##2##(2008-10#3)
high (r = 0##2##4##(1995-5#1)(2013-8#1)
high ACTH##2##2##(2011-1#2)
high Andean forest##2##3##(2013-7#2)
high BP##2##2##(2010-4#2)
high C-peptide values##2##3##(1994-12#2)
high CO(2) plants##2##3##(2008-10#2)
high CO(2)##4##2##(2008-10#4)
high COX-2##2##2##(2013-7#2)
high Ca##2##2##(2008-10#1)(2009-6#1)
high EI scores##3##3##(2013-1#3)
high HCV##3##2##(2007-7#2)(2013-1#1)
high HDL levels##2##3##(1993-12#2)
high HDL-C enhances the##2##4##(2012-6#2)
high HIV prevalence##2##3##(2008-10#1)(2010-5#1)
high HIV##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
high IGF-I##2##2##(2008-5#1)(2012-3#1)
high IGF-II##2##2##(1992-9#2)
high K(+)-evoked##2##2##(1992-6#2)
high K(+)-induced##2##2##(1995-11#2)
high K+##5##2##(1993-11#1)(1993-12#1)(1995-5#2)(1996-5#1)
high Km##2##2##(1990-11#1)(1992-3#1)
high LDL##2##2##(2008-3#1)(2011-1#1)
high Mg2+ medium##2##3##(1993-11#2)
high Mg2+##4##2##(1993-11#4)
high NaCl concentration##2##3##(2008-5#2)
high NaCl concentrations##2##3##(2012-7#2)
high NaCl##4##2##(2008-5#2)(2012-7#2)
high Q##2##2##(2007-12#1)(2008-3#1)
high RH##6##2##(2008-10#6)
high RI##2##2##(2008-10#1)(2013-1#1)
high SNR##2##2##(2008-3#1)(2012-1#1)
high SPF##4##2##(1993-11#2)(2008-5#2)
high TB incidence##2##3##(2007-2#1)(2013-1#1)
high [K(+)](o)##3##2##(2008-8#3)
high ability##2##2##(2008-10#1)(2010-5#1)
high absorption##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
high abundance##6##2##(1992-6#1)(1993-12#1)(1997-4#1)(2007-5#1)(2008-4#1)(2009-5#1)
high accuracy and precision##3##4##(2008-10#3)
high accuracy and##10##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
high accuracy in the##2##4##(2008-3#2)
high accuracy in##5##3##(2007-11#1)(2008-3#2)(2010-3#1)(2013-8#1)
high accuracy of the##3##4##(2007-12#1)(2008-10#2)
high accuracy of##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
high accuracy##43##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#11)(2008-7#3)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
high acid concentration##2##3##(2008-10#1)(2013-1#1)
high acid##3##2##(1997-1#1)(2008-10#1)(2013-1#1)
high acidities##2##2##(2008-10#2)
high active muscle power##2##4##(1995-8#2)
high activities of##2##3##(1995-11#2)
high activities##4##2##(1995-11#2)(2008-7#1)(2013-1#1)
high activity against##2##3##(1994-8#1)(2012-3#1)
high activity and##2##3##(1990-5#1)(2013-1#1)
high activity##10##2##(1990-5#1)(1994-8#2)(1997-8#1)(2007-10#1)(2008-7#2)(2010-11#1)(2012-3#1)(2013-1#1)
high advection##2##2##(2008-3#1)(2008-9#1)
high affinities for##2##3##(1991-12#1)(2008-10#1)
high affinities##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
high affinity (KD =##3##4##(1992-9#1)(1993-6#1)(1994-12#1)
high affinity (Kd = 0##4##5##(1993-11#1)(1994-8#2)(1995-12#1)
high affinity (Kd =##5##4##(1993-11#1)(1994-8#2)(1995-12#1)(1996-2#1)
high affinity (Kd##6##3##(1990-11#1)(1993-11#1)(1994-8#2)(1995-12#1)(1996-2#1)
high affinity IgE receptor##2##4##(2008-11#2)
high affinity and low capacity##2##5##(1993-1#2)
high affinity and##15##3##(1990-11#1)(1991-12#1)(1991-2#2)(1993-1#3)(1993-3#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-4#1)(2012-2#1)
high affinity binding of NE##2##5##(2008-3#2)
high affinity binding of##4##4##(1994-8#1)(2008-3#3)
high affinity binding sites##3##4##(1990-5#2)(1993-3#1)
high affinity binding##12##3##(1990-5#2)(1991-2#1)(1993-3#1)(1994-8#1)(1997-4#2)(2008-3#4)(2009-12#1)
high affinity copper##2##3##(2010-11#1)(2011-2#1)
high affinity endothelin-1##2##3##(1991-11#2)
high affinity for the motilin receptor##2##6##(1994-11#2)
high affinity for the##9##4##(1992-11#1)(1992-9#1)(1994-11#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
high affinity for##26##3##(1991-11#1)(1991-5#1)(1992-11#2)(1992-9#1)(1993-8#1)(1994-11#3)(1994-8#2)(1995-11#2)(1995-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
high affinity monoclonal##2##3##(1991-8#1)(1992-6#1)
high affinity of##4##3##(1991-5#1)(2008-10#1)(2008-9#1)(2010-1#1)
high affinity receptor##3##3##(1990-11#1)(1990-5#1)(1993-3#1)
high affinity receptors##4##3##(1993-6#2)(1994-11#1)(1996-5#1)
high affinity site##3##3##(1990-5#1)(1995-11#1)(1996-2#1)
high affinity to the##4##4##(1990-5#1)(1995-3#1)(1996-12#1)(2008-5#1)
high affinity to##11##3##(1990-5#2)(1992-3#1)(1993-6#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
high affinity uptake##2##3##(1996-12#1)(2008-7#1)
high affinity##152##2##(1990-11#5)(1990-12#6)(1990-5#6)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#7)(1991-5#3)(1991-8#2)(1992-11#3)(1992-3#1)(1992-6#2)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#7)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-8#7)(1995-11#5)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#4)(1997-4#3)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
high after##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
high alcohol##2##2##(1996-6#1)(2009-7#1)
high altitude pulmonary edema##5##4##(1992-2#5)
high altitude##10##2##(1992-2#5)(2007-11#1)(2012-2#3)(2013-1#1)
high amino acid sequence##2##4##(1993-8#1)(1997-4#1)
high amino acid##3##3##(1993-8#1)(1997-4#1)(2008-9#1)
high among##6##2##(2008-10#2)(2008-11#1)(2010-4#1)(2011-1#1)(2012-2#1)
high amount of##6##3##(2008-1#1)(2008-10#4)(2013-1#1)
high amounts in##2##3##(1993-12#1)(1994-8#1)
high amounts of##15##3##(1991-5#1)(1994-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
high amounts##19##2##(1991-5#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
high analytical##3##2##(2008-10#3)
high and intermediate##4##3##(2008-10#1)(2008-5#1)(2009-5#2)
high and low affinity##5##4##(1990-5#2)(1991-1#1)(1995-11#1)(1997-2#1)
high and low strata##2##4##(2013-1#2)
high and low trait##2##4##(2008-2#2)
high and low##37##3##(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-12#1)(2008-2#2)(2008-7#3)(2009-12#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
high and moderate##3##3##(1995-12#2)(2008-8#1)
high and the##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
high and very low##2##4##(1993-12#1)(2008-10#1)
high and##81##2##(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#3)(2009-12#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
high angular##2##2##(2008-2#1)(2012-12#1)
high animal##2##2##(2007-6#1)(2008-10#1)
high antibacterial##2##2##(2010-3#1)(2011-2#1)
high antibody titer##2##3##(2008-12#2)
high antibody##3##2##(1997-6#1)(2008-12#2)
high anxiety##2##2##(2009-7#2)
high aqueous##2##2##(2008-10#1)(2010-7#1)
high as 10##3##3##(1995-2#1)(2007-11#1)(2008-2#1)
high as approximately##2##3##(2008-3#1)(2013-1#1)
high as##134##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#11)(2007-12#14)(2007-8#1)(2008-10#17)(2008-11#9)(2008-2#14)(2008-3#22)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
high aspect ratio##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
high aspect##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
high association##2##2##(2008-1#1)(2012-12#1)
high at the##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
high at##8##2##(1990-10#1)(1995-3#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#1)
high atmospheric##2##2##(2008-3#2)
high attrition##4##2##(2008-11#1)(2008-8#1)(2009-4#1)(2012-3#1)
high average power##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
high average##7##2##(1994-11#1)(1994-2#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#1)
high background radiation##2##3##(2008-7#2)
high background##9##2##(1990-12#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-6#1)
high basal##3##2##(1994-11#2)(1995-5#1)
high beam quality##3##3##(2008-3#3)
high between##2##2##(2008-10#1)(2011-2#1)
high binding affinity##2##3##(1995-6#1)(2008-8#1)
high binding##5##2##(1994-2#1)(1995-3#1)(1995-6#1)(2008-5#1)(2008-8#1)
high biodiversity##2##2##(2008-8#1)(2013-7#1)
high biological##2##2##(2008-10#1)(2008-7#1)
high biomass##2##2##(2008-9#1)(2012-2#1)
high birth weight##2##3##(2013-1#2)
high blood pressure##19##3##(1992-6#1)(1993-2#2)(1994-6#1)(1997-2#2)(1997-3#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-1#1)(2010-9#2)(2011-2#1)
high blood##25##2##(1992-6#1)(1993-2#2)(1994-6#1)(1995-11#1)(1997-2#2)(1997-3#2)(1997-7#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-1#1)(2010-4#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
high bootstrap##2##2##(2008-5#1)(2008-6#1)
high burden of##4##3##(2008-3#1)(2011-1#1)(2011-2#2)
high but not##2##3##(1992-5#1)(1996-5#1)
high but##6##2##(1992-5#1)(1996-2#1)(1996-5#1)(2008-8#1)(2013-1#2)
high calcium##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
high calorie##2##2##(2008-10#1)(2011-2#1)
high capacities##2##2##(2008-10#1)(2008-3#1)
high capacity for##2##3##(2010-6#1)(2013-1#1)
high capacity to##2##3##(1993-12#1)(2008-9#1)
high capacity##11##2##(1993-1#1)(1993-12#1)(1993-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#1)
high carbohydrate##4##2##(1996-12#1)(2008-1#1)(2008-3#2)
high case fatality rates##2##4##(2011-1#1)(2013-8#1)
high case fatality##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
high catalytic##5##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)
high cell densities##4##3##(2008-11#3)(2008-7#1)
high cell density perfusion culture##3##5##(2008-11#3)
high cell density perfusion##4##4##(2008-11#4)
high cell density##15##3##(1993-9#3)(1994-5#1)(2008-11#9)(2008-7#1)(2011-1#1)
high cell growth##2##3##(2008-11#2)
high cell viability##3##3##(2008-11#3)
high cell##27##2##(1993-9#3)(1994-5#1)(2008-11#18)(2008-7#3)(2011-1#1)(2011-2#1)
high cellular##3##2##(2008-11#2)(2010-6#1)
high central venous pressure##2##4##(1990-9#1)(2007-8#1)
high chances of##2##3##(2013-8#2)
high chemical##3##2##(2008-2#1)(2012-2#1)(2013-8#1)
high cholesterol##4##2##(1992-6#1)(2009-4#1)(2013-1#2)
high clinical##2##2##(2008-5#1)(2010-11#1)
high co-morbidity##2##2##(2008-1#1)(2013-1#1)
high colour contrast stimuli##2##4##(1996-5#2)
high comorbidity##2##2##(2012-3#1)(2013-8#1)
high compared to##3##3##(1996-1#1)(2012-12#1)(2012-3#1)
high compared with##2##3##(1990-6#1)(2008-10#1)
high compared##5##2##(1990-6#1)(1996-1#1)(2008-10#1)(2012-12#1)(2012-3#1)
high compatibility with##2##3##(2008-10#1)(2008-11#1)
high complexity##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2010-11#1)(2013-1#1)
high complication rate##2##3##(2008-10#1)(2011-2#1)
high computational##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
high concentration in##6##3##(1990-9#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-3#1)
high concentration of iron and##2##5##(1995-3#1)(1996-2#1)
high concentration of the##2##4##(1992-6#1)(2012-3#1)
high concentration of##33##3##(1990-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2009-12#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
high concentration ratios##2##3##(2007-12#1)(2008-10#1)
high concentration##57##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#5)(2009-12#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
high concentrations in the##4##4##(1990-9#1)(2008-10#1)(2008-7#1)(2009-9#1)
high concentrations in##7##3##(1990-9#1)(1991-12#1)(1996-12#1)(2008-10#2)(2008-7#1)(2009-9#1)
high concentrations of drug##2##4##(1997-1#1)(2012-3#1)
high concentrations of flavonoids##2##4##(2008-10#1)(2012-12#1)
high concentrations of glucose##3##4##(1990-5#1)(2008-11#1)(2008-4#1)
high concentrations of other##2##4##(1990-2#1)(1994-9#1)
high concentrations of the##2##4##(1992-3#1)(1996-12#1)
high concentrations of##54##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-5#2)(2008-10#12)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)
high concentrations##90##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
high conductance##2##2##(2008-10#1)(2008-7#1)
high conductivity##2##2##(1996-5#1)(2012-2#1)
high confidence##2##2##(2008-7#1)(2011-1#1)
high conservation of##3##3##(1992-8#1)(2010-11#1)(2013-8#1)
high conservation##5##2##(1991-6#1)(1992-8#1)(2008-7#1)(2010-11#1)(2013-8#1)
high content of##12##3##(1990-2#1)(1991-2#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-5#2)(2010-4#1)(2012-2#1)(2012-3#1)
high content##13##2##(1990-2#1)(1991-2#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2010-4#1)(2012-2#1)(2012-3#1)
high contrast ratio##4##3##(2007-12#1)(2008-2#2)(2010-1#1)
high contrast##9##2##(1996-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-6#1)
high conversion efficiency##2##3##(2007-11#1)(2008-3#1)
high conversion##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
high copy number##5##3##(1993-6#1)(1993-9#1)(2008-10#1)(2008-11#1)(2009-10#1)
high copy##7##2##(1993-6#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
high correct##2##2##(2008-10#1)(2008-6#1)
high correlation between##8##3##(1992-9#1)(1995-3#1)(2008-10#3)(2008-9#2)(2009-12#1)
high correlation coefficient##4##3##(2008-10#2)(2011-2#1)(2011-3#1)
high correlation with##3##3##(1991-2#1)(2008-10#1)(2010-8#1)
high correlation##20##2##(1991-2#1)(1992-9#1)(1993-12#1)(1995-3#1)(2007-11#1)(2008-10#7)(2008-9#2)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)
high correlations##2##2##(2008-12#1)(2008-2#1)
high cost and##3##3##(2007-2#1)(2008-2#1)(2012-2#1)
high cost of##10##3##(1993-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
high cost##17##2##(1993-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
high costs and##2##3##(1992-2#1)(2007-6#1)
high costs of##4##3##(2008-8#3)(2008-9#1)
high costs##11##2##(1992-2#1)(1996-11#1)(1997-3#1)(2007-6#1)(2008-10#1)(2008-8#3)(2008-9#2)(2011-2#1)
high coupling efficiency##3##3##(2007-12#2)(2008-3#1)
high coupling##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
high coverage##2##2##(2008-10#1)(2013-1#1)
high current##2##2##(2008-10#2)
high data rates of##2##4##(2008-2#1)(2008-9#1)
high data rates##3##3##(2008-2#2)(2008-9#1)
high data##5##2##(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)
high death rate##3##3##(1990-6#1)(2007-12#1)(2013-8#1)
high degree of activity against all the##2##7##(2010-3#1)(2010-5#1)
high degree of agreement##2##4##(1992-12#1)(1993-12#1)
high degree of homology##9##4##(1990-2#1)(1992-8#1)(1993-11#1)(1993-2#3)(1994-11#1)(1997-1#1)(2008-10#1)
high degree of identity##2##4##(1991-2#1)(1996-2#1)
high degree of malignancy##2##4##(2011-1#2)
high degree of stability##2##4##(1996-6#1)(2008-10#1)
high degree of structural##2##4##(1991-6#1)(1997-2#1)
high degree of##122##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
high degree##125##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
high degrees of##3##3##(1992-12#1)(1995-6#1)(2013-1#1)
high demand##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
high demands on##2##3##(1992-3#1)(2008-10#1)
high demands##3##2##(1992-3#1)(2008-10#1)(2008-12#1)
high densities##2##2##(2008-10#1)(2013-1#1)
high density culture##2##3##(2008-11#2)
high density linkage map##4##4##(1995-6#1)(2008-5#2)(2013-8#1)
high density lipoprotein (HDL)##4##4##(1994-11#1)(2008-3#1)(2012-2#2)
high density lipoprotein (HDL)-cholesterol##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
high density lipoprotein cholesterol (HDL-C) levels##2##6##(2008-1#1)(2010-8#1)
high density lipoprotein cholesterol##3##4##(1993-12#1)(2008-1#1)(2010-8#1)
high density lipoprotein##15##3##(1991-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)
high density lipoproteins (HDL)##2##4##(1993-8#1)(1995-5#1)
high density lipoproteins##7##3##(1991-9#1)(1993-8#1)(1994-8#2)(1995-5#2)(2013-1#1)
high density of inoculum##3##4##(2008-10#3)
high density of##9##3##(1993-12#1)(1993-2#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
high density on##2##3##(2008-11#2)
high density perfusion##2##3##(2008-11#2)
high density polyethylene##3##3##(2008-10#1)(2009-3#2)
high density##70##2##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-5#2)(1995-6#1)(1996-10#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
high dependency care##2##3##(2007-8#1)(2008-11#1)
high dependency##3##2##(2006-10#1)(2007-8#1)(2008-11#1)
high detection limit##2##3##(2008-10#2)
high detection limits##2##3##(2008-10#2)
high detection sensitivity##2##3##(2008-10#1)(2012-12#1)
high detection##8##2##(1996-5#1)(2008-10#6)(2012-12#1)
high diagnostic yield##2##3##(1990-3#1)(2012-2#1)
high dielectric constant##2##3##(2008-10#1)(2013-1#1)
high diffraction efficiency and##3##4##(2008-3#3)
high diffraction efficiency##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
high diffraction##8##2##(2007-11#1)(2008-2#1)(2008-3#5)(2008-8#1)
high dimensional##2##2##(2008-10#1)(2011-3#1)
high dipole##2##2##(1997-6#1)(2008-10#1)
high discrimination##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
high disease##5##2##(2008-10#5)
high dispersion##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
high diversity of##3##3##(2010-3#1)(2010-6#1)(2010-8#1)
high diversity##5##2##(2008-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)
high dosage##2##2##(1994-8#1)(2010-9#1)
high dosages##2##2##(1994-3#1)(2010-8#1)
high dose chemotherapy##2##3##(2008-8#2)
high dose of##12##3##(1991-9#1)(1992-5#1)(1995-3#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-8#1)(2013-1#2)(2013-8#1)
high dose oral corticosteroids##3##4##(2008-11#3)
high dose radiation##2##3##(1994-8#1)(2008-7#1)
high dose rate brachytherapy##2##4##(1994-3#1)(2009-11#1)
high dose rate##4##3##(1994-3#1)(2007-11#1)(2008-7#1)(2009-11#1)
high dose##54##2##(1990-12#2)(1991-9#2)(1992-5#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-3#2)(1996-6#2)(1996-8#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#9)(2008-8#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
high doses and##4##3##(1994-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
high doses of estrogen and progesterone##2##6##(2007-10#2)
high doses of vitamin##2##4##(1992-9#1)(2010-1#1)
high doses of##25##3##(1990-10#1)(1991-6#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#2)
high doses##47##2##(1990-10#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#4)(2008-8#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
high drop-out##3##2##(1990-2#1)(2008-7#1)(2011-2#1)
high due to##2##3##(2008-10#1)(2009-10#1)
high during the##2##3##(1993-2#1)(1995-12#1)
high during##4##2##(1991-5#1)(1993-2#1)(1995-12#1)(2012-2#1)
high dye##2##2##(2008-2#1)(2008-3#1)
high dynamic range##3##3##(2008-10#1)(2008-3#2)
high dynamic##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
high economic##2##2##(2008-10#2)
high educational##2##2##(2009-7#1)(2010-11#1)
high effective##2##2##(2010-7#1)(2013-1#1)
high effectiveness for##2##3##(1997-2#1)(2007-11#1)
high efficacy and##3##3##(2008-12#1)(2010-10#1)(2012-2#1)
high efficacy##7##2##(2008-10#1)(2008-12#2)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
high efficiencies##4##2##(2008-2#1)(2008-3#3)
high efficiency of the##2##4##(2008-3#1)(2008-8#1)
high efficiency of##6##3##(1997-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
high efficiency##34##2##(1990-11#1)(1990-5#1)(1994-12#1)(1994-5#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#4)(2011-1#1)(2012-12#1)(2013-1#1)
high electrocatalytic##2##2##(2008-10#2)
high endogenous levels of##2##4##(1990-11#1)(2012-7#1)
high endogenous##3##2##(1990-11#1)(2009-9#1)(2012-7#1)
high energy and##3##3##(2008-10#2)(2008-2#1)
high energy##14##2##(1991-2#1)(1991-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2010-1#1)(2012-12#1)(2013-8#1)
high enough to perform##2##4##(1997-2#1)(2008-10#1)
high enough to##9##3##(1993-9#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-4#1)
high enough##16##2##(1991-11#1)(1993-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2009-4#1)(2010-12#1)
high enrichment factor##2##3##(2008-10#2)
high enzymatic##2##2##(2008-6#1)(2012-6#1)
high enzyme activity##3##3##(1993-3#1)(1994-11#2)
high even##2##2##(2008-10#1)(2008-3#1)
high excess##2##2##(2008-10#2)
high expectations for##2##3##(2008-10#1)(2011-2#1)
high expectations##6##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#1)
high expression levels of##2##4##(2008-10#1)(2008-11#1)
high expression levels##4##3##(2008-10#1)(2008-11#2)(2012-3#1)
high expression of FLIP##2##4##(2009-9#2)
high expression of the##4##4##(1992-12#1)(1996-12#1)(2009-8#1)(2013-1#1)
high expression of##16##3##(1991-5#1)(1992-12#1)(1996-12#2)(1997-8#1)(2008-12#1)(2009-8#2)(2009-9#4)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
high expression was##2##3##(2008-10#1)(2013-1#1)
high expression##27##2##(1991-5#1)(1992-12#1)(1992-3#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-8#2)(2009-9#4)(2010-3#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
high external##2##2##(1992-2#1)(2010-12#1)
high extinction ratios##2##3##(2007-12#1)(2008-3#1)
high extinction##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
high extraction efficiency##2##3##(2008-10#1)(2008-12#1)
high extraction##5##2##(2008-10#4)(2008-12#1)
high fasting##3##2##(2008-3#3)
high fat diet##4##3##(1996-12#2)(2008-3#1)(2013-1#1)
high fat##9##2##(1993-11#2)(1996-12#3)(2008-11#1)(2008-3#1)(2013-1#2)
high fatality rate##2##3##(1995-5#1)(2008-3#1)
high fatality##4##2##(1990-2#1)(1995-5#1)(2008-3#1)(2008-5#1)
high fertility##2##2##(1991-12#1)(2008-10#1)
high fever##3##2##(2006-10#1)(2006-5#1)(2012-3#1)
high fidelity of##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
high fidelity##9##2##(1997-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#1)
high field##4##2##(1996-2#1)(1997-6#1)(2008-10#1)(2008-3#1)
high final##2##2##(2008-11#1)(2008-7#1)
high financial##2##2##(2008-4#1)(2011-1#1)
high flow rates##2##3##(2007-7#1)(2008-10#1)
high flow##8##2##(1995-3#1)(1996-6#1)(1996-9#2)(2007-7#2)(2008-10#1)(2008-7#1)
high fluid intake##2##3##(2007-7#2)
high flux dialysis##2##3##(2007-8#1)(2008-1#1)
high flux##4##2##(1994-5#1)(2007-7#1)(2007-8#1)(2008-1#1)
high food##2##2##(2010-8#2)
high for those##2##3##(2008-10#1)(2009-7#1)
high for##11##2##(1995-12#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-7#1)(2009-3#1)(2009-7#1)(2012-3#1)
high fracture##2##2##(2007-11#1)(2012-2#1)
high frequencies of##2##3##(2008-7#1)(2011-2#1)
high frequencies##7##2##(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
high frequency and##3##3##(2008-10#1)(2008-5#2)
high frequency of##26##3##(1990-6#2)(1991-8#1)(1992-5#1)(1993-9#1)(1994-11#1)(1996-11#1)(1997-5#1)(1997-9#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
high frequency ventilation##3##3##(1994-6#3)
high frequency##73##2##(1990-6#3)(1990-8#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#5)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-9#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
high fringe contrast##2##3##(2008-3#2)
high fringe##3##2##(2008-3#3)
high functionality##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
high gain in##2##3##(2008-2#2)
high gain##7##2##(2007-11#3)(2007-12#2)(2008-2#2)
high gene##2##2##(2008-10#1)(2011-2#1)
high genetic differentiation among populations##2##5##(2008-8#2)
high genetic differentiation##5##3##(2008-10#3)(2008-8#2)
high genetic diversity and##2##4##(2010-5#1)(2010-8#1)
high genetic diversity in##2##4##(2008-10#2)
high genetic diversity##8##3##(2008-10#3)(2008-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2013-8#1)
high genetic##17##2##(2008-10#7)(2008-12#1)(2008-8#2)(2009-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#2)
high genotypic diversity##3##3##(2008-10#3)
high glass##3##2##(1995-3#1)(2009-7#1)(2010-4#1)
high glucose and##2##3##(2008-1#1)(2011-2#1)
high glucose conditions##2##3##(1992-8#1)(2012-4#1)
high glucose levels##2##3##(2008-7#1)(2011-2#1)
high glucose on##2##3##(2010-11#1)(2011-2#1)
high glucose reduced##2##3##(2012-4#2)
high glucose##24##2##(1992-6#5)(1992-8#2)(2008-1#2)(2008-7#2)(2010-11#2)(2011-2#4)(2012-4#5)(2012-5#1)(2013-1#1)
high glucose-induced damage in##2##4##(2012-4#2)
high glucose-induced damage##3##3##(2012-4#3)
high glucose-induced##5##2##(2008-1#1)(2011-2#1)(2012-4#3)
high grade astrocytoma##3##3##(2008-7#2)(2012-2#1)
high grade endometrial carcinomas##3##4##(2011-2#3)
high grade osteosarcoma##2##3##(2008-6#1)(2010-3#1)
high grade osteosarcomas##2##3##(2008-6#2)
high grade##26##2##(1992-1#2)(1992-4#1)(1994-2#1)(1997-3#1)(2008-6#7)(2008-7#2)(2010-11#1)(2010-3#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
high gradient##2##2##(2007-12#1)(2008-11#1)
high growth##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
high heritability##4##2##(2007-1#1)(2008-8#1)(2012-3#2)
high heterogeneity##3##2##(1992-2#1)(2008-9#1)(2013-8#1)
high histological##2##2##(2008-6#1)(2013-1#1)
high homology to the##7##4##(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-8#1)
high homology to yeast##2##4##(1994-6#2)
high homology to##15##3##(1990-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-8#1)(1996-8#1)(1997-2#1)(2008-9#1)
high homology with##5##3##(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
high homology##27##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-12#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-5#1)(2012-2#1)
high humidity##9##2##(2008-10#6)(2010-10#1)(2010-4#1)(2013-8#1)
high hydrolysis##2##2##(2008-10#1)(2013-1#1)
high hydrophobicity##2##2##(2008-12#1)(2010-4#1)
high ice nucleation activity##2##4##(2008-10#2)
high identity##4##2##(1992-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
high image quality##2##3##(2008-3#2)
high in all populations##2##4##(2008-10#2)
high in all##4##3##(2008-10#4)
high in both##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
high in patients with##3##4##(1994-9#1)(1995-10#1)(2008-7#1)
high in patients##5##3##(1994-9#1)(1995-10#1)(1996-11#1)(2008-7#1)(2011-2#1)
high in some##2##3##(1991-6#1)(2007-8#1)
high in the##13##3##(1990-11#1)(1990-5#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-8#1)(2008-1#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
high in##67##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-8#2)(1996-11#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
high incidence in##2##3##(2008-7#1)(2008-8#1)
high incidence of##37##3##(1990-2#1)(1991-12#1)(1992-2#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(2007-10#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
high incidence##45##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#2)(1993-12#1)(1993-3#2)(1994-12#2)(1994-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(2007-10#3)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
high index of suspicion is required to##4##7##(2007-7#1)(2008-1#1)(2010-1#1)(2012-12#1)
high index of suspicion is##6##5##(2007-7#3)(2008-1#1)(2010-1#1)(2012-12#1)
high index of suspicion##18##4##(2006-10#1)(2007-7#3)(2008-1#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#2)
high infection rate of##2##4##(1996-8#1)(2008-10#1)
high influenza##2##2##(1996-6#1)(2010-4#1)
high infratemporal fossa##2##3##(2012-3#2)
high initial##8##2##(1990-3#1)(1994-2#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-8#1)
high inoculation##2##2##(2008-10#2)
high inoculum density##3##3##(2008-10#3)
high inoculum##8##2##(1994-5#1)(2008-10#7)
high input##2##2##(2008-5#1)(2013-1#1)
high insertion torque##2##3##(2013-1#2)
high insertion##3##2##(2013-1#3)
high intake of marine n-3##2##5##(2010-6#2)
high intake of##4##3##(2008-10#1)(2010-4#1)(2010-6#2)
high intake##5##2##(2008-10#1)(2010-4#1)(2010-6#2)(2012-2#1)
high intensities##2##2##(2008-7#1)(2013-8#1)
high intensity in the##2##4##(2007-11#1)(2007-12#1)
high intensity probe##2##3##(2008-10#2)
high intensity##13##2##(1992-3#2)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
high interconnection##2##2##(2008-2#1)(2008-3#1)
high interest##3##2##(2008-10#2)(2008-5#1)
high internal##3##2##(1996-7#1)(2008-3#1)(2013-1#1)
high intracellular##2##2##(2008-4#1)(2008-8#1)
high intrinsic##3##2##(1990-7#1)(2008-10#1)(2008-3#1)
high ionic strength##9##3##(1992-4#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-10#3)(2009-5#1)(2010-5#1)
high iron##2##2##(1997-7#1)(2008-1#1)
high laser##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
high lateral resolution##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
high level expression of##3##4##(2008-11#1)(2008-5#1)(2011-1#1)
high level expression##5##3##(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)
high level in##5##3##(1993-3#1)(1994-5#1)(1995-11#1)(2009-6#1)(2010-8#1)
high level of IGF-IR mRNA##2##5##(2008-8#2)
high level of acceptance of##2##5##(1992-11#1)(1994-2#1)
high level of conservation##2##4##(2008-11#1)(2008-8#1)
high level of diversity##2##4##(2008-10#1)(2013-1#1)
high level of early abortion of##2##6##(2008-10#2)
high level of genetic##6##4##(2008-10#4)(2008-8#1)(2012-1#1)
high level of identity##2##4##(1991-9#1)(1992-11#1)
high level of keratinolytic activity##2##5##(2008-6#2)
high level of knowledge##2##4##(1995-3#1)(2013-8#1)
high level of sequence##2##4##(1995-11#1)(2008-7#1)
high level of suspicion##2##4##(1993-6#1)(2009-3#1)
high level of##125##3##(1990-12#1)(1990-2#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
high level profiles##2##3##(2010-5#2)
high level##160##2##(1990-12#1)(1990-2#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-3#2)(1993-6#3)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#3)(1995-3#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#29)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#12)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#2)
high levels by##2##3##(1991-11#1)(1992-8#1)
high levels for##2##3##(1992-2#1)(1993-8#1)
high levels in the##7##4##(1992-11#1)(1993-3#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
high levels in##17##3##(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-2#3)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)
high levels of both##2##4##(1996-2#1)(2007-10#1)
high levels of expression##5##4##(1994-8#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-8#1)
high levels of field resistance##2##5##(2008-10#2)
high levels of genetic diversity##3##5##(2008-10#1)(2010-8#1)(2013-1#1)
high levels of genetic##4##4##(2008-10#2)(2010-8#1)(2013-1#1)
high levels of genotypic diversity##2##5##(2008-10#2)
high levels of genotypic##3##4##(2008-10#3)
high levels of infection##2##4##(2008-10#1)(2008-12#1)
high levels of partial resistance##2##5##(2008-10#2)
high levels of recombinant protein##2##5##(2008-11#2)
high levels of resistance to##2##5##(2011-2#1)(2013-1#1)
high levels of resistance##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
high levels of satisfaction##2##4##(2008-10#2)
high levels of serum##2##4##(1995-2#1)(2010-1#1)
high levels of the##6##4##(1990-11#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-2#1)
high levels of transcripts##2##4##(1996-12#1)(2008-10#1)
high levels of##166##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#4)(1995-6#1)(1996-1#3)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#37)(2008-11#10)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#10)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#4)(2010-1#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
high levels were##2##3##(2008-6#1)(2013-1#1)
high levels##203##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#7)(1995-6#2)(1996-1#3)(1996-12#5)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#3)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#40)(2008-11#13)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#4)(2010-1#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
high light##9##2##(1992-8#1)(1996-4#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)
high linear##4##2##(2008-3#3)(2008-7#1)
high linearity##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
high lipid content##2##3##(2008-7#1)(2013-1#1)
high lipid##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
high loading##3##2##(1993-5#1)(2008-10#2)
high local concentration of##2##4##(2008-10#1)(2008-11#1)
high local concentration##3##3##(2008-10#2)(2008-11#1)
high local##8##2##(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#2)
high mannose##3##2##(1991-9#1)(1992-9#1)(2008-10#1)
high maternal##4##2##(1994-3#1)(1996-2#1)(2008-7#1)(2009-10#1)
high matrix##2##2##(2008-10#2)
high mean##3##2##(2008-9#2)(2012-2#1)
high mechanical stability##2##3##(2007-12#1)(2008-7#1)
high mechanical##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
high median##2##2##(2008-8#1)(2009-5#1)
high mental workload##2##3##(2011-2#2)
high mental##5##2##(2010-12#2)(2011-2#2)(2013-8#1)
high metabolic##4##2##(2008-11#1)(2008-3#2)(2010-7#1)
high metal##3##2##(1994-8#1)(2008-10#2)
high metastatic##3##2##(2008-11#1)(2008-6#1)(2008-9#1)
high mobility group##4##3##(1990-3#1)(1992-6#1)(1994-9#1)(1995-2#1)
high mobility##6##2##(1990-3#1)(1992-6#1)(1994-9#1)(1995-2#1)(2006-10#1)(2008-10#1)
high molar##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
high molecular weight (HMW)##5##4##(1990-12#2)(2008-10#2)(2010-8#1)
high molecular weight DNA##2##4##(1995-2#1)(2008-5#1)
high molecular weight EGFs##2##4##(1990-12#2)
high molecular weight and##2##4##(1991-2#1)(2008-5#1)
high molecular weight compounds##2##4##(2008-10#2)
high molecular weight duplex##2##4##(1995-2#2)
high molecular weight glycoproteins##2##4##(1990-12#2)
high molecular weight proteins##2##4##(1991-12#1)(2008-7#1)
high molecular weight##54##3##(1990-12#9)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-8#1)(1993-3#2)(1995-2#3)(1995-6#1)(1996-12#2)(1996-2#2)(2007-12#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#2)(2010-8#1)
high molecular##58##2##(1990-12#9)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-8#1)(1993-3#2)(1994-2#1)(1995-2#3)(1995-6#1)(1996-12#2)(1996-2#2)(2007-12#1)(2008-10#13)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-8#1)
high morbidity and mortality##14##4##(1990-12#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
high morbidity and##16##3##(1990-12#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
high morbidity##18##2##(1990-12#1)(1996-3#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
high mortality of##2##3##(1990-12#1)(2007-2#1)
high mortality rate and##2##4##(2008-6#1)(2010-5#1)
high mortality rate of##2##4##(2008-1#1)(2010-10#1)
high mortality rate##25##3##(1992-9#1)(1993-6#1)(1996-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#2)(2010-12#2)(2010-5#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
high mortality rates in##2##4##(2008-1#1)(2008-11#1)
high mortality rates##4##3##(2008-1#1)(2008-11#1)(2008-4#1)(2010-5#1)
high mortality##48##2##(1990-12#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-7#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-10#2)(2010-12#2)(2010-5#3)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
high multiplicity##3##2##(1991-6#1)(1995-12#1)(2008-9#1)
high myopia##2##2##(1991-2#1)(2011-2#1)
high negative predictive value##2##4##(2008-3#1)(2013-8#1)
high noise levels##2##3##(2008-2#1)(2008-3#1)
high noise##6##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
high nonlinearity of##2##3##(2007-12#2)
high nonlinearity##3##2##(2007-12#2)(2008-3#1)
high normal##2##2##(2008-3#1)(2013-1#1)
high number of scales between the lateral line and the##2##10##(2013-7#2)
high number of##24##3##(1990-10#1)(1993-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#4)
high number##26##2##(1990-10#1)(1993-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#4)
high numbers##5##2##(2008-10#3)(2008-12#1)(2012-2#1)
high numerical aperture##5##3##(2007-12#2)(2008-3#1)(2009-12#1)(2012-2#1)
high numerical apertures##2##3##(2008-2#1)(2008-3#1)
high numerical##7##2##(2007-12#2)(2008-2#1)(2008-3#2)(2009-12#1)(2012-2#1)
high nutrient##2##2##(2008-10#1)(2008-11#1)
high nutritional##2##2##(2012-2#1)(2013-8#1)
high occurrence##2##2##(1990-6#1)(2010-5#1)
high of##2##2##(1990-8#1)(1996-9#1)
high on##3##2##(2007-12#1)(2009-11#1)(2010-2#1)
high optical activity##2##3##(2008-3#2)
high optical throughput##2##3##(2007-12#1)(2008-2#1)
high optical##10##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)(2013-8#1)
high or low on a##2##5##(2007-7#1)(2008-12#1)
high or low##16##3##(1994-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-8#1)
high or##24##2##(1994-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
high order##3##2##(1994-5#1)(2010-2#1)(2013-1#1)
high osmolality##2##2##(2008-11#2)
high osmotic##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
high output power##3##3##(2007-12#1)(2008-2#2)
high output##6##2##(2007-12#1)(2008-10#1)(2008-2#4)
high overall##4##2##(1995-9#1)(1996-11#1)(1997-3#1)(2008-10#1)
high oxidative##2##2##(2010-5#1)(2011-2#1)
high oxygen##5##2##(1995-5#1)(2008-11#1)(2008-7#1)(2010-10#1)(2013-1#1)
high pH (&gt##2##3##(2008-10#1)(2012-2#1)
high pH (D)##2##3##(1991-9#2)
high pH##19##2##(1991-9#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#8)(2008-8#1)(2009-12#1)(2010-11#1)(2012-2#1)
high parametric##2##2##(2007-11#1)(2008-2#1)
high partition coefficients##2##3##(2008-10#2)
high peak intensities from##2##4##(2007-12#1)(2008-3#1)
high peak intensities##3##3##(2007-12#1)(2008-3#2)
high peak intensity##2##3##(2007-12#2)
high peak power##3##3##(2008-3#2)(2008-5#1)
high peak##10##2##(2007-12#3)(2008-3#5)(2008-5#1)(2012-2#1)
high penetration##3##2##(1996-3#1)(2007-12#1)(2008-5#1)
high percent##4##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
high percentage of patients##2##4##(1990-12#1)(2012-12#1)
high percentage of##19##3##(1990-12#1)(1991-12#1)(1991-6#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-12#3)(2012-3#2)
high percentage##23##2##(1990-12#1)(1991-12#1)(1991-6#1)(1994-5#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#2)
high performance is##2##3##(2008-10#1)(2008-3#1)
high performance liquid chromatographic (HPLC)##2##5##(2008-10#2)
high performance liquid chromatographic method for##2##6##(2008-10#1)(2011-1#1)
high performance liquid chromatographic method##5##5##(2008-10#2)(2010-3#1)(2011-1#1)(2012-2#1)
high performance liquid chromatographic##13##4##(2008-10#9)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
high performance liquid chromatography (HPLC) and##9##6##(1992-8#1)(2008-10#5)(2010-2#2)(2011-1#1)
high performance liquid chromatography (HPLC) coupled##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) method##5##6##(2008-10#3)(2008-5#1)(2011-2#1)
high performance liquid chromatography (HPLC) technique##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) was##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) with##6##6##(1997-2#1)(2008-10#3)(2008-5#1)(2010-5#1)
high performance liquid chromatography (HPLC)##49##5##(1991-8#1)(1992-8#1)(1997-2#1)(2008-10#33)(2008-11#1)(2008-5#3)(2008-8#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
high performance liquid chromatography (RP-HPLC)##3##5##(1990-2#1)(2008-10#1)(2011-1#1)
high performance liquid chromatography analysis##2##5##(2008-10#2)
high performance liquid chromatography and##6##5##(1990-2#2)(1990-7#1)(2008-10#3)
high performance liquid chromatography method##2##5##(2008-10#1)(2008-5#1)
high performance liquid chromatography separation##2##5##(2008-10#1)(2008-9#1)
high performance liquid chromatography with UV##2##6##(2008-10#2)
high performance liquid chromatography with diode array detector##2##8##(2008-10#2)
high performance liquid chromatography with fluorescence##5##6##(1993-2#1)(2008-10#4)
high performance liquid chromatography with##15##5##(1993-2#1)(1995-6#1)(2008-10#13)
high performance liquid chromatography##120##4##(1990-2#3)(1990-7#2)(1990-8#2)(1991-4#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#75)(2008-11#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
high performance liquid chromatography-electrospray ionization tandem mass spectrometry##2##8##(2008-10#1)(2011-1#1)
high performance liquid chromatography-electrospray ionization##3##5##(2008-10#2)(2011-1#1)
high performance liquid chromatography-electrospray##5##4##(2008-10#2)(2008-8#2)(2011-1#1)
high performance liquid chromatography-inductively coupled plasma##2##6##(2008-10#2)
high performance liquid chromatography-inductively coupled##3##5##(2008-10#3)
high performance liquid chromatography-microwave digestion-hydride generation-atomic absorption spectrometry##2##8##(2008-10#2)
high performance liquid chromatography-tandem mass spectrometry]##2##6##(2011-1#2)
high performance liquid chromatography-tandem mass##3##5##(2011-1#3)
high performance liquid chromatography/electrospray/mass spectrometry##3##5##(2008-10#3)
high performance liquid immunoaffinity chromatography##2##5##(1990-12#2)
high performance liquid##158##3##(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#98)(2008-11#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#10)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)
high performance runner who##2##4##(2011-2#2)
high performance runner##3##3##(2011-2#3)
high performance thin layer chromatography##2##5##(2009-7#1)(2012-2#1)
high performance##179##2##(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#105)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#11)(2011-2#7)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)
high personal##2##2##(2011-2#2)
high phosphorylation##3##2##(1991-9#3)
high photochemical stability##2##3##(2008-5#1)(2008-7#1)
high photon##2##2##(2008-2#1)(2010-10#1)
high photostability and##2##3##(2008-3#1)(2009-4#1)
high plasma concentrations of##2##4##(1992-3#1)(2008-6#1)
high plasma concentrations##3##3##(1991-1#1)(1992-3#1)(2008-6#1)
high plasma digoxin level and##3##5##(1994-6#3)
high plasma digoxin level##7##4##(1994-6#7)
high plasma##12##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-6#7)(2008-6#1)(2008-7#1)
high polymorphism##2##2##(2008-10#1)(2008-12#1)
high population densities##2##3##(2008-10#2)
high population##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2012-2#1)
high populations on##2##3##(2008-10#2)
high populations##4##2##(2008-10#4)
high porosity and##2##3##(2009-12#1)(2009-7#1)
high porosity##3##2##(2008-11#1)(2009-12#1)(2009-7#1)
high positive##5##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
high potency##6##2##(1991-12#1)(1992-12#1)(1995-11#1)(2009-10#2)(2011-2#1)
high potential for##4##3##(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
high potential of the##2##4##(2008-10#1)(2011-1#1)
high potential of##3##3##(1995-12#1)(2008-10#1)(2011-1#1)
high potential to##3##3##(2007-11#1)(2008-11#1)(2012-3#1)
high potential##11##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
high power density##2##3##(1992-12#1)(2008-3#1)
high power##12##2##(1992-12#1)(1994-2#1)(2008-10#3)(2008-3#3)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
high precision and accuracy##4##4##(2008-10#4)
high precision and reproducibility##2##4##(2008-10#2)
high precision and##9##3##(2008-10#7)(2008-3#1)(2008-5#1)
high precision##23##2##(2008-10#14)(2008-3#7)(2008-5#1)(2009-7#1)
high preconcentration##3##2##(2008-10#3)
high predictability##2##2##(2010-4#1)(2011-2#1)
high predictive value for##2##4##(2008-4#1)(2011-2#1)
high predictive##7##2##(2008-10#1)(2008-4#1)(2008-6#2)(2009-8#1)(2011-2#1)(2012-3#1)
high pressure and##5##3##(1992-11#1)(1995-6#2)(1996-5#1)(2008-10#1)
high pressure liquid chromatography (HPLC) with##2##6##(2008-10#2)
high pressure liquid chromatography (HPLC)##4##5##(1995-12#1)(2008-10#2)(2011-1#1)
high pressure liquid chromatography##7##4##(1995-12#1)(1995-3#1)(2008-10#2)(2008-5#1)(2011-1#2)
high pressure liquid##10##3##(1995-12#1)(1995-3#1)(2008-10#5)(2008-5#1)(2011-1#2)
high pressure system##2##3##(2008-10#2)
high pressure##37##2##(1992-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#3)(2012-2#2)
high pressures##6##2##(1994-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2010-12#1)
high prevalence in##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2013-1#1)
high prevalence of HIV infection##2##5##(2007-7#1)(2011-2#1)
high prevalence of anti-HCV##2##4##(2007-7#2)
high prevalence of the##2##4##(2007-11#1)(2007-7#1)
high prevalence of##41##3##(1992-5#1)(1992-8#1)(1993-6#1)(1994-6#1)(2007-11#1)(2007-7#7)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
high prevalence rate##2##3##(1990-6#1)(1991-12#1)
high prevalence##51##2##(1990-6#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-6#1)(2007-11#1)(2007-7#8)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-1#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
high price of##2##3##(1995-9#1)(2008-10#1)
high priority##10##2##(1994-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-1#2)
high probability of##7##3##(1997-6#1)(1997-8#1)(2007-11#1)(2008-11#2)(2008-5#1)(2013-1#1)
high probability##11##2##(1990-5#1)(1996-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-3#1)(2013-1#1)
high producing##2##2##(2008-11#2)
high production of##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
high production##6##2##(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)
high productivity##7##2##(2008-11#3)(2008-9#1)(2011-2#1)(2012-9#1)(2013-1#1)
high proliferative##4##2##(1994-8#1)(1995-12#1)(2008-11#2)
high propensity##2##2##(2008-8#1)(2013-8#1)
high proportion of##20##3##(1990-12#1)(1991-9#1)(1992-3#1)(1995-12#1)(1995-3#1)(1995-9#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)
high proportion##24##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-3#1)(1995-9#1)(1997-2#1)(2007-10#1)(2008-10#5)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)
high proportions of##2##3##(1991-8#1)(2008-10#1)
high proportions##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
high protein##6##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)
high pulmonary##2##2##(2008-11#1)(2010-6#1)
high pulse energy and##2##4##(2008-3#2)
high pulse energy##3##3##(2008-3#3)
high pulse##4##2##(2008-3#3)(2010-1#1)
high pump##4##2##(2008-2#1)(2008-3#3)
high purity Gd(2)O(3)##2##3##(2008-10#2)
high purity of##2##3##(1994-5#1)(2008-10#1)
high purity##24##2##(1994-5#1)(2008-10#18)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
high quality and##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
high quality care for##2##4##(1992-12#1)(1997-2#1)
high quality care##5##3##(1992-12#1)(1994-1#1)(1996-3#1)(1997-2#1)(2008-10#1)
high quality of##3##3##(2008-3#1)(2009-11#1)(2010-11#1)
high quality patient care##3##4##(1994-1#1)(1997-2#1)(2008-3#1)
high quality predictions##2##3##(2008-10#1)(2008-11#1)
high quality service##2##3##(1994-3#1)(1995-2#1)
high quality studies##2##3##(2007-7#1)(2008-8#1)
high quality##59##2##(1991-12#2)(1992-12#1)(1993-12#2)(1994-1#2)(1994-3#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#3)
high quantities##4##2##(1995-12#1)(2008-10#2)(2013-1#1)
high quantum yield of##2##4##(1994-12#1)(2007-12#1)
high quantum yield##5##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-9#1)
high quantum##6##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
high rainfall##2##2##(2008-10#1)(2012-9#1)
high rate of complications##2##4##(1991-9#1)(2012-12#1)
high rate of side effects##2##5##(1997-8#1)(2011-2#1)
high rate of##53##3##(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#3)(2013-1#2)(2013-8#1)
high rate##57##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#3)(2013-1#3)(2013-8#1)
high rates of recurrence##2##4##(2011-2#1)(2012-2#1)
high rates of##24##3##(1991-11#1)(1994-7#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
high rates##26##2##(1991-11#1)(1991-5#1)(1994-7#1)(1995-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
high ratio of##4##3##(2007-11#1)(2008-10#1)(2010-4#1)(2013-1#1)
high recoveries##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
high recovery of##2##3##(1991-5#1)(2008-10#1)
high recovery##5##2##(1991-5#1)(2008-10#4)
high recurrence rate##4##3##(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
high recurrence rates##2##3##(2010-8#1)(2013-1#1)
high recurrence##6##2##(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
high reflectance##3##2##(2008-2#2)(2008-3#1)
high reflection/suppression##2##2##(2008-3#2)
high reflectivity and##2##3##(2008-3#2)
high reflectivity##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
high refractive index##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
high refractive##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
high relative humidity##4##3##(2008-10#4)
high relative to##2##3##(1994-11#1)(2008-9#1)
high relative##10##2##(1991-2#1)(1992-3#1)(1994-11#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-4#1)
high relaxivity contrast agents in##2##5##(2008-7#2)
high relaxivity contrast agents##3##4##(2008-7#3)
high relaxivity##5##2##(2008-7#5)
high reliability##11##2##(1993-9#1)(1996-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2012-2#1)(2013-1#1)
high removal##2##2##(2011-2#1)(2013-1#1)
high repeatability##2##2##(2008-10#1)(2013-1#1)
high repetition rate##6##3##(2007-11#2)(2007-12#2)(2008-3#1)(2010-1#1)
high repetition##7##2##(2007-11#2)(2007-12#2)(2008-3#2)(2010-1#1)
high reproducibility of##2##3##(2008-10#1)(2012-3#1)
high reproducibility##7##2##(2008-10#6)(2012-3#1)
high resistance to##11##3##(1997-2#1)(2006-12#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-3#1)(2009-3#1)(2011-10#1)
high resistance##13##2##(1997-2#1)(2006-12#1)(2007-10#2)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-3#1)(2011-10#1)
high resolution GC-MS##2##3##(2008-10#2)
high resolution and accuracy##4##4##(2007-11#1)(2008-3#3)
high resolution and##9##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-3#4)(2008-7#1)(2011-7#1)
high resolution computed##2##3##(2007-8#2)
high resolution for long-range imaging##2##5##(2008-3#2)
high resolution in##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
high resolution is##2##3##(2008-3#2)
high resolution mass spectrometry##4##4##(2008-10#2)(2008-11#1)(2010-5#1)
high resolution mass##5##3##(2008-10#3)(2008-11#1)(2010-5#1)
high resolution of the##3##4##(1993-12#1)(1995-3#1)(2008-3#1)
high resolution of##6##3##(1993-12#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
high resolution separation##2##3##(2008-10#2)
high resolution separations##2##3##(2008-10#1)(2008-7#1)
high resolution structure##2##3##(1992-8#1)(1997-7#1)
high resolution two-dimensional gel electrophoresis##2##5##(1993-9#1)(1995-8#1)
high resolution##96##2##(1990-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#16)(2008-11#3)(2008-2#5)(2008-3#17)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
high response##4##2##(1991-12#1)(1991-8#1)(2008-10#1)(2008-8#1)
high retention##3##2##(2008-10#2)(2008-12#1)
high risk and more stable##2##5##(2007-5#2)
high risk and##7##3##(1991-6#1)(2007-5#2)(2008-10#1)(2011-1#2)(2012-3#1)
high risk behaviors##2##3##(1991-1#1)(2011-1#1)
high risk cases##2##3##(1994-3#1)(2007-8#1)
high risk due to the##2##5##(2008-11#1)(2008-4#1)
high risk factors for##2##4##(1994-11#1)(1994-2#1)
high risk for##24##3##(1991-5#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-1#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#7)
high risk group for##2##4##(2008-7#1)(2011-2#1)
high risk group##13##3##(1994-11#1)(1995-4#1)(2007-11#2)(2007-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
high risk groups##4##3##(1995-1#1)(2007-12#1)(2009-5#1)(2011-1#1)
high risk infants##2##3##(1993-12#1)(2009-5#1)
high risk of developing##3##4##(1992-6#1)(2008-7#1)(2010-3#1)
high risk of losing##2##4##(1992-5#1)(1996-11#1)
high risk of malignant transformation##2##5##(2009-12#1)(2012-12#1)
high risk of recurrence##6##4##(1993-9#1)(2008-5#1)(2008-8#1)(2010-3#1)(2013-7#2)
high risk of rupture##2##4##(2012-1#1)(2013-8#1)
high risk of the##2##4##(1994-9#1)(2008-1#1)
high risk of##55##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-9#1)(1994-9#2)(1995-5#1)(1996-11#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#3)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
high risk patient##2##3##(1996-9#1)(2013-1#1)
high risk patients and##2##4##(1992-6#1)(2010-3#1)
high risk patients is a##2##5##(2010-3#1)(2012-12#1)
high risk patients##16##3##(1992-6#1)(1996-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-7#1)(2009-7#1)(2010-10#2)(2010-3#3)(2012-12#1)
high risk populations##2##3##(2009-3#1)(2011-2#1)
high risk##192##2##(1990-2#1)(1990-3#3)(1990-5#1)(1991-1#2)(1991-11#2)(1991-5#1)(1991-6#2)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-11#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#3)(2007-2#5)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#7)(2008-1#5)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#3)(2010-3#5)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#17)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#2)
high risks##2##2##(1991-6#1)(2008-10#1)
high robustness of##2##3##(2010-8#1)(2011-2#1)
high robustness##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
high safety##2##2##(2008-11#1)(2012-3#1)
high saline##4##2##(2008-10#4)
high salinity##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
high salt and##2##3##(1995-6#1)(2008-7#1)
high salt concentrations##5##3##(1990-12#1)(1990-5#1)(1995-5#1)(2008-10#1)(2011-2#1)
high salt content##3##3##(2008-10#3)
high salt contents##2##3##(2008-10#2)
high salt##23##2##(1990-12#1)(1990-5#1)(1994-11#1)(1995-5#1)(1995-6#4)(1997-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
high sample throughput##8##3##(1992-11#1)(2008-10#6)(2008-9#1)
high sample##9##2##(1992-11#1)(2008-10#7)(2008-9#1)
high sampling frequency##3##3##(2008-10#3)
high sampling rate##3##3##(2008-10#2)(2008-3#1)
high sampling##8##2##(2008-10#5)(2008-3#2)(2008-5#1)
high satisfaction with##2##3##(2012-2#1)(2013-1#1)
high school students about##2##4##(2012-12#1)(2012-3#1)
high school students in Tehran##2##5##(2008-12#2)
high school students in the Tiko health district##3##8##(2013-1#3)
high school students in##5##4##(2008-12#2)(2013-1#3)
high school students##15##3##(1990-12#1)(1993-3#1)(2007-12#1)(2008-1#2)(2008-12#2)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#2)(2013-1#3)
high school##38##2##(1990-12#3)(1990-3#1)(1990-6#1)(1993-1#1)(1993-3#1)(2007-12#1)(2008-1#2)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-10#2)(2010-2#1)(2011-1#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
high schools in##3##3##(2009-7#1)(2009-8#1)(2013-1#1)
high schools##7##2##(1995-12#1)(2008-1#1)(2008-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
high score##3##2##(2008-8#1)(2013-1#2)
high secretion##2##2##(2008-11#2)
high security##3##2##(1997-5#2)(2008-10#1)
high seed##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
high selective vagotomy with pyloroplasty##3##5##(1990-6#3)
high selective vagotomy##4##3##(1990-6#4)
high selective##5##2##(1990-6#4)(2008-7#1)
high selectivity and sensitivity to##2##5##(2008-10#2)
high selectivity and sensitivity##8##4##(2008-10#8)
high selectivity and##11##3##(2008-10#9)(2008-9#1)(2009-12#1)
high selectivity for##12##3##(1991-3#1)(1994-11#1)(2008-10#9)(2008-2#1)
high selectivity is##2##3##(2008-10#1)(2010-12#1)
high selectivity of the##5##4##(2008-10#4)(2008-3#1)
high selectivity of##8##3##(2008-10#6)(2008-3#1)(2010-7#1)
high selectivity to##2##3##(2008-10#2)
high selectivity toward##4##3##(2008-10#3)(2013-1#1)
high selectivity towards##4##3##(2008-10#3)(2008-7#1)
high selectivity with the##2##4##(2008-10#1)(2012-2#1)
high selectivity##56##2##(1991-3#1)(1994-11#1)(2008-10#43)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-7#1)(2012-2#1)(2013-1#1)
high sensitive and##2##3##(2008-10#1)(2011-1#1)
high sensitive##8##2##(2008-10#5)(2008-3#1)(2011-1#1)(2013-1#1)
high sensitivities##5##2##(2008-10#3)(2012-12#1)(2012-3#1)
high sensitivity C-reactive protein##2##4##(2010-12#1)(2013-1#1)
high sensitivity and accuracy##2##4##(2007-11#1)(2010-4#1)
high sensitivity and fast response time##2##6##(2007-11#1)(2008-10#1)
high sensitivity and good selectivity##2##5##(2008-10#2)
high sensitivity and good##4##4##(2008-10#4)
high sensitivity and specificity##3##4##(2008-4#1)(2010-8#1)(2013-1#1)
high sensitivity and stability##2##4##(1990-8#1)(2008-10#1)
high sensitivity and##26##3##(1990-8#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#12)(2008-3#2)(2008-4#2)(2008-9#1)(2010-4#1)(2010-8#1)(2013-1#1)
high sensitivity for##4##3##(2008-10#3)(2008-3#1)
high sensitivity in##2##3##(2007-10#1)(2007-12#1)
high sensitivity is##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
high sensitivity of the##6##4##(2008-10#3)(2008-2#1)(2008-3#2)
high sensitivity of##15##3##(1990-2#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#1)(2010-1#1)(2010-5#1)(2013-8#1)
high sensitivity to##6##3##(1990-11#1)(1997-3#1)(2008-10#3)(2009-5#1)
high sensitivity with##2##3##(2008-10#1)(2008-2#1)
high sensitivity##130##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-11#1)(1995-12#1)(1996-2#1)(1997-3#2)(2007-10#1)(2007-11#5)(2007-12#2)(2008-10#72)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#2)
high separation efficiencies##2##3##(2008-10#1)(2008-11#1)
high separation efficiency##2##3##(2008-10#2)
high separation##7##2##(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)
high sequence identity to##2##4##(2008-10#2)
high sequence identity##4##3##(1993-2#1)(1997-4#1)(2008-10#2)
high sequence similarity##4##3##(1994-11#1)(2008-10#3)
high sequence##10##2##(1992-12#1)(1993-2#1)(1994-11#1)(1997-4#2)(2008-10#5)
high serum levels of##2##4##(1996-11#1)(2009-8#1)
high serum##8##2##(1990-3#1)(1991-11#1)(1991-6#1)(1996-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
high shear rates##2##3##(2008-11#2)
high shear##4##2##(1992-12#1)(2008-11#2)(2009-7#1)
high signal intensity on T##2##5##(1997-8#2)
high signal intensity on##5##4##(1991-11#1)(1997-8#3)(2011-2#1)
high signal intensity##6##3##(1991-11#1)(1997-8#3)(2011-2#1)(2013-8#1)
high signal##10##2##(1991-11#1)(1997-8#3)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
high signal-to-noise ratio (SNR)##2##4##(2008-3#1)(2011-1#1)
high signal-to-noise ratio##8##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)(2011-1#1)
high signal-to-noise ratios##2##3##(2008-10#1)(2008-3#1)
high signal-to-noise##10##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2011-1#1)
high similarity to##3##3##(1991-5#1)(1996-3#1)(2008-7#1)
high similarity with the##2##4##(1992-3#1)(2008-5#1)
high similarity##9##2##(1991-5#1)(1992-3#1)(1996-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#1)
high skin##2##2##(2008-3#1)(2008-5#1)
high social##6##2##(1993-3#2)(1994-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
high socioeconomic status##3##3##(1990-2#1)(2012-2#1)(2013-8#1)
high soil moisture##2##3##(2008-10#2)
high soil##3##2##(2008-10#3)
high solvent##2##2##(1992-9#1)(2013-1#1)
high spatial and temporal resolution##2##5##(2008-11#1)(2012-1#1)
high spatial and temporal resolutions##2##5##(2008-10#2)
high spatial and temporal##4##4##(2008-10#2)(2008-11#1)(2012-1#1)
high spatial and##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#2)
high spatial coherence##2##3##(2008-2#1)(2008-3#1)
high spatial resolution in##2##4##(2008-2#1)(2012-12#1)
high spatial resolution##19##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#2)
high spatial##32##2##(2007-11#3)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-9#1)(2010-12#1)(2012-1#3)(2012-12#2)(2012-2#2)
high specific activity##3##3##(1994-11#1)(1994-2#1)(2008-7#1)
high specific surface##2##3##(2008-10#1)(2008-5#1)
high specific##9##2##(1990-12#2)(1994-11#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
high specificity and##3##3##(1993-8#1)(1997-2#1)(2008-12#1)
high specificity for##6##3##(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
high specificity with##2##3##(1997-3#1)(2012-12#1)
high specificity##25##2##(1991-5#2)(1993-8#4)(1997-2#1)(1997-3#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
high spectral resolution##12##3##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#3)
high spectral##16##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#9)(2008-3#3)
high speed and##2##3##(2007-11#1)(2011-2#1)
high speed##18##2##(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
high speeds##2##2##(1994-12#1)(2008-4#1)
high spider fearful##2##3##(2009-9#2)
high stability in the##2##4##(2008-3#1)(2010-10#1)
high stability of the##2##4##(2008-10#1)(2011-1#1)
high stability of##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
high stability##19##2##(1990-12#1)(1990-5#1)(1993-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#2)(2010-10#1)(2011-1#1)(2013-1#1)
high standards of##4##3##(1992-9#1)(2007-2#1)(2008-4#1)(2009-7#1)
high standards##5##2##(1992-9#1)(1994-3#1)(2007-2#1)(2008-4#1)(2009-7#1)
high strength##4##2##(2009-6#1)(2009-7#1)(2013-1#2)
high substrate##6##2##(1991-5#1)(1992-3#2)(1997-2#1)(2008-12#1)(2008-7#1)
high success rate of##2##4##(2009-7#1)(2012-12#1)
high success rate##7##3##(1994-12#1)(1995-11#1)(1996-11#1)(1997-4#1)(2009-7#1)(2012-12#1)(2013-8#1)
high sugar levels##2##3##(2008-10#2)
high sugar##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
high surface area##4##3##(2008-10#2)(2008-6#1)(2009-7#1)
high surface##11##2##(1994-3#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)
high surgical risk##2##3##(2007-8#1)(2008-12#1)
high surgical##3##2##(2007-8#1)(2008-11#1)(2008-12#1)
high survival##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
high susceptibility to##3##3##(1993-8#1)(2008-10#2)
high susceptibility##6##2##(1993-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2012-1#1)
high symmetry##2##2##(2008-10#1)(2008-3#1)
high system##2##2##(2007-11#1)(2008-10#1)
high systemic levels##2##3##(2009-4#1)(2010-10#1)
high systemic##3##2##(1996-1#1)(2009-4#1)(2010-10#1)
high tech##2##2##(2008-12#1)(2010-4#1)
high technology##2##2##(1992-11#1)(2013-8#1)
high temperature and##5##3##(2008-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
high temperature conditions##2##3##(2008-12#1)(2008-8#1)
high temperature of##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
high temperature##50##2##(1991-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#16)(2008-11#1)(2008-12#5)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2010-4#1)(2011-2#3)(2012-2#3)(2012-9#1)(2013-1#1)(2013-8#4)
high temperatures and##2##3##(1995-5#1)(2008-12#1)
high temperatures##32##2##(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-5#1)
high temporal and spatial resolution##4##5##(2007-8#1)(2008-3#1)(2010-12#1)(2011-1#1)
high temporal resolution##3##3##(2008-3#1)(2009-9#1)(2012-1#1)
high temporal##8##2##(1996-2#1)(2007-8#1)(2008-3#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)
high thermal stability##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
high thermal##5##2##(2008-10#3)(2008-2#1)(2011-1#1)
high throughout the##3##3##(2008-10#2)(2008-8#1)
high throughput analysis of##2##4##(2008-10#1)(2008-4#1)
high throughput methods##2##3##(2008-10#2)
high throughput screening##10##3##(2008-10#6)(2009-6#2)(2010-12#2)
high throughput##38##2##(1997-4#2)(1997-6#1)(2008-10#15)(2008-11#1)(2008-4#5)(2008-7#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#3)(2011-2#2)(2012-3#3)
high titer##8##2##(1991-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
high titre##6##2##(1993-9#1)(1995-12#1)(1996-12#1)(2008-11#3)
high to##7##2##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#3)(2010-6#1)
high tolerance for##2##3##(2008-10#1)(2008-3#1)
high tolerance##3##2##(2008-10#2)(2008-3#1)
high tone##4##2##(2008-6#1)(2013-8#3)
high total##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
high toxicity##4##2##(1997-2#1)(2008-10#3)
high transfection efficiency##2##3##(2008-11#2)
high transfection##3##2##(2008-11#3)
high transmission##5##2##(1994-11#1)(2007-11#1)(2007-12#1)(2008-8#2)
high transparency##3##2##(2008-2#2)(2008-3#1)
high treatment##2##2##(2012-12#1)(2013-1#1)
high tumor##3##2##(1993-11#1)(2008-5#1)(2010-6#1)
high tuning##2##2##(2007-11#2)
high turnover##2##2##(1990-2#1)(2012-12#1)
high under##2##2##(2008-10#1)(2008-6#1)
high urogenital sinus##2##3##(2008-10#2)
high vacuum##2##2##(2008-2#1)(2008-6#1)
high valine##2##2##(2008-10#2)
high value for##2##3##(2007-12#1)(2008-2#1)
high value of##5##3##(1995-12#1)(2008-10#2)(2008-2#1)(2011-1#1)
high value##8##2##(1995-12#1)(2007-12#1)(2008-10#3)(2008-2#2)(2011-1#1)
high values for the##3##4##(2008-10#2)(2013-1#1)
high values of##8##3##(1990-12#1)(1993-11#1)(2008-10#4)(2008-5#2)
high values##14##2##(1990-12#1)(1993-11#1)(2007-12#1)(2008-10#6)(2008-5#2)(2011-2#2)(2013-1#1)
high vapour##3##2##(2008-10#1)(2008-5#2)
high variability of##2##3##(2008-10#1)(2008-9#1)
high variability##9##2##(1991-12#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#2)(2013-7#1)
high velocity##3##2##(2007-7#1)(2009-3#1)(2011-1#1)
high versus##2##2##(1990-6#1)(2008-4#1)
high viability##3##2##(2008-11#3)
high viable##2##2##(2008-11#1)(2013-1#1)
high virulence on peas##2##4##(2008-10#2)
high virulence on##4##3##(2008-10#4)
high virulence##7##2##(2008-10#7)
high virus##2##2##(2008-10#1)(2011-2#1)
high viscosity##2##2##(2008-10#1)(2008-5#1)
high voiding##2##2##(2008-10#2)
high voltage##10##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(2007-11#2)(2008-10#2)(2008-11#1)(2012-2#1)
high volume##10##2##(1991-3#1)(1992-11#1)(1992-2#1)(1995-8#1)(2008-11#4)(2011-2#1)(2013-1#1)
high volumes##2##2##(2008-10#1)(2009-3#1)
high volumetric##3##2##(2007-12#1)(2008-11#1)(2008-6#1)
high water content##2##3##(2009-6#1)(2009-9#1)
high water##6##2##(2008-5#2)(2008-7#1)(2009-6#1)(2009-9#1)(2012-3#1)
high when##5##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-3#1)(2009-8#1)
high with##3##2##(2008-1#1)(2008-10#1)(2013-8#1)
high x-ray##2##2##(2008-3#2)
high yield by##2##3##(1990-5#1)(2008-4#1)
high yield of##7##3##(1990-3#1)(1994-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
high yield##28##2##(1990-3#1)(1990-5#1)(1992-8#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
high yielding##5##2##(2007-11#1)(2008-10#1)(2009-12#1)(2010-2#1)(2011-2#1)
high yields from##2##3##(2008-11#1)(2008-4#1)
high yields of##6##3##(1994-6#1)(2008-1#1)(2008-4#2)(2008-6#1)(2011-2#1)
high yields##15##2##(1994-6#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
high##5955##1##(1990-10#3)(1990-11#21)(1990-12#44)(1990-2#23)(1990-3#12)(1990-5#32)(1990-6#24)(1990-7#6)(1990-8#22)(1990-9#8)(1991-1#6)(1991-10#1)(1991-11#14)(1991-12#25)(1991-2#18)(1991-3#7)(1991-4#1)(1991-5#20)(1991-6#24)(1991-8#13)(1991-9#21)(1992-1#2)(1992-10#3)(1992-11#15)(1992-12#22)(1992-2#17)(1992-3#28)(1992-4#2)(1992-5#11)(1992-6#25)(1992-7#1)(1992-8#17)(1992-9#21)(1993-1#10)(1993-11#28)(1993-12#27)(1993-2#14)(1993-3#29)(1993-5#3)(1993-6#23)(1993-8#21)(1993-9#19)(1994-1#4)(1994-11#32)(1994-12#21)(1994-2#23)(1994-3#17)(1994-5#17)(1994-6#27)(1994-7#2)(1994-8#24)(1994-9#11)(1995-1#5)(1995-10#2)(1995-11#30)(1995-12#31)(1995-2#29)(1995-3#29)(1995-4#1)(1995-5#15)(1995-6#21)(1995-8#14)(1995-9#5)(1996-1#8)(1996-10#2)(1996-11#12)(1996-12#31)(1996-2#33)(1996-3#7)(1996-4#3)(1996-5#21)(1996-6#10)(1996-7#4)(1996-8#3)(1996-9#6)(1997-1#12)(1997-2#31)(1997-3#23)(1997-4#29)(1997-5#7)(1997-6#16)(1997-7#23)(1997-8#13)(1997-9#1)(2006-10#12)(2006-12#1)(2006-5#1)(2006-6#3)(2007-1#3)(2007-10#22)(2007-11#106)(2007-12#124)(2007-2#11)(2007-4#4)(2007-5#11)(2007-6#3)(2007-7#46)(2007-8#31)(2008-1#75)(2008-10#1171)(2008-11#241)(2008-12#85)(2008-2#157)(2008-3#313)(2008-4#64)(2008-5#134)(2008-6#67)(2008-7#194)(2008-8#173)(2008-9#98)(2009-1#3)(2009-10#19)(2009-11#23)(2009-12#16)(2009-2#8)(2009-3#20)(2009-4#18)(2009-5#23)(2009-6#15)(2009-7#33)(2009-8#22)(2009-9#19)(2010-1#19)(2010-10#23)(2010-11#29)(2010-12#34)(2010-2#11)(2010-3#31)(2010-4#35)(2010-5#32)(2010-6#20)(2010-7#16)(2010-8#37)(2010-9#11)(2011-1#111)(2011-10#2)(2011-2#196)(2011-3#9)(2011-7#1)(2012-1#35)(2012-12#68)(2012-2#111)(2012-3#88)(2012-4#9)(2012-5#1)(2012-6#6)(2012-7#3)(2012-8#1)(2012-9#5)(2013-1#201)(2013-7#22)(2013-8#81)
high&quot##2##1##(1994-2#1)(2009-8#1)
high)##3##1##(1992-3#1)(2008-3#1)(2012-3#1)
high- Q##7##2##(2007-11#5)(2007-12#2)
high- and low-predation localities##2##4##(2008-8#2)
high- and low-predation##3##3##(2008-8#3)
high- and##9##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#3)(2013-1#1)
high- or##4##2##(1994-12#1)(2008-3#1)(2013-8#2)
high- to##2##2##(2007-12#1)(2012-3#1)
high-##25##1##(1990-11#1)(1994-12#1)(2007-11#6)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
high-GC##2##1##(2008-7#1)(2012-2#1)
high-N##4##1##(2007-11#1)(2008-3#3)
high-Q whispering##2##2##(2007-12#1)(2008-3#1)
high-Q##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
high-Tc##2##1##(1992-8#1)(1993-5#1)
high-Verticillium soil##3##2##(2008-10#3)
high-accuracy##10##1##(2008-10#3)(2008-2#1)(2008-3#5)(2013-8#1)
high-affinity GTPase activity in##2##4##(1995-11#2)
high-affinity GTPase activity##4##3##(1995-11#4)
high-affinity [3H]dextrorphan binding sites in rat##2##6##(1990-7#2)
high-affinity binders##2##2##(1997-4#1)(2008-9#1)
high-affinity binding site##2##3##(1990-2#1)(2012-2#1)
high-affinity binding sites##3##3##(1992-3#1)(1993-9#1)(1996-2#1)
high-affinity binding##14##2##(1990-11#1)(1990-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-4#2)(2012-2#1)
high-affinity receptor##2##2##(1996-12#1)(2008-9#1)
high-affinity site##2##2##(1993-11#1)(1994-3#1)
high-affinity sites##2##2##(1990-11#1)(1995-12#1)
high-affinity##67##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-6#1)(1992-10#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#5)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-4#7)(2008-5#2)(2008-7#1)(2008-9#3)(2009-6#2)(2009-7#2)(2010-5#1)(2012-2#1)
high-altitude##7##1##(2008-2#1)(2008-3#2)(2010-6#1)(2013-1#3)
high-aperture##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
high-aspect-ratio polymer nanopillars##2##3##(2009-11#2)
high-aspect-ratio##3##1##(2009-11#3)
high-average##2##1##(2008-2#1)(2011-2#1)
high-average-power laser##2##2##(2007-11#1)(2008-3#1)
high-average-power##7##1##(2007-11#2)(2007-12#2)(2008-3#3)
high-bandwidth communications##2##2##(2007-11#2)
high-bandwidth##7##1##(2007-11#3)(2008-3#4)
high-beam-quality##2##1##(2008-2#1)(2008-3#1)
high-biomass##2##1##(2008-10#1)(2012-2#1)
high-birefringent##4##1##(2008-2#4)
high-bit-rate##3##1##(2007-11#2)(2008-3#1)
high-brightness laser##2##2##(2007-12#1)(2008-2#1)
high-brightness##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
high-complexity##2##1##(1990-11#1)(2008-2#1)
high-concentration##2##1##(2008-10#1)(2008-6#1)
high-content##2##1##(2008-9#1)(2009-12#1)
high-contrast##17##1##(1993-5#1)(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#2)(2008-9#2)(2013-1#1)
high-copy##2##1##(1995-2#1)(1997-8#1)
high-copy-number vector##2##2##(1994-12#2)
high-copy-number##4##1##(1993-9#1)(1994-12#3)
high-cost##4##1##(1995-1#1)(1995-2#1)(2008-3#1)(2008-6#1)
high-curvature##3##1##(2007-12#1)(2007-7#1)(2008-3#1)
high-degree##2##1##(2010-11#1)(2011-2#1)
high-density intensity patterns##2##3##(2008-3#2)
high-density lipoprotein (HDL) cholesterol##4##4##(2008-1#1)(2008-3#1)(2008-6#1)(2012-2#1)
high-density lipoprotein (HDL)##10##3##(1991-12#1)(1993-6#1)(1994-6#1)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-4#1)(2012-2#1)
high-density lipoprotein cholesterol (HDL-C)##3##4##(2012-6#1)(2013-1#2)
high-density lipoprotein cholesterol##10##3##(2008-3#2)(2008-7#1)(2011-1#3)(2011-2#1)(2012-6#1)(2013-1#2)
high-density lipoprotein##32##2##(1991-12#2)(1991-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#3)(2008-6#4)(2008-7#2)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#1)
high-density lipoprotein-cholesterol##2##2##(2008-7#1)(2010-5#1)
high-density oligonucleotide microarrays were used to##2##6##(2008-10#1)(2009-12#1)
high-density oligonucleotide microarrays##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
high-density optical data storage##2##4##(2008-3#2)
high-density optical##4##2##(2008-2#1)(2008-3#3)
high-density##72##1##(1991-12#2)(1991-8#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#15)(2008-6#4)(2008-7#7)(2008-8#2)(2009-11#3)(2009-12#1)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#1)
high-depositing ZnPTO shampoo##2##3##(2008-5#2)
high-dimensional##5##1##(2008-11#1)(2009-9#1)(2012-1#1)(2012-12#2)
high-divergence##2##1##(2008-2#1)(2008-3#1)
high-dose aspirin##2##2##(1992-6#1)(2006-7#1)
high-dose atorvastatin##2##2##(2010-10#1)(2011-2#1)
high-dose chemotherapy and##3##3##(1994-8#1)(1995-9#1)(2008-1#1)
high-dose chemotherapy regimens##2##3##(2008-7#2)
high-dose chemotherapy##11##2##(1994-8#1)(1995-9#1)(1996-11#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-7#5)
high-dose methotrexate##3##2##(2010-3#2)(2011-2#1)
high-dose steroids##2##2##(2006-10#1)(2011-1#1)
high-dose##56##1##(1990-12#1)(1990-3#1)(1990-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-10#2)(2008-1#5)(2008-12#1)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
high-dynamic-range##3##1##(2007-11#2)(2007-12#1)
high-efficiency double compound parabolic concentrator##2##5##(2013-8#2)
high-efficiency sample##3##2##(2008-10#3)
high-efficiency##17##1##(1991-6#1)(1997-4#1)(2007-11#2)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2010-7#1)(2013-8#2)
high-elevation##4##1##(2008-10#1)(2008-3#1)(2009-2#2)
high-end##2##1##(2007-9#1)(2010-9#1)
high-energy phosphate##2##2##(1990-11#1)(2008-10#1)
high-energy photons##2##2##(2009-11#2)
high-energy x rays##2##3##(2008-2#2)
high-energy##32##1##(1990-11#1)(1990-12#1)(1992-12#1)(1993-5#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#8)(2008-7#2)(2008-9#1)(2009-11#2)(2009-3#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
high-energy-beam-sensitive glass##2##2##(2008-2#1)(2008-3#1)
high-fat diet##4##2##(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
high-fat##10##1##(1990-11#1)(2008-4#1)(2009-5#1)(2010-12#2)(2010-7#1)(2012-2#2)(2013-1#2)
high-fidelity DNA repair/apoptosis##2##3##(2008-7#2)
high-fidelity##17##1##(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#4)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
high-field##2##1##(1993-11#1)(2007-11#1)
high-finesse optical##2##2##(2008-3#2)
high-finesse##12##1##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#6)
high-flow cerebral arteriovenous malformation##2##4##(2008-7#2)
high-flow cerebral arteriovenous##3##3##(2008-7#3)
high-flow##9##1##(2007-7#1)(2008-10#4)(2008-7#4)
high-flux##3##1##(2007-7#1)(2008-1#2)
high-frequency antigens##2##2##(1994-6#2)
high-frequency components##2##2##(2007-12#1)(2008-2#1)
high-frequency conductance##2##2##(2008-5#2)
high-frequency data##2##2##(2012-12#2)
high-frequency red cell antigens##2##4##(1992-9#2)
high-frequency repetitive transcranial magnetic stimulation##2##5##(2010-7#1)(2011-1#1)
high-frequency stimulation##2##2##(1995-12#1)(2009-8#1)
high-frequency ultrasonic##2##2##(2012-3#2)
high-frequency ultrasound##2##2##(2009-5#1)(2012-3#1)
high-frequency##54##1##(1991-10#1)(1991-12#1)(1992-9#3)(1994-6#2)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#11)(2008-5#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
high-functioning autism##2##2##(2007-8#2)
high-functioning##4##1##(2007-8#2)(2008-11#1)(2013-1#1)
high-gain##5##1##(2007-11#3)(2007-12#1)(2008-3#1)
high-grade dysplasia##5##2##(1996-8#1)(2009-4#3)(2010-12#1)
high-grade fever##2##2##(2007-8#1)(2008-12#1)
high-grade glioma##4##2##(2008-2#1)(2011-2#1)(2013-1#2)
high-grade gliomas##2##2##(2013-1#1)(2013-8#1)
high-grade intraepithelial##2##2##(2011-1#1)(2012-2#1)
high-grade oligodendroglioma##3##2##(2007-10#3)
high-grade osteosarcoma##2##2##(1992-6#1)(2010-3#1)
high-grade renal##2##2##(2008-10#1)(2013-8#1)
high-grade soft-tissue sarcoma of the extremity##2##6##(2008-6#2)
high-grade soft-tissue sarcoma##3##3##(2008-6#3)
high-grade##51##1##(1992-6#1)(1994-12#1)(1996-8#1)(1997-1#2)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#9)(2009-4#3)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#4)
high-impact##4##1##(2012-12#3)(2013-1#1)
high-incidence group##2##2##(1997-3#2)
high-incidence##3##1##(1994-6#1)(1997-3#2)
high-income countries##2##2##(2009-10#1)(2012-12#1)
high-income##8##1##(2009-10#1)(2010-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
high-index film##3##2##(2007-11#2)(2008-3#1)
high-index##10##1##(2007-11#4)(2008-2#1)(2008-3#5)
high-intensity femtosecond##2##2##(2007-11#1)(2007-12#1)
high-intensity focused ultrasound##2##3##(2011-2#1)(2013-1#1)
high-intensity laser##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
high-intensity##23##1##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
high-level expression of cloned foreign genes##2##6##(1997-4#2)
high-level expression of##9##3##(1996-3#1)(1997-4#2)(2008-2#1)(2008-4#1)(2008-9#4)
high-level expression##17##2##(1991-9#1)(1994-12#2)(1996-3#1)(1997-4#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#2)(2008-9#4)
high-level production of##2##3##(1991-12#1)(2008-11#1)
high-level production##3##2##(1991-12#1)(2008-11#1)(2008-7#1)
high-level resistance##2##2##(2008-10#2)
high-level skills##2##2##(2008-7#1)(2013-8#1)
high-level##47##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-9#1)(1994-1#1)(1994-12#2)(1996-3#1)(1997-4#4)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#3)(2008-9#4)(2010-1#1)(2010-7#1)(2011-1#2)(2013-1#1)(2013-8#2)
high-line##2##1##(2008-8#2)
high-mannose##2##1##(1992-12#1)(2008-11#1)
high-mobility group##3##2##(1997-6#1)(2011-1#1)(2011-2#1)
high-mobility##4##1##(1997-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
high-molar-mass##3##1##(2007-12#1)(2011-1#2)
high-molecular##3##1##(1991-12#1)(2008-10#2)
high-molecular-mass##3##1##(1996-5#2)(2008-10#1)
high-molecular-weight##10##1##(1992-9#1)(1994-11#2)(2008-11#1)(2008-4#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)
high-mountain Mediterranean pastures##2##3##(2012-7#2)
high-mountain##4##1##(2008-2#1)(2012-7#3)
high-numerical-aperture (NA)##2##2##(2007-12#1)(2008-3#1)
high-numerical-aperture lenses##3##2##(2008-3#3)
high-numerical-aperture objective##3##2##(2008-2#1)(2008-3#2)
high-numerical-aperture objectives##2##2##(2007-11#1)(2008-3#1)
high-numerical-aperture optical##3##2##(2008-3#3)
high-numerical-aperture##23##1##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#14)
high-optical-purity l-lactate##2##2##(2013-1#2)
high-order dispersion management##2##3##(2007-11#2)
high-order harmonics##3##2##(2007-11#3)
high-order modes##2##2##(2007-11#1)(2008-3#1)
high-order phase##2##2##(2007-11#1)(2007-12#1)
high-order##24##1##(2007-11#10)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#1)(2011-1#1)
high-pass##2##1##(2008-2#1)(2008-3#1)
high-performance affinity chromatography##2##3##(1991-5#2)
high-performance anion-exchange chromatography##4##3##(1991-5#1)(1991-7#1)(2008-10#2)
high-performance anion-exchange##5##2##(1991-5#1)(1991-7#1)(1995-2#1)(2008-10#2)
high-performance capillary electrophoresis##4##3##(1996-12#2)(1996-5#1)(1997-2#1)
high-performance capillary zone electrophoresis##2##4##(2008-10#2)
high-performance capillary##6##2##(1996-12#2)(1996-5#1)(1997-2#1)(2008-10#2)
high-performance liquid chromatographic (HPLC) method##6##5##(1990-8#2)(1996-5#1)(2008-10#2)(2008-5#1)
high-performance liquid chromatographic (HPLC)##7##4##(1990-8#3)(1996-5#1)(2008-10#2)(2008-5#1)
high-performance liquid chromatographic assay##3##4##(1991-5#2)(1997-2#1)
high-performance liquid chromatographic determination of##4##5##(1991-5#1)(2008-10#3)
high-performance liquid chromatographic method for the determination of##4##8##(1990-8#1)(1993-9#1)(1996-5#1)(2008-10#1)
high-performance liquid chromatographic method for the##5##6##(1990-8#1)(1991-5#1)(1993-9#1)(1996-5#1)(2008-10#1)
high-performance liquid chromatographic method for##6##5##(1990-8#1)(1991-5#1)(1993-9#1)(1996-5#1)(1997-2#1)(2008-10#1)
high-performance liquid chromatographic method with##2##5##(1990-8#1)(1991-5#1)
high-performance liquid chromatographic method##16##4##(1990-8#2)(1991-5#5)(1993-9#1)(1996-5#2)(1997-2#3)(2008-10#3)
high-performance liquid chromatographic methods##2##4##(1990-8#1)(1995-2#1)
high-performance liquid chromatographic separation##3##4##(1991-5#1)(1997-2#1)(2008-10#1)
high-performance liquid chromatographic##46##3##(1990-8#7)(1991-2#1)(1991-5#12)(1993-9#1)(1995-2#1)(1995-6#1)(1996-5#4)(1997-2#6)(2008-10#12)(2008-5#1)
high-performance liquid chromatography (HPLC) in##2##5##(2008-10#2)
high-performance liquid chromatography (HPLC) method with##2##6##(2008-10#2)
high-performance liquid chromatography (HPLC) method##3##5##(2008-10#3)
high-performance liquid chromatography (HPLC) with a photo-diode array detector##2##9##(2008-10#2)
high-performance liquid chromatography (HPLC) with a##5##6##(2008-10#4)(2010-2#1)
high-performance liquid chromatography (HPLC) with##10##5##(1995-3#1)(1997-2#1)(2008-10#7)(2010-2#1)
high-performance liquid chromatography (HPLC)##52##4##(1990-8#3)(1991-5#1)(1992-11#2)(1992-2#1)(1992-6#1)(1994-12#1)(1995-3#2)(1996-2#1)(1997-2#1)(2008-10#34)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-2#1)
high-performance liquid chromatography (RP-HPLC)##5##4##(1990-8#1)(2008-10#4)
high-performance liquid chromatography analysis##2##4##(2008-10#2)
high-performance liquid chromatography and capillary##2##5##(1996-5#2)
high-performance liquid chromatography and##12##4##(1990-12#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-9#1)(1995-2#1)(1996-5#2)(2008-10#3)
high-performance liquid chromatography coupled with##3##5##(1995-11#1)(2008-10#2)
high-performance liquid chromatography in##5##4##(1990-8#4)(2008-10#1)
high-performance liquid chromatography method##2##4##(1990-8#1)(1997-2#1)
high-performance liquid chromatography of##2##4##(1990-8#1)(1997-3#1)
high-performance liquid chromatography on##4##4##(1990-8#2)(1997-2#1)(2008-10#1)
high-performance liquid chromatography using##3##4##(1991-5#1)(2008-10#2)
high-performance liquid chromatography with fluorescence detection and enhance mass spectrometric identification##2##11##(2008-10#2)
high-performance liquid chromatography with fluorescence detection and##3##7##(2008-10#3)
high-performance liquid chromatography with fluorescence detection##5##6##(1991-5#1)(2008-10#4)
high-performance liquid chromatography with post-column fluorescence derivatization##2##7##(1990-8#2)
high-performance liquid chromatography with##27##4##(1990-8#5)(1991-5#2)(1991-7#1)(1992-1#1)(1995-3#1)(1996-5#3)(1997-2#2)(2008-10#11)(2008-5#1)
high-performance liquid chromatography##187##3##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#27)(1991-12#1)(1991-2#1)(1991-5#15)(1991-7#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-6#3)(1993-11#1)(1993-9#3)(1994-12#2)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#2)(1996-2#1)(1996-5#9)(1997-2#8)(1997-3#1)(2008-10#84)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#3)(2010-2#1)(2011-2#1)
high-performance liquid chromatography/tandem electrospray ionization mass detector##2##7##(2008-10#2)
high-performance liquid##244##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#35)(1991-12#1)(1991-2#2)(1991-5#27)(1991-7#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-6#3)(1993-11#1)(1993-9#4)(1994-12#2)(1994-3#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#3)(1996-2#1)(1996-5#13)(1997-2#14)(1997-3#1)(2008-10#105)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-8#3)(2010-2#1)(2011-2#1)
high-performance liquid-chromatographic##2##2##(1997-2#1)(2008-10#1)
high-performance optical##2##2##(2007-12#1)(2008-3#1)
high-performance players##2##2##(2011-2#2)
high-performance thin layer##2##3##(2008-10#1)(2008-4#1)
high-performance thin-layer chromatography##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
high-performance thin-layer##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
high-performance##297##1##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#36)(1991-12#1)(1991-2#2)(1991-5#31)(1991-7#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-6#3)(1993-11#2)(1993-9#4)(1994-12#2)(1994-3#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-12#2)(1996-2#1)(1996-5#14)(1997-2#16)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#115)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-2#1)(2013-8#1)
high-performing##2##1##(1997-3#1)(2009-9#1)
high-permittivity scatterers##2##2##(2008-3#2)
high-permittivity##4##1##(2008-3#4)
high-potential iron-sulfur proteins##2##3##(1993-11#2)
high-potential##3##1##(1993-11#2)(1996-4#1)
high-power Nd##2##2##(2007-11#1)(2008-3#1)
high-power blue##2##2##(2007-12#2)
high-power diode laser in##2##4##(2007-11#1)(2007-12#1)
high-power diode laser##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
high-power diode##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
high-power femtosecond##3##2##(2007-12#2)(2008-3#1)
high-power laser diodes##2##3##(2007-11#2)
high-power laser pulses##3##3##(2007-12#2)(2008-3#1)
high-power laser##12##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#4)
high-power lasers##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
high-power light##2##2##(2008-3#1)(2011-2#1)
high-power picosecond##2##2##(2007-11#2)
high-power single-frequency##2##2##(2008-2#2)
high-power terahertz##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
high-power##85##1##(1997-7#1)(2007-11#14)(2007-12#29)(2008-2#8)(2008-3#27)(2010-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
high-powered##2##1##(1995-2#1)(2012-2#1)
high-precision measurement##2##2##(2007-11#1)(2008-3#1)
high-precision measurements##2##2##(1992-7#1)(2008-3#1)
high-precision##21##1##(1992-7#1)(2007-11#5)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#8)
high-predation environments##5##2##(2008-8#5)
high-predation##6##1##(2008-8#6)
high-pressure liquid chromatography (HPLC)##2##4##(2008-5#1)(2008-6#1)
high-pressure liquid chromatography##6##3##(1990-5#1)(1990-7#1)(1991-3#1)(2008-5#2)(2008-6#1)
high-pressure liquid##7##2##(1990-5#1)(1990-7#1)(1991-3#1)(2008-10#1)(2008-5#2)(2008-6#1)
high-pressure##31##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#8)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2013-8#2)
high-pressure-temperature##2##1##(1995-6#2)
high-prevalence##3##1##(1990-6#1)(2006-10#1)(2013-1#1)
high-protein##3##1##(1990-7#1)(2008-3#2)
high-pulse-energy##2##1##(2007-12#1)(2008-3#1)
high-purity water##2##2##(2008-10#2)
high-purity##8##1##(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)
high-quality TiO2 films by##2##4##(2008-3#2)
high-quality and##3##2##(2008-5#1)(2008-7#1)(2009-12#1)
high-quality articles via an open-access online publishing model##3##8##(2010-12#3)
high-quality evidence##2##2##(2008-8#1)(2010-12#1)
high-quality optical##2##2##(2007-11#1)(2008-3#1)
high-quality performance##2##2##(2007-12#1)(2008-11#1)
high-quality studies are needed##2##4##(2010-12#1)(2011-2#1)
high-quality studies##4##2##(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
high-quality##86##1##(1991-2#1)(1992-2#2)(1993-12#2)(1995-1#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-11#2)(2009-12#1)(2010-11#1)(2010-12#5)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
high-quality/low-cost##2##1##(2008-11#2)
high-rainfall##2##1##(2008-10#2)
high-rate##2##1##(2008-11#1)(2008-3#1)
high-reflectance coating##2##2##(2008-3#2)
high-reflectance mirrors##2##2##(2008-3#2)
high-reflectance stopbands##2##2##(2008-3#2)
high-reflectance##11##1##(2008-2#3)(2008-3#8)
high-reflection filters##2##2##(2008-3#2)
high-refractive-index##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
high-relaxivity contrast agents##2##3##(2008-7#2)
high-repetition-rate picosecond pulses##2##3##(2007-12#1)(2008-3#1)
high-repetition-rate##9##1##(2007-11#2)(2007-12#3)(2008-3#4)
high-resolution (HR)##2##2##(2008-10#1)(2012-2#1)
high-resolution 3D##3##2##(2007-12#1)(2008-2#1)(2011-7#1)
high-resolution CT and##2##3##(2008-1#1)(2011-2#1)
high-resolution CT##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
high-resolution Fourier-transform spectrometer##2##3##(2008-3#2)
high-resolution Fourier-transform##3##2##(2008-3#3)
high-resolution X-ray##2##2##(2006-4#1)(2012-2#1)
high-resolution analysis##2##2##(2008-9#1)(2012-2#1)
high-resolution atmospheric emission spectra##2##4##(2008-2#2)
high-resolution computed tomography (HRCT) and##2##5##(2011-2#2)
high-resolution computed tomography (HRCT)##3##4##(1991-12#1)(2011-2#2)
high-resolution computed tomography##4##3##(1991-12#1)(2006-10#1)(2011-2#2)
high-resolution confocal##2##2##(2007-11#1)(2007-12#1)
high-resolution determination of##2##3##(2008-10#1)(2008-8#1)
high-resolution differential scanning calorimetric (DSC)##2##5##(1990-7#2)
high-resolution fourier transform##2##3##(2008-3#2)
high-resolution gas##2##2##(2008-10#1)(2008-7#1)
high-resolution image reconstruction##2##3##(2008-3#2)
high-resolution image##5##2##(2008-2#2)(2008-3#3)
high-resolution images from##2##3##(2008-2#2)
high-resolution images of##2##3##(2010-9#1)(2012-2#1)
high-resolution images##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-9#1)(2012-2#1)
high-resolution imaging##5##2##(2007-12#1)(2008-1#1)(2008-3#3)
high-resolution mass spectrometry##2##3##(2008-10#2)
high-resolution measurement##2##2##(2007-11#1)(2008-3#1)
high-resolution optical##2##2##(2007-11#1)(2008-3#1)
high-resolution projection optics##2##3##(2008-3#2)
high-resolution separation##2##2##(1997-4#1)(2008-10#1)
high-resolution spectra##2##2##(2008-1#1)(2008-3#1)
high-resolution spectrographs##2##2##(2008-3#2)
high-resolution spectrometer##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
high-resolution spectroscopy in the##2##4##(2007-11#2)
high-resolution spectroscopy##7##2##(2007-11#4)(2007-12#3)
high-resolution three-dimensional##2##2##(1994-5#1)(2008-3#1)
high-resolution##200##1##(1990-7#3)(1991-12#2)(1991-6#1)(1992-11#1)(1992-3#1)(1994-3#3)(1994-5#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#1)(2006-4#2)(2007-11#15)(2007-12#14)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-2#18)(2008-3#55)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#6)(2011-2#5)(2011-7#1)(2012-2#5)(2012-3#5)
high-risk HPV##4##2##(2007-10#1)(2011-1#1)(2011-2#2)
high-risk activities##2##2##(1992-6#1)(2009-5#1)
high-risk acute##4##2##(2008-3#1)(2011-2#2)(2012-12#1)
high-risk alleles##2##2##(2012-12#2)
high-risk areas##2##2##(2012-2#2)
high-risk coronary##2##2##(2011-2#1)(2012-2#1)
high-risk differentiated thyroid##2##3##(2013-1#2)
high-risk for##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
high-risk group##9##2##(1994-11#1)(2007-10#1)(2007-7#1)(2007-8#2)(2009-8#2)(2011-2#1)(2013-1#1)
high-risk groups##4##2##(1994-3#1)(2007-8#1)(2008-7#1)(2010-8#1)
high-risk individuals and##2##3##(1997-1#1)(2011-2#1)
high-risk individuals##7##2##(1996-2#1)(1997-1#1)(2009-8#1)(2011-2#3)(2013-1#1)
high-risk patient##4##2##(1992-3#1)(1994-11#1)(2011-2#2)
high-risk patients in##2##3##(1994-6#1)(2010-8#1)
high-risk patients##24##2##(1992-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(2006-10#1)(2007-7#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
high-risk pediatric##2##2##(2009-12#1)(2012-3#1)
high-risk population##3##2##(1996-3#1)(2010-3#1)(2013-1#1)
high-risk sexual behavior##3##3##(1995-1#1)(2013-1#2)
high-risk sexual behaviors##3##3##(2009-5#2)(2013-1#1)
high-risk sexual##7##2##(1995-1#1)(2009-5#2)(2011-2#1)(2013-1#3)
high-risk strategy##2##2##(1991-6#2)
high-risk women##2##2##(2007-2#2)
high-risk##157##1##(1990-6#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-3#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#1)(1996-2#1)(1996-3#3)(1997-1#1)(2006-10#1)(2007-10#3)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#11)(2008-1#2)(2008-10#1)(2008-11#8)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#4)(2009-12#1)(2009-5#5)(2009-6#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#23)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#18)
high-school students##2##2##(2011-2#2)
high-school##3##1##(2010-5#1)(2011-2#2)
high-sensitive##2##1##(2008-10#1)(2008-5#1)
high-sensitivity C-reactive protein (hs-CRP)##2##4##(2012-5#1)(2013-1#1)
high-sensitivity C-reactive protein##3##3##(2010-4#1)(2012-5#1)(2013-1#1)
high-sensitivity##24##1##(1997-6#1)(2007-12#5)(2008-10#1)(2008-3#5)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-5#1)(2013-1#2)
high-solids anaerobic##2##2##(2008-6#2)
high-spatial-frequency##2##1##(2008-2#1)(2008-3#1)
high-spectral-resolution infrared##2##2##(2008-3#2)
high-spectral-resolution lidar##2##2##(2008-2#1)(2008-3#1)
high-spectral-resolution##8##1##(2008-2#2)(2008-3#6)
high-speed counter-current chromatography (HSCCC)##2##4##(2011-1#2)
high-speed counter-current chromatography##3##3##(2008-10#1)(2011-1#2)
high-speed counter-current chromatography]##2##3##(2011-1#2)
high-speed counter-current##5##2##(2008-10#1)(2011-1#4)
high-speed fiber-based##2##2##(2007-11#2)
high-speed gas##2##2##(2008-10#1)(2008-3#1)
high-speed modulation##3##2##(2007-11#3)
high-speed optical##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
high-speed parallel##2##2##(2008-3#2)
high-speed video##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
high-speed##76##1##(2007-11#16)(2007-12#6)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#24)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#1)(2011-1#7)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
high-spin##6##1##(1992-12#1)(1994-5#1)(1994-8#1)(2008-10#2)(2009-2#1)
high-stakes##3##1##(2008-12#1)(2008-5#1)(2011-2#1)
high-strain-rate##2##1##(2012-2#2)
high-tech##3##1##(1993-3#1)(2008-1#1)(2008-12#1)
high-technology##4##1##(1991-9#1)(1993-3#1)(1994-3#1)(2011-2#1)
high-temperature H(2)O##2##2##(2008-2#1)(2008-3#1)
high-temperature environments##2##2##(2008-2#2)
high-temperature superconductors##2##2##(1992-8#1)(1994-9#1)
high-temperature##29##1##(1990-12#1)(1992-8#1)(1994-12#1)(1994-9#2)(2007-12#3)(2008-10#4)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#1)(2009-8#1)(2011-2#1)
high-threat##4##1##(2008-10#2)(2012-12#2)
high-threshold MUAPs##2##2##(1993-9#2)
high-threshold##4##1##(1992-8#1)(1993-9#2)(2008-3#1)
high-throughput SNP##2##2##(2008-7#1)(2009-7#1)
high-throughput analysis of##2##3##(2008-10#1)(2008-9#1)
high-throughput analysis##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
high-throughput and##2##2##(2009-12#1)(2010-5#1)
high-throughput assays##3##2##(2008-7#1)(2008-8#2)
high-throughput cell based##2##3##(2008-10#2)
high-throughput experiments##2##2##(2008-3#1)(2008-7#1)
high-throughput gene expression##2##3##(2008-7#2)
high-throughput genotyping##2##2##(2008-7#2)
high-throughput method for##2##3##(2008-7#1)(2013-8#1)
high-throughput method##4##2##(2008-10#1)(2008-7#1)(2010-11#1)(2013-8#1)
high-throughput methods such as##2##4##(2009-5#1)(2011-2#1)
high-throughput methods##7##2##(2008-7#2)(2009-5#1)(2009-8#1)(2011-2#2)(2012-3#1)
high-throughput microarrays##2##2##(2010-12#2)
high-throughput molecular##2##2##(2009-4#1)(2011-2#1)
high-throughput screening (HTS)##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
high-throughput screening programs##2##3##(2008-10#2)
high-throughput screening##17##2##(1997-6#1)(2008-10#10)(2008-9#1)(2009-12#2)(2010-2#1)(2011-3#1)(2013-1#1)
high-throughput screens##2##2##(2008-1#1)(2008-10#1)
high-throughput sequencing##3##2##(2009-6#1)(2011-1#1)(2012-3#1)
high-throughput synthesis##2##2##(2008-10#1)(2008-4#1)
high-throughput techniques##3##2##(2008-4#1)(2008-7#1)(2009-3#1)
high-throughput technologies##3##2##(2008-8#2)(2012-2#1)
high-throughput##113##1##(1994-3#1)(1997-6#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#3)(2008-3#6)(2008-4#7)(2008-7#16)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
high-titer##5##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
high-titered##2##1##(1990-5#2)
high-value##6##1##(2008-10#2)(2008-11#1)(2011-1#2)(2012-2#1)
high-velocity##5##1##(2007-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
high-voltage##14##1##(1991-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#5)(2012-12#1)(2012-2#1)
high-volume albumin transfusion##3##3##(2013-1#3)
high-volume centers and##2##3##(2007-12#1)(2008-7#1)
high-volume##12##1##(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#4)
high-yield##4##1##(1992-11#1)(1997-7#1)(2008-3#1)(2008-4#1)
high-yielding##6##1##(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)
highbush blueberry##2##2##(2008-10#2)
higher (&gt##2##2##(2008-6#1)(2013-1#1)
higher (0##2##2##(2007-8#1)(2008-10#1)
higher (P &lt##12##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-2#8)
higher (P##13##2##(1991-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-2#8)
higher (P &lt##3##2##(2012-2#3)
higher (p &lt##4##3##(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
higher (p = 0##2##4##(1993-11#1)(2013-8#1)
higher (p##6##2##(1993-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
higher (p&lt##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
higher AUC##2##2##(2008-5#1)(2011-2#1)
higher BMI##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
higher Ca2+ concentration##2##3##(1995-6#1)(1996-2#1)
higher DNA##2##2##(1994-11#1)(1995-4#1)
higher DS##2##2##(2008-10#1)(2010-4#1)
higher HBV##2##2##(2009-12#1)(2012-1#1)
higher K##2##2##(2008-9#1)(2013-7#1)
higher T1##3##2##(2008-7#3)
higher absolute##3##2##(2008-9#1)(2011-1#1)(2012-3#1)
higher absorption coefficient##2##3##(2007-12#1)(2008-3#1)
higher absorption than##2##3##(2008-2#1)(2008-3#1)
higher absorption##6##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
higher accuracy in##2##3##(2008-2#1)(2009-8#1)
higher accuracy than##2##3##(2008-3#1)(2013-8#1)
higher accuracy##8##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)(2013-8#1)
higher acid stability than the##2##5##(1997-4#2)
higher activation##2##2##(1996-7#1)(1997-2#1)
higher activity against##2##3##(2008-5#1)(2013-1#1)
higher activity of##3##3##(1990-7#1)(2006-10#1)(2008-12#1)
higher activity than##2##3##(1992-6#1)(2008-10#1)
higher activity##11##2##(1990-7#1)(1992-6#1)(1996-9#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#1)
higher adhesion##2##2##(2009-7#1)(2010-4#1)
higher affinities##2##2##(1990-11#1)(1995-11#1)
higher affinity for##4##3##(1990-11#1)(1992-6#1)(1995-11#1)(2008-10#1)
higher affinity of##2##3##(1992-8#1)(1993-8#1)
higher affinity##11##2##(1990-11#1)(1992-6#2)(1992-8#1)(1993-8#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-8#1)
higher after##8##2##(1991-12#1)(1993-12#1)(1995-11#1)(1995-5#1)(2007-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
higher age##3##2##(1990-6#1)(2008-11#1)(2013-1#1)
higher altitudes##2##2##(2008-3#1)(2009-5#1)
higher aluminium hydroxo##2##3##(2008-10#2)
higher among patients with##3##4##(2007-10#1)(2008-7#1)(2013-1#1)
higher among patients##6##3##(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
higher among the##4##3##(2008-5#1)(2011-2#1)(2013-1#2)
higher among##29##2##(1991-1#1)(1993-11#1)(1994-6#1)(1995-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
higher amongst##2##2##(2008-11#1)(2011-2#1)
higher amount of##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
higher amounts of##11##3##(1990-2#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-8#1)
higher and more##2##3##(2010-8#1)(2011-2#1)
higher and the##3##3##(1992-9#1)(1995-12#1)(2008-10#1)
higher and##24##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-7#1)(1995-12#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
higher animals##3##2##(1991-12#1)(2012-2#2)
higher antibody##3##2##(1992-2#1)(2008-11#1)(2008-9#1)
higher antioxidant activity##3##3##(1991-2#1)(2013-8#2)
higher antioxidant##4##2##(1991-2#1)(2012-1#1)(2013-8#2)
higher as##4##2##(2007-11#2)(2007-8#1)(2008-11#1)
higher at 8##2##3##(1992-8#1)(2011-2#1)
higher at higher##2##3##(2008-10#1)(2008-8#1)
higher at the##2##3##(2010-8#1)(2013-7#1)
higher at##16##2##(1992-8#1)(1993-3#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
higher average##7##2##(1992-5#1)(1993-1#1)(1996-3#1)(2007-12#1)(2008-11#2)(2010-6#1)
higher bacterial##2##2##(2008-5#1)(2013-7#1)
higher baseline##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
higher basic##2##2##(1993-8#1)(2008-10#1)
higher before##2##2##(2010-7#1)(2012-3#1)
higher blood glucose##2##3##(2008-7#1)(2010-4#1)
higher blood##3##2##(1993-12#1)(2008-7#1)(2010-4#1)
higher body mass index (BMI)##2##5##(2008-3#1)(2010-4#1)
higher body mass index##5##4##(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-1#1)
higher body mass##6##3##(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-2#1)
higher body##7##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-2#2)
higher brain##5##2##(2007-12#1)(2007-8#2)(2008-1#1)(2011-1#1)
higher by##7##2##(1993-12#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-7#1)
higher catalytic efficiency and##2##4##(2009-11#1)(2013-1#1)
higher cell death rate##2##4##(2008-11#2)
higher cell##8##2##(1994-2#1)(2008-10#1)(2008-11#4)(2008-5#1)(2011-2#1)
higher cessation rates##2##3##(2008-11#2)
higher compared to the##2##4##(1994-12#1)(2008-5#1)
higher compared to those##2##4##(1994-8#1)(2011-1#1)
higher compared to##9##3##(1994-12#1)(1994-8#2)(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
higher compared with##5##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
higher compared##14##2##(1994-12#1)(1994-5#1)(1994-8#2)(1997-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)
higher concentration in##3##3##(1993-12#2)(2008-10#1)
higher concentration of the##3##4##(1995-2#1)(2008-11#1)(2008-4#1)
higher concentration of##16##3##(1991-12#1)(1991-9#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
higher concentration##31##2##(1991-12#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-9#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
higher concentrations in the##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
higher concentrations in##7##3##(2008-10#3)(2008-11#1)(2008-4#1)(2010-11#2)
higher concentrations of the##3##4##(2008-10#1)(2008-5#1)(2010-5#1)
higher concentrations of##24##3##(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#2)(2009-9#1)(2010-5#1)(2011-2#2)
higher concentrations than##3##3##(1994-3#1)(1997-3#1)(2008-11#1)
higher concentrations were##2##3##(1990-12#1)(2007-12#1)
higher concentrations##68##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-5#1)(2011-2#2)(2013-1#1)
higher content of##5##3##(1994-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
higher contrast##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
higher correlation##2##2##(1993-11#1)(2008-7#1)
higher cost##2##2##(1990-9#1)(2008-8#1)
higher costs for##2##3##(1994-3#1)(1997-3#1)
higher costs of##2##3##(1993-12#1)(2008-7#1)
higher costs##7##2##(1992-3#1)(1993-12#2)(1994-3#1)(1997-3#1)(2008-11#1)(2008-7#1)
higher counts##2##2##(1997-5#1)(2013-7#1)
higher coverage##2##2##(2007-12#1)(2011-2#1)
higher daily##3##2##(1994-6#1)(2008-2#1)(2011-2#1)
higher degree of##8##3##(1994-9#1)(1996-3#1)(2008-10#2)(2008-11#2)(2009-5#1)(2012-3#1)
higher degree##10##2##(1991-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2009-5#1)(2012-3#1)
higher densities##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
higher density of##3##3##(1994-6#1)(1994-8#1)(1996-5#1)
higher density##6##2##(1994-6#1)(1994-8#1)(1996-5#1)(2008-7#1)(2010-4#1)(2012-12#1)
higher desire for involvement##2##4##(1993-12#2)
higher detection##4##2##(2007-11#1)(2008-10#2)(2013-8#1)
higher diffraction efficiency##2##3##(2008-2#1)(2008-3#1)
higher dilution##2##2##(2008-11#1)(2008-7#1)
higher disease severity##2##3##(2006-10#1)(2008-10#1)
higher disease##7##2##(2006-10#1)(2008-10#4)(2011-1#1)(2011-2#1)
higher diversity compared to##2##4##(2008-5#1)(2013-1#1)
higher dosage##3##2##(1991-9#1)(2008-4#1)(2008-5#1)
higher dose of##7##3##(1991-7#1)(1995-5#1)(1996-12#1)(1997-4#2)(2008-5#1)(2012-3#1)
higher dose##17##2##(1990-2#1)(1991-6#1)(1991-7#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-12#1)(1997-4#2)(1997-7#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
higher doses are##2##3##(1991-2#1)(1994-9#1)
higher doses of##9##3##(1994-8#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)
higher doses##30##2##(1991-2#1)(1992-11#1)(1992-5#2)(1993-1#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-5#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)
higher during##4##2##(1995-11#2)(2008-11#2)
higher dynamic range##2##3##(2007-11#1)(2008-10#1)
higher education and##2##3##(1992-1#1)(2008-11#1)
higher education in the##2##4##(2008-11#2)
higher education in##3##3##(2008-11#2)(2008-12#1)
higher education institutions##3##3##(2008-12#3)
higher education##34##2##(1991-1#2)(1992-1#1)(1994-2#1)(1995-3#1)(1996-12#3)(2008-11#9)(2008-12#13)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
higher educational levels##2##3##(2012-1#1)(2012-3#1)
higher educational##6##2##(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-3#1)
higher effect than##2##3##(1994-11#1)(2008-10#1)
higher efficacy##3##2##(2008-8#2)(2013-1#1)
higher efficiency##6##2##(1993-2#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-1#1)
higher elastic##2##2##(2009-7#2)
higher energy##3##2##(2007-12#1)(2008-5#1)(2010-5#1)
higher enzyme##3##2##(2008-10#2)(2013-1#1)
higher ethanol##2##2##(2008-11#1)(2011-2#1)
higher eukaryotes##8##2##(1992-6#1)(1994-12#1)(2008-8#2)(2009-2#1)(2010-9#1)(2011-2#2)
higher eukaryotic##3##2##(1990-5#1)(2008-11#1)(2009-5#1)
higher excited##2##2##(2008-10#1)(2008-3#1)
higher expression levels##2##3##(1995-12#1)(2010-7#1)
higher expression of##2##3##(2008-11#1)(2013-8#1)
higher expression##7##2##(1995-12#2)(1997-8#1)(2008-11#1)(2010-7#1)(2013-8#2)
higher extent##2##2##(1992-6#1)(2012-3#1)
higher extraction##4##2##(2008-10#3)(2011-2#1)
higher family functioning was associated with##2##6##(2013-1#2)
higher family functioning##3##3##(2013-1#3)
higher family##4##2##(2008-12#1)(2013-1#3)
higher fasting##2##2##(2008-3#1)(2008-7#1)
higher fat##2##2##(2008-5#1)(2010-4#1)
higher fecundity##2##2##(2008-8#1)(2008-9#1)
higher feed##2##2##(2008-11#2)
higher fitness##2##2##(2008-8#2)
higher fluorescence##2##2##(2008-9#1)(2009-2#1)
higher following##2##2##(2012-2#1)(2013-1#1)
higher for a##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
higher for the##12##3##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#2)(2013-8#1)
higher for##54##2##(1990-8#1)(1991-6#1)(1992-12#2)(1993-12#1)(1993-2#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-12#2)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2010-2#2)(2010-4#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
higher fraction of##2##3##(1994-8#1)(2008-7#1)
higher fracture##2##2##(2012-2#1)(2013-1#1)
higher free##2##2##(1993-12#1)(2008-7#1)
higher frequencies##10##2##(1993-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2011-1#2)(2013-8#1)
higher frequency and##2##3##(2008-7#1)(2008-9#1)
higher frequency in##2##3##(2007-11#1)(2008-10#1)
higher frequency of##19##3##(1991-8#1)(1993-2#1)(1994-12#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-8#1)(2010-5#1)(2011-2#5)(2013-7#2)
higher frequency##28##2##(1991-8#1)(1992-3#1)(1993-2#2)(1994-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#4)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#5)(2013-7#2)
higher genetic##5##2##(1994-2#1)(2008-10#3)(2011-2#1)
higher growth rate##3##3##(1990-8#1)(2008-11#1)(2008-6#1)
higher growth##5##2##(1990-8#1)(2008-11#1)(2008-6#2)(2008-9#1)
higher hardness##3##2##(2008-12#3)
higher harmonics of the##2##4##(2007-12#1)(2008-10#1)
higher harmonics##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
higher health##3##2##(1994-3#1)(2013-1#2)
higher high-density lipoprotein##2##3##(2008-12#1)(2008-7#1)
higher hospital##3##2##(1993-12#1)(2008-7#2)
higher hydrogen##2##2##(2008-10#1)(2013-1#1)
higher if the##2##3##(2007-11#1)(2008-10#1)
higher in Gbogbe than##2##4##(2008-10#2)
higher in OO than OB##4##5##(2008-2#4)
higher in a##2##3##(1992-12#1)(2008-10#1)
higher in acromegalic patients##2##4##(2013-1#2)
higher in both##3##3##(1994-3#1)(2008-10#1)(2010-4#1)
higher in case##2##3##(2010-5#1)(2011-1#1)
higher in cases compared##2##4##(2007-10#1)(2008-12#1)
higher in cases##4##3##(1990-12#1)(1997-8#1)(2007-10#1)(2008-12#1)
higher in diabetic patients##2##4##(2008-1#1)(2008-3#1)
higher in females than in males##2##6##(2008-11#1)(2011-1#1)
higher in group##5##3##(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-6#1)
higher in inoculated##2##3##(2008-10#2)
higher in males than in females##5##6##(1995-6#1)(2008-11#1)(2009-3#1)(2010-3#1)(2010-8#1)
higher in males##7##3##(1995-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-3#1)(2010-3#1)(2010-8#1)
higher in mature##2##3##(2008-10#1)(2011-2#1)
higher in men than in women##2##6##(1994-5#1)(2011-2#1)
higher in men than##3##4##(1994-5#1)(2008-7#1)(2011-2#1)
higher in men##4##3##(1994-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
higher in normal##3##3##(2008-4#2)(2009-12#1)
higher in old##2##3##(2008-7#2)
higher in patients with abnormal##2##5##(1993-11#1)(1994-2#1)
higher in patients with##22##4##(1990-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-9#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#3)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#2)
higher in patients##26##3##(1990-8#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-9#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
higher in resistant##2##3##(2008-10#2)
higher in soil##2##3##(2008-10#2)
higher in stages##2##3##(2011-2#2)
higher in studies with mean##2##5##(2008-10#2)
higher in studies##4##3##(2008-10#4)
higher in subjects##2##3##(2008-7#1)(2012-2#1)
higher in the control##2##4##(2008-11#1)(2013-1#1)
higher in the first##2##4##(2008-10#1)(2011-2#1)
higher in the group##2##4##(1992-5#1)(2010-2#1)
higher in the infected##2##4##(1997-6#1)(2008-11#1)
higher in the patient##2##4##(1991-12#1)(1997-7#1)
higher in the presence of##2##5##(1992-11#1)(2008-10#1)
higher in the production trial compared with##2##7##(2013-8#2)
higher in the production##3##4##(2008-12#1)(2013-8#2)
higher in the##107##3##(1990-3#2)(1990-7#3)(1991-12#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-6#3)(1997-7#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
higher in those who##2##4##(2008-11#1)(2012-3#1)
higher in those##3##3##(2008-11#1)(2009-6#1)(2012-3#1)
higher in women##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-3#1)
higher in young##2##3##(1991-12#1)(2011-2#1)
higher in younger##3##3##(2011-2#2)(2012-3#1)
higher in##381##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-7#3)(1990-8#4)(1991-11#1)(1991-12#6)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#4)(1997-4#2)(1997-6#4)(1997-7#4)(1997-8#3)(2007-10#5)(2007-11#2)(2007-12#2)(2007-5#2)(2007-7#5)(2007-8#4)(2008-1#6)(2008-10#57)(2008-11#13)(2008-12#8)(2008-2#6)(2008-3#5)(2008-4#7)(2008-5#6)(2008-6#6)(2008-7#18)(2008-8#3)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#8)(2011-2#25)(2012-1#5)(2012-12#4)(2012-2#9)(2012-3#10)(2012-5#1)(2013-1#16)(2013-3#1)(2013-7#3)(2013-8#10)
higher incidence of##32##3##(1990-5#1)(1992-3#1)(1993-12#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
higher incidence##41##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-8#1)(1996-3#2)(1996-8#2)(2007-11#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
higher increase in##3##3##(1997-3#1)(1997-7#1)(2011-2#1)
higher infection##4##2##(2008-10#3)(2008-11#1)
higher initial##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
higher inoculum##3##2##(2008-10#3)
higher insulin##3##2##(1994-11#1)(2008-3#1)(2008-7#1)
higher intensity of##5##3##(1995-12#1)(2008-7#2)(2010-4#1)(2013-1#1)
higher intensity than SUMER in the He i 584-A line##2##10##(2008-3#2)
higher intensity##12##2##(1994-3#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-7#2)(2010-4#1)(2013-1#2)
higher intrinsic##2##2##(2008-6#1)(2008-8#1)
higher is##2##2##(2007-12#2)
higher latitudes##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
higher left ventricular##2##3##(2011-2#1)(2013-7#1)
higher level of MSAFP##2##4##(2011-2#2)
higher level of care##2##4##(2008-10#1)(2013-8#1)
higher level of genetic##2##4##(2008-10#2)
higher level of##36##3##(1991-2#1)(1991-5#1)(1994-3#1)(1995-8#1)(1996-10#1)(1997-8#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#2)(2009-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
higher level##46##2##(1991-2#1)(1991-5#1)(1994-3#1)(1995-8#1)(1996-10#1)(1997-8#2)(2007-8#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#2)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
higher levels during the##2##4##(1995-12#1)(2008-5#1)
higher levels in##4##3##(1992-2#1)(1996-12#1)(2008-10#1)(2010-7#1)
higher levels of F##2##4##(2008-10#2)
higher levels of IFN-gamma##2##4##(1996-12#1)(2008-11#1)
higher levels of brain##2##4##(2008-7#1)(2013-1#1)
higher levels of depression##3##4##(2007-12#1)(2008-2#1)(2009-5#1)
higher levels of depressive symptoms##3##5##(1994-2#1)(2009-5#2)
higher levels of education##3##4##(2008-1#1)(2009-11#1)(2011-2#1)
higher levels of exposure##2##4##(2008-12#1)(2009-9#1)
higher levels of resource availability##2##5##(2008-8#2)
higher levels of##102##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#6)(2008-8#5)(2009-11#1)(2009-12#2)(2009-5#7)(2009-7#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#2)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#6)
higher levels than the##2##4##(1990-8#1)(2008-10#1)
higher levels than##4##3##(1990-8#1)(2007-8#1)(2008-10#2)
higher levels with##2##3##(2008-10#1)(2012-3#1)
higher levels##124##2##(1990-12#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#3)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#7)(2009-6#1)(2009-7#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#6)
higher lifetime##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
higher light##2##2##(2008-8#1)(2008-9#1)
higher lipid##2##2##(2008-10#1)(2013-1#1)
higher lipophilicity##4##2##(2008-10#1)(2008-4#1)(2008-5#2)
higher loadings##2##2##(1997-2#1)(2010-8#1)
higher maximal##5##2##(1991-12#1)(2008-11#2)(2013-1#2)
higher maximum##2##2##(2008-11#2)
higher mean age##3##3##(2008-10#1)(2013-8#2)
higher mean##12##2##(1991-12#1)(1993-11#1)(1995-12#1)(1997-4#1)(2008-10#3)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#2)
higher mechanical##2##2##(1997-3#1)(2008-10#1)
higher median##4##2##(1991-12#1)(1993-1#1)(2006-10#1)(2008-12#1)
higher moisture##2##2##(2008-10#1)(2010-4#1)
higher molecular weight##6##3##(1990-12#1)(1991-5#1)(1992-2#1)(1995-8#1)(2008-10#2)
higher molecular##7##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-2#1)(1995-8#1)(2008-10#2)
higher morbidity##3##2##(1993-6#1)(2006-10#1)(2009-12#1)
higher mortality from##2##3##(2008-2#1)(2013-1#1)
higher mortality##18##2##(1991-6#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#3)(2011-2#2)(2013-1#4)
higher multimers and##2##3##(1993-3#2)
higher mutation rates##2##3##(2008-10#1)(2008-8#1)
higher net##2##2##(2008-11#2)
higher number of##23##3##(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#5)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
higher number##24##2##(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
higher numbers of##6##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2013-1#1)
higher numbers##7##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)(2013-1#1)
higher occurrence##2##2##(1996-5#1)(2010-4#1)
higher odds of##3##3##(2008-11#1)(2010-2#1)(2013-1#1)
higher odds##4##2##(2008-11#1)(2008-3#1)(2010-2#1)(2013-1#1)
higher of##3##2##(2008-10#1)(2009-6#1)(2013-8#1)
higher on CTA##2##3##(2008-10#2)
higher on the##6##3##(1991-2#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)
higher on##17##2##(1991-2#1)(1992-5#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-9#1)
higher only in##2##3##(2009-8#1)(2011-2#1)
higher or lower than##2##4##(2008-10#1)(2008-7#1)
higher or lower##3##3##(2008-10#2)(2008-7#1)
higher or##5##2##(2006-6#1)(2008-10#3)(2008-7#1)
higher order correlations##2##3##(2008-11#1)(2013-8#1)
higher order tracheae##2##3##(2007-12#2)
higher order##18##2##(1990-11#1)(1990-12#1)(2007-12#3)(2007-8#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
higher organic##2##2##(2008-10#2)
higher organisms##4##2##(2008-10#1)(2008-11#1)(2009-12#1)(2013-8#1)
higher osmotic potential##2##3##(2008-9#1)(2012-7#1)
higher overall##2##2##(2008-6#1)(2013-8#1)
higher pH and##2##3##(1991-9#1)(2008-10#1)
higher pH##8##2##(1991-9#1)(1997-2#1)(2008-10#5)(2010-4#1)
higher peak##8##2##(1994-12#1)(2008-10#2)(2008-2#2)(2008-3#3)
higher penetration##2##2##(2008-5#2)
higher per capita consumption##2##4##(2010-5#2)
higher per##3##2##(1994-2#1)(2010-5#2)
higher perceived quality of##2##4##(2010-4#1)(2011-1#1)
higher perceived##3##2##(2009-7#1)(2010-4#1)(2011-1#1)
higher percent extraction##2##3##(2008-10#2)
higher percent##5##2##(1995-12#1)(2008-10#3)(2008-6#1)
higher percentage of marked##2##4##(2013-8#2)
higher percentage of the##4##4##(1992-6#2)(1994-6#1)(2008-10#1)
higher percentage of##27##3##(1991-2#1)(1992-6#2)(1993-6#1)(1994-6#2)(1996-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#4)
higher percentage##30##2##(1991-2#1)(1992-6#2)(1993-6#1)(1994-6#2)(1996-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#4)
higher performance##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
higher photobleaching rate##2##3##(2008-3#2)
higher photostability##3##2##(2008-5#3)
higher plant plastocyanins##2##3##(1994-5#2)
higher plant##14##2##(1994-12#1)(1994-5#2)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2011-1#1)(2013-7#1)
higher plants and##3##3##(1995-8#1)(2008-7#1)(2008-8#1)
higher plants##16##2##(1991-5#2)(1993-6#1)(1995-2#3)(1995-8#2)(1996-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2012-1#1)
higher plasma##2##2##(1994-11#1)(2011-2#1)
higher potency in##3##3##(1994-8#1)(2008-7#1)(2013-1#1)
higher potency of##2##3##(1995-11#1)(2008-7#1)
higher potency##5##2##(1994-8#1)(1995-11#1)(2008-7#2)(2013-1#1)
higher power was##2##3##(2008-10#1)(2009-7#1)
higher power##7##2##(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-2#1)(2012-3#2)
higher precision##2##2##(2008-10#2)
higher prevalence in##2##3##(2008-3#1)(2013-8#1)
higher prevalence of abdominal obesity##2##5##(2008-3#1)(2013-8#1)
higher prevalence of diabetes##2##4##(2008-7#1)(2012-2#1)
higher prevalence of##23##3##(1990-12#1)(1992-9#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
higher prevalence##27##2##(1990-12#1)(1990-2#1)(1992-9#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
higher probabilities of##2##3##(1995-2#1)(2009-7#1)
higher probability of##5##3##(1994-12#1)(1995-12#1)(2009-12#1)(2012-12#1)(2012-3#1)
higher probability##6##2##(1994-12#1)(1995-12#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
higher processing speed##2##3##(2008-2#1)(2008-3#1)
higher production of##4##3##(1994-11#1)(2007-10#1)(2007-11#1)(2008-7#1)
higher productivity##4##2##(1991-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
higher proliferation##2##2##(2008-11#1)(2010-3#1)
higher propensity of##2##3##(2008-10#1)(2012-12#1)
higher proportion of children##2##4##(2008-2#2)
higher proportion of patients##2##4##(2011-2#1)(2012-3#1)
higher proportion of##22##3##(1990-3#1)(1992-2#1)(1992-4#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
higher proportion##24##2##(1990-3#1)(1992-2#1)(1992-3#1)(1992-4#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
higher proportions of##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
higher protein##2##2##(2008-7#1)(2013-1#1)
higher proton translocation activity##2##4##(2008-8#2)
higher pump intensities##2##3##(2008-2#1)(2008-3#1)
higher quality of life##3##4##(2011-1#2)(2012-12#1)
higher quality of##4##3##(1992-3#1)(2011-1#2)(2012-12#1)
higher quality##11##2##(1992-11#1)(1992-3#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#3)(2012-12#1)(2012-3#1)
higher rate of##18##3##(1990-11#1)(1992-10#1)(1994-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
higher rate##28##2##(1990-11#1)(1990-8#1)(1992-10#1)(1994-2#2)(1994-6#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
higher rates in##2##3##(2008-10#1)(2011-1#1)
higher rates of deaths##2##4##(2013-1#2)
higher rates of the##2##4##(2008-7#2)
higher rates of##24##3##(1990-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)
higher rates than##2##3##(1995-2#1)(2012-12#1)
higher rates##30##2##(1990-2#1)(1995-2#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#5)
higher ratios##2##2##(1995-11#1)(2008-10#1)
higher recoveries##2##2##(2008-10#2)
higher recurrence##2##2##(1993-1#1)(2011-2#1)
higher reflectance than##2##3##(2008-2#2)
higher refractive indices##2##3##(2007-11#1)(2008-3#1)
higher refractive##3##2##(2007-11#2)(2008-3#1)
higher relative##8##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-7#1)
higher repetition##2##2##(2007-11#1)(2007-12#1)
higher residual##2##2##(2008-11#1)(2009-5#1)
higher resistance to photoinhibition and##2##5##(2008-9#2)
higher resistance to##5##3##(1997-7#1)(2007-10#1)(2008-5#1)(2008-9#2)
higher resistance##10##2##(1997-7#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
higher resolution and##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
higher resolution is##2##3##(2008-3#1)(2011-1#1)
higher resolution than##2##3##(2008-10#1)(2008-7#1)
higher resolution##12##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
higher response##3##2##(1991-3#1)(2008-10#2)
higher results##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
higher risk for developing##2##4##(1993-1#1)(2008-12#1)
higher risk for subsequent events##2##5##(2008-7#2)
higher risk for##16##3##(1991-2#1)(1992-2#1)(1993-1#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
higher risk of developing MS##2##5##(2013-1#2)
higher risk of developing##9##4##(2008-12#2)(2008-4#1)(2008-8#2)(2009-3#1)(2012-3#1)(2013-1#2)
higher risk of fetal malformations##2##5##(2011-2#2)
higher risk of hypertriglyceridemia (aOR##2##5##(2013-1#2)
higher risk of##40##3##(1990-2#1)(1990-8#1)(1992-8#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
higher risk to##3##3##(2008-8#1)(2011-2#1)(2012-1#1)
higher risk##66##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
higher risks##2##2##(1994-2#1)(2011-1#1)
higher salinity and##2##3##(2013-7#1)(2013-8#1)
higher scale##2##2##(2008-10#2)
higher sclerophylly index##2##3##(2013-7#2)
higher scores for##4##3##(1996-12#1)(2008-8#1)(2013-1#1)(2013-7#1)
higher scores on the##2##4##(2008-12#1)(2012-5#1)
higher scores on##5##3##(2007-12#1)(2008-12#1)(2011-2#1)(2012-5#1)(2013-1#1)
higher scores##13##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-5#1)(2013-1#3)(2013-7#1)
higher selectivity for##2##3##(2008-10#2)
higher selectivity##4##2##(2008-10#3)(2013-8#1)
higher sensitivities##3##2##(2008-10#2)(2008-3#1)
higher sensitivity and wider dynamic range than##2##7##(2008-10#2)
higher sensitivity and##6##3##(2008-10#5)(2011-1#1)
higher sensitivity for##3##3##(1991-6#1)(1995-2#1)(2008-7#1)
higher sensitivity in##3##3##(2008-11#1)(2011-2#2)
higher sensitivity of the##2##4##(1993-8#1)(2008-11#1)
higher sensitivity of##7##3##(1993-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
higher sensitivity than##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
higher sensitivity to the##2##4##(1994-3#1)(2008-3#1)
higher sensitivity to##6##3##(1994-3#1)(2008-10#2)(2008-3#2)(2012-12#1)
higher sensitivity##33##2##(1991-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-8#1)
higher serum levels of##2##4##(2008-10#1)(2012-3#1)
higher serum##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
higher signal-to-noise ratio##3##3##(2007-12#1)(2008-3#2)
higher signal-to-noise##4##2##(2007-12#1)(2008-3#3)
higher social##3##2##(1991-9#1)(2009-4#1)(2013-1#1)
higher socioeconomic##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
higher soil##2##2##(1995-3#1)(2011-1#1)
higher spatial##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
higher species diversity##2##3##(2008-8#1)(2010-3#1)
higher species##3##2##(2008-8#1)(2010-3#1)(2013-1#1)
higher specific production rate of##2##5##(2008-11#1)(2011-2#1)
higher specific##6##2##(1997-2#1)(2008-11#4)(2011-2#1)
higher specificity##4##2##(1993-8#1)(2008-1#1)(2012-12#1)(2013-1#1)
higher speeds##4##2##(1997-2#1)(2008-2#1)(2008-3#1)(2011-2#1)
higher stability##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
higher stomatal density##2##3##(2013-7#2)
higher strain##2##2##(2008-10#1)(2008-3#1)
higher stress##5##2##(1996-9#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)
higher stresses##2##2##(2008-8#1)(2009-7#1)
higher substrate##2##2##(1996-8#1)(2008-10#1)
higher surface##2##2##(2008-10#2)
higher survival##2##2##(2008-11#1)(2012-12#1)
higher susceptibility to##2##3##(1997-4#1)(2011-2#1)
higher susceptibility##3##2##(1997-4#1)(2007-8#1)(2011-2#1)
higher taxa may##2##3##(2008-1#1)(2008-9#1)
higher temperature##4##2##(1990-12#1)(2008-10#1)(2008-6#1)(2012-2#1)
higher temperatures##19##2##(1994-12#1)(1995-5#1)(1995-8#1)(2008-10#12)(2008-3#1)(2008-6#1)(2012-5#1)(2013-1#1)
higher than 0##18##3##(1992-9#1)(2008-10#11)(2010-4#1)(2012-1#1)(2013-1#2)(2013-8#2)
higher than 1##8##3##(1992-9#1)(1994-5#1)(2008-10#3)(2008-3#1)(2010-1#1)(2013-1#1)
higher than 100##2##3##(1996-2#1)(2008-12#1)
higher than 2##2##3##(1997-3#1)(2007-11#1)
higher than 30##2##3##(2008-10#1)(2008-2#1)
higher than 301 variety##3##4##(2008-12#3)
higher than 301##6##3##(2008-12#6)
higher than 4##3##3##(1990-2#1)(2008-10#1)(2010-4#1)
higher than 5##3##3##(1994-3#1)(2008-10#1)(2009-2#1)
higher than 60##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
higher than 60%##2##3##(2008-10#1)(2013-7#1)
higher than 7##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
higher than 8##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
higher than 9##2##3##(1990-11#1)(2007-12#1)
higher than 90%##4##3##(2008-10#3)(2008-11#1)
higher than 95%##4##3##(1994-3#1)(2008-10#3)
higher than a##3##3##(1993-12#1)(1995-3#1)(2008-2#1)
higher than any##2##3##(1991-6#1)(2008-2#1)
higher than at##2##3##(1993-3#1)(2013-8#1)
higher than concentrations##2##3##(2008-10#1)(2011-2#1)
higher than control##6##3##(1997-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-11#1)
higher than controls##2##3##(2008-7#1)(2010-8#1)
higher than dominants only##2##4##(1992-1#2)
higher than expected in##2##4##(1990-12#1)(2008-7#1)
higher than expected##8##3##(1990-12#1)(1990-5#1)(1991-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)
higher than for##9##3##(1993-1#1)(1993-6#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
higher than in control##2##4##(1991-5#2)
higher than in males##2##4##(1990-11#1)(2010-8#1)
higher than in other##5##4##(1990-11#1)(1993-5#1)(2008-11#1)(2011-1#1)(2011-2#1)
higher than in previous studies##2##5##(2008-8#1)(2011-2#1)
higher than in the control##3##5##(1991-4#1)(2008-10#1)(2011-2#1)
higher than in the controls##2##5##(1991-4#1)(2008-7#1)
higher than in the##14##4##(1991-4#2)(1991-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)
higher than in##64##3##(1990-11#3)(1991-11#1)(1991-4#2)(1991-5#3)(1992-10#1)(1992-8#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
higher than levels##2##3##(1996-7#1)(2008-10#1)
higher than necessary to##2##4##(1991-5#1)(2008-5#1)
higher than normal##7##3##(1991-12#1)(1996-4#1)(2008-1#2)(2008-4#1)(2008-5#1)(2013-1#1)
higher than other##6##3##(2008-10#3)(2008-12#1)(2008-2#1)(2010-7#1)
higher than previously reported##2##4##(1994-6#1)(2008-12#1)
higher than previously##6##3##(1991-11#1)(1994-6#1)(2008-10#2)(2008-12#1)(2008-8#1)
higher than that by##2##4##(1995-8#1)(2008-6#1)
higher than that for the##3##5##(1997-7#1)(2008-2#1)(2008-8#1)
higher than that for##7##4##(1994-5#1)(1995-6#1)(1997-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
higher than that found in##2##5##(1991-9#1)(1994-11#1)
higher than that from##2##4##(1995-3#1)(2012-12#1)
higher than that in Xieyou 63##2##6##(2008-9#2)
higher than that in the##8##5##(1994-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-1#1)(2012-2#1)
higher than that in##24##4##(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-9#4)(2009-11#1)(2011-1#4)(2012-2#1)
higher than that observed in##2##5##(1993-6#1)(2008-2#1)
higher than that obtained##3##4##(1995-12#1)(2007-11#1)(2008-2#1)
higher than that of a##3##5##(2008-10#2)(2008-2#1)
higher than that of control##2##5##(2008-6#1)(2011-1#1)
higher than that of normal control##2##6##(2011-3#2)
higher than that of normal##4##5##(2008-5#1)(2008-8#1)(2011-3#2)
higher than that of the conventional##3##6##(2007-12#1)(2008-3#1)(2013-8#1)
higher than that of the##27##5##(1992-10#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#2)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
higher than that of##84##4##(1990-2#1)(1990-8#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-5#2)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-7#2)(2010-2#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#3)(2013-1#4)(2013-8#2)
higher than that on the##2##5##(2008-11#2)
higher than that reported in##2##5##(1994-12#1)(2008-10#1)
higher than that reported##4##4##(1994-12#1)(2007-7#1)(2008-10#1)(2012-12#1)
higher than that using a serum-supplemented medium on untreated dishes##2##10##(2008-11#2)
higher than that##153##3##(1990-2#1)(1990-8#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#12)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#7)(2008-9#9)(2009-11#1)(2009-7#2)(2010-2#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#2)(2011-3#4)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#2)
higher than the SGD group##2##5##(2013-8#2)
higher than the background##2##4##(1997-4#1)(2008-10#1)
higher than the control##3##4##(2008-8#2)(2009-10#1)
higher than the controls##3##4##(1991-5#1)(2008-10#1)(2011-1#1)
higher than the conventional##2##4##(2008-11#1)(2008-7#1)
higher than the corresponding##2##4##(2008-10#1)(2008-3#1)
higher than the critical##2##4##(2008-11#1)(2008-7#1)
higher than the limit of##2##5##(2008-10#1)(2011-2#1)
higher than the maximum##2##4##(2008-10#1)(2008-12#1)
higher than the mean##2##4##(2011-1#1)(2011-2#1)
higher than the national average##4##5##(2008-10#3)(2008-6#1)
higher than the national##6##4##(2008-10#3)(2008-6#1)(2010-5#2)
higher than the other##2##4##(1995-2#1)(2008-10#1)
higher than the rate of the##2##6##(2008-7#1)(2013-1#1)
higher than the rate##3##4##(1994-2#1)(2008-7#1)(2013-1#1)
higher than the recommended##2##4##(1997-3#1)(2011-1#1)
higher than the threshold##2##4##(2008-10#1)(2011-2#1)
higher than the##90##3##(1990-2#1)(1991-5#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
higher than their##2##3##(1993-1#1)(2008-10#1)
higher than those for the##2##5##(2008-10#1)(2012-3#1)
higher than those for##5##4##(1992-3#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)
higher than those from the##2##5##(2007-7#1)(2008-11#1)
higher than those from##4##4##(2007-7#1)(2008-11#3)
higher than those in the##9##5##(1990-5#1)(1994-3#1)(1996-7#2)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)
higher than those in##16##4##(1990-5#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-8#2)(1996-7#2)(2008-10#3)(2008-11#2)(2008-6#1)(2011-2#1)(2012-2#1)
higher than those observed##3##4##(2008-10#1)(2008-5#1)(2010-4#1)
higher than those obtained from##2##5##(2008-11#1)(2008-6#1)
higher than those obtained with##2##5##(2008-10#2)
higher than those obtained##6##4##(2008-10#4)(2008-11#1)(2008-6#1)
higher than those of other##3##5##(2008-10#1)(2009-7#1)(2012-1#1)
higher than those of the control##2##6##(1994-11#1)(2008-10#1)
higher than those of the##7##5##(1990-5#1)(1993-8#1)(1994-11#1)(2008-10#2)(2008-7#1)(2011-1#1)
higher than those of##35##4##(1990-5#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-5#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
higher than those reported##2##4##(2008-11#1)(2008-5#1)
higher than those with##2##4##(2008-10#2)
higher than those##88##3##(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-7#2)(1997-8#1)(2007-7#1)(2008-10#22)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
higher than two drinks##2##4##(1994-2#2)
higher than when the##2##4##(1995-5#1)(2008-10#1)
higher than with##5##3##(2008-10#2)(2008-3#2)(2011-1#1)
higher than##664##2##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#6)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#6)(1993-5#2)(1993-6#3)(1993-8#6)(1993-9#4)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2007-10#3)(2007-11#9)(2007-12#5)(2007-7#6)(2007-8#5)(2008-1#5)(2008-10#143)(2008-11#42)(2008-12#31)(2008-2#10)(2008-3#27)(2008-4#4)(2008-5#17)(2008-6#9)(2008-7#19)(2008-8#14)(2008-9#20)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#19)(2011-2#17)(2011-3#4)(2012-1#6)(2012-12#4)(2012-2#9)(2012-3#2)(2012-6#2)(2013-1#18)(2013-7#1)(2013-8#10)
higher that##2##2##(2008-7#1)(2013-8#1)
higher the##20##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-1#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
higher then control##3##3##(2008-12#3)
higher then##4##2##(2008-12#3)(2008-3#1)
higher throughput##2##2##(2007-11#1)(2012-2#1)
higher tissue##2##2##(1993-11#1)(1993-12#1)
higher tobacco##2##2##(2009-7#1)(2010-11#1)
higher tolerance to##2##3##(2008-6#1)(2008-9#1)
higher tolerance##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
higher total##13##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#3)
higher transcript##2##2##(1991-6#1)(1996-10#1)
higher treatment##2##2##(2008-7#1)(2010-12#1)
higher trophic levels##4##3##(2008-8#3)(2008-9#1)
higher tumor##2##2##(2011-2#1)(2013-1#1)
higher under elevated##2##3##(2008-10#2)
higher under##5##2##(1991-12#1)(1991-5#1)(2008-10#3)
higher uptake##2##2##(1995-6#1)(2008-12#1)
higher use of drugs##2##4##(1996-6#2)
higher utilization##2##2##(1995-3#1)(2010-5#1)
higher value##6##2##(1991-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
higher values of##6##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
higher values were##2##3##(1993-8#1)(2008-5#1)
higher values##15##2##(1991-12#1)(1993-8#1)(1995-12#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-1#1)
higher vertebrates##2##2##(2008-7#2)
higher water content##2##3##(2008-10#1)(2008-5#1)
higher water##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
higher when the##8##3##(1991-3#1)(1997-3#1)(2007-12#1)(2008-6#2)(2008-9#1)(2009-5#1)(2012-2#1)
higher when##19##2##(1991-3#1)(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2011-2#2)(2012-2#2)
higher while##2##2##(1991-12#1)(2013-8#1)
higher with the##4##3##(2007-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
higher with##22##2##(1992-12#1)(1993-6#2)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
higher yield##3##2##(2008-10#2)(2008-9#1)
higher yields than##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
higher yields##6##2##(1996-5#1)(2008-10#2)(2008-11#2)(2008-6#1)
higher##3627##1##(1990-11#13)(1990-12#16)(1990-2#11)(1990-3#5)(1990-4#1)(1990-5#11)(1990-6#2)(1990-7#6)(1990-8#15)(1990-9#2)(1991-1#4)(1991-11#3)(1991-12#24)(1991-2#10)(1991-3#5)(1991-4#2)(1991-5#18)(1991-6#11)(1991-7#1)(1991-8#3)(1991-9#9)(1992-1#7)(1992-10#3)(1992-11#6)(1992-12#17)(1992-2#12)(1992-3#23)(1992-4#1)(1992-5#9)(1992-6#13)(1992-8#14)(1992-9#12)(1993-1#12)(1993-10#1)(1993-11#15)(1993-12#24)(1993-2#16)(1993-3#17)(1993-5#3)(1993-6#15)(1993-8#20)(1993-9#6)(1994-1#1)(1994-11#17)(1994-12#16)(1994-2#28)(1994-3#17)(1994-5#10)(1994-6#18)(1994-7#1)(1994-8#13)(1994-9#5)(1995-1#2)(1995-11#10)(1995-12#25)(1995-2#25)(1995-3#13)(1995-4#2)(1995-5#14)(1995-6#12)(1995-8#10)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#4)(1996-12#29)(1996-2#11)(1996-3#8)(1996-4#2)(1996-5#10)(1996-6#7)(1996-7#8)(1996-8#5)(1996-9#7)(1997-2#17)(1997-3#10)(1997-4#15)(1997-5#4)(1997-6#8)(1997-7#8)(1997-8#16)(2006-10#8)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#26)(2007-11#35)(2007-12#45)(2007-2#2)(2007-5#4)(2007-6#1)(2007-7#17)(2007-8#30)(2008-1#29)(2008-10#602)(2008-11#203)(2008-12#111)(2008-2#57)(2008-3#122)(2008-4#28)(2008-5#101)(2008-6#49)(2008-7#146)(2008-8#101)(2008-9#91)(2009-1#2)(2009-10#14)(2009-11#8)(2009-12#14)(2009-2#5)(2009-3#6)(2009-4#7)(2009-5#22)(2009-6#8)(2009-7#25)(2009-8#15)(2009-9#8)(2010-1#3)(2010-10#8)(2010-11#7)(2010-12#11)(2010-2#25)(2010-3#13)(2010-4#28)(2010-5#16)(2010-6#6)(2010-7#9)(2010-8#21)(2010-9#7)(2011-1#67)(2011-10#1)(2011-2#175)(2011-3#5)(2011-7#2)(2012-1#28)(2012-12#40)(2012-2#60)(2012-3#52)(2012-5#5)(2012-6#3)(2012-7#3)(2012-9#2)(2013-1#144)(2013-3#1)(2013-7#24)(2013-8#83)
higher)##5##1##(2008-10#3)(2008-5#1)(2012-2#1)
higher-order Stokes##3##2##(2007-11#1)(2007-12#2)
higher-order aberrations##2##2##(2008-3#2)
higher-order correlation properties##2##3##(2008-11#2)
higher-order correlation##4##2##(2008-11#4)
higher-order dispersion##2##2##(2007-11#2)
higher-order modal measurements##3##3##(2008-2#3)
higher-order mode##2##2##(2008-2#1)(2008-3#1)
higher-order modes is##2##3##(2007-11#1)(2008-3#1)
higher-order modes##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
higher-order phase##2##2##(2007-11#1)(2007-12#1)
higher-order spatial correlations##3##3##(1994-8#3)
higher-order transverse modes##2##3##(2008-2#2)
higher-order##67##1##(1993-11#1)(1994-8#3)(1995-12#1)(2007-11#13)(2007-12#8)(2008-11#5)(2008-2#14)(2008-3#19)(2008-4#1)(2009-8#1)(2012-2#1)
higher-quality##3##1##(2008-8#2)(2011-7#1)
higher-than-expected##2##1##(2008-10#1)(2012-2#1)
highest absolute##3##2##(2008-10#2)(2009-4#1)
highest absorption##2##2##(2008-2#1)(2008-3#1)
highest accuracy##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
highest activity##7##2##(1994-7#1)(1994-8#1)(2008-12#1)(2009-6#2)(2010-3#1)(2013-1#1)
highest among the##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
highest among##8##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
highest amount##3##2##(2008-5#2)(2013-1#1)
highest amounts##2##2##(1990-11#1)(1992-9#1)
highest and the##2##3##(2008-12#1)(2008-3#1)
highest and##10##2##(1995-3#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-7#1)(2012-3#1)
highest at##10##2##(1993-11#1)(2008-10#6)(2008-5#1)(2011-2#1)(2013-1#1)
highest concentration of##10##3##(1990-3#1)(1993-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2012-1#1)(2013-1#1)
highest concentration##20##2##(1990-3#1)(1992-8#1)(1993-11#1)(1995-3#2)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#1)(2012-1#1)(2013-1#1)
highest concentrations##7##2##(1994-9#1)(1997-1#1)(2008-12#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
highest conversion efficiency##2##3##(2007-12#2)
highest conversion##3##2##(2007-12#2)(2013-1#1)
highest degree of##8##3##(1990-7#1)(1991-5#1)(1994-7#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
highest degree##10##2##(1990-7#1)(1991-5#1)(1994-7#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
highest densities##3##2##(1994-2#1)(2008-5#1)(2011-2#1)
highest diversity##2##2##(2008-10#1)(2008-5#1)
highest dose of##2##3##(1992-3#1)(2008-12#1)
highest dose##14##2##(1992-10#1)(1992-3#1)(1993-6#1)(1996-5#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-2#2)(2013-8#1)
highest doses##2##2##(1992-11#1)(1994-2#1)
highest during the first##2##4##(2008-11#1)(2008-7#1)
highest during##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
highest enzymatic##2##2##(2008-10#1)(2013-1#1)
highest enzyme##2##2##(2008-10#1)(2011-2#1)
highest expression level of##2##4##(2008-9#2)
highest expression##4##2##(2008-9#3)(2012-2#1)
highest fluorescence##3##2##(2007-11#2)(2008-10#1)
highest following##4##2##(2008-10#1)(2011-2#3)
highest for##9##2##(1991-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-1#1)
highest frequency##7##2##(1995-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)
highest homology##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
highest identity##2##2##(1994-8#1)(2013-1#1)
highest in U##2##3##(2009-7#2)
highest in group##2##3##(1994-7#1)(2007-11#1)
highest in the 8% PL diet group and##2##8##(2008-7#2)
highest in the##25##3##(1990-9#1)(1993-3#1)(1996-12#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#1)(2010-10#1)(2010-12#1)(2012-1#1)(2013-3#1)(2013-8#1)
highest in##71##2##(1990-8#1)(1990-9#1)(1991-4#2)(1991-5#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-12#3)(1997-6#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-10#15)(2008-11#6)(2008-12#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-7#5)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-3#1)(2013-7#1)(2013-8#1)
highest incidence of##9##3##(1990-3#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
highest incidence##15##2##(1990-3#1)(1991-11#1)(1992-4#1)(1992-9#2)(1993-9#1)(1994-9#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
highest increase in##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
highest irritation##2##2##(2008-5#2)
highest level of secreted##2##4##(1997-4#2)
highest level of##17##3##(1990-11#1)(1992-9#1)(1994-2#1)(1997-4#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-8#3)(2010-3#1)
highest level##23##2##(1990-11#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-3#1)(1997-2#1)(1997-4#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-8#3)(2010-3#1)(2012-2#1)
highest levels in##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
highest levels of expression##2##4##(1997-1#1)(1997-4#1)
highest levels of##17##3##(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-12#1)(1997-1#1)(1997-4#1)(2008-10#8)(2009-7#1)
highest levels were##4##3##(1997-4#1)(2008-6#1)(2008-7#1)(2009-3#1)
highest levels##27##2##(1991-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-12#1)(1997-1#1)(1997-4#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2013-1#1)
highest mean##7##2##(1990-2#2)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
highest mortality##3##2##(1992-5#1)(2010-8#1)(2013-1#1)
highest nucleotide##5##2##(2008-10#4)(2013-8#1)
highest number of##9##3##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)
highest number##10##2##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)
highest numbers of##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
highest numbers##5##2##(1996-12#1)(2008-10#1)(2011-2#1)(2013-7#2)
highest on##5##2##(1993-2#1)(1993-3#1)(2008-5#1)(2009-7#1)(2012-5#1)
highest peak##2##2##(2008-3#1)(2012-2#1)
highest percentage of##8##3##(1990-8#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
highest percentage##11##2##(1990-8#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2012-7#1)(2013-1#1)
highest percentages of##2##3##(1991-4#1)(2008-10#1)
highest percentages##3##2##(1991-4#1)(2008-10#1)(2010-6#1)
highest performing##2##2##(2010-12#1)(2012-1#1)
highest possible##4##2##(2007-11#2)(2008-10#1)(2011-2#1)
highest prevalence of##6##3##(1990-9#1)(2007-7#1)(2013-8#4)
highest prevalence##8##2##(1990-6#1)(1990-9#1)(1996-7#1)(2007-7#1)(2013-8#4)
highest priority for##2##3##(1994-2#1)(2012-2#1)
highest priority##3##2##(1994-2#1)(2012-12#1)(2012-2#1)
highest production##5##2##(2008-11#4)(2008-8#1)
highest proportion of##3##3##(1990-11#1)(1996-12#1)(2008-9#1)
highest proportion##5##2##(1990-11#1)(1996-12#1)(2008-9#1)(2013-8#2)
highest rate##11##2##(1997-8#1)(2006-6#1)(2008-10#2)(2008-12#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
highest ratio of##2##3##(2007-12#1)(2008-10#1)
highest ratio##3##2##(1993-6#1)(2007-12#1)(2008-10#1)
highest relative##2##2##(2008-10#1)(2008-7#1)
highest reported##10##2##(1990-12#1)(2006-10#1)(2007-12#3)(2008-11#2)(2008-2#1)(2008-5#1)(2010-3#1)
highest risk of developing##2##4##(1996-6#1)(2011-2#1)
highest risk of dying of##2##5##(1997-7#2)
highest risk of progression to##2##5##(2007-2#1)(2010-5#1)
highest risk of##11##3##(1996-5#1)(1996-6#1)(1997-7#2)(2007-2#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
highest risk##23##2##(1991-6#1)(1993-11#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
highest selectivity##3##2##(2008-10#3)
highest sensitivity for##2##3##(2008-10#1)(2008-3#1)
highest sensitivity##12##2##(2008-10#9)(2008-11#1)(2008-3#1)(2012-2#1)
highest susceptibility to##2##3##(2008-10#1)(2009-6#1)
highest total##3##2##(1996-12#1)(2008-9#1)(2011-2#1)
highest value of##2##3##(2008-12#1)(2008-3#1)
highest value##9##2##(2007-11#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)
highest values in##4##3##(2008-5#1)(2012-12#1)(2013-7#2)
highest values of##5##3##(2008-10#2)(2008-7#1)(2012-12#2)
highest values##14##2##(2007-1#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#2)
highest when##2##2##(2008-2#1)(2012-2#1)
highest with##5##2##(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
highest yield##2##2##(2008-12#2)
highest µSBS##2##2##(2013-1#2)
highest##839##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1992-10#3)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#7)(1993-1#1)(1993-11#4)(1993-2#4)(1993-3#3)(1993-6#6)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#2)(1994-7#4)(1994-8#2)(1994-9#4)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#10)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#6)(2007-11#19)(2007-12#8)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#187)(2008-11#34)(2008-12#39)(2008-2#15)(2008-3#17)(2008-4#4)(2008-5#41)(2008-6#7)(2008-7#25)(2008-8#14)(2008-9#23)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#10)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#8)(2010-9#2)(2011-1#11)(2011-2#46)(2012-1#7)(2012-12#8)(2012-2#16)(2012-3#9)(2012-5#1)(2012-7#1)(2013-1#38)(2013-3#1)(2013-7#6)(2013-8#17)
highest-order mode##2##2##(2007-11#2)
highest-order##3##1##(2007-11#3)
highland##6##1##(2008-10#2)(2013-7#4)
highlands of##8##2##(1991-12#1)(1991-3#1)(2008-10#3)(2008-5#1)(2011-2#2)
highlands##15##1##(1991-12#1)(1991-3#1)(2008-10#6)(2008-5#1)(2011-2#2)(2013-1#2)(2013-7#2)
highlight a##5##2##(2008-10#1)(2008-2#1)(2012-2#2)(2013-1#1)
highlight different##2##2##(2008-7#1)(2009-10#1)
highlight how##2##2##(2008-8#1)(2008-9#1)
highlight important##2##2##(1992-3#1)(2011-1#1)
highlight recent##5##2##(1992-12#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-7#1)
highlight some of the##2##4##(1995-3#1)(2008-4#1)
highlight some##6##2##(1995-3#1)(1996-11#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
highlight specific##3##2##(2009-12#1)(2009-3#1)(2010-11#1)
highlight that##5##2##(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
highlight the critical##2##3##(2012-12#1)(2013-1#1)
highlight the differences##2##3##(2008-10#1)(2012-12#1)
highlight the fact that##2##4##(1995-1#1)(2008-6#1)
highlight the importance of considering##3##5##(2008-8#1)(2011-2#1)(2012-12#1)
highlight the importance of understanding##2##5##(2011-2#1)(2013-1#1)
highlight the importance of##16##4##(1990-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
highlight the need for further##2##5##(2013-1#2)
highlight the need for##9##4##(2008-3#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#3)
highlight the need to##7##4##(1991-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
highlight the need##16##3##(1991-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#3)
highlight the potential role of##2##5##(1993-3#1)(2013-8#1)
highlight the potential##5##3##(1993-3#1)(1995-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
highlight the promise of##2##4##(2012-2#1)(2013-1#1)
highlight the role of##6##4##(1990-8#1)(1997-5#1)(2009-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
highlight the significance of##2##4##(2007-8#1)(2012-12#1)
highlight the value of##3##4##(2008-7#1)(2008-8#1)(2012-3#1)
highlight the##110##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#1)(2009-2#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#12)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
highlight those##2##2##(2011-1#1)(2012-2#1)
highlight two##2##2##(2008-3#1)(2008-8#1)
highlight##200##1##(1990-5#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-3#2)(1994-12#2)(1994-2#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1996-11#1)(1996-2#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#16)(2012-1#1)(2012-12#9)(2012-2#13)(2012-3#5)(2013-1#19)(2013-7#1)(2013-8#4)
highlighted as an example of the##2##6##(2008-10#1)(2010-12#1)
highlighted as an example##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
highlighted as an##4##3##(2008-10#2)(2008-8#1)(2010-12#1)
highlighted as##8##2##(2008-10#3)(2008-11#2)(2008-8#1)(2010-12#1)(2012-12#1)
highlighted by the##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-5#1)(2013-1#1)
highlighted by##10##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#2)(2010-2#1)(2010-5#1)(2013-1#1)
highlighted here##2##2##(2010-5#1)(2010-7#1)
highlighted in a##3##3##(1990-2#1)(2008-11#1)(2009-9#1)
highlighted in the literature##2##4##(2008-11#1)(2013-1#1)
highlighted in the##8##3##(2008-1#2)(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#2)(2013-7#1)
highlighted in this##2##3##(2008-2#1)(2010-10#1)
highlighted in##17##2##(1990-2#1)(1994-12#1)(1995-1#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2013-1#3)(2013-7#1)
highlighted that##7##2##(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
highlighted the critical role of##2##5##(2008-11#1)(2012-3#1)
highlighted the importance of##3##4##(2008-11#2)(2009-8#1)
highlighted the need for##2##4##(2011-2#1)(2013-8#1)
highlighted the##25##2##(1996-2#1)(1996-4#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-7#2)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
highlighted with##3##2##(2008-11#1)(2008-7#1)(2010-2#1)
highlighted##157##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#19)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#12)(2008-8#3)(2008-9#1)(2009-4#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#5)
highlighting key##3##2##(2008-7#1)(2009-9#1)(2010-10#1)
highlighting the importance of##2##4##(2012-2#1)(2013-1#1)
highlighting the need for##5##4##(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#2)
highlighting the need##6##3##(1997-6#1)(2008-10#2)(2008-7#1)(2008-9#2)
highlighting the##21##2##(1997-6#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#2)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
highlighting their##2##2##(2008-7#1)(2012-12#1)
highlighting##50##1##(1991-12#1)(1993-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#4)
highlights a##7##2##(2007-7#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
highlights from the##3##3##(2007-1#1)(2008-7#1)(2008-8#1)
highlights key##2##2##(2008-10#1)(2010-2#1)
highlights of the##6##3##(1994-1#1)(1997-7#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-4#1)
highlights of this##3##3##(1995-2#1)(2008-5#2)
highlights of##10##2##(1994-1#1)(1995-2#1)(1997-7#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-4#1)(2013-1#1)
highlights recent advances##2##3##(2008-10#1)(2008-4#1)
highlights several##2##2##(1997-2#1)(2013-1#1)
highlights some of the most##2##5##(2009-10#1)(2010-7#1)
highlights some of the##9##4##(1992-3#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-7#1)(2013-1#1)
highlights some of##10##3##(1991-3#1)(1992-3#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-7#1)(2013-1#1)
highlights some##15##2##(1991-3#1)(1992-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
highlights that the##2##3##(2008-12#1)(2013-1#1)
highlights that##5##2##(2007-7#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
highlights the challenges of##3##4##(2008-11#1)(2009-5#1)(2012-8#1)
highlights the importance of a##2##5##(2008-5#1)(2012-2#1)
highlights the importance of early##2##5##(2008-11#1)(2013-1#1)
highlights the importance of##17##4##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
highlights the importance##18##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
highlights the most##2##3##(1996-12#1)(2011-2#1)
highlights the need for further research##2##6##(2008-11#1)(2011-2#1)
highlights the need for##11##4##(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
highlights the need to##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
highlights the need##14##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
highlights the potential##2##3##(2007-8#1)(2009-4#1)
highlights the role of##2##4##(1992-9#1)(2011-2#1)
highlights the various##2##3##(2012-3#1)(2013-8#1)
highlights the##93##2##(1990-6#1)(1992-12#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
highlights their utility##2##3##(1993-12#1)(2008-4#1)
highlights their##3##2##(1993-12#1)(2008-4#1)(2013-1#1)
highlights##189##1##(1990-6#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#13)(2013-7#2)(2013-8#3)
highly (P &lt##2##3##(1992-11#2)
highly absorbing black appliqués in the##2##6##(2008-3#2)
highly absorbing black appliqués##3##4##(2008-3#3)
highly absorbing##8##2##(2008-10#2)(2008-3#6)
highly abundant##2##2##(1990-12#1)(1997-6#1)
highly acceptable##4##2##(1994-12#1)(1994-2#1)(2008-11#1)(2008-3#1)
highly accurate measurement of##3##4##(2008-2#1)(2008-3#2)
highly accurate##15##2##(1990-8#1)(1991-5#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
highly acidic##5##2##(1990-5#1)(2008-10#2)(2008-12#1)(2010-11#1)
highly active anti-retroviral therapy##2##4##(2008-1#2)
highly active antiretroviral therapy (HAART) has##3##6##(2008-3#2)(2011-2#1)
highly active antiretroviral therapy (HAART)##9##5##(2007-7#1)(2008-3#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)
highly active antiretroviral therapy##16##4##(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-2#3)
highly active antiretroviral##17##3##(2007-12#2)(2007-7#2)(2008-10#1)(2008-3#2)(2008-5#2)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-2#3)
highly active##31##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-3#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#2)(2011-2#3)(2012-2#1)(2013-1#1)
highly aggregated##3##2##(1997-2#2)(2008-4#1)
highly aggressive##14##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
highly aligned alliances##4##3##(2013-1#4)
highly aligned##6##2##(2007-12#1)(2013-1#5)
highly alpha-helical##2##2##(1993-8#1)(1995-5#1)
highly amenable to##2##3##(2008-2#1)(2008-4#1)
highly and specifically##2##3##(1992-12#1)(2008-11#1)
highly and weakly##2##3##(2008-10#2)
highly and##5##2##(1992-12#1)(2008-10#3)(2008-11#1)
highly anisotropic##2##2##(1997-7#1)(2009-7#1)
highly associated with##2##3##(2011-2#1)(2012-3#1)
highly associated##3##2##(2011-2#2)(2012-3#1)
highly asymmetric##3##2##(1990-7#1)(2010-2#1)(2013-8#1)
highly asymmetrical##3##2##(1991-2#1)(1993-3#1)(2012-3#1)
highly at the##2##3##(1991-12#1)(2008-9#1)
highly attractive##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
highly basic##2##2##(1993-2#1)(1996-2#1)
highly birefringent fiber##3##3##(2007-11#3)
highly birefringent fibers##8##3##(2007-12#1)(2008-2#4)(2008-3#3)
highly birefringent##13##2##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#3)
highly branched##2##2##(1991-12#1)(2007-12#1)
highly by##3##2##(1997-1#2)(2008-11#1)
highly cellular##2##2##(2008-12#1)(2011-2#1)
highly challenging##2##2##(2011-2#1)(2012-2#1)
highly charged##6##2##(1991-12#1)(1991-5#1)(1995-6#2)(1997-2#1)(2008-7#1)
highly chirped##2##2##(2007-12#2)
highly chlorinated biphenyls##3##3##(1993-12#3)
highly chlorinated##4##2##(1993-12#4)
highly coherent##5##2##(2006-4#1)(2007-12#1)(2008-3#2)(2008-7#1)
highly competitive##4##2##(1992-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
highly complex##11##2##(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
highly complicated##3##2##(2008-2#1)(2009-10#1)(2012-3#1)
highly concentrated##14##2##(1994-2#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
highly condensed##2##2##(1993-6#1)(2008-7#1)
highly congruent##2##2##(2008-1#1)(2010-6#1)
highly conserved amino acid##2##4##(1990-2#1)(1991-2#1)
highly conserved among##8##3##(1990-8#2)(1993-3#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#2)
highly conserved and##8##3##(1993-8#1)(1994-11#1)(1997-4#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
highly conserved between the##2##4##(1991-6#1)(2012-2#1)
highly conserved between##4##3##(1990-12#1)(1991-6#1)(1992-8#1)(2012-2#1)
highly conserved during##2##3##(1992-12#1)(2008-9#1)
highly conserved in evolution##3##4##(1990-8#1)(1991-5#1)(1991-6#1)
highly conserved in the##3##4##(1994-12#2)(1994-6#1)
highly conserved in##12##3##(1990-8#1)(1991-5#1)(1991-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-4#1)
highly conserved over##2##3##(1993-6#1)(1994-12#1)
highly conserved protein##2##3##(1994-12#1)(2008-8#1)
highly conserved region##4##3##(1994-11#1)(1994-12#1)(1994-5#1)(2008-10#1)
highly conserved regions of##2##4##(1995-2#1)(1995-6#1)
highly conserved regions##3##3##(1991-6#1)(1995-2#1)(1995-6#1)
highly conserved throughout evolution##3##4##(1993-12#1)(2008-5#1)(2012-2#1)
highly conserved throughout##4##3##(1993-12#1)(1997-7#1)(2008-5#1)(2012-2#1)
highly conserved##115##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#5)(1994-12#7)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-6#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#3)(2007-12#3)(2008-10#13)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
highly consistent##4##2##(1994-2#1)(1995-3#1)(2008-8#1)(2012-2#1)
highly controversial##4##2##(1991-8#1)(1994-1#2)(1995-1#1)
highly convergent##4##2##(2007-11#2)(2008-7#2)
highly correlated to the##2##4##(1990-2#1)(1990-8#1)
highly correlated to##5##3##(1990-2#1)(1990-8#1)(2007-10#1)(2008-10#1)(2008-9#1)
highly correlated with C levels##2##5##(2008-9#2)
highly correlated with the##3##4##(2008-1#1)(2008-6#1)(2008-7#1)
highly correlated with their##2##4##(1995-11#1)(2008-10#1)
highly correlated with##15##3##(1993-6#1)(1995-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#3)(2011-9#1)
highly correlated##33##2##(1990-2#1)(1990-5#1)(1990-8#1)(1993-6#1)(1995-11#1)(1997-2#2)(2007-10#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#4)(2010-10#1)(2011-9#1)(2012-3#1)
highly cross-linked##5##2##(1990-7#1)(1991-2#1)(2007-12#1)(2008-10#1)(2013-1#1)
highly curved##2##2##(1992-3#1)(2008-7#1)
highly degraded##2##2##(2008-10#1)(2008-12#1)
highly dependent on the##12##4##(1990-2#1)(1992-11#1)(1992-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
highly dependent on##17##3##(1990-2#1)(1992-11#1)(1992-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#2)
highly dependent##18##2##(1990-2#1)(1992-11#1)(1992-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#2)
highly desirable##8##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
highly destructive##3##2##(2008-10#2)(2013-1#1)
highly differentiated SNPs##2##3##(2013-1#2)
highly differentiated##8##2##(1990-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#2)
highly diffusing##3##2##(2007-12#2)(2008-2#1)
highly disabling##3##2##(1990-6#1)(2008-2#1)(2011-2#1)
highly dispersed##2##2##(2008-10#2)
highly dispersive##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
highly divergent##3##2##(1995-6#1)(2008-10#1)(2010-8#1)
highly diverging##2##2##(2007-12#1)(2008-2#1)
highly diverse and##2##3##(1994-5#1)(2008-10#1)
highly diverse low-PDT##2##3##(2008-12#2)
highly diverse##10##2##(1994-5#1)(1997-3#1)(2008-10#4)(2008-12#2)(2008-9#1)(2010-6#1)
highly dynamic but confined##2##4##(2012-2#2)
highly dynamic##7##2##(1995-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-8#1)(2012-2#2)
highly effective and##5##3##(1994-2#1)(1995-5#1)(2008-10#3)
highly effective in limiting##2##4##(2008-10#1)(2008-5#1)
highly effective in reducing the##2##5##(1993-10#1)(2008-5#1)
highly effective in##10##3##(1993-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#3)
highly effective medications##2##3##(2011-1#1)(2013-1#1)
highly effective treatment##2##3##(2012-3#1)(2013-1#1)
highly effective##37##2##(1991-2#1)(1993-10#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
highly efficacious##2##2##(2008-11#1)(2011-2#1)
highly efficient and##3##3##(2008-3#1)(2008-6#1)(2009-12#1)
highly efficient frequency##2##3##(2007-11#1)(2008-3#1)
highly efficient nonlinear##2##3##(2007-11#1)(2007-12#1)
highly efficient##54##2##(1993-2#1)(1994-5#1)(1996-5#1)(1997-8#1)(2007-11#7)(2007-12#7)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
highly elevated##3##2##(1992-3#1)(2008-11#1)(2009-5#1)
highly emetogenic chemotherapy##2##3##(2008-7#1)(2010-12#1)
highly enantioselective##2##2##(1992-8#1)(2011-1#1)
highly endemic area##3##3##(1994-11#1)(1995-12#1)(2013-8#1)
highly enriched in##6##3##(1993-11#2)(1997-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
highly enriched##7##2##(1993-11#2)(1993-8#1)(1997-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
highly experienced##2##2##(2008-10#1)(2010-9#1)
highly expressed during##3##3##(1993-3#1)(1997-6#2)
highly expressed in a##2##4##(1994-8#1)(2011-2#1)
highly expressed in cancer cells##2##5##(2008-8#1)(2011-2#1)
highly expressed in leaf##2##4##(2013-8#2)
highly expressed in skeletal muscle##2##5##(1994-12#2)
highly expressed in the##7##4##(1993-3#1)(1993-8#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-6#1)(2010-12#1)
highly expressed in##33##3##(1991-9#1)(1992-11#2)(1993-3#1)(1993-8#1)(1994-12#3)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#4)
highly expressed##48##2##(1991-11#1)(1991-9#1)(1992-11#2)(1993-3#2)(1993-8#1)(1994-12#3)(1994-6#2)(1994-8#1)(1995-6#2)(1995-8#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#3)(1997-9#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#4)
highly expressing recombinant##2##3##(2008-11#2)
highly extended##2##2##(2007-12#2)
highly favorable##3##2##(1992-8#1)(1994-9#1)(2013-1#1)
highly flexible and adaptive##2##4##(1994-12#1)(2008-10#1)
highly flexible##5##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
highly fluorescent##6##2##(1991-9#1)(2008-10#4)(2010-4#1)
highly focused##2##2##(1992-3#1)(2007-11#1)
highly fragmented##2##2##(2008-8#1)(2012-3#1)
highly frequent##2##2##(1995-2#1)(1997-6#1)
highly functional##2##2##(1993-11#1)(2010-10#1)
highly glycosylated##2##2##(1994-9#1)(2008-10#1)
highly heritable##3##2##(2008-8#1)(2009-10#1)(2012-3#1)
highly heterogeneous##6##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-8#1)
highly homogeneous##3##2##(2008-10#2)(2012-3#1)
highly homologous to that of the##2##6##(1991-9#1)(1994-11#1)
highly homologous to that##3##4##(1991-9#1)(1992-12#1)(1994-11#1)
highly homologous to the##12##4##(1990-11#2)(1990-12#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-9#1)(1995-8#1)(2008-8#2)
highly homologous to##24##3##(1990-11#2)(1990-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-6#2)(1995-8#1)(1997-2#2)(2008-10#1)(2008-8#2)
highly homologous##39##2##(1990-11#2)(1990-12#1)(1990-5#2)(1991-6#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#2)(1995-8#3)(1997-2#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-5#1)
highly hydrophilic##2##2##(1993-6#1)(2010-4#1)
highly hydrophobic##6##2##(1990-11#1)(1990-12#1)(1990-7#1)(2008-10#1)(2008-8#1)(2009-9#1)
highly identical##2##2##(1993-12#1)(2010-5#1)
highly immunogenic and##2##3##(1995-5#1)(2009-5#1)
highly immunogenic in##2##3##(1995-5#1)(2009-6#1)
highly immunogenic##10##2##(1994-3#1)(1994-8#1)(1995-5#3)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
highly important##3##2##(1991-5#1)(2012-2#1)(2013-8#1)
highly increased in##3##3##(1993-3#1)(1993-8#1)(2011-10#1)
highly increased##4##2##(1993-3#1)(1993-8#1)(1995-12#1)(2011-10#1)
highly individualized##3##2##(2007-12#1)(2008-8#1)(2009-10#1)
highly induced##4##2##(1995-11#1)(2008-10#2)(2008-4#1)
highly infectious##6##2##(1995-3#1)(1997-3#1)(2008-10#2)(2008-5#1)(2012-2#1)
highly inhibitory##3##2##(1992-5#1)(1997-1#1)(2008-6#1)
highly insensitive to##2##3##(2007-11#1)(2008-2#1)
highly insensitive##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
highly integrated##4##2##(2007-12#1)(2008-2#1)(2010-8#1)(2012-3#1)
highly interactive##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
highly interesting##3##2##(2007-11#1)(2012-1#1)(2013-1#1)
highly interrelated##2##2##(1997-1#1)(2011-2#1)
highly invasive##5##2##(1990-6#1)(1997-3#1)(2008-11#1)(2012-3#2)
highly lethal##4##2##(1992-8#1)(1994-3#1)(2008-10#2)
highly likely##3##2##(1990-3#2)(1997-3#1)
highly linear##3##2##(2007-12#1)(2008-10#2)
highly lipophilic##3##2##(1993-6#1)(2008-10#2)
highly localized##8##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
highly luminescent##2##2##(2008-10#2)
highly malignant##5##2##(1993-8#1)(1997-3#1)(2008-11#1)(2008-6#1)(2013-8#1)
highly metastatic##4##2##(1997-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
highly mobile##2##2##(2008-9#1)(2011-2#1)
highly modified##2##2##(2007-12#1)(2011-2#1)
highly motivated##2##2##(1995-11#1)(2008-11#1)
highly nonlinear dispersion-shifted fiber##2##4##(2007-11#2)
highly nonlinear fiber##2##3##(2007-11#2)
highly nonlinear holey fiber##2##4##(2007-11#2)
highly nonlinear##10##2##(2007-11#8)(2008-3#1)(2008-8#1)
highly optimized##3##2##(2008-4#1)(2011-1#1)(2012-2#1)
highly ordered##7##2##(1992-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)
highly organized##3##2##(2007-12#1)(2007-7#1)(2009-10#1)
highly oriented##3##2##(2007-12#1)(2008-8#1)(2010-4#1)
highly overlapping##2##2##(2008-10#1)(2008-11#1)
highly parallel##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
highly parallelized##3##2##(2011-2#1)(2013-1#2)
highly pathogenic##8##2##(2007-12#2)(2008-10#5)(2011-3#1)
highly penicillin- or cephalosporin-resistant strains##2##5##(2011-2#2)
highly phosphorylated in##3##3##(1995-6#1)(1995-8#1)(2008-8#1)
highly phosphorylated when expressed alone in COS-1 cells##2##8##(1995-2#2)
highly phosphorylated##9##2##(1991-9#1)(1995-2#3)(1995-6#2)(1995-8#1)(2008-8#1)(2010-12#1)
highly pleasurable foods##2##3##(2012-2#2)
highly pleasurable##3##2##(2012-2#3)
highly polar##2##2##(2008-10#1)(2008-11#1)
highly polarized##2##2##(1992-10#1)(2012-2#1)
highly polished##3##2##(2007-12#2)(2008-8#1)
highly polluted##2##2##(1992-3#1)(2008-7#1)
highly polymorphic##13##2##(1995-5#1)(1997-5#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2012-3#1)
highly potent##6##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)
highly precise##2##2##(2008-9#1)(2013-1#1)
highly predictive of##5##3##(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)
highly predictive##9##2##(1993-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-3#1)(2013-1#1)
highly prevalent in the##3##4##(2008-1#2)(2013-8#1)
highly prevalent in##10##3##(2007-7#1)(2008-1#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
highly prevalent##18##2##(2007-7#1)(2008-1#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
highly productive##8##2##(2007-5#1)(2008-10#1)(2008-11#5)(2010-12#1)
highly promising##5##2##(1991-2#1)(1997-6#1)(2008-10#2)(2012-3#1)
highly pure##2##2##(2008-11#1)(2008-9#1)
highly purified and functional##2##4##(2008-2#2)
highly purified from##4##3##(1990-5#1)(1993-3#1)(2008-9#2)
highly purified##21##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)
highly qualified##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
highly quantitative##2##2##(2008-10#1)(2008-11#1)
highly reactive##16##2##(1990-12#1)(1991-9#2)(1992-3#1)(1993-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-9#1)(2010-11#1)(2012-2#1)
highly reduced##3##2##(1991-6#1)(2008-10#1)(2013-1#1)
highly refined##2##2##(1994-5#1)(2011-2#1)
highly reflecting##5##2##(2007-11#1)(2008-3#4)
highly reflective dielectric##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
highly reflective##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
highly regioselective##2##2##(2007-11#1)(2008-4#1)
highly regulated##7##2##(1994-9#1)(1997-2#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-9#1)(2013-1#1)
highly related to##2##3##(1992-3#1)(1997-6#1)
highly related##5##2##(1992-3#1)(1996-2#1)(1997-6#2)(2007-2#1)
highly relevant##7##2##(1993-6#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
highly reliable and##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
highly reliable##8##2##(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
highly repetitive DNA##2##3##(1993-11#1)(2008-5#1)
highly repetitive##5##2##(1993-11#2)(2008-10#2)(2008-5#1)
highly reproducible and##4##3##(1996-9#1)(2008-10#2)(2011-1#1)
highly reproducible##22##2##(1995-12#1)(1995-3#1)(1996-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#2)(2011-1#1)(2011-2#1)
highly resistant lines##2##3##(2008-10#2)
highly resistant to bacterial blight##2##5##(2008-8#1)(2009-10#1)
highly resistant to the fungicide##2##5##(2008-10#2)
highly resistant to##20##3##(1992-8#1)(2008-10#10)(2008-11#1)(2008-8#3)(2009-10#1)(2011-2#4)
highly resistant##36##2##(1992-8#1)(2008-10#24)(2008-11#1)(2008-8#3)(2009-10#1)(2011-2#5)(2013-1#1)
highly rural and rural##2##4##(2012-1#2)
highly rural areas##2##3##(2012-1#2)
highly rural##7##2##(2012-1#7)
highly satisfactory##2##2##(2008-10#1)(2008-7#1)
highly satisfied with##3##3##(2008-2#1)(2013-1#2)
highly saturated##3##2##(2007-12#2)(2008-7#1)
highly scattering material##2##3##(2008-2#2)
highly scattering media##18##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#13)
highly scattering optical transmission##2##4##(2008-3#2)
highly scattering##29##2##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#20)
highly scintillated##2##2##(2008-3#2)
highly selected##2##2##(2011-2#2)
highly selective and sensitive##11##4##(2008-10#8)(2008-12#2)(2011-1#1)
highly selective and##16##3##(2008-10#12)(2008-12#2)(2009-2#1)(2011-1#1)
highly selective determination of##2##4##(2008-10#2)
highly selective for##10##3##(1990-8#1)(1991-5#1)(1991-7#1)(1994-12#1)(2008-10#5)(2010-1#1)
highly selective to##5##3##(2008-10#5)
highly selective##71##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1994-12#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#48)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
highly sensitive and selective method##3##5##(2008-10#3)
highly sensitive and selective##14##4##(2008-10#13)(2013-1#1)
highly sensitive and specific##4##4##(1995-11#1)(2008-10#3)
highly sensitive and##30##3##(1991-3#1)(1994-11#1)(1995-11#1)(1996-5#1)(2008-10#22)(2008-3#2)(2011-1#1)(2013-1#1)
highly sensitive approach##2##3##(2008-8#1)(2009-7#1)
highly sensitive assays##2##3##(1991-5#1)(2008-4#1)
highly sensitive detection of##3##4##(2008-10#3)
highly sensitive detection system##2##4##(2008-10#1)(2010-7#1)
highly sensitive detection##8##3##(2008-10#6)(2008-3#1)(2010-7#1)
highly sensitive for##2##3##(1994-11#1)(2008-10#1)
highly sensitive high-performance liquid chromatographic method##2##6##(1991-5#2)
highly sensitive method for the determination of##2##7##(2008-10#2)
highly sensitive method for##3##4##(2008-10#2)(2008-3#1)
highly sensitive method##6##3##(1991-5#1)(1997-4#1)(2008-10#3)(2008-3#1)
highly sensitive optical##3##3##(2008-10#3)
highly sensitive to changes in##2##5##(1990-8#1)(2008-4#1)
highly sensitive to the##4##4##(2007-11#1)(2008-3#3)
highly sensitive to##32##3##(1990-8#1)(1992-12#1)(1992-4#1)(1992-8#3)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)
highly sensitive with##2##3##(2008-10#1)(2008-2#1)
highly sensitive##166##2##(1990-8#1)(1991-3#1)(1991-5#5)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1994-11#3)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#2)(2007-5#1)(2008-10#86)(2008-11#1)(2008-2#4)(2008-3#12)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
highly significant (P &lt##6##4##(1995-6#1)(2008-10#5)
highly significant (P##9##3##(1992-8#1)(1995-6#1)(2008-10#7)
highly significant for##2##3##(1991-12#1)(2008-10#1)
highly significant in the##2##4##(2008-10#1)(2010-3#1)
highly significant reduction##2##3##(2012-2#2)
highly significant relationship between##2##4##(2008-10#1)(2008-8#1)
highly significant##56##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-6#1)(1997-6#1)(2007-10#2)(2007-7#1)(2008-10#18)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
highly significantly##2##2##(2008-10#1)(2011-1#1)
highly similar sequences##2##3##(1995-2#1)(2008-4#1)
highly similar to those##2##4##(2008-10#2)
highly similar to##7##3##(1991-2#1)(1991-6#1)(1994-12#1)(1995-6#1)(2008-10#3)
highly similar##14##2##(1991-2#1)(1991-6#3)(1994-12#1)(1995-2#1)(1995-6#1)(2008-10#5)(2008-4#1)(2012-2#1)
highly skewed##2##2##(1993-12#1)(2012-3#1)
highly skilled##2##2##(1992-12#1)(2008-10#1)
highly social species##2##3##(2008-8#1)(2008-9#1)
highly social##4##2##(2008-8#1)(2008-9#1)(2009-8#2)
highly soluble##2##2##(1997-1#1)(2008-5#1)
highly specialized on##2##3##(2008-8#1)(2008-9#1)
highly specialized##19##2##(1990-3#1)(1991-1#1)(1992-9#2)(1997-4#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
highly specific and sensitive##3##4##(1991-11#1)(1997-3#1)(2008-10#1)
highly specific and##10##3##(1991-11#1)(1991-5#1)(1991-9#1)(1996-11#1)(1997-3#1)(2008-10#3)(2009-6#1)(2012-2#1)
highly specific for##6##3##(1990-12#1)(1990-2#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-4#1)
highly specific in##2##3##(1990-12#1)(1992-12#1)
highly specific to##2##3##(2008-10#2)
highly specific##48##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#2)(1994-11#1)(1994-8#2)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-8#1)
highly stable in##2##3##(2008-10#2)
highly stable##12##2##(2007-11#3)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)
highly statistically significant##3##3##(1997-3#1)(2008-7#1)(2011-1#1)
highly statistically##4##2##(1997-3#1)(2007-11#1)(2008-7#1)(2011-1#1)
highly stimulated##3##2##(1990-11#1)(1993-3#1)(2009-8#1)
highly strained##2##2##(1990-8#2)
highly structured##8##2##(1990-5#1)(1992-8#1)(1993-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
highly substituted##2##2##(1996-5#1)(2008-10#1)
highly successful##7##2##(1992-2#1)(1993-12#1)(1995-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-8#1)
highly suggestive of##2##3##(2008-10#1)(2012-12#1)
highly suitable for##4##3##(1991-5#1)(2008-10#1)(2008-3#1)(2010-4#1)
highly suitable##6##2##(1991-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
highly sulfated##3##2##(1995-2#1)(2008-9#2)
highly susceptible cultivars and 12##2##5##(2008-10#2)
highly susceptible cv##3##3##(2008-10#3)
highly susceptible cvs##2##3##(2008-10#2)
highly susceptible to infection##2##4##(2008-10#2)
highly susceptible to the##2##4##(2008-10#1)(2008-5#1)
highly susceptible to##14##3##(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
highly susceptible##37##2##(1995-2#1)(2008-10#32)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
highly synergistic##2##2##(1993-8#1)(2009-4#1)
highly thermostable##2##2##(1994-11#1)(2008-9#1)
highly tolerant##2##2##(2007-11#1)(2008-3#1)
highly toxic##6##2##(1990-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
highly toxigenic##2##2##(2008-10#2)
highly transcribed##2##2##(1997-7#1)(2009-10#1)
highly transparent##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
highly tunable##2##2##(2012-2#2)
highly turbid##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
highly unlikely##4##2##(1996-12#2)(2008-7#1)(2011-2#1)
highly unstable##6##2##(1991-4#1)(1992-2#1)(1995-2#1)(1996-3#1)(2008-11#1)(2013-8#1)
highly valuable##2##2##(2007-12#1)(2008-6#1)
highly valued by##2##3##(1993-12#1)(1994-1#1)
highly valued##3##2##(1991-12#1)(1993-12#1)(1994-1#1)
highly variable and##3##3##(2008-10#2)(2013-8#1)
highly variable drugs##2##3##(2012-3#2)
highly variable from##2##3##(2008-7#1)(2013-1#1)
highly variable topography##3##3##(2013-7#3)
highly variable##42##2##(1992-5#1)(1995-8#1)(1996-4#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#5)(2013-8#3)
highly vascular##4##2##(2006-12#1)(2008-7#2)(2012-2#1)
highly vascularized##2##2##(1995-11#1)(2012-12#1)
highly versatile##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
highly virulent and##2##3##(2008-10#2)
highly virulent isolate##3##3##(2008-10#3)
highly virulent isolates##7##3##(2008-10#7)
highly virulent to##2##3##(2008-10#2)
highly virulent##25##2##(1992-2#1)(2008-10#21)(2008-5#2)(2009-6#1)
highly viscous##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
highly visible##2##2##(1993-2#1)(1993-9#1)
highly##2019##1##(1990-10#1)(1990-11#11)(1990-12#7)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#8)(1990-6#4)(1990-7#4)(1990-8#9)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#11)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#12)(1991-6#11)(1991-7#3)(1991-8#1)(1991-9#10)(1992-10#1)(1992-11#10)(1992-12#9)(1992-2#4)(1992-3#11)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#13)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#10)(1993-12#19)(1993-2#5)(1993-3#10)(1993-5#1)(1993-6#9)(1993-8#10)(1993-9#3)(1994-1#3)(1994-11#13)(1994-12#19)(1994-2#7)(1994-3#4)(1994-5#5)(1994-6#8)(1994-8#9)(1994-9#6)(1995-1#3)(1995-11#9)(1995-12#6)(1995-2#14)(1995-3#7)(1995-5#7)(1995-6#14)(1995-8#9)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#3)(1996-5#7)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#15)(1997-3#10)(1997-4#11)(1997-5#2)(1997-6#10)(1997-7#8)(1997-8#3)(1997-9#4)(2006-10#1)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#54)(2007-12#62)(2007-2#1)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#19)(2008-10#472)(2008-11#60)(2008-12#21)(2008-2#55)(2008-3#104)(2008-4#34)(2008-5#38)(2008-6#15)(2008-7#50)(2008-8#50)(2008-9#45)(2009-10#13)(2009-11#5)(2009-12#7)(2009-2#6)(2009-3#1)(2009-4#4)(2009-5#13)(2009-6#6)(2009-7#10)(2009-8#12)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#6)(2010-4#13)(2010-5#11)(2010-6#3)(2010-7#5)(2010-8#11)(2010-9#3)(2011-1#21)(2011-10#1)(2011-2#61)(2011-3#3)(2011-9#2)(2012-1#10)(2012-12#9)(2012-2#44)(2012-3#34)(2013-1#50)(2013-7#6)(2013-8#28)
highly-conserved##3##1##(1990-5#1)(1995-5#1)(2009-11#1)
highs and lows##2##3##(1994-1#1)(1994-2#1)
highs##3##1##(1994-1#1)(1994-2#1)(2007-4#1)
highthroughput##2##1##(2008-7#2)
highway##5##1##(1992-3#1)(1996-3#2)(2008-5#2)
hilA##2##1##(2008-11#2)
hilar biliary stricture##2##3##(2013-1#2)
hilar biliary##5##2##(2012-2#1)(2013-1#4)
hilar region##2##2##(1993-12#1)(2010-8#1)
hilar##17##1##(1993-12#1)(1996-1#1)(1997-8#1)(2007-8#2)(2008-1#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#5)
hilbert##2##1##(2008-2#1)(2008-3#1)
hills##3##1##(2008-10#1)(2008-12#1)(2013-7#1)
hillslope soils##2##2##(2013-7#2)
hillslope##4##1##(2013-7#4)
hilltop and hillslope##2##3##(2013-7#2)
hilltop soils##2##2##(2013-7#2)
hilltop##4##1##(2013-7#4)
hilum##3##1##(1997-1#1)(2008-11#1)(2008-7#1)
hilus##2##1##(1996-5#1)(2008-4#1)
him or##2##2##(1992-4#1)(2008-1#1)
him to##5##2##(1990-11#1)(1992-3#2)(1996-5#1)(2010-5#1)
him##27##1##(1990-11#2)(1992-3#4)(1992-4#1)(1993-3#1)(1995-6#3)(1996-5#5)(1997-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2011-1#3)(2012-12#1)
him/her to##2##2##(1993-6#1)(1995-11#1)
him/her##3##1##(1993-6#1)(1995-11#1)(2012-3#1)
himself##15##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1992-3#1)(1993-11#2)(1993-3#1)(1996-8#1)(2008-10#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#1)
hin1##2##1##(2008-10#2)
hind foot##4##2##(2010-3#2)(2011-2#1)(2012-2#1)
hind leg##8##2##(1995-2#1)(1997-2#1)(2007-12#5)(2008-9#1)
hind legs##4##2##(2007-12#4)
hind paw##2##2##(2008-5#2)
hind##24##1##(1995-2#1)(1997-2#1)(2007-12#12)(2008-5#2)(2008-9#2)(2010-12#1)(2010-3#3)(2011-2#1)(2012-2#1)
hindbrain##9##1##(1993-12#1)(1996-5#1)(2008-3#1)(2008-7#1)(2012-12#5)
hinder the##3##2##(1990-6#1)(2008-7#1)(2011-2#1)
hinder their##2##2##(2007-5#1)(2008-7#1)
hinder##17##1##(1990-6#1)(1994-1#1)(1994-2#1)(1995-3#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)
hindered by the lack of##2##5##(1997-7#1)(2008-11#1)
hindered by the##6##3##(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#2)(2010-5#1)
hindered by##11##2##(1994-9#1)(1995-6#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-9#1)(2010-5#1)(2012-2#1)
hindered the##3##2##(1991-8#1)(2008-10#1)(2012-2#1)
hindered##34##1##(1990-5#1)(1991-11#1)(1991-8#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#2)
hindering progress##2##2##(2008-8#1)(2012-2#1)
hindering the##4##2##(1994-3#1)(2008-11#1)(2008-8#1)(2009-9#1)
hindering##8##1##(1994-3#1)(1995-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-9#1)(2012-2#1)
hinders the##4##2##(1995-8#1)(2008-10#1)(2010-4#1)(2011-2#1)
hinders##7##1##(1991-12#1)(1995-8#1)(2008-10#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-2#1)
hindfoot##6##1##(2008-8#2)(2011-2#2)(2012-2#1)(2012-3#1)
hindgut##11##1##(2007-12#3)(2008-10#7)(2008-6#1)
hindlimb##9##1##(1990-11#1)(1991-12#1)(1992-12#2)(1993-11#2)(1993-12#1)(1997-2#1)(2008-7#1)
hindlimbs but##2##2##(1992-12#1)(1993-3#1)
hindlimbs##4##1##(1992-12#2)(1993-3#1)(1996-6#1)
hindpaw shaking behaviour and##3##4##(2008-4#3)
hindpaw##6##1##(2008-4#3)(2009-12#3)
hindquarters vasoconstriction##2##2##(1992-3#2)
hindquarters##3##1##(1992-3#2)(1996-12#1)
hindrance and##3##2##(1993-8#1)(2008-10#1)(2012-1#1)
hindrance to##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)
hindrance##23##1##(1990-8#1)(1993-8#1)(1994-11#1)(1994-9#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
hindrances to##2##2##(2008-10#1)(2008-11#1)
hindrances##4##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
hinds##2##1##(1993-2#1)(2008-9#1)
hinge flap##2##2##(2008-7#1)(2009-1#1)
hinge is##2##2##(2008-7#2)
hinge region of##2##3##(1995-6#2)
hinge region##8##2##(1995-11#1)(1995-6#3)(1997-2#1)(2013-1#3)
hinge##15##1##(1995-11#1)(1995-6#3)(1996-12#1)(1997-2#1)(2007-12#1)(2008-7#3)(2009-1#1)(2013-1#3)(2013-8#1)
hinges on##2##2##(1992-1#1)(2008-10#1)
hinges or##2##2##(2009-5#2)
hinges##11##1##(1992-1#1)(1995-2#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-7#2)(2009-5#2)
hinnavin I##2##2##(1997-8#2)
hint##6##1##(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
hints for##4##2##(1990-2#1)(1994-12#1)(1994-3#1)(2011-2#1)
hints on##6##2##(1997-4#1)(2008-1#1)(2008-9#2)(2010-11#1)(2010-4#1)
hints##15##1##(1990-2#1)(1994-12#1)(1994-3#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
hip (DDH)##5##2##(2007-11#1)(2007-8#2)(2013-7#1)(2013-8#1)
hip -##3##2##(2007-11#2)(2007-8#1)
hip abductor torque##2##3##(2008-12#2)
hip and knee arthroplasty##2##4##(2009-3#1)(2013-1#1)
hip and knee##7##3##(1995-12#1)(1995-5#1)(2007-8#1)(2009-3#1)(2012-2#2)(2013-1#1)
hip and shoulder##3##3##(2007-11#2)(2008-11#1)
hip and the##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
hip and##24##2##(1993-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(2007-11#4)(2007-8#2)(2008-11#3)(2008-4#1)(2009-3#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
hip arthroplasties##3##2##(1996-9#2)(2009-7#1)
hip arthroplasty (THA)##9##3##(1994-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
hip arthroplasty in##6##3##(2007-11#1)(2007-8#2)(2009-3#1)(2012-2#1)(2013-1#1)
hip arthroplasty is##3##3##(1997-6#1)(2007-11#2)
hip arthroplasty##57##2##(1994-3#1)(1996-9#1)(1997-6#1)(2007-11#6)(2007-8#5)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#13)(2009-3#3)(2009-4#1)(2011-2#10)(2012-12#1)(2012-2#6)(2013-1#6)
hip arthroscopy##2##2##(2008-8#2)
hip bone mineral density##2##4##(2008-8#1)(2012-12#1)
hip circumference##4##2##(2008-12#1)(2011-2#2)(2013-1#1)
hip disability##2##2##(2008-10#2)
hip dislocation in##3##3##(2007-8#1)(2009-3#1)(2011-2#1)
hip dislocation##9##2##(2007-11#2)(2007-8#3)(2009-3#1)(2009-4#1)(2011-2#2)
hip dysplasia in##2##3##(2007-11#1)(2007-8#1)
hip dysplasia##4##2##(2007-11#3)(2007-8#1)
hip flexion##3##2##(2007-11#1)(2011-2#2)
hip fracture and##2##3##(2008-12#2)
hip fracture in##2##3##(1990-9#1)(2008-8#1)
hip fracture##15##2##(1990-9#1)(1993-11#3)(2008-12#4)(2008-7#1)(2008-8#5)(2009-3#1)
hip fractures in##2##3##(1990-2#1)(1993-11#1)
hip fractures were##2##3##(2007-8#1)(2011-2#1)
hip fractures##15##2##(1990-2#1)(1993-11#5)(1995-2#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-3#1)(2010-9#1)(2011-2#2)
hip in the##2##3##(2007-11#2)
hip in##5##2##(2007-11#2)(2007-8#2)(2011-2#1)
hip is##5##2##(2007-11#3)(2007-8#1)(2009-3#1)
hip joint in the##2##4##(2007-11#1)(2007-8#1)
hip joint in##8##3##(2007-11#5)(2007-8#3)
hip joint##39##2##(1997-6#2)(2007-11#12)(2007-8#12)(2008-10#1)(2008-12#3)(2008-4#1)(2008-6#2)(2008-8#2)(2009-4#2)(2011-2#1)(2013-8#1)
hip joints is##2##3##(2007-11#1)(2013-1#1)
hip joints of preterm neonates born##2##6##(2007-11#2)
hip joints of##3##3##(2007-11#3)
hip joints##10##2##(2007-11#5)(2007-8#2)(2008-6#1)(2009-4#1)(2013-1#1)
hip or knee replacement##2##4##(1990-6#1)(2013-1#1)
hip or knee##3##3##(1990-6#1)(2013-1#2)
hip or##5##2##(1990-6#1)(2007-10#1)(2013-1#2)(2013-8#1)
hip pain##3##2##(2006-10#1)(2008-8#1)(2013-1#1)
hip plasty##3##2##(2007-11#3)
hip prosthesis##6##2##(2007-8#1)(2008-10#1)(2009-3#2)(2009-4#1)(2010-6#1)
hip protectors##2##2##(1993-11#1)(2008-8#1)
hip replacement has##2##3##(2007-8#1)(2008-7#1)
hip replacement##36##2##(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-6#1)(2006-10#2)(2007-11#3)(2007-8#3)(2008-7#3)(2008-8#1)(2009-3#3)(2009-4#1)(2010-10#9)(2011-2#1)(2013-1#2)(2013-7#1)
hip replacements##3##2##(2007-11#1)(2009-7#1)(2009-8#1)
hip stem##3##2##(2011-2#3)
hip surgery##4##2##(2007-10#1)(2011-2#1)(2013-1#2)
hip system##3##2##(2008-8#1)(2011-2#2)
hip was##5##2##(2007-11#2)(2009-3#1)(2010-3#1)(2013-7#1)
hip##400##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1993-11#11)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-6#2)(1996-8#1)(1996-9#4)(1997-6#3)(1997-8#1)(2006-10#4)(2007-10#2)(2007-11#70)(2007-8#61)(2008-10#7)(2008-11#6)(2008-12#12)(2008-4#3)(2008-6#5)(2008-7#6)(2008-8#35)(2009-11#1)(2009-3#23)(2009-4#9)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#10)(2010-3#3)(2010-6#1)(2010-9#2)(2011-2#43)(2012-1#1)(2012-12#5)(2012-2#8)(2013-1#24)(2013-7#7)(2013-8#5)
hippocampal 5-HT1A receptors##2##3##(1994-2#2)
hippocampal 5-HT1A##4##2##(1994-2#4)
hippocampal CA1 neurons##3##3##(1990-12#1)(1991-12#1)(2009-12#1)
hippocampal CA1##16##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#1)(1992-12#1)(1993-12#1)(1995-12#1)(1996-5#1)(1997-2#2)(2008-11#4)(2009-12#2)
hippocampal CA3 nerve cells##2##4##(1995-8#2)
hippocampal CA3##4##2##(1995-8#3)(2008-11#1)
hippocampal PKC activity##2##3##(1992-11#2)
hippocampal PKC##3##2##(1992-11#3)
hippocampal activity##2##2##(2008-11#1)(2013-8#1)
hippocampal afferent markers##2##3##(1993-5#2)
hippocampal afferent##4##2##(1993-5#4)
hippocampal and cerebellar##2##3##(1991-2#1)(1996-12#1)
hippocampal and cortical##3##3##(1996-5#2)(2013-8#1)
hippocampal and##10##2##(1991-2#1)(1992-8#1)(1994-2#1)(1996-12#1)(1996-5#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
hippocampal area##3##2##(1990-5#2)(1996-5#1)
hippocampal cell cultures##2##3##(2009-3#2)
hippocampal cell proliferation in##2##4##(2011-2#2)
hippocampal cell##7##2##(1997-6#1)(2008-11#1)(2009-3#3)(2011-2#2)
hippocampal cholinergic activity##2##3##(1993-12#2)
hippocampal cholinergic##4##2##(1993-12#4)
hippocampal connections##2##2##(1992-11#2)
hippocampal dentate gyrus##3##3##(1991-2#1)(2008-7#1)(2011-2#1)
hippocampal dentate##4##2##(1991-2#1)(2008-7#1)(2011-2#1)(2013-7#1)
hippocampal formation##10##2##(1990-11#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-4#1)(1997-6#2)
hippocampal function##5##2##(1993-12#2)(1996-5#1)(2007-8#2)
hippocampal functioning##2##2##(2008-7#2)
hippocampal homogenates##2##2##(1992-9#2)
hippocampal ischemia##2##2##(2012-2#2)
hippocampal lipofuscin##2##2##(1995-3#2)
hippocampal long-term potentiation in##2##4##(1993-12#1)(2009-8#1)
hippocampal long-term potentiation##4##3##(1993-12#1)(2008-7#1)(2009-8#1)(2013-8#1)
hippocampal membranes##2##2##(1995-12#1)(1995-6#1)
hippocampal network##2##2##(2013-8#2)
hippocampal neural##2##2##(1991-2#1)(2008-11#1)
hippocampal neuronal##2##2##(1993-12#1)(1996-12#1)
hippocampal neurones##4##2##(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)
hippocampal neurons in##3##3##(2009-12#2)(2012-2#1)
hippocampal neurons was##2##3##(2009-12#1)(2012-3#1)
hippocampal neurons were##2##3##(1997-2#1)(2012-2#1)
hippocampal neurons##17##2##(1995-2#1)(1996-12#1)(1997-2#2)(1997-7#2)(2008-8#1)(2009-12#5)(2010-12#1)(2012-2#2)(2012-3#2)
hippocampal pyramidal neurons##3##3##(1990-7#2)(1995-8#1)
hippocampal pyramidal##4##2##(1990-7#2)(1991-7#1)(1995-8#1)
hippocampal region##6##2##(1992-11#1)(1994-2#1)(1994-3#3)(1996-7#1)
hippocampal slice preparations##2##3##(2008-4#1)(2008-7#1)
hippocampal slice##3##2##(2008-4#2)(2008-7#1)
hippocampal slices prepared from##2##4##(1996-5#2)
hippocampal slices##23##2##(1990-12#2)(1990-7#2)(1991-12#1)(1995-12#5)(1995-2#1)(1996-2#1)(1996-5#4)(1997-2#2)(2008-2#3)(2008-4#1)(2008-7#1)
hippocampal stem cell line##2##4##(1997-6#2)
hippocampal structure and##2##3##(2008-7#1)(2012-2#1)
hippocampal subfield##2##2##(1995-3#1)(1996-7#1)
hippocampal synaptic plasticity##5##3##(1993-12#1)(2008-7#3)(2009-8#1)
hippocampal system##3##2##(1993-3#1)(1993-6#2)
hippocampal tissue##2##2##(1991-2#1)(1993-12#1)
hippocampal volume##6##2##(1994-3#4)(1996-7#1)(2008-6#1)
hippocampal##240##1##(1990-11#3)(1990-12#3)(1990-5#4)(1990-7#4)(1991-10#1)(1991-12#2)(1991-2#4)(1991-7#1)(1992-11#8)(1992-12#3)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#19)(1993-3#2)(1993-5#8)(1993-6#3)(1993-9#2)(1994-11#1)(1994-2#7)(1994-3#9)(1995-11#1)(1995-12#11)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#5)(1996-12#5)(1996-2#3)(1996-5#10)(1996-7#5)(1996-9#1)(1997-2#7)(1997-4#1)(1997-6#6)(1997-7#2)(2007-8#2)(2008-1#1)(2008-11#14)(2008-2#3)(2008-4#3)(2008-6#3)(2008-7#16)(2008-8#1)(2008-9#1)(2009-12#7)(2009-3#5)(2009-5#1)(2009-8#3)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#9)
hippocampal-dependent##3##1##(1994-8#1)(2008-7#1)(2009-8#1)
hippocampectomy##2##1##(1993-3#2)
hippocampi##6##1##(1991-2#1)(1995-12#4)(2009-12#1)
hippocampus after##4##2##(1990-5#1)(1992-12#1)(1995-12#1)(1997-3#1)
hippocampus and cerebellar cortex##2##4##(1997-2#2)
hippocampus and cerebellum##3##3##(1990-7#1)(1993-9#2)
hippocampus and striatum##2##3##(1995-11#1)(1996-2#1)
hippocampus and was##2##3##(1991-12#1)(1997-2#1)
hippocampus and##43##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#2)(1993-12#1)(1993-6#2)(1993-9#2)(1994-2#2)(1994-3#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#5)(1997-6#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
hippocampus are##3##2##(1993-12#1)(1997-2#1)(2013-8#1)
hippocampus by##2##2##(1993-5#1)(1996-12#1)
hippocampus dependent memory##2##3##(2008-7#2)
hippocampus following##2##2##(1991-2#1)(1996-12#1)
hippocampus in the##3##3##(1994-6#1)(1996-12#1)(2008-7#1)
hippocampus in##9##2##(1994-6#2)(1995-5#1)(1996-12#1)(2008-12#1)(2008-7#3)(2013-8#1)
hippocampus is##2##2##(1991-11#1)(1996-9#1)
hippocampus of the##8##3##(1990-7#1)(1992-10#1)(1993-3#2)(1995-12#2)(2010-12#1)(2013-1#1)
hippocampus of##24##2##(1990-7#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-6#1)(1995-12#6)(1995-5#2)(1996-12#3)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
hippocampus or##4##2##(1990-11#2)(1994-6#1)(1996-5#1)
hippocampus than in##2##3##(1990-7#1)(1997-2#1)
hippocampus to##3##2##(1992-8#1)(2008-11#1)(2008-12#1)
hippocampus was##4##2##(1990-5#1)(1994-6#1)(1995-5#1)(1996-5#1)
hippocampus##242##1##(1990-11#3)(1990-5#3)(1990-7#5)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-3#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-12#7)(1993-3#2)(1993-5#3)(1993-6#7)(1993-9#4)(1994-12#2)(1994-2#5)(1994-3#8)(1994-6#8)(1994-8#4)(1995-11#1)(1995-12#23)(1995-2#3)(1995-5#7)(1996-11#1)(1996-12#17)(1996-2#2)(1996-5#3)(1996-9#2)(1997-2#15)(1997-3#2)(1997-6#2)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#18)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#2)(2009-6#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#11)
hippocampus-dependent memory##2##2##(2008-7#2)
hippocampus-dependent##5##1##(1993-12#1)(2008-7#3)(2008-9#1)
hips healed without complications##2##4##(2013-1#2)
hips in##6##2##(2007-11#1)(2007-8#4)(2013-7#1)
hips is##2##2##(2007-11#1)(2013-8#1)
hips was##3##2##(2007-11#1)(2007-8#1)(2008-8#1)
hips were##2##2##(2006-10#1)(2013-1#1)
hips with##2##2##(2007-11#1)(2007-8#1)
hips without##2##2##(2012-2#2)
hips##48##1##(1996-9#1)(2006-10#1)(2007-11#13)(2007-8#18)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
hips)##3##1##(2007-8#2)(2009-3#1)
hirame##4##1##(2010-8#4)
hiratsukae##3##1##(2009-2#3)
hircus)##3##1##(2008-9#2)(2010-4#1)
hire##7##1##(1992-12#1)(1992-3#1)(1994-1#2)(1997-2#1)(1997-3#1)(2008-10#1)
hired##7##1##(1990-2#1)(1995-3#1)(1995-5#1)(2009-9#1)(2011-2#3)
hires##2##1##(1990-2#1)(2011-2#1)
hiring##7##1##(1994-1#2)(1994-12#2)(1994-2#1)(2007-4#2)
hirsuta##7##1##(1992-6#1)(2008-10#5)(2008-5#1)
hirsutism##4##1##(2008-1#2)(2008-3#1)(2008-4#1)
hirsutum L##9##2##(1993-3#1)(2008-8#2)(2011-2#6)
hirsutum LA407##2##2##(2008-10#2)
hirsutum##18##1##(1993-3#1)(2008-10#7)(2008-8#2)(2008-9#2)(2011-2#6)
hirudin in##2##2##(2008-10#1)(2013-8#1)
hirudin##8##1##(1990-7#2)(2008-10#3)(2008-3#1)(2013-8#2)
his &quot##2##2##(1992-6#1)(2008-12#1)
his 70th birthday##2##3##(1992-5#1)(1997-6#1)
his AIDS diagnosis##2##3##(1995-12#1)(1995-6#1)
his HIV status##5##3##(1991-7#1)(1995-6#1)(1996-5#2)(1997-5#1)
his HIV##6##2##(1991-7#1)(1995-6#2)(1996-5#2)(1997-5#1)
his ODI##2##2##(2008-12#2)
his ability to##4##3##(1990-5#1)(1992-3#1)(2008-1#1)(2008-4#1)
his article##2##2##(1992-12#1)(2008-1#1)
his book##4##2##(1992-12#1)(1993-3#1)(2009-10#1)(2013-1#1)
his books##2##2##(1995-1#1)(2009-10#1)
his brother##2##2##(1993-6#1)(1997-3#1)
his childhood##3##2##(1995-5#1)(2008-7#1)(2013-1#1)
his children##2##2##(2008-12#1)(2011-1#1)
his clinical practice##2##3##(2010-5#1)(2013-1#1)
his clinical##4##2##(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
his colleagues##3##2##(1992-9#1)(1996-1#1)(2008-9#1)
his condition##4##2##(1997-5#1)(2007-2#1)(2009-11#1)(2011-1#1)
his contribution to##3##3##(2007-5#1)(2009-10#1)(2013-1#1)
his contributions to##2##3##(1996-12#1)(2007-10#1)
his death##8##2##(1995-3#1)(1995-5#1)(1995-6#1)(2007-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#1)
his different##2##2##(2010-3#1)(2011-2#1)
his disease##2##2##(2008-6#1)(2013-1#1)
his doctor##2##2##(1991-4#1)(2011-1#1)
his doctors##2##2##(1995-6#2)
his early years of##2##4##(2008-10#1)(2010-1#1)
his early##3##2##(2008-10#1)(2008-5#1)(2010-1#1)
his efforts to##2##3##(1990-11#1)(1991-8#1)
his employer##2##2##(1995-12#1)(1995-6#1)
his experience in##2##3##(1990-9#1)(1996-2#1)
his experience##5##2##(1990-9#1)(1994-12#1)(1996-2#1)(2008-4#1)(2011-3#1)
his family##3##2##(1996-3#1)(2011-2#2)
his first##6##2##(1995-6#1)(1997-6#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
his home##2##2##(1995-1#1)(2010-8#1)
his hospital##8##2##(1991-1#1)(1992-2#2)(1992-3#1)(1993-12#2)(1994-2#1)(1996-12#1)
his house##2##2##(2010-5#1)(2013-1#1)
his ideas##2##2##(2008-10#1)(2008-7#1)
his initial##2##2##(2007-8#1)(2013-8#1)
his last##2##2##(2010-1#1)(2013-1#1)
his left ankle##2##3##(2009-1#2)
his left flank##2##3##(2008-12#2)
his left##9##2##(1996-6#1)(2007-8#1)(2008-12#2)(2009-1#3)(2010-5#1)(2010-9#1)
his legs##2##2##(2008-6#1)(2013-8#1)
his life and work##2##4##(2008-11#1)(2008-9#1)
his life and##6##3##(1993-3#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
his life##10##2##(1993-3#1)(1996-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
his lifetime##2##2##(1992-3#1)(2011-1#1)
his lower##3##2##(2008-6#1)(2008-7#1)(2011-2#1)
his main##2##2##(1993-11#1)(2008-12#1)
his medical##7##2##(1992-3#1)(1994-2#1)(1995-6#1)(2009-7#1)(2011-1#2)(2012-3#1)
his mother##3##2##(1990-7#1)(1997-5#1)(2008-10#1)
his normal##2##2##(2008-7#1)(2010-3#1)
his or her goals##2##4##(2008-7#2)
his or her own##2##4##(1993-3#1)(2008-2#1)
his or her##21##3##(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2009-10#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
his or##22##2##(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2009-10#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
his original##2##2##(2008-2#1)(2011-1#1)
his own personal##2##3##(1994-12#1)(2008-2#1)
his own##9##2##(1990-11#1)(1992-2#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
his parents##2##2##(1996-3#1)(2007-12#1)
his partner##2##2##(1996-5#1)(2008-8#1)
his patient##4##2##(1993-11#1)(1993-12#1)(2007-4#1)(2012-12#1)
his patients##3##2##(1993-11#1)(2008-10#1)(2011-1#1)
his physician##3##2##(1990-6#1)(2008-7#1)(2013-1#1)
his power of##2##3##(1997-5#1)(2012-3#1)
his previous##3##2##(2008-12#1)(2008-9#1)(2011-2#1)
his primary##2##2##(2008-11#1)(2011-1#1)
his research##2##2##(2007-7#1)(2010-5#1)
his right arm##2##3##(2008-5#1)(2011-2#1)
his right eye##4##3##(2010-10#2)(2011-2#1)(2013-8#1)
his right##16##2##(1991-11#1)(1991-6#1)(1995-6#1)(1996-2#1)(2007-8#1)(2008-5#1)(2010-10#2)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#2)(2013-8#1)
his security##2##2##(1996-12#1)(2008-12#1)
his serum##2##2##(1994-12#1)(1996-9#1)
his sexual##2##2##(1995-12#2)
his students that##2##3##(2008-10#2)
his studies in##2##3##(2009-10#1)(2010-1#1)
his symptoms##5##2##(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-2#1)
his theory##3##2##(2010-4#1)(2011-1#1)(2012-2#1)
his therapy##2##2##(2011-2#1)(2013-1#1)
his treatise##2##2##(2007-5#2)
his treatment##2##2##(2011-1#1)(2012-3#1)
his two##2##2##(1996-5#1)(2013-1#1)
his view of##2##3##(1993-11#1)(2008-12#1)
his view that the##2##4##(2008-12#2)
his view##4##2##(1993-11#1)(2008-12#3)
his views on##2##3##(1995-1#1)(1995-2#1)
his visit##2##2##(1995-3#1)(2011-1#1)
his wife##2##2##(1990-11#1)(2008-9#1)
his words##2##2##(1996-1#1)(2008-12#1)
his work##9##2##(1991-6#1)(1997-3#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2011-1#1)
his##562##1##(1990-11#5)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#2)(1991-3#3)(1991-4#1)(1991-6#6)(1991-7#2)(1991-8#2)(1992-12#4)(1992-2#5)(1992-3#6)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#9)(1993-12#6)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#4)(1995-1#5)(1995-12#11)(1995-2#3)(1995-3#3)(1995-5#5)(1995-6#17)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#8)(1996-5#9)(1996-6#3)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#6)(1997-5#8)(1997-6#4)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#8)(2007-2#2)(2007-4#2)(2007-5#8)(2007-7#1)(2007-8#9)(2008-1#6)(2008-10#18)(2008-11#8)(2008-12#31)(2008-2#4)(2008-3#1)(2008-4#12)(2008-5#8)(2008-6#7)(2008-7#25)(2008-8#7)(2008-9#8)(2009-1#4)(2009-10#14)(2009-11#1)(2009-2#4)(2009-3#1)(2009-5#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#14)(2010-10#4)(2010-12#1)(2010-2#1)(2010-3#7)(2010-4#1)(2010-5#9)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#20)(2011-2#29)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#11)(2013-1#20)(2013-8#8)
his/her family##2##2##(2008-9#1)(2010-3#1)
his/her social##2##2##(1993-1#1)(2013-8#1)
his/her##28##1##(1992-1#1)(1992-12#1)(1993-1#1)(1996-2#1)(1997-4#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-8#5)
histamine H1 receptor##3##3##(1992-11#3)
histamine H2 receptor##4##3##(1991-5#1)(1991-9#2)(1995-12#1)
histamine challenge##2##2##(1992-9#2)
histamine concentration##3##2##(1994-6#1)(2008-10#1)(2012-2#1)
histamine content##3##2##(1995-12#2)(2008-11#1)
histamine in human##2##3##(1994-2#1)(1994-6#1)
histamine in the##2##3##(1995-12#2)
histamine in##7##2##(1991-9#1)(1994-2#1)(1994-6#1)(1995-12#2)(1996-2#1)(2008-10#1)
histamine induced##2##2##(1991-12#1)(1995-12#1)
histamine iontophoresis##2##2##(2008-5#2)
histamine is##2##2##(1996-5#1)(1997-1#1)
histamine on##4##2##(1994-2#1)(1995-12#1)(1996-5#1)(2008-12#1)
histamine release from rat peritoneal mast cells induced by anti-IgE##2##10##(1991-12#2)
histamine release from##3##3##(1991-12#2)(2008-10#1)
histamine release in##2##3##(1991-12#1)(2009-12#1)
histamine release##10##2##(1991-12#3)(1992-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-12#1)
histamine was##3##2##(1995-12#1)(1996-5#1)(2008-12#1)
histamine##103##1##(1990-5#1)(1990-7#4)(1991-12#4)(1991-5#1)(1991-9#7)(1992-11#3)(1992-3#4)(1992-6#1)(1992-9#2)(1993-6#1)(1994-2#4)(1994-6#5)(1995-12#14)(1996-1#1)(1996-2#1)(1996-5#6)(1997-1#5)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#4)(2009-12#1)(2011-2#1)(2012-2#2)(2013-7#2)
histamine)##2##1##(2008-4#2)
histamine-induced##6##1##(1994-11#1)(1994-8#1)(1995-12#1)(1997-7#1)(2008-5#1)(2013-7#1)
histamine-orthophthalaldehyde##2##1##(2008-10#2)
histamine-releasing activity##2##2##(1995-11#2)
histaminergic##4##1##(1994-2#1)(1994-8#1)(1995-12#1)(2008-3#1)
histidase##11##1##(1994-5#9)(1994-6#2)
histidases##2##1##(1994-5#1)(1994-6#1)
histidine ammonia-lyase##3##2##(1994-5#1)(1994-6#2)
histidine and its metabolites##3##4##(2008-10#3)
histidine and##12##2##(1990-12#1)(1990-5#1)(1993-11#1)(1995-5#1)(2008-10#6)(2008-8#1)(2011-2#1)
histidine by##2##2##(1992-6#1)(2008-10#1)
histidine decarboxylase (HDC)##2##3##(1990-12#1)(1997-1#1)
histidine decarboxylase##3##2##(1990-12#1)(1997-1#2)
histidine in the##2##3##(1992-9#1)(1995-3#1)
histidine in##3##2##(1992-9#1)(1995-3#1)(2008-10#1)
histidine kinase gene##2##3##(2008-10#1)(2013-8#1)
histidine kinase##3##2##(2008-10#2)(2013-8#1)
histidine protein kinase##2##3##(2008-10#1)(2010-10#1)
histidine residue in##2##3##(1990-12#1)(1991-9#1)
histidine residue##8##2##(1990-12#1)(1991-9#1)(1992-8#2)(1993-3#1)(1995-5#1)(1996-8#1)(2008-10#1)
histidine residues in##2##3##(1990-12#1)(1995-5#1)
histidine residues of##2##3##(1994-8#1)(1995-2#1)
histidine residues##16##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-6#4)(1992-8#4)(1994-8#1)(1995-2#1)(1995-5#2)(2010-4#1)
histidine tag##3##2##(2008-10#3)
histidine##102##1##(1990-11#3)(1990-12#5)(1990-5#3)(1990-8#3)(1991-12#1)(1991-8#1)(1991-9#3)(1992-6#5)(1992-8#7)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-2#3)(1995-3#3)(1995-5#4)(1995-8#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#27)(2008-7#1)(2008-8#2)(2010-10#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
histidine-proline-rich glycoprotein##3##2##(1995-2#2)(1997-2#1)
histidine-proline-rich##4##1##(1995-2#2)(1997-2#2)
histidine-rich##2##1##(1990-5#1)(1997-2#1)
histidines##6##1##(1991-2#1)(1994-6#2)(1995-2#1)(1997-3#1)(2010-4#1)
histidyl residue##2##2##(1990-7#1)(1992-11#1)
histidyl residues##2##2##(1990-8#2)
histidyl##5##1##(1990-7#1)(1990-8#2)(1992-11#1)(1994-11#1)
histiocytes##5##1##(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#2)
histiocytic cells##2##2##(2011-1#1)(2012-12#1)
histiocytic##8##1##(1991-3#1)(1991-9#1)(1993-3#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
histiocytoma of##5##2##(1990-12#2)(2008-6#3)
histiocytoma##16##1##(1990-12#3)(1990-8#2)(2008-11#1)(2008-6#8)(2010-12#1)(2012-1#1)
histiocytosis X##2##2##(1993-12#2)
histiocytosis##14##1##(1993-12#2)(2006-10#1)(2007-10#2)(2007-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
histo-blood group##2##2##(1992-8#2)
histochemical and ultrastructural##2##3##(2007-12#1)(2009-7#1)
histochemical and##4##2##(2007-12#1)(2009-7#1)(2012-3#1)(2013-8#1)
histochemical assay##2##2##(1997-6#1)(2008-9#1)
histochemical changes##2##2##(2007-12#1)(2008-4#1)
histochemical investigations##2##2##(1990-2#1)(1996-12#1)
histochemical method##2##2##(2008-4#1)(2008-7#1)
histochemical staining for##2##3##(1997-3#2)
histochemical staining##6##2##(1992-1#1)(1993-12#1)(1996-5#1)(1997-3#2)(2008-9#1)
histochemical study of##2##3##(2008-7#1)(2011-2#1)
histochemical techniques##2##2##(2008-4#1)(2009-7#1)
histochemical##37##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1995-12#3)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#3)(1997-6#1)(2007-12#3)(2008-10#4)(2008-4#3)(2008-7#2)(2008-9#2)(2009-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
histochemically##2##1##(1990-7#1)(2008-10#1)
histochemistry and##4##2##(1990-7#1)(2008-11#2)(2013-8#1)
histochemistry of##2##2##(1996-12#1)(2008-4#1)
histochemistry was##2##2##(1992-12#1)(1994-11#1)
histochemistry##32##1##(1990-7#3)(1990-8#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#4)(1996-2#1)(1996-5#3)(1997-2#4)(1997-3#1)(1997-4#1)(2008-11#2)(2008-4#2)(2008-7#1)(2009-12#1)(2013-8#1)
histocompatibility and##2##2##(2008-1#1)(2012-3#1)
histocompatibility complex (MHC) class I and##2##6##(1995-12#1)(2008-7#1)
histocompatibility complex (MHC) class I##4##5##(1995-12#1)(1995-2#1)(2008-1#1)(2008-7#1)
histocompatibility complex (MHC)##9##3##(1990-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
histocompatibility complex##26##2##(1990-5#2)(1993-6#2)(1994-8#2)(1995-12#1)(1995-2#2)(1997-4#1)(1997-9#2)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
histocompatibility##48##1##(1990-11#1)(1990-12#2)(1990-5#2)(1991-5#1)(1993-6#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#1)(1997-4#1)(1997-9#3)(2007-12#1)(2008-1#3)(2008-10#1)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
histogenesis of##2##2##(2009-3#1)(2010-8#1)
histogenesis##3##1##(2006-12#1)(2009-3#1)(2010-8#1)
histogenetic##3##1##(2009-4#2)(2011-2#1)
histogram of##3##2##(2008-3#2)(2008-6#1)
histogram##21##1##(1992-1#1)(1995-8#1)(1995-9#1)(2007-10#1)(2008-1#1)(2008-3#3)(2008-6#9)(2008-9#2)(2010-8#1)(2013-8#1)
histograms and##3##2##(2008-2#1)(2008-6#1)(2008-8#1)
histograms of##7##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2011-2#1)
histograms##18##1##(1990-11#1)(1994-1#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-6#3)(2008-8#1)(2008-9#2)(2011-2#1)
histologic analysis##2##2##(1992-8#1)(2012-3#1)
histologic and immunohistochemical##2##3##(1994-6#1)(2009-3#1)
histologic and##10##2##(1990-3#1)(1991-12#1)(1994-6#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-3#1)
histologic changes##2##2##(1993-12#2)
histologic characteristics of##3##3##(2007-12#1)(2008-5#1)(2009-12#1)
histologic confirmation##2##2##(1991-12#1)(2011-1#1)
histologic criteria##2##2##(2011-2#2)
histologic diagnosis of benign##2##4##(1990-10#1)(1991-2#1)
histologic diagnosis of##4##3##(1990-10#1)(1991-2#1)(1995-3#1)(1996-2#1)
histologic diagnosis##9##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-8#1)(1995-3#1)(1996-2#1)(2007-11#1)
histologic evidence of##6##3##(1992-3#1)(1992-8#1)(1993-12#1)(1995-8#1)(2008-5#2)
histologic evidence##7##2##(1992-3#1)(1992-8#1)(1993-12#1)(1995-8#1)(2008-5#2)(2012-3#1)
histologic examination of##2##3##(1997-5#1)(2008-1#1)
histologic examination##8##2##(1990-6#1)(1991-6#1)(1993-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2010-6#1)
histologic features of##4##3##(1994-12#1)(2006-10#2)(2008-1#1)
histologic features##13##2##(1991-6#1)(1994-12#3)(2006-10#2)(2006-12#1)(2007-10#1)(2008-1#1)(2009-12#2)(2010-3#1)(2011-2#1)
histologic findings and##2##3##(2008-5#1)(2010-3#1)
histologic findings##7##2##(1991-12#1)(2006-12#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-6#1)
histologic grade of##2##3##(1990-12#1)(1997-7#1)
histologic grade##5##2##(1990-12#2)(1993-9#1)(1997-7#1)(2011-2#1)
histologic pattern##2##2##(1990-2#1)(2007-8#1)
histologic response of the primary tumor##2##6##(1992-6#2)
histologic response of the primary##3##5##(1992-6#3)
histologic response##6##2##(1990-12#2)(1992-6#3)(2010-3#1)
histologic specimens##2##2##(1994-12#1)(1997-8#1)
histologic subtypes##3##2##(1991-8#1)(2013-1#1)(2013-7#1)
histologic type##4##2##(1990-12#1)(1991-8#1)(1995-4#1)(2011-2#1)
histologic##127##1##(1990-10#1)(1990-12#5)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#1)(1991-12#4)(1991-2#4)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#6)(1993-12#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-6#1)(1995-3#1)(1995-4#2)(1995-8#1)(1996-2#1)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#2)(2006-12#3)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-5#6)(2008-7#2)(2008-9#3)(2009-1#1)(2009-12#3)(2009-3#2)(2010-11#1)(2010-3#4)(2010-6#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)
histological abnormalities in the##2##4##(1993-12#1)(1994-2#1)
histological analysis##6##2##(1996-6#1)(2008-5#2)(2010-7#1)(2013-1#1)(2013-7#1)
histological and electron##2##3##(2008-5#1)(2009-7#1)
histological and immunohistochemical analysis##3##4##(2008-7#1)(2013-8#2)
histological and immunohistochemical##6##3##(1990-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
histological and radiological##2##3##(2008-4#1)(2009-5#1)
histological and ultrastructural features of the##2##6##(2008-5#1)(2008-7#1)
histological and ultrastructural features of##3##5##(2008-5#2)(2008-7#1)
histological and ultrastructural##4##3##(2008-5#2)(2008-7#2)
histological and##30##2##(1990-12#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-2#1)(1997-5#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-9#2)(2011-2#2)(2012-2#2)(2013-8#4)
histological aspects##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
histological assessment##3##2##(1994-9#1)(2013-1#1)(2013-8#1)
histological changes in the##2##4##(2007-7#1)(2008-10#1)
histological changes of diabetic rats' skin and the effects on the percutaneous absorption of##2##14##(2011-3#2)
histological changes of##3##3##(2008-12#1)(2011-3#2)
histological changes##7##2##(2007-7#1)(2008-10#1)(2008-12#1)(2011-3#3)(2013-1#1)
histological classification##3##2##(2007-5#1)(2010-9#1)(2011-2#1)
histological confirmation##3##2##(1994-9#1)(2008-5#1)(2013-1#1)
histological criteria##2##2##(2008-10#1)(2011-2#1)
histological damage and##2##3##(2013-1#2)
histological damage##3##2##(2013-1#3)
histological data##3##2##(1990-6#1)(1992-3#1)(2007-12#1)
histological diagnoses##2##2##(1997-2#1)(2008-1#1)
histological diagnosis in##2##3##(2010-12#2)
histological diagnosis of renal##2##4##(2008-10#2)
histological diagnosis of##5##3##(2008-10#2)(2011-7#1)(2012-1#1)(2013-7#1)
histological diagnosis was##4##3##(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
histological diagnosis##22##2##(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-7#2)(2010-12#2)(2011-1#1)(2011-2#1)(2011-7#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
histological differentiation##3##2##(1991-6#1)(2008-9#1)(2011-2#1)
histological evaluation##3##2##(1991-8#1)(2008-11#1)(2008-2#1)
histological evidence of##3##3##(1991-2#1)(2008-4#1)(2008-5#1)
histological examination after##2##3##(2008-7#1)(2013-8#1)
histological examination of the##5##4##(1996-6#1)(2008-10#2)(2010-12#1)(2010-6#1)
histological examination of##7##3##(1992-2#1)(1996-6#1)(2007-8#1)(2008-10#2)(2010-12#1)(2010-6#1)
histological examination revealed##2##3##(2011-1#1)(2012-12#1)
histological examination##24##2##(1990-6#1)(1992-2#1)(1992-5#1)(1996-6#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#2)
histological features##10##2##(1991-11#1)(1991-8#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-3#1)
histological finding of##2##3##(2010-3#1)(2012-12#1)
histological finding##5##2##(1991-8#1)(2007-8#1)(2008-9#1)(2010-3#1)(2012-12#1)
histological findings and##2##3##(1994-9#1)(2008-10#1)
histological findings in##4##3##(1990-11#1)(1991-3#1)(2007-8#1)(2008-5#1)
histological findings of the discolored##2##5##(1995-11#2)
histological findings of##3##3##(1995-11#2)(2008-1#1)
histological findings##18##2##(1990-11#1)(1990-7#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#1)
histological grade##3##2##(1994-9#1)(2008-6#1)(2011-2#1)
histological grading of##2##3##(1996-9#1)(2011-3#1)
histological grading##6##2##(1994-10#1)(1996-9#1)(2011-3#1)(2013-8#3)
histological investigation##2##2##(1995-11#1)(2011-2#1)
histological lesions##2##2##(2008-5#2)
histological methods##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
histological parameters##2##2##(2008-6#1)(2011-2#1)
histological recurrence##2##2##(2008-8#2)
histological response##3##2##(2010-3#3)
histological sections of##4##3##(1992-9#1)(1994-11#1)(2008-1#1)(2011-2#1)
histological sections##17##2##(1991-6#1)(1992-9#1)(1994-11#1)(1996-12#6)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#4)(2013-1#1)
histological specimens##3##2##(1997-3#1)(2008-7#1)(2010-4#1)
histological studies##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
histological study of##2##3##(2007-5#1)(2011-2#1)
histological study##7##2##(2007-5#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
histological subtype##5##2##(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
histological subtypes of##2##3##(1997-3#1)(2013-1#1)
histological subtypes##3##2##(1997-3#2)(2013-1#1)
histological type and##3##3##(2006-8#1)(2008-2#1)(2011-2#1)
histological type of##2##3##(1993-11#1)(2008-1#1)
histological type##10##2##(1990-12#1)(1993-11#1)(1995-4#1)(2006-8#1)(2008-1#3)(2008-2#1)(2011-2#2)
histological types of##4##3##(1996-9#2)(2011-2#1)(2012-3#1)
histological types##7##2##(1996-9#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
histological##296##1##(1990-11#1)(1990-12#2)(1990-6#2)(1990-7#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#5)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-9#5)(1995-11#3)(1995-2#1)(1995-4#1)(1996-12#7)(1996-6#3)(1996-9#3)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#7)(2008-1#8)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#11)(2008-8#3)(2008-9#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#3)(2010-3#5)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#2)(2011-2#26)(2011-3#6)(2011-7#2)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#8)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#18)
histological)##2##1##(2011-2#1)(2012-3#1)
histologically and##3##2##(1990-12#1)(1995-12#1)(2013-1#1)
histologically benign##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
histologically confirmed##11##2##(1990-2#1)(1991-2#1)(1992-10#1)(1993-9#5)(1994-12#1)(1995-4#1)(2011-2#1)
histologically diagnosed in##2##3##(1990-2#1)(2008-5#1)
histologically diagnosed##4##2##(1990-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
histologically different tumours##2##3##(2012-3#2)
histologically different##3##2##(1993-12#1)(2012-3#2)
histologically examined##2##2##(1995-4#1)(2008-12#1)
histologically normal##2##2##(1994-2#1)(2008-7#1)
histologically proven mediastinal##2##3##(1990-8#1)(1997-8#1)
histologically proven##10##2##(1990-2#1)(1990-8#1)(1991-2#1)(1994-1#1)(1997-8#1)(2007-10#1)(2008-6#1)(2008-7#2)(2010-3#1)
histologically verified##4##2##(1992-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
histologically##84##1##(1990-12#1)(1990-2#3)(1990-8#2)(1990-9#1)(1991-2#3)(1991-9#1)(1992-10#2)(1993-12#2)(1993-6#1)(1993-9#5)(1994-1#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-4#3)(1997-3#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-8#3)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#7)(2009-1#1)(2010-10#1)(2010-12#1)(2010-3#4)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#4)
histologies##2##1##(2008-11#1)(2011-2#1)
histology and immunohistochemistry##2##3##(2007-12#1)(2011-2#1)
histology and##8##2##(1994-9#1)(1996-6#1)(2007-12#1)(2008-1#2)(2008-3#1)(2010-10#1)(2011-2#1)
histology in##2##2##(2007-8#1)(2008-1#1)
histology is##2##2##(1997-3#1)(2009-10#1)
histology of the##3##3##(1994-1#1)(1994-5#1)(2009-1#1)
histology of##12##2##(1994-1#1)(1994-5#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-1#1)(2009-12#1)(2013-1#1)(2013-7#1)
histology with##2##2##(2007-10#1)(2010-10#1)
histology##81##1##(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-6#1)(1992-8#2)(1994-1#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
histolytica and##2##2##(2009-10#2)
histolytica##14##1##(1991-7#1)(2007-12#1)(2009-10#3)(2009-7#2)(2009-8#5)(2012-3#2)
histolytica/E##2##1##(2009-10#2)
histomorphological##7##1##(1990-6#1)(1994-5#3)(1994-8#1)(2007-8#1)(2013-1#1)
histomorphometric##5##1##(1991-11#1)(2008-5#2)(2013-8#2)
histomorphometry##2##1##(2011-2#1)(2013-8#1)
histone H1##7##2##(1990-5#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-9#2)
histone H1(0) promoter##2##3##(1993-6#2)
histone H2AX##4##2##(2008-9#3)(2009-5#1)
histone H3 and##2##3##(1992-8#1)(2012-12#1)
histone H3 methylation##2##3##(2013-1#2)
histone H3##15##2##(1990-8#1)(1991-5#3)(1992-8#3)(1997-2#1)(2008-9#1)(2009-8#1)(2012-12#2)(2013-1#3)
histone deacetylase (HDAC) inhibitor##2##4##(2008-6#1)(2013-1#1)
histone deacetylase (HDAC)##3##3##(2008-6#1)(2010-6#1)(2013-1#1)
histone deacetylase inhibitors##2##3##(2011-2#1)(2012-2#1)
histone deacetylase to##2##3##(2011-2#2)
histone deacetylase##12##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
histone deacetylases##2##2##(2008-5#1)(2008-7#1)
histone deacetylation##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
histone degradation and##2##3##(1992-8#2)
histone degradation##4##2##(1992-8#4)
histone family##2##2##(2009-5#2)
histone gene##3##2##(1990-5#1)(1997-6#1)(2008-7#1)
histone homologue##3##2##(1993-9#3)
histone kinase##4##2##(1990-7#1)(1992-6#3)
histone methylation##3##2##(2009-3#1)(2012-2#1)(2013-1#1)
histone methyltransferase##2##2##(2009-3#1)(2010-11#1)
histone modifications##5##2##(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#2)
histone protein##2##2##(2011-2#1)(2011-9#1)
histone variants##2##2##(2008-7#2)
histone##100##1##(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-5#3)(1992-6#3)(1992-8#8)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#5)(1994-11#3)(1994-9#3)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#3)(2010-11#1)(2010-6#1)(2011-2#7)(2011-9#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
histones H2A##2##2##(1994-9#1)(2008-8#1)
histones and##3##2##(1994-9#3)
histones##15##1##(1990-2#1)(1992-8#2)(1994-9#5)(1995-2#2)(1996-12#1)(1996-6#1)(2008-4#1)(2008-8#1)(2013-1#1)
histopathologic analysis##2##2##(1997-7#1)(2008-10#1)
histopathologic assessment of##3##3##(2008-10#1)(2013-8#2)
histopathologic diagnosis##4##2##(1997-1#1)(2006-12#1)(2008-10#1)(2010-3#1)
histopathologic examination of the##2##4##(1996-3#1)(2007-10#1)
histopathologic examination of##3##3##(1996-3#1)(2007-10#1)(2008-10#1)
histopathologic examination revealed##3##3##(1990-10#1)(2010-6#1)(2011-1#1)
histopathologic examination##6##2##(1990-10#1)(1996-3#1)(2007-10#1)(2008-10#1)(2010-6#1)(2011-1#1)
histopathologic findings##7##2##(1995-3#1)(2006-10#2)(2007-10#1)(2010-6#2)(2012-12#1)
histopathologic study##4##2##(1995-3#1)(2008-5#2)(2010-6#1)
histopathologic##45##1##(1990-10#2)(1990-8#1)(1991-12#1)(1992-5#1)(1992-8#1)(1995-3#2)(1996-3#1)(1997-1#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-10#3)(2008-10#7)(2008-5#2)(2010-3#1)(2010-6#4)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
histopathological analysis of##2##3##(2008-10#1)(2008-7#1)
histopathological analysis##3##2##(2008-10#2)(2008-7#1)
histopathological and immunohistochemical##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
histopathological and##7##2##(2007-7#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
histopathological changes in##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
histopathological changes##8##2##(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#2)
histopathological classification##2##2##(1992-5#1)(2008-5#1)
histopathological confirmation##2##2##(2008-1#1)(2011-2#1)
histopathological diagnosis is##2##3##(2009-8#1)(2011-2#1)
histopathological diagnosis of##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
histopathological diagnosis was##3##3##(1997-8#2)(2009-5#1)
histopathological diagnosis##14##2##(1997-8#2)(2007-7#1)(2008-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)
histopathological evaluation of##2##3##(2011-2#1)(2012-3#1)
histopathological examination confirmed the diagnosis of##2##6##(2008-6#1)(2008-8#1)
histopathological examination of a##2##4##(2011-2#2)
histopathological examination of##3##3##(2011-2#2)(2013-7#1)
histopathological examination##16##2##(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
histopathological features of##2##3##(2008-1#1)(2011-2#1)
histopathological features##5##2##(2008-1#1)(2008-7#1)(2011-2#2)(2013-1#1)
histopathological findings of##2##3##(2008-6#1)(2008-7#1)
histopathological findings##19##2##(1996-12#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
histopathological grades##3##2##(2011-2#3)
histopathological grading##2##2##(1996-9#1)(2013-8#1)
histopathological lesions in##2##3##(1992-2#1)(2009-11#1)
histopathological lesions##4##2##(1992-2#1)(1997-6#1)(2008-5#1)(2009-11#1)
histopathological sections of##2##3##(1996-12#1)(2007-7#1)
histopathological sections##4##2##(1996-12#1)(2007-7#2)(2010-8#1)
histopathological study##6##2##(1991-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
histopathological type##2##2##(1997-8#1)(2008-1#1)
histopathological##135##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-9#3)(1997-6#1)(1997-8#4)(2007-12#2)(2007-7#10)(2007-8#4)(2008-1#5)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#2)(2009-11#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#24)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#3)
histopathologically and##2##2##(1994-12#1)(2008-5#1)
histopathologically as##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
histopathologically##20##1##(1991-12#1)(1991-8#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#2)
histopathology and##5##2##(2007-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
histopathology from##2##2##(2008-1#1)(2010-12#1)
histopathology in##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
histopathology of the##2##3##(2008-6#1)(2012-3#1)
histopathology of##5##2##(2008-10#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
histopathology showed##2##2##(2008-1#1)(2008-10#1)
histopathology study of##2##3##(2008-5#1)(2013-1#1)
histopathology study##3##2##(2008-5#2)(2013-1#1)
histopathology##47##1##(1994-7#2)(1995-5#1)(1997-8#1)(2007-10#4)(2007-12#1)(2007-7#4)(2008-1#3)(2008-10#4)(2008-4#1)(2008-5#5)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
histoplasmin##5##1##(2008-5#5)
histoplasmosis##10##1##(1990-9#1)(2006-10#2)(2007-7#2)(2008-1#3)(2008-5#2)
historians of##2##2##(2008-12#2)
historians##5##1##(2008-12#3)(2010-1#1)(2010-3#1)
historic##27##1##(1991-12#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-2#4)(2009-10#2)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
historical account##2##2##(2010-1#1)(2011-2#1)
historical and contemporary##2##3##(1996-1#1)(2007-8#1)
historical and evolutionary##3##3##(1994-12#1)(2009-5#2)
historical and theoretical##2##3##(1993-6#1)(2009-11#1)
historical and##16##2##(1993-6#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-5#2)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
historical approach##2##2##(2010-1#1)(2013-1#1)
historical context##4##2##(2008-9#1)(2009-6#1)(2013-1#2)
historical contexts##2##2##(1991-6#1)(1992-12#1)
historical controls##3##2##(1991-8#1)(2007-7#1)(2008-5#1)
historical data on##2##3##(2008-10#1)(2008-9#1)
historical data##7##2##(1993-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
historical demography of##2##3##(2010-8#2)
historical development##7##2##(1993-3#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
historical factors##2##2##(1992-1#1)(2008-3#1)
historical overview of spirituality in nursing##2##6##(2008-4#2)
historical overview of the##2##4##(2009-10#1)(2010-12#1)
historical overview of##5##3##(2008-4#2)(2009-10#1)(2010-1#1)(2010-12#1)
historical overview##8##2##(2008-4#2)(2009-10#1)(2010-1#1)(2010-12#1)(2011-2#3)
historical perspective and##2##3##(1991-12#1)(2008-11#1)
historical perspective on the##2##4##(1992-1#1)(2008-11#1)
historical perspective on##3##3##(1991-1#1)(1992-1#1)(2008-11#1)
historical processes that##2##3##(1991-3#1)(2012-3#1)
historical recombination##2##2##(2009-2#1)(2012-2#1)
historical review of##2##3##(2008-10#1)(2010-8#1)
historical review##7##2##(1990-10#1)(1994-5#1)(2008-10#2)(2009-10#1)(2010-8#1)(2011-2#1)
historical series##2##2##(2008-6#1)(2011-2#1)
historical sources##2##2##(2011-2#2)
historical study of##2##3##(2009-7#1)(2012-2#1)
historical study##3##2##(2008-1#1)(2009-7#1)(2012-2#1)
historical timeline##2##2##(2012-12#2)
historical weather##3##2##(2008-10#3)
historical##183##1##(1990-10#1)(1991-1#3)(1991-12#3)(1991-3#1)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#2)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#5)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#4)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#9)(2013-8#3)
historically been##3##2##(2006-10#1)(2008-9#1)(2012-12#1)
historically##29##1##(1990-8#1)(1992-2#2)(1994-12#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
histories and##4##2##(1991-8#1)(2008-1#1)(2008-11#1)(2009-2#1)
histories as##2##2##(1997-7#1)(2012-3#1)
histories for##2##2##(2008-3#1)(2011-2#1)
histories in##2##2##(1995-9#1)(1997-6#1)
histories of plant##2##3##(2008-8#1)(2012-3#1)
histories of the##3##3##(1996-11#1)(2012-2#1)(2012-3#1)
histories of##26##2##(1992-8#2)(1993-2#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
histories##80##1##(1991-1#1)(1991-12#3)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1995-11#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#2)
historiography##3##1##(2009-10#1)(2011-2#2)
history and clinical examination##2##4##(2008-12#1)(2009-12#1)
history and clinical##4##3##(2008-11#1)(2008-12#1)(2009-12#1)(2012-3#1)
history and examination##5##3##(2007-5#1)(2007-7#1)(2008-12#2)(2012-2#1)
history and its##3##3##(1990-3#1)(2008-1#1)(2010-3#1)
history and physical examination and##2##5##(2008-10#1)(2012-2#1)
history and physical examination are##2##5##(2010-1#1)(2013-8#1)
history and physical examination were##3##5##(2012-12#1)(2013-1#2)
history and physical examination##16##4##(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
history and physical##19##3##(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#3)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
history and the##8##3##(1995-5#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-6#1)(2012-12#1)
history and thorough##2##3##(1991-12#1)(2013-8#1)
history and with the##2##4##(2010-10#1)(2010-6#1)
history and##107##2##(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-12#2)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
history are##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
history as a##3##3##(1993-6#1)(2008-12#1)(2008-4#1)
history as well as##3##4##(2007-5#1)(2008-8#1)(2011-4#1)
history as##7##2##(1991-12#1)(1993-6#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-4#1)
history can##4##2##(1995-12#1)(2008-4#1)(2008-8#1)(2010-3#1)
history did not##2##3##(2010-3#1)(2013-8#1)
history documented##2##2##(2013-1#2)
history for##3##2##(2007-10#1)(2008-10#1)(2012-3#1)
history from##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
history in##8##2##(1992-5#1)(2008-3#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
history included##3##2##(1992-9#1)(2009-3#1)(2013-1#1)
history is not##3##3##(2009-4#1)(2010-5#1)(2011-7#1)
history is##10##2##(1992-2#1)(1993-2#1)(1996-3#1)(1996-7#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-5#1)(2011-7#1)(2012-2#1)
history of HIV##2##3##(1994-9#1)(2013-1#1)
history of OP pesticides exposure and clinical manifestations of a cholinergic syndrome is sufficient for management of the exposed patients##2##20##(2013-1#2)
history of P##2##3##(2008-10#1)(2009-2#1)
history of a##16##3##(1991-8#1)(1992-2#1)(1992-4#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#3)
history of abdominal##2##3##(2008-12#1)(2008-7#1)
history of adolescent##2##3##(2013-8#2)
history of alcoholism##3##3##(1991-1#1)(1994-2#2)
history of an##4##3##(1994-12#1)(1994-2#1)(2010-3#1)(2012-3#1)
history of animal##2##3##(2007-7#1)(2008-4#1)
history of ankle##2##3##(2007-11#1)(2013-1#1)
history of arterial hypertension##2##4##(2008-7#1)(2011-2#1)
history of arterial##3##3##(2008-7#1)(2011-2#2)
history of asbestos exposure##2##4##(1992-11#1)(2010-5#1)
history of asthma##2##3##(1995-6#1)(2010-6#1)
history of breast cancer##3##4##(1991-12#1)(1992-2#1)(1993-1#1)
history of breast##5##3##(1991-12#1)(1992-2#1)(1993-1#1)(1994-7#1)(2008-1#1)
history of bronchospasm##2##3##(1992-5#1)(1996-12#1)
history of cancer##3##3##(1995-9#1)(2008-12#1)(2011-2#1)
history of chile pepper cropping and##2##6##(2008-10#2)
history of chronic##5##3##(1992-10#1)(1994-6#1)(2009-8#1)(2012-1#1)(2012-2#1)
history of clinical##2##3##(1996-12#2)
history of coronary artery disease##3##5##(2008-3#2)(2013-8#1)
history of coronary##4##3##(2007-10#1)(2008-3#2)(2013-8#1)
history of depression##4##3##(2008-6#1)(2010-4#1)(2013-1#1)(2013-8#1)
history of development of##2##4##(2007-8#1)(2012-3#1)
history of diabetes and##2##4##(2008-3#1)(2012-3#1)
history of diabetes##5##3##(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
history of drug-induced##2##3##(2006-10#1)(2010-8#1)
history of epileptic##2##3##(2007-8#1)(2010-8#1)
history of exposure##2##3##(1994-2#1)(2007-2#1)
history of fever##2##3##(2008-10#1)(2012-3#1)
history of head##3##3##(2010-1#1)(2010-8#1)(2013-7#1)
history of headache##3##3##(1996-9#1)(2008-7#1)(2013-1#1)
history of hepatitis##2##3##(1996-11#1)(2010-10#1)
history of hypertension##8##3##(1994-12#1)(2007-8#1)(2008-1#1)(2008-7#3)(2010-4#2)
history of intermittent##4##3##(1993-9#1)(2011-2#2)(2012-2#1)
history of ischemic heart disease##2##5##(2008-8#1)(2010-8#1)
history of ischemic##4##3##(2007-10#2)(2008-8#1)(2010-8#1)
history of many##2##3##(2008-11#1)(2008-2#1)
history of medical##3##3##(2010-1#2)(2012-12#1)
history of medicine##5##3##(1993-11#1)(1993-6#1)(2008-9#1)(2010-6#1)(2011-2#1)
history of multiple##5##3##(1990-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2013-8#1)
history of myocardial infarction##2##4##(1996-8#1)(2008-7#1)
history of neonatal##3##3##(1996-12#1)(2007-7#1)(2008-11#1)
history of pancreatitis##2##3##(2013-1#2)
history of patients##3##3##(2011-2#3)
history of pregnancy##2##3##(2007-10#1)(2008-4#1)
history of previous##7##3##(1991-3#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
history of progressive##4##3##(1997-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
history of pulmonary##2##3##(2010-10#1)(2013-7#1)
history of recent##4##3##(1992-3#1)(1992-9#1)(1993-8#1)(2012-3#1)
history of recurrent##5##3##(2006-10#1)(2008-4#1)(2008-5#1)(2010-6#1)(2012-2#1)
history of research##2##3##(2009-10#1)(2012-12#1)
history of severe##2##3##(2008-5#1)(2012-2#1)
history of sexual abuse##2##4##(2009-9#1)(2012-1#1)
history of sexual##3##3##(2008-12#1)(2009-9#1)(2012-1#1)
history of slowly progressive##2##4##(2008-7#1)(2012-3#1)
history of smoking##3##3##(1992-3#1)(2007-7#1)(2008-12#1)
history of stroke or transient ischemic##2##6##(2007-10#1)(2007-7#1)
history of stroke##5##3##(1996-11#1)(2007-10#2)(2007-7#1)(2008-3#1)
history of the development of##4##5##(1996-12#1)(2008-9#1)(2010-5#1)(2010-8#1)
history of the disease##4##4##(1991-6#1)(1993-11#1)(2007-8#1)(2008-9#1)
history of the patient##2##4##(2008-12#1)(2010-6#1)
history of the species##3##4##(2008-5#1)(2012-3#1)(2012-5#1)
history of the##62##3##(1990-11#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2012-5#1)
history of this##5##3##(1990-12#1)(1991-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
history of trauma##5##3##(1990-9#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
history of tremor##2##3##(2008-7#2)
history of use in##2##4##(1997-1#1)(2008-5#1)
history of use##3##3##(1997-1#1)(2008-5#1)(2013-1#1)
history of vascular##2##3##(2010-4#2)
history of##592##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#4)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#6)(1994-2#7)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#7)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#4)(2007-10#11)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#13)(2007-8#11)(2008-1#17)(2008-10#24)(2008-11#25)(2008-12#16)(2008-2#4)(2008-3#9)(2008-4#11)(2008-5#10)(2008-6#9)(2008-7#26)(2008-8#10)(2008-9#8)(2009-10#4)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#5)(2010-10#6)(2010-11#1)(2010-12#2)(2010-3#7)(2010-4#5)(2010-5#2)(2010-6#13)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#7)(2011-2#43)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#12)(2012-2#15)(2012-3#30)(2012-5#1)(2012-8#1)(2013-1#41)(2013-7#4)(2013-8#17)
history on##4##2##(1990-6#1)(1994-2#1)(2007-12#1)(2008-7#1)
history or##7##2##(1996-9#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
history revealed##3##2##(2007-7#1)(2008-10#1)(2013-1#1)
history should be##2##3##(2007-7#1)(2011-2#1)
history showed##2##2##(2008-10#1)(2010-4#1)
history taking and##3##3##(1997-3#1)(2006-10#1)(2011-2#1)
history taking##5##2##(1995-5#1)(1997-3#1)(2006-10#1)(2007-10#1)(2011-2#1)
history that##4##2##(2008-6#2)(2008-9#1)(2011-2#1)
history to##5##2##(1997-8#1)(2007-12#1)(2007-5#1)(2008-8#1)(2011-2#1)
history was##11##2##(1992-11#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-7#1)(2010-4#1)(2010-6#1)(2012-5#1)(2013-1#1)
history were##3##2##(1997-4#1)(1997-5#1)(1997-8#1)
history which##2##2##(1991-3#1)(1995-5#1)
history with##3##2##(2009-6#1)(2010-4#1)(2010-6#1)
history##1032##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#4)(1990-6#4)(1990-8#1)(1990-9#4)(1991-1#7)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-12#10)(1994-2#10)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#10)(1996-6#6)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#8)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#6)(2006-10#5)(2006-5#1)(2007-10#14)(2007-11#10)(2007-12#14)(2007-2#5)(2007-4#1)(2007-5#4)(2007-7#21)(2007-8#14)(2008-1#23)(2008-10#52)(2008-11#38)(2008-12#28)(2008-2#8)(2008-3#18)(2008-4#18)(2008-5#15)(2008-6#17)(2008-7#43)(2008-8#37)(2008-9#21)(2009-1#1)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#3)(2009-9#7)(2010-1#9)(2010-10#8)(2010-11#1)(2010-12#5)(2010-3#16)(2010-4#10)(2010-5#7)(2010-6#19)(2010-7#4)(2010-8#15)(2010-9#4)(2011-1#12)(2011-2#67)(2011-3#1)(2011-4#1)(2011-7#2)(2012-1#6)(2012-12#21)(2012-2#33)(2012-3#36)(2012-5#2)(2012-8#1)(2013-1#62)(2013-7#5)(2013-8#31)
history)##3##1##(1995-1#1)(2008-10#1)(2008-8#1)
history]##2##1##(1990-2#1)(2008-10#1)
histotype##5##1##(1990-2#3)(1991-12#1)(1994-9#1)
histotypes##4##1##(1990-6#1)(1994-9#2)(2008-6#1)
hit by##2##2##(2008-3#1)(2013-1#1)
hit compounds##3##2##(2013-1#3)
hit the##2##2##(1992-5#1)(2011-2#1)
hit##22##1##(1991-3#1)(1992-5#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-8#1)(1996-3#1)(2008-3#2)(2008-6#2)(2011-2#3)(2013-1#7)
hit-miss transform##4##2##(2008-3#4)
hitherto neglected##2##2##(2010-10#1)(2010-2#1)
hitherto reported##2##2##(2008-1#1)(2008-7#1)
hitherto unknown##5##2##(1990-5#1)(1992-9#1)(2008-11#1)(2009-9#1)(2013-1#1)
hitherto unnoticed##2##2##(1991-3#1)(2008-7#1)
hitherto##40##1##(1990-11#2)(1990-5#1)(1990-8#1)(1991-3#1)(1992-9#1)(1995-2#1)(1995-6#3)(1997-3#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-7#1)(2013-1#2)
hits##8##1##(2008-3#1)(2009-11#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
hitting##3##1##(1997-6#1)(2010-11#1)(2011-2#1)
hive##3##1##(2008-10#3)
hives##9##1##(1996-3#1)(2008-10#1)(2008-5#7)
hlh-29##2##1##(2012-12#2)
hm2##3##1##(2012-3#3)
hmm##6##1##(2008-4#6)
hnRNP I/PTB##2##2##(1993-8#2)
hnRNP M4##3##2##(2008-8#3)
hnRNP##8##1##(1993-8#2)(2008-1#1)(2008-8#5)
hoarding in##2##2##(2008-10#1)(2008-9#1)
hoarding##7##1##(1993-6#1)(1994-3#1)(2008-10#2)(2008-9#3)
hoarseness and##2##2##(2007-8#1)(2008-11#1)
hoarseness in##2##2##(2010-7#1)(2011-2#1)
hoarseness of voice##2##3##(2009-7#1)(2012-2#1)
hoarseness##12##1##(1990-12#1)(2007-8#2)(2008-11#1)(2009-7#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
hoc##26##1##(1990-8#1)(1991-12#1)(1992-12#2)(1992-3#1)(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-9#1)(2012-12#2)(2012-2#1)
hock##3##1##(1997-3#3)
hockey##2##1##(2010-1#2)
hog liver flavin-containing monooxygenase##2##4##(1990-7#2)
hog##3##1##(1990-7#2)(2011-2#1)
hokouensis##5##1##(2010-3#5)
hold a great##2##3##(2008-11#1)(2011-2#1)
hold a##6##2##(2007-11#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
hold an##2##2##(1996-5#1)(1997-5#1)
hold for all##2##3##(1997-5#1)(2008-10#1)
hold for the##2##3##(1995-2#1)(2008-5#1)
hold for##7##2##(1990-8#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-5#1)
hold great promise for##4##4##(2008-10#2)(2012-12#1)(2012-2#1)
hold great promise##6##3##(2008-10#3)(2008-7#1)(2012-12#1)(2012-2#1)
hold more##2##2##(1996-3#1)(2008-7#1)
hold only##4##2##(1990-3#1)(1994-12#1)(2008-8#1)(2008-9#1)
hold promise for##6##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
hold promise##7##2##(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
hold the key##2##3##(2009-12#2)
hold the promise of##4##4##(2008-11#2)(2008-8#1)(2009-11#1)
hold the##11##2##(1996-2#1)(1997-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#2)
hold true##2##2##(2008-10#1)(2011-2#1)
hold##91##1##(1990-12#1)(1990-3#3)(1990-8#2)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#2)(2010-10#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
holder of##2##2##(2008-10#2)
holder to##2##2##(2008-2#1)(2010-5#1)
holder##11##1##(2007-8#3)(2008-10#5)(2008-2#2)(2010-5#1)
holders##4##1##(2007-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
holding beam##2##2##(2007-11#1)(2007-12#1)
holding beams##3##2##(2007-11#3)
holding chambers##2##2##(1996-2#1)(1997-1#1)
holding coil##9##2##(2008-10#9)
holding duration##2##2##(2013-8#2)
holding in##2##2##(1993-5#1)(2013-8#1)
holding of##2##2##(2008-10#1)(2009-5#1)
holding potential##4##2##(1995-12#2)(2008-8#2)
holding that##2##2##(1996-12#1)(1997-6#1)
holding the potential at +0##2##5##(2008-10#2)
holding the##6##2##(1993-11#1)(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
holding time##3##2##(2008-10#2)(2013-8#1)
holding##70##1##(1990-8#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#1)(1995-12#3)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-2#1)(2010-4#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#7)
holdings##4##1##(1995-3#1)(1996-3#1)(2011-1#1)(2011-2#1)
holds a##2##2##(2007-8#1)(2008-5#1)
holds for##5##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-3#2)
holds great promise for##5##4##(1997-1#1)(1997-4#1)(2008-10#1)(2008-9#1)(2013-1#1)
holds great promise in##2##4##(2010-6#1)(2011-2#1)
holds great promise##8##3##(1995-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
holds much##2##2##(1991-3#1)(1995-3#1)
holds out##2##2##(1991-11#1)(1994-3#1)
holds promise as a##2##4##(2007-11#1)(2008-5#1)
holds promise as##3##3##(2007-10#1)(2007-11#1)(2008-5#1)
holds promise for##4##3##(2008-1#1)(2008-10#2)(2012-2#1)
holds promise##9##2##(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
holds that##3##2##(1994-3#1)(2008-7#1)(2013-8#1)
holds the key to##2##4##(1994-1#1)(2010-4#1)
holds the##5##2##(1994-1#1)(1995-5#1)(2009-7#1)(2010-4#1)(2011-2#1)
holds true for##2##3##(1997-8#1)(2010-11#1)
holds##56##1##(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-8#1)(1994-1#1)(1994-3#2)(1995-3#2)(1995-5#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
hole and##2##2##(2009-7#1)(2011-2#1)
hole arrays##3##2##(2007-12#2)(2008-3#1)
hole burning in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
hole burning is##3##3##(2007-12#1)(2008-3#2)
hole burning on##2##3##(2007-11#1)(2008-3#1)
hole burning##22##2##(2007-11#5)(2007-12#8)(2008-2#1)(2008-3#8)
hole doping##2##2##(1990-12#1)(2008-10#1)
hole formation##2##2##(1992-5#1)(2013-1#1)
hole in the##5##3##(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
hole in##6##2##(1992-8#1)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
hole is##2##2##(2012-12#1)(2012-2#1)
hole was##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
hole##74##1##(1990-12#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-5#3)(1992-8#3)(1993-10#1)(1993-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#2)(2007-11#9)(2007-12#15)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-6#1)(2008-7#3)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)
hole-burning material##2##2##(2007-12#2)
hole-burning##9##1##(2007-11#2)(2007-12#4)(2008-3#3)
hole?##2##1##(1993-11#1)(1993-3#1)
holes and##2##2##(2007-11#1)(2008-3#1)
holes as##2##2##(1992-5#1)(2008-3#1)
holes can be##2##3##(2007-12#2)
holes in the##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
holes in##9##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
holes of##5##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#2)
holes on##2##2##(2007-12#1)(2008-2#1)
holes that##2##2##(2007-12#1)(2008-2#1)
holes to##2##2##(2007-11#2)
holes with##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
holes##67##1##(1992-5#2)(1992-8#1)(1995-6#1)(2006-4#1)(2007-11#15)(2007-12#10)(2008-10#3)(2008-2#6)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-11#1)(2009-4#1)(2011-2#2)(2013-8#1)
holey fiber (HF)##2##3##(2007-11#2)
holey fiber##7##2##(2007-11#3)(2007-12#4)
holey fibers##7##2##(2007-11#1)(2007-12#6)
holey optical##2##2##(2007-11#1)(2007-12#1)
holey##19##1##(2007-11#5)(2007-12#14)
holiday season##2##2##(2008-11#1)(2010-12#1)
holiday##9##1##(1995-12#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#2)
holistic and##3##2##(1997-3#1)(2008-10#1)(2012-12#1)
holistic care for##2##3##(2008-11#1)(2008-4#1)
holistic care##8##2##(2008-11#5)(2008-4#2)(2011-1#1)
holistic caring##2##2##(2008-11#2)
holistic healthcare##3##2##(2009-11#3)
holistic mode of cognition##2##4##(2009-8#2)
holistic view of##2##3##(1994-3#1)(2010-8#1)
holistic view##3##2##(1994-3#1)(2010-8#1)(2012-12#1)
holistic##45##1##(1991-2#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-6#2)(2008-1#2)(2008-10#2)(2008-11#11)(2008-12#3)(2008-4#2)(2008-7#1)(2009-11#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
hollow cube-corner retroreflector for a geosynchronous satellite##2##7##(2008-3#2)
hollow fiber bioreactor system##2##4##(2008-11#2)
hollow fiber bioreactor##5##3##(2008-11#5)
hollow fiber system##2##3##(2008-11#2)
hollow fiber##17##2##(2008-10#3)(2008-11#11)(2008-2#1)(2008-3#1)(2008-7#1)
hollow fiberbioreactor##2##2##(2008-11#2)
hollow fibers##5##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)
hollow fibre##2##2##(2008-11#2)
hollow glass waveguides##4##3##(2008-2#3)(2008-3#1)
hollow glass##6##2##(2008-2#4)(2008-3#2)
hollow taper##3##2##(2008-3#3)
hollow waveguide##13##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#1)(2008-7#1)
hollow waveguides for CO2##2##4##(2008-2#1)(2008-3#1)
hollow waveguides for##4##3##(2008-2#2)(2008-3#2)
hollow waveguides were##2##3##(2008-3#2)
hollow waveguides##14##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#6)
hollow##92##1##(1990-7#1)(1993-6#1)(1995-10#1)(2007-11#10)(2007-12#13)(2008-10#10)(2008-11#16)(2008-2#11)(2008-3#19)(2008-6#1)(2008-7#2)(2009-9#2)(2010-12#1)(2010-4#1)(2013-1#3)
hollow-core##3##1##(2007-11#1)(2007-12#1)(2012-3#1)
hollow-fiber##7##1##(1995-3#1)(2007-12#3)(2008-11#1)(2008-7#2)
hollow-glass##2##1##(2007-12#1)(2008-3#1)
hollow-taper-based coupling method##2##3##(2008-3#2)
hollowfiber bioreactor system##2##3##(2008-11#2)
holo human transferrin in##3##4##(2008-11#3)
holo human transferrin##5##3##(2008-11#5)
holo-CRBP##2##1##(1995-5#2)
holo-PKC epsilon##2##2##(1995-2#2)
holocycly to##3##2##(2008-9#3)
holoenzyme is a##2##3##(1994-12#1)(1994-3#1)
holoenzyme is##3##2##(1994-12#1)(1994-3#2)
holoenzyme##25##1##(1990-5#1)(1990-8#5)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-6#1)(1994-12#2)(1994-3#4)(1994-8#2)(1995-2#1)(2008-11#1)(2008-9#1)(2011-1#1)
holoepiphytes##2##1##(2008-5#2)
holoform##2##1##(1992-9#1)(2008-8#1)
hologram by##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
hologram formation##9##2##(2008-2#8)(2008-3#1)
hologram in a##2##3##(2008-3#2)
hologram in##4##2##(2008-2#1)(2008-3#3)
hologram is##9##2##(2007-12#2)(2008-1#1)(2008-3#6)
hologram multiplexing##3##2##(2007-12#2)(2008-3#1)
hologram of a##3##3##(2008-3#3)
hologram of the##2##3##(2007-11#1)(2008-3#1)
hologram of##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
hologram patterns##2##2##(2008-3#2)
hologram reconstruction##2##2##(2008-2#1)(2008-3#1)
hologram recording##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
hologram storage##2##2##(2007-12#2)
hologram with a##2##3##(2007-11#1)(2007-12#1)
hologram with##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
hologram##118##1##(2007-11#6)(2007-12#22)(2008-1#3)(2008-2#24)(2008-3#63)
holograms and##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
holograms are recorded in##2##4##(2007-12#1)(2008-3#1)
holograms are recorded##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
holograms are##15##2##(2007-12#5)(2008-2#2)(2008-3#8)
holograms based on##2##3##(2008-3#2)
holograms by##3##2##(2008-3#3)
holograms can be##2##3##(2008-2#1)(2008-3#1)
holograms for##3##2##(2007-11#2)(2008-3#1)
holograms in a##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
holograms in bacteriorhodopsin films##2##4##(2007-12#1)(2008-2#1)
holograms in the same##2##4##(2007-12#1)(2008-3#1)
holograms in##19##2##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#7)
holograms is##5##2##(2008-2#1)(2008-3#4)
holograms of equal##2##3##(2007-12#2)
holograms of##9##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
holograms recorded in##3##3##(2008-2#2)(2008-3#1)
holograms recorded with a##3##4##(2008-3#3)
holograms recorded with##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
holograms recorded##10##2##(2007-12#1)(2008-2#4)(2008-3#5)
holograms that are##2##3##(2007-11#1)(2008-3#1)
holograms to##4##2##(2007-12#1)(2008-3#3)
holograms were recorded##2##3##(2007-12#1)(2008-3#1)
holograms were##4##2##(2007-12#2)(2008-3#2)
holograms with a##3##3##(2007-11#1)(2008-3#2)
holograms with different##2##3##(2008-1#1)(2008-3#1)
holograms with##12##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#5)
holograms##154##1##(2007-11#11)(2007-12#37)(2008-1#1)(2008-2#33)(2008-3#72)
holographic Rowland##2##2##(2008-3#2)
holographic aerial##3##2##(2008-3#3)
holographic analogy##2##2##(2008-2#2)
holographic and##2##2##(2008-3#2)
holographic carrier##2##2##(2008-3#2)
holographic confocal##2##2##(2007-12#1)(2008-3#1)
holographic data storage##12##3##(2007-11#2)(2007-12#2)(2008-3#8)
holographic data##14##2##(2007-11#3)(2007-12#3)(2008-3#8)
holographic diffraction gratings##3##3##(2008-3#3)
holographic element##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
holographic grating is##2##3##(2007-11#1)(2008-3#1)
holographic grating##16##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#10)
holographic gratings are##2##3##(2008-2#1)(2008-3#1)
holographic gratings for##2##3##(2008-2#1)(2008-3#1)
holographic gratings in##4##3##(2007-12#1)(2008-3#3)
holographic gratings##22##2##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#13)
holographic images reconstructed by##2##4##(2008-3#2)
holographic images##9##2##(2007-11#1)(2007-12#1)(2008-3#7)
holographic imaging of phase errors##2##5##(2008-2#2)
holographic imaging##4##2##(2007-11#1)(2008-2#3)
holographic interferometry has##2##3##(2008-2#1)(2008-3#1)
holographic interferometry is##3##3##(2008-2#3)
holographic interferometry with##2##3##(2007-11#1)(2008-3#1)
holographic interferometry##20##2##(2007-11#1)(2008-2#12)(2008-3#7)
holographic lithography##3##2##(2007-11#1)(2008-3#2)
holographic material##2##2##(2007-12#1)(2008-2#1)
holographic memories##4##2##(2008-2#3)(2008-3#1)
holographic memory system that##2##4##(2007-12#1)(2008-3#1)
holographic memory system##8##3##(2007-12#2)(2008-2#1)(2008-3#5)
holographic memory##18##2##(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#8)
holographic method##2##2##(2007-11#1)(2008-2#1)
holographic microscopy##9##2##(2008-3#7)(2011-1#2)
holographic notch filters##2##3##(2008-3#2)
holographic optical element array##2##4##(2008-2#2)
holographic optical element##8##3##(2007-12#2)(2008-2#3)(2008-3#3)
holographic optical elements (HOE's)##3##4##(2008-2#2)(2008-3#1)
holographic optical elements##9##3##(2008-2#6)(2008-3#3)
holographic optical##20##2##(2007-11#1)(2007-12#3)(2008-2#10)(2008-3#6)
holographic plate##2##2##(2008-2#1)(2008-3#1)
holographic properties of##2##3##(2008-3#2)
holographic properties##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
holographic reconstruction##3##2##(2007-11#2)(2008-3#1)
holographic recording and##3##3##(2008-3#3)
holographic recording in##5##3##(2007-12#4)(2008-3#1)
holographic recording system##2##3##(2007-11#1)(2008-3#1)
holographic recording with##2##3##(2007-12#1)(2008-2#1)
holographic recording##27##2##(2007-11#3)(2007-12#11)(2008-2#5)(2008-3#8)
holographic reflector for reflective##2##4##(2008-3#2)
holographic reflector##4##2##(2008-3#4)
holographic screens##2##2##(2008-2#2)
holographic stamping##2##2##(2008-3#2)
holographic stereogram##2##2##(2008-2#1)(2008-3#1)
holographic storage in##2##3##(2007-12#1)(2008-3#1)
holographic storage systems##3##3##(2007-11#2)(2008-3#1)
holographic storage##11##2##(2007-11#2)(2007-12#5)(2008-3#4)
holographic switch##3##2##(2008-3#3)
holographic system##3##2##(2007-11#2)(2008-3#1)
holographic telescope##2##2##(2007-11#2)
holographic visualization of##2##3##(2007-11#2)
holographic wavelength-division multiplexers-demultiplexers##2##3##(2008-3#2)
holographic##298##1##(2007-11#36)(2007-12#40)(2008-2#65)(2008-3#154)(2011-1#3)
holographically formed polymer dispersed##2##4##(2007-11#2)
holographically in##5##2##(2007-12#1)(2008-3#4)
holographically recorded##2##2##(2008-3#2)
holographically##16##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#12)
holography and##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
holography for##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
holography in##2##2##(2008-2#1)(2008-3#1)
holography is used to##2##4##(2007-12#1)(2008-3#1)
holography is##9##2##(2007-12#3)(2008-2#1)(2008-3#5)
holography method##2##2##(2007-12#1)(2008-3#1)
holography on##2##2##(2007-12#1)(2008-3#1)
holography setup##2##2##(2008-3#2)
holography technique to##2##3##(2008-3#2)
holography with a##5##3##(2007-11#3)(2008-2#1)(2008-3#1)
holography with##11##2##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#5)
holography##111##1##(2007-11#14)(2007-12#22)(2008-2#14)(2008-3#61)
holometabolous insects##2##2##(2007-12#2)
holometabolous species##3##2##(2012-2#3)
holometabolous##5##1##(2007-12#2)(2012-2#3)
holoprosencephaly (HPE)##2##2##(2011-1#1)(2013-1#1)
holoprosencephaly##3##1##(2011-1#1)(2012-3#1)(2013-1#1)
holoprotein##3##1##(1993-8#3)
holothurian##2##1##(2008-5#1)(2008-6#1)
holotoxin##4##1##(1993-11#2)(1995-2#1)(2009-2#1)
holy basil oil##4##3##(2008-5#4)
holy basil##5##2##(2008-5#5)
holy##8##1##(1991-3#1)(2007-4#1)(2008-12#1)(2008-5#5)
homatropine methylbromide##3##2##(2008-10#3)
home IV therapy##3##3##(2012-2#3)
home and community##3##3##(1991-1#1)(1997-1#1)(2009-9#1)
home and community-based##3##3##(1993-1#1)(1994-2#1)(1996-2#1)
home and in##2##3##(2007-12#1)(2008-11#1)
home and##33##2##(1991-1#1)(1991-12#1)(1991-8#1)(1992-4#1)(1993-1#2)(1993-12#1)(1994-2#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-5#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
home appliances##2##2##(2008-12#1)(2008-7#1)
home as##2##2##(1993-3#1)(2007-12#1)
home birth##5##2##(2007-2#2)(2013-1#3)
home blood glucose monitoring##2##4##(2010-2#2)
home capital reimbursement##2##3##(1992-1#1)(1993-3#1)
home capital##3##2##(1992-1#2)(1993-3#1)
home care and hospice##3##4##(2011-2#3)
home care and##6##3##(1991-3#1)(1992-2#1)(1995-2#1)(2011-2#3)
home care for the##2##4##(1991-2#1)(1993-1#1)
home care for##3##3##(1991-2#1)(1993-1#1)(2009-3#1)
home care has##2##3##(1991-3#1)(2012-12#1)
home care in the##2##4##(1992-12#1)(2011-2#1)
home care in##4##3##(1991-12#1)(1992-12#1)(1993-2#1)(2011-2#1)
home care is an##2##4##(1991-2#1)(1996-3#1)
home care is##3##3##(1991-2#1)(1996-3#1)(2008-11#1)
home care managers##2##3##(1991-3#1)(2006-5#1)
home care nurse##2##3##(2011-2#1)(2013-8#1)
home care programs in##2##4##(1990-10#1)(1991-3#1)
home care quality##3##3##(1991-3#1)(1995-3#2)
home care service##2##3##(1991-12#1)(1993-3#1)
home care services##5##3##(1991-1#1)(1997-2#1)(2006-5#1)(2011-2#2)
home care##106##2##(1990-10#2)(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#7)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#4)(1994-2#1)(1994-8#1)(1995-2#5)(1995-3#12)(1995-5#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#4)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(2006-5#4)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#2)(2009-4#1)(2011-2#15)(2012-12#1)(2012-2#3)(2013-8#1)
home dialysis##3##2##(1994-1#1)(1995-12#2)
home environment##9##2##(1991-1#1)(1991-11#1)(1994-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2009-5#1)(2012-2#1)
home environments##2##2##(2009-10#1)(2010-8#1)
home exercise##3##2##(2007-12#1)(2011-2#2)
home for the##5##3##(1996-2#1)(2008-7#2)(2008-8#1)(2011-1#1)
home for##12##2##(1993-3#2)(1995-12#1)(1996-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
home health agencies##2##3##(1991-2#1)(1995-3#1)
home health agency##6##3##(1992-3#1)(1995-3#2)(1996-3#1)(1997-2#1)(2006-5#1)
home health benefit##2##3##(1995-3#2)
home health care for##2##4##(1995-1#1)(1995-3#1)
home health care in##3##4##(1991-2#1)(1995-3#2)
home health care is##3##4##(1991-12#1)(1993-1#1)(1993-12#1)
home health care program##2##4##(1996-12#1)(1997-2#1)
home health care##35##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-12#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#10)(1996-1#4)(1996-12#3)(1997-2#5)(1997-3#1)(2008-1#1)
home health services##7##3##(1994-2#1)(1995-3#6)
home health use##3##3##(1994-2#3)
home health users##3##3##(1994-2#1)(1995-3#2)
home health##79##2##(1991-12#2)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#4)(1994-2#8)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#33)(1996-1#4)(1996-12#3)(1996-3#1)(1997-2#8)(1997-3#1)(1997-6#3)(2006-5#1)(2008-1#1)(2012-3#1)
home hemodialysis##3##2##(1995-12#1)(2010-5#2)
home in the##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-4#1)
home in##13##2##(1991-12#1)(1991-2#1)(1994-12#1)(1995-1#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-4#1)(2010-10#1)(2010-8#1)(2011-3#1)(2013-1#1)
home is the##2##3##(2007-12#1)(2010-10#1)
home is##8##2##(1991-1#1)(1993-1#1)(2007-12#2)(2007-8#1)(2009-3#1)(2010-10#1)(2012-2#1)
home made##6##2##(2008-10#5)(2008-11#1)
home mechanical ventilation##3##3##(1995-2#2)(2011-2#1)
home nursing##2##2##(2010-7#2)
home on the##2##3##(1993-1#1)(2008-12#1)
home or##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
home ownership##2##2##(2008-1#2)
home oxygen in Bogota##2##4##(2012-12#2)
home oxygen therapy##2##3##(2008-1#1)(2013-1#1)
home oxygen##6##2##(2008-1#1)(2012-12#4)(2013-1#1)
home peritoneal dialysis##2##3##(2007-12#1)(2011-2#1)
home program##3##2##(1994-12#2)(2008-12#1)
home quality##7##2##(1992-2#1)(1996-2#2)(1997-1#1)(2008-11#3)
home range area##3##3##(2008-8#3)
home range overlap##2##3##(2008-8#1)(2010-4#1)
home range size##2##3##(2008-8#2)
home range##12##2##(2008-8#6)(2010-4#4)(2010-8#2)
home ranges than##2##3##(2008-8#2)
home ranges##11##2##(2008-8#5)(2008-9#2)(2010-4#4)
home residents##12##2##(1991-3#1)(1993-3#1)(1993-8#1)(1995-2#2)(1996-2#1)(2008-1#2)(2009-2#1)(2010-10#3)
home setting##6##2##(2009-10#1)(2009-11#1)(2009-3#1)(2012-12#1)(2012-2#2)
home support##6##2##(1992-5#1)(1994-2#1)(1997-4#4)
home test kit##2##3##(1996-5#2)
home test##3##2##(1996-5#3)
home testing##3##2##(1996-5#3)
home to##5##2##(1994-3#1)(1995-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
home treatment##2##2##(1991-12#1)(2010-5#1)
home visit##3##2##(1994-12#1)(1995-3#1)(2010-5#1)
home visiting nursing##2##3##(1993-12#2)
home visitors##5##2##(1992-2#4)(2010-9#1)
home visitors' and nurses'##2##4##(1992-2#2)
home visits##4##2##(1997-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
home were##3##2##(1995-3#1)(2011-2#1)(2012-2#1)
home with##6##2##(1992-2#1)(1992-3#1)(1995-3#1)(2010-5#1)(2010-7#1)(2012-12#1)
home##642##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-5#7)(1990-8#1)(1991-1#12)(1991-11#1)(1991-12#13)(1991-2#9)(1991-3#12)(1991-8#3)(1991-9#1)(1992-1#6)(1992-12#2)(1992-2#11)(1992-3#15)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#10)(1993-11#1)(1993-12#12)(1993-2#3)(1993-3#12)(1993-8#1)(1994-1#1)(1994-12#9)(1994-2#24)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#4)(1995-12#9)(1995-2#20)(1995-3#51)(1995-5#4)(1995-8#2)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#4)(1996-2#9)(1996-3#5)(1996-5#7)(1997-1#4)(1997-2#16)(1997-3#11)(1997-4#6)(1997-5#5)(1997-6#5)(1997-7#2)(1997-8#1)(2006-5#5)(2007-10#4)(2007-11#2)(2007-12#18)(2007-2#2)(2007-7#1)(2007-8#6)(2008-1#9)(2008-10#9)(2008-11#18)(2008-12#13)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#16)(2008-9#11)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#14)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#8)(2010-5#6)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#3)(2011-2#42)(2011-3#1)(2012-12#10)(2012-2#17)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#4)
home-based##10##1##(1992-12#1)(1995-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#2)(2010-8#1)(2012-12#1)
home-care services##2##2##(2008-5#2)
home-care##3##1##(2008-5#2)(2010-7#1)
home-made cell##2##2##(2008-10#2)
home-made##20##1##(1991-9#2)(2007-12#1)(2008-10#15)(2008-7#2)
home-produced eggs##2##2##(2008-10#2)
homebound elderly##7##2##(1994-1#4)(1995-12#1)(1996-12#1)(1997-2#1)
homebound##10##1##(1992-2#1)(1994-1#4)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)
homeless African American male youth##3##5##(2009-5#3)
homeless African American##4##3##(2009-5#4)
homeless drug##2##2##(2008-4#1)(2009-10#1)
homeless mothers'##2##2##(2012-3#2)
homeless people##2##2##(2012-12#2)
homeless shelter##2##2##(2008-10#1)(2012-3#1)
homeless##24##1##(1992-2#1)(1996-3#1)(2008-10#1)(2008-4#3)(2008-6#2)(2009-10#1)(2009-5#4)(2012-12#3)(2012-3#5)(2013-1#1)(2013-8#2)
homelessness##8##1##(1996-11#1)(1997-3#1)(2009-11#1)(2009-7#2)(2010-6#1)(2013-1#2)
homemade##8##1##(2008-1#1)(2008-10#4)(2008-3#1)(2012-3#2)
homemaker##2##1##(1996-5#1)(2007-10#1)
homeobox gene##3##2##(1993-2#1)(2007-12#1)(2008-8#1)
homeobox##7##1##(1993-2#1)(1994-9#1)(2007-12#1)(2008-8#3)(2013-1#1)
homeobox-containing##5##1##(1992-3#1)(1994-11#2)(2008-8#2)
homeodomain transcription factor##2##3##(2008-9#1)(2012-3#1)
homeodomain transcription factors##2##3##(2008-9#1)(2012-12#1)
homeodomain transcription##4##2##(2008-9#2)(2012-12#1)(2012-3#1)
homeodomain##12##1##(1992-6#1)(1995-5#3)(1995-6#4)(2008-9#2)(2012-12#1)(2012-3#1)
homeodomains##2##1##(1995-5#2)
homeologous recombination between##2##3##(1996-6#1)(1997-4#1)
homeologous recombination##3##2##(1996-6#2)(1997-4#1)
homeologous##6##1##(1996-6#4)(1997-4#1)(2010-3#1)
homeopathic combination preparation##2##3##(2008-10#2)
homeopathic pathogenetic experimentation##3##3##(2008-10#3)
homeopathic products (&quot##2##3##(2008-10#2)
homeopathic remedies##4##2##(2008-10#4)
homeopathic treatment##2##2##(2008-10#2)
homeopathic##24##1##(1994-2#1)(2008-10#23)
homeopathy##10##1##(1994-2#2)(1997-6#2)(2008-10#4)(2010-3#1)(2011-2#1)
homeostasis and in##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
homeostasis and##27##2##(1994-12#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-9#1)(2012-2#4)(2013-1#1)(2013-8#2)
homeostasis as##3##2##(2008-7#1)(2010-1#1)(2013-8#1)
homeostasis but##2##2##(2009-9#1)(2011-2#1)
homeostasis by##3##2##(2008-4#2)(2013-1#1)
homeostasis can be##3##3##(2008-5#1)(2012-2#2)
homeostasis due to the##2##4##(2008-1#1)(2013-1#1)
homeostasis in the##3##3##(1996-9#1)(2009-3#1)(2013-1#1)
homeostasis in##13##2##(1993-8#1)(1995-3#1)(1996-9#1)(1997-2#1)(2007-5#1)(2008-3#1)(2009-3#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
homeostasis is not##2##3##(1990-11#1)(1994-11#1)
homeostasis is##5##2##(1990-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(2008-3#1)
homeostasis model assessment (HOMA)##2##4##(2008-3#1)(2012-5#1)
homeostasis model assessment for insulin resistance (HOMA-IR)##3##7##(2011-1#2)(2013-8#1)
homeostasis model assessment##6##3##(2008-3#1)(2011-1#3)(2012-5#1)(2013-8#1)
homeostasis model##7##2##(2008-3#2)(2011-1#3)(2012-5#1)(2013-8#1)
homeostasis of the##4##3##(2008-12#1)(2009-10#1)(2013-1#1)(2013-8#1)
homeostasis of##11##2##(1992-5#1)(1994-12#1)(1995-12#2)(2008-12#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
homeostasis provides##2##2##(2012-2#1)(2013-1#1)
homeostasis system##4##2##(2011-2#1)(2013-1#3)
homeostasis through##2##2##(2008-10#2)
homeostasis under##2##2##(2008-1#1)(2008-11#1)
homeostasis will##2##2##(2008-1#1)(2008-10#1)
homeostasis##198##1##(1990-11#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#3)(1995-3#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-1#9)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#10)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#2)(2009-9#8)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2011-9#1)(2012-12#1)(2012-2#22)(2012-3#2)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#6)
homeostatic and##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
homeostatic confocal microscopy##2##3##(2008-11#2)
homeostatic mechanisms##4##2##(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#1)
homeostatic system##2##2##(1990-9#1)(2010-11#1)
homeostatic##22##1##(1990-12#1)(1990-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-11#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
homeotic gene##2##2##(2008-8#2)
homeotic genes##3##2##(1995-11#1)(2008-8#1)(2008-9#1)
homeotic##8##1##(1995-11#2)(2008-8#5)(2008-9#1)
homeotropically aligned##3##2##(2007-12#2)(2008-3#1)
homeotropically##4##1##(2007-12#2)(2008-3#2)
homeownership##7##1##(2011-2#7)
homes and communities##2##3##(2012-2#2)
homes and##12##2##(1991-1#1)(1991-3#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-11#2)(2009-9#1)(2012-2#2)(2013-1#1)
homes for##4##2##(1992-3#1)(1993-3#2)(1994-12#1)
homes in the##2##3##(1992-3#1)(1995-3#1)
homes in##12##2##(1992-3#1)(1995-3#1)(1996-3#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#4)(2010-11#1)(2011-2#1)
homes or##3##2##(1995-1#1)(1996-1#2)
homes to##3##2##(1997-1#1)(1997-3#1)(2012-12#1)
homes##109##1##(1990-12#2)(1990-4#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-8#2)(1992-3#10)(1993-11#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-8#1)(1995-1#2)(1995-2#8)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-3#2)(2009-7#1)(2009-9#1)(2010-10#13)(2010-11#2)(2010-8#1)(2011-2#3)(2012-12#5)(2012-2#4)(2013-1#4)
homes)##2##1##(1993-12#1)(2010-5#1)
homes]##2##1##(1994-9#1)(1996-6#1)
homicidal##2##1##(1995-11#1)(2011-1#1)
homicide rates##4##2##(2008-12#4)
homicide##20##1##(1992-2#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-12#5)(2008-9#1)(2011-2#9)(2012-2#1)
homicides were##2##2##(1995-3#2)
homicides##11##1##(1991-6#3)(1995-3#3)(2012-2#5)
homing pigeons##2##2##(1990-11#2)
homing##9##1##(1990-11#4)(2008-10#1)(2010-1#1)(2012-2#2)(2013-1#1)
hominid##4##1##(1994-3#3)(2008-1#1)
hominis##8##1##(1997-3#3)(2007-12#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
hominivorax##3##1##(2008-6#3)
hominoid##5##1##(1997-6#1)(2011-2#4)
hominoids##3##1##(1995-11#2)(2011-2#1)
homo##3##1##(2008-10#2)(2008-9#1)
homo- and##7##2##(1990-5#1)(1992-12#1)(1993-11#1)(1995-11#2)(2008-10#1)(2010-5#1)
homo- or##3##2##(1996-2#1)(2008-11#1)(2011-1#1)
homo-##10##1##(1990-5#1)(1992-12#1)(1993-11#1)(1995-11#2)(1996-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
homo-sexual transfer##2##2##(2008-11#2)
homoallylic alcohols##3##2##(2007-11#1)(2009-6#2)
homoallylic##4##1##(1996-5#1)(2007-11#1)(2009-6#2)
homobasidiomycetes##2##1##(2011-1#2)
homocentric diverging beams##2##3##(2008-3#2)
homocyst(e)ine levels##2##2##(1995-2#2)
homocyst(e)ine##5##1##(1995-2#5)
homocysteate##2##1##(1995-12#2)
homocysteine and##5##2##(2007-10#1)(2008-10#1)(2008-3#2)(2010-1#1)
homocysteine are##2##2##(1991-12#1)(1992-9#1)
homocysteine as##2##2##(2008-11#1)(2008-3#1)
homocysteine concentration##2##2##(1996-11#1)(2008-3#1)
homocysteine concentrations higher than 15 micromol/l were associated with##2##9##(2008-7#2)
homocysteine concentrations##7##2##(2008-3#3)(2008-7#3)(2012-3#1)
homocysteine in plasma##3##3##(1992-9#3)
homocysteine in##7##2##(1992-9#3)(2008-10#3)(2008-7#1)
homocysteine is##5##2##(1991-12#1)(1992-9#2)(2008-3#1)(2008-8#1)
homocysteine level##4##2##(1992-9#1)(2007-10#1)(2008-11#1)(2008-3#1)
homocysteine levels##8##2##(1992-9#2)(2007-9#1)(2008-11#3)(2008-3#2)
homocysteine metabolism and##3##3##(2008-3#3)
homocysteine metabolism##8##2##(2007-12#1)(2008-3#7)
homocysteine methyltransferase##3##2##(1991-12#3)
homocysteine remains##2##2##(1992-9#1)(2008-3#1)
homocysteine testing##4##2##(2007-10#4)
homocysteine will##2##2##(1992-9#1)(2008-8#1)
homocysteine##100##1##(1991-12#7)(1991-9#1)(1992-9#14)(1996-11#1)(2007-10#7)(2007-12#1)(2007-9#1)(2008-10#17)(2008-11#5)(2008-3#27)(2008-7#5)(2008-8#6)(2010-1#2)(2010-5#3)(2011-2#1)(2012-3#1)(2013-8#1)
homocystinuria##2##1##(1992-9#1)(2012-12#1)
homodimer formation##2##2##(1995-8#1)(2012-2#1)
homodimer in yeast##2##3##(2008-9#2)
homodimer of##2##2##(1995-6#1)(2008-9#1)
homodimer##15##1##(1990-7#1)(1990-8#2)(1993-11#2)(1994-8#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-9#4)(2012-2#2)
homodimeric##8##1##(1990-8#1)(1992-3#1)(1992-6#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-9#1)
homodimerization and##2##2##(2012-2#2)
homodimerization of##3##2##(1995-8#1)(2008-4#1)(2009-10#1)
homodimerization##6##1##(1995-8#1)(2008-4#1)(2009-10#1)(2012-2#3)
homodimers##7##1##(1990-12#1)(1992-3#1)(1994-5#1)(1995-2#2)(2007-11#1)(2009-10#1)
homodyne and heterodyne##3##3##(2007-12#3)
homodyne detection of ultrasonic surface displacements##2##6##(2007-11#2)
homodyne##11##1##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#1)
homoeocarpa##14##1##(2008-10#14)
homoeologous group##4##2##(2008-10#3)(2008-8#1)
homoeologous##6##1##(2008-10#3)(2008-5#2)(2008-8#1)
homoeopathic medicine##2##2##(1997-6#2)
homoeopathic##3##1##(1997-6#3)
homoeopathy##7##1##(1997-5#1)(1997-6#6)
homoeostasis##3##1##(1993-6#1)(2008-3#1)(2009-8#1)
homogalacturonan##3##1##(2008-10#3)
homogenate and##3##2##(1993-12#1)(2008-10#2)
homogenate in##2##2##(2008-10#1)(2013-7#1)
homogenate of##7##2##(1994-8#2)(2008-10#2)(2008-5#1)(2010-2#1)(2012-3#1)
homogenate was##4##2##(1992-12#1)(1997-4#1)(2008-10#1)(2010-4#1)
homogenate were##2##2##(2008-11#1)(2008-6#1)
homogenate with##2##2##(1990-12#1)(2011-2#1)
homogenate##45##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#3)(1991-2#2)(1992-12#1)(1993-12#1)(1994-6#1)(1994-8#2)(1996-2#1)(1997-2#1)(1997-4#2)(2007-6#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-7#1)
homogenates and soluble fractions##2##4##(1990-11#2)
homogenates and##4##2##(1990-11#3)(1992-6#1)
homogenates from##4##2##(1991-2#1)(1994-2#1)(1995-12#1)(1995-3#1)
homogenates of##9##2##(1991-12#1)(1991-5#1)(1992-11#1)(1993-6#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
homogenates were##2##2##(1993-8#1)(1994-8#1)
homogenates with##3##2##(1992-9#1)(1994-11#1)(2008-10#1)
homogenates##49##1##(1990-11#4)(1991-12#3)(1991-2#2)(1991-5#1)(1992-11#3)(1992-6#1)(1992-9#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#3)(1996-12#1)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#4)
homogeneity a##2##2##(1991-2#1)(1994-8#1)
homogeneity and##13##2##(1990-2#1)(1991-2#1)(1992-6#1)(1992-8#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)
homogeneity as judged by##3##4##(1990-10#1)(1990-11#1)(1991-2#1)
homogeneity by a single##2##4##(1990-8#1)(1993-6#1)
homogeneity by a##4##3##(1990-7#1)(1990-8#1)(1993-6#1)(2008-8#1)
homogeneity by##16##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#1)(1997-4#2)(2008-8#3)(2009-3#1)(2010-4#1)
homogeneity from human##3##3##(1990-12#1)(1990-5#1)(2008-8#1)
homogeneity from the cytosol of##2##5##(1991-12#1)(1996-5#1)
homogeneity from the##6##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1996-5#1)
homogeneity from##20##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-8#2)
homogeneity in the##2##3##(2010-2#1)(2011-2#1)
homogeneity in##6##2##(1994-12#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-3#1)
homogeneity is##3##2##(2007-10#1)(2008-5#1)(2008-9#1)
homogeneity of the##7##3##(2008-10#4)(2008-3#1)(2011-1#1)(2013-1#1)
homogeneity of##14##2##(1995-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2011-1#1)(2013-1#1)
homogeneity using##3##2##(1991-8#1)(1992-8#1)(2012-2#1)
homogeneity was##3##2##(1995-6#1)(2007-10#1)(2008-10#1)
homogeneity with##3##2##(1990-5#1)(1991-8#1)(1995-12#1)
homogeneity within##2##2##(2008-10#2)
homogeneity##133##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#5)(1990-7#3)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#4)(1991-5#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-6#4)(1992-8#4)(1993-11#3)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#5)(1994-9#1)(1995-12#3)(1995-2#5)(1995-6#3)(1996-5#1)(1997-2#2)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#1)(2007-10#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#7)(2008-9#1)(2009-3#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
homogeneous T1-SI identical to the SI of subcutaneous fat##3##9##(2012-2#3)
homogeneous and heterogeneous##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
homogeneous and inhomogeneous##2##3##(2008-3#2)
homogeneous and isointense to##2##4##(1997-8#1)(2012-2#1)
homogeneous and##18##2##(1990-5#1)(1995-12#1)(1997-8#1)(2007-12#3)(2008-10#4)(2008-3#4)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
homogeneous areas##2##2##(2008-3#2)
homogeneous as judged by##3##4##(1990-7#1)(1992-8#1)(1994-6#1)
homogeneous as##5##2##(1990-7#1)(1992-8#1)(1994-6#1)(1995-12#1)(2008-10#1)
homogeneous assay##2##2##(2008-4#2)
homogeneous background##2##2##(2007-11#1)(2007-12#1)
homogeneous by##2##2##(2008-6#1)(2008-7#1)
homogeneous catalytic##2##2##(2010-12#2)
homogeneous cell##2##2##(2007-12#1)(2011-2#1)
homogeneous format##2##2##(2008-10#2)
homogeneous group##4##2##(1996-12#1)(2008-10#3)
homogeneous groups of cases##2##4##(1992-12#1)(1993-12#1)
homogeneous groups of##3##3##(1992-12#1)(1993-12#1)(2010-12#1)
homogeneous histidase##2##2##(1994-5#2)
homogeneous immunoassay##2##2##(2008-10#2)
homogeneous in##3##2##(1996-7#1)(2009-9#1)(2010-3#1)
homogeneous layer##2##2##(2008-3#2)
homogeneous medium##2##2##(2008-2#1)(2008-3#1)
homogeneous mixture of##2##3##(2008-10#2)
homogeneous or##2##2##(1994-5#1)(2008-3#1)
homogeneous particles with##2##3##(2008-3#2)
homogeneous particles##3##2##(2008-3#3)
homogeneous pattern##3##2##(1991-11#1)(2008-10#1)(2008-5#1)
homogeneous phase##2##2##(2008-10#2)
homogeneous population of##3##3##(1995-2#1)(1996-12#1)(2009-8#1)
homogeneous population##7##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
homogeneous populations##3##2##(1997-5#1)(2008-8#1)(2012-3#1)
homogeneous porous##2##2##(2008-10#2)
homogeneous preparations##2##2##(1990-8#1)(1991-12#1)
homogeneous refractive##2##2##(2008-2#2)
homogeneous region##2##2##(2008-3#1)(2012-1#1)
homogeneous sample##2##2##(1996-7#1)(2008-4#1)
homogeneous scattering##3##2##(2007-11#1)(2008-3#2)
homogeneous series of##2##3##(1997-3#1)(2008-2#1)
homogeneous solution##6##2##(1995-2#1)(2008-10#1)(2008-5#3)(2008-7#1)
homogeneous spheres##2##2##(2008-2#1)(2008-3#1)
homogeneous spherical##2##2##(2008-2#2)
homogeneous strains of##2##3##(2012-3#2)
homogeneous ternary solvent system##2##4##(2008-10#2)
homogeneous time-resolved##2##2##(2008-10#1)(2011-1#1)
homogeneous with##2##2##(1995-12#1)(2008-10#1)
homogeneous##262##1##(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-5#4)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-12#2)(1996-4#3)(1996-7#2)(1997-3#1)(1997-5#2)(1997-8#1)(2007-11#3)(2007-12#11)(2008-1#2)(2008-10#59)(2008-11#1)(2008-2#22)(2008-3#46)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#6)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#1)
homogeneously distributed in##2##3##(1994-2#1)(2008-10#1)
homogeneously distributed##5##2##(1994-2#1)(2007-11#1)(2008-10#2)(2008-11#1)
homogeneously##14##1##(1990-12#1)(1990-5#1)(1994-2#2)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)
homogenisation##2##1##(2008-10#2)
homogenised##2##1##(2008-10#2)
homogenization of##2##2##(2008-10#1)(2008-2#1)
homogenization##12##1##(2008-1#2)(2008-10#3)(2008-2#2)(2008-7#3)(2011-3#1)(2013-1#1)
homogenized and##2##2##(1992-12#1)(2008-5#1)
homogenized tissue##4##2##(1994-8#1)(2008-10#2)(2008-4#1)
homogenized##26##1##(1991-5#1)(1992-12#1)(1994-8#2)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-4#1)(2008-5#1)(2009-7#4)(2013-8#1)
homogenizer##7##1##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)
homogenizers##4##1##(2008-2#2)(2008-3#2)
homogenizing##4##1##(2008-10#2)(2008-2#1)(2008-9#1)
homogenous and##2##2##(2007-12#1)(2008-10#1)
homogenous in##2##2##(2008-12#1)(2010-10#1)
homogenous##36##1##(1990-7#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
homogentisic acid##3##2##(2007-8#1)(2008-10#2)
homography##5##1##(2008-6#5)
homokaryons##2##1##(2008-10#2)
homolateral##2##1##(1991-5#1)(2007-10#1)
homoleptic##2##1##(1997-7#2)
homolog of human##2##3##(1993-12#1)(2008-9#1)
homolog of the Drosophila segment polarity gene##2##7##(1993-12#1)(1994-12#1)
homolog of the##8##3##(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(2008-10#1)(2008-5#1)
homolog of##18##2##(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#3)(1994-8#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-7#1)(2012-2#1)
homolog##47##1##(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#5)(1994-8#2)(1994-9#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-4#2)(2008-10#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-7#1)(2012-2#3)(2013-7#1)(2013-8#1)
homologated proteinogenic amino acids##2##4##(2006-12#2)
homologated##3##1##(2006-12#3)
homological##2##1##(2008-8#2)
homologies between##2##2##(2008-11#1)(2010-3#1)
homologies of##7##2##(1990-11#1)(1990-7#1)(1993-6#1)(1996-10#1)(1996-12#2)(2008-6#1)
homologies to the##2##3##(1991-9#1)(1993-6#1)
homologies to##3##2##(1991-9#1)(1993-6#1)(2008-10#1)
homologies were##2##2##(1995-2#1)(1997-2#1)
homologies with the##2##3##(1990-5#1)(1997-3#1)
homologies with##9##2##(1990-5#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-8#1)(1997-3#2)(2008-10#1)(2010-4#1)
homologies##29##1##(1990-11#1)(1990-5#2)(1990-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-8#1)(2010-3#1)(2010-4#1)
homologous DNA##4##2##(1992-2#1)(1992-6#2)(1993-9#1)
homologous DNA-pairing activities##2##3##(1995-2#2)
homologous amino acid##2##3##(1993-3#1)(1993-6#1)
homologous and heterologous##2##3##(1990-2#1)(1997-2#1)
homologous and##4##2##(1990-2#1)(1997-2#1)(2008-5#1)(2010-8#1)
homologous antigens##2##2##(2008-10#2)
homologous blood and blood products##2##5##(2007-9#2)
homologous blood##8##2##(1990-2#3)(1992-3#1)(1996-9#2)(2007-9#2)
homologous cDNA##2##2##(1995-8#1)(2009-10#1)
homologous chromosomes##2##2##(2008-12#1)(2011-2#1)
homologous fragments##2##2##(1992-2#1)(2008-10#1)
homologous gene##2##2##(2008-8#1)(2008-9#1)
homologous genes##5##2##(1997-7#1)(2007-12#1)(2008-7#1)(2008-9#2)
homologous halves##2##2##(1994-5#1)(2008-11#1)
homologous human##2##2##(1993-2#1)(2008-4#1)
homologous in##3##2##(1990-11#1)(1996-12#1)(2007-12#1)
homologous or heterologous##2##3##(1994-8#1)(2008-10#1)
homologous or##3##2##(1994-8#1)(2007-10#1)(2008-10#1)
homologous protein##4##2##(1994-5#1)(1995-9#1)(1997-7#1)(2013-8#1)
homologous proteins##5##2##(1992-8#1)(1994-5#1)(1997-6#1)(2008-7#2)
homologous recombination in embryonic stem cells##2##6##(1995-2#1)(2012-2#1)
homologous recombination in embryonic stem##3##5##(1995-11#1)(1995-2#1)(2012-2#1)
homologous recombination in##7##3##(1995-11#1)(1995-2#1)(2008-4#3)(2010-1#1)(2012-2#1)
homologous recombination using##2##3##(2008-10#1)(2008-6#1)
homologous recombination within##2##3##(2008-11#1)(2013-8#1)
homologous recombination##39##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-9#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-4#2)(2008-10#1)(2008-11#2)(2008-4#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
homologous region##2##2##(1990-11#1)(1990-5#1)
homologous regions in##2##3##(1992-12#1)(1997-6#1)
homologous regions##6##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-2#1)(1997-6#1)(2008-8#1)
homologous segments##2##2##(1990-5#1)(2007-8#1)
homologous sequence##5##2##(1995-8#1)(1996-6#1)(2008-4#1)(2008-9#1)(2011-1#1)
homologous sequences##9##2##(1991-9#1)(1993-2#1)(1993-8#1)(1995-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)
homologous series of##7##3##(1990-7#2)(1991-8#1)(1992-11#1)(1992-8#1)(2007-11#1)(2013-8#1)
homologous similarity##2##2##(2011-1#2)
homologous strain##2##2##(1997-3#1)(2008-12#1)
homologous to a region##2##4##(1995-6#1)(2008-10#1)
homologous to a##6##3##(1993-12#1)(1994-12#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-8#1)
homologous to known##4##3##(1991-6#1)(1994-12#1)(1997-8#1)(2008-10#1)
homologous to mammalian##3##3##(1990-5#1)(1996-6#1)(2008-11#1)
homologous to other known genes##3##5##(1996-12#2)(1996-6#1)
homologous to other known##4##4##(1993-11#1)(1996-12#2)(1996-6#1)
homologous to other##5##3##(1993-11#1)(1996-12#2)(1996-6#1)(1997-2#1)
homologous to previously characterized##2##4##(2008-10#1)(2013-1#1)
homologous to that of the##3##5##(1991-9#1)(1994-11#1)(2013-1#1)
homologous to that##7##3##(1991-7#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-8#1)(1995-6#1)(2013-1#1)
homologous to the corresponding##2##4##(1996-6#1)(2008-8#1)
homologous to the##30##3##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#3)(1994-9#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)
homologous to those of other##2##5##(1997-2#1)(2008-10#1)
homologous to those of##3##4##(1991-6#1)(1997-2#1)(2008-10#1)
homologous to those##5##3##(1990-12#1)(1990-5#1)(1991-6#1)(1997-2#1)(2008-10#1)
homologous to##101##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#4)(1991-7#3)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#7)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#2)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
homologous virus##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
homologous with the##2##3##(2008-4#1)(2010-3#1)
homologous with##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
homologous##329##1##(1990-11#6)(1990-12#5)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#10)(1990-7#3)(1990-8#1)(1991-12#4)(1991-2#2)(1991-6#6)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#3)(1993-6#5)(1993-8#2)(1993-9#4)(1994-11#2)(1994-12#7)(1994-2#1)(1994-5#6)(1994-6#3)(1994-8#8)(1994-9#2)(1995-11#4)(1995-2#7)(1995-5#1)(1995-6#10)(1995-8#5)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#6)(1996-9#3)(1997-2#5)(1997-3#4)(1997-4#5)(1997-6#3)(1997-7#6)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#9)(2007-8#1)(2007-9#2)(2008-10#25)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#16)(2009-10#2)(2009-5#3)(2009-6#3)(2010-1#1)(2010-3#2)(2010-8#1)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#4)
homologs from##2##2##(1991-12#1)(2010-3#1)
homologs in the##3##3##(2008-10#2)(2011-2#1)
homologs in##13##2##(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
homologs of the##2##3##(1991-12#1)(1994-12#1)
homologs of##8##2##(1991-12#1)(1994-12#2)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#1)(2012-3#1)
homologs to##3##2##(2008-7#1)(2008-9#2)
homologs were##4##2##(1994-12#1)(1997-4#1)(2008-10#1)(2010-10#1)
homologs##49##1##(1991-12#3)(1994-12#3)(1997-3#1)(1997-4#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#5)(2010-10#4)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
homologue for the human##2##4##(1997-7#1)(1997-9#1)
homologue in##2##2##(1995-2#1)(2008-8#1)
homologue is##2##2##(1993-8#1)(2008-7#1)
homologue of Drosophila##2##3##(1995-6#1)(1997-7#1)
homologue of the Drosophila##2##4##(1995-6#1)(1997-3#1)
homologue of the##10##3##(1991-9#1)(1992-12#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-3#2)(1997-7#1)(2007-12#1)
homologue of yeast##2##3##(1993-9#1)(1995-2#1)
homologue of##26##2##(1991-12#1)(1991-9#3)(1992-12#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-3#1)(1997-3#2)(1997-7#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)
homologue was##2##2##(1991-6#1)(1996-12#1)
homologue##70##1##(1990-7#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-9#3)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#6)(1994-12#3)(1995-2#3)(1995-6#7)(1995-8#2)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-3#3)(1997-7#5)(1997-9#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#1)
homologues and##5##2##(1993-2#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
homologues from##2##2##(1997-7#1)(2008-4#1)
homologues in##4##2##(1992-11#1)(1993-11#1)(1997-3#1)(2008-8#1)
homologues of the##7##3##(1993-6#1)(1993-8#1)(1997-3#2)(2006-12#1)(2007-12#1)(2008-7#1)
homologues of##16##2##(1992-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(2006-12#1)(2007-12#1)(2008-7#6)
homologues was##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
homologues##60##1##(1991-6#1)(1992-11#5)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-3#2)(1996-6#2)(1997-3#4)(1997-7#2)(2006-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#10)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
homology analysis##5##2##(1992-8#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-6#1)
homology and##4##2##(1993-2#1)(1993-6#2)(1994-8#1)
homology at the##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
homology at##4##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
homology between the##7##3##(1990-12#1)(1991-9#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
homology between##16##2##(1990-12#1)(1990-7#2)(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)
homology group##3##2##(2008-10#2)(2008-7#1)
homology in their##2##3##(1990-5#1)(2012-2#1)
homology in##7##2##(1990-5#1)(1991-12#1)(1994-11#1)(1995-3#1)(2008-4#2)(2012-2#1)
homology is##4##2##(1993-11#1)(1993-2#1)(2008-7#1)(2011-2#1)
homology model of the##2##4##(2008-4#1)(2008-8#1)
homology model##5##2##(2008-4#2)(2008-8#3)
homology modeling##6##2##(1994-5#1)(2008-4#2)(2008-8#2)(2012-2#1)
homology of the##4##3##(1997-6#1)(2008-9#2)(2011-2#1)
homology of##10##2##(1992-12#1)(1992-3#1)(1997-6#1)(2007-12#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)
homology search##7##2##(1995-12#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-5#2)
homology searches##2##2##(1996-2#1)(2010-11#1)
homology to a##5##3##(1990-5#1)(1991-12#1)(1997-3#1)(2008-10#1)(2008-8#1)
homology to each##2##3##(1993-12#1)(1993-3#1)
homology to known##3##3##(1995-11#1)(1995-12#1)(1995-9#1)
homology to mammalian##2##3##(1990-12#1)(1990-5#1)
homology to members of##2##4##(1994-12#1)(1995-6#1)
homology to other known proteins##2##5##(1993-6#1)(1997-2#1)
homology to other##7##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-6#2)(1996-3#1)(1997-2#1)
homology to proteins##2##3##(1995-8#1)(2008-6#1)
homology to that of##3##4##(1993-12#1)(1997-4#1)(1997-7#1)
homology to the antisense strand of the##2##7##(1992-8#2)
homology to the antisense##3##4##(1992-8#3)
homology to the##22##3##(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-8#1)(2008-10#2)(2008-7#1)(2008-8#2)
homology to yeast##3##3##(1994-6#2)(1996-6#1)
homology to##77##2##(1990-11#1)(1990-12#1)(1990-5#3)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#4)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#3)(2008-10#5)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)
homology was##3##2##(1993-6#1)(2008-9#2)
homology were identified##2##3##(1993-8#1)(1994-6#1)
homology with any##5##3##(1992-9#1)(1996-2#1)(1996-3#1)(2008-8#1)(2008-9#1)
homology with genes##3##3##(1997-6#1)(2008-10#1)(2008-9#1)
homology with human##3##3##(1993-12#1)(1993-6#2)
homology with known##3##3##(1993-9#1)(1997-3#1)(2008-9#1)
homology with other proteins##2##4##(1993-3#1)(1997-7#1)
homology with other##5##3##(1993-3#1)(1996-3#1)(1997-4#1)(1997-7#1)(2008-8#1)
homology with several##2##3##(1992-9#1)(1994-2#1)
homology with that of##4##4##(1990-11#1)(1993-6#1)(1996-10#1)(1997-4#1)
homology with the human##2##4##(1993-12#1)(1993-3#1)
homology with the rat and##2##5##(1993-8#1)(1997-2#1)
homology with the##24##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
homology with those of##3##4##(1990-11#1)(1990-2#1)(1992-12#1)
homology with those##4##3##(1990-11#1)(1990-2#1)(1992-12#1)(2008-9#1)
homology with##92##2##(1990-11#5)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#3)(1993-3#3)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#6)(1997-6#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-8#5)(2008-9#9)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
homology##311##1##(1990-11#6)(1990-12#4)(1990-2#2)(1990-5#6)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#9)(1992-9#2)(1993-11#6)(1993-12#11)(1993-2#4)(1993-3#4)(1993-6#10)(1993-8#5)(1993-9#3)(1994-11#4)(1994-12#5)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#9)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#10)(1995-8#5)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#9)(1997-6#3)(1997-7#5)(1997-8#3)(2007-12#1)(2008-10#26)(2008-11#3)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#21)(2008-9#18)(2009-10#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#1)
homology&quot##2##1##(2008-9#1)(2013-8#1)
homology) and the##2##3##(1991-12#2)
homology)##6##1##(1991-12#3)(1995-6#1)(1997-2#1)(2008-9#1)
homology-directed repair##2##2##(2013-1#2)
homomeric##3##1##(1990-8#1)(1995-11#2)
homonuclear and heteronuclear##2##3##(1992-4#1)(1993-11#1)
homonuclear##5##1##(1990-5#1)(1992-4#1)(1993-11#1)(1994-5#1)(2009-2#1)
homophobia and##2##2##(1995-12#1)(2008-12#1)
homophobia##6##1##(1995-12#1)(1996-11#1)(2008-12#4)
homoploid##3##1##(2009-2#1)(2010-6#2)
homopolymer##5##1##(2008-6#1)(2010-8#2)(2011-1#2)
homopolymers##7##1##(1994-8#1)(2009-10#2)(2010-5#1)(2010-8#1)(2013-1#2)
homopyrimidine##3##1##(1993-6#1)(1993-8#2)
homosalate##2##1##(2008-5#2)
homoscedastic##4##1##(1995-9#3)(2008-10#1)
homoscedasticity##2##1##(2008-10#2)
homoserine##3##1##(2008-10#1)(2008-9#2)
homosexual and bisexual men##6##4##(1991-11#1)(2013-7#5)
homosexual men##7##2##(1992-2#3)(1996-11#4)
homosexual transmission##2##2##(1992-9#1)(1993-6#1)
homosexual##21##1##(1990-3#1)(1991-11#1)(1992-2#4)(1992-9#1)(1993-6#1)(1996-11#4)(2007-12#1)(2008-5#2)(2011-2#1)(2013-7#5)
homosexuality##6##1##(1995-12#1)(2008-12#4)(2010-8#1)
homosexually##2##1##(1993-6#1)(1996-11#1)
homosexuals##14##1##(1990-2#2)(1990-9#3)(1993-1#3)(1993-6#1)(1995-12#2)(1996-11#1)(2008-5#2)
homosynaptic long-term potentiation##2##3##(2009-8#2)
homosynaptic##4##1##(1995-2#1)(2009-8#3)
homothallic##6##1##(2008-10#5)(2010-3#1)
homotropic##3##1##(1990-8#2)(1997-2#1)
homovanillic acid (HVA)##3##3##(1993-1#1)(1995-3#1)(2008-3#1)
homovanillic acid##6##2##(1993-1#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-3#1)
homozygosis##3##1##(2012-12#1)(2012-3#2)
homozygosity at##3##2##(2008-10#1)(2009-2#1)(2012-3#1)
homozygosity for the##2##3##(1994-11#1)(2008-9#1)
homozygosity##6##1##(1994-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-3#1)
homozygote class 1##2##3##(1990-2#2)
homozygote##9##1##(1990-2#2)(1997-8#2)(2008-1#3)(2008-9#1)(2010-4#1)
homozygotes and##3##2##(1994-12#1)(1995-2#1)(2007-7#1)
homozygotes for the##2##3##(1993-9#1)(1997-8#1)
homozygotes for##3##2##(1993-9#1)(1997-8#1)(2008-5#1)
homozygotes were##3##2##(1995-2#2)(2008-10#1)
homozygotes##15##1##(1992-8#2)(1993-9#1)(1994-12#1)(1995-2#3)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-1#2)
homozygotic familial hypercholesterolemia##3##3##(1991-11#3)
homozygous SCD##3##2##(2009-4#3)
homozygous at##2##2##(1997-7#1)(2011-1#1)
homozygous deletion at chromosome 2q33 in a small cell lung carcinoma##2##11##(1996-12#2)
homozygous deletion in##2##3##(1997-2#1)(2008-12#1)
homozygous deletion##8##2##(1996-12#3)(1997-2#1)(2008-12#3)(2011-1#1)
homozygous deletions##2##2##(1997-7#1)(2011-2#1)
homozygous for the recessive##2##4##(1990-5#2)
homozygous for the##14##3##(1990-5#2)(1994-11#1)(1995-12#2)(1995-2#2)(1996-5#1)(2008-10#4)(2012-3#2)
homozygous for##24##2##(1990-5#2)(1994-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-9#2)(2011-2#2)(2012-3#2)
homozygous genotype##2##2##(1997-7#1)(2008-9#1)
homozygous mutant##2##2##(1995-8#1)(2008-10#1)
homozygous or heterozygous##2##3##(1996-5#1)(2009-2#1)
homozygous or##3##2##(1996-5#1)(2008-4#1)(2009-2#1)
homozygous phenotype##2##2##(2008-6#2)
homozygous resistant##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
homozygous susceptible##2##2##(2008-10#2)
homozygous##103##1##(1990-5#2)(1990-8#1)(1991-8#1)(1992-8#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#1)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-5#3)(1997-2#1)(1997-7#4)(1997-8#1)(2007-7#1)(2008-10#20)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2011-1#5)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
homozygously deleted##2##2##(1997-2#2)
honest##5##1##(1993-12#1)(1995-5#2)(2008-7#1)(2008-9#1)
honesty in##3##2##(1995-5#1)(2008-1#1)(2008-9#1)
honesty##11##1##(1992-3#1)(1995-5#4)(1996-12#1)(2008-1#2)(2008-9#2)(2010-10#1)
honey and##4##2##(2008-10#3)(2008-6#1)
honey bee (Apis##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
honey bee##8##2##(2008-10#1)(2008-5#1)(2008-6#2)(2011-2#3)(2013-1#1)
honey bees##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
honey from##2##2##(2008-10#1)(2012-2#1)
honey samples from different##2##4##(2008-10#2)
honey samples using##2##3##(2008-10#2)
honey samples##13##2##(2008-10#13)
honey with##6##2##(2008-10#4)(2011-2#1)(2013-1#1)
honey##69##1##(2008-10#41)(2008-5#1)(2008-6#11)(2008-7#4)(2008-9#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#3)
honey)##3##1##(2008-10#1)(2008-5#1)(2012-1#1)
honeybee colonies##3##2##(2008-10#1)(2008-8#2)
honeybee##15##1##(1994-8#2)(2008-10#4)(2008-7#5)(2008-8#4)
honeybees##15##1##(1992-3#4)(2008-10#8)(2008-7#1)(2008-8#1)(2009-5#1)
honeycomb##7##1##(1994-2#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
honeycombing##2##1##(1997-3#1)(2006-10#1)
honeydew##5##1##(2008-10#4)(2011-2#1)
honeys formed a##2##3##(2008-10#2)
honeys from##2##2##(2008-10#1)(2011-2#1)
honeys were##3##2##(2008-10#2)(2011-2#1)
honeys##16##1##(2008-10#10)(2011-2#6)
honokiol and magnolol##5##3##(2008-10#5)
honokiol and##6##2##(2008-10#6)
honor of the##2##3##(2007-11#1)(2008-8#1)
honor of##6##2##(1993-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
honor##14##1##(1992-12#1)(1993-2#1)(1996-2#2)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2013-1#1)
honorary##2##1##(2007-5#1)(2008-9#1)
honored##3##1##(1996-12#1)(2007-5#1)(2008-6#1)
honors##9##1##(1992-3#1)(2008-10#8)
honour of##3##2##(1992-5#1)(2008-12#1)(2011-1#1)
honour##4##1##(1992-5#1)(2008-10#1)(2008-12#1)(2011-1#1)
hook effect##4##2##(2008-3#4)
hook##10##1##(1994-9#1)(2007-12#2)(2008-3#4)(2008-5#2)(2008-9#1)
hooked##5##1##(2008-10#2)(2008-12#1)(2008-5#2)
hooks of##2##2##(2011-2#1)(2012-2#1)
hooks##5##1##(2007-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
hookwire marking of peripheral##2##4##(2007-8#2)
hookwire##3##1##(2007-8#3)
hookworm##2##1##(2009-10#1)(2012-3#1)
hoop stress##2##2##(2009-7#2)
hop powdery mildew was##2##4##(2008-10#2)
hop powdery mildew##4##3##(2008-10#4)
hop##8##1##(2008-10#8)
hope and expectancy##4##3##(2008-11#4)
hope and wellbeing##2##3##(2010-10#2)
hope and##8##2##(1996-3#1)(2008-11#4)(2010-10#2)(2012-3#1)
hope for the##2##3##(2008-4#1)(2012-3#1)
hope for##8##2##(1995-2#1)(2007-9#1)(2008-12#1)(2008-4#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
hope in##4##2##(1997-5#1)(2010-10#2)(2012-3#1)
hope of##9##2##(1996-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-6#1)(2009-3#1)(2009-6#1)(2010-12#1)(2013-8#1)
hope or##2##2##(2008-7#1)(2008-9#1)
hope that it##2##3##(2008-12#1)(2013-8#1)
hope that the##4##3##(1990-2#1)(2007-3#1)(2010-3#1)(2013-8#1)
hope that this##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
hope that##23##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#2)
hope the##2##2##(1993-2#1)(2013-1#1)
hope to##8##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1996-2#1)(2007-10#1)(2008-7#1)(2013-8#1)
hope##85##1##(1990-2#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#10)(2008-12#5)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-10#7)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#5)
hoped that##27##2##(1991-1#1)(1992-9#1)(1994-2#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
hoped##37##1##(1991-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-2#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#3)
hopefully##19##1##(1991-1#1)(1991-12#1)(1992-8#1)(1993-2#1)(1996-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-7#1)
hopes and aspirations##2##3##(2008-6#2)
hopes and expectancies##3##3##(2008-11#3)
hopes and##8##2##(2008-11#4)(2008-6#2)(2011-2#1)(2013-1#1)
hopes of##5##2##(1992-2#1)(2007-12#1)(2008-9#1)(2011-2#2)
hopes to##3##2##(1990-11#2)(1994-1#1)
hopes##22##1##(1990-11#3)(1991-11#1)(1992-2#1)(1994-1#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-6#2)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
hoping##2##1##(1994-3#1)(1996-5#1)
hopping and##2##2##(2008-3#1)(2010-7#1)
hopping in##2##2##(1996-6#1)(2007-12#1)
hopping##21##1##(1991-3#1)(1992-12#2)(1996-6#1)(2007-12#5)(2008-10#2)(2008-2#2)(2008-3#5)(2009-11#2)(2010-7#1)
hops##2##1##(2007-12#1)(2010-12#1)
hordei (PSH)##2##2##(2008-10#2)
hordei DNA##2##2##(2008-10#2)
hordei and U##2##3##(2008-10#2)
hordei and##8##2##(2008-10#8)
hordei in##3##2##(2008-10#3)
hordei isolate VA90-34##2##3##(2008-10#2)
hordei races##2##2##(2008-10#2)
hordei##53##1##(2008-10#53)
hordei)##4##1##(2008-10#4)
hordei-murini##5##1##(2008-10#5)
horizon for##2##2##(2008-11#1)(2011-2#1)
horizon of the##2##3##(2008-10#1)(2012-2#1)
horizon of##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2010-8#1)(2012-2#2)
horizon##21##1##(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-9#2)(2009-5#1)(2009-8#3)(2010-8#1)(2011-2#1)(2012-2#4)
horizons for##3##2##(1996-2#1)(2008-11#1)(2008-9#1)
horizons of##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
horizons##11##1##(1993-2#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-3#1)
horizontal and vertical##5##3##(1996-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
horizontal and##10##2##(1996-1#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)
horizontal distance##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
horizontal distribution of##2##3##(2008-10#1)(2008-5#1)
horizontal edges##2##2##(2008-9#2)
horizontal gaze palsy and##2##4##(2007-10#2)
horizontal gene transfer##4##3##(1994-8#2)(2008-7#1)(2009-5#1)
horizontal gradients##2##2##(2008-3#1)(2008-8#1)
horizontal growth plate##3##3##(2007-11#3)
horizontal growth##4##2##(2007-11#3)(2008-10#1)
horizontal homogeneity##3##2##(2008-3#3)
horizontal inhomogeneity##2##2##(2008-2#2)
horizontal laser##2##2##(2008-3#2)
horizontal orientation##4##2##(2008-10#1)(2008-3#1)(2009-5#1)(2012-3#1)
horizontal position##2##2##(1993-1#1)(2008-5#1)
horizontal resistance to##2##3##(2008-8#1)(2009-6#1)
horizontal resistance##3##2##(2008-8#1)(2009-6#2)
horizontal resolution##2##2##(2008-3#1)(2013-1#1)
horizontal transfer of##3##3##(2008-10#2)(2009-6#1)
horizontal transfers##2##2##(2009-6#2)
horizontal transmission of##2##3##(2008-10#1)(2008-9#1)
horizontal transmission##5##2##(2008-10#1)(2008-9#2)(2012-3#2)
horizontal##146##1##(1990-11#1)(1990-7#1)(1991-5#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-3#2)(1994-8#2)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-10#3)(2007-11#7)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#3)(2008-2#11)(2008-3#34)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#6)(2008-9#9)(2009-10#1)(2009-5#2)(2009-6#5)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
horizontally and##2##2##(2008-10#2)
horizontally at##2##2##(2008-3#1)(2008-8#1)
horizontally homogeneous##2##2##(2008-2#1)(2008-3#1)
horizontally oriented##4##2##(2008-2#1)(2008-3#3)
horizontally##28##1##(1994-1#1)(1994-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#8)(2008-5#1)(2008-8#2)(2011-1#1)
hormesis and##2##2##(2008-7#2)
hormesis in##9##2##(2008-7#7)(2013-1#2)
hormesis is##3##2##(2008-7#3)
hormesis may be##2##3##(2008-7#2)
hormesis##44##1##(1996-6#2)(2008-12#1)(2008-7#38)(2013-1#3)
hormetic effect##2##2##(2008-7#2)
hormetic effects of##3##3##(2008-7#3)
hormetic effects##6##2##(2008-7#6)
hormetic response##2##2##(2008-7#2)
hormetic##26##1##(2008-12#1)(2008-7#25)
hormonal activity##3##2##(1995-12#1)(2008-1#1)(2012-1#1)
hormonal adjuvant therapy##2##3##(2010-7#2)
hormonal and metabolic##3##3##(1991-2#1)(2008-3#1)(2013-7#1)
hormonal and##10##2##(1990-6#1)(1991-2#1)(1995-11#1)(2008-10#2)(2008-3#2)(2009-5#2)(2013-7#1)
hormonal approach##2##2##(2007-8#1)(2008-3#1)
hormonal changes##5##2##(1990-9#1)(1991-3#1)(1993-12#1)(2008-11#1)(2008-5#1)
hormonal control of##2##3##(1991-12#1)(2008-8#1)
hormonal disturbances and##2##3##(1990-9#1)(2012-1#1)
hormonal effects on##2##3##(1990-12#1)(2008-11#1)
hormonal effects##4##2##(1990-12#1)(1991-3#1)(1995-11#1)(2008-11#1)
hormonal factors##2##2##(1992-11#1)(2013-1#1)
hormonal influences##2##2##(2008-10#1)(2008-5#1)
hormonal milieu##3##2##(2008-11#2)(2008-7#1)
hormonal or##2##2##(1994-3#1)(2008-6#1)
hormonal regulation of the##2##4##(1991-5#1)(2008-8#1)
hormonal regulation of##7##3##(1991-5#2)(1995-11#2)(1996-5#1)(2008-4#1)(2008-8#1)
hormonal regulation##10##2##(1991-5#2)(1992-3#1)(1995-11#3)(1996-5#1)(2008-4#1)(2008-7#1)(2008-8#1)
hormonal response##2##2##(2008-7#1)(2013-1#1)
hormonal responses of##2##3##(1994-12#1)(2008-3#1)
hormonal responses##7##2##(1991-8#1)(1994-12#2)(2008-3#2)(2008-4#1)(2013-1#1)
hormonal secretions##2##2##(1991-6#1)(2012-2#1)
hormonal status##2##2##(1994-5#1)(2012-2#1)
hormonal stimulation##2##2##(1992-12#1)(2009-2#1)
hormonal stimuli##3##2##(1990-2#1)(2008-2#1)(2008-4#1)
hormonal systems##2##2##(2008-3#2)
hormonal target##2##2##(1997-4#2)
hormonal therapy in##2##3##(2013-1#2)
hormonal therapy##6##2##(1992-2#1)(2007-10#1)(2013-1#4)
hormonal treatment##8##2##(1991-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-5#1)(2008-10#1)(2008-6#1)(2013-1#1)
hormonal##143##1##(1990-12#1)(1990-2#2)(1990-6#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#7)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-2#2)(2009-5#2)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#5)
hormonally active##4##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-4#1)
hormonally dependent##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
hormonally induced##2##2##(1991-3#1)(2008-9#1)
hormonally##12##1##(1990-7#1)(1991-3#1)(1994-9#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)
hormone (ACTH)##8##2##(1992-8#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
hormone (CRH)##6##2##(1990-12#2)(1992-6#1)(1994-9#1)(2008-11#1)(2008-4#1)
hormone (FSH) and luteinizing hormone (LH)##2##6##(2008-10#1)(2011-1#1)
hormone (FSH) in##3##3##(1993-11#2)(2010-5#1)
hormone (FSH)##9##2##(1990-11#1)(1993-11#2)(2008-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)
hormone (GH) has##2##3##(1996-11#1)(1997-8#1)
hormone (GH)##24##2##(1990-12#2)(1991-12#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
hormone (GnRH)##9##2##(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-5#1)(2008-6#1)
hormone (JH)##5##2##(1992-6#1)(1995-11#1)(2008-7#1)(2012-2#2)
hormone (LHRH)##4##2##(1992-12#1)(1995-12#2)(2007-7#1)
hormone (PTH) and##2##3##(1994-11#1)(1995-6#1)
hormone (PTH) is##2##3##(1997-7#1)(2008-8#1)
hormone (PTH)##15##2##(1990-11#1)(1990-2#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-6#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#3)(2012-12#1)(2013-8#1)
hormone (TRH)##7##2##(1991-12#1)(1992-2#1)(1992-6#1)(1995-5#1)(2007-7#1)(2008-4#1)(2013-7#1)
hormone (TSH)##6##2##(1990-8#1)(1994-9#1)(1995-5#1)(2008-6#1)(2012-12#1)(2012-3#1)
hormone 1-44 NH2 and 1-40 OH##4##6##(1992-9#4)
hormone 1-44 NH2##6##3##(1992-9#6)
hormone action##3##2##(2008-4#1)(2011-2#2)
hormone and 1##2##3##(1992-3#1)(1994-11#1)
hormone and glucocorticoid##2##3##(1992-2#1)(2008-6#1)
hormone and insulin-like growth##2##4##(2009-2#1)(2010-5#1)
hormone and prolactin##4##3##(1991-3#1)(1993-2#3)
hormone and receptor##3##3##(2008-1#2)(2008-4#1)
hormone and##38##2##(1990-2#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#4)(1993-5#2)(1994-11#2)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#2)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#1)
hormone as##2##2##(1996-5#1)(2008-3#1)
hormone at##3##2##(1990-3#1)(2008-12#1)(2009-8#1)
hormone balance##2##2##(1997-6#1)(2008-7#1)
hormone binding globulin##5##3##(1990-11#1)(1991-3#3)(2011-2#1)
hormone binding##11##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#3)(1993-6#1)(2008-1#1)(2011-2#1)(2013-1#1)
hormone biosynthesis##3##2##(1995-12#1)(2008-1#1)(2008-7#1)
hormone by##2##2##(1993-3#1)(1993-5#1)
hormone can##2##2##(1994-8#1)(2013-1#1)
hormone concentrations##3##2##(1990-3#1)(2008-1#1)(2013-1#1)
hormone deficiencies##3##2##(2013-1#3)
hormone deficiency in##2##3##(1996-11#1)(1997-8#1)
hormone deficiency##14##2##(1996-11#1)(1997-8#2)(2008-5#1)(2011-1#3)(2012-3#6)(2013-1#1)
hormone dependency##2##2##(1990-2#1)(1997-7#1)
hormone dependent##2##2##(1991-2#1)(1993-6#1)
hormone exhibited##2##2##(1990-12#1)(2008-9#1)
hormone for##3##2##(1991-10#1)(1995-12#1)(2013-1#1)
hormone from##2##2##(1993-5#1)(2010-4#1)
hormone gene##4##2##(1990-12#1)(1993-5#1)(1995-11#1)(2008-8#1)
hormone immunoreactive neurons in##3##4##(2007-12#3)
hormone immunoreactive##4##2##(1993-5#1)(2007-12#3)
hormone in the##5##3##(1991-5#1)(1993-5#2)(2008-10#1)(2013-1#1)
hormone in##30##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-5#1)(1992-6#2)(1993-5#4)(1993-6#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
hormone increases##2##2##(1995-12#1)(2008-4#1)
hormone index level##2##3##(2008-3#2)
hormone induced##2##2##(1991-3#1)(1993-6#1)
hormone is a##2##3##(2008-8#1)(2012-3#1)
hormone is##10##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#2)(2012-3#1)(2013-8#1)
hormone led to the##2##4##(1995-2#1)(1996-2#1)
hormone led to##3##3##(1995-2#2)(1996-2#1)
hormone level and##2##3##(2008-12#1)(2012-2#1)
hormone level##4##2##(1990-2#1)(1991-6#1)(2008-12#1)(2012-2#1)
hormone levels and##2##3##(1991-12#1)(2008-8#1)
hormone levels in##4##3##(1995-3#1)(2008-7#1)(2009-12#2)
hormone levels were##2##3##(1997-3#1)(2008-3#1)
hormone levels##14##2##(1991-12#1)(1992-5#1)(1995-3#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#2)(2012-3#1)
hormone manipulations##2##2##(1990-11#1)(2008-11#1)
hormone metabolic##2##2##(2013-1#2)
hormone of the##2##3##(1994-5#1)(2007-12#1)
hormone of##4##2##(1990-12#1)(1994-5#1)(2007-12#2)
hormone on##5##2##(1990-11#1)(1993-5#1)(1996-5#1)(2008-9#1)(2013-8#1)
hormone or##4##2##(1990-12#1)(1992-6#1)(2008-7#1)(2011-1#1)
hormone profiles##2##2##(1994-5#1)(2008-5#1)
hormone receptor gene##3##3##(2008-1#1)(2008-4#1)(2010-5#1)
hormone receptor in##2##3##(1990-8#1)(1997-1#1)
hormone receptor status##2##3##(2007-4#1)(2009-12#1)
hormone receptor superfamily##6##3##(1991-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-8#1)
hormone receptor##52##2##(1990-12#1)(1990-8#2)(1991-2#2)(1991-5#1)(1992-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#3)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1996-5#1)(1997-1#2)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2010-5#2)(2012-1#1)(2013-1#2)
hormone receptors and##3##3##(1991-5#1)(1996-9#1)(2013-7#1)
hormone receptors are##2##3##(1991-2#1)(2008-4#1)
hormone receptors in##3##3##(1997-7#1)(2008-2#1)(2008-9#1)
hormone receptors##19##2##(1991-2#1)(1991-5#1)(1992-11#1)(1993-5#1)(1993-6#2)(1995-2#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-9#1)(2013-7#1)
hormone regulated##2##2##(1997-7#1)(2008-10#1)
hormone regulation of##2##3##(1991-9#1)(2008-8#1)
hormone regulation##4##2##(1991-9#1)(2008-4#1)(2008-8#1)(2009-4#1)
hormone related peptide##2##3##(2013-7#2)
hormone release##5##2##(1993-5#2)(1994-8#1)(2008-3#1)(2008-5#1)
hormone releasing hormone##5##3##(1990-12#1)(1992-6#1)(1992-9#1)(2007-7#2)
hormone replacement therapy (HRT)##4##4##(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
hormone replacement therapy in##4##4##(1993-11#1)(1993-2#1)(2012-3#2)
hormone replacement therapy on##4##4##(1997-5#2)(2008-11#1)(2008-5#1)
hormone replacement therapy##20##3##(1993-11#1)(1993-2#1)(1994-9#2)(1996-11#1)(1996-6#1)(1997-5#2)(2008-11#2)(2008-3#1)(2008-5#2)(2009-9#1)(2010-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
hormone replacement##25##2##(1993-11#1)(1993-2#1)(1994-9#2)(1996-11#1)(1996-6#1)(1997-5#2)(1997-8#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2009-9#1)(2010-12#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-8#1)
hormone response element##3##3##(1990-8#1)(1992-6#1)(1993-8#1)
hormone response##5##2##(1990-8#1)(1991-2#1)(1992-6#1)(1993-8#1)(2013-1#1)
hormone responsive element of rat haptoglobin gene##2##7##(1993-8#2)
hormone responsive element##3##3##(1993-8#3)
hormone responsive##4##2##(1990-5#1)(1993-8#3)
hormone secretion by##2##3##(2008-4#1)(2010-9#1)
hormone secretion in##4##3##(1991-9#1)(1992-8#1)(1993-11#1)(2010-2#1)
hormone secretion##14##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-11#1)(2008-4#1)(2008-8#2)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#1)
hormone sensitive##2##2##(1990-11#1)(2008-7#1)
hormone signals##3##2##(2009-8#3)
hormone status##4##2##(1993-3#1)(1997-7#1)(2008-5#2)
hormone stimulation##3##2##(2009-4#3)
hormone that##2##2##(2007-7#1)(2008-5#1)
hormone therapy and##2##3##(1993-1#1)(2010-8#1)
hormone therapy##16##2##(1990-12#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-9#1)(2007-10#1)(2008-11#4)(2010-6#4)(2010-8#1)
hormone to##3##2##(1990-12#1)(1993-1#1)(2008-4#1)
hormone treatment##6##2##(1990-3#1)(1992-8#1)(1993-6#1)(2007-11#1)(2009-10#1)(2009-4#1)
hormone was##3##2##(1990-12#2)(2008-12#1)
hormone were##2##2##(1991-3#1)(1993-3#1)
hormone which##2##2##(2008-5#1)(2011-2#1)
hormone with##2##2##(1995-2#1)(2008-10#1)
hormone##747##1##(1990-11#8)(1990-12#28)(1990-2#14)(1990-3#4)(1990-4#2)(1990-5#3)(1990-8#7)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#8)(1991-3#16)(1991-5#4)(1991-6#8)(1991-8#3)(1991-9#4)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#12)(1992-8#6)(1992-9#10)(1993-1#3)(1993-11#9)(1993-12#2)(1993-2#7)(1993-3#9)(1993-5#22)(1993-6#13)(1993-8#8)(1993-9#2)(1994-11#11)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#2)(1994-8#6)(1994-9#7)(1995-11#12)(1995-12#15)(1995-2#13)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#5)(1995-9#1)(1996-11#5)(1996-12#2)(1996-2#5)(1996-3#2)(1996-5#7)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#4)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#9)(2007-4#1)(2007-5#1)(2007-7#10)(2008-1#11)(2008-10#20)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#18)(2008-4#39)(2008-5#24)(2008-6#5)(2008-7#16)(2008-8#20)(2008-9#6)(2009-10#2)(2009-12#4)(2009-2#2)(2009-4#5)(2009-6#3)(2009-7#1)(2009-8#10)(2009-9#3)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#10)(2010-6#5)(2010-8#2)(2010-9#1)(2011-1#18)(2011-10#1)(2011-2#14)(2012-1#3)(2012-12#4)(2012-2#12)(2012-3#19)(2013-1#21)(2013-7#12)(2013-8#7)
hormone)##3##1##(2008-4#1)(2008-8#1)(2010-1#1)
hormone- and##3##2##(1994-2#1)(2011-2#2)
hormone-binding globulin (SHBG)##2##3##(1990-2#1)(2008-3#1)
hormone-binding globulin##4##2##(1990-2#2)(1990-9#1)(2008-3#1)
hormone-binding##7##1##(1990-2#3)(1990-9#1)(2008-3#1)(2008-4#1)(2012-2#1)
hormone-dependent breast cancer##2##3##(2013-8#2)
hormone-dependent##11##1##(1992-5#1)(1993-1#2)(1993-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2013-8#2)
hormone-independent##2##1##(1994-12#1)(1997-7#1)
hormone-mediated##2##1##(1996-5#1)(2008-4#1)
hormone-regulated##2##1##(1995-11#1)(2009-8#1)
hormone-related peptide##4##2##(1993-3#2)(1995-6#1)(1997-6#1)
hormone-related##9##1##(1990-6#1)(1993-3#2)(1994-7#1)(1995-6#1)(1995-9#1)(1997-6#1)(2008-11#1)(2009-8#1)
hormone-releasing activity##2##2##(1990-2#2)
hormone-releasing hormone##13##2##(1992-12#2)(1992-9#6)(1993-1#2)(1995-12#2)(2008-7#1)
hormone-releasing##20##1##(1990-2#5)(1991-9#2)(1992-12#2)(1992-9#6)(1993-1#2)(1995-12#2)(2008-7#1)
hormone-sensitive##2##1##(1993-9#1)(2013-1#1)
hormone-specific##2##1##(1995-11#1)(1995-8#1)
hormone-stimulated##3##1##(1994-11#2)(1996-2#1)
hormone-treated##2##1##(2008-9#1)(2013-7#1)
hormones (insulin##2##2##(2008-11#1)(2008-5#1)
hormones and cytokines##2##3##(1996-2#2)
hormones and growth factors##2##4##(1993-12#2)
hormones and other##3##3##(2008-2#1)(2008-4#2)
hormones and the##2##3##(2008-11#1)(2013-7#1)
hormones and##38##2##(1990-11#1)(1991-3#1)(1993-12#2)(1994-9#1)(1995-8#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#2)
hormones are responsible for##2##4##(1990-9#1)(1992-10#1)
hormones are##10##2##(1990-4#1)(1990-9#1)(1991-3#1)(1992-10#1)(1993-3#1)(1995-2#2)(2008-3#1)(2008-7#1)(2013-8#1)
hormones as##4##2##(1990-6#1)(1995-2#1)(2011-1#1)(2012-2#1)
hormones by##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
hormones from##2##2##(1992-8#1)(2008-1#1)
hormones in the##3##3##(1990-3#1)(2008-2#1)(2009-10#1)
hormones in women##2##3##(1991-1#1)(2009-7#1)
hormones in##15##2##(1990-3#1)(1991-1#1)(1993-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
hormones increase##2##2##(1990-8#1)(1991-12#1)
hormones modulate##2##2##(1990-11#1)(2009-12#1)
hormones of##4##2##(1990-11#1)(2008-6#1)(2010-12#1)(2012-3#1)
hormones on the##5##3##(1990-8#1)(1993-8#1)(2008-6#1)(2012-3#1)(2013-8#1)
hormones on##7##2##(1990-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(2008-6#1)(2012-3#1)(2013-8#1)
hormones play##2##2##(2008-1#1)(2008-9#1)
hormones such as##2##3##(2008-11#1)(2011-2#1)
hormones that##6##2##(1994-8#1)(1995-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
hormones were examined in##2##4##(1990-3#1)(1995-12#1)
hormones were##5##2##(1990-3#1)(1991-3#1)(1995-12#1)(2008-8#1)(2012-2#1)
hormones with##2##2##(2008-10#1)(2011-2#1)
hormones##229##1##(1990-11#8)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#4)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#3)(1993-8#2)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#6)(1995-11#8)(1995-12#4)(1995-2#3)(1995-8#2)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-1#8)(2008-10#6)(2008-11#8)(2008-2#3)(2008-3#2)(2008-4#12)(2008-5#6)(2008-6#6)(2008-7#13)(2008-8#12)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#7)
hormonotherapy##4##1##(1993-1#3)(2007-11#1)
horn and##3##2##(1995-5#1)(1996-12#1)(1996-7#1)
horn is##2##2##(2013-1#2)
horn melon##2##2##(2008-10#2)
horn of the##5##3##(1990-9#1)(1994-2#1)(1995-12#1)(2008-2#1)(2008-7#1)
horn of##7##2##(1990-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
horn was##2##2##(1995-12#1)(2011-1#1)
horn where##2##2##(1995-5#1)(1997-3#1)
horn##65##1##(1990-5#1)(1990-7#7)(1990-9#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-12#3)(1994-2#3)(1994-8#1)(1995-12#4)(1995-5#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#8)(1997-5#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#6)(2011-2#1)(2013-1#4)
horns##4##1##(2007-12#2)(2008-7#1)(2009-3#1)
horny##3##1##(1990-6#1)(2008-5#2)
horror##3##1##(2008-7#2)(2012-12#1)
horse and##3##2##(1990-5#1)(1992-9#1)(1997-2#1)
horse chestnut##4##2##(2008-5#4)
horse heart myoglobin##2##3##(1990-8#1)(1995-2#1)
horse heart##6##2##(1990-8#1)(1992-3#1)(1994-5#2)(1995-2#1)(2008-7#1)
horse kidney##3##2##(2008-10#3)
horse liver alcohol dehydrogenase##5##4##(1990-5#1)(1993-11#1)(1995-3#1)(1995-5#2)
horse liver##6##2##(1990-5#1)(1993-11#1)(1995-3#1)(1995-5#2)(2008-11#1)
horse myoglobin##2##2##(1990-8#2)
horse owners##2##2##(2012-12#2)
horse serum##2##2##(2008-10#2)
horse was##4##2##(2012-12#2)(2013-1#1)(2013-8#1)
horse##61##1##(1990-5#3)(1990-8#3)(1992-3#1)(1992-9#1)(1993-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#2)(2010-4#6)(2011-2#1)(2012-1#1)(2012-12#8)(2012-2#1)(2013-1#2)(2013-8#1)
horse-drawn##2##1##(2008-12#2)
horse-radish peroxidase##6##2##(2008-10#6)
horseradish peroxidase (HRP) in##2##4##(1990-5#1)(2008-10#1)
horseradish peroxidase (HRP)##23##3##(1990-5#1)(1995-12#1)(2008-10#19)(2010-5#1)(2012-2#1)
horseradish peroxidase (HRP)-labeled##2##3##(2008-10#2)
horseradish peroxidase and hydrogen##2##4##(2008-10#2)
horseradish peroxidase and##6##3##(1990-12#1)(2007-12#1)(2008-10#3)(2008-9#1)
horseradish peroxidase##63##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-12#2)(2008-10#40)(2008-4#3)(2008-7#1)(2008-9#1)(2010-5#2)(2012-2#1)
horseradish##66##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-12#2)(2008-10#41)(2008-4#4)(2008-7#1)(2008-9#1)(2010-5#2)(2012-2#1)
horses and##5##2##(1990-11#1)(1990-3#2)(2011-1#1)(2012-12#1)
horses by##2##2##(1996-3#1)(2013-1#1)
horses from##2##2##(2012-12#1)(2012-3#1)
horses in##4##2##(1991-6#1)(1992-5#1)(2011-1#1)(2011-2#1)
horses were##4##2##(1991-6#1)(2012-12#2)(2013-1#1)
horses with##3##2##(1996-6#1)(2012-12#1)(2013-8#1)
horses##50##1##(1990-11#1)(1990-3#2)(1991-6#6)(1992-5#1)(1996-3#2)(1996-6#1)(1996-8#1)(2011-1#2)(2011-2#2)(2012-12#11)(2012-3#8)(2013-1#7)(2013-8#6)
horseshoe kidney##3##2##(2008-10#3)
horseshoe##4##1##(2008-10#3)(2011-1#1)
horticultural crops##4##2##(2008-10#4)
horticultural##11##1##(2008-10#9)(2008-12#2)
horticulture and##2##2##(1997-4#1)(2008-7#1)
horticulture##6##1##(1997-4#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-6#1)
hortorum##3##1##(2008-10#3)
hoshin planning##2##2##(1994-2#2)
hoshin##3##1##(1994-2#3)
hospice benefit##5##2##(1991-3#2)(1993-12#1)(1994-12#1)(1995-2#1)
hospice care##10##2##(1993-12#3)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(2008-6#1)(2009-3#1)(2012-12#1)
hospice expenditure##2##2##(1994-12#2)
hospice home care##2##3##(1990-10#2)
hospice program##2##2##(1990-10#1)(1994-12#1)
hospice referral##2##2##(2010-2#2)
hospice##47##1##(1990-10#4)(1991-2#1)(1991-3#2)(1992-12#1)(1993-12#5)(1993-2#1)(1994-12#8)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-6#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#6)(2011-2#5)(2012-12#2)(2013-8#1)
hospices##5##1##(1995-2#3)(1995-3#1)(2009-5#1)
hospital administration##4##2##(1991-12#1)(1994-1#2)(2008-1#1)
hospital administrators and##4##3##(1992-2#1)(1994-2#1)(1996-2#1)(2008-12#1)
hospital administrators##12##2##(1991-1#1)(1992-1#2)(1992-2#1)(1993-1#3)(1994-1#1)(1994-2#1)(1995-1#1)(1996-2#1)(2008-12#1)
hospital admission for##2##3##(2010-6#1)(2012-3#1)
hospital admission in patients##2##4##(2008-3#1)(2011-2#1)
hospital admission##16##2##(1992-3#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#2)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
hospital admissions were##2##3##(1990-12#1)(1996-3#1)
hospital admissions##12##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1992-5#1)(1996-3#1)(2007-1#1)(2007-10#1)(2008-1#3)(2008-4#1)
hospital after##3##2##(1990-2#1)(2007-8#1)(2011-2#1)
hospital and ambulatory##3##3##(1997-2#1)(2012-1#1)(2013-1#1)
hospital and community##2##3##(1995-1#1)(2008-11#1)
hospital and continued##2##3##(1996-1#1)(2010-7#1)
hospital and for##2##3##(1997-2#1)(2007-10#1)
hospital and general practice##2##4##(1992-2#1)(2008-3#1)
hospital and identified##2##3##(2007-10#2)
hospital and its##2##3##(2008-8#1)(2010-6#1)
hospital and physician##5##3##(1992-1#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-3#1)
hospital and primary care##3##4##(1996-11#1)(1996-3#1)(2011-2#1)
hospital and surgeon##2##3##(2008-7#2)
hospital and the##9##3##(1991-1#1)(1991-11#1)(1993-1#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
hospital and##69##2##(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-2#3)(1992-4#1)(1993-1#2)(1993-12#1)(1993-2#3)(1994-12#1)(1994-8#1)(1995-1#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#4)(1997-2#3)(1997-3#1)(2007-10#5)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
hospital antibiotic use and##2##4##(2013-1#2)
hospital archives##3##2##(1992-1#2)(1992-10#1)
hospital as a##3##3##(1991-1#1)(1994-3#1)(1995-2#1)
hospital as##5##2##(1991-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)
hospital associations##2##2##(1996-3#1)(2008-11#1)
hospital at##4##2##(1993-1#1)(1994-3#1)(2012-12#1)(2012-2#1)
hospital based case-control study##2##4##(1991-2#2)
hospital based study##3##3##(2007-7#1)(2012-3#2)
hospital based##14##2##(1991-2#2)(1992-2#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-11#1)(2012-3#2)(2013-8#2)
hospital because of##7##3##(1993-6#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
hospital because##9##2##(1993-6#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
hospital beds##6##2##(1990-6#1)(1993-11#1)(1994-12#1)(1996-1#1)(1997-5#1)(1997-6#1)
hospital behavior##3##2##(1991-2#1)(1994-12#1)(2008-11#1)
hospital bill##2##2##(1992-1#1)(1996-2#1)
hospital births##2##2##(2009-10#1)(2011-2#1)
hospital board effectiveness##2##3##(1991-1#2)
hospital board##5##2##(1991-1#2)(1991-12#1)(1992-12#1)(1994-1#1)
hospital boards##5##2##(1991-1#1)(1992-12#1)(1994-1#1)(2008-11#2)
hospital budgets##3##2##(1996-12#1)(1996-2#1)(2008-11#1)
hospital by##5##2##(1990-9#1)(1992-2#1)(1993-1#1)(2009-8#1)(2012-3#1)
hospital cafeterias##2##2##(1992-1#2)
hospital can take##2##3##(1992-1#1)(1996-2#1)
hospital capital##2##2##(1992-2#1)(1992-3#1)
hospital care are##2##3##(1991-3#1)(1992-2#1)
hospital care were##2##3##(1991-2#1)(1996-2#1)
hospital care##30##2##(1991-2#2)(1991-3#4)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#2)(1993-3#2)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
hospital case##2##2##(1992-9#1)(2011-2#1)
hospital cases##2##2##(1994-12#1)(2007-10#1)
hospital center##2##2##(1993-2#1)(2010-6#1)
hospital chief executive##2##3##(1996-2#2)
hospital choice in##3##3##(2008-7#3)
hospital choice##7##2##(1995-12#1)(2008-12#3)(2008-7#3)
hospital closures##2##2##(1996-3#2)
hospital companies##2##2##(1992-11#1)(1993-2#1)
hospital competition##5##2##(1993-2#2)(2008-11#3)
hospital cost containment##2##3##(1996-12#2)
hospital cost per adjusted##2##4##(2008-11#2)
hospital cost per##3##3##(2007-8#1)(2008-11#2)
hospital cost##7##2##(1992-12#1)(1995-2#1)(1996-12#2)(2007-8#1)(2008-11#2)
hospital costs and##2##3##(1993-1#1)(2007-9#1)
hospital costs were##2##3##(1994-2#1)(1995-3#1)
hospital costs while##2##3##(1991-12#1)(1992-2#1)
hospital costs##16##2##(1991-12#1)(1992-2#3)(1993-1#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#2)(2007-9#1)(2008-11#1)(2012-3#2)
hospital course##2##2##(2013-8#2)
hospital data##3##2##(1991-3#1)(1995-12#1)(2009-7#1)
hospital day##2##2##(1990-2#1)(2008-1#1)
hospital days##4##2##(1994-2#1)(1995-2#1)(1996-9#1)(2012-2#1)
hospital death##2##2##(2011-2#1)(2012-12#1)
hospital department##2##2##(1994-3#1)(1996-12#1)
hospital departments##5##2##(1990-3#1)(1991-11#1)(1991-3#1)(1995-12#1)(1996-1#1)
hospital did##2##2##(1996-2#1)(1996-9#1)
hospital discharge is##2##3##(2007-12#1)(2007-9#1)
hospital discharge##16##2##(1991-1#1)(1992-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
hospital discharges##4##2##(1992-2#1)(1995-8#1)(2013-1#1)(2013-8#1)
hospital during the influenza A(H1N1)##2##5##(2012-12#2)
hospital during the##3##3##(2012-12#3)
hospital during##5##2##(1992-6#1)(2008-7#1)(2012-12#3)
hospital efficiency##2##2##(1993-1#1)(2008-11#1)
hospital emergency departments##2##3##(2008-11#1)(2009-9#1)
hospital emergency room##2##3##(2008-11#1)(2013-8#1)
hospital emergency##6##2##(1993-11#1)(2008-11#2)(2009-1#1)(2009-9#1)(2013-8#1)
hospital employee##3##2##(1992-2#1)(1993-1#1)(1996-5#1)
hospital employees and##2##3##(1992-1#1)(1993-1#1)
hospital employees##12##2##(1992-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-12#2)(1997-1#1)(2008-12#1)(2011-1#2)
hospital environment##8##2##(1991-1#2)(1992-2#1)(1992-3#1)(1996-1#1)(2008-11#1)(2010-11#1)(2013-8#1)
hospital equipment##2##2##(1992-3#1)(1994-12#1)
hospital ethics committees##2##3##(1992-2#1)(2011-2#1)
hospital ethics##3##2##(1992-2#2)(2011-2#1)
hospital executives##5##2##(1991-12#1)(1993-12#1)(1994-12#2)(1994-3#1)
hospital expenses##2##2##(2008-11#1)(2011-2#1)
hospital experience##2##2##(1994-12#1)(2008-7#1)
hospital faces##2##2##(1991-3#1)(1992-3#1)
hospital facilities##2##2##(1991-2#1)(2008-9#1)
hospital facility##5##2##(1991-1#1)(1993-1#1)(1993-3#1)(1995-3#1)(2011-2#1)
hospital financial performance##2##3##(1993-1#1)(2008-11#1)
hospital financial##4##2##(1992-12#1)(1993-1#1)(1994-1#1)(2008-11#1)
hospital foodservice##2##2##(1993-2#2)
hospital for further##2##3##(2011-2#1)(2012-2#1)
hospital for the##2##3##(2007-12#1)(2008-1#1)
hospital for##26##2##(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-7#1)(1996-12#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#3)
hospital from##5##2##(1993-11#1)(2007-8#1)(2008-1#1)(2012-12#1)(2013-8#1)
hospital fund##2##2##(1992-1#1)(1992-3#1)
hospital funding##5##2##(1991-12#3)(1992-1#1)(1993-3#1)
hospital governance##3##2##(1994-1#2)(1995-3#1)
hospital governing##3##2##(1991-1#1)(1991-12#1)(2008-11#1)
hospital had##4##2##(1992-6#1)(1995-12#1)(1995-6#1)(1995-8#1)
hospital has##5##2##(1994-2#1)(1995-12#1)(2007-3#1)(2010-8#1)(2010-9#1)
hospital immediately##3##2##(1993-12#1)(2009-3#1)(2010-6#1)
hospital implemented##2##2##(1993-1#1)(2007-10#1)
hospital in Nigeria##2##3##(2013-1#2)
hospital in Rio##2##3##(2008-9#1)(2009-7#1)
hospital in Santiago##4##3##(2013-1#4)
hospital in a##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
hospital in the##9##3##(1991-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-12#1)(2007-2#2)(2007-8#1)(2008-3#1)
hospital in which##2##3##(1992-2#1)(2011-1#1)
hospital in##67##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#3)(1992-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-2#3)(2007-8#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#2)(2010-12#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#12)(2013-8#2)
hospital increased##2##2##(1992-5#1)(2013-1#1)
hospital infections and##3##3##(1990-6#2)(2012-2#1)
hospital infections##4##2##(1990-6#3)(2012-2#1)
hospital information platform design##2##4##(2012-3#2)
hospital information systems##6##3##(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(2007-10#1)
hospital information##11##2##(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#2)(2007-10#1)(2012-3#2)
hospital inpatient services##3##3##(1991-3#1)(1994-12#1)(2008-11#1)
hospital inpatient##6##2##(1991-1#1)(1991-3#1)(1993-12#1)(1994-12#2)(2008-11#1)
hospital inpatients##2##2##(2008-11#1)(2012-2#1)
hospital input price##2##3##(1992-1#2)
hospital is a##2##3##(1991-11#1)(2008-11#1)
hospital is##18##2##(1991-1#1)(1991-11#1)(1992-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)
hospital laboratory##4##2##(1994-12#1)(1997-1#1)(1997-3#1)(2008-10#1)
hospital leaders##3##2##(1994-2#1)(1995-3#1)(1997-2#1)
hospital length of stay##2##4##(2011-1#1)(2013-8#1)
hospital level##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
hospital library##5##2##(1995-2#1)(1995-3#2)(1997-3#2)
hospital located in##2##3##(2007-9#1)(2011-2#1)
hospital malpractice##2##2##(1991-12#2)
hospital management structures##2##3##(1990-4#1)(2012-1#1)
hospital management##10##2##(1990-4#1)(1991-12#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-2#1)(2012-1#1)
hospital managers##3##2##(1991-2#1)(1992-1#1)(1995-1#1)
hospital market##4##2##(1991-2#1)(1992-1#1)(1994-12#1)(2008-11#1)
hospital marketing##3##2##(1994-2#1)(2008-12#2)
hospital medical staff##3##3##(1992-1#1)(1993-12#1)(1994-1#1)
hospital medical##10##2##(1991-6#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-1#1)(1996-3#1)(2007-2#1)(2009-7#1)(2010-12#1)(2013-1#1)
hospital merger##3##2##(1992-2#1)(1997-2#1)(2008-11#1)
hospital mortality and morbidity##3##4##(2011-2#3)
hospital mortality##5##2##(1992-9#1)(2008-8#1)(2011-2#3)
hospital network##3##2##(1996-3#1)(2012-2#1)(2012-3#1)
hospital networks##2##2##(1996-3#2)
hospital nursing practice##4##3##(2013-1#4)
hospital of admission##2##3##(2006-8#2)
hospital of the##2##3##(1995-2#1)(2013-1#1)
hospital of##14##2##(1992-5#1)(1995-2#1)(2006-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
hospital on the##3##3##(1994-6#1)(2008-8#2)
hospital on##4##2##(1994-6#1)(1995-12#1)(2008-8#2)
hospital operating##3##2##(1995-1#1)(1996-12#1)(1997-8#1)
hospital operations##2##2##(1996-2#1)(2008-11#1)
hospital or##12##2##(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-11#1)(2011-2#3)(2013-8#1)
hospital organization##2##2##(1996-2#1)(2008-11#1)
hospital outpatient services##4##3##(1991-2#3)(1992-12#1)
hospital outpatient##8##2##(1990-6#1)(1991-2#3)(1992-1#1)(1992-12#2)(1996-1#1)
hospital over a##2##3##(1991-2#1)(2008-7#1)
hospital over##3##2##(1991-2#1)(2008-7#1)(2011-2#1)
hospital ownership and service##2##4##(1995-1#2)
hospital ownership##4##2##(1995-1#4)
hospital patient##4##2##(1992-2#1)(1994-12#1)(1997-2#1)(2008-11#1)
hospital patients##6##2##(1994-3#1)(1995-2#1)(1996-9#1)(2008-6#1)(2008-7#2)
hospital payments##2##2##(1992-12#2)
hospital performance##6##2##(1993-3#2)(1995-1#1)(2008-11#3)
hospital pharmacy efficiency##2##3##(2010-8#2)
hospital pharmacy##6##2##(2010-8#4)(2011-1#1)(2013-1#1)
hospital physicians##5##2##(1994-2#1)(1995-1#1)(1996-8#1)(1996-9#2)
hospital policies and##2##3##(1991-3#1)(2007-11#1)
hospital policies##3##2##(1991-3#1)(1993-2#1)(2007-11#1)
hospital policy##3##2##(1996-2#1)(1997-1#1)(2007-12#1)
hospital practice##2##2##(1992-1#1)(1994-9#1)
hospital practices##2##2##(1994-2#1)(1996-1#1)
hospital preparation##4##2##(1992-1#4)
hospital profitability##5##2##(2008-11#5)
hospital profits##2##2##(1993-1#2)
hospital program##2##2##(1991-1#1)(1993-2#1)
hospital programs##2##2##(1991-1#2)
hospital quality##3##2##(1994-2#1)(2010-12#2)
hospital radiology departments##3##3##(1993-3#1)(2012-2#2)
hospital records##7##2##(1990-12#1)(1990-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
hospital reimbursement##2##2##(1991-3#1)(1993-3#1)
hospital resource use##4##3##(1994-3#2)(1995-3#1)(1997-3#1)
hospital resources##4##2##(1996-1#3)(1997-3#1)
hospital revenue##2##2##(1992-12#1)(1996-2#1)
hospital risk management##2##3##(1991-12#2)
hospital risk##5##2##(1991-12#3)(1992-1#1)(2008-11#1)
hospital safety and security##2##4##(1992-2#1)(1996-12#1)
hospital security officers##2##3##(1996-12#1)(1997-2#1)
hospital security##23##2##(1991-1#1)(1991-12#3)(1992-12#1)(1992-2#2)(1993-2#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-2#5)
hospital service##3##2##(1994-12#1)(1994-3#1)(1995-6#1)
hospital services and##3##3##(1993-1#1)(1995-2#1)(2008-11#1)
hospital services for##6##3##(1991-1#1)(1997-5#5)
hospital services in##3##3##(1991-2#1)(1992-1#1)(1993-2#1)
hospital services##23##2##(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#2)(1993-6#2)(1994-3#2)(1995-2#2)(1996-9#1)(1997-5#5)(2008-11#1)
hospital setting##18##2##(1991-1#1)(1991-12#1)(1991-5#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2010-9#1)(2011-2#1)
hospital settings##5##2##(1992-1#1)(1996-1#1)(2008-11#2)(2010-8#1)
hospital should##2##2##(1993-1#1)(2010-11#1)
hospital size and##2##3##(1992-1#1)(1996-1#1)
hospital spending##5##2##(1992-2#3)(1993-1#1)(2008-11#1)
hospital staff##6##2##(1991-1#1)(1991-12#1)(1993-1#1)(2007-8#1)(2013-1#2)
hospital staffs##2##2##(1994-12#1)(1994-3#1)
hospital statistics##6##2##(1991-1#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
hospital status##2##2##(2008-11#2)
hospital stay and##3##3##(1994-5#1)(2011-2#1)(2012-3#1)
hospital stay for operable breast cancer##2##6##(1992-12#2)
hospital stay for##4##3##(1992-12#2)(2007-8#1)(2008-10#1)
hospital stay of##3##3##(1991-12#1)(2011-2#2)
hospital stay was 4##2##4##(2007-7#1)(2008-10#1)
hospital stay was##7##3##(2007-7#2)(2007-8#2)(2008-10#1)(2013-1#2)
hospital stay were##2##3##(1990-9#1)(2007-8#1)
hospital stay##54##2##(1990-9#1)(1991-12#3)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-2#3)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#7)(2008-1#2)(2008-10#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
hospital stays for total hip replacement##2##6##(1996-1#2)
hospital stays##13##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1996-1#2)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
hospital strategic##4##2##(1991-1#1)(1991-2#1)(1996-12#2)
hospital survey##2##2##(1991-8#1)(1996-12#1)
hospital system has##2##3##(1991-9#1)(2008-11#1)
hospital system with##2##3##(1993-12#1)(1993-3#1)
hospital system##8##2##(1991-9#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-3#1)(2008-11#1)(2009-7#1)(2010-8#1)
hospital systems##8##2##(1992-12#4)(1994-12#1)(2008-11#3)
hospital tax exemption and##2##4##(2008-11#2)
hospital tax exemption##5##3##(1996-2#1)(2008-11#4)
hospital that##3##2##(1991-12#1)(1994-12#1)(1995-12#1)
hospital the##3##2##(1992-2#1)(1995-11#1)(1997-7#1)
hospital through the##2##3##(1991-3#1)(2008-3#1)
hospital through##3##2##(1991-3#1)(1996-2#1)(2008-3#1)
hospital to determine##2##3##(1990-5#1)(2008-1#1)
hospital to maintain the##2##4##(1994-12#1)(1995-12#1)
hospital to provide##2##3##(1991-2#1)(1993-12#1)
hospital to##29##2##(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-3#3)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#2)
hospital transitional funding initiative##2##4##(1991-12#2)
hospital treatment##4##2##(1993-1#1)(2008-8#1)(2009-6#1)(2009-8#1)
hospital types##4##2##(1992-12#2)(1994-3#2)
hospital units##4##2##(1990-3#1)(2011-1#2)(2013-1#1)
hospital use##3##2##(1991-3#1)(1992-1#1)(1994-2#1)
hospital utilization##3##2##(1992-12#1)(1995-5#1)(1996-1#1)
hospital valuation expert##2##3##(2008-11#2)
hospital versus##3##2##(1991-1#1)(2008-11#1)(2008-4#1)
hospital visits##3##2##(1993-1#1)(1994-2#1)(2009-12#1)
hospital volume##2##2##(2008-7#2)
hospital wage##2##2##(1992-1#1)(1992-2#1)
hospital waiting lists##3##3##(1991-11#3)
hospital ward##2##2##(2007-10#1)(2010-8#1)
hospital wards##7##2##(1992-6#2)(1997-8#1)(2008-10#2)(2011-1#1)(2013-1#1)
hospital was##7##2##(1995-3#2)(1995-5#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-8#1)
hospital were##8##2##(1992-11#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-2#1)(2007-1#1)(2008-12#1)(2009-5#1)
hospital where##5##2##(1991-7#1)(1994-1#1)(1995-3#1)(2007-12#1)(2008-7#1)
hospital while##2##2##(2008-8#1)(2012-12#1)
hospital who were##2##3##(2006-10#1)(2011-2#1)
hospital who##3##2##(2006-10#1)(2011-2#1)(2012-1#1)
hospital will##2##2##(1994-2#1)(2008-11#1)
hospital with a##5##3##(1992-2#1)(1993-12#1)(2012-12#1)(2013-1#2)
hospital with abdominal pain##2##4##(1993-6#1)(2011-2#1)
hospital with complaints of##2##4##(2008-12#1)(2013-1#1)
hospital with severe##2##3##(1992-3#1)(2012-12#1)
hospital with##32##2##(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#7)(2012-12#3)(2013-1#4)
hospital without##2##2##(2008-11#2)
hospital workers##5##2##(1991-3#1)(1991-6#1)(1996-3#1)(2008-10#1)(2013-1#1)
hospital##1708##1##(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#6)(1990-4#4)(1990-5#3)(1990-6#8)(1990-9#8)(1991-1#41)(1991-11#10)(1991-12#38)(1991-2#27)(1991-3#34)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#40)(1992-10#1)(1992-11#6)(1992-12#31)(1992-2#54)(1992-3#21)(1992-4#3)(1992-5#12)(1992-6#9)(1992-8#3)(1992-9#2)(1993-1#26)(1993-11#3)(1993-12#32)(1993-2#43)(1993-3#26)(1993-5#2)(1993-6#11)(1993-8#2)(1993-9#4)(1994-1#18)(1994-11#2)(1994-12#43)(1994-2#32)(1994-3#30)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#22)(1995-10#1)(1995-11#4)(1995-12#20)(1995-2#28)(1995-3#22)(1995-5#6)(1995-6#6)(1995-8#3)(1996-1#27)(1996-11#1)(1996-12#21)(1996-2#32)(1996-3#34)(1996-5#6)(1996-8#2)(1996-9#7)(1997-1#7)(1997-2#23)(1997-3#11)(1997-4#6)(1997-5#6)(1997-6#4)(1997-7#3)(1997-8#10)(2006-10#3)(2006-8#2)(2007-1#3)(2007-10#24)(2007-11#7)(2007-12#8)(2007-2#10)(2007-3#1)(2007-7#13)(2007-8#23)(2007-9#4)(2008-1#25)(2008-10#20)(2008-11#99)(2008-12#19)(2008-3#17)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#43)(2008-8#18)(2008-9#4)(2009-1#2)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#6)(2009-8#2)(2009-9#1)(2010-10#6)(2010-11#8)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#13)(2010-7#4)(2010-8#18)(2010-9#4)(2011-1#20)(2011-2#68)(2011-3#2)(2012-1#4)(2012-12#24)(2012-2#20)(2012-3#29)(2013-1#74)(2013-7#1)(2013-8#30)
hospital's experience with##2##3##(1994-12#1)(1997-1#1)
hospital's experience##4##2##(1992-2#1)(1994-12#1)(1997-1#1)(1997-2#1)
hospital's medical##3##2##(1994-1#1)(1996-3#1)(1997-3#1)
hospital's##58##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-1#4)(1993-12#4)(1993-2#2)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
hospital)##2##1##(1990-5#1)(2012-3#1)
hospital-acquired infection##2##2##(2010-12#1)(2013-1#1)
hospital-acquired infections##2##2##(2008-10#1)(2010-10#1)
hospital-acquired##4##1##(2008-10#1)(2010-10#1)(2010-12#1)(2013-1#1)
hospital-based case-control studies##2##3##(2007-10#2)
hospital-based case-control study of ovarian cancer##2##6##(1993-9#2)
hospital-based case-control study of##3##4##(1993-9#3)
hospital-based case-control study##4##3##(1990-8#1)(1993-9#3)
hospital-based case-control##6##2##(1990-8#1)(1993-9#3)(2007-10#2)
hospital-based emergency services##2##3##(1996-1#2)
hospital-based emergency##3##2##(1996-1#2)(2008-8#1)
hospital-based managed##3##2##(1991-3#3)
hospital-based physicians##2##2##(1991-2#1)(1993-1#1)
hospital-based research##2##2##(1997-3#2)
hospital-based study##5##2##(2007-10#3)(2007-2#1)(2007-7#1)
hospital-based##43##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#4)(1992-1#2)(1993-1#2)(1993-3#1)(1993-9#3)(1994-1#3)(1994-12#1)(1995-3#1)(1996-1#3)(1997-3#2)(2007-10#8)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-1#1)(2012-3#1)
hospital-medical staff##2##2##(1994-1#2)
hospital-physician##4##1##(1991-3#3)(1993-1#1)
hospital-wide##3##1##(1994-3#1)(1996-1#2)
hospital? The##3##2##(1994-6#2)(1995-3#1)
hospital?##4##1##(1993-6#1)(1994-6#2)(1995-3#1)
hospital]##25##1##(1990-6#1)(1993-10#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-5#1)(2008-9#2)(2009-1#1)(2009-10#1)(2011-2#2)(2012-3#2)(2013-1#5)
hospitalier##6##1##(1993-12#1)(2008-2#5)
hospitalisation##13##1##(1992-2#1)(1994-5#1)(1995-2#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
hospitalised for##3##2##(2007-8#2)(2013-7#1)
hospitalised in##3##2##(1991-11#1)(2007-8#1)(2012-2#1)
hospitalised patients##3##2##(1991-8#1)(1992-5#1)(2007-1#1)
hospitalised##17##1##(1991-11#1)(1991-8#1)(1992-5#1)(1992-9#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-8#3)(2012-12#2)(2012-2#1)(2013-7#1)
hospitalists##4##1##(2008-3#4)
hospitality##3##1##(1993-1#1)(2008-1#1)(2008-11#1)
hospitalization and death##2##3##(1995-2#1)(2009-12#1)
hospitalization and##24##2##(1991-2#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-3#1)(2007-10#2)(2008-10#1)(2008-11#4)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
hospitalization charges##2##2##(1991-12#2)
hospitalization days##2##2##(1991-3#1)(1995-12#1)
hospitalization for asthma##2##3##(2008-11#2)
hospitalization for the##2##3##(1992-1#1)(2008-7#1)
hospitalization for##11##2##(1992-1#2)(1992-2#1)(1995-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#2)
hospitalization had##2##2##(1994-12#2)
hospitalization has##2##2##(1992-1#1)(2007-11#1)
hospitalization in the##2##3##(1992-1#1)(2013-1#1)
hospitalization in##7##2##(1992-1#1)(1994-12#1)(1997-3#1)(2010-10#1)(2013-1#3)
hospitalization is##5##2##(1991-1#1)(1991-6#1)(1992-1#2)(2013-1#1)
hospitalization may##2##2##(1991-1#1)(1994-2#1)
hospitalization of##4##2##(1991-2#1)(1992-3#1)(1993-3#1)(2011-1#1)
hospitalization on##3##2##(1991-2#1)(1993-1#1)(2008-11#1)
hospitalization or##3##2##(1991-1#1)(1991-2#1)(2008-11#1)
hospitalization period##2##2##(2008-10#1)(2010-4#1)
hospitalization rate##2##2##(2007-7#1)(2010-10#1)
hospitalization time and##2##3##(2009-9#1)(2013-1#1)
hospitalization time##4##2##(2007-8#1)(2008-8#1)(2009-9#1)(2013-1#1)
hospitalization was##5##2##(1991-12#1)(2010-10#2)(2011-2#1)(2012-3#1)
hospitalization were related to##2##4##(1991-1#1)(1993-12#1)
hospitalization were##4##2##(1991-1#2)(1993-12#1)(2013-1#1)
hospitalization with##3##2##(1992-3#1)(1993-2#1)(2008-7#1)
hospitalization##189##1##(1991-1#12)(1991-12#3)(1991-2#7)(1991-3#2)(1991-6#1)(1992-1#13)(1992-10#1)(1992-2#6)(1992-3#4)(1993-1#3)(1993-12#2)(1993-2#4)(1993-3#1)(1994-12#5)(1994-2#3)(1995-1#6)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#2)(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#4)(2006-10#1)(2007-10#3)(2007-11#4)(2007-7#3)(2007-8#4)(2008-10#4)(2008-11#10)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#5)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#16)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#18)(2013-8#1)
hospitalization]##2##1##(1991-6#1)(1997-3#1)
hospitalizations and##6##2##(1990-12#1)(1991-2#1)(1995-1#1)(2008-11#2)(2012-3#1)
hospitalizations due to##3##3##(2012-12#1)(2013-1#2)
hospitalizations for acute decompensated##2##4##(2008-3#2)
hospitalizations for##9##2##(1991-12#1)(1995-12#3)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)
hospitalizations were##3##2##(1995-1#1)(1996-3#2)
hospitalizations##31##1##(1990-12#1)(1991-12#2)(1991-2#2)(1992-2#1)(1993-1#1)(1993-3#1)(1995-1#2)(1995-12#4)(1996-3#2)(2007-5#1)(2008-11#4)(2008-3#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
hospitalized and treated##2##3##(1996-3#1)(2012-3#1)
hospitalized and##3##2##(1991-12#1)(1996-3#1)(2012-3#1)
hospitalized at##4##2##(1994-2#1)(2008-1#1)(2012-2#1)(2013-8#1)
hospitalized children and##2##3##(1992-3#1)(2008-11#1)
hospitalized children##14##2##(1991-1#2)(1991-2#1)(1992-3#2)(1993-12#1)(1994-12#1)(2008-11#3)(2013-1#4)
hospitalized for##21##2##(1990-8#1)(1991-1#1)(1995-6#1)(1997-3#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
hospitalized in a##3##3##(1991-1#1)(1992-2#1)(2009-1#1)
hospitalized in the##10##3##(1990-3#1)(1992-5#1)(1993-9#1)(1995-1#1)(2007-8#2)(2009-5#2)(2012-12#1)(2013-1#1)
hospitalized in##19##2##(1990-3#1)(1991-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-9#1)(1995-1#2)(2007-11#1)(2007-8#3)(2009-1#1)(2009-5#2)(2012-12#2)(2013-1#1)
hospitalized infants##2##2##(1993-12#1)(2008-10#1)
hospitalized on an##3##3##(1992-1#1)(1993-2#1)(1996-5#1)
hospitalized patients were##3##3##(1991-2#1)(2007-7#1)(2008-10#1)
hospitalized patients with##4##3##(2008-11#1)(2009-7#1)(2011-2#1)(2012-3#1)
hospitalized patients##28##2##(1991-2#1)(1992-1#1)(1992-5#1)(1997-3#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
hospitalized were##2##2##(1993-12#1)(2013-1#1)
hospitalized with##8##2##(1991-6#1)(1993-2#1)(2008-3#1)(2009-12#1)(2010-4#1)(2012-12#2)(2013-1#1)
hospitalized##139##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#4)(1991-12#1)(1991-2#3)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#3)(1993-1#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#4)(1997-6#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#4)(2009-7#1)(2010-10#2)(2010-4#3)(2011-2#6)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#13)(2013-8#4)
hospitals a##2##2##(2008-7#1)(2011-2#1)
hospitals across##3##2##(1994-2#1)(1995-1#1)(2008-11#1)
hospitals and health care systems##2##5##(1996-3#1)(1997-1#1)
hospitals and health care##3##4##(1995-2#1)(1996-3#1)(1997-1#1)
hospitals and health##4##3##(1993-2#1)(1995-2#1)(1996-3#1)(1997-1#1)
hospitals and in##2##3##(2011-2#1)(2012-2#1)
hospitals and managed care##2##4##(1991-12#1)(1995-2#1)
hospitals and medical##3##3##(1993-2#1)(2008-11#2)
hospitals and nursing homes##2##4##(1996-1#1)(2008-4#1)
hospitals and one##3##3##(1990-10#1)(1995-3#1)(1996-8#1)
hospitals and other##6##3##(1992-12#2)(1993-1#1)(1993-2#1)(1994-3#1)(1996-3#1)
hospitals and payors##2##3##(1992-3#1)(1994-1#1)
hospitals and physicians##5##3##(1991-3#1)(1992-1#1)(1996-12#1)(1996-3#1)(2008-7#1)
hospitals and the##9##3##(1991-2#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
hospitals and their##5##3##(1991-1#1)(1991-2#1)(1992-2#1)(1995-1#1)(2008-11#1)
hospitals and##93##2##(1990-10#1)(1990-11#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#4)(1993-6#2)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#4)(1995-2#5)(1995-3#6)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
hospitals are also##4##3##(1992-12#1)(1994-3#1)(1995-1#1)(1997-1#1)
hospitals are facing##2##3##(1991-9#1)(2008-11#1)
hospitals are implementing##2##3##(1994-1#1)(2012-2#1)
hospitals are in the##2##4##(1996-11#1)(2008-11#1)
hospitals are likely to##3##4##(1993-2#2)(1994-12#1)
hospitals are located##2##3##(1995-1#1)(1996-3#1)
hospitals are##45##2##(1990-4#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#5)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-11#3)(2008-12#2)(2012-2#1)(2013-8#1)
hospitals around the country##2##4##(1994-1#1)(1995-2#1)
hospitals as##3##2##(1991-3#1)(1995-3#1)(2009-5#1)
hospitals because##2##2##(1993-12#1)(2008-11#1)
hospitals being##3##2##(1992-2#1)(2008-11#1)(2009-6#1)
hospitals by rural beneficiaries##2##4##(1992-12#2)
hospitals by##3##2##(1992-12#2)(1995-1#1)
hospitals can use internal benchmark data to create effective managed care arrangements##2##12##(1995-1#2)
hospitals can use##3##3##(1995-1#2)(1995-2#1)
hospitals can##7##2##(1993-3#1)(1995-1#2)(1995-2#1)(1996-2#1)(2008-11#1)(2010-9#1)
hospitals could##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
hospitals do not##3##3##(1993-12#1)(1996-3#1)(2008-11#1)
hospitals do##5##2##(1992-12#2)(1993-12#1)(1996-3#1)(2008-11#1)
hospitals during the period##2##4##(1992-12#1)(2008-11#1)
hospitals during the##3##3##(1992-12#1)(1994-1#1)(2008-11#1)
hospitals during##4##2##(1990-2#1)(1992-12#1)(1994-1#1)(2008-11#1)
hospitals following##2##2##(1996-3#1)(2008-11#1)
hospitals for what they##3##4##(1992-12#3)
hospitals for##11##2##(1992-12#3)(1992-2#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-5#1)(1996-12#1)(2011-1#1)
hospitals from the##2##3##(1992-2#1)(2008-11#1)
hospitals from##5##2##(1990-6#1)(1992-2#1)(2008-1#2)(2008-11#1)
hospitals had##4##2##(1996-1#1)(1997-3#1)(2011-2#2)
hospitals has##4##2##(1992-12#2)(2012-3#1)(2013-8#1)
hospitals have been##2##3##(1996-12#1)(1996-3#1)
hospitals have##15##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-7#1)
hospitals in Canada##5##3##(1992-1#1)(1993-1#1)(1994-2#1)(2008-11#2)
hospitals in New##2##3##(1996-3#1)(2011-1#1)
hospitals in Norway in##2##4##(1992-4#1)(1995-6#1)
hospitals in Norway##4##3##(1991-2#1)(1992-4#1)(1995-6#1)(1997-2#1)
hospitals in Riyadh##2##3##(2007-7#1)(2008-1#1)
hospitals in Seoul##2##3##(1990-12#1)(1991-2#1)
hospitals in the United States##2##5##(2008-11#1)(2010-9#1)
hospitals in the##13##3##(1991-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-10#1)(2008-11#1)(2010-3#1)(2010-9#1)(2012-12#1)
hospitals in##90##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1997-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#4)(2008-4#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
hospitals into##2##2##(1991-1#1)(1992-12#1)
hospitals is not##2##3##(1990-6#1)(2010-8#1)
hospitals is##9##2##(1990-6#1)(1991-12#2)(1993-2#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(2010-8#1)
hospitals located in##6##3##(1992-12#1)(1994-3#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-9#1)
hospitals makes##2##2##(1992-12#1)(1994-3#1)
hospitals may##2##2##(2008-9#1)(2011-2#1)
hospitals merged##2##2##(1992-2#1)(2008-1#1)
hospitals need to##2##3##(1991-1#1)(2008-11#1)
hospitals need##4##2##(1991-1#1)(1993-12#1)(1994-1#1)(2008-11#1)
hospitals of a##2##3##(1993-12#1)(2008-7#1)
hospitals of the##4##3##(1993-9#1)(1995-8#1)(2011-2#2)
hospitals of##13##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-9#1)(1995-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#4)(2012-3#1)
hospitals often##2##2##(1992-8#1)(1993-12#1)
hospitals on the##2##3##(1992-2#1)(1995-2#1)
hospitals on##3##2##(1992-2#1)(1995-2#1)(2011-2#1)
hospitals or##5##2##(1991-3#1)(1992-6#1)(2008-11#2)(2011-2#1)
hospitals serving##3##2##(1991-6#1)(1992-2#1)(1994-1#1)
hospitals should##5##2##(1992-3#1)(1997-2#1)(1997-8#1)(2011-1#1)(2011-2#1)
hospitals showed##2##2##(1995-3#1)(1996-12#1)
hospitals that are##2##3##(1992-12#1)(2008-3#1)
hospitals that operate joint ventures##3##5##(2008-11#3)
hospitals that##15##2##(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1995-1#2)(2008-11#5)(2008-3#2)(2011-2#1)(2013-1#1)
hospitals throughout##2##2##(2007-12#1)(2008-11#1)
hospitals to adopt##2##3##(1995-2#1)(2008-11#1)
hospitals to consider##2##3##(1993-1#1)(1993-12#1)
hospitals to the##2##3##(1991-11#1)(1992-2#1)
hospitals to##35##2##(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#3)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#5)(1996-3#1)(1997-1#1)(2008-11#5)(2010-9#1)(2012-2#1)
hospitals today##4##2##(1991-12#1)(1993-2#1)(1997-2#1)(2008-1#1)
hospitals toward##4##2##(1991-3#1)(1993-1#1)(1994-1#1)(1995-3#1)
hospitals was##6##2##(1992-2#1)(1994-12#1)(1995-6#1)(2007-12#1)(2008-11#1)(2012-2#1)
hospitals were surveyed##2##3##(1996-1#1)(2010-11#1)
hospitals were##16##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#2)
hospitals will##3##2##(1992-2#1)(1994-2#1)(1996-2#1)
hospitals with ERs##2##3##(2008-8#2)
hospitals with a##2##3##(1992-12#1)(2011-2#1)
hospitals with higher##2##3##(1993-1#1)(1995-2#1)
hospitals with more than##2##4##(1993-2#1)(1997-3#1)
hospitals with##25##2##(1991-2#1)(1992-12#2)(1993-1#2)(1993-2#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-3#4)(2008-8#4)(2011-2#2)(2013-1#2)
hospitals without##4##2##(1992-12#1)(1992-3#1)(2008-3#2)
hospitals would be##3##3##(1993-12#1)(1996-1#1)(1996-2#1)
hospitals would##4##2##(1993-12#1)(1996-1#1)(1996-2#1)(2008-11#1)
hospitals##915##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#5)(1990-6#10)(1990-9#4)(1991-1#13)(1991-11#5)(1991-12#13)(1991-2#15)(1991-3#18)(1991-6#6)(1991-9#7)(1992-1#12)(1992-11#3)(1992-12#43)(1992-2#27)(1992-3#15)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#7)(1992-9#1)(1993-1#20)(1993-11#1)(1993-12#33)(1993-2#22)(1993-3#11)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#3)(1994-1#21)(1994-12#15)(1994-2#20)(1994-3#26)(1995-1#35)(1995-12#10)(1995-2#24)(1995-3#23)(1995-5#2)(1995-6#7)(1995-8#4)(1996-1#13)(1996-11#3)(1996-12#14)(1996-2#22)(1996-3#23)(1996-8#1)(1996-9#2)(1997-1#11)(1997-2#10)(1997-3#10)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#6)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#8)(2008-10#6)(2008-11#70)(2008-12#11)(2008-3#18)(2008-4#8)(2008-5#3)(2008-7#12)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#10)(2010-9#5)(2011-1#6)(2011-2#25)(2012-1#1)(2012-12#7)(2012-2#11)(2012-3#5)(2013-1#10)(2013-8#9)
hospitals'##20##1##(1992-12#1)(1992-2#2)(1993-2#1)(1994-12#1)(1994-2#4)(1995-2#4)(1995-3#1)(1996-12#1)(1997-5#1)(2008-11#2)(2011-2#2)
hospitals)##2##1##(2008-11#1)(2009-7#1)
hospitals?##3##1##(1991-1#1)(1992-12#1)(1996-3#1)
hospitals]##13##1##(1991-11#1)(1991-2#1)(1992-4#1)(1993-11#2)(1995-5#1)(1997-2#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
host DNA##5##2##(1994-8#1)(2008-10#4)
host adaptation and##2##3##(2008-10#2)
host adaptation##4##2##(2008-10#3)(2008-9#1)
host and a##2##3##(2007-12#1)(2008-3#1)
host and disease##2##3##(1995-5#2)
host and is##2##3##(2008-10#1)(2013-8#1)
host and non-host##2##3##(2007-12#1)(2008-10#1)
host and parasite life-history traits##2##5##(2008-8#2)
host and parasite##6##3##(2008-8#4)(2010-8#1)(2012-3#1)
host and parasitoid##2##3##(2008-8#2)
host and pathogen##5##3##(2008-10#4)(2008-9#1)
host and the##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
host and##46##2##(1994-11#1)(1995-2#1)(1995-5#2)(1997-4#1)(2007-12#3)(2008-10#16)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
host antitumor response##2##3##(1992-12#2)
host are##2##2##(2008-10#1)(2008-3#1)
host as well##2##3##(2008-6#1)(2012-2#1)
host axons##4##2##(2011-2#4)
host bacterium##2##2##(2011-2#1)(2013-1#1)
host by##6##2##(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
host cell changes##2##3##(2008-10#2)
host cell for##2##3##(2008-11#2)
host cell line##5##3##(1995-2#1)(2008-11#4)
host cell lines##4##3##(2008-11#4)
host cell wall##8##3##(2008-10#7)(2010-3#1)
host cell##53##2##(1990-2#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-10#18)(2008-11#16)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#3)
host cells and##3##3##(2008-5#1)(2009-3#1)(2012-12#1)
host cells for##2##3##(1997-4#1)(2008-11#1)
host cells is##2##3##(1994-2#1)(2008-10#1)
host cells##39##2##(1990-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-12#4)(1997-3#1)(1997-4#2)(2007-10#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
host cells)##2##2##(2008-6#1)(2013-8#1)
host chromosomal gene products##2##4##(1995-9#2)
host cultivar and##2##3##(2008-10#2)
host cultivar##7##2##(2008-10#7)
host cultivars##2##2##(2008-10#2)
host cytoplasm##5##2##(1996-12#2)(2008-10#3)
host damage##2##2##(2010-5#2)
host defense is##2##3##(2008-9#2)
host defense mechanisms##2##3##(2008-5#1)(2008-9#1)
host defense reactions##2##3##(2008-10#2)
host defense responses##2##3##(2008-10#2)
host defense##21##2##(1991-5#1)(1992-10#1)(1993-3#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
host defenses##8##2##(1994-5#1)(2008-10#2)(2008-5#1)(2008-9#4)
host defensive##2##2##(1994-8#1)(2008-11#1)
host density but##2##3##(2008-10#2)
host density##11##2##(2008-10#4)(2008-8#1)(2008-9#6)
host differential lines##2##3##(2008-10#2)
host differential##3##2##(2008-10#3)
host differentials##3##2##(2008-10#3)
host disease##4##2##(1997-8#1)(2007-4#1)(2008-5#1)(2008-7#1)
host diversity##7##2##(2008-10#7)
host encounter rate##2##3##(2008-9#2)
host encounter##4##2##(2008-9#4)
host environment##2##2##(2008-8#1)(2011-2#1)
host epidermal cells directly##2##4##(2008-10#2)
host epithelial##2##2##(2009-12#1)(2013-1#1)
host extinction##3##2##(2008-8#3)
host factors that interact with##2##5##(1997-4#1)(2008-10#1)
host factors that##3##3##(1996-2#1)(1997-4#1)(2008-10#1)
host factors##10##2##(1996-2#1)(1997-4#2)(2006-6#1)(2008-10#3)(2008-9#1)(2010-6#1)(2012-2#1)
host fecundity##2##2##(2008-8#1)(2008-9#1)
host female##2##2##(2008-8#2)
host fitness##3##2##(2008-10#1)(2008-9#2)
host for##11##2##(1991-8#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#2)
host gene##4##2##(2008-10#3)(2013-1#1)
host genetic background##4##3##(2008-10#4)
host genetic##8##2##(1997-7#1)(2008-10#5)(2009-2#2)
host genomes##2##2##(2008-8#1)(2010-3#1)
host genotype in##3##3##(2008-10#3)
host genotype mixtures##2##3##(2008-10#2)
host genotype##15##2##(2008-10#15)
host genotypes##17##2##(2008-10#17)
host growth and resistance##3##4##(2008-10#3)
host growth and##6##3##(2008-10#6)
host growth##10##2##(2008-10#10)
host has been##2##3##(2008-10#1)(2008-4#1)
host heterogeneity##2##2##(2008-9#2)
host hyphae##4##2##(2008-10#4)
host immune responses##4##3##(1994-5#1)(2008-10#2)(2008-8#1)
host immune##7##2##(1994-5#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
host immunity##5##2##(2007-12#2)(2008-8#1)(2010-1#1)(2013-1#1)
host in##7##2##(2008-10#3)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
host infection process##6##3##(2010-10#6)
host infection##9##2##(2008-10#2)(2008-8#1)(2010-10#6)
host is##10##2##(1996-3#1)(2008-10#4)(2008-8#2)(2008-9#3)
host leaf##3##2##(2008-10#3)
host life-history traits##2##3##(2008-8#2)
host lineages##2##2##(1995-3#2)
host material##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
host materials##4##2##(2010-4#4)
host matrix##2##2##(2007-11#1)(2008-10#1)
host miRNA##2##2##(2013-1#2)
host miRNAs##2##2##(2013-1#2)
host mixtures##4##2##(2008-10#4)
host molecules##2##2##(2008-10#2)
host mortality##2##2##(2008-9#2)
host of origin##8##3##(2008-10#6)(2008-4#1)(2008-9#1)
host of other##3##3##(1997-5#1)(2008-10#1)(2008-4#1)
host of the##2##3##(2008-10#2)
host of##29##2##(1992-12#1)(1995-1#1)(1995-3#1)(1997-5#1)(2008-10#12)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-7#2)
host or nonhost##2##3##(2008-10#2)
host or pathogen##2##3##(2008-10#2)
host or to##2##3##(2008-8#1)(2013-1#1)
host or vector##2##3##(2008-8#2)
host or##12##2##(2008-10#7)(2008-11#1)(2008-8#3)(2013-1#1)
host organisms##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
host origin##4##2##(2008-10#4)
host pH##2##2##(2008-10#2)
host penetration##2##2##(2008-10#2)
host phenology##3##2##(2008-10#3)
host physiology##2##2##(2010-1#1)(2011-2#1)
host plant genotype##2##3##(2008-10#2)
host plant resistance##3##3##(2008-10#2)(2011-2#1)
host plant species and##2##4##(2008-10#1)(2009-8#1)
host plant species##10##3##(2008-10#8)(2009-8#2)
host plant##56##2##(1990-8#1)(2007-12#1)(2008-10#40)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#4)(2010-3#1)(2011-2#4)(2012-3#1)
host plants and##5##3##(2008-10#4)(2008-8#1)
host plants by##2##3##(2007-12#1)(2008-10#1)
host plants using##2##3##(2008-9#1)(2010-10#1)
host plants were##3##3##(2008-10#3)
host plants with##3##3##(2008-10#3)
host plants##54##2##(2007-12#2)(2008-10#39)(2008-5#1)(2008-8#4)(2008-9#4)(2009-2#1)(2009-8#1)(2010-10#1)(2011-2#1)
host polymer##3##2##(2008-10#1)(2008-3#1)(2009-2#1)
host population was##2##3##(2008-10#2)
host population##20##2##(1994-2#1)(2008-10#9)(2008-8#2)(2008-9#3)(2009-2#2)(2011-2#2)(2012-12#1)
host populations##9##2##(2008-10#4)(2008-8#2)(2011-2#1)(2012-2#2)
host preference##9##2##(2008-10#5)(2008-8#1)(2008-9#2)(2010-10#1)
host preferences##2##2##(2008-8#1)(2011-2#1)
host proteins for##2##3##(2013-1#2)
host proteins##7##2##(1997-2#1)(2009-6#1)(2010-10#1)(2013-1#4)
host race formation##3##3##(2008-10#2)(2008-8#1)
host races##7##2##(2008-10#3)(2008-8#1)(2008-9#2)(2011-2#1)
host range and##3##3##(2008-10#2)(2008-5#1)
host range expanded viruses##2##4##(2008-11#2)
host range expanded##4##3##(2008-11#4)
host range of##13##3##(1997-4#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)
host range studies##3##3##(2008-10#2)(2010-10#1)
host range was##4##3##(2008-10#4)
host range##58##2##(1993-12#1)(1997-4#3)(2008-10#39)(2008-11#6)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
host ranges of these pathogens##2##5##(2008-10#2)
host ranges of##4##3##(2008-10#3)(2012-2#1)
host ranges##9##2##(2008-10#8)(2012-2#1)
host reactions##4##2##(2008-10#4)
host receptor-binding affinity##2##3##(2012-2#2)
host reproduction##4##2##(2008-10#1)(2008-8#3)
host reproductive effort##3##3##(2008-8#3)
host reproductive##4##2##(2008-8#4)
host resistance and stress tolerance##2##5##(2008-10#2)
host resistance and##7##3##(2008-10#5)(2008-8#2)
host resistance genes##2##3##(2008-10#2)
host resistance is##2##3##(2008-10#1)(2008-8#1)
host resistance to aflatoxin##2##4##(2008-10#2)
host resistance to##7##3##(2008-10#5)(2008-8#1)(2009-10#1)
host resistance was##2##3##(2008-10#2)
host resistance##54##2##(1996-12#2)(2008-10#40)(2008-8#11)(2009-10#1)
host response to infection##2##4##(2008-10#2)
host response to##7##3##(1990-2#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-5#1)
host response##11##2##(1990-2#1)(1994-2#1)(1995-2#1)(2008-10#5)(2008-5#1)(2009-11#1)(2011-2#1)
host responses##5##2##(1993-5#1)(2008-10#4)
host shift##4##2##(2008-8#4)
host sites##2##2##(2008-10#2)
host size##7##2##(2008-10#3)(2008-9#4)
host specialization in##5##3##(2008-10#4)(2008-9#1)
host specialization to##2##3##(2008-10#2)
host specialization##13##2##(2008-10#12)(2008-9#1)
host species and##3##3##(2008-10#3)
host species is##2##3##(2008-10#1)(2008-9#1)
host species may##2##3##(2008-10#2)
host species that##2##3##(2008-8#1)(2010-2#1)
host species##48##2##(2008-10#28)(2008-5#1)(2008-8#8)(2008-9#6)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
host specific##6##2##(2008-10#6)
host specificity exists in##2##4##(2008-10#2)
host specificity was##2##3##(2008-10#2)
host specificity##13##2##(2008-10#12)(2013-1#1)
host strain and##2##3##(1994-12#1)(2008-9#1)
host strain##9##2##(1990-5#1)(1994-12#1)(1995-12#1)(1997-4#3)(2008-8#1)(2008-9#1)(2009-3#1)
host strains##2##2##(1991-9#1)(1993-12#1)
host susceptibility##5##2##(2008-10#5)
host symptoms and##2##3##(2008-10#2)
host symptoms##3##2##(2008-10#3)
host system##2##2##(2008-10#1)(2008-3#1)
host tissue and##2##3##(2008-10#2)
host tissue by##2##3##(2008-10#2)
host tissue##15##2##(2008-10#15)
host tissues were##2##3##(2007-12#1)(2008-10#1)
host tissues##12##2##(2007-12#1)(2008-10#5)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
host to##6##2##(1991-5#1)(1991-9#1)(2008-10#3)(2008-8#1)
host translation inhibitory##2##3##(2010-4#2)
host use##3##2##(2008-8#3)
host was##6##2##(2008-10#4)(2008-6#1)(2013-1#1)
host were##5##2##(2008-10#4)(2012-2#1)
host##1344##1##(1990-11#3)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#4)(1992-10#2)(1992-12#3)(1992-3#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#3)(1995-9#2)(1996-12#9)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#11)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#23)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#666)(2008-11#35)(2008-12#5)(2008-2#5)(2008-3#12)(2008-4#12)(2008-5#18)(2008-6#6)(2008-7#10)(2008-8#119)(2008-9#91)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#12)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#4)(2009-8#12)(2009-9#1)(2010-1#4)(2010-10#14)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#4)(2010-4#8)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#10)(2011-2#54)(2012-1#2)(2012-12#7)(2012-2#12)(2012-3#7)(2013-1#39)(2013-7#4)(2013-8#8)
host's##9##1##(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-3#1)(2013-7#1)
host)##3##1##(2008-8#2)(2011-2#1)
host-adapted##4##1##(2008-10#3)(2008-9#1)
host-associated##2##1##(2008-10#1)(2011-2#1)
host-defense##3##1##(2008-5#1)(2009-6#1)(2013-1#1)
host-dependent##2##1##(2008-10#2)
host-derived##2##1##(2008-10#1)(2011-2#1)
host-diversity effect for reduced disease##2##5##(2008-10#2)
host-diversity effect for reduced##3##4##(2008-10#3)
host-diversity effect##4##2##(2008-10#4)
host-diversity effects for##2##3##(2008-10#2)
host-diversity effects on##3##3##(2008-10#3)
host-diversity effects##9##2##(2008-10#9)
host-diversity##13##1##(2008-10#13)
host-free period##4##2##(2008-10#4)
host-guest##8##1##(1996-2#1)(2008-10#4)(2010-12#2)(2010-4#1)
host-parasite coevolution##2##2##(2008-10#1)(2012-3#1)
host-parasite interaction##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
host-parasite interactions##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
host-parasite relatedness##2##2##(2008-8#2)
host-parasite system##2##2##(2008-1#1)(2011-2#1)
host-parasite##21##1##(1997-7#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-8#7)(2011-2#1)(2012-3#3)(2013-1#1)
host-parasitoid##4##1##(2008-8#4)
host-pathogen combinations##2##2##(2008-10#2)
host-pathogen interaction##4##2##(2008-10#3)(2013-1#1)
host-pathogen interactions has##3##3##(2008-9#1)(2010-8#1)(2013-1#1)
host-pathogen interactions##15##2##(2008-10#7)(2008-9#2)(2010-10#1)(2010-12#1)(2010-8#1)(2013-1#3)
host-pathogen systems##2##2##(2008-10#1)(2008-9#1)
host-pathogen##30##1##(2008-10#15)(2008-8#2)(2008-9#3)(2010-10#1)(2010-12#1)(2010-8#1)(2013-1#7)
host-plant##6##1##(2008-8#3)(2009-2#1)(2009-6#1)(2010-11#1)
host-seeking##2##1##(1990-11#1)(2009-8#1)
host-selective toxin##6##2##(2008-10#6)
host-selective toxins##2##2##(2008-10#2)
host-selective##9##1##(2008-10#9)
host-specialized forms of##2##3##(2008-10#2)
host-specialized##4##1##(2008-10#4)
host-specific toxin##3##2##(2008-10#3)
host-specific toxins##4##2##(2008-10#4)
host-specific##16##1##(2008-10#13)(2009-8#1)(2012-2#1)(2013-1#1)
host-vector##3##1##(1993-12#2)(2008-4#1)
host-virus interactions##2##2##(1997-4#1)(2008-10#1)
hostae clade##2##2##(2008-10#2)
hostae##4##1##(2008-10#4)
hostage##6##1##(1994-2#1)(1996-12#1)(2008-1#2)(2013-8#2)
hostages##2##1##(2008-1#2)
hosted a##2##2##(2008-10#1)(2009-6#1)
hosted by the##2##3##(2008-11#1)(2009-5#1)
hosted##9##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
hostile##4##1##(1997-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
hostility and##2##2##(2008-4#2)
hostility##12##1##(1990-11#1)(2007-10#1)(2008-4#7)(2008-7#1)(2008-9#1)(2010-7#1)
hosting the##3##2##(2008-11#1)(2008-12#1)(2008-2#1)
hosting##5##1##(1991-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-7#1)
hostpathogen##2##1##(2008-10#2)
hosts 5##2##2##(1996-2#2)
hosts adjacent to##2##3##(2008-10#2)
hosts and are##2##3##(2008-10#2)
hosts and habitats##2##3##(2008-10#2)
hosts and parasites##2##3##(2012-3#1)(2013-1#1)
hosts and the##3##3##(2008-10#2)(2013-8#1)
hosts and##29##2##(2008-1#1)(2008-10#20)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
hosts are##8##2##(2007-2#1)(2008-10#3)(2008-8#2)(2009-5#1)(2013-1#1)
hosts as##4##2##(2008-10#4)
hosts at##2##2##(2008-10#2)
hosts by##3##2##(2008-10#1)(2008-8#2)
hosts caused##2##2##(2008-10#2)
hosts for##10##2##(1993-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
hosts has##2##2##(2011-2#1)(2013-1#1)
hosts have##2##2##(2008-9#1)(2011-2#1)
hosts in the genus Solanum##2##5##(2008-10#2)
hosts in the##7##3##(2008-10#5)(2013-1#1)(2013-8#1)
hosts in##14##2##(2008-10#9)(2008-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
hosts is##7##2##(2008-10#4)(2008-8#1)(2008-9#1)(2012-12#1)
hosts may be##3##3##(2008-10#1)(2008-8#1)(2010-2#1)
hosts may##4##2##(2007-6#1)(2008-10#1)(2008-8#1)(2010-2#1)
hosts of C##2##3##(2008-10#2)
hosts of origin##2##3##(2008-10#2)
hosts of##12##2##(2008-10#8)(2008-12#1)(2008-8#1)(2011-2#2)
hosts or##5##2##(1990-11#1)(2008-10#2)(2011-2#1)(2012-2#1)
hosts other than##2##3##(2008-10#2)
hosts parasitized by##3##3##(2008-9#3)
hosts such as##2##3##(2008-10#1)(2011-2#1)
hosts that are##2##3##(1997-7#1)(2008-8#1)
hosts that##6##2##(1997-7#1)(2008-10#3)(2008-8#1)(2009-2#1)
hosts to##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)
hosts varied##2##2##(2008-10#2)
hosts was##2##2##(2008-10#2)
hosts were##9##2##(2008-10#9)
hosts with##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-12#1)
hosts##331##1##(1990-11#2)(1991-8#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-7#3)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#202)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#20)(2008-9#17)(2009-2#3)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#4)(2010-8#1)(2011-1#2)(2011-2#20)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#9)(2013-8#7)
hosts'##5##1##(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
hosts)##5##1##(2008-10#1)(2008-9#2)(2011-2#2)
hot air oven##3##3##(2008-12#3)
hot air##4##2##(2008-12#3)(2008-2#1)
hot and##5##2##(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
hot climate##2##2##(2007-2#1)(2008-8#1)
hot electrons##3##2##(2007-12#1)(2012-2#2)
hot flash experience in men is##2##6##(2009-5#2)
hot flash##5##2##(2008-7#3)(2009-5#2)
hot flashes in##5##3##(2008-7#4)(2012-3#1)
hot flashes##20##2##(2008-11#1)(2008-7#17)(2009-5#1)(2012-3#1)
hot in##2##2##(2008-8#2)
hot pepper##5##2##(2008-10#4)(2008-12#1)
hot plate##10##2##(1992-3#1)(1994-3#1)(1996-2#2)(2008-10#4)(2010-5#1)(2011-1#1)
hot spot##4##2##(1995-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
hot spots##9##2##(1993-11#1)(2007-5#1)(2008-10#2)(2008-3#2)(2009-10#1)(2011-2#1)(2012-3#1)
hot spring##6##2##(2008-10#5)(2008-8#1)
hot springs##2##2##(2011-2#1)(2012-2#1)
hot topics in structural genomics##2##5##(2008-7#2)
hot topics##4##2##(1997-1#1)(2008-7#2)(2013-1#1)
hot water extraction##3##3##(2008-10#2)(2012-1#1)
hot water pretreatment##2##3##(2013-1#2)
hot water##15##2##(2008-10#5)(2008-11#1)(2008-6#1)(2012-1#1)(2013-1#7)
hot wax##4##2##(1992-6#4)
hot##146##1##(1991-6#1)(1992-3#4)(1992-6#4)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-12#1)(1995-8#1)(1996-2#3)(1997-1#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#33)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#23)(2008-8#5)(2009-10#2)(2009-12#2)(2009-5#4)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
hot-carrier luminescence##3##2##(2007-12#3)
hot-electron##2##1##(1992-8#1)(2007-12#1)
hot-filament##2##1##(2008-3#2)
hot-pepper paste##3##2##(2010-4#3)
hot-plate##2##1##(1992-3#2)
hot-press##2##1##(2008-2#2)
hot-pressed##2##1##(2008-3#1)(2013-8#1)
hot-pressing##2##1##(2010-4#2)
hot-water extract of spruce wood##2##5##(2013-1#2)
hot-wire##2##1##(2008-10#2)
hotel##7##1##(1991-12#1)(1994-2#1)(1994-3#1)(2007-2#1)(2008-11#1)(2008-3#1)(2013-8#1)
hotspot##6##1##(1991-11#1)(2008-10#1)(2012-3#3)(2013-7#1)
hotspots and##2##2##(2008-10#1)(2012-3#1)
hotspots##4##1##(2008-10#1)(2009-7#1)(2011-1#1)(2012-3#1)
houbara bustards##2##2##(1997-3#2)
houdei##2##1##(2008-5#2)
hougasii##3##1##(2008-10#3)
hour after HS##2##3##(1991-12#2)
hour after##10##2##(1991-12#3)(1993-11#1)(1994-8#2)(1997-3#1)(2007-8#1)(2008-7#2)
hour ambulatory blood pressure##3##4##(2009-11#2)(2013-8#1)
hour and the##2##3##(2008-10#1)(2011-1#1)
hour and##14##2##(1992-3#1)(1997-2#1)(2008-10#10)(2008-5#1)(2011-1#1)
hour blood pressure monitoring##2##4##(1997-8#1)(2007-10#1)
hour fast##2##2##(2008-1#1)(2012-2#1)
hour for##3##2##(2008-10#2)(2012-3#1)
hour in the##2##3##(1992-5#1)(2008-10#1)
hour in##4##2##(1992-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
hour is##2##2##(2008-3#1)(2012-3#1)
hour of##9##2##(1992-6#1)(1994-9#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
hour per##2##2##(1993-8#1)(2008-9#1)
hour post##5##2##(2008-4#3)(2012-2#2)
hour prior to##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
hour time##2##2##(2008-8#1)(2010-8#1)
hour to##2##2##(1992-6#1)(2007-10#1)
hour were##4##2##(2008-10#3)(2008-12#1)
hour##200##1##(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#5)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#4)(1994-8#2)(1994-9#1)(1996-11#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-8#2)(2008-1#3)(2008-10#88)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#4)
hour's##2##1##(1990-12#1)(2008-7#1)
hourly measurements of##2##3##(2008-11#1)(2010-10#1)
hourly##12##1##(1990-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-10#1)
hours (n =##2##3##(1992-5#1)(2007-10#1)
hours after a##3##3##(1990-12#1)(1991-11#1)(1995-3#1)
hours after discharge##2##3##(2012-12#2)
hours after injection##5##3##(1990-12#1)(1992-12#1)(1993-11#1)(2008-7#2)
hours after injury##2##3##(2009-3#1)(2013-1#1)
hours after onset of stroke##2##5##(1995-5#1)(2009-11#1)
hours after onset of##3##4##(1992-5#1)(1995-5#1)(2009-11#1)
hours after surgery##2##3##(1997-3#1)(2009-1#1)
hours after the accident##3##4##(1990-9#2)(1992-4#1)
hours after the operation##2##4##(1994-11#2)
hours after the##13##3##(1990-9#2)(1991-6#1)(1992-4#1)(1994-11#2)(2007-10#1)(2007-8#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-1#1)
hours after treatment##2##3##(1993-8#1)(1994-11#1)
hours after virus injection##2##4##(1997-2#2)
hours after##77##2##(1990-12#4)(1990-5#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#2)(1993-11#1)(1993-3#1)(1993-8#3)(1994-11#3)(1994-6#1)(1995-3#2)(1995-5#2)(1997-2#2)(1997-3#2)(2007-10#5)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-1#2)(2013-8#2)
hours and the##4##3##(1990-2#1)(2009-9#1)(2010-8#2)
hours and##24##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-10#3)(2008-3#1)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#3)(2011-2#1)(2011-3#1)(2012-1#1)(2013-7#1)(2013-8#1)
hours at##3##2##(2008-1#1)(2008-12#1)(2008-5#1)
hours before the##2##3##(1996-5#1)(2011-2#1)
hours before##7##2##(1993-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#2)
hours by##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
hours daily##3##2##(2007-8#1)(2011-2#1)(2012-2#1)
hours following##5##2##(1993-5#2)(2008-11#1)(2008-12#1)(2012-12#1)
hours for##8##2##(1993-1#1)(1994-2#1)(2007-10#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
hours from##2##2##(2007-7#1)(2008-11#1)
hours in the##6##3##(1992-9#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-8#1)
hours in##12##2##(1990-6#1)(1992-9#1)(1994-3#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)
hours later##10##2##(1990-6#1)(1992-5#1)(1994-9#1)(1996-9#2)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#2)
hours of admission##3##3##(1990-9#1)(2007-10#1)(2013-1#1)
hours of continuous operation##2##4##(2007-9#1)(2008-10#1)
hours of continuous##3##3##(2007-9#1)(2008-10#2)
hours of cooling followed by 12 hours of controlled rewarming##2##10##(2007-10#2)
hours of culture##2##3##(1994-6#1)(2008-11#1)
hours of incubation##4##3##(1990-5#1)(1994-11#1)(1994-5#1)(2013-1#1)
hours of onset##2##3##(2007-10#2)
hours of stroke##2##3##(2007-10#2)
hours of symptoms onset##2##4##(2007-10#1)(2008-3#1)
hours of the day##2##4##(2008-10#1)(2011-2#1)
hours of the##5##3##(2007-10#1)(2008-10#2)(2011-2#2)
hours of##83##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1997-6#2)(2007-10#14)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-5#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-7#3)(2011-1#12)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
hours old##2##2##(1993-12#1)(2011-2#1)
hours on days##2##3##(1990-2#1)(2013-1#1)
hours on##4##2##(1990-2#1)(2007-12#1)(2010-6#1)(2013-1#1)
hours or##6##2##(1996-9#1)(1997-3#1)(2007-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
hours per day of##3##4##(1995-3#2)(2012-12#1)
hours per day##8##3##(1995-3#2)(1995-8#1)(2008-10#1)(2008-12#2)(2012-12#1)(2013-8#1)
hours per patient##2##3##(2007-10#1)(2007-8#1)
hours per week##2##3##(1992-6#1)(2008-8#1)
hours per##16##2##(1992-6#1)(1995-3#2)(1995-8#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
hours postoperatively in##2##3##(1993-12#2)
hours postoperatively##4##2##(1993-12#3)(2007-9#1)
hours prior to##3##3##(1992-11#1)(1996-9#1)(2008-11#1)
hours the##4##2##(1992-6#1)(2007-11#1)(2008-3#1)(2011-2#1)
hours to##12##2##(1994-12#1)(1995-6#2)(1997-1#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
hours was##2##2##(1996-6#1)(2010-6#1)
hours when relative humidity was##2##5##(2008-10#2)
hours when##3##2##(2008-10#2)(2010-6#1)
hours with##6##2##(2008-10#2)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#1)
hours##532##1##(1990-10#1)(1990-11#4)(1990-12#7)(1990-2#3)(1990-3#4)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#3)(1991-9#5)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#5)(1992-6#6)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#2)(1993-8#6)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#8)(1994-5#1)(1994-6#4)(1994-9#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#4)(1997-8#1)(2006-4#1)(2007-10#51)(2007-11#6)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#36)(2008-11#12)(2008-12#10)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#15)(2008-6#4)(2008-7#16)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#9)(2010-7#4)(2010-8#9)(2011-1#16)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#16)(2012-2#9)(2012-3#2)(2012-5#2)(2013-1#19)(2013-7#2)(2013-8#11)
hours) and##4##2##(1996-2#1)(2008-10#2)(2011-1#1)
hours)##17##1##(1990-12#1)(1991-5#1)(1991-9#2)(1995-5#1)(1996-2#1)(1996-8#1)(2007-10#3)(2008-10#2)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#2)
hours/week)##3##1##(2010-7#3)
house a##2##2##(1993-1#1)(2008-3#1)
house and##2##2##(2008-10#1)(2010-5#1)
house calls##6##2##(1992-5#1)(1995-3#1)(1997-8#1)(2011-2#3)
house dust mite allergen##2##4##(2010-5#1)(2012-3#1)
house dust mite##5##3##(2010-5#2)(2011-2#2)(2012-3#1)
house dust mites##3##3##(1994-9#1)(1995-6#1)(2013-8#1)
house dust##9##2##(1994-9#1)(1995-6#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
house finch##2##2##(2008-8#2)
house finches (Carpodacus mexicanus)##2##4##(2008-8#2)
house finches##4##2##(2008-8#4)
house of##2##2##(2008-10#1)(2009-7#1)
house officers reported that they##2##5##(1995-6#2)
house officers who##3##3##(1991-3#1)(1995-6#2)
house officers##13##2##(1990-3#1)(1991-3#1)(1995-6#8)(2008-3#1)(2009-7#1)(2013-8#1)
house sparrows (Passer domesticus) and##2##5##(2008-5#2)
house to the hospital##2##4##(2009-10#1)(2010-2#1)
house##74##1##(1990-11#1)(1990-3#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-1#3)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#10)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-12#2)(2008-3#3)(2008-5#2)(2008-8#7)(2008-9#1)(2009-10#2)(2009-7#2)(2010-2#1)(2010-5#3)(2011-2#9)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
house-invading##2##1##(2008-6#2)
house-to-house survey##2##2##(1994-9#1)(2008-11#1)
housed beef cattle##2##3##(1991-3#2)
housed in##5##2##(1992-3#2)(1993-6#1)(2010-1#1)(2010-2#1)
housed tethered for 2##2##4##(2008-11#2)
housed##17##1##(1991-2#1)(1991-3#2)(1992-3#2)(1993-6#1)(1996-12#1)(2008-11#3)(2009-4#1)(2010-1#1)(2010-2#3)(2010-8#1)(2012-12#1)
household and##6##2##(1991-1#1)(1991-12#1)(1997-4#2)(2008-10#1)(2008-5#1)
household contacts##2##2##(1991-12#2)
household food security##3##3##(2008-1#3)
household income and##3##3##(2009-5#1)(2011-1#1)(2012-12#1)
household labor##3##2##(2011-2#3)
household products##2##2##(2008-10#1)(2008-5#1)
household survey##3##2##(1990-12#1)(2010-3#1)(2013-8#1)
household surveys##2##2##(1993-6#1)(2013-8#1)
household trajectories##2##2##(2011-2#2)
household waste##2##2##(2008-12#2)
household##76##1##(1990-12#1)(1991-1#1)(1991-12#3)(1993-6#3)(1994-2#2)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-4#2)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#20)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#6)
household-level##4##1##(2011-2#4)
households and##3##2##(1991-12#1)(2010-5#1)(2011-2#1)
households in Sidama##2##3##(2010-6#2)
households in##5##2##(2008-1#1)(2009-7#1)(2010-6#2)(2013-1#1)
households to##2##2##(1995-3#1)(2012-12#1)
households with##3##2##(1994-2#1)(2007-11#1)(2011-2#1)
households##43##1##(1991-12#3)(1994-1#1)(1994-2#1)(1995-3#1)(1997-2#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)(2009-12#2)(2009-7#1)(2010-5#2)(2010-6#3)(2010-8#2)(2011-2#12)(2012-12#3)(2013-1#3)
housekeeping gene##2##2##(2007-12#1)(2008-10#1)
housekeeping genes##8##2##(1990-11#1)(1991-6#1)(1995-11#1)(1997-6#1)(2008-10#3)(2011-1#1)
housekeeping##13##1##(1990-11#1)(1991-6#1)(1995-11#1)(1995-6#2)(1997-6#1)(2007-12#1)(2008-10#4)(2008-7#1)(2011-1#1)
houses and the##2##3##(1996-12#1)(1996-6#1)
houses and##3##2##(1996-12#1)(1996-6#1)(2008-10#1)
houses were##3##2##(1996-12#1)(1996-3#1)(2011-2#1)
houses##28##1##(1990-2#1)(1990-3#2)(1993-1#1)(1996-12#3)(1996-3#1)(1996-6#1)(2007-10#1)(2007-12#2)(2007-6#2)(2008-10#1)(2008-6#2)(2009-3#1)(2010-11#1)(2010-6#1)(2011-2#6)(2012-12#2)
housewife and##2##2##(1993-3#1)(2011-2#1)
housewife##3##1##(1993-3#1)(2011-1#1)(2011-2#1)
housewives##2##1##(1990-3#1)(2013-1#1)
housework##4##1##(1991-6#1)(2011-2#3)
housing accessibility##4##2##(2008-7#4)
housing and##4##2##(1996-5#1)(2008-11#1)(2009-5#1)(2012-12#1)
housing condition##2##2##(2008-4#1)(2009-7#1)
housing##42##1##(1993-1#3)(1993-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-1#2)(2008-1#2)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#8)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-8#1)
housing)##2##1##(1993-1#1)(2008-11#1)
how &quot##2##2##(2008-10#1)(2008-12#1)
how African##2##2##(2009-11#1)(2010-1#1)
how HIV##2##2##(2008-8#1)(2010-12#1)
how IGFBP##2##2##(2008-4#2)
how a full##2##3##(1995-12#1)(2010-10#1)
how a laboratory##2##3##(1993-2#2)
how a new##4##3##(1997-2#1)(2008-12#2)(2009-3#1)
how a single##2##3##(2008-2#1)(2011-2#1)
how a##56##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-2#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-8#1)(2013-8#1)
how accurately##2##2##(2008-3#2)
how administrative##2##2##(1996-12#1)(2008-4#1)
how administrators##2##2##(1991-3#1)(1995-1#1)
how advances in##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
how an##12##2##(1992-9#1)(1993-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)
how and when##2##3##(2008-3#1)(2008-9#1)
how and why##7##3##(1994-12#1)(1996-3#1)(1997-1#1)(2008-9#1)(2010-1#1)(2013-1#2)
how and##13##2##(1991-6#1)(1994-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-1#1)(2010-12#1)(2013-1#2)
how appearance##2##2##(2008-11#2)
how are we doing?##2##4##(1996-2#1)(2011-2#1)
how are we##4##3##(1996-2#1)(2009-3#1)(2011-2#1)(2012-12#1)
how are##6##2##(1996-2#1)(1996-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
how best to##12##3##(1994-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
how best##13##2##(1994-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
how both##3##2##(2008-10#1)(2009-1#1)(2013-8#1)
how burnout##2##2##(2008-11#1)(2010-9#1)
how by##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
how can we##3##3##(1997-1#1)(2008-11#1)(2012-2#1)
how can##6##2##(1997-1#2)(2008-11#1)(2009-10#1)(2012-12#1)(2012-2#1)
how cell##4##2##(1994-3#1)(2008-10#1)(2008-7#2)
how changes in the##3##4##(1996-3#1)(2008-10#1)(2012-12#1)
how changes in##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2012-12#1)
how children##2##2##(1991-1#1)(1994-6#1)
how chromatin##2##2##(2012-2#2)
how common##2##2##(2008-4#2)
how community##2##2##(1997-3#1)(2008-8#1)
how complex##2##2##(2008-7#1)(2008-8#1)
how confident##2##2##(2009-10#1)(2010-8#1)
how consumers view##2##3##(1997-3#2)
how consumers##3##2##(1997-3#3)
how data##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
how did they##2##3##(2008-8#1)(2011-2#1)
how different##9##2##(1991-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-5#1)
how differential##2##2##(2008-2#1)(2009-7#1)
how do I##2##3##(1997-1#2)
how do##9##2##(1994-3#1)(1995-12#1)(1997-1#2)(1997-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)
how does it##2##3##(1995-12#1)(2012-12#1)
how does##4##2##(1995-11#1)(1995-12#1)(2008-9#1)(2012-12#1)
how drugs##3##2##(2007-3#1)(2009-8#1)(2011-2#1)
how dynamized##2##2##(2008-10#2)
how each##5##2##(1994-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(2010-5#1)
how effective##3##2##(2008-11#1)(2008-7#2)
how effectively##5##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
how energy##2##2##(2008-11#1)(2008-8#1)
how environmental##3##2##(1995-11#1)(2008-1#1)(2012-12#1)
how exposure##2##2##(2008-10#1)(2010-8#1)
how families##4##2##(2008-11#1)(2008-9#2)(2012-12#1)
how far the##2##3##(2008-11#1)(2008-7#1)
how far##8##2##(1993-2#1)(1994-12#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)
how formal##2##2##(2009-12#1)(2009-5#1)
how frequently##3##2##(2007-2#2)(2011-2#1)
how gene##2##2##(2008-9#1)(2012-3#1)
how genes##2##2##(2008-7#1)(2009-5#1)
how genetic##2##2##(2008-8#1)(2011-2#1)
how health care organizations##3##4##(1994-2#1)(1996-12#1)(2008-11#1)
how health care##4##3##(1991-12#1)(1994-2#1)(1996-12#1)(2008-11#1)
how health##8##2##(1991-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)
how high##4##2##(1990-8#1)(1993-2#1)(1996-2#1)(2010-3#1)
how hospital##2##2##(1991-2#1)(2013-8#1)
how hospitals are##2##3##(1992-1#1)(1993-12#1)
how hospitals can##2##3##(1995-1#1)(2008-11#1)
how hospitals##5##2##(1992-1#1)(1993-12#1)(1995-1#1)(1995-3#1)(2008-11#1)
how host##2##2##(2008-10#2)
how human##5##2##(2012-1#1)(2012-2#1)(2013-1#3)
how important##5##2##(1994-2#1)(1997-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
how individual##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
how individuals##4##2##(2007-12#1)(2008-11#1)(2012-2#2)
how information##3##2##(2007-12#1)(2007-8#1)(2010-11#1)
how integrated##2##2##(1995-12#1)(2009-5#1)
how interactions between##2##3##(2011-2#1)(2013-8#1)
how is it##3##3##(1994-12#1)(2008-7#1)(2011-1#1)
how is##4##2##(1994-12#1)(2007-10#1)(2008-7#1)(2011-1#1)
how it affects##2##3##(2007-10#1)(2008-7#1)
how it can be used##2##5##(1996-2#1)(2008-11#1)
how it can be##3##4##(1996-2#1)(2008-11#1)(2008-2#1)
how it can##4##3##(1996-2#1)(2007-2#1)(2008-11#1)(2008-2#1)
how it has been##2##4##(1993-2#1)(2009-6#1)
how it has##4##3##(1992-3#1)(1993-2#1)(1995-12#1)(2009-6#1)
how it is possible to##2##5##(1996-3#1)(2008-11#1)
how it is##8##3##(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2013-8#1)
how it relates to##2##4##(1995-1#1)(2008-4#1)
how it should be aligned for different applications (e##3##9##(2008-4#2)(2008-9#1)
how it should be##8##4##(2008-4#4)(2008-7#1)(2008-9#3)
how it will##2##3##(1994-1#1)(1994-12#1)
how it##53##2##(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#2)(2008-9#5)(2009-12#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
how its##2##2##(1993-3#1)(2008-11#1)
how knowledge and##2##3##(2010-1#1)(2012-2#1)
how learning##4##2##(1995-8#1)(2008-11#1)(2010-2#1)(2011-1#1)
how lecturers##2##2##(2008-11#2)
how light##4##2##(1997-6#1)(2008-4#1)(2008-8#1)(2008-9#1)
how likely##2##2##(2008-10#1)(2008-7#1)
how long##6##2##(1991-2#1)(1996-1#1)(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
how low##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
how managed care organizations##3##4##(1996-12#1)(2008-6#2)
how managed care##4##3##(1996-1#1)(1996-12#1)(2008-6#2)
how many of them encode##2##5##(2008-4#2)
how many times?##2##3##(1992-1#1)(2011-2#1)
how many##20##2##(1990-9#1)(1992-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(2007-12#1)(2008-3#1)(2008-4#5)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
how mental health nurses can##2##5##(2009-6#1)(2011-2#1)
how mental health##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
how metal##2##2##(1997-7#1)(2008-10#1)
how microarray##2##2##(2008-10#2)
how microtubules are reorganized##2##4##(2011-2#2)
how migration##3##2##(2008-8#2)(2013-1#1)
how model##2##2##(2008-8#1)(2013-1#1)
how molecular##2##2##(2008-7#1)(2009-6#1)
how much insurance##2##3##(1992-12#1)(1993-3#1)
how much of the##2##4##(1992-1#1)(1995-6#1)
how much of##5##3##(1992-1#1)(1994-3#1)(1995-6#1)(2008-11#1)(2011-2#1)
how much they##2##3##(1992-3#1)(1994-2#1)
how much##21##2##(1990-3#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#3)(2010-12#1)(2011-2#1)
how natural##3##2##(2008-8#1)(2009-6#1)(2013-1#1)
how nurse educators##2##3##(2008-11#1)(2010-3#1)
how nurse##4##2##(2008-11#3)(2010-3#1)
how occupational##3##2##(2010-9#2)(2011-2#1)
how of##2##2##(1997-5#1)(2007-10#1)
how older##3##2##(1997-3#1)(2009-7#1)(2010-1#1)
how one##7##2##(1996-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2011-1#2)(2011-2#1)
how our findings##2##3##(2009-8#1)(2013-1#1)
how our##10##2##(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-8#1)(2010-9#1)(2013-1#1)
how parents##3##2##(1993-12#1)(1997-2#1)(2010-9#1)
how patient data##2##3##(1995-1#1)(2007-10#1)
how patients##4##2##(1993-1#1)(2008-12#1)(2008-6#1)(2008-8#1)
how peer##2##2##(2009-8#1)(2013-1#1)
how people##5##2##(1995-1#1)(2007-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
how persons with##2##3##(2012-2#1)(2012-3#1)
how physicians##3##2##(1992-2#1)(1993-2#1)(2008-6#1)
how postwar##4##2##(2013-1#4)
how progress monitoring is being used##2##6##(2011-2#2)
how progress##3##2##(1993-2#1)(2011-2#2)
how proper##2##2##(2011-1#2)
how protein##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
how proteins##2##2##(2008-4#1)(2011-1#1)
how public health##2##3##(1995-12#1)(2010-8#1)
how quality##2##2##(1991-2#1)(1996-2#1)
how quickly foragers##2##3##(2008-8#1)(2008-9#1)
how quickly##3##2##(2008-12#1)(2008-8#1)(2008-9#1)
how radiology##2##2##(1991-12#1)(1994-1#1)
how rapidly they##2##3##(2010-3#1)(2012-2#1)
how rapidly##8##2##(1993-3#1)(1994-1#1)(1997-1#1)(1997-7#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
how reproductive##2##2##(2008-8#1)(2008-9#1)
how research##2##2##(1993-2#1)(2012-3#1)
how researchers##3##2##(2008-8#1)(2008-9#1)(2009-12#1)
how satisfied##2##2##(1991-2#1)(1992-1#1)
how security##2##2##(1995-2#1)(1997-2#1)
how sensitive##2##2##(2007-12#1)(2008-11#1)
how should it be treated?##2##5##(2008-4#1)(2008-7#1)
how should it##3##3##(1993-11#1)(2008-4#1)(2008-7#1)
how should we##2##3##(2008-10#1)(2008-7#1)
how should##6##2##(1993-11#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-7#2)
how small the##2##3##(2007-12#1)(2008-7#1)
how social##5##2##(1990-12#1)(2008-8#2)(2010-8#1)(2011-2#1)
how some##5##2##(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
how spatial##2##2##(2008-9#1)(2010-6#1)
how specific##3##2##(2008-10#2)(2011-2#1)
how steel is recycled across the country##2##7##(1996-12#1)(1996-3#1)
how stress##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
how students##2##2##(2008-11#1)(2008-12#1)
how substance##2##2##(2008-5#2)
how such a##2##3##(2008-11#1)(2008-7#1)
how such##18##2##(1992-1#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
how that##2##2##(2008-1#1)(2008-4#1)
how the activity of##2##4##(1994-2#1)(2008-5#1)
how the apparent##2##3##(1993-11#1)(1997-2#1)
how the approach##2##3##(2008-4#1)(2010-7#1)
how the brain##2##3##(2008-11#1)(2008-4#1)
how the chronic##2##3##(1995-3#1)(2012-12#1)
how the concept##2##3##(2008-12#1)(2010-11#1)
how the data##4##3##(1992-3#1)(1996-3#1)(1997-1#1)(2010-12#1)
how the genetic##2##3##(2008-8#1)(2009-8#1)
how the government##2##3##(1995-6#1)(2008-10#1)
how the investment##2##3##(1995-1#1)(2012-12#1)
how the measures of##2##4##(1996-12#1)(2008-10#1)
how the measures##4##3##(1996-12#2)(2008-10#1)(2008-11#1)
how the medication##2##3##(1992-12#1)(2008-6#1)
how the number of##2##4##(2008-8#1)(2011-2#1)
how the parameters of##2##4##(2008-10#1)(2008-2#1)
how the program##2##3##(1997-2#1)(2008-11#1)
how the proportion of##2##4##(1995-12#1)(1997-7#1)
how the system##2##3##(1994-1#1)(2008-7#1)
how the technique##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
how the use of##3##4##(1993-2#1)(2008-10#1)(2010-3#1)
how the various##2##3##(2008-3#2)
how the##264##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#4)(1994-3#1)(1995-1#3)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-8#4)(2008-10#19)(2008-11#19)(2008-12#6)(2008-2#9)(2008-3#17)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#11)(2008-8#16)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#4)
how their##14##2##(1991-1#2)(1991-12#1)(1996-3#2)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-3#1)(2012-3#1)(2013-1#2)
how these approaches##2##3##(2008-4#1)(2010-12#1)
how these are##2##3##(2009-5#1)(2013-8#1)
how these new##2##3##(2008-3#1)(2012-2#1)
how these proteins##2##3##(1997-7#1)(2008-11#1)
how these two##2##3##(1993-12#1)(2009-6#1)
how these##73##2##(1990-5#1)(1991-1#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#4)(2008-7#3)(2008-8#5)(2008-9#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
how they affect##4##3##(1991-3#1)(1996-3#1)(2010-3#1)(2013-7#1)
how they allocate##2##3##(1993-2#1)(2008-5#1)
how they are##10##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
how they can be##4##4##(1990-7#1)(1991-3#1)(1997-2#1)(2010-12#1)
how they can##8##3##(1990-7#1)(1991-3#1)(1996-3#1)(1997-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
how they have been##2##4##(1996-12#1)(1997-3#1)
how they have##5##3##(1996-12#1)(1997-3#1)(2007-12#1)(2008-7#1)(2008-8#1)
how they interact##5##3##(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
how they may be##2##4##(1991-3#1)(2008-7#1)
how they may##5##3##(1991-3#1)(1995-2#1)(2008-3#1)(2008-7#2)
how they might be##2##4##(2009-11#1)(2012-2#1)
how they relate to##2##4##(2009-8#1)(2013-8#1)
how they thought##2##3##(1997-4#1)(2007-12#1)
how they were##3##3##(1994-1#1)(2008-10#1)(2009-10#1)
how they would##2##3##(2011-1#1)(2013-1#1)
how they##83##2##(1990-7#1)(1991-2#1)(1991-3#3)(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
how this approach can##2##4##(2008-9#1)(2011-1#1)
how this approach##3##3##(1997-1#1)(2008-9#1)(2011-1#1)
how this information##4##3##(1996-3#1)(2007-12#1)(2010-5#1)(2012-2#1)
how this is achieved##2##4##(2008-9#1)(2012-1#1)
how this is##3##3##(2008-9#1)(2011-2#1)(2012-1#1)
how this may##2##3##(1997-3#1)(2008-8#1)
how this technique##3##3##(2008-11#1)(2009-3#1)(2012-2#1)
how this##58##2##(1991-3#1)(1992-1#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-3#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
how those privileges are lost##2##5##(1991-12#1)(1992-3#1)
how those##7##2##(1991-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(2008-4#1)(2009-9#1)(2013-8#1)
how tissue##2##2##(2009-5#1)(2010-9#1)
how to access##3##3##(2008-12#1)(2008-4#1)(2009-10#1)
how to acquire and##2##4##(2008-4#1)(2012-3#1)
how to address##2##3##(1995-2#1)(1997-1#1)
how to analyze##4##3##(2008-2#1)(2008-4#3)
how to apply them##2##4##(1995-3#1)(2013-8#1)
how to apply##4##3##(1995-3#1)(2008-4#1)(2008-6#1)(2013-8#1)
how to assess##2##3##(2008-4#1)(2008-8#1)
how to avoid##4##3##(1995-2#1)(1997-2#1)(1997-3#1)(2013-1#1)
how to be##2##3##(1994-3#1)(2013-8#1)
how to best##8##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-8#1)(2012-2#1)
how to calculate the##4##4##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)
how to calculate##6##3##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
how to combine##2##3##(1996-6#2)
how to conduct##2##3##(1996-12#1)(2008-4#1)
how to cope##2##3##(1993-12#1)(1995-9#1)
how to create a##2##4##(2008-3#1)(2013-1#1)
how to create##3##3##(1995-3#1)(2008-3#1)(2013-1#1)
how to deal with##4##4##(1993-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
how to define##2##3##(2008-3#1)(2012-2#1)
how to design the##2##4##(2008-1#1)(2010-8#1)
how to design##3##3##(2007-11#1)(2008-1#1)(2010-8#1)
how to detect##2##3##(2008-3#1)(2011-1#1)
how to determine##2##3##(2008-12#1)(2008-4#1)
how to develop a##3##4##(1993-2#1)(2010-11#1)(2013-1#1)
how to develop and implement a##2##6##(1991-12#1)(2007-4#1)
how to develop##7##3##(1991-12#1)(1993-2#1)(1994-3#1)(2007-4#1)(2008-3#1)(2010-11#1)(2013-1#1)
how to diagnose##2##3##(1996-3#1)(2011-2#1)
how to do##2##3##(1995-1#1)(2008-3#1)
how to establish##2##3##(1991-1#1)(2008-3#1)
how to estimate the##2##4##(1997-2#1)(2008-10#1)
how to estimate##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
how to evaluate##2##3##(2007-11#1)(2008-4#1)
how to get##2##3##(2008-12#1)(2008-7#1)
how to handle##4##3##(1994-3#1)(2008-11#1)(2012-2#2)
how to identify##2##3##(1996-2#1)(2009-10#1)
how to implement the##3##4##(1994-2#1)(2008-2#1)(2010-12#1)
how to improve the##2##4##(2008-5#1)(2010-8#1)
how to improve##4##3##(1994-1#1)(1994-2#1)(2008-5#1)(2010-8#1)
how to integrate##2##3##(1993-2#1)(2010-5#1)
how to interpret the##2##4##(2008-9#2)
how to keep your##3##4##(1991-1#1)(2007-10#1)(2008-10#1)
how to live with##2##4##(1995-9#1)(2008-8#1)
how to make an##2##4##(2008-7#1)(2009-10#1)
how to make##4##3##(2008-7#2)(2009-10#1)(2012-2#1)
how to manage##3##3##(1995-12#2)(2010-11#1)
how to measure##2##3##(1995-12#1)(2008-4#1)
how to obtain the##2##4##(1993-12#1)(2008-4#1)
how to obtain##5##3##(1993-12#1)(1995-1#1)(1997-2#1)(2007-12#1)(2008-4#1)
how to optimize##4##3##(2008-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
how to perform##2##3##(2008-1#1)(2008-4#1)
how to plan##3##3##(1992-2#1)(1994-2#1)(2008-11#1)
how to prevent the##2##4##(1990-9#1)(2008-1#1)
how to prevent##4##3##(1990-9#1)(1995-5#1)(1997-1#1)(2008-1#1)
how to promote##2##3##(2008-8#1)(2011-2#1)
how to provide##2##3##(1995-9#1)(2010-11#1)
how to quantify##2##3##(2008-10#1)(2010-11#1)
how to recognise##2##3##(2008-11#1)(2013-8#1)
how to reconcile the##2##4##(1993-11#1)(2008-8#1)
how to reduce the##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
how to reduce##5##3##(1996-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
how to report##2##3##(1993-3#1)(2008-11#1)
how to respond to##3##4##(1991-12#1)(1994-12#1)(2009-11#1)
how to save##2##3##(2008-4#1)(2010-11#1)
how to set up##3##4##(1991-3#1)(2008-4#1)(2008-9#1)
how to structure##2##3##(2008-8#1)(2012-2#1)
how to take##2##3##(1996-5#1)(2012-2#1)
how to treat##5##3##(1992-8#1)(1993-1#1)(1996-3#1)(2008-5#1)(2013-1#1)
how to use the##10##4##(1990-2#2)(2008-11#1)(2008-4#6)(2008-8#1)
how to use them##2##4##(1993-12#1)(2011-2#1)
how to use##27##3##(1990-2#2)(1993-12#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#13)(2008-8#1)(2008-9#2)(2011-2#1)
how to##301##2##(1990-11#1)(1990-2#2)(1990-3#5)(1990-9#1)(1991-1#3)(1991-12#3)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#4)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#1)(1995-9#3)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#4)(2008-10#11)(2008-11#13)(2008-12#7)(2008-2#6)(2008-3#13)(2008-4#47)(2008-5#2)(2008-6#8)(2008-7#5)(2008-8#10)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-11#5)(2010-12#3)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#6)(2013-8#6)
how uncertainties in##2##3##(2008-3#2)
how variation in##2##3##(2008-8#1)(2010-8#1)
how variations in##2##3##(2008-5#1)(2012-2#1)
how various##4##2##(1996-3#1)(1997-3#1)(1997-4#1)(2008-3#1)
how we##9##2##(1994-3#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-12#1)(2008-6#1)(2009-11#1)(2012-12#2)
how well do##2##3##(2008-10#1)(2008-8#1)
how well the##7##3##(1990-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
how well they are##2##4##(2007-10#1)(2008-10#1)
how well they##3##3##(2007-10#2)(2008-10#1)
how well##31##2##(1990-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-1#1)(2012-3#1)
how will##2##2##(1992-12#1)(2008-8#1)
how would##2##2##(1993-12#1)(2007-12#1)
how you##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
how your##2##2##(1995-2#1)(2011-2#1)
how youth##2##2##(2009-7#1)(2010-1#1)
how##1995##1##(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#6)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#12)(1991-12#12)(1991-2#9)(1991-3#11)(1991-6#3)(1991-9#1)(1992-1#9)(1992-10#1)(1992-12#10)(1992-2#11)(1992-3#11)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#9)(1993-11#3)(1993-12#15)(1993-2#20)(1993-3#12)(1993-5#1)(1993-6#2)(1994-1#15)(1994-11#5)(1994-12#17)(1994-2#18)(1994-3#14)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#13)(1995-11#3)(1995-12#18)(1995-2#17)(1995-3#13)(1995-5#9)(1995-6#5)(1995-8#1)(1995-9#4)(1996-1#12)(1996-12#16)(1996-2#17)(1996-3#21)(1996-5#1)(1996-6#6)(1996-9#1)(1997-1#17)(1997-2#24)(1997-3#21)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#7)(1997-8#2)(2006-10#4)(2006-5#1)(2007-10#9)(2007-11#6)(2007-12#41)(2007-2#6)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#18)(2008-10#108)(2008-11#126)(2008-12#44)(2008-2#36)(2008-3#63)(2008-4#103)(2008-5#26)(2008-6#27)(2008-7#70)(2008-8#94)(2008-9#74)(2009-1#2)(2009-10#14)(2009-11#14)(2009-12#15)(2009-2#2)(2009-3#11)(2009-4#5)(2009-5#28)(2009-6#18)(2009-7#14)(2009-8#20)(2009-9#9)(2010-1#10)(2010-10#11)(2010-11#19)(2010-12#17)(2010-2#4)(2010-3#23)(2010-4#5)(2010-5#13)(2010-6#3)(2010-7#2)(2010-8#17)(2010-9#14)(2011-1#26)(2011-2#76)(2011-3#1)(2012-1#8)(2012-12#31)(2012-2#54)(2012-3#35)(2012-8#1)(2013-1#67)(2013-7#6)(2013-8#33)
how&quot##4##1##(1994-2#3)(1996-2#1)
howardi##2##1##(2008-10#2)
however a number of##2##4##(2008-10#1)(2008-11#1)
however a##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)
however be##2##2##(2008-9#1)(2013-1#1)
however in the##2##3##(2007-12#1)(2008-7#1)
however in##7##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
however incomplete and##2##3##(2009-8#1)(2012-2#1)
however it does not##2##4##(1995-12#1)(2008-8#1)
however it is##3##3##(2007-11#1)(2008-4#1)(2010-6#1)
however it##8##2##(1995-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-6#1)(2013-8#1)
however its##2##2##(2008-7#1)(2009-1#1)
however little##2##2##(2008-5#1)(2008-7#1)
however many##2##2##(2007-8#1)(2009-3#1)
however none of the##2##4##(1997-4#1)(2008-10#1)
however only##4##2##(1990-8#1)(1995-11#1)(1995-12#1)(2008-10#1)
however revealed##2##2##(2008-5#1)(2010-3#1)
however small##2##2##(2008-12#1)(2009-8#1)
however some##2##2##(2007-5#1)(2008-11#1)
however the##15##2##(1990-5#1)(1991-6#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)(2012-12#1)(2012-3#1)
however there is no##2##4##(2011-2#1)(2013-1#1)
however there is##4##3##(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
however there##6##2##(2008-1#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
however they were##2##3##(2008-10#1)(2013-1#1)
however they##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
however this##4##2##(1992-8#1)(2008-1#1)(2008-11#1)(2009-8#1)
however until##2##2##(2008-10#1)(2011-2#1)
however was##2##2##(2008-10#1)(2008-8#1)
however with##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#1)
however##1571##1##(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#3)(1990-5#8)(1990-6#7)(1990-7#6)(1990-8#8)(1990-9#7)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#10)(1991-3#5)(1991-4#3)(1991-5#2)(1991-6#10)(1991-8#6)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#11)(1992-4#3)(1992-5#9)(1992-6#12)(1992-8#7)(1992-9#10)(1993-1#5)(1993-11#8)(1993-12#16)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#6)(1993-8#3)(1993-9#8)(1994-1#3)(1994-11#3)(1994-12#6)(1994-2#12)(1994-3#12)(1994-5#3)(1994-6#6)(1994-7#3)(1994-8#9)(1994-9#10)(1995-1#2)(1995-11#7)(1995-12#12)(1995-2#12)(1995-3#6)(1995-4#1)(1995-5#10)(1995-6#12)(1995-8#3)(1995-9#4)(1996-1#3)(1996-11#6)(1996-12#14)(1996-2#8)(1996-3#7)(1996-4#1)(1996-5#8)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#8)(1997-3#12)(1997-4#10)(1997-5#3)(1997-6#2)(1997-7#8)(1997-8#5)(2006-10#1)(2006-11#1)(2006-12#5)(2007-10#8)(2007-11#16)(2007-12#18)(2007-2#5)(2007-4#2)(2007-5#7)(2007-6#1)(2007-7#6)(2007-8#16)(2007-9#1)(2008-1#37)(2008-10#203)(2008-11#60)(2008-12#27)(2008-2#28)(2008-3#37)(2008-4#30)(2008-5#41)(2008-6#20)(2008-7#62)(2008-8#49)(2008-9#30)(2009-1#6)(2009-10#4)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#6)(2009-6#4)(2009-7#4)(2009-8#16)(2009-9#7)(2010-1#5)(2010-10#5)(2010-11#6)(2010-12#6)(2010-2#2)(2010-3#8)(2010-4#11)(2010-5#4)(2010-6#7)(2010-7#3)(2010-8#17)(2011-1#17)(2011-2#56)(2011-3#3)(2012-1#6)(2012-12#28)(2012-2#31)(2012-3#30)(2012-5#1)(2012-6#1)(2013-1#47)(2013-7#5)(2013-8#26)
hoxG gene##3##2##(1990-11#3)
hoxG##4##1##(1990-11#4)
hoxK and hoxG##2##3##(1990-11#2)
hoxK##4##1##(1990-11#4)
hpaG(Xoo)##2##1##(2008-10#2)
hph##4##1##(2008-10#4)
hpi##2##1##(2008-10#2)
hpm##4##1##(2013-1#4)
hpr3##2##1##(1990-5#2)
hprt##6##1##(1996-2#3)(1997-3#3)
hr after exposure##2##3##(1993-9#1)(1994-11#1)
hr after i##3##3##(1992-9#2)(2008-11#1)
hr after the injection##2##4##(1990-12#1)(2008-6#1)
hr after the##5##3##(1990-12#1)(2008-11#1)(2008-6#3)
hr after##23##2##(1990-12#1)(1992-9#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#5)(2011-2#1)(2013-1#1)
hr and the##2##3##(2008-5#2)
hr and##6##2##(2008-11#2)(2008-5#2)(2008-6#2)
hr before##2##2##(2008-10#1)(2013-1#1)
hr caused##2##2##(1993-3#1)(1994-8#1)
hr for##2##2##(2007-5#1)(2013-8#1)
hr in##4##2##(1992-11#1)(1993-6#1)(2008-11#1)(2012-12#1)
hr later##2##2##(1993-9#1)(1994-8#1)
hr of exposure##2##3##(2008-11#1)(2008-5#1)
hr of##7##2##(1994-11#1)(2008-11#4)(2008-5#1)(2008-6#1)
hr significantly##2##2##(1993-9#1)(2008-11#1)
hr was##3##2##(2008-11#3)
hr were##2##2##(1994-8#1)(2013-8#1)
hr##114##1##(1990-12#1)(1991-8#1)(1992-11#1)(1992-9#3)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#7)(1994-11#5)(1994-2#1)(1994-8#6)(1995-2#9)(1996-3#1)(1997-3#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-11#18)(2008-12#1)(2008-2#1)(2008-5#9)(2008-6#17)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#4)(2012-12#6)(2013-1#4)(2013-8#2)
hr(-1)##3##1##(2008-11#2)(2008-8#1)
hr(-1))##2##1##(2008-11#2)
hr) and##2##2##(2008-4#2)
hr)##10##1##(1995-2#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2013-8#1)
hr-1##3##1##(2008-11#3)
hrIL-1 alpha##4##2##(1994-8#4)
hrIL-1##5##1##(1994-8#5)
hrp##8##1##(2008-10#8)
hrpL gene##2##2##(2008-10#2)
hrpL##6##1##(2008-10#6)
hrpS##2##1##(2008-10#2)
hrs after##3##2##(2007-7#1)(2008-12#1)(2011-2#1)
hrs and##2##2##(1991-3#1)(1995-12#1)
hrs of##4##2##(1994-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
hrs##32##1##(1991-3#2)(1992-11#1)(1992-9#1)(1993-8#2)(1994-11#2)(1995-12#2)(2007-7#1)(2008-10#4)(2008-12#5)(2008-8#4)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
hrs)##2##1##(1993-8#1)(2008-12#1)
hs-CRP##11##1##(2008-3#1)(2011-1#2)(2011-2#5)(2012-3#1)(2012-5#2)
hsCRP##7##1##(2008-3#2)(2010-12#1)(2011-2#4)
hsc 70##3##2##(1995-11#3)
hsc70 proteins##2##2##(1993-6#2)
hsc73##2##1##(1994-11#2)
hsp expression##2##2##(2008-5#1)(2012-12#1)
hsp##11##1##(1995-11#1)(2008-5#9)(2012-12#1)
hsp110 and##2##2##(1995-6#2)
hsp110##6##1##(1995-6#6)
hsp25 pseudogene##2##2##(1993-6#2)
hsp25##7##1##(1993-6#7)
hsp27##15##1##(1991-12#2)(1991-2#5)(1993-6#4)(2008-5#4)
hsp40##5##1##(1993-11#4)(2008-4#1)
hsp56##6##1##(1992-11#6)
hsp70 expression##5##2##(1994-11#3)(2013-1#2)
hsp70 gene##2##2##(1994-11#1)(1995-2#1)
hsp70 genes##2##2##(1994-11#1)(1995-2#1)
hsp70 in##4##2##(1994-11#4)
hsp70 is##2##2##(1994-11#2)
hsp70##38##1##(1993-8#1)(1994-11#23)(1994-8#3)(1995-2#2)(1995-6#2)(2008-4#1)(2009-5#1)(2012-12#1)(2013-1#4)
hsp90 alpha##2##2##(1994-8#2)
hsp90 is##2##2##(1996-12#2)
hsp90##12##1##(1990-11#2)(1993-8#1)(1994-8#2)(1996-12#5)(2008-4#1)(2012-12#1)
hsps##3##1##(2009-5#1)(2012-12#2)
hsr203##2##1##(2008-10#2)
html##5##1##(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
html)##5##1##(2008-7#4)(2010-12#1)
http##67##1##(1997-6#1)(1997-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#15)(2011-2#11)(2012-1#10)(2013-1#1)(2013-8#7)
huanglongbing##3##1##(2011-2#2)(2013-8#1)
huasteco virus (PHV)##2##3##(2008-10#2)
huasteco virus##4##2##(2008-10#4)
huasteco##5##1##(2008-10#5)
hub##3##1##(1992-1#1)(2009-3#1)(2009-8#1)
hubs##3##1##(2008-11#1)(2008-2#1)(2013-8#1)
hue of the##2##3##(2008-5#2)
hue of##3##2##(2008-5#2)(2013-8#1)
hue##6##1##(2008-5#3)(2008-8#1)(2011-2#1)(2013-8#1)
huge amounts of##3##3##(2008-7#1)(2012-1#1)(2012-2#1)
huge amounts##4##2##(1994-5#1)(2008-7#1)(2012-1#1)(2012-2#1)
huge##60##1##(1994-5#1)(1995-10#1)(1995-12#1)(1997-6#1)(1997-8#3)(2007-12#2)(2007-8#4)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#3)(2008-7#8)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
hugely##2##1##(1992-9#1)(2008-6#1)
hugin neurons##2##2##(2008-9#2)
hugin neuropeptides##2##2##(2008-9#2)
hugin##7##1##(2008-9#7)
hull flour presented##2##3##(2012-2#2)
hull flour##6##2##(2012-2#6)
hull percentage##2##2##(2008-5#2)
hull##23##1##(2007-12#1)(2008-10#1)(2008-12#3)(2008-5#7)(2008-6#1)(2008-8#2)(2012-2#8)
hull-less soybean flour##5##3##(2012-2#5)
hulls##2##1##(2008-11#1)(2008-12#1)
human 1##7##2##(1990-12#2)(1992-12#2)(1993-3#3)
human 15-lipoxygenase was##2##3##(1995-5#2)
human 15-lipoxygenase##4##2##(1995-5#4)
human 293 cells##2##3##(2008-11#2)
human 5-HT1A##2##2##(1993-9#2)
human 5-HT2 and 5-HT1C receptors##2##5##(1991-12#2)
human A(3) adenosine receptor antagonists##2##5##(2008-4#2)
human A(3) adenosine receptor##3##4##(2008-4#3)
human A(3) adenosine##4##3##(2008-4#4)
human A(3)##7##2##(2008-4#7)
human AML blasts##2##3##(2006-6#1)(2011-2#1)
human AT2R gene##2##3##(1994-9#2)
human AT2R##4##2##(1994-9#4)
human Alu##2##2##(1994-12#1)(1995-3#1)
human B cell line##4##4##(1995-2#1)(2008-8#3)
human B cell##10##3##(1991-3#1)(1994-9#1)(1995-2#1)(2008-11#3)(2008-4#1)(2008-8#3)
human B cells##4##3##(1991-9#2)(2008-11#2)
human B lymphocytes##5##3##(1991-3#1)(1992-8#2)(1994-3#1)(2008-4#1)
human B##21##2##(1990-12#1)(1991-3#2)(1991-9#2)(1992-8#2)(1993-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-11#5)(2008-4#2)(2008-8#3)
human C##2##2##(1994-8#1)(2008-4#1)
human C5a##2##2##(1994-6#2)
human CES1##2##2##(2009-9#2)
human CFTR cDNA##2##3##(1994-5#1)(2011-3#1)
human CSF##2##2##(1996-2#2)
human CaD##2##2##(1993-11#2)
human DDK##3##2##(2012-3#3)
human DNA##13##2##(1991-9#1)(1994-12#2)(1995-6#1)(1996-6#2)(1997-7#1)(2008-12#4)(2008-4#1)(2008-5#1)
human E2 conjugating enzyme##2##4##(2009-7#2)
human ER##3##2##(1993-6#2)(2008-6#1)
human ES cell##3##3##(2008-9#3)
human ES cells##4##3##(2008-8#1)(2008-9#3)
human ES##7##2##(2008-8#1)(2008-9#6)
human ESC##2##2##(2008-10#1)(2008-11#1)
human ETA receptor##2##3##(1992-9#2)
human FLN29##2##2##(2009-7#2)
human GABAA receptors##2##3##(1995-11#2)
human GABAA##4##2##(1995-11#4)
human GH##3##2##(1990-12#1)(2007-11#1)(2008-1#1)
human GPIIb##2##2##(1994-12#2)
human GTP cyclohydrolase I##2##4##(1992-8#2)
human HBV##2##2##(1993-8#1)(1995-2#1)
human HGF##3##2##(1991-6#1)(1992-12#2)
human HP1##2##2##(2013-1#2)
human IA2##2##2##(1990-5#2)
human IBD##2##2##(2008-10#2)
human ICAM-1##2##2##(2008-10#2)
human IDO gene##2##3##(1992-11#2)
human IGF-I##2##2##(1992-9#1)(1996-2#1)
human IL-13##2##2##(2008-4#2)
human IL-5##2##2##(1995-6#1)(2008-4#1)
human IL-6##2##2##(1990-5#1)(2008-8#1)
human IgA##2##2##(1994-8#2)
human IgG##10##2##(1990-12#1)(1994-12#1)(1996-12#3)(2008-10#5)
human IgG1##4##2##(1994-12#1)(1996-12#1)(1997-2#1)(2009-2#1)
human KU812##2##2##(1990-5#2)
human L17A##2##2##(1991-6#2)
human LCAT##2##2##(1993-6#2)
human LPL cDNA##2##3##(1995-6#1)(2008-11#1)
human LPL##4##2##(1995-6#1)(2008-11#3)
human MAbs##2##2##(2008-11#2)
human MCF-7##3##2##(1992-12#1)(1993-6#1)(2012-2#1)
human MDS##2##2##(2010-8#2)
human MHC##4##2##(2008-4#2)(2008-8#1)(2008-9#1)
human MSCs (hMSCs)##2##3##(2010-8#1)(2012-7#1)
human MTHFR##2##2##(2008-8#2)
human MUC5AC##3##2##(1997-7#3)
human Mss4##2##2##(1995-8#2)
human NGF gene##2##3##(1990-8#2)
human NGF##7##2##(1990-8#7)
human NK cells##4##3##(2008-4#1)(2008-8#3)
human NK##5##2##(2008-4#2)(2008-8#3)
human NMJs##2##2##(1992-8#2)
human P2##2##2##(1995-12#2)
human P2Y(1)##2##2##(2008-4#2)
human PAR1 genes##2##3##(2008-7#2)
human PBL##5##2##(1991-9#1)(1997-4#2)(2008-11#2)
human Plasmodium##2##2##(2011-1#1)(2012-3#1)
human RNA##2##2##(2008-2#1)(2008-7#1)
human RNase##4##2##(2009-2#4)
human S100##2##2##(1991-2#1)(1993-12#1)
human Schwann cells##3##3##(1995-2#2)(2008-7#1)
human Schwann##4##2##(1995-2#3)(2008-7#1)
human T cell clones exhibiting natural killer-like activity##3##8##(2008-11#3)
human T cell leukemia virus##2##5##(2008-11#1)(2012-12#1)
human T cell lines##2##4##(1995-12#1)(2008-4#1)
human T cell##12##3##(1995-12#2)(2008-11#5)(2008-4#2)(2008-8#1)(2011-1#1)(2012-12#1)
human T cells##11##3##(1990-12#1)(1991-2#1)(1992-12#1)(2008-11#4)(2008-4#3)(2011-1#1)
human T lymphocytes##4##3##(1992-12#1)(1992-6#1)(2008-4#2)
human T##31##2##(1990-12#1)(1991-2#1)(1992-12#2)(1992-6#1)(1994-12#2)(1995-12#2)(1995-2#1)(2008-11#10)(2008-4#7)(2008-8#1)(2011-1#2)(2012-12#1)
human T-cell leukemia virus##3##4##(1991-12#1)(2008-11#1)(2012-12#1)
human T-cell lines##2##3##(1993-6#1)(1997-3#1)
human T-cell##9##2##(1990-10#1)(1991-12#1)(1992-12#1)(1993-6#1)(1997-2#1)(1997-3#1)(2008-11#1)(2012-12#2)
human T-lymphoblast leukemia##2##3##(1991-4#2)
human T-lymphotropic##2##2##(1991-12#2)
human TATA-binding protein##2##3##(1993-8#1)(2008-2#1)
human TGF-beta type II##2##4##(1993-3#1)(1997-2#1)
human TIMP-2##3##2##(2010-1#3)
human TNF##2##2##(1997-2#1)(2008-11#1)
human U1 snRNP-specific A protein##2##5##(1991-6#2)
human U1-A##2##2##(1991-6#2)
human U1A protein##2##3##(1997-2#2)
human VEGF##2##2##(2008-8#1)(2013-8#1)
human VLDL receptor##2##3##(1995-6#2)
human VLDL##4##2##(1995-6#4)
human X##4##2##(1990-12#1)(1990-3#1)(2008-7#1)(2010-5#1)
human XPAC##2##2##(1991-12#2)
human ability##2##2##(1995-5#1)(2012-2#1)
human acidic fibroblast growth factor##3##5##(1990-8#2)(1991-2#1)
human activated protein C##2##4##(1993-11#1)(2007-12#1)
human activities##8##2##(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-9#1)
human activity##3##2##(1992-3#1)(2011-2#1)(2013-1#1)
human acute monocytic##2##3##(1993-6#1)(1997-1#1)
human acute##7##2##(1991-9#1)(1993-6#1)(1995-11#1)(1997-1#1)(1997-7#1)(2006-6#1)(2011-2#1)
human acylamino acid-releasing enzyme##2##4##(1996-2#2)
human adenovirus##8##2##(1992-9#2)(2013-8#6)
human adipocyte precursor cells##2##4##(2008-5#2)
human adipose##3##2##(1993-3#1)(2008-5#2)
human adipose-derived stem cells (hASCs)##2##5##(2012-5#1)(2012-6#1)
human adrenal autoantibodies##2##3##(1992-8#2)
human adrenal tumor##2##3##(1990-11#1)(1990-12#1)
human adrenal##7##2##(1990-11#1)(1990-12#1)(1992-8#3)(1994-5#1)(1995-12#1)
human adult lung##3##3##(1994-11#2)(1994-9#1)
human adult##7##2##(1991-11#1)(1994-11#3)(1994-9#1)(2008-9#1)(2013-1#1)
human aging##6##2##(2008-11#1)(2008-7#1)(2009-8#2)(2010-1#2)
human airway##3##2##(1993-8#1)(1994-11#1)(1996-12#1)
human airways##2##2##(1992-3#1)(1997-1#1)
human albumin##5##2##(1990-12#1)(1993-6#1)(1996-1#1)(1997-3#1)(2013-1#1)
human alpha adrenergic##2##3##(1994-6#2)
human alpha##15##2##(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#1)(1993-12#1)(1994-6#3)(1994-9#1)(1995-11#5)
human alveolar type II (L-132) cells##2##6##(1993-3#2)
human amnion##2##2##(1993-3#1)(1994-12#1)
human amniotic##2##2##(1993-3#1)(2008-8#1)
human and animal fasciolosis##2##4##(2008-8#2)
human and animal health##3##4##(2008-10#1)(2012-1#1)(2013-1#1)
human and animal##23##3##(1994-6#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-8#3)(2008-9#2)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
human and bovine##5##3##(1991-6#1)(1992-10#1)(1994-6#1)(1995-8#1)(2008-10#1)
human and canine##2##3##(2008-8#1)(2011-2#1)
human and chimpanzee##3##3##(1991-12#1)(2008-11#1)(2010-5#1)
human and economic##3##3##(1994-2#1)(2007-12#2)
human and mouse gene##2##4##(1997-7#1)(2008-4#1)
human and mouse##15##3##(1991-6#1)(1993-12#1)(1993-2#1)(1997-7#2)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
human and murine Sm B##2##5##(1993-2#2)
human and murine interleukin##2##4##(1993-8#1)(2008-4#1)
human and murine##13##3##(1990-12#1)(1992-2#2)(1993-2#3)(1993-8#2)(1994-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
human and non-human##2##3##(1993-5#1)(2012-12#1)
human and phage DNA##2##4##(1991-9#2)
human and rat liver##3##4##(1994-3#1)(1994-8#2)
human and rat##17##3##(1990-2#1)(1991-12#3)(1992-10#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-2#1)(1996-12#1)(2008-4#3)(2012-12#1)
human and rodent##9##3##(1992-6#2)(1993-12#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-4#1)(2008-7#2)
human and yeast##4##3##(1993-6#2)(2010-2#1)(2012-3#1)
human and##133##2##(1990-12#1)(1990-2#1)(1991-12#4)(1991-5#2)(1991-6#2)(1991-9#2)(1992-10#2)(1992-2#2)(1992-3#1)(1992-6#2)(1993-12#3)(1993-2#4)(1993-5#1)(1993-6#2)(1993-8#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1997-6#2)(1997-7#2)(1997-8#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#9)(2008-7#6)(2008-8#6)(2008-9#4)(2009-7#1)(2010-11#1)(2010-2#2)(2010-5#5)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
human androgen receptor##3##3##(1991-5#1)(1991-9#1)(2008-4#1)
human angiotensin II type 2 receptor##2##6##(1994-11#2)
human angiotensin II type##3##4##(1992-3#1)(1994-11#2)
human angiotensin##4##2##(1992-3#1)(1994-11#2)(1995-12#1)
human antibodies##2##2##(2008-11#2)
human antibody##5##2##(2008-10#1)(2008-11#3)(2009-2#1)
human antigen-specific T cells##2##4##(2008-9#2)
human antithrombin III##3##3##(1992-10#1)(2008-7#2)
human antithrombin##4##2##(1992-10#2)(2008-7#2)
human aortic##3##2##(1994-9#1)(1996-2#1)(2007-11#1)
human apoB mRNA editing protein##3##5##(1994-8#3)
human apoB mRNA##5##3##(1992-11#2)(1994-8#3)
human apoE##3##2##(1995-6#2)(2008-9#1)
human apolipoprotein B mRNA##2##4##(1992-11#1)(1994-8#1)
human apolipoprotein B##4##3##(1992-11#1)(1994-8#1)(1995-2#2)
human apolipoprotein##9##2##(1991-12#1)(1992-11#2)(1993-8#1)(1994-8#1)(1995-2#2)(1995-6#1)(2008-6#1)
human arterial smooth-muscle##2##3##(1995-8#2)
human arterial##3##2##(1995-8#2)(2010-7#1)
human as##2##2##(2010-11#1)(2013-1#1)
human astrocytes##2##2##(2013-1#2)
human astrocytoma cells##3##3##(1993-6#1)(1993-8#1)(1995-12#1)
human astrocytoma##5##2##(1993-6#2)(1993-8#1)(1995-12#2)
human atherosclerotic##3##2##(1997-8#1)(2012-2#1)(2013-1#1)
human autoimmune##3##2##(1995-2#1)(1996-2#1)(2007-5#1)
human autopsy##2##2##(1995-3#1)(2013-1#1)
human axillary skin##2##3##(2008-5#2)
human beauty##2##2##(2008-5#2)
human behavior##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
human behaviors##2##2##(2008-11#2)
human behaviour in##2##3##(1996-12#1)(2009-10#1)
human behaviour##3##2##(1996-12#1)(2009-10#1)(2010-2#1)
human being##5##2##(2010-10#1)(2010-8#2)(2011-3#1)(2013-1#1)
human beings##13##2##(1992-9#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2010-1#1)(2012-2#2)(2013-1#1)
human beta MHC##2##3##(1992-11#2)
human beta##7##2##(1990-11#2)(1992-11#2)(1993-8#2)(1995-11#1)
human beta-1##2##2##(2008-9#2)
human beta-actin##2##2##(1996-2#1)(2008-11#1)
human beta-globin gene##2##3##(2008-8#2)
human beta-globin##3##2##(1993-6#1)(2008-8#2)
human beta2-microglobulin##2##2##(1997-9#2)
human beta2m##3##2##(1997-9#3)
human binge eating##2##3##(2008-4#2)
human biopsy##2##2##(1996-12#1)(2008-5#1)
human bladder##7##2##(1992-6#1)(1994-2#3)(2008-10#2)(2008-4#1)
human blood and##2##3##(1997-2#1)(2008-10#1)
human blood cells##2##3##(2008-9#1)(2009-11#1)
human blood coagulation##3##3##(1997-4#2)(2008-8#1)
human blood for##2##3##(1993-3#1)(2012-12#1)
human blood mononuclear cells##2##4##(2008-4#2)
human blood plasma samples##3##4##(2008-10#3)
human blood plasma##8##3##(1997-7#1)(2008-10#7)
human blood serum##6##3##(2008-10#5)(2008-3#1)
human blood##40##2##(1990-7#2)(1990-8#1)(1993-3#2)(1994-6#1)(1994-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-7#2)(2008-10#17)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-5#1)(2012-12#1)
human body is##4##3##(2008-10#1)(2008-7#1)(2009-5#1)(2010-11#1)
human body##37##2##(1990-2#1)(1991-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#4)(2008-8#2)(2009-12#1)(2009-5#2)(2010-10#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
human bone cells##2##3##(1994-6#2)
human bone marrow mesenchymal stem cells##6##6##(2008-11#3)(2009-12#1)(2012-1#2)
human bone marrow mesenchymal##7##4##(2008-11#3)(2009-12#1)(2012-1#3)
human bone marrow##16##3##(2008-11#8)(2008-9#2)(2009-12#1)(2009-4#1)(2010-6#1)(2012-1#3)
human bone##27##2##(1991-5#1)(1994-2#1)(1994-6#2)(1995-6#3)(2007-11#1)(2008-11#8)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-1#3)(2013-8#1)
human bone-marrow-derived side population cells##2##5##(2010-6#2)
human bones##3##2##(1995-6#1)(2008-10#2)
human brain and##5##3##(1993-3#1)(1997-7#1)(2008-7#1)(2009-8#1)(2012-12#1)
human brain cDNA libraries##2##4##(1996-8#1)(1997-2#1)
human brain cDNA##5##3##(1992-3#1)(1993-8#2)(1996-8#1)(1997-2#1)
human brain progenitor cells##2##4##(2008-7#2)
human brain temperature##2##3##(2008-1#2)
human brain tissue##5##3##(1993-9#1)(1995-12#1)(1996-12#2)(1997-2#1)
human brain tumor##2##3##(1990-6#1)(1995-2#1)
human brain tumors##3##3##(1995-12#1)(2008-5#2)
human brain##73##2##(1990-6#2)(1990-8#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#4)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-5#3)(1996-8#1)(1997-2#4)(1997-3#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
human brains##4##2##(1991-7#1)(1992-8#1)(1996-5#1)(2008-7#1)
human breast adenocarcinoma##2##3##(1993-9#1)(2012-2#1)
human breast and ovarian cancer cells##2##6##(1997-7#2)
human breast and ovarian cancer##3##5##(1997-7#3)
human breast and##4##3##(1993-1#1)(1997-7#3)
human breast cancer MCF-7##3##4##(1993-9#1)(2008-11#1)(2011-2#1)
human breast cancer and adenofibromas##2##5##(1993-5#1)(1994-2#1)
human breast cancer and estrogen independent MXT##2##7##(1993-1#2)
human breast cancer and##6##4##(1993-1#3)(1993-5#1)(1994-2#1)(1997-7#1)
human breast cancer cell line##4##5##(1990-11#1)(2008-11#2)(2012-3#1)
human breast cancer cell lines##5##5##(1992-4#1)(1997-7#1)(2008-11#3)
human breast cancer cell##11##4##(1990-11#1)(1992-4#1)(1997-7#1)(2008-11#7)(2012-3#1)
human breast cancer cells in##4##5##(1994-12#2)(1994-8#1)(2008-11#1)
human breast cancer cells##18##4##(1992-4#1)(1992-5#1)(1992-9#2)(1994-12#2)(1994-8#1)(1995-10#1)(2008-11#6)(2011-2#1)(2012-3#1)(2013-1#2)
human breast cancer##53##3##(1990-11#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-9#1)(1997-7#2)(2008-11#14)(2008-4#1)(2009-9#1)(2011-2#3)(2012-3#4)(2013-1#2)
human breast carcinoma##2##3##(1992-7#1)(2011-2#1)
human breast infiltrating ductal carcinoma of non special type##2##9##(2007-5#2)
human breast tumor##4##3##(1990-7#1)(1992-12#1)(1995-10#1)(1995-2#1)
human breast##81##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-9#2)(1993-1#8)(1993-11#4)(1993-12#1)(1993-5#1)(1993-9#2)(1994-12#4)(1994-2#2)(1994-7#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-9#1)(1996-10#1)(1997-7#5)(2007-5#2)(2008-10#1)(2008-11#14)(2008-3#3)(2008-4#1)(2009-12#2)(2009-9#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#2)
human c-Myc protein that is initiated at a non-AUG codon in exon 1##2##13##(1990-5#2)
human c-fos gene##3##3##(1991-12#3)
human c-fos##4##2##(1991-12#4)
human c-myb##2##2##(1990-6#1)(1994-10#1)
human c-myc gene##5##3##(1992-8#3)(1993-3#1)(2008-11#1)
human c-myc##7##2##(1992-8#3)(1993-3#1)(1993-8#1)(1997-7#1)(2008-11#1)
human cDNA clone##2##3##(1991-5#1)(2008-11#1)
human cDNA clones##2##3##(1993-6#1)(1996-10#1)
human cDNA##16##2##(1991-5#1)(1991-6#4)(1993-6#1)(1993-9#1)(1994-8#2)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-9#1)
human cDNAs##3##2##(1990-12#1)(1994-12#1)(2008-11#1)
human cadaveric##3##2##(2006-12#1)(2008-8#1)(2013-1#1)
human cancer and##2##3##(2007-10#1)(2008-11#1)
human cancer cell lines##9##4##(1995-12#1)(2008-11#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
human cancer cell##10##3##(1993-6#1)(1995-12#1)(2008-11#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
human cancer cells##10##3##(1990-2#1)(1994-11#1)(1997-4#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)
human cancer patients##2##3##(1995-12#1)(1997-4#1)
human cancer tissues##2##3##(2008-11#1)(2013-1#1)
human cancer##35##2##(1990-11#2)(1990-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-12#2)(1997-4#2)(2007-10#1)(2008-11#8)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
human cancers##33##2##(1992-5#1)(1995-2#1)(1997-7#2)(2007-11#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-5#2)(2009-9#3)(2011-1#1)(2011-2#6)(2012-12#5)(2012-2#1)(2013-1#6)
human capital investment##2##3##(2010-5#2)
human capital##4##2##(2008-1#1)(2010-5#3)
human carcinogen##2##2##(1993-11#1)(2008-11#1)
human carcinoma cell lines##3##4##(1995-9#1)(2008-5#1)(2013-1#1)
human carcinoma##5##2##(1991-9#1)(1992-9#1)(1995-9#1)(2008-5#1)(2013-1#1)
human caring##2##2##(2008-1#2)
human cases##3##2##(2008-5#1)(2008-8#1)(2013-1#1)
human cell line KG-1##5##4##(1995-8#2)(1996-2#3)
human cell line##14##3##(1990-5#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#3)(2008-10#1)(2008-11#2)(2008-9#2)
human cell lines##14##3##(1992-3#1)(1993-11#1)(1994-6#1)(1996-2#1)(1997-7#2)(2008-11#6)(2008-8#1)(2008-9#1)
human cell proliferation-associated nucleolar protein p120##2##6##(1990-11#2)
human cell types##2##3##(2008-11#1)(2009-3#1)
human cell##36##2##(1990-11#2)(1990-5#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#4)(1997-7#3)(2008-10#1)(2008-11#9)(2008-4#1)(2008-8#1)(2008-9#3)(2009-3#1)(2012-2#1)
human cells and##4##3##(1994-12#1)(2008-11#3)
human cells by##2##3##(1994-3#1)(2008-2#1)
human cells in##4##3##(1997-4#1)(1997-7#2)(2012-12#1)
human cells to##3##3##(1993-3#1)(1994-5#1)(1996-12#1)
human cells##50##2##(1991-5#1)(1992-3#2)(1992-9#1)(1993-3#3)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-7#5)(2007-8#1)(2008-1#2)(2008-11#12)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)
human cerebellum##4##2##(1991-12#2)(1993-9#2)
human cerebral cortex##3##3##(1991-9#1)(1996-5#2)
human cerebrospinal fluid (CSF)##3##4##(1991-2#1)(1993-8#1)(1996-2#1)
human cerebrospinal fluid##5##3##(1991-2#2)(1993-8#2)(1996-2#1)
human cerebrum##8##2##(2008-9#8)
human cervical cancer HeLa cells and##2##6##(2008-8#2)
human cervical cancer##5##3##(2008-11#1)(2008-8#2)(2010-12#1)(2010-3#1)
human cervical spine##2##3##(2009-4#2)
human cervical##8##2##(1992-2#1)(2008-11#1)(2008-8#2)(2009-4#2)(2010-12#1)(2010-3#1)
human children##2##2##(2012-2#2)
human chondrocytes##4##2##(2008-11#3)(2011-2#1)
human chorionic gonadotropin (hCG)##6##4##(1992-8#2)(1993-6#1)(1994-8#1)(1997-1#1)(2011-1#1)
human chorionic gonadotropin##14##3##(1992-8#2)(1993-12#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-4#1)(2011-1#1)
human chorionic##15##2##(1992-8#2)(1993-12#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-4#1)(2011-1#1)
human chromosome 1##3##3##(1994-12#1)(1997-8#1)(2008-9#1)
human chromosome 21##4##3##(1995-8#1)(1997-2#1)(1997-8#1)(2008-7#1)
human chromosome 21q22##2##3##(1997-2#1)(1997-8#1)
human chromosome 4p16##2##3##(1996-8#2)
human chromosome 7##3##3##(1996-6#3)
human chromosome Xq28 region##2##4##(1996-10#2)
human chromosome##36##2##(1990-5#1)(1991-9#1)(1993-2#1)(1994-11#1)(1994-12#3)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-6#3)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2012-3#1)
human chromosome-3-specific##2##2##(1994-12#2)
human chromosomes##6##2##(1991-6#1)(1993-11#1)(2007-11#3)(2008-7#1)
human chronic##4##2##(1991-4#1)(1991-6#1)(2011-2#2)
human clinical trials##3##3##(2008-11#1)(2008-5#1)(2009-11#1)
human clinical##8##2##(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-11#1)(2012-3#1)
human clotting factor IX (hFIX)##2##5##(2008-8#2)
human clotting factor IX##5##4##(2008-8#3)(2008-9#2)
human coagulation factor XIII##2##4##(2008-11#2)
human coagulation factor##4##3##(2008-11#2)(2008-8#1)(2008-9#1)
human collagen type IV##2##4##(2008-11#2)
human colligin-2##2##2##(1997-7#2)
human colon adenocarcinoma##2##3##(1990-12#1)(2008-11#1)
human colon cancer cell line##3##5##(1992-8#1)(1993-3#1)(1997-2#1)
human colon cancer cell lines##2##5##(1994-8#2)
human colon cancer cell##5##4##(1992-8#1)(1993-3#1)(1994-8#2)(1997-2#1)
human colon cancer cells##4##4##(1993-3#1)(1994-8#2)(1995-2#1)
human colon cancer##12##3##(1992-8#1)(1993-3#2)(1994-8#4)(1995-2#1)(1997-2#1)(1997-4#2)(2013-1#1)
human colon carcinoma cell line to transforming growth factor-beta 1##2##10##(1992-3#2)
human colon carcinoma cell line##4##5##(1992-3#2)(1992-9#2)
human colon carcinoma##7##3##(1992-3#2)(1992-9#2)(1994-8#1)(1995-3#1)(1995-5#1)
human colon cells##5##3##(1997-4#5)
human colon tissue##2##3##(1997-4#1)(2008-3#1)
human colon tumor cell lines were##2##6##(1992-2#2)
human colon tumor cell lines##6##5##(1992-2#6)
human colon##37##2##(1990-12#1)(1992-2#6)(1992-3#2)(1992-8#1)(1992-9#2)(1993-3#2)(1994-8#5)(1995-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#9)(2008-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
human colon-carcinoma cell lines##2##4##(1992-9#2)
human colonic##4##2##(1993-9#2)(1994-3#1)(2008-2#1)
human complement##4##2##(1993-11#1)(1995-11#1)(1997-9#1)(2008-4#1)
human condition##5##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
human cord blood by##2##4##(2008-10#1)(2008-9#1)
human cord blood##8##3##(2008-10#3)(2008-8#2)(2008-9#3)
human coronary arteries in##2##4##(2008-7#1)(2012-3#1)
human coronary##3##2##(1992-4#1)(2008-7#1)(2012-3#1)
human cortex##3##2##(1994-2#1)(1995-12#1)(1997-7#1)
human counterparts##2##2##(1992-3#1)(1997-7#1)
human creatine##2##2##(1990-11#1)(1991-2#1)
human culture##2##2##(1993-3#1)(2012-2#1)
human cultured##2##2##(1990-2#1)(1994-9#1)
human cutaneous##4##2##(1995-2#1)(2008-4#1)(2008-5#1)(2012-2#1)
human cytochrome##3##2##(1990-11#1)(1994-6#1)(2008-10#1)
human cytomegalovirus (HCMV)##4##3##(1993-8#1)(1996-12#1)(1997-3#1)(2008-9#1)
human cytomegalovirus##9##2##(1993-8#2)(1996-12#2)(1997-3#2)(1997-4#1)(2008-11#1)(2008-9#1)
human cytosolic phospholipase A2 (cPLA2)##3##5##(1993-11#1)(1993-6#1)(1994-11#1)
human cytosolic phospholipase A2##5##4##(1993-11#1)(1993-6#2)(1994-11#2)
human cytosolic##7##2##(1993-11#1)(1993-6#2)(1994-11#4)
human data##4##2##(2008-10#1)(2008-7#1)(2011-1#2)
human degenerative diseases##2##3##(1994-11#1)(2008-10#1)
human dendritic cells##4##3##(2008-4#1)(2008-8#2)(2012-2#1)
human dendritic##6##2##(2008-10#1)(2008-4#2)(2008-8#2)(2012-2#1)
human dermal fibroblasts##3##3##(1990-5#2)(2008-5#1)
human dermal##5##2##(1990-5#2)(2008-5#2)(2013-8#1)
human dermis##2##2##(2008-5#2)
human development and##3##3##(1993-12#1)(2008-11#1)(2009-3#1)
human development##10##2##(1992-5#1)(1993-12#2)(1995-3#1)(1995-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-3#1)
human diabetes##2##2##(2008-1#1)(2011-2#1)
human digestive tract##2##3##(2012-2#2)
human dihydrolipoamide dehydrogenase##3##3##(1995-6#3)
human diploid fibroblasts##2##3##(1997-1#1)(2008-11#1)
human diploid##3##2##(1997-1#2)(2008-11#1)
human disease and the##2##4##(2008-4#1)(2013-8#1)
human disease and##3##3##(2007-12#1)(2008-4#1)(2013-8#1)
human disease genes##3##3##(1997-8#1)(2007-7#1)(2012-3#1)
human disease has been##2##4##(2008-4#2)
human disease has##3##3##(2008-4#2)(2009-9#1)
human disease##42##2##(1991-9#2)(1994-5#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-4#12)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
human diseases and##2##3##(2010-11#1)(2012-12#1)
human diseases##30##2##(1990-5#1)(1993-3#1)(1994-11#1)(1994-5#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
human disorders##7##2##(1990-11#2)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
human dopamine##3##2##(1993-3#1)(1997-5#2)
human embryo##2##2##(2008-11#1)(2008-9#1)
human embryonic kidney (HEK) 293 cells##3##6##(2009-12#1)(2013-1#2)
human embryonic kidney##4##3##(2008-11#1)(2009-12#1)(2013-1#2)
human embryonic lung##2##3##(2008-11#2)
human embryonic stem cell culture##2##5##(2008-8#1)(2008-9#1)
human embryonic stem cell line##2##5##(2008-11#1)(2008-8#1)
human embryonic stem cell lines##3##5##(2008-8#2)(2008-9#1)
human embryonic stem cell##8##4##(2008-11#1)(2008-8#4)(2008-9#3)
human embryonic stem cells (hESC)##2##5##(2008-11#1)(2008-9#1)
human embryonic stem cells to##3##5##(2008-8#1)(2008-9#1)(2009-3#1)
human embryonic stem cells##11##4##(2008-11#2)(2008-8#1)(2008-9#4)(2009-3#1)(2012-3#2)(2012-5#1)
human embryonic stem##21##3##(2008-11#3)(2008-8#7)(2008-9#7)(2009-3#1)(2012-3#2)(2012-5#1)
human embryonic##28##2##(1992-3#1)(2008-11#6)(2008-8#7)(2008-9#7)(2009-12#1)(2009-3#1)(2012-3#2)(2012-5#1)(2013-1#2)
human endometrial stromal cells##4##4##(1994-9#3)(1995-12#1)
human endometrial##10##2##(1992-2#2)(1994-9#5)(1995-12#2)(2013-1#1)
human endometrium##12##2##(1994-9#9)(2010-12#1)(2012-3#1)(2013-8#1)
human endonexin II##3##3##(1994-11#3)
human endothelial cells by##2##4##(1994-8#1)(2010-1#1)
human endothelial cells##12##3##(1992-2#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-7#2)(2008-11#1)(2008-4#1)(2010-1#1)
human endothelial##14##2##(1992-2#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2013-1#1)
human eosinophils##3##2##(1992-11#1)(1994-11#1)(2008-4#1)
human epidermal growth factor receptor 2##2##6##(2011-2#1)(2012-3#1)
human epidermal growth factor receptor##4##5##(2008-7#1)(2011-2#2)(2012-3#1)
human epidermal growth factor##6##4##(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-3#1)
human epidermal keratinocytes##6##3##(1992-2#3)(2008-4#2)(2008-5#1)
human epidermal##16##2##(1992-2#3)(1992-3#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-9#1)(2011-2#2)(2012-3#1)
human epidermis and##2##3##(2008-3#1)(2008-4#1)
human epidermis##15##2##(2008-3#1)(2008-4#1)(2008-5#12)(2012-2#1)
human epithelial cells##2##3##(1990-2#2)
human epithelial##8##2##(1990-12#1)(1990-2#2)(1992-2#1)(1994-9#2)(2008-11#2)
human error in##2##3##(1993-9#1)(2007-4#1)
human error##4##2##(1993-9#1)(2007-4#1)(2009-10#2)
human erythrocyte ghosts##2##3##(1994-2#1)(2008-10#1)
human erythrocyte glucose transporter is##2##5##(1990-11#2)
human erythrocyte membranes##5##3##(1993-9#1)(1994-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
human erythrocyte##20##2##(1990-11#2)(1990-12#1)(1991-2#2)(1992-1#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-8#2)(2009-8#1)
human erythrocytes and##3##3##(1990-12#1)(1991-5#1)(1994-8#1)
human erythrocytes by##2##3##(1991-5#1)(1992-6#1)
human erythrocytes##26##2##(1990-11#2)(1990-12#4)(1991-5#5)(1992-6#2)(1992-8#3)(1993-8#1)(1994-8#2)(1995-6#3)(2008-10#1)(2008-11#2)(2008-8#1)
human erythroleukemia cell line##2##4##(1990-2#2)
human erythroleukemia##3##2##(1990-2#2)(2009-9#1)
human erythropoietin (hEp)-encoding##2##3##(1993-12#1)(1993-6#1)
human erythropoietin##13##2##(1993-12#1)(1993-6#1)(1995-1#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-8#1)(2011-2#1)
human erythropoietin-encoding gene contains##2##4##(1993-12#1)(1993-6#1)
human esophageal##4##2##(1992-8#3)(2012-2#1)
human estrogen receptor##5##3##(1992-3#2)(1993-6#1)(1995-11#2)
human evolution##8##2##(1996-5#2)(2008-12#1)(2008-7#2)(2012-1#1)(2012-2#2)
human ex vivo##2##3##(2006-6#2)
human experimental exposure##3##3##(2008-7#3)
human experimental##4##2##(2008-7#4)
human exposure to##4##3##(1992-3#2)(2008-11#1)(2008-8#1)
human exposure##9##2##(1990-8#1)(1992-3#2)(2008-11#1)(2008-8#1)(2008-9#3)(2013-1#1)
human exposures##2##2##(2010-11#1)(2011-2#1)
human eye aberrations##2##3##(2008-3#2)
human eye##12##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#4)(2011-7#1)(2013-8#1)
human facial##2##2##(2008-5#2)
human factor IX##4##3##(2008-9#4)
human factor##9##2##(1990-5#1)(1990-7#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-9#4)
human fecal##3##2##(1990-12#1)(1990-8#1)(1991-12#1)
human femoral##2##2##(1994-8#1)(1995-6#1)
human fetal brain##4##3##(1994-6#1)(1995-6#1)(1996-2#1)(2008-8#1)
human fetal hepatocytes##4##3##(2008-11#4)
human fetal liver cDNA##2##4##(2008-8#2)
human fetal liver##5##3##(2008-8#4)(2008-9#1)
human fetal lung##2##3##(1994-9#1)(1995-12#1)
human fetal pancreatic##2##3##(2010-11#2)
human fetal##27##2##(1992-5#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-11#5)(2008-8#5)(2008-9#2)(2009-10#3)(2010-11#2)(2012-12#1)
human fibrin##3##2##(1991-9#1)(1992-5#1)(1994-3#1)
human fibrinogen##3##2##(2006-6#1)(2008-10#2)
human fibroblast 34-kDa hyaluronic acid-binding protein##2##6##(1997-4#2)
human fibroblast cell##2##3##(2008-5#1)(2013-1#1)
human fibroblast##7##2##(1990-11#1)(1995-11#1)(1997-4#2)(2008-12#1)(2008-5#1)(2013-1#1)
human fibroblasts and##2##3##(1993-8#1)(1995-12#1)
human fibroblasts by##4##3##(1992-9#1)(1995-12#1)(2008-12#1)(2010-8#1)
human fibroblasts##27##2##(1990-12#2)(1990-5#2)(1992-9#2)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-6#2)(1997-7#3)(2008-10#1)(2008-12#1)(2008-5#3)(2009-8#2)(2010-8#1)(2012-2#1)(2013-1#1)
human fibrosarcoma cells##2##3##(2008-11#1)(2011-2#1)
human fibrosarcoma##5##2##(1992-5#1)(2008-11#2)(2011-2#1)(2012-2#1)
human fluids##2##2##(2008-10#2)
human foetal liver Zn-metallothioneins##3##4##(2008-10#3)
human foetal##5##2##(1992-5#1)(2008-10#4)
human follicular thyroid cancer##2##4##(2008-4#2)
human food##2##2##(2008-10#1)(2011-2#1)
human foreskin##2##2##(2007-12#1)(2008-11#1)
human fungal##2##2##(2009-8#1)(2012-3#1)
human gastric cancer##3##3##(1992-8#1)(2008-11#1)(2008-9#1)
human gastric carcinoma cell line##2##5##(1992-8#2)
human gastric##12##2##(1991-2#1)(1991-6#2)(1992-8#3)(1997-1#1)(2008-10#2)(2008-11#2)(2008-9#1)
human gastrointestinal##4##2##(2008-11#1)(2008-4#1)(2010-10#1)(2012-2#1)
human gene encoding##3##3##(1990-7#1)(1991-6#1)(1997-8#1)
human gene therapy##6##3##(1993-2#1)(1994-5#2)(1997-4#1)(2008-9#2)
human gene##25##2##(1990-7#2)(1991-6#2)(1991-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)
human geneGJB5 encoding gap junction protein beta-5##2##7##(2008-9#2)
human genes are##3##3##(1993-3#1)(1993-6#1)(2008-4#1)
human genes in##2##3##(1993-12#1)(2008-2#1)
human genes##18##2##(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-8#2)(1996-10#1)(1996-2#3)(1997-4#1)(1997-6#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)
human genetic disease##2##3##(1990-8#1)(1992-3#1)
human genetic##7##2##(1990-8#1)(1992-3#1)(1996-2#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-3#1)
human genetics##4##2##(2008-7#1)(2009-5#1)(2009-6#2)
human genome and##3##3##(1992-3#1)(2008-7#2)
human genome##36##2##(1990-12#1)(1991-2#1)(1991-6#2)(1992-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-4#6)(2008-5#2)(2008-7#12)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
human genomic DNA library using##2##5##(1992-11#1)(1997-4#1)
human genomic DNA library##4##4##(1991-2#1)(1992-11#1)(1994-9#1)(1997-4#1)
human genomic DNA sequences##2##4##(1997-6#1)(2008-9#1)
human genomic DNA##10##3##(1991-2#1)(1991-6#1)(1992-11#2)(1993-6#1)(1994-9#1)(1997-4#1)(1997-6#1)(2008-9#2)
human genomic library##3##3##(1991-6#1)(1994-11#1)(1994-6#1)
human genomic##19##2##(1990-8#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-11#2)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-7#2)(2008-9#2)(2009-5#1)
human gingival##2##2##(2011-2#1)(2012-3#1)
human glioblastoma cell lines##2##4##(1990-6#2)
human glioblastoma##4##2##(1990-6#2)(2013-1#2)
human glioblastomas##2##2##(1996-5#2)
human glioma U-373##2##3##(1994-11#2)
human glioma cell line##3##4##(1992-9#1)(1994-11#1)(1997-7#1)
human glioma##10##2##(1992-9#1)(1993-3#1)(1994-11#5)(1997-7#1)(2008-7#1)(2013-1#1)
human gliomas##2##2##(1995-2#1)(2008-7#1)
human glucagon##5##2##(2008-11#1)(2008-8#4)
human glucocerebrosidase##2##2##(1994-5#1)(1997-7#1)
human granulocyte colony-stimulating factor##3##4##(2008-11#1)(2010-6#1)(2012-3#1)
human granulocytes##2##2##(1990-7#1)(2008-4#1)
human granulocytic anaplasmosis##5##3##(2008-12#1)(2008-9#1)(2013-1#3)
human granulocytic##6##2##(2008-12#1)(2008-9#2)(2013-1#3)
human groups##2##2##(1994-3#1)(2009-10#1)
human growth hormone (hGH)##2##4##(1995-11#1)(2010-4#1)
human growth hormone receptor##2##4##(2008-8#2)
human growth hormone##11##3##(1990-12#1)(1991-3#1)(1995-11#1)(1997-2#3)(1997-8#1)(2008-8#2)(2010-4#1)(2013-1#1)
human growth##15##2##(1990-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1995-11#1)(1997-2#3)(1997-8#1)(2008-11#1)(2008-8#2)(2009-7#1)(2010-4#1)(2013-1#1)
human gut##2##2##(2010-1#1)(2011-2#1)
human hair and##8##3##(2008-10#7)(2012-3#1)
human hair by##3##3##(2008-10#2)(2008-5#1)
human hair follicle grown in vitro##2##6##(2008-5#2)
human hair follicle##5##3##(1990-3#2)(2008-5#2)(2013-8#1)
human hair samples##2##3##(2008-10#2)
human hair with##3##3##(2008-10#2)(2012-3#1)
human hair##43##2##(1990-3#2)(2008-10#17)(2008-5#16)(2011-1#1)(2012-2#1)(2012-3#5)(2013-8#1)
human head##5##2##(2008-1#1)(2008-3#2)(2008-5#1)(2012-3#1)
human health and##4##3##(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
human health in##4##3##(2008-8#1)(2011-2#1)(2013-1#2)
human health is##3##3##(2011-2#1)(2013-1#2)
human health of##2##3##(2008-10#1)(2008-5#1)
human health outcomes##2##3##(2007-12#1)(2011-1#1)
human health##57##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-3#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#2)(2011-1#4)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
human heart cDNA##2##3##(1991-6#1)(1994-11#1)
human heart failure##2##3##(2009-10#1)(2009-12#1)
human heart valves##2##3##(2008-3#1)(2010-12#1)
human heart##12##2##(1991-6#1)(1993-12#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-12#1)(2010-12#3)
human heart-valve tissues##2##3##(2008-3#2)
human heart-valve##3##2##(2008-3#3)
human hematopoietic progenitor cells##2##4##(2008-11#2)
human hematopoietic progenitor##3##3##(2008-11#3)
human hematopoietic stem cells##3##4##(2008-11#1)(2009-12#2)
human hematopoietic##13##2##(1992-3#1)(1994-5#1)(2008-11#8)(2008-4#1)(2009-12#2)
human hemoglobin##12##2##(1990-8#8)(1991-6#1)(1992-3#1)(1997-2#2)
human hepatic##6##2##(1990-12#1)(1990-5#1)(1991-5#2)(2008-11#1)(2010-11#1)
human hepatitis B##2##3##(1995-2#2)
human hepatoblastoma HepG2##2##3##(2008-11#2)
human hepatoblastoma##4##2##(2008-11#3)(2013-1#1)
human hepatocellular carcinoma (HCC)##2##4##(2008-8#1)(2011-2#1)
human hepatocellular carcinoma##4##3##(1993-8#1)(2008-8#2)(2011-2#1)
human hepatocellular##5##2##(1993-8#1)(2008-8#2)(2011-2#2)
human hepatocyte growth factor##2##4##(1991-6#1)(2008-9#1)
human hepatocyte growth##3##3##(1991-6#2)(2008-9#1)
human hepatocyte##5##2##(1991-6#2)(2008-11#2)(2008-9#1)
human hepatocytes with##2##3##(1995-2#1)(2013-1#1)
human hepatocytes##6##2##(1994-11#1)(1995-2#1)(2008-11#1)(2012-5#2)(2013-1#1)
human hepatoma cell line##3##4##(1997-1#1)(2008-8#1)(2013-8#1)
human hepatoma cell##5##3##(1990-8#2)(1997-1#1)(2008-8#1)(2013-8#1)
human hepatoma cells##2##3##(1990-5#1)(2008-11#1)
human hepatoma derived liver cell lines##2##6##(1992-3#2)
human hepatoma##14##2##(1990-5#1)(1990-8#2)(1992-3#2)(1995-2#1)(1997-1#1)(2008-11#3)(2008-8#2)(2008-9#1)(2013-8#1)
human hepatoma-derived cell line##2##4##(1997-1#2)
human hepatoma-derived##4##2##(1997-1#2)(2010-12#2)
human hexokinase II##2##3##(1993-11#1)(1994-11#1)
human hexokinase##3##2##(1993-11#2)(1994-11#1)
human history##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
human homolog##4##2##(1992-9#1)(1994-8#1)(1994-9#1)(2013-7#1)
human homologue of the##2##4##(1994-12#1)(1997-3#1)
human homologue of##4##3##(1993-11#1)(1994-12#1)(1997-3#1)(1997-7#1)
human homologue##6##2##(1993-11#1)(1993-3#1)(1994-12#1)(1997-3#1)(1997-7#1)(2009-5#1)
human host##4##2##(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
human hsp27##4##2##(1993-6#4)
human hybridomas##2##2##(1990-12#2)
human hypertrophic##2##2##(1996-8#1)(2008-9#1)
human iPS##2##2##(2012-5#1)(2013-1#1)
human immune system##8##3##(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
human immune##13##2##(1995-5#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
human immunodeficiency virus (HIV) and##2##5##(2007-2#1)(2008-5#1)
human immunodeficiency virus (HIV) epidemic##2##5##(2007-7#1)(2012-2#1)
human immunodeficiency virus (HIV) infected##2##5##(2009-11#1)(2011-2#1)
human immunodeficiency virus (HIV) infection to##2##6##(1990-3#1)(1993-12#1)
human immunodeficiency virus (HIV) infection##7##5##(1990-3#1)(1993-12#1)(1996-9#1)(1997-8#1)(2008-2#1)(2009-8#1)(2013-8#1)
human immunodeficiency virus (HIV) prevention##2##5##(1996-4#1)(1997-2#1)
human immunodeficiency virus (HIV)##37##4##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
human immunodeficiency virus (HIV-1)##3##4##(2009-7#1)(2009-8#1)(2010-11#1)
human immunodeficiency virus 1##2##4##(1994-8#2)
human immunodeficiency virus and##3##4##(1997-7#1)(2008-12#1)(2008-8#1)
human immunodeficiency virus infection##11##4##(1991-3#1)(1991-6#1)(1993-2#1)(1995-3#1)(1996-2#1)(1997-7#2)(2006-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
human immunodeficiency virus infection]##4##4##(1991-6#1)(1992-2#1)(1993-2#1)(1996-11#1)
human immunodeficiency virus type 1 (HIV-1) infection is##3##8##(2008-2#3)
human immunodeficiency virus type 1 (HIV-1) infection##4##7##(2008-2#4)
human immunodeficiency virus type 1 (HIV-1)##11##6##(1990-2#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-2#7)
human immunodeficiency virus type 1 and##2##6##(1991-2#1)(1997-3#1)
human immunodeficiency virus type 1 protease##3##6##(1991-9#2)(1992-11#1)
human immunodeficiency virus type 1##22##5##(1990-2#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-6#1)(1993-8#1)(1994-8#2)(1995-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#7)
human immunodeficiency virus type##23##4##(1990-2#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-6#2)(1993-8#1)(1994-8#2)(1995-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#7)
human immunodeficiency virus type-1##3##4##(1990-2#1)(1997-3#1)(2007-7#1)
human immunodeficiency virus##115##3##(1990-2#3)(1990-3#2)(1990-6#1)(1990-9#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#4)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#4)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#1)(2006-10#2)(2007-2#1)(2007-7#7)(2008-1#2)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
human immunodeficiency virus-1##4##3##(1992-12#1)(1992-8#1)(2008-11#1)(2012-1#1)
human immunodeficiency virus/acquired##2##3##(2010-11#1)(2010-12#1)
human immunodeficiency viruses##3##3##(1990-5#1)(2007-7#1)(2008-9#1)
human immunodeficiency##129##2##(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#4)(1992-11#1)(1992-12#3)(1992-2#2)(1992-6#4)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#1)(2006-10#2)(2007-2#1)(2007-7#8)(2008-1#2)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
human immunoglobulin G##3##3##(1996-12#1)(2008-10#2)
human immunoglobulin##5##2##(1996-12#1)(1997-8#1)(2008-10#2)(2011-2#1)
human in vivo##2##3##(2008-3#1)(2008-5#1)
human in##3##2##(2008-3#1)(2008-5#2)
human indoleamine 2##2##3##(1992-11#2)
human induced pluripotent##2##3##(2012-5#2)
human induced##3##2##(2012-5#2)(2013-1#1)
human infection##2##2##(2008-8#1)(2013-8#1)
human infections##3##2##(2009-5#1)(2012-2#2)
human inflammatory##2##2##(2008-10#1)(2011-2#1)
human influenza viruses in##3##4##(2013-1#3)
human influenza viruses##4##3##(2008-9#1)(2013-1#3)
human influenza##10##2##(1994-8#3)(2008-9#1)(2009-5#2)(2012-12#1)(2013-1#3)
human insulin receptor##3##3##(1991-12#2)(2008-4#1)
human insulin##18##2##(1990-12#1)(1991-12#2)(1991-8#4)(1992-3#1)(1992-6#2)(1995-6#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2011-1#1)
human insulin)##2##2##(1991-8#1)(2008-11#1)
human insulin-like growth factor-I (IGF-I)##2##5##(1992-9#1)(1993-9#1)
human insulin-like growth##3##3##(1990-11#1)(1992-9#1)(1993-9#1)
human interaction##3##2##(2008-10#1)(2008-11#2)
human interface##2##2##(2008-10#1)(2010-8#1)
human interferon gamma##2##3##(1993-9#1)(2008-4#1)
human interferon##3##2##(1993-9#1)(2008-4#1)(2008-8#1)
human interleukin##3##2##(2008-11#1)(2008-4#2)
human interleukin-1 beta##8##3##(1990-10#1)(1990-12#3)(1990-2#3)(1993-8#1)
human interleukin-1##10##2##(1990-10#1)(1990-12#3)(1990-2#3)(1992-3#1)(1993-8#1)(2008-5#1)
human interleukin-6 (hIL-6)##3##3##(1992-8#1)(2008-11#1)(2008-8#1)
human interleukin-6 receptor##2##3##(2008-8#2)
human interleukin-6##8##2##(1990-5#1)(1992-8#2)(2008-11#1)(2008-8#4)
human internal mammary artery##2##4##(1993-8#2)
human intervention##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
human intestinal bacteria##4##3##(2008-11#4)
human intestinal epithelial cells##2##4##(1990-2#1)(2008-6#1)
human intestinal epithelial##3##3##(1990-2#1)(2008-11#1)(2008-6#1)
human intestinal mucin cDNA##2##4##(1991-12#1)(1993-8#1)
human intestinal mucin##4##3##(1990-8#1)(1991-12#2)(1993-8#1)
human intestinal##19##2##(1990-2#1)(1990-8#1)(1991-12#2)(1993-8#1)(1995-12#1)(2007-11#1)(2008-11#9)(2008-4#1)(2008-6#1)(2011-2#1)
human is##2##2##(1995-8#1)(2008-7#1)
human islet transplantation##3##3##(1997-8#1)(2010-11#1)(2012-12#1)
human islet##6##2##(1994-8#1)(1997-8#1)(2010-11#2)(2011-2#1)(2012-12#1)
human kallikrein##2##2##(2008-4#2)
human keratinocyte##4##2##(1992-3#1)(1994-11#1)(2008-11#1)(2008-7#1)
human keratinocytes and##2##3##(2008-4#1)(2008-5#1)
human keratinocytes in culture##2##4##(1990-11#1)(1997-1#1)
human keratinocytes in##3##3##(1990-11#1)(1997-1#1)(2008-1#1)
human keratinocytes##26##2##(1990-11#1)(1991-9#1)(1992-9#1)(1993-5#1)(1994-3#2)(1994-6#1)(1996-2#2)(1997-1#2)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#8)(2008-7#2)
human kidney and##2##3##(1991-5#1)(2011-2#1)
human kidney cDNA##2##3##(1994-12#2)
human kidney cell line 293##2##5##(1990-8#2)
human kidney cells and##2##4##(1990-8#1)(2008-7#1)
human kidney soluble##2##3##(1990-2#2)
human kidney##14##2##(1990-2#3)(1990-8#3)(1991-5#1)(1994-12#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
human knee##3##2##(2009-7#2)(2013-1#1)
human language##7##2##(1997-8#1)(2010-5#2)(2012-12#4)
human laryngeal##3##2##(2008-10#2)(2011-2#1)
human larynx##2##2##(1992-8#1)(1996-12#1)
human lecithin##2##2##(1993-8#2)
human leiomyosarcoma##2##2##(2008-6#2)
human leucocyte antigen##2##3##(2011-2#1)(2012-2#1)
human leucocyte##5##2##(1993-8#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
human leucocytes##3##2##(1990-7#1)(1991-5#2)
human leukemia KU812 cells##2##4##(2008-11#2)
human leukemia cell line##2##4##(1993-12#1)(1994-12#1)
human leukemia cell##3##3##(1993-12#1)(1994-12#1)(2008-11#1)
human leukemia cells##2##3##(2010-6#2)
human leukemia##11##2##(1992-11#1)(1993-12#1)(1994-12#1)(2008-11#5)(2008-7#1)(2010-6#2)
human leukemic cell line##2##4##(1994-6#1)(2008-11#1)
human leukemic cell##3##3##(1994-6#1)(2008-11#1)(2008-4#1)
human leukemic cells##2##3##(2008-9#1)(2011-2#1)
human leukemic##5##2##(1994-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
human leukocyte elastase (HLE)##3##4##(1992-12#1)(2008-5#2)
human leukocyte elastase##4##3##(1992-12#1)(2008-5#3)
human leukocyte##12##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1997-4#1)(2008-11#1)(2008-5#3)(2010-6#1)
human leukocytes##5##2##(1990-11#1)(1991-5#3)(2008-5#1)
human life##8##2##(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-9#1)
human lipoprotein lipase##2##3##(1994-11#1)(2008-11#1)
human liver HepG2##2##3##(1995-6#2)
human liver UDP-glucuronosyltransferase cDNA##4##4##(2008-11#4)
human liver and##5##3##(1991-12#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#1)
human liver cDNA library##5##4##(1992-3#1)(1992-8#1)(1993-11#1)(1994-11#2)
human liver cDNA##8##3##(1990-12#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-11#2)(2008-11#1)
human liver cell line##2##4##(1994-6#1)(2008-11#1)
human liver cells##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
human liver expressed in##2##4##(1990-12#1)(1991-12#1)
human liver microsomes##11##3##(1990-5#2)(1991-5#3)(1993-6#3)(1994-8#1)(2011-3#2)
human liver##68##2##(1990-12#2)(1990-5#3)(1991-12#3)(1991-5#6)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#6)(1993-11#3)(1993-3#4)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#5)(1995-2#1)(1995-6#2)(1997-1#1)(2008-11#8)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#2)
human livers##2##2##(1991-5#1)(2008-8#1)
human lung adenocarcinoma cell line A549##2##6##(2008-11#1)(2013-1#1)
human lung adenocarcinoma cell line##3##5##(2008-11#2)(2013-1#1)
human lung adenocarcinoma##5##3##(2008-11#3)(2008-9#1)(2013-1#1)
human lung cDNA library##3##4##(1991-5#2)(1997-2#1)
human lung cancer cell line##2##5##(2008-8#1)(2013-1#1)
human lung cancer cell##3##4##(1992-9#1)(2008-8#1)(2013-1#1)
human lung cancer##11##3##(1990-5#1)(1991-12#1)(1992-9#1)(1993-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-8#1)(2013-1#2)
human lung carcinoma##3##3##(2008-11#1)(2008-8#2)
human lung cell line##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
human lung cells##3##3##(1995-8#2)(2008-8#1)
human lung fibroblasts##3##3##(1990-5#1)(1995-8#1)(2008-11#1)
human lung##40##2##(1990-5#2)(1991-12#1)(1991-5#2)(1992-12#1)(1992-9#2)(1993-11#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-8#3)(1996-2#1)(1997-2#1)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#2)(2010-8#1)(2012-1#1)(2013-1#3)
human lungs##3##2##(1992-12#2)(1995-8#1)
human lymph node##2##3##(2008-11#1)(2009-4#1)
human lymphoblastoid B cell line through sphingosine production##2##8##(1994-3#2)
human lymphoblastoid##3##2##(1994-3#2)(1996-12#1)
human lymphocyte##8##2##(1991-5#1)(1992-6#1)(1995-12#1)(1996-2#2)(2008-11#3)
human lymphocytes by##2##3##(1997-4#1)(2008-4#1)
human lymphocytes in##2##3##(1995-3#1)(2011-2#1)
human lymphocytes is##2##3##(1993-8#1)(2008-4#1)
human lymphocytes##32##2##(1990-8#1)(1992-11#4)(1992-12#3)(1992-6#1)(1993-3#1)(1993-8#3)(1995-3#2)(1996-2#2)(1997-4#5)(2008-11#3)(2008-4#3)(2008-7#1)(2011-2#2)(2012-2#1)
human lymphoid cells##3##3##(1991-6#1)(1995-12#2)
human lymphoid##4##2##(1991-6#1)(1994-2#1)(1995-12#2)
human lysosome-associated membrane protein-2##2##4##(1994-11#2)
human lysozyme##2##2##(1990-12#1)(1995-3#1)
human mAbs##4##2##(2008-11#4)
human mRNA##3##2##(1992-11#1)(1994-8#1)(2008-7#1)
human macrophages##4##2##(1994-6#1)(1994-8#3)
human malaria parasite##2##3##(1993-2#2)
human malaria##7##2##(1991-2#1)(1993-2#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
human male DNA##3##3##(2008-12#3)
human male##4##2##(2008-12#3)(2009-10#1)
human malignancies##10##2##(1993-9#1)(1994-10#1)(2008-11#1)(2008-6#1)(2009-3#2)(2009-4#1)(2011-2#1)(2013-1#2)
human malignant glioma##2##3##(1995-2#1)(1997-7#1)
human malignant##7##2##(1993-9#2)(1995-2#1)(1997-4#1)(1997-7#1)(2008-4#1)(2011-3#1)
human mammary epithelial cells##3##4##(1990-12#2)(1993-11#1)
human mammary##9##2##(1990-12#3)(1990-7#1)(1993-11#2)(1995-9#2)(2009-12#1)
human marrow##3##2##(1993-12#2)(2008-8#1)
human mast cell##2##3##(1993-3#1)(2011-2#1)
human mast cells##2##3##(2008-4#1)(2008-9#1)
human mast##4##2##(1993-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
human maxillary##2##2##(2008-4#1)(2013-1#1)
human medullary thyroid carcinoma cells##2##5##(1992-6#2)
human medullary thyroid##3##3##(1992-6#3)
human melanocytes##10##2##(1993-5#2)(1995-2#5)(2008-5#2)(2008-8#1)
human melanoma cell line A375##2##5##(1990-11#1)(1994-6#1)
human melanoma cell line##5##4##(1990-11#2)(1994-6#1)(1997-9#1)(2008-8#1)
human melanoma cell##7##3##(1990-11#2)(1992-2#2)(1994-6#1)(1997-9#1)(2008-8#1)
human melanoma cells##6##3##(1994-5#1)(1996-9#1)(2008-10#1)(2008-8#2)(2011-2#1)
human melanoma##26##2##(1990-11#2)(1992-2#4)(1993-9#1)(1994-5#4)(1994-6#3)(1995-11#1)(1996-9#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#4)(2011-2#1)
human menin from##2##3##(2008-11#2)
human menopausal gonadotropin for##2##4##(2007-7#2)
human mesenchymal stem cell##2##4##(2008-11#1)(2012-7#1)
human mesenchymal stem##6##3##(2008-11#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-7#1)
human mesothelioma cell lines##2##4##(1993-9#2)
human metabolic##2##2##(2012-2#1)(2013-1#1)
human metabolism##2##2##(2008-10#1)(2008-5#1)
human metaphase##2##2##(1995-12#1)(2008-9#1)
human metastatic##2##2##(1992-9#1)(2013-1#1)
human migration##2##2##(2009-5#1)(2011-2#1)
human milk##13##2##(2008-10#3)(2008-11#1)(2008-8#4)(2012-2#5)
human mirror neuron system##2##4##(2008-11#2)
human mitochondrial##4##2##(1990-12#1)(1995-11#1)(2008-8#2)
human monoclonal IgM##2##3##(1994-3#1)(2008-11#1)
human monoclonal antibodies##4##3##(2008-11#4)
human monoclonal antibody AE6F4##3##4##(2008-11#3)
human monoclonal antibody##16##3##(1992-2#2)(2008-10#1)(2008-11#11)(2008-7#1)(2012-3#1)
human monoclonal single-chain Fv##2##4##(2010-12#2)
human monoclonal##26##2##(1992-2#2)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#16)(2008-7#1)(2010-12#3)(2012-3#1)
human monocytes or##2##3##(1991-8#1)(1994-11#1)
human monocytes##15##2##(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#3)(1992-12#1)(1994-11#2)(1994-5#1)(1995-12#1)(1995-8#3)
human monocytic##5##2##(1990-2#1)(1993-12#1)(1994-2#1)(1995-6#1)(2008-10#1)
human mononuclear leukocytes##3##3##(1992-12#3)
human morbidity##2##2##(2011-2#1)(2013-8#1)
human mortality##2##2##(2008-1#2)
human movement##2##2##(2010-6#1)(2013-1#1)
human mucin gene##2##3##(1990-8#1)(1997-7#1)
human mucin##3##2##(1990-8#2)(1997-7#1)
human multiple sclerosis##2##3##(2008-7#1)(2011-2#1)
human multiple##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
human muscle cells##3##3##(1990-5#2)(2008-11#1)
human muscle glycogen phosphorylase##4##4##(1991-11#4)
human muscle##7##2##(1990-5#2)(1991-11#4)(2008-11#1)
human mutant##2##2##(2008-4#1)(2008-9#1)
human mutation##2##2##(2008-7#2)
human myeloid##3##2##(1993-3#2)(1993-8#1)
human myoglobin##3##2##(1995-2#3)
human myometrial##3##2##(1992-6#1)(1994-3#1)(1994-8#1)
human myometrium##5##2##(1991-12#1)(1993-12#1)(1994-3#1)(1994-8#2)
human nasopharyngeal carcinoma##4##3##(2008-8#2)(2012-2#1)(2013-1#1)
human nebulin##5##2##(2008-6#5)
human nerve growth factor##2##4##(1990-8#1)(2008-5#1)
human neuroblastoma cell line##3##4##(1991-9#1)(1992-5#1)(1996-10#1)
human neuroblastoma cell##4##3##(1991-9#1)(1992-5#1)(1996-10#2)
human neuroblastoma cells##4##3##(1992-5#1)(1994-10#1)(1995-12#1)(2008-8#1)
human neuroblastoma##10##2##(1991-9#1)(1992-5#2)(1994-10#2)(1995-12#1)(1996-10#2)(2008-8#1)(2013-1#1)
human neurodegenerative##2##2##(1990-5#1)(1994-5#1)
human neurological##2##2##(1994-11#1)(2009-2#1)
human neuromuscular##3##2##(1992-8#2)(2008-4#1)
human neutrophil##5##2##(1992-3#1)(1993-6#1)(1994-11#1)(2008-4#1)(2008-5#1)
human neutrophils by##3##3##(1991-12#1)(2008-4#2)
human neutrophils in##2##3##(2008-1#1)(2008-10#1)
human neutrophils was##4##3##(1991-12#1)(1992-12#1)(1993-6#1)(1994-6#1)
human neutrophils##38##2##(1990-2#2)(1991-12#2)(1991-8#1)(1991-9#1)(1992-12#4)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-6#2)(1994-8#1)(1995-6#1)(1996-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#5)(2011-2#1)
human non-pancreatic phospholipase A2##2##4##(1992-8#2)
human non-small cell lung cancer##2##5##(2008-11#1)(2013-1#1)
human normal##5##2##(1990-8#1)(2008-11#1)(2008-9#2)(2009-5#1)
human nutrition and health##2##4##(2008-10#2)
human nutrition##3##2##(2008-10#2)(2011-1#1)
human obesity##4##2##(1997-4#1)(2006-8#1)(2008-3#1)(2009-2#1)
human observer study##2##3##(2012-1#2)
human observer##4##2##(2008-11#1)(2010-8#1)(2012-1#2)
human occupants##2##2##(2008-9#2)
human ocular diseases##2##3##(2008-8#1)(2010-10#1)
human olfactory epithelium##2##3##(2012-1#2)
human oligodendrocytes and##3##3##(1996-5#3)
human oligodendrocytes##4##2##(1996-5#4)
human oocytes##4##2##(1990-10#1)(1994-11#2)(2011-2#1)
human or bovine collagen type I##2##6##(2008-11#2)
human or mouse IL-18##2##4##(2008-4#2)
human or mouse##3##3##(2008-4#3)
human or##12##2##(1995-11#1)(1996-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)
human oral cancer cells##2##4##(2010-2#1)(2013-1#1)
human oral cancer##4##3##(2010-2#1)(2013-1#3)
human oral fibroblasts##3##3##(1992-11#3)
human oral squamous cell carcinoma##2##5##(2010-12#2)
human oral##10##2##(1992-11#3)(1993-1#1)(2010-12#2)(2010-2#1)(2013-1#3)
human organism##3##2##(1990-6#1)(1996-6#1)(2012-3#1)
human organs##6##2##(1995-11#1)(2007-11#2)(2008-10#2)(2010-12#1)
human origin in##2##3##(1995-2#1)(2008-8#1)
human origin##4##2##(1995-2#1)(2008-8#2)(2009-2#1)
human osteoblast##2##2##(2008-11#1)(2013-1#1)
human osteoblast-like cell##2##3##(1994-6#1)(2008-11#1)
human osteoblast-like cells in##4##4##(1990-2#3)(2008-11#1)
human osteoblast-like cells##8##3##(1990-2#3)(1994-2#1)(1994-6#1)(2008-11#3)
human osteoblast-like##14##2##(1990-2#3)(1992-8#2)(1994-2#2)(1994-6#2)(2008-11#4)(2012-2#1)
human osteoblasts##5##2##(1993-3#2)(2008-11#1)(2010-3#1)(2013-1#1)
human osteosarcoma cells showed##2##4##(1994-6#2)
human osteosarcoma cells##3##3##(1994-6#2)(1995-8#1)
human osteosarcoma##7##2##(1994-2#1)(1994-6#2)(1995-8#1)(2008-6#2)(2010-3#1)
human ovarian cancer cell line##2##5##(1994-2#1)(2008-8#1)
human ovarian cancer cell##3##4##(1993-9#1)(1994-2#1)(2008-8#1)
human ovarian cancer cells##3##4##(1990-2#1)(1993-9#1)(1994-2#1)
human ovarian cancer##7##3##(1990-2#1)(1993-9#2)(1994-2#2)(1996-10#1)(2008-8#1)
human ovarian carcinoma cells##3##4##(1993-8#1)(1993-9#1)(2008-4#1)
human ovarian carcinoma##5##3##(1993-8#1)(1993-9#2)(2008-4#2)
human ovarian##17##2##(1990-2#1)(1993-8#2)(1993-9#5)(1994-2#2)(1994-9#1)(1996-10#1)(2008-4#3)(2008-8#2)
human pancreas##2##2##(2010-11#1)(2012-3#1)
human pancreatic cancer##2##3##(1993-3#1)(2012-12#1)
human pancreatic cells##2##3##(2010-11#2)
human pancreatic##10##2##(1993-3#1)(1994-11#1)(1994-8#1)(1997-4#1)(2010-11#3)(2012-12#2)(2012-3#1)
human papilloma virus (HPV)##3##4##(1991-2#2)(1996-12#1)
human papilloma virus infection##2##4##(1991-2#1)(2011-1#1)
human papilloma virus##8##3##(1991-2#3)(1994-8#1)(1996-12#1)(2007-8#1)(2011-1#2)
human papilloma##9##2##(1991-2#3)(1994-8#1)(1996-12#1)(2007-12#1)(2007-8#1)(2011-1#2)
human papillomavirus (HPV)##5##3##(1992-2#1)(1992-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
human papillomavirus and##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
human papillomavirus type 16##4##4##(1990-5#2)(1995-2#2)
human papillomavirus type##5##3##(1990-5#2)(1995-2#2)(2008-4#1)
human papillomavirus vaccine##2##3##(2008-10#1)(2013-1#1)
human papillomavirus##27##2##(1990-5#2)(1992-2#1)(1992-3#2)(1995-2#2)(2008-10#1)(2008-12#1)(2008-4#3)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
human pathogen associated with##2##4##(1995-2#1)(2008-7#1)
human pathogen##10##2##(1990-11#1)(1992-8#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-7#1)(2008-9#2)(2011-2#2)
human pathogenic##4##2##(1992-3#1)(1994-8#1)(2008-11#1)(2012-2#1)
human pathogens##4##2##(2008-4#1)(2008-9#1)(2010-10#1)(2012-3#1)
human pathological##2##2##(1994-3#1)(2012-12#1)
human pathologies##3##2##(1990-3#1)(2008-4#1)(2009-5#1)
human patients and##2##3##(2011-9#1)(2012-12#1)
human patients with##2##3##(1994-3#1)(2008-11#1)
human patients##10##2##(1994-3#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-2#2)(2010-7#1)(2011-2#1)(2011-9#1)(2012-12#1)
human performance##3##2##(2008-11#1)(2013-1#2)
human periodontal ligament (PDL)##2##4##(1995-8#1)(2013-1#1)
human periodontal ligament cells##2##4##(2013-1#2)
human periodontal ligament##6##3##(1995-8#1)(2013-1#4)(2013-8#1)
human periodontal##8##2##(1995-8#1)(2008-9#1)(2012-3#1)(2013-1#4)(2013-8#1)
human peripheral blood T##2##4##(1992-6#1)(1995-2#1)
human peripheral blood lymphocytes (PBL)##3##5##(1991-9#1)(1995-12#1)(2008-11#1)
human peripheral blood lymphocytes and##2##5##(1991-12#1)(1991-9#1)
human peripheral blood lymphocytes in##2##5##(2008-11#1)(2010-12#1)
human peripheral blood lymphocytes##20##4##(1991-12#1)(1991-4#1)(1991-9#2)(1993-8#2)(1995-12#2)(1997-4#1)(2008-11#8)(2008-9#1)(2010-12#2)
human peripheral blood mononuclear cell (PBMC)##2##6##(1997-2#1)(2008-7#1)
human peripheral blood mononuclear cells##5##5##(1990-2#1)(1992-12#1)(1995-3#1)(2008-11#1)(2008-9#1)
human peripheral blood mononuclear##7##4##(1990-2#1)(1992-12#1)(1995-3#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
human peripheral blood##36##3##(1990-2#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#2)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-11#9)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#2)(2012-2#1)
human peripheral##39##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#2)(1994-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-11#9)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#2)(2012-2#1)
human perturbations##4##2##(2008-10#4)
human phospholipase##2##2##(1993-11#1)(1996-6#1)
human physiology and##2##3##(2010-7#1)(2011-2#1)
human physiology##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
human placenta and##3##3##(1990-2#1)(1991-12#1)(1992-10#1)
human placenta cDNA##3##3##(1991-7#1)(1994-11#1)(2008-8#1)
human placenta##29##2##(1990-11#2)(1990-12#1)(1990-2#4)(1991-1#1)(1991-12#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-9#1)(1995-11#1)(1997-1#2)(2008-10#2)(2008-8#3)
human placental alkaline phosphatase (SEAP)##2##5##(2008-11#2)
human placental choriocarcinoma cells##2##4##(1994-6#2)
human placental membranes##3##3##(1990-2#1)(1994-6#1)(2012-12#1)
human placental##15##2##(1990-12#2)(1990-2#1)(1991-2#2)(1991-5#1)(1994-3#1)(1994-6#3)(2008-11#2)(2008-8#2)(2012-12#1)
human plasma and urine##2##4##(2008-10#1)(2008-11#1)
human plasma and##9##3##(1990-8#1)(1991-12#1)(1992-12#1)(2008-10#4)(2008-11#1)(2011-2#1)
human plasma by##10##3##(1990-8#2)(2008-10#6)(2011-2#1)(2012-1#1)
human plasma lipoproteins##3##3##(1993-6#2)(2012-2#1)
human plasma or##3##3##(2008-4#1)(2010-11#2)
human plasma samples using##2##4##(1996-5#1)(2008-10#1)
human plasma samples##10##3##(1996-5#1)(2008-10#7)(2011-2#1)(2012-1#1)
human plasma using##5##3##(2008-10#5)
human plasma was##2##3##(1990-8#1)(2008-10#1)
human plasma##79##2##(1990-12#4)(1990-8#5)(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-3#1)(1995-5#1)(1996-5#2)(1997-2#1)(2008-10#38)(2008-11#1)(2008-4#1)(2010-11#2)(2011-2#4)(2011-3#1)(2012-1#4)(2012-2#1)
human plasmin##2##2##(1990-7#1)(1993-8#1)
human plasminogen and##2##3##(1993-8#1)(1994-11#1)
human plasminogen mRNA##2##3##(1990-12#2)
human plasminogen##15##2##(1990-12#3)(1990-5#2)(1993-8#4)(1994-11#1)(1995-6#2)(2008-4#1)(2013-1#2)
human platelet aggregation##2##3##(1992-8#1)(1997-7#1)
human platelet##10##2##(1990-5#1)(1990-7#1)(1992-3#1)(1992-8#3)(1997-7#1)(2006-6#2)(2008-11#1)
human platelets were##2##3##(1991-9#1)(1995-11#1)
human platelets##27##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-9#1)(1992-12#5)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#2)(1994-6#2)(1995-11#2)(1996-7#1)(1997-7#2)(2006-6#4)(2008-4#1)
human poly(A)+ RNA##2##3##(1992-6#1)(1995-12#1)
human polymorphic epithelial mucin##2##4##(1990-12#2)
human polymorphonuclear leukocytes##4##3##(1993-11#2)(1995-6#1)(2008-8#1)
human polymorphonuclear neutrophils##2##3##(1992-10#1)(1993-6#1)
human polymorphonuclear##7##2##(1992-10#1)(1993-11#2)(1993-6#1)(1993-8#1)(1995-6#1)(2008-8#1)
human population##8##2##(1992-3#1)(2007-12#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)
human populations##17##2##(1992-11#1)(1993-11#1)(1994-3#2)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#3)(2010-10#1)(2011-1#1)(2012-3#1)
human potential##2##2##(2008-12#1)(2008-7#1)
human preadipocytes##5##2##(2008-5#5)
human prefrontal cortex##3##3##(1994-8#3)
human pregnancy##4##2##(1990-11#1)(1994-9#1)(1995-8#2)
human prevalence of##3##3##(2008-8#3)
human prevalence##5##2##(2008-8#5)
human primary visual cortex##3##4##(1995-12#3)
human primary##9##2##(1995-12#3)(1997-2#1)(2008-9#1)(2009-4#2)(2013-8#2)
human prion disease##2##3##(2010-12#2)
human probes##2##2##(1991-12#1)(2008-7#1)
human progastricsin##3##2##(1995-3#3)
human promyelocytic##3##2##(1991-12#1)(1993-6#1)(1994-6#1)
human prorenin was##2##3##(1990-5#1)(1991-9#1)
human prosomatostatin##2##2##(1994-11#2)
human prostate cancer cells and##2##5##(2011-2#1)(2012-3#1)
human prostate cancer cells##5##4##(2008-6#1)(2011-2#2)(2012-3#2)
human prostate cancer##8##3##(2008-4#1)(2008-6#1)(2011-2#3)(2012-3#3)
human prostate##13##2##(1994-11#3)(2008-4#1)(2008-6#1)(2011-2#4)(2012-12#1)(2012-3#3)
human prostatic##6##2##(1990-11#1)(1990-12#2)(1991-2#2)(1994-11#1)
human protein C##6##3##(1991-9#1)(1995-2#2)(2008-12#3)
human protein##11##2##(1991-2#1)(1991-6#1)(1991-9#1)(1994-8#1)(1995-2#2)(2008-10#1)(2008-12#3)(2009-5#1)
human proteins##8##2##(1992-6#1)(1994-5#1)(1997-4#2)(2008-11#1)(2012-2#2)(2013-1#1)
human pseudocathepsin D##2##3##(2008-4#2)
human pseudocathepsin##3##2##(2008-4#3)
human pseudogenes##2##2##(1991-6#1)(1995-11#1)
human purH gene##2##3##(1995-12#2)
human r-IgG##2##2##(2008-10#2)
human receptor subtypes##2##3##(1994-6#1)(1995-11#1)
human receptor##3##2##(1990-12#1)(1994-6#1)(1995-11#1)
human recombinant##15##2##(1991-3#1)(1992-8#4)(1994-11#1)(1994-8#2)(1994-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#1)
human red blood cells##4##4##(1991-8#1)(1993-8#1)(1994-2#1)(2008-10#1)
human red blood##5##3##(1991-8#1)(1993-8#1)(1994-2#1)(2008-10#1)(2008-3#1)
human red cell Ca2(+)-activated##2##4##(1990-11#2)
human red##7##2##(1990-11#2)(1991-8#1)(1993-8#1)(1994-2#1)(2008-10#1)(2008-3#1)
human red-sensitive pigment##4##3##(1990-12#4)
human remains##4##2##(1995-11#1)(1995-6#1)(2011-2#1)(2013-1#1)
human renal proximal tubule cells##2##5##(1992-8#2)
human renal##7##2##(1992-3#2)(1992-8#2)(1993-8#1)(2007-7#1)(2011-2#1)
human renin##4##2##(1990-8#1)(1993-6#3)
human repetitive##2##2##(1991-9#1)(1996-6#1)
human research##5##2##(1993-5#1)(2008-5#1)(2009-4#1)(2009-7#1)(2011-2#1)
human resource management skills##3##4##(1995-3#3)
human resource management##6##3##(1993-2#1)(1995-3#4)(2012-12#1)
human resource##11##2##(1991-3#1)(1993-2#2)(1995-2#1)(1995-3#4)(1997-3#1)(2008-1#1)(2012-12#1)
human resources and##3##3##(1994-12#1)(1995-1#1)(2011-1#1)
human resources##20##2##(1993-2#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-2#3)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)
human respiratory tract##7##3##(1995-12#1)(1995-3#1)(1997-1#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
human respiratory##9##2##(1992-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
human retina in##2##3##(2007-11#1)(2011-1#1)
human retina##13##2##(1990-7#1)(1991-10#2)(1996-5#2)(2007-11#5)(2007-12#2)(2011-1#1)
human retinal pigment epithelial cells##3##5##(1993-3#3)
human retinal##7##2##(1993-3#3)(2007-11#3)(2012-4#1)
human retroviral replication##3##3##(1995-2#3)
human retroviral##5##2##(1992-6#1)(1995-2#4)
human rhinovirus##3##2##(2008-10#1)(2013-8#2)
human right##3##2##(1990-6#1)(2010-12#1)(2012-12#1)
human rights##13##2##(1990-6#1)(1991-3#1)(1995-11#2)(2008-11#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#3)(2013-1#1)
human risk assessment##2##3##(1996-12#2)
human risk##5##2##(1996-12#3)(2008-11#1)(2010-9#1)
human rod##2##2##(1994-12#2)
human saliva##6##2##(2008-10#4)(2008-4#1)(2010-12#1)
human salivary alpha-amylase##3##3##(1990-12#3)
human salivary cystatin SN##2##4##(1994-12#2)
human salivary gland##2##3##(2011-2#2)
human salivary##7##2##(1990-12#3)(1994-12#2)(2011-2#2)
human samples##4##2##(1990-3#1)(2008-10#1)(2013-1#2)
human saphenous vein##2##3##(1994-6#2)
human sarcoma##3##2##(1994-12#1)(2008-6#2)
human scalp skin##2##3##(2008-5#2)
human scalp##5##2##(2008-10#2)(2008-5#2)(2011-1#1)
human seminal gamma-glutamyl transpeptidase##2##4##(1995-11#2)
human sequences##3##2##(1990-11#1)(1993-6#1)(1994-11#1)
human sera by##2##3##(2008-3#2)
human sera from##2##3##(1993-8#1)(2008-10#1)
human sera##14##2##(1990-12#1)(1993-3#1)(1993-8#1)(2008-10#5)(2008-3#5)(2008-5#1)
human serotonin##3##2##(1991-12#2)(1993-2#1)
human serum IgG##2##3##(2008-11#2)
human serum albumin (HSA) and human##2##6##(2008-10#2)
human serum albumin (HSA) and##5##5##(1994-8#1)(2008-10#4)
human serum albumin (HSA) is##2##5##(2008-10#2)
human serum albumin (HSA) was studied using##2##7##(2008-10#2)
human serum albumin (HSA)##18##4##(1994-8#1)(1997-2#1)(2008-10#16)
human serum albumin##25##3##(1990-12#1)(1994-8#1)(1997-2#1)(2008-10#21)(2008-7#1)
human serum and plasma##2##4##(2008-4#1)(2011-2#1)
human serum and urine##4##4##(2008-10#4)
human serum and##11##3##(2008-10#7)(2008-11#2)(2008-4#1)(2011-2#1)
human serum at##5##3##(1990-2#2)(2008-10#3)
human serum by##6##3##(1991-5#1)(2008-10#5)
human serum or##2##3##(1993-11#1)(2008-4#1)
human serum protein##2##3##(1992-8#1)(2008-5#1)
human serum samples are##2##4##(2008-10#2)
human serum samples were##5##4##(2008-10#5)
human serum samples##16##3##(2008-10#16)
human serum was##4##3##(2008-10#3)(2008-11#1)
human serum with##4##3##(2008-10#4)
human serum##141##2##(1990-12#1)(1990-2#2)(1990-8#4)(1990-9#1)(1991-2#1)(1991-5#4)(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-10#95)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#2)
human service##10##2##(1991-12#1)(1991-3#1)(1992-3#1)(1994-1#1)(1994-12#2)(1995-3#1)(1996-2#1)(2011-2#2)
human services programs##2##3##(1991-1#2)
human services##8##2##(1991-1#2)(1992-1#1)(1992-3#2)(1996-3#1)(2008-11#2)
human settlements##2##2##(2008-12#1)(2013-7#1)
human side##2##2##(2010-6#1)(2012-3#1)
human single chain##2##3##(1994-6#1)(2008-8#1)
human single-stranded-DNA-binding protein##2##3##(1994-8#2)
human skeletal muscle cDNA library##2##5##(1993-11#1)(1996-10#1)
human skeletal muscle##14##3##(1990-11#2)(1990-2#1)(1993-11#1)(1994-11#2)(1995-2#2)(1996-10#1)(2008-1#1)(2008-11#2)(2008-6#2)
human skeletal muscles##3##3##(1994-11#1)(2009-12#1)(2011-2#1)
human skeletal##18##2##(1990-11#2)(1990-2#1)(1993-11#1)(1994-11#3)(1995-2#2)(1996-10#1)(2008-1#1)(2008-11#2)(2008-6#2)(2009-12#1)(2011-2#1)(2012-2#1)
human skin and##4##3##(2008-3#2)(2008-5#2)
human skin are presented##2##4##(2007-11#1)(2007-12#1)
human skin fibroblast##2##3##(1995-3#1)(2008-11#1)
human skin fibroblasts and##7##4##(1991-12#1)(1993-12#1)(1994-6#1)(1995-3#1)(2008-5#2)(2009-8#1)
human skin fibroblasts##22##3##(1991-12#2)(1993-12#2)(1994-6#3)(1995-3#1)(2008-11#1)(2008-2#1)(2008-5#10)(2008-7#1)(2009-8#1)
human skin in vivo##6##4##(2008-3#1)(2008-5#4)(2012-3#1)
human skin in##7##3##(2008-3#1)(2008-5#5)(2012-3#1)
human skin is##2##3##(2008-5#2)
human skin model##3##3##(2008-5#1)(2012-3#2)
human skin permeation rates##2##4##(2008-5#2)
human skin to##2##3##(2008-5#2)
human skin was##2##3##(2008-10#1)(2008-5#1)
human skin were##2##3##(2008-11#1)(2008-5#1)
human skin##115##2##(1990-2#1)(1991-12#2)(1992-6#1)(1993-12#2)(1993-5#1)(1994-6#4)(1995-3#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#62)(2008-6#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#5)
human skull and##2##3##(2008-3#1)(2010-5#1)
human skull##3##2##(2008-3#2)(2010-5#1)
human small cell lung carcinoma##2##5##(1994-8#2)
human small##3##2##(1990-8#1)(1994-8#2)
human society##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
human soleus##4##2##(1993-12#1)(1993-9#2)(2013-1#1)
human solid tumors##3##3##(1990-2#1)(1992-10#1)(2008-11#1)
human soluble##3##2##(1991-8#2)(1994-2#1)
human somatic##2##2##(2008-2#2)
human space exploration##2##3##(2012-3#2)
human spaceflight##3##2##(2012-3#3)
human sperm##9##2##(1990-7#3)(1994-6#1)(1997-6#1)(2008-4#3)(2011-1#1)
human spermidine/spermine N1-acetyltransferase##3##3##(1991-9#1)(1992-10#1)(1995-2#1)
human stem cell research##2##4##(2008-9#2)
human stem cell##4##3##(2008-9#3)(2012-5#1)
human stomach##3##2##(1994-12#1)(1997-1#1)(2008-8#1)
human stratum corneum##6##3##(2008-5#6)
human stromal cell line##3##4##(1994-6#2)(2008-8#1)
human stromal##4##2##(1994-6#2)(2008-8#1)(2012-1#1)
human stromelysin##2##2##(1994-12#2)
human studies##20##2##(1993-11#1)(1994-11#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)
human study##2##2##(2008-5#1)(2010-6#1)
human subject and##2##3##(2008-4#1)(2008-9#1)
human subject##4##2##(1997-4#1)(2008-4#1)(2008-9#1)(2009-7#1)
human subjects with##2##3##(1995-6#1)(2009-7#1)
human subjects##33##2##(1991-12#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-5#3)(2008-7#1)(2009-4#3)(2009-6#1)(2009-7#1)(2012-3#1)(2013-1#1)
human tRNA gene##3##3##(1997-7#3)
human tear film##2##3##(2009-4#2)
human technology##2##2##(2008-10#1)(2011-2#1)
human teeth##4##2##(1991-2#2)(2008-3#1)(2011-1#1)
human telomerase reverse transcriptase (hTERT)##2##5##(2008-11#2)
human telomerase reverse transcriptase##4##4##(2007-12#1)(2008-11#3)
human telomerase##8##2##(2007-12#1)(2008-11#6)(2008-9#1)
human tenocytes##3##2##(2013-1#3)
human teratogen##2##2##(1992-2#1)(2008-4#1)
human testing##2##2##(2008-5#2)
human testis##8##2##(1990-2#3)(1990-9#1)(1995-8#1)(2008-8#2)(2008-9#1)
human tetherin##2##2##(2013-1#2)
human therapeutic##3##2##(2008-11#2)(2008-5#1)
human thioredoxin##2##2##(1990-12#1)(1991-2#1)
human thrombospondin 1##2##3##(1994-5#2)
human thromboxane synthase##2##3##(1991-5#2)
human thyroid cancer##2##3##(1992-8#2)
human thyroid carcinoma cell line##2##5##(1993-3#2)
human thyroid carcinoma##3##3##(1993-3#3)
human thyroid##16##2##(1990-2#1)(1991-2#1)(1992-8#4)(1993-3#3)(1994-11#4)(1994-6#3)
human thyrotropin receptor##6##3##(1991-12#2)(1991-5#1)(1991-9#1)(1995-12#2)
human thyrotropin##10##2##(1991-12#2)(1991-5#2)(1991-9#2)(1995-12#2)(2013-1#2)
human thyrotropin-releasing hormone receptor##2##4##(1993-8#2)
human tissue in##2##3##(2008-3#2)
human tissue inhibitor of metalloproteinase##2##5##(1990-8#1)(2010-1#1)
human tissue inhibitor of##3##4##(1990-8#1)(2010-1#2)
human tissue plasminogen activator##6##4##(1991-9#2)(1992-12#2)(2008-7#2)
human tissue##24##2##(1990-8#1)(1991-11#2)(1991-9#2)(1992-12#2)(1992-3#2)(1994-6#1)(1996-11#1)(2007-11#1)(2008-11#1)(2008-3#4)(2008-7#2)(2008-9#1)(2009-4#1)(2010-1#2)(2011-2#1)
human tissues at##2##3##(2008-3#1)(2008-8#1)
human tissues##30##2##(1990-12#1)(1991-11#1)(1991-5#3)(1991-6#2)(1993-11#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2011-1#2)(2012-12#2)
human tongue##2##2##(1996-5#1)(2012-3#1)
human tooth##2##2##(2008-3#1)(2013-1#1)
human topoisomerase II alpha##2##4##(1995-6#2)
human topoisomerase II beta##3##4##(1995-6#3)
human topoisomerase II##5##3##(1995-6#5)
human tracheal##2##2##(1991-9#2)
human traits##2##2##(1994-3#1)(2008-12#1)
human transcript##2##2##(1995-12#2)
human transferrin receptor##2##3##(1990-11#1)(1991-6#1)
human transferrin##13##2##(1990-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(2008-11#8)(2008-7#1)
human transforming growth factor##4##4##(1990-8#1)(1993-12#1)(2008-8#2)
human transketolase##2##2##(1992-3#2)
human treatment##2##2##(2008-10#1)(2012-3#1)
human trials##7##2##(1995-5#1)(2008-11#1)(2008-2#2)(2011-2#1)(2012-2#1)(2013-8#1)
human tumor cell lines##7##4##(1992-8#1)(1993-9#1)(1994-5#1)(2008-11#1)(2008-7#1)(2008-9#2)
human tumor cell##9##3##(1990-5#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#2)
human tumor cells##11##3##(1990-12#2)(1990-5#1)(1994-5#3)(1994-8#1)(2008-11#1)(2008-8#1)(2009-4#2)
human tumor microenvironments##2##3##(2011-1#2)
human tumor necrosis factor##5##4##(1990-7#1)(1992-9#1)(1994-2#1)(2008-8#2)
human tumor xenografts and##2##4##(1994-3#1)(2013-8#1)
human tumor xenografts in##2##4##(2008-6#1)(2013-7#1)
human tumor xenografts##4##3##(1994-3#1)(2008-6#1)(2013-7#1)(2013-8#1)
human tumor##40##2##(1990-12#3)(1990-5#2)(1990-7#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#1)(1995-3#1)(2008-11#3)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#2)(2011-1#2)(2012-12#1)(2013-7#1)(2013-8#1)
human tumors and##3##3##(1992-8#1)(2008-11#1)(2008-9#1)
human tumors##20##2##(1992-5#3)(1992-8#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-12#2)(2013-1#1)
human tumour cell##2##3##(1994-3#1)(1997-7#1)
human tumour##4##2##(1994-3#1)(1996-12#1)(1997-3#1)(1997-7#1)
human tumours##2##2##(1994-10#1)(2010-1#1)
human tympanic membrane keratinocytes##2##4##(2012-8#2)
human tympanic membrane##3##3##(2009-7#1)(2012-8#2)
human type 2##2##3##(1994-9#1)(2012-3#1)
human type I 5 alpha-reductase##2##5##(1995-3#2)
human type I##7##3##(1990-2#1)(1991-7#2)(1995-12#1)(1995-3#2)(2008-5#1)
human type II##2##3##(1994-11#1)(1995-3#1)
human type##11##2##(1990-2#1)(1991-7#2)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#3)(2008-5#1)(2012-3#1)
human uPA##5##2##(1997-4#1)(2008-11#4)
human umbilical cord blood##2##4##(2008-8#2)
human umbilical cord##4##3##(1995-2#1)(2008-11#1)(2008-8#2)
human umbilical vein endothelial cells (HUVEC)##8##6##(1993-11#1)(1994-8#1)(1997-1#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-2#1)
human umbilical vein endothelial cells (HUVECs)##2##6##(2008-10#2)
human umbilical vein endothelial cells##27##5##(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
human umbilical vein endothelial##30##4##(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)(2013-8#1)
human umbilical vein##32##3##(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)(2013-8#2)
human umbilical veins##3##3##(1993-3#1)(2008-8#1)(2008-9#1)
human umbilical##40##2##(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#1)(1997-1#2)(2008-10#4)(2008-11#6)(2008-7#1)(2008-8#5)(2008-9#4)(2010-3#1)(2012-2#2)(2013-8#2)
human urinary##3##2##(1990-12#1)(1994-8#1)(2010-12#1)
human urine and hair samples##2##5##(2008-10#2)
human urine and pharmaceuticals##2##4##(2008-10#2)
human urine and serum##12##4##(1990-8#2)(2008-10#10)
human urine and##23##3##(1990-7#1)(1990-8#2)(2008-10#20)
human urine by##13##3##(1990-8#3)(1995-12#1)(2008-10#8)(2008-11#1)
human urine has been developed##2##5##(2008-10#2)
human urine samples##12##3##(2008-10#11)(2010-11#1)
human urine were##2##3##(1990-8#2)
human urine##98##2##(1990-12#1)(1990-7#2)(1990-8#10)(1992-3#3)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#2)(1997-2#1)(2008-10#71)(2008-11#2)(2009-9#1)(2010-11#1)
human uterine LMS##3##3##(2012-2#3)
human uterine##8##2##(1993-12#1)(1994-9#1)(2008-11#1)(2008-6#1)(2012-2#3)(2013-1#1)
human vacuolar##2##2##(1993-11#1)(1995-6#1)
human vascular cells##2##3##(1992-3#1)(1993-3#1)
human vascular endothelial cells##5##4##(1993-11#1)(1993-6#2)(1994-11#1)(2010-1#1)
human vascular endothelial growth factor##2##5##(2008-8#2)
human vascular endothelial growth##3##4##(1997-7#1)(2008-8#2)
human vascular endothelial##8##3##(1993-11#1)(1993-6#2)(1994-11#1)(1997-7#1)(2008-8#2)(2010-1#1)
human vascular##12##2##(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-9#2)(1997-7#1)(2008-8#2)(2010-1#1)
human viruses##3##2##(1996-8#1)(2008-10#2)
human vision##4##2##(2008-3#3)(2012-2#1)
human visual##4##2##(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)
human volunteer##4##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
human volunteers##23##2##(1992-6#1)(1994-5#1)(1995-5#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-5#8)(2010-3#1)(2011-2#1)(2012-2#3)
human vomeronasal##3##2##(1994-2#1)(2012-2#2)
human whole blood##4##3##(1990-8#1)(2008-10#2)(2011-1#1)
human whole##5##2##(1990-8#1)(1997-8#1)(2008-10#2)(2011-1#1)
human xenograft##2##2##(2011-1#1)(2012-2#1)
human##5839##1##(1990-10#3)(1990-11#41)(1990-12#82)(1990-2#49)(1990-3#10)(1990-5#47)(1990-6#13)(1990-7#27)(1990-8#67)(1990-9#4)(1991-1#4)(1991-10#3)(1991-11#8)(1991-12#60)(1991-2#41)(1991-3#12)(1991-4#4)(1991-5#52)(1991-6#56)(1991-7#9)(1991-8#14)(1991-9#48)(1992-1#3)(1992-10#13)(1992-11#39)(1992-12#45)(1992-2#35)(1992-3#65)(1992-4#3)(1992-5#16)(1992-6#38)(1992-7#1)(1992-8#84)(1992-9#39)(1993-1#11)(1993-11#48)(1993-12#49)(1993-2#27)(1993-3#64)(1993-5#8)(1993-6#68)(1993-8#64)(1993-9#43)(1994-1#3)(1994-10#5)(1994-11#81)(1994-12#71)(1994-2#29)(1994-3#41)(1994-5#31)(1994-6#70)(1994-7#2)(1994-8#93)(1994-9#57)(1995-1#3)(1995-10#3)(1995-11#35)(1995-12#62)(1995-2#76)(1995-3#32)(1995-5#23)(1995-6#59)(1995-8#35)(1995-9#9)(1996-1#2)(1996-10#14)(1996-11#6)(1996-12#38)(1996-2#44)(1996-3#6)(1996-4#1)(1996-5#31)(1996-6#10)(1996-7#1)(1996-8#7)(1996-9#2)(1997-1#22)(1997-2#41)(1997-3#17)(1997-4#57)(1997-5#4)(1997-6#14)(1997-7#72)(1997-8#25)(1997-9#12)(2006-10#4)(2006-12#2)(2006-6#13)(2006-8#1)(2007-10#2)(2007-11#36)(2007-12#33)(2007-2#4)(2007-4#3)(2007-5#5)(2007-7#22)(2007-8#4)(2008-1#38)(2008-10#432)(2008-11#424)(2008-12#43)(2008-2#34)(2008-3#60)(2008-4#194)(2008-5#216)(2008-6#34)(2008-7#127)(2008-8#189)(2008-9#153)(2009-10#17)(2009-11#6)(2009-12#21)(2009-2#18)(2009-3#8)(2009-4#21)(2009-5#31)(2009-6#8)(2009-7#30)(2009-8#19)(2009-9#16)(2010-1#16)(2010-10#10)(2010-11#31)(2010-12#25)(2010-2#9)(2010-3#14)(2010-4#4)(2010-5#19)(2010-6#16)(2010-7#7)(2010-8#16)(2010-9#2)(2011-1#53)(2011-2#152)(2011-3#15)(2011-7#1)(2011-9#1)(2012-1#26)(2012-12#53)(2012-2#113)(2012-3#84)(2012-4#1)(2012-5#8)(2012-6#1)(2012-7#2)(2012-8#2)(2012-9#3)(2013-1#160)(2013-7#16)(2013-8#48)
human-derived##5##1##(1992-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)
human-friendly&quot##2##1##(1994-3#2)
human-hamster##3##1##(1991-6#1)(1992-3#1)(2008-8#1)
human-human hybridoma cell line##2##4##(2008-11#2)
human-human hybridoma cell##3##3##(2008-11#3)
human-human hybridoma##5##2##(2008-11#5)
human-human hybridomas##2##2##(2008-11#2)
human-human##7##1##(2008-11#7)
human-induced##4##1##(2008-5#1)(2011-1#1)(2012-3#1)(2012-9#1)
human-like##3##1##(1996-6#1)(2008-11#1)(2013-1#1)
human-mouse##3##1##(1990-12#1)(2008-11#1)(2008-4#1)
human-rodent somatic cell hybrids##2##4##(1991-6#1)(1991-9#1)
human-rodent somatic cell##3##3##(1991-6#1)(1991-9#1)(1994-11#1)
human-specific##2##1##(2008-7#1)(2010-6#1)
human/rodent##4##1##(1994-9#1)(1997-2#2)(1997-8#1)
humane##4##1##(1991-6#1)(1994-12#1)(1997-3#1)(2008-4#1)
humanism##3##1##(2008-11#1)(2013-8#2)
humanist##2##1##(2008-11#1)(2009-7#1)
humanistic##8##1##(1997-3#1)(2007-10#1)(2010-6#3)(2012-2#1)(2012-3#1)(2013-8#1)
humanitarian crisis##2##2##(2009-6#2)
humanitarian##8##1##(1995-2#1)(2008-1#2)(2009-6#3)(2011-2#2)
humanities and##2##2##(1993-12#1)(2011-2#1)
humanities in the##3##3##(2008-11#2)(2011-2#1)
humanities in##4##2##(1997-3#1)(2008-11#2)(2011-2#1)
humanities is##2##2##(1997-3#1)(2011-2#1)
humanities##15##1##(1993-12#1)(1997-3#2)(2008-11#4)(2011-2#6)(2013-8#2)
humanity##4##1##(2008-11#2)(2008-4#1)(2013-8#1)
humanization##2##1##(1995-5#1)(2008-5#1)
humanized antibody##2##2##(2008-11#2)
humanized monoclonal##4##2##(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)
humanized##11##1##(1995-2#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-2#2)(2010-5#1)
humanoid##4##1##(2008-11#1)(2009-11#1)(2009-5#2)
humans after##2##2##(2008-10#1)(2008-7#1)
humans and animals and##2##4##(2013-8#2)
humans and animals##10##3##(1991-8#1)(1996-5#1)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
humans and dogs##2##3##(2010-12#1)(2011-2#1)
humans and mice##5##3##(2008-10#3)(2012-2#2)
humans and other animals##3##4##(1991-8#1)(1993-3#1)(2008-10#1)
humans and other mammals##2##4##(2008-7#1)(2011-2#1)
humans and other##8##3##(1991-8#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
humans and rats##6##3##(1994-2#1)(2008-10#1)(2008-7#4)
humans and the##2##3##(1994-2#1)(2008-10#1)
humans and yeast##2##3##(2010-4#2)
humans and##74##2##(1991-12#2)(1991-5#1)(1991-8#2)(1992-11#1)(1993-3#1)(1994-2#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-9#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
humans are not##2##3##(2008-10#1)(2012-2#1)
humans are##8##2##(2007-7#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#3)
humans as a##2##3##(1993-11#1)(2010-5#1)
humans as well as in##3##5##(1995-5#1)(1996-7#1)(2012-2#1)
humans as well as##5##4##(1995-5#1)(1996-7#1)(2012-1#1)(2012-2#2)
humans as well##6##3##(1995-5#1)(1996-7#1)(2008-10#1)(2012-1#1)(2012-2#2)
humans as##11##2##(1993-11#1)(1994-9#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-2#3)
humans by##4##2##(1997-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
humans can be##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
humans can##4##2##(1990-5#1)(1996-3#1)(2008-4#1)(2008-7#1)
humans following##3##2##(1992-8#1)(2007-12#1)(2008-10#1)
humans for##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
humans from##2##2##(1995-2#1)(2010-1#1)
humans have a##2##3##(1996-2#1)(2007-12#1)
humans have been##3##3##(1994-2#1)(2008-10#1)(2009-12#1)
humans have evolved##2##3##(2008-5#1)(2012-1#1)
humans have##11##2##(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2012-1#1)
humans in the##2##3##(1994-5#1)(2013-1#1)
humans in##6##2##(1994-5#1)(2006-6#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
humans is a##4##3##(1997-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
humans is##20##2##(1992-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#2)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
humans may also##2##3##(2007-12#1)(2008-11#1)
humans may##3##2##(2007-12#1)(2008-11#1)(2008-8#1)
humans of##4##2##(1991-9#1)(2008-4#1)(2008-8#1)(2011-2#1)
humans or##3##2##(1990-5#1)(2008-4#1)(2012-2#1)
humans suggest that##2##3##(2009-8#1)(2010-5#1)
humans than##3##2##(2010-11#2)(2013-1#1)
humans that##3##2##(2008-9#2)(2010-5#1)
humans through the##2##3##(2008-10#1)(2013-8#1)
humans to##9##2##(1992-3#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#1)
humans were##3##2##(1991-12#1)(1994-5#1)(2008-8#1)
humans with the##2##3##(1992-12#1)(2012-2#1)
humans with##11##2##(1990-11#1)(1991-1#2)(1992-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
humans##492##1##(1990-11#3)(1990-5#5)(1990-6#1)(1990-7#1)(1991-1#11)(1991-12#7)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#4)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#5)(1994-5#7)(1994-6#2)(1994-8#4)(1994-9#3)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#3)(1995-9#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#39)(2008-11#17)(2008-12#9)(2008-2#4)(2008-3#3)(2008-4#13)(2008-5#17)(2008-6#2)(2008-7#23)(2008-8#12)(2008-9#9)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#2)(2010-11#7)(2010-12#1)(2010-3#1)(2010-4#9)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#4)(2011-2#36)(2012-1#6)(2012-12#10)(2012-2#29)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#12)
humans)##2##1##(1995-2#1)(2008-4#1)
humans]##2##1##(1997-5#1)(2012-12#1)
humectancies of d-tagatose and d-sorbitol##2##5##(2008-5#2)
humectancy##6##1##(2008-5#6)
humectant##2##1##(2008-5#2)
humeral bone##4##2##(2007-11#4)
humeral shaft##2##2##(2007-11#2)
humeral##28##1##(1997-6#1)(2007-11#9)(2007-8#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
humerii##6##1##(2013-8#6)
humerus - 10##2##3##(2007-11#2)
humerus and##4##2##(2007-11#1)(2012-1#1)(2013-8#2)
humerus fractures##13##2##(2007-11#1)(2007-8#6)(2008-9#1)(2009-3#3)(2013-1#2)
humerus in children##2##3##(2008-7#1)(2010-11#1)
humerus in##3##2##(2008-7#1)(2010-11#1)(2012-2#1)
humerus is##3##2##(2007-11#2)(2013-1#1)
humerus of##4##2##(1996-11#1)(2012-2#1)(2012-3#2)
humerus was##2##2##(2007-11#1)(2013-8#1)
humerus were##3##2##(2012-2#1)(2013-8#2)
humerus##59##1##(1995-6#2)(1996-11#1)(2007-11#11)(2007-8#9)(2008-6#4)(2008-7#2)(2008-9#1)(2009-3#3)(2009-4#1)(2010-11#1)(2010-3#2)(2011-2#2)(2012-1#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#7)
humic (HA) and fulvic##2##4##(2008-10#2)
humic acid (HA) and##2##4##(2008-10#1)(2013-8#1)
humic acid (HA)##3##3##(2008-10#2)(2013-8#1)
humic acid and cations Ca(II)##2##5##(2008-10#2)
humic acid and##3##3##(2008-10#3)
humic acid by##2##3##(2008-10#1)(2013-8#1)
humic acid##27##2##(2008-10#24)(2013-8#3)
humic acids (HAs)##2##3##(2008-10#2)
humic acids and##3##3##(2008-10#3)
humic acids##24##2##(2008-10#24)
humic and fulvic acids##2##4##(2008-10#2)
humic and fulvic##4##3##(2008-10#3)(2008-3#1)
humic compounds##5##2##(2008-10#5)
humic materials##3##2##(2008-10#3)
humic matter by##2##3##(2008-10#2)
humic matter##5##2##(2008-10#5)
humic solutes##4##2##(2008-10#4)
humic substance-metal##2##2##(2008-10#2)
humic substances (HS)##4##3##(2008-10#4)
humic substances and##4##3##(1992-5#1)(2008-10#3)
humic substances were##3##3##(1992-5#1)(2008-10#2)
humic substances##26##2##(1992-5#4)(2008-10#22)
humic##119##1##(1992-5#4)(2008-10#110)(2008-3#1)(2008-9#1)(2013-8#3)
humic-solute bulks##2##2##(2008-10#2)
humic-solute##3##1##(2008-10#3)
humic-type solutes##2##2##(2008-10#2)
humic-type##4##1##(2008-10#4)
humics##2##1##(2008-10#2)
humid air##2##2##(1993-3#1)(2008-10#1)
humid conditions##2##2##(1996-2#1)(2008-10#1)
humid tropics##3##2##(2008-9#1)(2010-7#2)
humid##14##1##(1993-3#1)(1996-2#1)(2008-10#5)(2008-9#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
humidified##3##1##(2008-11#1)(2008-5#1)(2013-1#1)
humidifier##2##1##(2007-11#1)(2013-8#1)
humidifiers##5##1##(2010-9#2)(2013-8#3)
humidities##15##1##(1996-12#2)(2008-10#10)(2010-4#2)(2011-2#1)
humidity &gt##3##2##(2008-10#3)
humidity (RH)##21##2##(1996-12#1)(2007-11#1)(2008-10#18)(2008-2#1)
humidity and##10##2##(1996-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2012-2#1)(2013-1#1)
humidity as the##2##3##(2008-10#2)
humidity as##4##2##(2008-10#2)(2011-1#2)
humidity at the##3##3##(1992-2#2)(2008-10#1)
humidity at##8##2##(1992-2#2)(2008-10#3)(2008-2#2)(2008-5#1)
humidity during##3##2##(2008-10#2)(2008-5#1)
humidity for##2##2##(2008-10#2)
humidity in the##2##3##(2008-10#1)(2008-3#1)
humidity in##3##2##(2008-10#2)(2008-3#1)
humidity level##2##2##(2008-10#2)
humidity levels##2##2##(2008-10#2)
humidity measurements##2##2##(2008-3#1)(2009-3#1)
humidity of the##2##3##(1995-3#1)(2008-10#1)
humidity of##6##2##(1992-2#1)(1995-3#1)(2008-10#1)(2008-2#1)(2011-1#2)
humidity on the##4##3##(2008-10#2)(2010-10#1)(2011-2#1)
humidity on##9##2##(2008-10#5)(2010-10#1)(2010-4#1)(2011-2#2)
humidity profiles##3##2##(1996-12#3)
humidity sensing##5##2##(2008-10#5)
humidity sensor##5##2##(2007-11#1)(2008-10#4)
humidity to##2##2##(2008-10#1)(2010-10#1)
humidity was##5##2##(2008-10#3)(2008-3#1)(2011-1#1)
humidity##185##1##(1992-2#3)(1995-3#3)(1996-12#5)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#106)(2008-2#9)(2008-3#9)(2008-5#11)(2008-8#2)(2009-3#1)(2009-5#2)(2010-10#3)(2010-4#2)(2010-5#1)(2011-1#5)(2011-2#6)(2012-2#5)(2013-1#3)(2013-7#2)(2013-8#3)
humidity)##5##1##(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)
humidity-sensitive##2##1##(2008-10#1)(2012-2#1)
humified##2##1##(1997-2#2)
humiliated##2##1##(2011-2#1)(2012-3#1)
humiliation##2##1##(1997-5#1)(2008-12#1)
hummingbird##6##1##(2008-5#2)(2008-8#1)(2008-9#2)(2012-12#1)
hummingbirds##2##1##(2008-9#2)
humor and##2##2##(2008-10#1)(2009-10#1)
humor indicators##2##2##(2008-10#2)
humor##18##1##(1996-2#1)(2007-2#1)(2008-10#6)(2008-12#6)(2009-10#1)(2009-3#2)(2011-3#1)
humoral and cellular immune responses against##2##6##(1995-5#1)(2007-5#1)
humoral and cellular immune responses##7##5##(1991-12#1)(1995-5#1)(1997-4#1)(2007-5#1)(2008-12#1)(2010-5#1)(2011-1#1)
humoral and cellular immune##8##4##(1991-12#2)(1995-5#1)(1997-4#1)(2007-5#1)(2008-12#1)(2010-5#1)(2011-1#1)
humoral and cellular##11##3##(1991-12#2)(1995-5#2)(1997-3#1)(1997-4#1)(2007-5#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#1)
humoral and##14##2##(1991-12#2)(1995-5#2)(1997-3#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#1)
humoral autoimmunity##2##2##(1993-3#1)(2010-5#1)
humoral factors##3##2##(1993-8#1)(2008-5#1)(2008-6#1)
humoral immune response of##2##4##(2008-11#1)(2008-3#1)
humoral immune response to##2##4##(2007-7#1)(2008-4#1)
humoral immune response##12##3##(1997-4#1)(1997-8#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
humoral immune responses of##2##4##(2008-11#1)(2008-12#1)
humoral immune responses##8##3##(1995-2#2)(2008-10#2)(2008-11#3)(2008-12#1)
humoral immune##23##2##(1995-2#2)(1996-9#1)(1997-4#1)(1997-8#2)(2007-7#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)
humoral immunity##21##2##(1993-12#1)(1995-12#2)(1995-5#1)(1996-12#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#3)(2012-2#2)(2012-3#1)
humoral response##6##2##(1991-12#2)(1993-12#1)(2006-10#1)(2007-10#1)(2008-10#1)
humoral responses##6##2##(1991-12#2)(1995-5#1)(2006-10#1)(2008-10#2)
humoral responsiveness##2##2##(1993-12#2)
humoral##89##1##(1991-12#6)(1993-12#4)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#3)(1995-2#2)(1995-5#5)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2006-10#3)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2010-5#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)
humorous##3##1##(2007-2#1)(2008-10#2)
humour and##2##2##(2008-11#1)(2008-5#1)
humour##3##1##(2008-11#1)(2008-4#1)(2008-5#1)
hump##5##1##(2007-11#4)(2011-2#1)
hundred and eight##3##3##(2007-8#1)(2008-3#1)(2011-1#1)
hundred and eighteen##2##3##(2007-7#1)(2008-7#1)
hundred and eighty##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
hundred and eighty-two##2##3##(2007-12#1)(2011-1#1)
hundred and eleven##2##3##(2008-4#1)(2010-6#1)
hundred and fifty##6##3##(1993-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-3#1)
hundred and fifty-five##2##3##(1992-1#1)(2007-10#1)
hundred and fifty-six##2##3##(2008-8#1)(2012-2#1)
hundred and nine##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
hundred and ninety-seven##2##3##(1993-12#1)(2012-12#1)
hundred and seven patients##2##4##(2007-8#1)(2013-8#1)
hundred and seventy-two##2##3##(1996-8#1)(2008-9#1)
hundred and sixty##2##3##(2007-10#1)(2012-12#1)
hundred and sixty-eight##3##3##(2007-12#1)(2008-10#1)(2012-1#1)
hundred and ten##2##3##(2008-12#1)(2009-4#1)
hundred and thirteen##4##3##(2007-2#2)(2008-5#1)(2013-8#1)
hundred and thirty-three##2##3##(1993-1#1)(2011-2#1)
hundred and three##3##3##(2007-8#1)(2008-10#1)(2010-4#1)
hundred and twelve##2##3##(1990-2#1)(2010-3#1)
hundred and twenty##6##3##(2007-7#2)(2008-10#1)(2012-2#1)(2013-1#2)
hundred and twenty-three##2##3##(1990-9#1)(1991-12#1)
hundred and##102##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-2#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-8#2)(1997-3#1)(1997-4#1)(2007-10#2)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#5)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#1)(2010-1#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
hundred eighty##3##2##(2008-1#1)(2010-8#1)(2011-1#1)
hundred eleven##2##2##(2007-8#1)(2012-2#1)
hundred fifty##2##2##(1992-12#1)(2008-1#1)
hundred fold##2##2##(2008-10#1)(2008-11#1)
hundred forty##3##2##(2013-1#2)(2013-8#1)
hundred forty-nine##2##2##(2008-10#2)
hundred genes##3##2##(2008-7#2)(2013-8#1)
hundred isolates##2##2##(2008-10#2)
hundred ninety##2##2##(2007-11#1)(2012-3#1)
hundred ninety-two##2##2##(2007-10#1)(2013-1#1)
hundred of##2##2##(1994-6#1)(2011-1#1)
hundred patients##4##2##(1992-2#1)(2007-7#1)(2008-12#1)(2011-2#1)
hundred six##2##2##(2012-2#1)(2013-1#1)
hundred sixty##2##2##(1991-12#1)(2013-8#1)
hundred sixty-four##2##2##(2008-10#1)(2013-1#1)
hundred thirty##2##2##(1995-3#1)(1997-2#1)
hundred thirty-five##2##2##(1992-1#1)(2012-2#1)
hundred thousand##4##2##(2008-2#1)(2012-12#1)(2012-3#2)
hundred times##2##2##(2007-11#1)(2007-12#1)
hundred twenty##2##2##(1991-2#1)(2007-11#1)
hundred years ago##3##3##(2012-12#1)(2013-1#2)
hundred years##10##2##(1990-6#1)(1991-12#1)(1997-2#1)(2008-2#1)(2009-10#1)(2012-12#1)(2013-1#2)(2013-8#2)
hundred##248##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#2)(1993-1#2)(1993-12#4)(1993-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#2)(1996-10#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#3)(2007-11#4)(2007-12#6)(2007-2#3)(2007-6#1)(2007-7#8)(2007-8#5)(2008-1#3)(2008-10#29)(2008-11#8)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#11)
hundreds of cases##2##3##(2008-4#1)(2011-2#1)
hundreds of genes##2##3##(2008-10#2)
hundreds of thousands of##4##4##(2008-6#1)(2008-7#2)(2009-8#1)
hundreds of years##2##3##(1996-9#1)(2011-2#1)
hundreds of##43##2##(1991-9#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#2)
hundreds to thousands of##3##4##(1991-2#1)(2008-4#2)
hundreds##49##1##(1991-2#1)(1991-9#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#2)
hung##2##1##(2008-2#1)(2013-1#1)
hungatei##2##1##(1990-2#2)
hunger in##2##2##(2008-1#1)(2012-12#1)
hunger##7##1##(1991-1#1)(2008-1#3)(2008-3#1)(2008-5#1)(2012-12#1)
hungry##3##1##(1993-6#1)(2011-2#1)(2012-12#1)
hunt for##2##2##(1995-11#1)(2011-2#1)
hunt##7##1##(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#1)
hunters##2##1##(1991-11#1)(2013-8#1)
hunting and##3##2##(2008-4#1)(2008-5#1)(2013-7#1)
hunting pressure##2##2##(2013-1#1)(2013-7#1)
hunting##11##1##(1991-11#3)(1992-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#2)(2013-7#2)
huntington##3##1##(1995-5#3)
hupB##2##1##(1990-11#1)(1994-11#1)
hupensis##5##1##(2008-8#4)(2012-3#1)
hurdle##7##1##(1993-12#1)(1997-7#1)(2008-11#1)(2009-11#1)(2010-10#1)(2012-12#1)(2012-3#1)
hurdles have##2##2##(2008-4#1)(2010-12#1)
hurdles that##3##2##(1994-2#1)(2008-4#1)(2012-3#1)
hurdles to##6##2##(1994-3#1)(2008-4#1)(2009-11#2)(2010-5#1)(2013-8#1)
hurdles##22##1##(1994-2#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-8#1)(2009-11#2)(2009-4#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
hurricane##3##1##(2007-10#1)(2008-8#1)(2012-2#1)
hurt##4##1##(1993-1#1)(2008-11#1)(2010-4#1)(2010-9#1)
husband##5##1##(1997-5#1)(2007-2#1)(2008-10#1)(2010-3#1)(2011-2#1)
husband's##2##1##(2008-9#1)(2013-8#1)
husbandry and##3##2##(2008-11#1)(2010-10#1)(2011-1#1)
husbandry conditions for maintaining multi-generation populations of this species##2##9##(2008-11#2)
husbandry conditions for maintaining multi-generation populations##3##6##(2008-11#3)
husbandry##13##1##(1997-3#1)(2008-11#7)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)
husbands and##4##2##(2008-9#1)(2011-1#2)(2011-2#1)
husbands##12##1##(1994-6#1)(1996-12#1)(2007-7#2)(2008-9#4)(2011-1#3)(2011-2#1)
husbands'##4##1##(2008-9#3)(2013-8#1)
husk extension##2##2##(2008-10#2)
husk##3##1##(2008-10#3)
hvmyb##3##1##(2008-8#3)
hy926 cells##2##2##(1995-2#2)
hy926 human##2##2##(1995-2#1)(2008-10#1)
hy926##4##1##(1995-2#3)(2008-10#1)
hyacinthi##2##1##(2008-10#2)
hyalin##4##1##(2008-10#1)(2013-7#3)
hyaline cartilage##2##2##(2011-2#1)(2013-8#1)
hyaline##6##1##(1991-12#1)(1991-8#1)(2008-10#1)(2011-2#2)(2013-8#1)
hyalinizing granuloma in HIV/AIDS##2##4##(2008-10#2)
hyalinizing granuloma##3##2##(2008-10#3)
hyalinizing##4##1##(1992-8#1)(2008-10#3)
hyaluronan (HA)##2##2##(2008-10#1)(2008-5#1)
hyaluronan is##2##2##(2011-1#2)
hyaluronan##23##1##(1993-6#2)(1995-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#11)(2011-2#3)
hyaluronate##4##1##(1992-9#2)(2008-10#2)
hyaluronic acid (HA)##3##3##(1996-12#1)(2008-10#1)(2010-10#1)
hyaluronic acid##22##2##(1992-12#1)(1994-5#1)(1996-12#2)(2008-10#4)(2008-5#2)(2010-10#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)
hyaluronic acid/dextranomer##2##2##(2008-10#2)
hyaluronic##27##1##(1992-12#1)(1994-5#1)(1996-12#2)(1997-4#2)(2008-10#6)(2008-5#3)(2010-10#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)
hyaluronidase activity##5##2##(1996-12#2)(2008-5#3)
hyaluronidase using##2##2##(1994-5#1)(2008-10#1)
hyaluronidase##13##1##(1994-5#4)(1994-8#1)(1996-12#2)(2008-10#2)(2008-5#4)
hybrid (diffractive-refractive)##2##2##(2007-11#2)
hybrid HBcAg particles##2##3##(1995-5#2)
hybrid PDMS-glass devices##2##3##(2008-10#2)
hybrid VLPs carrying##2##3##(1995-5#2)
hybrid abundance##2##2##(2012-3#2)
hybrid algorithm##2##2##(2008-3#1)(2010-2#1)
hybrid amplification##2##2##(2007-11#1)(2007-12#1)
hybrid and the pure diffusion models##2##6##(2008-3#2)
hybrid and the##3##3##(2008-3#3)
hybrid and##9##2##(2008-12#2)(2008-3#4)(2008-8#1)(2008-9#1)(2012-3#1)
hybrid approach##6##2##(2007-8#1)(2008-3#3)(2011-2#1)(2013-8#1)
hybrid artificial liver##5##3##(2008-11#5)
hybrid became infected##2##3##(2008-10#2)
hybrid between common carp and crucian carp##2##7##(2008-9#2)
hybrid between##7##2##(1994-5#1)(2008-10#2)(2008-4#1)(2008-9#3)
hybrid camera##2##2##(2008-6#2)
hybrid cell line##2##3##(1991-6#1)(2008-7#1)
hybrid cell##4##2##(1991-6#1)(1997-2#1)(1997-8#1)(2008-7#1)
hybrid cells##6##2##(1995-11#1)(1995-2#1)(1997-2#3)(1997-4#1)
hybrid clones regenerated from##2##4##(2008-8#2)
hybrid coatings##3##2##(2010-4#3)
hybrid containing the##2##3##(2008-10#2)
hybrid cultivars##2##2##(2008-10#2)
hybrid dysgenesis in##2##3##(1995-8#2)
hybrid dysgenesis##5##2##(1995-8#5)
hybrid fiber taper##2##3##(2007-11#2)
hybrid films##2##2##(2008-10#2)
hybrid filter##3##2##(2008-3#3)
hybrid fitness##3##2##(2008-8#3)
hybrid gene##2##2##(1994-12#1)(1995-6#1)
hybrid glass planar##2##3##(2007-11#2)
hybrid hemoglobin##3##2##(1990-8#1)(1993-8#2)
hybrid holographic microscopy##4##3##(2008-3#4)
hybrid imaging modality##2##3##(2011-1#1)(2012-12#1)
hybrid imaging##6##2##(2008-6#2)(2011-1#1)(2012-12#1)(2012-2#2)
hybrid individuals##3##2##(2008-8#1)(2008-9#2)
hybrid is##2##2##(1990-8#1)(2008-10#1)
hybrid isolates##3##2##(2008-10#3)
hybrid laser##4##2##(2007-11#1)(2008-2#3)
hybrid linear analysis (HLA)##4##4##(2008-10#4)
hybrid linear##5##2##(2008-10#5)
hybrid lines##2##2##(1992-9#1)(2008-8#1)
hybrid mapping panel##2##3##(1997-2#1)(1997-8#1)
hybrid material##2##2##(2007-12#1)(2008-7#1)
hybrid materials##4##2##(2008-10#1)(2008-5#2)(2010-4#1)
hybrid membrane##2##2##(2008-10#2)
hybrid mesoporous##2##2##(2010-4#2)
hybrid method is introduced as a combination of the four-flux method with coefficients##2##13##(2008-3#2)
hybrid method that combines##2##4##(2008-3#1)(2008-4#1)
hybrid method##8##2##(2008-3#7)(2008-4#1)
hybrid microlens##2##2##(2008-3#2)
hybrid mode locking##2##3##(2007-11#2)
hybrid model##3##2##(1994-2#1)(2008-3#2)
hybrid modeled-unmodeled##2##2##(2008-3#2)
hybrid modes##2##2##(2008-3#2)
hybrid molecules##2##2##(2008-4#1)(2011-2#1)
hybrid nafion/sol-gel silicate film##2##4##(2008-10#2)
hybrid nafion/sol-gel silicate##3##3##(2008-10#3)
hybrid of##5##2##(1993-1#1)(2008-10#3)(2008-9#1)
hybrid offspring##2##2##(2012-3#2)
hybrid optical##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
hybrid optical-digital correlator##2##3##(2008-3#2)
hybrid optical-digital##7##2##(2008-3#7)
hybrid organic/inorganic##2##2##(2008-7#2)
hybrid poplar##8##2##(2008-10#8)
hybrid populations and##2##3##(2008-10#2)
hybrid proteins##2##2##(1991-5#1)(1994-12#1)
hybrid recognition system##3##3##(2008-2#3)
hybrid rice##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
hybrid seed##3##2##(1997-5#1)(2008-10#2)
hybrid solgel glass##2##3##(2007-12#1)(2008-3#1)
hybrid solgel##4##2##(2007-12#2)(2008-3#2)
hybrid speciation##4##2##(2008-8#2)(2009-2#2)
hybrid species##2##2##(2009-2#1)(2013-1#1)
hybrid sterility##2##2##(2008-9#1)(2012-3#1)
hybrid strategy##3##2##(2011-2#1)(2012-12#2)
hybrid substrates##2##2##(2007-11#1)(2009-2#1)
hybrid system##6##2##(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)
hybrid systems##5##2##(2008-10#2)(2010-4#1)(2013-1#2)
hybrid technique&quot##2##2##(2008-8#2)
hybrid vigor##2##2##(2008-9#1)(2009-10#1)
hybrid viruses##2##2##(1995-2#2)
hybrid was##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
hybrid zones with##2##3##(2012-3#1)(2013-1#1)
hybrid zones##17##2##(2008-8#10)(2010-3#2)(2012-3#2)(2013-1#3)
hybrid##466##1##(1990-11#1)(1990-12#3)(1990-8#2)(1991-5#2)(1991-6#1)(1991-9#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#5)(1995-5#6)(1995-6#1)(1995-8#5)(1996-12#2)(1996-6#1)(1997-2#8)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#3)(2007-10#2)(2007-11#19)(2007-12#11)(2007-8#1)(2008-10#93)(2008-11#10)(2008-12#5)(2008-2#17)(2008-3#71)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#38)(2008-9#18)(2009-10#2)(2009-12#3)(2009-2#7)(2009-3#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#10)(2011-1#1)(2011-2#8)(2012-12#10)(2012-2#7)(2012-3#14)(2013-1#8)(2013-8#1)
hybrid-level##2##1##(2008-3#2)
hybrida##6##1##(2008-10#3)(2008-9#3)
hybridation##2##1##(2008-10#2)
hybridisation reactions##2##2##(2008-10#2)
hybridisation##17##1##(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#4)(2008-10#6)(2008-12#2)(2009-8#1)
hybridisation-RNase protection assay##4##3##(1996-12#4)
hybridisation-RNase protection##5##2##(1996-12#5)
hybridizable##3##1##(2008-9#3)
hybridization (FISH)##22##2##(1993-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
hybridization (GISH)##2##2##(2008-8#2)
hybridization analyses showed that the##2##5##(1997-8#1)(2008-6#1)
hybridization analyses##5##2##(1997-8#1)(2008-10#3)(2008-6#1)
hybridization analysis demonstrated that##3##4##(1992-9#1)(1995-8#1)(1996-2#1)
hybridization analysis of the##2##4##(2008-10#2)
hybridization analysis of##6##3##(1991-9#1)(2008-10#4)(2008-5#1)
hybridization analysis revealed that##2##4##(1996-12#1)(1996-6#1)
hybridization analysis using cloned cDNA probes to##2##7##(2008-10#2)
hybridization analysis using##5##3##(2008-10#2)(2008-4#2)(2008-9#1)
hybridization analysis with##6##3##(1991-2#1)(1997-2#1)(2008-10#2)(2008-4#2)
hybridization analysis##38##2##(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#2)(2008-10#17)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2012-3#1)
hybridization and DNA##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
hybridization and PCR##2##3##(1990-7#1)(2008-4#1)
hybridization and hybrid##2##3##(2008-8#1)(2008-9#1)
hybridization and introgression##2##3##(2008-10#1)(2009-2#1)
hybridization and polymerase chain reaction (PCR) amplification##2##7##(1996-10#1)(2008-10#1)
hybridization and polymerase chain reaction##3##5##(1996-10#1)(2008-10#2)
hybridization and##44##2##(1990-11#2)(1990-7#1)(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1996-10#2)(1996-12#2)(1997-3#1)(1997-7#2)(1997-8#3)(2008-10#12)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-3#1)(2010-6#1)(2012-3#2)
hybridization assay for detecting##2##4##(1991-9#1)(2008-10#1)
hybridization assay##9##2##(1991-9#3)(1995-8#1)(2008-10#5)
hybridization assays##2##2##(1990-5#1)(2008-10#1)
hybridization at##2##2##(2008-10#1)(2013-1#1)
hybridization between##8##2##(2008-10#3)(2008-8#1)(2008-9#2)(2010-3#1)(2012-3#1)
hybridization conditions##2##2##(1993-9#1)(2008-4#1)
hybridization detection##2##2##(2008-10#1)(2008-8#1)
hybridization event##4##2##(2008-10#4)
hybridization events##3##2##(2008-10#3)
hybridization experiments showed that##2##4##(2008-10#1)(2008-9#1)
hybridization experiments##5##2##(1996-12#1)(1997-6#1)(2008-10#2)(2008-9#1)
hybridization for the##2##3##(2008-10#1)(2008-4#1)
hybridization for##6##2##(1994-8#1)(1996-10#1)(2008-10#2)(2008-4#1)(2008-9#1)
hybridization from##2##2##(1993-3#1)(2008-8#1)
hybridization group was found##2##4##(2008-10#2)
hybridization group was##3##3##(2008-10#3)
hybridization group##6##2##(2008-10#6)
hybridization groups##2##2##(2008-10#2)
hybridization in the##5##3##(1996-4#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-8#1)
hybridization in##14##2##(1996-12#1)(1996-4#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-1#1)(2010-1#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-3#2)
hybridization indicated that the##2##4##(1991-9#1)(1993-9#1)
hybridization indicated that##5##3##(1991-9#1)(1993-3#1)(1993-9#1)(2008-8#1)(2008-9#1)
hybridization indicator##2##2##(2008-10#2)
hybridization is##2##2##(2008-10#1)(2008-4#1)
hybridization kinetics##4##2##(1995-12#1)(2008-7#1)(2010-5#2)
hybridization method##3##2##(1991-9#1)(2008-10#1)(2008-4#1)
hybridization of RNA##3##3##(1994-9#1)(2008-4#2)
hybridization of immobilized##2##3##(2008-10#2)
hybridization of the##8##3##(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
hybridization of##32##2##(1990-12#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#3)(1997-2#1)(1997-7#1)(2008-10#9)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#2)(2010-3#1)(2012-2#1)
hybridization on the##2##3##(2008-10#1)(2008-7#1)
hybridization on##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
hybridization or##2##2##(2008-4#2)
hybridization pattern##2##2##(2008-10#2)
hybridization patterns that were##2##4##(2008-10#2)
hybridization patterns##3##2##(2008-10#3)
hybridization probe##5##2##(1991-9#1)(1992-10#1)(1992-6#1)(1997-4#1)(2008-5#1)
hybridization probes for##2##3##(1992-6#1)(2008-10#1)
hybridization probes from blots##2##4##(2008-4#2)
hybridization probes##7##2##(1992-6#1)(2008-10#3)(2008-4#2)(2008-9#1)
hybridization properties of##2##3##(2008-10#1)(2008-4#1)
hybridization revealed##4##2##(1993-12#1)(2008-10#1)(2008-8#2)
hybridization showed that##3##3##(1996-12#1)(1997-1#1)(2008-10#1)
hybridization showed##6##2##(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)
hybridization signal##5##2##(1993-5#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-3#1)
hybridization signals to the##2##4##(1997-6#2)
hybridization signals##6##2##(1991-6#1)(1995-2#1)(1997-6#2)(2008-8#1)(2012-3#1)
hybridization studies##6##2##(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-8#1)
hybridization study##3##2##(1996-12#1)(1997-2#1)(2009-8#1)
hybridization technique##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
hybridization techniques##6##2##(1990-12#1)(1991-5#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-9#1)
hybridization to a##3##3##(1992-11#1)(2008-10#1)(2008-4#1)
hybridization to determine the##2##4##(1994-11#1)(2008-2#1)
hybridization to the##4##3##(1991-2#1)(1992-6#1)(2008-10#1)(2008-4#1)
hybridization to##30##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-4#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
hybridization using an##2##3##(1991-5#1)(1995-12#1)
hybridization using the##2##3##(1992-3#1)(2008-10#1)
hybridization using##11##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-5#1)(1995-12#1)(1996-12#2)(1996-6#1)(2008-10#2)
hybridization was##8##2##(1990-12#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-6#1)
hybridization with a##7##3##(1992-6#1)(1994-11#1)(1996-6#1)(1997-2#1)(2008-10#2)(2013-1#1)
hybridization with cDNA##2##3##(2008-10#1)(2008-9#1)
hybridization with complementary DNA##2##4##(2008-10#2)
hybridization with complementary##3##3##(2008-10#2)(2008-9#1)
hybridization with the target DNA##2##5##(2008-10#2)
hybridization with the##6##3##(2008-10#4)(2008-6#1)(2008-8#1)
hybridization with##25##2##(1990-7#1)(1992-6#1)(1994-11#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#11)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)
hybridization##551##1##(1990-11#2)(1990-12#8)(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#2)(1991-2#3)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#8)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#6)(1992-8#3)(1992-9#1)(1993-12#4)(1993-3#4)(1993-5#3)(1993-6#2)(1993-9#5)(1994-1#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#8)(1995-2#4)(1995-6#6)(1995-8#4)(1996-10#3)(1996-12#23)(1996-2#3)(1996-4#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#5)(1997-6#4)(1997-7#5)(1997-8#4)(2008-1#3)(2008-10#142)(2008-11#8)(2008-2#8)(2008-3#2)(2008-4#51)(2008-5#15)(2008-6#4)(2008-7#12)(2008-8#29)(2008-9#40)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#7)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#17)(2013-1#5)
hybridization)##6##1##(1995-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
hybridizations with##2##2##(1990-5#1)(2008-10#1)
hybridizations##11##1##(1990-5#1)(1991-5#1)(1996-6#1)(1997-3#1)(2008-10#7)
hybridize to##8##2##(1992-11#1)(1993-9#1)(1995-2#2)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
hybridize with the##2##3##(2008-10#2)
hybridize with##7##2##(2008-10#6)(2008-4#1)
hybridize##21##1##(1991-6#1)(1992-11#1)(1993-9#1)(1995-2#2)(1997-6#1)(2008-10#10)(2008-4#3)(2008-8#1)(2008-9#1)
hybridized CPs are##2##3##(2013-1#2)
hybridized at##2##2##(2008-10#1)(2013-1#1)
hybridized to a single##3##4##(1990-12#1)(1991-9#1)(1993-2#1)
hybridized to a##8##3##(1990-12#2)(1991-9#1)(1993-2#2)(1996-6#2)(2008-2#1)
hybridized to dsRNA from##2##4##(2008-10#2)
hybridized to the##9##3##(1990-12#1)(1991-2#1)(1996-12#1)(1996-6#2)(1997-6#1)(2008-10#2)(2008-9#1)
hybridized to##37##2##(1990-11#2)(1990-12#3)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-2#2)(1996-12#1)(1996-6#4)(1997-6#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-9#1)
hybridized with a##4##3##(1990-2#1)(2008-10#2)(2008-8#1)
hybridized with##17##2##(1990-2#1)(1991-12#1)(1992-8#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
hybridized##65##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#2)(1996-12#1)(1996-6#4)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#31)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#3)
hybridizes in##2##2##(1993-8#2)
hybridizes to##2##2##(1993-8#1)(1995-11#1)
hybridizes##5##1##(1993-8#3)(1995-11#1)(1995-6#1)
hybridizing to the##2##3##(1993-8#1)(2008-10#1)
hybridizing to##4##2##(1993-8#1)(2008-10#2)(2008-7#1)
hybridizing##12##1##(1990-8#1)(1992-11#1)(1992-3#1)(1993-8#1)(2008-10#6)(2008-4#1)(2008-7#1)
hybridoma and##3##2##(2008-11#3)
hybridoma cell cultures##3##3##(2008-11#3)
hybridoma cell line in chemically defined protein-free media##2##8##(2008-11#2)
hybridoma cell line was##2##4##(1994-5#1)(2008-11#1)
hybridoma cell line##17##3##(1990-8#1)(1994-2#1)(1994-5#2)(2008-10#1)(2008-11#10)(2008-4#1)(2008-7#1)
hybridoma cell lines##12##3##(1994-2#1)(1994-5#1)(2008-10#2)(2008-11#7)(2008-8#1)
hybridoma cell##38##2##(1990-8#1)(1994-2#3)(1994-5#3)(2008-10#3)(2008-11#25)(2008-4#1)(2008-7#1)(2008-8#1)
hybridoma cells and##2##3##(2008-10#1)(2008-11#1)
hybridoma cells grown in##2##4##(2008-11#2)
hybridoma cells in##3##3##(1994-5#1)(2008-11#2)
hybridoma cells under##2##3##(2008-11#2)
hybridoma cells##39##2##(1991-9#1)(1994-2#2)(1994-5#3)(2008-10#1)(2008-11#31)(2008-7#1)
hybridoma cultivation##2##2##(2008-11#2)
hybridoma culture##6##2##(1990-12#1)(1994-2#1)(2008-11#3)(2008-7#1)
hybridoma cultures##6##2##(2008-11#3)(2008-7#3)
hybridoma growth and##2##3##(2008-11#2)
hybridoma in##2##2##(1994-5#1)(2008-11#1)
hybridoma line##2##2##(2008-11#2)
hybridoma lines##3##2##(1991-12#2)(2008-9#1)
hybridoma##146##1##(1990-12#3)(1990-8#1)(1991-12#2)(1991-9#1)(1994-2#10)(1994-5#9)(1997-4#2)(2008-10#4)(2008-11#100)(2008-4#1)(2008-7#7)(2008-8#2)(2008-9#4)
hybridomas by##3##2##(1991-12#1)(2008-11#2)
hybridomas derived from##2##3##(1994-2#2)
hybridomas for##2##2##(2008-11#2)
hybridomas fused with##2##3##(2008-11#2)
hybridomas is##2##2##(2008-11#2)
hybridomas producing##5##2##(1994-2#3)(2008-11#2)
hybridomas secreting antibodies against##2##4##(2008-11#2)
hybridomas secreting##4##2##(1994-3#1)(1996-12#1)(2008-11#2)
hybridomas with##2##2##(2008-11#2)
hybridomas##43##1##(1990-12#4)(1991-12#1)(1991-9#2)(1994-2#8)(1994-3#1)(1994-9#2)(1996-12#1)(2007-10#1)(2008-11#22)(2008-8#1)
hybrids and the##2##3##(2008-5#1)(2008-8#1)
hybrids and their##2##3##(2008-10#1)(2008-5#1)
hybrids and##14##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-8#3)(2012-3#2)
hybrids are##5##2##(2007-12#1)(2008-10#2)(2013-1#2)
hybrids between##6##2##(2008-9#4)(2010-3#1)(2012-3#1)
hybrids by##2##2##(2008-8#1)(2008-9#1)
hybrids had##3##2##(2008-5#2)(2012-3#1)
hybrids have been##2##3##(2008-5#1)(2010-10#1)
hybrids have##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
hybrids in##3##2##(2008-10#2)(2008-9#1)
hybrids of##7##2##(1995-8#1)(2008-10#4)(2008-12#1)(2010-3#1)
hybrids that contained##2##3##(1996-6#2)
hybrids that##5##2##(1996-6#2)(2008-10#1)(2009-2#2)
hybrids was##5##2##(2008-10#4)(2008-9#1)
hybrids were##13##2##(1992-9#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)
hybrids with##9##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-3#1)(2012-3#2)
hybrids##157##1##(1990-2#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-9#4)(1994-12#2)(1995-11#2)(1995-2#1)(1995-8#1)(1996-6#3)(1997-2#2)(1997-9#1)(2007-12#1)(2008-10#59)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#16)(2008-7#1)(2008-8#14)(2008-9#10)(2009-10#2)(2009-2#2)(2010-10#1)(2010-3#2)(2010-4#4)(2011-2#2)(2011-3#2)(2012-3#8)(2013-1#3)
hydantoin##6##1##(1990-5#3)(1995-3#1)(2008-5#1)(2012-3#1)
hydantoins to##3##2##(1995-3#3)
hydantoins##4##1##(1995-3#3)(2010-2#1)
hydatid cyst in##2##3##(2008-10#1)(2010-11#1)
hydatid cyst of the##3##4##(1991-5#1)(1991-8#1)(2008-12#1)
hydatid cyst of##5##3##(1991-5#1)(1991-8#1)(2007-7#1)(2008-12#1)(2013-1#1)
hydatid cyst with##2##3##(1993-10#1)(2013-1#1)
hydatid cyst##17##2##(1991-5#1)(1991-8#1)(1993-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#4)
hydatid cysts in##2##3##(2012-2#1)(2013-7#1)
hydatid cysts##15##2##(1991-8#1)(2007-8#2)(2008-7#6)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
hydatid disease is##2##3##(2008-7#1)(2011-2#1)
hydatid disease##15##2##(1991-8#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-7#2)(2010-11#2)(2011-2#3)(2012-2#1)(2013-1#1)
hydatid##51##1##(1991-5#1)(1991-8#3)(1993-10#1)(2007-7#4)(2007-8#4)(2008-10#4)(2008-12#3)(2008-7#8)(2009-5#1)(2009-9#1)(2010-11#3)(2010-12#2)(2011-2#5)(2012-2#3)(2013-1#6)(2013-7#2)
hydatidosis is##2##2##(2010-11#1)(2013-7#1)
hydatidosis##17##1##(1993-9#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-7#2)
hydatidosis]##2##1##(1991-8#1)(2010-12#1)
hydatique##2##1##(2011-2#2)
hydei##4##1##(1993-12#4)
hydra##2##1##(1993-12#2)
hydralazine##3##1##(2008-4#3)
hydranencephaly##5##1##(1997-3#5)
hydrate and##3##2##(2008-10#2)(2011-1#1)
hydrate##18##1##(1990-9#1)(1991-9#2)(1994-2#1)(1994-5#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2011-1#2)(2013-1#1)
hydrate)##2##1##(2008-10#1)(2012-2#1)
hydrated collagen I##2##3##(1992-6#2)
hydrated iron(III) oxide##2##3##(2008-10#2)
hydrated##33##1##(1990-11#1)(1990-2#1)(1990-7#2)(1991-5#1)(1992-6#2)(1995-3#1)(2008-10#13)(2008-5#5)(2008-7#2)(2009-10#1)(2009-7#1)(2010-8#1)(2012-2#2)
hydrates##2##1##(2008-10#2)
hydrating##4##1##(2008-5#4)
hydration and biomechanical##2##3##(2008-5#2)
hydration and transepidermal water loss##2##5##(2008-5#2)
hydration and##14##2##(1992-8#1)(2008-10#1)(2008-5#8)(2008-7#1)(2011-2#1)(2012-2#2)
hydration by##2##2##(2008-5#2)
hydration free energies##4##3##(2010-2#4)
hydration in all##2##3##(2008-5#1)(2012-2#1)
hydration in##4##2##(1994-3#1)(2008-5#2)(2012-2#1)
hydration index##2##2##(2008-5#2)
hydration level and##2##3##(2008-5#2)
hydration level##6##2##(2008-5#6)
hydration of the skin##2##4##(2008-10#1)(2008-5#1)
hydration of the stratum corneum##2##5##(2008-5#2)
hydration of the##8##3##(1992-8#1)(1994-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#3)
hydration of##10##2##(1992-8#1)(1994-3#1)(1995-11#1)(1995-5#1)(1997-7#1)(2008-10#2)(2008-5#3)
hydration state##6##2##(2008-5#5)(2008-7#1)
hydration status##2##2##(2012-1#1)(2013-8#1)
hydration with##2##2##(2008-5#2)
hydration##103##1##(1990-11#2)(1991-11#1)(1991-12#1)(1992-6#1)(1992-8#2)(1994-3#2)(1995-11#3)(1995-5#1)(1997-7#1)(2006-4#1)(2008-10#16)(2008-5#51)(2008-6#1)(2008-7#4)(2009-11#1)(2010-2#4)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#6)(2013-8#1)
hydraulic and mechanical stress adaptations##2##5##(2009-8#2)
hydraulic and mechanical##4##3##(2009-8#4)
hydraulic conductance of##2##3##(2008-10#1)(2009-8#1)
hydraulic conductance##7##2##(2008-10#2)(2009-8#5)
hydraulic high-pressure##2##2##(2008-10#2)
hydraulic oils##2##2##(2008-10#2)
hydraulic resistance and fouling percentage##2##5##(2008-7#2)
hydraulic retention time (HRT)##2##4##(2013-1#2)
hydraulic retention time##4##3##(2010-6#1)(2013-1#3)
hydraulic retention##5##2##(2008-6#1)(2010-6#1)(2013-1#3)
hydraulic##34##1##(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#11)(2010-6#1)(2012-5#2)(2013-1#3)
hydraulics##3##1##(2008-7#1)(2009-8#1)(2010-3#1)
hydrazide in##3##2##(2008-10#3)
hydrazide##16##1##(1997-1#1)(1997-2#1)(2007-11#3)(2008-10#11)
hydrazides of##2##2##(2008-10#1)(2010-3#1)
hydrazine and hydroxylamine##2##3##(2008-10#2)
hydrazine and phenylhydrazine##6##3##(2008-10#6)
hydrazine and##10##2##(2008-10#10)
hydrazine by##3##2##(2008-10#3)
hydrazine compounds##3##2##(2008-10#3)
hydrazine hydrate##4##2##(2008-11#2)(2011-1#2)
hydrazine in the presence of##2##5##(2008-10#2)
hydrazine in the##3##3##(2008-10#2)(2010-5#1)
hydrazine in##12##2##(2008-10#11)(2010-5#1)
hydrazine is##3##2##(2008-10#3)
hydrazine to##2##2##(2008-10#2)
hydrazine was##2##2##(2008-10#2)
hydrazine with##4##2##(2008-10#3)(2013-1#1)
hydrazine##71##1##(1990-11#1)(1991-3#1)(1996-5#1)(1997-2#1)(2008-10#57)(2008-11#2)(2008-4#1)(2010-5#2)(2011-1#2)(2013-1#3)
hydrazines##2##1##(2008-10#1)(2013-1#1)
hydrazinolysis##3##1##(1991-12#1)(1993-11#1)(2009-8#1)
hydrazone (MBTH) in##2##3##(2008-10#2)
hydrazone (MBTH)##3##2##(2008-10#3)
hydrazone derivatives##2##2##(2008-10#2)
hydrazone##18##1##(1992-8#1)(1996-5#1)(1997-1#2)(2008-10#12)(2009-11#1)(2010-4#1)
hydrazones of##2##2##(1990-8#1)(2008-9#1)
hydrazones##8##1##(1990-8#3)(2007-11#1)(2008-9#2)(2009-10#1)(2010-7#1)
hydric##2##1##(1996-12#1)(2012-7#1)
hydride by adding a sodium tetrahydroborate (III) solution##2##8##(2008-10#2)
hydride generated##5##2##(2008-10#5)
hydride generation (HG)##7##3##(2008-10#7)
hydride generation - atomic absorption spectrometry##2##6##(2008-10#2)
hydride generation and atomic fluorescence spectrometry##2##6##(2008-10#2)
hydride generation and##11##3##(2008-10#11)
hydride generation atomic absorption spectrometry (HGAAS)##3##6##(2008-10#3)
hydride generation atomic absorption spectrometry##10##5##(2008-10#10)
hydride generation atomic absorption##11##4##(2008-10#11)
hydride generation atomic fluorescence spectrometry (HG-AFS)##3##6##(2008-10#3)
hydride generation atomic fluorescence spectrometry##11##5##(2008-10#11)
hydride generation atomic fluorescence##13##4##(2008-10#13)
hydride generation atomic##25##3##(2008-10#25)
hydride generation efficiency##2##3##(2008-10#2)
hydride generation for##2##3##(2008-10#2)
hydride generation from##2##3##(2008-10#2)
hydride generation gas phase molecular absorption spectrometry (HG-GPMAS)##2##8##(2008-10#2)
hydride generation gas phase molecular absorption spectrometry##4##7##(2008-10#4)
hydride generation inductively coupled plasma atomic emission spectrometry##2##8##(2008-10#2)
hydride generation is described##2##4##(2008-10#2)
hydride generation is##3##3##(2008-10#3)
hydride generation method##2##3##(2008-10#2)
hydride generation or##2##3##(2008-10#2)
hydride generation procedure##2##3##(2008-10#2)
hydride generation procedures for##2##4##(2008-10#2)
hydride generation system##3##3##(2008-10#3)
hydride generation techniques##3##3##(2008-10#3)
hydride generation the##2##3##(2008-10#2)
hydride generation##104##2##(2008-10#103)(2009-6#1)
hydride generation-atomic absorption spectrometry (HG-AAS)##2##5##(2008-10#2)
hydride generation-atomic fluorescence spectrometry##4##4##(2008-10#4)
hydride generation-atomic fluorescence##5##3##(2008-10#5)
hydride generation-atomic##7##2##(2008-10#7)
hydride generation-electrothermal atomic absorption##2##4##(2008-10#2)
hydride generator##5##2##(2008-10#5)
hydride is##2##2##(2008-10#2)
hydride transfer##4##2##(1993-11#1)(1994-11#2)(1995-2#1)
hydride was##2##2##(1997-7#1)(2008-10#1)
hydride##174##1##(1992-3#1)(1993-11#1)(1994-11#2)(1995-2#1)(1996-2#5)(1996-5#4)(1997-7#3)(2007-11#4)(2008-10#147)(2008-4#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)
hydride-forming species##2##2##(2008-10#2)
hydride-forming##3##1##(2008-10#3)
hydride-generation atomic absorption spectrometry##2##4##(2008-10#2)
hydride-generation##4##1##(2008-10#4)
hydrides are##3##2##(2008-10#3)
hydrides##10##1##(1996-2#1)(2008-10#9)
hydrido##2##1##(1996-2#2)
hydrindanes##2##1##(2009-8#2)
hydro##2##1##(2008-5#1)(2010-5#1)
hydro-alcoholic extract##2##2##(2010-2#1)(2013-1#1)
hydro-alcoholic##4##1##(2008-10#2)(2010-2#1)(2013-1#1)
hydroalcoholic extract of##4##3##(2008-12#2)(2010-3#1)(2012-12#1)
hydroalcoholic extract##6##2##(2008-12#2)(2008-5#1)(2010-3#1)(2010-5#1)(2012-12#1)
hydroalcoholic root extract of Rubia cordifolia##3##6##(2012-2#3)
hydroalcoholic##11##1##(2008-12#2)(2008-5#3)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#3)
hydrobromide##4##1##(1994-5#2)(1995-3#1)(1996-5#1)
hydrocarbon (PAH)##3##2##(1990-3#1)(2008-10#1)(2011-1#1)
hydrocarbon and##3##2##(1992-5#1)(2008-10#1)(2011-1#1)
hydrocarbon biodegradation##5##2##(2011-1#5)
hydrocarbon chain##5##2##(1990-7#1)(1992-8#1)(2007-12#1)(2008-10#2)
hydrocarbon chains of##2##3##(1996-8#1)(2008-11#1)
hydrocarbon chains##7##2##(1992-9#1)(1993-11#2)(1996-8#1)(2007-12#1)(2008-11#1)(2013-1#1)
hydrocarbon components##2##2##(2008-8#2)
hydrocarbon flame##2##2##(2007-12#1)(2008-2#1)
hydrocarbon mixtures##3##2##(2008-10#2)(2008-3#1)
hydrocarbon production##4##2##(2008-6#4)
hydrocarbon receptor (AhR) and##2##4##(2008-10#2)
hydrocarbon receptor (AhR)##3##3##(2008-10#3)
hydrocarbon receptor##8##2##(2008-10#5)(2008-7#2)(2013-1#1)
hydrocarbon##88##1##(1990-3#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-8#1)(2007-12#5)(2008-10#25)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#1)(2011-1#7)(2012-2#1)(2013-1#8)
hydrocarbons (PAHs) and##3##3##(2008-10#3)
hydrocarbons (PAHs) in##12##3##(2008-10#11)(2010-5#1)
hydrocarbons (PAHs)##37##2##(1990-7#1)(1992-3#1)(1994-3#1)(2008-10#31)(2010-5#3)
hydrocarbons and##13##2##(1992-3#1)(1992-5#1)(1994-9#1)(1995-11#1)(2008-10#6)(2008-11#1)(2010-7#1)(2012-3#1)
hydrocarbons are##4##2##(2008-10#3)(2011-1#1)
hydrocarbons at##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
hydrocarbons by##6##2##(2008-10#5)(2011-1#1)
hydrocarbons dissolved in seawater##2##4##(2008-10#2)
hydrocarbons dissolved in##3##3##(2008-10#3)
hydrocarbons found in##2##3##(1992-3#1)(2008-6#1)
hydrocarbons from##7##2##(2008-10#6)(2008-6#1)
hydrocarbons in seawater##2##3##(2008-10#2)
hydrocarbons in##25##2##(2008-10#20)(2008-11#5)
hydrocarbons on a##2##3##(2008-10#2)
hydrocarbons on##4##2##(2008-10#4)
hydrocarbons that##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
hydrocarbons was##2##2##(1990-7#1)(2008-9#1)
hydrocarbons were##6##2##(1990-7#1)(2008-10#4)(2008-9#1)
hydrocarbons with##2##2##(2007-11#1)(2008-11#1)
hydrocarbons##190##1##(1990-7#4)(1991-12#1)(1992-3#6)(1992-5#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#1)(1997-5#1)(2007-11#4)(2008-10#119)(2008-11#16)(2008-3#1)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#6)(2010-5#3)(2010-7#1)(2011-1#3)(2012-2#1)(2012-3#4)(2013-8#2)
hydrocele fluid##3##2##(2008-7#3)
hydrocele in##2##2##(2008-7#2)
hydrocele##10##1##(2008-10#2)(2008-7#8)
hydrocephalic##2##1##(2008-7#1)(2013-7#1)
hydrocephalus and##6##2##(1996-11#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
hydrocephalus secondary to##2##3##(2008-7#2)
hydrocephalus was##2##2##(2008-12#1)(2008-7#1)
hydrocephalus with##3##2##(1990-9#1)(2012-2#2)
hydrocephalus##36##1##(1990-9#1)(1995-5#1)(1996-11#1)(2007-10#2)(2007-2#1)(2008-12#2)(2008-7#10)(2011-2#8)(2012-12#3)(2012-2#6)(2012-3#1)
hydrochloric acid (HCl)##3##3##(2008-10#2)(2013-1#1)
hydrochloric acid and potassium##2##4##(2008-10#2)
hydrochloric acid and sodium tetrahydroborate##2##5##(2008-10#2)
hydrochloric acid and sodium##3##4##(2008-10#3)
hydrochloric acid and##15##3##(2008-10#15)
hydrochloric acid as##2##3##(2008-10#2)
hydrochloric acid concentration##4##3##(2008-10#4)
hydrochloric acid in##3##3##(2008-10#3)
hydrochloric acid media##7##3##(2008-10#7)
hydrochloric acid medium##4##3##(2008-10#4)
hydrochloric acid solution##6##3##(2008-10#6)
hydrochloric acid solutions##3##3##(1992-12#1)(2008-10#2)
hydrochloric acid was used for##2##5##(1997-2#1)(2008-10#1)
hydrochloric acid##89##2##(1992-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#84)(2013-1#1)
hydrochloric and##2##2##(2008-10#2)
hydrochloric##98##1##(1992-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#93)(2013-1#1)
hydrochloride (2)##2##2##(1995-11#1)(1996-5#1)
hydrochloride (22)##2##2##(1995-11#2)
hydrochloride and 0##3##3##(2008-10#2)(2013-1#1)
hydrochloride and##20##2##(1990-8#2)(1997-7#1)(2008-10#14)(2010-3#1)(2013-1#2)
hydrochloride by##4##2##(1990-8#1)(2008-10#2)(2012-3#1)
hydrochloride concentration##2##2##(1992-6#1)(2008-10#1)
hydrochloride from##2##2##(2008-10#1)(2010-5#1)
hydrochloride in bulk##2##3##(2008-10#1)(2010-5#1)
hydrochloride in pharmaceutical preparations##3##4##(2008-10#3)
hydrochloride in pharmaceutical##8##3##(2008-10#8)
hydrochloride in the##2##3##(2008-10#1)(2009-7#1)
hydrochloride in##22##2##(2008-10#18)(2009-7#1)(2010-5#2)(2012-3#1)
hydrochloride injection##2##2##(2008-10#2)
hydrochloride is described##2##3##(2008-10#2)
hydrochloride is##3##2##(2008-10#3)
hydrochloride loaded polymeric nanoparticles##2##4##(2013-1#2)
hydrochloride on the##2##3##(2008-10#1)(2013-1#1)
hydrochloride solution##2##2##(2008-10#1)(2010-5#1)
hydrochloride tablet##3##2##(2008-5#2)(2012-2#1)
hydrochloride using##5##2##(2008-10#3)(2011-1#1)(2012-2#1)
hydrochloride was##3##2##(1990-8#1)(1995-11#1)(2013-1#1)
hydrochloride were##2##2##(2008-10#2)
hydrochloride with##8##2##(1993-3#3)(1993-6#1)(2008-10#4)
hydrochloride##194##1##(1990-2#1)(1990-8#5)(1991-1#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#1)(1993-12#1)(1993-3#5)(1993-6#1)(1994-6#2)(1995-11#12)(1995-12#1)(1995-3#2)(1995-5#6)(1996-5#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#98)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-3#1)(2010-4#1)(2010-5#12)(2011-1#3)(2012-2#4)(2012-3#4)(2013-1#6)
hydrochloride-induced##2##1##(1995-5#2)
hydrochlorothiazide and indapamide##3##3##(2011-2#3)
hydrochlorothiazide and##6##2##(2008-10#1)(2011-2#3)(2012-2#2)
hydrochlorothiazide was##2##2##(2008-10#1)(2010-5#1)
hydrochlorothiazide##17##1##(2008-10#7)(2010-5#2)(2011-2#4)(2011-3#2)(2012-2#2)
hydrocolloid occlusive bandage##2##3##(1991-2#2)
hydrocolloid occlusive##3##2##(1991-2#3)
hydrocolloids##2##1##(2011-2#2)
hydrocortisone##21##1##(1991-12#4)(1992-2#1)(1992-5#1)(1993-1#1)(1995-11#1)(2008-10#1)(2008-11#6)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)
hydrocyclone##2##1##(2008-11#2)
hydrocyclones##3##1##(2008-11#3)
hydrodistillation method##2##2##(2008-10#1)(2013-1#1)
hydrodistillation##5##1##(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
hydrodynamic and##3##2##(1990-8#1)(2008-10#1)(2013-1#1)
hydrodynamic behavior##2##2##(1997-2#1)(2008-10#1)
hydrodynamic chromatography##2##2##(2008-10#2)
hydrodynamic conditions were##2##3##(2008-10#2)
hydrodynamic conditions##8##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-7#2)
hydrodynamic diameter##4##2##(2008-10#1)(2013-1#1)(2013-8#2)
hydrodynamic injection##4##2##(2008-10#3)(2008-4#1)
hydrodynamic sizes##2##2##(2008-10#1)(2011-1#1)
hydrodynamic voltammetry##3##2##(2008-10#3)
hydrodynamic##53##1##(1990-12#1)(1990-7#1)(1990-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-1#2)(2013-1#2)(2013-8#2)
hydrodynamically##2##1##(2008-10#2)
hydrodynamics of##2##2##(2008-7#2)
hydrodynamics##5##1##(2008-7#3)(2010-8#1)(2013-1#1)
hydroethidine##2##1##(2008-9#1)(2009-12#1)
hydrofluoric acid (HF)##2##3##(2008-10#2)
hydrofluoric acid##13##2##(2008-10#10)(2008-2#2)(2013-1#1)
hydrofluoric and##2##2##(2008-10#2)
hydrofluoric##21##1##(2008-10#18)(2008-2#2)(2013-1#1)
hydrofluoroalkane##2##1##(1996-1#1)(1996-2#1)
hydrogel and##6##2##(2008-10#3)(2008-5#1)(2009-7#1)(2013-1#1)
hydrogel can be##2##3##(2008-5#1)(2009-12#1)
hydrogel films##2##2##(2008-10#2)
hydrogel is##2##2##(2008-5#1)(2010-2#1)
hydrogel isolated from whole seeds of Ocimum##2##7##(2010-5#2)
hydrogel matrix##2##2##(2008-5#2)
hydrogel membrane was##3##3##(2008-5#2)(2010-4#1)
hydrogel membrane##5##2##(2008-5#4)(2010-4#1)
hydrogel microwell##2##2##(2009-12#2)
hydrogel patch##2##2##(2008-5#2)
hydrogel patches##3##2##(2008-5#3)
hydrogel showed##2##2##(2008-5#1)(2009-7#1)
hydrogel was##4##2##(2008-5#2)(2009-7#2)
hydrogel##79##1##(2008-10#8)(2008-5#32)(2009-11#1)(2009-12#5)(2009-7#9)(2010-12#1)(2010-2#6)(2010-4#2)(2010-5#2)(2011-2#1)(2012-3#11)(2013-1#1)
hydrogel-based##2##1##(2008-3#1)(2009-11#1)
hydrogels for##3##2##(2008-8#1)(2009-9#1)(2010-2#1)
hydrogels in##2##2##(2008-5#1)(2008-8#1)
hydrogels##22##1##(2008-5#3)(2008-8#3)(2009-3#1)(2009-7#1)(2009-9#5)(2010-10#2)(2010-12#1)(2010-2#2)(2012-3#3)(2012-7#1)
hydrogen (H)##2##2##(2008-6#1)(2011-2#1)
hydrogen abstraction##2##2##(1996-5#1)(2008-11#1)
hydrogen and##8##2##(1991-9#1)(1993-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)
hydrogen at the##3##3##(1990-7#1)(1991-3#1)(1994-11#1)
hydrogen at##4##2##(1990-7#1)(1991-3#1)(1994-11#1)(2008-10#1)
hydrogen atom abstraction##2##3##(1991-3#1)(2007-11#1)
hydrogen atom##3##2##(1991-3#1)(1995-11#1)(2007-11#1)
hydrogen atoms in##2##3##(1996-12#1)(2008-3#1)
hydrogen atoms##4##2##(1996-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
hydrogen bond acceptor##3##3##(1994-5#1)(2010-7#2)
hydrogen bond between Asp-94 alpha and Trp-37 beta##2##8##(1992-3#2)
hydrogen bond between##7##3##(1990-7#1)(1992-3#2)(1993-1#2)(1995-2#1)(1995-5#1)
hydrogen bond donor##2##3##(2010-7#2)
hydrogen bond donors and acceptors##2##5##(2010-7#2)
hydrogen bond network##2##3##(2008-10#1)(2010-4#1)
hydrogen bond to##3##3##(1992-6#1)(1995-3#1)(1997-7#1)
hydrogen bond##41##2##(1990-7#1)(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#5)(1992-6#2)(1992-8#1)(1993-1#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#3)(1997-7#1)(2008-10#7)(2008-8#2)(2010-4#1)(2010-7#6)(2012-2#1)(2012-3#1)(2013-1#1)
hydrogen bonded##3##2##(1991-3#1)(1995-2#2)
hydrogen bonding and##6##3##(1991-8#1)(1994-3#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-9#1)
hydrogen bonding behavior of water##2##5##(2009-10#2)
hydrogen bonding between##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
hydrogen bonding in the##3##4##(1991-1#1)(1991-8#1)(2008-4#1)
hydrogen bonding in##4##3##(1991-1#1)(1991-8#1)(1995-5#1)(2008-4#1)
hydrogen bonding interaction##4##3##(2008-10#3)(2012-2#1)
hydrogen bonding interactions##4##3##(1993-8#1)(2008-10#1)(2009-12#1)(2010-7#1)
hydrogen bonding##39##2##(1991-1#1)(1991-8#4)(1992-6#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#2)(2007-11#1)(2008-10#12)(2008-4#1)(2008-5#2)(2009-10#4)(2009-12#1)(2009-9#1)(2010-4#2)(2010-7#1)(2012-2#1)(2013-1#1)
hydrogen bonds between##2##3##(1992-6#1)(2008-8#1)
hydrogen bonds from##2##3##(1993-11#1)(1995-5#1)
hydrogen bonds in##3##3##(1992-3#1)(1995-5#1)(2008-11#1)
hydrogen bonds involving##2##3##(1992-12#1)(1997-7#1)
hydrogen bonds to##2##3##(1994-5#1)(1996-2#1)
hydrogen bonds with the##2##4##(1992-8#1)(2008-10#1)
hydrogen bonds with##3##3##(1991-8#1)(1992-8#1)(2008-10#1)
hydrogen bonds##33##2##(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#2)(1993-3#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-5#3)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
hydrogen bromide##2##2##(1996-12#2)
hydrogen carbonate##2##2##(2008-10#2)
hydrogen catalytic##2##2##(2008-10#2)
hydrogen chloride##6##2##(1996-12#3)(2008-10#1)(2008-3#1)(2008-5#1)
hydrogen concentration##3##2##(2008-3#1)(2008-7#2)
hydrogen cyanide (HCN)##3##3##(1996-12#2)(2008-10#1)
hydrogen cyanide gas##2##3##(2008-10#2)
hydrogen cyanide sensor##3##3##(2008-10#3)
hydrogen cyanide##11##2##(1996-12#4)(2008-10#7)
hydrogen desorption is##2##3##(2008-10#2)
hydrogen desorption via the##3##4##(2008-10#3)
hydrogen desorption##7##2##(2008-10#7)
hydrogen evolution##4##2##(2008-10#2)(2008-6#2)
hydrogen exchange##13##2##(1991-6#1)(1995-2#2)(1995-3#3)(1995-5#1)(1997-2#1)(2008-4#1)(2012-1#3)(2013-1#1)
hydrogen excretion##6##2##(1996-6#6)
hydrogen fermentation##2##2##(2013-1#2)
hydrogen fluoride##3##2##(1992-12#1)(1996-12#2)
hydrogen from the##2##3##(2007-11#1)(2008-6#1)
hydrogen from##3##2##(1996-5#1)(2007-11#1)(2008-6#1)
hydrogen gas##7##2##(1997-7#1)(2007-11#2)(2008-10#3)(2008-6#1)
hydrogen ion concentration##5##3##(2008-10#5)
hydrogen ion in##3##3##(2008-10#3)
hydrogen ion##14##2##(1993-12#1)(2008-10#13)
hydrogen ion-selective##3##2##(2008-10#3)
hydrogen ions##7##2##(2008-10#6)(2010-5#1)
hydrogen is##2##2##(2007-11#1)(2009-7#1)
hydrogen loading##2##2##(2007-11#1)(2007-12#1)
hydrogen partial pressure##3##3##(2008-7#3)
hydrogen peroxide (H(2)O(2)) and##3##4##(2008-10#1)(2013-1#2)
hydrogen peroxide (H(2)O(2)) in##2##4##(2008-10#2)
hydrogen peroxide (H(2)O(2))##15##3##(2008-10#8)(2008-2#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)
hydrogen peroxide (H2O2) and##3##4##(1997-4#1)(2008-4#1)(2008-7#1)
hydrogen peroxide (H2O2)##9##3##(1990-5#1)(1991-9#1)(1992-3#1)(1995-3#1)(1997-4#2)(2008-4#1)(2008-7#1)(2012-3#1)
hydrogen peroxide and glucose##2##4##(2008-10#2)
hydrogen peroxide and##29##3##(1991-9#1)(1993-12#1)(2008-10#20)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#2)(2013-1#1)
hydrogen peroxide as##3##3##(2008-10#3)
hydrogen peroxide at##5##3##(2008-10#5)
hydrogen peroxide based on##2##4##(2008-10#2)
hydrogen peroxide biosensor##5##3##(2008-10#4)(2009-3#1)
hydrogen peroxide by##3##3##(2008-10#3)
hydrogen peroxide catalyzed by##4##4##(1994-5#1)(2008-10#3)
hydrogen peroxide catalyzed##5##3##(1994-5#1)(2008-10#4)
hydrogen peroxide concentration##3##3##(2008-10#3)
hydrogen peroxide concentrations##3##3##(2008-10#2)(2008-5#1)
hydrogen peroxide electrode##2##3##(2008-10#2)
hydrogen peroxide formed in the##2##5##(2008-10#2)
hydrogen peroxide has been##2##4##(2008-10#1)(2009-8#1)
hydrogen peroxide in a##4##4##(2008-10#4)
hydrogen peroxide in an##2##4##(2008-10#2)
hydrogen peroxide in the absence##2##5##(1995-8#1)(2008-10#1)
hydrogen peroxide in the presence of##2##6##(2008-10#2)
hydrogen peroxide in the##8##4##(1994-8#1)(1995-8#1)(2008-10#6)
hydrogen peroxide in##33##3##(1994-8#1)(1995-8#1)(2008-10#30)(2009-5#1)
hydrogen peroxide is##6##3##(1991-9#1)(1992-11#1)(2008-10#4)
hydrogen peroxide or phorbol ester-activated neutrophils##2##6##(1991-9#2)
hydrogen peroxide or##4##3##(1991-9#3)(2008-10#1)
hydrogen peroxide produced##2##3##(2008-10#2)
hydrogen peroxide under##2##3##(2008-10#2)
hydrogen peroxide using##4##3##(2008-10#4)
hydrogen peroxide was developed##2##4##(2008-10#2)
hydrogen peroxide was##5##3##(2008-10#5)
hydrogen peroxide were investigated##2##4##(2008-10#2)
hydrogen peroxide were##4##3##(2008-10#4)
hydrogen peroxide with##7##3##(1991-9#1)(1996-2#1)(2008-10#5)
hydrogen peroxide##267##2##(1990-5#5)(1990-8#1)(1991-5#3)(1991-9#10)(1992-11#3)(1992-12#2)(1992-3#2)(1993-12#1)(1994-5#2)(1994-8#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#4)(2008-1#1)(2008-10#191)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-5#2)(2011-2#5)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#1)
hydrogen peroxide)##2##2##(2008-10#2)
hydrogen peroxide-based##2##2##(2008-5#2)
hydrogen peroxide-dependent##2##2##(1990-5#1)(2010-12#1)
hydrogen phosphate##3##2##(2008-10#2)(2009-7#1)
hydrogen producing bacterium (HHPB)##2##4##(2013-1#2)
hydrogen producing##3##2##(2013-1#3)
hydrogen production from##2##3##(1995-5#1)(2013-1#1)
hydrogen production yield##2##3##(2013-1#2)
hydrogen production##7##2##(1995-5#1)(2008-6#1)(2013-1#5)
hydrogen species are##2##3##(2008-1#2)
hydrogen species##3##2##(2008-1#3)
hydrogen sulfide determination##3##3##(2008-10#3)
hydrogen sulfide in##2##3##(2011-1#1)(2013-1#1)
hydrogen sulfide##23##2##(2007-12#1)(2008-10#15)(2008-6#2)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
hydrogen sulphide and##2##3##(1997-4#1)(2012-2#1)
hydrogen sulphide##4##2##(1997-4#1)(2008-10#2)(2012-2#1)
hydrogen transfer##2##2##(2008-5#1)(2008-7#1)
hydrogen was exhaled##3##3##(1996-6#3)
hydrogen was##5##2##(1996-6#3)(2008-10#2)
hydrogen##643##1##(1990-5#7)(1990-7#2)(1990-8#3)(1991-1#1)(1991-3#3)(1991-5#4)(1991-6#1)(1991-8#9)(1991-9#11)(1992-11#3)(1992-12#6)(1992-3#9)(1992-6#6)(1992-8#2)(1993-1#3)(1993-11#3)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#5)(1994-8#1)(1995-11#1)(1995-2#7)(1995-3#7)(1995-5#11)(1995-8#1)(1996-12#12)(1996-2#5)(1996-5#2)(1996-6#9)(1997-2#1)(1997-4#7)(1997-7#5)(2007-11#10)(2007-12#7)(2008-1#5)(2008-10#319)(2008-11#8)(2008-2#4)(2008-3#10)(2008-4#7)(2008-5#13)(2008-6#11)(2008-7#15)(2008-8#4)(2009-10#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#5)(2010-5#3)(2010-7#7)(2011-1#2)(2011-2#9)(2012-1#3)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#18)(2013-8#2)
hydrogen)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
hydrogen-air##3##1##(2008-10#1)(2008-3#2)
hydrogen-bond##2##1##(1991-3#1)(2008-8#1)
hydrogen-bonded##9##1##(1990-2#1)(1991-8#2)(1995-5#2)(2008-10#4)
hydrogen-bonding interaction##3##2##(2008-10#3)
hydrogen-bonding interactions##3##2##(1991-3#1)(1992-11#1)(2010-4#1)
hydrogen-bonding##22##1##(1990-11#1)(1990-2#1)(1991-3#1)(1992-11#1)(1993-11#2)(1993-8#1)(1995-2#2)(1995-5#1)(1996-5#1)(2008-10#9)(2010-4#1)(2012-2#1)
hydrogen-exchange##2##1##(1995-3#2)
hydrogen-loaded fibers##2##2##(2007-12#2)
hydrogen-loaded##6##1##(2007-11#1)(2007-12#5)
hydrogen-rich solution##2##2##(2011-2#2)
hydrogen-rich##4##1##(2008-11#1)(2010-12#1)(2011-2#2)
hydrogenase and##2##2##(1990-11#1)(1992-3#1)
hydrogenase small##2##2##(1990-11#2)
hydrogenase##19##1##(1990-11#3)(1990-8#3)(1992-3#9)(1995-5#4)
hydrogenases##4##1##(1990-8#4)
hydrogenated##7##1##(1994-12#1)(2007-11#3)(2008-3#2)(2009-7#1)
hydrogenation of##5##2##(1992-3#1)(1992-8#1)(1996-5#2)(2012-2#1)
hydrogenation##11##1##(1992-3#1)(1992-8#1)(1996-5#3)(2007-11#1)(2008-10#1)(2008-4#1)(2010-7#2)(2012-2#1)
hydrogencarbonate##2##1##(2008-10#2)
hydrogenophosphate##2##1##(2008-10#2)
hydrogenotrophic##5##1##(2008-7#5)
hydrogenphthalate##3##1##(1994-9#1)(2008-10#2)
hydrogens##3##1##(1993-11#1)(2008-1#1)(2009-9#1)
hydrolase activity##10##2##(1990-5#3)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#4)
hydrolase and##2##2##(1997-8#1)(2008-10#1)
hydrolase from human##3##3##(1990-11#1)(1994-8#1)(1997-7#1)
hydrolase##59##1##(1990-11#4)(1990-5#5)(1991-7#4)(1992-12#2)(1992-3#4)(1992-6#5)(1992-8#5)(1993-12#1)(1993-2#1)(1994-11#4)(1994-8#1)(1995-6#2)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#2)(2010-12#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)
hydrolase)##2##1##(1996-2#1)(2008-10#1)
hydrolases and oxidoreductases##2##3##(2008-10#2)
hydrolases are##2##2##(2008-10#1)(2012-12#1)
hydrolases degrade##3##2##(1995-6#1)(2009-2#1)(2012-12#1)
hydrolases from hypertrophic chondrocytes##2##4##(2012-12#2)
hydrolases##26##1##(1992-12#3)(1992-6#4)(1992-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(2008-10#4)(2008-7#1)(2009-2#4)(2009-3#1)(2012-12#5)
hydrolitic##2##1##(2008-10#2)
hydrologic##2##1##(2008-8#1)(2010-8#1)
hydrology##2##1##(2008-8#1)(2013-1#1)
hydrolysable##2##1##(2008-10#1)(2008-5#1)
hydrolysate and##4##2##(2008-10#1)(2008-11#2)(2008-6#1)
hydrolysate of iodinated casein##2##4##(2008-10#2)
hydrolysate of##7##2##(1990-7#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#2)
hydrolysate was##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
hydrolysate with##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
hydrolysate##46##1##(1990-7#1)(1992-3#1)(1995-3#1)(2008-10#6)(2008-11#11)(2008-5#8)(2008-6#7)(2008-7#1)(2009-9#1)(2010-2#3)(2011-1#3)(2013-1#3)
hydrolysates as##2##2##(2008-11#1)(2008-7#1)
hydrolysates by##4##2##(2008-10#1)(2008-6#2)(2008-7#1)
hydrolysates derived from##2##3##(1995-3#1)(2008-11#1)
hydrolysates from##3##2##(2008-11#1)(2008-5#2)
hydrolysates of##3##2##(1990-5#1)(1994-9#1)(2013-1#1)
hydrolysates were##3##2##(2008-5#2)(2008-6#1)
hydrolysates##43##1##(1990-5#1)(1990-7#2)(1994-9#1)(1995-3#1)(2008-10#2)(2008-11#12)(2008-5#11)(2008-6#4)(2008-7#2)(2011-1#3)(2013-1#4)
hydrolyse##4##1##(1993-11#1)(2008-5#1)(2009-3#1)(2011-1#1)
hydrolysed by##2##2##(1990-7#1)(2008-5#1)
hydrolysed in##2##2##(2008-10#2)
hydrolysed to##2##2##(1994-3#1)(1994-8#1)
hydrolysed##13##1##(1990-12#1)(1990-7#1)(1993-2#1)(1994-3#2)(1994-8#1)(2007-10#1)(2008-10#4)(2008-5#1)(2010-4#1)
hydrolyses in more alkaline sweat##2##5##(2008-5#2)
hydrolyses##7##1##(1992-12#1)(1994-8#1)(1997-3#2)(2008-10#1)(2008-5#2)
hydrolysis and synthesis of##2##4##(1997-1#2)
hydrolysis and synthesis##3##3##(1997-1#3)
hydrolysis and transglycosylation##2##3##(1994-5#2)
hydrolysis and##27##2##(1990-12#1)(1991-12#1)(1994-11#2)(1994-5#2)(1996-5#1)(1997-1#4)(1997-2#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-1#1)
hydrolysis as##2##2##(1990-8#1)(1997-8#1)
hydrolysis at the##2##3##(1992-6#1)(2010-4#1)
hydrolysis at##4##2##(1992-6#1)(2008-5#1)(2008-6#1)(2010-4#1)
hydrolysis by##11##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-5#1)(1994-11#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
hydrolysis catalyzed by##2##3##(1992-7#1)(1995-5#1)
hydrolysis constants##2##2##(2008-10#2)
hydrolysis conversion##2##2##(2013-1#2)
hydrolysis does not##2##3##(1992-9#1)(1997-1#1)
hydrolysis for##2##2##(1993-8#1)(2008-10#1)
hydrolysis from##2##2##(1991-12#1)(2013-1#1)
hydrolysis in##20##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-5#3)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#5)
hydrolysis is##6##2##(1991-5#1)(1991-9#1)(1997-4#1)(1997-7#1)(2013-1#2)
hydrolysis of 10##2##3##(1992-7#1)(1994-5#1)
hydrolysis of IP3##3##3##(1993-8#3)
hydrolysis of a protein##2##4##(2008-4#1)(2008-9#1)
hydrolysis of a##4##3##(1990-7#1)(1990-8#1)(2008-4#1)(2008-9#1)
hydrolysis of an##2##3##(2008-7#1)(2011-2#1)
hydrolysis of creatinine##2##3##(1992-11#1)(1995-3#1)
hydrolysis of inositol##2##3##(1992-9#1)(1993-8#1)
hydrolysis of pretreated##2##3##(2008-7#1)(2013-1#1)
hydrolysis of several##3##3##(1994-12#1)(1995-5#1)(2008-10#1)
hydrolysis of short##3##3##(2008-5#2)(2008-7#1)
hydrolysis of the##32##3##(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#2)(2013-1#1)
hydrolysis of urea##3##3##(2008-10#3)
hydrolysis of##153##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#10)(1994-11#5)(1994-12#1)(1994-3#4)(1994-5#8)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#35)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2010-3#1)(2011-1#2)(2011-2#6)(2013-1#7)
hydrolysis on##2##2##(2008-7#1)(2008-8#1)
hydrolysis or##3##2##(1994-8#1)(2008-6#1)(2008-8#1)
hydrolysis process##6##2##(2008-10#4)(2008-11#1)(2013-1#1)
hydrolysis product of##2##3##(1992-11#1)(2013-1#1)
hydrolysis product##5##2##(1992-11#1)(2008-10#3)(2013-1#1)
hydrolysis products in##2##3##(2008-10#2)
hydrolysis products##12##2##(1993-11#1)(1994-3#1)(2008-10#7)(2008-7#2)(2010-3#1)
hydrolysis rate##9##2##(1990-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2013-1#1)
hydrolysis rates of##2##3##(1994-3#1)(2008-10#1)
hydrolysis rates##3##2##(1994-3#1)(1995-3#1)(2008-10#1)
hydrolysis reaction##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
hydrolysis reactions##4##2##(2008-10#2)(2008-7#2)
hydrolysis stimulated by##2##3##(1996-5#2)
hydrolysis stress conditions##2##3##(2012-12#2)
hydrolysis to##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
hydrolysis was##8##2##(1991-3#1)(1991-5#1)(1997-7#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#2)
hydrolysis were##4##2##(1996-5#1)(2008-10#1)(2008-5#2)
hydrolysis with##5##2##(1992-7#1)(1994-11#1)(2007-11#1)(2008-10#2)
hydrolysis yield##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
hydrolysis yields##4##2##(2011-2#3)(2013-1#1)
hydrolysis##428##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#5)(1990-7#6)(1990-8#4)(1991-12#2)(1991-3#3)(1991-5#8)(1991-8#3)(1991-9#2)(1992-11#4)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#4)(1993-3#1)(1993-6#2)(1993-8#13)(1994-11#9)(1994-12#2)(1994-3#7)(1994-5#12)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#4)(1995-8#1)(1996-12#3)(1996-2#4)(1996-5#11)(1996-6#1)(1997-1#5)(1997-2#4)(1997-4#4)(1997-7#3)(1997-8#1)(2007-11#4)(2007-2#1)(2007-7#1)(2008-10#102)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#11)(2008-5#16)(2008-6#14)(2008-7#19)(2008-8#8)(2008-9#3)(2009-12#1)(2009-2#2)(2009-8#3)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#5)(2011-2#14)(2012-12#5)(2013-1#36)
hydrolysis)##5##1##(1996-12#1)(1997-7#1)(2008-10#2)(2008-3#1)
hydrolytic activity of##3##3##(1995-2#1)(2008-5#1)(2010-9#1)
hydrolytic activity##7##2##(1992-3#2)(1994-11#1)(1995-2#1)(2008-5#1)(2010-9#1)(2011-1#1)
hydrolytic degradation of##2##3##(2008-6#1)(2010-10#1)
hydrolytic degradation##3##2##(2008-6#2)(2010-10#1)
hydrolytic enzymes##4##2##(1992-3#1)(2008-10#2)(2012-2#1)
hydrolytic reaction##2##2##(1990-7#1)(2011-1#1)
hydrolytic species##6##2##(2008-10#6)
hydrolytic##37##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1992-3#3)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-12#2)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#2)(2009-9#2)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)
hydrolytically degradable##3##2##(2008-12#1)(2009-11#1)(2010-10#1)
hydrolytically##5##1##(1992-6#1)(1994-6#1)(2008-12#1)(2009-11#1)(2010-10#1)
hydrolyzates##5##1##(1997-2#4)(2008-6#1)
hydrolyze the##3##2##(1990-2#1)(1992-3#1)(1992-9#1)
hydrolyze##21##1##(1990-11#1)(1990-2#2)(1991-12#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-8#2)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
hydrolyzed and##3##2##(1990-7#1)(2008-10#1)(2008-11#1)
hydrolyzed at a##2##3##(1990-11#1)(2006-6#1)
hydrolyzed at the##2##3##(2006-6#1)(2008-6#1)
hydrolyzed at##4##2##(1990-11#1)(2006-6#2)(2008-6#1)
hydrolyzed by##7##2##(1990-5#1)(1992-11#1)(1995-6#1)(2008-10#3)(2008-11#1)
hydrolyzed in##2##2##(1993-9#1)(2008-10#1)
hydrolyzed proteins##2##2##(2008-10#1)(2008-6#1)
hydrolyzed to the##2##3##(1991-6#1)(1996-5#1)
hydrolyzed to##6##2##(1991-6#1)(1995-5#1)(1996-5#1)(2008-4#1)(2008-6#2)
hydrolyzed under##2##2##(1990-8#1)(2008-10#1)
hydrolyzed with##3##2##(2008-10#1)(2010-2#1)(2013-1#1)
hydrolyzed##61##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-6#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-5#1)(2006-6#2)(2008-10#18)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
hydrolyzes##11##1##(1990-7#2)(1990-8#1)(1992-12#1)(1994-5#1)(1994-8#1)(1995-6#2)(2008-10#1)(2008-11#1)(2008-8#1)
hydrolyzing activity##6##2##(1990-8#4)(2008-7#2)
hydrolyzing enzyme##2##2##(1995-3#1)(2008-5#1)
hydrolyzing the##3##2##(1992-10#1)(2008-10#1)(2008-5#1)
hydrolyzing##13##1##(1990-8#4)(1992-10#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#2)(2013-1#1)
hydrometeors##2##1##(2008-3#2)
hydromorphone##3##1##(2008-7#2)(2012-3#1)
hydronephrosis and##7##2##(2007-7#1)(2008-10#2)(2008-4#2)(2009-5#2)
hydronephrosis in##2##2##(2008-4#2)
hydronephrosis##31##1##(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-4#8)(2008-7#3)(2009-5#2)(2013-1#1)
hydropathy analysis##2##2##(1990-5#2)
hydropathy plots##2##2##(1990-8#1)(1993-2#1)
hydropathy profile##4##2##(1990-12#1)(1990-5#1)(1991-6#1)(1997-2#1)
hydropathy profiles##2##2##(1990-5#1)(1995-6#1)
hydropathy##12##1##(1990-12#1)(1990-5#4)(1990-8#1)(1991-6#1)(1993-2#1)(1993-3#1)(1995-6#1)(1997-2#1)(2008-1#1)
hydroperoxide glutathione peroxidase##5##3##(1993-6#4)(2009-10#1)
hydroperoxide levels##2##2##(2008-5#2)
hydroperoxide##23##1##(1991-2#1)(1992-11#2)(1993-12#1)(1993-6#4)(1993-8#1)(1994-2#1)(1995-11#1)(1995-2#2)(1996-2#2)(2008-10#2)(2008-11#1)(2008-5#3)(2009-10#1)(2009-8#1)
hydroperoxides and##3##2##(1992-11#2)(2008-10#1)
hydroperoxides are##2##2##(2008-10#1)(2008-5#1)
hydroperoxides in##2##2##(1995-2#1)(2013-1#1)
hydroperoxides of##3##2##(1990-5#2)(2008-10#1)
hydroperoxides##26##1##(1990-5#2)(1992-11#2)(1994-9#1)(1995-2#3)(2008-10#5)(2008-5#6)(2009-7#1)(2009-8#4)(2010-6#1)(2013-1#1)
hydroperoxides)##2##1##(1995-2#1)(2008-5#1)
hydrophila##3##1##(1992-5#1)(2007-7#1)(2008-11#1)
hydrophilia of the##2##3##(2008-5#2)
hydrophilia##3##1##(2008-5#3)
hydrophilic C-terminal##2##2##(1994-6#1)(1997-2#1)
hydrophilic and hydrophobic##6##3##(2008-10#1)(2008-5#1)(2009-9#1)(2010-10#2)(2012-1#1)
hydrophilic and lipophilic##2##3##(1990-2#1)(2008-10#1)
hydrophilic and##10##2##(1990-2#1)(1992-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-10#2)(2012-1#1)
hydrophilic membrane##2##2##(2008-10#2)
hydrophilic membranes##3##2##(2008-10#1)(2008-6#2)
hydrophilic polymer##2##2##(2007-12#1)(2010-5#1)
hydrophilic pore##4##2##(1990-11#3)(1995-11#1)
hydrophilic residues##2##2##(1995-5#1)(2008-8#1)
hydrophilic sequences##2##2##(1991-2#1)(1995-6#1)
hydrophilic substances##2##2##(2008-10#1)(2008-5#1)
hydrophilic surfaces was##2##3##(2008-7#1)(2010-10#1)
hydrophilic surfaces##4##2##(2008-10#2)(2008-7#1)(2010-10#1)
hydrophilic synthetic##2##2##(2008-10#1)(2012-2#1)
hydrophilic##109##1##(1990-11#3)(1990-2#3)(1990-8#3)(1991-2#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#3)(1995-11#2)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#3)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#24)(2008-11#4)(2008-3#1)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#2)
hydrophilic-interaction##3##1##(2008-10#3)
hydrophilicity of the##4##3##(1994-11#1)(1996-8#1)(2008-11#1)(2008-5#1)
hydrophilicity##7##1##(1991-2#1)(1992-6#1)(1994-11#1)(1996-8#1)(2008-11#1)(2008-5#2)
hydrophobia##2##1##(2008-5#2)
hydrophobic N-terminal##2##2##(1994-6#1)(1996-12#1)
hydrophobic amino acids##2##3##(1992-6#1)(1995-8#1)
hydrophobic analytes##2##2##(2008-10#2)
hydrophobic and hydrophilic##2##3##(1994-5#1)(1995-6#1)
hydrophobic and is##2##3##(1990-12#1)(1992-3#1)
hydrophobic and##10##2##(1990-12#1)(1992-3#1)(1994-5#1)(1995-6#2)(1997-2#1)(2007-11#1)(2008-10#2)(2008-5#1)
hydrophobic binding site##2##3##(1995-5#2)
hydrophobic binding##4##2##(1991-12#1)(1995-5#3)
hydrophobic carbon##2##2##(1990-8#1)(2008-6#1)
hydrophobic cavity##3##2##(2008-10#2)(2008-11#1)
hydrophobic characteristics##2##2##(1990-8#1)(2008-10#1)
hydrophobic chromatography##2##2##(1992-11#1)(1992-6#1)
hydrophobic cluster##2##2##(1990-5#1)(1990-7#1)
hydrophobic compounds##5##2##(1990-8#1)(1994-8#1)(2008-10#3)
hydrophobic core of the##3##4##(1994-5#1)(1994-6#1)(1995-5#1)
hydrophobic core of##6##3##(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-2#2)
hydrophobic core##8##2##(1991-5#1)(1991-6#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-2#2)
hydrophobic domain##4##2##(1990-7#2)(2008-7#1)(2011-2#1)
hydrophobic domains##2##2##(1991-5#1)(2009-9#1)
hydrophobic drugs##2##2##(1990-8#1)(2008-10#1)
hydrophobic environment##3##2##(1992-9#1)(1994-9#1)(2008-10#1)
hydrophobic groups##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
hydrophobic interaction chromatography (HIC)##3##4##(2008-10#2)(2011-1#1)
hydrophobic interaction chromatography##9##3##(1991-5#4)(2008-10#4)(2011-1#1)
hydrophobic interaction##23##2##(1990-11#1)(1991-5#4)(1994-9#1)(2008-10#15)(2011-1#1)(2013-1#1)
hydrophobic interactions##10##2##(1990-2#1)(1990-5#1)(1992-6#3)(1996-12#1)(2008-10#3)(2008-5#1)
hydrophobic leader sequence##2##3##(1991-10#1)(1993-6#1)
hydrophobic leader##3##2##(1991-10#1)(1993-6#1)(1995-6#1)
hydrophobic natural polymers##2##3##(2012-2#2)
hydrophobic patch##3##2##(1991-11#1)(1993-11#2)
hydrophobic peptide##2##2##(1992-3#2)
hydrophobic peptides##3##2##(1994-5#1)(2008-10#1)(2008-4#1)
hydrophobic pocket##2##2##(2008-8#2)
hydrophobic protein with##2##3##(1990-11#1)(2009-9#1)
hydrophobic protein##5##2##(1990-11#1)(1991-9#1)(1997-9#1)(2008-10#1)(2009-9#1)
hydrophobic proteins##2##2##(2008-10#2)
hydrophobic region##2##2##(1990-5#1)(2008-8#1)
hydrophobic regions##4##2##(1990-8#1)(1993-11#1)(2008-8#1)(2011-2#1)
hydrophobic residues##4##2##(1992-6#1)(1994-5#1)(1995-3#1)(1997-7#1)
hydrophobic segments##2##2##(2009-9#1)(2012-1#1)
hydrophobic selectivity##4##2##(1994-9#4)
hydrophobic sequences##2##2##(1995-6#1)(2008-4#1)
hydrophobic side chains##2##3##(1993-11#1)(1993-9#1)
hydrophobic side##3##2##(1990-2#1)(1993-11#1)(1993-9#1)
hydrophobic signal##2##2##(1990-5#1)(1997-7#1)
hydrophobic substrate##2##2##(2008-10#1)(2008-11#1)
hydrophobic surface##3##2##(1992-6#2)(1994-2#1)
hydrophobic surfaces##5##2##(1992-12#1)(1995-5#1)(2008-10#1)(2010-10#2)
hydrophobic surfactant##2##2##(2007-11#1)(2008-10#1)
hydrophobic##265##1##(1990-11#6)(1990-12#1)(1990-2#4)(1990-5#6)(1990-7#5)(1990-8#5)(1991-10#3)(1991-11#2)(1991-12#1)(1991-5#8)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#6)(1992-6#12)(1992-8#1)(1992-9#1)(1993-11#6)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#7)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#5)(1995-6#5)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#4)(1997-7#2)(1997-8#4)(1997-9#1)(2007-11#4)(2008-10#70)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#5)(2009-12#1)(2009-7#1)(2009-9#4)(2010-10#4)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-2#3)(2013-1#4)
hydrophobically##3##1##(1990-12#1)(1995-2#1)(2008-8#1)
hydrophobicity and a##2##3##(2008-10#1)(2008-8#1)
hydrophobicity and##8##2##(1991-5#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-5#1)(2008-8#1)
hydrophobicity in##2##2##(2008-10#1)(2008-5#1)
hydrophobicity of the solvent##2##4##(2008-10#1)(2008-7#1)
hydrophobicity of the##14##3##(1993-11#1)(1993-9#1)(1994-9#1)(1995-5#1)(1995-6#2)(2008-10#4)(2008-6#1)(2008-7#2)(2013-1#1)
hydrophobicity of##15##2##(1993-11#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-5#1)(1995-6#2)(2008-10#4)(2008-6#1)(2008-7#2)(2013-1#1)
hydrophobicity##49##1##(1990-8#1)(1991-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-5#3)(1995-6#2)(1996-12#2)(1996-8#1)(2008-10#17)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
hydrophone##2##1##(2008-2#1)(2008-3#1)
hydropic degeneration##2##2##(1995-8#1)(2011-1#1)
hydropneumothorax##3##1##(2008-7#3)
hydroponic culture##3##2##(2008-10#2)(2008-11#1)
hydroponic nutrient solution##4##3##(2008-10#4)
hydroponic nutrient##6##2##(2008-10#6)
hydroponic system##2##2##(2008-10#1)(2008-12#1)
hydroponic##16##1##(2008-10#14)(2008-11#1)(2008-12#1)
hydroponically##6##1##(2008-10#5)(2008-9#1)
hydroprimed seeds##2##2##(2008-10#2)
hydropriming##5##1##(2008-10#1)(2008-12#4)
hydrops fetalis##2##2##(2012-3#2)
hydrops##4##1##(1994-12#1)(1994-9#1)(2012-3#2)
hydroquinone and 1##2##3##(2008-10#2)
hydroquinone and##4##2##(2008-10#3)(2008-5#1)
hydroquinone as a mediator##2##4##(2008-10#2)
hydroquinone by##2##2##(2008-10#1)(2008-6#1)
hydroquinone in cosmetic creams##2##4##(2008-10#2)
hydroquinone in cosmetic##3##3##(2008-10#3)
hydroquinone in##10##2##(2008-10#10)
hydroquinone is##2##2##(2008-10#2)
hydroquinone##52##1##(1993-11#2)(2007-12#1)(2008-10#40)(2008-5#4)(2008-6#4)(2011-1#1)
hydrosalpinges and##2##2##(1991-12#1)(1993-1#1)
hydrosilylation##2##1##(2008-10#2)
hydrosoluble##3##1##(2008-10#2)(2008-5#1)
hydrostatic pressure was##2##3##(2008-10#1)(2008-2#1)
hydrostatic pressure##13##2##(2008-10#4)(2008-2#5)(2008-3#4)
hydrostatic##15##1##(1991-5#1)(2008-10#4)(2008-2#5)(2008-3#5)
hydrothermal influence##2##2##(2013-8#2)
hydrothermal process##2##2##(2009-11#2)
hydrothermal vent##2##2##(2008-10#1)(2011-2#1)
hydrothermal##27##1##(1995-3#2)(2008-10#11)(2008-6#1)(2009-11#3)(2011-2#4)(2013-1#1)(2013-8#5)
hydrothermally##3##1##(2008-10#1)(2012-1#1)(2013-1#1)
hydrotropic agents##3##2##(2012-2#3)
hydrotropic response##2##2##(2009-8#2)
hydrotropic##9##1##(2009-8#2)(2010-5#3)(2012-2#4)
hydrotropism##2##1##(2009-8#2)
hydrotropy##2##1##(2012-2#2)
hydrous manganese(IV) oxide##2##3##(2008-10#2)
hydrous oxide##2##2##(2008-10#2)
hydrous##8##1##(1990-12#1)(2008-10#7)
hydroxamate##2##1##(2010-2#1)(2013-1#1)
hydroxamic acid and##2##3##(2008-5#1)(2013-1#1)
hydroxamic acid biosynthesis in##2##4##(1997-2#2)
hydroxamic acid##18##2##(1997-2#2)(2008-10#10)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#3)
hydroxamic acids##2##2##(2008-10#2)
hydroxamic##21##1##(1997-2#2)(2008-10#13)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#3)
hydroxide and sodium##2##3##(2008-10#2)
hydroxide and##15##2##(2008-10#13)(2013-1#2)
hydroxide as##3##2##(1991-5#1)(1996-2#1)(2008-6#1)
hydroxide by##2##2##(2008-10#2)
hydroxide concentration##3##2##(2008-10#2)(2008-7#1)
hydroxide for##2##2##(2008-10#2)
hydroxide in##6##2##(1990-5#1)(2007-11#1)(2008-10#3)(2009-5#1)
hydroxide medium##2##2##(2008-10#2)
hydroxide or##2##2##(1995-6#1)(2008-10#1)
hydroxide precipitate##2##2##(2008-10#2)
hydroxide precipitation##2##2##(2008-10#2)
hydroxide solution##9##2##(2008-10#9)
hydroxide to##2##2##(2008-10#1)(2008-6#1)
hydroxide were##3##2##(2008-10#2)(2008-7#1)
hydroxide##130##1##(1990-5#1)(1991-5#3)(1991-7#1)(1991-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-10#92)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#10)
hydroxide)##5##1##(1990-8#1)(2008-10#4)
hydroxide-4##2##1##(2008-10#2)
hydroxides##10##1##(2008-10#9)(2010-4#1)
hydroxo##5##1##(1997-7#1)(2008-10#4)
hydroxy acids##4##2##(2008-5#4)
hydroxy group##2##2##(1996-5#1)(2008-10#1)
hydroxy groups##2##2##(2008-10#2)
hydroxy##21##1##(1991-12#1)(1993-11#1)(1993-6#1)(1996-5#1)(2007-11#1)(2008-10#9)(2008-5#5)(2011-1#1)(2013-1#1)
hydroxy-propyl-beta-cyclodextrin##2##1##(2008-10#2)
hydroxyalkenals formed from##2##3##(1990-5#2)
hydroxyanthraquinones##4##1##(2008-10#4)
hydroxyapatite (HA)##2##2##(2008-12#1)(2009-7#1)
hydroxyapatite cement and##2##3##(2011-2#2)
hydroxyapatite cement##4##2##(2011-2#4)
hydroxyapatite chromatography##2##2##(1990-5#1)(2009-2#1)
hydroxyapatite crystal growth##2##3##(2008-4#2)
hydroxyapatite##31##1##(1990-5#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#5)(2011-2#7)(2012-2#2)
hydroxybenzoic acids##3##2##(2008-10#2)(2011-2#1)
hydroxybenzoic##4##1##(2008-10#3)(2011-2#1)
hydroxychloroquine##11##1##(2006-10#2)(2008-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#5)
hydroxycinnamic##2##1##(2008-5#1)(2013-1#1)
hydroxyethylcellulose##2##1##(2008-10#1)(2008-5#1)
hydroxyl (OH)##2##2##(2008-10#1)(2008-3#1)
hydroxyl and##2##2##(2008-10#1)(2011-2#1)
hydroxyl concentration##3##2##(2007-11#1)(2008-3#2)
hydroxyl formation##2##2##(2007-12#2)
hydroxyl group in the##3##4##(1991-5#1)(1993-11#1)(2008-10#1)
hydroxyl group##13##2##(1991-5#1)(1992-6#1)(1993-11#2)(1995-5#1)(2008-10#5)(2008-11#2)(2011-3#1)
hydroxyl groups and##2##3##(2008-10#2)
hydroxyl groups in##2##3##(1990-9#1)(2008-8#1)
hydroxyl groups of the##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
hydroxyl groups of##8##3##(1996-5#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
hydroxyl groups##23##2##(1990-8#1)(1990-9#2)(1996-5#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2013-8#1)
hydroxyl radical and##2##3##(2008-10#2)
hydroxyl radical footprinting##2##3##(2008-4#2)
hydroxyl radical in##3##3##(1996-2#1)(1997-4#1)(2008-10#1)
hydroxyl radical is##2##3##(2008-10#1)(2008-4#1)
hydroxyl radical scavengers##4##3##(1995-2#1)(1995-6#2)(1996-2#1)
hydroxyl radical##33##2##(1990-5#2)(1991-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#2)(1997-4#1)(2008-10#8)(2008-11#1)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#2)(2011-1#1)
hydroxyl radicals in##2##3##(2008-10#2)
hydroxyl radicals##17##2##(1990-12#1)(1991-9#1)(1993-11#1)(1995-12#1)(1995-6#1)(2008-10#7)(2008-4#3)(2009-11#1)(2013-8#1)
hydroxyl species##2##2##(2007-12#1)(2008-10#1)
hydroxyl##118##1##(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-5#1)(1991-9#2)(1992-6#2)(1993-11#3)(1994-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#4)(1996-2#2)(1996-5#2)(1997-4#1)(2007-11#3)(2007-12#3)(2008-10#36)(2008-11#6)(2008-3#7)(2008-4#8)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#2)
hydroxyl-radical cleavage##2##2##(2008-4#2)
hydroxyl-radical##4##1##(1991-2#1)(2008-4#3)
hydroxyl-terminated monocationic ionic##2##3##(2011-1#2)
hydroxyl-terminated##8##1##(2008-10#5)(2011-1#3)
hydroxylamide##3##1##(2008-12#3)
hydroxylamine and##2##2##(1990-11#1)(1991-3#1)
hydroxylamine cleavage##2##2##(1994-11#2)
hydroxylamine hydrochloride##5##2##(2008-10#4)(2009-9#1)
hydroxylamine to##2##2##(1995-6#1)(2009-11#1)
hydroxylamine##25##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-3#1)(1994-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1997-2#3)(2008-10#7)(2008-4#1)(2009-11#1)(2009-2#1)(2009-9#1)
hydroxylapatite##10##1##(1990-7#1)(1994-11#1)(1994-6#1)(2008-10#4)(2008-3#2)(2011-2#1)
hydroxylase activity and##4##3##(1992-3#1)(1994-6#3)
hydroxylase activity##5##2##(1992-3#1)(1994-6#3)(2008-4#1)
hydroxylase and##3##2##(1993-5#1)(1996-12#1)(2012-2#1)
hydroxylase immunohistochemistry##2##2##(1992-10#1)(1996-5#1)
hydroxylase in##3##2##(1992-3#1)(1993-8#1)(2008-1#1)
hydroxylase##45##1##(1990-11#1)(1990-7#2)(1991-5#2)(1992-10#1)(1992-12#2)(1992-3#2)(1993-5#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-6#3)(1994-9#1)(1996-12#4)(1996-5#3)(1997-3#1)(1997-5#2)(1997-6#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
hydroxylase-immunoreactive##2##1##(1996-5#2)
hydroxylated##8##1##(1991-5#1)(1992-11#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
hydroxylation and##2##2##(1990-11#1)(1994-11#1)
hydroxylation at the##2##3##(1990-5#1)(2008-5#1)
hydroxylation by cytochrome##2##3##(1991-2#1)(1992-11#1)
hydroxylation of##5##2##(1992-12#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-3#1)
hydroxylation##23##1##(1990-11#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-3#2)(1997-7#1)(2008-10#1)(2008-5#1)(2011-1#1)
hydroxylations##2##1##(1992-9#1)(2008-4#1)
hydroxylpropyl-beta-CD##2##1##(2008-10#2)
hydroxyls##2##1##(2008-10#1)(2009-12#1)
hydroxymetabolites##2##1##(2008-10#2)
hydroxymethanesulfonate##2##1##(2008-10#2)
hydroxymethyl##2##1##(1990-9#1)(2007-11#1)
hydroxymethylpyrimidine is##2##2##(1990-2#2)
hydroxymethylpyrimidine uptake was##2##3##(1990-2#2)
hydroxymethylpyrimidine##4##1##(1990-2#4)
hydroxyproline content##3##2##(2008-10#2)(2013-8#1)
hydroxyproline excretion##2##2##(1990-2#1)(1995-2#1)
hydroxyproline residues##2##2##(1992-8#2)
hydroxyproline##15##1##(1990-2#1)(1992-8#2)(1995-2#5)(1995-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2013-8#1)
hydroxypropyl-beta-cyclodextrin##3##1##(2008-10#1)(2010-4#2)
hydroxypropylmethylcellulose##7##1##(2008-10#2)(2010-5#5)
hydroxyscopolamine##3##1##(2008-10#3)
hydroxysteroid dehydrogenase##3##2##(1990-8#1)(1994-6#2)
hydroxytoluene##10##1##(1992-9#1)(1994-3#1)(1994-5#2)(1995-3#2)(2008-10#1)(2008-11#1)(2008-5#2)
hydroxytoluene)##2##1##(1996-2#2)
hydroxyurea (HU)##2##2##(1994-11#1)(2012-3#1)
hydroxyurea and##3##2##(1992-10#1)(2007-11#1)(2012-3#1)
hydroxyurea augmentation (p=0##2##3##(2008-11#2)
hydroxyurea augmentation of##3##3##(2008-11#3)
hydroxyurea augmentation##6##2##(2008-11#6)
hydroxyurea for##2##2##(1994-8#1)(2008-5#1)
hydroxyurea##28##1##(1990-2#4)(1992-10#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-8#2)(1997-3#1)(2007-11#1)(2008-11#7)(2008-5#1)(2008-7#2)(2009-2#1)(2010-2#1)(2012-3#2)
hygB(R) strains##3##2##(2008-10#3)
hygiene and##13##2##(2007-12#1)(2007-7#1)(2008-11#1)(2009-7#1)(2011-1#2)(2012-12#5)(2013-1#2)
hygiene in##3##2##(1992-11#1)(2007-12#1)(2009-4#1)
hygiene interventions##2##2##(2011-2#2)
hygiene measures##2##2##(2009-10#1)(2013-8#1)
hygiene practices##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
hygiene products##2##2##(2007-12#1)(2013-1#1)
hygiene##84##1##(1991-12#2)(1991-8#1)(1992-11#1)(1993-3#1)(1996-11#1)(1996-3#1)(2007-12#7)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-10#2)(2009-4#7)(2009-5#8)(2009-7#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#5)
hygienic aspects##2##2##(2010-8#2)
hygienic conditions##2##2##(1992-11#1)(2013-8#1)
hygienic##14##1##(1992-11#1)(1996-3#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2010-8#2)(2013-8#2)
hygienist##2##1##(2009-10#1)(2011-2#1)
hygienists who##3##2##(1993-1#3)
hygienists##11##1##(1993-1#5)(2008-4#3)(2009-4#1)(2009-5#1)(2011-2#1)
hygroma##3##1##(2007-8#1)(2009-9#1)(2011-2#1)
hygromas##2##1##(1997-6#2)
hygrometer##2##1##(2008-3#2)
hygromycin B (hygB)##2##3##(2008-10#2)
hygromycin B resistance##8##3##(2008-10#8)
hygromycin B##15##2##(1995-2#1)(2008-10#14)
hygromycin B-resistant##2##2##(2008-10#2)
hygromycin resistance##3##2##(2008-10#2)(2011-1#1)
hygromycin selection##2##2##(2008-11#2)
hygromycin##24##1##(1995-2#1)(2008-10#20)(2008-11#2)(2011-1#1)
hygroscopic##11##1##(1990-7#1)(1994-12#1)(1996-12#3)(2007-11#1)(2008-5#1)(2013-1#4)
hyicus and Staphylococcus aureus isolated from clinical cases##2##8##(2013-8#2)
hyicus and##3##2##(2008-5#1)(2013-8#2)
hyicus##5##1##(2008-5#1)(2013-8#4)
hyk##2##1##(1992-12#2)
hymenopteran societies##2##2##(2008-8#2)
hymenopteran##3##1##(2008-8#3)
hyopneumoniae##4##1##(1992-5#4)
hypanthia##2##1##(2008-10#2)
hypanthium increased##2##2##(2008-10#2)
hypanthium##4##1##(2008-10#4)
hype##2##1##(2007-9#1)(2008-3#1)
hyper mobile##2##2##(2013-1#2)
hyper##11##1##(1990-10#1)(2008-1#1)(2008-11#2)(2009-1#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
hyper- and##2##2##(2010-3#1)(2013-1#1)
hyper-##3##1##(2008-11#1)(2010-3#1)(2013-1#1)
hyper-IgE##2##1##(2010-6#1)(2013-1#1)
hyper-IgM##2##1##(2008-9#1)(2011-2#1)
hyper-LDL and##2##2##(2008-8#2)
hyper-Rayleigh scattering##2##2##(2007-12#2)
hyper-Rayleigh##4##1##(2007-12#4)
hyper-osmotically elevated K+##2##3##(1997-1#2)
hyper-osmotically##3##1##(1997-1#3)
hyper-producing cell line##3##3##(2008-11#3)
hyper-producing cell##6##2##(2008-11#6)
hyper-producing##9##1##(2008-11#9)
hyper-reactivity##6##1##(1993-12#2)(2008-11#1)(2010-5#3)
hyperaccumulator##3##1##(2008-10#2)(2010-11#1)
hyperactivation of##2##2##(2008-7#1)(2013-8#1)
hyperactivation##3##1##(2008-7#1)(2009-4#1)(2013-8#1)
hyperactive##3##1##(1997-4#2)(2012-2#1)
hyperactivity and##11##2##(1991-2#2)(1993-12#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-2#2)
hyperactivity disorder (ADHD)##8##3##(1996-6#1)(2008-6#1)(2008-9#1)(2009-9#1)(2013-1#3)(2013-8#1)
hyperactivity disorder##17##2##(1996-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
hyperactivity in adolescent##2##3##(2013-8#2)
hyperactivity in##6##2##(1993-12#1)(1997-7#1)(2009-11#1)(2013-7#1)(2013-8#2)
hyperactivity##44##1##(1991-2#2)(1993-12#3)(1993-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-7#2)(2007-7#1)(2008-11#3)(2008-2#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#2)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#5)
hyperaemia##3##1##(2008-3#2)(2008-7#1)
hyperaggregability##4##1##(1990-11#1)(1991-11#1)(1991-12#1)(1997-6#1)
hyperalgesia and##2##2##(1995-12#1)(2008-9#1)
hyperalgesia in a rat model of##2##6##(1996-5#2)
hyperalgesia in a##3##3##(1995-12#1)(1996-5#2)
hyperalgesia in rats##2##3##(1996-5#2)
hyperalgesia in##9##2##(1993-12#1)(1995-12#1)(1996-5#7)
hyperalgesia was##2##2##(1996-5#2)
hyperalgesia##29##1##(1993-12#4)(1995-12#5)(1996-5#12)(1997-2#2)(2008-4#1)(2008-7#3)(2008-9#2)
hyperammonemia##5##1##(1990-8#1)(2008-1#1)(2009-8#3)
hyperammonemic##2##1##(2009-8#2)
hyperandrogenism and anovulation##2##3##(2008-4#1)(2010-11#1)
hyperandrogenism and insulin resistance##2##4##(2008-4#2)
hyperandrogenism and##4##2##(2008-4#3)(2010-11#1)
hyperandrogenism of##3##2##(2008-4#3)
hyperandrogenism##10##1##(2008-4#9)(2010-11#1)
hyperazotemia##2##1##(1993-5#1)(2008-7#1)
hyperbaric bupivacaine##2##2##(2011-2#2)
hyperbaric oxygen therapy##2##3##(2006-10#1)(2008-8#1)
hyperbaric oxygen##5##2##(1993-12#2)(2006-10#1)(2008-8#1)(2011-2#1)
hyperbaric##10##1##(1993-12#2)(2006-10#1)(2007-8#1)(2008-8#2)(2011-2#3)(2012-12#1)
hyperbilirubinemia##11##1##(1990-8#3)(1994-6#1)(2008-11#5)(2008-7#1)(2012-12#1)
hyperbolic expression##2##2##(2008-7#2)
hyperbolic saturation##3##2##(2008-10#3)
hyperbolic##22##1##(1992-5#1)(2007-11#1)(2008-10#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#4)(2009-12#1)
hyperboloid of revolution##2##3##(2008-2#2)
hyperboloid##5##1##(2008-2#3)(2008-3#2)
hyperboloids are analogous to##2##4##(2008-3#2)
hyperboloids##3##1##(2008-3#3)
hyperbranched##4##1##(2008-10#3)(2012-3#1)
hypercalcaemia##8##1##(1990-3#1)(1997-3#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-7#3)
hypercalcaemic##2##1##(2007-6#1)(2011-1#1)
hypercalcemia after##2##2##(1995-3#2)
hypercalcemia and##2##2##(1991-8#1)(2012-12#1)
hypercalcemia in##3##2##(1991-8#1)(1993-3#1)(2008-12#1)
hypercalcemia of malignancy##6##3##(1990-2#3)(1995-6#1)(1997-6#1)(2010-10#1)
hypercalcemia of##7##2##(1990-2#4)(1995-6#1)(1997-6#1)(2010-10#1)
hypercalcemia##29##1##(1990-2#5)(1991-12#1)(1991-5#1)(1991-8#4)(1993-3#1)(1995-3#2)(1995-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-1#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-10#1)(2012-12#1)
hypercalcemic##3##1##(1991-12#2)(1993-6#1)
hypercalciuria in##3##2##(1991-11#2)(2008-10#1)
hypercalciuria##9##1##(1991-11#4)(2008-10#3)(2008-4#1)(2008-7#1)
hypercapnia in##2##2##(1997-6#1)(2012-3#1)
hypercapnia##6##1##(1997-6#3)(2006-10#1)(2011-1#1)(2012-3#1)
hypercarbia##5##1##(2010-8#2)(2012-2#3)
hypercellular bone marrow##2##3##(2009-8#2)
hypercellularity##2##1##(1994-6#1)(2009-8#1)
hypercholesteremic animals##2##2##(2008-10#2)
hypercholesteremic##7##1##(2008-10#7)
hypercholesterolaemia##13##1##(1990-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(2008-6#4)(2008-8#1)(2012-2#1)(2013-8#1)
hypercholesterolemia and##2##2##(1991-11#1)(2008-1#1)
hypercholesterolemia in mice##2##3##(1990-11#2)
hypercholesterolemia in##7##2##(1990-11#2)(1991-6#1)(1995-2#1)(1997-8#1)(2007-10#1)(2008-1#1)
hypercholesterolemia with##2##2##(1991-11#1)(1991-6#1)
hypercholesterolemia##41##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-11#3)(1991-2#1)(1991-6#6)(1992-11#1)(1993-12#1)(1994-12#1)(1995-2#2)(1997-8#1)(2007-10#4)(2008-1#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#4)(2009-4#1)(2013-1#2)
hypercholesterolemia]##3##1##(1991-3#1)(1993-5#1)(1996-2#1)
hypercholesterolemic patients##4##2##(1991-12#2)(1991-2#2)
hypercholesterolemic##7##1##(1991-12#2)(1991-2#2)(1997-8#1)(2008-7#1)(2012-3#1)
hyperchromatic nuclei##2##2##(2010-6#1)(2011-1#1)
hyperchromatic##3##1##(2007-5#1)(2010-6#1)(2011-1#1)
hyperchylomicronaemia##3##1##(1996-11#1)(2008-10#2)
hypercoagulability##5##1##(1993-9#1)(2007-10#3)(2010-3#1)
hypercoagulable state##2##2##(1991-3#1)(2008-12#1)
hypercoagulable##6##1##(1991-3#1)(2007-10#1)(2007-7#2)(2008-12#1)(2008-3#1)
hypercoagulation abnormality was##2##3##(2007-10#2)
hypercoagulation abnormality##4##2##(2007-10#4)
hypercortisolism##2##1##(2008-7#1)(2011-2#1)
hypercube##4##1##(2008-2#4)
hypercytolipidemia##4##1##(2008-3#4)
hyperdivergent##2##1##(2010-3#1)(2013-1#1)
hyperdynamic##5##1##(1992-9#1)(1993-5#1)(1997-7#1)(2006-10#2)
hyperechogenic##2##1##(1994-9#1)(2012-3#1)
hyperechoic##4##1##(2007-10#2)(2011-2#1)(2013-1#1)
hyperekplexia##2##1##(1996-2#2)
hyperelastic##2##1##(2009-7#2)
hyperemia and##2##2##(1995-11#1)(2011-2#1)
hyperemia##10##1##(1995-11#1)(1995-12#2)(2008-4#6)(2011-2#1)
hyperendemic township##2##2##(2013-8#2)
hyperendemic##4##1##(2008-8#1)(2013-1#1)(2013-8#2)
hypereosinophilia##5##1##(1997-3#1)(2008-11#3)(2008-7#1)
hypereosinophilic syndrome is##2##3##(1995-8#1)(2008-7#1)
hypereosinophilic syndrome##5##2##(1995-8#2)(2008-7#3)
hypereosinophilic##6##1##(1995-8#2)(2008-7#4)
hyperexcitability##4##1##(2009-2#1)(2013-1#2)(2013-8#1)
hyperextension##2##1##(1993-3#1)(2011-1#1)
hyperferritinemia##2##1##(2011-2#2)
hyperfiltration##2##1##(2008-1#1)(2008-3#1)
hyperfine coupling##2##2##(2007-11#2)
hyperfine structure##5##2##(1991-9#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
hyperfine transitions##3##2##(2007-12#1)(2008-3#2)
hyperfine##17##1##(1990-4#1)(1991-9#1)(1993-11#2)(1993-8#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#4)
hyperfixation of HMPAO##3##3##(1995-5#3)
hyperfixation##4##1##(1995-5#4)
hyperflagellate##2##1##(1994-8#2)
hyperfractionated##3##1##(1992-10#1)(1993-9#1)(2008-6#1)
hyperfunction##2##1##(1992-12#1)(2011-1#1)
hyperfunctioning##2##1##(1990-6#1)(2008-10#1)
hypergastrinemia##2##1##(1997-1#2)
hyperglucagonemia##2##1##(2010-11#1)(2013-7#1)
hyperglycaemia and##5##2##(1990-5#1)(1996-11#1)(2008-1#2)(2011-1#1)
hyperglycaemia##13##1##(1990-5#1)(1994-12#1)(1996-11#1)(1996-12#1)(2008-1#4)(2008-7#1)(2010-4#1)(2011-1#2)(2012-2#1)
hyperglycaemic animals##3##2##(2008-1#3)
hyperglycaemic##6##1##(1990-5#1)(1994-12#1)(2008-1#4)
hyperglycemia and diabetes##2##3##(2012-7#1)(2013-1#1)
hyperglycemia and##6##2##(1992-8#1)(2008-3#1)(2010-11#1)(2012-4#1)(2012-7#1)(2013-1#1)
hyperglycemia as##2##2##(1991-7#1)(2008-1#1)
hyperglycemia but##4##2##(1991-7#1)(2009-11#2)(2010-11#1)
hyperglycemia by##2##2##(2008-3#1)(2010-11#1)
hyperglycemia in##2##2##(1991-7#1)(2009-11#1)
hyperglycemia is##3##2##(2008-1#3)
hyperglycemia may be##3##3##(1992-8#1)(2009-11#1)(2013-1#1)
hyperglycemia may##4##2##(1992-8#1)(1994-12#1)(2009-11#1)(2013-1#1)
hyperglycemia or ketoacidosis##2##3##(1994-6#2)
hyperglycemia##69##1##(1991-7#6)(1992-8#3)(1994-12#1)(1994-6#2)(2007-5#1)(2008-1#12)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#3)(2009-11#6)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-4#2)(2012-7#1)(2013-1#4)(2013-7#1)
hyperglycemic emergencies##2##2##(2008-11#1)(2013-1#1)
hyperglycemic events##2##2##(2009-11#2)
hyperglycemic piglets##2##2##(1994-2#2)
hyperglycemic rebound##2##2##(1990-5#2)
hyperglycemic##19##1##(1990-5#2)(1991-12#2)(1994-2#3)(2008-11#1)(2008-5#1)(2009-11#2)(2010-11#3)(2011-2#1)(2013-1#4)
hypergonadotropic hypogonadism##2##2##(1996-2#1)(2012-3#1)
hyperhidrosis##2##1##(2007-7#1)(2012-1#1)
hyperhomocysteinemia in##3##2##(2007-10#2)(2010-5#1)
hyperhomocysteinemia is##2##2##(2008-3#1)(2008-8#1)
hyperhomocysteinemia##19##1##(1992-9#1)(2007-10#2)(2008-3#12)(2008-8#1)(2010-5#2)(2011-1#1)
hyperhomocysteinemic rats##2##2##(2010-5#2)
hyperhydration##2##1##(1991-6#1)(2008-6#1)
hypericin##7##1##(2008-8#2)(2009-3#4)(2013-8#1)
hyperimmune##3##1##(1992-12#2)(1997-6#1)
hyperimmunization##4##1##(1995-2#1)(2008-10#2)(2009-5#1)
hyperimmunoglobulin##2##1##(1990-10#1)(2012-12#1)
hyperinflammation##2##1##(2011-2#2)
hyperinflation is a##2##3##(2013-7#2)
hyperinflation##6##1##(2007-8#1)(2013-7#5)
hyperinsulinaemia##2##1##(1996-2#1)(2013-8#1)
hyperinsulinemia and MS##2##3##(2008-3#2)
hyperinsulinemia and##5##2##(2007-5#1)(2008-3#3)(2008-4#1)
hyperinsulinemia##20##1##(1990-2#1)(1990-7#1)(1996-12#1)(2007-5#1)(2008-3#9)(2008-4#3)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
hyperinsulinemic clamp##2##2##(1990-7#1)(2008-3#1)
hyperinsulinemic rats##2##2##(1990-7#2)
hyperinsulinemic##7##1##(1990-7#3)(2007-5#2)(2008-3#2)
hyperinsulinism and##2##2##(2008-4#2)
hyperinsulinism##8##1##(1990-9#1)(1991-2#2)(2008-4#2)(2008-7#1)(2013-1#1)(2013-8#1)
hyperintense on##2##2##(2006-12#1)(2012-2#1)
hyperintense signal##2##2##(1996-5#1)(1997-8#1)
hyperintense##6##1##(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2011-2#1)(2012-2#1)
hyperintensity##6##1##(2007-9#1)(2009-11#2)(2011-2#1)(2012-12#1)(2012-3#1)
hyperkalaemia##2##1##(2008-8#1)(2010-1#1)
hyperkalemia##7##1##(2007-7#2)(2008-12#1)(2008-7#3)(2009-5#1)
hyperkalemic periodic paralysis##2##3##(1991-12#2)
hyperkeratosis and##7##2##(2007-7#1)(2008-5#1)(2008-9#2)(2012-3#3)
hyperkeratosis of the##2##3##(2008-5#1)(2008-9#1)
hyperkeratosis##25##1##(2007-7#1)(2008-5#2)(2008-9#17)(2010-6#1)(2012-3#4)
hyperkeratotic##4##1##(2008-5#2)(2010-6#1)(2012-2#1)
hyperkinetic atrial arrhythmia##2##3##(1990-9#2)
hyperkinetic disorder##2##2##(2006-10#2)
hyperkinetic##6##1##(1990-9#2)(1991-8#1)(1996-3#1)(2006-10#2)
hyperlipaemia##2##1##(1992-12#1)(1995-11#1)
hyperlipidaemia##11##1##(1992-12#1)(1996-12#1)(2008-11#4)(2008-3#3)(2008-7#1)(2011-2#1)
hyperlipidaemic##2##1##(1992-12#2)
hyperlipidemia and##2##2##(2008-4#1)(2011-3#1)
hyperlipidemia##37##1##(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-5#1)(1995-11#2)(1996-11#1)(2007-7#3)(2008-1#2)(2008-3#4)(2008-4#2)(2008-9#1)(2009-12#3)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#3)(2011-2#1)(2011-3#1)(2013-1#2)
hyperlipidemic##6##1##(1992-11#1)(1993-12#1)(1995-6#1)(2007-7#1)(2008-4#1)(2013-8#1)
hypermagnesaemia##2##1##(1991-6#1)(2008-6#1)
hypermelanosis##3##1##(2008-5#3)
hypermetabolism##2##1##(1995-5#1)(2012-3#1)
hypermethylated in##2##2##(2008-7#2)
hypermethylation of##2##2##(1996-10#1)(2009-8#1)
hypermethylation##5##1##(1996-10#1)(2008-4#1)(2008-7#2)(2009-8#1)
hypernatremia##2##1##(2010-1#1)(2013-1#1)
hyperoside##4##1##(2008-10#3)(2009-6#1)
hyperosmolar diabetic##3##2##(1990-3#2)(1993-6#1)
hyperosmolar saline##2##2##(1997-1#2)
hyperosmolar state and continuous seizure##2##5##(2013-8#2)
hyperosmolar##9##1##(1990-3#2)(1993-6#1)(1994-12#1)(1995-11#1)(1997-1#2)(2013-8#2)
hyperosmotic cultures##5##2##(2008-11#5)
hyperosmotic stress##4##2##(2008-11#3)(2009-6#1)
hyperosmotic##12##1##(1992-8#1)(1995-12#1)(2008-11#8)(2008-5#1)(2009-6#1)
hyperostosis##4##1##(2006-10#2)(2007-8#1)(2011-2#1)
hyperoxaluria type 1##5##3##(1992-6#1)(1993-9#2)(2007-12#1)(2009-3#1)
hyperoxaluria type##7##2##(1992-6#1)(1993-9#2)(1995-12#2)(2007-12#1)(2009-3#1)
hyperoxaluria##13##1##(1992-5#2)(1992-6#2)(1993-9#3)(1995-12#2)(2007-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
hyperoxia##6##1##(1997-6#1)(2008-8#3)(2009-11#2)
hyperparasite##8##1##(2008-10#3)(2008-9#5)
hyperparasites##2##1##(2008-9#2)
hyperparathyroid changes in##2##3##(2008-4#2)
hyperparathyroid##4##1##(2008-4#3)(2013-7#1)
hyperparathyroidism and##5##2##(1990-2#2)(1991-11#2)(2012-12#1)
hyperparathyroidism in##4##2##(1991-11#1)(1991-5#1)(1997-7#1)(2011-1#1)
hyperparathyroidism##48##1##(1990-2#5)(1991-11#7)(1991-12#1)(1991-5#4)(1991-8#1)(1993-11#2)(1993-3#3)(1993-9#1)(1995-11#1)(1996-2#1)(1996-9#3)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2009-5#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#1)(2013-1#1)
hyperperfusion in##2##2##(2008-7#1)(2012-2#1)
hyperperfusion##5##1##(2007-10#1)(2008-7#2)(2012-2#1)(2013-8#1)
hyperpermeability of##2##2##(1991-9#1)(2011-2#1)
hyperpermeability##3##1##(1991-9#1)(2009-2#1)(2011-2#1)
hyperphagia##2##1##(1996-12#1)(2012-2#1)
hyperphosphatemia in##2##2##(1991-8#2)
hyperphosphatemia##8##1##(1991-8#2)(2007-7#2)(2008-7#2)(2012-12#1)(2013-8#1)
hyperphosphorylated##6##1##(1994-8#2)(1996-12#1)(1996-2#1)(2008-4#1)(2009-6#1)
hyperphosphorylation of##3##2##(1994-8#2)(2009-9#1)
hyperpigmentation##11##1##(1996-11#1)(2007-7#2)(2008-5#4)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
hyperpigmented panelists##2##2##(2008-5#2)
hyperpigmented##13##1##(2007-7#2)(2008-5#5)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#3)
hyperplasia and##12##2##(1990-10#1)(1994-3#1)(1996-5#1)(1997-6#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)
hyperplasia as##4##2##(1994-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
hyperplasia at the site of application in##2##7##(2008-9#2)
hyperplasia in##8##2##(1994-9#1)(2006-6#2)(2007-7#1)(2008-9#3)(2012-2#1)
hyperplasia induced by##2##3##(1995-6#2)
hyperplasia is a##2##3##(2006-6#1)(2011-2#1)
hyperplasia is##5##2##(1991-8#1)(2006-6#1)(2007-7#1)(2008-12#1)(2011-2#1)
hyperplasia may be##2##3##(1994-9#1)(2008-10#1)
hyperplasia may##3##2##(1994-9#2)(2008-10#1)
hyperplasia of the epidermis##2##4##(2008-9#2)
hyperplasia of the##8##3##(1996-6#1)(2007-7#1)(2008-12#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-11#1)
hyperplasia of##14##2##(1992-11#1)(1996-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
hyperplasia or##3##2##(1992-9#1)(1994-3#1)(2008-10#1)
hyperplasia to##2##2##(2008-5#2)
hyperplasia was##2##2##(1990-12#1)(2006-6#1)
hyperplasia were##3##2##(2008-9#3)
hyperplasia with##2##2##(1996-7#1)(2012-12#1)
hyperplasia##166##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-9#5)(1991-2#3)(1991-8#1)(1992-11#1)(1992-9#2)(1993-2#1)(1993-5#1)(1994-11#4)(1994-12#2)(1994-3#3)(1994-7#1)(1994-9#6)(1995-6#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-6#1)(2006-6#7)(2007-10#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#4)(2008-4#12)(2008-5#9)(2008-7#4)(2008-8#3)(2008-9#32)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
hyperplastic glands##3##2##(2008-5#3)
hyperplastic polyps##2##2##(2009-12#1)(2011-2#1)
hyperplastic##24##1##(1990-12#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-5#5)(2008-8#1)(2009-12#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)
hyperpnea##2##1##(1997-1#1)(2012-3#1)
hyperpolarity and##2##2##(2008-8#2)
hyperpolarity##3##1##(2008-8#3)
hyperpolarizabilities##4##1##(2007-11#2)(2007-12#2)
hyperpolarizability in##2##2##(2007-12#2)
hyperpolarizability values##2##2##(2007-12#2)
hyperpolarizability##10##1##(2007-11#3)(2007-12#7)
hyperpolarization and##6##2##(1990-12#1)(1990-7#1)(1992-6#1)(1995-5#1)(1997-4#2)
hyperpolarization in##2##2##(1992-9#1)(1994-11#1)
hyperpolarization of the membrane potential##2##5##(1990-12#1)(1992-3#1)
hyperpolarization of the##4##3##(1990-12#1)(1992-3#1)(1992-9#1)(1993-3#1)
hyperpolarization of##5##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)
hyperpolarization that was##2##3##(2008-4#1)(2010-4#1)
hyperpolarization was##2##2##(1994-11#1)(2008-4#1)
hyperpolarization##21##1##(1990-12#2)(1990-7#1)(1990-8#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-11#3)(1995-5#1)(1997-4#2)(2008-2#1)(2008-4#2)(2008-5#1)(2010-4#1)
hyperpolarization-activated##3##1##(1994-12#1)(2012-2#2)
hyperpolarizations##2##1##(1990-5#2)
hyperpolarized##2##1##(1997-1#1)(2012-2#1)
hyperpolarizing##6##1##(1990-8#1)(1993-8#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-5#1)
hyperporphyrin##2##1##(1990-5#2)
hyperprolactinemia (n =##2##3##(1993-2#1)(2011-2#1)
hyperprolactinemia##8##1##(1993-2#1)(2008-7#2)(2008-8#1)(2011-1#2)(2011-2#2)
hyperreactivity to##4##2##(1992-3#3)(2008-5#1)
hyperreactivity##10##1##(1990-5#1)(1990-8#1)(1992-12#1)(1992-3#3)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
hyperreflexia##3##1##(1997-8#1)(2008-7#1)(2013-8#1)
hyperresponsiveness and##4##2##(1997-1#1)(2007-6#1)(2008-3#1)(2010-5#1)
hyperresponsiveness##13##1##(1992-2#2)(1992-3#2)(1993-9#1)(1997-1#1)(2007-6#1)(2008-10#1)(2008-3#4)(2010-5#1)
hypersaline environments##2##2##(2011-2#1)(2012-2#1)
hypersaline stress##2##2##(2013-1#2)
hypersaline##5##1##(2011-2#1)(2012-2#2)(2013-1#2)
hypersecretion of##3##2##(1994-8#1)(1996-7#1)(2012-1#1)
hypersecretion##6##1##(1994-8#1)(1996-7#1)(2007-7#2)(2012-1#1)(2013-1#1)
hypersensitive cell death (HCD)##2##4##(2008-10#2)
hypersensitive cell death##4##3##(2008-10#4)
hypersensitive reaction (HR) in##2##4##(2008-10#2)
hypersensitive reaction (HR)##4##3##(2008-10#4)
hypersensitive reaction on##2##3##(2008-10#2)
hypersensitive reaction##15##2##(2008-10#15)
hypersensitive reactions##3##2##(2008-10#3)
hypersensitive response (HR)##10##3##(2008-10#10)
hypersensitive response in##3##3##(2008-10#2)(2008-8#1)
hypersensitive response##21##2##(2008-10#19)(2008-8#2)
hypersensitive responses##2##2##(2008-10#2)
hypersensitive site##7##2##(1992-6#2)(1997-3#2)(2008-8#3)
hypersensitive sites##3##2##(1990-7#1)(1994-11#2)
hypersensitive sublines##2##2##(1992-9#2)
hypersensitive to##4##2##(1997-3#1)(2009-8#1)(2011-1#1)(2012-3#1)
hypersensitive##66##1##(1990-7#1)(1992-6#2)(1992-9#3)(1993-11#1)(1994-11#2)(1997-3#3)(1997-7#1)(2008-10#44)(2008-11#1)(2008-8#5)(2009-8#1)(2011-1#1)(2012-3#1)
hypersensitivity (DTH)##3##2##(2008-10#3)
hypersensitivity and##6##2##(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
hypersensitivity pneumonitis##3##2##(2007-12#1)(2008-12#1)(2011-2#1)
hypersensitivity reaction is##2##3##(2008-10#1)(2008-8#1)
hypersensitivity reaction##5##2##(2008-10#2)(2008-8#3)
hypersensitivity reactions in##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
hypersensitivity reactions to chemotherapy agents##2##5##(2008-8#2)
hypersensitivity reactions to##5##3##(2008-7#1)(2008-8#3)(2011-1#1)
hypersensitivity reactions##16##2##(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#8)(2010-5#1)(2011-1#2)(2011-2#1)
hypersensitivity responses##2##2##(2008-10#2)
hypersensitivity syndrome##4##2##(2008-8#4)
hypersensitivity to##9##2##(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#2)
hypersensitivity##87##1##(1990-3#2)(1991-8#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-2#4)(1997-3#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#18)(2009-10#1)(2010-5#1)(2011-1#2)(2011-2#11)(2012-12#1)(2013-1#9)
hypersomnia##4##1##(2008-7#1)(2011-2#1)(2012-2#2)
hypersomnolence and##2##2##(2012-2#2)
hyperspectral data##2##2##(2008-3#1)(2013-8#1)
hyperspectral image##4##2##(2008-3#2)(2013-8#2)
hyperspectral images##3##2##(2008-3#3)
hyperspectral imaging##2##2##(2008-3#2)
hyperspectral remote sensing##4##3##(2008-12#2)(2008-3#2)
hyperspectral##23##1##(2008-12#3)(2008-3#16)(2013-8#4)
hyperstimulation##5##1##(1994-9#2)(2008-5#1)(2011-1#1)(2012-3#1)
hypertelorism and##2##2##(2011-1#1)(2013-8#1)
hypertelorism##4##1##(1997-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
hypertension (EH)##2##2##(2008-9#1)(2011-2#1)
hypertension (OR##2##2##(1994-12#1)(2008-8#1)
hypertension (PH) is##2##3##(2008-1#1)(2010-10#1)
hypertension (PH)##5##2##(2008-1#1)(2009-4#1)(2010-10#2)(2010-6#1)
hypertension (n =##2##3##(2007-10#2)
hypertension -##2##2##(2010-12#1)(2012-12#1)
hypertension after##3##2##(1991-11#1)(2008-1#2)
hypertension among##4##2##(2008-1#1)(2008-7#1)(2009-10#1)(2012-12#1)
hypertension and acute##2##3##(2007-10#1)(2008-12#1)
hypertension and atherosclerosis##3##3##(2008-7#3)
hypertension and cardiovascular##2##3##(2010-2#1)(2012-2#1)
hypertension and cerebrovascular##2##3##(1991-6#1)(2008-5#1)
hypertension and diabetes mellitus##6##4##(1996-11#1)(2008-4#3)(2008-7#1)(2013-1#1)
hypertension and diabetes##13##3##(1990-2#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#4)(2008-7#1)(2012-2#1)(2013-1#1)
hypertension and hypertensive##2##3##(1990-2#1)(2008-8#1)
hypertension and other##3##3##(2009-10#1)(2009-9#1)(2012-2#1)
hypertension and the##4##3##(1991-8#1)(1994-6#1)(1997-3#1)(1997-8#1)
hypertension and##87##2##(1990-2#3)(1990-3#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#2)(2007-10#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#4)(2011-2#5)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#3)
hypertension are##6##2##(2006-10#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
hypertension as##6##2##(2007-7#1)(2008-11#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
hypertension awareness##2##2##(2011-1#2)
hypertension can##4##2##(1990-9#1)(1994-12#1)(1995-11#1)(2008-5#1)
hypertension caused by##3##3##(1990-12#1)(1990-2#1)(2012-3#1)
hypertension compared to##2##3##(2008-11#1)(2011-2#1)
hypertension continues to##2##3##(2010-5#1)(2010-6#1)
hypertension control##2##2##(2010-4#2)
hypertension developed##2##2##(2010-4#1)(2012-12#1)
hypertension did not##2##3##(2007-7#1)(2010-4#1)
hypertension during##2##2##(2009-1#1)(2012-3#1)
hypertension group##4##2##(2008-1#2)(2011-2#2)
hypertension has##4##2##(1992-11#1)(1992-8#1)(2007-7#1)(2013-8#1)
hypertension in a##2##3##(1995-10#1)(2011-1#1)
hypertension in cardiac##2##3##(2011-2#2)
hypertension in men##4##3##(1993-9#3)(2010-4#1)
hypertension in patients with##3##4##(2008-1#1)(2010-4#1)(2013-1#1)
hypertension in patients##4##3##(1993-8#1)(2008-1#1)(2010-4#1)(2013-1#1)
hypertension in pregnancy##2##3##(2008-4#2)
hypertension in the elderly##4##4##(1992-6#1)(2008-7#2)(2009-9#1)
hypertension in the##12##3##(1991-6#1)(1992-6#4)(1992-9#1)(1993-3#1)(1997-5#1)(2008-7#2)(2009-9#1)(2012-3#1)
hypertension in this##3##3##(1994-6#1)(2008-1#1)(2011-1#1)
hypertension in##71##2##(1991-6#1)(1992-6#6)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-6#2)(1995-10#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#12)(2008-11#7)(2008-4#3)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#4)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
hypertension including##2##2##(2008-1#1)(2008-7#1)
hypertension is a##3##3##(1995-2#1)(2008-11#1)(2011-2#1)
hypertension is not##2##3##(1990-2#1)(2010-4#1)
hypertension is##21##2##(1990-2#2)(1992-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-1#4)(2008-11#3)(2009-1#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#2)
hypertension may be##2##3##(2008-11#1)(2008-7#1)
hypertension of##4##2##(1993-8#1)(1997-6#1)(2008-10#1)(2011-2#1)
hypertension on the##2##3##(1990-2#1)(1992-8#1)
hypertension on##7##2##(1990-2#1)(1992-8#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-2#1)
hypertension or diabetes##3##3##(2007-10#1)(2008-8#1)(2010-8#1)
hypertension or pulmonary##2##3##(2008-7#1)(2012-2#1)
hypertension or##13##2##(1992-6#1)(1995-11#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#1)(2012-2#1)
hypertension prevalence##2##2##(2008-11#1)(2011-1#1)
hypertension should be##2##3##(1996-11#1)(2008-7#1)
hypertension should##3##2##(1996-11#1)(2008-7#1)(2013-1#1)
hypertension suggest##2##2##(2009-1#1)(2009-10#1)
hypertension than##2##2##(1990-3#1)(2008-2#1)
hypertension was##14##2##(1990-11#1)(1994-12#1)(1997-6#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)
hypertension were##4##2##(2007-10#1)(2008-7#1)(2010-1#1)(2013-8#1)
hypertension when##2##2##(1990-2#1)(1996-11#1)
hypertension which##2##2##(1996-3#1)(1997-3#1)
hypertension who##2##2##(2008-1#1)(2008-11#1)
hypertension with##2##2##(1994-3#1)(2009-9#1)
hypertension##695##1##(1990-11#2)(1990-12#1)(1990-2#12)(1990-3#5)(1990-6#2)(1990-9#7)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#4)(1991-6#4)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#9)(1992-8#14)(1992-9#1)(1993-1#1)(1993-11#4)(1993-2#4)(1993-3#2)(1993-8#4)(1993-9#5)(1994-11#1)(1994-12#6)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#3)(1995-6#1)(1996-11#4)(1996-3#3)(1996-6#3)(1997-2#5)(1997-3#7)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#5)(2006-10#8)(2007-10#10)(2007-7#18)(2007-8#11)(2008-1#52)(2008-10#12)(2008-11#33)(2008-12#5)(2008-2#2)(2008-3#21)(2008-4#12)(2008-5#9)(2008-6#2)(2008-7#45)(2008-8#16)(2008-9#5)(2009-1#10)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#8)(2010-1#3)(2010-10#22)(2010-12#3)(2010-2#1)(2010-4#29)(2010-5#9)(2010-6#13)(2010-8#3)(2011-1#13)(2011-2#42)(2011-3#4)(2012-12#9)(2012-2#17)(2012-3#6)(2013-1#24)(2013-7#2)(2013-8#27)
hypertension)##6##1##(1995-5#1)(1996-6#1)(2008-1#1)(2008-5#1)(2009-9#1)(2011-2#1)
hypertension]##27##1##(1991-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#3)(1994-2#1)(1994-6#1)(1995-2#1)(1996-3#2)(1997-4#1)(2008-10#2)(2010-12#1)(2010-6#8)(2013-1#1)(2013-8#1)
hypertensive and##7##2##(2007-10#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-8#2)
hypertensive compared to##2##3##(2008-11#1)(2012-2#1)
hypertensive disease##2##2##(2008-5#1)(2012-12#1)
hypertensive disorders##3##2##(1994-3#1)(2008-4#1)(2011-2#1)
hypertensive group##3##2##(2008-1#2)(2012-2#1)
hypertensive nephrosclerosis##3##2##(1990-7#1)(1992-8#1)(2007-7#1)
hypertensive patient##3##2##(1993-11#2)(2012-3#1)
hypertensive patients during##2##3##(2010-4#1)(2010-5#1)
hypertensive patients for##2##3##(2008-11#1)(2009-1#1)
hypertensive patients with a history of ischemic stroke##2##8##(2007-10#2)
hypertensive patients with a history of##3##6##(2007-10#3)
hypertensive patients with##6##3##(1992-8#1)(2007-10#4)(2009-7#1)
hypertensive patients##32##2##(1991-3#1)(1992-8#2)(1993-8#1)(2007-10#4)(2008-1#3)(2008-11#2)(2008-7#1)(2008-8#4)(2009-1#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
hypertensive patients]##2##2##(1996-3#1)(2013-8#1)
hypertensive pregnant##2##2##(1997-8#1)(2011-2#1)
hypertensive rat##3##2##(1990-7#1)(1994-8#1)(1997-2#1)
hypertensive rats##24##2##(1990-7#2)(1991-5#2)(1991-6#2)(1994-2#2)(1995-11#2)(1995-12#4)(1997-2#2)(1997-6#2)(2008-11#1)(2009-8#1)(2010-2#1)(2011-1#3)
hypertensive rats]##2##2##(2011-1#1)(2013-8#1)
hypertensive subjects and##2##3##(2011-2#1)(2013-8#1)
hypertensive subjects were##3##3##(2008-7#1)(2013-8#2)
hypertensive subjects##9##2##(1991-3#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#4)
hypertensive therapy##2##2##(2008-8#1)(2010-1#1)
hypertensive women with or without preeclampsia##2##6##(2011-2#2)
hypertensive women##4##2##(1997-8#1)(2011-2#2)(2012-12#1)
hypertensive##149##1##(1990-2#1)(1990-7#4)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#2)(1992-8#4)(1993-11#2)(1993-8#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#4)(1996-3#1)(1996-5#1)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#7)(2007-7#4)(2007-8#1)(2008-1#7)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#7)(2009-1#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#7)(2010-5#1)(2011-1#6)(2011-2#11)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#5)(2013-8#12)
hypertensive&quot##2##1##(1990-3#1)(2008-10#1)
hypertensives and##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
hypertensives##15##1##(1990-2#2)(1997-2#1)(2008-10#5)(2008-11#1)(2012-2#4)(2013-8#2)
hyperthermal##4##1##(2010-4#4)
hyperthermia and radiotherapy##2##3##(1992-8#2)
hyperthermia and##4##2##(1992-8#2)(1995-9#1)(2008-4#1)
hyperthermia as##2##2##(1997-3#1)(2013-8#1)
hyperthermia by##2##2##(2013-8#2)
hyperthermia during##2##2##(1994-11#1)(2008-7#1)
hyperthermia in the##2##3##(1990-3#1)(1997-3#1)
hyperthermia in##4##2##(1990-3#1)(1997-3#1)(2008-4#1)(2013-8#1)
hyperthermia on##2##2##(2008-5#1)(2008-7#1)
hyperthermia treatment##2##2##(2008-11#1)(2012-2#1)
hyperthermia##42##1##(1990-3#2)(1990-9#1)(1991-5#1)(1992-8#3)(1993-9#1)(1994-11#1)(1995-9#1)(1997-3#7)(2007-10#1)(2008-11#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#6)
hyperthermia-induced##2##1##(2013-8#2)
hyperthermic##7##1##(1991-5#2)(1992-8#1)(1997-3#1)(2007-10#1)(2008-6#1)(2008-7#1)
hyperthermophilic archaeon##4##2##(1993-9#2)(1995-5#1)(2011-2#1)
hyperthermophilic archaeonSulfolobus shibatae##2##3##(2008-9#2)
hyperthermophilic cocultures##2##2##(2008-7#2)
hyperthermophilic microorganisms##2##2##(1995-5#1)(2008-7#1)
hyperthermophilic##18##1##(1993-9#2)(1994-12#2)(1995-5#3)(2008-7#5)(2008-9#2)(2011-2#4)
hyperthyroid rats compared##2##3##(1990-8#1)(1993-12#1)
hyperthyroid rats##5##2##(1990-8#3)(1993-12#1)(1996-5#1)
hyperthyroid##8##1##(1990-8#4)(1993-12#2)(1996-5#1)(2007-8#1)
hyperthyroidism in##3##2##(2008-4#2)(2011-1#1)
hyperthyroidism##26##1##(1990-8#2)(1994-3#2)(1995-12#1)(1996-5#3)(1996-8#1)(2007-5#2)(2007-8#3)(2008-4#6)(2011-1#4)(2013-1#1)(2013-8#1)
hypertonic dextrose##2##2##(2008-9#2)
hypertonic media##2##2##(1992-8#1)(1996-8#1)
hypertonic saline##11##2##(1992-8#1)(1993-12#4)(2008-5#1)(2008-9#1)(2010-1#2)(2010-12#2)
hypertonic solution##2##2##(1992-8#1)(2013-7#1)
hypertonic##20##1##(1992-8#3)(1993-12#4)(1994-8#1)(1995-9#1)(1996-8#1)(2008-5#1)(2008-9#3)(2010-1#2)(2010-12#2)(2011-1#1)(2013-7#1)
hypertrichosis##5##1##(2007-7#3)(2010-6#2)
hypertriglyceridaemia##4##1##(1996-3#1)(2008-8#2)(2013-1#1)
hypertriglyceridemia and##5##2##(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
hypertriglyceridemia is##2##2##(2008-12#1)(2008-3#1)
hypertriglyceridemia##30##1##(1990-2#1)(1991-8#1)(1992-10#1)(1993-2#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-12#3)(2008-3#8)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#2)
hypertriglyceridemic patients##3##2##(1991-8#1)(1994-3#1)(2008-12#1)
hypertriglyceridemic##5##1##(1991-12#1)(1991-8#1)(1994-3#1)(2008-12#2)
hypertrophic cardiomyopathy##16##2##(1992-6#1)(1992-9#1)(1996-8#1)(1997-7#3)(2008-4#1)(2008-7#2)(2009-10#1)(2010-11#3)(2012-2#1)(2012-3#1)(2013-8#1)
hypertrophic chondrocytes##6##2##(2012-12#6)
hypertrophic cranial##3##2##(2008-7#1)(2012-2#2)
hypertrophic obstructive cardiomyopathy##2##3##(1992-9#1)(2010-12#1)
hypertrophic or##2##2##(2008-9#1)(2009-5#1)
hypertrophic pyloric stenosis##3##3##(2007-5#1)(2009-5#1)(2010-12#1)
hypertrophic pyloric##4##2##(1990-9#1)(2007-5#1)(2009-5#1)(2010-12#1)
hypertrophic response##2##2##(1994-5#1)(2008-5#1)
hypertrophic scar##2##2##(2008-9#2)
hypertrophic scarring##3##2##(1991-2#2)(2008-9#1)
hypertrophic scars##2##2##(2008-9#1)(2009-4#1)
hypertrophic##56##1##(1990-9#2)(1991-2#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#3)(1994-5#1)(1996-8#1)(1997-7#3)(2007-5#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-11#3)(2010-12#3)(2011-2#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-8#3)
hypertrophied guinea pig##2##3##(1996-9#2)
hypertrophied hearts##3##2##(1996-9#3)
hypertrophied##7##1##(1996-9#6)(1997-3#1)
hypertrophy and hyperplasia of##2##4##(2008-10#1)(2010-11#1)
hypertrophy and##15##2##(1990-11#1)(1996-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-1#2)(2013-8#1)
hypertrophy in 350 and 700 mg/L##2##6##(2008-9#2)
hypertrophy in patients with cardiac syndrome X##2##7##(2008-12#2)
hypertrophy in patients with##4##4##(2008-12#2)(2012-12#2)
hypertrophy in the##2##3##(1996-12#1)(2008-12#1)
hypertrophy in##14##2##(1995-11#1)(1996-12#1)(2008-12#3)(2008-9#4)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)
hypertrophy is associated with##3##4##(2008-7#1)(2010-12#1)(2012-2#1)
hypertrophy is##8##2##(2008-2#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
hypertrophy of the##7##3##(1990-9#1)(1992-9#2)(1996-3#1)(2008-8#1)(2010-10#1)(2010-12#1)
hypertrophy of##14##2##(1990-3#1)(1990-9#1)(1992-9#2)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-10#1)(2010-12#2)(2011-1#1)
hypertrophy or##3##2##(2009-1#1)(2012-2#1)(2013-8#1)
hypertrophy through##2##2##(2011-2#1)(2013-8#1)
hypertrophy were significantly increased in##2##5##(2008-9#2)
hypertrophy were##3##2##(2008-9#2)(2011-2#1)
hypertrophy with##5##2##(1997-6#1)(2008-5#1)(2010-6#1)(2010-8#1)(2012-12#1)
hypertrophy##122##1##(1990-11#1)(1990-2#1)(1990-3#3)(1990-9#1)(1991-5#2)(1992-8#1)(1992-9#2)(1994-11#2)(1994-12#2)(1995-11#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#8)(2009-1#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#13)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#10)(2012-12#8)(2012-2#5)(2013-1#4)(2013-8#3)
hypertrophy]##2##1##(1992-9#1)(1995-11#1)
hyperuricemia in##2##2##(2008-7#2)
hyperuricemia##6##1##(2007-7#1)(2008-7#5)
hyperuricemic nephropathy##2##2##(2007-7#1)(2008-7#1)
hyperuricemic##3##1##(1990-11#1)(2007-7#1)(2008-7#1)
hypervalent##2##1##(2008-11#1)(2010-12#1)
hypervariable region of##2##3##(1990-7#1)(1995-2#1)
hypervariable region##6##2##(1990-7#2)(1992-3#2)(1995-2#1)(2008-10#1)
hypervariable regions of##2##3##(1993-8#1)(2008-10#1)
hypervariable regions##3##2##(1991-2#1)(1993-8#1)(2008-10#1)
hypervariable##11##1##(1990-7#2)(1991-2#1)(1992-3#2)(1993-8#1)(1994-3#1)(1995-2#1)(2008-10#3)
hypervascular HCC##2##2##(2010-12#2)
hypervascular tumours##2##2##(1997-6#1)(2008-7#1)
hypervascular##12##1##(1992-3#1)(1997-6#2)(2008-1#3)(2008-10#1)(2008-2#1)(2008-7#2)(2010-12#2)
hypervascularity##2##1##(1997-6#1)(2011-2#1)
hypervelocity photoelectric modulation interferometer##2##4##(2013-8#2)
hyperventilation provocation##2##2##(1991-3#2)
hyperventilation##13##1##(1991-12#1)(1991-3#4)(1991-9#1)(1994-9#1)(2008-7#4)(2008-9#1)(2012-3#1)
hypervitaminosis D(3)##2##2##(1997-3#2)
hypervolaemia##2##1##(1995-11#1)(1995-12#1)
hyphae and##5##2##(2008-10#3)(2008-8#1)(2011-1#1)
hyphae appeared##2##2##(2008-10#1)(2008-11#1)
hyphae are##3##2##(2008-10#3)
hyphae began to##2##3##(2008-10#2)
hyphae colonized the##2##3##(2008-10#2)
hyphae from##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
hyphae grew##3##2##(2008-10#3)
hyphae had##2##2##(2008-10#2)
hyphae in the##2##3##(2008-10#1)(2008-11#1)
hyphae in##12##2##(2007-7#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)
hyphae may##2##2##(2008-10#2)
hyphae of P##2##3##(2008-10#2)
hyphae of R##4##3##(2008-10#4)
hyphae of both##4##3##(2008-10#4)
hyphae of the##3##3##(2008-10#3)
hyphae of##20##2##(2008-10#18)(2008-5#2)
hyphae or##2##2##(2008-10#1)(2008-7#1)
hyphae to##4##2##(2008-10#3)(2010-2#1)
hyphae was##4##2##(2008-10#4)
hyphae were designated##2##3##(2008-10#2)
hyphae were formed##2##3##(2008-10#2)
hyphae were found##2##3##(2008-10#2)
hyphae were##14##2##(2008-10#13)(2008-8#1)
hyphae within the##2##3##(2008-10#1)(2011-1#1)
hyphae within##3##2##(2008-10#2)(2011-1#1)
hyphae##149##1##(2007-7#1)(2008-10#121)(2008-11#5)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2010-10#1)(2010-2#2)(2010-3#1)(2011-1#7)(2012-2#2)
hyphal anastomosis##5##2##(2008-10#5)
hyphal biomass##2##2##(2008-10#2)
hyphal diameter##3##2##(2008-10#2)(2008-7#1)
hyphal elongation and##2##3##(2008-10#2)
hyphal growth and##2##3##(2008-10#1)(2008-8#1)
hyphal growth of the##2##4##(1997-6#1)(2008-10#1)
hyphal growth of##5##3##(1997-6#1)(2008-10#3)(2012-2#1)
hyphal growth rates##3##3##(2008-10#3)
hyphal growth##24##2##(1996-6#1)(1997-6#1)(2008-10#16)(2008-8#1)(2009-8#4)(2012-2#1)
hyphal interactions##3##2##(2008-10#3)
hyphal length##4##2##(2008-10#1)(2008-7#3)
hyphal tip##2##2##(2008-10#2)
hyphal tips of##2##3##(1997-4#1)(2008-10#1)
hyphal tips##3##2##(1997-4#1)(2008-10#2)
hyphal walls##2##2##(2008-10#2)
hyphal##79##1##(1991-9#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#54)(2008-11#2)(2008-7#7)(2008-8#5)(2009-8#6)(2012-2#1)
hyphenated system##2##2##(2008-10#1)(2012-1#1)
hyphenated techniques##9##2##(2008-10#8)(2010-11#1)
hyphenated##20##1##(2008-10#16)(2010-11#2)(2011-2#1)(2012-1#1)
hyphenation of##4##2##(2008-10#3)(2008-12#1)
hyphenation##8##1##(2008-10#7)(2008-12#1)
hyphomycetes##5##1##(2008-10#5)
hypnosis##5##1##(2008-2#1)(2009-9#4)
hypnotherapy##3##1##(1993-7#1)(2011-2#1)(2013-7#1)
hypnotic##6##1##(1991-8#1)(1993-9#1)(2008-11#1)(2008-6#1)(2009-10#1)(2011-2#1)
hypo- and hypercalcemia##2##3##(1991-8#2)
hypo- and hyperthyroidism##2##3##(2008-4#2)
hypo- and##5##2##(1991-8#2)(2008-4#2)(2012-3#1)
hypo- or hyperthyroid##2##3##(1993-12#2)
hypo- or##3##2##(1993-12#2)(2013-1#1)
hypo- versus##2##2##(1991-8#2)
hypo-##10##1##(1991-8#4)(1993-12#2)(2008-4#2)(2012-3#1)(2013-1#1)
hypoacusis##2##1##(1994-2#1)(2008-7#1)
hypoalbuminemia and##2##2##(2007-7#1)(2013-1#1)
hypoalbuminemia##7##1##(2006-10#1)(2007-7#2)(2011-2#1)(2013-1#3)
hypobaric hypoxia on##2##3##(1996-12#1)(2010-12#1)
hypobaric hypoxia##4##2##(1996-12#3)(2010-12#1)
hypobaric##5##1##(1990-8#1)(1996-12#3)(2010-12#1)
hypobetalipoproteinemia##2##1##(1993-12#1)(1995-2#1)
hypobromite##5##1##(2008-10#5)
hypocalcaemia##3##1##(2008-1#1)(2008-12#1)(2008-6#1)
hypocalcemia and##3##2##(1991-8#2)(2012-3#1)
hypocalcemia##10##1##(1991-8#2)(2008-7#2)(2011-2#4)(2012-3#1)(2013-8#1)
hypocellularity##2##1##(2008-10#2)
hypochlorite (NaOCl)##3##2##(2012-3#1)(2013-1#2)
hypochlorite and chlorate##2##3##(2008-10#2)
hypochlorite and the##2##3##(2007-7#1)(2008-10#1)
hypochlorite and##11##2##(2007-7#1)(2008-10#10)
hypochlorite in##2##2##(2008-10#2)
hypochlorite ion##2##2##(2008-10#2)
hypochlorite was##2##2##(2008-10#1)(2011-2#1)
hypochlorite##45##1##(2007-7#7)(2008-10#32)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#2)
hypochondriac##2##1##(2008-7#1)(2013-8#1)
hypochromic##2##1##(1991-5#1)(2011-1#1)
hypocotyl##9##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)
hypocotyls and##3##2##(2008-10#2)(2008-8#1)
hypocotyls grown##2##2##(2008-10#2)
hypocotyls with##2##2##(1997-6#1)(2008-10#1)
hypocotyls##14##1##(1997-6#4)(2008-10#9)(2008-8#1)
hypocrellin B##3##2##(2008-8#3)
hypocrellin##6##1##(2008-8#6)
hypocrellins##4##1##(2008-8#4)
hypodense##2##1##(2008-12#1)(2013-1#1)
hypodermal##6##1##(1990-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2013-7#1)
hypodermic needles##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
hypodermis##5##1##(2008-10#2)(2008-5#2)(2013-7#1)
hypodermosis##2##1##(2008-12#2)
hypodiploidy##3##1##(1990-3#2)(2008-9#1)
hypoechoic and##2##2##(2008-10#1)(2011-2#1)
hypoechoic##6##1##(2007-10#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-3#1)
hypoesthesia##2##1##(1993-12#1)(2012-12#1)
hypofractionated radiotherapy and##2##3##(2008-6#2)
hypofunction is##2##2##(1993-12#1)(2012-3#1)
hypofunction##5##1##(1993-12#2)(2011-1#1)(2012-3#2)
hypogammaglobulinemia with##2##2##(2011-2#2)
hypogammaglobulinemia##3##1##(1990-6#1)(2011-2#2)
hypogastric artery##2##2##(1994-1#2)
hypogastric##6##1##(1992-12#1)(1994-1#2)(1995-12#3)
hypoglossal canal##3##2##(2011-2#3)
hypoglossal nerve palsy##2##3##(2011-2#2)
hypoglossal nerve##5##2##(1993-12#1)(2008-2#1)(2011-2#3)
hypoglossal nucleus##2##2##(1991-12#1)(1993-12#1)
hypoglossal##17##1##(1991-12#1)(1993-12#3)(2008-2#2)(2011-2#10)(2013-1#1)
hypoglycaemia in##2##2##(1993-6#1)(2011-1#1)
hypoglycaemia was##2##2##(1991-8#2)
hypoglycaemia##22##1##(1991-11#1)(1991-8#7)(1993-6#1)(1995-9#1)(1996-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#8)
hypoglycaemic agents##2##2##(1993-12#1)(2008-1#1)
hypoglycaemic##5##1##(1991-8#1)(1993-12#1)(1994-12#1)(1997-3#1)(2008-1#1)
hypoglycemia and##2##2##(2008-1#1)(2010-11#1)
hypoglycemia as##2##2##(2007-5#1)(2008-1#1)
hypoglycemia caused by hyperinsulinism##2##4##(1991-2#2)
hypoglycemia during##4##2##(1994-2#1)(2009-4#1)(2010-2#2)
hypoglycemia in##4##2##(1991-1#1)(2007-12#1)(2008-1#1)(2013-1#1)
hypoglycemia is##2##2##(2007-12#1)(2007-5#1)
hypoglycemia was##2##2##(2007-5#1)(2012-3#1)
hypoglycemia##41##1##(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#2)(1994-2#1)(1994-6#2)(1996-8#1)(1997-2#2)(1997-4#1)(2007-12#3)(2007-5#4)(2008-1#3)(2008-3#1)(2008-5#1)(2009-4#3)(2010-11#2)(2010-2#2)(2010-4#1)(2011-1#5)(2012-3#1)(2012-4#1)(2013-1#1)
hypoglycemic activity##2##2##(1994-8#1)(2011-1#1)
hypoglycemic agents##2##2##(2008-1#1)(2009-3#1)
hypoglycemic and##2##2##(2009-11#1)(2012-2#1)
hypoglycemic clamp##2##2##(2007-5#2)
hypoglycemic effect##2##2##(2011-1#1)(2012-2#1)
hypoglycemic episodes##4##2##(2007-10#1)(2010-10#1)(2010-12#1)(2012-4#1)
hypoglycemic events##2##2##(2008-3#1)(2009-11#1)
hypoglycemic piglets##3##2##(1994-2#3)
hypoglycemic##28##1##(1990-5#1)(1994-2#3)(1994-8#2)(1997-2#1)(2007-10#1)(2007-5#2)(2008-1#1)(2008-3#1)(2009-11#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#6)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
hypogonadal##6##1##(2008-1#1)(2008-3#2)(2012-12#1)(2013-8#2)
hypogonadism in##2##2##(2008-3#1)(2009-6#1)
hypogonadism##13##1##(1993-2#1)(1996-2#1)(2008-3#3)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#3)
hypointense##2##1##(2006-12#1)(2007-11#1)
hypokalaemia##2##1##(1997-8#1)(2008-6#1)
hypokalemia is a##2##3##(2008-1#2)
hypokalemia##13##1##(1996-6#1)(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#4)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)
hypokalemic metabolic##2##2##(2007-7#1)(2008-1#1)
hypokalemic##5##1##(2007-7#2)(2008-1#3)
hypokinesis##3##1##(1997-3#2)(2010-5#1)
hypokinetic##4##1##(2008-10#2)(2008-7#1)(2011-1#1)
hypolipidemic agents##2##2##(1990-12#1)(2007-11#1)
hypolipidemic effect##2##2##(2011-2#1)(2013-1#1)
hypolipidemic##9##1##(1990-12#2)(1991-2#1)(1995-6#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#2)
hypomagnesaemia and##2##2##(1997-8#1)(2008-6#1)
hypomagnesaemia##3##1##(1997-8#1)(2008-6#2)
hypomagnesemia##4##1##(1990-6#1)(1996-6#1)(1997-8#1)(2008-7#1)
hypomania##3##1##(1996-7#2)(2012-2#1)
hypomanic##2##1##(1996-7#1)(2012-3#1)
hypomethylation of##2##2##(1992-3#1)(2008-3#1)
hypomethylation##5##1##(1991-5#1)(1992-3#1)(1992-9#1)(2008-3#2)
hypomobility in young patients##2##4##(2007-12#2)
hypomobility in##3##2##(2007-12#2)(2008-12#1)
hypomobility##7##1##(2007-12#3)(2008-10#1)(2008-12#3)
hypomorphic##4##1##(2008-9#4)
hyponatraemia##2##1##(2008-7#1)(2008-8#1)
hyponatremia##15##1##(1990-9#1)(1992-11#1)(1992-9#1)(1996-7#1)(2009-10#1)(2009-11#2)(2010-1#4)(2010-6#1)(2011-2#3)
hypoosmotic pressure##6##2##(2008-11#6)
hypoosmotic##9##1##(2008-11#6)(2008-5#1)(2008-7#2)
hypoparathyroidism##9##1##(1991-5#1)(1997-3#1)(2012-3#2)(2013-8#5)
hypoperfusion and##3##2##(2007-10#1)(2008-10#1)(2010-3#1)
hypoperfusion##12##1##(1996-3#1)(2007-10#2)(2008-10#1)(2008-7#6)(2009-6#1)(2010-3#1)
hypopharyngeal diverticulum##2##2##(1997-2#2)
hypopharyngeal gland##4##2##(2008-6#4)
hypopharyngeal##8##1##(1997-2#2)(2007-12#1)(2008-1#1)(2008-6#4)
hypopharynx##3##1##(1990-8#1)(1993-9#1)(1995-8#1)
hypophisiary##4##1##(2013-1#4)
hypophosphorylated##2##1##(1994-8#1)(2008-11#1)
hypophysectomized##5##1##(1995-8#1)(2008-5#2)(2012-1#2)
hypophysectomy##4##1##(1993-6#1)(1995-8#1)(2008-6#1)(2008-8#1)
hypophysis##4##1##(1992-12#1)(2009-8#2)(2011-1#1)
hypopigmentation##2##1##(1997-3#1)(2007-7#1)
hypopituitarism##5##1##(2008-7#3)(2011-2#1)(2013-1#1)
hypopituitary##3##1##(1997-8#2)(2012-3#1)
hypoplasia and##5##2##(2008-9#1)(2011-1#2)(2013-1#2)
hypoplasia in##4##2##(1994-3#1)(2008-12#2)(2011-2#1)
hypoplasia of the##4##3##(1992-6#1)(2007-8#2)(2010-11#1)
hypoplasia of##5##2##(1992-6#1)(2007-8#2)(2010-11#1)(2011-1#1)
hypoplasia or##2##2##(2008-7#1)(2011-1#1)
hypoplasia##43##1##(1992-6#1)(1994-3#2)(1994-6#1)(1997-3#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#6)(2008-4#2)(2008-7#4)(2008-9#5)(2010-11#1)(2011-1#6)(2011-2#2)(2012-3#2)(2013-1#4)
hypoplastic cochleas##2##2##(2008-9#2)
hypoplastic left heart syndrome##2##4##(2007-8#1)(2010-6#1)
hypoplastic left##3##2##(2007-8#1)(2010-6#1)(2011-1#1)
hypoplastic thumb##2##2##(2007-11#1)(2008-9#1)
hypoplastic##24##1##(1994-6#1)(2007-11#2)(2007-8#4)(2008-10#3)(2008-7#1)(2008-9#3)(2010-6#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
hypopnoea episodes##2##2##(2010-8#2)
hypopnoea##4##1##(2008-7#1)(2010-8#3)
hyporesponsive##2##1##(2008-11#1)(2011-1#1)
hyporesponsiveness##2##1##(2009-5#1)(2010-5#1)
hyposmolarity##6##1##(1990-7#4)(2008-8#2)
hypospadia##4##1##(2013-1#4)
hypospadias and bifid scrotum##2##4##(2008-10#2)
hypospadias and##5##2##(2008-10#4)(2009-5#1)
hypospadias have##2##2##(2008-10#1)(2009-5#1)
hypospadias in##3##2##(2008-10#2)(2009-5#1)
hypospadias repair##17##2##(2008-1#1)(2008-10#9)(2008-6#1)(2009-5#5)(2010-11#1)
hypospadias repairs##4##2##(2008-10#2)(2009-5#2)
hypospadias surgery##6##2##(2008-10#3)(2009-5#3)
hypospadias##68##1##(2008-1#1)(2008-10#32)(2008-6#1)(2009-5#33)(2010-11#1)
hypospadiology##5##1##(2009-5#5)
hypotaurine##2##1##(2008-5#2)
hypotension and other##2##3##(2008-6#1)(2011-2#1)
hypotension and##7##2##(1990-5#2)(1995-12#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-8#1)
hypotension by##3##2##(1990-9#1)(2008-1#1)(2008-4#1)
hypotension during##2##2##(1990-12#1)(2013-1#1)
hypotension in the##3##3##(1990-6#1)(2011-2#1)(2013-1#1)
hypotension in##5##2##(1990-6#1)(1990-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
hypotension is##4##2##(2008-1#1)(2008-7#2)(2011-2#1)
hypotension were associated with##2##4##(1990-12#1)(2012-3#1)
hypotension##66##1##(1990-12#4)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-9#1)(1994-11#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-5#1)(2007-8#2)(2008-1#7)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
hypotension)##2##1##(1990-5#1)(1996-3#1)
hypotensive##17##1##(1990-7#1)(1990-9#2)(1991-5#2)(1991-9#1)(1994-11#2)(1995-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
hypothalamic and pituitary cells##2##4##(2008-4#2)
hypothalamic and pituitary##4##3##(2008-4#4)
hypothalamic and##5##2##(1994-2#1)(2008-4#4)
hypothalamic area##7##2##(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(2008-9#2)(2013-7#1)
hypothalamic areas##3##2##(1991-5#1)(1993-12#2)
hypothalamic blood flow##2##3##(1995-12#2)
hypothalamic cells##3##2##(1993-12#1)(2008-4#2)
hypothalamic cultures##2##2##(1994-2#2)
hypothalamic gene expression##2##3##(1996-12#2)
hypothalamic grafts##2##2##(1993-12#2)
hypothalamic neuronal damage##2##3##(1995-12#2)
hypothalamic nuclei##5##2##(1993-5#1)(1994-2#1)(1996-12#1)(1997-2#1)(2007-8#1)
hypothalamic nucleus##4##2##(1994-2#1)(1997-3#1)(2008-8#2)
hypothalamic paraventricular nucleus (PVN)##2##4##(1994-8#1)(2008-4#1)
hypothalamic paraventricular nucleus##6##3##(1993-12#1)(1994-8#2)(1996-12#2)(2008-4#1)
hypothalamic paraventricular##8##2##(1993-12#3)(1994-8#2)(1996-12#2)(2008-4#1)
hypothalamic releasing hormones##2##3##(1994-9#2)
hypothalamic serotonin release##4##3##(1995-12#4)
hypothalamic serotonin##5##2##(1995-12#4)(1997-6#1)
hypothalamic stimulation##3##2##(1991-2#1)(1993-12#1)(1994-2#1)
hypothalamic##93##1##(1990-7#1)(1991-11#1)(1991-2#4)(1991-5#2)(1991-9#2)(1992-11#1)(1992-3#3)(1992-9#2)(1993-12#15)(1993-5#3)(1993-6#2)(1994-2#7)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#11)(1995-5#2)(1996-12#8)(1997-2#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-4#7)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2012-3#2)(2013-7#1)
hypothalamic-pituitary##3##1##(1991-2#1)(2008-4#1)(2010-2#1)
hypothalamic-pituitary-adrenal##11##1##(1994-5#2)(1996-12#1)(1997-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
hypothalamo-pituitary adrenal axis##2##3##(1995-12#2)
hypothalamus and##12##2##(1990-7#1)(1991-2#1)(1994-2#3)(1995-12#1)(1996-12#2)(1997-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
hypothalamus in##3##2##(1993-12#1)(1997-2#1)(2009-10#1)
hypothalamus is##3##2##(1990-7#1)(1993-6#1)(1996-2#1)
hypothalamus of##8##2##(1990-7#1)(1992-12#1)(1993-12#1)(1995-12#1)(1997-6#1)(2008-8#1)(2013-1#2)
hypothalamus was##3##2##(1995-12#1)(2008-8#1)(2011-1#1)
hypothalamus were##2##2##(1994-2#1)(2008-8#1)
hypothalamus##98##1##(1990-12#1)(1990-7#6)(1990-9#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1993-12#8)(1993-5#3)(1993-6#5)(1994-2#9)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#9)(1995-2#2)(1996-12#5)(1996-2#5)(1997-2#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#2)(2010-6#1)(2011-1#2)(2013-1#5)(2013-7#1)
hypothalamus-pituitary-adrenal (HPA) axis##2##3##(1990-3#1)(2008-11#1)
hypothalamus-pituitary-adrenal##3##1##(1990-3#1)(2007-7#1)(2008-11#1)
hypothenar fat pad flap##2##4##(2008-9#2)
hypothermia and circulatory arrest##2##4##(2007-8#1)(2011-2#1)
hypothermia and##8##2##(1992-11#1)(1995-11#1)(1995-3#1)(2007-8#1)(2008-7#1)(2011-2#2)(2013-8#1)
hypothermia for##4##2##(2008-8#4)
hypothermia has##2##2##(1991-3#2)
hypothermia in##7##2##(1993-12#1)(2006-7#1)(2007-10#4)(2013-8#1)
hypothermia is##5##2##(2007-10#1)(2008-8#2)(2011-2#1)(2013-8#1)
hypothermia on##3##2##(2008-9#2)(2010-9#1)
hypothermia that##2##2##(1993-12#1)(2011-2#1)
hypothermia using##2##2##(1995-12#1)(2007-10#1)
hypothermia##76##1##(1990-5#1)(1990-9#1)(1991-3#3)(1992-11#1)(1992-3#1)(1993-12#6)(1993-3#1)(1995-11#1)(1995-12#2)(1995-3#4)(1996-12#4)(2006-10#1)(2006-7#1)(2007-10#14)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#8)(2008-9#5)(2010-1#2)(2010-9#1)(2011-2#10)(2013-8#4)
hypothermic circulatory arrest##5##3##(2007-8#1)(2008-8#1)(2010-6#1)(2013-1#2)
hypothermic ischemic brains##3##3##(1995-12#3)
hypothermic ischemic##4##2##(1995-12#4)
hypothermic rats##2##2##(1995-3#1)(2007-10#1)
hypothermic response##2##2##(1994-2#2)
hypothermic storage##3##2##(2007-8#3)
hypothermic temperatures##4##2##(1990-12#4)
hypothermic##32##1##(1990-12#6)(1994-2#2)(1995-12#5)(1995-3#3)(1996-12#3)(1996-9#1)(2007-10#1)(2007-8#7)(2008-8#1)(2010-6#1)(2013-1#2)
hypotheses about the##8##3##(2007-8#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)
hypotheses about##16##2##(1992-11#1)(1996-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2012-3#1)(2013-8#2)
hypotheses and##10##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-8#1)
hypotheses are not mutually exclusive##2##5##(2008-9#1)(2013-1#1)
hypotheses are not##3##3##(2008-9#1)(2009-5#1)(2013-1#1)
hypotheses are##8##2##(2008-8#2)(2008-9#3)(2009-5#1)(2011-2#1)(2013-1#1)
hypotheses concerning the##2##3##(2007-8#1)(2008-10#1)
hypotheses concerning##5##2##(1993-1#1)(2007-8#1)(2008-10#3)
hypotheses for the origin of##2##5##(2008-8#1)(2009-6#1)
hypotheses for the##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2009-6#1)
hypotheses for##9##2##(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#2)(2009-6#1)(2012-2#1)(2013-8#1)
hypotheses have been proposed to explain##2##6##(2008-9#1)(2012-3#1)
hypotheses have been proposed##3##4##(2008-9#1)(2011-1#1)(2012-3#1)
hypotheses have##5##2##(1990-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
hypotheses in##2##2##(1995-6#1)(2012-3#1)
hypotheses is##2##2##(1993-12#1)(2008-9#1)
hypotheses of the##2##3##(1990-9#1)(2012-1#1)
hypotheses of##9##2##(1990-9#1)(1994-3#1)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
hypotheses on the##4##3##(1992-8#1)(2007-12#1)(2008-10#1)(2012-12#1)
hypotheses on##7##2##(1992-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-12#1)
hypotheses regarding the##7##3##(1991-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)
hypotheses regarding##10##2##(1991-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)(2011-1#1)
hypotheses that##15##2##(1992-3#1)(1994-3#1)(1996-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-3#2)
hypotheses to explain##2##3##(2008-8#1)(2008-9#1)
hypotheses to##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
hypotheses using##2##2##(2008-8#1)(2012-3#1)
hypotheses were##2##2##(1992-2#1)(2010-8#1)
hypotheses##148##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-3#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#4)(2007-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#15)(2008-9#19)(2009-10#1)(2009-11#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2010-3#5)(2010-6#3)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#3)
hypothesis - that##2##3##(2009-9#1)(2013-1#1)
hypothesis -##3##2##(2009-9#2)(2013-1#1)
hypothesis about##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
hypothesis also##2##2##(1992-8#1)(2008-5#1)
hypothesis and##3##2##(2008-7#1)(2009-2#1)(2010-1#1)
hypothesis as##4##2##(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)
hypothesis assumes that##2##3##(1994-3#1)(2008-9#1)
hypothesis by##6##2##(1993-6#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-7#1)
hypothesis for the##2##3##(2008-10#1)(2013-8#1)
hypothesis for##9##2##(2008-10#3)(2008-11#1)(2008-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
hypothesis generation and##2##3##(2008-7#1)(2011-3#1)
hypothesis has been##3##3##(1994-2#1)(1994-3#1)(2013-1#1)
hypothesis has##8##2##(1994-2#2)(1994-3#1)(1997-7#1)(2008-8#2)(2013-1#2)
hypothesis in the##2##3##(1990-8#1)(2008-3#1)
hypothesis in vivo##2##3##(2008-5#1)(2008-7#1)
hypothesis in##9##2##(1990-8#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#1)
hypothesis is that the##2##4##(1995-5#1)(2008-10#1)
hypothesis is that##11##3##(1992-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
hypothesis is##20##2##(1992-11#1)(1992-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
hypothesis of a role##2##4##(2007-12#1)(2008-10#1)
hypothesis of a specific##2##4##(1993-5#1)(1995-9#1)
hypothesis of a##15##3##(1991-12#1)(1991-2#1)(1991-5#1)(1993-5#1)(1994-11#1)(1995-9#1)(1997-5#1)(2007-12#1)(2008-10#5)(2009-10#1)(2013-1#1)
hypothesis of an##5##3##(1994-3#1)(2008-10#2)(2011-2#2)
hypothesis of random mating##3##4##(2008-10#3)
hypothesis of the##3##3##(1991-12#1)(1997-3#1)(2008-6#1)
hypothesis of##58##2##(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-5#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
hypothesis on the##3##3##(1993-12#1)(2008-12#1)(2010-1#1)
hypothesis on##4##2##(1991-9#1)(1993-12#1)(2008-12#1)(2010-1#1)
hypothesis or##3##2##(2008-8#2)(2012-3#1)
hypothesis predicts that##5##3##(2008-11#1)(2008-9#2)(2012-3#1)(2013-8#1)
hypothesis predicts##6##2##(2008-11#2)(2008-9#2)(2012-3#1)(2013-8#1)
hypothesis proposed##2##2##(1990-11#1)(2008-9#1)
hypothesis proposes##2##2##(2009-2#1)(2012-3#1)
hypothesis suggesting a##2##3##(2007-12#1)(2008-3#1)
hypothesis suggests that the##2##4##(2008-10#1)(2008-11#1)
hypothesis suggests that##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-1#1)
hypothesis tested##3##2##(1995-3#1)(1997-3#1)(2013-1#1)
hypothesis testing and##3##3##(1997-8#1)(2008-10#2)
hypothesis testing in##2##3##(1994-9#1)(1995-5#1)
hypothesis testing##9##2##(1994-9#1)(1995-5#2)(1995-9#1)(1997-8#1)(2008-10#2)(2010-11#1)(2011-2#1)
hypothesis tests##2##2##(1994-9#1)(2008-10#1)
hypothesis that a##14##3##(1990-5#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-8#2)(2009-5#1)(2012-1#1)(2013-8#1)
hypothesis that an##4##3##(1990-5#1)(1995-5#1)(2008-10#1)(2008-11#1)
hypothesis that insulin##2##3##(2008-10#1)(2008-3#1)
hypothesis that low##2##3##(2011-2#1)(2013-1#1)
hypothesis that populations##2##3##(2008-10#2)
hypothesis that the##63##3##(1990-6#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-7#1)(2010-1#2)(2010-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
hypothesis that there are##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
hypothesis that there##7##3##(1996-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)
hypothesis that two##2##3##(2008-5#1)(2009-10#1)
hypothesis that##298##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#2)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#8)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#3)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#46)(2008-11#7)(2008-12#2)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#15)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#3)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#4)
hypothesis to##3##2##(1997-2#1)(2009-6#1)(2012-3#1)
hypothesis using##3##2##(2008-8#1)(2009-8#1)(2011-2#1)
hypothesis was confirmed##2##3##(2008-10#1)(2008-7#1)
hypothesis was tested by##2##4##(1997-7#1)(2008-11#1)
hypothesis was tested using##2##4##(2008-9#1)(2013-1#1)
hypothesis was tested##7##3##(1994-8#1)(1996-3#1)(1997-7#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)
hypothesis was that##7##3##(2008-8#2)(2009-11#1)(2009-8#1)(2011-1#2)(2012-12#1)
hypothesis was##23##2##(1994-8#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#2)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
hypothesis we##3##2##(1992-8#1)(2008-1#1)(2009-8#1)
hypothesis which##2##2##(1992-3#1)(2009-8#1)
hypothesis##671##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#4)(1991-1#2)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#6)(1992-9#3)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#5)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#5)(1994-3#7)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-11#2)(1995-12#6)(1995-2#10)(1995-3#2)(1995-5#10)(1995-6#2)(1995-8#2)(1995-9#4)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#3)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#3)(1997-7#6)(1997-8#2)(1997-9#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-12#12)(2007-8#1)(2008-1#7)(2008-10#93)(2008-11#23)(2008-12#9)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#17)(2008-6#5)(2008-7#23)(2008-8#52)(2008-9#29)(2009-10#6)(2009-11#8)(2009-12#4)(2009-2#6)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#8)(2009-9#10)(2010-1#4)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#9)(2012-3#12)(2012-5#2)(2012-7#1)(2013-1#24)(2013-7#4)(2013-8#10)
hypothesis&quot##8##1##(2007-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2013-1#1)
hypothesis)##2##1##(2007-10#1)(2008-8#1)
hypothesis-driven##2##1##(2008-7#1)(2010-11#1)
hypothesised as a##2##3##(2008-7#1)(2009-4#1)
hypothesised that##4##2##(1990-6#1)(2006-6#1)(2010-12#1)(2011-10#1)
hypothesised##9##1##(1990-6#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-10#1)(2011-2#1)
hypothesize that an##2##3##(2008-11#1)(2008-4#1)
hypothesize that the##11##3##(1991-9#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-6#1)(1997-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#2)
hypothesize that##47##2##(1991-9#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#2)(2009-8#3)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
hypothesize##51##1##(1991-9#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
hypothesized dual##2##2##(2008-12#2)
hypothesized that a##3##3##(1990-2#1)(1995-5#1)(2007-7#1)
hypothesized that in##2##3##(2009-11#1)(2009-9#1)
hypothesized that the##23##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
hypothesized that they##2##3##(1992-2#1)(1992-8#1)
hypothesized that this##11##3##(1995-11#1)(2008-10#1)(2008-5#2)(2008-8#2)(2009-1#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
hypothesized that##93##2##(1990-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)
hypothesized to be a##2##4##(1995-3#1)(2010-3#1)
hypothesized to be##13##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#1)
hypothesized to protect##2##3##(1997-2#1)(2008-10#1)
hypothesized to##28##2##(1992-3#1)(1993-12#2)(1994-12#1)(1995-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#2)
hypothesized##149##1##(1990-2#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#4)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#2)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#21)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#10)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#8)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-7#2)
hypothesizing that##2##2##(2008-7#1)(2012-1#1)
hypothetical and##2##2##(1997-3#1)(2008-10#1)
hypothetical genes registered in databases##3##5##(1996-12#2)(1996-6#1)
hypothetical genes##5##2##(1995-8#1)(1996-12#2)(1996-6#2)
hypothetical model of##3##3##(2007-11#1)(2008-12#1)(2008-9#1)
hypothetical model##5##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
hypothetical situations##2##2##(1996-3#1)(2008-12#1)
hypothetical##72##1##(1990-11#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#4)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#3)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)
hypothetically##3##1##(1991-12#1)(2008-10#1)(2013-1#1)
hypothyroid rats##2##2##(1994-6#2)
hypothyroid##9##1##(1994-6#3)(1996-5#4)(2007-8#1)(2008-4#1)
hypothyroidism and##7##2##(1991-8#1)(1996-8#1)(2007-7#1)(2008-4#1)(2011-1#1)(2013-1#2)
hypothyroidism by##3##2##(1994-6#1)(2011-1#1)(2011-2#1)
hypothyroidism in infants##2##3##(1990-9#1)(2011-1#1)
hypothyroidism in##5##2##(1990-9#1)(2008-11#1)(2008-4#1)(2011-1#2)
hypothyroidism is##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
hypothyroidism##65##1##(1990-2#1)(1990-9#1)(1991-2#1)(1991-8#2)(1993-9#1)(1994-6#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-11#2)(2008-4#4)(2008-6#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#18)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#6)
hypotonia##2##1##(1993-3#1)(2013-8#1)
hypotonic hemolysis##2##2##(1990-11#1)(1993-8#1)
hypotonic solution##2##2##(1990-2#1)(2008-9#1)
hypotonic##14##1##(1990-11#1)(1990-2#5)(1992-11#1)(1992-9#1)(1993-11#1)(1993-8#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-3#1)
hypotrophic##2##1##(1993-3#2)
hypotrophy in##2##2##(1996-5#1)(2012-3#1)
hypotrophy##3##1##(1996-5#2)(2012-3#1)
hypovirulence by##2##2##(2008-9#2)
hypovirulence factor##2##2##(2008-10#2)
hypovirulence has##2##2##(2008-10#2)
hypovirulence in##3##2##(2008-10#2)(2008-9#1)
hypovirulence##14##1##(2008-10#11)(2008-9#3)
hypovirulence-associated double-stranded RNA (dsRNA)##2##4##(2008-10#2)
hypovirulence-associated##3##1##(2008-10#3)
hypovirulent isolate Sh12B significantly reduced##2##5##(2008-10#2)
hypovirulent isolate Sh12B##7##3##(2008-10#7)
hypovirulent isolate##11##2##(2008-10#11)
hypovirulent isolates Sh12B##2##3##(2008-10#2)
hypovirulent isolates of Sclerotinia homoeocarpa##2##5##(2008-10#2)
hypovirulent isolates##8##2##(2008-10#8)
hypovirulent phenotype were##2##3##(2008-10#2)
hypovirulent phenotype##5##2##(2008-10#5)
hypovirulent strains##5##2##(2008-10#5)
hypovirulent##38##1##(2008-10#37)(2008-9#1)
hypovirus##11##1##(2008-10#11)
hypovirus-infected##3##1##(2008-10#3)
hypovolaemia##2##1##(1995-12#2)
hypovolaemic##2##1##(1995-12#1)(2011-2#1)
hypovolemia##3##1##(1992-4#1)(1995-11#1)(2009-6#1)
hypoxaemia##3##1##(1992-11#1)(2007-8#1)(2008-10#1)
hypoxanthine (HX)##2##2##(1990-5#1)(2008-11#1)
hypoxanthine and##2##2##(1993-12#2)
hypoxanthine##19##1##(1990-5#2)(1991-9#1)(1993-12#4)(1994-5#2)(1994-8#2)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#2)(2010-12#1)(2011-1#1)
hypoxemia and##6##2##(1990-11#1)(2009-5#1)(2010-5#1)(2012-2#2)(2013-7#1)
hypoxemia in##3##2##(2012-2#3)
hypoxemia##28##1##(1990-11#1)(1990-3#1)(1991-9#2)(1993-11#1)(2006-10#1)(2008-1#4)(2009-5#1)(2010-5#1)(2010-8#1)(2012-2#13)(2013-1#1)(2013-7#1)
hypoxia and the##4##3##(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
hypoxia and##15##2##(1990-7#2)(1994-2#2)(1995-5#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
hypoxia are##2##2##(2010-11#1)(2012-2#1)
hypoxia exposure##3##2##(2010-4#2)(2010-8#1)
hypoxia in##8##2##(1990-7#2)(1993-6#1)(1994-5#1)(1995-12#1)(1996-12#1)(2010-11#1)(2013-1#1)
hypoxia inducible##2##2##(2011-2#1)(2013-8#1)
hypoxia is##4##2##(1993-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
hypoxia leads to##2##3##(1993-12#1)(2010-11#1)
hypoxia on neuronal##2##3##(1990-7#1)(1996-12#1)
hypoxia on the##3##3##(1993-12#2)(2013-1#1)
hypoxia on##10##2##(1990-12#1)(1990-7#1)(1993-12#2)(1994-5#1)(1996-12#1)(2010-12#3)(2013-1#1)
hypoxia through##2##2##(1990-3#1)(2013-1#1)
hypoxia tolerance and##2##3##(2013-1#2)
hypoxia tolerance##5##2##(2012-2#1)(2013-1#4)
hypoxia with##3##2##(1990-7#1)(1995-12#1)(2012-2#1)
hypoxia##131##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#9)(1990-8#1)(1991-2#2)(1992-2#1)(1992-9#1)(1993-12#7)(1993-6#2)(1994-2#8)(1994-5#9)(1995-12#4)(1995-5#1)(1996-12#6)(1996-6#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-11#8)(2010-12#3)(2010-4#11)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#8)(2013-1#15)(2013-8#1)
hypoxia-induced##5##1##(2008-1#1)(2013-1#4)
hypoxia-inducible##2##1##(2010-7#1)(2013-1#1)
hypoxia-ischemia##3##1##(1996-5#3)
hypoxia-selective cytotoxin##2##2##(1995-3#2)
hypoxia-selective##3##1##(1995-3#3)
hypoxia-sensitive##2##1##(2013-1#2)
hypoxia-tolerant##2##1##(2013-1#2)
hypoxia/reoxygenation##4##1##(2008-11#4)
hypoxic and##3##2##(1993-12#1)(2008-4#1)(2010-9#1)
hypoxic cells##4##2##(1995-3#2)(2010-7#1)(2011-2#1)
hypoxic conditions##2##2##(1994-5#1)(2008-11#1)
hypoxic hearts##3##2##(1993-6#1)(1994-5#2)
hypoxic or##2##2##(2008-7#1)(2011-2#1)
hypoxic regions##3##2##(2008-11#1)(2010-7#1)(2013-1#1)
hypoxic stress##2##2##(2010-11#1)(2010-7#1)
hypoxic tumor cells##2##3##(1995-3#1)(2010-7#1)
hypoxic water was##2##3##(2010-8#2)
hypoxic water##3##2##(2010-8#3)
hypoxic##51##1##(1990-5#2)(1992-2#2)(1992-9#1)(1993-12#5)(1993-6#3)(1994-5#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-2#3)(2013-1#3)(2013-8#1)
hypoxic-ischemic brain damage##3##3##(1996-12#1)(1996-5#2)
hypoxic-ischemic brain##4##2##(1996-12#1)(1996-5#3)
hypoxic-ischemic encephalopathy##2##2##(2008-11#2)
hypoxic-ischemic##10##1##(1996-12#2)(1996-5#4)(2008-11#2)(2010-7#1)(2013-1#1)
hypoxylon##2##1##(2008-9#2)
hypsochromic##3##1##(1997-7#1)(2008-10#2)
hypusine##3##1##(1994-3#3)
hysterectomies performed##3##2##(1992-5#1)(1993-12#2)
hysterectomies were##2##2##(1995-12#1)(2011-2#1)
hysterectomies##19##1##(1992-5#1)(1993-12#4)(1995-1#8)(1995-12#1)(1996-2#2)(1996-9#2)(2011-2#1)
hysterectomy and bilateral##2##3##(2010-12#1)(2013-1#1)
hysterectomy and##11##2##(1993-12#2)(1994-2#2)(1995-12#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#2)
hysterectomy for stage##2##3##(2007-10#1)(2013-1#1)
hysterectomy for##4##2##(1991-11#1)(1994-2#1)(2007-10#1)(2013-1#1)
hysterectomy group##3##2##(2011-2#3)
hysterectomy in the##2##3##(1993-12#1)(1996-2#1)
hysterectomy in##5##2##(1993-12#2)(1995-12#1)(1996-2#1)(2011-1#1)
hysterectomy is##6##2##(1991-12#1)(1991-3#1)(1993-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
hysterectomy or##2##2##(1994-2#1)(2012-3#1)
hysterectomy to##2##2##(1993-12#1)(2008-8#1)
hysterectomy was performed##2##3##(1994-2#1)(1995-12#1)
hysterectomy was##4##2##(1994-2#2)(1995-12#1)(1996-2#1)
hysterectomy with##9##2##(1993-2#1)(1994-2#2)(1995-1#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
hysterectomy##126##1##(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#5)(1992-12#1)(1993-12#13)(1993-2#4)(1993-3#4)(1994-1#1)(1994-12#2)(1994-2#19)(1994-9#1)(1995-1#3)(1995-12#9)(1995-3#3)(1996-1#3)(1996-2#7)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-3#13)(2011-1#2)(2011-2#11)(2012-3#3)(2013-1#8)(2013-8#1)
hysteresis in the power-tuning curve of a single-mode continuous-wave##2##9##(2008-2#2)
hysteresis in##3##2##(2008-2#2)(2008-7#1)
hysteresis##18##1##(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#2)(2009-9#1)(2011-1#1)(2012-2#1)
hysterosalpingography##2##1##(1991-3#1)(2011-2#1)
hysteroscope##7##1##(1991-12#1)(1991-2#3)(1992-1#1)(1996-1#2)
hysteroscopic endometrial resection##2##3##(1996-2#2)
hysteroscopic endometrial##3##2##(1996-2#3)
hysteroscopic examination under##2##3##(1992-12#2)
hysteroscopic metroplasty##2##2##(1994-9#2)
hysteroscopic removal##2##2##(1991-2#2)
hysteroscopic surgery##2##2##(1996-2#2)
hysteroscopic##17##1##(1991-2#3)(1992-1#2)(1992-12#2)(1994-2#1)(1994-9#4)(1996-2#5)
hysteroscopies##2##1##(1991-12#1)(1993-12#1)
hysteroscopy in##2##2##(1993-12#1)(1996-2#1)
hysteroscopy under local anesthesia##2##4##(1992-12#2)
hysteroscopy##14##1##(1991-11#1)(1991-12#2)(1992-12#4)(1993-12#3)(1993-2#1)(1994-9#2)(1996-2#1)
hysterotomy##3##1##(2008-12#1)(2011-2#2)
hystopathology##2##1##(2008-10#1)(2013-8#1)
i = 1##2##3##(2008-10#1)(2008-2#1)
i =##4##2##(1995-11#2)(2008-10#1)(2008-2#1)
i##905##1##(1990-10#1)(1990-11#5)(1990-12#7)(1990-2#8)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#7)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#3)(1991-6#5)(1991-8#5)(1992-10#1)(1992-11#3)(1992-12#11)(1992-2#5)(1992-3#28)(1992-5#4)(1992-8#8)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#1)(1993-5#3)(1993-6#7)(1993-8#8)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#9)(1994-3#2)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#3)(1995-11#9)(1995-12#32)(1995-2#4)(1995-3#9)(1995-5#9)(1995-6#3)(1996-11#2)(1996-12#7)(1996-2#19)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#18)(1997-3#6)(1997-4#12)(1997-6#7)(1997-7#11)(1997-8#1)(1997-9#1)(2007-11#25)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#13)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#174)(2008-11#29)(2008-12#16)(2008-2#17)(2008-3#35)(2008-4#8)(2008-5#33)(2008-6#5)(2008-7#26)(2008-8#11)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#1)(2010-12#1)(2010-3#5)(2010-5#3)(2010-7#7)(2010-8#4)(2011-1#10)(2011-10#1)(2011-2#21)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#5)
i) a##2##2##(2011-2#1)(2012-2#1)
i) the##2##2##(1997-4#1)(2009-8#1)
i)##19##1##(1993-5#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
i)perylene and##2##2##(2008-10#2)
i-VAS##2##1##(2009-3#2)
iGenomicViewer##3##1##(2011-3#3)
iHPlg was converted to##2##4##(1993-8#2)
iHPlg##5##1##(1993-8#5)
iHPlm##2##1##(1993-8#2)
iNK T cells##3##3##(2010-5#3)
iNOS activity##3##2##(1993-3#3)
iNOS and##6##2##(1996-12#1)(2008-10#3)(2008-9#1)(2011-2#1)
iNOS expression##6##2##(1995-12#1)(1996-12#3)(2008-7#1)(2008-9#1)
iNOS gene expression##3##3##(2011-2#3)
iNOS gene##4##2##(2011-2#4)
iNOS induction by##2##3##(1993-8#1)(1996-12#1)
iNOS mRNA expression##3##3##(1993-8#1)(1995-12#1)(2008-9#1)
iNOS mRNA##6##2##(1993-8#3)(1995-12#2)(2008-9#1)
iNOS##33##1##(1993-3#3)(1993-8#4)(1995-12#3)(1996-12#5)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2011-1#1)(2011-2#5)
iPLA2beta##2##1##(2008-8#2)
iPod device##2##2##(2012-12#2)
iPod##5##1##(2012-12#5)
iProXpress##2##1##(2008-7#2)
iR drop##2##2##(2008-10#2)
iSEC6 strains##2##2##(2009-2#2)
iSEC6##3##1##(2009-2#3)
iTFA##4##1##(2012-2#4)
iView-GT##3##1##(2009-11#3)
iaaM##4##1##(2008-10#4)
iatrogenic cause##2##2##(2007-8#1)(2008-12#1)
iatrogenic causes##2##2##(1996-3#1)(2012-12#1)
iatrogenic complications##6##2##(1993-10#1)(1996-3#4)(2007-9#1)
iatrogenic femoral##2##2##(2008-7#2)
iatrogenic foreign body in the airway##2##6##(2008-12#2)
iatrogenic illness##2##2##(1996-3#2)
iatrogenic nerve##2##2##(2008-9#1)(2012-2#1)
iatrogenic problems##2##2##(1996-3#1)(2008-3#1)
iatrogenic##54##1##(1990-3#1)(1990-9#1)(1991-6#1)(1993-1#1)(1993-10#1)(1995-11#2)(1995-8#1)(1996-3#11)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-3#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
ibandronic acid##5##2##(2011-2#4)(2013-8#1)
ibo##3##1##(1991-9#3)
ibogaine-induced##2##1##(1997-2#2)
ibotenate lesions##2##2##(1992-10#2)
ibotenate##3##1##(1992-10#3)
ibotenic acid lesions of the nucleus##2##6##(1994-3#1)(1995-12#1)
ibotenic acid lesions of the##3##5##(1993-12#1)(1994-3#1)(1995-12#1)
ibotenic acid lesions of##4##4##(1993-12#1)(1993-6#1)(1994-3#1)(1995-12#1)
ibotenic acid lesions##6##3##(1993-12#2)(1993-6#2)(1994-3#1)(1995-12#1)
ibotenic acid nucleus##2##3##(1991-9#1)(1993-6#1)
ibotenic acid##14##2##(1990-5#2)(1991-9#1)(1993-12#2)(1993-3#1)(1993-6#4)(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#1)
ibotenic acid-induced##2##2##(2008-10#2)
ibotenic##19##1##(1990-5#2)(1991-9#2)(1992-10#1)(1992-11#1)(1993-12#2)(1993-3#1)(1993-6#4)(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#3)
ibuprofen and chlorzoxazone in formulations##2##5##(2008-10#2)
ibuprofen and chlorzoxazone##3##3##(2008-10#3)
ibuprofen and##5##2##(1995-11#1)(2008-10#3)(2012-12#1)
ibuprofen in##10##2##(1997-3#1)(2008-10#7)(2012-12#2)
ibuprofen sodium##2##2##(2010-5#2)
ibuprofen suppository##2##2##(2012-12#2)
ibuprofen syrup##2##2##(2012-12#2)
ibuprofen##45##1##(1990-12#1)(1991-3#2)(1994-8#1)(1995-11#1)(1997-3#1)(1997-5#1)(2008-10#17)(2008-11#3)(2010-5#2)(2011-2#2)(2012-12#14)
icEEG data##3##2##(2013-8#3)
ice clouds##5##2##(2008-2#2)(2008-3#3)
ice core samples##2##3##(2008-10#2)
ice core##3##2##(2008-10#3)
ice cream##5##2##(2011-2#5)
ice crystal clouds##2##3##(2008-2#1)(2008-3#1)
ice crystal size##2##3##(2008-2#1)(2008-3#1)
ice crystal##9##2##(2008-2#3)(2008-3#6)
ice crystals and##2##3##(2008-2#2)
ice crystals in##2##3##(2008-3#2)
ice crystals of##2##3##(2007-12#1)(2008-3#1)
ice crystals that##2##3##(2007-11#1)(2008-3#1)
ice crystals##26##2##(1990-12#1)(2007-11#3)(2007-12#1)(2008-2#9)(2008-3#12)
ice films##2##2##(2008-3#2)
ice in the##3##3##(2008-3#3)
ice nucleation activity##4##3##(2008-10#4)
ice nucleation and antifreeze activities##2##5##(2008-10#2)
ice nucleation temperature##2##3##(2008-10#1)(2009-2#1)
ice nucleation##9##2##(2008-10#8)(2009-2#1)
ice particles##4##2##(2008-2#2)(2008-3#2)
ice spheres##2##2##(2008-3#2)
ice spheroids with##2##3##(2008-3#2)
ice storm##11##2##(2008-2#10)(2008-9#1)
ice##122##1##(1990-12#1)(1992-1#1)(1993-6#1)(1995-12#1)(1995-2#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#33)(2008-3#49)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#5)
ice-creams and##2##2##(2012-2#2)
ice-like water##7##2##(2008-5#7)
ice-like##8##1##(2008-5#8)
ice-nucleation##2##1##(2008-10#2)
ice-originated supercritical##2##2##(2008-10#2)
ice-particle##3##1##(2008-2#3)
ice-water##2##1##(1990-5#1)(2011-2#1)
iceberg##3##1##(1994-2#1)(2008-10#1)(2008-5#1)
icepick-like##2##1##(1992-2#2)
ichneumonids##3##1##(2008-5#3)
ichthyosiform sarcoidosis##2##2##(2007-7#2)
ichthyosiform##4##1##(2007-7#2)(2010-6#2)
ichthyosis with##2##2##(2007-7#2)
ichthyosis##4##1##(2007-7#3)(2010-6#1)
icicles##2##1##(2008-2#2)
iconic gestures##2##2##(2010-5#2)
iconic##5##1##(2008-4#1)(2010-5#4)
icons##2##1##(2008-6#1)(2008-8#1)
icosahedral capsid##2##2##(2008-4#1)(2008-8#1)
icosahedral virus##2##2##(1995-2#1)(2008-8#1)
icosahedral##9##1##(1995-2#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#4)
ictal##2##1##(2009-9#1)(2010-8#1)
icterus##3##1##(1992-6#1)(1993-3#1)(2012-3#1)
ictus to##2##2##(2007-10#1)(2012-3#1)
ictus##4##1##(2007-10#2)(2008-7#1)(2012-3#1)
id##2##1##(1990-2#1)(1991-1#1)
idarubicin##2##1##(2007-4#1)(2008-5#1)
idazoxan##3##1##(1995-12#1)(1997-4#2)
idea about the##2##3##(2008-1#1)(2008-10#1)
idea about##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
idea and##2##2##(2012-3#1)(2013-8#1)
idea by##3##2##(2007-11#1)(2009-5#1)(2012-2#1)
idea for##2##2##(2008-2#1)(2008-3#1)
idea has##2##2##(2011-1#1)(2013-1#1)
idea is that##2##3##(2011-2#1)(2013-8#1)
idea is to##5##3##(1997-2#1)(2008-2#1)(2009-8#1)(2010-5#2)
idea is##9##2##(1995-6#1)(1997-2#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-2#1)(2013-8#1)
idea of a##8##3##(1994-12#2)(2008-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
idea of the##7##3##(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2010-11#1)
idea of using##2##3##(2007-11#1)(2007-12#1)
idea of##41##2##(1992-11#1)(1994-12#2)(1995-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
idea that the##11##3##(1990-10#1)(1990-5#1)(1993-12#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)
idea that##60##2##(1990-10#1)(1990-11#2)(1990-5#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#3)
idea was##2##2##(2008-10#2)
idea##153##1##(1990-10#1)(1990-11#2)(1990-5#2)(1991-2#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#6)(2013-8#5)
ideal and##6##2##(2007-9#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-10#1)(2013-1#1)
ideal body weight##2##3##(2008-11#1)(2008-12#1)
ideal body##3##2##(2007-12#1)(2008-11#1)(2008-12#1)
ideal bone##2##2##(2007-12#1)(2010-6#1)
ideal candidate##4##2##(1991-9#1)(2008-7#1)(2009-2#1)(2012-2#1)
ideal complex-valued filter##2##3##(2008-2#2)
ideal conditions##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
ideal data##2##2##(2008-4#2)
ideal estimate of the object to be reconstructed##2##8##(2008-3#2)
ideal estimate##3##2##(2008-3#3)
ideal extraction##2##2##(2008-10#2)
ideal for the##2##3##(1992-12#1)(2008-7#1)
ideal for use in##2##4##(1992-3#1)(2008-7#1)
ideal for use##3##3##(1992-3#1)(2008-7#1)(2012-2#1)
ideal for##27##2##(1992-12#1)(1992-3#2)(2007-12#3)(2008-1#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#2)(2012-2#1)
ideal framework for##2##3##(1996-1#1)(2013-1#1)
ideal framework##3##2##(1996-1#1)(2008-7#1)(2013-1#1)
ideal glass##2##2##(1995-3#1)(2008-3#1)
ideal injection##2##2##(2008-10#1)(2008-3#1)
ideal of##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
ideal performance##2##2##(2008-2#2)
ideal research##2##2##(2010-6#1)(2011-2#1)
ideal surgical##2##2##(2007-8#2)
ideal target##2##2##(2008-1#1)(2012-2#1)
ideal time##2##2##(2007-2#1)(2012-7#1)
ideal##226##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#3)(1993-11#1)(1993-12#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#3)(1997-4#3)(2007-11#3)(2007-12#13)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#5)(2008-2#15)(2008-3#26)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#3)
ideal&quot##4##1##(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
ideal-observer performance##3##2##(2008-3#3)
idealised##2##1##(2007-12#2)
ideality##4##1##(1992-4#1)(2008-10#2)(2008-4#1)
idealized commercials##2##2##(2007-12#2)
idealized##9##1##(2007-12#3)(2008-3#4)(2008-9#1)(2012-2#1)
ideally be##2##2##(2008-10#1)(2009-10#1)
ideally placed to##2##3##(2007-10#1)(2008-11#1)
ideally placed##3##2##(2007-10#1)(2008-11#1)(2010-5#1)
ideally suited for##5##3##(1990-12#1)(1993-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
ideally suited to the##2##4##(1990-9#1)(2008-3#1)
ideally suited to##6##3##(1990-9#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)
ideally suited##13##2##(1990-12#1)(1990-8#1)(1990-9#1)(1993-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2012-2#1)(2012-3#1)
ideally##32##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1993-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-4#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
ideals##8##1##(1995-1#1)(1995-2#1)(2007-12#4)(2009-12#1)(2010-7#1)
ideas about how##2##3##(2012-1#1)(2013-1#1)
ideas about##3##2##(1996-1#1)(2012-1#1)(2013-1#1)
ideas and approaches##2##3##(1997-2#1)(2008-11#1)
ideas and##16##2##(1990-8#1)(1991-1#1)(1992-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2012-2#1)(2012-3#1)
ideas are##2##2##(1997-3#1)(2008-3#1)
ideas as##2##2##(1991-1#1)(2012-2#1)
ideas behind##2##2##(2008-4#1)(2008-6#1)
ideas concerning##2##2##(2008-8#1)(2010-1#1)
ideas for##4##2##(1991-3#1)(1992-2#1)(1996-6#1)(2011-1#1)
ideas have##5##2##(1993-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
ideas in the##2##3##(2009-10#1)(2011-3#1)
ideas in##5##2##(2008-3#1)(2009-10#1)(2011-3#1)(2012-12#1)(2012-3#1)
ideas of##4##2##(2008-12#2)(2010-12#1)(2012-1#1)
ideas on the##4##3##(1993-6#1)(2008-10#1)(2009-10#1)(2012-2#1)
ideas on##8##2##(1993-6#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#1)
ideas that##4##2##(2008-11#1)(2008-12#1)(2009-3#1)(2012-2#1)
ideas to improve##2##3##(2008-1#1)(2013-8#1)
ideas to##6##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
ideas with##3##2##(1995-3#1)(2008-10#1)(2008-8#1)
ideas##112##1##(1990-11#1)(1990-8#1)(1991-1#3)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-1#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#9)(2008-12#6)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#3)(2009-3#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#4)
ideation and##6##2##(1996-3#1)(2010-6#1)(2010-8#1)(2013-1#3)
ideation##20##1##(1992-1#2)(1996-3#1)(2008-11#2)(2008-4#1)(2010-6#3)(2010-8#4)(2011-1#1)(2012-1#1)(2013-1#5)
identical aggregates##2##2##(2008-3#2)
identical amino acid##4##3##(1994-9#2)(2008-4#1)(2010-11#1)
identical amino##5##2##(1991-12#1)(1994-9#2)(2008-4#1)(2010-11#1)
identical and##10##2##(1993-11#1)(1995-6#1)(1995-9#2)(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
identical at the amino acid##2##5##(1992-12#1)(1993-6#1)
identical at the##5##3##(1991-6#1)(1992-12#1)(1993-6#2)(1994-11#1)
identical at##8##2##(1991-6#1)(1992-12#1)(1993-6#2)(1994-11#1)(2008-10#1)(2008-11#2)
identical clones##2##2##(2008-5#1)(2008-8#1)
identical coding##3##2##(1992-8#1)(1993-8#1)(1997-7#1)
identical conditions##9##2##(1990-5#1)(1991-12#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#2)(2010-7#1)(2011-1#1)
identical copies of a##2##4##(2008-3#1)(2008-7#1)
identical culture##2##2##(1994-11#1)(2008-11#1)
identical except for##3##3##(1990-8#1)(2008-11#1)(2008-2#1)
identical expression##2##2##(1994-8#1)(2008-7#1)
identical for##8##2##(1997-2#1)(2006-4#1)(2008-10#5)(2008-3#1)
identical haplotypes##2##2##(2008-10#2)
identical in both cases##2##4##(1990-5#1)(2008-7#1)
identical in both##3##3##(1990-3#1)(1990-5#1)(2008-7#1)
identical in sequence to##2##4##(1994-11#1)(1994-12#1)
identical in sequence##3##3##(1994-11#1)(1994-12#1)(2008-10#1)
identical in size##2##3##(1992-9#1)(2008-10#1)
identical in these##2##3##(2008-11#1)(2010-12#1)
identical in##22##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-11#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
identical laser##2##2##(2008-2#1)(2008-3#1)
identical molecules##2##2##(1990-2#1)(2008-4#1)
identical nucleotide sequences##2##3##(2008-10#1)(2013-1#1)
identical nucleotide##3##2##(1993-6#1)(2008-10#1)(2013-1#1)
identical or similar to##3##4##(1996-12#2)(1996-6#1)
identical or very similar##2##4##(2008-10#2)
identical or##9##2##(1991-9#1)(1995-3#1)(1996-12#2)(1996-6#1)(2008-10#4)
identical overall##2##2##(2008-11#1)(2008-5#1)
identical position##2##2##(1995-6#2)
identical results##3##2##(2008-3#1)(2008-7#1)(2009-6#1)
identical sequence##4##2##(1995-8#1)(1997-4#1)(1997-7#1)(2007-12#1)
identical sequences and##2##3##(1993-8#1)(2008-10#1)
identical sequences##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
identical spheres##3##2##(2008-2#3)
identical strain##2##2##(2008-7#1)(2012-3#1)
identical to a##4##3##(1991-5#1)(1993-6#1)(1996-8#1)(2013-1#1)
identical to each other##3##4##(1993-11#1)(2008-10#1)(2010-5#1)
identical to human##2##3##(1991-2#1)(1993-2#1)
identical to that in the##2##5##(1991-5#1)(2008-10#1)
identical to that in##5##4##(1991-11#1)(1991-5#1)(1995-11#1)(2008-10#2)
identical to that observed##2##4##(1997-3#1)(2008-10#1)
identical to that obtained from##2##5##(1993-12#1)(2007-11#1)
identical to that of a##2##5##(1996-12#1)(2008-10#1)
identical to that of the##11##5##(1990-12#1)(1990-5#2)(1990-8#1)(1992-3#1)(1992-8#1)(1994-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)
identical to that of##29##4##(1990-11#1)(1990-12#3)(1990-5#3)(1990-8#1)(1992-3#1)(1992-8#3)(1993-11#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-8#1)
identical to that##44##3##(1990-11#1)(1990-12#3)(1990-5#3)(1990-8#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#1)
identical to the corresponding##2##4##(1991-2#1)(1991-6#1)
identical to the extracellular##2##4##(1991-6#1)(2008-4#1)
identical to the one##2##4##(2009-11#1)(2010-2#1)
identical to the previously##2##4##(1992-10#1)(2008-10#1)
identical to the recently##2##4##(1993-9#1)(2008-6#1)
identical to the sequence##2##4##(1993-6#1)(2008-12#1)
identical to the##55##3##(1990-11#1)(1990-2#1)(1990-7#2)(1991-2#2)(1991-6#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#3)(1995-9#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#1)(2012-2#3)
identical to their##2##3##(2008-10#1)(2012-2#1)
identical to those in the##2##5##(1990-8#1)(2008-3#1)
identical to those in##4##4##(1990-8#1)(1992-11#1)(2008-3#1)(2008-9#1)
identical to those observed##3##4##(1992-12#1)(2008-10#1)(2009-2#1)
identical to those obtained##3##4##(1992-3#1)(2008-10#2)
identical to those of the##2##5##(1995-2#2)
identical to those of##11##4##(1992-6#1)(1993-1#1)(1995-2#2)(1995-6#1)(2007-5#1)(2008-10#4)(2008-7#1)
identical to those recently##2##4##(1993-3#1)(1996-12#1)
identical to those##32##3##(1990-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-10#11)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-7#1)
identical to##182##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#4)(1990-7#3)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#6)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#5)(1995-9#4)(1996-12#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(1997-9#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-7#1)(2012-2#4)(2013-1#2)
identical twin##3##2##(2007-7#1)(2011-1#2)
identical with that of##3##4##(1990-7#1)(1991-12#1)(1996-5#1)
identical with that##8##3##(1990-7#2)(1991-12#1)(1991-2#2)(1993-3#1)(1995-3#1)(1996-5#1)
identical with the##3##3##(1991-8#1)(2006-10#1)(2008-10#1)
identical with those of##3##4##(1992-11#1)(1997-7#1)(2008-10#1)
identical with those##4##3##(1992-11#1)(1997-7#1)(2008-10#2)
identical with##29##2##(1990-5#1)(1990-7#3)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#7)(2013-1#1)
identical##561##1##(1990-11#4)(1990-12#7)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#12)(1990-7#7)(1990-8#6)(1991-11#1)(1991-12#6)(1991-2#5)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#4)(1992-10#2)(1992-11#5)(1992-12#6)(1992-2#2)(1992-3#7)(1992-6#5)(1992-8#10)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#11)(1993-8#9)(1993-9#2)(1994-11#7)(1994-12#11)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#6)(1995-11#4)(1995-12#2)(1995-2#10)(1995-3#4)(1995-5#1)(1995-6#9)(1995-8#2)(1995-9#6)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#1)(1997-2#7)(1997-3#5)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#4)(1997-9#4)(2006-10#1)(2006-4#1)(2007-11#9)(2007-12#7)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#114)(2008-11#15)(2008-12#4)(2008-2#11)(2008-3#24)(2008-4#8)(2008-5#9)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#10)
identical) and##2##2##(1995-6#2)
identical)##4##1##(1991-7#1)(1993-9#1)(1995-6#2)
identical-chain##2##1##(1990-7#2)
identically with##2##2##(1990-2#1)(1992-8#1)
identically##12##1##(1990-2#1)(1992-8#1)(1993-8#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
identifiability and##2##2##(1995-9#1)(2008-11#1)
identifiability##3##1##(1995-9#1)(2008-11#1)(2011-1#1)
identifiable by##2##2##(2007-12#1)(2008-9#1)
identifiable cause##4##2##(2007-10#2)(2007-7#1)(2011-2#1)
identifiable disabilities##2##2##(1995-1#2)
identifiable in##2##2##(2007-10#1)(2008-7#1)
identifiable using##2##2##(2008-3#1)(2010-6#1)
identifiable##36##1##(1990-8#1)(1991-12#1)(1991-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#2)
identification among##2##2##(2008-9#1)(2011-1#1)
identification and analysis of##2##4##(2008-9#1)(2009-10#1)
identification and characterization of a##2##5##(1994-12#1)(2008-5#1)
identification and characterization of##7##4##(1994-12#1)(1997-1#1)(2008-10#1)(2008-4#3)(2008-5#1)
identification and characterization##8##3##(1994-12#1)(1997-1#1)(2008-10#1)(2008-4#3)(2008-5#2)
identification and classification of##2##4##(2008-10#1)(2008-9#1)
identification and classification##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)
identification and communication of##2##4##(2008-11#1)(2008-9#1)
identification and detection##2##3##(2008-10#1)(2008-9#1)
identification and determination of##5##4##(1992-11#1)(1995-2#1)(2008-10#2)(2009-8#1)
identification and determination##6##3##(1992-11#1)(1995-2#1)(2008-10#2)(2009-8#1)(2013-1#1)
identification and differentiation of phytoplasmas##2##5##(2008-10#2)
identification and differentiation of##4##4##(2007-7#1)(2008-10#3)
identification and enumeration of##4##4##(2008-10#1)(2008-9#3)
identification and follow-up##2##3##(1996-3#2)
identification and isolation of##2##4##(1995-12#1)(2008-8#1)
identification and management of##2##4##(1991-3#1)(2008-10#1)
identification and management##3##3##(1991-3#1)(2008-10#1)(2009-4#1)
identification and modification of##3##4##(2008-2#1)(2010-6#1)(2013-8#1)
identification and preservation of##2##4##(2010-8#1)(2011-2#1)
identification and quantification of##9##4##(2008-10#5)(2008-5#1)(2008-9#2)(2013-8#1)
identification and quantification##13##3##(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-7#1)(2013-8#1)
identification and quantitation of##3##4##(1994-12#1)(2008-10#2)
identification and quantitation##4##3##(1994-12#1)(2008-10#3)
identification and quantitative analysis of##2##5##(2008-10#2)
identification and quantitative determination##3##4##(2008-5#3)
identification and quantitative##6##3##(2008-10#2)(2008-5#4)
identification and structural##2##3##(2008-4#1)(2008-7#1)
identification and the##2##3##(1994-9#1)(2008-10#1)
identification and##139##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-12#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-1#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#11)(2008-7#4)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-4#3)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#4)(2013-8#5)
identification are presented##3##3##(2008-10#2)(2008-2#1)
identification are##4##2##(1994-9#1)(2008-10#2)(2008-2#1)
identification assay##2##2##(2008-10#1)(2008-7#1)
identification before##2##2##(2008-4#1)(2010-3#1)
identification by the##3##3##(1995-6#1)(2008-12#1)(2010-5#1)
identification by##12##2##(1990-2#1)(1991-12#1)(1993-8#1)(1995-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-9#1)(2010-5#1)
identification for the##2##3##(2008-10#1)(2008-11#1)
identification for##3##2##(2008-10#2)(2008-11#1)
identification from##2##2##(2010-2#1)(2012-12#1)
identification has been##2##3##(1995-3#1)(2008-10#1)
identification has##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
identification have##2##2##(1993-12#1)(2008-10#1)
identification in##14##2##(1995-6#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-2#1)
identification is presented##2##3##(2008-6#1)(2013-7#1)
identification is##8##2##(1995-6#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
identification may##2##2##(2008-10#1)(2008-12#1)
identification method##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
identification methods##2##2##(2008-5#1)(2011-1#1)
identification of QTL##2##3##(2008-10#1)(2012-3#1)
identification of a human##2##4##(1991-9#1)(1993-9#1)
identification of a mutation##2##4##(1997-7#1)(2013-1#1)
identification of a new##4##4##(1991-12#1)(2008-10#1)(2010-9#1)(2012-3#1)
identification of a novel##4##4##(2008-10#1)(2009-6#1)(2009-8#1)(2012-2#1)
identification of a unique##2##4##(1995-11#1)(2008-10#1)
identification of a##53##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-7#3)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
identification of all##4##3##(1993-12#1)(2008-9#1)(2011-3#1)(2012-2#1)
identification of an##5##3##(2008-10#3)(2009-11#1)(2012-2#1)
identification of bacteria##2##3##(2008-10#1)(2010-12#1)
identification of children##2##3##(1990-12#1)(2008-11#1)
identification of clinical##2##3##(1995-12#1)(2013-1#1)
identification of critical##3##3##(1997-7#1)(2009-10#1)(2011-1#1)
identification of different##3##3##(1993-1#1)(1997-2#1)(2008-2#1)
identification of each##2##3##(2008-10#1)(2008-5#1)
identification of female##2##3##(2008-12#1)(2011-2#1)
identification of four##3##3##(1991-5#1)(2007-7#1)(2008-10#1)
identification of functional##5##3##(1990-5#1)(1992-12#1)(2008-7#3)
identification of gene##4##3##(2008-1#1)(2008-9#1)(2011-2#2)
identification of genes##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#2)
identification of genetic##2##3##(2011-3#1)(2012-2#1)
identification of individuals at##2##4##(2008-2#1)(2011-2#1)
identification of insect##2##3##(1997-4#1)(2008-10#1)
identification of major##2##3##(1995-2#1)(2013-8#1)
identification of multiple##4##3##(2008-10#3)(2008-7#1)
identification of mutations##3##3##(1997-3#1)(2008-1#1)(2008-7#1)
identification of new drug##3##4##(2008-7#1)(2010-12#2)
identification of new##11##3##(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
identification of nitrogen compounds in crude oil##2##7##(2008-10#2)
identification of patients at higher risk##2##6##(2007-11#1)(2010-10#1)
identification of patients at risk##4##5##(1992-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
identification of patients at##7##4##(1992-12#2)(2007-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2012-2#1)
identification of patients with##4##4##(1990-3#1)(2007-10#1)(2008-9#1)(2010-10#1)
identification of patients##13##3##(1990-3#1)(1992-12#2)(2007-10#1)(2007-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#2)(2012-2#1)
identification of persons##2##3##(2008-10#1)(2012-3#1)
identification of potential##7##3##(1991-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-8#1)
identification of proteins##4##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
identification of risk factors##2##4##(2011-2#1)(2013-1#1)
identification of single##2##3##(2007-11#1)(2007-3#1)
identification of some##2##3##(2008-10#2)
identification of species##3##3##(2008-10#3)
identification of specific##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
identification of students##2##3##(2008-12#1)(2012-3#1)
identification of subjects##2##3##(1991-6#1)(2008-3#1)
identification of such##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
identification of susceptible##2##3##(1997-1#1)(2008-8#1)
identification of the causal##2##4##(2008-10#2)
identification of the causative agent##2##5##(2008-8#1)(2011-2#1)
identification of the characteristic##2##4##(2008-10#1)(2011-2#1)
identification of the products##2##4##(1995-3#1)(2008-10#1)
identification of the three##4##4##(1990-7#1)(1995-6#1)(2008-10#2)
identification of the##94##3##(1990-12#2)(1990-2#1)(1990-7#1)(1993-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-9#1)(1996-2#3)(1997-3#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
identification of their##2##3##(2008-2#1)(2009-10#1)
identification of these##5##3##(1993-12#1)(1993-6#1)(2008-10#1)(2009-6#1)(2012-2#1)
identification of this##5##3##(1996-12#1)(2009-10#1)(2009-2#1)(2010-12#1)(2012-12#1)
identification of those##3##3##(1992-10#1)(2007-10#1)(2013-8#1)
identification of three##4##3##(1995-2#1)(1997-4#1)(2008-11#1)(2009-4#1)
identification of two new##4##4##(1993-6#1)(2008-10#2)(2008-11#1)
identification of two##12##3##(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-9#1)(2008-10#4)(2008-11#2)(2011-2#1)
identification of unknown##3##3##(1995-2#2)(2011-2#1)
identification of yeasts##3##3##(2008-5#3)
identification of##631##2##(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#6)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#4)(1997-7#5)(1997-8#2)(2006-10#1)(2007-10#8)(2007-11#6)(2007-12#2)(2007-3#1)(2007-7#8)(2007-8#1)(2008-1#5)(2008-10#133)(2008-11#19)(2008-12#8)(2008-2#6)(2008-3#11)(2008-4#18)(2008-5#17)(2008-6#4)(2008-7#34)(2008-8#15)(2008-9#22)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#4)(2009-5#5)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#1)(2010-9#4)(2011-1#8)(2011-2#28)(2011-3#4)(2012-1#3)(2012-12#4)(2012-2#23)(2012-3#16)(2013-1#13)(2013-7#1)(2013-8#15)
identification problems##3##2##(2007-9#2)(2008-2#1)
identification process##2##2##(2008-12#1)(2009-6#1)
identification protocol##4##2##(2007-7#3)(2008-10#1)
identification rate of##3##3##(1997-3#1)(1997-4#1)(2013-8#1)
identification rate##5##2##(1997-3#1)(1997-4#1)(2013-8#3)
identification system##3##2##(1993-12#1)(2009-4#1)(2011-2#1)
identification tasks##3##2##(2008-2#1)(2010-7#1)(2013-8#1)
identification tests in##2##3##(2008-9#2)
identification the##2##2##(2007-8#1)(2010-11#1)
identification to##3##2##(2008-5#2)(2010-8#1)
identification using the##2##3##(1993-2#1)(2008-12#1)
identification using##7##2##(1993-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
identification was##4##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-5#1)
identification with the##5##3##(1991-6#1)(1992-6#1)(1996-4#1)(2008-10#1)(2010-8#1)
identification with##7##2##(1991-6#1)(1992-6#2)(1996-4#1)(2008-10#2)(2010-8#1)
identification##1022##1##(1990-11#5)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#3)(1990-8#3)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#13)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#5)(1997-6#1)(1997-7#7)(1997-8#2)(2006-10#1)(2007-10#8)(2007-11#6)(2007-12#3)(2007-3#1)(2007-7#15)(2007-8#3)(2007-9#2)(2008-1#9)(2008-10#215)(2008-11#30)(2008-12#29)(2008-2#14)(2008-3#15)(2008-4#31)(2008-5#41)(2008-6#9)(2008-7#46)(2008-8#18)(2008-9#49)(2009-10#9)(2009-11#5)(2009-12#3)(2009-2#3)(2009-4#6)(2009-5#5)(2009-6#10)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#13)(2010-2#4)(2010-3#5)(2010-4#8)(2010-5#5)(2010-6#6)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#13)(2011-2#41)(2011-3#6)(2012-1#6)(2012-12#7)(2012-2#27)(2012-3#20)(2013-1#20)(2013-7#2)(2013-8#31)
identifications of##4##2##(2008-10#3)(2008-4#1)
identifications were made##2##3##(1995-11#1)(2008-10#1)
identifications were##3##2##(1995-11#1)(2008-10#2)
identifications##15##1##(1995-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-2#2)
identified 11##2##2##(2008-10#1)(2008-6#1)
identified 12##2##2##(2011-2#1)(2012-3#1)
identified 2##2##2##(2008-5#1)(2011-2#1)
identified 24##3##2##(2007-7#1)(2008-10#1)(2010-12#1)
identified 33##2##2##(2009-10#1)(2013-1#1)
identified 45##2##2##(2008-10#1)(2012-2#1)
identified a RAPD marker##2##4##(2008-10#1)(2008-9#1)
identified a gene##2##3##(1995-9#1)(2008-2#1)
identified a new##2##3##(1996-12#1)(1997-7#1)
identified a novel##5##3##(1990-5#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)
identified a number of##5##4##(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-1#1)
identified a possible##2##3##(1992-8#1)(2008-10#1)
identified a region##5##3##(1993-8#1)(1994-9#1)(2008-11#1)(2010-3#2)
identified a single##5##3##(1990-8#1)(1993-2#1)(1995-6#1)(2008-10#2)
identified a total of##2##4##(2008-1#1)(2010-12#1)
identified a##98##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#5)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
identified according to the##2##4##(2008-6#1)(2008-7#1)
identified according to##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
identified across##2##2##(2008-10#1)(2009-9#1)
identified additional##2##2##(1995-1#1)(2008-9#1)
identified all##5##2##(1993-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
identified among##19##2##(1991-8#1)(2008-1#1)(2008-10#14)(2012-2#1)(2013-8#2)
identified an open reading frame##2##5##(1995-8#1)(1997-2#1)
identified an##10##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2010-11#1)
identified and analyzed##3##3##(1990-12#1)(1997-1#1)(2008-10#1)
identified and assessed##2##3##(1994-1#1)(2008-10#1)
identified and characterized in the##2##5##(2007-12#1)(2008-7#1)
identified and characterized##12##3##(1991-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)
identified and cloned##3##3##(1993-6#1)(1994-12#1)(2008-9#1)
identified and described by##2##4##(1993-11#1)(1993-6#1)
identified and described##3##3##(1993-11#1)(1993-6#1)(2007-11#1)
identified and designated##2##3##(2008-10#1)(2008-9#1)
identified and discussed##2##3##(2007-11#1)(2013-1#1)
identified and isolated##3##3##(1995-12#1)(1995-2#1)(1997-2#1)
identified and prioritized##3##3##(1996-1#1)(2013-8#2)
identified and provided##2##3##(1996-1#1)(2012-3#1)
identified and quantified in##2##4##(2008-3#1)(2013-8#1)
identified and quantified##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2013-8#1)
identified and removed##2##3##(2007-8#1)(2008-2#1)
identified and sequenced##2##3##(1990-8#1)(2013-1#1)
identified and shown to be##2##5##(1991-8#1)(2008-10#1)
identified and shown to##3##4##(1991-8#1)(2006-8#1)(2008-10#1)
identified and the##4##3##(1993-3#1)(1995-12#1)(2011-1#1)(2013-1#1)
identified and their##4##3##(1991-4#1)(2008-10#1)(2009-6#1)(2010-11#1)
identified and##115##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-2#2)(1993-11#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-12#3)(1995-2#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#2)(1997-2#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#22)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#8)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-12#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#3)
identified another##2##2##(1994-8#1)(1995-2#1)
identified are##5##2##(1990-12#1)(1990-7#1)(2008-10#1)(2009-5#1)(2012-2#1)
identified areas of##2##3##(2008-3#1)(2011-2#1)
identified as &quot##2##3##(2008-8#1)(2011-2#1)
identified as Alternaria##2##3##(2008-10#2)
identified as Bacillus##2##3##(2008-10#1)(2013-1#1)
identified as C##6##3##(2008-10#3)(2008-5#1)(2010-3#2)
identified as P##5##3##(2008-10#4)(2008-8#1)
identified as Pseudomonas##3##3##(2008-10#2)(2012-2#1)
identified as R##2##3##(1995-12#1)(2008-10#1)
identified as a component of##2##5##(1990-8#1)(2013-1#1)
identified as a major##3##4##(1991-2#1)(2008-11#1)(2012-1#1)
identified as a potential##2##4##(1995-6#1)(2008-11#1)
identified as a##73##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#12)
identified as actin##2##3##(1993-3#2)
identified as an important##3##4##(1994-12#1)(2008-10#1)(2012-2#1)
identified as an##16##3##(1990-12#1)(1991-3#1)(1991-9#1)(1993-5#1)(1994-12#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
identified as being the most##2##5##(1995-5#1)(2011-2#1)
identified as being##8##3##(1991-12#1)(1991-2#1)(1993-6#1)(1995-5#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-7#1)
identified as belonging to the##2##5##(2008-10#2)
identified as candidate##2##3##(1997-2#1)(2008-2#1)
identified as components of##2##4##(1994-5#1)(2008-5#1)
identified as encoding##2##3##(1991-9#1)(1996-10#1)
identified as having##6##3##(2008-12#1)(2008-3#3)(2008-9#1)(2012-12#1)
identified as important in##3##4##(1996-3#1)(2008-11#1)(2012-3#1)
identified as important##6##3##(1996-3#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-2#1)(2012-3#1)
identified as key##5##3##(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
identified as linked to##2##4##(2008-10#1)(2008-5#1)
identified as one of the##2##5##(1997-2#1)(2008-10#1)
identified as one##3##3##(1997-2#1)(2008-10#2)
identified as potential##4##3##(2008-10#2)(2009-6#1)(2010-4#1)
identified as salt tolerant##3##4##(2008-12#3)
identified as such##2##3##(1994-11#1)(2007-12#1)
identified as targets for##2##4##(2012-2#1)(2012-3#1)
identified as the cause of##2##5##(1994-12#1)(2011-2#1)
identified as the first##2##4##(1997-7#1)(2010-3#1)
identified as the major##4##4##(1994-1#1)(1994-11#1)(1994-9#1)(1997-3#1)
identified as the target##2##4##(1994-12#1)(2012-2#1)
identified as the##49##3##(1990-8#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
identified as two##2##3##(2008-10#1)(2013-1#1)
identified as well##2##3##(1996-3#1)(2008-10#1)
identified as##378##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-8#3)(1993-1#1)(1993-11#6)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#8)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#87)(2008-11#17)(2008-12#9)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#15)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#2)(2009-6#3)(2009-8#2)(2010-10#1)(2010-12#3)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#12)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#17)
identified at least nine##2##4##(2008-10#1)(2011-1#1)
identified at least##4##3##(1996-10#1)(2008-10#2)(2011-1#1)
identified at the molecular level##2##5##(2008-9#2)
identified at the species level##2##5##(2008-10#1)(2011-2#1)
identified at the##6##3##(1992-12#1)(2008-10#1)(2008-9#2)(2011-2#2)
identified at##22##2##(1990-8#1)(1992-12#1)(1993-3#1)(1996-10#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)
identified barriers##4##2##(2008-11#3)(2011-1#1)
identified based on##6##3##(1997-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
identified based##8##2##(1997-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)
identified between##9##2##(2007-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
identified binding##2##2##(1990-11#1)(1993-3#1)
identified both##3##2##(1990-12#1)(2012-2#2)
identified by AFLP##2##3##(2008-10#2)
identified by GC-MS in##2##4##(1991-5#1)(1992-5#1)
identified by GC-MS##4##3##(1991-5#1)(1992-5#1)(2008-10#2)
identified by MS##2##3##(2009-6#1)(2010-12#1)
identified by PCR##2##3##(2008-10#1)(2011-1#1)
identified by a##8##3##(1995-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)
identified by amino acid##2##4##(1990-8#1)(1995-6#1)
identified by an##2##3##(2008-11#1)(2010-8#1)
identified by chromatography##2##3##(1992-3#1)(2008-10#1)
identified by its##4##3##(1992-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
identified by means of##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
identified by microarray##2##3##(2008-10#1)(2013-8#1)
identified by patients##2##3##(2011-2#1)(2012-1#1)
identified by restriction##3##3##(1993-6#1)(2008-10#2)
identified by sequencing##2##3##(1993-12#1)(1993-3#1)
identified by the##29##3##(1990-12#1)(1992-1#1)(1992-2#1)(1992-5#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
identified by their##7##3##(1996-12#1)(2008-10#3)(2008-11#2)(2008-6#1)
identified by using##5##3##(1992-3#1)(2008-10#1)(2008-12#2)(2013-8#1)
identified by##207##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#46)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#9)
identified cells from the median domain in the##2##8##(2007-12#2)
identified cells##3##2##(2007-12#3)
identified chronic##2##2##(2010-10#1)(2010-3#1)
identified compounds##2##2##(2008-10#2)
identified correctly##2##2##(2007-2#1)(2011-1#1)
identified critical##2##2##(1997-8#1)(2012-2#1)
identified early##4##2##(2007-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
identified either##2##2##(1993-9#1)(2008-10#1)
identified explicitly##2##2##(1996-2#1)(2011-2#1)
identified factors##2##2##(2007-10#1)(2013-8#1)
identified five genes##2##3##(2008-10#1)(2008-7#1)
identified five##8##2##(1993-12#1)(1997-4#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
identified for the##9##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
identified for##32##2##(1991-12#2)(1991-9#1)(1994-12#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-3#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
identified four genes##2##3##(2008-7#1)(2012-3#1)
identified four##15##2##(1992-1#1)(1993-11#1)(1994-11#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-3#1)(2012-3#3)(2013-1#1)(2013-7#1)
identified from a##3##3##(1994-12#1)(2008-10#1)(2008-6#1)
identified from the##14##3##(1993-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-10#7)(2008-11#1)(2011-1#1)(2013-8#1)
identified from##50##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-12#3)(1995-12#1)(1996-12#1)(2008-10#16)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-8#1)
identified gene##6##2##(1993-6#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)
identified genes##10##2##(1996-3#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)
identified genetic##3##2##(2008-10#1)(2011-2#2)
identified here##3##2##(1995-12#1)(1995-2#1)(2013-1#1)
identified important##2##2##(2008-7#1)(2013-1#1)
identified in 2##2##3##(2008-10#1)(2008-11#1)
identified in a patient##3##4##(1995-6#1)(2012-3#2)
identified in a##19##3##(1990-11#1)(1990-6#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2012-3#2)
identified in an##3##3##(2008-10#2)(2008-9#1)
identified in association with##2##4##(2008-10#1)(2011-1#1)
identified in both##2##3##(1994-8#1)(2008-1#1)
identified in each##2##3##(1996-12#1)(2007-12#1)
identified in exon##2##3##(1990-5#1)(1993-3#1)
identified in human##4##3##(1991-11#1)(1992-12#1)(2010-7#1)(2012-12#1)
identified in humans and##2##4##(1994-8#1)(2008-7#1)
identified in humans##3##3##(1994-8#1)(2008-7#1)(2010-7#1)
identified in many##2##3##(1996-2#1)(2008-11#1)
identified in other##4##3##(1992-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
identified in our##2##3##(1993-9#1)(2010-11#1)
identified in porcine brain##2##4##(1990-7#2)
identified in rat##3##3##(1990-12#1)(1991-11#1)(1994-8#1)
identified in several##2##3##(1997-1#1)(2008-8#1)
identified in some##2##3##(1991-12#1)(2008-10#1)
identified in the 5'-flanking region##2##5##(1991-6#1)(1991-7#1)
identified in the proximal##2##4##(1991-5#1)(1991-7#1)
identified in the region##2##4##(2008-10#1)(2011-2#1)
identified in the same##2##4##(1995-12#1)(1997-4#1)
identified in the##69##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
identified in this study may##2##5##(2008-10#1)(2010-12#1)
identified in this study##8##4##(2007-5#1)(2008-10#4)(2008-8#1)(2010-11#1)(2010-12#1)
identified in this##15##3##(1991-9#1)(1997-7#2)(2007-5#1)(2008-10#5)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)
identified in three##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
identified in which##3##3##(2007-11#1)(2007-12#1)(2012-1#1)
identified in##257##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#4)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#67)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#10)(2012-2#1)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#3)
identified include##3##2##(1991-12#1)(2008-8#1)(2012-2#1)
identified including##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
identified individual##2##2##(2008-5#1)(2010-8#1)
identified iron##2##2##(2008-5#1)(2011-2#1)
identified it##2##2##(1991-2#1)(2010-2#1)
identified key##3##2##(2008-9#1)(2009-11#1)(2013-1#1)
identified more##4##2##(1994-12#2)(2008-5#1)(2012-2#1)
identified morphologically##2##2##(2008-10#1)(2008-4#1)
identified mutations##2##2##(2008-1#1)(2012-2#1)
identified needs##2##2##(1991-12#1)(1992-3#1)
identified neuron of##2##3##(1990-7#1)(1991-5#1)
identified neuron##4##2##(1990-7#2)(1991-5#1)(2008-8#1)
identified novel##2##2##(2011-1#1)(2011-2#1)
identified on chromosomes 1##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
identified on chromosomes##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
identified on the basis of##3##5##(1993-11#1)(1993-9#1)(2009-4#1)
identified on the##8##3##(1993-11#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-4#1)
identified on these##2##3##(1995-8#1)(1996-3#1)
identified on##31##2##(1990-11#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2012-12#1)
identified one##4##2##(1990-5#1)(1994-6#1)(2012-12#1)(2012-3#1)
identified only in##2##3##(2008-10#1)(2010-11#1)
identified only##5##2##(1997-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)
identified polymorphisms between##2##3##(2008-10#2)
identified potential##5##2##(1993-9#1)(1995-3#1)(2008-10#1)(2010-3#1)(2011-2#1)
identified previously in the##2##4##(1993-9#1)(2008-10#1)
identified previously##5##2##(1991-12#2)(1993-9#1)(1995-2#1)(2008-10#1)
identified proteins##6##2##(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)
identified recently##2##2##(1994-8#1)(2011-2#1)
identified regions of##2##3##(1995-2#1)(2009-9#1)
identified regions##5##2##(1992-8#1)(1995-2#1)(2008-1#1)(2009-6#1)(2009-9#1)
identified residues at the NS2(Pro) dimer interface that##2##8##(2012-2#2)
identified residues##3##2##(2008-10#1)(2012-2#2)
identified risk factors for##2##4##(2007-10#1)(2012-3#1)
identified risk factors##3##3##(2007-10#1)(2009-5#1)(2012-3#1)
identified seven##2##2##(2008-10#1)(2008-8#1)
identified several##7##2##(1994-9#1)(2008-10#2)(2008-2#1)(2012-3#1)(2013-1#2)
identified signatures##2##2##(2008-7#2)
identified significant##3##2##(1991-3#1)(1995-1#1)(1997-3#1)
identified sites on##2##3##(1997-5#1)(2008-8#1)
identified six##7##2##(1992-3#1)(1993-2#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
identified so far##4##3##(1991-12#1)(2008-10#1)(2009-5#1)(2009-8#1)
identified some##3##2##(1990-12#1)(2008-7#1)(2011-2#1)
identified specific##4##2##(1990-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
identified targets##2##2##(2009-5#1)(2013-7#1)
identified that are##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
identified that were##2##3##(2008-10#2)
identified that##37##2##(1992-5#1)(1995-12#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
identified the causal##2##3##(2008-10#2)
identified the major##2##3##(1992-12#1)(2008-10#1)
identified the need for a##2##5##(2008-10#1)(2008-11#1)
identified the need##3##3##(2008-10#1)(2008-11#2)
identified the presence of##2##4##(2007-2#1)(2008-10#1)
identified the target##2##3##(2007-8#1)(2008-10#1)
identified the##80##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
identified them as##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
identified them##4##2##(1993-12#2)(2008-10#1)(2008-7#1)
identified themselves as##2##3##(1993-3#1)(2010-2#1)
identified this##2##2##(1992-3#1)(1996-2#1)
identified three major##2##3##(1993-11#1)(1993-8#1)
identified three##10##2##(1990-11#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-12#1)(1996-5#1)(2007-10#1)(2008-10#1)(2012-12#1)(2012-3#1)
identified through a##3##3##(2007-11#1)(2008-3#1)(2010-2#1)
identified through the##5##3##(1995-12#1)(1996-3#1)(1997-5#1)(2008-5#1)(2008-9#1)
identified through##24##2##(1992-1#1)(1995-12#1)(1996-3#1)(1997-5#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-2#1)(2012-12#3)(2013-1#1)
identified thus far in##2##4##(2008-10#2)
identified to be a##2##4##(1996-7#1)(2012-3#1)
identified to be##9##3##(1990-12#1)(1993-8#2)(1996-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
identified to date##4##3##(1992-12#1)(1992-3#1)(1995-8#1)(2008-4#1)
identified to enhance##2##3##(2007-12#1)(2008-3#1)
identified to have##2##3##(1991-12#1)(2013-8#1)
identified to##39##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-8#2)(1995-8#1)(1996-10#1)(1996-7#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
identified transcription factors##2##3##(2012-3#2)
identified two##16##2##(1990-11#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-3#1)(2008-10#3)(2008-8#1)(2012-3#3)
identified under##2##2##(2008-3#1)(2008-5#1)
identified upon##2##2##(1990-12#1)(2010-11#1)
identified using conventional##2##3##(2008-7#1)(2011-2#1)
identified using the##10##3##(1995-2#1)(1997-4#1)(2007-7#1)(2007-8#5)(2008-10#2)
identified using##37##2##(1990-5#1)(1993-12#1)(1994-12#1)(1995-2#1)(1997-4#1)(2007-7#1)(2007-8#5)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-8#2)(2011-2#1)(2012-3#2)
identified via##2##2##(1997-4#1)(2013-1#1)
identified was##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
identified were##13##2##(2007-11#1)(2008-10#5)(2008-11#3)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
identified which##8##2##(1991-9#1)(1994-11#1)(1995-2#1)(1996-6#1)(2008-11#2)(2008-7#1)(2009-7#1)
identified who##2##2##(2008-12#1)(2008-9#1)
identified with a##6##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
identified with an##2##3##(2009-8#1)(2012-2#1)
identified with any##2##3##(1990-7#1)(2008-7#1)
identified with the##3##3##(1997-9#1)(2008-10#2)
identified with##41##2##(1990-7#1)(1991-11#1)(1992-3#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)
identified within the##11##3##(1995-8#1)(1996-3#1)(2008-10#4)(2008-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
identified within##16##2##(1995-8#1)(1996-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
identified##2572##1##(1990-11#15)(1990-12#16)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#13)(1990-6#2)(1990-7#10)(1990-8#12)(1991-1#4)(1991-10#1)(1991-11#4)(1991-12#26)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#12)(1991-6#7)(1991-7#4)(1991-8#9)(1991-9#11)(1992-1#7)(1992-11#3)(1992-12#11)(1992-2#7)(1992-3#12)(1992-5#5)(1992-6#11)(1992-7#1)(1992-8#12)(1992-9#4)(1993-1#2)(1993-11#12)(1993-12#13)(1993-2#6)(1993-3#16)(1993-5#2)(1993-6#23)(1993-8#15)(1993-9#7)(1994-1#2)(1994-11#15)(1994-12#22)(1994-2#9)(1994-3#9)(1994-5#3)(1994-6#10)(1994-8#15)(1994-9#7)(1995-1#4)(1995-11#6)(1995-12#23)(1995-2#23)(1995-3#8)(1995-4#1)(1995-5#13)(1995-6#23)(1995-8#16)(1995-9#5)(1996-1#8)(1996-10#8)(1996-11#3)(1996-12#22)(1996-2#16)(1996-3#11)(1996-4#2)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#15)(1997-3#18)(1997-4#16)(1997-5#5)(1997-6#9)(1997-7#12)(1997-8#7)(1997-9#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#18)(2007-11#18)(2007-12#37)(2007-2#5)(2007-4#1)(2007-5#3)(2007-7#11)(2007-8#12)(2007-9#1)(2008-1#16)(2008-10#546)(2008-11#94)(2008-12#44)(2008-2#21)(2008-3#36)(2008-4#28)(2008-5#64)(2008-6#28)(2008-7#78)(2008-8#42)(2008-9#57)(2009-1#2)(2009-10#22)(2009-11#3)(2009-12#6)(2009-2#3)(2009-3#6)(2009-4#6)(2009-5#15)(2009-6#16)(2009-7#5)(2009-8#21)(2009-9#5)(2010-1#3)(2010-10#10)(2010-11#16)(2010-12#15)(2010-2#9)(2010-3#18)(2010-4#11)(2010-5#13)(2010-6#4)(2010-7#7)(2010-8#13)(2010-9#1)(2011-1#34)(2011-2#86)(2011-3#4)(2012-1#8)(2012-12#54)(2012-2#57)(2012-3#60)(2012-5#2)(2013-1#78)(2013-7#11)(2013-8#56)
identifier##3##1##(1992-11#2)(2008-4#1)
identifiers##3##1##(1995-12#1)(2008-10#1)(2008-4#1)
identifies a novel##2##3##(1992-3#1)(1994-6#1)
identifies a##9##2##(1990-5#1)(1992-3#2)(1994-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
identifies an##2##2##(1991-11#1)(2008-8#1)
identifies many##2##2##(1996-1#1)(2012-3#1)
identifies potential##2##2##(2008-11#1)(2008-4#1)
identifies some of the##2##4##(1991-2#1)(2011-2#1)
identifies some##5##2##(1991-2#1)(1996-1#1)(2010-7#1)(2011-2#2)
identifies the differentiation of the chromosomes based on##2##8##(2008-1#2)
identifies the##25##2##(1990-12#1)(1993-2#2)(1994-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#3)
identifies two##2##2##(1993-1#1)(2008-12#1)
identifies##92##1##(1990-12#2)(1990-5#1)(1991-11#1)(1991-2#1)(1992-3#2)(1993-1#1)(1993-2#3)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-10#1)(2007-12#1)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#5)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#2)(2013-8#4)
identify &quot##4##2##(1995-1#1)(2008-10#1)(2010-8#1)(2012-3#1)
identify a group of##2##4##(1991-12#1)(2007-12#1)
identify a novel##2##3##(2008-6#1)(2012-2#1)
identify a set of##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
identify a##42##2##(1990-10#1)(1990-11#2)(1990-12#1)(1991-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
identify all the##2##3##(2008-10#1)(2010-3#1)
identify all##5##2##(2008-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
identify an##6##2##(1991-9#1)(1997-8#1)(2008-3#1)(2008-7#1)(2010-11#1)(2013-8#1)
identify and characterize the##3##4##(1995-2#1)(2008-10#1)(2008-12#1)
identify and characterize##6##3##(1995-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2009-3#1)
identify and develop##2##3##(2008-10#1)(2013-1#1)
identify and differentiate##3##3##(2008-10#3)
identify and distinguish##2##3##(1993-12#1)(2006-4#1)
identify and implement##2##3##(2007-12#1)(2008-9#1)
identify and investigate##2##3##(2009-6#1)(2010-11#1)
identify and quantify##6##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
identify and##84##2##(1991-12#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
identify any##7##2##(1995-1#1)(1995-12#1)(2008-5#2)(2008-9#1)(2011-1#1)(2012-4#1)
identify apoptotic##3##2##(2008-7#2)(2008-9#1)
identify areas for practice change##2##5##(2008-11#2)
identify areas##6##2##(2007-10#1)(2008-11#3)(2008-12#1)(2013-8#1)
identify as##6##2##(1990-11#1)(1991-3#1)(2008-12#4)
identify at-risk##2##2##(1997-1#1)(2008-11#1)
identify barriers to##2##3##(1997-1#1)(2013-1#1)
identify brain regions##2##3##(2009-2#1)(2012-12#1)
identify candidate##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
identify cases##3##2##(2009-10#1)(2010-3#1)(2012-12#1)
identify cells##4##2##(2008-4#1)(2008-9#2)(2011-1#1)
identify challenges##2##2##(2011-2#1)(2012-3#1)
identify combinations##2##2##(2009-12#1)(2012-3#1)
identify conditions##2##2##(2008-3#1)(2012-12#1)
identify conserved##2##2##(1995-2#1)(2008-4#1)
identify different##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
identify differentially expressed##3##3##(2008-2#1)(2008-8#1)(2010-12#1)
identify environmental##3##2##(1991-1#1)(2008-8#2)
identify factors contributing##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
identify factors that influence##4##4##(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
identify factors that##10##3##(1994-12#1)(2007-10#2)(2008-11#1)(2008-9#1)(2013-1#3)(2013-8#2)
identify factors##23##2##(1994-12#1)(2007-10#2)(2008-11#3)(2008-12#2)(2008-9#1)(2009-4#1)(2010-11#1)(2011-1#2)(2012-12#1)(2013-1#5)(2013-8#4)
identify four##2##2##(2008-10#1)(2008-6#1)
identify functional##2##2##(2009-10#1)(2009-8#1)
identify gene products##2##3##(1996-3#1)(2008-4#1)
identify genes involved in##2##4##(2008-9#1)(2010-1#1)
identify genes##18##2##(1991-5#1)(1992-9#1)(1994-9#1)(1995-11#1)(2008-10#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-3#2)
identify health##3##2##(1996-1#2)(2008-11#1)
identify how##3##2##(2006-5#1)(2007-10#1)(2011-1#1)
identify important##7##2##(1992-3#1)(1993-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)
identify in##3##2##(1997-1#1)(2008-10#1)(2013-7#1)
identify incident##2##2##(1997-3#2)
identify individuals##4##2##(1990-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
identify it##2##2##(2008-10#1)(2011-1#1)
identify its##3##2##(1996-7#1)(2008-8#1)(2013-8#1)
identify key##6##2##(1993-2#1)(1994-1#1)(2007-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
identify latent##2##2##(2008-10#1)(2010-4#1)
identify mutations##2##2##(2008-4#1)(2011-3#1)
identify newly##2##2##(2007-12#1)(2010-3#1)
identify novel targets for##2##4##(1997-6#1)(2008-8#1)
identify novel targets##3##3##(1997-6#1)(2008-8#1)(2010-6#1)
identify novel##10##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
identify older##2##2##(2010-10#1)(2011-1#1)
identify one##2##2##(1994-9#1)(2008-9#1)
identify opportunities for##4##3##(1995-12#1)(1996-3#1)(1997-1#1)(2008-11#1)
identify patients at##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
identify patients who##3##3##(2009-4#1)(2010-5#1)(2012-12#1)
identify patients##15##2##(1992-11#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
identify plant##2##2##(2008-10#1)(2009-10#1)
identify possible##5##2##(2008-10#1)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
identify potential##18##2##(1990-8#1)(1993-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)
identify predictors of##7##3##(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)
identify problems and##2##3##(1993-3#1)(2009-5#1)
identify problems##3##2##(1993-2#1)(1993-3#1)(2009-5#1)
identify protein##2##2##(1993-3#1)(2010-11#1)
identify proteins##3##2##(1992-8#1)(2008-7#1)(2008-9#1)
identify regions##2##2##(1993-11#1)(2007-12#1)
identify relationships between##2##3##(2008-10#1)(2013-7#1)
identify rodent and human cell##2##5##(1997-7#1)(2008-11#1)
identify several##2##2##(2011-3#1)(2012-2#1)
identify sex##2##2##(2009-2#1)(2010-3#1)
identify significant##4##2##(2008-8#2)(2010-2#1)(2012-3#1)
identify similar##3##2##(2007-11#1)(2008-4#1)(2012-2#1)
identify six##2##2##(2008-10#1)(2012-2#1)
identify some of the##3##4##(1991-1#1)(2009-3#1)(2013-8#1)
identify some##7##2##(1991-1#1)(1991-2#1)(2008-10#2)(2009-3#1)(2012-2#1)(2013-8#1)
identify specific##15##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)
identify strategies for##3##3##(1993-12#1)(1993-2#1)(2008-4#1)
identify strategies to##2##3##(2008-11#1)(2012-3#1)
identify strategies##5##2##(1993-12#1)(1993-2#1)(2008-11#1)(2008-4#1)(2012-3#1)
identify subjects##2##2##(2010-6#1)(2010-9#1)
identify targets for##2##3##(2008-11#1)(2012-2#1)
identify targets##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
identify the available##2##3##(2012-12#1)(2012-3#1)
identify the best##3##3##(1993-12#1)(1995-2#1)(2008-8#1)
identify the characteristics of##3##4##(1994-7#1)(2008-11#1)(2011-2#1)
identify the early stage of##2##5##(1990-6#1)(1997-8#1)
identify the exact##2##3##(1995-2#1)(2008-7#1)
identify the functional##3##3##(1996-2#1)(2008-7#1)(2009-5#1)
identify the gene##4##3##(1995-6#1)(2008-10#1)(2008-9#1)(2011-3#1)
identify the key factors##2##4##(2008-11#1)(2008-6#1)
identify the key##6##3##(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#3)
identify the main##6##3##(2008-10#3)(2008-2#1)(2009-10#1)(2012-3#1)
identify the metabolites##3##3##(1990-11#1)(1996-5#1)(2008-10#1)
identify the most important##2##4##(2008-10#2)
identify the most##6##3##(1995-12#1)(1996-1#1)(2007-11#1)(2008-10#2)(2011-2#1)
identify the origin of##2##4##(1990-7#1)(1994-6#1)
identify the presence of##2##4##(2008-9#1)(2009-9#1)
identify the required##2##3##(2008-7#1)(2012-12#1)
identify the risk##4##3##(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
identify the specific##4##3##(1994-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
identify the##258##2##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#2)(1990-6#2)(1990-7#2)(1991-12#3)(1991-2#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1997-2#2)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#34)(2008-11#12)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#10)(2011-3#2)(2012-12#4)(2012-2#5)(2012-3#9)(2013-1#13)(2013-7#4)(2013-8#7)
identify their##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)
identify these##8##2##(1990-6#1)(1991-6#1)(1992-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)
identify those patients##4##3##(2008-1#1)(2008-10#1)(2012-1#2)
identify those##13##2##(1990-7#1)(1993-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-8#1)
identify three##3##2##(1993-3#1)(1996-11#1)(2012-3#1)
identify two##5##2##(2008-10#3)(2008-9#1)(2013-8#1)
identify unknown##4##2##(2008-10#2)(2009-9#1)(2012-3#1)
identify variables which have an influence on satisfaction with##2##9##(2012-2#2)
identify variables##4##2##(2007-10#1)(2008-8#1)(2012-2#2)
identify which##9##2##(1992-6#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-6#1)
identify with##3##2##(2008-5#1)(2010-3#1)(2010-8#1)
identify##1217##1##(1990-10#3)(1990-11#9)(1990-12#4)(1990-2#4)(1990-6#3)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#10)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#10)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#7)(1995-1#9)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#10)(1995-3#1)(1995-5#3)(1995-6#6)(1996-1#6)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#4)(1996-7#1)(1997-1#10)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#8)(2007-11#13)(2007-12#12)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#17)(2008-10#151)(2008-11#63)(2008-12#28)(2008-2#20)(2008-3#20)(2008-4#33)(2008-5#15)(2008-6#13)(2008-7#42)(2008-8#28)(2008-9#43)(2009-1#2)(2009-10#13)(2009-12#8)(2009-2#4)(2009-3#8)(2009-4#4)(2009-5#8)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#3)(2010-1#4)(2010-10#8)(2010-11#18)(2010-12#7)(2010-2#3)(2010-3#15)(2010-4#3)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#19)(2011-2#49)(2011-3#6)(2011-8#1)(2012-1#5)(2012-12#30)(2012-2#31)(2012-3#52)(2012-4#2)(2012-7#1)(2012-8#1)(2013-1#58)(2013-7#10)(2013-8#40)
identifying a##10##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
identifying agents##2##2##(1997-3#1)(2013-8#1)
identifying all##3##2##(2007-4#1)(2008-6#1)(2013-8#1)
identifying an##3##2##(1992-3#1)(2008-9#1)(2011-1#1)
identifying and implementing##2##3##(1995-2#1)(2012-2#1)
identifying and treating##2##3##(2007-10#1)(2011-1#1)
identifying and##20##2##(1990-5#1)(1993-12#1)(1994-2#2)(1995-2#1)(1995-3#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
identifying areas in which##2##4##(1996-3#1)(2008-11#1)
identifying areas##3##2##(1996-3#1)(2008-11#1)(2009-11#1)
identifying as##3##2##(2008-12#3)
identifying critical##2##2##(1991-9#1)(2011-2#1)
identifying differentially expressed##2##3##(2008-4#1)(2012-3#1)
identifying factors##2##2##(1996-3#1)(2011-2#1)
identifying five##2##2##(1992-3#1)(2008-8#1)
identifying genes##5##2##(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#1)
identifying genetic##2##2##(2008-10#2)
identifying high-risk##2##2##(1994-6#1)(2012-2#1)
identifying new##4##2##(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)
identifying novel##6##2##(2008-11#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-8#2)
identifying patients with##2##3##(1993-9#1)(2012-3#1)
identifying patients##3##2##(1993-9#1)(2007-10#1)(2012-3#1)
identifying people##2##2##(2010-5#1)(2011-2#1)
identifying plant##3##2##(2008-11#3)
identifying potential##6##2##(1995-12#1)(2008-10#1)(2008-7#3)(2013-7#1)
identifying potentially##2##2##(2008-5#1)(2012-2#1)
identifying proteins in##2##3##(2008-4#2)
identifying proteins##4##2##(1993-8#1)(2008-4#2)(2012-3#1)
identifying single##2##2##(2008-10#1)(2012-2#1)
identifying some of the##2##4##(2008-9#1)(2013-1#1)
identifying subjects with##2##3##(2011-2#1)(2012-3#1)
identifying that##2##2##(2008-10#1)(2010-2#1)
identifying the fundamental##2##3##(1992-5#1)(2008-9#1)
identifying the most##2##3##(2011-1#1)(2011-2#1)
identifying the purpose of##2##4##(1995-12#1)(2008-11#1)
identifying the source##2##3##(2010-9#1)(2012-3#1)
identifying the##64##2##(1992-5#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-4#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#7)
identifying their##2##2##(2008-11#1)(2012-12#1)
identifying these##5##2##(1994-8#1)(1994-9#1)(1996-2#1)(2008-12#1)(2011-2#1)
identifying this##2##2##(1995-3#1)(2008-10#1)
identifying those##9##2##(1994-12#1)(1995-3#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#2)
identifying useful##2##2##(1997-2#1)(2010-12#1)
identifying when##2##2##(2010-6#1)(2010-8#1)
identifying which##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
identifying##328##1##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-3#3)(1992-5#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#5)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#5)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#19)(2008-12#8)(2008-2#3)(2008-3#3)(2008-4#17)(2008-5#5)(2008-6#6)(2008-7#12)(2008-8#6)(2008-9#14)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#12)(2013-1#9)(2013-7#1)(2013-8#14)
identities among##2##2##(1990-7#1)(2008-10#1)
identities and the##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
identities and##11##2##(2008-10#6)(2008-8#1)(2008-9#2)(2009-7#2)
identities between the##2##3##(2008-10#2)
identities in##3##2##(2008-11#1)(2008-8#2)
identities of 95##2##3##(2008-10#2)
identities of the##4##3##(1994-12#1)(2008-10#3)
identities of these##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
identities of##15##2##(1990-12#1)(1991-6#1)(1994-12#1)(2007-12#1)(2008-10#8)(2008-8#1)(2008-9#1)(2011-2#1)
identities to##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
identities with##3##2##(2008-10#2)(2008-8#1)
identities##63##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-6#1)(1994-12#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#35)(2008-11#1)(2008-5#1)(2008-8#5)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#4)(2011-2#1)(2012-1#1)(2013-8#1)
identity among##5##2##(1993-2#1)(2008-10#4)
identity and the##2##3##(1991-2#1)(2008-7#1)
identity and##34##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#2)
identity as a##2##3##(1995-1#1)(2009-7#1)
identity as##4##2##(1995-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
identity at the##2##3##(1997-6#1)(2008-4#1)
identity between isolates of##2##4##(2008-10#2)
identity between the two##2##4##(1994-12#1)(2008-10#1)
identity between the##4##3##(1991-5#1)(1994-12#1)(2008-10#2)
identity between##13##2##(1991-5#1)(1993-11#1)(1993-8#1)(1994-12#1)(2008-10#7)(2008-5#1)(2012-3#1)
identity by##2##2##(1997-5#1)(2007-11#1)
identity cards##2##2##(2008-10#2)
identity development is##2##3##(2012-12#2)
identity development##10##2##(2008-12#1)(2009-7#4)(2012-12#5)
identity gene##2##2##(2007-12#1)(2008-8#1)
identity in the##7##3##(1990-7#2)(1991-10#1)(1993-6#1)(2008-10#2)(2009-2#1)
identity in##19##2##(1990-11#1)(1990-7#2)(1991-10#1)(1993-6#1)(1995-11#2)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
identity is##3##2##(1993-3#1)(1994-12#1)(1994-8#1)
identity may##2##2##(2008-12#1)(2012-12#1)
identity of a##5##3##(1990-8#1)(1993-8#1)(1996-5#1)(2008-10#2)
identity of the isolated##2##4##(1993-11#1)(1993-6#1)
identity of the##40##3##(1990-12#1)(1990-5#1)(1990-7#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-5#1)(1995-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#3)(2011-2#2)(2013-8#2)
identity of##73##2##(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#2)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-12#2)(2010-3#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#2)
identity on##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
identity or##3##2##(1996-3#1)(2008-10#1)(2010-8#1)
identity over the entire##2##4##(1992-3#1)(1996-6#1)
identity performance##5##2##(2008-5#5)
identity should be##2##3##(2008-11#1)(2008-8#1)
identity to that of##2##4##(1995-8#1)(1996-12#1)
identity to the##14##3##(1993-12#2)(1993-3#1)(1993-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#4)(2012-2#1)
identity to##28##2##(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1995-8#2)(1996-12#3)(1996-3#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#8)(2012-2#1)
identity was##7##2##(1997-4#1)(2008-10#1)(2009-7#1)(2010-7#2)(2013-8#2)
identity were##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
identity will##2##2##(1991-6#1)(2008-8#1)
identity with a##2##3##(1995-9#1)(1996-2#1)
identity with each other##4##4##(1991-10#1)(1995-8#1)(2008-5#1)(2008-7#1)
identity with human##3##3##(1993-11#1)(1994-12#1)(2008-6#1)
identity with other##3##3##(1994-12#1)(2008-10#1)(2008-7#1)
identity with the Streptococcus##2##4##(2009-6#2)
identity with the enzyme from##3##5##(1992-3#3)
identity with the human##2##4##(1993-2#1)(1997-4#1)
identity with the recently##2##4##(1995-6#2)
identity with the##25##3##(1992-3#4)(1993-11#1)(1993-2#2)(1993-3#1)(1994-11#1)(1995-11#2)(1995-6#3)(1996-10#1)(1997-4#2)(2008-10#4)(2008-4#1)(2009-6#2)(2009-8#1)
identity with those of##4##4##(1994-12#1)(2008-10#3)
identity with##71##2##(1991-10#1)(1991-5#1)(1992-11#1)(1992-3#4)(1992-8#1)(1993-11#3)(1993-2#2)(1993-3#1)(1994-11#2)(1994-12#3)(1995-11#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-4#4)(1997-7#1)(2008-10#25)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-8#1)(2010-5#2)(2013-8#1)
identity within##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
identity##433##1##(1990-11#1)(1990-12#4)(1990-5#1)(1990-7#3)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#3)(1993-2#7)(1993-3#7)(1993-6#4)(1993-8#3)(1994-11#2)(1994-12#9)(1994-3#1)(1994-5#2)(1994-8#4)(1995-1#1)(1995-11#4)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#4)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#3)(1997-2#3)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#109)(2008-11#8)(2008-12#16)(2008-3#1)(2008-4#8)(2008-5#13)(2008-6#3)(2008-7#11)(2008-8#10)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#7)(2009-6#3)(2009-7#14)(2009-8#4)(2010-10#2)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#7)(2011-2#6)(2012-1#2)(2012-12#11)(2012-2#9)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#7)
identity) and##3##2##(1993-12#1)(1994-12#1)(1997-9#1)
identity) are##2##2##(1993-9#1)(2010-10#1)
identity) with##2##2##(1996-3#1)(2008-10#1)
identity)##18##1##(1990-7#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-6#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-9#1)(2008-10#3)(2010-10#1)(2010-7#1)
ideogram for##3##2##(2010-3#3)
ideogram##4##1##(2010-3#4)
ideological##8##1##(1991-6#1)(1993-12#1)(1996-12#1)(2008-11#1)(2008-9#1)(2010-1#1)(2013-1#2)
ideologies##2##1##(2009-7#1)(2012-3#1)
ideology and##2##2##(2008-11#1)(2012-12#1)
ideology of##3##2##(1991-6#1)(2007-12#1)(2008-10#1)
ideology##9##1##(1991-6#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#3)
idiogram##3##1##(2008-5#1)(2008-9#2)
idiomorph##2##1##(2008-10#2)
idiopathic Parkinson's disease (PD)##3##4##(2008-11#1)(2008-7#2)
idiopathic Parkinson's disease##5##3##(2008-11#1)(2008-7#4)
idiopathic SFN##2##2##(2013-1#2)
idiopathic and##2##2##(1997-8#1)(2008-11#1)
idiopathic arthritis##3##2##(2011-2#1)(2012-3#2)
idiopathic central DI and##2##4##(1997-8#2)
idiopathic central DI##3##3##(1997-8#3)
idiopathic central##4##2##(1997-8#4)
idiopathic dilated cardiomyopathy in##2##4##(2007-8#1)(2008-10#1)
idiopathic dilated cardiomyopathy##5##3##(2007-8#1)(2008-10#1)(2009-5#1)(2010-8#2)
idiopathic granulomatous mastitis##2##3##(1997-8#1)(2011-1#1)
idiopathic granulomatous##3##2##(1997-8#1)(2008-7#1)(2011-1#1)
idiopathic hypercalciuria in##2##3##(1991-11#1)(2008-10#1)
idiopathic hypercalciuria##5##2##(1991-11#1)(2008-10#3)(2008-7#1)
idiopathic infertility##2##2##(2013-8#2)
idiopathic interstitial##3##2##(1997-3#1)(2008-1#2)
idiopathic mental retardation##2##3##(2009-5#1)(2012-2#1)
idiopathic mental##3##2##(2009-5#2)(2012-2#1)
idiopathic polyneuropathy##2##2##(2006-12#2)
idiopathic pulmonary arterial hypertension (PAH)##2##5##(2010-10#2)
idiopathic pulmonary arterial hypertension##5##4##(2008-10#1)(2010-10#4)
idiopathic pulmonary arterial hypertension]##2##4##(2008-10#1)(2013-1#1)
idiopathic pulmonary arterial##7##3##(2008-10#2)(2010-10#4)(2013-1#1)
idiopathic pulmonary fibrosis##3##3##(1994-3#1)(2009-10#1)(2010-5#1)
idiopathic pulmonary##11##2##(1994-3#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-10#4)(2010-5#1)(2013-1#1)
idiopathic recurrent##2##2##(1994-2#1)(2008-10#1)
idiopathic rhinitis##2##2##(2011-1#2)
idiopathic scoliosis##13##2##(2007-11#3)(2007-8#6)(2008-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
idiopathic thrombocytopenic purpura##5##3##(1992-5#1)(1997-8#2)(2006-10#1)(2012-2#1)
idiopathic ulcerative colitis##3##3##(1995-10#2)(1997-8#1)
idiopathic##145##1##(1990-9#3)(1991-11#1)(1991-5#4)(1992-11#1)(1992-2#1)(1992-5#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-8#1)(1997-3#1)(1997-8#10)(2006-10#2)(2006-12#2)(2007-11#3)(2007-12#1)(2007-8#11)(2008-1#4)(2008-10#8)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#21)(2008-8#1)(2009-10#2)(2009-3#2)(2009-5#4)(2009-8#1)(2010-10#6)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#7)(2013-8#7)
idiopathic&quot##2##1##(2008-4#2)
idiosyncratic drug reactions##2##3##(2008-10#1)(2008-8#1)
idiosyncratic reaction##3##2##(1990-3#1)(2008-10#1)(2013-8#1)
idiosyncratic reactions##2##2##(2008-10#2)
idiosyncratic##16##1##(1990-3#2)(2008-10#6)(2008-4#1)(2008-8#3)(2008-9#1)(2011-1#1)(2013-8#2)
idiotype##2##1##(1993-6#1)(2008-4#1)
idiotypic##3##1##(1991-8#1)(2008-10#2)
idler beam##2##2##(2008-3#2)
idler light##3##2##(2007-12#3)
idler output power##2##3##(2007-11#1)(2007-12#1)
idler output##8##2##(2007-11#5)(2007-12#2)(2008-3#1)
idler pulse##2##2##(2008-2#1)(2008-3#1)
idler pulses##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
idler radiation at 2##2##4##(2007-11#1)(2007-12#1)
idler radiation##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
idler tuning##2##2##(2007-11#1)(2007-12#1)
idler wavelength##2##2##(2007-12#2)
idler wavelengths##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
idler waves##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
idler##60##1##(2007-11#22)(2007-12#22)(2008-2#6)(2008-3#10)
ie##8##1##(1990-12#1)(1997-7#2)(2008-1#1)(2008-7#2)(2012-2#1)(2013-8#1)
ie-2##4##1##(1997-3#4)
if 50 microM PDTC##2##4##(1993-3#2)
if I##3##2##(2008-4#1)(2008-8#1)(2010-12#1)
if MA##2##2##(1994-2#1)(2011-1#1)
if MRI##2##2##(2006-10#1)(2009-3#1)
if a detectable signal is too##2##6##(2008-9#2)
if a particular##2##3##(2008-4#1)(2009-11#1)
if a patient##2##3##(2008-7#1)(2008-9#1)
if a relationship##3##3##(2008-12#1)(2010-2#2)
if a trial##2##3##(1996-6#1)(2012-2#1)
if a##62##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#1)
if adequate##2##2##(2006-12#1)(2008-1#1)
if all##10##2##(1994-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-11#1)(2011-2#1)
if an##15##2##(1990-9#1)(1991-12#1)(1993-1#1)(1994-2#2)(1997-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
if and how##3##3##(2008-12#2)(2011-1#1)
if and only if##4##4##(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)
if and when##3##3##(1995-5#1)(2008-1#1)(2008-4#1)
if and##10##2##(1995-5#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#1)
if any##39##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#1)(2013-7#1)
if anything##2##2##(1994-2#1)(2008-7#1)
if applied to##2##3##(2008-10#2)
if applied##5##2##(1991-3#1)(2008-10#3)(2011-2#1)
if appropriate##3##2##(2008-3#1)(2008-9#1)(2009-5#1)
if associated with##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
if at all##5##3##(1993-6#1)(1997-3#1)(2008-3#1)(2008-8#1)(2010-3#1)
if at least##2##3##(1993-8#1)(2008-11#1)
if at##7##2##(1993-6#1)(1993-8#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)
if available##3##2##(2008-8#1)(2012-1#1)(2012-9#1)
if basic##2##2##(2008-7#1)(2013-1#1)
if both##2##2##(2008-10#2)
if clinical##3##2##(1991-11#1)(2008-10#1)(2013-1#1)
if combination##2##2##(1997-5#1)(2013-1#1)
if combined with##2##3##(2008-1#1)(2008-6#1)
if compared with##2##3##(1990-8#1)(2008-10#1)
if confirmed##2##2##(1993-9#1)(1994-8#1)
if consumers##2##2##(1997-3#1)(2008-8#1)
if continued##2##2##(1997-1#1)(2008-6#1)
if current##2##2##(1993-3#1)(2011-1#1)
if declining##2##2##(2009-2#1)(2011-2#1)
if delirium##2##2##(2011-2#1)(2013-1#1)
if detected##2##2##(2008-9#1)(2013-7#1)
if diagnosed early##2##3##(2008-9#1)(2009-3#1)
if diagnosed in##2##3##(2010-12#1)(2010-8#1)
if diagnosed##8##2##(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#2)
if dichlorofluorescein##2##2##(2008-10#2)
if differences in##3##3##(1990-2#1)(2007-5#1)(2008-10#1)
if different##4##2##(1993-5#1)(2009-7#1)(2013-8#2)
if either the##2##3##(2008-7#1)(2013-1#1)
if either##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
if ever##4##2##(1997-2#1)(2008-11#1)(2008-12#1)(2012-12#1)
if feasible##2##2##(2010-12#1)(2011-2#1)
if further##3##2##(1992-3#1)(2008-10#2)
if he##2##2##(1992-11#1)(1993-12#1)
if her##2##2##(2008-4#1)(2008-9#1)
if high##3##2##(1990-3#1)(2008-8#1)(2012-12#1)
if in##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
if it does not##2##4##(2008-1#1)(2008-11#1)
if it does##3##3##(2008-1#2)(2008-11#1)
if it has##2##3##(2008-2#1)(2011-2#1)
if it improves##2##3##(2008-4#2)
if it is not##4##4##(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)
if it is possible##2##4##(2008-2#1)(2011-2#1)
if it is to be##2##5##(1992-3#1)(2008-10#1)
if it is to##3##4##(1992-3#1)(1993-2#1)(2008-10#1)
if it is##24##3##(1990-5#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
if it persists##2##3##(2013-1#2)
if it was possible to##2##5##(1992-11#1)(2008-11#1)
if it was##5##3##(1992-11#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
if it were##4##3##(1995-12#1)(2007-2#1)(2008-7#1)(2008-8#1)
if it##55##2##(1990-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
if its##8##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-7#1)(2011-2#1)
if left untreated##3##3##(2010-5#1)(2012-3#2)
if left##4##2##(2007-10#1)(2010-5#1)(2012-3#2)
if loss##2##2##(1994-6#1)(2013-8#1)
if members of##2##3##(2008-11#1)(2010-11#1)
if necessary##16##2##(1990-8#1)(1992-6#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#2)(2009-5#1)(2011-1#2)(2011-3#1)(2013-1#1)(2013-8#1)
if needed##4##2##(1992-2#1)(1996-3#1)(2008-1#1)(2011-2#1)
if new##3##2##(1997-2#1)(1997-7#1)(2010-4#1)
if no##11##2##(1990-3#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
if not all##8##3##(1990-8#1)(1992-8#1)(1995-6#2)(2008-9#2)(2009-4#1)(2010-7#1)
if not detected##2##3##(2007-12#1)(2011-1#1)
if not identical##2##3##(1993-9#1)(2008-1#1)
if not impossible##4##3##(1992-12#1)(2007-12#1)(2008-3#1)(2008-4#1)
if not the##2##3##(1992-9#1)(1995-3#1)
if not treated##2##3##(1990-9#1)(2012-3#1)
if not##45##2##(1990-8#1)(1990-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
if nuclear##3##2##(1993-6#1)(2008-7#1)(2008-9#1)
if one focuses on##2##4##(2008-8#2)
if one of the##2##4##(2008-11#1)(2008-8#1)
if one##14##2##(1992-3#1)(1992-9#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2011-2#1)
if only a##3##3##(1992-3#1)(2007-2#1)(2008-2#1)
if only the##2##3##(1996-5#1)(2008-3#1)
if only##8##2##(1991-2#1)(1992-3#1)(1996-5#1)(2007-2#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-4#1)
if pain##2##2##(2007-11#1)(2010-11#1)
if para-hydrogen##2##2##(2008-10#2)
if patient##2##2##(1991-3#1)(2007-7#1)
if patients are##2##3##(2008-1#1)(2011-2#1)
if patients##5##2##(2008-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
if possible##7##2##(1991-12#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-7#1)
if present at##2##3##(2008-10#2)
if present in##2##3##(2008-10#1)(2012-3#1)
if present##9##2##(1996-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
if proper##2##2##(2008-10#1)(2008-3#1)
if properly##2##2##(1991-12#1)(2008-5#1)
if relative##2##2##(2008-2#1)(2008-5#1)
if required##5##2##(2008-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
if research##2##2##(1997-7#1)(2013-1#1)
if sensitivity##2##2##(1997-3#1)(2011-2#1)
if sensory##2##2##(1992-11#1)(2009-8#1)
if several##2##2##(2008-10#1)(2010-12#1)
if significant differences##2##3##(1995-2#1)(2008-12#1)
if significant##3##2##(1995-2#1)(2008-12#1)(2011-2#1)
if small##2##2##(1994-3#1)(2008-11#1)
if so##19##2##(1990-5#1)(1991-3#1)(1993-12#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)(2012-3#2)(2012-7#1)
if social##2##2##(2008-7#1)(2013-1#1)
if some of the##2##4##(2012-2#1)(2012-3#1)
if some##3##2##(1996-3#1)(2012-2#1)(2012-3#1)
if successful##2##2##(1995-2#1)(2008-10#1)
if such##6##2##(1996-9#1)(1997-4#1)(2008-10#3)(2008-8#1)
if supplied##2##2##(2008-11#2)
if the amount of##2##4##(2008-10#2)
if the binding##2##3##(1990-12#1)(2008-10#1)
if the clinical##2##3##(1996-9#1)(1997-4#1)
if the disease##2##3##(2013-1#2)
if the dispersal##2##3##(2008-8#2)
if the distribution##2##3##(1992-2#1)(2008-10#1)
if the dose##2##3##(1995-3#1)(2009-11#1)
if the duration##2##3##(1997-4#1)(2008-12#1)
if the effective recombination rate is##2##6##(2008-8#2)
if the electrode was##2##4##(2008-10#1)(2008-9#1)
if the error##3##3##(2008-2#2)(2008-3#1)
if the extinction##2##3##(2008-3#1)(2008-8#1)
if the fiber##2##3##(2008-2#1)(2008-3#1)
if the first##2##3##(1990-11#1)(2007-2#1)
if the flow##2##3##(2008-4#1)(2011-2#1)
if the group size is##2##5##(2008-8#2)
if the immigrants##2##3##(2008-8#2)
if the lesion##2##3##(1994-12#1)(2012-2#1)
if the lower##2##3##(2008-8#1)(2013-1#1)
if the measured##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
if the mother##2##3##(2007-2#1)(2012-2#1)
if the noise is##2##4##(2008-3#2)
if the noise##3##3##(2007-11#1)(2008-3#2)
if the number of##3##4##(1992-9#1)(2008-10#1)(2008-3#1)
if the organism is##2##4##(2007-12#1)(2011-2#1)
if the organization##2##3##(1991-2#1)(2006-5#1)
if the original##2##3##(1997-1#1)(2008-9#1)
if the parasite##2##3##(2008-8#1)(2008-9#1)
if the patient had##2##4##(2007-10#1)(2008-3#1)
if the patient has##4##4##(1993-11#1)(1997-5#1)(2010-6#1)(2012-2#1)
if the patient is##8##4##(1993-2#1)(1994-3#2)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
if the patient##20##3##(1992-12#1)(1993-11#1)(1993-2#1)(1994-3#2)(1996-9#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
if the patients##2##3##(2008-7#2)
if the phase##2##3##(2008-3#2)
if the presence of##2##4##(2008-6#1)(2008-7#1)
if the problem##2##3##(2007-11#1)(2011-2#1)
if the process##2##3##(2007-10#1)(2008-3#1)
if the pump##2##3##(2007-11#1)(2008-2#1)
if the ratio between##2##4##(2008-2#1)(2013-1#1)
if the ratio##3##3##(2008-1#1)(2008-2#1)(2013-1#1)
if the same##3##3##(1993-6#1)(1993-9#1)(1995-6#1)
if the sample is##3##4##(2008-10#2)(2008-3#1)
if the sample##4##3##(2007-7#1)(2008-10#2)(2008-3#1)
if the spatial##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
if the system##2##3##(1993-3#1)(2008-10#1)
if the test##4##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
if the time##2##3##(1993-12#1)(2008-11#1)
if the total##2##3##(1995-8#1)(2008-10#1)
if the true##2##3##(2008-2#2)
if the two##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
if the water##2##3##(2008-10#2)
if the whole##2##3##(2008-10#1)(2010-8#1)
if the##417##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#3)(2007-11#15)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#58)(2008-11#16)(2008-12#1)(2008-2#18)(2008-3#40)(2008-4#12)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#28)(2008-9#10)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#19)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#10)
if their serum-cholesterol was high##2##5##(1990-6#2)
if their##11##2##(1990-6#2)(1995-2#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)
if there are no##2##4##(2008-4#1)(2013-8#1)
if there are##12##3##(1992-11#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
if there is a##7##4##(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
if there is##18##3##(1995-12#1)(1997-5#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
if there was##3##3##(2008-10#2)(2008-8#1)
if there were##2##3##(1994-12#1)(2011-2#1)
if there##37##2##(1992-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-5#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
if these differences##2##3##(2007-11#1)(2008-5#1)
if these findings##2##3##(1996-7#1)(2008-10#1)
if these##23##2##(1996-12#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
if they are designed##2##4##(1996-3#1)(2010-2#1)
if they are in##2##4##(2010-10#1)(2013-7#1)
if they are to be##2##5##(1996-3#1)(2007-11#1)
if they are to take##2##5##(1992-3#1)(1994-2#1)
if they are to##12##4##(1992-3#1)(1994-2#3)(1994-9#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-12#2)(2012-12#1)
if they are##37##3##(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-2#3)(1994-9#1)(1995-5#1)(1996-3#2)(1996-8#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
if they can##2##3##(2009-10#1)(2011-1#1)
if they do not##3##4##(1992-3#1)(2008-7#1)(2011-3#1)
if they do##4##3##(1992-3#1)(2008-7#2)(2011-3#1)
if they find that negligence was##2##6##(1992-2#2)
if they had##4##3##(1995-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
if they have##7##3##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
if they show##2##3##(2008-10#2)
if they were##13##3##(1993-12#1)(1995-12#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-2#1)(2011-2#1)
if they##110##2##(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#5)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
if this is not##2##4##(1997-8#1)(2010-3#1)
if this is##3##3##(1997-8#1)(2010-3#1)(2013-1#1)
if this problem##2##3##(1993-12#1)(2012-2#1)
if this##23##2##(1990-12#1)(1992-12#1)(1993-12#1)(1994-8#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#3)(2008-5#2)(2009-9#1)(2010-3#1)(2012-2#2)(2012-7#1)(2013-1#3)
if those##4##2##(1992-2#1)(2008-9#1)(2009-5#1)(2011-2#1)
if total##2##2##(2007-11#1)(2008-10#1)
if treated##2##2##(1992-9#1)(2012-2#1)
if treatment##3##2##(1997-3#1)(1997-5#1)(2007-12#1)
if two##2##2##(2008-2#1)(2012-2#1)
if use##2##2##(1992-3#1)(2012-1#1)
if used in##2##3##(1996-3#1)(2008-8#1)
if used##7##2##(1996-3#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)
if vaccination##2##2##(2007-6#1)(2008-4#1)
if we are to##4##4##(1992-9#1)(2006-10#1)(2010-3#1)(2013-1#1)
if we are##5##3##(1992-9#1)(2006-10#1)(2008-4#1)(2010-3#1)(2013-1#1)
if we include##2##3##(2006-12#1)(2008-2#1)
if we##16##2##(1992-9#1)(1995-3#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
if you##5##2##(1992-1#2)(2008-7#1)(2010-12#2)
if##1573##1##(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#7)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#5)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#3)(1991-3#8)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#6)(1992-12#6)(1992-2#10)(1992-3#17)(1992-4#3)(1992-5#4)(1992-6#3)(1992-8#4)(1992-9#9)(1993-1#6)(1993-11#3)(1993-12#17)(1993-2#7)(1993-3#8)(1993-5#3)(1993-6#6)(1993-8#3)(1993-9#4)(1994-1#2)(1994-11#4)(1994-12#11)(1994-2#17)(1994-3#11)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#1)(1995-11#5)(1995-12#14)(1995-2#11)(1995-3#8)(1995-5#6)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#8)(1996-11#2)(1996-12#9)(1996-2#2)(1996-3#10)(1996-4#2)(1996-5#9)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#7)(1997-2#13)(1997-3#12)(1997-4#6)(1997-5#7)(1997-6#4)(1997-7#7)(1997-8#5)(2006-10#2)(2006-12#2)(2006-5#1)(2007-10#7)(2007-11#28)(2007-12#22)(2007-2#7)(2007-5#4)(2007-6#3)(2007-7#8)(2007-8#7)(2008-1#23)(2008-10#181)(2008-11#63)(2008-12#17)(2008-2#41)(2008-3#72)(2008-4#36)(2008-5#19)(2008-6#18)(2008-7#60)(2008-8#75)(2008-9#50)(2009-1#2)(2009-10#4)(2009-11#6)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#9)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#7)(2010-1#2)(2010-10#3)(2010-11#9)(2010-12#14)(2010-2#6)(2010-3#10)(2010-4#6)(2010-5#6)(2010-6#4)(2010-7#11)(2010-8#11)(2011-1#14)(2011-2#67)(2011-3#4)(2012-1#6)(2012-12#20)(2012-2#30)(2012-3#20)(2012-7#2)(2012-9#2)(2013-1#55)(2013-7#7)(2013-8#31)
if&quot##2##1##(1996-2#1)(2008-8#1)
ifenprodil##4##1##(1996-2#4)
ifosfamide and cisplatin (MVIP)##2##4##(2007-10#2)
ifosfamide and doxorubicin##3##3##(2008-6#3)
ifosfamide and##8##2##(1992-6#1)(2007-10#2)(2008-6#4)(2010-3#1)
ifosfamide in##4##2##(1994-12#1)(2008-6#2)(2010-3#1)
ifosfamide with##2##2##(2008-6#1)(2010-3#1)
ifosfamide##30##1##(1992-6#1)(1994-12#1)(1996-8#1)(2007-10#3)(2008-6#17)(2010-3#7)
igneous rock##2##2##(2008-10#2)
igneous##3##1##(2008-10#3)
igniarius##2##1##(2008-10#2)
igniting##2##1##(2010-4#1)(2010-8#1)
ignition of the##2##3##(2008-3#1)(2010-9#1)
ignition##8##1##(1995-6#1)(2007-12#1)(2008-3#3)(2010-9#1)(2013-1#1)(2013-8#1)
ignorable##3##1##(1995-9#1)(2008-2#1)(2009-12#1)
ignorance about the##2##3##(1993-12#1)(2009-10#1)
ignorance of the##2##3##(2010-4#1)(2011-2#1)
ignorance of##5##2##(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2011-3#1)
ignorance##12##1##(1993-12#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)
ignore a##2##2##(2008-8#1)(2011-3#1)
ignore the##11##2##(1990-6#1)(1991-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
ignore##26##1##(1990-6#1)(1991-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2011-3#2)
ignored in##4##2##(1995-5#1)(2007-8#1)(2008-3#1)(2008-8#1)
ignored or##2##2##(2010-7#1)(2013-8#1)
ignored the##2##2##(2008-8#1)(2008-9#1)
ignored##43##1##(1992-3#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
ignores the##3##2##(1996-11#1)(2007-12#1)(2013-1#1)
ignores##8##1##(1996-11#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#2)
ignoring the##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
ignoring##11##1##(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)
iguanian lizards##2##2##(2008-7#1)(2010-3#1)
ii)##18##1##(1993-5#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
iii)##11##1##(1993-5#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2009-9#1)(2010-8#1)(2012-2#2)(2013-8#2)
il##2##1##(2008-5#1)(2011-2#1)
ilarviruses affecting stone fruit trees##2##5##(2008-10#2)
ilarviruses##3##1##(2008-10#3)
ileal conduits##2##2##(1991-11#2)
ileal pouch##4##2##(2009-12#4)
ileal##26##1##(1990-11#2)(1990-3#2)(1991-11#2)(1991-6#1)(1991-9#4)(1992-6#1)(1992-8#2)(1996-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-12#5)(2009-5#1)(2013-1#2)
ileo-anal##2##1##(1991-6#2)
ileocecal##6##1##(1990-8#1)(1992-5#1)(1994-5#1)(1994-8#1)(2009-7#1)(2010-12#1)
ileocolic##4##1##(1991-9#1)(2009-9#1)(2013-1#2)
ileorectal##2##1##(2010-12#1)(2012-1#1)
ileostomy site##3##2##(2009-2#1)(2009-5#2)
ileostomy##7##1##(2009-2#1)(2009-5#5)(2013-1#1)
ileum and##5##2##(1991-11#1)(1994-12#1)(1995-12#1)(1997-7#1)(2011-1#1)
ileum is##2##2##(2008-12#1)(2013-7#1)
ileum##42##1##(1990-5#1)(1991-11#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#6)(1995-3#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#6)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#2)(2012-2#2)(2013-1#2)(2013-7#2)
ileus in a##2##3##(2008-12#1)(2013-1#1)
ileus##12##1##(1997-8#3)(2008-10#1)(2008-12#2)(2008-6#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
ilex and Q##2##3##(2008-10#2)
ilex##4##1##(2008-10#2)(2011-10#2)
iliac artery##14##2##(1990-3#1)(2006-6#1)(2007-7#1)(2008-12#2)(2008-3#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
iliac bone graft##2##3##(2008-11#1)(2008-6#1)
iliac bone##3##2##(2008-11#1)(2008-6#1)(2010-3#1)
iliac crest##12##2##(1991-6#1)(2007-11#1)(2008-7#2)(2009-10#3)(2009-9#2)(2010-3#1)(2010-6#1)(2010-8#1)
iliac fossa pain##2##3##(1997-3#1)(2008-7#1)
iliac fossa##4##2##(1997-3#1)(2008-7#2)(2009-3#1)
iliac screws##2##2##(2008-12#2)
iliac vein##3##2##(1990-3#1)(1997-8#1)(2008-12#1)
iliac vessels##2##2##(1996-6#2)
iliac##53##1##(1990-3#2)(1991-11#2)(1991-6#1)(1996-6#2)(1997-3#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-12#6)(2008-3#2)(2008-6#1)(2008-7#7)(2009-10#3)(2009-3#1)(2009-9#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
iliacus hematoma is##2##3##(2009-3#2)
iliacus hematoma##4##2##(2009-3#4)
iliacus##8##1##(2006-10#1)(2009-3#7)
iliofemoral##5##1##(1997-8#4)(2008-4#1)
iliopsoas##3##1##(2006-10#1)(2007-8#1)(2008-8#1)
ilium##2##1##(2008-7#1)(2011-2#1)
ill abroad##3##2##(2007-2#3)
ill and##12##2##(1992-3#1)(1992-5#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-2#2)(2008-7#2)(2013-1#2)(2013-8#1)
ill child##3##2##(1990-10#2)(2011-2#1)
ill children identified more##2##4##(1994-12#2)
ill children##11##2##(1990-10#3)(1992-3#1)(1993-1#2)(1994-12#2)(1995-12#1)(1996-1#1)(2012-2#1)
ill equipped##2##2##(1996-1#1)(2010-12#1)
ill health##2##2##(2008-1#1)(2008-8#1)
ill in##2##2##(1991-3#1)(1997-2#1)
ill infants##2##2##(1994-6#1)(2011-1#1)
ill informed##2##2##(1991-11#1)(1995-12#1)
ill parents##2##2##(1993-12#1)(2009-7#1)
ill patient##8##2##(2007-8#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-11#1)(2012-3#2)
ill patients and##5##3##(1990-10#1)(2008-11#1)(2009-11#1)(2010-8#1)(2013-1#1)
ill patients in##3##3##(1996-9#1)(1997-1#1)(2013-1#1)
ill patients was##2##3##(1990-10#1)(1992-3#1)
ill patients who##2##3##(1990-10#1)(1995-2#1)
ill patients##49##2##(1990-10#4)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-9#1)(1997-1#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
ill people##3##2##(2007-8#1)(2009-7#2)
ill##175##1##(1990-10#12)(1990-11#1)(1990-2#1)(1990-8#3)(1991-11#2)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#2)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1993-1#2)(1993-12#4)(1993-5#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-8#1)(1996-1#4)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-6#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#4)(2007-7#2)(2007-8#6)(2008-1#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#4)(2009-11#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#7)(2013-8#3)
ill-conditioned##2##1##(2008-10#2)
ill-defined and##2##2##(1994-7#1)(1996-1#1)
ill-defined##9##1##(1992-6#1)(1994-7#2)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
ill-posed inversion##2##2##(2008-3#2)
ill-posed##8##1##(1997-2#1)(2008-11#2)(2008-2#1)(2008-3#4)
ill-prepared##2##1##(2012-2#1)(2012-3#1)
illegal drug##2##2##(2008-11#1)(2013-1#1)
illegal drugs##5##2##(1996-1#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
illegal remuneration##2##2##(1993-1#1)(1994-3#1)
illegal##19##1##(1991-12#1)(1991-6#1)(1993-1#2)(1994-12#1)(1994-3#1)(1996-1#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#2)
illegally##5##1##(1995-12#1)(2007-2#1)(2008-10#1)(2009-10#1)(2011-1#1)
illicit amphetamines##5##2##(2008-10#5)
illicit drug use in middle adulthood##3##6##(2009-7#3)
illicit drug use##8##3##(2007-12#1)(2008-1#1)(2009-7#4)(2010-4#2)
illicit drug##14##2##(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#1)(2009-7#4)(2010-4#2)(2012-12#1)
illicit drugs##10##2##(1996-4#1)(2008-10#1)(2010-4#2)(2012-12#3)(2013-8#3)
illicit heroin##5##2##(2008-10#2)(2012-2#3)
illicit substances##2##2##(2008-10#1)(2013-8#1)
illicit##44##1##(1991-12#1)(1996-4#1)(2007-12#1)(2008-1#2)(2008-10#15)(2008-12#1)(2008-5#1)(2009-7#4)(2010-4#4)(2010-5#1)(2012-1#1)(2012-12#5)(2012-2#3)(2013-8#4)
illiteracy##4##1##(1991-12#1)(1997-5#1)(2008-1#1)(2008-7#1)
illiterate##4##1##(1994-3#1)(2009-6#1)(2009-9#1)(2012-12#1)
illiterates in##2##2##(2009-9#2)
illiterates##5##1##(2009-9#5)
illness (ILI)##3##2##(2010-4#1)(2011-2#1)(2011-9#1)
illness among##5##2##(1991-12#1)(1995-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
illness and death in##2##4##(1997-4#1)(2010-12#1)
illness and death##6##3##(1993-12#1)(1995-6#3)(1997-4#1)(2010-12#1)
illness and recovery##2##3##(1992-11#1)(2013-1#1)
illness and the##7##3##(1994-6#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-3#1)
illness and treatment##4##3##(1992-12#3)(2012-3#1)
illness and##58##2##(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#4)(1993-12#3)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-6#3)(1996-1#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)
illness are##2##2##(1990-5#1)(2011-2#1)
illness burden##2##2##(1995-2#1)(2012-3#1)
illness by##2##2##(1993-3#1)(2008-9#1)
illness can be##2##3##(1992-2#1)(1997-6#1)
illness can##3##2##(1992-2#1)(1997-6#1)(2008-9#1)
illness characterized by##2##3##(1994-9#1)(2012-12#1)
illness compared to##2##3##(1994-2#1)(2011-1#1)
illness due to##2##3##(1990-3#1)(2008-1#1)
illness during##5##2##(1995-9#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
illness features##2##2##(2008-11#1)(2008-6#1)
illness from##3##2##(1995-12#1)(2011-1#1)(2013-8#1)
illness had##2##2##(1996-8#1)(2009-10#1)
illness has##2##2##(1990-9#1)(2007-12#1)
illness have##3##2##(1990-5#1)(2010-1#1)(2011-2#1)
illness in Nepal##2##3##(2012-3#2)
illness in children##3##3##(1991-8#1)(2010-2#2)
illness in the##4##3##(1997-5#1)(2009-12#1)(2009-7#1)(2012-3#1)
illness in##27##2##(1991-8#1)(1992-12#1)(1993-12#1)(1993-5#1)(1995-3#1)(1996-11#2)(1997-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-12#1)(2009-7#1)(2010-2#3)(2012-2#1)(2012-3#3)(2013-7#1)
illness is##10##2##(1993-2#1)(1995-5#1)(2007-12#1)(2008-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
illness occurs##3##2##(1994-12#1)(1996-3#1)(2008-6#1)
illness of##6##2##(1994-12#1)(1996-3#1)(2007-5#1)(2011-2#3)
illness on the##2##3##(1996-1#1)(2008-11#1)
illness on##3##2##(1996-1#1)(2007-2#1)(2008-11#1)
illness or disability##2##3##(1992-2#1)(2012-3#1)
illness or injury##2##3##(1997-2#1)(2012-12#1)
illness or##12##2##(1992-2#1)(1992-3#1)(1993-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#1)
illness oriented##2##2##(2007-10#1)(2009-9#1)
illness perception##2##2##(2010-2#1)(2013-1#1)
illness play##2##2##(2008-11#1)(2011-2#1)
illness rather than##2##3##(2010-12#1)(2013-1#1)
illness reported##2##2##(1997-5#1)(2013-1#1)
illness representation##2##2##(2010-2#2)
illness severity##2##2##(1996-2#1)(2008-11#1)
illness symptoms##2##2##(2011-2#1)(2013-1#1)
illness than##2##2##(1995-11#1)(1997-6#1)
illness that was##2##3##(2008-10#1)(2009-10#1)
illness that##6##2##(1996-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
illness to##2##2##(1991-9#1)(2013-8#1)
illness was##5##2##(1996-3#1)(2006-10#1)(2009-4#1)(2012-12#1)(2013-1#1)
illness which##2##2##(2010-8#1)(2011-2#1)
illness with##2##2##(2007-12#1)(2008-8#1)
illness##420##1##(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#3)(1993-1#7)(1993-12#13)(1993-2#2)(1993-3#4)(1993-5#1)(1993-9#1)(1994-12#4)(1994-2#8)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#4)(1995-9#1)(1996-1#4)(1996-11#5)(1996-2#1)(1996-3#5)(1996-8#2)(1997-1#7)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#7)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#10)(2007-2#7)(2007-5#1)(2007-7#3)(2008-1#3)(2008-10#7)(2008-11#15)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#10)(2008-7#14)(2008-8#2)(2008-9#3)(2009-10#6)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#11)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#20)(2011-2#34)(2011-3#1)(2011-9#1)(2012-12#12)(2012-2#6)(2012-3#13)(2013-1#20)(2013-7#2)(2013-8#4)
illnesses and##10##2##(1990-5#1)(1993-3#1)(1995-6#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
illnesses are##5##2##(1993-3#1)(2009-4#1)(2010-12#2)(2012-12#1)
illnesses can##2##2##(2007-2#1)(2008-4#1)
illnesses in##3##2##(2007-10#1)(2008-12#1)(2013-8#1)
illnesses of##2##2##(1991-3#1)(1997-4#1)
illnesses such as##3##3##(1992-3#1)(2008-11#1)(2008-7#1)
illnesses that##2##2##(2008-12#1)(2008-4#1)
illnesses was##2##2##(1993-3#1)(2007-7#1)
illnesses##96##1##(1990-5#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#6)(1994-12#1)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#9)(2008-9#4)(2009-10#2)(2009-4#2)(2009-5#4)(2010-1#1)(2010-12#4)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
illuminance##2##1##(2008-2#1)(2008-3#1)
illuminate the##8##2##(1997-3#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-12#1)
illuminate##20##1##(1994-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-3#4)(2008-6#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#1)(2012-12#1)(2012-3#2)
illuminated and##4##2##(1992-8#1)(2008-3#2)(2012-2#1)
illuminated by a coherent##2##4##(2007-12#1)(2008-3#1)
illuminated by a focused laser beam##2##6##(2008-2#1)(2008-3#1)
illuminated by a multimode optical fiber##2##6##(2008-3#2)
illuminated by a plane wave##3##5##(2007-11#1)(2008-3#2)
illuminated by a quasi-monochromatic##3##4##(2008-3#3)
illuminated by a##22##3##(1991-2#1)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#11)
illuminated by an##2##3##(2007-12#1)(2008-1#1)
illuminated by the##3##3##(2008-2#1)(2008-3#2)
illuminated by##36##2##(1991-2#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#7)(2008-3#17)(2011-3#1)
illuminated from##2##2##(2008-3#2)
illuminated liquid core waveguide##2##4##(2008-10#2)
illuminated liquid##3##2##(2008-10#2)(2008-2#1)
illuminated object##3##2##(2008-2#1)(2008-3#2)
illuminated with a##3##3##(2007-12#1)(2008-3#1)(2009-6#1)
illuminated with an##2##3##(2007-12#1)(2008-2#1)
illuminated with##10##2##(2007-12#2)(2008-2#2)(2008-3#5)(2009-6#1)
illuminated##82##1##(1991-12#1)(1991-2#1)(1992-8#1)(1994-8#2)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#3)(2008-2#18)(2008-3#39)(2008-8#2)(2009-6#1)(2011-3#1)(2012-2#1)
illuminates a##3##2##(2008-3#3)
illuminates the##3##2##(1994-8#1)(2007-11#1)(2008-11#1)
illuminates##10##1##(1994-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2012-12#1)
illuminating a##3##2##(2008-2#1)(2008-3#2)
illuminating beam##4##2##(2008-2#3)(2008-3#1)
illuminating light##2##2##(2008-3#2)
illuminating the##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-11#1)
illuminating##23##1##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#9)(2008-3#8)(2010-11#1)(2011-2#1)
illumination and detection##2##3##(2008-3#2)
illumination and##16##2##(1992-8#1)(2008-2#4)(2008-3#10)(2008-9#1)
illumination angle##4##2##(2008-2#1)(2008-3#3)
illumination are##2##2##(2008-2#1)(2010-8#1)
illumination at a##2##3##(2008-2#1)(2008-6#1)
illumination at the##2##3##(2007-12#1)(2008-3#1)
illumination at##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)
illumination beam##2##2##(2008-3#2)
illumination by##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
illumination can be##2##3##(2008-2#1)(2011-1#1)
illumination changes##2##2##(2008-6#2)
illumination conditions##6##2##(2008-2#2)(2008-3#4)
illumination during##2##2##(2008-3#1)(2008-6#1)
illumination for##3##2##(2008-3#3)
illumination from##3##2##(1991-2#2)(2008-2#1)
illumination has been##2##3##(2008-2#1)(2008-3#1)
illumination in##2##2##(2007-11#1)(2008-9#1)
illumination intensity##2##2##(2008-3#2)
illumination is used##2##3##(2008-2#1)(2008-3#1)
illumination is##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
illumination of a##4##3##(2008-3#3)(2010-12#1)
illumination of the##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
illumination of##20##2##(1993-3#2)(1994-12#1)(1996-10#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#9)(2008-4#1)(2010-12#1)
illumination on##3##2##(2007-12#1)(2008-3#2)
illumination or##2##2##(1996-4#1)(2008-2#1)
illumination system is##3##3##(2008-3#2)(2011-1#1)
illumination system##4##2##(2008-3#3)(2011-1#1)
illumination systems##2##2##(2007-12#1)(2008-3#1)
illumination to##2##2##(2007-12#1)(2008-3#1)
illumination using##2##2##(2008-3#1)(2012-2#1)
illumination was##3##2##(1992-9#1)(2008-4#1)(2012-3#1)
illumination with a##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
illumination with##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-7#1)
illumination##214##1##(1991-12#1)(1991-2#7)(1992-8#1)(1992-9#4)(1993-3#4)(1994-12#1)(1996-10#1)(1996-4#1)(2006-8#1)(2007-11#15)(2007-12#15)(2008-10#2)(2008-11#1)(2008-2#41)(2008-3#91)(2008-4#2)(2008-6#5)(2008-7#1)(2008-9#8)(2009-6#2)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-2#1)(2012-3#1)
illuminative##2##1##(2008-11#2)
illuminator for##3##2##(2008-3#3)
illuminator is presented##2##3##(2008-2#1)(2008-3#1)
illuminator is##3##2##(2008-2#1)(2008-3#2)
illuminator that##2##2##(2008-2#1)(2008-3#1)
illuminator with##4##2##(2008-2#2)(2008-3#2)
illuminator##22##1##(2008-11#1)(2008-2#8)(2008-3#13)
illus##14##1##(1990-11#6)(1990-3#3)(1990-8#4)(2007-2#1)
illusion##10##1##(1990-6#1)(1995-1#2)(1996-5#1)(2007-12#2)(2008-10#1)(2013-1#1)(2013-8#2)
illusions##2##1##(2007-12#2)
illusory arm extension and##2##4##(2007-12#2)
illusory contours are##2##3##(2008-9#2)
illusory contours##8##2##(2008-8#2)(2008-9#6)
illusory##14##1##(2007-12#4)(2008-8#2)(2008-9#7)(2013-8#1)
illustrate a##6##2##(1992-11#1)(1993-12#1)(2008-2#1)(2008-7#2)(2010-11#1)
illustrate clinical##2##2##(1990-5#1)(1994-10#1)
illustrate current##2##2##(2008-7#1)(2013-7#1)
illustrate how it##2##3##(1994-3#1)(1996-3#1)
illustrate how the##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
illustrate how this##2##3##(2010-6#1)(2011-1#1)
illustrate how##20##2##(1994-3#2)(1995-2#1)(1995-3#1)(1996-3#2)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-6#1)(2011-1#1)(2013-1#1)
illustrate important##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
illustrate its##3##2##(2008-9#1)(2010-3#1)(2012-3#1)
illustrate our##2##2##(2009-5#1)(2012-3#1)
illustrate several##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
illustrate some of the##2##4##(1994-1#1)(2008-4#1)
illustrate some of##3##3##(1994-1#1)(2008-4#1)(2012-2#1)
illustrate that the##6##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
illustrate that##19##2##(1992-9#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#3)(2013-8#1)
illustrate the application of##2##4##(1997-7#1)(2013-1#1)
illustrate the approach with##2##4##(1995-2#1)(2009-9#1)
illustrate the approach##3##3##(1995-2#1)(2008-7#1)(2009-9#1)
illustrate the clinical##2##3##(1996-11#1)(2011-1#1)
illustrate the complex##2##3##(1995-8#1)(1997-3#1)
illustrate the complexity of the##2##5##(2008-10#1)(2012-2#1)
illustrate the design##2##3##(1994-2#1)(2013-1#1)
illustrate the effect##2##3##(2008-10#1)(2008-3#1)
illustrate the efficacy of##2##4##(2008-3#1)(2012-3#1)
illustrate the importance of##4##4##(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)
illustrate the method with##3##4##(1994-9#1)(2009-5#1)(2012-1#1)
illustrate the method##7##3##(1994-9#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-1#1)
illustrate the methods##3##3##(1995-12#1)(1995-9#1)(1997-7#1)
illustrate the model##2##3##(1995-2#1)(1996-2#1)
illustrate the need##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
illustrate the performance of the##4##5##(2008-2#2)(2008-3#2)
illustrate the performance of##5##4##(2008-2#2)(2008-3#3)
illustrate the potential for##4##4##(2008-10#1)(2008-3#2)(2011-2#1)
illustrate the potential of##2##4##(2008-3#1)(2008-7#1)
illustrate the potential##9##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)
illustrate the problems##2##3##(1993-3#1)(2008-10#1)
illustrate the process of##2##4##(2008-11#1)(2008-9#1)
illustrate the role of##2##4##(1995-6#1)(2008-7#1)
illustrate the success of##2##4##(2008-11#2)
illustrate the technique##2##3##(1996-12#1)(1997-4#1)
illustrate the utility of##2##4##(2007-12#1)(2008-8#1)
illustrate the##144##2##(1990-8#1)(1991-1#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#2)(1994-3#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#3)(1997-7#4)(1997-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#17)(2008-4#4)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#1)
illustrate their##6##2##(1993-2#1)(1994-12#1)(1994-2#1)(2010-1#1)(2010-4#1)(2011-2#1)
illustrate these##2##2##(1992-6#1)(2007-12#1)
illustrate this approach##2##3##(2008-8#1)(2012-2#1)
illustrate this method##2##3##(2008-10#1)(2008-3#1)
illustrate this technique##2##3##(2008-2#1)(2008-3#1)
illustrate this##14##2##(1994-2#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#2)(2012-2#1)
illustrate##269##1##(1990-5#1)(1990-8#1)(1991-1#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#5)(1994-3#5)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-7#4)(1997-8#1)(2007-11#5)(2007-12#7)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#16)(2008-3#26)(2008-4#10)(2008-6#4)(2008-7#18)(2008-8#9)(2008-9#4)(2009-10#2)(2009-12#1)(2009-5#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#17)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
illustrated and##5##2##(1995-1#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-8#1)
illustrated as##2##2##(2008-5#1)(2013-1#1)
illustrated by a recent##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
illustrated by a##10##3##(1991-6#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-8#1)(2010-8#1)
illustrated by an##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
illustrated by considering##2##3##(1991-9#1)(2008-4#1)
illustrated by the##13##3##(1992-6#1)(1994-11#1)(1994-2#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
illustrated by##57##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-11#2)(1994-2#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#8)(2008-4#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
illustrated for##5##2##(2008-10#2)(2008-3#1)(2009-11#1)(2010-5#1)
illustrated in a##3##3##(1990-5#1)(2008-10#1)(2011-1#1)
illustrated in the##8##3##(1991-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-1#1)
illustrated in this##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
illustrated in##18##2##(1990-5#1)(1991-12#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)
illustrated on the##2##3##(2008-5#1)(2013-1#1)
illustrated on##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
illustrated that the##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
illustrated that##10##2##(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2012-2#1)
illustrated the##6##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-5#1)(2013-1#1)
illustrated through a##3##3##(1991-1#1)(2009-4#1)(2013-8#1)
illustrated through the##2##3##(1994-12#1)(2008-7#1)
illustrated through##7##2##(1991-1#1)(1994-12#1)(1997-4#1)(2008-7#1)(2009-4#1)(2010-6#1)(2013-8#1)
illustrated using##8##2##(1992-9#1)(1994-11#2)(2009-7#1)(2012-1#2)(2012-3#1)(2013-8#1)
illustrated with a##6##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)
illustrated with numerical##2##3##(2007-12#1)(2008-3#1)
illustrated with several##2##3##(2008-11#1)(2011-2#1)
illustrated with the##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2011-1#1)
illustrated with##35##2##(1990-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-3#7)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
illustrated##201##1##(1990-12#2)(1990-5#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#4)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#47)(2008-11#12)(2008-12#1)(2008-2#6)(2008-3#21)(2008-4#5)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-7#1)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#5)(2013-8#3)
illustrates a##10##2##(1990-7#1)(1992-9#1)(1994-3#1)(1996-2#2)(2008-10#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-2#1)
illustrates how to use##2##4##(2008-11#1)(2008-9#1)
illustrates how to##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
illustrates how##12##2##(1991-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
illustrates that a##2##3##(2008-10#1)(2008-3#1)
illustrates that the##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
illustrates that##18##2##(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#2)(2011-2#2)(2012-3#1)
illustrates the challenges##2##3##(2007-7#1)(2008-4#1)
illustrates the importance of##4##4##(1992-4#1)(1994-3#1)(2012-1#1)(2013-8#1)
illustrates the need to##2##4##(2007-2#1)(2008-7#1)
illustrates the need##3##3##(2007-2#1)(2008-11#1)(2008-7#1)
illustrates the potential for##2##4##(1992-2#1)(1995-1#1)
illustrates the potential##5##3##(1992-2#1)(1995-1#1)(2008-1#1)(2012-1#1)(2012-12#1)
illustrates the results##2##3##(1990-9#1)(2009-8#1)
illustrates the##44##2##(1990-9#1)(1991-3#2)(1992-12#2)(1992-2#1)(1992-4#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
illustrates their##2##2##(2008-6#1)(2013-1#1)
illustrates this##2##2##(1995-5#1)(2007-11#1)
illustrates##107##1##(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-9#1)(1993-1#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
illustrating a##2##2##(2007-11#1)(2008-8#1)
illustrating that the##2##3##(1995-6#1)(2008-8#1)
illustrating that##5##2##(1995-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)
illustrating the##23##2##(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)
illustrating##42##1##(1992-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2013-7#1)
illustration of the##8##3##(1990-5#1)(1990-8#1)(1991-3#1)(2008-11#1)(2008-3#2)(2009-5#1)(2012-2#1)
illustration of##11##2##(1990-5#1)(1990-8#1)(1991-3#2)(2008-11#1)(2008-3#3)(2008-7#1)(2009-5#1)(2012-2#1)
illustration purposes##2##2##(1997-2#1)(2008-11#1)
illustration##29##1##(1990-5#1)(1990-8#1)(1991-3#2)(1993-3#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-3#3)(2008-7#1)(2009-5#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
illustrations##11##1##(1991-12#1)(1995-2#1)(2007-2#4)(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)(2013-8#1)
illustrative case##3##2##(2006-10#1)(2009-3#1)(2011-2#1)
illustrative data##2##2##(1997-3#1)(2008-4#1)
illustrative example##5##2##(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
illustrative examples##5##2##(1997-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#1)
illustrative##24##1##(1992-2#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
illustrators'##2##1##(2013-8#2)
iloprost was##2##2##(2008-7#1)(2011-2#1)
iloprost##12##1##(2008-10#1)(2008-7#3)(2009-10#1)(2011-2#6)(2013-1#1)
im##3##1##(1994-6#2)(2007-11#1)
image (E##2##2##(2008-3#2)
image a##5##2##(1990-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
image acquisition and processing##2##4##(2007-11#1)(2008-9#1)
image acquisition and##4##3##(2007-11#1)(2008-9#1)(2009-12#1)(2010-5#1)
image acquisition rate##2##3##(2007-11#1)(2011-1#1)
image acquisition##17##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-7#1)
image an##3##2##(1993-3#1)(2007-12#1)(2008-3#1)
image analysis and##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-7#1)
image analysis for##2##3##(2008-1#1)(2008-9#1)
image analysis is##3##3##(2008-2#1)(2008-9#1)(2010-8#1)
image analysis of##10##3##(1995-2#1)(2008-10#4)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)
image analysis revealed that##2##4##(1992-8#1)(1997-2#1)
image analysis software##4##3##(1995-12#1)(2007-5#1)(2008-10#1)(2008-4#1)
image analysis system##6##3##(2008-10#4)(2008-7#1)(2010-12#1)
image analysis techniques##2##3##(2008-10#2)
image analysis to##3##3##(2008-5#1)(2009-10#1)(2010-10#1)
image analysis was##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
image analysis##80##2##(1992-3#1)(1992-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#3)(2008-9#8)(2009-10#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#3)(2013-1#1)
image and size perceptions##2##4##(2007-12#2)
image and the##9##3##(1995-5#1)(2008-2#2)(2008-3#6)
image and##42##2##(1992-2#1)(1994-8#1)(1995-5#1)(2007-11#1)(2007-12#14)(2008-12#2)(2008-2#3)(2008-3#13)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#2)
image appeared##2##2##(2012-2#1)(2013-8#1)
image approximation##4##2##(2010-12#4)
image approximations##2##2##(2010-12#2)
image are##4##2##(2008-3#3)(2010-4#1)
image array##2##2##(2007-11#1)(2012-1#1)
image artifacts##2##2##(2007-12#1)(2012-12#1)
image as a##2##3##(2007-10#1)(2008-3#1)
image as##4##2##(2007-10#1)(2007-12#1)(2008-3#1)(2010-11#1)
image at a##3##3##(2008-3#2)(2013-1#1)
image at##7##2##(2008-2#1)(2008-3#3)(2010-5#2)(2013-1#1)
image attributes##2##2##(2008-2#2)
image averaging##3##2##(1996-5#2)(2008-5#1)
image based##2##2##(2007-12#1)(2012-12#1)
image by use of##3##4##(2008-2#2)(2008-3#1)
image by##11##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-8#1)
image can be transmitted##2##4##(2007-11#2)
image can be##7##3##(2007-11#3)(2008-3#3)(2011-2#1)
image can##9##2##(2007-11#3)(2008-3#4)(2011-1#1)(2011-2#1)
image capture##3##2##(2008-1#1)(2008-4#1)(2013-7#1)
image compression##7##2##(2008-3#4)(2009-3#1)(2010-8#1)(2012-2#1)
image contrast and##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
image contrast from##2##3##(2007-11#1)(2007-12#1)
image contrast##19##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#11)(2009-10#1)(2012-12#1)(2012-2#1)
image correlation##2##2##(2007-12#1)(2010-9#1)
image corrosion beneath the##2##4##(2007-12#2)
image cytometry##9##2##(2008-9#8)(2010-8#1)
image data and##3##3##(1994-3#1)(2008-6#1)(2012-3#1)
image data from##4##3##(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
image data##19##2##(1994-3#1)(2007-12#2)(2007-7#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
image data-patching method##2##3##(2008-3#2)
image deformation##5##2##(2010-5#5)
image degradation##4##2##(2008-2#2)(2008-3#1)(2008-9#1)
image depth##2##2##(2008-3#2)
image detection##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
image detectors##2##2##(2007-12#1)(2008-4#1)
image display##2##2##(2008-2#1)(2008-3#1)
image dissatisfaction##14##2##(2007-12#12)(2012-2#2)
image distance##2##2##(2008-3#2)
image distortion##2##2##(2008-3#1)(2011-1#1)
image distribution##4##2##(2007-11#1)(2008-2#3)
image edge##3##2##(2008-2#1)(2008-3#2)
image edges##2##2##(2008-2#2)
image encryption##3##2##(2007-12#2)(2008-3#1)
image enhancement##2##2##(2008-9#1)(2010-4#1)
image features##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
image fidelity##3##2##(2008-3#3)
image field##3##2##(2008-3#3)
image for##5##2##(1991-1#1)(1991-3#1)(2008-3#3)
image formation by##2##3##(2008-2#1)(2008-9#1)
image formation in##3##3##(2007-11#1)(2008-3#2)
image formation##12##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)(2008-9#2)
image formed with##2##3##(2008-2#1)(2008-3#1)
image formed##3##2##(2008-2#1)(2008-3#2)
image from the##2##3##(2008-3#2)
image from##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
image fusion##2##2##(2012-2#2)
image generation##2##2##(2008-3#1)(2011-1#1)
image guidance systems##2##3##(2007-8#1)(2012-1#1)
image guidance##5##2##(2007-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
image guided##3##2##(2009-12#1)(2011-2#1)(2013-7#1)
image guides##2##2##(2007-12#1)(2008-3#1)
image has a##2##3##(2007-12#1)(2013-8#1)
image has##5##2##(2007-12#3)(2008-2#1)(2013-8#1)
image hologram by##2##3##(2007-12#2)
image if##2##2##(2008-2#1)(2013-8#1)
image in a##4##3##(2008-1#1)(2008-3#3)
image in the##2##3##(2008-3#1)(2013-8#1)
image in##12##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#6)(2013-8#1)
image information##3##2##(2010-8#2)(2012-2#1)
image integration##2##2##(2008-12#1)(2008-6#1)
image intensifier##6##2##(2007-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#1)
image intensity is##2##3##(2008-3#2)
image intensity##6##2##(1990-5#1)(2008-3#3)(2008-7#1)(2010-9#1)
image interpretation##4##2##(2007-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
image is described##2##3##(2008-3#2)
image is presented##2##3##(2008-3#2)
image is used##2##3##(2008-3#1)(2010-8#1)
image is##36##2##(1994-12#1)(1995-11#1)(1995-6#2)(1996-2#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#21)(2010-8#1)(2012-1#1)
image management##2##2##(1991-12#2)
image noise##9##2##(2008-2#5)(2008-7#2)(2009-5#1)(2012-12#1)
image of a##15##3##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#5)
image of the grating##2##4##(2008-3#2)
image of the object##5##4##(2008-2#1)(2008-3#4)
image of the##34##3##(1991-11#1)(1991-8#1)(1995-1#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
image of##69##2##(1991-11#1)(1991-8#1)(1993-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#20)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
image on the##4##3##(1991-11#1)(1995-6#1)(2008-2#1)(2008-3#1)
image on##6##2##(1991-11#1)(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
image optimization##2##2##(2009-4#1)(2009-5#1)
image pair##2##2##(2008-2#1)(2008-3#1)
image patches##2##2##(2008-6#1)(2010-8#1)
image plane with##2##3##(2008-3#2)
image plane##15##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#9)
image plates##2##2##(2007-12#1)(2008-3#1)
image point##4##2##(2007-11#1)(2008-3#1)(2010-12#2)
image problems##2##2##(1991-12#1)(2007-12#1)
image processing and##2##3##(2008-3#1)(2008-9#1)
image processing system##2##3##(2008-3#2)
image processing techniques##3##3##(1992-9#1)(2008-10#1)(2008-3#1)
image processing##46##2##(1992-9#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-2#10)(2008-3#19)(2008-4#2)(2008-6#2)(2008-9#5)(2011-1#1)(2013-8#1)
image processor##2##2##(1995-6#1)(2008-2#1)
image quality and##7##3##(2008-2#3)(2008-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
image quality assessment##2##3##(2008-3#2)
image quality in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
image quality is also##2##4##(2008-2#1)(2008-3#1)
image quality is##5##3##(2008-2#1)(2008-3#4)
image quality objectives##3##3##(2012-1#3)
image quality of a##3##4##(2008-2#1)(2008-3#2)
image quality of##5##3##(2008-2#2)(2008-3#2)(2011-1#1)
image quality##56##2##(1997-8#5)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#12)(2008-3#18)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#2)(2012-1#9)(2012-12#1)(2012-3#1)(2013-8#1)
image recognition##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
image reconstruction algorithm##2##3##(2008-3#2)
image reconstruction algorithms##2##3##(2010-2#1)(2012-1#1)
image reconstruction from##2##3##(2008-3#2)
image reconstruction in the##2##4##(2007-11#1)(2011-1#1)
image reconstruction in turbid media##2##5##(2007-12#2)
image reconstruction in##5##3##(2007-11#1)(2007-12#2)(2008-3#1)(2011-1#1)
image reconstruction of##5##3##(2008-3#4)(2011-1#1)
image reconstruction to##2##3##(2007-11#1)(2008-3#1)
image reconstruction##36##2##(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#20)(2008-7#1)(2009-5#1)(2010-2#1)(2011-1#2)(2012-1#1)
image reconstructions##2##2##(2008-2#1)(2008-9#1)
image registration##3##2##(2008-9#2)(2009-2#1)
image representing##2##2##(2008-3#1)(2012-3#1)
image resolution##9##2##(2007-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)
image resolutions##2##2##(2007-12#1)(2008-6#1)
image restoration##7##2##(2008-2#3)(2008-3#4)
image retrieval##2##2##(2007-11#1)(2008-3#1)
image segmentation##4##2##(2008-3#2)(2008-6#1)(2009-10#1)
image sensor##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
image separately##2##2##(2008-3#1)(2010-9#1)
image sequence of##2##3##(2008-3#1)(2012-2#1)
image sequence##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
image sequences##7##2##(2008-3#6)(2008-6#1)
image series##3##2##(2008-3#1)(2008-4#2)
image showed##2##2##(2008-12#1)(2012-3#1)
image shows that the##2##4##(2008-10#1)(2008-3#1)
image shows##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
image similar to##2##3##(2007-11#1)(2008-3#1)
image space##4##2##(2007-12#1)(2008-2#1)(2008-6#1)(2011-2#1)
image storage##4##2##(1995-6#2)(2008-3#2)
image synthesis##2##2##(2008-3#2)
image systems##2##2##(1996-2#1)(2008-2#1)
image taken##2##2##(2007-10#1)(2008-3#1)
image testing##2##2##(2008-3#2)
image than##2##2##(2008-2#1)(2008-3#1)
image that has been##2##4##(2008-3#1)(2011-2#1)
image that has##3##3##(2008-3#2)(2011-2#1)
image that is##5##3##(2007-12#1)(2008-12#1)(2008-2#3)
image that##10##2##(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#3)(2009-10#1)(2011-2#1)
image the spatial distribution of##2##5##(1995-3#1)(2008-2#1)
image the##14##2##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2009-12#1)(2010-12#1)(2011-7#1)
image through##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
image to be##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
image to obtain##2##3##(2008-3#1)(2008-5#1)
image to the##2##3##(2008-3#2)
image to##14##2##(2007-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2012-1#1)(2013-8#1)
image transfer through##2##3##(2008-3#2)
image transfer##3##2##(1995-12#1)(2008-3#2)
image transmission##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
image transmitted##2##2##(2007-12#1)(2008-3#1)
image was successfully##2##3##(1991-8#1)(2008-3#1)
image was##9##2##(1991-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-12#1)(2010-8#1)
image were##3##2##(2007-12#2)(2008-2#1)
image when##2##2##(2008-3#2)
image with the##2##3##(2008-3#1)(2011-1#1)
image with##9##2##(2008-10#1)(2008-2#3)(2008-3#3)(2010-9#1)(2011-1#1)
image##1231##1##(1990-11#1)(1990-5#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-3#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#12)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#5)(2007-10#3)(2007-11#64)(2007-12#144)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#8)(2008-10#40)(2008-11#7)(2008-12#14)(2008-2#166)(2008-3#371)(2008-4#12)(2008-5#19)(2008-6#36)(2008-7#16)(2008-8#3)(2008-9#44)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#15)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#9)(2010-6#2)(2010-8#18)(2010-9#5)(2011-1#28)(2011-2#16)(2011-7#3)(2012-1#14)(2012-12#7)(2012-2#20)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#14)
image&quot##2##1##(1991-12#1)(1995-2#1)
image-acquisition##2##1##(2008-2#1)(2008-3#1)
image-analysis##2##1##(2008-4#1)(2008-9#1)
image-based rendering##2##2##(2008-6#2)
image-based##4##1##(1994-5#1)(2008-3#1)(2008-6#2)
image-compression##2##1##(2008-3#2)
image-correction grating##2##2##(2008-3#2)
image-forming##5##1##(2008-3#1)(2008-4#2)(2008-9#2)
image-guided radiotherapy##3##2##(2008-2#1)(2009-11#2)
image-guided surgery applications##2##3##(2009-12#2)
image-guided surgery##6##2##(2009-12#4)(2012-2#2)
image-guided##14##1##(2008-2#1)(2009-11#3)(2009-12#4)(2010-7#1)(2011-1#2)(2012-2#2)(2013-1#1)
image-pair##3##1##(2008-2#3)
image-plane##7##1##(2007-11#1)(2008-3#6)
image-processing tasks##2##2##(2008-3#2)
image-processing##12##1##(2008-10#1)(2008-2#3)(2008-3#8)
image-quality equation##2##2##(2008-3#2)
image-quality##4##1##(2008-2#2)(2008-3#2)
image-reconstruction algorithm##2##2##(2012-1#2)
image-reconstruction##3##1##(2008-3#1)(2012-1#2)
imaged at##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
imaged by a##4##3##(2008-2#2)(2008-3#2)
imaged by##9##2##(2007-10#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2010-1#1)
imaged in##4##2##(1994-11#1)(2007-12#1)(2008-12#1)(2008-7#1)
imaged onto##2##2##(2008-2#1)(2008-3#1)
imaged point##2##2##(2008-2#1)(2008-3#1)
imaged simultaneously by use of##2##5##(2007-11#1)(2008-2#1)
imaged the##4##2##(2007-11#2)(2008-2#1)(2011-1#1)
imaged through a##2##3##(2008-2#2)
imaged through##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
imaged to##2##2##(2008-3#1)(2009-5#1)
imaged using##2##2##(2009-10#1)(2009-12#1)
imaged with##6##2##(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)
imaged##61##1##(1990-11#1)(1994-11#1)(2007-10#1)(2007-11#6)(2007-12#4)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#17)(2008-5#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-8#3)(2011-1#2)(2012-12#1)
imager is a##2##3##(2008-10#1)(2008-2#1)
imager is##4##2##(2008-10#1)(2008-2#2)(2013-8#1)
imager##25##1##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#13)(2009-4#1)(2013-8#4)
imagers##6##1##(2007-11#1)(2008-2#3)(2008-3#2)
imagery and##2##2##(2008-3#1)(2008-4#1)
imagery from##2##2##(2008-3#2)
imagery of##4##2##(2008-3#2)(2008-7#1)(2010-7#1)
imagery or##2##2##(1992-12#1)(2008-6#1)
imagery was##2##2##(2008-3#2)
imagery were##2##2##(1992-12#1)(2008-3#1)
imagery with##3##2##(2008-2#1)(2008-3#2)
imagery##71##1##(1992-12#14)(1995-11#4)(2007-5#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#25)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-6#3)(2010-7#1)(2013-8#5)
images a##2##2##(1996-2#1)(2008-2#1)
images acquired by##2##3##(2008-3#2)
images acquired##5##2##(1995-5#1)(2007-12#1)(2008-3#3)
images allowed##2##2##(2011-2#2)
images also##2##2##(2008-3#1)(2012-2#1)
images and also##2##3##(2008-2#1)(2009-3#1)
images and are##2##3##(2007-12#1)(2008-3#1)
images and the##9##3##(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)
images and##38##2##(1991-11#1)(1994-5#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#8)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
images are also##2##3##(2008-3#1)(2008-6#1)
images are analyzed##2##3##(2008-3#1)(2011-1#1)
images are combined##2##3##(2007-11#1)(2008-2#1)
images are encrypted by##2##4##(2007-11#1)(2008-3#1)
images are encrypted##3##3##(2007-11#1)(2008-3#2)
images are not##2##3##(2008-3#1)(2008-7#1)
images are obtained##5##3##(2007-12#2)(2008-3#2)(2013-8#1)
images are presented##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
images are reconstructed and##2##4##(2007-11#2)
images are reconstructed##3##3##(2007-11#2)(2007-12#1)
images are shown##2##3##(2008-2#2)
images are stored##2##3##(2008-3#2)
images are##65##2##(1991-2#1)(2007-11#8)(2007-12#4)(2008-1#3)(2008-2#7)(2008-3#27)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
images as a##3##3##(2008-1#1)(2008-2#1)(2009-3#1)
images as well as##3##4##(1994-12#1)(2007-12#1)(2008-3#1)
images as##7##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-3#1)
images at##9##2##(1992-5#1)(2008-10#1)(2008-2#4)(2008-3#2)(2012-1#1)
images based on##4##3##(2007-12#1)(2008-3#1)(2013-8#2)
images blurred##2##2##(2008-2#1)(2008-3#1)
images by the##2##3##(2008-3#1)(2012-2#1)
images by use of a##2##5##(2008-2#1)(2008-3#1)
images by use of##8##4##(2007-12#1)(2008-2#1)(2008-3#6)
images by##19##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#10)(2008-9#1)(2012-2#1)
images can be acquired##2##4##(2008-10#1)(2011-7#1)
images can be obtained##2##4##(2013-8#2)
images can be##11##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-8#1)(2011-7#1)(2013-8#2)
images can##17##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-7#1)(2013-8#2)
images clearly##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
images collected##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
images degraded by##2##3##(2007-12#1)(2008-3#1)
images displayed##2##2##(1996-5#1)(2008-2#1)
images for##15##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-7#1)(2013-1#1)
images formed by##4##3##(2008-3#3)(2008-7#1)
images formed##5##2##(2008-3#3)(2008-6#1)(2008-7#1)
images from a##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
images from the##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
images from##16##2##(2007-11#1)(2007-12#2)(2007-4#1)(2008-2#5)(2008-3#5)(2008-6#1)(2009-11#1)
images had##2##2##(2007-11#1)(2011-2#1)
images has##4##2##(2008-3#2)(2013-1#2)
images have been##2##3##(2008-10#1)(2012-3#1)
images have##4##2##(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
images in a##5##3##(1997-8#1)(2007-12#1)(2008-3#1)(2010-4#1)(2011-7#1)
images in the##4##3##(1991-2#1)(1992-12#1)(2007-11#1)(2008-2#1)
images in##24##2##(1991-2#1)(1992-12#1)(1995-11#1)(1997-8#4)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)(2008-9#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
images is a##2##3##(2008-6#1)(2010-8#1)
images is developed##2##3##(2008-3#1)(2010-8#1)
images is proposed##4##3##(2007-11#1)(2008-6#1)(2010-8#1)(2013-8#1)
images is##26##2##(1995-5#1)(2007-11#4)(2007-12#1)(2008-2#3)(2008-3#6)(2008-6#2)(2010-8#4)(2012-2#3)(2013-1#1)(2013-8#1)
images made##2##2##(1995-6#1)(2007-8#1)
images obtained by##4##3##(2007-12#2)(2008-3#1)(2008-7#1)
images obtained with##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
images obtained##8##2##(1995-11#1)(2007-12#3)(2008-3#2)(2008-7#2)
images of a single object##2##5##(2008-2#2)
images of a##16##3##(2007-11#5)(2008-2#4)(2008-3#5)(2008-8#1)(2011-2#1)
images of biological samples##2##4##(2007-11#1)(2008-1#1)
images of biological##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
images of both##2##3##(2007-12#1)(2008-3#1)
images of different##2##3##(2007-12#1)(2008-3#1)
images of human##2##3##(2007-12#1)(2008-3#1)
images of interest##2##3##(2008-9#2)
images of living##4##3##(2007-11#2)(2011-1#1)(2012-2#1)
images of men##2##3##(2009-9#1)(2013-8#1)
images of nursing##2##3##(2008-12#1)(2010-10#1)
images of objects##2##3##(1990-3#1)(2007-11#1)
images of obliquely lit##2##4##(2008-5#2)
images of small##2##3##(2008-3#2)
images of the Catphan phantom##2##5##(2012-1#2)
images of the same##2##4##(2007-11#1)(2008-3#1)
images of the skin##2##4##(2008-5#1)(2008-6#1)
images of the two##2##4##(1996-5#1)(2008-1#1)
images of the##49##3##(1995-6#1)(1996-5#1)(1997-8#1)(2007-11#8)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#12)(2008-5#3)(2008-6#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)
images of three##2##3##(2008-10#1)(2008-2#1)
images of various##2##3##(2008-3#1)(2012-2#1)
images of##185##2##(1990-3#1)(1992-11#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-8#5)(2007-10#2)(2007-11#20)(2007-12#20)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#19)(2008-3#41)(2008-4#4)(2008-5#7)(2008-6#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#2)(2011-7#1)(2012-1#5)(2012-12#1)(2012-2#7)(2012-3#2)(2013-8#1)
images on the##2##3##(2008-3#2)
images on##4##2##(2008-3#3)(2009-5#1)
images or##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
images over##2##2##(2008-3#1)(2011-2#1)
images presented##2##2##(1997-8#1)(2008-2#1)
images reconstructed by##3##3##(2007-11#1)(2008-3#2)
images reconstructed##5##2##(2007-11#1)(2008-3#4)
images recorded##2##2##(2007-11#1)(2008-3#1)
images remain##2##2##(2008-3#1)(2011-7#1)
images reveal##2##2##(2007-11#1)(2008-3#1)
images revealed not only##2##4##(1994-3#1)(2011-2#1)
images revealed that the##2##4##(2008-10#1)(2013-1#1)
images revealed##8##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#2)
images show a##2##3##(2007-12#1)(2008-10#1)
images show##5##2##(1997-2#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-6#1)
images showed better lesion conspicuity than##2##6##(1997-8#2)
images showed that##2##3##(2008-10#1)(2013-8#1)
images showed##6##2##(1997-8#2)(2008-10#2)(2008-7#1)(2013-8#1)
images taken from##3##3##(1995-6#1)(2007-12#1)(2010-8#1)
images taken##7##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-8#1)
images that are##4##3##(1994-8#1)(2008-2#2)(2008-3#1)
images that##16##2##(1994-8#1)(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#7)(2012-2#1)
images through##3##2##(2007-11#1)(2008-3#2)
images to be##2##3##(2011-1#1)(2012-2#1)
images to provide##2##3##(2009-12#1)(2010-3#1)
images to##10##2##(1995-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-2#1)
images together##2##2##(2007-11#1)(2008-5#1)
images using a##2##3##(2008-3#1)(2010-8#1)
images using any##2##3##(1995-2#1)(2008-9#1)
images using##10##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#3)(2012-3#1)
images was##6##2##(1995-6#1)(2007-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
images were acquired##6##3##(1997-8#1)(2007-11#1)(2008-5#1)(2008-7#2)(2010-12#1)
images were analyzed##2##3##(2008-10#1)(2013-1#1)
images were computed##2##3##(2007-11#1)(2007-12#1)
images were found##2##3##(2007-12#1)(2008-7#1)
images were obtained by##2##4##(2007-11#2)
images were obtained##8##3##(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#1)
images were reconstructed##2##3##(2008-3#2)
images were recorded##3##3##(1995-8#1)(2008-2#1)(2008-3#1)
images were taken##5##3##(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#1)(2013-1#1)
images were##56##2##(1995-8#1)(1997-8#3)(2007-10#3)(2007-11#8)(2007-12#5)(2008-10#2)(2008-12#3)(2008-2#2)(2008-3#7)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#2)(2011-7#2)(2012-1#1)(2012-2#1)(2013-1#2)
images will##2##2##(2008-3#1)(2013-1#1)
images with a spatial resolution of##2##6##(2007-12#1)(2008-3#1)
images with a##7##3##(2007-12#1)(2008-3#6)
images with high##2##3##(2007-8#1)(2008-3#1)
images with##33##2##(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#1)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)
images without##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
images##938##1##(1990-3#1)(1991-11#3)(1991-2#2)(1992-11#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#6)(1995-8#1)(1996-1#1)(1996-2#4)(1996-3#1)(1996-5#4)(1996-7#1)(1997-2#1)(1997-8#26)(2006-12#1)(2007-10#5)(2007-11#77)(2007-12#75)(2007-4#2)(2007-8#2)(2008-1#9)(2008-10#29)(2008-11#9)(2008-12#9)(2008-2#101)(2008-3#242)(2008-4#8)(2008-5#21)(2008-6#19)(2008-7#23)(2008-8#7)(2008-9#16)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#24)(2010-9#2)(2011-1#13)(2011-2#19)(2011-3#3)(2011-7#8)(2012-1#12)(2012-12#9)(2012-2#34)(2012-3#7)(2013-1#19)(2013-8#17)
images'##2##1##(2008-3#1)(2012-3#1)
images) are##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
images)##6##1##(2008-12#1)(2008-3#2)(2008-7#2)(2010-8#1)
imaginal disc##2##2##(2009-5#1)(2012-3#1)
imaginal discs##3##2##(1993-2#1)(2008-10#2)
imaginal##8##1##(1993-2#1)(1995-11#1)(2008-10#2)(2008-6#2)(2009-5#1)(2012-3#1)
imaginary indices of refraction##2##4##(2008-2#1)(2008-3#1)
imaginary indices##3##2##(2008-2#1)(2008-3#2)
imaginary part of the##5##4##(2007-11#1)(2008-3#4)
imaginary part##14##2##(2007-11#1)(2007-12#1)(2008-3#12)
imaginary parts of the refractive index##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
imaginary parts of the##12##4##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#4)
imaginary parts of##13##3##(2007-11#3)(2007-12#2)(2008-2#4)(2008-3#4)
imaginary##38##1##(1995-1#1)(2007-11#4)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#20)(2008-7#1)(2009-10#1)
imagination and##4##2##(1992-1#1)(1992-3#1)(2008-5#1)(2011-2#1)
imagination##13##1##(1992-1#1)(1992-3#1)(2008-11#1)(2008-5#3)(2009-10#2)(2009-5#1)(2010-7#1)(2011-2#2)(2013-8#1)
imaginative##4##1##(1994-3#1)(1996-6#1)(2013-1#1)(2013-8#1)
imagine##3##1##(2010-2#1)(2011-2#1)(2012-8#1)
imagined exercise##3##2##(1992-12#3)
imagined##11##1##(1992-11#1)(1992-12#3)(1993-5#1)(1997-3#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-1#1)(2013-8#1)
imaging (DWI)##4##2##(2007-10#3)(2010-12#1)
imaging (MRI) and##5##3##(1992-3#1)(1996-7#1)(2007-11#1)(2008-7#1)(2012-2#1)
imaging (MRI)##72##2##(1992-3#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#10)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
imaging a##5##2##(2008-3#2)(2008-9#1)(2009-12#1)(2012-2#1)
imaging aberrations##2##2##(2008-3#2)
imaging agent##2##2##(1993-5#1)(2009-9#1)
imaging allows##2##2##(2007-11#1)(2009-1#1)
imaging analysis of confocal and conventional polarization microscopes by##2##9##(2008-3#2)
imaging analysis##4##2##(2008-10#1)(2008-3#2)(2008-4#1)
imaging and a##2##3##(2008-6#1)(2012-2#1)
imaging and clinical##2##3##(1996-6#1)(2008-12#1)
imaging and detection of micro-retroreflectors##2##5##(2011-1#2)
imaging and detection of##3##4##(2011-1#2)(2011-2#1)
imaging and genetic evidence##2##4##(2012-12#2)
imaging and in##2##3##(2012-12#1)(2012-2#1)
imaging and laboratory##2##3##(1992-12#1)(2008-7#1)
imaging and spectroscopy techniques##2##4##(2008-11#1)(2012-12#1)
imaging and spectroscopy##5##3##(2008-11#1)(2008-2#1)(2012-12#3)
imaging and the##4##3##(2009-11#1)(2009-9#1)(2010-12#1)(2012-1#1)
imaging and therapy##3##3##(1996-1#1)(2010-6#1)(2012-12#1)
imaging and##103##2##(1991-12#1)(1992-12#2)(1992-3#1)(1993-11#1)(1995-1#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#2)(2008-6#3)(2008-7#7)(2008-9#2)(2009-11#2)(2009-9#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#10)(2012-2#12)(2012-3#1)(2013-1#3)(2013-8#3)
imaging appearances of##2##3##(2008-1#1)(2012-2#1)
imaging appearances##5##2##(2008-1#1)(2011-2#1)(2012-2#3)
imaging appears##2##2##(2008-1#1)(2012-2#1)
imaging applications##8##2##(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)
imaging approach is##2##3##(2007-12#2)
imaging approach##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
imaging approaches##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
imaging are described##3##3##(2008-7#1)(2008-9#1)(2011-7#1)
imaging are discussed##2##3##(2010-9#1)(2011-2#1)
imaging are##13##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-12#2)(2010-9#1)(2011-2#1)(2011-7#1)
imaging at the##2##3##(2008-2#1)(2008-3#1)
imaging at##10##2##(1993-3#1)(1996-2#1)(1997-8#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-8#2)
imaging based on##9##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#3)
imaging biological samples in liquid##2##5##(2008-2#2)
imaging biological samples##3##3##(2008-2#2)(2008-4#1)
imaging biomarkers##2##2##(2008-8#1)(2013-8#1)
imaging but##4##2##(2008-7#2)(2009-11#1)(2011-7#1)
imaging by use of##6##4##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
imaging by using##2##3##(2008-3#2)
imaging by##22##2##(1994-9#1)(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#5)(2009-11#1)(2010-5#1)(2010-9#2)(2012-2#2)
imaging can be used##2##4##(2012-2#2)
imaging can be##6##3##(2007-11#1)(2008-3#2)(2009-5#1)(2012-2#2)
imaging can reveal##2##3##(2008-9#1)(2011-1#1)
imaging can##11##2##(2007-11#1)(2008-3#2)(2008-9#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-2#2)
imaging capabilities and##2##3##(2007-11#1)(2011-1#1)
imaging capabilities##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2011-1#1)(2013-1#1)
imaging capability##4##2##(2008-3#3)(2011-1#1)
imaging centers##5##2##(1991-1#3)(1993-2#2)
imaging characteristics of##8##3##(1994-5#1)(1997-8#1)(2007-10#1)(2008-2#1)(2012-2#4)
imaging characteristics##12##2##(1994-5#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-2#1)(2011-2#2)(2012-2#5)
imaging concept##2##2##(2007-11#1)(2008-3#1)
imaging configuration##2##2##(2008-2#2)
imaging confirmed##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
imaging contrast##2##2##(2007-11#1)(2010-5#1)
imaging could##2##2##(2012-2#1)(2013-7#1)
imaging criteria for##2##3##(2008-2#1)(2013-1#1)
imaging data to##2##3##(2009-8#1)(2013-1#1)
imaging data##11##2##(2007-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#4)(2013-8#1)
imaging demonstrated##6##2##(1992-12#1)(2006-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
imaging department##4##2##(1992-2#1)(1994-12#1)(1994-2#1)(2008-7#1)
imaging departments##2##2##(1991-1#1)(1995-12#1)
imaging depth##4##2##(2008-1#1)(2008-3#1)(2009-5#1)(2011-1#1)
imaging detector##5##2##(2008-2#1)(2008-3#3)(2010-3#1)
imaging device##7##2##(1991-2#1)(1993-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2012-2#1)
imaging devices are##2##3##(2008-3#1)(2008-6#1)
imaging devices##9##2##(2008-2#3)(2008-3#3)(2008-6#3)
imaging diagnosis of##2##3##(2008-2#1)(2011-2#1)
imaging diagnosis##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
imaging diagnostics##3##2##(2007-11#1)(2007-8#1)(2008-3#1)
imaging during resection of##2##4##(2008-7#2)
imaging during##5##2##(2008-7#2)(2009-10#1)(2009-11#1)(2013-1#1)
imaging ellipsometer##2##2##(2007-11#2)
imaging equipment##6##2##(1995-1#2)(1996-2#3)(2007-12#1)
imaging examination##2##2##(1990-8#1)(1995-12#1)
imaging examinations##3##2##(2008-4#2)(2012-12#1)
imaging features of##3##3##(2008-1#1)(2012-2#2)
imaging features##14##2##(1997-8#3)(2008-1#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#1)
imaging fiber bundles##3##3##(2008-3#3)
imaging fiber-based nanoarrays##2##3##(2008-10#2)
imaging field##2##2##(1994-1#1)(2013-1#1)
imaging findings and##3##3##(2008-8#1)(2011-2#2)
imaging findings of##4##3##(1997-8#2)(2012-2#1)(2012-3#1)
imaging findings were##3##3##(2008-7#1)(2011-2#2)
imaging findings##22##2##(1997-8#3)(2008-7#3)(2008-8#3)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
imaging fluorescent##2##2##(1992-6#1)(2008-4#1)
imaging for diagnosis##2##3##(2008-2#1)(2010-7#1)
imaging for the##2##3##(2010-12#1)(2010-5#1)
imaging for##18##2##(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
imaging from##2##2##(2007-11#1)(2008-3#1)
imaging geometry##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
imaging has a##2##3##(2007-11#1)(2011-2#1)
imaging has become##2##3##(2010-12#1)(2010-8#1)
imaging has been##4##3##(2007-12#1)(2008-2#1)(2010-3#1)(2012-12#1)
imaging has##18##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#1)
imaging have##7##2##(2007-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#2)(2012-12#1)
imaging in a##4##3##(2007-12#2)(2008-12#1)(2013-3#1)
imaging in live##2##3##(2008-10#1)(2008-4#1)
imaging in multiple##2##3##(2009-11#1)(2010-12#1)
imaging in patients##4##3##(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
imaging in regions where##3##4##(2007-12#1)(2008-3#2)
imaging in scattering media##2##4##(2007-12#1)(2008-3#1)
imaging in the diagnosis##3##4##(1990-12#1)(2009-10#1)(2012-2#1)
imaging in the##18##3##(1990-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#1)(2009-4#2)(2010-12#1)(2012-2#2)
imaging in turbid media##4##4##(2007-12#4)
imaging in turbid##5##3##(2007-12#4)(2008-3#1)
imaging in vivo##2##3##(2008-4#1)(2013-1#1)
imaging in##98##2##(1990-11#1)(1990-12#1)(1995-8#1)(1996-2#2)(1996-7#1)(1997-8#1)(2007-11#7)(2007-12#9)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#3)(2008-2#4)(2008-3#14)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#3)(2009-4#4)(2010-12#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#4)(2012-2#7)(2013-1#2)(2013-3#1)(2013-8#3)
imaging instrument##2##2##(2007-11#2)
imaging is a promising technique##2##5##(2007-11#1)(2011-1#1)
imaging is a##7##3##(2007-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
imaging is demonstrated##2##3##(2007-12#1)(2008-2#1)
imaging is of##2##3##(2008-1#1)(2012-2#1)
imaging is proposed##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
imaging is##49##2##(1990-12#1)(1994-11#1)(1997-8#1)(2006-4#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#4)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#1)
imaging lens##2##2##(2007-12#1)(2008-3#1)
imaging may be helpful in the##2##6##(2008-9#1)(2009-3#1)
imaging may be##4##3##(1994-1#1)(2008-9#1)(2009-3#1)(2012-2#1)
imaging may##8##2##(1994-1#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-2#1)
imaging measurements##3##2##(1994-3#1)(2008-11#1)(2008-7#1)
imaging method and##2##3##(2008-10#2)
imaging method##9##2##(2007-12#1)(2008-10#4)(2008-11#2)(2012-2#2)
imaging methodology##2##2##(2008-4#1)(2011-1#1)
imaging methods can##2##3##(2008-12#1)(2012-2#1)
imaging methods for##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
imaging methods##20##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-2#6)(2013-8#1)
imaging microscope##4##2##(2007-12#2)(2009-12#1)(2011-1#1)
imaging microscopy##6##2##(1993-11#1)(2008-1#2)(2008-3#1)(2009-4#1)(2011-1#1)
imaging modalities and##3##3##(2007-7#1)(2010-11#1)(2010-9#1)
imaging modalities in the##2##4##(2007-4#1)(2008-7#1)
imaging modalities in##3##3##(2007-4#1)(2008-7#1)(2009-4#1)
imaging modalities which##2##3##(2008-3#1)(2011-2#1)
imaging modalities##22##2##(2007-12#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-9#4)(2011-2#2)(2012-2#1)(2013-1#1)
imaging modality for the##2##4##(2010-6#1)(2012-2#1)
imaging modality for##4##3##(2008-7#1)(2010-3#1)(2010-6#1)(2012-2#1)
imaging modality in the##2##4##(2010-12#1)(2011-7#1)
imaging modality of choice##2##4##(2011-2#1)(2012-12#1)
imaging modality that##2##3##(2011-2#1)(2013-1#1)
imaging modality to##2##3##(2008-10#1)(2010-6#1)
imaging modality##21##2##(2008-10#1)(2008-2#1)(2008-7#3)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#2)
imaging mode##2##2##(2008-5#1)(2009-5#1)
imaging modes##2##2##(2011-1#2)
imaging of a##12##3##(2007-12#3)(2008-2#2)(2008-3#4)(2009-12#1)(2011-2#1)(2013-1#1)
imaging of an##2##3##(1990-11#1)(2007-12#1)
imaging of apoptosis with##2##4##(2008-8#2)
imaging of apoptosis##3##3##(2008-8#3)
imaging of atherosclerosis##3##3##(2008-8#1)(2010-9#1)(2012-3#1)
imaging of biological tissues##2##4##(2008-3#1)(2008-9#1)
imaging of breast cancer##2##4##(1994-12#1)(2010-6#1)
imaging of cancer##3##3##(2010-6#1)(2011-1#1)(2012-12#1)
imaging of fluorescent##2##3##(2009-6#1)(2010-12#1)
imaging of glioblastoma##2##3##(2008-7#2)
imaging of hard##2##3##(2008-2#1)(2008-3#1)
imaging of highly scattering media##2##5##(2008-2#1)(2008-3#1)
imaging of highly scattering##3##4##(2008-2#2)(2008-3#1)
imaging of human##3##3##(1994-8#1)(2007-11#1)(2008-3#1)
imaging of intracellular##3##3##(1993-5#1)(2009-8#2)
imaging of living##2##3##(2007-12#1)(2011-1#1)
imaging of patients##2##3##(2008-7#1)(2011-7#1)
imaging of phase##3##3##(2007-11#1)(2008-2#2)
imaging of surfaces##2##3##(2008-10#1)(2008-3#1)
imaging of the liver##2##4##(2010-12#1)(2012-1#1)
imaging of the posterior##2##4##(1997-8#1)(2011-7#1)
imaging of the##45##3##(1990-11#1)(1990-3#1)(1994-11#1)(1996-3#3)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#2)(2010-12#5)(2010-9#1)(2011-2#4)(2011-7#2)(2012-1#1)(2013-1#1)
imaging of tissue##3##3##(2007-11#2)(2011-1#1)
imaging of turbid##2##3##(2008-3#1)(2009-10#1)
imaging of##204##2##(1990-11#2)(1990-3#1)(1991-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1996-3#3)(1997-8#6)(2007-10#1)(2007-11#19)(2007-12#20)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#14)(2008-3#29)(2008-5#3)(2008-7#16)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#12)(2010-2#2)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#5)(2011-7#6)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#2)(2013-8#1)
imaging offers##2##2##(2008-10#1)(2008-2#1)
imaging on the##2##3##(2008-2#1)(2012-1#1)
imaging on##5##2##(1991-12#1)(2008-2#2)(2012-1#1)(2012-3#1)
imaging optics##5##2##(2008-2#1)(2008-3#4)
imaging or##6##2##(2007-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
imaging over##2##2##(2008-7#1)(2012-12#1)
imaging parameters##5##2##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
imaging performance of the##2##4##(2008-2#2)
imaging performance of##8##3##(2008-2#5)(2008-3#2)(2012-1#1)
imaging performance##13##2##(2008-11#1)(2008-2#7)(2008-3#4)(2012-1#1)
imaging performed##2##2##(2010-8#1)(2012-8#1)
imaging personnel##5##2##(1991-2#1)(1994-1#4)
imaging photon detector##2##3##(2008-3#2)
imaging plays a##2##3##(2011-1#1)(2011-2#1)
imaging plays##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
imaging polarimetry##5##2##(2008-3#5)
imaging probe##3##2##(2008-3#1)(2012-12#2)
imaging probes##2##2##(2010-9#1)(2012-12#1)
imaging problems##2##2##(2008-2#1)(2008-3#1)
imaging procedure##5##2##(1993-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2010-8#1)
imaging procedures##8##2##(1993-1#1)(1995-12#2)(2007-11#3)(2011-1#1)(2012-2#1)
imaging process##4##2##(2008-2#2)(2008-3#2)
imaging processes##2##2##(2008-2#1)(2008-3#1)
imaging properties and the##2##4##(2007-11#1)(2008-3#1)
imaging properties of##4##3##(2008-3#3)(2008-7#1)
imaging properties##7##2##(2007-11#1)(2008-3#5)(2008-7#1)
imaging protocol##3##2##(2007-10#1)(2010-6#1)(2012-2#1)
imaging protocols##2##2##(2008-7#1)(2011-2#1)
imaging quality##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
imaging requires##2##2##(2010-1#1)(2012-2#1)
imaging research##2##2##(2008-11#1)(2008-2#1)
imaging resolution##2##2##(2008-3#2)
imaging results with##2##3##(2008-2#2)
imaging results##5##2##(2007-11#1)(2008-11#1)(2008-2#2)(2010-11#1)
imaging revealed##9##2##(2007-10#2)(2008-11#1)(2008-12#3)(2009-3#1)(2012-12#1)(2013-8#1)
imaging scanning##2##2##(2008-10#1)(2008-7#1)
imaging scheme##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
imaging sensors##2##2##(2008-3#2)
imaging services##8##2##(1992-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1995-12#2)
imaging showed##9##2##(1997-6#1)(2007-8#1)(2008-7#2)(2010-10#1)(2011-2#2)(2013-7#2)
imaging shows##2##2##(1996-2#1)(2013-8#1)
imaging software##3##2##(2008-2#1)(2008-4#1)(2010-12#1)
imaging specialists##2##2##(1994-1#1)(2008-2#1)
imaging spectrometer based on toroidal##2##5##(2013-8#2)
imaging spectrometer is##2##3##(2008-2#1)(2013-8#1)
imaging spectrometer##10##2##(2007-12#1)(2008-2#2)(2008-3#4)(2013-8#3)
imaging spectrometers with##2##3##(2008-2#2)
imaging spectrometers##11##2##(2008-2#5)(2008-3#5)(2013-8#1)
imaging spectroradiometer##6##2##(2008-2#1)(2008-3#5)
imaging strategies for##2##3##(2010-12#1)(2010-7#1)
imaging strategies##4##2##(2008-2#2)(2010-12#1)(2010-7#1)
imaging studies have##2##3##(2008-2#2)
imaging studies of##3##3##(1996-5#1)(2008-3#1)(2008-8#1)
imaging studies that##2##3##(2009-10#1)(2009-2#1)
imaging studies with##2##3##(1995-2#1)(2011-1#1)
imaging studies##27##2##(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
imaging study##8##2##(1993-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#1)
imaging system by##2##3##(2007-11#1)(2008-3#1)
imaging system for##4##3##(2008-3#2)(2008-9#1)(2011-1#1)
imaging system has been##3##4##(2007-11#1)(2007-12#1)(2010-5#1)
imaging system in##2##3##(1990-5#1)(2008-3#1)
imaging system is##5##3##(2007-12#1)(2008-3#4)
imaging system that##6##3##(2007-11#1)(2008-3#4)(2011-1#1)
imaging system was##2##3##(1995-6#1)(2011-3#1)
imaging system##60##2##(1990-5#1)(1995-6#1)(2007-11#7)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#24)(2008-4#1)(2008-5#1)(2008-9#3)(2009-8#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-3#1)(2012-2#1)(2013-8#2)
imaging systems and##2##3##(2008-2#1)(2008-3#1)
imaging systems is##2##3##(2007-12#1)(2008-3#1)
imaging systems##23##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#9)(2008-9#1)(2010-8#1)(2011-1#2)(2012-2#2)
imaging technique and##2##3##(2012-2#1)(2013-1#1)
imaging technique for the##4##4##(1997-8#1)(2008-3#1)(2010-11#1)(2012-2#1)
imaging technique for##9##3##(1997-8#2)(2007-12#3)(2008-3#2)(2010-11#1)(2012-2#1)
imaging technique in##2##3##(1994-1#1)(2012-1#1)
imaging technique that uses##2##4##(2007-12#1)(2008-5#1)
imaging technique that##5##3##(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-9#1)
imaging technique##42##2##(1994-1#1)(1994-9#1)(1997-8#2)(2007-11#1)(2007-12#6)(2007-7#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#7)(2013-1#1)
imaging techniques and##6##3##(2007-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-6#1)(2013-1#1)
imaging techniques are##3##3##(1997-8#1)(2008-3#1)(2010-8#1)
imaging techniques available##2##3##(2012-2#1)(2013-1#1)
imaging techniques for##4##3##(2008-10#1)(2008-3#1)(2010-6#1)(2012-2#1)
imaging techniques have been##2##4##(2008-8#1)(2009-11#1)
imaging techniques have##5##3##(2008-4#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)
imaging techniques in the##2##4##(2011-1#1)(2011-2#1)
imaging techniques in##6##3##(1991-2#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
imaging techniques may##2##3##(1991-12#1)(2008-12#1)
imaging techniques such as##4##4##(2007-11#1)(2008-2#1)(2008-7#2)
imaging techniques to##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
imaging techniques##66##2##(1991-12#1)(1991-2#1)(1993-5#2)(1997-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#5)(2012-2#9)(2012-3#1)(2013-1#2)
imaging technologies##9##2##(1992-11#1)(2008-2#4)(2008-6#1)(2008-9#1)(2010-9#1)(2012-2#1)
imaging technology for##2##3##(1994-9#1)(2012-2#1)
imaging technology##12##2##(1994-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2011-7#1)(2012-2#3)
imaging test##4##2##(1991-12#1)(2008-3#1)(2009-5#1)(2010-8#1)
imaging tests##4##2##(1992-12#1)(2008-7#1)(2010-6#1)(2012-3#1)
imaging that is##3##3##(2008-2#1)(2008-3#2)
imaging that uses##2##3##(2007-11#1)(2008-3#1)
imaging that##10##2##(1997-6#1)(2007-11#1)(2007-4#1)(2008-2#3)(2008-3#3)(2009-5#1)
imaging the##17##2##(1991-12#1)(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-7#3)(2012-2#2)
imaging through a scattering medium##3##5##(2007-12#1)(2008-2#2)
imaging through a##5##3##(2007-12#3)(2008-2#2)
imaging through scattering media##5##4##(2007-12#3)(2008-2#1)(2008-3#1)
imaging through turbid media##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
imaging through turbulence##2##3##(2008-3#2)
imaging through##22##2##(2007-11#2)(2007-12#9)(2008-2#4)(2008-3#7)
imaging time##2##2##(2009-8#1)(2012-2#1)
imaging to demonstrate##2##3##(2007-12#1)(2011-2#1)
imaging to provide##2##3##(2007-12#1)(2013-1#1)
imaging to record##2##3##(2007-12#1)(2008-3#1)
imaging to the##2##3##(2007-12#1)(2008-9#1)
imaging to##22##2##(1990-12#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-11#2)(2008-3#3)(2008-9#2)(2009-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
imaging tool##2##2##(2007-11#1)(2011-2#1)
imaging tools##2##2##(1994-5#1)(2013-1#1)
imaging using a##3##3##(2007-11#1)(2007-12#1)(2008-12#1)
imaging using##11##2##(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#2)(2011-1#1)(2011-7#1)
imaging variable##2##2##(2007-12#1)(2008-3#1)
imaging volume##2##2##(2009-4#2)
imaging was performed##6##3##(2007-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#2)
imaging was used to detect##2##5##(1994-8#1)(1996-2#1)
imaging was used to##4##4##(1994-8#1)(1996-2#1)(2007-12#1)(2008-11#1)
imaging was##20##2##(1994-8#1)(1996-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#2)(2013-8#1)
imaging were##6##2##(1995-11#1)(1997-8#2)(2007-11#1)(2008-12#1)(2011-2#1)
imaging will##3##2##(2008-1#2)(2012-2#1)
imaging with CT and MRI##2##5##(2008-1#1)(2008-2#1)
imaging with CT##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
imaging with a dynamic aperture##2##5##(2007-12#2)
imaging with a dynamic##3##4##(2007-12#2)(2008-3#1)
imaging with a##14##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#7)(2012-2#1)
imaging with an##4##3##(2008-1#1)(2008-3#2)(2010-12#1)
imaging with partially coherent##2##4##(2007-12#1)(2008-2#1)
imaging with surface coils##2##4##(1990-10#1)(1997-8#1)
imaging with the##2##3##(2007-11#1)(2007-12#1)
imaging with##62##2##(1990-10#1)(1992-12#1)(1997-8#1)(2007-11#7)(2007-12#12)(2008-1#4)(2008-2#4)(2008-3#15)(2008-7#8)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)
imaging without##3##2##(2007-11#1)(2011-1#2)
imaging##2142##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#4)(1991-11#2)(1991-12#5)(1991-2#3)(1992-1#1)(1992-11#1)(1992-12#9)(1992-2#2)(1992-3#8)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#3)(1993-5#5)(1993-6#1)(1993-9#1)(1994-1#11)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#8)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#1)(1997-8#40)(2006-10#3)(2006-12#2)(2006-4#4)(2007-10#17)(2007-11#131)(2007-12#130)(2007-4#8)(2007-5#2)(2007-7#2)(2007-8#18)(2007-9#3)(2008-1#44)(2008-10#36)(2008-11#31)(2008-12#20)(2008-2#160)(2008-3#306)(2008-4#17)(2008-5#13)(2008-6#22)(2008-7#107)(2008-8#45)(2008-9#52)(2009-1#1)(2009-10#13)(2009-11#16)(2009-12#10)(2009-2#7)(2009-3#10)(2009-4#24)(2009-5#19)(2009-6#3)(2009-7#6)(2009-8#12)(2009-9#8)(2010-1#3)(2010-10#3)(2010-11#7)(2010-12#45)(2010-2#5)(2010-3#10)(2010-4#2)(2010-5#16)(2010-6#20)(2010-7#8)(2010-8#21)(2010-9#26)(2011-1#68)(2011-2#69)(2011-3#1)(2011-7#26)(2012-1#10)(2012-12#48)(2012-2#154)(2012-3#18)(2012-8#1)(2013-1#45)(2013-3#2)(2013-7#6)(2013-8#32)
imaging-based##4##1##(2008-8#2)(2008-9#1)(2013-1#1)
imagings##2##1##(1995-4#1)(2008-7#1)
imatinib mesylate and hydroxyurea##2##4##(2008-7#2)
imatinib mesylate##4##2##(2008-7#2)(2009-4#1)(2010-11#1)
imatinib##21##1##(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#2)(2010-11#1)(2010-4#1)(2011-2#5)(2012-12#8)
imazalil##4##1##(2008-10#4)
imazethapyr##3##1##(2008-10#3)
imbalance and##4##2##(1994-12#1)(2008-11#1)(2008-7#1)(2012-7#1)
imbalance between reactive oxygen species##2##5##(2008-1#1)(2008-7#1)
imbalance between the##2##3##(2008-3#1)(2013-8#1)
imbalance between##16##2##(1993-2#1)(1993-3#1)(1995-2#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-12#1)(2009-7#1)(2011-2#2)(2013-8#2)
imbalance in the##7##3##(1990-2#1)(1991-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
imbalance in##17##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-9#2)(1994-12#1)(1994-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
imbalance of the##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
imbalance of##4##2##(1997-3#1)(2007-11#1)(2008-7#1)(2008-8#1)
imbalance##70##1##(1990-2#1)(1990-9#1)(1991-2#1)(1991-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#4)(1994-2#1)(1995-2#2)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#4)
imbalanced##4##1##(1990-9#1)(2008-10#1)(2008-7#1)(2010-8#1)
imbalances and##2##2##(1996-12#1)(2011-2#1)
imbalances in##3##2##(1994-2#1)(2008-3#1)(2013-1#1)
imbalances##13##1##(1993-9#2)(1994-12#1)(1994-2#1)(1996-12#1)(1997-3#2)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#2)
imbedded in##2##2##(1991-2#1)(2008-3#1)
imbedded##4##1##(1991-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
imbibition##5##1##(2008-10#2)(2008-12#1)(2009-6#2)
imbricata##2##1##(2013-1#2)
imidacloprid##5##1##(2008-10#3)(2011-2#2)
imidazole as the##2##3##(2008-10#2)
imidazole as##3##2##(2008-10#3)
imidazole carboxamide##2##2##(1992-2#2)
imidazole derivative##3##2##(2008-10#2)(2011-2#1)
imidazole derivatives##5##2##(2008-10#4)(2008-8#1)
imidazole in##2##2##(1994-5#1)(2008-10#1)
imidazole##36##1##(1991-5#1)(1992-2#2)(1992-6#1)(1994-5#7)(1995-3#1)(1995-5#1)(2008-10#14)(2008-8#4)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
imidazole]##4##1##(1991-8#4)
imidazoles##2##1##(1995-3#1)(1997-7#1)
imidazoline derivatives##3##2##(2008-5#3)
imidazoline receptor##2##2##(2008-5#2)
imidazoline receptors##2##2##(2007-11#1)(2008-5#1)
imidazoline##9##1##(1995-11#1)(2007-11#1)(2008-5#7)
imidazolium bis(trifluoromethyl) sulfonylimide##3##3##(2011-1#3)
imide##4##1##(1992-6#1)(2007-11#2)(2009-9#1)
imiglucerase##7##1##(2008-10#7)
imine##2##1##(1991-3#1)(1996-5#1)
imines##2##1##(1995-3#1)(2010-4#1)
iminiums##2##1##(1991-9#2)
imino proton##3##2##(1991-8#1)(1993-11#1)(1994-8#1)
imino##7##1##(1990-8#2)(1991-8#2)(1993-11#1)(1994-8#1)(1996-5#1)
iminodiacetate chelating##3##2##(2008-10#3)
iminodiacetate groups##2##2##(2008-10#2)
iminodiacetate resin##3##2##(2008-10#3)
iminodiacetate##9##1##(2008-10#9)
iminodiacetate-agarose adsorbent##2##2##(2008-10#2)
iminodiacetic acid (IDA)##2##3##(1990-8#1)(2008-10#1)
iminodiacetic acid##4##2##(1990-8#1)(1997-2#1)(2008-10#2)
iminodiacetic groups##2##2##(2008-10#2)
iminodiacetic##6##1##(1990-8#1)(1997-2#1)(2008-10#4)
iminodipeptide##2##1##(1994-11#2)
iminophosphorane##2##1##(1997-4#2)
imipenem and##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
imipenem##6##1##(2007-7#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
imipramine administration##4##2##(1994-2#4)
imipramine and their main metabolites##2##5##(2008-10#2)
imipramine and their##3##3##(2008-10#3)
imipramine and##5##2##(1990-5#2)(2008-10#3)
imipramine binding##3##2##(1990-5#1)(1996-7#2)
imipramine##20##1##(1990-5#4)(1994-2#6)(1996-7#2)(2008-10#7)(2008-7#1)
imitate the##2##2##(1991-2#1)(2009-12#1)
imitate##5##1##(1991-2#1)(2008-2#1)(2008-6#1)(2009-12#1)(2012-3#1)
imitated##3##1##(2008-11#1)(2008-8#1)(2012-12#1)
imitates##3##1##(1994-2#1)(2011-1#1)(2012-3#1)
imitating the##2##2##(2007-8#1)(2012-12#1)
imitating##4##1##(1997-3#1)(2007-8#1)(2012-12#2)
imitation##2##1##(2008-2#1)(2009-2#1)
immature CEs##6##2##(2008-5#6)
immature and mature##4##3##(2008-10#1)(2008-11#2)(2010-3#1)
immature and##5##2##(2008-10#1)(2008-11#2)(2010-3#1)(2011-2#1)
immature bone##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
immature brain is##2##3##(1996-5#2)
immature brain##3##2##(1996-5#3)
immature cells##2##2##(1991-12#1)(2008-4#1)
immature female##2##2##(2008-6#1)(2011-2#1)
immature forms were##2##3##(2011-2#2)
immature fruit##6##2##(2008-10#6)
immature fruits##2##2##(2008-10#1)(2012-2#1)
immature internodes##2##2##(2011-2#2)
immature lymphocytes##2##2##(1994-3#1)(1997-9#1)
immature or##3##2##(2008-10#3)
immature particles##2##2##(2009-7#2)
immature pear##2##2##(2008-10#2)
immature rats##3##2##(1993-12#1)(1996-2#1)(2008-5#1)
immature secretory granules##2##3##(1992-12#2)
immature stages of Aedes aegypti##2##5##(2008-5#2)
immature stages of##3##3##(2007-10#1)(2008-5#2)
immature stages##4##2##(2007-10#1)(2008-5#3)
immature teratoma in##2##3##(2008-10#1)(2009-5#1)
immature teratoma##4##2##(1992-8#1)(2008-10#1)(2009-5#2)
immature##116##1##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#3)(1997-4#1)(1997-9#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#23)(2008-11#7)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#2)(2009-7#2)(2010-11#1)(2010-3#3)(2010-6#1)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
immaturity of##3##2##(1995-8#1)(2008-5#1)(2013-1#1)
immaturity##6##1##(1991-6#1)(1995-3#1)(1995-8#1)(2008-5#1)(2010-3#1)(2013-1#1)
immeasurable##3##1##(1994-9#1)(2008-6#1)(2013-8#1)
immediate action##2##2##(1996-2#1)(2012-2#1)
immediate and delayed##8##3##(1992-9#1)(1993-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-7#2)(2013-8#1)
immediate and long-term results##2##4##(1991-6#2)
immediate and long-term##6##3##(1991-6#2)(1997-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
immediate and##26##2##(1990-5#1)(1991-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-7#2)(2013-1#2)(2013-8#2)
immediate application##2##2##(2009-4#1)(2011-2#1)
immediate control of the##3##4##(1991-2#1)(2008-10#2)
immediate early gene##3##3##(1993-12#1)(1993-6#1)(1994-11#1)
immediate early genes (IEGs)##2##4##(1995-12#1)(1996-12#1)
immediate early genes##9##3##(1993-6#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#2)(1996-12#1)
immediate early promoter##2##3##(1997-4#1)(1997-8#1)
immediate early protein##2##3##(1993-8#2)
immediate early##20##2##(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1996-12#1)(1997-4#1)(1997-8#1)(2008-11#1)
immediate effects of traditional Thai massage##2##6##(2010-12#2)
immediate effects of##5##3##(1991-9#1)(2008-12#2)(2010-12#2)
immediate effects##6##2##(1991-9#1)(2008-12#2)(2009-4#1)(2010-12#2)
immediate feedback##2##2##(1996-1#1)(2013-1#1)
immediate hypersensitivity to##2##3##(2013-1#2)
immediate hypersensitivity##3##2##(2008-10#1)(2013-1#2)
immediate implant placement##2##3##(2007-12#1)(2013-1#1)
immediate loading in the rehabilitation of partial edentulies##2##8##(2013-1#2)
immediate loading##8##2##(2008-11#1)(2010-12#1)(2011-7#1)(2013-1#5)
immediate nursing home placement##2##4##(1990-5#2)
immediate onset of##2##3##(2012-12#1)(2012-3#1)
immediate onset##3##2##(2007-10#1)(2012-12#1)(2012-3#1)
immediate post-operative##6##2##(2007-11#2)(2007-7#1)(2011-2#1)(2012-2#2)
immediate postoperative##12##2##(1990-3#2)(1990-9#1)(2007-11#1)(2007-8#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2013-8#1)
immediate reconstruction with##2##3##(1993-11#1)(2011-2#1)
immediate release MT##3##3##(2008-11#3)
immediate release##4##2##(2008-11#4)
immediate response##3##2##(2008-11#1)(2008-6#1)(2012-12#1)
immediate steps##2##2##(1994-9#1)(1996-11#1)
immediate stress##2##2##(2008-3#1)(2008-7#1)
immediate surgical##3##2##(1994-12#1)(2007-12#1)(2012-12#1)
immediate treatment##3##2##(1996-9#1)(2010-12#1)(2012-1#1)
immediate type hypersensitivity reaction##2##4##(2008-10#2)
immediate use##2##2##(2007-6#1)(2013-8#1)
immediate visual##2##2##(1996-12#1)(2009-6#1)
immediate##287##1##(1990-11#1)(1990-2#1)(1990-3#4)(1990-5#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#3)(1991-9#2)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#17)(2008-11#16)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#2)(2008-6#5)(2008-7#10)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#9)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#3)(2012-7#2)(2012-8#1)(2013-1#25)(2013-8#5)
immediate-early gene##6##2##(1991-10#1)(1991-7#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-4#1)
immediate-early genes##8##2##(1992-12#1)(1994-9#1)(1996-12#1)(1997-3#3)(2008-11#1)(2008-7#1)
immediate-early##14##1##(1991-10#1)(1991-7#1)(1992-12#1)(1994-9#1)(1996-12#2)(1996-5#1)(1997-3#3)(2008-11#2)(2008-4#1)(2008-7#1)
immediate-release##2##1##(2008-1#1)(2008-3#1)
immediately adjacent to the##4##4##(1994-12#1)(1994-8#1)(1995-6#1)(2008-3#1)
immediately adjacent to##7##3##(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
immediately adjacent trees##3##3##(2008-10#3)
immediately adjacent##10##2##(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-3#1)(2008-5#1)
immediately after R2##2##3##(2013-1#2)
immediately after a##4##3##(1997-4#1)(1997-5#1)(2007-8#1)(2009-3#1)
immediately after instruction##2##3##(2013-1#2)
immediately after one##2##3##(2008-5#1)(2013-1#1)
immediately after reperfusion##2##3##(2011-2#2)
immediately after sample collection##2##4##(2008-10#2)
immediately after the competition##2##4##(2008-5#2)
immediately after the##18##3##(1990-2#1)(1991-9#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#1)(2010-8#1)(2012-2#2)(2013-8#1)
immediately after their##2##3##(2010-8#1)(2013-1#1)
immediately after training##2##3##(1994-8#1)(2013-1#1)
immediately after treatment##5##3##(1992-9#3)(1996-9#1)(1997-4#1)
immediately after##94##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#10)(2013-8#2)
immediately and##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
immediately available##2##2##(2007-8#1)(2008-7#1)
immediately before the##4##3##(1990-12#1)(1995-8#1)(2009-8#1)(2012-2#1)
immediately before##13##2##(1990-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
immediately by a##2##3##(1991-2#1)(2008-11#1)
immediately discharged##2##2##(2008-3#2)
immediately distal to the##2##4##(2007-8#1)(2008-11#1)
immediately downstream of the##3##4##(1990-11#1)(1992-9#1)(1997-2#1)
immediately downstream of##6##3##(1990-11#1)(1992-9#1)(1996-6#1)(1997-2#1)(2008-11#1)(2008-3#1)
immediately downstream##7##2##(1990-11#1)(1992-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-3#1)
immediately followed by a##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
immediately followed by##5##3##(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
immediately following the##7##3##(1991-6#1)(1992-12#1)(1993-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)
immediately following##15##2##(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)
immediately in##4##2##(1994-9#1)(2008-10#2)(2008-6#1)
immediately linked to##2##3##(1994-12#1)(2008-7#1)
immediately loaded mini dental implants##2##5##(2013-1#2)
immediately loaded##4##2##(2011-7#1)(2013-1#3)
immediately or##5##2##(1992-9#1)(2007-11#1)(2008-7#1)(2012-7#1)(2013-1#1)
immediately preceding the##2##3##(1991-6#1)(2010-6#1)
immediately preceding##3##2##(1991-6#1)(2008-10#1)(2010-6#1)
immediately prior to##5##3##(1992-6#1)(1993-12#1)(1993-6#1)(1996-9#1)(2008-10#1)
immediately to##2##2##(2008-11#1)(2008-12#1)
immediately upon##3##2##(1995-2#1)(2008-2#1)(2012-12#1)
immediately upstream of the##4##4##(1992-11#1)(1993-2#1)(1994-6#1)(1995-8#1)
immediately upstream of##5##3##(1992-11#1)(1993-2#1)(1994-6#1)(1995-8#1)(2011-1#1)
immediately upstream##7##2##(1992-11#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-8#1)(2008-11#1)(2011-1#1)
immediately##264##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#4)(1997-2#2)(1997-4#2)(1997-5#3)(1997-6#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#30)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#23)(2013-8#4)
immense##13##1##(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
immensely##3##1##(2008-4#1)(2011-1#1)(2012-2#1)
immerse##2##1##(1990-2#1)(2008-10#1)
immersed boundary method##2##3##(2009-11#1)(2011-1#1)
immersed in a##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-5#1)(2011-1#1)
immersed in liquid##2##3##(2007-12#1)(2008-3#1)
immersed in the##3##3##(2008-10#2)(2008-7#1)
immersed in water##2##3##(2008-10#1)(2008-5#1)
immersed in##29##2##(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
immersed into##3##2##(2008-10#3)
immersed##35##1##(1990-5#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
immersed-boundary method for##2##3##(2009-11#2)
immersing the electrode##2##3##(2008-10#2)
immersing the##7##2##(2008-10#5)(2008-4#2)
immersing##14##1##(2008-10#9)(2008-4#2)(2009-12#1)(2009-7#2)
immersion and##4##2##(2008-10#1)(2008-5#2)(2013-7#1)
immersion in 0##4##3##(2013-1#4)
immersion in a##2##3##(2007-11#1)(2012-2#1)
immersion in##11##2##(1992-4#1)(2007-11#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#6)
immersion medium##2##2##(2008-2#1)(2008-3#1)
immersion of##2##2##(1990-5#1)(1995-12#1)
immersion time##2##2##(1995-3#1)(2008-10#1)
immersion##52##1##(1990-5#1)(1992-4#1)(1995-12#1)(1995-3#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#10)(2008-5#5)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#3)(2012-6#1)(2013-1#8)(2013-7#5)(2013-8#1)
immersive##5##1##(2008-6#3)(2010-4#1)(2013-8#1)
immigrant and##2##2##(1992-5#1)(2008-11#1)
immigrant families##4##2##(2009-7#3)(2013-8#1)
immigrant students##2##2##(2008-12#2)
immigrant youth##3##2##(2008-12#1)(2010-5#2)
immigrant##25##1##(1992-5#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-8#2)(2009-7#3)(2010-11#2)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
immigrants and refugees##2##3##(2011-2#2)
immigrants and##8##2##(1992-5#1)(1993-3#1)(1997-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
immigrants from endemic##2##3##(1996-6#1)(2007-12#1)
immigrants from the##2##3##(1997-6#1)(2008-10#1)
immigrants from##9##2##(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
immigrants living in Brazil##2##4##(2008-2#2)
immigrants with the##2##3##(1991-5#1)(1994-12#1)
immigrants with##3##2##(1991-5#1)(1994-12#1)(2010-12#1)
immigrants##59##1##(1991-5#1)(1992-1#1)(1992-5#6)(1993-3#1)(1993-6#1)(1994-12#1)(1996-6#1)(1997-2#1)(1997-6#5)(1997-8#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-7#6)(2008-8#3)(2008-9#2)(2010-12#4)(2010-4#1)(2010-8#1)(2011-2#6)(2012-1#3)(2013-1#4)(2013-8#1)
immigrating##2##1##(2008-10#1)(2008-8#1)
immigration and##3##2##(1990-3#1)(2008-10#2)
immigration from##3##2##(1995-3#1)(2007-5#1)(2008-8#1)
immigration in##2##2##(2008-10#2)
immigration of##3##2##(2008-10#1)(2008-8#2)
immigration to the##2##3##(2008-10#1)(2013-8#1)
immigration to##3##2##(2008-10#2)(2013-8#1)
immigration##33##1##(1990-3#1)(1991-12#1)(1992-8#1)(1995-3#1)(2007-5#1)(2008-10#12)(2008-12#1)(2008-8#7)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#4)
immigrations##2##1##(2008-10#1)(2008-9#1)
imminent##16##1##(1991-3#1)(1992-2#1)(1993-6#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#2)
immiscible##8##1##(1993-5#1)(1993-8#1)(2008-10#4)(2008-8#1)(2009-11#1)
immobile and##2##2##(1993-12#1)(2008-7#1)
immobile##7##1##(1991-5#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-7#2)(2008-8#1)
immobilisation and##2##2##(2008-10#2)
immobilisation in##2##2##(2008-10#1)(2008-11#1)
immobilisation methods##2##2##(2008-10#2)
immobilisation of##5##2##(1997-3#1)(2008-10#3)(2008-11#1)
immobilisation##26##1##(1997-3#1)(2007-11#1)(2008-10#21)(2008-11#2)(2008-12#1)
immobilised antibody##2##2##(2008-10#2)
immobilised enzyme##2##2##(2008-10#2)
immobilised human##2##2##(1994-12#2)
immobilised in##2##2##(2008-10#2)
immobilised metal ion affinity##3##4##(1997-2#3)
immobilised on a##4##3##(2008-10#4)
immobilised on the##7##3##(2008-10#7)
immobilised on##18##2##(2008-10#18)
immobilised onto the##2##3##(2008-10#2)
immobilised onto##5##2##(1997-2#3)(2008-10#2)
immobilised##63##1##(1990-12#1)(1991-12#1)(1993-8#2)(1994-12#2)(1997-2#7)(2007-11#1)(2008-10#48)(2008-12#1)
immobility and##2##2##(1991-12#1)(2007-11#1)
immobility than##2##2##(2008-11#2)
immobility##11##1##(1991-12#4)(2007-11#2)(2008-11#3)(2008-4#1)(2013-1#1)
immobilization and the##2##3##(2007-11#1)(2008-10#1)
immobilization and##11##2##(1994-2#1)(2007-11#2)(2008-10#5)(2008-8#1)(2008-9#1)(2010-7#1)
immobilization for##2##2##(2007-8#1)(2008-10#1)
immobilization has##2##2##(1993-6#1)(2008-10#1)
immobilization in##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
immobilization is##5##2##(2008-10#3)(2008-9#1)(2009-3#1)
immobilization matrix##2##2##(2008-10#2)
immobilization method for##2##3##(2008-10#1)(2010-11#1)
immobilization method##5##2##(2008-10#4)(2010-11#1)
immobilization methods##2##2##(2008-10#2)
immobilization of a##5##3##(2008-10#3)(2009-3#1)(2010-12#1)
immobilization of horseradish peroxidase##2##4##(2008-10#2)
immobilization of the enzyme##2##4##(2008-10#2)
immobilization of the target##2##4##(2008-10#2)
immobilization of the##18##3##(1995-5#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)
immobilization of##71##2##(1992-3#1)(1993-12#1)(1994-3#2)(1995-5#1)(2008-10#48)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#2)
immobilization on silica##2##3##(2008-10#2)
immobilization on the##5##3##(2008-10#2)(2009-3#2)(2011-2#1)
immobilization on##13##2##(1997-2#2)(2008-10#8)(2009-3#2)(2011-2#1)
immobilization stress##4##2##(1995-12#2)(2012-1#2)
immobilization technique##2##2##(2008-10#2)
immobilization was##2##2##(2008-9#1)(2011-2#1)
immobilization with##2##2##(2008-7#1)(2013-1#1)
immobilization##163##1##(1990-2#1)(1992-3#1)(1993-12#2)(1993-6#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-5#1)(1997-2#2)(2007-11#2)(2007-8#3)(2008-10#96)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-3#4)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-1#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
immobilize single##2##2##(2008-10#1)(2008-7#1)
immobilize##16##1##(1990-2#1)(1991-5#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)
immobilized 1##2##2##(2008-10#2)
immobilized HA and##2##3##(2008-10#2)
immobilized HA##3##2##(2008-10#3)
immobilized Ru(bpy)(3)(2+) were##2##3##(2008-10#2)
immobilized Ru(bpy)(3)(2+)##4##2##(2008-10#4)
immobilized and##10##2##(1993-12#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-7#1)
immobilized antibodies##2##2##(2008-10#1)(2008-4#1)
immobilized antibody##3##2##(1990-12#2)(2008-10#1)
immobilized at the##3##3##(2008-10#3)
immobilized at##4##2##(2008-10#3)(2009-3#1)
immobilized by crosslinking##2##3##(2008-10#2)
immobilized by##8##2##(2008-10#6)(2008-4#2)
immobilized cell##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
immobilized cells in##2##3##(2008-11#1)(2008-7#1)
immobilized cells is##2##3##(2008-12#1)(2008-6#1)
immobilized cells of##2##3##(2008-6#1)(2008-7#1)
immobilized cells##12##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#4)
immobilized covalently on##2##3##(2008-10#2)
immobilized enzymatic reactors##3##3##(2008-12#3)
immobilized enzyme reactor##2##3##(2008-10#2)
immobilized enzyme##11##2##(1994-11#1)(2008-10#7)(2008-6#1)(2008-7#1)(2009-10#1)
immobilized enzymes##6##2##(1992-11#2)(1995-3#1)(2008-10#3)
immobilized human serum albumin##2##4##(2008-10#2)
immobilized human##5##2##(1993-8#3)(2008-10#2)
immobilized in a##12##3##(1990-5#1)(1996-12#1)(2008-10#8)(2008-11#2)
immobilized in calcium alginate##2##4##(2008-5#1)(2008-6#1)
immobilized in chitosan##2##3##(2008-10#2)
immobilized in mesoporous MCM-41##2##4##(2010-4#2)
immobilized in the fibrous##2##4##(2008-11#2)
immobilized in the##4##3##(2008-10#2)(2008-11#2)
immobilized in##39##2##(1990-5#1)(1996-12#1)(2008-10#24)(2008-11#5)(2008-5#1)(2008-6#4)(2010-3#1)(2010-4#2)
immobilized into##2##2##(2008-10#1)(2008-6#1)
immobilized lipase##3##2##(2008-6#1)(2008-7#2)
immobilized metal ion affinity chromatography##2##5##(1990-8#2)
immobilized metal##5##2##(1990-8#2)(1995-8#1)(2008-10#1)(2011-2#1)
immobilized nanometer TiO(2)##3##3##(2008-10#3)
immobilized on 2 Celite derivatives##2##5##(1997-2#2)
immobilized on Amberlite IRA-743 resin##2##5##(2008-10#2)
immobilized on Amberlite##3##3##(2008-10#3)
immobilized on a rotating disk##3##5##(2008-10#3)
immobilized on a silica support##2##5##(2008-10#2)
immobilized on a##18##3##(2008-10#14)(2008-11#1)(2008-4#1)(2008-7#2)
immobilized on an anion-exchange##4##4##(2008-10#4)
immobilized on an eggshell membrane##2##5##(2008-10#2)
immobilized on an##10##3##(2008-10#9)(2008-12#1)
immobilized on chitosan membranes##2##4##(2008-10#2)
immobilized on controlled pore glass (CPG) by##2##7##(2008-10#2)
immobilized on controlled pore glass##5##5##(2008-10#5)
immobilized on sepiolite##6##3##(2008-10#6)
immobilized on silica gel as##2##5##(2008-10#2)
immobilized on silica gel##4##4##(2008-10#4)
immobilized on silica##7##3##(2008-10#7)
immobilized on the surface of a##2##6##(2008-10#2)
immobilized on the surface of the##3##6##(2008-10#2)(2008-11#1)
immobilized on the surface of##7##5##(2008-10#6)(2008-11#1)
immobilized on the surface##8##4##(1991-5#1)(2008-10#6)(2008-11#1)
immobilized on the##29##3##(1991-5#1)(2008-10#22)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)
immobilized on top of##2##4##(2008-10#2)
immobilized on##124##2##(1990-8#1)(1991-5#2)(1993-6#1)(1996-5#1)(1997-2#4)(2008-10#93)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2009-10#1)(2010-4#1)
immobilized onto a##4##3##(2008-10#4)
immobilized onto an##2##3##(2008-10#2)
immobilized onto gold##2##3##(2008-10#2)
immobilized onto the##2##3##(2008-10#2)
immobilized onto##24##2##(1991-5#1)(1993-6#1)(2008-10#22)
immobilized pH gradient##2##3##(2008-10#1)(2008-7#1)
immobilized pH##3##2##(2008-10#2)(2008-7#1)
immobilized phosphatidylcholines##2##2##(1994-11#2)
immobilized protein##4##2##(1996-12#1)(2008-10#2)(2009-2#1)
immobilized proteinase##2##2##(1990-5#2)
immobilized reactor##2##2##(2008-10#2)
immobilized recombinant##3##2##(1994-6#1)(1995-6#1)(2008-10#1)
immobilized redox indicators##2##3##(2008-10#2)
immobilized redox##3##2##(2008-10#3)
immobilized silica gel##3##3##(2008-10#3)
immobilized the##3##2##(1993-8#1)(2008-10#2)
immobilized through##2##2##(2008-10#2)
immobilized to##3##2##(2008-10#3)
immobilized urease##4##2##(1992-11#1)(1994-11#2)(2008-10#1)
immobilized with gelatin by##2##4##(2008-10#2)
immobilized with gelatin##3##3##(2008-10#3)
immobilized with##7##2##(2008-10#6)(2010-5#1)
immobilized##471##1##(1990-12#5)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-5#5)(1992-11#5)(1992-12#1)(1992-6#1)(1993-11#3)(1993-12#2)(1993-6#2)(1993-8#4)(1994-11#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-3#5)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#9)(2007-12#1)(2008-10#302)(2008-11#22)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#6)(2008-6#13)(2008-7#28)(2008-8#3)(2009-10#2)(2009-2#1)(2009-3#2)(2010-11#1)(2010-3#1)(2010-4#4)(2010-5#1)(2011-2#1)
immobilized-enzyme reactors##3##2##(2008-10#3)
immobilized-enzyme##4##1##(2008-10#4)
immobilizing a##2##2##(2008-10#1)(2010-7#1)
immobilizing antibodies##2##2##(2008-10#2)
immobilizing the##5##2##(2007-10#1)(2008-10#3)(2008-9#1)
immobilizing##29##1##(1991-5#1)(1992-11#1)(2007-10#1)(2007-11#1)(2008-10#22)(2008-11#1)(2008-9#1)(2010-7#1)
immodest proposal##2##2##(1995-3#1)(1997-1#1)
immoral##2##1##(2008-8#1)(2013-8#1)
immortal cell##2##2##(2008-11#2)
immortal cells##3##2##(1990-5#1)(1993-11#1)(2008-9#1)
immortal##10##1##(1990-5#1)(1993-11#3)(1997-7#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)
immortalised##5##1##(2008-11#5)
immortalization and carcinogenesis##2##3##(2008-11#2)
immortalization and##3##2##(2008-11#2)(2008-6#1)
immortalization of mouse##2##3##(1993-11#1)(2008-2#1)
immortalization of##7##2##(1993-11#2)(2008-11#2)(2008-2#3)
immortalization##15##1##(1993-11#3)(1994-8#1)(2008-11#6)(2008-2#3)(2008-6#2)
immortalize human T cells##3##4##(2008-11#3)
immortalize primary human cells##2##4##(2008-11#2)
immortalize primary##3##2##(2008-11#2)(2008-2#1)
immortalize##8##1##(2008-11#7)(2008-2#1)
immortalized T cells##3##3##(2008-11#3)
immortalized T##6##2##(2008-11#6)
immortalized and##3##2##(1992-10#1)(2008-7#1)(2009-12#1)
immortalized by the##2##3##(1997-6#1)(2007-10#1)
immortalized by##3##2##(1997-6#1)(2007-10#1)(2008-11#1)
immortalized rat##2##2##(1992-1#2)
immortalized##32##1##(1991-9#1)(1992-1#2)(1992-10#1)(1994-9#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-10#1)(2008-10#1)(2008-11#14)(2008-4#2)(2008-7#2)(2009-12#1)(2013-1#1)
immune activation and##2##3##(2011-2#1)(2012-2#1)
immune activation##7##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
immune activity##4##2##(2008-7#1)(2009-12#1)(2012-2#2)
immune alterations##3##2##(2008-10#3)
immune and##6##2##(1991-8#1)(1993-6#1)(1995-12#1)(2009-6#1)(2012-3#1)(2013-7#1)
immune assay##2##2##(2008-10#2)
immune cell activation##3##3##(2008-4#1)(2012-3#2)
immune cell function##2##3##(2008-10#1)(2008-3#1)
immune cell##15##2##(1992-2#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
immune cells have##2##3##(1991-2#1)(2013-8#1)
immune cells in the##2##4##(2008-10#1)(2012-3#1)
immune cells in##5##3##(2008-10#1)(2008-9#1)(2009-3#1)(2012-3#2)
immune cells involved in##2##4##(1992-12#1)(1994-5#1)
immune cells##41##2##(1991-1#2)(1991-2#1)(1992-12#1)(1994-11#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#1)
immune clearance##2##2##(2013-8#2)
immune complex formation##3##3##(1996-5#2)(2011-2#1)
immune complex glomerulonephritis##2##3##(2008-1#2)
immune complex##10##2##(1996-5#3)(1997-8#1)(2007-7#1)(2008-1#2)(2008-4#1)(2009-7#1)(2011-2#1)
immune complexes (CIC)##2##3##(1990-12#1)(2008-10#1)
immune complexes##12##2##(1990-12#2)(1991-2#2)(1996-5#1)(1997-8#2)(2008-10#2)(2008-4#1)(2010-5#1)(2012-3#1)
immune defects##4##2##(1994-3#2)(2012-3#1)(2013-8#1)
immune defense##12##2##(2008-6#1)(2008-8#4)(2008-9#3)(2009-6#2)(2009-9#1)(2012-3#1)
immune deficiencies##2##2##(2009-12#1)(2011-2#1)
immune deficiency syndrome##5##3##(1991-9#1)(1992-2#1)(1994-3#1)(2010-11#1)(2011-2#1)
immune deficiency##11##2##(1991-9#1)(1992-2#1)(1994-3#1)(1995-5#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
immune destruction of##2##3##(1997-2#1)(2011-2#1)
immune deviation##3##2##(1995-6#1)(2008-4#1)(2010-1#1)
immune dysfunction##5##2##(1995-6#1)(2008-10#1)(2008-12#3)
immune effector##4##2##(1994-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
immune effects##5##2##(1991-3#1)(2008-10#4)
immune evasion##2##2##(2009-8#1)(2011-1#1)
immune from##3##2##(1995-6#1)(1997-6#1)(2009-8#1)
immune function and##4##3##(2008-10#3)(2008-8#1)
immune function in the##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
immune function in##13##3##(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)
immune function of lymphocytes##2##4##(1995-8#2)
immune function of##3##3##(1995-8#2)(2008-10#1)
immune function testing##2##3##(2008-10#2)
immune function tests##2##3##(2008-10#2)
immune function with##2##3##(2008-10#2)
immune function##51##2##(1991-1#1)(1993-12#1)(1995-12#1)(1995-8#2)(2008-10#23)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#6)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#2)(2012-3#1)
immune functioning##3##2##(2008-11#2)(2008-2#1)
immune functions of##2##3##(1993-12#2)
immune functions##10##2##(1992-9#1)(1993-12#4)(1994-11#1)(1995-12#1)(2008-5#1)(2009-3#1)(2011-2#1)
immune gene##2##2##(2012-3#2)
immune genes##3##2##(2012-3#2)(2013-1#1)
immune globulin##6##2##(1992-12#1)(1994-6#3)(2009-6#1)(2010-11#1)
immune hemolytic anemia##2##3##(1994-6#2)
immune inflammatory##3##2##(1995-2#1)(2013-1#2)
immune mechanisms##2##2##(2011-2#1)(2012-2#1)
immune mediated##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
immune memory##2##2##(2012-12#2)
immune modulation##3##2##(1994-6#1)(2008-10#2)
immune parameters##4##2##(1991-1#1)(2008-10#2)(2008-11#1)
immune physiology##3##2##(2010-3#3)
immune privilege##5##2##(2010-1#5)
immune processes##2##2##(2009-12#1)(2012-2#1)
immune profile of##2##3##(1995-12#2)
immune reaction to##2##3##(2008-10#1)(2008-11#1)
immune reaction##9##2##(1996-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2013-8#1)
immune reactions##6##2##(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-3#1)
immune reactivity##3##2##(2006-10#1)(2008-7#1)(2010-12#1)
immune recognition of the bacterium##2##5##(2008-7#2)
immune recognition of##3##3##(2008-4#1)(2008-7#2)
immune recognition##4##2##(2008-4#1)(2008-7#2)(2012-2#1)
immune reconstitution inflammatory syndrome (IRIS) is a##2##7##(2009-7#1)(2010-5#1)
immune reconstitution inflammatory syndrome (IRIS)##3##5##(2009-7#1)(2010-5#1)(2012-2#1)
immune reconstitution inflammatory syndrome##5##4##(2008-10#1)(2009-7#1)(2010-5#2)(2012-2#1)
immune reconstitution syndrome in##2##4##(2007-12#1)(2009-7#1)
immune reconstitution syndrome##3##3##(2007-12#2)(2009-7#1)
immune reconstitution##9##2##(2007-12#2)(2008-1#1)(2008-10#1)(2009-7#2)(2010-5#2)(2012-2#1)
immune regulation##7##2##(1991-12#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-3#1)
immune regulators##2##2##(2011-2#2)
immune response against##6##3##(1994-3#1)(2008-10#1)(2008-9#3)(2013-1#1)
immune response and inflammation##2##4##(2012-12#2)
immune response and##12##3##(1992-9#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
immune response are##2##3##(1991-2#1)(1997-7#1)
immune response by intramuscular injection of##2##6##(1997-8#2)
immune response by##5##3##(1997-8#3)(2008-4#1)(2013-1#1)
immune response in an##2##4##(2008-11#1)(2008-8#1)
immune response in the##2##4##(2008-10#1)(2008-7#1)
immune response in##15##3##(1991-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#3)(2013-1#1)
immune response is##5##3##(1994-11#1)(2006-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
immune response of the##2##4##(1996-3#1)(2008-7#1)
immune response of##9##3##(1991-12#1)(1992-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
immune response through##2##3##(2010-5#1)(2013-1#1)
immune response to a##3##4##(1995-2#1)(1995-5#1)(2008-4#1)
immune response to cancer##2##4##(1994-11#1)(2008-4#1)
immune response to different##2##4##(2007-10#1)(2007-5#1)
immune response to hepatitis##3##4##(2007-7#1)(2009-12#1)(2013-1#1)
immune response to infection##2##4##(2008-10#1)(2008-2#1)
immune response to recombinant hepatitis B##2##6##(1997-4#2)
immune response to scabies##2##4##(1996-12#2)
immune response to the##5##4##(1993-8#1)(1994-11#3)(2008-11#1)
immune response to##33##3##(1990-12#1)(1993-8#1)(1994-11#4)(1995-2#1)(1995-5#1)(1996-12#2)(1997-4#2)(2007-10#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2009-12#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
immune response triggered by##2##4##(2008-9#1)(2013-8#1)
immune response was##6##3##(1995-12#2)(1997-8#2)(2008-10#1)(2013-1#1)
immune response##167##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-9#4)(1993-1#1)(1993-12#2)(1993-8#1)(1994-11#5)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#4)(1996-12#2)(1996-3#1)(1997-4#5)(1997-7#1)(1997-8#6)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#23)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#15)(2013-7#2)(2013-8#4)
immune responses against bacterial infections##2##5##(1992-5#1)(2012-12#1)
immune responses against##9##3##(1992-5#1)(1995-5#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)
immune responses and##9##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
immune responses are##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)
immune responses elicited by##2##4##(1997-4#1)(2008-11#1)
immune responses in the##4##4##(1995-12#2)(2008-10#2)
immune responses in##12##3##(1994-9#1)(1995-12#2)(2008-10#5)(2008-5#1)(2009-8#1)(2010-5#1)(2013-8#1)
immune responses mediated by##3##4##(1992-2#1)(2006-10#1)(2012-12#1)
immune responses of bats##2##4##(2013-1#2)
immune responses of##5##3##(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#2)
immune responses than##2##3##(2007-12#1)(2008-9#1)
immune responses that##2##3##(1994-11#1)(2008-10#1)
immune responses to##13##3##(1991-12#1)(1991-5#1)(1995-2#1)(1995-5#2)(2007-11#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
immune responses were##2##3##(2008-11#2)
immune responses##126##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#5)(1995-5#5)(1996-12#1)(1997-4#2)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#18)(2008-11#16)(2008-12#3)(2008-4#10)(2008-5#6)(2008-8#2)(2008-9#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#5)(2010-10#1)(2010-12#1)(2010-5#3)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
immune responsiveness##3##2##(1994-5#1)(2008-10#1)(2009-4#1)
immune sera##2##2##(1990-12#1)(1995-12#1)
immune serum##4##2##(1991-9#1)(1992-12#2)(1996-12#1)
immune status of##3##3##(2007-2#1)(2008-5#1)(2011-1#1)
immune status##9##2##(1990-2#1)(1992-9#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#2)
immune stimulating##2##2##(2008-10#2)
immune stimulation##3##2##(1996-2#1)(2008-10#2)
immune stimulatory effects##2##3##(2008-10#1)(2011-2#1)
immune stimulatory##4##2##(2008-10#3)(2011-2#1)
immune suppression and##3##3##(2006-10#1)(2008-6#1)(2009-5#1)
immune suppression##7##2##(1991-8#1)(1995-3#1)(2006-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#1)
immune suppressive##2##2##(2010-1#1)(2012-3#1)
immune surveillance##3##2##(1992-2#1)(2008-1#1)(2008-10#1)
immune system activation##2##3##(2007-12#1)(2009-4#1)
immune system and the##3##4##(1995-12#1)(2009-12#1)(2010-8#1)
immune system and##14##3##(1990-11#1)(1990-9#1)(1995-12#1)(1996-11#1)(2006-10#1)(2008-12#2)(2008-7#1)(2009-12#2)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
immune system can be##2##4##(2008-10#1)(2008-5#1)
immune system can##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
immune system function##2##3##(2008-10#1)(2009-5#1)
immune system had##2##3##(1990-9#1)(2008-10#1)
immune system in HIV infection##2##5##(2008-12#2)
immune system in##9##3##(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
immune system is##4##3##(1991-8#1)(1995-6#1)(2009-6#1)(2013-1#1)
immune system of##7##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
immune system to mount##2##4##(2008-4#1)(2009-12#1)
immune system to recognize##2##4##(2010-8#1)(2013-7#1)
immune system to##5##3##(2008-4#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
immune system with##2##3##(2010-2#1)(2013-1#1)
immune system##163##2##(1990-11#1)(1990-9#2)(1991-1#1)(1991-8#1)(1993-12#3)(1993-3#3)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-6#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-12#4)(2008-2#2)(2008-4#15)(2008-5#9)(2008-7#6)(2008-9#2)(2009-1#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#4)(2013-8#3)
immune system's##2##2##(2013-7#2)
immune systems##8##2##(1990-7#1)(1992-12#1)(1993-8#1)(2006-5#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
immune to the##4##3##(2008-10#3)(2008-3#1)
immune to##19##2##(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#4)(2013-8#1)
immune tolerance##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
immune##927##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-7#1)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-12#6)(1992-2#4)(1992-5#1)(1992-6#1)(1992-9#7)(1993-1#1)(1993-11#1)(1993-12#10)(1993-3#4)(1993-6#1)(1993-8#2)(1994-11#9)(1994-3#6)(1994-5#4)(1994-6#8)(1994-8#3)(1994-9#2)(1995-12#14)(1995-2#10)(1995-3#1)(1995-5#10)(1995-6#4)(1995-8#2)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#4)(1996-9#1)(1997-2#1)(1997-4#8)(1997-6#1)(1997-7#2)(1997-8#12)(1997-9#2)(2006-10#9)(2006-5#1)(2006-6#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#5)(2007-5#4)(2007-7#2)(2008-1#8)(2008-10#168)(2008-11#41)(2008-12#12)(2008-2#8)(2008-3#12)(2008-4#42)(2008-5#24)(2008-6#5)(2008-7#16)(2008-8#15)(2008-9#32)(2009-1#1)(2009-10#4)(2009-12#9)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#7)(2009-6#5)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#12)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#8)(2010-5#13)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#41)(2012-1#2)(2012-12#21)(2012-2#31)(2012-3#34)(2013-1#44)(2013-7#12)(2013-8#22)
immune-competent patient##2##2##(2013-8#2)
immune-competent##4##1##(1994-5#1)(2013-8#3)
immune-complex kinase assay##2##3##(1993-6#1)(2008-4#1)
immune-complex##4##1##(1993-6#1)(1994-6#1)(1997-8#1)(2008-4#1)
immune-compromised##2##1##(2010-12#1)(2013-8#1)
immune-mediated disorders##2##2##(2008-10#2)
immune-mediated inflammatory responses in##2##4##(2008-10#2)
immune-mediated inflammatory responses##3##3##(2008-10#3)
immune-mediated inflammatory##10##2##(2008-10#3)(2011-2#6)(2013-1#1)
immune-mediated##21##1##(1993-6#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#9)(2013-1#1)
immune-modulating##2##1##(2010-11#1)(2010-5#1)
immunisation against##2##2##(1992-2#2)
immunisation by the##2##3##(1992-2#2)
immunisation coverage##3##2##(2011-2#3)
immunisation of##2##2##(1996-12#2)
immunisation schedule##2##2##(1992-2#1)(2013-8#1)
immunisation with a##2##3##(2007-2#2)
immunisation##19##1##(1991-3#2)(1992-2#5)(1996-12#2)(2007-2#2)(2008-7#1)(2009-5#1)(2011-2#3)(2013-8#3)
immunised with the##2##3##(1992-2#1)(1995-12#1)
immunised##5##1##(1992-2#2)(1995-12#2)(1996-12#1)
immunising##4##1##(1995-12#3)(2010-1#1)
immunity against##6##2##(1995-2#2)(1997-6#1)(2007-8#1)(2008-3#1)(2009-6#1)
immunity and protect##2##3##(2011-2#1)(2013-8#1)
immunity and##16##2##(1991-3#1)(1995-12#1)(1996-12#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#3)(2012-3#4)(2013-8#1)
immunity are##4##2##(2007-12#1)(2008-9#1)(2009-6#1)(2012-3#1)
immunity as##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
immunity by##6##2##(1997-4#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#1)
immunity for##2##2##(1994-1#1)(2009-5#1)
immunity from##4##2##(1991-3#1)(1995-5#1)(2008-3#2)
immunity in mice##2##3##(1995-12#1)(2008-10#1)
immunity in the##4##3##(1996-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
immunity in##17##2##(1995-12#1)(1996-1#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-3#1)
immunity induced by##3##3##(1995-12#1)(1997-3#1)(2011-2#1)
immunity is##7##2##(2007-5#1)(2008-4#2)(2008-5#1)(2008-9#1)(2013-1#2)
immunity may play##2##3##(1997-3#1)(2007-7#1)
immunity of##4##2##(1990-8#1)(2008-12#1)(2008-3#1)(2008-7#1)
immunity or##4##2##(1995-5#1)(1996-11#1)(2008-4#1)(2008-8#1)
immunity to##11##2##(1992-1#1)(1995-5#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)
immunity was assessed by##2##4##(2008-10#2)
immunity was##3##2##(2008-10#2)(2008-9#1)
immunity were reflected##2##3##(2008-10#1)(2008-5#1)
immunity were##3##2##(2008-10#2)(2008-5#1)
immunity##186##1##(1990-8#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-2#2)(1995-5#7)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#6)(1997-4#3)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-10#17)(2008-11#3)(2008-12#5)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#4)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#11)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#8)(2013-8#1)
immunity) and##2##2##(2009-7#1)(2012-3#1)
immunity)##3##1##(2009-7#1)(2010-11#1)(2012-3#1)
immunization against##5##2##(1996-3#1)(1997-6#2)(2009-5#1)(2013-1#1)
immunization and##7##2##(1995-12#1)(1995-5#1)(2008-10#2)(2008-4#2)(2008-9#1)
immunization at##3##2##(1995-12#1)(1996-2#1)(2008-10#1)
immunization by##3##2##(1994-6#1)(1996-3#1)(2013-1#1)
immunization can##2##2##(1994-9#1)(2008-11#1)
immunization completion##2##2##(1996-12#2)
immunization coverage in##2##3##(1996-12#2)
immunization coverage##4##2##(1996-12#3)(2013-1#1)
immunization in this group##2##4##(2009-5#2)
immunization in##4##2##(2007-12#1)(2009-5#3)
immunization is##4##2##(1994-9#4)
immunization levels and##2##3##(1996-12#2)
immunization levels##4##2##(1996-12#4)
immunization of mice with##3##4##(1995-5#1)(2009-6#2)
immunization of mice##4##3##(1995-5#2)(2009-6#2)
immunization of rabbits with##4##4##(1995-5#1)(1996-2#1)(2008-10#2)
immunization of rabbits##5##3##(1995-5#1)(1996-2#1)(2008-10#3)
immunization of##14##2##(1995-3#1)(1995-5#3)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#2)
immunization programs##7##2##(1996-12#3)(2007-12#2)(2010-10#1)(2013-1#1)
immunization protocol for##2##3##(2008-11#1)(2010-12#1)
immunization rate##2##2##(1997-8#1)(2008-4#1)
immunization rates by##2##3##(1996-12#1)(1996-3#1)
immunization rates##9##2##(1996-12#8)(1996-3#1)
immunization records##2##2##(1996-1#1)(1996-12#1)
immunization route##2##2##(2008-10#2)
immunization schedule##4##2##(1995-5#2)(1996-3#1)(2008-4#1)
immunization schedules##3##2##(1995-5#3)
immunization services##2##2##(1996-12#1)(2010-3#1)
immunization status##8##2##(1996-1#1)(1996-12#4)(1996-3#1)(2008-12#1)(2008-4#1)
immunization with a##5##3##(1994-8#1)(1995-2#1)(2008-11#1)(2008-4#2)
immunization with one or more doses of##2##7##(1995-5#2)
immunization with the##2##3##(1995-12#1)(1995-2#1)
immunization with##23##2##(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#4)(1996-11#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)
immunization##194##1##(1990-12#2)(1990-8#1)(1992-5#1)(1993-2#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#13)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#16)(1996-1#3)(1996-11#1)(1996-12#33)(1996-2#2)(1996-3#9)(1997-6#4)(1997-8#4)(2007-11#1)(2007-12#6)(2007-2#1)(2008-1#1)(2008-10#12)(2008-11#19)(2008-12#2)(2008-3#1)(2008-4#14)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#7)(2009-12#1)(2009-4#2)(2009-5#5)(2009-6#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
immunizations##17##1##(1992-3#1)(1992-6#1)(1995-5#2)(1996-12#8)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
immunize##7##1##(1993-8#1)(1994-3#1)(1995-3#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
immunized animals##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
immunized by##3##2##(1995-12#1)(1996-3#1)(2008-9#1)
immunized mice##4##2##(1990-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
immunized with EP-IPV##2##3##(1995-5#2)
immunized with a##2##3##(1990-12#1)(1995-5#1)
immunized with bovine##2##3##(1994-9#1)(2008-7#1)
immunized with recombinant##3##3##(1991-5#1)(2008-11#1)(2011-2#1)
immunized with sheep red blood cells##2##6##(2008-10#1)(2008-7#1)
immunized with##27##2##(1990-12#1)(1991-5#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-5#5)(2007-10#1)(2008-10#2)(2008-11#6)(2008-7#3)(2008-8#1)(2009-5#1)(2011-2#1)
immunized##56##1##(1990-12#4)(1991-11#1)(1991-5#1)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#5)(1995-6#1)(1996-3#2)(2007-10#1)(2008-10#4)(2008-11#13)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#2)(2011-2#2)
immunizing the##3##2##(2008-4#2)(2008-8#1)
immunizing##13##1##(1991-5#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)
immuno##3##1##(2007-7#1)(2008-10#2)
immuno-PCR##4##1##(2008-8#4)
immuno-chromatographic assay##2##2##(2008-11#2)
immuno-chromatographic##3##1##(2007-2#1)(2008-11#2)
immuno-enhancing effects##2##2##(1992-8#2)
immuno-gold##2##1##(2008-10#1)(2008-8#1)
immuno-histology##2##1##(1993-9#1)(2008-11#1)
immuno-inflammatory##2##1##(2008-7#2)
immuno-modulation##2##1##(2008-10#1)(2010-12#1)
immuno-modulatory##2##1##(1997-4#1)(2008-11#1)
immuno-sorbent assay##2##2##(2008-10#2)
immuno-suppressed##2##1##(2008-12#1)(2008-5#1)
immunoadsorbent assay##2##2##(2008-10#1)(2011-1#1)
immunoadsorption##3##1##(1993-12#1)(2011-2#2)
immunoaffinity chromatography and##2##3##(1990-7#1)(2008-11#1)
immunoaffinity chromatography##13##2##(1990-11#1)(1990-12#2)(1990-7#1)(1993-9#2)(1994-11#1)(1995-6#1)(2008-11#3)(2008-4#1)(2012-2#1)
immunoaffinity column##10##2##(1990-7#1)(1992-3#1)(2008-10#4)(2008-11#3)(2008-4#1)
immunoaffinity mixed gels##2##3##(1993-12#2)
immunoaffinity purification of the##3##4##(1993-9#1)(2008-2#2)
immunoaffinity purification##5##2##(1993-6#1)(1993-9#1)(2008-2#3)
immunoaffinity##44##1##(1990-11#1)(1990-12#2)(1990-7#2)(1991-8#1)(1992-3#1)(1993-12#4)(1993-6#1)(1993-9#3)(1994-11#1)(1995-6#1)(1997-1#1)(2008-10#11)(2008-11#7)(2008-2#3)(2008-4#3)(2008-7#1)(2012-2#1)
immunoaffinity-purified##3##1##(1990-7#1)(1991-2#1)(1997-4#1)
immunoagents##2##1##(2009-2#2)
immunoallergic##2##1##(1992-2#1)(2008-8#1)
immunoanalysis##3##1##(2008-10#2)(2010-5#1)
immunoassay and##5##2##(1993-2#1)(2008-10#2)(2008-3#1)(2010-5#1)
immunoassay based on##7##3##(1990-8#2)(1991-5#1)(2008-10#2)(2008-7#1)(2010-6#1)
immunoassay for clenbuterol (CLB)##2##4##(2008-10#2)
immunoassay for clenbuterol##3##3##(2008-10#3)
immunoassay for human##3##3##(1991-2#2)(2008-10#1)
immunoassay for serum##2##3##(1992-6#1)(2008-10#1)
immunoassay for the detection of##2##5##(1990-12#1)(2010-5#1)
immunoassay for the determination of##3##5##(1993-8#1)(2008-10#2)
immunoassay for the##6##3##(1990-12#1)(1993-8#1)(2008-10#3)(2010-5#1)
immunoassay for##31##2##(1990-12#2)(1991-2#2)(1992-12#1)(1992-6#1)(1993-8#1)(1993-9#1)(1996-12#1)(2007-7#1)(2008-10#19)(2010-5#2)
immunoassay format##5##2##(2008-10#3)(2008-11#1)(2010-5#1)
immunoassay in which##2##3##(2008-10#1)(2008-7#1)
immunoassay in##6##2##(2008-10#4)(2008-4#1)(2008-7#1)
immunoassay is##3##2##(2008-10#2)(2008-9#1)
immunoassay method##3##2##(2008-10#3)
immunoassay methods##2##2##(1990-2#1)(2008-10#1)
immunoassay of antibody activity##2##4##(2008-10#2)
immunoassay of##12##2##(1990-11#1)(1993-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2012-1#1)
immunoassay system has##2##3##(2008-10#2)
immunoassay system##5##2##(2008-10#5)
immunoassay to##3##2##(1995-9#1)(2008-10#2)
immunoassay using a##2##3##(1990-8#1)(2008-10#1)
immunoassay using##6##2##(1990-8#1)(2008-10#4)(2008-6#1)
immunoassay was##9##2##(1991-12#1)(2008-10#6)(2008-11#1)(2012-2#1)
immunoassay with a##2##3##(1992-11#1)(2008-10#1)
immunoassay with##3##2##(1992-11#1)(2008-10#2)
immunoassay##176##1##(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#5)(1991-12#1)(1991-2#2)(1991-5#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#3)(1993-9#3)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#3)(1997-2#1)(2007-7#1)(2008-10#102)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-5#5)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
immunoassay)##3##1##(1990-12#1)(1994-2#1)(1995-11#1)
immunoassays and##4##2##(1995-11#1)(2008-10#1)(2010-11#1)(2011-1#1)
immunoassays can be##2##3##(2008-4#1)(2008-9#1)
immunoassays for the##2##3##(2008-10#1)(2010-11#1)
immunoassays for##3##2##(2007-12#1)(2008-10#1)(2010-11#1)
immunoassays to##3##2##(1992-9#1)(2008-10#2)
immunoassays using##3##2##(2008-10#2)(2008-12#1)
immunoassays##49##1##(1990-11#1)(1990-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#4)(2009-2#1)(2010-11#5)(2011-1#1)
immunobiological##2##1##(2008-12#1)(2009-8#1)
immunoblot analyses##2##2##(2008-10#2)
immunoblot analysis of##2##3##(1993-8#1)(2008-10#1)
immunoblot analysis with##2##3##(1992-3#1)(2008-10#1)
immunoblot analysis##17##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-4#1)
immunoblot and##4##2##(1990-5#1)(1994-12#1)(2008-10#1)(2008-8#1)
immunoblot assay##2##2##(2008-1#1)(2008-10#1)
immunoblot##34##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)
immunoblots of##3##2##(1990-5#1)(1991-9#1)(1995-6#1)
immunoblots##12##1##(1990-11#2)(1990-5#2)(1991-9#2)(1995-6#2)(1997-4#2)(2008-10#2)
immunoblotting analysis##3##2##(1996-12#2)(2008-10#1)
immunoblotting and##11##2##(1990-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)
immunoblotting with##3##2##(1993-12#1)(1994-11#1)(1995-11#1)
immunoblotting##62##1##(1990-11#3)(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#2)(1991-5#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-5#2)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
immunocapture##6##1##(2008-10#4)(2011-2#2)
immunochemical analyses##2##2##(1994-8#1)(2013-1#1)
immunochemical analysis##3##2##(1990-7#1)(1997-2#1)(2008-1#1)
immunochemical inhibition##2##2##(1997-7#1)(2006-6#1)
immunochemical method##2##2##(2008-10#2)
immunochemical methods##3##2##(1995-12#1)(2008-10#2)
immunochemical##27##1##(1990-7#1)(1990-8#1)(1991-12#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#9)(2008-5#1)(2011-2#1)(2013-1#1)
immunochemically##4##1##(1992-8#1)(1995-2#1)(1995-3#2)
immunochemiluminometric##2##1##(1992-9#1)(2008-10#1)
immunochemistry##7##1##(1993-9#1)(1996-5#1)(2008-10#3)(2009-3#1)(2010-11#1)
immunochromatographic antigen detection assay##2##4##(2007-7#2)
immunochromatographic test strip for##2##4##(2012-3#2)
immunochromatographic##8##1##(2007-7#3)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#2)
immunocompetence handicap hypothesis##2##3##(2008-8#2)
immunocompetence in##2##2##(2008-10#1)(2008-4#1)
immunocompetence##5##1##(2008-10#1)(2008-4#1)(2008-8#3)
immunocompetent cells##5##2##(1994-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
immunocompetent patient##7##2##(1996-6#1)(2008-10#1)(2009-4#2)(2010-12#1)(2011-2#1)(2013-1#1)
immunocompetent patients##3##2##(1996-6#1)(2011-2#1)(2012-12#1)
immunocompetent##34##1##(1994-5#1)(1996-3#1)(1996-6#4)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
immunocomplex vasculitis##2##2##(1990-8#2)
immunocomplex##10##1##(1990-8#4)(1993-8#1)(2008-10#5)
immunocomposite##3##1##(2008-10#3)
immunocompromised hosts##4##2##(1996-6#1)(2008-7#1)(2011-2#2)
immunocompromised patient##3##2##(2007-12#2)(2008-7#1)
immunocompromised patients##20##2##(1990-12#1)(1990-5#1)(1990-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
immunocompromised states##2##2##(2007-5#1)(2008-5#1)
immunocompromised##41##1##(1990-12#1)(1990-5#1)(1990-6#1)(1995-8#1)(1996-6#1)(1997-5#1)(2006-10#3)(2006-5#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
immunocompromized##2##1##(2011-2#2)
immunoconjugates##2##1##(2008-11#1)(2008-7#1)
immunocytes to##2##2##(1995-12#2)
immunocytes##6##1##(1995-12#5)(2008-11#1)
immunocytochemical analysis##2##2##(1992-12#1)(1993-3#1)
immunocytochemical and ultrastructural features of##2##5##(1991-8#1)(1992-8#1)
immunocytochemical and ultrastructural##3##3##(1991-8#1)(1992-8#1)(2008-7#1)
immunocytochemical and##13##2##(1991-1#1)(1991-8#1)(1992-8#1)(1993-12#1)(1995-5#1)(1997-2#1)(2007-12#2)(2008-11#1)(2008-7#2)(2009-8#1)(2012-3#1)
immunocytochemical assay##2##2##(1992-10#1)(2011-2#1)
immunocytochemical detection of histone##2##4##(2008-9#2)
immunocytochemical detection of##8##3##(1996-5#2)(2008-7#1)(2008-9#4)(2011-2#1)
immunocytochemical detection##10##2##(1996-5#2)(2008-7#1)(2008-9#6)(2011-2#1)
immunocytochemical labeling##2##2##(2008-7#1)(2011-1#1)
immunocytochemical localization of##2##3##(2007-12#1)(2011-2#1)
immunocytochemical methods##3##2##(1993-11#1)(2007-12#2)
immunocytochemical staining##3##2##(1993-12#1)(2008-5#1)(2008-8#1)
immunocytochemical studies##2##2##(1996-12#1)(2007-12#1)
immunocytochemical techniques##4##2##(1991-12#1)(1997-3#1)(2008-11#1)(2009-5#1)
immunocytochemical##52##1##(1991-1#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1995-5#1)(1996-12#2)(1996-5#5)(1997-2#1)(1997-3#1)(2007-12#7)(2008-11#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#7)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
immunocytochemically##7##1##(1991-6#1)(1993-6#1)(1995-5#1)(1995-6#1)(2007-5#1)(2008-6#1)(2008-9#1)
immunocytochemistry and in situ hybridization##3##5##(1992-6#2)(2008-9#1)
immunocytochemistry and##10##2##(1992-6#2)(1995-12#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)
immunocytochemistry in##5##2##(1991-10#1)(1992-10#1)(1993-12#1)(2008-4#1)(2008-7#1)
immunocytochemistry to##3##2##(1995-11#1)(1997-7#1)(2007-12#1)
immunocytochemistry using##4##2##(1990-11#1)(1993-12#1)(1996-5#1)(2008-10#1)
immunocytochemistry with##2##2##(1994-2#1)(1994-8#1)
immunocytochemistry##43##1##(1990-11#1)(1990-5#1)(1991-10#1)(1992-10#1)(1992-6#2)(1993-12#2)(1993-9#1)(1994-2#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)
immunodeficiencies##3##1##(1991-9#1)(2007-2#1)(2008-4#1)
immunodeficiency and##3##2##(1990-9#1)(2008-10#2)
immunodeficiency disease##3##2##(1995-2#1)(2011-2#1)(2012-12#1)
immunodeficiency diseases##3##2##(2012-12#3)
immunodeficiency syndrome (AIDS)##20##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-12#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2011-3#1)
immunodeficiency syndrome and##2##3##(1994-5#1)(2010-12#1)
immunodeficiency syndrome##38##2##(1990-10#1)(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2008-1#1)(2008-12#1)(2008-2#2)(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
immunodeficiency virus (HIV) antibodies##2##4##(2007-7#1)(2008-10#1)
immunodeficiency virus (HIV) is##2##4##(1992-6#1)(2007-7#1)
immunodeficiency virus (HIV)##43##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
immunodeficiency virus infection in##2##4##(1991-3#1)(2008-4#1)
immunodeficiency virus infection##12##3##(1991-3#1)(1991-6#1)(1993-2#1)(1995-3#1)(1996-2#1)(1997-7#2)(2006-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
immunodeficiency virus protease##3##3##(1991-9#2)(1992-6#1)
immunodeficiency virus type 1 (HIV-1)##13##5##(1990-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-2#7)(2011-2#1)
immunodeficiency virus type 1##24##4##(1990-2#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-6#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#7)(2011-2#1)
immunodeficiency virus type##25##3##(1990-2#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-6#2)(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#7)(2011-2#1)
immunodeficiency virus type-1##5##3##(1990-2#1)(1994-11#1)(1997-3#1)(1997-4#1)(2007-7#1)
immunodeficiency virus##146##2##(1990-2#3)(1990-3#2)(1990-6#1)(1990-9#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#7)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#6)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#7)(1995-3#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#9)(1997-4#2)(1997-7#3)(1997-8#1)(2006-10#2)(2007-2#1)(2007-7#9)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
immunodeficiency virus-1 protease##3##3##(1991-9#2)(1992-8#1)
immunodeficiency virus-1##7##2##(1991-9#2)(1992-12#1)(1992-8#1)(1994-5#1)(2008-11#1)(2012-1#1)
immunodeficiency viruses in##2##3##(1991-5#1)(2007-7#1)
immunodeficiency viruses##7##2##(1990-5#1)(1991-5#1)(1997-6#1)(2007-7#1)(2008-9#2)(2012-12#1)
immunodeficiency##230##1##(1990-10#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#5)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#3)(1991-9#11)(1992-11#1)(1992-12#4)(1992-2#3)(1992-6#6)(1992-8#1)(1993-1#3)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#11)(1995-3#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#11)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#2)(2007-2#2)(2007-7#10)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
immunodeficient mice##8##2##(1990-7#1)(1991-8#1)(2008-5#4)(2009-12#1)(2013-1#1)
immunodeficient patients##5##2##(1991-6#1)(1994-3#1)(2007-2#3)
immunodeficient##22##1##(1990-7#1)(1991-6#1)(1991-8#3)(1994-3#1)(2007-2#4)(2008-11#1)(2008-12#1)(2008-5#8)(2009-12#1)(2013-1#1)
immunodepressed patients##2##2##(1991-5#1)(2009-4#1)
immunodepressed##4##1##(1991-5#1)(1994-5#2)(2009-4#1)
immunodepression##7##1##(1991-5#4)(1994-5#1)(2007-6#1)(2007-8#1)
immunodetectable##4##1##(1993-8#1)(1994-6#1)(1995-3#1)(1995-8#1)
immunodetection reagents##2##2##(2008-4#2)
immunodetection##9##1##(1994-2#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-4#4)(2010-11#1)
immunodiffusion and##2##2##(1993-2#1)(1996-12#1)
immunodiffusion##6##1##(1990-2#1)(1993-2#1)(1996-12#1)(2007-10#1)(2008-10#2)
immunodominant antigen##2##2##(1994-11#1)(1996-12#1)
immunodominant##7##1##(1990-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-4#1)(2009-5#1)
immunoelectron microscopic procedures##2##3##(1990-8#2)
immunoelectron microscopy##6##2##(1994-8#1)(1995-6#3)(1996-3#1)(2011-1#1)
immunoelectron##8##1##(1990-8#2)(1994-8#1)(1995-6#3)(1996-3#1)(2011-1#1)
immunoelectronmicroscopy##2##1##(1994-10#1)(2008-8#1)
immunoelectrophoresis##2##1##(1991-8#1)(1992-3#1)
immunoenzymatic test##2##2##(2012-12#2)
immunoenzymometric##2##1##(1993-8#2)
immunoexpression and##2##2##(2013-8#2)
immunoexpression of##3##2##(2010-7#1)(2013-8#2)
immunoexpression##6##1##(2010-7#1)(2013-8#5)
immunofluorescence analysis##3##2##(1995-6#1)(2008-9#1)(2012-2#1)
immunofluorescence and##10##2##(1991-3#1)(1993-12#1)(1994-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
immunofluorescence assay##2##2##(1994-2#1)(2011-2#1)
immunofluorescence experiments##2##2##(1992-11#1)(2008-5#1)
immunofluorescence in##2##2##(1991-12#1)(2007-7#1)
immunofluorescence method##2##2##(1993-12#1)(2012-3#1)
immunofluorescence microassay##3##2##(1990-12#3)
immunofluorescence microscopy##10##2##(1991-12#1)(1994-8#1)(1995-6#2)(2007-12#3)(2007-7#1)(2008-10#1)(2008-7#1)
immunofluorescence staining##4##2##(1997-4#1)(2008-1#1)(2011-2#1)(2012-12#1)
immunofluorescence studies##2##2##(1990-11#1)(2012-1#1)
immunofluorescence study##2##2##(1993-12#1)(2007-7#1)
immunofluorescence techniques##2##2##(2007-10#1)(2008-5#1)
immunofluorescence using a monoclonal antibody##2##5##(2008-10#1)(2008-5#1)
immunofluorescence using a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
immunofluorescence was##2##2##(1995-5#1)(2007-7#1)
immunofluorescence with FITC##2##3##(2008-4#2)
immunofluorescence with##4##2##(1996-6#1)(2008-4#2)(2008-5#1)
immunofluorescence##88##1##(1990-11#1)(1990-12#3)(1990-2#1)(1991-11#1)(1991-12#2)(1991-3#2)(1992-11#2)(1993-12#3)(1994-10#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-12#3)(2007-6#1)(2007-7#7)(2008-1#4)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#10)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
immunofluorescence/flow cytometry##2##2##(2008-9#2)
immunofluorescent antibody##2##2##(1991-3#2)
immunofluorescent assay (IFA)##2##3##(2007-2#1)(2008-12#1)
immunofluorescent assay##3##2##(2007-2#1)(2008-12#1)(2013-8#1)
immunofluorescent labeling##4##2##(2008-10#3)(2008-4#1)
immunofluorescent staining##3##2##(2008-8#2)(2013-1#1)
immunofluorescent##21##1##(1991-3#2)(1995-12#1)(1997-1#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2013-1#1)(2013-8#1)
immunogen##12##1##(1991-5#1)(1991-9#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-8#2)
immunogenetics##2##1##(1995-5#1)(2008-1#1)
immunogenic and##6##2##(1992-2#1)(1995-5#1)(1997-4#1)(2007-10#1)(2009-5#1)(2011-2#1)
immunogenic in##4##2##(1995-5#1)(2007-11#2)(2009-6#1)
immunogenic properties##2##2##(1994-3#1)(2011-2#1)
immunogenic##43##1##(1990-12#1)(1990-5#1)(1992-2#1)(1992-9#4)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#3)(1996-12#1)(1997-4#2)(2006-12#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
immunogenicity and##5##2##(1995-12#2)(2008-10#1)(2008-3#1)(2010-5#1)
immunogenicity have been##2##3##(1995-11#1)(2009-2#1)
immunogenicity in##3##2##(2007-10#1)(2008-4#1)(2008-7#1)
immunogenicity is##2##2##(2008-10#2)
immunogenicity of biotherapeutics##2##3##(2008-10#2)
immunogenicity of new##2##3##(2007-11#1)(2008-10#1)
immunogenicity of the##2##3##(1990-12#1)(1994-8#1)
immunogenicity of##24##2##(1990-12#1)(1994-8#1)(1995-2#1)(1995-5#2)(1997-6#1)(2007-11#3)(2008-10#9)(2008-8#3)(2009-4#1)(2012-2#1)(2013-1#1)
immunogenicity risk assessment##2##3##(2008-10#2)
immunogenicity with##2##2##(1990-12#1)(1995-5#1)
immunogenicity##79##1##(1990-12#3)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#8)(1996-12#1)(1997-6#1)(2007-10#2)(2007-11#5)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
immunogens may##2##2##(1990-12#1)(1995-5#1)
immunogens##7##1##(1990-12#1)(1995-5#1)(2008-10#3)(2008-4#1)(2008-5#1)
immunoglobulin (IVIG)##4##2##(1994-9#1)(2007-12#1)(2012-2#1)(2012-3#1)
immunoglobulin (Ig)##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
immunoglobulin A (IgA)##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
immunoglobulin A##12##2##(1990-12#1)(1991-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#2)(2013-1#2)(2013-8#1)
immunoglobulin G (IgG)##4##3##(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)
immunoglobulin G with##3##3##(1993-8#2)(2008-10#1)
immunoglobulin G##21##2##(1991-5#1)(1993-8#2)(1994-12#1)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
immunoglobulin M##4##2##(1992-12#1)(1994-3#1)(1995-2#1)(1996-12#1)
immunoglobulin and T-cell receptor##3##4##(1994-3#1)(1997-7#1)(1997-9#1)
immunoglobulin and T-cell##4##3##(1994-3#1)(1997-5#1)(1997-7#1)(1997-9#1)
immunoglobulin and##6##2##(1994-3#1)(1997-5#1)(1997-7#1)(1997-9#1)(2007-2#1)(2012-3#1)
immunoglobulin constant region##2##3##(2008-4#2)
immunoglobulin for##3##2##(1990-3#1)(1996-3#1)(2007-12#1)
immunoglobulin from##2##2##(1994-3#1)(2010-8#1)
immunoglobulin gene##3##2##(1992-10#1)(1992-6#1)(1997-7#1)
immunoglobulin heavy chain##6##3##(2008-11#4)(2008-7#1)(2012-2#1)
immunoglobulin heavy##7##2##(2008-11#4)(2008-7#1)(2011-2#1)(2012-2#1)
immunoglobulin heavy-chain##3##2##(1994-8#1)(1995-2#1)(2009-8#1)
immunoglobulin in##3##2##(1992-8#1)(1996-11#2)
immunoglobulin kappa##2##2##(1993-2#1)(1997-8#1)
immunoglobulin light chain##4##3##(1992-3#1)(2008-9#1)(2010-4#2)
immunoglobulin light##6##2##(1992-3#1)(1995-2#2)(2008-9#1)(2010-4#2)
immunoglobulin pool size##3##3##(2008-11#3)
immunoglobulin pool##4##2##(2008-11#4)
immunoglobulin production stimulating activity of##2##5##(2008-11#2)
immunoglobulin production##5##2##(2008-11#4)(2008-4#1)
immunoglobulin receptor##2##2##(1991-2#1)(2012-2#1)
immunoglobulin secretion##2##2##(1992-8#1)(2008-4#1)
immunoglobulin synthesis using the##2##4##(2008-4#2)
immunoglobulin synthesis using##3##3##(2008-4#3)
immunoglobulin synthesis##4##2##(2008-4#4)
immunoglobulin##162##1##(1990-12#3)(1990-3#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-2#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#7)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#5)(1995-5#2)(1995-6#1)(1996-11#3)(1996-12#4)(1996-3#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#20)(2008-4#17)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#2)(2009-8#4)(2010-11#1)(2010-4#4)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
immunoglobulin-like##2##1##(1992-12#1)(1993-8#1)
immunoglobulins (Igs)##3##2##(1994-2#1)(2007-10#1)(2008-10#1)
immunoglobulins and##5##2##(1995-12#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
immunoglobulins in##2##2##(2007-10#1)(2008-11#1)
immunoglobulins##32##1##(1990-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-2#1)(2007-10#2)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#2)
immunogold electron microscopy##3##3##(1994-10#1)(2007-12#1)(2008-9#1)
immunogold labeling##7##2##(2008-10#6)(2011-2#1)
immunogold labelling##3##2##(1997-3#1)(2008-11#1)(2008-5#1)
immunogold method##2##2##(1997-2#1)(1997-3#1)
immunogold##19##1##(1994-10#1)(1997-2#2)(1997-3#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#2)(2011-2#1)
immunohistochemical analyses##5##2##(1995-6#1)(1996-12#1)(2008-5#1)(2008-6#1)(2012-12#1)
immunohistochemical analysis has##2##3##(1997-7#1)(2008-7#1)
immunohistochemical analysis of the##2##4##(1997-7#1)(2008-7#1)
immunohistochemical analysis of##4##3##(1995-2#1)(1997-7#1)(2008-7#1)(2013-8#1)
immunohistochemical analysis##18##2##(1995-2#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#3)(2013-8#4)
immunohistochemical and clinical##2##3##(1990-8#1)(1993-6#1)
immunohistochemical and electron##2##3##(2007-4#1)(2008-6#1)
immunohistochemical and in situ hybridization##2##5##(1991-5#2)
immunohistochemical and ultrastructural studies##3##4##(1992-8#1)(2008-5#1)(2008-6#1)
immunohistochemical and ultrastructural##5##3##(1990-12#1)(1992-2#1)(1992-8#1)(2008-5#1)(2008-6#1)
immunohistochemical and##16##2##(1990-12#1)(1990-8#1)(1991-5#2)(1992-2#1)(1992-8#1)(1993-6#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2013-8#1)
immunohistochemical data##2##2##(1991-8#1)(2012-3#1)
immunohistochemical detection of the##2##4##(1997-7#1)(2008-6#1)
immunohistochemical detection of##3##3##(1997-7#1)(2008-4#1)(2008-6#1)
immunohistochemical examination##2##2##(2007-8#1)(2008-6#1)
immunohistochemical findings are##2##3##(2008-3#1)(2013-7#1)
immunohistochemical findings##5##2##(1994-8#1)(2008-3#1)(2009-3#1)(2013-7#1)(2013-8#1)
immunohistochemical localization##2##2##(1992-3#1)(1993-9#1)
immunohistochemical markers of##2##3##(2008-3#1)(2008-4#1)
immunohistochemical markers##3##2##(1992-12#1)(2008-3#1)(2008-4#1)
immunohistochemical method for##2##3##(1995-12#1)(1996-5#1)
immunohistochemical method##6##2##(1990-5#1)(1995-12#1)(1996-12#1)(1996-5#2)(2008-5#1)
immunohistochemical methods##4##2##(1993-6#1)(1994-2#1)(2008-7#1)(2011-2#1)
immunohistochemical reactivity##2##2##(2009-12#1)(2012-1#1)
immunohistochemical staining for##2##3##(2008-7#1)(2012-12#1)
immunohistochemical staining of PTHrP##2##4##(1994-7#2)
immunohistochemical staining of##4##3##(1994-7#2)(2011-2#1)(2013-8#1)
immunohistochemical staining##18##2##(1991-7#1)(1992-3#1)(1992-8#1)(1994-7#2)(1995-4#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-7#2)(2011-2#2)(2012-12#1)(2013-8#1)
immunohistochemical stains##2##2##(1993-6#1)(2009-1#1)
immunohistochemical studies##8##2##(1990-10#1)(1994-7#1)(1994-9#1)(1995-12#1)(1996-2#1)(2007-5#1)(2008-12#1)(2011-2#1)
immunohistochemical study of##4##3##(1991-6#1)(1993-8#1)(2007-12#1)(2012-3#1)
immunohistochemical study##14##2##(1991-6#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-3#2)
immunohistochemical techniques##5##2##(1990-8#1)(1992-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
immunohistochemical##145##1##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#4)(1993-6#3)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#2)(1994-7#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-4#4)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#3)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#4)(2008-10#5)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#2)(2009-3#2)(2010-11#1)(2010-7#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#7)
immunohistochemically positive for##2##3##(2010-6#1)(2011-2#1)
immunohistochemically reacted##2##2##(2008-11#2)
immunohistochemically with##2##2##(1995-12#1)(2008-10#1)
immunohistochemically##19##1##(1992-6#1)(1994-12#2)(1995-12#2)(1995-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)
immunohistochemistry (IHC)##4##2##(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
immunohistochemistry against##2##2##(2007-12#2)
immunohistochemistry also##2##2##(1994-11#1)(1997-3#1)
immunohistochemistry and RT-PCR##2##3##(2008-7#1)(2011-3#1)
immunohistochemistry and##10##2##(1997-2#2)(2007-7#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
immunohistochemistry for##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
immunohistochemistry in##7##2##(1993-9#1)(1994-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2010-8#1)
immunohistochemistry is##4##2##(2007-12#1)(2008-4#1)(2008-5#1)(2010-8#1)
immunohistochemistry of the##2##3##(2008-10#1)(2008-4#1)
immunohistochemistry of##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
immunohistochemistry on##2##2##(2009-4#1)(2013-1#1)
immunohistochemistry revealed##3##2##(1996-5#1)(2009-12#1)(2012-2#1)
immunohistochemistry to##2##2##(1991-8#1)(2008-8#1)
immunohistochemistry using##3##2##(1991-5#1)(1997-6#1)(2007-8#1)
immunohistochemistry were##2##2##(2008-12#1)(2012-1#1)
immunohistochemistry with##6##2##(1992-8#1)(1996-5#3)(1997-7#1)(2011-2#1)
immunohistochemistry##112##1##(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#5)(1997-2#4)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#4)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#5)(2009-4#2)(2009-5#1)(2009-8#3)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#5)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#5)
immunohistological studies##3##2##(1991-2#1)(2008-5#1)(2012-3#1)
immunohistological##9##1##(1990-6#1)(1991-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#1)(2012-3#1)
immunohistology and##2##2##(1993-9#1)(2008-5#1)
immunohistology##5##1##(1993-9#1)(2008-4#1)(2008-5#2)(2009-8#1)
immunoinhibition##2##1##(1993-12#1)(2006-6#1)
immunoinhibitory##4##1##(1995-12#2)(2008-4#1)(2012-3#1)
immunolabeled##6##1##(1992-12#1)(1996-5#3)(1997-2#1)(2013-8#1)
immunolabeling##3##1##(1992-12#1)(1997-2#1)(2008-10#1)
immunolabelled##2##1##(1996-5#1)(1997-2#1)
immunolabelling##5##1##(1995-5#1)(1995-8#1)(1997-2#1)(2007-12#1)(2009-12#1)
immunoliposomes for##2##2##(1995-2#1)(2008-10#1)
immunoliposomes##11##1##(1995-2#9)(2008-10#2)
immunolocalization of##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
immunolocalization studies##2##2##(2008-10#1)(2008-11#1)
immunolocalization##8##1##(1994-2#1)(1994-9#1)(2008-10#3)(2008-11#1)(2008-9#2)
immunolocalized to##2##2##(1994-2#1)(1995-12#1)
immunolocalized##3##1##(1994-2#1)(1995-12#2)
immunologic and##2##2##(1990-2#1)(2008-7#1)
immunologic factors##3##2##(1992-10#1)(1997-8#1)(2013-1#1)
immunologic memory##4##2##(1991-12#1)(1995-5#2)(2012-3#1)
immunologic pathway for intravascular catabolism of##2##6##(1991-2#2)
immunologic response##2##2##(1996-6#1)(2009-4#1)
immunologic responses##2##2##(2009-5#1)(2013-1#1)
immunologic state##2##2##(1991-6#1)(2008-10#1)
immunologic##50##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-5#5)(1996-6#1)(1997-8#3)(2006-10#1)(2008-10#3)(2008-2#1)(2008-4#3)(2008-7#3)(2008-9#2)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)
immunological activities in vitro##2##4##(1990-12#2)
immunological analysis##2##2##(1996-3#1)(2009-8#1)
immunological and molecular##2##3##(1992-6#1)(1997-7#1)
immunological and##11##2##(1990-6#1)(1992-11#1)(1992-6#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)
immunological assays##6##2##(2008-10#5)(2008-4#1)
immunological effects##3##2##(1991-1#1)(2007-11#1)(2008-11#1)
immunological events##2##2##(1995-12#1)(2008-8#1)
immunological intervention strategies##2##3##(2007-5#2)
immunological mechanisms##3##2##(1996-12#1)(2008-10#1)(2009-5#1)
immunological memory##2##2##(1997-4#1)(2012-3#1)
immunological methods##6##2##(1992-8#1)(2008-10#4)(2008-9#1)
immunological parameters##6##2##(1991-5#3)(2008-10#1)(2010-5#1)(2010-8#1)
immunological point of view##2##4##(1992-6#1)(2013-1#1)
immunological reaction##3##2##(1996-12#1)(2008-10#2)
immunological reactivity##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
immunological research##2##2##(1995-6#1)(2008-8#1)
immunological response##7##2##(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
immunological responses##3##2##(2007-7#1)(2012-12#1)(2013-1#1)
immunological risk##3##2##(2008-9#1)(2011-2#2)
immunological status##2##2##(1997-5#1)(2008-7#1)
immunological studies##5##2##(1991-9#1)(1994-3#1)(2008-4#1)(2010-2#1)(2011-2#1)
immunological surveillance##2##2##(2013-7#2)
immunological system##2##2##(2009-5#1)(2011-2#1)
immunological tests##3##2##(2007-2#2)(2011-2#1)
immunological tolerance##2##2##(2010-1#1)(2012-3#1)
immunological##159##1##(1990-12#7)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#5)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#5)(1992-8#1)(1993-12#2)(1993-3#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#4)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#8)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#4)(2008-1#2)(2008-10#18)(2008-11#4)(2008-4#7)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
immunologically mediated##4##2##(2007-11#2)(2009-10#1)(2012-3#1)
immunologically privileged##3##2##(2008-4#1)(2009-10#2)
immunologically related##2##2##(1991-2#1)(1995-12#1)
immunologically relevant##3##2##(1991-9#1)(2008-4#2)
immunologically##27##1##(1990-11#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-2#1)(1995-12#2)(1996-12#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-10#3)(2012-3#1)(2013-1#2)
immunologist##2##1##(2008-4#1)(2012-12#1)
immunology and##3##2##(1994-12#1)(2008-7#1)(2012-3#1)
immunology##38##1##(1991-11#1)(1992-12#2)(1994-11#1)(1994-12#3)(1994-9#1)(2006-10#5)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
immunoluminometric assay##2##2##(2007-10#1)(2013-1#1)
immunomagnetic bead##2##2##(2008-10#2)
immunomagnetic beads##2##2##(2008-11#1)(2008-4#1)
immunomagnetic separation##2##2##(2008-10#1)(2012-2#1)
immunomagnetic##9##1##(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#1)(2010-3#2)(2012-2#1)
immunometric##2##1##(1994-2#1)(2009-11#1)
immunomodulating effects##2##2##(2008-10#2)
immunomodulating peptides##2##2##(1994-12#2)
immunomodulating properties##3##2##(1991-6#1)(1994-12#1)(1994-3#1)
immunomodulating##14##1##(1991-3#1)(1991-5#1)(1991-6#2)(1994-12#3)(1994-3#1)(1995-12#1)(1997-5#1)(2008-10#3)(2012-3#1)
immunomodulation of##2##2##(2008-10#1)(2008-8#1)
immunomodulation##13##1##(1993-12#1)(1995-12#1)(2008-1#1)(2008-10#6)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
immunomodulator##4##1##(1991-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
immunomodulatory activity of##2##3##(1991-1#1)(2008-10#1)
immunomodulatory activity##5##2##(1991-1#2)(2008-10#2)(2008-11#1)
immunomodulatory drugs##2##2##(1991-5#1)(1993-12#1)
immunomodulatory effect of##2##3##(2008-10#1)(2008-11#1)
immunomodulatory effects of##4##3##(2008-10#2)(2011-1#1)(2012-3#1)
immunomodulatory effects on##2##3##(2008-10#2)
immunomodulatory effects##12##2##(1997-4#1)(2008-10#5)(2008-11#3)(2008-8#1)(2011-1#1)(2012-3#1)
immunomodulatory potential##4##2##(2008-10#2)(2012-2#2)
immunomodulatory therapy##2##2##(2009-6#1)(2012-1#1)
immunomodulatory##38##1##(1991-1#2)(1991-5#1)(1993-12#2)(1997-4#1)(2007-11#1)(2008-10#16)(2008-11#6)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
immunopathogenesis of##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)
immunopathology##3##1##(1991-3#1)(1995-2#1)(2012-2#1)
immunoperoxidase method##2##2##(1993-12#1)(1995-5#1)
immunoperoxidase staining##3##2##(1991-2#2)(1997-2#1)
immunoperoxidase##13##1##(1991-2#2)(1991-3#3)(1991-8#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-2#1)(2008-10#2)
immunophenotype and##2##2##(1995-3#2)
immunophenotype in##3##2##(1991-2#1)(2008-11#1)(2008-9#1)
immunophenotype of##2##2##(1991-2#1)(1995-3#1)
immunophenotype##12##1##(1991-2#3)(1995-3#3)(2007-2#1)(2008-11#2)(2008-9#2)(2009-8#1)
immunophenotyped##2##1##(2008-9#2)
immunophenotypic analysis of##2##3##(2008-9#2)
immunophenotypic changes##3##2##(2008-10#1)(2011-2#2)
immunophenotypic identification and##2##3##(2008-9#2)
immunophenotypic identification##3##2##(2008-4#1)(2008-9#2)
immunophenotypic##13##1##(1995-12#1)(1997-1#1)(2008-10#1)(2008-4#2)(2008-9#5)(2011-2#3)
immunophenotypically##2##1##(2008-12#1)(2010-1#1)
immunophenotyping is##2##2##(2008-9#2)
immunophenotyping of##2##2##(2008-9#2)
immunophenotyping##17##1##(1997-3#1)(2008-12#1)(2008-5#1)(2008-9#11)(2009-2#1)(2009-8#1)(2012-3#1)
immunophilin##5##1##(1991-9#3)(1992-11#1)(1993-8#1)
immunopositive##8##1##(1992-9#1)(1993-12#1)(1996-5#1)(2008-6#3)(2013-8#2)
immunoprecipitate##5##1##(1990-11#1)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)
immunoprecipitated by##2##2##(1993-2#1)(1995-6#1)
immunoprecipitated with##8##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-11#1)(1996-2#1)
immunoprecipitated##20##1##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-6#2)(1996-2#2)(2008-2#5)
immunoprecipitates##7##1##(1992-10#1)(1992-12#2)(1992-9#1)(1993-8#1)(1997-6#1)(2008-3#1)
immunoprecipitation (ChIP)##3##2##(2008-2#3)
immunoprecipitation analysis##2##2##(1992-12#1)(2009-8#1)
immunoprecipitation and##3##2##(1990-5#1)(2008-2#1)(2008-4#1)
immunoprecipitation experiments##2##2##(1992-9#1)(1994-6#1)
immunoprecipitation for determining##2##3##(2008-2#2)
immunoprecipitation of the protein##2##4##(2008-2#1)(2008-4#1)
immunoprecipitation of the##4##3##(1991-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
immunoprecipitation of##12##2##(1991-12#1)(1991-2#1)(1992-8#1)(1992-9#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#4)
immunoprecipitation with##4##2##(1992-12#2)(1994-2#1)(1997-6#1)
immunoprecipitation##49##1##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(2008-1#2)(2008-11#4)(2008-2#12)(2008-4#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
immunoprecipitations##2##1##(1993-2#1)(2008-2#1)
immunoprophylaxis##2##1##(1992-6#1)(1996-11#1)
immunopurified##2##1##(1990-7#1)(1995-2#1)
immunoradiometric assay##4##2##(1990-6#1)(1991-3#1)(1993-2#2)
immunoreaction of##2##2##(2008-10#2)
immunoreaction##16##1##(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#13)
immunoreactions##4##1##(1996-5#1)(2008-10#3)
immunoreactive (ir-)##3##2##(1991-5#1)(1993-11#1)(1994-6#1)
immunoreactive and##2##2##(1994-9#1)(1997-3#1)
immunoreactive axons##2##2##(2007-12#2)
immunoreactive bands##2##2##(1990-7#1)(1994-6#1)
immunoreactive cells in##2##3##(1990-2#1)(1997-2#1)
immunoreactive cells were##2##3##(1997-2#2)
immunoreactive cells##8##2##(1990-2#1)(1997-2#3)(1997-3#1)(2010-11#3)
immunoreactive fibers##2##2##(2008-5#1)(2008-6#1)
immunoreactive for GABA##2##3##(1997-2#2)
immunoreactive for glycine##2##3##(1997-2#2)
immunoreactive for##8##2##(1991-8#1)(1995-5#1)(1997-2#5)(2013-1#1)
immunoreactive insulin##2##2##(1991-7#1)(1994-12#1)
immunoreactive nerve##2##2##(1992-6#1)(1996-5#1)
immunoreactive neural cells were##2##4##(1993-12#2)
immunoreactive neuronal##2##2##(1993-9#2)
immunoreactive neurons in the##2##4##(2007-12#1)(2008-7#1)
immunoreactive neurons in##4##3##(2007-12#3)(2008-7#1)
immunoreactive terminals are##2##3##(1994-8#1)(1995-12#1)
immunoreactive to##4##2##(1996-12#2)(1997-3#1)(2008-9#1)
immunoreactive##87##1##(1990-2#2)(1990-5#2)(1990-7#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#3)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-5#2)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#12)(1997-3#4)(2007-10#2)(2007-12#7)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2010-11#3)(2013-1#1)
immunoreactivities##10##1##(1990-5#1)(1993-8#1)(1996-5#4)(1997-2#2)(2011-2#2)
immunoreactivity (IR)##3##2##(1990-5#1)(1992-9#1)(1995-8#1)
immunoreactivity (PKC-beta-LI)##2##2##(1990-7#1)(1991-12#1)
immunoreactivity and##11##2##(1991-12#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-12#1)(2008-5#1)(2009-12#1)(2009-7#1)(2011-2#1)
immunoreactivity for both##2##3##(1996-5#2)
immunoreactivity for##9##2##(1991-6#2)(1995-5#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-10#1)(2010-12#1)
immunoreactivity in different##2##3##(1993-12#1)(1993-5#1)
immunoreactivity in the rat##4##4##(1990-5#2)(1990-7#1)(1995-8#1)
immunoreactivity in the spinal cord##2##5##(1993-12#1)(2008-5#1)
immunoreactivity in the##19##3##(1990-5#4)(1990-7#2)(1991-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-5#3)(1997-2#2)(2008-10#1)(2008-5#1)
immunoreactivity in##39##2##(1990-5#5)(1990-7#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-2#4)(1994-8#1)(1995-12#6)(1995-8#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#3)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)
immunoreactivity is##5##2##(1994-2#1)(1996-5#2)(1996-6#1)(2008-7#1)
immunoreactivity of the antibody##4##4##(2008-7#4)
immunoreactivity of the##5##3##(1990-5#1)(2008-7#4)
immunoreactivity of##11##2##(1990-5#1)(1991-12#1)(1992-8#2)(1993-11#2)(2008-7#4)(2013-8#1)
immunoreactivity to PKC-beta##2##3##(1990-7#2)
immunoreactivity to##5##2##(1990-7#2)(1993-6#1)(1994-12#1)(1996-2#1)
immunoreactivity was detected##2##3##(1990-5#1)(1994-2#1)
immunoreactivity was observed##2##3##(1991-5#1)(2009-8#1)
immunoreactivity was##15##2##(1990-5#2)(1991-5#2)(1993-12#1)(1994-2#3)(1995-12#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-8#1)
immunoreactivity were##3##2##(1992-8#1)(1993-11#1)(1997-2#1)
immunoreactivity with##2##2##(1994-6#1)(2008-10#1)
immunoreactivity##163##1##(1990-12#2)(1990-2#2)(1990-5#10)(1990-7#5)(1991-12#5)(1991-5#2)(1991-6#3)(1991-8#4)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#6)(1993-3#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#12)(1994-6#1)(1994-8#2)(1995-12#13)(1995-5#4)(1995-8#2)(1996-12#4)(1996-2#2)(1996-5#12)(1996-6#3)(1997-2#8)(1997-3#2)(1997-4#1)(1997-7#7)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#7)(2009-1#1)(2009-12#2)(2009-7#1)(2009-8#4)(2010-12#1)(2011-2#4)(2012-3#1)(2013-8#1)
immunoreactor##4##1##(2008-10#4)
immunoreagents##2##1##(1997-3#1)(2008-10#1)
immunoreceptors##2##1##(2008-4#1)(2012-2#1)
immunoregulation##6##1##(1990-5#1)(1991-2#1)(1991-9#1)(1995-12#1)(2011-2#1)(2011-3#1)
immunoregulatory properties##2##2##(1993-8#1)(1994-6#1)
immunoregulatory##6##1##(1993-8#1)(1994-6#1)(1994-8#1)(2008-4#1)(2009-10#1)(2013-1#1)
immunoscintigraphy##2##1##(1990-6#2)
immunoscreening##2##1##(1993-11#1)(2008-4#1)
immunosenescence##2##1##(1995-3#1)(2010-2#1)
immunosensing system##4##2##(2008-10#4)
immunosensing##10##1##(2008-10#10)
immunosensor based on##7##3##(2008-10#7)
immunosensor can be regenerated by simply##2##6##(2008-10#2)
immunosensor can be##3##3##(2008-10#3)
immunosensor for detection of##2##4##(2008-10#2)
immunosensor for the detection of##3##5##(2008-10#3)
immunosensor for the determination of##2##5##(2008-10#2)
immunosensor for the direct determination of##2##6##(2008-10#2)
immunosensor for the##9##3##(2008-10#9)
immunosensor for##15##2##(2008-10#15)
immunosensor has##3##2##(2008-10#3)
immunosensor in##2##2##(2008-10#2)
immunosensor was developed for the##2##5##(2008-10#2)
immunosensor was developed for##3##4##(2008-10#3)
immunosensor was successfully##2##3##(2008-10#2)
immunosensor was##6##2##(2008-10#6)
immunosensor with##4##2##(2008-10#1)(2008-7#3)
immunosensor##59##1##(1990-12#1)(2008-10#54)(2008-7#3)(2010-11#1)
immunosensors for##3##2##(2008-10#3)
immunosensors were##2##2##(2008-10#2)
immunosensors##15##1##(2008-10#12)(2010-11#3)
immunosorbent assay (ELISA) and##8##4##(1992-3#1)(1992-5#1)(1997-6#1)(2008-1#1)(2008-10#4)
immunosorbent assay (ELISA) for the##3##5##(1990-2#1)(2008-10#2)
immunosorbent assay (ELISA) for##7##4##(1990-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
immunosorbent assay (ELISA) was used to##2##6##(2007-2#1)(2010-4#1)
immunosorbent assay (ELISA) was##4##4##(1995-11#1)(2007-2#1)(2008-10#1)(2010-4#1)
immunosorbent assay (ELISA)##55##3##(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-11#1)(1996-9#1)(1997-4#2)(1997-6#1)(2007-2#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-4#5)(2008-5#1)(2008-6#1)(2010-4#2)(2010-5#1)(2011-2#1)(2011-3#1)(2013-7#1)
immunosorbent assay and##6##3##(1997-6#1)(2008-10#4)(2009-5#1)
immunosorbent assay for##7##3##(1995-11#1)(1995-8#1)(2008-10#4)(2011-2#1)
immunosorbent assay using##8##3##(2008-10#7)(2010-4#1)
immunosorbent assay##125##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#2)(1995-8#1)(1996-9#1)(1997-4#3)(1997-6#2)(2007-2#1)(2008-1#1)(2008-10#74)(2008-11#2)(2008-4#5)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
immunosorbent assay)##4##2##(1993-2#1)(2008-10#2)(2008-8#1)
immunosorbent assays (ELISA)##6##3##(1995-12#1)(2008-10#2)(2011-2#2)(2013-1#1)
immunosorbent assays##13##2##(1993-2#1)(1995-12#1)(2008-10#7)(2008-3#1)(2011-2#2)(2013-1#1)
immunosorbent electron microscopy##3##3##(2008-10#3)
immunosorbent##146##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#2)(1995-12#1)(1995-8#1)(1996-9#1)(1997-4#3)(1997-6#2)(2007-2#1)(2008-1#1)(2008-10#87)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#7)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
immunostained for##3##2##(1995-12#1)(2008-9#1)(2012-8#1)
immunostained##8##1##(1993-12#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-6#1)(2008-9#1)(2012-8#1)
immunostaining as##2##2##(1997-3#1)(2008-7#1)
immunostaining for Mac-1##3##3##(1997-3#3)
immunostaining for##8##2##(1994-9#1)(1997-3#4)(2008-10#1)(2008-9#1)(2012-1#1)
immunostaining in##2##2##(1997-2#1)(2008-7#1)
immunostaining of##5##2##(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-3#1)
immunostaining was not##2##3##(1993-9#1)(1994-9#1)
immunostaining was##5##2##(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(2008-7#1)
immunostaining##44##1##(1990-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#4)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#6)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#5)(2008-9#2)(2009-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
immunostimulants##3##1##(1993-8#3)
immunostimulating##3##1##(1993-3#1)(1997-2#1)(2008-10#1)
immunostimulatory##4##1##(1994-5#1)(1994-8#1)(1995-12#1)(2013-1#1)
immunosuppressant therapy##2##2##(1990-3#1)(2010-12#1)
immunosuppressant##9##1##(1990-3#1)(1993-8#1)(1994-3#1)(1995-6#1)(2007-11#1)(2008-5#1)(2010-12#2)(2010-3#1)
immunosuppressants and##2##2##(1997-3#1)(2010-12#1)
immunosuppressants##7##1##(1991-9#1)(1997-3#1)(2008-1#1)(2009-3#1)(2010-10#1)(2010-12#1)(2013-1#1)
immunosuppressed individuals##2##2##(2007-12#1)(2008-5#1)
immunosuppressed patients and##2##3##(2010-5#1)(2013-1#1)
immunosuppressed patients##5##2##(2010-5#3)(2013-1#2)
immunosuppressed with##2##2##(2008-5#2)
immunosuppressed##15##1##(1996-8#1)(2007-12#2)(2008-5#5)(2009-8#1)(2010-5#3)(2013-1#3)
immunosuppression and##8##2##(1993-12#1)(2007-8#1)(2008-5#2)(2010-4#1)(2011-2#3)
immunosuppression in##2##2##(1994-8#1)(2008-10#1)
immunosuppression may##2##2##(2008-3#1)(2011-2#1)
immunosuppression on the##3##3##(2008-5#2)(2011-3#1)
immunosuppression##59##1##(1991-1#2)(1991-3#1)(1992-12#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#11)(2008-3#2)(2008-4#1)(2008-5#7)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
immunosuppressive activity of##4##3##(1990-5#2)(1991-1#2)
immunosuppressive activity##5##2##(1990-5#2)(1991-1#3)
immunosuppressive agent##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
immunosuppressive agents##11##2##(1993-11#1)(1994-5#1)(1997-2#1)(2006-10#1)(2007-11#3)(2008-10#2)(2010-12#1)(2012-3#1)
immunosuppressive drug##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
immunosuppressive drugs have##2##3##(1994-5#1)(2010-7#1)
immunosuppressive drugs with##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
immunosuppressive drugs##19##2##(1991-9#1)(1994-5#1)(1995-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#2)(2010-7#1)(2011-2#3)(2011-3#1)(2013-1#2)
immunosuppressive effect##6##2##(1994-2#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-4#1)
immunosuppressive effects of##4##3##(1990-12#2)(2008-10#1)(2011-1#1)
immunosuppressive medication##2##2##(2006-10#1)(2007-11#1)
immunosuppressive medications##3##2##(2006-10#1)(2007-12#1)(2010-6#1)
immunosuppressive regimens##2##2##(2008-1#1)(2008-3#1)
immunosuppressive therapy and##2##3##(1994-5#1)(2008-1#1)
immunosuppressive therapy may lead to##2##5##(1994-5#1)(2008-3#1)
immunosuppressive therapy##17##2##(1994-5#2)(2006-10#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
immunosuppressive treatment##10##2##(1991-11#1)(1991-9#1)(1996-3#1)(2006-10#1)(2007-7#1)(2011-3#3)(2012-2#1)(2012-3#1)
immunosuppressive##104##1##(1990-12#3)(1990-5#4)(1990-9#1)(1991-1#3)(1991-11#1)(1991-9#2)(1993-11#1)(1993-2#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#4)(1995-2#1)(1995-3#2)(1996-3#1)(1996-8#1)(1997-2#1)(2006-10#6)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#9)(2008-10#11)(2008-11#1)(2008-3#6)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#8)(2011-3#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
immunosuppressives##2##1##(2012-3#2)
immunosupression##2##1##(2008-1#1)(2011-2#1)
immunotherapeutic approach##2##2##(2012-3#1)(2013-8#1)
immunotherapeutic approaches##2##2##(2012-2#2)
immunotherapeutic effects##2##2##(2013-1#2)
immunotherapeutic strategies##3##2##(2011-1#1)(2011-2#2)
immunotherapeutic##13##1##(1995-6#1)(2007-12#1)(2007-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
immunotherapies##4##1##(1995-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
immunotherapy against##2##2##(2008-11#1)(2013-1#1)
immunotherapy and##2##2##(2010-12#1)(2013-1#1)
immunotherapy for##8##2##(1990-12#1)(1991-8#1)(2008-11#2)(2008-5#1)(2010-5#2)(2013-1#1)
immunotherapy has been##2##3##(2012-2#1)(2013-1#1)
immunotherapy in##2##2##(2010-3#1)(2011-2#1)
immunotherapy is##3##2##(2009-2#1)(2009-3#1)(2010-5#1)
immunotherapy of cancer##2##3##(1990-8#1)(2012-2#1)
immunotherapy of##5##2##(1990-12#1)(1990-8#1)(1993-11#1)(1994-5#1)(2012-2#1)
immunotherapy to##2##2##(2008-11#1)(2012-2#1)
immunotherapy with##6##2##(1990-12#2)(1991-11#1)(1994-12#1)(2007-5#1)(2008-11#1)
immunotherapy##75##1##(1990-12#5)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#2)(2007-11#1)(2007-5#1)(2008-11#11)(2008-5#3)(2008-6#1)(2008-8#4)(2009-10#1)(2009-2#2)(2009-3#2)(2010-12#2)(2010-3#4)(2010-5#4)(2011-2#7)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#1)
immunotoxic effects##2##2##(2008-10#2)
immunotoxic potential##5##2##(2008-10#5)
immunotoxic potentials of##2##3##(2008-10#2)
immunotoxic##15##1##(2008-10#15)
immunotoxicants##4##1##(2008-10#4)
immunotoxicities##2##1##(2008-10#2)
immunotoxicity in mice##2##3##(2008-10#2)
immunotoxicity in##5##2##(2008-10#5)
immunotoxicity of##4##2##(1993-12#1)(2008-10#3)
immunotoxicity potential##2##2##(2008-10#2)
immunotoxicity studies##3##2##(2008-10#3)
immunotoxicity testing##5##2##(2008-10#5)
immunotoxicity##41##1##(1992-12#1)(1993-12#1)(2008-10#38)(2008-4#1)
immunotoxicological potential of##3##3##(2008-10#3)
immunotoxicological studies##2##2##(2008-10#2)
immunotoxicological##9##1##(2008-10#9)
immunotoxicology of##2##2##(2008-10#2)
immunotoxicology##15##1##(2008-10#15)
immunotoxin##3##1##(1990-12#1)(1997-4#2)
immunotoxins##5##1##(1990-12#4)(1990-8#1)
immunoturbidimetric##3##1##(1992-12#1)(2008-3#1)(2011-2#1)
immunovesicle##2##1##(2008-11#2)
immunovesicles##2##1##(2008-11#2)
immutable##2##1##(2008-12#2)
impact analysis##5##2##(1991-2#1)(1997-3#3)(2008-10#1)
impact and implications for pediatric nurses##2##6##(2011-1#2)
impact and##16##2##(1993-11#1)(1996-11#1)(1997-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)
impact are##3##2##(2007-11#1)(2008-2#2)
impact as well##2##3##(1992-3#1)(2013-8#1)
impact as##4##2##(1992-3#1)(1997-5#1)(2011-2#1)(2013-8#1)
impact at the##2##3##(1997-5#1)(2010-12#1)
impact at##4##2##(1997-5#1)(2007-11#1)(2008-11#1)(2010-12#1)
impact by##2##2##(1996-12#1)(2007-5#1)
impact clinical##2##2##(1997-1#1)(2010-12#1)
impact could##2##2##(2008-10#1)(2010-4#1)
impact craters##3##2##(1997-5#3)
impact evaluation##2##2##(2008-11#2)
impact events##2##2##(1997-5#2)
impact experiments##2##2##(2008-3#2)
impact factors##5##2##(1995-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
impact for##4##2##(1994-1#1)(2008-6#1)(2008-9#1)(2012-2#1)
impact if##2##2##(2008-8#1)(2011-2#1)
impact in the##6##3##(1993-6#1)(1997-5#1)(2008-3#1)(2008-7#3)
impact in##17##2##(1993-6#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-7#6)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
impact is to##2##3##(2010-8#2)
impact is##9##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-12#1)
impact mitigation##2##2##(2007-7#2)
impact not only##2##3##(1991-12#1)(2012-2#1)
impact of DM on##2##4##(2011-1#1)(2011-2#1)
impact of Federal##2##3##(1996-3#2)
impact of HMO##2##3##(2008-11#2)
impact of HPV##2##3##(1993-9#1)(2008-8#1)
impact of IDHR##2##3##(2008-10#2)
impact of Medicaid##3##3##(1994-1#1)(1994-3#1)(1995-12#1)
impact of a##31##3##(1991-2#1)(1992-1#1)(1993-12#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#1)
impact of aflatoxin##2##3##(1997-6#2)
impact of age##2##3##(2008-3#2)
impact of an##5##3##(2007-7#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
impact of cancer##2##3##(1992-2#1)(2010-2#1)
impact of case##2##3##(1993-12#1)(1995-2#1)
impact of clinical decision-making##2##4##(2008-11#2)
impact of clinical##4##3##(1994-12#2)(2008-11#2)
impact of different##7##3##(1994-1#1)(1996-3#1)(1996-7#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-4#1)
impact of early##4##3##(1990-8#1)(2008-4#1)(2009-5#1)(2011-2#1)
impact of education##3##3##(2007-10#1)(2008-11#1)(2008-9#1)
impact of exposure to##3##4##(2008-11#1)(2010-12#1)(2011-2#1)
impact of health care reform on##2##6##(1995-12#2)
impact of health care##3##4##(1995-12#2)(2007-12#1)
impact of health management indicators on a public health service's##2##10##(2012-12#2)
impact of health##6##3##(1995-12#2)(2007-12#1)(2012-12#2)(2013-1#1)
impact of high##2##3##(2008-7#1)(2010-6#1)
impact of human##2##3##(2008-8#2)
impact of increasing##2##3##(2010-1#1)(2011-2#1)
impact of insulin##2##3##(2008-1#1)(2009-10#1)
impact of lifestyle##2##3##(2008-2#1)(2013-8#1)
impact of maternal##2##3##(1997-7#1)(2010-6#1)
impact of medical##3##3##(1995-1#1)(2008-11#1)(2011-1#1)
impact of mental disorders##2##4##(2008-9#1)(2013-8#1)
impact of mental##3##3##(2008-9#1)(2012-3#1)(2013-8#1)
impact of muscle training##2##4##(2007-11#2)
impact of new##3##3##(1995-12#1)(1996-1#1)(2008-2#1)
impact of physical##2##3##(2007-12#1)(2013-8#1)
impact of poverty##3##3##(2008-11#2)(2009-8#1)
impact of primary##2##3##(1994-3#1)(1996-6#1)
impact of selected biological factors on##2##6##(2007-8#2)
impact of selected##4##3##(2007-8#2)(2010-3#1)(2011-2#1)
impact of spontaneous activity##2##4##(2013-8#2)
impact of state##3##3##(1993-1#1)(1994-2#2)
impact of stress on##3##4##(1994-2#1)(2012-3#2)
impact of stress##4##3##(1994-2#1)(2011-2#1)(2012-3#2)
impact of surgical##2##3##(1994-12#1)(2010-3#1)
impact of synthetic##2##3##(2008-11#1)(2010-4#1)
impact of temperature on##2##4##(2008-7#1)(2011-2#1)
impact of temperature##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
impact of the epidemic##2##4##(2007-7#1)(2012-3#1)
impact of the implementation of##2##5##(1991-1#1)(2013-1#1)
impact of the##80##3##(1991-1#1)(1991-12#3)(1991-2#2)(1992-1#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#3)(1994-2#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
impact of these programs##4##4##(2007-11#1)(2012-12#1)(2013-1#2)
impact of these##20##3##(1992-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
impact of this disease##3##4##(2008-10#1)(2008-11#1)(2009-5#1)
impact of this##17##3##(1991-3#1)(1994-1#1)(2007-10#1)(2008-10#3)(2008-11#3)(2008-12#2)(2009-5#2)(2011-2#2)(2012-2#1)(2013-7#1)
impact of those##2##3##(2008-11#1)(2011-2#1)
impact of three##2##3##(1997-1#1)(2008-6#1)
impact of ticks on human##2##5##(2008-8#2)
impact of treatment##5##3##(1992-9#1)(2008-2#1)(2011-2#1)(2013-1#2)
impact of two##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
impact of various##3##3##(1993-12#1)(2008-10#1)(2009-5#1)
impact of##620##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#6)(1991-8#1)(1992-1#5)(1992-12#2)(1992-2#3)(1992-3#5)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-1#8)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#6)(1995-12#9)(1995-2#4)(1995-3#6)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#6)(1996-12#3)(1996-2#6)(1996-3#6)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#2)(2006-10#2)(2007-1#1)(2007-10#8)(2007-11#7)(2007-12#14)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#7)(2008-10#43)(2008-11#45)(2008-12#10)(2008-2#14)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#7)(2008-7#18)(2008-8#16)(2008-9#11)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#6)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#8)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#5)(2011-1#11)(2011-2#44)(2011-8#1)(2012-1#3)(2012-12#11)(2012-2#13)(2012-3#16)(2012-4#1)(2012-9#1)(2013-1#31)(2013-7#3)(2013-8#22)
impact on US##2##3##(2008-11#1)(2012-12#1)
impact on access to##2##4##(1996-1#1)(1996-3#1)
impact on access##3##3##(1994-12#1)(1996-1#1)(1996-3#1)
impact on affected##2##3##(2008-7#1)(2012-12#1)
impact on all##4##3##(1992-8#1)(1996-1#1)(2008-10#1)(2013-8#1)
impact on attitudes##2##3##(1997-5#1)(2011-2#1)
impact on basic##2##3##(2008-10#1)(2008-11#1)
impact on both##2##3##(2008-10#1)(2012-2#1)
impact on cell##3##3##(2008-11#2)(2009-6#1)
impact on cortical cells##2##4##(2008-11#2)
impact on disease##2##3##(2008-7#1)(2012-2#1)
impact on health##9##3##(1991-2#1)(1992-3#1)(1995-1#1)(2007-10#1)(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
impact on healthcare facilities##2##4##(1992-12#1)(1996-2#1)
impact on hospital##2##3##(1992-12#1)(1997-3#1)
impact on hospitals##2##3##(1993-2#1)(2008-11#1)
impact on how##2##3##(2009-7#1)(2013-8#1)
impact on human health and##2##5##(2010-4#1)(2011-2#1)
impact on human health##5##4##(2008-10#1)(2008-8#2)(2010-4#1)(2011-2#1)
impact on human##7##3##(2008-10#1)(2008-7#1)(2008-8#3)(2010-4#1)(2011-2#1)
impact on immunization##2##3##(1995-5#1)(1996-12#1)
impact on its##2##3##(2008-3#1)(2012-2#1)
impact on long-term survival##2##4##(2008-11#1)(2009-5#1)
impact on long-term##4##3##(2008-1#1)(2008-11#1)(2009-5#1)(2013-8#1)
impact on medical##2##3##(1992-1#1)(1993-1#1)
impact on nuclear##2##3##(2008-10#1)(2011-2#1)
impact on nursing##3##3##(2007-10#1)(2008-11#2)
impact on other##2##3##(2008-10#1)(2008-3#1)
impact on our##2##3##(2008-7#1)(2010-1#1)
impact on outcome##2##3##(2006-10#1)(2011-2#1)
impact on overall##2##3##(1992-1#1)(2008-10#1)
impact on patient outcomes in##2##5##(1994-3#1)(2007-12#1)
impact on patient satisfaction##2##4##(1997-3#1)(2010-2#1)
impact on patient##7##3##(1994-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2010-2#1)(2010-8#1)
impact on patient's##2##3##(1992-2#1)(2011-2#1)
impact on patients with##2##4##(2008-7#1)(2011-2#1)
impact on patients##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
impact on patients'##2##3##(2010-2#1)(2011-2#1)
impact on payment##2##3##(1992-12#1)(1993-3#1)
impact on performance##2##3##(2007-12#1)(2012-3#1)
impact on prognosis##3##3##(1990-8#1)(2010-11#1)(2012-3#1)
impact on public health##2##4##(2008-1#1)(2008-8#1)
impact on quality of life##7##5##(2008-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
impact on quality##9##3##(1994-3#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
impact on relationships##2##3##(2008-11#1)(2013-1#1)
impact on resistance##2##3##(2008-10#1)(2013-1#1)
impact on survival##2##3##(1990-2#1)(2011-2#1)
impact on the ability of##4##5##(1991-3#1)(1996-12#1)(2007-12#1)(2013-8#1)
impact on the course of##2##5##(2008-3#1)(2011-2#1)
impact on the development of##2##5##(1995-5#1)(1996-3#1)
impact on the environment##3##4##(2008-10#3)
impact on the health care##2##5##(1992-1#1)(1994-12#1)
impact on the health##4##4##(1992-1#1)(1994-12#1)(2008-7#1)(2012-12#1)
impact on the patient's quality of life##2##7##(2007-8#1)(2013-1#1)
impact on the patient's##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
impact on the practice of##2##5##(1991-6#1)(2008-11#1)
impact on the quality of life and##2##7##(2007-7#1)(2011-2#1)
impact on the quality of life##4##6##(2007-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
impact on the quality of##8##5##(1995-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
impact on the retention##2##4##(1996-5#1)(2008-11#1)
impact on the way##3##4##(1996-1#1)(2011-2#1)(2013-8#1)
impact on the##132##3##(1990-11#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#3)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#3)(2011-10#1)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#5)
impact on their lives##2##4##(1992-1#1)(2008-7#1)
impact on their##5##3##(1991-1#1)(1992-1#1)(2008-1#1)(2008-7#1)(2011-1#1)
impact on therapeutic##2##3##(1991-7#1)(2012-12#1)
impact on these##2##3##(1996-6#1)(2009-12#1)
impact on this##2##3##(2007-7#1)(2008-11#1)
impact on##421##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-6#3)(1991-7#1)(1992-1#5)(1992-12#3)(1992-2#3)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1996-1#6)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(2006-10#3)(2007-10#4)(2007-11#4)(2007-12#7)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#10)(2008-10#36)(2008-11#28)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#5)(2008-7#19)(2008-8#13)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-10#1)(2011-2#33)(2011-7#1)(2012-1#2)(2012-12#16)(2012-2#12)(2012-3#8)(2012-5#2)(2013-1#25)(2013-7#1)(2013-8#11)
impact pressure##2##2##(2008-11#2)
impact record##2##2##(1997-5#2)
impact represents a##2##3##(1997-5#1)(2009-10#1)
impact scale##2##2##(1995-3#1)(2008-7#1)
impact structures are##2##3##(1997-5#2)
impact structures##5##2##(1997-5#5)
impact than##3##2##(1997-3#1)(2012-2#1)(2012-3#1)
impact that the##3##3##(1992-1#1)(2007-12#1)(2008-12#1)
impact that##10##2##(1992-1#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-7#1)(2012-12#1)(2013-8#1)
impact the ability##2##3##(2007-7#1)(2008-5#1)
impact the morbidity##3##3##(2012-12#1)(2013-8#2)
impact the quality##2##3##(2012-2#1)(2013-8#1)
impact the##31##2##(1994-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#3)(2010-10#2)(2010-12#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#5)
impact these##3##2##(1992-3#1)(2008-7#1)(2008-9#1)
impact to the##2##3##(2008-3#1)(2010-8#1)
impact to##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
impact upon the##3##3##(1997-2#1)(2008-12#1)(2010-2#1)
impact upon##13##2##(1994-1#1)(1997-2#1)(1997-6#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-2#1)(2013-1#1)
impact was##2##2##(1995-1#1)(2008-10#1)
impact with##2##2##(2009-11#2)
impact xylose utilization##2##3##(2012-3#2)
impact##1381##1##(1990-11#2)(1990-2#3)(1990-6#1)(1990-8#2)(1991-1#4)(1991-11#1)(1991-12#7)(1991-2#7)(1991-3#9)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#15)(1992-12#5)(1992-2#7)(1992-3#10)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#6)(1993-11#4)(1993-12#7)(1993-2#5)(1993-3#2)(1993-6#7)(1993-9#1)(1994-1#13)(1994-11#2)(1994-12#13)(1994-2#10)(1994-3#11)(1994-5#4)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#10)(1995-12#10)(1995-2#6)(1995-3#11)(1995-5#3)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#14)(1996-11#3)(1996-12#10)(1996-2#7)(1996-3#11)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-1#8)(1997-2#6)(1997-3#11)(1997-4#2)(1997-5#33)(1997-6#4)(1997-7#2)(2006-10#5)(2007-1#1)(2007-10#14)(2007-11#16)(2007-12#23)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#11)(2008-1#18)(2008-10#104)(2008-11#85)(2008-12#19)(2008-2#23)(2008-3#29)(2008-4#16)(2008-5#18)(2008-6#11)(2008-7#59)(2008-8#42)(2008-9#20)(2009-10#9)(2009-11#8)(2009-12#7)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#12)(2009-6#5)(2009-7#7)(2009-8#13)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#6)(2010-3#11)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#15)(2010-9#3)(2011-1#24)(2011-10#1)(2011-2#101)(2011-4#1)(2011-7#1)(2011-8#1)(2012-1#8)(2012-12#34)(2012-2#43)(2012-3#31)(2012-4#1)(2012-5#2)(2012-9#1)(2013-1#70)(2013-7#4)(2013-8#42)
impact)##3##1##(2008-11#1)(2008-12#1)(2011-2#1)
impact?##3##1##(1993-3#1)(1997-3#1)(2010-3#1)
impacted and##2##2##(2008-7#1)(2009-7#1)
impacted by the##2##3##(2009-9#1)(2011-2#1)
impacted by##12##2##(2007-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
impacted lower##2##2##(1991-3#1)(2013-1#1)
impacted on the##3##3##(2008-11#2)(2008-4#1)
impacted on##6##2##(2007-10#1)(2008-11#3)(2008-4#1)(2013-1#1)
impacted stone##2##2##(2010-12#2)
impacted teeth in children##3##4##(2007-12#3)
impacted teeth##6##2##(1990-2#1)(2007-12#4)(2013-1#1)
impacted the##2##2##(2008-10#1)(2010-10#1)
impacted##56##1##(1990-2#1)(1990-6#1)(1991-3#1)(1997-1#1)(2007-10#1)(2007-12#5)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-4#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-12#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)
impacting on the##4##3##(2008-11#1)(2008-2#1)(2009-4#1)(2012-12#1)
impacting on##8##2##(2008-10#2)(2008-11#2)(2008-2#2)(2009-4#1)(2012-12#1)
impacting the##9##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-8#2)
impacting with##2##2##(1995-6#1)(2008-10#1)
impacting##29##1##(1991-12#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-8#2)
impaction and##3##2##(1996-2#1)(2008-11#1)(2013-8#1)
impaction of##4##2##(2008-12#2)(2011-1#1)(2013-1#1)
impaction##17##1##(1992-2#1)(1995-3#2)(1996-2#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-12#2)(2011-1#1)(2013-1#2)(2013-8#4)
impactions##2##1##(2008-10#2)
impactor was fixed##2##3##(2008-10#2)
impactor##12##1##(1992-2#1)(1994-12#1)(1995-3#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-12#1)
impactors##4##1##(1992-3#2)(1997-5#1)(2008-5#1)
impacts and##3##2##(1995-6#1)(1996-1#1)(2010-12#1)
impacts are##5##2##(1992-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
impacts in##6##2##(1991-12#1)(1997-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
impacts of the##8##3##(1996-12#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-9#1)
impacts of##44##2##(1991-1#1)(1992-3#1)(1994-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-5#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-5#1)(2008-9#3)(2009-9#1)(2010-10#1)(2010-11#2)(2011-1#4)(2012-2#2)(2012-6#1)(2013-1#2)
impacts on health##2##3##(1991-11#1)(2011-1#1)
impacts on the##7##3##(1991-6#1)(1993-12#1)(1997-5#1)(1997-7#1)(2007-3#1)(2009-9#1)(2012-2#1)
impacts on##26##2##(1991-11#1)(1991-12#1)(1991-6#2)(1992-3#1)(1993-12#1)(1994-12#1)(1996-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
impacts that##2##2##(1997-5#1)(2008-1#1)
impacts the##4##2##(1996-2#1)(1997-6#1)(2008-10#1)(2012-3#1)
impacts upon##2##2##(2007-12#1)(2008-5#1)
impacts##133##1##(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#2)(1992-3#4)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#2)(1995-3#2)(1995-4#1)(1995-6#4)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-5#12)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#4)(2009-3#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-2#6)(2012-3#3)(2012-6#2)(2013-1#5)(2013-7#1)(2013-8#1)
impair immune##3##2##(1992-2#1)(2008-3#1)(2008-8#1)
impair object##2##2##(1992-10#2)
impair quality of life##2##4##(2008-3#1)(2008-7#1)
impair the##16##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-4#1)(2011-2#2)(2012-1#1)(2012-3#1)
impair##59##1##(1990-12#1)(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#2)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
impaired GH##2##2##(2007-11#1)(2007-7#1)
impaired and##7##2##(1993-3#1)(1994-1#1)(2007-10#1)(2008-1#1)(2008-7#1)(2010-4#1)(2013-1#1)
impaired anorectal motor##2##3##(2011-2#2)
impaired as##2##2##(2007-8#1)(2008-7#1)
impaired at##2##2##(1992-11#1)(2008-4#1)
impaired both##3##2##(1993-12#1)(1993-6#1)(2008-10#1)
impaired by the##2##3##(1997-8#1)(2013-1#1)
impaired by##18##2##(1990-2#1)(1992-1#1)(1992-12#1)(1993-12#2)(1993-6#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-5#1)(2010-11#1)(2011-3#3)(2012-12#3)(2013-1#1)
impaired elderly##2##2##(1990-3#1)(1990-5#1)
impaired energy##2##2##(2008-11#1)(2009-11#1)
impaired fasting glucose##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
impaired fertility##3##2##(1993-8#1)(2009-5#1)(2012-3#1)
impaired for##2##2##(2009-2#2)
impaired glucose regulation##6##3##(2008-11#1)(2008-7#5)
impaired glucose tolerance (IGT)##6##4##(1994-12#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-3#2)
impaired glucose tolerance and##2##4##(1996-2#1)(2010-10#1)
impaired glucose tolerance##22##3##(1994-12#2)(1995-12#1)(1996-2#1)(2008-1#4)(2008-3#2)(2008-7#5)(2010-10#1)(2010-4#1)(2011-1#2)(2012-3#2)(2013-8#1)
impaired glucose##30##2##(1994-12#2)(1995-12#1)(1996-2#1)(2007-5#1)(2008-1#4)(2008-11#1)(2008-3#3)(2008-7#10)(2010-10#1)(2010-4#1)(2011-1#2)(2012-3#2)(2013-8#1)
impaired growth##5##2##(1996-5#1)(1996-6#2)(2008-10#1)(2010-6#1)
impaired in the elderly##2##4##(2008-8#1)(2010-2#1)
impaired in the##8##3##(1990-2#1)(1994-3#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-2#1)
impaired in their##4##3##(2008-10#3)(2008-11#1)
impaired in##35##2##(1990-2#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
impaired insulin##2##2##(2010-11#1)(2012-2#1)
impaired left ventricular##2##3##(2007-8#1)(2008-4#1)
impaired memory##3##2##(1993-12#1)(2008-7#1)(2009-6#1)
impaired mobility##2##2##(1991-3#1)(2009-12#1)
impaired motor function##2##3##(1994-5#1)(2011-2#1)
impaired nitric oxide##2##3##(2009-4#1)(2010-4#1)
impaired on the##2##3##(1993-5#2)
impaired on##3##2##(1993-5#2)(1994-3#1)
impaired or##2##2##(1997-1#1)(2012-3#1)
impaired patients##3##2##(1992-3#1)(1993-12#1)(2011-2#1)
impaired performance##2##2##(2008-7#1)(2009-2#1)
impaired quality of life##2##4##(2009-6#1)(2012-1#1)
impaired renal function##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
impaired responsiveness##2##2##(1993-11#1)(2008-10#1)
impaired retention##2##2##(1993-12#1)(1993-5#1)
impaired spatial learning##3##3##(1993-12#3)
impaired spatial##5##2##(1993-12#3)(2008-11#1)(2008-7#1)
impaired sympathetic nerve function##2##4##(2008-7#2)
impaired than##5##2##(1994-8#1)(1996-7#1)(2008-12#3)
impaired the##8##2##(1992-10#1)(1993-3#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
impaired when the##2##3##(1994-3#1)(1995-11#1)
impaired when##6##2##(1990-11#1)(1994-3#1)(1995-11#1)(2008-7#2)(2012-2#1)
impaired with##2##2##(2008-10#1)(2009-9#1)
impaired##332##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#11)(1993-2#1)(1993-3#5)(1993-5#3)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#3)(1996-5#3)(1996-6#2)(1996-7#2)(1997-1#3)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#10)(2008-10#23)(2008-11#14)(2008-12#7)(2008-3#6)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#36)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#5)(2010-6#1)(2010-7#6)(2010-8#1)(2011-1#5)(2011-2#12)(2011-3#3)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#11)(2013-1#13)(2013-7#2)(2013-8#7)
impairing##8##1##(1997-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)
impairment according to##3##3##(2007-8#1)(2009-2#2)
impairment after##4##2##(1991-11#1)(2009-10#1)(2009-3#1)(2010-12#1)
impairment and depression##2##3##(1990-3#1)(2012-12#1)
impairment and disability##2##3##(1991-12#1)(1996-3#1)
impairment and iron deficiency##2##4##(2011-1#2)
impairment and subsequent##2##3##(2008-9#1)(2012-12#1)
impairment and##27##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#1)
impairment as a##2##3##(2008-2#1)(2012-12#1)
impairment as##3##2##(1997-2#1)(2008-2#1)(2012-12#1)
impairment associated with##3##3##(2008-2#1)(2008-4#1)(2009-6#1)
impairment during the##3##3##(2009-4#1)(2010-7#1)(2012-12#1)
impairment during##4##2##(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
impairment for##2##2##(1995-5#1)(2010-8#1)
impairment in Parkinson's disease##2##4##(2008-6#1)(2008-7#1)
impairment in a##3##3##(1997-2#1)(2009-6#2)
impairment in the##11##3##(1990-3#1)(1991-2#1)(1992-11#1)(1995-8#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#2)(2012-2#1)
impairment in this##3##3##(1997-2#1)(2009-6#1)(2011-1#1)
impairment in##47##2##(1990-3#1)(1991-1#1)(1991-2#2)(1992-11#2)(1992-12#1)(1994-3#2)(1995-8#1)(1996-12#1)(1997-2#3)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-6#3)(2009-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
impairment is a##2##3##(1991-9#1)(2013-8#1)
impairment is the##2##3##(2010-4#1)(2012-2#1)
impairment is##13##2##(1991-9#1)(1993-3#1)(1995-2#1)(1996-5#1)(2008-1#2)(2008-11#1)(2008-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
impairment most##2##2##(1997-2#1)(2013-8#1)
impairment observed##4##2##(1994-6#2)(2008-2#1)(2013-8#1)
impairment of LTP in##2##4##(1996-2#1)(2008-7#1)
impairment of LTP##3##3##(1996-2#1)(2008-7#2)
impairment of balance function##2##4##(1996-7#2)
impairment of learning##2##3##(2008-7#1)(2013-1#1)
impairment of motor##2##3##(1997-2#1)(2009-10#1)
impairment of quality of life##2##5##(2011-2#1)(2013-1#1)
impairment of quality##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
impairment of the##8##3##(1990-9#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-6#1)(2013-8#1)
impairment of this##2##3##(1990-3#1)(2008-5#1)
impairment of##79##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-2#2)(1997-7#2)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#14)(2008-8#3)(2009-10#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#3)
impairment on the##2##3##(1990-11#1)(2013-1#1)
impairment on##4##2##(1990-11#1)(2007-10#1)(2013-1#1)(2013-8#1)
impairment or##2##2##(2011-2#1)(2013-8#1)
impairment profiles##2##2##(2008-4#2)
impairment scores##2##2##(2011-1#2)
impairment was investigated##2##3##(1994-3#1)(1997-6#1)
impairment was not##3##3##(1993-12#2)(2011-2#1)
impairment was observed##2##3##(2008-10#1)(2008-11#1)
impairment was##13##2##(1990-12#1)(1993-12#3)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
impairment with##2##2##(2012-12#1)(2012-3#1)
impairment##369##1##(1990-11#3)(1990-12#1)(1990-3#6)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#6)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#4)(1993-3#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-6#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#3)(1997-2#13)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#10)(2008-10#9)(2008-11#11)(2008-12#2)(2008-2#11)(2008-3#5)(2008-4#6)(2008-5#4)(2008-6#7)(2008-7#22)(2008-8#6)(2008-9#10)(2009-10#11)(2009-11#2)(2009-2#6)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#6)(2010-8#1)(2011-1#15)(2011-2#16)(2012-1#2)(2012-12#13)(2012-2#11)(2012-3#12)(2012-6#1)(2013-1#21)(2013-7#1)(2013-8#20)
impairment-based##2##1##(2008-12#1)(2010-7#1)
impairments and##7##2##(1991-3#1)(1993-3#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)
impairments are##3##2##(1992-11#1)(2008-6#1)(2013-1#1)
impairments as##2##2##(2009-10#1)(2011-1#1)
impairments associated with##2##3##(2007-12#1)(2011-1#1)
impairments in patients with##2##4##(2008-12#1)(2013-1#1)
impairments in the##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
impairments in##29##2##(1991-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-8#2)(1997-2#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
impairments of##3##2##(1991-7#1)(1994-3#1)(2008-12#1)
impairments on##2##2##(1992-11#1)(2011-2#1)
impairments that##2##2##(1993-3#1)(2011-1#1)
impairments##84##1##(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-11#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-2#4)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#4)(2008-12#5)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#2)(2009-10#2)(2009-9#1)(2010-3#1)(2010-4#2)(2011-1#10)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
impairs endothelial function##2##3##(2008-8#1)(2013-8#1)
impairs induction of##2##3##(2008-7#2)
impairs spatial##2##2##(1993-12#1)(2008-11#1)
impairs the##8##2##(1992-3#1)(1992-8#1)(1997-8#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
impairs##34##1##(1991-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#2)(1997-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
impala as##2##2##(2008-10#2)
impala##8##1##(2008-10#8)
impalpable testis##2##2##(2008-10#2)
impalpable##5##1##(1993-12#1)(2008-10#4)
impart##8##1##(2008-10#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-4#2)
imparted by##2##2##(2008-10#1)(2008-2#1)
imparted##8##1##(1997-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2010-6#1)(2012-12#1)
impartial##2##1##(1995-12#1)(2011-1#1)
imparting resistance to##2##3##(2008-10#2)
imparting##7##1##(1994-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2011-1#1)
imparts##4##1##(1990-12#1)(2007-12#1)(2010-5#1)(2012-12#1)
impatiens##6##1##(2008-10#6)
impedance analysis##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
impedance and histology##2##3##(1996-5#2)
impedance and##6##2##(1996-5#2)(2008-10#4)
impedance at##3##2##(2008-10#3)
impedance boundary conditions##2##3##(2008-2#1)(2008-7#1)
impedance boundary##3##2##(2008-2#1)(2008-7#2)
impedance in##3##2##(1990-5#1)(2008-3#1)(2008-9#1)
impedance is##2##2##(2008-11#1)(2010-4#1)
impedance matching##3##2##(2007-11#2)(2011-1#1)
impedance measurement##3##2##(1995-11#1)(2008-10#2)
impedance measurements##4##2##(2008-10#2)(2009-11#1)(2012-2#1)
impedance mismatch##3##2##(2007-11#2)(2011-2#1)
impedance of the##2##3##(1995-11#1)(2009-5#1)
impedance of##4##2##(1995-11#1)(2008-10#2)(2009-5#1)
impedance spectra##2##2##(2008-10#2)
impedance spectroscopy (EIS)##5##3##(2008-10#5)
impedance spectroscopy and##3##3##(2008-10#3)
impedance spectroscopy##23##2##(2008-10#20)(2009-9#1)(2010-4#1)(2012-2#1)
impedance technique##2##2##(2008-10#2)
impedance values##2##2##(2008-9#2)
impedance was##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
impedance##115##1##(1990-3#1)(1990-5#2)(1995-11#3)(1996-5#4)(1997-7#1)(2007-11#4)(2007-12#1)(2008-10#58)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#6)(2009-1#1)(2009-11#2)(2009-5#1)(2009-9#1)(2010-4#2)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
impedances##4##1##(2008-10#1)(2008-9#3)
impede successful##2##2##(2007-12#1)(2010-12#1)
impede the##6##2##(1995-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2010-10#1)(2010-8#1)
impede##22##1##(1994-12#1)(1995-12#2)(1995-3#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)
impeded by##2##2##(1994-11#1)(2008-8#1)
impeded the##2##2##(2008-11#1)(2008-7#1)
impeded##14##1##(1994-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)
impedes##3##1##(1992-3#1)(1992-5#1)(1997-4#1)
impediment to##3##2##(1996-3#1)(1997-1#1)(2010-12#1)
impediment##7##1##(1996-3#1)(1997-1#1)(2007-7#1)(2008-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
impediments to##2##2##(1995-1#1)(1996-2#1)
impediments##3##1##(1995-1#1)(1996-2#1)(2008-12#1)
impedimetric##2##1##(2008-10#1)(2009-9#1)
impeding the##2##2##(2008-10#2)
impeding##3##1##(2008-10#2)(2008-11#1)
impeller##9##1##(1992-1#2)(2008-6#5)(2008-8#2)
impellers##2##1##(2008-6#2)
impending##17##1##(1992-3#1)(1995-1#2)(2007-11#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
imperative and##3##2##(1992-1#1)(2010-10#1)(2011-2#1)
imperative for##5##2##(2008-4#1)(2009-11#1)(2010-11#1)(2012-1#1)(2013-8#1)
imperative of##3##2##(1996-1#1)(1996-2#1)(1997-1#1)
imperative to improve##2##3##(2008-11#1)(2013-8#1)
imperative to prevent##2##3##(2010-8#1)(2012-2#1)
imperative to##18##2##(1997-1#1)(1997-2#2)(2008-11#3)(2008-3#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
imperative##54##1##(1992-1#2)(1993-12#1)(1993-3#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#2)(2007-12#1)(2007-4#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
imperatives##2##1##(1997-2#1)(2013-8#1)
imperfect base pairing with the##2##5##(2011-2#2)
imperfect inverted##2##2##(1993-12#1)(1995-8#1)
imperfect##24##1##(1991-2#1)(1993-12#1)(1995-8#2)(1996-8#1)(2007-12#1)(2008-2#1)(2008-3#9)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
imperfecta type II##2##3##(2008-7#2)
imperfections and##2##2##(2007-12#1)(2008-3#1)
imperfections in the##2##3##(2008-3#1)(2013-8#1)
imperfections in##3##2##(2008-3#2)(2013-8#1)
imperfections of the##2##3##(2008-3#2)
imperfections of##3##2##(2008-3#3)
imperfections##13##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#8)(2013-8#1)
imperfectly##5##1##(1990-3#1)(1992-5#1)(1993-2#1)(2008-8#1)(2013-1#1)
imperforate anus##6##2##(2008-10#1)(2009-5#3)(2013-1#2)
imperial##3##1##(2010-1#2)(2012-2#1)
imperil##2##1##(1995-6#1)(2008-8#1)
impermeable##8##1##(1992-11#1)(1992-8#1)(1993-11#1)(1996-2#1)(1997-1#1)(2009-8#1)(2011-1#1)(2012-12#1)
impermeant##2##1##(1990-7#1)(2008-10#1)
impersonal and##2##2##(2008-11#1)(2009-4#1)
impersonal##6##1##(2008-10#1)(2008-11#4)(2009-4#1)
impetigo and##2##2##(2008-5#1)(2010-6#1)
impetigo##7##1##(1997-5#1)(2008-12#3)(2008-5#2)(2010-6#1)
impetus for the##2##3##(1996-11#1)(2008-2#1)
impetus for##10##2##(1996-1#1)(1996-11#2)(1997-1#1)(1997-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)
impetus##14##1##(1996-1#1)(1996-11#2)(1996-2#1)(1997-1#2)(1997-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-11#1)
impinge on the##2##3##(2008-2#1)(2008-3#1)
impinge on##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
impinge##7##1##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-8#1)
impingement syndromes are##2##3##(2011-2#2)
impingement##15##1##(2007-11#2)(2008-12#1)(2008-8#2)(2011-2#8)(2012-12#1)(2013-1#1)
impinges on##2##2##(1992-1#1)(2007-12#1)
impinges upon##2##2##(2007-12#1)(2008-1#1)
impinges##5##1##(1992-1#1)(2007-12#2)(2008-1#1)(2010-7#1)
impinging on the##3##3##(2008-3#1)(2009-3#1)(2012-12#1)
impinging on##4##2##(2008-3#1)(2009-3#1)(2012-12#1)(2012-2#1)
impinging##6##1##(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2012-12#1)(2012-2#1)
implant and the##2##3##(2007-8#1)(2012-2#1)
implant and use##2##3##(2007-8#1)(2008-9#1)
implant and##8##2##(1995-12#1)(2007-7#1)(2007-8#2)(2008-9#1)(2012-2#2)(2012-3#1)
implant as##2##2##(2008-9#1)(2013-1#1)
implant at##3##2##(2008-9#3)
implant biocompatibility##2##2##(2009-7#2)
implant dentistry##3##2##(2007-12#2)(2012-12#1)
implant design##2##2##(2008-9#1)(2009-7#1)
implant during##2##2##(2008-9#2)
implant experience##4##2##(2008-9#3)(2010-10#1)
implant failure##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
implant failures##2##2##(2013-1#2)
implant has##2##2##(2008-1#1)(2008-9#1)
implant in the##3##3##(2007-7#1)(2009-11#1)(2012-3#1)
implant in##7##2##(2007-7#1)(2008-9#4)(2009-11#1)(2012-3#1)
implant insertion##2##2##(2007-12#1)(2011-2#1)
implant is##4##2##(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
implant loosening and##2##3##(2008-11#2)
implant loosening##3##2##(2008-11#3)
implant materials##2##2##(2008-11#1)(2012-2#1)
implant outcomes##2##2##(2008-9#2)
implant patients'##2##2##(2008-9#2)
implant placement and##2##3##(2007-12#2)
implant placement##15##2##(2007-12#7)(2012-12#1)(2013-1#7)
implant positioning##2##2##(2009-4#1)(2011-2#1)
implant programme##5##2##(2008-9#5)
implant recipients##11##2##(2008-9#9)(2012-2#2)
implant removal##3##2##(2009-7#2)(2012-2#1)
implant restorations##2##2##(2010-12#1)(2013-1#1)
implant site development##4##3##(2007-12#4)
implant site##7##2##(2007-12#5)(2008-9#1)(2012-3#1)
implant stability##2##2##(2008-11#1)(2010-12#1)
implant success##3##2##(2013-1#3)
implant surgery in##3##3##(2008-9#2)(2013-1#1)
implant surgery##12##2##(2008-9#5)(2012-2#4)(2013-1#3)
implant survival##3##2##(2009-4#1)(2013-1#2)
implant system##7##2##(2008-8#1)(2008-9#5)(2010-12#1)
implant systems were##2##3##(1996-3#1)(2008-9#1)
implant systems##3##2##(1996-3#1)(2008-9#2)
implant team##2##2##(2008-9#1)(2012-2#1)
implant technology##4##2##(2008-9#4)
implant that##2##2##(2008-9#2)
implant to##2##2##(2008-7#1)(2008-9#1)
implant treatment is##2##3##(2007-12#1)(2011-7#1)
implant treatment##4##2##(2007-12#1)(2008-11#1)(2011-7#1)(2013-1#1)
implant use##6##2##(2008-9#5)(2012-2#1)
implant users to##2##3##(2008-9#2)
implant users##36##2##(2008-9#31)(2011-1#2)(2011-2#2)(2012-2#1)
implant was performed##3##3##(2007-11#1)(2008-6#1)(2012-2#1)
implant was##13##2##(1992-9#1)(1994-11#1)(2007-11#1)(2008-6#1)(2008-9#3)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#3)
implant were##4##2##(2008-9#3)(2011-1#1)
implant with a##2##3##(2008-9#2)
implant##383##1##(1991-1#1)(1992-9#4)(1994-11#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#18)(2007-7#3)(2007-8#4)(2008-1#2)(2008-11#9)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#198)(2009-11#2)(2009-4#6)(2009-7#9)(2010-10#3)(2010-12#4)(2010-3#1)(2010-6#1)(2011-1#5)(2011-2#20)(2011-7#1)(2012-12#4)(2012-2#27)(2012-3#3)(2013-1#40)(2013-8#1)
implant-supported single crown##2##3##(2013-1#2)
implant-supported##6##1##(2013-1#6)
implantable LVADs##3##2##(2010-8#3)
implantable biomaterials##2##2##(2008-11#1)(2009-11#1)
implantable biosensors##3##2##(2009-11#3)
implantable cardioverter defibrillator implantation##2##4##(2008-12#2)
implantable cardioverter##3##2##(2008-12#2)(2010-5#1)
implantable cardioverter-defibrillator##2##2##(2008-12#2)
implantable device##3##2##(2007-8#1)(2009-10#1)(2010-10#1)
implantable devices##6##2##(2009-11#5)(2010-8#1)
implantable drug delivery systems##2##4##(2008-7#2)
implantable drug##3##2##(2008-7#2)(2010-10#1)
implantable##47##1##(1993-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-12#7)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#9)(2009-5#1)(2010-10#3)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#1)(2012-3#2)
implantation and follow-up##2##3##(2007-7#1)(2009-10#1)
implantation and the##3##3##(2009-11#2)(2011-2#1)
implantation and##25##2##(1994-9#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#4)(2009-10#1)(2009-11#2)(2010-10#2)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
implantation at##2##2##(2008-9#1)(2013-1#1)
implantation can##2##2##(2008-10#1)(2012-2#1)
implantation has been##2##3##(2008-11#1)(2008-9#1)
implantation has##4##2##(2008-11#1)(2008-9#3)
implantation in a child with##3##5##(2008-9#2)(2012-2#1)
implantation in a##11##3##(2008-9#7)(2009-12#1)(2012-2#2)(2013-1#1)
implantation in children with##3##4##(2012-2#3)
implantation in children##8##3##(2008-9#2)(2012-2#6)
implantation in chronic##3##3##(2008-9#3)
implantation in paediatric##2##3##(2008-9#2)
implantation in patients with##4##4##(2008-9#2)(2009-5#1)(2011-2#1)
implantation in patients##5##3##(2008-9#3)(2009-5#1)(2011-2#1)
implantation in the##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
implantation in##52##2##(1993-9#1)(1994-9#1)(2007-8#2)(2008-11#1)(2008-9#31)(2009-12#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#9)(2013-1#2)
implantation into##3##2##(2008-12#1)(2009-11#1)(2009-3#1)
implantation is a##3##3##(2008-9#2)(2012-2#1)
implantation is##14##2##(1990-8#1)(1996-3#1)(2008-3#1)(2008-9#8)(2010-6#1)(2012-2#2)
implantation may##2##2##(2008-9#1)(2010-12#1)
implantation of Verisyse##2##3##(2011-2#2)
implantation of a##15##3##(1994-2#1)(1994-8#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-7#2)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#1)
implantation of new##2##3##(2010-8#1)(2011-2#1)
implantation of the##2##3##(1993-8#1)(2011-2#1)
implantation of##61##2##(1990-5#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-9#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-8#1)(1996-2#1)(2007-10#2)(2007-11#1)(2007-8#4)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#12)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
implantation on the##3##3##(1990-3#1)(2008-10#1)(2008-9#1)
implantation on##4##2##(1990-3#1)(2008-10#1)(2008-9#1)(2009-3#1)
implantation period##2##2##(2012-3#2)
implantation sites##3##2##(1996-12#1)(2008-11#1)(2008-9#1)
implantation surgery##4##2##(2008-9#2)(2010-9#1)(2012-2#1)
implantation was##12##2##(1994-12#1)(2008-11#1)(2008-9#7)(2012-1#1)(2012-2#2)
implantation were##2##2##(2011-2#1)(2012-2#1)
implantation window##3##2##(2012-3#1)(2013-8#2)
implantation with a dose of##2##5##(2007-12#2)
implantation with##7##2##(1997-6#1)(2007-12#2)(2008-9#2)(2012-2#2)
implantation##368##1##(1990-3#2)(1990-5#1)(1990-8#2)(1991-12#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#9)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-7#3)(2007-8#9)(2008-10#6)(2008-11#10)(2008-12#5)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#127)(2009-10#2)(2009-11#7)(2009-12#2)(2009-3#3)(2009-5#2)(2010-10#3)(2010-12#2)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#31)(2012-1#8)(2012-12#2)(2012-2#44)(2012-3#7)(2013-1#7)(2013-8#6)
implantation]##3##1##(1991-2#1)(2011-3#1)(2013-1#1)
implantations and##3##2##(1996-12#2)(2008-9#1)
implantations##9##1##(1993-6#1)(1996-12#2)(2007-8#1)(2008-9#4)(2012-2#1)
implanted after external fixation of##2##5##(2009-4#2)
implanted at##2##2##(1996-5#1)(2012-2#1)
implanted children##8##2##(2008-9#5)(2011-1#1)(2012-2#2)
implanted device##3##2##(1994-9#1)(2010-6#1)(2011-2#1)
implanted devices##2##2##(2008-7#1)(2009-11#1)
implanted for##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
implanted in a##2##3##(2007-12#1)(2007-7#1)
implanted in the##8##3##(1992-4#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
implanted in##23##2##(1990-8#1)(1991-3#1)(1992-4#1)(1992-5#1)(1997-7#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-3#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#2)
implanted into the##8##3##(1992-8#1)(1997-2#1)(2008-11#1)(2008-5#2)(2009-11#1)(2011-2#1)(2012-1#1)
implanted into##13##2##(1992-8#1)(1993-1#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
implanted off-bypass in the inferior vena cava##2##7##(2007-8#2)
implanted pastures##2##2##(2013-7#2)
implanted port##3##2##(2007-7#3)
implanted under##2##2##(2008-9#1)(2010-7#1)
implanted with a##2##3##(2008-7#1)(2008-9#1)
implanted with the##3##3##(1997-2#1)(2008-9#2)
implanted with##13##2##(1993-12#2)(1995-5#1)(1997-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#4)(2010-8#1)
implanted younger##2##2##(2008-9#2)
implanted##151##1##(1990-7#1)(1990-8#1)(1991-3#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#7)(2007-8#7)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#6)(2008-7#7)(2008-8#7)(2008-9#29)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#3)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#2)
implantees in##2##2##(2008-9#2)
implantees were##2##2##(2008-9#2)
implantees##20##1##(2008-9#20)
implanting a##2##2##(2008-12#1)(2011-2#1)
implanting##7##1##(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
implantology##3##1##(1990-5#1)(2011-7#1)(2013-1#1)
implants and##16##2##(1993-2#1)(2007-11#1)(2008-9#5)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#1)
implants are##11##2##(1996-11#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-9#3)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#1)
implants at 2 months##2##4##(2012-2#2)
implants at 2##3##3##(2007-11#1)(2012-2#2)
implants at##8##2##(1992-4#1)(2007-11#1)(2008-9#2)(2012-2#4)
implants because of##2##3##(2009-11#1)(2012-2#1)
implants by##2##2##(2008-9#1)(2013-1#1)
implants for##8##2##(1991-5#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
implants had##2##2##(2008-8#1)(2013-1#1)
implants have been##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
implants have##10##2##(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#2)
implants in children##2##3##(2007-12#1)(2008-9#1)
implants in the##6##3##(2008-9#3)(2010-5#1)(2013-1#2)
implants in##18##2##(2007-11#2)(2007-12#2)(2008-11#1)(2008-5#1)(2008-9#5)(2009-8#1)(2010-5#2)(2013-1#4)
implants inserted with a torque##2##5##(2013-1#2)
implants inserted with##3##3##(2013-1#3)
implants inserted##5##2##(2011-7#1)(2013-1#4)
implants is##4##2##(1996-3#1)(2007-11#1)(2012-2#2)
implants may be##3##3##(1996-11#1)(2009-8#1)(2012-12#1)
implants may##4##2##(1996-11#1)(2008-9#1)(2009-8#1)(2012-12#1)
implants of##3##2##(1992-5#1)(2008-6#2)
implants placed in the##2##4##(2013-1#2)
implants placed##4##2##(2013-1#4)
implants showed a##2##3##(2008-5#2)
implants showed##3##2##(2008-5#2)(2008-8#1)
implants that##2##2##(2008-11#1)(2010-10#1)
implants to##2##2##(2008-9#1)(2012-2#1)
implants used##2##2##(2013-1#2)
implants using##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
implants was##3##2##(2007-11#1)(2008-12#1)(2008-9#1)
implants were##8##2##(1992-9#1)(2008-6#1)(2008-9#2)(2009-7#2)(2013-1#2)
implants with##4##2##(2008-11#1)(2009-3#1)(2009-8#1)(2013-1#1)
implants##291##1##(1991-5#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-11#5)(1996-3#3)(1996-6#2)(1997-6#1)(2007-11#10)(2007-12#9)(2008-11#7)(2008-12#6)(2008-5#11)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#87)(2009-11#3)(2009-3#1)(2009-4#8)(2009-7#7)(2009-8#7)(2010-10#4)(2010-5#4)(2010-6#2)(2010-8#1)(2011-2#16)(2011-7#6)(2012-12#4)(2012-2#29)(2012-3#2)(2013-1#38)
implants]##4##1##(1991-2#1)(1991-3#1)(1992-6#1)(2013-1#1)
implausible##2##1##(2008-7#1)(2008-8#1)
implement TQM##2##2##(1993-2#1)(1994-2#1)
implement a comprehensive##2##3##(1994-1#1)(2008-1#1)
implement a new##4##3##(1994-9#1)(1996-1#1)(2007-11#1)(2012-3#1)
implement a novel##2##3##(2007-11#1)(2013-1#1)
implement a##32##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#2)(2007-11#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-9#2)(2012-3#1)(2013-1#3)
implement an optical##2##3##(2008-2#1)(2008-3#1)
implement an##10##2##(1992-2#1)(1993-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)
implement and##8##2##(1995-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)
implement effective##2##2##(2008-11#1)(2012-3#1)
implement numerical##2##2##(2007-11#1)(2008-3#1)
implement our##2##2##(2008-3#1)(2012-12#1)
implement safe and effective##2##4##(2007-12#1)(2010-6#1)
implement strategies##4##2##(2007-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
implement such a program##2##4##(1993-2#1)(2012-12#1)
implement such a##3##3##(1993-2#1)(2007-12#1)(2012-12#1)
implement such##7##2##(1991-12#1)(1991-2#1)(1993-2#1)(2007-12#1)(2008-3#1)(2012-12#2)
implement the new##2##3##(2008-11#1)(2008-3#1)
implement the##31##2##(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)
implement these##6##2##(1992-3#1)(1993-1#1)(1996-1#1)(2008-11#1)(2009-6#1)(2011-2#1)
implement total quality management (TQM)##3##5##(1993-12#1)(1994-1#1)(1994-2#1)
implement##214##1##(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#4)(1993-2#4)(1993-3#2)(1994-1#5)(1994-12#3)(1994-2#6)(1994-3#3)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-1#4)(1996-2#1)(1996-3#2)(1997-1#6)(1997-3#2)(1997-7#2)(2007-10#2)(2007-11#10)(2007-12#7)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#21)(2008-11#12)(2008-12#2)(2008-2#13)(2008-3#25)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#1)
implementation activities##2##2##(1993-12#2)
implementation and evaluation of the##2##5##(2008-11#1)(2008-7#1)
implementation and evaluation of##5##4##(2008-11#2)(2008-4#1)(2008-7#1)(2010-3#1)
implementation and evaluation##6##3##(1996-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-3#1)
implementation and impact##2##3##(1992-1#1)(2007-12#1)
implementation and management##3##3##(1993-3#2)(2008-6#1)
implementation and the##2##3##(2008-10#1)(2008-2#1)
implementation and##34##2##(1992-1#1)(1993-3#2)(1995-3#1)(1996-2#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
implementation are described##3##3##(1996-1#1)(2008-3#2)
implementation are discussed##2##3##(1995-2#1)(1995-3#1)
implementation are##9##2##(1993-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-3#4)(2011-1#1)
implementation at##3##2##(1992-2#1)(1996-1#1)(1996-12#1)
implementation based on##2##3##(2008-2#1)(2008-3#1)
implementation challenges##4##2##(1996-2#2)(1997-1#1)(2013-1#1)
implementation date##2##2##(1997-2#1)(2012-12#1)
implementation details##2##2##(1992-2#1)(1994-1#1)
implementation for the##2##3##(2008-2#1)(2008-3#1)
implementation for##6##2##(2007-11#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-8#1)
implementation in a##3##3##(1997-2#1)(2008-3#2)
implementation in the##5##3##(2008-10#1)(2010-10#1)(2013-1#3)
implementation in##16##2##(1994-12#2)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-10#1)(2010-5#2)(2013-1#3)
implementation is difficult because##2##4##(2008-3#2)
implementation is to##2##3##(1993-2#1)(2013-1#1)
implementation is##14##2##(1992-2#1)(1993-2#1)(1995-2#1)(1996-1#1)(2008-11#1)(2008-3#4)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
implementation issues in##2##3##(1993-3#1)(2007-12#1)
implementation issues##8##2##(1993-3#1)(1994-3#1)(1996-1#1)(1996-3#1)(2007-12#2)(2008-2#1)(2008-3#1)
implementation may##2##2##(2008-10#1)(2012-2#1)
implementation methodology##2##2##(2008-2#2)
implementation of EMR##2##3##(2008-4#1)(2012-3#1)
implementation of TQM##2##3##(1992-2#1)(1995-3#1)
implementation of a critical pathway##2##5##(2008-3#2)
implementation of a new##2##4##(1996-2#1)(2012-2#1)
implementation of a##56##3##(1991-12#1)(1991-2#1)(1992-2#1)(1993-3#3)(1994-3#2)(1995-3#2)(1996-2#2)(1996-3#1)(1997-2#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#11)(2008-7#1)(2008-9#1)(2009-11#1)(2010-10#2)(2010-7#1)(2011-1#1)(2012-2#4)(2013-1#4)
implementation of an##14##3##(1992-3#1)(1994-2#1)(1996-1#1)(2008-1#1)(2008-11#2)(2008-3#5)(2008-7#1)(2011-1#1)(2011-2#1)
implementation of cellular neural networks##2##5##(2008-2#2)
implementation of choice##2##3##(2008-7#2)
implementation of community-based education##2##4##(2010-3#2)
implementation of continuous##3##3##(1994-1#2)(2008-10#1)
implementation of control##2##3##(2011-2#1)(2013-1#1)
implementation of evidence-based policies##2##4##(2008-11#2)
implementation of evidence-based##4##3##(2008-11#2)(2008-3#2)
implementation of first aid##2##4##(2010-8#2)
implementation of health##4##3##(1995-1#1)(2011-1#2)(2013-8#1)
implementation of integrated##2##3##(2008-8#1)(2008-9#1)
implementation of linear scale up##2##5##(2008-7#2)
implementation of modified##2##3##(2008-3#1)(2011-2#1)
implementation of new##8##3##(1995-3#1)(1997-2#1)(2008-10#3)(2008-7#1)(2009-12#1)(2011-2#1)
implementation of orthogonal phase-code multiplexing##2##5##(2007-12#2)
implementation of preventive##2##3##(2011-2#1)(2012-12#1)
implementation of programs that##2##4##(2012-12#1)(2012-3#1)
implementation of programs##5##3##(1992-1#1)(1994-1#1)(1994-2#1)(2012-12#1)(2012-3#1)
implementation of such##3##3##(1991-1#1)(2007-12#1)(2010-3#1)
implementation of the Medicare##2##4##(1991-3#1)(1995-12#1)
implementation of the managed care system##3##6##(2006-10#3)
implementation of the method##2##4##(2007-12#1)(2008-3#1)
implementation of the model##2##4##(1996-2#2)
implementation of the new##4##4##(2008-11#1)(2008-2#1)(2012-3#2)
implementation of the prospective payment system##2##6##(1991-1#1)(1991-2#1)
implementation of the strategic plan##2##5##(1992-3#2)
implementation of the strategic##3##4##(1992-3#2)(1994-2#1)
implementation of the system##2##4##(1992-3#1)(2008-3#1)
implementation of the##87##3##(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-3#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#3)(1997-3#1)(1997-8#1)(2006-10#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#10)(2008-3#15)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
implementation of therapeutic##2##3##(2009-9#1)(2011-2#1)
implementation of these##10##3##(1992-3#1)(1994-1#2)(1997-7#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-4#1)(2011-3#1)(2013-1#1)
implementation of this technique##2##4##(2008-2#1)(2013-1#1)
implementation of this##13##3##(1996-1#1)(1996-2#1)(2007-12#2)(2008-11#2)(2008-2#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
implementation of treatment##2##3##(1997-2#1)(2012-12#1)
implementation of visible##2##3##(2008-2#1)(2010-4#1)
implementation of##367##2##(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#2)(1992-1#4)(1992-2#4)(1992-3#5)(1993-12#1)(1993-2#2)(1993-3#6)(1993-6#1)(1994-1#5)(1994-12#1)(1994-2#4)(1994-3#5)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#8)(1995-5#1)(1996-1#4)(1996-11#1)(1996-2#7)(1996-3#1)(1996-4#1)(1997-2#5)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-12#1)(2007-11#7)(2007-12#16)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#26)(2008-11#18)(2008-12#5)(2008-2#20)(2008-3#47)(2008-4#4)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#17)(2013-7#4)(2013-8#3)
implementation on##2##2##(1992-12#1)(1994-1#1)
implementation plan##2##2##(1996-2#1)(2012-2#1)
implementation preparation##4##2##(1997-2#4)
implementation process##6##2##(1992-2#1)(1996-1#2)(2007-5#1)(2008-10#1)(2008-11#1)
implementation requires##2##2##(1992-9#1)(2010-5#1)
implementation strategies##6##2##(2010-12#1)(2013-1#5)
implementation technique##2##2##(2008-2#1)(2008-3#1)
implementation that##3##2##(2008-2#1)(2008-6#1)(2012-2#1)
implementation to##3##2##(1992-12#1)(1996-3#1)(2008-2#1)
implementation will##3##2##(1991-1#1)(2011-1#2)
implementation with##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
implementation##674##1##(1991-1#4)(1991-12#5)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#5)(1992-12#3)(1992-2#9)(1992-3#5)(1992-9#1)(1993-12#5)(1993-2#4)(1993-3#15)(1993-6#1)(1994-1#10)(1994-12#5)(1994-2#7)(1994-3#8)(1994-7#1)(1995-1#2)(1995-12#5)(1995-2#8)(1995-3#16)(1995-5#2)(1996-1#17)(1996-11#1)(1996-12#4)(1996-2#16)(1996-3#6)(1996-4#1)(1997-1#2)(1997-2#17)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#3)(2006-12#1)(2007-11#13)(2007-12#25)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#34)(2008-11#33)(2008-12#10)(2008-2#39)(2008-3#83)(2008-4#6)(2008-6#7)(2008-7#15)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#10)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#23)(2012-3#10)(2013-1#38)(2013-7#4)(2013-8#6)
implementations of a##2##3##(2008-2#1)(2009-12#1)
implementations of the##3##3##(2008-3#1)(2008-6#1)(2009-12#1)
implementations of this##2##3##(2008-2#1)(2008-3#1)
implementations of##14##2##(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#2)(2009-10#1)(2009-12#2)(2012-3#1)
implementations onto##2##2##(2008-3#2)
implementations##28##1##(1997-2#1)(2007-12#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#3)(2011-1#1)(2012-2#1)(2012-3#1)
implemented a##22##2##(1991-1#1)(1991-5#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-3#1)(1997-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)
implemented an##2##2##(2007-10#1)(2007-9#1)
implemented and tested##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
implemented and##13##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2009-8#1)(2010-4#1)(2011-3#1)
implemented as a##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
implemented as##8##2##(2008-10#3)(2008-2#1)(2008-3#2)(2011-1#1)(2012-1#1)
implemented at pilot scale in##2##5##(2008-11#2)
implemented at##12##2##(1991-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2012-12#1)(2013-1#3)
implemented by a##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
implemented by the##4##3##(1996-12#1)(1997-5#1)(2008-11#1)(2008-3#1)
implemented by use of##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
implemented by##28##2##(1992-2#1)(1994-2#1)(1996-12#2)(1997-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#6)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
implemented correctly##2##2##(1993-2#1)(1996-8#1)
implemented for the##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
implemented for##18##2##(1992-4#1)(1994-3#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2010-8#2)(2011-2#1)
implemented in a large##3##4##(2007-8#1)(2008-11#1)(2008-3#1)
implemented in a##17##3##(1993-3#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
implemented in an##2##3##(2011-2#1)(2013-1#1)
implemented in order to##2##4##(2008-10#1)(2013-1#1)
implemented in practice##2##3##(2007-10#1)(2008-3#1)
implemented in the SeaWiFS##2##4##(2008-2#1)(2008-3#1)
implemented in the United##2##4##(1994-1#1)(2008-10#1)
implemented in the##19##3##(1994-1#2)(1995-2#1)(1997-2#1)(2006-4#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)(2013-1#1)
implemented in##80##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#3)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#3)(2008-3#13)(2008-4#1)(2008-7#4)(2008-9#2)(2009-5#2)(2009-8#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
implemented into##2##2##(2008-3#1)(2008-7#1)
implemented is##3##2##(2008-11#1)(2008-2#1)(2010-11#1)
implemented on a##5##3##(1992-3#1)(1993-9#1)(2008-3#2)(2011-1#1)
implemented on an existing##2##4##(2008-3#2)
implemented on the##2##3##(2008-3#1)(2010-2#1)
implemented on##16##2##(1992-3#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#7)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
implemented optically##3##2##(2008-2#2)(2008-3#1)
implemented policies##2##2##(1990-12#1)(2012-2#1)
implemented simultaneously##2##2##(2008-3#1)(2011-2#1)
implemented that##4##2##(1997-1#1)(2007-11#1)(2008-3#1)(2008-7#1)
implemented the##5##2##(1995-6#1)(2008-12#1)(2008-3#3)
implemented this##2##2##(2008-3#1)(2013-1#1)
implemented through##5##2##(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2009-9#1)
implemented to improve##2##3##(2008-11#1)(2011-1#1)
implemented to reduce##4##3##(2008-3#1)(2013-1#2)(2013-8#1)
implemented to##22##2##(1992-3#1)(1993-1#1)(1996-8#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2010-11#1)(2011-1#3)(2012-3#2)(2013-1#3)(2013-8#1)
implemented using a##2##3##(2011-1#1)(2012-3#1)
implemented using##5##2##(2010-5#1)(2011-1#2)(2012-3#1)(2013-7#1)
implemented with a##5##3##(2008-2#1)(2008-3#3)(2008-7#1)
implemented with only##2##3##(2008-3#1)(2013-1#1)
implemented with the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
implemented with##24##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#12)(2008-6#1)(2008-7#1)(2013-1#1)
implemented##399##1##(1990-12#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1993-1#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-1#4)(1994-12#3)(1994-2#3)(1994-3#7)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#5)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#1)(1996-8#3)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#1)(1997-7#1)(2006-4#1)(2007-10#2)(2007-11#9)(2007-12#15)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#28)(2008-11#20)(2008-12#6)(2008-2#23)(2008-3#75)(2008-4#3)(2008-6#4)(2008-7#13)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-5#4)(2009-6#4)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#3)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#5)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#18)(2013-7#1)(2013-8#2)
implementers##5##1##(1994-3#2)(2010-8#2)(2012-12#1)
implementing OI's##2##2##(2008-3#2)
implementing PFC##2##2##(1994-1#2)
implementing TQM##5##2##(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#1)
implementing a comprehensive##2##3##(1995-12#1)(1996-3#1)
implementing a##25##2##(1991-2#1)(1992-2#2)(1993-2#1)(1994-3#1)(1995-12#3)(1996-3#2)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#2)
implementing an##4##2##(1992-3#1)(1994-2#1)(1995-3#1)(1996-2#1)
implementing and evaluating the use of##2##6##(2008-11#1)(2008-12#1)
implementing and evaluating the##3##4##(2008-11#2)(2008-12#1)
implementing and##7##2##(2008-11#4)(2008-12#1)(2010-8#1)(2012-12#1)
implementing clinical##2##2##(2008-10#1)(2012-2#1)
implementing continuous quality improvement##3##4##(1994-1#1)(1994-12#1)(1994-2#1)
implementing control##2##2##(2008-2#1)(2012-2#1)
implementing evidence-based##4##2##(2012-2#4)
implementing national##2##2##(2007-11#1)(2008-11#1)
implementing programs##2##2##(1994-2#1)(2013-1#1)
implementing strategies##2##2##(2008-10#1)(2011-2#1)
implementing the demonstrations##2##3##(1991-2#1)(1996-1#1)
implementing the new##2##3##(1992-1#1)(2008-4#1)
implementing the##29##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#2)(2009-10#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
implementing them##3##2##(1992-2#1)(1994-3#1)(2008-11#1)
implementing these##3##2##(1994-1#1)(1996-2#1)(2008-7#1)
implementing this##3##2##(2008-12#1)(2008-6#1)(2010-9#1)
implementing two##2##2##(2007-12#1)(2008-10#1)
implementing##181##1##(1990-9#1)(1991-1#3)(1991-12#2)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#3)(1993-12#2)(1993-2#2)(1994-1#8)(1994-12#3)(1994-2#8)(1994-3#5)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#3)(1996-2#4)(1996-3#3)(1997-1#4)(1997-2#2)(1997-3#3)(2007-11#4)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#13)(2008-12#8)(2008-2#3)(2008-3#12)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#13)(2013-1#7)(2013-8#1)
implements a##3##2##(1995-12#1)(2008-3#1)(2008-4#1)
implements the##4##2##(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)
implements this##2##2##(2008-3#1)(2008-4#1)
implements##22##1##(1991-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2011-2#1)
implicate a##3##2##(1992-3#1)(2006-10#1)(2008-3#1)
implicate stress##2##2##(2008-10#1)(2008-11#1)
implicate the##4##2##(1992-8#1)(1993-11#1)(1993-3#1)(2008-10#1)
implicate##28##1##(1990-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#2)(2006-10#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-2#1)(2011-9#1)(2012-2#2)
implicated as a##10##3##(1991-8#1)(1994-8#1)(1995-3#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
implicated as an##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
implicated as the##5##3##(1990-3#1)(1991-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
implicated as##25##2##(1990-3#1)(1991-5#2)(1991-8#1)(1994-8#2)(1995-2#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
implicated by##2##2##(2008-5#1)(2012-3#1)
implicated in a number of human##2##6##(1993-3#1)(2009-5#1)
implicated in a number of##5##5##(1993-3#1)(1995-11#1)(2009-5#1)(2009-6#1)(2012-12#1)
implicated in a variety of##6##5##(1990-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-4#1)(2013-8#1)
implicated in a##13##3##(1990-11#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(2008-4#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-8#1)
implicated in both##2##3##(1993-12#1)(2010-4#1)
implicated in cell##2##3##(1992-8#1)(1993-3#1)
implicated in human##2##3##(2008-10#1)(2008-4#1)
implicated in its pathogenesis##2##4##(1991-3#1)(2010-10#1)
implicated in its##3##3##(1991-3#1)(1991-9#1)(2010-10#1)
implicated in neurotransmitter release##2##4##(1994-11#1)(1994-9#1)
implicated in regulating##2##3##(2012-12#1)(2013-1#1)
implicated in regulation of##2##4##(2008-10#1)(2008-4#1)
implicated in the control of##4##5##(1993-3#1)(1996-5#1)(2008-7#1)(2009-9#1)
implicated in the development and##2##5##(2008-7#1)(2012-3#1)
implicated in the development of both##2##6##(1991-8#1)(2008-1#1)
implicated in the development of##3##5##(1991-8#1)(2008-1#2)
implicated in the development##5##4##(1991-8#1)(2008-1#2)(2008-7#1)(2012-3#1)
implicated in the etiology of##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
implicated in the genesis of##2##5##(2008-10#1)(2008-2#1)
implicated in the pathogenesis of Alzheimer's disease##2##7##(1993-12#1)(1996-12#1)
implicated in the pathogenesis of diabetic vascular##2##7##(2008-1#2)
implicated in the pathogenesis of##14##5##(1992-12#1)(1993-12#1)(1996-12#2)(1996-7#2)(2008-1#2)(2008-7#2)(2010-5#1)(2012-2#1)(2013-8#2)
implicated in the pathophysiology of##4##5##(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#1)
implicated in the pathophysiology##6##4##(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#2)
implicated in the regulation of##4##5##(1992-9#1)(2008-4#1)(2008-9#1)(2012-2#1)
implicated in the##85##3##(1990-12#1)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-5#1)(1996-7#2)(1997-8#1)(2008-1#5)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
implicated in this##3##3##(1992-3#1)(2008-1#1)(2008-6#1)
implicated in transmission##2##3##(2007-7#1)(2008-10#1)
implicated in tumor##2##3##(2010-3#1)(2011-2#1)
implicated in##212##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#4)(1993-3#4)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#8)(1995-5#1)(1995-6#3)(1996-12#4)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#6)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#12)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#7)
implicated the##3##2##(1994-3#1)(2011-2#1)(2013-1#1)
implicated##280##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#5)(1992-5#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#4)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#3)(1996-6#1)(1996-7#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2008-1#7)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#14)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#11)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#9)(2013-7#4)(2013-8#9)
implicates a##3##2##(1990-11#1)(1993-11#1)(2007-10#1)
implicates##9##1##(1990-11#1)(1991-9#2)(1993-11#1)(1994-6#1)(2007-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
implicating a##2##2##(1992-8#1)(2010-10#1)
implicating the##2##2##(2008-4#1)(2009-8#1)
implicating##20##1##(1992-8#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
implication and##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
implication in##10##2##(1992-8#1)(1993-3#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
implication is that##6##3##(1993-2#1)(1993-9#1)(1996-1#1)(2007-12#1)(2008-10#2)
implication of a##2##3##(2008-1#1)(2008-10#1)
implication of the##3##3##(1995-11#1)(2008-6#1)(2011-2#1)
implication of these findings is##2##5##(2007-12#1)(2009-7#1)
implication of these##4##3##(2007-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
implication of this##2##3##(2008-3#1)(2008-7#1)
implication of##28##2##(1992-6#1)(1995-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
implication on##5##2##(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)
implication##62##1##(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)
implications and future research directions are discussed##2##7##(2007-12#1)(2009-9#1)
implications and limitations##2##3##(2008-12#1)(2008-3#1)
implications and suggestions for##2##4##(2008-12#1)(2010-11#1)
implications and the##2##3##(1997-1#1)(2012-12#1)
implications and##22##2##(1990-8#1)(1991-3#1)(1993-1#1)(1996-2#2)(1997-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-3#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
implications are also##2##3##(1996-1#1)(2010-10#1)
implications are discussed##8##3##(1991-2#1)(1991-3#1)(2007-12#3)(2008-10#1)(2008-12#1)(2010-5#1)
implications are##15##2##(1991-2#1)(1991-3#2)(1992-3#1)(1996-1#1)(1997-5#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#1)
implications beyond##2##2##(2008-1#1)(2008-8#1)
implications both for##2##3##(2009-5#1)(2010-6#1)
implications for a##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
implications for applications##2##3##(2007-11#1)(2008-11#1)
implications for biological##2##3##(1992-12#1)(2008-5#1)
implications for both the##2##4##(2008-5#1)(2008-7#1)
implications for both##3##3##(1991-2#1)(2008-5#1)(2008-7#1)
implications for cell##3##3##(2008-8#1)(2009-8#1)(2011-2#1)
implications for clinical practice and##3##5##(2007-12#1)(2008-7#1)(2012-2#1)
implications for clinical##5##3##(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
implications for conservation and##2##4##(2008-8#2)
implications for counseling##2##3##(2009-7#1)(2010-8#1)
implications for design##2##3##(1992-9#1)(1997-3#1)
implications for diagnosis and##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
implications for diagnosis##4##3##(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
implications for disease control strategies##2##5##(2008-10#2)
implications for disease management##2##4##(2008-10#2)
implications for disease##6##3##(2008-10#5)(2008-11#1)
implications for evaluation##2##3##(1991-1#1)(2008-3#1)
implications for functional brain imaging##2##5##(2009-5#2)
implications for future##4##3##(1993-11#1)(2008-10#1)(2008-7#1)(2012-1#1)
implications for health care organizations##2##5##(1994-12#1)(2008-12#1)
implications for health care reform##2##5##(1994-12#1)(1995-3#1)
implications for health care##9##4##(1991-12#1)(1994-12#2)(1995-2#1)(1995-3#1)(1997-3#1)(2008-12#2)(2010-2#1)
implications for health##15##3##(1991-12#1)(1993-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-12#3)(2008-3#1)(2008-6#1)(2010-2#1)
implications for hospital##2##3##(1995-12#1)(1995-2#1)
implications for information##2##3##(1995-1#1)(1995-2#1)
implications for intervention##3##3##(1992-12#1)(1994-6#1)(2011-2#1)
implications for interventions##2##3##(2009-5#1)(2013-1#1)
implications for management##2##3##(1992-2#1)(2008-12#1)
implications for managers##2##3##(1991-12#1)(1993-1#1)
implications for medical##2##3##(1991-3#1)(1994-3#1)
implications for nursing##2##3##(1994-2#1)(2008-11#1)
implications for optical##2##3##(2008-2#1)(2008-3#1)
implications for policy##3##3##(1994-1#1)(2010-10#1)(2012-12#1)
implications for recruitment##2##3##(2010-10#1)(2012-3#1)
implications for research and##2##4##(1995-1#1)(2011-2#1)
implications for response to##2##4##(2008-4#1)(2009-4#1)
implications for risk##2##3##(2008-12#1)(2008-7#1)
implications for seed dispersal##2##4##(2008-9#2)
implications for studies of##2##4##(1992-11#1)(2008-8#1)
implications for the design of##3##5##(1992-12#1)(2008-2#1)(2013-8#1)
implications for the development of##3##5##(2008-11#1)(2010-12#1)(2012-2#1)
implications for the evolution of##2##5##(2008-8#1)(2008-9#1)
implications for the genetic##2##4##(1997-4#1)(2008-9#1)
implications for the management of##5##5##(2008-7#1)(2008-9#2)(2010-4#1)(2013-1#1)
implications for the treatment of##2##5##(2011-2#1)(2012-12#1)
implications for the treatment##3##4##(2007-12#1)(2011-2#1)(2012-12#1)
implications for the way##2##4##(2008-3#1)(2008-8#1)
implications for the##62##3##(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-12#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
implications for their##3##3##(1996-7#1)(2008-11#1)(2009-10#1)
implications for therapy##2##3##(1992-2#1)(1993-6#1)
implications for transcription##2##3##(1994-8#1)(1994-9#1)
implications for treatment and prevention##2##5##(2008-12#1)(2008-7#1)
implications for treatment and##6##4##(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-7#1)
implications for treatment##7##3##(2007-7#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-7#1)
implications for undergraduate education##2##4##(1991-1#1)(2013-1#1)
implications for understanding the##2##4##(1993-11#1)(1994-8#1)
implications for understanding##4##3##(1993-11#1)(1994-8#1)(2008-7#1)(2009-9#1)
implications for##340##2##(1990-7#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#1)(1996-7#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#15)(2008-12#11)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#13)(2008-8#12)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#4)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#11)(2012-1#6)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#3)
implications from a##2##3##(1992-11#1)(2008-10#1)
implications from##5##2##(1991-1#1)(1992-11#1)(1992-12#1)(2008-10#2)
implications in breast cancer##2##4##(1993-11#1)(2008-4#1)
implications in clinical##2##3##(1993-5#1)(2010-5#1)
implications in human##2##3##(2012-2#2)
implications in the##5##3##(2008-1#1)(2008-10#2)(2009-8#1)(2011-2#1)
implications in treatment##2##3##(2008-7#1)(2010-11#1)
implications in##34##2##(1990-6#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-5#1)(1997-1#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
implications of a##7##3##(1994-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(2007-6#1)(2009-5#1)(2012-12#1)
implications of in##2##3##(1997-2#1)(2011-2#1)
implications of its##2##3##(2008-11#1)(2011-2#1)
implications of our study##2##4##(2008-10#1)(2008-9#1)
implications of our##7##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-9#1)
implications of specific##2##3##(2006-10#1)(2008-6#1)
implications of the findings##2##4##(1993-11#1)(1994-3#1)
implications of the results for##5##5##(1993-12#1)(2007-11#1)(2008-6#1)(2009-7#1)(2011-2#1)
implications of the results##6##4##(1993-12#1)(2007-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2011-2#1)
implications of the study##2##4##(2009-11#1)(2010-8#1)
implications of the##32##3##(1990-2#1)(1991-1#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
implications of these findings are discussed##6##6##(1991-2#1)(1993-1#1)(1994-2#1)(2010-9#1)(2012-1#1)(2013-1#1)
implications of these findings for the nature of##2##8##(1991-5#1)(2012-1#1)
implications of these findings for the##4##6##(1991-5#1)(2009-11#1)(2009-9#1)(2012-1#1)
implications of these findings for##8##5##(1991-5#1)(1992-3#1)(2008-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-2#1)
implications of these findings##22##4##(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-2#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-9#1)(2012-1#2)(2012-2#1)(2013-1#1)
implications of these results are discussed##2##6##(2008-11#1)(2008-2#1)
implications of these results are##3##5##(1991-5#1)(2008-11#1)(2008-2#1)
implications of these results for the##2##6##(1994-1#1)(2008-10#1)
implications of these results for##6##5##(1991-5#1)(1994-1#1)(2007-12#1)(2008-10#2)(2008-8#1)
implications of these results##11##4##(1991-5#2)(1993-12#1)(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
implications of these##51##3##(1990-9#1)(1991-2#2)(1991-5#3)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#2)(2010-9#2)(2012-1#2)(2012-2#1)(2013-1#1)
implications of this result##3##4##(1992-3#1)(2008-2#1)(2008-9#1)
implications of this##23##3##(1991-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#2)
implications of those##2##3##(1994-12#1)(1996-2#1)
implications of using##5##3##(1992-1#1)(1994-1#1)(2008-11#1)(2008-4#1)(2009-7#1)
implications of##216##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#4)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#1)(1994-1#2)(1994-12#4)(1994-2#4)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#18)(2008-12#5)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#5)(2009-11#2)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#4)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
implications on the##2##3##(2009-4#1)(2012-3#1)
implications on##11##2##(1991-12#1)(1992-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
implications raised##2##2##(1993-3#1)(2008-11#1)
implications regarding the##2##3##(2008-2#1)(2013-1#1)
implications that##11##2##(1990-2#1)(1991-1#1)(1991-12#1)(1992-1#1)(1994-2#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
implications the##2##2##(2008-12#1)(2013-1#1)
implications to the##2##3##(1994-11#1)(2008-12#1)
implications to##6##2##(1990-10#1)(1994-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)
implications##811##1##(1990-10#1)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#7)(1991-12#13)(1991-2#6)(1991-3#7)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#3)(1992-12#11)(1992-2#6)(1992-3#6)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#5)(1993-11#4)(1993-12#18)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#8)(1994-2#11)(1994-3#7)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#5)(1995-2#8)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#5)(1996-2#14)(1996-3#6)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#3)(1997-5#2)(1997-8#3)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#4)(2007-12#20)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#48)(2008-11#44)(2008-12#24)(2008-2#19)(2008-3#18)(2008-4#6)(2008-5#10)(2008-6#13)(2008-7#33)(2008-8#22)(2008-9#16)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#11)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#7)(2010-1#6)(2010-10#7)(2010-11#6)(2010-12#3)(2010-2#5)(2010-3#6)(2010-4#6)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#5)(2011-1#13)(2011-2#28)(2012-1#8)(2012-12#15)(2012-2#16)(2012-3#8)(2013-1#29)(2013-7#7)(2013-8#7)
implications]##4##1##(1990-2#1)(1990-3#1)(2007-8#1)(2011-8#1)
implicit and explicit attitudes toward fatness and thinness##2##8##(2007-12#2)
implicit and explicit attitudes toward##3##5##(2007-12#2)(2009-9#1)
implicit attitudes##3##2##(2007-12#1)(2009-9#2)
implicit in##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
implicit memory bias##2##3##(2008-2#2)
implicit memory##3##2##(2008-2#3)
implicit solvation##2##2##(2009-12#1)(2009-5#1)
implicit##37##1##(1991-12#1)(1991-5#1)(1993-1#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-9#4)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)
implicit-solvent model##2##2##(2010-2#2)
implicitly or explicitly##2##3##(2007-7#1)(2009-7#1)
implicitly##14##1##(1993-2#1)(1994-1#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2009-9#2)(2010-3#2)(2012-2#1)(2013-1#1)
implied by the##2##3##(1991-2#1)(2008-8#1)
implied by##6##2##(1991-2#1)(1996-2#1)(1997-8#1)(2008-3#1)(2008-8#2)
implied in the##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
implied in##5##2##(2007-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#1)
implied that the##5##3##(1990-5#1)(1995-5#1)(1996-5#1)(2008-5#1)(2008-8#1)
implied that##18##2##(1990-5#1)(1992-9#1)(1994-12#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#3)(2008-8#2)(2008-9#2)
implied##41##1##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#3)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
implies a##11##2##(1992-12#1)(1992-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)
implies an##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
implies its##2##2##(2008-10#1)(2013-1#1)
implies that a##2##3##(2007-12#1)(2008-8#1)
implies that oxygen##2##3##(2008-11#1)(2013-8#1)
implies that the##23##3##(1990-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1995-2#2)(1996-4#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-10#1)
implies that##67##2##(1990-11#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#2)(1996-12#1)(1996-4#2)(1996-6#1)(1997-7#1)(2007-12#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#5)(2008-8#8)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#3)(2010-5#2)(2011-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
implies the##9##2##(1990-8#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2013-1#1)
implies##118##1##(1990-11#2)(1990-8#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-6#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#5)(2008-7#7)(2008-8#11)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#3)(2010-5#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
imply a##6##2##(1992-2#1)(1997-5#1)(2008-9#2)(2009-6#1)(2011-2#1)
imply an##3##2##(1994-11#1)(2008-10#1)(2013-1#1)
imply that a##7##3##(1993-11#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)
imply that multiple##2##3##(1995-2#1)(1997-2#1)
imply that the##13##3##(1995-12#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
imply that##59##2##(1991-1#1)(1993-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#3)(2007-6#1)(2008-10#8)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-8#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
imply the presence of##2##4##(2008-2#1)(2008-4#1)
imply the##5##2##(1997-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)
imply##94##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#8)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
implying a##4##2##(1990-5#1)(1992-9#1)(2008-3#1)(2008-7#1)
implying an##3##2##(1997-3#1)(2008-11#1)(2013-7#1)
implying different##2##2##(2008-8#1)(2010-12#1)
implying that the##9##3##(1991-12#1)(1992-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)
implying that this##2##3##(2007-12#1)(2008-7#1)
implying that##29##2##(1991-12#1)(1992-2#1)(1992-6#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
implying the##6##2##(1995-2#2)(2007-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
implying##55##1##(1990-5#1)(1991-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
import and##4##2##(1994-11#2)(1995-2#1)(2008-10#1)
import of##6##2##(1991-2#1)(1994-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#1)
import substrate##3##2##(1995-2#3)
import##30##1##(1991-2#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#4)(2007-11#1)(2007-5#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2012-2#4)
importance and quality - part 1##2##6##(2012-3#2)
importance and quality##3##3##(2012-3#3)
importance and##21##2##(1990-2#1)(1995-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#3)
importance are##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
importance as a##5##3##(2007-12#1)(2008-5#1)(2008-9#2)(2011-2#1)
importance as##11##2##(1994-3#1)(2007-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)
importance by##2##2##(1993-12#1)(2011-2#1)
importance due to##2##3##(2008-12#1)(2008-5#1)
importance during##2##2##(2008-7#1)(2009-10#1)
importance for a##2##3##(1992-12#1)(2008-5#1)
importance for applications##2##3##(2008-3#1)(2008-7#1)
importance for the##24##3##(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1996-5#2)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
importance for tissue##2##3##(2010-10#1)(2010-9#1)
importance for##61##2##(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-4#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-5#2)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#4)(2008-9#4)(2009-3#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
importance from##3##2##(1992-8#1)(1994-1#1)(2008-10#1)
importance if##2##2##(1995-11#1)(2008-9#1)
importance in establishing##2##3##(1990-12#1)(2007-11#1)
importance in relation to##2##4##(1993-11#1)(2011-1#1)
importance in the development of##2##5##(1997-7#1)(2008-10#1)
importance in the process of##2##5##(1992-9#1)(2013-1#1)
importance in the regulation of##2##5##(1994-9#1)(2010-8#1)
importance in the##31##3##(1990-11#1)(1990-12#1)(1991-9#1)(1992-9#1)(1993-3#2)(1994-5#1)(1994-9#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
importance in these##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
importance in this##2##3##(1992-4#1)(2008-10#1)
importance in##94##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
importance is##12##2##(1991-12#1)(1991-2#1)(1992-6#1)(1993-5#1)(1995-2#1)(1997-1#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#2)(2012-12#1)
importance not only for##2##4##(1997-7#1)(2008-10#1)
importance not only##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
importance of a multidisciplinary approach##3##5##(2013-1#3)
importance of a##27##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
importance of accurate##2##3##(2008-10#1)(2010-8#1)
importance of age##2##3##(2008-7#1)(2009-12#1)
importance of an accurate##2##4##(1991-11#1)(1995-11#1)
importance of an##8##3##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1995-11#1)(2008-4#1)
importance of both##2##3##(2008-3#1)(2012-12#1)
importance of calcium##2##3##(1997-7#1)(2008-10#1)
importance of cell##2##3##(2008-11#1)(2008-5#1)
importance of choosing the##2##4##(1995-6#1)(2008-2#1)
importance of clinical##4##3##(1990-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
importance of combined##2##3##(1990-2#1)(2007-8#1)
importance of considering##14##3##(1993-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
importance of context in##2##4##(2007-10#1)(2009-7#1)
importance of determining##2##3##(1993-3#1)(2008-10#1)
importance of different##2##3##(1990-8#1)(2012-3#1)
importance of each##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)
importance of early##10##3##(1990-9#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)
importance of establishing##2##3##(2008-11#1)(2008-8#1)
importance of exogenous##3##3##(1990-8#1)(2008-10#1)(2010-10#1)
importance of experiential##2##3##(1996-1#1)(2008-11#1)
importance of genetic testing in##2##5##(2009-7#1)(2011-2#1)
importance of genetic##4##3##(2006-10#1)(2009-7#1)(2009-9#1)(2011-2#1)
importance of having a##2##4##(2007-9#1)(2008-10#1)
importance of having##3##3##(2007-9#1)(2008-10#1)(2008-12#1)
importance of health for persons with psychiatric disabilities##2##8##(2009-6#2)
importance of health##3##3##(2009-6#2)(2010-10#1)
importance of high##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
importance of including##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
importance of information##2##3##(1995-5#1)(2008-11#1)
importance of integrating##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
importance of its##2##3##(2008-10#1)(2012-3#1)
importance of learning##2##3##(2008-11#1)(2012-3#1)
importance of local##6##3##(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-6#1)(2012-2#1)
importance of maintaining a##2##4##(2008-10#1)(2012-3#1)
importance of maintaining##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
importance of management##2##3##(1993-1#1)(2008-1#1)
importance of molecular##2##3##(1997-3#1)(2008-7#1)
importance of muscle##2##3##(2008-7#1)(2012-2#1)
importance of patient##4##3##(1993-11#1)(1993-2#1)(2008-7#1)(2012-2#1)
importance of primary and secondary infection##2##6##(2008-10#2)
importance of primary##3##3##(2008-10#2)(2010-5#1)
importance of proper##2##3##(1993-1#1)(2007-12#1)
importance of recognizing##5##3##(1993-12#1)(1995-2#1)(2007-5#1)(2011-1#1)(2013-1#1)
importance of regular##3##3##(1997-4#1)(2011-2#1)(2013-8#1)
importance of screening and##2##4##(2012-3#2)
importance of several##2##3##(1993-12#1)(2008-2#1)
importance of social support from##2##5##(2009-7#2)
importance of social support##3##4##(2009-7#3)
importance of social##5##3##(2008-11#1)(2009-7#3)(2010-6#1)
importance of some##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2009-6#1)
importance of such##5##3##(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)
importance of the close##2##4##(1991-6#1)(2008-11#1)
importance of the disease##2##4##(2010-1#1)(2013-1#1)
importance of the immune##2##4##(2013-1#2)
importance of the parameters##2##4##(2008-10#2)
importance of the proper##2##4##(2007-11#1)(2009-8#1)
importance of the team##2##4##(1996-3#1)(2008-10#1)
importance of the##83##3##(1990-12#1)(1990-5#1)(1991-12#2)(1991-3#2)(1991-6#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-9#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
importance of these##19##3##(1990-2#1)(1990-9#1)(1991-8#1)(1994-12#1)(1995-1#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#2)(2013-8#2)
importance of this##20##3##(1990-5#1)(1991-2#1)(1994-5#2)(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
importance of understanding##6##3##(1996-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
importance of using##4##3##(1991-6#1)(2008-10#2)(2011-2#1)
importance of various##3##3##(2008-4#1)(2009-4#1)(2011-2#1)
importance of##747##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#5)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#8)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#4)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#4)(1993-6#3)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#7)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#6)(1996-6#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#9)(2007-2#4)(2007-4#1)(2007-5#4)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#83)(2008-11#50)(2008-12#11)(2008-2#9)(2008-3#10)(2008-4#10)(2008-5#13)(2008-6#7)(2008-7#27)(2008-8#24)(2008-9#21)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#12)(2009-8#6)(2009-9#2)(2010-1#5)(2010-10#11)(2010-11#1)(2010-12#6)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#16)(2011-2#33)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#16)(2012-3#18)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#24)(2013-7#2)(2013-8#11)
importance on##3##2##(1993-1#1)(1996-3#1)(2008-12#1)
importance since##3##2##(1994-8#1)(2008-3#1)(2008-8#1)
importance than##2##2##(2008-11#1)(2013-1#1)
importance that##6##2##(1991-9#1)(1994-2#1)(1995-1#1)(2008-11#1)(2010-4#1)(2011-2#1)
importance to quality##2##3##(1992-9#1)(2010-5#1)
importance to the##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
importance to##40##2##(1990-12#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-6#2)(1996-1#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
importance when##3##2##(1993-12#1)(2008-2#1)(2008-7#1)
importance with##2##2##(2010-4#1)(2012-1#1)
importance within##2##2##(2007-12#1)(2008-11#1)
importance##1159##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#7)(1990-3#2)(1990-5#5)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#5)(1991-1#1)(1991-11#2)(1991-12#8)(1991-2#7)(1991-3#3)(1991-5#5)(1991-6#11)(1991-7#1)(1991-8#3)(1991-9#5)(1992-11#2)(1992-12#7)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#4)(1993-1#5)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#10)(1993-5#1)(1993-6#5)(1993-8#1)(1994-1#3)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#3)(1994-8#7)(1994-9#4)(1995-1#7)(1995-11#5)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#4)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#8)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#7)(1996-5#2)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#11)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#6)(1997-9#1)(2006-10#4)(2006-6#3)(2007-10#5)(2007-11#19)(2007-12#14)(2007-2#6)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#12)(2008-10#127)(2008-11#67)(2008-12#18)(2008-2#16)(2008-3#17)(2008-4#14)(2008-5#34)(2008-6#9)(2008-7#49)(2008-8#31)(2008-9#37)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#7)(2009-7#13)(2009-8#7)(2009-9#3)(2010-1#6)(2010-10#13)(2010-11#3)(2010-12#9)(2010-3#8)(2010-4#7)(2010-5#9)(2010-6#6)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#26)(2011-10#1)(2011-2#56)(2011-3#1)(2012-1#6)(2012-12#16)(2012-2#21)(2012-3#31)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#38)(2013-7#6)(2013-8#15)
importance&quot##2##1##(1993-12#1)(2008-5#1)
important actions##2##2##(1992-3#1)(1996-1#1)
important active##2##2##(1993-3#1)(1997-4#1)
important activities##4##2##(2008-10#1)(2012-12#3)
important activity##2##2##(1996-1#1)(2012-12#1)
important advance in our##2##4##(2008-4#1)(2008-9#1)
important advance in##3##3##(2008-4#1)(2008-9#2)
important advances in the##2##4##(2010-10#1)(2013-1#1)
important advances in##3##3##(2010-10#1)(2010-7#1)(2013-1#1)
important advances##4##2##(2008-8#1)(2010-10#1)(2010-7#1)(2013-1#1)
important advantage of this##2##4##(1994-2#1)(2013-8#1)
important advantage of##5##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
important advantages##2##2##(1997-5#1)(2008-5#1)
important after##3##2##(1991-3#1)(1992-5#1)(2008-5#1)
important analytical parameters##3##3##(2008-10#3)
important analytical##7##2##(2008-10#5)(2008-2#1)(2008-9#1)
important and essential##2##3##(2008-8#1)(2013-1#1)
important and frequently##2##3##(1993-1#1)(2012-2#1)
important and may##2##3##(2008-12#1)(2009-7#1)
important and useful##2##3##(2008-4#1)(2010-3#1)
important and widely##2##3##(2008-4#1)(2011-2#1)
important and##45##2##(1990-5#1)(1991-3#1)(1992-4#1)(1993-1#1)(1993-3#1)(1994-8#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-7#3)(2010-10#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#3)
important antioxidant##2##2##(2008-10#1)(2009-12#1)
important antitumor##2##2##(1990-2#1)(1995-6#1)
important application##2##2##(2008-11#1)(2008-9#1)
important applications in##2##3##(2007-12#1)(2008-2#1)
important applications of##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
important applications##7##2##(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)
important are the##2##3##(1991-11#1)(2008-6#1)
important are##5##2##(1991-11#1)(2008-10#1)(2008-5#1)(2008-6#2)
important area for##2##3##(1991-9#1)(2009-4#1)
important area of##4##3##(2008-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
important area##7##2##(1991-9#1)(2008-12#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
important areas in##2##3##(2009-3#1)(2010-11#1)
important areas of##2##3##(1996-2#1)(2010-8#1)
important areas##4##2##(1996-2#1)(2009-3#1)(2010-11#1)(2010-8#1)
important articles##2##2##(2008-5#1)(2012-3#1)
important as a##4##3##(1993-11#1)(2007-10#1)(2008-3#1)(2009-6#1)
important as the##6##3##(1997-4#1)(2008-10#1)(2008-11#3)(2008-12#1)
important as##26##2##(1990-12#1)(1992-12#1)(1993-11#1)(1993-9#1)(1996-12#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-1#1)(2013-7#1)
important aspect in##3##3##(2008-5#1)(2010-11#1)(2013-8#1)
important aspect of the##5##4##(1991-1#1)(1991-11#1)(1997-4#1)(2008-10#1)(2008-2#1)
important aspect of##18##3##(1991-1#1)(1991-11#1)(1992-11#1)(1994-11#1)(1997-3#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-8#1)(2011-2#2)(2012-2#1)
important aspect##25##2##(1991-1#1)(1991-11#1)(1992-11#1)(1994-11#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
important aspects of a##2##4##(1992-2#1)(2011-2#1)
important aspects of care##2##4##(1993-2#2)
important aspects of the##8##4##(1991-5#1)(1995-5#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-9#1)(2013-1#1)
important aspects of##18##3##(1991-5#1)(1992-2#1)(1993-2#2)(1994-2#1)(1995-5#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-7#1)(2013-1#2)
important aspects##25##2##(1991-5#1)(1992-2#1)(1993-2#2)(1994-2#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#2)
important association##2##2##(2008-8#2)
important atmospheric##2##2##(2007-11#1)(2008-2#1)
important barrier to##2##3##(2008-11#1)(2008-8#1)
important barrier##3##2##(2008-11#1)(2008-8#1)(2010-9#1)
important because of##3##3##(1993-11#1)(2008-7#1)(2013-1#1)
important because##24##2##(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2013-1#1)
important behavior##2##2##(2008-11#1)(2009-12#1)
important biochemical##2##2##(2007-7#1)(2009-7#1)
important biological function##2##3##(1995-12#1)(2012-2#1)
important biological functions##2##3##(1994-6#1)(1997-3#1)
important biological processes##2##3##(2008-8#1)(2008-9#1)
important biological##13##2##(1991-3#1)(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2012-2#1)
important biomarkers##2##2##(2008-10#1)(2008-7#1)
important both##3##2##(1996-2#1)(2008-10#2)
important but##6##2##(1995-3#1)(1996-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)
important case##2##2##(1997-7#1)(2009-11#1)
important causal agent of the disease in##2##7##(2008-10#2)
important cause of chronic##2##4##(2007-2#1)(2011-2#1)
important cause of morbidity and mortality among##2##7##(2008-1#1)(2010-8#1)
important cause of morbidity and mortality##6##6##(2007-2#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
important cause of mortality##2##4##(1995-8#1)(2007-8#1)
important cause of##31##3##(1992-4#1)(1994-5#1)(1995-8#1)(2007-2#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
important cause##32##2##(1992-4#1)(1994-5#1)(1995-8#1)(2007-2#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
important causes of##6##3##(1994-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)
important cell##3##2##(1993-2#1)(2008-1#1)(2008-11#1)
important cellular processes##2##3##(1995-2#1)(2009-8#1)
important cellular##4##2##(1995-2#1)(2008-11#1)(2008-8#1)(2009-8#1)
important challenge##6##2##(1994-12#1)(1997-2#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)
important challenges##4##2##(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
important change##2##2##(1996-3#1)(2008-7#1)
important changes in the##2##4##(1994-12#1)(1996-2#1)
important changes in##4##3##(1993-3#1)(1994-12#1)(1996-2#1)(1997-2#1)
important changes##6##2##(1993-3#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2013-1#1)
important character##3##2##(2007-12#1)(2008-12#1)(2013-7#1)
important characteristics of##2##3##(1992-9#1)(2008-3#1)
important characteristics##8##2##(1992-9#1)(2007-8#1)(2008-12#2)(2008-2#1)(2008-3#1)(2012-4#1)(2013-8#1)
important class of##5##3##(1995-2#1)(2008-1#1)(2008-10#2)(2012-12#1)
important clinical implications##3##3##(2008-1#1)(2010-11#1)(2013-7#1)
important clinical problem##2##3##(2012-3#1)(2013-8#1)
important clinical##13##2##(1992-2#1)(1994-2#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
important clues about##2##3##(1991-2#1)(2008-10#1)
important clues on the##2##4##(2008-9#1)(2009-5#1)
important clues##7##2##(1991-2#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)
important coastal##2##2##(2010-8#1)(2011-2#1)
important cofactor##3##2##(1992-9#1)(2008-10#1)(2008-12#1)
important commercial##2##2##(2011-2#1)(2013-7#1)
important component of the##9##4##(1994-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
important component of##18##3##(1993-3#1)(1994-2#1)(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)
important component##26##2##(1992-5#1)(1993-3#1)(1994-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#2)
important components for##2##3##(2008-7#1)(2009-10#1)
important components of the##3##4##(1997-1#1)(2008-5#1)(2009-6#1)
important components of##9##3##(1992-12#1)(1997-1#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)
important components##12##2##(1992-12#1)(1997-1#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-8#1)(2013-1#1)
important compound##2##2##(2008-10#2)
important compounds##3##2##(1991-5#1)(2008-10#2)
important conclusion##2##2##(1997-2#1)(2008-3#1)
important conclusions##2##2##(2008-10#2)
important consequences for the##2##4##(2008-3#1)(2008-9#1)
important consequences for##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
important conservation##2##2##(2008-8#1)(2013-7#1)
important consideration for##2##3##(1994-11#1)(2010-6#1)
important consideration##9##2##(1993-1#1)(1994-11#1)(2008-10#2)(2008-9#2)(2010-11#1)(2010-6#1)(2013-1#1)
important considerations for##2##3##(1992-3#1)(2008-11#1)
important considerations in##2##3##(2008-4#1)(2012-12#1)
important considerations when##2##3##(1993-12#1)(2008-2#1)
important considerations##9##2##(1992-3#2)(1993-12#1)(1994-1#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#1)
important constituent of##2##3##(2008-9#1)(2009-8#1)
important constituent##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
important constructs##2##2##(1995-1#1)(2012-2#1)
important contaminants##3##2##(1991-3#1)(2008-10#2)
important contribution##6##2##(1995-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2010-7#1)
important contributions to##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
important contributor to##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
important contributors to##2##3##(2008-1#1)(2013-1#1)
important correlates of##2##3##(2008-11#1)(2008-8#1)
important criteria##3##2##(1995-1#1)(2008-4#2)
important criterion##2##2##(1992-12#1)(2008-10#1)
important data##2##2##(2008-11#1)(2008-12#1)
important decisions##2##2##(1991-1#1)(2012-12#1)
important demographic##2##2##(2009-8#1)(2012-2#1)
important determinant of##19##3##(1990-12#1)(1990-2#1)(1992-2#2)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
important determinant##20##2##(1990-12#1)(1990-2#1)(1992-2#2)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
important determinants of##6##3##(1990-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)
important determinants##9##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)
important developmental##2##2##(2008-7#1)(2010-5#1)
important developments##2##2##(2008-4#2)
important diagnostic and prognostic information##2##5##(1991-2#1)(2010-11#1)
important diagnostic and##3##3##(1991-2#1)(2010-11#1)(2013-8#1)
important diagnostic##12##2##(1991-2#1)(1992-4#1)(1992-6#1)(2007-12#2)(2007-8#1)(2008-12#2)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
important difference between the##2##4##(1994-3#1)(2008-9#1)
important difference between##3##3##(1994-3#1)(1994-5#1)(2008-9#1)
important difference##5##2##(1993-9#1)(1994-3#1)(1994-5#1)(2008-9#1)(2012-2#1)
important differences between##6##3##(1991-3#1)(1993-6#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
important differences exist between commonly prescribed antidepressants##2##7##(2012-3#2)
important differences in##5##3##(1992-4#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-9#1)
important differences were##2##3##(2007-11#1)(2009-12#1)
important differences##20##2##(1991-3#1)(1992-4#1)(1993-6#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-3#2)
important discrepancies##2##2##(2008-2#1)(2008-3#1)
important disease of##12##3##(2007-2#1)(2008-10#11)
important disease##16##2##(2007-2#1)(2008-10#13)(2008-11#1)(2008-2#1)
important diseases of wheat##3##4##(2008-10#2)(2011-10#1)
important diseases of##5##3##(2008-10#4)(2011-10#1)
important diseases##11##2##(2007-5#1)(2008-10#7)(2010-1#1)(2011-10#1)(2013-8#1)
important due to the fact that##2##6##(1991-6#1)(2012-2#1)
important due to the##3##4##(1991-6#1)(2008-7#1)(2012-2#1)
important during the##2##3##(1996-12#1)(2008-6#1)
important during##6##2##(1996-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
important ecological##3##2##(2008-8#2)(2009-8#1)
important effect on##3##3##(1996-3#1)(2008-12#2)
important effects on the##2##4##(2008-10#1)(2008-9#1)
important effects on##4##3##(1992-1#1)(2008-10#2)(2008-9#1)
important effects##8##2##(1990-12#1)(1992-1#1)(2007-7#1)(2008-10#3)(2008-9#1)(2009-7#1)
important elements in##2##3##(1994-3#1)(2011-2#1)
important elements of##2##3##(2007-11#1)(2008-8#1)
important elements##5##2##(1994-3#1)(2007-11#1)(2008-2#1)(2008-8#1)(2011-2#1)
important emerging##2##2##(2007-5#1)(2008-9#1)
important environmental##6##2##(1994-3#1)(2008-10#2)(2008-12#2)(2008-5#1)
important enzymes##2##2##(2008-12#1)(2011-1#1)
important epidemiological##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
important ethical##3##2##(2008-11#2)(2011-2#1)
important etiological##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
important event in##2##3##(1993-9#1)(2008-7#1)
important events##5##2##(1991-12#1)(1997-7#1)(2007-8#1)(2008-7#2)
important examples of##2##3##(2008-11#1)(2012-3#1)
important explanatory##2##2##(2008-7#1)(2013-8#1)
important factor for##7##3##(1992-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-3#1)(2013-7#1)
important factor in the##10##4##(1992-6#1)(1993-9#1)(1996-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-3#1)(2012-2#1)
important factor in##30##3##(1990-8#1)(1992-6#1)(1993-9#1)(1994-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-8#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
important factor that##3##3##(1994-7#1)(2008-1#1)(2008-10#1)
important factor##56##2##(1990-8#1)(1991-12#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-2#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
important factors affecting##4##3##(1992-12#1)(1996-2#1)(2008-10#1)(2008-6#1)
important factors determining##2##3##(2007-11#1)(2008-9#1)
important factors for##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
important factors in determining##2##4##(2007-8#1)(2008-11#1)
important factors in##10##3##(1994-1#2)(1996-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
important factors such as##2##4##(1991-12#1)(2008-10#1)
important factors that determine##2##4##(2008-7#1)(2013-7#1)
important factors that##7##3##(1993-1#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-7#1)
important factors##48##2##(1991-12#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-1#2)(1996-12#1)(1996-2#1)(1996-6#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#3)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
important feature of the##6##4##(1992-4#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#1)
important feature of##11##3##(1992-4#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
important feature##13##2##(1992-4#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
important features in the##2##4##(2008-11#1)(2009-10#1)
important features in##3##3##(2008-11#1)(2009-10#1)(2010-8#1)
important features of##5##3##(1994-1#1)(2008-10#2)(2008-3#1)(2011-2#1)
important features that##2##3##(2008-3#1)(2009-4#1)
important features##14##2##(1994-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-5#1)
important field##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
important finding##4##2##(1994-5#1)(2008-10#1)(2010-5#1)(2011-1#1)
important findings##2##2##(2011-2#1)(2012-2#1)
important fish pathogen##2##3##(2010-4#1)(2013-1#1)
important fish##3##2##(2008-9#1)(2010-4#1)(2013-1#1)
important foliar disease##2##3##(2008-10#2)
important foliar##4##2##(2008-10#4)
important food##4##2##(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)
important for all##3##3##(1996-2#1)(2008-3#1)(2009-8#1)
important for an##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
important for applications##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
important for appropriate##2##3##(1991-3#1)(2008-8#1)
important for clinicians to##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
important for determining the##2##4##(2008-3#1)(2010-12#1)
important for development of##2##4##(1996-4#1)(2008-8#1)
important for environmental##2##3##(2008-10#2)
important for future##3##3##(1992-3#1)(2008-11#1)(2008-12#1)
important for health##2##3##(1991-2#1)(1993-2#1)
important for its##3##3##(1990-2#1)(2008-8#1)(2011-2#1)
important for many##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
important for normal##5##3##(1997-7#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)
important for physicians##3##3##(1991-1#1)(2006-10#1)(2011-1#1)
important for preventing##2##3##(2008-10#1)(2011-2#1)
important for protection against##2##4##(2008-5#2)
important for reducing##2##3##(1997-1#1)(2008-9#1)
important for regulation of##3##4##(1991-6#1)(2009-2#1)(2012-3#1)
important for surgeons##2##3##(2008-7#1)(2013-1#1)
important for the development of##3##5##(1990-2#1)(1995-6#1)(2007-11#1)
important for the diagnosis of##2##5##(2008-10#1)(2012-2#1)
important for the diagnosis##3##4##(1990-11#1)(2008-10#1)(2012-2#1)
important for the study of##2##5##(1996-12#1)(2008-7#1)
important for the##72##3##(1990-11#2)(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-6#2)(2009-7#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#1)
important for this##2##3##(1994-6#1)(2011-1#1)
important for understanding the##7##4##(1995-2#1)(2007-5#1)(2008-10#3)(2008-9#1)(2011-2#1)
important for understanding##8##3##(1995-2#1)(2007-5#1)(2008-10#3)(2008-9#1)(2009-7#1)(2011-2#1)
important for##303##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#2)(1992-6#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#7)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#1)(2006-10#1)(2007-11#6)(2007-12#6)(2007-5#1)(2008-1#3)(2008-10#23)(2008-11#14)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#14)(2008-8#6)(2008-9#12)(2009-10#2)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#17)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#2)
important from##4##2##(1996-5#1)(2008-10#2)(2008-3#1)
important function##5##2##(1995-6#1)(2008-12#1)(2008-4#1)(2012-2#2)
important functional domains of##2##4##(1992-3#1)(2013-1#1)
important functional##4##2##(1992-3#1)(1994-11#1)(2012-2#1)(2013-1#1)
important functions in the##2##4##(2008-11#1)(2012-2#1)
important functions in##6##3##(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
important functions##8##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
important gene##2##2##(2008-7#1)(2013-8#1)
important general##4##2##(2008-7#1)(2009-11#1)(2009-3#1)(2010-11#1)
important genes and##3##3##(1996-12#1)(2008-11#1)(2008-5#1)
important genes in##2##3##(2006-8#1)(2008-8#1)
important genes##8##2##(1996-12#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
important goal##4##2##(2007-12#1)(2008-6#1)(2012-2#1)(2013-8#1)
important goals##4##2##(1992-5#1)(1993-6#1)(2008-10#1)(2008-11#1)
important group of##2##3##(1996-2#1)(2009-5#1)
important groups of##2##3##(2008-9#1)(2011-1#1)
important groups##6##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#1)
important health care##2##3##(1996-3#1)(1997-2#1)
important health##7##2##(1996-3#1)(1997-2#1)(2007-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
important homeostatic##2##2##(2008-11#1)(2008-7#1)
important human##5##2##(1992-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)
important if##2##2##(2006-10#1)(2008-3#1)
important implications for the##6##4##(1993-3#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-7#1)
important implications for##34##3##(1991-3#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-12#2)(1996-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
important implications in##5##3##(2007-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2012-12#1)
important implications##46##2##(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-12#2)(1996-12#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
important improvements in##2##3##(1996-3#1)(2008-7#1)
important in a##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
important in assessing the##2##4##(2008-10#2)
important in assessing##5##3##(1992-3#1)(2008-10#3)(2010-12#1)
important in determining the##5##4##(2007-8#2)(2008-10#1)(2008-8#1)(2009-8#1)
important in determining##7##3##(2007-8#2)(2008-10#2)(2008-8#2)(2009-8#1)
important in maintaining##2##3##(1997-6#1)(2010-10#1)
important in order to##5##4##(1992-11#1)(1995-2#1)(1996-3#1)(2008-10#1)(2010-2#1)
important in our##2##3##(1993-11#1)(2009-4#1)
important in predicting##5##3##(2008-12#1)(2009-11#1)(2012-3#1)(2013-1#2)
important in providing##2##3##(1995-11#1)(2011-1#1)
important in regulating##5##3##(1992-12#1)(1996-3#1)(2008-8#1)(2010-3#2)
important in shaping the##2##4##(1997-1#1)(2008-10#1)
important in shaping##3##3##(1996-6#1)(1997-1#1)(2008-10#1)
important in studies##2##3##(1990-5#1)(2013-8#1)
important in the detection##2##4##(2010-12#1)(2011-2#1)
important in the development of##4##5##(1992-11#1)(1995-3#1)(2010-12#1)(2011-2#1)
important in the differential diagnosis##2##5##(1993-2#1)(2007-10#1)
important in the pathogenesis of##3##5##(1995-2#1)(2008-7#2)
important in the regulation of##3##5##(1993-8#1)(1995-12#1)(2011-2#1)
important in the##76##3##(1990-2#1)(1991-11#1)(1992-11#3)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-9#2)(2011-2#7)(2012-2#2)(2013-1#1)
important in these##3##3##(1990-5#1)(1991-11#1)(2008-10#1)
important in this##3##3##(1992-12#1)(1994-9#1)(1995-2#1)
important in tumor##2##3##(2008-10#1)(2013-8#1)
important in##225##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-6#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#4)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-6#2)(2007-10#1)(2007-12#4)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#2)(2011-2#13)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#8)
important indication##2##2##(1996-3#1)(2010-6#1)
important indications##2##2##(1992-9#1)(2008-3#1)
important indicator of the##2##4##(1990-9#1)(2008-12#1)
important indicator of##3##3##(1990-9#1)(2008-12#1)(2009-5#1)
important indicators##2##2##(2007-12#1)(2008-7#1)
important influence of##2##3##(2008-5#2)
important influence on##6##3##(1990-12#1)(1996-1#1)(1996-4#1)(2008-10#1)(2008-5#2)
important influence##8##2##(1990-12#1)(1996-1#1)(1996-4#1)(2008-10#1)(2008-5#4)
important information about the##4##4##(1992-5#1)(1996-4#1)(2008-2#1)(2008-7#1)
important information about##5##3##(1992-12#1)(1992-5#1)(1996-4#1)(2008-2#1)(2008-7#1)
important information for##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#1)
important information on##4##3##(1991-2#1)(1994-11#1)(2008-3#1)(2013-1#1)
important information##22##2##(1990-3#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-5#2)(1994-11#1)(1996-4#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-6#1)(2013-1#3)
important inorganic##2##2##(2008-1#1)(2008-10#1)
important insect##2##2##(2008-10#1)(2010-1#1)
important insight into the##2##4##(1997-3#1)(2008-3#1)
important insight into##3##3##(1997-3#1)(2008-3#1)(2010-8#1)
important insight##5##2##(1997-3#1)(2008-1#1)(2008-3#1)(2010-8#1)(2013-8#1)
important insights into the##5##4##(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)
important insights into##6##3##(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
important insights##8##2##(1993-3#1)(2008-4#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
important is a##2##3##(1990-6#1)(1997-5#1)
important is##8##2##(1990-6#1)(1997-5#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-3#1)(2012-3#2)
important issue in the##2##4##(2008-10#1)(2008-8#1)
important issue in##6##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)
important issue is to##2##4##(2008-8#1)(2008-9#1)
important issue##15##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-9#1)(2011-2#2)(2012-2#1)
important issues in##4##3##(1994-3#1)(1997-3#1)(2008-7#1)(2008-9#1)
important issues to be##2##4##(2008-3#1)(2010-10#1)
important issues##16##2##(1992-9#1)(1994-3#1)(1995-1#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)
important it is##2##3##(1997-4#1)(2008-10#1)
important it##3##2##(1997-4#1)(2008-10#1)(2013-1#1)
important items were##2##3##(1991-2#2)
important items##3##2##(1991-2#2)(2008-5#1)
important key##3##2##(2008-4#1)(2009-8#1)(2010-12#1)
important lessons##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
important limitations##2##2##(2008-10#1)(2008-6#1)
important losses##2##2##(2008-10#2)
important management##2##2##(1992-3#1)(2008-1#1)
important markers##2##2##(2008-8#1)(2013-1#1)
important means of##6##3##(1992-2#1)(1993-1#1)(2008-10#2)(2010-1#1)(2011-1#1)
important means to##2##3##(2010-11#1)(2011-1#1)
important means##9##2##(1992-2#1)(1993-1#1)(1995-5#1)(2008-10#2)(2010-1#1)(2010-11#1)(2011-1#2)
important mechanisms of##2##3##(1996-2#1)(2013-8#1)
important mechanisms##5##2##(1992-2#1)(1994-5#1)(1996-2#1)(2007-11#1)(2013-8#1)
important mediator of##4##3##(1994-11#2)(2008-10#1)(2008-6#1)
important mediator##6##2##(1994-11#2)(2008-10#2)(2008-6#1)(2010-9#1)
important member of the##2##4##(1991-2#1)(1993-6#1)
important metabolic##3##2##(1992-5#1)(2008-1#1)(2012-1#1)
important methods##3##2##(2007-10#1)(2010-7#1)(2011-2#1)
important model##4##2##(2008-4#1)(2008-6#1)(2008-7#2)
important modifications in##2##3##(1990-8#1)(1991-5#1)
important modifications##3##2##(1990-8#1)(1991-5#1)(2008-3#1)
important modulator of##3##3##(2009-8#1)(2010-11#1)(2012-2#1)
important molecular##2##2##(2008-2#1)(2008-7#1)
important natural##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
important nerve##2##2##(2008-9#2)
important new##4##2##(1994-11#1)(2009-11#1)(2011-1#1)(2013-8#1)
important not##3##2##(1990-3#1)(2008-1#1)(2008-8#1)
important objective##4##2##(1991-1#1)(1996-2#1)(2011-3#1)(2013-1#1)
important of##2##2##(1997-3#1)(2007-11#1)
important ones were##4##3##(1991-2#4)
important ones##6##2##(1991-2#4)(1994-2#1)(2010-8#1)
important or##2##2##(1993-2#1)(2008-8#1)
important organ##2##2##(2008-11#1)(2010-10#1)
important outcome variable##2##3##(1991-11#1)(1997-3#1)
important outcome##6##2##(1991-11#1)(1996-1#1)(1997-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
important outcomes##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
important parameter for the##2##4##(2008-10#2)
important parameter for##3##3##(2008-10#2)(2008-9#1)
important parameter in the##2##4##(2008-2#1)(2008-7#1)
important parameter in##3##3##(1992-5#1)(2008-2#1)(2008-7#1)
important parameter##11##2##(1992-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)
important parameters to##2##3##(2008-10#1)(2012-12#1)
important parameters##10##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2012-12#1)(2012-9#1)
important parasite##2##2##(1993-2#1)(2009-7#1)
important part of the##13##4##(1990-6#1)(1993-12#1)(1996-3#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
important part of##30##3##(1990-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-7#1)
important part##38##2##(1990-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-3#2)(1996-6#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)
important pathogen of##3##3##(2008-10#3)
important pathogen##10##2##(1992-8#1)(2006-10#1)(2008-10#7)(2011-2#1)
important pathogens in##2##3##(2011-2#1)(2012-2#1)
important pathogens of##2##3##(2008-10#1)(2010-10#1)
important pathogens##6##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
important patient##2##2##(2008-10#1)(2008-11#1)
important physical##2##2##(2008-3#1)(2008-5#1)
important physiological and maturational changes##2##5##(2008-9#2)
important physiological functions##2##3##(2008-8#2)
important physiological##10##2##(1992-12#1)(1995-2#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)
important place in##3##3##(1992-5#1)(2008-11#1)(2011-2#1)
important plants##3##2##(2008-10#2)(2010-3#1)
important point is that##2##4##(2008-11#2)
important point##4##2##(1996-6#1)(2008-10#1)(2008-11#2)
important policy implications##3##3##(1991-12#1)(1993-12#1)(1994-12#1)
important policy##4##2##(1991-12#1)(1993-12#1)(1994-12#1)(1994-2#1)
important potential##2##2##(2008-10#1)(2008-3#1)
important predictor of##2##3##(1995-2#1)(1996-3#1)
important predictor##3##2##(1994-11#1)(1995-2#1)(1996-3#1)
important predictors of##3##3##(2008-12#1)(2011-2#2)
important predictors##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#2)
important problem in##4##3##(1996-8#1)(2008-12#1)(2011-1#1)(2013-1#1)
important problem##5##2##(1996-8#1)(2007-11#1)(2008-12#1)(2011-1#1)(2013-1#1)
important problems##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
important processes##4##2##(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
important prognostic factor##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
important prognostic factors in##2##4##(2008-7#1)(2011-2#1)
important prognostic factors##4##3##(1996-12#1)(2007-4#1)(2008-7#1)(2011-2#1)
important prognostic information and##2##4##(2009-4#1)(2011-2#1)
important prognostic information##3##3##(2009-4#1)(2011-2#2)
important prognostic##12##2##(1996-12#1)(2007-4#1)(2008-7#2)(2009-4#1)(2011-2#4)(2012-2#2)(2013-8#1)
important progress##3##2##(2007-8#1)(2008-8#1)(2011-2#1)
important properties##4##2##(2007-11#1)(2008-3#1)(2010-7#1)(2013-1#1)
important property##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
important public health issues##2##4##(2011-1#2)
important public health problem##5##4##(2007-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
important public health##12##3##(1991-6#1)(2007-12#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
important quality##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
important question##10##2##(1991-9#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-1#1)(2011-3#1)
important questions as to##2##4##(1993-12#1)(2008-9#1)
important questions for##2##3##(1993-6#1)(2009-5#1)
important questions that##3##3##(1993-12#1)(2008-11#1)(2009-6#1)
important questions##13##2##(1993-12#2)(1993-6#1)(1994-1#1)(1995-11#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#2)
important reactive oxygen species##2##4##(1991-9#1)(2008-10#1)
important reactive##3##2##(1991-9#1)(2008-10#2)
important reason for##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
important reasons for##3##3##(1992-5#1)(1993-1#1)(2012-2#1)
important reasons##4##2##(1992-5#1)(1993-1#1)(2012-2#1)(2013-1#1)
important recent##4##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
important region##2##2##(1990-8#1)(1994-12#1)
important regulators of the##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
important regulators of##7##3##(1995-2#1)(2008-3#2)(2008-4#2)(2010-11#1)(2013-1#1)
important regulatory mechanism##4##3##(1992-8#1)(1996-12#1)(2008-2#1)(2008-4#1)
important regulatory##9##2##(1990-8#1)(1991-5#1)(1992-8#1)(1993-12#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-2#1)(2008-4#1)
important relationships##2##2##(2008-4#1)(2008-7#1)
important research##3##2##(2008-9#1)(2010-10#1)(2011-1#1)
important residue##2##2##(1992-1#1)(1993-11#1)
important results##2##2##(2008-8#1)(2012-3#1)
important risk factor for cardiovascular disease##2##6##(2008-1#1)(2012-12#1)
important risk factor for##6##4##(2008-1#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
important risk factor##11##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
important risk factors for##2##4##(2007-8#1)(2013-7#1)
important risk factors##5##3##(1991-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-7#1)
important risk##18##2##(1991-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
important role during##5##3##(1991-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
important role for the##5##4##(1991-8#1)(1995-2#1)(1996-5#1)(1997-6#1)(2012-2#1)
important role for##18##3##(1990-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-2#1)(1995-2#2)(1996-5#2)(1997-1#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)(2012-3#1)
important role in breast##2##4##(2008-4#1)(2009-2#1)
important role in mediating##5##4##(1990-12#1)(1995-12#1)(2008-4#2)(2008-9#1)
important role in our##2##4##(1992-12#1)(2008-9#1)
important role in regulating the##4##5##(1991-3#1)(1994-11#1)(2008-11#2)
important role in regulating##7##4##(1991-12#1)(1991-3#1)(1994-11#1)(2008-11#2)(2008-4#1)(2008-8#1)
important role in the evolution of##2##6##(1995-8#1)(2008-12#1)
important role in the pathogenesis of##5##6##(2008-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-3#1)
important role in the pathogenesis##6##5##(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-3#1)
important role in the regulation of##10##6##(1991-5#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-8#2)(2012-2#1)(2012-3#1)
important role in the treatment of##4##6##(1995-11#1)(2007-4#1)(2011-1#1)(2011-3#1)
important role in the##132##4##(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#6)(2013-3#1)(2013-7#2)(2013-8#1)
important role in this##7##4##(1992-3#1)(1993-11#1)(1996-2#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)
important role in##315##3##(1990-12#2)(1990-2#1)(1990-8#2)(1990-9#3)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#25)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#10)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#18)(2008-9#12)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#7)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#12)(2013-3#1)(2013-7#4)(2013-8#2)
important role of the##2##4##(2008-10#1)(2009-11#1)
important role of this##2##4##(1991-6#1)(2013-1#1)
important role of##22##3##(1991-6#1)(1991-7#1)(1995-12#2)(1995-3#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#2)
important role played by##3##4##(2006-10#1)(2008-9#1)(2012-2#1)
important role to play in the##4##6##(1992-3#1)(2008-11#1)(2008-3#1)(2012-12#1)
important role to play in##5##5##(1992-3#1)(2008-11#2)(2008-3#1)(2012-12#1)
important role to play##6##4##(1992-3#1)(1993-12#1)(2008-11#2)(2008-3#1)(2012-12#1)
important role to##8##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-12#1)(2012-3#1)
important role##399##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-8#2)(1990-9#3)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#3)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#4)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#33)(2008-11#14)(2008-12#5)(2008-2#2)(2008-3#11)(2008-4#12)(2008-5#10)(2008-6#3)(2008-7#11)(2008-8#20)(2008-9#15)(2009-10#2)(2009-11#4)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#7)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#7)(2011-2#25)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#9)(2012-7#1)(2013-1#15)(2013-3#1)(2013-7#4)(2013-8#4)
important roles in the regulation of##3##6##(2008-5#1)(2009-8#1)(2013-1#1)
important roles in the##16##4##(1994-12#1)(1995-11#1)(1995-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
important roles in##53##3##(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
important roles##64##2##(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
important secondary##3##2##(1991-8#1)(2008-5#1)(2008-7#1)
important side##2##2##(1995-8#1)(1996-3#1)
important sign##2##2##(1990-6#1)(2010-6#1)
important signal##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
important signaling molecules##2##3##(1993-3#1)(2008-2#1)
important signaling##5##2##(1992-8#1)(1993-3#1)(2008-2#1)(2009-8#1)(2011-1#1)
important similarities##2##2##(2008-10#1)(2012-9#1)
important since the##2##3##(1993-12#1)(2008-10#1)
important since##9##2##(1992-2#1)(1993-12#1)(1993-2#1)(1996-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
important site##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
important situations##2##2##(1992-9#1)(2008-6#1)
important social##2##2##(2008-11#1)(2013-1#1)
important source of##6##3##(1993-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-7#1)
important source##7##2##(1993-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)(2013-7#1)
important sources of##5##3##(1992-6#1)(1995-1#1)(2008-1#1)(2008-9#1)(2011-3#1)
important sources##6##2##(1992-6#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-3#1)
important spatial##2##2##(1995-5#1)(2008-2#1)
important species in the##2##4##(2012-2#1)(2013-7#1)
important species##5##2##(2008-10#1)(2012-2#1)(2013-7#3)
important step for##2##3##(2008-1#1)(2008-10#1)
important step in the##5##4##(1997-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)
important step in##14##3##(1994-9#1)(1996-2#2)(1997-2#1)(2008-11#3)(2008-3#1)(2008-5#2)(2009-7#1)(2009-8#2)(2010-11#1)
important step##24##2##(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
important steps to##2##3##(2007-2#1)(2008-4#1)
important steps##5##2##(2007-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
important strain##2##2##(1994-3#1)(2013-1#1)
important strategies##2##2##(2008-1#1)(2010-11#1)
important structural##10##2##(1994-11#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)
important structure##2##2##(2008-11#1)(2008-8#1)
important structures in##2##3##(2008-5#1)(2011-2#1)
important structures##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
important survival mechanism##2##3##(2008-10#1)(2008-8#1)
important survival##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
important target##7##2##(1995-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2012-2#2)(2013-8#1)
important targets##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
important task for##3##3##(2008-3#2)(2010-8#1)
important task of the##2##4##(1995-11#1)(2011-4#1)
important task##10##2##(1995-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-4#1)(2013-1#1)
important tasks##3##2##(1994-1#1)(1996-12#1)(2013-8#1)
important technique in##2##3##(2008-3#1)(2009-11#1)
important technique##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)
important technology for##3##3##(1995-2#1)(2008-2#1)(2008-7#1)
important technology##5##2##(1995-2#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)
important than##17##2##(1990-7#1)(1993-1#1)(1994-7#1)(1995-1#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
important that doctors##2##3##(1995-2#1)(2011-2#1)
important that the##7##3##(1995-6#1)(1996-1#1)(2008-12#1)(2008-7#1)(2010-8#2)(2013-8#1)
important that we##3##3##(1991-1#1)(1993-12#1)(2008-5#1)
important that##31##2##(1991-1#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
important the##2##2##(1994-2#1)(2013-1#1)
important therapeutic##5##2##(2007-11#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
important to achieve##2##3##(2008-12#1)(2008-4#1)
important to assess##6##3##(2008-10#1)(2009-11#2)(2011-2#1)(2013-1#2)
important to avoid complications##2##4##(1991-6#1)(2012-12#1)
important to avoid##8##3##(1991-6#1)(1997-5#1)(2007-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
important to be able to##3##5##(1991-1#1)(2008-2#1)(2009-11#1)
important to be##6##3##(1991-1#1)(1993-12#1)(1995-2#1)(2008-2#2)(2009-11#1)
important to characterize the##2##4##(2008-3#1)(2013-8#1)
important to characterize##3##3##(2008-3#1)(2012-2#1)(2013-8#1)
important to consider##8##3##(2006-10#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
important to continue##2##3##(1997-6#1)(2008-10#1)
important to define the##2##4##(1994-2#1)(2010-9#1)
important to define##3##3##(1994-2#1)(2010-9#1)(2011-2#1)
important to determine whether##4##4##(1994-6#1)(2008-4#1)(2008-8#1)(2010-6#1)
important to determine##9##3##(1994-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-2#1)
important to develop a##2##4##(2008-12#1)(2008-6#1)
important to develop##6##3##(1992-9#1)(1994-9#1)(2007-8#1)(2008-12#1)(2008-6#1)(2010-8#1)
important to distinguish##4##3##(2008-10#1)(2011-1#1)(2011-2#2)
important to establish a##2##4##(1996-11#1)(2011-1#1)
important to establish##10##3##(1993-1#1)(1996-11#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)
important to evaluate the##3##4##(2008-7#1)(2008-8#1)(2012-2#1)
important to evaluate##5##3##(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
important to further##2##3##(1992-3#1)(2008-1#1)
important to investigate##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
important to isolate##2##3##(2008-5#1)(2008-9#1)
important to maintaining##2##3##(2010-7#1)(2011-2#1)
important to obtain##2##3##(2008-1#1)(2008-5#1)
important to perform##3##3##(2008-7#2)(2012-3#1)
important to physicians##2##3##(1992-1#1)(1994-3#1)
important to prevent##3##3##(1991-11#1)(2007-10#1)(2009-3#1)
important to provide##2##3##(1993-6#1)(2013-1#1)
important to recognise##3##3##(1997-7#1)(2007-7#1)(2012-2#1)
important to recognize the##5##4##(2008-2#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
important to recognize##8##3##(2006-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
important to the health##2##4##(2007-12#1)(2007-2#1)
important to the success of##2##5##(2007-9#1)(2010-5#1)
important to the##16##3##(1991-7#1)(1994-8#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-8#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
important to understand the##8##4##(1994-3#2)(1997-7#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
important to understand##16##3##(1994-3#2)(1995-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
important to use##2##3##(2008-3#1)(2009-9#1)
important to##256##2##(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#19)(2008-11#4)(2008-12#5)(2008-2#8)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#9)(2008-9#5)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#5)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#11)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#5)
important tool in##12##3##(1992-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-8#1)
important tool##33##2##(1992-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
important tools for##3##3##(1991-9#1)(2010-8#1)(2013-1#1)
important tools in the##2##4##(2007-8#1)(2008-10#1)
important tools in##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
important tools##10##2##(1991-9#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
important topic##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-9#1)
important topics for##2##3##(2007-11#1)(2008-5#1)
important topics##4##2##(2007-11#1)(2008-5#1)(2009-9#1)(2012-3#1)
important toxicity##2##2##(1990-6#1)(2008-7#1)
important trace gases##2##3##(2008-11#1)(2008-3#1)
important traits##2##2##(2008-8#1)(2013-8#1)
important transcription##2##2##(2008-1#1)(2012-2#1)
important treatment##2##2##(1990-9#1)(2010-12#1)
important tumor##2##2##(2008-10#1)(2012-2#1)
important type of##2##3##(1996-3#1)(2012-3#1)
important types##2##2##(2008-10#1)(2008-8#1)
important variable##3##2##(2008-10#3)
important variables in##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
important variables##7##2##(1995-6#1)(2008-10#4)(2008-11#1)(2008-7#1)
important virulence##2##2##(2011-2#1)(2013-1#1)
important when considering##2##3##(2008-5#1)(2008-7#1)
important when the##2##3##(2008-3#1)(2008-7#1)
important when##12##2##(1996-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-1#1)(2010-8#1)
important with##4##2##(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
important yeast##2##2##(2008-6#1)(2008-7#1)
important##3660##1##(1990-11#7)(1990-12#10)(1990-2#9)(1990-3#4)(1990-5#5)(1990-6#5)(1990-7#3)(1990-8#10)(1990-9#7)(1991-1#6)(1991-11#7)(1991-12#13)(1991-2#17)(1991-3#12)(1991-5#7)(1991-6#10)(1991-7#2)(1991-8#6)(1991-9#14)(1992-1#6)(1992-10#2)(1992-11#8)(1992-12#19)(1992-2#16)(1992-3#25)(1992-4#8)(1992-5#13)(1992-6#10)(1992-8#12)(1992-9#10)(1993-1#11)(1993-10#1)(1993-11#15)(1993-12#22)(1993-2#15)(1993-3#21)(1993-6#9)(1993-8#7)(1993-9#7)(1994-1#7)(1994-11#21)(1994-12#17)(1994-2#20)(1994-3#18)(1994-5#18)(1994-6#10)(1994-7#2)(1994-8#13)(1994-9#12)(1995-1#10)(1995-11#8)(1995-12#21)(1995-2#32)(1995-3#10)(1995-4#1)(1995-5#18)(1995-6#21)(1995-8#12)(1995-9#4)(1996-1#14)(1996-11#3)(1996-12#25)(1996-2#20)(1996-3#24)(1996-4#4)(1996-5#7)(1996-6#9)(1996-7#3)(1996-8#6)(1996-9#2)(1997-1#14)(1997-2#18)(1997-3#14)(1997-4#20)(1997-5#6)(1997-6#13)(1997-7#8)(1997-8#12)(1997-9#2)(2006-10#10)(2006-12#1)(2006-5#2)(2006-6#3)(2006-8#1)(2007-10#11)(2007-11#42)(2007-12#46)(2007-2#9)(2007-3#2)(2007-4#3)(2007-5#13)(2007-6#1)(2007-7#11)(2007-8#19)(2007-9#4)(2008-1#54)(2008-10#403)(2008-11#143)(2008-12#60)(2008-2#57)(2008-3#118)(2008-4#76)(2008-5#105)(2008-6#38)(2008-7#151)(2008-8#142)(2008-9#112)(2009-1#2)(2009-10#17)(2009-11#20)(2009-12#13)(2009-2#10)(2009-3#10)(2009-4#14)(2009-5#20)(2009-6#19)(2009-7#19)(2009-8#34)(2009-9#13)(2010-1#15)(2010-10#30)(2010-11#34)(2010-12#23)(2010-2#14)(2010-3#19)(2010-4#12)(2010-5#19)(2010-6#15)(2010-7#16)(2010-8#37)(2010-9#11)(2011-1#50)(2011-10#3)(2011-2#178)(2011-3#12)(2011-4#2)(2011-7#6)(2012-1#18)(2012-12#47)(2012-2#93)(2012-3#66)(2012-4#1)(2012-5#2)(2012-7#1)(2012-9#2)(2013-1#117)(2013-3#2)(2013-7#29)(2013-8#68)
important)##2##1##(1992-4#1)(2009-9#1)
important?##3##1##(2009-11#1)(2012-12#1)(2013-7#1)
important]##2##1##(1993-3#1)(1994-8#1)
importante##2##1##(2008-5#1)(2011-2#1)
importantly for##2##2##(2007-7#1)(2009-5#1)
importantly involved in the##2##4##(1991-9#1)(1992-6#1)
importantly##69##1##(1990-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-12#2)(1995-2#4)(1995-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#3)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
importation and##2##2##(2012-2#2)
importation of foods##2##3##(2007-12#2)
importation of##5##2##(2007-12#3)(2008-10#1)(2011-1#1)
importation rate##2##2##(2012-2#2)
importation##12##1##(2007-12#3)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#5)
imported and##2##2##(2008-10#1)(2010-4#1)
imported by##2##2##(1997-3#1)(2007-2#1)
imported cases##2##2##(2008-11#1)(2012-2#1)
imported falciparum malaria cases of Nantong City from 2001 to##2##10##(2012-3#2)
imported falciparum malaria cases of Nantong City##3##7##(2012-3#3)
imported falciparum malaria cases##4##4##(2012-3#4)
imported falciparum malaria##6##3##(2012-3#6)
imported from an Asian country##2##5##(2008-10#2)
imported from##7##2##(1993-3#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-7#1)
imported into the nucleus##2##4##(1994-9#1)(2011-2#1)
imported into the##5##3##(1994-9#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
imported into##6##2##(1994-9#1)(1997-6#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
imported malaria##4##2##(2007-2#2)(2012-2#2)
imported systems##2##2##(2008-10#2)
imported warning systems##2##3##(2008-10#2)
imported##53##1##(1991-11#1)(1993-3#1)(1994-9#3)(1997-3#1)(1997-6#2)(2007-12#3)(2007-2#7)(2007-6#1)(2008-1#4)(2008-10#10)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#6)(2013-8#1)
importers of##2##2##(1994-3#1)(2010-4#1)
importers##4##1##(1994-3#1)(2010-4#3)
importing##2##1##(2008-2#2)
imports##3##1##(2008-10#2)(2013-1#1)
impose an##2##2##(1990-8#1)(1997-5#1)
impose##16##1##(1990-8#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
imposed by the##18##3##(1994-12#1)(1997-1#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2009-12#1)(2011-2#1)(2012-2#2)
imposed by##38##2##(1991-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#7)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-2#3)(2012-3#1)
imposed in##4##2##(1991-2#1)(2007-11#1)(2008-3#1)(2012-7#1)
imposed on the##5##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
imposed on##16##2##(1991-5#1)(1991-6#1)(1994-8#1)(1996-5#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-11#1)(2011-1#1)(2011-2#1)
imposed##79##1##(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-12#1)(2007-11#4)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#12)(2008-4#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-8#1)(2010-10#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2012-7#1)(2013-8#1)
imposes a##6##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
imposes an##2##2##(1996-4#1)(1997-7#1)
imposes##14##1##(1995-2#1)(1996-4#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
imposing a##2##2##(2008-8#1)(2012-3#1)
imposing##12##1##(1994-3#1)(1997-5#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-3#2)(2012-7#1)
imposition of##9##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-8#1)
impossible dream?##2##2##(1996-2#1)(1997-1#1)
impossible to detect##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
impossible to differentiate##2##3##(2008-3#1)(2011-2#1)
impossible to obtain##3##3##(2008-3#2)(2008-8#1)
impossible to##35##2##(1990-8#2)(1991-1#1)(1994-2#1)(1995-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-7#1)
impossible##64##1##(1990-11#1)(1990-12#2)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#1)
impotence##5##1##(1990-6#1)(1994-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
impotent##2##1##(1995-12#1)(2008-6#1)
impounded##3##1##(2009-7#1)(2011-1#2)
impoverished rats##2##2##(1992-8#2)
impoverished##13##1##(1992-8#5)(1997-5#1)(2007-2#2)(2008-12#1)(2008-8#1)(2011-2#3)
impracticable##2##1##(2007-8#1)(2008-2#1)
impractical for##4##2##(1992-10#1)(1996-4#1)(2008-10#1)(2009-5#1)
impractical to##2##2##(2008-3#1)(2008-7#1)
impractical##16##1##(1992-10#1)(1994-5#1)(1995-2#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#1)
imprecise##4##1##(1994-11#1)(1996-12#1)(2008-3#1)(2011-2#1)
imprecision for##2##2##(1994-9#1)(2008-10#1)
imprecision##12##1##(1991-12#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-2#1)(2008-10#6)(2008-8#1)
impregnated activated carbon##2##3##(2008-10#2)
impregnated catheters##4##2##(2007-7#4)
impregnated resin##4##2##(2008-10#4)
impregnated with a##2##3##(2008-10#2)
impregnated with##12##2##(1996-12#1)(2008-10#11)
impregnated##31##1##(1996-12#2)(2007-7#5)(2008-10#22)(2008-2#1)(2009-11#1)
impregnation and##3##2##(2008-12#2)(2011-2#1)
impregnation of##4##2##(2008-10#3)(2011-2#1)
impregnation##10##1##(2008-10#4)(2008-12#2)(2008-7#1)(2011-2#2)(2012-2#1)
impressed##2##1##(2009-10#1)(2011-2#1)
impression is##2##2##(1991-12#1)(2008-11#1)
impression management##2##2##(2007-12#2)
impression of a##2##3##(2008-11#1)(2008-5#1)
impression of an##2##3##(1991-12#1)(1995-12#1)
impression of the##2##3##(2008-12#1)(2013-1#1)
impression of##9##2##(1991-12#1)(1995-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)
impression that##5##2##(1990-6#1)(1991-12#1)(1994-6#1)(1995-6#1)(2008-7#1)
impression##36##1##(1990-6#1)(1991-12#3)(1994-6#1)(1995-12#1)(1995-6#1)(2007-12#2)(2008-11#5)(2008-12#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#2)(2011-1#1)(2012-2#6)(2013-1#2)
impressions of the##2##3##(2008-12#1)(2010-11#1)
impressions of##3##2##(2008-12#1)(2009-7#1)(2010-11#1)
impressions##8##1##(1990-9#1)(2008-10#2)(2008-12#3)(2009-7#1)(2010-11#1)
impressive and##2##2##(1996-6#1)(2011-2#1)
impressive clinical##2##2##(2008-5#1)(2012-1#1)
impressive results##2##2##(1993-3#1)(2008-7#1)
impressive##19##1##(1991-11#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-6#2)(1997-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#1)
impressively##2##1##(2008-10#1)(2010-10#1)
imprint##6##1##(2007-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
imprinted electrode##2##2##(2008-10#2)
imprinted gene##2##2##(2008-7#2)
imprinted genes##7##2##(1996-10#1)(2008-7#6)
imprinted in##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
imprinted monolithic precolumn##2##3##(2008-10#2)
imprinted polymer##17##2##(2008-10#17)
imprinted polymers##5##2##(2008-10#5)
imprinted sol-gel film##4##3##(2008-10#4)
imprinted##60##1##(1996-10#3)(2008-10#41)(2008-11#1)(2008-3#2)(2008-7#11)(2008-8#1)(2011-2#1)
imprinting and the##2##3##(2008-8#1)(2010-3#1)
imprinting and##7##2##(1994-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#1)
imprinting effect are##2##3##(2008-10#2)
imprinting may##2##2##(2008-8#2)
imprinting techniques##2##2##(2008-7#1)(2008-8#1)
imprinting technology##2##2##(2008-10#2)
imprinting##31##1##(1993-1#1)(1994-11#1)(1996-10#2)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)
imprisoned##2##1##(1990-5#1)(1996-6#1)
improper treatment##2##2##(2008-10#2)
improper use of##2##3##(2008-10#1)(2009-5#1)
improper##18##1##(1991-12#2)(1992-3#1)(1993-1#1)(1995-12#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-3#1)(2013-8#1)
improperly##9##1##(1990-3#1)(1993-1#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2013-1#1)
improve Maori##2##2##(2008-1#1)(2008-8#1)
improve SNR of##2##3##(2013-8#2)
improve access and##2##3##(1994-3#1)(1997-2#1)
improve access to##2##3##(2008-7#1)(2009-5#1)
improve access##4##2##(1994-3#1)(1997-2#1)(2008-7#1)(2009-5#1)
improve accuracy of##2##3##(2007-10#1)(2010-7#1)
improve accuracy##4##2##(2007-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
improve adherence to the##2##4##(2008-3#2)
improve adherence to##5##3##(2008-3#2)(2008-4#1)(2010-12#1)(2013-1#1)
improve adherence##9##2##(2008-3#2)(2008-4#1)(2009-4#2)(2010-12#1)(2011-1#2)(2013-1#1)
improve after##2##2##(1990-5#1)(2011-2#1)
improve air quality##3##3##(1996-8#1)(2008-6#1)(2010-5#1)
improve an##2##2##(1995-2#1)(2008-6#1)
improve and##7##2##(1997-2#1)(1997-3#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
improve asthma##2##2##(2008-7#1)(2013-1#1)
improve both##7##2##(1992-8#1)(1994-2#1)(2008-3#1)(2008-5#1)(2009-10#2)(2013-1#1)
improve but##2##2##(1992-6#1)(2008-4#1)
improve cardiac function##4##3##(2010-12#1)(2012-12#2)(2012-3#1)
improve care for##5##3##(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#2)
improve care##18##2##(1994-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
improve children's##2##2##(2011-1#1)(2012-3#1)
improve clinical outcome##2##3##(2011-1#1)(2011-2#1)
improve clinical outcomes and##2##4##(1997-2#1)(2008-11#1)
improve clinical outcomes##4##3##(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#1)
improve clinical##15##2##(1990-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2011-1#2)(2011-2#1)(2013-1#1)
improve communication about##2##3##(2008-3#1)(2010-4#1)
improve communication##6##2##(1994-11#1)(1996-11#1)(2008-3#1)(2010-4#1)(2011-1#2)
improve control##2##2##(1993-9#1)(2008-10#1)
improve coping##2##2##(1993-12#1)(2008-4#1)
improve cost efficiency##2##3##(1996-3#1)(2012-2#1)
improve cost##3##2##(1996-3#1)(2006-10#1)(2012-2#1)
improve current##2##2##(2008-11#1)(2010-6#1)
improve customer satisfaction across an entire managed care system##2##9##(1996-1#1)(1996-2#1)
improve data##2##2##(2008-12#1)(2008-3#1)
improve detection and characterization of##2##5##(2008-7#2)
improve detection##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
improve diagnosis##4##2##(1996-12#2)(2008-7#1)(2011-2#1)
improve diagnostic accuracy##3##3##(1991-3#1)(2008-10#1)(2010-12#1)
improve diagnostic##4##2##(1991-3#1)(2008-10#2)(2010-12#1)
improve disease##3##2##(2008-10#3)
improve dyspnea##3##2##(2013-8#3)
improve early##2##2##(2009-9#1)(2010-12#1)
improve efficiency and##3##3##(1995-3#1)(1996-2#1)(2007-9#1)
improve efficiency##8##2##(1995-3#1)(1996-2#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)
improve endothelial function##2##3##(2011-2#1)(2012-3#1)
improve endothelial##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
improve exercise##2##2##(2010-10#1)(2012-12#1)
improve functional##5##2##(2007-10#1)(2008-6#1)(2008-8#2)(2011-2#1)
improve future##2##2##(2007-4#1)(2011-1#1)
improve health and##2##3##(2011-1#1)(2013-8#1)
improve health care delivery##3##4##(1997-2#1)(2007-7#1)(2008-6#1)
improve health care quality##2##4##(1996-3#1)(1997-2#1)
improve health care##13##3##(1993-3#1)(1995-3#1)(1996-3#1)(1997-2#3)(1997-3#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-8#2)
improve health outcomes##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
improve health##24##2##(1993-3#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#3)(1997-3#2)(2007-7#1)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
improve hospital##4##2##(1991-1#1)(1992-5#1)(1997-8#1)(2008-11#1)
improve image##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
improve in##6##2##(1994-1#1)(1994-11#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
improve insulin sensitivity and##2##4##(1993-2#1)(2010-10#1)
improve insulin sensitivity##4##3##(1993-2#1)(2008-11#1)(2008-3#1)(2010-10#1)
improve its performance##2##3##(2008-3#2)
improve its##11##2##(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-11#1)(2011-2#1)
improve knowledge##2##2##(2008-1#1)(2010-4#1)
improve laboratory##2##2##(2008-10#2)
improve laser##2##2##(2007-11#1)(2008-3#1)
improve long-term##5##2##(1994-1#2)(2007-8#1)(2008-3#1)(2010-12#1)
improve lung function##2##3##(2007-8#1)(2012-2#1)
improve lung##3##2##(2007-8#2)(2012-2#1)
improve management##2##2##(1993-3#1)(2008-10#1)
improve many of the##2##4##(2008-11#1)(2008-3#1)
improve many##4##2##(2008-11#1)(2008-3#1)(2009-9#1)(2013-1#1)
improve muscle##2##2##(2012-7#1)(2013-1#1)
improve myocardial##2##2##(1996-9#1)(2009-10#1)
improve on the##3##3##(2008-3#1)(2010-8#1)(2013-1#1)
improve on these##2##3##(2008-7#2)
improve on##7##2##(1991-4#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
improve or##4##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
improve our understanding of cancer##2##5##(2009-6#1)(2012-12#1)
improve our understanding of how##3##5##(1993-12#1)(2008-10#1)(2008-4#1)
improve our understanding of the biology of##2##7##(2007-10#1)(2008-10#1)
improve our understanding of the##6##5##(2007-10#1)(2008-10#2)(2008-11#1)(2009-10#1)(2013-1#1)
improve our understanding of##12##4##(1993-12#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2009-6#1)(2012-12#1)(2013-1#1)
improve our##18##2##(1992-2#1)(1993-12#1)(1996-10#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
improve outcome in##2##3##(2008-7#1)(2012-12#1)
improve outcome##4##2##(2007-10#1)(2008-7#2)(2012-12#1)
improve outcomes for patients with##2##5##(2008-3#1)(2010-4#1)
improve outcomes for##5##3##(2008-3#1)(2008-6#1)(2009-10#1)(2010-4#1)(2013-1#1)
improve outcomes##12##2##(1997-1#1)(2008-11#2)(2008-3#1)(2008-6#2)(2009-10#1)(2010-4#1)(2013-1#3)(2013-8#1)
improve overall##4##2##(1995-1#1)(2008-3#1)(2010-1#1)(2011-2#1)
improve oxygenation##2##2##(1994-6#1)(2012-3#1)
improve patient care##6##3##(1994-2#1)(1996-12#1)(1996-3#1)(2008-7#1)(2010-3#1)(2013-7#1)
improve patient outcomes##3##3##(1995-3#1)(2008-9#1)(2011-2#1)
improve patient satisfaction##3##3##(1994-2#1)(2010-8#1)(2011-1#1)
improve patient##26##2##(1994-2#2)(1995-3#1)(1996-12#1)(1996-3#2)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
improve performance of##2##3##(2008-2#1)(2012-3#1)
improve performance##6##2##(1994-1#1)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
improve population health##2##3##(1996-12#2)
improve post-operative lung function##2##4##(2007-8#2)
improve post-operative##3##2##(2007-8#2)(2008-11#1)
improve prediction of##2##3##(2008-10#1)(2009-4#1)
improve preventive##2##2##(2010-9#1)(2012-2#1)
improve professional##2##2##(1993-3#1)(2008-12#1)
improve prognosis##2##2##(1993-9#1)(1997-3#1)
improve protection##2##2##(2009-12#2)
improve provider##3##2##(1996-1#1)(1997-3#1)(2007-9#1)
improve public##2##2##(1996-2#1)(2008-12#1)
improve quality and##4##3##(1994-2#1)(1994-3#1)(1996-2#1)(2010-8#1)
improve quality of care##3##4##(1996-3#1)(2008-3#2)
improve quality of life for##2##5##(2008-11#1)(2012-12#1)
improve quality of life##8##4##(2007-12#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
improve quality of##13##3##(1993-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
improve quality##30##2##(1992-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#2)(1996-3#2)(1997-1#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
improve quantitative##2##2##(2008-2#1)(2009-5#1)
improve rehabilitation##2##2##(1991-12#1)(2013-1#1)
improve research##2##2##(2009-4#1)(2010-5#1)
improve resistance##3##2##(2008-10#2)(2012-5#1)
improve results##2##2##(1991-3#1)(2008-10#1)
improve safety##2##2##(1996-3#1)(2011-2#1)
improve satisfaction##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
improve sensitivity and##2##3##(2008-10#1)(2008-7#1)
improve sensitivity##5##2##(1996-12#1)(2008-10#3)(2008-7#1)
improve service##5##2##(1993-12#1)(1993-2#1)(1994-2#1)(1995-3#1)(2012-3#1)
improve significantly the##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
improve significantly##8##2##(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
improve skin##4##2##(2008-5#3)(2012-2#1)
improve speech##2##2##(2007-12#1)(2007-7#1)
improve strategic##2##2##(1994-12#1)(1994-2#1)
improve survival##7##2##(1994-6#1)(2007-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
improve symptoms and##3##3##(2008-3#1)(2009-6#1)(2010-6#1)
improve symptoms##5##2##(2008-3#2)(2008-7#1)(2009-6#1)(2010-6#1)
improve the ability of##3##4##(1997-1#1)(1997-2#1)(2008-10#1)
improve the ability##4##3##(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#1)
improve the accuracy of the##6##5##(2008-10#1)(2008-3#3)(2008-6#1)(2010-2#1)
improve the accuracy of trace##2##5##(2008-10#1)(2008-2#1)
improve the accuracy of##14##4##(2008-10#3)(2008-2#2)(2008-3#6)(2008-6#1)(2008-8#1)(2010-2#1)
improve the accuracy##17##3##(2008-10#4)(2008-2#3)(2008-3#7)(2008-6#1)(2008-8#1)(2010-2#1)
improve the analytical sensitivity##2##4##(2008-10#2)
improve the axial##3##3##(2007-11#2)(2008-6#1)
improve the care##2##3##(1994-2#1)(2008-3#1)
improve the clinical##2##3##(2008-3#1)(2011-2#1)
improve the completeness##2##3##(2008-10#1)(2013-7#1)
improve the design##2##3##(1993-12#1)(2010-8#1)
improve the detection limit##2##4##(2008-3#2)
improve the detection of##4##4##(1991-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
improve the detection##8##3##(1991-6#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-2#1)(2013-8#1)
improve the diagnosis of##2##4##(1991-6#1)(2011-1#1)
improve the diagnosis##3##3##(1991-6#1)(2011-1#1)(2013-1#1)
improve the effectiveness of##5##4##(1994-2#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-9#1)
improve the efficacy of##3##4##(1994-5#1)(2008-10#2)
improve the efficiency##9##3##(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-7#1)
improve the final##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
improve the health of the##3##5##(1991-6#1)(1995-3#1)(2013-1#1)
improve the health of##5##4##(1991-6#1)(1993-3#1)(1995-1#1)(1995-3#1)(2013-1#1)
improve the health##8##3##(1991-6#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-7#1)(2013-1#1)
improve the image##2##3##(2008-3#2)
improve the lipid##2##3##(2008-5#1)(2012-2#1)
improve the lives of##2##4##(1995-6#1)(2008-7#1)
improve the long-term##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
improve the outcome of##3##4##(2008-11#1)(2008-3#1)(2010-3#1)
improve the outcome##5##3##(1992-4#1)(2008-11#1)(2008-3#1)(2010-3#1)(2012-2#1)
improve the outcomes##2##3##(2008-3#1)(2011-2#1)
improve the overall##4##3##(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
improve the patient's quality of##2##5##(2008-10#1)(2009-9#1)
improve the patient's##4##3##(1993-12#1)(1996-3#1)(2008-10#1)(2009-9#1)
improve the performance of a##3##5##(1993-12#1)(2008-2#1)(2008-3#1)
improve the performance of the##3##5##(2008-10#1)(2008-2#1)(2012-1#1)
improve the performance of##14##4##(1990-3#1)(1993-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2012-1#1)
improve the performance##17##3##(1990-3#1)(1993-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2010-8#1)(2012-1#1)
improve the power##2##3##(2007-12#1)(2012-3#1)
improve the precision##2##3##(2008-10#1)(2008-8#1)
improve the prognosis##3##3##(1990-5#1)(2010-3#1)(2011-2#1)
improve the quality and##4##4##(1993-3#1)(1994-2#1)(2008-10#1)(2008-3#1)
improve the quality of care##5##5##(1996-1#1)(1996-12#1)(1997-1#1)(2008-12#1)(2008-3#1)
improve the quality of health##2##5##(1996-3#1)(2008-7#1)
improve the quality of life and##2##6##(2010-11#1)(2010-5#1)
improve the quality of life with##2##6##(2007-11#1)(2009-6#1)
improve the quality of life##8##5##(1990-12#1)(1990-2#1)(2007-11#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)
improve the quality of patient care##3##6##(1993-3#1)(1994-1#1)(2009-8#1)
improve the quality of services##2##5##(1997-3#1)(2007-4#1)
improve the quality of the##6##5##(1996-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)
improve the quality of##45##4##(1990-12#1)(1990-2#1)(1991-11#1)(1992-2#2)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
improve the quality##49##3##(1990-12#1)(1990-2#1)(1991-11#1)(1992-2#2)(1992-3#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
improve the reliability of the##2##5##(2008-7#1)(2011-2#1)
improve the reliability of##4##4##(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
improve the resolution##3##3##(1996-12#1)(2008-3#2)
improve the response##2##3##(2008-10#1)(2010-11#1)
improve the results of##2##4##(2007-8#1)(2012-1#1)
improve the safety and##2##4##(2008-12#1)(2008-9#1)
improve the safety##3##3##(2008-12#1)(2008-9#1)(2013-8#1)
improve the selectivity and##2##4##(2008-10#2)
improve the selectivity##3##3##(2008-10#3)
improve the sensitivity and specificity of##2##6##(2008-10#1)(2008-4#1)
improve the sensitivity and##4##4##(2008-10#2)(2008-3#1)(2008-4#1)
improve the sensitivity of##6##4##(2007-12#1)(2008-10#4)(2008-9#1)
improve the sensitivity##11##3##(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-9#1)
improve the separation##5##3##(2008-10#4)(2008-5#1)
improve the signal-to-noise ratio of##2##5##(2008-2#1)(2008-3#1)
improve the signal-to-noise ratio##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
improve the specificity of##2##4##(1995-6#1)(2008-7#1)
improve the success of##2##4##(1994-12#1)(2008-12#1)
improve the success##3##3##(1994-12#1)(2008-12#1)(2012-2#1)
improve the survival of##2##4##(2008-5#1)(2010-12#1)
improve the survival##4##3##(1990-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
improve the treatment results##2##4##(2011-2#2)
improve the treatment##3##3##(2008-11#1)(2011-2#2)
improve the use of##2##4##(2008-10#1)(2012-12#1)
improve the use##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
improve the viability of##2##4##(2008-11#1)(2009-9#1)
improve the##460##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-6#3)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1993-12#4)(1993-3#5)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1995-1#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#13)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#84)(2008-11#25)(2008-12#9)(2008-2#14)(2008-3#45)(2008-4#5)(2008-5#13)(2008-6#8)(2008-7#12)(2008-8#5)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#5)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#5)(2011-2#11)(2011-7#1)(2012-1#4)(2012-12#4)(2012-2#9)(2012-3#6)(2012-8#1)(2013-1#19)(2013-7#1)(2013-8#7)
improve their collective##2##3##(1996-12#1)(2008-12#1)
improve their quality of life##2##5##(2011-2#2)
improve their##38##2##(1992-12#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#1)(1996-12#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#3)(2010-6#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)
improve these##5##2##(1991-12#1)(1997-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
improve this##3##2##(1992-4#1)(2008-3#1)(2010-1#1)
improve treatment and##2##3##(2008-6#1)(2010-3#1)
improve treatment##8##2##(1990-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2010-3#1)(2013-8#1)
improve tumour kill##2##3##(2008-7#2)
improve understanding of##3##3##(2008-10#2)(2011-2#1)
improve understanding##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
improve various##2##2##(1993-5#1)(2008-11#1)
improve with the##2##3##(2008-3#1)(2010-8#1)
improve with##5##2##(1994-12#1)(1997-8#1)(2008-3#1)(2008-6#1)(2010-8#1)
improve##1283##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#3)(1991-11#2)(1991-12#4)(1991-3#4)(1991-4#1)(1991-6#4)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#11)(1993-2#6)(1993-3#12)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#10)(1994-11#3)(1994-12#7)(1994-2#12)(1994-3#4)(1994-5#3)(1994-6#5)(1994-9#1)(1995-1#6)(1995-11#2)(1995-12#4)(1995-2#10)(1995-3#14)(1995-4#1)(1995-5#1)(1995-6#4)(1996-1#8)(1996-10#1)(1996-11#2)(1996-12#21)(1996-2#14)(1996-3#20)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#8)(1997-2#11)(1997-3#12)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#3)(2007-10#11)(2007-11#18)(2007-12#23)(2007-2#5)(2007-4#2)(2007-7#10)(2007-8#13)(2007-9#4)(2008-1#12)(2008-10#141)(2008-11#65)(2008-12#24)(2008-2#25)(2008-3#80)(2008-4#15)(2008-5#31)(2008-6#25)(2008-7#43)(2008-8#22)(2008-9#20)(2009-10#8)(2009-11#3)(2009-12#7)(2009-2#1)(2009-3#4)(2009-4#7)(2009-5#7)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#6)(2010-1#4)(2010-10#8)(2010-11#4)(2010-12#11)(2010-2#2)(2010-3#7)(2010-4#13)(2010-5#11)(2010-6#6)(2010-7#3)(2010-8#20)(2010-9#5)(2011-1#25)(2011-2#50)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#7)(2012-12#17)(2012-2#28)(2012-3#25)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#68)(2013-7#5)(2013-8#24)
improved CRP method##3##3##(2008-10#3)
improved IR##2##2##(2013-8#2)
improved QoL##2##2##(2008-3#1)(2011-2#1)
improved access and quality of care##2##6##(1995-1#1)(2012-2#1)
improved access and##3##3##(1995-1#2)(2012-2#1)
improved access to##2##3##(1996-3#1)(1997-2#1)
improved access##8##2##(1995-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2009-3#1)(2012-1#1)(2012-2#1)
improved accuracy of the##2##4##(2007-11#1)(2008-3#1)
improved accuracy##8##2##(2007-11#2)(2008-10#1)(2008-3#4)(2010-7#1)
improved activities##2##2##(2008-5#1)(2011-1#1)
improved after embolisation##2##3##(1995-11#1)(1996-6#1)
improved after surgery##2##3##(2008-7#1)(2011-2#1)
improved after the##5##3##(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
improved after treatment with##2##4##(1992-12#1)(2008-1#1)
improved after treatment##5##3##(1992-12#1)(1996-6#1)(2007-2#1)(2008-1#1)(2011-1#1)
improved after##21##2##(1990-11#1)(1991-8#1)(1992-12#1)(1995-11#1)(1996-6#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
improved algorithm##2##2##(2007-11#1)(2008-2#1)
improved all##2##2##(2011-2#1)(2013-1#1)
improved analytical##4##2##(2007-11#1)(2008-10#3)
improved and a##2##3##(1992-6#1)(1996-1#1)
improved and##17##2##(1990-6#1)(1992-3#1)(1992-6#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2012-2#1)(2013-8#2)
improved as##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
improved at##2##2##(1997-2#1)(2008-10#1)
improved biocontrol activity##2##3##(2008-10#2)
improved biological control of##2##4##(2008-10#2)
improved both##2##2##(2006-4#1)(2008-11#1)
improved but##3##2##(2008-12#1)(2008-5#1)(2009-12#1)
improved by a factor##4##4##(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
improved by a##8##3##(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-7#2)(2011-2#1)
improved by increasing##3##3##(1996-3#1)(2008-10#2)
improved by more than##3##4##(1997-4#1)(2007-11#1)(2007-12#1)
improved by the addition of##5##5##(1992-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)
improved by the##10##3##(1992-2#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2010-2#1)(2011-3#1)
improved by use of a##5##5##(2007-11#1)(2007-2#1)(2008-3#3)
improved by use of##9##4##(2007-11#3)(2007-2#1)(2008-2#1)(2008-3#4)
improved by using##6##3##(1990-8#1)(2008-10#4)(2010-7#1)
improved by##101##2##(1990-7#1)(1990-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-12#3)(1996-3#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#6)(2007-12#3)(2007-2#1)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)
improved cardiac##3##2##(2010-4#1)(2012-12#1)(2012-2#1)
improved care and##2##3##(1991-12#1)(2008-9#1)
improved care for##2##3##(1996-2#1)(2008-3#1)
improved care##5##2##(1991-12#1)(1995-2#1)(1996-2#1)(2008-3#1)(2008-9#1)
improved catalytic##2##2##(2008-10#2)
improved cellular##3##2##(1994-12#1)(2008-11#1)(2008-7#1)
improved characteristics##2##2##(2008-10#1)(2010-7#1)
improved clearly##2##2##(2008-11#1)(2012-2#1)
improved clinical outcomes##2##3##(2008-3#1)(2012-12#1)
improved clinical##4##2##(2007-8#1)(2008-3#1)(2011-2#1)(2012-12#1)
improved cognitive##3##2##(1994-6#2)(2008-7#1)
improved communication##2##2##(2008-11#1)(2011-2#1)
improved compared with##3##3##(2008-3#1)(2008-7#1)(2010-7#1)
improved compared##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)
improved considerably##6##2##(1990-3#1)(1997-1#1)(2007-12#1)(2008-3#1)(2008-6#1)(2012-3#1)
improved control of##2##3##(2008-10#1)(2011-2#1)
improved control##6##2##(2008-10#5)(2011-2#1)
improved coordination of##2##3##(1994-3#1)(2007-10#1)
improved coordination##3##2##(1994-3#1)(2007-10#1)(2009-7#1)
improved crystallinity and ion-beam etching##2##5##(2007-11#2)
improved cultivars##2##2##(2008-10#1)(2010-10#1)
improved data##3##2##(1994-3#1)(1997-2#1)(2008-10#1)
improved delivery##3##2##(1994-5#1)(2008-5#1)(2013-1#1)
improved design of##3##3##(2008-3#1)(2013-8#2)
improved design##4##2##(2008-3#1)(2013-8#3)
improved detection of##2##3##(2008-3#1)(2008-7#1)
improved detection##10##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-12#1)
improved diagnoses##2##2##(2007-12#1)(2009-6#1)
improved diagnostic##4##2##(2007-11#1)(2008-3#1)(2009-3#1)(2010-8#1)
improved diagnostics##3##2##(1995-6#1)(2008-5#1)(2011-2#1)
improved disaster##2##2##(1992-12#1)(2012-12#1)
improved discrimination##2##2##(2008-3#2)
improved disease##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
improved dramatically##6##2##(1996-3#1)(2009-12#1)(2010-3#1)(2010-8#1)(2013-1#2)
improved during##2##2##(1991-6#1)(2007-11#1)
improved efficacy##4##2##(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
improved efficiency and##2##3##(1996-2#1)(2007-11#1)
improved efficiency##4##2##(1996-2#1)(2007-11#1)(2008-3#1)(2011-2#1)
improved especially##2##2##(1992-6#1)(2008-10#1)
improved fire test##2##3##(1996-12#2)
improved flexibility##3##2##(2008-10#3)
improved following##2##2##(2007-7#1)(2008-7#1)
improved for##4##2##(1992-3#1)(1995-6#1)(2008-10#1)(2008-12#1)
improved from 0##3##3##(2008-1#1)(2008-8#1)(2012-2#1)
improved from 11 to##2##4##(2008-10#1)(2012-2#1)
improved from##22##2##(1991-8#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
improved function##2##2##(2008-6#1)(2010-12#1)
improved functionality##2##2##(2010-1#1)(2010-4#1)
improved further##2##2##(2008-10#1)(2011-1#1)
improved gradually##2##2##(2008-7#1)(2013-8#1)
improved greatly by##2##3##(2008-3#1)(2011-3#1)
improved greatly##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2011-3#1)
improved growth##2##2##(2008-11#1)(2011-2#1)
improved health##6##2##(2008-8#2)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
improved healthcare performance##2##3##(2010-8#2)
improved hearing##2##2##(2008-4#1)(2008-9#1)
improved if the##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
improved if##4##2##(1996-11#1)(2007-12#1)(2008-3#1)(2013-8#1)
improved image##2##2##(2007-11#1)(2007-12#1)
improved in all##2##3##(2008-10#1)(2008-7#1)
improved in both groups##2##4##(1996-1#1)(2010-12#1)
improved in both##3##3##(1996-1#1)(2007-8#1)(2010-12#1)
improved in four##2##3##(2008-10#1)(2011-2#1)
improved in nine##2##3##(2008-10#1)(2008-6#1)
improved in the last decade##2##5##(1994-3#1)(2011-1#1)
improved in the last##3##4##(1994-3#1)(2011-1#1)(2012-1#1)
improved in the presence of##2##5##(2008-10#2)
improved in the##16##3##(1994-3#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-1#3)
improved in##42##2##(1990-12#1)(1991-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#6)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-3#2)(2013-1#3)
improved insulin##2##2##(1997-1#1)(2009-12#1)
improved its##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
improved lesion##2##2##(2008-7#2)
improved liver##2##2##(2008-11#1)(2012-3#1)
improved management of##2##3##(1997-8#1)(2008-7#1)
improved measurement##2##2##(2008-3#1)(2012-2#1)
improved mechanical##4##2##(2008-11#1)(2009-7#2)(2012-2#1)
improved medical##3##2##(1993-12#1)(2012-2#1)(2013-8#1)
improved memory in##2##3##(1993-12#1)(2008-5#1)
improved method for##6##3##(1994-3#1)(1995-11#1)(1996-5#1)(2008-11#1)(2008-3#1)(2012-3#1)
improved method##14##2##(1990-12#1)(1994-3#1)(1995-11#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2012-3#1)
improved microwave##2##2##(2008-10#2)
improved models##2##2##(2007-11#1)(2012-4#1)
improved morale and##2##3##(1992-12#1)(2007-10#1)
improved more for##2##3##(2008-12#1)(2009-11#1)
improved more##3##2##(2008-12#1)(2008-7#1)(2009-11#1)
improved on##4##2##(2008-10#1)(2008-3#3)
improved only##3##2##(1992-3#1)(1994-5#1)(2012-12#1)
improved optical##2##2##(2008-2#1)(2008-3#1)
improved or##3##2##(1992-5#1)(2011-1#1)(2012-3#1)
improved our##2##2##(2008-3#1)(2012-12#1)
improved outcome##4##2##(2008-1#1)(2008-12#1)(2008-8#1)(2010-8#1)
improved outcomes for##4##3##(1997-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
improved outcomes in these##2##4##(2008-1#1)(2011-2#1)
improved outcomes in##3##3##(2008-1#1)(2011-2#2)
improved outcomes##14##2##(1996-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-9#1)(2011-2#3)(2012-2#1)
improved over the##2##3##(2007-11#1)(2011-1#1)
improved over time##2##3##(1993-5#1)(2010-10#1)
improved over##4##2##(1993-5#1)(2007-11#1)(2010-10#1)(2011-1#1)
improved overall survival##2##3##(2008-8#1)(2010-4#1)
improved overall##4##2##(2008-3#1)(2008-8#2)(2010-4#1)
improved owing to##2##3##(2007-8#1)(2008-10#1)
improved pain##2##2##(2008-10#1)(2013-1#1)
improved patient care and##2##4##(1992-12#1)(1997-2#1)
improved patient compliance##2##3##(2010-5#1)(2010-8#1)
improved patient education##2##3##(1996-1#1)(1997-1#1)
improved patient outcomes##6##3##(1996-1#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
improved patient safety##2##3##(1994-3#1)(2008-9#1)
improved patient##15##2##(1992-12#1)(1994-3#1)(1995-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
improved peak shapes##2##3##(1994-9#1)(2007-12#1)
improved peak##3##2##(1994-9#1)(2007-12#1)(2008-10#1)
improved performance in##3##3##(2008-3#1)(2010-12#1)(2012-1#1)
improved performance over##2##3##(2008-3#1)(2008-7#1)
improved performance##18##2##(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-3#1)
improved peritonitis##2##2##(2011-2#2)
improved physical##2##2##(2008-11#1)(2010-8#1)
improved plant##2##2##(2008-10#1)(2011-10#1)
improved prediction of##2##3##(2008-10#1)(2009-4#1)
improved prevention##2##2##(1997-8#1)(2008-1#1)
improved procedure##5##2##(1990-12#1)(1991-8#1)(1992-6#1)(2007-11#1)(2008-11#1)
improved prognosis##3##2##(2009-3#1)(2010-11#1)(2013-1#1)
improved quality of care##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
improved quality of life##9##4##(1992-10#1)(1992-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)
improved quality of##13##3##(1992-10#1)(1992-3#2)(1993-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)
improved quality##14##2##(1992-10#1)(1992-3#2)(1993-2#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)
improved rapidly##2##2##(1994-6#1)(2008-7#1)
improved rates of##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
improved recovery method##2##3##(2008-10#1)(2012-12#1)
improved recovery##4##2##(1990-7#1)(2007-8#1)(2008-10#1)(2012-12#1)
improved resolution and contrast##2##4##(2007-12#1)(2009-5#1)
improved resolution##8##2##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-5#2)(2011-1#1)
improved response to##2##3##(2008-6#1)(2008-9#1)
improved response##4##2##(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)
improved results##2##2##(2008-2#1)(2013-1#1)
improved safety##4##2##(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
improved selectivity##6##2##(1994-2#1)(2008-10#4)(2010-7#1)
improved sensitivity and##3##3##(1990-2#1)(1996-2#1)(2008-10#1)
improved sensitivity##11##2##(1990-2#1)(1996-2#1)(2008-10#6)(2008-3#1)(2009-8#1)(2010-11#1)
improved service##2##2##(1993-1#1)(1995-1#1)
improved signal-to-noise ratios##2##3##(2007-12#1)(2008-3#1)
improved signal-to-noise##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
improved significantly by##2##3##(2008-10#1)(2008-3#1)
improved significantly compared##2##3##(2007-10#1)(2008-10#1)
improved significantly in##2##3##(2008-10#1)(2009-3#1)
improved significantly over time##2##4##(2008-9#1)(2011-3#1)
improved significantly##21##2##(1990-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-8#1)(2011-3#1)(2012-2#2)(2013-1#3)
improved soon after##2##3##(2006-12#1)(2008-7#1)
improved spatial resolution##3##3##(2008-3#2)(2008-7#1)
improved spatial##5##2##(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
improved specificity##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
improved spectral##2##2##(2007-12#1)(2008-2#1)
improved speech perception performance in##2##5##(2012-2#2)
improved speech perception##4##3##(2008-9#1)(2012-2#3)
improved speed##3##2##(2008-12#1)(2008-2#1)(2011-7#1)
improved stability of the##2##4##(1994-8#1)(2008-5#1)
improved stability##4##2##(1994-12#1)(1994-8#1)(2007-11#1)(2008-5#1)
improved student##2##2##(2010-3#2)
improved survival##13##2##(1994-6#1)(2008-11#2)(2008-6#1)(2008-7#6)(2010-3#1)(2010-9#1)(2013-1#1)
improved symptoms and##2##3##(2008-4#1)(2008-8#1)
improved symptoms##4##2##(2006-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
improved system##4##2##(2008-3#4)
improved technique##3##2##(1994-5#1)(1996-1#1)(2007-12#1)
improved technology##2##2##(2008-10#1)(2008-12#1)
improved the outcome of patients with##2##6##(2007-5#1)(2010-3#1)
improved the outcome##4##3##(2007-5#1)(2010-3#3)
improved the overall##2##3##(2008-10#1)(2008-5#1)
improved the performance##2##3##(2008-1#1)(2008-10#1)
improved the quality of life##2##5##(1995-12#1)(2010-12#1)
improved the quality of##5##4##(1993-3#1)(1995-12#1)(2008-3#1)(2010-12#1)(2012-12#1)
improved the repeatability of##2##4##(2008-10#2)
improved the resolution of the voltammetric method##2##7##(2008-10#2)
improved the stability and##2##4##(2008-10#1)(2008-3#1)
improved the stability##3##3##(2008-10#2)(2008-3#1)
improved the treatment##3##3##(2011-2#3)
improved the##98##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#5)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
improved their##8##2##(1990-11#1)(1993-11#1)(1993-5#1)(1997-6#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
improved therapeutic strategies##2##3##(1995-2#1)(2007-12#1)
improved therapeutic##5##2##(1995-2#1)(1996-9#1)(2007-12#1)(2008-5#1)(2008-7#1)
improved therapy##2##2##(2008-7#1)(2012-2#1)
improved through the##3##3##(2008-10#1)(2009-9#1)(2010-7#1)
improved through##5##2##(2008-10#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)
improved to 0##2##3##(2008-10#1)(2012-3#1)
improved to##20##2##(1990-11#1)(2008-1#1)(2008-10#3)(2008-3#5)(2008-7#1)(2008-9#2)(2010-10#1)(2012-2#2)(2012-3#1)(2013-1#3)
improved traits##2##2##(2008-11#1)(2011-2#1)
improved treatment##5##2##(2008-1#1)(2008-3#1)(2009-11#2)(2012-3#1)
improved understanding of the##2##4##(2008-10#2)
improved understanding of##5##3##(1997-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
improved understanding##6##2##(1992-8#1)(1997-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
improved up to##2##3##(1995-8#1)(2008-7#1)
improved upon##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2010-12#1)
improved using##8##2##(1992-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-3#1)
improved viability##2##2##(2008-11#1)(2009-6#1)
improved water##2##2##(1995-3#1)(2008-10#1)
improved wheat##3##2##(2008-10#1)(2008-12#2)
improved when the##2##3##(2008-10#1)(2008-11#1)
improved when##7##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
improved with the##3##3##(2008-7#1)(2008-9#1)(2009-11#1)
improved with##16##2##(1994-12#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
improved xylose##2##2##(2012-3#2)
improved yield##2##2##(1994-6#1)(2008-6#1)
improved yields and##2##3##(2008-8#1)(2010-12#1)
improved yields##3##2##(2007-11#1)(2008-8#1)(2010-12#1)
improved##1361##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#6)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#4)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#9)(1994-5#4)(1994-6#7)(1994-8#3)(1994-9#7)(1995-1#4)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#4)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#8)(1996-11#2)(1996-12#9)(1996-2#4)(1996-3#10)(1996-5#2)(1996-6#3)(1996-9#2)(1997-1#7)(1997-2#8)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#4)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#43)(2007-12#27)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#9)(2008-1#18)(2008-10#227)(2008-11#54)(2008-12#27)(2008-2#38)(2008-3#121)(2008-4#12)(2008-5#30)(2008-6#23)(2008-7#65)(2008-8#21)(2008-9#24)(2009-1#1)(2009-11#8)(2009-12#7)(2009-2#2)(2009-3#12)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#10)(2010-2#3)(2010-3#17)(2010-4#8)(2010-5#2)(2010-6#4)(2010-7#9)(2010-8#19)(2010-9#2)(2011-1#18)(2011-10#1)(2011-2#53)(2011-3#6)(2011-7#1)(2012-1#8)(2012-12#19)(2012-2#40)(2012-3#22)(2012-4#1)(2013-1#48)(2013-7#2)(2013-8#21)
improved&quot##2##1##(2008-2#2)
improvement (QI)##3##2##(1994-12#1)(1994-3#1)(2013-1#1)
improvement activities##4##2##(1994-2#1)(1996-3#1)(2009-9#1)(2010-8#1)
improvement after##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
improvement and the##2##3##(1995-3#1)(1995-6#1)
improvement and##32##2##(1991-2#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-3#2)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
improvement are##4##2##(1995-2#1)(2008-3#1)(2010-10#1)(2010-12#1)
improvement assessment##2##2##(2008-11#2)
improvement at##3##2##(1993-3#1)(2008-6#1)(2010-6#1)
improvement because of##2##3##(2008-11#1)(2009-10#1)
improvement by use of##2##4##(2007-11#1)(2008-3#1)
improvement by##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
improvement can be##3##3##(2007-10#1)(2007-12#1)(2012-1#1)
improvement compared with##2##3##(2008-3#2)
improvement compared##3##2##(2008-10#1)(2008-3#2)
improvement could be##2##3##(2007-8#1)(2008-5#1)
improvement efforts##13##2##(1992-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-3#1)(1997-1#2)(2012-3#1)(2013-1#1)
improvement for the##2##3##(1994-2#1)(1996-2#1)
improvement for##9##2##(1993-2#1)(1994-2#1)(1996-2#1)(1997-2#1)(2008-2#2)(2010-12#1)(2011-2#1)(2012-2#1)
improvement has been achieved##2##4##(2007-11#1)(2012-3#1)
improvement has been##3##3##(1993-1#1)(2007-11#1)(2012-3#1)
improvement has##5##2##(1993-1#1)(1997-1#1)(2007-11#1)(2008-7#1)(2012-3#1)
improvement in MODQ score##2##4##(2012-2#2)
improvement in S/N ratio was achieved##2##6##(2008-10#2)
improvement in a##3##3##(2007-8#1)(2008-3#1)(2013-1#1)
improvement in accuracy##2##3##(2007-12#1)(2008-6#1)
improvement in all the##2##4##(2008-7#1)(2013-1#1)
improvement in all##5##3##(1996-5#1)(2007-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
improvement in blood pressure control##2##5##(2007-7#1)(2009-1#1)
improvement in blood##3##3##(1993-2#1)(2007-7#1)(2009-1#1)
improvement in both##2##3##(1994-5#1)(2013-1#1)
improvement in clinical##4##3##(1991-12#1)(1994-12#1)(2011-2#1)(2012-3#1)
improvement in cognitive##2##3##(2008-6#1)(2008-7#1)
improvement in disease activity##2##4##(2008-10#1)(2012-1#1)
improvement in disease##3##3##(2008-10#2)(2012-1#1)
improvement in facial##2##3##(2009-7#1)(2013-1#1)
improvement in functional##2##3##(2008-7#1)(2011-2#1)
improvement in gait and##2##4##(2007-10#1)(2010-9#1)
improvement in grip strength after##2##5##(2008-9#2)
improvement in grip strength##3##4##(2008-9#3)
improvement in health care##3##4##(1994-1#1)(1994-3#1)(1995-12#1)
improvement in health##6##3##(1994-1#1)(1994-3#1)(1995-12#3)(2011-1#1)
improvement in her##2##3##(2008-12#1)(2012-12#1)
improvement in his##2##3##(2008-12#2)
improvement in its##2##3##(2008-2#1)(2013-1#1)
improvement in long-term##2##3##(1997-1#1)(2010-4#1)
improvement in metal##2##3##(2008-10#1)(2008-7#1)
improvement in neurological##2##3##(2007-11#1)(2012-3#1)
improvement in overall##3##3##(1991-2#1)(2008-11#1)(2008-6#1)
improvement in pain and##2##4##(2008-12#2)
improvement in pain##4##3##(2008-12#2)(2008-7#1)(2012-3#1)
improvement in patient outcome##2##4##(2008-5#1)(2011-2#1)
improvement in patient##3##3##(1997-1#1)(2008-5#1)(2011-2#1)
improvement in performance with##2##4##(2007-11#1)(2011-1#1)
improvement in performance##10##3##(1993-3#1)(1997-1#1)(2007-11#5)(2008-11#1)(2011-1#1)(2012-3#1)
improvement in precision##2##3##(2008-10#2)
improvement in quality of life##6##5##(2007-8#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
improvement in quality of##7##4##(2007-8#1)(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
improvement in resolution##2##3##(2008-10#1)(2008-3#1)
improvement in sensitivity##4##3##(2008-10#3)(2008-2#1)
improvement in signal-to-noise ratio##2##4##(2007-11#1)(2007-12#1)
improvement in stability##2##3##(1995-3#1)(2008-5#1)
improvement in subjective pain rating##2##5##(2008-9#2)
improvement in survival##3##3##(1992-10#1)(2008-6#1)(2010-12#1)
improvement in symptoms##3##3##(1991-4#1)(2007-2#1)(2008-4#1)
improvement in the accuracy of the##2##6##(2008-10#1)(2008-2#1)
improvement in the amount of energy delivered##2##7##(2013-1#2)
improvement in the diagnosis of##2##5##(2008-7#1)(2011-3#1)
improvement in the efficiency of##2##5##(1994-12#1)(2008-3#1)
improvement in the health##2##4##(1995-12#1)(2011-2#1)
improvement in the management of##3##5##(2008-3#1)(2008-4#1)(2010-12#1)
improvement in the management##4##4##(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
improvement in the measurement##2##4##(1995-2#1)(2008-2#1)
improvement in the quality of care##4##6##(1996-2#1)(1996-9#1)(1997-1#1)(2008-7#1)
improvement in the quality of##8##5##(1996-2#2)(1996-9#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
improvement in the sensitivity##3##4##(2008-10#3)
improvement in the stability of the##2##6##(2007-8#1)(2008-3#1)
improvement in the##88##3##(1991-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-5#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
improvement in their##4##3##(1995-3#1)(2008-5#2)(2013-1#1)
improvement in three##2##3##(1990-5#1)(2008-3#1)
improvement in time##2##3##(1990-2#1)(2011-2#1)
improvement in##373##2##(1990-2#4)(1990-5#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#5)(1995-6#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#2)(1996-9#2)(1997-1#6)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#4)(2007-10#2)(2007-11#18)(2007-12#9)(2007-2#3)(2007-6#2)(2007-7#6)(2007-8#6)(2008-1#2)(2008-10#34)(2008-11#11)(2008-12#7)(2008-2#13)(2008-3#18)(2008-4#7)(2008-5#13)(2008-6#6)(2008-7#26)(2008-8#2)(2008-9#7)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#18)(2011-3#2)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#8)(2013-1#22)(2013-8#5)
improvement initiative##11##2##(1994-2#1)(1995-1#1)(1996-2#3)(2008-3#1)(2010-2#1)(2013-1#4)
improvement initiatives##4##2##(1995-3#1)(1997-1#1)(1997-3#1)(2010-8#1)
improvement is achieved##2##3##(2008-2#2)
improvement is quantified##2##3##(2008-2#1)(2008-3#1)
improvement is still##2##3##(2010-12#1)(2011-2#1)
improvement is##25##2##(1993-11#1)(1994-12#1)(1995-2#1)(2007-11#3)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#3)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
improvement may##2##2##(2011-2#2)
improvement of a##5##3##(1995-2#1)(2008-11#1)(2008-2#2)(2011-2#1)
improvement of clinical##3##3##(1990-3#1)(2007-12#1)(2013-1#1)
improvement of current##2##3##(2008-11#1)(2009-6#1)
improvement of different##2##3##(1996-2#1)(2011-1#1)
improvement of function##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
improvement of global health##2##4##(2008-10#1)(2011-1#1)
improvement of global##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2012-1#1)
improvement of health care##2##4##(1994-3#2)
improvement of health##3##3##(1994-3#2)(2011-2#1)
improvement of heart failure##2##4##(2007-8#1)(2012-3#1)
improvement of heart##3##3##(2007-8#1)(2012-3#1)(2013-1#1)
improvement of medical##3##3##(1993-12#1)(1997-4#1)(2010-4#1)
improvement of our##2##3##(2010-12#1)(2012-1#1)
improvement of pain##3##3##(1991-3#1)(2008-9#2)
improvement of patient##2##3##(2007-12#1)(2008-5#1)
improvement of quality of life in##2##6##(2007-1#1)(2011-2#1)
improvement of quality of life##4##5##(2007-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
improvement of quality##5##3##(1994-12#1)(2007-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
improvement of surgical##2##3##(1993-5#1)(2008-7#1)
improvement of symptoms##3##3##(1990-10#1)(1997-6#1)(2007-8#1)
improvement of the clinical##2##4##(1997-2#1)(2007-10#1)
improvement of the correlation##2##4##(1995-2#1)(2008-10#1)
improvement of the health##2##4##(1993-6#1)(1997-8#1)
improvement of the sensitivity##2##4##(2008-10#1)(2008-7#1)
improvement of the##55##3##(1990-9#1)(1991-11#1)(1991-6#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
improvement of their##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
improvement of this##2##3##(2008-3#2)
improvement of##217##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#6)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#30)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#16)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#14)(2011-7#1)(2012-1#6)(2012-12#2)(2012-2#5)(2012-3#5)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#4)
improvement on the##4##3##(2007-12#1)(2008-10#1)(2008-6#1)(2011-1#1)
improvement on##11##2##(1995-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2009-11#2)(2011-1#1)
improvement opportunities##3##2##(1995-2#1)(1996-3#1)(1997-1#1)
improvement or##3##2##(1991-1#1)(2007-11#1)(2008-7#1)
improvement over current##2##3##(2008-11#1)(2010-5#1)
improvement over previous##2##3##(2007-12#1)(2008-3#1)
improvement over the standard##3##4##(1994-9#1)(2008-3#2)
improvement over the##6##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#3)
improvement over time##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
improvement over##22##2##(1994-1#1)(1994-12#1)(1994-9#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#6)(2008-6#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
improvement process##6##2##(1993-2#1)(1995-2#2)(1996-1#1)(1996-3#1)(2008-3#1)
improvement program##5##2##(1992-3#1)(1993-1#1)(1993-12#1)(1996-1#1)(2008-3#1)
improvement programs##5##2##(1995-12#1)(1996-12#1)(2008-10#2)(2012-2#1)
improvement project##5##2##(1993-12#2)(1993-3#1)(2013-1#1)(2013-8#1)
improvement strategies to##2##3##(1994-3#1)(2013-1#1)
improvement strategies##6##2##(1994-3#3)(2008-7#1)(2010-8#1)(2013-1#1)
improvement teams##9##2##(1993-12#6)(1994-1#1)(1994-12#1)(2008-4#1)
improvement techniques##2##2##(1996-3#1)(2008-10#1)
improvement than##2##2##(2008-9#1)(2013-8#1)
improvement that##3##2##(1997-6#1)(2008-7#1)(2012-2#1)
improvement the##4##2##(1992-12#1)(2007-12#1)(2008-3#1)(2013-1#1)
improvement through##2##2##(1996-3#1)(2012-3#1)
improvement to the##2##3##(2007-12#1)(2008-3#1)
improvement to##9##2##(1994-3#1)(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)
improvement tools##3##2##(1993-2#1)(1994-1#1)(2008-3#1)
improvement upon##2##2##(1990-2#1)(2013-8#1)
improvement using##3##2##(1995-3#1)(2012-2#1)(2012-3#1)
improvement versus##2##2##(2008-3#1)(2012-2#1)
improvement was achieved##2##3##(2008-10#1)(2013-8#1)
improvement was demonstrated##2##3##(2010-9#1)(2013-1#1)
improvement was found in##2##4##(2008-7#1)(2011-2#1)
improvement was found##5##3##(1990-11#1)(1996-3#1)(2008-2#1)(2008-7#1)(2011-2#1)
improvement was not##2##3##(2007-8#1)(2013-1#1)
improvement was noted in##2##4##(1991-3#1)(2010-3#1)
improvement was observed in the##3##5##(1995-4#1)(2008-1#1)(2010-9#1)
improvement was observed in##5##4##(1995-4#1)(2008-1#1)(2010-9#1)(2013-1#2)
improvement was observed##8##3##(1995-4#1)(2008-1#1)(2008-10#2)(2010-9#1)(2013-1#3)
improvement was##39##2##(1990-11#1)(1991-3#1)(1993-6#1)(1995-4#1)(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-3#3)(2010-9#2)(2011-2#3)(2013-1#6)(2013-8#1)
improvement with NSS)##2##3##(2008-9#2)
improvement with the##2##3##(2008-7#1)(2011-2#1)
improvement with##11##2##(1996-2#1)(1997-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#2)
improvement within##2##2##(2008-6#1)(2011-2#1)
improvement##1176##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#8)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#20)(1993-2#15)(1993-3#18)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#12)(1994-11#1)(1994-12#21)(1994-2#13)(1994-3#16)(1994-5#3)(1994-9#1)(1995-1#9)(1995-11#1)(1995-12#19)(1995-2#13)(1995-3#23)(1995-4#1)(1995-5#1)(1995-6#6)(1995-9#1)(1996-1#9)(1996-11#3)(1996-12#6)(1996-2#20)(1996-3#19)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#22)(1997-2#11)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#8)(2006-6#1)(2007-1#1)(2007-10#6)(2007-11#37)(2007-12#25)(2007-2#4)(2007-6#2)(2007-7#9)(2007-8#14)(2008-1#11)(2008-10#90)(2008-11#35)(2008-12#19)(2008-2#32)(2008-3#65)(2008-4#13)(2008-5#38)(2008-6#17)(2008-7#55)(2008-8#6)(2008-9#22)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#8)(2010-9#4)(2011-1#13)(2011-2#53)(2011-3#2)(2011-7#1)(2012-1#10)(2012-12#12)(2012-2#25)(2012-3#22)(2012-7#1)(2013-1#65)(2013-7#1)(2013-8#19)
improvement&quot##2##1##(2008-3#1)(2011-2#1)
improvement)##2##1##(2008-12#1)(2011-1#1)
improvements and the##2##3##(2008-1#1)(2012-3#1)
improvements and##8##2##(1994-3#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#2)(2012-3#1)
improvements are##12##2##(1993-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-11#1)(2013-1#2)(2013-8#1)
improvements as##2##2##(1990-4#1)(2008-9#1)
improvements can##4##2##(1990-11#1)(1992-3#1)(1993-9#1)(2008-2#1)
improvements for##2##2##(2008-3#2)
improvements from##2##2##(2007-12#1)(2009-11#1)
improvements have been##6##3##(1997-8#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-5#1)(2013-1#1)
improvements have occurred in##2##4##(2008-10#1)(2012-2#1)
improvements have##10##2##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
improvements in a##2##3##(2008-9#1)(2012-3#1)
improvements in clinical##4##3##(2007-9#1)(2008-11#1)(2011-2#1)(2013-1#1)
improvements in design##2##3##(2008-3#1)(2013-1#1)
improvements in functional##2##3##(2008-7#2)
improvements in imaging##2##3##(2008-2#2)
improvements in pain##2##3##(2008-12#2)
improvements in protein##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
improvements in quality##2##3##(1995-12#1)(1996-7#1)
improvements in resolution##2##3##(2008-3#1)(2011-1#1)
improvements in specificity##2##3##(1992-3#1)(2008-10#1)
improvements in the quality of##2##5##(1995-12#1)(2012-3#1)
improvements in the quality##3##4##(1995-12#1)(2008-11#1)(2012-3#1)
improvements in the##24##3##(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)
improvements in their##2##3##(1996-2#1)(2012-3#1)
improvements in treatment##2##3##(2010-11#1)(2012-2#1)
improvements in##147##2##(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#8)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)
improvements of the##4##3##(2008-11#2)(2008-2#1)(2011-2#1)
improvements of##15##2##(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)
improvements on the##4##3##(1995-2#1)(2008-3#2)(2010-3#1)
improvements on##6##2##(1995-2#1)(2008-12#1)(2008-3#2)(2010-3#1)(2012-3#1)
improvements over the##2##3##(2008-10#1)(2008-3#1)
improvements over##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2009-3#1)
improvements that##2##2##(1996-3#1)(2008-3#1)
improvements to the##5##3##(1991-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)
improvements to##13##2##(1991-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-1#1)
improvements were found##2##3##(1991-2#1)(2007-12#1)
improvements were sustained##2##3##(1991-12#1)(2008-8#1)
improvements were##12##2##(1991-12#1)(1991-2#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
improvements will##3##2##(1993-2#1)(1994-1#1)(2010-3#1)
improvements with regard to##2##4##(2008-12#1)(2009-3#1)
improvements with##4##2##(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)
improvements##292##1##(1990-11#1)(1990-4#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#4)(1995-2#4)(1995-3#5)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#10)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#15)(2008-11#7)(2008-12#6)(2008-2#14)(2008-3#31)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#15)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#3)(2009-3#4)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#6)(2012-8#1)(2013-1#12)(2013-7#1)(2013-8#2)
improver##2##1##(2008-5#2)
improves cardiac function##2##3##(2008-7#1)(2011-2#1)
improves cognition and##3##3##(1996-9#1)(2008-7#1)(2009-10#1)
improves cognition##4##2##(1994-6#1)(1996-9#1)(2008-7#1)(2009-10#1)
improves cognitive##2##2##(1990-7#1)(2010-4#1)
improves functional##3##2##(2007-11#1)(2009-10#1)(2013-1#1)
improves insulin resistance##2##3##(2008-1#1)(2008-3#1)
improves on##2##2##(2007-11#1)(2008-3#1)
improves outcomes##3##2##(2009-3#1)(2013-1#1)(2013-8#1)
improves patient##2##2##(1996-12#1)(2007-8#1)
improves patients'##3##2##(2007-7#1)(2008-3#2)
improves performance##4##2##(1992-11#1)(2008-3#1)(2012-1#1)(2012-12#1)
improves quality of life##3##4##(2008-4#1)(2013-1#1)(2013-8#1)
improves quality of##4##3##(2008-4#2)(2013-1#1)(2013-8#1)
improves quality##5##2##(2008-4#2)(2009-9#1)(2013-1#1)(2013-8#1)
improves reading efficiency##2##3##(2012-2#2)
improves reading##3##2##(2010-7#1)(2012-2#2)
improves significantly##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
improves survival##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#2)(2012-2#1)
improves the ability of##2##4##(2008-12#1)(2009-5#1)
improves the ability##3##3##(2008-12#1)(2009-5#1)(2011-2#1)
improves the accuracy of##3##4##(2008-2#1)(2008-3#1)(2010-7#1)
improves the accuracy##5##3##(2008-2#2)(2008-3#1)(2010-7#1)(2010-8#1)
improves the comfort of##2##4##(2007-11#1)(2011-2#1)
improves the image##2##3##(2008-2#1)(2008-3#1)
improves the images of##2##4##(2008-2#2)
improves the power##2##3##(2008-3#1)(2012-3#1)
improves the prognosis##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
improves the quality of life##2##5##(1993-6#1)(2007-11#1)
improves the quality of##5##4##(1993-6#1)(2007-11#2)(2008-10#1)(2008-9#1)
improves the robustness of##2##4##(2008-11#1)(2008-3#1)
improves the robustness to##2##4##(1994-9#1)(2008-3#1)
improves the robustness##4##3##(1994-9#1)(2008-11#1)(2008-3#2)
improves the##86##2##(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-11#7)(2007-12#3)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-2#3)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
improves their##2##2##(2008-12#1)(2008-5#1)
improves##233##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#12)(2007-12#5)(2007-7#1)(2007-8#7)(2008-1#5)(2008-10#21)(2008-11#4)(2008-12#6)(2008-2#13)(2008-3#20)(2008-4#4)(2008-5#5)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#4)(2011-1#4)(2011-2#10)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#9)(2013-8#5)
improving access to care##2##4##(1996-3#1)(2012-2#1)
improving access to health##2##4##(1995-1#1)(2011-1#1)
improving access to##5##3##(1994-12#1)(1995-1#1)(1996-3#1)(2011-1#1)(2012-2#1)
improving and##3##2##(1995-1#1)(2008-1#1)(2008-5#1)
improving body##2##2##(2007-12#1)(2008-5#1)
improving both##5##2##(1991-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2010-5#1)
improving cognition##2##2##(2008-7#1)(2009-8#1)
improving community##2##2##(1996-2#1)(1997-1#1)
improving conditions of production medium##2##5##(2012-2#2)
improving control##2##2##(2009-11#1)(2012-12#1)
improving current##2##2##(2008-1#1)(2008-5#1)
improving customer##2##2##(1996-2#2)
improving diagnostic##2##2##(2011-1#1)(2013-1#1)
improving health care quality##3##4##(1996-2#1)(2009-5#1)(2010-8#1)
improving health care##5##3##(1996-1#1)(1996-2#1)(2009-5#1)(2010-8#1)(2012-2#1)
improving health status##2##3##(2010-5#1)(2013-1#1)
improving health##16##2##(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-7#2)(2009-5#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
improving healthcare delivery##2##3##(2013-1#2)
improving healthcare##3##2##(2013-1#3)
improving hospital##2##2##(1996-2#1)(2010-8#1)
improving its##5##2##(1994-2#1)(1995-6#1)(2008-1#1)(2011-2#1)(2012-12#1)
improving knowledge about##2##3##(1991-6#1)(2010-10#1)
improving long-term##2##2##(1997-1#1)(2010-11#1)
improving management##2##2##(2009-11#1)(2010-5#1)
improving on##2##2##(2009-11#1)(2011-2#1)
improving our##3##2##(1994-1#1)(2007-7#1)(2011-2#1)
improving outcomes in##3##3##(2008-6#1)(2008-7#2)
improving outcomes##6##2##(2008-6#2)(2008-7#3)(2010-3#1)
improving patient care##2##3##(1993-2#1)(2010-3#1)
improving patient outcomes##2##3##(1993-2#1)(2013-1#1)
improving patient##8##2##(1993-2#2)(2007-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
improving performance##3##2##(1995-2#1)(1996-11#1)(2008-3#1)
improving practice##2##2##(2007-11#1)(2008-11#1)
improving prognosis##2##2##(1996-11#1)(2008-1#1)
improving quality at##2##3##(1996-12#1)(1996-2#1)
improving quality in##2##3##(1992-11#1)(1996-2#1)
improving quality of##6##3##(1995-1#1)(1997-2#1)(2008-1#2)(2008-7#1)(2009-10#1)
improving quality##11##2##(1992-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-1#2)(2008-7#1)(2009-10#1)
improving road safety##3##3##(2011-2#2)(2013-1#1)
improving rural##2##2##(1996-3#1)(2011-2#1)
improving sensitivity##3##2##(2008-10#3)
improving service##3##2##(1994-2#1)(1995-1#1)(1995-2#1)
improving services##2##2##(1991-3#1)(1994-2#1)
improving symptoms##4##2##(1992-1#1)(2008-9#1)(2009-8#1)(2011-2#1)
improving the delivery of##2##4##(2008-4#1)(2010-3#1)
improving the design##2##3##(1990-11#1)(2008-5#1)
improving the detection##2##3##(2007-12#1)(2012-2#1)
improving the effectiveness of##2##4##(1991-1#1)(1991-7#1)
improving the efficiency of##5##4##(1992-2#1)(1994-12#1)(1994-5#1)(2008-12#1)(2010-8#1)
improving the efficiency##6##3##(1992-2#1)(1994-12#1)(1994-5#1)(2008-12#1)(2008-2#1)(2010-8#1)
improving the health of##3##4##(1995-2#1)(2008-4#1)(2010-9#1)
improving the health status of##2##5##(1995-2#1)(1996-12#1)
improving the health##5##3##(1995-2#2)(1996-12#1)(2008-4#1)(2010-9#1)
improving the level of##3##4##(1997-1#1)(2011-2#1)(2013-1#1)
improving the outcome##2##3##(2010-11#1)(2010-5#1)
improving the patient's##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
improving the performance of##2##4##(1996-12#1)(2008-2#1)
improving the prognosis of##2##4##(1990-2#1)(2011-2#1)
improving the quality of care##3##5##(1996-2#1)(1996-3#1)(2008-11#1)
improving the quality of life##3##5##(1993-3#1)(2008-1#1)(2013-8#1)
improving the quality of##13##4##(1993-2#1)(1993-3#1)(1996-2#2)(1996-3#1)(1996-9#1)(2008-1#1)(2008-11#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
improving the quality##15##3##(1993-2#1)(1993-3#1)(1994-7#1)(1996-2#2)(1996-3#1)(1996-9#1)(2008-1#1)(2008-11#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
improving the reliability of##2##4##(1996-2#1)(2008-10#1)
improving the sensitivity of##2##4##(1994-1#1)(2010-7#1)
improving the sensitivity##3##3##(1994-1#1)(2009-11#1)(2010-7#1)
improving the treatment of##2##4##(2008-5#1)(2008-6#1)
improving the treatment##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
improving the understanding of##3##4##(2008-8#1)(2011-1#1)(2013-8#1)
improving the##139##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-3#3)(1994-1#2)(1994-12#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#2)(1996-12#2)(1996-2#5)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#3)
improving their quality of life##2##5##(2009-11#1)(2009-9#1)
improving their##10##2##(1996-2#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-3#1)
improving these##3##2##(2008-3#2)(2012-12#1)
improving vision and##2##3##(2007-11#1)(2008-7#1)
improving work##2##2##(1997-2#1)(2013-1#1)
improving##446##1##(1990-11#1)(1990-2#3)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#3)(1993-2#4)(1993-3#5)(1994-1#3)(1994-12#3)(1994-2#5)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#6)(1995-12#3)(1995-2#7)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#15)(1996-3#6)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#3)(1997-4#1)(2006-10#3)(2007-10#1)(2007-11#14)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#2)(2008-1#12)(2008-10#37)(2008-11#14)(2008-12#7)(2008-2#6)(2008-3#19)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#27)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#5)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#7)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#8)(2011-2#19)(2012-1#1)(2012-12#10)(2012-2#16)(2012-3#9)(2013-1#23)(2013-7#1)(2013-8#8)
improvisation##3##1##(1991-1#1)(1991-12#1)(2011-2#1)
improvised##2##1##(2007-11#1)(2010-11#1)
impulse activity##6##2##(2008-5#5)(2009-3#1)
impulse conduction##2##2##(2008-5#1)(2008-7#1)
impulse control##5##2##(2008-4#1)(2009-10#1)(2009-7#1)(2012-12#1)(2013-8#1)
impulse discharge from##2##3##(2008-8#2)
impulse response is##2##3##(2008-2#1)(2008-3#1)
impulse response of##2##3##(2007-11#1)(2008-3#1)
impulse response##12##2##(2007-11#1)(2008-2#3)(2008-3#8)
impulse##39##1##(1990-8#2)(1991-5#1)(2007-11#1)(2008-11#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
impulses##8##1##(1992-5#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2013-1#1)
impulsive behaviour##2##2##(2013-1#2)
impulsive behaviours##2##2##(2013-1#2)
impulsive##15##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2010-6#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)
impulsively excited##3##2##(2007-11#3)
impulsiveness##6##1##(1990-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)
impulsivity paradigms##2##2##(2010-6#2)
impulsivity##22##1##(2008-2#2)(2008-4#1)(2008-6#1)(2009-10#1)(2010-6#7)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#6)
impurities are##2##2##(2008-10#2)
impurities by##2##2##(1990-8#1)(2008-10#1)
impurities for a stavudine synthesis control##3##6##(2008-10#3)
impurities from##2##2##(2008-10#1)(2008-11#1)
impurities in the##2##3##(2008-10#1)(2010-2#1)
impurities in##18##2##(2008-10#14)(2008-3#2)(2010-2#1)(2012-12#1)
impurities of similar structure##2##4##(2008-10#2)
impurities of##6##2##(2008-10#6)
impurities was##5##2##(2008-10#2)(2010-2#2)(2012-12#1)
impurities were##5##2##(2008-10#1)(2008-4#1)(2010-2#2)(2012-2#1)
impurities##73##1##(1990-8#1)(1994-3#1)(1996-1#1)(2008-10#41)(2008-11#2)(2008-3#4)(2008-4#1)(2008-7#4)(2010-2#9)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
impurity band##2##2##(2007-11#2)
impurity elements##3##2##(2013-8#3)
impurity in a crystal with##2##5##(2007-11#2)
impurity in a crystal##3##4##(2007-11#3)
impurity in##6##2##(1992-11#1)(2007-11#5)
impurity of##2##2##(2008-11#1)(2008-5#1)
impurity profile##3##2##(2008-10#3)
impurity was##3##2##(2008-10#3)
impurity##33##1##(1992-11#1)(2007-11#10)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-2#2)(2013-8#3)
imputation##3##1##(2012-3#2)(2013-1#1)
imputed data##2##2##(2009-12#2)
imputed##3##1##(2009-12#2)(2012-3#1)
imputing missing##2##2##(2009-12#2)
in % overBMI##3##3##(2008-3#3)
in %##4##2##(1990-8#1)(2008-3#3)
in &gt##10##2##(2008-10#3)(2008-7#4)(2011-2#2)(2013-1#1)
in &lt##7##2##(1997-5#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-7#1)
in &quot##31##2##(1990-2#1)(1990-5#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-6#1)(1996-1#1)(1996-9#2)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)
in 'Burley 21'##2##3##(2008-10#2)
in 'Montenegrina'##2##2##(2008-6#2)
in (1)##7##2##(2007-5#1)(2008-12#1)(2010-8#2)(2012-12#2)(2012-7#1)
in (1)D##2##2##(2008-10#2)
in (13)C##2##2##(2010-3#2)
in (i)##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
in 0##116##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1995-3#1)(1996-12#3)(1996-2#1)(2007-1#1)(2007-11#1)(2008-10#76)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#7)
in 1 (3##2##3##(2011-1#2)
in 1 M##3##3##(1991-8#1)(2008-10#2)
in 1 case of type##2##5##(2013-8#2)
in 1 case of##3##4##(1994-1#1)(2013-8#2)
in 1 case##12##3##(1990-6#1)(1990-9#2)(1991-3#1)(1992-8#1)(1994-1#1)(1996-2#1)(2007-10#1)(2008-11#1)(2009-10#1)(2013-8#2)
in 1 h##4##3##(1996-5#1)(2008-10#3)
in 1 in##4##3##(2007-11#1)(2007-2#1)(2012-3#1)(2013-1#1)
in 1 mM##2##3##(2006-11#1)(2008-10#1)
in 1 min##4##3##(2008-10#4)
in 1 ml of##3##4##(2008-10#3)
in 1 of##2##3##(2008-7#1)(2011-1#1)
in 1 patient and##2##4##(2007-10#1)(2008-10#1)
in 1 patient##15##3##(1990-3#1)(1990-8#1)(1992-1#1)(1994-12#3)(2007-10#3)(2007-11#2)(2008-10#2)(2010-7#1)(2012-2#1)
in 1 s##5##3##(2007-12#4)(2008-2#1)
in 1 second (FEV1)##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
in 1 were##2##3##(1993-3#1)(2006-10#1)
in 1##153##2##(1990-11#1)(1990-3#1)(1990-6#3)(1990-8#4)(1990-9#5)(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-3#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-2#5)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#3)(2006-11#1)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#37)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#5)(2012-2#3)(2012-3#8)(2013-1#2)(2013-8#3)
in 1% Triton X-100 plus 0##2##6##(2008-10#2)
in 1% of##2##3##(2008-8#1)(2011-2#1)
in 1%##9##2##(1990-12#1)(1990-2#1)(1992-2#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
in 1-##2##2##(2008-10#1)(2008-6#1)
in 1/3##2##2##(1992-8#1)(2008-5#1)
in 10 and##2##3##(2008-5#1)(2008-6#1)
in 10 cases##7##3##(1991-2#1)(2007-11#1)(2008-6#2)(2008-9#1)(2011-2#2)
in 10 days##2##3##(1992-12#1)(2008-12#1)
in 10 mM##4##3##(1992-6#3)(1993-9#1)
in 10 min##4##3##(2008-10#3)(2008-11#1)
in 10 ml of##4##4##(2008-10#4)
in 10 non-chemotactic mutants##2##4##(1995-8#2)
in 10 of the 13##2##5##(1996-12#1)(2008-5#1)
in 10 of the##5##4##(1996-12#2)(2008-10#2)(2008-5#1)
in 10 of##11##3##(1991-6#1)(1993-9#1)(1994-7#1)(1996-1#1)(1996-12#2)(2008-10#3)(2008-5#1)(2013-1#1)
in 10 patients with##3##4##(2007-11#1)(2007-8#1)(2008-5#1)
in 10 patients##16##3##(1990-12#1)(1990-8#1)(1991-4#1)(1993-10#1)(1995-11#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
in 10 per thousand SW and then decreased in FW##2##10##(2008-7#2)
in 10 per thousand SW##3##5##(2008-7#3)
in 10 s##2##3##(2008-10#2)
in 10 states##2##3##(1995-2#1)(2008-10#1)
in 10##108##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-10#1)(1993-9#2)(1994-7#1)(1995-11#2)(1995-2#1)(1995-5#3)(1995-8#2)(1996-1#1)(1996-12#2)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#4)(2008-9#2)(2009-3#1)(2009-5#1)(2011-2#9)(2012-12#1)(2013-1#4)(2013-8#1)
in 10% FBS##3##3##(1994-2#3)
in 10% UF##3##3##(1994-2#3)
in 10% of cases##2##4##(1990-12#1)(2011-2#1)
in 10% of patients##2##4##(1996-11#1)(2008-7#1)
in 10% of the cases##2##5##(1991-8#1)(2008-7#1)
in 10% of the##4##4##(1991-8#1)(2008-1#1)(2008-5#1)(2008-7#1)
in 10% of##11##3##(1990-12#1)(1991-8#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
in 10% pear juice##2##4##(2008-10#2)
in 10%##33##2##(1990-12#1)(1991-8#1)(1993-6#1)(1994-2#6)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#3)(2013-1#3)
in 10(4)##2##2##(2008-2#1)(2008-3#1)
in 10(5)##3##2##(2007-12#1)(2008-3#2)
in 10(6) volume-mixing##2##3##(2008-3#2)
in 10(6)##14##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#6)
in 10(9) by##4##3##(2007-12#2)(2008-3#2)
in 10(9)##13##2##(2007-12#3)(2008-2#3)(2008-3#7)
in 10(9))##3##2##(2008-2#1)(2008-3#2)
in 100 consecutive##2##3##(2008-7#1)(2011-2#1)
in 100 mg/kg females##3##4##(2008-9#3)
in 100 mg/kg males were significantly greater than those in the vehicle##2##12##(2008-9#2)
in 100 mg/kg males were significantly##4##6##(2008-9#4)
in 100 mg/kg males##6##4##(2008-9#6)
in 100 mg/kg##9##3##(2008-9#9)
in 100 patients##5##3##(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(2010-4#1)
in 100##38##2##(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(1993-9#1)(1994-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#10)(2009-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#2)
in 100% and##2##3##(2008-7#1)(2013-1#1)
in 100% of##4##3##(1990-3#1)(1991-2#1)(2008-11#2)
in 100% oxygen##2##3##(2011-2#1)(2012-3#1)
in 100%##13##2##(1990-3#1)(1991-2#1)(1994-8#1)(2007-11#2)(2008-11#2)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
in 1000##3##2##(1997-5#1)(2008-12#1)(2008-3#1)
in 102 patients##3##3##(1994-9#1)(2007-11#2)
in 102##5##2##(1990-2#2)(1994-9#1)(2007-11#2)
in 103##3##2##(1991-8#1)(1994-2#1)(2011-1#1)
in 1031 healthy##2##3##(1994-12#1)(2012-3#1)
in 1031##3##2##(1994-12#2)(2012-3#1)
in 105##3##2##(1997-3#1)(2008-7#1)(2013-1#1)
in 107##2##2##(1991-3#1)(2013-1#1)
in 109##4##2##(1992-3#1)(2007-8#1)(2008-12#1)(2010-3#1)
in 11 (12%)##2##3##(1997-3#1)(2007-11#1)
in 11 cases##4##3##(1992-12#1)(1995-5#1)(2007-7#1)(2007-8#1)
in 11 of the##2##4##(2008-1#1)(2008-7#1)
in 11 of##6##3##(1991-5#1)(1992-2#1)(1994-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
in 11 out of##3##4##(2007-10#1)(2008-1#1)(2009-8#1)
in 11 patients##16##3##(1992-2#1)(1996-7#1)(1996-9#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in 11##65##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-5#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#4)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
in 11% of the##2##4##(1996-9#1)(2008-1#1)
in 11% of##3##3##(1996-9#1)(2007-8#1)(2008-1#1)
in 11%##7##2##(1996-9#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2013-1#1)
in 110##2##2##(2008-4#1)(2009-5#1)
in 112 (23##2##3##(1992-9#1)(2007-10#1)
in 112##5##2##(1990-3#1)(1992-9#1)(1995-6#1)(2007-10#1)(2013-8#1)
in 114##2##2##(1992-5#1)(2007-10#1)
in 115##2##2##(2008-1#1)(2008-7#1)
in 116##3##2##(2007-12#2)(2008-10#1)
in 12 and##2##3##(2008-12#1)(2013-8#1)
in 12 cases##3##3##(2008-3#1)(2011-2#2)
in 12 healthy##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
in 12 mg/kg males##3##4##(2008-9#3)
in 12 mg/kg##6##3##(2008-9#6)
in 12 min##2##3##(2008-10#2)
in 12 of##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
in 12 patients and##2##4##(1991-5#1)(2007-11#1)
in 12 patients with##4##4##(1993-2#1)(2006-10#2)(2008-5#1)
in 12 patients##12##3##(1990-11#1)(1991-5#1)(1993-2#1)(1994-12#1)(2006-10#2)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
in 12##69##2##(1990-11#1)(1990-9#1)(1991-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1997-5#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
in 12% of patients##3##4##(1996-1#1)(2013-1#2)
in 12% of the##4##4##(1991-9#1)(1992-9#1)(2007-8#1)(2012-3#1)
in 12% of##8##3##(1991-9#1)(1992-9#1)(1996-1#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
in 12%##12##2##(1991-9#1)(1992-9#1)(1996-1#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
in 120##5##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)
in 121##2##2##(1992-5#1)(2008-8#1)
in 122 children##2##3##(2008-12#1)(2013-1#1)
in 122##3##2##(2007-8#1)(2008-12#1)(2013-1#1)
in 128 and 256 mg/kg females##2##6##(2008-9#2)
in 128 mg/kg females and 256 mg/kg males and females##2##10##(2008-9#2)
in 128##5##2##(1990-3#1)(2008-9#4)
in 13 (15##3##3##(2008-1#3)
in 13 (65%)##2##3##(2013-8#2)
in 13 and##2##3##(1991-5#1)(1993-9#1)
in 13 cases##8##3##(1997-8#1)(2007-11#3)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)
in 13 of##5##3##(1991-11#1)(1993-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
in 13 out of##3##4##(2008-10#2)(2011-1#1)
in 13 patients with intracranial##2##5##(1995-11#1)(2008-7#1)
in 13 patients with##3##4##(1995-11#1)(2008-7#1)(2010-7#1)
in 13 patients##10##3##(1991-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-7#1)(2010-7#1)
in 13##58##2##(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
in 13% of##5##3##(1990-12#1)(1993-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
in 13%##6##2##(1990-12#1)(1993-9#1)(1997-3#1)(2008-1#1)(2011-2#1)(2012-12#1)
in 1321N1 cells##2##3##(1997-7#2)
in 1321N1##3##2##(1997-7#3)
in 137##3##2##(1993-2#1)(2008-9#1)(2011-1#1)
in 138##3##2##(1990-3#1)(1992-2#1)(1994-5#1)
in 14 and##2##3##(1994-12#1)(2008-6#1)
in 14 cases and##2##4##(1991-11#1)(2012-2#1)
in 14 cases##4##3##(1990-2#1)(1991-11#1)(2008-5#1)(2012-2#1)
in 14 cities##2##3##(2008-10#2)
in 14 of them##2##4##(1995-12#1)(2011-2#1)
in 14 of##5##3##(1991-6#1)(1995-12#1)(1995-3#1)(2008-9#1)(2011-2#1)
in 14 patients with advanced##2##5##(1991-8#1)(1992-10#1)
in 14 patients with##3##4##(1991-8#1)(1992-10#1)(1993-1#1)
in 14 patients##8##3##(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(1995-11#1)(1997-8#1)(2011-2#1)(2013-1#1)
in 14##63##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
in 14% of##2##3##(2007-11#1)(2008-7#1)
in 14-3-3 proteins and##2##4##(2008-11#2)
in 142 patients##2##3##(2007-1#1)(2008-9#1)
in 142##3##2##(1990-2#1)(2007-1#1)(2008-9#1)
in 144##3##2##(1992-6#1)(2008-5#1)(2010-7#1)
in 145##2##2##(1990-3#1)(2012-12#1)
in 147##2##2##(2011-2#1)(2012-12#1)
in 149##2##2##(2008-10#1)(2011-1#1)
in 15 cases##3##3##(1994-7#1)(2008-7#1)(2011-2#1)
in 15 healthy##2##3##(2008-5#1)(2013-1#1)
in 15 min##3##3##(1992-2#1)(2008-10#1)(2009-8#1)
in 15 of##2##3##(1990-8#1)(2008-10#1)
in 15 out of##2##4##(1990-6#1)(2008-10#1)
in 15 patients with##3##4##(1990-2#1)(1990-9#1)(1991-9#1)
in 15 patients##11##3##(1990-2#2)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
in 15 s##2##3##(2008-10#1)(2008-5#1)
in 15##54##2##(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in 15% of the##2##4##(2008-1#1)(2008-10#1)
in 15% of##5##3##(1993-9#1)(1995-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
in 15%##11##2##(1993-9#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
in 150 mM##2##3##(1991-5#1)(1994-5#1)
in 150##5##2##(1991-11#1)(1991-5#1)(1994-5#1)(2008-5#1)(2009-10#1)
in 151 patients##2##3##(1990-9#1)(2011-1#1)
in 152##2##2##(2011-2#1)(2012-3#1)
in 154##2##2##(2008-5#1)(2013-8#1)
in 155##2##2##(2008-10#1)(2011-1#1)
in 156##3##2##(1996-6#1)(2011-2#2)
in 16 cases##2##3##(1990-2#1)(2007-11#1)
in 16 different##2##3##(1990-2#1)(2010-3#1)
in 16 h##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
in 16 healthy##2##3##(1996-7#1)(2013-8#1)
in 16 of##4##3##(1994-1#1)(2007-2#1)(2008-10#1)(2011-2#1)
in 16 out of##2##4##(1991-2#1)(1994-6#1)
in 16 patients with##4##4##(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
in 16 patients##7##3##(1997-8#1)(2007-11#1)(2008-5#1)(2010-1#1)(2011-2#2)(2013-8#1)
in 16##52##2##(1990-10#1)(1990-2#2)(1991-2#1)(1991-6#2)(1994-1#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-8#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
in 16% of the cases##2##5##(1997-8#1)(2008-5#1)
in 16% of##3##3##(1993-12#1)(1997-8#1)(2008-5#1)
in 16%##8##2##(1993-12#1)(1996-9#1)(1997-8#1)(2007-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
in 160##3##2##(2007-7#1)(2008-7#1)(2013-1#1)
in 162##2##2##(1992-9#1)(2008-8#1)
in 163##2##2##(2010-7#1)(2011-2#1)
in 166##2##2##(1991-5#1)(2008-10#1)
in 169##2##2##(2008-5#1)(2012-12#1)
in 16th-century##2##2##(2008-11#2)
in 17 (8##2##3##(2008-1#1)(2011-2#1)
in 17 cases##3##3##(1994-9#1)(2007-11#1)(2008-6#1)
in 17 out of##2##4##(2008-6#1)(2009-8#1)
in 17 patients##11##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#1)(1994-7#1)(1996-7#1)(2008-1#1)(2008-6#1)(2008-7#2)(2011-2#1)
in 17##42##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1993-10#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-5#2)(1996-11#1)(1996-7#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#3)(2009-8#1)(2010-3#1)(2011-2#4)
in 17% of##3##3##(1991-11#1)(1996-3#1)(2013-1#1)
in 17%##4##2##(1991-11#1)(1996-3#1)(2010-9#1)(2013-1#1)
in 171##2##2##(1996-8#1)(2012-3#1)
in 1760##2##2##(2011-2#1)(2013-1#1)
in 177##2##2##(2009-4#1)(2012-1#1)
in 178##2##2##(1990-3#1)(2011-2#1)
in 18 cases##3##3##(1990-12#1)(2007-11#1)(2007-8#1)
in 18 out of##2##4##(2009-8#1)(2011-2#1)
in 18 patients and##2##4##(2008-4#1)(2008-7#1)
in 18 patients with##2##4##(1991-4#1)(1996-5#1)
in 18 patients##12##3##(1990-3#1)(1991-4#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
in 18 subjects##2##3##(1995-5#1)(1996-6#1)
in 18##47##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
in 18% of the##2##4##(1990-2#1)(2008-10#1)
in 18% of##4##3##(1990-2#1)(1993-8#1)(2008-10#1)(2013-1#1)
in 18- and##2##3##(2012-12#2)
in 180##2##2##(2007-7#1)(2008-10#1)
in 1808##2##2##(1991-6#1)(2012-2#1)
in 184##4##2##(1993-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
in 1864##2##2##(1993-3#1)(2008-6#1)
in 187 patients##2##3##(1990-6#1)(2007-11#1)
in 187##4##2##(1990-6#1)(1993-3#1)(2007-11#1)(2011-2#1)
in 1888 to##2##3##(2012-2#2)
in 1888##4##2##(2012-2#4)
in 19 and##2##3##(1992-8#1)(2008-7#1)
in 19 cases##5##3##(1990-2#1)(1991-11#1)(2007-8#1)(2008-6#1)(2011-2#1)
in 19 countries##2##3##(2011-2#1)(2013-8#1)
in 19 of the##2##4##(2011-2#2)
in 19 of##3##3##(1990-8#1)(2011-2#2)
in 19 patients##3##3##(1991-6#1)(1996-11#1)(2013-1#1)
in 19##38##2##(1990-2#1)(1990-8#2)(1991-11#1)(1991-6#2)(1992-8#1)(1994-2#1)(1994-7#1)(1996-11#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
in 19%##3##2##(1992-5#1)(2007-10#1)(2008-7#1)
in 1902##2##2##(2008-10#1)(2010-1#1)
in 1913##2##2##(2007-8#1)(2011-2#1)
in 1918##2##2##(2010-1#1)(2010-5#1)
in 1918-1919##2##2##(2011-2#2)
in 192##4##2##(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
in 1921##3##2##(1991-3#1)(2011-2#2)
in 1926##2##2##(2010-8#1)(2012-2#1)
in 1928##2##2##(2007-5#1)(2008-10#1)
in 1944##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
in 1949##2##2##(2008-10#1)(2008-7#1)
in 1952##2##2##(1997-1#1)(2007-12#1)
in 1954##3##2##(2007-7#1)(2008-12#1)(2010-8#1)
in 1955##3##2##(1994-3#1)(2009-7#1)(2010-3#1)
in 1956##3##2##(1996-1#1)(2008-10#2)
in 1957##3##2##(2007-5#1)(2008-3#1)(2008-9#1)
in 1958##3##2##(2008-9#1)(2009-7#1)(2012-12#1)
in 1960 to##2##3##(2009-4#1)(2011-2#1)
in 1960##4##2##(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)
in 1962##2##2##(1996-8#1)(2008-10#1)
in 1964##5##2##(1992-6#1)(1995-1#1)(2007-8#1)(2008-9#1)(2012-2#1)
in 1965##5##2##(1992-6#1)(2007-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
in 1966##3##2##(1990-3#1)(2008-10#1)(2010-8#1)
in 1967##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
in 1968##2##2##(2008-9#1)(2009-4#1)
in 1969##2##2##(1991-12#1)(1995-2#1)
in 1970 and##2##3##(1990-12#1)(1997-4#1)
in 1970 to##2##3##(1994-9#1)(1997-4#1)
in 1970##11##2##(1990-12#1)(1991-12#2)(1994-9#1)(1997-4#2)(1997-5#1)(2008-5#1)(2009-4#2)(2010-8#1)
in 1972##6##2##(1991-12#1)(1991-9#1)(2008-10#1)(2010-3#1)(2010-8#1)(2013-1#1)
in 1975##6##2##(1992-6#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
in 1976##3##2##(2008-10#2)(2008-6#1)
in 1977 and##2##3##(1993-12#1)(2010-3#1)
in 1977 to##2##3##(2008-8#1)(2011-1#1)
in 1977##4##2##(1993-12#1)(2008-8#1)(2010-3#1)(2011-1#1)
in 1978 by##2##3##(1990-6#1)(2008-5#1)
in 1978##9##2##(1990-6#1)(1991-12#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#1)
in 1979##5##2##(1990-6#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-3#1)
in 1980 and##2##3##(1990-2#1)(1990-3#1)
in 1980##6##2##(1990-2#1)(1990-3#1)(2007-5#1)(2008-10#1)(2009-4#2)
in 1981##7##2##(1992-8#1)(1994-1#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-12#1)
in 1982 and##3##3##(1991-3#1)(2007-8#1)(2011-2#1)
in 1982##12##2##(1990-12#1)(1991-3#2)(1993-1#1)(1994-9#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
in 1983##12##2##(1990-3#2)(1991-12#1)(1991-3#1)(1995-2#1)(2007-11#1)(2008-10#3)(2010-10#1)(2011-1#1)(2011-2#1)
in 1983-84##2##2##(1991-2#1)(2008-5#1)
in 1984 and##3##3##(1991-7#1)(1993-1#1)(1996-11#1)
in 1984##15##2##(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-5#2)(1997-6#1)(2008-7#1)
in 1985##13##2##(1990-3#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-4#1)(2012-1#1)
in 1986 and##4##3##(1990-3#1)(1991-2#1)(1994-6#1)(2008-10#1)
in 1986 to##5##3##(1990-3#1)(1992-2#1)(1993-3#1)(1996-11#1)(2008-10#1)
in 1986##28##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-2#2)(1992-2#2)(1992-5#1)(1993-3#1)(1993-8#2)(1994-2#2)(1994-6#2)(1996-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#1)
in 1987 and##2##3##(1997-6#1)(2011-2#1)
in 1987 by##2##3##(1990-6#1)(1991-3#1)
in 1987##16##2##(1990-2#3)(1990-6#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1997-6#1)(2007-5#1)(2008-1#1)(2008-5#1)(2011-2#1)(2011-3#1)
in 1988 the##2##3##(1991-8#1)(1997-4#1)
in 1988 to##3##3##(1995-6#1)(1997-6#1)(2008-10#1)
in 1988##33##2##(1990-2#1)(1990-3#2)(1990-6#3)(1991-3#5)(1991-6#1)(1991-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
in 1989 and 1991##2##4##(1992-4#1)(1995-1#1)
in 1989 and##4##3##(1992-2#1)(1992-4#1)(1995-1#2)
in 1989 to##4##3##(1995-1#1)(1995-3#1)(1996-3#1)(2008-10#1)
in 1989##33##2##(1990-3#1)(1990-6#4)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-4#3)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#3)(1995-3#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-10#3)(2008-11#1)
in 1989]##2##2##(1990-6#1)(1990-9#1)
in 199##2##2##(1994-12#1)(2008-9#1)
in 1990 and##8##3##(1991-11#1)(1991-12#1)(1993-2#1)(1994-2#1)(1995-12#1)(2008-10#2)(2009-4#1)
in 1990 in##2##3##(1992-3#1)(1996-6#1)
in 1990 to##6##3##(1992-2#2)(1994-9#1)(2007-2#2)(2008-11#1)
in 1990##40##2##(1991-11#2)(1991-12#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-4#2)(2013-8#1)
in 1990-93##2##2##(1995-6#1)(1996-7#1)
in 1991 and 1992##2##4##(2008-10#2)
in 1991 and##8##3##(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)
in 1991 to##5##3##(1994-9#1)(1996-1#1)(2008-10#1)(2009-11#1)(2010-12#1)
in 1991##37##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-6#1)(1993-8#2)(1994-1#3)(1994-12#1)(1994-3#1)(1994-9#3)(1995-1#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-11#1)(2010-12#1)(2011-2#1)
in 1991-92##2##2##(1996-1#2)
in 1992 and 1993##5##4##(1994-11#1)(2008-10#4)
in 1992 and##6##3##(1994-11#1)(1996-2#1)(2008-10#4)
in 1992 there##2##3##(1993-8#2)
in 1992##44##2##(1992-2#1)(1993-11#2)(1993-6#1)(1993-8#5)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)
in 1992-93##2##2##(1994-3#1)(1994-9#1)
in 1993 and##3##3##(1996-3#2)(1996-6#1)
in 1993 were##2##3##(1997-4#1)(2008-10#1)
in 1993##29##2##(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#9)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
in 1994 and 1995##5##4##(1996-3#1)(2008-10#4)
in 1994 and##8##3##(1996-3#1)(2008-10#5)(2008-11#1)(2009-9#1)
in 1994 to##2##3##(1996-7#1)(2011-2#1)
in 1994##35##2##(1992-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-5#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#1)
in 1995 and 1996##6##4##(2008-10#6)
in 1995 and##11##3##(2007-6#1)(2008-10#7)(2008-7#1)(2010-5#1)(2012-2#1)
in 1995 in##2##3##(2008-10#2)
in 1995##42##2##(1992-2#1)(1992-6#1)(1994-6#1)(1995-12#1)(1996-11#3)(1996-12#3)(1996-7#1)(1997-3#1)(2007-1#1)(2007-6#4)(2008-10#16)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
in 1995)##2##2##(1996-11#1)(2008-10#1)
in 1996 and 1997##6##4##(2008-10#6)
in 1996 and##13##3##(2006-8#1)(2007-6#1)(2008-10#10)(2008-2#1)
in 1996 in##2##3##(1997-6#1)(2008-11#1)
in 1996 were##2##3##(1997-6#1)(2008-10#1)
in 1996##36##2##(1997-5#1)(1997-6#4)(2006-8#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)
in 1997 and 1998##7##4##(2008-10#6)(2008-5#1)
in 1997 and##12##3##(2008-10#9)(2008-11#1)(2008-5#1)(2009-12#1)
in 1997 but##2##3##(2008-10#2)
in 1997 to##2##3##(2008-10#2)
in 1997 were##2##3##(2008-10#2)
in 1997##58##2##(1994-12#1)(1996-3#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2009-12#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#2)
in 1997-1998##2##2##(2008-12#1)(2011-2#1)
in 1998 and 1999##3##4##(2008-10#3)
in 1998 and##6##3##(2008-10#5)(2012-12#1)
in 1998 to##3##3##(2008-1#1)(2008-10#2)
in 1998 when##2##3##(2008-10#1)(2008-5#1)
in 1998##42##2##(2007-11#1)(2008-1#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)
in 1999 and 2000##3##4##(2008-10#3)
in 1999 and##6##3##(2007-2#1)(2008-10#4)(2008-5#1)
in 1999 by the##2##4##(2008-7#2)
in 1999 by##3##3##(2008-7#2)(2008-9#1)
in 1999 to 2000##3##4##(2008-10#3)
in 1999 to##4##3##(2008-10#3)(2010-5#1)
in 1999##33##2##(2006-10#2)(2007-2#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
in 1M HCl##2##3##(2008-10#2)
in 1mg dried##2##3##(2008-10#2)
in 2 M##3##3##(2008-10#3)
in 2 and##6##3##(1990-6#1)(1993-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-1#1)
in 2 cases for##2##4##(1991-6#2)
in 2 cases##17##3##(1990-9#1)(1991-11#1)(1991-6#2)(1992-12#1)(1993-2#1)(1993-9#1)(1994-9#2)(1996-6#1)(2007-8#1)(2008-11#1)(2009-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
in 2 min##2##3##(1992-3#1)(2008-10#1)
in 2 of the##2##4##(1996-12#1)(2009-1#1)
in 2 of##8##3##(1990-10#1)(1990-8#1)(1992-5#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-1#1)
in 2 out of##4##4##(1990-6#1)(2008-5#2)(2010-2#1)
in 2 patients and##3##4##(2006-10#2)(2007-8#1)
in 2 patients##24##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1992-6#1)(1993-3#1)(1997-4#1)(2006-10#2)(2007-11#6)(2007-8#3)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
in 2 species##2##3##(2008-5#1)(2010-3#1)
in 2 weeks##2##3##(1997-8#1)(2010-11#1)
in 2 years##5##3##(2007-8#1)(2008-10#4)
in 2##134##2##(1990-10#2)(1990-12#3)(1990-6#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-9#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-8#2)(2006-10#4)(2007-10#1)(2007-11#11)(2007-12#3)(2007-2#1)(2007-8#9)(2008-1#2)(2008-10#16)(2008-11#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#2)
in 2%##6##2##(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)
in 2-##2##2##(1997-2#1)(2008-4#1)
in 2-3##3##2##(1990-6#1)(2008-10#1)(2008-12#1)
in 2-5##2##2##(1993-9#1)(2008-11#1)
in 2-HPbetaCD##3##2##(2008-11#3)
in 2-VO rats##2##3##(1997-2#2)
in 2-VO##3##2##(1997-2#3)
in 2-month-old##3##2##(1990-7#1)(1993-12#1)(1996-12#1)
in 2-oxoglutarate levels##3##3##(1991-3#3)
in 2-year-old##4##2##(1996-2#1)(1997-9#1)(2007-10#1)(2009-5#1)
in 2/4##2##2##(2008-6#1)(2011-2#1)
in 20 and##3##3##(2008-1#1)(2008-6#1)(2013-8#1)
in 20 black##2##3##(1991-11#2)
in 20 cases##2##3##(2007-8#1)(2011-2#1)
in 20 healthy##3##3##(1995-11#1)(1996-5#1)(2008-5#1)
in 20 mM phosphate buffer##2##5##(1996-5#1)(2008-10#1)
in 20 min##4##3##(2008-10#2)(2008-5#2)
in 20 normal##2##3##(1995-12#1)(2008-6#1)
in 20 patients with chronic##2##5##(2008-1#1)(2010-4#1)
in 20 patients with##5##4##(1991-11#1)(2008-1#1)(2008-6#1)(2010-4#1)(2013-1#1)
in 20 patients##16##3##(1990-12#1)(1990-6#1)(1991-11#1)(1993-1#1)(1994-12#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-9#2)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
in 20 young##2##3##(1991-12#1)(1996-7#1)
in 20##74##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#3)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-8#5)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#5)(2008-7#3)(2008-9#3)(2009-6#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
in 20% of##2##3##(1996-3#1)(2013-1#1)
in 20%##7##2##(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2010-6#1)(2013-1#1)
in 200##7##2##(1992-11#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-1#1)
in 2000 and 2001##5##4##(2008-10#5)
in 2000 and##12##3##(2008-10#10)(2008-11#1)(2010-12#1)
in 2000 for##2##3##(2006-12#1)(2008-5#1)
in 2000 to##2##3##(2008-5#1)(2008-9#1)
in 2000##41##2##(2006-12#1)(2007-2#2)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2011-2#3)(2012-12#1)
in 2001 and 2002##5##4##(2008-10#4)(2008-12#1)
in 2001 and##6##3##(2008-10#4)(2008-12#1)(2010-8#1)
in 2001 has##2##3##(2007-8#1)(2011-2#1)
in 2001 in##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
in 2001 on leaves sprayed##2##5##(2008-10#2)
in 2001 to##4##3##(2013-8#4)
in 2001##32##2##(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-12#3)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#4)
in 2002 and 2003##4##4##(2008-10#3)(2008-11#1)
in 2002 and 2004##2##4##(2008-10#2)
in 2002 and##10##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-2#1)
in 2002 to##2##3##(2012-12#1)(2013-7#1)
in 2002##29##2##(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-7#3)
in 2003 and 2004##3##4##(2008-10#3)
in 2003 and##9##3##(2008-10#5)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
in 2003##30##2##(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#1)
in 2004 and 2005##3##4##(2008-10#2)(2008-12#1)
in 2004 in##2##3##(2011-2#1)(2013-8#1)
in 2004##30##2##(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-5#1)(2008-9#1)(2009-12#3)(2010-12#1)(2010-8#2)(2011-2#4)(2013-1#3)(2013-8#1)
in 2005 and 2006##3##4##(2010-8#1)(2011-2#2)
in 2005 and 2008##2##4##(2011-2#1)(2012-12#1)
in 2005 and##6##3##(2008-10#1)(2010-8#1)(2011-2#3)(2012-12#1)
in 2005 but##2##3##(2011-2#1)(2012-2#1)
in 2005 to##3##3##(2012-12#2)(2013-1#1)
in 2005##41##2##(1994-2#1)(1996-2#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#8)(2012-12#6)(2012-2#1)(2013-1#3)
in 2005-2006##2##2##(2011-1#1)(2013-1#1)
in 2006 and 2007##2##4##(2009-2#1)(2011-2#1)
in 2006 and##4##3##(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
in 2006 to##2##3##(2010-4#1)(2012-12#1)
in 2006 were##2##3##(2010-3#1)(2012-3#1)
in 2006##35##2##(2008-12#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
in 2007 and##5##3##(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
in 2007##22##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
in 2008 from##2##3##(2011-2#1)(2012-2#1)
in 2008##31##2##(2009-8#2)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#6)
in 2009 and 2011##2##4##(2012-12#1)(2013-8#1)
in 2009 and##4##3##(2012-12#2)(2013-1#1)(2013-8#1)
in 2009##30##2##(2010-11#1)(2011-2#7)(2012-12#9)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#3)
in 2010 and##3##3##(2013-1#1)(2013-8#2)
in 2010##21##2##(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#4)
in 2010]##2##2##(2012-3#1)(2013-8#1)
in 2011 (p = 0##2##5##(2012-12#2)
in 2011##10##2##(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
in 2012##5##2##(2011-4#1)(2012-12#1)(2013-7#2)(2013-8#1)
in 2020##2##2##(1991-11#1)(1992-2#1)
in 2030##2##2##(2010-8#1)(2012-1#1)
in 20min##2##2##(2008-10#2)
in 21 cases##3##3##(1990-12#1)(1991-11#1)(1991-8#1)
in 21 patients with##3##4##(2008-6#1)(2008-7#1)(2009-3#1)
in 21 patients##10##3##(1990-9#1)(1991-3#1)(1992-1#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-2#1)
in 21##35##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-3#2)(2009-8#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#2)
in 21% of the##2##4##(1996-3#1)(2008-10#1)
in 21% of##4##3##(1991-8#1)(1992-2#1)(1996-3#1)(2008-10#1)
in 21%##6##2##(1991-8#1)(1992-2#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-10#1)
in 22 and##3##3##(1991-8#1)(2007-11#1)(2008-6#1)
in 22 of##2##3##(1991-3#1)(1994-1#1)
in 22 patients with##3##4##(1991-12#1)(1997-3#1)(2013-8#1)
in 22 patients##7##3##(1991-12#1)(1992-2#1)(1997-3#1)(2007-11#1)(2008-4#1)(2008-6#1)(2013-8#1)
in 22##28##2##(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-3#1)(1997-3#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-9#1)(2010-9#1)(2011-2#4)(2012-2#2)(2013-8#2)
in 22% and##2##3##(1992-11#1)(2007-10#1)
in 22% of##2##3##(1990-3#1)(1995-11#1)
in 22%##5##2##(1990-3#1)(1992-11#1)(1995-11#1)(2007-10#1)(2010-11#1)
in 222##2##2##(1991-3#1)(2010-12#1)
in 223##2##2##(1992-6#1)(2012-1#1)
in 23 patients##3##3##(1996-12#1)(1996-6#1)(1997-7#1)
in 23##23##2##(1991-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
in 23% of the cases##2##5##(2007-7#1)(2008-8#1)
in 23% of the##3##4##(2007-7#1)(2008-7#1)(2008-8#1)
in 23% of##4##3##(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
in 23%##7##2##(1992-4#1)(2007-7#3)(2007-8#1)(2008-7#1)(2008-8#1)
in 24 and##3##3##(1994-8#1)(2008-8#1)(2013-8#1)
in 24 cases##2##3##(1993-5#1)(2011-2#1)
in 24 h##7##3##(1991-3#2)(1994-3#1)(2008-12#2)(2008-8#1)(2012-2#1)
in 24 healthy##2##3##(1996-5#1)(2008-5#1)
in 24 hours##2##3##(2011-2#1)(2012-2#1)
in 24 patients with##5##4##(1992-3#1)(1994-11#1)(1995-5#1)(2007-10#1)(2008-7#1)
in 24 patients##10##3##(1990-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-3#1)(1995-5#1)(2007-10#1)(2008-4#1)(2008-7#1)
in 24##45##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#1)
in 24%##2##2##(2007-8#1)(2012-2#1)
in 24-h urine##2##3##(1995-12#1)(2008-10#1)
in 24-h##5##2##(1995-11#3)(1995-12#1)(2008-10#1)
in 25 and##3##3##(2008-10#1)(2008-9#2)
in 25 cases##2##3##(1990-6#1)(1995-5#1)
in 25 ml##2##3##(2008-10#2)
in 25 patients##5##3##(1990-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
in 25##37##2##(1990-6#2)(1992-8#1)(1993-12#2)(1994-9#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-9#3)(2011-2#1)(2013-1#2)
in 25% and##2##3##(2011-2#2)
in 25% of cases##2##4##(2007-8#1)(2008-7#1)
in 25% of patients##2##4##(2008-8#1)(2012-12#1)
in 25% of the##2##4##(1992-6#1)(2008-11#1)
in 25% of those##2##4##(2008-1#1)(2009-5#1)
in 25% of##8##3##(1992-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#1)
in 25% to##2##3##(1994-2#1)(2007-10#1)
in 25%##18##2##(1992-6#1)(1994-2#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
in 250##4##2##(1991-1#1)(1991-5#1)(1992-11#1)(2010-5#1)
in 255 patients##2##3##(1993-9#1)(2007-7#1)
in 255##3##2##(1993-9#1)(2007-7#1)(2008-10#1)
in 256 mg/kg females were##2##5##(2008-9#2)
in 256 mg/kg males##4##4##(2008-9#4)
in 256 mg/kg##6##3##(2008-9#6)
in 256##7##2##(2008-9#6)(2010-8#1)
in 26 cases##2##3##(1990-9#1)(2007-11#1)
in 26 patients##10##3##(1991-4#1)(1992-6#1)(1994-9#2)(1997-8#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-1#2)
in 26##27##2##(1990-9#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1994-9#2)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#2)(2013-1#3)
in 26% of##2##3##(1993-2#1)(2012-12#1)
in 26%##4##2##(1993-2#1)(1997-3#1)(2007-10#1)(2012-12#1)
in 26-month-old than in younger rats##2##6##(1991-12#2)
in 26-month-old##3##2##(1991-12#3)
in 265##2##2##(1994-12#1)(2008-12#1)
in 27 cases##4##3##(1990-8#1)(1997-3#1)(1997-8#1)(2008-6#1)
in 27 patients with##2##4##(1990-11#1)(1997-3#1)
in 27 patients##4##3##(1990-11#1)(1992-9#1)(1997-3#1)(2013-1#1)
in 27##18##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-9#1)(1997-3#2)(1997-8#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-6#1)(2011-2#2)(2013-1#1)
in 27% of##3##3##(2011-1#1)(2012-1#1)(2013-1#1)
in 27%##5##2##(1997-3#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
in 28 patients##2##3##(2007-10#1)(2008-7#1)
in 28##19##2##(1990-12#1)(1990-8#1)(1991-8#1)(1994-2#1)(1994-6#1)(1996-7#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
in 28% of the##2##4##(1991-12#1)(2008-8#1)
in 28% of##3##3##(1991-12#1)(1992-12#1)(2008-8#1)
in 28%##4##2##(1991-12#1)(1992-12#1)(2007-10#1)(2008-8#1)
in 29 cases##2##3##(2008-10#1)(2008-6#1)
in 29 patients##5##3##(1991-2#1)(1997-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
in 29##29##2##(1990-8#1)(1991-2#2)(1991-8#1)(1992-3#1)(1994-3#1)(1995-11#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
in 29%##2##2##(1994-11#1)(2007-8#1)
in 293 cells and##3##4##(1992-10#1)(1995-2#1)(2008-9#1)
in 293 cells##5##3##(1992-10#2)(1995-2#1)(2008-11#1)(2008-9#1)
in 293(EBNA) cells##2##3##(2008-11#2)
in 2D##2##2##(2008-11#1)(2012-2#1)
in 3 and##2##3##(1997-8#1)(2007-2#1)
in 3 cases of##2##4##(2008-9#1)(2011-2#1)
in 3 cases##17##3##(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-4#1)(1997-8#1)(2007-11#4)(2008-10#1)(2008-9#1)(2011-2#2)(2013-8#1)
in 3 mg/kg or greater##2##5##(2008-9#2)
in 3 mg/kg##4##3##(2008-9#4)
in 3 of the##2##4##(1990-7#1)(2008-11#1)
in 3 of##9##3##(1990-7#1)(1992-2#1)(1994-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
in 3 or##2##3##(1992-8#2)
in 3 patients and##2##4##(1990-12#1)(1992-1#1)
in 3 patients##14##3##(1990-12#1)(1990-2#1)(1991-8#2)(1992-1#1)(1993-2#1)(1995-11#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2011-2#1)
in 3 with##2##3##(1990-9#2)
in 3 years and##2##4##(1994-9#1)(2008-10#1)
in 3##114##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#4)(1991-11#3)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#2)(1994-2#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#8)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
in 3% of##3##3##(1991-8#1)(1997-8#1)(2012-3#1)
in 3-D geometry##2##3##(2012-2#2)
in 3-D##7##2##(2008-10#1)(2008-11#3)(2011-1#1)(2012-2#2)
in 3-month-old##2##2##(1990-3#1)(1991-12#1)
in 3/4##2##2##(1991-4#1)(2009-2#1)
in 30 cases##2##3##(1990-2#1)(2008-4#1)
in 30 children with##2##4##(1996-1#1)(2012-2#1)
in 30 days##2##3##(2012-3#1)(2013-1#1)
in 30 fractions##2##3##(2008-10#1)(2011-2#1)
in 30 healthy##3##3##(1991-4#1)(2008-7#1)(2010-2#1)
in 30 min##6##3##(1997-4#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-3#1)
in 30 patients##8##3##(1990-6#1)(1990-8#1)(1991-3#1)(1992-8#1)(1996-6#1)(2007-7#1)(2008-4#1)(2013-1#1)
in 30##58##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-6#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
in 30% of the cases##2##5##(1990-6#1)(2008-5#1)
in 30% of the##4##4##(1990-6#1)(1992-6#1)(2008-1#1)(2008-5#1)
in 30% of##7##3##(1990-6#1)(1992-6#1)(1993-11#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-5#1)
in 30%##9##2##(1990-6#1)(1992-6#1)(1993-11#1)(1996-9#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
in 30- and 60-day STZ rats##2##6##(1991-12#2)
in 30- and##3##3##(1991-12#2)(2008-6#1)
in 30-60##2##2##(2007-11#1)(2008-10#1)
in 30-70% of##2##3##(2007-11#1)(2011-1#1)
in 301##2##2##(1997-2#1)(2008-12#1)
in 31 patients with##2##4##(2008-5#1)(2013-7#1)
in 31 patients##7##3##(1990-9#1)(1992-1#1)(2007-8#1)(2008-5#1)(2011-2#2)(2013-7#1)
in 31##17##2##(1990-6#1)(1990-9#2)(1992-1#1)(1992-8#1)(1993-9#1)(1995-11#1)(2007-8#2)(2008-1#3)(2008-5#1)(2010-12#1)(2011-2#2)(2013-7#1)
in 31% of##2##3##(1994-2#1)(2011-2#1)
in 32 cases##2##3##(1993-8#1)(2011-2#1)
in 32##19##2##(1990-11#1)(1991-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-2#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
in 32%##3##2##(1996-5#1)(1997-6#1)(2008-5#1)
in 33 children##2##3##(2011-1#1)(2012-12#1)
in 33 patients##4##3##(1997-7#1)(2007-11#1)(2007-8#1)(2013-1#1)
in 33##16##2##(1990-6#1)(1991-11#1)(1991-12#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
in 33% of the##2##4##(1992-9#1)(2008-12#1)
in 33% of##4##3##(1990-3#1)(1992-9#1)(2007-8#1)(2008-12#1)
in 33%##5##2##(1990-3#1)(1992-9#1)(2007-8#1)(2008-12#1)(2008-7#1)
in 337##2##2##(1995-4#1)(2008-3#1)
in 34 cases##2##3##(1992-5#1)(2012-3#1)
in 34 patients##2##3##(2011-2#1)(2012-2#1)
in 34##20##2##(1992-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
in 34%##2##2##(1992-11#1)(2008-4#1)
in 35 patients with##2##4##(1990-3#1)(1990-9#1)
in 35 patients##4##3##(1990-3#1)(1990-9#1)(2007-7#2)
in 35##14##2##(1990-3#1)(1990-9#1)(1991-2#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
in 35%##4##2##(1991-5#1)(2008-6#1)(2009-8#1)(2011-2#1)
in 350 and 700 mg/L males were significantly##2##8##(2008-9#2)
in 350 and 700 mg/L males##4##6##(2008-9#4)
in 350 and 700 mg/L##5##5##(2008-9#5)
in 350 and##6##3##(2008-11#1)(2008-9#5)
in 353##2##2##(1992-9#1)(1997-8#1)
in 357##2##2##(2008-12#1)(2011-1#1)
in 36 patients with##2##4##(1991-3#1)(2008-7#1)
in 36 patients##7##3##(1990-11#1)(1991-2#1)(1991-3#1)(1994-3#1)(1997-8#1)(2008-7#1)(2013-8#1)
in 36##24##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-9#1)(1994-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in 36% of##3##3##(1990-2#1)(1991-4#1)(1991-9#1)
in 36%##5##2##(1990-2#1)(1991-4#1)(1991-9#1)(2007-8#1)(2011-1#1)
in 37 and 43 degrees C##2##6##(2008-12#2)
in 37 and##3##3##(2008-12#2)(2013-8#1)
in 37 degrees C##2##4##(2008-10#1)(2008-12#1)
in 37 degrees##3##3##(1995-11#1)(2008-10#1)(2008-12#1)
in 37 patients##7##3##(1990-9#1)(1991-6#1)(1992-8#1)(1995-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
in 37##21##2##(1990-9#1)(1991-6#1)(1992-8#1)(1993-9#2)(1995-11#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-12#4)(2008-4#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
in 37% of##4##3##(1994-3#1)(1995-11#1)(2008-7#1)(2013-8#1)
in 37%##7##2##(1994-3#1)(1995-11#1)(1996-5#1)(2008-7#2)(2011-2#1)(2013-8#1)
in 38 patients##4##3##(1990-3#1)(2007-11#1)(2008-5#1)(2008-7#1)
in 38##19##2##(1990-3#1)(1991-11#1)(1991-2#1)(1994-1#1)(1995-8#1)(1996-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
in 38% and##2##3##(1991-8#1)(2007-7#1)
in 38% of##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
in 38%##6##2##(1991-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
in 39 out of##2##4##(2007-7#1)(2008-10#1)
in 39 patients##3##3##(1997-2#1)(2008-3#1)(2013-1#1)
in 39##17##2##(1993-9#2)(1997-2#1)(1997-8#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
in 3D##8##2##(2008-11#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
in 3MC-induced##2##2##(1994-8#2)
in 3T3##2##2##(1993-8#1)(1994-8#1)
in 3T3-L1 adipocytes and##2##4##(1995-8#2)
in 3T3-L1 adipocytes##8##3##(1991-12#3)(1993-8#1)(1995-8#4)
in 3T3-L1##9##2##(1991-12#3)(1993-8#1)(1995-8#4)(2008-3#1)
in 4 cases##11##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(2007-11#1)(2008-11#1)(2011-2#4)(2013-8#1)
in 4 groups##3##3##(1991-2#1)(2007-11#1)(2011-2#1)
in 4 h##2##3##(1991-5#1)(2008-10#1)
in 4 min##2##3##(2008-10#2)
in 4 out of 10##2##5##(2008-1#1)(2008-10#1)
in 4 out of##3##4##(1997-7#1)(2008-1#1)(2008-10#1)
in 4 patients and##2##4##(1992-5#1)(1997-8#1)
in 4 patients with##3##4##(1990-8#1)(1997-4#1)(2013-1#1)
in 4 patients##23##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-5#1)(1993-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#2)
in 4 sheep breeds from##2##5##(2011-1#2)
in 4##101##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#4)(2007-10#2)(2007-11#7)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#4)(2011-2#10)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
in 4% of the patients##2##5##(2008-10#2)
in 4% of the##4##4##(2008-10#2)(2008-4#1)(2013-8#1)
in 4%##6##2##(2008-10#4)(2008-4#1)(2013-8#1)
in 4/15 cases (26##2##4##(2008-10#2)
in 40 cases##2##3##(1997-3#1)(2008-7#1)
in 40 h##2##3##(2008-6#1)(2008-7#1)
in 40 of##2##3##(1990-8#1)(2008-10#1)
in 40 patients##3##3##(1991-3#1)(1997-8#1)(2007-10#1)
in 40##25##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1994-6#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2012-2#1)(2013-8#1)
in 40% cases##2##3##(2007-8#1)(2010-7#1)
in 40% of patients##2##4##(2008-10#1)(2012-2#1)
in 40% of the##2##4##(1991-11#1)(2009-8#1)
in 40% of##6##3##(1991-11#1)(1991-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
in 40%##11##2##(1991-11#1)(1991-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-7#1)(2012-2#2)
in 400 and 800 mg/L females at 27 weeks##2##9##(2008-9#2)
in 400 and 800 mg/L females##3##6##(2008-9#3)
in 400 and 800 mg/L##4##5##(2008-9#4)
in 400 and 800##5##4##(2008-9#5)
in 400##8##2##(2008-11#1)(2008-9#7)
in 41 cases##2##3##(1990-2#1)(2007-11#1)
in 41 patients##3##3##(2007-10#1)(2007-11#1)(2007-7#1)
in 41##11##2##(1990-2#1)(1991-12#1)(1994-9#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-10#2)(2008-6#1)
in 42 different##2##3##(1990-3#1)(2008-10#1)
in 42 patients with##3##4##(1990-9#1)(1992-6#1)(2013-1#1)
in 42 patients##5##3##(1990-9#1)(1992-6#1)(2013-1#2)(2013-8#1)
in 42##12##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-8#2)(2013-1#2)(2013-8#1)
in 42% of##2##3##(2008-9#1)(2011-2#1)
in 42%##5##2##(1997-3#1)(2008-8#2)(2008-9#1)(2011-2#1)
in 429##2##2##(1996-8#2)
in 43 days##2##3##(2008-11#1)(2008-12#1)
in 43##10##2##(1992-5#1)(1994-6#1)(1996-6#1)(2008-11#1)(2008-12#2)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
in 43% of patients##2##4##(2008-1#1)(2008-9#1)
in 43% of##3##3##(1990-6#1)(2008-1#1)(2008-9#1)
in 43%##5##2##(1990-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
in 44 cases##2##3##(1990-12#1)(2013-8#1)
in 44##16##2##(1990-12#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-5#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
in 44% of the##3##4##(1990-9#1)(1992-2#1)(2008-10#1)
in 44% of##5##3##(1990-9#1)(1992-2#1)(1993-8#1)(2008-10#1)(2011-1#1)
in 44%##7##2##(1990-9#1)(1992-11#1)(1992-2#1)(1993-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
in 45 cases##2##3##(2007-11#1)(2009-8#1)
in 45 degrees##2##3##(2008-10#1)(2008-8#1)
in 45 of##2##3##(1994-1#2)
in 45##15##2##(1990-9#1)(1991-11#1)(1993-6#1)(1994-1#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-8#1)(2011-1#1)
in 45% of the##2##4##(1991-2#1)(1995-6#1)
in 46##8##2##(1991-3#1)(1991-6#1)(1992-3#1)(1996-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2012-2#1)
in 46% of the##2##4##(1993-12#1)(2010-4#1)
in 46% of##3##3##(1993-12#1)(2010-12#1)(2010-4#1)
in 46%##4##2##(1990-9#1)(1993-12#1)(2010-12#1)(2010-4#1)
in 47 cases##2##3##(2007-11#1)(2007-8#1)
in 47 patients##2##3##(1992-5#1)(1995-12#1)
in 47##14##2##(1992-5#1)(1995-12#1)(1997-2#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-8#2)(2010-12#1)(2011-2#1)
in 47% of the patients##2##5##(1990-8#1)(2008-1#1)
in 47% of the##3##4##(1990-8#1)(2008-1#1)(2008-10#1)
in 47% of##5##3##(1990-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)
in 47%##6##2##(1990-8#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)
in 48 h##3##3##(1994-2#1)(2008-12#1)(2008-6#1)
in 48 patients##3##3##(2008-5#1)(2008-7#2)
in 48##18##2##(1990-6#1)(1991-3#1)(1994-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#3)(2012-3#2)(2013-1#1)
in 48%##2##2##(2007-8#1)(2008-5#1)
in 49 patients##2##3##(1990-8#1)(2008-1#1)
in 49##9##2##(1990-8#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-3#1)
in 49%##3##2##(1997-6#1)(2008-4#1)(2011-2#1)
in 5 Hz CPT##2##4##(2006-12#2)
in 5 Hz##3##3##(2006-12#2)(2008-12#1)
in 5 and##2##3##(2007-10#1)(2011-2#1)
in 5 cases and##2##4##(1990-6#1)(1995-4#1)
in 5 cases##9##3##(1990-2#1)(1990-6#1)(1991-11#1)(1993-2#1)(1995-4#1)(2007-11#2)(2007-8#1)(2011-2#1)
in 5 min##2##3##(2008-10#2)
in 5 ml of the final DMF solution##2##8##(2008-10#2)
in 5 ml of##5##4##(2008-10#5)
in 5 ml##6##3##(1996-12#1)(2008-10#5)
in 5 of 7##2##4##(2006-10#1)(2008-7#1)
in 5 of the##4##4##(1997-7#1)(2011-2#2)(2012-12#1)
in 5 of##11##3##(1992-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-12#1)
in 5 patients and##2##4##(1990-12#1)(2007-11#1)
in 5 patients##15##3##(1990-12#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-2#1)(1994-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2011-1#1)(2011-2#2)(2012-2#2)
in 5 year##2##3##(1990-6#1)(1997-8#1)
in 5##96##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#2)(1991-11#2)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-6#1)(1994-11#3)(1994-12#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#3)(2006-12#2)(2007-1#1)(2007-10#3)(2007-11#7)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-2#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#3)(2013-1#2)
in 5% and##2##3##(1996-12#1)(1996-3#1)
in 5% of##2##3##(2008-10#1)(2008-9#1)
in 5%##10##2##(1996-12#1)(1996-3#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-9#1)
in 5' upstream##2##3##(2008-9#2)
in 5'##3##2##(1993-6#1)(2008-9#2)
in 5-10 ml##2##3##(1994-9#1)(2008-10#1)
in 5-6##2##2##(1990-7#1)(2008-10#1)
in 5-HT##3##2##(1997-6#1)(2008-2#1)(2008-5#1)
in 5-HT-induced proliferation of rat##3##5##(2011-3#3)
in 5-HT1A##2##2##(1993-9#2)
in 5-HTT sites##2##3##(1995-5#2)
in 5/14##2##2##(1990-2#1)(1992-9#1)
in 5/28##2##2##(2008-6#1)(2012-12#1)
in 50 patients with##3##4##(1990-12#1)(2008-5#1)(2008-7#1)
in 50 patients##7##3##(1990-12#1)(1991-2#1)(1997-3#1)(2008-5#1)(2008-7#2)(2009-3#1)
in 50##36##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-2#1)(1993-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#2)(2011-2#1)(2012-12#1)(2012-3#1)
in 50% of cases with##2##5##(1991-2#1)(1997-3#1)
in 50% of cases##3##4##(1991-2#1)(1997-3#1)(2007-8#1)
in 50% of patients##3##4##(2008-9#1)(2011-2#1)(2012-2#1)
in 50% of the##3##4##(1990-2#1)(2007-12#1)(2008-1#1)
in 50% of##14##3##(1990-2#1)(1991-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
in 50%##28##2##(1990-2#1)(1991-2#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in 500##3##2##(2007-7#1)(2008-9#2)
in 5000##3##2##(1990-9#1)(2008-4#1)(2008-8#1)
in 503##2##2##(2008-10#1)(2012-3#1)
in 51 patients##3##3##(1995-3#1)(2008-7#1)(2011-2#1)
in 51##11##2##(1990-9#1)(1991-11#1)(1991-6#1)(1993-12#1)(1993-2#1)(1995-3#1)(2008-12#1)(2008-7#1)(2011-2#3)
in 52##10##2##(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
in 53##10##2##(1993-12#1)(1995-2#1)(1997-3#1)(2007-7#2)(2007-8#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
in 53% of the##2##4##(1995-6#1)(2008-4#1)
in 53%##5##2##(1994-5#2)(1995-6#1)(1996-3#1)(2008-4#1)
in 54 patients##5##3##(1991-11#1)(1992-5#1)(1997-3#1)(2008-4#1)(2013-1#1)
in 54##13##2##(1991-11#1)(1992-5#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
in 54%##3##2##(1992-2#1)(1997-3#1)(2008-6#1)
in 55 patients##2##3##(2006-6#1)(2008-12#1)
in 55##10##2##(1991-11#1)(1994-6#1)(1995-4#1)(1996-9#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#1)
in 55%##2##2##(2010-11#1)(2013-1#1)
in 56 patients##3##3##(2007-11#1)(2007-8#1)(2012-12#1)
in 56##10##2##(1993-12#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in 56% of##4##3##(1990-10#1)(2007-12#1)(2007-7#1)(2008-10#1)
in 56%##7##2##(1990-10#1)(1990-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
in 57 patients##4##3##(1993-1#1)(2008-4#1)(2008-7#1)(2012-3#1)
in 57##10##2##(1990-3#1)(1993-1#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-3#2)(2013-8#1)
in 58 patients##2##3##(2008-1#1)(2008-7#1)
in 58##15##2##(1990-2#1)(1994-7#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in 58% of##2##3##(1992-9#1)(1994-8#1)
in 58%##3##2##(1992-9#1)(1994-8#1)(2008-11#1)
in 59##8##2##(1992-1#1)(1996-12#1)(1997-8#1)(2007-11#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
in 59%##2##2##(2012-1#1)(2012-12#1)
in 5HT2A receptor density##2##4##(1996-7#2)
in 6 M HCl##2##4##(2008-10#2)
in 6 and 12 mg/kg males and##3##7##(2008-9#3)
in 6 and##5##3##(1990-6#1)(1994-9#1)(2008-9#3)
in 6 cases##7##3##(1991-1#1)(1992-12#1)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
in 6 different##2##3##(2012-3#1)(2013-1#1)
in 6 of the##3##4##(1990-3#2)(2008-12#1)
in 6 of##8##3##(1990-3#2)(1994-1#1)(1994-9#1)(1997-3#1)(2006-10#1)(2008-12#1)(2008-7#1)
in 6 out of##3##4##(1992-5#1)(2008-12#2)
in 6 patients##14##3##(1990-12#1)(1991-3#1)(1994-12#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
in 6 to##2##3##(1995-1#1)(1997-3#1)
in 6% of##2##3##(1991-3#1)(2008-1#1)
in 6%##5##2##(1990-9#1)(1991-3#1)(1993-2#1)(2008-1#1)(2013-7#1)
in 6-hydroxydopamine-treated mice##4##3##(1995-12#4)
in 6/8##2##2##(2008-8#1)(2010-1#1)
in 60 patients treated##2##4##(1991-6#1)(2012-2#1)
in 60 patients##8##3##(1991-6#1)(1992-2#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-4#1)(2012-2#1)
in 60##20##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1994-7#1)(1996-11#1)(1996-7#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-7#1)
in 60% methanol##2##3##(1995-3#2)
in 60% of cases##2##4##(1993-9#1)(2013-1#1)
in 60% of the##3##4##(1993-2#1)(1994-2#1)(2008-5#1)
in 60% of##11##3##(1993-2#1)(1993-9#1)(1994-2#1)(1996-9#1)(2007-7#1)(2008-5#1)(2008-7#2)(2011-2#2)(2013-1#1)
in 60%##16##2##(1993-1#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-3#2)(1996-9#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
in 61 patients##3##3##(1991-11#1)(1994-12#1)(2008-1#1)
in 61##8##2##(1991-11#1)(1994-11#1)(1994-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2013-8#1)
in 61%##2##2##(1993-9#1)(1996-5#1)
in 62##8##2##(1991-11#1)(1991-3#1)(1993-1#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
in 62% of##2##3##(1993-12#1)(2007-10#1)
in 62%##3##2##(1990-8#1)(1993-12#1)(2007-10#1)
in 63##9##2##(1990-6#1)(1991-3#1)(1994-1#1)(1994-2#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-6#1)(2012-2#1)
in 63% of##2##3##(1990-9#1)(1995-8#1)
in 64##10##2##(1991-12#1)(1992-5#1)(1994-5#1)(1996-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in 64%##5##2##(1996-2#1)(2007-10#2)(2008-4#1)(2012-2#1)
in 65 patients##2##3##(1991-8#1)(2007-7#1)
in 65##7##2##(1991-8#1)(1996-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2011-1#1)
in 65% of##2##3##(2008-10#1)(2013-1#1)
in 65%##4##2##(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
in 66 patients##3##3##(2007-11#1)(2007-8#1)(2008-4#1)
in 66 subjects##2##3##(1990-8#1)(2008-3#1)
in 66##10##2##(1990-2#1)(1990-8#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#1)(2010-3#1)(2011-1#1)
in 66%##2##2##(1997-3#1)(2013-1#1)
in 67##3##2##(1996-2#1)(2008-10#1)(2010-8#1)
in 67% of the##2##4##(2007-7#1)(2008-10#1)
in 67% of##3##3##(1990-3#1)(2007-7#1)(2008-10#1)
in 68##7##2##(1991-3#1)(1993-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
in 68%##2##2##(1997-3#1)(2012-1#1)
in 69 patients##2##3##(2007-11#1)(2007-8#1)
in 69##9##2##(1990-11#1)(1993-2#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-6#1)(2009-9#1)
in 7 (6##3##3##(1997-8#2)(2007-8#1)
in 7 cases##11##3##(1991-11#1)(1991-6#1)(1992-5#1)(1996-2#1)(1997-8#1)(2007-11#2)(2007-8#1)(2009-6#2)(2013-8#1)
in 7 of 11##2##4##(2008-10#1)(2011-2#1)
in 7 of##4##3##(2008-10#2)(2011-2#2)
in 7 out of##2##4##(1992-8#1)(2008-7#1)
in 7 patients and##4##4##(1991-2#1)(1991-4#1)(1993-2#1)(2011-2#1)
in 7 patients with##2##4##(1993-11#1)(2012-12#1)
in 7 patients##18##3##(1990-2#1)(1991-2#1)(1991-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(2007-11#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
in 7##64##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#3)(2006-10#1)(2007-11#7)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-6#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
in 7% and##2##3##(2008-7#2)
in 7% of##3##3##(1990-3#1)(2008-4#1)(2013-1#1)
in 7%##12##2##(1990-3#1)(1991-1#1)(1994-12#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-1#1)
in 7-day-old##2##2##(1994-6#1)(1996-12#1)
in 7/8##2##2##(1991-12#1)(2011-2#1)
in 70##8##2##(1991-3#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
in 70% of the##2##4##(1991-3#1)(2008-7#1)
in 70% of##6##3##(1990-6#1)(1991-12#1)(1991-3#1)(1997-6#1)(2008-4#1)(2008-7#1)
in 70%##8##2##(1990-6#1)(1991-12#1)(1991-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
in 70/30 ethanol/water at 50 degrees C##2##7##(2009-9#2)
in 70/30 ethanol/water##3##3##(2009-9#3)
in 700 mg/L females were##2##5##(2008-9#2)
in 700 mg/L males were##2##5##(2008-9#2)
in 700 mg/L##4##3##(2008-9#4)
in 704 var##2##3##(2008-12#2)
in 704 variety##2##3##(2008-12#2)
in 704##5##2##(2008-12#5)
in 71 patients##2##3##(2007-11#1)(2008-1#1)
in 71##4##2##(1994-7#1)(2007-11#1)(2008-1#1)(2008-10#1)
in 71% of the##2##4##(1992-11#1)(1994-6#1)
in 71%##3##2##(1992-11#1)(1994-6#1)(2013-1#1)
in 72 h##2##3##(2008-12#2)
in 72##11##2##(1993-1#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-7#1)(1997-8#1)(2008-12#2)(2008-6#1)(2011-1#1)(2011-2#1)
in 73##7##2##(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2010-7#1)
in 73% of the##2##4##(2007-7#1)(2008-12#1)
in 73% of##3##3##(2007-7#1)(2008-1#1)(2008-12#1)
in 73%##4##2##(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)
in 74 patients##2##3##(1991-4#1)(2013-7#1)
in 74##4##2##(1991-4#1)(2008-7#1)(2013-1#1)(2013-7#1)
in 75 patients##2##3##(2007-7#1)(2011-2#1)
in 75##6##2##(1994-12#1)(2007-7#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
in 75% of patients##2##4##(1990-3#1)(1993-6#1)
in 75% of##7##3##(1990-3#1)(1992-4#1)(1993-6#1)(1994-6#1)(2008-5#1)(2012-2#1)(2013-1#1)
in 75%##8##2##(1990-3#1)(1992-4#1)(1993-6#1)(1994-6#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
in 76##4##2##(1997-8#1)(2007-7#1)(2011-2#1)(2012-3#1)
in 76% of##3##3##(1994-11#1)(1994-2#1)(2007-10#1)
in 76%##4##2##(1994-11#1)(1994-2#1)(2007-10#1)(2008-7#1)
in 77##5##2##(1990-3#1)(1990-6#1)(2009-3#1)(2011-2#2)
in 77%##3##2##(1991-2#1)(2008-6#1)(2012-3#1)
in 770##2##2##(1990-3#1)(2013-1#1)
in 78##5##2##(1992-9#1)(1996-3#1)(2008-1#1)(2008-12#1)(2010-11#1)
in 78%##2##2##(1992-11#1)(2007-10#1)
in 79%##2##2##(1992-2#1)(2011-1#1)
in 8 cases and##2##4##(2007-11#1)(2007-7#1)
in 8 cases##9##3##(1991-11#1)(1991-2#1)(2007-11#4)(2007-7#1)(2011-3#1)(2013-8#1)
in 8 children##2##3##(1991-8#1)(2007-11#1)
in 8 of 16##2##4##(1994-11#1)(2008-11#1)
in 8 of##6##3##(1994-11#1)(1994-9#1)(1995-4#1)(1996-12#1)(2008-10#1)(2008-11#1)
in 8 out of 14 patients##2##6##(1991-5#1)(2013-1#1)
in 8 out##3##3##(1991-5#1)(1997-3#1)(2013-1#1)
in 8 patients and##3##4##(1990-8#1)(1996-7#1)(2008-7#1)
in 8 patients##12##3##(1990-12#1)(1990-8#1)(1991-3#1)(1996-3#1)(1996-7#1)(1997-8#2)(2007-11#2)(2007-7#1)(2008-7#1)(2013-1#1)
in 8##68##2##(1990-12#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#8)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
in 8% of the##2##4##(1994-3#1)(2008-10#1)
in 8% of##3##3##(1994-3#1)(1994-5#1)(2008-10#1)
in 8%##5##2##(1994-3#1)(1994-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
in 8/15 cases (53##2##4##(2008-10#2)
in 80 % of cases##2##5##(1997-8#1)(2007-8#1)
in 80##13##2##(1992-2#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-7#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
in 80% after##2##3##(1993-6#2)
in 80% and##2##3##(1990-12#1)(1995-3#1)
in 80% of cases##2##4##(2008-7#1)(2013-1#1)
in 80% of the cases##2##5##(1990-10#1)(2013-1#1)
in 80% of the##4##4##(1990-10#1)(2008-1#1)(2010-5#1)(2013-1#1)
in 80% of##8##3##(1990-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#2)
in 80%##16##2##(1990-10#1)(1990-12#1)(1993-6#2)(1995-3#1)(1996-9#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2013-1#2)
in 800 mg/L females##3##4##(2008-9#3)
in 800 mg/L males and females##2##6##(2008-9#2)
in 800 mg/L males at 43 weeks##3##7##(2008-9#3)
in 800 mg/L males##5##4##(2008-9#5)
in 800 mg/L##8##3##(2008-9#8)
in 800##9##2##(1994-2#1)(2008-9#8)
in 81 patients##2##3##(1993-8#1)(1997-8#1)
in 81##6##2##(1990-8#1)(1993-8#1)(1997-8#1)(2009-2#1)(2011-2#1)(2012-3#1)
in 81%##2##2##(2008-10#1)(2008-4#1)
in 82 patients##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
in 82##7##2##(1997-8#2)(2007-11#1)(2007-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
in 82% of the##2##4##(1993-2#1)(2008-5#1)
in 82% of##4##3##(1990-2#1)(1993-2#1)(2008-5#1)(2008-8#1)
in 82%##5##2##(1990-2#1)(1993-2#1)(1995-3#1)(2008-5#1)(2008-8#1)
in 83##7##2##(1994-12#1)(2008-1#1)(2008-12#1)(2008-8#2)(2011-1#1)(2011-2#1)
in 83% of the##2##4##(1990-2#1)(2008-10#1)
in 83% of##3##3##(1990-2#1)(2008-10#1)(2008-9#1)
in 83%##4##2##(1990-2#1)(2008-10#2)(2008-9#1)
in 84##7##2##(1990-6#1)(1994-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
in 84% of cases##2##4##(2008-5#1)(2008-7#1)
in 84% of##5##3##(1990-11#1)(1990-9#1)(2007-11#1)(2008-5#1)(2008-7#1)
in 84%##6##2##(1990-11#1)(1990-9#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)
in 85##5##2##(1990-6#1)(2007-7#1)(2008-12#1)(2011-2#1)(2012-3#1)
in 85%##3##2##(1996-11#1)(1996-5#1)(2011-1#1)
in 85-90%##2##2##(1996-5#1)(2012-2#1)
in 86##7##2##(1990-3#1)(1991-5#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
in 86% of##3##3##(1996-11#1)(2008-1#1)(2013-1#1)
in 87##7##2##(1991-2#1)(1991-6#1)(2007-8#2)(2008-1#1)(2008-5#1)(2012-3#1)
in 87%##2##2##(1997-3#1)(2008-11#1)
in 88 patients##2##3##(2007-8#1)(2009-9#1)
in 88##7##2##(2007-11#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-9#1)(2010-3#1)(2013-8#1)
in 88% of the##2##4##(2008-10#1)(2008-4#1)
in 88% of##3##3##(2007-7#1)(2008-10#1)(2008-4#1)
in 88%##4##2##(2007-7#2)(2008-10#1)(2008-4#1)
in 89 patients##3##3##(1990-2#1)(1992-11#1)(1992-9#1)
in 89##4##2##(1990-2#1)(1992-11#1)(1992-9#1)(2009-10#1)
in 89% after laser##2##4##(1993-6#2)
in 9 cases##5##3##(1991-11#1)(1997-8#1)(2007-11#2)(2009-3#1)
in 9 of the 10##2##5##(1996-5#1)(2008-5#1)
in 9 of the##3##4##(1990-2#1)(1996-5#1)(2008-5#1)
in 9 of##9##3##(1990-2#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
in 9 patients##7##3##(1994-11#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-7#2)(2011-2#1)
in 9##37##2##(1990-2#1)(1991-11#2)(1994-11#1)(1994-2#1)(1996-5#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2011-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
in 9%##3##2##(2007-10#1)(2007-7#1)(2012-2#1)
in 9/10##2##2##(2008-8#1)(2012-3#1)
in 90##7##2##(1990-9#1)(1991-3#1)(1993-6#1)(2007-7#1)(2008-11#1)(2012-12#1)(2013-1#1)
in 90% of cases##2##4##(1990-6#1)(2007-8#1)
in 90% of patients with##2##5##(2012-2#1)(2013-1#1)
in 90% of patients##5##4##(1991-6#1)(2007-7#2)(2012-2#1)(2013-1#1)
in 90% of the patients##3##5##(1992-1#1)(1992-4#1)(2007-7#1)
in 90% of the##4##4##(1992-1#1)(1992-4#1)(2007-7#1)(2008-10#1)
in 90% of##12##3##(1990-6#1)(1991-6#1)(1992-1#1)(1992-4#1)(2007-7#3)(2007-8#1)(2008-10#2)(2012-2#1)(2013-1#1)
in 90%##15##2##(1990-6#1)(1991-6#1)(1992-1#1)(1992-4#1)(2007-7#3)(2007-8#1)(2008-10#4)(2012-12#1)(2012-2#1)(2013-1#1)
in 91##4##2##(1991-8#1)(1995-9#1)(2007-7#1)(2013-1#1)
in 91% of##3##3##(1994-10#1)(2008-1#1)(2008-7#1)
in 91%##5##2##(1990-8#1)(1994-10#1)(2008-1#1)(2008-7#1)(2011-2#1)
in 92##5##2##(1990-9#1)(1992-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
in 93##4##2##(1991-3#1)(1992-6#1)(1995-12#1)(2008-11#1)
in 93% of patients##2##4##(1993-9#1)(2008-3#1)
in 93%##3##2##(1993-9#1)(2008-3#1)(2013-1#1)
in 94##7##2##(1990-10#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#1)
in 94% of patients##2##4##(1997-3#1)(2008-6#1)
in 94% of##3##3##(1992-11#1)(1997-3#1)(2008-6#1)
in 95 patients##2##3##(1997-8#2)
in 95##6##2##(1991-11#1)(1992-5#1)(1997-8#2)(2008-11#1)(2008-8#1)
in 95% of##2##3##(1996-1#1)(2007-8#1)
in 95%##4##2##(1996-1#1)(2007-8#1)(2008-10#1)(2011-1#1)
in 96 well##2##3##(2008-11#2)
in 96##7##2##(1993-6#1)(1995-11#1)(2008-10#1)(2008-11#2)(2012-3#2)
in 96% of the##2##4##(2008-10#1)(2008-5#1)
in 96% of##4##3##(2008-10#2)(2008-5#1)(2012-12#1)
in 96-well##4##2##(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
in 960##2##2##(2008-10#2)
in 97##3##2##(1993-6#1)(1997-5#1)(2008-6#1)
in 97% of cases##2##4##(1997-4#1)(2007-11#1)
in 97% of##3##3##(1996-9#1)(1997-4#1)(2007-11#1)
in 98##2##2##(1993-8#1)(2007-8#1)
in 99##3##2##(1991-9#1)(2008-10#1)(2008-4#1)
in 99%##2##2##(1992-2#1)(1996-5#1)
in A and##2##3##(1992-12#1)(2008-6#1)
in A beta##2##3##(1995-12#1)(1996-2#1)
in A##32##2##(1992-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-2#2)(2007-12#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2008-9#3)(2009-5#1)(2011-2#2)(2012-3#1)
in A1##2##2##(2008-10#1)(2008-11#1)
in A431 cells##4##3##(1990-11#1)(1992-3#2)(1993-3#1)
in AA##2##2##(1994-11#1)(2008-4#1)
in ABA concentration in##2##4##(2008-8#2)
in ABA##3##2##(2008-8#2)(2009-8#1)
in AC Taber##2##3##(2008-10#2)
in ACS Surgery##3##3##(2008-4#3)
in ACS##5##2##(2008-4#4)(2010-4#1)
in AD and##4##3##(1993-12#2)(1995-12#1)(2008-7#1)
in AD may##2##3##(1997-2#1)(2009-12#1)
in AD patients##4##3##(1996-5#2)(2010-2#1)(2012-1#1)
in AD##38##2##(1991-1#1)(1993-12#4)(1995-12#2)(1995-5#4)(1996-5#3)(1997-2#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
in ADC##2##2##(1996-5#2)
in ADHD##7##2##(2008-11#1)(2008-2#5)(2012-1#1)
in ADL##2##2##(2008-7#2)
in ADLs##3##2##(2007-10#1)(2008-7#2)
in ADPKD##3##2##(2010-6#2)(2013-1#1)
in ADX rats##2##3##(1990-12#2)
in AF patients##2##3##(2008-10#1)(2010-12#1)
in AFLP##2##2##(2008-10#2)
in AG##4##2##(2007-8#1)(2012-3#1)(2013-8#2)
in AGS##3##2##(2008-12#3)
in AIDS patients##8##3##(1990-11#1)(1991-3#1)(1996-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)
in AIDS service organizations##2##4##(1995-12#1)(1996-3#1)
in AIDS##27##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1993-12#2)(1994-11#1)(1994-8#1)(1995-12#1)(1996-3#2)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-5#1)
in AII##2##2##(1997-2#2)
in AILT##2##2##(2009-8#2)
in AKR##2##2##(2013-1#2)
in ALL##2##2##(2011-2#2)
in ALP activity##2##3##(2008-11#1)(2013-1#1)
in ALT/d-LDH##2##2##(2008-10#2)
in AMD##2##2##(2011-2#2)
in AML##5##2##(2010-4#2)(2011-2#3)
in AMPA receptor binding##2##4##(1996-5#2)
in AMPA receptor##3##3##(1996-5#3)
in AN is##3##3##(2007-7#3)
in AN##5##2##(2007-7#4)(2008-10#1)
in AP##2##2##(1996-5#1)(2007-8#1)
in APOE##2##2##(1996-12#1)(1996-6#1)
in APP mRNA levels##2##4##(1996-12#2)
in APP mRNA##3##3##(1993-3#1)(1996-12#2)
in APP##4##2##(1992-6#1)(1993-3#1)(1996-12#2)
in APS##2##2##(1994-3#1)(2013-8#1)
in AQP2 transfected##3##3##(2012-12#3)
in AR##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
in ARDS##4##2##(1991-9#1)(1993-2#1)(1997-1#2)
in ARF##2##2##(2008-11#1)(2008-4#1)
in ARG1(+/-)##2##2##(2013-8#2)
in AROM##2##2##(2008-12#2)
in AS##4##2##(2007-11#1)(2011-2#3)
in ASM-treated leaves##2##3##(2008-10#2)
in AT##3##2##(1992-3#1)(2008-5#1)(2013-1#1)
in ATP##3##2##(1995-12#1)(2008-4#1)(2008-5#1)
in AVM##2##2##(2012-3#2)
in Aboriginal##2##2##(2008-12#1)(2008-6#1)
in Abu Dhabi##2##3##(2013-1#1)(2013-7#1)
in AcNPV##2##2##(1997-3#2)
in AcOEC2##2##2##(2008-10#2)
in Acala NemX##2##3##(2008-10#2)
in Acid##2##2##(1997-1#1)(2008-10#1)
in Acute##5##2##(1997-3#1)(2007-10#1)(2007-2#2)(2012-12#1)
in Adolescent##2##2##(2008-9#1)(2013-1#1)
in Adolescents##2##2##(2013-1#2)
in Adult##4##2##(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
in Adults##3##2##(2008-12#1)(2008-3#2)
in Advanced##2##2##(2010-2#1)(2013-1#1)
in Africa and##6##3##(1993-6#1)(1997-7#1)(2007-2#1)(2008-10#3)
in Africa south of Sahara##2##5##(1990-12#2)
in Africa##48##2##(1990-12#3)(1993-3#1)(1993-6#2)(1994-3#2)(1995-1#1)(1997-4#2)(1997-7#1)(2007-2#4)(2008-1#1)(2008-10#12)(2008-8#6)(2008-9#1)(2009-3#1)(2010-1#1)(2010-8#1)(2012-2#4)(2012-3#2)(2013-1#3)
in African American and##2##4##(2008-4#1)(2011-2#1)
in African American men##4##4##(2009-5#4)
in African American##9##3##(2007-10#1)(2008-4#3)(2009-5#4)(2011-2#1)
in African Americans and##2##4##(2012-3#1)(2013-1#1)
in African Americans##9##3##(2007-10#1)(2008-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
in African children##2##3##(2009-10#1)(2013-8#1)
in African populations##3##3##(2008-12#1)(2010-3#1)(2010-5#1)
in African##27##2##(1993-6#1)(1995-12#1)(2007-10#2)(2008-12#1)(2008-4#4)(2008-9#1)(2009-10#1)(2009-5#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in African-American##2##2##(1995-11#1)(1995-9#1)
in African-Americans##4##2##(1997-3#1)(2006-10#1)(2007-7#1)(2008-1#1)
in AgGaS(2)##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
in Agricultural Systems##2##3##(2008-10#2)
in Agricultural##3##2##(2008-10#3)
in Aini population##2##3##(2011-1#2)
in Aini##3##2##(2011-1#3)
in Air##2##2##(2008-10#1)(2010-10#1)
in Akt##2##2##(2008-1#1)(2009-5#1)
in AlGaAs##3##2##(2007-12#1)(2008-2#2)
in Alberta and##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
in Alberta##11##2##(1992-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
in Alfalfa##2##2##(2008-10#2)
in Algeria##4##2##(1996-6#1)(2010-1#3)
in Alternaria##2##2##(2008-10#2)
in Alzheimer disease (AD)##2##4##(2008-7#1)(2009-5#1)
in Alzheimer disease and##3##4##(1990-3#1)(1994-8#1)(1997-2#1)
in Alzheimer disease##8##3##(1990-3#1)(1994-8#2)(1997-2#1)(2008-7#1)(2009-5#2)(2013-7#1)
in Alzheimer##9##2##(1990-3#1)(1993-12#1)(1994-8#2)(1997-2#1)(2008-7#1)(2009-5#2)(2013-7#1)
in Alzheimer's Disease##2##3##(1992-12#1)(1993-12#1)
in Alzheimer's disease (AD)##3##4##(1992-12#1)(1992-9#1)(1995-5#1)
in Alzheimer's disease and##8##4##(1993-2#1)(1996-6#1)(1996-9#1)(2007-8#1)(2008-7#2)(2012-3#1)(2013-1#1)
in Alzheimer's disease##45##3##(1991-10#1)(1991-11#4)(1991-12#1)(1991-9#1)(1992-12#4)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-6#3)(1995-12#3)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-8#1)(2008-7#4)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
in Alzheimer's##48##2##(1991-10#1)(1991-11#4)(1991-12#1)(1991-9#1)(1992-12#5)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-5#1)(1994-6#3)(1995-12#3)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-8#1)(2008-7#4)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
in Ambae##2##2##(2008-1#2)
in Amberlite##2##2##(2008-10#2)
in America is##2##3##(1995-2#1)(2013-7#1)
in America##7##2##(1992-5#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-11#1)(2013-1#1)(2013-7#1)
in American health care##3##4##(1992-2#1)(1994-1#1)(1995-12#1)
in American##10##2##(1991-3#1)(1992-2#1)(1994-1#1)(1995-1#1)(1995-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
in Amsterdam##4##2##(1990-3#2)(1990-6#2)
in An##2##2##(2007-12#1)(2008-8#1)
in Analytical##3##2##(2008-10#3)
in Andean##2##2##(2008-10#1)(2013-7#1)
in Andersen syndrome##2##3##(2008-8#2)
in Aneurysm##2##2##(2012-2#1)(2012-3#1)
in Angelica dahurica Benth and its##2##6##(2008-10#2)
in Angelica##3##2##(2008-10#2)(2013-8#1)
in Ankara##3##2##(2008-10#1)(2008-12#2)
in Aotearoa##3##2##(2008-1#3)
in Apartadó##2##2##(2012-12#2)
in Aplysia##5##2##(1994-8#2)(2008-10#1)(2008-4#1)(2008-6#1)
in Apo##2##2##(1990-8#1)(2013-7#1)
in Apple##3##2##(2008-10#3)
in April 2009##2##3##(2011-2#1)(2012-12#1)
in April and May##7##4##(2008-10#6)(2010-2#1)
in April and##10##3##(2008-10#7)(2008-5#2)(2010-2#1)
in April##22##2##(1993-1#1)(1993-12#1)(1997-5#1)(2008-10#9)(2008-12#1)(2008-5#3)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)
in Aqueous##2##2##(2009-8#1)(2010-4#1)
in Ar##4##2##(2007-11#1)(2008-10#3)
in Arabidopsis and##4##3##(2008-7#1)(2009-5#1)(2009-8#1)(2011-10#1)
in Arabidopsis plants##2##3##(2009-8#1)(2011-1#1)
in Arabidopsis roots##2##3##(2009-10#1)(2009-8#1)
in Arabidopsis thaliana and##3##4##(1996-10#1)(2008-10#1)(2008-7#1)
in Arabidopsis thaliana##16##3##(1996-10#2)(1997-2#1)(1997-8#1)(2008-10#4)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#1)
in Arabidopsis##58##2##(1996-10#3)(1997-2#1)(1997-8#3)(2007-12#3)(2008-10#11)(2008-7#5)(2008-9#5)(2009-10#4)(2009-5#2)(2009-6#2)(2009-8#10)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#2)(2012-2#2)
in Arabs##3##2##(1997-8#1)(2008-1#2)
in Argentina##13##2##(1996-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-10#1)(2009-7#2)(2013-7#2)
in Argentina's##2##2##(2009-7#2)
in Argentina]##2##2##(2009-10#1)(2009-7#1)
in Argentine##2##2##(2008-5#1)(2013-1#1)
in Arizona##10##2##(1995-12#2)(1997-5#1)(2008-10#2)(2008-5#1)(2011-2#4)
in Arkansas##2##2##(2008-10#1)(2013-8#1)
in As##2##2##(2008-10#2)
in Asellus aquaticus##2##3##(2008-12#2)
in Asia Pacific##2##3##(2012-12#2)
in Asia and##5##3##(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
in Asia##20##2##(2007-12#2)(2008-10#3)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)
in Asian Indians##4##3##(2008-3#4)
in Asian PD patients##4##4##(2007-12#4)
in Asian countries##7##3##(1997-8#1)(2009-5#1)(2013-1#4)(2013-8#1)
in Asian populations##2##3##(2007-5#1)(2010-3#1)
in Asian water##2##3##(2008-5#2)
in Asian##25##2##(1997-8#2)(2007-12#5)(2007-5#1)(2008-3#5)(2008-5#2)(2009-10#1)(2009-5#1)(2010-10#1)(2010-3#1)(2012-1#1)(2013-1#4)(2013-8#1)
in Asians##3##2##(2010-1#1)(2010-6#1)(2011-2#1)
in Aspergillus nidulans and Aspergillus terreus##2##6##(2008-5#2)
in Aspergillus nidulans and##3##4##(1997-4#1)(2008-5#2)
in Aspergillus nidulans##7##3##(1997-4#1)(1997-7#1)(1997-8#1)(2008-5#2)(2010-2#1)(2010-7#1)
in Aspergillus niger##2##3##(1991-9#1)(1993-2#1)
in Aspergillus##13##2##(1990-11#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#2)(2010-2#1)(2010-7#1)
in Asthma##2##2##(1993-2#1)(2012-12#1)
in Aswan Governorate##2##3##(1994-9#2)
in AtT-20 cells##4##3##(1990-12#3)(1994-11#1)
in Atenas##2##2##(2008-5#2)
in Athens##5##2##(1993-9#3)(2007-10#1)(2008-10#1)
in Atlanta##2##2##(1997-2#1)(2008-11#1)
in Atlantic salmon##2##3##(1992-9#1)(1994-7#1)
in Atlantic##4##2##(1991-8#1)(1992-9#1)(1994-7#1)(2012-3#1)
in Au##3##2##(2007-12#2)(2008-3#1)
in August 1994##2##3##(1995-5#1)(2008-10#1)
in August 2004##2##3##(2008-1#1)(2008-10#1)
in August 2006##2##3##(2011-1#1)(2012-12#1)
in August 2008##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
in August and##2##3##(2008-5#2)
in August##21##2##(1993-12#1)(1995-5#1)(2008-1#1)(2008-10#8)(2008-5#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
in Augustine's##2##2##(2008-12#2)
in Australasia##2##2##(2007-2#1)(2009-8#1)
in Australia and New Zealand##3##5##(2008-12#1)(2012-12#2)
in Australia and the United##2##5##(1992-1#1)(2012-12#1)
in Australia and##8##3##(1992-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2012-12#3)
in Australia in##2##3##(2008-10#1)(2008-11#1)
in Australia using##2##3##(2008-10#2)
in Australia##59##2##(1990-2#1)(1991-2#1)(1991-8#2)(1992-1#5)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-11#4)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#6)(2012-12#5)(2013-8#1)
in Australian Aboriginal##2##3##(1996-12#1)(2008-6#1)
in Australian and New Zealand##2##5##(2007-11#1)(2008-10#1)
in Australian health care##2##4##(1992-1#1)(1996-2#1)
in Australian nursing homes##2##4##(2008-11#2)
in Australian##22##2##(1991-11#1)(1992-1#2)(1996-12#1)(1996-2#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
in Austria##7##2##(1990-2#1)(1993-3#1)(1994-12#1)(2007-1#1)(2007-10#1)(2009-10#1)(2010-4#1)
in Austrian##2##2##(1990-2#1)(2008-10#1)
in B cell##3##3##(1991-5#1)(2008-4#1)(2009-4#1)
in B cells##3##3##(1991-1#1)(1991-9#1)(1995-6#1)
in B decays##2##3##(1990-12#1)(1992-11#1)
in B medium##2##3##(2008-10#2)
in B##36##2##(1990-11#3)(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1995-6#1)(1997-7#1)(2007-10#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
in B(6)C(3)F(1) mice##3##3##(2008-10#3)
in B(6)C(3)F(1) than in MRL(+/+) mice##2##6##(2008-10#2)
in B(6)C(3)F(1)##5##2##(2008-10#5)
in B-##2##2##(1994-3#1)(2008-10#1)
in B-DNA##2##2##(1993-8#2)
in B-cell##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
in B16##3##2##(1993-5#1)(2008-11#1)(2008-5#1)
in B16-C3 cells##2##3##(1991-5#2)
in B6##2##2##(1996-12#2)
in B6C3F(1) and Tg##2##4##(2008-9#2)
in BALB mice##3##3##(1994-5#3)
in BALB/c mice##9##3##(1992-5#1)(1992-8#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2012-2#2)
in BALB/c##11##2##(1992-5#1)(1992-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2012-2#2)(2013-1#1)
in BALF##2##2##(1992-11#1)(1994-8#1)
in BB##2##2##(2007-7#1)(2008-10#1)
in BBA 2890##3##3##(2008-10#3)
in BBA##5##2##(2008-10#5)
in BBO##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
in BCCAO##2##2##(2007-10#2)
in BCF##2##2##(2008-12#2)
in BDNF mRNA##2##3##(1997-2#1)(2012-2#1)
in BDNF##3##2##(1997-2#1)(2012-2#1)(2013-8#1)
in BGM cell cultures##2##4##(2008-5#2)
in BHK cells##2##3##(1994-9#1)(2008-11#1)
in BK(-/-)##2##2##(2009-2#2)
in BL##2##2##(2007-7#2)
in BMD##4##2##(2007-11#1)(2010-1#1)(2011-2#2)
in BMI##5##2##(2010-8#3)(2013-1#2)
in BMV-infected##2##2##(2008-10#2)
in BN rats##2##3##(2008-10#2)
in BNCT##2##2##(1994-3#2)
in BP and##2##3##(1990-5#2)
in BP##4##2##(1990-5#3)(2012-3#1)
in BPTI##2##2##(1991-11#2)
in BSA##4##2##(1991-5#2)(1993-11#1)(2008-10#1)
in BSC##2##2##(1994-8#2)
in BT##5##2##(2007-7#5)
in BV##2##2##(2008-11#2)
in BYDV-PAV-infected##2##2##(2008-10#2)
in BaF(2)##3##2##(2008-2#3)
in BaTiO(3)##10##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#3)
in BaWO(4) crystal##2##3##(2007-11#2)
in Bacillus subtilis##12##3##(1990-11#2)(1990-12#2)(1994-12#1)(1995-6#1)(1995-8#2)(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#1)
in Bacillus##18##2##(1990-11#2)(1990-12#2)(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#2)(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)
in Bahia State##2##3##(2008-10#2)
in Bahia and Rio de Janeiro##2##6##(1991-6#2)
in Bahia and##3##3##(1991-6#2)(2008-10#1)
in Bahia##11##2##(1991-6#3)(2008-10#3)(2008-5#1)(2008-8#1)(2009-10#3)
in Bali##2##2##(2011-2#2)
in Balint's syndrome##2##3##(2008-4#2)
in Bangladesh and##2##3##(2008-10#1)(2011-2#1)
in Bangladesh##13##2##(1991-8#2)(1994-9#1)(2007-7#1)(2008-10#4)(2010-11#1)(2010-2#1)(2011-2#3)
in Bangladeshi patients##2##3##(2011-2#2)
in Bangladeshi##3##2##(2011-2#3)
in Barbados##3##2##(2008-10#1)(2011-2#2)
in Barcelona and##2##3##(1993-2#1)(2008-10#1)
in Barcelona##5##2##(1993-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
in Barley##7##2##(2008-10#7)
in Barrett's esophagus##3##3##(2008-12#2)(2010-12#1)
in Barrett's##6##2##(2008-12#3)(2009-4#1)(2010-12#2)
in Basal##2##2##(2008-11#1)(2012-3#1)
in Beijing##9##2##(1994-3#1)(2008-10#2)(2011-1#5)(2013-1#1)
in Belarus##2##2##(2008-10#1)(2012-3#1)
in Belfast##2##2##(1997-8#1)(2013-8#1)
in Belgium##4##2##(2008-10#1)(2008-12#1)(2011-2#2)
in Belgorod Province##2##3##(2013-1#2)
in Belgorod##3##2##(2013-1#3)
in Beltsville##2##2##(2008-10#2)
in Benghazi##2##2##(1994-12#2)
in Benin##2##2##(2008-10#1)(2012-3#1)
in Bergen in##3##3##(1992-6#1)(1993-3#2)
in Bergen##9##2##(1990-6#1)(1992-6#3)(1993-3#2)(1993-6#2)(1997-8#1)
in Bhutanese##2##2##(2008-10#1)(2008-7#1)
in Bioinformatics##2##2##(2008-4#1)(2008-7#1)
in Biological##3##2##(2008-10#2)(2008-11#1)
in Biology and Medicine##2##4##(2009-7#1)(2010-2#1)
in Bipolar Disorder##4##3##(2009-8#2)(2013-8#2)
in Bipolar##5##2##(2009-8#2)(2012-2#1)(2013-8#2)
in Black##3##2##(2012-2#2)(2013-7#1)
in Bland##2##2##(2007-7#1)(2008-12#1)
in BmN cells##4##3##(1997-3#2)(1997-4#1)(1997-8#1)
in BmN##5##2##(1997-3#2)(1997-4#1)(1997-8#2)
in Bmax##2##2##(1991-6#1)(1997-2#1)
in Bogota##4##2##(2011-2#1)(2012-12#3)
in Bogotá##10##2##(2011-2#2)(2012-12#6)(2013-1#2)
in Bolivia##3##2##(2011-2#2)(2012-12#1)
in Bombyx##4##2##(1997-4#1)(2008-6#3)
in Bon Accord Lagoon were compared to##2##7##(2007-5#2)
in Bon Accord Lagoon##3##4##(2007-5#3)
in Borrelia##2##2##(1990-12#1)(1992-3#1)
in Boston##8##2##(1992-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
in Botryosphaeria dothidea##2##3##(2008-10#2)
in Botrytis cinerea##3##3##(2008-10#3)
in Botrytis##4##2##(2008-10#4)
in Botswana##2##2##(2013-1#2)
in Braak stage##2##3##(2009-12#2)
in Bragg gratings##2##3##(2007-12#1)(2008-3#1)
in Bragg wavelength##4##3##(2007-11#1)(2013-8#3)
in Bragg##8##2##(2007-11#1)(2007-12#3)(2008-3#1)(2013-8#3)
in Brassica napus##4##3##(2008-10#3)(2008-12#1)
in Brassica##10##2##(2008-10#7)(2008-12#1)(2011-10#1)(2012-3#1)
in Brazil and##7##3##(1991-6#1)(2008-10#2)(2008-9#2)(2011-2#2)
in Brazil are##2##3##(1991-6#1)(1993-8#1)
in Brazil during##3##3##(1991-6#1)(2008-10#1)(2008-9#1)
in Brazil in##2##3##(2008-5#1)(2010-1#1)
in Brazil is##2##3##(2008-5#1)(2013-8#1)
in Brazil##81##2##(1991-6#9)(1993-6#2)(1993-8#2)(1996-12#1)(2008-10#21)(2008-11#2)(2008-2#3)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#5)(2009-10#4)(2010-1#4)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#10)
in Brazil]##2##2##(1990-12#1)(2013-1#1)
in Brazilian Portuguese##2##3##(2009-11#2)
in Brazilian hemodialysis##2##3##(2013-1#2)
in Brazilian patients with##2##4##(2008-12#1)(2008-5#1)
in Brazilian##14##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#2)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
in Brazilians##2##2##(2012-2#1)(2013-8#1)
in Breast Cancer##8##3##(1994-12#1)(1994-7#3)(1997-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
in Breast##9##2##(1994-12#1)(1994-7#3)(1995-4#1)(1997-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
in Brisbane##2##2##(2008-7#2)
in Britain and##3##3##(1997-6#1)(2007-12#2)
in Britain##19##2##(1990-6#2)(1991-8#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-6#3)(2007-12#2)(2008-5#2)(2010-1#3)(2011-1#1)(2011-2#1)
in British Columbia and##2##4##(2008-10#1)(2011-2#1)
in British Columbia##21##3##(1992-2#1)(1994-1#2)(1994-2#1)(1997-2#1)(2007-12#5)(2008-10#3)(2008-11#5)(2009-5#1)(2010-8#1)(2011-2#1)
in British##23##2##(1990-6#1)(1992-2#1)(1994-1#2)(1994-2#1)(1997-2#1)(2007-12#5)(2008-10#3)(2008-11#6)(2009-5#1)(2010-8#1)(2011-2#1)
in Britton Robinson##2##3##(2008-10#2)
in Britton-Robinson (BR) buffer##3##4##(2008-10#3)
in Britton-Robinson buffer solution##2##4##(2008-10#2)
in Britton-Robinson buffer##7##3##(2008-10#7)
in Britton-Robinson buffers##2##3##(2008-10#2)
in Britton-Robinson##12##2##(2008-10#12)
in Brugge (Bruges)##2##3##(2009-7#2)
in Brugge##4##2##(2008-10#2)(2009-7#2)
in Buenos Aires##4##3##(2008-5#1)(2009-10#2)(2009-7#1)
in Buerger's##2##2##(1990-2#1)(1997-8#1)
in Buffalo rats##2##3##(1993-12#2)
in Buffon's##2##2##(2008-12#2)
in Bulgaria is##2##3##(2008-11#1)(2011-1#1)
in Bulgaria##10##2##(2007-5#3)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#3)(2013-8#1)
in Burkina Faso##3##3##(1990-6#1)(2009-10#1)(2010-6#1)
in Burkina##4##2##(1990-6#1)(2009-10#2)(2010-6#1)
in Bydgoszcz##2##2##(2007-11#1)(2008-9#1)
in C and##2##3##(2008-6#1)(2010-2#1)
in C##70##2##(1990-11#1)(1991-2#1)(1991-9#3)(1992-3#1)(1993-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#22)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2010-2#11)(2010-3#1)(2010-8#1)(2012-1#2)(2012-12#2)(2012-3#1)(2012-8#1)(2013-1#3)
in C(18) columns##2##3##(2008-10#2)
in C(18)##4##2##(2008-10#4)
in C-terminal##3##2##(2008-6#1)(2011-2#1)(2012-12#1)
in C2##2##2##(1995-6#1)(2008-9#1)
in C2C12##2##2##(2008-11#1)(2008-4#1)
in C2D2Cl4##2##2##(1995-2#2)
in C3H/10T1/2##3##2##(1992-5#3)
in C3H/HeJ mice##2##3##(2008-10#2)
in C57BL##2##2##(1993-5#2)
in C57BL/10 mice##3##3##(1990-3#3)
in C57BL/6##2##2##(1993-12#1)(2008-7#1)
in C57BL/6J##2##2##(1992-3#1)(1993-5#1)
in C6##3##2##(1993-6#1)(1994-11#1)(2008-4#1)
in CA 1##2##3##(1995-3#2)
in CA and##2##3##(2008-10#1)(2011-1#1)
in CA##7##2##(1995-11#1)(1995-3#2)(2008-10#2)(2011-1#2)
in CA1##6##2##(1991-12#1)(1993-12#1)(1996-5#1)(1997-2#1)(2008-12#1)(2008-7#1)
in CA4##2##2##(1996-12#2)
in CAB2 expression##2##3##(1995-2#2)
in CAB2##3##2##(1995-2#3)
in CAD events##2##3##(1991-8#2)
in CAD##3##2##(1991-8#2)(2012-2#1)
in CAPD patients##3##3##(2007-12#1)(2007-7#1)(2011-2#1)
in CAPD##6##2##(2007-12#1)(2007-7#3)(2008-10#1)(2011-2#1)
in CAT activity##3##3##(1991-11#2)(1993-8#1)
in CAT##6##2##(1991-11#2)(1993-8#1)(1995-6#1)(2008-11#1)(2008-7#1)
in CAdSV##2##2##(2008-10#2)
in CB##3##2##(1994-5#1)(1995-12#1)(2009-12#1)
in CBA##2##2##(1996-5#1)(2013-1#1)
in CCD##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
in CCH5##3##2##(2012-3#3)
in CCI rats##2##3##(2008-9#2)
in CCl(4)##3##2##(1996-5#2)(2008-10#1)
in CD##3##2##(1990-12#1)(1990-9#1)(2012-2#1)
in CD-1##2##2##(1991-6#1)(2008-11#1)
in CD133-high cells##2##3##(2009-9#2)
in CD28##3##2##(2008-7#3)
in CD4(+) T-lymphocytes##2##3##(2008-10#2)
in CD4(+)##4##2##(2008-10#3)(2010-1#1)
in CD4+##4##2##(1991-1#2)(1994-12#1)(2008-10#1)
in CD44##2##2##(1994-10#2)
in CDCl(3) at -78 degrees C##2##6##(1996-5#2)
in CDCl(3)##3##2##(1996-5#2)(2008-10#1)
in CDGP##2##2##(2011-1#1)(2011-2#1)
in CE##5##2##(2008-10#3)(2008-5#1)(2011-1#1)
in CEO##2##2##(1995-2#2)
in CF##2##2##(1997-1#1)(1997-6#1)
in CGRP##2##2##(1990-7#1)(1992-6#1)
in CH(2)Cl(2) at -78 degrees C followed by reduction with dimethyl sulfide gave the##2##14##(1996-5#2)
in CH(2)Cl(2) at -78 degrees C followed by##3##8##(1996-5#3)
in CH(2)Cl(2)##7##2##(1996-2#2)(1996-5#3)(2007-11#1)(2009-9#1)
in CHCl(3)##2##2##(2008-10#2)
in CHD##2##2##(2008-4#1)(2010-8#1)
in CHO Cells##2##3##(2008-11#2)
in CHO cells and##2##4##(1994-11#1)(2008-11#1)
in CHO cells by##3##4##(1995-2#1)(2008-11#2)
in CHO cells overexpressing the##2##5##(1995-6#2)
in CHO cells overexpressing##3##4##(1994-11#1)(1995-6#2)
in CHO cells was##2##4##(2008-11#1)(2008-7#1)
in CHO cells##34##3##(1990-12#1)(1992-10#1)(1992-6#1)(1994-11#3)(1995-2#2)(1995-6#2)(2008-11#20)(2008-4#2)(2008-7#2)
in CHO##43##2##(1990-12#1)(1992-10#1)(1992-6#1)(1994-11#3)(1995-12#1)(1995-2#2)(1995-6#2)(1997-4#1)(2008-11#25)(2008-4#3)(2008-7#2)(2011-2#1)
in CHO-K1 cells##3##3##(1993-6#1)(1994-11#1)(2008-11#1)
in CHO-K1##4##2##(1993-6#1)(1994-11#1)(2008-11#2)
in CI##2##2##(2008-10#1)(2008-7#1)
in CIDP##2##2##(2013-1#2)
in CKD patients##5##3##(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
in CKD##9##2##(2009-1#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
in CL##5##2##(2008-10#3)(2008-5#1)(2008-8#1)
in CL-treated##2##2##(2008-12#2)
in CLB doses##2##3##(2007-10#2)
in CLL##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
in CLS resistance##2##3##(2012-3#2)
in CM334##2##2##(2008-10#2)
in CMC##2##2##(2008-10#1)(2010-11#1)
in CML##4##2##(1990-2#1)(1992-2#1)(2010-4#1)(2012-12#1)
in CNS##8##2##(1990-9#1)(1991-12#2)(1995-12#1)(1996-2#1)(2008-7#2)(2013-1#1)
in CO(2)##3##2##(2008-10#2)(2008-2#1)
in COPD patients##6##3##(1997-7#1)(2011-2#1)(2013-7#1)(2013-8#3)
in COPD##13##2##(1997-7#1)(2010-5#3)(2011-2#2)(2013-7#2)(2013-8#5)
in COS 1 cells##5##4##(1995-12#1)(2008-11#4)
in COS cells##10##3##(1991-9#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1997-9#1)(2008-11#3)(2008-8#1)
in COS##16##2##(1991-9#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-9#1)(2008-11#8)(2008-8#1)
in COS-1 cells##9##3##(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-2#2)(2008-8#1)
in COS-7 cells and##2##4##(1992-9#1)(1993-11#1)
in COS-7 cells##9##3##(1990-11#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(2008-9#1)
in COS-7##11##2##(1990-11#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(2008-4#1)(2008-9#1)
in CP##5##2##(2007-11#1)(2008-10#3)(2008-12#1)
in CPA##2##2##(2011-2#1)(2012-3#1)
in CPD census##3##3##(2011-2#3)
in CPE##2##2##(2008-10#2)
in CPTs##2##2##(2006-12#2)
in CRC##3##2##(2008-12#1)(2008-5#2)
in CRP##3##2##(2008-10#1)(2008-8#2)
in CSF GABA##2##3##(1995-11#2)
in CSF and plasma##2##4##(1994-8#2)
in CSF##15##2##(1991-2#2)(1992-3#1)(1994-8#3)(1994-9#1)(1995-11#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
in CT and##2##3##(2008-8#1)(2012-2#1)
in CT##10##2##(1997-8#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#3)(2012-2#1)
in CTAB micelle##2##3##(2008-10#2)
in CTAB##4##2##(2008-10#4)
in CTEPH##2##2##(2010-6#2)
in CV 1 cells##2##4##(1994-11#2)
in CV##3##2##(1994-11#2)(2010-7#1)
in CVD prevention##2##3##(2009-4#2)
in CVD##4##2##(2009-4#2)(2010-12#1)(2011-1#1)
in CXB H mice##2##4##(1994-5#2)
in CYP1A1##2##2##(1994-6#1)(2008-10#1)
in Ca##2##2##(1992-6#1)(1995-8#1)
in Ca(2+)##4##2##(2006-6#1)(2008-11#1)(2008-4#2)
in Ca(2+)-free medium##2##3##(1993-12#1)(1995-11#1)
in Ca(2+)-free##5##2##(1993-12#2)(1995-11#2)(1996-5#1)
in Ca2+##9##2##(1990-12#1)(1990-2#1)(1992-5#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-8#1)
in CaF(2)##2##2##(2007-12#1)(2008-3#1)
in CaF2##2##2##(1993-5#1)(2008-3#1)
in Caco-2 cell monolayer##2##4##(2011-3#2)
in Caco-2##4##2##(2008-11#2)(2011-3#2)
in Caenorhabditis elegans##5##3##(1990-5#2)(2008-10#1)(2008-2#1)(2008-3#1)
in Cairo in##2##3##(1997-8#1)(2008-11#1)
in Cairo##3##2##(1997-8#1)(2008-11#1)(2010-10#1)
in Calabar##3##2##(2008-10#1)(2013-1#2)
in Calgary##2##2##(1992-3#1)(2012-2#1)
in Cali##2##2##(2012-12#2)
in California and the##2##4##(2008-10#2)
in California and##8##3##(1992-2#1)(2008-10#6)(2008-9#1)
in California in##5##3##(1992-2#1)(1997-3#1)(2008-10#3)
in California was##2##3##(2008-10#2)
in California##72##2##(1991-12#1)(1992-2#3)(1995-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#50)(2008-6#2)(2008-8#1)(2008-9#4)(2011-2#4)(2012-3#1)
in Cambridge to##2##3##(2008-4#1)(2008-9#1)
in Cameroon##3##2##(2007-7#2)(2008-10#1)
in Campinas##3##2##(2008-10#1)(2008-9#2)
in Campylobacter##2##2##(1990-3#1)(2011-1#1)
in Canada and the United States##5##6##(1993-3#2)(2007-12#1)(2008-10#1)(2012-2#1)
in Canada and the##6##4##(1993-3#2)(1996-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
in Canada and##12##3##(1993-3#2)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#4)(2012-2#1)
in Canada in 2007##2##4##(2008-12#1)(2010-10#1)
in Canada in##6##3##(1993-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)
in Canada is##7##3##(1993-12#1)(1993-3#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
in Canada to##4##3##(1992-2#1)(1995-2#1)(1996-1#1)(1996-2#1)
in Canada##169##2##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#5)(1992-2#2)(1993-1#2)(1993-12#3)(1993-2#3)(1993-3#4)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#1)(1995-1#4)(1995-2#4)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#3)(2007-12#42)(2008-10#17)(2008-11#18)(2008-12#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-5#2)(2009-8#1)(2010-10#3)(2010-12#3)(2010-8#1)(2011-2#5)(2012-2#2)(2013-1#2)
in Canadian children##3##3##(2007-12#2)(2008-11#1)
in Canadian health care##2##4##(1993-2#2)
in Canadian hospitals##6##3##(1993-1#1)(1993-2#1)(1994-12#2)(1995-1#1)(1996-2#1)
in Canadian paediatric##2##3##(2008-11#2)
in Canadian##22##2##(1993-1#1)(1993-2#3)(1994-12#2)(1995-1#1)(1996-2#1)(2007-12#4)(2008-10#2)(2008-11#4)(2009-5#1)(2010-12#1)(2013-1#2)
in Cancer##9##2##(2008-11#1)(2008-7#1)(2009-8#2)(2010-6#1)(2010-8#1)(2012-12#3)
in Candida albicans from##2##4##(1996-11#1)(2008-5#1)
in Candida albicans##5##3##(1996-11#1)(2008-5#3)(2011-2#1)
in Candida maltosa##2##3##(1991-9#1)(1993-12#1)
in Candida##9##2##(1991-9#1)(1993-12#1)(1996-11#1)(2008-5#3)(2011-2#2)(2013-1#1)
in Canton##3##2##(1996-11#3)
in Cape Town##3##3##(2008-8#1)(2010-3#2)
in Capsicum annuum##2##3##(2008-10#2)
in Capsicum##3##2##(2008-10#3)
in Cardiovascular##2##2##(2008-3#1)(2010-11#1)
in Cartagena##7##2##(2011-2#4)(2012-12#3)
in Cast (RIP) mice##2##4##(2010-11#2)
in Castilla y León##2##4##(2008-10#2)
in Catalan##2##2##(2013-8#2)
in Catalonia##3##2##(1990-6#1)(1997-3#1)(2008-7#1)
in Cattle in##2##3##(2012-2#1)(2013-8#1)
in Caucasian populations##3##3##(2009-5#1)(2009-9#1)(2010-3#1)
in Caucasian women##2##3##(2010-3#2)
in Caucasian##9##2##(1997-3#1)(1997-8#1)(2009-5#1)(2009-9#1)(2010-3#3)(2010-8#2)
in Caucasians##5##2##(1990-8#1)(2008-5#1)(2012-2#3)
in Cd##3##2##(1997-4#1)(2008-12#1)(2008-9#1)
in Central America##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
in Central Asia and the Caucasus##2##6##(2008-10#2)
in Central Coastal California##2##4##(2008-10#2)
in Central Europe##2##3##(2008-10#1)(2012-9#1)
in Central Pacific Costa Rica##3##5##(2008-5#3)
in Central Spain##2##3##(2008-10#2)
in Central and Eastern Europe##3##5##(1995-3#3)
in Central##23##2##(1995-12#1)(1995-3#3)(2007-11#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#4)(2011-2#1)(2012-9#1)
in Cercospora##2##2##(2008-10#2)
in Chadoora##2##2##(2013-8#2)
in Changsha##2##2##(2011-1#1)(2012-3#1)
in Chemical##2##2##(2008-12#1)(2008-2#1)
in Chemistry##4##2##(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
in Chengdu##2##2##(2008-8#1)(2011-2#1)
in Chennai##3##2##(2007-7#2)(2007-8#1)
in Chiang##2##2##(1990-3#1)(2013-8#1)
in Chiapas##2##2##(2008-5#2)
in Chicago##7##2##(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2009-6#1)
in Chickpea##5##2##(2008-10#5)
in Child's grade C##3##4##(2012-3#3)
in Childhood##3##2##(2009-12#1)(2012-2#1)(2012-3#1)
in Children and Adolescents##4##4##(2012-2#1)(2013-1#2)(2013-8#1)
in Children with##3##3##(2007-8#1)(2012-1#1)(2013-1#1)
in Children##16##2##(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-12#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
in Chile and##3##3##(2011-2#2)(2013-1#1)
in Chile were##2##3##(2013-1#1)(2013-8#1)
in Chile##28##2##(2008-8#1)(2011-2#6)(2013-1#13)(2013-8#8)
in Chile]##6##2##(2013-1#4)(2013-8#2)
in Chilean adolescents##2##3##(2013-1#2)
in Chilean##8##2##(2008-10#1)(2012-2#1)(2013-1#6)
in China and Japan##4##4##(2008-10#4)
in China and##9##3##(1993-9#1)(2008-10#6)(2011-2#2)
in China as##2##3##(2013-8#2)
in China based on##2##4##(2011-2#2)
in China is##2##3##(1997-4#1)(2010-10#1)
in China##73##2##(1993-9#1)(1994-3#1)(1995-6#1)(1997-4#4)(1997-5#2)(2008-10#10)(2008-2#1)(2008-4#1)(2008-8#9)(2008-9#8)(2010-10#4)(2010-12#3)(2010-5#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#6)
in Chinese Hamster Ovary (CHO)##3##5##(1993-3#1)(2008-11#2)
in Chinese Han##2##3##(2010-12#1)(2011-1#1)
in Chinese artichoke (Stachys Sieboldii Miq##2##6##(2008-10#2)
in Chinese artichoke##4##3##(2008-10#4)
in Chinese hamster ovary (CHO) cells##4##6##(1990-12#1)(1994-11#1)(2008-11#1)(2008-7#1)
in Chinese hamster ovary cells##12##5##(1990-12#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#3)(2008-11#2)(2008-8#1)
in Chinese hamster ovary##16##4##(1990-12#2)(1991-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#3)(2008-11#3)(2008-7#1)(2008-8#1)
in Chinese hamster##17##3##(1990-12#2)(1991-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#3)(1997-3#1)(2008-11#3)(2008-7#1)(2008-8#1)
in Chinese medicine##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
in Chinese patients##2##3##(2007-12#1)(2013-7#1)
in Chinese subjects##3##3##(2008-7#1)(2012-2#2)
in Chinese women##2##3##(2011-1#1)(2011-2#1)
in Chinese##66##2##(1990-12#2)(1991-5#1)(1992-9#1)(1993-3#3)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#3)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-9#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#4)
in Chlamydomonas reinhardtii##2##3##(1993-11#1)(2012-3#1)
in Chlamydomonas##3##2##(1993-11#1)(2008-7#1)(2012-3#1)
in Chlor-alkali cell effluents##2##4##(2008-10#2)
in Chlorella##2##2##(1991-12#1)(2008-10#1)
in Chongqing##2##2##(2011-2#1)(2013-8#1)
in Chronic##5##2##(2008-1#1)(2010-7#1)(2012-12#1)(2013-8#2)
in Citrus##3##2##(2008-10#2)(2008-6#1)
in Clarion##2##2##(2008-9#2)
in Clinical##6##2##(1992-2#1)(1994-12#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)
in Clostridium##2##2##(2008-6#1)(2011-2#1)
in Cochin##2##2##(2007-5#2)
in Cochliobolus sativus##2##3##(2008-10#2)
in Cochliobolus##3##2##(2008-10#3)
in Colima##2##2##(2011-2#2)
in Colletotrichum gloeosporioides infecting species of the tropical##2##8##(2008-10#2)
in Colletotrichum gloeosporioides##5##3##(2008-10#5)
in Colletotrichum graminicola##2##3##(2008-10#2)
in Colletotrichum##12##2##(2008-10#12)
in Colombia and##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
in Colombia by applying catalytic##2##5##(2012-12#2)
in Colombia from##2##3##(2012-12#2)
in Colombia were##2##3##(2012-12#2)
in Colombia##44##2##(2008-10#4)(2008-12#1)(2008-5#2)(2011-2#4)(2012-12#31)(2013-1#2)
in Colombia]##5##2##(2012-12#3)(2013-1#2)
in Colombian municipalities##3##3##(2012-12#3)
in Colombian##9##2##(2012-12#5)(2013-1#4)
in Colorado and##2##3##(1995-2#1)(2008-10#1)
in Colorado##3##2##(1995-2#1)(2007-3#1)(2008-10#1)
in Colorectal Cancer##2##3##(2008-10#2)
in Columbia##2##2##(2008-10#1)(2013-1#1)
in Columbus##3##2##(1991-9#1)(1995-2#1)(1996-3#1)
in Combination with##4##3##(2006-12#3)(2010-12#1)
in Common Bean##3##3##(2008-10#3)
in Complex##2##2##(1991-12#1)(2009-9#1)
in Computing##3##2##(2008-2#2)(2008-3#1)
in Connecticut##6##2##(1991-12#1)(1992-2#1)(1993-12#1)(1996-3#3)
in Controlling##2##2##(1997-7#1)(2008-5#1)
in Copenhagen##5##2##(1993-3#1)(2011-2#1)(2011-4#2)(2013-1#1)
in Corcovado National Park##2##4##(2008-5#2)
in Corcovado##5##2##(2008-5#5)
in Corn##3##2##(2008-10#3)
in Coronary Artery Disease##2##4##(2008-11#1)(2010-11#1)
in Coronary Artery##3##3##(2008-11#1)(2010-11#1)(2010-8#1)
in Corsica##3##2##(1991-12#2)(2008-7#1)
in Cortex fraxini##2##3##(2008-10#2)
in Cosmetic##2##2##(2008-5#2)
in Costa Rica and##2##4##(2008-10#2)
in Costa Rica##12##3##(2008-10#4)(2008-5#4)(2009-9#1)(2011-2#2)(2012-2#1)
in Costa##13##2##(2008-10#4)(2008-5#4)(2009-9#1)(2011-2#2)(2012-2#2)
in Cotton##2##2##(2008-10#2)
in Crete##2##2##(2008-3#1)(2011-2#1)
in Critical Care##2##3##(2013-1#2)
in Croatia and##2##3##(2008-10#1)(2011-1#1)
in Croatia##15##2##(2008-10#3)(2011-1#5)(2011-2#7)
in Croatia]##2##2##(2008-10#2)
in Croatian##3##2##(2008-10#2)(2011-1#1)
in Crohn's disease##15##3##(1990-6#1)(1994-6#1)(2008-4#1)(2008-7#1)(2010-12#7)(2012-1#1)(2012-2#2)(2013-8#1)
in Cronartium ribicola##2##3##(2008-10#2)
in Cruzeiro do Sul##3##4##(2011-2#3)
in CsCl media##2##3##(2008-10#2)
in CsLiB6O10##2##2##(2008-2#1)(2008-3#1)
in Csb mice##2##3##(1990-12#2)
in Cu##3##2##(1991-12#1)(2008-10#1)(2013-8#1)
in Cuba and##3##3##(2007-10#2)(2013-1#1)
in Cuba compared to that##2##5##(2013-1#2)
in Cuba##17##2##(1993-8#1)(1996-11#1)(1997-5#1)(2007-10#3)(2007-12#1)(2008-5#2)(2013-1#8)
in Cucumber##4##2##(2008-10#4)
in Cucurbits##2##2##(2008-10#2)
in Culture##5##2##(2008-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
in Cushing's disease##2##3##(1990-3#1)(1991-11#1)
in Czochralski-grown##2##2##(2008-2#2)
in Côte d'Ivoire##2##3##(2008-10#2)
in Côte##3##2##(2008-10#2)(2009-10#1)
in D islets##5##3##(1995-8#5)
in D rats##2##3##(1994-6#2)
in D##26##2##(1994-6#2)(1995-6#1)(1995-8#6)(1996-2#1)(1997-5#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in D(2)O##2##2##(1996-5#1)(2008-10#1)
in D-penicillamine-induced autoimmunity##3##3##(2008-10#3)
in D29 cells##4##3##(2008-11#4)
in DA##4##2##(1995-12#1)(1996-12#1)(2008-7#1)(2011-1#1)
in DAS##2##2##(2008-1#1)(2008-3#1)
in DBA/2 mice##2##3##(1995-12#2)
in DBA/2##4##2##(1991-9#1)(1995-12#2)(1995-2#1)
in DCs##3##2##(2010-12#1)(2012-3#2)
in DD##4##2##(2008-5#3)(2013-7#1)
in DHH children##2##3##(2011-2#2)
in DL and T2D patients##2##5##(2011-2#2)
in DL##3##2##(2008-4#1)(2011-2#2)
in DM##3##2##(2010-2#1)(2012-2#1)(2012-5#1)
in DM2 patients##2##3##(1994-12#1)(2008-7#1)
in DMF##3##2##(2008-10#2)(2011-2#1)
in DMF-water mixture##2##3##(2008-10#2)
in DMSO##12##2##(1991-12#1)(1991-5#1)(1995-2#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2013-7#1)
in DMSO-water##2##2##(2008-10#2)
in DNA and##3##3##(1994-11#1)(1994-8#1)(2008-4#1)
in DNA binding##6##3##(1990-11#1)(1993-2#1)(1995-5#1)(1995-8#2)(2010-10#1)
in DNA chips##2##3##(2008-10#1)(2010-12#1)
in DNA content in##2##4##(2008-10#1)(2008-11#1)
in DNA content##3##3##(2008-10#1)(2008-11#2)
in DNA damage and##2##4##(1994-8#1)(2009-12#1)
in DNA damage##5##3##(1994-8#1)(1997-4#1)(2008-9#2)(2009-12#1)
in DNA from##3##3##(1993-3#1)(1994-5#1)(2008-10#1)
in DNA in##2##3##(1992-3#1)(1995-5#1)
in DNA metabolism##2##3##(2008-11#1)(2010-2#1)
in DNA repair##7##3##(1993-12#1)(1996-2#1)(2007-7#1)(2008-11#1)(2009-4#1)(2009-7#1)(2010-6#1)
in DNA replication##3##3##(1993-11#1)(2009-8#2)
in DNA samples extracted from##3##5##(2008-10#1)(2012-3#1)(2013-1#1)
in DNA samples##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
in DNA sequence##4##3##(1997-8#1)(2008-1#1)(2008-4#1)(2011-2#1)
in DNA sequences##3##3##(1995-2#1)(1996-3#1)(2008-4#1)
in DNA single-strand breaks##2##4##(1994-8#1)(1997-4#1)
in DNA synthesis and##3##4##(1990-2#1)(1992-3#1)(1993-9#1)
in DNA synthesis##7##3##(1990-2#1)(1992-3#2)(1993-11#1)(1993-9#3)
in DNA##96##2##(1990-11#2)(1990-2#1)(1990-5#2)(1991-2#1)(1992-3#4)(1992-4#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#4)(1995-12#1)(1995-2#3)(1995-5#2)(1995-8#3)(1996-2#3)(1996-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-4#7)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
in DNA-DNA interactions##3##3##(1995-12#3)
in DNA-binding##2##2##(1990-12#1)(1992-11#1)
in DNCB-treated cells##2##3##(2008-10#2)
in DOCA-salt WT##2##3##(2013-8#2)
in DOS##2##2##(2008-10#2)
in DOT##4##2##(2011-1#4)
in DPCSV##2##2##(2008-10#2)
in DPPC and##2##3##(1991-5#2)
in DR##4##2##(2008-1#2)(2008-11#1)(2011-2#1)
in DRG neurons##2##3##(1996-12#1)(2008-8#1)
in DRG##5##2##(1995-8#1)(1996-12#1)(1997-2#1)(2008-8#1)(2008-9#1)
in DSB repair##2##3##(1995-6#1)(2011-2#1)
in DSM-IV##2##2##(1997-8#1)(2011-2#1)
in DW##2##2##(1996-5#1)(2008-10#1)
in De##3##2##(2008-11#2)(2008-7#1)
in December 1995##2##3##(1995-12#1)(2008-7#1)
in December 1997##2##3##(2008-1#1)(2008-5#1)
in December 2000##2##3##(2007-7#1)(2008-11#1)
in December##16##2##(1991-8#1)(1993-1#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
in Delta##2##2##(2008-10#1)(2008-5#1)
in Denmark and Norway##5##4##(1990-11#2)(2008-7#3)
in Denmark##18##2##(1990-11#3)(1990-12#1)(1991-9#2)(1995-3#2)(1996-9#1)(1997-3#3)(1997-6#1)(2008-7#3)(2011-2#1)(2013-1#1)
in Department of##4##3##(2007-8#1)(2008-10#1)(2011-2#2)
in Deutsches Arzteblatt##2##3##(2009-7#2)
in Developing##3##2##(2008-10#3)
in Development##4##2##(2008-10#1)(2008-7#3)
in Diamond##2##2##(1996-9#1)(2007-10#1)
in Dictyostelium##5##2##(1991-2#2)(1993-6#1)(1995-8#1)(2008-9#1)
in Diesel##2##2##(2008-3#1)(2009-8#1)
in Different##6##2##(2008-10#3)(2008-11#1)(2009-12#1)(2009-5#1)
in Doppler global velocimetry##2##4##(2008-3#2)
in Doppler##4##2##(2008-1#1)(2008-3#3)
in Dordogne##2##2##(2008-10#2)
in Douglas-fir##3##2##(2008-10#3)
in Down syndrome##4##3##(1996-6#2)(2008-11#1)(2008-7#1)
in Down's syndrome##2##3##(1991-1#1)(1996-12#1)
in Down's##3##2##(1991-1#1)(1993-12#1)(1996-12#1)
in Drosophila and##3##3##(2007-12#1)(2008-10#1)(2009-7#1)
in Drosophila cell culture##2##4##(2008-2#1)(2012-2#1)
in Drosophila have not##2##4##(2008-10#1)(2008-9#1)
in Drosophila innubila##2##3##(2012-3#2)
in Drosophila melanogaster and##2##4##(1991-5#1)(2008-7#1)
in Drosophila melanogaster##24##3##(1991-5#1)(1993-2#4)(1994-9#1)(1995-6#1)(1995-8#2)(1997-6#1)(1997-7#4)(1997-8#1)(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-9#1)(2012-3#1)
in Drosophila##92##2##(1990-3#1)(1991-5#1)(1993-12#2)(1993-2#4)(1993-8#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-6#1)(1997-6#2)(1997-7#5)(1997-8#2)(2007-12#3)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#14)(2009-3#2)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#7)(2012-3#11)(2013-1#1)
in DuPont##2##2##(2008-2#1)(2008-5#1)
in Dukes##3##2##(2006-8#3)
in Dunedin##3##2##(1990-2#3)
in Dupuytren's##2##2##(2008-9#2)
in Dutch TAD soils##2##4##(2008-10#2)
in Dutch##7##2##(1990-9#1)(1994-3#1)(2008-10#3)(2008-5#1)(2009-12#1)
in E mu-myc transgenic mice##3##5##(1991-5#3)
in E##66##2##(1990-11#4)(1990-5#3)(1990-8#2)(1991-12#2)(1991-5#5)(1991-9#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-5#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#1)(2012-3#1)
in E1 activity##2##3##(2008-9#2)
in E1##3##2##(1991-12#1)(2008-9#2)
in EAE##2##2##(2007-11#1)(2010-12#1)
in EBV##3##2##(1992-12#2)(1995-2#1)
in EC deprived of L-arginine##2##5##(1990-12#2)
in EC deprived of##3##4##(1990-12#3)
in EC##5##2##(1990-12#3)(1997-2#1)(2013-8#1)
in EC-IC bypass##2##3##(2012-2#2)
in EC50##3##2##(1995-2#1)(1995-6#1)(2008-11#1)
in ECM##2##2##(1993-3#1)(2011-2#1)
in ECW123##2##2##(2008-10#2)
in ECW12346##2##2##(2008-10#2)
in ED##4##2##(2007-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
in EDL (P &lt##2##4##(1995-12#2)
in EDL##4##2##(1995-12#3)(2008-9#1)
in EDMD patients##2##3##(2008-7#2)
in EDMD##3##2##(2008-7#3)
in EDTA##4##2##(1992-3#1)(1993-12#2)(2008-11#1)
in EEG##3##2##(1991-1#1)(2010-8#1)(2013-8#1)
in ELISA##9##2##(1992-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-9#1)(1997-3#1)(2008-10#2)(2008-5#1)
in EMG activity##2##3##(2013-1#2)
in EMG##3##2##(2010-8#1)(2013-1#2)
in EMT6-S##2##2##(2008-11#2)
in EPC number##3##3##(2009-11#3)
in EPC##4##2##(2008-1#1)(2009-11#3)
in EPO##2##2##(2008-11#2)
in ER##2##2##(1990-5#1)(2008-11#1)
in ER-positive##2##2##(1994-7#1)(2011-2#1)
in ERMs##2##2##(2008-1#2)
in ES cells and##2##4##(1992-12#1)(1995-2#1)
in ES cells##4##3##(1992-12#1)(1995-2#2)(2012-12#1)
in ES##5##2##(1992-12#1)(1995-2#2)(2012-12#1)(2013-1#1)
in ESRD patients##2##3##(2007-7#1)(2008-7#1)
in ESRD##4##2##(2007-7#1)(2008-1#2)(2008-7#1)
in ET##3##2##(2008-7#3)
in Early##6##2##(1995-4#1)(2008-1#1)(2008-10#2)(2010-9#1)(2011-1#1)
in East Asia##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
in East and Southeast Asia##2##5##(2009-5#2)
in East and##3##3##(2009-5#3)
in East##14##2##(1993-2#1)(2008-10#6)(2008-8#2)(2009-5#3)(2011-1#1)(2013-1#1)
in Eastern##11##2##(1991-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#2)
in EcPFK##2##2##(1995-5#2)
in Ecuador and##2##3##(2008-10#2)
in Ecuador##10##2##(2008-10#9)(2008-5#1)
in Egypt in##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
in Egypt##26##2##(1994-11#1)(2007-7#5)(2008-1#4)(2008-10#6)(2008-12#3)(2010-10#2)(2010-4#2)(2011-2#1)(2013-1#2)
in El Salvador##2##3##(1994-2#1)(2011-2#1)
in El##3##2##(1994-2#1)(2011-2#1)(2013-7#1)
in Elderly##3##2##(2011-2#1)(2012-3#2)
in England and Wales in##2##5##(1991-11#1)(2011-2#1)
in England and Wales##15##4##(1990-6#1)(1991-11#1)(1991-8#1)(1995-3#3)(1995-6#1)(1996-8#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#3)
in England and##18##3##(1990-6#2)(1991-11#1)(1991-8#1)(1995-3#3)(1995-6#1)(1996-8#1)(2007-12#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-12#1)
in England in##2##3##(1996-3#1)(2010-1#1)
in England##32##2##(1990-6#2)(1991-11#1)(1991-8#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-7#3)(2008-8#1)(2010-1#1)(2011-2#4)(2012-12#1)(2013-8#1)
in English and##3##3##(1996-9#1)(2008-2#1)(2012-1#1)
in English or##2##3##(2011-2#1)(2013-1#1)
in English##27##2##(1993-6#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
in Enugu were##2##3##(2010-8#2)
in Enugu##5##2##(2010-8#3)(2013-1#2)
in Epstein-Barr virus##3##3##(1992-12#1)(1994-3#1)(1994-8#1)
in Er##2##2##(2007-11#1)(2008-3#1)
in Eretz Israel##3##3##(2011-2#3)
in Erie County##2##3##(1996-1#2)
in Escherichia coli K-12##2##4##(1990-11#1)(2009-6#1)
in Escherichia coli and Salmonella typhimurium##2##6##(1994-8#2)
in Escherichia coli and##16##4##(1990-11#1)(1990-5#1)(1991-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-2#2)(1995-6#1)(1997-4#1)(2007-6#1)(2008-10#1)(2011-1#1)
in Escherichia coli by##2##4##(1993-9#1)(2008-11#1)
in Escherichia coli from a##2##5##(1991-5#1)(1993-12#1)
in Escherichia coli from##3##4##(1991-5#1)(1993-12#1)(2011-1#1)
in Escherichia coli of a##3##5##(1992-12#1)(1993-9#1)(2008-7#1)
in Escherichia coli to##2##4##(1993-12#1)(2009-3#1)
in Escherichia coli under##2##4##(1992-3#1)(1994-12#1)
in Escherichia coli using the##3##5##(1992-8#1)(1993-8#1)(1997-4#1)
in Escherichia coli using##4##4##(1991-3#1)(1992-8#1)(1993-8#1)(1997-4#1)
in Escherichia coli was##6##4##(1990-5#2)(1993-9#1)(1994-11#1)(1994-12#1)(2008-1#1)
in Escherichia coli##132##3##(1990-11#5)(1990-5#4)(1990-7#1)(1990-8#2)(1991-12#4)(1991-3#2)(1991-5#4)(1991-7#2)(1991-9#5)(1992-12#2)(1992-3#1)(1992-6#4)(1992-8#3)(1993-11#2)(1993-12#3)(1993-6#3)(1993-8#2)(1993-9#5)(1994-11#3)(1994-12#8)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#7)(1995-6#4)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-6#1)(1997-8#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)
in Essential##3##2##(2008-7#2)(2012-2#1)
in Essex County##2##3##(2008-10#2)
in Estonia##2##2##(2012-12#2)
in EtOH##3##2##(2008-10#2)(2008-8#1)
in Ethiopia##9##2##(1994-3#1)(1995-9#2)(2008-10#2)(2008-8#1)(2010-4#2)(2012-3#1)
in Eucalyptus##3##2##(2008-10#2)(2009-12#1)
in Europe and North America##3##5##(2008-10#1)(2008-7#1)(2012-3#1)
in Europe and North##4##4##(2008-10#1)(2008-7#1)(2012-3#2)
in Europe and the##6##4##(2008-1#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)
in Europe and##13##3##(1991-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-3#2)
in Europe compared##2##3##(2008-8#1)(2009-4#1)
in Europe is##2##3##(1996-7#1)(2009-4#1)
in Europe or##2##3##(1997-6#1)(2008-10#1)
in Europe since##2##3##(1997-6#1)(2011-2#1)
in Europe##105##2##(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-9#1)(1995-3#2)(1996-12#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#7)(2009-11#1)(2009-4#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-10#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#3)
in European countries##2##3##(2013-1#2)
in European hazelnut orchards##2##4##(2008-10#2)
in European health##2##3##(1995-3#1)(2008-7#1)
in European##21##2##(1991-12#1)(1991-4#2)(1992-1#1)(1995-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#4)
in Europids##2##2##(2010-4#2)
in Eutypa##2##2##(2008-10#2)
in Evaluating##2##2##(2008-10#1)(2010-7#1)
in Experiment 1##5##3##(2007-6#1)(2008-11#1)(2008-6#1)(2009-2#1)(2013-8#1)
in Experiment 2##2##3##(2008-2#1)(2008-6#1)
in Experiment 3##3##3##(1994-2#1)(2008-5#2)
in Experiment##13##2##(1994-2#2)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#4)(2008-6#2)(2009-2#1)(2013-8#1)
in Experimental Group##2##3##(2007-6#2)
in Express Five SFM##2##4##(2008-7#2)
in Ezafluor mouth wash##2##4##(2008-10#2)
in F islets##2##3##(1995-8#2)
in F##13##2##(1995-8#3)(2008-10#8)(2011-10#1)(2013-1#1)
in F(2) population##2##3##(2008-8#2)
in F(2)##3##2##(2008-10#1)(2008-8#2)
in F1 and F2##2##4##(2008-12#2)
in F1##3##2##(1997-6#1)(2008-12#2)
in F2##2##2##(1993-2#1)(2008-12#1)
in F344/N rats##4##3##(1994-2#1)(2008-9#3)
in FA##2##2##(1997-3#2)
in FACT-F##2##2##(2008-7#2)
in FALS mice##2##3##(1996-5#2)
in FAST schools##2##3##(2012-12#2)
in FAST##3##2##(2012-12#3)
in FBG##3##2##(2008-10#1)(2008-5#2)
in FD patients##3##3##(2008-10#3)
in FDC-P2##2##2##(1997-7#2)
in FEV1##4##2##(2007-2#2)(2011-2#1)(2012-3#1)
in FEy1##2##2##(2007-2#2)
in FHB##2##2##(2008-10#2)
in FIA mode##2##3##(2008-10#2)
in FIA##5##2##(2008-10#5)
in FISH##2##2##(2008-4#2)
in FLHCC##2##2##(2010-3#2)
in FM patients##2##3##(2009-11#1)(2010-12#1)
in FM##3##2##(2009-11#1)(2010-12#2)
in FMS##3##2##(2011-2#3)
in FTIR##2##2##(2008-10#1)(2013-1#1)
in Family##2##2##(2008-11#1)(2009-12#1)
in Fan##2##2##(2010-12#1)(2012-12#1)
in Fao cells##3##3##(1992-10#1)(2008-4#2)
in Fao##4##2##(1992-10#2)(2008-4#2)
in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice compared to p48(Cre/+)-LSL-Kras(G12D/+) mice##2##7##(2013-1#2)
in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+)##3##2##(2013-1#3)
in Fe##5##2##(1995-3#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
in February 1994##2##3##(1996-3#1)(1997-2#1)
in February 2008##2##3##(2011-2#2)
in February and March##2##4##(2008-10#1)(2013-8#1)
in February and##6##3##(2008-10#1)(2008-3#1)(2008-5#2)(2013-8#2)
in February##20##2##(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#3)(2010-2#1)(2011-2#5)(2012-2#1)(2013-7#1)(2013-8#2)
in Female##2##2##(1994-12#1)(2008-10#1)
in Field Populations of Mycosphaerella graminicola##3##6##(2008-10#3)
in Field Populations of##4##4##(2008-10#4)
in Field##9##2##(2008-10#9)
in Fiji##18##2##(2008-1#15)(2008-10#1)(2012-12#1)(2013-8#1)
in Finland and##2##3##(1990-11#1)(2011-1#1)
in Finland##9##2##(1990-11#2)(1992-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-5#1)(2011-1#1)
in Finnish##3##2##(1994-12#1)(1996-3#1)(2008-7#1)
in Finnmark##4##2##(1993-11#1)(1993-3#1)(1993-6#2)
in Finnmark]##4##2##(1993-11#1)(1993-6#1)(1995-6#2)
in Fischer##2##2##(1994-6#1)(1996-9#1)
in Flanders##2##2##(2010-8#1)(2013-8#1)
in Florida and Texas##2##4##(2008-10#2)
in Florida and the Caribbean and##2##6##(2011-2#2)
in Florida and the Caribbean##5##5##(2008-10#1)(2011-2#4)
in Florida and##16##3##(1992-8#1)(2008-10#8)(2011-2#5)(2012-3#1)(2013-8#1)
in Florida is caused##2##4##(2008-10#2)
in Florida to##2##3##(1993-3#1)(2011-2#1)
in Florida##48##2##(1992-8#2)(1993-3#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#28)(2011-2#10)(2012-3#3)(2013-8#1)
in Forestier's disease##2##3##(2007-8#2)
in Fortaleza##2##2##(1991-9#1)(2007-2#1)
in Fourier space##2##3##(2008-2#1)(2010-6#1)
in Fourier transform infrared##2##4##(2008-10#1)(2008-3#1)
in Fourier transform spectroscopy##5##4##(2008-2#5)
in Fourier transform##9##3##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#2)
in Fourier##11##2##(2007-11#1)(2008-10#1)(2008-2#6)(2008-3#2)(2010-6#1)
in Fourier-transform##2##2##(2007-11#1)(2008-3#1)
in France and##7##3##(2008-10#4)(2008-2#1)(2012-2#1)(2013-8#1)
in France for##2##3##(2008-10#1)(2008-5#1)
in France from##2##3##(2008-10#1)(2010-1#1)
in France##47##2##(1990-8#1)(1991-11#2)(1994-12#1)(1997-5#2)(2007-12#1)(2008-1#1)(2008-10#19)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in France]##4##2##(1996-3#1)(2007-6#1)(2010-6#2)
in French Soudan##2##3##(2010-1#2)
in French beans##2##3##(2008-10#2)
in French children##2##3##(2009-7#2)
in French##10##2##(1990-8#1)(2008-10#5)(2009-7#2)(2010-1#2)
in Fungi##2##2##(2009-9#1)(2011-2#1)
in Fusarium oxysporum f##4##4##(2008-10#4)
in Fusarium##5##2##(2008-10#5)
in G protein##2##3##(1997-2#1)(2009-12#1)
in G##12##2##(1993-12#1)(1995-6#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)
in G-1##5##2##(1996-9#5)
in G-2##5##2##(1996-9#5)
in G0 + G1##2##4##(1990-11#2)
in G1 and##2##3##(1997-3#1)(1997-8#1)
in G1 extract##3##3##(1994-8#3)
in G1 phase##2##3##(2008-11#2)
in G1##13##2##(1993-9#1)(1994-8#4)(1997-3#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-7#1)(2008-9#1)
in G2##2##2##(1996-3#1)(1997-3#1)
in G6PD-deficient subjects##2##3##(1991-2#2)
in GABA##2##2##(1995-12#2)
in GABAergic inhibition##3##3##(2009-8#1)(2013-8#2)
in GABAergic##4##2##(2008-1#1)(2009-8#1)(2013-8#2)
in GAD67##2##2##(1996-12#1)(2013-8#1)
in GBM##5##2##(2009-4#3)(2011-2#2)
in GBW##2##2##(2008-10#2)
in GBW07401##2##2##(2008-10#2)
in GC##2##2##(2008-10#2)
in GC/ECD##3##2##(2008-10#3)
in GC/MS##2##2##(2008-10#2)
in GEPR-3 compared to SD rats and GEPR-9##2##8##(1996-12#2)
in GEPR-3##3##2##(1996-12#3)
in GEPR-9##2##2##(1996-12#2)
in GFAP##4##2##(1990-7#4)
in GFR##2##2##(2008-1#2)
in GH3 cells##3##3##(1992-8#2)(1996-2#1)
in GH3 pituitary cells##2##4##(1992-8#1)(1993-8#1)
in GH3##5##2##(1992-8#3)(1993-8#1)(1996-2#1)
in GH4C1 cells##4##3##(1990-7#2)(1991-6#2)
in GLP-1##2##2##(2011-2#2)
in GR##2##2##(1994-2#2)
in GST##2##2##(1997-7#1)(2008-8#1)
in GT##2##2##(2006-6#1)(2008-9#1)
in GTP##3##2##(2008-3#2)(2008-4#1)
in GVA-infected##2##2##(2008-10#2)
in GaAs for##2##3##(2008-3#2)
in GaAs microdisks##2##3##(2007-11#2)
in GaAs##9##2##(1990-12#1)(1996-12#1)(2007-11#2)(2008-2#1)(2008-3#4)
in GaP##2##2##(2007-11#2)
in Gansu Province during 2011##2##5##(2013-8#2)
in Gansu Province during##3##4##(2013-8#3)
in Gansu Province##6##3##(2013-8#6)
in Gaza##2##2##(2008-1#1)(2008-9#1)
in Ge(20)As(25)S(55)##3##2##(2007-12#3)
in Ge-doped##2##2##(2007-11#1)(2007-12#1)
in GenBank##9##2##(1990-11#1)(1996-2#1)(2008-10#3)(2008-8#1)(2008-9#3)
in General Practice##2##3##(2008-1#1)(2013-1#1)
in Geneva##4##2##(1990-2#1)(1991-6#1)(2010-12#1)(2010-5#1)
in Georgia##11##2##(1991-11#1)(1996-12#1)(2008-10#8)(2008-6#1)
in Germany and Italy##2##4##(2011-2#2)
in Germany and the##2##4##(1992-12#1)(2008-10#1)
in Germany and##9##3##(1992-12#1)(2008-10#4)(2011-2#3)(2013-1#1)
in Germany in##2##3##(2008-10#1)(2008-11#1)
in Germany##41##2##(1992-1#1)(1992-12#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
in Germany]##2##2##(1995-11#1)(2010-12#1)
in Ghana##4##2##(1997-4#1)(2009-12#2)(2011-1#1)
in Ginkgo biloba##2##3##(2008-11#2)
in Glycyrrhizae radix et rhizoma##4##5##(2011-1#4)
in Gorski Kotar##2##3##(2011-2#2)
in Gossypium##2##2##(2008-10#1)(2008-9#1)
in Grace's medium with##2##4##(2008-11#2)
in Grace's medium##3##3##(2008-11#3)
in Granada##2##2##(2008-5#1)(2009-10#1)
in Grapevine Leaves##2##3##(2008-10#2)
in Grapevine##4##2##(2008-10#4)
in Graves' disease##4##3##(1992-5#1)(1994-11#1)(2008-4#1)(2013-8#1)
in Graves'##7##2##(1992-5#1)(1994-11#1)(2008-4#1)(2008-7#3)(2013-8#1)
in Great Britain has##2##4##(1996-3#1)(2008-5#1)
in Great Britain##5##3##(1991-2#1)(1996-11#1)(1996-3#1)(2008-5#2)
in Great##6##2##(1991-2#1)(1996-11#1)(1996-3#1)(2008-5#2)(2012-3#1)
in Greece and##2##3##(1993-9#1)(2008-8#1)
in Greece##7##2##(1993-9#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)
in Greek offspring##2##3##(2010-4#2)
in Greek##3##2##(2010-4#2)(2010-6#1)
in Group 1##6##3##(2008-12#1)(2010-3#1)(2011-1#2)(2011-2#2)
in Group 2##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
in Group 3##2##3##(2011-2#2)
in Group A##2##3##(2010-12#1)(2010-7#1)
in Group I was##2##4##(2007-8#1)(2008-8#1)
in Group I##10##3##(1992-11#3)(2007-8#4)(2008-8#1)(2013-1#2)
in Group II were##2##4##(2013-1#2)
in Group II##9##3##(1992-11#2)(2007-8#4)(2008-10#1)(2013-1#2)
in Group III##2##3##(2007-8#2)
in Group##37##2##(1992-11#5)(2007-8#10)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-3#2)(2010-7#4)(2011-1#3)(2011-2#5)(2013-1#4)
in Group-I##2##2##(2007-8#2)
in Groups##4##2##(2007-8#1)(2008-10#1)(2009-10#1)(2010-12#1)
in Guadalajara##2##2##(2012-12#2)
in Guadeloupe in 2005##2##4##(2008-10#2)
in Guadeloupe##7##2##(2008-10#7)
in Guangzhou##5##2##(2011-2#1)(2013-8#4)
in Guatemala City##2##3##(2011-1#2)
in Guatemala##4##2##(2008-10#1)(2010-1#1)(2011-1#2)
in Guinea-Bissau##2##2##(1996-6#1)(2011-1#1)
in H##24##2##(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-9#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
in H(2)##8##2##(2007-11#3)(2008-2#1)(2008-7#1)(2010-12#1)(2010-4#2)
in H295R##3##2##(1995-12#2)(2013-1#1)
in H4##2##2##(1994-6#2)
in H9 cells##2##3##(1990-8#1)(1992-6#1)
in HA##2##2##(2008-10#2)
in HARTOB##2##2##(2008-10#2)
in HASTs was##2##3##(2013-1#2)
in HASTs##3##2##(2013-1#3)
in HBV##2##2##(1990-8#1)(2009-4#1)
in HBeAg-negative patients##2##3##(2013-1#2)
in HBsAg-negative##2##2##(2008-4#1)(2011-2#1)
in HC##4##2##(2008-11#2)(2012-3#2)
in HCC cells##2##3##(2008-8#2)
in HCC development##2##3##(2013-8#2)
in HCC patients##3##3##(2008-10#3)
in HCC##11##2##(2008-10#4)(2008-8#3)(2010-12#1)(2011-2#1)(2013-8#2)
in HCCs##2##2##(1991-11#1)(2011-2#1)
in HCM##4##2##(2008-10#1)(2008-7#2)(2012-2#1)
in HCT116 colon cancer cells##2##5##(2011-2#2)
in HCT116##3##2##(2011-2#3)
in HCV replication##2##3##(2012-2#1)(2013-1#1)
in HCV##5##2##(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#2)
in HCl and##2##3##(2008-10#2)
in HCl medium##3##3##(2008-10#3)
in HCl solution##2##3##(2008-10#2)
in HCl##8##2##(2008-10#8)
in HD##6##2##(1995-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-10#1)(2011-8#1)
in HDL-C##2##2##(2013-1#2)
in HEC##2##2##(1995-12#1)(2008-5#1)
in HEK 293##2##3##(2008-11#1)(2011-2#1)
in HEK293 and COS-1 cells##3##5##(2008-8#3)
in HEK293 and##4##3##(2008-11#1)(2008-8#3)
in HEK293 cells##6##3##(2008-4#1)(2008-8#1)(2009-12#1)(2010-1#2)(2011-2#1)
in HEK293##11##2##(2008-11#1)(2008-4#1)(2008-8#5)(2009-12#1)(2010-1#2)(2011-2#1)
in HEPES##2##2##(2008-10#2)
in HG mode##3##3##(2008-10#3)
in HG##7##2##(1992-8#4)(2008-10#3)
in HHR##2##2##(2011-2#1)(2012-2#1)
in HI##2##2##(1997-3#1)(2008-1#1)
in HIIE (p##2##3##(2013-8#2)
in HIV controllers##2##3##(2012-2#2)
in HIV disease##3##3##(1995-3#1)(2008-4#2)
in HIV infected individuals##2##4##(2009-4#1)(2012-12#1)
in HIV infected patients##3##4##(2007-7#1)(2008-8#1)(2013-8#1)
in HIV infected##8##3##(2007-7#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-8#2)
in HIV infection##9##3##(1990-6#1)(1991-8#1)(2008-11#1)(2008-12#2)(2012-12#1)(2013-8#3)
in HIV infection]##2##3##(1996-6#1)(1997-4#1)
in HIV patients##3##3##(2007-10#1)(2008-1#1)(2013-1#1)
in HIV positive patient##2##4##(2007-7#1)(2010-12#1)
in HIV positive patients##3##4##(2008-5#2)(2010-12#1)
in HIV positive##5##3##(2007-7#1)(2008-5#2)(2010-12#2)
in HIV prevention##3##3##(1996-11#1)(1997-5#1)(2009-5#1)
in HIV##57##2##(1990-2#1)(1990-6#1)(1991-8#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-7#4)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-4#3)(2009-5#3)(2010-12#2)(2010-5#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#6)
in HIV-1 infected individuals##4##4##(2008-11#3)(2010-8#1)
in HIV-1 infected##8##3##(2007-12#1)(2008-11#5)(2010-8#2)
in HIV-1 infection##3##3##(1994-6#1)(2008-2#1)(2013-8#1)
in HIV-1##22##2##(1992-6#2)(1994-6#1)(1995-9#2)(2007-12#1)(2008-11#5)(2008-2#3)(2009-8#2)(2010-8#2)(2012-12#1)(2013-8#3)
in HIV-associated##2##2##(2011-2#1)(2013-1#1)
in HIV-infected children##3##3##(1992-8#1)(2007-12#1)(2009-7#1)
in HIV-infected individuals##2##3##(1996-8#1)(2009-7#1)
in HIV-infected patients##7##3##(1996-11#1)(2007-12#1)(2008-1#1)(2008-5#2)(2008-8#1)(2010-5#1)
in HIV-infected##16##2##(1992-8#3)(1996-11#1)(1996-8#1)(2007-12#2)(2008-1#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#3)(2010-5#1)
in HIV-related##2##2##(1990-9#1)(2009-10#1)
in HIV/AIDS patients##2##3##(2010-9#1)(2012-12#1)
in HIV/AIDS##7##2##(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2010-9#1)(2012-12#1)
in HIV/AIDS-related##2##2##(2011-2#1)(2013-1#1)
in HL-60 cells##12##3##(1993-6#1)(1994-11#2)(1994-8#2)(1995-6#1)(1996-2#2)(2008-8#3)(2011-2#1)
in HL-60##16##2##(1993-6#1)(1994-11#2)(1994-8#3)(1995-6#2)(1995-8#1)(1996-2#2)(2008-8#3)(2011-2#2)
in HL60 cells##2##3##(1994-8#1)(2012-12#1)
in HMD's##2##2##(2008-3#2)
in HMO##2##2##(1993-12#1)(1996-3#1)
in HMOs##6##2##(1993-3#1)(1994-3#3)(1997-2#2)
in HNO(3)##2##2##(2008-10#2)
in HNSCC##2##2##(1997-7#1)(2013-1#1)
in HOBs##2##2##(2013-1#2)
in HOMA-IR##3##2##(2008-3#1)(2013-8#2)
in HPB##2##2##(2013-1#2)
in HPLC##8##2##(2008-10#7)(2008-5#1)
in HPV##2##2##(1995-9#1)(2013-1#1)
in HPX rats##2##3##(2008-5#2)
in HR##6##2##(2008-10#1)(2010-7#1)(2012-2#1)(2013-8#3)
in HR-HPV##2##2##(2011-1#2)
in HRS cells in##2##4##(1993-9#2)
in HSCs##2##2##(2009-7#2)
in HSE##3##2##(1995-5#3)
in HSP70 mRNA##2##3##(2008-6#2)
in HT-29##2##2##(1994-8#1)(2010-1#1)
in HT29 colon cancer##2##4##(1992-8#2)
in HTH##2##2##(1996-5#2)
in HTLV-I##2##2##(1991-11#1)(1991-12#1)
in HUH7-ins##2##2##(2010-11#2)
in HUVEC##6##2##(1993-11#2)(1997-1#1)(2012-2#1)(2013-8#2)
in HaCaT keratinocytes##2##3##(2009-6#2)
in Hacinas##3##2##(2009-10#3)
in Haiti##3##2##(2008-4#2)(2011-2#1)
in Halobacterium halobium##2##3##(1990-11#1)(1990-5#1)
in Hamilton##2##2##(1996-7#1)(2009-3#1)
in Han Chinese populations##2##4##(2008-8#2)
in Han Chinese##4##3##(2008-8#2)(2008-9#2)
in Han##6##2##(2008-8#2)(2008-9#2)(2011-1#2)
in Hartmanngrams##2##2##(2008-3#2)
in Hawai'i##2##2##(2008-1#2)
in Hawaii##10##2##(1994-2#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-7#1)(2011-2#1)
in Hb##2##2##(1992-3#1)(1994-12#1)
in HbA1##3##2##(1991-5#3)
in HcNPV##2##2##(2008-11#2)
in Hca-F cells##2##3##(2012-3#2)
in HeLa cells##15##3##(1990-5#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2012-2#2)
in HeLa##16##2##(1990-5#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)(2012-2#2)
in Head##2##2##(2011-2#1)(2012-2#1)
in Health Care##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
in Health##13##2##(1991-1#2)(1994-2#1)(1996-2#1)(1997-2#3)(2007-2#1)(2008-11#1)(2011-1#1)(2012-2#2)(2012-3#1)
in Healthy Adults##2##3##(2008-3#1)(2012-3#1)
in Healthy##7##2##(2008-10#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
in Helianthus##2##2##(2008-10#1)(2009-6#1)
in Helicobacter pylori##4##3##(1996-11#1)(1997-7#1)(2009-6#1)(2012-12#1)
in Helicobacter##5##2##(1996-11#1)(1997-7#1)(2008-8#1)(2009-6#1)(2012-12#1)
in Heliconius##2##2##(2013-1#2)
in Helix##2##2##(2008-12#1)(2013-1#1)
in Helsinki##2##2##(1992-3#1)(2008-7#1)
in Hep G2 cells##3##4##(2008-11#3)
in Hep-2 cells##2##3##(2011-2#2)
in HepG2 cells##2##3##(1993-6#1)(1994-8#1)
in High Five cell cultures##3##5##(2008-7#3)
in High##6##2##(2008-7#4)(2010-7#1)(2011-2#1)
in Higher Education##3##3##(2008-11#1)(2012-3#2)
in Higher##4##2##(1996-9#1)(2008-11#1)(2012-3#2)
in Hispanic##4##2##(1994-9#1)(2008-9#1)(2010-8#1)(2012-2#1)
in Ho Chi Minh City##2##5##(2008-7#2)
in Hodgkin's disease##2##3##(1994-12#1)(1996-3#1)
in Hong Kong and##2##4##(2008-7#1)(2011-1#1)
in Hong Kong##20##3##(1997-1#1)(2007-12#2)(2008-10#2)(2008-7#3)(2008-9#2)(2009-5#2)(2010-11#4)(2011-1#1)(2011-2#1)(2012-6#1)(2013-8#1)
in Hordaland##2##2##(1994-11#1)(1996-6#1)
in Hospital##2##2##(2008-5#1)(2013-1#1)
in Houston##3##2##(1994-3#1)(2008-10#1)(2010-3#1)
in Houttuynia cordata Thunb##2##4##(2008-10#2)
in Human##13##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#2)
in Humans##2##2##(2010-8#1)(2012-2#1)
in Hungary##13##2##(1991-3#3)(1996-6#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-7#2)(2013-8#1)
in Hungary]##2##2##(1997-3#1)(1997-8#1)
in Huntington's disease##5##3##(1995-5#1)(2008-5#1)(2008-7#1)(2011-10#1)(2011-2#1)
in Huntington's##6##2##(1995-5#1)(2008-5#1)(2008-7#1)(2011-10#2)(2011-2#1)
in Hybrid Poplars##3##3##(2008-10#3)
in Hybrid##4##2##(2008-10#3)(2008-3#1)
in I##5##2##(1997-7#1)(2008-10#1)(2008-9#1)(2013-7#1)(2013-8#1)
in IBD##2##2##(2010-6#1)(2013-8#1)
in ICC 14216 K##2##4##(2008-10#2)
in ICP##2##2##(2006-7#1)(2008-10#1)
in ICP-AES##2##2##(2008-10#2)
in ICU patients##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
in ICU##5##2##(1995-12#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
in ICUs##3##2##(2008-8#1)(2012-2#2)
in IL-3##2##2##(1995-6#2)
in IL-6##2##2##(1995-12#1)(2008-10#1)
in IL-6-mediated##2##2##(1995-12#1)(2009-4#1)
in IMR-90##2##2##(1995-12#1)(1997-1#1)
in IMS##2##2##(2008-10#2)
in IP differs from##2##4##(2008-7#2)
in IP##4##2##(2008-7#4)
in IPD##2##2##(2008-7#2)
in IPL-41 medium##2##3##(2008-11#2)
in IPMN##2##2##(2012-2#2)
in IR##2##2##(2008-10#1)(2008-3#1)
in IT##2##2##(1995-2#2)
in IVF##2##2##(2011-1#1)(2012-3#1)
in IVMD101 medium##3##3##(2008-11#3)
in Ibadan##5##2##(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#2)
in Ibn##2##2##(2008-1#1)(2013-1#1)
in Iceland in the##2##4##(1993-3#1)(2006-8#1)
in Iceland##5##2##(1993-3#1)(2006-10#1)(2006-8#2)(2011-2#1)
in Icelandic##3##2##(2006-8#1)(2007-10#1)(2011-2#1)
in IgA##2##2##(1992-8#1)(2009-6#1)
in IgG##2##2##(2008-10#1)(2008-7#1)
in IgM##2##2##(1992-8#1)(2008-7#1)
in Illinois##7##2##(1994-12#1)(2008-10#6)
in Ilorin##3##2##(2011-1#3)
in InP##2##2##(2008-3#2)
in India and other##3##4##(2008-10#1)(2009-4#2)
in India and the##2##4##(2008-1#1)(2011-2#1)
in India and##8##3##(2008-1#1)(2008-10#2)(2008-11#1)(2009-4#3)(2011-2#1)
in India in##2##3##(2008-10#1)(2011-1#1)
in India is##2##3##(1995-10#1)(2009-12#1)
in India to##2##3##(1996-9#2)
in India##83##2##(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#2)(1996-11#1)(1996-8#1)(1996-9#3)(1997-5#1)(1997-8#1)(2007-12#1)(2007-7#5)(2008-1#3)(2008-10#10)(2008-11#2)(2008-3#5)(2008-5#1)(2008-7#2)(2009-10#2)(2009-12#3)(2009-4#6)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#5)(2013-8#1)
in Indian patients##4##3##(1997-8#2)(2007-7#1)(2008-3#1)
in Indian population##3##3##(2012-2#3)
in Indian##14##2##(1997-8#2)(2007-7#3)(2008-11#1)(2008-3#1)(2012-2#4)(2013-1#2)(2013-8#1)
in Indiana and##2##3##(2008-10#2)
in Indiana##4##2##(2008-10#4)
in Indians##3##2##(2008-8#1)(2009-4#2)
in Indigenous##4##2##(2011-1#3)(2013-1#1)
in Indonesia##5##2##(2008-12#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-5#1)
in Infected##3##2##(2008-10#2)(2008-11#1)
in Inflammatory Bowel##2##3##(2010-12#1)(2012-12#1)
in Inflammatory##3##2##(2008-5#1)(2010-12#1)(2012-12#1)
in Inner Mongolia in 2010##2##5##(2013-8#2)
in Inner Mongolia##6##3##(2013-8#6)
in Inoculated##2##2##(2008-10#2)
in InsP3 and InsP4 levels##2##5##(1991-12#2)
in Intensive Care Units##3##4##(2007-11#1)(2010-4#1)(2013-1#1)
in Intensive Care##5##3##(2007-11#2)(2010-4#1)(2012-12#1)(2013-1#1)
in Internal##2##2##(2008-10#1)(2013-1#1)
in Iowa from##2##3##(2008-10#2)
in Iowa##14##2##(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#9)(2008-12#1)
in Ipomoea nil##2##3##(2008-10#2)
in Iran##34##2##(2007-7#1)(2007-9#2)(2008-10#3)(2008-12#9)(2008-3#2)(2008-7#2)(2010-8#3)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)
in Iranian##11##2##(2008-12#8)(2012-12#2)(2013-1#1)
in Iraq and##2##3##(2007-7#1)(2013-1#1)
in Iraq##3##2##(2007-7#1)(2009-6#1)(2013-1#1)
in Ireland##9##2##(1993-2#2)(1997-4#1)(2008-11#3)(2009-5#1)(2012-2#1)(2012-3#1)
in Irish##3##2##(1991-11#1)(1997-8#1)(2008-11#1)
in Irrigation Water##2##3##(2008-10#2)
in Isfahan##4##2##(2010-8#2)(2012-12#2)
in Israel and Palestine##3##4##(2009-2#3)
in Israel and##7##3##(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#3)(2011-2#1)
in Israel##27##2##(1997-1#1)(1997-8#1)(2008-1#2)(2008-10#14)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#3)(2011-2#3)
in Israel]##2##2##(2011-2#2)
in Istanbul##2##2##(1996-5#1)(2010-11#1)
in Italian##14##2##(1990-8#2)(1992-2#1)(1994-12#1)(1994-2#2)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#4)
in Italy and##5##3##(1992-9#1)(1994-8#1)(2008-12#1)(2008-8#1)(2011-2#1)
in Italy is##3##3##(1991-2#1)(1995-9#1)(2008-2#1)
in Italy was##2##3##(2008-12#1)(2008-8#1)
in Italy##43##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1992-2#1)(1992-8#1)(1992-9#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-9#2)(2008-10#4)(2008-12#2)(2008-2#1)(2008-8#3)(2009-10#1)(2009-4#1)(2010-1#1)(2011-2#5)(2011-3#1)(2013-8#3)
in Ivory Coast##3##3##(2008-10#2)(2013-1#1)
in J##4##2##(2008-2#1)(2008-5#1)(2009-10#1)(2012-3#1)
in J774 cells##4##3##(1990-7#1)(1994-8#3)
in J774##5##2##(1990-7#1)(1994-8#3)(1996-12#1)
in Jack##2##2##(2008-10#2)
in Jamaica##23##2##(2007-5#1)(2008-10#1)(2009-7#11)(2011-2#10)
in Jamaican children##4##3##(2009-7#2)(2011-2#2)
in Jamaican##6##2##(2009-7#3)(2011-2#3)
in January 1992##3##3##(1992-1#1)(1992-12#1)(1996-9#1)
in January 2002##2##3##(2008-7#1)(2008-9#1)
in January 2007##2##3##(2009-5#1)(2010-5#1)
in January 2008##2##3##(2009-9#1)(2011-2#1)
in January 2010##2##3##(2013-1#2)
in January##26##2##(1990-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-3#1)(1995-3#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
in Japan and other##2##4##(2010-12#1)(2011-3#1)
in Japan and##10##3##(1993-2#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
in Japan between##2##3##(2008-5#1)(2013-1#1)
in Japan by##2##3##(2008-10#1)(2008-5#1)
in Japan could##2##3##(2009-2#1)(2010-2#1)
in Japan during the##2##4##(2011-2#2)
in Japan for##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
in Japan in##3##3##(2008-5#1)(2010-4#1)(2010-6#1)
in Japan is##3##3##(1996-4#1)(2006-10#1)(2008-10#1)
in Japan were##5##3##(1997-8#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-3#1)
in Japan##142##2##(1991-2#1)(1991-8#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-4#2)(1996-6#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#5)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-1#5)(2008-10#21)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#11)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#4)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#5)(2010-6#2)(2010-8#6)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#6)(2013-1#6)(2013-8#2)
in Japanese Black cows##3##4##(2013-1#3)
in Japanese Black##5##3##(2010-2#2)(2013-1#3)
in Japanese flounder##2##3##(2008-6#1)(2010-8#1)
in Japanese forests from 1980 to 2009##2##7##(2012-2#2)
in Japanese forests##3##3##(2012-2#3)
in Japanese patients with moderate to severe Crohn's disease##2##9##(2012-2#2)
in Japanese patients with##4##4##(2009-8#1)(2012-2#3)
in Japanese patients##7##3##(1995-8#1)(1997-8#1)(2009-8#1)(2012-2#4)
in Japanese plum##3##3##(2008-10#2)(2011-2#1)
in Japanese##38##2##(1990-5#1)(1993-8#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-8#2)(2007-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-6#1)(2009-7#2)(2009-8#1)(2010-2#4)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#7)(2013-1#3)
in Jerusalem##3##2##(1995-3#1)(2008-1#1)(2011-2#1)
in Jiangsu province##3##3##(2008-8#2)(2011-1#1)
in Jinuo##3##2##(2011-1#3)
in Jordan##6##2##(2007-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2013-7#1)
in Journal of##3##3##(1997-6#1)(2009-8#1)(2013-1#1)
in July 1991##2##3##(1992-12#1)(1995-12#1)
in July 1997##2##3##(2008-10#1)(2008-5#1)
in July 1998##2##3##(2008-5#2)
in July 2002##2##3##(2008-10#1)(2008-7#1)
in July and##8##3##(2008-10#3)(2008-5#1)(2009-12#4)
in July##28##2##(1991-11#1)(1992-12#1)(1993-1#1)(1995-12#1)(2007-9#1)(2008-10#8)(2008-5#5)(2008-7#1)(2009-12#5)(2010-8#1)(2011-2#2)(2013-1#1)
in June 2004##2##3##(2008-10#1)(2008-12#1)
in June 2009##3##3##(2010-4#1)(2011-2#1)(2012-2#1)
in June was##2##3##(2010-2#1)(2012-2#1)
in June##23##2##(1990-2#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-2#3)
in K(m)##2##2##(2008-7#1)(2010-11#1)
in K+##3##2##(1990-11#1)(1992-6#1)(2008-12#1)
in K562 cells and modulated self-renewal##2##6##(2008-8#1)(2008-9#1)
in K562 cells and##3##4##(2008-8#1)(2008-9#2)
in K562 cells##9##3##(1990-11#1)(2008-8#3)(2008-9#5)
in KCl and##2##3##(1992-6#1)(2008-10#1)
in KMB17 cells##5##3##(2013-8#5)
in KNbO(3) near##2##3##(2007-11#2)
in KNbO(3)##3##2##(2007-11#2)(2007-12#1)
in KOH##3##2##(2008-10#3)
in KSA##4##2##(2008-1#4)
in KTP##4##2##(2007-11#1)(2008-3#3)
in KTiOPO(4)##2##2##(2007-12#2)
in Kaduna##3##2##(1997-4#1)(2009-4#1)(2013-1#1)
in Kaliningrad##2##2##(1997-6#2)
in Kampala##2##2##(2009-4#2)
in Kansas and##2##3##(2008-10#2)
in Kansas##5##2##(1995-3#2)(2008-10#3)
in Kaposi's sarcoma##3##3##(1992-2#3)
in Kashmir##4##2##(2008-7#1)(2011-2#2)(2012-2#1)
in Kathmandu##4##2##(2008-7#3)(2012-3#1)
in Kc cells##3##3##(1995-6#3)
in Kent County fields##2##4##(2008-10#2)
in Kent County##4##3##(2008-10#4)
in Kentucky##5##2##(1991-1#1)(2008-10#2)(2008-4#1)(2008-8#1)
in Kenya##6##2##(2008-10#2)(2009-3#4)
in Kerala##2##2##(1994-3#1)(2008-11#1)
in Kern##2##2##(2008-10#1)(2011-2#1)
in Kerr media##2##3##(2007-11#1)(2007-12#1)
in Khartoum##4##2##(2013-1#4)
in Kibaha district##2##3##(2010-8#2)
in Kibaha##3##2##(2010-8#3)
in Kidney##2##2##(2008-1#1)(2013-1#1)
in Kinston##2##2##(2008-10#2)
in Kinyarwanda##2##2##(2009-12#2)
in Kir3##3##2##(2008-8#3)
in Kisumu municipality##2##3##(2011-1#2)
in Klang##2##2##(2011-1#2)
in Klebsiella spp##2##3##(2007-7#2)
in Klebsiella##4##2##(1993-9#1)(2007-7#2)(2008-9#1)
in Kolkata##2##2##(2007-7#1)(2011-2#1)
in Korea and##7##3##(2008-10#5)(2008-8#1)(2013-8#1)
in Korea over##2##3##(2008-10#1)(2011-2#1)
in Korea##35##2##(1997-6#1)(1997-8#1)(2008-10#15)(2008-8#2)(2009-8#1)(2010-4#2)(2010-6#4)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
in Korea]##3##2##(1990-12#1)(1991-2#2)
in Korean patients with##3##4##(1997-4#1)(1997-8#1)(2013-8#1)
in Korean##8##2##(1997-4#1)(1997-8#2)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in Koreans##4##2##(1997-4#1)(1997-8#2)(2008-12#1)
in Kota Bharu##2##3##(2008-8#2)
in Krebs##2##2##(1992-9#1)(1993-8#1)
in Kuala Lumpur##4##3##(2008-10#1)(2008-8#2)(2011-1#1)
in Kupffer##2##2##(1991-2#1)(1993-6#1)
in Kuwait##3##2##(1991-8#1)(1997-4#1)(2008-7#1)
in KwaZulu-Natal##4##2##(2011-1#1)(2012-12#3)
in Kyoto##2##2##(2009-5#1)(2010-6#1)
in L##10##2##(1990-11#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#1)
in L(w)##2##2##(2008-2#2)
in L24 mutant##3##3##(2008-8#1)(2008-9#2)
in L6 myotubes##6##3##(2008-11#6)
in L6##9##2##(1990-12#1)(1993-3#1)(2008-11#7)
in L929 cells##2##3##(1994-8#1)(2008-10#1)
in L929##3##2##(1994-8#1)(2008-10#1)(2009-2#1)
in LADA patients##3##3##(2008-3#3)
in LADA##4##2##(2008-3#4)
in LB and##2##3##(2008-10#2)
in LB##5##2##(1997-6#1)(2008-10#3)(2008-9#1)
in LD##3##2##(2008-5#2)(2008-9#1)
in LDL and##4##3##(1991-12#1)(1991-6#1)(1991-8#1)(2013-1#1)
in LDL cholesterol##3##3##(1991-2#1)(2008-3#1)(2012-2#1)
in LDL##16##2##(1990-8#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1993-6#2)(1994-11#1)(1996-3#1)(2008-3#2)(2012-2#2)(2013-1#1)
in LEC rats##2##3##(1995-3#2)
in LFD tests##2##3##(2008-10#2)
in LGSCs##2##2##(2012-12#2)
in LIF##2##2##(2008-11#1)(2008-3#1)
in LLC-PK1 cells##3##3##(1991-12#3)
in LLC-PK1A cells##3##3##(1992-5#3)
in LLC-PK1A##4##2##(1992-5#4)
in LNCaP##2##2##(2010-1#1)(2011-2#1)
in LOS for##2##3##(1993-12#2)
in LPS-primed alveolar macrophages##2##4##(1992-8#2)
in LR of##3##3##(2008-10#3)
in LS##4##2##(2012-1#4)
in LSCs of CML##2##4##(2011-2#2)
in LSCs of##3##3##(2011-2#3)
in LTC##2##2##(2008-1#1)(2010-10#1)
in LTP##2##2##(1997-2#1)(2009-8#1)
in La Dorada##4##3##(2011-2#4)
in La##12##2##(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#3)(2011-2#6)
in Laboratory##6##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
in Laccaria##2##2##(2011-1#2)
in Lactobacillus delbrueckii subsp##2##4##(1995-8#2)
in Lactobacillus##3##2##(1995-8#2)(2008-6#1)
in Lactococcus##3##2##(1993-12#2)(2008-6#1)
in Lagos University Teaching Hospital##2##5##(2010-9#1)(2013-1#1)
in Lagos##3##2##(2010-9#1)(2012-12#1)(2013-1#1)
in Lahore##3##2##(2007-7#1)(2010-11#1)(2013-8#1)
in Lake Baikal##2##3##(2008-3#2)
in Lake Maracaibo##4##3##(2013-7#4)
in Lake Tahoe##5##3##(2008-10#4)(2008-2#1)
in Lake##15##2##(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2011-1#1)(2013-7#4)(2013-8#1)
in Laminaria##2##2##(2008-10#1)(2013-1#1)
in Langmuir-Blodgett (LB)##2##3##(2007-12#1)(2008-8#1)
in Las Vegas##2##3##(2008-10#1)(2011-2#1)
in Latin America and the##2##5##(1991-3#1)(2008-5#1)
in Latin America##13##3##(1990-6#1)(1991-3#1)(1991-9#2)(1992-5#1)(1993-6#2)(2006-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in Latin America]##2##3##(1992-5#1)(2012-2#1)
in Latin American##3##3##(1995-12#1)(2011-2#2)
in Latin##19##2##(1990-6#1)(1991-3#1)(1991-9#2)(1992-5#2)(1993-6#2)(1995-12#1)(2006-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
in Latin-America##2##2##(2011-2#2)
in Latino##2##2##(2010-2#1)(2012-2#1)
in Leaf##2##2##(2008-10#1)(2008-12#1)
in Lebanon##3##2##(1993-2#3)
in Leber hereditary optic neuropathy##3##5##(1991-12#3)
in Leishmania spp##2##3##(2012-2#2)
in Leishmania##3##2##(2008-9#1)(2012-2#2)
in Lemhi##2##2##(2008-10#2)
in Lettuce##3##2##(2008-10#3)
in Lewis rats##2##3##(1995-12#1)(2008-5#1)
in Leydig cell function##2##4##(1990-6#1)(1992-12#1)
in LiNbO(3) and LiTaO(3)##2##4##(2007-11#1)(2008-3#1)
in LiNbO(3)##13##2##(2007-11#3)(2007-12#6)(2008-3#4)
in Lima##2##2##(1991-8#1)(2008-10#1)
in Lincoln##2##2##(2008-12#2)
in Lisbon##2##2##(2008-10#1)(2008-5#1)
in Liver##2##2##(2008-6#1)(2013-1#1)
in Locomotor##2##2##(2008-5#2)
in Lombardy##2##2##(1994-8#1)(2011-2#1)
in London##14##2##(1992-3#1)(1994-1#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#2)(2010-5#1)
in Long##2##2##(2008-3#1)(2012-2#1)
in Long-term##2##2##(2011-2#1)(2013-1#1)
in Los Angeles County##2##4##(1995-3#1)(2009-7#1)
in Los Angeles and##2##4##(1992-2#1)(2013-8#1)
in Los Angeles##7##3##(1991-2#1)(1992-2#1)(1995-3#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
in Lotka-Volterra##2##2##(2008-8#2)
in Louisiana##3##2##(2008-10#3)
in Lung Cancer##3##3##(2010-5#1)(2010-8#2)
in M##28##2##(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-7#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-10#2)(2012-2#1)(2012-3#2)(2013-7#1)
in MAP##4##2##(1991-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
in MAPK activity##2##3##(2008-9#2)
in MAPK##3##2##(2008-9#2)(2013-8#1)
in MAb##2##2##(2008-10#1)(2008-11#1)
in MB##2##2##(2008-10#2)
in MC##8##2##(1992-11#1)(1994-8#4)(2011-2#1)(2013-7#2)
in MC3T3-E1 preosteoblastic cells##2##4##(2008-8#2)
in MCF-7 cells##7##3##(1992-4#1)(2007-11#1)(2008-11#4)(2008-9#1)
in MCF-7##9##2##(1992-4#1)(2007-11#2)(2008-11#5)(2008-9#1)
in MCI##2##2##(2008-5#1)(2010-7#1)
in MCL##2##2##(2009-8#2)
in MCT-treated##2##2##(1994-5#2)
in MDA levels##3##3##(2008-10#1)(2009-5#2)
in MDA##4##2##(2008-10#1)(2009-5#2)(2013-1#1)
in MDA-MB 468 breast carcinoma cells##2##6##(1993-3#2)
in MDA-MB-231 cells##2##3##(2011-2#1)(2013-1#1)
in MDCK4 cells##4##3##(1992-5#4)
in MDCT##3##2##(2008-7#3)
in MDI##2##2##(1992-3#2)
in MDIs##4##2##(1992-3#2)(1996-1#2)
in MDS##2##2##(1994-10#1)(2010-1#1)
in MDSS2##3##2##(2008-11#3)
in MDSS2N##2##2##(2008-11#2)
in MDX##3##2##(1992-12#3)
in MEKC##2##2##(1990-8#1)(1994-9#1)
in MGLP biosynthesis##2##3##(2012-2#2)
in MHC class##2##3##(1991-2#1)(1997-9#1)
in MI patients##2##3##(2013-1#2)
in MI##4##2##(2012-2#2)(2013-1#2)
in MIC##2##2##(1991-8#1)(2007-7#1)
in MIN6##2##2##(1996-5#2)
in MM##2##2##(2010-4#2)
in MMP##2##2##(2008-2#1)(2008-5#1)
in MNG##2##2##(2012-3#2)
in MPTP-induced##3##2##(1990-7#1)(2013-7#2)
in MR##5##2##(1994-8#1)(2007-11#1)(2008-7#2)(2012-2#1)
in MRI##10##2##(1991-12#1)(1995-1#2)(2007-11#1)(2008-3#1)(2009-11#1)(2010-12#2)(2011-2#1)(2013-1#1)
in MRL(+/+) mice##7##3##(2008-10#7)
in MRL(+/+)##8##2##(2008-10#8)
in MRL/lpr##2##2##(1992-9#1)(1997-8#1)
in MRS medium##2##3##(2008-6#1)(2010-2#1)
in MS have##2##3##(2008-7#1)(2012-2#1)
in MS medium containing##2##4##(2008-10#2)
in MS medium##6##3##(2008-10#4)(2008-12#2)
in MS patients##2##3##(2012-3#2)
in MS##16##2##(2008-10#4)(2008-12#3)(2008-7#3)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
in MSA-C than in MSA-P##2##5##(2008-7#2)
in MSA-C##7##2##(2008-7#7)
in MT##4##2##(1992-6#1)(1996-12#1)(1996-7#1)(2008-10#1)
in MTs##2##2##(1992-6#1)(2008-10#1)
in Madagascar##2##2##(2008-10#1)(2010-6#1)
in Madrid##4##2##(2007-6#1)(2008-10#1)(2008-11#2)
in Maewo##5##2##(2008-1#5)
in Magnaporthe grisea##2##3##(2008-10#2)
in Mahlavu cells##4##3##(1990-8#2)(1997-1#2)
in Maine##6##2##(1992-2#1)(1992-3#1)(1996-3#1)(1997-2#3)
in Mainland China during##2##4##(2013-8#2)
in Mainland China##4##3##(2013-8#4)
in Maize##5##2##(2008-10#4)(2012-3#1)
in Malawi##6##2##(1996-12#1)(2008-10#1)(2009-4#1)(2010-12#1)(2012-2#2)
in Malaysia and##2##3##(2010-2#1)(2011-1#1)
in Malaysia##16##2##(1993-8#1)(2008-12#3)(2008-8#1)(2010-2#3)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#1)
in Malaysian public hospitals##3##4##(2008-8#3)
in Malaysian rheumatoid arthritis##2##4##(2011-2#2)
in Malaysian##8##2##(2008-8#4)(2011-1#2)(2011-2#2)
in Mali##5##2##(2008-8#4)(2009-4#1)
in Manchester##2##2##(2008-7#2)
in Mandarin-speaking##2##2##(2008-9#2)
in Manger##2##2##(1993-3#1)(1993-6#1)
in Manitoba##4##2##(1995-2#1)(2008-10#2)(2010-8#1)
in Mapuche persons in the Metropolitan Region##2##7##(2012-2#2)
in March 2006##2##3##(2011-1#1)(2012-12#1)
in March and April##2##4##(2008-10#1)(2012-2#1)
in March##15##2##(1991-2#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-5#1)(2007-5#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
in Marek's disease##2##3##(2008-5#2)
in Maryland and##2##3##(1997-5#1)(2008-10#1)
in Maryland##4##2##(1992-3#1)(1996-1#1)(1997-5#1)(2008-10#1)
in Mashad##4##2##(2008-12#4)
in Mashhad##2##2##(2011-2#2)
in Massachusetts and##2##3##(1994-2#1)(2012-3#1)
in Massachusetts##5##2##(1994-2#2)(1995-1#1)(2008-12#1)(2012-3#1)
in Maternal##2##2##(2007-12#1)(2008-7#1)
in Matrigel##2##2##(2008-6#1)(2012-4#1)
in May (1##2##3##(2008-5#1)(2013-7#1)
in May 1998##2##3##(2008-5#2)
in May 2004##2##3##(2008-1#1)(2008-10#1)
in May 2011##4##3##(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
in May and##3##3##(2008-10#2)(2008-5#1)
in May##27##2##(1992-1#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#8)(2010-11#2)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#2)
in Mazandaran##2##2##(2008-12#1)(2012-2#1)
in MeOH##3##2##(1996-5#1)(2008-10#2)
in Medellin##2##2##(2011-2#1)(2012-12#1)
in Medellín##3##2##(2011-2#1)(2012-12#2)
in Medicago truncatula##3##3##(2008-10#2)(2009-8#1)
in Medicaid costs##3##3##(1993-3#3)
in Medicaid spending##2##3##(1995-1#1)(1995-6#1)
in Medicaid##16##2##(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#3)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-6#1)
in Medical##6##2##(1994-12#1)(2008-4#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
in Medicare and##3##3##(1992-2#1)(1997-2#2)
in Medicare managed care##3##4##(1997-1#1)(1997-2#2)
in Medicare patients##2##3##(1994-12#1)(1996-2#1)
in Medicare payment##2##3##(1991-2#1)(1993-1#1)
in Medicare reimbursement##3##3##(1994-3#1)(1995-3#1)(2008-6#1)
in Medicare risk##2##3##(1994-12#1)(1995-12#1)
in Medicare##32##2##(1991-1#3)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#3)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
in Medicine##7##2##(1994-12#1)(1996-2#1)(2008-7#2)(2012-12#1)(2013-1#2)
in Medline##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
in Melbourne##3##2##(1991-6#1)(2007-5#1)(2008-8#1)
in Meloidogyne##2##2##(2008-10#2)
in Melon##2##2##(2008-10#2)
in Mental##2##2##(2012-3#1)(2013-1#1)
in Metropolitan Toronto##3##3##(1991-2#1)(1993-1#1)(1994-1#1)
in Metropolitan##4##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-1#1)
in Mexican American##2##3##(2007-12#1)(2009-7#1)
in Mexican##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-7#1)(2012-3#1)
in Mexico and##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
in Mexico since##2##3##(2008-10#2)
in Mexico##31##2##(1996-2#1)(1997-8#4)(2008-10#9)(2008-11#5)(2008-5#4)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
in Mexico]##3##2##(2008-11#2)(2012-3#1)
in Mg##2##2##(2008-3#1)(2012-2#1)
in MgO-doped periodically poled##2##4##(2007-11#2)
in Mice##10##2##(2008-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#4)
in Michigan and##3##3##(1991-1#1)(1995-3#1)(2008-10#1)
in Michigan from##2##3##(2008-10#2)
in Michigan##18##2##(1991-1#1)(1992-2#1)(1995-3#1)(2007-10#1)(2008-10#13)(2008-12#1)
in Middle-Aged##2##2##(2009-11#1)(2013-1#1)
in Milan (Italy)##2##3##(1990-8#1)(2013-8#1)
in Milan from##2##3##(1991-4#1)(2013-8#1)
in Milan##7##2##(1990-8#1)(1991-4#1)(1991-6#1)(1992-6#1)(2008-10#1)(2013-8#2)
in Minas Gerais##2##3##(2008-5#1)(2013-1#1)
in Minnesota and Wisconsin##2##4##(2008-12#2)
in Minnesota and##4##3##(2008-10#2)(2008-12#2)
in Minnesota##16##2##(1993-3#2)(1994-3#1)(1995-12#1)(1996-3#1)(2008-10#7)(2008-12#2)(2012-12#2)
in Mississippi##5##2##(2008-10#1)(2008-8#1)(2010-9#2)(2012-12#1)
in Missouri during the##2##4##(2008-10#1)(2011-2#1)
in Missouri##7##2##(2007-3#1)(2008-10#3)(2011-2#1)(2013-8#2)
in Mll##2##2##(1995-11#2)
in Mn##4##2##(1996-9#1)(2008-10#1)(2008-3#2)
in MnSOD##3##2##(1995-6#2)(2008-5#1)
in Moghan##2##2##(2008-12#2)
in Mongolia##2##2##(2009-4#2)
in Monilinia fructicola##3##3##(2008-10#3)
in Monilinia##4##2##(2008-10#4)
in Montenegro##2##2##(2008-6#2)
in Montreal##5##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
in Montréal##2##2##(1992-2#1)(2008-2#1)
in Moroccan##2##2##(2007-7#1)(2011-2#1)
in Morocco##3##2##(2007-7#1)(2008-10#1)(2009-9#1)
in Mouse##3##2##(2008-8#1)(2009-5#1)(2010-11#1)
in Mozambique and##2##3##(1991-11#1)(2007-2#1)
in Mozambique##8##2##(1991-11#1)(1997-6#5)(2007-2#2)
in Mulago##3##2##(2009-4#1)(2010-8#2)
in Multiple Sclerosis##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
in Mumbai##3##2##(2008-7#2)(2012-1#1)
in Munich##5##2##(1994-3#1)(2008-10#1)(2008-5#3)
in Murine##2##2##(2008-6#1)(2011-2#1)
in Muscle##2##2##(2008-10#1)(2008-3#1)
in Mycobacterium##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
in Mycosphaerella##2##2##(2008-10#2)
in Mäori##3##2##(2008-1#3)
in N composition##2##3##(2012-8#2)
in N##22##2##(1996-1#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-8#3)(2008-9#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)(2012-8#3)(2013-8#1)
in N(2)##2##2##(2008-3#2)
in N1E-115##2##2##(1992-6#1)(1994-11#1)
in N2##5##2##(1995-8#1)(2008-10#4)
in NC##3##2##(2008-10#3)
in NCA##2##2##(2011-2#2)
in NCH##3##2##(2012-3#3)
in NG##2##2##(1992-8#2)
in NGF##2##2##(1996-12#1)(1997-6#1)
in NH(3)-NH(4)Cl##2##2##(2008-10#2)
in NHE with##2##3##(1993-5#2)
in NHK grown at##2##4##(1994-3#2)
in NHL##2##2##(1994-10#1)(2013-7#1)
in NHS##2##2##(1996-11#1)(2012-1#1)
in NI and##2##3##(2013-8#2)
in NI##3##2##(2013-8#3)
in NICU settings##2##3##(1991-12#2)
in NIDDM##2##2##(1991-12#1)(2008-5#1)
in NIH 3T3##4##3##(1991-12#1)(1994-8#1)(2009-12#1)(2012-12#1)
in NIH##5##2##(1991-12#1)(1993-8#1)(1994-8#1)(2009-12#1)(2012-12#1)
in NIST SRM##2##3##(2008-10#2)
in NK cells##3##3##(1991-6#1)(1993-6#1)(2008-9#1)
in NK##4##2##(1991-6#1)(1993-6#2)(2008-9#1)
in NMDA-induced##2##2##(1996-5#2)
in NMR spectra##2##3##(2008-7#2)
in NMR studies##2##3##(1992-4#1)(2009-7#1)
in NMR##4##2##(1992-4#1)(2008-7#2)(2009-7#1)
in NO##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
in NOD##2##2##(2007-5#1)(2008-10#1)
in NOS-containing##2##2##(1995-12#2)
in NP##2##2##(1997-4#1)(2012-12#1)
in NR##2##2##(2008-11#2)
in NRB##2##2##(1993-5#2)
in NSCLC##6##2##(1992-12#1)(1993-9#1)(2010-8#2)(2012-2#1)(2012-3#1)
in NSW##3##2##(1990-2#1)(2013-1#2)
in NTPDase3##2##2##(2008-4#2)
in NWFP##2##2##(2009-7#1)(2010-11#1)
in NYC drug##2##3##(1991-1#2)
in NYC##5##2##(1991-1#2)(1996-3#3)
in NYHA class##3##3##(1994-11#2)(2008-4#1)
in NYHA##4##2##(1994-11#2)(2008-10#1)(2008-4#1)
in Na(+)##3##2##(2008-10#3)
in NaCl or##2##3##(1992-6#1)(2008-10#1)
in NaCl solution##2##3##(2008-10#1)(2013-1#1)
in NaCl##8##2##(1992-6#1)(1993-12#1)(2008-10#4)(2011-1#1)(2013-1#1)
in NaClO(4)##3##2##(2008-10#3)
in NaOH##2##2##(2008-10#2)
in Nafion##4##2##(2008-10#4)
in Nagabuna##2##2##(2008-5#2)
in NahG##2##2##(2008-10#2)
in Najran##2##2##(2007-2#1)(2008-1#1)
in Namibia##9##2##(1997-6#3)(2010-4#2)(2011-1#4)
in Nasarawa State##2##3##(2010-8#1)(2011-1#1)
in National##2##2##(1992-1#1)(2011-2#1)
in Natural Populations of##2##4##(2008-10#1)(2008-5#1)
in Nature##2##2##(2011-1#1)(2013-1#1)
in Navarre##7##2##(2013-1#7)
in Nd##10##2##(1993-1#2)(2007-11#4)(2008-2#1)(2008-3#3)
in Necker##2##2##(2007-5#2)
in Nef##4##2##(1997-3#4)
in Nepal and##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
in Nepal is not##2##4##(2008-3#1)(2008-7#1)
in Nepal is##3##3##(2008-3#1)(2008-7#1)(2010-8#1)
in Nepal##57##2##(2007-2#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-7#21)(2010-11#3)(2010-4#2)(2010-5#1)(2010-8#9)(2012-3#8)(2013-8#1)
in Nepalese##5##2##(2008-10#1)(2008-3#1)(2010-8#1)(2012-3#2)
in Neurospora crassa##4##3##(1992-8#2)(2008-10#1)(2012-3#1)
in Neurospora##5##2##(1992-8#2)(2008-10#1)(2012-3#2)
in Neurosurgery##2##2##(2010-7#1)(2012-3#1)
in New Brunswick##4##3##(1991-2#1)(1993-1#1)(1995-1#1)(1996-1#1)
in New Caledonia##2##3##(2008-1#2)
in New Castle County##2##4##(2013-1#2)
in New Delhi##7##3##(1994-8#1)(1995-12#1)(2007-7#3)(2008-11#1)(2010-5#1)
in New Jersey compared to##2##5##(2008-8#2)
in New Jersey##9##3##(1992-2#1)(1993-1#1)(2008-10#3)(2008-8#4)
in New Mexico##3##3##(1991-3#1)(2008-10#2)
in New Orleans##3##3##(1993-2#1)(2012-2#2)
in New South Wales##4##4##(2008-12#1)(2011-1#1)(2011-2#2)
in New York City (NYC)##4##5##(1996-1#1)(1996-3#2)(2012-2#1)
in New York City##23##4##(1991-1#2)(1991-12#1)(1992-3#1)(1994-2#1)(1994-9#2)(1996-1#1)(1996-3#5)(2007-4#1)(2008-12#1)(2008-8#1)(2009-5#4)(2011-2#1)(2012-2#2)
in New York State##8##4##(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#2)(1996-3#1)(2008-10#2)
in New York state##2##4##(1992-1#1)(1992-8#1)
in New York##49##3##(1991-1#2)(1991-12#1)(1991-3#1)(1992-1#3)(1992-12#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-9#2)(1996-1#2)(1996-12#1)(1996-3#6)(1997-2#1)(2007-4#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#2)(2009-5#4)(2010-10#1)(2011-2#1)(2012-2#2)
in New Zealand (Aotearoa)##2##4##(2008-1#2)
in New Zealand and##4##4##(2008-1#2)(2008-12#1)(2011-2#1)
in New Zealand are##2##4##(2008-1#1)(2012-3#1)
in New Zealand born residents of##3##6##(1990-2#3)
in New Zealand were##2##4##(1996-12#1)(2012-12#1)
in New Zealand##48##3##(1990-2#7)(1991-2#1)(1992-1#1)(1993-1#1)(1996-12#2)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#13)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in New Zealand's##2##3##(1991-2#1)(2012-3#1)
in New##139##2##(1990-2#8)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#3)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-1#3)(1996-12#3)(1996-3#6)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-7#3)(2008-1#15)(2008-10#17)(2008-11#2)(2008-12#4)(2008-3#2)(2008-5#2)(2008-8#7)(2009-5#4)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
in Nicotiana benthamiana plants##2##4##(2008-10#1)(2011-2#1)
in Nicotiana benthamiana##8##3##(2008-10#7)(2011-2#1)
in Nicotiana tabacum##2##3##(1997-2#1)(2008-10#1)
in Nicotiana##11##2##(1997-2#1)(2008-10#8)(2008-7#1)(2011-2#1)
in Nigeria and Ghana##2##4##(2011-1#2)
in Nigeria and##4##3##(2008-10#1)(2008-12#1)(2011-1#2)
in Nigeria##34##2##(1990-3#2)(1992-5#1)(1995-9#1)(2008-10#1)(2008-12#2)(2008-5#3)(2008-8#1)(2009-10#3)(2009-6#3)(2009-7#2)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#1)(2013-1#4)
in Ningxia##3##2##(2011-1#3)
in Nogales##3##2##(2006-10#1)(2011-2#2)
in Non-small Cell Lung Cancer##6##5##(2010-8#6)
in North America and Europe##4##5##(1991-9#1)(2006-10#1)(2008-7#1)(2009-2#1)
in North America and##9##4##(1991-9#1)(1992-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)
in North America are##2##4##(2008-1#1)(2008-10#1)
in North America in##2##4##(2008-10#1)(2013-1#1)
in North America that##3##4##(2008-10#1)(2011-2#2)
in North America were##2##4##(2008-10#2)
in North America with##2##4##(1996-1#1)(2008-5#1)
in North America##58##3##(1991-8#1)(1991-9#1)(1992-1#1)(1994-2#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
in North American##2##3##(2008-10#1)(2010-3#1)
in North Carolina##10##3##(1993-3#1)(2008-10#8)(2012-12#1)
in North Central##2##3##(2008-10#1)(2010-8#1)
in North Dakota and western##2##5##(2008-10#2)
in North Dakota and##4##4##(2008-10#4)
in North Dakota##5##3##(2008-10#5)
in North and South##2##4##(1996-1#1)(2012-3#1)
in North##94##2##(1991-8#4)(1991-9#1)(1992-1#1)(1993-3#2)(1994-2#1)(1996-1#2)(1996-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#39)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
in Northeast Brazil##2##3##(2011-2#1)(2013-7#1)
in Northeast Thailand##3##3##(2008-12#3)
in Northeast##6##2##(2008-12#4)(2011-2#1)(2013-7#1)
in Northeastern Brazil##2##3##(1993-6#1)(2013-7#1)
in Northern Chile##2##3##(1993-12#1)(2008-3#1)
in Northern Ontario##2##3##(1994-3#2)
in Northern blot analysis##2##4##(1993-6#1)(2008-8#1)
in Northern blot##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
in Northern##18##2##(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
in Northwest of Iran##2##4##(2008-12#2)
in Northwest##3##2##(2008-12#2)(2008-9#1)
in Norway (population 4##3##4##(1996-11#3)
in Norway and##4##3##(1991-9#1)(1994-2#1)(1996-11#1)(2008-10#1)
in Norway as##3##3##(1991-9#1)(1993-3#1)(1993-6#1)
in Norway during the##2##4##(1990-9#1)(1991-9#1)
in Norway have##2##3##(1990-11#1)(1994-6#1)
in Norway in 1985##2##4##(1991-9#1)(1995-2#1)
in Norway in the##4##4##(1991-6#1)(1995-2#1)(1995-6#1)(1996-11#1)
in Norway in##10##3##(1990-6#1)(1991-6#1)(1991-9#1)(1992-4#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-11#2)
in Norway increased##2##3##(1995-2#1)(1996-11#1)
in Norway is##2##3##(1991-6#1)(1996-3#1)
in Norway the##2##3##(1997-2#1)(2008-7#1)
in Norway were##2##3##(1996-11#1)(1997-8#1)
in Norway##100##2##(1990-11#3)(1990-2#1)(1990-6#6)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#2)(1991-6#6)(1991-9#6)(1992-11#2)(1992-4#3)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#4)(1994-11#1)(1994-2#3)(1994-6#4)(1994-9#1)(1995-2#4)(1995-5#3)(1995-6#3)(1995-8#1)(1996-11#15)(1996-3#2)(1996-6#3)(1996-9#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2012-3#1)
in Norway]##11##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-4#2)(1993-3#1)(1996-11#3)
in Norwegian health##2##3##(1990-9#1)(1996-9#1)
in Norwegian##7##2##(1990-9#1)(1991-6#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)
in Nova Scotia##2##3##(2007-12#2)
in November 1991##2##3##(1993-11#1)(2008-2#1)
in November 1996##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
in November##13##2##(1991-9#1)(1993-11#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2011-2#1)(2013-8#1)
in Nursing##9##2##(2008-11#5)(2012-3#3)(2013-8#1)
in O##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
in O-342 cells##2##3##(1992-2#2)
in O2##4##2##(1991-10#3)(1997-2#1)
in OA##2##2##(2007-11#1)(2013-1#1)
in OAA- and aniline-treated mice##2##5##(2008-10#2)
in OAA-##3##2##(2008-10#3)
in OB than##2##3##(2008-2#2)
in OB##4##2##(1990-7#1)(2008-2#2)(2013-1#1)
in OCD##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
in OCT##2##2##(2008-3#1)(2011-7#1)
in ODA##2##2##(2008-10#2)
in OEC##2##2##(2008-8#2)
in ON and##2##3##(2008-10#1)(2008-7#1)
in OO##6##2##(2008-2#6)
in OPCAB##2##2##(2007-8#1)(2010-8#1)
in OSCC##2##2##(2010-12#2)
in OUR##2##2##(2008-7#2)
in OY-M##2##2##(2008-10#2)
in Oats##3##2##(2008-10#3)
in Ob1771##3##2##(1990-12#3)
in Obese Children##2##3##(2011-1#2)
in Obese##4##2##(2011-1#2)(2012-3#1)(2013-1#1)
in Obesity##3##2##(2008-3#2)(2010-4#1)
in October 1992##2##3##(1993-6#1)(2008-2#1)
in October 1997##2##3##(2008-10#2)
in October 2001##2##3##(2008-3#1)(2008-7#1)
in October##27##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-8#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
in Ohio and##2##3##(2008-10#2)
in Ohio##17##2##(1995-2#1)(1996-6#1)(2007-3#1)(2008-10#13)(2010-9#1)
in Okinawa##13##2##(2008-10#10)(2008-2#1)(2009-7#1)(2011-2#1)
in Oklahoma##3##2##(1995-12#1)(2013-8#2)
in Older Adults with##2##4##(2012-12#1)(2013-1#1)
in Older Adults##3##3##(2012-12#2)(2013-1#1)
in Older##4##2##(2008-12#1)(2012-12#2)(2013-1#1)
in Oncology##5##2##(2007-8#1)(2008-7#2)(2011-2#1)(2012-3#1)
in One##2##2##(2010-8#1)(2012-2#1)
in Ontario soils##2##3##(2008-10#2)
in Ontario to##2##3##(1996-1#1)(1997-1#1)
in Ontario##43##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-1#2)(1996-12#1)(1997-1#2)(1997-3#2)(2007-1#1)(2007-12#7)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
in Ontario's##4##2##(1991-2#1)(1995-1#1)(1997-3#1)(2009-3#1)
in Ophiostoma##2##2##(2008-10#2)
in Opole##2##2##(2012-3#2)
in Orange##2##2##(1991-9#1)(1992-2#1)
in Orchards##2##2##(2008-10#2)
in Oregon##11##2##(1992-2#3)(1995-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)(2013-1#2)
in Oryza sativa L##2##4##(2008-9#2)
in Osaka City##2##3##(2013-8#2)
in Osaka##3##2##(1990-5#1)(2013-8#2)
in Osijek-Baranya County##4##3##(2011-2#4)
in Oslo in##2##3##(1993-6#1)(1995-2#1)
in Oslo##9##2##(1990-11#1)(1992-5#2)(1993-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-2#1)
in Oslo]##3##2##(1995-11#1)(1997-4#1)(1997-6#1)
in Ottawa##2##2##(2007-12#1)(2013-1#1)
in Ouagadougou##2##2##(2008-12#1)(2009-10#1)
in P ferox##3##3##(2013-7#3)
in P##63##2##(1990-11#1)(1990-5#1)(1992-8#1)(1994-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#25)(2008-12#3)(2008-5#1)(2008-7#4)(2008-9#2)(2009-6#4)(2009-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#4)(2013-8#2)
in P19 embryonal carcinoma cells##2##5##(1992-12#2)
in P19 teratocarcinoma cells##2##4##(1994-11#2)
in P19##7##2##(1991-2#1)(1992-12#3)(1994-11#3)
in P2##3##2##(2008-4#1)(2008-8#1)(2013-1#1)
in P21##2##2##(1996-5#1)(2008-10#1)
in P29##3##2##(2008-10#2)(2008-5#1)
in P3##2##2##(1994-5#1)(2008-10#1)
in P388/Adr cells##2##3##(1991-4#2)
in P388/S##2##2##(1991-12#1)(1991-4#1)
in PA##4##2##(2008-8#2)(2011-2#1)(2012-2#1)
in PAA##2##2##(2008-10#1)(2009-12#1)
in PACS-2 and MESS-2##3##4##(2008-10#3)
in PACS-2##5##2##(2008-10#5)
in PACT II##2##3##(2013-1#2)
in PACT##3##2##(2013-1#3)
in PAF##2##2##(2008-3#1)(2013-1#1)
in PAH##3##2##(2008-10#1)(2010-10#2)
in PAM##2##2##(1993-8#1)(2008-10#1)
in PB##2##2##(2011-2#2)
in PBL##2##2##(1995-12#1)(2012-2#1)
in PBMC##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
in PBS##4##2##(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
in PC##4##2##(1994-3#1)(2009-8#1)(2012-12#1)(2013-1#1)
in PC12 cells were##2##4##(2008-11#2)
in PC12 cells##16##3##(1990-5#1)(1993-8#2)(1995-12#1)(1997-2#1)(2008-11#10)(2008-4#1)
in PC12 pheochromocytoma cells##2##4##(1997-2#1)(2008-11#1)
in PC12##22##2##(1990-5#1)(1993-8#2)(1995-12#1)(1997-2#2)(2008-11#14)(2008-4#1)(2013-7#1)
in PCOS##4##2##(2008-4#3)(2013-1#1)
in PCR products##2##3##(1992-8#1)(1994-11#1)
in PCR##7##2##(1992-8#1)(1994-11#1)(1995-11#1)(2008-10#2)(2008-4#1)(2008-7#1)
in PCa cells##3##3##(2013-1#3)
in PCa##5##2##(2013-1#5)
in PD and##4##3##(2008-6#1)(2012-12#1)(2013-7#1)(2013-8#1)
in PD is##6##3##(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
in PD patients with##2##4##(2008-7#1)(2012-12#1)
in PD patients##12##3##(2008-7#6)(2011-2#5)(2012-12#1)
in PD##46##2##(2008-10#1)(2008-11#2)(2008-6#4)(2008-7#21)(2010-12#1)(2011-2#5)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
in PDE-derived culture##2##3##(2013-1#2)
in PEI##3##2##(2008-10#3)
in PG##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
in PI 88788##4##3##(2008-10#4)
in PI##7##2##(1992-12#1)(2008-10#5)(2009-8#1)
in PIH##2##2##(2012-2#2)
in PKC##7##2##(1991-5#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-12#1)(1993-3#1)
in PL##4##2##(1997-4#4)
in PLA##2##2##(2008-6#2)
in PMA-containing medium##2##3##(1995-2#2)
in PMBCL##2##2##(2009-8#2)
in PMC##2##2##(1992-3#2)
in PMMA##2##2##(2008-2#1)(2008-3#1)
in PN mode and##2##4##(2008-10#2)
in POA##2##2##(1991-5#2)
in PPS 7##3##3##(1993-3#3)
in PPS##4##2##(1992-2#1)(1993-3#3)
in PRL##2##2##(1990-7#1)(2008-7#1)
in PRP##3##2##(2007-9#1)(2008-7#2)
in PS##3##2##(1990-2#2)(2008-7#1)
in PSA##3##2##(2010-1#2)(2010-12#1)
in PSII##4##2##(2008-4#3)(2008-8#1)
in PT cells##2##3##(1995-11#2)
in PT##4##2##(1995-11#3)(2012-2#1)
in PTFE##2##2##(1990-9#1)(2007-7#1)
in PTSD##5##2##(1996-5#1)(1996-7#1)(2008-6#2)(2009-11#1)
in PTSD-SA##2##2##(1996-5#2)
in PUB##2##2##(2008-3#2)
in PVA medium##2##3##(2008-10#2)
in PVA##4##2##(1993-11#1)(2008-10#3)
in PVC matrix##5##3##(2008-10#5)
in PVC membrane##2##3##(2008-10#2)
in PVC##12##2##(2008-10#12)
in PVX##2##2##(2008-10#2)
in PaO2##2##2##(1997-3#1)(2011-2#1)
in Pacific countries##2##3##(2008-1#2)
in Pacific##5##2##(2008-1#4)(2012-12#1)
in Pakistan##11##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-4#1)(2009-7#2)(2010-4#1)(2012-2#2)
in Pakistani##4##2##(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
in Palau in##2##3##(2008-1#2)
in Palau was##2##3##(2008-1#2)
in Palau##15##2##(2008-1#15)
in Panum's limiting case##3##4##(2008-9#3)
in Papua New Guinea##2##4##(2008-1#2)
in Paramecium primaurelia##2##3##(2008-12#2)
in Paramecium##5##2##(1992-6#1)(2008-12#3)(2008-4#1)
in Paris##5##2##(2007-5#1)(2008-5#1)(2010-1#3)
in Parkinson##3##2##(2008-7#2)(2013-1#1)
in Parkinson's disease (PD) patients##2##5##(2008-7#2)
in Parkinson's disease (PD)##10##4##(1995-5#1)(2008-7#7)(2010-12#1)(2013-8#1)
in Parkinson's disease##65##3##(1992-9#1)(1995-12#1)(1995-5#2)(1995-8#1)(2008-2#1)(2008-6#3)(2008-7#42)(2009-11#2)(2009-8#2)(2010-12#2)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
in Parkinson's##67##2##(1992-9#1)(1995-12#1)(1995-5#2)(1995-8#1)(2008-11#1)(2008-2#1)(2008-6#3)(2008-7#42)(2009-11#2)(2009-8#2)(2010-12#2)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
in Parkinsonian patients##6##3##(1996-5#1)(2008-7#5)
in Parma##2##2##(2008-2#1)(2011-2#1)
in Part 1##3##3##(2008-12#2)(2008-7#1)
in Part I##4##3##(1992-3#1)(1993-2#1)(2007-5#1)(2008-3#1)
in Part II##2##3##(1992-3#1)(2008-11#1)
in Part##10##2##(1992-3#2)(1993-2#1)(2007-5#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)
in Pathogenicity and##2##3##(2008-10#2)
in Pathogenicity of Xanthomonas##2##4##(2008-10#2)
in Pathogenicity of##3##3##(2008-10#3)
in Pathogenicity##6##2##(2008-10#6)
in Patient##6##2##(1991-1#1)(1995-1#1)(1996-3#1)(2007-12#1)(2011-2#2)
in Patients with##16##3##(1997-7#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
in Patients##21##2##(1997-7#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)
in Pea##3##2##(2008-10#3)
in Peach Orchards##3##3##(2008-10#3)
in Peach##4##2##(2008-10#4)
in Peanut##2##2##(2008-10#2)
in Penang##2##2##(2011-1#2)
in Pennsylvania healthcare facilities##2##4##(2007-12#2)
in Pennsylvania##7##2##(1992-1#1)(2007-12#2)(2008-10#3)(2010-11#1)
in People##2##2##(2007-5#1)(2012-2#1)
in People's Republic of China in##2##6##(2012-3#2)
in Pepper##2##2##(2008-10#2)
in Perth##3##2##(2007-10#1)(2008-10#1)(2008-5#1)
in Perthes disease##2##3##(1992-11#1)(2007-11#1)
in Peru##11##2##(1991-8#1)(1992-5#3)(2008-10#5)(2008-11#1)(2008-3#1)
in Peyer's patch cells##3##4##(2008-10#1)(2008-11#2)
in Peyer's##4##2##(2008-10#1)(2008-11#3)
in Ph+ ALL##2##3##(2011-1#1)(2012-12#1)
in Phase I##2##3##(1997-1#1)(2012-3#1)
in Phase##5##2##(1997-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
in Phaseolus vulgaris##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
in Phaseolus##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
in Philadelphia##4##2##(1991-12#1)(1992-2#1)(2009-5#1)(2009-7#1)
in Phoenix##3##2##(1991-3#1)(2012-12#2)
in Phytophthora infestans##5##3##(2008-10#5)
in Phytophthora melonis##2##3##(2008-10#2)
in Phytophthora##10##2##(2008-10#10)
in Pichia pastoris##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
in Piedmont##2##2##(2008-10#1)(2008-8#1)
in Piekary Slaskie##2##3##(2007-11#1)(2007-8#1)
in Pima S-7##2##3##(2008-10#2)
in Pinus monticola##3##3##(2008-10#3)
in Pinus##4##2##(2008-10#3)(2011-10#1)
in Piriformospora indica-colonized##2##3##(2008-10#2)
in Plagioscion squamosissimus##2##3##(2008-7#2)
in Plant##3##2##(2009-8#1)(2011-2#1)(2012-1#1)
in Plants##7##2##(2008-10#4)(2011-2#2)(2012-1#1)
in Plasmodium falciparum##3##3##(1990-12#1)(2012-12#1)(2013-7#1)
in Plasmodium##4##2##(1990-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
in Pohnpei##2##2##(2008-1#2)
in Poisson##2##2##(2008-11#1)(2008-3#1)
in Pokhara##2##2##(2008-7#2)
in Poland and worldwide##2##4##(2013-1#2)
in Poland and##3##3##(2008-5#1)(2013-1#2)
in Poland##36##2##(1994-12#1)(1995-3#1)(2007-11#3)(2007-8#12)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
in Poland]##2##2##(2009-5#1)(2012-3#1)
in Polish##2##2##(2007-8#1)(2008-12#1)
in Pony Club horses##3##4##(2012-12#3)
in Poplar##3##2##(2008-10#3)
in Populations of the##2##4##(2008-10#2)
in Populations of##10##3##(2008-10#10)
in Populus deltoides##2##3##(2008-10#2)
in Populus##3##2##(2008-10#2)(2012-3#1)
in Port##2##2##(2008-10#1)(2010-5#1)
in Portland##3##2##(1992-1#1)(1995-3#1)(1997-2#1)
in Porto Alegre##2##3##(2012-1#1)(2013-8#1)
in Porto Nacional##2##3##(2008-6#2)
in Porto##4##2##(2008-6#2)(2012-1#1)(2013-8#1)
in Portugal##5##2##(1997-7#1)(2008-11#1)(2011-2#1)(2012-1#2)
in Posterior##2##2##(2012-3#1)(2013-1#1)
in Postmenopausal Women##2##3##(2008-3#1)(2013-1#1)
in Potato##5##2##(2008-10#5)
in Potting##2##2##(2008-10#2)
in Poznań##2##2##(2011-2#1)(2013-1#1)
in Practice##4##2##(2007-11#1)(2008-11#2)(2008-12#1)
in Prague]##2##2##(1994-2#1)(2011-3#1)
in Prahova County##2##3##(2008-10#2)
in Pregnancy##3##2##(2008-3#1)(2008-4#1)(2013-1#1)
in Pregnant##2##2##(2007-2#1)(2009-9#1)
in Primary##4##2##(1997-5#1)(2008-11#1)(2011-1#1)(2013-1#1)
in Primorsko-Goranska County##5##3##(2011-2#5)
in Primorsko-Goranska##7##2##(2011-2#7)
in Prince Edward Island##2##4##(2010-8#1)(2012-3#1)
in Prostate Cancer##2##3##(2012-12#1)(2013-1#1)
in Prostate##3##2##(2012-12#2)(2013-1#1)
in Protein##3##2##(2007-5#1)(2008-10#1)(2012-1#1)
in Prunus species##2##3##(2008-9#1)(2011-2#1)
in Prunus spp##3##3##(2008-10#3)
in Prunus##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
in PsA##2##2##(2006-10#2)
in Pseudomonas aeruginosa##4##3##(2008-10#1)(2008-7#2)(2009-6#1)
in Pseudomonas fluorescens##2##3##(2008-10#2)
in Pseudomonas putida##3##3##(1991-7#2)(2008-10#1)
in Pseudomonas syringae pv##2##4##(2008-10#2)
in Pseudomonas syringae##4##3##(2008-10#4)
in Pseudomonas##15##2##(1991-7#2)(2008-10#8)(2008-7#2)(2008-8#1)(2009-6#1)(2012-2#1)
in Psoriasis##2##2##(2012-3#1)(2013-7#1)
in Psychiatric##3##2##(1997-8#1)(2008-11#1)(2012-2#1)
in Psychiatry##2##2##(2009-10#1)(2012-2#1)
in Pt##2##2##(2008-10#2)
in PubMed##2##2##(2009-5#1)(2010-5#1)
in Public Health##5##3##(1991-2#1)(1996-2#1)(1997-2#1)(2008-7#1)(2012-2#1)
in Puerto Rico and##2##4##(2007-5#1)(2011-1#1)
in Puerto Rico##7##3##(2006-10#3)(2007-5#2)(2011-1#2)
in Puerto##8##2##(2006-10#3)(2007-5#2)(2011-1#2)(2012-12#1)
in Punjab##4##2##(2008-10#3)(2010-11#1)
in PurR##2##2##(2008-8#2)
in Purkinje##2##2##(1995-8#1)(1996-2#1)
in Pyricularia grisea##2##3##(2008-10#2)
in Pythium##4##2##(2008-10#4)
in Q##7##2##(2007-11#1)(2008-10#1)(2008-12#1)(2012-5#1)(2012-7#3)
in Q-switched##3##2##(2008-2#2)(2008-3#1)
in Qassim##2##2##(2013-8#2)
in Qatar##2##2##(2007-10#1)(2013-8#1)
in Qing' e Pills##2##4##(2011-1#2)
in QoL##2##2##(2012-1#1)(2013-1#1)
in Quebec##9##2##(1992-1#1)(2007-12#2)(2008-11#1)(2009-5#1)(2010-8#1)(2011-2#3)
in Quercus##4##2##(2008-10#1)(2008-12#2)(2012-5#1)
in Québec##5##2##(1994-1#1)(2008-2#4)
in R##11##2##(1995-8#2)(2008-10#6)(2008-7#1)(2011-2#1)(2012-8#1)
in RA patients##2##3##(1993-2#1)(2011-2#1)
in RA##4##2##(1993-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
in RAPD##3##2##(2008-10#3)
in RAW 264##2##3##(2011-2#2)
in RBC##2##2##(1996-7#1)(2008-7#1)
in RCA##2##2##(1992-3#1)(2013-8#1)
in RCC##4##2##(1990-2#1)(2011-2#3)
in RE##3##2##(2008-8#3)
in REM sleep##4##3##(1990-7#2)(1991-5#1)(2013-8#1)
in RES and ELI MOs##2##5##(1990-2#2)
in RES##3##2##(1990-2#3)
in RH##5##2##(2008-10#5)
in RHR than in##2##4##(2008-11#2)
in RLC-16 hepatocytes##2##3##(2008-11#2)
in RLC-16##3##2##(2008-11#3)
in RLS##3##2##(2012-12#3)
in RNA processing##2##3##(1993-12#1)(1995-2#1)
in RNA##24##2##(1991-8#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-6#3)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2011-1#2)(2012-3#1)
in ROM##2##2##(2008-12#2)
in ROS##7##2##(1991-3#1)(1993-3#1)(1997-1#2)(2008-1#1)(2010-12#1)(2012-3#1)
in RP##2##2##(2008-10#1)(2011-2#1)
in RPMI 1640##2##3##(2008-11#2)
in RPMI medium##2##3##(1992-6#1)(2008-11#1)
in RPMI##4##2##(1992-6#1)(2008-11#3)
in Radiation Oncology##2##3##(1994-3#1)(2008-10#1)
in Radiology##3##2##(1995-2#2)(1995-3#1)
in Ragusa##2##2##(1991-2#1)(1992-12#1)
in Ramadan##2##2##(2008-4#1)(2012-3#1)
in Raman##2##2##(2007-11#1)(2008-10#1)
in Rana temporaria##2##3##(2011-2#2)
in Raphidia##2##2##(2008-12#2)
in Ras control of##2##4##(1996-2#2)
in Ras##5##2##(1995-2#2)(1995-8#1)(1996-2#2)
in Rat##2##2##(2009-12#1)(2009-8#1)
in Rats##13##2##(2008-10#4)(2008-12#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in Ravenna##2##2##(1992-8#1)(1993-12#1)
in Rb##2##2##(1993-11#1)(2008-2#1)
in Recife##3##2##(2008-9#3)
in Recreational##2##2##(2012-2#1)(2012-3#1)
in Reduced##2##2##(2008-10#1)(2008-3#1)
in Reference##2##2##(2008-12#1)(2008-3#1)
in Rehabilitation Psychology##2##3##(2009-8#2)
in Rehabilitation##4##2##(2007-11#2)(2009-8#2)
in Relation to##9##3##(2008-10#8)(2013-7#1)
in Relationship##2##2##(2012-2#1)(2013-1#1)
in Renal Disease##4##3##(1994-3#1)(2006-10#1)(2011-2#1)(2013-1#1)
in Renal##6##2##(1994-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
in Rendu-Osler-Weber disease##2##3##(1992-2#2)
in Replica 2##2##3##(1992-12#2)
in Replica##3##2##(1992-12#3)
in Republic##2##2##(2008-1#1)(2008-5#1)
in Research##2##2##(2008-10#1)(2009-3#1)
in Resistance##2##2##(2008-10#2)
in Resistant and Susceptible##3##4##(2008-10#3)
in Resistant##4##2##(2008-10#4)
in Response to##12##3##(1997-3#1)(2008-10#8)(2008-12#1)(2009-12#1)(2013-1#1)
in Reye's syndrome##3##3##(1991-12#3)
in Reye's##4##2##(1991-12#4)
in Rhipicephalus (Boophilus)##2##3##(2010-10#1)(2013-1#1)
in Rhode Island##3##3##(1994-2#1)(1996-12#2)
in Rhodococcus##2##2##(1994-3#1)(2008-8#1)
in Rice##3##2##(2008-10#3)
in Rio Grande do Sul##2##5##(2008-5#1)(2009-7#1)
in Rio de Janeiro##6##4##(1991-6#2)(2008-9#1)(2009-10#1)(2012-3#2)
in Rio##9##2##(1991-6#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-3#2)
in Ripley and Rps2 in L76-1988##2##6##(2008-10#2)
in Riyadh and##2##3##(2008-1#1)(2013-1#1)
in Riyadh##7##2##(2007-2#1)(2007-7#1)(2008-1#4)(2013-1#1)
in Rochester##5##2##(1992-12#1)(1993-2#1)(1996-2#2)(2009-7#1)
in Roman##4##2##(2008-10#3)(2012-2#1)
in Romania##5##2##(1991-6#1)(2008-10#2)(2010-10#1)(2010-4#1)
in Rome##3##2##(1990-8#1)(2007-7#1)(2008-11#1)
in Rose and##2##3##(2008-10#2)
in Rumania##2##2##(1991-6#2)
in Rural##4##2##(1996-3#1)(2010-12#1)(2013-1#2)
in Russia and Ukraine##3##4##(2013-1#3)
in Russia and##5##3##(1997-1#2)(2013-1#3)
in Russia##16##2##(1994-12#1)(1997-1#7)(1997-6#2)(2010-12#2)(2012-3#1)(2013-1#3)
in S rats##2##3##(1994-11#2)
in S strain incidence in##2##5##(2008-10#2)
in S strain incidence##4##4##(2008-10#4)
in S##69##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-9#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-6#2)(1996-2#1)(1996-3#3)(1996-6#3)(1997-3#1)(1997-7#1)(2007-7#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#1)
in S(0) state##2##3##(2008-8#2)
in S-D##2##2##(2008-11#2)
in SAD patients##2##3##(1995-11#2)
in SAM-P/2##4##2##(1991-12#4)
in SAMP8##2##2##(2008-7#2)
in SB##2##2##(2008-11#2)
in SBP##2##2##(1991-10#1)(2013-1#1)
in SC##5##2##(1993-3#1)(2008-5#4)
in SCLP##2##2##(2012-3#2)
in SD rats and##2##4##(1996-12#1)(2010-1#1)
in SD rats##4##3##(1996-12#1)(2008-10#2)(2010-1#1)
in SD##7##2##(1996-12#1)(2008-10#2)(2009-2#2)(2010-1#1)(2012-2#1)
in SDCL C/N 30##3##4##(2008-10#3)
in SDCL##4##2##(2008-10#4)
in SDS##3##2##(1995-2#1)(1996-5#1)(2012-2#1)
in SDS-PAGE##7##2##(1990-11#1)(1991-2#1)(1992-6#2)(2008-1#1)(2008-12#1)(2008-4#1)
in SF900II##2##2##(2008-11#2)
in SFM##3##2##(2008-11#3)
in SG##2##2##(2012-12#1)(2012-2#1)
in SH-SY5Y cells and##2##4##(1997-2#2)
in SHR rats##2##3##(1996-5#1)(2011-1#1)
in SHR##8##2##(1990-7#1)(1994-2#1)(1996-5#2)(1997-6#1)(2011-1#3)
in SI##4##2##(1993-10#2)(1995-12#1)(2012-2#1)
in SJL/J mice##6##3##(1993-2#2)(1997-4#3)(2008-4#1)
in SJL/J##7##2##(1993-2#2)(1997-4#3)(2008-4#1)(2012-1#1)
in SLC24A5##2##2##(2009-5#2)
in SLE##6##2##(2011-2#1)(2013-1#5)
in SMC##3##2##(1994-11#1)(1995-8#1)(2008-10#1)
in SNR##2##2##(2007-12#1)(2012-1#1)
in SNX##2##2##(2008-7#2)
in SOD##3##2##(1990-3#1)(2009-5#2)
in SPC mode##2##3##(2011-1#2)
in SR and##2##3##(2008-8#2)
in SR##4##2##(2008-8#4)
in SRH##4##2##(2013-1#4)
in SRIF release##2##3##(1997-2#2)
in SSA##4##2##(2008-8#4)
in SSG GIP gene expression##2##5##(1995-11#2)
in ST2 cells was##2##4##(2008-11#2)
in ST2 cells##4##3##(2008-11#4)
in STZ-induced diabetic##2##3##(2011-1#1)(2012-3#1)
in STZ-induced hyperglycemic##2##3##(2013-1#2)
in STZ-induced##4##2##(2011-1#1)(2012-3#1)(2013-1#2)
in SW eels##2##3##(2008-5#2)
in Saccharomyces cerevisiae and##2##4##(1996-3#2)
in Saccharomyces cerevisiae is##2##4##(1993-9#2)
in Saccharomyces cerevisiae was##2##4##(1994-12#1)(1997-3#1)
in Saccharomyces cerevisiae##44##3##(1990-12#2)(1990-2#1)(1990-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#3)(1995-11#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-3#3)(1996-6#2)(1997-2#1)(1997-3#2)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-3#2)
in Saccharomyces##49##2##(1990-12#2)(1990-2#1)(1990-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#3)(1995-11#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-3#3)(1996-6#2)(1997-2#1)(1997-3#2)(2008-10#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#2)(2012-3#3)(2013-1#1)
in Saimiri##2##2##(2011-2#2)
in Saint Lucia and Trinidad##2##5##(2008-4#2)
in Salmonella typhimurium strains##3##4##(2008-9#3)
in Salmonella typhimurium##11##3##(1992-8#1)(1992-9#1)(1996-2#1)(2008-8#3)(2008-9#5)
in Salmonella##13##2##(1990-6#1)(1992-8#1)(1992-9#1)(1996-2#1)(2008-8#3)(2008-9#5)(2012-3#1)
in Salvador##4##2##(1991-9#2)(2008-10#1)(2009-10#1)
in Samoa and Tonga##2##4##(2012-12#2)
in Samoa##5##2##(2008-1#3)(2012-12#2)
in San Diego##2##3##(1993-12#1)(2008-10#1)
in San Francisco##5##3##(1991-11#1)(1996-3#1)(2008-5#1)(2009-11#1)(2010-8#1)
in San Joaquin##2##3##(2008-10#2)
in San Luis Potosí##3##4##(2011-2#3)
in San Luis##5##3##(2011-2#4)(2013-7#1)
in San##16##2##(1991-11#1)(1993-12#1)(1996-3#1)(2008-10#3)(2008-5#1)(2009-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-7#2)
in Santa Fe##4##3##(2008-2#1)(2008-3#1)(2008-5#2)
in Santa##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)
in Santiago de Cuba##2##4##(2007-10#1)(2008-7#1)
in Santiago de##3##3##(2007-10#1)(2008-7#1)(2013-1#1)
in Santiago##11##2##(2007-10#1)(2008-7#1)(2012-2#2)(2013-1#7)
in Sarawak##2##2##(2008-12#2)
in Sardinia##3##2##(2013-8#3)
in Saskatchewan##2##2##(2008-7#2)
in Saskatoon##2##2##(1993-12#1)(2008-12#1)
in Saudi Arabia is##2##4##(2007-7#1)(2008-4#1)
in Saudi Arabia##30##3##(1994-2#1)(2007-2#3)(2007-7#3)(2008-1#16)(2008-10#1)(2008-4#5)(2010-11#1)
in Saudi##31##2##(1994-2#1)(2007-2#3)(2007-7#3)(2008-1#17)(2008-10#1)(2008-4#5)(2010-11#1)
in Saxony (Germany)##2##3##(2008-11#2)
in Sc##3##2##(1995-8#3)
in ScA##3##2##(2008-11#3)
in Scandinavia##5##2##(1990-11#1)(1991-11#1)(1992-4#1)(1995-8#1)(2008-10#1)
in Sceloporus##5##2##(2010-3#5)
in Schizophrenia##2##2##(2010-6#1)(2011-1#1)
in School Children##2##3##(2008-7#1)(2009-7#1)
in Schwann cell##2##3##(2008-7#2)
in Schwann cells##2##3##(2008-7#2)
in Schwann##4##2##(2008-7#4)
in Science##2##2##(1991-8#1)(1995-3#1)
in Sclerotinia sclerotiorum##2##3##(2008-10#2)
in Scotland##7##2##(1990-9#1)(2008-10#2)(2008-9#3)(2011-2#1)
in Se##2##2##(2012-2#2)
in Seattle##3##2##(1992-1#1)(2008-5#2)
in Senegal##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
in Seoul##4##2##(1990-10#1)(1990-12#2)(1991-2#1)
in Sephadex##2##2##(1992-6#1)(2008-10#1)
in September 1988##2##3##(1995-12#1)(2008-5#1)
in September 2001##2##3##(2008-5#1)(2010-4#1)
in September##13##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-5#4)(2009-12#3)(2010-4#1)(2012-2#1)(2013-1#1)
in Serbia##5##2##(2008-10#1)(2008-11#2)(2011-2#2)
in Serratia marcescens##2##3##(2008-10#1)(2009-6#1)
in Sertoli cells##5##3##(2008-4#1)(2009-10#2)(2012-2#2)
in Sertoli##6##2##(1990-4#1)(2008-4#1)(2009-10#2)(2012-2#2)
in Sf cells##2##3##(1997-4#1)(1997-8#1)
in Sf##3##2##(1993-8#1)(1997-4#1)(1997-8#1)
in Sf-21##2##2##(2008-11#2)
in Sf-9 cell cultures##2##4##(2008-7#2)
in Sf-900 II##2##3##(2008-7#2)
in Sf9 cells##3##3##(2008-11#1)(2008-8#2)
in Sf9 insect cells##2##4##(1992-10#1)(2008-11#1)
in Sf9 insect##3##3##(1992-10#1)(2008-11#2)
in Sf9##6##2##(1992-10#1)(2008-11#3)(2008-8#2)
in SfB than in ScA##2##5##(2008-11#2)
in SfB##3##2##(2008-11#3)
in Shanghai##8##2##(1990-2#1)(1992-10#4)(2011-2#2)(2013-8#1)
in Shimane##2##2##(2010-8#1)(2010-9#1)
in Shiraz##3##2##(2008-12#3)
in Si##2##2##(2008-7#2)
in SiO(2)##2##2##(2008-10#1)(2008-3#1)
in Siberia##2##2##(2010-8#2)
in Siberian##2##2##(1996-6#1)(2009-4#1)
in Singapore##7##2##(1997-2#1)(2008-10#1)(2009-4#1)(2012-2#3)(2013-7#1)
in Singaporean Chinese##2##3##(2008-3#2)
in Single Photon##2##3##(2009-12#1)(2011-1#1)
in Single##4##2##(1997-7#1)(2008-10#1)(2009-12#1)(2011-1#1)
in Sjögren's syndrome##2##3##(1990-2#1)(2006-10#1)
in Sjögren's##4##2##(1990-2#1)(2006-10#3)
in SkM mitochondrial##2##3##(2012-3#2)
in Slovakia##3##2##(1995-3#1)(1996-3#1)(2008-10#1)
in Slovenia##2##2##(1994-5#1)(2011-2#1)
in Soccer##2##2##(2012-3#2)
in Soft##2##2##(2008-10#1)(2008-6#1)
in Soil and##4##3##(2008-10#4)
in Soil##7##2##(2008-10#7)
in Solution##2##2##(1996-2#1)(2008-10#1)
in South Africa are##4##4##(1997-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
in South Africa from##3##4##(2008-12#1)(2008-5#1)(2011-1#1)
in South Africa is##2##4##(2011-1#1)(2012-12#1)
in South Africa was##3##4##(2009-5#1)(2011-1#2)
in South Africa##47##3##(1992-9#1)(1996-6#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(2007-7#3)(2008-10#4)(2008-12#3)(2008-5#1)(2008-8#1)(2009-5#1)(2010-1#3)(2010-3#4)(2010-4#1)(2010-5#1)(2011-1#8)(2011-2#2)(2012-12#2)(2013-1#3)
in South African##2##3##(2008-10#1)(2011-1#1)
in South America and##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
in South America##12##3##(2006-10#1)(2008-10#4)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
in South American countries##2##4##(2011-2#1)(2012-3#1)
in South American##3##3##(2011-2#1)(2012-3#2)
in South Asia##2##3##(1994-3#1)(2008-10#1)
in South Australia and##2##4##(2008-10#2)
in South Carolina##6##3##(1991-8#1)(2008-11#1)(2012-12#3)(2013-1#1)
in South East Asia##7##4##(1992-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#3)
in South East##8##3##(1992-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#3)
in South Florida##2##3##(2007-5#1)(2009-9#1)
in South India##3##3##(2007-7#1)(2009-10#1)(2013-1#1)
in South Korea##4##3##(1997-3#1)(2010-1#1)(2011-2#1)(2013-7#1)
in South Texas##5##3##(2008-10#5)
in South##107##2##(1991-11#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(2006-10#1)(2007-5#1)(2007-7#4)(2008-10#20)(2008-11#1)(2008-12#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#4)(2010-3#4)(2010-4#2)(2010-5#1)(2011-1#9)(2011-2#7)(2012-12#6)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#2)
in South-Western##2##2##(2008-12#1)(2010-4#1)
in Southeast Asia##6##3##(1996-2#1)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#1)
in Southeast Michigan##2##3##(2011-2#2)
in Southeast##10##2##(1996-2#1)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#3)(2013-1#2)
in Southern Brazil##4##3##(2012-2#1)(2013-7#3)
in Southern California##4##3##(1996-4#2)(2008-10#1)(2011-2#1)
in Southern Spain##4##3##(2008-10#4)
in Southern##20##2##(1996-4#2)(2008-1#1)(2008-10#10)(2008-11#1)(2011-2#2)(2012-2#1)(2013-7#3)
in Southwest##2##2##(2007-5#1)(2013-8#1)
in Soxhlet##2##2##(2008-10#2)
in Soybean##4##2##(2008-10#4)
in Spain and##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
in Spain in 1996##2##4##(2008-10#1)(2008-5#1)
in Spain in##4##3##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
in Spain since##2##3##(2008-10#1)(2011-2#1)
in Spain that##3##3##(1991-11#1)(2008-10#1)(2013-1#1)
in Spain##52##2##(1990-3#1)(1990-8#1)(1991-11#1)(1994-12#2)(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#11)(2013-8#1)
in Spain]##7##2##(1990-3#1)(1991-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(2009-7#1)(2011-2#1)
in Spanish##13##2##(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
in Spirulina platensis##2##3##(2008-8#2)
in Spodoptera frugiperda (Sf9)##2##4##(1992-3#1)(2008-11#1)
in Spodoptera frugiperda##4##3##(1992-3#1)(1997-4#1)(2008-11#1)(2008-7#1)
in Spodoptera##5##2##(1992-3#1)(1997-4#1)(2008-11#1)(2008-7#2)
in Sprague-Dawley rats##7##3##(1991-9#1)(1993-12#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-4#1)(2012-1#1)
in Sprague-Dawley##12##2##(1991-9#1)(1993-12#1)(1996-5#1)(1996-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2012-1#1)
in Sri Lanka##4##3##(2007-5#1)(2008-10#2)(2012-12#1)
in Srinagarind Hospital##2##3##(2011-2#2)
in St##12##2##(1991-9#1)(1994-1#1)(1995-12#1)(2007-8#1)(2008-10#5)(2008-12#3)
in Staphylococcus aureus##5##3##(1990-7#1)(1995-8#2)(1997-2#1)(2007-7#1)
in Staphylococcus##7##2##(1990-7#1)(1995-8#2)(1997-2#1)(2007-7#1)(2008-7#2)
in State Medicaid programs##2##4##(1996-1#1)(1997-2#1)
in State##3##2##(1991-1#1)(1996-1#1)(1997-2#1)
in States##2##2##(1992-3#1)(1996-3#1)
in Stockholm##6##2##(1993-6#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-4#1)
in Stored##2##2##(2008-10#2)
in Strasbourg##2##2##(2008-1#2)
in Strehl ratio##2##3##(2007-12#2)
in Streptomyces coelicolor##3##3##(1990-5#1)(2008-8#2)
in Streptomyces##6##2##(1990-5#1)(1994-3#2)(2008-8#2)(2012-3#1)
in Streptozotocin-Induced##2##2##(2008-8#1)(2012-3#1)
in Study 1##2##3##(1991-2#1)(2008-12#1)
in Study 2##2##3##(1991-2#1)(2008-12#1)
in Study##4##2##(1991-2#2)(2008-12#2)
in Sub-Saharan Africa##5##3##(1995-9#1)(1997-7#1)(2008-11#1)(2008-8#1)(2011-1#1)
in Subjects with##2##3##(2008-12#1)(2013-7#1)
in Subsaharan##2##2##(2008-10#1)(2012-2#1)
in Sudan##8##2##(1992-2#1)(2007-10#1)(2007-7#2)(2008-4#1)(2009-2#1)(2011-2#2)
in Sugar Beet##2##3##(2008-10#1)(2012-3#1)
in Sugar##3##2##(2008-10#2)(2012-3#1)
in Sunflower##3##2##(2008-10#3)
in Super-CHO##2##2##(2008-11#2)
in Surface##2##2##(2008-10#2)
in Suwon 92##4##3##(2008-10#4)
in Svendborg##2##2##(1996-9#2)
in Sweden##20##2##(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-1#1)(2008-11#2)(2008-7#3)(2010-10#4)(2010-12#1)(2010-3#2)(2012-3#1)(2013-8#1)
in Sweden]##3##2##(1990-2#1)(1991-2#1)(1993-3#1)
in Swedish FAD##2##3##(1996-5#2)
in Swedish subjects##2##3##(1995-6#2)
in Swedish##5##2##(1995-6#2)(1996-5#3)
in Sweet##2##2##(2008-10#2)
in Swiss 3T3 cells##7##4##(1990-2#3)(1993-8#2)(1993-9#1)(1997-7#1)
in Swiss 3T3##8##3##(1990-2#3)(1993-8#2)(1993-9#1)(1997-6#1)(1997-7#1)
in Swiss albino mice##2##4##(1992-5#1)(2013-1#1)
in Swiss mice##2##3##(1993-5#1)(2012-12#1)
in Swiss##15##2##(1990-2#3)(1991-12#1)(1992-5#1)(1993-5#1)(1993-8#2)(1993-9#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-1#1)
in Switzerland and##3##3##(1990-3#1)(1993-3#1)(2008-10#1)
in Switzerland##28##2##(1990-3#1)(1990-9#1)(1991-11#4)(1991-2#1)(1991-4#1)(1991-6#1)(1993-3#1)(1993-8#1)(1996-11#2)(1996-6#4)(1997-3#1)(1997-4#1)(1997-8#3)(2008-1#1)(2008-10#3)(2008-2#1)(2012-5#1)
in Sydney##5##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-9#1)
in São José do Rio Preto##2##6##(2008-9#2)
in São Luís##2##3##(2008-9#2)
in São Paulo##5##3##(1990-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
in São##9##2##(1990-12#1)(2008-10#2)(2008-5#1)(2008-9#4)(2013-8#1)
in Sør-Trøndelag county##2##3##(1991-6#1)(1994-6#1)
in T cell##4##3##(1992-11#1)(2007-6#1)(2008-11#1)(2008-5#1)
in T cells##4##3##(1996-9#1)(1997-2#1)(2008-4#2)
in T##32##2##(1990-11#1)(1992-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2012-3#2)(2012-5#1)(2013-8#1)
in T(1)##2##2##(2008-10#1)(2010-8#1)
in T(f)##2##2##(2008-12#1)(2008-2#1)
in T-cell##7##2##(1992-8#1)(1994-12#1)(1994-8#2)(1995-2#1)(1997-6#1)(1997-9#1)
in T-flask##2##2##(2008-11#2)
in T-flasks##4##2##(2008-11#4)
in T-lymphocyte##2##2##(1991-2#1)(2008-10#1)
in T-lymphocytes##2##2##(1991-6#1)(1991-9#1)
in T1 and T2##7##4##(2006-12#1)(2010-2#6)
in T1 and##8##3##(2006-12#1)(2010-2#6)(2010-9#1)
in T1 than other groups##2##5##(2010-2#2)
in T1 than##4##3##(2010-2#4)
in T1##15##2##(1991-8#1)(2006-12#1)(2010-2#10)(2010-9#1)(2011-2#1)(2013-1#1)
in T2##4##2##(1990-2#1)(2010-2#3)
in T2D patients##2##3##(2011-2#2)
in T2D##6##2##(2011-2#2)(2012-3#2)(2012-6#1)(2013-7#1)
in T4##2##2##(1990-2#1)(1991-8#1)
in T88-M cells##2##3##(1990-12#2)
in TA##3##2##(1997-8#2)(2007-10#1)
in TAI-27##2##2##(2008-9#2)
in TB##2##2##(2011-2#1)(2013-7#1)
in TC##3##2##(1991-12#1)(2008-1#1)(2008-12#1)
in TDI controls##2##3##(2008-10#2)
in TDI##3##2##(2008-10#3)
in TEWL##2##2##(2008-5#2)
in TGF-beta-treated SFME cells##2##4##(2008-11#2)
in THA patients##2##3##(2011-2#2)
in THA##3##2##(2008-11#1)(2011-2#2)
in THF##3##2##(1996-5#1)(1997-7#1)(2008-10#1)
in THF/water##3##2##(2008-10#3)
in THz##2##2##(2007-11#1)(2008-3#1)
in TJ permeability##2##3##(2008-11#2)
in TKA patients##2##3##(2011-2#2)
in TKA##5##2##(2007-8#1)(2008-8#2)(2011-2#2)
in TKR##2##2##(2008-8#1)(2013-1#1)
in TLR4 gene##2##3##(2008-3#2)
in TMSG-1 transfectant##2##3##(2008-9#2)
in TNF-alpha##2##2##(1992-8#1)(1997-7#1)
in TNM-FH##2##2##(2008-11#2)
in TP53##2##2##(2008-7#2)
in TPO2##2##2##(1995-12#2)
in TRM##4##2##(2008-1#4)
in TSH##2##2##(1990-12#1)(2012-3#1)
in TSWV##2##2##(2008-10#2)
in TT##6##2##(2007-7#6)
in Tabasco##4##2##(2012-12#4)
in Tablets##2##2##(2010-3#1)(2010-5#1)
in Taiwan and##3##3##(2006-10#1)(2008-10#2)
in Taiwan were##2##3##(2007-6#1)(2009-5#1)
in Taiwan##25##2##(2006-10#1)(2007-6#3)(2008-10#6)(2008-12#3)(2008-7#1)(2009-5#3)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
in Takayasu arteritis##2##3##(1997-8#2)
in Talbot Interferometry##3##3##(2008-3#3)
in Talbot interferometry##7##3##(2008-3#7)
in Talbot##10##2##(2008-3#10)
in Tanzania##10##2##(2008-10#1)(2010-8#9)
in Tasmania##2##2##(2008-10#1)(2010-8#1)
in Tasmanian##2##2##(2008-10#2)
in Tc##2##2##(1994-2#2)
in Teaching##2##2##(2008-11#1)(2013-1#1)
in Tedlar bags##2##3##(2008-10#2)
in Tehran##10##2##(2007-7#1)(2007-9#1)(2008-12#3)(2011-2#3)(2012-2#1)(2013-8#1)
in Telemark##2##2##(1994-11#2)
in Tetrahymena thermophila##3##3##(2008-3#2)(2012-3#1)
in Tetrahymena##6##2##(2008-12#1)(2008-3#3)(2012-12#1)(2012-3#1)
in Tetraploid Wheat##3##3##(2008-10#2)(2012-3#1)
in Texas##9##2##(1991-1#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-3#2)(2008-10#1)(2008-2#1)
in Tg##4##2##(2008-9#4)
in Th2##2##2##(2008-11#1)(2008-9#1)
in Thai##2##2##(2011-2#2)
in Thailand in##2##3##(1990-3#1)(2007-12#1)
in Thailand##23##2##(1990-3#1)(1992-6#1)(1995-12#2)(1996-9#1)(1997-8#1)(2007-12#1)(2007-2#6)(2008-10#3)(2008-11#1)(2008-8#2)(2010-2#2)(2011-2#2)
in Thais##2##2##(2011-1#2)
in The Hague##3##3##(1990-3#1)(1992-5#2)
in The Netherlands##12##3##(1990-3#2)(1990-9#2)(1991-8#1)(1994-12#1)(1996-11#2)(1996-6#2)(2008-11#1)(2011-2#1)
in The Netherlands?]##2##3##(1990-3#1)(1996-11#1)
in The Netherlands]##9##3##(1990-9#1)(1991-11#1)(1992-2#1)(1992-5#2)(1995-12#2)(1996-11#1)(1996-6#1)
in The##32##2##(1990-3#4)(1990-9#3)(1991-11#1)(1991-8#1)(1992-2#1)(1992-5#4)(1994-12#2)(1995-1#1)(1995-12#2)(1996-11#4)(1996-6#3)(2008-11#2)(2009-8#2)(2011-2#1)(2013-1#1)
in Thurgau##5##2##(1996-11#5)
in Thy during##2##3##(1993-12#2)
in Ti##2##2##(2007-11#1)(2008-2#1)
in TiO(2)##2##2##(2008-10#2)
in Tianjin##2##2##(2008-10#1)(2012-2#1)
in Time##4##2##(1996-12#1)(2008-12#1)(2008-3#2)
in Tm##3##2##(1997-2#1)(2007-12#1)(2008-2#1)
in TnC##2##2##(1995-6#2)
in Tobacco Plants##2##3##(2008-10#2)
in Tobacco##5##2##(2008-10#5)
in Tokyo##3##2##(1993-8#1)(1997-8#1)(2008-2#1)
in Tomato by##2##3##(2008-10#2)
in Tomato##7##2##(2008-10#7)
in Toronto##8##2##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-3#1)
in Total Knee Arthroplasty##2##4##(2013-1#2)
in Total Knee##3##3##(2013-1#3)
in Total##6##2##(1996-3#1)(2008-11#1)(2012-12#1)(2013-1#3)
in Transgenic Arabidopsis##2##3##(2008-10#2)
in Transgenic Soybean##2##3##(2008-10#2)
in Transgenic##8##2##(2008-10#8)
in Transition##2##2##(2008-6#1)(2011-1#1)
in Treatment##2##2##(2008-12#1)(2008-7#1)
in Trichoderma##2##2##(2008-10#2)
in Trichogramma##2##2##(2008-8#2)
in Trichoplusia ni##2##3##(1995-12#1)(2008-7#1)
in Trinidad and Tobago##2##4##(2007-5#1)(2008-10#1)
in Trinidad##4##2##(2007-5#2)(2008-10#1)(2008-9#1)
in Tris buffer##2##3##(1992-10#1)(1995-6#1)
in Tris##3##2##(1992-10#2)(1995-6#1)
in Ts65Dn mice##2##3##(1997-2#2)
in Ts65Dn##4##2##(1997-2#4)
in Tsukuba##2##2##(2008-2#2)
in Tulipa spp##3##3##(2009-12#3)
in Tunisia##11##2##(1992-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#2)
in Tunisian##3##2##(2008-10#2)(2009-5#1)
in Turkey as##2##3##(2008-12#1)(2010-8#1)
in Turkey##21##2##(1991-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-8#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-8#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
in Turkish orthopedic patients##2##4##(2010-6#2)
in Turkish patients##2##3##(2008-2#2)
in Turkish population##2##3##(2012-12#1)(2012-2#1)
in Turkish##14##2##(2008-12#1)(2008-2#2)(2009-12#1)(2010-10#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)
in Tuscany##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2013-8#1)
in Tween 80 medium##2##4##(2008-10#2)
in Tween 80##3##3##(2008-10#3)
in Twin Falls##2##3##(1995-2#2)
in Two##4##2##(1996-9#1)(2008-10#1)(2011-1#1)(2012-3#1)
in Type 1 Diabetes##2##4##(2009-3#1)(2013-1#1)
in Type 1 diabetes mellitus##2##5##(2008-1#1)(2010-5#1)
in Type 1 diabetes##3##4##(2008-1#1)(2010-5#2)
in Type 1##5##3##(2008-1#1)(2009-3#1)(2010-5#2)(2013-1#1)
in Type 2 Diabetic##2##4##(2012-3#2)
in Type 2 diabetes##3##4##(2008-1#1)(2010-10#2)
in Type 2##6##3##(2008-1#2)(2010-10#2)(2012-3#2)
in Type##12##2##(2007-7#1)(2008-1#3)(2009-3#1)(2010-10#2)(2010-5#2)(2012-3#2)(2013-1#1)
in Táchira##2##2##(2008-9#2)
in U##16##2##(1991-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#3)
in U937 cells##2##3##(1993-3#1)(2012-12#1)
in U937##3##2##(1993-3#1)(2008-10#1)(2012-12#1)
in UC##5##2##(2008-10#1)(2011-2#1)(2013-8#3)
in UGT8 expression between##2##4##(2013-8#2)
in UK##3##2##(1994-7#1)(1996-8#1)(2010-12#1)
in UOS##2##2##(2012-3#2)
in US##7##2##(1991-3#1)(1995-9#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-1#1)
in USA##4##2##(1992-5#1)(1996-8#1)(2008-10#1)(2008-11#1)
in USM##2##2##(2008-10#2)
in UV##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
in UV-vis##2##2##(2008-10#2)
in Uganda##13##2##(1993-3#1)(1995-9#1)(2008-10#3)(2008-5#3)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
in United Kingdom##2##3##(2008-10#1)(2008-11#1)
in United States##4##3##(2007-7#1)(2008-3#2)(2008-8#1)
in United##6##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)
in Uppsala##2##2##(2008-10#1)(2008-8#1)
in Urban##2##2##(2012-2#1)(2013-1#1)
in Urbana##3##2##(2008-10#3)
in Urmia##2##2##(2008-12#1)(2013-1#1)
in Uruguay##3##2##(2010-8#1)(2011-2#2)
in Utah##2##2##(2008-3#1)(2013-1#1)
in Uterine##2##2##(2008-6#1)(2008-8#1)
in Utero##2##2##(1991-3#1)(2012-12#1)
in V##16##2##(1995-2#1)(1997-8#1)(2008-10#13)(2011-2#1)
in V1##5##2##(1994-8#2)(2008-11#3)
in VAM##3##2##(2008-10#3)
in VAT##7##2##(2008-5#2)(2013-1#5)
in VCG 0030##2##3##(2008-10#2)
in VCG 0031##2##3##(2008-10#2)
in VCG 0080##2##3##(2008-10#2)
in VCG 0082##2##3##(2008-10#2)
in VCG##10##2##(2008-10#10)
in VCG2B##5##2##(2008-10#5)
in VCGs##2##2##(2008-10#2)
in VDR##2##2##(2008-1#2)
in VLDL##6##2##(1990-8#3)(1991-12#1)(1992-12#1)(2012-2#1)
in VSMC##3##2##(1990-12#1)(1993-2#1)(1994-9#1)
in Vancouver##4##2##(2008-12#3)(2013-1#1)
in Vanuatu##2##2##(2008-1#2)
in Varanasi##2##2##(2008-10#1)(2012-2#1)
in Various##2##2##(2008-10#2)
in Venezuela##12##2##(2008-5#6)(2008-9#2)(2011-2#1)(2012-12#1)(2013-7#2)
in Venezuela]##2##2##(2011-2#1)(2013-7#1)
in Venezuelan##2##2##(2011-2#2)
in Venice##2##2##(2008-11#2)
in Venturia inaequalis##2##3##(2008-10#2)
in Vermont##2##2##(1992-2#1)(2010-8#1)
in Vero##2##2##(2007-10#1)(2008-11#1)
in Verticillium dahliae##2##3##(2008-10#2)
in Verticillium##3##2##(2008-10#3)
in Vest-Agder##2##2##(1997-8#2)
in Vicia faba##3##3##(2008-12#1)(2008-8#2)
in Victoria##6##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)
in Vienna in##2##3##(2009-7#1)(2011-1#1)
in Vietnam##5##2##(1994-3#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)
in Vietnamese women is comparable to##2##6##(2010-3#2)
in Vietnamese women##5##3##(2010-3#5)
in Virginia##3##2##(1995-12#1)(1995-6#1)(2008-8#1)
in Virulence##4##2##(2008-10#4)
in Vmax##5##2##(1990-10#1)(1994-8#1)(1995-2#2)(1995-5#1)
in WB##2##2##(2008-10#2)
in WEHI 231 cells##3##4##(1994-10#3)
in WEHI 231##4##3##(1994-10#4)
in WEHI-3B##3##2##(1992-3#2)(1994-11#1)
in WI-38 human lung cells##2##5##(1995-8#2)
in WKY##8##2##(1993-12#2)(1994-2#2)(2008-2#1)(2011-1#3)
in WNK3 knockout mice was not##2##6##(2012-12#2)
in WNK3 knockout mice##3##4##(2012-12#3)
in WP##4##2##(2008-7#4)
in WS##2##2##(1992-9#1)(2010-2#1)
in WT##3##2##(2013-1#1)(2013-8#2)
in Warsaw##8##2##(1991-1#1)(2007-11#4)(2007-8#3)
in Washington State##5##3##(1996-2#1)(2008-10#2)(2013-8#2)
in Washington##17##2##(1990-4#1)(1995-2#1)(1996-2#1)(2008-10#9)(2008-6#1)(2008-8#1)(2009-6#1)(2013-8#2)
in Wave##2##2##(2008-2#1)(2013-8#1)
in Werner's syndrome##3##3##(1994-12#3)
in West Africa##6##3##(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2013-7#1)
in West Bank##2##3##(2009-2#2)
in West Bengal##2##3##(1994-3#1)(2008-10#1)
in West##12##2##(1994-3#1)(1996-5#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-2#2)(2009-4#1)(2013-7#1)
in Western Australia##14##3##(2008-10#10)(2008-11#2)(2010-3#2)
in Western Europe##4##3##(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
in Western Guatemala##2##3##(2013-7#2)
in Western blot analysis##2##4##(1992-8#1)(1992-9#1)
in Western blot##3##3##(1991-5#1)(1992-8#1)(1992-9#1)
in Western blots and##2##4##(2008-10#1)(2012-12#1)
in Western blots##3##3##(1995-12#1)(2008-10#1)(2012-12#1)
in Western countries##11##3##(1992-10#1)(1993-9#1)(1996-8#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in Western patients##2##3##(2007-12#1)(2012-2#1)
in Western society##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
in Western##57##2##(1991-5#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-12#2)(1996-8#1)(1997-6#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
in Westernized##2##2##(2010-5#1)(2010-8#1)
in Wheat##13##2##(2008-10#13)
in Whites##2##2##(1991-2#1)(2011-2#1)
in Wild##2##2##(2008-10#1)(2013-7#1)
in Wiley##2##2##(2011-2#1)(2013-1#1)
in Wisconsin and##2##3##(2008-10#2)
in Wisconsin##11##2##(1991-12#1)(2008-10#10)
in Wistar and stroke-prone spontaneously hypertensive rats##2##7##(1995-12#2)
in Wistar rats##14##3##(1991-5#1)(1992-12#1)(1993-12#2)(1994-11#2)(1994-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#2)
in Wistar##18##2##(1991-5#1)(1992-12#1)(1993-12#2)(1994-11#2)(1994-6#1)(1995-12#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
in Wistars##2##2##(1995-12#2)
in World##4##2##(2012-2#1)(2012-3#1)(2013-1#2)
in X##8##2##(1993-12#1)(2008-10#7)
in X-ray##3##2##(1992-9#1)(2006-4#1)(2008-10#1)
in Xanthomonas##2##2##(2008-10#2)
in Xenopus laevis oocytes##5##4##(1991-12#1)(1992-3#1)(1994-8#2)(2010-2#1)
in Xenopus laevis##12##3##(1991-12#1)(1992-3#1)(1993-5#1)(1994-8#2)(1995-3#1)(1997-7#3)(2008-11#1)(2008-9#1)(2010-2#1)
in Xenopus oocytes##17##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1994-12#1)(1995-11#4)(1995-2#2)(1995-5#1)(1997-2#1)(2008-4#3)(2012-12#1)
in Xenopus##33##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-8#2)(1995-11#4)(1995-2#2)(1995-3#1)(1995-5#1)(1997-2#2)(1997-7#4)(2008-1#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-2#1)(2012-12#1)
in Xhosa-speaking families in South Africa##2##6##(2008-12#2)
in Xieyou 63##3##3##(2008-9#3)
in Xieyou 9308##3##3##(2008-9#3)
in Xieyou##6##2##(2008-9#6)
in Xq28##4##2##(1993-3#2)(1993-6#2)
in Y79##2##2##(1994-8#2)
in YAG##3##2##(2008-2#2)(2008-3#1)
in YBa2Cu3O7##2##2##(1993-5#1)(1994-2#1)
in Yangzhong City from##2##4##(2012-3#2)
in Yangzhou City##2##3##(2012-3#2)
in Yb##2##2##(2008-3#2)
in Yb(3+)-doped##2##2##(2007-11#1)(2008-2#1)
in Yemen##7##2##(2008-10#1)(2010-6#6)
in Yolo##2##2##(2008-10#2)
in Young Adults##3##3##(2011-2#1)(2013-1#2)
in Young##7##2##(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#3)
in Ytre Nordhordland##2##3##(1993-11#1)(1993-6#1)
in Yunnan Province##2##3##(2008-8#1)(2008-9#1)
in Yunnan province##2##3##(2011-1#2)
in Yunnan##6##2##(2008-8#1)(2008-9#2)(2011-1#2)(2013-8#1)
in Zagreb in##2##3##(2008-10#2)
in Zaire##2##2##(1995-9#1)(1996-8#1)
in Zambézia Province##2##3##(2012-12#2)
in Zanzibar##3##2##(2012-2#3)
in Zaragoza city##2##3##(1996-12#2)
in Zaragoza##3##2##(1996-12#2)(2008-3#1)
in Zea mays##3##3##(2008-10#2)(2008-12#1)
in Zhejiang Province##2##3##(2008-10#1)(2008-9#1)
in Zhejiang province##4##3##(2011-1#4)
in Zhejiang##7##2##(2008-10#1)(2008-9#1)(2011-1#4)(2013-1#1)
in Zimbabwe##5##2##(1996-3#1)(2008-11#1)(2011-1#3)
in Zn##2##2##(2012-2#2)
in ZnO##2##2##(2007-11#1)(2008-10#1)
in ZnT4##2##2##(2008-10#2)
in Zone##2##2##(2007-12#2)
in Zucker##3##2##(2008-4#2)(2012-1#1)
in Zuker diabetic##2##3##(2011-1#2)
in Zulia##2##2##(2011-2#1)(2012-12#1)
in Zymomonas mobilis##2##3##(2009-5#2)
in Zymomonas##3##2##(2008-6#1)(2009-5#2)
in [14C]oxalacetate##2##2##(1993-11#2)
in [3H]##2##2##(1992-11#1)(1996-5#1)
in [Ca2+]i and##6##3##(1990-12#1)(1990-7#2)(1994-3#1)(1994-6#1)(1997-1#1)
in [Ca2+]i in response to##2##5##(1992-6#1)(1994-2#1)
in [Ca2+]i in these cells##2##5##(1992-9#1)(1994-2#1)
in [Ca2+]i in##7##3##(1992-6#2)(1992-9#1)(1993-3#1)(1994-2#2)(1997-2#1)
in [Ca2+]i induced by##2##4##(1990-12#1)(1993-3#1)
in [Ca2+]i using##2##3##(1992-9#1)(1995-12#1)
in [Ca2+]i was##4##3##(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)
in [Ca2+]i were##3##3##(1994-6#1)(1994-9#1)(1995-11#1)
in [Ca2+]i##42##2##(1990-12#3)(1990-7#4)(1992-6#3)(1992-9#2)(1993-3#4)(1994-11#1)(1994-2#7)(1994-3#3)(1994-6#3)(1994-9#3)(1995-11#2)(1995-12#3)(1997-1#2)(1997-2#2)
in [cAMP]i##3##2##(1991-3#3)
in a &quot##9##3##(1990-8#1)(1991-2#1)(1994-1#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
in a 0##9##3##(1996-5#1)(2008-10#7)(2013-1#1)
in a 1##33##3##(1990-5#1)(1992-2#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#3)(2012-1#2)
in a 1%##2##3##(2008-9#1)(2010-2#1)
in a 1-mm silica cell##3##5##(2008-10#3)
in a 1-year##2##3##(2013-1#1)(2013-8#1)
in a 1-year-old##2##3##(2012-12#1)(2012-3#1)
in a 10-fold##3##3##(1990-8#1)(1992-3#1)(1995-3#1)
in a 10-year-old boy##2##4##(2008-7#1)(2013-1#1)
in a 10-year-old##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
in a 100##3##3##(2008-10#2)(2008-11#1)
in a 100-L##2##3##(2008-6#2)
in a 12-week##4##3##(2007-12#1)(2008-5#3)
in a 12-year-old girl##3##4##(2007-12#1)(2008-10#2)
in a 12-year-old##4##3##(2007-12#1)(2008-10#2)(2012-12#1)
in a 13##2##3##(1993-6#1)(2013-1#1)
in a 13-year-old##3##3##(2007-10#1)(2007-9#1)(2012-2#1)
in a 14-year-old##3##3##(2007-7#1)(2008-12#1)(2013-1#1)
in a 15-year-old girl##2##4##(2007-2#1)(2009-3#1)
in a 15-year-old##4##3##(2007-2#1)(2008-10#1)(2009-3#1)(2013-1#1)
in a 2##10##3##(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-9#1)(2010-4#1)
in a 2-month-old##3##3##(2007-5#2)(2010-6#1)
in a 2-week##3##3##(2008-7#2)(2010-2#1)
in a 2-year-old boy##2##4##(2011-2#1)(2012-2#1)
in a 2-year-old##3##3##(2011-2#1)(2012-1#1)(2012-2#1)
in a 20-year-old man##2##4##(1992-2#1)(2008-9#1)
in a 200##2##3##(2008-10#1)(2010-5#1)
in a 23 year##2##4##(2010-11#1)(2012-2#1)
in a 23-year-old woman##3##4##(2007-8#1)(2008-7#1)(2010-12#1)
in a 23-year-old##5##3##(1997-8#1)(2007-8#1)(2008-7#1)(2010-12#1)(2013-1#1)
in a 25-year-old##2##3##(2011-1#1)(2013-1#1)
in a 28-year-old man##2##4##(2008-12#2)
in a 29-year-old female##2##4##(2008-11#1)(2008-7#1)
in a 29-year-old male##2##4##(1990-3#1)(2010-7#1)
in a 29-year-old##5##3##(1990-3#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
in a 3##8##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
in a 3-D##2##3##(2008-11#1)(2008-3#1)
in a 3-month-old##2##3##(2008-10#2)
in a 3-year-old##3##3##(1994-2#1)(2008-9#1)(2011-1#1)
in a 30##4##3##(1991-5#1)(1996-5#1)(2013-1#2)
in a 32-year-old man##3##4##(2007-10#1)(2009-1#1)(2012-3#1)
in a 32-year-old##7##3##(2007-10#2)(2008-11#1)(2009-1#1)(2011-1#2)(2012-3#1)
in a 34##2##3##(1991-8#1)(2007-12#1)
in a 35-year old##2##4##(2011-1#1)(2011-2#1)
in a 35-year-old##5##3##(2007-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-2#1)
in a 36-year-old##2##3##(2009-11#1)(2012-3#1)
in a 37##3##3##(2007-8#1)(2008-11#1)(2008-8#1)
in a 38-year-old woman##2##4##(2006-10#1)(2007-7#1)
in a 39##2##3##(2008-3#1)(2010-3#1)
in a 3D##2##3##(2012-1#2)
in a 4##6##3##(1995-2#1)(1996-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
in a 40 cm##3##4##(2008-10#2)(2012-12#1)
in a 40##4##3##(1996-5#1)(2008-10#2)(2012-12#1)
in a 41-year-old##2##3##(2008-12#1)(2013-1#1)
in a 42 year##2##4##(1994-8#1)(2008-7#1)
in a 42-year-old man with##2##5##(1991-5#1)(2012-3#1)
in a 42-year-old##3##3##(1991-5#1)(2008-7#1)(2012-3#1)
in a 43-year-old##2##3##(1991-6#1)(2007-12#1)
in a 48-year-old woman##2##4##(2009-1#1)(2012-3#1)
in a 48-year-old##3##3##(2009-1#1)(2012-3#1)(2013-1#1)
in a 5##5##3##(1994-2#1)(2008-10#2)(2008-2#1)(2008-6#1)
in a 5%##2##3##(2007-11#1)(2008-10#1)
in a 5-year##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
in a 5-year-old##4##3##(1990-6#1)(2008-10#1)(2008-9#1)(2013-8#1)
in a 50##4##3##(1996-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
in a 50% decrease in##2##5##(1991-11#1)(1993-6#1)
in a 50% decrease##3##4##(1990-11#1)(1991-11#1)(1993-6#1)
in a 50% reduction##2##4##(2008-10#2)
in a 50%##7##3##(1990-11#1)(1991-11#1)(1993-6#1)(2008-10#4)
in a 500##2##3##(1990-9#1)(2008-11#1)
in a 51-year-old woman##2##4##(2008-5#1)(2008-6#1)
in a 51-year-old##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
in a 52-year-old##2##3##(2012-12#1)(2013-1#1)
in a 53-year-old##2##3##(1997-3#1)(2008-11#1)
in a 54-year-old##2##3##(2013-1#1)(2013-7#1)
in a 57-year-old##2##3##(2008-12#1)(2010-5#1)
in a 58-year-old man##2##4##(2008-7#1)(2009-3#1)
in a 58-year-old##3##3##(2007-8#1)(2008-7#1)(2009-3#1)
in a 59-year-old##2##3##(2009-8#1)(2012-12#1)
in a 6##2##3##(2007-12#1)(2012-2#1)
in a 6-year-old##2##3##(2010-3#1)(2010-6#1)
in a 60##2##3##(2008-10#1)(2008-11#1)
in a 60-year-old##2##3##(2012-3#1)(2013-1#1)
in a 61-year-old##2##3##(1992-8#1)(2008-11#1)
in a 62-year-old woman##3##4##(1991-11#1)(1994-6#1)(2009-3#1)
in a 62-year-old##5##3##(1991-11#1)(1994-6#1)(2008-12#1)(2008-4#1)(2009-3#1)
in a 63##3##3##(2007-8#1)(2010-12#1)(2013-1#1)
in a 64-year-old##2##3##(1996-11#1)(2013-1#1)
in a 66-year-old##2##3##(1992-2#1)(2009-1#1)
in a 67-year-old man##2##4##(1991-8#1)(2008-7#1)
in a 7##2##3##(2008-10#1)(2012-2#1)
in a 7-year-old##2##3##(2008-10#1)(2013-1#1)
in a 70-year-old##3##3##(1991-12#1)(1992-2#1)(2008-12#1)
in a 71-year-old##3##3##(1992-12#1)(1992-2#1)(2010-12#1)
in a 72##2##3##(1991-12#1)(1991-5#1)
in a 72-year-old woman with##2##5##(1997-7#1)(2010-7#1)
in a 72-year-old woman##3##4##(1997-7#1)(2007-8#1)(2010-7#1)
in a 78-year-old##3##3##(1990-8#1)(2010-4#1)(2013-1#1)
in a 9-year-old boy##2##4##(2008-10#1)(2012-12#1)
in a 9-year-old##4##3##(1991-6#1)(2008-10#1)(2012-12#2)
in a AgGaSe(2)##2##3##(2008-2#2)
in a Bachelor of Nursing##2##5##(2008-12#1)(2012-3#1)
in a Bayesian framework##2##4##(1996-6#1)(2011-1#1)
in a Bayesian##3##3##(1996-6#1)(2008-8#1)(2011-1#1)
in a Ca(2+)-dependent manner##3##4##(1992-6#1)(1995-6#1)(2008-4#1)
in a Ca(2+)-free##3##3##(1994-6#1)(1996-2#1)(2008-8#1)
in a California##3##3##(1992-2#1)(2008-10#2)
in a Canadian##9##3##(1992-12#1)(1996-12#1)(2007-12#3)(2008-10#2)(2008-11#1)(2013-1#1)
in a Caucasian##2##3##(1990-8#1)(2009-5#1)
in a Ce##3##3##(2007-12#2)(2008-3#1)
in a Child with##2##4##(1996-6#1)(2010-9#1)
in a Chilean elderly sample##2##5##(2013-1#2)
in a Chilean elderly##3##4##(2013-1#3)
in a Chinese Han population##3##5##(2011-2#3)
in a Chinese population##3##4##(2011-2#2)(2013-7#1)
in a Chinese##7##3##(2008-11#1)(2011-2#5)(2013-7#1)
in a Community##2##3##(2008-11#1)(2011-2#1)
in a Cr##2##3##(2007-11#1)(2007-12#1)
in a DNA duplex##4##4##(1993-11#1)(1995-12#2)(2008-4#1)
in a DNA##6##3##(1993-11#1)(1995-12#2)(2008-10#1)(2008-4#1)(2012-2#1)
in a European##2##3##(2008-10#2)
in a FIA assembly##3##4##(2008-10#3)
in a FIA##6##3##(2008-10#6)
in a French hospital##3##4##(2008-7#2)(2011-2#1)
in a French##4##3##(2008-3#1)(2008-7#2)(2011-2#1)
in a GaAs single crystal is##2##6##(2008-2#2)
in a GaAs##5##3##(2007-11#2)(2008-2#3)
in a GaAsP photodiode##2##4##(2007-12#2)
in a GaN##2##3##(2007-11#2)
in a GaSe##2##3##(2007-11#1)(2008-3#1)
in a Gaussian beam##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
in a General Hospital##2##4##(2009-10#1)(2013-1#1)
in a Japanese##5##3##(1992-8#1)(1993-12#1)(2008-5#1)(2010-10#1)(2010-2#1)
in a KTP crystal##3##4##(2007-12#3)
in a Kerr medium##3##4##(2007-12#3)
in a Kerr##4##3##(2007-11#1)(2007-12#3)
in a LiNbO(3)##4##3##(2007-12#1)(2008-3#3)
in a Lima##3##3##(1991-8#1)(2012-12#2)
in a Malaysian##2##3##(2008-8#1)(2012-12#1)
in a Medicare##2##3##(1993-12#1)(1994-12#1)
in a Mediterranean cohort##2##4##(2013-1#2)
in a Mediterranean##3##3##(2008-10#1)(2013-1#2)
in a Mexican##2##3##(2011-2#1)(2013-7#1)
in a Michelson interferometer##2##4##(2007-11#2)
in a Nd##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
in a Nigerian##4##3##(2010-9#1)(2012-12#2)(2013-1#1)
in a North##2##3##(2007-2#1)(2008-11#1)
in a Norwegian##2##3##(1996-3#1)(1997-2#1)
in a Novel##2##3##(1996-5#1)(2008-2#1)
in a PVC matrix##2##4##(2008-10#2)
in a PVC##4##3##(2008-10#4)
in a PW have higher rates of disfluency than those that##2##11##(2008-2#2)
in a PW##3##3##(2008-2#3)
in a Patient with##3##4##(1994-12#1)(2008-12#2)
in a Patient##4##3##(1994-12#1)(2008-1#1)(2008-12#2)
in a Plexiglas##2##3##(2008-10#1)(2008-5#1)
in a Q-switched##2##3##(2008-2#1)(2008-3#1)
in a Rat##2##3##(2008-10#1)(2012-3#1)
in a Ronchi##2##3##(2008-3#2)
in a Saudi##2##3##(2007-2#2)
in a Southeastern##2##3##(1996-1#1)(2012-2#1)
in a Swedish##2##3##(1997-5#1)(2007-10#1)
in a T-maze##4##3##(1991-2#1)(1993-3#2)(1994-8#1)
in a TB##2##3##(1996-3#1)(2008-7#1)
in a TBI rat model##2##5##(2012-2#2)
in a TBI##3##3##(2009-10#1)(2012-2#2)
in a TEM(00)##2##3##(2007-11#1)(2007-12#1)
in a Ti##2##3##(2008-2#1)(2008-3#1)
in a Turkish population##2##4##(2011-2#2)
in a U##2##3##(2010-6#1)(2013-8#1)
in a UV-sensitive##2##3##(1993-3#2)
in a University##2##3##(1995-12#1)(2007-2#1)
in a baculovirus system##3##4##(1992-3#1)(1994-8#2)
in a baculovirus##4##3##(1992-3#1)(1994-8#2)(2008-11#1)
in a basal-to-apical direction##2##4##(2008-9#2)
in a basic##5##3##(1993-1#1)(1996-9#1)(2007-12#1)(2008-10#1)(2012-3#1)
in a batch##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
in a battery##2##3##(1995-3#1)(2007-6#1)
in a benign##2##3##(1994-5#1)(2008-11#1)
in a better position to##3##5##(1996-2#1)(2008-11#1)(2008-3#1)
in a better way##2##4##(2007-6#1)(2012-3#1)
in a better##13##3##(1990-10#1)(1991-6#1)(1996-2#1)(2007-10#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2012-3#1)
in a bilayer##2##3##(1993-11#2)
in a bioassay##2##3##(1991-6#1)(2008-10#1)
in a biocontrol experiment##2##4##(2008-10#2)
in a biodegradable##3##3##(2008-5#1)(2008-7#2)
in a biological assay##2##4##(1994-5#1)(2008-11#1)
in a biological system##2##4##(1995-5#1)(2008-4#1)
in a biological##10##3##(1994-5#1)(1995-5#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
in a biologically##3##3##(1994-8#1)(2008-12#1)(2013-1#1)
in a bioprocess##2##3##(2008-10#1)(2008-11#1)
in a bioreactor##5##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
in a biphasic##8##3##(1990-2#1)(1991-10#2)(1992-7#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-1#1)
in a birefringent##2##3##(2008-3#2)
in a blind##4##3##(1990-5#1)(1997-2#1)(2008-5#1)(2008-6#1)
in a blinded##2##3##(2007-10#1)(2008-5#1)
in a boron-codoped germanosilicate fiber##2##5##(2008-2#2)
in a boy with##2##4##(1994-3#1)(2008-10#1)
in a breast cancer##2##4##(1993-3#1)(2008-9#1)
in a breast##3##3##(1993-3#1)(1995-6#1)(2008-9#1)
in a broad range of##4##5##(2008-10#2)(2008-7#1)(2008-9#1)
in a broad sense##3##4##(2008-10#2)(2009-9#1)
in a broad spectrum##2##4##(1996-12#1)(2008-5#1)
in a broad##14##3##(1993-1#1)(1996-12#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)
in a broader##2##3##(2008-3#1)(2009-6#1)
in a brother and sister##2##5##(2007-7#2)
in a bubble##2##3##(2008-6#2)
in a buffer##4##3##(2008-10#2)(2008-8#1)(2009-3#1)
in a bulk medium##2##4##(2007-11#1)(2007-12#1)
in a bulk##11##3##(2007-11#5)(2007-12#6)
in a bundle##2##3##(2008-4#1)(2008-9#1)
in a bus##2##3##(2008-1#1)(2008-6#1)
in a busy##2##3##(1996-2#1)(2012-2#1)
in a cancer##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
in a canine model##2##4##(2009-8#1)(2013-1#1)
in a canine##4##3##(2009-8#1)(2012-3#1)(2013-1#2)
in a cap-independent##2##3##(2008-11#2)
in a capillary##3##3##(2008-10#3)
in a cardiac##2##3##(2011-1#1)(2013-1#1)
in a caring##2##3##(1990-6#1)(2008-12#1)
in a carrier stream of##2##5##(2008-10#2)
in a carrier##3##3##(2008-10#3)
in a case of##28##4##(1990-9#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-1#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
in a case study##2##4##(2008-10#1)(2008-2#1)
in a case with##4##4##(1993-3#1)(1995-3#1)(2007-9#1)(2008-9#1)
in a case##36##3##(1990-9#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1995-3#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-10#1)(2011-1#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
in a cat##4##3##(1992-5#1)(1997-8#1)(2008-3#1)(2012-3#1)
in a cationic micellar solution of##2##6##(2008-10#2)
in a cavity##2##3##(2007-11#1)(2008-3#1)
in a cell containing##2##4##(2008-2#1)(2008-3#1)
in a cell density-dependent manner##2##5##(1993-8#1)(1995-2#1)
in a cell free system##2##5##(1990-12#1)(1991-2#1)
in a cell line##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
in a cell population##2##4##(2008-1#1)(2008-4#1)
in a cell type-specific manner##2##5##(1995-11#1)(1995-8#1)
in a cell##31##3##(1990-12#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-8#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)
in a cell-cycle##2##3##(2008-11#1)(2008-9#1)
in a cell-free system##12##4##(1990-11#1)(1990-5#2)(1991-5#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#2)
in a cell-free##14##3##(1990-11#1)(1990-5#2)(1991-5#2)(1992-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#3)
in a cellular##3##3##(1997-7#1)(2008-11#1)(2011-1#1)
in a cellulose##3##3##(1991-11#1)(2008-10#2)
in a central##2##3##(1993-5#1)(2008-3#1)
in a centrifugal##3##3##(1995-12#1)(2008-2#1)(2013-1#1)
in a cerium-doped potassium sodium strontium barium niobate crystal##2##9##(2008-3#2)
in a cerium-doped potassium sodium strontium barium niobate##4##8##(2007-12#1)(2008-3#3)
in a cerium-doped##5##3##(2007-12#1)(2008-3#4)
in a certain group of patients##2##6##(2009-6#1)(2013-1#1)
in a certain group of##3##5##(2009-6#1)(2013-1#2)
in a certain##10##3##(1990-11#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#2)
in a certified##2##3##(2008-10#2)
in a change of##4##4##(1991-2#1)(1992-6#1)(2008-10#1)(2008-8#1)
in a change##7##3##(1991-2#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)
in a changing environment##2##4##(1991-2#1)(2011-2#1)
in a changing health care##2##5##(1993-12#1)(1997-3#1)
in a changing##7##3##(1991-2#1)(1993-12#1)(1997-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-7#1)
in a chaotic##2##3##(2007-11#1)(2008-10#1)
in a chemical##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
in a chemically##2##3##(2008-10#1)(2008-5#1)
in a chest pain##2##4##(2008-3#2)
in a child who##2##4##(2010-6#1)(2011-2#1)
in a child with acute##2##5##(2009-4#1)(2011-2#1)
in a child with##11##4##(2007-8#1)(2008-10#3)(2008-9#3)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
in a child##50##3##(1995-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#2)(2009-9#2)(2010-6#1)(2011-2#4)(2012-12#8)(2012-2#3)(2013-1#2)
in a chiral##2##3##(1995-2#1)(1997-2#1)
in a chirped-pulse##2##3##(2007-12#1)(2008-2#1)
in a chitosan-gelatin##2##3##(2008-5#2)
in a chromatographic system##2##4##(2008-10#2)
in a chromatographic##3##3##(2008-10#3)
in a chromatomembrane cell##2##4##(2008-10#2)
in a chronic##2##3##(1993-9#1)(2011-2#1)
in a chronically##2##3##(1991-3#1)(1997-8#1)
in a circular##3##3##(2008-3#3)
in a cirrhotic##2##3##(2008-1#1)(2011-2#1)
in a civil##2##3##(1994-3#1)(2012-3#1)
in a clade##2##3##(2008-8#1)(2011-2#1)
in a classical##4##3##(1994-5#1)(2008-11#2)(2008-5#1)
in a clean##2##3##(2008-10#1)(2008-3#1)
in a clearly##3##3##(1990-11#1)(1992-8#1)(2009-7#1)
in a climate chamber##3##4##(1992-3#1)(2008-10#1)(2008-5#1)
in a clinic or##2##4##(1997-3#1)(2009-5#1)
in a clinic##4##3##(1996-5#1)(1997-3#1)(2008-9#1)(2009-5#1)
in a clinical laboratory##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
in a clinical setting##6##4##(2008-3#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
in a clinical study##2##4##(2008-10#1)(2013-1#1)
in a clinical trial of##2##5##(2009-11#1)(2012-3#1)
in a clinical trial##4##4##(2009-11#1)(2009-6#1)(2010-6#1)(2012-3#1)
in a clinical##25##3##(1994-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in a clinostat##2##3##(2008-11#1)(2008-8#1)
in a clonal##3##3##(1996-2#1)(2008-5#1)(2009-2#1)
in a closed form##3##4##(1993-3#1)(2007-12#1)(2008-3#1)
in a closed system##2##4##(2008-10#2)
in a closed##11##3##(1993-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)
in a closed-vessel microwave##2##4##(2013-8#2)
in a coherent##9##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#4)(2012-2#2)
in a cohort of individuals with##2##6##(1994-12#1)(2013-1#1)
in a cohort of patients##2##5##(2007-10#1)(2011-2#1)
in a cohort of##16##4##(1994-12#1)(2007-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
in a cohort##17##3##(1994-12#1)(1994-2#1)(2007-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
in a cold##8##3##(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#2)
in a collaborative##2##3##(2008-1#1)(2008-7#1)
in a collection of##2##4##(2008-10#2)
in a college##2##3##(2008-11#1)(2011-1#1)
in a colony##3##3##(1992-1#1)(1997-8#1)(2008-9#1)
in a color##2##3##(2007-12#1)(2008-3#1)
in a column##17##3##(2008-10#17)
in a combination of##2##4##(2008-5#1)(2012-2#1)
in a combined##2##3##(2007-11#1)(2008-10#1)
in a comfortable##2##3##(1991-2#1)(2011-2#1)
in a commercial##9##3##(2007-12#1)(2007-6#2)(2008-10#6)
in a commercially##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
in a common##10##3##(1991-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
in a community hospital##8##4##(1993-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)
in a community of##2##4##(2008-12#1)(2008-8#1)
in a community rehabilitation hospital##2##5##(1990-5#2)
in a community sample of##3##5##(1992-1#1)(2007-12#1)(2011-1#1)
in a community sample##4##4##(1992-1#1)(2007-12#1)(2011-1#1)(2013-8#1)
in a community setting##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
in a community##29##3##(1990-5#2)(1992-1#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#3)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
in a community-based sample##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
in a community-based##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
in a compact##2##3##(2007-11#1)(2011-1#1)
in a companion paper##2##4##(2008-3#1)(2012-2#1)
in a comparative##4##3##(1991-12#1)(2008-10#2)(2008-8#1)
in a comparison##3##3##(1990-2#1)(1994-3#1)(2011-2#1)
in a competitive##9##3##(1990-8#1)(1991-12#1)(1992-3#2)(1993-1#1)(2007-8#1)(2008-10#2)(2008-4#1)
in a complementary##2##3##(1994-12#1)(2008-10#1)
in a complete##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2010-4#1)
in a completely randomized design##3##5##(2008-12#2)(2012-2#1)
in a completely randomized##4##4##(2008-10#1)(2008-12#2)(2012-2#1)
in a completely##5##3##(2008-10#1)(2008-12#2)(2010-8#1)(2012-2#1)
in a complex manner##5##4##(1990-7#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
in a complex mixture##3##4##(2008-10#2)(2008-4#1)
in a complex way##2##4##(1997-2#1)(2012-12#1)
in a complex with##2##4##(1992-11#1)(2012-3#1)
in a complex##23##3##(1990-7#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-3#2)
in a composite rod##2##4##(2008-2#2)
in a composite##7##3##(2007-11#2)(2008-2#3)(2008-9#1)(2012-2#1)
in a comprehensive manner##3##4##(1996-12#1)(2008-10#1)(2008-9#1)
in a comprehensive##7##3##(1993-6#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
in a compressed##2##3##(2007-12#1)(2008-3#1)
in a computer##8##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)
in a concentration dependent manner##3##5##(1990-5#1)(2012-2#1)(2013-8#1)
in a concentration of 1##2##5##(2008-10#1)(2008-2#1)
in a concentration of##5##4##(1995-5#1)(2008-10#2)(2008-2#1)(2009-9#1)
in a concentration range from##2##5##(2008-10#2)
in a concentration range of##6##5##(2008-10#5)(2011-3#1)
in a concentration range##8##4##(2008-10#7)(2011-3#1)
in a concentration##20##3##(1990-5#1)(1993-3#1)(1994-6#1)(1995-5#1)(2008-10#10)(2008-2#1)(2009-8#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-8#1)
in a concentration- and time-dependent##2##5##(1995-2#1)(1997-4#1)
in a concentration-dependent fashion##6##4##(1990-5#1)(1994-6#1)(1997-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
in a concentration-dependent manner at##2##5##(1991-6#1)(1992-6#1)
in a concentration-dependent manner in##4##5##(1990-7#1)(1992-2#1)(1993-12#1)(1995-11#1)
in a concentration-dependent manner with##4##5##(1995-11#1)(1995-12#1)(1995-5#1)(2008-8#1)
in a concentration-dependent manner##35##4##(1990-5#1)(1990-7#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-11#2)(1995-12#3)(1995-5#2)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#1)
in a concentration-dependent##44##3##(1990-5#2)(1990-7#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#4)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#2)(1995-11#2)(1995-12#4)(1995-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#2)
in a concentration-related manner##2##4##(1995-12#1)(2008-8#1)
in a confined space##2##4##(2010-3#1)(2012-1#1)
in a confocal##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in a conformation##2##3##(1994-11#1)(1995-3#1)
in a conical configuration##3##4##(2007-11#3)
in a conical##4##3##(2007-11#3)(2008-10#1)
in a considerable##4##3##(2008-10#3)(2008-6#1)
in a consistent manner##2##4##(1991-1#1)(2009-10#1)
in a consistent##4##3##(1991-1#1)(1996-1#1)(2009-10#1)(2010-9#1)
in a constant##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
in a contaminated##2##3##(2008-10#2)
in a context of##6##4##(1991-11#1)(1991-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
in a context##8##3##(1991-11#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-8#1)
in a continuous algal production system##2##6##(2012-1#2)
in a continuous flow system##5##5##(2008-10#5)
in a continuous flow##6##4##(2008-10#6)
in a continuous mode##3##4##(2008-10#3)
in a continuous reactor##2##4##(1992-11#1)(2008-6#1)
in a continuous##26##3##(1992-11#1)(1995-5#1)(1996-1#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-6#2)(2008-7#2)(2011-2#1)(2012-1#2)
in a continuously stirred reactor and a fermentation process of##2##10##(2008-10#2)
in a continuously##3##3##(2008-10#3)
in a control group of##3##5##(1992-6#1)(2008-7#1)(2012-12#1)
in a control##6##3##(1992-12#1)(1992-6#1)(2008-7#1)(2009-2#1)(2010-4#1)(2012-12#1)
in a controlled environment##8##4##(2007-11#1)(2008-10#5)(2008-3#1)(2011-2#1)
in a controlled fashion##2##4##(2006-12#1)(2010-10#1)
in a controlled manner##6##4##(1994-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)
in a controlled way##2##4##(2008-5#1)(2009-12#1)
in a controlled##22##3##(1990-9#1)(1994-11#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-12#2)(2010-10#1)(2010-4#1)(2011-2#1)
in a convective##2##3##(2008-2#1)(2008-6#1)
in a convenience sample of##3##5##(2009-5#1)(2010-6#1)(2010-9#1)
in a convenient form##2##4##(2008-10#1)(2008-3#1)
in a conventional##8##3##(1990-6#1)(1994-5#1)(2007-11#2)(2008-10#2)(2008-3#1)(2011-7#1)
in a cool##2##3##(1994-2#1)(2008-10#1)
in a cooperative manner##4##4##(1991-5#1)(1994-6#1)(2008-10#1)(2008-11#1)
in a cooperative##5##3##(1991-5#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-11#1)
in a coordinated manner##2##4##(1996-12#1)(2008-12#1)
in a corresponding increase in##2##5##(1993-6#1)(2011-1#1)
in a cost-effective manner##3##4##(1993-12#1)(1993-9#1)(2011-2#1)
in a cost-effective##4##3##(1993-12#1)(1993-9#1)(1997-7#1)(2011-2#1)
in a counterpropagating quasi-phase-matched##2##4##(2007-12#1)(2008-2#1)
in a counterpropagating##4##3##(2007-12#2)(2008-2#2)
in a counting task##2##4##(2013-8#2)
in a country where##2##4##(1997-6#1)(2008-10#1)
in a country##3##3##(1997-6#1)(2008-10#1)(2010-4#1)
in a county##2##3##(1990-11#1)(1991-3#1)
in a couple of##2##4##(2007-4#1)(2012-12#1)
in a coupled-resonator optical waveguide##2##5##(2007-11#2)
in a critical care##2##4##(1994-3#1)(2007-12#1)
in a cross between##3##4##(2008-10#2)(2008-4#1)
in a cross##4##3##(1990-6#1)(2008-10#2)(2008-4#1)
in a cross-sectional study of##2##5##(1996-2#1)(2008-7#1)
in a cross-sectional##3##3##(1996-2#1)(1997-4#1)(2008-7#1)
in a crystal of##2##4##(2007-12#2)
in a crystal with##3##4##(2007-11#3)
in a crystal##6##3##(2007-11#4)(2007-12#2)
in a crystalline##2##3##(1990-2#1)(2010-12#1)
in a culturally##2##3##(2008-1#1)(2008-7#1)
in a culture medium##2##4##(1995-3#1)(2008-10#1)
in a culture of##2##4##(2008-11#2)
in a culture##7##3##(1995-3#1)(2008-10#2)(2008-11#3)(2008-4#1)
in a cure##2##3##(1997-6#1)(2007-12#1)
in a cv##2##3##(2008-10#2)
in a cw##2##3##(2007-12#1)(2008-2#1)
in a cylindrical##6##3##(2007-12#3)(2008-10#1)(2008-3#1)(2010-7#1)
in a database##2##3##(2008-11#2)
in a day care##4##4##(1994-6#1)(1995-5#1)(1995-6#2)
in a day##6##3##(1994-6#1)(1995-5#1)(1995-6#2)(2012-3#2)
in a decline in##2##4##(1991-7#1)(2013-1#1)
in a decline##3##3##(1991-7#1)(1995-5#1)(2013-1#1)
in a decrease in the##7##5##(1991-9#1)(1993-11#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-7#2)
in a decrease in##19##4##(1991-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2013-1#1)(2013-8#1)
in a decrease of the##2##5##(2008-10#2)
in a decrease of##5##4##(2008-1#1)(2008-10#2)(2008-2#1)(2013-1#1)
in a decrease##24##3##(1991-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-12#1)(2006-6#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2013-1#2)(2013-8#1)
in a decreased##6##3##(1992-11#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)
in a deep##2##3##(2008-11#1)(2009-3#1)
in a defect##2##3##(2007-11#1)(2008-4#1)
in a defined##5##3##(1991-12#1)(1993-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
in a degenerate optical parametric amplifier##2##6##(2007-11#2)
in a degenerate##3##3##(2007-11#2)(2007-12#1)
in a delayed##2##3##(1994-11#1)(1996-9#1)
in a dense##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
in a dental##3##3##(1994-12#1)(2013-1#1)(2013-8#1)
in a department of##3##4##(1991-11#2)(1997-4#1)
in a depressed##2##3##(1996-7#2)
in a derivative##2##3##(1991-9#1)(1993-12#1)
in a detailed##2##3##(1995-5#1)(2008-3#1)
in a developer##7##3##(2008-10#7)
in a developing country##6##4##(1993-9#1)(2007-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
in a developmental##2##3##(2008-8#1)(2012-12#1)
in a developmentally regulated##2##4##(1993-3#1)(2012-3#1)
in a developmentally##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
in a diabetic patient##2##4##(2008-8#1)(2013-1#1)
in a diabetic##3##3##(2008-8#2)(2013-1#1)
in a dielectric##2##3##(2007-11#1)(2008-3#1)
in a different light##2##4##(1993-5#1)(1997-8#1)
in a different way##2##4##(2008-10#2)
in a different##18##3##(1990-11#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2010-12#1)
in a differential manner##2##4##(1996-12#1)(2009-3#1)
in a differential pulse##2##4##(2008-10#2)
in a differential##6##3##(1996-12#1)(2008-10#3)(2008-3#1)(2009-3#1)
in a dilution##2##3##(2008-10#1)(2012-3#1)
in a diode-end-pumped##3##3##(2007-11#1)(2008-2#2)
in a diode-pumped Nd##2##4##(2007-12#1)(2008-3#1)
in a diode-pumped##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
in a diploid##3##3##(2008-4#2)(2009-9#1)
in a direct##4##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
in a direction##2##3##(1995-5#1)(2008-3#1)
in a discrete##2##3##(1995-12#1)(2008-4#1)
in a discussion of##2##4##(1990-3#1)(2009-9#1)
in a dispersion-managed##3##3##(2007-12#3)
in a dispersive##2##3##(2007-11#2)
in a distinct##5##3##(2008-10#5)
in a distributed##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
in a distributed-feedback##2##3##(2007-12#1)(2008-3#1)
in a district##3##3##(1990-3#1)(1990-6#1)(2008-7#1)
in a diverse range of##2##5##(2008-2#1)(2008-5#1)
in a diverse##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2010-1#1)
in a dog##7##3##(1995-9#1)(1997-5#1)(2006-6#1)(2008-5#1)(2012-3#1)(2013-8#2)
in a domain##2##3##(1993-3#1)(2009-5#1)
in a domestic environment##2##4##(2011-1#1)(2011-2#1)
in a domestic microwave oven##2##5##(2008-10#2)
in a domestic or public setting##2##6##(2013-1#2)
in a domestic##6##3##(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
in a dose dependent manner##6##5##(1991-12#1)(1994-11#1)(1994-3#1)(1997-7#1)(2007-10#1)(2007-11#1)
in a dose dependent##7##4##(1990-5#1)(1991-12#1)(1994-11#1)(1994-3#1)(1997-7#1)(2007-10#1)(2007-11#1)
in a dose of##6##4##(1994-8#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2012-2#1)
in a dose range of##2##5##(1992-6#1)(2008-9#1)
in a dose related manner##2##5##(1993-8#1)(1994-11#1)
in a dose related##3##4##(1993-8#1)(1994-11#1)(2008-10#1)
in a dose##20##3##(1990-5#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
in a dose- and time-dependent manner##8##6##(1991-5#1)(1994-9#2)(1996-2#1)(1997-6#1)(2008-11#2)(2011-2#1)
in a dose- and time-dependent##9##5##(1991-5#1)(1994-9#2)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
in a dose- and##10##4##(1991-5#1)(1994-9#2)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
in a dose-dependent fashion in##3##5##(1991-5#1)(1992-12#1)(2007-10#1)
in a dose-dependent fashion##12##4##(1991-5#1)(1992-12#3)(1992-3#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1997-7#1)(2007-10#1)(2008-5#1)
in a dose-dependent manner and##3##5##(1993-11#1)(1993-6#1)(1994-8#1)
in a dose-dependent manner by##2##5##(1993-9#1)(1997-7#1)
in a dose-dependent manner in##4##5##(1992-8#1)(1993-11#1)(1994-6#1)(2008-11#1)
in a dose-dependent manner up to##2##6##(1993-3#1)(2008-11#1)
in a dose-dependent manner when##2##5##(2008-1#1)(2008-5#1)
in a dose-dependent manner with##3##5##(1991-2#1)(1992-5#1)(1995-12#1)
in a dose-dependent manner##80##4##(1990-12#1)(1990-2#1)(1990-8#3)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#4)(1995-6#1)(1995-8#4)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#2)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
in a dose-dependent##100##3##(1990-12#1)(1990-2#1)(1990-8#3)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#6)(1995-2#1)(1995-6#1)(1995-8#4)(1996-12#3)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-12#2)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
in a dose-related manner##10##4##(1991-12#1)(1994-2#1)(1995-11#1)(1997-2#2)(2008-11#1)(2008-6#2)(2008-9#2)
in a dose-related##11##3##(1991-12#1)(1991-8#1)(1994-2#1)(1995-11#1)(1997-2#2)(2008-11#1)(2008-6#2)(2008-9#2)
in a dose-response##2##3##(1992-10#1)(2009-9#1)
in a dot##2##3##(1997-4#1)(2008-10#1)
in a double blind##3##4##(1990-5#1)(2008-5#2)
in a double##6##3##(1990-5#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
in a double-blind study##3##4##(1991-2#1)(1996-1#1)(2008-5#1)
in a double-blind trial##2##4##(2008-5#2)
in a double-blind##10##3##(1990-9#1)(1991-2#1)(1996-1#1)(2008-5#6)(2013-1#1)
in a double-pass##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
in a doubled haploid##2##4##(2008-10#1)(2012-3#1)
in a doubly##2##3##(2007-12#1)(2008-2#1)
in a dramatic##6##3##(1991-5#1)(1993-3#1)(1994-8#1)(2007-11#1)(2008-12#1)(2008-7#1)
in a drastic reduction in the##2##6##(1997-4#1)(2008-8#1)
in a drastic reduction##3##4##(1997-4#1)(2008-10#1)(2008-8#1)
in a drastic##6##3##(1997-4#1)(1997-5#1)(2008-10#2)(2008-8#1)(2011-1#1)
in a drop of the##2##5##(1991-3#1)(2008-10#1)
in a drop##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
in a drug##3##3##(2007-7#1)(2008-8#1)(2012-2#1)
in a dry##2##3##(2008-10#1)(2008-11#1)
in a dynamic##7##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-7#1)(2013-8#1)
in a factorial##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
in a fairly##2##3##(2008-3#1)(2009-8#1)
in a family of Turkish origin##2##6##(1991-12#2)
in a family of##4##4##(1991-12#2)(1992-6#1)(2008-6#1)
in a family##10##3##(1991-12#2)(1991-8#1)(1992-6#1)(1995-12#1)(1997-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)
in a fashion analogous to the##2##6##(1997-2#1)(2008-2#1)
in a fashion that##2##4##(2008-10#1)(2009-11#1)
in a fashion##7##3##(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)
in a fast and##3##4##(2008-10#2)(2010-12#1)
in a fast##6##3##(1994-5#1)(1994-6#1)(2008-10#2)(2010-12#1)(2011-2#1)
in a faster##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
in a fatal outcome##3##4##(2006-10#1)(2011-2#1)(2013-8#1)
in a fault system##2##4##(1996-4#2)
in a fed-batch system##2##4##(2008-6#2)
in a fed-batch##4##3##(1992-11#1)(2008-6#2)(2011-1#1)
in a female child##3##4##(2008-10#3)
in a female patient##2##4##(1992-12#1)(2008-12#1)
in a female##13##3##(1990-9#1)(1992-12#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-4#1)(2012-1#2)(2012-3#1)
in a femtosecond##2##3##(2007-12#2)
in a few cases##7##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
in a few hours##2##4##(2008-3#1)(2008-8#1)
in a few studies##2##4##(1996-5#1)(2008-8#1)
in a few weeks##2##4##(1996-5#1)(2008-10#1)
in a few##30##3##(1990-6#1)(1992-11#1)(1992-6#1)(1994-1#1)(1994-3#1)(1996-12#1)(1996-5#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
in a fiber Bragg grating##3##5##(2007-12#3)
in a fiber grating##2##4##(2007-11#1)(2007-12#1)
in a fiber##11##3##(2007-11#5)(2007-12#5)(2008-2#1)
in a fiber-optic##2##3##(2007-12#1)(2008-3#1)
in a field environment##2##4##(2008-10#1)(2008-3#1)
in a field experiment##5##4##(2008-10#3)(2008-8#1)(2008-9#1)
in a field rust nursery##2##5##(2008-10#2)
in a field trial##3##4##(1990-6#1)(2008-10#2)
in a field##25##3##(1990-6#1)(1996-2#1)(2008-10#19)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
in a film##2##3##(2008-10#2)
in a final##6##3##(1995-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
in a finite##2##3##(1996-4#1)(2013-1#1)
in a first step##2##4##(2008-10#2)
in a first##5##3##(1996-7#1)(2007-12#1)(2008-10#2)(2011-2#1)
in a fish##2##3##(2008-10#1)(2013-1#1)
in a five year old##2##5##(2008-8#1)(2011-1#1)
in a five##5##3##(2008-11#1)(2008-8#1)(2010-4#2)(2011-1#1)
in a five-year-old##2##3##(2008-11#1)(2008-9#1)
in a fixed bed bioreactor##2##5##(2008-11#2)
in a fixed bed##3##4##(2008-11#3)
in a fixed orientation##2##4##(2008-3#1)(2008-8#1)
in a fixed##8##3##(1991-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)
in a fixed-bed##2##3##(2008-11#1)(2008-12#1)
in a flat plate##2##4##(2008-7#2)
in a flat##4##3##(2007-11#1)(2008-11#1)(2008-7#2)
in a flexible##2##3##(1994-5#1)(2008-2#1)
in a flow cell##5##4##(2008-10#5)
in a flow injection analysis##4##5##(2008-10#4)
in a flow injection system coupled##2##6##(2008-10#2)
in a flow injection system for the determination of##2##9##(2008-10#2)
in a flow injection system with##3##6##(2008-10#3)
in a flow injection system##15##5##(2008-10#15)
in a flow injection##25##4##(2008-10#25)
in a flow system##7##4##(2008-10#7)
in a flow##42##3##(2008-10#41)(2008-9#1)
in a flow-injection system for##2##5##(2008-10#2)
in a flow-injection system with the electrodes polarized at##2##9##(2008-10#2)
in a flow-injection system##9##4##(2008-10#9)
in a flow-injection##10##3##(2008-10#10)
in a flow-through##4##3##(2008-10#4)
in a flowing medium##2##4##(2008-2#2)
in a flowing##4##3##(2008-10#2)(2008-2#2)
in a fluid##3##3##(1996-4#1)(2007-11#1)(2011-1#1)
in a fluidized bed##2##4##(2008-11#1)(2008-7#1)
in a fluidized-bed reactor##2##4##(2008-6#2)
in a focused laser beam##2##5##(2008-2#1)(2008-3#1)
in a focused microwave##2##4##(2008-10#2)
in a focused##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
in a follow-up##2##3##(1990-11#1)(1991-1#1)
in a food##3##3##(1997-2#1)(2008-9#1)(2010-4#1)
in a forced##3##3##(1990-11#1)(1991-12#1)(2008-11#1)
in a forensic##2##3##(2008-10#1)(2011-2#1)
in a form of##2##4##(1995-3#1)(2013-1#1)
in a form that##2##4##(1996-12#1)(2008-4#1)
in a form##5##3##(1995-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
in a formal##3##3##(1996-6#1)(2008-11#2)
in a format that can be##2##6##(1994-2#1)(2008-10#1)
in a format that##3##4##(1994-2#1)(2008-10#2)
in a format##4##3##(1994-2#1)(1995-12#1)(2008-10#2)
in a former##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
in a four species mixed oak forest##2##7##(2012-5#2)
in a four##3##3##(2008-11#1)(2012-5#2)
in a fraction of##3##4##(1992-3#1)(2008-7#2)
in a fraction##4##3##(1991-5#1)(1992-3#1)(2008-7#2)
in a fragmented landscape##2##4##(2008-8#1)(2013-7#1)
in a fragmented##3##3##(2008-8#1)(2013-7#2)
in a free##2##3##(1991-3#1)(2012-2#1)
in a free-living##3##3##(1992-9#1)(1995-5#1)(2010-4#1)
in a frequency##2##3##(2008-10#1)(2008-11#1)
in a full##2##3##(2010-12#1)(2013-1#1)
in a fully##3##3##(2008-11#1)(2009-7#1)(2012-3#1)
in a functional##4##3##(1992-9#1)(2008-4#1)(2011-2#1)(2012-3#1)
in a functionalized##2##3##(2008-10#1)(2008-2#1)
in a further##2##3##(1994-12#1)(2008-11#1)
in a fused-silica##3##3##(1994-9#1)(1996-5#1)(2008-2#1)
in a fusion##2##3##(1991-5#1)(2008-7#1)
in a future##3##3##(1993-1#1)(2008-10#1)(2008-11#1)
in a gamma##3##3##(1992-10#1)(1993-11#1)(2008-11#1)
in a gas##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
in a gas-liquid separator##2##4##(2008-10#2)
in a gel##3##3##(1993-6#1)(2008-2#1)(2008-4#1)
in a gene that##2##4##(2007-8#1)(2011-2#1)
in a gene##9##3##(1991-2#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
in a general hospital##5##4##(2008-7#1)(2011-2#1)(2013-1#3)
in a general hospital]##2##4##(1993-10#1)(2013-1#1)
in a general population sample of##2##6##(2008-11#2)
in a general population sample##4##5##(2008-11#3)(2009-2#1)
in a general population##6##4##(1991-1#1)(1995-9#1)(2008-11#3)(2009-2#1)
in a general way##2##4##(2007-12#1)(2008-7#1)
in a general##24##3##(1990-2#1)(1991-1#1)(1993-10#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#4)
in a generalized##2##3##(1995-12#1)(2008-3#1)
in a generic##2##3##(2008-3#1)(2008-7#1)
in a genetic##2##3##(2008-10#1)(2012-12#1)
in a genetically##3##3##(2008-4#1)(2012-3#1)(2013-8#1)
in a genomically##2##3##(2011-2#2)
in a geriatric##4##3##(1990-5#1)(1992-12#1)(2008-7#1)(2011-2#1)
in a given area##2##4##(2008-8#2)
in a given cell##3##4##(1996-10#1)(2008-4#1)(2008-9#1)
in a given direction##2##4##(2008-10#2)
in a given patient and##2##5##(1997-2#1)(2008-9#1)
in a given patient##4##4##(1992-8#1)(1997-2#1)(1997-3#1)(2008-9#1)
in a given##33##3##(1992-3#1)(1992-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-6#1)(2012-3#1)
in a glass column##2##4##(2008-10#2)
in a glass##4##3##(1995-3#1)(2007-11#1)(2008-10#2)
in a glasshouse##2##3##(2008-10#2)
in a global##3##3##(1993-3#1)(2008-11#1)(2008-3#1)
in a goat##3##3##(1990-3#1)(1997-5#1)(2011-1#1)
in a good agreement with the##6##6##(2007-11#1)(2007-12#1)(2008-10#4)
in a good agreement with##8##5##(2007-11#1)(2007-12#1)(2008-10#5)(2010-2#1)
in a good clinical##2##4##(2008-7#1)(2013-1#1)
in a good##15##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-7#3)(2010-2#1)(2011-3#1)(2013-1#1)
in a graduate##3##3##(1996-1#1)(2013-1#2)
in a graphite##3##3##(2008-10#3)
in a grating##2##3##(2008-3#2)
in a great variety of##2##5##(1993-11#1)(2007-10#1)
in a great##3##3##(1993-11#1)(2007-10#1)(2010-5#1)
in a greater than##2##4##(1992-5#1)(2007-11#1)
in a greater##7##3##(1992-5#1)(1997-1#1)(2007-11#1)(2008-2#1)(2010-4#1)(2011-1#1)(2013-7#1)
in a greenhouse test##2##4##(2008-10#2)
in a greenhouse##13##3##(2008-10#12)(2008-5#1)
in a group of 17 patients##2##6##(2013-1#2)
in a group of equal##2##5##(2008-9#2)
in a group of male##2##5##(1996-6#1)(2013-7#1)
in a group of young##2##5##(2013-1#1)(2013-8#1)
in a group of##47##4##(1990-12#2)(1990-6#2)(1991-8#1)(1992-5#1)(1993-11#1)(1994-8#1)(1995-11#1)(1996-6#2)(1996-7#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
in a group practice##3##4##(1993-1#1)(1996-3#1)(2013-7#1)
in a group##59##3##(1990-12#2)(1990-6#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-6#2)(1996-7#2)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#8)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#1)
in a growing number of##3##5##(1995-2#1)(2008-4#1)(2011-2#1)
in a growing##6##3##(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
in a growth chamber at##3##5##(2008-10#2)(2011-2#1)
in a growth chamber##8##4##(2006-11#1)(2008-10#6)(2011-2#1)
in a growth##12##3##(1995-2#2)(2006-11#1)(2008-10#7)(2010-1#1)(2011-2#1)
in a habitat##2##3##(2008-10#1)(2009-8#1)
in a harmonically mode-locked##2##4##(2007-11#1)(2007-12#1)
in a health administration curriculum##2##5##(1996-1#1)(1996-2#1)
in a health administration##3##4##(1993-1#1)(1996-1#1)(1996-2#1)
in a health care center##2##5##(1991-3#1)(2008-10#1)
in a health care##7##4##(1991-3#1)(1994-12#2)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
in a health center]##2##4##(1994-9#1)(1997-2#1)
in a health##21##3##(1991-12#1)(1991-3#1)(1993-1#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)
in a healthcare setting##2##4##(1993-2#1)(2010-3#1)
in a healthcare##4##3##(1993-2#2)(1997-2#1)(2010-3#1)
in a healthy population##2##4##(1990-3#1)(2010-1#1)
in a healthy volunteer##2##4##(1993-2#1)(2008-10#1)
in a healthy##9##3##(1990-3#1)(1990-8#1)(1993-2#1)(1995-1#1)(2008-10#1)(2010-1#1)(2013-1#1)(2013-3#1)(2013-8#1)
in a heated static cell and##2##6##(2008-2#1)(2008-3#1)
in a heated##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
in a hemodialysis##2##3##(2007-7#2)
in a hen##2##3##(2008-5#2)
in a hepatitis##2##3##(2013-8#2)
in a herd##2##3##(1993-2#1)(2008-5#1)
in a heterogeneous population##2##4##(1997-3#1)(2008-11#1)
in a heterogeneous##7##3##(1997-3#1)(1997-5#1)(2008-11#2)(2008-8#1)(2010-2#1)(2012-2#1)
in a heterologous##3##3##(1997-2#1)(1997-8#1)(2008-10#1)
in a hierarchy##2##3##(2008-10#2)
in a high performance##2##4##(2011-2#2)
in a high proportion of##2##5##(2008-10#1)(2008-7#1)
in a high throughput##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
in a high yield##2##4##(1994-3#1)(2008-11#1)
in a high##33##3##(1992-11#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-2#1)(2007-7#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
in a high-##2##3##(2007-11#1)(2013-7#1)
in a high-affinity##2##3##(2008-10#1)(2008-4#1)
in a high-performance##3##3##(2008-10#1)(2008-3#2)
in a high-pressure##2##3##(2008-10#1)(2008-3#1)
in a high-risk setting##2##4##(2009-5#1)(2013-1#1)
in a high-risk##6##3##(1992-3#1)(1994-11#1)(2008-11#2)(2009-5#1)(2013-1#1)
in a high-speed##2##3##(2007-11#1)(2012-3#1)
in a high-temperature##2##3##(1990-12#1)(2008-3#1)
in a high-throughput##2##3##(2008-11#1)(2008-2#1)
in a higher##11##3##(1994-11#1)(1994-12#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
in a highly birefringent fiber##2##5##(2007-11#2)
in a highly conserved##2##4##(1993-8#1)(2008-10#1)
in a highly purified##3##4##(1990-11#1)(1996-3#1)(2008-2#1)
in a highly regulated manner##2##5##(1994-9#1)(2013-1#1)
in a highly saturated##2##4##(2007-12#2)
in a highly scattering##2##4##(2008-3#2)
in a highly specific##2##4##(2008-10#1)(2008-2#1)
in a highly##36##3##(1990-11#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-11#4)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in a hippocampal##2##3##(1993-6#1)(1994-3#1)
in a historical##2##3##(1993-6#1)(1996-1#1)
in a holey fiber##2##4##(2007-12#2)
in a holistic##2##3##(2008-12#1)(2013-8#1)
in a hollow fiber bioreactor##2##5##(2008-11#2)
in a hollow fiber##3##4##(2008-10#1)(2008-11#2)
in a hollow waveguide##4##4##(2007-11#1)(2007-12#3)
in a hollow##7##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)
in a hollow-fiber bioreactor##2##4##(2008-7#2)
in a hollow-fiber##3##3##(2007-12#1)(2008-7#2)
in a holodiagram##2##3##(2008-3#2)
in a home##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
in a home-based pulmonary maintenance program##2##6##(2010-10#2)
in a homogeneous##7##3##(1996-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
in a horizontal##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
in a hormone##2##3##(1991-2#1)(1995-2#1)
in a hospital in##2##4##(2009-10#1)(2013-1#1)
in a hospital setting##6##4##(1995-12#1)(1995-2#1)(1996-3#1)(2008-12#2)(2008-9#1)
in a hospital##24##3##(1990-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
in a hospital's##2##3##(1993-12#1)(1994-2#1)
in a host##2##3##(2008-4#1)(2009-8#1)
in a house##2##3##(1995-11#1)(1997-4#1)
in a human skin##2##4##(2012-2#1)(2012-3#1)
in a human##23##3##(1990-10#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#3)(1995-10#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)(2012-3#2)(2013-1#2)
in a hybrid PBL curriculum##2##5##(2008-10#2)
in a hybrid##8##3##(1997-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)
in a hydrogen atmosphere##2##4##(2008-3#1)(2010-4#1)
in a hydrogen##3##3##(1996-2#1)(2008-3#1)(2010-4#1)
in a joint fractional##2##4##(2008-3#2)
in a joint transform correlator##3##5##(2008-2#3)
in a joint transform##4##4##(2008-2#3)(2008-3#1)
in a joint##8##3##(2008-2#3)(2008-3#3)(2009-3#1)(2011-1#1)
in a key##2##3##(1997-1#1)(2008-12#1)
in a kidney transplant##2##4##(1991-3#1)(2010-12#1)
in a killer whale##2##4##(2012-3#2)
in a knotted##2##3##(2008-10#2)
in a laboratory of##4##4##(2008-10#3)(2010-12#1)
in a laboratory##18##3##(1992-3#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#2)
in a lack of##4##4##(1997-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
in a laminar methane jet##2##5##(2008-3#2)
in a laminar##4##3##(2008-2#1)(2008-3#3)
in a large amount of##2##5##(2008-10#1)(2010-8#1)
in a large animal model##2##5##(2012-12#1)(2012-2#1)
in a large cohort of##2##5##(2008-3#1)(2011-2#1)
in a large cohort##3##4##(2008-3#1)(2011-2#2)
in a large group##2##4##(1991-11#1)(2008-12#1)
in a large number of##11##5##(1994-12#1)(1995-12#1)(1996-2#2)(1996-7#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-4#1)
in a large population of##3##5##(1994-8#1)(1997-3#1)(2010-3#1)
in a large population##6##4##(1994-8#1)(1997-3#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-3#1)
in a large proportion of##2##5##(1991-4#1)(2008-4#1)
in a large randomized##2##4##(2008-7#1)(2010-10#1)
in a large sample of##3##5##(2008-11#1)(2008-12#1)(2010-3#1)
in a large sample##4##4##(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)
in a large scale##5##4##(1994-5#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-8#1)
in a large teaching and##2##5##(1993-3#1)(2007-2#1)
in a large urban##2##4##(1992-1#1)(2011-2#1)
in a large variety of##3##5##(2008-7#2)(2008-9#1)
in a large volume of##2##5##(2008-10#1)(2008-8#1)
in a large volume##3##4##(2008-10#2)(2008-8#1)
in a large##93##3##(1990-5#1)(1991-11#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#2)(1996-2#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-3#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-3#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
in a larger series##2##4##(2008-10#1)(2008-4#1)
in a larger##7##3##(1994-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#1)(2013-8#1)
in a laser beam##4##4##(2007-11#1)(2007-12#2)(2009-12#1)
in a laser cavity##2##4##(2008-3#2)
in a laser diode##2##4##(2007-12#1)(2008-3#1)
in a laser##10##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)(2009-12#1)
in a laser-diode-pumped LiNdP(4)O(12)##2##4##(2007-11#1)(2007-12#1)
in a laser-diode-pumped microchip Nd##2##5##(2007-12#2)
in a laser-diode-pumped microchip##3##4##(2007-12#3)
in a laser-diode-pumped##5##3##(2007-11#1)(2007-12#4)
in a late preterm infant##2##5##(2010-11#2)
in a left##2##3##(1990-8#1)(1990-9#1)
in a less##2##3##(1997-3#1)(2008-10#1)
in a level III academic##2##5##(2008-10#2)
in a level III##3##4##(2008-10#2)(2008-11#1)
in a level##4##3##(2008-10#2)(2008-11#2)
in a lifetime##2##3##(2009-3#1)(2012-12#1)
in a light-scattering##2##3##(2008-3#2)
in a limited number of##2##5##(1994-2#1)(2008-3#1)
in a limited range##2##4##(1996-2#1)(2008-10#1)
in a limited##9##3##(1990-11#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)
in a linear fashion##4##4##(2008-7#2)(2008-9#1)(2013-8#1)
in a linear##15##3##(2007-11#2)(2008-10#3)(2008-2#3)(2008-3#2)(2008-7#2)(2008-9#1)(2010-2#1)(2013-8#1)
in a lipid##4##3##(1991-5#1)(1993-11#1)(1994-11#1)(2008-10#1)
in a liquid##11##3##(2008-10#4)(2008-2#3)(2008-3#2)(2008-7#1)(2012-2#1)
in a liquid-crystal##3##3##(2007-12#2)(2008-2#1)
in a lithium triborate crystal##2##5##(2007-12#1)(2008-3#1)
in a liver transplant recipient caused by a Trichophyton spp##2##10##(2009-2#2)
in a local population of##2##5##(2008-9#2)
in a local##6##3##(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
in a long-term##7##3##(1994-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
in a longer##5##3##(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)
in a longitudinal direction##3##4##(2011-2#3)
in a longitudinal study##3##4##(1990-2#1)(2009-11#1)(2012-12#1)
in a longitudinal##12##3##(1990-2#1)(1996-7#1)(2008-5#1)(2009-11#1)(2009-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-8#1)
in a looped-back##2##3##(2008-3#2)
in a loss of##6##4##(1994-11#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)
in a low level##2##4##(2008-10#1)(2012-3#1)
in a low##14##3##(1992-3#1)(1993-11#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
in a low-birefringence##2##3##(2008-3#2)
in a low-frequency fluctuation regime##2##5##(2007-12#2)
in a low-income##3##3##(1995-3#1)(1997-2#1)(2008-9#1)
in a lower detection limit##2##5##(2008-10#1)(2008-11#1)
in a lower##7##3##(1992-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-12#1)
in a lowland##2##3##(2008-5#1)(2010-8#1)
in a luminol solution##2##4##(2008-10#2)
in a lung##2##3##(1997-2#2)
in a magnetic field is##2##5##(2008-3#1)(2010-9#1)
in a magnetic field##4##4##(2008-3#3)(2010-9#1)
in a maize##2##3##(2008-10#2)
in a major##6##3##(1991-2#2)(1995-3#1)(1996-5#1)(2008-11#1)(2008-7#1)
in a majority of the##2##5##(1996-2#1)(2013-8#1)
in a majority of##3##4##(1996-2#1)(2010-5#1)(2013-8#1)
in a male patient##2##4##(2007-10#1)(2007-12#1)
in a male##5##3##(2007-10#2)(2007-12#1)(2008-11#1)(2008-12#1)
in a mammary##2##3##(1993-6#1)(2012-3#1)
in a man with##3##4##(2012-3#2)(2013-1#1)
in a man##4##3##(2007-10#1)(2012-3#2)(2013-1#1)
in a managed care environment##3##5##(1994-12#1)(1994-2#1)(1996-12#1)
in a managed care setting##2##5##(1997-2#2)
in a managed care system##2##5##(1993-12#1)(2006-10#1)
in a managed care##8##4##(1993-12#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-10#1)
in a managed##10##3##(1991-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-10#1)
in a manner analogous to##3##5##(1991-12#1)(1994-11#1)(2008-10#1)
in a manner consistent with##3##5##(2008-4#1)(2011-2#1)(2012-3#1)
in a manner indicative of##2##5##(2008-10#1)(2008-11#1)
in a manner reminiscent of##2##5##(1992-9#1)(2010-12#1)
in a manner similar to that of##2##7##(1997-2#1)(2007-10#1)
in a manner similar to that##3##6##(1997-2#1)(2007-10#1)(2008-11#1)
in a manner similar to the##4##6##(1991-5#1)(1992-11#1)(1994-6#1)(2008-2#1)
in a manner similar to##14##5##(1990-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)
in a manner that is##3##5##(2008-3#1)(2008-8#1)(2010-11#1)
in a manner that##11##4##(1991-8#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)
in a manner which##3##4##(1993-8#1)(1994-6#1)(2010-9#1)
in a manner##49##3##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
in a marked decrease##4##4##(1992-8#1)(1995-12#1)(1995-3#1)(2008-10#1)
in a marked reduction in##3##5##(1993-8#1)(1996-12#1)(2010-10#1)
in a marked##10##3##(1992-8#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-6#1)(2008-10#2)(2010-10#1)
in a mathematical##2##3##(1994-5#1)(2008-11#1)
in a matrix of##2##4##(2008-10#1)(2008-5#1)
in a matrix##3##3##(1993-5#1)(2008-10#1)(2008-5#1)
in a matter of##2##4##(1991-3#1)(2008-3#1)
in a mature##4##3##(1996-9#1)(2012-3#2)(2013-8#1)
in a maximum##2##3##(2008-2#1)(2008-7#1)
in a mean duration of##2##5##(2008-1#2)
in a mean##4##3##(2008-1#3)(2008-10#1)
in a measurable way##2##4##(1994-1#1)(2007-11#1)
in a measurement##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
in a measuring##2##3##(2008-10#1)(2008-2#1)
in a medical research##2##4##(1991-2#1)(2010-1#1)
in a medical##12##3##(1991-12#1)(1991-2#1)(1992-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(2008-1#1)(2008-7#2)(2010-1#1)(2010-8#2)
in a medium containing##10##4##(1994-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)
in a medium that##2##4##(1997-4#1)(2008-1#1)
in a medium with##2##4##(2008-10#1)(2009-8#1)
in a medium##22##3##(1994-8#1)(1995-12#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)
in a membrane##10##3##(1994-5#1)(1994-8#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-8#1)
in a meta-analysis##3##3##(1995-2#1)(1997-7#1)(2008-6#1)
in a metabolic##2##3##(2008-7#2)
in a metal##3##3##(1993-5#1)(2007-12#2)
in a metallic##3##3##(1991-9#1)(2007-11#1)(2012-2#1)
in a metapopulation of##2##4##(2008-8#1)(2008-9#1)
in a metapopulation##4##3##(2008-8#1)(2008-9#3)
in a methyl methacrylate##2##4##(2008-10#2)
in a metropolitan##2##3##(1991-3#1)(1997-8#1)
in a micellar medium##2##4##(2008-10#2)
in a micellar##3##3##(2008-10#3)
in a microcavity##2##3##(2007-11#1)(2008-3#1)
in a microchip##3##3##(2007-11#2)(2007-12#1)
in a microemulsion##3##3##(2008-10#3)
in a microfluidic flow injection##2##5##(2008-10#2)
in a microfluidic##5##3##(2008-10#4)(2009-12#1)
in a microscope##2##3##(1992-9#1)(2008-3#1)
in a microstructured##2##3##(2007-11#2)
in a microwave oven##4##4##(1993-12#1)(2008-10#3)
in a microwave##6##3##(1993-12#1)(2008-10#5)
in a middle##3##3##(1995-8#1)(2007-10#1)(2008-7#1)
in a mini-column##4##3##(2008-10#4)
in a miniaturized##2##3##(2008-10#1)(2008-3#1)
in a minicolumn and##2##4##(2008-10#2)
in a minicolumn##9##3##(2008-10#9)
in a minimal medium##2##4##(2008-10#2)
in a minimal##6##3##(1993-12#1)(2008-10#4)(2009-6#1)
in a minimally invasive##2##4##(2008-8#1)(2011-2#1)
in a minority of##3##4##(1990-6#1)(2012-12#1)(2013-8#1)
in a minority##4##3##(1990-6#1)(1996-6#1)(2012-12#1)(2013-8#1)
in a mirror##2##3##(2008-2#1)(2008-6#1)
in a mixed population of##3##5##(1992-6#1)(1994-9#1)(1995-5#1)
in a mixed solvent##2##4##(2008-10#2)
in a mixed##12##3##(1990-11#1)(1992-6#1)(1993-9#1)(1994-9#1)(1995-5#1)(1997-4#1)(2008-10#6)
in a mixing coil##2##4##(2008-10#2)
in a mixture of amino acids##2##6##(2008-10#2)
in a mixture of glucose##2##5##(2008-6#1)(2008-7#1)
in a mixture of##12##4##(2008-10#8)(2008-2#2)(2008-6#1)(2008-7#1)
in a mixture solution##2##4##(2008-10#2)
in a mixture##25##3##(1990-12#1)(2008-10#20)(2008-2#2)(2008-6#1)(2008-7#1)
in a model for##3##4##(1996-3#1)(2008-5#1)(2008-7#1)
in a model of##10##4##(1990-7#1)(1993-12#1)(1996-5#1)(2008-11#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
in a model system##5##4##(2008-10#3)(2009-5#1)(2012-3#1)
in a model##29##3##(1990-7#1)(1991-9#1)(1993-12#1)(1996-3#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
in a modeled##2##3##(2008-6#1)(2009-11#1)
in a moderate##2##3##(1993-11#1)(2008-5#1)
in a moderately##2##3##(2008-10#2)
in a modified slump test position##2##6##(2008-12#2)
in a modified slump##3##4##(2008-12#3)
in a modified##10##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#2)
in a molar ratio of##3##5##(1993-6#1)(1994-12#1)(2008-10#1)
in a molecular##2##3##(1992-11#1)(2008-9#1)
in a molecule##3##3##(1991-5#1)(2008-7#1)(2009-12#1)
in a monitoring program##2##4##(2007-7#1)(2008-10#1)
in a monolithic##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
in a more detailed##2##4##(1992-9#1)(2013-8#1)
in a more##23##3##(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#1)(1994-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
in a motor neurone disease clinic##2##6##(2011-2#2)
in a mouse model of##5##5##(1992-8#1)(2008-10#1)(2009-6#1)(2012-2#2)
in a mouse model##9##4##(1992-8#1)(1994-5#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#2)
in a mouse##13##3##(1990-8#1)(1992-8#1)(1994-11#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#2)
in a much##3##3##(2008-3#1)(2010-1#1)(2012-8#1)
in a muffle furnace##2##4##(2008-10#2)
in a multi-analyte##2##3##(2008-10#1)(2013-1#1)
in a multi-pumping flow system##2##5##(2008-10#2)
in a multicellular organism##2##4##(2008-9#1)(2012-3#1)
in a multicenter##3##3##(2007-7#1)(2008-5#1)(2010-11#1)
in a multidimensional vector space##2##5##(2008-11#2)
in a multidisciplinary##3##3##(2012-12#1)(2013-1#2)
in a multilayer stack##2##4##(2008-3#2)
in a multilayer##3##3##(2008-3#3)
in a multimode optical fiber##3##5##(2007-12#1)(2008-3#2)
in a multimode##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
in a multinode##2##3##(2008-3#2)
in a multiple##2##3##(1996-3#1)(2008-7#1)
in a multiplex##3##3##(2008-10#3)
in a multispecialty group##2##4##(1996-1#1)(2008-11#1)
in a multispecialty##3##3##(1995-2#1)(1996-1#1)(2008-11#1)
in a multitude of##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
in a multivariate analysis##3##4##(2009-4#1)(2009-7#1)(2013-1#1)
in a multiwavelength semiconductor laser##2##5##(2007-11#2)
in a murine mammary##2##4##(2008-11#1)(2012-2#1)
in a murine model of##2##5##(2010-6#1)(2012-2#1)
in a murine model##4##4##(2007-11#1)(2008-11#1)(2010-6#1)(2012-2#1)
in a murine##9##3##(1992-2#1)(1992-8#1)(1993-6#1)(2007-11#1)(2008-11#2)(2010-6#1)(2012-2#2)
in a mutant##2##3##(1993-6#1)(1997-3#1)
in a nanosecond##2##3##(2007-12#2)
in a narrow range##2##4##(2007-11#1)(2008-12#1)
in a narrow##4##3##(2007-11#2)(2008-12#1)(2008-2#1)
in a narrower##2##3##(1994-5#1)(2008-10#1)
in a nasal spray##2##4##(2008-10#1)(2008-5#1)
in a national##10##3##(1991-12#1)(1993-12#1)(1995-9#1)(1996-2#1)(2008-1#2)(2009-2#1)(2012-3#3)
in a natural population##3##4##(2008-12#1)(2008-8#1)(2008-9#1)
in a natural system##2##4##(2008-9#2)
in a natural water##2##4##(2008-10#2)
in a natural##10##3##(1995-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#3)(2012-12#1)
in a naturally##3##3##(1995-2#1)(1995-9#1)(2008-8#1)
in a near-diffraction-limited##2##3##(2007-12#1)(2008-3#1)
in a near-field optical-fiber probe##2##5##(2007-12#2)
in a near-field##3##3##(2007-12#3)
in a nearly##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
in a negative##6##3##(1992-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)
in a nematic##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
in a neonatal intensive care unit##5##6##(1991-1#1)(1994-12#1)(1994-2#1)(2008-11#1)(2010-8#1)
in a neonatal intensive care##7##5##(1991-1#1)(1994-12#1)(1994-2#1)(2007-12#1)(2008-11#2)(2010-8#1)
in a neonate##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
in a nested##3##3##(2008-10#2)(2009-3#1)
in a network##4##3##(2008-11#1)(2008-7#2)(2011-2#1)
in a neuronal##2##3##(1991-12#1)(1996-11#1)
in a neutral##4##3##(2008-10#3)(2008-2#1)
in a new and##2##4##(2008-3#1)(2011-2#1)
in a new assay##3##4##(2008-10#3)
in a new era of##2##5##(2008-9#1)(2011-7#1)
in a new era##3##4##(1993-6#1)(2008-9#1)(2011-7#1)
in a new family##3##4##(1991-9#1)(1995-5#1)(2008-5#1)
in a new##36##3##(1990-6#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-3#1)
in a newborn intensive care unit##2##6##(1991-12#2)
in a newborn##10##3##(1991-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2011-1#2)
in a newly discovered##2##4##(2008-10#2)
in a newly##4##3##(1995-2#1)(2008-10#2)(2013-1#1)
in a non-clinical##2##3##(2008-1#1)(2011-1#1)
in a non-competitive way##4##4##(1990-5#2)(1992-3#2)
in a non-competitive##5##3##(1990-5#2)(1992-12#1)(1992-3#2)
in a non-invasive manner##2##4##(2008-1#1)(2009-5#1)
in a non-invasive##3##3##(2008-1#1)(2008-8#1)(2009-5#1)
in a non-threatening##2##3##(1996-12#1)(2008-12#1)
in a nonbirefringent single-mode##3##4##(2007-11#3)
in a noncollinear geometry##2##4##(2007-11#1)(2007-12#1)
in a noncollinear##3##3##(2007-11#2)(2007-12#1)
in a nondestructive##2##3##(2008-2#1)(2008-3#1)
in a nonlinear crystal##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
in a nonlinear optical crystal##2##5##(2008-3#2)
in a nonlinear##9##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)
in a nonspecific manner##2##4##(1995-2#1)(2008-10#1)
in a normal##5##3##(1990-6#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
in a novel##17##3##(1993-6#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#3)(2008-9#2)(2013-1#2)
in a nuclear##5##3##(1992-4#1)(1995-2#1)(1995-8#1)(2008-10#1)(2009-10#1)
in a number of European countries##2##6##(1991-4#1)(2007-2#1)
in a number of different##4##5##(1991-5#1)(1991-8#1)(2008-7#1)(2009-11#1)
in a number of human##4##5##(1993-3#1)(1993-9#1)(2008-4#1)(2009-5#1)
in a number of neurological##2##5##(1995-12#1)(2011-2#1)
in a number of species##2##5##(1993-2#1)(2008-2#1)
in a number of ways##3##5##(1996-3#1)(1997-4#1)(2008-5#1)
in a number of##64##4##(1991-4#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
in a nursing home##4##4##(2008-7#1)(2010-10#3)
in a nursing##7##3##(2008-11#2)(2008-5#1)(2008-7#1)(2010-10#3)
in a nutrient##2##3##(2008-12#1)(2008-7#1)
in a one##3##3##(1997-7#1)(2007-7#1)(2013-1#1)
in a one-dimensional##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
in a one-step##3##3##(2008-3#2)(2011-1#1)
in a pH 5##2##4##(1990-12#1)(2008-10#1)
in a pH range of##8##5##(2008-10#8)
in a pH##16##3##(1990-12#1)(2008-10#14)(2009-12#1)
in a packed bed##2##4##(2008-11#2)
in a packed##3##3##(2008-10#1)(2008-11#2)
in a packed-bed bioreactor##3##4##(2008-11#2)(2008-7#1)
in a paediatric##2##3##(2008-11#2)
in a pair of blind##2##5##(2012-3#2)
in a pair of monozygotic twins##3##6##(2008-7#3)
in a pair of##8##4##(1997-7#1)(2008-12#1)(2008-7#3)(2010-8#1)(2012-3#2)
in a palliative care##2##4##(2008-12#1)(2010-2#1)
in a panel of##3##4##(1992-3#1)(1995-12#1)(2013-1#1)
in a panel##4##3##(1992-3#1)(1995-12#1)(1995-3#1)(2013-1#1)
in a panmictic population##2##4##(2008-9#2)
in a paper##2##3##(2008-3#2)
in a paracrine manner##3##4##(2008-4#2)(2013-1#1)
in a paracrine##4##3##(2008-4#2)(2013-1#1)(2013-8#1)
in a paraelectric##2##3##(2007-11#1)(2007-12#1)
in a parallel##8##3##(1992-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2013-8#1)
in a particular area##2##4##(1991-2#1)(1995-3#1)
in a particular geographical region##2##5##(2008-1#1)(2012-3#1)
in a particular##23##3##(1991-2#2)(1992-12#1)(1992-8#1)(1995-11#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-7#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-3#1)
in a passively mode-locked##2##4##(2007-11#2)
in a patch##2##3##(2008-5#1)(2008-8#1)
in a patient affected by##3##5##(1993-12#1)(1993-9#1)(2008-5#1)
in a patient infected with##2##5##(2007-7#1)(2011-2#1)
in a patient of##4##4##(1990-12#1)(2008-12#1)(2012-12#1)(2012-2#1)
in a patient on##2##4##(2008-1#1)(2008-5#1)
in a patient presenting with##3##5##(2008-12#1)(2008-4#1)(2011-2#1)
in a patient presenting##4##4##(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
in a patient suffering##2##4##(1990-11#1)(2007-2#1)
in a patient treated for##2##5##(1991-11#1)(1996-3#1)
in a patient treated with##2##5##(1990-6#1)(2007-2#1)
in a patient treated##4##4##(1990-6#1)(1991-11#1)(1996-3#1)(2007-2#1)
in a patient who##4##4##(1991-3#1)(2008-7#1)(2010-5#2)
in a patient with AIDS##2##5##(2007-10#1)(2008-10#1)
in a patient with a history of##3##7##(2009-4#1)(2012-3#1)(2013-8#1)
in a patient with a##13##5##(1992-9#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
in a patient with acute##4##5##(2007-4#1)(2008-5#1)(2009-6#1)(2013-1#1)
in a patient with an##5##5##(2007-6#1)(2007-8#1)(2008-7#2)(2009-11#1)
in a patient with chronic renal##2##6##(2010-5#1)(2013-1#1)
in a patient with chronic whiplash syndrome##2##7##(2008-12#2)
in a patient with chronic##8##5##(2006-10#1)(2007-10#1)(2008-12#2)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
in a patient with clinical##2##5##(2009-6#1)(2012-3#1)
in a patient with end-stage renal##2##6##(2008-1#1)(2013-1#1)
in a patient with familial##2##5##(1992-8#1)(2011-2#1)
in a patient with liver##2##5##(1991-11#1)(2008-1#1)
in a patient with metastatic##3##5##(1990-9#1)(1992-2#1)(2008-11#1)
in a patient with multiple##4##5##(1992-12#1)(1993-12#1)(1997-8#1)(2009-4#1)
in a patient with neurofibromatosis type 1##2##7##(2007-8#1)(2013-1#1)
in a patient with neurofibromatosis##3##5##(2007-8#1)(2008-6#1)(2013-1#1)
in a patient with partial##2##5##(1990-5#1)(2007-2#1)
in a patient with renal##2##5##(1991-8#1)(1997-3#1)
in a patient with resistant##2##5##(2012-3#1)(2013-8#1)
in a patient with severe##3##5##(2007-10#1)(2007-2#1)(2007-7#1)
in a patient with ulcerative colitis##2##6##(2007-10#1)(2010-12#1)
in a patient with##150##4##(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-10#6)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#7)(2008-5#1)(2008-6#5)(2008-7#10)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#11)(2013-1#7)(2013-7#3)(2013-8#5)
in a patient without##2##4##(1996-8#1)(2009-5#1)
in a patient##201##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1993-9#2)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-10#7)(2007-12#2)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#7)(2008-1#6)(2008-10#4)(2008-11#6)(2008-12#9)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#5)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-12#4)(2012-2#5)(2012-3#13)(2013-1#7)(2013-7#3)(2013-8#6)
in a patient's##4##3##(1990-8#1)(1991-12#1)(1993-12#1)(2012-3#1)
in a pattern##3##3##(1994-8#1)(1995-5#1)(1996-12#1)
in a peak##2##3##(2007-11#1)(2008-3#1)
in a pediatric patient##2##4##(2011-1#1)(2012-12#1)
in a pediatric##8##3##(1992-2#1)(1993-2#1)(1995-11#1)(2007-5#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)
in a peptide##2##3##(1993-11#1)(1994-6#1)
in a perinuclear##2##3##(1995-3#1)(2009-10#1)
in a period of##5##4##(1990-12#1)(1993-3#1)(1995-3#1)(1997-5#1)(2008-2#1)
in a period##7##3##(1990-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-2#1)
in a periodic##4##3##(1996-12#1)(2007-11#1)(2008-3#1)(2011-1#1)
in a periodically poled LiNbO(3)##3##5##(2007-11#1)(2007-12#2)
in a periodically poled lithium niobate##2##6##(2007-11#1)(2007-12#1)
in a periodically poled##9##4##(2007-11#3)(2007-12#6)
in a periodically##10##3##(2007-11#3)(2007-12#6)(2008-3#1)
in a permanent##2##3##(2008-10#1)(2008-12#1)
in a persistent manner##4##4##(2008-10#4)
in a persistent vegetative state##3##5##(1990-11#1)(1991-12#1)(2008-2#1)
in a persistent##7##3##(1990-11#1)(1991-12#1)(2008-10#4)(2008-2#1)
in a phage##2##3##(1994-12#2)
in a phantom##4##3##(1994-3#1)(2008-3#1)(2009-11#1)(2012-12#1)
in a pharmaceutical development##2##4##(2008-10#2)
in a pharmaceutical preparation##2##4##(2008-10#2)
in a pharmaceutical##8##3##(2008-10#6)(2008-11#2)
in a pharmacokinetic##2##3##(2008-10#1)(2013-1#1)
in a phase##5##3##(2008-3#3)(2008-5#1)(2008-6#1)
in a phase-stepping##2##3##(2008-2#1)(2008-3#1)
in a phosphate buffer##4##4##(2008-10#4)
in a phosphate##5##3##(2008-10#5)
in a photoconducting##2##3##(2007-11#1)(2008-2#1)
in a photographic developing solution##6##5##(2008-10#6)
in a photographic##7##3##(2008-10#7)
in a photonic crystal fiber##2##5##(2007-12#2)
in a photonic crystal##4##4##(2007-11#1)(2007-12#3)
in a photonic##5##3##(2007-11#2)(2007-12#3)
in a photopolymer##3##3##(2007-12#2)(2008-3#1)
in a photorefractive crystal is##2##5##(2007-12#1)(2008-3#1)
in a photorefractive crystal##12##4##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#4)
in a photorefractive material##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
in a photorefractive medium##2##4##(2008-2#1)(2008-3#1)
in a photorefractive polymer##2##4##(2007-11#2)
in a photorefractive##28##3##(2007-11#4)(2007-12#9)(2008-2#4)(2008-3#11)
in a physical##2##3##(2008-3#1)(2008-7#1)
in a physiologically##2##3##(1990-8#1)(1996-5#1)
in a pig##2##3##(2007-8#1)(2012-3#1)
in a pilot plant##2##4##(2008-10#2)
in a pilot##5##3##(1992-5#1)(2007-10#1)(2008-10#2)(2010-8#1)
in a pituitary##2##3##(1996-2#1)(1997-7#1)
in a plane##3##3##(2008-3#2)(2009-11#1)
in a plant##2##3##(2008-10#1)(2008-12#1)
in a plantation##2##3##(2008-10#1)(2008-5#1)
in a plasmid##4##3##(1990-11#1)(1990-8#1)(1991-9#1)(2008-10#1)
in a plasmid-based##2##3##(1994-12#1)(1997-7#1)
in a plastic##2##3##(1994-10#1)(2008-10#1)
in a plasticized##3##3##(2008-10#3)
in a polar##3##3##(2008-10#2)(2008-3#1)
in a poled##2##3##(2007-11#2)
in a polluted##2##3##(2008-3#1)(2008-5#1)
in a poly(vinyl chloride) membrane##2##5##(2008-10#2)
in a poly(vinyl##3##3##(2008-10#3)
in a polyacrylamide##3##3##(2008-10#2)(2008-2#1)
in a polymer matrix##2##4##(2008-7#1)(2012-2#1)
in a polymer##9##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#3)(2010-5#1)(2012-2#1)
in a polymeric##3##3##(2008-10#2)(2008-11#1)
in a polyvinyl alcohol##2##4##(2008-2#1)(2009-11#1)
in a poor##4##3##(2010-9#1)(2012-2#1)(2013-1#2)
in a population in##2##4##(2008-8#1)(2012-3#1)
in a population of patients with##2##6##(2008-5#1)(2012-12#1)
in a population of viruliferous##2##5##(2008-10#2)
in a population of##29##4##(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#2)(1995-11#2)(1995-12#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
in a population sample##3##4##(1993-3#1)(2008-12#2)
in a population with##3##4##(1990-3#1)(1994-12#1)(2007-10#1)
in a population##49##3##(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#2)(1993-10#1)(1993-3#1)(1994-12#1)(1995-11#2)(1995-12#1)(1997-3#1)(2007-10#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
in a population-based sample of##2##5##(2008-7#2)
in a population-based##7##3##(1991-6#1)(1992-6#1)(2007-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
in a porcine model##3##4##(2007-8#1)(2008-4#1)(2013-1#1)
in a porcine##4##3##(2007-8#1)(2008-4#1)(2009-7#1)(2013-1#1)
in a position to##4##4##(1991-12#1)(1994-3#1)(1997-6#1)(2008-11#1)
in a position##7##3##(1991-12#1)(1993-3#1)(1994-3#1)(1997-6#1)(1997-7#1)(2008-11#1)(2012-12#1)
in a positive or negative##2##5##(1993-5#1)(1995-11#1)
in a positive##6##3##(1993-5#1)(1994-7#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-5#1)
in a post-Golgi compartment##2##4##(1992-12#1)(1995-8#1)
in a potato##3##3##(2008-10#1)(2008-5#2)
in a potential##3##3##(2008-10#2)(2013-1#1)
in a potentially##3##3##(1992-11#1)(2008-1#1)(2010-3#1)
in a practical##6##3##(2008-3#3)(2009-1#1)(2013-1#1)(2013-8#1)
in a practice context##2##4##(2008-11#2)
in a precise##2##3##(2008-10#1)(2008-3#1)
in a precisely##2##3##(2008-7#1)(2008-9#1)
in a preclinical##2##3##(2008-10#1)(2010-6#1)
in a predictable manner##2##4##(1993-3#1)(2008-9#1)
in a predictable##5##3##(1993-3#1)(1997-1#1)(2008-9#1)(2011-2#1)(2012-2#1)
in a pregnancy##2##3##(1996-8#1)(2009-3#1)
in a pregnant woman##2##4##(1990-6#1)(2008-7#1)
in a pregnant##4##3##(1990-6#1)(2008-7#1)(2011-1#2)
in a premixed##2##3##(2008-2#2)
in a prevention##2##3##(2008-12#1)(2008-7#1)
in a previous paper##2##4##(2008-10#2)
in a previous study##5##4##(1994-8#1)(1995-11#1)(2008-10#2)(2010-4#1)
in a previous##15##3##(1994-8#1)(1995-1#1)(1995-11#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-4#2)
in a previously healthy adult##2##5##(2009-3#1)(2009-8#1)
in a previously healthy##3##4##(2009-3#1)(2009-8#2)
in a previously undiagnosed sickle cell hemoglobinopathy##2##7##(2013-8#2)
in a previously##8##3##(2008-2#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2013-8#2)
in a primary care setting##2##5##(2008-4#1)(2008-8#1)
in a primary care##6##4##(1993-12#1)(1997-5#2)(2008-4#1)(2008-7#1)(2008-8#1)
in a primary##12##3##(1991-6#1)(1992-11#1)(1993-12#1)(1997-5#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
in a private fee-for-service system##2##5##(2006-10#2)
in a private##4##3##(1997-5#1)(2006-10#2)(2008-5#1)
in a problem-based learning##2##4##(2008-10#1)(2011-1#1)
in a process of##2##4##(2007-11#1)(2008-11#1)
in a process that##3##4##(1996-2#1)(2008-12#1)(2008-4#1)
in a process##8##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-3#1)
in a production##2##3##(2008-11#1)(2008-6#1)
in a program##4##3##(2008-1#1)(2008-6#1)(2012-3#1)(2013-8#1)
in a programmed##2##3##(2008-10#2)
in a progressive##3##3##(1992-12#1)(2008-4#1)(2013-1#1)
in a project##2##3##(2008-12#2)
in a prolonged##2##3##(2008-9#1)(2012-2#1)
in a proper way##2##4##(1991-11#1)(2008-6#1)
in a proportion of &gt##2##5##(2008-10#2)
in a proportion of##5##4##(1997-3#1)(2008-10#3)(2008-5#1)
in a proportion##6##3##(1997-3#1)(2008-10#4)(2008-5#1)
in a prospective cohort##2##4##(2008-9#1)(2013-1#1)
in a prospective payment system##2##5##(1992-12#1)(1994-3#1)
in a prospective randomized##2##4##(2007-8#1)(2008-6#1)
in a prospective study##2##4##(2008-3#1)(2008-7#1)
in a prospective##17##3##(1992-12#1)(1992-5#1)(1994-3#2)(1997-8#1)(2007-7#2)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-6#1)(2013-1#1)
in a protein network##2##4##(2008-2#1)(2010-10#1)
in a protein##10##3##(1993-11#1)(1994-5#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)
in a province##2##3##(1993-2#1)(2009-6#1)
in a proximal##2##3##(1992-6#1)(2010-3#1)
in a psychiatric hospital##2##4##(1991-2#1)(1993-2#1)
in a psychiatric##4##3##(1991-2#1)(1993-2#1)(2012-3#2)
in a public hospital in##4##5##(2013-1#4)
in a public hospital##5##4##(2013-1#5)
in a public university##2##4##(1993-1#1)(2012-3#1)
in a public##14##3##(1991-3#1)(1993-1#1)(1993-5#1)(1996-11#1)(1996-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#5)
in a pulsatile##2##3##(1997-2#1)(2008-7#1)
in a pulsed##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)
in a punctuate pattern##2##4##(2008-11#2)
in a pure##3##3##(1993-11#1)(2008-3#1)(2010-4#1)
in a putative##2##3##(1995-2#1)(1995-5#1)
in a qualitative manner##3##4##(2008-10#3)
in a qualitative##5##3##(2008-10#3)(2008-9#1)(2012-1#1)
in a quantitative##7##3##(1994-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
in a quasi-phase-matched##3##3##(2007-11#1)(2007-12#2)
in a questionnaire##3##3##(1991-6#1)(1993-3#1)(1994-9#1)
in a rabbit model of focal cerebral ischemia##2##8##(1997-6#2)
in a rabbit model of##4##5##(1997-6#2)(2007-8#1)(2012-3#1)
in a rabbit model##5##4##(1997-6#2)(2007-8#1)(2009-3#1)(2012-3#1)
in a rabbit##6##3##(1997-6#2)(2007-8#1)(2009-3#2)(2012-3#1)
in a rabbit's##2##3##(2008-2#2)
in a random medium##2##4##(2007-11#1)(2008-2#1)
in a random sample##2##4##(1996-8#1)(2008-7#1)
in a random##10##3##(1992-11#2)(1992-9#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-7#2)(2013-8#1)
in a randomised trial##2##4##(1990-2#1)(1991-8#1)
in a randomised##3##3##(1990-2#1)(1991-8#1)(2008-2#1)
in a randomized and##2##4##(2008-5#2)
in a randomized clinical trial##3##5##(1991-12#1)(1995-11#1)(1996-3#1)
in a randomized complete block design##3##6##(2008-10#3)
in a randomized controlled trial##2##5##(2011-1#1)(2013-1#1)
in a randomized trial##2##4##(1993-11#1)(2012-2#1)
in a randomized##26##3##(1990-12#1)(1991-12#1)(1991-8#1)(1993-11#1)(1995-11#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#7)(2008-5#3)(2008-7#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in a randomly selected sample of##2##6##(1990-5#1)(1994-12#1)
in a range from 0##3##5##(2008-10#2)(2010-4#1)
in a range from##4##4##(1995-3#1)(2008-10#2)(2010-4#1)
in a range of 0##2##5##(1992-11#1)(2008-10#1)
in a range of##31##4##(1991-12#1)(1992-11#1)(1993-9#1)(1994-6#1)(1995-12#1)(1997-3#1)(2007-10#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
in a range##40##3##(1991-12#1)(1992-11#1)(1993-9#2)(1994-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
in a rapid##13##3##(1990-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1995-6#1)(2008-10#2)(2008-11#3)(2010-5#1)(2010-7#1)
in a rapidly changing##2##4##(1995-12#1)(2008-10#1)
in a rat model of chronic##3##6##(2009-6#1)(2011-2#2)
in a rat model of##11##5##(1996-5#2)(1997-2#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
in a rat model##17##4##(1990-12#1)(1992-9#1)(1995-12#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
in a rat##26##3##(1990-12#1)(1991-12#1)(1992-9#1)(1994-11#1)(1995-12#1)(1996-12#2)(1996-5#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
in a ratio of 1##3##5##(1990-12#1)(2008-10#2)
in a ratio of##4##4##(1990-12#1)(1992-6#1)(2008-10#2)
in a ratio##5##3##(1990-12#1)(1992-6#1)(2008-10#3)
in a reaction that##2##4##(2008-2#1)(2009-6#1)
in a reaction##8##3##(1993-11#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-2#1)(2009-6#1)(2009-8#1)
in a reactive##2##3##(1993-12#1)(2008-3#1)
in a real sample##2##4##(2008-10#2)
in a real##6##3##(2008-10#2)(2008-12#1)(2008-3#2)(2013-8#1)
in a realistic situation##2##4##(2009-10#1)(2010-2#1)
in a realistic##3##3##(2008-3#1)(2009-10#1)(2010-2#1)
in a reasonable##2##3##(2008-11#1)(2013-8#1)
in a recent study##3##4##(1990-11#1)(2011-2#2)
in a recent##14##3##(1990-11#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#1)
in a recently##2##3##(1991-11#1)(2010-11#1)
in a reciprocal##4##3##(1994-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
in a recirculating loop##2##4##(2007-11#1)(2007-12#1)
in a recirculating##3##3##(1996-12#1)(2007-11#1)(2007-12#1)
in a recombinant##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
in a reconstituted##6##3##(1990-8#1)(1996-3#1)(2008-4#2)(2008-5#2)
in a rectangular##3##3##(1992-12#1)(2008-10#1)(2008-3#1)
in a recurrent neural network model##3##6##(2008-11#3)
in a recurrent##4##3##(2008-1#1)(2008-11#3)
in a recycle batch##2##4##(2008-7#2)
in a reduced number of##2##5##(1996-2#1)(2008-10#1)
in a reduced##8##3##(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#3)
in a reduction in the##3##5##(1995-6#1)(2007-11#1)(2012-2#1)
in a reduction in##6##4##(1994-8#1)(1995-6#1)(2007-11#1)(2012-2#2)(2013-1#1)
in a reduction of the##2##5##(1994-5#1)(2011-1#1)
in a reduction of##3##4##(1994-5#1)(1996-5#1)(2011-1#1)
in a reduction##9##3##(1994-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(2007-11#1)(2011-1#1)(2012-2#2)(2013-1#1)
in a reference##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
in a referral center##4##4##(2011-2#2)(2013-8#2)
in a referral##5##3##(2007-7#1)(2011-2#2)(2013-8#2)
in a reflectance geometry##2##4##(2007-12#1)(2008-2#1)
in a reflection##2##3##(2007-12#2)
in a regime##2##3##(2008-11#1)(2008-3#1)
in a region of interest##2##5##(2010-2#1)(2013-1#1)
in a region that##2##4##(1993-6#1)(2008-10#1)
in a region##14##3##(1993-6#2)(1996-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
in a regular##3##3##(1990-11#1)(2008-10#2)
in a regulatory##2##3##(2008-10#1)(2008-11#1)
in a relatively high##2##4##(2008-10#1)(2008-3#1)
in a relatively narrow##2##4##(2008-5#1)(2008-7#1)
in a relatively simple##2##4##(2007-11#1)(2008-3#1)
in a relatively small##3##4##(1995-11#1)(2007-10#1)(2008-10#1)
in a relatively young##2##4##(2008-1#1)(2008-4#1)
in a relatively##17##3##(1991-12#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)
in a remote area##2##4##(1992-1#1)(2008-5#1)
in a renal transplant patient##4##5##(2007-2#1)(2007-7#1)(2008-1#1)(2013-1#1)
in a renal transplant recipient##2##5##(2007-7#1)(2008-1#1)
in a renal transplant##6##4##(2007-2#1)(2007-7#2)(2008-1#2)(2013-1#1)
in a renal##7##3##(2007-2#1)(2007-7#2)(2008-1#2)(2010-4#1)(2013-1#1)
in a repeated##3##3##(1996-2#1)(2008-10#2)
in a representative sample of##2##5##(1995-8#1)(2013-1#1)
in a representative##4##3##(1995-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
in a reproducible##3##3##(2007-8#1)(2008-5#1)(2013-1#1)
in a research##2##3##(1991-6#1)(2008-4#1)
in a residency##2##3##(1993-12#1)(1995-1#1)
in a residential home##2##4##(2011-1#2)
in a resistance-training program##2##4##(2008-5#2)
in a resistant##2##3##(2008-10#2)
in a resonant##2##3##(2007-12#2)
in a resource##2##3##(2008-10#1)(2009-4#1)
in a restricted##2##3##(2008-10#1)(2012-3#1)
in a restructured##2##3##(1996-3#2)
in a retrospective study##3##4##(1990-9#1)(1991-4#1)(2007-8#1)
in a retrospective##6##3##(1990-9#1)(1991-4#1)(1994-6#1)(2007-8#1)(2008-3#1)(2012-2#1)
in a reversed##2##3##(2008-10#1)(2008-3#1)
in a reversible fashion##2##4##(2007-12#1)(2008-12#1)
in a reversible##4##3##(2007-11#1)(2007-12#1)(2008-12#1)(2009-11#1)
in a revised##2##3##(1991-9#1)(2008-3#1)
in a right##2##3##(1991-5#1)(2008-9#1)
in a ring cavity that is##2##6##(2007-12#1)(2008-3#1)
in a ring##6##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
in a robust##4##3##(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
in a rotating##2##3##(1994-2#1)(2012-2#1)
in a routine laboratory##2##4##(1990-2#1)(1994-1#1)
in a row##2##3##(2008-10#1)(2009-9#1)
in a rural area##3##4##(1995-3#2)(2008-2#1)
in a rural community in##4##5##(2008-11#1)(2009-10#1)(2010-6#2)
in a rural community##5##4##(1994-1#1)(2008-11#1)(2009-10#1)(2010-6#2)
in a rural health##2##4##(1997-3#1)(2012-3#1)
in a rural region of##2##5##(1992-2#1)(2011-2#1)
in a rural##23##3##(1990-12#1)(1991-1#1)(1991-3#1)(1992-2#1)(1993-10#1)(1994-1#1)(1995-3#2)(1995-9#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
in a safe and##2##4##(2008-10#1)(2013-8#1)
in a safe##3##3##(2008-10#2)(2013-8#1)
in a sample of parents##2##5##(2012-12#2)
in a sample of the elderly population##2##7##(2008-7#2)
in a sample of##50##4##(1990-6#1)(1992-8#1)(1993-12#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#3)
in a sample solution##2##4##(2008-10#2)
in a sample volume of##4##5##(2008-10#4)
in a sample volume##5##4##(2008-10#5)
in a sample##84##3##(1990-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#4)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
in a sandy##2##3##(2008-10#1)(2013-7#1)
in a satisfactory##2##3##(1996-12#1)(2008-7#1)
in a scanning##3##3##(1992-12#1)(2007-11#1)(2008-2#1)
in a scattering medium##10##4##(2007-11#1)(2007-12#5)(2008-3#4)
in a scattering slab##3##4##(2008-3#3)
in a scattering##16##3##(2007-11#2)(2007-12#5)(2008-3#9)
in a scene##2##3##(2008-9#2)
in a school population##2##4##(1995-2#1)(2011-2#1)
in a school##3##3##(1991-12#1)(1995-2#1)(2011-2#1)
in a search##2##3##(1992-11#1)(2008-10#1)
in a season##2##3##(2008-10#2)
in a seasonal##2##3##(2008-8#1)(2008-9#1)
in a second##16##3##(1993-2#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
in a second-order##2##3##(2007-12#1)(2008-6#1)
in a secondary##2##3##(1990-8#1)(2008-10#1)
in a secure##3##3##(1996-9#1)(2007-12#1)(2012-2#1)
in a seed orchard##2##4##(2008-10#1)(2009-12#1)
in a seemingly##2##3##(2008-10#1)(2011-2#1)
in a segregating population from a cross between a##2##9##(2008-10#1)(2012-3#1)
in a segregating population##3##4##(2008-10#2)(2012-3#1)
in a selected group of##2##5##(1990-9#1)(2013-1#1)
in a selected##6##3##(1990-9#1)(1996-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2013-1#1)
in a selection##2##3##(1996-3#1)(2008-3#1)
in a self-contained##3##3##(2008-7#2)(2012-2#1)
in a semiconductor laser##3##4##(2007-11#2)(2008-3#1)
in a semiconductor##7##3##(2007-11#2)(2007-12#4)(2008-3#1)
in a sensitive##4##3##(1995-11#1)(2008-10#2)(2008-11#1)
in a sentence##2##3##(1997-8#1)(2007-12#1)
in a separate##11##3##(1992-5#1)(1993-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
in a sequence of##3##4##(2008-10#2)(2008-2#1)
in a sequence##4##3##(1992-6#1)(2008-10#2)(2008-2#1)
in a sequence-specific manner##2##4##(1990-11#1)(2008-9#1)
in a sequence-specific##3##3##(1990-11#1)(2008-4#1)(2008-9#1)
in a sequential injection analysis system##3##6##(2008-10#3)
in a sequential injection##7##4##(2008-10#7)
in a sequential##10##3##(2007-11#1)(2008-10#8)(2008-8#1)
in a series addressing the structuring of group medical practice entities##2##11##(1993-2#1)(1994-1#1)
in a series addressing the structuring of group medical##3##9##(1993-2#1)(1993-3#1)(1994-1#1)
in a series addressing the##4##5##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
in a series analyzing the physician-hospital contracting process from the physician's perspective--addresses##2##12##(1994-1#1)(1994-3#1)
in a series analyzing the##3##5##(1993-3#1)(1994-1#1)(1994-3#1)
in a series of 20##3##5##(2008-10#2)(2008-7#1)
in a series of 36##2##5##(1994-2#1)(2008-7#1)
in a series of four units##2##6##(2008-4#2)
in a series of six articles to discuss the major classes of dietary supplements (vitamins##3##15##(2008-5#3)
in a series of three articles regarding steel can recycling from foodservice operations of healthcare facilities##2##16##(1996-12#1)(1996-3#1)
in a series of##49##4##(1990-12#1)(1990-6#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-8#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-4#1)(2012-1#1)(2012-3#1)
in a series on health care litigation##3##7##(1992-1#1)(1992-2#1)(1992-3#1)
in a series on##4##4##(1992-1#1)(1992-2#1)(1992-3#1)(2008-3#1)
in a series##62##3##(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-4#1)(2012-1#1)(2012-3#1)
in a serum-free medium##6##4##(1990-11#1)(1993-6#1)(2008-11#4)
in a set of##6##4##(2008-4#2)(2008-6#1)(2008-9#3)
in a set##7##3##(2008-4#2)(2008-6#1)(2008-9#3)(2011-2#1)
in a setting of##2##4##(2007-7#1)(2013-1#1)
in a setting##3##3##(1994-2#1)(2007-7#1)(2013-1#1)
in a severe##6##3##(1992-5#1)(2006-10#1)(2008-2#1)(2009-1#1)(2009-5#1)(2011-2#1)
in a severely##2##3##(2008-10#1)(2013-8#1)
in a sheltered##2##3##(2008-10#1)(2008-9#1)
in a short period of time##3##6##(2007-8#1)(2008-2#1)(2010-11#1)
in a short period##4##4##(2007-8#1)(2008-11#1)(2008-2#1)(2010-11#1)
in a short time##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)
in a short##16##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-7#1)
in a short-term##2##3##(2008-11#1)(2008-4#1)
in a shorter##2##3##(1990-5#1)(2008-10#1)
in a sigma##2##3##(1995-2#1)(2007-11#1)
in a significant decrease in##6##5##(1990-7#1)(1991-6#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
in a significant decrease##8##4##(1990-7#1)(1991-6#1)(1991-9#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
in a significant improvement in##2##5##(2008-10#1)(2012-2#1)
in a significant improvement##3##4##(2008-10#1)(2012-2#1)(2012-7#1)
in a significant increase in the##3##6##(2008-10#2)(2008-12#1)
in a significant increase in##12##5##(1992-12#1)(1994-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-6#1)(2013-1#1)(2013-7#1)
in a significant increase##14##4##(1992-12#1)(1994-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-7#1)
in a significant loss of##2##5##(1994-5#1)(2009-12#1)
in a significant minority of patients##2##6##(2008-6#1)(2010-5#1)
in a significant proportion of##2##5##(2008-11#1)(2008-9#1)
in a significant reduction in##4##5##(1991-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
in a significant reduction##7##4##(1991-12#1)(1992-1#1)(2008-10#2)(2008-3#2)(2008-5#1)
in a significant##59##3##(1990-7#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-7#1)(2007-10#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-9#1)(2009-12#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#2)(2013-7#1)
in a significantly lower##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
in a significantly##7##3##(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-8#1)(2012-3#1)
in a similar fashion and##2##5##(1997-2#1)(2008-10#1)
in a similar fashion in##2##5##(1993-8#1)(2008-9#1)
in a similar fashion##10##4##(1990-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-3#1)
in a similar manner as##2##5##(1990-11#1)(2008-10#1)
in a similar manner##8##4##(1990-11#1)(1990-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
in a similar way to##5##5##(1991-9#1)(2008-10#2)(2008-8#1)(2008-9#1)
in a similar way##10##4##(1990-12#1)(1991-9#1)(1992-11#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)
in a similar##39##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-10#1)(1991-9#1)(1992-11#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2013-8#1)
in a simple and##5##4##(2007-12#3)(2008-10#1)(2012-2#1)
in a simple way##4##4##(1993-12#1)(2008-10#1)(2008-3#2)
in a simple##29##3##(1990-5#1)(1991-5#1)(1993-12#1)(1996-11#1)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#5)(2008-5#1)(2009-11#1)(2012-2#1)
in a simulated competition of short terrestrial duathlon##3##8##(2008-5#3)
in a simulated##5##3##(2008-11#1)(2008-3#1)(2008-5#3)
in a simulation study##4##4##(1994-11#1)(1995-9#1)(2008-10#1)(2011-1#1)
in a simulation##8##3##(1992-6#1)(1994-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
in a simultaneous##2##3##(2008-10#2)
in a single analysis##3##4##(1990-8#1)(1997-3#1)(2012-12#1)
in a single assay##3##4##(1991-5#1)(2008-10#2)
in a single cell##6##4##(1997-7#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-12#1)(2013-8#1)
in a single channel##2##4##(2007-12#1)(2008-3#1)
in a single crystal##3##4##(2007-12#2)(2008-3#1)
in a single experiment##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
in a single gene##2##4##(1995-6#1)(1995-8#1)
in a single layer##2##4##(2008-10#1)(2008-2#1)
in a single operation##2##4##(2008-7#1)(2008-8#1)
in a single pass by##2##5##(2007-12#2)
in a single pass##4##4##(2007-12#2)(2008-10#1)(2008-12#1)
in a single patient##5##4##(1990-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
in a single reaction##2##4##(2008-9#1)(2012-2#1)
in a single round of##2##5##(1994-12#1)(2008-10#1)
in a single scan##2##4##(2008-10#1)(2012-2#1)
in a single shot##2##4##(2007-12#2)
in a single stage##2##4##(2008-6#1)(2011-2#1)
in a single step by##3##5##(1994-12#1)(1996-2#1)(2008-10#1)
in a single step##9##4##(1994-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2010-5#1)(2013-8#1)
in a single tube##3##4##(1992-3#1)(2008-10#2)
in a single two-dimensional##2##4##(2007-11#2)
in a single visit##2##4##(2013-8#2)
in a single##162##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-2#1)(1993-6#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#7)(2007-12#15)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#32)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#7)(2009-10#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#6)
in a single-mode optical fiber##3##5##(2007-12#3)
in a single-mode##5##3##(2007-12#5)
in a single-pass##2##3##(2007-11#1)(2007-12#1)
in a single-shot##2##3##(2007-12#1)(2008-3#1)
in a situation of##2##4##(2008-7#1)(2010-4#1)
in a situation##3##3##(2007-12#1)(2008-7#1)(2010-4#1)
in a skin##2##3##(2008-3#1)(2008-5#1)
in a slab##2##3##(2007-11#1)(2008-4#1)
in a slight##3##3##(2008-10#2)(2011-2#1)
in a slightly##4##3##(1996-10#1)(2008-10#2)(2008-5#1)
in a slow##4##3##(1990-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
in a small but##2##4##(1996-5#1)(2008-11#1)
in a small local area##2##5##(2008-3#2)
in a small number of##4##5##(1992-2#1)(1992-8#1)(2007-10#1)(2013-1#1)
in a small number##5##4##(1992-2#1)(1992-8#1)(1995-5#1)(2007-10#1)(2013-1#1)
in a small proportion##2##4##(1995-11#1)(2008-5#1)
in a small region##2##4##(1990-5#1)(1993-8#1)
in a small volume of##2##5##(2008-10#1)(2008-8#1)
in a small##41##3##(1990-12#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-11#2)(1996-12#2)(1996-5#1)(1997-1#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
in a small-volume##2##3##(2008-3#2)
in a smaller degree##2##4##(2009-8#2)
in a smaller##4##3##(2008-10#1)(2009-8#2)(2013-1#1)
in a social##2##3##(1993-1#1)(1995-3#1)
in a society##3##3##(1991-3#1)(1992-6#2)
in a soil sample##2##4##(2008-10#2)
in a soil##7##3##(1992-3#1)(2008-10#6)
in a solid##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
in a solid-phase##2##3##(2008-10#1)(2012-12#1)
in a solid-state dye##3##4##(2007-12#1)(2008-2#2)
in a solid-state##4##3##(2007-12#2)(2008-2#2)
in a soluble form in##2##5##(1992-6#1)(1994-8#1)
in a soluble form##6##4##(1992-6#1)(1994-8#2)(2008-7#1)(2012-2#2)
in a soluble##8##3##(1990-11#1)(1992-6#1)(1994-8#2)(2008-4#1)(2008-7#1)(2012-2#2)
in a solution containing##7##4##(2007-11#1)(2008-10#5)(2008-4#1)
in a solution of##7##4##(2008-10#6)(2008-3#1)
in a solution##19##3##(2007-11#1)(2008-10#15)(2008-3#2)(2008-4#1)
in a solvent of##2##4##(2008-10#1)(2010-12#1)
in a solvent##4##3##(2008-10#2)(2008-2#1)(2010-12#1)
in a source-sink##2##3##(2008-8#2)
in a space##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in a spatial##5##3##(1994-3#1)(1996-5#1)(2008-10#2)(2013-8#1)
in a spatially##5##3##(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)
in a special way##2##4##(1997-6#1)(2008-10#1)
in a special##7##3##(1993-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-7#1)
in a specialist##3##3##(1997-7#1)(2010-10#1)(2011-2#1)
in a specialized##4##3##(1990-5#1)(1991-9#1)(1995-12#1)(2012-2#1)
in a specially designed##2##4##(2008-5#1)(2008-7#1)
in a specially##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
in a specific##16##3##(1990-2#1)(1990-7#1)(1992-9#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#2)
in a speckle##2##3##(2008-2#1)(2008-3#1)
in a spectrum of##2##4##(2008-5#1)(2008-7#1)
in a spherical##2##3##(1996-5#1)(2009-4#1)
in a spiked##2##3##(2008-10#2)
in a spinner flask##2##4##(2008-11#2)
in a spinner##3##3##(2008-11#3)
in a spiral##3##3##(2008-10#1)(2011-2#2)
in a split plot##2##4##(2008-12#2)
in a stable transformed Sf9 insect cell line##2##8##(2008-11#2)
in a stable##9##3##(1994-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)
in a standard reference##2##4##(2008-10#2)
in a standard##21##3##(1990-7#1)(1996-12#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
in a standardised##2##3##(2012-12#1)(2013-8#1)
in a standardized##2##3##(2008-12#1)(2008-7#1)
in a state of##7##4##(1995-3#1)(2008-1#2)(2008-12#1)(2008-8#1)(2010-6#1)(2013-1#1)
in a state##12##3##(1990-11#1)(1993-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2007-2#1)(2008-1#2)(2008-12#1)(2008-8#1)(2010-6#1)(2013-1#1)
in a stationary##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
in a step-by-step way##2##4##(2008-10#1)(2011-2#1)
in a stepwise fashion##2##4##(2008-10#1)(2008-3#1)
in a stepwise manner##2##4##(2007-12#1)(2008-10#1)
in a stepwise##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
in a stereotyped##2##3##(1993-12#1)(2007-12#1)
in a still##2##3##(2008-10#2)
in a stirred tank bioreactor##3##5##(2008-11#3)
in a stirred tank##4##4##(2008-11#3)(2008-7#1)
in a stirred##6##3##(2008-11#4)(2008-7#2)
in a stochastic environment##2##4##(2008-8#2)
in a stochastic##4##3##(1997-3#1)(2008-8#2)(2008-9#1)
in a straight segment of an artery##2##7##(2008-9#2)
in a straightforward manner##2##4##(2008-10#1)(2008-4#1)
in a straightforward##3##3##(1994-11#1)(2008-10#1)(2008-4#1)
in a strain lacking##2##4##(1992-10#1)(1995-11#1)
in a strain of##3##4##(1993-12#1)(2007-10#1)(2011-2#1)
in a strain##6##3##(1992-10#1)(1993-12#1)(1995-11#1)(1997-7#1)(2007-10#1)(2011-2#1)
in a strictly##2##3##(2008-7#1)(2011-2#1)
in a strong##4##3##(1990-11#1)(1994-1#1)(2008-3#1)(2008-9#1)
in a strongly absorbing##2##4##(2007-12#1)(2008-3#1)
in a strongly##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
in a study of##3##4##(2008-6#1)(2008-7#1)(2012-12#1)
in a study to determine##2##5##(2008-10#1)(2008-2#1)
in a study to##3##4##(2008-10#2)(2008-2#1)
in a study##12##3##(1992-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
in a sub-sample of##2##4##(2010-8#1)(2013-1#1)
in a subgroup of##3##4##(1992-9#1)(1996-7#1)(2009-9#1)
in a subject with##2##4##(1995-8#2)
in a submerged##2##3##(2007-12#1)(2008-7#1)
in a subpopulation of##3##4##(1992-3#1)(1995-12#1)(2008-7#1)
in a subsequent##2##3##(1990-2#1)(2008-9#1)
in a subset of the##2##5##(2009-8#1)(2010-11#1)
in a subset of##10##4##(1992-8#1)(1993-12#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)
in a subset##11##3##(1992-8#1)(1993-12#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)
in a substantial proportion of##3##5##(2010-1#1)(2010-12#1)(2013-1#1)
in a substantial##7##3##(1993-8#1)(2007-12#1)(2008-10#1)(2010-1#1)(2010-12#1)(2013-1#2)
in a suburban##2##3##(2008-11#1)(2013-1#1)
in a successful##2##3##(1993-2#1)(1996-1#1)
in a sucrose##2##3##(1997-6#1)(2008-10#1)
in a sufficient amount##2##4##(1990-12#1)(1997-7#1)
in a sufficient##3##3##(1990-12#1)(1997-7#1)(2008-12#1)
in a suitable##4##3##(1990-2#1)(2008-10#3)
in a superorbital##2##3##(2008-2#2)
in a supersonic##2##3##(2007-12#1)(2009-11#1)
in a supervised##2##3##(2009-7#2)
in a support##4##3##(1992-12#1)(2008-2#1)(2008-4#2)
in a surgical##2##3##(1990-6#1)(1995-6#1)
in a survey of##4##4##(1991-8#1)(2008-10#2)(2011-1#1)
in a survey on##2##4##(1994-2#1)(1997-6#1)
in a survey##9##3##(1990-3#1)(1991-8#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2011-1#1)(2012-12#1)
in a susceptible cultivar##3##4##(2008-10#3)
in a susceptible##6##3##(2008-10#6)
in a suspended##2##3##(2007-11#1)(2008-3#1)
in a suspension##3##3##(2008-10#2)(2008-11#1)
in a switch##2##3##(2008-10#1)(2008-8#1)
in a synergistic manner##2##4##(1991-9#1)(1992-10#1)
in a synergistic##3##3##(1991-9#2)(1992-10#1)
in a syngeneic##2##3##(2010-11#1)(2011-1#1)
in a synthetic medium containing##2##5##(2008-10#2)
in a synthetic medium##3##4##(2008-10#3)
in a synthetic##11##3##(2008-10#8)(2008-3#1)(2008-5#2)
in a system of two##2##5##(2008-8#1)(2009-8#1)
in a system with##2##4##(1990-11#1)(2008-3#1)
in a system##9##3##(1990-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)
in a systematic manner##2##4##(1992-3#1)(2012-1#1)
in a systematic way##4##4##(2008-10#2)(2008-3#1)(2012-1#1)
in a systematic##6##3##(1992-3#1)(2008-10#2)(2008-3#1)(2012-1#2)
in a systemic##2##3##(2006-10#1)(2008-10#1)
in a table##3##3##(1990-5#1)(1996-1#1)(2008-4#1)
in a tablet##2##3##(2008-10#1)(2012-2#1)
in a tandem##2##3##(1991-6#1)(2007-11#1)
in a tank##2##3##(2008-4#1)(2008-8#1)
in a tapered##2##3##(2007-11#1)(2008-2#1)
in a taxonomic##2##3##(2008-8#1)(2012-2#1)
in a teaching hospital##10##4##(1994-2#1)(2008-11#1)(2008-3#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-3#2)(2012-3#2)
in a technique##2##3##(2008-3#1)(2008-7#1)
in a temperature##2##3##(2008-3#2)
in a temporal water body##2##5##(2008-5#2)
in a temporal##3##3##(2008-10#1)(2008-5#2)
in a temporally##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
in a terminal##3##3##(2008-7#1)(2011-2#2)
in a terrestrial##2##3##(1990-5#1)(2010-8#1)
in a tertiary care hospital in##4##6##(2008-11#2)(2009-7#1)(2011-2#1)
in a tertiary care hospital##14##5##(2007-7#2)(2008-11#2)(2009-7#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in a tertiary care##20##4##(2007-7#2)(2008-11#2)(2008-7#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
in a tertiary referral##2##4##(2011-1#1)(2011-2#1)
in a tertiary##29##3##(2007-7#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#2)(2009-7#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
in a theoretical##2##3##(2008-3#2)
in a thermal##2##3##(2008-3#1)(2008-4#1)
in a thin##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
in a third##3##3##(1991-12#1)(2008-3#1)(2011-1#1)
in a three years##2##4##(1990-6#1)(1994-2#1)
in a three##5##3##(1990-6#1)(1994-2#1)(2008-1#1)(2008-7#1)(2010-11#1)
in a three-component##2##3##(2008-10#2)
in a three-dimensional (3D)##2##4##(2007-12#1)(2011-2#1)
in a three-dimensional##8##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
in a three-level##3##3##(2007-11#2)(2007-12#1)
in a three-part series of articles reprinted from a report by the##2##12##(1995-1#1)(1995-2#1)
in a time and##3##4##(1994-11#1)(1994-9#1)(2008-11#1)
in a time of##7##4##(1993-12#3)(1997-2#1)(1997-3#2)(2008-3#1)
in a time##18##3##(1993-12#3)(1994-11#1)(1994-9#1)(1997-2#1)(1997-3#2)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)
in a time- and concentration-dependent manner##5##6##(1992-6#1)(1994-8#1)(1997-1#2)(2008-9#1)
in a time- and concentration-dependent##7##5##(1991-5#1)(1992-6#1)(1993-11#1)(1994-8#1)(1997-1#2)(2008-9#1)
in a time- and dose-dependent##2##5##(1992-8#1)(1995-8#1)
in a time- and##10##4##(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-8#1)(1997-1#2)(2008-9#1)
in a time-dependent fashion##2##4##(2008-8#1)(2008-9#1)
in a time-dependent manner##7##4##(1992-3#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
in a time-dependent##9##3##(1992-3#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-8#2)(2008-9#2)(2012-12#1)
in a time-resolved##2##3##(2007-11#1)(2008-10#1)
in a timely and##2##4##(2008-9#1)(2011-1#1)
in a timely fashion##6##4##(1994-2#1)(1995-12#1)(2008-10#1)(2010-11#2)(2010-3#1)
in a timely manner##5##4##(1994-12#1)(1997-3#1)(2008-10#1)(2010-5#1)(2011-2#1)
in a timely##13##3##(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-9#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
in a tissue specific manner##4##5##(1990-12#1)(1993-11#1)(1993-8#1)(2010-7#1)
in a tissue##6##3##(1990-12#1)(1993-11#1)(1993-8#1)(2008-7#2)(2010-7#1)
in a tissue-specific manner##5##4##(1990-12#1)(1991-12#1)(1994-8#1)(1997-7#1)(2011-2#1)
in a tissue-specific##7##3##(1990-11#1)(1990-12#1)(1991-12#1)(1994-8#1)(1995-2#1)(1997-7#1)(2011-2#1)
in a tissuelike##2##3##(2008-3#2)
in a tobacco##2##3##(1997-2#1)(2008-10#1)
in a total of##8##4##(1990-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#1)
in a total##11##3##(1990-8#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
in a traditional Chinese##2##4##(2008-10#2)
in a transient##6##3##(1993-9#1)(2007-12#1)(2008-10#3)(2008-7#1)
in a transition##3##3##(1992-3#1)(1996-12#1)(1996-2#1)
in a transmission system with##3##5##(2007-11#1)(2007-12#2)
in a transmission##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
in a transmissive tilted grating##2##5##(2008-3#2)
in a transparent##2##3##(2008-6#1)(2010-3#1)
in a transverse##2##3##(2007-12#2)
in a traveling-wave excitation scheme##2##5##(2007-11#1)(2007-12#1)
in a traveller##3##3##(2007-2#1)(2008-10#2)
in a treatment##3##3##(2008-10#1)(2010-1#1)(2012-12#1)
in a triangular##2##3##(2007-12#1)(2008-10#1)
in a tropical environment##4##4##(1995-6#1)(1996-12#1)(2008-10#1)(2008-5#1)
in a tropical##7##3##(1995-6#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2013-7#1)
in a true##2##3##(2008-7#1)(2009-3#1)
in a tubular adenoma##2##4##(2009-1#2)
in a tumor##4##3##(1995-1#1)(2008-11#1)(2009-12#1)(2011-2#1)
in a tungsten coil atomizer##2##5##(2008-10#2)
in a tungsten coil##3##4##(2008-10#3)
in a turbid medium##10##4##(2007-12#5)(2008-2#1)(2008-3#4)
in a turbid##12##3##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#4)
in a turbulent flame##2##4##(2008-3#2)
in a turbulent##4##3##(2008-3#4)
in a two year##2##4##(2008-12#1)(2010-8#1)
in a two##4##3##(1997-7#1)(2008-11#1)(2008-12#1)(2010-8#1)
in a two-beam coupling geometry##2##5##(2008-3#2)
in a two-beam coupling##3##4##(2008-3#3)
in a two-beam##4##3##(2007-12#1)(2008-3#3)
in a two-channel##2##3##(2007-11#1)(2007-12#1)
in a two-dimensional (2D)##2##4##(2007-12#2)
in a two-dimensional##12##3##(1992-5#1)(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#2)
in a two-layer##2##3##(2007-12#2)
in a two-part series##2##4##(1996-2#1)(2008-10#1)
in a two-photon##3##3##(2008-2#2)(2008-3#1)
in a two-stage##2##3##(1991-6#1)(2008-11#1)
in a two-step##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
in a two-way##3##3##(1991-2#1)(1996-5#1)(2012-2#1)
in a type II##3##4##(1991-10#1)(2007-12#1)(2008-2#1)
in a type##5##3##(1991-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
in a typical##9##3##(1991-4#1)(1992-9#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)
in a uniform##4##3##(1996-3#1)(2008-2#1)(2008-9#1)(2012-3#1)
in a unique position to educate##2##6##(2009-11#1)(2010-4#1)
in a unique position to##8##5##(1995-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-11#1)(2009-11#1)(2010-4#1)(2011-1#1)
in a unique##17##3##(1990-7#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-11#1)(2010-4#1)(2011-1#1)
in a univariate##2##3##(1991-2#1)(2008-10#1)
in a universal testing machine at a crosshead speed of 0##2##11##(2008-12#1)(2013-1#1)
in a university hospital##2##4##(2012-3#1)(2013-1#1)
in a university pilot plant##2##5##(2012-2#2)
in a university##5##3##(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
in a useful##2##3##(1994-8#1)(2008-7#1)
in a vaccine##2##3##(2008-11#1)(2012-3#1)
in a vacuum##5##3##(1994-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
in a variety of animal models##2##6##(2008-8#1)(2012-12#1)
in a variety of animal##4##5##(1992-6#1)(2008-11#1)(2008-8#1)(2012-12#1)
in a variety of applications##3##5##(1996-1#1)(2008-10#1)(2008-6#1)
in a variety of biological##2##5##(1990-11#1)(2008-10#1)
in a variety of cells##3##5##(1992-7#1)(1995-6#1)(2012-2#1)
in a variety of cellular processes##2##6##(1994-12#1)(2008-7#1)
in a variety of different##2##5##(2008-10#1)(2008-5#1)
in a variety of diseases##2##5##(2007-8#1)(2008-10#1)
in a variety of formats##2##5##(2008-1#1)(2011-3#1)
in a variety of human##4##5##(1990-11#1)(1994-10#2)(2008-8#1)
in a variety of organisms##2##5##(2008-4#1)(2012-3#1)
in a variety of other##2##5##(1997-8#1)(2011-2#1)
in a variety of settings##4##5##(1996-8#1)(2008-11#1)(2012-12#1)(2013-8#1)
in a variety of situations##3##5##(1996-3#1)(2008-9#1)(2011-2#1)
in a variety of tissues from##2##6##(1993-3#1)(1994-11#1)
in a variety of ways##10##5##(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
in a variety of##113##4##(1990-11#3)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-3#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-8#4)
in a vector##3##3##(1997-3#1)(2008-11#1)(2013-8#1)
in a vein of Galen malformation##2##6##(1996-6#2)
in a vein of##3##4##(1996-6#3)
in a vertical##2##3##(2008-6#1)(2009-5#1)
in a very small##2##4##(2008-10#1)(2012-2#1)
in a very wide##2##4##(1995-3#1)(2007-11#1)
in a very##18##3##(1990-12#1)(1990-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-3#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2012-2#1)
in a viable##2##3##(2008-11#1)(2008-7#1)
in a village##2##3##(1992-12#1)(2008-8#1)
in a viral##2##3##(1990-7#1)(1995-2#1)
in a virtual reality##2##4##(2011-7#2)
in a virtual##3##3##(2008-10#1)(2011-7#2)
in a visual##2##3##(1996-2#1)(2008-10#1)
in a vitamin C tablet##2##5##(2008-10#2)
in a volume of##2##4##(2007-12#1)(2008-10#1)
in a wall-jet##3##3##(2008-10#3)
in a water bath##2##4##(2008-10#2)
in a water maze##3##4##(1991-2#1)(1994-8#1)(1997-2#1)
in a water sample##3##4##(2008-10#3)
in a water##11##3##(1991-2#1)(1994-8#1)(1997-2#1)(2008-10#6)(2008-2#1)(2008-5#1)
in a waterworks##2##3##(2008-10#2)
in a waveguide##2##3##(2007-11#1)(2008-3#1)
in a wavelength range from##2##5##(2007-11#2)
in a wavelength range##3##4##(2007-11#2)(2008-3#1)
in a wavelength##4##3##(2007-11#2)(2008-3#2)
in a way that is##4##5##(1997-6#1)(2008-10#1)(2008-9#1)(2009-4#1)
in a way that##18##4##(1991-2#1)(1993-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)
in a way##22##3##(1991-2#1)(1993-12#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
in a weak##3##3##(1997-6#1)(2008-10#2)
in a wedge##2##3##(1990-11#1)(2007-12#1)
in a week##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
in a well##5##3##(1994-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
in a well-characterized model of##2##5##(1996-12#1)(2010-6#1)
in a wheat field##2##4##(2008-10#2)
in a wheat##8##3##(2008-10#8)
in a white-throated monitor lizard##2##5##(2011-1#2)
in a whole cell##3##4##(1990-11#1)(1991-12#1)(2008-11#1)
in a whole##5##3##(1990-11#1)(1991-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
in a wide concentration range##4##5##(2008-10#4)
in a wide range of pH##3##6##(2008-10#3)
in a wide range of##25##5##(1992-11#1)(1994-2#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
in a wide range##28##4##(1992-11#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
in a wide spectral range##2##5##(2008-3#2)
in a wide variety of applications##2##6##(1995-1#1)(2011-1#1)
in a wide variety of cell types##2##7##(1992-3#1)(1996-2#1)
in a wide variety of organisms##2##6##(2008-11#1)(2008-6#1)
in a wide variety of##26##5##(1990-2#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#2)
in a wide##65##3##(1990-2#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#1)
in a wider variety of##2##5##(2008-10#1)(2008-6#1)
in a wider##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#1)
in a wild##2##3##(2008-11#1)(2009-2#1)
in a wild-type##2##3##(2008-10#1)(2008-9#1)
in a woman aged##2##4##(1990-6#1)(1991-9#1)
in a woman with##2##4##(1990-10#1)(2013-1#1)
in a woman##6##3##(1990-10#1)(1990-6#1)(1991-9#1)(1995-11#1)(2010-12#1)(2013-1#1)
in a working memory##2##4##(1993-12#2)
in a world of##2##4##(1992-3#2)
in a world##3##3##(1992-3#2)(2011-2#1)
in a year##3##3##(1994-2#1)(2008-8#1)(2012-3#1)
in a yeast##3##3##(1995-6#1)(1997-7#1)(2008-7#1)
in a yet unidentified##2##4##(2008-10#1)(2008-5#1)
in a young adult##2##4##(1990-3#1)(2007-9#1)
in a young child##5##4##(1993-3#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)
in a young female patient##2##5##(2008-6#2)
in a young female##9##4##(2007-7#1)(2008-12#3)(2008-6#2)(2010-10#1)(2011-2#1)(2012-2#1)
in a young male##2##4##(2008-10#1)(2008-7#1)
in a young patient##5##4##(2011-2#4)(2013-1#1)
in a young woman##2##4##(1991-3#1)(1992-12#1)
in a young##36##3##(1990-3#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-3#2)(1995-12#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)
in a zigzag pattern##3##4##(2008-10#3)
in a##8622##2##(1990-10#3)(1990-11#43)(1990-12#31)(1990-2#18)(1990-3#14)(1990-4#3)(1990-5#35)(1990-6#23)(1990-7#14)(1990-8#34)(1990-9#13)(1991-1#9)(1991-10#4)(1991-11#17)(1991-12#40)(1991-2#27)(1991-3#25)(1991-4#4)(1991-5#24)(1991-6#18)(1991-7#3)(1991-8#18)(1991-9#22)(1992-1#9)(1992-10#6)(1992-11#29)(1992-12#40)(1992-2#25)(1992-3#40)(1992-4#2)(1992-5#13)(1992-6#34)(1992-7#2)(1992-8#27)(1992-9#18)(1993-1#15)(1993-10#4)(1993-11#30)(1993-12#55)(1993-2#18)(1993-3#46)(1993-5#13)(1993-6#41)(1993-8#33)(1993-9#19)(1994-1#13)(1994-10#4)(1994-11#34)(1994-12#51)(1994-2#31)(1994-3#28)(1994-5#30)(1994-6#31)(1994-7#1)(1994-8#37)(1994-9#22)(1995-1#15)(1995-10#2)(1995-11#41)(1995-12#61)(1995-2#45)(1995-3#41)(1995-4#1)(1995-5#25)(1995-6#35)(1995-8#21)(1995-9#8)(1996-1#23)(1996-10#3)(1996-11#8)(1996-12#49)(1996-2#46)(1996-3#36)(1996-4#8)(1996-5#32)(1996-6#16)(1996-7#10)(1996-8#7)(1996-9#12)(1997-1#24)(1997-2#44)(1997-3#39)(1997-4#25)(1997-5#18)(1997-6#23)(1997-7#39)(1997-8#18)(2006-10#15)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#3)(2006-8#1)(2007-10#50)(2007-11#280)(2007-12#368)(2007-2#21)(2007-4#4)(2007-5#5)(2007-6#6)(2007-7#52)(2007-8#53)(2007-9#4)(2008-1#60)(2008-10#1533)(2008-11#386)(2008-12#122)(2008-2#294)(2008-3#543)(2008-4#107)(2008-5#218)(2008-6#107)(2008-7#277)(2008-8#139)(2008-9#179)(2009-1#13)(2009-10#27)(2009-11#27)(2009-12#23)(2009-2#13)(2009-3#24)(2009-4#22)(2009-5#31)(2009-6#23)(2009-7#25)(2009-8#45)(2009-9#30)(2010-1#15)(2010-10#30)(2010-11#27)(2010-12#29)(2010-2#21)(2010-3#31)(2010-4#37)(2010-5#26)(2010-6#22)(2010-7#16)(2010-8#29)(2010-9#16)(2011-1#91)(2011-2#248)(2011-3#6)(2011-4#1)(2011-7#6)(2012-1#27)(2012-12#108)(2012-2#146)(2012-3#148)(2012-5#3)(2012-7#3)(2012-8#1)(2013-1#242)(2013-3#1)(2013-7#24)(2013-8#116)
in aMCI and AD CSF##2##5##(2011-2#2)
in abandoned groves##2##3##(2011-2#2)
in abandoned##4##2##(2011-2#4)
in abdominal obesity##2##3##(2008-3#2)
in abdominal##13##2##(1992-6#2)(1993-2#1)(1994-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#1)(2013-8#2)
in ability to##5##3##(1990-4#1)(1993-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
in ablation therapy for##2##4##(2010-12#2)
in ablation##4##2##(2008-3#1)(2010-12#2)(2013-1#1)
in abnormal##5##2##(1997-2#1)(2008-8#1)(2012-2#2)(2012-3#1)
in abortion##3##2##(1994-2#1)(1995-6#1)(2012-3#1)
in about 15##3##3##(1992-9#1)(2008-5#1)(2011-2#1)
in about 20% of patients with##2##6##(1996-5#1)(2008-1#1)
in about 20% of patients##3##5##(1996-5#1)(2008-1#1)(2008-2#1)
in about 20% of##6##4##(1995-3#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)
in about 30##2##3##(2008-10#1)(2008-4#1)
in about 30% of##2##4##(1990-10#1)(2007-10#1)
in about 30%##3##3##(1990-10#1)(2007-10#1)(2008-10#1)
in about 50% of##3##4##(1990-6#1)(2007-10#1)(2011-2#1)
in about 50%##4##3##(1990-6#1)(2007-10#1)(2011-2#2)
in about 80% of##3##4##(1990-9#1)(2008-2#1)(2008-8#1)
in about a##2##3##(2008-6#1)(2009-4#1)
in about half of##2##4##(2008-7#1)(2010-5#1)
in about half the patients##2##5##(2008-6#1)(2012-2#1)
in about half the##3##4##(2008-6#1)(2008-9#1)(2012-2#1)
in about half##5##3##(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
in about one##2##3##(2008-10#1)(2008-8#1)
in about one-third of##2##4##(1994-8#1)(2012-12#1)
in about##57##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-9#1)(1991-6#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
in absence of any##2##4##(1991-8#1)(2013-8#1)
in absence of the##2##4##(2008-6#1)(2012-2#1)
in absence of##12##3##(1991-8#1)(1997-8#1)(2008-10#3)(2008-6#1)(2011-2#4)(2012-2#1)(2013-8#1)
in absence##13##2##(1991-8#1)(1997-8#1)(2008-10#4)(2008-6#1)(2011-2#4)(2012-2#1)(2013-8#1)
in absolute ethanol##2##3##(2007-11#1)(2010-6#1)
in absolute numbers and as a proportion of##2##8##(2007-7#1)(2008-7#1)
in absolute numbers##4##3##(1991-3#1)(2007-7#1)(2008-10#1)(2008-7#1)
in absolute terms##2##3##(1996-2#1)(2008-10#1)
in absolute##15##2##(1991-3#1)(1996-2#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)(2013-1#1)
in absorbance at##5##3##(1992-8#1)(2008-10#3)(2008-11#1)
in absorbance measurements##3##3##(2008-10#2)(2008-3#1)
in absorbance of the##4##4##(2008-10#4)
in absorbance of##13##3##(2008-10#13)
in absorbance##31##2##(1992-8#1)(2008-10#26)(2008-11#1)(2008-3#3)
in absorption coefficient##2##3##(2007-11#1)(2008-3#1)
in absorption spectrum##2##3##(2008-10#1)(2008-2#1)
in absorption##9##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)
in abstract##2##2##(1990-5#1)(2012-1#1)
in abundance##9##2##(1990-2#1)(1993-6#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-7#1)
in academia##3##2##(2008-11#2)(2009-3#1)
in academic medicine##4##3##(2007-4#1)(2009-7#1)(2012-3#2)
in academic##20##2##(1993-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(2007-4#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-7#4)(2010-8#1)(2012-3#2)
in accelerated##3##2##(2008-10#3)
in accelerating##2##2##(1994-5#1)(2013-8#1)
in acceleration##2##2##(2008-12#1)(2013-1#1)
in acceptable##2##2##(2007-10#1)(2008-6#1)
in access to##5##3##(1994-12#1)(1995-12#2)(2008-4#1)(2011-1#1)
in access##8##2##(1992-2#1)(1994-12#1)(1995-12#2)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)
in accessing and utilising##2##4##(2008-11#1)(2013-8#1)
in accessing##6##2##(1992-3#1)(2008-11#3)(2008-12#1)(2013-8#1)
in accident##2##2##(1991-3#1)(2013-1#1)
in accidents at##2##3##(1995-8#2)
in accommodating##2##2##(2007-3#1)(2008-11#1)
in accord with a##2##4##(2007-12#1)(2009-5#1)
in accord with the##6##4##(1991-9#3)(2008-3#2)(2008-9#1)
in accord with##19##3##(1991-6#1)(1991-9#4)(1992-6#2)(1994-2#1)(1994-8#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)
in accordance to the##2##4##(2007-7#1)(2008-11#1)
in accordance to##5##3##(2007-7#1)(2007-8#2)(2008-11#1)(2012-3#1)
in accordance with a##5##4##(1995-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)
in accordance with previous studies##2##5##(2008-4#1)(2008-7#1)
in accordance with the ISO##2##5##(2008-10#1)(2008-12#1)
in accordance with the##35##4##(1993-6#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
in accordance with toxicokinetics##2##4##(1995-3#2)
in accordance with##71##3##(1990-3#1)(1990-5#1)(1993-6#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
in accordance##76##2##(1990-3#1)(1990-5#1)(1993-6#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
in account the##2##3##(2008-10#1)(2009-10#1)
in account##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)
in accounting for##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
in accreditation##3##2##(1993-1#1)(1995-3#1)(2012-2#1)
in accumulation of##5##3##(1994-5#1)(1997-7#1)(2008-10#2)(2012-3#1)
in accumulation##6##2##(1994-5#1)(1997-7#1)(2008-10#2)(2008-12#1)(2012-3#1)
in accuracy##8##2##(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
in acetabular cup##2##3##(2008-5#1)(2008-8#1)
in acetate buffer (0##2##4##(2008-10#2)
in acetate buffer at pH 4##2##6##(2008-10#2)
in acetate buffer at pH##3##5##(2008-10#3)
in acetate buffer at##4##4##(2008-10#4)
in acetate buffer##12##3##(2008-10#12)
in acetate##13##2##(2008-10#12)(2008-7#1)
in acetic acid##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
in acetic##9##2##(2007-12#1)(2008-10#5)(2008-6#1)(2012-12#1)(2013-7#1)
in acetone for 6 months##2##5##(2008-9#2)
in acetone##26##2##(1990-5#1)(1992-2#1)(1996-2#1)(2008-10#5)(2008-5#1)(2008-9#17)
in acetonitrile with##4##3##(1995-6#1)(1996-2#1)(2013-1#2)
in acetonitrile##15##2##(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#8)(2011-1#1)(2013-1#2)
in acetonitrile-water mixtures##2##3##(2008-10#2)
in acetonitrile-water##3##2##(2008-10#3)
in acetonitrile/water##2##2##(2007-12#1)(2008-10#1)
in acetylcholine##6##2##(1992-6#1)(1994-8#2)(2008-8#2)(2009-11#1)
in achieving the##6##3##(1995-2#1)(2007-9#1)(2008-12#1)(2009-12#2)(2011-2#1)
in achieving this goal##2##4##(1994-11#1)(2010-3#1)
in achieving##22##2##(1992-1#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in achondroplastic##2##2##(2007-8#1)(2011-1#1)
in acid media##2##3##(2008-10#2)
in acid medium##4##3##(2008-10#4)
in acid mine drainage##2##4##(2008-10#2)
in acid##20##2##(1994-11#1)(1996-5#1)(2008-10#17)(2008-9#1)
in acid-base equilibria##2##3##(2008-10#2)
in acid-base##4##2##(1993-8#1)(2007-12#1)(2008-10#2)
in acid-digested##3##2##(2008-10#3)
in acidic and##2##3##(2008-10#2)
in acidic conditions##2##3##(1995-8#1)(2012-2#1)
in acidic media##11##3##(2008-10#8)(2010-3#1)(2010-6#1)(2012-2#1)
in acidic medium to form##5##5##(2008-10#5)
in acidic medium was##2##4##(2008-10#2)
in acidic medium##21##3##(2008-10#21)
in acidic solution##5##3##(2008-10#5)
in acidic solutions##2##3##(2008-10#2)
in acidic##49##2##(1990-2#1)(1990-9#1)(1992-7#1)(1994-2#1)(1995-6#1)(1995-8#1)(2008-10#39)(2010-3#1)(2010-6#1)(2012-2#2)
in acidified soil##2##3##(2008-10#2)
in acidified##4##2##(1990-12#1)(2008-10#3)
in acini and chief cells##2##5##(1994-8#2)
in acini##3##2##(1994-8#2)(1995-11#1)
in acne vulgaris##3##3##(2007-7#3)
in acne##7##2##(1993-2#1)(2007-7#4)(2008-10#1)(2011-1#1)
in acoustic##4##2##(2007-12#1)(2008-9#1)(2009-5#1)(2013-7#1)
in acquired##2##2##(1997-8#1)(2012-12#1)
in acquisition of##2##3##(1993-5#1)(1995-8#1)
in acquisition##6##2##(1992-12#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(2008-10#1)
in acromegalic patients##4##3##(2013-1#4)
in acromegaly##3##2##(2008-4#1)(2009-2#1)(2011-1#1)
in acrylic##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
in action potential##2##3##(2008-11#1)(2008-8#1)
in action potentials##2##3##(1993-9#1)(2008-11#1)
in action##14##2##(1993-9#1)(1995-3#1)(1996-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-2#1)
in activated B cells##2##4##(1995-6#2)
in activated lymphocytes##2##3##(2008-4#1)(2008-7#1)
in activated microglia##2##3##(2008-8#1)(2009-12#1)
in activated platelets##2##3##(1997-7#1)(2006-6#1)
in activated##12##2##(1990-12#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-6#2)(1997-7#1)(2006-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)
in activating##9##2##(1990-5#1)(1991-9#1)(1995-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-8#1)(2013-1#1)
in activation of cellular##2##4##(1993-3#1)(2012-3#1)
in activation of the##3##4##(1990-5#1)(1995-6#1)(2008-6#1)
in activation of##12##3##(1990-5#1)(1993-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(2008-6#1)(2010-11#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
in activation##18##2##(1990-5#1)(1991-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in active children##2##3##(2007-12#1)(2010-7#1)
in active##23##2##(1991-1#2)(1994-11#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)
in active-matrix##2##2##(2008-7#2)
in actively##3##2##(1993-11#1)(2007-7#1)(2008-1#1)
in activities of daily living and##2##6##(1991-12#1)(2013-1#1)
in activities of daily living##4##5##(1991-12#1)(1993-3#1)(2008-7#1)(2013-1#1)
in activities of##5##3##(1991-12#1)(1993-3#1)(2008-7#1)(2013-1#2)
in activities##16##2##(1991-12#2)(1992-1#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-12#1)(2010-10#2)(2012-2#1)(2013-1#2)
in activity for##2##3##(1995-11#1)(2008-10#1)
in activity is##2##3##(1991-12#1)(2008-10#1)
in activity levels##2##3##(2008-6#1)(2009-9#1)
in activity of##5##3##(1993-11#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
in activity##32##2##(1991-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
in activity-dependent##2##2##(2008-1#1)(2009-8#1)
in actual sample##2##3##(2008-10#2)
in actual samples##2##3##(2008-10#2)
in actual use##2##3##(2008-3#1)(2008-5#1)
in actual##15##2##(1992-2#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
in actuality##2##2##(2009-9#1)(2012-2#1)
in acupuncture##3##2##(2008-10#2)(2012-3#1)
in acute KD##2##3##(2011-2#2)
in acute and chronic##6##4##(1992-6#1)(1994-11#1)(2006-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
in acute and##9##3##(1992-6#1)(1994-11#1)(1995-11#1)(2006-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
in acute bacterial##2##3##(1994-2#1)(2007-5#1)
in acute carbon monoxide poisoning##2##5##(1990-5#1)(2009-11#1)
in acute care hospitals##5##4##(1992-2#1)(1997-1#1)(2008-11#1)(2010-10#1)(2010-8#1)
in acute care##12##3##(1991-12#1)(1992-1#1)(1992-2#1)(1997-1#1)(2008-11#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-3#1)
in acute coronary syndrome##2##4##(2008-7#1)(2010-5#1)
in acute coronary syndromes##6##4##(2008-3#2)(2008-4#1)(2010-3#1)(2011-2#2)
in acute coronary##12##3##(2008-10#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
in acute exacerbations of chronic##2##5##(1996-11#1)(2007-12#1)
in acute exacerbations##3##3##(1996-11#1)(2007-12#1)(2011-2#1)
in acute hepatic##2##3##(1997-2#1)(2008-9#1)
in acute hospital stroke units##2##5##(2011-1#2)
in acute intermittent porphyria##2##4##(1990-2#1)(1991-2#1)
in acute intracerebral##2##3##(2008-7#2)
in acute ischemic stroke##9##4##(2007-10#6)(2008-8#1)(2009-11#1)(2012-12#1)
in acute leukemia and##2##4##(1991-9#1)(1997-7#1)
in acute leukemia##8##3##(1991-2#1)(1991-9#1)(1997-7#1)(2007-2#2)(2008-9#2)(2011-2#1)
in acute myeloid##4##3##(2007-10#1)(2010-4#1)(2011-2#1)(2011-3#1)
in acute myocardial infarct##2##4##(1990-12#1)(1992-5#1)
in acute myocardial infarction##11##4##(1993-12#3)(1995-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-7#1)(2011-2#1)(2012-3#1)
in acute myocardial##15##3##(1990-12#1)(1992-5#1)(1993-12#3)(1994-6#1)(1995-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-7#1)(2011-2#1)(2012-3#1)
in acute pancreatitis##8##3##(2008-5#2)(2013-1#6)
in acute pulmonary embolism##2##4##(2011-2#2)
in acute pulmonary##3##3##(1991-11#1)(2011-2#2)
in acute respiratory##2##3##(1992-2#1)(2007-11#1)
in acute stroke and##2##4##(2007-10#1)(2008-8#1)
in acute stroke units##2##4##(2011-1#2)
in acute stroke##16##3##(1996-3#1)(2007-10#7)(2007-9#1)(2008-8#4)(2009-11#1)(2011-1#2)
in acute studies##2##3##(1995-12#2)
in acute ward##2##3##(2008-11#1)(2011-1#1)
in acute##166##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#15)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#9)(2008-8#5)(2008-9#3)(2009-11#4)(2009-5#2)(2009-7#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
in acutely hospitalized##2##3##(2008-6#1)(2011-2#1)
in acutely##4##2##(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)
in adaptation to##5##3##(1993-1#1)(1994-11#1)(2008-10#1)(2012-6#1)(2013-8#1)
in adaptation##6##2##(1991-2#1)(1993-1#1)(1994-11#1)(2008-10#1)(2012-6#1)(2013-8#1)
in adapting to##2##3##(1992-2#1)(1993-12#1)
in adapting##4##2##(1992-2#1)(1993-12#1)(2012-2#2)
in adaptive designs##2##3##(2012-2#2)
in adaptive optics##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
in adaptive##9##2##(1995-2#1)(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#2)
in addicted##2##2##(1996-5#1)(2007-7#1)
in addiction##2##2##(2009-10#1)(2009-7#1)
in adding the##3##3##(2008-11#3)
in adding##8##2##(1990-12#1)(2008-11#6)(2009-6#1)
in addition also##2##3##(1990-8#1)(2008-5#1)
in addition the##2##3##(1997-4#1)(2008-10#1)
in addition to a##6##4##(1990-2#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
in addition to an##2##4##(1991-2#1)(2008-10#1)
in addition to conventional##3##4##(2008-5#1)(2009-11#1)(2011-1#1)
in addition to diabetes##2##4##(1994-6#1)(2008-9#1)
in addition to infectious##2##4##(1990-6#1)(1997-8#1)
in addition to its role in##2##6##(1997-6#1)(2008-10#1)
in addition to its##7##4##(1993-8#1)(1997-6#2)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
in addition to other##6##4##(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
in addition to preventing##3##4##(2007-2#1)(2008-10#1)(2009-11#1)
in addition to providing##2##4##(2008-9#1)(2009-11#1)
in addition to that of##2##5##(1991-7#1)(2008-10#1)
in addition to that##3##4##(1991-7#1)(2008-10#1)(2010-4#1)
in addition to the common analytical methods##2##7##(2008-10#2)
in addition to the common##3##5##(1991-6#1)(2008-10#2)
in addition to the direct##2##5##(2008-2#1)(2008-3#1)
in addition to the effects of##2##6##(1990-8#1)(2008-8#1)
in addition to the fact that##2##6##(2008-10#1)(2008-11#1)
in addition to the presence of##2##6##(1996-12#1)(2010-10#1)
in addition to the previously##4##5##(1992-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
in addition to the specific##2##5##(1991-2#1)(2008-5#1)
in addition to the##86##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)
in addition to their##9##4##(1992-8#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-1#1)(2011-1#2)(2012-12#1)
in addition to those##3##4##(1990-8#1)(2008-5#1)(2012-3#1)
in addition to##282##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#34)(2008-11#10)(2008-12#5)(2008-2#9)(2008-3#12)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#8)(2009-1#1)(2009-11#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#3)
in addition##327##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#2)(1991-2#5)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#42)(2008-11#12)(2008-12#5)(2008-2#9)(2008-3#15)(2008-4#5)(2008-5#12)(2008-6#4)(2008-7#12)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#10)(2013-8#4)
in additional##5##2##(1990-12#1)(1990-5#1)(1996-6#1)(2010-7#1)(2011-2#1)
in additive##2##2##(2008-10#1)(2013-8#1)
in addressing NCDs##2##3##(2012-12#1)(2013-8#1)
in addressing the##5##3##(1991-3#1)(1993-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
in addressing##15##2##(1991-3#1)(1993-3#1)(1996-12#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
in adduct levels##2##3##(1994-2#1)(2008-12#1)
in adduct##3##2##(1994-2#1)(1995-6#1)(2008-12#1)
in adefovir refractory patients##2##4##(2013-1#2)
in adenoma tissues##3##3##(2010-12#3)
in adenoma##4##2##(2010-12#4)
in adenomas##2##2##(2008-1#2)
in adenomatous##2##2##(1990-10#1)(1990-3#1)
in adenosine##3##2##(1994-6#1)(2008-4#1)(2009-8#1)
in adenylyl cyclase##2##3##(1995-6#1)(2008-4#1)
in adequate amounts##3##3##(1995-8#1)(2011-2#1)(2013-8#1)
in adequate##6##2##(1995-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
in adherence##2##2##(1992-12#1)(2013-8#1)
in adherent cells##2##3##(2010-10#1)(2010-11#1)
in adherent cultures##2##3##(1991-6#1)(2008-11#1)
in adherent##7##2##(1991-6#1)(1991-7#1)(1994-6#1)(2008-11#1)(2010-10#1)(2010-11#1)(2011-2#1)
in adhesion##6##2##(1992-12#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-11#1)(2012-2#1)
in adipocytes##5##2##(1993-6#1)(1994-6#2)(2008-5#2)
in adipogenesis##2##2##(2008-11#1)(2008-3#1)
in adiponectin##3##2##(2011-1#2)(2013-1#1)
in adipose tissue##12##3##(1993-6#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)(2012-2#2)(2012-8#2)(2013-1#1)
in adipose##14##2##(1990-11#1)(1993-6#2)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)(2012-2#2)(2012-8#2)(2013-1#1)
in adjacent neurons##2##3##(2008-4#2)
in adjacent##10##2##(1991-2#1)(1992-11#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2012-12#1)
in adjusting##2##2##(2008-11#1)(2008-7#1)
in adjuvant##4##2##(1991-6#1)(1993-3#1)(2009-5#1)(2013-8#1)
in adjuvant-arthritic rats##2##3##(1995-3#2)
in administering##3##2##(1993-6#1)(2010-7#1)(2011-2#1)
in administration##2##2##(2008-11#1)(2011-2#1)
in administrative##3##2##(1994-3#1)(1996-3#1)(2010-8#1)
in admission##2##2##(1990-9#1)(1995-9#1)
in admissions##3##2##(1992-1#1)(1992-2#1)(1993-12#1)
in admitted##2##2##(2013-1#2)
in adolescence and##3##3##(1993-9#1)(2008-11#1)(2013-1#1)
in adolescence##20##2##(1993-9#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-9#2)(2009-5#1)(2009-7#5)(2009-8#1)(2012-2#1)(2013-1#2)
in adolescent and##2##3##(2011-1#1)(2012-12#1)
in adolescent girls##2##3##(2007-12#1)(2008-4#1)
in adolescent health##3##3##(2008-8#3)
in adolescent##18##2##(1991-1#1)(1995-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#3)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#2)
in adolescents and adults##4##4##(2007-8#3)(2013-8#1)
in adolescents and young adults##4##5##(2008-6#3)(2013-1#1)
in adolescents and##10##3##(2007-8#3)(2008-6#3)(2008-8#1)(2013-1#2)(2013-8#1)
in adolescents attending##2##3##(2011-2#1)(2012-12#1)
in adolescents from##2##3##(2010-9#1)(2013-1#1)
in adolescents with a##2##4##(2008-4#1)(2009-3#1)
in adolescents with low SES##2##5##(2011-1#2)
in adolescents with schizophrenia##2##4##(2011-2#2)
in adolescents with##11##3##(2008-4#2)(2009-11#1)(2009-3#1)(2011-1#4)(2011-2#2)(2012-2#1)
in adolescents##46##2##(1992-1#1)(1993-3#1)(1994-2#1)(1996-6#1)(1997-5#2)(2007-8#3)(2008-10#1)(2008-4#2)(2008-6#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-9#1)(2011-1#8)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#2)
in adolescents'##7##2##(2009-7#4)(2009-9#1)(2010-7#2)
in adolescents?##3##2##(2008-8#1)(2009-7#1)(2011-2#1)
in adopting##3##2##(2010-8#2)(2012-2#1)
in adrenal cortex##2##3##(1990-11#1)(1996-2#1)
in adrenal##8##2##(1990-11#2)(1991-3#1)(1992-6#1)(1994-6#1)(1996-2#1)(1996-5#1)(2008-7#1)
in adrenalectomized##3##2##(1990-12#2)(1990-5#1)
in adrenoleukodystrophy##2##2##(1993-3#1)(1995-2#1)
in adriamycin##3##2##(1990-2#1)(1993-12#1)(2008-7#1)
in adult and##2##3##(1994-3#1)(2013-7#1)
in adult animals and##2##4##(1994-12#1)(2008-4#1)
in adult animals##4##3##(1994-12#1)(2008-4#3)
in adult cardiac surgical patients##2##5##(2007-9#1)(2008-12#1)
in adult cardiac##3##3##(2007-9#2)(2008-12#1)
in adult cardiomyocytes##2##3##(1994-6#1)(2008-7#1)
in adult cochlear implant users##2##5##(2008-9#2)
in adult cochlear implant##4##4##(2008-9#4)
in adult human##4##3##(1994-2#2)(2008-9#1)(2010-8#1)
in adult life##9##3##(1995-12#4)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
in adult male albino##2##4##(1993-5#1)(2008-10#1)
in adult male##5##3##(1993-5#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-11#1)
in adult males##2##3##(2008-7#1)(2008-9#1)
in adult mammals##2##3##(1995-11#1)(2012-12#1)
in adult mice##2##3##(1993-3#1)(2008-10#1)
in adult mouse urine##2##4##(1990-12#2)
in adult or##2##3##(1992-10#1)(2008-11#1)
in adult pancreas##2##3##(2013-7#2)
in adult patients with cochlear implants##2##6##(2008-9#2)
in adult patients with##8##4##(2007-6#1)(2008-6#2)(2008-9#2)(2011-2#1)(2012-1#1)(2012-3#1)
in adult patients##15##3##(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-9#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
in adult plants##3##3##(2008-10#3)
in adult population##2##3##(2008-11#1)(2012-12#1)
in adult psychiatry##2##3##(2010-5#1)(2012-12#1)
in adult rat##3##3##(1995-5#1)(1996-12#2)
in adult rats##13##3##(1991-12#1)(1992-12#2)(1994-2#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-2#2)(2007-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
in adult respiratory distress syndrome##2##5##(1991-9#1)(1993-2#1)
in adult stem cell lineages##2##5##(2009-3#2)
in adult subjects##2##3##(2008-5#1)(2008-6#1)
in adult tissues##4##3##(1992-9#1)(1993-8#1)(1997-7#1)(2008-6#1)
in adult visual cortex##3##4##(1994-8#3)
in adult zebrafish##2##3##(2008-10#1)(2008-7#1)
in adult##170##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#2)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#11)(2009-10#1)(2009-3#2)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#7)(2013-1#3)(2013-7#5)(2013-8#1)
in adult-onset##2##2##(2006-10#1)(2008-3#1)
in adulthood and senescence##2##4##(1994-6#2)
in adulthood and##3##3##(1994-6#2)(1997-8#1)
in adulthood##41##2##(1992-2#3)(1993-3#2)(1994-6#2)(1994-8#1)(1995-11#1)(1996-5#3)(1997-8#4)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-10#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#5)
in adults and adolescents##2##4##(2008-7#1)(2013-8#1)
in adults and children##8##4##(1996-2#1)(1996-7#1)(2007-11#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-2#1)
in adults and##21##3##(1994-3#1)(1996-2#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#2)
in adults as a##2##4##(2009-4#1)(2012-2#1)
in adults as##3##3##(1992-9#1)(2009-4#1)(2012-2#1)
in adults have##2##3##(2008-9#1)(2010-5#1)
in adults in##9##3##(1991-11#1)(2007-8#1)(2008-1#3)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
in adults is##5##3##(1991-11#1)(1996-11#2)(1997-8#1)(2013-7#1)
in adults with attention-deficit/hyperactivity disorder##2##5##(2008-2#1)(2011-2#1)
in adults with##31##3##(1991-8#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
in adults##170##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-9#1)(1994-3#1)(1996-11#4)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#7)(2008-10#5)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#9)(2009-1#1)(2009-10#1)(2009-4#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#4)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#10)(2013-7#8)(2013-8#4)
in adults]##3##2##(1994-12#1)(1996-11#1)(1997-8#1)
in advance of the##3##4##(2008-10#3)
in advance of##4##3##(2008-10#3)(2008-7#1)
in advance##19##2##(1991-1#1)(1991-12#1)(1995-6#1)(1996-4#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#3)
in advanced breast cancer##2##4##(1991-6#1)(1994-8#1)
in advanced breast##3##3##(1991-6#1)(1994-8#1)(2007-10#1)
in advanced cancer patients##3##4##(1992-10#1)(2010-2#2)
in advanced cancer##5##3##(1992-10#1)(2008-7#2)(2010-2#2)
in advanced colorectal cancer##2##4##(1990-8#1)(1992-2#1)
in advanced colorectal##3##3##(1990-8#1)(1992-2#1)(2008-5#1)
in advanced malignant melanoma##2##4##(1991-6#1)(1993-6#1)
in advanced prostate##2##3##(1990-2#1)(2010-10#1)
in advanced stages of##3##4##(1993-9#1)(1997-6#1)(2008-5#1)
in advanced stages##4##3##(1993-9#1)(1997-6#1)(2008-5#2)
in advanced##53##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-8#1)(1991-6#2)(1992-10#2)(1992-2#2)(1992-8#2)(1993-1#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-10#1)(1997-6#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#5)(2009-10#2)(2009-12#1)(2010-10#2)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
in advancing the##2##3##(2008-11#1)(2012-3#1)
in advising patients##2##3##(2011-1#1)(2011-2#1)
in advising##4##2##(1993-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
in advocacy##2##2##(2007-5#1)(2012-12#1)
in advocating##2##2##(2008-8#1)(2012-12#1)
in aerated##2##2##(2008-10#2)
in aerobic##4##2##(2007-3#1)(2007-7#1)(2013-1#1)(2013-8#1)
in aerosol by##2##3##(2008-10#2)
in aerosol studies##2##3##(1994-1#2)
in aerosol##16##2##(1992-3#1)(1994-1#3)(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)
in aerosols##6##2##(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
in affected individuals##3##3##(1990-12#1)(1994-8#1)(2013-8#1)
in affected##16##2##(1990-12#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-5#2)(2008-11#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in affecting##5##2##(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
in affective##2##2##(2012-2#1)(2013-8#1)
in affinity chromatography##2##3##(2008-10#1)(2008-4#1)
in affinity for##2##3##(1995-2#1)(1995-5#1)
in affinity##12##2##(1993-11#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-4#2)
in aflatoxin##2##2##(2008-10#2)
in agar##9##2##(1990-6#1)(1994-6#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2012-2#1)
in agarose gel electrophoresis##3##4##(1991-5#1)(2008-10#2)
in agarose gel##4##3##(1991-5#1)(2008-10#3)
in agarose##7##2##(1991-5#1)(1995-2#1)(2008-10#3)(2008-4#2)
in age between##2##3##(2008-1#1)(2008-4#1)
in age from##15##3##(1990-2#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-8#3)(2008-11#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#1)
in age group##2##3##(2007-7#1)(2008-11#1)
in age groups##2##3##(1996-9#1)(2007-12#1)
in age of##3##3##(1990-9#1)(2009-7#1)(2013-1#1)
in age##36##2##(1990-12#1)(1990-2#1)(1990-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-5#1)(2013-1#2)
in age-matched##4##2##(1995-5#1)(2007-8#1)(2008-10#2)
in age-related##4##2##(2008-7#1)(2009-9#1)(2012-2#1)(2012-3#1)
in aged animals##2##3##(2009-12#1)(2013-7#1)
in aged brains##2##3##(1990-5#2)
in aged care##4##3##(2010-10#2)(2011-1#1)(2013-1#1)
in aged humans and rats##3##5##(2008-7#3)
in aged individuals##2##3##(1994-5#1)(2009-1#1)
in aged mice##2##3##(2008-3#2)
in aged people##3##3##(2007-11#2)(2013-1#1)
in aged rat brain##3##4##(1990-5#1)(2009-12#2)
in aged rat##4##3##(1990-5#1)(2009-12#2)(2009-5#1)
in aged rats##10##3##(1993-12#2)(1994-8#1)(1995-8#1)(1997-2#1)(2008-7#1)(2009-5#1)(2012-1#3)
in aged##47##2##(1990-5#3)(1993-12#3)(1994-11#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#6)(2009-1#1)(2009-12#3)(2009-5#2)(2009-8#1)(2010-10#2)(2010-12#1)(2011-1#1)(2012-1#3)(2013-1#2)(2013-7#1)
in aged-care##3##2##(2010-10#3)
in ageing##5##2##(1996-5#1)(2008-7#1)(2012-2#1)(2013-7#2)
in aggregate##3##2##(1992-2#1)(2008-9#1)(2012-1#1)
in aggression##2##2##(2008-10#1)(2009-4#1)
in aggressive PCa##2##3##(2013-1#2)
in aggressive##9##2##(2007-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
in aggressiveness between##2##3##(2008-10#2)
in aggressiveness##10##2##(2008-10#10)
in aging human skeletal muscles##2##5##(1994-11#1)(2009-12#1)
in aging mice##3##3##(1994-5#1)(2013-7#2)
in aging research##2##3##(2008-7#1)(2009-5#1)
in aging##24##2##(1991-12#1)(1992-5#1)(1994-11#3)(1994-5#2)(1994-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-6#1)(2012-2#1)(2013-7#2)
in agitated##3##2##(1994-3#1)(2008-11#2)
in agonist##5##2##(1991-12#1)(1993-3#1)(2008-3#2)(2013-8#1)
in agreement at the 95% confidence level##4##7##(2008-10#4)
in agreement at##6##3##(2008-10#6)
in agreement with a##7##4##(1990-12#1)(1990-7#1)(1991-9#1)(1995-3#1)(1995-5#1)(2008-10#2)
in agreement with certified values of standard reference materials##2##9##(2008-10#2)
in agreement with certified values##3##5##(2008-10#3)
in agreement with certified##4##4##(2008-10#4)
in agreement with earlier##3##4##(1996-2#1)(2008-7#1)(2008-8#1)
in agreement with experimental data##2##5##(2007-12#1)(2008-2#1)
in agreement with experimental##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
in agreement with other##2##4##(2008-12#1)(2008-2#1)
in agreement with our##2##4##(1990-5#1)(1995-6#1)
in agreement with previous studies##2##5##(2008-10#1)(2009-8#1)
in agreement with previous work##2##5##(1996-12#1)(2008-10#1)
in agreement with previous##10##4##(1992-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-11#1)
in agreement with that##3##4##(2008-10#3)
in agreement with the certified ones##2##6##(2008-10#2)
in agreement with the certified value of##2##7##(2008-10#2)
in agreement with the certified values##2##6##(2008-10#2)
in agreement with the certified##7##5##(2008-10#7)
in agreement with the literature##2##5##(1990-3#1)(1993-3#1)
in agreement with the predicted##2##5##(2008-3#1)(2008-7#1)
in agreement with the results##2##5##(2008-2#1)(2013-1#1)
in agreement with the##40##4##(1990-3#1)(1991-5#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#20)(2008-2#2)(2008-3#3)(2008-7#1)(2013-1#2)
in agreement with theoretical predictions##2##5##(2007-11#1)(2007-12#1)
in agreement with theoretical##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
in agreement with those obtained by a##3##7##(2008-10#3)
in agreement with those obtained by##9##6##(2008-10#9)
in agreement with those obtained##12##5##(2008-10#11)(2008-5#1)
in agreement with those##18##4##(1992-1#1)(2008-10#16)(2008-5#1)
in agreement with##129##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-8#2)(2008-10#57)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2013-1#2)(2013-8#2)
in agreement##140##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-8#2)(2008-10#65)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-6#1)(2013-1#2)(2013-8#2)
in agricultural fields##3##3##(2008-10#3)
in agricultural practices##2##3##(2008-10#1)(2008-11#1)
in agricultural production##2##3##(2008-10#2)
in agricultural soils##2##3##(2008-10#2)
in agricultural systems##2##3##(2008-10#1)(2008-8#1)
in agricultural workers##2##3##(2008-11#1)(2008-12#1)
in agricultural##21##2##(1992-11#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
in agriculture is##2##3##(2008-11#1)(2008-12#1)
in agriculture##21##2##(1990-6#1)(1995-11#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-7#2)(2012-3#1)(2013-1#2)
in agroecosystems##2##2##(2008-10#1)(2008-6#1)
in aiding##2##2##(2011-2#1)(2012-2#1)
in air and in##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
in air and##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
in air are##2##3##(2008-3#2)
in air at atmospheric pressure##2##5##(2008-2#2)
in air at##6##3##(2008-10#2)(2008-2#2)(2012-2#2)
in air by using##2##4##(2008-10#2)
in air by##4##3##(2007-12#1)(2008-10#3)
in air has##2##3##(2007-11#1)(2012-7#1)
in air of##2##3##(2008-10#1)(2012-2#1)
in air samples were##2##4##(2008-10#2)
in air samples##8##3##(1992-3#1)(2008-10#7)
in air was##4##3##(2008-10#3)(2012-2#1)
in air with##3##3##(2007-11#1)(2008-10#2)
in air within the##2##4##(2008-10#1)(2012-2#1)
in air##90##2##(1992-3#1)(1996-2#1)(2007-11#6)(2007-12#9)(2008-10#44)(2008-2#9)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2012-2#5)(2012-7#1)(2013-1#2)
in air-silica microstructure fiber##3##4##(2007-11#3)
in airborne particles##2##3##(1997-2#1)(2008-10#1)
in airborne particulate matter##7##4##(2008-10#7)
in airborne particulate##8##3##(2008-10#8)
in airborne##14##2##(1997-2#1)(2008-10#12)(2008-2#1)
in aircraft##3##2##(1996-12#2)(2007-2#1)
in airlift reactors##2##3##(2008-7#2)
in airport##2##2##(2007-2#1)(2008-10#1)
in airway epithelium##3##3##(1994-6#1)(1995-11#1)(2008-4#1)
in airway##13##2##(1991-11#1)(1992-2#1)(1994-11#1)(1994-6#1)(1995-11#1)(1997-1#2)(1997-4#1)(1997-7#1)(2007-2#1)(2008-4#1)(2012-1#1)(2012-3#1)
in airways##2##2##(1992-3#1)(1994-12#1)
in albino rats##4##3##(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)
in albumin##3##2##(1991-12#1)(2008-1#1)(2008-7#1)
in alcohol dependence##3##3##(1995-11#1)(2008-2#1)(2012-2#1)
in alcohol##16##2##(1990-2#2)(1993-12#1)(1994-8#1)(1995-11#1)(1997-4#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
in alcohol-dependent##2##2##(2008-2#2)
in alcoholic beverages##5##3##(2008-10#4)(2008-8#1)
in alcoholic liver disease##2##4##(1993-12#1)(2006-10#1)
in alcoholic liver##4##3##(1993-12#1)(1994-7#2)(2006-10#1)
in alcoholic##15##2##(1991-12#1)(1993-12#1)(1994-7#3)(1996-11#1)(2006-10#1)(2008-10#6)(2008-8#1)(2011-2#1)
in alcoholics##2##2##(2008-11#1)(2008-6#1)
in alcoholism##9##2##(1993-12#2)(1994-2#1)(1996-7#1)(2008-11#1)(2008-2#4)
in alcoholism]##2##2##(1992-9#1)(1994-3#1)
in alfalfa##15##2##(2008-10#9)(2008-5#3)(2008-8#2)(2011-2#1)
in alga samples##2##3##(2008-10#2)
in algae##6##2##(2008-10#2)(2012-1#1)(2012-2#3)
in alginate##2##2##(2008-10#1)(2012-2#1)
in alignment##2##2##(1995-12#1)(2011-2#1)
in aliphatic##2##2##(2008-10#1)(2008-11#1)
in alkali solution##2##3##(2008-10#1)(2008-9#1)
in alkali##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
in alkaline conditions##2##3##(1995-8#1)(2008-10#1)
in alkaline media##5##3##(2008-10#5)
in alkaline medium has been##2##5##(2008-10#2)
in alkaline medium##14##3##(2008-10#14)
in alkaline phosphatase activity##3##4##(2008-11#2)(2013-1#1)
in alkaline phosphatase##4##3##(1990-6#1)(2008-11#2)(2013-1#1)
in alkaline solution to##2##4##(2008-10#2)
in alkaline solution##7##3##(1995-6#1)(2008-10#6)
in alkaline solutions##2##3##(2008-10#2)
in alkaline##38##2##(1990-6#1)(1995-6#1)(1995-8#1)(2008-10#32)(2008-11#2)(2013-1#1)
in all 10##3##3##(1991-1#1)(1991-9#1)(2011-2#1)
in all 11##2##3##(2008-10#1)(2013-1#1)
in all 15##2##3##(2008-10#1)(2010-12#1)
in all 24##2##3##(2008-7#2)
in all 3##4##3##(1992-8#1)(1996-11#1)(2008-10#1)(2009-3#1)
in all 30##2##3##(2007-8#1)(2008-5#1)
in all 5##5##3##(1991-8#1)(1994-11#1)(2008-1#1)(2008-7#1)(2010-6#1)
in all 9##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
in all adult patients##2##4##(1991-2#1)(2008-5#1)
in all adult##3##3##(1991-2#1)(1993-6#1)(2008-5#1)
in all age groups##6##4##(1991-12#1)(1996-5#1)(1996-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
in all age##7##3##(1991-12#1)(1996-5#1)(1996-9#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
in all analyzed patients##2##4##(2011-2#2)
in all analyzed##3##3##(2011-2#2)(2013-1#1)
in all animals##4##3##(1995-11#2)(2008-12#1)(2013-1#1)
in all areas of the##2##5##(2007-8#1)(2012-1#1)
in all areas of##5##4##(1997-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-1#1)
in all areas##7##3##(1997-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-1#1)
in all aspects of##6##4##(1993-1#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
in all but 3##2##4##(2008-12#1)(2009-3#1)
in all but one patient##2##5##(2007-8#1)(2011-2#1)
in all but one##3##4##(2007-8#1)(2009-10#1)(2011-2#1)
in all but the##2##4##(2007-12#1)(2008-12#1)
in all but two patients##2##5##(1993-2#1)(2008-7#1)
in all but two##4##4##(1993-2#1)(1994-3#1)(2008-7#1)(2012-3#1)
in all but##14##3##(1990-2#1)(1993-2#1)(1994-3#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-12#2)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-3#1)
in all cases and##6##4##(1990-12#1)(1993-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#1)
in all cases except##2##4##(1991-8#1)(2007-7#1)
in all cases of##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
in all cases the##4##4##(1992-3#1)(2008-10#2)(2008-5#1)
in all cases to##2##4##(2007-8#1)(2008-10#1)
in all cases was##2##4##(2007-10#1)(2012-12#1)
in all cases where##3##4##(1990-11#1)(1992-11#1)(1997-6#1)
in all cases with##2##4##(2008-2#1)(2008-5#1)
in all cases##102##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-3#2)(1993-9#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-7#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#3)(2012-4#1)(2013-1#2)(2013-7#1)
in all categories of##2##4##(2008-6#1)(2008-7#1)
in all categories##3##3##(2008-6#1)(2008-7#1)(2010-8#1)
in all cell lines examined##2##5##(1995-12#1)(1997-7#1)
in all cell lines##3##4##(1992-9#1)(1995-12#1)(1997-7#1)
in all cell types##2##4##(1995-12#1)(2009-12#1)
in all cell##5##3##(1992-9#1)(1995-12#2)(1997-7#1)(2009-12#1)
in all cells of##2##4##(2008-10#1)(2008-4#1)
in all cells##4##3##(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
in all cellular##2##3##(1994-5#1)(2008-10#1)
in all children##4##3##(2007-8#1)(2011-1#1)(2011-2#2)
in all combinations##2##3##(2008-10#1)(2008-7#1)
in all conditions##4##3##(2008-11#2)(2009-2#1)(2010-4#1)
in all cortical##2##3##(1991-10#1)(1996-5#1)
in all countries##3##3##(1997-1#1)(2009-6#1)(2010-2#1)
in all crosses##2##3##(2008-10#2)
in all cultures##2##3##(1990-8#1)(2008-11#1)
in all data sets##2##4##(2008-10#1)(2008-9#1)
in all developmental##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
in all directions##6##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#2)
in all domains##3##3##(2007-10#1)(2007-11#1)(2011-3#1)
in all dopaminergic neurons##2##4##(1996-12#2)
in all dosed groups except##3##5##(2008-9#3)
in all dosed groups of males##2##6##(2008-9#2)
in all dosed groups of##3##5##(2008-9#3)
in all dosed groups##6##4##(2008-9#6)
in all dosed##7##3##(2008-9#7)
in all eight##5##3##(1992-8#1)(1994-8#1)(1996-12#1)(2008-10#2)
in all endocrine##2##3##(2010-11#2)
in all experimental##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
in all experiments##3##3##(2008-10#2)(2008-7#1)
in all exposed groups of males##4##6##(2008-9#4)
in all exposed groups of##5##5##(2008-9#5)
in all fields##2##3##(2007-8#1)(2008-10#1)
in all five patients##2##4##(2008-5#1)(2013-1#1)
in all five##8##3##(1990-12#1)(1990-3#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
in all four cases##2##4##(1996-12#1)(2008-10#1)
in all four limbs##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
in all four##11##3##(1991-12#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
in all fractions##2##3##(1992-3#1)(2008-10#1)
in all grades of##2##4##(1995-12#1)(2011-2#1)
in all groups but##2##4##(2007-6#1)(2008-7#1)
in all groups except##2##4##(2008-7#1)(2009-7#1)
in all groups of patients##2##5##(2007-11#1)(2011-1#1)
in all groups of##4##4##(1994-11#1)(2007-11#1)(2008-10#1)(2011-1#1)
in all groups##20##3##(1992-10#1)(1993-5#1)(1994-11#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
in all instances##6##3##(2008-10#6)
in all its##3##3##(1994-3#1)(2009-10#1)(2009-6#1)
in all kinds of##2##4##(1997-3#1)(2008-3#1)
in all known##6##3##(1992-6#1)(1993-11#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-4#1)
in all layers##2##3##(1997-3#1)(2011-2#1)
in all lipid##2##3##(1994-12#1)(2008-11#1)
in all locations##2##3##(2008-10#1)(2013-8#1)
in all main##2##3##(1996-7#1)(2008-10#1)
in all major##3##3##(1997-5#1)(2008-12#1)(2011-7#1)
in all mammalian##3##3##(1993-12#1)(2008-11#1)(2013-7#1)
in all mammary##2##3##(1991-11#1)(1994-7#1)
in all materials in##2##4##(2013-1#2)
in all media##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
in all members of the##3##5##(1995-2#2)(2008-10#1)
in all metazoans##2##3##(2008-4#1)(2009-8#1)
in all models##3##3##(2007-10#2)(2011-1#1)
in all mouse##2##3##(1995-6#1)(2013-8#1)
in all muscles##2##3##(1990-7#1)(2012-3#1)
in all newborns##2##3##(2007-11#1)(2011-1#1)
in all of the cases##2##5##(2008-10#1)(2008-7#1)
in all of the##20##4##(1990-8#1)(1991-2#1)(1992-2#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
in all of them##2##4##(1996-6#1)(1997-8#1)
in all of these##4##4##(1994-2#1)(2008-10#1)(2008-9#1)(2013-7#1)
in all of##29##3##(1990-8#1)(1990-9#1)(1991-2#1)(1992-2#1)(1994-11#1)(1994-2#1)(1996-6#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-8#1)(2013-7#1)
in all other aspects##2##4##(2008-10#2)
in all other##13##3##(1991-2#1)(1994-1#1)(1995-8#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-9#2)(2009-11#1)(2012-2#1)
in all parameters##2##3##(2008-5#1)(2012-3#1)
in all parts of the##4##5##(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
in all patients and##4##4##(1993-3#1)(2007-7#1)(2007-8#1)(2012-2#1)
in all patients by##2##4##(2012-2#1)(2013-8#1)
in all patients in##2##4##(1990-8#1)(2007-7#1)
in all patients regardless of tumour grade##2##7##(2011-2#2)
in all patients with##7##4##(1990-9#1)(1992-5#1)(1993-2#1)(2006-10#1)(2008-4#1)(2011-2#2)
in all patients##52##3##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1992-5#1)(1993-2#1)(1993-3#2)(1994-5#1)(1995-3#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2010-1#1)(2010-6#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
in all phases of the cell cycle##2##7##(2008-11#2)
in all phases of the##3##5##(1995-6#1)(2008-11#2)
in all phases of##7##4##(1992-1#1)(1992-2#1)(1995-6#1)(2008-1#1)(2008-11#2)(2012-2#1)
in all phases##8##3##(1992-1#1)(1992-2#1)(1995-6#1)(2008-1#1)(2008-11#3)(2012-2#1)
in all plots##2##3##(2008-10#2)
in all plum cultivars##2##4##(2011-2#2)
in all population##2##3##(2008-10#1)(2013-1#1)
in all populations##6##3##(2008-10#4)(2013-8#2)
in all possible##2##3##(2008-10#2)
in all probability##2##3##(1994-5#1)(2008-7#1)
in all procedures##2##3##(2008-10#1)(2009-3#1)
in all prokaryotes##2##3##(2011-2#2)
in all public##2##3##(1996-1#1)(2012-2#1)
in all regions##6##3##(1994-3#1)(2008-10#3)(2008-12#2)
in all samples##11##3##(2007-5#1)(2008-10#7)(2008-12#1)(2009-4#1)(2011-2#1)
in all segments of the##2##5##(1995-5#1)(1997-1#1)
in all series##2##3##(2008-8#1)(2011-2#1)
in all settings##2##3##(2010-9#1)(2011-2#1)
in all sites##2##3##(2008-10#1)(2008-4#1)
in all six##6##3##(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
in all size classes##2##4##(1996-12#2)
in all slices##2##3##(1996-7#2)
in all soil##2##3##(2008-10#2)
in all species of##2##4##(1991-2#1)(2013-1#1)
in all species##4##3##(1991-2#1)(2009-4#1)(2012-8#1)(2013-1#1)
in all specimens##2##3##(2007-12#1)(2013-1#1)
in all stages of##4##4##(1996-6#1)(1997-8#1)(2008-5#1)(2011-2#1)
in all strains##3##3##(1997-7#1)(2008-10#2)
in all studies##2##3##(2011-2#1)(2012-12#1)
in all subjects##7##3##(1996-5#1)(2008-7#3)(2011-2#1)(2012-2#2)
in all tested##6##3##(1990-12#1)(1991-6#1)(1996-8#1)(2007-11#1)(2008-10#2)
in all tests##4##3##(1994-8#1)(2008-10#2)(2013-8#1)
in all the SPM groups was significantly##2##7##(2012-2#2)
in all the cases##7##4##(1994-9#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-12#1)
in all the four##2##4##(1990-11#1)(2008-10#1)
in all the groups##4##4##(1994-8#1)(2008-5#2)(2008-8#1)
in all the other##2##4##(2008-7#1)(2011-2#1)
in all the patients##5##4##(2008-1#1)(2008-7#1)(2010-7#3)
in all the samples##6##4##(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in all the studied##2##4##(2008-10#1)(2011-2#1)
in all the three groups##2##5##(2012-2#2)
in all the three##3##4##(2012-2#2)(2013-1#1)
in all the tissues##2##4##(2008-5#1)(2009-7#1)
in all the##81##3##(1990-11#2)(1990-5#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-9#1)(1993-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#2)(2009-5#2)(2009-7#2)(2010-5#1)(2010-7#4)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
in all these##7##3##(2008-1#1)(2008-10#2)(2008-11#2)(2010-10#1)(2013-1#1)
in all three cases##2##4##(2007-12#1)(2008-10#1)
in all three cell lines##2##5##(1995-6#1)(2008-11#1)
in all three dimensions##2##4##(2008-3#1)(2012-2#1)
in all three groups##4##4##(1997-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
in all three soils##2##4##(2008-10#2)
in all three strains##4##4##(1994-2#2)(2008-10#2)
in all three types of##2##5##(1995-3#1)(2008-10#1)
in all three##50##3##(1990-5#2)(1991-12#2)(1991-3#1)(1993-8#1)(1994-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-3#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#1)
in all tissues##6##3##(1990-11#1)(1993-11#1)(1993-3#1)(2008-10#1)(2008-7#1)(2010-5#1)
in all types of##5##4##(2008-10#2)(2010-8#1)(2012-3#1)(2013-8#1)
in all years##4##3##(2008-10#2)(2008-5#1)(2010-2#1)
in all##921##2##(1990-11#5)(1990-12#5)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#5)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#6)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-11#5)(1995-12#4)(1995-2#8)(1995-3#7)(1995-5#4)(1995-6#4)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#8)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#5)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#8)(1997-4#2)(1997-5#1)(1997-6#7)(1997-7#6)(1997-8#5)(1997-9#1)(2006-10#2)(2007-10#6)(2007-11#11)(2007-12#13)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#15)(2008-1#11)(2008-10#194)(2008-11#23)(2008-12#17)(2008-2#3)(2008-3#11)(2008-4#16)(2008-5#27)(2008-6#9)(2008-7#38)(2008-8#15)(2008-9#23)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#62)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#14)(2012-2#18)(2012-3#12)(2012-4#1)(2012-8#2)(2013-1#29)(2013-7#4)(2013-8#15)
in allele frequencies##7##3##(1994-3#1)(2008-10#3)(2008-8#1)(2009-5#1)(2010-4#1)
in allele##11##2##(1994-3#1)(1997-5#2)(2008-10#3)(2008-12#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-3#1)
in allergic diseases##2##3##(1991-2#1)(2008-3#1)
in allergic patients##2##3##(2011-1#1)(2013-1#1)
in allergic reactions##2##3##(1994-11#1)(1995-12#1)
in allergic##12##2##(1991-2#1)(1992-3#1)(1992-5#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#2)
in allergy##2##2##(1990-12#1)(2012-12#1)
in alleviating##2##2##(2008-10#1)(2008-7#1)
in allocating##2##2##(1995-12#1)(1995-2#1)
in allocation##3##2##(2008-8#1)(2008-9#2)
in allografts##2##2##(2008-1#1)(2008-8#1)
in allopatry##3##2##(2008-10#3)
in allowing##2##2##(1995-6#1)(2008-10#1)
in alloy samples##2##3##(2008-10#2)
in alloy steels and industrial effluents##2##6##(2008-10#2)
in alloy##4##2##(2008-10#4)
in alloys and environmental samples##2##5##(2008-10#2)
in alloys and##3##3##(2008-10#3)
in alloys by##2##3##(2008-10#2)
in alloys##10##2##(2008-10#10)
in almost all cases##2##4##(2008-4#1)(2009-8#1)
in almost all patients##2##4##(2007-7#1)(2010-12#1)
in almost all##18##3##(1990-5#1)(1990-6#1)(1991-12#1)(1993-1#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-8#1)(2012-2#1)
in almost complete##4##3##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
in almost every##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
in almost##32##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
in alpha##6##2##(1992-12#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-12#1)
in alpha(1B)-AR##3##2##(2008-4#3)
in alpha-helix##3##2##(1995-2#1)(2008-10#2)
in altered##3##2##(1991-5#1)(1992-6#1)(1997-3#1)
in altering the CD##2##4##(1995-5#2)
in altering the##5##3##(1995-5#2)(2013-1#2)(2013-8#1)
in alternate##3##2##(2008-3#1)(2008-4#2)
in alternative 3' splice-site selection##2##5##(1993-6#2)
in alternative medicine##3##3##(1997-5#2)(1997-6#1)
in alternative##8##2##(1993-11#1)(1993-6#2)(1997-5#2)(1997-6#1)(2008-12#1)(2010-3#1)
in altitude##2##2##(2008-3#1)(2012-6#1)
in aluminium##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
in aluminum##3##2##(2007-11#1)(2008-10#2)
in alveolar macrophages##3##3##(1993-3#1)(1993-8#1)(1994-12#1)
in alveolar##6##2##(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(2008-1#2)
in ambient air##14##3##(1991-12#1)(2007-12#3)(2008-10#9)(2008-3#1)
in ambient and##2##3##(2008-10#1)(2008-2#1)
in ambient##24##2##(1991-12#1)(1991-6#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)
in ambulance workers##2##3##(2012-1#2)
in ambulatory care##2##3##(1993-12#1)(2012-3#1)
in ambulatory##14##2##(1990-9#1)(1992-6#1)(1993-12#1)(1997-7#1)(2008-11#1)(2009-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in amended##2##2##(2008-10#2)
in amino acid changes##3##4##(1992-3#1)(1994-11#1)(2008-10#1)
in amino acid sequence##2##4##(2008-9#1)(2013-1#1)
in amino acid sequences##2##4##(2008-4#1)(2008-5#1)
in amino acid##12##3##(1990-12#1)(1992-3#1)(1994-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-9#1)(2013-1#1)
in amino acids##3##3##(2008-10#2)(2010-4#1)
in amino##19##2##(1990-12#1)(1992-3#2)(1994-11#1)(1994-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-8#2)(2012-9#1)(2013-1#1)
in ammonia##3##2##(2008-10#2)(2008-7#1)
in ammonium##4##2##(2008-10#4)
in amniotic fluid##8##3##(1990-12#3)(1992-10#1)(1992-6#1)(1995-8#2)(2012-2#1)
in amoeboid##2##2##(2008-6#1)(2012-2#1)
in amorphous##5##2##(1990-4#1)(2007-12#2)(2008-10#2)
in amount##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
in amounts of##2##3##(2008-10#1)(2012-1#1)
in amounts##6##2##(1990-5#1)(1993-11#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-1#1)
in amperometric##4##2##(2008-10#3)(2009-10#1)
in amphibians##4##2##(1996-5#1)(1997-3#1)(1997-7#1)(2008-8#1)
in amplified##2##2##(2008-10#2)
in amplifying DNA##2##3##(2008-10#1)(2008-4#1)
in amplifying##3##2##(1993-8#1)(2008-10#1)(2008-4#1)
in amplitude and phase##2##4##(2008-3#2)
in amplitude##5##2##(1990-8#1)(2008-3#3)(2008-7#1)
in amputees##2##2##(2008-6#1)(2013-1#1)
in amygdala##3##2##(1993-12#1)(1997-2#1)(1997-7#1)
in amygdala-kindled rats##3##3##(1992-3#2)(1994-2#1)
in an &quot##3##3##(1996-1#1)(1996-12#1)(2008-10#1)
in an 11 year old boy##2##6##(1996-6#1)(2012-3#1)
in an 11-month-old infant##2##4##(2008-12#2)
in an 11-month-old##3##3##(2008-12#3)
in an 11-year-old boy##2##4##(2008-1#1)(2008-10#1)
in an 11-year-old##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
in an 8##2##3##(2008-10#1)(2011-2#1)
in an 85-year-old##2##3##(1993-9#1)(2013-7#1)
in an A##2##3##(2008-3#1)(2009-5#1)
in an AlGaAs##2##3##(2007-12#1)(2008-2#1)
in an Alpine valley##2##4##(2008-10#2)
in an Arab-Israeli community##2##4##(2008-6#2)
in an Asian##4##3##(2007-7#1)(2008-3#2)(2013-3#1)
in an Australian##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
in an E##2##3##(1993-6#1)(1997-7#1)
in an ELISA##2##3##(1995-2#1)(1997-3#1)
in an Escherichia coli##3##4##(1994-5#1)(2008-6#1)(2008-7#1)
in an F(2) population##2##4##(2008-10#2)
in an F2 population##2##4##(2008-8#2)
in an HBV- and HCV-endemic area##2##6##(2013-8#2)
in an HIV positive patient##2##5##(2007-7#1)(2010-12#1)
in an HIV##4##3##(1993-12#1)(2007-7#1)(2010-12#1)(2013-8#1)
in an HIV-infected##2##3##(2007-12#2)
in an HMO##3##3##(1993-12#2)(1997-1#1)
in an Infant with##2##4##(2011-1#1)(2012-3#1)
in an Irish##3##3##(1991-12#1)(2008-11#1)(2008-12#1)
in an Italian##2##3##(2008-10#1)(2008-8#1)
in an O(2)##2##3##(2008-10#1)(2008-8#1)
in an RNA##2##3##(1997-6#1)(2008-4#1)
in an ablation##2##3##(2008-1#1)(2008-7#1)
in an ablative-wall##2##3##(2008-2#2)
in an absorbing medium##4##4##(2007-12#1)(2008-3#3)
in an absorbing solution was##2##5##(2008-10#2)
in an absorbing##7##3##(2007-12#1)(2008-10#2)(2008-3#4)
in an academic health##5##4##(1994-3#4)(1995-1#1)
in an academic medical##2##4##(1991-1#1)(2008-3#1)
in an academic##14##3##(1991-1#1)(1992-1#2)(1994-3#4)(1995-1#1)(1995-2#1)(2008-3#2)(2010-8#1)(2011-1#1)(2011-2#1)
in an accelerated##2##3##(2007-11#1)(2008-10#1)
in an accredited##2##3##(1994-12#1)(2008-11#1)
in an accumulation of##3##4##(1994-11#1)(2013-1#2)
in an acetic##2##3##(2008-10#2)
in an acid medium to##2##5##(2008-10#1)(2008-5#1)
in an acid medium##3##4##(2008-10#2)(2008-5#1)
in an acidic environment##2##4##(2009-11#1)(2012-2#1)
in an acidic media##2##4##(2008-10#2)
in an acidic medium##5##4##(2008-10#5)
in an acidic##13##3##(1994-5#1)(2008-10#10)(2009-11#1)(2012-2#1)
in an active form##2##4##(1990-2#2)
in an active##7##3##(1990-2#2)(1991-9#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
in an acute care hospital##3##5##(2010-10#2)(2010-11#1)
in an acute care setting##3##5##(1994-2#1)(1995-12#1)(2007-10#1)
in an acute care##10##4##(1994-2#1)(1994-3#1)(1995-12#1)(2007-10#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#1)
in an acute geriatric##2##4##(2008-7#2)
in an acute##21##3##(1992-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#4)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
in an additional##2##3##(1992-8#1)(2010-3#1)
in an additive fashion##2##4##(2011-2#1)(2013-8#1)
in an additive manner##2##4##(1996-2#1)(2008-6#1)
in an additive##5##3##(1996-2#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
in an adjacent##2##3##(1993-8#1)(2008-3#1)
in an adolescent with scoliosis and a history of early feeding difficulties##2##12##(2008-4#2)
in an adolescent##7##3##(2008-10#1)(2008-4#4)(2009-3#1)(2010-12#1)
in an adult male##2##4##(2007-2#1)(2007-7#1)
in an adult patient##5##4##(2007-10#1)(2007-7#1)(2009-10#1)(2011-2#1)(2013-7#1)
in an adult population##2##4##(1995-9#1)(1997-4#1)
in an adult with##5##4##(1997-3#1)(2010-11#1)(2012-3#2)(2013-8#1)
in an adult##26##3##(1990-3#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
in an advanced##3##3##(1993-1#1)(1994-12#1)(2008-11#1)
in an aged care##2##4##(2008-11#1)(2012-3#1)
in an agency setting##2##4##(1996-2#2)
in an agricultural##2##3##(2008-10#1)(2008-5#1)
in an air##2##3##(2008-2#1)(2008-3#1)
in an aircraft##2##3##(1996-12#1)(2009-9#1)
in an alkaline medium##9##4##(2008-10#9)
in an alkaline##14##3##(2008-10#14)
in an all-dielectric##2##3##(2007-11#1)(2008-3#1)
in an alliance##2##3##(1997-2#1)(2013-1#1)
in an ambisense arrangement##2##4##(2008-10#2)
in an ambisense##3##3##(2008-10#3)
in an ambulatory##2##3##(2008-11#2)
in an amino acid substitution##4##5##(1993-3#1)(1994-11#1)(2008-10#2)
in an amino acid##8##4##(1991-2#1)(1992-2#1)(1993-3#1)(1994-11#1)(1997-7#1)(2008-10#2)(2008-5#1)
in an amorphous##2##3##(2007-11#1)(2008-5#1)
in an amount##2##3##(1996-9#1)(2008-5#1)
in an amperometric##2##3##(2008-10#2)
in an anaerobic##2##3##(2008-6#2)
in an analogous##4##3##(1995-3#1)(2006-6#1)(2008-1#1)(2008-11#1)
in an analytical procedure##2##4##(2008-10#2)
in an analytical##4##3##(2008-10#4)
in an anechoic chamber##2##4##(2008-9#1)(2011-1#1)
in an animal model of##3##5##(2010-1#1)(2012-12#1)(2012-2#1)
in an animal model##8##4##(1995-11#1)(1997-8#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
in an animal##9##3##(1995-11#1)(1997-8#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
in an annual##2##3##(1997-8#1)(2008-9#1)
in an antigen##3##3##(2008-11#3)
in an antiparallel##2##3##(1990-5#1)(1995-5#1)
in an apomorphine-induced##2##3##(1995-3#2)
in an apparatus##3##3##(1990-7#1)(1991-9#1)(2008-10#1)
in an apparently healthy##2##4##(2008-7#1)(2009-7#1)
in an apparently##3##3##(1991-9#1)(2008-7#1)(2009-7#1)
in an appropriate##4##3##(1995-5#1)(1996-4#1)(2008-10#1)(2008-9#1)
in an approximate##2##3##(2008-3#1)(2013-1#1)
in an aqueous environment##3##4##(1992-6#1)(2008-3#1)(2009-12#1)
in an aqueous medium##3##4##(2008-10#3)
in an aqueous solution##7##4##(1996-2#1)(2008-10#3)(2008-3#1)(2009-4#1)(2009-6#1)
in an aqueous##25##3##(1992-12#1)(1992-6#1)(1996-2#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-5#2)(2009-12#1)(2009-4#1)(2009-6#1)
in an area endemic for##2##5##(2008-8#1)(2009-8#1)
in an area of southwest Germany##2##6##(1997-6#2)
in an area of##10##4##(1994-8#1)(1996-1#1)(1996-4#1)(1997-6#3)(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
in an area##31##3##(1991-12#3)(1992-12#1)(1992-6#1)(1993-1#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-6#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#2)
in an argon-filled single-mode hollow waveguide##2##6##(2007-12#2)
in an array##2##3##(2008-3#2)
in an artificial##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2010-8#1)
in an assay##3##3##(1994-2#1)(1994-5#1)(2010-12#1)
in an asymmetric##4##3##(2008-10#1)(2008-3#2)(2008-4#1)
in an asymptomatic##2##3##(1991-11#1)(1991-2#1)
in an atmosphere of 5% CO2 in air##2##8##(2008-5#1)(2013-1#1)
in an atmosphere##4##3##(2008-2#1)(2008-5#2)(2013-1#1)
in an atmospheric##2##3##(2008-3#2)
in an atomic##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
in an attempt to develop##2##5##(2008-10#1)(2008-11#1)
in an attempt to elucidate##2##5##(1996-2#1)(2008-9#1)
in an attempt to identify##4##5##(1992-3#1)(2008-7#1)(2010-3#1)(2012-3#1)
in an attempt to reduce##2##5##(1995-12#1)(2012-2#1)
in an attempt to understand the##2##6##(1990-5#1)(2008-3#1)
in an attempt to understand##5##5##(1990-5#1)(2008-3#1)(2008-9#2)(2010-6#1)
in an attempt to##47##4##(1990-5#1)(1992-11#1)(1992-3#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-7#2)(2008-9#4)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in an automated fashion##2##4##(2008-10#1)(2010-8#1)
in an automated##6##3##(1995-12#1)(2008-10#3)(2009-10#1)(2010-8#1)
in an automatic##2##3##(2008-10#2)
in an autosomal##2##3##(1992-6#1)(2007-8#1)
in an earlier paper##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
in an earlier study##5##4##(1991-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
in an earlier##14##3##(1991-3#1)(1994-3#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2010-1#1)(2010-3#1)(2012-12#1)
in an early stage##2##4##(2008-10#1)(2013-8#1)
in an early##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
in an ecosystem##2##3##(1997-7#2)
in an educational##2##3##(1995-6#1)(2007-12#1)
in an effort to assess##2##5##(1996-2#1)(2012-3#1)
in an effort to better##2##5##(2009-9#1)(2010-9#1)
in an effort to develop##2##5##(1997-7#1)(2009-9#1)
in an effort to help##2##5##(1996-1#1)(2008-1#1)
in an effort to identify##2##5##(1997-1#1)(2008-11#1)
in an effort to prevent##2##5##(2010-11#1)(2012-12#1)
in an effort to##31##4##(1990-11#1)(1992-3#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2009-4#1)(2009-9#3)(2010-11#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#1)
in an elderly patient with##2##5##(2008-7#1)(2009-10#1)
in an elderly patient##4##4##(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
in an elderly population##4##4##(2008-3#1)(2008-7#3)
in an elderly woman##2##4##(1991-2#1)(2012-2#1)
in an elderly##14##3##(1991-2#1)(1993-6#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2012-2#1)(2013-8#1)
in an electrochemical##2##3##(2008-10#2)
in an electron##2##3##(1996-2#1)(2008-7#1)
in an electronic health record##5##5##(2007-12#1)(2013-1#4)
in an electronic##9##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#4)
in an electronically tuned Ti##2##5##(2007-12#2)
in an elevated##2##3##(1990-5#1)(2008-10#1)
in an emergency department##3##4##(1994-2#1)(2007-5#1)(2008-3#1)
in an emergency##5##3##(1994-2#1)(1994-3#1)(2007-5#1)(2008-3#1)(2009-6#1)
in an end-pumped##4##3##(2007-11#2)(2008-2#2)
in an endemic area for paracoccidioidomycosis in##2##7##(2008-5#2)
in an endemic##3##3##(2008-5#2)(2012-3#1)
in an enhanced##4##3##(1990-5#1)(1990-7#1)(2007-12#1)(2008-12#1)
in an enhancement##2##3##(2008-11#2)
in an enriched environment##2##4##(1992-11#2)
in an enriched##3##3##(1992-11#2)(1992-8#1)
in an enrichment factor of##2##5##(2008-10#2)
in an entire##2##3##(2008-4#1)(2008-9#1)
in an environment of##2##4##(1996-12#1)(2013-1#1)
in an environment to which##2##5##(1997-7#2)
in an environment where##3##4##(1991-12#1)(2008-12#1)(2009-9#1)
in an environment##14##3##(1991-12#1)(1995-6#1)(1996-12#1)(1997-7#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in an environmentally##2##3##(2008-8#2)
in an epoxy##2##3##(2008-10#1)(2008-3#1)
in an equal##2##3##(1991-3#1)(2013-1#1)
in an era of health care reform##2##7##(1993-12#1)(1997-3#1)
in an era of health reform##2##6##(1996-3#2)
in an era of health##4##5##(1993-12#1)(1996-3#2)(1997-3#1)
in an era of##10##4##(1993-12#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
in an era##11##3##(1993-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
in an erbium-doped fiber##2##4##(2007-11#1)(2007-12#1)
in an established##2##3##(1997-7#1)(2008-11#1)
in an ethical##2##3##(1992-3#1)(2008-12#1)
in an ethylene diffusion flame##2##5##(2008-2#2)
in an evolutionary##2##3##(2008-8#2)
in an ex vivo##2##4##(2008-5#1)(2012-2#1)
in an exact##2##3##(2008-3#2)
in an excellent##2##3##(2008-12#2)
in an experiment##5##3##(1997-6#1)(2007-12#1)(2008-3#2)(2013-7#1)
in an experimental animal model##2##5##(1996-3#1)(2012-2#1)
in an experimental model##2##4##(2008-5#1)(2011-2#1)
in an experimental system##2##4##(1996-2#1)(2008-8#1)
in an experimental##15##3##(1996-2#2)(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
in an explicit##2##3##(2008-3#1)(2008-4#1)
in an exposed##2##3##(1994-11#1)(1995-6#1)
in an extended##4##3##(2008-12#1)(2008-3#2)(2012-2#1)
in an extension##2##3##(1991-11#1)(2008-5#1)
in an extensive##2##3##(1992-4#1)(2007-12#1)
in an external cavity##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
in an external resonant cavity##2##5##(2007-11#1)(2007-12#1)
in an external resonator##3##4##(2007-11#1)(2008-2#2)
in an external##12##3##(1993-12#1)(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#3)
in an external-cavity configuration##2##4##(2007-11#1)(2008-3#1)
in an identical manner##2##4##(1993-8#1)(2008-10#1)
in an identical##4##3##(1990-11#1)(1993-8#1)(1995-6#1)(2008-10#1)
in an identified neuron##2##4##(1990-7#1)(2008-8#1)
in an image##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
in an immediate##2##3##(1993-3#1)(1996-7#1)
in an immunocompetent patient##4##4##(1996-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
in an immunocompetent##8##3##(1996-3#1)(1996-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
in an immunocompromised##2##3##(1997-5#1)(2007-12#1)
in an implementation of##2##4##(2007-12#1)(2008-10#1)
in an important##2##3##(2007-12#1)(2012-12#1)
in an impoverished community##2##4##(2007-2#1)(2011-2#1)
in an impoverished##4##3##(2007-2#2)(2011-2#2)
in an improved##2##3##(2008-3#1)(2008-7#1)
in an improvement of##2##4##(2008-10#1)(2008-11#1)
in an improvement##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
in an in situ##2##4##(1994-8#1)(1997-1#1)
in an in vitro system##2##5##(1995-11#1)(2008-11#1)
in an in vitro##9##4##(1992-3#1)(1993-11#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
in an in vivo assay##2##5##(1990-5#1)(1991-12#1)
in an in vivo##5##4##(1990-11#2)(1990-5#1)(1991-12#1)(2008-12#1)
in an in##16##3##(1990-11#2)(1990-5#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)
in an in-depth##2##3##(1994-2#1)(1995-6#1)
in an inactive state that##2##5##(1990-2#1)(2013-8#1)
in an inactive state##3##4##(1990-2#1)(1993-8#1)(2013-8#1)
in an inactive##4##3##(1990-2#1)(1991-10#1)(1993-8#1)(2013-8#1)
in an increase in the##7##5##(1991-6#1)(1995-3#1)(1997-6#1)(2008-10#4)
in an increase in##23##4##(1990-11#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-3#1)(1995-3#1)(1996-12#2)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#2)(2013-8#1)
in an increase of the##4##5##(1993-8#1)(2008-10#1)(2008-5#2)
in an increase of##11##4##(1991-5#1)(1993-8#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-8#1)(2013-7#1)
in an increase##34##3##(1990-11#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-7#1)(2013-8#1)
in an increased number##2##4##(2008-7#1)(2013-8#1)
in an increased##16##3##(1990-2#1)(1990-6#1)(1991-12#1)(1992-1#1)(1993-8#1)(1995-12#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
in an increasing##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
in an increasingly competitive##3##4##(1994-12#1)(1994-2#1)(2008-10#1)
in an increasingly##7##3##(1994-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-3#1)
in an incubation##2##3##(1994-12#1)(2008-10#1)
in an incubator without CO(2) addition##2##6##(2008-11#2)
in an incubator##6##3##(2008-10#1)(2008-11#3)(2008-5#2)
in an independent##2##3##(2007-10#1)(2012-3#1)
in an individual patient##2##4##(2009-9#1)(2012-1#1)
in an individual with##3##4##(1994-9#1)(2008-4#1)(2009-2#1)
in an individual##10##3##(1994-9#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#2)
in an induction of##2##4##(1995-6#1)(2008-10#1)
in an inductively coupled plasma##2##5##(2007-12#1)(2008-10#1)
in an industrial environment##2##4##(2007-11#1)(2008-10#1)
in an industrial##6##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
in an infant with##2##4##(1997-3#1)(2011-1#1)
in an infant##11##3##(1995-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#3)
in an infinite##2##3##(2007-11#1)(2008-2#1)
in an inhomogeneous##3##3##(2008-10#1)(2008-2#2)
in an inhomogeneously##2##3##(2007-11#1)(2008-2#1)
in an innovative##4##3##(1992-5#1)(2008-1#1)(2008-12#1)(2013-1#1)
in an insect cell line##2##5##(2008-7#2)
in an insect##3##3##(1993-12#1)(2008-7#2)
in an insoluble##2##3##(1992-12#1)(2008-10#1)
in an institution for##2##4##(1991-6#1)(1992-12#1)
in an insulin##2##3##(1990-12#1)(1990-8#1)
in an integrated curriculum##2##4##(2012-3#2)
in an integrated delivery system##2##5##(1996-1#1)(2008-1#1)
in an integrated delivery##4##4##(1996-1#1)(1996-3#1)(1997-1#1)(2008-1#1)
in an integrated##11##3##(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2012-2#1)(2012-3#3)
in an intensive care unit##4##5##(1992-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
in an intensive care unit]##2##5##(1991-3#1)(2011-2#1)
in an intensive care##8##4##(1991-3#1)(1992-2#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#2)(2011-2#1)
in an intensive##9##3##(1991-3#1)(1992-2#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#2)(2011-2#1)(2013-8#1)
in an inter-laboratory study##2##4##(2008-10#2)
in an interacting system##2##4##(2008-2#2)
in an interacting##3##3##(2008-2#2)(2009-11#1)
in an interactive##3##3##(2007-12#1)(2008-1#1)(2008-11#1)
in an interdisciplinary##2##3##(2008-1#1)(2013-1#1)
in an interferometer##2##3##(2008-2#1)(2008-3#1)
in an interferometric##3##3##(2008-2#1)(2008-3#2)
in an intermediate##2##3##(1990-3#1)(2012-1#1)
in an internal medicine##3##4##(1992-5#2)(2009-9#1)
in an internal##4##3##(1992-5#2)(2008-3#1)(2009-9#1)
in an international##7##3##(1997-4#1)(2008-10#5)(2008-12#1)
in an irregular labeling of Penicillium cell walls##2##8##(2008-10#2)
in an irreversible##3##3##(1990-12#1)(2008-10#1)(2012-3#1)
in an isolated##2##3##(1991-12#1)(1995-5#1)
in an isotropic##2##3##(2008-2#1)(2008-3#1)
in an iterative##4##3##(2008-2#2)(2008-8#1)(2012-2#1)
in an objective##2##3##(1990-12#1)(2008-2#1)
in an office environment##3##4##(1991-1#3)
in an office-based plastic surgery practice with an already high standard of care##2##13##(2013-1#2)
in an oil-in-water##3##3##(1992-9#1)(2008-10#1)(2008-5#1)
in an old##3##3##(2008-9#1)(2010-11#1)(2013-1#1)
in an older population##2##4##(2008-3#1)(2012-12#1)
in an older##3##3##(2008-3#1)(2010-10#1)(2012-12#1)
in an on-line preconcentration system for##2##6##(2008-10#2)
in an on-line##6##3##(2008-10#6)
in an online##2##3##(2008-11#1)(2008-4#1)
in an open environment##2##4##(2010-7#1)(2011-1#1)
in an open field##4##4##(1992-12#2)(2008-11#1)(2012-12#1)
in an open##16##3##(1991-2#1)(1992-12#2)(1993-1#1)(1993-2#1)(1993-6#1)(2008-10#6)(2008-11#1)(2010-7#1)(2011-1#1)(2012-12#1)
in an operating diode-pumped Nd##2##5##(2008-3#2)
in an optical disk##3##4##(2008-2#2)(2008-3#1)
in an optical fiber is##2##5##(2007-11#1)(2007-12#1)
in an optical fiber with##3##5##(2007-11#2)(2007-12#1)
in an optical fiber##13##4##(2007-11#7)(2007-12#3)(2008-3#3)
in an optical head##2##4##(2008-3#2)
in an optical trap##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
in an optical##35##3##(2007-11#7)(2007-12#5)(2008-2#3)(2008-3#18)(2009-5#1)(2012-2#1)
in an optically accessible##3##4##(2008-2#1)(2008-3#2)
in an optically dense##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
in an optically thick##2##4##(2007-12#1)(2008-10#1)
in an optically##10##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
in an optoelectronic##2##3##(2008-3#2)
in an oral##2##3##(2007-11#1)(2008-12#1)
in an orbital##2##3##(1996-2#1)(2013-7#1)
in an ordered fashion##2##4##(1994-3#1)(1994-5#1)
in an ordered##5##3##(1994-2#1)(1994-3#1)(1994-5#1)(2008-3#1)(2008-7#1)
in an organ##3##3##(1993-12#1)(2008-12#1)(2008-8#1)
in an organic solvent##2##4##(2008-10#2)
in an organic##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
in an organism##2##3##(1990-7#1)(2009-5#1)
in an organization##3##3##(1992-5#1)(2012-3#2)
in an organized##2##3##(1990-12#1)(2012-3#1)
in an oriented##2##3##(2008-10#1)(2009-11#1)
in an otherwise##5##3##(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)
in an outbreak##2##3##(1995-6#1)(2007-12#1)
in an outpatient setting##2##4##(1991-1#1)(2009-2#1)
in an outpatient##4##3##(1991-1#1)(2009-2#1)(2012-12#2)
in an overall reduction##2##4##(2007-10#1)(2008-3#1)
in an overall##8##3##(1992-9#1)(1993-9#1)(1996-5#1)(1997-7#1)(2007-10#1)(2008-3#2)(2008-7#1)
in an ulcerative colitis patient##2##5##(2010-11#1)(2010-12#1)
in an ultrafiltration##3##3##(1995-2#1)(1995-3#1)(2011-2#1)
in an ultralow-birefringence spun##2##4##(2007-12#2)
in an ultrasonic bath##4##4##(2008-10#4)
in an ultrasonic##5##3##(2008-10#4)(2008-3#1)
in an undergraduate##4##3##(2008-11#4)
in an unknown##2##3##(2007-12#1)(2008-2#1)
in an unstable##2##3##(2007-12#1)(2008-1#1)
in an unusual##4##3##(1990-3#1)(2006-10#1)(2007-5#1)(2009-8#1)
in an upright building##2##4##(2013-1#2)
in an urban area##4##4##(2008-10#1)(2009-10#1)(2011-1#1)(2012-12#1)
in an urban community##2##4##(1996-3#1)(2011-1#1)
in an urban environment##2##4##(1994-1#1)(2008-5#1)
in an urban population of##3##5##(1991-1#1)(2008-11#1)(2008-3#1)
in an urban population##4##4##(1990-2#1)(1991-1#1)(2008-11#1)(2008-3#1)
in an urban##23##3##(1990-2#1)(1991-1#1)(1993-10#1)(1994-1#1)(1996-3#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2009-10#3)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#3)
in an##1503##2##(1990-11#6)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#2)(1991-1#7)(1991-10#1)(1991-11#2)(1991-12#10)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#7)(1992-1#3)(1992-11#5)(1992-12#7)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#5)(1992-6#5)(1992-8#3)(1992-9#4)(1993-1#8)(1993-10#1)(1993-11#1)(1993-12#11)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#6)(1993-8#6)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#6)(1994-2#10)(1994-3#13)(1994-5#6)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-11#6)(1995-12#8)(1995-2#9)(1995-3#7)(1995-5#5)(1995-6#11)(1995-8#5)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#11)(1996-3#11)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#2)(1997-3#8)(1997-4#4)(1997-5#2)(1997-6#8)(1997-7#11)(1997-8#4)(2006-10#2)(2006-6#2)(2007-10#9)(2007-11#41)(2007-12#55)(2007-2#4)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#12)(2008-10#232)(2008-11#66)(2008-12#26)(2008-2#57)(2008-3#126)(2008-4#16)(2008-5#33)(2008-6#17)(2008-7#40)(2008-8#29)(2008-9#17)(2009-1#2)(2009-10#11)(2009-11#8)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#10)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#10)(2010-1#4)(2010-10#5)(2010-11#7)(2010-12#8)(2010-2#1)(2010-3#8)(2010-4#9)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#16)(2011-2#39)(2012-1#5)(2012-12#24)(2012-2#22)(2012-3#33)(2013-1#42)(2013-3#1)(2013-7#9)(2013-8#19)
in anaerobic conditions##2##3##(1997-4#1)(2013-1#1)
in anaerobic granular sludges##2##4##(2008-10#2)
in anaerobic##14##2##(1997-4#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#3)
in anaesthesiology##3##2##(2009-5#2)(2010-7#1)
in anaesthetic##2##2##(2010-7#1)(2011-2#1)
in anaesthetised##2##2##(1995-12#1)(1997-2#1)
in anaesthetized rats##2##3##(1995-12#1)(1996-5#1)
in anaesthetized##5##2##(1995-12#3)(1996-5#1)(2007-10#1)
in analogy to##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
in analogy##5##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
in analyses of##4##3##(1993-12#1)(2008-1#1)(2008-10#2)
in analyses##6##2##(1993-12#1)(1997-7#1)(2008-1#1)(2008-10#3)
in analysis and##2##3##(1997-1#1)(2012-12#1)
in analysis of the##2##4##(1991-6#1)(2013-8#1)
in analysis of##5##3##(1991-6#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
in analysis##12##2##(1991-6#1)(1997-1#1)(2008-10#3)(2008-8#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in analyte##3##2##(2008-10#3)
in analytical and environmental chemistry##2##5##(2008-10#2)
in analytical and##3##3##(2008-10#3)
in analytical chemistry and##2##4##(2008-10#2)
in analytical chemistry is##2##4##(2008-10#1)(2010-7#1)
in analytical chemistry##24##3##(2008-10#19)(2010-7#5)
in analytical development##2##3##(2008-10#1)(2010-7#1)
in analytical##40##2##(2008-10#33)(2008-8#1)(2010-7#6)
in analyzing the##8##3##(1992-12#1)(1993-12#1)(1995-12#1)(1996-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
in analyzing##16##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-8#1)(2013-8#2)
in anastomosis##2##2##(2008-10#2)
in anatomic##2##2##(1994-12#1)(2008-1#1)
in anatomy##2##2##(2010-7#1)(2012-3#1)
in ancient##7##2##(1995-6#1)(2008-10#2)(2008-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
in and around a##2##4##(1993-9#1)(2010-5#1)
in and around##7##3##(1990-6#1)(1993-9#1)(1995-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-5#1)
in and between##2##3##(2011-1#1)(2011-2#1)
in and of itself##4##4##(1995-2#2)(2008-1#1)(2011-2#1)
in and out of the nucleus##2##6##(2011-2#2)
in and out of the##4##5##(1996-4#1)(2008-12#1)(2011-2#2)
in and out of##5##4##(1996-4#1)(2008-12#2)(2011-2#2)
in and##44##2##(1990-6#1)(1991-10#1)(1991-3#1)(1993-11#1)(1993-9#1)(1994-1#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#5)(2013-1#3)
in androgen##4##2##(1991-5#1)(1994-2#1)(2012-12#1)(2013-1#1)
in anemia##2##2##(2008-1#1)(2008-8#1)
in anemic patients with cancer receiving chemotherapy##2##7##(2008-7#2)
in anemic patients with cancer##3##5##(2008-7#3)
in anemic patients with##4##4##(2008-7#4)
in anemic patients##5##3##(2008-7#5)
in anesthesia##4##2##(1994-3#1)(1997-2#1)(2010-8#1)(2011-1#1)
in anesthetic##2##2##(1991-1#1)(2007-7#1)
in anesthetized dogs##2##3##(1995-12#1)(1997-1#1)
in anesthetized guinea pigs##2##4##(1992-3#1)(1994-11#1)
in anesthetized rats##7##3##(1990-5#2)(1992-3#1)(1992-7#1)(1995-11#1)(1997-7#1)(2009-8#1)
in anesthetized##12##2##(1990-5#2)(1992-3#2)(1992-7#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-7#1)(2009-8#1)
in angiogenesis##2##2##(2008-8#1)(2010-2#1)
in angiosperms##6##2##(1994-8#1)(2008-7#1)(2009-2#2)(2009-8#2)
in angular##2##2##(1993-5#1)(2011-2#1)
in anhydrous acetic##2##3##(2008-10#1)(2008-11#1)
in anhydrous##8##2##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)
in animal and##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
in animal carcasses##2##3##(2008-6#2)
in animal cell culture##5##4##(2008-11#4)(2008-7#1)
in animal cell##12##3##(2008-10#1)(2008-11#8)(2008-7#2)(2009-8#1)
in animal cells##4##3##(1993-2#2)(1994-11#1)(2008-11#1)
in animal experiments##3##3##(1993-12#1)(2008-1#1)(2008-7#1)
in animal faeces by tungsten coil electrothermal atomic absorption spectrometry##2##10##(2008-10#2)
in animal feed##3##3##(2008-10#3)
in animal feeds##3##3##(2008-10#2)(2011-2#1)
in animal model##3##3##(1994-6#1)(2008-12#1)(2011-3#1)
in animal models as well as in##2##7##(2008-11#1)(2010-6#1)
in animal models have##2##4##(2009-3#1)(2009-5#1)
in animal models of human##2##5##(2008-3#1)(2009-8#1)
in animal models of##19##4##(1995-5#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
in animal models##45##3##(1991-9#2)(1994-5#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#2)
in animal studies##5##3##(1992-6#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-7#1)
in animal urine##2##3##(2011-1#2)
in animal##115##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#2)(1992-6#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-9#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)
in animals and humans##9##4##(1992-9#1)(1994-11#1)(2008-10#2)(2008-12#2)(2008-2#1)(2010-4#1)(2013-1#1)
in animals and##15##3##(1992-9#1)(1994-11#1)(1996-3#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#2)
in animals bearing the MAC16 tumour and##2##7##(1992-8#2)
in animals bearing##5##3##(1992-8#3)(1993-12#1)(1996-5#1)
in animals but##3##3##(1995-2#1)(2008-12#1)(2008-8#1)
in animals pretreated with vitamin C##2##6##(2011-1#2)
in animals pretreated with##4##4##(1993-12#1)(1996-9#1)(2011-1#2)
in animals that were##3##4##(1993-6#1)(2008-11#1)(2011-1#1)
in animals that##7##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-3#1)
in animals to##3##3##(2008-4#1)(2010-4#1)(2013-1#1)
in animals with lesions##2##4##(1993-12#2)
in animals with##8##3##(1993-12#3)(1993-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
in animals##92##2##(1990-11#1)(1990-5#2)(1991-3#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-12#8)(1993-2#1)(1993-6#2)(1994-11#1)(1994-7#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#5)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)
in anion##2##2##(1990-8#1)(2008-10#1)
in anionic##3##2##(1996-5#1)(2008-10#1)(2008-4#1)
in anisotropic##7##2##(1990-4#1)(2008-2#1)(2008-3#5)
in ankylosing spondylitis##2##3##(1990-6#1)(2008-5#1)
in annual plant assemblages##2##4##(2008-8#2)
in annual plant##3##3##(2008-8#3)
in annual##10##2##(1994-3#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-8#3)(2008-9#1)
in anodic##3##2##(2008-10#3)
in anorexia nervosa##2##3##(2007-7#2)
in another group of##2##4##(1991-5#1)(2009-8#1)
in another group##3##3##(1991-5#1)(1996-9#1)(2009-8#1)
in another species##2##3##(1994-8#1)(2012-2#1)
in another way than##2##4##(1991-6#1)(2008-8#1)
in another##41##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-9#1)(1997-5#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
in anoxic##3##2##(1996-9#1)(2008-11#2)
in antagonist##2##2##(2008-10#1)(2008-7#1)
in antagonistic##3##2##(1995-3#1)(2008-9#1)(2012-3#1)
in antagonizing the##3##3##(1994-2#1)(1994-8#1)(1995-12#1)
in antagonizing##5##2##(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#2)
in antecedents##2##2##(1993-3#1)(2009-12#1)
in antenatal##3##2##(1991-6#1)(2007-10#1)(2009-7#1)
in anterior chamber##2##3##(2008-7#2)
in anterior pituitary cells##5##4##(1990-12#1)(1990-7#1)(1996-2#2)(1996-5#1)
in anterior pituitary##8##3##(1990-12#1)(1990-7#1)(1992-3#1)(1994-6#1)(1996-2#2)(1996-5#2)
in anterior##18##2##(1990-12#1)(1990-7#1)(1992-3#1)(1994-6#1)(1995-5#1)(1996-2#2)(1996-5#2)(2007-11#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
in anthers##2##2##(1997-2#1)(1997-8#1)
in anti-HIV-1##2##2##(2011-2#1)(2011-3#1)
in anti-cancer##3##2##(1994-2#1)(2008-9#1)(2012-3#1)
in antibiotic therapy##2##3##(2007-12#1)(2010-6#1)
in antibiotic##4##2##(1996-11#1)(2007-12#1)(2008-10#1)(2010-6#1)
in antibody production##2##3##(1995-12#1)(2008-2#1)
in antibody titers##2##3##(2012-3#1)(2013-1#1)
in antibody##8##2##(1991-5#1)(1992-9#1)(1993-12#1)(1995-12#1)(2008-11#1)(2008-2#1)(2012-3#1)(2013-1#1)
in anticipating##2##2##(2010-10#1)(2012-12#1)
in antigen presentation and##2##4##(1995-11#1)(1997-2#1)
in antigen presentation##4##3##(1990-12#1)(1995-11#1)(1997-2#1)(2008-4#1)
in antigen##9##2##(1990-12#1)(1991-2#1)(1995-11#1)(1997-2#1)(1997-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
in antihypertensive##2##2##(1992-8#1)(2010-4#1)
in antimicrobial activity##2##3##(2008-10#1)(2012-12#1)
in antimicrobial stewardship programs##2##4##(2013-1#2)
in antimicrobial##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
in antimycin##2##2##(2010-12#2)
in antioxidant##5##2##(1996-9#1)(2008-5#2)(2009-8#1)(2013-1#1)
in antisense##2##2##(1994-10#1)(2008-8#1)
in antisocial##3##2##(2008-11#1)(2013-7#1)(2013-8#1)
in antithrombin III##2##3##(1995-2#1)(2008-7#1)
in anuric patients##3##3##(2011-2#3)
in anxiety disorders##3##3##(2008-1#1)(2013-8#2)
in anxiety##10##2##(1993-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#2)(2011-2#1)(2013-8#3)
in any age band##2##4##(1991-4#2)
in any age group##2##4##(1992-8#1)(1993-11#1)
in any age##4##3##(1991-4#2)(1992-8#1)(1993-11#1)
in any attempt to##2##4##(2007-12#1)(2008-11#1)
in any brain region##2##4##(1996-12#2)
in any case##4##3##(1994-2#1)(1995-3#1)(1997-6#1)(2012-2#1)
in any combination##2##3##(1995-11#1)(1996-1#1)
in any direction##3##3##(2008-12#1)(2008-3#2)
in any given year##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
in any given##6##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
in any group##3##3##(1993-1#1)(2008-5#1)(2011-2#1)
in any health care setting##2##5##(1994-1#1)(2008-1#1)
in any meaningful##2##3##(1995-3#1)(2011-2#1)
in any of the groups##2##5##(1997-8#1)(2013-7#1)
in any of the three##6##5##(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-8#1)
in any of the##36##4##(1991-8#2)(1992-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-7#3)(2008-1#2)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-7#1)
in any of these##5##4##(1991-2#1)(1992-6#1)(1995-6#1)(2007-12#1)(2008-7#1)
in any of##44##3##(1991-2#1)(1991-8#2)(1992-5#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-7#1)
in any other country##2##4##(1995-12#1)(2008-10#1)
in any other##7##3##(1995-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-2#1)
in any part of the body##2##6##(2007-8#1)(2013-1#1)
in any part of the##3##5##(2007-8#1)(2008-10#1)(2013-1#1)
in any patient##2##3##(2008-7#1)(2009-10#1)
in any sample##3##3##(1997-6#1)(2008-12#1)(2008-3#1)
in any situation##2##3##(1996-6#1)(2008-8#1)
in any species##3##3##(1995-8#1)(2008-10#2)
in any specific##2##3##(1996-1#1)(1997-3#1)
in any system##2##3##(2008-10#2)
in any treatments##2##3##(2008-10#1)(2009-5#1)
in any way##2##3##(1996-3#1)(1996-6#1)
in any##194##2##(1990-6#1)(1991-2#1)(1991-4#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#27)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
in aorta and##2##3##(1993-12#1)(1997-8#1)
in aorta##5##2##(1993-12#1)(1997-6#1)(1997-8#1)(2013-8#2)
in aortas from##2##3##(2008-3#2)
in aortic membranes##2##3##(2008-3#2)
in aortic smooth muscle cells##2##5##(1995-11#1)(1995-12#1)
in aortic##9##2##(1990-12#1)(1995-11#1)(1995-12#1)(2007-8#1)(2008-3#3)(2013-3#2)
in apatite##2##2##(2008-10#2)
in aperiodic##2##2##(2007-12#2)
in aphid transmission##2##3##(2008-10#2)
in aphid##3##2##(1996-12#1)(2008-10#2)
in apical##2##2##(2007-8#1)(2009-10#1)
in apo E-deficient mice##3##4##(1994-6#2)(2008-1#1)
in apo##7##2##(1990-11#1)(1990-8#2)(1994-6#2)(2008-1#1)(2008-3#1)
in apoB-100##2##2##(1990-11#1)(1992-11#1)
in apoE##2##2##(1995-6#1)(2008-6#1)
in apocrine sweat##2##3##(2008-5#2)
in apocrine##3##2##(2008-4#1)(2008-5#2)
in apoprotein B##2##3##(1991-5#1)(1991-6#1)
in apoptosis and##3##3##(2010-10#1)(2010-8#1)(2012-1#1)
in apoptosis of##2##3##(2008-8#1)(2010-12#1)
in apoptosis##24##2##(1994-10#2)(1997-7#1)(2008-10#1)(2008-11#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#2)
in apoptotic cell##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
in apoptotic cells##4##3##(2008-6#1)(2008-9#1)(2010-1#1)(2011-1#1)
in apoptotic##12##2##(1994-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-8#2)
in apparent affinity##2##3##(1993-6#1)(1996-12#1)
in apparent##10##2##(1990-6#1)(1991-5#1)(1992-6#1)(1993-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-3#1)(2008-9#1)(2009-11#1)
in apparently healthy##2##3##(2010-12#1)(2010-3#1)
in apparently##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)
in appearance##11##2##(1991-1#2)(1993-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
in appetite regulation##2##3##(2009-8#2)
in appetite##3##2##(2009-8#2)(2013-8#1)
in appetitive behaviors##2##3##(2007-8#1)(2008-4#1)
in apple breeding programs##3##4##(2008-10#3)
in apple trees##2##3##(2008-10#2)
in apple wounds##4##3##(2008-10#4)
in apple##22##2##(2008-10#21)(2011-10#1)
in application of the##3##4##(2007-2#1)(2008-10#1)(2012-3#1)
in application of##4##3##(2007-2#1)(2008-10#2)(2012-3#1)
in application##11##2##(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2012-3#1)
in applications requiring##2##3##(2008-10#1)(2008-7#1)
in applications such as##4##4##(2008-11#1)(2008-2#2)(2008-3#1)
in applications##12##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
in applied##2##2##(1997-3#1)(2013-1#1)
in applying the##3##3##(2008-10#1)(2009-9#1)(2013-1#1)
in applying this##2##3##(2008-11#2)
in applying##12##2##(1993-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-9#1)(2010-11#1)(2013-1#2)
in appreciable amount##2##3##(1991-12#1)(2008-10#1)
in appreciable##3##2##(1991-12#1)(2008-10#2)
in appressorium differentiation in M##2##5##(2008-10#2)
in appressorium##4##2##(2008-10#4)
in approach to##2##3##(2008-11#1)(2008-7#1)
in approach##3##2##(1993-1#1)(2008-11#1)(2008-7#1)
in appropriate##8##2##(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2013-8#1)
in approved injectable products##3##4##(2012-2#3)
in approximately 30% of the##2##5##(1992-3#1)(2008-5#1)
in approximately 30%##3##3##(1992-3#1)(2008-5#1)(2011-2#1)
in approximately 85% of##2##4##(2008-11#1)(2010-3#1)
in approximately half##2##3##(1995-11#1)(2012-12#1)
in approximately one-third of##2##4##(2008-1#1)(2008-7#1)
in approximately##45##2##(1991-10#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-8#1)(2013-1#1)
in apricot##7##2##(2008-10#2)(2012-8#5)
in aquaculture##5##2##(2008-5#2)(2008-7#1)(2010-5#1)(2013-1#1)
in aquatic ecosystems##2##3##(2008-10#1)(2013-1#1)
in aquatic environments by##2##4##(2008-10#1)(2008-9#1)
in aquatic environments##7##3##(2008-10#5)(2008-3#1)(2008-9#1)
in aquatic systems##3##3##(2008-10#3)
in aquatic##20##2##(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-2#1)(2013-1#1)
in aqueous TiO(2) dispersions##2##4##(2008-10#2)
in aqueous Triton X-100##2##4##(2008-10#2)
in aqueous acidic buffer##2##4##(2008-10#2)
in aqueous ammonia##2##3##(2008-10#2)
in aqueous and urine##2##4##(2008-10#2)
in aqueous and##8##3##(2008-10#8)
in aqueous extracts of##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
in aqueous humor##4##3##(2008-12#4)
in aqueous media by##2##4##(2008-10#1)(2008-6#1)
in aqueous media have been studied by##2##7##(2008-10#2)
in aqueous media using##5##4##(2008-10#4)(2009-7#1)
in aqueous media##28##3##(1990-2#2)(2008-10#19)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-7#1)(2012-2#1)
in aqueous medium in the##2##5##(1997-2#1)(2008-10#1)
in aqueous medium is##2##4##(2008-10#2)
in aqueous medium##24##3##(1997-2#2)(2008-10#22)
in aqueous micellar solutions of##2##5##(2008-10#1)(2008-7#1)
in aqueous micellar##6##3##(2008-10#5)(2008-7#1)
in aqueous phase##9##3##(2008-10#9)
in aqueous sample##2##3##(2008-10#2)
in aqueous samples by##3##4##(2008-10#3)
in aqueous samples is described##2##5##(2008-10#2)
in aqueous samples is##3##4##(2008-10#3)
in aqueous samples##19##3##(2008-10#19)
in aqueous sodium##2##3##(2008-10#1)(2009-5#1)
in aqueous solution and in blood##2##6##(2008-10#2)
in aqueous solution and in##3##5##(1990-2#1)(2008-10#2)
in aqueous solution and to##2##5##(2008-10#1)(2008-5#1)
in aqueous solution and##13##4##(1990-2#1)(1990-5#1)(2008-10#10)(2008-5#1)
in aqueous solution are##3##4##(1990-8#1)(1991-8#1)(1997-2#1)
in aqueous solution at 25 degrees C##2##7##(2008-10#2)
in aqueous solution at pH##2##5##(2008-10#2)
in aqueous solution at##7##4##(1995-11#1)(1995-2#1)(2008-10#5)
in aqueous solution containing##2##4##(2008-10#2)
in aqueous solution for##2##4##(2008-10#1)(2008-11#1)
in aqueous solution have been determined##2##6##(2008-10#1)(2008-5#1)
in aqueous solution have been studied by##2##7##(1990-9#1)(2008-10#1)
in aqueous solution have been##4##5##(1990-9#1)(2008-10#2)(2008-5#1)
in aqueous solution in##2##4##(2008-10#2)
in aqueous solution of##2##4##(2008-10#2)
in aqueous solution using##2##4##(1992-8#1)(2008-10#1)
in aqueous solution was##4##4##(2008-10#3)(2009-8#1)
in aqueous solution were##4##4##(2008-10#3)(2008-8#1)
in aqueous solution with##2##4##(2008-10#2)
in aqueous solution##109##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-8#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#4)(1997-7#1)(2007-3#1)(2008-10#74)(2008-11#2)(2008-5#4)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2013-1#2)
in aqueous solutions and##2##4##(2008-10#1)(2008-11#1)
in aqueous solutions at##2##4##(2008-10#2)
in aqueous solutions containing##5##4##(2008-10#5)
in aqueous solutions for##2##4##(2008-10#1)(2009-6#1)
in aqueous solutions has been##2##5##(2008-10#2)
in aqueous solutions is extended##2##5##(2008-10#2)
in aqueous solutions is##6##4##(2008-10#5)(2008-5#1)
in aqueous solutions of##3##4##(1990-12#1)(2008-10#2)
in aqueous solutions shows an average recovery of##2##8##(2008-10#2)
in aqueous solutions was studied##2##5##(2008-10#2)
in aqueous solutions##56##3##(1990-12#1)(2007-12#1)(2008-10#46)(2008-11#2)(2008-3#3)(2008-5#1)(2009-6#1)(2011-2#1)
in aqueous suspensions of##2##4##(2007-12#1)(2008-10#1)
in aqueous systems##2##3##(2008-10#1)(2008-3#1)
in aqueous two-phase systems##2##4##(2008-6#1)(2008-7#1)
in aqueous##323##2##(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-8#2)(1992-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#6)(1997-7#1)(2007-11#4)(2007-12#3)(2007-3#1)(2008-10#238)(2008-11#6)(2008-12#6)(2008-3#4)(2008-5#11)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)
in archaeological##2##2##(2008-10#2)
in area 18 of##2##4##(2008-8#2)
in area CA1 and##2##4##(2008-9#2)
in area CA1 of hippocampal slices##2##6##(1995-2#1)(1996-5#1)
in area CA1 of##5##4##(1995-2#1)(1996-5#3)(2008-9#1)
in area CA1##9##3##(1995-2#1)(1996-2#1)(1996-5#3)(2008-9#4)
in area estimates##2##3##(1997-3#2)
in area##16##2##(1995-2#1)(1996-2#1)(1996-5#3)(1997-3#2)(2008-10#1)(2008-8#2)(2008-9#4)(2012-2#1)(2012-3#1)
in areas in which##2##4##(2008-8#1)(2011-2#1)
in areas of low transmission##2##5##(2008-8#1)(2012-12#1)
in areas of low##3##4##(2008-2#1)(2008-8#1)(2012-12#1)
in areas of##13##3##(1997-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)
in areas such as##5##4##(1994-3#1)(1995-11#1)(2008-12#1)(2010-12#1)(2012-2#1)
in areas that##4##3##(1990-9#1)(1994-1#1)(2007-6#1)(2008-4#1)
in areas where##8##3##(1994-3#1)(1996-12#1)(2007-2#2)(2008-10#2)(2008-8#1)(2012-3#1)
in areas with##6##3##(1990-11#1)(2008-10#3)(2008-8#1)(2011-2#1)
in areas##59##2##(1990-11#1)(1990-9#1)(1993-12#1)(1994-1#1)(1994-3#2)(1995-11#1)(1996-1#2)(1996-12#5)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-2#2)(2007-6#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
in argon##2##2##(2008-10#2)
in arid##2##2##(2008-10#1)(2008-8#1)
in arm##2##2##(1993-6#1)(1996-5#1)
in aroma##3##2##(2008-10#1)(2011-1#2)
in aromatic##2##2##(2008-10#2)
in around##3##2##(2010-11#1)(2012-3#1)(2013-7#1)
in arrays of##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
in arrays##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
in arresting##2##2##(2008-8#1)(2010-6#1)
in arsenic##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
in art##2##2##(1990-11#1)(1995-1#1)
in arterial and##2##3##(1994-3#1)(1997-8#1)
in arterial blood##2##3##(2009-11#1)(2013-1#1)
in arterial hypertension]##2##3##(1993-2#1)(1997-4#1)
in arterial plasma##2##3##(2008-10#2)
in arterial##19##2##(1990-11#1)(1991-11#1)(1993-2#1)(1994-3#1)(1996-3#1)(1997-4#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
in arteries##4##2##(2008-11#1)(2008-7#2)(2009-11#1)
in arteriosclerotic lesions##5##3##(1994-11#5)
in arteriovenous##2##2##(1996-3#1)(2012-1#1)
in arthritis##3##2##(2008-5#2)(2008-7#1)
in arthrogryposis##2##2##(1996-12#1)(2008-10#1)
in arthropod##3##2##(1991-5#1)(2007-12#1)(2008-7#1)
in arthropods##2##2##(2007-12#2)
in arthroscopic treatment of##2##4##(2007-11#2)
in arthroscopic##3##2##(2007-11#2)(2009-3#1)
in artichoke##2##2##(2008-10#2)
in artificial diet##2##3##(2011-2#2)
in artificial seawater##2##3##(2008-10#2)
in artificial##20##2##(1993-6#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
in artificially infested soil samples##2##5##(2008-10#2)
in artificially inoculated##2##3##(2008-10#2)
in artificially ventilated##2##3##(1996-9#2)
in artificially##8##2##(1996-9#2)(2008-10#5)(2008-9#1)
in as little as##6##4##(1991-9#1)(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
in as little##7##3##(1991-9#1)(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2012-8#1)(2013-1#1)
in as many##2##3##(2007-4#1)(2008-1#1)
in as much as##3##4##(2009-5#1)(2009-7#1)(2012-12#1)
in as##14##2##(1991-9#1)(1993-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-7#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
in asbestos abatement##2##3##(1991-12#1)(1992-2#1)
in asbestos##3##2##(1991-12#1)(1992-2#1)(2013-8#1)
in ascertaining##2##2##(2008-12#1)(2008-9#1)
in ascidian##2##2##(1993-6#1)(2008-6#1)
in ascites##4##2##(1997-6#1)(2008-11#2)(2013-1#1)
in ascomycete##2##2##(2008-10#2)
in ascospore production##2##3##(2008-10#1)(2008-8#1)
in ascospore##4##2##(2008-10#3)(2008-8#1)
in aseptic loosening of##2##4##(2007-11#1)(2008-8#1)
in aseptic##5##2##(1992-9#1)(2007-11#2)(2008-8#1)(2011-2#1)
in asexual##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
in ash##3##2##(2008-10#3)
in asian##3##2##(2008-3#1)(2013-1#2)
in aspirin-treated##2##2##(1992-8#1)(1993-3#1)
in assay conditions##2##3##(1992-9#2)
in assay##4##2##(1992-9#2)(2010-5#1)(2013-1#1)
in assays of##3##3##(1992-4#1)(2008-10#1)(2010-11#1)
in assays##6##2##(1992-4#1)(2008-10#3)(2008-8#1)(2010-11#1)
in assessing effectiveness##2##3##(1995-3#1)(2008-10#1)
in assessing for##2##3##(2011-2#1)(2012-3#1)
in assessing functional status##2##4##(2008-7#2)
in assessing patients##2##3##(2008-10#1)(2008-11#1)
in assessing the potential##2##4##(1997-2#1)(2008-10#1)
in assessing the risk of##2##5##(2008-10#2)
in assessing the##13##3##(1990-8#1)(1992-1#1)(1994-1#1)(1995-11#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-1#1)(2010-10#1)
in assessing##43##2##(1990-3#1)(1990-8#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-1#1)(1995-11#2)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
in assessment of##10##3##(1991-6#1)(1996-2#1)(2007-11#3)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
in assessment##13##2##(1991-6#1)(1994-2#1)(1996-1#1)(1996-2#1)(2007-11#3)(2008-11#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
in assigning##2##2##(1994-12#1)(2008-7#1)
in assimilating##2##2##(2008-11#1)(2013-8#1)
in assisted living##2##3##(2008-12#1)(2010-8#1)
in assisted##4##2##(2007-7#1)(2008-12#1)(2009-10#1)(2010-8#1)
in assisting##7##2##(1994-3#1)(1995-6#1)(2007-12#1)(2008-12#1)(2010-10#1)(2010-5#1)(2012-12#1)
in associated##3##2##(1991-2#1)(2008-8#1)(2009-4#1)
in association with a##12##4##(1991-12#2)(1992-9#1)(1993-1#1)(1995-12#1)(2008-10#3)(2008-6#2)(2008-8#1)(2010-5#1)
in association with an##2##4##(2011-2#2)
in association with both##2##4##(1995-8#1)(2007-5#1)
in association with flow injection analysis##2##6##(2008-10#2)
in association with malignant##2##4##(2010-3#1)(2011-2#1)
in association with other##2##4##(2008-10#1)(2013-1#1)
in association with the##8##4##(1993-1#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
in association with##96##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-6#1)(1994-12#2)(1994-3#2)(1994-6#2)(1995-12#3)(1995-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#3)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
in association##100##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-6#1)(1994-12#2)(1994-3#2)(1994-6#2)(1995-12#3)(1995-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#3)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
in associative##3##2##(2008-3#2)(2012-2#1)
in assuring##2##2##(1992-12#1)(1993-1#1)
in aster##3##2##(2008-10#3)
in asthma##18##2##(1992-12#1)(1992-2#3)(1992-3#1)(1994-1#1)(1996-1#1)(2007-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#2)(2012-12#2)(2012-3#1)(2013-1#1)
in asthmatic patients##2##3##(1997-1#1)(2007-2#1)
in asthmatic##5##2##(1990-9#1)(1997-1#1)(2007-2#1)(2008-1#1)(2010-1#1)
in asthmatics##2##2##(2007-6#1)(2009-1#1)
in astrocytes in##2##3##(1997-3#1)(2009-5#1)
in astrocytes##16##2##(1995-12#1)(1995-2#2)(1995-5#1)(1997-1#1)(1997-3#1)(2008-12#1)(2008-4#3)(2008-7#3)(2009-5#3)
in astrocytic tumours##2##3##(1996-5#2)
in astrocytic##3##2##(1996-5#2)(2008-7#1)
in astronomy##2##2##(1995-6#1)(2008-3#1)
in asymmetric##5##2##(1997-2#2)(2007-12#2)(2008-9#1)
in asymptomatic obese##2##3##(2011-1#1)(2012-2#1)
in asymptomatic patients##3##3##(1991-12#1)(2010-6#1)(2013-1#1)
in asymptomatic smokers##2##3##(1991-4#1)(1991-9#1)
in asymptomatic subjects##2##3##(2008-12#2)
in asymptomatic##18##2##(1990-2#1)(1991-12#1)(1991-4#1)(1991-9#1)(1995-4#1)(2008-12#2)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
in asynchronous##3##2##(1995-9#1)(1997-8#1)(2009-12#1)
in at least one##7##4##(1991-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-11#1)(2010-8#1)(2013-8#1)
in at least some##6##4##(1990-5#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(2010-3#1)
in at least two##6##4##(1990-12#1)(1990-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
in at least##30##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-3#2)(2010-8#1)(2012-3#1)(2013-8#1)
in at##33##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
in at-risk##3##2##(2009-12#1)(2009-9#1)(2013-7#1)
in atherogenesis##5##2##(1990-2#1)(1991-3#1)(1992-12#1)(1995-8#1)(2008-1#1)
in atherosclerosis and##4##3##(2008-1#1)(2008-3#1)(2008-4#2)
in atherosclerosis plaques##2##3##(2012-3#2)
in atherosclerosis##16##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2010-9#1)(2012-3#3)
in atherosclerotic lesions##5##3##(1991-2#1)(1992-5#1)(1993-3#1)(2011-1#2)
in atherosclerotic plaques##2##3##(2008-7#1)(2013-8#1)
in atherosclerotic##11##2##(1991-2#1)(1992-5#1)(1993-3#1)(1994-8#1)(2007-8#1)(2008-7#1)(2011-1#2)(2012-2#2)(2013-8#1)
in athletes##12##2##(1996-6#1)(2008-5#1)(2009-7#1)(2010-1#2)(2010-7#1)(2012-1#5)(2013-1#1)
in athymic mice##7##3##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-9#1)(1997-7#1)
in atlantic Canada##2##3##(1991-8#1)(2011-2#1)
in atmosphere##3##2##(2007-12#1)(2008-10#2)
in atmospheres##3##2##(2008-10#2)(2008-2#1)
in atmospheric aerosol##2##3##(2008-10#2)
in atmospheric liquids##2##3##(2008-10#2)
in atmospheric optics##2##3##(2008-2#1)(2008-3#1)
in atmospheric particulate matter##2##4##(2008-10#2)
in atmospheric pressure flames##2##4##(2008-2#1)(2008-3#1)
in atmospheric##19##2##(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#3)(2013-8#1)
in atomic absorption spectrometry##2##4##(2008-10#2)
in atomic absorption##3##3##(1995-5#1)(2008-10#2)
in atomic##7##2##(1995-5#1)(2006-4#2)(2007-11#1)(2008-10#2)(2013-1#1)
in atopic and nonatopic##2##4##(2012-3#2)
in atopic disorders##2##3##(2009-5#2)
in atopic##7##2##(1992-9#2)(1994-9#1)(2009-5#2)(2012-3#2)
in atria##3##2##(1992-6#1)(2013-1#2)
in atrial fibrillation##5##3##(1994-3#1)(1997-5#1)(2009-12#1)(2012-12#1)(2013-7#1)
in atrial##10##2##(1994-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
in attachment##2##2##(1992-3#1)(2012-2#1)
in attaining##3##2##(1990-6#1)(2007-7#1)(2008-3#1)
in attempts to##3##3##(1991-12#1)(2008-5#1)(2012-3#1)
in attendance##2##2##(1991-12#1)(2008-9#1)
in attending##3##2##(1993-12#2)(2013-8#1)
in attention##7##2##(1994-12#1)(1995-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-12#1)(2012-3#1)
in attitude##3##2##(2008-9#1)(2010-1#1)(2013-8#1)
in attracting the##2##3##(1990-11#1)(2010-9#1)
in attracting##5##2##(1990-11#1)(1996-8#1)(2008-10#1)(2008-11#1)(2010-9#1)
in attractive traits##2##3##(2008-8#2)
in auditory cortex##3##3##(1996-2#1)(2008-11#1)(2013-8#1)
in auditory##7##2##(1996-2#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
in augmenting##2##2##(2008-5#1)(2010-6#1)
in autism can##2##3##(2012-3#2)
in autism is##2##3##(1997-8#1)(2008-11#1)
in autism spectrum disorders##2##4##(2011-2#2)
in autism##10##2##(1997-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-9#1)(2011-2#2)(2012-3#2)
in autistic##2##2##(1997-8#1)(2008-3#1)
in autoclaved##5##2##(2008-10#5)
in autoimmune disease##2##3##(1993-3#1)(1994-8#1)
in autoimmune diseases##3##3##(1994-8#1)(2010-5#1)(2011-2#1)
in autoimmune hepatitis##2##3##(1990-9#1)(2006-10#1)
in autoimmune##15##2##(1990-3#1)(1990-9#1)(1991-2#1)(1993-3#2)(1994-8#2)(1995-3#1)(2006-10#1)(2007-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
in autoimmunity##2##2##(1992-8#1)(2010-5#1)
in automated##3##2##(2008-1#1)(2008-5#1)(2009-11#1)
in automatic##2##2##(1991-8#1)(2008-10#1)
in automation of##2##3##(2008-10#1)(2011-2#1)
in automation##4##2##(2008-10#3)(2011-2#1)
in automobile exhaust##2##3##(2008-10#1)(2008-11#1)
in automotive fuel ethanol##2##4##(2008-10#2)
in automotive fuel##3##3##(2008-10#3)
in automotive##4##2##(2008-10#4)
in autonomic##4##2##(1995-12#2)(2007-10#2)
in autonomous##2##2##(2012-2#1)(2013-1#1)
in autophagy##4##2##(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
in autumn and winter##2##4##(2008-10#1)(2008-5#1)
in autumn and##4##3##(2008-10#2)(2008-5#2)
in autumn##14##2##(1996-12#1)(2008-10#4)(2008-5#2)(2010-8#3)(2011-2#2)(2011-9#1)(2013-7#1)
in auxin##2##2##(2009-10#1)(2009-8#1)
in available##3##2##(1993-1#1)(2012-2#2)
in average cost##2##3##(1992-12#2)
in average temperature factors##2##4##(2008-9#2)
in average torque##2##3##(2008-12#2)
in average##24##2##(1992-12#3)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-8#1)(2012-1#1)(2012-3#1)
in avian##3##2##(1997-6#1)(2008-3#1)(2009-2#1)
in avirulence##2##2##(2008-10#2)
in avoiding##9##2##(1990-9#1)(1996-9#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
in awake##4##2##(1997-7#1)(2007-10#2)(2010-12#1)
in axenic media##2##3##(2008-10#2)
in axenic##3##2##(2008-10#3)
in axial##5##2##(1995-11#2)(2008-10#1)(2008-9#1)(2012-12#1)
in axillary skin surface pH##3##5##(2008-5#3)
in axillary skin##5##3##(2008-5#5)
in axillary##13##2##(1995-4#1)(2008-5#9)(2008-8#1)(2009-8#1)(2013-1#1)
in axon terminals of##2##4##(1997-2#2)
in axon terminals##3##3##(1995-12#1)(1997-2#2)
in axonal length were##2##4##(2008-7#2)
in azobenzene side-chain polymers##2##4##(2008-3#2)
in babies born##2##3##(1991-3#1)(2008-11#1)
in babies##5##2##(1991-3#1)(1996-2#1)(2007-7#1)(2008-11#1)(2012-3#1)
in baboons##2##2##(1991-1#2)
in baccalaureate nursing##2##3##(2008-11#1)(2008-12#1)
in bacilli##2##2##(2011-2#2)
in back pain##4##3##(2007-11#3)(2007-8#1)
in back##5##2##(2007-11#3)(2007-8#1)(2010-2#1)
in background##4##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-3#1)
in backscatter##2##2##(2008-2#1)(2008-3#1)
in backscattering##2##2##(2008-2#1)(2008-3#1)
in bacteria and##6##3##(1993-12#1)(1995-6#1)(2008-10#1)(2008-3#1)(2013-8#2)
in bacteria are##2##3##(1990-8#1)(2008-9#1)
in bacteria by##2##3##(2008-9#1)(2012-2#1)
in bacteria in food-producing animals##2##5##(2010-4#2)
in bacteria in##3##3##(2008-4#1)(2010-4#2)
in bacteria that##3##3##(2008-11#1)(2009-6#1)(2010-4#1)
in bacteria##35##2##(1990-8#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-6#2)(1995-6#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-4#5)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#3)
in bacterial cells##3##3##(1993-8#1)(1994-6#1)(2008-10#1)
in bacterial levels##2##3##(2008-10#1)(2008-5#1)
in bacterial pathogenesis##2##3##(2013-1#2)
in bacterial populations##2##3##(2008-10#2)
in bacterial strains##2##3##(2011-2#1)(2012-12#1)
in bacterial vaginosis##2##3##(2007-7#1)(2011-2#1)
in bacterial##36##2##(1990-2#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(2007-5#1)(2007-7#1)(2008-10#12)(2008-4#1)(2008-5#3)(2010-10#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
in bacteriophage##3##2##(1997-7#2)(2013-1#1)
in bacteriorhodopsin films##3##3##(2007-12#1)(2008-2#2)
in baculovirus-infected insect cells##3##4##(1993-6#1)(1994-8#1)(1997-4#1)
in bags##2##2##(2008-10#1)(2012-2#1)
in bahrain##2##2##(2007-7#1)(2008-4#1)
in balanced funds##2##3##(2011-2#2)
in banana##2##2##(2008-10#2)
in bangladesh##2##2##(2007-7#1)(2008-10#1)
in bar##2##2##(1990-11#1)(2008-3#1)
in bariatric surgery##3##3##(1993-3#1)(1993-5#1)(2013-1#1)
in bariatric surgery]##2##3##(1993-3#1)(1993-5#1)
in bariatric##5##2##(1993-3#2)(1993-5#2)(2013-1#1)
in bark samples##2##3##(2008-10#2)
in bark##4##2##(2008-10#4)
in barley aleurone##2##3##(2008-8#2)
in barley and##2##3##(2008-10#2)
in barley is##2##3##(2008-10#1)(2008-9#1)
in barley to##3##3##(2008-10#2)(2008-5#1)
in barley##35##2##(1997-6#1)(2008-10#25)(2008-12#1)(2008-5#5)(2008-8#2)(2008-9#1)
in barrier function##2##3##(2008-5#1)(2008-7#1)
in basal and##4##3##(1995-6#1)(1996-12#1)(2008-11#1)(2011-2#1)
in basal conditions##5##3##(1990-2#1)(1991-9#1)(1995-5#1)(1997-2#1)(2013-7#1)
in basal medium##2##3##(1994-3#2)
in basal plasma##2##3##(1990-5#2)
in basal##35##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-9#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-7#1)
in baseline##6##2##(1992-8#1)(2008-10#3)(2009-12#1)(2011-2#1)
in basement##2##2##(1993-3#1)(1997-4#1)
in basic conditions##2##3##(1990-5#1)(2012-2#1)
in basic medium##5##3##(2008-10#5)
in basic research##3##3##(1997-4#1)(2008-5#1)(2008-8#1)
in basic##27##2##(1990-5#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
in basidiomycetes##2##2##(2008-6#1)(2011-1#1)
in basolateral membranes##2##3##(1993-3#2)
in basolateral##4##2##(1993-3#2)(1994-12#1)(2012-12#1)
in batch and continuous##6##4##(1994-5#2)(2008-11#1)(2008-12#1)(2008-6#2)
in batch and fed-batch cultures##3##5##(2008-11#3)
in batch and fed-batch##5##4##(2008-11#5)
in batch and##12##3##(1994-5#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-6#2)
in batch culture and##2##4##(2008-11#2)
in batch culture of##2##4##(1994-8#1)(2008-11#1)
in batch culture##11##3##(1994-8#1)(2008-11#10)
in batch cultures of##2##4##(2008-11#1)(2012-3#1)
in batch cultures##5##3##(1995-9#1)(2008-11#2)(2008-6#1)(2012-3#1)
in batch experiments##2##3##(2008-10#1)(2008-6#1)
in batch fecundity##2##3##(2010-8#2)
in batch mode##2##3##(2008-10#1)(2008-11#1)
in batch systems##2##3##(2008-7#2)
in batch##48##2##(1994-5#2)(1994-8#1)(1995-9#1)(1996-7#1)(2008-10#11)(2008-11#20)(2008-12#1)(2008-3#1)(2008-6#4)(2008-7#2)(2010-8#2)(2012-3#2)
in beam quality##2##3##(2008-2#1)(2008-3#1)
in beam##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
in bean and##2##3##(2008-10#2)
in bean##8##2##(1992-8#1)(2008-10#7)
in beating##2##2##(1996-2#1)(2010-8#1)
in bed##3##2##(1994-3#1)(2007-8#1)(2013-1#1)
in beef cattle sheds##2##4##(2010-4#2)
in beef cattle##3##3##(2010-4#2)(2012-3#1)
in beef##5##2##(1996-3#1)(1996-6#1)(2010-4#2)(2012-3#1)
in beer samples##3##3##(2008-10#3)
in beer using##2##3##(2008-10#2)
in beer##12##2##(2008-10#11)(2008-7#1)
in beers##3##2##(2008-10#3)
in beetles##2##2##(2007-12#2)
in behaving animals##2##3##(2007-8#1)(2008-4#1)
in behavior##5##2##(1990-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2009-2#1)
in behavioral##9##2##(1995-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-9#1)(2011-2#1)
in behaviour##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
in being##4##2##(1996-12#1)(2007-12#2)(2008-9#1)
in bell pepper##3##3##(2008-10#3)
in below##3##2##(2010-3#1)(2012-2#1)(2012-3#1)
in benchmarking##3##2##(1996-3#2)(1997-1#1)
in beneficiary costs##2##3##(1991-3#1)(1993-3#1)
in benign and malignant##2##4##(1993-11#2)
in benign##12##2##(1990-6#1)(1993-1#1)(1993-11#3)(1993-2#1)(1994-8#1)(1995-11#2)(1997-7#1)(2008-8#1)(2013-1#1)
in benthic##2##2##(2008-5#1)(2012-1#1)
in benzene##5##2##(1996-2#2)(2007-12#1)(2008-10#2)
in berries##3##2##(2008-10#3)
in beryllium##2##2##(1990-5#1)(2008-10#1)
in beta 1##2##3##(1993-11#2)
in beta##6##2##(1993-11#2)(1993-12#1)(2007-12#1)(2008-1#1)(2008-3#1)
in beta-1##2##2##(2008-10#2)
in beta-CD##3##2##(2008-10#3)
in beta-cells##3##2##(1996-2#1)(1996-5#2)
in beta-cyclodextrin##4##2##(2008-10#4)
in beta-oxidation##2##2##(1990-5#1)(1995-6#1)
in beta-sheets##2##2##(1995-2#1)(1997-7#1)
in better##12##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
in between the##6##3##(2007-12#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-1#1)
in between##20##2##(1990-12#1)(1991-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-5#2)(2010-8#2)(2011-1#1)
in beverages by##3##3##(2008-10#3)
in beverages##11##2##(2008-10#9)(2010-9#2)
in bias##2##2##(1997-5#1)(2007-12#1)
in biased estimates##2##3##(1994-11#1)(2008-2#1)
in biased##4##2##(1994-11#1)(1996-11#1)(2007-12#1)(2008-2#1)
in bigger##2##2##(1995-12#1)(2010-10#1)
in bilateral cleft lip and palate patient##2##7##(2013-1#2)
in bilateral cochlear implant##2##4##(2008-9#2)
in bilateral cochlear##3##3##(2008-9#3)
in bilateral##12##2##(1996-12#1)(2008-9#3)(2010-5#1)(2011-2#3)(2013-1#2)(2013-8#2)
in bilaterally##2##2##(1990-5#1)(2008-9#1)
in bile ductular epithelial cells##2##5##(1990-12#2)
in bile##12##2##(1990-12#2)(1991-12#2)(1992-3#1)(1993-3#1)(2008-5#3)(2008-8#2)(2012-2#1)
in biliary##3##2##(1990-8#1)(1994-6#1)(2012-2#1)
in binary mixtures of##2##4##(2008-10#2)
in binary mixtures were studied##3##5##(2008-10#3)
in binary mixtures with##2##4##(2008-10#1)(2008-3#1)
in binary mixtures##9##3##(2008-10#8)(2008-3#1)
in binary##17##2##(1995-2#1)(2007-12#1)(2008-10#13)(2008-3#2)
in binding affinity##5##3##(1995-3#3)(2009-7#1)(2012-2#1)
in binding of the##2##4##(1992-6#1)(1992-8#1)
in binding of##4##3##(1990-11#1)(1992-6#1)(1992-8#1)(1994-5#1)
in binding sites was##2##4##(1994-11#2)
in binding to the##6##4##(1991-5#1)(1993-11#1)(1995-6#2)(2008-11#1)(2010-5#1)
in binding to##16##3##(1990-2#1)(1991-5#1)(1992-10#1)(1992-12#2)(1993-11#1)(1993-3#1)(1994-5#1)(1995-6#3)(1997-7#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)
in binding##43##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#3)(1995-3#4)(1995-5#1)(1995-6#3)(1996-12#1)(1997-2#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-5#1)(2012-2#2)
in bio-optical imaging##2##3##(2008-3#2)
in bioanalysis##5##2##(2008-10#2)(2010-11#3)
in bioanalytical##2##2##(2008-10#1)(2010-11#1)
in bioassays##4##2##(2008-10#4)
in biochemical##7##2##(1990-8#1)(1994-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2011-3#1)
in biochemistry##4##2##(1992-11#1)(1997-2#1)(2008-11#1)(2008-4#1)
in biocompatible##2##2##(2009-11#1)(2010-10#1)
in biocontrol efficacy##2##3##(2008-10#2)
in biocontrol##3##2##(2008-10#3)
in biodiesel blends##2##3##(2008-10#2)
in biodiesel##3##2##(2008-10#2)(2013-1#1)
in bioethical decision-making##3##3##(1994-12#3)
in bioethical##4##2##(1994-12#3)(2008-1#1)
in biofilm formation##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
in biofilm##5##2##(2008-10#1)(2009-6#2)(2011-1#1)(2012-2#1)
in biofilms##2##2##(2008-3#2)
in biofluids##2##2##(2010-11#2)
in bioinformatics##3##2##(2007-12#1)(2008-7#2)
in biologic##2##2##(2008-10#1)(2008-3#1)
in biological and environmental samples##3##5##(2008-10#3)
in biological and medical research##2##5##(1991-6#1)(2007-11#1)
in biological and##9##3##(1991-6#1)(2007-11#1)(2008-10#5)(2008-2#1)(2010-3#1)
in biological cells##2##3##(2007-11#1)(2008-10#1)
in biological control of##3##4##(2008-10#3)
in biological control##7##3##(2008-10#7)
in biological fluid##2##3##(2008-10#2)
in biological fluids by high-performance liquid chromatography##2##7##(1990-8#1)(1992-1#1)
in biological fluids by##3##4##(1990-8#1)(1992-1#1)(2008-10#1)
in biological fluids is##3##4##(1990-12#1)(2008-10#2)
in biological fluids such as##2##5##(2008-11#1)(2008-4#1)
in biological fluids##26##3##(1990-12#3)(1990-8#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#2)(1996-12#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-4#1)(2010-11#2)(2011-1#1)
in biological macromolecules##3##3##(1990-8#2)(1997-6#1)
in biological materials and waters##2##5##(2008-10#2)
in biological materials and##3##4##(2008-10#3)
in biological materials by##5##4##(1991-7#1)(2008-10#4)
in biological materials##11##3##(1991-7#1)(2008-10#9)(2008-3#1)
in biological matrices by##2##4##(2008-10#2)
in biological matrices##8##3##(2008-10#4)(2010-11#3)(2012-12#1)
in biological media##3##3##(2008-10#2)(2010-7#1)
in biological membranes##3##3##(1992-3#1)(1992-9#1)(1994-5#1)
in biological neural networks##2##4##(2008-11#2)
in biological processes##3##3##(2008-10#2)(2013-1#1)
in biological reference materials##2##4##(2008-10#2)
in biological samples by##6##4##(1993-9#1)(2008-10#5)
in biological samples is##2##4##(1993-9#1)(2008-10#1)
in biological samples of##2##4##(2010-11#1)(2012-3#1)
in biological samples using##2##4##(2008-10#2)
in biological samples##39##3##(1993-9#2)(2008-10#33)(2008-4#1)(2009-12#1)(2010-11#1)(2012-3#1)
in biological systems are##2##4##(2008-10#1)(2009-2#1)
in biological systems##19##3##(1990-3#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2010-11#1)(2010-2#1)(2010-3#1)(2013-1#1)
in biological tissue##6##3##(2007-12#2)(2008-3#2)(2009-8#1)(2011-1#1)
in biological tissues with##2##4##(2008-10#1)(2008-3#1)
in biological tissues##11##3##(2008-10#4)(2008-2#2)(2008-3#4)(2013-8#1)
in biological##176##2##(1990-12#3)(1990-3#1)(1990-8#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#2)(1993-12#1)(1993-9#2)(1994-2#2)(1994-5#2)(1994-9#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#89)(2008-11#5)(2008-2#3)(2008-3#7)(2008-4#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#9)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in biology and medicine##2##4##(2008-3#1)(2010-7#1)
in biology##21##2##(1990-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-2#1)(2010-7#1)(2012-2#3)(2012-3#1)(2012-5#1)
in biomarker discovery##2##3##(2008-10#1)(2010-5#1)
in biomarker##3##2##(2008-10#1)(2010-5#2)
in biomass and##2##3##(2008-12#1)(2008-7#1)
in biomass##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
in biomechanical##2##2##(2008-5#1)(2008-9#1)
in biomedical imaging##3##3##(2007-11#1)(2008-3#1)(2009-5#1)
in biomedical research##9##3##(1996-3#1)(1997-2#2)(1997-4#1)(2008-7#1)(2009-6#2)(2009-9#1)(2013-1#1)
in biomedical##20##2##(1994-3#1)(1996-3#1)(1997-2#2)(1997-4#1)(2007-11#1)(2007-7#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2013-1#1)
in biomedicine##2##2##(2010-6#1)(2013-8#1)
in biomembranes##2##2##(2008-11#1)(2008-7#1)
in biopharmaceutical process##2##3##(2008-11#1)(2010-11#1)
in biopharmaceutical production##2##3##(2008-11#2)
in biopharmaceutical##4##2##(2008-11#3)(2010-11#1)
in biophysical##2##2##(2008-2#1)(2008-5#1)
in biophysics##2##2##(2009-9#1)(2012-3#1)
in biopolymer##2##2##(2008-4#1)(2011-2#1)
in biopsy##2##2##(1993-12#1)(2012-3#1)
in bioreactor vent gases##2##4##(2008-3#2)
in bioreactor##6##2##(2008-11#4)(2008-3#2)
in bioreactors##11##2##(2008-11#6)(2008-7#4)(2010-11#1)
in biotechnological##3##2##(2008-10#2)(2009-5#1)
in biotechnology and##2##3##(1995-11#1)(2011-2#1)
in biotechnology##6##2##(1995-11#1)(1997-4#1)(2008-11#1)(2008-9#1)(2011-2#2)
in biotransformation##2##2##(2007-11#1)(2008-10#1)
in bipolar disorder##4##3##(2009-8#2)(2012-2#2)
in bipolar##8##2##(1996-7#1)(2008-1#1)(2009-8#2)(2010-2#1)(2012-2#2)(2013-8#1)
in birds and mammals is##2##5##(2008-8#1)(2008-9#1)
in birds and mammals##3##4##(1994-5#1)(2008-8#1)(2008-9#1)
in birds##23##2##(1991-6#1)(1992-2#1)(1994-5#1)(1995-9#1)(1997-3#1)(1997-6#1)(2008-5#1)(2008-8#6)(2008-9#10)
in birefringence##3##2##(2008-3#3)
in birefringent##5##2##(2007-12#2)(2008-3#3)
in birefringently phase-matched GaAs/Al(2)O(3) waveguides##2##5##(2007-12#2)
in birth##6##2##(1992-5#1)(1995-9#1)(1997-7#2)(2008-11#1)(2012-12#1)
in bismuth silicon oxide##4##4##(2007-12#2)(2008-3#2)
in bit-patterned##2##2##(2009-6#2)
in bivariate analysis##2##3##(2008-10#1)(2012-12#1)
in black rockfish Sebastes melanops##2##5##(2010-8#2)
in black women##2##3##(2013-1#2)
in black##10##2##(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#2)
in blacks##4##2##(1995-11#3)(2010-3#1)
in bladder cancer patients##2##4##(2008-4#1)(2013-8#1)
in bladder cancer##7##3##(1995-8#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2013-8#2)
in bladder exstrophy##2##3##(2008-10#2)
in bladder##12##2##(1991-11#1)(1992-12#1)(1994-2#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2013-8#2)
in blank##2##2##(2008-10#1)(2012-3#1)
in bleeding##3##2##(2009-3#2)(2012-3#1)
in blind chicks##2##3##(1990-11#2)
in blind##3##2##(1990-11#3)
in blocking the##2##3##(1995-12#1)(2008-8#1)
in blood and in##2##4##(1992-5#1)(2008-2#1)
in blood and##10##3##(1992-5#1)(1997-7#2)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#2)
in blood coagulation##4##3##(1991-3#1)(1991-6#1)(2006-6#1)(2007-8#1)
in blood culture##3##3##(2010-12#2)(2011-2#1)
in blood cultures##2##3##(1997-7#1)(2010-12#1)
in blood donors##5##3##(1991-11#2)(2009-3#1)(2011-2#2)
in blood flow##9##3##(1990-7#1)(1996-3#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
in blood gases and##2##4##(1993-2#1)(1996-5#1)
in blood glucose level##2##4##(1991-2#1)(2008-10#1)
in blood glucose##7##3##(1990-6#1)(1991-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-5#1)
in blood is##3##3##(1991-2#1)(2008-10#2)
in blood or in##2##4##(1990-2#1)(2008-8#1)
in blood or##4##3##(1990-2#1)(1990-8#1)(2006-10#1)(2008-8#1)
in blood plasma##9##3##(2007-8#1)(2008-10#6)(2011-2#1)(2013-1#1)
in blood pressure and heart rate##2##6##(1995-12#2)
in blood pressure and##3##4##(1995-12#2)(2012-1#1)
in blood pressure elicited by intravenous##2##6##(1995-12#2)
in blood pressure of##2##4##(1995-12#1)(2007-10#1)
in blood pressure##29##3##(1990-2#1)(1990-3#1)(1990-5#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-12#6)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2011-2#1)(2012-1#2)
in blood samples of##3##4##(1990-8#1)(2011-2#1)(2013-1#1)
in blood samples##9##3##(1990-8#2)(1992-3#1)(2008-10#2)(2008-3#1)(2011-2#2)(2013-1#1)
in blood serum and##5##4##(2008-10#2)(2008-5#1)(2008-7#2)
in blood serum of patients of different age##2##8##(2013-1#2)
in blood serum of##3##4##(2008-5#1)(2013-1#2)
in blood serum samples##4##4##(2008-10#4)
in blood serum##20##3##(2008-10#11)(2008-5#2)(2008-7#2)(2011-1#1)(2013-1#4)
in blood using##2##3##(1992-3#1)(2008-10#1)
in blood vessels##4##3##(1991-8#1)(2008-4#2)(2012-1#1)
in blood volume flow##2##4##(2006-10#2)
in blood was##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
in blood##172##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#3)(1994-11#2)(1995-11#1)(1995-12#6)(1996-12#1)(1996-3#3)(1996-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-10#3)(2006-6#1)(2007-10#3)(2007-11#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#44)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2010-12#3)(2010-3#1)(2011-1#3)(2011-2#9)(2012-1#4)(2012-2#1)(2012-5#1)(2013-1#9)
in blubber of##2##3##(2008-10#2)
in blue light##2##3##(1991-9#1)(2012-3#1)
in blue tit nests##2##4##(2008-8#2)
in blue##6##2##(1991-9#1)(2007-12#1)(2008-8#3)(2012-3#1)
in blunt##4##2##(1990-2#2)(2009-6#1)(2012-2#1)
in bobcats##2##2##(2009-4#2)
in body fat##2##3##(2008-5#1)(2010-6#1)
in body fluids##6##3##(1990-12#1)(2008-10#3)(2008-5#1)(2009-11#1)
in body image##2##3##(2007-12#2)
in body mass index##2##4##(2009-6#1)(2011-1#1)
in body mass##5##3##(2008-5#2)(2008-9#1)(2009-6#1)(2011-1#1)
in body size at maturity##2##5##(2008-8#2)
in body size##10##3##(2008-8#4)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
in body temperature and##2##4##(1995-3#1)(2008-5#1)
in body weight and##2##4##(1992-10#1)(1995-3#1)
in body weight gain##3##4##(2008-12#1)(2010-4#1)(2013-1#1)
in body weight##13##3##(1992-10#1)(1993-8#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#2)
in body##55##2##(1990-12#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-3#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#10)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#1)
in boiling##2##2##(2007-11#2)
in bone and##3##3##(2007-11#2)(2008-6#1)
in bone banks##2##3##(1996-3#2)
in bone density##4##3##(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)
in bone is##2##3##(2008-8#1)(2009-3#1)
in bone marrow aspirate##4##4##(2007-4#2)(2008-7#2)
in bone marrow cells of##2##5##(2010-1#2)
in bone marrow cells##6##4##(1990-6#1)(1992-8#1)(2010-1#2)(2010-8#1)(2013-1#1)
in bone marrow in##2##4##(2011-2#2)
in bone marrow of##2##4##(2008-4#1)(2008-9#1)
in bone marrow##29##3##(1990-6#1)(1992-8#1)(1993-8#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-4#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#5)(2012-12#1)(2013-1#1)
in bone mass##6##3##(1991-11#1)(1993-11#4)(2011-2#1)
in bone metabolism##4##3##(1991-11#1)(1993-11#1)(2008-11#1)(2013-1#1)
in bone metastases##3##3##(2007-11#3)
in bone mineral density##2##4##(2007-7#1)(2012-2#1)
in bone tissue##2##3##(2007-11#1)(2009-7#1)
in bone tumors##2##3##(2007-10#1)(2007-8#1)
in bone turnover##2##3##(2008-11#1)(2010-10#1)
in bone##80##2##(1990-11#2)(1990-6#1)(1991-11#2)(1992-8#1)(1993-11#5)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-3#2)(1997-1#2)(2006-10#1)(2007-10#2)(2007-11#7)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#4)
in borate buffer (pH 9##2##5##(1994-9#1)(2008-10#1)
in borate buffer##4##3##(1994-9#1)(1996-12#1)(2008-10#1)(2011-1#1)
in border##4##2##(1994-3#1)(1996-5#1)(2008-10#2)
in borderline personality##2##3##(2009-10#1)(2009-9#1)
in borderline##3##2##(2006-10#1)(2009-10#1)(2009-9#1)
in boron neutron capture therapy##2##5##(1994-3#2)
in boron##4##2##(1990-3#1)(1994-3#2)(2008-10#1)
in botanical##3##2##(2008-10#3)
in both 2- and##2##4##(1997-2#1)(2012-12#1)
in both English and Spanish##2##5##(2008-12#1)(2012-12#1)
in both RNA##2##3##(1992-3#1)(2012-2#1)
in both S##2##3##(1994-12#1)(2008-10#1)
in both States##2##3##(1991-1#2)
in both a##4##3##(1991-3#1)(1994-8#1)(1994-9#1)(1995-9#1)
in both adults and children##2##5##(1996-2#1)(2008-6#1)
in both an##2##3##(2008-3#1)(2012-2#1)
in both animal and##3##4##(1991-12#1)(1992-3#1)(2008-7#1)
in both animal models and human studies##2##7##(2008-10#1)(2012-2#1)
in both animal##6##3##(1991-12#1)(1992-3#1)(1993-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
in both animals and humans##2##5##(2008-11#1)(2012-2#1)
in both animals and##4##4##(1996-5#1)(2008-11#1)(2010-4#1)(2012-2#1)
in both aqueous and non-aqueous mediums is##2##7##(2008-10#2)
in both aqueous and non-aqueous##3##5##(2008-10#3)
in both aqueous and##5##4##(2008-10#4)(2008-6#1)
in both aqueous##6##3##(2008-10#4)(2008-6#2)
in both areas##4##3##(1992-10#1)(1997-2#1)(2008-4#1)(2010-8#1)
in both assays##6##3##(1991-12#1)(1993-12#2)(2008-10#1)(2010-5#1)(2012-2#1)
in both basic and clinical research##2##6##(2008-9#2)
in both batch and fed-batch##2##5##(2008-11#1)(2008-7#1)
in both batch and##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
in both calves##2##3##(1996-11#1)(2013-1#1)
in both cases the##2##4##(2008-7#1)(2013-1#1)
in both cases##31##3##(1990-5#1)(1990-7#1)(1991-2#1)(1995-11#1)(1995-5#1)(1997-7#1)(2007-12#2)(2008-10#10)(2008-7#4)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in both cell lines##8##4##(1991-5#1)(1994-11#1)(1997-2#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#2)
in both cell types##2##4##(2008-11#1)(2008-5#1)
in both cell##13##3##(1991-5#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#2)
in both cells##4##3##(1993-8#1)(1994-12#1)(1997-8#1)(2011-2#1)
in both cerebral hemispheres using surface EMG recording in bilateral SHM##2##11##(2011-2#2)
in both children and adults##3##5##(2007-8#1)(2008-12#1)(2008-9#1)
in both clinical and##2##4##(1993-12#1)(2008-11#1)
in both clinical##5##3##(1993-12#1)(1995-5#1)(2008-11#2)(2008-5#1)
in both conditions##4##3##(1996-5#1)(2008-4#1)(2009-11#1)(2012-12#1)
in both control and##3##4##(1995-12#1)(2007-7#1)(2008-11#1)
in both coronary##2##3##(1991-8#1)(2009-9#1)
in both cortex and##2##4##(1992-7#1)(1996-5#1)
in both countries##4##3##(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
in both crystal##2##3##(2007-11#1)(2008-8#1)
in both cultivars and in##2##5##(2008-10#2)
in both cultivars##7##3##(2008-10#7)
in both cultures##2##3##(2008-11#1)(2013-8#1)
in both cytosolic and##2##4##(1993-8#1)(1997-4#1)
in both cytosolic##3##3##(1990-7#1)(1993-8#1)(1997-4#1)
in both deoxy and carbonmonoxy forms##2##6##(1990-8#2)
in both developed and##2##4##(2008-5#1)(2009-6#1)
in both diagnostic and##2##4##(1993-1#1)(2008-9#1)
in both directions and##2##4##(2008-3#1)(2008-8#1)
in both directions##8##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-2#1)
in both diseases##4##3##(2009-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
in both domestic##2##3##(1996-12#1)(2010-8#1)
in both environments##2##3##(2008-10#1)(2008-9#1)
in both enzymatic##2##3##(1990-12#1)(2013-1#1)
in both enzyme-linked immunosorbent##2##4##(2008-10#2)
in both epithelial##2##3##(2008-10#1)(2013-1#1)
in both experiments##7##3##(1992-10#1)(1993-3#1)(2007-12#1)(2008-10#4)
in both eyes##7##3##(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
in both fed and fasted rats##2##6##(1994-8#2)
in both fed and fasted##3##5##(1994-8#2)(2008-7#1)
in both female and male##2##5##(1992-8#1)(2010-8#1)
in both flag leaves and##2##5##(2008-9#2)
in both flag##3##3##(2008-9#3)
in both forms##2##3##(2008-7#1)(2013-1#1)
in both fractions##4##3##(1990-12#1)(1993-12#1)(1996-5#1)(2008-10#1)
in both genders##3##3##(2006-6#1)(2008-3#1)(2008-7#1)
in both groups and##5##4##(1992-6#1)(1993-12#1)(2007-7#2)(2008-12#1)
in both groups of mice##2##5##(1995-12#1)(1997-2#1)
in both groups of##7##4##(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
in both groups were##7##4##(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#2)
in both groups##89##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1995-12#1)(1995-6#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#2)
in both healthy##2##3##(2010-6#1)(2012-12#1)
in both hemispheres##2##3##(1996-12#1)(1996-5#1)
in both homodyne and heterodyne Michelson interferometers##2##7##(2007-12#2)
in both human and experimental##2##5##(1997-8#1)(2008-1#1)
in both human and##5##4##(1994-3#1)(1997-8#1)(2008-1#1)(2008-9#1)(2012-3#1)
in both human##6##3##(1990-2#1)(1994-3#1)(1997-8#1)(2008-1#1)(2008-9#1)(2012-3#1)
in both humans and##3##4##(1997-9#1)(2008-11#1)(2013-8#1)
in both in##2##3##(2008-4#1)(2012-3#1)
in both inoculated and##2##4##(2008-10#2)
in both insects and vertebrates##3##5##(2007-12#3)
in both insects##4##3##(2007-12#3)(2008-8#1)
in both intact and##2##4##(1990-11#1)(1994-11#1)
in both intact##3##3##(1990-11#1)(1992-11#1)(1994-11#1)
in both internal and external rotation of the lower leg##2##10##(2007-8#2)
in both intervention##2##3##(2010-7#1)(2012-2#1)
in both its##2##3##(1994-5#1)(2008-2#1)
in both juvenile and##2##4##(2012-2#1)(2013-1#1)
in both laboratory##2##3##(2008-10#1)(2008-5#1)
in both legs##3##3##(1995-3#1)(2008-12#2)
in both loading##2##3##(2009-3#2)
in both lobes##2##3##(2010-11#1)(2011-1#1)
in both locations##3##3##(2008-1#1)(2008-10#2)
in both male and female DNA##2##6##(1992-11#2)
in both male and female##4##5##(1992-11#2)(1993-5#1)(2008-9#1)
in both males and females##4##5##(1995-2#1)(2008-4#1)(2012-2#1)(2013-7#1)
in both media##2##3##(2008-10#1)(2008-11#1)
in both men and women##9##5##(1994-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-4#1)(2011-1#2)(2013-1#2)
in both men and##10##4##(1994-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-4#1)(2011-1#2)(2013-1#2)
in both methods##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)
in both models##4##3##(1992-3#1)(1996-4#1)(2008-10#1)(2012-12#1)
in both modes##3##3##(2008-10#3)
in both mouse##4##3##(1993-3#1)(2008-5#2)(2012-2#1)
in both muscles##5##3##(1995-12#1)(2009-3#1)(2010-4#3)
in both neuronal##2##3##(1994-2#1)(1995-5#1)
in both normal and##6##4##(1992-3#1)(1994-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
in both normal human dermal##2##5##(2008-5#2)
in both normal##8##3##(1992-3#1)(1994-5#1)(2008-5#2)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
in both of the treatment groups##3##6##(1994-12#3)
in both of the##8##4##(1994-12#3)(2008-10#2)(2008-7#2)(2012-1#1)
in both of them##2##4##(1991-6#1)(2011-1#1)
in both of these##2##4##(2008-7#1)(2012-12#1)
in both of##14##3##(1991-6#1)(1994-12#3)(2008-10#2)(2008-7#3)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
in both optical##2##3##(2008-3#2)
in both parameters##2##3##(2007-11#1)(2008-6#1)
in both patients##10##3##(1992-2#1)(1992-4#1)(1997-6#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
in both pharmacological and##2##4##(2008-11#1)(2009-7#1)
in both plant##2##3##(2008-10#2)
in both plants##2##3##(2008-10#2)
in both populations and##2##4##(2011-1#1)(2013-7#1)
in both populations##11##3##(1990-8#4)(1993-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-7#1)
in both prairie and##2##4##(2008-8#1)(2008-9#1)
in both procedures##3##3##(2008-12#1)(2011-2#2)
in both prokaryotes and eukaryotes##2##5##(1996-12#1)(2012-3#1)
in both pure##2##3##(2008-10#1)(2008-7#1)
in both quality and##2##4##(2008-11#1)(2008-5#1)
in both quantitative and qualitative##2##5##(2008-7#1)(2012-12#1)
in both rat and##2##4##(1993-12#1)(1995-3#1)
in both rats and mice##3##5##(2008-10#1)(2008-4#1)(2008-9#1)
in both rats##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
in both reference##2##3##(2008-10#2)
in both rural and urban areas##2##6##(2009-7#1)(2011-2#1)
in both rural and urban##3##5##(2009-7#1)(2011-2#1)(2012-2#1)
in both samples##3##3##(2008-10#1)(2009-11#1)(2011-1#1)
in both serum##2##3##(1990-3#1)(2008-8#1)
in both serum-free media##2##4##(2008-11#2)
in both sexes and##2##4##(1991-6#1)(2012-12#1)
in both sexes in##2##4##(2012-3#1)(2013-1#1)
in both sexes of##2##4##(2008-10#1)(2008-9#1)
in both sexes were##2##4##(1990-2#1)(2011-2#1)
in both sexes##27##3##(1990-2#1)(1990-3#1)(1991-6#2)(1992-12#1)(1994-2#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in both sides##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
in both situation##3##3##(1990-12#3)
in both situations##2##3##(1990-12#1)(2007-12#1)
in both small##2##3##(2008-11#1)(2012-12#1)
in both solvents##3##3##(1992-4#1)(1995-2#1)(1996-5#1)
in both species##13##3##(1993-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)
in both static and dynamic##3##5##(1990-7#1)(2008-10#1)(2008-3#1)
in both strains of mice##4##5##(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
in both strains of##6##4##(1993-12#2)(1996-12#2)(2008-10#1)(2008-11#1)
in both strains##11##3##(1993-12#2)(1994-5#1)(1996-12#2)(2007-10#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)
in both studied##2##3##(2008-12#1)(2013-8#1)
in both studies and##2##4##(2008-10#1)(2008-9#1)
in both studies##17##3##(1992-8#1)(2008-10#1)(2008-7#1)(2008-9#13)(2010-1#1)
in both suspension and##3##4##(2008-11#3)
in both synthetic and##2##4##(2008-10#1)(2012-2#1)
in both systems##9##3##(1994-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)
in both the absence and the presence of##2##8##(1993-9#1)(1995-5#1)
in both the absence and##3##5##(1993-9#1)(1995-5#1)(2008-10#1)
in both the absence##4##4##(1993-9#1)(1995-5#1)(2008-10#2)
in both the aqueous and organic##2##6##(2010-4#2)
in both the cases##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
in both the cell##2##4##(1991-9#1)(2009-3#1)
in both the central##2##4##(1996-5#1)(2008-10#1)
in both the control and the##2##6##(2008-10#1)(2012-3#1)
in both the control##3##4##(2008-10#1)(2009-5#1)(2012-3#1)
in both the cytosolic and membranous fractions##2##7##(1993-12#2)
in both the forward##2##4##(1992-3#1)(2010-9#1)
in both the frequency##2##4##(1995-3#1)(2007-11#1)
in both the liver and##2##5##(1992-11#1)(2010-5#1)
in both the normal##2##4##(2007-11#1)(2008-10#1)
in both the patients##2##4##(2007-7#1)(2008-11#1)
in both the presence and absence of##2##7##(2008-10#1)(2008-11#1)
in both the public and private##2##6##(1992-12#1)(2011-2#1)
in both the total sample and the subgroup of responders##2##10##(2008-5#2)
in both the##149##3##(1990-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-3#3)(1995-5#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#25)(2008-11#7)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#2)
in both these##3##3##(1991-12#1)(2008-7#1)(2009-6#1)
in both time and##2##4##(2007-12#1)(2011-1#1)
in both tissues##5##3##(1990-5#1)(1991-8#1)(1992-9#1)(1996-12#1)(2008-6#1)
in both transmission and reflection##2##5##(2007-12#1)(2008-2#1)
in both treatment groups##2##4##(2007-8#1)(2010-12#1)
in both treatment##3##3##(2007-8#1)(2008-6#1)(2010-12#1)
in both treatments##4##3##(2008-10#1)(2008-9#3)
in both trials were##2##4##(2008-10#1)(2010-12#1)
in both types of##7##4##(1993-8#2)(2007-12#1)(2008-10#2)(2008-12#1)(2013-7#1)
in both univariate and multivariate analyses##2##6##(2008-6#1)(2013-8#1)
in both untreated and##2##4##(1995-11#1)(2008-10#1)
in both urban and rural##2##5##(1993-12#1)(2009-4#1)
in both urban##3##3##(1993-12#1)(2008-12#1)(2009-4#1)
in both visual##2##3##(2007-8#1)(2013-1#1)
in both workers and queens##2##5##(2007-12#2)
in both worlds##2##3##(2009-11#2)
in both wrists##2##3##(2006-10#1)(2009-3#1)
in both years and##3##4##(2007-6#1)(2008-10#1)(2008-4#1)
in both years##25##3##(2007-6#2)(2008-10#13)(2008-11#4)(2008-4#2)(2008-6#1)(2011-2#3)
in both young and##2##4##(1997-6#1)(2008-7#1)
in both young##3##3##(1997-6#1)(2008-5#1)(2008-7#1)
in both##1276##2##(1990-11#1)(1990-12#9)(1990-2#3)(1990-3#3)(1990-5#2)(1990-7#5)(1990-8#11)(1991-1#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#4)(1991-6#4)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#20)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#2)(1993-8#13)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#9)(1994-3#9)(1994-5#8)(1994-6#5)(1994-7#1)(1994-8#10)(1994-9#3)(1995-1#1)(1995-11#8)(1995-12#9)(1995-2#5)(1995-3#8)(1995-5#13)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#12)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#10)(1997-3#3)(1997-4#7)(1997-6#8)(1997-7#5)(1997-8#6)(1997-9#2)(2006-10#1)(2006-6#2)(2007-10#5)(2007-11#16)(2007-12#23)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#19)(2007-9#1)(2008-1#10)(2008-10#216)(2008-11#51)(2008-12#24)(2008-2#15)(2008-3#30)(2008-4#18)(2008-5#38)(2008-6#11)(2008-7#53)(2008-8#22)(2008-9#39)(2009-1#1)(2009-10#4)(2009-11#7)(2009-12#6)(2009-2#1)(2009-3#9)(2009-4#4)(2009-5#3)(2009-6#8)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#1)(2010-3#4)(2010-4#13)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#26)(2011-2#54)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#24)(2012-2#27)(2012-3#16)(2012-4#1)(2012-7#1)(2013-1#35)(2013-7#13)(2013-8#17)
in boths site##2##3##(2011-2#2)
in bottled##2##2##(2008-10#1)(2008-8#1)
in bovine adrenal chromaffin cells##2##5##(1994-5#1)(1995-11#1)
in bovine adrenal##3##3##(1994-5#1)(1994-8#1)(1995-11#1)
in bovine brain cytosol##2##4##(1992-11#1)(1994-9#1)
in bovine brain##6##3##(1990-8#1)(1992-11#1)(1994-11#1)(1994-9#2)(1996-12#1)
in bovine calves##2##3##(2013-1#2)
in bovine liver and##3##4##(1992-10#1)(2008-10#2)
in bovine liver##5##3##(1992-10#1)(1992-3#1)(2008-10#3)
in bovine milk##2##3##(2008-10#1)(2012-3#1)
in bovine ovarian##2##3##(1990-8#1)(1995-12#1)
in bovine rumen##2##3##(1991-12#2)
in bovine serum##3##3##(1995-6#1)(2008-10#2)
in bovine skeletal muscle##2##4##(1991-9#2)
in bovine##55##2##(1990-8#2)(1991-12#2)(1991-8#3)(1991-9#3)(1992-10#3)(1992-11#3)(1992-3#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#2)(1997-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
in boys and##6##3##(1991-9#1)(2011-1#4)(2013-8#1)
in boys with##2##3##(2008-10#1)(2013-1#1)
in boys##13##2##(1991-9#1)(1992-11#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#4)(2011-2#1)(2013-1#1)(2013-8#1)
in brachytherapy##3##2##(1990-10#1)(2008-10#2)
in brackets##2##2##(2008-10#2)
in brain and gut##2##4##(1991-8#1)(1994-11#1)
in brain and##12##3##(1990-7#2)(1991-1#1)(1991-8#2)(1993-11#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-4#1)
in brain cells of##2##4##(2008-8#2)
in brain cells##3##3##(2008-8#3)
in brain is##2##3##(1993-8#2)
in brain of##2##3##(1990-7#1)(1993-6#1)
in brain perfusion##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
in brain regions and spinal cord of##2##7##(1997-2#2)
in brain regions and spinal cord##3##6##(1997-2#3)
in brain regions associated with##2##5##(2008-10#1)(2008-11#1)
in brain regions##9##3##(1996-12#2)(1997-2#3)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)
in brain slices##5##3##(2008-4#2)(2008-5#1)(2008-7#2)
in brain stem##3##3##(1992-6#1)(1993-9#1)(2008-2#1)
in brain tissue from##2##4##(1994-11#1)(1996-5#1)
in brain tissue##10##3##(1994-11#3)(1996-5#1)(2007-10#1)(2008-7#3)(2010-11#1)(2013-1#1)
in brain tissues##2##3##(1990-5#1)(1994-11#1)
in brain##123##2##(1990-3#5)(1990-5#1)(1990-7#4)(1991-1#2)(1991-8#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#9)(2008-8#8)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
in brains of##2##3##(1993-3#1)(1994-5#1)
in brains##5##2##(1992-12#1)(1993-3#1)(1994-5#1)(2008-7#1)(2008-8#1)
in brass##5##2##(2008-10#5)
in bread wheat##2##3##(2008-10#2)
in bread##3##2##(1991-6#1)(2008-10#2)
in breast cancer and##3##4##(2010-8#1)(2011-1#1)(2013-1#1)
in breast cancer cell##3##4##(1993-11#1)(2009-4#1)(2012-2#1)
in breast cancer cells##4##4##(1990-12#1)(2008-4#1)(2009-4#1)(2012-3#1)
in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy##2##10##(2009-4#2)
in breast cancer patients treated with neoadjuvant##3##7##(2009-4#3)
in breast cancer patients##14##4##(1990-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-4#1)(2008-10#1)(2008-7#1)(2009-4#3)(2011-2#1)(2012-3#2)
in breast cancer patients]##2##4##(1991-3#1)(2007-10#1)
in breast cancer screening##2##4##(1995-4#1)(1997-1#1)
in breast cancer xenografts##2##4##(2013-1#1)(2013-8#1)
in breast cancer##80##3##(1990-12#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#12)(1993-12#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-4#3)(1995-8#3)(1997-1#1)(1997-7#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-4#6)(2008-5#1)(2008-7#2)(2009-4#5)(2009-5#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
in breast cancer]##2##3##(2012-2#1)(2013-8#1)
in breast cancers##4##3##(1993-11#1)(1994-2#1)(1995-12#1)(2011-2#1)
in breast carcinogenesis##2##3##(1990-6#1)(1993-11#1)
in breast carcinoma##5##3##(1991-2#1)(1993-1#1)(1997-5#1)(2007-4#1)(2008-10#1)
in breast conservation therapy##2##4##(2007-11#2)
in breast conservation##3##3##(2007-11#2)(2010-7#1)
in breast cyst fluid##2##4##(2008-12#2)
in breast cyst##3##3##(2008-12#2)(2008-4#1)
in breast feeding##2##3##(1990-2#2)
in breast milk##4##3##(2008-10#3)(2013-1#1)
in breast tumors##2##3##(1994-12#1)(1997-7#1)
in breast##128##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-1#3)(1993-11#14)(1993-12#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-4#3)(1995-6#1)(1995-8#3)(1997-1#1)(1997-5#1)(1997-7#4)(2007-10#3)(2007-11#5)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-4#8)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#5)(2009-5#2)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
in breastfeeding##2##2##(2007-2#1)(2010-5#1)
in breathing##2##2##(1994-5#1)(2008-10#1)
in breeding programs##6##3##(2008-10#5)(2012-3#1)
in breeding##10##2##(1997-3#1)(2008-10#7)(2011-1#1)(2012-3#1)
in brief##8##2##(1991-1#1)(1993-1#1)(1995-1#1)(1997-1#1)(1997-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
in bright##2##2##(2008-10#1)(2008-11#1)
in bringing##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2010-6#1)
in brittle##2##2##(2009-7#1)(2013-8#1)
in broad##2##2##(2008-10#1)(2008-9#1)
in broadening##2##2##(2007-11#1)(2008-2#1)
in broiler chickens##4##3##(1997-3#1)(1997-6#1)(2007-6#2)
in broiler##10##2##(1997-3#4)(1997-6#2)(2007-6#2)(2008-12#1)(2011-2#1)
in broilers##5##2##(1991-11#1)(1995-9#1)(1997-3#2)(2010-4#1)
in bronchial aspirates##2##3##(1990-9#1)(1992-5#1)
in bronchial##6##2##(1990-9#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(2012-2#1)
in bronchoalveolar lavage fluid##7##4##(1990-2#1)(1992-3#2)(1994-11#1)(1994-5#1)(1994-8#1)(2012-2#1)
in bronchoalveolar lavage##8##3##(1990-2#1)(1992-3#2)(1994-11#1)(1994-5#1)(1994-8#1)(2007-8#1)(2012-2#1)
in bronchopleural##2##2##(1995-11#1)(2012-2#1)
in broth media##2##3##(1997-4#1)(2008-10#1)
in broth##4##2##(1997-4#1)(1997-6#1)(2008-10#1)(2008-6#1)
in brown##5##2##(2008-10#2)(2008-5#1)(2009-8#1)(2013-1#1)
in brush-border##2##2##(1991-5#1)(2013-1#1)
in budding yeast##6##3##(1995-2#1)(1996-3#1)(1996-6#2)(2008-2#1)(2012-3#1)
in budding##7##2##(1995-2#1)(1996-3#1)(1996-6#2)(2008-2#1)(2009-8#1)(2012-3#1)
in buffer containing##3##3##(1990-2#1)(1995-6#1)(1997-1#1)
in buffer solution##5##3##(2007-12#1)(2008-10#3)(2008-4#1)
in buffer solutions##2##3##(2008-4#1)(2008-8#1)
in buffer##19##2##(1990-12#1)(1990-2#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#8)(2008-4#2)(2008-8#1)
in buffered##4##2##(2008-10#4)
in building the##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
in building##8##2##(1991-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2012-3#1)
in buildings##6##2##(1991-12#5)(2011-2#1)
in bulk GaAs##2##3##(2007-12#1)(2008-2#1)
in bulk Kerr##2##3##(2007-12#2)
in bulk LiNbO(3)##2##3##(2008-3#2)
in bulk and dosage forms##2##5##(2008-10#2)
in bulk and pharmaceutical##2##4##(2008-10#1)(2011-1#1)
in bulk and##6##3##(1990-5#1)(2008-10#4)(2011-1#1)
in bulk drug and##4##4##(2008-10#2)(2010-5#1)(2011-1#1)
in bulk samples##2##3##(2007-12#1)(2008-2#1)
in bulk##42##2##(1990-5#1)(1991-8#1)(2007-11#2)(2007-12#10)(2008-10#15)(2008-2#4)(2008-3#3)(2008-5#1)(2009-12#1)(2010-5#1)(2011-1#2)(2013-1#1)
in bullying##2##2##(2008-11#1)(2008-12#1)
in bundle branch##2##3##(1994-1#1)(2008-7#1)
in burbot##7##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#4)
in buried##3##2##(2007-11#1)(2008-10#2)
in burn##2##2##(1992-2#1)(1994-5#1)
in burned and unburned Venezuelan crude oil##2##7##(2008-10#2)
in burned##3##2##(2008-10#2)(2008-11#1)
in burnout##2##2##(1997-1#1)(2008-11#1)
in burst volume##2##3##(2010-4#2)
in bursting##2##2##(1993-12#1)(2009-8#1)
in buses##3##2##(2008-6#3)
in business school##2##3##(1996-3#2)
in business##4##2##(1991-2#1)(1996-3#2)(1997-3#1)
in butterfly wings##2##3##(2012-2#2)
in butterfly##5##2##(2008-2#1)(2008-8#2)(2012-2#2)
in buttock##4##2##(2010-8#4)
in by##3##2##(1993-1#1)(2007-8#1)(2008-5#1)
in c-fos##2##2##(1996-12#2)
in cAMP##7##2##(1993-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#1)
in cDNA##2##2##(1996-8#1)(2012-3#1)
in cGMP##2##2##(1990-12#1)(2008-11#1)
in ca##4##2##(1994-9#1)(2008-10#1)(2008-12#1)(2008-6#1)
in cacao##2##2##(2008-10#1)(2012-3#1)
in cadaveric##3##2##(2008-7#1)(2010-6#1)(2011-2#1)
in cadavers##2##2##(2008-9#1)(2011-2#1)
in cadmium##2##2##(2008-10#1)(2008-12#1)
in cafeteria diet induced obesity in##2##6##(2013-1#2)
in cages##3##2##(2008-10#3)
in calcific aortic##2##3##(2008-12#1)(2011-2#1)
in calcific##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
in calcitonin##2##2##(1990-2#1)(1990-7#1)
in calcium##18##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-9#1)(1993-3#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
in calculating the##2##3##(1994-1#1)(2008-3#1)
in calculation of##2##3##(2008-10#1)(2008-3#1)
in calculation##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
in calculations##2##2##(2008-10#1)(2008-3#1)
in calf##2##2##(1990-12#1)(2008-4#1)
in calibration##5##2##(2008-10#2)(2008-3#2)(2008-6#1)
in california##6##2##(1990-11#1)(2008-10#5)
in calves##8##2##(1991-8#1)(1996-11#1)(1997-5#1)(2010-5#2)(2012-2#1)(2012-3#2)
in camels (Camelus dromedarius)##2##4##(1996-12#1)(2011-2#1)
in camels##5##2##(1996-12#1)(2011-2#4)
in cancellous bone##2##3##(1993-11#1)(2009-7#1)
in cancer and other##2##4##(2008-11#1)(2009-2#1)
in cancer and##5##3##(1993-9#1)(2008-11#2)(2009-2#1)(2009-7#1)
in cancer care##3##3##(2010-10#1)(2010-9#1)(2012-3#1)
in cancer cell lines##2##4##(1997-7#1)(2008-9#1)
in cancer cell##3##3##(1997-7#1)(2008-9#1)(2010-8#1)
in cancer cells and##2##4##(2008-8#1)(2011-2#1)
in cancer cells in##3##4##(1995-12#1)(2010-12#1)(2011-2#1)
in cancer cells may##2##4##(1992-5#1)(2008-4#1)
in cancer cells##22##3##(1991-12#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-12#1)(2008-2#1)(2008-4#3)(2008-8#2)(2009-4#1)(2010-12#3)(2011-2#5)(2012-1#1)(2012-3#1)
in cancer chemotherapy##3##3##(1995-6#1)(2008-11#1)(2010-11#1)
in cancer development##4##3##(2011-2#2)(2013-1#2)
in cancer diagnosis##2##3##(1991-8#1)(2008-8#1)
in cancer initiation##2##3##(2009-12#1)(2012-12#1)
in cancer metastasis##2##3##(2008-9#1)(2012-12#1)
in cancer mortality##4##3##(1990-8#2)(1990-9#1)(1996-6#1)
in cancer of##2##3##(1990-8#1)(2013-8#1)
in cancer patients should##2##4##(2007-8#1)(2013-1#1)
in cancer patients##28##3##(1990-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-8#3)(1994-8#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#5)(2013-1#3)
in cancer progression##2##3##(2012-12#2)
in cancer research##3##3##(1990-2#1)(2008-7#1)(2009-4#1)
in cancer risk##2##3##(2008-12#1)(2008-7#1)
in cancer surgery##3##3##(1992-9#1)(2007-8#1)(2012-12#1)
in cancer survivors##2##3##(2008-7#1)(2009-10#1)
in cancer therapy##4##3##(1994-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
in cancer tissues##2##3##(2008-10#1)(2010-12#1)
in cancer treatment##6##3##(1993-3#1)(2007-10#1)(2008-7#1)(2008-8#2)(2011-2#1)
in cancer##153##2##(1990-2#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-9#2)(1993-3#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-1#2)(1997-3#4)(1997-7#1)(2007-10#1)(2007-8#3)(2008-1#5)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#3)(2008-7#15)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#17)(2012-1#1)(2012-12#8)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#2)
in cancers of##2##3##(1991-8#1)(2011-2#1)
in cancers with##2##3##(1990-9#1)(2013-1#1)
in cancers##7##2##(1990-9#1)(1991-8#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
in candidates for##3##3##(2010-6#1)(2013-1#2)
in canine mammary##2##3##(2012-1#1)(2012-3#1)
in canine##15##2##(1991-6#1)(1992-3#1)(1992-5#2)(1994-6#2)(1994-8#1)(1996-12#1)(2008-10#1)(2011-2#3)(2012-1#1)(2012-3#2)
in canned##2##2##(2008-4#1)(2008-7#1)
in canola##2##2##(2008-10#2)
in capillaries##2##2##(1995-12#1)(2012-4#1)
in capillary electrokinetic chromatography##2##4##(2008-10#2)
in capillary electrophoresis##4##3##(2008-10#2)(2013-1#2)
in capillary zone electrophoresis##2##4##(2008-10#2)
in capillary##10##2##(2008-10#7)(2008-3#1)(2013-1#2)
in capital##7##2##(1992-2#1)(1994-3#6)
in capsaicin-treated##3##2##(2008-11#3)
in capsules and human##2##4##(2008-10#2)
in capsules and plasma##3##4##(2008-10#3)
in capsules and##6##3##(2008-10#6)
in capsules##11##2##(1996-5#1)(2008-10#9)(2011-1#1)
in captive chimpanzees##3##3##(2007-12#3)
in captive##13##2##(1991-3#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-12#3)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#2)
in captivity##5##2##(1996-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)
in carbohydrate metabolism and##2##4##(2008-5#2)
in carbohydrate metabolism##3##3##(2008-10#1)(2008-5#2)
in carbohydrate##5##2##(1997-2#1)(2008-10#2)(2008-5#2)
in carbon nanotubes##4##3##(2008-7#4)
in carbon paste##2##3##(2008-10#2)
in carbon tetrachloride##4##3##(1995-3#1)(2007-12#1)(2010-2#1)(2013-1#1)
in carbon##19##2##(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
in carbonmonoxyhemoglobin##2##2##(1990-8#1)(1997-2#1)
in carboxylated##2##2##(2008-10#2)
in carcinogenesis##9##2##(1990-8#1)(1992-8#1)(1993-9#1)(2008-11#2)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
in carcinoma of##2##3##(1993-9#1)(2011-2#1)
in carcinoma##3##2##(1993-9#1)(2007-11#1)(2011-2#1)
in cardiac and##4##3##(1992-11#1)(1992-6#1)(1995-2#1)(2007-8#1)
in cardiac cells##3##3##(2008-7#3)
in cardiac index##2##3##(1993-10#1)(2008-5#1)
in cardiac myocytes from##2##4##(2008-8#2)
in cardiac myocytes##4##3##(2008-8#2)(2008-9#2)
in cardiac output and##3##4##(1991-5#1)(1991-6#1)(2008-3#1)
in cardiac patients##2##3##(2008-10#1)(2009-5#1)
in cardiac repair##2##3##(2012-12#2)
in cardiac surgery##25##3##(2006-10#3)(2007-8#13)(2007-9#1)(2008-11#1)(2010-7#1)(2010-8#2)(2011-2#3)(2013-1#1)
in cardiac##67##2##(1990-6#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-6#1)(1993-10#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(2006-10#3)(2007-8#14)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#2)(2010-7#1)(2010-8#3)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)
in cardioembolic stroke##2##3##(2007-10#2)
in cardiology##7##2##(1994-2#1)(2008-11#3)(2009-9#1)(2010-5#1)(2011-2#1)
in cardiology]##2##2##(1991-2#1)(1992-5#1)
in cardiometabolic##2##2##(2011-1#1)(2011-2#1)
in cardiomyocytes##4##2##(1994-3#1)(1996-2#1)(1996-9#1)(2010-12#1)
in cardioprotection##2##2##(2010-12#1)(2013-7#1)
in cardiopulmonary##2##2##(1993-6#1)(2006-10#1)
in cardiovascular and##2##3##(2008-10#1)(2008-8#1)
in cardiovascular control##3##3##(1995-12#2)(2009-9#1)
in cardiovascular disease and##2##4##(2008-4#1)(2011-1#1)
in cardiovascular disease##10##3##(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
in cardiovascular diseases and##2##4##(2008-8#1)(2011-1#1)
in cardiovascular diseases##6##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
in cardiovascular function##2##3##(1992-3#1)(2013-8#1)
in cardiovascular medicine##3##3##(1991-9#1)(2010-6#1)(2011-2#1)
in cardiovascular prevention##2##3##(2008-3#1)(2013-1#1)
in cardiovascular research##3##3##(2008-7#1)(2010-4#1)(2010-5#1)
in cardiovascular risk##6##3##(1994-6#1)(2008-7#4)(2010-10#1)
in cardiovascular surgery##2##3##(2007-8#1)(2010-8#1)
in cardiovascular systems##2##3##(2009-10#2)
in cardiovascular##56##2##(1991-9#1)(1992-3#2)(1992-5#1)(1994-6#1)(1995-12#2)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#2)(2009-1#1)(2009-10#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#3)(2013-1#2)(2013-8#2)
in care and##2##3##(1994-1#1)(2013-1#1)
in care##16##2##(1992-3#1)(1993-12#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-10#1)(2013-1#3)
in carefully selected patients##4##4##(1997-6#1)(1997-8#1)(2008-10#1)(2008-6#1)
in carefully selected##5##3##(1997-6#1)(1997-8#1)(2008-10#2)(2008-6#1)
in caregivers##2##2##(1996-10#1)(2013-1#1)
in caring for patients with##3##5##(2010-3#1)(2010-7#2)
in caring for patients##5##4##(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)
in caring for the##2##4##(2008-11#2)
in caring for their##3##4##(1996-12#1)(2011-2#1)(2012-3#1)
in caring for##18##3##(1996-12#1)(1996-9#1)(2007-10#1)(2008-11#4)(2010-10#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
in caring##20##2##(1996-12#1)(1996-9#1)(2007-10#1)(2008-11#4)(2010-10#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#1)
in carnivores##3##2##(2008-11#1)(2012-3#2)
in carotid##4##2##(1990-9#2)(2012-2#1)(2012-3#1)
in carp##2##2##(1993-12#1)(2008-8#1)
in carpal tunnel##3##3##(1997-2#1)(2008-9#2)
in carpels##2##2##(1997-2#1)(1997-8#1)
in carrageenan-induced##2##2##(1993-2#1)(2010-5#1)
in carrier##4##2##(1992-11#1)(1994-5#1)(2013-1#1)(2013-8#1)
in carriers##2##2##(2007-10#1)(2008-11#1)
in carrot##5##2##(2008-10#4)(2008-9#1)
in carrying out##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
in cartilage and bone##2##4##(2007-11#1)(2011-2#1)
in cartilage##5##2##(2007-11#1)(2008-12#1)(2008-3#2)(2011-2#1)
in case 1 and case 2 waters##2##7##(2008-3#2)
in case 1 and##3##4##(2008-3#2)(2009-2#1)
in case 1 waters##3##4##(2008-2#1)(2008-3#2)
in case 1##6##3##(2008-2#1)(2008-3#4)(2009-2#1)
in case 2##3##3##(2008-3#1)(2009-2#2)
in case management##2##3##(1996-2#1)(2008-1#1)
in case mix##3##3##(1991-3#1)(1994-12#1)(1994-3#1)
in case of failure##2##4##(2009-4#1)(2012-2#1)
in case of hemorrhagic fever with renal syndrome##2##8##(2013-1#2)
in case of positive##2##4##(1993-2#1)(2012-2#1)
in case of the##10##4##(2007-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2013-8#1)
in case of##79##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1993-2#1)(1993-3#1)(1996-3#1)(1996-6#1)(1997-4#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#24)(2008-11#4)(2008-12#2)(2008-5#3)(2008-8#1)(2009-4#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-2#6)(2011-3#2)(2012-1#1)(2012-2#3)(2013-1#8)(2013-8#1)
in case the##3##3##(2008-1#1)(2008-8#1)(2012-1#1)
in case they##2##3##(2007-7#1)(2011-2#1)
in case##103##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-8#2)(2009-2#3)(2009-4#1)(2009-5#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#2)(2012-2#3)(2013-1#9)(2013-8#1)
in case-control studies##2##3##(1995-2#1)(1995-9#1)
in case-control##3##2##(1994-2#1)(1995-2#1)(1995-9#1)
in cases and controls##2##4##(1991-7#1)(2007-10#1)
in cases compared to controls##3##5##(1990-8#1)(2008-12#1)(2011-2#1)
in cases compared##4##3##(1990-8#1)(2007-10#1)(2008-12#1)(2011-2#1)
in cases in which##6##4##(1991-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
in cases of a##2##4##(1994-2#1)(2012-12#1)
in cases of accidental##2##4##(1995-3#1)(2010-5#1)
in cases of acute##2##4##(1990-6#1)(2008-12#1)
in cases of severe##3##4##(2007-8#1)(2010-5#1)(2011-2#1)
in cases of suspected##3##4##(1992-11#1)(1995-11#1)(2011-1#1)
in cases of##72##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1995-11#3)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
in cases that##2##3##(2008-1#1)(2011-2#1)
in cases when##6##3##(2007-8#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
in cases where a##2##4##(1992-6#1)(2013-1#1)
in cases where there##2##4##(2008-11#1)(2012-2#1)
in cases where##11##3##(1990-2#1)(1990-9#1)(1992-6#1)(1993-2#1)(1994-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
in cases with ER-rich tumors vs##2##6##(1993-1#2)
in cases with recurrent##2##4##(2007-2#1)(2007-8#1)
in cases with severe##3##4##(1990-12#1)(2011-1#1)(2013-8#1)
in cases with##24##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1993-1#2)(1997-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#6)(2011-8#1)(2013-8#1)
in cases##131##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-11#2)(1992-6#2)(1992-9#1)(1993-1#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1995-11#4)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#15)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
in castrated males##2##3##(1993-8#1)(1994-2#1)
in castrated##5##2##(1990-11#1)(1991-12#1)(1993-8#1)(1994-2#1)(1996-2#1)
in casual sex##5##3##(2010-8#5)
in casual##6##2##(2008-10#1)(2010-8#5)
in cat primary visual cortex##2##5##(2008-7#1)(2008-8#1)
in cat##9##2##(1990-11#1)(1990-5#1)(1991-10#1)(1993-12#2)(2008-11#2)(2008-7#1)(2008-8#1)
in catalase##2##2##(2008-12#1)(2008-7#1)
in catalysis##6##2##(1992-3#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-7#1)(2010-12#1)
in catalytic efficiency##2##3##(1994-5#1)(1995-2#1)
in catalytic##5##2##(1992-6#1)(1994-5#1)(1995-2#1)(1995-5#1)(2008-10#1)
in catfish##2##2##(2008-10#1)(2008-7#1)
in cation##2##2##(2008-10#1)(2008-7#1)
in cationic micellar medium##2##4##(2008-10#2)
in cationic micellar##3##3##(2008-10#3)
in cats with GBS##2##4##(2012-3#2)
in cats with##3##3##(2008-3#1)(2012-3#2)
in cats##14##2##(1993-1#1)(1993-12#1)(1996-11#1)(1997-2#1)(2008-3#2)(2012-3#6)(2013-8#2)
in cattle and other##2##4##(1992-12#1)(2013-1#1)
in cattle and##4##3##(1991-8#1)(1992-12#1)(2013-1#2)
in cattle herds in##2##4##(2010-4#1)(2012-3#1)
in cattle to##2##3##(1994-3#1)(1996-12#1)
in cattle##34##2##(1991-8#3)(1992-12#1)(1993-2#2)(1994-11#1)(1994-3#1)(1994-7#2)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#2)(2010-2#3)(2010-4#4)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
in caudate##2##2##(1992-8#1)(2008-7#1)
in cauliflower##4##2##(2008-10#4)
in causing a##2##3##(2008-10#1)(2008-11#1)
in causing disease##2##3##(2008-10#1)(2008-7#1)
in causing##21##2##(1990-11#1)(1992-12#1)(1995-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#2)(2011-3#1)
in caveolin##2##2##(1995-2#2)
in cavitation##2##2##(2008-10#1)(2008-12#1)
in cell adhesion and##2##4##(1994-5#1)(2012-2#1)
in cell adhesion##6##3##(1993-11#1)(1994-5#1)(1994-9#1)(2008-1#1)(2010-11#1)(2012-2#1)
in cell and tissue##3##4##(2008-11#1)(2008-7#2)
in cell and##5##3##(2008-11#1)(2008-4#1)(2008-7#3)
in cell biology and##2##4##(2008-8#1)(2011-2#1)
in cell biology##5##3##(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
in cell culture and##2##4##(2008-11#1)(2008-9#1)
in cell culture supernatants##2##4##(2008-10#1)(2008-4#1)
in cell culture systems##3##4##(1994-5#1)(2008-11#2)
in cell culture##27##3##(1991-12#1)(1994-2#2)(1994-5#1)(1995-5#1)(1997-3#1)(2008-10#3)(2008-11#13)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)
in cell cultures##9##3##(1994-11#1)(2006-12#1)(2008-11#6)(2008-4#1)
in cell cycle arrest##2##4##(1995-2#1)(2012-1#1)
in cell cycle##3##3##(1995-2#1)(2008-7#1)(2012-1#1)
in cell death##5##3##(2008-1#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
in cell density##2##3##(1995-3#1)(2008-11#1)
in cell diameter##2##3##(2008-11#1)(2013-1#1)
in cell differentiation##2##3##(2008-5#2)
in cell extracts##5##3##(1994-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
in cell growth and proliferation##2##5##(2008-11#1)(2011-2#1)
in cell growth and##5##4##(1994-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
in cell growth control##2##4##(1992-8#1)(2011-2#1)
in cell growth inhibition##2##4##(1993-12#1)(2008-3#1)
in cell growth##13##3##(1992-12#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#3)(2013-7#1)
in cell height##2##3##(2009-7#2)
in cell lines derived from##2##5##(1991-2#1)(2008-4#1)
in cell lines from##4##4##(1993-8#1)(1995-2#1)(1996-7#2)
in cell lines infected with##2##5##(1991-12#2)
in cell lines##16##3##(1991-12#2)(1991-2#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-7#2)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
in cell membranes##5##3##(1990-11#1)(1991-5#2)(1992-6#1)(2008-9#1)
in cell migration and##2##4##(2008-7#1)(2012-12#1)
in cell migration##5##3##(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
in cell morphology and##4##4##(1990-8#2)(2008-1#1)(2008-8#1)
in cell morphology##9##3##(1990-8#3)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)
in cell number##5##3##(1994-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-11#1)
in cell numbers##3##3##(1995-3#1)(2008-11#1)(2011-2#1)
in cell populations##2##3##(1991-9#1)(2010-10#1)
in cell proliferation and differentiation##2##5##(1993-3#1)(2008-9#1)
in cell proliferation and##6##4##(1993-3#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-9#2)
in cell proliferation##14##3##(1990-6#1)(1990-8#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-5#1)(2012-1#1)(2013-7#1)
in cell shape##3##3##(1993-8#1)(2008-7#1)(2012-2#1)
in cell signal transduction##2##4##(2008-10#1)(2008-9#1)
in cell size##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
in cell survival##2##3##(1993-8#1)(2008-11#1)
in cell suspension cultures of wheat##2##6##(2008-11#2)
in cell suspension cultures##3##4##(2008-11#3)
in cell suspensions##2##3##(1993-3#1)(1994-11#1)
in cell therapy##2##3##(2008-5#1)(2012-12#1)
in cell viability##2##3##(2008-11#1)(2008-6#1)
in cell volume and##2##4##(1993-8#1)(2013-8#1)
in cell volume##3##3##(1993-8#1)(2009-12#1)(2013-8#1)
in cell wall##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
in cell walls of##2##4##(2008-10#2)
in cell walls##3##3##(2008-10#3)
in cell##238##2##(1990-11#2)(1990-5#2)(1990-6#1)(1990-8#4)(1991-11#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-9#3)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-10#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1996-12#2)(1996-2#1)(1996-7#3)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#3)(2008-10#21)(2008-11#46)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#12)(2009-10#2)(2009-12#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
in cell-attached##3##2##(1995-11#3)
in cell-based##3##2##(2008-4#1)(2008-9#1)(2012-12#1)
in cell-cell##4##2##(1994-12#1)(2008-4#1)(2008-5#1)(2009-8#1)
in cell-cycle##2##2##(2008-8#1)(2008-9#1)
in cell-free extracts of##3##4##(1992-9#1)(1994-11#1)(2008-8#1)
in cell-free##5##2##(1992-11#1)(1992-9#1)(1994-11#1)(2008-7#1)(2008-8#1)
in cell-mediated##2##2##(1993-6#1)(2008-7#1)
in cells and##9##3##(1990-5#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
in cells exposed to##2##4##(1994-3#1)(1995-6#1)
in cells expressing the##4##4##(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)
in cells expressing##6##3##(1995-11#1)(1995-2#2)(1995-6#1)(1996-5#1)(1997-7#1)
in cells from##2##3##(1997-4#2)
in cells grown at##2##4##(1991-11#2)
in cells grown in##2##4##(1991-11#1)(1995-11#1)
in cells grown##6##3##(1990-5#1)(1991-11#3)(1992-12#1)(1995-11#1)
in cells in which##2##4##(1994-10#1)(2011-2#1)
in cells in##3##3##(1994-10#1)(2008-9#1)(2011-2#1)
in cells infected with##2##4##(2008-2#1)(2012-2#1)
in cells is##2##3##(1995-11#1)(2008-9#1)
in cells maintained##2##3##(1994-8#1)(1995-2#1)
in cells of the##4##4##(1995-12#1)(1996-5#1)(1997-7#1)(2007-11#1)
in cells of##14##3##(1990-11#1)(1990-6#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-1#1)(2013-1#1)
in cells prepared from either the SH or the HI group##2##11##(1996-5#2)
in cells prepared from the HI group##3##7##(1996-5#3)
in cells prepared from the##4##5##(1996-5#4)
in cells prepared from##6##4##(1996-5#6)
in cells prepared##7##3##(1996-5#6)(2008-11#1)
in cells that##5##3##(1993-3#1)(1995-12#1)(1995-8#1)(2008-10#1)(2013-1#1)
in cells transfected with##6##4##(1995-6#2)(1995-8#1)(2008-11#2)(2009-8#1)
in cells transformed##2##3##(1995-2#1)(2009-7#1)
in cells treated with##7##4##(1991-2#1)(1992-3#1)(1995-8#5)
in cells treated##8##3##(1991-2#1)(1992-3#1)(1995-8#5)(2008-11#1)
in cells using##2##3##(1993-3#1)(2008-1#1)
in cells which##2##3##(1994-8#1)(2008-7#1)
in cells with##9##3##(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#1)(2010-1#1)(2010-3#1)(2013-7#1)
in cells##148##2##(1990-11#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#3)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#7)(1995-6#7)(1995-8#8)(1996-5#8)(1997-1#2)(1997-4#2)(1997-7#5)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#6)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
in cellular and##3##3##(1997-2#1)(2008-7#1)(2012-3#1)
in cellular environments##2##3##(2008-10#1)(2008-4#1)
in cellular function##2##3##(2011-2#1)(2012-2#1)
in cellular physiology##3##3##(1994-11#1)(2008-8#1)(2008-9#1)
in cellular proliferation##3##3##(1991-9#1)(2008-11#1)(2011-2#1)
in cellular regulation##2##3##(1991-5#1)(2008-1#1)
in cellular senescence##3##3##(2006-10#1)(2008-11#2)
in cellular signalling##2##3##(2008-4#1)(2008-7#1)
in cellular##50##2##(1990-4#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
in cement##4##2##(2008-10#1)(2008-6#1)(2011-2#2)
in cementless##2##2##(2009-3#2)
in centers where##2##3##(1990-6#1)(2008-1#1)
in centers##4##2##(1990-6#1)(2008-1#1)(2010-6#1)(2011-2#1)
in central Florida##2##3##(2008-10#2)
in central and peripheral neurons##2##5##(1996-12#2)
in central and peripheral##3##4##(1996-12#2)(2008-5#1)
in central and southern##2##4##(2008-10#1)(2011-2#1)
in central and##7##3##(1996-12#2)(2008-10#2)(2008-5#1)(2011-2#1)(2013-7#1)
in central nervous system##4##4##(1996-6#1)(2008-4#1)(2008-7#1)(2013-1#1)
in central nervous##5##3##(1996-6#1)(2008-4#2)(2008-7#1)(2013-1#1)
in central##39##2##(1990-8#1)(1991-3#1)(1994-12#1)(1996-12#3)(1996-6#1)(2007-10#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
in centrally##2##2##(2007-8#1)(2012-2#1)
in centric occlusion##3##3##(2010-9#3)
in centrosymmetric##3##2##(1992-8#1)(2007-12#2)
in cephalometry##2##2##(2010-8#2)
in ceramic##3##2##(2008-10#3)
in cereals##7##2##(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#2)(2013-8#1)
in cerebellar granule cells##2##4##(2008-9#1)(2009-8#1)
in cerebellar##10##2##(1991-2#1)(1993-8#1)(1995-12#1)(1995-8#1)(2007-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2013-8#1)
in cerebellum##10##2##(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-2#2)(2008-10#1)(2012-2#1)
in cerebral AVM##2##3##(2012-3#2)
in cerebral AVMs##2##3##(1997-3#1)(2012-3#1)
in cerebral arteriovenous malformations##2##4##(1997-3#2)
in cerebral arteriovenous##3##3##(1997-3#2)(2008-7#1)
in cerebral blood flow##5##4##(2006-7#1)(2008-7#2)(2012-1#1)(2013-1#1)
in cerebral cells##2##3##(1994-5#2)
in cerebral cortex##4##3##(1995-11#1)(1997-2#2)(2011-1#1)
in cerebral endovascular##2##3##(1996-6#2)
in cerebral palsy##3##3##(1996-11#1)(2009-3#2)
in cerebral vascular##2##3##(1996-11#1)(2008-7#1)
in cerebral##40##2##(1990-11#1)(1994-11#1)(1994-2#2)(1994-5#2)(1995-11#2)(1995-12#1)(1996-11#2)(1996-6#2)(1997-2#2)(1997-3#3)(2006-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#5)(2008-8#2)(2009-3#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)
in cerebrospinal fluid (CSF) from##2##5##(1993-8#1)(1994-9#1)
in cerebrospinal fluid (CSF)##6##4##(1990-2#1)(1993-1#1)(1993-8#1)(1994-9#1)(2007-8#1)(2012-3#1)
in cerebrospinal fluid from patients with##2##6##(1990-2#1)(1994-9#1)
in cerebrospinal fluid from psychotic patients##2##6##(1993-8#2)
in cerebrospinal fluid from##4##4##(1990-2#1)(1993-8#2)(1994-9#1)
in cerebrospinal fluid in##3##4##(1993-2#1)(1994-8#1)(2012-3#1)
in cerebrospinal fluid of##3##4##(2009-4#1)(2010-12#1)(2011-2#1)
in cerebrospinal fluid##22##3##(1990-2#2)(1993-1#1)(1993-2#1)(1993-8#3)(1994-8#3)(1994-9#2)(1995-11#2)(2007-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
in cerebrospinal liquor##2##3##(2013-1#2)
in cerebrospinal##24##2##(1990-2#2)(1993-1#1)(1993-2#1)(1993-8#3)(1994-8#3)(1994-9#2)(1995-11#2)(2007-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
in cerebrovascular surgery##3##3##(2012-2#3)
in cerebrovascular##4##2##(2012-2#4)
in certain areas##2##3##(1992-11#1)(2013-8#1)
in certain cases##4##3##(1991-2#1)(1994-12#1)(1996-6#1)(2008-10#1)
in certain cell lines##2##4##(1992-2#1)(1993-6#1)
in certain cell##4##3##(1992-2#1)(1993-6#1)(2012-12#1)(2013-1#1)
in certain nomadic localities in Sudan##2##6##(2011-2#2)
in certain types of##2##4##(2008-11#1)(2008-3#1)
in certain vulnerable##2##3##(2011-2#1)(2013-1#1)
in certain##75##2##(1990-3#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-2#1)(1993-6#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#6)(2008-8#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
in certified reference materials of##2##5##(2008-10#2)
in certified reference materials##5##4##(2008-10#5)
in certified reference##7##3##(2008-10#7)
in certified##10##2##(2008-10#10)
in ceruloplasmin##2##2##(2008-9#2)
in cervical cancer##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
in cervical radiculopathy##3##3##(2007-11#2)(2008-7#1)
in cervical##12##2##(1992-10#1)(1992-8#1)(1995-2#1)(1996-6#1)(2007-11#3)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in cervix##4##2##(1990-10#1)(1996-12#1)(2011-1#1)(2013-1#1)
in cesarean##3##2##(1997-1#1)(2013-1#2)
in cesium ion selective electrodes##3##5##(2008-10#3)
in cesium lithium borate##2##4##(2007-12#2)
in cesium##6##2##(2007-12#2)(2008-10#4)
in chain##4##2##(1992-6#1)(2008-12#2)(2008-5#1)
in chains##2##2##(1991-5#1)(2008-8#1)
in chalcogenide glasses##3##3##(2007-11#3)
in chalcogenide##4##2##(1990-4#1)(2007-11#3)
in challenging##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
in change in##3##3##(1990-3#1)(2008-10#1)(2008-8#1)
in changes in the##2##4##(1990-8#1)(1992-6#1)
in changes in##7##3##(1990-8#1)(1992-6#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-9#1)
in changes of##4##3##(1992-5#1)(1997-2#1)(2008-5#1)(2009-2#1)
in changes##13##2##(1990-8#1)(1992-5#1)(1992-6#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-2#1)(2012-3#1)
in changing the##4##3##(1996-4#1)(2007-8#1)(2008-10#1)(2013-1#1)
in changing##8##2##(1992-9#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
in channel##6##2##(1992-12#1)(1994-2#1)(2008-2#1)(2008-3#1)(2008-8#2)
in chaparral##2##2##(2010-6#2)
in character##2##2##(2008-10#1)(2008-11#1)
in characterizing the##3##3##(2008-10#2)(2008-2#1)
in characterizing##13##2##(1993-11#1)(1995-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#2)(2010-5#1)
in charge of the##3##4##(1994-9#1)(2007-12#1)(2008-10#1)
in charge of##13##3##(1992-5#1)(1994-9#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-3#1)(2011-3#1)(2013-1#1)
in charge##16##2##(1991-6#1)(1992-5#1)(1994-9#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-3#1)(2013-1#1)
in charged##2##2##(1994-5#1)(1997-8#1)
in charges##2##2##(1992-12#2)
in check##2##2##(2008-4#1)(2013-1#1)
in chemerin-deficient##2##2##(2012-2#2)
in chemical analysis##10##3##(2008-10#8)(2010-7#2)
in chemical and##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
in chemical##33##2##(1991-3#1)(1993-6#1)(1995-2#1)(2006-12#1)(2008-10#18)(2008-3#1)(2008-7#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#2)(2012-2#1)(2013-8#1)
in chemically defined medium##2##4##(1993-6#1)(2008-5#1)
in chemically defined##5##3##(1993-6#1)(1997-4#1)(2008-11#2)(2008-5#1)
in chemically##6##2##(1993-6#2)(1997-4#1)(2008-11#2)(2008-5#1)
in chemistry##3##2##(2008-5#1)(2008-7#1)(2010-12#1)
in chemoprevention of##2##3##(1991-9#1)(1995-9#1)
in chemosensitivity##2##2##(1991-8#1)(1997-7#1)
in chemotherapy##5##2##(2007-11#2)(2008-11#1)(2008-7#1)(2010-11#1)
in chemotherapy-induced##2##2##(2008-11#1)(2010-12#1)
in cherry##2##2##(2008-10#1)(2008-2#1)
in chest pain##2##3##(2008-3#1)(2013-1#1)
in chest surgery##2##3##(2010-8#2)
in chest wall tuberculosis##2##4##(2007-8#2)
in chest wall##4##3##(2007-8#2)(2012-2#2)
in chest##11##2##(1991-11#1)(1991-9#1)(2007-8#3)(2008-3#1)(2010-8#2)(2012-2#2)(2013-1#1)
in chick##11##2##(1992-5#1)(1992-9#4)(1995-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-1#1)
in chicken adipocyte##2##3##(1992-9#2)
in chicken brain##3##3##(1993-6#2)(1995-3#1)
in chicken eggs##2##3##(1997-7#1)(2008-10#1)
in chicken embryos##2##3##(1997-6#1)(2007-6#1)
in chicken plasma##2##3##(2008-10#2)
in chicken##25##2##(1990-9#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#3)(1995-3#1)(1997-6#1)(1997-7#1)(2007-3#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)
in chickens with SHS##2##4##(1997-3#2)
in chickens##22##2##(1991-9#1)(1997-3#2)(1997-6#7)(2007-6#1)(2008-12#1)(2008-5#4)(2008-8#1)(2011-1#2)(2012-1#1)(2013-1#2)
in chickpea##8##2##(2008-10#8)
in chicks##8##2##(1990-3#1)(1992-9#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#1)
in chicory##2##2##(2008-10#2)
in child care##2##3##(2009-4#1)(2012-3#1)
in child health##2##3##(1991-3#1)(2008-11#1)
in child life##2##3##(1991-3#1)(1993-12#1)
in child##22##2##(1991-3#2)(1992-1#2)(1993-12#1)(1996-9#1)(2007-3#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in childbearing age##2##3##(2009-8#1)(2013-1#1)
in childbirth##3##2##(2007-2#2)(2010-3#1)
in childhood and adolescence that##2##5##(2009-12#1)(2011-2#1)
in childhood and adolescence##9##4##(1995-2#1)(1996-11#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-12#2)(2010-3#1)(2011-2#1)
in childhood and adult life##2##5##(2008-10#1)(2010-5#1)
in childhood and##22##3##(1990-6#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)
in childhood are##2##3##(2008-11#1)(2013-1#1)
in childhood but##2##3##(1995-6#1)(2008-4#1)
in childhood cancer##2##3##(2008-11#1)(2012-2#1)
in childhood in##2##3##(1992-11#1)(2012-2#1)
in childhood is rare##2##4##(1991-6#1)(2012-3#1)
in childhood is##4##3##(1991-6#1)(1996-11#1)(2011-2#1)(2012-3#1)
in childhood##94##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-5#1)(1993-9#1)(1994-2#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#2)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#6)(2011-2#8)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
in childhood]##5##2##(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1994-6#1)
in children after##3##3##(2008-10#2)(2013-1#1)
in children aged from##2##4##(2008-12#2)
in children aged##9##3##(2008-12#2)(2008-9#2)(2009-10#2)(2012-1#1)(2012-12#2)
in children and adolescents with##8##5##(2007-11#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
in children and adolescents##35##4##(1990-6#1)(1991-2#1)(1994-8#1)(1996-7#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)
in children and adults with##3##5##(2008-8#1)(2008-9#1)(2010-12#1)
in children and adults##15##4##(2007-11#3)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2013-8#2)
in children and its##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
in children and the##2##4##(2011-2#2)
in children and to##3##4##(2007-8#1)(2008-11#1)(2010-5#1)
in children and young adults##3##5##(2011-2#1)(2012-2#1)(2013-1#1)
in children and young people##2##5##(2009-5#1)(2013-1#1)
in children and young##5##4##(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
in children and##79##3##(1990-6#1)(1991-2#1)(1992-2#1)(1994-8#1)(1996-7#1)(1997-8#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#12)(2011-5#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#2)
in children are##3##3##(2007-8#1)(2010-5#1)(2012-2#1)
in children as##2##3##(1992-4#1)(2012-12#1)
in children below the age of##2##6##(2008-1#1)(2008-8#1)
in children below##4##3##(2008-1#2)(2008-12#1)(2008-8#1)
in children but the##2##4##(2008-8#1)(2012-2#1)
in children by##2##3##(1994-12#1)(2010-11#1)
in children during the##2##4##(1994-2#1)(2013-1#1)
in children during##3##3##(1994-2#1)(2013-1#2)
in children for##2##3##(2009-5#1)(2013-8#1)
in children from##5##3##(1992-3#1)(1995-3#1)(2007-7#1)(2007-9#1)(2008-9#1)
in children have been##2##4##(1991-8#1)(2012-2#1)
in children have##3##3##(1991-8#1)(2012-2#1)(2013-1#1)
in children hospitalized##3##3##(1994-2#1)(2009-12#1)(2009-5#1)
in children in British Columbia##2##5##(2007-12#2)
in children in##12##3##(1996-3#1)(1996-7#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
in children is##7##3##(1991-8#1)(1997-2#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in children it##2##3##(2010-4#1)(2011-2#1)
in children less than 1##2##5##(1990-2#1)(1995-8#1)
in children living##2##3##(2009-7#1)(2011-2#1)
in children may##2##3##(2008-10#1)(2008-11#1)
in children of all ages##2##5##(2008-11#1)(2012-2#1)
in children of##12##3##(1991-4#1)(1994-3#1)(2007-7#1)(2008-11#5)(2011-1#1)(2012-2#1)(2012-3#2)
in children over##4##3##(1992-4#1)(1995-12#1)(2011-2#1)(2012-12#1)
in children receiving##2##3##(1991-2#1)(2007-11#1)
in children treated with inhaled##2##5##(2007-11#2)
in children treated with##4##4##(2007-11#3)(2008-4#1)
in children treated##5##3##(2007-11#3)(2008-4#1)(2010-3#1)
in children under 16 years of age##2##7##(1991-8#2)
in children under 5 years##2##5##(2009-5#1)(2012-12#1)
in children under##9##3##(1991-8#2)(2007-8#1)(2008-1#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#2)
in children undergoing##2##3##(2011-2#1)(2013-8#1)
in children using cochlear implants##2##5##(2008-9#2)
in children using##5##3##(2008-10#1)(2008-9#3)(2009-3#1)
in children were##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
in children who are##2##4##(2008-2#1)(2012-12#1)
in children who clutter##3##4##(2011-1#3)
in children who have##2##4##(1994-9#1)(2012-2#1)
in children who##12##3##(1994-6#1)(1994-9#1)(2008-2#1)(2008-6#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in children with CDGP compared to##2##6##(2011-1#2)
in children with CDGP were##2##5##(2011-1#1)(2011-2#1)
in children with CDGP##4##4##(2011-1#3)(2011-2#1)
in children with HIV##2##4##(1996-1#1)(1996-8#1)
in children with a##2##4##(2008-7#1)(2013-1#1)
in children with acute respiratory infections in Gansu Province##2##9##(2013-8#2)
in children with acute##9##4##(2008-1#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#2)
in children with an##2##4##(2007-5#1)(2008-8#1)
in children with cancer##4##4##(2008-11#1)(2010-9#1)(2012-2#2)
in children with cerebral palsy##4##5##(2007-11#1)(2009-3#2)(2012-12#1)
in children with chronic##3##4##(1992-2#1)(2009-5#1)(2013-8#1)
in children with cochlear implants##4##5##(2008-9#4)
in children with complex needs##2##5##(2012-2#2)
in children with constitutional delay of growth and puberty (CDGP)##2##10##(2011-1#1)(2011-2#1)
in children with constitutional delay of growth and puberty##3##9##(2011-1#2)(2011-2#1)
in children with nephrotic syndrome##2##5##(2008-1#2)
in children with obesity##4##4##(2008-12#3)(2012-3#1)
in children with severe##4##4##(1991-3#1)(2006-8#1)(2008-10#1)(2008-5#1)
in children with sickle-cell##2##4##(2009-10#1)(2013-1#1)
in children with##124##3##(1990-11#1)(1991-3#1)(1992-11#1)(1992-2#1)(1994-3#1)(1994-6#2)(1996-1#1)(1996-8#1)(1997-4#1)(2006-8#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#3)(2008-1#4)(2008-10#10)(2008-11#3)(2008-12#5)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-9#1)(2011-1#16)(2011-2#16)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
in children without##2##3##(1996-6#1)(2012-2#1)
in children younger than##2##4##(2008-11#1)(2013-1#1)
in children##593##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-8#5)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#4)(1992-7#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-3#2)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#4)(1997-4#4)(1997-8#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#21)(2007-12#20)(2007-2#2)(2007-5#3)(2007-7#12)(2007-8#9)(2007-9#1)(2008-1#15)(2008-10#51)(2008-11#29)(2008-12#13)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#5)(2008-7#10)(2008-8#9)(2008-9#23)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#9)(2009-4#1)(2009-5#13)(2009-6#1)(2009-7#4)(2009-8#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#6)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#30)(2011-2#64)(2011-5#1)(2012-1#4)(2012-12#12)(2012-2#31)(2012-3#11)(2013-1#38)(2013-7#8)(2013-8#18)
in children's hospitals##2##3##(2010-9#2)
in children's##12##2##(1991-3#1)(1994-2#1)(1995-2#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-9#3)(2011-2#2)(2012-3#1)
in children?##3##2##(2007-8#1)(2008-11#1)(2012-2#1)
in children]##25##2##(1990-11#1)(1990-2#1)(1991-2#2)(1992-11#1)(1992-4#1)(1992-5#1)(1995-2#1)(1995-5#1)(1996-6#2)(1996-7#1)(2007-6#1)(2008-11#1)(2009-5#4)(2011-2#3)(2012-3#1)(2013-1#3)
in chimeric##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
in chimpanzees##2##2##(2007-12#2)
in china##2##2##(1991-8#1)(2008-9#1)
in chinchilla##4##2##(2009-5#2)(2013-8#2)
in chinese##2##2##(2011-1#1)(2011-2#1)
in chiropractic and osteopathic practice##2##5##(2007-11#2)
in chiropractic and##3##3##(2007-11#3)
in chitin##3##2##(1997-3#1)(2008-10#2)
in chitosan film##2##3##(2008-10#2)
in chitosan membrane##2##3##(2008-10#2)
in chitosan##5##2##(2008-10#5)
in chloride rich##2##3##(2008-10#2)
in chloride##3##2##(2008-10#3)
in chloride-free##2##2##(1990-5#1)(2008-10#1)
in chlorinated sea water samples##2##5##(2008-10#2)
in chlorinated sea water##3##4##(2008-10#3)
in chloroform as the##2##4##(2007-12#1)(2008-10#1)
in chloroform at##2##3##(1995-2#1)(2008-10#1)
in chloroform solution##2##3##(2008-10#2)
in chloroform was##3##3##(2007-12#1)(2008-10#2)
in chloroform##40##2##(1994-3#1)(1995-2#1)(2007-11#5)(2007-12#2)(2007-7#1)(2008-10#30)
in chlorophyll##2##2##(2008-10#2)
in chloroplast##5##2##(1991-12#1)(1994-11#1)(2008-10#2)(2012-3#1)
in chloroquine##2##2##(1994-3#2)
in chloroquine-induced##3##2##(1995-12#3)
in choice of##3##3##(1991-6#1)(1995-1#1)(2008-10#1)
in choice##4##2##(1991-6#1)(1993-3#1)(1995-1#1)(2008-10#1)
in cholestatic liver diseases##3##4##(1995-10#1)(2008-8#1)(2013-1#1)
in cholestatic##5##2##(1995-10#1)(2008-8#3)(2013-1#1)
in cholesteric liquid crystals##2##4##(2007-11#1)(2008-7#1)
in cholesterol and sphingolipid enriched membranes and##2##7##(2008-8#2)
in cholesterol and sphingolipid enriched##3##5##(2008-8#3)
in cholesterol and##6##3##(1991-12#1)(1993-2#1)(1995-12#1)(2008-8#3)
in cholesterol##13##2##(1991-12#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2011-2#1)
in cholesteryl ester##2##3##(1995-5#1)(2009-8#1)
in cholesteryl##3##2##(1990-8#1)(1995-5#1)(2009-8#1)
in cholinergic##6##2##(1993-5#1)(1994-8#1)(1996-5#2)(1997-2#1)(2008-5#1)
in chondrocytes##2##2##(2007-11#1)(2013-8#1)
in chondrogenic media##3##3##(2008-5#3)
in choosing a##2##3##(1991-2#1)(2008-10#1)
in choosing the##3##3##(2008-4#1)(2009-5#1)(2011-2#1)
in choosing##11##2##(1991-2#1)(1993-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-8#1)
in chromaffin cells##3##3##(1990-5#2)(1997-7#1)
in chromaffin granules##2##3##(1990-5#2)
in chromaffin##6##2##(1990-11#1)(1990-5#4)(1997-7#1)
in chromatin structure##2##3##(2008-7#1)(2010-2#1)
in chromatin##9##2##(1990-2#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-1#1)
in chrome tanning liquors after its breakdown to 2-mercaptobenzothiazole##2##9##(2008-10#2)
in chromium##2##2##(1996-12#1)(2008-10#1)
in chromosomal DNA##2##3##(2009-5#1)(2009-7#1)
in chromosomal##5##2##(1991-12#1)(1994-12#1)(2008-7#1)(2009-5#1)(2009-7#1)
in chromosome##17##2##(1996-6#1)(1997-3#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#3)(2009-12#1)(2009-8#1)(2010-3#2)(2012-3#2)
in chronic HBV##2##3##(2009-8#1)(2013-1#1)
in chronic active##2##3##(1990-3#1)(1991-6#1)
in chronic and##2##3##(2008-5#1)(2008-8#1)
in chronic cerebral hypoperfusion##3##4##(2008-7#3)
in chronic disease##3##3##(1997-3#1)(2007-11#1)(2008-10#1)
in chronic fatigue syndrome##2##4##(1996-3#1)(2008-12#1)
in chronic heart failure##3##4##(1991-6#1)(2011-2#1)(2013-8#1)
in chronic heart##4##3##(1991-6#1)(2011-2#2)(2013-8#1)
in chronic hemodialysis patients##2##4##(2007-7#2)
in chronic hemodialysis##3##3##(2007-7#3)
in chronic hepatitis C##4##4##(2009-8#1)(2012-12#1)(2013-1#2)
in chronic hepatitis##5##3##(1995-10#1)(2009-8#1)(2012-12#1)(2013-1#2)
in chronic illness##2##3##(1997-1#1)(2012-12#1)
in chronic kidney disease patients##3##5##(2010-8#2)(2013-1#1)
in chronic kidney disease##4##4##(2010-8#2)(2011-2#1)(2013-1#1)
in chronic liver disease##2##4##(2008-3#1)(2009-8#1)
in chronic lung##2##3##(1992-11#1)(2008-8#1)
in chronic lymphocytic leukemia##2##4##(1991-4#1)(2008-9#1)
in chronic myeloid leukemia##3##4##(2008-7#1)(2011-2#2)
in chronic myeloid##4##3##(1997-3#1)(2008-7#1)(2011-2#2)
in chronic noxious##2##3##(2008-4#2)
in chronic obstructive pulmonary disease##3##5##(2011-2#3)
in chronic obstructive pulmonary disease]##4##5##(2011-2#3)(2013-1#1)
in chronic obstructive pulmonary##8##4##(2011-2#6)(2013-1#1)(2013-8#1)
in chronic obstructive##10##3##(1990-6#1)(2008-4#1)(2011-2#6)(2013-1#1)(2013-8#1)
in chronic pain##3##3##(1996-5#1)(2008-7#2)
in chronic patients##2##3##(1997-2#1)(2008-12#1)
in chronic periodontitis##3##3##(2008-12#2)(2012-3#1)
in chronic peritoneal dialysis##2##4##(2011-2#2)
in chronic renal failure patients is##2##6##(2008-1#1)(2011-1#1)
in chronic renal failure patients##4##5##(2008-1#2)(2008-4#1)(2011-1#1)
in chronic renal failure##10##4##(1990-9#1)(1991-5#1)(2008-1#5)(2008-12#1)(2008-4#1)(2011-1#1)
in chronic rhinosinusitis##2##3##(2011-1#1)(2012-1#1)
in chronic suppurative lung##2##4##(1994-12#2)
in chronic suppurative##3##3##(1994-12#2)(2008-9#1)
in chronic tension type headache##2##5##(2010-9#2)
in chronic thromboembolic pulmonary hypertension]##5##5##(2010-6#5)
in chronic wounds##3##3##(2008-9#3)
in chronic##143##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#2)(2008-12#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#8)(2009-10#1)(2009-4#1)(2009-8#3)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#15)(2012-1#2)(2012-12#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#5)
in chronically##5##2##(2007-10#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-2#1)
in chylomicrons##2##2##(1990-8#1)(1992-3#1)
in cigarette smoking##2##3##(2009-7#1)(2011-2#1)
in cigarettes##3##2##(2008-10#3)
in circulating##11##2##(1990-12#1)(1994-11#1)(1994-8#2)(1995-5#1)(1997-4#1)(2008-1#1)(2008-10#3)(2012-2#1)
in circulation##7##2##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
in circumpolar indigenous##2##3##(2013-1#2)
in circumscribed##3##2##(1995-8#1)(1997-3#1)(2008-11#1)
in circumstances##2##2##(1996-5#1)(2008-7#1)
in cirrhosis##6##2##(1991-3#1)(1992-2#1)(1997-7#2)(2007-12#1)(2012-3#1)
in cirrhotic liver##3##3##(2008-1#1)(2010-12#2)
in cirrhotic patients after protein supplementation##2##6##(2013-1#2)
in cirrhotic patients##7##3##(1993-3#1)(1994-7#1)(2009-8#2)(2013-1#3)
in cirrhotic##11##2##(1992-5#1)(1993-3#1)(1994-7#1)(2008-1#1)(2009-8#2)(2010-12#2)(2013-1#3)
in cirrhotics##3##2##(1991-11#1)(2009-8#2)
in cirrus##2##2##(2007-11#1)(2008-3#1)
in cis##5##2##(1991-6#1)(1993-2#1)(1995-6#1)(1997-7#1)(2007-12#1)
in citric acid##2##3##(2008-10#1)(2008-7#1)
in citrus fruit##4##3##(2008-10#4)
in citrus##9##2##(2008-10#7)(2008-5#1)(2008-6#1)
in clade##2##2##(2008-10#2)
in claims##2##2##(1992-2#1)(1994-2#1)
in clarifying##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
in class II##3##3##(1995-11#2)(2008-8#1)
in class##11##2##(1990-2#1)(1993-6#1)(1994-1#1)(1995-11#2)(1995-8#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)
in classical conditioning##2##3##(1993-12#1)(2008-5#1)
in classical##10##2##(1993-12#1)(1994-11#1)(2008-5#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
in classifying##4##2##(1992-12#1)(1994-2#1)(2010-8#1)(2010-9#1)
in classroom teaching##3##3##(2008-11#3)
in classroom##5##2##(2008-11#3)(2008-12#2)
in clay loam##3##3##(2008-10#3)
in clay##6##2##(2008-10#4)(2008-7#1)(2012-12#1)
in cleanroom environments##2##3##(2012-2#2)
in clear ocean water##2##4##(2008-2#2)
in clear##9##2##(1996-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
in cleavage of##2##3##(1994-5#1)(1995-8#1)
in cleavage##4##2##(1991-11#1)(1994-5#1)(1995-8#1)(1997-7#1)
in cleft lip##2##3##(2007-12#1)(2012-1#1)
in cleft##3##2##(2007-12#1)(2011-2#1)(2012-1#1)
in clients with##3##3##(2007-6#1)(2008-7#1)(2013-8#1)
in climate##5##2##(1992-3#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
in climate-controlled rooms##2##3##(2008-10#2)
in climatic##2##2##(2008-6#1)(2010-3#1)
in clinic for##2##3##(2008-10#1)(2008-9#1)
in clinic##8##2##(1990-2#1)(2008-10#1)(2008-9#1)(2011-3#2)(2013-1#2)(2013-7#1)
in clinical analysis##5##3##(1990-12#1)(1990-8#1)(2008-10#3)
in clinical and##10##3##(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-6#1)(2010-9#1)(2011-7#1)(2012-1#1)
in clinical application##3##3##(2012-3#3)
in clinical assessment##2##3##(1990-6#1)(2008-11#1)
in clinical biochemistry##4##3##(1994-12#4)
in clinical blood samples##2##4##(1991-12#1)(2008-10#1)
in clinical blood##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
in clinical cardiac electrophysiology##2##4##(2008-12#2)
in clinical cardiology##3##3##(1991-2#1)(2006-6#1)(2008-12#1)
in clinical chemistry##9##3##(1994-12#8)(2008-10#1)
in clinical decision making##2##4##(2007-11#1)(2010-12#1)
in clinical decision-making##2##3##(2008-11#1)(2010-8#1)
in clinical diagnosis of##2##4##(1997-5#1)(2012-1#1)
in clinical diagnosis##4##3##(1997-3#1)(1997-5#1)(2008-9#1)(2012-1#1)
in clinical isolates##3##3##(1997-8#1)(2008-8#1)(2011-1#1)
in clinical laboratories##2##3##(2008-10#2)
in clinical laboratory##3##3##(1994-12#2)(2008-10#1)
in clinical medicine##14##3##(1992-3#1)(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)
in clinical nutrition##3##3##(1992-2#1)(1993-2#2)
in clinical oncology##6##3##(1994-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
in clinical outcomes##3##3##(2008-3#1)(2008-8#1)(2013-1#1)
in clinical penetrance##2##3##(2008-5#2)
in clinical populations##2##3##(2007-12#1)(2011-2#1)
in clinical practice and##7##4##(1995-11#1)(2006-10#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
in clinical practice for##3##4##(1997-8#1)(2008-7#1)(2011-1#1)
in clinical practice has##2##4##(2008-3#1)(2013-8#1)
in clinical practice in##2##4##(2010-11#1)(2010-12#1)
in clinical practice is##4##4##(1994-12#1)(1997-3#1)(1997-7#1)(2008-12#1)
in clinical practice remains##2##4##(2010-5#1)(2012-3#1)
in clinical practice to##2##4##(2009-8#1)(2010-12#1)
in clinical practice was##2##4##(2008-12#1)(2013-8#1)
in clinical practice##87##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1997-3#3)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#7)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
in clinical practice?##2##3##(2008-3#1)(2008-7#1)
in clinical practice]##5##3##(1991-3#1)(1993-5#1)(1996-3#1)(2009-5#1)(2013-1#1)
in clinical research##8##3##(1991-3#2)(1991-9#1)(2008-10#1)(2009-6#1)(2010-8#1)(2012-2#2)
in clinical routine##3##3##(2012-2#3)
in clinical samples##3##3##(1997-3#1)(2008-10#1)(2009-9#1)
in clinical settings and##2##4##(2010-3#1)(2010-9#1)
in clinical settings##15##3##(1995-1#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
in clinical specimens##2##3##(2007-12#1)(2008-11#1)
in clinical studies to##2##4##(1994-11#1)(2008-5#1)
in clinical studies##15##3##(1992-2#1)(1994-11#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-6#1)(2010-8#2)(2011-2#1)(2013-1#1)
in clinical treatment##2##3##(2011-2#2)
in clinical trial##3##3##(1995-5#1)(2007-9#1)(2010-2#1)
in clinical trials and##3##4##(1996-3#1)(2009-12#1)(2010-12#1)
in clinical trials for##2##4##(2008-5#1)(2009-4#1)
in clinical trials on##2##4##(1991-6#1)(1992-10#1)
in clinical trials##63##3##(1990-3#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#4)(1995-9#1)(1996-3#1)(1996-6#1)(1997-4#2)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-5#5)(2008-8#5)(2009-11#3)(2009-12#1)(2009-4#1)(2009-6#2)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#2)
in clinical use for##2##4##(1996-11#1)(2009-7#1)
in clinical use##13##3##(1996-11#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
in clinical##383##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#2)(1991-3#4)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#18)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1995-1#4)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#5)(1997-4#4)(1997-5#1)(1997-7#4)(1997-8#4)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#26)(2008-12#15)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#17)(2008-6#2)(2008-7#10)(2008-8#15)(2008-9#5)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#2)(2010-3#2)(2010-5#4)(2010-6#4)(2010-8#7)(2010-9#2)(2011-1#5)(2011-2#19)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#11)(2013-1#10)(2013-7#1)(2013-8#3)
in clinically##4##2##(2008-6#1)(2009-2#1)(2009-3#1)(2012-3#1)
in clinics##7##2##(1990-2#1)(2008-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-3#1)(2013-8#1)
in clonal##5##2##(1994-11#1)(1997-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
in clones##2##2##(1992-9#1)(1996-10#1)
in cloning##3##2##(1991-2#1)(1994-12#1)(2008-7#1)
in clonogenic##2##2##(1993-9#1)(2008-11#1)
in close agreement with the##2##5##(1995-2#1)(2008-8#1)
in close agreement with##5##4##(1995-2#1)(2008-10#3)(2008-8#1)
in close agreement##6##3##(1995-2#1)(2008-10#3)(2008-2#1)(2008-8#1)
in close analogy to the##2##5##(1997-6#2)
in close association with each other##2##6##(2007-12#1)(2008-10#1)
in close association with##7##4##(1995-12#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-9#1)
in close connection with##2##4##(1994-12#1)(2008-8#1)
in close connection##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
in close contact with the##2##5##(2009-10#2)
in close contact with##5##4##(1995-3#1)(2008-10#1)(2008-5#1)(2009-10#2)
in close correlation with##2##4##(1996-3#1)(2008-3#1)
in close proximity to the##5##5##(1992-9#1)(1996-7#1)(2008-10#2)(2010-5#1)
in close proximity to##9##4##(1992-9#1)(1996-7#1)(2008-10#4)(2009-12#1)(2010-5#1)(2012-12#1)
in close proximity##15##3##(1992-9#1)(1996-7#1)(2008-10#6)(2008-2#2)(2008-3#1)(2009-12#1)(2010-11#1)(2010-5#1)(2012-12#1)
in close relationship with##2##4##(1994-12#2)
in close##46##2##(1992-9#1)(1994-12#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#2)(2007-12#1)(2008-10#13)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
in closed##8##2##(1990-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)
in closely##2##2##(2007-12#1)(2012-3#1)
in clouds##4##2##(2008-3#4)
in cloudy##2##2##(2008-2#1)(2008-3#1)
in clusters##5##2##(1991-9#1)(1993-11#1)(2008-10#2)(2008-3#1)
in clutches with##2##3##(1991-5#1)(2008-9#1)
in clutches##3##2##(1991-5#1)(2008-9#2)
in co-culture##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2012-4#1)
in co-solvent media##2##3##(2013-1#2)
in coadministration with atorvastatin##2##4##(2011-1#2)
in coal by##4##3##(2008-10#4)
in coal##11##2##(2008-10#10)(2011-2#1)
in coastal California##2##3##(2008-10#2)
in coastal and##2##3##(2008-10#1)(2008-2#1)
in coastal areas##2##3##(2007-12#1)(2008-10#1)
in coastal regions##2##3##(2008-2#1)(2013-8#1)
in coastal waters##8##3##(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
in coastal##23##2##(2007-12#1)(2007-5#1)(2008-10#9)(2008-2#4)(2008-3#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
in cobia (Rachycentron canadum) larvae##2##5##(2008-7#2)
in cocaine##2##2##(1991-1#1)(2012-2#1)
in cochlear implant patients##4##4##(2008-9#4)
in cochlear implant users##5##4##(2008-9#5)
in cochlear implant##12##3##(2008-9#11)(2012-2#1)
in cochlear implantation##7##3##(2008-9#7)
in cochlear implantees##2##3##(2008-9#2)
in cochlear##24##2##(2008-9#22)(2012-2#2)
in coconut##5##2##(2008-10#5)
in coculture with##2##3##(2008-4#1)(2008-6#1)
in coculture##3##2##(2008-4#1)(2008-6#1)(2008-9#1)
in cocultures##2##2##(1995-2#1)(2012-1#1)
in coding region##2##3##(2010-7#2)
in coding##5##2##(2007-12#1)(2008-9#1)(2010-7#2)(2012-12#1)
in codon##3##2##(1991-9#2)(1994-8#1)
in coeliac disease##4##3##(1991-12#2)(1992-12#1)(2008-10#1)
in coeliac patients##2##3##(1991-12#1)(2011-7#1)
in coeliac##6##2##(1991-12#3)(1992-12#1)(2008-10#1)(2011-7#1)
in coexistence##2##2##(2008-10#1)(2012-2#1)
in coffee and tea##2##4##(2008-10#2)
in coffee##7##2##(2008-10#4)(2008-11#2)(2008-6#1)
in cognition##3##2##(1994-3#1)(1996-2#1)(2013-8#1)
in cognitive control##2##3##(2012-12#1)(2013-8#1)
in cognitive function##3##3##(2008-7#2)(2013-7#1)
in cognitive performance##2##3##(2008-7#1)(2013-1#1)
in cognitive##14##2##(1990-3#1)(1990-8#1)(1995-6#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
in coherent lidar receivers##2##4##(2008-2#2)
in coherent##10##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
in cohesive##2##2##(2008-7#1)(2009-8#1)
in cohort##2##2##(1995-9#1)(2008-7#1)
in cohorts of##2##3##(2013-1#2)
in coiled high-birefringent fibers##2##4##(2008-2#2)
in coinfected plants##2##3##(2008-10#2)
in coinfected##3##2##(2008-10#3)
in cold water##2##3##(1990-9#1)(2008-10#1)
in cold##14##2##(1990-9#1)(1992-3#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
in collaboration with the National Agricultural Statistics Service##3##8##(2008-10#3)
in collaboration with the National##5##5##(1996-4#1)(2008-10#3)(2008-5#1)
in collaboration with the##13##4##(1996-2#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
in collaboration with##28##3##(1996-1#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
in collagen biosynthesis##2##3##(1997-7#1)(2008-5#1)
in collagen##8##2##(1997-7#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#1)
in collected##2##2##(2006-10#1)(2013-8#1)
in collecting##2##2##(2007-12#1)(2008-12#1)
in collection##2##2##(2007-11#1)(2010-8#1)
in collections from##3##3##(2008-10#3)
in collections of##3##3##(2008-10#2)(2008-7#1)
in collections##6##2##(2008-10#5)(2008-7#1)
in collective##2##2##(1993-1#1)(2009-10#1)
in college students##4##3##(2007-12#1)(2008-4#1)(2012-2#1)(2013-8#1)
in college##8##2##(2007-12#1)(2008-11#2)(2008-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
in college-age individuals##2##3##(2009-3#2)
in colleges##2##2##(2010-3#1)(2013-8#1)
in colloidal##2##2##(2008-9#1)(2010-8#1)
in colon cancer##6##3##(1995-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)
in colon##13##2##(1993-2#1)(1995-12#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-6#1)(2013-1#1)
in colonic epithelial cells##2##4##(1993-8#1)(2013-1#1)
in colonic epithelial##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
in colonic##12##2##(1992-6#1)(1993-8#1)(1993-9#3)(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#2)(2013-1#1)
in colonies##3##2##(2008-8#1)(2008-9#1)(2009-5#1)
in colonization and infection##2##4##(2008-10#1)(2008-5#1)
in colonization of##2##3##(2008-10#1)(2013-1#1)
in colonization##6##2##(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#1)
in colony morphology##2##3##(2008-11#1)(2013-1#1)
in colony##4##2##(1990-5#1)(1991-12#1)(2008-11#1)(2013-1#1)
in color space##2##3##(2008-3#1)(2008-6#1)
in color than when##2##4##(2012-2#2)
in color##15##2##(1993-5#1)(1994-12#1)(2008-10#4)(2008-3#3)(2008-6#1)(2010-1#1)(2011-1#1)(2012-2#3)
in colorectal adenoma##3##3##(2008-7#1)(2010-12#2)
in colorectal cancer##24##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-8#2)(1992-9#2)(1994-2#1)(1997-4#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
in colorectal carcinogenesis##5##3##(1993-9#1)(2008-10#1)(2009-9#1)(2011-1#2)
in colorectal carcinoma##2##3##(1993-12#1)(2009-4#1)
in colorectal surgery##3##3##(1992-9#1)(2012-1#1)(2013-1#1)
in colorectal##46##2##(1990-2#1)(1991-12#2)(1991-3#1)(1992-5#1)(1992-8#3)(1992-9#4)(1993-12#1)(1993-9#2)(1994-2#1)(1995-9#1)(1997-4#1)(2007-4#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-9#2)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#2)
in colostrum##4##2##(1991-11#1)(2012-2#3)
in colour##6##2##(1993-12#1)(1995-6#3)(2008-10#2)
in column##3##2##(2008-10#2)(2008-7#1)
in coma##4##2##(1990-9#1)(1991-12#1)(2007-11#1)(2011-1#1)
in combating##5##2##(2008-1#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
in combination for the##2##4##(1997-2#1)(2009-12#1)
in combination for##3##3##(1997-2#1)(2008-11#1)(2009-12#1)
in combination in the##2##4##(2008-10#1)(2008-6#1)
in combination in##4##3##(1994-11#1)(2008-10#1)(2008-12#1)(2008-6#1)
in combination therapy##2##3##(2008-3#1)(2012-3#1)
in combination to the##2##4##(2008-10#2)
in combination to##9##3##(2007-11#2)(2008-10#4)(2008-9#1)(2010-11#1)(2012-2#1)
in combination with DNA##2##4##(2008-9#1)(2010-7#1)
in combination with a dissolved oxygen probe##2##7##(2008-10#2)
in combination with a single##2##5##(2008-12#1)(2008-4#1)
in combination with a##36##4##(1992-3#1)(1993-12#1)(1994-5#1)(1996-5#1)(2007-12#4)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
in combination with additional##2##4##(1990-8#1)(2008-10#1)
in combination with an##7##4##(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-12#1)(2012-1#1)
in combination with antidepressants##2##4##(1993-12#1)(1997-6#1)
in combination with capecitabine##2##4##(2013-1#2)
in combination with chemotherapy in##2##5##(2012-2#1)(2012-3#1)
in combination with chemotherapy##4##4##(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
in combination with conventional##2##4##(2008-3#1)(2010-4#1)
in combination with different##4##4##(2008-10#1)(2008-7#1)(2011-1#1)(2012-1#1)
in combination with differential##2##4##(2008-10#1)(2008-3#1)
in combination with indinavir##2##4##(2008-5#2)
in combination with laser##2##4##(2012-1#2)
in combination with measurements##2##4##(2008-10#1)(2008-9#1)
in combination with oral##2##4##(1990-12#1)(2009-5#1)
in combination with other antihypertensive##3##5##(2008-3#2)(2012-3#1)
in combination with other methods##2##5##(2008-7#1)(2009-10#1)
in combination with other##15##4##(1991-4#1)(1992-3#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in combination with our##2##4##(1996-2#1)(2008-8#1)
in combination with prostanoids##2##4##(2010-10#2)
in combination with radiation##2##4##(2013-1#1)(2013-8#1)
in combination with the##25##4##(1992-1#1)(1993-12#1)(1994-2#1)(1995-5#2)(1996-10#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)
in combination with two##3##4##(1993-12#1)(2007-8#1)(2008-2#1)
in combination with vitamin##2##4##(2008-3#1)(2013-1#1)
in combination with zidovudine##2##4##(2008-5#2)
in combination with##283##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#1)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#48)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#3)(2008-5#16)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#8)(2009-10#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#2)
in combination##349##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#11)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#4)(1994-2#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-5#3)(1996-7#2)(1997-2#2)(1997-5#1)(1997-6#1)(2006-6#1)(2007-11#5)(2007-12#6)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#59)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#17)(2008-4#3)(2008-5#17)(2008-6#6)(2008-7#8)(2008-8#6)(2008-9#10)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#4)(2010-4#3)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#7)(2012-1#5)(2012-12#3)(2012-2#12)(2012-3#9)(2012-6#1)(2013-1#17)(2013-7#2)(2013-8#3)
in combinations##3##2##(2008-10#3)
in combinatorial chemistry##2##3##(1997-4#1)(2008-10#1)
in combinatorial##3##2##(1997-4#1)(2008-10#2)
in combined dosage form##3##4##(2010-3#1)(2010-5#1)(2012-2#1)
in combined##9##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)(2010-5#1)(2012-2#2)
in combining the##2##3##(2007-12#1)(2010-5#1)
in combustion environments##3##3##(2008-2#3)
in combustion##9##2##(1996-12#2)(2008-2#6)(2008-3#1)
in coming years##2##3##(1995-5#1)(2012-3#1)
in coming##6##2##(1995-5#1)(1996-1#1)(1997-1#1)(2008-8#1)(2012-3#1)(2013-8#1)
in commercial citrus plantings##2##4##(2008-10#2)
in commercial fields planted to##2##5##(2008-10#1)(2011-2#1)
in commercial fields##4##3##(2008-10#3)(2011-2#1)
in commercial formulations##3##3##(2008-10#3)
in commercial greenhouses##2##3##(2008-10#2)
in commercial hemodialysis##2##3##(2008-10#2)
in commercial juices##2##3##(2008-10#2)
in commercial orchards##3##3##(2008-10#3)
in commercial pharmaceutical preparations##2##4##(2008-10#2)
in commercial pharmaceutical##4##3##(2008-10#4)
in commercial preparations##2##3##(2008-10#2)
in commercial samples of##2##4##(2008-10#1)(2008-5#1)
in commercial samples##4##3##(2008-10#3)(2008-5#1)
in commercial tablets##2##3##(2008-10#2)
in commercial##68##2##(1990-3#1)(1997-1#1)(2007-11#1)(2007-6#1)(2008-10#53)(2008-3#3)(2008-5#4)(2008-8#2)(2011-2#2)
in commercially available##7##3##(2008-10#7)
in commercially##8##2##(2008-10#7)(2011-2#1)
in committing suicide##2##3##(1993-9#2)
in common bean##7##3##(2008-10#6)(2013-8#1)
in common for##2##3##(2008-10#1)(2008-3#1)
in common the##2##3##(1990-8#1)(2006-10#1)
in common wheat##6##3##(2008-10#3)(2008-5#2)(2008-8#1)
in common wheat-Th##2##3##(2008-9#2)
in common with##6##3##(1993-11#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-4#2)
in common##51##2##(1990-11#1)(1990-5#1)(1990-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-10#15)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
in commons##2##2##(2008-12#2)
in communicating##6##2##(1993-2#2)(2010-4#1)(2012-3#2)(2013-8#1)
in communication and##2##3##(1993-12#1)(2011-2#1)
in communication between##2##3##(2008-9#1)(2009-8#1)
in communication skills##4##3##(1992-6#1)(1997-3#1)(2012-2#2)
in communication with##4##3##(2007-11#2)(2008-9#1)(2013-8#1)
in communication##16##2##(1992-5#1)(1992-6#1)(1993-12#1)(1997-3#2)(2007-11#3)(2008-10#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
in communications between##2##3##(1990-7#1)(1994-3#1)
in communications##3##2##(1990-7#1)(1994-3#1)(1997-3#1)
in communities##11##2##(1994-3#2)(1995-6#1)(1997-1#1)(2008-11#1)(2008-9#3)(2010-1#1)(2010-10#1)(2012-2#1)
in community and##3##3##(2008-11#2)(2010-5#1)
in community based##3##3##(1993-12#1)(2008-7#1)(2013-7#1)
in community care and##2##4##(1995-8#1)(1996-7#1)
in community care##3##3##(1995-3#1)(1995-8#1)(1996-7#1)
in community health##3##3##(1995-1#1)(1996-1#2)
in community hospitals##3##3##(1990-6#1)(1995-3#1)(2007-10#1)
in community medicine##2##3##(2008-1#1)(2008-3#1)
in community pharmacies##2##3##(2008-11#2)
in community settings##5##3##(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
in community structure##2##3##(2008-9#2)
in community##46##2##(1990-6#2)(1990-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-1#2)(1996-12#3)(1996-7#1)(2007-10#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
in community-based##3##2##(2009-4#1)(2010-9#1)(2013-1#1)
in community-dwelling elders in Korea##2##5##(2010-4#2)
in community-dwelling elders##3##3##(2008-12#1)(2010-4#2)
in compact islets##2##3##(2008-5#2)
in compact##3##2##(2007-11#1)(2008-5#2)
in company with##2##3##(2008-11#1)(2008-8#1)
in company##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
in comparable conditions##2##3##(1994-3#1)(2008-10#1)
in comparable##5##2##(1990-11#1)(1990-5#1)(1994-3#1)(2008-10#1)(2008-7#1)
in comparative studies##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
in comparative##7##2##(1996-12#1)(1997-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
in compared##2##2##(1996-6#1)(2012-2#1)
in comparing the##3##3##(1995-2#1)(1995-3#1)(2008-11#1)
in comparing##5##2##(1995-2#1)(1995-3#1)(2008-11#1)(2009-12#1)(2013-1#1)
in comparison to control##2##4##(2008-7#1)(2013-1#1)
in comparison to conventional##3##4##(2009-12#2)(2010-5#1)
in comparison to healthy controls##2##5##(1996-7#1)(2009-6#1)
in comparison to normal##2##4##(1990-12#1)(1993-3#1)
in comparison to other##7##4##(1991-4#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-8#1)
in comparison to that in##2##5##(2008-8#1)(2013-7#1)
in comparison to that##5##4##(2008-5#1)(2008-8#1)(2012-3#2)(2013-7#1)
in comparison to the control group##3##6##(1995-12#1)(2008-12#1)(2009-12#1)
in comparison to the control##5##5##(1995-12#1)(2008-10#1)(2008-12#2)(2009-12#1)
in comparison to the other two##2##6##(2007-10#1)(2008-10#1)
in comparison to the other##3##5##(2007-10#1)(2008-10#2)
in comparison to the placebo##2##5##(2008-5#2)
in comparison to the##41##4##(1990-9#1)(1993-2#1)(1994-3#1)(1995-12#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2009-12#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
in comparison to their##3##4##(2008-10#1)(2008-12#1)(2009-7#1)
in comparison to those of##2##5##(2008-10#2)
in comparison to those with a##2##6##(1990-9#1)(1991-5#1)
in comparison to those##7##4##(1990-9#1)(1991-5#1)(1994-11#1)(2008-10#3)(2013-1#1)
in comparison to##131##3##(1990-12#1)(1990-9#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#10)(2008-12#7)(2008-2#2)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#3)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
in comparison with a##7##4##(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#2)
in comparison with an##3##4##(1993-12#1)(1994-9#1)(2007-7#1)
in comparison with baseline##2##4##(1996-6#1)(2013-1#1)
in comparison with control##2##4##(1993-8#1)(1995-12#1)
in comparison with conventional##4##4##(1992-10#1)(2008-10#2)(2008-3#1)
in comparison with darkness##2##4##(2006-11#2)
in comparison with normal##3##4##(1992-9#1)(2007-10#1)(2008-8#1)
in comparison with other##11##4##(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#2)(2012-1#1)
in comparison with previously##2##4##(2007-12#1)(2008-10#1)
in comparison with results##2##4##(2008-11#1)(2009-9#1)
in comparison with that encoded by##2##6##(2008-8#2)
in comparison with that of the##3##6##(1995-3#1)(2008-12#1)(2008-8#1)
in comparison with that of##9##5##(1994-11#1)(1995-3#1)(1997-6#1)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)
in comparison with that##13##4##(1994-11#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#4)(2008-9#1)
in comparison with the control group##3##6##(1993-3#1)(2007-11#2)
in comparison with the control##6##5##(1993-3#2)(1997-2#1)(2007-11#2)(2008-12#1)
in comparison with the controls##3##5##(2008-10#1)(2010-4#1)(2013-8#1)
in comparison with the other##2##5##(2008-10#1)(2008-2#1)
in comparison with the patients with cancer of the stomach##2##10##(2008-7#2)
in comparison with the##49##4##(1990-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1995-12#1)(1997-2#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2010-4#2)(2011-2#4)(2013-8#2)
in comparison with their counterparts##2##5##(2007-6#1)(2008-12#1)
in comparison with their##3##4##(1992-12#1)(2007-6#1)(2008-12#1)
in comparison with those##5##4##(1991-9#1)(1992-11#1)(1995-8#1)(1997-8#1)(2008-3#1)
in comparison with water control##3##5##(2008-12#3)
in comparison with##188##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-11#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#37)(2008-11#11)(2008-12#10)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#2)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
in comparison##322##2##(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#4)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-3#2)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-8#1)(2006-11#2)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#66)(2008-11#21)(2008-12#17)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#2)(2009-1#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#6)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#6)
in comparisons among##2##3##(1994-3#1)(2008-10#1)
in comparisons between##2##3##(2007-6#1)(2008-8#1)
in comparisons##5##2##(1994-3#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-8#1)
in compatible##2##2##(2008-10#2)
in compensation##3##2##(1996-1#1)(1996-2#1)(2013-7#1)
in compensatory##2##2##(1995-6#1)(2010-11#1)
in competing for##2##3##(1991-5#1)(1992-3#1)
in competing##5##2##(1991-5#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-8#1)
in competition with##5##3##(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)
in competition##14##2##(1991-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-12#1)(2010-8#1)(2012-2#1)
in competitive ability##2##3##(2008-8#1)(2008-9#1)
in competitive health insurance markets##2##5##(2008-7#2)
in competitive##10##2##(1997-3#1)(1997-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)
in complement##3##2##(1991-8#1)(2008-10#2)
in complementary and alternative medicine (CAM)##2##6##(2008-10#2)
in complementary##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
in complementing##2##2##(2008-11#1)(2008-8#1)
in complete Freund's adjuvant##2##4##(1995-12#1)(2008-4#1)
in complete absence of##2##4##(1995-6#1)(1995-8#1)
in complete darkness##2##3##(1995-5#1)(2008-8#1)
in complete remission##4##3##(1995-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
in complete visual##2##3##(2011-2#2)
in complete##28##2##(1991-8#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
in completely##2##2##(2008-5#2)
in complex environmental matrices##2##4##(2008-10#2)
in complex environments##2##3##(2008-12#1)(2012-3#1)
in complex matrices by##3##4##(2008-10#2)(2008-5#1)
in complex matrices such as##2##5##(2008-10#2)
in complex matrices##18##3##(2008-10#16)(2008-5#2)
in complex mixtures##4##3##(2008-1#1)(2008-10#1)(2008-4#2)
in complex partial##2##3##(1996-9#2)
in complex sample##3##3##(2008-10#2)(2008-3#1)
in complex samples##6##3##(2008-10#3)(2008-4#1)(2010-11#1)(2013-1#1)
in complex ways##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
in complex with substrate##2##4##(2011-1#2)
in complex with##7##3##(1992-6#1)(2008-8#1)(2009-7#3)(2011-1#2)
in complex##83##2##(1992-6#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-7#3)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in complexation##2##2##(2008-10#2)
in complexes of##3##3##(1992-4#1)(1995-5#2)
in complexes##6##2##(1992-4#1)(1995-5#2)(1997-2#1)(1997-7#1)(2008-10#1)
in compliance with##9##3##(1991-12#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#1)
in complicated##8##2##(2008-10#4)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
in complication##3##2##(1996-2#1)(2008-3#1)(2012-2#1)
in complications##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
in composite PEO-based polymer electrolytes by##2##6##(2008-10#2)
in composite##7##2##(1990-9#1)(2008-10#5)(2011-2#1)
in composites##2##2##(2008-10#1)(2013-1#1)
in composition and##3##3##(1990-7#1)(2012-2#1)(2013-8#1)
in composition of##4##3##(2008-10#1)(2011-2#2)(2012-8#1)
in composition##13##2##(1990-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-8#1)
in compost##3##2##(2008-10#3)
in compounds##3##2##(1994-3#1)(1994-8#1)(2008-4#1)
in comprehensive##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
in computational##6##2##(2008-2#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
in computed tomography (CT)##3##4##(2008-8#1)(2010-9#1)(2012-1#1)
in computed tomography##5##3##(1994-2#1)(2008-12#1)(2008-8#1)(2010-9#1)(2012-1#1)
in computer simulations of##2##4##(1995-3#1)(2009-12#1)
in computer simulations##3##3##(1995-3#1)(2008-10#1)(2009-12#1)
in computer vision and##2##4##(2008-6#2)
in computer vision##4##3##(2008-3#2)(2008-6#2)
in computer##16##2##(1993-2#1)(1995-3#1)(1996-12#1)(2006-12#1)(2008-10#2)(2008-3#3)(2008-6#2)(2009-12#1)(2010-12#2)(2010-3#1)(2013-8#1)
in computer-aided photoelasticity##2##3##(2008-2#2)
in computer-aided##3##2##(2008-2#2)(2008-3#1)
in computing the##2##3##(1994-1#1)(2008-3#1)
in computing##6##2##(1994-1#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
in concentrated nitric acid##2##4##(2008-10#2)
in concentrated solutions of##2##4##(1990-8#1)(2008-10#1)
in concentrated suspensions##2##3##(2007-12#2)
in concentrated##16##2##(1990-8#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-3#1)(2010-5#1)
in concentration of##7##3##(1991-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-3#1)(2012-2#1)
in concentration range of##3##4##(2008-10#2)(2010-5#1)
in concentration ranges##3##3##(2008-10#3)
in concentration##22##2##(1991-9#1)(1994-3#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
in concentrations between##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
in concentrations of##7##3##(1992-3#1)(1993-8#1)(2007-1#1)(2008-10#2)(2008-7#1)(2009-8#1)
in concentrations ranging from##6##4##(1997-8#1)(2008-10#4)(2008-6#1)
in concentrations##26##2##(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-8#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-1#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)
in concept and##2##3##(2008-3#1)(2008-4#1)
in concept##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
in concert to##3##3##(1996-12#1)(2011-2#1)(2011-3#1)
in concert with the##3##4##(2008-11#2)(2010-7#1)
in concert with##13##3##(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#2)
in concert##22##2##(1995-12#1)(1995-6#2)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)
in concluding##2##2##(2008-10#1)(2008-7#1)
in concordance with the##2##4##(2008-7#1)(2013-1#1)
in concordance##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
in conditioned media##2##3##(1997-3#1)(2008-11#1)
in conditioned##3##2##(1997-3#1)(2008-11#2)
in conditions of low##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
in conditions of malnutrition##2##4##(2007-7#2)
in conditions of##11##3##(1991-12#1)(1997-6#1)(2007-12#1)(2007-7#2)(2008-10#1)(2010-9#1)(2011-2#2)(2012-3#2)
in conditions such as##2##4##(2011-2#1)(2013-1#1)
in conditions##21##2##(1990-9#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-9#1)(1997-6#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-7#2)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
in conducting research##2##3##(2009-6#1)(2010-9#1)
in conducting this##2##3##(1996-1#1)(2008-10#1)
in conducting##13##2##(1994-3#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-8#1)
in conduction##3##2##(1994-3#1)(2008-8#1)(2013-1#1)
in conductive##2##2##(2010-8#1)(2013-8#1)
in conductivity##3##2##(2008-10#2)(2008-7#1)
in conferring protection against##2##4##(2010-8#1)(2013-1#1)
in conferring resistance##2##3##(2008-10#2)
in conferring##6##2##(1994-6#1)(2008-10#2)(2010-8#1)(2011-1#1)(2013-1#1)
in confining##2##2##(1995-1#1)(2008-7#1)
in confirming the diagnosis##2##4##(2007-10#1)(2008-12#1)
in confirming##4##2##(1997-8#1)(2007-10#1)(2008-12#1)(2011-2#1)
in conflict with the##4##4##(1996-6#1)(2008-3#1)(2008-9#2)
in conflict with##6##3##(1995-2#1)(1996-6#1)(2008-3#1)(2008-9#2)(2011-2#1)
in conflict##9##2##(1995-2#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)
in confluent##2##2##(1992-12#1)(1997-7#1)
in confocal scanning##2##3##(2008-2#1)(2008-3#1)
in confocal##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
in conformation##4##2##(1993-8#1)(1995-3#2)(2008-5#1)
in conformity with the##2##4##(1997-2#1)(2008-11#1)
in conformity with##3##3##(1997-2#1)(2008-11#1)(2008-7#1)
in confusion##2##2##(1995-11#1)(2008-12#1)
in congenital heart disease##4##4##(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)
in congenital heart##5##3##(1990-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)
in congenital##15##2##(1990-11#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#2)
in congestive heart failure##8##4##(1990-9#1)(1997-8#1)(2008-3#1)(2008-7#4)(2011-2#1)
in congruence##2##2##(2010-4#2)
in conidia##6##2##(1992-8#2)(2008-10#3)(2008-5#1)
in conidial##2##2##(2008-10#2)
in conifer##2##2##(2008-10#2)
in conifers##2##2##(2009-8#2)
in conjugated##2##2##(1993-3#1)(2008-10#1)
in conjunction with a##31##4##(1992-9#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-11#2)(2007-12#3)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#2)(2010-10#1)(2012-1#1)
in conjunction with an##10##4##(1991-3#1)(1993-12#1)(1993-3#1)(1996-2#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
in conjunction with data##2##4##(1993-12#1)(2008-2#1)
in conjunction with detailed##2##4##(1990-3#1)(2008-9#1)
in conjunction with local and national guidelines and regulations##2##9##(2008-4#1)(2008-9#1)
in conjunction with on-line##2##4##(2008-10#1)(2013-1#1)
in conjunction with other##5##4##(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
in conjunction with the use of a##2##7##(2008-10#1)(2008-3#1)
in conjunction with the use of##3##6##(1994-3#1)(2008-10#1)(2008-3#1)
in conjunction with the##33##4##(1994-3#1)(1995-3#1)(1996-2#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#1)(2013-1#1)
in conjunction with these##2##4##(2008-8#1)(2008-9#1)
in conjunction with three##3##4##(2008-10#2)(2008-11#1)
in conjunction with time-of-flight##2##4##(2008-10#1)(2009-10#1)
in conjunction with##196##3##(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#44)(2008-11#11)(2008-12#4)(2008-2#14)(2008-3#22)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
in conjunction##197##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#44)(2008-11#11)(2008-12#4)(2008-2#14)(2008-3#22)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
in connecting to##2##3##(2008-11#1)(2009-9#1)
in connection to##2##3##(2010-5#2)
in connection with a##2##4##(2008-10#1)(2011-2#1)
in connection with the##11##4##(1990-2#1)(1991-3#1)(1992-5#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
in connection with##35##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#2)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#2)
in connection##37##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#2)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#2)(2011-2#2)
in connective tissues and##2##4##(1993-3#1)(2008-11#1)
in conscious rabbits##2##3##(1995-12#2)
in conscious##5##2##(1991-12#1)(1991-9#1)(1992-3#1)(1995-12#2)
in consecutive##8##2##(1992-9#1)(1995-12#1)(1995-2#1)(1996-4#1)(2008-10#2)(2010-2#1)(2011-2#1)
in consensus##2##2##(1996-3#1)(2013-1#1)
in consequence of##2##3##(2007-11#1)(2012-1#1)
in consequence##4##2##(2007-11#1)(2008-12#1)(2008-7#1)(2012-1#1)
in conservation tillage##2##3##(2008-10#2)
in conservation##5##2##(2008-10#2)(2009-2#1)(2013-1#1)(2013-7#1)
in conservation-till than in conventional-till fields in all states except##2##10##(2008-10#2)
in conservative treatment##2##3##(2007-11#1)(2007-8#1)
in conservative##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
in conserved##2##2##(1995-8#1)(2008-10#1)
in considerable amounts##4##3##(2008-10#4)
in considerable reduction in##2##4##(1992-11#1)(2008-10#1)
in considerable##14##2##(1992-11#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-7#1)(2011-2#2)
in considerably##2##2##(1993-9#1)(1997-3#1)
in consideration of the##2##4##(2008-2#1)(2008-3#1)
in consideration of##5##3##(1993-6#1)(2008-2#2)(2008-3#1)(2012-3#1)
in consideration##6##2##(1993-6#1)(2007-11#1)(2008-2#2)(2008-3#1)(2012-3#1)
in considering##6##2##(1990-12#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-10#1)
in consolidation##2##2##(2007-8#1)(2011-2#1)
in constant darkness##2##3##(1994-8#1)(1995-11#1)
in constant time##2##3##(2008-2#1)(2008-3#1)
in constant##14##2##(1992-9#1)(1994-8#1)(1995-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)(2011-2#1)
in constitutive##2##2##(1991-9#1)(1995-12#1)
in constructing a##3##3##(1996-10#1)(2009-9#1)(2013-1#1)
in constructing##7##2##(1996-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
in construction of a##2##4##(1993-11#1)(2008-10#1)
in construction of##3##3##(1993-11#1)(2008-10#2)
in construction##7##2##(1991-12#1)(1991-2#1)(1993-11#1)(1993-3#1)(2008-10#2)(2008-3#1)
in constructs##2##2##(1996-5#1)(2009-6#1)
in consultation with##2##3##(1996-5#1)(2008-11#1)
in consultation##4##2##(1993-5#1)(1996-5#1)(2008-11#1)(2012-3#1)
in consumer products##2##3##(2008-11#1)(2008-5#1)
in consumer##5##2##(1997-3#2)(2008-11#1)(2008-12#1)(2008-5#1)
in consumption##2##2##(2012-3#1)(2013-8#1)
in contact with 0##2##4##(2008-10#2)
in contact with a##3##4##(2008-10#2)(2009-5#1)
in contact with soft##2##4##(1995-2#1)(2012-12#1)
in contact with the##14##4##(1991-12#1)(1992-3#1)(1994-5#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2010-12#1)(2012-12#1)
in contact with##41##3##(1991-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#2)(2009-5#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-12#2)(2013-7#1)
in contact##47##2##(1990-9#1)(1991-12#1)(1992-3#1)(1992-9#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#3)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-7#1)
in contacts##2##2##(1992-9#1)(1994-2#1)
in containers##2##2##(2008-11#1)(2009-7#1)
in containing the##2##3##(1992-2#1)(2011-2#1)
in containing##3##2##(1992-2#1)(1994-5#1)(2011-2#1)
in contaminated soil and##2##4##(2008-10#2)
in contaminated soil##3##3##(2008-10#2)(2008-11#1)
in contaminated soils##3##3##(2008-10#2)(2008-12#1)
in contaminated##14##2##(1990-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
in contemporary healthcare##2##3##(2008-7#1)(2009-8#1)
in contemporary society##2##3##(2008-12#1)(2008-9#1)
in contemporary##21##2##(1993-12#1)(1995-6#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#3)(2011-2#3)
in content of##3##3##(2007-1#1)(2011-1#1)(2013-1#1)
in content##6##2##(2007-1#1)(2007-12#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
in context of##2##3##(1991-1#1)(2012-2#1)
in context with nectar##2##4##(2007-12#2)
in context with##4##3##(1997-8#1)(2007-12#2)(2010-11#1)
in context##8##2##(1991-1#1)(1997-1#1)(1997-8#1)(2007-12#2)(2009-7#1)(2010-11#1)(2012-2#1)
in continental##2##2##(1997-6#1)(2008-10#1)
in continuing care retirement communities##3##5##(1991-2#1)(1994-2#2)
in continuing##4##2##(1991-2#1)(1994-2#2)(2008-8#1)
in continuity of##2##3##(1994-3#1)(2012-12#1)
in continuity##3##2##(1994-3#1)(2008-2#1)(2012-12#1)
in continuous ambulatory peritoneal dialysis patients##5##6##(2007-12#5)
in continuous ambulatory peritoneal dialysis##7##5##(2007-12#7)
in continuous ambulatory peritoneal##9##4##(2007-12#9)
in continuous culture##6##3##(2008-11#5)(2008-6#1)
in continuous flow##5##3##(1990-12#1)(2008-10#3)(2008-7#1)
in continuous growth##2##3##(2008-10#1)(2008-11#1)
in continuous hybridoma cell##2##4##(2008-11#2)
in continuous light##2##3##(1996-10#1)(2008-10#1)
in continuous use##3##3##(2008-10#3)
in continuous##45##2##(1990-12#1)(1994-5#1)(1996-10#1)(1996-3#1)(2007-12#9)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#4)
in continuous-wave##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
in contracting##2##2##(1991-3#1)(1996-2#1)
in contrast to ATP##2##4##(1993-8#1)(1994-2#1)
in contrast to a##3##4##(1990-2#1)(1992-10#1)(2008-10#1)
in contrast to control##2##4##(2008-10#1)(2008-11#1)
in contrast to controls##3##4##(1992-12#1)(1996-12#1)(2008-7#1)
in contrast to conventional##3##4##(2007-11#1)(2009-7#1)(2012-2#1)
in contrast to its##2##4##(1994-2#1)(1997-7#1)
in contrast to normal##2##4##(1990-11#1)(1992-8#1)
in contrast to other known##2##5##(1995-2#1)(1995-8#1)
in contrast to other##7##4##(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-11#1)(2008-8#1)(2009-7#1)
in contrast to previous##2##4##(1993-5#1)(2008-10#1)
in contrast to that observed##2##5##(2007-12#1)(2009-12#1)
in contrast to that##4##4##(1996-2#1)(2007-12#1)(2008-10#1)(2009-12#1)
in contrast to the case##2##5##(1992-6#1)(2008-3#1)
in contrast to the situation##2##5##(1991-5#1)(1997-4#1)
in contrast to the##44##4##(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
in contrast to their##2##4##(2008-10#1)(2008-5#1)
in contrast to##126##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-5#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#7)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-8#1)(2011-2#5)(2011-9#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
in contrast with a##2##4##(2007-11#1)(2007-12#1)
in contrast with the##6##4##(1992-12#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-8#1)
in contrast with##22##3##(1991-11#1)(1992-12#1)(1995-6#1)(1996-2#2)(1997-1#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#3)(2010-3#1)
in contrast##183##2##(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#4)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#6)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#7)(2008-7#8)(2008-8#12)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#5)(2011-9#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
in contributing to the##2##4##(2010-8#1)(2011-2#1)
in contributing to##4##3##(1997-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
in contributing##5##2##(1997-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
in control and##11##3##(1990-8#1)(1991-12#2)(1993-12#1)(1993-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)
in control animals##4##3##(1993-12#2)(1997-3#1)(2008-10#1)
in control cells##10##3##(1991-5#1)(1992-3#1)(1994-6#2)(1997-4#2)(2008-4#2)(2010-1#1)(2010-11#1)
in control group 6##2##4##(2010-4#2)
in control group##12##3##(1994-7#1)(1996-3#1)(2008-12#4)(2010-4#2)(2010-6#1)(2011-2#1)(2013-1#2)
in control groups##2##3##(1993-3#1)(2008-1#1)
in control mice##3##3##(1997-2#2)(2008-8#1)
in control of the##3##4##(1996-1#1)(1996-2#1)(2009-6#1)
in control of##12##3##(1996-1#1)(1996-2#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-6#2)(2010-4#1)
in control or##2##3##(1991-5#1)(2008-9#1)
in control plants##2##3##(2008-10#2)
in control rats and##2##4##(1995-3#1)(1997-7#1)
in control rats##13##3##(1990-7#1)(1993-12#1)(1993-5#2)(1995-11#1)(1995-12#1)(1995-3#3)(1997-7#1)(2007-10#2)(2008-10#1)
in control subjects##4##3##(1991-11#1)(1993-12#1)(1996-7#1)(2008-6#1)
in control to##5##3##(1995-12#4)(2013-1#1)
in control##122##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#4)(1991-8#1)(1992-3#1)(1993-12#5)(1993-3#1)(1993-5#2)(1993-8#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#5)(1995-3#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-7#3)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#9)(2008-4#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#2)(2010-1#1)(2010-11#2)(2010-4#3)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#3)
in controlled conditions##2##3##(2008-10#2)
in controlled environment chambers##2##4##(2008-10#2)
in controlled environment##4##3##(2008-10#4)
in controlled environments##2##3##(2008-10#1)(2008-8#1)
in controlled laboratory experiments##2##4##(2008-10#1)(2008-2#1)
in controlled studies##3##3##(1996-12#1)(1997-3#1)(1997-4#1)
in controlled##23##2##(1992-5#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)
in controlling chronic##2##3##(1997-1#1)(2012-3#1)
in controlling local##2##3##(2010-10#2)
in controlling postoperative pain##2##4##(2007-11#1)(2010-7#1)
in controlling the##23##3##(1991-9#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-6#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
in controlling##75##2##(1991-8#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#2)(2009-3#1)(2009-6#1)(2010-10#3)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
in controls (P##4##3##(2011-1#2)(2012-3#1)(2013-8#1)
in controls and##3##3##(1991-12#1)(1995-12#1)(2011-2#1)
in controls##56##2##(1991-12#3)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#3)(1995-8#1)(1996-5#2)(1996-7#1)(1996-9#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#4)(2008-7#4)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#3)
in controls)##4##2##(1990-3#1)(1992-2#1)(1994-6#2)
in conventional techniques##2##3##(2008-10#1)(2008-2#1)
in conventional tillage##2##3##(2008-10#2)
in conventional##32##2##(1990-8#1)(1991-11#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#3)(2011-1#1)(2013-8#1)
in conversion##2##2##(1992-3#1)(2008-6#1)
in conveying##2##2##(1994-8#1)(2010-3#1)
in cooked##4##2##(1997-2#1)(2008-10#2)(2010-4#1)
in cooler##4##2##(2008-10#3)(2008-8#1)
in cooperation with the##2##4##(1993-6#1)(2008-10#1)
in cooperation with##7##3##(1993-2#1)(1993-6#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
in cooperation##8##2##(1993-2#1)(1993-6#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)(2013-1#2)
in cooperative##3##2##(2008-8#2)(2010-12#1)
in coordinating the##2##3##(1997-3#1)(2013-8#1)
in coordinating##4##2##(1995-12#1)(1997-3#1)(2009-11#1)(2013-8#1)
in coordination with##2##3##(1990-3#1)(1991-9#1)
in coordination##4##2##(1990-3#1)(1991-9#1)(1993-11#1)(2008-10#1)
in coping with##3##3##(1992-12#1)(2009-7#2)
in coping##6##2##(1990-10#1)(1992-12#1)(1996-3#1)(2009-7#2)(2010-5#1)
in copper##6##2##(2008-10#3)(2011-2#1)(2013-8#2)
in copper-sensitive strains##2##3##(2008-10#2)
in coppice##2##2##(2008-10#2)
in copy number##2##3##(1994-11#1)(2009-7#1)
in coral larvae##2##3##(2012-12#2)
in coral reef##2##3##(2007-5#1)(2008-9#1)
in coral##6##2##(2007-5#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
in cord blood##4##3##(2008-11#2)(2008-9#2)
in core temperature##3##3##(1992-3#3)
in core##4##2##(1992-3#3)(1997-2#1)
in cores of##2##3##(2008-10#1)(2008-9#1)
in corn kernels##2##3##(2008-10#2)
in corn oil by gavage for##2##6##(2008-9#2)
in corn oil by gavage##4##5##(2008-9#4)
in corn oil##5##3##(2008-9#4)(2009-5#1)
in corn##12##2##(2008-10#7)(2008-9#4)(2009-5#1)
in cornea##3##2##(2008-4#3)
in coronary arteries##5##3##(1992-6#1)(2008-3#1)(2008-4#2)(2008-7#1)
in coronary artery bypass##7##4##(1996-9#1)(2007-8#3)(2011-2#2)(2012-12#1)
in coronary artery disease##5##4##(2008-11#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
in coronary artery##15##3##(1996-9#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#4)(2012-12#1)(2013-1#1)
in coronary bypass surgery##2##4##(2012-3#2)
in coronary bypass##3##3##(1995-12#1)(2012-3#2)
in coronary care units at##2##5##(2007-8#2)
in coronary heart disease##2##4##(1991-6#1)(2009-4#1)
in coronary heart##4##3##(1991-6#1)(1994-11#1)(1995-12#1)(2009-4#1)
in coronary vessels##3##3##(2008-7#2)(2009-5#1)
in coronary##45##2##(1990-8#2)(1991-6#1)(1992-6#1)(1994-11#1)(1995-12#2)(1996-9#2)(2007-8#5)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#2)
in corpora lutea##3##3##(1994-6#1)(1995-12#1)(2008-8#1)
in corpora##4##2##(1994-6#1)(1995-12#1)(2008-7#1)(2008-8#1)
in correcting severe##2##3##(1997-3#1)(2010-3#1)
in correction of##3##3##(1997-3#1)(2010-11#1)(2012-2#1)
in correctly##3##2##(2009-9#1)(2010-11#1)(2010-5#1)
in correlation with the##2##4##(2008-10#1)(2011-2#1)
in correlation with##6##3##(1992-9#1)(2008-10#1)(2010-11#1)(2011-2#3)
in correlation##12##2##(1992-9#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-3#3)(2010-11#1)(2011-2#3)
in correspondence to##2##3##(1997-4#1)(2008-2#1)
in correspondence##3##2##(1997-4#1)(2008-10#1)(2008-2#1)
in corresponding##5##2##(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
in corrosive##2##2##(2008-10#1)(2008-11#1)
in cortex##6##2##(1993-3#2)(1996-5#2)(2008-4#1)(2008-8#1)
in cortical and##3##3##(1996-5#1)(2008-10#1)(2013-8#1)
in cortical bone##2##3##(2008-10#1)(2009-7#1)
in cortical cells##5##3##(1996-2#1)(2008-10#4)
in cortical neurons##2##3##(1995-2#1)(1997-2#1)
in cortical##26##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2009-7#1)(2013-8#1)
in corticosterone##2##2##(2008-7#1)(2008-9#1)
in cortisol##2##2##(2010-2#1)(2012-2#1)
in cosmetic formulations##8##3##(2008-5#8)
in cosmetic industry##2##3##(2008-5#2)
in cosmetic products by##2##4##(2008-5#2)
in cosmetic products##8##3##(2008-10#3)(2008-5#5)
in cosmetic##36##2##(2007-12#1)(2007-7#1)(2008-10#8)(2008-5#26)
in cosmetics##22##2##(2008-5#21)(2013-1#1)
in cost##8##2##(1992-1#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#1)
in costly##2##2##(2008-11#1)(2008-8#1)
in costs##8##2##(1995-2#1)(1996-3#2)(2008-10#2)(2008-11#2)(2008-12#1)
in cot##2##2##(1990-11#1)(1992-4#1)
in cotton roots by##2##4##(2008-10#2)
in cotton roots##3##3##(2008-10#3)
in cotton seedlings##2##3##(2008-10#1)(2008-8#1)
in cotton##16##2##(2008-10#11)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
in cotyledons##2##2##(2008-10#1)(2008-8#1)
in cough##7##2##(1991-2#2)(2008-10#3)(2008-4#1)(2013-1#1)
in cough-cold##3##2##(2008-10#3)
in counseling##3##2##(2009-9#1)(2013-1#1)(2013-8#1)
in counselling##2##2##(2008-9#1)(2010-5#1)
in countries in##2##3##(2007-12#1)(2008-4#1)
in countries of the##3##4##(1997-6#1)(2008-10#1)(2011-2#1)
in countries where the disease is##2##6##(1995-3#1)(2012-12#1)
in countries where##5##3##(1990-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
in countries##15##2##(1990-6#1)(1991-8#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-12#1)
in county##2##2##(1995-3#1)(2012-3#1)
in couple therapy and relationship education##2##6##(2012-2#2)
in couple therapy##3##3##(2012-2#3)
in couple##4##2##(2008-10#1)(2012-2#3)
in coupled##7##2##(1993-5#1)(2007-11#1)(2007-12#4)(2008-3#1)
in couples##5##2##(2007-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)
in coupling and##2##3##(2008-10#2)
in coupling phase##4##3##(2008-10#4)
in coupling with##2##3##(2008-10#1)(2008-12#1)
in coupling##16##2##(1992-12#1)(1994-8#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-9#1)(2010-2#2)
in course##4##2##(1994-12#1)(2012-12#3)
in courses of##2##3##(1994-12#1)(2013-1#1)
in court##3##2##(1993-12#1)(2008-12#1)(2012-1#1)
in courtship##2##2##(2007-12#1)(2008-8#1)
in covalent##2##2##(1993-11#2)
in coverage of##2##3##(1994-8#1)(2008-11#1)
in coverage##4##2##(1994-3#1)(1994-8#1)(2008-11#1)(2011-2#1)
in cow##3##2##(1995-11#1)(2008-10#2)
in cow's milk##2##3##(2008-10#2)
in cow's##3##2##(2008-10#3)
in cows fed the FB diet##2##6##(2012-2#2)
in cows##4##2##(1991-6#1)(2012-2#2)(2012-3#1)
in crack##2##2##(2008-1#1)(2009-6#1)
in cranial##2##2##(2007-12#1)(2012-3#1)
in craniofacial surgery##2##3##(2007-12#2)
in craniofacial##5##2##(1995-6#1)(1996-6#1)(2007-12#3)
in crayfish##3##2##(1993-12#1)(2008-5#2)
in creatine kinase##2##3##(1993-11#1)(2010-8#1)
in creatine##3##2##(1993-11#1)(1994-8#1)(2010-8#1)
in creating a##6##3##(1990-8#1)(1992-2#1)(2007-11#1)(2008-6#1)(2009-3#1)(2013-1#1)
in creating an##2##3##(1994-3#1)(2013-8#1)
in creating and##3##3##(1997-2#1)(2009-9#1)(2010-3#1)
in creating the##2##3##(1992-1#1)(2008-2#1)
in creating##18##2##(1990-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-3#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
in credentialing##3##2##(1991-12#2)(1995-12#1)
in creeping bentgrass##3##3##(2008-10#3)
in crime##4##2##(1994-12#1)(1996-12#2)(2008-10#1)
in criminal##2##2##(2008-12#2)
in crisis##3##2##(1993-1#1)(1995-3#1)(2012-12#1)
in critical care##2##3##(2008-11#1)(2012-12#1)
in critical ill##2##3##(2012-3#2)
in critical thinking skills between##2##5##(2008-11#2)
in critical##21##2##(1991-2#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-12#2)(2007-11#1)(2008-1#1)(2008-11#4)(2008-4#2)(2012-12#1)(2012-3#3)(2013-1#3)
in critically ill adult##2##4##(2007-12#1)(2012-3#1)
in critically ill patients##12##4##(1991-3#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in critically ill patients]##2##4##(2009-5#1)(2013-1#1)
in critically ill##21##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(2007-12#3)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
in critically phase-matched##2##3##(2007-12#2)
in critically##23##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(2007-12#5)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
in crop rotation##3##3##(2008-12#3)
in crop##11##2##(2008-10#4)(2008-12#4)(2008-7#1)(2012-2#2)
in crops##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
in cross section##2##3##(2008-10#1)(2008-3#1)
in cross##4##2##(2008-10#3)(2008-3#1)
in cross-polarized##2##2##(2008-2#2)
in cross-sectional##3##2##(2008-2#1)(2008-5#1)(2011-2#1)
in crosses between##2##3##(2008-10#2)
in crosses of race 2##2##5##(2008-10#2)
in crosses with the##2##4##(2008-10#2)
in crosses with##4##3##(2008-10#4)
in crosses##9##2##(2008-10#9)
in crowded plant populations##2##4##(2008-8#2)
in crowded##5##2##(1996-3#1)(2008-8#2)(2012-2#1)(2012-3#1)
in crude enzyme##2##3##(1994-12#1)(2010-3#1)
in crude extracts##5##3##(1992-3#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-4#1)
in crude oil##3##3##(2008-10#3)
in crude oils##2##3##(2008-3#2)
in crude supernatant fraction of##2##5##(1991-12#2)
in crude##23##2##(1991-12#2)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2010-3#2)(2012-2#1)
in crystal form##2##3##(2008-8#2)
in crystal##8##2##(1992-8#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#2)
in crystalline##5##2##(1992-8#1)(1992-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
in crystals of the##2##4##(1996-2#1)(2007-11#1)
in crystals of##5##3##(1996-2#1)(2006-4#1)(2007-11#2)(2008-7#1)
in cubic##3##2##(2007-11#2)(2009-9#1)
in cucumber (Cucumis sativus)##2##4##(2008-10#2)
in cucumber##14##2##(2008-10#12)(2009-12#2)
in cucurbits##6##2##(2008-10#6)
in cultivar##9##2##(2008-10#8)(2008-12#1)
in cultivars##2##2##(2008-10#2)
in cultivated##4##2##(1994-11#1)(2008-10#2)(2010-10#1)
in cultivation##2##2##(2008-10#2)
in cultural##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
in culture and in the##2##5##(1994-8#1)(2008-10#1)
in culture and in##4##4##(1992-11#1)(1993-12#1)(1994-8#1)(2008-10#1)
in culture and##13##3##(1992-11#1)(1993-12#1)(1993-9#1)(1994-6#2)(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#3)(2009-3#1)(2012-2#1)
in culture as##3##3##(2008-11#2)(2008-9#1)
in culture but##2##3##(1995-6#1)(2008-10#1)
in culture filtrates##2##3##(2008-10#2)
in culture for##2##3##(1996-5#1)(2008-11#1)
in culture in##2##3##(1995-2#1)(2008-11#1)
in culture media containing##2##4##(2008-10#1)(2013-8#1)
in culture media supplemented with##2##5##(2008-10#2)
in culture media##6##3##(1994-6#1)(2008-10#3)(2011-2#1)(2013-8#1)
in culture over##2##3##(2009-11#1)(2012-2#1)
in culture supernatants##2##3##(2008-10#1)(2008-11#1)
in culture was##5##3##(1990-2#1)(1991-12#1)(1992-3#1)(1995-5#1)(1996-8#1)
in culture##163##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-2#3)(1991-5#1)(1992-11#1)(1992-3#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-6#6)(1994-8#1)(1995-12#7)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#2)(2008-1#1)(2008-10#30)(2008-11#34)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#5)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
in cultured Drosophila##2##3##(1995-6#1)(2008-2#1)
in cultured bovine aortic endothelial cells##3##6##(1990-12#2)(1993-8#1)
in cultured bovine##4##3##(1990-12#2)(1993-8#1)(1995-5#1)
in cultured cells in##3##4##(1991-9#1)(1994-12#1)(2008-11#1)
in cultured cells##14##3##(1990-12#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)
in cultured endothelial cells##2##4##(1991-2#1)(1993-3#1)
in cultured fibroblasts##2##3##(1993-12#1)(1994-11#1)
in cultured hippocampal##2##3##(1990-7#1)(1995-2#1)
in cultured human cells##2##4##(2008-11#1)(2008-2#1)
in cultured human fibroblasts##3##4##(1990-12#2)(2008-10#1)
in cultured human keratinocytes##3##4##(1994-3#1)(1996-2#2)
in cultured human skin fibroblasts##2##5##(1994-6#1)(2008-5#1)
in cultured human umbilical vein endothelial cells (HUVEC)##2##8##(1993-11#1)(1997-1#1)
in cultured human umbilical vein endothelial cells##4##7##(1993-11#1)(1997-1#1)(2008-11#2)
in cultured human##20##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)
in cultured lymphocytes##2##3##(1990-8#2)
in cultured mammalian cells##3##4##(1991-12#1)(1991-5#1)(2008-8#1)
in cultured neural##2##3##(1992-3#1)(1992-6#1)
in cultured neurons##2##3##(1992-12#1)(2012-2#1)
in cultured normal human keratinocytes##2##5##(1994-6#1)(2008-5#1)
in cultured normal##3##3##(1994-6#1)(1994-8#1)(2008-5#1)
in cultured porcine##2##3##(1993-3#1)(1995-12#1)
in cultured primary##2##3##(1996-12#1)(2013-1#1)
in cultured rat hepatocytes##4##4##(1990-7#1)(1990-8#1)(1995-12#1)(2008-7#1)
in cultured rat mesangial cells##3##5##(1992-6#1)(1993-8#1)(1995-11#1)
in cultured rat##13##3##(1990-7#1)(1990-8#1)(1992-6#1)(1993-5#2)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-5#1)(2008-7#1)
in cultured skin fibroblasts from##2##5##(1991-5#1)(1996-7#1)
in cultured skin fibroblasts##3##4##(1991-5#2)(1996-7#1)
in cultured skin##4##3##(1991-5#2)(1996-7#1)(2008-5#1)
in cultured vascular endothelial cells##2##5##(1991-9#1)(1994-6#1)
in cultured##119##2##(1990-11#1)(1990-12#6)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1991-12#2)(1991-2#1)(1991-5#4)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#6)(1994-12#1)(1994-3#1)(1994-6#6)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#3)(1996-7#1)(1997-1#2)(1997-4#2)(2008-10#2)(2008-11#10)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#3)
in cultures and##2##3##(2008-10#1)(2009-12#1)
in cultures of human##2##4##(1995-2#1)(2012-2#1)
in cultures of the##2##4##(2008-10#1)(2008-11#1)
in cultures of##10##3##(1991-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#3)(2012-2#1)
in cultures##22##2##(1991-12#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(2008-10#3)(2008-11#5)(2008-7#3)(2009-12#1)(2012-2#1)(2013-1#1)
in cumulative##3##2##(2008-10#2)(2012-2#1)
in curative##3##2##(1993-9#1)(2008-7#1)(2013-8#1)
in cure##2##2##(2008-7#1)(2011-2#1)
in cured meat products##2##4##(2008-10#2)
in cured##3##2##(1997-7#1)(2008-10#2)
in curing##3##2##(1991-9#1)(2008-7#1)(2011-2#1)
in current practice##3##3##(2008-7#1)(2008-8#1)(2009-4#1)
in current use##2##3##(2008-2#1)(2008-3#1)
in current##28##2##(1990-5#3)(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
in curricula##2##2##(2008-12#1)(2010-3#1)
in curriculum##2##2##(1993-2#1)(2008-11#1)
in custody##3##2##(2008-1#1)(2010-1#2)
in cutaneous melanoma##2##3##(2008-7#1)(2009-4#1)
in cutaneous##8##2##(1991-8#1)(1997-3#1)(2007-7#1)(2008-5#2)(2008-7#1)(2009-4#1)(2012-3#1)
in cv##19##2##(2008-10#19)
in cvs##2##2##(2008-10#2)
in cw##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
in cyanobacteria##2##2##(1992-3#1)(2008-10#1)
in cycle 1##4##3##(2008-7#4)
in cycle##6##2##(1993-12#1)(2008-7#4)(2008-9#1)
in cyclic AMP accumulation##2##4##(1994-2#1)(2008-4#1)
in cyclic AMP##3##3##(1994-2#1)(1995-11#1)(2008-4#1)
in cyclic voltammetry##2##3##(2008-10#2)
in cyclic##7##2##(1994-2#1)(1995-11#1)(2008-10#4)(2008-4#1)
in cyclin A-activated G1##2##4##(1994-8#2)
in cyclodextrin##2##2##(2008-10#1)(2013-1#1)
in cyclohexane##3##2##(1994-8#1)(2008-10#2)
in cylindrical##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
in cynomolgus monkeys##2##3##(2008-10#2)
in cynomolgus##4##2##(2008-10#3)(2009-6#1)
in cyst##4##2##(1993-1#1)(1994-7#1)(1996-3#1)(2008-7#1)
in cystathionine beta-synthase##2##3##(1995-2#2)
in cystic fibrosis##4##3##(1991-12#1)(1997-5#1)(2007-12#1)(2008-5#1)
in cystic##7##2##(1991-12#1)(1991-2#1)(1997-5#1)(1997-8#2)(2007-12#1)(2008-5#1)
in cystine##2##2##(2008-10#1)(2008-11#1)
in cysts##2##2##(2008-10#1)(2008-7#1)
in cytoarchitecture##2##2##(1994-3#1)(2008-3#1)
in cytochrome P-450scc##2##3##(1991-12#2)
in cytochrome c oxidase##2##4##(1992-12#1)(1995-2#1)
in cytochrome c##5##3##(1992-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-10#1)
in cytochrome oxidase##3##3##(1990-3#1)(1994-8#1)(2011-2#1)
in cytochrome##12##2##(1990-3#1)(1991-12#2)(1992-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(2008-10#2)(2008-8#1)(2011-2#1)
in cytogenetics##2##2##(2008-9#2)
in cytokine##3##2##(1994-11#1)(1996-2#1)(2007-2#1)
in cytokinesis##3##2##(2008-11#1)(2009-8#2)
in cytological##2##2##(1990-2#1)(2008-10#1)
in cytology##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
in cytometry##3##2##(2008-9#3)
in cytomics analysis##2##3##(2008-9#2)
in cytoplasm of##2##3##(1993-11#1)(2013-1#1)
in cytoplasm##9##2##(1992-6#1)(1993-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2013-1#1)
in cytoplasmic Ca2+##2##3##(1992-6#1)(1995-11#1)
in cytoplasmic##9##2##(1992-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(2006-6#1)(2008-11#1)(2008-7#1)(2012-1#1)
in cytosol##5##2##(1993-3#1)(1994-6#1)(2008-9#1)(2013-1#2)
in cytosolic Ca2+ concentration##2##4##(1994-8#1)(1995-12#1)
in cytosolic Ca2+##6##3##(1992-4#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-2#1)
in cytosolic calcium##2##3##(1995-12#1)(2008-9#1)
in cytosolic free Ca2+ concentration##2##5##(1995-11#1)(1995-5#1)
in cytosolic free calcium##2##4##(1994-9#2)
in cytosolic free##6##3##(1990-7#1)(1994-9#2)(1995-11#1)(1995-5#1)(2009-2#1)
in cytosolic##20##2##(1990-7#1)(1992-4#1)(1992-8#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)
in cytotoxic activity##2##3##(1993-9#1)(1994-2#1)
in cytotoxic##4##2##(1993-6#1)(1993-9#1)(1994-2#1)(2008-7#1)
in cytotoxicity##6##2##(1990-5#1)(1994-2#2)(1994-3#1)(2008-11#2)
in d' or arcsine terms##2##5##(1991-2#2)
in daily activities##4##3##(2007-10#1)(2007-11#2)(2009-1#1)
in daily care##2##3##(1996-3#1)(2007-12#1)
in daily clinical practice##4##4##(2011-2#3)(2013-8#1)
in daily life with psoriasis##2##5##(2013-1#2)
in daily life##9##3##(1993-12#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-6#1)(2012-1#1)(2013-1#2)
in daily practice##10##3##(1993-11#1)(1995-5#1)(1997-4#1)(2008-11#3)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
in daily use##2##3##(1991-9#1)(2008-3#1)
in daily##44##2##(1991-11#1)(1991-9#1)(1993-11#3)(1993-12#1)(1994-2#1)(1995-5#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-5#2)(2009-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in dairy cows##2##3##(1996-8#1)(2012-2#1)
in dairy goats##2##3##(2008-12#1)(2008-9#1)
in dairy##10##2##(1996-3#1)(1996-8#1)(2008-12#1)(2008-9#1)(2012-12#2)(2012-2#1)(2012-3#3)
in dammam central hospital##2##4##(2008-1#2)
in dance##4##2##(2008-2#3)(2009-7#1)
in dandruff##3##2##(2008-5#3)
in danger of##2##3##(2007-12#1)(2011-2#1)
in danger##3##2##(2007-12#1)(2011-2#2)
in dark##2##2##(2008-10#1)(2008-7#1)
in dark-skinned##2##2##(2008-5#1)(2011-2#1)
in darkness##4##2##(1991-12#1)(2006-11#1)(2008-10#1)(2008-4#1)
in data analysis##4##3##(1993-9#1)(2008-3#1)(2008-7#1)(2012-3#1)
in data monitoring##2##3##(1996-6#2)
in data##15##2##(1993-9#1)(1995-2#1)(1995-9#1)(1996-6#2)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-3#1)(2013-8#1)
in database##5##2##(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)
in databases##11##2##(1996-12#2)(1996-6#2)(1997-3#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-3#1)
in day care centres##2##4##(1994-6#2)
in day care##4##3##(1994-6#3)(1997-5#1)
in day surgery##3##3##(2009-2#1)(2009-3#1)(2012-3#1)
in day##11##2##(1991-2#1)(1994-6#3)(1997-4#1)(1997-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2012-3#2)
in daycare##3##2##(2007-12#1)(2008-11#1)(2010-6#1)
in daylight##2##2##(2008-10#1)(2008-3#1)
in db/db mice##3##3##(2012-3#3)
in db/db##5##2##(2012-3#5)
in de novo##7##3##(1990-7#1)(1991-4#1)(1994-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2010-1#1)
in dead##2##2##(1991-12#1)(2008-10#1)
in deaf##2##2##(2008-9#1)(2012-2#1)
in dealing with the##2##4##(2007-12#1)(2008-11#1)
in dealing with these##2##4##(1992-3#1)(2010-8#1)
in dealing with##11##3##(1992-1#1)(1992-3#1)(1993-12#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-8#1)
in death##8##2##(1997-3#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)
in deaths from##2##3##(1991-11#1)(1997-3#1)
in deaths##3##2##(1991-11#1)(1997-3#1)(2011-3#1)
in decapods##2##2##(2007-12#2)
in decerebrated cats##2##3##(2013-1#2)
in decerebrated##3##2##(1997-6#1)(2013-1#2)
in deciding whether##2##3##(2008-10#1)(2008-9#1)
in deciding##6##2##(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
in deciduous##2##2##(2008-11#1)(2008-12#1)
in decision making and##2##4##(1992-3#1)(2011-1#1)
in decision making for##3##4##(1993-12#1)(2010-2#1)(2011-2#1)
in decision making##13##3##(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)
in decision##14##2##(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)
in decision-making##5##2##(1993-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2010-7#1)
in decisions affecting their##2##4##(1996-12#1)(1997-3#1)
in decisions that##2##3##(1993-12#2)
in decisions##8##2##(1993-12#4)(1996-12#1)(1997-3#1)(2008-11#1)(2008-7#1)
in decomposing leaves##2##3##(2008-10#2)
in decomposing##3##2##(2008-10#3)
in decomposition of##2##3##(2008-3#1)(2013-8#1)
in decomposition##4##2##(2008-11#2)(2008-3#1)(2013-8#1)
in decreased##16##2##(1990-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#2)
in decreasing order##2##3##(2008-10#1)(2012-2#1)
in decreasing the##5##3##(1990-8#1)(1996-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
in decreasing##12##2##(1990-8#1)(1996-12#1)(2007-8#1)(2008-10#3)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in deep seated AVMs##2##4##(2012-2#2)
in deep sediment cores##2##4##(2013-8#2)
in deep##26##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-9#1)(1994-8#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
in deeper##5##2##(1990-6#1)(1995-2#2)(2008-10#1)(2008-5#1)
in defective##3##2##(1994-8#1)(2008-10#1)(2012-12#1)
in defects in##2##3##(1995-2#1)(2012-2#1)
in defects of##2##3##(2008-6#1)(2008-7#1)
in defects##5##2##(1995-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
in defence##2##2##(2008-10#1)(2012-2#1)
in defending##2##2##(2008-8#1)(2008-9#1)
in defense against##2##3##(1990-11#1)(2008-10#1)
in defense responses##2##3##(2008-10#2)
in defense##10##2##(1990-11#1)(2007-12#1)(2008-10#5)(2008-9#2)(2010-7#1)
in defined##5##2##(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
in defining the##9##3##(1991-5#1)(1992-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#2)
in defining##22##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-6#1)(1996-1#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2009-6#1)(2009-9#1)(2010-1#1)(2012-2#1)
in definitive##5##2##(1991-2#1)(1993-9#1)(2008-9#2)(2012-12#1)
in deformed##2##2##(2007-12#2)
in degenerative diseases##2##3##(2008-7#1)(2013-1#1)
in degenerative##6##2##(1993-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2013-1#1)
in degradation of##3##3##(1993-11#1)(1993-8#1)(2008-7#1)
in dehydrated##3##2##(2008-10#1)(2008-9#2)
in deionized water##7##3##(2008-10#2)(2008-3#1)(2009-7#1)(2010-3#2)(2013-1#1)
in delay##2##2##(2008-4#1)(2013-8#1)
in delayed##7##2##(1992-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
in delaying##3##2##(1992-9#1)(2008-10#1)(2010-11#1)
in deletion##5##2##(1992-8#1)(1994-8#1)(1997-3#1)(2008-7#1)(2008-9#1)
in deliberate##4##2##(1992-5#1)(2010-3#2)(2013-8#1)
in delineating the##2##3##(2009-1#1)(2011-1#1)
in delirium##4##2##(2010-10#2)(2011-2#1)(2013-1#1)
in delivering##6##2##(1993-2#1)(1996-1#1)(2008-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
in delivery of##3##3##(2009-6#1)(2011-2#2)
in delivery##5##2##(1994-2#1)(2009-6#1)(2011-2#2)(2012-12#1)
in delta##5##2##(1992-6#1)(1994-11#1)(1995-3#1)(2013-8#2)
in deltamethrin##2##2##(2008-10#2)
in demand##3##2##(1990-2#1)(1992-2#1)(1994-12#1)
in demented patients##2##3##(2008-7#2)
in demented##4##2##(2008-7#4)
in dementia##12##2##(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2013-1#2)(2013-8#3)
in demographic##3##2##(1994-3#1)(2010-7#1)(2010-8#1)
in demonstrating the##4##3##(1990-12#1)(1990-2#1)(2008-10#1)(2009-5#1)
in demonstrating##7##2##(1990-12#1)(1990-2#1)(1992-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-8#1)
in denaturing conditions##2##3##(2008-10#1)(2008-12#1)
in dendrite##2##2##(1996-6#1)(2008-11#1)
in dendritic##5##2##(1996-6#1)(2007-11#1)(2008-10#2)(2012-2#1)
in denervated neuropil regions##3##4##(1997-3#3)
in denervated neuropil##5##3##(1997-3#5)
in dense periodic##2##3##(2007-12#2)
in dense suspensions##2##3##(2007-12#1)(2008-10#1)
in dense##7##2##(1997-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2009-2#1)
in densely packed##2##3##(1992-6#1)(2007-12#1)
in density and##3##3##(2008-10#2)(2008-7#1)
in density of##2##3##(1996-6#1)(2008-10#1)
in density##15##2##(1993-12#1)(1993-9#1)(1995-6#1)(1996-6#1)(2007-5#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#2)
in dental clinics##3##3##(2008-1#3)
in dental education##6##3##(2008-8#1)(2012-1#1)(2013-1#4)
in dental office was very important##2##6##(2008-1#2)
in dental settings##2##3##(1993-1#1)(2012-2#1)
in dental##22##2##(1993-1#1)(1993-12#1)(2007-7#1)(2008-1#7)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#6)
in dentate gyrus granule cells##2##5##(1990-7#1)(1997-6#1)
in dentate gyrus##3##3##(1990-7#1)(1995-12#1)(1997-6#1)
in dentate##5##2##(1990-7#1)(1995-12#1)(1997-6#1)(2008-1#1)(2010-11#1)
in dentin##2##2##(2011-2#1)(2012-12#1)
in dentistry and medicine##2##4##(2009-8#1)(2012-1#1)
in dentistry and##3##3##(2009-7#1)(2009-8#1)(2012-1#1)
in dentistry##18##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1993-3#2)(2007-12#1)(2008-1#1)(2008-12#1)(2009-12#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-2#2)(2013-1#2)
in dentists during##2##3##(1990-10#1)(1990-6#1)
in dentoalveolar surgery##3##3##(2007-12#3)
in deoxy Hb A##2##4##(1992-3#2)
in deoxyhemoglobin##2##2##(1990-8#2)
in departments##2##2##(1991-3#1)(2012-3#1)
in dependence of##2##3##(2008-10#2)
in dependence on##2##3##(2008-10#1)(2008-7#1)
in dependence##4##2##(2008-10#3)(2008-7#1)
in depolarization##3##2##(2007-12#1)(2008-3#2)
in depressed adolescents##3##3##(2008-11#3)
in depressed##6##2##(2008-11#3)(2008-7#1)(2009-11#1)(2012-12#1)
in depression and##2##3##(1996-7#1)(2013-7#1)
in depression##19##2##(1993-3#1)(1995-11#1)(1996-7#2)(2008-4#2)(2008-6#2)(2010-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
in depressive symptoms and##3##4##(2009-7#2)(2010-4#1)
in depressive symptoms##4##3##(2009-7#2)(2010-4#2)
in depressive##5##2##(2008-10#1)(2009-7#2)(2010-4#2)
in depth in##2##3##(2008-10#1)(2008-11#1)
in depth of##2##3##(1993-1#1)(2007-12#1)
in depth##21##2##(1992-3#1)(1993-1#1)(1993-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-8#1)
in derived##2##2##(2008-2#1)(2008-3#1)
in dermal##4##2##(1993-8#1)(2007-7#1)(2008-7#1)(2012-2#1)
in dermatology##8##2##(2007-7#7)(2008-5#1)
in descending order##2##3##(1992-8#1)(2011-2#1)
in descending##3##2##(1991-1#1)(1992-8#1)(2011-2#1)
in describing the##4##3##(1991-3#1)(2007-12#1)(2008-10#1)(2009-10#1)
in describing##10##2##(1991-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-6#1)(2013-1#2)
in desiccated##2##2##(2008-10#1)(2013-7#1)
in desiccation resistance##2##3##(2008-10#2)
in design and##4##3##(1993-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
in design of##7##3##(1995-5#1)(2007-11#1)(2008-6#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
in design##15##2##(1992-9#1)(1993-6#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-6#1)(2009-7#1)(2010-10#1)(2012-3#2)(2013-1#2)
in designing a##5##3##(1994-3#2)(1997-2#1)(2010-12#1)(2010-5#1)
in designing an##2##3##(1997-4#1)(2012-2#1)
in designing and##3##3##(1995-2#1)(2007-7#1)(2008-12#1)
in designing the##2##3##(1994-2#1)(2008-3#1)
in designing##33##2##(1994-2#2)(1994-3#2)(1995-2#2)(1996-1#1)(1997-2#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
in desquamation##2##2##(2008-5#2)
in destruction of##2##3##(2009-8#1)(2010-8#1)
in detached flowers##2##3##(2008-10#2)
in detached leaf tissues##3##4##(2008-10#1)(2008-8#2)
in detached leaves##2##3##(2008-10#2)
in detached##9##2##(2008-10#6)(2008-4#1)(2008-8#2)
in detail a##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
in detail and##16##3##(1993-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-6#1)(2011-2#1)
in detail are##2##3##(1991-1#1)(1997-6#1)
in detail by using##2##4##(2008-10#2)
in detail by##6##3##(1992-12#1)(1996-5#1)(2008-10#4)
in detail for##3##3##(1992-12#1)(1993-11#1)(2008-9#1)
in detail from the##2##4##(2008-10#1)(2008-3#1)
in detail in a##2##4##(2008-10#1)(2008-3#1)
in detail in the following##2##5##(1996-2#1)(2008-10#1)
in detail in the##3##4##(1996-2#1)(2008-10#1)(2008-4#1)
in detail in this##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
in detail in##10##3##(1996-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
in detail the effect of##2##5##(2008-3#1)(2008-7#1)
in detail the##23##3##(1990-10#1)(1991-6#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-6#1)(1997-3#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in detail through##2##3##(2008-10#1)(2012-3#1)
in detail to##9##3##(2008-10#8)(2008-3#1)
in detail##242##2##(1990-10#1)(1990-2#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#94)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#35)(2008-4#10)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#9)(2009-12#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#1)
in detailed##4##2##(2007-11#1)(2008-8#1)(2008-9#1)(2009-9#1)
in details##8##2##(1996-3#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)
in detecting early##2##3##(1991-3#1)(2007-9#1)
in detecting the##9##3##(2008-10#2)(2008-3#2)(2008-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
in detecting##46##2##(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#1)(1993-12#1)(1996-12#2)(1997-1#1)(1997-3#1)(2007-11#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)
in detection and##5##3##(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
in detection of metastatic##2##4##(2008-7#1)(2010-3#1)
in detection of the##2##4##(1994-7#1)(2010-11#1)
in detection of##19##3##(1990-12#1)(1991-3#1)(1994-7#1)(1994-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
in detection##32##2##(1990-12#1)(1991-3#1)(1994-7#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in detergents##3##2##(2008-10#3)
in determination of##15##3##(2008-10#13)(2008-3#1)(2008-8#1)
in determination##16##2##(2008-10#13)(2008-3#1)(2008-7#1)(2008-8#1)
in determining best##2##3##(2008-11#1)(2008-8#1)
in determining contest##2##3##(2009-9#2)
in determining future##2##3##(2008-10#1)(2010-8#1)
in determining how##2##3##(1993-2#1)(2008-3#1)
in determining if##2##3##(1992-2#1)(2008-10#1)
in determining the degree of##3##5##(2008-7#2)(2008-8#1)
in determining the formation of##2##5##(1990-8#1)(2007-12#1)
in determining the mechanisms of##2##5##(1995-2#1)(2008-7#1)
in determining the optical properties of##3##6##(2007-11#1)(2008-2#1)(2009-2#1)
in determining the performance of##3##5##(2007-8#1)(2008-3#1)(2008-5#1)
in determining the prevalence of##2##5##(1991-12#1)(2011-1#1)
in determining the response to##2##5##(2008-6#1)(2008-8#1)
in determining the specificity of the##2##6##(2009-10#1)(2009-8#1)
in determining the success##2##4##(2008-10#1)(2011-1#1)
in determining the value of##2##5##(2007-8#1)(2008-8#1)
in determining the##76##3##(1990-12#1)(1990-8#2)(1991-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)
in determining their##2##3##(2008-11#1)(2008-9#1)
in determining what##2##3##(2008-4#1)(2012-1#1)
in determining whether or not a##2##6##(1991-1#1)(2008-5#1)
in determining whether or not##3##5##(1991-1#1)(2008-5#1)(2008-7#1)
in determining whether##7##3##(1991-1#1)(1993-1#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
in determining which##5##3##(1990-5#1)(1994-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
in determining##152##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#2)(1992-2#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#5)(2008-1#2)(2008-10#22)(2008-11#12)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#13)(2008-9#7)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
in deuterostomes##2##2##(2008-7#2)
in developed and##2##3##(2011-3#1)(2012-1#1)
in developed countries are##3##4##(1992-6#1)(2009-8#1)(2012-2#1)
in developed countries where##2##4##(1991-6#1)(2007-2#1)
in developed countries##35##3##(1991-6#1)(1992-6#5)(1996-1#1)(2007-10#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#1)
in developed##40##2##(1991-3#1)(1991-6#1)(1992-6#5)(1996-1#1)(2007-10#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
in developing a##16##3##(1991-12#1)(1992-1#1)(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-11#2)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#2)
in developing an##3##3##(1995-9#1)(2012-12#2)
in developing and evaluating##2##4##(1995-3#1)(1997-7#1)
in developing and implementing a##2##5##(1995-12#2)
in developing and mature##2##4##(1991-7#1)(1996-2#1)
in developing and testing##2##4##(1997-3#1)(2009-8#1)
in developing and##13##3##(1990-9#1)(1991-7#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-2#1)
in developing apple fruit##2##4##(2008-9#2)
in developing apple##3##3##(2008-9#3)
in developing bolls##2##3##(2008-10#2)
in developing countries and##3##4##(2007-7#1)(2010-6#1)(2011-2#1)
in developing countries is##4##4##(1991-6#1)(1994-9#1)(2008-1#1)(2009-4#1)
in developing countries should##2##4##(1991-8#1)(1993-3#1)
in developing countries such as India##2##6##(2007-12#1)(2009-4#1)
in developing countries to##3##4##(2009-4#1)(2011-1#2)
in developing countries##62##3##(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-5#1)(1993-3#3)(1994-12#1)(1994-9#1)(1995-9#2)(1996-12#2)(1996-3#1)(1997-7#3)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#2)(2013-1#3)
in developing educational##2##3##(1996-1#1)(2010-3#1)
in developing effective##2##3##(1997-3#1)(2008-10#1)
in developing endosperm of Zea mays##2##6##(2008-5#2)
in developing new##5##3##(1997-3#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-3#1)
in developing professional confidence##2##4##(2008-11#2)
in developing rat##2##3##(1991-7#1)(1993-11#1)
in developing the##8##3##(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#3)(2008-11#1)
in developing##205##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-9#2)(1995-12#3)(1995-3#3)(1995-9#3)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#5)(1997-6#1)(1997-7#5)(2007-10#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#22)(2008-11#14)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#6)(2011-3#4)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#3)
in development and##11##3##(1993-8#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#1)
in development for##4##3##(1992-1#1)(2008-11#1)(2008-7#1)(2010-8#1)
in development of the##3##4##(1991-9#1)(2007-11#1)(2013-7#1)
in development of##18##3##(1991-9#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
in development##54##2##(1990-11#1)(1991-9#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-5#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
in developmental biology##4##3##(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#1)
in developmental dysplasia of the hip##2##6##(2007-11#1)(2007-8#1)
in developmental##16##2##(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#2)(2013-8#1)
in device##2##2##(2007-11#1)(2008-9#1)
in devices that##2##3##(2008-2#1)(2008-7#1)
in dew##5##2##(2008-10#5)
in diabetes is##2##3##(2009-1#1)(2011-1#1)
in diabetes may be##2##4##(1993-3#1)(2008-1#1)
in diabetes may##3##3##(1990-12#1)(1993-3#1)(2008-1#1)
in diabetes mellitus##13##3##(1991-2#1)(1993-5#2)(1997-8#3)(2008-1#1)(2008-3#1)(2009-11#2)(2010-11#1)(2012-3#2)
in diabetes research##3##3##(2010-10#1)(2010-11#1)(2012-12#1)
in diabetes will##2##3##(2008-1#1)(2011-2#1)
in diabetes##79##2##(1990-12#2)(1991-2#1)(1993-3#2)(1993-5#2)(1994-2#1)(1994-8#2)(1996-12#1)(1997-8#7)(2008-1#20)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#4)(2009-1#1)(2009-11#5)(2010-10#4)(2010-11#4)(2010-7#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#4)(2012-5#1)
in diabetic and nondiabetic##2##4##(2008-3#1)(2009-11#1)
in diabetic brain##2##3##(1996-2#2)
in diabetic complications##2##3##(2008-1#1)(2008-3#1)
in diabetic foot ulcers##2##4##(2008-5#2)
in diabetic foot##4##3##(2008-5#2)(2008-7#1)(2012-12#1)
in diabetic liver##3##3##(1993-3#3)
in diabetic mice##2##3##(1994-11#1)(2011-2#1)
in diabetic nephropathy##2##3##(2008-1#1)(2008-3#1)
in diabetic neuropathy##2##3##(2009-11#1)(2012-3#1)
in diabetic patients and the##2##5##(2008-1#1)(2008-9#1)
in diabetic patients and##6##4##(2008-1#3)(2008-8#1)(2008-9#1)(2012-12#1)
in diabetic patients in##2##4##(2011-2#1)(2012-4#1)
in diabetic patients was##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
in diabetic patients with##4##4##(1995-2#1)(1997-8#1)(2008-1#1)(2008-7#1)
in diabetic patients##46##3##(1990-5#1)(1991-2#1)(1991-5#2)(1991-6#1)(1993-2#1)(1994-12#1)(1995-2#2)(1997-8#1)(2008-1#13)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-4#1)(2013-1#2)(2013-8#1)
in diabetic patients]##3##3##(1991-6#1)(1996-10#1)(2012-12#1)
in diabetic rats##6##3##(1991-12#1)(1994-8#1)(1996-9#1)(2008-12#1)(2010-11#1)(2011-2#1)
in diabetic retinopathy##6##3##(1996-8#1)(2010-10#4)(2011-2#1)
in diabetic subjects##5##3##(2008-1#1)(2012-12#3)(2013-7#1)
in diabetic##104##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-11#2)(1994-12#4)(1994-8#3)(1995-2#2)(1996-10#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-8#1)(2008-1#18)(2008-10#2)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-3#1)(2010-10#4)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#11)(2012-12#8)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
in diabetics##13##2##(2007-2#1)(2007-7#2)(2008-1#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#3)
in diagnosing and##2##3##(1996-2#1)(2012-2#1)
in diagnosing lung cancer##2##4##(1991-8#2)
in diagnosing such lesions##2##4##(2009-10#1)(2011-2#1)
in diagnosing the primary##2##4##(2013-8#2)
in diagnosing the##5##3##(2007-2#1)(2011-1#1)(2011-2#1)(2013-8#2)
in diagnosing##22##2##(1991-11#1)(1991-8#2)(1993-6#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-7#1)(2013-8#2)
in diagnosis and management of fibro-osseous lesions##2##7##(2007-12#2)
in diagnosis and management of##6##5##(2007-12#2)(2008-3#2)(2010-3#1)(2013-8#1)
in diagnosis and therapy##2##4##(2008-4#1)(2011-2#1)
in diagnosis and to##2##4##(2008-12#1)(2009-10#1)
in diagnosis and##21##3##(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
in diagnosis of the patients##2##5##(2007-11#2)
in diagnosis of the##3##4##(2007-11#3)
in diagnosis of##18##3##(1996-11#1)(1997-5#1)(2007-11#4)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
in diagnosis##64##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-8#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-5#2)(2006-10#2)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in diagnostic accuracy##2##3##(1997-8#1)(2012-2#1)
in diagnostic and##2##3##(1993-3#1)(2010-6#1)
in diagnostic approaches##2##3##(2011-2#1)(2012-2#1)
in diagnostic criteria##2##3##(1991-9#1)(1997-2#1)
in diagnostic radiology##3##3##(1994-1#1)(2007-4#2)
in diagnostic##23##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-6#1)(1997-2#1)(1997-8#1)(2007-4#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
in diagnostics##5##2##(1997-4#1)(1997-7#1)(2010-7#1)(2013-1#2)
in dialysate##2##2##(2008-1#2)
in dialysis catheters##2##3##(2010-3#2)
in dialysis patients in##2##4##(2008-1#1)(2011-2#1)
in dialysis patients##12##3##(2007-7#1)(2008-1#4)(2008-4#1)(2011-1#1)(2011-2#5)
in dialysis##27##2##(1993-6#1)(2007-7#5)(2008-1#5)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#2)(2011-1#1)(2011-2#5)(2013-1#1)
in dialyzed##2##2##(1990-11#1)(2011-2#1)
in diameter and a##2##4##(2008-11#1)(2008-3#1)
in diameter and involving##2##4##(2007-8#2)
in diameter and##18##3##(1991-12#1)(1995-11#1)(1997-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
in diameter are##2##3##(2008-10#1)(2013-1#1)
in diameter in##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2012-2#1)
in diameter of##2##3##(2010-5#1)(2013-1#1)
in diameter were found##2##4##(2008-7#1)(2013-1#1)
in diameter were##7##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-1#1)
in diameter with##4##3##(1994-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
in diameter##94##2##(1990-11#1)(1991-12#1)(1992-10#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#4)(1997-4#1)(1997-5#6)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
in diameter) and##4##3##(2008-10#3)(2012-3#1)
in diameter) usually##2##3##(2008-10#2)
in diameter) were##2##3##(2008-10#1)(2013-1#1)
in diameter)##21##2##(1990-10#1)(1991-6#1)(2007-5#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
in diamond##4##2##(2007-11#2)(2007-12#2)
in diapause##2##2##(2008-5#1)(2013-1#1)
in diaphyseal shape##2##3##(2009-10#2)
in diaphyseal##3##2##(2009-10#3)
in diastole##2##2##(2013-1#2)
in diastolic blood pressure##4##4##(1990-5#1)(2008-1#1)(2008-3#1)(2012-2#1)
in diastolic##5##2##(1990-5#1)(1996-3#1)(2008-1#1)(2008-3#1)(2012-2#1)
in dichloromethane##9##2##(2007-11#1)(2008-10#6)(2008-5#2)
in dichromated gelatin##4##3##(2008-2#2)(2008-3#2)
in dichromated poly(vinyl alcohol)##2##4##(2008-3#2)
in dichromated##6##2##(2008-2#2)(2008-3#4)
in dielectrics##2##2##(2007-11#1)(2008-3#1)
in diesel lubricating oil##2##4##(2008-10#2)
in diesel##3##2##(2008-10#2)(2009-8#1)
in diet and##2##3##(1990-6#1)(2008-10#1)
in diet##5##2##(1990-6#1)(1997-4#1)(2008-10#2)(2009-8#1)
in dietary##7##2##(1990-8#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-6#1)(2012-2#2)
in dietetics##2##2##(1994-2#2)
in different Arab countries##2##4##(2008-1#1)(2008-10#1)
in different age groups##2##4##(1994-5#1)(2008-9#1)
in different age##3##3##(1990-6#1)(1994-5#1)(2008-9#1)
in different amounts##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
in different areas of the same breast##2##7##(1994-5#2)
in different areas of the##5##5##(1994-5#2)(2008-1#1)(2008-10#1)(2008-2#1)
in different areas of##10##4##(1994-5#2)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2013-1#1)
in different areas##16##3##(1992-12#1)(1994-5#2)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-3#1)(2013-1#3)
in different biological##2##3##(2008-10#1)(2010-12#1)
in different brain areas of##3##5##(2011-1#2)(2011-2#1)
in different brain areas##4##4##(2009-10#1)(2011-1#2)(2011-2#1)
in different brain##5##3##(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#1)
in different buffer solutions##2##4##(2008-10#2)
in different buffer##3##3##(2008-10#3)
in different buffers##2##3##(1993-11#1)(2008-10#1)
in different cancers##2##3##(2008-7#1)(2012-12#1)
in different cell types##8##4##(1992-6#1)(1993-3#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-4#1)(2008-8#1)(2012-12#1)
in different cell##10##3##(1992-6#1)(1993-3#1)(1994-11#1)(1995-11#1)(1996-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
in different cells##2##3##(1992-12#1)(2008-8#1)
in different centers##2##3##(2007-4#1)(2011-2#1)
in different clinical settings##2##4##(2008-8#1)(2011-2#1)
in different clinical##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
in different combinations##2##3##(2008-10#1)(2008-11#1)
in different communities##2##3##(1994-3#1)(2009-6#1)
in different components of cow milk##2##6##(2008-10#2)
in different concentrations of aflatoxin##2##5##(2008-12#2)
in different concentrations##4##3##(2008-10#1)(2008-12#2)(2009-7#1)
in different conditions##4##3##(2007-11#1)(2008-10#1)(2009-7#1)(2013-1#1)
in different countries to##3##4##(2008-11#2)(2008-3#1)
in different countries##9##3##(1992-3#1)(1995-5#1)(2008-11#3)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
in different degrees##3##3##(2008-8#2)(2008-9#1)
in different developmental stages##2##4##(1997-1#1)(1997-6#1)
in different directions##3##3##(2007-11#1)(2008-11#1)(2008-6#1)
in different diseases##3##3##(1991-12#1)(2008-7#1)(2011-2#1)
in different environmental##4##3##(2008-10#1)(2008-8#3)
in different environments##13##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
in different ethnic##2##3##(2008-5#1)(2008-8#1)
in different experimental models##2##4##(2009-7#1)(2012-1#1)
in different experimental##4##3##(1991-6#1)(2008-11#1)(2009-7#1)(2012-1#1)
in different fields of##2##4##(2008-2#1)(2011-1#1)
in different fields##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)(2011-1#1)
in different formats##2##3##(2010-10#2)
in different forms of##3##4##(1994-8#1)(2010-5#1)(2011-2#1)
in different forms##4##3##(1994-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
in different functional states##2##4##(2008-9#2)
in different geographic locations##2##4##(2008-10#1)(2008-9#1)
in different groups##2##3##(2007-12#1)(2008-10#1)
in different hospitals##2##3##(1992-2#1)(2008-1#1)
in different kinds of##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
in different lineages##3##3##(2010-3#1)(2013-8#2)
in different local##2##3##(1994-9#1)(2008-3#1)
in different locations##3##3##(2008-10#3)
in different manners##2##3##(2008-10#1)(2011-1#1)
in different matrices##5##3##(2008-10#5)
in different molecular##2##3##(2008-5#1)(2011-1#1)
in different organs##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
in different oxidation states##2##4##(2008-10#2)
in different parts of the Alps##2##6##(2008-11#2)
in different parts of the##9##5##(1990-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
in different parts of##10##4##(1990-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
in different pepper genotypes##2##4##(2008-10#2)
in different phases of##2##4##(2008-10#1)(2008-4#1)
in different phases##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
in different physiological##2##3##(2009-8#1)(2011-2#1)
in different populations##4##3##(1993-12#1)(2007-1#1)(2008-12#1)(2010-5#1)
in different proportions##4##3##(2008-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
in different ratios were used##2##5##(2010-3#1)(2012-2#1)
in different ratios##6##3##(2008-10#2)(2008-5#2)(2010-3#1)(2012-2#1)
in different regions of the##6##5##(1990-11#1)(1990-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
in different regions of##10##4##(1990-11#1)(1990-3#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-1#1)
in different regions##13##3##(1990-11#1)(1990-3#1)(1993-12#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
in different samples of natural water##2##6##(2008-10#2)
in different samples of natural##3##5##(2008-10#3)
in different samples of##5##4##(2008-10#5)
in different samples##9##3##(1997-5#1)(2008-10#8)
in different seasons and hibernating phases##2##6##(2008-8#2)
in different seasons##3##3##(2008-8#2)(2012-2#1)
in different sections of##2##4##(2007-11#1)(2008-10#1)
in different segments##2##3##(2008-3#1)(2010-1#1)
in different settings##4##3##(2009-10#1)(2009-12#1)(2011-1#1)(2012-3#1)
in different sites##3##3##(2008-10#1)(2010-5#1)(2013-7#1)
in different situations##2##3##(1990-9#1)(2009-11#1)
in different solvents are reported##2##5##(2008-10#1)(2008-5#1)
in different species##3##3##(2007-12#1)(2008-3#1)(2009-8#1)
in different stages of##7##4##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)
in different states##3##3##(1992-6#1)(2008-4#1)(2008-8#1)
in different strains of##2##4##(1997-7#1)(2008-10#1)
in different strains##4##3##(1997-7#1)(2008-10#1)(2008-5#2)
in different studies##3##3##(2008-5#1)(2012-2#2)
in different tissues of the##2##5##(1994-8#1)(2008-10#1)
in different tissues of##5##4##(1994-8#1)(2008-10#2)(2008-12#2)
in different tissues##9##3##(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-12#2)(2009-8#1)(2013-8#1)
in different trimester##2##3##(2012-3#2)
in different types of waters##2##5##(2008-10#2)
in different types of##11##4##(2007-8#1)(2008-10#8)(2008-11#1)(2011-2#1)
in different water samples##7##4##(2008-10#7)
in different water types##2##4##(2008-10#2)
in different water##11##3##(2007-10#1)(2008-10#10)
in different ways##16##3##(1990-3#1)(1993-12#1)(1993-2#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
in different years##4##3##(2008-10#3)(2008-12#1)
in different##513##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#3)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-2#2)(1996-5#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#7)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#148)(2008-11#17)(2008-12#15)(2008-2#5)(2008-3#12)(2008-4#8)(2008-5#20)(2008-6#4)(2008-7#10)(2008-8#27)(2008-9#12)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#19)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#5)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#20)(2013-7#4)(2013-8#15)
in differential absorption lidar##3##4##(2008-2#2)(2008-3#1)
in differential diagnosis of the##2##5##(2008-7#1)(2013-1#1)
in differential diagnosis of##5##4##(1991-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
in differential diagnosis##9##3##(1991-3#1)(1991-8#1)(1993-8#1)(2008-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in differential phase-shift-keyed systems by use of lumped nonlinear phase-shift compensation##2##11##(2007-11#2)
in differential pulse##3##3##(2008-10#3)
in differential##21##2##(1991-3#1)(1991-8#1)(1992-8#1)(1993-8#1)(2007-11#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
in differentiated and nondifferentiated##2##4##(1993-8#2)
in differentiated cell##2##3##(1997-2#1)(2008-8#1)
in differentiated##14##2##(1990-11#1)(1991-11#1)(1993-8#2)(1994-11#3)(1995-6#2)(1997-2#1)(2008-8#2)(2011-2#1)(2012-2#1)
in differentiating between##4##3##(1990-2#1)(2011-2#1)(2012-2#2)
in differentiating normal mesenchymal tissue from soft tissue sarcoma##2##9##(2008-6#2)
in differentiating normal mesenchymal##3##4##(2008-6#3)
in differentiating the##3##3##(2007-12#1)(2008-10#1)(2009-5#1)
in differentiating##36##2##(1990-2#1)(1990-5#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-12#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#2)
in differentiation of##2##3##(2008-7#1)(2008-8#1)
in differentiation##8##2##(1990-5#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-7#1)
in differing##4##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
in difficult cases##2##3##(2011-2#1)(2012-3#1)
in difficult##6##2##(1993-3#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
in diffraction efficiency##4##3##(2008-3#4)
in diffraction tomography##4##3##(2008-2#1)(2008-3#3)
in diffraction##11##2##(2007-12#1)(2008-2#1)(2008-3#9)
in diffuse connective tissue diseases##2##5##(1995-5#2)
in diffuse connective tissue##3##4##(1995-5#3)
in diffuse reflectance##2##3##(2008-10#1)(2008-3#1)
in diffuse##11##2##(1992-3#1)(1995-5#3)(2007-11#1)(2008-10#1)(2008-3#2)(2009-8#1)(2009-9#1)(2012-2#1)
in diffusion##3##2##(1991-9#1)(1996-5#1)(2011-2#1)
in digestion##2##2##(2008-11#1)(2008-7#1)
in digestive##3##2##(2012-12#1)(2012-3#1)(2013-1#1)
in digests of##2##3##(2008-10#2)
in digital holography##3##3##(2007-11#1)(2007-12#2)
in digital imaging##2##3##(2008-12#1)(2008-2#1)
in digital speckle-pattern interferometry (DSPI)##2##5##(2008-2#1)(2008-3#1)
in digital##18##2##(1997-8#1)(2007-11#1)(2007-12#3)(2007-5#2)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-12#1)(2010-8#1)
in dilated cardiomyopathy##2##3##(2008-7#1)(2013-7#1)
in dilated##4##2##(1993-6#1)(2008-7#1)(2010-10#1)(2013-7#1)
in dill (Anethum graveolens L##2##5##(2008-10#2)
in dilute aqueous##3##3##(2008-10#3)
in dilute nitric acid##3##4##(2008-10#3)
in dilute nitric##4##3##(2008-10#4)
in dilute##18##2##(1990-5#1)(1995-6#1)(2008-10#13)(2008-11#1)(2008-3#1)(2009-8#1)
in diluted##5##2##(2007-11#1)(2008-10#4)
in dimension##4##2##(2007-8#2)(2008-10#1)(2012-2#1)
in dimethyl sulfoxide (DMSO)##2##4##(2008-10#2)
in dimethyl sulfoxide##3##3##(1996-2#1)(2008-10#2)
in dimethyl##4##2##(1991-12#1)(1996-2#1)(2008-10#2)
in dimethylformamide##4##2##(2008-10#4)
in diminished##2##2##(1996-2#1)(2007-11#1)
in diode-end-pumped##2##2##(2008-2#2)
in diphthamide biosynthesis##2##3##(1993-9#2)
in diploid cells##2##3##(1995-6#1)(1997-3#1)
in diploid##4##2##(1995-6#1)(1996-6#1)(1997-3#1)(2008-12#1)
in diplopods##2##2##(2007-12#2)
in direct ELISA##2##3##(1997-3#2)
in direct contact with the##4##5##(2007-12#2)(2008-10#2)
in direct contact with##5##4##(2007-12#2)(2008-10#2)(2011-2#1)
in direct relation to the##2##5##(2008-9#1)(2009-8#1)
in direct relation to##3##4##(1993-9#1)(2008-9#1)(2009-8#1)
in direct##22##2##(1990-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1997-3#2)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
in directing the##5##3##(1992-1#1)(1992-3#1)(1995-6#1)(2007-4#1)(2008-7#1)
in directing##9##2##(1992-1#1)(1992-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(2007-4#1)(2008-1#1)(2008-7#1)(2010-3#1)
in direction cosine space##2##4##(2008-3#2)
in direction of the##2##4##(2008-3#2)
in direction of##3##3##(2008-10#1)(2008-3#2)
in direction##9##2##(1996-6#1)(2008-10#2)(2008-3#5)(2008-8#1)
in directional##2##2##(2008-7#1)(2008-8#1)
in directions##3##2##(2008-2#2)(2008-3#1)
in directly##2##2##(1997-2#1)(2008-10#1)
in disability##3##2##(1990-9#1)(1992-3#1)(1996-1#1)
in disadvantaged##2##2##(2008-11#1)(2008-8#1)
in disagreement with##2##3##(1991-2#1)(2010-10#1)
in disarray##2##2##(2007-11#1)(2010-4#1)
in disaster##2##2##(2008-11#1)(2008-9#1)
in disc cells##2##3##(1997-6#2)
in disc##3##2##(1997-6#2)(2007-11#1)
in discerning##2##2##(1997-1#1)(2008-3#1)
in discovering new##2##3##(2009-6#1)(2012-3#1)
in discovering##6##2##(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
in discrete##11##2##(1991-7#1)(1992-3#1)(1995-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#2)
in discriminating between the##2##4##(2008-10#1)(2008-5#1)
in discriminating between##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
in discriminating the##2##3##(2008-10#1)(2009-8#1)
in discriminating##9##2##(1990-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
in discriminative accuracy##2##3##(1992-11#2)
in discussing##4##2##(1991-1#1)(2008-11#1)(2010-4#1)(2010-5#1)
in discussions about##2##3##(1996-6#1)(2008-11#1)
in discussions of##4##3##(1996-2#1)(2008-12#1)(2008-3#1)(2008-9#1)
in discussions##7##2##(1996-2#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-4#1)
in disease activity##3##3##(2008-10#1)(2012-1#2)
in disease and##4##3##(1992-6#1)(2008-10#2)(2010-11#1)
in disease caused by##2##4##(2008-10#2)
in disease control##6##3##(2008-10#5)(2009-10#1)
in disease development##2##3##(2008-10#2)
in disease incidence among##3##4##(2008-10#3)
in disease incidence and##2##4##(2008-10#2)
in disease incidence##10##3##(1997-3#1)(2008-10#9)
in disease induction is##2##4##(1991-12#1)(2008-10#1)
in disease management##4##3##(2008-10#4)
in disease pathogenesis##3##3##(1994-8#1)(1995-3#1)(1997-5#1)
in disease phenotypes##2##3##(2008-10#1)(2008-9#1)
in disease prevalence##2##3##(2008-10#2)
in disease reporting##2##3##(2011-2#2)
in disease resistance and##2##4##(2008-10#1)(2009-8#1)
in disease resistance##6##3##(1997-6#1)(2008-10#4)(2009-8#1)
in disease severity##15##3##(2008-10#14)(2012-2#1)
in disease suppression##3##3##(2008-10#3)
in disease##99##2##(1991-12#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#62)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)
in diseased plants##2##3##(2008-10#2)
in diseased##11##2##(1993-9#1)(2008-10#10)
in diseases of##2##3##(2008-7#1)(2010-8#1)
in diseases such as##2##4##(2008-1#1)(2008-4#1)
in diseases##7##2##(2008-1#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
in disengagement##2##2##(2010-7#2)
in dishes with##2##3##(1995-8#1)(2013-1#1)
in disk-shaped##2##2##(2007-12#1)(2009-6#1)
in disordered##2##2##(2010-8#1)(2012-2#1)
in disorders of the##2##4##(2008-7#1)(2011-2#1)
in disorders of##3##3##(1996-5#1)(2008-7#1)(2011-2#1)
in dispersal and##2##3##(2008-8#2)
in dispersal##3##2##(2008-8#3)
in dispersion##2##2##(2007-12#1)(2008-2#1)
in dispersion-compensating fibers##2##3##(2007-11#2)
in dispersion-managed fiber##2##3##(2007-12#2)
in dispersion-managed soliton propagation##2##4##(2007-12#2)
in dispersion-managed soliton systems##3##4##(2007-11#3)
in dispersion-managed soliton##7##3##(2007-11#5)(2007-12#2)
in dispersion-managed systems##2##3##(2007-12#2)
in dispersion-managed##14##2##(2007-11#8)(2007-12#6)
in dispersive media##3##3##(2007-11#2)(2007-12#1)
in dispersive##5##2##(2007-11#3)(2007-12#1)(2008-10#1)
in displacing##2##2##(1990-2#1)(1993-1#1)
in disruptive passenger behaviour on board UK registered##2##8##(2007-2#2)
in dissecting##2##2##(2008-2#1)(2012-2#1)
in disseminated##6##2##(1990-8#2)(1996-12#1)(2007-12#1)(2008-5#1)(2010-5#1)
in disseminating the##2##3##(2008-10#1)(2009-10#1)
in disseminating##4##2##(2008-10#2)(2009-10#1)(2012-12#1)
in dissociated cell culture##3##4##(1993-12#1)(1996-2#1)(1997-6#1)
in dissociated cultures of##2##4##(1996-2#1)(2009-8#1)
in dissociated cultures##3##3##(1996-2#1)(1997-6#1)(2009-8#1)
in dissociated##7##2##(1993-12#1)(1996-12#1)(1996-2#2)(1997-6#2)(2009-8#1)
in dissociation##2##2##(2008-10#2)
in dissolution studies##2##3##(2008-10#2)
in dissolution##5##2##(2008-10#2)(2008-5#2)(2012-2#1)
in distal radius##4##3##(2007-11#2)(2011-2#2)
in distal##11##2##(2007-11#3)(2008-11#1)(2010-11#1)(2010-12#1)(2011-2#4)(2013-1#1)
in distance education##2##3##(2012-3#2)
in distance##4##2##(2008-10#1)(2008-3#1)(2012-3#2)
in distant##2##2##(1993-2#1)(1993-9#1)
in distilled water##12##3##(1992-8#1)(2007-12#1)(2008-10#4)(2008-5#3)(2009-8#1)(2010-5#1)(2013-1#1)
in distilled##13##2##(1992-8#1)(2007-12#1)(2008-10#5)(2008-5#3)(2009-8#1)(2010-5#1)(2013-1#1)
in distinct##10##2##(1990-8#1)(1993-8#1)(1995-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-2#1)
in distinctive##2##2##(2008-9#1)(2011-2#1)
in distinctly different##2##3##(2009-5#1)(2009-7#1)
in distinguishing##7##2##(1994-12#1)(1995-5#1)(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
in distraction##4##2##(2007-8#2)(2012-3#2)
in distributed environments##2##3##(2010-8#2)
in distributed##3##2##(2007-12#1)(2010-8#2)
in distribution and##2##3##(2007-7#1)(2008-7#1)
in distribution of##4##3##(1992-12#1)(1992-6#1)(1993-2#1)(2012-12#1)
in distribution##7##2##(1992-12#1)(1992-6#1)(1993-2#1)(2007-7#1)(2008-7#1)(2010-6#1)(2012-12#1)
in district##3##2##(2010-11#1)(2013-8#2)
in disturbed habitats##2##3##(2008-8#2)
in disturbed##3##2##(2008-5#1)(2008-8#2)
in disulfide##2##2##(1995-3#1)(2012-1#1)
in divalent##2##2##(2008-12#1)(2008-4#1)
in divergent light##3##3##(2008-3#3)
in diverse environments##2##3##(2008-9#1)(2011-2#1)
in diverse human cancer cell lines##2##6##(2011-2#1)(2012-2#1)
in diverse human##3##3##(2011-2#2)(2012-2#1)
in diverse populations##2##3##(2011-2#1)(2012-2#1)
in diverse regions##2##3##(2008-10#1)(2008-4#1)
in diverse##29##2##(1991-5#1)(1992-11#1)(1995-12#1)(1995-2#2)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
in diversification rates##3##3##(2008-9#3)
in diversification##4##2##(2008-9#4)
in diversity##7##2##(2008-10#2)(2008-5#2)(2008-8#2)(2010-3#1)
in dividing cells##2##3##(2008-10#1)(2008-9#1)
in dividing##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
in dodecane##2##2##(1997-2#1)(2008-10#1)
in dog##4##2##(1990-12#1)(2008-8#1)(2009-4#1)(2012-3#1)
in dogs and cats##2##4##(2008-3#1)(2012-3#1)
in dogs and rabbits##3##4##(1994-8#1)(1996-9#2)
in dogs and##7##3##(1994-8#1)(1996-9#2)(2008-10#1)(2008-3#1)(2012-3#2)
in dogs with GM1 gangliosidosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry##2##13##(2012-3#2)
in dogs with GM1 gangliosidosis##3##5##(2012-3#3)
in dogs with lymphoma##2##4##(2011-2#2)
in dogs with##9##3##(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
in dogs##43##2##(1991-3#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-9#4)(2008-10#5)(2008-12#1)(2008-3#2)(2009-4#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-3#7)(2013-1#5)(2013-8#1)
in doing so##2##3##(2008-11#1)(2008-9#1)
in doing##8##2##(1993-2#1)(1995-1#1)(1995-3#1)(2007-2#1)(2008-11#1)(2008-9#3)
in domain##2##2##(1997-4#1)(2008-4#1)
in domain-2##3##2##(2008-8#3)
in domains with higher##2##4##(1996-2#2)
in domains with##3##3##(1996-2#3)
in domains##4##2##(1992-4#1)(1996-2#3)
in domestic animals##4##3##(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)
in domestic homicide cases##3##4##(2011-2#3)
in domestic homicide##4##3##(2011-2#4)
in domestic##12##2##(1994-3#1)(1997-3#1)(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-3#1)
in domesticated##2##2##(1996-3#1)(2008-10#1)
in donor##4##2##(1994-2#1)(1994-9#1)(2008-10#1)(2011-3#1)
in dopamine D2 receptors##2##4##(1996-5#2)
in dopamine cell##2##3##(1994-2#1)(1995-2#1)
in dopamine levels##2##3##(2008-5#1)(2009-8#1)
in dopamine receptor##2##3##(1992-12#1)(1995-2#1)
in dopamine##17##2##(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-2#2)(1996-5#2)(1997-7#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
in dopaminergic neurons##7##3##(1995-11#1)(1996-12#3)(2008-7#3)
in dopaminergic##10##2##(1991-5#1)(1993-12#1)(1995-11#1)(1996-12#3)(1996-2#1)(2008-7#3)
in doped##2##2##(2008-10#1)(2008-2#1)
in doping control##3##3##(2010-11#3)
in dormant##3##2##(1993-6#1)(2008-10#1)(2011-2#1)
in dorsal##5##2##(1990-5#1)(1992-9#1)(1994-8#1)(1996-2#1)(2008-11#1)
in dosage form##5##3##(2008-10#4)(2012-2#1)
in dosage forms##5##3##(2008-10#5)
in dosage or dosage schedule##2##5##(2007-11#2)
in dosage##13##2##(1996-3#1)(2007-11#2)(2008-10#9)(2012-2#1)
in dose##5##2##(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
in dose- and time-dependent manners##2##5##(2011-2#1)(2013-1#1)
in dosed feed##2##3##(2008-8#1)(2008-9#1)
in dosed##7##2##(1995-11#1)(2008-8#1)(2008-9#5)
in doses of##7##3##(1991-6#1)(2007-6#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)
in doses##11##2##(1991-6#1)(1992-8#1)(2007-11#1)(2007-6#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-3#1)
in dot blot hybridizations##2##4##(2008-10#2)
in dot##4##2##(1990-5#1)(2008-10#2)(2008-8#1)
in double transgenic##2##3##(2008-10#2)
in double##11##2##(1995-6#1)(2007-12#1)(2008-10#6)(2009-10#1)(2009-12#1)(2012-2#1)
in double-stranded RNA##2##3##(2008-10#1)(2010-9#1)
in double-stranded##3##2##(1995-6#1)(2008-10#1)(2010-9#1)
in doubling##2##2##(2008-11#1)(2011-2#1)
in doubly doped LiNbO(3)##2##4##(2007-12#1)(2008-3#1)
in doubly doped##3##3##(2007-12#2)(2008-3#1)
in doubly##5##2##(2007-12#4)(2008-3#1)
in doubt##2##2##(2011-2#2)
in doubtful##2##2##(2009-5#1)(2012-2#1)
in down-regulation of##2##3##(1996-5#1)(2013-1#1)
in downstream##3##2##(2008-3#1)(2008-4#1)(2010-9#1)
in dramatic##3##2##(1994-12#1)(2011-1#1)(2013-1#1)
in drawing##2##2##(1991-12#1)(2009-8#1)
in dried blood spots##3##4##(1991-2#2)(1992-12#1)
in dried press juice##2##4##(2008-10#2)
in dried##8##2##(1991-2#2)(1992-12#1)(2008-10#5)
in drinking water and##4##4##(2008-10#4)
in drinking water as##2##4##(2008-10#1)(2008-9#1)
in drinking water by##6##4##(2008-10#6)
in drinking water for 26 or 42 weeks##2##8##(2008-9#2)
in drinking water for 27 or 43 weeks##2##8##(2008-9#2)
in drinking water for 27##3##5##(2008-9#3)
in drinking water for##8##4##(1995-12#1)(2008-5#1)(2008-9#6)
in drinking water has been##3##5##(2008-10#3)
in drinking water is##6##4##(2008-10#6)
in drinking water samples by##3##5##(2008-10#3)
in drinking water samples##4##4##(2008-10#4)
in drinking water with satisfactory results##3##6##(2008-10#3)
in drinking water with##4##4##(2008-10#4)
in drinking water##62##3##(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#46)(2008-5#2)(2008-9#8)(2013-1#1)
in drinking waters##3##3##(2008-10#3)
in drinking##70##2##(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-10#53)(2008-5#2)(2008-9#8)(2013-1#1)
in driving##3##2##(2010-3#1)(2010-4#1)(2012-3#1)
in droplets##3##2##(2007-10#2)(2008-2#1)
in drought##2##2##(2008-12#2)
in drug abuse research##2##4##(2008-10#1)(2008-2#1)
in drug abuse##5##3##(1991-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-7#1)
in drug analysis##2##3##(2008-10#2)
in drug and##2##3##(2008-10#2)
in drug concentrations##2##3##(1995-2#2)
in drug design##2##3##(1992-5#1)(2008-5#1)
in drug development##8##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)
in drug discovery##10##3##(1997-1#1)(1997-4#2)(2008-10#5)(2008-11#1)(2008-8#1)
in drug formulations##6##3##(2008-10#6)
in drug metabolism##3##3##(1994-5#1)(2008-8#1)(2012-2#1)
in drug resistance##5##3##(2008-11#5)
in drug samples##3##3##(2008-10#3)
in drug substance##2##3##(2010-4#1)(2011-2#1)
in drug therapy##3##3##(1997-1#1)(2008-11#1)(2008-4#1)
in drug use##3##3##(1992-12#1)(2008-1#1)(2011-1#1)
in drug##83##2##(1990-12#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#2)(1997-1#3)(1997-4#3)(2008-1#1)(2008-10#21)(2008-11#14)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
in drug-free patients##2##3##(1996-7#2)
in drug-induced##4##2##(1995-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
in drugs and##4##3##(2008-10#4)
in drugs by##2##3##(2008-10#2)
in drugs##15##2##(2008-10#13)(2010-4#1)(2010-9#1)
in dry bean##2##3##(2008-10#2)
in dry nitrogen##2##3##(2008-10#2)
in dry skin##6##3##(2008-5#6)
in dry##32##2##(2006-10#1)(2007-12#1)(2008-10#16)(2008-2#1)(2008-3#2)(2008-5#9)(2012-5#1)(2013-8#1)
in dual##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
in duodenal ulcer##4##3##(1997-1#2)(2007-8#1)(2012-12#1)
in duodenal##7##2##(1990-10#1)(1990-12#1)(1992-11#1)(1997-1#2)(2007-8#1)(2012-12#1)
in duplicate##5##2##(2008-10#1)(2008-2#1)(2008-5#2)(2010-11#1)
in duration of##2##3##(1995-5#1)(2011-2#1)
in duration##13##2##(1990-7#1)(1995-5#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#2)
in durums##2##2##(2008-12#2)
in dust and orange juice##3##5##(2010-5#3)
in dust and##6##3##(2008-10#1)(2010-5#5)
in dust##8##2##(2008-10#1)(2008-11#1)(2010-5#6)
in dye-doped##5##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
in dynamic light scattering##2##4##(2008-3#2)
in dynamic lung##2##3##(1991-9#1)(2012-2#1)
in dynamic mode##2##3##(2008-10#2)
in dynamic##15##2##(1991-9#1)(1992-3#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#5)(2009-2#1)(2012-2#1)(2013-7#1)
in dynamically##2##2##(2008-10#1)(2008-8#1)
in dynamics##2##2##(2011-1#1)(2013-1#1)
in dysphagia practice##3##3##(2012-3#3)
in dystrophic##2##2##(1995-10#1)(2012-2#1)
in e##2##2##(1996-12#2)
in eIF-5A##2##2##(1994-3#2)
in each State##2##3##(1992-2#1)(1996-3#1)
in each animal##2##3##(1994-2#1)(2008-7#1)
in each area##4##3##(2008-10#2)(2008-12#1)(2012-1#1)
in each brain##2##3##(1996-12#1)(2013-1#1)
in each case##20##3##(1990-7#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-2#2)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
in each cell##2##3##(2008-10#1)(2013-8#1)
in each comparison)##2##3##(1994-12#2)
in each container##2##3##(2008-5#2)
in each cross##2##3##(2008-10#2)
in each experiment##2##3##(2008-10#1)(2008-11#1)
in each field##4##3##(2008-10#3)(2009-12#1)
in each fraction##2##3##(2008-10#2)
in each frame##2##3##(2011-1#2)
in each funnel##2##3##(2008-10#2)
in each group were sacrificed##2##5##(2006-6#1)(2008-11#1)
in each group were##3##4##(2006-6#1)(2008-10#1)(2008-11#1)
in each group##34##3##(1991-12#2)(1991-8#2)(1992-5#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#2)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
in each group)##3##3##(1994-3#1)(2008-5#1)(2012-2#1)
in each locality##2##3##(2008-11#1)(2013-7#1)
in each of six##2##4##(1996-12#1)(2008-10#1)
in each of the four##3##5##(1994-2#1)(2007-6#1)(2008-10#1)
in each of the three##2##5##(2008-10#1)(2008-8#1)
in each of the##29##4##(1990-5#1)(1990-8#1)(1991-3#1)(1994-2#1)(1996-12#1)(1996-5#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#2)
in each of these##15##4##(1991-1#1)(1991-5#1)(1992-3#2)(1992-4#1)(1995-2#1)(1995-6#1)(2007-4#1)(2008-3#2)(2008-4#2)(2009-11#1)(2009-12#1)(2009-5#1)
in each of three##5##4##(1992-2#1)(1995-8#1)(2007-11#1)(2008-10#2)
in each of two##4##4##(2008-10#4)
in each of##63##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-12#2)
in each orchard##2##3##(2008-10#2)
in each patient##8##3##(1990-2#1)(1991-3#1)(1991-5#1)(1996-1#1)(1997-3#1)(2007-10#1)(2008-10#1)(2013-7#1)
in each phase##2##3##(2008-10#1)(2012-12#1)
in each pixel##2##3##(2008-3#2)
in each plot was##3##4##(2008-10#3)
in each plot##5##3##(2008-10#5)
in each population##3##3##(2008-10#2)(2009-8#1)
in each quadrat##2##3##(2008-10#1)(2008-5#1)
in each reaction##2##3##(2008-10#2)
in each region##3##3##(1995-3#1)(2008-10#1)(2012-3#1)
in each sample##2##3##(1991-3#1)(2008-2#1)
in each segment##2##3##(2008-3#1)(2008-6#1)
in each session##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
in each state##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
in each strain##2##3##(1993-9#1)(2012-3#1)
in each subunit##4##3##(1990-5#1)(1992-6#1)(1994-5#1)(1997-2#1)
in each tissue##3##3##(1990-2#1)(2008-2#1)(2012-2#1)
in each treatment group##3##4##(1992-6#1)(2007-8#1)(2012-3#1)
in each treatment##4##3##(1992-6#1)(2007-8#1)(2011-2#1)(2012-3#1)
in each year##2##3##(1992-6#1)(2010-2#1)
in each##339##2##(1990-11#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#2)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#5)(1993-9#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#81)(2008-11#7)(2008-12#5)(2008-2#9)(2008-3#11)(2008-4#7)(2008-5#13)(2008-6#5)(2008-7#4)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#3)(2009-8#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#5)(2011-1#6)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#5)(2012-7#1)(2013-1#7)(2013-7#5)(2013-8#2)
in ear##2##2##(2008-10#1)(2008-11#1)
in earlier research##2##3##(2008-2#1)(2009-2#1)
in earlier studies##5##3##(1993-3#1)(2008-10#3)(2010-3#1)
in earlier work##2##3##(2008-11#1)(2010-3#1)
in earlier##15##2##(1993-3#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-3#2)(2011-2#1)
in early 2006##2##3##(2008-11#1)(2008-12#1)
in early adolescence##5##3##(2009-7#3)(2010-1#2)
in early adolescents##2##3##(2008-12#2)
in early adulthood##5##3##(1996-9#1)(2008-11#1)(2009-12#1)(2009-8#1)(2009-9#1)
in early and late##3##4##(1996-5#1)(2008-10#1)(2013-8#1)
in early and##4##3##(1996-5#1)(2008-10#1)(2012-7#1)(2013-8#1)
in early breast cancer##8##4##(1991-8#2)(1994-3#1)(1995-11#1)(1995-4#1)(2007-11#2)(2007-5#1)
in early child development##2##4##(2010-12#2)
in early child##4##3##(2008-2#1)(2010-12#2)(2013-8#1)
in early childhood##14##3##(2007-10#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
in early clinical##2##3##(1993-5#1)(2008-8#1)
in early detection of prostate cancer in##2##7##(1994-12#1)(1995-9#1)
in early detection of##4##4##(1994-12#1)(1995-9#1)(2009-12#1)(2013-8#1)
in early development##4##3##(1993-3#1)(1997-4#1)(2008-4#1)(2012-2#1)
in early diagnosis and##2##4##(2008-3#1)(2011-2#1)
in early diagnosis##4##3##(2008-3#1)(2011-2#2)(2012-12#1)
in early embryogenesis##3##3##(1994-12#1)(1997-8#1)(2008-6#1)
in early embryonic##2##3##(1995-2#1)(2012-3#1)
in early infancy##5##3##(2008-1#1)(2008-11#1)(2010-11#1)(2010-6#1)(2012-2#1)
in early juveniles##4##3##(2007-12#4)
in early labor##2##3##(1994-3#2)
in early life##4##3##(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
in early modern England##2##4##(2008-10#2)
in early modern##7##3##(2008-10#5)(2008-11#2)
in early morning##2##3##(1995-12#1)(2012-12#1)
in early onset##3##3##(1994-2#1)(1996-2#1)(2008-7#1)
in early phase##2##3##(1991-8#1)(2008-12#1)
in early postoperative period##2##4##(2007-11#1)(2012-3#1)
in early postoperative##3##3##(2007-11#1)(2012-3#2)
in early pregnancy##8##3##(1990-11#2)(1991-3#1)(1993-12#3)(1994-9#1)(1996-12#1)
in early pupae##2##3##(2008-9#2)
in early spring##2##3##(2008-10#1)(2011-2#1)
in early stage breast##2##4##(1994-8#1)(2007-10#1)
in early stage of##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
in early stage##7##3##(1994-8#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
in early stages of##2##4##(1993-9#1)(2008-7#1)
in early stages##5##3##(1993-9#1)(2008-7#1)(2009-1#1)(2010-7#1)(2010-8#1)
in early##185##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-8#3)(1992-12#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#6)(2009-1#1)(2009-12#2)(2009-4#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#6)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#4)
in early-stage##2##2##(1995-9#1)(2010-11#1)
in ears##2##2##(2008-10#1)(2012-3#1)
in earthquake##2##2##(1996-4#2)
in earthworms##2##2##(2008-10#1)(2008-5#1)
in east##3##2##(1991-2#1)(1991-4#1)(2008-6#1)
in eastern Australia##2##3##(2008-10#1)(2011-2#1)
in eastern Canada and##3##4##(1993-2#1)(2008-10#1)(2009-6#1)
in eastern China##2##3##(2008-10#1)(2008-8#1)
in eastern Europe##2##3##(1991-11#1)(2012-5#1)
in eastern Germany##3##3##(1992-1#1)(2008-11#1)(2009-10#1)
in eastern Nepal##5##3##(2007-12#1)(2007-7#1)(2008-7#3)
in eastern North America##4##4##(2008-10#3)(2008-8#1)
in eastern North##5##3##(2008-10#4)(2008-8#1)
in eastern Washington in##2##4##(2008-10#2)
in eastern Washington##4##3##(2008-10#4)
in eastern##41##2##(1991-11#1)(1992-1#1)(1993-2#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
in easy##2##2##(2008-9#1)(2012-2#1)
in eating disorders##2##3##(2010-11#1)(2012-12#1)
in eating##5##2##(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
in eccrine sweat##3##3##(2008-5#3)
in ecological models##2##3##(2008-3#1)(2008-9#1)
in ecological##11##2##(2008-10#2)(2008-3#1)(2008-8#3)(2008-9#3)(2012-12#1)(2013-1#1)
in ecology##5##2##(2008-8#3)(2008-9#1)(2013-8#1)
in economic growth##2##3##(1994-2#2)
in economic terms##2##3##(2008-8#1)(2008-9#1)
in economic##8##2##(1994-2#2)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
in ecosystem##2##2##(1990-8#1)(2008-10#1)
in ecosystems##5##2##(1995-1#1)(2008-8#3)(2008-9#1)
in ectotherms##2##2##(2008-8#2)
in edge##2##2##(2008-3#1)(2008-5#1)
in edible oils and seeds##2##5##(2008-10#2)
in edible oils##4##3##(2008-10#4)
in edible##6##2##(2008-10#6)
in educating the##2##3##(1994-1#1)(1995-1#1)
in education and##4##3##(1990-2#1)(1996-2#1)(2008-11#1)(2012-1#1)
in education##18##2##(1990-2#1)(1995-9#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-11#7)(2008-12#3)(2012-1#2)(2012-2#1)
in educational##3##2##(2007-8#1)(2008-12#1)(2009-10#1)
in effect in##2##3##(2008-10#1)(2008-11#1)
in effect##16##2##(1992-1#1)(1993-3#1)(1993-8#1)(1994-1#1)(1996-4#1)(1996-5#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#1)
in effective##10##2##(1991-12#1)(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-5#1)(2013-8#1)
in effectiveness##2##2##(1996-3#1)(2008-5#1)
in effector cells##2##3##(2008-4#2)
in effector##3##2##(2008-10#1)(2008-4#2)
in efficacy and##4##3##(2008-3#1)(2011-2#2)(2013-1#1)
in efficacy##7##2##(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#2)(2013-1#1)
in efficiency##3##2##(1992-2#1)(1995-3#1)(2010-8#1)
in efficient##7##2##(1991-2#1)(1997-4#1)(2007-12#2)(2009-6#1)(2010-11#1)(2012-2#1)
in effluent##4##2##(1994-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
in effluents##3##2##(2008-10#3)
in effort##2##2##(2009-5#1)(2009-9#1)
in egg white##2##3##(2008-10#2)
in egg yolk##3##3##(2008-10#2)(2010-2#1)
in egg##14##2##(1997-6#1)(2008-10#6)(2008-8#4)(2010-2#1)(2013-1#1)(2013-7#1)
in eggs and##5##3##(2008-10#2)(2008-12#2)(2010-2#1)
in eggs from free range hens##2##6##(2008-10#2)
in eggs##12##2##(1994-7#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2010-10#1)(2010-2#1)
in egocentric##2##2##(1994-3#1)(1994-8#1)
in egypt##2##2##(2008-1#2)
in eight different##2##3##(2008-10#1)(2009-5#1)
in eight dogs##2##3##(1992-5#2)
in eight healthy##3##3##(1992-11#1)(2008-5#1)(2012-2#1)
in eight normal##2##3##(1996-2#1)(1996-5#1)
in eight of##4##3##(1992-3#1)(2008-10#2)(2008-7#1)
in eight patients with##3##4##(1990-3#1)(1992-6#1)(2008-5#1)
in eight patients##7##3##(1990-3#1)(1990-8#1)(1991-6#1)(1992-6#1)(2008-5#1)(2008-6#1)(2008-9#1)
in eight steps to homogeneity##2##5##(1997-6#2)
in eight##67##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#12)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#4)(2008-9#2)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in eighteen##2##2##(1992-3#1)(2007-7#1)
in ein2-1##3##2##(2008-10#3)
in either a##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
in either case the##2##4##(2008-10#1)(2011-1#1)
in either case##4##3##(2008-10#2)(2009-4#1)(2011-1#1)
in either cell##2##3##(1991-9#1)(1993-9#1)
in either group##10##3##(1995-12#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-7#1)
in either of the##8##4##(1990-11#1)(1991-2#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
in either of these##2##4##(1991-9#1)(2008-10#1)
in either of##11##3##(1990-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#1)
in either sex##3##3##(1994-2#1)(1996-5#1)(2008-8#1)
in either strain##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
in either study##2##3##(2008-6#1)(2008-9#1)
in either the##17##3##(1994-3#1)(1995-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
in either##139##2##(1990-11#2)(1990-2#2)(1990-7#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#4)(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#4)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#2)(2012-5#1)(2013-1#5)(2013-8#1)
in elaborating the##2##3##(2008-10#1)(2008-7#1)
in elderly donors##3##3##(2011-2#3)
in elderly hospitalized patients##2##4##(1992-5#1)(2012-12#1)
in elderly individuals##3##3##(2007-12#1)(2007-7#1)(2008-7#1)
in elderly patients suffering from##2##5##(2008-7#2)
in elderly patients with recurrent major depression##2##7##(1996-7#2)
in elderly patients with##15##4##(1990-2#1)(1993-12#1)(1994-12#1)(1996-7#2)(1997-2#1)(2007-11#1)(2008-7#7)(2011-2#1)
in elderly patients##41##3##(1990-2#3)(1990-3#1)(1991-11#1)(1991-3#1)(1991-4#1)(1993-12#1)(1994-12#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-7#2)(1997-2#1)(1997-8#2)(2007-11#1)(2008-11#1)(2008-7#14)(2009-8#1)(2011-2#5)(2012-3#1)
in elderly people##4##3##(1990-3#1)(1994-9#1)(2011-1#1)(2011-2#1)
in elderly persons##2##3##(1990-3#1)(1997-4#1)
in elderly subjects with##2##4##(1993-9#1)(2008-7#1)
in elderly women##8##3##(1990-9#1)(1991-4#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2007-8#1)
in elderly##92##2##(1990-2#3)(1990-3#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-2#2)(1997-4#1)(1997-8#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#21)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
in elective and##3##3##(1990-11#1)(1991-3#1)(2010-8#1)
in elective##8##2##(1990-11#2)(1991-3#1)(1992-6#1)(1996-9#1)(2010-8#2)(2013-1#1)
in electric##3##2##(1996-8#1)(2008-10#1)(2009-8#1)
in electrical shock##2##3##(1994-5#2)
in electrical trauma units and##2##5##(1994-5#2)
in electrical##7##2##(1994-5#4)(2007-12#1)(2008-5#2)
in electrically insulating oil##2##4##(2009-5#2)
in electrically##5##2##(1992-8#1)(2008-3#1)(2009-5#2)(2010-7#1)
in electro-optic##2##2##(2008-2#2)
in electroacupuncture##2##2##(1996-12#1)(2012-3#1)
in electrochemical##5##2##(2008-10#3)(2010-11#1)(2013-1#1)
in electrochemically##3##2##(2008-10#3)
in electrode##5##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#2)
in electrodeposited##2##2##(1990-4#1)(2010-4#1)
in electrolyte leakage##4##3##(2008-10#4)
in electrolyte##9##2##(2008-10#9)
in electrolytic manganese##2##3##(2008-10#2)
in electron microscopy##2##3##(2008-10#1)(2008-9#1)
in electron transfer##2##3##(2008-5#1)(2008-8#1)
in electron##7##2##(1994-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)
in electronic health##2##3##(2010-8#2)
in electronic medical records##2##4##(2010-8#1)(2012-3#1)
in electronic speckle##2##3##(2008-2#2)
in electronic##12##2##(1991-5#1)(2008-10#2)(2008-2#2)(2008-3#3)(2010-8#3)(2012-3#1)
in electronics##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
in electrophoresis##2##2##(2008-10#1)(2008-5#1)
in electrophoretic##3##2##(1992-8#1)(2008-10#1)(2011-1#1)
in electrophysiological##2##2##(2008-4#1)(2008-7#1)
in electroplating##5##2##(1994-9#1)(2008-10#4)
in electrostatic##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
in electrothermal atomic absorption##2##4##(2008-10#2)
in electrothermal##3##2##(2008-10#3)
in elemental analysis##2##3##(2008-10#2)
in elementary school##2##3##(2009-5#1)(2012-12#1)
in elementary##4##2##(2008-12#1)(2009-5#1)(2012-12#1)(2012-2#1)
in elevated##4##2##(1991-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
in elevating##2##2##(1992-8#1)(1997-6#1)
in eleven##3##2##(2007-7#1)(2008-5#1)(2013-8#1)
in eliciting##6##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
in eligible patients##2##3##(2008-3#1)(2010-10#1)
in eliminating##8##2##(1994-2#1)(1994-5#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-5#1)(2012-3#1)
in elimination of##3##3##(1994-8#1)(2008-10#2)
in elimination##4##2##(1994-8#1)(2008-10#3)
in elite##5##2##(1996-8#1)(2008-10#1)(2009-1#1)(2010-1#1)(2012-1#1)
in elliptical cylinder coordinates##2##4##(2008-3#2)
in eloquent areas##3##3##(1996-3#1)(2008-7#1)(2012-3#1)
in eluates##4##2##(1996-12#1)(2008-10#3)
in elucidating the##5##3##(1993-11#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-7#1)
in elucidating##7##2##(1993-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#2)
in elution##2##2##(1990-11#1)(2008-10#1)
in embryo##5##2##(1990-3#1)(1991-9#1)(1994-8#1)(1995-11#1)(2008-11#1)
in embryogenesis##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
in embryonal carcinoma##2##3##(1994-9#1)(2013-1#1)
in embryonic and early postnatal##2##5##(1997-2#1)(2008-4#1)
in embryonic and##4##3##(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#1)
in embryonic lethality##2##3##(1995-2#1)(2008-9#1)
in embryonic stage##2##3##(2008-8#2)
in embryonic stem (ES) cells##2##5##(1995-11#1)(1997-8#1)
in embryonic stem cells##6##4##(1995-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
in embryonic stem##9##3##(1995-11#1)(1995-2#1)(1997-8#2)(2008-11#2)(2008-4#1)(2008-9#1)(2012-2#1)
in embryonic##34##2##(1992-12#1)(1994-11#1)(1995-11#1)(1995-2#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-11#4)(2008-4#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-3#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
in embryos and##2##3##(2008-10#1)(2008-6#1)
in embryos of##4##3##(1997-7#1)(2008-10#1)(2008-7#2)
in embryos##13##2##(1993-12#1)(1993-2#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#2)
in emergencies##2##2##(2011-1#1)(2013-1#1)
in emergency department##2##3##(2010-2#1)(2013-1#1)
in emergency departments and##2##4##(2008-11#1)(2013-8#1)
in emergency departments##4##3##(1991-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
in emergency medicine##6##3##(2007-5#2)(2009-6#4)
in emergency nursing##4##3##(2008-11#2)(2013-1#2)
in emergency situations##4##3##(1995-3#1)(2009-6#3)
in emergency surgery##4##3##(1991-3#2)(1992-9#2)
in emergency##37##2##(1991-3#3)(1991-6#1)(1992-11#1)(1992-9#2)(1993-2#1)(1994-1#1)(1994-9#1)(1995-3#1)(2007-5#2)(2007-8#1)(2008-11#3)(2008-7#2)(2009-6#7)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
in emergent literacy##2##3##(2011-2#2)
in emerging##3##2##(2009-9#1)(2010-7#1)(2012-3#1)
in emission intensity##2##3##(1996-12#1)(2008-10#1)
in emission##7##2##(1992-3#1)(1993-11#1)(1996-12#1)(2007-11#1)(2008-10#2)(2010-2#1)
in emissions and working areas##3##5##(2008-10#3)
in emotion-focused##2##2##(1991-1#1)(2008-1#1)
in emotional##8##2##(1996-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-6#3)(2013-8#1)
in empirical##2##2##(2010-8#1)(2011-2#1)
in employee##2##2##(1995-2#1)(2008-6#1)
in employees##2##2##(1991-12#1)(2009-10#1)
in employing##2##2##(2008-10#1)(2008-11#1)
in employment##3##2##(1993-1#1)(1996-2#1)(2013-1#1)
in emulsion##2##2##(1993-12#1)(2008-5#1)
in enabling##4##2##(1990-9#1)(2008-11#1)(2008-7#1)(2013-1#1)
in encoding##5##2##(1994-12#1)(1995-12#1)(1996-5#1)(2009-10#1)(2013-1#1)
in encouraging the##2##3##(1994-12#1)(1994-7#1)
in encouraging##5##2##(1993-2#1)(1994-12#1)(1994-7#1)(2008-11#1)(2008-5#1)
in end of life care##2##5##(2008-12#1)(2010-10#1)
in end##5##2##(1996-3#1)(2008-12#1)(2008-5#1)(2010-10#1)(2011-2#1)
in end-of-life##4##2##(2009-11#1)(2010-10#1)(2010-4#2)
in end-stage renal disease patients##3##5##(2008-7#3)
in end-stage renal disease##4##4##(2008-7#4)
in end-stage##7##2##(1990-12#1)(1994-3#1)(2008-7#4)(2010-8#1)
in endemic areas and##2##4##(1994-11#1)(2007-2#1)
in endemic areas##8##3##(1994-11#3)(1996-11#1)(2007-2#2)(2011-2#1)(2012-3#1)
in endemic regions##4##3##(1991-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
in endemic##13##2##(1991-8#1)(1994-11#3)(1996-11#1)(2007-2#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
in endocrine##6##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#1)(1994-11#1)(2012-12#1)
in endocrinology##3##2##(2008-4#1)(2013-1#2)
in endocytosis##2##2##(1995-6#1)(2009-8#1)
in endogenous##8##2##(1995-12#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)
in endometrial##6##2##(1994-9#4)(2011-2#2)
in endometriosis cells##2##3##(1995-12#2)
in endometriosis##3##2##(1994-9#1)(1995-12#2)
in endoplasmic reticulum##3##3##(1991-11#1)(1995-3#1)(2008-8#1)
in endoscopic surgery##2##3##(2011-2#1)(2013-1#1)
in endoscopic##7##2##(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#3)
in endosomes##5##2##(1995-6#4)(2009-2#1)
in endosperm##2##2##(2008-9#1)(2009-10#1)
in endothelial cell killing##2##4##(1991-9#2)
in endothelial cell##5##3##(1991-9#2)(1993-3#1)(2008-7#1)(2013-8#1)
in endothelial cells in situ##2##5##(1991-12#2)
in endothelial cells is##2##4##(1991-9#1)(1994-6#1)
in endothelial cells isolated from##2##5##(1993-3#2)
in endothelial cells was##2##4##(1992-12#1)(1993-12#1)
in endothelial cells##22##3##(1990-2#1)(1990-5#2)(1991-12#2)(1991-9#3)(1992-10#1)(1992-12#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-6#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-2#2)
in endothelial##32##2##(1990-2#1)(1990-5#2)(1991-12#2)(1991-9#6)(1992-10#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-8#1)
in endothelium##2##2##(1993-8#2)
in endothelium-denuded##2##2##(1990-12#1)(1997-6#1)
in endothelium-intact##3##2##(1990-12#2)(1993-8#1)
in endovascular##4##2##(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)
in endurance capacity##3##3##(1991-8#2)(2013-8#1)
in endurance sports##2##3##(2010-1#1)(2012-1#1)
in endurance##6##2##(1991-8#2)(2010-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
in energy and##4##3##(1991-12#1)(1994-11#1)(2008-3#1)(2013-1#1)
in energy conversion##2##3##(1994-3#1)(2007-11#1)
in energy intake##3##3##(1992-8#1)(2008-5#1)(2012-2#1)
in energy than##3##3##(1996-5#1)(2008-8#1)(2011-2#1)
in energy##24##2##(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#2)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in engineering##4##2##(1990-8#1)(2008-10#2)(2008-3#1)
in enhanced##11##2##(1992-6#1)(1992-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-3#1)
in enhancement of##3##3##(1992-8#1)(2008-8#1)(2008-9#1)
in enhancement##4##2##(1992-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
in enhancing the##7##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)
in enhancing their##2##3##(1997-1#1)(2008-12#1)
in enhancing##24##2##(1991-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-1#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
in enlarging##2##2##(2008-10#1)(2013-1#1)
in ensuring that##4##3##(1996-7#1)(2008-11#1)(2012-12#1)(2012-2#1)
in ensuring the##2##3##(1994-2#1)(2008-11#1)
in ensuring##12##2##(1994-12#1)(1994-2#1)(1995-12#2)(1996-7#1)(2008-10#1)(2008-11#4)(2012-12#1)(2012-2#1)
in enthalpy##3##2##(1997-2#1)(2008-10#2)
in entorhinal cortex##3##3##(1992-1#1)(1994-2#1)(2008-11#1)
in environment and##2##3##(1996-2#1)(2008-10#1)
in environment##3##2##(1996-2#1)(2008-10#2)
in environmental analysis##6##3##(2008-10#5)(2008-11#1)
in environmental and biological samples##14##5##(2008-10#14)
in environmental and biological##15##4##(2008-10#15)
in environmental and food##2##4##(2008-10#1)(2010-5#1)
in environmental and##25##3##(2008-10#22)(2008-11#1)(2009-8#1)(2010-5#1)
in environmental conditions##2##3##(2008-4#1)(2008-9#1)
in environmental health##2##3##(2008-1#2)
in environmental matrices##5##3##(2008-10#4)(2008-11#1)
in environmental samples by graphite furnace atomic absorption spectrometry after##2##10##(2008-10#2)
in environmental samples by##5##4##(2008-10#5)
in environmental samples is##2##4##(2008-10#2)
in environmental samples using##2##4##(2008-10#2)
in environmental samples with##2##4##(2008-10#1)(2011-2#1)
in environmental samples##42##3##(2008-10#40)(2011-2#2)
in environmental solid samples##2##4##(2008-10#2)
in environmental water samples##7##4##(2008-10#7)
in environmental water##9##3##(2008-10#8)(2008-9#1)
in environmental waters##5##3##(2008-10#5)
in environmental##126##2##(1992-12#1)(1995-11#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#97)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)
in environments##4##2##(2008-3#1)(2008-8#1)(2011-2#2)
in enzymatic activity##2##3##(2008-10#1)(2008-7#1)
in enzymatic##8##2##(1991-5#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
in enzyme activity##4##3##(1990-11#1)(1990-7#1)(1994-6#1)(1994-8#1)
in enzyme catalysis##2##3##(1990-7#1)(2008-10#1)
in enzyme##13##2##(1990-11#2)(1990-7#2)(1992-11#1)(1992-9#1)(1994-6#1)(1994-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
in enzymes##3##2##(2009-9#1)(2012-2#2)
in epidemic##3##2##(1991-12#1)(2008-10#2)
in epidemics##2##2##(2008-10#2)
in epidemiologic studies##5##3##(1991-12#1)(2008-7#2)(2010-5#1)(2013-8#1)
in epidemiologic##6##2##(1991-12#1)(1996-7#1)(2008-7#2)(2010-5#1)(2013-8#1)
in epidemiological and##2##3##(1997-7#1)(2008-10#1)
in epidemiological data##3##3##(2008-7#3)
in epidemiological studies##6##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
in epidemiological##14##2##(1997-7#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#4)(2011-1#1)(2012-3#1)(2013-8#1)
in epidemiology and##2##3##(1997-1#1)(2011-2#1)
in epidemiology##5##2##(1994-3#1)(1997-1#1)(2008-10#1)(2010-4#1)(2011-2#1)
in epidermal and##2##3##(2008-10#1)(2008-9#1)
in epidermal cell walls##2##4##(2008-10#2)
in epidermal cell##3##3##(1993-12#1)(2008-10#2)
in epidermal cells by##2##4##(1994-6#1)(2008-10#1)
in epidermal cells##8##3##(1994-6#2)(2008-10#6)
in epidermal##18##2##(1992-9#1)(1993-12#1)(1994-6#2)(1994-8#1)(2008-10#9)(2008-5#3)(2008-9#1)
in epidermis of##2##3##(1994-6#2)
in epidermis##3##2##(1994-6#2)(2008-5#1)
in epigenetic regulation##2##3##(2009-3#1)(2011-2#1)
in epigenetic##4##2##(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
in epilepsy patients##2##3##(2008-8#2)
in epilepsy##10##2##(1990-7#1)(1995-5#1)(1997-4#1)(2008-8#4)(2009-9#1)(2012-12#1)(2012-3#1)
in epileptic##2##2##(1994-2#1)(2008-3#1)
in episodic##2##2##(2008-10#1)(2008-3#1)
in epitaxially##2##2##(2008-3#2)
in epithelial cells of##2##4##(1994-2#1)(2008-10#1)
in epithelial cells##8##3##(1990-11#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
in epithelial tissues##2##3##(2009-5#1)(2010-9#1)
in epithelial##14##2##(1990-11#1)(1994-2#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
in epoxy##3##2##(2008-10#2)(2008-11#1)
in equal amounts##3##3##(2008-10#1)(2008-11#2)
in equal##9##2##(2008-10#6)(2008-11#2)(2013-1#1)
in equilibrium with##4##3##(1991-9#3)(1992-6#1)
in equilibrium##10##2##(1991-9#3)(1992-3#1)(1992-5#1)(1992-6#1)(2008-10#2)(2008-5#1)(2012-2#1)
in equimolar##2##2##(1994-8#1)(2008-5#1)
in equine urine##2##3##(2008-10#2)
in equine##4##2##(1991-6#1)(2008-10#3)
in equivalent##2##2##(1991-9#1)(2008-10#1)
in eradicating##3##2##(1997-4#1)(2008-8#1)(2011-2#1)
in eradication of##2##3##(1993-2#1)(2011-2#1)
in eradication##3##2##(1993-2#1)(2011-2#2)
in erbium-doped fiber##2##3##(2007-11#2)
in erbium-doped##3##2##(2007-11#2)(2008-3#1)
in erectile##2##2##(2008-3#1)(2012-3#1)
in erosive OLP##3##3##(2013-1#3)
in erroneous##2##2##(2008-2#1)(2011-2#1)
in error##7##2##(2008-3#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-1#2)(2011-2#1)
in errors##3##2##(1996-2#1)(2007-4#1)(2008-4#1)
in erythrocyte membrane##2##3##(1990-11#1)(1993-6#1)
in erythrocyte membranes##2##3##(1992-9#1)(2009-8#1)
in erythrocyte##13##2##(1990-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-8#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#1)
in erythrocytes and##2##3##(1991-2#1)(1995-8#1)
in erythrocytes by##2##3##(1990-11#1)(2008-10#1)
in erythrocytes is##3##3##(1993-6#2)(2008-7#1)
in erythrocytes##14##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1993-6#2)(1995-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2013-1#1)
in erythroid cells##3##3##(1991-5#1)(1994-8#2)
in erythroid##5##2##(1991-5#1)(1994-8#2)(2008-9#2)
in esophageal cancer##2##3##(2010-12#1)(2012-12#1)
in esophageal squamous cell carcinoma##2##5##(2012-2#2)
in esophageal squamous cell##3##4##(2012-2#3)
in esophageal##7##2##(1992-5#1)(2010-12#1)(2012-12#1)(2012-2#3)(2013-8#1)
in essence##2##2##(2008-10#1)(2008-6#1)
in essential hypertension##4##3##(2009-1#1)(2010-4#2)(2013-8#1)
in essential tremor##3##3##(2008-7#3)
in essential##11##2##(2008-10#2)(2008-7#3)(2008-9#1)(2009-1#1)(2010-4#2)(2013-1#1)(2013-8#1)
in essentially##3##2##(1990-2#1)(2008-10#1)(2009-10#1)
in established##2##2##(1993-11#1)(2008-10#1)
in establishing a##7##3##(1990-12#1)(1992-3#1)(1994-8#1)(1997-4#1)(2008-11#2)(2013-8#1)
in establishing an##2##3##(1990-8#1)(2008-11#1)
in establishing and maintaining##3##4##(2008-4#1)(2009-2#1)(2011-1#1)
in establishing the##7##3##(1992-2#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-5#1)(2010-9#1)
in establishing##37##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
in estimated##7##2##(1992-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-12#1)
in estimates##3##2##(2008-9#1)(2010-11#1)(2011-2#1)
in estimating the##8##3##(1991-11#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)
in estimating##12##2##(1991-11#1)(1992-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-1#1)(2011-2#1)(2012-2#1)
in estimation of##2##3##(1994-11#1)(2008-6#1)
in estimation##4##2##(1994-11#1)(2008-6#1)(2009-7#1)(2010-1#1)
in estrogen receptor##3##3##(1990-12#1)(1990-5#1)(1991-2#1)
in estrogen responsive##2##3##(2008-10#1)(2011-2#1)
in estrogen##8##2##(1990-12#1)(1990-5#1)(1991-2#1)(2008-10#1)(2008-11#2)(2011-2#2)
in estuarine and coastal waters##3##5##(2008-10#3)
in estuarine and##5##3##(2008-10#5)
in estuarine sediments##2##3##(2008-10#2)
in estuarine waters##5##3##(2008-10#5)
in estuarine##14##2##(2008-10#12)(2013-1#2)
in ethanol and##2##3##(1995-2#1)(2008-10#1)
in ethanol at##3##3##(1994-8#2)(2007-11#1)
in ethanol fuel##2##3##(2008-10#2)
in ethanol induced##2##3##(2009-12#1)(2010-11#1)
in ethanol production from##2##4##(2008-6#2)
in ethanol reinforcement##2##3##(2009-7#2)
in ethanol##33##2##(1994-8#2)(1995-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-6#4)(2008-9#9)(2009-12#1)(2009-7#2)(2010-11#1)(2012-12#1)(2012-3#1)
in ethanol-induced##2##2##(2012-3#1)(2013-8#1)
in ethanol-water##5##2##(1996-5#1)(2008-10#1)(2008-5#1)(2013-1#2)
in ethanolic##3##2##(2008-10#3)
in ethics##2##2##(1996-8#1)(2013-8#1)
in ethnic populations##2##3##(2010-8#2)
in ethnic##6##2##(2008-5#1)(2009-7#2)(2010-8#3)
in ethnically diverse##2##3##(2008-12#1)(2010-1#1)
in ethnically heterogeneous classes##2##4##(2010-1#2)
in ethnically##4##2##(2008-12#1)(2010-1#3)
in ethyl##4##2##(2008-10#3)(2008-3#1)
in ethylene glycol##3##3##(2008-10#1)(2008-3#2)
in ethylene##6##2##(2008-10#1)(2008-3#3)(2009-6#2)
in ethylene-insensitive##2##2##(2008-10#2)
in etiology and##2##3##(2007-8#1)(2012-2#1)
in etiology##4##2##(2007-8#1)(2008-12#1)(2012-2#1)(2012-3#1)
in etiopathogenesis of##2##3##(2007-11#1)(2009-5#1)
in eukaryotes##20##2##(1993-12#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-7#3)(2009-10#2)(2009-2#1)(2009-5#2)(2009-8#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-2#3)
in eukaryotic cells##12##3##(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
in eukaryotic genomes##4##3##(1996-2#1)(2008-7#1)(2008-9#1)(2010-5#1)
in eukaryotic##27##2##(1993-8#2)(1993-9#1)(1994-12#2)(1994-6#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in eusocial##3##2##(2008-8#3)
in evaluating a##2##3##(1992-2#1)(2009-10#1)
in evaluating and##4##3##(1993-2#1)(2007-5#1)(2009-6#1)(2011-2#1)
in evaluating the clinical##2##4##(1993-12#1)(2011-2#1)
in evaluating the effectiveness of##2##5##(2008-2#1)(2008-7#1)
in evaluating the##10##3##(1993-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-8#2)(2011-2#2)
in evaluating this##2##3##(1991-12#1)(2007-10#1)
in evaluating##42##2##(1990-9#1)(1991-12#3)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)
in evaluation of the##2##4##(2008-7#1)(2011-2#1)
in evaluation of##5##3##(2007-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
in evaluation##9##2##(1990-3#1)(1994-2#1)(2007-10#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
in evaluations##2##2##(2008-10#1)(2011-2#1)
in even##2##2##(1990-12#1)(1995-11#1)
in event##2##2##(2008-11#1)(2008-7#1)
in events##2##2##(1997-5#1)(2012-6#1)
in ever##2##2##(2008-3#1)(2013-8#1)
in every case##4##3##(1992-5#1)(1992-9#1)(1996-3#1)(2008-5#1)
in every day##2##3##(2007-11#1)(2011-2#1)
in every four##2##3##(2010-3#1)(2010-8#1)
in every laboratory##3##3##(2008-2#1)(2008-4#1)(2009-8#1)
in every patient##3##3##(1990-3#1)(1994-9#1)(2008-7#1)
in every region##3##3##(1997-5#1)(2007-12#1)(2008-2#1)
in every situation##2##3##(2007-12#1)(2007-2#1)
in every##54##2##(1990-3#2)(1991-8#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#2)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#3)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#2)
in everyday clinical practice##2##4##(1997-3#1)(2010-12#1)
in everyday medical##2##3##(1992-12#1)(1996-3#1)
in everyday practice##2##3##(1997-3#1)(2006-5#1)
in everyday##10##2##(1992-12#1)(1996-3#1)(1997-3#2)(2006-5#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
in evidence##3##2##(1990-9#1)(1995-8#1)(2008-11#1)
in evidence-based medicine##2##3##(2012-12#2)
in evidence-based##4##2##(2010-11#1)(2012-12#3)
in evolution and##3##3##(1991-5#1)(2009-8#1)(2010-4#1)
in evolution##16##2##(1990-8#1)(1991-5#1)(1991-6#2)(1993-6#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
in evolutionary biology##2##3##(2009-5#1)(2012-3#1)
in evolutionary terms##2##3##(1991-6#1)(2010-5#1)
in evolutionary##6##2##(1991-6#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
in evolving##4##2##(1991-9#1)(1997-6#1)(1997-7#1)(2012-3#1)
in ewes##2##2##(1991-8#1)(2010-12#1)
in ex vivo##4##3##(2006-6#1)(2008-5#1)(2011-1#1)(2013-1#1)
in exacerbation of##2##3##(2008-7#1)(2013-1#1)
in examination##2##2##(1997-4#1)(2012-12#1)
in examining interfering compounds##2##4##(2008-10#2)
in examining the##5##3##(1991-1#1)(1992-6#1)(2007-8#1)(2008-10#1)(2008-9#1)
in examining##8##2##(1991-1#1)(1992-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-9#1)
in excellent agreement with a##3##5##(2007-12#1)(2008-3#2)
in excellent agreement with the##12##5##(1990-8#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2009-5#1)(2009-9#2)(2011-2#1)
in excellent agreement with##22##4##(1990-8#1)(1993-11#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#4)(2009-5#1)(2009-9#2)(2011-2#1)
in excellent agreement##25##3##(1990-8#1)(1993-11#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#6)(2009-5#1)(2009-9#2)(2011-2#1)
in excellent yields##4##3##(2007-11#2)(2008-4#1)(2008-5#1)
in excellent##35##2##(1990-8#1)(1993-11#1)(1995-2#1)(1997-6#1)(2007-11#4)(2007-12#3)(2008-10#8)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
in excess of 10##5##4##(1995-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
in excess of 200##2##4##(1992-5#1)(2008-3#1)
in excess of 300##2##4##(2007-11#1)(2008-10#1)
in excess of that##2##4##(1996-2#1)(2008-5#1)
in excess of the##4##4##(1992-9#1)(1993-1#1)(1994-11#1)(1995-6#1)
in excess of##43##3##(1991-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(2007-11#3)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2009-7#1)(2010-4#1)
in excess over##3##3##(1991-5#2)(1993-12#1)
in excess to the##2##4##(1992-3#1)(2008-10#1)
in excess to##3##3##(1992-3#1)(1994-2#1)(2008-10#1)
in excess##59##2##(1990-7#1)(1991-12#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(2007-11#3)(2007-12#4)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2009-7#1)(2010-4#1)(2013-1#4)
in excessive##3##2##(1996-3#1)(2008-10#2)
in exchange for##3##3##(1993-12#1)(1997-1#2)
in exchange##4##2##(1993-12#1)(1997-1#2)(2008-10#1)
in excised leaf tissues##4##4##(2008-10#4)
in excised leaves##3##3##(2008-10#3)
in excised##10##2##(1994-11#1)(2008-10#8)(2012-8#1)
in excitatory##3##2##(1995-6#2)(2009-8#1)
in excited##2##2##(2008-10#1)(2009-12#1)
in excitotoxicity##2##2##(1995-12#2)
in excretory/secretory##2##2##(1992-8#2)
in executive##2##2##(2009-6#1)(2009-9#1)
in exercise capacity##3##3##(1997-8#1)(2008-10#1)(2010-10#1)
in exercise##11##2##(1991-6#1)(1991-8#1)(1992-2#1)(1997-8#1)(2007-12#1)(2007-6#3)(2008-10#1)(2008-5#1)(2010-10#1)
in exhaled##2##2##(2008-10#1)(2011-2#1)
in exile##2##2##(1990-6#2)
in existence for##2##3##(2008-10#1)(2011-2#1)
in existence##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
in existing##8##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-10#1)(2013-1#1)
in exit-site##2##2##(2007-12#2)
in exocytosis##4##2##(1990-8#1)(1993-11#1)(1995-11#2)
in exogenous##2##2##(2010-10#1)(2012-3#1)
in exon 1 and##3##4##(1990-5#1)(2008-2#1)(2012-3#1)
in exon 1##6##3##(1990-5#2)(2008-2#3)(2012-3#1)
in exon 3##4##3##(1993-6#1)(1995-6#1)(2008-1#1)(2008-2#1)
in exon 4 of##2##4##(1990-5#1)(2008-12#1)
in exon 7 of the##2##5##(1993-3#2)
in exon 7##4##3##(1993-3#2)(2008-7#1)(2009-8#1)
in exon##24##2##(1990-12#1)(1990-5#3)(1990-7#1)(1991-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-12#1)(2008-2#4)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
in exons 3##2##3##(1994-12#2)
in exons##4##2##(1993-11#1)(1994-12#3)
in exotic##2##2##(2008-5#1)(2009-4#1)
in expanding##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
in expenditures##4##2##(1991-3#1)(1993-12#1)(2008-11#1)(2013-1#1)
in experienced hands##2##3##(1994-2#1)(2011-2#1)
in experienced rats##2##3##(1995-12#2)
in experienced##5##2##(1994-2#1)(1995-12#2)(2008-9#1)(2011-2#1)
in experiment 1##3##3##(2008-10#3)
in experiment 2##3##3##(2008-10#3)
in experiment##7##2##(2008-10#6)(2008-8#1)
in experimental and clinical##3##4##(1991-9#1)(2008-1#1)(2008-7#1)
in experimental and##5##3##(1991-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
in experimental animal models##3##4##(1992-6#1)(1993-11#1)(1995-5#1)
in experimental animal##5##3##(1991-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(2008-7#1)
in experimental animals##8##3##(1991-2#1)(1994-5#1)(1997-2#1)(2006-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
in experimental autoimmune encephalomyelitis##2##4##(2010-12#1)(2012-2#1)
in experimental conditions##3##3##(1991-6#1)(2008-10#1)(2008-9#1)
in experimental diabetes##4##3##(1994-8#1)(2008-1#2)(2011-2#1)
in experimental models of##2##4##(1996-6#1)(2009-6#1)
in experimental models##5##3##(1996-6#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-1#1)
in experimental plots##2##3##(2008-10#2)
in experimental populations of##3##4##(1997-7#1)(2008-8#1)(2013-1#1)
in experimental rats##3##3##(2013-1#3)
in experimental stroke##2##3##(2007-10#2)
in experimental studies##2##3##(2007-11#1)(2007-4#1)
in experimental##76##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-5#3)(1994-7#1)(1994-8#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-4#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#5)
in experiments conducted##2##3##(2008-3#1)(2010-8#1)
in experiments with##4##3##(1992-3#1)(1994-2#1)(2008-3#1)(2012-2#1)
in experiments##18##2##(1992-3#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#4)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
in expired##2##2##(1995-6#1)(2008-6#1)
in explaining population size##2##4##(2008-8#2)
in explaining##13##2##(1991-2#1)(1997-8#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#2)
in explicit solvent##2##3##(2009-7#1)(2010-2#1)
in explicit##3##2##(2009-7#1)(2009-9#1)(2010-2#1)
in exploratory##5##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
in exploring the##2##3##(2008-11#1)(2010-11#1)
in exploring##3##2##(2008-11#1)(2009-5#1)(2010-11#1)
in exponentially growing##3##3##(1995-2#1)(2008-11#1)(2012-3#1)
in exposed##8##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-1#1)
in exposure measurement upon the##2##5##(2008-7#2)
in exposure measurement##3##3##(2008-7#3)
in exposure of##2##3##(1997-4#1)(2008-11#1)
in exposure to infection##2##4##(1994-2#2)
in exposure to##4##3##(1992-1#1)(1994-2#2)(2008-8#1)
in exposure##14##2##(1992-1#1)(1994-2#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-8#1)(2012-2#1)
in expressed##2##2##(2008-10#1)(2012-3#1)
in expression and##2##3##(1990-12#1)(1990-2#1)
in expression levels##3##3##(2008-11#2)(2008-7#1)
in expression of the##3##4##(1993-3#1)(1994-12#1)(1994-8#1)
in expression of##21##3##(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1996-12#1)(1996-2#1)(1996-5#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#1)
in expression##40##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#2)(1996-12#2)(1996-2#1)(1996-5#2)(2007-11#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in expressions for##2##3##(2008-10#1)(2008-2#1)
in extant##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
in extended##3##2##(1995-3#1)(2008-11#1)(2012-3#1)
in extending the##2##3##(2008-2#1)(2012-3#1)
in extending##4##2##(2008-2#1)(2008-7#1)(2011-1#1)(2012-3#1)
in extension and##2##3##(2008-9#1)(2010-11#1)
in extension##5##2##(1997-2#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)
in extensive##7##2##(1991-5#1)(1992-3#1)(1996-12#1)(2007-7#1)(2008-10#2)(2012-2#1)
in extensively##2##2##(1990-11#1)(2013-8#1)
in extent##2##2##(1995-11#1)(1996-6#1)
in external##8##2##(1990-7#1)(1992-5#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-9#1)(2010-8#1)
in extinction and##2##3##(2008-3#2)
in extinction##4##2##(1992-3#1)(2008-2#1)(2008-3#2)
in extracellular calcium##2##3##(1991-12#1)(2008-11#1)
in extracellular matrix##2##3##(1994-12#1)(2012-1#1)
in extracellular##17##2##(1991-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2012-1#2)
in extracorporeal shock wave lithotripsy##2##5##(1990-8#1)(2007-10#1)
in extracorporeal##3##2##(1990-8#1)(2007-10#1)(2010-8#1)
in extract##3##2##(2008-10#3)
in extracted##4##2##(2008-10#4)
in extracting##5##2##(2008-10#3)(2011-1#1)(2012-2#1)
in extraction##11##2##(2008-10#7)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#1)
in extracts from the##2##4##(2008-5#1)(2011-2#1)
in extracts from##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
in extracts of infected##3##4##(2008-10#3)
in extracts of##8##3##(1994-8#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-7#1)
in extracts##13##2##(1994-8#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
in extraembryonic##2##2##(1995-8#1)(1997-4#1)
in extrahepatic##3##2##(1991-5#1)(1993-9#1)(1995-6#1)
in extrapyramidal and limbic##2##4##(1991-1#1)(1997-7#1)
in extravascular lung water##2##4##(1994-8#2)
in extreme##6##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)
in extreme-ultraviolet##2##2##(2008-3#2)
in extremely##5##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)
in extremity##4##2##(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#1)
in eye care##2##3##(1992-11#1)(2011-2#1)
in eye opening##3##3##(2007-10#3)
in eye##14##2##(1991-11#1)(1992-11#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
in eyespot##2##2##(2008-10#1)(2012-2#1)
in fMRI##2##2##(2009-9#1)(2013-8#1)
in fabricating##4##2##(2008-10#1)(2008-2#1)(2012-2#2)
in face of##3##3##(1993-3#1)(2009-4#1)(2012-12#1)
in face##5##2##(1993-3#1)(2007-8#1)(2009-4#1)(2012-1#1)(2012-12#1)
in facet joints##2##3##(2011-2#1)(2013-8#1)
in facial##11##2##(1990-11#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-7#1)(2010-8#3)(2013-1#1)
in facilitating electron transfer##2##4##(1990-5#1)(1995-2#1)
in facilitating the##3##3##(1997-1#1)(2010-12#1)(2012-2#1)
in facilitating##10##2##(1990-5#1)(1991-1#1)(1995-2#1)(1997-1#1)(2008-11#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
in fact a##2##3##(2008-3#1)(2008-9#1)
in fact be##3##3##(1991-2#1)(1994-5#1)(2011-2#1)
in fact decrease##2##3##(1990-5#1)(1996-9#1)
in fact explained by##2##4##(2008-10#1)(2008-9#1)
in fact performed##2##3##(1993-12#1)(2008-3#1)
in fact similar to the##2##5##(1997-4#1)(2007-12#1)
in fact##61##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#2)(1992-1#1)(1992-8#2)(1993-12#1)(1993-6#2)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
in factorial greenhouse##2##3##(2008-10#2)
in factorial##3##2##(2008-10#3)
in faculty research##3##3##(2008-12#1)(2010-3#2)
in faculty##5##2##(2008-12#2)(2010-3#2)(2012-3#1)
in faecal samples##2##3##(1996-12#2)
in faecal##5##2##(1995-11#1)(1996-12#4)
in faeces##7##2##(1990-12#1)(1991-11#1)(1994-7#1)(2008-5#2)(2011-1#1)(2012-3#1)
in failure of##2##3##(2007-12#1)(2008-7#1)
in failure##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
in fairly##3##2##(1997-5#1)(2008-11#1)(2008-4#1)
in fall##8##2##(1994-9#1)(2008-10#5)(2008-9#1)(2010-11#1)
in familial adenomatous polyposis (FAP)##2##5##(2008-11#1)(2008-4#1)
in familial##9##2##(1990-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-7#1)
in families and##3##3##(1990-12#1)(2007-3#1)(2009-5#1)
in families of##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
in families that emphasized##2##4##(2009-8#2)
in families with children##2##4##(2010-12#1)(2012-2#1)
in families with##8##3##(2007-6#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
in families##26##2##(1990-12#1)(1996-2#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#2)(2009-5#1)(2009-8#4)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in family and community medicine##2##5##(1993-5#1)(1997-6#1)
in family and community##4##4##(1993-3#1)(1993-5#1)(1994-2#1)(1997-6#1)
in family and##5##3##(1993-3#1)(1993-5#1)(1994-2#1)(1997-6#1)(2010-11#1)
in family medicine##2##3##(1996-9#1)(1997-6#1)
in family medicine]##2##3##(1994-9#1)(1996-11#1)
in family practice##4##3##(1991-6#1)(1996-11#1)(1996-8#1)(2012-3#1)
in family##24##2##(1991-6#1)(1992-4#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-11#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
in far-field##4##2##(2007-12#1)(2008-3#3)
in farm##2##2##(2011-2#1)(2013-1#1)
in farmed Atlantic salmon##2##4##(1991-8#1)(1994-7#1)
in farmed##3##2##(1991-8#1)(1993-2#1)(1994-7#1)
in farmers##2##2##(1996-12#1)(1996-8#1)
in farms##7##2##(1996-12#1)(2008-12#5)(2012-3#1)
in fast inactivation-deficient hNa(v)1##2##4##(2008-8#2)
in fast##13##2##(1991-10#1)(1991-12#1)(1994-3#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-8#2)(2010-5#2)(2011-1#1)
in fasted##3##2##(1991-12#1)(1992-12#1)(1994-8#1)
in fasting and postprandial ghrelin levels##2##6##(2011-1#2)
in fasting##8##2##(1990-8#1)(1991-3#1)(1992-9#2)(2011-1#2)(2012-2#1)(2012-3#1)
in fat and##2##3##(1995-2#1)(2009-4#1)
in fat mass##3##3##(2008-3#1)(2008-5#2)
in fat##11##2##(1995-2#2)(1997-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2012-2#1)
in fatal##3##2##(1991-8#1)(1995-5#1)(2009-7#1)
in fatigue##5##2##(1993-9#1)(2008-7#3)(2009-7#1)
in fattening pigs at slaughter##2##5##(1990-3#2)
in fattening pigs##4##3##(1990-3#4)
in fatty acid##5##3##(1990-5#1)(1996-3#1)(2008-10#2)(2008-7#1)
in fatty acids##2##3##(1994-12#1)(2010-8#1)
in fatty##8##2##(1990-5#1)(1994-12#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)
in fault##2##2##(1996-4#2)
in favor of a##2##4##(2011-2#1)(2012-3#1)
in favor of the##11##4##(1990-12#1)(1991-2#1)(1991-9#1)(1993-12#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
in favor of##30##3##(1990-12#1)(1990-3#1)(1991-1#2)(1991-2#1)(1991-9#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-11#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)
in favor##31##2##(1990-12#1)(1990-3#1)(1991-1#2)(1991-2#1)(1991-9#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-11#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)
in favour of SLIT##2##4##(2011-2#2)
in favour of the##4##4##(1990-6#1)(1991-2#1)(1995-11#1)(2013-1#1)
in favour of##22##3##(1990-6#1)(1991-2#1)(1992-11#1)(1993-3#1)(1995-11#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2009-9#1)(2010-3#1)(2011-2#3)(2013-1#1)
in fear##2##2##(2010-4#1)(2012-2#1)
in febrile neutropenia##2##3##(2008-7#2)
in febrile##6##2##(2007-2#2)(2008-10#1)(2008-7#2)(2013-1#1)
in feces##4##2##(1990-8#2)(1991-3#1)(2010-2#1)
in fed rats##2##3##(1992-12#1)(1994-8#1)
in fed##3##2##(1992-12#1)(1994-8#1)(1996-5#1)
in fed-batch##6##2##(2008-11#3)(2008-7#2)(2013-1#1)
in fedbatch##2##2##(2008-7#2)
in federal##5##2##(1991-1#1)(1991-2#1)(1993-2#1)(2008-10#1)(2012-2#1)
in feed and food##3##4##(2008-10#3)
in feed and##4##3##(2008-10#4)
in feed##9##2##(2008-10#6)(2008-12#1)(2008-9#1)(2010-8#1)
in feedback##2##2##(1994-5#1)(2013-8#1)
in feeding situation##3##3##(1990-12#3)
in feeding##7##2##(1990-12#3)(2007-12#1)(2010-11#1)(2011-2#2)
in feeds##2##2##(2008-10#2)
in feedstuffs and skin##2##4##(1994-9#2)
in feedstuffs##3##2##(1994-9#2)(2008-10#1)
in female and male##5##4##(1992-11#1)(1994-2#1)(1994-6#1)(2008-12#1)(2010-8#1)
in female athletes##2##3##(1990-6#1)(2012-3#1)
in female p53 haploinsufficient mice administered##2##6##(2008-9#2)
in female p53 haploinsufficient mice##3##5##(2008-9#3)
in female patient##2##3##(2013-1#2)
in female patients and##2##4##(2008-4#1)(2010-12#1)
in female patients##5##3##(2007-8#1)(2008-4#1)(2010-12#1)(2010-8#1)(2013-1#1)
in female rats##11##3##(1990-11#1)(1992-5#2)(1993-6#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-12#2)(2013-1#1)
in female##66##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
in females (p &lt##2##4##(2008-1#1)(2008-11#1)
in females and##8##3##(1993-8#1)(1994-2#5)(2008-5#1)(2008-8#1)
in females as##2##3##(1995-6#1)(2012-3#1)
in females during the reproductive##2##5##(1990-12#1)(2012-2#1)
in females than in males##5##5##(2008-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
in females was##2##3##(1997-7#1)(2008-9#1)
in females##76##2##(1990-12#2)(1991-6#4)(1992-12#1)(1993-8#2)(1994-2#5)(1994-6#3)(1995-2#1)(1995-6#3)(1995-9#1)(1996-3#2)(1997-4#1)(1997-7#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-11#3)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-3#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#3)
in females)##5##2##(1991-6#1)(1994-6#1)(2008-11#1)(2008-3#2)
in femoral shaft##2##3##(2007-11#1)(2012-2#1)
in femoral##4##2##(2007-11#2)(2007-8#1)(2012-2#1)
in femtosecond lasers##2##3##(2008-2#1)(2008-3#1)
in femtosecond##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
in femur and##2##3##(1997-4#1)(2012-2#1)
in femur##4##2##(1997-4#1)(2007-11#2)(2012-2#1)
in fermentation##4##2##(2008-10#1)(2008-6#2)(2008-8#1)
in ferric anguibactin##2##3##(2011-2#2)
in fertilisers##2##2##(2008-10#2)
in fertility##3##2##(1995-12#1)(1997-1#2)
in fertilization##3##2##(1994-5#1)(2008-8#1)(2011-1#1)
in fetal##15##2##(1990-11#3)(1992-8#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
in fetuses and##2##3##(2007-11#1)(2010-11#1)
in fetuses with##3##3##(1996-12#1)(2008-11#1)(2011-2#1)
in fetuses##7##2##(1996-12#1)(2007-11#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#2)
in few cases##3##3##(2007-7#1)(2011-1#1)(2012-3#1)
in few##4##2##(2007-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
in few-mode fibers##2##3##(2007-11#2)
in fewer complications##3##3##(2010-12#1)(2013-1#2)
in fewer##5##2##(2008-9#1)(2010-12#1)(2013-1#3)
in fiber##3##2##(2007-12#2)(2008-3#1)
in fibers with polarization mode dispersion##3##6##(2007-11#1)(2007-12#2)
in fibers with##6##3##(2007-11#2)(2007-12#3)(2008-3#1)
in fibroblast##2##2##(1992-9#1)(1994-8#1)
in fibroblastic cells##3##3##(1991-9#1)(2008-4#2)
in fibroblasts from##5##3##(1990-8#1)(1991-7#1)(1993-8#1)(1994-11#1)(1995-11#1)
in fibroblasts##14##2##(1990-2#1)(1990-8#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-8#1)(1997-6#1)(2008-1#1)(2012-12#1)(2012-2#1)
in fibromyalgia##4##2##(1997-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
in field conditions##4##3##(2008-10#4)
in field experiments conducted##3##4##(2008-10#3)
in field experiments from##2##4##(2008-10#2)
in field experiments##14##3##(2008-10#13)(2008-8#1)
in field microplots##4##3##(2008-10#4)
in field plots of##2##4##(2008-10#2)
in field plots##5##3##(2008-10#5)
in field populations of##4##4##(2008-10#2)(2008-9#1)(2011-2#1)
in field populations##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
in field samples##4##3##(2008-10#4)
in field soil##4##3##(2008-10#4)
in field studies##4##3##(2008-10#4)
in field tests##2##3##(2008-2#1)(2008-3#1)
in field trials in##2##4##(2008-10#2)
in field trials##6##3##(2008-10#6)
in field##68##2##(1997-7#1)(2008-10#55)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-2#4)
in fields as##2##3##(2008-10#1)(2012-2#1)
in fields before##2##3##(2008-10#2)
in fields of##2##3##(1991-6#2)
in fields such as##2##4##(1993-2#1)(2008-12#1)
in fields with##4##3##(2008-10#4)
in fields##24##2##(1991-6#2)(1993-2#1)(2008-10#17)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
in fifty cases##2##3##(1991-12#1)(2007-7#1)
in fig##2##2##(2008-10#2)
in fighting##3##2##(1990-11#1)(1991-12#1)(2010-5#1)
in filamentous fungi##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
in filter##2##2##(2008-2#1)(2008-9#1)
in filters##2##2##(2008-10#1)(2008-7#1)
in final cell##2##3##(2008-11#2)
in final solution with##2##4##(2008-10#2)
in final solution##3##3##(2008-10#3)
in final##8##2##(2008-10#5)(2008-11#2)(2011-2#1)
in finance##2##2##(1995-1#1)(2010-5#1)
in financial and##3##3##(1994-1#2)(1997-3#1)
in financial status##2##3##(2008-11#2)
in financial##7##2##(1994-1#2)(1997-3#1)(2007-9#1)(2008-11#2)(2008-12#1)
in finding##12##2##(1992-1#1)(1993-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-3#1)
in fine##4##2##(1990-10#1)(1995-6#1)(1997-7#1)(2008-10#1)
in fine-tuning##2##2##(2008-10#1)(2010-8#1)
in finishing pigs##3##3##(2010-2#1)(2012-2#2)
in finishing##4##2##(2010-2#2)(2012-2#2)
in finite##4##2##(2008-3#3)(2013-1#1)
in fire##2##2##(1996-12#1)(2008-10#1)
in firing##3##2##(1996-2#1)(2008-11#2)
in first CR##2##3##(2011-2#2)
in first grade##3##3##(2008-12#3)
in first##23##2##(1990-3#1)(1991-8#1)(1992-1#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-10#1)(2011-2#5)(2012-3#2)(2013-1#2)
in first-line therapy##2##3##(2008-5#1)(2010-11#1)
in first-line##3##2##(2008-5#1)(2010-11#1)(2012-3#1)
in fiscal##2##2##(1991-12#1)(1997-1#1)
in fish and##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2012-1#1)(2013-7#1)
in fish cells and fry##2##5##(1992-6#2)
in fish exposed to##3##4##(2008-10#1)(2010-8#2)
in fish muscle##2##3##(2008-10#2)
in fish of##3##3##(2008-10#2)(2008-12#1)
in fish samples##3##3##(2008-10#3)
in fish tissue##2##3##(1997-4#1)(2008-10#1)
in fish tissues##2##3##(2008-10#1)(2012-12#1)
in fish with##2##3##(2008-8#2)
in fish##56##2##(1991-8#1)(1992-6#3)(1994-11#1)(1997-4#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-7#1)(2010-1#1)(2010-5#7)(2010-8#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#4)
in fishes and##2##3##(1995-12#1)(2010-8#1)
in fishes##6##2##(1995-12#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-7#1)
in fission yeast##5##3##(1993-9#1)(1995-2#2)(2009-3#1)(2011-2#1)
in fitness components##2##3##(2008-8#1)(2008-9#1)
in fitness##9##2##(2008-8#7)(2008-9#2)
in fitting##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
in five adult##2##3##(1996-6#1)(2007-8#1)
in five and four##2##4##(2008-5#1)(2008-6#1)
in five cases of##2##4##(2008-3#1)(2013-8#1)
in five cases##9##3##(1991-6#1)(1997-3#3)(1997-8#1)(2006-12#1)(2007-8#1)(2008-3#1)(2013-8#1)
in five different##8##3##(1992-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)
in five healthy volunteers##2##4##(1995-12#1)(1996-5#1)
in five healthy##3##3##(1992-6#1)(1995-12#1)(1996-5#1)
in five of six##2##4##(2008-10#2)
in five of the seven##3##5##(1993-3#1)(1996-6#1)(2008-8#1)
in five of the##4##4##(1993-3#1)(1994-8#1)(1996-6#1)(2008-8#1)
in five of##8##3##(1993-3#1)(1994-8#1)(1996-6#1)(2006-6#1)(2008-10#2)(2008-8#1)(2012-3#1)
in five or##2##3##(2008-6#1)(2008-8#1)
in five patients with##4##4##(1990-9#1)(2008-1#1)(2012-3#1)(2013-1#1)
in five patients##9##3##(1990-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
in five species##2##3##(1990-11#1)(2010-8#1)
in five##99##2##(1990-11#2)(1990-9#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-3#2)(1993-9#2)(1994-1#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-3#5)(1997-8#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#17)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
in fixed##12##2##(1990-3#1)(1990-5#1)(1994-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-5#1)(2009-8#1)(2013-8#1)
in flag leaves in Xieyou##2##5##(2008-9#2)
in flames##6##2##(2007-12#1)(2008-3#5)
in flasks##4##2##(2008-5#1)(2008-8#1)(2011-2#2)
in flexibility##2##2##(1993-11#1)(1997-3#1)
in flexion and##2##3##(2008-8#1)(2012-2#1)
in flexion##3##2##(2007-8#1)(2008-8#1)(2012-2#1)
in flexor##2##2##(2009-11#1)(2012-3#1)
in flies##4##2##(2007-12#2)(2008-9#1)(2012-3#1)
in flight##4##2##(1991-2#1)(1996-12#1)(2008-3#1)(2011-2#1)
in floral##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)
in flow analysis##9##3##(2008-10#9)
in flow cytometry and##2##4##(2008-9#2)
in flow cytometry##13##3##(1995-8#1)(2008-9#11)(2012-12#1)
in flow injection analysis for##3##5##(2008-10#3)
in flow injection analysis system##2##5##(2008-10#2)
in flow injection analysis##10##4##(2008-10#10)
in flow injection mode##2##4##(2008-10#2)
in flow injection##15##3##(2008-10#15)
in flow rates with Parineb##2##5##(1996-12#2)
in flow rates with##3##4##(1996-12#3)
in flow systems##5##3##(2008-10#5)
in flow##60##2##(1991-9#1)(1995-3#1)(1995-8#1)(1996-12#3)(1997-1#2)(2008-10#31)(2008-11#1)(2008-2#3)(2008-7#1)(2008-9#15)(2012-12#1)
in flow-injection analysis##3##3##(2008-10#3)
in flow-injection##5##2##(2008-10#5)
in flow-through##2##2##(2008-10#2)
in flower##7##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)
in flowering plants##2##3##(2008-8#1)(2008-9#1)
in flowers of##2##3##(2008-10#1)(2012-3#1)
in flowers##5##2##(2008-10#4)(2012-3#1)
in flowing##5##2##(2008-10#4)(2008-11#1)
in fluency##2##2##(2008-2#1)(2013-1#1)
in fluid##3##2##(1992-6#1)(2007-11#1)(2008-8#1)
in fluidity of the##2##4##(1992-6#1)(2008-9#1)
in fluidity of##3##3##(1991-5#1)(1992-6#1)(2008-9#1)
in fluorescence excitation##2##3##(2006-4#1)(2007-11#1)
in fluorescence intensity##10##3##(1990-5#1)(1992-3#1)(1995-11#1)(1995-5#1)(2008-10#5)(2008-4#1)
in fluorescence microscopy##2##3##(2007-11#2)
in fluorescence quenching##2##3##(1997-8#1)(2008-10#1)
in fluorescence##34##2##(1990-5#1)(1992-3#1)(1994-5#1)(1995-11#1)(1995-5#2)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#5)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2013-7#1)
in fluorescent intensity##2##3##(2008-10#2)
in fluorescent##3##2##(2008-1#1)(2008-10#2)
in fluoride##2##2##(1991-6#1)(2008-10#1)
in flux##5##2##(1990-5#1)(1991-3#1)(1995-6#1)(2007-11#1)(2008-6#1)
in fly ash##5##3##(2008-10#4)(2008-3#1)
in fly##7##2##(2008-10#4)(2008-3#1)(2008-9#2)
in foams##2##2##(2008-11#1)(2008-7#1)
in focal cerebral ischemia##2##4##(2007-10#1)(2008-10#1)
in focal cerebral##3##3##(1996-11#1)(2007-10#1)(2008-10#1)
in focal liver lesions##2##4##(2008-7#2)
in focal liver##3##3##(2008-7#3)
in focal##11##2##(1996-11#1)(2007-10#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#3)(2013-1#1)
in focus groups##4##3##(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#1)
in focus##11##2##(1993-12#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-3#1)(2011-1#2)(2012-12#1)
in focusing##3##2##(1996-6#1)(2008-8#1)(2011-2#1)
in fog-water##3##2##(2008-10#3)
in folate##2##2##(1993-6#1)(1995-2#1)
in folding##4##2##(1992-6#1)(2008-7#1)(2008-8#2)
in foliar##3##2##(2008-10#2)(2011-10#1)
in follicle cells of##2##4##(2008-7#2)
in follicle cells##3##3##(2008-7#3)
in follicular fluid##2##3##(1991-12#1)(2012-3#1)
in follicular##6##2##(1990-8#1)(1991-12#1)(2008-11#1)(2010-11#1)(2010-8#1)(2012-3#1)
in follow up##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
in follow-up##5##2##(2007-11#2)(2008-11#1)(2008-7#1)(2011-2#1)
in following##6##2##(1991-12#1)(1992-12#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-1#1)
in food analysis and environmental research##2##6##(2008-10#2)
in food analysis##4##3##(2008-10#4)
in food and feed##4##4##(2008-10#4)
in food and##14##3##(1992-5#1)(1993-12#1)(2008-10#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-6#1)(2010-7#1)
in food intake##2##3##(2008-11#1)(2010-6#1)
in food products##7##3##(1992-11#1)(2007-12#1)(2008-10#3)(2009-8#1)(2011-2#1)
in food samples##12##3##(2008-10#12)
in food webs##2##3##(2008-9#1)(2012-12#1)
in food##95##2##(1992-11#1)(1992-5#2)(1993-12#1)(1993-6#1)(1994-3#2)(2007-12#4)(2008-10#45)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#8)(2009-3#1)(2009-8#1)(2010-5#5)(2010-6#2)(2010-7#4)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
in food-deprived##3##2##(1993-12#2)(1995-5#1)
in food-producing animals in##2##4##(2010-4#2)
in food-producing animals##6##3##(2010-4#5)(2010-5#1)
in foods by##2##3##(2008-10#2)
in foods rich in##2##4##(1997-8#2)
in foods##24##2##(1994-3#3)(1997-8#2)(2007-12#2)(2008-10#12)(2010-2#1)(2011-2#3)(2012-2#1)
in foodstuffs##8##2##(1990-8#1)(2008-10#6)(2011-2#1)
in for##7##2##(1991-2#1)(1992-8#2)(1992-9#1)(1994-7#1)(2008-2#1)(2010-8#1)
in for-profit##2##2##(1992-3#1)(1995-1#1)
in foraging##2##2##(2008-5#1)(2008-9#1)
in force##4##2##(1997-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
in forced##4##2##(1991-8#1)(2012-2#2)(2012-3#1)
in forebrain##2##2##(1993-12#1)(2008-2#1)
in forensic analysis##2##3##(2008-10#1)(2008-12#1)
in forensic cases##2##3##(1995-6#1)(2008-10#1)
in forensic psychiatry##3##3##(2011-2#2)(2013-8#1)
in forensic samples##3##3##(2008-10#1)(2008-12#2)
in forensic##22##2##(1995-6#1)(1997-8#1)(2008-10#6)(2008-12#4)(2008-7#1)(2010-5#1)(2011-2#6)(2012-3#1)(2013-8#1)
in forest pathology##3##3##(2008-10#3)
in forest soils##2##3##(2008-10#1)(2008-11#1)
in forest trees##2##3##(2008-8#2)
in forest##15##2##(2008-10#7)(2008-11#1)(2008-8#5)(2008-9#1)(2012-3#1)
in forestry##2##2##(2008-11#1)(2012-12#1)
in forests##4##2##(2008-10#3)(2008-9#1)
in form and##2##3##(1995-2#1)(2008-8#1)
in form of##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2010-5#1)
in form##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)
in formal##3##2##(1996-6#1)(2008-12#1)(2012-2#1)
in formaldehyde##2##2##(2008-10#2)
in formalin##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
in formalin-fixed##4##2##(1994-7#1)(1997-3#1)(1997-7#1)(2012-3#1)
in formation of the##3##4##(1992-3#1)(1996-2#1)(2006-6#1)
in formation of##8##3##(1992-3#1)(1995-2#1)(1996-2#1)(2006-6#1)(2008-10#3)(2008-9#1)
in formation##10##2##(1992-3#1)(1995-2#1)(1996-2#1)(2006-6#1)(2008-10#3)(2008-9#2)(2009-11#1)
in former##3##2##(1993-3#1)(1994-5#1)(2008-11#1)
in forming##10##2##(1993-11#1)(1994-11#1)(1997-3#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
in formulating##6##2##(1994-12#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
in formulation##2##2##(2008-5#2)
in formulations##8##2##(2008-10#6)(2008-5#1)(2012-2#1)
in forward##4##2##(2006-6#1)(2008-10#1)(2008-2#1)(2012-3#1)
in fossil##2##2##(2007-12#1)(2012-9#1)
in foster children##2##3##(2008-12#2)
in foster##4##2##(1995-5#1)(2008-12#2)(2009-9#1)
in fostering##2##2##(1996-3#1)(2008-11#1)
in four Danish counties##2##4##(1997-3#2)
in four Norwegian##3##3##(1991-6#1)(1992-6#1)(1994-6#1)
in four age groups (4##3##5##(2008-7#3)
in four areas##2##3##(2008-12#1)(2012-12#1)
in four beaches##2##3##(2008-5#2)
in four cases and##2##4##(2007-8#1)(2008-7#1)
in four cases##13##3##(1990-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1997-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#2)
in four categories##2##3##(1992-3#1)(2013-7#1)
in four cities##2##3##(2007-12#1)(2013-1#1)
in four different regions##2##4##(1990-8#1)(2008-10#1)
in four different ways and##2##5##(2008-10#1)(2013-1#1)
in four different##14##3##(1990-2#1)(1990-5#1)(1990-8#1)(2008-10#9)(2010-10#1)(2013-1#1)
in four distinct##2##3##(2011-2#1)(2012-2#1)
in four experiments##2##3##(2011-1#1)(2013-8#1)
in four field experiments##2##4##(2008-10#2)
in four fields##4##3##(1993-12#1)(2008-10#2)(2013-7#1)
in four forests##2##3##(2008-10#2)
in four groups of##4##4##(1991-8#1)(2012-12#1)(2013-1#2)
in four groups##7##3##(1991-8#1)(1992-6#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-1#2)
in four human##2##3##(1990-6#1)(1992-2#1)
in four hybrid##2##3##(2008-8#1)(2012-2#1)
in four individual##2##3##(1997-4#1)(2008-8#1)
in four individuals##2##3##(2008-10#1)(2013-1#1)
in four lesions##2##3##(2008-6#2)
in four locations##2##3##(2008-10#1)(2010-12#1)
in four months##2##3##(2007-8#1)(2008-5#1)
in four of five##3##4##(1997-4#2)(2008-10#1)
in four of six##4##4##(2008-10#1)(2008-5#2)(2008-7#1)
in four of the five##4##5##(1991-6#1)(1995-5#1)(2008-10#2)
in four of the##6##4##(1991-6#1)(1995-5#1)(2007-12#1)(2008-10#2)(2009-2#1)
in four of##14##3##(1991-6#1)(1995-5#1)(1997-4#2)(2007-12#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-2#1)
in four oral locations##2##4##(2010-12#2)
in four other##2##3##(1997-3#1)(2008-1#1)
in four out of the##2##5##(1996-5#1)(2008-5#1)
in four out of##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
in four patients of group##2##5##(2007-8#2)
in four patients##12##3##(1991-5#1)(1993-1#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#3)
in four sampling##2##3##(2008-10#2)
in four species of##2##4##(2009-2#1)(2011-2#1)
in four species##3##3##(2008-7#1)(2009-2#1)(2011-2#1)
in four steps##3##3##(2008-10#2)(2008-3#1)
in four studies##2##3##(2008-10#1)(2008-3#1)
in four years##2##3##(2007-12#1)(2010-8#1)
in four##215##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#7)(2008-1#7)(2008-10#52)(2008-11#2)(2008-12#4)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#8)(2008-7#12)(2008-8#6)(2008-9#3)(2009-2#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-3#1)(2013-7#5)(2013-8#1)
in fourier-transform##2##2##(2008-2#1)(2008-3#1)
in fourteen##3##2##(1991-5#1)(2008-7#1)(2011-2#1)
in fractal environments##2##3##(2008-8#2)
in fraction##2##2##(1992-12#1)(2008-10#1)
in fractionated##2##2##(1993-3#1)(1995-12#1)
in fractions##5##2##(1990-5#1)(1990-8#1)(1996-5#1)(2008-10#2)
in fracture risk##2##3##(1993-11#1)(2012-12#1)
in fracture##6##2##(1993-11#1)(2007-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
in fragment##2##2##(1997-4#1)(2008-10#1)
in fragmented landscapes##4##3##(2008-8#2)(2008-9#2)
in fragmented##7##2##(1995-3#1)(2008-8#2)(2008-9#4)
in fragments##2##2##(1995-12#1)(1995-5#1)
in frame##6##2##(1992-12#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-9#1)(2008-10#1)
in free radical##2##3##(2008-5#1)(2009-5#1)
in free solution##2##3##(1990-2#1)(1992-6#1)
in free space##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
in free time##2##3##(2011-2#2)
in free##18##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-6#1)(1992-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#2)(2013-1#1)
in free-living##2##2##(1997-6#1)(2008-7#1)
in free-running and##2##3##(2008-2#1)(2008-3#1)
in free-running##3##2##(2008-2#2)(2008-3#1)
in free-space optical interconnects##4##4##(2008-3#4)
in free-space##6##2##(2007-12#1)(2008-3#5)
in freely moving rats##3##4##(1992-3#1)(1994-8#1)(1997-3#1)
in freely moving##6##3##(1992-3#1)(1993-9#1)(1994-8#1)(1997-3#1)(2007-12#2)
in freely##7##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-8#1)(1997-3#1)(2007-12#2)
in freeze-dried##2##2##(2008-10#2)
in frequencies of##3##3##(2008-10#3)
in frequencies##7##2##(1996-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-8#1)
in frequency among##2##3##(2008-10#1)(2009-5#1)
in frequency and##4##3##(1990-3#1)(1991-9#1)(1992-3#1)(2008-3#1)
in frequency of##11##3##(1992-5#2)(1993-8#2)(1997-5#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)
in frequency##38##2##(1990-3#1)(1991-9#1)(1992-3#1)(1992-5#2)(1993-8#2)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#2)
in frequent##2##2##(1994-8#1)(2008-3#1)
in fresh and marine waters##2##5##(2008-10#2)
in fresh and##5##3##(2008-10#4)(2008-11#1)
in fresh medium##4##3##(1990-11#1)(2008-11#3)
in fresh water##6##3##(1995-2#1)(2008-10#4)(2008-5#1)
in fresh##31##2##(1990-11#1)(1991-4#1)(1995-2#1)(1997-1#1)(2008-10#16)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#2)
in freshly collected##3##3##(2008-10#3)
in freshly isolated##4##3##(1992-3#1)(1995-11#1)(1997-1#1)(2007-8#1)
in freshly##11##2##(1992-3#1)(1995-11#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-10#5)(2008-7#1)
in freshwater samples##4##3##(2008-10#4)
in freshwater##13##2##(2008-10#9)(2008-5#1)(2008-7#1)(2012-12#2)
in frog pituitary melanotrophs##2##4##(1993-5#2)
in frog##5##2##(1991-5#1)(1993-3#1)(1993-5#2)(2008-5#1)
in front of a##5##4##(1991-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
in front of the##23##4##(1991-2#1)(1992-9#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#1)
in front of##37##3##(1991-2#1)(1991-6#1)(1992-9#1)(1996-5#1)(1997-3#1)(2007-11#5)(2007-12#5)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#5)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#2)
in front##40##2##(1991-2#1)(1991-6#1)(1992-9#1)(1996-5#1)(1997-3#1)(2007-11#5)(2007-12#6)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#5)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)
in frontal and##2##3##(1996-12#1)(2012-1#1)
in frontal cortex and##3##4##(1994-2#1)(1996-2#1)(1996-5#1)
in frontal cortex##6##3##(1994-2#1)(1995-12#1)(1996-2#2)(1996-5#1)(2008-8#1)
in frontal##8##2##(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(2008-8#1)(2012-1#1)
in fructose##2##2##(1990-5#1)(1990-8#1)
in fructose-induced insulin resistant rats##2##5##(2012-3#2)
in fruit and##3##3##(2008-12#1)(2009-3#1)(2013-8#1)
in fruit development##2##3##(2008-10#2)
in fruit juices and##3##4##(2008-10#3)
in fruit juices##8##3##(2008-10#8)
in fruit##25##2##(2008-10#19)(2008-12#1)(2009-3#1)(2010-4#1)(2011-2#2)(2013-8#1)
in fruits and leaves##2##4##(2008-12#1)(2008-5#1)
in fruits and vegetables##3##4##(2008-4#1)(2013-1#2)
in fruits and##5##3##(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#2)
in fruits##7##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#2)
in fuel alcohol by##2##4##(2008-10#2)
in fuel##3##2##(2008-10#3)
in full##8##2##(1996-12#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
in full-text biomedical articles##2##4##(2010-12#2)
in fully##7##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)
in fumigated##4##2##(2008-10#4)
in function of storage time and##2##6##(2008-10#2)
in function of time##2##4##(2007-8#1)(2008-10#1)
in function of##7##3##(1991-11#1)(2007-8#1)(2008-1#2)(2008-10#3)
in function##19##2##(1990-11#1)(1991-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-6#1)
in functional diffuse optical tomography##2##5##(2011-1#2)
in functional genomics##2##3##(2008-7#1)(2012-12#1)
in functional studies##2##3##(2008-2#1)(2008-4#1)
in functional##31##2##(1991-5#1)(1994-1#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)
in functionality##2##2##(2007-11#1)(2009-10#1)
in functionally##2##2##(1990-12#1)(1993-8#1)
in functions##2##2##(1996-12#1)(2008-7#1)
in fundamental##5##2##(1995-6#1)(2008-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
in funding##4##2##(1995-6#1)(1996-12#1)(2008-2#1)(2012-12#1)
in fungal populations##2##3##(2008-10#2)
in fungal##12##2##(2008-10#9)(2008-3#1)(2008-5#1)(2012-2#1)
in fungi##3##2##(1991-5#1)(2008-10#1)(2009-8#1)
in fungicide##2##2##(2008-10#2)
in further decrease of##2##4##(1993-11#1)(2008-10#1)
in further detail##2##3##(1997-8#1)(2009-8#1)
in further studies##4##3##(1993-1#1)(1993-8#1)(2008-5#1)(2008-7#1)
in further##21##2##(1993-1#2)(1993-11#1)(1993-8#1)(1994-8#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
in fusarium head blight##2##4##(2008-10#2)
in fused silica##11##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)
in fused##13##2##(1991-11#2)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)
in fused-silica##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
in fusion##2##2##(1992-6#1)(2008-11#1)
in future assessment##2##3##(2008-10#1)(2009-2#1)
in future clinical trials##3##4##(2007-11#1)(2008-10#1)(2008-6#1)
in future investigations##3##3##(2008-5#1)(2009-11#1)(2012-2#1)
in future research##2##3##(1994-12#1)(2007-12#1)
in future studies of##5##4##(1995-9#1)(2007-7#1)(2008-10#1)(2008-9#1)(2013-1#1)
in future studies##9##3##(1993-12#1)(1995-9#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-7#1)(2013-1#1)
in future##59##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#3)
in gaining##2##2##(1991-1#1)(2008-11#1)
in gait and##3##3##(1992-5#1)(2007-10#1)(2010-9#1)
in gait##6##2##(1992-5#1)(2007-10#1)(2009-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
in galactose##2##2##(1997-3#1)(2012-3#1)
in gallbladder cancer##2##3##(2013-1#2)
in gallbladder mucosa##2##3##(2013-8#2)
in gallbladder##7##2##(1996-6#1)(2008-1#1)(2008-11#1)(2013-1#2)(2013-8#2)
in gallium arsenide##2##3##(1990-12#1)(2008-3#1)
in gallium##8##2##(1990-12#1)(2007-11#2)(2008-10#2)(2008-3#3)
in gamblers##3##2##(2008-3#3)
in gambling##2##2##(2008-11#2)
in game##3##2##(1990-3#1)(1997-8#1)(2009-9#1)
in gamma-aminobutyric acid##2##3##(1995-12#1)(2013-8#1)
in gas chromatography##2##3##(2008-10#2)
in gas mixtures##2##3##(2007-12#1)(2008-3#1)
in gas phase and particulates##2##5##(2008-10#2)
in gas##12##2##(2007-12#2)(2008-10#7)(2008-3#2)(2013-1#1)
in gaseous samples##4##3##(2008-10#4)
in gaseous##5##2##(2008-10#5)
in gasoline##8##2##(1992-3#2)(2008-10#6)
in gastric cancer cell##2##4##(2008-9#2)
in gastric cancer##5##3##(1990-2#1)(2008-9#3)(2011-2#1)
in gastric carcinoma using##2##4##(2008-11#1)(2011-2#1)
in gastric carcinoma##4##3##(2008-11#1)(2011-2#3)
in gastric mucosa##2##3##(1997-7#1)(2013-8#1)
in gastric parietal cells##2##4##(1997-1#2)
in gastric units##2##3##(1995-6#2)
in gastric##26##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1995-6#2)(1997-1#2)(1997-7#1)(2008-11#1)(2008-9#4)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
in gastroenterology##5##2##(1993-12#1)(1994-3#1)(1995-6#1)(2012-2#1)(2013-1#1)
in gastrointestinal cancers##2##3##(2008-11#1)(2011-1#1)
in gastrointestinal##11##2##(1991-3#1)(1992-6#1)(2007-4#1)(2008-11#2)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#2)(2011-2#1)
in gathering##2##2##(1994-12#1)(2007-12#1)
in gay##3##2##(1990-3#1)(1992-9#1)(2010-8#1)
in gel##5##2##(1990-8#1)(1994-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
in gelatin##3##2##(2008-10#1)(2008-11#1)(2012-7#1)
in gels and##2##3##(2008-1#1)(2008-4#1)
in gels##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#4)
in gene cloning##2##3##(1993-11#2)
in gene content##2##3##(2008-7#1)(2010-5#1)
in gene expression and##3##4##(2007-12#1)(2008-7#1)(2010-1#1)
in gene expression are##3##4##(2008-7#1)(2009-8#1)(2010-5#1)
in gene expression for##2##4##(1996-2#1)(1997-2#1)
in gene expression induced##2##4##(2008-10#2)
in gene expression that are##2##5##(2008-8#1)(2011-1#1)
in gene expression that##3##4##(2008-7#1)(2008-8#1)(2011-1#1)
in gene expression##39##3##(1991-1#1)(1993-12#1)(1993-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-7#8)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
in gene flow##3##3##(2009-2#3)
in gene pyramiding##2##3##(2008-10#2)
in gene regulation##4##3##(1995-6#1)(2008-7#1)(2009-7#1)(2012-3#1)
in gene regulatory##2##3##(2008-4#1)(2013-1#1)
in gene therapy for##3##4##(2008-8#1)(2010-1#1)(2011-3#1)
in gene therapy##8##3##(1993-6#1)(2008-5#1)(2008-8#3)(2010-1#2)(2011-3#1)
in gene##78##2##(1991-1#1)(1993-11#2)(1993-12#1)(1993-6#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#11)(2008-8#6)(2009-2#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
in general agreement with##4##4##(1993-8#1)(2008-2#2)(2008-3#1)
in general and plant##2##4##(2008-10#1)(2010-5#1)
in general and##18##3##(1990-9#1)(1991-6#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
in general are##4##3##(1992-3#1)(2008-1#1)(2008-10#1)(2008-2#1)
in general be##2##3##(1990-8#1)(2008-8#1)
in general health##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
in general hospitals##2##3##(1990-6#1)(1993-12#1)
in general increased##2##3##(2008-5#1)(2008-7#1)
in general is##4##3##(2007-4#1)(2007-6#1)(2008-3#1)(2012-12#1)
in general lower##2##3##(2008-10#1)(2008-4#1)
in general medicine##4##3##(1995-3#1)(2007-7#1)(2009-8#1)(2013-8#1)
in general not##2##3##(1997-4#1)(2009-2#1)
in general or##2##3##(2008-10#1)(2009-8#1)
in general population##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
in general practice as##2##4##(1994-11#1)(2008-7#1)
in general practice to##2##4##(1994-2#1)(2007-2#1)
in general practice were##2##4##(1991-11#1)(1994-6#1)
in general practice##51##3##(1990-3#1)(1990-6#2)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-5#3)(1993-11#1)(1993-2#3)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#4)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-9#2)(1997-4#1)(1997-5#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#3)(2011-2#4)(2012-3#2)
in general practice]##11##3##(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)
in general surgery##6##3##(1990-3#1)(1993-2#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
in general the##4##3##(1996-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
in general were##2##3##(1992-6#1)(2008-11#1)
in general##275##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-3#5)(1992-5#3)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#9)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-2#4)(1994-5#2)(1994-6#7)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#20)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#17)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#4)
in general/family practice##2##3##(1993-11#2)
in generalized##3##2##(2008-3#2)(2009-12#1)
in generally##2##2##(1996-5#1)(2008-2#1)
in generating##17##2##(1991-5#1)(1992-6#1)(1994-1#2)(1995-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-8#1)(2008-9#1)(2012-12#1)
in generation of##2##3##(1993-3#1)(2013-1#1)
in generation##3##2##(1993-3#1)(2008-12#1)(2013-1#1)
in genes encoding##2##3##(1990-5#1)(2012-2#1)
in genes that##2##3##(2008-10#1)(2011-2#1)
in genes##7##2##(1990-5#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
in genetic diversity##4##3##(2008-10#2)(2008-12#1)(2010-6#1)
in genetic research##4##3##(1994-2#1)(2007-3#1)(2008-4#1)(2008-7#1)
in genetic studies##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
in genetic##27##2##(1994-2#1)(1997-4#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
in genetically modified (FVB Tg##6##5##(2008-8#1)(2008-9#5)
in genetically modified [B6##7##4##(2008-8#1)(2008-9#6)
in genetically modified##13##3##(2008-8#2)(2008-9#11)
in genetically##17##2##(1993-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#11)(2011-2#1)
in genetics##4##2##(2008-12#1)(2009-6#2)(2011-2#1)
in geniculocortical##2##2##(2008-1#2)
in genital organs##2##3##(1996-12#1)(2008-10#1)
in genital tissue##3##3##(1996-12#3)
in genital##7##2##(1990-6#1)(1996-12#4)(2008-10#1)(2011-1#1)
in genitourinary malignancies##2##3##(1995-12#2)
in genitourinary##3##2##(1990-6#1)(1995-12#2)
in genome size##3##3##(2008-10#1)(2008-8#2)
in genome##11##2##(2008-10#3)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
in genome-wide association studies##4##4##(2009-8#1)(2010-11#1)(2012-3#2)
in genomes##2##2##(2008-7#1)(2010-8#1)
in genomic DNA##4##3##(1993-3#1)(1994-12#1)(2008-4#2)
in genomic and##2##3##(2008-11#1)(2008-7#1)
in genomic##10##2##(1993-3#1)(1994-12#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-5#1)(2010-12#1)(2012-3#1)
in genomics##10##2##(2008-7#5)(2009-5#4)(2012-2#1)
in genotype distribution##2##3##(2011-2#2)
in genotype##7##2##(2006-6#1)(2008-10#4)(2011-2#2)
in genotypic cluster 1##2##4##(2012-3#2)
in genotypic cluster##3##3##(2012-3#3)
in genotypic##5##2##(2008-10#1)(2012-3#3)(2012-5#1)
in genotyping##2##2##(2008-4#1)(2009-8#1)
in geographic##3##2##(1992-12#1)(1992-9#1)(2008-10#1)
in geological samples by flame##2##5##(2008-10#2)
in geological samples by##5##4##(2008-10#5)
in geological samples##8##3##(2008-10#6)(2013-8#2)
in geological##11##2##(2008-10#7)(2013-8#4)
in geraniol##2##2##(2007-11#2)
in geriatric medicine##2##3##(1996-3#1)(1997-4#1)
in geriatric patients##2##3##(1990-11#1)(1992-9#1)
in geriatric##11##2##(1990-11#1)(1991-11#1)(1992-9#2)(1994-3#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
in geriatrics##3##2##(1993-12#1)(1994-6#1)(2010-6#1)
in germ cells##2##3##(2009-3#1)(2012-2#1)
in germ##3##2##(2009-3#2)(2012-2#1)
in germanosilicate fibers##2##3##(2007-12#2)
in germinated kernels##3##3##(2008-10#3)
in germinating##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)
in germination##5##2##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#2)
in gerontology##3##2##(1991-12#1)(1992-1#1)(1994-1#1)
in gerontopsychiatry and##2##3##(1994-6#2)
in gerontopsychiatry##4##2##(1994-6#4)
in gestation##4##2##(1993-5#1)(1993-6#1)(1995-2#1)(2008-10#1)
in gestational diabetes mellitus##4##4##(1992-12#1)(1996-2#3)
in gestational##5##2##(1992-12#2)(1996-2#3)
in getting the##2##3##(1992-1#1)(1993-12#1)
in getting##7##2##(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-4#1)
in ghana##2##2##(2011-2#2)
in ghrelin##3##2##(2011-2#1)(2013-8#2)
in giant##5##2##(1991-5#1)(1997-8#1)(2008-10#1)(2008-8#2)
in gill##2##2##(2008-11#1)(2008-7#1)
in gills##2##2##(2008-10#1)(2008-7#1)
in ginkgo##2##2##(2008-10#2)
in girls and##2##3##(2008-10#1)(2008-6#1)
in girls with##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
in girls##19##2##(1994-12#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
in given##3##2##(2008-11#1)(2008-3#1)(2011-3#1)
in giving##5##2##(1997-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
in gizzard##2##2##(1993-11#1)(2008-12#1)
in glacial acetic acid##2##4##(1994-3#1)(2008-10#1)
in glass are##2##3##(2008-2#1)(2008-3#1)
in glass by##2##3##(2008-3#2)
in glass##19##2##(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#5)(2008-6#1)(2012-2#1)
in glasses by##2##3##(2007-11#1)(2007-12#1)
in glasses##5##2##(1995-3#1)(2007-11#1)(2007-12#2)(2010-8#1)
in glasshouse##3##2##(2008-10#3)
in glassy##2##2##(2007-12#1)(2010-4#1)
in glaucoma patients##3##3##(2011-2#3)
in glaucoma##6##2##(1990-11#1)(2010-8#2)(2011-2#3)
in glia##3##2##(1995-12#1)(1995-5#1)(2008-7#1)
in glial cells##5##3##(1995-5#1)(1996-6#1)(2007-12#1)(2009-9#1)(2012-2#1)
in glial##7##2##(1995-5#1)(1996-6#1)(2007-12#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
in glioblastoma##6##2##(1990-6#1)(2008-7#2)(2011-2#2)(2012-3#1)
in glioma##3##2##(2008-9#1)(2013-1#2)
in gliomas##3##2##(1997-7#1)(2008-7#2)
in global##17##2##(1990-12#1)(1995-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-4#3)(2008-7#2)(2009-6#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
in glomerular filtration rate##2##4##(1996-6#1)(2011-2#1)
in glomerulonephritis##3##2##(1993-2#3)
in glucagon##2##2##(2011-2#2)
in glucokinase-loaded erythrocytes##2##3##(1990-11#2)
in glucose and##6##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
in glucose concentration##2##3##(1990-6#1)(2010-2#1)
in glucose degradation products##2##4##(2011-2#2)
in glucose homeostasis##3##3##(2008-1#2)(2012-2#1)
in glucose metabolism##3##3##(1994-6#1)(1996-2#1)(2013-7#1)
in glucose transfer##2##3##(1991-5#2)
in glucose transport##2##3##(1990-11#1)(1994-12#1)
in glucose##33##2##(1990-11#3)(1990-6#1)(1991-5#2)(1994-12#3)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-6#1)(2010-11#2)(2010-2#1)(2011-2#3)(2012-2#1)(2013-7#1)
in glucose-free medium##5##3##(1995-8#5)
in glucose-free##6##2##(1995-8#6)
in glucose-starved Sl cells##2##4##(2008-11#2)
in glucose-stimulated insulin secretion in##2##5##(2008-1#1)(2010-11#1)
in glutamate##3##2##(1995-12#1)(2008-11#1)(2009-8#1)
in glutamatergic##2##2##(2009-8#2)
in glutamine##2##2##(1996-12#1)(2008-11#1)
in glutaralaldehyde##2##2##(2008-10#2)
in glutathione##3##2##(1990-3#1)(2008-8#1)(2011-2#1)
in glycemic control##2##3##(2008-3#2)
in glycemic##3##2##(2008-1#1)(2008-3#2)
in glycerol gradients##2##3##(1990-11#2)
in glycerol##3##2##(1990-11#2)(1991-3#1)
in glycine##3##2##(1990-12#1)(2008-5#1)(2008-7#1)
in glycolipid metabolism##3##3##(2010-10#3)
in glycolysis##2##2##(1994-11#1)(2008-3#1)
in glycoprotein##2##2##(1994-9#1)(2008-7#1)
in glycoproteins##2##2##(1990-12#1)(1994-9#1)
in glycosylation##3##2##(1992-12#1)(1995-2#1)(2008-11#1)
in gnotobiotic##3##2##(2008-12#1)(2008-5#2)
in go as compared to nogo##2##6##(2013-8#2)
in goat##3##2##(2010-4#1)(2013-1#2)
in goats was##2##3##(2008-12#1)(2008-8#1)
in goats##9##2##(1996-12#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-4#2)(2011-2#1)
in going from the##2##4##(1997-7#1)(2008-5#1)
in goldfish##7##2##(1991-2#1)(1994-8#4)(2008-6#1)(2011-2#1)
in golf##2##2##(2008-10#1)(2011-2#1)
in gonadal##4##2##(1993-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
in gonadotropes##2##2##(1993-11#1)(1995-2#1)
in gonorrhoea##2##2##(1990-3#2)
in good accordance with##2##4##(1995-11#1)(2008-10#1)
in good agreement with certified values##4##6##(2008-10#4)
in good agreement with certified##5##5##(2008-10#5)
in good agreement with data##3##5##(2008-10#1)(2008-2#1)(2008-8#1)
in good agreement with experimental##2##5##(2008-2#1)(2008-3#1)
in good agreement with previously##2##5##(2008-10#1)(2008-3#1)
in good agreement with that obtained by the##2##8##(2008-10#2)
in good agreement with that##4##5##(1997-7#1)(2008-10#2)(2008-3#1)
in good agreement with the certified value##3##7##(2008-10#3)
in good agreement with the certified values and##3##8##(2008-10#3)
in good agreement with the certified values##7##7##(2008-10#7)
in good agreement with the certified##10##6##(2008-10#10)
in good agreement with the experimental##4##6##(2007-11#1)(2008-2#2)(2008-3#1)
in good agreement with the measured##2##6##(2007-12#1)(2008-3#1)
in good agreement with the results##3##6##(2007-12#1)(2008-10#1)(2013-8#1)
in good agreement with the theoretical##7##6##(2007-11#1)(2008-2#1)(2008-3#5)
in good agreement with the values##2##6##(2007-11#1)(2008-10#1)
in good agreement with the##56##5##(1991-11#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-11#1)(1996-2#1)(2007-11#5)(2007-12#2)(2008-10#22)(2008-11#1)(2008-2#6)(2008-3#11)(2009-12#1)(2010-7#1)(2013-8#1)
in good agreement with theoretical predictions and##2##7##(2007-12#2)
in good agreement with theoretical predictions##4##6##(2007-11#2)(2007-12#2)
in good agreement with theoretical##6##5##(2007-11#3)(2007-12#2)(2011-1#1)
in good agreement with theory##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
in good agreement with those obtained by the standard##2##9##(2008-10#2)
in good agreement with those obtained by the##5##8##(2008-10#5)
in good agreement with those obtained by using##2##8##(2008-10#2)
in good agreement with those obtained by##17##7##(2008-10#17)
in good agreement with those obtained##20##6##(2008-10#19)(2008-3#1)
in good agreement with those of the##4##7##(2008-10#1)(2008-2#1)(2008-3#2)
in good agreement with those of##5##6##(2008-10#2)(2008-2#1)(2008-3#2)
in good agreement with those##34##5##(2008-10#28)(2008-2#2)(2008-3#4)
in good agreement with##144##4##(1991-11#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-9#1)(1995-11#1)(1996-2#1)(1997-7#1)(2007-11#11)(2007-12#10)(2008-10#64)(2008-11#1)(2008-2#15)(2008-3#26)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
in good agreement##168##3##(1991-11#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-7#1)(2007-11#11)(2007-12#11)(2008-10#75)(2008-11#2)(2008-2#17)(2008-3#33)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#2)
in good condition##2##3##(2008-12#1)(2010-12#1)
in good correlation with the##2##5##(2007-12#1)(2008-10#1)
in good health##9##3##(1991-6#1)(1993-6#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-1#1)
in good overall yields##2##4##(1996-5#1)(2009-5#1)
in good physical condition and##2##5##(2008-5#1)(2012-12#1)
in good physical condition##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
in good to excellent##3##4##(2010-7#2)(2010-8#1)
in good to moderate yields##2##5##(2007-11#1)(2009-12#1)
in good to##5##3##(2007-11#1)(2009-12#1)(2010-7#2)(2010-8#1)
in good yield##6##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)
in good yields by##4##4##(1996-5#2)(2008-4#1)(2008-5#1)
in good yields##8##3##(1996-5#2)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-7#1)
in good##226##2##(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-6#1)(1996-2#1)(1996-5#4)(1997-7#1)(2007-11#14)(2007-12#12)(2007-7#1)(2007-8#1)(2008-10#81)(2008-11#3)(2008-12#3)(2008-2#19)(2008-3#34)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#6)
in governing##2##2##(2009-5#1)(2011-2#1)
in government##4##2##(1990-3#1)(1993-3#1)(1994-1#1)(1997-3#1)
in grade I##2##3##(1997-7#1)(2008-9#1)
in grade II##3##3##(1990-12#1)(1997-7#1)(2008-9#1)
in grade##8##2##(1990-12#2)(1997-7#2)(2008-12#1)(2008-9#2)(2009-8#1)
in graded-index##2##2##(2007-12#1)(2008-3#1)
in grades##6##2##(2008-12#1)(2009-7#2)(2009-8#1)(2012-12#2)
in gradient-index rod lenses##2##4##(2008-3#2)
in gradient-index##3##2##(2008-3#3)
in graduate medical education##2##4##(1991-8#1)(2007-4#1)
in graduate##6##2##(1991-8#2)(1992-1#1)(1993-1#1)(2006-9#1)(2007-4#1)
in graft##2##2##(1996-3#1)(2008-5#1)
in grafts of approximately##2##4##(1995-2#2)
in grain and##4##3##(2008-10#4)
in grain##19##2##(1996-5#1)(2008-10#17)(2012-2#1)
in grains and##3##3##(2008-10#2)(2008-3#1)
in grains##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
in granule##2##2##(1990-11#1)(1991-12#1)
in granulomas##2##2##(1997-3#1)(2012-3#1)
in granulosa cells##6##3##(2008-12#2)(2008-8#3)(2008-9#1)
in granulosa##8##2##(1992-9#1)(2008-12#3)(2008-8#3)(2008-9#1)
in grape berries##3##3##(2008-10#3)
in grape##4##2##(2008-10#3)(2008-7#1)
in grapes##4##2##(2008-10#3)(2008-11#1)
in grapevine leaves##3##3##(2008-10#3)
in grapevine##7##2##(2008-10#7)
in grapevines##4##2##(2008-10#4)
in graphite##8##2##(2007-12#1)(2008-10#3)(2008-3#2)(2012-2#2)
in grass##2##2##(2008-11#1)(2010-4#1)
in grasslands of the Southern Pampas region##2##7##(2013-7#2)
in grating##3##2##(2008-2#2)(2008-3#1)
in gravitational-wave detectors##2##3##(2007-12#1)(2008-3#1)
in gray##2##2##(2008-12#1)(2013-1#1)
in great demand##2##3##(2008-6#1)(2009-10#1)
in great detail##3##3##(2008-9#1)(2012-1#1)(2013-7#1)
in great need##2##3##(1990-12#1)(2008-10#1)
in great part##3##3##(2008-6#2)(2011-2#1)
in great##16##2##(1990-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
in greater depth##4##3##(1992-5#1)(2008-11#1)(2008-12#1)(2012-3#1)
in greater detail##12##3##(1992-3#1)(1993-1#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
in greater than##2##3##(1992-8#1)(2007-11#1)
in greater##42##2##(1991-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-3#1)(2013-1#3)
in greatest##2##2##(1995-12#1)(2010-12#1)
in green and##2##3##(1996-10#1)(2008-10#1)
in green##10##2##(1996-10#1)(2008-10#6)(2008-11#1)(2008-6#2)
in greenhouse and##2##3##(2008-10#2)
in greenhouse assays##3##3##(2008-10#2)(2011-2#1)
in greenhouse experiments##5##3##(2008-10#5)
in greenhouse studies##2##3##(2008-10#2)
in greenhouse tests##5##3##(2008-10#5)
in greenhouse trials##4##3##(2008-10#4)
in greenhouse##26##2##(2008-10#25)(2011-2#1)
in greenhouse-grown##2##2##(2008-10#2)
in greenhouses##3##2##(2008-10#2)(2008-6#1)
in grey treefrogs##2##3##(2009-5#1)(2009-9#1)
in grey##3##2##(2009-5#1)(2009-9#2)
in greywater##2##2##(2008-10#2)
in grip strength after##3##4##(2008-9#3)
in grip strength##5##3##(2008-9#5)
in gross##4##2##(1990-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
in ground water samples##2##4##(2008-10#2)
in ground water##7##3##(2008-10#7)
in ground##10##2##(1990-5#1)(2008-10#8)(2008-2#1)
in groundwater samples##2##3##(2008-10#2)
in groundwater##9##2##(2008-10#9)
in group 1 and##3##4##(1992-9#1)(2008-10#1)(2011-2#1)
in group 1##10##3##(1990-8#1)(1992-9#2)(2008-1#3)(2008-10#1)(2010-4#2)(2011-2#1)
in group 2 and##2##4##(2008-1#2)
in group 2##6##3##(1992-9#1)(2008-1#2)(2009-6#1)(2011-2#2)
in group 3##4##3##(1992-6#1)(2008-1#2)(2011-2#1)
in group 4##2##3##(1992-6#1)(2008-11#1)
in group A##14##3##(1990-6#1)(1995-12#1)(1996-6#2)(2007-8#3)(2007-9#3)(2008-1#1)(2010-12#1)(2010-7#1)(2011-2#1)
in group B##9##3##(1990-6#1)(1996-6#2)(2007-8#2)(2007-9#1)(2008-1#2)(2011-2#1)
in group C##5##3##(2008-12#1)(2010-7#2)(2011-2#1)(2012-2#1)
in group D##2##3##(1996-1#1)(2008-12#1)
in group I and##2##4##(2007-8#2)
in group I##8##3##(1991-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2010-1#1)(2013-1#2)
in group II (P=0##2##4##(2007-8#2)
in group II##8##3##(1991-3#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#2)(2010-1#1)(2013-1#1)
in group III compared to##2##5##(2009-3#1)(2012-2#1)
in group III##6##3##(2006-6#1)(2007-7#2)(2009-3#1)(2012-2#2)
in group L required##2##4##(1996-3#2)
in group L##9##3##(1996-3#9)
in group N##2##3##(2007-8#2)
in group P##4##3##(2007-8#4)
in group S and##3##4##(2007-8#3)
in group S##8##3##(1996-3#4)(2007-8#4)
in group of the patients##4##5##(2008-7#4)
in group with##2##3##(2007-11#2)
in group##121##2##(1990-6#2)(1990-8#1)(1991-3#3)(1992-1#1)(1992-6#2)(1992-9#3)(1993-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-1#1)(1996-3#13)(1996-6#4)(2006-12#1)(2006-6#2)(2007-11#4)(2007-7#4)(2007-8#19)(2007-9#4)(2008-1#10)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-4#3)(2010-7#3)(2010-8#1)(2011-2#7)(2012-2#5)(2013-1#4)(2013-8#1)
in grouping##2##2##(2008-10#1)(2008-7#1)
in groups 1 and 2##2##5##(1992-9#1)(2008-11#1)
in groups 1 and##3##4##(1992-9#1)(2008-11#1)(2008-12#1)
in groups 1##5##3##(1992-9#1)(2008-11#1)(2008-12#2)(2010-4#1)
in groups A and B##2##5##(2007-8#2)
in groups C and E##2##5##(2011-2#2)
in groups of patients##2##4##(1995-2#1)(2007-11#1)
in groups of##8##3##(1993-6#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
in groups with##2##3##(2012-1#2)
in groups##37##2##(1990-11#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-8#4)(2008-10#1)(2008-11#3)(2008-12#2)(2008-6#1)(2008-9#3)(2009-6#1)(2010-4#2)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
in growing number of##2##4##(2007-8#1)(2011-2#1)
in growing patients##3##3##(2007-12#2)(2012-12#1)
in growing pigs given a corn-soybean meal based diet##2##9##(2010-2#2)
in growing pigs##5##3##(2008-9#1)(2010-2#4)
in growing##19##2##(2007-12#3)(2007-8#1)(2008-9#1)(2009-7#1)(2010-2#7)(2011-2#2)(2012-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
in growth and##4##3##(1997-1#1)(1997-2#1)(2012-3#1)(2012-5#1)
in growth cabinets##3##3##(2008-10#2)(2008-11#1)
in growth chambers and##2##4##(2008-10#2)
in growth chambers##8##3##(2008-10#7)(2012-5#1)
in growth hormone##2##3##(1996-11#1)(2008-7#1)
in growth inhibition##2##3##(1993-9#1)(2010-2#1)
in growth of##4##3##(2009-9#1)(2010-8#1)(2011-2#2)
in growth rate and##2##4##(2008-11#1)(2008-8#1)
in growth rate##6##3##(2008-11#2)(2008-12#1)(2008-8#2)(2013-8#1)
in growth rates##4##3##(1994-2#1)(2008-10#1)(2008-8#2)
in growth##65##2##(1991-9#1)(1992-2#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-8#7)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-4#1)(2012-5#2)(2013-1#1)(2013-8#1)
in guanidine solutions##2##3##(1990-5#2)
in guideline implementation##2##3##(1996-12#1)(2008-3#1)
in guideline##4##2##(1996-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
in guidelines for##2##3##(2009-4#1)(2011-3#1)
in guiding the##4##3##(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
in guiding##10##2##(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in guinea pig and pig liver##2##6##(1990-2#2)
in guinea pig##10##3##(1990-2#2)(1991-1#1)(1992-3#1)(1993-5#1)(1994-9#1)(1996-5#2)(2008-1#1)(2008-12#1)
in guinea pigs##8##3##(1990-11#1)(1992-3#2)(1995-12#1)(1997-7#1)(2008-5#1)(2008-9#2)
in guinea##18##2##(1990-11#1)(1990-2#2)(1991-1#1)(1992-3#3)(1993-5#1)(1994-9#1)(1995-12#1)(1996-5#2)(1997-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#2)
in guinea-pig brain##2##3##(2008-2#2)
in guinea-pig oesophageal muscularis mucosae##2##5##(1995-12#2)
in guinea-pig oesophageal##3##3##(1995-12#3)
in guinea-pig ventricular myocytes##2##4##(1994-8#2)
in guinea-pig##17##2##(1990-5#1)(1994-8#3)(1995-12#7)(1997-7#1)(2008-2#4)(2008-9#1)
in guppies (Poecilia reticulata)##2##4##(2008-8#2)
in guppies##4##2##(2008-8#4)
in gustatory##2##2##(1993-12#2)
in gynecologic##4##2##(1992-12#2)(1993-6#1)(1996-3#1)
in gynecological##3##2##(1990-10#1)(2009-3#1)(2012-3#1)
in gynecology]##3##2##(1991-11#1)(2011-1#1)(2012-2#1)
in gyno-carp##2##2##(2008-7#2)
in gynodioecious plants##2##3##(2008-9#2)
in hEp should##2##3##(1993-12#1)(1993-6#1)
in hIAPP##2##2##(1994-8#2)
in habitat quality##3##3##(2008-8#3)
in habitat##5##2##(2008-8#5)
in habitats##2##2##(2007-12#1)(2008-9#1)
in haematological##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
in haematopoietic##3##2##(1990-5#1)(1994-10#1)(2010-8#1)
in haemodialysis patients##2##3##(1991-11#1)(2008-12#1)
in haemoglobin##3##2##(1991-5#1)(1993-2#1)(2007-11#1)
in hair and##4##3##(1995-6#1)(2008-10#3)
in hair dyeing##2##3##(2011-1#2)
in hair##21##2##(1993-6#1)(1993-9#1)(1995-6#1)(2008-10#5)(2008-5#6)(2008-9#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
in hair-care##2##2##(2008-10#2)
in hairless##3##2##(2008-5#1)(2012-2#2)
in hairy roots##2##3##(2008-10#2)
in half of the##3##4##(1994-6#1)(2008-10#1)(2008-5#1)
in half of##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2009-9#1)
in half the##4##3##(1991-5#1)(1996-12#1)(1997-3#1)(2012-2#1)
in half##9##2##(1991-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-2#1)
in hallucinogenic mushrooms##2##3##(2008-10#1)(2011-2#1)
in hallux##2##2##(2010-3#1)(2012-2#1)
in halothane##2##2##(1992-3#1)(1995-3#1)
in hamster##4##2##(1990-6#1)(1995-6#1)(1996-2#2)
in hamsters##4##2##(1992-10#1)(1992-5#2)(2010-10#1)
in hamstring muscle length between##2##5##(2012-2#2)
in hamstring muscle length##3##4##(2012-2#3)
in hand surgery##2##3##(2007-8#2)
in hand##14##2##(1990-8#1)(2006-8#1)(2007-12#3)(2007-8#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
in handedness##2##2##(2008-9#1)(2013-1#1)
in handling##7##2##(1996-12#1)(2008-10#3)(2008-4#2)(2009-12#1)
in hands##2##2##(2007-7#1)(2008-9#1)
in haploid invasive growth##2##4##(2008-11#2)
in haploid##4##2##(1995-6#2)(2008-11#2)
in haploids##2##2##(2008-11#2)
in hard##2##2##(2008-10#1)(2008-2#1)
in hardware##4##2##(1992-1#1)(1997-6#1)(2008-10#1)(2013-1#1)
in harmony##2##2##(1997-6#1)(2008-10#1)
in harvested apple fruit##2##4##(2008-10#2)
in harvested wheat grain##2##4##(2008-10#2)
in harvested##8##2##(1994-5#1)(1996-5#1)(2008-10#6)
in having a##3##3##(2008-11#1)(2011-2#1)(2013-7#1)
in having##9##2##(1991-3#1)(1995-1#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-7#2)
in head and neck cancer##2##5##(1997-7#1)(2008-2#1)
in head and neck reconstruction##2##5##(2007-5#1)(2008-4#1)
in head and neck##12##4##(1990-12#1)(1991-4#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#3)(2008-4#2)(2013-8#1)
in head injury##2##3##(2008-8#1)(2012-2#1)
in head magnetic stimulation##3##4##(2008-7#3)
in head##26##2##(1990-12#1)(1990-6#1)(1991-4#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#3)(2008-4#2)(2008-7#4)(2008-8#1)(2010-5#1)(2010-9#2)(2011-1#1)(2012-2#1)(2013-8#1)
in headache##2##2##(2008-12#1)(2008-9#1)
in healing##2##2##(1993-11#1)(2010-12#1)
in health administration education programs##3##5##(1993-2#1)(1995-12#1)(1996-3#1)
in health administration education##11##4##(1992-2#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#3)(1997-3#2)(2009-8#1)
in health administration programs##5##4##(1993-1#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)
in health administration##34##3##(1991-1#3)(1991-2#2)(1992-2#1)(1993-1#2)(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#4)(1995-12#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#5)(1997-2#1)(1997-3#4)(2009-8#1)
in health among##2##3##(2008-11#1)(2008-7#1)
in health and behavioral sciences##2##5##(2010-7#2)
in health and disease##17##4##(1993-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#3)
in health and health care##2##5##(1990-12#1)(2009-5#1)
in health and health##3##4##(1990-12#1)(2009-5#1)(2011-2#1)
in health and social care##2##5##(2008-11#1)(2008-12#1)
in health and##27##3##(1990-12#1)(1992-5#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#3)
in health behaviors##3##3##(2010-5#2)(2013-1#1)
in health care administration##5##4##(1994-3#1)(1995-1#2)(1996-2#1)(2008-1#1)
in health care and##6##4##(1995-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2013-1#1)
in health care are##2##4##(1992-1#1)(1993-2#1)
in health care as##2##4##(1992-1#1)(1997-3#1)
in health care costs##3##4##(1994-3#1)(1996-2#1)(1997-2#1)
in health care delivery##6##4##(1993-12#1)(1996-12#1)(1997-3#1)(2008-1#1)(2010-12#1)(2010-8#1)
in health care environments##2##4##(1994-2#1)(2008-11#1)
in health care facilities##7##4##(1990-5#1)(1991-12#1)(1992-1#1)(1994-1#1)(1995-1#1)(2007-10#1)(2009-6#1)
in health care has##3##4##(1993-12#1)(1996-2#1)(2008-12#1)
in health care in##3##4##(1992-1#1)(1994-12#1)(1997-8#1)
in health care institutions##6##4##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(2008-7#1)
in health care management##5##4##(1994-12#2)(1994-2#1)(1995-2#1)(2008-1#1)
in health care organizations and##3##5##(1994-3#1)(1995-2#2)
in health care organizations##11##4##(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-3#1)
in health care policy##4##4##(1993-12#2)(1997-2#2)
in health care quality##6##4##(1993-3#4)(1994-3#1)(1995-1#1)
in health care reform##10##4##(1992-2#2)(1994-12#2)(1994-3#1)(1995-12#2)(1996-1#1)(1996-2#1)(2008-8#1)
in health care settings##4##4##(1991-3#1)(1992-3#1)(2007-12#1)(2010-8#1)
in health care system##2##4##(2010-8#1)(2011-2#1)
in health care today##2##4##(1994-1#1)(1994-3#1)
in health care workers##2##4##(2007-7#1)(2009-7#1)
in health care##205##3##(1990-5#1)(1991-12#2)(1991-2#3)(1991-3#5)(1991-9#1)(1992-1#9)(1992-12#1)(1992-2#5)(1992-3#5)(1993-1#2)(1993-12#5)(1993-2#3)(1993-3#6)(1994-1#4)(1994-12#14)(1994-2#10)(1994-3#9)(1995-1#9)(1995-12#7)(1995-2#9)(1995-3#1)(1996-1#4)(1996-12#5)(1996-2#8)(1996-3#6)(1997-1#1)(1997-2#7)(1997-3#4)(1997-5#1)(1997-8#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#7)(2008-10#2)(2008-11#9)(2008-12#5)(2008-7#9)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-8#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
in health care--a##2##3##(1994-3#1)(2008-11#1)
in health care]##3##3##(1993-11#1)(1994-2#1)(1996-6#1)
in health centers of##2##4##(1994-2#1)(1997-3#1)
in health centers##3##3##(1994-2#1)(1997-3#1)(2008-10#1)
in health in##2##3##(2008-1#1)(2013-1#1)
in health information systems##3##4##(1993-12#2)(2012-12#1)
in health insurance##2##3##(1994-12#1)(1995-12#1)
in health maintenance organizations##3##4##(1991-3#1)(1997-2#1)(2011-2#1)
in health maintenance##4##3##(1991-3#1)(1996-3#1)(1997-2#1)(2011-2#1)
in health management education##3##4##(1994-12#1)(1995-12#1)(1996-1#1)
in health outcomes##3##3##(2008-11#1)(2010-4#1)(2012-2#1)
in health planning##2##3##(1990-12#1)(1993-6#1)
in health policy and##2##4##(1994-2#1)(2012-2#1)
in health policy##6##3##(1992-1#1)(1993-2#1)(1994-2#1)(2012-2#3)
in health promotion##7##3##(1991-6#1)(2008-11#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
in health reform##2##3##(1995-1#1)(1996-1#1)
in health research##4##3##(2008-1#1)(2008-8#1)(2009-6#2)
in health sciences libraries##2##4##(1991-12#1)(1996-3#1)
in health sciences##4##3##(1991-12#1)(1996-3#1)(2011-1#1)(2012-3#1)
in health sector##2##3##(1997-1#2)
in health service##3##3##(1996-3#1)(1997-1#1)(2013-1#1)
in health services administration education##2##5##(1993-1#1)(1993-2#1)
in health services administration##5##4##(1993-1#1)(1993-2#1)(1994-1#1)(1996-2#1)(1996-3#1)
in health services management##3##4##(1992-1#3)
in health services##21##3##(1991-2#1)(1992-1#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-1#1)(1995-1#1)(1996-2#1)(1996-3#2)(2007-10#1)(2008-12#2)(2008-7#3)(2013-8#1)
in health status##6##3##(1995-2#1)(2008-7#1)(2009-5#2)(2010-10#1)(2011-1#1)
in health systems##5##3##(1993-1#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
in health##407##2##(1990-12#2)(1990-5#1)(1991-1#3)(1991-12#4)(1991-2#6)(1991-3#6)(1991-6#1)(1991-9#1)(1992-1#13)(1992-12#1)(1992-2#8)(1992-3#7)(1992-5#1)(1993-1#6)(1993-11#1)(1993-12#7)(1993-2#7)(1993-3#6)(1993-6#1)(1993-9#1)(1994-1#6)(1994-12#17)(1994-2#13)(1994-3#10)(1994-6#1)(1995-1#18)(1995-11#1)(1995-12#12)(1995-2#10)(1995-3#1)(1996-1#12)(1996-12#7)(1996-2#13)(1996-3#17)(1996-6#2)(1997-1#4)(1997-2#9)(1997-3#11)(1997-5#1)(1997-8#2)(2007-10#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#9)(2008-10#5)(2008-11#17)(2008-12#12)(2008-4#1)(2008-6#1)(2008-7#22)(2008-8#4)(2009-12#1)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#5)
in health's##2##2##(1991-9#2)
in health-related quality of life##2##5##(1995-2#1)(2009-12#1)
in health-related##3##2##(1995-2#1)(2009-12#1)(2010-11#1)
in healthcare facilities##2##3##(1993-2#1)(1997-2#1)
in healthcare institutions##2##3##(1993-2#1)(2013-8#1)
in healthcare organizations##3##3##(1995-3#1)(2008-12#2)
in healthcare reform##2##3##(1995-1#1)(1996-2#1)
in healthcare security##2##3##(1992-12#1)(1992-2#1)
in healthcare settings##3##3##(1994-3#1)(2008-12#1)(2013-1#1)
in healthcare##52##2##(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-2#3)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#4)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-12#8)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#6)(2013-7#1)(2013-8#3)
in healthy adult##4##3##(1994-12#1)(2011-2#2)(2012-12#1)
in healthy adults##5##3##(2008-5#1)(2011-2#1)(2012-1#1)(2013-8#2)
in healthy and##9##3##(1990-5#1)(1991-12#1)(1993-9#1)(2008-10#2)(2008-5#2)(2010-3#1)(2011-2#1)
in healthy children##4##3##(2010-1#1)(2011-2#2)(2012-12#1)
in healthy condition##2##3##(1994-9#1)(2011-1#1)
in healthy controls##5##3##(1990-3#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
in healthy human volunteers##3##4##(2008-11#1)(2008-5#1)(2011-2#1)
in healthy human##4##3##(1992-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
in healthy humans##2##3##(2010-4#1)(2012-2#1)
in healthy individuals and patients##3##5##(1994-8#1)(2011-2#2)
in healthy individuals##13##3##(1993-8#1)(1994-8#1)(2007-10#1)(2008-12#1)(2008-3#3)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
in healthy male##2##3##(2008-3#1)(2012-2#1)
in healthy medical##2##3##(2008-12#1)(2010-12#1)
in healthy neonates##2##3##(2008-11#2)
in healthy newborns##2##3##(1990-12#1)(2011-1#1)
in healthy people##4##3##(1995-2#1)(1997-6#1)(2011-2#1)(2013-1#1)
in healthy subjects and##4##4##(1996-1#2)(2008-1#1)(2010-12#1)
in healthy subjects##17##3##(1992-3#1)(1996-1#3)(1996-5#1)(1996-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
in healthy volunteers after##2##4##(2008-5#1)(2013-1#1)
in healthy volunteers##11##3##(2006-12#2)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#4)(2013-1#1)
in healthy women##2##3##(1992-9#1)(1993-2#1)
in healthy young##2##3##(2008-3#1)(2012-2#1)
in healthy##133##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-1#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#10)(2013-8#3)
in hearing##4##2##(1995-6#1)(2008-4#1)(2008-9#1)(2013-1#1)
in heart disease##3##3##(2008-10#1)(2009-10#1)(2010-12#1)
in heart failure patients##2##4##(2012-2#2)
in heart failure##9##3##(1991-3#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#3)(2013-8#1)
in heart rate and##2##4##(1993-12#1)(2007-10#1)
in heart rate##11##3##(1990-10#1)(1993-12#1)(1993-2#1)(1995-12#2)(2007-10#2)(2008-3#1)(2012-3#1)(2013-8#2)
in heart surgery]##2##3##(1990-2#1)(1992-3#1)
in heart##42##2##(1990-10#1)(1990-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-12#2)(1995-6#1)(1996-9#1)(1997-8#1)(2007-10#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
in hearts with##4##3##(2010-12#2)(2010-8#2)
in hearts##6##2##(1994-12#1)(1997-6#1)(2010-12#2)(2010-8#2)
in heat production##2##3##(2009-8#2)
in heat shocked##2##3##(1995-12#2)
in heat##12##2##(1990-12#1)(1995-12#2)(1995-5#1)(2008-10#3)(2008-7#1)(2009-8#2)(2011-2#1)(2012-1#1)
in heat-treated##3##2##(2008-1#1)(2008-10#2)
in heated##4##2##(1990-12#1)(2011-2#3)
in heavily##7##2##(1992-2#2)(2007-12#3)(2008-10#2)
in heavy##11##2##(1992-3#1)(1994-3#1)(1995-1#1)(1995-6#1)(2008-10#2)(2008-6#1)(2009-10#1)(2012-3#1)(2013-1#2)
in height and##2##3##(2008-11#1)(2009-12#1)
in height##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-7#1)
in helix##2##2##(1993-11#1)(1995-2#1)
in helping patients##2##3##(2008-7#1)(2010-11#1)
in helping students##2##3##(2008-11#1)(2010-9#1)
in helping the##2##3##(1992-3#1)(2010-11#1)
in helping to##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
in helping##22##2##(1991-1#1)(1992-3#2)(1997-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-7#1)
in hematocrit##4##2##(1994-12#1)(2008-4#1)(2008-9#2)
in hematologic malignancies##2##3##(2008-7#1)(2010-11#1)
in hematologic##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
in hematological malignancies##3##3##(2008-9#1)(2012-12#1)(2013-8#1)
in hematological##4##2##(2008-9#1)(2009-7#1)(2012-12#1)(2013-8#1)
in hematopoietic cells##2##3##(1995-2#2)
in hematopoietic stem##2##3##(1993-8#1)(2011-2#1)
in hematopoietic##8##2##(1993-8#1)(1995-2#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
in heme##2##2##(1993-8#1)(1994-8#1)
in hemerythrin##2##2##(1992-8#2)
in hemiparkinsonian monkeys##2##3##(2008-7#2)
in hemodialysis (HD) patients##3##4##(2007-7#1)(2008-1#1)(2012-12#1)
in hemodialysis (HD)##5##3##(2007-7#2)(2008-1#2)(2012-12#1)
in hemodialysis access management##2##4##(2007-7#2)
in hemodialysis access##3##3##(2007-7#3)
in hemodialysis catheters##2##3##(2010-3#2)
in hemodialysis patients##22##3##(1997-7#1)(2007-10#2)(2007-7#6)(2008-1#7)(2011-1#5)(2011-2#1)
in hemodialysis##44##2##(1997-7#1)(2007-10#2)(2007-7#15)(2007-8#1)(2008-1#10)(2008-10#5)(2009-5#1)(2010-3#2)(2011-1#5)(2011-2#1)(2012-12#1)
in hemodynamically##2##2##(2008-12#1)(2011-2#1)
in hemodynamics##2##2##(2008-3#1)(2009-1#1)
in hemoglobin levels##3##3##(2008-7#3)
in hemoglobin##13##2##(1990-8#1)(1992-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#5)(2012-12#1)
in hemorrhagic##2##2##(1996-6#1)(2009-12#1)
in hemostasis##2##2##(1995-2#1)(2007-10#1)
in heparin##5##2##(1990-9#1)(1992-5#1)(1995-2#1)(2008-1#1)(2008-10#1)
in hepatic cell##2##3##(1994-11#1)(2008-10#1)
in hepatic cells##2##3##(1993-6#1)(2011-1#1)
in hepatic gluconeogenesis##3##3##(1994-8#1)(1995-6#1)(1996-2#1)
in hepatic metabolism##2##3##(2008-3#2)
in hepatic stellate cells (HSCs)##2##5##(2006-10#1)(2009-7#1)
in hepatic tissue##2##3##(1994-6#2)
in hepatic##34##2##(1990-11#1)(1991-5#2)(1992-10#1)(1992-6#1)(1993-6#1)(1994-11#2)(1994-6#2)(1994-8#3)(1995-6#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-3#4)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
in hepatitis B virus##2##4##(1995-2#1)(1996-8#1)
in hepatitis B##4##3##(1995-2#1)(1996-3#1)(1996-8#1)(2011-2#1)
in hepatitis C##4##3##(2006-10#1)(2008-11#1)(2013-8#2)
in hepatitis##9##2##(1995-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#2)
in hepatocarcinogenesis##3##2##(1990-5#2)(2011-2#1)
in hepatocellular carcinoma (HCC)##3##4##(1991-11#1)(2008-8#1)(2013-8#1)
in hepatocellular carcinoma##8##3##(1990-8#1)(1991-11#2)(1996-8#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
in hepatocellular##9##2##(1990-8#1)(1991-11#2)(1996-8#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
in hepatocyte##4##2##(1993-3#1)(1995-11#1)(2008-7#1)(2012-12#1)
in hepatocytes and##2##3##(1990-3#1)(1994-8#1)
in hepatocytes by##2##3##(1993-3#1)(1995-8#1)
in hepatocytes of young##2##4##(1994-6#2)
in hepatocytes of##4##3##(1994-6#2)(2008-9#2)
in hepatocytes##33##2##(1990-12#3)(1990-3#1)(1990-5#2)(1991-2#1)(1992-5#3)(1993-11#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-6#2)(1994-8#2)(1995-8#3)(1997-4#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
in hepatology##2##2##(2006-10#1)(2010-6#1)
in hepatoma##2##2##(2008-4#1)(2012-12#1)
in hepatoma-derived cells##2##3##(1991-12#1)(2010-12#1)
in hepatopancreatobilliary##2##2##(2011-2#2)
in her early##2##3##(1992-4#1)(2012-12#1)
in her flat##2##3##(1995-3#2)
in her pregnancy##2##3##(2008-11#1)(2013-1#1)
in her right eye##3##4##(2011-1#2)(2013-7#1)
in her right##10##3##(2006-10#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-7#1)
in her##36##2##(1991-6#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-3#2)(1997-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#1)
in herbal##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
in herbicide##2##2##(2008-10#1)(2008-11#1)
in herd##2##2##(1992-5#1)(2011-2#1)
in herds with a##2##4##(1996-8#2)
in herds##3##2##(1996-8#2)(2011-1#1)
in hereditary##4##2##(1994-6#1)(2009-10#1)(2009-4#1)(2012-3#1)
in hermaphroditic##3##2##(2008-9#2)(2010-5#1)
in hernia##2##2##(1996-9#1)(2011-2#1)
in heroin##2##2##(1991-12#1)(2012-2#1)
in heterochromatic regions##3##3##(2009-10#3)
in heterochromatin##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
in heterogeneous catalysis##2##3##(2010-12#2)
in heterogeneous landscapes##3##3##(2008-8#2)(2008-9#1)
in heterogeneous systems##3##3##(2008-10#1)(2008-5#2)
in heterogeneous##13##2##(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#2)
in heterogenous##3##2##(2008-7#2)(2008-9#1)
in heterologous##5##2##(1991-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
in heterozygous##2##2##(1996-5#1)(2008-4#1)
in hexagonal##2##2##(1990-2#1)(2008-2#1)
in hexane##5##2##(2008-10#2)(2008-7#1)(2013-8#2)
in hibernation##2##2##(2008-8#2)
in high affinity##3##3##(1990-12#2)(1991-8#1)
in high and moderate##2##4##(1995-12#2)
in high and##4##3##(1993-12#1)(1993-8#1)(1995-12#2)
in high cell density##3##4##(2008-11#2)(2008-7#1)
in high concentrations in the##2##5##(2008-7#1)(2009-9#1)
in high concentrations in##3##4##(2008-10#1)(2008-7#1)(2009-9#1)
in high concentrations##7##3##(1991-12#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-9#1)
in high density##6##3##(2008-11#2)(2010-5#1)(2011-2#2)(2013-8#1)
in high dose##2##3##(1995-11#1)(2008-8#1)
in high doses##2##3##(2007-7#1)(2012-12#1)
in high glucose##2##3##(1992-8#1)(2012-4#1)
in high grade##2##3##(2008-6#2)
in high humidity##2##3##(2008-10#2)
in high levels of##2##4##(2008-10#2)
in high morbidity and##2##4##(2007-12#1)(2010-12#1)
in high performance##3##3##(2008-10#2)(2011-2#1)
in high purity grade##2##4##(2008-10#2)
in high purity##8##3##(2008-10#8)
in high quantities##3##3##(1995-12#1)(2008-10#2)
in high rates of##2##4##(2011-2#1)(2012-3#1)
in high resolution##2##3##(1995-8#1)(2010-8#1)
in high risk patients##3##4##(2007-8#2)(2008-7#1)
in high risk##11##3##(1993-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
in high saline##3##3##(2008-10#3)
in high soil##2##3##(2008-10#2)
in high throughput##4##3##(2008-10#1)(2009-4#1)(2009-7#1)(2012-3#1)
in high yield from##2##4##(1995-11#1)(1995-3#1)
in high yield##8##3##(1992-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-4#1)(2008-6#1)(2010-2#1)(2012-3#1)
in high yields##6##3##(1996-5#1)(2007-11#1)(2008-4#3)(2009-12#1)
in high##143##2##(1990-12#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-8#1)(1994-12#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#35)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#3)
in high-density lipoprotein (HDL)##2##4##(1993-6#1)(2010-4#1)
in high-density lipoprotein##3##3##(1993-6#1)(2010-4#1)(2011-1#1)
in high-density##6##2##(1993-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)
in high-dimensional##2##2##(2008-11#1)(2009-9#1)
in high-frequency##2##2##(2008-3#1)(2008-9#1)
in high-performance liquid chromatography (HPLC)##3##5##(2008-10#3)
in high-performance liquid chromatography##7##4##(1990-8#1)(1996-5#1)(2008-10#5)
in high-performance liquid##8##3##(1990-8#2)(1996-5#1)(2008-10#5)
in high-performance##12##2##(1990-8#3)(1996-5#1)(2008-10#5)(2008-3#2)(2013-8#1)
in high-power##2##2##(2007-12#1)(2008-3#1)
in high-precision##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
in high-pressure##5##2##(2008-2#5)
in high-purity##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
in high-quality##2##2##(2008-8#1)(2010-8#1)
in high-resolution##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
in high-risk patients##8##3##(1992-8#1)(1994-8#1)(2007-8#2)(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
in high-risk##25##2##(1992-6#1)(1992-8#1)(1994-3#1)(1994-8#1)(2007-5#1)(2007-8#4)(2008-10#1)(2009-12#1)(2009-5#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#5)
in high-speed##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2011-2#1)
in high-spired##2##2##(2008-9#2)
in high-temperature##4##2##(1992-8#1)(2008-2#2)(2011-2#1)
in high-volume##2##2##(2007-12#1)(2011-2#1)
in higher animals##2##3##(1991-12#1)(2012-2#1)
in higher concentrations##3##3##(1990-5#1)(1997-4#1)(2008-10#1)
in higher doses##2##3##(2008-12#1)(2010-7#1)
in higher education##8##3##(1995-3#1)(1996-12#2)(2008-11#2)(2008-12#2)(2010-2#1)
in higher eukaryotes##4##3##(1992-6#1)(1994-12#1)(2009-2#1)(2011-2#1)
in higher plants##7##3##(1991-5#1)(1995-2#2)(2008-7#1)(2008-9#1)(2009-8#2)
in higher rates of##2##4##(2008-10#1)(2012-2#1)
in higher##66##2##(1990-5#2)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#2)(2009-8#3)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#7)
in higher-plant cells##2##3##(2008-11#2)
in highest##2##2##(2008-11#1)(2013-1#1)
in highly acidic##2##3##(2008-10#1)(2010-11#1)
in highly concentrated##4##3##(2007-12#1)(2008-10#3)
in highly purified##2##3##(1994-6#1)(1995-12#1)
in highly rural##2##3##(2012-1#2)
in highly saline##2##3##(2008-10#2)
in highly scattering media is##2##5##(2008-2#1)(2008-3#1)
in highly scattering media##8##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
in highly susceptible##2##3##(2008-10#2)
in highly##45##2##(1992-3#1)(1994-12#1)(1994-6#2)(1995-12#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#7)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)
in hip and##2##3##(2008-11#1)(2009-3#1)
in hip arthroplasty##2##3##(2011-2#2)
in hip##11##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#3)(2013-1#1)
in hippocampal dentate gyrus##2##4##(1991-2#1)(2011-2#1)
in hippocampal neurons##2##3##(2012-2#1)(2012-3#1)
in hippocampal slices##6##3##(1990-7#1)(1995-12#2)(1996-5#2)(2008-2#1)
in hippocampal##24##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-5#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
in hippocampus and neocortex##2##4##(1995-2#1)(2007-8#1)
in hippocampus and##6##3##(1995-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-8#1)(2013-1#1)
in hippocampus##14##2##(1991-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#2)(1997-2#2)(1997-6#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-1#1)
in hips##2##2##(2007-8#2)
in his activities##2##3##(2009-10#1)(2011-2#1)
in his book##2##3##(1992-12#1)(2013-1#1)
in his clinical##2##3##(2011-2#1)(2013-1#1)
in his left##2##3##(2010-5#1)(2010-9#1)
in his or her##2##4##(2009-10#1)(2010-5#1)
in his right eye##2##4##(2010-10#1)(2013-8#1)
in his right##4##3##(2007-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
in his##49##2##(1990-5#2)(1991-3#1)(1991-8#1)(1992-12#1)(1993-3#2)(1997-3#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#7)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-7#1)(2010-10#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#4)(2013-8#1)
in histological and##2##3##(1995-2#1)(2013-8#1)
in histological sections of##2##4##(1992-9#1)(1994-11#1)
in histological sections##8##3##(1991-6#1)(1992-9#1)(1994-11#1)(1996-12#5)
in histological##12##2##(1991-6#1)(1992-9#1)(1994-11#1)(1995-2#1)(1996-12#5)(2008-12#1)(2013-8#2)
in histopathological sections##2##3##(2007-7#2)
in histopathological##3##2##(2007-7#2)(2010-12#1)
in historical##3##2##(2007-8#1)(2008-9#1)(2012-2#1)
in history##3##2##(1997-8#1)(2007-8#1)(2008-2#1)
in holding##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
in hollow waveguides##3##3##(2007-11#2)(2007-12#1)
in hollow##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2008-6#1)
in holographic particle image velocimetry##2##5##(2008-3#2)
in holographic##8##2##(2008-2#1)(2008-3#7)
in home care##8##3##(1992-1#1)(1993-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2006-5#2)(2009-3#1)
in home health care##2##4##(1995-3#2)
in home range##2##3##(2010-4#2)
in home##15##2##(1992-1#1)(1993-1#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-5#2)(2008-10#1)(2009-3#1)(2010-4#2)
in homes and##3##3##(1991-3#1)(2008-11#1)(2012-2#1)
in homes##5##2##(1991-3#1)(2008-11#1)(2011-2#2)(2012-2#1)
in homicide##3##2##(2008-12#2)(2012-2#1)
in homocysteine##3##2##(1992-9#1)(2008-3#1)(2010-5#1)
in homogenates of##2##3##(2007-12#1)(2008-10#1)
in homogenates##4##2##(1990-11#1)(1995-12#1)(2007-12#1)(2008-10#1)
in homogeneous solution##4##3##(1995-2#1)(2008-10#1)(2008-5#2)
in homogeneous##12##2##(1991-12#1)(1995-2#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-8#1)
in homogenized##2##2##(1991-5#1)(1994-8#1)
in homogenous##2##2##(2008-10#1)(2013-1#1)
in homologous##5##2##(1993-12#1)(1995-8#1)(1997-7#1)(2011-1#1)(2012-2#1)
in homosexual##2##2##(1992-2#2)
in homozygous##5##2##(1990-8#1)(1996-5#1)(2008-12#1)(2008-7#1)(2009-4#1)
in honey bee##2##3##(2008-10#1)(2011-2#1)
in honey by##2##3##(2008-10#2)
in honey samples##2##3##(2008-10#2)
in honey using##2##3##(2008-10#2)
in honey with##2##3##(2008-10#1)(2013-1#1)
in honey##14##2##(2008-10#11)(2008-9#1)(2011-2#1)(2013-1#1)
in honeybee##3##2##(2008-10#1)(2008-8#2)
in honeybees##7##2##(1992-3#2)(2008-10#4)(2008-8#1)
in honeydew##2##2##(2008-10#2)
in honor of##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
in horizontal##2##2##(2008-3#1)(2010-8#1)
in hormonal regulation##2##3##(2008-7#1)(2008-8#1)
in hormonal##4##2##(1994-9#1)(2008-7#1)(2008-8#1)(2010-7#1)
in hormone##6##2##(1990-5#1)(1991-12#1)(1996-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
in horses in##2##3##(1992-5#1)(2011-2#1)
in horses##10##2##(1990-11#1)(1992-5#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#2)
in hospice##4##2##(1993-12#1)(2010-2#2)(2013-8#1)
in hospital and##6##3##(1990-6#1)(1992-2#1)(1994-8#1)(1996-1#1)(1997-2#1)(2012-2#1)
in hospital choice##3##3##(1995-12#1)(2008-12#2)
in hospital costs##3##3##(1992-2#1)(1996-12#1)(2007-9#1)
in hospital discharges and##2##4##(2013-1#1)(2013-8#1)
in hospital for##2##3##(2008-7#1)(2008-9#1)
in hospital is##3##3##(1991-11#1)(1993-6#1)(2008-8#1)
in hospital mortality##2##3##(2008-8#1)(2011-2#1)
in hospital on the day of surgery##2##7##(2008-8#2)
in hospital or##2##3##(1995-2#1)(2011-2#1)
in hospital patients##2##3##(2008-6#1)(2008-7#1)
in hospital personnel]##2##3##(1993-6#1)(1996-3#1)
in hospital pharmacy##2##3##(2010-8#1)(2013-1#1)
in hospital quality assurance##2##4##(1994-2#1)(2010-12#1)
in hospital settings##2##3##(1992-1#1)(1996-1#1)
in hospital strategic decision-making##2##4##(1996-12#2)
in hospital was##2##3##(1997-8#1)(2007-12#1)
in hospital##95##2##(1990-3#1)(1990-4#1)(1990-6#3)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-3#2)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-5#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#2)(1994-2#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#4)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2007-1#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-2#5)(2012-2#2)(2013-1#8)(2013-8#1)
in hospitalised##2##2##(1991-8#1)(2007-2#1)
in hospitalizations for CHF##2##4##(1995-12#2)
in hospitalizations for##3##3##(1991-12#1)(1995-12#2)
in hospitalized patients##8##3##(1992-1#1)(1997-3#1)(2007-12#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#2)
in hospitalized##11##2##(1992-1#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#3)
in hospitals and nonhospitals##2##4##(1995-3#2)
in hospitals and##7##3##(1990-9#1)(1995-3#4)(1996-1#1)(2011-2#1)
in hospitals are##3##3##(1996-11#1)(1997-4#1)(2013-8#1)
in hospitals for##3##3##(1992-2#1)(1994-2#1)(1995-2#1)
in hospitals today##2##3##(1991-12#1)(2008-1#1)
in hospitals##62##2##(1990-9#1)(1991-1#1)(1991-12#5)(1991-3#1)(1992-12#1)(1992-2#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
in hospitals'##3##2##(1992-2#1)(1994-12#1)(1996-12#1)
in hospitals]##7##2##(1991-11#1)(1993-11#2)(1995-5#1)(2008-9#1)(2012-3#2)
in host and##3##3##(1995-5#1)(2008-8#1)(2013-8#1)
in host density##3##3##(2008-9#3)
in host fitness##2##3##(2008-9#2)
in host mixtures##3##3##(2008-10#3)
in host plant resistance##2##4##(2008-10#1)(2011-2#1)
in host plant##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
in host plants##3##3##(2008-10#3)
in host range##3##3##(1997-4#1)(2008-10#2)
in host resistance##3##3##(1996-12#2)(2008-10#1)
in host tissue##2##3##(2008-10#2)
in host tissues##2##3##(2008-9#1)(2011-2#1)
in host##43##2##(1992-12#1)(1993-5#1)(1995-5#1)(1996-12#2)(1997-4#1)(2008-10#19)(2008-4#1)(2008-8#1)(2008-9#8)(2009-10#1)(2010-2#2)(2011-2#4)(2013-8#1)
in host-parasitoid coevolution##2##3##(2008-8#2)
in host-pathogen##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
in hosts##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
in hot pepper##2##3##(2008-10#1)(2008-12#1)
in hot spring water##2##4##(2008-10#2)
in hot spring waters##2##4##(2008-10#2)
in hot spring##4##3##(2008-10#4)
in hot##13##2##(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
in hours of##2##3##(1993-12#1)(1993-2#1)
in hours##6##2##(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(2006-4#1)(2009-12#1)
in house##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
in how the##2##3##(1997-2#1)(2008-7#1)
in how##23##2##(1992-1#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
in human MCF-7##2##3##(1992-12#1)(2012-2#1)
in human acute##4##3##(1991-9#1)(1995-11#1)(1997-7#1)(2011-2#1)
in human adult##3##3##(1991-11#1)(1994-11#2)
in human and animal##3##4##(2010-5#1)(2010-7#1)(2012-12#1)
in human and rat liver##2##5##(1994-8#2)
in human and rat##3##4##(1994-3#1)(1994-8#2)
in human and rodent cell##2##5##(1993-12#1)(2008-7#1)
in human and rodent##3##4##(1993-12#1)(2008-7#2)
in human and##13##3##(1991-12#1)(1993-12#1)(1994-3#1)(1994-8#2)(2008-7#2)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)
in human beings##3##3##(1992-9#1)(1997-5#1)(2008-10#1)
in human bladder##2##3##(1994-2#1)(2008-10#1)
in human blood plasma samples##2##5##(2008-10#2)
in human blood plasma##5##4##(2008-10#5)
in human blood serum##5##4##(2008-10#5)
in human blood##18##3##(1993-3#1)(1994-6#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-10#11)(2008-9#1)(2010-5#1)
in human body##4##3##(2008-1#1)(2008-10#2)(2013-8#1)
in human bone##2##3##(1995-6#1)(2009-12#1)
in human bones of##2##4##(2008-10#2)
in human brain and##2##4##(1993-3#1)(1997-7#1)
in human brain tissue##2##4##(1993-9#1)(1997-2#1)
in human brain##12##3##(1990-6#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-9#1)
in human breast cancer MCF-7 cells##2##6##(1993-9#1)(2008-11#1)
in human breast cancer cells##7##5##(1992-4#1)(1992-9#1)(1995-10#1)(2008-11#3)(2013-1#1)
in human breast cancer##17##4##(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-9#1)(2008-11#4)(2008-4#1)(2013-1#1)
in human breast##24##3##(1992-10#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-4#1)(2013-1#1)
in human breath##3##3##(2008-10#2)(2008-3#1)
in human cancer cells##3##4##(1994-11#1)(2008-11#1)(2008-9#1)
in human cancer##9##3##(1993-9#1)(1994-11#1)(1994-9#1)(1995-12#2)(2008-11#2)(2008-9#1)(2013-1#1)
in human cancers##11##3##(1997-7#1)(2008-11#1)(2009-5#2)(2009-9#2)(2011-1#1)(2011-2#3)(2012-12#1)
in human cell##2##3##(2008-9#2)
in human cells in response to cold stress##2##8##(1997-7#2)
in human cells in##3##4##(1997-4#1)(1997-7#2)
in human cells##14##3##(1991-5#1)(1994-12#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-2#2)
in human cerebrospinal fluid (CSF)##2##5##(1991-2#1)(1993-8#1)
in human cerebrospinal fluid##3##4##(1991-2#2)(1993-8#1)
in human chronic myeloid leukemia##3##5##(1991-4#1)(2011-2#2)
in human colon carcinoma cells##2##5##(1994-8#1)(1995-5#1)
in human colon cells##4##4##(1997-4#4)
in human colon##10##3##(1990-12#1)(1992-2#1)(1994-8#1)(1995-5#1)(1997-4#5)(2012-3#1)
in human colonic##2##3##(1993-9#1)(1994-3#1)
in human colorectal##2##3##(1992-9#2)
in human cord blood##2##4##(2008-10#2)
in human cutaneous##2##3##(2008-5#1)(2012-2#1)
in human disease##9##3##(1991-9#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
in human diseases##5##3##(1994-11#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
in human embryonic kidney (HEK) 293 cells##2##7##(2013-1#2)
in human embryonic##4##3##(1992-3#1)(2008-11#1)(2013-1#2)
in human endometrium##3##3##(1994-9#3)
in human endothelial cells##5##4##(1993-12#1)(1993-6#1)(1994-6#1)(1997-7#1)(2010-1#1)
in human endothelial##6##3##(1993-12#1)(1993-6#1)(1994-6#1)(1997-7#1)(2010-1#1)(2013-1#1)
in human erythrocytes##7##3##(1990-11#1)(1990-12#3)(1992-6#1)(1992-8#1)(1993-8#1)
in human fetal##3##3##(1994-11#1)(2008-8#1)(2010-11#1)
in human fibroblasts by##2##4##(2008-12#1)(2010-8#1)
in human fibroblasts##4##3##(1990-5#1)(1995-6#1)(2008-12#1)(2010-8#1)
in human gastric cancer cell##2##5##(1992-8#1)(2008-9#1)
in human gastric juice##2##4##(2008-10#2)
in human gastric##6##3##(1991-6#2)(1992-8#1)(2008-10#2)(2008-9#1)
in human genetics##2##3##(2008-7#1)(2009-6#1)
in human genome##2##3##(2008-7#2)
in human glioblastoma##3##3##(1990-6#1)(2013-1#2)
in human glioma##3##3##(1993-3#1)(1994-11#1)(2013-1#1)
in human granulosa and cumulus cells##2##6##(1992-9#2)
in human hair and animal fur##2##6##(2008-10#2)
in human hair and##3##4##(2008-10#3)
in human hair by##2##4##(2008-10#2)
in human hair follicle##2##4##(1990-3#2)
in human hair##10##3##(1990-3#2)(2008-10#6)(2008-5#2)
in human health##5##3##(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
in human heart##2##3##(2010-12#2)
in human hemoglobin##3##3##(1990-8#1)(1992-3#1)(1997-2#1)
in human hepatoma cell lines##2##5##(1990-8#2)
in human hepatoma-derived##2##3##(2010-12#2)
in human hippocampus and cerebellum##2##5##(1993-9#2)
in human immunodeficiency virus (HIV)##3##5##(2009-11#1)(2012-3#1)(2013-8#1)
in human immunodeficiency virus infection]##2##5##(1992-2#1)(1993-2#1)
in human immunodeficiency virus##11##4##(1992-2#1)(1993-2#1)(1994-9#1)(1995-2#1)(2007-7#1)(2009-11#2)(2012-2#1)(2012-3#2)(2013-8#1)
in human immunodeficiency##12##3##(1992-2#1)(1993-2#1)(1994-9#1)(1995-2#2)(2007-7#1)(2009-11#2)(2012-2#1)(2012-3#2)(2013-8#1)
in human keratinocytes##2##3##(2008-5#2)
in human kidney##2##3##(1990-2#1)(2008-7#1)
in human leukemia HL-60 cells##2##5##(1992-11#1)(2008-11#1)
in human leukemia##3##3##(1992-11#1)(2008-11#1)(2010-6#1)
in human liver and##2##4##(1993-11#1)(1994-2#1)
in human liver microsomes##4##4##(1991-5#1)(1993-6#3)
in human liver##23##3##(1991-5#3)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-9#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-6#1)(1997-1#1)(2008-8#1)
in human lung cancer##3##4##(2008-4#1)(2010-8#1)(2013-1#1)
in human lung carcinoma##2##4##(2008-8#2)
in human lung##6##3##(2008-12#1)(2008-4#1)(2008-8#2)(2010-8#1)(2013-1#1)
in human lymphoblastoid##2##3##(1994-3#1)(1996-12#1)
in human lymphocyte cultures##3##4##(1996-2#2)(2008-11#1)
in human lymphocytes##17##3##(1990-8#1)(1992-11#3)(1992-12#1)(1992-6#1)(1993-8#2)(1996-2#2)(1997-4#4)(2008-11#2)(2011-2#1)
in human lymphoid##2##3##(1991-6#1)(1994-2#1)
in human melanocytes##3##3##(1993-5#1)(2008-5#2)
in human melanoma cells##3##4##(1996-9#1)(2008-8#2)
in human melanoma##5##3##(1992-2#1)(1996-9#1)(2008-7#1)(2008-8#2)
in human milk##8##3##(2008-10#2)(2008-11#1)(2008-8#3)(2012-2#2)
in human monocytes##5##3##(1991-2#1)(1991-8#1)(1992-12#1)(1994-11#1)(1995-8#1)
in human myometrial##2##3##(1992-6#1)(1994-3#1)
in human myometrium##2##3##(1994-3#1)(1994-8#1)
in human neuroblastoma cells##2##4##(1992-5#1)(1994-10#1)
in human neuroblastoma##4##3##(1992-5#1)(1994-10#2)(2013-1#1)
in human neutrophils and##2##4##(1992-12#1)(1994-8#1)
in human neutrophils##12##3##(1990-2#1)(1991-8#1)(1992-12#2)(1992-8#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(2008-4#3)
in human normal##3##3##(1990-8#1)(2008-9#2)
in human oral cancer##2##4##(2013-1#2)
in human oral##4##3##(1992-11#1)(2010-12#1)(2013-1#2)
in human osteoblast-like cells##2##4##(1994-6#1)(2008-11#1)
in human osteosarcoma##2##3##(1995-8#1)(2008-6#1)
in human ovarian cancer cells##2##5##(1990-2#1)(1994-2#1)
in human ovarian cancer##3##4##(1990-2#1)(1993-9#1)(1994-2#1)
in human ovarian carcinoma cells##2##5##(1993-8#1)(2008-4#1)
in human ovarian##6##3##(1990-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(2008-4#2)
in human pathology##2##3##(2008-10#1)(2008-5#1)
in human patients##4##3##(1994-3#1)(2007-4#1)(2010-7#1)(2011-9#1)
in human periodontal ligament##2##4##(2013-1#1)(2013-8#1)
in human periodontal##3##3##(2012-3#1)(2013-1#1)(2013-8#1)
in human peripheral blood lymphocytes##5##5##(1991-4#1)(1993-8#2)(1997-4#1)(2008-11#1)
in human pineal gland##2##4##(2012-1#2)
in human placenta##2##3##(1990-11#1)(1990-2#1)
in human placental##2##3##(1990-2#1)(1994-6#1)
in human plasma and##6##4##(1990-8#1)(2008-10#4)(2011-2#1)
in human plasma by high-performance liquid chromatography##3##7##(2008-10#3)
in human plasma by##8##4##(1990-8#2)(2008-10#4)(2011-2#1)(2012-1#1)
in human plasma or##2##4##(2008-4#1)(2010-11#1)
in human plasma samples##3##4##(1996-5#1)(2008-10#2)
in human plasma using##3##4##(2008-10#3)
in human plasma were##3##4##(2008-10#3)
in human plasma with##3##4##(2008-10#3)
in human plasma##45##3##(1990-12#2)(1990-8#4)(1992-3#1)(1992-6#1)(1993-9#1)(1996-5#2)(1997-2#1)(2008-10#26)(2008-4#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-1#1)
in human platelets##14##3##(1990-8#1)(1991-9#1)(1992-12#5)(1992-9#1)(1994-6#2)(2006-6#4)
in human populations##10##3##(1992-11#1)(1993-11#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-10#1)(2011-1#1)
in human primary cutaneous melanomas##2##5##(2009-4#2)
in human primary fibroblasts##2##4##(2013-8#2)
in human primary visual cortex##2##5##(1995-12#2)
in human primary##7##3##(1995-12#2)(1997-2#1)(2009-4#2)(2013-8#2)
in human prostate cancer##3##4##(2011-2#1)(2012-3#2)
in human red blood cells##3##5##(1991-8#1)(1993-8#1)(1994-2#1)
in human renal cell carcinoma##2##5##(1992-3#2)
in human renal##4##3##(1992-3#2)(1992-8#1)(1993-8#1)
in human saliva##4##3##(2008-10#3)(2010-12#1)
in human scalp##3##3##(2008-10#2)(2008-5#1)
in human sera##7##3##(1990-12#1)(1993-3#1)(2008-10#3)(2008-3#2)
in human serum and##4##4##(2008-10#3)(2011-2#1)
in human serum at 37 degrees C##2##7##(1990-2#2)
in human serum at##3##4##(1990-2#2)(2008-10#1)
in human serum by##5##4##(2008-10#5)
in human serum could be##2##5##(1990-8#1)(1994-8#1)
in human serum is##4##4##(1990-8#2)(2008-10#1)(2008-4#1)
in human serum samples##5##4##(2008-10#5)
in human serum using##5##4##(1991-5#1)(1993-12#1)(2008-10#3)
in human serum was##3##4##(2008-10#3)
in human serum with##3##4##(2008-10#3)
in human serum##60##3##(1990-2#2)(1990-8#4)(1991-5#2)(1993-12#1)(1993-6#1)(1994-8#1)(1995-8#1)(2008-10#42)(2008-3#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-12#1)
in human skin fibroblasts##2##4##(1993-12#1)(1994-6#1)
in human skin##15##3##(1993-12#1)(1994-6#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#4)(2010-11#1)(2011-2#1)
in human soleus##2##3##(1993-12#1)(1993-9#1)
in human sperm##2##3##(2008-4#2)
in human subjects##10##3##(1992-3#1)(1997-1#2)(1997-7#1)(2008-11#5)(2009-7#1)
in human testis##2##3##(1990-2#1)(2008-8#1)
in human thyroid##6##3##(1990-2#1)(1994-11#3)(1994-6#2)
in human tissue##5##3##(1991-11#2)(1992-3#2)(1994-6#1)
in human tissues and##2##4##(2008-9#1)(2009-5#1)
in human tissues##9##3##(1991-11#1)(1991-5#2)(1994-11#1)(1995-12#1)(2008-12#1)(2008-9#1)(2009-5#1)(2012-12#1)
in human tumor cell lines##2##5##(2008-9#2)
in human tumor cell##3##4##(1995-3#1)(2008-9#2)
in human tumor cells##2##4##(1994-8#1)(2009-4#1)
in human tumor##7##3##(1994-8#1)(1995-3#1)(2008-9#2)(2009-4#1)(2011-1#1)(2012-12#1)
in human tumors and##2##4##(1992-8#1)(2008-11#1)
in human tumors##6##3##(1992-8#1)(2008-11#2)(2008-4#1)(2009-9#1)(2011-2#1)
in human umbilical vein endothelial cells##7##6##(1993-12#1)(1993-3#1)(1997-1#1)(2008-10#2)(2008-8#1)(2012-2#1)
in human umbilical vein endothelial##8##5##(1993-12#1)(1993-3#1)(1997-1#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-8#1)
in human urine and serum samples##3##6##(2008-10#3)
in human urine and serum##8##5##(1990-8#2)(2008-10#6)
in human urine and##13##4##(1990-8#2)(2008-10#11)
in human urine as##2##4##(1992-3#1)(2008-10#1)
in human urine by high performance liquid##2##7##(2008-10#2)
in human urine by high-performance liquid chromatography##2##7##(1990-8#2)
in human urine by##11##4##(1990-8#3)(1995-12#1)(2008-10#6)(2008-11#1)
in human urine samples by##2##5##(2008-10#1)(2010-11#1)
in human urine samples##7##4##(2008-10#6)(2010-11#1)
in human urine was##3##4##(1992-3#1)(1995-2#1)(2008-10#1)
in human urine with##3##4##(2008-10#3)
in human urine without any##2##5##(2008-10#2)
in human urine##69##3##(1990-8#8)(1992-3#3)(1993-12#1)(1995-12#1)(1995-2#1)(1996-5#2)(1997-2#1)(2008-10#48)(2008-11#2)(2009-9#1)(2010-11#1)
in human uterine LMS##2##4##(2012-2#2)
in human uterine##4##3##(1993-12#1)(2012-2#2)(2013-1#1)
in human vascular endothelial cells##4##5##(1993-11#1)(1993-6#1)(1994-11#1)(2010-1#1)
in human vascular##5##3##(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(2010-1#1)
in human volunteers##5##3##(1992-6#1)(2008-10#2)(2008-5#2)
in human##925##2##(1990-11#2)(1990-12#8)(1990-2#10)(1990-3#2)(1990-5#6)(1990-6#2)(1990-8#23)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#5)(1991-4#2)(1991-5#10)(1991-6#4)(1991-8#4)(1991-9#4)(1992-10#1)(1992-11#9)(1992-12#15)(1992-2#4)(1992-3#17)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#9)(1992-9#9)(1993-1#3)(1993-11#6)(1993-12#10)(1993-2#2)(1993-3#12)(1993-5#2)(1993-6#12)(1993-8#13)(1993-9#13)(1994-10#2)(1994-11#13)(1994-12#6)(1994-2#5)(1994-3#12)(1994-5#1)(1994-6#14)(1994-7#1)(1994-8#9)(1994-9#9)(1995-10#1)(1995-11#1)(1995-12#10)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#5)(1995-9#3)(1996-12#4)(1996-2#7)(1996-5#6)(1996-9#1)(1997-1#8)(1997-2#8)(1997-4#14)(1997-5#1)(1997-6#1)(1997-7#11)(1997-8#1)(2006-6#6)(2007-11#4)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#180)(2008-11#32)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#20)(2008-5#20)(2008-6#3)(2008-7#20)(2008-8#15)(2008-9#14)(2009-11#2)(2009-12#3)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#8)(2010-3#1)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#8)(2011-2#25)(2011-3#4)(2011-9#1)(2012-1#5)(2012-12#8)(2012-2#19)(2012-3#12)(2012-9#1)(2013-1#26)(2013-8#10)
in humanitarian##2##2##(2009-6#2)
in humans and animal models##4##5##(1996-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
in humans and animals##5##4##(1996-5#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
in humans and in animal models##2##6##(2008-10#2)
in humans and in##3##4##(1991-12#1)(2008-10#2)
in humans and mice##2##4##(2008-10#2)
in humans and other animals##2##5##(1993-3#1)(2008-10#1)
in humans and other##3##4##(1993-3#1)(1994-8#1)(2008-10#1)
in humans and rats##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
in humans and##36##3##(1991-12#2)(1991-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in humans as well as in##2##6##(1995-5#1)(1996-7#1)
in humans as well as##4##5##(1995-5#1)(1996-7#1)(2012-1#1)(2012-2#1)
in humans as well##5##4##(1995-5#1)(1996-7#1)(2008-10#1)(2012-1#1)(2012-2#1)
in humans as##6##3##(1994-9#1)(1995-5#1)(1996-7#1)(2008-10#1)(2012-1#1)(2012-2#1)
in humans but##3##3##(1990-7#1)(1996-5#1)(2012-12#1)
in humans by##2##3##(2012-12#1)(2013-8#1)
in humans can be##2##4##(1990-5#1)(2008-7#1)
in humans following##2##3##(2007-12#1)(2008-10#1)
in humans has not##2##4##(1994-6#1)(2009-5#1)
in humans has##3##3##(1994-6#1)(2008-4#1)(2009-5#1)
in humans have been##2##4##(1994-2#1)(2009-12#1)
in humans have##5##3##(1994-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2009-12#1)
in humans in##3##3##(1994-5#1)(2006-6#1)(2008-5#1)
in humans is a##3##4##(1997-7#1)(2010-4#1)(2012-2#1)
in humans is much##2##4##(1996-2#1)(2012-1#1)
in humans is##15##3##(1995-2#1)(1996-2#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#2)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
in humans may##2##3##(2008-11#1)(2008-8#1)
in humans of##2##3##(2008-4#1)(2011-2#1)
in humans the##3##3##(1990-11#1)(1991-6#1)(1995-12#1)
in humans to##3##3##(1994-8#1)(2011-2#1)(2012-2#1)
in humans were##2##3##(1994-5#1)(2008-8#1)
in humans with##6##3##(1990-11#1)(1991-1#2)(2008-10#1)(2008-9#1)(2010-8#1)
in humans##259##2##(1990-11#2)(1990-5#4)(1990-6#1)(1990-7#1)(1991-1#9)(1991-12#5)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#3)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#4)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#9)(2008-9#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#5)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#15)(2012-1#5)(2012-12#5)(2012-2#11)(2012-3#8)(2013-1#7)(2013-8#5)
in humic##2##2##(2008-10#2)
in humic-rich##2##2##(2008-10#2)
in humidity##3##2##(2008-10#2)(2012-2#1)
in humoral##2##2##(2008-4#1)(2008-7#1)
in hybrid maize##2##3##(2008-10#2)
in hybrid##28##2##(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
in hybridization and##2##3##(2008-8#1)(2010-3#1)
in hybridoma cells##4##3##(2008-11#4)
in hybridoma cultures##4##3##(2008-11#2)(2008-7#2)
in hybridoma##12##2##(1991-12#1)(2008-11#9)(2008-7#2)
in hybrids##2##2##(1995-8#1)(2008-8#1)
in hydrated ethanol##2##3##(2008-10#2)
in hydrocarbon biodegradation##3##3##(2011-1#3)
in hydrocarbon##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#3)
in hydrochloric acid media##3##4##(2008-10#3)
in hydrochloric acid solutions##2##4##(1992-12#1)(2008-10#1)
in hydrochloric acid to##2##4##(2008-10#2)
in hydrochloric acid##11##3##(1992-12#1)(2008-10#10)
in hydrochloric##12##2##(1992-12#1)(2008-10#11)
in hydrogen##8##2##(1995-5#1)(1997-4#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)
in hydrogen-free##2##2##(2007-11#2)
in hydrogen-loaded##2##2##(2007-12#2)
in hydrogenated fibers##2##3##(2007-11#1)(2008-3#1)
in hydrogenated##3##2##(2007-11#2)(2008-3#1)
in hydrolysate##2##2##(2008-10#1)(2010-2#1)
in hydrolysis of##3##3##(1993-8#1)(1995-8#1)(1997-4#1)
in hydrolysis yields##2##3##(2011-2#2)
in hydrolysis##6##2##(1993-8#1)(1995-8#1)(1997-4#1)(2008-6#1)(2011-2#2)
in hydrolyzed##2##2##(2008-10#1)(2008-5#1)
in hydrophilic##2##2##(1990-11#1)(2008-10#1)
in hydrophobicity##2##2##(2008-10#2)
in hydroponic##5##2##(2008-10#4)(2008-12#1)
in hydrothermal##3##2##(1995-3#1)(2008-10#2)
in hygiene and##2##3##(2007-12#1)(2009-7#1)
in hyper-##2##2##(2008-11#1)(2010-3#1)
in hypercalcemia of malignancy##2##4##(1990-2#1)(1997-6#1)
in hypercalcemia of##3##3##(1990-2#2)(1997-6#1)
in hypercholesteremic rats##2##3##(2008-10#2)
in hypercholesteremic##4##2##(2008-10#4)
in hypercholesterolemic rabbits##2##3##(1997-8#1)(2008-7#1)
in hypercholesterolemic##3##2##(1991-12#1)(1997-8#1)(2008-7#1)
in hyperglycaemic##2##2##(2008-1#2)
in hyperglycemia##4##2##(2008-1#4)
in hyperglycemic##2##2##(1994-2#1)(2010-11#1)
in hypertension and##2##3##(2008-7#1)(2013-8#1)
in hypertension##6##2##(1992-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2013-8#1)
in hypertensive and normotensive subjects##2##5##(2013-8#2)
in hypertensive patients with##4##4##(1992-8#1)(2007-10#2)(2009-7#1)
in hypertensive patients##10##3##(1992-8#1)(1993-8#1)(2007-10#2)(2008-8#1)(2009-1#3)(2009-7#1)(2010-4#1)
in hypertensive subjects##2##3##(1991-3#1)(2011-2#1)
in hypertensive##20##2##(1991-3#1)(1992-8#1)(1993-8#1)(2007-10#2)(2008-12#2)(2008-8#1)(2009-1#3)(2009-7#1)(2010-4#1)(2011-2#5)(2013-8#2)
in hypertensives##2##2##(1990-2#1)(2012-2#1)
in hyperthyroidism##3##2##(1990-8#2)(2013-1#1)
in hypertrophic cardiomyopathy##2##3##(1992-9#1)(2009-10#1)
in hypertrophic##5##2##(1992-9#1)(2009-10#1)(2010-12#1)(2012-12#2)
in hypertrophy##2##2##(1994-11#1)(2007-10#1)
in hyphal##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
in hypoglycemic episodes##2##3##(2007-10#1)(2010-10#1)
in hypoglycemic##4##2##(1994-2#1)(2007-10#1)(2008-3#1)(2010-10#1)
in hypogonadal men##3##3##(2012-12#1)(2013-8#2)
in hypoosmotic environments##2##3##(2008-7#2)
in hypophysectomized##2##2##(2008-5#1)(2012-1#1)
in hypopituitary adults##2##3##(1997-8#1)(2012-3#1)
in hypospadias repair##3##3##(2008-10#2)(2010-11#1)
in hypospadias surgery##4##3##(2008-10#2)(2009-5#2)
in hypospadias##9##2##(2008-10#4)(2009-5#4)(2010-11#1)
in hypothalamic and pituitary##2##4##(2008-4#2)
in hypothalamic##4##2##(1993-12#1)(1996-12#1)(2008-4#2)
in hypothalamus of##4##3##(1997-6#1)(2008-8#1)(2013-1#2)
in hypothalamus##13##2##(1990-9#1)(1991-12#1)(1992-1#2)(1997-6#1)(2008-8#6)(2013-1#2)
in hypothermic ischemic brains##2##4##(1995-12#2)
in hypothermic##4##2##(1995-12#3)(1995-3#1)
in hypothetical##2##2##(2008-12#1)(2008-8#1)
in hypothyroid##3##2##(1994-6#1)(1996-5#2)
in hypovirulent isolate Sh12B of##2##5##(2008-10#2)
in hypovirulent isolates##2##3##(2008-10#2)
in hypovirulent##4##2##(2008-10#4)
in hypoxic##8##2##(1990-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
in hypoxic-ischemic##2##2##(1996-12#1)(2010-7#1)
in ice clouds##2##3##(2008-3#2)
in identical##3##2##(1993-12#1)(2008-10#1)(2010-1#1)
in identification of the##2##4##(1993-11#1)(2008-12#1)
in identification of##9##3##(1990-12#1)(1991-12#1)(1993-11#1)(2008-10#2)(2008-12#2)(2008-8#1)(2013-8#1)
in identification##13##2##(1990-12#1)(1991-12#1)(1993-11#1)(1995-6#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2013-8#1)
in identified##3##2##(1994-2#1)(2007-12#1)(2008-4#1)
in identifying new##2##3##(2008-4#1)(2008-7#1)
in identifying patients##2##3##(1993-9#1)(2007-10#1)
in identifying the##18##3##(1994-2#1)(1994-7#1)(1997-1#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-3#2)
in identifying those patients with##2##5##(2007-10#1)(2011-1#1)
in identifying those patients##3##4##(2007-10#2)(2011-1#1)
in identifying those##6##3##(2007-10#2)(2008-10#1)(2008-3#1)(2011-1#2)
in identifying##59##2##(1992-1#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-7#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-10#4)(2008-10#7)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
in idiopathic Parkinsonism##3##3##(2008-7#3)
in idiopathic hypercalciuria##2##3##(1991-11#1)(2008-10#1)
in idiopathic##15##2##(1991-11#1)(1997-8#2)(2007-8#2)(2008-10#1)(2008-7#3)(2009-5#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
in ileum-jejunum##2##2##(1993-11#2)
in illicit heroin seized in Malaysia##2##6##(2012-2#2)
in illicit heroin##4##3##(2008-10#1)(2012-2#3)
in illicit##6##2##(2008-1#1)(2008-10#2)(2012-2#3)
in illness##2##2##(2008-9#1)(2011-1#1)
in illuminated##2##2##(1991-12#1)(2008-10#1)
in illumination##4##2##(2007-11#1)(2008-3#2)(2008-6#1)
in image acquisition##2##3##(2008-2#1)(2011-7#1)
in image processing##3##3##(2008-3#2)(2008-6#1)
in image space##2##3##(2007-12#1)(2008-2#1)
in image##19##2##(2007-12#1)(2008-2#3)(2008-3#5)(2008-6#2)(2008-9#3)(2009-12#1)(2009-3#1)(2011-7#2)(2012-1#1)
in images of##4##3##(2008-1#1)(2008-3#1)(2010-8#2)
in images##9##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#2)(2010-8#3)
in imaginal discs##2##3##(1993-2#1)(2008-10#1)
in imaging have##2##3##(2008-2#1)(2008-8#1)
in imaging of##5##3##(2007-11#1)(2008-3#2)(2012-2#1)(2012-3#1)
in imaging systems##2##3##(2008-3#2)
in imaging techniques##2##3##(2007-12#1)(2010-5#1)
in imaging technologies##2##3##(2008-2#1)(2008-6#1)
in imaging technology##2##3##(2008-2#1)(2011-1#1)
in imaging##32##2##(2007-11#2)(2007-12#2)(2008-2#6)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)
in immature or##2##3##(2008-10#2)
in immature##5##2##(2008-10#4)(2011-2#1)
in immediate and##2##3##(1993-11#1)(2010-11#1)
in immediate##8##2##(1993-11#1)(1995-2#1)(2008-11#1)(2010-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
in immigrant families##3##3##(2009-7#3)
in immobilized##2##2##(1994-11#1)(2008-12#1)
in immortalized T##2##3##(2008-11#2)
in immortalized##3##2##(1992-1#1)(2008-11#2)
in immune cells##2##3##(1991-1#2)
in immune defense##3##3##(2008-9#2)(2009-9#1)
in immune function##10##3##(1993-12#1)(2008-10#4)(2008-8#2)(2008-9#2)(2010-2#1)
in immune response##5##3##(1994-11#2)(2008-8#1)(2010-12#1)(2011-2#1)
in immune responses##3##3##(1995-12#1)(2008-9#1)(2010-5#1)
in immune##35##2##(1991-1#2)(1991-11#1)(1991-8#1)(1993-12#2)(1994-11#2)(1995-12#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)
in immune-competent##2##2##(1994-5#1)(2013-8#1)
in immune-mediated##2##2##(2008-10#1)(2011-2#1)
in immunity##4##2##(2008-10#1)(2009-6#1)(2010-3#1)(2012-3#1)
in immunization##3##2##(1994-9#1)(1996-12#1)(2009-5#1)
in immunized rabbits##2##3##(1990-12#2)
in immunoassays with##2##3##(2008-11#1)(2008-5#1)
in immunoassays##8##2##(1994-12#1)(2008-10#5)(2008-11#1)(2008-5#1)
in immunoblot and##2##3##(2008-10#1)(2008-8#1)
in immunoblot##3##2##(2008-10#2)(2008-8#1)
in immunoblotting##2##2##(1990-5#1)(2008-10#1)
in immunocompetent and##2##3##(2007-12#1)(2011-2#1)
in immunocompetent individuals##2##3##(2009-9#1)(2010-4#1)
in immunocompetent mice##2##3##(2011-2#1)(2013-1#1)
in immunocompetent patients##2##3##(2011-2#1)(2012-12#1)
in immunocompetent persons##2##3##(1996-6#1)(2006-10#1)
in immunocompetent##10##2##(1996-6#1)(2006-10#1)(2007-12#1)(2009-9#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-1#1)
in immunocompromised hosts##2##3##(1996-6#1)(2008-7#1)
in immunocompromised patients##10##3##(1990-6#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-11#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
in immunocompromised##14##2##(1990-6#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in immunodeficient patients##3##3##(1991-6#1)(1994-3#1)(2007-2#1)
in immunodeficient##8##2##(1991-6#1)(1991-8#1)(1994-3#1)(2007-2#1)(2008-12#1)(2008-5#3)
in immunodetectable##2##2##(1994-6#1)(1995-3#1)
in immunogenic cells##2##3##(1992-9#1)(2008-10#1)
in immunogenicity##2##2##(1995-5#1)(2008-10#1)
in immunohistochemical##3##2##(1992-8#1)(1995-11#1)(2008-5#1)
in immunohistochemistry##2##2##(2009-8#1)(2011-2#1)
in immunology##5##2##(2006-10#2)(2008-10#1)(2008-2#1)(2008-4#1)
in immunomodulation##2##2##(1995-12#1)(2011-1#1)
in immunophenotyping##2##2##(2008-9#2)
in immunoprecipitates obtained with##2##4##(1992-12#2)
in immunoprecipitates##3##2##(1992-12#2)(2008-3#1)
in immunoregulation##3##2##(1991-9#1)(1995-12#1)(2011-2#1)
in immunostaining##4##2##(1990-7#1)(1995-11#1)(1997-3#2)
in immunosuppressed patients##2##3##(2010-5#1)(2013-1#1)
in immunosuppressed##3##2##(1996-8#1)(2010-5#1)(2013-1#1)
in immunotoxicology##2##2##(2008-10#2)
in impaired##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
in imparting information##2##3##(2008-12#1)(2011-1#1)
in implant technology##2##3##(2008-9#2)
in implant##7##2##(2007-12#4)(2008-9#2)(2011-2#1)
in implantation and##2##3##(1994-9#2)
in implantation##3##2##(1994-9#2)(2012-3#1)
in implanted##3##2##(1996-12#1)(2008-8#1)(2008-9#1)
in implants##2##2##(1991-5#2)
in implementation##3##2##(1993-3#1)(1996-2#1)(2008-11#1)
in implementing TQM##2##3##(1994-1#1)(1994-2#1)
in implementing an##3##3##(1992-3#1)(1995-3#1)(1996-2#1)
in implementing##21##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-1#2)(1994-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-2#2)(2013-1#1)
in importance when##2##3##(1993-12#1)(2008-7#1)
in importance##9##2##(1991-11#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-1#1)(2012-3#1)
in important##5##2##(2008-1#1)(2009-8#1)(2010-10#2)(2012-1#1)
in improved clinical##2##3##(2011-2#1)(2012-12#1)
in improved detection##2##3##(2008-2#1)(2008-7#1)
in improved health##2##3##(2010-5#1)(2012-2#1)
in improved quality of care and##2##6##(1992-3#1)(2008-10#1)
in improved quality of##3##4##(1992-3#1)(2008-10#1)(2010-12#1)
in improved##33##2##(1992-3#1)(1993-3#1)(1997-1#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)
in improvement of##4##3##(1996-2#1)(2008-10#1)(2008-4#1)(2012-3#1)
in improvements##2##2##(1996-3#1)(2013-1#1)
in improving and##2##3##(1995-1#1)(2008-5#1)
in improving care##2##3##(1996-11#1)(2008-3#1)
in improving patient##2##3##(2010-4#1)(2013-1#1)
in improving skin hydration##4##4##(2008-5#4)
in improving the quality of life##2##6##(1993-3#1)(2008-1#1)
in improving the quality of##5##5##(1993-2#1)(1993-3#1)(1996-3#1)(2008-1#1)(2012-3#1)
in improving the##23##3##(1993-2#1)(1993-3#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
in improving their##2##3##(2008-6#1)(2010-3#1)
in improving##60##2##(1991-6#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#2)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#7)(2008-6#2)(2008-7#5)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
in impulsive and##2##3##(2008-11#1)(2008-3#1)
in impulsive##3##2##(2008-11#1)(2008-3#1)(2012-12#1)
in in vitro and in vivo##3##6##(2008-10#1)(2008-11#1)(2008-8#1)
in in vitro assays##2##4##(2008-10#2)
in in vitro binding assays##2##5##(2008-10#1)(2010-5#1)
in in vitro study##2##4##(2008-8#1)(2011-1#1)
in in vitro systems##2##4##(1991-9#1)(2009-3#1)
in in vitro##22##3##(1990-12#1)(1990-7#1)(1991-9#1)(1992-9#1)(1993-1#1)(1995-2#1)(2008-10#6)(2008-11#2)(2008-8#3)(2009-12#1)(2009-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
in in vivo and##2##4##(1993-6#1)(2008-10#1)
in in vivo models##2##4##(2008-8#1)(2012-12#1)
in in vivo study##2##4##(2008-8#1)(2011-1#1)
in in vivo##11##3##(1992-12#1)(1993-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#2)(2011-1#1)(2012-12#1)
in in##39##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-2#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#5)(2009-12#1)(2009-3#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#3)
in inactivation of the##2##4##(1994-8#1)(2008-10#1)
in inactivation of##3##3##(1994-8#1)(2008-10#1)(2008-4#1)
in inbred##3##2##(1991-12#1)(1997-7#2)
in incidence among##2##3##(1995-9#1)(2008-4#1)
in incidence of##7##3##(1995-5#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
in incidence##21##2##(1990-11#1)(1991-12#1)(1991-4#2)(1994-9#1)(1995-2#2)(1995-5#2)(1995-9#1)(1996-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
in incident##4##2##(2007-11#1)(2008-3#1)(2009-10#1)(2011-2#1)
in inclusion##2##2##(1994-9#1)(1995-8#1)
in incorporating##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
in incorporation##2##2##(2008-11#2)
in increased expression##2##3##(2008-9#1)(2010-1#1)
in increased intracellular##2##3##(1997-2#1)(2008-10#1)
in increased##67##2##(1990-11#1)(1990-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#3)
in increases in##3##3##(1993-12#1)(1994-1#1)(1994-8#1)
in increasing bone density##2##4##(2008-8#2)
in increasing concentrations##2##3##(2008-11#1)(2013-1#1)
in increasing the##10##3##(1990-5#1)(1993-3#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
in increasing##30##2##(1990-5#1)(1991-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2013-1#3)
in incubates##2##2##(1991-12#1)(2011-3#1)
in incubation##2##2##(1990-11#1)(2008-10#1)
in independent##3##2##(1992-2#1)(1995-9#1)(2008-8#1)
in index##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
in indica rice##2##3##(2006-12#1)(2008-9#1)
in indicating the##2##3##(2013-1#1)(2013-8#1)
in indicating##4##2##(1994-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
in indicator##2##2##(1997-3#1)(2008-10#1)
in indicators##2##2##(1993-3#1)(2012-12#1)
in indigenous##7##2##(1991-12#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
in indirect enzyme-linked immunosorbent assay##2##5##(2008-10#2)
in indirect##4##2##(2008-10#4)
in individual animals##2##3##(1995-5#1)(2008-10#1)
in individual cases##2##3##(1993-12#1)(1997-8#1)
in individual cells##2##3##(2008-11#1)(2008-9#1)
in individual patients and##2##4##(2008-7#1)(2012-3#1)
in individual patients##9##3##(1990-8#1)(1991-3#1)(2007-8#1)(2008-7#1)(2009-3#1)(2011-3#1)(2012-3#1)(2012-5#1)(2013-1#1)
in individual plants##2##3##(2008-10#1)(2008-5#1)
in individual presynaptic boutons##2##4##(1997-7#2)
in individual subjects##3##3##(2008-11#3)
in individual tissue##2##3##(2008-10#1)(2008-3#1)
in individual##61##2##(1990-8#1)(1991-3#1)(1991-5#1)(1992-3#2)(1993-12#1)(1995-5#1)(1996-2#1)(1997-7#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)
in individually##2##2##(1996-6#1)(2008-6#1)
in individuals aged##2##3##(2007-7#1)(2008-7#1)
in individuals at##3##3##(1991-1#1)(2012-1#1)(2012-12#1)
in individuals from##5##3##(1993-12#1)(2006-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
in individuals of##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
in individuals who##2##3##(2007-12#1)(2009-12#1)
in individuals with##31##3##(1992-2#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-12#1)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
in individuals without##2##3##(2010-9#1)(2013-8#1)
in individuals##63##2##(1990-9#1)(1991-1#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1996-12#1)(2006-10#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
in indoor air##3##3##(2008-10#2)(2010-5#1)
in indoor and outdoor air##4##5##(2008-10#4)
in indoor and outdoor##5##4##(2008-10#5)
in indoor##10##2##(1995-11#1)(2008-10#8)(2010-5#1)
in induced cells##3##3##(1993-9#1)(1994-12#1)(2008-10#1)
in induced sputum##2##3##(2008-3#1)(2008-7#1)
in induced##7##2##(1993-9#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)
in inducing a##2##3##(1990-12#1)(1996-3#1)
in inducing and##2##3##(2008-8#1)(2012-12#1)
in inducing##18##2##(1990-12#2)(1991-9#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
in induction of apoptosis##2##4##(2008-8#2)
in induction of##8##3##(1991-12#1)(1992-8#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-8#2)(2013-1#1)
in induction##9##2##(1991-12#1)(1992-8#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2013-1#1)
in inductively coupled plasma optical emission spectrometry##2##7##(2008-10#2)
in inductively coupled plasma##4##4##(2008-10#4)
in inductively coupled##5##3##(2008-10#5)
in industrial and##4##3##(1995-2#1)(2008-10#3)
in industrial applications##4##3##(2008-10#2)(2008-11#1)(2010-2#1)
in industrial areas##2##3##(1996-3#1)(2008-10#1)
in industrial biotechnology##2##3##(2008-11#1)(2013-1#1)
in industrial environments##2##3##(2008-3#2)
in industrial waste##2##3##(2008-10#2)
in industrial##46##2##(1993-3#1)(1995-2#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in industrialised##2##2##(2007-2#1)(2010-11#1)
in industrialized countries##6##3##(1990-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-6#1)(2012-2#1)
in industrialized societies##3##3##(2009-12#1)(2010-7#1)(2013-1#1)
in industrialized##13##2##(1990-6#1)(1994-12#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
in industries##3##2##(1994-3#1)(2008-9#1)(2009-12#1)
in industry for##2##3##(1994-12#1)(2008-7#1)
in industry##16##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-7#1)
in infancy and early childhood##2##5##(2008-1#1)(2010-5#1)
in infancy and##8##3##(1996-8#1)(1996-9#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
in infancy##30##2##(1991-3#1)(1992-11#1)(1994-3#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-7#1)(2008-1#4)(2008-11#3)(2008-6#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
in infant acute lymphoblastic leukemia##2##5##(1991-2#2)
in infant formulas##2##3##(2008-10#2)
in infant mortality##2##3##(1990-11#1)(2013-1#1)
in infant##14##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#3)(1992-3#1)(2007-2#1)(2008-10#2)(2008-12#1)(2012-2#2)(2013-1#1)
in infantile autism##2##3##(1991-2#1)(1995-5#1)
in infantile##3##2##(1991-2#1)(1995-5#1)(2009-4#1)
in infants and children##9##4##(1991-12#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#3)(2011-2#1)
in infants and small children##3##5##(1992-4#1)(2008-1#2)
in infants and toddlers with##3##5##(2012-2#3)
in infants and toddlers##4##4##(2012-2#4)
in infants and young children##3##5##(1997-1#1)(2008-11#1)(2011-2#1)
in infants and##22##3##(1991-12#1)(1992-3#1)(1992-4#1)(1997-1#2)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2009-5#3)(2011-2#2)(2012-2#5)
in infants in the##2##4##(2008-11#1)(2011-2#1)
in infants in##5##3##(1992-2#1)(1995-12#1)(2008-11#1)(2011-2#2)
in infants of##2##3##(1991-9#1)(2011-1#1)
in infants up to 6##2##5##(2007-8#1)(2008-10#1)
in infants who##4##3##(1991-2#1)(1991-3#1)(1995-5#1)(2007-5#1)
in infants with##8##3##(1990-8#1)(1995-5#2)(2007-11#1)(2010-9#2)(2011-2#1)(2012-3#1)
in infants##73##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-4#1)(1994-6#1)(1995-12#3)(1995-3#1)(1995-5#4)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#4)(2009-5#3)(2010-9#2)(2011-1#5)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#2)(2013-8#2)
in infected and##2##3##(1995-2#1)(2008-11#1)
in infected barley leaves##2##4##(2008-10#2)
in infected blood##3##3##(1991-2#3)
in infected cells##4##3##(2009-11#1)(2009-2#1)(2009-8#1)(2012-3#1)
in infected leaves##3##3##(2008-10#3)
in infected plant##2##3##(2008-10#2)
in infected plants##4##3##(2008-10#4)
in infected tissue##2##3##(2008-10#2)
in infected##49##2##(1990-2#1)(1991-2#3)(1993-6#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#31)(2008-11#3)(2008-6#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#1)(2012-3#1)
in infection in##2##3##(2008-10#1)(2010-8#1)
in infection of##2##3##(2008-10#1)(2012-2#1)
in infection##15##2##(1990-6#1)(2008-10#8)(2008-5#1)(2009-8#1)(2010-8#2)(2012-12#1)(2012-2#1)
in infections with##2##3##(1994-8#1)(2008-10#1)
in infections##6##2##(1994-8#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-2#1)
in infectious diseases##3##3##(2007-12#1)(2008-8#1)(2009-5#1)
in infectious mononucleosis##2##3##(2008-5#1)(2011-2#1)
in infectious##8##2##(1992-12#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
in infective endocarditis##2##3##(2006-6#1)(2011-2#1)
in infective##4##2##(2006-6#1)(2008-10#1)(2011-2#2)
in inferior##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
in inferotemporal and prefrontal association##2##5##(1997-2#2)
in infertile##4##2##(1997-4#1)(2008-12#1)(2011-1#1)(2013-1#1)
in infertility and##2##3##(1995-2#1)(2010-3#1)
in infertility##4##2##(1991-3#1)(1992-3#1)(1995-2#1)(2010-3#1)
in infested##6##2##(2008-10#6)
in infinite##2##2##(2007-11#1)(2008-3#1)
in inflammation and cardiovascular disease##2##5##(2008-1#2)
in inflammation and##5##3##(2008-1#2)(2008-10#1)(2008-7#1)(2013-8#1)
in inflammation##14##2##(1990-2#1)(1990-9#1)(1993-6#1)(1994-11#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-7#1)(2013-8#2)
in inflammatory arthritis##4##3##(1994-8#1)(2008-5#2)(2008-8#1)
in inflammatory bowel disease##2##4##(1992-6#1)(2010-12#1)
in inflammatory bowel diseases##7##4##(2008-10#1)(2010-12#6)
in inflammatory bowel##9##3##(1992-6#1)(2008-10#1)(2010-12#7)
in inflammatory cell##2##3##(1992-2#1)(2013-1#1)
in inflammatory conditions##3##3##(1993-3#1)(1994-11#1)(2012-12#1)
in inflammatory diseases##2##3##(1995-12#1)(2009-6#1)
in inflammatory##38##2##(1990-2#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-12#2)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#7)(2010-5#1)(2012-12#2)(2013-1#2)(2013-8#1)
in influencing##12##2##(1993-1#1)(1993-12#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-11#2)(2010-10#1)
in influenza##2##2##(2009-12#1)(2012-12#1)
in informal##2##2##(1997-4#1)(2013-1#1)
in information processing by the nervous system##2##7##(2009-3#2)
in information processing##5##3##(2008-3#1)(2008-5#1)(2009-3#2)(2012-12#1)
in information retrieval##2##3##(1992-1#1)(1994-8#1)
in information##11##2##(1992-1#1)(1992-2#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#2)(2010-10#1)(2012-12#1)
in informing##2##2##(2010-2#1)(2011-2#1)
in infrainguinal##2##2##(1991-11#2)
in infrared##2##2##(2008-1#1)(2008-3#1)
in inguinal hernia##2##3##(1996-9#1)(2011-2#1)
in inguinal##4##2##(1994-3#1)(1996-9#1)(2011-2#1)(2012-12#1)
in inhibiting the binding of##2##5##(1990-5#1)(1995-2#1)
in inhibiting the##11##3##(1990-5#1)(1992-3#3)(1992-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
in inhibiting##23##2##(1990-12#1)(1990-5#1)(1992-3#3)(1992-5#1)(1994-11#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2012-3#1)
in inhibition of##6##3##(1995-12#1)(1995-3#2)(1996-2#1)(2008-10#1)(2011-1#1)
in inhibition##9##2##(1990-2#1)(1990-7#1)(1995-12#1)(1995-3#2)(1996-2#1)(2008-10#1)(2008-5#1)(2011-1#1)
in inhibitory##4##2##(1994-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
in initial stages of##2##4##(2008-10#1)(2008-5#1)
in initial##13##2##(1990-2#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-3#1)(2013-1#1)
in initially##2##2##(2008-10#1)(2008-11#1)
in initiating and##2##3##(1994-8#1)(1995-3#1)
in initiating the##3##3##(1994-11#1)(2008-10#1)(2009-2#1)
in initiating##13##2##(1993-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(2008-1#1)(2008-10#3)(2009-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
in initiation of##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
in initiation##5##2##(1991-9#1)(1993-3#1)(1996-7#1)(2008-10#1)(2013-1#1)
in injectable##2##2##(1996-4#1)(2008-10#1)
in injection##5##2##(2008-10#5)
in injections##2##2##(2008-10#1)(2010-4#1)
in injuries##2##2##(1993-12#1)(2008-12#1)
in injury##2##2##(2008-1#1)(2008-4#1)
in inner-city minority##2##3##(2009-11#1)(2011-1#1)
in innovative##2##2##(1991-12#1)(2008-7#1)
in inoculated and##4##3##(2008-10#3)(2011-10#1)
in inoculated leaves##4##3##(2008-10#4)
in inoculated plants##2##3##(2008-10#2)
in inoculated##16##2##(2008-10#14)(2011-10#1)(2011-2#1)
in inoculation tests##2##3##(2008-10#2)
in inoculation##4##2##(2008-10#4)
in inoculum##7##2##(2008-10#7)
in inorganic##4##2##(1991-5#1)(1994-2#1)(2008-10#1)(2008-7#1)
in inositol##9##2##(1990-12#1)(1992-9#2)(1993-8#1)(1994-9#3)(1996-12#1)(1997-7#1)
in inpatient##4##2##(1991-2#1)(1993-12#1)(1993-2#1)(2009-5#1)
in insect and##2##3##(2007-12#1)(2008-8#1)
in insect cell##3##3##(1997-8#1)(2008-11#2)
in insect cells and##3##4##(1994-8#1)(1997-4#2)
in insect cells##13##3##(1993-6#2)(1993-8#1)(1994-8#4)(1997-4#2)(2008-2#1)(2008-7#3)
in insect##29##2##(1993-6#2)(1993-8#1)(1994-8#4)(1997-4#2)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#5)(2008-8#3)(2011-2#1)(2012-2#1)(2013-8#1)
in insecticide resistance of##2##4##(2011-2#2)
in insects and vertebrates##2##4##(2007-12#2)
in insects and##5##3##(2007-12#4)(2008-8#1)
in insects is##2##3##(2008-9#1)(2013-1#1)
in insects##19##2##(1990-7#1)(1991-5#1)(1993-5#1)(2007-12#6)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-1#1)(2013-1#1)
in instant##2##2##(2008-10#1)(2011-2#1)
in institutional##4##2##(1993-12#1)(2008-7#3)
in institutionalised##2##2##(2008-10#1)(2008-7#1)
in institutionalized elderly##2##3##(1994-6#1)(2008-1#1)
in institutions##5##2##(1990-6#2)(1991-6#1)(1992-5#1)(2007-10#1)
in instrument design##2##3##(2008-10#2)
in instrument##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2009-2#1)
in instrumental##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
in instrumentation##5##2##(1992-11#1)(2008-10#3)(2009-2#1)
in insulin mRNA stability##2##4##(2008-1#2)
in insulin mRNA##3##3##(2008-1#3)
in insulin receptor##2##3##(1994-6#1)(2010-11#1)
in insulin release##2##3##(1990-8#1)(2010-11#1)
in insulin resistance and##3##4##(2008-1#3)
in insulin resistance##6##3##(2008-1#3)(2008-4#1)(2011-1#1)(2013-8#1)
in insulin secretion and in development of insulin resistance##2##9##(2011-1#2)
in insulin secretion and##3##4##(2008-1#1)(2011-1#2)
in insulin secretion##4##3##(2008-1#1)(2008-4#1)(2011-1#2)
in insulin signal transduction##2##4##(2008-3#1)(2010-4#1)
in insulin signal##3##3##(1992-10#1)(2008-3#1)(2010-4#1)
in insulin##32##2##(1990-8#1)(1992-10#1)(1994-6#2)(1996-2#1)(1997-1#1)(2008-1#8)(2008-3#1)(2008-4#2)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#2)(2011-1#5)(2013-8#1)
in insulin-dependent diabetes mellitus##3##4##(1993-9#1)(1997-5#1)(2008-1#1)
in insulin-dependent diabetes##4##3##(1991-8#1)(1993-9#1)(1997-5#1)(2008-1#1)
in insulin-dependent##6##2##(1991-8#1)(1993-9#1)(1995-5#1)(1997-5#1)(2008-1#1)(2013-1#1)
in insulin-producing liver cells##2##4##(2010-11#2)
in insulin-producing##3##2##(1993-3#1)(2010-11#2)
in insulin-receptor##2##2##(1992-3#1)(1995-11#1)
in insulin-secreting##3##2##(1997-1#2)(1997-4#1)
in insurance coverage##3##3##(1993-12#1)(2007-2#1)(2011-2#1)
in insurance##4##2##(1992-3#1)(1993-12#1)(2007-2#1)(2011-2#1)
in intact and##3##3##(1990-11#1)(1994-2#1)(1994-8#1)
in intact cells and##2##4##(1990-11#1)(1995-12#1)
in intact cells##10##3##(1990-11#2)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)
in intact human erythrocytes##2##4##(1992-8#2)
in intact liver##2##3##(1994-6#2)
in intact organisms##2##3##(1993-12#1)(2009-5#1)
in intact plants of the water mossFontinalis antipyretica##2##8##(2008-11#2)
in intact plants##4##3##(2008-10#1)(2008-11#3)
in intact rats##2##3##(1990-12#1)(1993-12#1)
in intact##47##2##(1990-11#3)(1990-12#1)(1990-2#2)(1991-8#1)(1992-12#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#2)(2009-5#1)(2012-2#1)(2013-1#1)
in integrated delivery systems##2##4##(1996-1#1)(1996-12#1)
in integrated optical waveguides by use of a microwave-modulated optical wave##2##11##(2007-11#2)
in integrated pest management##4##4##(2008-10#3)(2013-8#1)
in integrated photoelasticity##3##3##(2008-3#3)
in integrated##18##2##(1996-1#2)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-10#5)(2008-3#5)(2013-8#1)
in integrating the##3##3##(2008-1#2)(2009-2#1)
in integrating##6##2##(1997-2#1)(2008-1#2)(2008-4#1)(2009-2#1)(2010-12#1)
in intense##2##2##(2008-10#2)
in intensity of the##2##4##(1990-5#1)(2008-10#1)
in intensity of##8##3##(1990-5#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)
in intensity with##2##3##(1996-5#1)(2008-10#1)
in intensity##15##2##(1990-5#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-5#2)(2008-10#5)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)
in intensive care patients##2##4##(1990-2#1)(2008-7#1)
in intensive care unit##2##4##(2008-4#1)(2011-2#1)
in intensive care units (ICUs)##2##5##(2008-8#1)(2011-2#1)
in intensive care units in##3##5##(2007-2#1)(2008-8#1)(2009-5#1)
in intensive care units##10##4##(1996-3#1)(2007-11#1)(2007-2#1)(2008-8#2)(2009-5#2)(2010-12#1)(2011-2#1)(2012-3#1)
in intensive care##15##3##(1990-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#2)(2010-12#1)(2011-2#2)(2012-3#1)
in intensive##18##2##(1990-2#1)(1991-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#3)(2010-12#1)(2011-2#2)(2012-3#2)
in inter-##2##2##(1991-2#1)(2008-10#1)
in interacting with##2##3##(1991-12#1)(1991-2#1)
in interacting##3##2##(1991-12#1)(1991-2#1)(2008-10#1)
in interaction with##4##3##(1990-4#1)(1995-8#1)(2008-10#1)(2011-2#1)
in interaction##7##2##(1990-4#1)(1995-8#1)(2008-10#2)(2008-8#1)(2010-9#1)(2011-2#1)
in interactions between##2##3##(2008-10#2)
in interactions with myosin##2##4##(1995-2#2)
in interactions with##4##3##(1995-2#2)(2008-10#1)(2008-4#1)
in interactions##10##2##(1990-8#1)(1995-2#2)(2008-10#5)(2008-4#1)(2008-8#1)
in intercellular spaces of##2##4##(2008-10#2)
in intercellular spaces##3##3##(2008-10#3)
in intercellular##10##2##(1994-9#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
in interference with##2##3##(1997-4#1)(2008-10#1)
in interfering##2##2##(2008-10#1)(2008-2#1)
in interferometric##2##2##(2008-3#2)
in intergenic regions##2##3##(2012-3#2)
in intermediate##2##2##(1997-8#1)(2008-10#1)
in internal and general medicine##2##5##(1995-6#2)
in internal combustion engines##2##4##(2008-2#2)
in internal medicine##2##3##(1993-6#1)(2008-9#1)
in internal##18##2##(1990-2#2)(1990-5#1)(1992-11#2)(1993-6#1)(1994-3#1)(1995-6#2)(2008-10#2)(2008-2#2)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
in international contexts##3##3##(2010-9#3)
in international journals##2##3##(1993-6#1)(1994-12#1)
in international research##2##3##(2009-6#2)
in international##13##2##(1990-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(2007-8#1)(2008-10#1)(2009-6#2)(2010-9#3)(2011-2#1)(2012-12#1)
in interphase and##2##3##(1990-11#1)(2009-3#1)
in interphase##5##2##(1990-11#1)(2008-4#1)(2009-3#1)(2011-2#2)
in interpretation of the data##2##5##(1994-3#1)(1995-11#1)
in interpretation of##4##3##(1991-12#1)(1994-3#1)(1995-11#1)(2008-4#1)
in interpretation##7##2##(1991-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(2008-4#1)(2010-8#1)(2013-1#1)
in interpreting the##4##3##(1995-5#1)(1996-3#1)(2011-2#1)(2012-3#1)
in interpreting##9##2##(1993-12#1)(1995-5#1)(1996-3#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
in interspecific##2##2##(2008-10#1)(2008-8#1)
in interstitial cells##2##3##(2008-8#1)(2009-12#1)
in intervals##4##2##(2008-3#1)(2008-5#3)
in intervention group##2##3##(2008-12#2)
in intervention vs##2##3##(2012-3#2)
in intervention##9##2##(1992-2#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#2)
in interventional radiology##5##3##(2012-2#5)
in interventional##7##2##(2008-11#1)(2008-3#1)(2012-2#5)
in interventions##2##2##(2011-1#1)(2012-2#1)
in intestinal##18##2##(1990-3#1)(1991-12#1)(1991-8#1)(1993-9#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2011-3#1)(2013-1#1)
in intestine and##2##3##(2008-4#1)(2013-1#1)
in intestine##5##2##(1991-8#1)(2008-10#1)(2008-4#1)(2011-3#1)(2013-1#1)
in intimate contact with##2##4##(2010-10#1)(2012-3#1)
in intracellular Ca(2+)##3##3##(2006-6#1)(2008-11#1)(2012-2#1)
in intracellular Ca++ level##2##4##(1991-9#2)
in intracellular Ca2+ levels##2##4##(1993-3#1)(1997-4#1)
in intracellular Ca2+##6##3##(1991-5#1)(1993-3#2)(1994-2#1)(1996-2#1)(1997-4#1)
in intracellular and##2##3##(2008-7#1)(2012-1#1)
in intracellular calcium##4##3##(1991-12#1)(1991-3#1)(1995-12#1)(1995-8#1)
in intracellular cyclic AMP##2##4##(1995-11#2)
in intracellular free##3##3##(1991-9#1)(1993-12#1)(1995-8#1)
in intracellular pH##4##3##(1991-5#1)(1994-6#1)(1994-8#1)(2008-9#1)
in intracellular##43##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-9#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#1)(1997-3#1)(1997-4#1)(2006-6#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
in intracerebral##3##2##(1996-6#1)(2008-7#1)(2013-8#1)
in intracranial EEG##2##3##(2013-8#2)
in intracranial##7##2##(1991-2#1)(1993-9#1)(2008-7#1)(2012-2#1)(2013-8#3)
in intractable##2##2##(1993-1#1)(2012-2#1)
in intraductal papillary##2##3##(2012-2#1)(2012-3#1)
in intraocular##2##2##(2008-3#1)(2010-10#1)
in intraoperative##7##2##(1993-1#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-7#2)
in intrauterine insemination##2##3##(2007-10#1)(2012-3#1)
in intrauterine##4##2##(1994-12#1)(1995-8#1)(2007-10#1)(2012-3#1)
in intravascular##2##2##(1996-6#1)(2008-8#1)
in intravenous drug##3##3##(1991-1#1)(1991-5#1)(2008-12#1)
in intravenous##4##2##(1991-1#1)(1991-5#1)(2008-12#1)(2008-6#1)
in intrinsic##5##2##(1992-8#1)(1995-6#1)(2008-11#1)(2008-3#1)(2009-5#1)
in introducing##2##2##(1994-1#1)(2008-12#1)
in introduction##2##2##(2007-11#1)(2008-8#1)
in introductory##2##2##(2008-10#1)(2012-2#1)
in intron 3 of##2##4##(2010-4#1)(2011-1#1)
in intron size##2##3##(2008-8#2)
in intron##9##2##(2007-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)
in introns##4##2##(1994-12#1)(1997-6#1)(2008-10#1)(2011-2#1)
in introverted##2##2##(2009-7#2)
in invasion of the##2##4##(2008-11#1)(2008-7#1)
in invasion of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
in inverse proportion to the##3##5##(1990-8#1)(2008-10#1)(2008-3#1)
in inverse##5##2##(1990-8#1)(1994-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
in invertebrate##2##2##(2008-7#1)(2009-6#1)
in invertebrates##5##2##(1991-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
in inverted and rotated cultures##2##5##(2008-11#2)
in inverted##3##2##(1993-12#1)(2008-11#2)
in investigated##2##2##(2008-10#1)(2008-7#1)
in investigating this##2##3##(1992-2#1)(2008-12#1)
in investigating##8##2##(1992-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)
in investigation of##2##3##(1997-8#1)(2008-4#1)
in investigations of##2##3##(2008-10#1)(2008-8#1)
in iodized common##2##3##(2008-10#2)
in iodized##3##2##(2008-10#3)
in ion and water##2##4##(2007-12#2)
in ion chromatography##3##3##(2008-10#3)
in ion mobility spectrometry##4##4##(2008-10#4)
in ion##15##2##(1993-3#1)(1996-7#1)(2007-12#2)(2008-10#9)(2008-2#1)(2013-1#1)
in ion-exchange##2##2##(2008-10#1)(2008-6#1)
in ion-pair extraction##2##3##(2008-10#2)
in ionic##6##2##(1997-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-1#1)
in ipsilateral##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
in iran##7##2##(2007-10#1)(2012-2#1)(2013-1#5)
in ire1a/ire1b##2##2##(2012-2#2)
in iron and##3##3##(1995-3#1)(2008-10#2)
in iron homeostasis##2##3##(1990-5#1)(2010-12#1)
in iron##20##2##(1990-12#1)(1990-5#1)(1994-5#1)(1995-3#1)(1995-8#3)(2008-10#7)(2008-11#1)(2010-12#2)(2012-2#2)(2013-8#1)
in iron-doped lithium##2##3##(2007-12#2)
in iron-rich##2##2##(2008-10#2)
in iron-sulphur cluster##2##3##(2008-7#2)
in irradiance##2##2##(2008-3#1)(2008-8#1)
in irradiated cells##3##3##(1995-6#1)(2011-2#2)
in irradiated##6##2##(1993-8#1)(1995-6#1)(2008-10#1)(2011-2#3)
in irradiation##2##2##(2012-2#1)(2013-1#1)
in irrigated##2##2##(2008-10#2)
in irrigation from the I2 to I3##2##7##(2008-12#2)
in irrigation water##7##3##(2008-10#7)
in irrigation##9##2##(2008-10#7)(2008-12#2)
in irritable bowel syndrome##2##4##(2007-10#1)(2010-6#1)
in irritable bowel##3##3##(2007-10#1)(2008-4#1)(2010-6#1)
in ischaemic stroke patients##3##4##(2008-8#3)
in ischaemic stroke##4##3##(2008-7#1)(2008-8#3)
in ischaemic##6##2##(2008-10#1)(2008-7#2)(2008-8#3)
in ischemic heart##3##3##(1996-9#1)(2012-12#1)(2013-1#1)
in ischemic preconditioning##2##3##(1996-9#1)(2007-8#1)
in ischemic stroke##8##3##(2007-10#6)(2008-8#1)(2012-12#1)
in ischemic##20##2##(1993-6#1)(1995-12#1)(1996-2#1)(1996-9#4)(2007-10#6)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
in islet cells##2##3##(1995-11#1)(2010-11#1)
in islet##8##2##(1995-11#1)(1995-8#2)(1996-2#1)(2008-11#2)(2010-11#2)
in islets##7##2##(1995-11#2)(1995-8#2)(2008-4#1)(2008-5#1)(2010-11#1)
in isocratic mode##3##3##(2008-10#1)(2010-11#1)(2010-3#1)
in isocratic##4##2##(2008-10#2)(2010-11#1)(2010-3#1)
in isolate##3##2##(2008-10#3)
in isolated adult rat##2##4##(1994-6#2)
in isolated and##3##3##(1995-5#1)(2008-5#2)
in isolated enterocytes of##2##4##(1994-6#1)(1997-6#1)
in isolated hepatocytes was##2##4##(1990-8#1)(1994-8#1)
in isolated hepatocytes##9##3##(1990-8#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#3)(1994-8#1)(1995-11#1)
in isolated mitochondria##2##3##(1991-3#1)(1995-11#1)
in isolated perfused rat hearts##2##5##(1991-9#1)(1995-3#1)
in isolated perfused rat##3##4##(1991-9#1)(1995-3#1)(2008-11#1)
in isolated populations##2##3##(2008-9#1)(2010-8#1)
in isolated rabbit gastric##2##4##(1995-12#2)
in isolated rabbit##4##3##(1990-7#1)(1995-12#3)
in isolated rat aorta##2##4##(1995-12#2)
in isolated rat hepatocytes##6##4##(1990-5#1)(1992-3#1)(1993-3#1)(1995-11#1)(1996-2#2)
in isolated rat##12##3##(1990-5#1)(1992-3#1)(1993-3#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-2#2)(1996-5#1)
in isolated##73##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-11#4)(1994-6#7)(1994-8#3)(1995-11#4)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
in isolates from##8##3##(1997-3#1)(2007-12#1)(2008-10#6)
in isolates of##4##3##(1995-8#1)(2008-10#3)
in isolates##19##2##(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#16)
in isolation and##2##3##(2008-5#1)(2011-2#1)
in isolation##25##2##(1991-5#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
in isopropanol##4##2##(1991-5#2)(2008-10#1)(2008-11#1)
in isotropic third-order nonlinear media with magneto-optic properties##2##8##(2007-12#2)
in isotropic##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
in isozyme##3##2##(1991-2#1)(2008-10#2)
in it and##2##3##(1996-12#1)(2008-3#1)
in it##10##2##(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#1)
in its Japanese victims##2##4##(1997-4#2)
in its N-terminal##2##3##(1995-8#1)(2011-1#1)
in its N-terminus##2##3##(1991-5#1)(2012-2#1)
in its ability to##9##4##(1990-11#1)(1991-3#1)(2008-10#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
in its absence##4##3##(1993-8#1)(1997-7#1)(2008-10#2)
in its active##2##3##(1991-6#1)(1993-11#1)
in its activity##2##3##(1997-1#1)(2008-8#1)
in its anti-invasive action##2##4##(2008-11#2)
in its detection##2##3##(2007-7#1)(2013-1#1)
in its diagnosis##2##3##(2007-5#1)(2009-9#1)
in its earliest##2##3##(2010-10#1)(2010-9#1)
in its early stages##3##4##(2007-7#1)(2011-2#2)
in its early##4##3##(2007-7#1)(2010-8#1)(2011-2#2)
in its effects##2##3##(2008-10#1)(2008-5#1)
in its elimination of##2##4##(1997-7#1)(2009-2#1)
in its environment##3##3##(2008-3#1)(2008-7#1)(2009-12#1)
in its expression in the CA1 region##2##7##(1995-12#2)
in its expression in##3##4##(1995-12#2)(2009-9#1)
in its expression##4##3##(1995-12#2)(2006-10#1)(2009-9#1)
in its first##2##3##(1995-1#1)(2008-5#1)
in its functional##2##3##(2008-9#1)(2009-9#1)
in its implementation##2##3##(1996-1#1)(2009-4#1)
in its infancy##9##3##(1995-5#1)(1996-2#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
in its management##2##3##(1991-2#1)(2013-1#1)
in its native##2##3##(1990-11#1)(1993-11#1)
in its natural##4##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
in its own plane##3##4##(2007-11#1)(2008-3#2)
in its own right##4##4##(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
in its own##12##3##(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
in its pathogenesis##5##3##(1991-3#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-1#1)
in its pattern of##2##4##(1991-5#1)(2013-8#1)
in its performance##2##3##(2008-10#1)(2008-2#1)
in its pharmaceutical formulation##2##4##(2008-10#2)
in its pharmaceutical formulations##2##4##(2008-10#2)
in its pharmaceutical##4##3##(2008-10#4)
in its potential##2##3##(2008-10#2)
in its program##2##3##(1993-1#1)(2008-7#1)
in its pure form##2##4##(2008-10#2)
in its pure##3##3##(2008-10#3)
in its putative##2##3##(1994-12#1)(2009-9#1)
in its recognition by##2##4##(1994-3#1)(1995-2#1)
in its reduced##2##3##(1993-11#1)(1997-7#1)
in its regulation##2##3##(1994-11#1)(2006-6#1)
in its response##2##3##(2008-10#1)(2009-12#1)
in its screening##2##3##(1991-7#1)(1997-2#1)
in its use##2##3##(2008-11#1)(2009-7#1)
in its value##2##3##(2008-2#1)(2008-3#1)
in its various##2##3##(2008-11#1)(2012-12#1)
in its##304##2##(1990-10#1)(1990-11#2)(1990-2#4)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#3)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#5)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#6)(2006-10#2)(2006-6#1)(2007-11#3)(2007-12#5)(2007-5#2)(2007-7#3)(2008-1#3)(2008-10#44)(2008-11#15)(2008-12#5)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#14)(2008-9#4)(2009-10#5)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#2)
in itself##9##2##(1990-12#1)(1994-1#1)(1996-1#1)(1997-6#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
in jM##2##2##(1997-6#2)
in jasmonic acid production##2##4##(2008-5#2)
in jaw##2##2##(2007-12#1)(2008-9#1)
in jejunal##2##2##(1991-9#1)(1994-6#1)
in jet turbines##2##3##(2008-11#2)
in job satisfaction##2##3##(2008-12#1)(2013-1#1)
in job##4##2##(2008-11#1)(2008-12#1)(2009-5#1)(2013-1#1)
in joint##3##2##(1992-12#1)(2010-10#1)(2011-2#1)
in jordan##5##2##(2007-7#1)(2008-1#2)(2008-4#1)(2012-3#1)
in judgment##2##2##(2007-12#1)(2009-9#1)
in juice##2##2##(2008-10#2)
in jujube fruit##3##3##(2008-10#3)
in junD##2##2##(1996-12#2)
in junction dynamics##2##3##(2009-10#1)(2012-2#1)
in junction##3##2##(2009-10#2)(2012-2#1)
in just one step##2##4##(2008-3#2)
in just##7##2##(1996-2#1)(2008-10#1)(2008-3#2)(2008-6#1)(2012-2#1)(2013-8#1)
in juvenile and##2##3##(2012-2#1)(2013-1#1)
in juvenile##9##2##(1993-5#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
in kaart##2##2##(2012-12#2)
in karyotype##2##2##(1994-12#1)(2008-12#1)
in kcat/Km of##3##3##(1995-2#3)
in keeping with the##7##4##(1994-1#1)(1994-12#1)(1995-1#1)(1997-8#1)(2008-12#1)(2008-7#1)(2009-8#1)
in keeping with##11##3##(1994-1#1)(1994-12#1)(1995-1#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)
in keeping##14##2##(1992-9#1)(1994-1#1)(1994-12#1)(1995-1#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
in kenkey##2##2##(1997-4#2)
in keratinocyte differentiation##2##3##(1994-3#1)(2008-4#1)
in keratinocytes##4##2##(1991-9#1)(2008-11#1)(2009-6#1)(2011-2#1)
in kernels of##4##3##(2008-10#4)
in kernels##7##2##(2008-10#7)
in kerosene##6##2##(2008-10#6)
in key##3##2##(1997-3#1)(2009-8#1)(2012-3#1)
in khuzestan##2##2##(2012-2#1)(2013-1#1)
in kidney and liver##3##4##(1992-6#1)(2008-6#1)(2013-1#1)
in kidney and##7##3##(1992-6#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-8#1)(2008-6#1)(2013-1#1)
in kidney diseases##2##3##(1990-8#1)(2008-4#1)
in kidney failure##2##3##(2008-11#1)(2012-12#1)
in kidney transplant recipients##2##4##(2007-7#1)(2008-1#1)
in kidney transplant##3##3##(1994-5#1)(2007-7#1)(2008-1#1)
in kidney##34##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-11#2)(1994-5#1)(1995-3#2)(1997-8#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#3)
in kidneys with##2##3##(1996-6#2)
in kidneys##6##2##(1994-5#2)(1996-6#2)(1997-7#1)(2009-6#1)
in killing##6##2##(1990-7#1)(2008-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
in kinase##2##2##(2009-10#1)(2012-12#1)
in kindergarten##3##2##(2008-12#2)(2013-1#1)
in kindled rats##2##3##(1990-5#1)(1992-12#1)
in kinetic##3##2##(1996-7#1)(2008-10#1)(2009-6#1)
in kitten heart##2##3##(1995-11#2)
in kitten##3##2##(1993-12#1)(1995-11#2)
in knee arthroplasty##4##3##(2011-2#4)
in knee##7##2##(1992-3#1)(2007-8#1)(2008-12#1)(2011-2#4)
in knockout mice##2##3##(2008-8#1)(2012-12#1)
in knockout##3##2##(2008-8#1)(2012-12#2)
in knowledge and##2##3##(2010-3#1)(2013-1#1)
in knowledge##14##2##(1992-2#1)(1995-1#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in known##3##2##(1990-5#1)(1993-9#1)(2012-1#1)
in korea##2##2##(1990-10#1)(2008-9#1)
in korean##2##2##(2008-10#1)(2010-1#1)
in lab##3##2##(2008-10#1)(2012-3#2)
in labeled##2##2##(1993-11#1)(2008-3#1)
in labeling##5##2##(1990-7#1)(1997-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
in labelling##2##2##(2008-1#2)
in laboratories##5##2##(1991-9#1)(1995-3#1)(2008-11#1)(2008-8#1)(2013-1#1)
in laboratory and##2##3##(2008-10#1)(2009-3#1)
in laboratory animals##3##3##(2007-11#1)(2008-10#1)(2013-7#1)
in laboratory automation##3##3##(2008-10#3)
in laboratory bioassays##2##3##(1992-8#1)(2011-2#1)
in laboratory conditions##4##3##(2008-10#3)(2008-3#1)
in laboratory cultures##2##3##(1994-8#2)
in laboratory experiments and the##2##5##(2008-10#2)
in laboratory experiments and##4##4##(2008-10#2)(2008-3#1)(2010-5#1)
in laboratory experiments##5##3##(2008-10#3)(2008-3#1)(2010-5#1)
in laboratory medicine##2##3##(1994-12#2)
in laboratory or##3##3##(1995-9#1)(2007-11#1)(2008-10#1)
in laboratory##58##2##(1991-12#1)(1992-8#1)(1993-12#1)(1994-12#3)(1994-8#2)(1995-6#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#2)(2008-10#21)(2008-12#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-7#1)
in labour##4##2##(1993-10#1)(1994-5#1)(2013-1#2)
in lacking##3##2##(1991-12#1)(2012-2#1)(2013-7#1)
in lacquer##2##2##(2008-10#2)
in lactate dehydrogenase##2##3##(1994-6#1)(1995-3#1)
in lactate##7##2##(1990-11#1)(1990-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)
in lactating##5##2##(1990-11#1)(1991-12#1)(2011-2#3)
in lactic acid##2##3##(2008-6#1)(2012-2#1)
in lactic##3##2##(2008-6#1)(2010-10#1)(2012-2#1)
in lairage##2##2##(1994-7#2)
in lake and##3##3##(2008-10#1)(2012-3#2)
in lake sediment samples##2##4##(2008-10#2)
in lake water samples##3##4##(2008-10#3)
in lake water##5##3##(2008-10#5)
in lake##12##2##(1991-8#1)(2008-10#9)(2012-3#2)
in lakes##3##2##(2008-5#1)(2008-9#2)
in lambda##6##2##(1990-5#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)
in lambs##8##2##(1990-3#1)(1990-6#1)(1991-8#1)(1996-12#4)(2008-7#1)
in lamin##2##2##(2011-2#2)
in lamina##5##2##(1997-2#1)(1997-3#2)(2008-7#2)
in laminae I and II of the##2##7##(1995-12#1)(1997-2#1)
in laminae I and II##4##5##(1995-12#2)(1997-2#2)
in laminar##3##2##(2008-3#2)(2008-9#1)
in land plants and algae##2##5##(2012-2#2)
in land plants and##3##4##(2012-2#3)
in land plants##5##3##(2009-6#1)(2012-2#4)
in land##9##2##(1990-9#1)(2008-10#1)(2009-6#1)(2010-7#1)(2012-2#4)(2013-8#1)
in landfill gas##3##3##(2008-10#3)
in landfill leachates##2##3##(2008-10#2)
in landfill##6##2##(2008-10#5)(2012-1#1)
in landscape##2##2##(2008-10#1)(2013-1#1)
in language##4##2##(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)
in laparoscopic surgery##3##3##(1993-12#1)(1995-1#1)(2008-10#1)
in laparoscopic##8##2##(1993-12#2)(1995-1#2)(2008-10#2)(2012-12#2)
in large amounts##5##3##(1992-6#2)(2008-11#1)(2008-6#1)(2011-1#1)
in large antral follicles##2##4##(2008-9#2)
in large artery##3##3##(2007-10#2)(2013-8#1)
in large excess##3##3##(2008-10#3)
in large families##2##3##(2012-3#2)
in large field plots##2##4##(2008-10#2)
in large field##3##3##(2008-10#2)(2010-10#1)
in large groups##2##3##(2008-10#1)(2010-8#1)
in large neurons than##2##4##(1996-12#2)
in large neurons##3##3##(1996-12#3)
in large numbers and##2##4##(2008-4#1)(2012-2#1)
in large numbers##6##3##(1997-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
in large part by the##2##5##(2007-8#1)(2008-1#1)
in large part by##3##4##(1993-2#1)(2007-8#1)(2008-1#1)
in large part to##3##4##(1995-12#1)(2008-9#1)(2009-12#1)
in large part##14##3##(1993-2#1)(1995-12#1)(1995-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
in large quantities in##2##4##(1994-8#1)(2008-10#1)
in large quantities##8##3##(1994-8#1)(2008-10#4)(2008-11#2)(2008-6#1)
in large quantity##2##3##(2008-8#1)(2011-1#1)
in large scale##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
in large urban areas##2##4##(1992-12#1)(2008-3#1)
in large urban##3##3##(1992-12#1)(1995-5#1)(2008-3#1)
in large##127##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-3#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#7)(2009-12#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#1)
in large-scale production##2##3##(2008-11#2)
in large-scale##10##2##(2008-11#4)(2008-3#1)(2008-7#2)(2009-6#1)(2009-8#1)(2012-3#1)
in larger groups of patients##2##5##(1995-11#1)(1996-7#1)
in larger groups##4##3##(1995-11#1)(1996-7#1)(2008-8#2)
in larger studies##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
in larger##19##2##(1991-4#1)(1995-11#1)(1996-7#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
in larvae##4##2##(1993-9#1)(2008-12#1)(2010-8#2)
in larval drug concentrations##2##4##(1995-2#2)
in larval growth##3##3##(2007-5#2)(2010-8#1)
in larval##11##2##(1995-2#2)(2007-5#2)(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
in laryngeal##4##2##(1991-4#1)(2011-2#2)(2012-3#1)
in laser material processing##2##4##(2008-3#2)
in laser performance##2##3##(2008-2#1)(2008-3#1)
in laser resonators##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
in laser##27##2##(1993-6#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#13)
in laser-enhanced ionization##2##3##(2008-10#2)
in laser-induced##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
in lasers##2##2##(2007-11#1)(2008-2#1)
in last##3##2##(2008-11#1)(2009-3#1)(2010-8#1)
in late 1997##2##3##(2008-9#1)(2011-1#1)
in late 1998##2##3##(2008-10#1)(2011-1#1)
in late blight##2##3##(2008-10#2)
in late fall##2##3##(2008-10#1)(2011-2#1)
in late normal tissue##2##4##(1995-8#1)(2008-6#1)
in late spring##2##3##(2008-10#1)(2011-2#1)
in late stages of##3##4##(1994-12#1)(2011-3#2)
in late stages##4##3##(1994-12#1)(2010-12#1)(2011-3#2)
in late##46##2##(1990-11#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-9#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-2#1)
in latency##3##2##(1992-9#1)(1996-5#1)(2011-2#1)
in latent period##2##3##(2008-10#2)
in latent##4##2##(1994-5#1)(2008-10#3)
in later life##8##3##(1995-12#1)(2008-11#1)(2009-8#1)(2012-2#3)(2013-1#2)
in later stages##2##3##(2008-2#1)(2013-8#1)
in later##17##2##(1993-6#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-2#4)(2013-1#2)(2013-8#1)
in lateral root##2##3##(2008-8#1)(2011-1#1)
in lateral##9##2##(1993-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-1#3)
in layer IV of##3##4##(1995-2#1)(2008-1#2)
in layer IV##8##3##(1993-12#2)(1995-2#3)(1997-3#1)(2008-1#2)
in layer##16##2##(1993-12#2)(1994-2#2)(1995-12#1)(1995-2#3)(1997-3#1)(1997-6#1)(2008-1#2)(2008-11#2)(2008-5#1)(2013-1#1)
in layers I##2##3##(1993-12#1)(1995-12#1)
in layers II and##2##4##(1994-2#2)
in layers II##6##3##(1993-12#1)(1994-2#4)(1997-2#1)
in layers##11##2##(1993-12#3)(1994-2#5)(1995-12#1)(1997-2#1)(2007-11#1)
in lead silicate glasses##2##4##(2007-12#2)
in lead##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2010-1#2)
in lead-treated rats##2##3##(2008-7#2)
in leadership##4##2##(2008-1#1)(2008-11#1)(2010-10#1)(2012-3#1)
in leading##2##2##(1993-6#1)(2008-11#1)
in leaf and##4##3##(2008-10#3)(2013-8#1)
in leaf dip##3##3##(2008-10#1)(2011-2#2)
in leaf discs of##2##4##(2008-10#2)
in leaf extracts from##2##4##(2008-10#2)
in leaf lesions##2##3##(2008-10#2)
in leaf temperature##2##3##(2008-10#2)
in leaf tissue##2##3##(2008-10#1)(2013-8#1)
in leaf tissues##2##3##(2008-10#2)
in leaf##42##2##(2008-10#28)(2008-12#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-5#1)(2012-7#1)(2012-9#1)(2013-8#3)
in leafhoppers##2##2##(2008-10#2)
in lean and##3##3##(1997-7#1)(2008-3#2)
in lean mass##2##3##(2008-5#1)(2011-2#1)
in lean##11##2##(1995-5#4)(1997-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2011-2#1)
in learning and development goals##2##5##(2011-1#2)
in learning and memory##11##4##(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-8#1)(2012-2#2)
in learning and##15##3##(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#2)(2009-8#1)(2011-1#2)(2012-2#2)
in learning is##2##3##(2008-11#1)(2009-7#1)
in learning##27##2##(1993-12#1)(1993-3#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)
in leather##3##2##(2008-10#2)(2009-12#1)
in leaves and roots##2##4##(2008-12#1)(2009-8#1)
in leaves and stems##3##4##(2008-10#3)
in leaves and##10##3##(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
in leaves from##2##3##(2008-10#2)
in leaves of##12##3##(2008-10#7)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#2)
in leaves was##2##3##(2007-1#1)(2008-10#1)
in leaves##47##2##(2007-1#1)(2008-10#27)(2008-12#2)(2008-5#1)(2008-8#3)(2008-9#3)(2009-8#1)(2011-10#4)(2012-2#1)(2012-3#1)(2013-1#3)
in left ventricular##4##3##(1994-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
in left##12##2##(1994-12#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
in left-to-right##2##2##(2008-11#1)(2010-10#1)
in leg##2##2##(1997-4#1)(2008-5#1)
in legged##2##2##(2007-12#2)
in legume##2##2##(2008-10#2)
in length and contains an open reading frame of##2##9##(1993-2#2)
in length and contains an open reading frame##3##8##(1993-2#2)(1994-12#1)
in length and contains an##4##5##(1993-2#2)(1994-12#1)(2008-8#1)
in length and contains##6##4##(1990-12#1)(1993-2#2)(1994-12#1)(1997-7#1)(2008-8#1)
in length and##14##3##(1990-12#1)(1993-2#2)(1994-12#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)
in length of stay##7##4##(1993-12#1)(1994-12#2)(1994-3#2)(1995-12#1)(2012-2#1)
in length of##12##3##(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-12#1)(1997-4#2)(2008-1#1)(2012-2#1)(2013-1#1)
in length to##2##3##(1994-12#1)(1997-4#1)
in length with##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
in length##80##2##(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-8#1)(1994-12#4)(1994-3#2)(1995-12#2)(1995-3#1)(1996-4#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
in length) were##2##3##(1990-2#1)(2013-7#1)
in length)##9##2##(1990-2#1)(1990-5#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-12#1)(2013-7#1)
in lengthenings##2##2##(2007-8#2)
in lens##2##2##(2007-12#1)(2008-3#1)
in lens-axicon##2##2##(2008-2#2)
in leprosy##8##2##(1991-11#1)(1991-6#1)(2007-7#5)(2012-12#1)
in leptin and##2##3##(2013-8#2)
in leptin##4##2##(2008-10#1)(2013-8#3)
in lesion area##2##3##(2012-3#2)
in lesion size##3##3##(2007-10#1)(2008-10#2)
in lesion##9##2##(1997-8#1)(2007-10#1)(2008-10#4)(2010-12#1)(2012-3#2)
in lesion-induced##2##2##(1991-2#1)(1993-3#1)
in lesioned##3##2##(1992-3#1)(1993-12#1)(1993-5#1)
in lesions##4##2##(2008-10#3)(2008-12#1)
in less than 1 s##3##5##(2007-12#1)(2008-3#2)
in less than 1##10##4##(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#3)(2012-3#2)
in less than 1% of##2##5##(1996-11#1)(1997-1#1)
in less than 1%##3##4##(1996-11#1)(1996-5#1)(1997-1#1)
in less than 10 min##4##5##(2008-10#4)
in less than 10##5##4##(2008-10#4)(2008-11#1)
in less than 10% of cases##2##6##(2010-12#1)(2012-2#1)
in less than 10min##2##4##(2008-10#2)
in less than 2 min##2##5##(2008-10#2)
in less than 2##4##4##(2008-10#3)(2008-11#1)
in less than 30##3##4##(2008-10#1)(2008-6#1)(2011-1#1)
in less than 4 min##2##5##(2008-10#2)
in less than 5 min##3##5##(1993-3#1)(2008-10#1)(2011-1#1)
in less than 5##4##4##(1993-3#1)(2008-10#2)(2011-1#1)
in less than 5% of##3##5##(2007-10#1)(2008-5#1)(2009-8#1)
in less than a##3##4##(2007-12#1)(2008-11#1)(2012-3#1)
in less than##64##3##(1993-3#1)(1995-11#1)(1996-11#2)(1996-5#1)(1997-1#1)(1997-4#1)(2007-10#2)(2007-12#3)(2008-10#27)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#2)
in less time##2##3##(2007-8#1)(2011-2#1)
in less##80##2##(1993-3#1)(1995-11#1)(1996-11#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-12#3)(2007-8#2)(2008-10#30)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#4)
in lethal##3##2##(1995-2#1)(2009-5#1)(2013-1#1)
in lettuce and##5##3##(2008-10#4)(2008-5#1)
in lettuce to##2##3##(2008-5#1)(2013-8#1)
in lettuce##17##2##(2008-10#13)(2008-5#3)(2013-8#1)
in leukemia##2##2##(1991-3#1)(2011-2#1)
in leukemic cells from##2##4##(1991-9#1)(2008-9#1)
in leukemic cells##3##3##(1991-9#1)(1995-2#1)(2008-9#1)
in leukemic##4##2##(1991-4#1)(1991-9#1)(1995-2#1)(2008-9#1)
in leukocyte##3##2##(2009-12#1)(2009-6#1)(2010-5#1)
in leukocytes or platelets##2##4##(1990-8#2)
in leukocytes##5##2##(1990-8#2)(1991-8#1)(1997-4#1)(2009-7#1)
in level and##2##3##(1996-3#1)(2010-5#1)
in level of##4##3##(1990-5#1)(1996-7#1)(2012-3#2)
in level##8##2##(1990-5#1)(1996-3#1)(1996-7#1)(2010-5#1)(2011-2#2)(2012-3#2)
in levels of##12##3##(1991-12#1)(1992-3#1)(1993-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)
in levels##15##2##(1991-12#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-12#2)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)
in lexical##2##2##(2008-4#1)(2009-9#1)
in lichen samples##3##3##(2008-10#3)
in lichen##9##2##(1992-3#1)(2007-7#1)(2008-10#3)(2010-6#3)(2012-1#1)
in lichens and plants##2##4##(2008-10#2)
in lidar data##3##3##(2008-3#3)
in lidar measurements##2##3##(2008-2#1)(2008-3#1)
in lidar##8##2##(2008-2#3)(2008-3#5)
in lieu of##6##3##(1996-12#1)(1997-3#1)(2008-7#2)(2012-2#1)(2013-8#1)
in life and##2##3##(2008-7#1)(2010-11#1)
in life expectancy##5##3##(1993-11#1)(1996-3#3)(2011-2#1)
in life science##2##3##(2012-2#1)(2013-1#1)
in life##42##2##(1990-3#1)(1991-6#1)(1993-11#1)(1995-5#1)(1996-3#3)(1996-5#1)(2007-10#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)
in life-history traits##5##3##(2008-8#3)(2008-9#1)(2013-7#1)
in life-history##6##2##(2008-8#4)(2008-9#1)(2013-7#1)
in life-threatening##2##2##(1996-9#1)(2011-2#1)
in lifestyle##4##2##(2008-1#3)(2008-10#1)
in lifetime##4##2##(2007-12#1)(2008-9#1)(2013-1#2)
in ligand binding##2##3##(1990-8#1)(2012-2#1)
in ligand##3##2##(1990-8#1)(1995-6#1)(2012-2#1)
in ligand-dependent##2##2##(1995-2#1)(2008-10#1)
in light microscopy##3##3##(2008-5#1)(2008-9#2)
in light of current##4##4##(1991-12#1)(2008-11#1)(2008-2#1)(2008-9#1)
in light of new##2##4##(2008-9#1)(2010-12#1)
in light of previous##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
in light of the present##2##5##(2008-5#1)(2009-10#1)
in light of the##19##4##(1993-11#1)(1994-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in light of these##2##4##(1993-1#1)(2007-5#1)
in light of##47##3##(1991-1#1)(1991-12#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-2#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
in light scattering##2##3##(2008-3#2)
in light##63##2##(1991-1#1)(1991-12#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-2#1)(1996-6#1)(1997-6#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
in lignifying##2##2##(2008-11#2)
in lignin##3##2##(2008-6#2)(2009-8#1)
in limb reconstruction##2##3##(1996-3#1)(2008-8#1)
in limb##4##2##(1995-8#1)(1996-3#1)(2008-8#1)(2011-2#1)
in limbic and cortical##2##4##(1991-10#2)
in limbic and##3##3##(1991-10#3)
in limbs in which the main arteries##2##7##(1997-8#2)
in limited##11##2##(1993-2#1)(1995-9#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-6#1)(2011-2#3)(2013-1#1)
in limiting the##3##3##(2008-3#1)(2009-2#1)(2010-5#1)
in limiting##9##2##(1997-6#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-2#1)(2010-5#1)
in line with previous##2##4##(2008-1#1)(2008-11#1)
in line with the hypothesis that##3##6##(1990-12#1)(1996-5#1)(2008-10#1)
in line with the lack of##2##6##(1992-3#1)(2008-10#1)
in line with the##14##4##(1990-12#1)(1991-1#1)(1992-3#1)(1996-5#1)(2008-1#1)(2008-10#5)(2009-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
in line with##33##3##(1990-12#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in line##44##2##(1990-12#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-1#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
in lineages##4##2##(2008-10#3)(2012-3#1)
in linear models##2##3##(1992-6#1)(2011-2#1)
in linear##11##2##(1992-6#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#2)
in lines##3##2##(2008-10#3)
in linkage disequilibrium##2##3##(2008-12#1)(2012-3#1)
in linkage##7##2##(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2012-3#1)
in linking##4##2##(2008-3#1)(2009-7#1)(2012-12#1)(2012-3#1)
in lipase##2##2##(1994-7#1)(2008-8#1)
in lipid and##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
in lipid bilayer##2##3##(1993-11#1)(2011-1#1)
in lipid droplets##3##3##(2007-12#1)(2012-2#1)(2013-1#1)
in lipid metabolism##3##3##(1996-3#1)(2007-7#1)(2008-11#1)
in lipid packing##2##3##(2008-10#1)(2008-5#1)
in lipid peroxidation##4##3##(1990-3#1)(1996-9#1)(2009-8#1)(2013-1#1)
in lipid profile##2##3##(2008-1#1)(2013-1#1)
in lipid transport##2##3##(1992-9#1)(1995-6#1)
in lipid##40##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1992-9#2)(1993-11#1)(1995-6#1)(1996-3#1)(1996-9#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#3)(2008-8#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#3)
in lipids##4##2##(1994-11#1)(1994-6#1)(2008-12#1)(2013-1#1)
in lipolysis##2##2##(2008-3#1)(2008-5#1)
in lipophilic##2##2##(1994-11#1)(1997-6#1)
in lipoprotein##2##2##(2008-5#1)(2008-6#1)
in lipoproteins##2##2##(1993-12#1)(2013-8#1)
in liposomal##2##2##(2008-8#2)
in liposomes##3##2##(1994-12#2)(2008-8#1)
in lipstick##2##2##(2008-5#2)
in liquid and solid##2##4##(2008-10#2)
in liquid and##3##3##(1994-6#1)(2008-10#2)
in liquid are##2##3##(2008-2#2)
in liquid chromatography##3##3##(2008-10#2)(2010-7#1)
in liquid crystal materials##2##4##(2008-10#2)
in liquid crystal##3##3##(2008-10#3)
in liquid culture##6##3##(2008-10#4)(2013-1#2)
in liquid cultures##2##3##(2008-10#1)(2011-2#1)
in liquid egg##2##3##(2011-2#2)
in liquid media and##3##4##(2008-8#2)(2008-9#1)
in liquid media##8##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#2)(2010-4#1)
in liquid medium##4##3##(1990-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
in liquid nitrogen and##2##4##(2008-10#2)
in liquid nitrogen##9##3##(1990-11#1)(1990-12#1)(1992-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)
in liquid phase##3##3##(2008-10#3)
in liquid samples##2##3##(2007-12#1)(2008-10#1)
in liquid solutions##2##3##(2008-10#1)(2008-3#1)
in liquid whole##2##3##(2011-2#2)
in liquid##81##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1992-2#1)(1992-8#1)(1994-6#1)(2007-12#4)(2008-10#32)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-4#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#3)(2013-8#1)
in liquid-liquid extraction##2##3##(2008-10#2)
in liquid-liquid systems##3##3##(2008-2#3)
in liquid-liquid##5##2##(2008-10#2)(2008-2#3)
in liquid-solid interface##2##3##(2008-10#2)
in liquids##5##2##(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
in liquified##2##2##(1996-1#2)
in liquor##2##2##(2008-10#1)(2013-8#1)
in listener perceptions##2##3##(2011-1#2)
in literature##33##2##(1990-2#1)(1990-6#1)(1992-9#1)(1996-3#1)(2007-11#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
in lithium niobate##8##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)
in lithium##11##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#2)
in live animals##2##3##(1990-7#1)(2009-2#1)
in live cells##7##3##(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-6#1)
in live wheat leaves##2##4##(2008-10#2)
in live##20##2##(1990-7#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
in liver DNA##2##3##(1992-11#2)
in liver GST##2##3##(1997-7#1)(2008-7#1)
in liver ID1 mRNA levels##2##5##(1995-12#2)
in liver ID1##3##3##(1995-12#3)
in liver and muscle##2##4##(1996-12#1)(2008-10#1)
in liver and##10##3##(1990-12#2)(1990-7#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-8#1)(2012-2#2)
in liver cell##2##3##(1995-2#1)(1995-6#1)
in liver cells##7##3##(1994-6#2)(1995-6#1)(1997-1#1)(1997-4#1)(2008-10#1)(2010-5#1)
in liver cirrhosis and##2##4##(1991-5#1)(1997-7#1)
in liver cirrhosis##3##3##(1991-5#1)(1995-3#1)(1997-7#1)
in liver from reindeer##2##4##(1995-6#2)
in liver from##3##3##(1993-11#1)(1995-6#2)
in liver metastases##3##3##(1991-6#1)(1994-6#1)(2008-7#1)
in liver microsomes##4##3##(1991-2#1)(1994-8#1)(2011-3#2)
in liver of##3##3##(1990-7#1)(2010-5#1)(2012-2#1)
in liver only##2##3##(1990-11#1)(1997-7#1)
in liver regeneration##2##3##(1993-8#1)(2008-8#1)
in liver stroma and##2##4##(2013-1#2)
in liver tissue and##2##4##(1990-2#1)(2008-10#1)
in liver tissue##5##3##(1990-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
in liver ultrasound##3##3##(2008-7#3)
in liver##113##2##(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#4)(1994-8#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-6#4)(1996-12#2)(1997-1#1)(1997-4#2)(1997-7#3)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2010-5#5)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#3)(2012-2#3)(2013-1#9)(2013-8#1)
in liver-derived cells##2##3##(1994-6#1)(2011-2#1)
in livers##2##2##(1995-3#1)(2012-2#1)
in livestock##5##2##(1994-3#1)(1997-7#2)(2011-2#1)(2013-1#1)
in living animals##2##3##(2008-10#1)(2008-4#1)
in living cells by##4##4##(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
in living cells using##2##4##(2008-1#1)(2008-4#1)
in living cells##26##3##(1995-11#1)(2008-1#6)(2008-11#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-7#2)(2010-12#3)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
in living flies##2##3##(1995-6#2)
in living yeast cells##2##4##(1996-6#2)
in living##47##2##(1990-11#1)(1991-9#1)(1995-11#1)(1995-6#2)(1996-6#2)(2007-7#1)(2008-1#6)(2008-10#3)(2008-11#5)(2008-4#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
in lizards##8##2##(1991-5#1)(2008-10#2)(2008-7#1)(2010-3#4)
in loblolly pine##3##3##(2008-10#1)(2008-7#2)
in local bacterial resistance##2##4##(2008-10#2)
in local communities##2##3##(1991-1#1)(2009-2#1)
in local markets##3##3##(1993-2#1)(1997-1#2)
in local##50##2##(1990-5#1)(1990-8#1)(1991-1#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-9#1)(1997-1#2)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in localization##3##2##(1990-3#1)(1990-7#1)(2010-5#1)
in localized##9##2##(1991-2#1)(1992-2#1)(1992-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
in localizing the##2##3##(1995-11#1)(2009-9#1)
in localizing##5##2##(1995-11#1)(1995-6#1)(2008-12#1)(2009-9#1)(2012-12#1)
in locally advanced##6##3##(1990-6#1)(1991-8#1)(1994-6#1)(2007-10#1)(2007-4#1)(2008-10#1)
in locally##8##2##(1990-6#1)(1991-8#1)(1993-1#1)(1994-6#1)(2007-10#1)(2007-4#1)(2008-10#1)(2011-2#1)
in locating##3##2##(1993-12#1)(1995-1#1)(1996-7#1)
in location and##2##3##(1996-5#1)(2011-2#1)
in locomotion##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
in locusts##2##2##(1991-5#1)(2007-12#1)
in log##5##2##(1993-6#1)(2008-10#4)
in long bones and##3##4##(2007-11#3)
in long bones##7##3##(1995-6#1)(2007-11#6)
in long term care##5##4##(1993-2#1)(1994-12#1)(1994-3#1)(2008-12#1)(2012-12#1)
in long term##13##3##(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#4)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
in long##34##2##(1993-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#4)(2007-11#7)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
in long-distance##3##2##(2007-12#2)(2012-8#1)
in long-lasting##2##2##(1992-8#1)(2009-11#1)
in long-lived##2##2##(2008-8#1)(2008-9#1)
in long-term abstinent alcoholics##2##4##(1996-7#2)
in long-term care facilities##7##4##(1991-1#1)(1993-3#2)(1995-3#1)(1996-2#1)(1997-2#1)(2013-8#1)
in long-term care for##2##4##(1993-3#1)(1996-2#1)
in long-term care settings##3##4##(1997-1#2)(2009-4#1)
in long-term care##32##3##(1991-1#1)(1992-3#3)(1993-2#1)(1993-3#5)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#6)(1997-2#1)(2008-12#1)(2008-7#1)(2009-3#2)(2009-4#2)(2010-10#1)(2012-3#1)(2013-8#1)
in long-term cultured astrocytes##2##4##(1995-5#2)
in long-term cultures##4##3##(2008-11#3)(2013-7#1)
in long-term home health care##2##5##(1993-12#1)(1997-3#1)
in long-term management##2##3##(2008-8#1)(2010-11#1)
in long-term memory##3##3##(1992-11#1)(2009-6#1)(2013-8#1)
in long-term survivors of##3##4##(1996-1#1)(2008-7#1)(2010-3#1)
in long-term survivors##4##3##(1996-1#1)(1997-3#1)(2008-7#1)(2010-3#1)
in long-term##73##2##(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-2#1)(1993-3#6)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-2#2)(1996-3#2)(1996-7#2)(1997-1#6)(1997-2#1)(1997-3#2)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#3)(2009-4#2)(2009-6#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
in longer##3##2##(1995-1#1)(2007-12#1)(2008-7#1)
in longevity##3##2##(2008-10#1)(2009-12#1)(2012-3#1)
in longissimus muscle##2##3##(2010-4#2)
in longitudinal models##2##3##(2013-1#2)
in longitudinal studies##4##3##(1992-12#1)(1994-9#1)(2009-9#1)(2013-1#1)
in longitudinal##6##2##(1992-12#1)(1994-9#1)(2009-9#1)(2013-1#3)
in loose islets##3##3##(2008-5#3)
in loss of axon-Schwann cell interactions and collagen deposition##2##9##(2008-7#2)
in loss of##10##3##(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-1#1)(2013-1#1)
in loss was##2##3##(2008-2#1)(2008-3#1)
in loss##15##2##(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#2)(2011-1#1)(2013-1#1)
in low and intermediate##2##4##(2008-10#1)(2012-2#1)
in low and middle-income countries##2##5##(2008-10#2)
in low and##5##3##(2008-10#3)(2008-8#1)(2012-2#1)
in low birth weight##2##4##(2008-12#1)(2013-1#1)
in low concentration in##2##4##(2008-10#2)
in low concentration##4##3##(2008-10#3)(2008-12#1)
in low concentrations in##2##4##(2008-10#1)(2013-8#1)
in low concentrations##4##3##(1990-5#1)(1993-11#1)(2008-10#1)(2013-8#1)
in low cost##2##3##(2008-6#1)(2010-7#1)
in low resource##2##3##(2011-2#1)(2013-1#1)
in low serum##3##3##(2008-11#3)
in low##55##2##(1990-12#1)(1990-5#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
in low- and middle-income countries##2##5##(2010-11#1)(2012-12#1)
in low- and middle-income##3##4##(2010-11#1)(2011-2#1)(2012-12#1)
in low- and##4##3##(1992-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
in low-coherence##2##2##(2007-11#1)(2008-2#1)
in low-grade astrocytomas##2##3##(1994-8#1)(2008-7#1)
in low-grade##4##2##(1994-8#1)(2008-6#1)(2008-7#1)(2013-7#1)
in low-income countries##2##3##(2010-5#1)(2012-12#1)
in low-income##8##2##(2008-11#2)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in low-risk##3##2##(2013-1#3)
in low-threat##2##2##(2012-12#2)
in lower concentrations##3##3##(1996-9#1)(2008-10#1)(2013-8#1)
in lower elevation populations##2##4##(2012-7#2)
in lower eukaryotes##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
in lower extremities showing a##2##5##(1997-8#2)
in lower extremity##2##3##(2008-12#1)(2008-9#1)
in lower limb##3##3##(2007-11#1)(2013-1#2)
in lower##42##2##(1992-12#1)(1992-5#1)(1994-5#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-7#2)(2013-1#4)(2013-7#1)(2013-8#1)
in lowering the##5##3##(1993-1#1)(1995-2#1)(2007-10#2)(2008-1#1)
in lowering##6##2##(1993-1#1)(1994-8#1)(1995-2#1)(2007-10#2)(2008-1#1)
in lubricating oils##6##3##(2008-10#6)
in lubricating##7##2##(2008-10#7)
in luciferase activity##2##3##(1996-5#1)(2008-11#1)
in lumbar disc##2##3##(1997-3#1)(2007-11#1)
in lumbar spinal##2##3##(2007-8#2)
in lumbar##5##2##(1991-8#1)(1997-3#1)(2007-11#1)(2007-8#2)
in lumbosacral##2##2##(2007-8#1)(2008-7#1)
in lumen##3##2##(2009-1#1)(2011-3#2)
in luminance##2##2##(1992-8#1)(1996-2#1)
in luminescence##2##2##(2008-10#1)(2008-2#1)
in lung cancer mortality##2##4##(2008-2#1)(2013-1#1)
in lung cancer##11##3##(1993-8#1)(1994-6#1)(1996-3#1)(2007-8#1)(2008-2#2)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
in lung cancer]##2##3##(2008-1#1)(2012-2#1)
in lung cancers##2##3##(1993-8#1)(2009-11#1)
in lung colonization by##2##4##(1992-9#2)
in lung deposition##2##3##(1997-1#1)(2008-11#1)
in lung function##3##3##(1997-1#1)(2008-11#1)(2010-5#1)
in lung immune##3##3##(2008-10#2)(2008-6#1)
in lung parenchyma##3##3##(1991-12#2)(1992-1#1)
in lung resistance##2##3##(1992-3#2)
in lung transplantation##2##3##(2011-3#2)
in lung##58##2##(1990-5#1)(1990-6#1)(1991-12#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-8#2)(1994-1#1)(1994-5#1)(1994-6#1)(1995-8#2)(1996-3#1)(1997-1#2)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-6#1)(2009-11#1)(2009-4#1)(2010-5#1)(2011-2#3)(2011-3#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
in lungs##3##2##(1993-3#1)(1996-3#1)(2011-3#1)
in lymph node##3##3##(2008-9#1)(2012-3#2)
in lymph##5##2##(1997-8#1)(2008-10#1)(2008-9#1)(2012-3#2)
in lymphocyte and##2##3##(1996-12#1)(1997-4#1)
in lymphocyte##7##2##(1991-6#1)(1992-12#2)(1996-12#1)(1997-4#1)(2011-3#1)(2013-8#1)
in lymphocytes and##2##3##(1991-12#1)(2008-4#1)
in lymphocytes of##5##3##(1991-4#1)(1993-1#2)(1996-12#1)(2008-7#1)
in lymphocytes##17##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#1)(1993-1#2)(1993-8#1)(1994-2#1)(1995-12#1)(1996-12#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#2)
in lymphocytic##2##2##(2007-11#1)(2012-2#1)
in lymphoid cells##4##3##(1993-3#1)(1994-8#1)(2008-4#1)(2008-5#1)
in lymphoid organs##2##3##(2008-4#1)(2008-8#1)
in lymphoid##8##2##(1993-3#1)(1994-2#1)(1994-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)
in lymphoma##3##2##(2009-4#1)(2009-8#1)(2011-2#1)
in lysates of##3##3##(1993-9#1)(1994-6#1)(1995-8#1)
in lysates##4##2##(1993-9#1)(1994-6#1)(1994-8#1)(1995-8#1)
in lysosomal##4##2##(1992-12#1)(1993-9#1)(2009-8#1)(2012-12#1)
in lysosomes##5##2##(1990-11#1)(1992-11#1)(1992-12#2)(2010-11#1)
in mGuHCl##2##2##(1992-6#2)
in mPFC##3##2##(2008-11#1)(2008-7#2)
in mRNA expression##4##3##(1996-12#2)(2008-10#1)(2008-5#1)
in mRNA level##3##3##(1994-11#2)(1996-12#1)
in mRNA levels##3##3##(1993-5#1)(1994-11#1)(1996-12#1)
in mRNA stability##2##3##(2008-11#2)
in mRNA##14##2##(1993-5#1)(1993-8#1)(1994-11#3)(1995-2#1)(1996-12#4)(2008-10#1)(2008-11#2)(2008-5#1)
in mRNAs##2##2##(1996-2#1)(2008-7#1)
in macaques with##2##3##(1991-2#2)
in macaques##3##2##(1991-2#2)(1991-9#1)
in macromolecular##2##2##(2008-10#1)(2008-4#1)
in macrophage##5##2##(1992-5#1)(1993-8#1)(1995-2#1)(2008-11#1)(2008-4#1)
in macrophages and##2##3##(1993-8#1)(1994-8#1)
in macrophages##17##2##(1990-6#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-2#1)(2008-11#1)(2008-8#1)(2013-1#2)(2013-8#1)
in macroscopic##2##2##(2008-10#1)(2013-7#1)
in macular##2##2##(2008-7#1)(2013-1#1)
in magnetic resonance imaging##3##4##(1995-5#1)(2007-11#1)(2010-5#1)
in magnetic resonance##5##3##(1995-5#1)(2007-11#1)(2008-10#1)(2010-5#1)(2013-1#1)
in magnetic##8##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-5#1)(2013-1#1)
in magneto-optical##3##2##(2007-12#2)(2008-2#1)
in magnitude with##2##3##(1997-2#1)(2008-5#1)
in magnitude##15##2##(1990-10#1)(1993-3#1)(1994-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-6#1)
in mainland China##2##3##(2011-2#1)(2013-8#1)
in mainland##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
in mainstream cigarette smoke by ultra performance liquid chromatography##2##9##(2011-1#2)
in mainstream cigarette smoke by##4##5##(2011-1#3)(2013-8#1)
in mainstream cigarette smoke##6##4##(2011-1#5)(2013-8#1)
in mainstream##11##2##(1996-1#1)(2008-9#1)(2011-1#6)(2011-2#2)(2013-8#1)
in maintaining a##4##3##(1995-12#1)(1997-6#1)(2007-9#1)(2008-11#1)
in maintaining the integrity of##2##5##(1990-2#1)(2008-9#1)
in maintaining the##10##3##(1990-2#1)(1995-6#2)(1995-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#1)
in maintaining##45##2##(1990-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in maintenance##4##2##(1990-12#1)(2007-7#1)(2009-6#1)(2013-7#1)
in maize (Zea mays L##2##5##(2008-12#1)(2012-3#1)
in maize and##2##3##(2008-10#1)(2011-2#1)
in maize ears##2##3##(2008-10#2)
in maize kernels##2##3##(2008-10#2)
in maize leaves##3##3##(1994-8#1)(2008-10#2)
in maize silage##3##3##(2008-10#3)
in maize##39##2##(1994-8#1)(2008-10#25)(2008-12#4)(2009-10#1)(2009-8#2)(2011-2#2)(2012-2#1)(2012-3#3)
in major abdominal and thoracic surgical patients##2##7##(1993-12#2)
in major depression##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
in major##26##2##(1991-2#1)(1992-4#1)(1993-12#2)(1997-5#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in majority of cases##2##4##(2010-7#1)(2011-2#1)
in majority of the##2##4##(2007-7#1)(2010-8#1)
in majority of##5##3##(2007-7#1)(2008-11#1)(2010-7#1)(2010-8#1)(2011-2#1)
in making a##3##3##(1993-12#1)(1996-2#1)(2010-12#1)
in making decisions##3##3##(1996-2#1)(2009-10#1)(2011-2#1)
in making the diagnosis of##2##5##(2008-12#1)(2011-2#1)
in making the##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
in making##28##2##(1990-2#1)(1993-12#1)(1994-3#2)(1995-2#1)(1996-2#3)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#2)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
in malacostracan##2##2##(2007-12#2)
in malaria clinical research##2##4##(2009-6#2)
in malaria clinical##3##3##(2009-6#3)
in malaria parasites##2##3##(2012-3#2)
in malaria##10##2##(1991-5#1)(1994-8#1)(2009-6#4)(2010-1#1)(2012-12#1)(2012-3#2)
in male F344 rats##2##4##(1992-3#2)
in male Fischer 344 rats##3##5##(1992-12#1)(1994-3#1)(2008-7#1)
in male Fischer##5##3##(1990-3#1)(1992-12#1)(1993-12#1)(1994-3#1)(2008-7#1)
in male Sprague-Dawley rats##4##4##(1995-3#1)(1996-2#1)(2008-4#1)(2011-2#1)
in male Tg##3##3##(2008-9#3)
in male and female Tg##5##5##(2008-8#1)(2008-9#4)
in male and female mice##3##5##(1995-11#1)(2008-9#2)
in male and female##18##4##(1994-2#1)(1995-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#9)(2011-1#1)(2012-2#1)(2013-7#1)
in male and##19##3##(1994-2#1)(1995-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#9)(2011-1#1)(2012-2#2)(2013-7#1)
in male dogs##2##3##(1996-11#2)
in male germ cells##2##4##(1997-3#1)(2012-2#1)
in male meiosis##3##3##(2008-12#1)(2008-5#2)
in male mice##5##3##(1990-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
in male or female Tg##5##5##(2008-9#5)
in male or female p53 haploinsufficient mice exposed to 0##2##10##(2008-9#2)
in male or female p53 haploinsufficient mice exposed to##4##9##(2008-8#1)(2008-9#3)
in male or female p53 haploinsufficient mice##5##7##(2008-8#1)(2008-9#4)
in male or female p53##6##5##(2008-8#1)(2008-9#5)
in male or female##11##4##(2008-8#1)(2008-9#10)
in male patients with##4##4##(1996-7#1)(2007-7#2)(2011-2#1)
in male patients##12##3##(1990-5#1)(1991-2#1)(1996-7#1)(2007-10#1)(2007-7#3)(2008-4#1)(2009-11#1)(2011-2#2)(2013-1#1)
in male rats##19##3##(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#5)
in male sexual##2##3##(1991-2#1)(1995-12#1)
in male skin##3##3##(2008-5#3)
in male than in female rats##2##6##(1994-11#1)(1994-2#1)
in male##132##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1991-2#2)(1992-11#2)(1992-12#1)(1992-3#3)(1993-12#1)(1994-11#3)(1994-2#5)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#4)(1995-8#1)(1996-11#3)(1996-2#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-12#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#25)(2009-10#1)(2009-11#1)(2009-5#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)
in males and females exposed to dichloroacetic acid##2##8##(2008-9#2)
in males and females exposed to##3##6##(2008-9#3)
in males and females receiving 3 mg/kg or more##2##9##(2008-9#2)
in males and females##12##4##(1990-8#1)(1994-2#1)(2008-1#1)(2008-9#8)(2013-7#1)
in males and##24##3##(1990-8#1)(1991-6#1)(1993-12#1)(1994-2#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-9#10)(2011-2#2)(2012-2#1)(2013-7#1)
in males but not##2##4##(2008-9#1)(2013-8#1)
in males but##3##3##(1994-6#1)(2008-9#1)(2013-8#1)
in males exposed to##2##4##(2008-8#1)(2008-9#1)
in males in##3##3##(1997-7#1)(2008-9#1)(2009-1#1)
in males than in females##9##5##(1990-12#1)(1992-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)
in males was##4##3##(1993-8#1)(1995-9#1)(2011-2#2)
in males while##2##3##(1997-7#1)(2007-12#1)
in males with##3##3##(1991-1#1)(2008-5#1)(2012-2#1)
in males##104##2##(1990-11#1)(1990-12#2)(1990-8#2)(1991-1#1)(1991-2#2)(1991-6#5)(1992-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#7)(1994-6#1)(1994-7#1)(1995-2#2)(1995-6#2)(1995-9#2)(1996-5#1)(1997-3#1)(1997-7#4)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#13)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
in malignancy##5##2##(1991-8#2)(1994-11#2)(2008-7#1)
in malignant cells##4##3##(1993-1#1)(1994-3#1)(2012-2#2)
in malignant glioma##4##3##(2008-5#1)(2008-8#1)(2011-2#2)
in malignant gliomas##4##3##(2008-12#2)(2008-7#2)
in malignant melanoma cells##2##4##(1991-5#1)(2011-2#1)
in malignant melanoma##5##3##(1991-5#1)(1993-8#2)(2007-10#1)(2011-2#1)
in malignant tissues##3##3##(2008-12#2)(2010-3#1)
in malignant transformation##4##3##(2008-6#2)(2010-12#1)(2012-12#1)
in malignant##36##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-8#2)(1994-3#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-12#4)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#4)
in malnourished##2##2##(1992-9#1)(2008-11#1)
in malpractice##4##2##(1991-12#1)(1993-12#1)(1993-2#1)(1995-5#1)
in mammalian and##2##3##(1994-11#1)(2008-11#1)
in mammalian brain##3##3##(1993-11#1)(2008-7#1)(2008-9#1)
in mammalian cell culture##3##4##(2008-11#2)(2008-7#1)
in mammalian cell cultures##3##4##(2008-11#3)
in mammalian cell##10##3##(2008-11#7)(2008-7#1)(2009-8#1)(2013-8#1)
in mammalian cells and##5##4##(1996-2#1)(2008-11#2)(2008-8#2)
in mammalian cells are##2##4##(1994-12#1)(2008-9#1)
in mammalian cells has been##2##5##(2008-11#1)(2011-1#1)
in mammalian cells has##4##4##(1995-6#1)(2008-11#1)(2008-7#1)(2011-1#1)
in mammalian cells##62##3##(1990-5#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-6#4)(1994-11#1)(1994-12#2)(1994-8#3)(1995-2#1)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2008-1#1)(2008-11#12)(2008-2#4)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)
in mammalian genomes##3##3##(1991-6#1)(1995-2#1)(2008-11#1)
in mammalian species##2##3##(1993-6#1)(2008-4#1)
in mammalian sperm##2##3##(1993-6#1)(2008-4#1)
in mammalian systems##4##3##(1994-5#1)(2008-11#1)(2008-8#1)(2009-10#1)
in mammalian##113##2##(1990-11#2)(1990-5#2)(1990-8#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-6#6)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#5)(1994-9#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#4)(2008-1#1)(2008-10#1)(2008-11#22)(2008-2#4)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#9)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#3)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
in mammals and##5##3##(2008-12#1)(2008-8#2)(2012-2#1)(2013-1#1)
in mammals are##2##3##(2008-8#2)
in mammals is##5##3##(1992-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
in mammals##45##2##(1990-5#1)(1991-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-7#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-2#1)(2012-2#5)(2013-1#3)
in mammary carcinogenesis##2##3##(1995-9#2)
in mammary epithelial cells##2##4##(1995-9#1)(2008-8#1)
in mammary gland##6##3##(1991-12#1)(1992-9#2)(1995-11#1)(1997-6#1)(2008-8#1)
in mammary glands of##2##4##(1991-12#2)
in mammary glands##4##3##(1991-12#2)(2011-2#1)(2012-3#1)
in mammary##20##2##(1990-2#2)(1991-11#1)(1991-12#3)(1992-9#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-9#3)(1997-6#1)(2008-8#2)(2011-2#1)(2012-3#1)
in man and animals##2##4##(1990-5#2)
in man and##5##3##(1990-5#2)(1992-3#2)(1997-8#1)
in man##32##2##(1990-3#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#4)(1994-5#1)(1994-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-2#1)(2008-5#1)
in managed care are##2##4##(1995-1#1)(2008-11#1)
in managed care contracting##3##4##(1992-2#2)(1994-12#1)
in managed care contracts##2##4##(1991-3#1)(1992-2#1)
in managed care is##2##4##(1997-3#2)
in managed care plans##4##4##(1991-3#1)(1994-3#1)(1995-12#1)(1997-3#1)
in managed care##33##3##(1991-3#2)(1992-2#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#5)(2008-11#1)(2008-12#2)(2008-6#1)(2009-6#1)
in managed##37##2##(1991-3#2)(1992-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#5)(2008-11#1)(2008-12#2)(2008-6#1)(2009-4#1)(2009-6#1)
in management and##2##3##(2008-3#1)(2009-12#1)
in management of these##2##4##(1993-11#1)(2009-10#1)
in management of##17##3##(1993-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
in management##34##2##(1991-12#1)(1991-6#1)(1992-1#1)(1993-11#1)(1994-1#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
in managing aggressive##2##3##(1995-2#1)(2008-7#1)
in managing the##8##3##(1992-1#1)(1995-1#2)(1997-8#1)(2008-10#1)(2011-1#1)(2013-1#2)
in managing##34##2##(1991-1#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
in mandibular##2##2##(1994-6#1)(2012-2#1)
in manifestation of##2##3##(1994-2#1)(2012-1#1)
in mannitol##2##2##(1994-6#1)(2008-7#1)
in mantle cell lymphoma##2##4##(2008-7#1)(2009-8#1)
in manual##2##2##(2009-3#1)(2012-2#1)
in manufacturing industries##2##3##(1995-2#1)(2008-10#1)
in manufacturing##8##2##(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)
in many applications##3##3##(2008-3#2)(2008-9#1)
in many areas of the##2##5##(1992-12#1)(2008-10#1)
in many areas##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-9#1)
in many aspects of##8##4##(1996-6#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
in many aspects##12##3##(1996-6#1)(2008-11#4)(2008-2#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
in many biological##6##3##(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)
in many cancers##2##3##(2011-2#1)(2012-12#1)
in many cases the##2##4##(2010-3#1)(2011-2#1)
in many cases to##2##4##(1997-2#1)(2008-1#1)
in many cases##33##3##(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#1)(1994-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-3#2)(2010-4#1)(2011-2#1)(2013-1#1)
in many cell types##2##4##(1991-9#1)(2008-9#1)
in many cell##4##3##(1991-9#1)(2008-9#1)(2011-2#1)(2013-1#1)
in many cellular processes##2##4##(1994-11#1)(2008-7#1)
in many cellular##3##3##(1994-11#1)(2008-7#1)(2011-2#1)
in many centers##4##3##(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#1)
in many chemical##2##3##(2008-10#2)
in many conditions##2##3##(2007-7#1)(2008-12#1)
in many cosmetic##2##3##(2008-5#2)
in many countries in##2##4##(1991-6#1)(2009-3#1)
in many countries##20##3##(1991-4#1)(1991-6#2)(1993-12#1)(1994-2#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#2)(2012-12#2)
in many different ways##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
in many different##9##3##(2008-10#2)(2008-3#1)(2008-4#1)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in many diseases##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2012-3#1)
in many eukaryotic promoters##2##4##(1992-3#1)(1995-2#1)
in many eukaryotic##4##3##(1992-3#1)(1995-2#1)(1996-2#1)(2008-7#1)
in many fields##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
in many forms##3##3##(1997-8#1)(2008-5#1)(2010-11#1)
in many human cancers##3##4##(2011-2#2)(2012-12#1)
in many human##5##3##(1993-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
in many important##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
in many instances##5##3##(1997-2#1)(2008-11#1)(2011-2#2)(2012-3#1)
in many laboratories##3##3##(1990-5#1)(1997-4#1)(2007-11#1)
in many medical##4##3##(1996-3#1)(1997-3#1)(2010-5#1)(2013-1#1)
in many neurodegenerative##2##3##(2008-12#1)(2013-8#1)
in many of its##2##4##(2008-6#1)(2009-8#1)
in many of the##4##4##(1990-12#1)(1992-1#1)(1994-11#1)(2008-12#1)
in many of##7##3##(1990-12#1)(1992-1#1)(1994-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2009-8#1)
in many other regions##2##4##(2008-10#2)
in many other tissues##2##4##(1995-12#1)(2010-5#1)
in many other##11##3##(1993-12#1)(1995-12#1)(1995-3#1)(1997-2#2)(2008-10#3)(2010-5#1)(2010-8#1)(2011-2#1)
in many parts of the world##4##6##(2007-7#1)(2008-10#1)(2011-1#1)(2012-2#1)
in many parts of the##6##5##(1990-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
in many patients with##2##4##(2007-11#1)(2008-7#1)
in many patients##8##3##(1994-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-12#1)(2013-1#1)
in many physiological and##2##4##(2008-8#1)(2013-8#1)
in many primate species##2##4##(2008-11#1)(2008-8#1)
in many real##2##3##(2008-10#2)
in many regions of the##2##5##(1995-2#1)(2008-5#1)
in many regions##5##3##(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
in many respects##5##3##(1991-5#1)(2007-8#1)(2008-8#1)(2012-12#1)(2013-1#1)
in many settings##2##3##(1996-12#1)(2012-2#1)
in many species##2##3##(1997-3#1)(2008-10#1)
in many studies##4##3##(1992-3#1)(2008-3#1)(2012-2#1)(2013-8#1)
in many systems##2##3##(2008-8#2)
in many tissues##7##3##(1992-3#1)(1994-11#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-4#1)
in many tropical##2##3##(1996-11#1)(2008-10#1)
in many types of##2##4##(2008-11#1)(2011-1#1)
in many ways##8##3##(1996-3#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
in many##366##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#5)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#8)(2008-10#58)(2008-11#18)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#11)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#14)(2008-9#17)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#3)(2010-8#3)(2011-1#2)(2011-2#18)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#8)
in mapping##2##2##(2008-8#1)(2011-2#1)
in marginal##2##2##(1994-2#1)(2008-9#1)
in marine and##2##3##(2009-5#1)(2011-2#1)
in marine ecosystems##2##3##(2008-10#1)(2012-2#1)
in marine environments##2##3##(2008-10#2)
in marine optics##2##3##(2008-3#2)
in marine organisms##2##3##(2008-5#1)(2012-12#1)
in marine sediment samples##2##4##(2008-10#2)
in marine sediment##4##3##(2008-10#4)
in marine sediments##2##3##(2008-10#2)
in marine waters##5##3##(2008-10#4)(2008-2#1)
in marine##40##2##(1991-6#1)(1994-8#1)(2007-5#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
in marked suppression of##2##4##(2008-5#1)(2010-4#1)
in marked##8##2##(1993-12#2)(1995-2#1)(1996-12#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-1#1)
in marker##2##2##(2008-11#1)(2008-8#1)
in marker-assisted breeding##2##3##(2008-10#1)(2008-12#1)
in marker-assisted selection##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
in marker-assisted##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#1)
in marketed##2##2##(2008-5#1)(2008-8#1)
in markets where##3##3##(1993-12#2)(1994-3#1)
in markets##4##2##(1993-12#2)(1994-3#1)(2008-11#1)
in married women from Beijing##2##5##(2011-1#2)
in marrow##2##2##(2008-5#1)(2008-6#1)
in marshland##2##2##(2012-3#2)
in mass spectrometry##3##3##(2008-4#1)(2010-7#1)(2011-2#1)
in mass##19##2##(1990-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1997-5#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
in massive##4##2##(1996-3#1)(2007-10#1)(2007-7#1)(2012-2#1)
in mast cells##2##3##(1991-12#2)
in mast##4##2##(1991-12#2)(2008-7#1)(2010-8#1)
in mastocytosis##2##2##(2008-9#1)(2011-2#1)
in matching##3##2##(1994-2#1)(2008-3#1)(2008-5#1)
in mate choice within##2##4##(2008-9#2)
in mate choice##3##3##(2008-9#3)
in mate recognition##3##3##(2008-8#2)(2008-9#1)
in mate##6##2##(2008-8#2)(2008-9#4)
in material##6##2##(2008-10#1)(2008-3#3)(2008-9#1)(2011-2#1)
in materials science##4##3##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
in materials##9##2##(1990-8#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
in maternal and##3##3##(1990-12#2)(2010-12#1)
in maternal blood##4##3##(1996-12#4)
in maternal health##2##3##(2008-7#1)(2013-8#1)
in maternal mortality##2##3##(2010-12#1)(2011-1#1)
in maternal plasma##2##3##(1990-12#1)(2010-11#1)
in maternal##23##2##(1990-12#3)(1995-8#3)(1996-12#4)(2007-12#1)(2008-7#1)(2008-8#5)(2010-11#1)(2010-12#2)(2011-1#1)(2012-3#1)(2013-8#1)
in maternity care##2##3##(1994-1#1)(2012-3#1)
in maternity##3##2##(1994-1#1)(2012-3#2)
in mathematical##2##2##(2010-5#1)(2013-8#1)
in mating and##2##3##(2008-11#1)(2008-8#1)
in mating##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
in matrices of##2##3##(2008-10#1)(2008-3#1)
in matrices##7##2##(2007-11#1)(2008-10#5)(2008-3#1)
in matrix##7##2##(2008-1#2)(2008-10#3)(2008-3#1)(2008-8#1)
in matters##2##2##(2007-6#1)(2009-5#1)
in mature internodes##2##3##(2011-2#2)
in mature##25##2##(1990-5#1)(1991-12#1)(1992-12#1)(1993-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
in matured##2##2##(1993-12#1)(2008-5#1)
in maxillary##2##2##(2012-12#1)(2013-1#1)
in maxillofacial surgery##2##3##(2007-12#2)
in maxillofacial##5##2##(2007-12#5)
in maximal##6##2##(1990-6#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-7#1)(2010-9#1)
in maximum##8##2##(1994-3#1)(2008-10#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
in mdx##3##2##(2008-7#3)
in mean arterial##2##3##(2008-7#1)(2011-2#1)
in mean cell hemoglobin and mean cell hemoglobin concentration values##2##10##(2008-9#2)
in mean cycle duration##2##4##(1990-9#2)
in mean##23##2##(1990-9#2)(1991-12#1)(1993-12#1)(1997-2#1)(1997-4#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)
in meaningful activities##2##3##(2007-10#2)
in meaningful##3##2##(1995-12#1)(2007-10#2)
in means was##2##3##(2008-10#1)(2008-6#1)
in measles epidemics##2##3##(1995-5#1)(2008-9#1)
in measles##3##2##(1995-5#1)(1996-1#1)(2008-9#1)
in measured##6##2##(2007-6#1)(2008-10#2)(2008-3#3)
in measurement of##2##3##(1994-9#1)(1996-2#1)
in measurement##6##2##(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-1#1)
in measurements of##4##3##(1991-9#1)(2008-2#1)(2008-3#1)(2009-11#1)
in measurements##8##2##(1991-9#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)
in measures of##3##3##(2008-11#1)(2009-7#1)(2013-1#1)
in measures##4##2##(2008-11#1)(2008-9#1)(2009-7#1)(2013-1#1)
in measuring and improving the quality of##2##7##(1996-2#2)
in measuring and improving##3##4##(1996-2#3)
in measuring and##4##3##(1996-2#3)(1997-1#1)
in measuring the##8##3##(1996-3#2)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)
in measuring##22##2##(1992-2#1)(1992-5#1)(1993-6#1)(1994-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#2)(2008-9#1)
in meat and##2##3##(2008-10#2)
in meat by##2##3##(2008-10#2)
in meat food products using ion mobility spectrometry##2##8##(2008-10#2)
in meat products##6##3##(2008-10#2)(2010-4#4)
in meat samples by##2##4##(2008-10#2)
in meat samples##4##3##(2008-10#4)
in meat##23##2##(2008-10#16)(2010-2#1)(2010-4#6)
in mechanical properties##4##3##(2008-6#2)(2009-4#1)(2010-7#1)
in mechanical##8##2##(1997-3#1)(2007-11#1)(2008-6#2)(2009-4#1)(2009-7#1)(2010-7#1)(2013-1#1)
in mechanics##2##2##(2008-5#1)(2011-2#1)
in mechanism##2##2##(2008-10#1)(2008-8#1)
in mechanisms##2##2##(2008-7#2)
in mecobalamin-deficient rats##2##3##(1995-11#2)
in medaka##4##2##(2008-11#1)(2008-5#2)(2009-7#1)
in media containing##3##3##(1992-12#1)(1992-8#1)(2012-7#1)
in media##17##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-9#1)(1995-12#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-7#1)(2013-1#1)
in medial##4##2##(1991-2#1)(2008-11#1)(2008-6#1)(2010-11#1)
in median survival##2##3##(2008-4#1)(2008-6#1)
in median##3##2##(2007-7#1)(2008-4#1)(2008-6#1)
in mediating the effects of##3##5##(1993-6#1)(1994-8#1)(1996-12#1)
in mediating the interaction##2##4##(2006-6#1)(2008-12#1)
in mediating the oxidative burst##2##5##(2008-10#2)
in mediating the##22##3##(1991-12#1)(1992-8#1)(1993-12#1)(1993-6#3)(1994-8#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-1#2)
in mediating this##4##3##(1993-12#1)(1995-12#1)(2008-9#1)(2009-10#1)
in mediating##48##2##(1990-12#1)(1991-12#1)(1992-8#1)(1993-12#2)(1993-6#3)(1994-3#1)(1994-8#2)(1995-12#3)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(2006-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-1#4)
in mediation of##2##3##(1994-8#1)(2012-12#1)
in medical admissions##2##3##(1996-3#1)(2010-12#1)
in medical and##5##3##(1993-12#1)(1995-9#1)(2008-8#1)(2010-5#1)(2012-3#1)
in medical applications##2##3##(2009-8#1)(2012-1#1)
in medical audit##2##3##(1991-8#1)(1992-2#1)
in medical care##9##3##(1991-2#1)(1992-1#1)(1993-2#1)(1994-1#1)(1995-8#1)(1996-9#1)(2006-10#1)(2008-1#1)(2013-1#1)
in medical decision-making##2##3##(1993-12#1)(2009-11#1)
in medical diagnostics##2##3##(2008-7#1)(2009-8#1)
in medical education##8##3##(1991-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
in medical ethics##2##3##(2008-8#1)(2013-8#1)
in medical journals##2##3##(1994-12#1)(2008-11#1)
in medical literature##3##3##(2009-7#1)(2011-2#1)(2013-8#1)
in medical malpractice##5##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)
in medical practice##5##3##(1991-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2009-4#1)
in medical practices##2##3##(2008-7#1)(2012-2#1)
in medical research##4##3##(1992-6#1)(2007-7#1)(2008-11#1)(2012-12#1)
in medical research]##2##3##(1992-9#1)(1993-6#1)
in medical schools##4##3##(1993-1#1)(1993-11#1)(1994-12#1)(1997-3#1)
in medical settings##2##3##(2008-4#1)(2009-6#1)
in medical staff credentialing##2##4##(1994-3#1)(1997-2#1)
in medical staff planning##2##4##(1994-1#2)
in medical staff##4##3##(1994-1#2)(1994-3#1)(1997-2#1)
in medical students##3##3##(2011-2#2)(2012-2#1)
in medical technology##2##3##(1994-12#1)(2008-7#1)
in medical treatment##2##3##(1997-3#1)(2009-10#1)
in medical##114##2##(1990-11#1)(1990-9#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-1#3)(1994-12#4)(1994-3#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-4#2)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#3)(2010-5#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
in medical-scientific##2##2##(1997-5#2)
in medically##2##2##(1993-1#1)(1994-12#1)
in medication##2##2##(2010-5#1)(2011-1#1)
in medicinal plant##2##3##(2008-10#2)
in medicinal plants##2##3##(2008-10#2)
in medicinal##5##2##(2008-10#4)(2008-11#1)
in medicine and human urine##2##5##(2008-10#2)
in medicine and##7##3##(1996-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)
in medicine##45##2##(1991-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-6#2)(1995-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
in medicine]##7##2##(1990-2#1)(1992-5#1)(1997-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in medieval##2##2##(2008-12#1)(2010-6#1)
in medium and##2##3##(1993-8#1)(1994-3#1)
in medium containing##10##3##(1991-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-8#2)
in medium of##4##3##(1991-11#2)(2008-10#2)
in medium with##3##3##(2008-12#1)(2008-7#2)
in medium##29##2##(1991-11#2)(1991-12#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-1#1)
in medulla##2##2##(1996-5#1)(2008-8#1)
in meeting future##2##3##(2008-7#1)(2008-8#1)
in meeting the##5##3##(1997-3#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-4#1)
in meeting##12##2##(1994-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
in meiosis##3##2##(1995-9#1)(2008-1#1)(2008-9#1)
in meiotic recombination##2##3##(1995-6#1)(2008-9#1)
in melancholia##2##2##(2010-6#2)
in melanin##2##2##(1994-12#1)(2008-5#1)
in melanocytes##3##2##(1996-9#1)(2008-9#1)(2013-1#1)
in melanogenesis##3##2##(1996-9#2)(2010-4#1)
in melanoma cell##2##3##(2008-11#1)(2008-7#1)
in melanoma cells was##2##4##(2008-8#1)(2013-1#1)
in melanoma cells##6##3##(1991-5#1)(1992-3#1)(2008-8#1)(2012-12#1)(2013-1#2)
in melanoma patients##2##3##(1993-5#1)(2011-2#1)
in melanoma##24##2##(1991-5#1)(1992-3#1)(1993-5#2)(1995-11#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
in melanotrope cells of Xenopus laevis##3##6##(1993-5#3)
in melon##3##2##(2008-10#3)
in members of the##3##4##(1991-12#1)(1997-3#1)(2009-6#1)
in membrane composition and fluidity##2##5##(1990-7#1)(1991-5#1)
in membrane composition##3##3##(1990-7#1)(1991-5#1)(2008-10#1)
in membrane patches##2##3##(1994-12#1)(1997-6#1)
in membrane potential##6##3##(1993-11#1)(1996-2#1)(1997-1#1)(2008-4#1)(2008-9#2)
in membrane preparation##2##3##(1990-7#2)
in membrane preparations##2##3##(1993-1#1)(2008-11#1)
in membrane transport##2##3##(1993-9#1)(1994-8#1)
in membrane##40##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#3)(1991-5#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#2)(2008-9#3)(2009-6#1)(2012-2#1)(2013-1#3)
in membrane-bound##2##2##(2008-10#1)(2008-6#1)
in membranes from##5##3##(1993-1#2)(1993-6#1)(1994-11#1)(1996-5#1)
in membranes of##5##3##(1993-1#1)(1994-2#1)(1995-11#1)(1995-12#2)
in membranes##16##2##(1990-12#1)(1990-8#1)(1993-1#3)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#2)(1996-5#1)(1997-1#1)(2008-7#1)
in memory and##2##3##(2013-8#2)
in memory for##2##3##(1993-12#1)(2012-1#1)
in memory formation##3##3##(1994-8#2)(2013-8#1)
in memory##22##2##(1993-12#2)(1994-6#1)(1994-8#2)(1996-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#5)
in men (P##2##3##(2011-1#2)
in men and from##2##4##(2013-1#2)
in men and in##2##4##(2008-5#1)(2013-8#1)
in men and women were##2##5##(2011-1#2)
in men and women##14##4##(1990-11#1)(1996-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#3)(2011-2#2)
in men and##31##3##(1990-11#1)(1990-2#1)(1991-6#2)(1992-8#1)(1995-11#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#4)(2011-2#2)(2013-1#2)(2013-8#1)
in men in the##3##4##(2008-11#1)(2010-10#1)(2013-1#1)
in men in##4##3##(1995-11#1)(2008-11#1)(2010-10#1)(2013-1#1)
in men of##2##3##(2008-1#1)(2008-3#1)
in men than in women##6##5##(1990-12#1)(1994-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
in men than in##7##4##(1990-12#1)(1992-3#1)(1994-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
in men than##8##3##(1990-12#1)(1992-3#1)(1994-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
in men were##2##3##(2011-2#1)(2012-12#1)
in men who have sex with men##2##7##(2008-10#1)(2008-11#1)
in men with##9##3##(1990-11#1)(1991-5#1)(1992-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
in men##110##2##(1990-11#2)(1990-12#1)(1990-2#2)(1991-11#2)(1991-5#1)(1991-6#3)(1991-8#2)(1992-3#3)(1992-8#1)(1993-11#3)(1993-2#1)(1993-9#3)(1994-5#2)(1995-11#2)(1996-3#2)(1997-6#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#1)(2009-4#1)(2009-5#6)(2009-8#2)(2010-1#1)(2010-10#3)(2010-4#1)(2011-1#8)(2011-2#8)(2012-12#2)(2013-1#6)(2013-8#3)
in men's##2##2##(2007-12#1)(2008-11#1)
in mental disorders]##2##3##(1997-3#1)(2013-7#1)
in mental health care##2##4##(2008-11#1)(2013-1#1)
in mental health has##2##4##(1996-7#1)(2012-3#1)
in mental health service delivery##2##5##(1992-3#1)(2008-11#1)
in mental health services##2##4##(2012-2#1)(2013-1#1)
in mental health settings##2##4##(2008-12#1)(2010-3#1)
in mental health##18##3##(1991-1#1)(1992-3#1)(1996-7#1)(2008-11#2)(2008-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#4)(2012-3#1)(2013-1#3)
in mental well-being##3##3##(1991-8#3)
in mental##26##2##(1991-1#1)(1991-8#3)(1992-3#1)(1996-2#1)(1996-7#1)(1997-3#1)(2008-11#2)(2008-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
in merchant seamen##3##3##(1991-12#3)
in mesangial cells##3##3##(1992-6#1)(1995-11#2)
in mesenchymal##2##2##(2009-4#1)(2013-1#1)
in mesenteric##2##2##(2011-2#1)(2011-3#1)
in mesogenic materials##2##3##(2007-12#2)
in mesophyll##3##2##(1990-5#1)(1994-8#1)(2008-10#1)
in mesoporous##3##2##(2008-10#1)(2010-4#2)
in meta-analysis##2##2##(1997-8#1)(2008-9#1)
in metabolic and##2##3##(1992-12#1)(2008-10#1)
in metabolic control##3##3##(1994-12#3)
in metabolic pathways##2##3##(2008-10#1)(2008-8#1)
in metabolic syndrome##4##3##(2008-2#1)(2008-3#3)
in metabolic##28##2##(1992-12#1)(1994-12#3)(1994-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-4#2)(2010-5#1)(2012-2#1)
in metabolically active##2##3##(1993-1#1)(2008-11#1)
in metabolically##3##2##(1992-9#1)(1993-1#1)(2008-11#1)
in metabolism and##3##3##(1995-6#1)(2010-11#1)(2011-1#1)
in metabolism##8##2##(1994-11#1)(1995-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
in metabolite abundance##2##3##(2012-1#2)
in metabolite##3##2##(2008-7#1)(2012-1#2)
in metal##11##2##(1993-2#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-8#1)
in metallic films##3##3##(2008-3#2)(2008-7#1)
in metallic##11##2##(1990-4#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-7#2)(2010-12#1)(2012-2#1)
in metallomics##2##2##(2008-10#1)(2010-11#1)
in metalloproteins and##3##3##(2010-11#3)
in metaphase##6##2##(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#2)
in metapopulation dynamics##2##3##(2008-9#2)
in metapopulation##3##2##(2008-8#1)(2008-9#2)
in metapopulations##3##2##(2008-8#1)(2008-9#2)
in metastases##2##2##(1992-12#1)(2008-9#1)
in metastatic colorectal cancer patients##3##5##(1990-2#1)(1991-4#1)(1992-12#1)
in metastatic colorectal cancer##7##4##(1990-2#2)(1991-4#2)(1992-12#1)(1992-8#1)(2010-9#1)
in metastatic colorectal##8##3##(1990-2#2)(1991-4#2)(1992-12#2)(1992-8#1)(2010-9#1)
in metastatic melanoma##2##3##(1992-2#1)(2009-3#1)
in metastatic prostate cancer##4##4##(1990-2#1)(2007-5#2)(2013-8#1)
in metastatic prostate##5##3##(1990-2#1)(2007-5#2)(2011-2#1)(2013-8#1)
in metastatic renal##2##3##(1993-8#1)(2011-3#1)
in metastatic##30##2##(1990-10#2)(1990-2#4)(1991-4#2)(1992-12#3)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-9#1)(1996-11#1)(2007-5#2)(2008-1#1)(2008-4#1)(2009-3#1)(2010-9#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#2)
in metazoans##4##2##(2007-12#1)(2008-1#1)(2009-8#1)(2010-2#1)
in metered dose inhalers (MDI)##2##5##(1992-3#1)(1996-1#1)
in metered dose inhalers##5##4##(1992-3#3)(1996-1#2)
in methadone maintenance program##2##4##(2008-10#2)
in methadone maintenance##3##3##(1991-1#1)(2008-10#2)
in methadone treatment##2##3##(1991-1#1)(2008-10#1)
in methadone##6##2##(1991-1#3)(2008-10#3)
in methadone-maintained patients##2##3##(1991-1#2)
in methane##2##2##(2007-12#1)(2008-6#1)
in methane-air##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
in methanol and##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
in methanol at##2##3##(1990-9#1)(2008-10#1)
in methanol to##2##3##(2007-11#1)(2008-10#1)
in methanol was##2##3##(1992-3#1)(2008-10#1)
in methanol##28##2##(1990-9#1)(1992-3#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-5#2)(2007-11#3)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-9#1)
in methanol)##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
in methanol/water##2##2##(2008-10#2)
in methanolic solution##2##3##(2006-12#1)(2008-10#1)
in methanolic##4##2##(2006-12#1)(2008-10#3)
in methicillin-resistant##2##2##(1991-3#1)(2008-3#1)
in methionine metabolism##2##3##(1992-8#1)(1993-9#1)
in methionine##4##2##(1992-6#1)(1992-8#1)(1993-9#1)(2010-5#1)
in method##2##2##(1997-3#1)(2008-9#1)
in methods of##2##3##(2008-7#1)(2013-8#1)
in methods##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
in methyl##5##2##(1995-2#1)(2008-10#3)(2008-2#1)
in methylene chloride##3##3##(1996-5#1)(2008-10#2)
in methylene##4##2##(1996-5#1)(1997-1#1)(2008-10#2)
in metropolitan areas##3##3##(1996-1#1)(2011-2#2)
in metropolitan##6##2##(1996-1#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-12#1)
in mice administered##2##3##(2008-9#2)
in mice after##3##3##(2010-11#1)(2010-9#1)(2013-8#1)
in mice and guinea pigs##4##5##(1995-12#4)
in mice and rats##6##4##(1993-12#1)(2008-10#2)(2008-4#2)(2008-5#1)
in mice and##23##3##(1993-12#1)(1994-12#1)(1995-12#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in mice are##2##3##(2008-10#1)(2008-4#1)
in mice bearing##4##3##(1992-3#1)(1992-9#1)(1997-3#1)(1997-7#1)
in mice but##2##3##(2008-10#1)(2008-11#1)
in mice by administration of##2##5##(1992-12#1)(2008-10#1)
in mice by##13##3##(1990-12#1)(1991-1#1)(1992-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2010-2#1)(2012-12#1)
in mice carrying a mutation (Wld(S)) that causes delayed Wallerian degeneration##2##11##(1997-3#2)
in mice carrying##4##3##(1996-2#1)(1997-3#3)
in mice during##2##3##(1992-3#1)(1997-4#1)
in mice exposed to##2##4##(1997-4#1)(2008-7#1)
in mice fed the##2##4##(2012-2#2)
in mice fed##4##3##(1990-7#1)(2012-2#2)(2013-1#1)
in mice have##2##3##(1995-5#1)(2012-2#1)
in mice in vivo##2##4##(1997-4#1)(2009-12#1)
in mice in##3##3##(1997-4#1)(2008-7#1)(2009-12#1)
in mice infected##2##3##(2009-4#1)(2012-3#1)
in mice is##4##3##(1992-12#1)(1995-3#1)(2008-4#2)
in mice lacking##2##3##(1996-2#1)(2013-1#1)
in mice of##4##3##(1995-12#2)(2013-1#2)
in mice treated with##2##4##(2008-10#1)(2008-7#1)
in mice using the##2##4##(2008-4#2)
in mice using##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
in mice was##2##3##(1993-3#1)(2008-9#1)
in mice when##2##3##(2008-5#2)
in mice with an MRL background##2##6##(1997-8#2)
in mice with##9##3##(1997-3#1)(1997-8#3)(2007-8#1)(2010-7#2)(2011-1#1)(2013-1#1)
in mice##266##2##(1990-11#2)(1990-12#3)(1990-5#3)(1990-6#2)(1990-7#3)(1991-1#2)(1991-12#4)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#4)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1994-12#4)(1994-3#3)(1994-5#4)(1994-8#2)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#3)(1995-5#3)(1996-12#8)(1996-2#4)(1996-5#1)(1997-3#5)(1997-4#6)(1997-7#4)(1997-8#3)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#10)(2008-12#13)(2008-3#1)(2008-4#24)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#3)(2009-9#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#6)
in mice]##4##2##(2012-3#3)(2013-8#1)
in micellar and##2##3##(1996-5#1)(2008-10#1)
in micellar electrokinetic chromatography##3##4##(1994-9#1)(2008-10#2)
in micellar media##6##3##(2008-10#6)
in micellar medium##4##3##(2008-10#4)
in micellar systems##2##3##(2008-10#1)(2008-5#1)
in micellar##22##2##(1994-9#1)(1996-5#1)(2008-10#19)(2008-5#1)
in micelles##4##2##(1994-12#1)(1995-2#2)(2008-10#1)
in micro##3##2##(2008-11#2)(2011-1#1)
in microarray format##2##3##(2008-10#2)
in microarray##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
in microbial##6##2##(1997-4#1)(2008-10#3)(2008-9#1)(2011-2#1)
in microbiology and##2##3##(2007-12#1)(2011-1#1)
in microbiology##6##2##(1995-3#2)(2007-12#1)(2007-7#1)(2008-9#1)(2011-1#1)
in microbodies##3##2##(2008-10#1)(2011-1#2)
in microcarrier cultures##2##3##(2008-11#2)
in microcarrier##3##2##(2008-11#3)
in microchip lasers##2##3##(2007-12#2)
in microchip##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
in microcirculatory##2##2##(1997-2#1)(2009-7#1)
in microfluidic devices##2##3##(2008-10#2)
in microfluidic##6##2##(2008-10#5)(2008-12#1)
in microglia##2##2##(2008-6#1)(2008-7#1)
in microgravity and normal gravity##2##5##(2008-3#2)
in microgravity##3##2##(2008-3#3)
in micronucleus##2##2##(2008-9#2)
in microorganisms##2##2##(2010-12#1)(2012-3#1)
in microplates##2##2##(1990-12#1)(2008-11#1)
in microreactors##2##2##(2008-10#2)
in microsamples##2##2##(2008-10#2)
in microscale##2##2##(2013-8#2)
in microscopic##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)
in microsomal##2##2##(1992-3#1)(1993-6#1)
in microsomes and##2##3##(1991-9#1)(1997-1#1)
in microsomes from##3##3##(1991-5#3)
in microsomes##10##2##(1991-2#1)(1991-5#4)(1991-9#1)(1994-11#1)(1994-6#1)(1997-1#1)(2008-8#1)
in microsporocytes##2##2##(2009-10#1)(2009-12#1)
in microstructure fiber##5##3##(2007-11#4)(2007-12#1)
in microstructure##6##2##(2007-11#4)(2007-12#1)(2013-1#1)
in microstructured optical fibers##5##4##(2007-11#5)
in microstructures##2##2##(1997-6#2)
in microsurgical##2##2##(2011-2#2)
in microtiter plates##2##3##(2008-4#1)(2011-2#1)
in microtubule##2##2##(2009-10#1)(2011-2#1)
in microvascular disease##2##3##(2009-10#1)(2011-2#1)
in microvascular##6##2##(1995-12#2)(1997-2#1)(2008-2#1)(2009-10#1)(2011-2#1)
in midbrain and hippocampus##2##4##(1995-12#1)(1997-2#1)
in midbrain and##4##3##(1992-1#1)(1995-12#1)(1997-2#2)
in midbrain##7##2##(1992-1#1)(1995-12#2)(1997-2#3)(2013-1#1)
in middle age##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
in middle aged##3##3##(2008-7#1)(2010-5#1)(2011-2#1)
in middle school##2##3##(1993-1#1)(2010-12#1)
in middle##18##2##(1993-1#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#4)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)
in middle-age##2##2##(2009-11#1)(2011-1#1)
in middle-aged adults##2##3##(2007-8#1)(2009-11#1)
in middle-aged and##2##3##(2008-5#1)(2013-1#1)
in middle-aged men##3##3##(2008-5#2)(2011-2#1)
in middle-aged##10##2##(1991-6#2)(2007-8#1)(2008-5#3)(2009-11#2)(2011-2#1)(2013-1#1)
in midlife##2##2##(2012-1#2)
in midwinter##2##2##(2013-1#2)
in migraine and##2##3##(1991-8#1)(2008-9#1)
in migraine##3##2##(1991-8#1)(2008-9#1)(2012-3#1)
in migrants##4##2##(1994-12#1)(1994-2#3)
in migration##4##2##(1993-6#1)(1993-9#1)(1994-8#1)(2008-10#1)
in migratory##2##2##(2009-8#1)(2011-2#1)
in mild and##2##3##(2008-7#1)(2013-1#1)
in mild to moderate##2##4##(1995-2#1)(1996-1#1)
in mild to##3##3##(1995-2#1)(1996-1#1)(2010-12#1)
in mild traumatic##2##3##(1991-12#1)(2009-8#1)
in mild##17##2##(1991-12#1)(1992-3#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in mildly##2##2##(2008-10#1)(2008-5#1)
in military##7##2##(1990-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2009-7#1)(2010-4#1)(2011-2#1)
in milk and in coconut water##2##6##(2008-10#2)
in milk and##6##3##(1991-12#1)(2008-10#3)(2012-2#1)(2013-1#1)
in milk by##4##3##(2008-10#4)
in milk from##2##3##(1992-3#1)(2008-11#1)
in milk powder and##2##4##(2008-10#2)
in milk samples by hydride generation atomic fluorescence spectrometry##2##9##(2008-10#2)
in milk samples##6##3##(1993-2#1)(2008-10#5)
in milk were##2##3##(2008-10#1)(2013-1#1)
in milk##38##2##(1991-11#1)(1991-12#1)(1992-3#1)(1993-2#1)(2008-10#23)(2008-11#1)(2008-8#3)(2011-2#1)(2012-2#4)(2013-1#2)
in millimeters##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
in millions of##2##3##(1995-3#1)(2007-12#1)
in mind and##2##3##(2008-12#1)(2013-8#1)
in mind in patients with##2##5##(2006-10#1)(2013-8#1)
in mind in##5##3##(2006-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
in mind that the##4##4##(1992-3#1)(2008-3#1)(2010-8#1)(2011-3#1)
in mind that##10##3##(1992-3#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in mind the##9##3##(1995-3#1)(2007-6#1)(2008-11#1)(2009-1#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
in mind when##6##3##(1992-4#1)(2007-8#1)(2008-1#2)(2008-7#2)
in mind##56##2##(1990-11#1)(1992-3#1)(1992-4#1)(1994-6#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
in mindfulness-based##2##2##(2013-1#2)
in mineral and##2##3##(2008-10#2)
in mineral waters##5##3##(2008-10#5)
in mineral##19##2##(2008-10#13)(2008-4#1)(2008-7#1)(2009-8#2)(2013-7#2)
in mineralized##2##2##(2008-11#1)(2013-8#1)
in mini-orchards of##2##3##(2008-10#2)
in minimal medium##4##3##(2008-10#1)(2012-2#3)
in minimal##10##2##(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)
in minimally invasive direct coronary artery##2##6##(1997-8#1)(2007-8#1)
in minimally invasive##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
in minimally##5##2##(1995-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2011-2#1)
in minimizing##3##2##(1990-9#1)(2008-7#1)(2013-8#1)
in minimum##2##2##(2008-10#1)(2010-3#1)
in minimum-till##2##2##(2008-10#2)
in minor##7##2##(1990-6#1)(1991-3#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
in minutes##2##2##(2008-11#1)(2010-3#1)
in mirror##2##2##(2007-12#1)(2008-3#1)
in mist##2##2##(2008-10#2)
in mitigating##2##2##(2007-7#1)(2008-1#1)
in mitochondria from hypoxic hearts##2##5##(1994-5#2)
in mitochondria from##4##3##(1994-5#4)
in mitochondria isolated from##2##4##(1990-11#1)(2008-7#1)
in mitochondria of##3##3##(1990-3#1)(1994-11#1)(1997-2#1)
in mitochondria##18##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1994-11#1)(1994-12#2)(1994-5#4)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
in mitochondrial DNA##4##3##(2008-2#2)(2009-2#1)(2013-8#1)
in mitochondrial function##2##3##(2008-1#1)(2009-12#1)
in mitochondrial membranes##2##3##(1990-12#1)(1995-3#1)
in mitochondrial##22##2##(1990-12#1)(1992-11#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#3)
in mitogenic##2##2##(1990-11#1)(1997-7#1)
in mitosis##4##2##(1993-9#1)(1995-6#1)(2009-10#1)(2009-3#1)
in mitotic cells##3##3##(1994-8#1)(1995-5#2)
in mitotic##10##2##(1993-8#1)(1994-8#1)(1995-5#3)(2008-11#1)(2008-5#1)(2010-1#1)(2012-12#1)(2012-2#1)
in mitral regurgitation##2##3##(2009-10#1)(2009-4#1)
in mitral valve##3##3##(2007-8#3)
in mitral##6##2##(2007-8#3)(2009-10#1)(2009-12#1)(2009-4#1)
in mixed infection##2##3##(1996-12#1)(2008-10#1)
in mixed infections of##2##4##(2008-10#2)
in mixed infections with##3##4##(2008-10#3)
in mixed infections##8##3##(2008-10#8)
in mixed populations##2##3##(2008-5#1)(2008-9#1)
in mixed protic solvents##2##4##(2008-10#2)
in mixed solvents##3##3##(1990-8#2)(2008-10#1)
in mixed##40##2##(1990-11#1)(1990-12#1)(1990-8#3)(1996-12#1)(1996-5#2)(1996-7#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2012-12#1)
in mixed-phase##2##2##(2008-2#1)(2012-3#1)
in mixture samples##2##3##(2008-10#2)
in mixture spectra##2##3##(2007-12#1)(2008-10#1)
in mixture##13##2##(2007-12#1)(2008-10#10)(2008-8#1)(2009-9#1)
in mixtures by##2##3##(2008-10#2)
in mixtures containing##2##3##(2008-10#2)
in mixtures of##7##3##(1994-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-7#1)
in mixtures using##3##3##(2008-10#3)
in mixtures with##6##3##(1994-12#1)(2008-10#4)(2008-5#1)
in mixtures##35##2##(1994-12#1)(1994-5#1)(2008-1#1)(2008-10#28)(2008-2#1)(2008-5#1)(2008-7#1)(2012-7#1)
in mobile phase##6##3##(2007-12#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
in mobile##7##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
in mobility##6##2##(2008-7#5)(2011-2#1)
in mobilizing##2##2##(1992-12#2)
in mode-locked lasers##2##3##(2007-11#2)
in mode-locked##3##2##(2007-11#2)(2007-12#1)
in model organisms##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
in model selection and##2##4##(2010-8#1)(2011-1#1)
in model systems##2##3##(1993-12#1)(2008-7#1)
in model##22##2##(1990-12#1)(1993-12#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2009-8#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-9#1)
in modeling and##2##3##(2007-12#1)(2008-10#1)
in modeling##10##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-8#1)(2013-8#1)
in modelling##6##2##(1995-12#1)(2008-5#1)(2008-7#2)(2011-1#2)
in models of##2##3##(2008-3#1)(2011-3#1)
in models##7##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-7#1)(2011-1#1)(2011-3#1)
in moderate or##2##3##(1993-8#1)(2010-11#1)
in moderate to##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
in moderate##10##2##(1993-8#1)(1996-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
in moderately##6##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
in moderation##2##2##(2008-7#1)(2012-2#1)
in modern health##2##3##(1996-8#1)(2008-1#1)
in modern hypospadiology##3##3##(2009-5#3)
in modern life sciences##2##4##(2010-11#1)(2011-2#1)
in modern medical##2##3##(2008-10#1)(2009-11#1)
in modern medicine##2##3##(1997-8#1)(2013-8#1)
in modern optical##2##3##(2008-2#1)(2008-3#1)
in modern societies##2##3##(2009-7#1)(2011-2#1)
in modern society##4##3##(1991-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
in modern##46##2##(1990-2#1)(1991-6#1)(1993-6#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-2#2)(2013-8#2)
in modification of##2##3##(1997-4#1)(2008-10#1)
in modified##6##2##(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
in modifying the##2##3##(1996-4#1)(2008-10#1)
in modifying##6##2##(1990-9#1)(1996-4#1)(2008-10#1)(2008-5#1)(2011-3#1)(2013-1#1)
in modulating gene expression##2##4##(1994-6#2)
in modulating synaptic##2##3##(1993-12#1)(2009-8#1)
in modulating the##6##3##(1992-1#1)(1992-11#1)(1994-5#1)(2008-11#1)(2012-12#1)(2013-7#1)
in modulating##24##2##(1990-5#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-8#1)(2012-12#1)(2013-7#2)(2013-8#1)
in modulation of##7##3##(1996-2#1)(1997-6#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#2)
in modulation##8##2##(1996-2#1)(1997-6#1)(2008-11#1)(2008-3#2)(2009-10#1)(2011-1#2)
in moist chambers##2##3##(2008-10#2)
in moist##4##2##(2008-10#4)
in mol(-1)dm(3)) of##2##3##(2008-10#2)
in molecular biology have##4##4##(2007-7#1)(2009-1#1)(2010-5#1)(2012-3#1)
in molecular biology##18##3##(1990-12#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-5#1)(2012-3#2)(2013-1#1)
in molecular complexes##3##3##(1995-5#2)(2008-4#1)
in molecular dynamics simulations of##2##5##(1993-5#1)(2012-2#1)
in molecular epidemiology##2##3##(1997-4#1)(2010-11#1)
in molecular genetics##2##3##(1991-11#1)(2008-9#1)
in molecular masses##2##3##(1993-3#1)(2008-10#1)
in molecular medicine##2##3##(2007-7#1)(2009-11#1)
in molecular weight##3##3##(1991-10#1)(2008-6#1)(2008-8#1)
in molecular##64##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1992-6#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-5#2)(1997-2#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
in molecules##3##2##(1997-6#1)(2008-7#1)(2010-7#1)
in molluscan hemocytes##2##3##(2008-7#2)
in molluscs##2##2##(1995-5#2)
in molten alkali metal carbonates##2##5##(2008-10#2)
in molten##3##2##(2008-10#3)
in monitoring of waste water systems##2##6##(2008-10#2)
in monitoring the##5##3##(1991-4#1)(2008-10#2)(2008-11#1)(2008-5#1)
in monitoring##25##2##(1991-1#1)(1991-4#2)(1994-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-12#1)
in monkey##10##2##(1990-7#3)(1991-5#1)(1992-6#1)(1993-6#1)(1994-8#2)(2008-11#1)(2012-2#1)
in monkeys##15##2##(1992-11#2)(1993-12#2)(1994-3#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2012-3#2)
in monoclonal##2##2##(1993-2#1)(2008-9#1)
in monoculture##2##2##(2008-10#2)
in monocyte##2##2##(1992-12#1)(1993-12#1)
in monocytes##2##2##(1991-6#1)(1994-8#1)
in monolayer and##3##3##(2008-11#2)(2011-2#1)
in monolayer culture##11##3##(1990-2#1)(1990-8#1)(1992-9#1)(1997-1#1)(2008-11#7)
in monolayer cultures of##2##4##(1992-6#1)(1992-9#1)
in monolayer cultures##3##3##(1990-12#1)(1992-6#1)(1992-9#1)
in monolayer##28##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-3#1)(1995-5#1)(1997-1#1)(2008-11#15)(2008-5#1)(2011-2#1)
in monolayers of hepatocytes##2##4##(1994-11#2)
in monolayers of##3##3##(1992-6#1)(1994-11#2)
in monolayers##5##2##(1991-9#1)(1992-6#1)(1994-11#2)(2010-10#1)
in mononuclear##2##2##(1991-11#1)(2012-3#1)
in monoterpene##2##2##(2008-10#1)(2011-10#1)
in monotherapy##2##2##(2008-1#1)(2012-2#1)
in monozygotic and dizygotic##2##4##(1997-5#1)(1997-8#1)
in monozygotic and##3##3##(1997-5#1)(1997-8#1)(2008-7#1)
in monozygotic##5##2##(1997-5#1)(1997-8#1)(2008-7#1)(2010-1#1)(2010-12#1)
in month 1##2##3##(2008-11#2)
in month 10)##2##3##(2008-11#2)
in month##4##2##(2008-11#4)
in monthly##3##2##(2008-12#1)(2012-2#1)(2012-3#1)
in mood##6##2##(1991-1#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-11#1)(2012-12#1)
in moral##3##2##(2008-11#1)(2010-11#1)(2013-8#1)
in morbidity##5##2##(1990-11#1)(1992-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
in morbidly obese patients##2##4##(2012-5#2)
in more accurate##3##3##(1990-3#1)(1994-3#1)(2008-6#1)
in more advanced stages of##2##5##(2008-4#1)(2009-8#1)
in more advanced stages##3##4##(2008-4#1)(2009-8#1)(2012-3#1)
in more advanced##4##3##(2008-4#1)(2009-8#1)(2012-2#1)(2012-3#1)
in more detail in##2##4##(2008-4#1)(2008-5#1)
in more detail the##2##4##(2008-3#1)(2008-8#1)
in more detail##19##3##(1990-8#1)(1991-2#1)(1993-9#1)(1995-6#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)
in more recent##2##3##(1990-9#1)(1991-12#1)
in more than 50% of patients##2##6##(2007-7#1)(2010-12#1)
in more than 50% of the cases##2##7##(1997-6#1)(2012-12#1)
in more than 50% of##5##5##(1993-3#1)(1997-6#1)(2007-7#1)(2010-12#1)(2012-12#1)
in more than 70% of##2##5##(2007-8#1)(2008-10#1)
in more than 80% of##3##5##(2007-2#1)(2009-8#1)(2011-2#1)
in more than 90% of cases##2##6##(2007-8#1)(2008-10#1)
in more than 90% of##4##5##(1994-9#1)(2007-8#1)(2008-10#1)(2008-12#1)
in more than half of the##2##6##(1995-6#1)(2008-3#1)
in more than half of##3##5##(1995-6#1)(2008-1#1)(2008-3#1)
in more than half##4##4##(1995-6#1)(2007-2#1)(2008-1#1)(2008-3#1)
in more than one##10##4##(1992-12#1)(1995-12#1)(1995-3#1)(1997-6#2)(2008-1#2)(2010-7#1)(2010-8#1)(2013-1#1)
in more than three decades##2##5##(1997-1#1)(1997-3#1)
in more than##40##3##(1990-7#1)(1991-11#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-6#3)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
in more##106##2##(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)
in moribund##2##2##(2008-7#1)(2008-8#1)
in morning##2##2##(1996-1#1)(2012-2#1)
in morphine antinociception##2##3##(1997-2#2)
in morphine##4##2##(1997-2#4)
in morphine-dependent##4##2##(1991-1#1)(1996-2#3)
in morphological changes##3##3##(1994-11#1)(1994-6#1)(2007-8#1)
in morphological##8##2##(1990-7#1)(1994-11#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
in morphologically##2##2##(2009-12#1)(2011-2#1)
in morphology of the##2##4##(2007-11#1)(2012-2#1)
in morphology of##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
in morphology##11##2##(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2010-6#1)(2012-2#1)(2013-1#2)
in mortality and##2##3##(1996-11#1)(2013-8#1)
in mortality from##4##3##(1990-6#1)(1990-8#1)(1995-12#1)(1996-3#1)
in mortality in##4##3##(1995-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
in mortality of##2##3##(2008-10#1)(2011-2#1)
in mortality or##2##3##(2008-7#1)(2008-9#1)
in mortality rates##3##3##(1993-12#1)(2008-9#1)(2013-8#1)
in mortality##32##2##(1990-6#1)(1990-8#1)(1991-3#1)(1993-12#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#2)(2013-8#3)
in mosquitoes##3##2##(2007-12#1)(2008-8#1)(2011-3#1)
in moss##2##2##(2008-10#2)
in most DRG neurons##2##4##(1996-12#2)
in most European##2##3##(2008-2#1)(2012-2#1)
in most cases by##2##4##(1991-6#1)(2009-6#1)
in most cases is##2##4##(1997-3#1)(2012-3#1)
in most cases of##3##4##(1991-11#1)(2008-4#1)(2008-5#1)
in most cases##67##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-12#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
in most centers##2##3##(1994-3#1)(2011-2#1)
in most children##2##3##(2008-11#2)
in most clinical situations##2##4##(1992-11#1)(2012-1#1)
in most clinical##4##3##(1992-11#1)(2008-9#1)(2009-10#1)(2012-1#1)
in most countries##8##3##(1992-11#1)(1994-3#1)(1996-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
in most eukaryotic cells##2##4##(2011-2#1)(2011-3#1)
in most health care organizations##2##5##(1995-1#1)(1996-2#1)
in most health##4##3##(1992-12#1)(1995-1#1)(1996-2#1)(2008-12#1)
in most instances##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
in most natural waters##2##4##(2008-10#2)
in most neurons##2##3##(1997-7#2)
in most of the cases##3##5##(2008-10#2)(2008-8#1)
in most of the samples##2##5##(2008-10#2)
in most of the##29##4##(1993-12#1)(1993-6#1)(1996-10#1)(2007-11#2)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in most of these##6##4##(1991-10#1)(1992-2#1)(1993-3#1)(2008-4#1)(2010-3#1)(2012-3#1)
in most of##39##3##(1990-12#1)(1991-10#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-10#1)(2007-11#2)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in most organisms##2##3##(2008-7#1)(2009-2#1)
in most other##3##3##(1993-6#1)(1997-6#1)(2009-10#1)
in most patients with##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
in most patients##14##3##(1991-4#1)(1992-12#1)(1992-8#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2013-1#1)
in most plants##2##3##(2008-10#2)
in most regions##3##3##(1996-5#1)(2008-10#2)
in most samples##2##3##(2008-10#1)(2008-11#1)
in most settings##2##3##(1995-12#1)(2011-2#1)
in most situations##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
in most species##2##3##(2009-3#1)(2010-8#1)
in most studies##4##3##(1994-2#1)(1996-9#1)(2010-5#1)(2012-3#1)
in most taxa##2##3##(2010-3#1)(2011-2#1)
in most tissue##2##3##(1993-2#1)(1995-11#1)
in most tissues and##2##4##(1993-3#1)(2008-7#1)
in most tissues##4##3##(1991-9#1)(1993-2#1)(1993-3#1)(2008-7#1)
in most types of##2##4##(2007-8#1)(2008-6#1)
in most##281##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#46)(2008-11#12)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#9)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#7)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#8)(2012-3#8)(2013-1#9)(2013-8#3)
in mother and##2##3##(1990-6#2)
in mother##4##2##(1990-6#2)(1993-8#1)(1993-9#1)
in mother's##2##2##(2007-10#1)(2012-2#1)
in mothers and##2##3##(2011-1#1)(2012-3#1)
in mothers of children with##3##5##(2011-2#3)
in mothers of##5##3##(1990-10#1)(1990-2#1)(2011-2#3)
in mothers who##2##3##(2008-11#2)
in mothers##13##2##(1990-10#1)(1990-2#1)(1996-11#1)(2008-11#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-3#1)
in motion##8##2##(2007-8#2)(2008-10#1)(2008-9#3)(2009-9#1)(2012-2#1)
in motor control##3##3##(2007-8#1)(2009-2#1)(2013-1#1)
in motor initiation and execution##2##5##(1991-6#2)
in motor nerves##2##3##(1993-5#1)(2007-12#1)
in motor##26##2##(1991-2#3)(1991-6#2)(1993-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#2)(2012-12#1)(2013-1#2)(2013-8#2)
in mountain##2##2##(1991-2#1)(2008-11#1)
in mouse C2 myotubes##2##4##(1995-6#2)
in mouse and human##5##4##(1993-3#1)(1993-5#1)(2008-8#1)(2012-2#2)
in mouse and rat##3##4##(1991-12#1)(1993-12#1)(1993-2#1)
in mouse and##9##3##(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(2008-8#1)(2010-3#1)(2012-2#2)
in mouse anterior pituitary##3##4##(1990-5#3)
in mouse brain by##2##4##(1995-2#1)(1996-12#1)
in mouse brain##9##3##(1991-1#1)(1993-8#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-12#1)(2008-7#1)(2009-10#1)
in mouse cells##3##3##(1992-6#1)(1993-12#1)(2008-3#1)
in mouse embryonic stem (ES) cells##2##6##(1995-2#1)(2008-11#1)
in mouse embryonic stem cells##4##5##(1995-2#3)(2008-11#1)
in mouse embryonic stem##6##4##(1995-2#4)(2008-11#2)
in mouse embryonic##8##3##(1995-2#5)(2008-11#2)(2013-1#1)
in mouse epidermis in vivo##2##5##(1993-8#2)
in mouse epidermis##3##3##(1991-9#1)(1993-8#2)
in mouse kidney##3##3##(1990-12#1)(1992-3#1)(1996-5#1)
in mouse liver by myristicin##2##5##(1997-7#2)
in mouse liver##5##3##(1995-2#1)(1995-3#1)(1997-7#2)(2008-11#1)
in mouse lung##2##3##(1995-3#1)(1996-12#1)
in mouse macrophages##2##3##(1995-2#2)
in mouse mammary##2##3##(1991-12#1)(2008-8#1)
in mouse model##2##3##(2012-2#1)(2013-1#1)
in mouse models of##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
in mouse models##6##3##(1994-5#1)(1997-1#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
in mouse peripheral blood erythrocytes##4##5##(2008-9#4)
in mouse peritoneal macrophages##4##4##(1993-6#2)(1994-9#1)(2008-10#1)
in mouse peritoneal##6##3##(1992-5#1)(1993-6#2)(1994-9#1)(2008-10#1)(2008-11#1)
in mouse phenotyping##2##3##(2008-2#2)
in mouse plasma##2##3##(1996-5#1)(2008-9#1)
in mouse serum##2##3##(2008-4#1)(2010-5#1)
in mouse skin keratinocytes##2##4##(1997-4#2)
in mouse skin##5##3##(1990-11#2)(1992-9#1)(1997-4#2)
in mouse##135##2##(1990-11#4)(1990-12#1)(1990-5#4)(1990-7#2)(1991-1#3)(1991-12#3)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#10)(1995-3#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#3)(1997-1#1)(1997-4#2)(1997-7#4)(2007-8#1)(2008-10#4)(2008-11#7)(2008-2#5)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#8)(2009-10#1)(2009-7#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
in mouth air##2##3##(2008-10#2)
in mouth##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
in movement##4##2##(2008-10#1)(2010-5#1)(2010-8#1)(2013-8#1)
in moving from##2##3##(2007-8#1)(2008-1#1)
in moving##9##2##(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-1#1)
in mtDNA##2##2##(2008-12#1)(2009-8#1)
in much of##2##3##(2008-4#1)(2010-10#1)
in much##8##2##(1991-12#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)
in mucosa##4##2##(1991-12#1)(2010-5#2)(2013-8#1)
in mucosal##9##2##(1993-11#2)(1995-12#1)(1995-6#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
in mulch layers##2##3##(2008-10#2)
in mulch##3##2##(2008-10#3)
in mulches##2##2##(2008-10#2)
in multi-layered protein films##2##4##(2008-12#2)
in multicellular organisms##3##3##(2008-2#1)(2008-4#1)(2008-8#1)
in multichip##2##2##(2007-12#1)(2008-2#1)
in multicolor##2##2##(2008-9#1)(2009-9#1)
in multicomponent glasses##2##3##(2007-11#2)
in multicomponent##7##2##(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)
in multiconjugate adaptive optics##2##4##(2007-12#2)
in multidisciplinary teams##3##3##(1996-7#1)(2011-1#2)
in multidisciplinary##4##2##(1996-7#1)(2009-8#1)(2011-1#2)
in multidrug resistant##2##3##(1990-2#1)(2013-1#1)
in multidrug-resistant##2##2##(2007-7#1)(2008-7#1)
in multilayer##3##2##(2007-11#1)(2008-3#1)(2009-11#1)
in multilayers##2##2##(2007-12#1)(2008-10#1)
in multilevel##2##2##(2012-12#2)
in multimode circular fibers##2##4##(2008-3#2)
in multimode##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
in multiparas##2##2##(2008-4#2)
in multiparous##5##2##(1992-5#2)(1997-4#3)
in multiple forms##2##3##(2008-12#1)(2011-2#1)
in multiple lineages##2##3##(2008-11#1)(2013-1#1)
in multiple myeloma##6##3##(1991-12#1)(2008-1#1)(2009-3#1)(2010-10#1)(2010-4#2)
in multiple organ##3##3##(2009-5#1)(2012-12#1)(2012-3#1)
in multiple pregnancies##2##3##(2008-11#1)(2010-8#1)
in multiple reaction monitoring (MRM) mode##3##6##(2011-1#3)
in multiple sclerosis (MS)##4##4##(1995-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
in multiple sclerosis and##2##4##(1995-12#1)(2010-12#1)
in multiple sclerosis##17##3##(1995-12#2)(1997-5#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#3)(2010-4#1)(2012-2#2)(2012-3#2)(2013-8#1)
in multiple system atrophy##3##4##(2008-7#2)(2009-11#1)
in multiple tissues##2##3##(1996-10#1)(1997-7#1)
in multiple ways##2##3##(2008-11#1)(2013-1#1)
in multiple##84##2##(1990-6#1)(1991-12#1)(1991-2#1)(1995-12#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
in multiple-quantum-well binary-phase modulators##2##4##(2008-2#2)
in multiply##3##2##(1990-12#1)(1995-2#1)(2008-3#1)
in multispecies##2##2##(2008-8#1)(2008-9#1)
in multivariable logistic regression##2##4##(2013-1#2)
in multivariable##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
in multivariate analysis were##2##4##(2007-10#1)(2011-2#1)
in multivariate analysis##7##3##(1994-12#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#1)
in multivariate##9##2##(1994-12#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
in multiwalled carbon nanotubes##3##4##(2008-3#3)
in multiwalled##4##2##(2008-3#3)(2008-7#1)
in multiwavelength##5##2##(2007-12#3)(2008-10#2)
in municipalities with##3##3##(1993-6#1)(2013-8#2)
in municipalities##5##2##(1993-6#1)(1994-6#1)(2012-12#1)(2013-8#2)
in murine FM3A##2##3##(1995-11#2)
in murine and##2##3##(1992-2#2)
in murine cells##2##3##(1991-2#1)(1993-2#1)
in murine hybridoma cells##2##4##(1991-9#1)(2008-11#1)
in murine macrophages##3##3##(1990-8#2)(1994-6#1)
in murine models##4##3##(1991-8#1)(1995-5#2)(2011-2#1)
in murine##46##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#3)(1992-5#2)(1992-8#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#2)(1995-11#3)(1995-12#1)(1995-5#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in muscle by using##2##4##(1997-8#2)
in muscle of patients with##2##5##(1992-2#1)(1995-12#1)
in muscle of##4##3##(1990-8#1)(1992-2#1)(1995-12#2)
in muscle strength##3##3##(1993-11#1)(2007-11#1)(2009-3#1)
in muscle tension##2##3##(1994-2#1)(2013-1#1)
in muscle tone were##3##4##(1995-2#3)
in muscle tone##4##3##(1990-9#1)(1995-2#3)
in muscle##40##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-8#2)(1995-12#3)(1995-2#3)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
in muscles##6##2##(1990-8#1)(1995-8#2)(1997-8#1)(2010-6#1)(2012-12#1)
in muscovy duckling##2##3##(1997-1#2)
in muscular##2##2##(2012-2#2)
in musculo-skeletal##2##2##(2007-11#2)
in music##4##2##(2008-11#1)(2009-9#1)(2013-8#2)
in mussel##4##2##(2008-10#4)
in mussels by tungsten coil electrothermal atomic absorption spectrometry##2##9##(2008-10#2)
in mussels by##4##3##(2008-10#4)
in mussels##6##2##(2008-10#6)
in mutant##13##2##(1990-5#1)(1990-8#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
in mutants##2##2##(1995-12#1)(2008-10#1)
in mutual##2##2##(2008-11#1)(2012-2#1)
in my##8##2##(1991-8#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#1)
in mycelial##3##2##(2008-10#3)
in mycobacteria##7##2##(1995-5#2)(1997-4#2)(2008-7#1)(2008-8#1)(2013-1#1)
in mycoplasmas##2##2##(1993-12#2)
in mycorrhizal##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
in myelodysplastic syndromes and##3##4##(1992-12#1)(2007-5#1)(2010-11#1)
in myelodysplastic syndromes##5##3##(1992-12#1)(2007-5#1)(2010-11#3)
in myelodysplastic##7##2##(1992-12#1)(2007-5#1)(2008-5#1)(2010-11#3)(2012-2#1)
in myeloid##6##2##(1992-3#1)(1992-8#1)(2009-7#1)(2010-4#2)(2012-2#1)
in myeloma cells##4##3##(1991-9#1)(1995-8#1)(2013-1#2)
in myeloma##7##2##(1991-9#1)(1995-8#1)(2008-3#2)(2008-9#1)(2013-1#2)
in myoblasts##2##2##(1995-8#1)(2008-4#1)
in myocard##2##2##(2012-3#2)
in myocardial cells##2##3##(1996-9#2)
in myocardial infarction##3##3##(2012-2#2)(2013-8#1)
in myocardial##14##2##(1994-11#1)(1995-3#1)(1996-9#2)(2007-9#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-8#2)(2012-2#2)(2013-8#1)
in myocytes##6##2##(1993-3#1)(1996-9#4)(2008-1#1)
in myogenesis##2##2##(1993-12#2)
in myogenic cells##2##3##(1992-8#1)(1993-8#1)
in myogenic##4##2##(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)
in myoglobin (Mb)##2##3##(1994-5#1)(2010-4#1)
in myoglobin##3##2##(1993-11#1)(1994-5#1)(2010-4#1)
in myometrial tissue##2##3##(1994-11#1)(1994-3#1)
in myometrial##4##2##(1994-11#2)(1994-3#2)
in myopathies##2##2##(2008-11#1)(2008-7#1)
in myotubes##2##2##(1995-8#1)(2008-4#1)
in myringoplasty##2##2##(2012-8#2)
in n-heptane##4##2##(2007-12#3)(2008-10#1)
in n-hexane##3##2##(2008-10#1)(2008-7#1)(2009-9#1)
in naive rats##2##3##(1994-2#1)(1995-12#1)
in naive##5##2##(1994-2#1)(1995-12#3)(2013-1#1)
in nanogram##2##2##(1991-2#1)(2008-10#1)
in nanopatterning##2##2##(2008-10#2)
in nanoribbons##2##2##(2008-7#2)
in nanoscale##2##2##(2008-7#2)
in nanotechnology##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
in narcolepsy##3##2##(1991-5#1)(1997-9#2)
in nasal##9##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
in nasopharyngeal carcinoma##3##3##(2008-9#2)(2012-1#1)
in national health##3##3##(1992-3#1)(1993-2#1)(1994-2#1)
in national##9##2##(1992-3#1)(1993-2#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
in native##19##2##(1990-12#1)(1991-5#1)(1992-2#1)(1993-8#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
in natural and industrial##2##4##(2008-10#2)
in natural and synthetic##2##4##(1993-3#1)(2013-1#1)
in natural and tap##2##4##(2008-10#2)
in natural and##14##3##(1993-3#1)(2008-10#11)(2008-5#1)(2013-1#1)
in natural ecosystems##2##3##(2008-10#2)
in natural environments##3##3##(2008-10#2)(2011-1#1)
in natural habitats##2##3##(2008-10#1)(2013-7#1)
in natural hybrid zones##2##4##(2008-8#2)
in natural pathosystems##2##3##(2008-10#2)
in natural populations of the##2##5##(2008-10#1)(2008-9#1)
in natural populations of##7##4##(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
in natural populations##18##3##(1995-2#1)(2008-10#3)(2008-8#3)(2008-9#6)(2011-2#1)(2012-3#4)
in natural soil##2##3##(2008-10#1)(2008-11#1)
in natural systems##6##3##(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#2)
in natural water after##2##4##(2008-10#2)
in natural water and##5##4##(2008-10#5)
in natural water by##6##4##(2008-10#5)(2013-8#1)
in natural water samples by##2##5##(2008-10#2)
in natural water samples using##2##5##(2008-10#2)
in natural water samples##22##4##(2008-10#22)
in natural water##49##3##(2008-10#48)(2013-8#1)
in natural waters and aluminium alloys##2##6##(2008-10#2)
in natural waters and biological samples##2##6##(2008-10#2)
in natural waters and##11##4##(2008-10#11)
in natural waters based on##2##5##(2008-10#2)
in natural waters by##6##4##(2008-10#5)(2008-3#1)
in natural waters is##2##4##(2008-10#2)
in natural waters using##3##4##(2008-10#3)
in natural waters were##3##4##(2008-10#3)
in natural waters with##4##4##(2008-10#4)
in natural waters##70##3##(1994-8#1)(2008-10#67)(2008-12#1)(2008-3#1)
in natural##208##2##(1991-5#1)(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(2007-7#1)(2008-10#155)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#8)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
in naturally infected##5##3##(2008-10#5)
in naturally infested fields##2##4##(2008-10#2)
in naturally infested##5##3##(2008-10#5)
in naturally occurring and certified##2##5##(2008-10#2)
in naturally occurring##8##3##(1997-8#1)(2008-10#5)(2008-9#1)(2012-3#1)
in naturally##23##2##(1997-6#2)(1997-8#1)(2008-10#18)(2008-9#1)(2012-3#1)
in nature and may##2##4##(2008-8#2)
in nature and that##3##4##(1993-2#1)(2008-10#2)
in nature and##15##3##(1992-12#1)(1993-2#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
in nature are##2##3##(1991-9#1)(2012-3#1)
in nature as##2##3##(2008-5#1)(2012-2#1)
in nature in##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
in nature is##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
in nature of##2##3##(2008-10#2)
in nature or##2##3##(1995-1#1)(2008-10#1)
in nature##116##2##(1990-12#1)(1991-12#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-1#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(2007-12#3)(2008-10#28)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#15)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#1)
in naïve##2##2##(2010-12#1)(2013-1#1)
in near infrared noninvasive biochemical analysis##2##6##(2013-8#2)
in near infrared noninvasive biochemical##3##5##(2013-8#3)
in near real time##2##4##(2008-2#1)(2008-3#1)
in near##11##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)(2013-7#1)(2013-8#5)
in near-field data##3##3##(2008-3#3)
in near-field scanning optical microscopy##2##5##(2007-12#2)
in near-field##9##2##(2007-12#4)(2008-3#5)
in near-infrared##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
in near-surface##2##2##(2008-10#1)(2008-3#1)
in nearby managed##2##3##(2011-2#2)
in nearby##3##2##(2008-11#1)(2011-2#2)
in nearly 50% of##2##4##(1992-3#1)(2011-2#1)
in nearly 50%##3##3##(1992-3#1)(2011-2#1)(2013-1#1)
in nearly all##6##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
in nearly every##2##3##(1994-1#1)(2013-1#1)
in nearly##18##2##(1990-11#1)(1990-8#1)(1992-3#1)(1994-1#1)(1994-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#3)
in neat##4##2##(1992-6#1)(1996-2#2)(2011-1#1)
in neck##3##2##(2007-11#1)(2008-7#1)(2010-9#1)
in necrotic##5##2##(2008-10#4)(2008-7#1)
in need of##29##3##(1990-11#1)(1991-6#1)(1991-8#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#4)(2013-1#2)
in need##34##2##(1990-11#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-3#1)(2007-2#2)(2007-7#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#5)(2013-1#2)
in needle##2##2##(2008-10#2)
in needs assessments##2##3##(1997-1#2)
in needs##3##2##(1996-2#1)(1997-1#2)
in negative mode##2##3##(2008-10#2)
in negative##9##2##(2007-12#1)(2007-2#1)(2008-10#4)(2008-8#1)(2010-6#1)(2012-2#1)
in negatively##3##2##(1997-2#1)(2008-2#1)(2008-9#1)
in neglect patients##3##3##(1996-2#2)(2009-10#1)
in neighboring##6##2##(1992-1#1)(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#1)
in neither the##2##3##(1993-12#1)(1994-8#1)
in neither##4##2##(1991-4#1)(1993-12#1)(1994-8#1)(1996-6#1)
in nematic liquid crystals##4##4##(2007-11#2)(2007-12#2)
in nematode##5##2##(1995-3#1)(2008-10#4)
in neocortical##3##2##(1992-10#1)(1996-5#2)
in neonatal and senescent rats##2##5##(1991-2#2)
in neonatal follow-up##2##3##(2008-11#2)
in neonatal intensive care units##4##5##(1991-12#1)(1994-3#1)(1995-5#1)(2010-8#1)
in neonatal intensive care##10##4##(1991-12#5)(1993-8#1)(1994-3#1)(1995-5#1)(2008-11#1)(2010-8#1)
in neonatal rat ventricular myocytes##2##5##(1993-3#2)
in neonatal rat##5##3##(1993-3#2)(1994-6#1)(1995-5#1)(2010-12#1)
in neonatal rats##7##3##(1992-8#1)(1993-5#1)(1996-12#2)(1997-2#1)(2013-1#2)
in neonatal##41##2##(1990-11#1)(1991-12#5)(1991-2#2)(1992-10#2)(1992-8#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-5#3)(1996-12#2)(1997-2#1)(2008-1#1)(2008-11#4)(2009-12#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-3#2)(2013-1#2)
in neonate##6##2##(1990-11#1)(2007-11#1)(2008-5#2)(2012-3#2)
in neonates and##2##3##(2007-7#1)(2013-1#1)
in neonates with##2##3##(2008-10#1)(2012-1#1)
in neonates##12##2##(1994-2#1)(1994-6#1)(1997-1#1)(2007-7#2)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#2)
in neoplasia##3##2##(1993-5#1)(1994-3#1)(2012-3#1)
in neoplastic cells##5##3##(1990-6#2)(1995-3#1)(2008-4#2)
in neoplastic##10##2##(1990-6#2)(1991-11#1)(1992-8#1)(1995-3#1)(2007-11#1)(2007-2#1)(2008-4#2)(2012-3#1)
in nephrolithiasis##3##2##(2008-10#1)(2008-12#2)
in nephrology##4##2##(1991-3#1)(2008-1#2)(2008-10#1)
in nerve conduction##2##3##(2008-6#1)(2012-1#1)
in nerve fibers##2##3##(1990-5#1)(1997-4#1)
in nerve growth factor##2##4##(1991-12#1)(1996-12#1)
in nerve##10##2##(1990-5#1)(1991-12#1)(1992-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-6#1)(2008-8#1)(2012-1#1)
in nervous system##3##3##(1990-8#1)(2008-7#1)(2008-9#1)
in nervous tissue##3##3##(1994-11#1)(2011-1#2)
in nervous##6##2##(1990-8#1)(1994-11#1)(2008-7#1)(2008-9#1)(2011-1#2)
in nest##2##2##(2007-5#1)(2012-2#1)
in nestlings##2##2##(1994-3#1)(2008-8#1)
in net##6##2##(2008-1#1)(2008-10#3)(2008-11#1)(2012-5#1)
in network##3##2##(1992-3#1)(1996-12#1)(2013-8#1)
in network-based managed care##2##4##(1994-1#2)
in networks##4##2##(2008-11#1)(2008-3#1)(2012-2#2)
in neural cells##2##3##(1995-12#1)(2009-7#1)
in neural development and##2##4##(1996-12#1)(2008-7#1)
in neural development##4##3##(1996-12#1)(1996-5#1)(2008-7#1)(2009-9#1)
in neural precursor cells##2##4##(1992-12#1)(2008-11#1)
in neural tissues##3##3##(1992-9#1)(1997-4#1)(2008-6#1)
in neural##28##2##(1992-12#1)(1992-5#1)(1992-9#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-5#2)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2012-12#1)(2013-8#2)
in neurite##2##2##(2013-1#2)
in neurobiology##3##2##(2008-4#2)(2009-6#1)
in neuroblastoma##6##2##(1991-9#1)(2008-8#1)(2011-2#4)
in neurodegeneration##3##2##(1992-9#1)(1996-5#1)(2013-8#1)
in neurodegenerative diseases##2##3##(1995-12#1)(2008-4#1)
in neurodegenerative##4##2##(1993-12#1)(1995-12#2)(2008-4#1)
in neuroendocrine cells##2##3##(1995-2#1)(2008-9#1)
in neuroendocrine##4##2##(1995-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
in neurofibromatosis##4##2##(1997-3#1)(2008-6#1)(2009-1#1)(2010-11#1)
in neurogenesis##2##2##(1993-9#1)(2008-7#1)
in neuroimaging##7##2##(1995-5#1)(2007-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)
in neurologic disease##3##3##(1990-9#1)(1995-3#1)(2012-3#1)
in neurologic##6##2##(1990-9#1)(1995-3#1)(2008-7#1)(2008-8#1)(2012-3#2)
in neurological##6##2##(2007-11#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#1)
in neurology and##2##3##(2009-8#1)(2010-12#1)
in neurology practice##2##3##(2008-7#2)
in neurology##7##2##(2008-7#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#1)
in neuromuscular stimulation systems##2##4##(2010-8#2)
in neuromuscular##5##2##(2008-5#1)(2010-8#2)(2013-1#2)
in neuronal and glial cells##3##5##(1990-7#3)
in neuronal and##6##3##(1990-7#3)(1991-1#1)(1995-12#1)(2008-8#1)
in neuronal cell##2##3##(1995-6#1)(2008-7#1)
in neuronal cells##4##3##(1991-2#1)(1994-11#1)(1995-6#1)(2009-12#1)
in neuronal cultures##2##3##(2008-8#1)(2009-8#1)
in neuronal##37##2##(1990-5#1)(1990-7#4)(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-7#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2012-2#3)(2012-3#1)(2013-8#1)
in neurons and##4##3##(1995-5#2)(2008-7#1)(2012-3#1)
in neurons in the##2##4##(1990-5#1)(1994-2#1)
in neurons in##5##3##(1990-5#2)(1993-12#1)(1994-2#1)(2008-7#1)
in neurons of the##3##4##(1991-12#1)(1994-8#1)(1997-4#1)
in neurons of##4##3##(1991-12#1)(1994-8#1)(1996-6#1)(1997-4#1)
in neurons##31##2##(1990-5#2)(1990-7#1)(1991-12#3)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#4)(2008-8#2)(2012-3#1)(2013-1#1)
in neuropathic pain has##2##4##(2008-4#1)(2011-2#1)
in neuropathic pain##5##3##(2008-12#1)(2008-4#3)(2011-2#1)
in neuropathic##8##2##(1990-9#1)(1996-5#1)(2008-12#1)(2008-4#3)(2008-7#1)(2011-2#1)
in neurophysiology##2##2##(2007-12#1)(2010-6#1)
in neuropil##2##2##(1995-12#1)(1996-5#1)
in neuropsychiatric##4##2##(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
in neuropsychiatry##3##2##(1996-11#1)(2008-6#1)(2009-10#1)
in neuropsychology##2##2##(1996-11#2)
in neuropteran##2##2##(2007-12#2)
in neuroscience##6##2##(2007-8#1)(2008-11#1)(2008-4#3)(2009-6#1)
in neurosurgery##7##2##(2008-1#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in neurosurgical##3##2##(1996-11#1)(2010-7#1)(2012-12#1)
in neuroticism##2##2##(2008-11#1)(2008-6#1)
in neurotransmission##2##2##(1995-12#1)(1995-5#1)
in neurotransmitter##3##2##(1994-11#1)(1994-9#1)(2008-7#1)
in neutral and alkaline##3##4##(2008-10#3)
in neutral and##5##3##(2008-10#5)
in neutral medium##2##3##(2008-10#2)
in neutral##18##2##(1990-2#1)(2007-11#1)(2008-10#14)(2008-11#2)
in neutrophil##2##2##(1991-9#1)(1994-11#1)
in neutrophils from##2##3##(2008-10#2)
in neutrophils##10##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-6#1)(2008-10#3)(2008-5#1)(2013-8#1)
in never smokers##3##3##(2008-11#1)(2008-7#2)
in new and##3##3##(2008-10#2)(2009-11#1)
in new areas##2##3##(2010-3#1)(2012-2#1)
in new jersey##3##3##(2008-10#3)
in new types of human##2##5##(2013-8#2)
in new ways##2##3##(2010-4#1)(2010-5#1)
in new##38##2##(1990-2#1)(1992-1#1)(1993-12#2)(1993-2#1)(1996-2#1)(1996-5#2)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
in newborn infants##2##3##(1990-8#1)(1994-6#1)
in newborn piglets##2##3##(1990-5#2)
in newborn##10##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1993-6#1)(1994-6#1)(2008-10#1)(2010-3#1)(2011-1#1)
in newborns and##4##3##(2007-11#2)(2008-5#1)(2011-2#1)
in newborns with Down syndrome##2##5##(2008-12#2)
in newborns with##4##3##(2008-12#2)(2011-1#1)(2011-2#1)
in newborns##19##2##(1990-12#1)(1994-6#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2011-1#4)(2011-2#3)(2012-12#1)
in newly diagnosed cases of type 2 diabetes mellitus##2##9##(2012-2#2)
in newly diagnosed type 1 diabetes##2##6##(2011-1#2)
in newly diagnosed##7##3##(1991-2#1)(2010-4#1)(2011-1#2)(2012-2#2)(2013-1#1)
in newly##14##2##(1990-7#1)(1991-2#1)(1994-12#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-1#2)(2012-2#3)(2013-1#1)
in newspaper##3##2##(1997-6#1)(2008-9#2)
in ng##2##2##(2008-10#2)
in nickel##2##2##(1994-9#1)(2007-12#1)
in nigral cell##2##3##(2008-7#2)
in nigral dopamine neurons##2##4##(1996-2#2)
in nigral##4##2##(1996-2#2)(2008-7#2)
in nikkomycin biosynthesis##2##3##(2008-9#2)
in nine cases##4##3##(1997-3#1)(2008-9#1)(2013-1#1)(2013-8#1)
in nine countries##2##3##(1991-9#1)(1996-12#1)
in nine of##4##3##(2006-11#1)(2008-6#1)(2008-7#2)
in nine patients with##2##4##(2008-1#1)(2008-10#1)
in nine patients##7##3##(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-6#1)
in nine##43##2##(1990-3#1)(1991-6#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-11#1)(2007-7#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
in nitric acid medium##2##4##(2008-10#2)
in nitric acid##5##3##(2008-10#5)
in nitric##6##2##(2008-10#5)(2013-7#1)
in nitrobenzene solvent##3##3##(2008-10#3)
in nitrogen##6##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#2)
in nitrogen-vacancy##2##2##(2007-11#2)
in no case##7##3##(1990-2#1)(1991-3#1)(1991-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2011-1#1)
in no significant##4##3##(1993-11#2)(2008-5#1)(2013-1#1)
in no##23##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-11#2)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
in no-till fields##3##3##(2008-10#3)
in no-till##6##2##(2008-10#6)
in nociceptive neurons##2##3##(2008-8#1)(2009-12#1)
in nociceptive##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)
in nociceptors##2##2##(2008-8#2)
in node-positive##2##2##(1993-9#1)(1996-10#1)
in nodular##2##2##(1990-5#1)(2008-10#1)
in noise and##2##3##(2008-9#2)
in noise with##3##3##(2008-9#3)
in noise##14##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#7)(2011-2#1)(2012-2#2)
in noisy social##2##3##(2009-5#2)
in noisy##5##2##(2008-2#1)(2008-6#1)(2009-5#2)(2009-8#1)
in nomadic pastoral##2##3##(2011-2#2)
in nomadic##3##2##(2011-2#3)
in nomenclature##2##2##(2008-10#2)
in non##7##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#2)
in non-acute##2##2##(2010-5#1)(2011-3#1)
in non-alcoholic##3##2##(2007-8#1)(2012-2#2)
in non-aqueous media##3##3##(2008-10#3)
in non-aqueous medium##2##3##(2008-10#2)
in non-aqueous solvents##3##3##(2007-11#1)(2008-10#2)
in non-aqueous##10##2##(2007-11#1)(2008-10#9)
in non-cirrhotic##2##2##(1991-11#1)(2011-2#1)
in non-diabetic##2##2##(1994-12#1)(2010-11#1)
in non-hospital settings##2##3##(1995-11#1)(1996-1#1)
in non-hospital sites##2##3##(1996-1#2)
in non-hospital##4##2##(1995-11#1)(1996-1#3)
in non-human primates##4##3##(1994-2#1)(2007-12#1)(2008-2#1)(2009-3#1)
in non-human##5##2##(1993-12#1)(1994-2#1)(2007-12#1)(2008-2#1)(2009-3#1)
in non-hypertensive patients##4##3##(2007-10#4)
in non-insulin-dependent diabetes mellitus##3##4##(1992-9#1)(1994-8#1)(1995-8#1)
in non-insulin-dependent diabetic patients##2##4##(1994-8#1)(1997-7#1)
in non-insulin-dependent##5##2##(1992-9#1)(1994-8#2)(1995-8#1)(1997-7#1)
in non-ionic micellar medium##2##4##(2008-10#2)
in non-ionic micellar##3##3##(2008-10#3)
in non-islet cells##2##3##(1995-8#2)
in non-metropolitan areas##2##3##(1996-3#1)(2009-8#1)
in non-neoplastic##2##2##(1992-2#1)(2008-10#1)
in non-neural##3##2##(1994-2#2)(2008-9#1)
in non-neurological##3##2##(1997-2#2)(2008-7#1)
in non-neuronal##2##2##(1995-8#1)(2009-10#1)
in non-phagocytic cells##2##3##(2009-5#1)(2012-2#1)
in non-polar##2##2##(2008-10#1)(2008-7#1)
in non-pregnant##2##2##(2011-2#1)(2013-1#1)
in non-rodent##3##2##(2008-10#2)(2012-2#1)
in non-small cell lung cancer##4##5##(1993-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
in non-small cell lung##5##4##(1993-9#1)(2010-8#2)(2011-2#1)(2012-1#1)
in non-small##6##2##(1993-9#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-1#1)
in non-small-cell lung cancer (NSCLC)##2##5##(1991-2#1)(2012-3#1)
in non-small-cell lung cancer##5##4##(1991-2#2)(1993-9#1)(2010-8#1)(2012-3#1)
in non-small-cell lung carcinoma (NSCLC)##2##5##(1993-9#1)(2012-12#1)
in non-small-cell lung##7##3##(1991-2#2)(1993-9#2)(2010-8#1)(2012-12#1)(2012-3#1)
in non-smoker##3##2##(2008-10#1)(2008-12#2)
in non-smokers and non-alcoholic drinkers##2##5##(2013-1#2)
in non-smokers and##3##3##(2013-1#3)
in non-smokers##7##2##(1996-3#1)(2008-10#1)(2008-12#2)(2013-1#3)
in non-survivors##2##2##(2009-6#1)(2011-2#1)
in non-synaptic##2##2##(1990-3#2)
in nonaqueous solution##2##3##(2013-1#2)
in nonaqueous##4##2##(2008-7#2)(2013-1#2)
in nonautoclaved##3##2##(2008-10#3)
in noncardiac surgery##2##3##(2006-10#1)(2008-3#1)
in noncardiac##3##2##(2006-10#1)(2008-3#1)(2008-7#1)
in noncritically##2##2##(2007-11#1)(2009-11#1)
in noncultivated soil but significantly##2##5##(2008-10#2)
in noncultivated soil##3##3##(2008-10#3)
in noncultivated##6##2##(2008-10#6)
in nondenaturing polyacrylamide gels##2##4##(1992-2#1)(1995-6#1)
in nondenaturing##5##2##(1992-2#1)(1994-6#1)(1995-6#1)(2008-2#1)(2008-4#1)
in nondopaminergic neurons##2##3##(2008-7#2)
in none##2##2##(1992-5#1)(2012-2#1)
in nonfumigated soil##2##3##(2008-10#2)
in nonfumigated##3##2##(2008-10#3)
in nonhepatocytes##2##2##(2008-9#2)
in nonhuman primates##2##3##(1994-8#1)(1996-6#1)
in nonhuman##3##2##(1994-8#1)(1996-6#1)(2008-4#1)
in noninoculated leaves was##2##4##(2008-10#2)
in noninoculated leaves##3##3##(2008-10#3)
in noninoculated##6##2##(2008-10#6)
in nonionic microemulsion medium##2##4##(2008-10#2)
in nonlinear optical##2##3##(2007-12#2)
in nonlinear##8##2##(2007-11#1)(2007-12#6)(2007-8#1)
in nonmodel deceptive##2##3##(2008-9#2)
in nonoverlapping noise##2##3##(2007-12#2)
in nonoverlapping##3##2##(2007-12#3)
in nonpigmented##2##2##(1992-8#1)(1993-8#1)
in nonpolar and##2##3##(1992-5#1)(2008-3#1)
in nonpolar##4##2##(1992-5#1)(1994-3#1)(2008-11#1)(2008-3#1)
in nonprofit nursing homes##2##4##(1992-3#2)
in nonprofit organizations##3##3##(1993-12#2)(1995-12#1)
in nonprofit##6##2##(1992-3#2)(1993-12#2)(1995-12#1)(2008-11#1)
in nonrhizosphere##2##2##(2008-10#2)
in nonsmokers##2##2##(1991-1#1)(2008-12#1)
in nonsterile soil##2##3##(2008-10#2)
in nonsterile##3##2##(2008-10#3)
in nonstimulated peripheral blood cells##3##5##(1995-2#3)
in nonstimulated peripheral blood##4##4##(1995-2#4)
in nontransgenic and transgenic##2##4##(1992-8#1)(1997-7#1)
in nontransgenic##4##2##(1992-8#1)(1994-8#1)(1997-7#1)(2008-10#1)
in nontreated soil##2##3##(2008-10#2)
in nontreated##8##2##(2007-11#1)(2008-10#6)(2008-11#1)
in noradrenergic##2##2##(1996-12#1)(2008-7#1)
in normal Ca2+ medium##2##4##(1993-11#2)
in normal adult##2##3##(1990-5#1)(1991-7#1)
in normal ageing##3##3##(2009-10#3)
in normal aging##2##3##(1994-6#1)(2008-7#1)
in normal and alloxan-induced diabetic rats##2##6##(2011-1#1)(2012-2#1)
in normal and atherosclerotic human arteries##2##6##(1993-3#2)
in normal and cancer cells##2##5##(2008-10#1)(2008-11#1)
in normal and cancer##4##4##(2008-10#3)(2008-11#1)
in normal and diabetic rats##2##5##(2011-1#1)(2013-8#1)
in normal and diabetic##3##4##(1994-8#1)(2011-1#1)(2013-8#1)
in normal and neoplastic##3##4##(1994-2#1)(1995-12#1)(2011-2#1)
in normal and pathological##3##4##(1991-5#1)(2009-8#1)(2012-3#1)
in normal and second-derivative electrophoregrams were##2##6##(2008-10#2)
in normal and transformed human cells##2##6##(1992-3#2)
in normal and transformed human##3##5##(1992-3#2)(1993-11#1)
in normal and tumor##2##4##(2008-11#1)(2008-4#1)
in normal and tumour##2##4##(1991-5#1)(2008-2#1)
in normal and##46##3##(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#3)(1994-2#3)(1994-8#2)(1995-12#2)(1995-8#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in normal animals##5##3##(1991-2#2)(1993-6#1)(1995-12#1)(2008-4#1)
in normal body##2##3##(2011-2#1)(2013-8#1)
in normal brain##6##3##(1996-5#2)(1996-6#1)(2008-7#2)(2013-1#1)
in normal canine##2##3##(2011-2#1)(2012-3#1)
in normal cell##2##3##(2008-4#1)(2009-8#1)
in normal cells##2##3##(2008-11#1)(2013-1#1)
in normal cellular##2##3##(2008-5#1)(2011-1#1)
in normal children##2##3##(1991-12#1)(2013-8#1)
in normal condition##4##3##(1991-12#1)(2012-3#3)
in normal conditions##4##3##(2007-11#2)(2008-8#1)(2008-9#1)
in normal controls##3##3##(1992-12#1)(1996-12#1)(2008-7#1)
in normal development##4##3##(2008-1#1)(2008-7#1)(2009-3#1)(2010-11#1)
in normal feet##2##3##(2012-2#2)
in normal females##2##3##(1993-12#1)(1995-8#1)
in normal fibroblasts##3##3##(1992-8#1)(1992-9#1)(1997-7#1)
in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas##2##10##(2012-12#2)
in normal fimbrial epithelial cells of##3##6##(2012-12#3)
in normal hepatocytes but##2##4##(1994-8#2)
in normal hepatocytes##4##3##(1992-6#1)(1994-8#2)(2008-4#1)
in normal human fibroblasts##3##4##(1997-7#1)(2009-8#2)
in normal human subjects##2##4##(1995-9#1)(1996-5#1)
in normal human##18##3##(1990-9#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
in normal individuals##2##3##(1991-5#1)(2008-1#1)
in normal mice##6##3##(1993-8#1)(1994-11#1)(1995-2#1)(1997-3#2)(2008-11#1)
in normal physiologic circumstances##2##4##(2011-2#2)
in normal plasma##2##3##(1993-11#1)(1994-2#1)
in normal population##2##3##(2008-7#1)(2012-12#1)
in normal pregnancy and##2##4##(1990-9#1)(1994-9#1)
in normal rat##3##3##(1991-5#1)(1992-6#1)(2008-9#1)
in normal rats##2##3##(2011-1#1)(2012-2#1)
in normal skin##4##3##(2008-5#2)(2012-3#2)
in normal subjects and##3##4##(1990-5#1)(2008-4#2)
in normal subjects##14##3##(1990-5#2)(1991-1#1)(1991-2#1)(1991-9#1)(1992-6#1)(1994-3#1)(1995-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-3#1)
in normal tissue##2##3##(1990-5#1)(2008-11#1)
in normal tissues##7##3##(2008-11#1)(2008-4#2)(2008-9#2)(2011-2#1)(2013-8#1)
in normal weight women##2##4##(2007-7#2)
in normal women##2##3##(1990-11#1)(2008-10#1)
in normal##258##2##(1990-11#2)(1990-12#7)(1990-5#6)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#4)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#5)(1993-12#4)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#5)(1994-3#1)(1994-6#1)(1994-8#8)(1994-9#2)(1995-12#4)(1995-2#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-5#6)(1996-6#1)(1996-7#1)(1997-3#3)(1997-7#3)(2007-10#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#11)(2008-5#5)(2008-7#13)(2008-8#3)(2008-9#8)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-8#1)(2011-1#9)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#11)(2013-1#6)(2013-7#1)(2013-8#6)
in normalizing##2##2##(2008-7#1)(2013-1#1)
in normally##3##2##(1991-5#1)(1992-9#1)(2012-2#1)
in normoglycemic##2##2##(1990-7#1)(2010-8#1)
in normotensive females##2##3##(2010-7#2)
in normotensive##8##2##(1990-2#1)(1990-7#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#2)(2012-2#1)
in normoxic##3##2##(1993-6#1)(1997-1#1)(2009-11#1)
in north Indian##2##3##(2008-12#1)(2013-1#1)
in north Indians##2##3##(2007-7#2)
in north america##5##3##(2008-10#5)
in north and##2##3##(1991-4#1)(2012-3#1)
in north eastern##3##3##(2011-2#1)(2013-1#2)
in north of##2##3##(2008-10#1)(2011-1#1)
in north##18##2##(1991-4#1)(1996-8#1)(2007-7#2)(2008-10#6)(2008-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
in northeast##2##2##(2008-10#1)(2008-9#1)
in northeastern North America##2##4##(2008-10#1)(2011-2#1)
in northeastern North##3##3##(2008-10#1)(2011-2#2)
in northeastern##6##2##(2008-10#2)(2009-5#1)(2011-2#3)
in northern California##3##3##(1991-7#1)(1992-2#1)(2008-10#1)
in northern Europe##3##3##(1991-11#1)(2008-9#1)(2012-2#1)
in northern Italy##5##3##(1990-2#1)(1990-8#1)(1994-8#1)(2008-8#1)(2011-2#1)
in northern Nigeria##4##3##(1997-4#1)(2011-1#2)(2011-2#1)
in northern##39##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-9#4)(2011-1#2)(2011-2#2)(2012-2#1)
in northwest##3##2##(1996-8#1)(2008-12#1)(2010-4#1)
in northwestern California##2##3##(2010-6#2)
in northwestern Costa Rica##2##4##(2008-5#2)
in northwestern##6##2##(2008-10#1)(2008-3#1)(2008-5#2)(2010-6#2)
in not only the##2##4##(2008-11#1)(2012-1#1)
in not only##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
in not##4##2##(2008-10#1)(2008-11#1)(2009-10#1)(2012-1#1)
in novel##12##2##(1996-2#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-3#1)(2012-1#1)
in nuclear DNA##2##3##(1995-6#1)(2008-9#1)
in nuclear assembly##2##3##(2008-8#1)(2010-5#1)
in nuclear emergency tablets##2##4##(2008-10#2)
in nuclear magnetic resonance##2##4##(1993-3#1)(2010-5#1)
in nuclear medicine##2##3##(1993-2#1)(2008-7#1)
in nuclear morphology##2##3##(1991-2#1)(2008-8#1)
in nuclear##33##2##(1991-2#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#7)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#2)(2009-5#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
in nuclear-transferred embryos##3##3##(2008-8#3)
in nuclease##3##2##(1992-6#1)(1997-2#1)(2008-4#1)
in nuclei of##3##3##(1993-8#1)(1994-2#1)(2011-1#1)
in nuclei##5##2##(1993-8#1)(1994-2#1)(2011-1#1)(2011-2#2)
in nucleic acid##6##3##(2008-10#2)(2008-4#2)(2008-9#2)
in nucleic##7##2##(2008-10#2)(2008-4#3)(2008-9#2)
in nucleotide sequence##2##3##(2008-10#2)
in nucleotide##7##2##(1997-4#1)(2008-10#2)(2008-4#3)(2008-9#1)
in nucleotides##3##2##(1994-6#1)(2008-10#2)
in nucleus accumbens##3##3##(1993-12#1)(1993-6#1)(1997-7#1)
in nucleus##6##2##(1993-12#1)(1993-6#1)(1997-7#1)(2008-9#3)
in nude and SCID/beige mice##2##5##(1991-8#2)
in nude mice bearing##2##4##(1995-3#2)
in nude mice##26##3##(1992-9#4)(1993-1#1)(1993-9#3)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#2)(1995-9#1)(2008-5#1)(2008-6#2)(2008-8#5)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
in nude##30##2##(1991-8#2)(1992-9#4)(1993-1#1)(1993-9#3)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#2)(1995-9#1)(2008-5#1)(2008-6#3)(2008-8#5)(2010-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
in number and are##2##4##(1994-2#1)(2008-7#1)
in number and##10##3##(1993-12#2)(1994-2#1)(1995-12#1)(1996-5#2)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)
in number in the##2##4##(2008-8#1)(2011-2#1)
in number in##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
in number of mounts and intromissions##2##6##(1991-2#2)
in number of##18##3##(1991-2#3)(1996-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
in number##47##2##(1990-6#1)(1991-12#1)(1991-2#3)(1993-12#3)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
in numbers of##12##3##(1994-12#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-8#3)(2008-10#2)(2008-5#1)(2010-1#1)
in numbers##15##2##(1991-7#1)(1994-12#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-8#3)(2008-10#2)(2008-5#1)(2008-7#1)(2010-1#1)(2013-8#1)
in numerical##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)
in numerous studies##2##3##(2008-3#1)(2010-1#1)
in numerous##29##2##(1990-11#1)(1992-5#1)(1993-6#1)(1995-2#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in nurse education is##2##4##(2008-11#2)
in nurse education##21##3##(2008-11#17)(2008-12#4)
in nurse##25##2##(2008-11#18)(2008-12#6)(2009-6#1)
in nurseries##2##2##(2008-10#2)
in nursery##4##2##(1996-12#1)(2008-10#3)
in nurses of##2##3##(2009-5#2)
in nurses##7##2##(2008-11#1)(2008-12#1)(2009-5#3)(2010-3#1)(2013-8#1)
in nursing and##5##3##(2008-10#1)(2008-11#2)(2008-12#1)(2012-12#1)
in nursing are##2##3##(2007-10#1)(2008-11#1)
in nursing care##3##3##(1996-1#1)(2007-10#1)(2013-1#1)
in nursing course##2##3##(2008-11#2)
in nursing education and##4##4##(2008-1#1)(2008-11#2)(2008-12#1)
in nursing education are##2##4##(2008-11#1)(2008-12#1)
in nursing education research##2##4##(2008-12#2)
in nursing education##22##3##(2008-1#1)(2008-11#8)(2008-12#13)
in nursing facilities##2##3##(1994-3#1)(2008-5#1)
in nursing for##2##3##(1995-2#1)(2008-4#1)
in nursing home patients##2##4##(1994-2#1)(2008-7#1)
in nursing home##7##3##(1992-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-7#1)(2010-10#1)
in nursing homes##17##3##(1991-12#1)(1992-3#1)(1993-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-2#2)(2009-3#1)(2010-10#3)(2010-11#1)(2012-12#2)
in nursing programmes##2##3##(2012-3#1)(2013-8#1)
in nursing students##2##3##(2008-12#2)
in nursing##105##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#4)(1996-1#2)(1996-2#1)(1997-2#2)(2007-10#3)(2008-1#4)(2008-10#1)(2008-11#24)(2008-12#23)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#4)(2010-11#1)(2010-3#2)(2010-5#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
in nutrient broth##2##3##(2008-10#2)
in nutrient##14##2##(1994-12#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-8#2)(2008-9#1)(2009-4#1)
in nutrition##9##2##(1992-12#1)(1992-2#1)(1995-3#2)(2008-7#1)(2011-2#2)(2012-2#2)
in nutritional##4##2##(2008-1#1)(2008-10#1)(2010-4#1)(2012-12#1)
in nymphs##2##2##(2013-7#2)
in o##3##2##(2008-10#3)
in oak##2##2##(2010-6#1)(2012-9#1)
in oat (Avena##2##3##(2008-10#2)
in oat##10##2##(1990-5#1)(2008-10#7)(2008-5#2)
in oats##2##2##(2008-10#2)
in obese and##2##3##(1995-5#1)(2012-2#1)
in obese animals##2##3##(2012-3#2)
in obese group##2##3##(2012-2#2)
in obese individuals##5##3##(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
in obese patients##2##3##(2011-2#1)(2012-12#1)
in obese people##5##3##(1993-3#1)(1993-5#2)(2010-8#1)(2013-8#1)
in obese subjects##2##3##(1990-9#1)(1992-12#1)
in obese than in lean rats##3##6##(1995-5#3)
in obese women##3##3##(1990-9#1)(2013-1#2)
in obese##42##2##(1990-9#2)(1992-12#1)(1993-3#1)(1993-5#3)(1995-5#6)(1996-12#2)(2008-1#2)(2008-3#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#3)
in obesity and##2##3##(2008-1#1)(2012-2#1)
in obesity may be##2##4##(2009-10#1)(2010-4#1)
in obesity##11##2##(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#2)
in obesity-related##2##2##(2010-11#1)(2013-7#1)
in objective##4##2##(1992-12#1)(2009-10#1)(2009-11#1)(2011-2#1)
in observed##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
in obsessive-compulsive disorder##2##3##(2008-6#1)(2012-1#1)
in obstetric care##2##3##(2011-1#1)(2011-2#1)
in obstetric patients##2##3##(1993-10#2)
in obstetric##8##2##(1993-10#4)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
in obstetrics and##6##3##(1990-3#1)(1993-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
in obstetrics##7##2##(1990-3#1)(1993-12#1)(1994-2#1)(2010-8#1)(2012-3#1)(2013-1#2)
in obstructive##3##2##(1993-2#1)(2007-12#1)(2011-2#1)
in obtaining a##4##3##(1993-3#2)(2008-2#1)(2011-2#1)
in obtaining an internship##2##4##(1992-2#1)(1993-3#1)
in obtaining the##3##3##(2008-3#1)(2011-1#1)(2012-12#1)
in obtaining##30##2##(1992-2#2)(1992-9#1)(1993-1#1)(1993-3#3)(1994-11#1)(1994-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
in occasional##2##2##(1994-3#1)(2008-10#1)
in occipital and##2##3##(1991-12#1)(2007-8#1)
in occupational and##2##3##(1991-12#1)(2013-7#1)
in occupational health##2##3##(1991-3#1)(2008-12#1)
in occupational medicine]##2##3##(1990-3#1)(1997-8#1)
in occupational##9##2##(1990-3#1)(1991-12#1)(1991-3#1)(1997-8#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-7#1)
in occupations##2##2##(1991-12#1)(1994-3#1)
in occupied##2##2##(2011-2#2)
in occurrence##2##2##(1994-2#1)(2010-8#1)
in ocean color remote sensing##2##5##(2008-2#1)(2008-3#1)
in ocean color##3##3##(2008-2#1)(2008-3#2)
in ocean##5##2##(2008-2#1)(2008-3#4)
in oceanic ecosystem models##2##4##(2008-3#2)
in oceanic##3##2##(2008-3#3)
in octogenarians##2##2##(1995-3#1)(2011-2#1)
in ocular##3##2##(2006-10#1)(2008-4#1)(2011-1#1)
in odour perception##3##3##(2008-7#3)
in of##3##2##(2008-3#2)(2013-1#1)
in off-pump coronary artery bypass##2##5##(2007-8#1)(2010-8#1)
in off-pump coronary##3##3##(2007-8#2)(2010-8#1)
in offender##2##2##(2008-11#1)(2009-9#1)
in offering a##2##3##(1992-1#1)(2010-5#1)
in offering##3##2##(1992-1#1)(2008-10#1)(2010-5#1)
in offspring of##3##3##(2007-5#1)(2008-10#1)(2008-8#1)
in offspring##7##2##(1991-5#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)
in oil##8##2##(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)(2011-1#1)(2011-2#1)
in oil-in-water emulsions##2##3##(2008-10#1)(2008-5#1)
in old age is##3##4##(1990-11#1)(2012-1#1)(2013-7#1)
in old age##15##3##(1990-11#2)(1990-3#2)(1994-5#1)(1996-3#1)(1996-5#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-1#3)(2013-7#1)
in old and young##2##4##(1994-6#1)(2009-12#1)
in old animals##2##3##(1991-12#1)(2008-3#1)
in old as compared to young##2##6##(1991-12#2)
in old male rats##2##4##(2008-7#2)
in old male##3##3##(2008-7#2)(2013-1#1)
in old mice##2##3##(2013-7#2)
in old rats as##2##4##(1994-6#1)(2008-7#1)
in old rats of both sexes##2##6##(2008-7#2)
in old rats##10##3##(1991-12#1)(1994-6#3)(2008-7#6)
in old than in young##2##5##(2008-7#2)
in old##54##2##(1990-11#2)(1990-2#1)(1990-3#3)(1991-12#4)(1992-11#1)(1994-5#2)(1994-6#5)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#17)(2008-9#1)(2009-12#1)(2012-1#4)(2013-1#1)(2013-7#3)(2013-8#1)
in old-field interaction webs##2##4##(2008-9#2)
in older adults with OA##2##5##(2010-11#2)
in older adults with##6##4##(1992-6#1)(2010-11#3)(2012-12#1)(2012-3#1)
in older adults##25##3##(1992-6#2)(2007-7#2)(2008-8#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-11#3)(2010-7#2)(2010-8#2)(2011-1#3)(2012-12#2)(2012-3#1)(2013-1#3)
in older age groups##2##4##(2008-9#1)(2013-1#1)
in older age##3##3##(2008-9#1)(2010-10#1)(2013-1#1)
in older and##2##3##(1994-6#1)(2011-2#1)
in older animals##3##3##(1990-3#1)(2008-3#1)(2009-12#1)
in older athletes taking statins##3##5##(2013-1#3)
in older children and##3##4##(2008-10#1)(2011-2#2)
in older children with##3##4##(1991-2#2)(2007-8#1)
in older children##9##3##(1991-2#2)(1994-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2009-3#1)(2011-2#2)
in older dogs##2##3##(2012-3#2)
in older individuals##2##3##(2007-12#1)(2009-8#1)
in older medical inpatients##2##4##(2013-1#2)
in older men##2##3##(2008-4#1)(2009-5#1)
in older patients and##2##4##(2007-12#1)(2011-2#1)
in older patients with##4##4##(1991-1#1)(1996-7#1)(2008-7#1)(2011-2#1)
in older patients##15##3##(1991-1#1)(1995-5#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#2)
in older people##6##3##(2008-3#4)(2012-12#1)(2013-8#1)
in older subjects##2##3##(1995-5#1)(2008-7#1)
in older women##8##3##(2008-3#2)(2008-7#1)(2010-10#2)(2011-2#1)(2012-12#2)
in older##102##2##(1990-3#2)(1991-1#1)(1991-2#2)(1992-6#2)(1992-8#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#2)(1996-2#1)(1996-7#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#8)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#3)(2009-3#1)(2009-5#3)(2009-8#1)(2010-10#4)(2010-11#3)(2010-3#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#11)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#11)(2013-8#3)
in olfactory bulb##3##3##(2012-2#1)(2013-1#2)
in olfactory learning##2##3##(2012-2#2)
in olfactory##11##2##(1993-6#1)(1996-12#1)(1996-5#1)(2007-12#3)(2012-2#3)(2013-1#2)
in oligodendrocyte progenitors##2##3##(1996-12#2)
in oligodendrocyte##4##2##(1996-12#3)(2008-7#1)
in oligodendrocytes##5##2##(1991-5#1)(1995-5#1)(1996-5#2)(2009-6#1)
in olive oil##3##3##(1995-11#1)(2008-10#2)
in olive##7##2##(1994-5#1)(1995-11#1)(2008-10#4)(2008-12#1)
in oman##2##2##(2008-10#1)(2012-12#1)
in on##5##2##(1993-2#1)(1997-6#1)(2008-12#1)(2008-6#1)(2010-12#1)
in on-line##4##2##(2008-10#2)(2008-3#2)
in oncogenic transformation##2##3##(1994-8#1)(1995-2#1)
in oncologic patients##3##3##(2011-1#2)(2013-1#1)
in oncologic##4##2##(2008-1#1)(2011-1#2)(2013-1#1)
in oncological##4##2##(2007-5#1)(2007-7#1)(2008-6#1)(2011-3#1)
in oncology and in##2##4##(1991-3#1)(2011-3#1)
in oncology and##4##3##(1991-3#1)(1997-8#1)(2010-10#1)(2011-3#1)
in oncology is##2##3##(2010-5#1)(2011-2#1)
in oncology##25##2##(1991-11#1)(1991-3#1)(1997-8#1)(2008-10#3)(2008-2#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2010-1#1)(2010-10#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
in oncolytic##2##2##(2013-1#2)
in one (4##4##3##(2007-7#1)(2013-1#3)
in one (6##2##3##(2008-4#1)(2013-8#1)
in one 1##2##3##(2008-9#2)
in one Ca2+ binding site##2##5##(1990-11#2)
in one and a##2##4##(2007-7#1)(2008-9#1)
in one and##5##3##(1995-12#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-9#1)
in one area##3##3##(1995-12#1)(2008-8#1)(2012-12#1)
in one arm##2##3##(2007-11#1)(2008-3#1)
in one case and##3##4##(2007-11#1)(2008-5#1)(2008-7#1)
in one case of##2##4##(1993-9#1)(2007-7#1)
in one case the##3##4##(1990-8#1)(1994-9#1)(2007-11#1)
in one case##32##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(2006-12#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#6)(2009-1#1)
in one cell##2##3##(2008-8#1)(2012-12#1)
in one dimension##3##3##(2007-11#1)(2008-3#1)(2009-12#1)
in one direction##3##3##(1995-5#1)(2007-11#1)(2008-3#1)
in one experiment##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
in one eye##2##3##(2008-7#1)(2013-8#1)
in one field##3##3##(2007-6#1)(2008-10#2)
in one format##2##3##(2008-4#1)(2010-10#1)
in one fourth of##2##4##(1990-12#1)(2007-10#1)
in one group##9##3##(1996-2#1)(1996-9#1)(2008-10#4)(2010-4#1)(2011-2#1)(2013-8#1)
in one instance##2##3##(2008-10#1)(2010-4#1)
in one large##2##3##(1994-8#1)(1997-5#1)
in one man##2##3##(2007-11#1)(2011-2#1)
in one mouse##3##3##(2008-10#1)(2008-8#2)
in one of five##3##4##(1992-11#1)(2008-10#1)(2008-11#1)
in one of four##2##4##(1995-3#1)(1996-2#1)
in one of six##2##4##(2007-12#1)(2008-12#1)
in one of the most##4##5##(2007-11#1)(2008-9#2)(2013-1#1)
in one of the two##3##5##(2008-10#3)
in one of the##24##4##(1990-2#1)(1991-6#1)(1992-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-1#1)(2013-1#3)
in one of them##2##4##(1990-7#2)
in one of these##3##4##(1990-10#1)(2008-10#1)(2011-1#1)
in one of three##3##4##(1994-2#1)(2008-10#2)
in one of two##3##4##(1995-8#1)(2008-3#1)(2013-1#1)
in one of##52##3##(1990-10#1)(1990-2#1)(1990-7#2)(1991-6#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2011-1#2)(2012-1#1)(2013-1#5)(2013-7#1)(2013-8#1)
in one or both##5##4##(2008-10#2)(2008-7#1)(2010-8#1)(2013-7#1)
in one or more of the##2##6##(1995-5#1)(2009-6#1)
in one or more of##3##5##(1995-5#1)(2008-10#1)(2009-6#1)
in one or more##8##4##(1995-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
in one or the other##2##5##(1994-11#1)(2007-8#1)
in one or two##3##4##(1990-11#1)(2008-2#1)(2008-5#1)
in one or##20##3##(1990-11#1)(1990-8#1)(1994-11#1)(1995-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
in one out of##2##4##(1992-5#1)(2007-7#1)
in one patient and##6##4##(1997-5#1)(2006-12#1)(2008-1#2)(2011-1#1)(2012-2#1)
in one patient who##2##4##(1997-6#1)(2007-8#1)
in one patient with##2##4##(1990-12#1)(1994-12#1)
in one patient##29##3##(1990-12#1)(1994-12#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#5)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
in one piece##3##3##(2008-12#2)(2011-2#1)
in one population##3##3##(2008-10#3)
in one sample##3##3##(2008-10#2)(2008-11#1)
in one second##3##3##(2007-2#1)(2007-8#1)(2012-3#1)
in one series##2##3##(2008-11#1)(2010-3#1)
in one single##6##3##(1992-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-6#1)
in one species##2##3##(2012-2#1)(2012-3#1)
in one step by##2##4##(2008-8#1)(2009-2#1)
in one step##11##3##(1996-5#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-3#1)
in one study##3##3##(1992-3#1)(2013-1#1)(2013-8#1)
in one to##2##3##(1995-8#1)(2008-9#1)
in one university##2##3##(2008-11#2)
in one year##5##3##(1994-3#1)(2008-10#2)(2012-3#2)
in one##396##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#4)(1997-9#1)(2006-12#2)(2007-10#2)(2007-11#14)(2007-12#3)(2007-2#1)(2007-6#3)(2007-7#6)(2007-8#8)(2008-1#8)(2008-10#55)(2008-11#18)(2008-12#7)(2008-2#9)(2008-3#13)(2008-4#11)(2008-5#10)(2008-6#6)(2008-7#20)(2008-8#16)(2008-9#11)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#8)
in one's##3##2##(2008-1#1)(2008-10#1)(2012-1#1)
in one)##2##2##(1990-8#1)(1992-5#1)
in one-dimensional##4##2##(2007-12#1)(2008-8#1)(2010-11#1)(2013-8#1)
in one-pot##3##2##(2008-10#2)(2012-3#1)
in ongoing##3##2##(1992-10#1)(2008-11#1)(2011-7#1)
in onion##4##2##(1993-12#1)(2008-10#3)
in only 1##4##3##(1990-12#1)(1990-3#1)(1990-9#1)(1993-2#1)
in only 10##2##3##(2008-1#1)(2008-10#1)
in only 13##2##3##(2008-10#1)(2008-9#1)
in only 2##4##3##(1993-2#1)(1994-7#1)(1997-8#1)(2008-8#1)
in only 2%##2##3##(1990-8#1)(1992-8#1)
in only 29% of the##2##5##(2008-1#1)(2008-4#1)
in only 3##2##3##(2007-8#1)(2008-1#1)
in only 4##3##3##(1991-11#1)(2007-7#1)(2008-7#1)
in only 8##2##3##(2008-10#1)(2009-8#1)
in only a few##2##4##(1990-2#1)(2010-2#1)
in only a small percentage of##2##6##(1991-3#1)(2011-2#1)
in only a small##5##4##(1991-3#1)(1994-8#1)(1997-1#1)(2008-3#1)(2011-2#1)
in only a##8##3##(1990-2#1)(1991-3#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-3#1)(2010-2#1)(2011-2#1)
in only one case##3##4##(1990-9#1)(1991-8#1)(2007-8#1)
in only one of four##2##5##(2008-10#1)(2008-7#1)
in only one of the##2##5##(2008-10#1)(2008-8#1)
in only one of##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
in only one##23##3##(1990-8#1)(1990-9#1)(1991-8#1)(1993-12#1)(1994-3#1)(1996-11#1)(2007-10#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-4#1)(2010-7#1)
in only the##2##3##(2007-12#1)(2008-7#1)
in only two cases##2##4##(1996-9#1)(1997-3#1)
in only two of##3##4##(1996-11#1)(2008-10#2)
in only two##6##3##(1996-11#1)(1996-9#1)(1997-3#1)(2008-10#2)(2011-1#1)
in only##105##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-2#3)(1996-11#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
in ontario##2##2##(2011-2#1)(2012-2#1)
in ontogeny and##2##3##(1991-5#1)(2013-7#1)
in ontologies##2##2##(2008-7#1)(2010-5#1)
in oocyte##2##2##(1994-9#1)(2008-8#1)
in oocytes and##5##3##(1994-12#2)(2008-8#1)(2008-9#1)(2012-2#1)
in oocytes expressing the##2##4##(1995-11#1)(2008-4#1)
in oocytes expressing##4##3##(1990-8#1)(1995-11#1)(2008-4#2)
in oocytes of##2##3##(1995-2#1)(1997-2#1)
in oocytes##17##2##(1990-8#1)(1994-12#2)(1995-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#5)(2012-2#1)
in oogenesis##2##2##(2009-7#1)(2010-5#1)
in op/op##4##2##(1990-5#1)(1991-5#3)
in open and##3##3##(1992-9#1)(2007-8#1)(2008-5#1)
in open heart surgery##2##4##(1990-2#2)
in open heart##4##3##(1990-2#2)(2007-8#1)(2008-5#1)
in open##21##2##(1990-2#2)(1992-9#1)(1993-12#1)(1994-3#1)(2007-8#4)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
in operable breast cancer##2##4##(1993-11#1)(1994-6#1)
in operable##4##2##(1993-11#1)(1994-6#1)(1997-8#2)
in operating rooms##2##3##(1991-6#1)(2011-2#1)
in operating##5##2##(1991-6#1)(1995-1#1)(2008-8#1)(2010-11#1)(2011-2#1)
in operation##13##2##(1994-12#2)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2012-3#1)(2013-8#1)
in operational##4##2##(1993-2#2)(2008-3#1)(2012-2#1)
in operations##2##2##(2010-8#1)(2011-2#1)
in operative laparoscopy##5##3##(1992-12#1)(1993-12#4)
in operative time##2##3##(1995-1#1)(1996-2#1)
in operative##10##2##(1992-12#1)(1993-12#4)(1995-1#1)(1996-2#1)(2007-11#1)(2010-6#1)(2013-1#1)
in ophthalmic##2##2##(2008-10#1)(2010-10#1)
in ophthalmology##9##2##(1991-2#1)(1991-9#1)(1992-5#1)(2008-2#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)
in opiate##3##2##(1991-1#2)(2008-11#1)
in opioid##5##2##(1995-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-4#1)
in opposing ways##2##3##(2012-9#1)(2013-1#1)
in opposing##3##2##(2011-2#1)(2012-9#1)(2013-1#1)
in opposite directions##7##3##(1997-3#2)(2007-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
in opposite orientations##2##3##(1990-11#1)(1993-12#1)
in opposite##13##2##(1990-11#1)(1993-12#1)(1997-3#2)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-3#1)
in opposition##2##2##(2008-11#1)(2009-11#1)
in optical and##2##3##(2008-10#2)
in optical coherence tomography (OCT)##3##5##(2008-3#1)(2011-7#2)
in optical coherence tomography##10##4##(2007-11#4)(2008-3#4)(2011-7#2)
in optical data storage##3##4##(2008-2#3)
in optical data##5##3##(2008-2#3)(2008-3#2)
in optical density##2##3##(1994-11#1)(2008-2#1)
in optical disk##3##3##(2008-2#1)(2008-3#2)
in optical fiber##11##3##(2007-11#4)(2007-12#5)(2008-3#2)
in optical fibers with##2##4##(2007-11#1)(2007-12#1)
in optical fibers##15##3##(2007-11#8)(2007-12#3)(2008-3#4)
in optical frequency##2##3##(2007-11#1)(2007-12#1)
in optical measurement##2##3##(2008-2#2)
in optical metrology##4##3##(2008-2#1)(2008-3#3)
in optical parametric##3##3##(2007-11#3)
in optical path length##3##4##(2008-2#2)(2008-3#1)
in optical path##5##3##(2008-2#2)(2008-3#2)(2013-8#1)
in optical pattern recognition##2##4##(2008-3#2)
in optical subscriber-network applications##2##4##(2008-2#2)
in optical systems##6##3##(2008-2#3)(2008-3#3)
in optical tomography##2##3##(2007-12#1)(2008-2#1)
in optical##123##2##(1994-11#2)(2007-11#24)(2007-12#16)(2008-10#5)(2008-2#23)(2008-3#47)(2009-5#1)(2010-12#1)(2011-7#2)(2012-2#1)(2013-8#1)
in optically dense##2##3##(2008-2#1)(2008-3#1)
in optically thick##2##3##(2007-11#1)(2007-12#1)
in optically##9##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2008-5#1)
in optics##2##2##(2007-11#1)(2008-2#1)
in optimal conditions##2##3##(2008-10#1)(2008-5#1)
in optimal##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
in optimization of##3##3##(2008-10#2)(2008-3#1)
in optimizing the##2##3##(2008-6#1)(2013-1#1)
in optimizing##6##2##(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-1#1)
in optimum##2##2##(2008-11#1)(2008-3#1)
in or adjacent to the##2##5##(1997-3#1)(2008-7#1)
in or near##3##3##(1993-11#1)(1993-3#1)(2007-12#1)
in or on##3##3##(2008-10#2)(2008-9#1)
in or very##2##3##(1996-2#1)(2008-4#1)
in or##18##2##(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
in oral and maxillofacial surgery##2##5##(2007-12#1)(2008-7#1)
in oral and##4##3##(1991-2#1)(2007-12#1)(2008-7#1)(2013-1#1)
in oral cancer##4##3##(1991-6#1)(2013-1#1)(2013-8#2)
in oral cavity##2##3##(2011-2#1)(2013-1#1)
in oral health##2##3##(2013-1#1)(2013-7#1)
in oral lichen planus##2##4##(1991-3#1)(2009-6#1)
in oral mucosa##2##3##(2008-3#1)(2009-5#1)
in oral sex##2##3##(1996-5#1)(2009-7#1)
in oral##31##2##(1991-2#2)(1991-3#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
in orbit##2##2##(2008-2#2)
in orchard soils##3##3##(2008-10#3)
in orchard##6##2##(2008-10#6)
in orchards with##4##3##(2008-10#4)
in orchards##9##2##(2008-10#9)
in order for the##2##4##(2008-4#1)(2011-2#1)
in order for##6##3##(1992-3#1)(1994-3#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#1)
in order of decreasing frequency##2##5##(1993-9#2)
in order of frequency##2##4##(1991-2#1)(2008-10#1)
in order of##9##3##(1991-2#2)(1993-9#2)(1994-1#1)(1995-2#1)(2008-10#2)(2008-3#1)
in order that##4##3##(2008-11#2)(2008-12#1)(2008-5#1)
in order to account for##2##5##(1997-4#1)(2008-10#1)
in order to achieve a##5##5##(1991-9#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-8#1)
in order to achieve high##2##5##(2008-10#2)
in order to achieve the##6##5##(2008-1#1)(2008-10#2)(2009-8#1)(2010-11#1)(2011-2#1)
in order to achieve##22##4##(1991-9#1)(1992-3#2)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
in order to adapt##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
in order to address the##2##5##(2008-7#1)(2012-12#1)
in order to address##4##4##(1997-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
in order to adequately##2##4##(2008-1#1)(2008-8#1)
in order to aid##2##4##(2008-1#1)(2008-5#1)
in order to allow the determination of##2##7##(2008-10#2)
in order to allow the##4##5##(2008-10#3)(2013-1#1)
in order to allow##5##4##(2008-10#3)(2009-4#1)(2013-1#1)
in order to analyse##3##4##(1990-12#1)(2010-10#1)(2010-6#1)
in order to analyze##5##4##(1994-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
in order to appropriately##3##4##(1996-3#1)(2012-2#1)(2013-7#1)
in order to ascertain##2##4##(2008-10#1)(2008-11#1)
in order to assess the influence of##2##7##(1993-12#1)(2008-11#1)
in order to assess the##14##5##(1990-8#1)(1991-11#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2009-3#1)
in order to assess##22##4##(1990-8#1)(1991-11#1)(1993-12#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#3)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
in order to attain a##2##5##(1997-8#1)(2008-1#1)
in order to attain##3##4##(1997-8#1)(2008-1#1)(2010-9#1)
in order to avoid possible##2##5##(1991-12#1)(2008-10#1)
in order to avoid the##6##5##(1991-8#1)(2007-11#1)(2008-10#3)(2008-11#1)
in order to avoid##20##4##(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
in order to be able to##3##6##(1990-6#1)(1991-11#1)(2008-10#1)
in order to be able##4##5##(1990-6#1)(1991-11#1)(2008-10#1)(2008-11#1)
in order to be##15##4##(1990-6#1)(1991-11#1)(1994-3#2)(1994-6#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
in order to become##3##4##(2008-11#2)(2011-2#1)
in order to benefit##2##4##(1995-2#1)(2009-6#1)
in order to better##2##4##(2009-11#1)(2009-5#1)
in order to carry##2##4##(1997-6#1)(2008-10#1)
in order to characterize the##5##5##(1995-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
in order to characterize##8##4##(1994-8#1)(1995-12#1)(2008-10#2)(2008-2#1)(2008-7#3)
in order to check##4##4##(2008-10#2)(2010-8#1)(2012-7#1)
in order to clarify the##2##5##(1991-12#1)(1995-8#1)
in order to clarify##4##4##(1991-12#1)(1995-8#1)(2007-10#1)(2007-12#1)
in order to classify##2##4##(1994-6#1)(2012-1#1)
in order to collect##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
in order to compare and##2##5##(2008-10#2)
in order to compare the information##2##6##(2008-10#1)(2008-5#1)
in order to compare the##4##5##(2008-10#2)(2008-5#1)(2012-2#1)
in order to compare##9##4##(1991-7#1)(2008-10#5)(2008-5#1)(2011-2#1)(2012-2#1)
in order to conduct##2##4##(2010-3#1)(2012-2#1)
in order to confirm or##2##5##(1990-2#1)(1997-8#1)
in order to confirm the diagnosis##2##6##(2007-11#1)(2008-5#1)
in order to confirm the##6##5##(1992-12#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#2)
in order to confirm##10##4##(1990-2#1)(1990-5#1)(1992-12#1)(1994-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#2)(2012-3#1)
in order to contribute to##3##5##(2008-11#1)(2008-4#1)(2008-9#1)
in order to control the##3##5##(2007-8#1)(2008-10#2)
in order to control##4##4##(2007-8#1)(2008-10#2)(2013-8#1)
in order to correlate##3##4##(2008-10#1)(2008-5#1)(2012-9#1)
in order to decide##2##4##(2007-2#1)(2010-12#1)
in order to decrease the risk of##2##7##(2008-12#1)(2009-10#1)
in order to define a##2##5##(2011-2#1)(2012-2#1)
in order to define the##2##5##(1993-11#1)(2010-11#1)
in order to define##4##4##(1993-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
in order to demonstrate that##2##5##(1996-9#1)(2008-10#1)
in order to demonstrate the##2##5##(2008-10#2)
in order to demonstrate##7##4##(1996-9#1)(1997-7#1)(2008-10#5)
in order to derive##2##4##(2008-10#1)(2008-7#1)
in order to describe##2##4##(2008-10#1)(2008-11#1)
in order to detect an##2##5##(1992-6#1)(1992-9#1)
in order to detect and##3##5##(1993-2#1)(2008-10#1)(2012-12#1)
in order to detect the##2##5##(1996-12#1)(2008-3#1)
in order to detect##17##4##(1990-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1996-12#1)(1996-5#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
in order to determine how##3##5##(1991-3#1)(2008-9#1)(2013-1#1)
in order to determine if##2##5##(2008-1#1)(2008-4#1)
in order to determine the depth of anesthesia in the continuation stage of the anesthesia and to estimate the amount of medicine to be applied at that moment##2##28##(2010-8#2)
in order to determine the effect of##2##7##(1995-3#1)(2013-1#1)
in order to determine the optimum conditions for##2##8##(2008-10#2)
in order to determine the##28##5##(1990-11#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
in order to determine their##2##5##(2007-12#1)(2011-1#1)
in order to determine whether##2##5##(1991-3#1)(1992-5#1)
in order to determine##51##4##(1990-11#1)(1991-3#2)(1992-5#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
in order to develop a new##2##6##(2008-5#1)(2009-7#1)
in order to develop a##7##5##(1990-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)
in order to develop more##2##5##(2010-5#1)(2011-2#1)
in order to develop the##2##5##(2008-11#1)(2008-9#1)
in order to develop##20##4##(1990-12#1)(1990-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
in order to devise strategies##2##5##(2009-4#1)(2013-1#1)
in order to devise##3##4##(2009-4#1)(2013-1#2)
in order to differentiate##2##4##(2008-10#2)
in order to discover##2##4##(1994-12#1)(2012-3#1)
in order to distinguish##5##4##(2008-10#4)(2012-2#1)
in order to eliminate the##2##5##(2008-10#1)(2011-1#1)
in order to eliminate##6##4##(1996-3#1)(2007-11#2)(2008-10#1)(2011-1#1)(2012-3#1)
in order to elucidate the##5##5##(1993-3#1)(2008-10#2)(2008-5#1)(2010-4#1)
in order to elucidate##6##4##(1993-3#1)(1996-9#1)(2008-10#2)(2008-5#1)(2010-4#1)
in order to enable##5##4##(1991-5#1)(1995-3#1)(2008-10#2)(2008-6#1)
in order to enhance the##4##5##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
in order to enhance##7##4##(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
in order to ensure a##2##5##(2009-5#1)(2009-6#1)
in order to ensure##14##4##(1990-5#1)(1995-1#1)(2008-10#5)(2008-11#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2012-2#1)
in order to establish the##7##5##(1991-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)
in order to establish##16##4##(1991-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)
in order to estimate the##3##5##(1995-6#1)(2008-10#1)(2013-8#1)
in order to estimate##6##4##(1995-5#1)(1995-6#1)(2008-10#2)(2009-7#1)(2013-8#1)
in order to evaluate its##3##5##(1990-12#1)(1994-7#1)(2007-5#1)
in order to evaluate the effect of##2##7##(1997-4#1)(2008-10#1)
in order to evaluate the effects of##4##7##(1995-2#1)(2007-11#1)(2008-10#2)
in order to evaluate the##21##5##(1990-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1997-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#11)(2013-8#1)
in order to evaluate their##2##5##(2008-10#1)(2008-7#1)
in order to evaluate whether##2##5##(2008-10#1)(2008-12#1)
in order to evaluate##32##4##(1990-12#1)(1990-2#1)(1990-6#1)(1992-5#1)(1993-3#1)(1994-7#1)(1995-2#1)(1997-4#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#2)(2013-8#1)
in order to examine the##4##5##(2008-11#3)(2008-5#1)
in order to examine##10##4##(1992-6#1)(1997-2#1)(2008-11#4)(2008-12#1)(2008-5#1)(2009-9#1)(2010-8#1)
in order to expand the##2##5##(2008-10#2)
in order to explain the##2##5##(1994-5#1)(2008-10#1)
in order to explain##4##4##(1993-12#1)(1994-5#1)(2008-10#1)(2012-2#1)
in order to explore##2##4##(2010-10#1)(2012-3#1)
in order to facilitate the##2##5##(1990-7#1)(2008-10#1)
in order to facilitate##14##4##(1990-7#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
in order to find a##2##5##(1993-8#1)(1997-6#1)
in order to find out##3##5##(1991-11#1)(2013-1#2)
in order to find the best##2##6##(2008-10#2)
in order to find the##4##5##(2008-10#3)(2008-8#1)
in order to find##13##4##(1990-5#1)(1991-11#1)(1993-8#1)(1996-5#1)(1997-6#1)(2008-10#5)(2008-8#1)(2013-1#2)
in order to form##2##4##(2008-10#1)(2008-8#1)
in order to further##3##4##(1994-1#1)(2008-10#1)(2008-11#1)
in order to gain##3##4##(2008-5#1)(2008-9#2)
in order to get##8##4##(2008-10#4)(2008-5#1)(2008-7#2)(2011-1#1)
in order to give##2##4##(2008-11#2)
in order to have##4##4##(1993-11#1)(2008-12#2)(2008-7#1)
in order to help prevent##2##5##(2007-2#1)(2012-12#1)
in order to help##7##4##(1992-2#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
in order to identify potential##2##5##(2008-1#1)(2008-7#1)
in order to identify the##5##5##(1993-6#1)(2008-10#2)(2010-5#1)(2013-1#1)
in order to identify##29##4##(1990-10#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#2)
in order to illustrate##2##4##(1990-8#1)(2008-10#1)
in order to improve clinical##2##5##(1996-12#1)(2013-1#1)
in order to improve the##18##5##(1991-6#1)(1996-2#1)(2008-10#9)(2008-2#1)(2008-6#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
in order to improve their##3##5##(1993-2#1)(2009-7#1)(2010-3#1)
in order to improve##33##4##(1991-3#1)(1991-6#1)(1993-2#1)(1994-11#1)(1996-12#1)(1996-2#1)(2008-10#12)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
in order to increase the sensitivity##2##6##(2008-10#1)(2010-5#1)
in order to increase the##9##5##(1995-1#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#1)
in order to increase##19##4##(1995-1#1)(1995-6#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-7#1)(2012-2#1)
in order to introduce##2##4##(2008-10#1)(2008-9#1)
in order to investigate the##8##5##(1994-3#2)(1995-6#1)(1996-12#2)(2008-10#1)(2008-3#1)(2012-1#1)
in order to investigate their##3##5##(1990-12#1)(2008-11#1)(2013-1#1)
in order to investigate##17##4##(1990-12#1)(1994-3#2)(1995-6#1)(1996-12#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2011-1#2)(2012-1#1)(2013-1#1)
in order to keep##3##4##(1990-3#1)(1992-1#1)(1993-11#1)
in order to know the##4##5##(1991-9#1)(2008-10#2)(2013-8#1)
in order to learn##3##4##(1996-12#1)(2009-4#1)(2011-2#1)
in order to maintain the integrity of##2##7##(2008-1#1)(2008-12#1)
in order to maintain the##5##5##(1990-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)
in order to maintain##6##4##(1990-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
in order to make a##2##5##(1997-2#1)(2012-12#1)
in order to make the##4##5##(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
in order to make##18##4##(1990-3#1)(1991-2#1)(1993-9#1)(1994-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-12#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
in order to maximize the##4##5##(2008-10#2)(2008-11#1)(2008-8#1)
in order to maximize##7##4##(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)
in order to measure##7##4##(1994-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
in order to meet the##6##5##(1994-2#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)
in order to mimic##2##4##(2008-10#1)(2009-2#1)
in order to minimize the##4##5##(1996-3#1)(1997-6#1)(2008-10#2)
in order to minimize##5##4##(1993-8#1)(1996-3#1)(1997-6#1)(2008-10#2)
in order to modulate the##2##5##(2008-5#1)(2011-1#1)
in order to observe##4##4##(2008-10#2)(2008-9#1)(2009-10#1)
in order to obtain a##8##5##(2008-10#5)(2008-4#1)(2010-5#1)(2012-2#1)
in order to obtain accurate##2##5##(2008-10#2)
in order to obtain an##3##5##(2008-10#1)(2008-5#1)(2009-7#1)
in order to obtain better##2##5##(2008-10#2)
in order to obtain high##3##5##(2008-11#1)(2008-12#1)(2013-1#1)
in order to obtain more##2##5##(1996-2#1)(2009-4#1)
in order to obtain the##10##5##(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)
in order to obtain##46##4##(1990-5#1)(1991-12#1)(1991-2#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#2)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
in order to operate##3##4##(2008-11#1)(2008-3#1)(2010-8#1)
in order to optimise##2##4##(2007-11#1)(2008-10#1)
in order to optimize the##5##5##(2008-10#3)(2008-3#1)(2008-4#1)
in order to optimize##7##4##(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)
in order to perform##3##4##(2008-10#2)(2010-11#1)
in order to plan##2##4##(2008-10#1)(2013-1#1)
in order to position##2##4##(1995-5#2)
in order to prepare##4##4##(2008-10#2)(2010-7#1)(2012-3#1)
in order to preserve the##2##5##(2008-10#1)(2010-8#1)
in order to prevent or##2##5##(2011-2#1)(2011-3#1)
in order to prevent the spread of AIDS##2##8##(1993-8#1)(1997-6#1)
in order to prevent the##3##5##(1993-8#1)(1997-6#1)(2008-1#1)
in order to prevent##14##4##(1991-6#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-11#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
in order to promote##6##4##(1991-3#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-3#1)
in order to propose##2##4##(2008-11#1)(2009-3#1)
in order to protect the##2##5##(2008-1#1)(2008-11#1)
in order to protect##3##4##(1996-12#1)(2008-1#1)(2008-11#1)
in order to prove##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
in order to provide a##3##5##(2008-11#1)(2009-9#1)(2011-2#1)
in order to provide the##3##5##(1991-1#1)(2008-10#2)
in order to provide##16##4##(1991-1#1)(1995-1#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2010-5#1)(2011-2#2)
in order to quantify##4##4##(2008-10#3)(2009-7#1)
in order to raise##2##4##(2011-2#2)
in order to reach##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
in order to recognize##2##4##(2008-1#1)(2011-2#1)
in order to reduce the risk of##4##7##(1990-2#1)(2008-10#1)(2013-8#2)
in order to reduce the##13##5##(1990-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
in order to reduce##21##4##(1990-2#1)(1991-6#1)(1992-11#1)(1992-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
in order to regulate the expression of##2##7##(1995-9#1)(2012-12#1)
in order to remove the##3##5##(2008-10#3)
in order to remove##5##4##(2008-10#3)(2008-6#1)(2013-1#1)
in order to reproduce##2##4##(1997-2#1)(2008-11#1)
in order to restore##2##4##(2008-7#1)(2013-1#1)
in order to reveal the##2##5##(1994-6#1)(1997-3#1)
in order to satisfy##2##4##(2008-10#1)(2008-9#1)
in order to select##3##4##(1996-6#1)(2008-10#2)
in order to separate##2##4##(2008-10#2)
in order to shed light on##2##6##(2007-12#1)(2013-1#1)
in order to shed##3##4##(2007-12#1)(2008-11#1)(2013-1#1)
in order to shorten the##2##5##(1992-11#1)(2008-10#1)
in order to show##2##4##(1990-10#1)(2007-8#1)
in order to simulate the##2##5##(2008-10#2)
in order to simulate##4##4##(1995-3#1)(2008-10#2)(2009-7#1)
in order to stay##2##4##(2008-6#1)(2011-2#1)
in order to stimulate##2##4##(1996-12#1)(2008-6#1)
in order to study the##6##5##(1990-6#1)(1992-6#1)(1993-11#1)(2008-5#1)(2009-1#1)(2011-2#1)
in order to study their##2##5##(1994-6#1)(2007-11#1)
in order to study##11##4##(1990-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-1#1)(2011-2#1)(2012-1#1)
in order to supply##2##4##(2008-11#2)
in order to support the##3##5##(1996-7#1)(2009-11#1)(2010-6#1)
in order to support##6##4##(1996-7#1)(2008-11#1)(2009-11#1)(2010-6#1)(2010-8#1)(2012-3#1)
in order to suppress##2##4##(2008-10#2)
in order to sustain##3##4##(1993-6#1)(2008-11#1)(2013-7#1)
in order to take into account the##2##7##(2008-10#2)
in order to take##3##4##(2008-10#2)(2010-5#1)
in order to test for##2##5##(1994-2#1)(1996-2#1)
in order to test the##3##5##(2008-10#1)(2009-9#1)(2012-2#1)
in order to test whether##2##5##(1994-3#1)(2008-8#1)
in order to test##9##4##(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
in order to treat##4##4##(1993-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
in order to understand how##2##5##(1997-6#1)(2008-8#1)
in order to understand the##5##5##(2008-10#3)(2008-6#1)(2010-3#1)
in order to understand##12##4##(1995-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-3#1)(2013-1#2)
in order to use##2##4##(2007-11#1)(2008-10#1)
in order to validate the##2##5##(2008-10#1)(2010-12#1)
in order to validate##3##4##(1995-5#1)(2008-10#1)(2010-12#1)
in order to verify the##2##5##(1991-6#1)(2008-10#1)
in order to verify##4##4##(1991-6#1)(2008-10#1)(2008-7#1)(2013-7#1)
in order to yield##2##4##(2008-5#1)(2013-1#1)
in order to##1028##3##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#3)(1992-9#3)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#5)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-12#4)(1995-2#5)(1995-3#4)(1995-5#6)(1995-6#5)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#10)(1996-2#5)(1996-3#5)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#8)(1997-7#2)(1997-8#2)(2006-6#1)(2007-10#6)(2007-11#14)(2007-12#5)(2007-2#4)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#23)(2008-10#257)(2008-11#62)(2008-12#26)(2008-2#6)(2008-3#5)(2008-4#19)(2008-5#27)(2008-6#13)(2008-7#33)(2008-8#15)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#9)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#7)(2010-2#2)(2010-3#8)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#2)(2010-8#10)(2010-9#4)(2011-1#12)(2011-2#39)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#12)(2012-2#16)(2012-3#17)(2012-7#1)(2012-9#1)(2013-1#33)(2013-7#6)(2013-8#9)
in order##1051##2##(1990-10#3)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#4)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#3)(1992-9#3)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#4)(1994-1#6)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#6)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#6)(1995-6#5)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#10)(1996-2#5)(1996-3#5)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#8)(1997-7#2)(1997-8#2)(2006-6#1)(2007-10#6)(2007-11#14)(2007-12#5)(2007-2#4)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#23)(2008-10#260)(2008-11#65)(2008-12#27)(2008-2#6)(2008-3#6)(2008-4#20)(2008-5#28)(2008-6#13)(2008-7#33)(2008-8#15)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#9)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#7)(2010-2#2)(2010-3#8)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#2)(2010-8#10)(2010-9#5)(2011-1#12)(2011-2#41)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#12)(2012-2#17)(2012-3#17)(2012-7#1)(2012-9#1)(2013-1#33)(2013-7#6)(2013-8#9)
in ordinary##11##2##(1991-5#1)(1991-6#1)(1992-6#2)(1993-2#1)(1994-5#1)(2007-12#2)(2008-7#1)(2010-4#1)(2013-1#1)
in ore samples##2##3##(2007-12#1)(2008-10#1)
in ore##4##2##(2007-12#1)(2008-10#3)
in organ culture##5##3##(1994-2#1)(1995-3#2)(1995-8#2)
in organ transplant##2##3##(1991-11#1)(2013-1#1)
in organ##16##2##(1991-11#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-8#2)(1997-3#1)(1997-8#1)(2008-10#2)(2008-9#1)(2010-3#1)(2013-1#1)
in organelle##3##2##(1994-6#1)(2008-7#1)(2008-9#1)
in organic and conventional##2##4##(2008-10#2)
in organic and##3##3##(2008-10#2)(2012-2#1)
in organic compounds##2##3##(2008-2#1)(2008-3#1)
in organic materials##3##3##(2007-12#1)(2008-7#2)
in organic media##6##3##(2008-7#5)(2009-7#1)
in organic orchards##2##3##(2008-10#2)
in organic phase##3##3##(2008-10#3)
in organic plots##2##3##(2008-10#2)
in organic solvent##3##3##(1994-12#1)(2008-10#1)(2009-11#1)
in organic solvents such as##2##5##(2008-10#1)(2013-1#1)
in organic solvents##19##3##(1990-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(2008-10#6)(2008-4#1)(2008-7#2)(2013-1#5)
in organic synthesis##2##3##(2009-12#1)(2012-2#1)
in organic than##4##3##(2008-10#4)
in organic##65##2##(1990-5#1)(1992-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#29)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#9)(2009-11#1)(2009-12#1)(2009-7#1)(2012-2#2)(2013-1#5)(2013-8#1)
in organically modified##2##3##(2008-10#2)
in organically##3##2##(2008-10#3)
in organisms that##2##3##(2008-8#1)(2012-12#1)
in organisms with##2##3##(1997-7#1)(2008-9#1)
in organisms##7##2##(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)
in organization of##2##3##(2008-10#1)(2012-2#1)
in organization##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#1)
in organizational structure##2##3##(1991-3#1)(2008-10#1)
in organizational##5##2##(1991-3#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-7#1)
in organizations is##2##3##(1993-12#1)(1996-3#1)
in organizations##9##2##(1992-1#1)(1993-12#2)(1995-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
in organized medicine##2##3##(2007-4#1)(2008-4#1)
in organizing##3##2##(2008-9#1)(2009-9#1)(2010-5#1)
in organogenesis##2##2##(1995-8#1)(2012-1#1)
in organs and tissues##2##4##(2008-10#1)(2012-2#1)
in organs and##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
in organs##9##2##(1994-5#1)(2007-5#1)(2008-10#3)(2009-9#1)(2012-12#1)(2012-2#2)
in orientation##3##2##(1990-11#1)(1995-3#1)(2010-5#1)
in oriented##4##2##(2008-11#1)(2008-3#1)(2008-6#1)(2012-8#1)
in origin##7##2##(1990-3#1)(1994-7#1)(1997-3#1)(2007-7#1)(2009-4#1)(2009-8#1)(2012-1#1)
in ornamental##2##2##(2008-10#1)(2012-2#1)
in orthopaedic surgery##2##3##(2008-11#1)(2011-2#1)
in orthopaedic##4##2##(1994-3#1)(2007-11#1)(2008-11#1)(2011-2#1)
in orthopaedics##2##2##(2007-8#1)(2012-2#1)
in orthopedic patients##2##3##(2011-2#1)(2012-2#1)
in orthopedic surgery##3##3##(2008-8#1)(2009-4#1)(2011-2#1)
in orthopedic##8##2##(2007-11#1)(2007-8#2)(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)
in orthopedics##6##2##(1997-6#1)(2007-11#2)(2007-8#2)(2008-8#1)
in orthorhombic crystal form I##2##5##(2008-8#2)
in osmolarity of##2##3##(1993-3#1)(2009-12#1)
in osmolarity##4##2##(1993-3#1)(2008-11#1)(2009-12#2)
in osmoregulatory organs##2##3##(2008-7#2)
in osmotic##3##2##(2008-10#2)(2009-6#1)
in osteo-articular##2##2##(1990-5#1)(1990-6#1)
in osteoarthritis##6##2##(2007-11#4)(2010-4#1)(2011-2#1)
in osteoarticular##2##2##(2011-2#2)
in osteoblast-like cells##2##3##(1990-12#1)(1993-8#1)
in osteoblastic metastases##2##3##(1991-8#2)
in osteoblasts##3##2##(1990-11#1)(2008-11#1)(2011-1#1)
in osteogenic##3##2##(1992-12#1)(2008-11#2)
in osteomyelitis##3##2##(2010-6#3)
in osteoporosis and##2##3##(1992-6#1)(2012-12#1)
in osteoporosis##19##2##(1991-11#1)(1991-12#1)(1992-6#2)(1993-11#4)(1996-11#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-12#1)
in osteoporotic patients##2##3##(1997-7#1)(2007-11#1)
in osteoporotic##5##2##(1997-7#1)(2007-11#2)(2010-3#1)(2012-12#1)
in osteosarcoma##15##2##(1990-12#1)(1992-6#1)(1993-12#1)(2008-6#1)(2008-8#1)(2010-3#10)
in ostriches##2##2##(1997-6#1)(2008-5#1)
in other European##2##3##(2007-2#1)(2008-11#1)
in other animals##2##3##(1994-9#1)(2008-8#1)
in other areas of the##3##5##(1992-8#1)(2008-10#1)(2012-2#1)
in other areas of##8##4##(1991-2#1)(1992-8#2)(2008-10#2)(2008-6#1)(2008-7#1)(2012-2#1)
in other areas##11##3##(1991-2#1)(1992-8#2)(2008-10#3)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
in other cancers##2##3##(2011-1#1)(2012-3#1)
in other cases##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
in other cell types##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
in other cell##5##3##(2008-1#1)(2008-11#2)(2008-7#1)(2013-1#1)
in other cells##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
in other countries in##2##4##(2008-8#1)(2010-8#1)
in other countries such as##2##5##(2008-7#1)(2010-12#1)
in other countries##21##3##(1991-12#2)(1991-9#1)(1993-6#1)(1995-1#1)(2007-11#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
in other disorders##2##3##(2008-1#1)(2012-12#1)
in other domains##2##3##(2008-1#1)(2008-3#1)
in other examined##2##3##(2007-11#1)(2008-8#1)
in other families##2##3##(2008-8#2)
in other fields##2##3##(2011-1#1)(2011-3#1)
in other genes##2##3##(2008-10#1)(2008-7#1)
in other groups##6##3##(1990-6#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-2#1)
in other health##2##3##(1997-3#1)(2008-11#1)
in other host##3##3##(2008-10#2)(2012-12#1)
in other hosts##3##3##(2008-10#1)(2011-2#2)
in other human##2##3##(1993-6#1)(2013-1#1)
in other industrialized##2##3##(1995-3#1)(2011-2#1)
in other industries##4##3##(1993-12#1)(1995-12#2)(2009-11#1)
in other insect species##2##4##(2007-12#1)(2008-7#1)
in other layers##4##3##(1994-2#3)(1997-3#1)
in other major##2##3##(1991-2#1)(2011-10#1)
in other mammals##2##3##(1994-2#1)(2008-5#1)
in other medical specialties##2##4##(1996-7#1)(2007-11#1)
in other medical##3##3##(1996-7#1)(2007-11#1)(2011-2#1)
in other members of this family##2##6##(2008-10#1)(2008-4#1)
in other members of##3##4##(1994-12#1)(2008-10#1)(2008-4#1)
in other models##3##3##(2008-5#1)(2008-8#1)(2011-1#1)
in other organisms##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
in other organs##5##3##(1994-5#1)(1995-2#1)(2007-5#1)(2007-7#1)(2008-7#1)
in other parts of the world##2##6##(2008-10#1)(2009-2#1)
in other parts of the##5##5##(1994-5#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-5#1)
in other parts of##6##4##(1991-12#1)(1994-5#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-5#1)
in other patients##2##3##(1990-11#1)(2008-8#1)
in other plant##5##3##(2008-10#2)(2008-8#1)(2010-11#1)(2011-2#1)
in other plants##2##3##(2008-10#1)(2012-2#1)
in other populations##8##3##(1991-9#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
in other proteins##3##3##(1992-3#1)(1996-2#1)(1997-2#1)
in other regions during 1995 to##2##6##(2011-1#2)
in other regions of the##2##5##(1993-12#1)(2008-11#1)
in other regions##8##3##(1993-12#1)(2007-10#1)(2008-11#1)(2008-2#1)(2011-1#2)(2012-1#1)(2013-7#1)
in other reports##2##3##(2008-7#1)(2008-8#1)
in other settings##5##3##(1992-1#1)(1994-3#1)(1996-2#1)(2008-7#1)(2013-1#1)
in other situations##4##3##(1991-12#1)(1991-6#1)(2008-10#1)(2011-10#1)
in other solvents##2##3##(2008-10#1)(2008-2#1)
in other species##12##3##(1991-3#1)(1992-9#1)(1994-8#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)
in other spectral##2##3##(2008-3#1)(2008-7#1)
in other strains of##2##4##(1991-12#1)(2008-7#1)
in other strains##3##3##(1991-12#1)(1995-9#1)(2008-7#1)
in other studies##9##3##(1990-5#1)(1992-3#1)(2007-6#1)(2008-1#2)(2008-5#2)(2011-2#1)(2013-1#1)
in other systems##7##3##(1994-10#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
in other tissues##7##3##(1990-11#1)(1991-8#1)(1993-3#1)(1994-6#1)(1997-1#1)(2008-10#1)(2010-3#1)
in other tropical##2##3##(2008-5#2)
in other ways##2##3##(2008-7#1)(2008-9#1)
in other##404##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-12#5)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#7)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-1#10)(2008-10#43)(2008-11#17)(2008-12#6)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#14)(2008-6#5)(2008-7#25)(2008-8#15)(2008-9#9)(2009-10#3)(2009-11#2)(2009-2#2)(2009-4#2)(2009-8#6)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#9)(2011-10#3)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#5)
in others a##2##3##(2008-11#1)(2008-12#1)
in others##13##2##(1991-12#1)(1997-3#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#3)(2009-10#1)
in otherwise healthy##3##3##(1991-8#1)(1997-6#1)(2012-2#1)
in otherwise##8##2##(1991-8#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
in otoliths##2##2##(2008-10#1)(2008-7#1)
in our County##3##3##(2011-2#3)
in our Department##3##3##(1992-5#1)(1992-6#1)(2012-2#1)
in our ICU##2##3##(2010-11#1)(2013-1#1)
in our analysis##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)
in our area##2##3##(1990-6#1)(2008-4#1)
in our case##11##3##(1990-8#1)(1991-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)
in our cases##3##3##(1990-2#1)(2007-10#1)(2007-8#1)
in our center is##2##4##(2008-1#1)(2011-1#1)
in our center##6##3##(2007-11#1)(2007-7#2)(2008-1#1)(2011-1#1)(2013-1#1)
in our clinic##6##3##(2007-8#3)(2008-1#1)(2011-1#1)(2012-3#1)
in our community##2##3##(1994-12#1)(2012-3#1)
in our countries##2##3##(2009-6#1)(2011-2#1)
in our country##14##3##(1990-12#1)(1990-9#1)(1992-2#1)(1995-5#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#3)(2013-1#1)
in our data##2##3##(2008-10#1)(2013-1#1)
in our day##2##3##(2008-8#1)(2012-3#1)
in our department between##2##4##(2008-1#1)(2008-9#1)
in our department in the##2##5##(1991-11#1)(2012-2#1)
in our department in##3##4##(1991-11#1)(2008-9#1)(2012-2#1)
in our department##19##3##(1990-9#1)(1991-11#1)(1993-6#1)(1994-9#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)
in our earlier##2##3##(1996-12#1)(2008-2#1)
in our environment##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
in our experience##4##3##(1990-8#1)(1993-9#1)(2008-1#1)(2008-9#1)
in our experiment##2##3##(1991-12#1)(2007-11#1)
in our experimental conditions##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
in our experimental##4##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)
in our experiments##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
in our field##3##3##(2008-10#2)(2009-10#1)
in our hospital is##3##4##(1993-2#1)(1994-11#1)(2010-6#1)
in our hospital over##2##4##(1991-2#1)(2011-2#1)
in our hospital##22##3##(1991-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-11#1)(1997-8#1)(2007-7#2)(2007-8#2)(2008-12#1)(2010-6#4)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#2)
in our hospitals##2##3##(1990-6#1)(2011-2#1)
in our institute##2##3##(1995-5#1)(2007-8#1)
in our institution between##2##4##(2008-6#1)(2013-8#1)
in our institution##10##3##(1991-8#1)(1992-6#1)(1996-3#1)(2007-11#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-8#1)
in our knowledge about##2##4##(2008-8#1)(2009-10#1)
in our knowledge of##2##4##(2008-9#1)(2010-6#1)
in our knowledge##8##3##(2007-8#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-7#1)
in our lab##3##3##(2008-10#2)(2008-7#1)
in our laboratories##3##3##(2008-10#3)
in our laboratory and##5##4##(1997-2#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-2#1)
in our laboratory##34##3##(1991-2#1)(1993-1#2)(1993-9#1)(1994-12#1)(1994-9#1)(1996-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(2007-2#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
in our material was##2##4##(2007-8#1)(2013-7#1)
in our model##5##3##(1992-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-8#1)
in our opinion##2##3##(2008-6#1)(2013-8#1)
in our own##6##3##(1991-11#1)(1991-8#1)(1994-1#1)(2007-11#1)(2008-12#1)(2010-2#1)
in our patient population##2##4##(2008-1#1)(2008-9#1)
in our patient was##2##4##(2009-3#2)
in our patient##12##3##(1996-8#2)(2008-1#1)(2008-2#1)(2008-9#2)(2009-3#3)(2011-2#1)(2013-1#1)(2013-7#1)
in our patients were##2##4##(2008-1#2)
in our patients with##3##4##(1990-8#1)(2008-1#1)(2011-2#1)
in our patients##16##3##(1990-8#1)(1991-2#1)(1992-8#1)(1997-5#1)(2007-10#1)(2008-1#6)(2008-12#1)(2008-6#1)(2011-2#2)(2012-3#1)
in our population##7##3##(1994-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#1)
in our previous study##3##4##(2008-10#2)(2008-9#1)
in our previous##5##3##(1994-2#1)(1997-8#1)(2008-10#2)(2008-9#1)
in our region##2##3##(2008-1#1)(2009-4#1)
in our research group##3##4##(2011-1#1)(2012-12#2)
in our research##4##3##(1991-12#1)(2011-1#1)(2012-12#2)
in our residency##2##3##(1995-1#2)
in our results##2##3##(2008-5#1)(2010-6#1)
in our sample of##2##4##(1997-5#1)(2011-1#1)
in our sample##5##3##(1997-5#1)(2008-10#1)(2009-5#1)(2011-1#1)(2013-8#1)
in our samples##2##3##(2008-3#1)(2008-8#1)
in our search##2##3##(2007-4#1)(2010-12#1)
in our series##10##3##(1993-5#2)(1997-3#1)(2007-7#3)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
in our setting##4##3##(1995-10#1)(1996-9#1)(2010-8#1)(2011-2#1)
in our simulation##2##3##(2008-3#1)(2012-12#1)
in our society##11##3##(1990-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-2#1)(2007-7#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)
in our study##24##3##(1990-2#1)(1991-6#1)(1994-3#1)(1994-6#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-3#2)
in our transplant##2##3##(2008-1#2)
in our understanding of how##3##5##(2008-7#1)(2008-8#1)(2011-2#1)
in our understanding of the mechanisms##2##6##(2008-4#1)(2010-3#1)
in our understanding of the##9##5##(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2013-7#1)
in our understanding of these enigmatic##2##6##(2007-7#1)(2009-3#1)
in our understanding of##26##4##(1992-12#1)(1992-2#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in our understanding##27##3##(1992-12#1)(1992-2#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in our unit##2##3##(1993-12#1)(2007-7#1)
in our work##2##3##(1993-8#1)(2008-10#1)
in our##449##2##(1990-12#2)(1990-2#2)(1990-6#3)(1990-8#3)(1990-9#3)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#3)(2007-11#12)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#12)(2007-8#11)(2008-1#19)(2008-10#47)(2008-11#11)(2008-12#7)(2008-2#8)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#14)(2008-8#12)(2008-9#13)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#9)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#30)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#11)(2013-1#13)(2013-7#6)(2013-8#6)
in out-patient##2##2##(2011-2#1)(2012-2#1)
in outbreak##2##2##(2008-7#1)(2008-8#1)
in outbred rodents##2##3##(2008-10#2)
in outbred##3##2##(2008-10#3)
in outcome between##2##3##(1990-2#1)(2010-3#1)
in outcome##14##2##(1990-2#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-7#4)(2010-3#2)(2011-2#1)(2012-3#1)
in outcomes##4##2##(1996-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
in outdoor air##2##3##(2008-10#1)(2010-5#1)
in outdoor##8##2##(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#2)(2010-11#1)(2010-5#1)
in outer diameter##2##3##(2008-5#1)(2008-8#1)
in outer##8##2##(1991-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)
in outpatient services##2##3##(1992-5#1)(1993-12#1)
in outpatient##13##2##(1992-1#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1995-1#1)(1996-1#1)(1997-5#1)(2007-10#1)(2008-8#1)(2011-2#2)(2013-8#1)
in outpatients with##2##3##(2013-7#1)(2013-8#1)
in outpatients##7##2##(1997-3#2)(2007-11#1)(2008-10#1)(2008-7#1)(2013-7#1)(2013-8#1)
in output##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
in ovarian cancer##4##3##(1993-12#1)(2010-11#1)(2013-8#2)
in ovarian##9##2##(1992-3#1)(1993-12#1)(1993-8#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
in ovariectomized##2##2##(1993-9#1)(2010-10#1)
in ovaries of##2##3##(2008-5#1)(2012-3#1)
in ovaries##4##2##(2008-10#2)(2008-5#1)(2012-3#1)
in over 50%##3##3##(2011-1#1)(2013-1#2)
in over##16##2##(1990-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-7#3)(2011-1#2)(2012-12#1)(2013-1#2)
in over-the-counter##2##2##(2008-5#1)(2010-9#1)
in overall body##2##3##(2008-11#1)(2008-5#1)
in overall survival##2##3##(1991-2#1)(2008-6#1)
in overall##19##2##(1991-2#1)(1994-6#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
in overcoming the##2##3##(2008-1#1)(2009-12#1)
in overcoming##5##2##(2008-1#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
in overseas##2##2##(1995-6#1)(2010-1#1)
in overweight and non-overweight##2##4##(2009-8#2)
in overweight and obesity##2##4##(2012-12#2)
in overweight and##5##3##(2009-8#2)(2012-12#2)(2013-1#1)
in overweight##15##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in ovine neutrophils##2##3##(2008-11#2)
in ovine##3##2##(1992-9#1)(2008-11#2)
in ovo##5##2##(1996-12#3)(1996-5#1)(2008-12#1)
in own material##2##3##(2007-11#1)(2012-12#1)
in own##3##2##(2007-11#2)(2012-12#1)
in oxalic##2##2##(2008-10#2)
in oxidant-antioxidant##2##2##(1991-9#2)
in oxidative metabolism##2##3##(1993-6#1)(2008-4#1)
in oxidative stress##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
in oxidative##12##2##(1993-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in oxidized##6##2##(1990-8#2)(1993-11#1)(2008-10#1)(2009-8#2)
in oxygen affinity##2##3##(1990-7#1)(1990-8#1)
in oxygen##6##2##(1990-5#1)(1990-7#1)(1990-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
in oxytocin##2##2##(1992-11#1)(1996-12#1)
in oyster tissue##3##3##(2008-10#3)
in ozone##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
in p53 and nuclear##2##4##(2010-10#2)
in p53##5##2##(1991-5#1)(1997-7#1)(2008-9#1)(2010-10#2)
in pEA29##2##2##(2008-10#2)
in pEJ30##2##2##(2008-10#2)
in pEP36##2##2##(2008-10#2)
in pH 1##2##3##(2008-10#2)
in pH 2##2##3##(2008-10#2)
in pH 3##2##3##(2008-10#2)
in pH 5##4##3##(2008-10#4)
in pH 7##3##3##(2008-10#3)
in pH 9##3##3##(2008-10#3)
in pH and##4##3##(2008-11#2)(2008-5#1)(2008-9#1)
in pH from##2##3##(1994-3#1)(2011-2#1)
in pH range of 3-9##2##5##(2008-10#2)
in pH range of##4##4##(2008-10#4)
in pH range##7##3##(2008-10#6)(2008-11#1)
in pH##45##2##(1990-11#1)(1991-12#1)(1994-3#1)(1995-6#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
in pK(a)##2##2##(2008-10#2)
in pPGN##3##2##(1995-3#3)
in pachytene##2##2##(2012-2#2)
in packing##3##2##(1990-12#1)(1993-8#1)(1994-5#1)
in paediatric age group##2##4##(2007-8#1)(2012-2#1)
in paediatric and##3##3##(2008-11#1)(2010-10#1)(2012-3#1)
in paediatric cardiac anaesthesia##2##4##(2007-9#2)
in paediatric cardiac##4##3##(2007-9#4)
in paediatric cochlear implantation##2##4##(2008-9#2)
in paediatric cochlear##3##3##(2008-9#3)
in paediatric oncology##2##3##(2007-12#1)(2008-11#1)
in paediatric patients##6##3##(2008-10#1)(2008-7#2)(2008-9#1)(2012-2#2)
in paediatric urology##2##3##(2008-10#2)
in paediatric##44##2##(2007-12#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#4)(2008-11#9)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
in paediatrics##7##2##(1990-3#2)(2007-8#2)(2008-11#1)(2008-7#1)(2010-7#1)
in paid employment##2##3##(1991-9#1)(1995-1#1)
in paid##3##2##(1991-9#1)(1992-2#1)(1995-1#1)
in pain and##3##3##(2008-12#3)
in pain assessment##2##3##(2008-11#1)(2012-2#1)
in pain control and##2##4##(2008-7#2)
in pain management##5##3##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#2)
in pain score##2##3##(1994-3#2)
in pain transmission##2##3##(1996-12#1)(2008-4#1)
in pain##36##2##(1993-2#1)(1994-3#2)(1996-12#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-12#5)(2008-4#3)(2008-7#5)(2008-8#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)
in painful##2##2##(1996-3#1)(1996-6#1)
in paired##2##2##(1994-2#1)(2007-2#1)
in pairs##6##2##(1997-3#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
in palladium-catalyzed##2##2##(2007-11#1)(2009-12#1)
in palliation##2##2##(2007-8#1)(2010-3#1)
in palliative care##5##3##(1992-2#1)(2008-11#2)(2011-2#1)(2012-3#1)
in palliative##11##2##(1992-2#1)(2007-11#4)(2008-11#2)(2011-2#1)(2012-12#2)(2012-3#1)
in pancreas##4##2##(2009-3#1)(2013-1#1)(2013-7#2)
in pancreatic beta-cells##5##3##(1994-11#2)(1996-5#2)(2013-1#1)
in pancreatic cancer##4##3##(2009-7#1)(2012-12#2)(2013-1#1)
in pancreatic islet development and##2##5##(2010-11#2)
in pancreatic islet##3##3##(2010-11#3)
in pancreatic islets and##2##4##(1995-8#1)(2008-10#1)
in pancreatic islets##6##3##(1995-8#1)(2008-10#2)(2009-8#1)(2010-11#2)
in pancreatic tissues##2##3##(2013-1#1)(2013-8#1)
in pancreatic β-cell function##2##4##(2010-10#1)(2010-11#1)
in pancreatic β-cells##3##3##(2010-11#3)
in pancreatic##30##2##(1994-11#3)(1995-11#1)(1995-8#1)(1996-5#2)(2008-10#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#10)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
in papaya##2##2##(2008-10#2)
in paper##4##2##(2008-9#1)(2010-12#1)(2013-1#2)
in papillae##3##2##(2008-10#3)
in papillary##2##2##(2011-2#1)(2012-1#1)
in paracetamol##2##2##(2008-10#2)
in paraelectric crystals##3##3##(2008-2#3)
in paraffin##6##2##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
in parallel and##2##3##(2008-3#1)(2008-7#1)
in parallel by the##2##4##(2008-10#1)(2008-11#1)
in parallel by##5##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)
in parallel in##3##3##(1990-2#1)(2007-7#1)(2008-5#1)
in parallel on##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
in parallel to the##2##4##(1996-5#1)(2009-8#1)
in parallel to##9##3##(1994-11#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-8#1)
in parallel with the##8##4##(1990-12#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-2#1)(2008-10#1)
in parallel with##19##3##(1990-12#1)(1990-3#1)(1991-12#1)(1992-6#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)
in parallel##74##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#6)(2008-5#5)(2008-6#3)(2008-7#6)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#3)(2013-1#1)
in paralytic dislocation##2##3##(2009-3#2)
in parameter space##2##3##(2007-11#1)(2007-12#1)
in parameter##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
in parameters##2##2##(2010-10#1)(2012-1#1)
in paranoid##2##2##(2012-2#1)(2013-7#1)
in parasites##7##2##(1994-11#1)(1996-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)
in parasitic##3##2##(2008-10#2)(2012-2#1)
in parasitoid##2##2##(2007-12#1)(2008-9#1)
in parenchymal##3##2##(1993-6#1)(2010-3#1)(2011-2#1)
in parent-adolescent##2##2##(2009-7#1)(2013-1#1)
in parental##7##2##(1991-12#1)(1992-2#1)(1997-6#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
in parenteral solutions##2##3##(2008-10#2)
in parenteral##6##2##(2008-10#5)(2013-1#1)
in parenthesis)##2##2##(1990-2#1)(2008-10#1)
in parents of children with##2##5##(2008-9#1)(2010-7#1)
in parents of##5##3##(1996-3#1)(2008-9#1)(2010-7#2)(2011-2#1)
in parietal cells##4##3##(1995-11#1)(1997-1#2)(2013-8#1)
in parietal cortex##2##3##(1991-12#1)(2008-11#1)
in parietal##9##2##(1991-12#2)(1995-11#1)(1996-12#1)(1997-1#2)(2008-11#1)(2010-7#1)(2013-8#1)
in parkinsonian##4##2##(2008-12#1)(2008-7#2)(2012-2#1)
in part I##2##3##(2008-3#2)
in part at least##2##4##(1991-12#1)(1994-8#1)
in part at##3##3##(1991-12#1)(1994-8#1)(2008-5#1)
in part be##3##3##(1994-11#1)(2007-8#1)(2009-12#1)
in part because of the##3##5##(1990-11#1)(2007-10#1)(2013-8#1)
in part because of##6##4##(1990-11#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-8#1)(2013-8#1)
in part because the##2##4##(1994-1#1)(2008-10#1)
in part because##11##3##(1990-11#1)(1994-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
in part by the##4##4##(1990-8#1)(2008-4#1)(2008-8#2)
in part by##20##3##(1990-8#1)(1992-9#1)(1994-6#1)(1995-12#1)(2007-10#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
in part due to a##2##5##(1991-6#1)(1997-6#1)
in part due to the##4##5##(2008-10#1)(2008-5#1)(2009-11#1)(2012-12#1)
in part due to##9##4##(1991-6#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-12#1)
in part from the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
in part from##8##3##(1996-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in part on the##2##4##(1994-3#1)(2012-12#1)
in part on##6##3##(1993-3#1)(1994-3#1)(1995-12#1)(2008-5#1)(2008-8#1)(2012-12#1)
in part related to the##2##5##(1994-6#1)(2006-8#1)
in part related to##3##4##(1994-6#1)(2006-8#1)(2012-3#1)
in part the##4##3##(1997-8#1)(2007-12#1)(2008-4#1)(2013-1#1)
in part through the##3##4##(1990-12#1)(2007-12#1)(2009-12#1)
in part through##7##3##(1990-12#1)(1995-1#1)(1997-1#1)(2007-12#1)(2009-12#1)(2011-2#1)(2013-1#1)
in part to the##10##4##(1990-8#1)(1995-9#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)
in part to variation in##2##5##(1996-2#1)(2008-10#1)
in part to##28##3##(1990-2#2)(1990-8#2)(1992-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
in part upon the##2##4##(1992-3#1)(1993-10#1)
in part##221##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-8#5)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#6)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#12)(2008-2#4)(2008-3#3)(2008-4#10)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#13)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
in partial hospitalization##2##3##(1992-1#2)
in partial or total denervation of the muscles of the upper extremity##2##12##(2008-9#2)
in partial##12##2##(1990-2#1)(1992-1#2)(1992-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#1)(2013-1#1)
in partially non-aqueous medium##4##4##(2008-10#4)
in partially##6##2##(1995-2#1)(2008-10#4)(2010-12#1)
in participants##3##2##(2011-2#2)(2012-3#1)
in participating##2##2##(2011-2#1)(2012-2#1)
in participatory research##2##3##(1997-3#2)
in particle##6##2##(2008-10#2)(2008-3#1)(2009-11#1)(2011-1#1)(2011-3#1)
in particles##2##2##(1995-3#1)(1996-2#1)
in particular an##2##3##(1991-11#1)(2008-3#1)
in particular and##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
in particular are##3##3##(2010-5#1)(2012-3#1)(2013-8#1)
in particular by##2##3##(1994-12#1)(2008-9#1)
in particular for the##2##4##(2008-1#1)(2008-10#1)
in particular for##10##3##(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2012-2#1)
in particular has##2##3##(1991-6#1)(2008-5#1)
in particular how##2##3##(1995-5#1)(2008-11#1)
in particular if##2##3##(2011-2#1)(2013-1#1)
in particular in the case of##2##6##(1991-11#1)(1994-3#1)
in particular in the##9##4##(1991-11#1)(1994-11#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)
in particular in##13##3##(1990-11#1)(1991-11#1)(1994-11#1)(1994-3#1)(1995-5#1)(2007-6#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
in particular is##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
in particular its##4##3##(1992-6#1)(1996-12#1)(1997-7#1)(2007-2#1)
in particular of the##2##4##(1997-3#1)(2008-2#1)
in particular of##3##3##(1994-5#1)(1997-3#1)(2008-2#1)
in particular on negative symptoms such as withdrawal retardation##2##9##(2008-6#2)
in particular on the##2##4##(1991-12#1)(1992-11#1)
in particular on##4##3##(1991-12#1)(1992-11#1)(2008-6#2)
in particular that##3##3##(2008-8#1)(2009-9#1)(2011-1#1)
in particular the##22##3##(1991-6#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2009-3#1)(2012-2#3)(2013-1#1)(2013-8#1)
in particular their##2##3##(1992-3#1)(2013-8#1)
in particular those##6##3##(1994-9#1)(2008-10#3)(2008-12#1)(2011-2#1)
in particular to the##2##4##(2008-10#1)(2008-8#1)
in particular to##4##3##(1993-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
in particular using##2##3##(2008-2#1)(2009-12#1)
in particular when##4##3##(1991-12#1)(1997-2#1)(2008-10#1)(2013-1#1)
in particular with the##2##4##(1990-11#1)(2012-2#1)
in particular with##7##3##(1990-11#1)(1991-6#2)(1995-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
in particular##292##2##(1990-11#4)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#6)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#3)(1995-6#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#34)(2008-11#9)(2008-12#3)(2008-2#10)(2008-3#15)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#7)(2013-1#5)(2013-8#8)
in particular)##3##2##(1994-11#1)(2008-12#1)(2012-12#1)
in particulate##4##2##(1996-12#1)(1997-6#2)(2008-10#1)
in partnership with the##4##4##(2008-11#2)(2008-12#2)
in partnership with##9##3##(1993-12#1)(1993-2#1)(2008-11#3)(2008-12#3)(2011-2#1)
in partnership##12##2##(1993-12#1)(1993-2#1)(1996-12#1)(1996-2#1)(2008-11#4)(2008-12#3)(2011-2#1)
in parts of Europe and##2##5##(2007-2#1)(2008-10#1)
in parts of the##2##4##(1995-3#1)(2008-11#1)
in parts of##6##3##(1995-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#2)
in passive##4##2##(1991-2#1)(1991-5#1)(1997-6#1)(2008-10#1)
in past##7##2##(1997-8#1)(2008-1#1)(2008-10#2)(2011-2#2)(2012-7#1)
in patch##6##2##(2008-10#1)(2008-8#3)(2008-9#2)
in patches of##3##3##(2008-8#1)(2008-9#2)
in patches##9##2##(1991-2#1)(1994-9#1)(2008-4#1)(2008-8#2)(2008-9#3)(2013-1#1)
in paternal care##2##3##(2008-9#2)
in paternal##3##2##(2008-9#3)
in paternity testing##3##3##(2008-12#2)(2008-5#1)
in paternity##6##2##(2008-12#4)(2008-5#1)(2008-8#1)
in pathogen populations##2##3##(2008-10#2)
in pathogen##12##2##(2008-10#10)(2008-9#1)(2009-8#1)
in pathogenesis and##4##3##(1990-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
in pathogenesis of##8##3##(1992-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2011-2#1)(2013-1#2)
in pathogenesis##17##2##(1990-6#1)(1992-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2011-1#1)(2011-2#3)(2013-1#3)
in pathogenic fungi##3##3##(2008-7#2)(2009-9#1)
in pathogenic##6##2##(2008-10#1)(2008-7#3)(2009-5#1)(2009-9#1)
in pathogenicity in##2##3##(2008-10#2)
in pathogenicity of X##4##4##(2008-10#4)
in pathogenicity of##5##3##(2008-10#5)
in pathogenicity tests##2##3##(2008-10#2)
in pathogenicity was##2##3##(2008-10#2)
in pathogenicity were##2##3##(2008-10#2)
in pathogenicity##25##2##(2008-10#25)
in pathologic##2##2##(1990-12#1)(1991-6#1)
in pathological pain states##2##4##(2008-4#2)
in pathological##8##2##(1992-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-4#3)(2010-12#1)
in pathologies##2##2##(2008-4#1)(2012-12#1)
in pathology##6##2##(1990-3#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-2#2)
in pathophysiology and##2##3##(2006-10#1)(2007-11#1)
in pathophysiology##3##2##(2006-10#1)(2007-11#1)(2013-7#1)
in pathways##2##2##(1990-5#1)(2009-2#1)
in patient access to##3##4##(2008-6#2)(2011-1#1)
in patient blood after myocardial damage##2##6##(2008-10#2)
in patient care##19##3##(1992-11#1)(1992-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-1#1)(2007-12#1)(2007-4#1)(2008-8#1)(2010-8#3)(2011-2#1)(2012-2#2)(2013-1#1)
in patient mitochondria##2##3##(1994-8#2)
in patient populations##3##3##(2008-10#1)(2010-6#1)(2013-1#1)
in patient selection##2##3##(2008-7#1)(2012-1#1)
in patient with##7##3##(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
in patient##68##2##(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#2)(1995-12#2)(1995-2#2)(1996-12#1)(1996-3#1)(1997-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
in patient's##2##2##(1991-7#1)(2007-11#1)
in patients above##3##3##(2007-7#1)(2008-12#1)(2012-3#1)
in patients affected by##9##4##(1994-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
in patients affected##10##3##(1994-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#2)
in patients after cardiac surgery##2##5##(2012-3#2)
in patients after##9##3##(1993-12#2)(2007-11#1)(2007-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
in patients aged &lt##2##4##(2013-1#2)
in patients aged##5##3##(1990-6#1)(1994-2#1)(2012-2#1)(2013-1#2)
in patients and##5##3##(1997-2#1)(1997-5#1)(2009-3#1)(2010-11#1)(2013-1#1)
in patients at high risk of recurrence##2##7##(2008-5#1)(2008-8#1)
in patients at high##3##4##(2008-5#1)(2008-8#1)(2010-4#1)
in patients at risk for##2##5##(2006-10#1)(2008-7#1)
in patients at risk##3##4##(1991-9#1)(2006-10#1)(2008-7#1)
in patients at##12##3##(1991-9#1)(1994-5#1)(2006-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
in patients being treated with##2##5##(1993-2#1)(2008-11#1)
in patients displaying##2##3##(1994-2#1)(2007-10#1)
in patients exposed to##3##4##(2008-7#1)(2010-5#1)(2013-1#1)
in patients failing##2##3##(2008-8#1)(2011-2#1)
in patients from##9##3##(1991-6#1)(1993-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2009-3#1)(2012-12#2)
in patients given##2##3##(2008-3#1)(2013-1#1)
in patients has##2##3##(2012-1#1)(2013-1#1)
in patients having##2##3##(2012-3#1)(2013-8#1)
in patients hospitalized with##3##4##(1993-2#1)(2008-3#1)(2012-12#1)
in patients hospitalized##4##3##(1993-2#1)(2008-3#2)(2012-12#1)
in patients in critical##2##4##(2013-1#2)
in patients in remission##2##4##(1990-11#1)(1990-3#1)
in patients in the##4##4##(1992-9#1)(1995-5#1)(2009-8#1)(2011-2#1)
in patients in whom##5##4##(1991-11#2)(2008-1#1)(2008-4#1)(2008-5#1)
in patients in##17##3##(1990-11#1)(1990-3#1)(1991-11#2)(1991-3#1)(1992-9#1)(1995-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
in patients may##2##3##(2008-11#1)(2011-2#1)
in patients not##3##3##(1992-2#1)(2008-4#2)
in patients of##10##3##(1990-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)
in patients older than##8##4##(2007-8#1)(2008-7#1)(2009-1#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
in patients older##9##3##(2007-8#1)(2008-7#1)(2009-1#1)(2009-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
in patients on continuous ambulatory peritoneal dialysis##2##7##(2007-12#2)
in patients on dialysis##3##4##(2008-1#1)(2011-2#2)
in patients on hemodialysis##4##4##(1991-6#1)(1993-6#1)(2007-7#1)(2011-2#1)
in patients on##15##3##(1991-6#1)(1993-6#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#2)(2011-2#3)(2013-1#1)
in patients operated on for endometrial cancer##2##7##(1992-12#2)
in patients operated##7##3##(1990-11#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#2)
in patients over 65##2##4##(1996-6#1)(2008-11#1)
in patients over the age of##2##6##(2008-3#1)(2011-2#1)
in patients over##9##3##(1996-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-3#1)
in patients presenting to##2##4##(2008-3#1)(2012-2#1)
in patients presenting with acute##3##5##(2007-10#1)(2011-2#2)
in patients presenting with##8##4##(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#2)(2012-1#1)
in patients presenting##13##3##(1990-11#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
in patients receiving##26##3##(1990-12#1)(1990-6#1)(1993-8#1)(1996-3#1)(2006-10#2)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-4#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#2)
in patients referred##2##3##(2007-11#1)(2012-2#1)
in patients requiring##2##3##(1996-9#1)(2007-7#1)
in patients subjected to##3##4##(2007-11#1)(2008-11#1)(2011-2#1)
in patients submitted to##2##4##(1991-6#1)(2013-7#1)
in patients suffering from bipolar disorder##2##6##(2008-6#2)
in patients suffering from chronic##2##5##(2008-10#1)(2008-7#1)
in patients suffering from##11##4##(1996-5#1)(1996-8#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#1)
in patients suffering##13##3##(1996-5#1)(1996-8#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-5#2)(2008-6#3)(2008-7#1)(2009-5#1)
in patients taking##5##3##(1995-11#1)(2006-10#1)(2008-11#2)(2009-4#1)
in patients than in control##2##5##(2008-6#1)(2013-8#1)
in patients than in##3##4##(2008-6#1)(2013-8#2)
in patients than##4##3##(2008-6#1)(2013-8#3)
in patients that received##2##4##(2007-8#1)(2011-2#1)
in patients that##6##3##(2007-8#1)(2010-12#1)(2011-2#3)(2012-2#1)
in patients treated by##3##4##(1994-6#1)(2007-10#1)(2008-7#1)
in patients treated for##3##4##(1995-8#1)(2010-3#1)(2012-12#1)
in patients treated in##2##4##(2008-7#1)(2011-2#1)
in patients treated with high-dose chemotherapy##2##6##(2008-7#2)
in patients treated with the##2##5##(2007-11#1)(2008-10#1)
in patients treated with##25##4##(1991-5#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-8#1)(2007-10#1)(2007-11#1)(2008-1#4)(2008-10#2)(2008-5#1)(2008-7#5)(2008-8#2)(2011-2#2)(2012-12#2)
in patients treated##35##3##(1991-5#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(2007-10#3)(2007-11#1)(2008-1#4)(2008-10#2)(2008-5#1)(2008-7#7)(2008-8#2)(2010-3#1)(2011-2#4)(2012-12#3)
in patients under##4##3##(1994-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
in patients undergoing cardiac surgery##2##5##(2007-8#1)(2008-12#1)
in patients undergoing coronary artery bypass##2##6##(2007-7#1)(2007-8#1)
in patients undergoing coronary artery##3##5##(2007-7#1)(2007-8#1)(2008-12#1)
in patients undergoing coronary##6##4##(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)
in patients undergoing lumbar spine surgery##3##6##(2008-7#3)
in patients undergoing open heart surgery##2##6##(1996-9#1)(2007-9#1)
in patients undergoing right upper lobectomy with complete oblique fissure##2##10##(2007-8#2)
in patients undergoing##49##3##(1990-6#1)(1991-5#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in patients wearing##2##3##(1990-12#1)(2013-1#1)
in patients when##2##3##(1990-9#1)(2008-7#1)
in patients who are##2##4##(2011-2#1)(2013-1#1)
in patients who developed##2##4##(2008-7#2)
in patients who did not##2##5##(1993-1#1)(2007-10#1)
in patients who did##3##4##(1993-1#2)(2007-10#1)
in patients who had##7##4##(1992-12#1)(1994-3#1)(2009-4#2)(2010-7#1)(2012-3#1)(2013-1#1)
in patients who have had##5##5##(1997-6#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-6#1)
in patients who have presented previous reactions##2##7##(2011-1#2)
in patients who have##17##4##(1990-5#1)(1993-1#1)(1996-11#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-7#2)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#2)(2012-12#2)(2012-2#1)
in patients who underwent##8##4##(2007-8#1)(2008-9#1)(2011-2#4)(2012-2#1)(2012-3#1)
in patients who were##2##4##(2007-11#1)(2011-2#1)
in patients who##62##3##(1990-3#1)(1990-5#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-1#3)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-10#4)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-3#2)(2010-7#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
in patients whose##4##3##(1990-3#1)(1993-1#1)(2007-8#1)(2012-3#1)
in patients with &quot##3##4##(1990-11#1)(2011-2#1)(2012-12#1)
in patients with AIDS##2##4##(1991-2#1)(1991-5#1)
in patients with AR##8##4##(1995-3#5)(2011-2#3)
in patients with Alzheimer's disease##4##5##(1994-5#1)(2008-5#1)(2008-7#1)(2009-9#1)
in patients with COPD##8##4##(1997-1#1)(1997-7#1)(2008-12#1)(2008-7#1)(2013-7#1)(2013-8#3)
in patients with CTEPH##2##4##(2010-6#2)
in patients with Crohn's disease##2##5##(2010-12#2)
in patients with HCM##2##4##(2008-7#2)
in patients with HCV##4##4##(2006-10#3)(2013-1#1)
in patients with HIV infection##2##5##(1996-11#1)(1996-3#1)
in patients with HIV##5##4##(1996-11#1)(1996-3#1)(2008-10#1)(2010-12#2)
in patients with HIV-1 infection##2##5##(1990-2#1)(2010-11#1)
in patients with LOCAH##2##4##(1990-11#2)
in patients with MS##5##4##(2010-12#2)(2012-3#3)
in patients with PD##2##4##(2008-10#1)(2013-1#1)
in patients with Parkinson's disease##3##5##(1993-2#1)(2008-7#2)
in patients with RA##3##4##(1993-2#1)(2008-7#1)(2011-2#1)
in patients with RM##2##4##(1994-12#2)
in patients with SS##5##4##(2007-11#5)
in patients with ST-segment elevation myocardial infarction##2##7##(2009-12#1)(2009-5#1)
in patients with Takayasu arteritis and severe aortic regurgitation##2##9##(1997-8#2)
in patients with a history of##6##6##(1992-5#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
in patients with a##24##4##(1990-12#1)(1992-5#2)(1996-1#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
in patients with abdominal pain##2##5##(2011-2#1)(2012-12#1)
in patients with abdominal##4##4##(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
in patients with abnormal thermograms##2##5##(1993-11#2)
in patients with abnormal##5##4##(1990-6#1)(1991-11#1)(1993-11#2)(1994-2#1)
in patients with acquired##2##4##(2008-2#1)(2011-1#1)
in patients with active##3##4##(2008-7#1)(2009-6#1)(2010-12#1)
in patients with acute and chronic##2##6##(2013-1#1)(2013-8#1)
in patients with acute bacterial prostatitis##2##6##(2008-10#2)
in patients with acute coronary syndrome##3##6##(2008-11#1)(2011-2#2)
in patients with acute coronary syndromes and##2##7##(2008-3#2)
in patients with acute coronary##6##5##(2008-11#1)(2008-3#2)(2009-10#1)(2011-2#2)
in patients with acute exacerbation of chronic##2##7##(2008-10#1)(2011-2#1)
in patients with acute ischemic stroke##3##6##(2007-10#2)(2008-10#1)
in patients with acute leukemia##2##5##(2008-7#1)(2011-2#1)
in patients with acute myocardial infarction##4##6##(1992-9#1)(2008-3#3)
in patients with acute myocardial##5##5##(1990-12#1)(1992-9#1)(2008-3#3)
in patients with acute stroke##4##5##(2007-10#3)(2008-8#1)
in patients with acute##35##4##(1990-12#1)(1992-9#1)(2007-10#6)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#2)(2011-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
in patients with adult##2##4##(1992-2#1)(2012-12#1)
in patients with advanced##12##4##(1990-10#2)(1993-11#1)(2006-10#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#2)
in patients with advanced-stage cancer##2##5##(2008-7#2)
in patients with alcoholic##2##4##(1993-12#2)
in patients with allergic asthma##2##5##(2009-6#1)(2010-5#1)
in patients with an##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
in patients with and without previous successful##2##7##(2007-8#2)
in patients with and without##5##5##(1997-7#1)(2007-8#3)(2011-2#1)
in patients with ankylosing##2##4##(2008-10#2)
in patients with aortic arch##2##5##(2007-8#1)(2008-8#1)
in patients with aortic##6##4##(2007-8#2)(2008-8#1)(2012-1#2)(2012-2#1)
in patients with asthma and##3##5##(2012-12#3)
in patients with asthma##6##4##(2008-7#1)(2010-5#1)(2012-12#4)
in patients with atrial fibrillation##4##5##(1996-6#1)(2008-3#1)(2009-12#1)(2012-12#1)
in patients with atrial##5##4##(1996-6#1)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
in patients with auditory##2##4##(2008-9#1)(2012-1#1)
in patients with autosomal dominant polycystic kidney##2##7##(2013-1#2)
in patients with back pain associated with myofascial trigger points##2##10##(2010-12#2)
in patients with back pain##4##5##(2007-11#1)(2009-1#1)(2010-12#2)
in patients with basilar artery occlusion##2##6##(2007-10#1)(2008-8#1)
in patients with beta-thalassaemia major##2##5##(2007-11#2)
in patients with bilateral##2##4##(2008-12#1)(2008-4#1)
in patients with bipolar disorder##5##5##(2008-6#1)(2009-3#1)(2013-8#3)
in patients with bladder##2##4##(2007-9#1)(2008-10#1)
in patients with blunt##2##4##(1990-2#1)(2011-2#1)
in patients with bone metastases from breast cancer##2##8##(2008-7#2)
in patients with bone metastases from##4##6##(2008-7#4)
in patients with bone metastases##7##5##(2007-11#2)(2008-10#1)(2008-7#4)
in patients with bone##8##4##(2007-11#2)(2008-10#1)(2008-7#4)(2011-1#1)
in patients with breast cancer and bone metastases##2##8##(1993-11#1)(2007-10#1)
in patients with breast cancer and##4##6##(1992-12#1)(1993-11#1)(2007-10#1)(2007-11#1)
in patients with breast cancer receiving##2##6##(2008-7#1)(2013-1#1)
in patients with breast cancer##16##5##(1992-10#1)(1992-12#1)(1993-11#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#3)(2013-1#2)
in patients with breast##18##4##(1992-10#1)(1992-12#1)(1993-11#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#4)(2013-1#2)
in patients with cancer and##2##5##(2008-7#2)
in patients with cancer receiving##2##5##(2008-7#2)
in patients with cancer##23##4##(1990-6#1)(1992-8#1)(2008-7#15)(2010-11#1)(2010-4#1)(2010-9#1)(2013-1#3)
in patients with cardiac##5##4##(2008-12#2)(2011-2#2)(2012-2#1)
in patients with cardiovascular##2##4##(2008-8#1)(2012-12#1)
in patients with cerebral##2##4##(1994-9#1)(2007-10#1)
in patients with cerebrovascular##2##4##(1991-11#1)(2007-10#1)
in patients with chronic congestive heart##2##6##(2008-7#2)
in patients with chronic heart failure##3##6##(2008-7#1)(2009-10#1)(2012-2#1)
in patients with chronic heart failure]##2##6##(2011-1#1)(2013-8#1)
in patients with chronic heart##5##5##(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
in patients with chronic hepatitis B##2##6##(2010-8#1)(2011-2#1)
in patients with chronic hepatitis C##3##6##(2009-10#1)(2012-12#1)(2013-1#1)
in patients with chronic hepatitis##5##5##(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
in patients with chronic kidney disease##3##6##(2008-11#1)(2011-2#2)
in patients with chronic kidneys disease##2##6##(2013-1#2)
in patients with chronic liver disease##2##6##(2008-1#1)(2009-4#1)
in patients with chronic obstructive pulmonary disease##5##7##(1991-9#1)(1997-7#2)(2011-2#2)
in patients with chronic obstructive pulmonary##6##6##(1991-9#1)(1993-11#1)(1997-7#2)(2011-2#2)
in patients with chronic obstructive rhinitis##3##6##(2008-4#3)
in patients with chronic obstructive##10##5##(1991-9#1)(1993-11#1)(1997-7#2)(2008-1#1)(2008-4#3)(2011-2#2)
in patients with chronic pain##2##5##(1997-6#1)(2009-7#1)
in patients with chronic periodontitis##2##5##(2008-12#2)
in patients with chronic renal failure##3##6##(1992-6#1)(1993-1#1)(1994-12#1)
in patients with chronic renal##6##5##(1992-6#1)(1993-1#1)(1994-12#1)(2006-10#1)(2008-1#2)
in patients with chronic schizophrenia##2##5##(2009-10#1)(2011-2#1)
in patients with chronic thromboembolic pulmonary##3##6##(2010-6#3)
in patients with chronic wrist pain##2##6##(2008-9#2)
in patients with chronic##65##4##(1991-2#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-12#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#3)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-6#3)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
in patients with cirrhosis and##2##5##(2011-2#1)(2013-1#1)
in patients with cirrhosis##6##4##(1994-7#1)(2008-7#1)(2009-4#2)(2011-2#1)(2013-1#1)
in patients with colorectal##3##4##(1992-8#1)(2008-10#1)(2011-2#1)
in patients with congenital heart disease and##2##7##(2009-10#1)(2009-5#1)
in patients with congenital heart disease##5##6##(2009-10#2)(2009-5#1)(2010-10#1)(2012-2#1)
in patients with congenital##8##4##(1994-11#1)(2009-10#2)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#2)
in patients with coronary artery disease##5##6##(2006-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-7#1)
in patients with coronary heart disease and##4##7##(1993-12#1)(1993-2#1)(2008-5#1)(2008-7#1)
in patients with coronary heart disease##8##6##(1990-8#1)(1992-5#1)(1993-12#1)(1993-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
in patients with coronary##15##4##(1990-8#1)(1992-5#1)(1993-12#1)(1993-2#2)(2006-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
in patients with cystic fibrosis##2##5##(1994-12#1)(2008-10#1)
in patients with degenerative changes##2##5##(2007-8#2)
in patients with degenerative disease of the femoropatellar joint##2##9##(2007-11#2)
in patients with degenerative##4##4##(2007-11#2)(2007-8#2)
in patients with dementia##2##4##(2008-7#2)
in patients with diabetes mellitus is##2##6##(1992-5#1)(2008-3#1)
in patients with diabetes mellitus##7##5##(1992-5#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
in patients with diabetes##15##4##(1992-5#1)(2008-1#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
in patients with diabetes/metabolic syndrome##2##5##(2008-5#2)
in patients with diastolic##2##4##(1992-5#1)(2012-12#1)
in patients with different degrees of##2##6##(1991-5#2)
in patients with different##5##4##(1991-5#2)(1993-2#1)(2009-3#1)(2011-2#1)
in patients with disseminated##3##4##(1996-12#2)(2010-3#1)
in patients with dysthymic disorder##2##5##(2011-2#2)
in patients with dysthymic##3##4##(2011-2#3)
in patients with early##2##4##(1991-12#1)(2010-11#1)
in patients with elevated levels of##2##6##(1990-2#1)(1990-9#1)
in patients with end-stage renal disease##3##6##(2007-12#1)(2007-7#1)(2008-1#1)
in patients with end-stage##4##4##(2007-12#1)(2007-7#1)(2008-1#1)(2012-12#1)
in patients with environmental exposures##2##5##(1991-12#2)
in patients with established##6##4##(1991-9#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-3#1)(2011-2#1)
in patients with extensive##3##4##(1993-8#1)(2007-11#1)(2007-8#1)
in patients with failed##2##4##(2012-3#1)(2013-1#1)
in patients with gastric##2##4##(1990-2#1)(2008-12#1)
in patients with gastroesophageal reflux disease##2##6##(2009-11#1)(2013-8#1)
in patients with gastroesophageal reflux##3##5##(2009-11#1)(2013-8#2)
in patients with gastroesophageal##4##4##(2009-11#1)(2013-1#1)(2013-8#2)
in patients with gastrointestinal##3##4##(1997-3#1)(2013-7#1)(2013-8#1)
in patients with grade##4##4##(2008-7#4)
in patients with haematological##2##4##(2008-5#1)(2009-3#1)
in patients with head injuries##2##5##(2008-7#2)
in patients with head##4##4##(2008-7#4)
in patients with heart failure##5##5##(1996-8#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
in patients with heart##8##4##(1990-12#1)(1996-8#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
in patients with hematologic malignancies##8##5##(2008-7#7)(2012-12#1)
in patients with hematologic##9##4##(2008-7#7)(2012-12#2)
in patients with hepatocellular carcinoma##2##5##(1992-3#1)(2008-12#1)
in patients with heterozygous familial##2##5##(1990-12#1)(2012-2#1)
in patients with high##3##4##(2007-8#1)(2008-3#1)(2008-7#1)
in patients with high-risk acute myeloid leukemia##2##7##(2011-2#2)
in patients with high-risk##6##4##(2011-2#5)(2013-1#1)
in patients with human immunodeficiency virus##3##6##(1993-2#1)(1996-11#1)(2008-2#1)
in patients with hyperlipidaemia##2##4##(2008-3#2)
in patients with hypertension##4##4##(2007-10#1)(2008-7#1)(2010-4#1)(2013-1#1)
in patients with hypertrophic cardiomyopathy##2##5##(2008-7#2)
in patients with idiopathic##2##4##(1995-10#1)(2009-10#1)
in patients with increased##3##4##(2008-12#1)(2008-4#1)(2011-2#1)
in patients with inflammatory bowel disease##8##6##(2008-10#1)(2010-12#2)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
in patients with inflammatory bowel diseases##2##6##(2012-2#2)
in patients with inflammatory bowel##10##5##(2008-10#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
in patients with inoperable oesophageal##2##5##(1993-6#2)
in patients with intracerebral##3##4##(2007-10#1)(2008-7#2)
in patients with ischaemic heart disease##2##6##(2008-7#1)(2012-2#1)
in patients with ischaemic##3##4##(2007-8#1)(2008-7#1)(2012-2#1)
in patients with ischemic##4##4##(1996-9#1)(2008-7#1)(2008-8#1)(2011-2#1)
in patients with isolated##2##4##(2007-10#1)(2011-2#1)
in patients with knee##2##4##(2007-8#1)(2013-1#1)
in patients with known##2##4##(1996-12#1)(2012-2#1)
in patients with large##2##4##(2006-7#1)(2008-9#1)
in patients with left##2##4##(2008-7#2)
in patients with limited##3##4##(1993-5#1)(1995-8#1)(2010-3#1)
in patients with liver cirrhosis##4##5##(1992-2#1)(2010-8#1)(2013-1#1)(2013-8#1)
in patients with liver disease##2##5##(2013-1#2)
in patients with liver##7##4##(1992-2#1)(2010-8#1)(2011-1#1)(2013-1#3)(2013-8#1)
in patients with locally advanced##3##5##(1997-7#1)(2008-10#1)(2009-5#1)
in patients with locally##4##4##(1990-8#1)(1997-7#1)(2008-10#1)(2009-5#1)
in patients with long##3##4##(2007-11#1)(2010-9#1)(2012-2#1)
in patients with low##4##4##(1990-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
in patients with lumbar##3##4##(2011-2#1)(2012-12#2)
in patients with major depression##3##5##(1995-11#1)(2008-6#1)(2009-8#1)
in patients with major##5##4##(1995-11#1)(1996-7#1)(2008-6#1)(2009-8#1)(2011-2#1)
in patients with malignant glioma##2##5##(1994-3#1)(2008-8#1)
in patients with malignant melanoma##2##5##(1993-8#1)(2007-5#1)
in patients with malignant##5##4##(1993-8#1)(1994-3#1)(2007-5#1)(2008-8#2)
in patients with mechanical neck pain##2##6##(2008-12#2)
in patients with mechanical##4##4##(2008-12#2)(2011-1#1)(2012-3#1)
in patients with metabolic syndrome##3##5##(2008-11#1)(2008-5#1)(2012-2#1)
in patients with metastases##2##4##(2007-11#2)
in patients with metastatic disease##2##5##(2010-3#1)(2011-1#1)
in patients with metastatic##6##4##(1990-2#1)(2007-5#1)(2008-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
in patients with migraine##2##4##(2008-9#1)(2012-3#1)
in patients with mild##4##4##(2008-7#1)(2009-5#1)(2010-7#1)(2013-8#1)
in patients with moderate and severe airways obstruction##2##8##(2008-7#2)
in patients with moderate to severe##2##6##(2008-3#1)(2009-5#1)
in patients with moderate##4##4##(2008-3#1)(2008-7#2)(2009-5#1)
in patients with multiple myeloma##3##5##(2008-7#3)
in patients with multiple sclerosis##4##5##(2012-12#1)(2012-3#3)
in patients with multiple##11##4##(1992-6#1)(2007-11#2)(2008-11#1)(2008-7#3)(2012-12#1)(2012-3#3)
in patients with musculoskeletal##2##4##(2008-5#1)(2008-6#1)
in patients with myeloma##2##4##(1990-9#1)(2007-11#1)
in patients with myocardial ischemia##2##5##(2008-5#1)(2012-3#1)
in patients with myocardial##3##4##(1996-9#1)(2008-5#1)(2012-3#1)
in patients with neck pain##4##5##(2008-12#3)(2010-12#1)
in patients with neuroendocrine##2##4##(1992-11#2)
in patients with neuromuscular##3##4##(2008-7#3)
in patients with non-small cell lung cancer##2##7##(2008-1#1)(2013-1#1)
in patients with non-small##3##4##(2008-1#1)(2009-4#1)(2013-1#1)
in patients with normal##4##4##(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
in patients with or without##2##5##(2007-7#1)(2008-3#1)
in patients with osteoporosis##4##4##(1997-6#1)(2007-11#1)(2008-8#2)
in patients with other##3##4##(1994-12#1)(1997-8#1)(2011-2#1)
in patients with panic disorder##5##5##(1996-7#1)(2007-1#1)(2013-8#3)
in patients with papillary thyroid##2##5##(2008-10#2)
in patients with patellofemoral pain syndrome##2##6##(2008-12#2)
in patients with peripheral##2##4##(1995-2#1)(2013-1#1)
in patients with persistent##4##4##(1991-8#1)(2008-12#1)(2008-3#1)(2008-9#1)
in patients with pneumococcal meningitis##2##5##(2011-2#2)
in patients with pneumococcal##3##4##(2011-2#3)
in patients with posterior##2##4##(2007-8#1)(2012-3#1)
in patients with previous##3##4##(1992-10#1)(2010-12#1)(2011-1#1)
in patients with primary breast cancer##2##6##(1990-8#1)(2007-5#1)
in patients with primary##5##4##(1990-8#1)(1995-10#1)(2007-2#1)(2007-5#1)(2011-1#1)
in patients with prostate cancer##2##5##(2008-7#1)(2012-3#1)
in patients with prostatic cancer##2##5##(1995-11#1)(1995-12#1)
in patients with prostatic##3##4##(1993-6#1)(1995-11#1)(1995-12#1)
in patients with pulmonary##2##4##(1997-5#1)(2011-1#1)
in patients with recent transient ischaemic attack or##2##8##(2008-8#2)
in patients with recent##4##4##(2007-10#1)(2008-8#2)(2012-2#1)
in patients with rectal cancer##2##5##(2008-10#2)
in patients with recurrent##8##4##(1994-12#1)(2007-10#1)(2007-7#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
in patients with refractory heart failure##2##6##(2011-2#2)
in patients with refractory##3##4##(2010-5#1)(2011-2#2)
in patients with renal##4##4##(1995-12#1)(1996-6#1)(2008-1#1)(2013-1#1)
in patients with rheumatoid arthritis##6##5##(2006-10#2)(2008-5#1)(2008-7#2)(2008-8#1)
in patients with sarcoma##3##4##(2008-6#3)
in patients with schizophrenia and##2##5##(2010-1#1)(2010-6#1)
in patients with schizophrenia##14##4##(1995-12#2)(1996-5#1)(1996-7#1)(2009-12#1)(2010-1#2)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
in patients with serious##2##4##(1990-6#1)(2010-5#1)
in patients with severe aphthous ulceration##2##6##(2012-1#2)
in patients with severe atherosclerosis##2##5##(2007-8#1)(2008-1#1)
in patients with severe##24##4##(1991-9#1)(1994-12#1)(1996-5#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
in patients with sickle cell disease##2##6##(2009-2#1)(2009-4#1)
in patients with sickle cell##3##5##(2009-2#1)(2009-4#2)
in patients with simultaneous##2##4##(2008-10#1)(2008-7#1)
in patients with soft tissue sarcomas##2##6##(2008-6#2)
in patients with solid tumors##4##5##(2008-7#2)(2010-10#1)(2010-11#1)
in patients with spinal##3##4##(1993-2#1)(2007-11#1)(2012-3#1)
in patients with stable##5##4##(1992-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
in patients with stroke##3##4##(2007-10#3)
in patients with suspected##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
in patients with systemic sclerosis##2##5##(2010-10#1)(2012-2#1)
in patients with systemic##4##4##(2006-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
in patients with the acquired immunodeficiency syndrome##2##7##(1991-12#1)(1993-9#1)
in patients with the metabolic syndrome##2##6##(2010-4#1)(2011-2#1)
in patients with the nephrotic syndrome##2##6##(2008-1#2)
in patients with the##10##4##(1991-12#2)(1993-9#1)(2006-10#1)(2007-11#1)(2008-1#3)(2010-4#1)(2011-2#1)
in patients with this##4##4##(1990-5#1)(1991-11#1)(1993-9#1)(2008-12#1)
in patients with thyroid##3##4##(2011-1#1)(2012-1#1)(2013-1#1)
in patients with total##2##4##(1996-11#1)(2010-7#1)
in patients with traumatic##2##4##(2007-11#1)(2007-8#1)
in patients with troublesome belching and##2##6##(2013-8#2)
in patients with troublesome belching##3##5##(2013-8#3)
in patients with type 1 and type 2 diabetes##2##9##(2012-4#2)
in patients with type 1 diabetes##2##6##(2008-1#1)(2013-8#1)
in patients with type 1##4##5##(2008-1#1)(2012-4#2)(2013-8#1)
in patients with type 2 diabetes mellitus##3##7##(2008-3#1)(2010-10#1)(2013-8#1)
in patients with type 2 diabetes##12##6##(2008-1#1)(2008-3#3)(2010-10#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-8#2)
in patients with type 2##13##5##(2008-1#1)(2008-3#3)(2010-10#1)(2011-2#3)(2012-3#1)(2012-5#2)(2013-8#2)
in patients with type##19##4##(1994-2#1)(2008-1#2)(2008-3#3)(2010-10#1)(2011-2#3)(2012-3#2)(2012-4#2)(2012-5#2)(2013-8#3)
in patients with underlying##3##4##(1990-3#1)(2007-7#1)(2011-2#1)
in patients with unilateral##2##4##(2008-9#1)(2009-2#1)
in patients with unstable angina pectoris##2##6##(1990-12#2)
in patients with unstable angina##3##5##(1990-12#2)(2008-5#1)
in patients with unstable##4##4##(1990-12#2)(2007-8#1)(2008-5#1)
in patients with untreated Graves' disease##2##6##(2012-3#2)
in patients with urinary##2##4##(1995-12#1)(2013-8#1)
in patients with vascular##3##4##(2007-10#1)(2007-12#1)(2010-1#1)
in patients with##1232##3##(1990-10#3)(1990-11#4)(1990-12#7)(1990-2#7)(1990-3#4)(1990-5#1)(1990-6#7)(1990-8#4)(1990-9#2)(1991-11#4)(1991-12#7)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#5)(1992-5#7)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#9)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#10)(1994-2#3)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#4)(1995-12#9)(1995-2#3)(1995-3#6)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#4)(1996-12#5)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#6)(1996-8#2)(1996-9#6)(1997-1#3)(1997-3#5)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#11)(1997-9#1)(2006-10#14)(2006-7#2)(2007-1#1)(2007-10#36)(2007-11#39)(2007-12#4)(2007-2#2)(2007-5#7)(2007-7#15)(2007-8#33)(2007-9#4)(2008-1#31)(2008-10#39)(2008-11#10)(2008-12#31)(2008-2#4)(2008-3#26)(2008-4#14)(2008-5#22)(2008-6#15)(2008-7#116)(2008-8#20)(2008-9#16)(2009-1#2)(2009-10#10)(2009-11#1)(2009-12#5)(2009-2#5)(2009-3#5)(2009-4#10)(2009-5#5)(2009-6#6)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#5)(2010-10#7)(2010-11#7)(2010-12#22)(2010-3#6)(2010-4#4)(2010-5#5)(2010-6#13)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#16)(2011-2#96)(2011-3#1)(2012-1#9)(2012-12#33)(2012-2#33)(2012-3#36)(2012-4#2)(2012-5#2)(2013-1#64)(2013-7#4)(2013-8#44)
in patients without cirrhosis##2##4##(1994-7#1)(2006-10#1)
in patients without##22##3##(1990-2#1)(1990-3#1)(1990-9#1)(1994-11#1)(1994-7#1)(2006-10#2)(2007-10#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-3#1)
in patients younger than 20##2##5##(1993-8#1)(2007-8#1)
in patients younger than##3##4##(1993-8#1)(2007-8#1)(2010-12#1)
in patients##1715##2##(1990-10#3)(1990-11#8)(1990-12#9)(1990-2#8)(1990-3#8)(1990-5#3)(1990-6#10)(1990-8#4)(1990-9#5)(1991-11#7)(1991-12#7)(1991-2#4)(1991-3#6)(1991-4#1)(1991-5#7)(1991-6#7)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#6)(1992-5#7)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#7)(1993-11#8)(1993-12#6)(1993-2#11)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#4)(1993-9#5)(1994-11#4)(1994-12#11)(1994-2#6)(1994-3#4)(1994-5#3)(1994-6#1)(1994-7#3)(1994-8#2)(1994-9#4)(1995-10#2)(1995-11#6)(1995-12#10)(1995-2#3)(1995-3#7)(1995-5#2)(1995-6#1)(1995-8#5)(1996-1#1)(1996-11#5)(1996-12#5)(1996-3#4)(1996-5#3)(1996-6#4)(1996-7#7)(1996-8#3)(1996-9#8)(1997-1#3)(1997-2#2)(1997-3#5)(1997-5#3)(1997-6#4)(1997-7#8)(1997-8#14)(1997-9#1)(2006-10#24)(2006-7#3)(2007-1#1)(2007-10#53)(2007-11#51)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#7)(2007-7#27)(2007-8#50)(2007-9#6)(2008-1#45)(2008-10#56)(2008-11#20)(2008-12#34)(2008-2#4)(2008-3#39)(2008-4#19)(2008-5#35)(2008-6#21)(2008-7#146)(2008-8#30)(2008-9#18)(2009-1#3)(2009-10#14)(2009-11#2)(2009-12#6)(2009-2#6)(2009-3#9)(2009-4#15)(2009-5#8)(2009-6#6)(2009-7#3)(2009-8#14)(2009-9#4)(2010-1#6)(2010-10#7)(2010-11#8)(2010-12#31)(2010-2#1)(2010-3#9)(2010-4#7)(2010-5#8)(2010-6#14)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#21)(2011-2#139)(2011-3#1)(2012-1#12)(2012-12#48)(2012-2#48)(2012-3#50)(2012-4#2)(2012-5#2)(2013-1#92)(2013-3#1)(2013-7#6)(2013-8#51)
in patients'##2##2##(1995-3#1)(2006-10#1)
in pattern recognition##2##3##(2011-3#1)(2013-8#1)
in pattern##6##2##(1995-11#1)(1997-4#1)(2008-5#1)(2008-6#1)(2011-3#1)(2013-8#1)
in patterns of##3##3##(1997-4#1)(2008-1#1)(2008-8#1)
in patterns##5##2##(1992-2#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-8#1)
in pea aphids##2##3##(2008-8#2)
in pea plants##2##3##(2008-10#2)
in pea##9##2##(1993-6#2)(2008-10#4)(2008-8#2)(2011-2#1)
in peach##2##2##(2008-10#2)
in peak##9##2##(1991-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)
in peanut seed##3##3##(2008-10#3)
in peanut##6##2##(2008-10#6)
in pear##2##2##(2008-10#2)
in pears##3##2##(2008-10#3)
in peat##3##2##(2008-10#3)
in peatlands##2##2##(2008-8#2)
in pediatric and##2##3##(2010-3#1)(2011-2#1)
in pediatric patients with##3##4##(2010-11#2)(2011-2#1)
in pediatric patients##13##3##(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2010-11#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
in pediatric spinal injures##2##4##(2007-8#2)
in pediatric surgery]##3##3##(1990-5#1)(1991-3#1)(2011-2#1)
in pediatric urology##3##3##(2008-10#2)(2009-5#1)
in pediatric##51##2##(1990-5#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-1#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-11#3)(2010-3#2)(2010-5#3)(2011-1#3)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
in pediatrics and##2##3##(2009-10#2)
in pediatrics##8##2##(1991-3#1)(2007-12#1)(2008-5#1)(2009-10#2)(2011-2#3)
in peer review##2##3##(1992-12#1)(2010-5#1)
in pelletized##4##2##(2008-1#3)(2008-6#1)
in pelvic##4##2##(1994-3#1)(1997-7#1)(2008-7#1)(2012-1#1)
in pelvis##2##2##(2008-12#1)(2008-7#1)
in penetrating##2##2##(2007-8#1)(2008-10#1)
in peninsular Malaysia##6##3##(2008-10#1)(2008-12#3)(2008-8#2)
in peninsular##7##2##(2008-10#2)(2008-12#3)(2008-8#2)
in people aged##3##3##(1995-5#1)(2011-2#2)
in people at##2##3##(2007-10#1)(2011-1#1)
in people living with HIV/AIDS##2##5##(2008-12#2)
in people living with##3##4##(2008-12#2)(2010-10#1)
in people over##2##3##(1993-9#1)(2012-1#1)
in people with cancer##2##4##(2009-10#1)(2012-2#1)
in people with schizophrenia##3##4##(2009-7#2)(2013-1#1)
in people with spinal##2##4##(2008-12#1)(2013-1#1)
in people with##19##3##(2007-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-7#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#2)
in people##37##2##(1993-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#4)(2008-3#3)(2008-7#1)(2009-10#1)(2009-7#2)(2010-10#2)(2010-4#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#2)
in people's##3##2##(1992-9#1)(2008-5#1)(2010-4#1)
in pepper##8##2##(2008-10#8)
in pepsinogen secretion from##3##4##(1995-8#3)
in pepsinogen secretion##4##3##(1995-8#4)
in peptic ulcer disease patients and healthy##2##7##(2008-5#2)
in peptic ulcer disease patients and##3##6##(2008-5#3)
in peptic ulcer##5##3##(1992-9#1)(2008-5#4)
in peptide##7##2##(1993-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-6#2)
in per##4##2##(1994-12#1)(2008-8#2)(2011-2#1)
in perceived##6##2##(2007-12#2)(2008-3#1)(2008-6#1)(2011-2#2)
in percent body fat and##2##5##(2008-11#1)(2008-4#1)
in percent##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#1)
in percentage cover##2##3##(2008-9#2)
in percentage of##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
in percentage##8##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-5#1)(2011-2#1)
in perception of##3##3##(2008-9#1)(2011-2#2)
in perception##8##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
in perceptions##2##2##(2008-9#1)(2010-1#1)
in perchloric acid##3##3##(2008-10#3)
in perchloric##4##2##(2008-10#4)
in percutaneous coronary intervention##4##4##(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#1)
in percutaneous coronary##6##3##(2008-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#2)
in percutaneous##7##2##(1996-6#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#2)
in perennial##5##2##(2008-10#3)(2008-8#2)
in perfect##2##2##(1993-2#1)(2008-1#1)
in performance and##2##3##(2007-11#1)(2008-2#1)
in performance are##2##3##(2007-11#1)(2010-7#1)
in performance at##4##3##(2008-8#4)
in performance in the##2##4##(2008-11#1)(2011-2#1)
in performance in##3##3##(2008-11#2)(2011-2#1)
in performance of##3##3##(1993-12#2)(2011-2#1)
in performance on##2##3##(2008-9#1)(2012-3#1)
in performance##35##2##(1993-12#2)(1993-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(2007-11#5)(2008-10#2)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
in performing##11##2##(1991-3#1)(1996-12#1)(1996-2#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
in perfused liver##3##3##(1991-3#1)(1994-6#2)
in perfused rat##2##3##(1994-12#1)(1994-6#1)
in perfused##6##2##(1991-3#2)(1994-12#1)(1994-6#3)
in perfusion cultures##2##3##(2008-11#2)
in perfusion pressure##2##3##(1993-3#2)
in perfusion##14##2##(1993-3#3)(1994-5#1)(1996-5#1)(1997-2#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-11#1)
in peri-implant tissues##2##3##(2008-11#2)
in periapical##2##2##(2011-2#1)(2012-3#1)
in perinatal care##4##3##(2013-1#4)
in perinatal outcomes##2##3##(2012-3#1)(2013-1#1)
in perinatal##7##2##(2011-2#1)(2012-3#1)(2013-1#5)
in perinatology##2##2##(1993-12#1)(1994-3#1)
in periodic anisotropic layered media##2##5##(2008-3#2)
in periodic anisotropic##3##3##(2008-3#3)
in periodic##7##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-3#4)
in periodically poled KTP##5##4##(2007-11#4)(2007-12#1)
in periodically poled LiNbO(3)##3##4##(2007-12#3)
in periodically poled lithium niobate##8##5##(2007-11#4)(2007-12#3)(2008-3#1)
in periodically poled lithium##10##4##(2007-11#4)(2007-12#5)(2008-3#1)
in periodically poled##22##3##(2007-11#10)(2007-12#11)(2008-3#1)
in periodically##23##2##(2007-11#10)(2007-12#11)(2008-3#2)
in periodontal regeneration##2##3##(2012-3#2)
in periodontal treatment##2##3##(2012-3#2)
in periodontal##11##2##(1990-9#1)(2008-12#2)(2008-5#1)(2012-3#4)(2013-1#3)
in periodontitis##2##2##(2007-7#1)(2011-2#1)
in periods of##3##3##(1993-9#1)(2008-10#1)(2013-7#1)
in periods##4##2##(1993-9#1)(2008-10#1)(2010-1#1)(2013-7#1)
in perioperative##2##2##(2012-3#1)(2013-1#1)
in peripheral and##2##3##(2008-3#1)(2008-8#1)
in peripheral blood and##3##4##(1995-11#1)(1995-2#1)(2008-1#1)
in peripheral blood lymphocyte##2##4##(1992-2#1)(2008-10#1)
in peripheral blood mononuclear cells##2##5##(2008-10#1)(2008-7#1)
in peripheral blood of##2##4##(1996-9#1)(2008-9#1)
in peripheral blood##23##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#5)(2009-6#1)(2011-2#2)(2013-1#2)
in peripheral lymphocytes##2##3##(2008-8#1)(2012-3#1)
in peripheral mononuclear##2##3##(1991-11#1)(2008-7#1)
in peripheral nerve##4##3##(1995-5#1)(2008-7#1)(2011-2#2)
in peripheral nerves##3##3##(1997-4#1)(2008-7#1)(2011-2#1)
in peripheral organs##2##3##(2008-5#1)(2008-7#1)
in peripheral tissue##3##3##(1993-11#2)(2008-7#1)
in peripheral tissues and##3##4##(1993-11#1)(2008-3#1)(2012-2#1)
in peripheral tissues of fetal rhesus##2##6##(1990-11#2)
in peripheral tissues##8##3##(1990-11#3)(1991-11#1)(1993-11#1)(1997-7#1)(2008-3#1)(2012-2#1)
in peripheral##66##2##(1990-11#4)(1990-12#1)(1991-11#2)(1991-2#2)(1991-5#2)(1992-2#1)(1993-11#3)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#5)(2009-12#1)(2009-6#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#3)
in peritoneal dialysis (PD) patients##2##5##(2007-12#1)(2011-2#1)
in peritoneal dialysis (PD)##5##4##(2007-12#2)(2008-1#1)(2011-2#2)
in peritoneal dialysis patients##5##4##(2007-12#1)(2011-2#3)(2013-1#1)
in peritoneal dialysis##12##3##(2007-12#3)(2008-1#2)(2008-5#1)(2011-2#5)(2013-1#1)
in peritoneal##19##2##(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#7)(2013-1#1)
in periwinkle##2##2##(2008-10#2)
in periwinkles infected with AYP##2##5##(2008-10#2)
in periwinkles infected with##4##4##(2008-10#4)
in permanent maxillary incisors##2##4##(2013-1#2)
in permanent##11##2##(1995-11#1)(2007-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#4)
in permeability##2##2##(1990-5#1)(2008-11#1)
in permeabilized rat##2##3##(1992-11#2)
in permeabilized##9##2##(1991-8#1)(1992-11#2)(1992-12#1)(1993-8#2)(1994-5#1)(2008-7#2)
in peroxisomal##2##2##(1992-11#1)(2009-10#1)
in peroxisomes##2##2##(1995-2#1)(2013-1#1)
in persimmon##2##2##(2008-10#2)
in persistent pain##3##3##(1996-6#1)(2008-7#2)
in persistent##8##2##(1996-6#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
in person##2##2##(1991-3#1)(2012-1#1)
in personal care products##2##4##(2008-5#2)
in personal care##4##3##(2008-5#4)
in personal moral dilemmas##2##4##(2008-11#2)
in personal moral judgment##2##4##(2008-11#2)
in personal moral##4##3##(2008-11#4)
in personal##13##2##(1993-1#1)(1995-6#1)(1996-8#1)(2008-11#5)(2008-5#4)(2012-3#1)
in personality##2##2##(2007-11#1)(2008-9#1)
in personalized medicine##2##3##(2010-5#1)(2013-8#1)
in personnel##2##2##(1991-2#1)(1994-1#1)
in persons who##2##3##(2008-1#1)(2013-1#1)
in persons with chronic##3##4##(2007-10#1)(2009-4#1)(2013-1#1)
in persons with diabetes##2##4##(1993-6#1)(2008-1#1)
in persons with schizophrenia##4##4##(2008-3#2)(2008-6#1)(2012-12#1)
in persons with##27##3##(1993-2#1)(1993-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
in persons##37##2##(1993-2#1)(1993-6#2)(1995-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#5)(2013-7#1)
in perspective##5##2##(1991-1#1)(2008-4#1)(2011-2#1)(2012-2#2)
in pesticide formulations##6##3##(2008-10#6)
in pesticide##10##2##(1990-9#1)(2008-10#8)(2008-11#1)
in pet##2##2##(1995-9#1)(2012-3#1)
in petri dishes##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
in petri##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
in petrochemical##3##2##(2008-10#2)(2010-12#1)
in petrolatum##2##2##(2008-5#1)(2012-3#1)
in petroleum oils##4##3##(2008-10#4)
in petroleum products##2##3##(2008-10#2)
in petroleum##9##2##(2008-10#7)(2011-2#1)(2013-1#1)
in phagocytes##2##2##(1993-8#1)(1994-8#1)
in phagocytic cells##2##3##(1990-2#1)(2012-2#1)
in phagocytic##5##2##(1990-2#1)(1991-8#1)(2008-10#1)(2012-2#2)
in phakic##2##2##(2011-2#2)
in phantoms and##2##3##(2007-12#1)(2013-1#1)
in phantoms##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
in pharmaceutical analysis##2##3##(1990-8#1)(2008-10#1)
in pharmaceutical and##2##3##(2008-10#1)(2008-11#1)
in pharmaceutical development##2##3##(2008-10#1)(2008-8#1)
in pharmaceutical dosage form##3##4##(2008-10#3)
in pharmaceutical dosage forms and biological fluids##2##7##(2008-10#2)
in pharmaceutical dosage forms##8##4##(2008-10#8)
in pharmaceutical dosage##11##3##(2008-10#11)
in pharmaceutical formulation and##4##4##(2008-10#4)
in pharmaceutical formulation##10##3##(2008-10#10)
in pharmaceutical formulations and biological fluids using##2##7##(2008-10#2)
in pharmaceutical formulations and##5##4##(2008-10#5)
in pharmaceutical formulations by using a##2##6##(2008-10#2)
in pharmaceutical formulations by using##3##5##(2008-10#3)
in pharmaceutical formulations by##6##4##(2008-10#6)
in pharmaceutical formulations is described##3##5##(2008-10#3)
in pharmaceutical formulations is##6##4##(2008-10#6)
in pharmaceutical formulations using a sequential injection##2##7##(2008-10#2)
in pharmaceutical formulations using a##4##5##(2008-10#4)
in pharmaceutical formulations using silicotungstic acid as precipitant reagent##2##9##(2008-10#2)
in pharmaceutical formulations using##12##4##(2008-10#12)
in pharmaceutical formulations with##2##4##(2008-10#2)
in pharmaceutical formulations##65##3##(2008-10#64)(2008-5#1)
in pharmaceutical preparation and##3##4##(2008-10#3)
in pharmaceutical preparation##10##3##(2008-10#10)
in pharmaceutical preparations and biological fluids##5##6##(2008-10#3)(2010-4#2)
in pharmaceutical preparations and the results##2##6##(2008-10#2)
in pharmaceutical preparations and##18##4##(2008-10#16)(2010-4#2)
in pharmaceutical preparations by##9##4##(2008-10#9)
in pharmaceutical preparations in##2##4##(2008-10#2)
in pharmaceutical preparations is##2##4##(2008-10#2)
in pharmaceutical preparations using##6##4##(2008-10#6)
in pharmaceutical preparations##79##3##(2008-10#77)(2010-4#2)
in pharmaceutical products are in##2##5##(2008-10#2)
in pharmaceutical products by micellar electrokinetic chromatography (MEKC) is described##2##10##(2008-10#2)
in pharmaceutical products by##3##4##(2008-10#3)
in pharmaceutical products##14##3##(2008-10#14)
in pharmaceutical samples with##2##4##(2008-10#1)(2012-2#1)
in pharmaceutical samples##8##3##(2008-10#7)(2012-2#1)
in pharmaceutical##216##2##(1990-8#1)(2007-3#1)(2008-10#205)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#2)(2012-2#4)
in pharmaceuticals and biological fluids##3##5##(2008-10#3)
in pharmaceuticals and foods##2##4##(2008-10#2)
in pharmaceuticals and human serum##2##5##(2008-10#2)
in pharmaceuticals and##9##3##(2008-10#9)
in pharmaceuticals using##2##3##(2008-10#2)
in pharmaceuticals with##2##3##(2008-10#2)
in pharmaceuticals##40##2##(1996-2#1)(2008-10#36)(2012-2#3)
in pharmacokinetic study of tibolone##2##5##(2008-10#2)
in pharmacokinetic study of##3##4##(2008-10#2)(2011-3#1)
in pharmacokinetic study##4##3##(2008-10#2)(2011-3#2)
in pharmacokinetic##7##2##(2008-10#3)(2010-10#1)(2011-2#1)(2011-3#2)
in pharmacokinetics##3##2##(2008-5#1)(2008-8#2)
in pharmacological##3##2##(2007-9#1)(2008-10#1)(2009-7#1)
in pharmacology##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
in pharmacotherapy##2##2##(1990-6#1)(2012-2#1)
in pharmacovigilance##4##2##(2008-11#2)(2008-8#2)
in pharmacy##3##2##(2010-3#1)(2011-2#2)
in phase 2##3##3##(1993-3#1)(2007-10#1)(2013-1#1)
in phase I##3##3##(2008-5#2)(2011-2#1)
in phase II clinical trials as a potential treatment for##2##10##(2008-5#2)
in phase II clinical trials##5##5##(2008-5#5)
in phase II clinical##6##4##(2008-5#6)
in phase II trials##4##4##(2007-7#1)(2008-5#3)
in phase II##11##3##(1990-9#1)(2007-7#1)(2008-5#9)
in phase III clinical trials##3##5##(1994-11#1)(2008-11#1)(2008-5#1)
in phase III clinical##4##4##(1994-11#1)(2008-11#1)(2008-5#1)(2011-3#1)
in phase III trials##2##4##(2008-5#2)
in phase III##8##3##(1994-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#3)(2011-3#1)
in phase maps##2##3##(2008-3#2)
in phase##38##2##(1990-9#1)(1993-3#1)(1994-11#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#8)(2008-5#14)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
in phase-change##2##2##(2008-3#2)
in phase-shift keying transmission##2##4##(2007-11#2)
in phase-shifting digital holography##3##4##(2007-11#1)(2008-3#2)
in phase-shifting##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
in phase-stepped##2##2##(2008-3#2)
in phased-array antennas##2##3##(2008-2#1)(2008-3#1)
in pheasant poults##2##3##(1990-6#1)(1992-2#1)
in pheasant##3##2##(1990-6#1)(1992-2#1)(2007-6#1)
in pheasants##2##2##(1996-8#1)(2007-6#1)
in phenotype##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
in phenotypic transformation of##2##4##(1991-12#2)
in phenotypic##9##2##(1991-12#2)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2013-1#1)
in phenotyping##2##2##(1994-3#2)
in philanthropy##2##2##(1992-12#1)(1995-1#1)
in phloem and xylem of##2##5##(2012-8#2)
in phloem of##2##3##(2008-10#1)(2012-8#1)
in phloem tissues##3##3##(2008-10#3)
in phloem##10##2##(2008-10#5)(2008-9#1)(2012-8#4)
in phorbol##2##2##(1990-2#1)(1994-11#1)
in phosphate and acetate buffer##2##5##(2009-10#2)
in phosphate buffer (pH 7##4##5##(1995-5#1)(1997-4#1)(2008-10#2)
in phosphate buffer (pH##6##4##(1995-5#1)(1997-4#1)(2008-10#4)
in phosphate buffer at pH 6##2##6##(2008-10#1)(2008-5#1)
in phosphate buffer at##3##4##(1995-5#1)(2008-10#1)(2008-5#1)
in phosphate buffer pH##2##4##(2008-10#1)(2011-1#1)
in phosphate buffer saline##2##4##(1992-3#1)(2008-10#1)
in phosphate buffer solution##3##4##(2008-10#2)(2009-7#1)
in phosphate buffer with##2##4##(2008-10#2)
in phosphate buffer##30##3##(1990-12#1)(1990-8#1)(1992-10#1)(1992-3#1)(1995-5#3)(1997-4#1)(2008-10#18)(2008-5#1)(2008-6#1)(2009-7#1)(2011-1#1)
in phosphate buffered saline##2##4##(2009-11#1)(2009-9#1)
in phosphate##38##2##(1990-12#1)(1990-8#1)(1992-10#1)(1992-3#1)(1995-5#3)(1995-8#1)(1997-4#1)(2008-1#1)(2008-10#20)(2008-5#1)(2008-6#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-9#1)(2011-1#1)
in phosphatidylcholine and phosphatidylethanolamine molecular species##2##6##(1990-2#2)
in phosphatidylcholine and phosphatidylethanolamine##3##4##(1990-2#2)(1992-8#1)
in phosphatidylcholine##4##2##(1990-2#2)(1992-8#1)(1992-9#1)
in phosphatidylinositol##3##2##(1992-12#1)(1994-3#1)(2008-8#1)
in phosphoenolpyruvate##2##2##(2008-7#1)(2009-9#1)
in phospholipid bilayers##2##3##(1993-11#1)(1994-5#1)
in phospholipid vesicles##2##3##(1991-5#1)(1992-3#1)
in phospholipid##6##2##(1991-5#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-6#1)
in photoaged##2##2##(2008-5#1)(2012-2#1)
in photobleaching##3##2##(2008-1#2)(2011-1#1)
in photochemical##2##2##(1991-12#1)(2008-5#1)
in photodynamic therapy##3##3##(2008-7#2)(2012-3#1)
in photoelastic stress##2##3##(2008-3#2)
in photoelastic##4##2##(2008-3#4)
in photographic##3##2##(2007-11#1)(2008-10#2)
in photon##2##2##(2008-2#2)
in photonic crystal and tapered optical fibers##2##7##(2007-11#2)
in photonic crystal fibers##4##4##(2007-11#1)(2007-12#3)
in photonic crystal##11##3##(2007-11#7)(2007-12#4)
in photonic crystals##4##3##(2007-11#4)
in photonic##18##2##(2007-11#11)(2007-12#4)(2008-3#3)
in photoprotection##2##2##(2011-2#1)(2012-2#1)
in photoreceptors##2##2##(2008-7#1)(2008-9#1)
in photorefractive crystals##5##3##(2007-12#2)(2008-3#3)
in photorefractive strontium barium niobate crystal##2##6##(2007-11#2)
in photorefractive##13##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#4)
in photoresist##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
in photosensitive materials##2##3##(2007-11#1)(2007-12#1)
in photosensitive##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
in photosensitivity##4##2##(2007-12#4)
in photosynthesis##5##2##(2008-10#4)(2012-1#1)
in photosynthetic tissues##4##3##(2008-9#4)
in photosynthetic##11##2##(1996-6#1)(2008-10#1)(2008-7#2)(2008-9#4)(2009-10#1)(2010-2#2)
in photosystem II##2##3##(2008-8#2)
in phototherapy##2##2##(1992-4#1)(2007-11#1)
in phthirapterans##4##2##(2007-12#4)
in phylogenetic analyses##2##3##(1995-11#1)(2008-10#1)
in phylogenetic trees##2##3##(2008-10#1)(2008-7#1)
in phylogenetic##6##2##(1995-11#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-6#1)
in physical activity and##2##4##(2010-1#1)(2011-1#1)
in physical activity##6##3##(2009-6#1)(2010-1#1)(2010-11#2)(2011-1#1)(2012-12#1)
in physical and##3##3##(2010-9#1)(2012-12#1)(2012-3#1)
in physical fitness##2##3##(1991-8#1)(2012-2#1)
in physical function##2##3##(2008-6#1)(2008-7#1)
in physical therapy##2##3##(1996-1#1)(2008-12#1)
in physical##32##2##(1991-8#1)(1992-5#1)(1993-6#1)(1995-6#2)(1996-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
in physically active##2##3##(1992-5#1)(2012-3#1)
in physically##3##2##(1992-5#1)(2009-9#1)(2012-3#1)
in physician payment policy##2##4##(1994-1#2)
in physician payment##3##3##(1994-1#3)
in physician performance##2##3##(2010-9#1)(2013-1#1)
in physician practice##2##3##(1992-12#1)(2010-8#1)
in physician##11##2##(1992-12#1)(1993-1#1)(1994-1#3)(1995-3#1)(2008-10#1)(2008-3#1)(2010-8#1)(2010-9#1)(2013-1#1)
in physician-hospital arrangements##2##3##(1994-3#2)
in physico-chemical properties##3##3##(1990-7#1)(1992-6#1)(1997-7#1)
in physics##3##2##(2008-1#1)(2008-9#1)(2012-2#1)
in physiological and##3##3##(1992-2#1)(2008-10#1)(2011-1#1)
in physiological concentrations##2##3##(2008-10#2)
in physiological conditions##5##3##(1990-7#1)(1990-9#1)(1992-9#1)(2008-10#1)(2012-2#1)
in physiological fluids##2##3##(2008-10#1)(2008-4#1)
in physiological functions##2##3##(2008-7#1)(2013-8#1)
in physiological##31##2##(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-9#1)(1993-3#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#2)
in physiologically##3##2##(1992-7#1)(2008-12#1)(2012-9#1)
in physiology##2##2##(2008-8#1)(2008-9#1)
in physiotherapy practice##2##3##(1991-6#1)(1996-1#1)
in physiotherapy##7##2##(1991-6#1)(1993-1#2)(1994-2#1)(1996-1#1)(2008-3#1)(2012-3#1)
in phytopathogenic##2##2##(2008-10#1)(2009-8#1)
in phytophagous insect##2##3##(2008-9#2)
in phytophagous insects##2##3##(2008-9#2)
in phytophagous##4##2##(2008-9#4)
in phytoplankton##2##2##(2008-8#1)(2008-9#1)
in picosecond##2##2##(2007-11#1)(2007-12#1)
in pig and##3##3##(1990-5#1)(1993-11#1)(2012-2#1)
in pig small intestine##2##4##(1990-11#2)
in pig##12##2##(1990-11#2)(1990-5#1)(1990-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-8#1)
in pigeonpea##4##2##(2010-10#4)
in pigeons##4##2##(1995-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
in piglets##2##2##(2011-2#2)
in pigment##2##2##(2008-8#2)
in pigmentation##2##2##(2008-6#1)(2008-9#1)
in pigmented##3##2##(1992-3#2)(1992-8#1)
in pigments and##2##3##(2008-10#1)(2008-3#1)
in pigments##3##2##(2008-10#1)(2008-3#2)
in pigs in##2##3##(1990-3#1)(2009-5#1)
in pigs##15##2##(1990-3#1)(1990-9#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#4)(2012-3#2)
in pilot scale##4##3##(1994-5#1)(2008-11#3)
in pilot##5##2##(1994-5#1)(2008-11#4)
in pineal##3##2##(1994-2#1)(1995-3#2)
in pinnipeds##3##2##(2008-9#3)
in pitch##2##2##(2008-10#1)(2013-8#1)
in pituitary##6##2##(1990-12#1)(1990-6#1)(1992-12#1)(2010-5#2)(2013-1#1)
in pityriasis versicolor##2##3##(2007-7#2)
in pixel-matched##2##2##(2007-12#1)(2008-3#1)
in place and##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
in place at##2##3##(2008-1#1)(2008-2#1)
in place by##3##3##(1991-1#1)(1991-5#1)(2008-10#1)
in place for##11##3##(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)
in place in##5##3##(1991-1#1)(1991-12#2)(1996-1#1)(2007-12#1)
in place of a##2##4##(1994-8#1)(2008-10#1)
in place of the##9##4##(1995-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-2#1)(2012-3#1)
in place of##24##3##(1991-3#1)(1992-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2012-2#1)(2012-3#1)
in place to##9##3##(1991-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
in place##99##2##(1990-8#1)(1991-1#2)(1991-12#6)(1991-3#3)(1991-5#1)(1992-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-6#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)
in placebo group##2##3##(2012-2#2)
in placebo##3##2##(1995-9#1)(2012-2#2)
in placement##2##2##(1996-2#1)(2011-2#1)
in placenta and##3##3##(1990-2#1)(1990-5#1)(2012-3#1)
in placenta##5##2##(1990-2#1)(1990-5#1)(1994-2#1)(2012-2#1)(2012-3#1)
in places##4##2##(1995-6#1)(2008-12#1)(2008-4#1)(2008-8#1)
in placing##3##2##(1992-8#1)(1995-5#1)(2007-12#1)
in planar BLM##2##3##(1997-7#2)
in planar##11##2##(1990-12#1)(1997-7#2)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#3)(2012-3#1)
in planned##2##2##(2007-11#1)(2008-7#1)
in planning and##3##3##(1995-3#1)(1996-3#1)(2007-12#1)
in planning##21##2##(1991-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-6#2)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#1)(2010-3#1)(2013-1#4)
in plans##2##2##(1994-7#1)(1996-2#1)
in plant and##2##3##(2008-5#1)(2009-8#1)
in plant breeding##3##3##(2008-10#2)(2008-8#1)
in plant cell##2##3##(2009-10#1)(2009-8#1)
in plant cells##16##3##(1994-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#4)(2009-10#2)(2009-6#1)(2009-8#3)(2011-2#1)
in plant defense against##4##4##(1990-12#1)(2008-10#3)
in plant defense##5##3##(1990-12#1)(2008-10#4)
in plant development and##3##4##(2008-9#1)(2009-8#1)(2012-3#1)
in plant development##6##3##(2008-10#1)(2008-9#1)(2009-8#3)(2012-3#1)
in plant disease##6##3##(2008-10#6)
in plant evolution##2##3##(2009-6#2)
in plant extracts##2##3##(2008-10#1)(2013-1#1)
in plant genomes##2##3##(2009-6#1)(2012-3#1)
in plant growth and development##2##5##(2008-9#1)(2011-1#1)
in plant growth and##3##4##(2008-9#1)(2011-1#1)(2013-8#1)
in plant growth##9##3##(2008-10#3)(2008-12#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#2)
in plant material##5##3##(2008-10#5)
in plant pathogens##3##3##(2008-10#2)(2009-8#1)
in plant pathology##11##3##(1992-9#1)(2008-10#10)
in plant physiology##3##3##(2008-10#1)(2008-7#2)
in plant populations##2##3##(2008-9#2)
in plant responses to##3##4##(2008-8#1)(2009-8#2)
in plant responses##4##3##(2008-10#1)(2008-8#1)(2009-8#2)
in plant samples##8##3##(2008-10#8)
in plant tissue##5##3##(1996-12#1)(2008-10#3)(2008-11#1)
in plant tissues##4##3##(1997-2#1)(2008-10#3)
in plant##146##2##(1990-12#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#67)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#7)(2008-9#9)(2009-10#3)(2009-6#4)(2009-8#19)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
in planta and##3##3##(2008-10#3)
in planta wound inoculation##2##4##(2008-10#2)
in planta##50##2##(1997-3#1)(2008-10#41)(2008-9#2)(2009-12#4)(2010-11#1)(2011-2#1)
in plantar##2##2##(2011-2#1)(2012-2#1)
in plants and animals##3##4##(2008-2#1)(2009-3#1)(2009-5#1)
in plants and the##2##4##(1997-3#1)(2011-2#1)
in plants and##12##3##(1997-3#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-3#2)(2009-5#1)(2009-8#1)(2011-2#1)
in plants are##2##3##(1991-11#1)(2008-10#1)
in plants as##2##3##(1997-3#1)(1997-8#1)
in plants at##2##3##(2008-10#2)
in plants by tissue##2##4##(2008-10#2)
in plants by##6##3##(2008-10#6)
in plants can##2##3##(2008-10#1)(2009-8#1)
in plants from##3##3##(2008-10#1)(2009-2#1)(2012-7#1)
in plants grown at low NaCl concentration (10 per thousand)##2##10##(2008-5#2)
in plants grown in the##3##5##(2008-10#3)
in plants grown##6##3##(2008-10#4)(2008-5#2)
in plants has##2##3##(1992-3#1)(2008-8#1)
in plants in##2##3##(2008-10#2)
in plants infected with##4##4##(2008-10#4)
in plants infected##5##3##(2008-10#5)
in plants inoculated with##3##4##(2008-10#2)(2008-12#1)
in plants is limited##2##4##(2008-7#1)(2009-6#1)
in plants is##5##3##(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)
in plants not##2##3##(2008-10#2)
in plants that##2##3##(2008-10#1)(2008-5#1)
in plants was##2##3##(2008-10#1)(2008-8#1)
in plants with##4##3##(2008-10#3)(2009-8#1)
in plants##164##2##(1991-11#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#6)(1997-2#1)(1997-3#5)(1997-8#1)(2008-10#57)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#9)(2008-8#8)(2008-9#7)(2009-10#7)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#9)(2009-8#15)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#1)
in plaque##3##2##(1991-10#1)(1993-11#1)(1993-8#1)
in plaques##3##2##(1991-1#1)(1991-10#2)
in plasma GABA##2##3##(1995-11#2)
in plasma and erythrocytes##2##4##(1991-12#1)(2008-7#1)
in plasma and in##2##4##(1993-2#1)(2008-10#1)
in plasma and of##2##4##(1990-12#1)(2008-8#1)
in plasma and urine by##3##5##(1993-9#1)(2013-1#2)
in plasma and urine##4##4##(1991-12#1)(1993-9#1)(2013-1#2)
in plasma and##25##3##(1990-12#2)(1991-12#3)(1991-5#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-9#2)(1995-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#2)
in plasma are##4##3##(1992-3#1)(1994-12#1)(2008-8#1)(2012-3#1)
in plasma by##5##3##(1990-8#1)(2008-10#2)(2011-3#2)
in plasma cholesterol##2##3##(1994-8#1)(1995-2#1)
in plasma from healthy##2##4##(1992-3#1)(2008-8#1)
in plasma from##5##3##(1992-3#1)(1993-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
in plasma glucose concentration##2##4##(2010-10#2)
in plasma glucose##3##3##(2010-10#2)(2010-7#1)
in plasma have been##2##4##(1993-12#1)(1996-7#1)
in plasma hemolytic complement activity##2##5##(1994-11#2)
in plasma is##8##3##(1990-12#1)(1991-12#1)(1992-9#1)(1993-2#1)(1993-9#1)(2008-10#2)(2008-9#1)
in plasma level of##2##4##(2008-12#1)(2011-2#1)
in plasma levels of##3##4##(1996-12#1)(2008-6#1)(2010-12#1)
in plasma lipid##2##3##(2008-7#1)(2009-5#1)
in plasma lipoproteins##2##3##(1992-12#1)(2012-2#1)
in plasma may##2##3##(1990-12#1)(2012-3#1)
in plasma membrane##3##3##(1990-5#1)(2008-7#1)(2011-2#1)
in plasma membranes##2##3##(1994-2#2)
in plasma of##3##3##(1990-2#1)(2012-2#1)(2013-8#1)
in plasma samples of##2##4##(2008-10#1)(2013-1#1)
in plasma samples##4##3##(1992-11#1)(1997-3#1)(2008-10#1)(2013-1#1)
in plasma vitamin E##2##4##(1990-8#1)(2008-7#1)
in plasma were##3##3##(1996-5#1)(2008-10#2)
in plasma##164##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#6)(1992-6#2)(1992-9#5)(1993-11#1)(1993-12#1)(1993-2#5)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#4)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-12#1)(1996-5#3)(1996-7#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#1)
in plasma-enhanced chemical vapor deposition##2##5##(2008-3#2)
in plasmas##2##2##(1990-12#1)(1992-8#1)
in plasmid##6##2##(1991-7#1)(1993-9#1)(1994-8#1)(2008-4#1)(2008-8#2)
in plastic bags##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
in plastic##8##2##(1992-3#1)(1996-3#1)(2008-10#4)(2008-5#1)(2011-2#1)
in plasticised PVC##2##3##(2008-10#2)
in plasticized PVC membranes##2##4##(2008-10#2)
in plasticized PVC##5##3##(2008-10#5)
in plasticized poly(vinyl chloride)##3##4##(2008-10#3)
in plasticized##10##2##(2008-10#10)
in plastids##4##2##(2008-10#1)(2008-9#3)
in plate assays##2##3##(2008-10#2)
in plate##4##2##(2008-10#3)(2008-3#1)
in platelet activation##3##3##(1992-8#1)(2011-2#2)
in platelet aggregation##2##3##(1991-12#1)(2008-4#1)
in platelet count and##2##4##(2007-10#1)(2008-10#1)
in platelet counts and##2##4##(2007-10#1)(2010-3#1)
in platelet counts##5##3##(1990-10#1)(2007-10#2)(2010-3#2)
in platelet##25##2##(1990-10#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-8#1)(1995-11#1)(1995-3#1)(1997-7#1)(2006-6#2)(2007-10#3)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#2)(2011-1#1)(2011-2#4)
in platelet-derived##2##2##(1995-2#1)(2008-11#1)
in platelet-rich plasma (PRP)##2##4##(1997-7#1)(2008-7#1)
in platelet-rich plasma##4##3##(1991-12#1)(1995-5#1)(1997-7#1)(2008-7#1)
in platelets and its##2##4##(1992-12#1)(1995-11#1)
in platelets and##3##3##(1992-12#2)(1995-11#1)
in platelets from##2##3##(1991-12#1)(1996-7#1)
in platelets of##2##3##(1995-11#1)(1996-7#1)
in platelets##22##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#4)(1992-6#2)(1993-11#1)(1995-11#3)(1995-12#1)(1996-7#2)(2008-3#1)(2008-4#1)(2011-1#3)
in play##2##2##(2009-6#1)(2013-1#1)
in pleural##3##2##(1991-12#1)(2007-12#1)(2012-2#1)
in plots irrigated with saline water##2##6##(2008-10#2)
in plots receiving##2##3##(2008-10#2)
in plots where##4##3##(2008-10#4)
in plots with##2##3##(2008-10#2)
in plots##16##2##(2008-10#14)(2008-12#1)(2008-6#1)
in poeciliid fishes##2##3##(2008-8#2)
in polar non aqueous solvents##2##5##(2008-10#2)
in polar##10##2##(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)
in polarity##2##2##(2008-10#2)
in polarization##5##2##(2008-3#5)
in polarization-maintaining##2##2##(2007-11#2)
in polarized fluorescence##2##3##(2007-11#2)
in polarized##6##2##(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#1)
in police##5##2##(2010-1#4)(2012-3#1)
in policy development##2##3##(1994-2#1)(1995-2#1)
in policy##9##2##(1993-3#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#1)
in policymaking##2##2##(2007-3#1)(2010-4#1)
in political##5##2##(1996-3#2)(1997-2#1)(2008-7#1)(2012-2#1)
in pollen grains and pollen tubes##2##6##(2008-8#2)
in pollen tubes##2##3##(2009-10#2)
in pollen wasps##3##3##(2007-12#3)
in pollen##11##2##(2007-12#3)(2008-10#1)(2008-8#2)(2009-10#4)(2012-7#1)
in pollination##2##2##(2008-8#1)(2008-9#1)
in polluted##5##2##(2008-10#3)(2008-11#2)
in pollution##2##2##(2008-10#2)
in poly##2##2##(2008-10#1)(2008-12#1)
in poly(methyl methacrylate)##2##3##(2008-3#1)(2010-4#1)
in poly(vinyl chloride) membrane electrodes##2##5##(2008-10#2)
in poly(vinyl chloride)##4##3##(2008-10#4)
in poly(vinyl##5##2##(2008-10#4)(2010-5#1)
in polyacrylamide gel##4##3##(1996-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
in polyacrylamide##9##2##(1992-3#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-9#1)(2013-1#1)
in polycystic##2##2##(2008-4#1)(2011-1#1)
in polyelectrolyte-ELISA and##2##3##(2008-10#2)
in polyethylene##2##2##(2008-7#2)
in polygenic##2##2##(1991-2#1)(2012-3#1)
in polylactide##2##2##(2008-6#1)(2009-12#1)
in polymer films##3##3##(2007-11#2)(2008-3#1)
in polymer matrices##2##3##(2008-3#2)
in polymer##15##2##(1993-11#1)(1995-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)(2011-2#1)
in polymerase chain reactions##3##4##(1993-8#1)(1997-4#1)(2008-10#1)
in polymerase chain##4##3##(1993-8#1)(1997-4#1)(2008-10#2)
in polymeric##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
in polymerization contraction force values##2##5##(2008-12#2)
in polymers##4##2##(1995-3#1)(2007-11#2)(2008-2#1)
in polyploid##2##2##(2012-3#2)
in polypropylene##2##2##(2008-10#1)(2012-3#1)
in polystyrene layer##2##3##(2008-10#2)
in polystyrene##4##2##(2008-10#3)(2008-11#1)
in polytetrafluoroethylene##2##2##(2007-7#1)(2008-10#1)
in polyvinyl##2##2##(2008-10#1)(2008-3#1)
in pome fruit##2##3##(2011-2#2)
in poor responders##2##3##(2012-3#2)
in poor##12##2##(1990-2#1)(1990-5#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
in poor-prognosis##2##2##(2009-11#1)(2010-3#1)
in poorer##4##2##(1994-1#1)(1995-12#1)(2008-11#1)(2009-9#1)
in poorly differentiated##2##3##(1993-9#1)(2008-9#1)
in poorly##5##2##(1993-9#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#1)
in popularity##5##2##(1992-11#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
in population and##3##3##(1991-2#1)(2008-1#1)(2010-8#1)
in population density and##3##4##(2008-8#2)(2008-9#1)
in population density##7##3##(1994-5#1)(2008-8#5)(2008-9#1)
in population growth rate and##2##5##(2008-8#1)(2008-9#1)
in population growth rate##3##4##(2008-8#2)(2008-9#1)
in population of##2##3##(2008-7#1)(2013-7#1)
in population over 65 years old##2##6##(2011-2#2)
in population over 65 years##3##5##(2011-2#3)
in population size##8##3##(1996-6#2)(2008-12#1)(2008-8#5)
in population##39##2##(1991-2#1)(1992-1#1)(1994-5#1)(1994-8#1)(1996-6#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#13)(2008-9#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
in population-based##2##2##(2008-1#1)(2013-8#1)
in populations and##2##3##(2007-12#1)(2008-3#1)
in populations from##2##3##(2008-10#1)(2012-7#1)
in populations living near nuclear facilities##2##6##(1991-3#2)
in populations living##3##3##(1991-3#2)(2007-5#1)
in populations of C##3##4##(2008-10#3)
in populations of##17##3##(2008-10#12)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)
in populations where##2##3##(1996-11#1)(2008-8#1)
in populations with##4##3##(1992-2#1)(2006-10#1)(2007-10#1)(2010-5#1)
in populations##39##2##(1991-3#2)(1992-2#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#16)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-7#1)
in porcine brain##6##3##(1990-7#5)(1996-12#1)
in porcine coronary artery##2##4##(1992-9#2)
in porcine coronary##3##3##(1992-9#2)(1994-11#1)
in porcine platelets##3##3##(1992-6#2)(1993-11#1)
in porcine serum##3##3##(1991-12#3)
in porcine##27##2##(1990-7#6)(1991-11#1)(1991-12#3)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1994-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-8#1)(2013-1#2)(2013-7#1)
in pore##3##2##(1994-2#2)(2011-1#1)
in pore-forming##2##2##(1994-2#1)(2012-12#1)
in porous carriers##2##3##(2008-11#2)
in porous##5##2##(1992-11#1)(2008-11#3)(2008-7#1)
in portable##2##2##(1992-2#1)(2008-2#1)
in portal pressure##2##3##(1991-5#1)(1993-3#1)
in portal##6##2##(1991-5#1)(1993-3#1)(1994-7#1)(2009-8#1)(2009-9#1)(2010-12#1)
in position##12##2##(1990-12#1)(1992-1#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-2#2)(2008-5#1)(2009-11#2)(2013-1#1)
in positional##2##2##(2008-7#1)(2012-3#1)
in positions of##2##3##(2011-2#1)(2013-1#1)
in positions##5##2##(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#2)
in positive ion##2##3##(2008-10#2)
in positive##13##2##(1995-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
in possessing a##2##3##(2008-7#2)
in post##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-9#1)
in post-Katrina New Orleans##4##4##(2012-2#4)
in post-menopausal women##4##3##(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
in post-menopausal##8##2##(2008-10#1)(2008-11#3)(2008-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
in post-mortem##4##2##(1992-3#2)(2008-7#1)(2009-12#1)
in post-translational modification##2##3##(2008-8#1)(2013-1#1)
in post-translational##3##2##(1992-8#1)(2008-8#1)(2013-1#1)
in post-transplant##3##2##(2008-10#1)(2008-4#2)
in post-traumatic stress disorder##2##4##(2008-6#2)
in post-war##2##2##(1996-8#1)(2013-8#1)
in posterior urethral##2##3##(2008-10#2)
in posterior##5##2##(2007-12#1)(2008-10#2)(2008-12#1)(2010-5#1)
in postgraduate dental education##2##4##(2013-1#2)
in postgraduate##4##2##(2007-7#1)(2013-1#3)
in postlingually##2##2##(2008-9#2)
in postmenopausal breast cancer##2##4##(1993-11#1)(2012-3#1)
in postmenopausal patients##3##3##(1991-12#1)(1994-12#1)(2007-5#1)
in postmenopausal women##13##3##(1992-1#2)(1992-3#2)(1994-9#1)(2008-11#1)(2008-3#3)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
in postmenopausal##22##2##(1991-12#1)(1992-1#2)(1992-3#2)(1993-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(2007-5#1)(2008-11#1)(2008-3#3)(2008-5#1)(2010-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
in postmitotic##2##2##(1994-5#1)(1995-5#1)
in postmortem human brain of suicide victims##2##7##(2008-7#2)
in postmortem human brain##3##4##(1995-12#1)(2008-7#2)
in postmortem##5##2##(1993-9#1)(1995-12#1)(2008-7#2)(2012-2#1)
in postnatal##5##2##(1990-11#1)(1991-2#1)(2008-12#1)(2010-4#1)(2012-2#1)
in postoperative patients##2##3##(2011-2#2)
in postoperative##18##2##(1991-11#1)(1991-5#1)(1992-3#1)(1993-5#1)(1994-3#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-11#1)(2009-2#1)(2010-8#1)(2011-2#4)(2012-1#2)(2013-1#1)
in postpartum##2##2##(1996-11#1)(1996-12#1)
in poststroke patients##2##3##(2008-2#1)(2013-1#1)
in poststroke##3##2##(2008-2#1)(2013-1#2)
in postsynaptic##6##2##(1995-2#1)(2008-11#1)(2009-8#1)(2012-12#2)(2012-2#1)
in posttraining performance##2##3##(1993-5#2)
in posttraumatic stress disorder patients with substance abuse histories##2##9##(1996-5#2)
in posttraumatic##3##2##(1996-5#2)(2008-9#1)
in pot experiments##2##3##(2008-10#2)
in potable water##3##3##(2008-10#3)
in potassium hydroxide solution##2##4##(2008-10#2)
in potassium hydroxide##3##3##(2008-10#3)
in potassium ion##2##3##(2008-10#1)(2008-6#1)
in potassium titanyl phosphate##3##4##(2007-11#1)(2007-12#2)
in potassium##12##2##(2007-11#1)(2007-12#3)(2008-10#7)(2008-6#1)
in potato cv##2##3##(2008-10#2)
in potato dextrose broth##3##4##(2008-10#3)
in potato fields##2##3##(2008-10#2)
in potato tuber##3##3##(2008-10#3)
in potato##21##2##(2008-10#18)(2008-12#1)(2009-6#2)
in potency##3##2##(1992-3#1)(1994-6#1)(2008-8#1)
in potential##12##2##(1994-12#1)(2008-10#10)(2008-2#1)
in potentially##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-4#1)
in potentiometric titration of##11##4##(2008-10#11)
in potentiometric titrations of##3##4##(2008-10#3)
in potentiometric titrations##6##3##(2008-10#6)
in potentiometric##20##2##(2008-10#20)
in pots##3##2##(2008-10#2)(2008-12#1)
in potting mixtures##2##3##(2008-10#2)
in potting##4##2##(2008-10#4)
in poultry##7##2##(1990-6#1)(2007-6#1)(2008-9#1)(2010-2#1)(2010-4#2)(2010-7#1)
in poults fed greater than or equal to 50##2##9##(2008-5#2)
in poults fed##4##3##(2008-5#4)
in poverty##6##2##(1995-1#1)(2008-11#4)(2008-8#1)
in powder##4##2##(2008-10#3)(2012-2#1)
in powdered##2##2##(2008-10#1)(2009-8#1)
in power##13##2##(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#2)(2010-12#1)(2010-9#1)(2011-2#1)
in practical applications##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
in practical terms##2##3##(1990-11#1)(2007-12#1)
in practical##12##2##(1990-11#1)(1994-1#1)(1995-6#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)
in practically all##2##3##(1991-11#1)(2008-3#1)
in practice and##5##3##(1993-12#1)(2007-10#1)(2008-11#1)(2008-12#2)
in practice are##2##3##(2008-11#1)(2010-12#1)
in practice has been##2##4##(2008-11#2)
in practice is##2##3##(2008-12#1)(2008-9#1)
in practice management##3##3##(1991-12#1)(1994-3#2)
in practice placements##2##3##(2008-11#2)
in practice settings##3##3##(2008-11#3)
in practice the##2##3##(2008-11#1)(2008-3#1)
in practice##104##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-9#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#36)(2008-12#12)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in practice]##2##2##(1993-2#1)(1994-8#1)
in prairie and##2##3##(2008-8#1)(2008-9#1)
in prairie##3##2##(2008-8#2)(2008-9#1)
in pre##2##2##(2007-11#1)(2012-12#1)
in pre- and postsynaptic##3##4##(2009-8#1)(2009-9#2)
in pre-clinical models##2##3##(2009-4#1)(2011-2#1)
in pre-clinical studies##2##3##(1994-11#1)(2011-2#1)
in pre-clinical##6##2##(1994-11#2)(2009-4#1)(2011-2#2)(2013-1#1)
in pre-operative assessment##2##3##(2011-2#2)
in pre-registration##5##2##(2008-11#4)(2012-3#1)
in pre-term infants##2##3##(1995-8#2)
in pre-term##3##2##(1995-8#2)(2011-1#1)
in pre-treatment##2##2##(2008-1#1)(2013-1#1)
in preadipocytes and adipocytes##2##4##(1993-6#2)
in preantral and##2##3##(2008-8#2)
in precise##2##2##(1997-7#1)(2008-7#1)
in precisely##2##2##(2008-10#1)(2011-2#1)
in precision##5##2##(2008-10#4)(2009-11#1)
in preclinical models##2##3##(2009-3#1)(2010-11#1)
in preclinical studies##3##3##(2008-5#1)(2010-10#1)(2012-12#1)
in preclinical##11##2##(2007-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in preconcentration##2##2##(2008-10#2)
in preconditioned##2##2##(1996-9#2)
in predialysis patients##2##3##(2008-1#2)
in predialysis period##2##3##(2008-7#2)
in predialysis##5##2##(2008-1#2)(2008-7#3)
in predicting long term##2##4##(2013-1#2)
in predicting the outcome##2##4##(2008-9#1)(2012-3#1)
in predicting the presence of##2##5##(2008-12#1)(2013-8#1)
in predicting the prognosis##2##4##(2011-3#1)(2013-1#1)
in predicting the risk of##2##5##(1994-3#1)(2008-5#1)
in predicting the##22##3##(1991-4#1)(1994-3#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
in predicting##63##2##(1991-11#1)(1991-4#1)(1992-3#2)(1994-3#1)(1995-11#1)(1996-12#1)(1996-6#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#3)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
in prediction of##5##3##(1994-12#1)(1994-3#1)(2008-10#2)(2010-11#1)
in prediction##6##2##(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#1)(2010-11#1)
in predisposing##2##2##(2008-10#1)(2011-2#1)
in predominantly##4##2##(2007-12#1)(2010-12#1)(2011-1#1)(2012-3#1)
in preexisting cavities in wood##2##5##(2008-6#2)
in preexisting##3##2##(2008-6#3)
in preference to##4##3##(2007-11#1)(2008-9#2)(2012-12#1)
in preference##5##2##(1995-2#1)(2007-11#1)(2008-9#2)(2012-12#1)
in pregnancies with##3##3##(1996-12#1)(2012-12#2)
in pregnancies##4##2##(1995-6#1)(1996-12#1)(2012-12#2)
in pregnancy and lactation##2##4##(2008-11#1)(2008-7#1)
in pregnancy and##10##3##(1991-11#1)(2007-2#1)(2008-11#3)(2008-4#1)(2008-7#1)(2012-3#3)
in pregnancy has been##2##4##(1990-6#1)(1995-6#1)
in pregnancy has##4##3##(1990-6#1)(1995-6#1)(2008-7#2)
in pregnancy in##2##3##(2008-4#1)(2013-1#1)
in pregnancy is##4##3##(1990-9#1)(2008-7#1)(2013-1#2)
in pregnancy##81##2##(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1994-3#3)(1994-9#1)(1995-12#1)(1995-6#4)(1995-8#2)(1996-11#1)(1996-3#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#6)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#4)(2008-7#8)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-3#6)(2012-8#3)(2013-1#6)(2013-8#1)
in pregnancy-induced hypertension##6##3##(1990-3#2)(2011-2#3)(2012-2#1)
in pregnancy-induced##7##2##(1990-3#2)(1994-3#1)(2011-2#3)(2012-2#1)
in pregnancy]##7##2##(1991-3#1)(1993-9#1)(1994-6#1)(1996-11#3)(2013-1#1)
in pregnant women in##2##4##(1990-6#1)(2012-12#1)
in pregnant women with##2##4##(2008-11#1)(2011-1#1)
in pregnant women##16##3##(1990-6#1)(1991-1#1)(1993-12#1)(1993-9#1)(1994-6#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
in pregnant##24##2##(1990-6#1)(1991-1#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-6#1)(2007-12#1)(2007-2#2)(2007-7#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in preimplantation##3##2##(1995-2#1)(2008-5#2)
in preliminary##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
in prelingually deafened children with cochlear##2##6##(2008-9#2)
in prelingually deafened children##3##4##(2008-9#3)
in premature and##2##3##(1990-8#1)(2010-10#1)
in premature infants##5##3##(1996-6#1)(2007-11#3)(2013-1#1)
in premature##8##2##(1990-8#1)(1996-11#1)(1996-6#1)(2007-11#3)(2010-10#1)(2013-1#1)
in premenopausal breast cancer##2##4##(1991-4#1)(1992-12#1)
in premenopausal patients##2##3##(1997-7#1)(2007-5#1)
in premenopausal##9##2##(1991-4#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1997-7#1)(2007-5#2)(2010-6#1)
in premolars and molars##2##4##(2009-2#2)
in premolars##3##2##(2009-2#3)
in prenatal care##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
in prenatal diagnosis##3##3##(1996-12#1)(1997-3#1)(2012-2#1)
in prenatal##9##2##(1993-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#2)
in preoperative##9##2##(1994-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#4)(2012-1#1)
in preovulatory follicles##3##3##(2008-8#3)
in prepaid plans##2##3##(1991-2#2)
in prepaid##3##2##(1991-2#2)(1994-2#1)
in preparation for the##2##4##(1994-1#1)(2011-2#1)
in preparation for##9##3##(1994-1#1)(1995-11#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
in preparation##13##2##(1992-3#1)(1994-1#1)(1995-11#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
in preparations of##3##3##(1997-8#1)(2008-1#1)(2008-4#1)
in preparations##6##2##(1992-5#2)(1995-5#1)(1997-8#1)(2008-1#1)(2008-4#1)
in preparing for##3##3##(1992-1#1)(1995-3#1)(2012-3#1)
in preparing the##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
in preparing##11##2##(1992-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
in prepubertal male calves##2##4##(2013-1#2)
in prepubertal##4##2##(2008-4#1)(2012-3#1)(2013-1#2)
in preschool children##5##3##(2008-11#2)(2011-1#2)(2013-1#1)
in preschool##6##2##(2008-11#2)(2011-1#2)(2012-12#1)(2013-1#1)
in prescribing##6##2##(1996-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-9#1)
in prescription drug##2##3##(1995-1#2)
in prescription##4##2##(1993-1#1)(1995-1#2)(1995-11#1)
in presence of 1##3##4##(1992-12#1)(2008-10#2)
in presence of PMS##3##4##(2008-10#3)
in presence of a##3##4##(2008-10#3)
in presence of hydrogen peroxide catalyses the oxidation of##2##9##(2008-10#2)
in presence of hydrogen peroxide##3##5##(2008-10#3)
in presence of interfering ions##2##5##(2008-10#2)
in presence of other##2##4##(2008-10#2)
in presence of the##2##4##(2008-10#2)
in presence of thiols##2##4##(2010-11#2)
in presence of##85##3##(1991-8#1)(1992-12#1)(1994-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-7#1)(2008-10#62)(2008-11#4)(2008-3#1)(2008-7#2)(2010-11#3)(2011-2#2)(2012-2#2)(2013-1#2)
in presence##87##2##(1991-8#1)(1992-12#1)(1994-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-7#1)(2008-10#63)(2008-11#5)(2008-3#1)(2008-7#2)(2010-11#3)(2011-2#2)(2012-2#2)(2013-1#2)
in presensitized##2##2##(2007-12#2)
in present##5##2##(1992-3#1)(2008-12#1)(2010-3#1)(2010-8#1)(2012-3#1)
in presentation of##4##3##(1997-4#1)(2008-4#1)(2010-12#1)(2012-2#1)
in presentation##8##2##(1997-4#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
in preserving alveolar ridge dimensions following tooth extraction##2##8##(2007-12#2)
in preserving##6##2##(2007-12#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
in press]##3##2##(1990-5#1)(2008-10#2)
in pressure##8##2##(1996-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-1#1)
in presumed##2##2##(1993-12#1)(2006-5#1)
in presynaptic##3##2##(1996-12#2)(2009-9#1)
in preteen and teen patients##3##5##(2013-1#3)
in preterm infants with##2##4##(1990-12#1)(2013-1#1)
in preterm infants##9##3##(1990-12#1)(1993-12#2)(1993-2#3)(2011-2#2)(2013-1#1)
in preterm labor##2##3##(2011-2#1)(2012-3#1)
in preterm##17##2##(1990-12#2)(1992-4#1)(1993-12#2)(1993-2#3)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
in pretreated advanced breast cancer##2##5##(1993-2#1)(1994-8#1)
in pretreated metastatic breast cancer##2##5##(1991-6#1)(1993-8#1)
in pretreated##5##2##(1991-6#1)(1993-2#1)(1993-8#1)(1994-8#2)
in prevalence in##3##3##(1995-9#1)(2008-10#1)(2012-2#1)
in prevalence of##6##3##(1990-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
in prevalence with age##2##4##(2008-7#1)(2013-1#1)
in prevalence##20##2##(1990-2#1)(1990-3#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
in preventing acute##2##3##(1990-6#1)(2008-3#1)
in preventing and##3##3##(2007-11#1)(2010-8#1)(2013-7#1)
in preventing cardiovascular##2##3##(1993-2#1)(2008-8#1)
in preventing diarrhea##2##3##(1991-3#1)(1992-12#1)
in preventing postoperative shivering##2##4##(2010-7#2)
in preventing the##8##3##(1991-9#1)(1992-12#1)(2008-1#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
in preventing##72##2##(1990-6#3)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)
in prevention and treatment of##2##5##(2011-2#1)(2011-3#1)
in prevention and treatment##4##4##(1995-1#1)(2008-8#1)(2011-2#1)(2011-3#1)
in prevention and##7##3##(1995-1#1)(2007-7#1)(2008-7#2)(2008-8#1)(2011-2#1)(2011-3#1)
in prevention of postoperative##2##4##(2012-3#2)
in prevention of##17##3##(1991-11#1)(1991-3#1)(1993-11#2)(1994-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#2)
in prevention programs##2##3##(1995-12#1)(2009-7#1)
in prevention##30##2##(1991-11#1)(1991-3#1)(1993-11#2)(1994-9#2)(1995-1#1)(1995-12#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#2)(2011-3#2)(2012-3#3)(2013-1#2)
in preventive health##2##3##(2009-5#2)
in preventive services##2##3##(1995-12#1)(2009-5#1)
in preventive##7##2##(1991-11#1)(1994-2#1)(1995-12#1)(2007-2#1)(2009-5#3)
in preverbal children##2##3##(2008-9#2)
in previous experiments##2##3##(1994-5#1)(2008-10#1)
in previous investigations##2##3##(2008-3#2)
in previous literature##2##3##(2008-11#1)(2013-2#1)
in previous papers##2##3##(2008-10#1)(2008-2#1)
in previous research##3##3##(2007-2#1)(2009-7#1)(2012-12#1)
in previous studies and##2##4##(1994-12#1)(2008-10#1)
in previous studies##19##3##(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
in previous work##3##3##(2008-10#2)(2008-7#1)
in previous years##3##3##(1990-12#1)(1996-3#1)(2008-8#1)
in previous##52##2##(1990-12#1)(1990-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-7#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-2#1)
in previously reported##3##3##(1994-5#2)(2008-3#1)
in previously untreated patients##2##4##(2007-7#1)(2008-7#1)
in previously untreated##4##3##(2007-7#1)(2008-7#2)(2013-1#1)
in previously##16##2##(1993-6#1)(1994-12#1)(1994-5#2)(2006-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
in previtellogenic##2##2##(2008-8#2)
in prey##5##2##(1995-12#1)(2008-9#3)(2010-8#1)
in primary afferent##4##3##(1990-5#1)(1993-12#1)(2008-4#1)(2008-7#1)
in primary and recurrent##2##4##(1990-9#1)(2012-1#1)
in primary and secondary##2##4##(2011-2#1)(2012-3#1)
in primary and##6##3##(1990-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
in primary auditory cortex##2##4##(1996-2#1)(2008-11#1)
in primary biliary cirrhosis##2##4##(1992-9#1)(1993-5#1)
in primary breast##2##3##(1994-8#1)(2007-5#1)
in primary care and##2##4##(1993-5#1)(2012-1#1)
in primary care settings##4##4##(2008-11#2)(2009-12#1)(2009-9#1)
in primary care##55##3##(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-8#3)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-12#1)(2009-9#2)(2010-4#2)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
in primary care?]##3##3##(1995-5#1)(1996-11#1)(1997-6#1)
in primary care]##25##3##(1993-11#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#3)(1996-6#2)(1996-9#2)
in primary cell cultures##2##4##(1996-12#1)(2008-7#1)
in primary chicken##2##3##(1994-8#1)(2008-11#1)
in primary culture and##2##4##(1990-12#1)(1993-8#1)
in primary culture express##2##4##(1991-5#1)(1993-3#1)
in primary culture of adult rat hepatocytes##2##7##(1993-8#2)
in primary culture of##4##4##(1992-3#1)(1993-8#2)(2013-1#1)
in primary culture##14##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-8#3)(2008-6#1)(2013-1#1)
in primary cultured human preadipocytes##2##5##(2008-5#2)
in primary cultured##4##3##(1993-6#1)(2008-5#3)
in primary cultures of mouse##3##5##(1990-5#1)(1994-2#2)
in primary cultures of rat##4##5##(1997-6#2)(2008-11#1)(2008-4#1)
in primary cultures of##15##4##(1990-12#1)(1990-5#1)(1992-9#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-5#1)(1997-6#2)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)
in primary cultures##16##3##(1990-12#1)(1990-5#1)(1992-9#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-6#2)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)
in primary health care##16##4##(1992-11#1)(1993-6#1)(1994-3#2)(1995-11#1)(1995-5#2)(1997-4#1)(2007-8#1)(2011-1#1)(2011-2#5)(2012-3#1)
in primary health care]##6##4##(1992-11#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-5#1)(1997-8#1)
in primary health##23##3##(1992-11#2)(1993-3#1)(1993-6#1)(1994-3#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-8#1)(2011-1#1)(2011-2#5)(2012-3#1)
in primary healthcare##5##3##(2008-10#1)(2009-3#2)(2011-2#1)(2012-12#1)
in primary human##6##3##(1992-8#1)(1997-7#1)(2008-11#1)(2008-9#1)(2012-5#1)(2013-1#1)
in primary lung cancer##2##4##(1992-3#1)(1993-8#1)
in primary molars##2##3##(2008-12#2)
in primary prevention groups##2##4##(2010-12#2)
in primary prevention##3##3##(1997-8#1)(2010-12#2)
in primary teeth##3##3##(2010-3#2)(2011-2#1)
in primary total hip arthroplasty##3##5##(2008-8#3)
in primary total hip##4##4##(1996-9#1)(2008-8#3)
in primary visual cortex##4##4##(1995-11#1)(2008-11#2)(2008-7#1)
in primary##236##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#3)(1992-3#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#4)(1993-5#4)(1993-6#4)(1993-8#5)(1993-9#4)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#5)(1995-11#5)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#1)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#7)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#15)(2008-12#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#2)(2009-8#1)(2009-9#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#3)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
in primate##5##2##(1993-5#1)(1994-12#1)(1995-3#1)(1997-2#1)(2012-3#1)
in primates##10##2##(1993-9#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-3#2)(2012-3#3)
in priming##5##2##(1995-2#2)(2008-10#2)(2012-2#1)
in primiparous mothers##2##3##(1992-5#2)
in principle and##2##3##(1992-3#1)(2008-2#1)
in principle be##2##3##(2007-12#1)(2008-8#1)
in principle##30##2##(1990-8#1)(1992-3#2)(1993-3#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
in prison for##4##3##(1996-5#1)(1997-5#3)
in prison##8##2##(1992-2#1)(1996-5#4)(1997-5#3)
in private health##2##3##(1997-3#1)(2008-7#1)
in private hospitals##3##3##(1992-2#1)(2007-7#2)
in private practice##9##3##(1992-10#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2008-4#1)(2008-8#1)(2009-10#1)
in private psychiatric##2##3##(1993-2#1)(2012-2#1)
in private schools##4##3##(2008-9#4)
in private##30##2##(1990-6#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-1#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2012-2#1)(2013-8#2)
in pro-active safety surveillance##2##4##(2008-11#2)
in probable##2##2##(2007-11#1)(2008-7#1)
in probe angle##2##3##(1994-5#2)
in problem solving##4##3##(1992-1#1)(1992-2#1)(2008-10#1)(2008-2#1)
in problem##6##2##(1992-1#1)(1992-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-7#1)
in procedures##3##2##(2008-10#1)(2009-9#1)(2011-2#1)
in process of##2##3##(1990-10#1)(2008-8#1)
in process##9##2##(1990-10#1)(1993-12#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-8#2)
in processed##2##2##(2007-10#1)(2008-10#1)
in processes##6##2##(1996-5#1)(1997-3#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
in processing##14##2##(1991-2#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
in prodromal##2##2##(2011-8#2)
in producing a##2##3##(2008-12#1)(2011-2#1)
in producing the##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
in producing##26##2##(1990-6#1)(1992-12#1)(1994-9#1)(1995-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#2)(2011-2#2)(2012-2#1)(2013-1#5)
in product yield##2##3##(1997-6#1)(2008-11#1)
in product##7##2##(1997-6#1)(2008-11#2)(2008-5#2)(2008-7#1)(2013-1#1)
in production of##11##3##(1990-5#1)(1990-8#1)(1992-9#1)(1995-2#1)(2008-10#5)(2008-12#1)(2008-4#1)
in production##21##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-9#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
in productivity##8##2##(1992-3#1)(1994-1#1)(1995-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)
in products##5##2##(2008-10#4)(2012-2#1)
in professional education##2##3##(2008-12#2)
in professional soccer players##2##4##(2008-5#1)(2010-3#1)
in professional##7##2##(2008-11#1)(2008-12#3)(2008-5#1)(2010-10#1)(2010-3#1)
in profile##4##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
in profoundly deaf children##2##4##(2008-9#2)
in profoundly##3##2##(2008-5#1)(2008-9#2)
in progenies of##2##3##(2008-10#2)
in progeny derived from the cross between##2##7##(2008-10#2)
in progeny derived from##3##4##(2008-10#3)
in progeny##7##2##(2008-10#6)(2012-3#1)
in prognostic##3##2##(2008-10#1)(2008-7#2)
in program decision making##2##4##(1995-3#2)
in program design##2##3##(1995-1#1)(1997-2#1)
in program##8##2##(1995-1#3)(1995-3#2)(1996-1#1)(1997-2#1)(2013-1#1)
in programmable##2##2##(2007-11#1)(2008-2#1)
in programming##6##2##(1991-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)
in programs##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-5#1)
in progress or##3##3##(1997-8#1)(2008-10#1)(2011-1#1)
in progress to##5##3##(1997-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2011-1#1)
in progress##30##2##(1990-3#1)(1991-2#1)(1992-10#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2010-10#1)(2011-1#3)(2011-2#1)(2012-12#1)
in progressing##2##2##(1996-12#1)(2008-9#1)
in progression of##4##3##(2008-1#3)(2010-3#1)
in progression##5##2##(1994-8#1)(2008-1#3)(2010-3#1)
in progressive liver##2##3##(2009-5#1)(2012-2#1)
in progressive##8##2##(1994-3#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
in prokaryotic##6##2##(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
in proliferating and quiescent cultures of murine##2##7##(1992-3#2)
in proliferating##7##2##(1991-11#1)(1992-3#2)(1992-6#1)(1994-6#1)(1994-9#1)(2009-8#1)
in proliferation of##4##3##(1991-3#1)(1992-2#1)(1993-8#1)(1996-3#1)
in proliferation##13##2##(1991-3#1)(1992-2#1)(1993-12#1)(1993-8#3)(1995-11#1)(1996-3#1)(1997-6#1)(2008-11#1)(2008-4#1)(2009-12#1)(2012-3#1)
in proliferative##4##2##(2008-6#1)(2008-7#1)(2010-12#1)(2012-1#1)
in prolonged##5##2##(1994-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
in prolonging survival in patients##2##5##(1994-7#1)(2008-7#1)
in prolonging##6##2##(1994-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
in promoter##4##2##(1991-6#1)(1996-12#1)(2008-9#1)(2012-3#1)
in promoting the##4##3##(1992-2#1)(1994-3#2)(2009-10#1)
in promoting##28##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-3#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)
in proper##5##2##(2007-7#1)(2008-10#2)(2008-5#1)(2013-1#1)
in properly selected##2##3##(2007-8#1)(2010-8#1)
in properly##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
in properties##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#2)
in prophase##2##2##(1991-5#1)(1992-11#1)
in prophylactic##2##2##(1990-2#1)(1995-5#1)
in prophylaxis and##2##3##(1993-2#1)(2008-7#1)
in prophylaxis##3##2##(1993-2#1)(2007-11#1)(2008-7#1)
in proportion of##4##3##(1992-12#1)(2008-10#2)(2012-3#1)
in proportion to the concentration of##6##6##(1994-8#1)(2008-10#4)(2010-3#1)
in proportion to the##11##4##(1992-6#1)(1994-8#1)(2008-10#5)(2008-5#1)(2008-7#2)(2010-3#1)
in proportion to##14##3##(1992-6#1)(1994-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#3)(2010-3#1)
in proportion##21##2##(1992-12#1)(1992-6#1)(1994-8#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-3#1)(2012-3#1)
in proportions of##3##3##(1992-9#1)(2008-10#1)(2008-6#1)
in proportions##5##2##(1992-9#1)(2008-10#2)(2008-6#1)(2013-1#1)
in propylene glycol and##2##4##(1991-5#1)(2008-11#1)
in propylene glycol##7##3##(1991-5#4)(2008-11#2)(2008-5#1)
in prospective##7##2##(1993-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
in prostate cancer cells##2##4##(2011-2#2)
in prostate cancer detection##2##4##(2011-2#2)
in prostate cancer diagnostics##3##4##(2011-2#3)
in prostate cancer patients##3##4##(1994-8#1)(2009-5#1)(2012-12#1)
in prostate cancer##25##3##(1994-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-2#15)(2012-12#2)
in prostate cancers##2##3##(2011-2#1)(2012-12#1)
in prostate carcinoma patients##3##4##(2013-1#3)
in prostate carcinoma##5##3##(2008-9#1)(2013-1#4)
in prostate##39##2##(1994-8#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-5#2)(2010-12#1)(2011-2#18)(2012-12#5)(2013-1#4)
in prostatic##2##2##(2008-4#1)(2009-5#1)
in prosthesis##2##2##(1991-2#1)(1993-6#1)
in prosthetic##2##2##(1990-5#1)(2007-7#1)
in protecting against##6##3##(1992-5#1)(1993-5#1)(1994-5#1)(2008-10#1)(2008-7#1)(2009-12#1)
in protecting cells##2##3##(1992-7#1)(2008-11#1)
in protecting the##4##3##(1992-3#2)(1992-8#1)(2013-8#1)
in protecting##23##2##(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-5#1)(1997-6#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-12#3)(2013-8#2)
in protection against##5##3##(1992-5#1)(1995-5#1)(2009-6#1)(2013-7#1)(2013-8#1)
in protection##8##2##(1992-5#1)(1995-2#1)(1995-5#2)(2008-4#1)(2009-6#1)(2013-7#1)(2013-8#1)
in protective##5##2##(1992-2#1)(2008-10#1)(2008-12#2)(2008-5#1)
in protein abundance##2##3##(1990-5#1)(2010-11#1)
in protein analysis##2##3##(2008-10#1)(2010-7#1)
in protein and##3##3##(1997-6#1)(1997-8#1)(2008-4#1)
in protein degradation##2##3##(1995-2#1)(2011-2#1)
in protein evolution##2##3##(1996-10#1)(1997-6#1)
in protein expression##2##3##(2008-4#2)
in protein folding and##2##4##(1994-8#1)(2009-9#1)
in protein folding##3##3##(1994-8#1)(2009-9#2)
in protein kinase C##2##4##(1997-6#1)(2010-12#1)
in protein kinase##3##3##(1994-5#1)(1997-6#1)(2010-12#1)
in protein structure##2##3##(2008-4#1)(2009-5#1)
in protein synthesis##7##3##(1992-12#1)(1992-6#1)(1994-11#1)(2008-5#3)(2008-8#1)
in protein##66##2##(1990-12#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-6#4)(1997-8#2)(2008-10#3)(2008-11#2)(2008-4#7)(2008-5#7)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#3)(2010-7#2)(2011-1#1)(2011-2#5)(2012-3#1)
in protein-free conditions##3##3##(1993-9#3)
in protein-free culture##3##3##(2008-11#3)
in protein-free medium##5##3##(2008-11#5)
in protein-free##15##2##(1993-9#3)(2008-11#12)
in protein-freeculture##2##2##(2008-11#2)
in proteins##21##2##(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#1)
in proteoliposomes##3##2##(1990-11#1)(1995-8#2)
in proteolytic##2##2##(1995-6#1)(2008-1#1)
in proteome analysis##2##3##(2008-12#2)
in proteome##4##2##(2008-12#3)(2012-3#1)
in proteomic##2##2##(2010-12#1)(2012-2#1)
in proteomics##4##2##(2008-5#1)(2008-7#3)
in protic##2##2##(1994-8#1)(2008-10#1)
in protocol A and B was##2##6##(2008-4#2)
in protocol A and B##4##5##(2008-4#4)
in protocol A was##2##4##(2008-4#2)
in protocol A##7##3##(2008-4#7)
in protocol B##4##3##(2008-4#4)
in protocol design##2##3##(1997-1#1)(2008-7#1)
in protocol##13##2##(1997-1#1)(2008-4#11)(2008-7#1)
in protoplast##3##2##(2008-8#2)(2008-9#1)
in protoplasts were##2##3##(1997-3#2)
in protoplasts##5##2##(1997-3#2)(2008-8#1)(2009-8#2)
in providing a##5##3##(1990-6#1)(1997-2#2)(2007-11#1)(2008-12#1)
in providing an##2##3##(1992-1#1)(2008-10#1)
in providing care for##2##4##(1996-2#1)(2011-2#1)
in providing care to##4##4##(2007-10#1)(2009-5#1)(2010-9#1)(2011-1#1)
in providing care##6##3##(1996-2#1)(2007-10#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
in providing health##2##3##(1996-12#1)(2011-2#1)
in providing holistic care##2##4##(2008-4#1)(2011-1#1)
in providing the##3##3##(1994-11#1)(1995-12#1)(2006-5#1)
in providing##48##2##(1990-6#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#3)(2006-5#1)(2007-10#2)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2013-1#1)
in provincial##3##2##(1993-1#1)(1993-2#1)(1995-12#1)
in proximal end of the femur##3##6##(2007-11#3)
in proximal femur##2##3##(2007-11#2)
in proximal tubular##2##3##(1993-3#1)(1994-5#1)
in proximal##14##2##(1992-8#1)(1993-3#1)(1994-5#1)(2007-11#5)(2008-11#1)(2008-12#2)(2009-5#1)(2012-3#1)(2013-1#1)
in proximity to##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2010-6#1)(2011-2#1)
in pseudoislets formation##2##3##(2010-11#2)
in pseudoislets##5##2##(2010-11#5)
in pseudophakic group##2##3##(2011-2#2)
in pseudopregnant##2##2##(1997-6#1)(2008-8#1)
in psi##2##2##(2008-3#2)
in psoriasis##3##2##(2007-11#1)(2008-6#1)(2013-1#1)
in psychiatric disorders##3##3##(2008-1#1)(2008-9#1)(2012-2#1)
in psychiatric hospitals##2##3##(1992-2#1)(1992-3#1)
in psychiatric nursing##2##3##(2008-11#2)
in psychiatric patients##4##3##(2008-1#1)(2008-4#2)(2009-9#1)
in psychiatric##20##2##(1992-2#1)(1992-3#1)(1996-5#1)(2006-9#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-9#1)(2009-9#2)(2012-1#2)(2012-2#1)
in psychiatry##13##2##(1991-1#1)(1992-9#2)(1997-8#1)(2006-9#1)(2008-2#3)(2008-4#2)(2008-9#1)(2010-6#1)(2013-7#1)
in psychiatry]##3##2##(1992-11#1)(2009-10#1)(2012-1#1)
in psychological##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)
in psychology##6##2##(1990-2#1)(1994-12#1)(1995-6#1)(1996-6#1)(2008-11#1)(2013-1#1)
in psychopathology##2##2##(2008-1#1)(2008-7#1)
in psychopharmacology##2##2##(2008-11#1)(2008-4#1)
in psychotic##2##2##(2008-7#1)(2012-2#1)
in puberty is##2##3##(2009-6#1)(2011-1#1)
in puberty##5##2##(2009-6#2)(2011-1#1)(2011-2#1)(2013-8#1)
in public and private##3##4##(2008-9#2)(2013-1#1)
in public and##5##3##(1996-1#1)(1996-5#1)(2008-9#2)(2013-1#1)
in public health and##2##4##(2007-12#1)(2008-11#1)
in public health insurance##3##4##(1995-3#1)(2008-7#2)
in public health is##2##4##(2010-8#1)(2012-12#1)
in public health##32##3##(1991-2#1)(1993-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
in public hospitals##4##3##(1993-3#1)(1994-2#1)(2011-2#1)(2013-8#1)
in public schools and 1##2##5##(2008-9#2)
in public schools##5##3##(2008-9#5)
in public situations##2##3##(2009-11#2)
in public##67##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#3)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#7)(2009-11#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
in publications##2##2##(2008-11#1)(2011-2#1)
in published##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
in pulmonary arterial hypertension##3##4##(2010-10#3)
in pulmonary arterial##5##3##(1991-6#1)(2008-11#1)(2010-10#3)
in pulmonary artery##2##3##(2007-8#1)(2007-9#1)
in pulmonary function##2##3##(1992-6#1)(2012-2#1)
in pulmonary hypertension##2##3##(2008-1#1)(2010-10#1)
in pulmonary vein myocardium##3##4##(2013-1#3)
in pulmonary##27##2##(1990-3#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1995-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#4)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#5)
in pulp##2##2##(2008-10#1)(2008-7#1)
in pulse energy##2##3##(2007-11#2)
in pulse##8##2##(2007-11#4)(2007-12#2)(2008-2#1)(2009-9#1)
in pulsed##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
in pulses##3##2##(2007-11#1)(2008-11#1)(2008-2#1)
in pummelo 2240##2##3##(2008-5#2)
in pump power##2##3##(2008-2#1)(2008-3#1)
in pump##3##2##(2008-2#1)(2008-3#2)
in punitive damages awards##4##4##(1992-2#1)(1992-3#3)
in purchasing##2##2##(1994-1#1)(1995-12#1)
in pure culture##2##3##(2008-8#1)(2012-2#1)
in pure form and in##2##5##(2008-10#2)
in pure form in##2##4##(2010-5#1)(2012-2#1)
in pure form or in##3##5##(2008-10#3)
in pure form##9##3##(2008-10#7)(2010-5#1)(2012-2#1)
in pure silica-core fibers##3##4##(2007-11#3)
in pure stand and##2##4##(2008-10#2)
in pure water##6##3##(1995-3#1)(2008-10#2)(2008-2#2)(2013-8#1)
in pure##45##2##(1995-11#1)(1995-3#1)(2007-10#1)(2007-11#7)(2007-12#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2010-5#1)(2012-2#2)(2013-8#1)
in purely##2##2##(1990-7#1)(1994-2#1)
in purification##3##2##(1991-5#1)(1994-2#1)(2008-7#1)
in purified##10##2##(1991-12#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-7#1)
in pursuit of##2##3##(2008-6#1)(2013-1#1)
in putamen##3##2##(1993-12#1)(2008-7#2)
in putative##3##2##(1993-11#1)(1996-2#1)(2013-1#1)
in pyramidal##2##2##(2008-2#1)(2009-8#1)
in pyridine##2##2##(1992-12#1)(2011-1#1)
in qatar##2##2##(2008-4#2)
in quadratic media##3##3##(2007-11#2)(2007-12#1)
in quadratic##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
in quadrature##3##2##(2008-2#1)(2008-3#2)
in quail myotubes##2##3##(1995-6#2)
in quail##6##2##(1995-6#3)(2008-12#2)(2008-6#1)
in qualitative agreement with##2##4##(2007-11#1)(2008-3#1)
in qualitative analysis of aromatic fraction of##2##7##(2008-10#2)
in qualitative research##6##3##(1997-1#1)(1997-3#1)(2008-11#3)(2008-12#1)
in qualitative##12##2##(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)
in quality assessment##2##3##(1996-1#1)(2010-9#1)
in quality control##6##3##(1992-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)
in quality improvement##4##3##(1995-12#1)(1997-1#1)(1997-2#1)(2009-3#1)
in quality management##2##3##(1995-1#1)(1995-12#1)
in quality of care##2##4##(1992-2#1)(1997-8#1)
in quality of life##12##4##(1996-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#2)(2013-1#1)
in quality of##17##3##(1992-2#2)(1996-7#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
in quality##44##2##(1992-11#1)(1992-2#2)(1993-3#2)(1995-1#1)(1995-12#4)(1996-1#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-8#1)
in quantifying the##2##3##(1992-9#1)(1997-7#1)
in quantifying##5##2##(1992-9#1)(1997-7#1)(2008-10#2)(2008-3#1)
in quantitative analysis##2##3##(2008-10#1)(2013-1#1)
in quantitative terms##2##3##(2007-11#1)(2008-3#1)
in quantitative##19##2##(1992-9#1)(1993-11#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-9#1)(2013-1#1)
in quantitatively##2##2##(2012-3#1)(2013-8#1)
in quantities##5##2##(1992-8#1)(1995-11#1)(2008-10#2)(2008-8#1)
in quantity##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
in quantum##3##2##(2008-10#1)(2009-9#1)(2010-10#1)
in quarantine##3##2##(2008-10#2)(2011-2#1)
in quartz##2##2##(2008-1#1)(2012-2#1)
in quasi-phase-matched second-harmonic generation##2##4##(2007-11#1)(2007-12#1)
in quasi-phase-matched##6##2##(2007-11#4)(2007-12#2)
in quaternary##2##2##(1990-8#1)(2008-10#1)
in quest##2##2##(1996-3#1)(2008-12#1)
in question with##2##3##(1996-4#1)(2011-2#1)
in question##22##2##(1990-8#1)(1991-12#1)(1992-5#1)(1993-8#1)(1994-6#1)(1995-6#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
in quiescent##4##2##(1993-12#1)(1994-8#1)(1994-9#1)(2008-10#1)
in rCBF##2##2##(1996-2#1)(2007-10#1)
in rPCNs##4##2##(2008-4#4)
in rRNA gene##2##3##(2008-8#1)(2013-1#1)
in rRNA##3##2##(2008-8#1)(2010-4#1)(2013-1#1)
in rTMS##2##2##(2013-1#2)
in rabbit and##2##3##(1992-6#1)(1997-4#1)
in rabbit aorta##6##3##(1990-12#1)(1990-2#3)(1995-12#2)
in rabbit arteries##4##3##(2008-4#2)(2011-1#2)
in rabbit myocardium##2##3##(1990-11#1)(1994-8#1)
in rabbit ooplasm and support early##2##6##(2008-9#2)
in rabbit platelets##4##3##(1994-3#2)(1995-11#2)
in rabbit reticulocyte lysate##2##4##(1991-12#1)(1993-12#1)
in rabbit reticulocyte##3##3##(1991-12#1)(1992-11#1)(1993-12#1)
in rabbit skin##2##3##(1992-6#2)
in rabbit ventricular##3##3##(1990-11#2)(2013-1#1)
in rabbit##51##2##(1990-11#3)(1990-12#1)(1990-2#3)(1991-12#1)(1991-5#2)(1992-11#1)(1992-6#4)(1992-9#1)(1993-12#1)(1994-3#2)(1994-8#2)(1995-11#2)(1995-12#4)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-10#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-8#1)(2008-9#2)(2011-1#2)(2011-3#1)(2013-1#1)
in rabbits and rats##2##4##(2008-9#1)(2010-7#1)
in rabbits and##4##3##(2008-10#1)(2008-9#2)(2010-7#1)
in rabbits from##2##3##(2010-4#2)
in rabbits which received##2##4##(1995-12#2)
in rabbits##35##2##(1990-5#1)(1990-8#1)(1991-7#1)(1993-12#1)(1995-12#4)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#5)(2008-5#3)(2008-9#3)(2009-3#1)(2010-10#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-3#1)(2012-2#2)(2012-3#2)
in rabbits]##2##2##(2010-12#1)(2013-8#1)
in race##3##2##(2008-10#3)
in racial##2##2##(2008-1#1)(2009-7#1)
in radial##2##2##(2008-10#1)(2011-2#1)
in radiation protection##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
in radiation##12##2##(1990-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(2008-7#4)(2012-2#1)(2013-1#1)(2013-8#2)
in radical##4##2##(1990-6#1)(1990-9#1)(2008-7#1)(2009-5#1)
in radiobiology##2##2##(2008-10#1)(2008-7#1)
in radiodiagnosis##3##2##(1996-8#1)(2009-10#2)
in radiography##3##2##(1995-2#2)(2009-9#1)
in radiological##3##2##(2007-11#1)(2008-1#1)(2012-2#1)
in radiology departments##3##3##(2007-4#3)
in radiology practices##2##3##(1993-3#1)(2007-4#1)
in radiology##19##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-1#1)(1995-2#2)(1996-1#1)(1997-8#1)(2007-4#4)(2009-9#1)(2012-2#3)
in radiometric##2##2##(2008-2#1)(2008-3#1)
in radionuclide##2##2##(2007-11#1)(2008-7#1)
in radioreceptor##2##2##(1991-3#1)(1995-8#1)
in radioresistance##2##2##(2008-5#1)(2013-1#1)
in radiosensitive##2##2##(1993-8#1)(1993-9#1)
in radiotherapy of head and neck##2##6##(1992-10#2)
in radiotherapy of##3##3##(1992-10#2)(2008-7#1)
in radiotherapy planning##3##3##(2008-2#2)(2008-6#1)
in radiotherapy##10##2##(1992-10#2)(2008-2#4)(2008-6#1)(2008-7#1)(2009-11#1)(2012-3#1)
in radish##5##2##(2008-10#5)
in railroads##4##2##(1991-12#4)
in rain##6##2##(2008-10#5)(2008-3#1)
in rainwater samples##2##3##(2008-10#2)
in rainwater varied##2##3##(2008-10#2)
in rainwater##11##2##(2008-10#11)
in raising##4##2##(1991-12#1)(1995-1#1)(2010-9#1)(2013-1#1)
in random dot patterns##2##4##(2008-8#2)
in random media##2##3##(2007-12#1)(2008-2#1)
in random order##4##3##(1991-8#1)(1994-12#1)(1995-11#1)(2013-8#1)
in random##14##2##(1991-8#1)(1994-12#1)(1995-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2013-8#1)
in randomised##2##2##(1993-2#1)(2012-3#1)
in randomized clinical trials##3##4##(1992-9#1)(2008-12#1)(2011-2#1)
in randomized clinical##4##3##(1992-9#1)(2008-12#1)(2011-2#1)(2012-3#1)
in randomized controlled trials##2##4##(2008-10#1)(2009-11#1)
in randomized controlled##3##3##(2008-10#1)(2009-11#1)(2009-9#1)
in randomized trials##2##3##(2012-1#1)(2012-3#1)
in randomized##15##2##(1991-8#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#3)
in range of##6##3##(2007-8#1)(2008-1#1)(2008-10#3)(2008-9#1)
in range##8##2##(2007-8#1)(2008-1#1)(2008-10#5)(2008-9#1)
in rank##2##2##(1991-3#1)(2010-8#1)
in raphe##5##2##(1995-12#1)(1996-12#1)(1997-2#1)(2008-7#2)
in rapid and##2##3##(2008-10#1)(2012-1#1)
in rapid##11##2##(1991-8#1)(1992-8#1)(1994-11#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
in rare cases##3##3##(2009-6#1)(2011-2#2)
in rare earth##2##3##(2008-10#2)
in rare##9##2##(1990-11#1)(1991-12#1)(2008-10#2)(2009-6#1)(2010-3#1)(2011-2#2)(2013-1#1)
in rare-earth-doped##3##2##(2007-12#1)(2008-2#2)
in rat CL##3##3##(2008-9#3)
in rat UMR-106##2##3##(1994-11#2)
in rat adipocytes##4##3##(1997-1#2)(2008-8#1)(2011-2#1)
in rat adipose tissue##2##4##(2008-10#1)(2010-6#1)
in rat adrenal cortex##2##4##(1991-5#1)(1996-2#1)
in rat adrenal##6##3##(1991-5#1)(1995-12#3)(1996-2#2)
in rat and mouse##6##4##(1991-12#1)(1991-6#1)(1992-6#2)(1995-3#1)(2008-4#1)
in rat and##11##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#2)(1995-2#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-4#1)
in rat aorta##5##3##(1990-12#1)(1997-7#2)(2008-3#1)(2011-2#1)
in rat aortic##4##3##(1990-12#1)(1991-5#1)(1994-5#1)(1995-11#1)
in rat basophilic leukemia (RBL-2H3) cells##2##6##(1993-3#2)
in rat basophilic leukemia##4##4##(1990-8#2)(1993-3#2)
in rat blood##2##3##(2008-10#2)
in rat brain and##5##4##(1993-11#1)(1993-5#1)(1996-12#1)(1997-2#2)
in rat brain by in situ hybridization##2##7##(1992-12#1)(1996-12#1)
in rat brain by in##3##5##(1992-12#1)(1996-12#1)(1997-1#1)
in rat brain by##4##4##(1992-12#1)(1996-12#1)(1997-1#2)
in rat brain combined with##2##5##(2008-10#2)
in rat brain cortical membranes##2##5##(1993-6#2)
in rat brain cortical##3##4##(1993-6#2)(1997-1#1)
in rat brain slices##3##4##(1993-5#1)(2008-2#1)(2009-12#1)
in rat brain were##2##4##(1996-2#1)(2008-10#1)
in rat brain##48##3##(1990-12#1)(1990-7#3)(1991-1#1)(1991-10#1)(1992-12#1)(1993-11#2)(1993-5#3)(1993-6#3)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#3)(1997-1#3)(1997-2#6)(1997-7#1)(2008-10#7)(2008-2#2)(2008-4#1)(2009-12#1)(2012-1#1)
in rat central nervous system##2##5##(1993-11#1)(1993-12#1)
in rat cerebellar membranes##2##4##(1992-3#1)(1996-2#1)
in rat cerebellar##3##3##(1992-3#1)(1996-2#1)(1996-5#1)
in rat colon cells##2##4##(1997-4#2)
in rat colon##3##3##(1997-4#3)
in rat colonic circular muscle##2##5##(1996-5#2)
in rat corpus##2##3##(1992-7#1)(2008-9#1)
in rat cultures##2##3##(1996-2#2)
in rat embryonal and fetal intestine##2##6##(1993-6#2)
in rat embryos##2##3##(2011-2#1)(2012-1#1)
in rat heart##5##3##(1990-7#1)(1991-9#1)(1993-5#1)(1994-11#1)(1995-11#1)
in rat hearts subjected to##2##5##(2013-7#2)
in rat hearts##3##3##(2013-7#3)
in rat hepatocytes##7##3##(1990-12#2)(1990-5#1)(1991-12#2)(1992-3#1)(2008-8#1)
in rat hepatoma cells##2##4##(1992-3#1)(1994-11#1)
in rat hepatoma##3##3##(1992-3#1)(1994-11#2)
in rat hippocampal CA1 slices##2##5##(1997-2#2)
in rat hippocampal CA1##3##4##(1996-5#1)(1997-2#2)
in rat hippocampal slices##4##4##(1990-12#1)(1996-2#1)(1997-2#1)(2008-2#1)
in rat hippocampal##11##3##(1990-12#1)(1993-12#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-2#3)(1997-6#1)(2008-2#1)
in rat hippocampus##2##3##(1995-12#2)
in rat kidney##3##3##(1991-5#1)(2008-11#2)
in rat liver by##3##4##(1994-6#1)(1994-8#2)
in rat liver cells by##2##5##(1995-6#1)(2008-8#1)
in rat liver cells##4##4##(1994-6#1)(1995-6#1)(2008-8#2)
in rat liver microsomes##4##4##(1990-12#1)(1991-2#1)(1992-8#1)(1993-8#1)
in rat liver plasma membranes##2##5##(1995-8#2)
in rat liver##31##3##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#3)(1994-8#2)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#3)
in rat lungs##2##3##(2008-12#2)
in rat model of U-ARF##3##5##(2008-8#3)
in rat model of##4##4##(2008-8#4)
in rat model##5##3##(2008-8#4)(2012-2#1)
in rat models of##3##4##(1993-8#1)(1997-2#2)
in rat neural tissue##2##4##(1994-12#2)
in rat ovary during pregnancy##2##5##(2008-9#2)
in rat ovary##3##3##(2008-12#1)(2008-9#2)
in rat pancreas##4##3##(1992-8#2)(1995-11#2)
in rat pituitary cell cultures##2##5##(1990-7#1)(1992-9#1)
in rat pituitary##5##3##(1990-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1997-2#1)
in rat plasma by##2##4##(2008-10#1)(2011-2#1)
in rat plasma##11##3##(1990-8#1)(1991-3#2)(1991-5#1)(1997-2#1)(2008-10#4)(2011-2#2)
in rat primary cortical neurons##2##5##(2008-4#2)
in rat primary hepatocyte##2##4##(1990-5#1)(2008-11#1)
in rat primary##4##3##(1990-5#1)(2008-11#1)(2008-4#2)
in rat serum##2##3##(1994-11#2)
in rat skeletal muscle##7##4##(1991-12#2)(1993-11#1)(2008-10#1)(2008-8#2)(2008-9#1)
in rat small intestine##2##4##(1991-12#1)(1997-6#1)
in rat spinal cord##2##4##(1996-5#2)
in rat spinal##3##3##(1992-6#1)(1996-5#2)
in rat striatal membranes##2##4##(1995-11#1)(1996-5#1)
in rat striatal##3##3##(1993-12#1)(1995-11#1)(1996-5#1)
in rat striatum##6##3##(1991-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1997-7#1)
in rat suprachiasmatic##2##3##(1993-9#2)
in rat synoviocytes##2##3##(2008-10#2)
in rat thymus##2##3##(1992-11#1)(1994-3#1)
in rat tissues after##2##4##(1992-9#1)(2012-3#1)
in rat tissues##5##3##(1992-9#1)(1993-3#1)(1994-11#1)(1997-4#1)(2012-3#1)
in rat urine##6##3##(1994-8#1)(2008-10#3)(2013-8#2)
in rat##362##2##(1990-11#3)(1990-12#9)(1990-5#2)(1990-7#7)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#3)(1991-5#6)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#6)(1992-6#8)(1992-7#1)(1992-8#6)(1992-9#3)(1993-11#8)(1993-12#8)(1993-3#6)(1993-5#4)(1993-6#7)(1993-8#7)(1993-9#2)(1994-11#8)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#6)(1994-8#3)(1995-11#8)(1995-12#16)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-12#6)(1996-2#11)(1996-5#8)(1997-1#10)(1997-2#13)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#5)(2006-7#1)(2007-10#1)(2008-10#28)(2008-11#5)(2008-12#7)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#14)(2008-9#14)(2009-12#2)(2010-6#1)(2011-2#7)(2011-3#1)(2012-1#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
in rate##6##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
in rates of##10##3##(1993-6#1)(1995-12#1)(1996-4#1)(2008-1#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2013-8#1)
in rates##14##2##(1991-1#2)(1993-6#1)(1994-2#1)(1995-12#1)(1996-4#1)(2008-1#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2013-8#2)
in rational##2##2##(1997-7#1)(2008-10#1)
in ratios of##2##3##(1997-8#1)(2010-8#1)
in ratios##3##2##(1997-8#1)(2009-8#1)(2010-8#1)
in rats after##7##3##(1990-12#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-12#1)(2008-8#1)(2011-2#1)
in rats and dogs##2##4##(1992-6#1)(2008-5#1)
in rats and mice##11##4##(1991-1#1)(1991-12#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-4#6)
in rats and rabbits##2##4##(1990-11#2)
in rats and##21##3##(1990-11#2)(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-4#6)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)
in rats at##2##3##(1990-2#1)(1994-5#1)
in rats by##6##3##(1994-11#1)(1997-2#1)(1997-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
in rats during##2##3##(1991-12#1)(1997-6#1)
in rats exposed to##2##4##(1993-12#1)(2008-11#1)
in rats fed ethanol##2##4##(2008-11#2)
in rats fed with##2##4##(2012-12#1)(2012-2#1)
in rats fed##5##3##(1993-12#1)(2008-11#2)(2012-12#1)(2012-2#1)
in rats given##2##3##(1994-5#1)(2008-11#1)
in rats have##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
in rats in the##3##4##(1990-5#1)(1994-7#1)(2011-2#1)
in rats injected with##3##4##(2008-11#1)(2013-7#2)
in rats is##4##3##(1994-11#1)(1995-12#1)(2011-2#1)(2013-8#1)
in rats on##2##3##(1994-11#1)(2008-10#1)
in rats pretreated with##2##4##(1992-11#1)(1993-12#1)
in rats revealed##2##3##(1992-11#1)(1996-12#1)
in rats subjected to##3##4##(1991-12#1)(1993-3#1)(2012-1#1)
in rats that##2##3##(1994-6#1)(2013-1#1)
in rats through##2##3##(1992-6#1)(1997-4#1)
in rats trained##2##3##(1997-7#1)(2008-7#1)
in rats treated with##6##4##(1995-12#1)(1995-3#2)(2007-10#1)(2009-4#1)(2011-1#1)
in rats using##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
in rats were investigated##2##4##(1994-5#1)(1996-2#1)
in rats which##2##3##(1994-5#1)(1994-8#1)
in rats with a##2##4##(1991-5#1)(1993-2#1)
in rats with##28##3##(1991-5#1)(1992-10#2)(1993-2#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#3)(1997-6#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
in rats without##2##3##(1991-12#1)(2011-2#1)
in rats##315##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#4)(1991-12#10)(1991-2#2)(1991-5#3)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#1)(1992-6#4)(1992-9#3)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#5)(1994-3#2)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#7)(1995-11#2)(1995-12#14)(1995-2#2)(1995-3#5)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#6)(1996-5#5)(1996-9#1)(1997-1#1)(1997-2#7)(1997-4#5)(1997-6#3)(1997-7#2)(2006-12#1)(2007-10#4)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#14)(2008-12#8)(2008-3#3)(2008-4#19)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#2)(2011-1#7)(2011-2#13)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#15)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#3)(2013-8#6)
in rats]##10##2##(2010-12#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
in raw and##3##3##(2008-12#2)(2010-4#1)
in raw materials##2##3##(2008-5#1)(2011-2#1)
in raw pork##2##3##(1997-4#1)(2010-2#1)
in raw##14##2##(1997-4#1)(2008-10#6)(2008-12#2)(2008-5#1)(2010-2#1)(2010-4#2)(2011-2#1)
in re-engineering##2##2##(1995-2#1)(1996-2#1)
in reaching##7##2##(1992-11#1)(1994-3#1)(2008-10#1)(2008-6#1)(2010-7#2)(2012-3#1)
in reaction mixtures##2##3##(1992-3#1)(2008-10#1)
in reaction time##2##3##(1995-12#1)(2008-11#1)
in reaction with##3##3##(1993-8#2)(1996-5#1)
in reaction##13##2##(1992-3#1)(1992-6#1)(1993-8#2)(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)
in reactional##2##2##(2007-7#1)(2011-2#1)
in reactions##5##2##(1993-8#1)(1995-11#1)(1996-5#1)(2009-9#1)(2011-1#1)
in reactive arthritis##2##3##(1994-8#1)(2012-2#1)
in reactive oxygen##2##3##(2012-1#1)(2012-12#1)
in reactive##11##2##(1992-8#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
in reactivity##4##2##(1992-6#1)(1996-2#1)(2008-10#2)
in reactor##4##2##(2008-10#3)(2008-7#1)
in readiness##2##2##(2008-4#1)(2012-3#1)
in reading rates##2##3##(2007-12#2)
in reading##8##2##(2007-12#3)(2008-12#1)(2008-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
in readout##2##2##(2008-3#2)
in reagent##3##2##(1996-12#1)(2008-10#2)
in real and##2##3##(1996-2#1)(2008-10#1)
in real life##2##3##(2010-3#1)(2010-4#1)
in real samples by##2##4##(2008-10#2)
in real samples such as##2##5##(2008-10#2)
in real samples were##2##4##(2008-10#2)
in real samples##41##3##(2008-10#40)(2010-11#1)
in real solution samples##3##4##(2008-10#3)
in real systems##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
in real time and##3##4##(2008-1#1)(2008-3#1)(2011-1#1)
in real time by##7##4##(2007-11#2)(2008-10#1)(2008-3#3)(2012-2#1)
in real time for##2##4##(2008-2#1)(2010-8#1)
in real time in##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
in real time the##2##4##(2008-11#1)(2008-2#1)
in real time to##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
in real time using##4##4##(1995-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
in real time with##2##4##(2008-11#1)(2008-2#1)
in real time##72##3##(1995-12#1)(1995-2#2)(1997-6#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#7)(2008-3#21)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#3)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
in real water samples##3##4##(2008-10#3)
in real water##5##3##(2008-10#4)(2010-4#1)
in real##151##2##(1993-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-6#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#70)(2008-11#2)(2008-2#7)(2008-3#23)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-8#3)(2011-1#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
in real-life##2##2##(2008-10#1)(2012-3#1)
in real-time PCR assays##2##4##(2008-10#1)(2008-9#1)
in real-time##23##2##(1992-3#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#3)
in real-world##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
in realistic##3##2##(2008-10#1)(2008-7#2)
in reality##4##2##(2008-1#1)(2008-10#1)(2010-3#1)(2013-8#1)
in reasonable agreement with the theoretical##2##6##(2008-10#1)(2008-5#1)
in reasonable agreement with the##4##5##(2008-10#2)(2008-5#2)
in reasonable agreement with##5##4##(2008-10#2)(2008-3#1)(2008-5#2)
in reasonable agreement##6##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)
in reasonable##7##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#2)
in reasonably##2##2##(2008-10#2)
in rebuilding##2##2##(1992-12#1)(2007-11#1)
in receipt of a DG##3##5##(2012-12#3)
in receiver##2##2##(2008-2#1)(2008-3#1)
in receiving##2##2##(1997-3#1)(2008-12#1)
in recent decades##5##3##(2007-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
in recent times##3##3##(1996-1#1)(2007-7#1)(2008-11#1)
in recent years and##4##4##(2008-11#1)(2008-12#1)(2010-12#1)(2011-7#1)
in recent years as an##2##5##(2008-10#1)(2011-1#1)
in recent years as##3##4##(2007-7#1)(2008-10#1)(2011-1#1)
in recent years by the##2##5##(2009-7#1)(2013-1#1)
in recent years due to##2##5##(2013-1#1)(2013-8#1)
in recent years has##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
in recent years have##5##4##(1991-12#1)(2008-1#1)(2008-3#1)(2010-3#1)(2011-2#1)
in recent years in##2##4##(1992-1#1)(2013-8#1)
in recent years on##2##4##(2008-10#1)(2011-3#1)
in recent years since##2##4##(2008-1#1)(2010-3#1)
in recent years there have been##2##6##(1990-11#1)(2011-2#1)
in recent years there##3##4##(1990-11#1)(2008-1#1)(2011-2#1)
in recent years to##2##4##(1994-8#1)(2008-5#1)
in recent years with##2##4##(2006-4#1)(2008-11#1)
in recent years##96##3##(1990-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-4#1)(2007-7#3)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#3)(2011-7#1)(2012-1#2)(2013-1#6)(2013-8#4)
in recent##117##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#4)(2008-1#4)(2008-10#9)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
in recently##5##2##(1991-12#1)(1991-3#1)(1994-3#1)(2008-5#1)(2008-9#1)
in receptor binding##5##3##(1992-12#1)(1992-8#2)(1994-5#1)(1995-6#1)
in receptor density##3##3##(1992-5#1)(1993-12#1)(1995-3#1)
in receptor##17##2##(1992-12#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)
in recessive dystrophic epidermolysis bullosa##2##5##(2012-3#2)
in reciprocal##3##2##(2008-10#2)(2012-12#1)
in recognition of##4##3##(1991-10#1)(1995-2#1)(1996-3#1)(2008-7#1)
in recognition##8##2##(1991-10#1)(1994-11#1)(1995-2#1)(1996-3#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)
in recognizing##13##2##(1990-2#1)(1991-12#1)(1994-8#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
in recombinant Chinese hamster ovary (CHO)##2##6##(2008-11#2)
in recombinant Chinese hamster ovary##3##5##(2008-11#3)
in recombinant E##2##3##(1994-12#1)(2008-7#1)
in recombinant human##2##3##(1990-8#1)(1992-12#1)
in recombinant##18##2##(1990-8#1)(1992-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#3)
in recombination##3##2##(1995-8#1)(2008-11#1)(2010-3#1)
in recombinogenic##2##2##(1994-8#1)(2008-11#1)
in recommended care##2##3##(2007-2#2)
in reconstructed##2##2##(2008-5#1)(2008-9#1)
in reconstructing##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
in reconstruction of##2##3##(2008-10#1)(2011-2#1)
in reconstruction##5##2##(1992-5#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
in reconstructive surgery##3##3##(1992-5#1)(2007-11#1)(2008-7#1)
in recording##3##2##(2007-12#1)(2008-2#1)(2008-9#1)
in recovered##3##2##(1996-7#1)(2008-10#1)(2013-8#1)
in recovering##2##2##(2008-7#1)(2009-11#1)
in recovery of##5##3##(1990-7#1)(1991-2#2)(2008-10#1)(2013-1#1)
in recovery##9##2##(1990-7#1)(1991-2#3)(2008-10#1)(2008-2#1)(2008-6#1)(2012-3#1)(2013-1#1)
in recreational activities##2##3##(1992-12#1)(2012-2#1)
in recreational bobsledders##2##3##(2012-12#2)
in recreational##7##2##(1992-12#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
in recruit##2##2##(2007-5#1)(2010-8#1)
in recruiting and##2##3##(1991-2#1)(2012-2#1)
in recruitment and##3##3##(1991-11#1)(2007-12#1)(2008-12#1)
in recruitment##6##2##(1991-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-4#1)(2013-7#1)
in recruits##2##2##(2013-1#2)
in rectal cancer##4##3##(1990-10#1)(2008-1#1)(2008-10#2)
in rectal cancer]##2##3##(2008-10#2)
in rectal carcinoma]##2##3##(1990-9#1)(1996-8#1)
in rectal lumen and to remove outside through the anus##2##10##(2013-1#2)
in rectal##12##2##(1990-10#1)(1990-9#1)(1996-8#1)(2008-1#1)(2008-10#4)(2009-11#2)(2013-1#2)
in rectangular##3##2##(2008-2#1)(2008-3#2)
in recurrent##8##2##(1990-12#1)(1992-5#1)(1993-1#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)
in red blood cell##3##4##(1994-2#1)(1995-8#1)(2008-10#1)
in red blood cells##2##4##(1990-2#1)(2012-2#1)
in red blood##5##3##(1990-2#1)(1994-2#1)(1995-8#1)(2008-10#1)(2012-2#1)
in red cells##3##3##(1990-11#1)(1990-9#1)(2008-8#1)
in red wine##2##3##(2008-10#1)(2008-7#1)
in red##16##2##(1990-11#1)(1990-2#1)(1990-9#1)(1994-2#1)(1995-8#1)(1997-6#1)(2008-10#5)(2008-7#1)(2008-8#2)(2010-5#1)(2012-2#1)
in redox##2##2##(1994-3#1)(2008-10#1)
in reduced##28##2##(1990-12#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in reducing cardiovascular##2##3##(1992-6#1)(2012-12#1)
in reducing chemotherapy-induced##2##3##(2008-7#2)
in reducing child##2##3##(1996-2#1)(2008-11#1)
in reducing disease symptoms##2##4##(2008-10#2)
in reducing disease##5##3##(2008-10#4)(2008-8#1)
in reducing morbidity##2##3##(2011-2#1)(2012-2#1)
in reducing resistance##2##3##(2008-11#1)(2013-1#1)
in reducing the disease##2##4##(2008-10#2)
in reducing the number##2##4##(1990-3#1)(2008-2#1)
in reducing the postoperative##2##4##(2007-8#1)(2009-5#1)
in reducing the risk of##2##5##(2008-10#1)(2008-7#1)
in reducing the risk##5##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
in reducing the severity##3##4##(2008-10#2)(2008-5#1)
in reducing the##35##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1993-10#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-12#1)
in reducing##131##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#7)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#7)(2008-7#6)(2008-8#6)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
in reduction of##10##3##(1992-1#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in reduction##13##2##(1990-5#1)(1990-9#1)(1992-1#1)(1996-1#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in reference and##2##3##(2008-10#1)(2010-3#1)
in reference memory##2##3##(2008-12#2)
in reference to##7##3##(1990-12#1)(1990-3#1)(1995-3#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
in reference##17##2##(1990-12#1)(1990-3#1)(1995-3#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
in referral centers##3##3##(2011-2#3)
in referral##6##2##(1994-1#2)(2010-10#1)(2011-2#3)
in reflectance##4##2##(2008-2#1)(2008-3#3)
in reflection and##5##3##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)
in reflection##12##2##(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)
in reflectivity##4##2##(2008-2#1)(2008-3#3)
in refluxing ethanol##2##3##(1996-2#1)(2008-10#1)
in refractive index of##2##4##(2007-11#1)(2008-2#1)
in refractive index##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
in refractive##6##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
in refractory##4##2##(1990-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
in refugee##2##2##(1994-9#1)(2011-2#1)
in regard to brow height##2##5##(2012-12#2)
in regard to the##10##4##(1990-5#1)(1990-8#1)(1992-12#1)(1994-5#1)(1996-2#1)(1996-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)
in regard to their##2##4##(1992-3#1)(2009-7#1)
in regard to various##2##4##(1992-1#1)(2012-12#1)
in regard to##40##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1994-3#1)(1994-5#2)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-3#1)
in regards to the##2##4##(2008-8#1)(2009-10#1)
in regards to##6##3##(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)
in regenerating##5##2##(1990-5#1)(1995-12#1)(1997-6#1)(2013-1#2)
in regeneration##3##2##(1993-3#1)(2011-2#1)(2012-3#1)
in regenerative medicine##7##3##(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#3)(2012-12#1)
in regenerative##11##2##(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#3)(2010-6#1)(2012-12#3)
in region##2##2##(1994-6#1)(2011-2#1)
in regional##10##2##(1992-12#1)(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
in regions of the##3##4##(2008-10#1)(2008-3#2)
in regions of##8##3##(1990-11#1)(1991-11#1)(1994-6#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-3#2)
in regions that##2##3##(1995-2#1)(2008-3#1)
in regions where the##3##4##(2008-3#2)(2013-1#1)
in regions where##7##3##(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#2)(2013-1#1)
in regions with##6##3##(1992-6#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
in regions##33##2##(1990-11#2)(1991-11#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-10#5)(2008-3#7)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
in registered nurses##2##3##(2007-10#1)(2008-12#1)
in registered##4##2##(1994-2#1)(2007-10#1)(2008-12#1)(2011-2#1)
in regression models##2##3##(1992-9#1)(2013-8#1)
in regression##4##2##(1992-9#1)(1997-1#1)(2009-8#1)(2013-8#1)
in regular physical activity##2##4##(2007-6#2)
in regular##10##2##(1997-4#1)(2007-6#2)(2008-10#3)(2010-12#1)(2011-2#2)(2013-1#1)
in regularly##2##2##(2008-10#1)(2009-4#1)
in regulated##2##2##(2008-8#1)(2012-2#1)
in regulating cell growth##2##4##(1992-9#1)(2009-9#1)
in regulating cell##5##3##(1991-12#1)(1992-9#1)(2008-11#1)(2008-9#1)(2009-9#1)
in regulating energy balance##2##4##(2008-3#2)
in regulating fruit##2##3##(2009-8#1)(2011-2#1)
in regulating spermatogenesis##2##3##(1996-2#1)(2009-10#1)
in regulating the expression of the##2##6##(1997-7#1)(1997-8#1)
in regulating the expression of##5##5##(1997-7#1)(1997-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
in regulating the level##2##4##(2008-11#1)(2009-8#1)
in regulating the##31##3##(1991-3#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-5#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#2)(2009-5#1)(2009-8#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
in regulating##102##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#5)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#2)(2009-5#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#6)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#7)
in regulation of cell##2##4##(1993-9#1)(2008-8#1)
in regulation of energy##2##4##(1994-8#1)(2008-4#1)
in regulation of the##4##4##(1994-5#1)(1995-8#1)(2008-1#1)(2008-9#1)
in regulation of##35##3##(1991-2#1)(1991-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-8#2)(1996-10#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
in regulation##37##2##(1991-2#1)(1991-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-8#2)(1996-10#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
in regulatory##3##2##(2008-7#2)(2013-1#1)
in rehabilitation of##3##3##(2007-11#1)(2008-10#1)(2010-9#1)
in rehabilitation##15##2##(1992-12#1)(1992-2#1)(1994-3#2)(1996-11#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-6#1)(2010-9#1)(2012-2#2)(2013-1#1)
in relapse and##3##3##(1992-3#1)(1993-12#1)(2008-5#1)
in relapse##5##2##(1992-3#1)(1993-12#2)(2008-5#1)(2011-2#1)
in relapsed or##2##3##(2007-4#1)(2008-7#1)
in related to activity intensity##2##5##(2009-3#2)
in related to##3##3##(2009-3#2)(2010-6#1)
in related##5##2##(1992-3#1)(2009-3#2)(2010-6#1)(2013-7#1)
in relating##3##2##(1992-9#1)(1993-5#1)(1994-12#1)
in relation to a previously##2##5##(1992-3#1)(1992-6#1)
in relation to a##9##4##(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(2008-1#2)(2008-2#1)(2008-3#1)
in relation to alcohol##2##4##(1993-9#1)(2012-1#1)
in relation to both##2##4##(1995-1#1)(2008-12#1)
in relation to cardiometabolic diseases##2##5##(2011-1#2)
in relation to cell##2##4##(1990-11#1)(2009-9#1)
in relation to changes in##2##5##(1997-2#1)(2012-12#1)
in relation to clinical##4##4##(2007-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
in relation to current##2##4##(2012-1#1)(2013-8#1)
in relation to different##2##4##(1993-5#1)(2008-10#1)
in relation to environmental##3##4##(2008-12#1)(2008-5#1)(2008-8#1)
in relation to follicular##2##4##(2008-12#1)(2008-8#1)
in relation to health##2##4##(1995-6#1)(2012-2#1)
in relation to host##3##4##(2008-10#2)(2012-3#1)
in relation to human##2##4##(2008-8#1)(2011-1#1)
in relation to infection by##2##5##(2008-10#2)
in relation to infection##3##4##(2008-10#3)
in relation to insulin sensitivity##2##5##(2008-3#2)
in relation to its##3##4##(1995-11#1)(2007-11#1)(2008-1#1)
in relation to new##2##4##(2009-5#1)(2010-5#1)
in relation to obesity##2##4##(2011-1#2)
in relation to other##4##4##(1993-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
in relation to seasonal##3##4##(2011-1#1)(2012-2#2)
in relation to smoking##2##4##(2010-2#2)
in relation to temperature##2##4##(2008-10#1)(2008-5#1)
in relation to the distribution##2##5##(1991-6#1)(1992-3#1)
in relation to the improvement of epidermal function##2##8##(2012-2#2)
in relation to the need##2##5##(2009-8#1)(2012-2#1)
in relation to the number of##2##6##(2008-7#1)(2008-9#1)
in relation to the patient's##2##5##(1990-5#1)(2009-4#1)
in relation to the potential##2##5##(2007-11#1)(2008-10#1)
in relation to the results##2##5##(1990-9#1)(1994-2#1)
in relation to the total##2##5##(2008-9#1)(2011-1#1)
in relation to the##111##4##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)
in relation to their##8##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#2)(2009-7#1)(2012-2#1)
in relation to those of##3##5##(1994-6#1)(1995-3#1)(1996-1#1)
in relation to time##3##4##(2008-10#3)
in relation to type##2##4##(2012-1#1)(2013-1#1)
in relation to women##2##4##(2011-2#1)(2012-3#1)
in relation to##380##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#3)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#4)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#5)(2007-11#4)(2007-12#7)(2007-7#1)(2008-1#6)(2008-10#59)(2008-11#22)(2008-12#13)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#9)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#12)(2011-2#8)(2012-1#6)(2012-12#5)(2012-2#10)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#2)
in relation with the##2##4##(1990-5#1)(2008-10#1)
in relation with##8##3##(1990-5#1)(1990-8#1)(2008-10#3)(2008-5#1)(2009-5#2)
in relation##389##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#4)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#5)(2007-11#4)(2007-12#7)(2007-7#1)(2008-1#6)(2008-10#62)(2008-11#22)(2008-12#13)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#9)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#12)(2011-2#8)(2012-1#6)(2012-12#5)(2012-2#10)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#2)
in relationship to##3##3##(2008-12#1)(2013-1#2)
in relationship##7##2##(1991-6#1)(2007-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
in relationships##2##2##(2008-5#1)(2009-11#1)
in relative##17##2##(1992-9#1)(1993-12#2)(1994-3#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#2)(2013-1#1)
in relatively high##3##3##(2008-10#2)(2008-11#1)
in relatively large##3##3##(2008-10#3)
in relatively short##2##3##(2008-10#1)(2012-3#1)
in relatively young patients with##2##5##(1996-7#1)(2008-7#1)
in relatively young patients##3##4##(1991-8#1)(1996-7#1)(2008-7#1)
in relatively young##4##3##(1991-8#1)(1996-7#1)(2008-5#1)(2008-7#1)
in relatively##22##2##(1991-5#1)(1991-8#1)(1996-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
in relaxation##2##2##(1994-3#1)(2012-7#1)
in relaxed##3##2##(1990-2#1)(1993-8#1)(1995-6#1)
in release##2##2##(2008-11#1)(2008-7#1)
in relevance##2##2##(2011-1#1)(2012-2#1)
in relevant##3##2##(1992-1#1)(1997-4#1)(2008-8#1)
in reliable##2##2##(2008-3#1)(2009-8#1)
in reliance on##2##3##(1991-2#1)(1994-3#1)
in relief of##2##3##(2006-10#1)(2011-2#1)
in relieving##6##2##(1994-11#1)(1994-12#1)(2008-7#1)(2011-2#3)
in religious##5##2##(2008-12#1)(2009-7#3)(2010-10#1)
in remaining vegetated patches##2##4##(2008-8#2)
in remaining##5##2##(1996-12#1)(2007-7#1)(2008-8#3)
in remission from acute myeloid leukaemia##2##6##(2009-3#2)
in remission##16##2##(1990-11#1)(1990-3#2)(1991-5#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-12#2)(2008-1#1)(2008-10#1)(2009-3#2)(2011-2#1)(2012-2#1)
in remote areas##4##3##(1990-6#1)(1996-12#1)(2008-10#1)(2008-7#1)
in remote locations##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
in remote sensing##2##3##(2008-3#2)
in remote##15##2##(1990-6#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#4)(2008-7#2)(2010-6#1)
in removal of##5##3##(1990-5#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
in removal##6##2##(1990-5#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
in removing##7##2##(1994-5#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
in renal allograft recipients##3##4##(2008-1#3)
in renal allografts##2##3##(2007-7#1)(2008-1#1)
in renal cell carcinoma##3##4##(1992-3#1)(1992-8#1)(2009-7#1)
in renal epithelial cells##2##4##(2012-12#2)
in renal failure##3##3##(2008-1#1)(2008-7#2)
in renal function and##2##4##(2007-7#1)(2008-3#1)
in renal function##6##3##(1994-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)
in renal haemodynamics##2##3##(1995-12#2)
in renal hypertensive rats##2##4##(1991-5#1)(2008-11#1)
in renal patients##2##3##(2007-12#2)
in renal tissue##3##3##(1990-12#1)(2011-2#2)
in renal transplant patients##4##4##(1990-3#1)(2008-1#3)
in renal transplant recipients##9##4##(2008-3#5)(2008-4#3)(2008-8#1)
in renal transplant##15##3##(1990-3#1)(2007-7#1)(2008-1#3)(2008-3#5)(2008-4#3)(2008-7#1)(2008-8#1)
in renal transplantation##3##3##(2008-1#2)(2008-4#1)
in renal##78##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-5#1)(1992-8#3)(1993-3#1)(1994-12#1)(1994-5#2)(1995-12#6)(1996-6#1)(2007-10#1)(2007-12#3)(2007-7#3)(2008-1#12)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#4)(2008-7#4)(2008-8#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-1#4)(2013-8#2)
in rendering##2##2##(2009-9#1)(2013-1#1)
in reorganization##2##2##(1993-8#1)(1994-12#1)
in repair of##3##3##(1994-5#1)(2008-10#1)(2012-3#1)
in repair##6##2##(1994-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
in repeat##5##2##(2007-8#1)(2008-11#3)(2009-5#1)
in repeated batch cultures##2##4##(2008-11#2)
in repeated measures##2##3##(1992-9#1)(1994-9#1)
in repeated##11##2##(1991-6#1)(1992-9#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#1)(2012-3#2)
in repetitive##3##2##(1994-8#1)(2008-11#1)(2010-3#1)
in replant orchard soils##2##4##(2008-10#2)
in replant##4##2##(2008-10#4)
in replicate##3##2##(2008-8#1)(2008-9#1)(2012-1#1)
in replicated field plots##2##4##(2008-10#2)
in replicated field trials##3##4##(2008-10#2)(2008-4#1)
in replicated field##5##3##(2008-10#4)(2008-4#1)
in replicated trials##2##3##(2008-10#2)
in replicated##8##2##(2008-10#7)(2008-4#1)
in replication##9##2##(1991-12#1)(1997-2#3)(2008-10#2)(2008-5#1)(2008-9#1)(2013-1#1)
in reported health##2##3##(1994-1#1)(1996-6#1)
in reported##12##2##(1991-9#1)(1992-2#2)(1994-1#1)(1996-6#1)(2007-10#1)(2007-12#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
in reporting##5##2##(1996-3#1)(2010-5#3)(2011-2#1)
in reports of##3##3##(1995-3#1)(2008-4#2)
in representative##3##2##(2007-12#1)(2008-10#1)(2010-7#1)
in representing the##2##3##(2013-8#2)
in representing##4##2##(1996-2#1)(2008-3#1)(2013-8#2)
in reproduction##7##2##(1991-11#2)(2008-8#2)(2009-6#1)(2012-1#2)
in reproductive health##2##3##(2008-1#1)(2013-1#1)
in reproductive success between##2##4##(2009-12#2)
in reproductive success##3##3##(2009-12#3)
in reproductive##14##2##(1991-12#1)(1994-6#1)(2008-1#1)(2008-4#1)(2008-8#3)(2009-12#3)(2011-2#2)(2011-3#1)(2013-1#1)
in reptiles##2##2##(2008-8#1)(2010-3#1)
in repulsion phase##2##3##(2008-10#2)
in repulsion##5##2##(2008-10#5)
in requests for##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
in required##2##2##(2008-3#2)
in research and clinical##3##4##(1997-5#1)(2011-2#1)(2012-2#1)
in research and development of##2##5##(2008-10#1)(2013-1#1)
in research and##18##3##(1992-3#1)(1992-6#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
in research in##4##3##(1993-11#1)(1994-3#1)(1995-11#1)(2008-1#1)
in research laboratories##2##3##(2008-10#1)(2010-10#1)
in research on the##2##4##(2007-11#1)(2008-10#1)
in research on##7##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
in research projects##4##3##(1992-3#1)(1992-6#1)(2009-6#2)
in research related to##2##4##(1992-12#1)(2010-11#1)
in research synthesis##2##3##(1996-11#1)(1996-6#1)
in research that##2##3##(1993-12#1)(2007-12#1)
in research##80##2##(1991-12#1)(1992-12#2)(1992-3#3)(1992-6#3)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#6)(2009-8#1)(2010-10#1)(2010-11#4)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#1)
in researcher-managed##2##2##(2008-12#2)
in resected##4##2##(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in resident education##2##3##(2007-4#2)
in resident##5##2##(1990-2#1)(1991-2#1)(2007-4#2)(2008-7#1)
in residential aged care##2##4##(2010-10#2)
in residential settings##2##3##(2008-10#1)(2008-7#1)
in residential##7##2##(1993-12#1)(2008-10#1)(2008-7#1)(2010-10#2)(2013-1#1)(2013-8#1)
in residents of##3##3##(1995-12#1)(2008-12#1)(2012-1#1)
in residents##4##2##(1995-12#1)(2008-12#1)(2012-1#1)(2012-3#1)
in residual##2##2##(2007-12#1)(2009-7#1)
in residues of##2##3##(2008-10#2)
in resilience##3##2##(2009-8#1)(2011-1#2)
in resin##3##2##(2008-10#1)(2013-1#2)
in resistance against##2##3##(1992-7#1)(2008-10#1)
in resistance and##2##3##(2008-10#1)(2012-2#1)
in resistance may be##2##4##(2008-10#1)(2009-11#1)
in resistance to LSD##2##4##(2008-10#2)
in resistance to various##2##4##(1994-8#1)(2008-7#1)
in resistance to##13##3##(1994-8#1)(1996-1#1)(2008-10#7)(2008-7#1)(2011-2#2)(2013-1#1)
in resistance##29##2##(1992-7#1)(1994-8#1)(1996-1#1)(2008-10#16)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#2)(2012-2#1)(2013-1#3)
in resistance-trained males##2##3##(2008-5#2)
in resistance-trained##4##2##(2008-5#4)
in resistant and susceptible##5##4##(1996-12#1)(2008-10#4)
in resistant berries##2##3##(2008-10#2)
in resistant cells##6##3##(1991-4#1)(1994-8#1)(2008-11#3)(2008-4#1)
in resistant genotypes##2##3##(2008-10#2)
in resistant isolates##2##3##(2008-10#2)
in resistant maize##2##3##(2008-10#2)
in resistant plants##6##3##(2008-10#6)
in resistant##41##2##(1991-4#1)(1994-8#1)(1996-12#2)(2008-10#31)(2008-11#3)(2008-4#2)(2009-4#1)
in resolution##11##2##(1995-3#1)(2008-10#3)(2008-3#4)(2008-9#1)(2011-1#1)(2012-2#1)
in resolving the##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2012-12#1)
in resolving##13##2##(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
in resonance##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
in resorption##7##2##(2008-5#1)(2011-1#6)
in resource availability##2##3##(2008-8#1)(2012-2#1)
in resource poor##4##3##(1995-9#1)(2007-2#1)(2008-4#1)(2012-2#1)
in resource##11##2##(1992-4#1)(1993-12#1)(1995-9#1)(2007-2#1)(2008-4#1)(2008-8#3)(2012-2#2)(2013-8#1)
in resource-constrained countries##2##3##(2012-2#2)
in resource-constrained settings##2##3##(2010-4#1)(2011-2#1)
in resource-constrained##4##2##(2010-4#1)(2011-2#1)(2012-2#2)
in resource-poor##4##2##(2008-11#1)(2009-8#1)(2012-12#1)(2012-2#1)
in respect of the##2##4##(1995-6#1)(2013-8#1)
in respect of##9##3##(1992-6#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-10#1)(2013-8#1)
in respect to the##2##4##(2008-10#2)
in respect to##12##3##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
in respect##21##2##(1991-12#1)(1992-6#1)(1995-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
in respectively##3##2##(1992-2#2)(2007-8#1)
in respiratory and##2##3##(1994-3#1)(2013-1#1)
in respiratory mechanics##2##3##(2012-2#2)
in respiratory tract##2##3##(2011-2#2)
in respiratory##13##2##(1991-10#1)(1992-8#1)(1994-3#1)(1995-8#1)(2007-6#1)(2008-7#1)(2009-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
in responding for##2##3##(1993-6#2)
in responding to##5##3##(1993-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)
in responding##12##2##(1993-1#1)(1993-6#4)(2007-12#1)(2008-11#1)(2008-2#1)(2009-8#2)(2010-2#1)(2012-3#1)
in response characteristics##2##3##(2008-10#2)
in response of##2##3##(2008-10#1)(2008-11#1)
in response rates##4##3##(1993-6#1)(1994-7#1)(1995-4#1)(2008-6#1)
in response to 'correct' and 'social' compared with 'incorrect' and 'unsocial' gaze shifts##2##13##(2008-11#2)
in response to 1##2##4##(1990-2#2)
in response to ADP##2##4##(2008-4#1)(2008-7#1)
in response to AI-2##2##4##(2008-9#2)
in response to C##2##4##(2008-10#2)
in response to EPEC##2##4##(1992-2#2)
in response to IGF-I production##2##5##(2008-11#2)
in response to IGF-I##4##4##(1993-6#1)(1997-1#1)(2008-11#2)
in response to LPS##3##4##(1993-6#1)(2008-8#1)(2008-9#1)
in response to TNF##2##4##(1995-2#1)(2011-2#1)
in response to a given##2##5##(2008-11#1)(2012-2#1)
in response to a variety of##2##6##(2008-11#1)(2011-2#1)
in response to a##30##4##(1990-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
in response to activation of the##3##6##(1997-6#1)(2008-11#2)
in response to activation of##4##5##(1996-2#1)(1997-6#1)(2008-11#2)
in response to activation with##2##5##(1993-6#2)
in response to activation##6##4##(1993-6#2)(1996-2#1)(1997-6#1)(2008-11#2)
in response to acute##3##4##(1993-2#1)(1995-6#1)(1996-2#1)
in response to all##3##4##(2008-10#2)(2008-5#1)
in response to an increase in##4##6##(1993-3#1)(2008-5#1)(2008-7#1)(2009-1#1)
in response to an##10##4##(1993-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#2)
in response to apple##2##4##(2008-10#2)
in response to both##3##4##(1992-4#1)(1992-8#1)(2007-12#1)
in response to cAMP##2##4##(1991-2#1)(1996-12#1)
in response to cage transfer##2##5##(2008-11#2)
in response to cellular##2##4##(1993-9#1)(1996-2#1)
in response to changes in environmental##2##6##(1992-12#1)(1995-11#1)
in response to changes in##5##5##(1990-6#1)(1992-12#1)(1995-11#1)(2008-10#1)(2009-8#1)
in response to changing##2##4##(1992-2#1)(2009-6#1)
in response to cyclic##2##4##(1994-6#1)(2010-4#1)
in response to cytokines and##2##5##(1990-2#1)(2008-4#1)
in response to different##5##4##(2008-10#2)(2009-10#1)(2010-10#1)(2012-2#1)
in response to either##2##4##(2008-9#1)(2009-5#1)
in response to electrical stimulation##2##5##(1990-7#1)(2008-7#1)
in response to electrical##3##4##(1990-7#1)(1993-12#1)(2008-7#1)
in response to elevated glucose##2##5##(1992-8#1)(2010-11#1)
in response to endothelin-1##2##4##(1990-8#2)
in response to environmental and##2##5##(2008-8#1)(2011-1#1)
in response to environmental changes##2##5##(2009-6#1)(2013-8#1)
in response to environmental cues##2##5##(2012-1#2)
in response to environmental##8##4##(2008-8#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-8#1)
in response to external##4##4##(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)
in response to extracellular stimuli##2##5##(1996-2#2)
in response to extracellular##4##4##(1996-2#2)(1996-5#1)(2008-4#1)
in response to glucose and##2##5##(1995-8#1)(1996-3#1)
in response to glucose##3##4##(1995-8#1)(1996-3#1)(2010-11#1)
in response to granulocyte macrophage colony stimulating factor (GM-CSF)##2##9##(1992-3#2)
in response to growth factors##5##5##(1990-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(2011-2#1)
in response to growth##6##4##(1990-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(1995-11#1)(2011-2#1)
in response to heat##2##4##(2008-7#1)(2008-8#1)
in response to infection##2##4##(2008-10#2)
in response to injury##2##4##(2008-1#2)
in response to insulin##3##4##(2008-3#1)(2010-11#1)(2010-4#1)
in response to low doses of##4##6##(2008-7#4)
in response to low doses##5##5##(2008-7#5)
in response to low##6##4##(2008-7#5)(2009-8#1)
in response to other##2##4##(1994-11#1)(2012-12#1)
in response to phorbol ester##2##5##(1994-11#1)(1994-8#1)
in response to physiologic##2##4##(2008-10#1)(2010-10#1)
in response to portal infusion of hypertonic saline##3##8##(1993-12#3)
in response to selection for##2##5##(2008-7#1)(2008-9#1)
in response to several##3##4##(1995-8#1)(2008-10#1)(2010-5#1)
in response to sodium depletion##2##5##(1993-12#2)
in response to some##2##4##(2010-3#1)(2012-12#1)
in response to specific##3##4##(2008-10#1)(2009-12#1)(2012-12#1)
in response to stimulation with brucella##2##6##(1996-12#2)
in response to stimulation with##4##5##(1991-2#1)(1996-12#2)(2008-6#1)
in response to stimulation##6##4##(1991-2#1)(1992-3#1)(1996-12#2)(2008-10#1)(2008-6#1)
in response to stress##4##4##(1994-11#1)(1994-8#1)(2012-2#1)(2013-8#1)
in response to taste stimuli##4##5##(1996-8#1)(2012-12#1)(2013-1#2)
in response to taste##5##4##(1996-8#2)(2012-12#1)(2013-1#2)
in response to the##36##4##(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
in response to these##2##4##(1990-2#1)(2008-8#1)
in response to various stimuli##4##5##(1995-8#1)(2008-4#2)(2009-3#1)
in response to various##7##4##(1995-8#1)(2008-1#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-1#1)
in response to water##2##4##(2009-8#2)
in response to##471##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#1)(1992-6#2)(1992-8#9)(1992-9#2)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#5)(1993-6#9)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#9)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#3)(1995-8#5)(1996-1#1)(1996-12#6)(1996-2#10)(1996-3#3)(1996-5#3)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#4)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#10)(2008-10#59)(2008-11#20)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#6)(2008-7#22)(2008-8#16)(2008-9#21)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#13)(2012-1#3)(2012-12#10)(2012-2#6)(2012-3#3)(2012-8#2)(2013-1#10)(2013-7#2)(2013-8#6)
in response##489##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#5)(1992-4#1)(1992-6#2)(1992-8#9)(1992-9#2)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#5)(1993-6#10)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#9)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#5)(1996-1#1)(1996-12#6)(1996-2#10)(1996-3#3)(1996-5#3)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#4)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#10)(2008-10#64)(2008-11#22)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#8)(2008-7#22)(2008-8#17)(2008-9#21)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#14)(2012-1#3)(2012-12#10)(2012-2#6)(2012-3#3)(2012-8#2)(2013-1#10)(2013-7#2)(2013-8#6)
in responses to##5##3##(2007-12#2)(2008-8#1)(2009-4#1)(2012-3#1)
in responses##6##2##(2007-12#2)(2008-10#1)(2008-8#1)(2009-4#1)(2012-3#1)
in responsive##2##2##(2008-7#1)(2011-2#1)
in resting T cells##2##4##(1992-6#2)
in resting platelets##3##3##(1992-6#1)(1993-8#1)(2006-6#1)
in resting tension in##2##4##(1990-12#1)(1996-9#1)
in resting##16##2##(1990-12#1)(1990-2#1)(1992-6#3)(1993-8#1)(1993-9#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-7#1)(2006-6#1)(2008-3#1)(2008-5#2)(2008-7#1)
in restorative##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
in restoring the##2##3##(2008-7#1)(2012-2#1)
in restoring##3##2##(2008-7#1)(2012-2#2)
in restriction##2##2##(1997-8#1)(2008-10#1)
in restrictive anorexia nervosa##2##4##(2012-3#2)
in restructuring##2##2##(1993-1#1)(1995-3#1)
in retail##3##2##(1997-1#1)(2007-12#1)(2013-1#1)
in retention and##2##3##(1992-1#1)(1995-6#1)
in retention##5##2##(1992-1#1)(1992-12#1)(1994-8#1)(1995-6#1)(2009-5#1)
in reticular##3##2##(2013-1#3)
in reticulocyte lysate##3##3##(1994-5#3)
in reticulocyte lysates##3##3##(1993-2#1)(1994-5#1)(1994-6#1)
in reticulocyte##6##2##(1993-2#1)(1994-5#4)(1994-6#1)
in reticulocytes##2##2##(1993-2#1)(1994-6#1)
in retina##2##2##(2010-1#1)(2012-12#1)
in retinal##9##2##(1990-11#1)(1993-8#1)(1995-5#1)(1997-1#1)(2008-3#1)(2011-1#2)(2011-2#1)(2011-9#1)
in retinoic##2##2##(1993-3#1)(2012-1#1)
in retrieving##3##2##(1997-3#1)(2008-2#1)(2008-3#1)
in retrograde##2##2##(1994-12#1)(2009-2#1)
in retroperitoneal##2##2##(1992-12#1)(2012-12#1)
in return for##4##3##(1990-4#1)(1995-12#2)(2008-12#1)
in return##6##2##(1990-4#1)(1994-3#1)(1995-12#2)(2008-12#1)(2008-6#1)
in returned##3##2##(2007-2#1)(2011-2#2)
in returning travelers##2##3##(2011-2#2)
in returning travellers##3##3##(2007-2#1)(2009-5#2)
in returning##5##2##(2007-2#1)(2009-5#2)(2011-2#2)
in revascularization##2##2##(1990-5#1)(2008-11#1)
in revealing##5##2##(1990-6#1)(2008-1#1)(2008-12#1)(2008-5#2)
in reverse mode and determination##2##5##(2008-10#2)
in reverse##12##2##(1993-2#1)(1995-3#2)(1996-2#1)(2008-10#6)(2008-7#1)(2011-1#1)
in reversed micellar systems##2##4##(1990-5#2)
in reversed micelles##3##3##(1995-3#1)(2008-10#2)
in reversed phase liquid chromatography (RPLC)##2##6##(2008-10#2)
in reversed phase##3##3##(2008-10#3)
in reversed##10##2##(1990-5#2)(1995-3#1)(2008-10#5)(2008-8#2)
in reversed-phase HPLC##2##3##(1993-11#1)(2008-10#1)
in reversed-phase high-performance liquid chromatography##4##5##(1990-8#2)(1992-6#1)(1996-5#1)
in reversed-phase##9##2##(1990-8#2)(1992-6#1)(1993-11#1)(1995-3#1)(1996-5#3)(2008-10#1)
in reversible##3##2##(1995-6#1)(2009-10#2)
in reversing resistance to##2##4##(1992-8#1)(1994-10#1)
in reversing the##3##3##(1992-12#1)(2012-2#2)
in reversing##8##2##(1992-12#1)(1992-8#2)(1993-11#1)(1994-10#1)(2008-8#1)(2012-2#2)
in review##2##2##(2008-12#1)(2009-12#1)
in reviewing##3##2##(1996-1#1)(1996-3#1)(2010-9#1)
in revision surgery##2##3##(2009-7#1)(2011-2#1)
in revision##4##2##(2008-11#1)(2009-7#1)(2011-2#2)
in reward magnitude##3##3##(1993-12#3)
in reward##7##2##(1992-11#1)(1993-12#4)(1994-8#1)(2013-8#1)
in rhesus monkeys##7##3##(1991-1#2)(1995-2#1)(1996-2#4)
in rheumatic##4##2##(1991-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
in rheumatoid arthritis##10##3##(1993-2#1)(1995-5#1)(1997-6#1)(2007-11#4)(2007-8#1)(2008-8#1)(2012-2#1)
in rheumatoid arthritis]##2##3##(1991-11#1)(1991-3#1)
in rheumatoid##13##2##(1991-11#1)(1991-3#1)(1993-2#2)(1995-5#1)(1997-6#1)(2007-11#4)(2007-8#1)(2008-8#1)(2012-2#1)
in rheumatology##5##2##(1997-3#1)(1997-4#1)(2006-10#2)(2010-12#1)
in rhizosphere##3##2##(2008-10#2)(2013-8#1)
in rhumatoid##2##2##(2007-8#2)
in ribosomal##2##2##(2008-8#1)(2009-11#1)
in ribosome##5##2##(1991-6#1)(2008-9#1)(2011-2#2)(2012-3#1)
in rice (Oryza sativa L##2##5##(2008-9#2)
in rice (Oryza sativa##3##4##(2008-9#2)(2009-10#1)
in rice (Oryza##4##3##(2008-9#2)(2009-10#2)
in rice and##5##3##(2008-10#2)(2008-12#1)(2009-10#1)(2011-3#1)
in rice flour##2##3##(2008-10#2)
in rice genome##5##3##(2008-8#2)(2008-9#3)
in rice grain##2##3##(2013-1#2)
in rice grains##2##3##(2008-12#2)
in rice improvement##2##3##(2009-10#2)
in rice leaves##2##3##(2008-10#2)
in rice plants##3##3##(2008-10#2)(2008-9#1)
in rice using liquid##2##4##(2011-1#2)
in rice using##3##3##(2009-10#1)(2011-1#2)
in rice was##2##3##(1993-11#1)(2008-4#1)
in rice wines##2##3##(2008-10#2)
in rice##100##2##(1993-11#2)(1995-6#1)(1996-10#2)(1996-8#1)(1997-2#1)(2008-10#27)(2008-12#5)(2008-4#3)(2008-7#2)(2008-8#10)(2008-9#16)(2009-10#20)(2009-8#1)(2011-1#3)(2011-3#3)(2013-1#2)(2013-8#1)
in rich##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
in richness and abundance##2##4##(2008-6#2)
in right##10##2##(2007-8#2)(2008-3#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in ring 3##3##3##(2011-2#3)
in ring##6##2##(1991-8#1)(2008-10#1)(2008-2#1)(2011-2#3)
in ringed##2##2##(2007-6#1)(2008-10#1)
in rising##2##2##(1990-6#1)(1997-5#1)
in risk assessment##7##3##(1991-12#1)(1993-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
in risk for##2##3##(2008-11#1)(2009-12#1)
in risk management##3##3##(1993-2#2)(1994-2#1)
in risk of##4##3##(1990-6#1)(1992-10#1)(1993-11#1)(2013-1#1)
in risk##40##2##(1990-6#2)(1991-12#1)(1991-6#1)(1992-10#2)(1993-1#1)(1993-11#2)(1993-2#3)(1993-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
in risky##7##2##(2008-3#2)(2009-10#1)(2009-9#1)(2013-1#1)(2013-8#2)
in river and reservoir water##3##5##(2008-10#3)
in river and seawater##2##4##(2008-10#2)
in river and tap water##2##5##(2008-10#2)
in river and##11##3##(2008-10#11)
in river sediment##2##3##(2008-10#2)
in river water by##4##4##(2008-10#4)
in river water is##2##4##(2008-10#2)
in river water samples and in technical formulations##2##8##(2008-10#2)
in river water samples and##3##5##(2008-10#3)
in river water samples##6##4##(2008-10#6)
in river water with##2##4##(2008-10#2)
in river water##34##3##(2008-10#34)
in river waters##6##3##(2008-10#6)
in river##59##2##(2008-10#58)(2013-7#1)
in riverine##2##2##(2008-10#2)
in roach##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
in road##3##2##(2010-11#2)(2011-1#1)
in robot##2##2##(2007-12#2)
in rocks and##2##3##(2008-10#1)(2010-12#1)
in rockwool##2##2##(2008-10#2)
in rodent and human##2##4##(1994-12#1)(1995-9#1)
in rodent and##3##3##(1992-12#1)(1994-12#1)(1995-9#1)
in rodent models##2##3##(2008-10#1)(2010-5#1)
in rodent##11##2##(1991-5#1)(1992-12#1)(1992-3#2)(1993-12#1)(1994-12#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-9#1)(2010-5#1)
in rodents and primates##2##4##(2008-1#1)(2013-8#1)
in rodents and##6##3##(1995-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-8#1)
in rodents has##2##3##(2008-5#1)(2008-7#1)
in rodents##37##2##(1990-3#1)(1991-9#1)(1992-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-9#1)(1997-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#7)(2008-5#2)(2008-7#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
in role##2##2##(1995-3#1)(2011-2#1)
in roller bottles##2##3##(2008-11#2)
in romantic relationships##2##3##(2007-12#1)(2008-9#1)
in room##2##2##(2008-10#1)(2008-3#1)
in room-temperature##3##2##(2008-2#3)
in rooms with##2##3##(1990-2#2)
in rooms##3##2##(1990-2#3)
in root apices##2##3##(2009-6#1)(2012-2#1)
in root coverage##2##3##(2013-1#2)
in root cultures##2##3##(2008-11#2)
in root tissues##2##3##(2008-10#2)
in root##23##2##(1993-2#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#3)
in roots and leaves of##3##5##(2008-12#2)(2012-7#1)
in roots and shoots##2##4##(2008-12#2)
in roots and##8##3##(2008-10#2)(2008-12#4)(2010-5#1)(2012-7#1)
in roots of##6##3##(2008-10#4)(2008-9#1)(2013-8#1)
in roots were##3##3##(2008-10#2)(2008-12#1)
in roots##28##2##(2008-10#13)(2008-11#1)(2008-12#6)(2008-9#2)(2010-5#1)(2011-10#2)(2012-7#2)(2013-8#1)
in rose##2##2##(2008-10#2)
in rosy-faced lovebirds##2##3##(1997-3#2)
in rotation##4##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#1)
in rough##2##2##(1994-5#1)(2007-12#1)
in round##4##2##(2007-11#2)(2008-2#1)(2008-9#1)
in route##2##2##(2008-3#1)(2010-8#1)
in routine analysis##3##3##(2008-10#3)
in routine clinical practice##2##4##(2008-3#1)(2012-2#1)
in routine clinical##4##3##(2008-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
in routine laboratories##3##3##(2008-10#2)(2009-8#1)
in routine##26##2##(1993-9#1)(1997-2#1)(2007-10#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
in ruling out##2##3##(2006-5#1)(2012-2#1)
in ruminants##2##2##(2012-2#1)(2013-1#1)
in rural America##2##3##(1996-3#1)(2009-8#1)
in rural India##2##3##(2009-5#1)(2012-2#1)
in rural Malawi##3##3##(1996-12#1)(2010-12#2)
in rural Saskatchewan##2##3##(1996-1#2)
in rural and urban##2##4##(1994-2#1)(2007-9#1)
in rural and##7##3##(1994-2#1)(1997-4#1)(2007-9#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-12#1)
in rural areas of##2##4##(2011-1#1)(2012-3#1)
in rural areas where##2##4##(1996-12#1)(1996-5#1)
in rural areas##27##3##(1991-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-2#2)(2007-7#1)(2008-5#1)(2009-4#3)(2010-10#3)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in rural communities##4##3##(1996-11#1)(1997-4#1)(2010-4#1)(2013-1#1)
in rural community##2##3##(2008-12#1)(2010-9#1)
in rural counties##3##3##(1996-3#2)(2008-10#1)
in rural health##3##3##(1995-2#1)(1996-3#1)(2012-12#1)
in rural settings##4##3##(1996-1#2)(2008-11#1)(2013-1#1)
in rural##89##2##(1991-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-3#9)(1996-5#1)(1997-2#2)(1997-4#2)(1997-7#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-12#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-10#4)(2010-12#5)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
in rust##3##2##(2008-10#3)
in rye##2##2##(2008-10#2)
in safe##2##2##(2008-11#1)(2011-1#1)
in safety between##2##3##(2011-1#1)(2012-2#1)
in safety testing##3##3##(2008-5#2)(2010-11#1)
in safety##10##2##(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-11#2)(2011-1#1)(2012-2#1)
in sagittal##2##2##(1995-12#1)(2009-4#1)
in salary##2##2##(1991-12#1)(1991-3#1)
in saline matrices##4##3##(2008-10#4)
in saline solution##2##3##(2008-5#1)(2009-6#1)
in saline##17##2##(1994-12#1)(1994-2#1)(1994-5#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#1)(2009-6#1)(2010-10#1)(2013-1#1)
in saliva and##2##3##(2008-10#2)
in saliva by##2##3##(2008-10#2)
in saliva flow rate##2##4##(2013-1#1)(2013-8#1)
in saliva##14##2##(1991-8#1)(2008-10#9)(2013-1#1)(2013-8#3)
in salivary glands##5##3##(1990-12#1)(1994-7#2)(2011-2#2)
in salivary##11##2##(1990-12#1)(1993-12#1)(1994-7#2)(2008-10#1)(2011-2#3)(2013-8#3)
in salmon egg cell cytoplasm##3##5##(2008-10#3)
in salmon##4##2##(2008-10#3)(2008-8#1)
in salmonids##4##2##(2008-10#1)(2008-7#1)(2009-6#2)
in salt##5##2##(1990-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
in same##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
in sample preparation##5##3##(2008-10#4)(2008-9#1)
in sample solution##3##3##(2008-10#3)
in sample solutions##3##3##(2008-10#1)(2013-8#2)
in sample##25##2##(2008-10#18)(2008-12#1)(2008-4#1)(2008-9#2)(2010-3#1)(2013-8#2)
in samples and##3##3##(2008-10#3)
in samples collected in##2##4##(2008-10#2)
in samples collected##5##3##(1992-3#1)(2008-10#4)
in samples containing high amounts of various organic compounds##2##9##(2008-10#1)(2009-8#1)
in samples containing##7##3##(1992-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-8#1)
in samples from Si+ plants##3##5##(2008-10#3)
in samples from a##2##4##(2008-10#2)
in samples from##16##3##(1995-8#2)(1997-6#1)(2008-10#12)(2011-2#1)
in samples obtained from##2##4##(1991-12#1)(2008-10#1)
in samples of##20##3##(1991-2#1)(2008-10#12)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
in samples such as particulate matter##2##6##(2008-10#2)
in samples such as##3##4##(2008-10#3)
in samples taken from##2##4##(2008-12#1)(2013-1#1)
in samples that##2##3##(2008-10#2)
in samples was##2##3##(2008-10#2)
in samples with##5##3##(2008-10#3)(2008-9#1)(2011-2#1)
in samples##94##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#2)(1995-12#1)(1995-8#2)(1997-6#1)(2007-7#1)(2008-10#57)(2008-11#2)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#2)(2013-1#2)
in sampling##5##2##(1992-3#1)(2008-10#2)(2008-3#1)(2013-8#1)
in sand##3##2##(2008-10#2)(2011-2#1)
in sandy loam##2##3##(2008-10#1)(2011-1#1)
in sandy soil at##3##4##(2008-10#3)
in sandy soil##4##3##(2008-10#4)
in sandy##8##2##(2008-10#6)(2011-1#1)(2013-1#1)
in saphenous##2##2##(1991-6#1)(1996-5#1)
in sapphire are##2##3##(2007-12#2)
in sapphire##3##2##(2007-12#3)
in sarcoidosis##3##2##(2008-4#1)(2013-1#2)
in sarcolemmal##2##2##(1991-5#1)(1996-9#1)
in sarcoma cells##2##3##(2008-6#2)
in sarcoma patients##2##3##(2008-6#2)
in sarcoma##5##2##(2008-6#5)
in sarcomas##7##2##(2008-6#6)(2012-12#1)
in satisfaction##2##2##(2007-10#1)(2010-2#1)
in satisfactory agreement with the##2##5##(2008-2#2)
in satisfactory agreement with##4##4##(2008-10#2)(2008-2#2)
in satisfactory##8##2##(1992-2#1)(2007-11#1)(2008-10#4)(2008-2#2)
in satisfying##2##2##(1993-12#1)(2008-3#1)
in saturated glutaraldehyde##2##3##(2008-10#2)
in saturated##6##2##(1990-8#1)(1993-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
in saudi arabia##6##3##(2007-7#1)(2008-1#5)
in sauropsids##2##2##(2010-3#2)
in saving##2##2##(1993-8#1)(2011-1#1)
in savings##2##2##(1994-9#1)(1996-1#1)
in sawdust particles##2##3##(2008-12#2)
in sawdust##4##2##(2008-12#4)
in scale##4##2##(2007-12#2)(2008-5#1)(2012-2#1)
in scaliness##2##2##(2008-5#2)
in scanning electron##2##3##(2008-10#1)(2008-11#1)
in scanning tunneling optical microscopy##2##5##(2007-12#2)
in scanning##8##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)
in scattered##2##2##(1995-12#1)(2008-3#1)
in scattering media by##2##4##(2007-12#1)(2008-3#1)
in scattering media is##2##4##(2007-12#1)(2008-3#1)
in scattering media##13##3##(2007-12#3)(2008-2#3)(2008-3#7)
in scattering##17##2##(2007-12#3)(2008-2#6)(2008-3#8)
in scavenging##4##2##(1995-3#1)(1995-6#1)(2008-10#1)(2008-4#1)
in schistosomiasis##3##2##(2012-3#3)
in schizophrenia and##4##3##(2008-2#1)(2009-6#1)(2010-1#1)(2010-9#1)
in schizophrenia patients##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
in schizophrenia that##2##3##(2009-7#1)(2011-2#1)
in schizophrenia##48##2##(1990-2#1)(1993-9#7)(1995-11#4)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#4)(1996-7#3)(1996-8#1)(1997-5#1)(2008-2#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)
in schizophrenia]##3##2##(2008-9#1)(2012-1#1)(2012-12#1)
in schizophrenic patients##8##3##(1995-12#1)(1995-5#3)(1996-7#2)(2008-9#1)(2013-1#1)
in schizophrenic##9##2##(1995-12#1)(1995-5#3)(1996-7#2)(1997-5#1)(2008-9#1)(2013-1#1)
in school and##3##3##(1996-12#1)(2008-11#1)(2009-7#1)
in school children in##2##4##(2009-2#1)(2011-2#1)
in school children##3##3##(2009-2#1)(2009-7#1)(2011-2#1)
in school going children##3##4##(2007-7#1)(2008-7#1)(2012-3#1)
in school##22##2##(1991-12#3)(1993-6#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#6)(2011-2#1)(2012-2#1)(2012-3#1)
in school-age children in##2##4##(2009-9#1)(2011-2#1)
in school-age children##5##3##(1995-1#1)(2009-9#1)(2011-1#1)(2011-2#2)
in schools in the##2##4##(2007-12#1)(2008-7#1)
in schools in##3##3##(2007-12#1)(2008-7#1)(2010-1#1)
in schools of public health##2##5##(1996-3#2)
in schools##15##2##(1991-12#1)(1994-2#1)(1995-8#1)(1996-3#2)(1997-6#1)(2007-12#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
in sciatic##2##2##(1993-5#2)
in scid mice##2##3##(1994-3#2)
in science and##3##3##(1991-6#1)(2008-11#1)(2010-8#1)
in science##16##2##(1990-11#1)(1990-8#2)(1991-6#1)(1992-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-11#2)(2009-6#1)(2009-7#1)(2010-8#1)(2012-2#2)(2013-8#1)
in scientific articles##2##3##(2008-8#1)(2010-12#1)
in scientific journals##2##3##(1996-12#1)(2010-1#1)
in scientific##8##2##(1996-12#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
in scleroderma fibroblasts##3##3##(1992-8#3)
in scleroderma##4##2##(1992-8#3)(2006-10#1)
in scoliosis##2##2##(2007-8#1)(2009-3#1)
in scope and##2##3##(1994-3#1)(2008-12#1)
in scope##9##2##(1994-3#2)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)
in score##3##2##(1997-8#1)(2008-4#1)(2009-11#1)
in scores for##2##3##(2007-10#1)(2008-5#1)
in scores##5##2##(1990-3#1)(2007-10#1)(2008-5#1)(2009-10#1)(2013-1#1)
in scoring##3##2##(2007-11#1)(2009-5#1)(2010-11#1)
in scrapings##2##2##(1992-9#1)(1996-12#1)
in screening and##2##3##(1996-12#1)(2008-10#1)
in screening for##4##3##(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
in screening##14##2##(1990-10#1)(1996-12#2)(1996-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
in screw##2##2##(2008-10#1)(2008-8#1)
in sea temperature##2##3##(2010-8#2)
in sea water by##3##4##(2008-10#3)
in sea water samples##3##4##(2008-10#3)
in sea water##17##3##(1992-2#1)(1996-2#1)(2008-10#12)(2008-12#2)(2008-5#1)
in sea##23##2##(1990-5#1)(1992-2#1)(1996-2#1)(2008-10#14)(2008-12#2)(2008-5#1)(2008-7#1)(2010-8#2)
in seabream##2##2##(2008-11#1)(2010-5#1)
in seafood by inductively coupled plasma atomic emission spectrometry with##2##10##(2008-10#2)
in seafood##3##2##(2008-10#3)
in sealed##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
in search of a##4##4##(2008-3#1)(2010-2#1)(2010-3#1)(2013-8#1)
in search of the##3##4##(2008-3#1)(2010-5#1)(2012-3#1)
in search of##10##3##(1995-12#1)(1996-2#1)(2008-3#2)(2010-2#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-8#2)
in search##11##2##(1995-1#1)(1995-12#1)(1996-2#1)(2008-3#2)(2010-2#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-8#2)
in searching##2##2##(1992-12#1)(1995-2#1)
in seasonal##2##2##(1990-2#1)(2008-8#1)
in seawater and##2##3##(2008-10#2)
in seawater by ion-exclusion##2##4##(2008-10#2)
in seawater by##8##3##(2008-10#8)
in seawater is##2##3##(2008-10#2)
in seawater of##2##3##(2008-2#2)
in seawater samples##6##3##(2008-10#6)
in seawater using##5##3##(2008-10#5)
in seawater were##2##3##(2008-10#2)
in seawater##53##2##(2008-10#47)(2008-2#2)(2008-3#1)(2008-5#1)(2009-6#2)
in seborrheic keratosis##2##3##(2007-8#1)(2012-12#1)
in second degree##2##3##(1994-12#1)(2013-7#1)
in second trimester##3##3##(1996-12#2)(2012-12#1)
in second##10##2##(1993-2#1)(1994-12#1)(1996-12#2)(2009-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
in second-harmonic generation##2##3##(2008-2#1)(2008-3#1)
in second-harmonic##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
in secondary schools##2##3##(2008-10#1)(2013-1#1)
in secondary##20##2##(1991-5#1)(1993-2#1)(1993-9#2)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
in secreted##3##2##(1990-5#1)(1994-9#1)(2008-7#1)
in secretion of##2##3##(1997-1#1)(2008-9#1)
in secretion##7##2##(1990-11#1)(1991-6#1)(1994-12#1)(1997-1#1)(2008-6#1)(2008-7#1)(2008-9#1)
in secretory granules##4##3##(1993-5#1)(1995-8#1)(1996-5#1)(2008-4#1)
in secretory##10##2##(1993-2#1)(1993-5#1)(1995-8#1)(1996-5#2)(2007-12#2)(2008-11#2)(2008-4#1)
in section##2##2##(1990-12#1)(2008-10#1)
in sectioned material##2##3##(2008-4#2)
in sections of##4##3##(1990-5#1)(1994-9#1)(1997-3#1)(2008-9#1)
in securing##2##2##(1995-3#1)(2008-8#1)
in security##3##2##(1996-12#1)(2008-3#1)(2009-6#1)
in sedating the children##2##4##(2012-2#2)
in sedentary##5##2##(2008-3#1)(2008-9#2)(2012-2#1)(2013-1#1)
in sediment and##3##3##(2008-10#2)(2008-11#1)
in sediment pore waters and extracts##2##6##(2008-10#2)
in sediment samples##3##3##(2008-10#3)
in sediment##15##2##(2008-10#11)(2008-11#2)(2012-1#1)(2013-1#1)
in sediments using##3##3##(2008-10#3)
in sediments##17##2##(2008-10#15)(2008-5#2)
in seed output##3##3##(2008-9#3)
in seed production fields##2##4##(2008-10#2)
in seed production##4##3##(2008-10#2)(2008-9#2)
in seed yield##3##3##(2008-10#1)(2008-12#2)
in seed##21##2##(2008-10#12)(2008-12#3)(2008-9#5)(2009-8#1)
in seeded##3##2##(2007-11#3)
in seedling##6##2##(2008-10#5)(2008-5#1)
in seedlings of##3##3##(2008-10#2)(2008-8#1)
in seedlings##10##2##(2008-10#8)(2008-8#2)
in seeds and##3##3##(2008-10#2)(2008-5#1)
in seeds cooked for##2##4##(2010-2#2)
in seeds of##3##3##(2008-5#1)(2013-7#2)
in seeds##12##2##(2008-10#3)(2008-5#4)(2008-9#1)(2010-2#2)(2013-7#2)
in seeing##2##2##(2008-9#1)(2012-12#1)
in segment##2##2##(1992-4#1)(2013-8#1)
in segmented waveguides##2##3##(2008-2#2)
in segments##2##2##(2009-11#1)(2013-7#1)
in seismicity##2##2##(1996-4#2)
in seizure##2##2##(1990-5#1)(1994-2#1)
in seizure-naive GEPR-3##2##3##(1996-12#2)
in seizure-naive##3##2##(1996-12#3)
in select##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in selected brain regions of subordinate##2##6##(1992-1#2)
in selected cases of##3##4##(1990-10#1)(1990-9#1)(2012-2#1)
in selected cases##11##3##(1990-10#1)(1990-9#1)(1991-2#1)(1994-9#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2009-7#1)(2010-12#1)(2012-2#1)
in selected ion monitoring mode##2##5##(2008-10#2)
in selected ion monitoring##3##4##(2008-10#3)
in selected patient##2##3##(1996-11#1)(2011-2#1)
in selected patients with##5##4##(2007-8#2)(2008-11#1)(2009-5#2)
in selected patients##17##3##(1994-6#1)(2006-7#1)(2007-8#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
in selected##63##2##(1990-10#1)(1990-9#1)(1991-2#1)(1992-1#2)(1992-11#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
in selecting a##3##3##(1995-12#1)(1995-9#1)(2008-10#1)
in selecting patients##3##3##(2008-8#1)(2009-3#1)(2012-3#1)
in selecting the##4##3##(1990-9#1)(2008-12#1)(2012-2#1)(2013-1#1)
in selecting##19##2##(1990-9#1)(1991-12#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
in selection for##2##3##(2008-10#1)(2008-9#1)
in selection of##3##3##(1993-11#1)(2010-8#1)(2013-7#1)
in selection pressures##2##3##(2008-8#1)(2010-3#1)
in selection##9##2##(1993-11#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
in selective brain regions##3##4##(1994-6#3)
in selective##11##2##(1994-6#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)(2013-7#1)
in selectivity##7##2##(1994-9#2)(1995-3#1)(2008-10#4)
in selenite##3##2##(2008-10#3)
in selenium##3##2##(1997-8#1)(2008-10#2)
in selenium-deficient rats##2##3##(1991-12#1)(1992-11#1)
in self-control##2##2##(2008-12#2)
in self-esteem##4##2##(2007-12#1)(2008-5#1)(2009-7#1)(2010-3#1)
in self-referred##2##2##(1991-12#2)
in self-reported##4##2##(1991-9#1)(1994-6#1)(2007-12#1)(2010-12#1)
in semantic dementia##3##3##(2009-2#3)
in semantic##4##2##(2009-2#3)(2010-8#1)
in semen##7##2##(1991-8#1)(1992-6#1)(1996-9#1)(2008-12#2)(2008-7#1)(2013-1#1)
in semi-closed##2##2##(2011-2#2)
in semiarid grasslands##2##3##(2008-8#2)
in semiarid##3##2##(2008-8#3)
in semiconductor lasers##2##3##(2007-11#2)
in semiconductor optical amplifiers##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
in semiconductor##20##2##(1990-12#1)(1995-11#1)(2007-11#10)(2007-12#3)(2008-2#1)(2008-3#3)(2008-7#1)
in semiconductors##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
in semicontinuous##2##2##(2008-11#1)(2008-6#1)
in senescence##4##2##(1990-5#1)(1993-11#1)(2008-3#2)
in senescent rats##3##3##(1991-2#1)(2008-3#1)(2013-7#1)
in senescent##9##2##(1991-2#1)(1992-9#2)(1994-5#2)(2008-3#1)(2009-10#1)(2013-7#2)
in senile dementia and##3##4##(1994-5#1)(1994-6#1)(2008-7#1)
in senile dementia of Alzheimer's type##2##6##(1994-6#2)
in senile dementia##5##3##(1994-5#1)(1994-6#3)(2008-7#1)
in senile##9##2##(1990-3#1)(1991-7#1)(1994-5#1)(1994-6#3)(2008-7#2)(2012-1#1)
in sensitive and##2##3##(2008-10#1)(2008-11#1)
in sensitive cultivars##2##3##(2008-10#2)
in sensitive##13##2##(1990-2#1)(1991-4#1)(1995-3#1)(2008-10#7)(2008-11#1)(2010-9#1)(2012-12#1)
in sensitivity of the##2##4##(1990-5#1)(2008-10#1)
in sensitivity of##4##3##(1990-5#1)(2008-10#2)(2008-2#1)
in sensitivity to##8##3##(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2012-6#1)
in sensitivity was##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
in sensitivity##40##2##(1990-5#1)(1991-6#1)(1992-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-6#1)
in sensitized##2##2##(2010-5#1)(2011-2#1)
in sensor##4##2##(2008-10#1)(2008-3#1)(2009-9#1)(2011-1#1)
in sensory neurons##3##3##(2008-4#1)(2008-8#2)
in sensory##9##2##(1992-6#1)(1993-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)
in sentence processing##2##3##(2008-1#2)
in sentence##5##2##(1997-5#1)(2007-12#1)(2008-1#3)
in separate groups##2##3##(1996-5#1)(2008-10#1)
in separate##18##2##(1992-1#1)(1994-12#2)(1996-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#3)(2012-2#1)(2012-4#1)(2013-1#1)
in separated##2##2##(2008-10#1)(2013-1#1)
in separating##2##2##(2008-10#1)(2012-3#1)
in separation of##2##3##(2008-10#2)
in separation##7##2##(1994-12#1)(1997-2#1)(2008-10#5)
in sepsis##9##2##(1991-3#1)(1992-5#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-7#2)(2010-8#1)(2011-2#1)
in septic##2##2##(1991-9#1)(1995-2#1)
in septo-hippocampal##2##2##(1996-2#2)
in septum##2##2##(1994-8#2)
in sequence databases##2##3##(1996-8#1)(2010-11#1)
in sequence homology##2##3##(2008-10#1)(2008-9#1)
in sequence##20##2##(1990-8#2)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#2)
in sequencing##4##2##(1994-12#1)(2008-10#1)(2009-5#1)(2012-3#1)
in sequential##5##2##(1991-8#1)(1992-9#1)(1995-8#1)(2008-10#1)(2011-2#1)
in sera from patients with##3##5##(1993-2#2)(1996-12#1)
in sera from##8##3##(1992-11#3)(1993-2#2)(1994-6#1)(1996-12#2)
in sera of patients with##2##5##(1993-1#1)(1994-11#1)
in sera of patients##3##4##(1991-2#1)(1993-1#1)(1994-11#1)
in sera##15##2##(1990-8#1)(1991-2#1)(1992-11#3)(1993-1#1)(1993-2#2)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#2)(2008-10#1)(2010-4#1)
in serial##2##2##(1996-5#1)(2012-3#1)
in series to##2##3##(1990-8#1)(2008-3#1)
in series with##2##3##(2008-10#1)(2008-11#1)
in series##28##2##(1990-8#3)(1991-5#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2011-1#1)
in serious##7##2##(1992-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)
in serogroup Y##2##3##(2007-12#2)
in serological##3##2##(1994-6#1)(2008-10#1)(2012-3#1)
in seropositive##2##2##(1990-9#1)(2010-12#1)
in serotonergic signaling##5##3##(2012-3#5)
in serous##2##2##(2008-10#1)(2008-7#1)
in serum (P &lt##2##3##(2012-2#2)
in serum (p = 0##2##5##(2008-7#2)
in serum T##3##3##(2013-8#3)
in serum and liver##2##4##(2008-10#1)(2008-12#1)
in serum and plasma##3##4##(2008-10#1)(2011-2#2)
in serum and rat brain##2##5##(2008-10#2)
in serum and tissues##2##4##(1991-8#1)(2013-1#1)
in serum and urine by##3##5##(1992-11#1)(2006-10#1)(2008-7#1)
in serum and urine##9##4##(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(2006-10#1)(2008-10#3)(2008-7#1)
in serum and##32##3##(1990-12#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#2)(2013-1#1)
in serum are##2##3##(1990-2#1)(2008-10#1)
in serum bilirubin##2##3##(1990-8#1)(2013-1#1)
in serum by##7##3##(1992-3#1)(2008-10#5)(2008-4#1)
in serum cholesterol##3##3##(1993-12#1)(1993-9#1)(1997-7#1)
in serum containing medium##4##4##(2008-11#4)
in serum containing##5##3##(2008-11#5)
in serum from patients##2##4##(1991-12#1)(2011-2#1)
in serum from##3##3##(1991-12#1)(2008-9#1)(2011-2#1)
in serum is##2##3##(2008-10#1)(2008-7#1)
in serum of patients with##3##5##(1990-6#1)(1994-8#1)(1996-10#1)
in serum of##9##3##(1990-6#1)(1994-8#1)(1996-10#1)(2008-10#2)(2008-7#2)(2013-1#2)
in serum or plasma##4##4##(1990-8#1)(1994-2#1)(2008-4#1)(2009-6#1)
in serum samples from##2##4##(1996-12#1)(2008-5#1)
in serum samples##10##3##(1996-12#1)(1997-6#1)(2008-10#7)(2008-5#1)
in serum specimens##2##3##(1991-12#1)(1994-3#1)
in serum triglyceride of##2##4##(2008-3#2)
in serum triglycerides##2##3##(1991-8#1)(1993-12#1)
in serum was##5##3##(1990-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
in serum were measured##2##4##(1992-6#1)(1993-12#1)
in serum were##5##3##(1990-8#2)(1992-6#1)(1993-12#1)(2010-5#1)
in serum with##2##3##(1991-12#1)(2008-3#1)
in serum##199##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#9)(1991-12#6)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#4)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#7)(1993-2#6)(1993-9#1)(1994-2#1)(1994-3#3)(1994-8#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#4)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-7#1)(2007-10#2)(2007-8#1)(2008-10#48)(2008-11#8)(2008-12#1)(2008-3#6)(2008-4#4)(2008-5#3)(2008-7#9)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#9)
in serum-containing media##2##3##(2008-11#2)
in serum-containing medium##6##3##(2008-11#6)
in serum-containing##10##2##(1994-9#1)(2008-11#9)
in serum-deprived L6J1##3##3##(1990-12#3)
in serum-deprived##5##2##(1990-12#3)(1996-2#1)(2008-8#1)
in serum-free collagen gel culture##2##5##(1990-7#2)
in serum-free culture##5##3##(1992-9#1)(2008-11#4)
in serum-free media for mammalian##2##5##(2008-11#2)
in serum-free media for##3##4##(2008-11#3)
in serum-free media##7##3##(2008-11#7)
in serum-free medium in##3##4##(2008-11#3)
in serum-free medium##18##3##(1990-12#1)(1992-12#1)(1992-2#2)(1992-9#1)(1995-11#1)(2008-11#9)(2008-4#1)(2008-9#2)
in serum-free suspension culture##5##4##(2008-11#5)
in serum-free suspension##6##3##(2008-11#6)
in serum-free##45##2##(1990-12#1)(1990-7#2)(1991-12#1)(1992-12#1)(1992-2#2)(1992-9#2)(1995-11#1)(2008-11#31)(2008-4#1)(2008-7#1)(2008-9#2)
in serum-supplemented##3##2##(2008-11#3)
in serum/plasma##2##2##(1990-11#1)(2011-2#1)
in service delivery##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
in service use##3##3##(1991-1#2)(1995-3#1)
in service##17##2##(1991-1#2)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-3#2)(1996-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
in serving##2##2##(1993-1#1)(2011-1#1)
in set shifting##2##3##(2008-11#2)
in setting up##3##3##(1990-2#1)(2007-12#2)
in setting##10##2##(1990-2#1)(1993-9#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2012-12#1)
in settings such as##2##4##(2007-12#2)
in settings##5##2##(1993-1#1)(2007-12#2)(2008-8#1)(2012-12#1)
in seven Canadian##2##3##(2007-12#1)(2008-10#1)
in seven European countries##2##4##(2008-7#1)(2009-5#1)
in seven European##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
in seven different##2##3##(2008-10#1)(2008-3#1)
in seven of the##3##4##(1991-12#1)(1997-3#1)(2013-7#1)
in seven of them##2##4##(1992-6#1)(1994-9#1)
in seven of##7##3##(1990-5#2)(1991-12#1)(1992-6#1)(1994-9#1)(1997-3#1)(2013-7#1)
in seven patients and##2##4##(1993-2#1)(2011-2#1)
in seven patients with##2##4##(2006-12#1)(2010-8#1)
in seven patients##7##3##(1993-2#1)(2006-12#1)(2008-1#2)(2010-8#1)(2011-2#2)
in seven##65##2##(1990-5#2)(1991-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#2)
in seventeenth-century##3##2##(2008-10#2)(2008-11#1)
in several applications##2##3##(2008-12#1)(2008-7#1)
in several areas of##2##4##(1994-11#1)(2008-10#1)
in several areas##5##3##(1993-3#1)(1994-11#1)(2008-10#2)(2009-4#1)
in several aspects##2##3##(2007-2#1)(2008-8#1)
in several assays##2##3##(1992-11#1)(1995-2#1)
in several brain regions##2##4##(1994-2#1)(2012-3#1)
in several cancers##3##3##(2008-7#1)(2010-8#1)(2012-2#1)
in several cases##3##3##(1996-6#1)(2008-8#1)(2011-2#1)
in several cell types##2##4##(1992-12#1)(2008-4#1)
in several cell##3##3##(1992-12#1)(2008-4#1)(2013-8#1)
in several clinical##2##3##(1995-3#1)(2012-2#1)
in several countries##4##3##(1993-3#1)(2011-2#2)(2013-1#1)
in several different##8##3##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
in several disciplines##3##3##(1996-1#1)(2007-2#1)(2008-10#1)
in several fish species##2##4##(2010-8#2)
in several formats##3##3##(1997-1#1)(2007-11#1)(2008-4#1)
in several forms##2##3##(1995-6#1)(2008-1#1)
in several human##4##3##(1991-6#1)(1992-3#1)(1995-5#1)(2011-2#1)
in several hundred##3##3##(1991-9#1)(2008-5#1)(2013-8#1)
in several important##3##3##(2007-12#1)(2008-6#1)(2010-8#1)
in several in##2##3##(1992-2#1)(2012-3#1)
in several laboratories##3##3##(1995-12#1)(1996-2#1)(2008-10#1)
in several other##6##3##(1992-9#1)(1995-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
in several populations of##2##4##(2008-1#1)(2011-2#1)
in several regions of##2##4##(2008-10#1)(2008-4#1)
in several samples##4##3##(1992-5#1)(2008-10#3)
in several soil samples that yielded a relative error of 1% in the concentrations##2##14##(2008-10#2)
in several species##3##3##(1990-2#1)(1990-3#1)(1992-6#1)
in several standard reference materials (alloys and steels)##2##8##(2008-10#2)
in several strains of##2##4##(2008-4#1)(2008-9#1)
in several strains##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
in several studies##5##3##(1992-10#1)(2007-10#1)(2008-2#1)(2010-5#1)(2012-4#1)
in several synthetic mixtures containing different concentration ratios of##2##9##(2008-10#2)
in several synthetic mixtures containing different concentration##3##7##(2008-10#3)
in several synthetic mixtures##4##4##(2008-10#4)
in several synthetic##7##3##(2008-10#7)
in several taxa##2##3##(2008-8#1)(2008-9#1)
in several tissues##2##3##(1994-12#1)(2008-12#1)
in several types of##2##4##(2008-10#2)
in several water samples##2##4##(2008-10#2)
in several ways##7##3##(1991-3#1)(1996-3#1)(1996-6#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)
in several##246##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#4)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#3)(2007-11#2)(2007-12#8)(2007-2#2)(2008-1#3)(2008-10#62)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#6)(2009-12#4)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#5)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#6)(2013-8#2)
in severe and##3##3##(1990-6#1)(1992-9#1)(2011-2#1)
in severe cases##5##3##(2007-12#1)(2008-8#2)(2013-1#2)
in severe chronic##2##3##(2008-6#1)(2011-2#1)
in severe sepsis and septic shock##3##6##(2011-2#3)
in severe sepsis##7##3##(2009-5#1)(2009-6#2)(2009-9#1)(2011-2#3)
in severe##48##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-5#1)(2011-2#7)(2012-1#1)(2012-2#2)(2013-1#5)
in severe-to-profound hearing-impaired patients##3##4##(2008-2#3)
in severely damaged##2##3##(2008-10#1)(2010-10#1)
in severely overweight youth##2##4##(2008-3#2)
in severely overweight##3##3##(2008-3#3)
in severely##9##2##(1990-8#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-4#1)(2010-10#1)(2010-5#1)
in severity of##4##3##(1993-12#1)(2008-10#2)(2008-12#1)
in severity##10##2##(1992-3#1)(1993-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2010-12#1)
in sewage samples have been##2##5##(2008-10#2)
in sewage sludge##6##3##(1997-4#2)(2008-10#4)
in sewage##11##2##(1991-11#1)(1997-4#2)(2008-10#6)(2008-11#1)(2009-12#1)
in sex determination##2##3##(2010-3#2)
in sex ratio##2##3##(2008-8#1)(2008-9#1)
in sex##12##2##(1991-3#1)(1997-7#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-3#2)(2010-8#1)(2012-3#2)
in sex-determining mechanisms##2##3##(2010-3#2)
in sexual assault##2##3##(1996-5#1)(2012-3#1)
in sexual relations##2##3##(2009-5#1)(2012-2#1)
in sexual##20##2##(1991-3#1)(1993-9#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-3#3)(2012-2#3)(2012-3#4)(2013-1#1)
in sexually##7##2##(1990-6#1)(1995-12#4)(2008-10#1)(2012-1#1)
in shake flasks##3##3##(2008-11#2)(2008-12#1)
in shake##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
in shake-flask##3##2##(2008-11#1)(2008-7#2)
in shallow tillage##2##3##(2008-12#2)
in shallow##4##2##(2008-12#2)(2008-2#1)(2008-5#1)
in shallow-flooded plots##2##3##(2013-8#2)
in sham##2##2##(1995-12#1)(2012-3#1)
in sham-operated animals##2##3##(1990-5#2)
in sham-operated##3##2##(1990-5#2)(1994-8#1)
in shampoo##3##2##(2008-10#1)(2008-5#2)
in shampoos##3##2##(2008-5#3)
in shape and size##2##4##(2007-12#1)(2009-5#1)
in shape and##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-5#1)(2011-2#1)(2012-2#1)
in shape##21##2##(1993-9#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
in shaping the##5##3##(1995-11#1)(1997-1#1)(2008-10#1)(2008-8#1)(2011-3#1)
in shaping##12##2##(1993-1#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-8#3)(2009-7#1)(2011-3#1)(2012-3#1)
in shared##2##2##(1990-8#1)(1995-1#1)
in sharp contrast##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
in sharp##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
in shear##2##2##(2008-8#1)(2013-1#1)
in sheep and goats##2##4##(1996-5#1)(2008-12#1)
in sheep and##5##3##(1996-3#2)(1996-5#1)(2008-12#1)(2008-8#1)
in sheep was##2##3##(2008-12#1)(2008-8#1)
in sheep##21##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-2#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-4#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-4#1)(2011-1#2)
in sheets##2##2##(1991-6#1)(2012-12#1)
in shifting the##2##3##(1994-3#1)(2008-10#1)
in shifting##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
in shiitake mushroom##4##3##(2008-10#4)
in shock##2##2##(2007-8#1)(2013-1#1)
in shoots of##2##3##(2008-10#1)(2008-12#1)
in shoots##6##2##(2008-10#1)(2008-12#5)
in short supply##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
in short term##3##3##(1994-2#1)(2012-2#1)(2013-1#1)
in short time##4##3##(2008-10#1)(2008-11#1)(2011-3#1)(2012-12#1)
in short##23##2##(1990-2#1)(1993-10#1)(1994-2#1)(1996-8#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
in short)##2##2##(2008-5#2)
in short-circuit current##2##3##(1990-5#1)(1991-5#1)
in short-term##10##2##(1991-10#1)(1992-9#1)(1995-3#1)(2008-11#3)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
in shorter##2##2##(2007-6#1)(2008-4#1)
in shoulder##2##2##(2007-11#1)(2013-1#1)
in showing##3##2##(1990-2#1)(2008-11#1)(2009-7#1)
in siblings##4##2##(1997-5#1)(2007-8#2)(2008-10#1)
in sickle cell disease##5##4##(1991-6#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
in sickle cell##6##3##(1991-6#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
in sieve##2##2##(2008-10#2)
in sight for##3##3##(1990-3#1)(1995-8#1)(1996-3#1)
in sight##4##2##(1990-3#1)(1991-2#1)(1995-8#1)(1996-3#1)
in signal processing##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
in signal transduction and##2##4##(1991-9#1)(2010-4#1)
in signal transduction pathways##2##4##(1992-12#1)(2008-11#1)
in signal transduction##19##3##(1991-9#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-4#1)(2012-12#1)
in signal transmission##3##3##(1993-9#1)(1994-11#1)(2011-7#1)
in signal##30##2##(1990-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2010-4#1)(2011-1#2)(2011-7#1)(2012-12#1)(2012-2#1)
in signal-to-noise ratio##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
in signaling pathways##3##3##(2008-1#1)(2009-6#1)(2012-12#1)
in signaling##9##2##(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#2)(2012-12#1)
in signalling to##2##3##(2009-10#2)
in signalling##3##2##(1994-6#1)(2009-10#2)
in signals##4##2##(2008-2#1)(2008-4#1)(2008-8#2)
in significant amounts##2##3##(1990-11#1)(1995-2#1)
in significant changes##4##3##(1997-4#1)(2008-10#1)(2008-8#1)(2012-2#1)
in significant decreases in##2##4##(1993-6#1)(2008-5#1)
in significant differences in##2##4##(1996-1#1)(2009-9#1)
in significant differences##4##3##(1993-2#1)(1994-3#1)(1996-1#1)(2009-9#1)
in significant##56##2##(1990-11#2)(1992-6#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#3)
in significantly fewer##2##3##(1992-2#1)(1996-12#1)
in significantly higher numbers##2##4##(2008-10#1)(2011-2#1)
in significantly higher##6##3##(2008-10#3)(2011-2#3)
in significantly increased##2##3##(2008-2#1)(2008-9#1)
in significantly reduced##2##3##(2007-7#1)(2008-10#1)
in significantly##22##2##(1992-2#1)(1996-12#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#2)
in silage##3##2##(1990-6#1)(2008-10#2)
in silica glasses##2##3##(2007-12#2)
in silica##11##2##(2007-11#2)(2007-12#4)(2008-10#3)(2008-12#1)(2008-3#1)
in silico analysis##2##3##(2009-8#1)(2011-2#1)
in silico approach##2##3##(2008-8#1)(2012-2#1)
in silico##23##2##(2008-10#2)(2008-4#1)(2008-7#4)(2008-8#1)(2009-8#2)(2009-9#3)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
in silicon##10##2##(1991-5#1)(1991-9#1)(1992-11#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
in silicon-treated plants##2##3##(2008-10#2)
in silicosis##4##2##(2008-7#2)(2009-12#1)(2012-2#1)
in silk##2##2##(2012-2#2)
in silkworm##2##2##(1997-3#1)(2008-9#1)
in silt loam soil##2##4##(2008-10#2)
in silt loam##3##3##(2008-10#3)
in silty clay##2##3##(2008-10#1)(2012-12#1)
in silver halide##2##3##(2008-3#2)
in silver##5##2##(2008-10#1)(2008-3#3)(2010-5#1)
in similar conditions##2##3##(2008-12#1)(2009-7#1)
in similar groups##2##3##(2007-12#1)(2010-4#1)
in similar populations##2##3##(1994-1#1)(1996-3#1)
in similar##26##2##(1990-6#1)(1991-12#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-4#2)
in similarity##2##2##(1994-6#1)(2008-9#1)
in simple##14##2##(1990-6#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#4)(2013-1#1)
in simulated mixtures##3##3##(2008-10#3)
in simulated##16##2##(1994-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
in simulation experiments##2##3##(1995-9#1)(2008-10#1)
in simulation of##2##3##(2008-3#1)(2009-7#1)
in simulation studies##2##3##(2010-3#1)(2012-3#1)
in simulation##8##2##(1995-9#1)(2008-10#1)(2008-3#2)(2009-7#1)(2010-3#1)(2012-1#1)(2012-3#1)
in simulations and in##2##4##(2011-1#1)(2012-3#1)
in simulations##4##2##(2007-11#1)(2008-10#1)(2011-1#1)(2012-3#1)
in simultaneous determination of##2##4##(2008-10#2)
in simultaneous##4##2##(2008-10#3)(2008-3#1)
in single cells##4##3##(1991-5#1)(1994-11#1)(1995-5#1)(2008-10#1)
in single or##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
in single pyramidal cells of##2##5##(2008-11#2)
in single pyramidal cells##3##4##(2008-11#3)
in single rat trigeminal ganglion neurons##2##6##(1996-12#2)
in single subjects##2##3##(1991-8#1)(2008-11#1)
in single##60##2##(1991-2#3)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#2)(1993-5#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#3)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#18)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#1)(2008-7#3)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
in single- and##3##3##(2008-2#2)(2008-3#1)
in single-##6##2##(2008-2#2)(2008-3#4)
in single-arm##2##2##(1995-2#1)(2008-6#1)
in single-crystal##2##2##(2008-2#2)
in single-genotype plots##2##3##(2008-10#2)
in single-genotype##3##2##(2008-10#3)
in single-mode optical fibers##2##4##(2007-11#1)(2007-12#1)
in single-mode##8##2##(2007-11#3)(2007-12#3)(2008-2#2)
in single-molecule##2##2##(2007-11#1)(2009-4#1)
in single-walled##2##2##(2008-10#1)(2008-7#1)
in singleton pregnancies##2##3##(2007-11#1)(2012-3#1)
in singly##4##2##(2007-11#1)(2008-10#2)(2010-2#1)
in sink##2##2##(2008-10#2)
in sinus rhythm##4##3##(1995-12#1)(1996-6#1)(2007-8#1)(2008-11#1)
in sinus##7##2##(1995-12#1)(1996-6#2)(2007-12#1)(2007-8#2)(2008-11#1)
in sites##4##2##(2007-8#1)(2008-2#1)(2008-5#1)(2012-3#1)
in sitting position##5##3##(2012-12#1)(2012-3#4)
in sitting##7##2##(2011-2#1)(2012-12#1)(2012-3#5)
in situ (without##2##3##(2007-8#1)(2008-11#1)
in situ DNA##2##3##(2008-11#1)(2008-9#1)
in situ Raman##2##3##(2007-12#1)(2008-10#1)
in situ analysis of##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
in situ analysis##11##3##(2008-10#5)(2008-2#1)(2008-3#1)(2009-12#2)(2013-8#2)
in situ and in real time##2##6##(2007-12#1)(2012-2#1)
in situ and in##5##4##(1993-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
in situ and suggest##2##4##(1992-3#1)(1996-12#1)
in situ and##19##3##(1990-2#1)(1992-3#1)(1993-5#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-8#1)
in situ applications##2##3##(2008-10#1)(2008-3#1)
in situ at the##2##4##(2008-10#2)
in situ at##5##3##(2008-10#4)(2008-2#1)
in situ but##2##3##(2008-10#1)(2012-2#1)
in situ by##12##3##(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(2008-10#6)(2008-2#1)(2013-8#1)
in situ cell##2##3##(2008-11#1)(2008-8#1)
in situ chemical##2##3##(2008-10#2)
in situ combustion##2##3##(2008-2#1)(2008-3#1)
in situ conservation##3##3##(2008-8#3)
in situ data##5##3##(2007-5#1)(2008-2#2)(2008-3#2)
in situ detection of##3##4##(1993-12#1)(2008-11#1)(2008-9#1)
in situ detection##4##3##(1993-12#1)(2008-11#1)(2008-9#2)
in situ determination of##2##4##(2008-10#2)
in situ diagnostic##2##3##(2008-3#2)
in situ end labeling##2##4##(2008-7#2)
in situ end##3##3##(1994-10#1)(2008-7#2)
in situ extraction##5##3##(1990-11#1)(1994-11#4)
in situ fluorescent hybridization##2##4##(2009-5#1)(2010-8#1)
in situ fluorescent##3##3##(2009-5#1)(2010-8#1)(2013-7#1)
in situ for##5##3##(1990-10#1)(2008-3#2)(2011-1#1)(2011-2#1)
in situ from##2##3##(1996-5#1)(2007-12#1)
in situ gels##2##3##(2010-5#2)
in situ generated##3##3##(2008-10#2)(2010-2#1)
in situ generation of##4##4##(1992-11#2)(2008-10#2)
in situ hybridisation##6##3##(1994-12#1)(1996-12#2)(2008-12#2)(2009-8#1)
in situ hybridization (FISH)##18##4##(1993-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)
in situ hybridization (ISH)##6##4##(1992-12#1)(1996-12#1)(2008-4#1)(2010-1#1)(2012-3#2)
in situ hybridization analysis##5##4##(1991-5#1)(1994-12#1)(1997-4#2)(2008-9#1)
in situ hybridization and##9##4##(1990-11#1)(1991-12#1)(1991-2#1)(1996-12#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-5#1)
in situ hybridization as well as##2##6##(1997-1#1)(2008-9#1)
in situ hybridization experiments##2##4##(1996-12#1)(2008-10#1)
in situ hybridization for##2##4##(1994-8#1)(2008-4#1)
in situ hybridization histochemistry with##2##5##(1993-12#1)(1997-4#1)
in situ hybridization histochemistry##14##4##(1990-8#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)
in situ hybridization in##3##4##(1996-12#1)(2009-1#1)(2010-1#1)
in situ hybridization methods##2##4##(1996-12#1)(2008-9#1)
in situ hybridization of##5##4##(1996-12#3)(2008-9#1)(2010-3#1)
in situ hybridization showed that##2##5##(1996-12#1)(1997-1#1)
in situ hybridization showed##3##4##(1996-12#1)(1997-1#1)(2008-5#1)
in situ hybridization studies##2##4##(2008-4#1)(2009-8#1)
in situ hybridization study##2##4##(1996-12#1)(2009-8#1)
in situ hybridization technique##2##4##(2008-11#1)(2010-12#1)
in situ hybridization techniques##3##4##(1991-5#1)(1995-12#1)(2008-9#1)
in situ hybridization to##3##4##(1995-12#1)(1997-7#1)(2008-4#1)
in situ hybridization using##2##4##(1993-5#1)(2008-10#1)
in situ hybridization##145##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-6#2)(1996-12#17)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#2)(1997-8#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-4#13)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#16)(2009-1#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#2)(2010-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#1)
in situ hybridization)##3##3##(2008-4#1)(2008-9#1)(2010-3#1)
in situ in the##3##4##(1991-9#1)(1997-1#1)(2010-8#1)
in situ in##6##3##(1991-9#1)(1997-1#2)(2008-10#2)(2010-8#1)
in situ is##2##3##(2012-12#1)(2012-2#1)
in situ lipofection of liver and intraperitoneal##2##7##(1997-4#2)
in situ measurement of##2##4##(2008-2#1)(2008-3#1)
in situ measurement##4##3##(2008-2#1)(2008-3#3)
in situ measurements in the##2##5##(2008-3#2)
in situ measurements in##3##4##(2008-2#1)(2008-3#2)
in situ measurements of neutral##2##5##(2008-3#2)
in situ measurements of the beam attenuation coefficient##2##8##(2008-2#1)(2008-3#1)
in situ measurements of##11##4##(2008-10#1)(2008-2#3)(2008-3#6)(2008-6#1)
in situ measurements##21##3##(2008-10#1)(2008-2#6)(2008-3#13)(2008-6#1)
in situ method##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
in situ monitoring of##6##4##(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#3)
in situ monitoring##9##3##(1993-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)
in situ nick translation##3##4##(2008-4#3)
in situ observations##2##3##(2008-2#1)(2012-2#1)
in situ of the##2##4##(1993-9#1)(2008-1#1)
in situ of##3##3##(1993-9#1)(2008-1#1)(2008-10#1)
in situ plated in thiocyanate media##2##6##(2008-10#2)
in situ polymerization##2##3##(2007-12#1)(2008-10#1)
in situ product removal##3##4##(2008-7#1)(2013-1#2)
in situ quantitative##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in situ results##2##3##(1993-12#1)(2008-5#1)
in situ sampling of##2##4##(2008-10#2)
in situ sizing technique for single levitated##2##7##(2008-2#2)
in situ spectrometer with##2##4##(2008-10#2)
in situ study##2##3##(2008-10#2)
in situ surface-enhanced Raman spectroscopy##2##5##(2007-12#1)(2013-1#1)
in situ synthesis of DNA microarrays##2##6##(2008-4#2)
in situ synthesis##4##3##(1996-5#1)(2008-4#3)
in situ techniques##2##3##(1995-12#1)(2007-5#1)
in situ the##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
in situ thermal hydrolysis/methylation##2##4##(2008-10#2)
in situ to invasive##2##4##(2010-6#1)(2011-2#1)
in situ to##5##3##(2008-3#1)(2008-9#1)(2010-6#2)(2011-2#1)
in situ total##2##3##(2008-3#2)
in situ trapping##2##3##(2007-12#1)(2008-10#1)
in situ using padlock probes##3##5##(2008-4#2)(2008-9#1)
in situ using##7##3##(2008-10#2)(2008-4#3)(2008-9#2)
in situ was developed##2##4##(1991-3#1)(2008-7#1)
in situ was##3##3##(1991-3#1)(1995-3#1)(2008-7#1)
in situ with##6##3##(1995-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)
in situ##579##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#3)(1992-3#2)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#5)(1993-5#3)(1993-6#2)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#8)(1994-12#4)(1994-2#1)(1994-8#6)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#4)(1995-4#2)(1995-6#2)(1996-12#23)(1996-2#2)(1996-5#3)(1996-6#1)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#6)(1997-6#1)(1997-7#2)(1997-8#3)(2006-4#3)(2007-11#5)(2007-12#11)(2007-5#4)(2007-8#2)(2008-1#7)(2008-10#112)(2008-11#10)(2008-12#2)(2008-2#27)(2008-3#65)(2008-4#25)(2008-5#16)(2008-6#6)(2008-7#14)(2008-8#14)(2008-9#28)(2009-1#1)(2009-11#1)(2009-12#6)(2009-5#1)(2009-7#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#6)(2010-5#4)(2010-6#6)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#6)
in situations requiring##3##3##(2008-7#1)(2009-12#1)(2012-12#1)
in situations where the##4##4##(2008-4#1)(2008-7#2)(2009-3#1)
in situations where##11##3##(1993-8#1)(1994-12#1)(1995-11#2)(1997-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)
in situations##20##2##(1993-8#1)(1994-12#1)(1995-11#2)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
in situs inversus##2##3##(1993-9#1)(2009-8#1)
in six animals##2##3##(1994-8#1)(1996-3#1)
in six areas##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
in six cases##4##3##(1994-6#1)(1997-3#2)(2007-8#1)
in six countries##4##3##(1995-2#1)(2008-10#1)(2012-2#2)
in six different##4##3##(1994-1#1)(2008-10#2)(2008-5#1)
in six dogs##2##3##(1996-12#1)(2012-3#1)
in six months##2##3##(1991-2#1)(2012-2#1)
in six of seven##3##4##(1991-2#1)(2008-10#2)
in six of the##2##4##(2008-10#1)(2011-2#1)
in six of these##2##4##(1995-5#1)(2008-10#1)
in six of##9##3##(1991-2#1)(1995-5#1)(2008-10#6)(2011-2#1)
in six patients##11##3##(1990-11#1)(1991-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)
in six states##2##3##(1995-12#1)(2012-2#1)
in six steps##3##3##(1992-12#1)(1997-2#1)(2008-4#1)
in six volunteers##2##3##(1992-3#1)(2008-5#1)
in six##97##2##(1990-11#1)(1990-3#1)(1990-8#2)(1991-2#3)(1991-5#1)(1991-6#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#21)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#2)(2010-10#1)(2010-2#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
in sixteen##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
in sixteenth-century##3##2##(2008-11#3)
in size and each##2##4##(1994-2#1)(2008-12#1)
in size and number of##2##5##(2007-12#2)
in size and##22##3##(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#1)(1997-2#1)(2007-12#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in size as the##2##4##(1992-12#1)(2008-10#1)
in size but##4##3##(1996-2#1)(2007-12#1)(2012-3#1)(2013-7#1)
in size by##2##3##(1991-8#1)(2012-12#1)
in size for##2##3##(2011-1#1)(2013-1#1)
in size from##11##3##(1990-12#2)(1992-12#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-3#2)
in size in##2##3##(1992-9#1)(2008-10#1)
in size of the##5##4##(1993-12#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
in size of##7##3##(1993-12#1)(2008-10#3)(2008-8#1)(2011-1#1)(2013-8#1)
in size to those##2##4##(2008-10#2)
in size to##4##3##(1995-2#1)(2008-10#2)(2008-5#1)
in size with##3##3##(2008-1#1)(2008-5#1)(2010-5#1)
in size##124##2##(1990-12#2)(1990-2#2)(1990-7#1)(1991-12#1)(1991-8#2)(1992-12#3)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#2)(2007-11#1)(2007-12#7)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#4)
in size) and##2##3##(2008-10#1)(2012-12#1)
in size)##5##2##(1994-12#1)(1996-6#1)(2008-10#1)(2012-12#2)
in sizes##2##2##(2008-7#1)(2010-8#1)
in skeletal muscle and##4##4##(1990-11#1)(1990-8#1)(1993-11#1)(2008-1#1)
in skeletal muscle by##2##4##(1992-6#1)(2008-1#1)
in skeletal muscle cells##2##4##(2008-11#1)(2008-8#1)
in skeletal muscle is##5##4##(1997-2#1)(1997-3#1)(2008-1#3)
in skeletal muscle##28##3##(1990-11#1)(1990-8#2)(1992-6#1)(1993-11#1)(1994-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#6)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#2)
in skeletal muscles##4##3##(1990-8#1)(1993-5#1)(1995-2#1)(2008-11#1)
in skeletal##41##2##(1990-11#2)(1990-8#3)(1992-6#1)(1993-11#1)(1993-5#1)(1994-12#2)(1994-5#1)(1994-7#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#6)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#3)
in skilled##2##2##(1994-3#1)(2012-2#1)
in skills##2##2##(1995-6#1)(1996-3#1)
in skin ageing##2##3##(2008-5#2)
in skin aging##4##3##(2008-5#3)(2011-2#1)
in skin and##3##3##(1995-12#1)(2008-5#2)
in skin care##2##3##(2008-5#2)
in skin of##3##3##(2008-5#1)(2008-9#2)
in skin physiology##2##3##(2008-5#2)
in skin pigmentation##2##3##(2008-9#1)(2009-5#1)
in skin smoothness##2##3##(2008-5#2)
in skin structure and function##2##5##(2008-5#1)(2011-2#1)
in skin structure and##3##4##(2008-5#2)(2011-2#1)
in skin surface pH##4##4##(2008-5#4)
in skin surface##5##3##(2008-5#5)
in skin##56##2##(1990-6#1)(1993-3#1)(1994-6#1)(1995-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#38)(2008-9#5)(2009-5#1)(2009-6#1)(2011-2#3)(2012-3#1)
in skin-incised mice##2##3##(2009-12#2)
in skin-whitening##2##2##(2008-5#2)
in skull base surgery##2##4##(2011-2#2)
in skull##4##2##(1995-6#1)(2011-2#2)(2012-12#1)
in slab##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
in slalom chromatography##3##3##(2008-10#3)
in slaughtered##2##2##(2008-12#1)(2011-2#1)
in slaughterhouse##3##2##(2008-12#1)(2013-1#2)
in sleep and##2##3##(2008-11#1)(2012-2#1)
in sleep regulation##2##3##(1991-9#2)
in sleep##18##2##(1991-9#2)(1995-12#2)(1997-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
in slices from##2##3##(1995-12#1)(1995-2#1)
in slices of##2##3##(1995-12#1)(2013-8#1)
in slices##6##2##(1995-12#3)(1995-2#1)(1996-5#1)(2013-8#1)
in slight##2##2##(1993-11#1)(2008-1#1)
in slightly##5##2##(1992-2#1)(2008-10#3)(2009-7#1)
in slope##3##2##(1995-8#1)(2008-10#2)
in slow##6##2##(1991-12#2)(1993-11#1)(1996-7#2)(2013-1#1)
in slowing the##4##3##(1995-3#1)(2007-8#1)(2008-10#1)(2012-12#1)
in slowing##7##2##(1995-3#1)(1995-5#1)(2007-8#1)(2008-10#2)(2012-12#2)
in sludges##2##2##(2008-10#2)
in slurried##2##2##(2008-10#2)
in slurry reactors was##2##4##(2008-7#2)
in slurry reactors##3##3##(2008-7#3)
in small and##4##3##(1994-1#1)(1996-12#1)(2008-9#1)(2011-2#1)
in small animals##2##3##(1990-12#1)(2011-1#1)
in small artery##2##3##(2007-10#2)
in small children##4##3##(1990-11#1)(1996-11#1)(2008-10#1)(2012-12#1)
in small communities##3##3##(1994-11#1)(2008-10#1)(2010-9#1)
in small groups##3##3##(1996-5#1)(2008-5#1)(2008-9#1)
in small hospitals##3##3##(1994-2#3)
in small island##2##3##(1996-6#1)(2008-1#1)
in small ruminants##2##3##(1991-8#1)(2013-1#1)
in small samples##2##3##(2008-10#2)
in small scale experiments##2##4##(2008-11#2)
in small scale##5##3##(2008-11#4)(2008-6#1)
in small volumes##3##3##(2008-10#1)(2008-9#2)
in small##86##2##(1990-11#1)(1990-12#2)(1991-4#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#4)(1995-11#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-5#1)(2007-10#3)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-1#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
in small-cell lung cancer##2##4##(2008-7#1)(2010-12#1)
in smaller##7##2##(1990-7#1)(1995-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-4#1)
in smoke##5##2##(1996-12#2)(2007-11#1)(2008-11#2)
in smoker men##2##3##(2008-12#2)
in smoker##3##2##(2008-12#2)(2012-12#1)
in smokers and##3##3##(2008-10#1)(2008-12#2)
in smokers than non-smokers##2##4##(2008-10#2)
in smokers##16##2##(1991-3#1)(1992-9#4)(1993-2#1)(1994-6#1)(2008-10#3)(2008-12#4)(2008-7#2)
in smokers'##2##2##(1993-8#1)(2011-2#1)
in smoking cessation##4##3##(1997-4#1)(2008-8#1)(2009-4#1)(2013-1#1)
in smoking prevalence suggest##2##4##(1996-3#2)
in smoking prevalence##5##3##(1994-6#1)(1996-3#2)(2008-7#1)(2011-2#1)
in smoking##17##2##(1992-2#1)(1994-11#1)(1994-6#2)(1996-3#2)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#2)(2011-2#2)(2013-1#2)
in smooth muscle cells##3##4##(1990-7#1)(1994-11#1)(1995-2#1)
in smooth muscle relaxation##2##4##(1992-6#1)(1993-6#1)
in smooth muscle##9##3##(1990-7#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#1)
in smooth##11##2##(1990-7#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#1)(2007-12#1)
in snail##3##2##(1994-6#1)(1995-5#1)(1997-4#1)
in snails##4##2##(2008-5#1)(2008-9#1)(2010-4#2)
in snap bean##4##3##(2008-10#4)
in snap##5##2##(2008-10#5)
in snow##3##2##(2008-10#3)
in so many##2##3##(1992-2#1)(2011-1#1)
in so##3##2##(1990-9#1)(1992-2#1)(2011-1#1)
in so-called &quot##3##3##(1990-8#1)(1991-3#1)(2008-6#1)
in so-called##4##2##(1990-8#1)(1991-3#1)(2008-6#1)(2008-9#1)
in social and##4##3##(2007-12#1)(2009-5#1)(2012-12#1)(2012-2#1)
in social comparisons##3##3##(2007-12#3)
in social function##3##3##(2013-1#2)(2013-8#1)
in social insects##2##3##(2008-8#1)(2008-9#1)
in social memory/recognition##2##3##(1994-3#2)
in social psychology##3##3##(2008-2#1)(2008-5#2)
in social surveys##2##3##(2010-1#2)
in social##49##2##(1992-5#1)(1994-3#2)(1996-12#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-5#1)(2009-7#1)(2010-1#3)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
in society##11##2##(1992-3#1)(2007-8#2)(2008-1#1)(2009-6#1)(2010-10#2)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
in soda-lime glass##2##3##(2007-11#1)(2008-3#1)
in sodium acetate-acetic##2##3##(2008-10#1)(2009-10#1)
in sodium dodecyl sulfate##2##4##(1992-3#1)(2008-10#1)
in sodium dodecyl##3##3##(1992-3#1)(2008-10#2)
in sodium hydroxide##2##3##(2008-10#2)
in sodium##13##2##(1992-3#1)(2007-12#1)(2008-10#8)(2009-10#1)(2009-7#1)(2013-1#1)
in soft agar##5##3##(1991-12#2)(1995-2#1)(2008-11#2)
in soft drink##5##3##(2008-10#5)
in soft drinks##5##3##(2008-10#5)
in soft tissue sarcoma##3##4##(2008-6#3)
in soft tissue sarcomas##4##4##(2008-6#4)
in soft tissue##11##3##(2008-11#1)(2008-12#1)(2008-6#9)
in soft tissues##5##3##(2008-12#2)(2008-3#2)(2010-5#1)
in soft##38##2##(1991-12#2)(1995-2#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-3#3)(2008-5#3)(2008-6#9)(2010-4#1)(2010-5#1)(2012-2#2)
in software##2##2##(2008-11#1)(2008-3#1)
in soil GHG fluxes##3##4##(2012-2#3)
in soil and plant##2##4##(2008-10#2)
in soil and sediment samples##3##5##(2008-10#3)
in soil and sediment##8##4##(2008-10#8)
in soil and water##4##4##(2008-10#4)
in soil and##33##3##(2008-10#30)(2008-11#1)(2008-2#2)
in soil aqua regia extracts##2##5##(2008-10#2)
in soil at##3##3##(2008-10#3)
in soil by##7##3##(2008-10#6)(2008-11#1)
in soil disks equilibrated at##2##5##(2008-10#2)
in soil extract##2##3##(2008-10#2)
in soil extracts using##2##4##(2008-10#2)
in soil extracts##11##3##(1996-5#1)(2008-10#10)
in soil from plots with##2##5##(2008-10#2)
in soil from the##4##4##(2008-10#3)(2008-5#1)
in soil from##12##3##(1990-9#1)(2008-10#10)(2008-5#1)
in soil infested with##4##4##(2008-10#4)
in soil is##4##3##(1990-9#1)(2006-12#1)(2008-10#1)(2008-11#1)
in soil layers##3##3##(2008-10#3)
in soil leachates and runoff waters##2##6##(2008-10#2)
in soil of##2##3##(2008-10#2)
in soil planted##2##3##(2008-10#2)
in soil samples by##4##4##(2008-10#4)
in soil samples from##3##4##(2008-10#3)
in soil samples was##2##4##(2008-10#2)
in soil samples were##2##4##(2008-10#2)
in soil samples##21##3##(2008-10#19)(2008-11#2)
in soil so##3##3##(2008-10#3)
in soil solution##3##3##(2008-10#2)(2008-11#1)
in soil taken from##2##4##(2008-10#2)
in soil than##2##3##(2008-10#1)(2008-11#1)
in soil that##3##3##(1990-9#1)(2008-10#2)
in soil using##2##3##(2008-10#2)
in soil was##4##3##(2008-10#4)
in soil with##2##3##(2008-10#1)(2008-6#1)
in soil##210##2##(1990-9#4)(1992-3#3)(1996-5#2)(2006-12#1)(2008-10#171)(2008-11#11)(2008-2#2)(2008-5#3)(2008-6#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#3)(2012-5#1)(2013-7#2)(2013-8#1)
in soilless##3##2##(2008-10#3)
in soils amended with##3##4##(2008-10#3)
in soils and sediments by##2##5##(2008-10#2)
in soils and sediments##4##4##(2008-10#4)
in soils and##12##3##(2008-10#12)
in soils by##3##3##(2008-10#3)
in soils from##5##3##(2008-10#4)(2013-7#1)
in soils have##2##3##(2008-10#2)
in soils infested with##2##4##(2008-10#2)
in soils were in the##2##5##(2008-10#2)
in soils##63##2##(2008-10#54)(2008-11#2)(2008-7#1)(2010-5#3)(2010-7#1)(2013-7#2)
in sol-gel derived##2##3##(2008-10#2)
in sol-gel##5##2##(2008-10#5)
in solar##4##2##(1995-5#1)(2008-10#1)(2008-3#2)
in soldiers##4##2##(2007-12#3)(2012-12#1)
in soleus##3##2##(1993-12#2)(1995-12#1)
in solid and##2##3##(2008-10#2)
in solid breast lumps##2##4##(1990-10#2)
in solid or##2##3##(2008-10#2)
in solid organ transplant recipients##2##5##(2007-12#1)(2008-10#1)
in solid organ##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
in solid parahydrogen##2##3##(2007-12#2)
in solid pharmaceutical formulations##2##4##(2008-10#2)
in solid phase extraction##2##4##(2008-10#2)
in solid phase##4##3##(2008-10#4)
in solid samples##6##3##(2008-10#6)
in solid state##2##3##(2008-10#1)(2008-5#1)
in solid tumor##2##3##(1994-12#1)(2008-9#1)
in solid tumors##8##3##(1996-7#1)(2008-7#5)(2012-12#2)
in solid tumours##2##3##(1994-10#1)(1997-4#1)
in solid##52##2##(1990-10#2)(1991-9#1)(1994-10#1)(1994-12#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#26)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#2)(2011-2#1)(2012-12#2)
in solid-phase organic##2##3##(1997-3#1)(1997-4#1)
in solid-phase##7##2##(1997-3#2)(1997-4#2)(2008-10#1)(2008-4#2)
in solid-state lasers##3##3##(2007-12#2)(2008-2#1)
in solid-state##8##2##(2007-12#4)(2008-2#2)(2008-3#1)(2011-2#1)
in solids##2##2##(2007-11#2)
in solitary##2##2##(2007-11#1)(2008-9#1)
in solubility##4##2##(1995-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
in soluble##6##2##(1990-11#1)(2008-10#3)(2010-5#1)(2011-2#1)
in solution and in the##2##5##(1997-7#1)(2008-10#1)
in solution and in##3##4##(1997-7#1)(2008-10#1)(2009-9#1)
in solution and##11##3##(1991-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2009-9#1)
in solution are##3##3##(2008-10#2)(2008-8#1)
in solution as##2##3##(1990-7#1)(2008-10#1)
in solution by##6##3##(1991-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#2)
in solution has been##2##4##(2008-10#2)
in solution in##2##3##(2008-10#2)
in solution is##2##3##(2008-10#1)(2008-4#1)
in solution of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
in solution or##2##3##(2008-10#2)
in solution phase##3##3##(2008-10#3)
in solution to##3##3##(2008-10#3)
in solution was 2##2##4##(2008-10#2)
in solution was##5##3##(2008-10#5)
in solution were studied##2##4##(2008-10#2)
in solution were##4##3##(2008-10#4)
in solution with##3##3##(2008-10#2)(2013-8#1)
in solution within the##2##4##(2008-10#2)
in solution##173##2##(1990-7#2)(1991-3#2)(1992-11#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#3)(1995-6#2)(1996-12#1)(1996-2#6)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#96)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-7#1)(2012-1#3)(2012-2#1)(2013-1#3)(2013-8#1)
in solution)##2##2##(2008-10#2)
in solutions containing a##2##4##(2008-10#2)
in solutions containing##11##3##(1991-8#1)(2008-10#8)(2009-6#1)(2011-2#1)
in solutions obtained after digestion of##2##6##(2008-10#2)
in solutions obtained##3##3##(2008-10#3)
in solutions of##10##3##(1990-12#1)(1995-5#1)(2008-10#7)(2010-1#1)
in solutions that##2##3##(2008-10#2)
in solutions with##3##3##(2008-10#3)
in solutions##38##2##(1990-12#1)(1991-8#1)(1995-5#1)(2008-10#31)(2008-11#1)(2009-6#1)(2010-1#1)(2011-2#1)
in solvent polymeric##3##3##(2008-10#3)
in solvent##8##2##(2008-10#7)(2008-4#1)
in solvents##5##2##(2008-3#3)(2008-4#2)
in solving the##2##3##(2009-12#1)(2009-8#1)
in solving this problem##2##4##(2008-7#1)(2013-1#1)
in solving##9##2##(1992-1#1)(1993-11#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#1)(2013-1#1)
in somatic cells of##2##4##(1994-11#2)
in somatic cells##8##3##(1994-11#2)(1997-4#1)(2008-11#1)(2009-10#1)(2009-3#2)(2011-2#1)
in somatic##15##2##(1993-12#2)(1994-11#2)(1995-12#1)(1997-4#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2011-2#1)(2012-2#1)
in some affected##2##3##(2008-10#1)(2009-6#1)
in some areas of##2##4##(2011-1#1)(2013-1#1)
in some areas##11##3##(1993-3#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)(2013-1#1)
in some biological##2##3##(2008-10#2)
in some cancers##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
in some cases by##2##4##(2008-3#1)(2008-9#1)
in some cases for##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
in some cases of##3##4##(1991-12#1)(1997-6#1)(2011-1#1)
in some cases the##5##4##(1991-2#1)(2008-10#2)(2008-11#1)(2010-4#1)
in some cases to##3##4##(2007-11#1)(2008-10#1)(2010-11#1)
in some cases##87##3##(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1992-11#1)(1993-12#2)(1993-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
in some cell##3##3##(1992-3#1)(1996-12#1)(2011-2#1)
in some cells##4##3##(1990-2#1)(1992-3#1)(1992-6#1)(2008-10#1)
in some children##2##3##(2008-1#1)(2008-12#1)
in some circumstances##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
in some clinical##4##3##(1990-8#1)(2008-1#3)
in some countries##8##3##(1993-11#1)(1993-3#1)(2007-2#2)(2008-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
in some degree##2##3##(1997-8#1)(2008-5#1)
in some detail##8##3##(1992-1#1)(1992-4#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2012-1#1)
in some drugs##2##3##(1991-1#1)(2008-10#1)
in some experimental##2##3##(1990-2#1)(2008-10#1)
in some experiments##3##3##(1994-8#1)(2008-10#1)(2008-3#1)
in some form##2##3##(1995-1#1)(1997-3#1)
in some individuals##2##3##(2008-5#1)(2013-1#1)
in some industrial##2##3##(2008-10#1)(2008-3#1)
in some instances##13##3##(1990-11#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2011-1#1)
in some lines##2##3##(2008-10#1)(2008-9#1)
in some manner##2##3##(1992-2#1)(2008-7#1)
in some materials##2##3##(2008-10#1)(2008-3#1)
in some models##2##3##(2008-10#1)(2008-3#1)
in some natural##3##3##(2008-10#3)
in some neural##2##3##(1995-12#1)(2011-1#1)
in some of the groups investigated##2##6##(2008-11#2)
in some of the most##2##5##(2007-4#1)(2008-2#1)
in some of the##24##4##(1991-12#1)(1994-5#1)(1994-9#1)(1996-10#1)(1996-5#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
in some of these##2##4##(1991-11#1)(2008-11#1)
in some of##30##3##(1991-11#1)(1991-12#2)(1994-5#1)(1994-9#1)(1996-10#1)(1996-5#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)
in some other##7##3##(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2010-3#1)(2013-1#1)
in some parts of the##3##5##(2007-12#1)(2008-11#1)(2010-12#1)
in some patients with##7##4##(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-12#1)(1997-7#1)(1997-8#1)
in some patients##21##3##(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
in some pharmaceutical##4##3##(2008-10#3)(2008-11#1)
in some places##2##3##(1995-11#1)(2012-2#1)
in some plants##2##3##(2008-10#2)
in some populations##3##3##(2008-1#1)(2010-11#2)
in some relatively##2##3##(1991-12#1)(2008-10#1)
in some respects##2##3##(2008-3#1)(2010-8#1)
in some samples##6##3##(2008-10#4)(2008-3#1)(2008-4#1)
in some selected##2##3##(2008-10#1)(2011-2#1)
in some settings##2##3##(2011-2#1)(2012-1#1)
in some situations##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
in some solid##2##3##(1992-9#1)(2012-12#1)
in some specific##2##3##(1996-12#1)(2010-5#1)
in some studies##4##3##(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in some subjects##2##3##(1994-3#1)(1995-5#1)
in some synthetic mixtures and##2##5##(2008-10#2)
in some synthetic##3##3##(2008-10#3)
in some tissues##2##3##(1992-9#1)(2008-12#1)
in some treatments##2##3##(2008-12#1)(2008-8#1)
in some types of##2##4##(2007-11#1)(2008-10#1)
in some way##3##3##(1991-6#1)(1994-8#1)(2008-11#1)
in some years##2##3##(2008-10#2)
in some##455##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#8)(1991-2#2)(1991-6#3)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#5)(1993-3#3)(1993-5#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-3#4)(1995-5#3)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#5)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#6)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#103)(2008-11#21)(2008-12#14)(2008-2#5)(2008-3#14)(2008-4#7)(2008-5#16)(2008-7#9)(2008-8#13)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#5)(2010-12#2)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#21)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#5)
in song##5##2##(1997-2#2)(2008-8#3)
in songbirds##3##2##(2008-9#3)
in sonicated##2##2##(1994-5#1)(2008-10#1)
in sorghum##2##2##(2008-9#1)(2009-10#1)
in sound##3##2##(1995-1#1)(1995-12#1)(2010-2#1)
in south India##4##3##(2007-7#2)(2007-8#1)(2010-10#1)
in south of##2##3##(2009-5#1)(2009-7#1)
in south##15##2##(1991-11#1)(1991-4#1)(1994-3#1)(1995-9#1)(1996-8#1)(2007-7#2)(2007-8#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-2#1)
in south-eastern Australia##2##3##(2010-8#1)(2013-1#1)
in south-eastern##3##2##(2008-8#1)(2010-8#1)(2013-1#1)
in south-west##3##2##(1993-8#1)(2010-3#1)(2011-2#1)
in southeast##6##2##(1994-9#1)(2007-2#1)(2008-10#2)(2010-1#1)(2010-4#1)
in southeastern##5##2##(2008-10#2)(2008-6#1)(2009-4#1)(2011-2#1)
in southern Africa##4##3##(2008-10#1)(2010-1#1)(2011-2#1)(2013-1#1)
in southern Arizona##2##3##(2008-10#1)(2009-8#1)
in southern California##7##3##(1996-4#2)(2008-10#4)(2011-2#1)
in southern Europe##2##3##(2011-2#2)
in southern Italy##5##3##(1996-3#1)(1997-5#1)(2008-7#1)(2008-8#2)
in southern New##2##3##(2008-10#2)
in southern Spain and##2##4##(2008-10#2)
in southern Spain##7##3##(2008-10#7)
in southern Taiwan##3##3##(2008-10#1)(2013-8#2)
in southern##52##2##(1991-6#2)(1994-9#1)(1996-3#1)(1996-4#2)(1997-4#1)(1997-5#1)(2007-2#1)(2008-10#22)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-1#1)(2011-2#7)(2012-3#1)(2013-1#2)(2013-8#4)
in southwest##7##2##(2007-5#1)(2008-10#4)(2008-8#1)(2010-5#1)
in southwestern Ontario##2##3##(1996-12#1)(1997-3#1)
in southwestern##5##2##(1994-3#1)(1996-12#1)(1997-3#1)(2008-10#2)
in sows##3##2##(2010-2#3)
in soy sauce##3##3##(1996-2#1)(2010-4#2)
in soy##4##2##(1996-2#1)(2010-1#1)(2010-4#2)
in soya##3##2##(1990-3#1)(2008-10#2)
in soybean##15##2##(1992-8#1)(2008-10#12)(2008-8#1)(2011-10#1)
in soybeans##3##2##(2008-10#3)
in space and time##7##4##(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-8#1)
in space and##9##3##(1995-5#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-8#2)
in space group##4##3##(1995-2#1)(1997-7#2)(2008-4#1)
in space is##2##3##(2007-11#2)
in space was##2##3##(1996-5#1)(2008-3#1)
in space##39##2##(1991-2#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-7#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-8#2)(2011-1#1)(2012-2#1)(2013-8#3)
in sparse##2##2##(1992-12#1)(2008-11#1)
in sparsely populated##2##3##(1991-1#1)(1994-8#1)
in spatial and temporal##2##4##(2008-2#1)(2012-2#1)
in spatial and##5##3##(1993-12#1)(1993-5#1)(1994-8#1)(2008-2#1)(2012-2#1)
in spatial learning##4##3##(1994-3#1)(1994-8#1)(2008-9#1)(2013-8#1)
in spatial light modulators##3##4##(2008-2#1)(2008-3#2)
in spatial resolution##2##3##(2008-1#1)(2009-5#1)
in spatial##20##2##(1993-12#2)(1993-5#1)(1994-3#2)(1994-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-9#2)(2009-5#1)(2012-2#1)(2013-8#1)
in spatially##8##2##(2007-11#1)(2008-10#2)(2008-8#3)(2009-8#1)(2012-2#1)
in spatiotemporal##2##2##(2007-12#1)(2008-3#1)
in special cases##2##3##(2008-10#1)(2012-2#1)
in special##12##2##(1996-3#1)(1997-7#1)(2008-10#3)(2008-12#1)(2009-6#1)(2009-8#2)(2010-5#1)(2012-2#1)(2013-8#1)
in specialized##12##2##(1990-11#1)(1994-11#1)(1994-3#1)(1995-11#2)(2007-11#1)(2008-2#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)
in specially designed##3##3##(2007-11#2)(2010-8#1)
in speciation analysis of##2##4##(2008-10#1)(2010-11#1)
in speciation##9##2##(2008-10#4)(2008-8#2)(2008-9#1)(2010-11#1)(2012-3#1)
in species from##2##3##(1995-2#1)(2008-10#1)
in species in which##2##4##(2008-8#1)(2013-1#1)
in species of##4##3##(2008-10#3)(2013-1#1)
in species richness is##2##4##(2008-8#2)
in species richness with productivity##2##5##(2008-9#2)
in species richness##13##3##(2008-8#10)(2008-9#3)
in species that exhibit##2##4##(2008-8#1)(2008-9#1)
in species that##5##3##(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)
in species with##2##3##(2008-8#1)(2008-9#1)
in species##38##2##(1994-3#1)(1995-2#1)(2008-10#6)(2008-8#15)(2008-9#6)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2013-1#5)
in species'##4##2##(2008-8#2)(2008-9#2)
in specific activity##3##3##(1993-8#1)(2008-7#2)
in specific applications##2##3##(2008-10#1)(2008-6#1)
in specific areas of rat brain##2##6##(1990-7#1)(1991-12#1)
in specific brain regions##2##4##(1994-6#1)(2008-4#1)
in specific brain##3##3##(1994-2#1)(1994-6#1)(2008-4#1)
in specific clinical situations##2##4##(1997-4#1)(2008-8#1)
in specific clinical##3##3##(1997-4#1)(2008-8#1)(2010-4#1)
in specific parts of the##2##5##(2008-11#1)(2008-5#1)
in specific regions of the##2##5##(1995-3#1)(1996-12#1)
in specific regions of##4##4##(1995-3#2)(1996-12#1)(2008-6#1)
in specific regions##5##3##(1995-3#2)(1996-12#1)(2008-10#1)(2008-6#1)
in specific##63##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
in specificity##6##2##(1992-3#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-2#1)
in specifying the##2##3##(1992-1#1)(1994-12#1)
in specifying##4##2##(1992-1#1)(1994-12#1)(2007-12#1)(2012-12#1)
in specimens from##2##3##(2008-5#1)(2013-7#1)
in specimens##4##2##(1994-7#1)(2008-5#1)(2009-8#1)(2013-7#1)
in speckle##3##2##(2007-11#1)(2008-2#2)
in spectral shape##2##3##(1994-6#1)(2008-2#1)
in spectral##13##2##(1994-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-7#2)
in spectrophotometric and spectrofluorimetric##2##4##(2008-10#2)
in spectrophotometric##6##2##(2008-10#6)
in spectrophotometry##2##2##(2008-10#2)
in spectroscopic and##2##3##(1994-5#1)(2007-12#1)
in spectroscopy##3##2##(2007-12#1)(2008-10#2)
in speech##8##2##(1991-3#1)(2008-2#1)(2008-9#2)(2009-10#2)(2009-2#1)(2011-1#1)
in speed and##2##3##(2008-2#1)(2009-12#1)
in speed##6##2##(1994-8#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
in spelling##2##2##(2008-12#1)(2008-2#1)
in spending##2##2##(1996-5#1)(1997-3#1)
in spent CAPD fluids##3##4##(2008-10#3)
in spent male##2##3##(2010-4#2)
in spent##7##2##(2008-10#5)(2010-4#2)
in sperm and##2##3##(1996-9#1)(2009-10#1)
in sperm cells##3##3##(1997-4#1)(1997-6#1)(2008-8#1)
in sperm##11##2##(1991-2#1)(1996-9#1)(1997-4#2)(1997-6#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#3)
in sperm-ZP interactions##2##3##(2013-1#2)
in spermatid##2##2##(2008-7#2)
in spermatogenesis##7##2##(2009-10#4)(2010-5#1)(2012-3#1)(2013-8#1)
in spermatogonia and spermatocytes at##2##5##(2008-5#2)
in spermatogonia and##3##3##(2008-5#2)(2008-9#1)
in spermatogonia##5##2##(2008-5#2)(2008-9#1)(2010-5#1)(2012-2#1)
in spherical##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
in spheroid culture##3##3##(2008-11#3)
in spheroid##4##2##(2008-11#4)
in spheroidal coordinates##3##3##(2008-2#3)
in spheroids##3##2##(1995-12#1)(1997-4#2)
in spiked human serum##4##4##(1995-3#1)(2008-10#3)
in spiked human urine and##3##5##(2008-10#3)
in spiked human urine##4##4##(2008-10#4)
in spiked human##8##3##(1995-3#1)(2008-10#7)
in spiked natural water samples##2##5##(2008-10#2)
in spiked river and tap water##2##6##(2008-10#2)
in spiked river water##2##4##(2008-10#2)
in spiked river##4##3##(2008-10#4)
in spiked samples##3##3##(2008-10#3)
in spiked urine samples##2##4##(1995-2#1)(2008-10#1)
in spiked urine##3##3##(1995-2#1)(2008-10#2)
in spiked water and##2##4##(2008-10#2)
in spiked water samples##2##4##(2008-10#2)
in spiked water##4##3##(2008-10#4)
in spiked waters##2##3##(2008-10#2)
in spiked##45##2##(1995-2#1)(1995-3#1)(2008-10#43)
in spin##3##2##(1992-11#1)(2008-11#1)(2012-2#1)
in spinach and##2##3##(2008-10#2)
in spinach##7##2##(1994-11#1)(2008-10#5)(2012-2#1)
in spinal anesthesia##3##3##(2011-2#2)(2012-12#1)
in spinal cord##9##3##(1990-11#1)(1992-12#1)(1993-12#1)(1996-2#1)(1996-5#1)(2013-1#1)(2013-8#3)
in spinal ganglion neurons of##2##5##(2008-7#2)
in spinal ganglion neurons##3##4##(2008-7#3)
in spinal metastases##2##3##(2007-11#2)
in spinal surgery##2##3##(2008-8#2)
in spinal##29##2##(1990-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-5#1)(2007-11#2)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#2)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
in spindle##2##2##(1997-3#1)(2008-11#1)
in spine##5##2##(2007-11#1)(2008-12#1)(2011-2#1)(2012-12#2)
in spinner flasks##2##3##(2008-11#1)(2008-7#1)
in spinner##5##2##(2008-11#4)(2008-7#1)
in spirometric##2##2##(1997-3#1)(2011-2#1)
in spirometry##2##2##(1996-1#1)(2011-2#1)
in spite of a##5##4##(1990-5#1)(1992-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
in spite of an##2##4##(1995-11#1)(2007-8#1)
in spite of immunosuppressive therapy##2##5##(2011-2#2)
in spite of its##8##4##(1992-9#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2009-6#1)(2013-7#1)(2013-8#1)
in spite of many##3##4##(1996-9#1)(2008-10#1)(2008-8#1)
in spite of the fact that##4##6##(1991-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
in spite of the great##2##5##(1997-4#1)(2008-10#1)
in spite of the##28##4##(1991-2#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)
in spite of their##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
in spite of##86##3##(1990-11#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-4#1)(2006-12#1)(2007-11#3)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
in spleen weight##3##3##(1996-12#2)(2008-10#1)
in spleen##7##2##(1991-12#1)(1996-12#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-9#1)
in splenic##6##2##(1993-9#1)(2008-10#4)(2012-2#1)
in splenocyte##3##2##(1993-11#1)(2008-10#2)
in split##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
in spoken##2##2##(2008-11#1)(2009-10#1)
in spontaneous motor activity##2##4##(1995-12#1)(2008-12#1)
in spontaneous pneumothorax##2##3##(2007-8#2)
in spontaneous##15##2##(1990-11#1)(1990-5#1)(1990-9#1)(1993-9#1)(1995-12#2)(2007-10#2)(2007-8#2)(2008-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
in spontaneously hypertensive rats (SHR)##4##5##(1990-7#1)(1994-2#1)(2010-2#1)(2011-1#1)
in spontaneously hypertensive rats##7##4##(1990-7#1)(1994-2#1)(1997-6#1)(2010-2#1)(2011-1#3)
in spontaneously hypertensive##8##3##(1990-7#1)(1994-2#1)(1997-6#1)(2010-2#1)(2011-1#3)(2013-8#1)
in spontaneously##12##2##(1990-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-6#1)(2007-9#1)(2010-2#1)(2011-1#3)(2013-8#1)
in sporadic##4##2##(1994-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
in spore density##2##3##(2008-10#2)
in spore##7##2##(2008-10#4)(2008-8#1)(2010-2#1)(2011-2#1)
in sport activities##2##3##(1996-9#1)(2009-3#1)
in sport##11##2##(1996-9#1)(2007-8#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#1)
in sports before##2##3##(2007-11#2)
in sports##12##2##(1993-3#2)(1996-6#1)(2007-11#5)(2007-8#1)(2009-7#1)(2011-2#1)(2012-2#1)
in spread of##2##3##(1995-8#1)(2008-10#1)
in spreading##3##2##(1991-5#1)(1997-3#1)(2008-10#1)
in spring and winter##3##4##(2008-10#2)(2008-12#1)
in spring and##7##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)
in spring wheat than in winter wheat##2##7##(2008-10#2)
in spring wheat##3##3##(2008-10#3)
in spring##19##2##(2008-10#12)(2008-12#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
in sputum##4##2##(1997-1#2)(2008-1#1)(2008-5#1)
in squamous cell carcinoma##2##4##(2013-1#1)(2013-8#1)
in squamous cell##4##3##(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
in squamous##5##2##(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in squash##3##2##(2008-10#2)(2008-5#1)
in sri lanka##2##3##(2009-10#2)
in stability and##2##3##(1992-6#1)(1995-3#1)
in stability##12##2##(1990-2#1)(1991-6#1)(1992-6#3)(1995-2#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-5#2)
in stabilizing the##3##3##(1993-11#1)(1993-8#1)(2013-8#1)
in stabilizing##6##2##(1991-6#1)(1993-11#1)(1993-8#1)(1996-2#1)(2008-4#1)(2013-8#1)
in stable and##2##3##(2008-3#1)(2010-8#1)
in stable patients##2##3##(2008-10#1)(2011-2#1)
in stable##17##2##(1991-12#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#3)
in stably Harvey-ras transfected C3H10T1/2 cells##3##6##(2008-4#3)
in stably transfected##2##3##(1994-2#1)(2008-11#1)
in stably##5##2##(1994-2#1)(2008-11#1)(2008-4#3)
in stack emissions##2##3##(2008-10#1)(2008-2#1)
in staff##3##2##(1993-12#1)(1996-1#1)(2008-11#1)
in staffing##2##2##(1991-1#1)(1994-12#1)
in stage I##2##3##(1990-9#1)(1995-12#1)
in stage II##3##3##(1990-9#1)(2007-8#2)
in stage III##4##3##(1990-9#1)(1993-2#1)(2007-8#1)(2008-8#1)
in stage IV##2##3##(1990-6#1)(1990-9#1)
in stage T1##2##3##(1990-2#1)(2013-1#1)
in stage##27##2##(1990-2#1)(1990-6#1)(1990-9#4)(1993-1#2)(1993-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(2006-8#4)(2007-8#3)(2008-6#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
in stages II##2##3##(1990-8#1)(2011-2#1)
in stages##9##2##(1990-2#1)(1990-8#2)(2008-10#1)(2011-2#3)(2012-3#1)(2013-1#1)
in staging##5##2##(1992-9#1)(2008-1#2)(2008-2#2)
in stainless steel##3##3##(2008-10#3)
in stainless##4##2##(2007-12#1)(2008-10#3)
in standard alloys and##3##4##(2008-10#3)
in standard alloys##6##3##(2008-10#6)
in standard and##5##3##(2008-10#3)(2008-11#2)
in standard fibers##3##3##(2007-12#1)(2008-3#2)
in standard length##2##3##(2008-5#1)(2010-8#1)
in standard mixtures##2##3##(2008-10#2)
in standard reference materials and##2##5##(2008-10#2)
in standard reference materials##4##4##(2008-10#4)
in standard reference##5##3##(2008-10#5)
in standard solution##4##3##(2008-10#3)(2008-8#1)
in standard solutions##2##3##(2008-10#2)
in standard##46##2##(1993-6#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#26)(2008-11#3)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)
in standardization##2##2##(1996-3#1)(2008-10#1)
in standards of##2##3##(1993-2#1)(2011-2#1)
in standards##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
in standing##3##2##(2007-8#1)(2010-10#1)(2013-8#1)
in stands with##2##3##(2008-10#2)
in stands##3##2##(2008-10#3)
in starch to##2##3##(2007-11#1)(2008-10#1)
in starch##7##2##(1990-7#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-9#2)
in stark contrast to##2##4##(1996-12#1)(2013-1#1)
in state III respiration##2##4##(1994-8#2)
in state##12##2##(1990-2#2)(1994-8#3)(1996-3#2)(1997-3#2)(2008-6#1)(2008-9#1)(2010-6#1)
in states of##2##3##(2011-2#2)
in states which##2##3##(1994-2#1)(1996-1#1)
in states with##2##3##(1994-2#2)
in states##8##2##(1994-2#3)(1996-1#1)(1997-2#1)(2010-12#1)(2011-2#2)
in statewide##2##2##(1996-12#1)(2012-2#1)
in static and dynamic##2##4##(2008-2#1)(2010-7#1)
in static and##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2010-7#1)
in static conditions##2##3##(2008-11#1)(2009-12#1)
in static##10##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-12#1)(2010-7#1)(2013-1#1)
in stationary batch culture##3##4##(2008-11#3)
in stationary##4##2##(2008-11#3)(2012-3#1)
in statistical analysis##2##3##(1994-1#1)(2008-8#1)
in statistical theory##2##3##(2008-10#2)
in statistical##6##2##(1994-1#1)(2008-10#2)(2008-8#2)(2009-11#1)
in statistics##2##2##(1992-11#1)(2011-2#1)
in steady state##2##3##(2008-10#1)(2011-2#1)
in steady##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
in steady-state##4##2##(2008-11#1)(2008-4#1)(2009-7#1)(2013-8#1)
in steel alloys##4##3##(2008-10#4)
in steel and##2##3##(2008-10#2)
in steel samples##2##3##(2008-10#2)
in steel##14##2##(2008-10#14)
in steels##5##2##(2008-10#5)
in steels)##2##2##(2008-10#2)
in stem and##2##3##(2008-10#1)(2011-3#1)
in stem cell biology##4##4##(2008-11#3)(2009-3#1)
in stem cell therapy##3##4##(2008-10#1)(2009-3#1)(2010-12#1)
in stem cell##10##3##(2008-10#2)(2008-11#3)(2008-7#1)(2009-3#2)(2010-11#1)(2010-12#1)
in stem cells##3##3##(2009-3#1)(2010-7#1)(2011-2#1)
in stem##23##2##(2008-10#10)(2008-11#3)(2008-7#1)(2009-3#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)
in stems and##3##3##(2008-10#3)
in stems##11##2##(2008-10#9)(2008-11#1)(2011-10#1)
in step with the##2##4##(2008-1#1)(2008-9#1)
in step##3##2##(2007-11#1)(2008-1#1)(2008-9#1)
in steps##2##2##(2008-3#1)(2008-4#1)
in stepwise##2##2##(1994-8#1)(2008-7#1)
in sterile##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
in steroid##5##2##(1992-11#1)(2007-7#2)(2008-11#1)(2008-4#1)
in steroidogenic tissues##3##3##(1995-12#1)(1995-2#1)(2012-2#1)
in stimulated##8##2##(1992-8#1)(1994-9#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-9#1)
in stimulating fusion##2##3##(1992-6#2)
in stimulating the oxidative burst##2##5##(2008-10#2)
in stimulating the##5##3##(1990-9#1)(1997-1#1)(2008-10#2)(2010-2#1)
in stimulating##19##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-6#2)(1994-5#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#5)(2008-8#1)(2010-2#1)(2013-8#1)
in stimulation##3##2##(1995-8#1)(2009-12#1)(2013-1#1)
in stimulatory##3##2##(2008-11#2)(2013-1#1)
in stimulus##2##2##(2011-2#1)(2012-2#1)
in stirred tank##2##3##(2008-11#2)
in stirred##6##2##(2008-10#1)(2008-11#3)(2008-7#2)
in stochastic environments##3##3##(2008-8#3)
in stoichiometric##2##2##(2008-7#1)(2012-2#1)
in stomach cancer cells##2##4##(2009-9#2)
in stomach##6##2##(1997-7#1)(2009-9#2)(2011-2#1)(2012-12#1)(2013-8#1)
in stone formers##4##3##(1991-12#4)
in stone fruit##2##3##(2008-10#2)
in stone##7##2##(1991-12#4)(1993-6#1)(2008-10#2)
in stool specimens##4##3##(2012-2#3)(2013-8#1)
in stool##7##2##(1993-3#1)(2011-2#1)(2012-2#4)(2013-8#1)
in storage##6##2##(2008-10#3)(2008-2#1)(2008-5#1)(2010-4#1)
in stored pollen##3##3##(2011-2#3)
in stored##6##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-2#3)
in strain and##2##3##(2007-12#1)(2009-4#1)
in strain##10##2##(1990-7#1)(1994-2#1)(1994-6#1)(2007-12#1)(2008-10#4)(2009-4#1)(2010-6#1)
in strained##2##2##(2007-11#1)(2007-12#1)
in strains of##2##3##(2007-10#1)(2008-10#1)
in strains##12##2##(1990-5#1)(1992-10#1)(1993-9#2)(1995-2#1)(1995-8#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-8#1)
in strategic planning##2##3##(1992-3#1)(2008-11#1)
in strategic##3##2##(1992-3#1)(1995-12#1)(2008-11#1)
in strategies##2##2##(2007-6#1)(2012-2#1)
in stratified##6##2##(1995-9#1)(2008-3#1)(2010-3#1)(2012-2#2)(2013-1#1)
in stratifying the##3##3##(2011-1#1)(2011-2#2)
in stratifying##4##2##(2011-1#1)(2011-2#3)
in stratum corneum##4##3##(2008-5#4)
in stratum##5##2##(2008-5#5)
in strawberry##4##2##(2008-10#4)
in strength and##3##3##(2008-3#1)(2009-12#1)(2013-1#1)
in strength##8##2##(2007-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2012-2#1)(2013-1#1)
in strengthening##3##2##(2008-10#2)(2012-12#1)
in streptozotocin##3##2##(1996-12#1)(2008-12#1)(2010-2#1)
in streptozotocin-induced diabetic##2##3##(2008-12#2)
in streptozotocin-induced##4##2##(2008-12#3)(2012-3#1)
in stress and##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
in stress responses##2##3##(2012-12#1)(2013-1#1)
in stress##16##2##(1995-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
in stress-related##2##2##(1995-8#1)(2008-6#1)
in stressed##2##2##(1995-12#1)(2008-7#1)
in stretched##2##2##(1993-11#1)(2012-7#1)
in striatal synaptosomes##2##3##(1995-11#2)
in striatal##8##2##(1990-7#1)(1993-12#1)(1994-5#1)(1995-11#2)(1996-12#1)(1996-5#1)(2008-7#1)
in striatum and##3##3##(1994-8#2)(1996-2#1)
in striatum##9##2##(1990-9#1)(1994-8#3)(1996-2#2)(1996-5#1)(1997-2#2)
in strictly##2##2##(2007-8#1)(2008-3#1)
in strip-tilled than conventionally tilled##2##5##(2008-10#2)
in strip-tilled##3##2##(2008-10#3)
in stripping##3##2##(2008-10#3)
in stroke and##4##3##(1996-6#1)(2007-10#1)(2008-8#2)
in stroke incidence##2##3##(2007-10#1)(2007-9#1)
in stroke management##2##3##(2007-9#1)(2008-8#1)
in stroke patients with dysphagia##2##5##(2007-10#2)
in stroke patients with##3##4##(2007-10#3)
in stroke patients##15##3##(2007-10#6)(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-12#1)
in stroke prevention##3##3##(1994-9#1)(2011-2#1)(2012-2#1)
in stroke survivors at##2##4##(2007-10#2)
in stroke##43##2##(1990-3#1)(1993-10#1)(1994-9#1)(1996-6#1)(2007-10#12)(2007-2#1)(2007-9#3)(2008-2#1)(2008-3#1)(2008-8#15)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
in stroma##2##2##(1994-2#1)(2008-12#1)
in stromal cells##2##3##(1993-11#1)(1993-9#1)
in stromal##7##2##(1993-11#1)(1993-9#1)(1994-9#1)(2008-11#1)(2008-3#1)(2013-1#2)
in strong acidic##3##3##(2008-10#2)(2008-11#1)
in strong##14##2##(1992-3#1)(1995-3#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#2)
in stronger##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
in strongly acidic solution##2##4##(2008-10#2)
in strongly acidic##4##3##(2008-10#4)
in strongly dispersion-managed optical##2##4##(2007-11#2)
in strongly dispersion-managed transmission systems##3##5##(2007-11#2)(2007-12#1)
in strongly dispersion-managed##6##3##(2007-11#5)(2007-12#1)
in strongly scattering##2##3##(1992-8#1)(2007-11#1)
in strongly##18##2##(1992-8#1)(1997-2#1)(2007-11#7)(2007-12#1)(2008-10#5)(2008-3#2)(2012-2#1)
in structural##10##2##(1995-2#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-11#1)(2013-8#2)
in structurally normal##2##3##(2009-5#1)(2011-2#1)
in structure and##6##3##(1995-11#1)(1997-7#1)(2008-12#1)(2008-6#1)(2009-7#1)(2011-3#1)
in structure determination##2##3##(2008-4#1)(2010-7#1)
in structure##15##2##(1990-5#1)(1991-2#1)(1995-11#1)(1997-7#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
in structured##2##2##(2008-8#2)
in structures with##2##3##(2008-2#1)(2008-7#1)
in structuring##6##2##(1991-1#1)(1993-12#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
in student##2##2##(2008-12#1)(2008-8#1)
in students##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
in students'##3##2##(1996-1#1)(2012-2#1)(2012-3#1)
in studies aimed at##2##4##(1991-5#1)(2008-7#1)
in studies conducted in##2##4##(2008-10#2)
in studies conducted using spring wheat cultivars##2##7##(2008-10#2)
in studies conducted using##3##4##(2008-10#3)
in studies conducted##5##3##(2008-10#5)
in studies of genetic##2##4##(2008-10#1)(2008-7#1)
in studies of the##8##4##(1992-6#1)(1993-11#1)(1997-5#2)(2007-11#1)(2008-4#1)(2008-8#1)(2009-8#1)
in studies of##35##3##(1991-8#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1997-5#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-8#2)(2009-9#1)(2010-9#1)(2012-2#1)(2013-8#1)
in studies on the##4##4##(1991-12#1)(1992-6#1)(1993-6#1)(2008-10#1)
in studies on##6##3##(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(2008-10#1)
in studies that##2##3##(2008-10#1)(2008-8#1)
in studies using##3##3##(1990-5#1)(1997-5#1)(2008-10#1)
in studies with mean DON##2##5##(2008-10#2)
in studies with mean IND##2##5##(2008-10#2)
in studies with mean##4##4##(2008-10#4)
in studies with##6##3##(2008-10#6)
in studies##67##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1996-12#1)(1997-5#3)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#4)(2008-9#5)(2009-8#2)(2009-9#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
in study design##2##3##(2012-2#2)
in study group##4##3##(2007-11#1)(2007-7#2)(2011-2#1)
in study##10##2##(1991-1#1)(1996-3#1)(2007-11#1)(2007-7#2)(2010-3#1)(2011-2#1)(2012-2#3)
in studying the##7##3##(1990-5#1)(1993-6#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
in studying##21##2##(1990-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1995-11#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-8#1)(2012-12#1)(2013-1#1)
in stuttering##5##2##(2008-2#3)(2012-12#2)
in style##2##2##(2008-7#1)(2009-12#1)
in sub-Saharan Africa##13##3##(1996-8#1)(1997-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#3)(2012-12#1)(2013-1#1)
in sub-Saharan##15##2##(1996-8#1)(1997-4#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
in subacute##2##2##(1991-3#1)(2008-7#1)
in subarachnoid##2##2##(2008-7#1)(2011-2#1)
in subcellular##3##2##(1992-11#1)(1993-12#1)(2009-7#1)
in subcutaneous##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
in subdiffusive##2##2##(2008-3#2)
in subgroups##4##2##(1994-5#1)(1997-3#1)(2008-10#1)(2008-7#1)
in subjective##5##2##(1996-11#1)(2008-11#1)(2008-9#2)(2010-5#1)
in subjects immunized with##2##4##(1995-5#2)
in subjects of##3##3##(1991-11#1)(2008-11#1)(2012-12#1)
in subjects under##2##3##(1991-3#1)(2013-8#1)
in subjects who were##2##4##(1994-3#1)(2008-3#1)
in subjects who##4##3##(1991-3#1)(1994-3#1)(2008-10#1)(2008-3#1)
in subjects with Parkinson's disease##2##5##(2008-7#1)(2013-1#1)
in subjects with SI joint dysfunction##2##6##(2012-2#2)
in subjects with a history of##3##6##(2007-11#3)
in subjects with and without PCa##2##6##(2013-1#2)
in subjects with and without##3##5##(1991-3#1)(2013-1#2)
in subjects with chronic##2##4##(2008-4#1)(2011-2#1)
in subjects with colorectal polyps##2##5##(1993-9#2)
in subjects with normal##3##4##(1992-11#1)(2011-1#1)(2012-7#1)
in subjects with##47##3##(1990-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1993-8#1)(1993-9#2)(1994-12#1)(1995-8#1)(1996-11#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-7#2)(2013-1#6)
in subjects##72##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-7#2)(2013-1#7)(2013-8#1)
in submerged##4##2##(1990-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
in subpopulations of##2##3##(1995-6#1)(2007-8#1)
in subpopulations##4##2##(1995-6#1)(2007-8#1)(2008-10#1)(2008-9#1)
in subsequent cohorts##2##3##(2008-6#1)(2010-3#1)
in subsequent##22##2##(1990-6#2)(1991-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1996-12#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)
in subsets of##2##3##(1997-5#1)(2008-9#1)
in substance abuse treatment##2##4##(2010-11#1)(2012-12#1)
in substance abuse##4##3##(1991-1#1)(2009-9#1)(2010-11#1)(2012-12#1)
in substance use##6##3##(2008-6#1)(2009-7#4)(2010-6#1)
in substance##14##2##(1991-1#3)(2008-12#1)(2008-6#2)(2009-7#4)(2009-9#1)(2010-11#1)(2010-6#1)(2012-12#1)
in substantia nigra##2##3##(1994-2#1)(1996-12#1)
in substantia##3##2##(1994-2#1)(1996-12#1)(1997-6#1)
in substantial##6##2##(1996-12#1)(2007-8#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
in substitope algorithms##2##3##(2008-6#2)
in substitution##2##2##(1991-12#1)(2008-10#1)
in substrate binding and catalysis##2##5##(1993-8#1)(1995-5#1)
in substrate binding##3##3##(1993-8#1)(1994-5#1)(1995-5#1)
in substrate specificity##2##3##(1995-5#1)(2008-10#1)
in substrate##13##2##(1991-12#1)(1993-8#1)(1994-5#2)(1995-5#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)
in subsurface##3##2##(2007-5#1)(2008-10#2)
in subterranean##2##2##(2008-10#1)(2012-3#1)
in subtle##2##2##(2008-10#1)(2009-8#1)
in subunit I of cytochrome c oxidase from Saccharomyces cerevisiae##2##10##(1997-7#2)
in subunit##3##2##(1997-7#2)(2009-9#1)
in successful##5##2##(1994-9#1)(2008-12#1)(2008-7#1)(2010-7#1)(2012-3#1)
in successive generations##2##3##(1997-5#2)
in successive##9##2##(1994-12#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)
in such a manner##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
in such a patient##2##4##(2006-10#1)(2007-8#1)
in such a setting##2##4##(1993-1#1)(2009-6#1)
in such a way as to##2##6##(2008-10#1)(2008-4#1)
in such a way that it##3##6##(2008-3#2)(2011-2#1)
in such a way that the##7##6##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2012-1#1)
in such a way that they can##2##7##(1997-5#1)(2013-8#1)
in such a way that they##5##6##(1997-4#1)(1997-5#2)(2009-4#1)(2013-8#1)
in such a way that##28##5##(1990-12#1)(1991-9#1)(1997-4#1)(1997-5#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
in such a way to##3##5##(1990-12#1)(2008-11#1)(2011-1#1)
in such a way##33##4##(1990-12#2)(1991-9#1)(1997-4#1)(1997-5#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
in such a##65##3##(1990-12#3)(1991-9#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-5#2)(2006-10#1)(2006-6#1)(2007-12#5)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
in such an##3##3##(2008-10#2)(2011-2#1)
in such cases##13##3##(1991-5#1)(1993-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
in such circumstances##3##3##(1994-2#1)(2010-5#1)(2011-2#1)
in such environments##2##3##(2008-8#1)(2012-5#1)
in such fibers##2##3##(2007-11#2)
in such patients is##3##4##(2007-11#1)(2007-8#1)(2008-9#1)
in such patients##14##3##(1991-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
in such samples##3##3##(2008-10#2)(2008-12#1)
in such settings##2##3##(2008-1#1)(2010-7#1)
in such situations##2##3##(2008-10#1)(2011-2#1)
in such studies##5##3##(2008-11#1)(2008-6#1)(2008-8#2)(2012-3#1)
in such##182##2##(1990-12#3)(1991-4#1)(1991-5#1)(1991-9#2)(1992-2#1)(1993-1#3)(1993-3#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#7)(2008-2#1)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#7)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
in sucrose##3##2##(1994-8#1)(1997-3#1)(2008-12#1)
in sudden##5##2##(1991-9#1)(2008-4#1)(2008-7#2)(2011-2#1)
in sufficient amounts to##2##4##(2008-11#1)(2010-4#1)
in sufficient detail to##2##4##(2008-11#1)(2008-8#1)
in sufficient quantity##2##3##(1995-6#1)(1997-4#1)
in sufficient##7##2##(1995-6#1)(1997-4#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)
in sufficiently##2##2##(2008-10#1)(2008-5#1)
in sugar and##3##3##(2008-10#2)(2010-6#1)
in sugar beet and wheat##2##5##(2008-10#2)
in sugar beet and##3##4##(2008-10#3)
in sugar beet##8##3##(2008-10#5)(2008-12#2)(2012-3#1)
in sugar beets##2##3##(2008-10#2)
in sugar pine (P##2##4##(2008-10#2)
in sugar pine##4##3##(2008-10#4)
in sugar##18##2##(2008-10#14)(2008-12#2)(2010-6#1)(2012-3#1)
in sugarcane and marine##2##4##(2008-10#2)
in sugarcane##6##2##(2008-10#4)(2011-2#2)
in sugars##2##2##(1990-9#1)(2012-1#1)
in suicidal ideation##2##3##(2010-8#2)
in suicidal##3##2##(2010-8#2)(2012-12#1)
in suitable##7##2##(1990-12#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
in sulfur##2##2##(2008-10#1)(2010-4#1)
in sulfuric acid media##3##4##(2008-10#3)
in sulfuric acid medium##6##4##(2008-10#6)
in sulfuric acid solution##2##4##(2008-10#2)
in sulfuric acid##13##3##(2008-10#13)
in sulphuric acid##5##3##(2008-10#5)
in sum##2##2##(2007-8#1)(2008-2#1)
in summer and autumn##2##4##(2008-10#1)(2011-2#1)
in summer and winter##2##4##(2013-1#1)(2013-8#1)
in summer and##6##3##(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
in summer##20##2##(1992-11#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
in sunflower plants##2##3##(2008-10#2)
in sunflower##4##2##(1991-5#1)(2008-10#2)(2009-6#1)
in sunlight##2##2##(2008-10#1)(2008-5#1)
in sunny##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
in sunscreen##6##2##(2008-10#1)(2008-5#4)(2012-2#1)
in supercritical CO(2)##7##3##(2008-10#7)
in supercritical carbon dioxide##9##4##(2008-10#5)(2008-3#4)
in supercritical##16##2##(2008-10#12)(2008-3#4)
in superficial and deep##2##4##(1993-12#1)(2007-10#1)
in superficial##15##2##(1991-3#1)(1993-12#3)(1996-5#2)(2007-10#1)(2007-7#1)(2008-5#2)(2008-6#1)(2009-8#1)(2011-2#3)
in superior##2##2##(2008-3#1)(2010-6#1)
in supernatant##7##2##(1997-4#1)(2008-11#2)(2008-8#2)(2008-9#1)(2013-8#1)
in superoxide##3##2##(1993-6#1)(1994-11#1)(2012-2#1)
in supervised##2##2##(2008-12#1)(2013-8#1)
in supine position##6##3##(2008-1#1)(2012-12#2)(2012-3#3)
in supine posture##2##3##(2012-3#2)
in supine##10##2##(1992-8#1)(2008-1#1)(2008-7#1)(2012-12#2)(2012-3#5)
in supply of##2##3##(1993-12#1)(2011-2#1)
in supply##3##2##(1993-12#1)(2011-2#2)
in supplying##2##2##(1991-9#1)(1996-6#1)
in support of the quality##2##5##(2008-10#2)
in support of the##14##4##(1994-12#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2009-2#1)(2011-1#2)(2011-2#2)(2013-1#1)
in support of##28##3##(1992-12#1)(1994-12#1)(1995-2#1)(1996-11#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
in support##30##2##(1992-12#1)(1994-12#1)(1995-2#1)(1996-11#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
in supporting electrolyte##3##3##(2008-10#3)
in supporting growth##2##3##(1995-2#1)(2008-11#1)
in supporting the student##2##4##(2008-11#2)
in supporting the##3##3##(2008-11#2)(2008-9#1)
in supporting##19##2##(1994-5#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2013-8#2)
in supportive##8##2##(2008-7#8)
in suppressing the##4##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
in suppressing##18##2##(1994-11#1)(1994-2#1)(1994-8#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2011-3#1)(2012-12#1)
in suppression of cell growth##2##5##(2008-11#1)(2012-12#1)
in suppression of##9##3##(1992-8#1)(2008-10#4)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
in suppressive##2##2##(2008-10#2)
in supracondylar##2##2##(2008-7#1)(2009-3#1)
in surf clam oocytes##2##4##(1992-11#2)
in surface Brillouin light scattering##2##5##(2008-2#2)
in surface area##6##3##(2008-10#2)(2010-10#3)(2013-1#1)
in surface charge density##2##4##(2008-5#1)(2009-8#1)
in surface roughness##2##3##(2008-10#1)(2008-3#1)
in surface water from##2##4##(2007-5#1)(2008-10#1)
in surface water samples##3##4##(2008-10#3)
in surface water##11##3##(2007-5#1)(2008-10#10)
in surface waters##3##3##(2008-10#3)
in surface##44##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-5#1)(2007-5#1)(2008-10#22)(2008-2#2)(2008-3#4)(2008-5#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#1)(2013-1#1)
in surfactant micelles##2##3##(2008-10#2)
in surfactant##5##2##(1990-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
in surgery and##2##3##(2008-4#1)(2013-8#1)
in surgery of##4##3##(1990-9#1)(1994-8#1)(2007-11#1)(2007-8#1)
in surgery##23##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
in surgery]##5##2##(1992-3#1)(1992-9#2)(1993-9#1)(1996-3#1)
in surgical and##2##3##(2007-7#1)(2008-3#1)
in surgical oncology##2##3##(2012-12#1)(2012-3#1)
in surgical patients##2##3##(2007-8#1)(2013-8#1)
in surgical procedures##2##3##(1996-9#1)(2013-1#1)
in surgical prophylaxis in childhood##2##5##(1990-5#1)(1991-3#1)
in surgical site infection##2##4##(2008-8#2)
in surgical treatment of##4##4##(2007-8#1)(2010-8#1)(2012-1#1)(2012-3#1)
in surgical##30##2##(1990-5#1)(1991-3#2)(1996-9#1)(1997-7#1)(2007-7#1)(2007-8#3)(2008-3#1)(2008-6#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
in surimi##2##2##(2011-2#2)
in surveillance and##2##3##(1997-3#1)(2008-2#1)
in surveillance##5##2##(1997-3#1)(2008-2#1)(2011-2#3)
in survey##4##2##(1993-2#1)(1994-2#1)(2008-10#1)(2010-1#1)
in surveys##2##2##(1993-2#1)(1993-9#1)
in survival and##3##3##(2011-2#1)(2013-7#2)
in survival between the##2##4##(1996-9#1)(2010-3#1)
in survival between##3##3##(1996-9#1)(2008-6#1)(2010-3#1)
in survival curves##3##3##(2012-2#3)
in survival has##2##3##(1992-10#1)(2010-12#1)
in survival of##2##3##(2008-10#1)(2008-12#1)
in survival rate##4##3##(1990-8#2)(1992-10#1)(2008-10#1)
in survival was##2##3##(1992-10#1)(1992-12#1)
in survival##31##2##(1990-6#1)(1990-8#3)(1991-8#1)(1992-10#3)(1992-12#1)(1995-4#1)(1996-9#1)(2008-10#4)(2008-12#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#3)(2013-7#2)
in surviving##4##2##(2008-7#1)(2010-10#1)(2010-2#1)(2010-4#1)
in survivors of##3##3##(1990-5#1)(2008-6#1)(2008-7#1)
in survivors##4##2##(1990-5#1)(2008-6#1)(2008-7#1)(2009-6#1)
in susceptibility and##3##3##(2008-10#2)(2008-9#1)
in susceptibility of##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
in susceptibility to the##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
in susceptibility to##13##3##(1997-5#2)(2007-12#2)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#1)
in susceptibility##23##2##(1994-2#1)(1995-12#1)(1996-12#1)(1997-5#2)(2007-12#2)(2008-10#9)(2008-7#1)(2008-9#3)(2011-2#2)(2011-3#1)
in susceptible and##2##3##(2008-10#2)
in susceptible berries##2##3##(2008-10#2)
in susceptible cultivars and##2##4##(2008-10#2)
in susceptible cultivars##5##3##(2008-10#5)
in susceptible or##2##3##(2008-10#2)
in susceptible plants##4##3##(2008-10#2)(2009-8#2)
in susceptible##37##2##(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#32)(2009-8#2)
in suspect##2##2##(1993-1#1)(1997-8#1)
in suspected cases for##2##4##(2009-7#1)(2013-8#1)
in suspected##8##2##(1991-12#1)(1995-11#2)(1996-8#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
in suspending##2##2##(1993-3#1)(2008-8#1)
in suspension and##3##3##(2008-11#3)
in suspension culture and##2##4##(1997-1#1)(2008-11#1)
in suspension culture##11##3##(1992-9#1)(1997-1#1)(2008-11#9)
in suspension cultures in##2##4##(2008-11#1)(2008-7#1)
in suspension cultures##5##3##(2008-11#2)(2008-7#3)
in suspension in a##2##4##(2008-11#2)
in suspension in##5##3##(2008-11#5)
in suspension or in##2##4##(1994-5#1)(2008-11#1)
in suspension or##3##3##(1994-5#1)(2008-11#1)(2008-9#1)
in suspension##56##2##(1990-8#1)(1992-9#1)(1994-5#1)(1997-1#1)(2008-1#2)(2008-10#2)(2008-11#34)(2008-3#3)(2008-4#5)(2008-7#3)(2008-8#1)(2008-9#2)
in sustained##2##2##(1995-3#1)(2008-2#1)
in sweet##4##2##(2008-10#3)(2008-5#1)
in sweetpotato weevil##2##3##(2011-2#2)
in swimming pool water##3##4##(2008-10#3)
in swimming##5##2##(2008-10#3)(2009-1#2)
in swine populations##2##3##(2011-2#1)(2013-8#1)
in swine##5##2##(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
in swiss##2##2##(2008-10#1)(2008-12#1)
in switching##2##2##(2008-2#1)(2008-3#1)
in symmetric##2##2##(1997-2#1)(2008-3#1)
in sympathetic##2##2##(2008-7#1)(2010-5#1)
in sympatry and##2##3##(2008-10#2)
in sympatry##9##2##(2008-10#4)(2008-8#5)
in symptom development and##2##4##(2008-10#2)
in symptom development##4##3##(2008-10#4)
in symptom##8##2##(2008-10#5)(2008-7#1)(2009-11#1)(2011-2#1)
in symptomatic beets##4##3##(2008-10#4)
in symptomatic patients##4##3##(1991-11#1)(2009-4#1)(2010-6#1)(2013-1#1)
in symptomatic##16##2##(1991-11#1)(1993-1#1)(2007-10#2)(2008-10#6)(2009-4#1)(2010-6#1)(2010-7#1)(2012-12#2)(2013-1#1)
in symptomatology##2##2##(2008-10#2)
in symptomless pine shoots##2##4##(2008-10#2)
in symptomless##4##2##(2008-10#4)
in symptoms and##2##3##(1990-11#1)(2006-10#1)
in symptoms of neuroticism##2##4##(2008-6#2)
in symptoms##12##2##(1990-11#1)(1991-4#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-12#1)
in synapse##3##2##(1992-6#1)(2009-11#2)
in synaptic and non-synaptic brain mitochondria##2##6##(1990-3#2)
in synaptic and non-synaptic##3##4##(1990-3#3)
in synaptic function##2##3##(2008-4#1)(2008-7#1)
in synaptic plasma membranes##5##4##(1995-6#2)(1997-1#3)
in synaptic plasticity and##3##4##(1996-2#1)(2008-11#1)(2008-7#1)
in synaptic plasticity##8##3##(1993-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
in synaptic transmission and##2##4##(2008-7#1)(2009-8#1)
in synaptic vesicles##2##3##(1993-12#1)(2008-1#1)
in synaptic##34##2##(1990-3#4)(1993-12#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-3#2)(1997-7#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-7#7)(2009-8#2)(2009-9#1)(2012-2#1)
in sync##2##2##(1994-1#1)(1994-3#1)
in synchronism with the##2##4##(2008-3#2)
in synchronized##3##2##(1997-7#1)(2008-11#1)(2013-8#1)
in synchronous##3##2##(2008-9#1)(2010-3#1)(2013-8#1)
in synchrony##2##2##(2008-11#1)(2008-2#1)
in synergism with##3##3##(1990-2#1)(2008-4#2)
in synergy with##3##3##(1992-8#1)(1995-12#1)(2008-12#1)
in syngeneic##2##2##(1991-6#1)(2013-1#1)
in synovial sarcoma##3##3##(1993-12#1)(2008-6#2)
in synovial##7##2##(1990-6#1)(1993-12#1)(1996-9#1)(2008-6#2)(2008-7#1)(2013-1#1)
in synthesis of##3##3##(1990-5#1)(2007-11#1)(2012-2#1)
in synthesis##5##2##(1990-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2012-2#1)
in synthesizing##3##2##(1996-12#1)(2008-7#1)(2013-8#1)
in synthetic and real##2##4##(2008-10#2)
in synthetic and##4##3##(1997-3#1)(2008-10#2)(2011-2#1)
in synthetic biology##2##3##(2009-5#1)(2012-2#1)
in synthetic bone##2##3##(2008-8#1)(2008-9#1)
in synthetic broth##2##3##(2008-8#2)
in synthetic gene##2##3##(2008-11#2)
in synthetic medium##2##3##(2008-5#1)(2008-6#1)
in synthetic mixture and##2##4##(2008-10#2)
in synthetic mixtures and##4##4##(2008-10#4)
in synthetic mixtures##9##3##(2008-10#9)
in synthetic samples and practical samples##2##6##(2008-10#2)
in synthetic samples and##5##4##(2008-10#5)
in synthetic samples has been obtained and the interferences from different cations and anions have been studied##2##17##(2008-10#2)
in synthetic samples with satisfactory results##2##6##(2008-10#2)
in synthetic samples##19##3##(2008-10#19)
in synthetic wine##2##3##(2008-10#2)
in synthetic##67##2##(1994-2#1)(1995-11#1)(1997-3#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#43)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
in syrups##2##2##(2008-10#2)
in system##4##2##(1993-2#1)(2007-11#1)(2008-10#1)(2008-2#1)
in systematic##2##2##(2009-3#1)(2012-2#1)
in systemic infection of##2##4##(2008-10#2)
in systemic lupus erythematosus##9##4##(2006-10#2)(2008-1#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in systemic sclerosis##4##3##(1992-8#1)(2006-10#2)(2010-10#1)
in systemic##31##2##(1991-11#1)(1991-4#1)(1992-8#2)(1995-12#1)(1996-12#2)(1997-1#1)(2006-10#4)(2008-1#1)(2008-10#4)(2008-12#3)(2008-4#1)(2009-12#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
in systemically infected##3##3##(2008-10#3)
in systemically##4##2##(2008-10#4)
in systems biology##2##3##(2008-8#1)(2011-2#1)
in systems of##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
in systems that are##2##4##(2013-8#2)
in systems that##4##3##(2008-11#2)(2013-8#2)
in systems with##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
in systems##23##2##(1995-6#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#4)
in systolic and diastolic blood pressure##3##6##(1992-8#1)(2008-11#1)(2012-3#1)
in systolic blood pressure##4##4##(1992-12#1)(2008-3#1)(2012-1#2)
in systolic##9##2##(1990-9#1)(1992-12#1)(1992-8#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#2)(2012-3#1)
in table salt samples##4##4##(2008-10#4)
in table salt##9##3##(2008-10#9)
in table##11##2##(2008-10#11)
in tables##2##2##(1995-1#1)(2008-10#1)
in tablet dosage form##5##4##(2008-10#2)(2010-5#2)(2012-12#1)
in tablet##8##2##(2008-10#5)(2010-5#2)(2012-12#1)
in tablets and biological fluids##3##5##(2008-10#3)
in tablets and##8##3##(2008-10#8)
in tablets with##3##3##(2008-10#3)
in tablets##25##2##(2008-10#21)(2010-5#3)(2013-8#1)
in tadpoles##2##2##(2011-2#1)(2012-12#1)
in tail length##2##3##(2008-8#2)
in take-all suppression##2##3##(2008-10#2)
in take-all##4##2##(2008-10#4)
in taking care of##2##4##(1990-10#1)(1991-6#1)
in taking##11##2##(1990-10#1)(1991-6#1)(1993-3#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-4#3)(2012-12#1)(2012-2#1)
in talbot interferometry with##2##4##(2008-3#2)
in tall fescue##2##3##(2008-10#2)
in tamoxifen treated##2##3##(1992-2#1)(2008-7#1)
in tandem with the##3##4##(1995-2#1)(2009-9#1)(2010-7#1)
in tandem with##6##3##(1995-2#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-7#1)(2013-7#1)
in tandem##21##2##(1993-12#1)(1995-2#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
in tannery wastewaters##2##3##(2008-10#2)
in tannery##5##2##(2008-10#5)
in tanycytes##2##2##(2012-1#2)
in tap and river water samples##2##6##(2008-10#2)
in tap and##5##3##(2008-10#5)
in tap water and lake water##2##6##(2008-10#2)
in tap water and total arsenic in biological samples##2##9##(2008-10#2)
in tap water and##7##4##(2008-10#7)
in tap water was##2##4##(2008-10#2)
in tap water##17##3##(2008-10#16)(2011-2#1)
in tap##29##2##(2008-10#28)(2011-2#1)
in tapping##2##2##(1991-12#1)(2008-10#1)
in tapwater and##3##3##(2008-10#3)
in tapwater##4##2##(2008-10#4)
in target cells##6##3##(1991-9#3)(1997-8#3)
in target##12##2##(1991-9#3)(1994-8#1)(1997-8#3)(2008-1#1)(2008-3#2)(2009-11#1)(2010-8#1)
in targeted cancer therapy and imaging##2##6##(2011-1#2)
in targeted communities##2##3##(1995-2#1)(2013-1#1)
in targeted##9##2##(1995-2#1)(1996-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#2)(2013-1#1)
in targeting more##2##3##(1992-12#1)(2008-7#1)
in targeting##5##2##(1992-12#1)(1997-2#1)(2008-7#1)(2009-12#1)(2011-1#1)
in task##2##2##(2008-11#1)(2009-10#1)
in tasks##4##2##(2008-11#1)(2009-10#1)(2009-5#1)(2012-12#1)
in tax##3##2##(1993-8#1)(2008-8#1)(2010-12#1)
in taxa##2##2##(2008-8#1)(2010-3#1)
in tea and soil##4##4##(2011-1#4)
in tea and##7##3##(2008-10#3)(2011-1#4)
in tea samples##2##3##(2008-10#2)
in tea##14##2##(2008-10#9)(2011-1#4)(2012-8#1)
in teaching about##2##3##(2007-10#1)(2008-10#1)
in teaching and##6##3##(1990-12#1)(1995-2#1)(1995-3#1)(2008-11#2)(2008-12#1)
in teaching situation and##2##4##(1990-12#2)
in teaching situation##4##3##(1990-12#4)
in teaching##25##2##(1990-12#5)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(2007-10#2)(2008-10#1)(2008-11#7)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
in teams##2##2##(1993-12#1)(2013-8#1)
in tear##2##2##(2009-4#1)(2013-8#1)
in technical formulations##3##3##(2008-10#3)
in technical##8##2##(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-8#1)
in technique##3##2##(1993-12#1)(2008-6#1)(2012-3#1)
in techniques##8##2##(1995-1#1)(1995-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#1)
in technology##13##2##(1992-1#1)(1994-1#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-6#1)(2013-1#1)
in tehran##2##2##(2007-7#1)(2011-2#1)
in telemedicine##2##2##(1996-2#2)
in teleost##2##2##(2008-1#1)(2008-7#1)
in teleosts##3##2##(1996-5#1)(1997-3#1)(2008-1#1)
in telephone##2##2##(2008-10#1)(2008-11#1)
in telomerase##2##2##(2008-11#1)(2011-1#1)
in telomere maintenance##2##3##(2011-1#2)
in telomere##3##2##(2011-1#2)(2012-3#1)
in telotrophic ovaries##2##3##(2008-12#2)
in temperate and##2##3##(2008-10#1)(2008-12#1)
in temperate cereals##2##3##(2009-8#1)(2012-3#1)
in temperate climates##2##3##(2008-10#2)
in temperate regions##4##3##(2007-2#1)(2008-10#2)(2008-8#1)
in temperate##13##2##(2007-2#1)(2008-10#7)(2008-12#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
in temperature and##4##3##(1990-7#1)(2008-3#1)(2009-9#1)(2013-8#1)
in temperature is##2##3##(2008-3#2)
in temperature##29##2##(1990-7#1)(1990-8#1)(1996-2#2)(1997-2#3)(2007-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2009-2#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-6#2)(2013-8#2)
in temporal and##3##3##(2008-2#2)(2012-2#1)
in temporal lobe##2##3##(2009-2#1)(2010-8#1)
in temporal lobectomy##2##3##(1992-12#2)
in temporal##12##2##(1992-12#2)(1994-8#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
in temporary##5##2##(1990-5#1)(1993-9#1)(1997-3#1)(2010-8#1)(2013-7#1)
in ten municipalities of##2##4##(2012-12#2)
in ten years##2##3##(1995-6#1)(2008-3#1)
in ten##17##2##(1990-12#1)(1990-3#1)(1991-5#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
in tendons##2##2##(2007-12#1)(2008-6#1)
in tensile properties##2##3##(2008-5#2)
in tensile strength##3##3##(2008-12#2)(2009-3#1)
in tensile##5##2##(2008-12#2)(2008-5#2)(2009-3#1)
in tension##2##2##(2008-10#1)(2009-7#1)
in terahertz imaging and spectroscopy##2##5##(2012-12#2)
in term of##6##3##(2008-10#3)(2008-11#1)(2008-12#1)(2009-3#1)
in term##10##2##(2008-10#4)(2008-11#3)(2008-12#1)(2009-3#1)(2011-2#1)
in terminal differentiation##2##3##(2008-11#1)(2009-3#1)
in terminal##11##2##(1990-3#1)(1992-5#4)(1993-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)
in terminology##3##2##(2009-7#1)(2011-1#1)(2012-3#1)
in terms of a model##2##5##(1990-11#1)(2011-2#1)
in terms of a simple model##2##6##(2008-3#1)(2009-10#1)
in terms of a two-state##2##5##(1991-8#1)(1993-11#1)
in terms of a##29##4##(1990-11#1)(1990-8#1)(1991-8#1)(1993-11#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
in terms of absorbed##2##4##(2008-2#2)
in terms of accuracy##4##4##(2008-10#2)(2008-3#2)
in terms of age##2##4##(2013-1#2)
in terms of an##7##4##(1990-8#1)(1991-8#1)(2008-2#2)(2008-3#1)(2008-9#1)(2013-1#1)
in terms of analytical##2##4##(2008-10#1)(2008-3#1)
in terms of association##2##4##(2008-10#1)(2009-8#1)
in terms of both##14##4##(1992-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2010-8#1)(2011-2#1)(2013-1#1)
in terms of cell##6##4##(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-12#1)
in terms of changes in##3##5##(1993-12#1)(2008-10#1)(2008-2#1)
in terms of clinical##2##4##(1993-12#1)(1997-1#1)
in terms of detection##4##4##(2008-10#2)(2008-3#1)(2010-12#1)
in terms of efficacy##2##4##(1990-6#1)(1993-11#1)
in terms of either##2##4##(2008-10#1)(2008-7#1)
in terms of evolutionary##3##4##(2007-12#2)(2010-12#1)
in terms of food##2##4##(2007-12#1)(2008-5#1)
in terms of gender##2##4##(2008-1#1)(2008-9#1)
in terms of health##3##4##(1995-11#1)(2008-11#1)(2010-2#1)
in terms of high##2##4##(1994-5#1)(2008-12#1)
in terms of host##2##4##(2008-10#2)
in terms of how##2##4##(1994-2#1)(2008-12#1)
in terms of improvement in##2##5##(1996-9#1)(2008-7#1)
in terms of increasing##2##4##(1990-9#1)(2010-10#1)
in terms of information##3##4##(1990-8#1)(2008-10#1)(2010-5#1)
in terms of its##14##4##(1990-11#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
in terms of linear##2##4##(2008-10#2)
in terms of linearity##3##4##(2008-10#1)(2010-3#1)(2012-2#1)
in terms of loss of##2##5##(2008-5#1)(2008-8#1)
in terms of maximum##2##4##(2008-10#1)(2008-2#1)
in terms of mean##2##4##(2008-10#1)(2009-2#1)
in terms of medical##2##4##(1991-12#1)(2010-5#1)
in terms of membrane##2##4##(2008-10#2)
in terms of microbial##2##4##(1997-4#1)(2012-2#1)
in terms of mortality##2##4##(1995-3#1)(1996-12#1)
in terms of optical##4##4##(2008-2#1)(2008-3#2)(2008-9#1)
in terms of overall##3##4##(2008-6#1)(2008-7#1)(2012-12#1)
in terms of pain##3##4##(2007-11#1)(2010-10#1)(2011-2#1)
in terms of patient##4##4##(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
in terms of physics##2##4##(1996-4#2)
in terms of plant##2##4##(2008-10#2)
in terms of probability##2##4##(2008-10#2)
in terms of protein##3##4##(1991-3#1)(2009-8#1)(2012-3#1)
in terms of pyrolysis and atomization temperatures##2##7##(2008-10#2)
in terms of quality of life##2##6##(2008-7#1)(2012-2#1)
in terms of rapidity##2##4##(2008-10#1)(2008-2#1)
in terms of reducing##2##4##(2009-10#1)(2010-11#1)
in terms of relative standard deviation##2##6##(2008-10#2)
in terms of relative##4##4##(2008-10#3)(2011-2#1)
in terms of repeatability##2##4##(2008-10#2)
in terms of reproducibility##2##4##(1994-9#1)(2013-1#1)
in terms of resolution##2##4##(1991-7#1)(2008-9#1)
in terms of response time##2##5##(2007-8#1)(2010-8#1)
in terms of safety and##2##5##(2008-7#1)(2008-8#1)
in terms of sample##3##4##(2008-10#2)(2008-4#1)
in terms of sensitivity and##3##5##(2008-10#3)
in terms of sensitivity##10##4##(2008-10#8)(2012-2#1)(2012-8#1)
in terms of specific##3##4##(1991-5#1)(1991-9#1)(2013-7#1)
in terms of speed##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
in terms of surface##2##4##(1997-2#1)(2008-10#1)
in terms of surgical##2##4##(2008-6#1)(2011-2#1)
in terms of survival and##2##5##(2007-8#1)(2013-7#1)
in terms of survival##5##4##(1991-2#1)(1993-2#1)(2007-8#1)(2008-7#1)(2013-7#1)
in terms of symptomatic##2##4##(2007-2#1)(2008-7#1)
in terms of teaching##2##4##(1996-1#1)(2012-1#1)
in terms of the M(2)##2##5##(2008-2#1)(2008-3#1)
in terms of the amount of##2##6##(2008-11#2)
in terms of the distribution of##2##6##(2008-8#1)(2008-9#1)
in terms of the effects of##2##6##(2008-10#1)(2008-6#1)
in terms of the mass##2##5##(2008-10#1)(2010-7#1)
in terms of the model##2##5##(2008-2#1)(2008-9#1)
in terms of the molecular##2##5##(1997-2#1)(2008-10#1)
in terms of the number of##2##6##(2008-12#1)(2009-4#1)
in terms of the overall##2##5##(2008-11#1)(2008-9#1)
in terms of the parameters##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
in terms of the phase##2##5##(2007-11#1)(2008-2#1)
in terms of the rate##2##5##(1990-8#1)(1992-3#1)
in terms of the relative##3##5##(1992-2#1)(2008-10#1)(2008-11#1)
in terms of the role of##2##6##(1990-7#1)(2007-12#1)
in terms of the##144##4##(1990-11#1)(1990-7#2)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1997-2#2)(1997-3#2)(2007-11#4)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#5)(2008-2#12)(2008-3#10)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
in terms of their##34##4##(1990-7#1)(1991-2#1)(1992-11#2)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-4#1)(2013-1#2)
in terms of three basic matrices##2##6##(2007-11#1)(2007-12#1)
in terms of three##3##4##(1995-2#1)(2007-11#1)(2007-12#1)
in terms of time##4##4##(2008-10#2)(2008-12#1)(2008-8#1)
in terms of two##3##4##(1995-5#1)(2007-11#1)(2008-8#1)
in terms of type##2##4##(2012-3#1)(2013-1#1)
in terms of##770##3##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#9)(1990-9#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#2)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#16)(2007-12#13)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#146)(2008-11#30)(2008-12#12)(2008-2#40)(2008-3#62)(2008-4#5)(2008-5#22)(2008-6#9)(2008-7#21)(2008-8#19)(2008-9#15)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#23)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#16)(2012-3#9)(2012-4#2)(2012-8#1)(2013-1#23)(2013-7#6)(2013-8#8)
in terms##774##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#9)(1990-9#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#2)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#16)(2007-12#13)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#148)(2008-11#30)(2008-12#12)(2008-2#40)(2008-3#62)(2008-4#5)(2008-5#22)(2008-6#9)(2008-7#21)(2008-8#19)(2008-9#15)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#23)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#17)(2012-3#9)(2012-4#2)(2012-8#1)(2013-1#23)(2013-7#6)(2013-8#8)
in ternary##4##2##(1990-7#1)(1996-5#1)(2007-12#1)(2008-10#1)
in terpene emission rates##2##4##(2011-10#2)
in terrestrial##8##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-4#1)
in territorial##4##2##(2008-8#3)(2008-9#1)
in tertiary care##2##3##(2012-2#2)
in tertiary referral##2##3##(2008-1#1)(2011-2#1)
in tertiary##6##2##(1994-2#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-2#2)
in test##9##2##(1991-1#1)(2008-10#7)(2012-1#1)
in testes##5##2##(1993-12#1)(2008-1#1)(2008-12#1)(2008-8#1)(2013-7#1)
in testicular##9##2##(1990-9#1)(2008-10#4)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
in testing##3##2##(2008-4#1)(2009-5#1)(2013-8#1)
in testis##5##2##(1990-11#1)(1995-6#1)(1995-8#2)(2008-8#1)
in testosterone##3##2##(1990-6#1)(1994-2#1)(2008-12#1)
in tests of reasoning##2##4##(1990-3#2)
in tests of##6##3##(1990-3#2)(1992-5#1)(2009-8#1)(2010-10#1)(2012-2#1)
in tests##14##2##(1990-3#2)(1991-1#1)(1992-5#1)(1993-3#1)(2007-11#1)(2008-10#4)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)
in tetrahydrofuran##6##2##(1996-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)
in tetramethylammonium chloride##2##3##(2008-10#2)
in tetraploid##3##2##(2008-10#2)(2012-3#1)
in text and##2##3##(1995-1#1)(2008-12#1)
in text##8##2##(1995-1#1)(2008-12#1)(2008-7#2)(2010-7#2)(2012-2#1)(2012-3#1)
in textbooks##2##2##(2008-9#1)(2009-6#1)
in texture##2##2##(2008-10#2)
in thalassemic patients was greater than that of normal individuals##2##10##(2011-2#2)
in that a##3##3##(2008-10#2)(2008-5#1)
in that area##2##3##(2008-10#1)(2011-2#1)
in that case##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
in that field##2##3##(2007-10#1)(2013-8#1)
in that it is not##2##5##(1991-9#1)(1992-3#1)
in that it is##10##4##(1990-11#1)(1991-9#1)(1992-3#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)
in that it##26##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-9#2)(1992-10#1)(1992-3#1)(1993-2#1)(1993-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
in that of the##2##4##(1990-11#1)(2010-1#1)
in that order##4##3##(1990-10#1)(2008-6#1)(2011-1#1)(2012-1#1)
in that region##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
in that sample##2##3##(2008-10#2)
in that site##2##3##(2007-5#1)(2008-8#1)
in that state##2##3##(1992-2#1)(1995-3#1)
in that study##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
in that symptoms##2##3##(2008-10#1)(2008-2#1)
in that system##2##3##(1995-2#1)(2007-4#1)
in that the##16##3##(1992-2#1)(1992-6#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
in that their##2##3##(2007-12#1)(2008-4#1)
in that there##2##3##(1995-12#1)(2007-6#1)
in that these##2##3##(2008-10#1)(2008-5#1)
in that they were##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
in that they##12##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#2)
in that this##2##3##(1994-5#1)(2013-1#1)
in that way##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
in that year##2##3##(1991-1#1)(1993-12#1)
in that##161##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-2#4)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-3#3)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#26)(2008-11#12)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#4)
in the &lt##2##3##(1994-12#1)(2008-10#1)
in the &quot##20##3##(1990-6#2)(1994-11#1)(1994-2#1)(1994-8#1)(1996-1#2)(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
in the (SSB)35 mode##3##4##(1997-2#3)
in the +1 and -1 orders##3##6##(2008-2#1)(2008-3#2)
in the +1 and##4##4##(2008-2#1)(2008-3#3)
in the +1 order##2##4##(2008-2#1)(2008-3#1)
in the +1##8##3##(2007-12#1)(2008-2#2)(2008-3#5)
in the -1 order and##2##5##(2008-2#1)(2008-3#1)
in the -1 order##5##4##(2008-2#3)(2008-3#2)
in the 0##22##3##(1991-3#1)(1994-11#1)(1994-5#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2012-2#1)
in the 1 x##2##4##(2008-8#2)
in the 1##22##3##(1992-6#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-8#3)(2008-9#1)(2010-8#1)
in the 10##10##3##(1990-8#1)(1993-12#1)(1995-1#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-12#2)(2011-1#1)
in the 10-20##2##3##(1996-2#1)(2008-11#1)
in the 100-350-A wavelength##2##4##(2008-2#2)
in the 11##3##3##(2008-3#2)(2013-8#1)
in the 12##4##3##(1991-11#1)(1996-12#1)(2007-11#1)(2008-9#1)
in the 125-325-A wavelength region##2##5##(2008-3#2)
in the 12th##2##3##(1992-8#2)
in the 13 degrees C than in the 7##2##9##(2010-8#2)
in the 133##2##3##(2008-1#1)(2008-10#1)
in the 14##3##3##(2009-8#1)(2012-12#1)(2013-1#1)
in the 144##2##3##(2007-7#1)(2008-10#1)
in the 15##2##3##(1997-8#1)(2008-9#1)
in the 1550-nm##2##3##(2007-11#2)
in the 16##6##3##(1994-3#1)(2008-11#1)(2008-8#2)(2009-6#1)(2012-2#1)
in the 16S rRNA gene##2##5##(2008-10#1)(2013-8#1)
in the 17th##2##3##(1997-8#1)(2008-10#1)
in the 18S##2##3##(2008-10#1)(2008-5#1)
in the 18th century##2##4##(1993-11#1)(2010-1#1)
in the 19##4##3##(1991-1#2)(2008-12#1)(2008-8#1)
in the 1918-1919 influenza pandemic##3##5##(2011-2#3)
in the 1930s##5##3##(1993-12#1)(2007-5#2)(2008-8#1)(2013-8#1)
in the 1950s##8##3##(1991-4#1)(1994-9#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
in the 1960s and##4##4##(1992-3#1)(2008-10#2)(2013-1#1)
in the 1960s##10##3##(1992-3#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-6#1)(2013-1#1)
in the 1970s and 1980s##2##5##(1996-9#1)(2008-10#1)
in the 1970s##13##3##(1991-3#2)(1993-2#1)(1995-2#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-3#1)(2013-1#1)
in the 1980s by##2##4##(2008-4#1)(2008-7#1)
in the 1980s##16##3##(1990-4#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)
in the 1988-1989##2##3##(1994-2#1)(2008-10#1)
in the 1990's]##2##3##(1990-6#1)(1995-2#1)
in the 1990s by##2##4##(2008-11#1)(2010-5#1)
in the 1990s##27##3##(1990-11#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#4)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
in the 1992##2##3##(1993-12#1)(1996-1#1)
in the 1994##2##3##(1997-4#2)
in the 1996##2##3##(2008-10#2)
in the 1999-2000##3##3##(2008-10#2)(2011-3#1)
in the 19th Century##2##4##(2009-10#1)(2012-2#1)
in the 19th##4##3##(1993-11#1)(2009-10#1)(2012-2#2)
in the 1st and##2##4##(1992-12#1)(2008-7#1)
in the 1st##5##3##(1990-8#1)(1992-12#1)(1993-11#1)(2008-7#1)(2010-12#1)
in the 2 groups##3##4##(1991-11#2)(1997-3#1)
in the 2##15##3##(1991-11#2)(1992-9#1)(1993-9#2)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)
in the 2+##2##3##(1993-8#2)
in the 2-position##4##3##(1994-5#1)(1995-5#1)(1997-1#1)(2009-9#1)
in the 20##3##3##(1997-5#1)(2007-8#1)(2008-12#1)
in the 2001##2##3##(2008-10#1)(2009-5#1)
in the 2003##2##3##(2008-12#1)(2010-3#1)
in the 2010##2##3##(2012-2#1)(2013-1#1)
in the 20th##2##3##(2007-12#1)(2008-10#1)
in the 21##3##3##(1996-12#1)(2008-6#1)(2010-12#1)
in the 21st century##18##4##(1990-12#1)(1994-2#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2013-1#3)
in the 21st##20##3##(1990-12#1)(1994-2#2)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-1#3)
in the 24 h##3##4##(1996-12#1)(1996-2#1)(2008-10#1)
in the 24##4##3##(1996-12#1)(1996-2#1)(2008-10#1)(2012-12#1)
in the 26-week study##2##4##(2008-9#2)
in the 26-week##3##3##(2008-9#3)
in the 28-42-A wavelength##2##4##(2008-2#2)
in the 2D##2##3##(2007-11#1)(2008-10#1)
in the 2nd and 3rd trimesters##2##6##(2010-12#2)
in the 2nd and 3rd##3##5##(2008-7#1)(2010-12#2)
in the 2nd##8##3##(1990-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-1#1)
in the 3##5##3##(1991-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
in the 3' end##2##4##(1990-2#1)(1997-7#1)
in the 3' expression##2##4##(2012-3#2)
in the 3' non-coding region##2##5##(1990-7#1)(1993-12#1)
in the 3' untranslated region##2##5##(1994-11#1)(1995-2#1)
in the 3'##12##3##(1990-2#1)(1990-7#2)(1993-12#1)(1994-11#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2012-3#3)
in the 3-4-microm##2##3##(2008-2#2)
in the 3-D model##2##4##(2008-3#1)(2008-8#1)
in the 3-D##6##3##(2008-11#2)(2008-3#3)(2008-8#1)
in the 30##2##3##(2008-10#1)(2012-2#1)
in the 33 degrees C-cells##2##5##(1995-11#2)
in the 35##3##3##(2006-8#1)(2008-10#2)
in the 39-week study##2##4##(2008-9#2)
in the 3D##3##3##(2008-3#1)(2012-1#2)
in the 3rd##5##3##(1990-8#1)(1991-8#1)(1992-9#1)(1996-11#1)(2012-2#1)
in the 4##6##3##(1991-3#1)(2008-10#2)(2008-2#1)(2010-5#1)(2010-8#1)
in the 4-position##2##3##(1995-5#1)(2008-10#1)
in the 48##2##3##(2008-2#1)(2013-1#1)
in the 4th##3##3##(1992-9#1)(2008-7#1)(2009-8#1)
in the 5 min##2##4##(1995-12#1)(2010-10#1)
in the 5##10##3##(1991-5#1)(1995-12#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2010-10#1)
in the 5' and 3'##2##5##(1992-8#1)(1997-8#1)
in the 5' end##2##4##(1992-12#1)(2008-10#1)
in the 5' exonuclease##2##4##(1997-8#2)
in the 5' flanking region##4##5##(1992-3#1)(1993-12#1)(1993-3#1)(1996-10#1)
in the 5' flanking##6##4##(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-10#1)
in the 5' proximal##2##4##(1994-11#1)(2008-10#1)
in the 5' untranslated region of##2##6##(1997-8#1)(2008-11#1)
in the 5' untranslated region##3##5##(1997-8#1)(2008-11#1)(2009-5#1)
in the 5'##22##3##(1991-6#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-8#4)(2008-10#2)(2008-11#1)(2009-5#1)(2012-3#1)
in the 5'-flanking region of##2##5##(1991-2#1)(2008-9#1)
in the 5'-flanking region##5##4##(1991-2#1)(1991-6#1)(1991-7#1)(2008-9#1)(2010-5#1)
in the 5'-flanking##6##3##(1991-2#1)(1991-6#1)(1991-7#1)(1995-6#1)(2008-9#1)(2010-5#1)
in the 5'-untranslated region##2##4##(1991-7#1)(1994-12#1)
in the 5'-upstream##2##3##(1997-7#1)(2008-11#1)
in the 50 KDa range##2##5##(1993-11#2)
in the 50##5##3##(1993-11#2)(2007-7#1)(2008-8#1)(2010-5#1)
in the 500##2##3##(1996-12#1)(2008-9#1)
in the 6 months##2##4##(2008-1#1)(2013-1#1)
in the 6##7##3##(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
in the 61##3##3##(1990-11#1)(1992-6#1)(2011-2#1)
in the 65##2##3##(2008-12#1)(2008-7#1)
in the 6m2##2##3##(1991-8#2)
in the 6th##3##3##(2007-5#1)(2008-6#1)(2009-7#1)
in the 7##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#2)
in the 70##2##3##(1997-7#1)(2008-5#1)
in the 760-800-nm wavelength range##2##5##(2008-3#2)
in the 8##3##3##(1990-3#1)(2008-10#1)(2010-5#1)
in the 800-900-cm(-1)##2##3##(2008-3#2)
in the 9##2##3##(1994-7#1)(2008-3#1)
in the 9-11-mum##2##3##(2008-3#2)
in the 90##2##3##(2007-8#1)(2009-5#1)
in the 90's##2##3##(1993-3#1)(2008-1#1)
in the 900-1100-nm range##2##4##(2008-3#2)
in the 90s##4##3##(1991-12#1)(1994-1#1)(1994-2#1)(1995-12#1)
in the 940-nm##2##3##(2008-3#2)
in the 95%##2##3##(1994-2#1)(2012-2#1)
in the A##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
in the AC##2##3##(2008-7#1)(2009-11#1)
in the AD cases##2##4##(1991-1#2)
in the AD##4##3##(1991-1#2)(2008-7#1)(2011-2#1)
in the AFLP##2##3##(2008-10#2)
in the AFM##2##3##(2008-3#2)
in the AHP Fall##2##4##(1994-1#1)(1995-1#1)
in the AHP##3##3##(1994-1#1)(1995-1#1)(1995-3#1)
in the AIDS-associated##2##3##(2009-8#2)
in the APC gene##2##4##(2008-4#2)
in the ARC muscle##2##4##(1994-8#2)
in the ASC##2##3##(2013-1#2)
in the ASE##2##3##(2007-11#1)(2008-10#1)
in the ATP##2##3##(1994-11#1)(2008-11#1)
in the ATP7A gene##3##4##(2011-1#3)
in the Absence of##2##4##(2008-10#2)
in the Acb##2##3##(2007-8#2)
in the African##2##3##(2010-8#2)
in the Age##2##3##(2009-7#1)(2012-1#1)
in the Alzheimer##4##3##(1990-3#3)(1994-8#1)
in the Alzheimer's##2##3##(1995-11#1)(2008-7#1)
in the American continent##2##4##(2008-6#1)(2011-2#1)
in the American##5##3##(1993-2#1)(1997-3#1)(2008-6#1)(2011-2#2)
in the Americas and##2##4##(1993-8#1)(1994-9#1)
in the Americas##5##3##(1993-8#1)(1994-9#1)(2006-10#2)(2008-10#1)
in the Ames##3##3##(1996-12#1)(2008-2#1)(2008-4#1)
in the Andean##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
in the Andes and##2##4##(2008-10#1)(2013-1#1)
in the Andes##6##3##(2008-10#3)(2008-8#2)(2013-1#1)
in the Aplysia##2##3##(1990-7#1)(2008-6#1)
in the Arab countries##4##4##(2008-4#4)
in the Arab world##2##4##(2008-4#1)(2012-2#1)
in the Arab##8##3##(2008-1#2)(2008-4#5)(2012-2#1)
in the Arabidopsis genome##2##4##(2009-10#2)
in the Asia-Pacific##4##3##(2008-10#4)
in the Asian population##2##4##(2010-6#1)(2010-8#1)
in the Atlantic Ocean##2##4##(1996-4#1)(2012-3#1)
in the Atp7a gene##3##4##(2008-12#3)
in the Australian born##3##4##(1990-2#3)
in the Australian##9##3##(1990-2#3)(1995-3#1)(2007-12#2)(2007-2#1)(2009-2#1)(2013-1#1)
in the Authie##2##3##(2008-10#2)
in the B##8##3##(1994-1#1)(2008-10#6)(2008-11#1)
in the B2 protein of ribonucleotide reductase##2##7##(1991-5#2)
in the B73 genome##2##4##(2012-3#2)
in the B73##3##3##(2008-10#1)(2012-3#2)
in the BCT group##2##4##(1995-4#2)
in the BM25 group##2##4##(2011-2#2)
in the BTH-treated##2##3##(2008-10#2)
in the Balkans##2##3##(2008-11#1)(2011-1#1)
in the Baltic##2##3##(2008-10#1)(2010-8#1)
in the Barley##2##3##(2008-10#2)
in the Basic##3##3##(1993-6#1)(2008-4#2)
in the Belgian##2##3##(2008-10#2)
in the Belousov-Zhabotinskii##2##3##(2008-10#2)
in the Biceps femoris##2##4##(2010-4#2)
in the Biocontrol##3##3##(2008-10#3)
in the Biological##2##3##(2008-10#1)(2008-6#1)
in the Boston##2##3##(2007-12#1)(2008-9#1)
in the Brazilian state of##2##5##(2008-10#1)(2009-10#1)
in the Brazilian##7##3##(2008-10#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-8#1)
in the British##3##3##(1991-1#1)(2008-10#1)(2010-2#1)
in the Brown Norway rat##2##5##(2008-10#2)
in the C##15##3##(1990-5#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2012-1#2)
in the C-ADR group##3##4##(2012-12#3)
in the C-terminal domains##2##4##(2008-10#2)
in the C-terminal half of the##2##6##(1993-11#1)(1994-5#1)
in the C-terminal half of##3##5##(1993-11#1)(1994-5#1)(1995-8#1)
in the C-terminal half##4##4##(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)
in the C-terminal region##3##4##(1995-2#1)(1997-2#1)(2008-10#1)
in the C-terminal##12##3##(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#4)
in the C-terminus##3##3##(1992-3#1)(2008-8#1)(2010-11#1)
in the C1q-deficient SLE patients##2##5##(2011-2#2)
in the C1q-deficient SLE##3##4##(2011-2#3)
in the CA1 region of##2##5##(1995-12#1)(1996-12#1)
in the CA1 region##6##4##(1990-7#1)(1995-12#3)(1996-12#1)(1997-2#1)
in the CA1 subfield##2##4##(1990-5#2)
in the CA1##10##3##(1990-5#2)(1990-7#1)(1994-6#1)(1995-12#3)(1996-12#2)(1997-2#1)
in the CA3##2##3##(1996-12#1)(1996-7#1)
in the CAF+FT group##2##4##(1997-7#2)
in the CAF+FT##3##3##(1997-7#3)
in the CAF+FT+TAM group##2##4##(1997-7#2)
in the CCA group##2##4##(2011-2#2)
in the CEF and##2##4##(2008-10#2)
in the CER3 acyl chains##2##5##(2008-10#2)
in the CFTR gene##2##4##(1997-1#1)(1997-3#1)
in the CFTR protein##2##4##(1990-8#2)
in the CFTR##4##3##(1990-8#2)(1997-1#1)(1997-3#1)
in the CH region##2##4##(2008-10#2)
in the CHO##3##3##(1993-8#1)(2008-11#2)
in the CL##5##3##(2008-10#2)(2008-9#3)
in the CNC##4##3##(2013-8#4)
in the CNMI##4##3##(2008-1#4)
in the CNS and##5##4##(1996-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
in the CNS of##2##4##(1994-2#1)(2008-7#1)
in the CNS##30##3##(1991-12#2)(1992-10#3)(1993-5#1)(1994-2#1)(1995-12#1)(1996-12#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#9)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the CO##2##3##(2008-3#2)
in the CP##4##3##(2008-10#3)(2008-9#1)
in the CP/PPn##4##3##(1995-12#2)(1996-5#2)
in the CS group##2##4##(2008-10#1)(2012-3#1)
in the CSF##6##3##(1995-12#2)(1996-12#1)(1996-2#1)(2011-2#1)(2012-3#1)
in the CT field##2##4##(2009-5#1)(2012-1#1)
in the CYP21##2##3##(2008-1#2)
in the Ca##2##3##(2008-3#1)(2008-5#1)
in the Caenorhabditis elegans RNA##2##5##(2012-3#2)
in the California##2##3##(1995-8#1)(2008-10#1)
in the Campeche Bank##2##4##(2013-7#2)
in the Canadian context##2##4##(1996-3#2)
in the Canadian health care system##2##6##(1994-1#1)(1996-12#1)
in the Canadian##7##3##(1994-1#1)(1996-12#1)(1996-3#2)(2008-10#2)(2008-11#1)
in the Cancer##2##3##(2008-5#1)(2011-1#1)
in the Canton of Zurich##3##5##(1996-11#3)
in the Cape##2##3##(1992-8#1)(2011-2#1)
in the Caribbean and##2##4##(2008-10#1)(2009-7#1)
in the Caribbean for##2##4##(2007-5#1)(2011-2#1)
in the Caribbean##19##3##(1996-6#1)(2007-2#1)(2007-5#4)(2008-10#5)(2008-12#1)(2008-4#1)(2009-7#3)(2011-2#3)
in the Caucasian##2##3##(2008-1#1)(2008-7#1)
in the Center and##2##4##(1992-2#2)
in the Center##4##3##(1992-2#3)(2013-1#1)
in the Central Ciscaucasia##2##4##(2011-2#2)
in the Central##5##3##(1996-5#1)(2008-10#1)(2011-2#3)
in the Chikuma cohort##2##4##(2012-7#2)
in the Chinese population##2##4##(2011-1#2)
in the Chinese##8##3##(1995-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-1#3)
in the Cincinnati##2##3##(1994-12#1)(2008-5#1)
in the Cinnulin PF(R) group##2##5##(2008-5#2)
in the Claroideoglomus lineage##2##4##(2013-1#2)
in the Class III##2##4##(2009-7#2)
in the Clinic of##2##4##(1996-11#1)(2012-3#1)
in the Colombian##2##3##(2008-5#1)(2013-7#1)
in the Columbia Basin of Washington##2##6##(2008-10#2)
in the Columbia Basin##5##4##(2008-10#5)
in the Commonwealth of the Northern Mariana Islands (CNMI)##2##9##(2008-1#1)(2013-8#1)
in the Commonwealth of the Northern Mariana Islands##4##8##(2008-1#3)(2013-8#1)
in the Community##2##3##(1991-5#1)(2012-2#1)
in the Control##4##3##(2008-4#2)(2011-2#2)
in the Cricket##2##3##(2008-5#1)(2008-6#1)
in the Cu##3##3##(1997-4#1)(1997-8#1)(2008-12#1)
in the Czech Republic##4##4##(1990-11#1)(1996-7#1)(2008-7#1)(2011-2#1)
in the Czech Republic]##3##4##(1990-11#1)(1996-7#1)(2007-10#1)
in the Czech##8##3##(1990-11#3)(1996-7#2)(2007-10#1)(2008-7#1)(2011-2#1)
in the DDR##2##3##(2011-2#1)(2013-1#1)
in the DDR2 kinase gene##2##5##(2012-2#2)
in the DG##3##3##(1996-12#2)(2007-7#1)
in the DNA damage##2##4##(2011-2#1)(2012-12#1)
in the DNA of##4##4##(1991-5#1)(1993-11#1)(1993-8#1)(1994-7#1)
in the DNA##16##3##(1991-5#1)(1992-3#1)(1993-11#3)(1993-8#2)(1994-7#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
in the DNA-binding domain##2##4##(1991-6#1)(1993-12#1)
in the DPPH##2##3##(2008-10#1)(2008-5#1)
in the DRG and##3##4##(1997-2#1)(2008-9#2)
in the DRG##5##3##(1991-12#1)(1997-2#2)(2008-9#2)
in the DRN##2##3##(1995-5#2)
in the DSM##2##3##(1996-9#1)(2009-10#1)
in the Dagua##2##3##(2008-5#2)
in the Danish##3##3##(1990-12#1)(1992-5#1)(2011-2#1)
in the Del Fuerte Valley##6##5##(2008-10#6)
in the Department of Obstetrics and##2##6##(1996-1#1)(1996-9#1)
in the Department of Pathology##2##5##(2008-5#1)(2013-8#1)
in the Department of##15##4##(1991-9#1)(1994-1#1)(1995-11#1)(1996-1#1)(1996-9#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-5#2)(2011-2#2)(2013-1#1)(2013-8#1)
in the Department##16##3##(1991-9#1)(1994-1#1)(1995-11#1)(1996-1#1)(1996-9#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-5#2)(2011-2#3)(2013-1#1)(2013-8#1)
in the Developing##2##3##(2009-9#1)(2013-1#1)
in the Development of##3##4##(2008-10#1)(2010-11#1)(2011-1#1)
in the Development##4##3##(2008-10#2)(2010-11#1)(2011-1#1)
in the Diels-Alder reaction of##2##5##(1996-5#2)
in the Diels-Alder##3##3##(1996-5#3)
in the Differential##2##3##(2008-10#2)
in the District of##2##4##(1991-5#1)(1992-2#1)
in the Dominican Republic##6##4##(2008-10#5)(2011-2#1)
in the Drosophila##10##3##(1991-5#1)(1995-2#1)(2008-10#2)(2008-7#1)(2008-9#3)(2009-3#2)
in the Dutch##2##3##(2008-10#2)
in the E##9##3##(1990-11#1)(1992-8#2)(1993-6#3)(2010-4#1)(2010-5#1)(2011-2#1)
in the EBL##2##3##(2008-11#1)(2008-12#1)
in the EBRI/ICI 401(k) database##2##5##(2011-2#2)
in the ECT##2##3##(2008-12#1)(2012-12#1)
in the ED##19##3##(1997-2#2)(2007-5#1)(2008-11#5)(2009-6#2)(2009-8#2)(2010-8#1)(2012-2#2)(2013-1#4)
in the EDP##2##3##(2008-7#2)
in the EGFR gene##2##4##(2012-1#2)
in the EGFR##3##3##(2010-5#1)(2012-1#2)
in the EMBL database##2##4##(1991-9#1)(1996-8#1)
in the ER##3##3##(1993-2#1)(1995-2#1)(2008-8#1)
in the ERP##2##3##(2013-8#2)
in the EU##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
in the EUV##6##3##(2007-11#1)(2008-3#5)
in the Earth##2##3##(1996-4#1)(2008-10#1)
in the Earth's atmosphere##2##4##(2008-11#1)(2008-3#1)
in the Earth's##3##3##(2008-11#1)(2008-3#2)
in the East Asian region##2##5##(2008-8#2)
in the East Asian##4##4##(2008-8#2)(2010-3#2)
in the East##7##3##(2008-10#2)(2008-8#2)(2010-3#2)(2011-2#1)
in the Eastern Quebec population##2##5##(1997-5#2)
in the Eastern##6##3##(1996-9#1)(1997-5#2)(2007-2#1)(2011-2#1)(2013-7#1)
in the Elderly##5##3##(1997-3#2)(2008-7#1)(2012-3#2)
in the Emergency Department (ED)##2##5##(2008-11#1)(2008-3#1)
in the Emergency Department##5##4##(1991-12#1)(2008-11#1)(2008-3#3)
in the English literature of##2##5##(2008-11#1)(2011-2#1)
in the English literature##11##4##(2006-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
in the English##16##3##(1995-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
in the European Community and##2##5##(1993-2#1)(2008-10#1)
in the European Union and the United States##2##8##(2008-10#2)
in the European Union##6##4##(1996-3#1)(2008-10#4)(2008-5#1)
in the European##10##3##(1993-2#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-5#1)
in the Evaluation##2##3##(2010-9#1)(2012-3#1)
in the F##4##3##(2008-10#4)
in the F(1)##4##3##(2008-10#3)(2009-9#1)
in the F(2) and backcross populations##2##6##(2008-10#2)
in the F(2) population##3##4##(2008-10#3)
in the F(2)##6##3##(2008-10#6)
in the F(3)##2##3##(2008-10#2)
in the F-dish##4##3##(2008-11#4)
in the F1##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
in the FDA##2##3##(2012-12#2)
in the FTIR spectra##3##4##(2008-10#2)(2013-8#1)
in the Faculty of##2##4##(1996-12#1)(2011-1#1)
in the Faraday##2##3##(1993-5#1)(2007-12#1)
in the Federal Republic of Germany##4##6##(1990-12#1)(1991-12#1)(1992-1#2)
in the Federal Republic of##5##5##(1990-12#1)(1991-12#1)(1991-5#1)(1992-1#2)
in the Federal Republic##6##4##(1990-12#1)(1991-12#1)(1991-5#1)(1992-1#3)
in the Federal##8##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-1#4)(2013-1#1)
in the Felipe Angeles##2##4##(2012-12#2)
in the Field##2##3##(2008-10#2)
in the First##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
in the Florence##2##3##(1992-10#2)
in the Florida Keys##3##4##(2007-5#3)
in the Florida##4##3##(2007-5#3)(2008-2#1)
in the Foster/CIho##3##3##(2008-10#3)
in the Fourier domain##10##4##(2007-11#4)(2008-3#6)
in the Fourier plane##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
in the Fourier spectrum##2##4##(2007-12#1)(2008-2#1)
in the Fourier##16##3##(2007-11#5)(2007-12#1)(2008-2#2)(2008-3#8)
in the Free##2##3##(2008-3#1)(2012-12#1)
in the French samples##2##4##(1990-8#2)
in the French##6##3##(1990-8#2)(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)
in the Fresnel diffraction region##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
in the Fresnel domain##5##4##(2007-11#1)(2007-12#3)(2008-2#1)
in the Fresnel##12##3##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#4)
in the Fungus##2##3##(2008-10#2)
in the Fusarium##2##3##(2008-10#2)
in the G##2##3##(1990-6#1)(1997-4#1)
in the G0/G1 phase##2##4##(1993-8#1)(1993-9#1)
in the G0/G1##3##3##(1993-8#1)(1993-9#1)(2008-11#1)
in the G1 cell cycle phase##2##6##(2008-11#2)
in the G1 phase##3##4##(1993-3#1)(1994-11#1)(2008-11#1)
in the G1##5##3##(1993-3#1)(1994-11#1)(2008-11#3)
in the G1-phase##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
in the GC##2##3##(1993-3#1)(2008-10#1)
in the GH##2##3##(1995-11#1)(2008-1#1)
in the GJB2 gene##2##4##(2008-4#2)
in the GO##2##3##(2010-1#1)(2012-2#1)
in the GST##2##3##(1997-7#2)
in the GenBank##2##3##(1994-12#1)(2009-2#1)
in the General##2##3##(2008-10#1)(2008-3#1)
in the German##6##3##(1990-11#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
in the Golgi and##2##4##(1993-6#1)(2008-11#1)
in the Golgi apparatus##3##4##(1990-5#1)(1992-12#1)(2008-11#1)
in the Golgi##7##3##(1990-5#1)(1992-12#2)(1993-6#1)(2008-11#2)(2008-8#1)
in the Government##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
in the Great Plains region of the United States##2##9##(2008-10#2)
in the Great Plains##4##4##(2008-10#4)
in the Great##5##3##(2008-10#5)
in the Gulf of Nicoya##4##5##(2008-5#2)(2013-7#2)
in the Gulf of##9##4##(2007-5#1)(2008-11#1)(2008-5#2)(2009-2#1)(2011-2#1)(2013-7#3)
in the H group##3##4##(2011-2#3)
in the H##7##3##(1997-3#1)(2011-2#6)
in the HA group and##2##5##(2011-2#2)
in the HA group##3##4##(2011-2#3)
in the HA##5##3##(2008-10#1)(2008-5#1)(2011-2#3)
in the HD##3##3##(1996-8#1)(2008-3#2)
in the HIV##4##3##(1991-1#1)(1996-1#1)(2010-12#1)(2013-1#1)
in the Harran Plain##3##4##(2008-12#3)
in the Health Care Financing Administration##2##6##(1991-2#1)(1994-1#1)
in the Health##6##3##(1990-2#1)(1991-2#1)(1994-1#1)(1996-2#1)(1997-2#2)
in the Helsinki area##2##4##(1992-3#2)
in the HepG2 cell line##3##5##(1992-3#2)(2007-10#1)
in the HepG2##5##3##(1992-3#2)(2007-10#3)
in the Hg(II)##2##3##(2008-10#2)
in the Hispanic##2##3##(2010-8#2)
in the Hospital##4##3##(1993-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
in the Human##2##3##(1994-9#1)(2008-10#1)
in the Hunter Region##2##4##(2007-10#2)
in the I##3##3##(2011-2#3)
in the IBM##2##3##(2008-8#1)(2012-3#1)
in the IBV + CSP group##2##6##(1997-6#2)
in the IBV##3##3##(1997-6#3)
in the ICH##2##3##(2008-10#2)
in the ICU##11##3##(1991-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#3)(2010-12#1)(2013-1#2)
in the III-IV cytoplasmic loop##2##5##(1992-3#2)
in the IR##6##3##(1992-6#1)(1996-2#1)(2007-12#2)(2008-2#1)(2008-3#1)
in the ITA group##2##4##(2007-8#2)
in the ITA##3##3##(2007-8#3)
in the ITS region##2##4##(2008-10#2)
in the IVB##2##3##(2011-2#2)
in the IVB/IVT##2##3##(2011-2#2)
in the Iberian##2##3##(2008-10#2)
in the Indian subcontinent##3##4##(2007-12#1)(2008-10#2)
in the Indian##10##3##(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-5#2)(2010-5#1)(2013-8#1)
in the Indo-Pacific##2##3##(2008-5#2)
in the Information##2##3##(2008-1#1)(2009-8#1)
in the Interaction##2##3##(2008-10#2)
in the Internal Medicine##2##4##(1992-5#1)(1996-11#1)
in the Internal##3##3##(1991-2#1)(1992-5#1)(1996-11#1)
in the International##4##3##(1991-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
in the Intervention practices##2##4##(2008-4#2)
in the Intervention##3##3##(2008-4#3)
in the Iowa##2##3##(1994-2#1)(2012-2#1)
in the Iranian##3##3##(2008-12#2)(2008-7#1)
in the Irbid Governorate##2##4##(1994-3#2)
in the Israeli##2##3##(2008-1#2)
in the Italian samples##2##4##(1990-8#2)
in the Italian##4##3##(1990-8#2)(1992-10#1)(1994-12#1)
in the Jackson Heart Study##2##5##(2011-2#1)(2013-8#1)
in the Japanese population##5##4##(1993-3#2)(1997-8#1)(2007-10#1)(2008-7#1)
in the Japanese##11##3##(1993-3#2)(1997-8#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)
in the Jaynes-Cummings##2##3##(1990-12#1)(2007-11#1)
in the Joban area##2##4##(2010-8#2)
in the Journal of the##2##5##(1990-6#1)(2008-3#1)
in the Journal of##5##4##(1990-6#1)(2008-3#1)(2008-5#2)(2010-7#1)
in the KP theory##2##4##(2009-9#2)
in the Kagoshima prefecture##3##4##(1994-6#3)
in the Kingdom of Saudi Arabia##2##6##(2008-4#1)(2013-1#1)
in the Kingdom##7##3##(2008-1#3)(2008-4#2)(2009-6#1)(2013-1#1)
in the Kinkazan##2##3##(2008-5#2)
in the Km##2##3##(1990-5#1)(1995-6#1)
in the Kretschmann configuration##2##4##(2008-2#1)(2008-3#1)
in the L intermediate##3##4##(1995-5#3)
in the L##6##3##(1993-11#1)(1995-5#3)(1997-4#1)(2011-2#1)
in the L3##2##3##(1993-12#1)(2008-8#1)
in the LA and L groups##3##6##(2011-2#3)
in the LA##4##3##(2011-2#4)
in the LAB diet group##2##5##(2011-1#2)
in the LAD group##2##4##(2013-1#2)
in the LAD##5##3##(2013-1#2)(2013-7#3)
in the LC##2##3##(2008-4#1)(2011-2#1)
in the LC-DECD##2##3##(2008-10#2)
in the LDL##3##3##(1991-12#1)(2008-6#1)(2011-1#1)
in the LIDT##2##3##(2007-11#1)(2008-3#1)
in the LV vent line##2##5##(1991-3#2)
in the Laboratory##2##3##(2010-12#1)(2012-2#1)
in the Latin American##2##4##(2008-10#2)
in the Ligasure group##2##4##(2011-2#2)
in the Littrow##2##3##(2007-11#1)(2008-3#1)
in the Longissimus##2##3##(2010-4#2)
in the MCF-7##3##3##(1992-9#1)(2012-3#2)
in the MDB##3##3##(2010-8#3)
in the MFS##2##3##(1994-1#1)(1996-1#1)
in the MPOA##2##3##(1992-5#1)(1994-2#1)
in the MS##6##3##(1996-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
in the MTX##2##3##(1994-2#1)(2008-11#1)
in the MVB group##2##4##(2007-7#2)
in the MZ##2##3##(2009-7#2)
in the Madinah region##2##4##(2008-1#2)
in the Man region##2##4##(2009-10#2)
in the Management of##4##4##(2008-1#1)(2010-6#1)(2011-1#1)(2011-2#1)
in the Marshall Islands##4##4##(1994-9#2)(2008-1#2)
in the Maximizer##3##3##(2008-11#3)
in the Medaka Fish##2##4##(2008-5#1)(2008-6#1)
in the Medicaid##3##3##(1994-2#1)(1996-1#1)(1997-2#1)
in the Medical Department##2##4##(1992-9#1)(1996-3#1)
in the Medical##4##3##(1991-8#1)(1992-9#1)(1995-6#1)(1996-3#1)
in the Medicare and##2##4##(1991-12#1)(1991-2#1)
in the Medicare##9##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-1#1)
in the Mediterranean##8##3##(1996-4#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#1)
in the Mexican and##2##4##(2008-10#1)(2013-7#1)
in the Mexican##4##3##(2008-10#1)(2008-12#1)(2012-12#1)(2013-7#1)
in the Middle East and##2##5##(1997-8#1)(2008-10#1)
in the Middle East##9##4##(1997-8#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#1)
in the Middle##12##3##(1997-8#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-7#1)(2011-2#1)(2013-8#1)
in the Midwest##5##3##(2007-10#1)(2007-9#1)(2008-10#2)(2009-8#1)
in the Mitochondrial##2##3##(2008-10#2)
in the Mongolian gerbil##2##4##(1992-12#2)
in the Morris water maze##7##5##(1993-12#4)(1993-3#1)(1994-6#1)(2008-12#1)
in the Morris water task##2##5##(1992-11#2)
in the Morris water##9##4##(1992-11#2)(1993-12#4)(1993-3#1)(1994-6#1)(2008-12#1)
in the Morris##10##3##(1992-11#2)(1993-12#4)(1993-3#2)(1994-6#1)(2008-12#1)
in the Municipality of##2##4##(1991-6#1)(2008-5#1)
in the Murchison meteorite##2##4##(1995-11#2)
in the Murcia##2##3##(1993-11#1)(1994-6#1)
in the Murray-Darling Basin##2##4##(2010-8#2)
in the Mycosphaerella##2##3##(2008-10#2)
in the N-terminal arm##2##4##(2008-9#2)
in the N-terminal half##2##4##(1994-2#1)(1997-2#1)
in the N-terminal##10##3##(1990-2#1)(1992-9#1)(1994-2#1)(1994-5#2)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#2)
in the NC##2##3##(2007-10#1)(2010-2#1)
in the NHS##6##3##(1991-8#1)(1996-11#1)(2008-11#1)(2013-8#3)
in the NICU##5##3##(1991-12#2)(1994-2#1)(1995-1#1)(2009-6#1)
in the NIL##2##3##(1992-12#1)(2008-10#1)
in the NILs##2##3##(2008-10#2)
in the NIMH genetics initiative pedigrees##2##6##(1997-5#2)
in the NIR##3##3##(2008-10#3)
in the NIST##2##3##(2008-1#1)(2008-10#1)
in the NIb##2##3##(2008-10#2)
in the NMR##3##3##(1991-11#2)(1994-5#1)
in the NTS##2##3##(1992-3#1)(1995-12#1)
in the NW##3##3##(2008-11#1)(2008-7#2)
in the National Health Service##3##5##(2008-11#1)(2008-3#1)(2008-7#1)
in the National Health##4##4##(1995-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
in the National Institute of Cardiology##2##6##(2008-10#2)
in the National Institute of##3##5##(2007-8#1)(2008-10#2)
in the National##10##3##(1992-1#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
in the Nepalese Himalayas##2##4##(2008-8#2)
in the Netherlands and##3##4##(1996-1#1)(2008-10#2)
in the Netherlands in the##3##5##(2008-12#3)
in the Netherlands in##6##4##(1995-12#1)(1997-5#1)(2008-11#1)(2008-12#3)
in the Netherlands is##2##4##(1992-2#1)(1997-3#1)
in the Netherlands were##2##4##(1992-12#1)(2008-10#1)
in the Netherlands##43##3##(1990-3#2)(1991-11#2)(1992-12#2)(1992-2#2)(1992-5#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-5#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#5)(2008-2#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2012-3#1)(2013-8#2)
in the New##6##3##(1997-1#1)(2007-2#1)(2008-10#2)(2011-2#2)
in the Nicoya Peninsula##2##4##(2008-5#2)
in the Nile River Delta##2##5##(2008-10#2)
in the Nordic countries##5##4##(1990-11#1)(1990-6#1)(1992-11#1)(1997-6#1)(2008-10#1)
in the North American##2##4##(1996-5#1)(2008-10#1)
in the North Sea##3##4##(2009-10#3)
in the North of##2##4##(1990-8#1)(2008-3#1)
in the North##16##3##(1990-8#1)(1991-1#1)(1992-2#4)(1993-3#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-6#2)(2009-10#3)
in the Northeast##5##3##(1995-6#2)(2007-10#3)
in the Northeastern##2##3##(2008-5#1)(2013-7#1)
in the Northern Bolivian Altiplano##2##5##(2008-8#2)
in the Northern Cape Province and##2##6##(2011-1#2)
in the Northern Cape Province##3##5##(2011-1#3)
in the Northern Guinea Savanna##2##5##(2008-12#2)
in the Northern##14##3##(1992-2#1)(1994-9#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#2)(2011-1#4)(2013-1#1)(2013-8#1)
in the Northwest##2##3##(2008-11#1)(2008-12#1)
in the Northwestern##2##3##(2007-12#1)(2011-2#1)
in the Norwegian##7##3##(1990-6#1)(1991-8#1)(1992-11#1)(1995-6#1)(1997-6#2)(2010-6#1)
in the O##2##3##(2008-10#2)
in the OCN##2##3##(2010-2#2)
in the OR##3##3##(1997-1#1)(2008-4#1)(2008-6#1)
in the Old##2##3##(1995-11#1)(2011-2#1)
in the Oregon Coast Range##2##5##(2008-10#2)
in the Oregon##3##3##(2008-10#3)
in the Orthopaedic Clinic##2##4##(2007-11#2)
in the P branch##2##4##(2008-10#1)(2008-3#1)
in the P##12##3##(1990-2#1)(1993-11#1)(2008-10#6)(2008-3#1)(2012-1#3)
in the P1 position##2##4##(1994-5#2)
in the P1##5##3##(1994-5#2)(1995-6#1)(2008-10#2)
in the P3 position directs##2##5##(1994-5#2)
in the P3##3##3##(1994-5#2)(2008-10#1)
in the PACU##2##3##(1994-2#1)(2012-2#1)
in the PBC group##3##4##(1992-6#3)
in the PBC##4##3##(1992-6#4)
in the PBL group##2##4##(2013-8#2)
in the PC12 cell line##3##5##(1997-6#3)
in the PC12##4##3##(1992-12#1)(1997-6#3)
in the PD##6##3##(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2013-1#1)
in the PDB##5##3##(2008-7#3)(2011-3#2)
in the PDS gene##2##4##(2011-1#2)
in the PEDOT##2##3##(2009-11#2)
in the PEG-rich phase##2##4##(2011-2#2)
in the PEP group##2##4##(2009-12#2)
in the PFC of##2##4##(1997-2#2)
in the PFC##6##3##(1996-5#1)(1997-2#3)(2008-7#1)(2013-8#1)
in the PLNA##2##3##(2008-10#2)
in the PM 1648 and PM(2##2##6##(2008-10#2)
in the PM##4##3##(2008-10#2)(2008-7#2)
in the PMG and##2##4##(2008-1#2)
in the PMG##3##3##(2008-1#3)
in the PNW##2##3##(2008-10#2)
in the PPIgroup##2##3##(2013-1#2)
in the PSD##3##3##(1996-12#2)(1997-2#1)
in the Pacific Island##2##4##(2008-1#2)
in the Pacific Northwest##7##4##(2008-10#6)(2008-5#1)
in the Pacific region##2##4##(2008-1#2)
in the Pacific##29##3##(1994-9#1)(2008-1#13)(2008-10#6)(2008-5#1)(2012-12#8)
in the Palauan society##3##4##(2008-1#3)
in the Paneth cells##2##4##(1993-9#2)
in the Parkinsonian##2##3##(2008-7#2)
in the Parque Nacional##2##4##(2008-5#1)(2011-2#1)
in the Peruvian##2##3##(2008-10#1)(2013-8#1)
in the Philippines##3##3##(2008-5#1)(2008-8#2)
in the Phycodnaviridae##2##3##(2013-1#2)
in the Phytophthora##2##3##(2008-10#2)
in the Pilates##2##3##(2009-3#2)
in the Plant##2##3##(2008-10#2)
in the Pleistocene##2##3##(1996-6#1)(2010-8#1)
in the Plzen Surgical Clinic##2##5##(2011-3#2)
in the Polish##4##3##(2007-8#1)(2008-11#1)(2011-2#2)
in the Population##5##3##(1996-8#1)(2008-10#2)(2008-3#1)(2010-12#1)
in the Presence of##3##4##(1996-5#1)(2008-10#1)(2011-1#1)
in the Programme of Action##2##5##(2008-11#2)
in the Protein Data Bank##2##5##(2008-4#1)(2011-3#1)
in the Public##3##3##(1996-9#1)(2008-9#1)(2012-2#1)
in the Purkinje cell##3##4##(1992-12#2)(2013-8#1)
in the Purkinje##4##3##(1992-12#2)(2008-10#1)(2013-8#1)
in the Q-switched mode##3##4##(2008-3#3)
in the Q-switched##4##3##(2008-3#4)
in the Qualified##2##3##(1995-12#2)
in the R##9##3##(1990-8#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-7#1)
in the RCC1-related protein pim1##2##5##(1995-2#2)
in the RM##2##3##(1991-4#1)(2008-10#1)
in the RNA##4##3##(1993-8#1)(1997-7#1)(2008-11#2)
in the RNase A superfamily##2##5##(1992-11#2)
in the RP##2##3##(2010-1#1)(2012-2#1)
in the RVC matrix##2##4##(2008-10#2)
in the Raman spectrum##2##4##(2008-3#2)
in the Raman##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
in the Rayleigh limit##2##4##(2008-2#1)(2008-3#1)
in the Rayleigh##3##3##(2008-2#1)(2008-3#2)
in the Rehabilitation##2##3##(2007-11#1)(2008-10#1)
in the Republic of Croatia##3##5##(2011-2#1)(2013-1#2)
in the Republic of Korea##2##5##(2012-2#2)
in the Republic of Palau##4##5##(2008-1#3)(2013-8#1)
in the Republic of South Africa##2##6##(2010-11#1)(2010-3#1)
in the Republic of the##2##5##(2008-1#1)(2013-8#1)
in the Republic of##17##4##(1995-3#1)(1997-8#1)(2008-1#4)(2008-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
in the Republic##18##3##(1995-3#1)(1997-8#1)(2008-1#4)(2008-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
in the Rhizosphere of Wheat##2##5##(2008-10#2)
in the Rhizosphere##5##3##(2008-10#5)
in the Rocky##2##3##(2008-10#1)(2008-9#1)
in the Romanian##2##3##(1990-5#1)(2010-4#1)
in the Russian Federation and##2##5##(1995-3#1)(2012-12#1)
in the Russian Federation##4##4##(1995-3#1)(1997-1#1)(2008-8#1)(2012-12#1)
in the Río de la Plata and##3##7##(2010-8#3)
in the S##5##3##(1993-2#1)(1994-3#1)(2008-11#2)(2008-9#1)
in the S1 spike protein##2##5##(1997-3#1)(2008-5#1)
in the S1##4##3##(1997-3#1)(2008-10#1)(2008-5#2)
in the SA##2##3##(1995-11#1)(2008-10#1)
in the SBWMV transmission model##2##5##(2008-10#2)
in the SC##10##3##(2008-10#2)(2008-5#8)
in the SCLP##2##3##(2012-3#2)
in the SCN##4##3##(1993-12#2)(1994-2#2)
in the SDS##2##3##(1994-9#1)(2008-10#1)
in the SE##2##3##(2008-10#1)(2008-11#1)
in the SF##2##3##(2008-1#1)(2008-10#1)
in the SF-CO(2)##2##3##(2008-10#2)
in the SG##3##3##(1993-12#2)(2012-2#1)
in the SN##2##3##(1994-2#2)
in the SOM##2##3##(2012-3#2)
in the SPR##2##3##(2008-10#1)(2008-3#1)
in the SSF##2##3##(2008-6#2)
in the SSG##3##3##(1995-11#3)
in the SVG and##2##4##(2007-8#2)
in the SVG##3##3##(2007-8#3)
in the SVZ##2##3##(2008-7#2)
in the SW613-S##2##3##(1992-9#2)
in the SZ##3##3##(2009-7#3)
in the Saccharomyces cerevisiae##3##4##(1990-5#1)(1997-1#1)(2008-7#1)
in the Salinas Valley##2##4##(2008-10#2)
in the Salinas##4##3##(2008-10#4)
in the Salmonella##2##3##(1995-11#1)(2010-8#1)
in the San Joaquin Valley##2##5##(2008-10#2)
in the Santiago##2##3##(2007-10#1)(2012-2#1)
in the Schaffer##2##3##(2008-7#2)
in the School of##3##4##(1996-1#1)(2008-10#1)(2008-12#1)
in the SeaWiFS##3##3##(2008-2#1)(2008-3#2)
in the Sierra Nevada##2##4##(2008-10#2)
in the Slave River##3##4##(1997-4#3)
in the Sonoran Desert##2##4##(2008-10#1)(2009-8#1)
in the Soret band##2##4##(1990-8#2)
in the South Hills##2##4##(2013-1#2)
in the South Marmara##2##4##(1997-3#2)
in the South Pacific region##2##5##(2008-1#2)
in the South Pacific##4##4##(2008-1#3)(2008-5#1)
in the South West##2##4##(2008-11#1)(2008-5#1)
in the South##23##3##(1990-11#1)(1992-2#3)(1992-3#1)(1997-3#2)(2007-10#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in the Southeast##2##3##(2008-12#1)(2008-9#1)
in the Southern##5##3##(2008-2#2)(2008-5#1)(2012-12#1)(2013-7#1)
in the Southwest##2##3##(1995-6#1)(2008-3#1)
in the Spanish##4##3##(1990-9#1)(1996-5#1)(2009-10#1)(2011-1#1)
in the Sprague-Dawley rat##2##4##(1992-5#1)(2008-10#1)
in the State of Rio de Janeiro##2##7##(2008-6#2)
in the State of Rio##3##5##(1993-6#1)(2008-6#2)
in the State of##13##4##(1990-11#1)(1991-1#1)(1993-6#1)(1994-9#1)(2008-10#2)(2008-6#2)(2008-8#1)(2009-11#1)(2010-10#1)(2013-7#2)
in the Stone maze##2##4##(1994-6#2)
in the Study of##2##4##(1995-11#1)(2008-10#1)
in the Surgical##2##3##(1990-9#1)(1994-12#1)
in the SwissProt##2##3##(1995-6#1)(1997-3#1)
in the Synthesis of##3##4##(1996-2#1)(1996-5#1)(2009-11#1)
in the Syrian hamster embryo (SHE)##2##6##(1990-7#1)(1992-2#1)
in the Syrian hamster hypothalamus##2##5##(1990-7#2)
in the Syrian hamster##4##4##(1990-7#3)(1992-2#1)
in the Syrian##5##3##(1990-6#1)(1990-7#3)(1992-2#1)
in the T##5##3##(1990-8#2)(1992-8#1)(2008-8#1)(2013-1#1)
in the TCA cycle##6##4##(1993-11#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
in the TIMI##2##3##(2008-3#2)
in the Texas Panhandle##3##4##(2008-10#3)
in the Texas##6##3##(2008-10#5)(2011-2#1)
in the Third##2##3##(1993-6#1)(2013-1#1)
in the Toluca Valley##4##4##(2008-10#4)
in the Toluca##5##3##(2008-10#5)
in the Treatment of Advanced##2##5##(1994-7#1)(2008-6#1)
in the Treatment of##13##4##(1994-7#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-6#1)(2010-8#1)(2012-3#2)
in the Troposphere##4##3##(2008-3#4)
in the Tunisian##2##3##(2007-8#1)(2008-10#1)
in the Turkish population##3##4##(2008-2#3)
in the Turkish##4##3##(2008-12#1)(2008-2#3)
in the U##39##3##(1990-11#1)(1990-6#1)(1991-2#1)(1992-1#2)(1992-3#1)(1993-1#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#4)(2008-1#1)(2008-10#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#3)
in the U-clipped group##2##4##(2007-8#2)
in the UAE##2##3##(2008-1#2)
in the UK and the##3##5##(1991-4#1)(2008-12#1)(2008-5#1)
in the UK and##9##4##(1991-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)
in the UK in##2##4##(2008-11#1)(2013-1#1)
in the UK is##2##4##(2012-12#1)(2013-8#1)
in the UK were##2##4##(2008-5#1)(2008-9#1)
in the UK##58##3##(1991-4#2)(1996-3#2)(1997-4#1)(2007-2#1)(2008-10#5)(2008-11#15)(2008-12#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#5)(2012-3#1)(2013-1#3)(2013-8#4)
in the US and##5##4##(2008-11#1)(2008-3#1)(2008-5#2)(2010-12#1)
in the US##40##3##(1990-2#1)(1990-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-8#1)(1996-9#4)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#10)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the US-affiliated Pacific Islands (USAPI)##11##6##(2013-8#11)
in the US-affiliated Pacific Islands##13##5##(2013-8#13)
in the USA and##4##4##(1992-2#1)(2008-1#1)(2008-5#1)(2010-12#1)
in the USA##19##3##(1992-2#1)(1994-3#1)(1996-6#1)(1997-8#1)(2008-1#3)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-8#1)
in the USSR##2##3##(1990-3#2)
in the UV region##3##4##(2008-2#3)
in the UV##14##3##(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#3)(2009-12#1)
in the UV-B region##2##4##(2008-2#2)
in the UV-vis##2##3##(1995-2#1)(2008-10#1)
in the UVA##2##3##(2008-5#2)
in the UniformMu##2##3##(2012-3#2)
in the United Arab Emirates##2##5##(2008-1#1)(2013-8#1)
in the United Kingdom and##2##5##(2008-10#1)(2008-9#1)
in the United Kingdom in##2##5##(2008-10#1)(2011-2#1)
in the United Kingdom##36##4##(1991-3#1)(1991-8#2)(1993-2#1)(1994-12#1)(1994-7#2)(1995-2#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-2#3)(2008-10#7)(2008-11#6)(2008-12#3)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
in the United States Pharmacopeia (USP)##2##6##(2008-10#2)
in the United States Pharmacopeia##3##5##(2008-10#3)
in the United States and Canada were##2##7##(2007-12#1)(2008-10#1)
in the United States and Canada##9##6##(1991-12#1)(2007-12#1)(2008-10#4)(2008-8#1)(2012-2#2)
in the United States and Europe##3##6##(2008-7#1)(2008-8#1)(2013-1#1)
in the United States and Western Europe##2##7##(2008-1#1)(2011-2#1)
in the United States and other##2##6##(1993-1#1)(2009-11#1)
in the United States and##39##5##(1990-10#1)(1991-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#10)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)
in the United States are##4##5##(1993-1#1)(2009-6#1)(2010-6#1)(2011-2#1)
in the United States because##2##5##(2008-10#1)(2012-3#1)
in the United States by##2##5##(1995-3#1)(2012-12#1)
in the United States during the##2##6##(2007-2#1)(2008-5#1)
in the United States during##3##5##(1995-6#1)(2007-2#1)(2008-5#1)
in the United States each year##2##6##(2011-2#1)(2013-8#1)
in the United States for##3##5##(1992-12#1)(2008-10#1)(2008-11#1)
in the United States from##2##5##(1997-1#1)(2007-2#1)
in the United States has##2##5##(1997-2#1)(2010-3#1)
in the United States have##3##5##(1993-3#1)(2008-10#1)(2013-1#1)
in the United States in 1990 and##2##7##(1994-2#1)(2008-10#1)
in the United States in##8##5##(1994-1#1)(1994-2#2)(2008-10#4)(2011-2#1)
in the United States is##4##5##(1992-3#1)(2008-1#1)(2008-9#1)(2013-1#1)
in the United States since##4##5##(1992-8#1)(1995-3#1)(2008-10#1)(2012-3#1)
in the United States to##2##5##(2008-10#1)(2013-1#1)
in the United States was##2##5##(2008-10#1)(2011-2#1)
in the United States were##3##5##(2008-10#3)
in the United States will##3##5##(1993-3#1)(1995-12#1)(1995-2#1)
in the United States with##3##5##(1993-2#1)(2008-8#1)(2010-10#1)
in the United States##297##4##(1990-10#1)(1990-3#1)(1991-1#1)(1991-12#4)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-2#4)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#4)(1994-3#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#5)(1997-2#4)(1997-3#7)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#6)(2008-1#4)(2008-10#66)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#6)(2009-5#4)(2009-6#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#22)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#12)(2013-8#7)
in the United##345##3##(1990-10#1)(1990-3#1)(1991-1#1)(1991-12#4)(1991-3#3)(1991-8#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-2#6)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#2)(1994-7#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#5)(1997-2#5)(1997-3#7)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#10)(2008-1#6)(2008-10#74)(2008-11#13)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#4)(2009-11#6)(2009-5#4)(2009-6#1)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#23)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#7)(2013-1#13)(2013-8#8)
in the University Clinic of Navarre##2##6##(2013-1#2)
in the University Hospital##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
in the University##5##3##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#2)
in the Upper Galilee##2##4##(2011-2#2)
in the Upper##5##3##(1993-6#1)(2008-10#1)(2011-2#3)
in the V(D)J##2##3##(1997-7#1)(2008-7#1)
in the VZ##2##3##(1996-5#2)
in the Vector Nematode Xiphinema americanum##2##6##(2008-10#2)
in the Venezuelan##2##3##(2008-5#2)
in the Venus##2##3##(1991-5#1)(2009-8#1)
in the Veterans##2##3##(2008-7#1)(2012-12#1)
in the Vmax of##2##4##(1990-5#1)(1991-5#1)
in the Vmax##5##3##(1990-2#1)(1990-5#1)(1991-5#1)(1992-6#2)
in the WGP##2##3##(2008-5#2)
in the Wave Bioreactor##2##4##(2008-11#2)
in the West and the East##2##6##(2008-10#1)(2010-8#1)
in the West##9##3##(1993-9#1)(1995-1#1)(1996-8#1)(2007-7#1)(2008-10#2)(2009-4#2)(2010-8#1)
in the Western Cape##2##4##(2010-3#1)(2011-2#1)
in the Western Hemisphere##2##4##(2008-10#1)(2013-7#1)
in the Western world##7##4##(1997-8#1)(2008-1#3)(2008-7#1)(2010-10#1)(2011-2#1)
in the Western##16##3##(1997-8#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#3)(2013-7#1)(2013-8#1)
in the Wisconsin##2##3##(2008-10#1)(2008-7#1)
in the World Health Organization##2##5##(2011-7#1)(2013-1#1)
in the World##3##3##(2011-3#1)(2011-7#1)(2013-1#1)
in the X-ray##3##3##(1992-12#1)(1993-11#1)(2008-10#1)
in the Xenopus##2##3##(1995-3#1)(1997-2#1)
in the Zurich Oberland##2##4##(1996-11#2)
in the abattoir##2##3##(2010-4#2)
in the abdomen##3##3##(1990-9#1)(1992-5#1)(2013-8#1)
in the abdominal and thoracic cavities##2##6##(2012-1#1)(2012-3#1)
in the abdominal cavity##3##4##(1993-6#1)(1993-9#1)(2013-1#1)
in the abdominal wall##2##4##(1996-8#1)(2011-2#1)
in the abdominal##11##3##(1993-6#1)(1993-9#1)(1996-8#1)(1997-8#1)(2008-6#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
in the ability of cells##2##5##(1994-11#1)(2008-5#1)
in the ability of cultured cells to##2##7##(1994-11#2)
in the ability of the##4##5##(1990-2#1)(2008-10#2)(2011-1#1)
in the ability of##13##4##(1990-2#1)(1994-11#3)(1994-6#1)(2008-10#4)(2008-5#2)(2011-1#2)
in the ability to##5##4##(1991-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-2#1)
in the ability##18##3##(1990-2#1)(1991-12#1)(1994-11#3)(1994-6#1)(2008-10#5)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#1)(2011-1#2)
in the abnormal##2##3##(2008-4#1)(2011-2#1)
in the abomasum##2##3##(2010-2#1)(2011-2#1)
in the above##8##3##(1992-6#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)(2012-1#1)
in the above-mentioned##2##3##(2007-9#1)(2008-3#1)
in the above-water##3##3##(2008-3#3)
in the absence and in the presence of##4##8##(1991-2#1)(1994-6#1)(2008-10#1)(2008-8#1)
in the absence and presence of##14##6##(1990-8#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2012-5#1)
in the absence and##20##4##(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#1)(2012-5#1)
in the absence of CYP1A induction##2##6##(2008-10#2)
in the absence of Ca2+##2##5##(1995-6#1)(1996-2#1)
in the absence of EDTA##2##5##(1995-6#2)
in the absence of HEL##2##5##(2008-11#2)
in the absence of S9##2##5##(1992-2#1)(2008-9#1)
in the absence of T7 RNA polymerase##2##7##(1991-12#2)
in the absence of a##16##5##(1992-3#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2007-9#1)(2008-10#3)(2008-6#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)
in the absence of acetyl CoA##2##6##(1993-11#2)
in the absence of added##3##5##(1990-11#1)(1994-8#1)(2008-10#1)
in the absence of aminoacylation##2##5##(1997-3#2)
in the absence of an##4##5##(1990-3#1)(1991-2#1)(1996-12#1)(2008-7#1)
in the absence of any added##2##6##(1990-12#1)(2008-10#1)
in the absence of any other##2##6##(1992-9#1)(2008-8#1)
in the absence of any##15##5##(1990-12#1)(1992-9#1)(1993-8#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)
in the absence of cooperativity##2##5##(1990-8#2)
in the absence of detectable##3##5##(1990-12#1)(1992-6#1)(1995-6#1)
in the absence of diacylglycerol##3##5##(1994-5#3)
in the absence of disease##3##5##(2008-10#2)(2013-1#1)
in the absence of divalent##2##5##(1995-2#1)(1995-5#1)
in the absence of external Ca2+##2##6##(1993-12#2)
in the absence of external##5##5##(1990-5#1)(1993-12#2)(1993-3#1)(2008-10#1)
in the absence of extracellular##2##5##(1990-5#1)(1992-3#1)
in the absence of feeder cells##2##6##(1993-9#2)
in the absence of fungicides##2##5##(2008-10#2)
in the absence of intrinsic##2##5##(2006-10#1)(2008-8#1)
in the absence of ligand##2##5##(1993-8#1)(1994-12#1)
in the absence of mating##2##5##(1991-5#1)(2008-8#1)
in the absence of other cytokines##2##6##(2008-4#2)
in the absence of other##5##5##(1991-12#1)(2008-4#3)(2013-1#1)
in the absence of prior##2##5##(1990-11#1)(1992-8#1)
in the absence of reducing##2##5##(1991-2#1)(1995-11#1)
in the absence of serum##4##5##(1990-11#1)(2008-11#3)
in the absence of specific##3##5##(1992-9#1)(2007-8#1)(2008-9#1)
in the absence of such##3##5##(1991-12#1)(2008-11#1)(2013-8#1)
in the absence of symptoms##4##5##(1990-6#3)(1991-6#1)
in the absence of the##20##5##(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
in the absence of these##3##5##(1995-2#1)(2008-11#1)(2011-1#1)
in the absence of urea##2##5##(1995-2#1)(2008-2#1)
in the absence of##327##4##(1990-11#7)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#5)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-5#2)(1993-6#5)(1993-8#5)(1993-9#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#9)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#47)(2008-11#24)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#15)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2012-7#1)(2013-1#6)(2013-8#4)
in the absence or presence of##7##6##(1994-6#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
in the absence or##9##4##(1990-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
in the absence##360##3##(1990-11#7)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#5)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#6)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-5#2)(1993-6#5)(1993-8#5)(1993-9#5)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#10)(1995-8#5)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#4)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#50)(2008-11#26)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#16)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#6)(2013-8#4)
in the absolute##4##3##(2008-12#1)(2008-5#1)(2008-8#2)
in the absorbance##10##3##(2008-10#10)
in the absorbing solution##2##4##(2008-10#2)
in the absorbing##3##3##(2008-10#2)(2008-3#1)
in the absorption and##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
in the absorption coefficient##3##4##(2008-2#2)(2008-3#1)
in the absorption spectrum of##2##5##(2007-12#1)(2008-2#1)
in the absorption spectrum##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
in the absorption##16##3##(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#1)
in the abundance of##3##4##(1994-6#1)(2008-10#1)(2008-9#1)
in the abundance##4##3##(1994-5#1)(1994-6#1)(2008-10#1)(2008-9#1)
in the academic setting##2##4##(2008-11#1)(2010-1#1)
in the academic##4##3##(2008-11#2)(2009-10#1)(2010-1#1)
in the acceleration of##2##4##(1996-2#1)(2008-5#1)
in the acceptor stream##2##4##(2008-10#2)
in the acceptor##5##3##(2008-10#5)
in the access to##2##4##(1991-9#1)(1995-11#1)
in the accessibility of##2##4##(1992-12#1)(1995-2#1)
in the accident##2##3##(1995-11#1)(2013-1#1)
in the accreditation process##2##4##(1996-12#2)
in the accumulation of ammonia##2##5##(2008-10#2)
in the accumulation of##15##4##(1992-6#1)(1994-11#1)(1995-6#3)(1997-4#1)(2008-10#4)(2008-7#3)(2009-12#1)(2009-8#1)
in the accumulation##16##3##(1992-6#1)(1994-11#1)(1995-6#3)(1997-4#1)(2008-10#5)(2008-7#3)(2009-12#1)(2009-8#1)
in the accuracy and precision##2##5##(2008-10#2)
in the accuracy and##3##4##(2008-10#2)(2008-3#1)
in the accuracy of##4##4##(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)
in the accuracy##7##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
in the achievement of##2##4##(2010-3#1)(2012-2#1)
in the acid##7##3##(1990-5#1)(1995-12#1)(2008-10#5)
in the acidic##6##3##(1994-3#1)(2008-10#4)(2008-5#1)
in the acoustic##4##3##(2008-3#1)(2009-2#1)(2009-9#2)
in the acquired group##3##4##(2009-3#3)
in the acquired##7##3##(1991-2#1)(2008-3#1)(2008-7#1)(2009-3#3)(2010-6#1)
in the acquisition of##5##4##(1992-10#1)(1993-6#1)(2008-11#2)(2008-9#1)
in the acquisition##6##3##(1992-10#1)(1993-6#1)(2008-11#3)(2008-9#1)
in the acrosome##5##3##(2008-4#1)(2008-7#2)(2008-8#2)
in the action of##5##4##(1990-2#1)(1992-3#1)(1992-6#1)(2008-11#1)(2008-5#1)
in the action##6##3##(1990-2#1)(1992-3#1)(1992-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
in the activated state of##2##5##(1994-3#2)
in the activated##6##3##(1994-3#2)(1994-8#1)(2008-10#1)(2008-9#1)(2010-11#1)
in the activation of protein##2##5##(1990-8#1)(1995-11#1)
in the activation of##19##4##(1990-12#1)(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
in the activation##23##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#3)(1996-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the active site of##7##5##(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-5#2)(1995-6#1)
in the active site##21##4##(1990-5#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1994-5#4)(1994-6#1)(1995-5#1)(1995-6#2)(1997-6#2)(2009-11#1)
in the active sites of##2##5##(1992-8#1)(2012-12#1)
in the active sites##3##4##(1992-8#1)(1995-5#1)(2012-12#1)
in the active##33##3##(1990-5#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#2)(1994-5#4)(1994-6#1)(1995-5#2)(1995-6#2)(1997-2#1)(1997-6#2)(2007-11#2)(2008-2#1)(2008-3#1)(2009-11#1)(2012-1#1)(2012-12#1)(2013-1#2)
in the activities of the##2##5##(1992-2#1)(2012-2#1)
in the activities of##7##4##(1990-3#2)(1992-2#1)(1994-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
in the activities##8##3##(1990-3#2)(1992-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
in the activity of the##8##5##(1990-11#1)(1990-8#1)(1992-5#1)(1994-11#1)(2007-12#1)(2007-7#1)(2011-2#1)(2012-12#1)
in the activity of##18##4##(1990-11#1)(1990-12#1)(1990-8#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
in the activity##19##3##(1990-11#1)(1990-12#1)(1990-8#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
in the acute and##5##4##(1991-9#1)(1994-2#1)(2007-8#1)(2008-3#2)
in the acute care##3##4##(1996-2#1)(1997-1#1)(2011-1#1)
in the acute phase of a cerebral infarction##4##8##(1997-5#4)
in the acute phase of the##2##6##(1997-3#1)(1997-5#1)
in the acute phase of##8##5##(1997-3#1)(1997-5#6)(2008-7#1)
in the acute phase##11##4##(1997-3#1)(1997-5#6)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#1)
in the acute response to##2##5##(1995-12#1)(2009-5#1)
in the acute stage of##4##5##(1990-9#1)(1995-5#2)(2008-12#1)
in the acute stage##8##4##(1990-12#1)(1990-9#1)(1995-5#3)(2008-12#1)(2008-7#1)(2009-11#1)
in the acute##39##3##(1990-12#1)(1990-6#1)(1990-9#2)(1991-9#1)(1994-2#1)(1995-12#3)(1995-5#3)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#6)(2007-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
in the acylation of##2##4##(1990-5#2)
in the adaptation of##2##4##(1994-8#1)(2008-8#1)
in the adaptation##3##3##(1994-8#1)(2008-8#1)(2011-1#1)
in the adaptive responses##2##4##(1994-12#1)(1994-2#1)
in the adaptive##6##3##(1994-12#1)(1994-2#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-11#1)
in the adenosinergic modulation##2##4##(1997-2#2)
in the adherence##2##3##(1993-9#1)(2012-3#1)
in the adhesion##2##3##(2008-11#1)(2012-1#1)
in the adhesive##2##3##(2008-5#1)(2012-2#1)
in the adipose tissue##3##4##(2008-3#2)(2012-2#1)
in the adipose##4##3##(2008-3#2)(2010-8#1)(2012-2#1)
in the adjacent##7##3##(1992-5#1)(1992-9#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-10#1)
in the adjuvant##3##3##(1997-5#1)(2008-6#1)(2010-7#1)
in the administration##2##3##(2007-11#1)(2013-1#1)
in the administrative##2##3##(1994-3#1)(1995-12#1)
in the adolescent##2##3##(2008-3#1)(2013-1#1)
in the adrenal gland##4##4##(1990-5#1)(1993-3#2)(2008-4#1)
in the adrenal##9##3##(1990-5#2)(1991-5#2)(1993-3#2)(2008-4#1)(2011-2#1)(2012-12#1)
in the adrenals##2##3##(1995-3#1)(2008-4#1)
in the adsorption##2##3##(2008-2#1)(2008-7#1)
in the adult and##2##4##(1991-12#1)(2013-7#1)
in the adult central nervous system##3##6##(1993-12#1)(2009-8#1)(2013-1#1)
in the adult human brain##2##5##(1996-10#1)(2007-8#1)
in the adult liver##2##4##(2008-7#1)(2013-1#1)
in the adult male##3##4##(1993-12#1)(2008-5#2)
in the adult population of##2##5##(1992-5#1)(2013-1#1)
in the adult population##3##4##(1992-5#1)(2008-8#1)(2013-1#1)
in the adult rat striatum##3##5##(1996-12#3)
in the adult rat##7##4##(1993-12#1)(1993-3#1)(1996-12#3)(1997-3#2)
in the adult##70##3##(1990-11#1)(1990-5#2)(1991-12#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#4)(1993-3#2)(1993-6#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#6)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#2)
in the adults##2##3##(2007-12#2)
in the advanced management of prostate cancer##2##7##(2010-12#2)
in the advanced##4##3##(2008-10#2)(2010-12#2)
in the adventitial##2##3##(1992-12#1)(2010-4#1)
in the aerosol##6##3##(1991-1#2)(1992-2#1)(2008-3#3)
in the aetiology of##6##4##(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#2)
in the aetiology##7##3##(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-8#2)
in the affected area##2##4##(1996-6#1)(2013-8#1)
in the affected region##2##4##(1990-6#1)(1994-12#1)
in the affected##17##3##(1990-3#1)(1990-6#1)(1991-8#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#1)
in the affinity of the##2##5##(1993-8#1)(1994-6#1)
in the affinity of##4##4##(1990-2#1)(1990-7#1)(1993-8#1)(1994-6#1)
in the affinity##6##3##(1990-2#1)(1990-7#1)(1991-5#1)(1993-8#1)(1994-6#1)(2008-9#1)
in the affluent##2##3##(1997-7#1)(2007-9#1)
in the aforementioned##2##3##(2008-7#1)(2012-12#1)
in the aftermath of the##3##5##(1993-12#1)(2008-4#1)(2012-1#1)
in the aftermath of##4##4##(1993-12#1)(2008-4#1)(2012-1#1)(2013-8#1)
in the afternoon##4##3##(1993-12#1)(2008-3#1)(2008-5#2)
in the agar##2##3##(2008-10#2)
in the age distribution of##2##5##(1996-1#1)(2009-7#1)
in the age group of##4##5##(2008-11#1)(2010-5#2)(2013-8#1)
in the age group##9##4##(1990-12#1)(1990-6#1)(1991-12#1)(1993-11#1)(2008-11#1)(2010-5#2)(2011-1#1)(2013-8#1)
in the age groups##2##4##(2007-10#1)(2013-8#1)
in the age of##4##4##(1992-5#1)(1994-11#1)(2008-10#1)(2011-2#1)
in the age range of##2##5##(2008-7#1)(2013-8#1)
in the age range##4##4##(2008-7#1)(2013-1#1)(2013-8#2)
in the age##22##3##(1990-12#1)(1990-6#1)(1991-12#2)(1992-5#1)(1993-11#1)(1994-11#1)(1996-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#4)
in the aged group##2##4##(1997-2#2)
in the aged##11##3##(1990-11#1)(1990-3#2)(1991-6#1)(1992-12#1)(1995-8#1)(1997-2#3)(2007-8#1)(2008-7#1)
in the ageing##2##3##(1995-8#1)(2009-12#1)
in the aging brain##3##4##(1994-5#1)(1996-11#1)(2008-7#1)
in the aging process##5##4##(1994-5#1)(1994-6#1)(1995-6#1)(2008-4#1)(2012-2#1)
in the aging##8##3##(1994-5#2)(1994-6#1)(1995-6#1)(1996-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
in the agricultural##3##3##(1991-6#1)(2008-10#1)(2008-12#1)
in the air and##4##4##(2008-10#2)(2009-7#1)(2010-4#1)
in the air by##2##4##(2008-10#1)(2013-8#1)
in the air of##2##4##(2010-4#2)
in the air sample##2##4##(2008-10#2)
in the air samples##3##4##(2008-10#3)
in the air was##3##4##(2008-10#3)
in the air with##3##4##(2008-10#2)(2008-2#1)
in the air##31##3##(1990-3#1)(1992-11#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#2)(2009-7#1)(2010-4#3)(2013-8#1)
in the airway##6##3##(1994-6#1)(1997-1#1)(1997-2#1)(2008-12#3)
in the airways of the##2##5##(1997-1#1)(2008-3#1)
in the airways of##5##4##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#1)(2008-3#1)
in the airways##10##3##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#3)(1997-2#1)(2007-6#1)(2008-3#1)(2013-8#1)
in the albino rat##2##4##(1994-8#2)
in the alcoholic patients##2##4##(1991-12#2)
in the alcoholic##3##3##(1991-1#1)(1991-12#2)
in the algal##2##3##(2008-10#1)(2012-1#1)
in the algorithm are##2##4##(2008-2#1)(2008-3#1)
in the algorithm##5##3##(2008-2#2)(2008-3#1)(2010-8#1)(2011-1#1)
in the algorithm's##2##3##(2008-2#2)
in the alimentary##3##3##(2008-10#1)(2008-5#2)
in the alkaline solution##2##4##(2008-10#2)
in the alkaline##5##3##(2008-10#3)(2008-11#1)(2008-9#1)
in the alkyl chain##3##4##(1990-11#1)(1995-11#1)(2007-11#1)
in the alligator gar##2##4##(2008-7#2)
in the alligator##3##3##(2008-7#2)(2010-3#1)
in the allosteric##4##3##(1995-2#2)(1995-5#2)
in the alpha##8##3##(1990-7#2)(1991-5#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(2008-3#1)
in the alpha-chain of##2##4##(1995-6#2)
in the alpha-chain##3##3##(1995-6#3)
in the alpha-globin genes##3##4##(1990-8#3)
in the alpha2##2##3##(2008-11#2)
in the altered##3##3##(1990-5#1)(1992-6#1)(2008-7#1)
in the alternate##2##3##(2008-2#1)(2008-4#1)
in the alveolar region of the##2##6##(1992-12#1)(1997-1#1)
in the alveolar region##4##4##(1992-12#1)(1994-12#1)(1995-12#1)(1997-1#1)
in the alveolar##7##3##(1992-12#1)(1994-12#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2013-1#1)
in the alveoli##2##3##(2007-8#2)
in the ambient##4##3##(2007-12#1)(2008-10#3)
in the ambulatory##3##3##(1996-3#1)(1997-3#1)(2012-3#1)
in the amino acid sequence of the##2##7##(1991-12#1)(1997-6#1)
in the amino acid sequence of##3##6##(1991-12#1)(1997-6#1)(2008-9#1)
in the amino acid sequence##7##5##(1991-12#1)(1992-9#1)(1997-6#1)(2008-9#1)(2009-2#1)(2011-2#2)
in the amino acid sequences##2##5##(1997-4#1)(2008-5#1)
in the amino acid##9##4##(1991-12#1)(1992-9#1)(1997-4#1)(1997-6#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#2)
in the amino##13##3##(1991-12#1)(1992-9#1)(1994-11#3)(1997-4#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#2)
in the amino-terminal##2##3##(1990-12#1)(1995-6#1)
in the amniotic fluid in##2##5##(1990-12#1)(1990-9#1)
in the amniotic fluid##3##4##(1990-12#1)(1990-9#1)(2012-12#1)
in the amorphous##2##3##(2008-10#1)(2008-3#1)
in the amount and##2##4##(1995-11#1)(1995-5#1)
in the amount of albicidin produced in vitro##2##8##(2008-10#2)
in the amount of food##2##5##(2008-9#2)
in the amount of the##4##5##(1990-12#1)(1992-3#1)(1992-6#1)(2009-8#1)
in the amount of##38##4##(1990-12#1)(1990-7#1)(1992-1#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-2#1)(2013-1#2)
in the amount##42##3##(1990-12#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-2#1)(2013-1#2)
in the amplification of##3##4##(2008-10#2)(2010-4#1)
in the amplification##6##3##(1990-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2010-4#1)
in the amplified spontaneous emission##2##5##(2007-11#1)(2008-3#1)
in the amplified##3##3##(2007-11#2)(2008-3#1)
in the amplifier##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
in the amplitude and##3##4##(1990-12#1)(2011-2#1)(2012-1#1)
in the amplitude of the##2##5##(2008-3#1)(2010-3#1)
in the amplitude##5##3##(1990-12#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-1#1)
in the amygdala in##2##4##(1991-1#1)(1992-6#1)
in the amygdala##8##3##(1991-1#1)(1992-6#3)(1993-6#1)(1996-12#1)(2008-11#1)(2008-7#1)
in the amyloid##2##3##(1991-11#1)(1996-5#1)
in the anaesthetised rat##2##4##(1991-2#2)
in the anal##2##3##(2013-1#1)(2013-7#1)
in the analysed samples##2##4##(2008-10#2)
in the analysed##3##3##(1993-9#1)(2008-10#2)
in the analyses of##2##4##(2008-10#1)(2008-7#1)
in the analyses were##2##4##(2008-10#1)(2011-2#1)
in the analyses##8##3##(2008-10#4)(2008-7#2)(2011-2#1)(2013-8#1)
in the analysis and##2##4##(1992-3#1)(2008-7#1)
in the analysis is##2##4##(2008-10#1)(2008-3#1)
in the analysis of a##2##5##(2008-10#2)
in the analysis of certified reference materials##3##7##(2008-10#3)
in the analysis of data##2##5##(2008-10#1)(2012-12#1)
in the analysis of pharmaceutical formulations##2##6##(2008-10#2)
in the analysis of the##6##5##(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)
in the analysis of##72##4##(1990-2#1)(1991-6#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the analysis##96##3##(1990-2#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#43)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
in the analytical process##2##4##(2008-10#1)(2013-1#1)
in the analytical##11##3##(2008-10#8)(2008-6#1)(2010-10#1)(2013-1#1)
in the analyzed##5##3##(2008-10#3)(2011-2#1)(2012-1#1)
in the anatomical##2##3##(2009-2#1)(2011-2#1)
in the angle of##2##4##(2007-11#1)(2008-2#1)
in the angular##3##3##(2007-12#1)(2008-3#2)
in the animal pole##2##4##(2013-1#2)
in the animal##13##3##(1992-6#1)(1993-6#1)(1994-5#1)(1996-12#1)(1997-6#2)(1997-7#1)(2008-7#1)(2009-12#1)(2010-11#1)(2012-2#1)(2013-1#2)
in the animals##4##3##(1992-3#1)(2008-11#1)(2008-7#2)
in the ankle##2##3##(2011-2#2)
in the annotation of##2##4##(2008-9#2)
in the anodic##3##3##(2008-10#3)
in the anolyte##3##3##(2013-1#3)
in the anomalous-dispersion##2##3##(2007-11#2)
in the antagonism##2##3##(2008-10#2)
in the antenna##3##3##(1993-11#1)(2007-12#1)(2008-5#1)
in the anterior and lateral##2##5##(2007-11#1)(2008-7#1)
in the anterior and posterior##2##5##(2008-8#1)(2013-1#1)
in the anterior and##5##4##(1992-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
in the anterior cerebral##2##4##(2007-10#1)(2008-9#1)
in the anterior lobe##2##4##(1992-9#2)
in the anterior maxilla##4##4##(2007-12#1)(2009-8#2)(2013-1#1)
in the anterior part##2##4##(2008-5#1)(2009-4#1)
in the anterior pituitary##3##4##(1992-10#1)(1993-5#2)
in the anterior region of the##2##6##(2008-7#1)(2009-1#1)
in the anterior##36##3##(1991-8#1)(1992-10#1)(1992-12#1)(1992-9#2)(1993-12#2)(1993-5#2)(1997-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-1#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
in the anterolateral##2##3##(2011-2#1)(2013-8#1)
in the anticonvulsant##4##3##(1990-5#1)(1994-2#1)(1994-8#1)(1995-12#1)
in the antigen-combining site##2##4##(1995-5#2)
in the antigenic##2##3##(2011-1#1)(2013-8#1)
in the antioxidant##2##3##(2009-8#1)(2013-1#1)
in the antiproliferative##2##3##(1990-12#1)(1995-2#1)
in the antisense##2##3##(1994-10#1)(2008-10#1)
in the aorta of##2##4##(1991-9#2)
in the aorta##6##3##(1991-9#3)(1993-6#2)(2008-3#1)
in the aperture##2##3##(2007-11#1)(2011-2#1)
in the apex of spine curve##2##6##(2007-8#2)
in the apex##3##3##(2007-8#2)(2008-10#1)
in the aphid##2##3##(2007-12#2)
in the apical##11##3##(1992-5#1)(1995-11#2)(1997-1#1)(2007-12#2)(2008-11#1)(2008-7#2)(2009-10#1)(2012-2#1)
in the apo##2##3##(1991-12#1)(2009-7#1)
in the apoptotic pathway##2##4##(2008-4#1)(2008-9#1)
in the apoptotic##7##3##(1995-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)
in the apparent Km##2##4##(1995-5#1)(1997-2#1)
in the apparent##8##3##(1990-7#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#2)(2008-7#1)(2011-1#1)
in the appearance of##8##4##(1992-8#1)(1993-11#1)(1993-8#1)(1995-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
in the appendix##3##3##(1990-8#1)(2009-7#1)(2013-1#1)
in the application of the##3##5##(1997-1#1)(1997-3#1)(2008-10#1)
in the application of##18##4##(1991-12#1)(1994-3#1)(1995-3#1)(1997-1#2)(1997-3#1)(2008-1#1)(2008-10#6)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
in the application##19##3##(1991-12#1)(1994-3#1)(1995-3#1)(1997-1#2)(1997-3#1)(2008-1#1)(2008-10#7)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
in the approach to##3##4##(2007-12#1)(2008-8#1)(2012-3#1)
in the approach##4##3##(2007-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
in the appropriate limit##3##4##(2007-11#3)
in the appropriate##8##3##(1995-12#1)(1996-8#1)(2007-11#3)(2008-10#1)(2008-5#1)(2010-12#1)
in the approval##3##3##(1993-12#1)(2008-10#2)
in the approximate##2##3##(1997-7#1)(2008-3#1)
in the aquatic environment##3##4##(2008-10#2)(2010-8#1)
in the aquatic##7##3##(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#1)(2013-7#1)
in the aqueous phase and##4##5##(2008-10#3)(2010-4#1)
in the aqueous phase was##2##5##(2008-10#1)(2008-5#1)
in the aqueous phase##12##4##(1991-5#1)(2008-10#8)(2008-5#1)(2008-7#1)(2010-4#1)
in the aqueous solution of##2##5##(1997-2#1)(2008-10#1)
in the aqueous solution##7##4##(1997-2#1)(2008-10#5)(2008-5#1)
in the aqueous solutions##2##4##(2008-10#2)
in the aqueous##30##3##(1991-5#1)(1997-2#1)(2008-10#22)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)
in the arab##2##3##(2007-7#1)(2008-4#1)
in the arcjet plume##2##4##(2008-3#2)
in the arctic##2##3##(1991-5#1)(2012-3#1)
in the arcuate nucleus##2##4##(1993-5#1)(1996-12#1)
in the area around##2##4##(1992-1#1)(2008-10#1)
in the area of Ioannina##2##5##(2008-10#2)
in the area of industrial##2##5##(2012-12#2)
in the area of the##12##5##(1991-3#1)(1992-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#1)
in the area of##61##4##(1991-3#1)(1992-1#1)(1992-6#1)(1993-12#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#3)(2009-3#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#2)
in the area served##2##4##(1991-6#1)(2010-12#1)
in the area where##3##4##(1993-6#1)(2008-10#2)
in the area##90##3##(1991-3#1)(1991-6#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-3#2)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
in the areas of patient##2##5##(1995-3#1)(2010-10#1)
in the areas of##16##4##(1992-2#1)(1993-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2010-10#1)(2011-1#1)(2012-1#1)
in the areas##24##3##(1992-2#1)(1993-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#2)(2009-4#1)(2010-10#1)(2011-1#1)(2012-1#1)
in the arena of##2##4##(2009-3#1)(2012-3#1)
in the arid##2##3##(2008-12#2)
in the arm##4##3##(1990-11#1)(2007-8#1)(2008-7#2)
in the armamentarium of##2##4##(2007-12#1)(2012-3#1)
in the arms##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
in the army##2##3##(2013-1#2)
in the array##8##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
in the arsenal##2##3##(2008-10#2)
in the arterial system##2##4##(2008-9#2)
in the arterial wall##2##4##(2008-3#1)(2013-1#1)
in the arterial##10##3##(1993-12#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#2)(2013-1#2)
in the arthroplasty##2##3##(2008-8#1)(2012-12#1)
in the article##10##3##(1994-12#1)(1996-9#1)(1997-6#1)(2008-6#1)(2010-11#1)(2011-1#3)(2011-3#1)(2012-3#1)
in the artificial mouth##3##4##(2008-10#3)
in the artificial seawater##2##4##(2008-10#2)
in the artificial##5##3##(2008-10#5)
in the ascending aorta##7##4##(1997-8#1)(2007-8#5)(2008-3#1)
in the ascending##9##3##(1997-8#1)(2006-8#1)(2007-8#5)(2008-10#1)(2008-3#1)
in the ascites##2##3##(1991-4#2)
in the aspartate##2##3##(1991-12#1)(1992-8#1)
in the aspect of##2##4##(2008-4#1)(2008-8#1)
in the assay of##5##4##(1992-6#1)(1996-12#1)(2008-10#3)
in the assay##17##3##(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#1)(1992-6#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
in the assays##3##3##(1993-2#1)(1995-5#1)(2008-9#1)
in the assembly and##2##4##(1990-5#1)(1995-8#1)
in the assembly of##3##4##(1995-8#1)(2011-2#1)(2013-1#1)
in the assembly##7##3##(1990-5#1)(1995-8#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
in the assessment and##2##4##(2010-12#2)
in the assessment of this##2##5##(1991-6#1)(2011-2#1)
in the assessment of##32##4##(1990-2#1)(1991-6#1)(1992-2#1)(1995-3#1)(1997-8#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)
in the assessment##37##3##(1990-2#1)(1991-6#1)(1992-2#1)(1995-3#1)(1997-2#1)(1997-8#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)
in the assisted##2##3##(2010-8#1)(2011-2#1)
in the associated##3##3##(2008-10#1)(2008-5#1)(2010-11#1)
in the association##3##3##(1990-5#1)(2008-10#2)
in the aster yellows##3##4##(2008-10#3)
in the asymmetric unit was##2##5##(2008-8#1)(2008-9#1)
in the asymmetric unit##8##4##(1992-4#2)(1992-9#1)(1993-8#1)(2008-8#3)(2008-9#1)
in the asymmetric##11##3##(1992-4#2)(1992-9#1)(1993-8#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-8#3)(2008-9#1)
in the asymptomatic phase##2##4##(1990-8#2)
in the asymptomatic##3##3##(1990-8#2)(2008-10#1)
in the atmosphere above##2##4##(2008-10#1)(2008-3#1)
in the atmosphere and##5##4##(1992-3#1)(2007-11#1)(2008-10#1)(2008-3#2)
in the atmosphere as##2##4##(2007-11#1)(2008-3#1)
in the atmosphere in##2##4##(2008-11#1)(2008-3#1)
in the atmosphere of the city of Granada (South of Spain)##2##11##(2008-5#2)
in the atmosphere of##6##4##(2008-10#3)(2008-3#1)(2008-5#2)
in the atmosphere that##2##4##(2007-11#1)(2008-3#1)
in the atmosphere with a##2##5##(2008-3#2)
in the atmosphere with##4##4##(2008-2#1)(2008-3#3)
in the atmosphere##50##3##(1992-3#1)(1996-1#1)(2007-11#4)(2007-12#2)(2008-10#9)(2008-11#4)(2008-2#4)(2008-3#22)(2008-5#2)(2011-2#1)
in the atmospheric boundary layer##2##5##(2008-3#2)
in the atmospheric##5##3##(2008-3#5)
in the atrophic##2##3##(2008-4#1)(2010-5#1)
in the attempt to##2##4##(1997-6#1)(2008-2#1)
in the attenuation##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
in the attitude##2##3##(1992-5#1)(2010-8#1)
in the auditory##3##3##(2007-7#1)(2008-8#1)(2008-9#1)
in the author's##2##3##(1996-2#1)(2011-2#1)
in the authors'##2##3##(1990-9#1)(2008-4#1)
in the autograft##2##3##(2007-8#1)(2012-3#1)
in the autoimmune##3##3##(1997-2#1)(2006-10#1)(2008-10#1)
in the automated##3##3##(2008-10#1)(2009-6#1)(2009-8#1)
in the automotive industry##2##4##(2008-3#1)(2011-2#1)
in the autonomic nervous system##2##5##(1997-2#1)(2008-2#1)
in the autosampler cup##2##4##(2008-10#2)
in the autosampler##4##3##(2008-10#4)
in the autumn of##2##4##(2008-2#1)(2010-8#1)
in the autumn##6##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#2)
in the availability of##2##4##(2008-10#1)(2008-5#1)
in the available##3##3##(2007-11#1)(2008-7#2)
in the average##13##3##(1995-12#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2013-8#2)
in the avian##2##3##(1997-2#1)(2008-5#1)
in the aviation industry##2##4##(2009-10#2)
in the avrBs1##2##3##(2008-10#2)
in the awake##2##3##(1990-7#1)(2009-8#1)
in the awareness##2##3##(2010-12#1)(2013-7#1)
in the axial##6##3##(1996-2#1)(2008-3#2)(2009-7#1)(2012-12#1)(2012-2#1)
in the axilla##8##3##(1995-9#1)(2008-5#7)
in the azygos vein##3##4##(2012-12#2)(2012-3#1)
in the back direction##2##4##(2008-3#2)
in the back##6##3##(1997-4#1)(1997-7#1)(2008-3#3)(2008-7#1)
in the back-reef area##2##4##(2007-5#2)
in the background of##5##4##(1995-8#1)(2008-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
in the background##9##3##(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-8#1)
in the backscattered##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
in the bacteria##2##3##(1994-8#1)(1996-12#1)
in the bacterial##5##3##(1991-3#1)(1992-6#1)(1997-4#1)(2008-10#1)(2011-2#1)
in the baculovirus expression system##2##5##(1995-6#1)(1997-4#1)
in the baculovirus expression##3##4##(1995-6#1)(1997-4#1)(2008-7#1)
in the baculovirus##5##3##(1995-6#1)(1997-4#1)(2008-2#1)(2008-7#2)
in the baculovirus-insect cell system##2##5##(1997-4#1)(2008-7#1)
in the baking##2##3##(1990-3#1)(2010-7#1)
in the balance##2##3##(2008-1#1)(2008-11#1)
in the band##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
in the barley##2##3##(2008-10#1)(2008-5#1)
in the barn##2##3##(1990-5#1)(2008-9#1)
in the barrel cortex##2##4##(1997-3#1)(2009-5#1)
in the barrel##5##3##(1991-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-5#1)
in the basal forebrain##3##4##(1992-10#1)(1993-12#1)(1996-5#1)
in the basal ganglia##7##4##(2008-7#5)(2012-1#1)(2012-2#1)
in the basal layer and##2##5##(2008-5#1)(2011-2#1)
in the basal layer of the epidermis##2##7##(1996-2#1)(2010-6#1)
in the basal layer##4##4##(1996-2#1)(2008-5#1)(2010-6#1)(2011-2#1)
in the basal##23##3##(1991-9#1)(1992-10#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-5#2)(2008-7#8)(2009-6#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
in the base##2##3##(2008-9#1)(2013-1#1)
in the baseline##6##3##(1992-11#1)(1997-4#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
in the basic protocol##2##4##(2008-4#2)
in the basic##6##3##(1995-11#1)(2008-10#1)(2008-4#4)
in the basilar artery of##3##5##(1996-6#1)(2008-4#2)
in the basilar##4##3##(1996-6#1)(2008-4#2)(2008-7#1)
in the basolateral membrane##2##4##(1992-5#1)(2008-11#1)
in the basolateral##3##3##(1992-5#1)(2008-11#2)
in the batch##5##3##(1994-8#1)(2008-10#3)(2010-4#1)
in the bath##2##3##(1995-3#1)(2008-4#1)
in the bathtub##6##3##(1995-3#6)
in the battle against##2##4##(2009-5#1)(2012-2#1)
in the battle##3##3##(1995-2#1)(2009-5#1)(2012-2#1)
in the beam##4##3##(1997-8#2)(2007-11#1)(2008-3#1)
in the bean##2##3##(2008-10#1)(2010-11#1)
in the bed##7##3##(1994-2#1)(2007-12#1)(2008-11#1)(2008-7#3)(2008-9#1)
in the beginning of the##3##5##(2007-10#1)(2008-10#1)(2013-1#1)
in the beginning of##4##4##(1991-12#1)(2007-10#1)(2008-10#1)(2013-1#1)
in the beginning##6##3##(1991-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2013-1#1)
in the behavior of the##2##5##(2012-2#2)
in the behavior of##3##4##(2008-11#1)(2012-2#2)
in the behavioral##3##3##(1991-1#1)(1995-12#1)(2010-12#1)
in the behaviour of##2##4##(2008-11#1)(2011-2#1)
in the best interest of##3##5##(1992-12#1)(1997-1#1)(2009-6#1)
in the best##10##3##(1990-12#1)(1992-12#1)(1997-1#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-9#2)(2011-2#1)
in the beta 2 strand of##2##6##(2008-11#2)
in the beta chains##2##4##(1990-7#2)
in the beta##7##3##(1990-7#4)(1996-7#1)(2008-11#2)
in the beta- and gamma-globin genes##2##6##(1990-8#2)
in the beta-oxidation of##2##4##(1990-5#1)(2012-2#1)
in the bibliography##2##3##(2008-10#2)
in the bilateral##7##3##(1996-2#1)(1996-5#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
in the bilayer##5##3##(1990-11#1)(1992-5#1)(1992-6#1)(1995-2#1)(2008-10#1)
in the bilayers##2##3##(1992-5#1)(2008-10#1)
in the bile and##3##4##(1996-5#1)(2008-10#1)(2008-9#1)
in the biliary system##3##4##(2010-12#3)
in the biliary##5##3##(2008-9#1)(2010-12#3)(2012-2#1)
in the binary##2##3##(2007-12#1)(2008-10#1)
in the binding and##3##4##(1993-11#1)(1994-5#1)(2008-5#1)
in the binding media##2##4##(1992-12#1)(2008-10#1)
in the binding of the##3##5##(1990-8#1)(1991-11#1)(2008-10#1)
in the binding of##8##4##(1990-8#3)(1991-11#1)(1991-8#1)(1994-8#1)(1995-2#1)(2008-10#1)
in the binding pocket##2##4##(1991-8#1)(1994-5#1)
in the binding process##2##4##(1997-2#1)(2008-10#1)
in the binding sites##3##4##(1990-8#1)(1994-11#1)(2008-10#1)
in the binding##31##3##(1990-5#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-8#2)(1992-12#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#7)(2008-5#1)(2010-7#1)(2013-8#1)
in the biochemical##2##3##(1994-9#1)(1995-11#1)
in the biodegradable##2##3##(2008-12#1)(2009-12#1)
in the biofilm##3##3##(2008-7#2)(2013-8#1)
in the biological control of##2##5##(2008-10#2)
in the biological control##3##4##(2008-10#3)
in the biological samples##3##4##(2008-10#3)
in the biological##13##3##(1991-11#1)(1991-5#1)(1992-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)(2011-3#1)
in the biology and##4##4##(1993-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
in the biology of the##2##5##(2008-10#1)(2008-12#1)
in the biology of##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
in the biology##7##3##(1993-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-4#1)
in the biomass and##2##4##(2008-12#2)
in the biomass##3##3##(2008-10#1)(2008-12#2)
in the biomechanical##2##3##(2008-5#1)(2013-1#1)
in the biomedical domain##2##4##(2008-7#2)
in the biomedical field##2##4##(2011-1#2)
in the biomedical##4##3##(2008-7#2)(2011-1#2)
in the biopathology##2##3##(2008-10#2)
in the biopsies##2##3##(2007-7#1)(2008-9#1)
in the bioreactor##8##3##(2008-11#8)
in the biosynthesis of the##3##5##(1992-8#1)(1994-8#1)(2008-10#1)
in the biosynthesis of##15##4##(1990-5#1)(1992-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)
in the biosynthetic pathway##2##4##(1997-6#1)(2008-1#1)
in the biosynthetic##3##3##(1994-3#1)(1997-6#1)(2008-1#1)
in the biotechnology industry##2##4##(2008-7#2)
in the biotechnology##3##3##(2008-7#2)(2010-2#1)
in the birds in##2##4##(2007-6#2)
in the birds##4##3##(1992-2#1)(1997-3#1)(2007-6#2)
in the black##2##3##(1995-6#1)(2009-8#1)
in the bladder and##2##4##(1996-12#1)(2007-9#1)
in the bladder epithelium##2##4##(1991-9#1)(1992-3#1)
in the bladder##8##3##(1991-9#1)(1992-3#1)(1993-11#1)(1996-12#1)(2007-9#1)(2008-10#2)(2010-12#1)
in the blank##2##3##(2008-10#2)
in the blastoderm##2##3##(1993-9#1)(1994-8#1)
in the blood and##2##4##(1996-5#1)(2009-2#1)
in the blood is##2##4##(1991-11#1)(2008-10#1)
in the blood of living animals##2##6##(2008-10#1)(2009-2#1)
in the blood of living rabbits##2##6##(2008-10#2)
in the blood of living##4##5##(2008-10#3)(2009-2#1)
in the blood of##13##4##(1990-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the blood samples##2##4##(2008-5#1)(2011-1#1)
in the blood serum##4##4##(2008-10#1)(2008-7#2)(2011-1#1)
in the blood were##2##4##(1993-8#1)(2008-10#1)
in the blood##57##3##(1990-12#2)(1990-2#1)(1991-11#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2009-2#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#2)
in the bloodstream##3##3##(2009-11#1)(2010-12#1)(2013-1#1)
in the blubber of ringed##2##5##(2008-10#2)
in the blubber##3##3##(2008-10#3)
in the blue and green##2##5##(2008-3#2)
in the blue and in the red##2##7##(2008-3#2)
in the blue and##4##4##(2008-3#4)
in the blue region of the spectrum##2##7##(2008-2#2)
in the blue##13##3##(1990-9#1)(1994-11#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#5)
in the blue-green##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
in the body and##7##4##(1992-3#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#2)
in the body fluids##3##4##(2008-10#3)
in the body of the##5##5##(1996-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-5#1)
in the body of##9##4##(1996-10#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
in the body##53##3##(1992-3#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-9#5)(2009-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
in the bone marrow##15##4##(1993-8#2)(1994-12#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-11#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-3#1)
in the bone remodeling process##2##5##(2007-8#1)(2010-9#1)
in the bone##26##3##(1991-11#1)(1993-8#2)(1994-12#1)(1995-6#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-7#1)(2010-11#1)(2010-6#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
in the border of##2##4##(2008-10#1)(2012-2#1)
in the border##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
in the bottom##3##3##(1994-1#1)(2008-10#1)(2011-2#1)
in the bound state##3##4##(1993-11#1)(1993-3#1)(1997-2#1)
in the bound##4##3##(1993-11#1)(1993-3#1)(1997-2#1)(2012-12#1)
in the boundary layer##3##4##(2008-11#2)(2008-3#1)
in the boundary##6##3##(2007-12#1)(2008-11#2)(2008-3#2)(2013-8#1)
in the bovine##4##3##(1990-8#1)(1991-5#1)(1993-3#2)
in the bowel##4##3##(1991-3#1)(1996-3#1)(2007-5#1)(2009-12#1)
in the brain and in##2##5##(1991-11#1)(1995-3#1)
in the brain and spinal cord##3##6##(1996-12#1)(1997-3#1)(2010-12#1)
in the brain and##20##4##(1991-11#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)
in the brain as well as##2##6##(2008-11#1)(2008-6#1)
in the brain as##3##4##(1994-5#1)(2008-11#1)(2008-6#1)
in the brain associated with##2##5##(2008-11#1)(2013-1#1)
in the brain but##2##4##(1990-11#1)(1992-6#1)
in the brain can be##2##5##(1993-11#1)(2008-2#1)
in the brain in##3##4##(1997-2#1)(2013-1#2)
in the brain is##3##4##(1995-12#1)(2007-8#1)(2009-5#1)
in the brain of rats##2##5##(1993-3#1)(2012-1#1)
in the brain of the##6##5##(1993-5#1)(1994-2#1)(1996-12#1)(1997-3#1)(2008-6#2)
in the brain of##18##4##(1990-7#1)(1992-12#1)(1993-3#1)(1993-5#2)(1994-2#2)(1994-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-6#4)(2008-7#2)(2012-1#1)
in the brain parenchyma##2##4##(1992-12#1)(2008-8#1)
in the brain stem##5##4##(1990-5#1)(1995-12#1)(2008-7#1)(2011-1#1)(2012-3#1)
in the brain tissue##2##4##(1995-12#1)(2008-5#1)
in the brain was##2##4##(1993-12#2)
in the brain##163##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-12#4)(1992-6#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#3)(1993-5#3)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#4)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#9)(1995-3#1)(1995-6#1)(1996-12#6)(1996-2#2)(1996-5#4)(1996-7#1)(1997-2#4)(1997-3#2)(1997-7#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#6)(2008-2#3)(2008-4#3)(2008-5#2)(2008-6#7)(2008-7#9)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#3)(2009-7#3)(2009-8#3)(2010-1#1)(2010-12#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#2)
in the brains and##2##4##(2008-6#2)
in the brains of patients with progressive supranuclear palsy##2##9##(1992-8#2)
in the brains of patients with##3##6##(1992-8#2)(2011-1#1)
in the brains of##10##4##(1991-5#1)(1992-8#2)(1995-12#1)(1996-5#2)(1997-3#1)(2007-12#1)(2008-11#1)(2011-1#1)
in the brains##12##3##(1991-5#1)(1992-8#2)(1995-12#1)(1996-5#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-6#2)(2011-1#1)
in the brainstem##6##3##(1991-5#1)(1992-3#1)(1994-3#1)(2007-10#1)(2008-4#1)(2012-3#1)
in the breast##5##3##(1990-10#1)(1994-7#1)(1997-7#1)(2008-12#1)(2008-3#1)
in the breeding season##4##4##(2008-5#1)(2008-8#2)(2010-8#1)
in the breeding##5##3##(2008-10#1)(2008-5#1)(2008-8#2)(2010-8#1)
in the brewing industry##2##4##(2013-1#2)
in the broad##3##3##(1997-5#1)(2007-12#1)(2008-10#1)
in the broader context of##2##5##(2008-8#1)(2009-8#1)
in the bronchoalveolar lavage##2##4##(1995-12#1)(2013-8#1)
in the brush##2##3##(1990-11#1)(2009-5#1)
in the budding yeast##2##4##(1992-8#1)(2008-9#1)
in the budding##3##3##(1992-8#1)(2008-9#1)(2011-2#1)
in the buffer solution##2##4##(1990-5#1)(2008-3#1)
in the buffer##7##3##(1990-12#1)(1990-5#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-4#1)
in the buffering##2##3##(2008-10#2)
in the bulk of a##2##5##(2007-12#1)(2008-2#1)
in the bulk of the##4##5##(2007-12#1)(2008-10#3)
in the bulk of##9##4##(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#1)
in the bulk phase##2##4##(2008-6#1)(2008-7#1)
in the bulk solution##4##4##(2008-10#4)
in the bulk##22##3##(2007-12#4)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-1#1)
in the burden##2##3##(2008-7#1)(2008-8#1)
in the buried##2##3##(1992-3#1)(2008-10#1)
in the business##2##3##(1992-3#1)(1995-12#1)
in the butenafine group and##2##5##(2007-7#2)
in the cDNA##4##3##(1993-6#1)(1994-9#1)(1995-6#1)(2008-12#1)
in the calcium##2##3##(1994-5#1)(2008-4#1)
in the calculated##4##3##(1996-5#1)(2008-3#2)(2013-8#1)
in the calculation of the##2##5##(2008-2#1)(2008-3#1)
in the calculation of##8##4##(1995-3#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)
in the calculation##9##3##(1995-3#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)
in the calculations##3##3##(2008-10#2)(2011-1#1)
in the calf##2##3##(1995-3#1)(2007-11#1)
in the calibration model##2##4##(2008-10#2)
in the calibration set##2##4##(2008-10#2)
in the calibration stage##2##4##(2008-10#2)
in the calibration##12##3##(2008-10#9)(2008-3#3)
in the callus##2##3##(2008-12#2)
in the calorimetric##3##3##(1990-2#1)(1997-2#2)
in the calyptra##2##3##(2008-10#2)
in the cambium##3##3##(2008-10#3)
in the cancer##6##3##(1997-4#2)(2008-7#2)(2011-2#1)(2012-3#1)
in the cancerous##2##3##(1992-9#1)(1994-7#1)
in the canine##4##3##(1996-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
in the canopy##3##3##(2008-10#3)
in the capacity for##2##4##(1994-12#1)(2008-1#1)
in the capacity of the##2##5##(1993-5#1)(2009-8#1)
in the capacity of##3##4##(1993-5#1)(1995-3#1)(2009-8#1)
in the capacity##6##3##(1993-5#1)(1994-12#1)(1995-3#1)(2008-1#1)(2009-8#1)(2012-3#1)
in the capillary##6##3##(1996-5#1)(2008-1#1)(2008-10#3)(2013-8#1)
in the capital##3##3##(2007-10#1)(2008-1#1)(2009-10#1)
in the capsid##2##3##(2008-10#2)
in the capture##2##3##(1994-11#1)(2012-2#1)
in the carbohydrate##3##3##(1997-4#1)(1997-6#1)(2008-9#1)
in the carbon paste##2##4##(2008-10#2)
in the carbon##6##3##(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)
in the carboxy-terminal domain##2##4##(1991-9#2)
in the carboxyl terminal region of##2##6##(1993-8#1)(1995-5#1)
in the carboxyl-terminal##2##3##(1992-5#1)(1994-8#1)
in the carcass##2##3##(2008-6#1)(2013-1#1)
in the carcinoid cells##3##4##(2011-2#3)
in the cardiac muscle##3##4##(2008-5#2)(2011-1#1)
in the cardiac##7##3##(1994-11#1)(1995-12#1)(1997-6#1)(2008-5#2)(2011-1#2)
in the cardiovascular system##6##4##(2008-4#3)(2009-10#1)(2011-2#1)(2013-1#1)
in the cardiovascular##9##3##(2008-11#2)(2008-4#3)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
in the care and##2##4##(1992-1#1)(2008-11#1)
in the care of cancer##2##5##(1992-2#1)(2008-1#1)
in the care of elderly##2##5##(1992-3#1)(2008-11#1)
in the care of older people##2##6##(2010-10#2)
in the care of patients with##2##6##(1997-4#1)(2012-3#1)
in the care of persons living with a SPMI##2##9##(2008-6#2)
in the care of persons##3##5##(1995-3#1)(2008-6#2)
in the care of the##2##5##(1992-11#1)(2008-7#1)
in the care of##25##4##(1992-11#1)(1992-2#1)(1992-3#2)(1995-3#2)(1995-5#1)(1996-1#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#2)(2011-2#2)(2012-3#2)
in the care##29##3##(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-3#1)(1995-3#2)(1995-5#1)(1996-1#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#2)(2011-2#3)(2012-3#2)
in the carotid##4##3##(1991-3#1)(1996-6#1)(2006-6#1)(2008-8#1)
in the carpal tunnel##2##4##(2008-12#1)(2008-9#1)
in the carrier solution##5##4##(2008-10#5)
in the carrier stream##3##4##(2008-10#3)
in the carrier##10##3##(2008-10#9)(2008-5#1)
in the cartridge is##2##4##(2008-10#2)
in the cascade of##3##4##(2008-3#1)(2012-2#1)(2012-3#1)
in the case group##2##4##(2011-2#2)
in the case of Cu##2##5##(2008-10#2)
in the case of P##2##5##(2008-8#1)(2010-3#1)
in the case of PurE##2##5##(2006-4#2)
in the case of a##15##5##(1993-6#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
in the case of an##2##5##(2008-10#1)(2008-3#1)
in the case of deoxycholate##2##5##(1990-12#1)(2008-10#1)
in the case of high##3##5##(2008-3#2)(2012-2#1)
in the case of other##2##5##(1993-5#1)(1997-3#1)
in the case of rat liver##2##6##(2008-10#2)
in the case of the##30##5##(1991-11#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1997-2#1)(1997-7#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
in the case of very high##3##6##(2008-10#3)
in the case of##229##4##(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#3)(2006-12#1)(2006-4#2)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#68)(2008-11#9)(2008-2#8)(2008-3#18)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#10)(2013-7#2)(2013-8#2)
in the case where##3##4##(1995-9#1)(2008-11#1)(2009-4#1)
in the case with##3##4##(2008-7#1)(2011-2#2)
in the case##249##3##(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#3)(2006-12#1)(2006-4#2)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#69)(2008-11#10)(2008-12#1)(2008-2#8)(2008-3#19)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#10)(2013-7#2)(2013-8#4)
in the cases of##3##4##(2011-1#1)(2012-2#1)(2013-1#1)
in the cases where##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
in the cases##9##3##(1993-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
in the cat##6##3##(1991-2#1)(1992-3#1)(1993-9#2)(1997-6#1)(2008-8#1)
in the catabolism of##3##4##(1991-9#1)(1994-8#1)(2008-11#1)
in the catalysis##2##3##(1990-5#1)(1993-8#1)
in the catalytic chains##2##4##(1990-8#1)(1995-6#1)
in the catalytic cycle##2##4##(1996-2#1)(2013-1#1)
in the catalytic domain##2##4##(1990-5#1)(1993-12#1)
in the catalytic mechanism of##2##5##(1992-6#1)(1993-11#1)
in the catalytic site##3##4##(1995-5#2)(2009-7#1)
in the catalytic##25##3##(1990-5#1)(1990-8#3)(1992-3#1)(1992-6#3)(1993-11#2)(1993-12#1)(1993-2#1)(1994-5#1)(1995-5#3)(1995-6#1)(1996-2#1)(1997-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
in the catch##2##3##(2008-5#1)(2008-6#1)
in the catchment area of the##2##6##(1994-2#1)(1997-2#1)
in the catfish##2##3##(2008-5#1)(2008-7#1)
in the cathode##2##3##(2007-12#1)(2008-10#1)
in the caudal##5##3##(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
in the caudate nucleus of##2##5##(2008-10#1)(2008-7#1)
in the caudate nucleus##3##4##(2008-10#1)(2008-7#2)
in the caudate putamen##3##4##(1995-6#1)(1996-12#2)
in the caudate##9##3##(1991-4#1)(1992-8#1)(1995-6#1)(1996-12#2)(1997-7#1)(2008-10#1)(2008-7#2)
in the cause of##2##4##(1995-5#1)(2009-3#1)
in the cavernous sinus##5##4##(2008-7#2)(2009-6#1)(2011-2#2)
in the cavernous##6##3##(1996-9#1)(2008-7#2)(2009-6#1)(2011-2#2)
in the cavity and##2##4##(2008-3#2)
in the cavity##10##3##(1995-2#1)(1996-5#1)(2007-12#3)(2008-2#1)(2008-3#4)
in the cell and##5##4##(1990-8#1)(1994-6#1)(1996-9#1)(2009-5#1)(2013-8#1)
in the cell clusters##2##4##(2008-7#2)
in the cell culture##3##4##(1991-6#1)(2008-11#1)(2008-8#1)
in the cell cultures##2##4##(1991-12#1)(2008-11#1)
in the cell cycle##6##4##(2008-11#4)(2008-9#1)(2011-2#1)
in the cell cytoplasm##3##4##(1997-6#1)(2007-12#1)(2008-10#1)
in the cell lines##2##4##(2008-2#1)(2008-9#1)
in the cell membrane##3##4##(1992-9#1)(2009-2#1)(2013-8#1)
in the cell surface##3##4##(1992-2#1)(1993-12#1)(2008-5#1)
in the cell to##2##4##(1992-9#1)(1995-2#1)
in the cell wall fraction##2##5##(2008-10#2)
in the cell wall##8##4##(1990-5#1)(1994-2#1)(2008-10#3)(2008-11#2)(2011-2#1)
in the cell##84##3##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#2)(1996-9#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#14)(2008-2#3)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#6)(2009-2#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#2)
in the cell-based AI assay##2##5##(2010-2#2)
in the cell-free##2##3##(2008-8#1)(2011-2#1)
in the cells and##2##4##(1991-12#1)(1995-2#1)
in the cells of##4##4##(2007-12#1)(2008-11#1)(2010-3#1)(2013-1#1)
in the cells with##2##4##(2008-11#1)(2008-7#1)
in the cells##29##3##(1990-2#2)(1991-12#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#3)(1995-8#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-7#1)
in the cellular and##2##4##(2008-7#2)
in the cellular environment##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
in the cellular##16##3##(1991-4#1)(1993-11#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-11#1)(2008-5#2)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
in the center of a##3##5##(2008-3#2)(2008-8#1)
in the center of the##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
in the center of##9##4##(1991-3#1)(1992-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
in the center##17##3##(1991-3#1)(1992-8#1)(1993-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)
in the centers of##2##4##(1991-10#1)(2008-10#1)
in the central airways##2##4##(1990-6#1)(1994-12#1)
in the central and northern##2##5##(2007-1#1)(2008-10#1)
in the central and peripheral nervous system##4##7##(1996-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central and peripheral nervous##5##6##(1996-12#1)(1997-6#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central and##8##4##(1996-12#1)(1997-6#2)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central cell##2##4##(2008-9#2)
in the central dopaminergic areas##2##5##(2008-10#2)
in the central nervous system (CNS)##13##6##(1991-5#1)(1994-2#1)(1996-12#2)(1997-2#1)(2007-7#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the central nervous system and##6##6##(1996-12#2)(1997-8#1)(2007-12#1)(2008-7#1)(2012-3#1)
in the central nervous system are##2##6##(1995-2#1)(2012-2#1)
in the central nervous system of the##2##7##(1992-6#1)(1997-3#1)
in the central nervous system of##4##6##(1992-6#1)(1993-12#1)(1995-2#1)(1997-3#1)
in the central nervous system##58##5##(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-12#5)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
in the central part of the##2##6##(2008-3#1)(2013-8#1)
in the central posterior/prepacemaker nucleus of##2##6##(1995-12#1)(1996-5#1)
in the central posterior/prepacemaker nucleus##3##5##(1995-12#1)(1996-5#2)
in the central region of the##3##6##(2008-10#1)(2008-7#1)(2008-9#1)
in the central region##4##4##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
in the central##110##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#2)(1996-12#6)(1996-2#2)(1996-5#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#4)(1997-8#1)(2006-12#1)(2007-1#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-6#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
in the centre of##3##4##(2007-12#1)(2008-5#1)(2010-11#1)
in the cereal bar##2##4##(2012-2#2)
in the cerebellar cortex of young rats##2##7##(1996-5#2)
in the cerebellar cortex of##4##5##(1995-8#1)(1996-5#3)
in the cerebellar cortex##7##4##(1992-11#1)(1992-6#1)(1995-8#1)(1996-5#3)(2013-8#1)
in the cerebellar slice##2##4##(2008-4#2)
in the cerebellar##11##3##(1992-11#1)(1992-6#1)(1995-8#1)(1996-5#3)(2008-4#2)(2008-7#1)(2013-7#1)(2013-8#1)
in the cerebellopontine angle##2##4##(2008-7#1)(2012-3#1)
in the cerebellum and##2##4##(1993-6#1)(2013-8#1)
in the cerebellum##17##3##(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-2#1)(1996-12#5)(1997-8#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the cerebral cortex and striatum of##2##7##(1997-2#2)
in the cerebral cortex and striatum##3##6##(1997-2#3)
in the cerebral cortex and the##2##6##(1996-12#1)(2008-11#1)
in the cerebral cortex and##8##5##(1990-7#1)(1996-12#1)(1997-2#3)(2008-11#1)(2008-7#2)
in the cerebral cortex of the##2##6##(1997-2#1)(2008-7#1)
in the cerebral cortex of##4##5##(1993-12#1)(1994-2#1)(1997-2#1)(2008-7#1)
in the cerebral cortex##28##4##(1990-7#3)(1991-2#1)(1993-12#3)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#6)(1997-4#1)(2008-11#3)(2008-7#6)(2012-1#1)
in the cerebral cortical mantle##2##5##(2008-7#2)
in the cerebral ganglion of##2##5##(1990-5#1)(2008-7#1)
in the cerebral ganglion##3##4##(1990-5#1)(2008-5#1)(2008-7#1)
in the cerebral hemisphere##2##4##(2008-7#1)(2013-8#1)
in the cerebral white matter##2##5##(2008-7#1)(2010-12#1)
in the cerebral##42##3##(1990-5#1)(1990-7#3)(1991-2#1)(1993-12#3)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#6)(1997-3#1)(1997-4#1)(2008-11#4)(2008-5#2)(2008-7#12)(2009-4#1)(2010-12#1)(2012-1#1)(2013-8#1)
in the cerebrospinal fluid (CSF)##2##5##(1995-12#1)(2011-2#1)
in the cerebrospinal fluid##7##4##(1995-12#2)(1997-5#1)(2008-3#1)(2009-11#1)(2010-5#1)(2011-2#1)
in the certified##3##3##(2008-10#3)
in the cervical and##2##4##(2008-12#1)(2013-8#1)
in the cervical lymph nodes##2##5##(2013-8#2)
in the cervical spine##7##4##(1995-11#1)(2007-11#1)(2007-8#2)(2012-12#3)
in the cervical##18##3##(1992-9#1)(1995-11#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-8#3)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#3)
in the chain##2##3##(1995-11#1)(2008-10#1)
in the chalazal##2##3##(2008-11#2)
in the chalcogenide glass##2##4##(2008-10#2)
in the challenge##3##3##(1996-12#2)(2010-4#1)
in the chamber##3##3##(2007-11#1)(2008-1#1)(2008-10#1)
in the change##2##3##(1995-3#2)
in the changing##4##3##(1996-12#1)(1996-2#1)(1997-2#1)(2013-8#1)
in the channel##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
in the chaotic##2##3##(2007-11#2)
in the characterisation and##2##4##(2008-5#1)(2012-2#1)
in the characterisation##3##3##(1993-11#1)(2008-5#1)(2012-2#1)
in the characteristic position of##2##5##(1990-12#2)
in the characteristic##3##3##(1990-12#2)(2008-7#1)
in the characteristics of the##2##5##(2007-11#1)(2008-1#1)
in the characteristics##3##3##(1996-7#1)(2007-11#1)(2008-1#1)
in the characterization and##2##4##(2008-7#1)(2010-12#1)
in the characterization of##6##4##(1992-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2009-5#1)(2013-7#1)
in the characterization##8##3##(1992-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2013-7#1)
in the cheeks##3##3##(2008-5#3)
in the chemical and##3##4##(1994-12#1)(2008-9#1)(2009-10#1)
in the chemical properties of##2##5##(1997-2#1)(2008-10#1)
in the chemical##9##3##(1991-5#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-10#1)
in the chemoprevention of##2##4##(1995-9#1)(2007-4#1)
in the chemotherapy group##2##4##(1991-8#1)(2008-6#1)
in the chemotherapy##3##3##(1991-8#1)(2008-6#1)(2008-7#1)
in the chest pain center##3##5##(2008-3#3)
in the chest##7##3##(1990-5#1)(1995-8#1)(2007-8#2)(2008-3#3)
in the chick chorioallantoic membrane##2##5##(1990-4#1)(2008-1#1)
in the chick embryo##3##4##(1994-5#1)(1996-5#1)(2008-1#1)
in the chick hindbrain##2##4##(2012-12#2)
in the chick##7##3##(1990-4#1)(1994-5#1)(1996-5#1)(2008-1#2)(2012-12#2)
in the chicken ureter##2##4##(1997-3#2)
in the chicken##13##3##(1994-5#1)(1995-3#1)(1996-5#1)(1997-3#3)(1997-9#2)(2007-6#1)(2008-11#1)(2008-5#3)
in the child##8##3##(1991-6#1)(1996-7#1)(2007-6#1)(2008-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2013-8#1)
in the childhood##2##3##(2007-8#1)(2008-7#1)
in the children##2##3##(2007-11#1)(2012-12#1)
in the children's##2##3##(1993-6#1)(2008-9#1)
in the chitosan##2##3##(2008-10#2)
in the chlorination and caustic extraction stage##2##7##(2008-10#2)
in the chloroplast##6##3##(1994-11#1)(2008-10#1)(2009-5#1)(2010-10#1)(2012-3#2)
in the choice of the##2##5##(1997-3#1)(2008-12#1)
in the choice of##7##4##(1995-5#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-1#1)
in the choice##8##3##(1995-5#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2011-2#1)
in the choroid plexus##4##4##(1993-12#1)(1996-12#2)(1996-5#1)
in the chosen##2##3##(2008-10#1)(2008-11#1)
in the chromatin##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
in the chromatograms of##2##4##(2008-10#2)
in the chromatograms##3##3##(2008-10#3)
in the chromatographic determination##2##4##(2008-10#2)
in the chromatographic##3##3##(2008-10#3)
in the chromosomal##4##3##(1995-8#1)(1997-5#1)(2008-7#1)(2008-8#1)
in the chromosome##2##3##(1995-8#1)(2008-8#1)
in the chronic##4##3##(2009-1#1)(2009-11#1)(2011-2#1)(2013-8#1)
in the cicatricial tissue##2##4##(2012-1#2)
in the cichlid##2##3##(2008-7#1)(2010-8#1)
in the circuits##2##3##(1995-3#1)(2013-8#1)
in the circulating reagent solution##2##5##(2008-10#2)
in the circulating##6##3##(1993-11#1)(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
in the circulation and##4##4##(1994-8#1)(2008-4#2)(2009-6#1)
in the circulation of##2##4##(1992-3#1)(2008-1#1)
in the circulation##10##3##(1992-3#1)(1994-5#1)(1994-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)
in the circumference of the thigh##2##6##(2007-11#2)
in the circumference of the##3##5##(2007-11#2)(2007-8#1)
in the cities of##5##4##(2008-9#1)(2012-12#2)(2013-8#2)
in the cities##6##3##(1990-6#1)(2008-9#1)(2012-12#2)(2013-8#2)
in the citrus##2##3##(2008-10#2)
in the city of Manaus##2##5##(2011-2#2)
in the city of Medellín##3##5##(2009-7#2)(2012-12#1)
in the city of Porto##2##5##(2009-7#1)(2013-8#1)
in the city of##33##4##(1991-6#1)(1991-9#1)(1992-8#1)(1995-3#1)(1995-6#2)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-7#3)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
in the city##37##3##(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1995-3#1)(1995-6#2)(1997-4#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-7#4)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
in the city's##2##3##(1995-12#1)(2013-1#1)
in the cladding##4##3##(2007-11#3)(2007-12#1)
in the class III region of the##2##7##(1997-6#1)(2008-4#1)
in the class III region of##3##6##(1997-6#1)(2008-4#2)
in the class III##4##4##(1997-6#2)(2008-4#2)
in the class##9##3##(1997-6#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#1)
in the classic##2##3##(2009-10#1)(2013-1#1)
in the classical##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
in the classification of##4##4##(1994-2#1)(1996-3#1)(2008-10#1)(2008-3#1)
in the classification##5##3##(1994-2#1)(1996-3#1)(2008-10#2)(2008-3#1)
in the classroom and##2##4##(2008-12#1)(2009-7#1)
in the classroom##9##3##(2008-11#3)(2008-12#5)(2009-7#1)
in the cleavage of##2##4##(1992-12#1)(1994-9#1)
in the cleavage##3##3##(1992-12#1)(1994-9#1)(2008-10#1)
in the cleft palate##2##4##(2007-12#1)(2009-7#1)
in the cleft##3##3##(2007-12#2)(2009-7#1)
in the clinic is##2##4##(2010-12#1)(2013-8#1)
in the clinic##20##3##(1992-3#1)(1993-9#1)(1994-1#1)(1996-3#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the clinical and##2##4##(2012-3#1)(2013-1#1)
in the clinical area##5##4##(2008-11#5)
in the clinical course##2##4##(2008-7#1)(2009-5#1)
in the clinical environment##2##4##(2008-12#2)
in the clinical investigation##2##4##(1993-11#1)(2011-1#1)
in the clinical laboratory##5##4##(1994-1#2)(1994-12#1)(2008-12#1)(2008-9#1)
in the clinical learning environment##2##5##(2008-12#1)(2009-12#1)
in the clinical management of patients##2##6##(2008-11#1)(2009-7#1)
in the clinical management of##3##5##(2008-11#1)(2008-2#1)(2009-7#1)
in the clinical management##4##4##(2008-11#1)(2008-2#1)(2009-7#1)(2011-2#1)
in the clinical practice##4##4##(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
in the clinical setting and##3##5##(2008-11#1)(2008-12#1)(2012-12#1)
in the clinical setting of##3##5##(2007-7#1)(2008-10#1)(2011-2#1)
in the clinical setting##24##4##(1991-11#1)(1992-3#1)(1993-3#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#1)(2011-2#1)(2012-12#2)
in the clinical situation##2##4##(1996-9#1)(2013-1#1)
in the clinical##80##3##(1991-11#2)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#2)(1995-11#1)(1996-9#1)(1997-3#3)(2006-10#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#11)(2008-12#9)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
in the clinics##4##3##(1994-1#2)(2008-1#1)(2011-1#1)
in the cloned##2##3##(1991-2#1)(1995-5#1)
in the close vicinity##2##4##(1994-8#1)(2012-3#1)
in the closed##2##3##(2007-8#1)(2008-8#1)
in the clotrimazole group##2##4##(2007-7#2)
in the cloud##2##3##(2008-3#1)(2013-7#1)
in the cluster##3##3##(2008-10#1)(2008-6#1)(2009-5#1)
in the coastal side##2##4##(2008-8#2)
in the coastal##8##3##(2008-10#1)(2008-3#1)(2008-8#2)(2010-4#1)(2011-2#2)(2013-8#1)
in the coasts of##2##4##(2008-5#1)(2013-7#1)
in the coat protein##3##4##(1997-2#1)(2008-10#2)
in the cochlear implant##2##4##(2008-9#2)
in the cochlear##4##3##(1993-12#1)(2008-9#2)(2009-5#1)
in the cockroach##2##3##(1995-11#1)(2008-8#1)
in the coding region of the##2##6##(1990-5#2)
in the coding region of##4##5##(1990-5#2)(1992-8#1)(1994-12#1)
in the coding region##12##4##(1990-5#2)(1992-8#1)(1993-2#2)(1994-12#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-5#1)
in the coding sequence##2##4##(1992-8#1)(1997-8#1)
in the coding##19##3##(1990-5#2)(1992-8#2)(1993-2#3)(1994-12#1)(1995-6#1)(1997-7#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-12#1)
in the codon##3##3##(1993-9#1)(2008-10#2)
in the cofactor##2##3##(1991-9#1)(1995-5#1)
in the cognitive##5##3##(1990-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
in the cohort##3##3##(1995-9#1)(2007-10#1)(2008-7#1)
in the cold##5##3##(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
in the collagen##5##3##(1991-11#1)(1992-6#2)(2008-5#1)(2008-7#1)
in the collected##2##3##(2008-6#1)(2011-2#1)
in the collection of airborne##2##5##(2008-10#2)
in the collection of##6##4##(2008-10#5)(2008-6#1)
in the collection##11##3##(1992-1#1)(1994-2#1)(2008-10#7)(2008-5#1)(2008-6#1)
in the colloid phase##2##4##(2008-10#2)
in the colloid##3##3##(2008-10#2)(2008-2#1)
in the colon and##3##4##(1992-8#1)(2008-12#2)
in the colon of rats##2##5##(2008-12#2)
in the colon of##4##4##(2008-12#4)
in the colon##19##3##(1991-4#1)(1991-6#2)(1992-6#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-12#8)(2009-1#1)(2009-12#1)(2013-1#1)
in the colonic mucosa##3##4##(1992-8#2)(2011-3#1)
in the colonic##4##3##(1991-12#1)(1992-8#2)(2011-3#1)
in the color##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-2#1)
in the colour##2##3##(1992-11#1)(2008-10#1)
in the column##6##3##(1993-6#1)(2008-10#4)(2008-9#1)
in the combination group##2##4##(2008-12#1)(2008-7#1)
in the combination of##4##4##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
in the combination##10##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
in the combined therapy group##2##5##(2013-1#2)
in the combined treatment##3##4##(2012-6#3)
in the combined##11##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-6#3)(2013-1#2)
in the combustion region above a flat-flame burner##2##8##(2008-3#2)
in the combustion##4##3##(2008-2#2)(2008-3#2)
in the comet assay##2##4##(1997-4#1)(2008-10#1)
in the coming##3##3##(1991-11#1)(2011-2#1)(2012-12#1)
in the commentary##2##3##(2008-4#2)
in the commercial##7##3##(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-7#1)
in the common iliac artery and##2##6##(2011-2#2)
in the common morning glory Ipomoea purpurea##3##7##(2008-9#3)
in the common##8##3##(1993-12#1)(2008-10#1)(2008-9#3)(2010-4#1)(2011-2#2)
in the communication##2##3##(1997-6#1)(2008-4#1)
in the communities in which##2##5##(1996-3#1)(2008-1#1)
in the communities##3##3##(1996-3#1)(2008-1#1)(2008-10#1)
in the community and##4##4##(1990-9#1)(1994-3#1)(2007-7#1)(2013-1#1)
in the community as##2##4##(2008-8#1)(2012-12#1)
in the community of##2##4##(1995-3#1)(2008-1#1)
in the community setting##3##4##(2008-11#2)(2012-12#1)
in the community##52##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-7#2)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
in the comparison##2##3##(1994-2#1)(1995-1#1)
in the compensation of##2##4##(1991-2#1)(2009-6#1)
in the competition##2##3##(1996-5#1)(2008-3#1)
in the competitive##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
in the complete##6##3##(1990-7#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
in the completely##3##3##(1990-5#1)(1997-6#1)(2008-12#1)
in the complex and##3##4##(2007-10#1)(2007-12#1)(2008-10#1)
in the complex is##2##4##(1995-12#1)(2007-12#1)
in the complex process##2##4##(1995-12#1)(2011-2#1)
in the complex was much faster##2##6##(2009-10#2)
in the complex was##3##4##(1994-11#1)(2009-10#2)
in the complex with##2##4##(1995-2#1)(2008-10#1)
in the complex##30##3##(1990-8#1)(1991-3#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#3)(1995-2#1)(1997-2#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-2#1)(2012-3#1)
in the complexation in##2##4##(2008-10#2)
in the complexation##3##3##(2008-10#3)
in the complexes##2##3##(1996-2#1)(2008-10#1)
in the complexity of##2##4##(1994-2#1)(2010-8#1)
in the composite##4##3##(2007-10#1)(2008-10#2)(2009-7#1)
in the composition and##2##4##(1996-9#1)(2008-10#1)
in the composition of their##2##5##(2008-5#1)(2010-7#1)
in the composition of##8##4##(1995-12#1)(1995-3#1)(2008-10#3)(2008-5#1)(2010-7#1)(2011-2#1)
in the composition##12##3##(1995-12#1)(1995-3#1)(1996-9#1)(2007-12#1)(2008-10#5)(2008-5#1)(2010-7#1)(2011-2#1)
in the compost mix##4##4##(2008-10#4)
in the compost##5##3##(2008-10#5)
in the compound##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
in the computational##2##3##(2008-3#1)(2009-3#1)
in the computer##4##3##(1992-4#1)(1996-2#1)(2006-4#1)(2007-11#1)
in the concentration and##2##4##(2008-10#1)(2008-2#1)
in the concentration of the##3##5##(1995-3#1)(2008-10#1)(2008-12#1)
in the concentration of##15##4##(1990-7#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-2#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
in the concentration range 0##11##5##(1996-5#1)(2008-10#10)
in the concentration range 1##2##5##(2008-10#2)
in the concentration range 2##2##5##(2008-10#2)
in the concentration range 3##2##5##(1996-5#1)(2008-10#1)
in the concentration range 5##3##5##(2008-10#3)
in the concentration range between##4##5##(1992-3#1)(2008-10#3)
in the concentration range from 1##2##6##(2008-10#2)
in the concentration range from 5 to##3##7##(2008-10#3)
in the concentration range from 5##5##6##(2008-10#5)
in the concentration range from##19##5##(2008-10#19)
in the concentration range of 0##16##6##(2008-10#15)(2011-1#1)
in the concentration range of 1##2##6##(1995-11#1)(2008-10#1)
in the concentration range of 2##4##6##(2008-10#4)
in the concentration range of 7##2##6##(2008-10#2)
in the concentration range of##41##5##(1995-11#1)(2008-10#38)(2010-5#1)(2011-1#1)
in the concentration range studied##2##5##(2008-10#2)
in the concentration range##106##4##(1992-3#1)(1995-11#1)(1996-5#3)(2008-10#99)(2010-5#1)(2011-1#1)
in the concentration ranges of##5##5##(2008-10#5)
in the concentration ranges##9##4##(2008-10#9)
in the concentration scale##2##4##(2008-10#2)
in the concentration##136##3##(1990-7#1)(1992-3#2)(1993-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#3)(2007-7#1)(2008-10#117)(2008-12#1)(2008-2#2)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in the concentrations of##4##4##(1992-9#1)(2008-10#2)(2008-5#1)
in the concentrations##9##3##(1992-9#1)(1993-9#1)(2008-10#5)(2008-5#1)(2010-3#1)
in the concept of##6##4##(1991-12#1)(1995-5#1)(1996-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
in the concept##7##3##(1991-12#1)(1995-5#1)(1996-7#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
in the conceptual##2##3##(2008-1#1)(2008-7#1)
in the condensed phase##2##4##(2008-10#2)
in the condition##3##3##(1994-9#1)(2007-10#1)(2008-3#1)
in the conditioned medium##2##4##(1990-2#1)(2008-11#1)
in the conditioned##4##3##(1990-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
in the conditions of##4##4##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
in the configuration of##2##4##(2008-10#1)(2012-2#1)
in the configuration##3##3##(2008-10#2)(2012-2#1)
in the conformation of the##3##5##(1995-6#1)(2008-7#1)(2012-12#1)
in the conformation##4##3##(1995-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
in the congenital group and##2##5##(2009-3#2)
in the congenital group##3##4##(2009-3#3)
in the conscious rat##2##4##(1991-1#1)(1995-12#1)
in the consequences of##2##4##(2009-10#1)(2009-12#1)
in the conservative approach of breast cancer##2##7##(1993-8#2)
in the conservative treatment of##2##5##(2007-8#1)(2013-1#1)
in the conservative##6##3##(1993-8#2)(1993-9#1)(2007-8#2)(2013-1#1)
in the conserved breast##2##4##(1990-12#2)
in the conserved##6##3##(1990-12#2)(1991-8#1)(1991-9#1)(1995-6#1)(2010-10#1)
in the constitutive##2##3##(1992-12#1)(2013-1#1)
in the constructed##2##3##(1990-11#1)(2008-10#1)
in the construction and##2##4##(2008-2#1)(2011-1#1)
in the construction of the##2##5##(1992-6#1)(2008-8#1)
in the construction of##13##4##(1992-6#1)(1994-12#1)(1995-2#2)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)
in the construction##15##3##(1992-6#1)(1994-12#1)(1995-2#2)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#1)
in the contact##4##3##(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
in the contamination of##2##4##(1997-5#1)(2008-11#1)
in the contamination##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
in the contemporary##3##3##(1994-12#1)(2007-12#1)(2013-8#1)
in the content of##5##4##(1993-12#1)(1994-6#1)(2008-10#1)(2009-8#2)
in the content##6##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-7#1)(2009-8#2)
in the context of HIV##3##5##(2008-6#1)(2012-2#2)
in the context of a##22##5##(1993-12#1)(1995-12#1)(1995-2#2)(1997-4#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
in the context of an##6##5##(1992-1#1)(2008-1#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-3#1)
in the context of climate change##3##6##(2009-5#2)(2012-8#1)
in the context of clinical##2##5##(2007-4#1)(2009-9#1)
in the context of conventional##3##5##(2008-6#2)(2010-9#1)
in the context of current##2##5##(2008-7#1)(2011-1#1)
in the context of family##2##5##(2010-8#1)(2012-3#1)
in the context of previous##3##5##(2008-9#2)(2012-2#1)
in the context of public health##2##6##(1995-6#1)(2008-8#1)
in the context of recent##2##5##(2008-8#1)(2009-8#1)
in the context of the##30##5##(1991-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
in the context of these##3##5##(2007-8#1)(2008-3#1)(2008-5#1)
in the context of##201##4##(1990-11#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#2)(1994-2#1)(1994-3#3)(1994-5#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#8)(2008-7#8)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#5)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#10)(2012-3#6)(2012-8#1)(2013-1#3)(2013-8#3)
in the continuity of##2##4##(1995-3#1)(2012-12#1)
in the continuous##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
in the contour##3##3##(1991-2#2)(2008-10#1)
in the contralateral cortex##2##4##(2008-5#2)
in the contralateral hemisphere##2##4##(1993-12#1)(2009-11#1)
in the contralateral side##4##4##(1995-12#1)(2008-7#1)(2008-9#2)
in the contralateral##19##3##(1990-3#1)(1993-12#6)(1994-12#1)(1995-12#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-11#1)(2011-2#1)(2013-8#1)
in the contribution of##2##4##(2008-10#1)(2010-8#1)
in the contribution##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)
in the control and##6##4##(1991-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
in the control cell line##2##5##(2008-11#2)
in the control group (p &lt##4##6##(2007-10#1)(2009-12#1)(2011-1#2)
in the control group (p = 0##3##7##(2008-10#1)(2009-10#1)(2011-1#1)
in the control group (p##8##5##(2007-10#1)(2008-10#1)(2009-10#1)(2009-12#1)(2011-1#3)(2011-2#1)
in the control group (p&lt##4##5##(1994-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
in the control group and##2##5##(2007-9#1)(2013-1#1)
in the control group received##2##5##(2007-11#1)(2009-12#1)
in the control group##86##4##(1990-11#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-12#3)(1994-8#3)(1996-12#1)(1996-7#1)(1997-4#1)(2007-10#3)(2007-11#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#4)(2010-12#1)(2010-2#1)(2010-4#3)(2011-1#10)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
in the control groups##7##4##(1992-8#1)(2008-11#1)(2008-9#2)(2011-2#2)(2012-12#1)
in the control of cell polarity in##2##7##(1990-5#1)(2009-10#1)
in the control of cell proliferation##4##6##(1992-12#1)(1993-3#1)(2008-4#1)(2009-5#1)
in the control of cell##8##5##(1990-5#1)(1992-12#1)(1993-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)
in the control of energy##2##5##(2008-1#1)(2008-4#1)
in the control of food intake and##2##7##(1997-3#1)(2008-3#1)
in the control of growth##4##5##(1993-9#2)(1994-10#1)(2010-5#1)
in the control of the##5##5##(1995-6#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)
in the control of this##2##5##(2007-10#1)(2008-5#1)
in the control of##61##4##(1990-11#2)(1990-12#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-6#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#3)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-2#2)(2013-8#2)
in the control over behaviour by conditioned##2##7##(1993-6#2)
in the control population##2##4##(1997-4#1)(2007-10#1)
in the control subjects##2##4##(1996-12#1)(2011-2#1)
in the control waveguide##2##4##(2008-3#2)
in the control with 10% fat to 0##2##8##(2010-4#2)
in the control##194##3##(1990-11#3)(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-8#5)(1995-3#1)(1995-6#2)(1996-12#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#2)(1997-6#2)(2007-10#5)(2007-11#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#10)(2008-12#5)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#6)(2009-10#5)(2009-12#4)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#5)(2010-5#1)(2011-1#12)(2011-2#7)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#4)
in the controls##26##3##(1990-3#3)(1991-12#1)(1991-4#1)(1992-2#2)(1993-12#1)(1995-8#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-7#3)(2009-12#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-3#1)
in the conventional and OPCAB groups##2##6##(2007-8#2)
in the conventional loading group##2##5##(2013-1#2)
in the conventional tillage##3##4##(2008-10#3)
in the conventional##19##3##(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#1)(2009-12#1)(2009-2#1)(2011-2#1)(2013-1#3)
in the conversion of##7##4##(1990-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-9#1)(1995-6#1)(2008-5#1)
in the conversion##9##3##(1990-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-6#1)(2008-5#2)
in the cooperatively breeding acorn woodpecker##2##6##(2008-9#2)
in the coordination of##3##4##(2008-10#1)(2010-9#1)(2013-1#1)
in the coordination##5##3##(2008-10#3)(2010-9#1)(2013-1#1)
in the copolymer##2##3##(2008-10#1)(2009-7#1)
in the copolymerization##2##3##(2012-12#2)
in the coral##2##3##(2008-6#1)(2010-8#1)
in the cord##2##3##(2008-10#1)(2008-7#1)
in the core##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-1#1)
in the corn##4##3##(1990-7#1)(2008-10#2)(2009-8#1)
in the cornea##3##3##(1997-3#1)(2008-4#1)(2012-2#1)
in the coronary artery##2##4##(2007-8#2)
in the coronary##6##3##(2007-8#2)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
in the corpora##2##3##(1995-11#1)(2008-9#1)
in the corpus##3##3##(1993-12#2)(1994-6#1)
in the correct##5##3##(1994-3#2)(2007-7#1)(2008-4#1)(2008-9#1)
in the correction of satellite ocean color imagery##2##8##(2008-3#2)
in the correction of the##3##5##(2008-1#1)(2008-3#1)(2009-10#1)
in the correction of##8##4##(1997-8#1)(2008-1#1)(2008-3#4)(2009-10#2)
in the correction##9##3##(1997-8#1)(2008-1#1)(2008-3#5)(2009-10#2)
in the correlation##4##3##(2008-10#3)(2008-2#1)
in the correlator##2##3##(2007-12#1)(2008-3#1)
in the corresponding##19##3##(1991-6#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-7#1)(1995-9#1)(1996-2#2)(2006-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)
in the cortex and hippocampus##2##5##(1994-2#1)(2013-1#1)
in the cortex and##3##4##(1994-2#1)(1995-6#1)(2013-1#1)
in the cortex of the central cell##2##7##(2008-11#1)(2008-9#1)
in the cortex of the##3##5##(2008-11#1)(2008-9#1)(2011-2#1)
in the cortex of##6##4##(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
in the cortex was##2##4##(1992-7#1)(2008-11#1)
in the cortex##22##3##(1992-7#1)(1994-2#2)(1995-6#1)(1996-12#1)(2007-10#1)(2008-10#4)(2008-11#5)(2008-5#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
in the cortical##14##3##(1991-10#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
in the cosmetic##4##3##(2008-5#4)
in the cost of##2##4##(1995-2#1)(2008-9#1)
in the cost##5##3##(1995-2#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-9#1)
in the country and##2##4##(1991-6#1)(2011-2#1)
in the country in##3##4##(1997-6#1)(2008-1#1)(2008-8#1)
in the country##25##3##(1991-6#3)(1992-8#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-6#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
in the county of##7##4##(1991-9#1)(1992-11#1)(1993-6#2)(1994-11#1)(1996-9#2)
in the coupling##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
in the course had##2##4##(1996-1#1)(2008-11#1)
in the course of Crohn's disease##2##6##(2010-12#2)
in the course of a trial##2##6##(1996-6#1)(2008-10#1)
in the course of a##6##5##(1991-3#1)(1996-6#1)(2008-10#2)(2008-7#1)(2008-9#1)
in the course of phylogeny##2##5##(1994-5#2)
in the course of the last##2##6##(1991-11#1)(2012-12#1)
in the course of the##13##5##(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the course of their##3##5##(1991-12#1)(2008-12#1)(2008-9#1)
in the course of##82##4##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1994-2#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#4)(2008-9#6)(2009-4#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)
in the course##89##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1994-2#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#6)(2009-4#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#1)
in the cranial##2##3##(2008-1#1)(2013-8#1)
in the craniofacial##2##3##(2008-4#1)(2008-9#1)
in the creation of a##3##5##(1995-1#1)(1997-3#1)(2010-1#1)
in the creation of the##3##5##(2008-11#1)(2008-3#1)(2009-7#1)
in the creation of##9##4##(1995-1#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-1#1)
in the credentialing process##2##4##(1991-12#1)(1992-1#1)
in the credentialing##3##3##(1991-12#1)(1991-3#1)(1992-1#1)
in the cricopharynx of a##3##5##(2012-2#3)
in the criminal justice system##5##5##(1996-1#1)(2008-11#3)(2009-11#1)
in the criminal##7##3##(1996-1#1)(2008-11#3)(2009-11#1)(2011-2#2)
in the criteria##3##3##(1992-3#1)(2008-4#1)(2008-8#1)
in the critical care setting##3##5##(1991-1#3)
in the critical care##4##4##(1991-1#3)(2012-12#1)
in the critical##9##3##(1991-1#3)(1994-2#1)(1997-3#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-12#1)
in the critically ill patient##3##5##(2007-8#2)(2010-11#1)
in the critically ill##4##4##(2007-8#2)(2008-8#1)(2010-11#1)
in the critically##6##3##(2007-8#2)(2008-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
in the cross##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
in the cross-sectional##3##3##(1996-8#1)(2008-7#1)(2011-2#1)
in the crosses##2##3##(2008-10#2)
in the crude extracts##2##4##(2008-10#1)(2008-8#1)
in the crude oil##2##4##(2008-10#2)
in the crude##14##3##(1990-6#1)(1994-5#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)
in the crypts##2##3##(1991-12#1)(2013-1#1)
in the crystal lattice##2##4##(2006-4#1)(2007-12#1)
in the crystal structure##4##4##(1991-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the crystal structures##2##4##(1994-5#1)(2009-11#1)
in the crystal##20##3##(1991-11#1)(1992-4#1)(1992-9#1)(1994-5#1)(1997-7#4)(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-11#1)(2013-8#2)
in the crystals##3##3##(1990-7#1)(1992-9#1)(2008-10#1)
in the cubital tunnel##2##4##(2008-9#2)
in the cubital##3##3##(2008-7#1)(2008-9#2)
in the cuff##2##3##(1991-12#1)(2007-11#1)
in the cultivar with the##2##5##(2008-10#2)
in the cultivar##6##3##(2008-10#6)
in the cultivation of##3##4##(2006-11#1)(2008-11#2)
in the cultivation##4##3##(2006-11#1)(2008-11#2)(2008-6#1)
in the cultural and##2##4##(2008-10#1)(2008-11#1)
in the cultural##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
in the culture filtrate##2##4##(2008-10#1)(2008-8#1)
in the culture media##3##4##(1992-5#1)(1994-9#1)(2013-1#1)
in the culture medium and##2##5##(2008-7#1)(2012-6#1)
in the culture medium of##2##5##(1994-6#1)(1997-4#1)
in the culture medium##23##4##(1990-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-11#4)(2008-5#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-6#1)
in the culture of##2##4##(2008-11#2)
in the culture supernatant of##2##5##(1993-11#1)(2008-6#1)
in the culture using FC##2##5##(2008-11#2)
in the culture##48##3##(1990-2#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-9#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#13)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-6#1)(2013-1#1)
in the cultured cells##2##4##(2009-12#1)(2012-2#1)
in the cultured##6##3##(1993-3#2)(1995-11#1)(1995-6#1)(2009-12#1)(2012-2#1)
in the cultures of##2##4##(1996-2#1)(2008-11#1)
in the cultures##9##3##(1992-8#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#4)(2008-5#1)
in the cumulative##2##3##(2008-11#1)(2008-2#1)
in the currency of##2##4##(1992-3#1)(2008-8#1)
in the current paper##2##4##(1993-6#1)(1997-4#1)
in the current study##5##4##(1996-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
in the current##34##3##(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
in the curriculum of##2##4##(2007-11#1)(2011-2#1)
in the curriculum##4##3##(1995-2#1)(2007-11#1)(2008-11#1)(2011-2#1)
in the curvature##2##3##(2008-3#1)(2009-2#1)
in the cw##2##3##(2007-12#1)(2008-3#1)
in the cyanobacterium##2##3##(1992-12#1)(1996-6#1)
in the cynomolgus monkey##3##4##(2008-10#3)
in the cyst cells##3##4##(2012-2#3)
in the cyst##7##3##(2007-7#1)(2008-7#1)(2012-2#4)(2013-1#1)
in the cystic duct remnant##2##5##(2010-12#2)
in the cysts##4##3##(1993-1#1)(2008-10#1)(2008-7#2)
in the cytochrome##3##3##(1992-12#1)(1994-6#1)(2008-10#1)
in the cytokine network##2##4##(1991-2#1)(2007-8#1)
in the cytoplasm and##6##4##(1994-12#1)(1997-4#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
in the cytoplasm of the##7##5##(1991-2#1)(1992-2#1)(2008-11#2)(2008-9#1)(2009-2#1)(2012-2#1)
in the cytoplasm of##23##4##(1990-11#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
in the cytoplasm##62##3##(1990-11#1)(1991-11#1)(1991-2#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#2)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-2#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
in the cytoplasmic domain##2##4##(2008-5#1)(2013-1#1)
in the cytoplasmic membrane##2##4##(1994-2#1)(2011-2#1)
in the cytoplasmic##8##3##(1992-6#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(2008-5#1)(2011-2#1)(2013-1#1)
in the cytosol and##6##4##(1990-2#1)(1990-5#1)(1992-3#1)(1993-9#1)(2008-11#1)(2009-8#1)
in the cytosol of##6##4##(1991-2#1)(1992-12#1)(1993-6#1)(1995-11#1)(1997-4#1)(2013-1#1)
in the cytosol##26##3##(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-11#2)(1995-9#1)(1997-4#1)(1997-7#1)(2008-11#2)(2008-5#1)(2009-3#1)(2009-8#1)(2013-1#1)
in the cytosolic fraction##2##4##(1992-11#1)(1992-6#1)
in the cytosolic##7##3##(1990-2#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-6#2)(1994-6#1)
in the cytotoxic##2##3##(1992-10#1)(1995-8#1)
in the daily##5##3##(1991-12#1)(1993-12#1)(1995-12#1)(2008-11#1)(2009-9#1)
in the damaged##4##3##(1991-2#1)(2008-3#1)(2010-1#1)(2012-1#1)
in the dark at##2##4##(2008-10#1)(2008-5#1)
in the dark for##2##4##(2008-10#2)
in the dark period##2##4##(1997-2#2)
in the dark to##2##4##(2008-10#1)(2008-6#1)
in the dark##26##3##(1992-8#1)(1993-6#1)(1997-2#2)(2006-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)
in the data##27##3##(1990-3#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
in the database##5##3##(1995-12#1)(1997-2#1)(1997-3#1)(2008-7#2)
in the databases##8##3##(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-7#2)(2013-8#1)
in the day##2##3##(1995-1#1)(2008-7#1)
in the days##2##3##(2008-10#1)(2011-2#1)
in the dead##4##3##(2007-8#1)(2008-10#2)(2008-11#1)
in the death of##2##4##(1991-8#1)(2009-8#1)
in the death##3##3##(1991-8#1)(2009-2#1)(2009-8#1)
in the debate about##2##4##(1992-2#1)(1997-6#1)
in the debate##5##3##(1992-2#1)(1994-12#1)(1996-5#1)(1997-6#1)(2008-12#1)
in the decade##2##3##(1992-6#1)(2008-11#1)
in the decay##2##3##(2008-10#1)(2009-5#1)
in the decision##7##3##(1992-3#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-3#2)(2013-1#1)
in the decision-making process of##2##5##(2009-1#1)(2009-6#1)
in the decision-making process##5##4##(2008-12#1)(2009-1#1)(2009-6#2)(2011-2#1)
in the decline##2##3##(1995-3#1)(2010-3#1)
in the decoration of##2##4##(1995-2#1)(2008-10#1)
in the decrease in##2##4##(1991-5#1)(1995-11#1)
in the decrease of##4##4##(1993-11#1)(2008-10#1)(2009-10#1)(2013-1#1)
in the decrease##6##3##(1991-5#1)(1993-11#1)(1995-11#1)(2008-10#1)(2009-10#1)(2013-1#1)
in the decreasing##2##3##(1992-12#1)(2008-9#1)
in the deep cortical layers##2##5##(1993-12#2)
in the deep ultraviolet##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
in the deep##13##3##(1993-12#3)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
in the deepest##3##3##(2008-5#3)
in the defect##3##3##(2007-11#1)(2008-5#1)(2013-1#1)
in the defense response##3##4##(2008-10#2)(2008-9#1)
in the defense system##2##4##(1994-6#1)(2008-10#1)
in the defense##8##3##(1992-12#1)(1994-6#1)(2008-10#3)(2008-9#2)(2010-7#1)
in the definition of##4##4##(1993-2#1)(2008-11#2)(2008-7#1)
in the degenerative##2##3##(1997-6#1)(2008-7#1)
in the degradation of the##2##5##(1994-2#1)(2008-3#1)
in the degradation of##5##4##(1992-10#1)(1994-2#1)(1994-9#1)(2008-3#1)(2008-7#1)
in the degradation##6##3##(1992-10#1)(1994-2#1)(1994-9#1)(2008-3#1)(2008-7#1)(2010-4#1)
in the degree of##14##4##(1990-6#1)(1992-9#2)(1993-12#1)(1995-2#1)(1995-5#1)(2008-10#4)(2008-5#2)(2008-7#1)(2011-1#1)
in the delayed##3##3##(1993-12#1)(2013-1#2)
in the deletion##2##3##(1995-12#1)(1997-2#1)
in the delivery and##2##4##(1992-3#1)(1995-1#1)
in the delivery of health care##2##6##(1994-12#1)(2010-8#1)
in the delivery of health services##3##6##(1993-2#1)(2008-1#1)(2009-3#1)
in the delivery of health##6##5##(1993-2#1)(1994-1#1)(1994-12#1)(2008-1#1)(2009-3#1)(2010-8#1)
in the delivery of##23##4##(1991-2#1)(1991-3#2)(1992-1#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
in the delivery##28##3##(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
in the delta##4##3##(2008-11#2)(2008-2#1)(2013-8#1)
in the deltoid muscle##2##4##(2009-9#1)(2010-4#1)
in the demand for##3##4##(1990-6#2)(2006-6#1)
in the demilitarized zone between Iraq and Kuwait##2##8##(1992-6#2)
in the dendritic##2##3##(1990-5#1)(1991-5#1)
in the denervated laminae was##2##5##(1997-3#2)
in the denervated neuropil##3##4##(1997-3#3)
in the denervated##7##3##(1995-11#1)(1997-3#6)
in the denominator##3##3##(1992-12#1)(2008-9#1)(2013-1#1)
in the density of##6##4##(1990-5#3)(1990-7#1)(1995-8#1)(2008-11#1)
in the density##8##3##(1990-5#3)(1990-7#1)(1995-8#1)(2008-11#1)(2008-5#2)
in the dental##10##3##(1990-9#1)(1991-3#1)(1993-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#4)
in the dentate gyrus and##4##5##(1996-12#2)(2008-11#1)(2009-8#1)
in the dentate gyrus in vivo##2##6##(1995-12#2)
in the dentate gyrus of##4##5##(1994-8#2)(1995-12#2)
in the dentate gyrus##22##4##(1990-5#1)(1990-7#2)(1994-8#2)(1995-12#7)(1996-12#4)(1996-2#1)(1997-6#1)(2008-11#1)(2009-8#2)(2013-8#1)
in the dentate##23##3##(1990-5#1)(1990-7#2)(1994-8#2)(1995-12#8)(1996-12#4)(1996-2#1)(1997-6#1)(2008-11#1)(2009-8#2)(2013-8#1)
in the department of##3##4##(1993-3#1)(2008-10#2)
in the department##5##3##(1991-11#1)(1993-3#1)(1995-12#1)(2008-10#2)
in the deposition of##3##4##(1996-5#1)(2008-10#1)(2010-5#1)
in the deposition##5##3##(1996-5#1)(2008-10#3)(2010-5#1)
in the depressed patients##2##4##(1996-5#1)(1996-7#1)
in the depression of##2##4##(1995-12#1)(2008-9#1)
in the depth##2##3##(2007-11#1)(2007-12#1)
in the derivation of the##2##5##(2007-12#1)(2008-3#1)
in the derivation of##4##4##(2007-12#1)(2008-3#2)(2009-3#1)
in the derived##2##3##(2008-3#2)
in the dermal and##3##4##(2008-5#2)(2013-8#1)
in the dermal microvascular endothelial cells##2##6##(2013-8#2)
in the dermal##8##3##(2008-5#4)(2013-8#4)
in the dermatologic##2##3##(2006-10#1)(2010-6#1)
in the dermis and##4##4##(1996-12#1)(2008-5#2)(2010-6#1)
in the dermis##14##3##(1996-12#5)(2008-5#3)(2008-9#1)(2010-6#3)(2011-1#1)(2012-3#1)
in the descending##2##3##(1993-9#1)(2013-3#1)
in the description of##4##4##(2007-11#1)(2008-9#1)(2009-6#1)(2010-7#1)
in the descriptive epidemiology of##2##5##(1991-6#2)
in the desert##3##3##(1992-6#1)(1996-12#1)(2008-10#1)
in the design and execution of##2##6##(2012-12#2)
in the design and implementation of##4##6##(1991-1#1)(1995-1#1)(2008-10#1)(2010-11#1)
in the design and monitoring of##2##6##(1996-6#2)
in the design and##13##4##(1991-1#1)(1992-6#1)(1995-1#1)(1996-6#2)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2012-12#2)(2013-8#1)
in the design of a##3##5##(2007-11#1)(2008-3#1)(2008-7#1)
in the design of future##2##5##(2009-5#1)(2010-3#1)
in the design of more##2##5##(1993-11#1)(2012-2#1)
in the design of new##2##5##(2008-1#1)(2010-12#1)
in the design of novel##2##5##(2008-1#1)(2008-3#1)
in the design of##36##4##(1992-9#1)(1993-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
in the design process##2##4##(2008-2#1)(2010-10#1)
in the design##59##3##(1991-1#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#5)(2008-2#3)(2008-3#10)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
in the designated##2##3##(2007-6#1)(2010-8#1)
in the desired##2##3##(2008-10#1)(2012-2#1)
in the destruction of##3##4##(1992-9#1)(2007-11#1)(2013-1#1)
in the details of##2##4##(1996-6#1)(1997-5#1)
in the detected##2##3##(2007-12#1)(2008-3#1)
in the detection and characterization of##2##6##(2008-1#1)(2011-2#1)
in the detection and evaluation of##2##6##(1995-6#1)(2010-12#1)
in the detection and##11##4##(1995-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#2)(2011-2#1)(2013-1#1)
in the detection cell##2##4##(2008-10#2)
in the detection limit##2##4##(1995-2#1)(1996-5#1)
in the detection of a##2##5##(1991-9#1)(2008-3#1)
in the detection of pancreatic islet cell tumours##2##8##(2008-2#2)
in the detection of small##2##5##(2008-2#1)(2008-7#1)
in the detection of##36##4##(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2010-5#2)(2011-1#1)(2011-2#2)(2011-7#1)
in the detection plane##2##4##(2008-2#1)(2008-3#1)
in the detection system##2##4##(2008-10#1)(2008-3#1)
in the detection##61##3##(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#4)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#3)(2011-7#1)(2013-1#1)
in the detector##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
in the determination of Cu(2+)##2##5##(2008-10#2)
in the determination of acid volatile sulfide##2##7##(2008-10#2)
in the determination of copper##2##5##(2008-10#2)
in the determination of glucose##2##5##(2008-10#2)
in the determination of nitrite in saliva##2##7##(2008-10#2)
in the determination of rutin##2##5##(2008-10#2)
in the determination of thallium##2##5##(2008-10#2)
in the determination of the##15##5##(1990-7#1)(1995-11#1)(2008-10#8)(2008-2#2)(2008-3#2)(2011-1#1)
in the determination of these##3##5##(2008-10#3)
in the determination of trace amounts of##2##7##(2008-10#2)
in the determination of trace##4##5##(2008-10#3)(2013-8#1)
in the determination of##94##4##(1990-7#1)(1991-11#1)(1994-11#1)(1995-11#1)(1995-4#1)(1997-7#1)(2008-10#75)(2008-2#5)(2008-3#3)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
in the determination##98##3##(1990-7#1)(1991-11#1)(1994-11#1)(1995-11#1)(1995-4#1)(1997-7#1)(2008-10#79)(2008-2#5)(2008-3#3)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
in the determinations of##2##4##(2008-10#2)
in the determinations##3##3##(2008-10#3)
in the developed countries##5##4##(2007-7#1)(2008-10#1)(2008-3#2)(2010-8#1)
in the developed world and##2##5##(1994-9#1)(2008-8#1)
in the developed world##7##4##(1994-9#1)(2007-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-12#1)
in the developed##16##3##(1994-9#1)(1997-7#1)(2007-7#2)(2008-10#4)(2008-3#2)(2008-8#2)(2010-12#1)(2010-8#2)(2012-12#1)
in the developing CNS##2##4##(2008-7#2)
in the developing Drosophila##2##4##(1993-12#1)(2008-9#1)
in the developing and adult brain##2##6##(2008-1#1)(2008-4#1)
in the developing and adult##4##5##(1996-12#1)(1996-5#1)(2008-1#1)(2008-4#1)
in the developing and##5##4##(1995-5#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-4#1)
in the developing brain##4##4##(1994-2#1)(1995-12#2)(2007-12#1)
in the developing countries##5##4##(2007-12#1)(2007-7#2)(2008-11#1)(2011-2#1)
in the developing embryo##2##4##(1994-8#1)(2010-11#1)
in the developing limb##3##4##(2008-11#2)(2010-3#1)
in the developing neural##3##4##(1992-9#1)(1996-12#1)(1996-5#1)
in the developing rat##4##4##(1993-11#1)(1996-12#1)(1996-5#2)
in the developing world where##3##5##(2007-2#1)(2008-10#1)(2008-12#1)
in the developing world##16##4##(1997-7#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-2#1)(2013-8#2)
in the developing##66##3##(1991-7#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#2)(1994-8#2)(1995-12#3)(1995-5#1)(1996-12#4)(1996-2#2)(1996-5#5)(1997-3#1)(1997-7#2)(1997-9#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
in the development and application of##2##6##(1994-3#1)(2008-8#1)
in the development and implementation of##2##6##(1994-2#1)(2008-11#1)
in the development and maintenance of##2##6##(1996-5#1)(2008-7#1)
in the development and maintenance##3##5##(1996-5#1)(2008-7#1)(2011-2#1)
in the development and progression of##9##6##(2008-1#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#2)
in the development and##29##4##(1991-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#5)
in the development of a##10##5##(1994-11#1)(1996-6#1)(1997-6#1)(2008-10#3)(2008-11#2)(2011-2#2)
in the development of an##2##5##(1995-8#1)(2008-10#1)
in the development of analytical##2##5##(2008-10#1)(2011-2#1)
in the development of apple replant disease##2##7##(2008-10#2)
in the development of autoimmunity##2##5##(2008-10#1)(2010-5#1)
in the development of cancer##2##5##(1990-12#1)(2009-5#1)
in the development of clinical##2##5##(2008-12#1)(2008-5#1)
in the development of early##2##5##(2008-10#1)(2012-2#1)
in the development of effective##2##5##(2008-10#1)(2012-1#1)
in the development of human##3##5##(1994-12#1)(1995-3#1)(2007-10#1)
in the development of hypertension##2##5##(1997-6#1)(2011-2#1)
in the development of malignancy##2##5##(1995-6#1)(2009-2#1)
in the development of more##2##5##(2008-7#1)(2012-2#1)
in the development of new##15##5##(1991-8#1)(1993-3#1)(1994-1#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2010-10#1)(2011-1#1)
in the development of novel##2##5##(2011-2#1)(2013-8#1)
in the development of rickets##2##5##(2008-1#2)
in the development of several##2##5##(2011-2#1)(2013-8#1)
in the development of the##16##5##(1993-3#1)(1994-3#1)(1996-5#2)(1997-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
in the development of therapeutic##2##5##(2007-8#1)(2012-2#1)
in the development of these##3##5##(1995-12#1)(2008-11#1)(2011-2#1)
in the development of this##2##5##(2008-12#1)(2012-3#1)
in the development of tumors##2##5##(2011-1#1)(2013-1#1)
in the development of various##2##5##(2010-3#1)(2013-8#1)
in the development of##225##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#6)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#33)(2008-11#11)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#7)
in the development##259##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#8)(2008-10#33)(2008-11#15)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#20)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#9)(2013-7#1)(2013-8#7)
in the developmental##4##3##(1996-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
in the device##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
in the diabetes group##2##4##(1996-11#2)
in the diabetes##3##3##(1996-11#3)
in the diabetic elderly##2##4##(2008-12#1)(2008-7#1)
in the diabetic foot##2##4##(2007-11#1)(2012-2#1)
in the diabetic patient##2##4##(2008-7#1)(2008-9#1)
in the diabetic population##2##4##(2008-8#1)(2012-2#1)
in the diabetic##13##3##(1991-12#1)(1994-11#1)(2007-11#1)(2008-1#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#2)
in the diagnosis and follow-up of##4##6##(2011-1#1)(2011-2#1)(2012-2#2)
in the diagnosis and management of##17##6##(1993-11#1)(2007-12#1)(2008-12#2)(2008-3#3)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#2)(2011-7#4)(2012-2#1)
in the diagnosis and treatment of this##2##7##(2011-7#1)(2013-1#1)
in the diagnosis and treatment of##10##6##(1991-5#1)(1992-2#1)(1997-8#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-7#2)(2013-1#1)
in the diagnosis and treatment##11##5##(1991-5#1)(1992-2#1)(1997-8#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-7#2)(2013-1#1)
in the diagnosis and##41##4##(1990-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1996-11#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-7#6)(2012-2#4)(2013-1#1)(2013-8#1)
in the diagnosis of ICR##2##5##(2013-1#2)
in the diagnosis of a##2##5##(2010-5#1)(2012-3#1)
in the diagnosis of breast cancer##2##6##(1991-12#2)
in the diagnosis of chronic##2##5##(1992-5#1)(1994-11#1)
in the diagnosis of coronary artery disease##2##7##(2012-1#1)(2012-2#1)
in the diagnosis of patients##2##5##(2011-2#1)(2013-1#1)
in the diagnosis of renal##2##5##(2008-1#1)(2011-2#1)
in the diagnosis of the##2##5##(1990-3#1)(2008-12#1)
in the diagnosis of these##3##5##(2009-3#1)(2010-2#1)(2012-2#1)
in the diagnosis of this##2##5##(2009-3#1)(2010-8#1)
in the diagnosis of##83##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1992-5#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#1)
in the diagnosis##133##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-9#1)(1996-11#2)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#5)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#1)(2011-7#6)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#10)(2013-8#2)
in the diagnostic accuracy##2##4##(2008-12#1)(2012-2#1)
in the diagnostic process##4##4##(1996-11#1)(2007-4#1)(2008-10#1)(2013-1#1)
in the diagnostic work-up##2##4##(1997-3#1)(2012-2#1)
in the diagnostic##21##3##(1992-12#1)(1994-2#1)(1996-11#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
in the diagnostics of##2##4##(2007-11#1)(2013-8#1)
in the diagnostics##3##3##(2007-11#2)(2013-8#1)
in the dialysate##7##3##(1995-12#2)(2008-1#1)(2008-10#3)(2011-2#1)
in the dialysis##2##3##(2007-7#1)(2011-2#1)
in the diencephalic##2##3##(1993-8#1)(2008-7#1)
in the diet of##3##4##(2008-5#1)(2012-12#1)(2012-2#1)
in the diet##13##3##(1991-2#1)(1992-3#3)(1992-8#2)(1994-9#1)(2008-5#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
in the dietary##3##3##(1990-8#1)(1994-12#1)(2008-10#1)
in the diets##2##3##(2010-8#1)(2011-2#1)
in the different cell##2##4##(2008-11#2)
in the different plant##2##4##(2008-10#1)(2013-7#1)
in the different regions##2##4##(2007-10#1)(2008-10#1)
in the different rockwool treatments##2##5##(2008-10#2)
in the different samples##2##4##(2008-10#1)(2012-2#1)
in the different##44##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-6#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in the differential diagnosis for##2##5##(2010-11#1)(2011-2#1)
in the differential diagnosis of a##4##6##(1992-2#1)(2007-12#1)(2009-1#1)(2010-12#1)
in the differential diagnosis of an##2##6##(2008-12#1)(2012-12#1)
in the differential diagnosis of any##3##6##(1997-3#1)(2006-10#1)(2012-3#1)
in the differential diagnosis of culture-negative##2##6##(1996-11#1)(2011-2#1)
in the differential diagnosis of many##2##6##(2008-5#1)(2013-8#1)
in the differential diagnosis of##43##5##(1990-11#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-12#2)(2008-5#3)(2008-7#3)(2009-1#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
in the differential diagnosis##55##4##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-2#2)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-1#1)(2009-3#4)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
in the differential##63##3##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-2#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-1#1)(2009-3#4)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
in the differentiating##2##3##(1990-5#2)
in the differentiation between##3##4##(2008-1#1)(2008-6#1)(2012-2#1)
in the differentiation of##7##4##(1992-8#1)(1992-9#1)(1994-12#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
in the differentiation##13##3##(1992-8#1)(1992-9#1)(1994-12#1)(1995-6#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
in the difficult##3##3##(1992-12#1)(2008-10#1)(2012-3#1)
in the diffraction pattern##2##4##(2008-3#2)
in the diffraction##7##3##(2007-12#2)(2008-3#5)
in the diffusion of##2##4##(1990-12#1)(1991-9#1)
in the diffusion##8##3##(1990-12#1)(1991-9#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
in the digested and slurry samples##2##6##(2008-10#2)
in the digestive gland##2##4##(2008-10#2)
in the digestive tract of##2##5##(2008-11#1)(2012-2#1)
in the digestive tract##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
in the digestive##10##3##(1992-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
in the diluted##3##3##(2008-10#3)
in the direct and indirect##2##5##(2008-10#2)
in the direct##10##3##(2008-10#8)(2008-11#1)(2013-1#1)
in the direction of natural selection##2##6##(2012-3#2)
in the direction of the##10##5##(1992-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-6#2)(2011-2#1)
in the direction of##23##4##(1990-11#1)(1990-9#1)(1991-8#1)(1992-11#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2009-12#1)(2009-6#1)(2011-2#2)(2012-3#2)
in the direction perpendicular to the plane of##2##8##(2008-3#2)
in the direction perpendicular to the##5##6##(2007-11#1)(2008-3#4)
in the direction transverse to the##2##6##(2007-12#2)
in the direction##35##3##(1990-11#1)(1990-9#1)(1991-8#1)(1992-11#1)(1997-1#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#9)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#3)(2012-3#2)
in the disability##2##3##(1991-1#1)(1995-3#1)
in the disappearance of the##2##5##(2009-2#1)(2009-9#1)
in the disappearance of##3##4##(1997-5#1)(2009-2#1)(2009-9#1)
in the discovery of##7##4##(1994-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-6#1)(2010-7#1)
in the discussion of##3##4##(1992-2#1)(2007-12#1)(2010-9#1)
in the discussion##5##3##(1992-2#1)(1995-3#1)(2007-12#1)(2008-12#1)(2010-9#1)
in the disease##8##3##(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#2)
in the diseased organ##2##4##(1992-3#2)
in the display##2##3##(1991-2#1)(2008-3#1)
in the dispute##2##3##(1992-2#1)(2009-7#1)
in the disruption of##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
in the dissemination of##2##4##(1993-6#1)(2008-10#1)
in the dissociation##2##3##(2008-10#1)(2008-6#1)
in the dissolved##3##3##(2008-10#3)
in the distal aortic arch##2##5##(2007-8#2)
in the distal part of the##3##6##(2008-5#1)(2008-7#1)(2013-1#1)
in the distal part##4##4##(2008-5#2)(2008-7#1)(2013-1#1)
in the distal portion of##2##5##(1991-5#1)(1997-4#1)
in the distal##27##3##(1991-5#1)(1991-9#2)(1994-12#1)(1994-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-8#3)(2008-10#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#2)
in the distance from the##2##5##(2008-3#1)(2008-9#1)
in the distant##2##3##(1993-1#1)(1996-5#1)
in the distinction##2##3##(1995-8#1)(2013-7#1)
in the distribution of the##7##5##(1991-1#1)(1992-2#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-12#1)
in the distribution of##23##4##(1990-5#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-3#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
in the distribution##25##3##(1990-5#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
in the disturbed##2##3##(2008-5#1)(2013-7#1)
in the diversity of##3##4##(2008-4#1)(2008-6#1)(2008-9#1)
in the diversity##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
in the division##3##3##(1994-3#1)(2008-9#1)(2009-12#1)
in the docking##2##3##(1995-2#1)(1997-7#1)
in the dog##8##3##(1991-1#1)(1993-2#1)(2008-10#2)(2008-8#1)(2011-1#3)
in the domain of contingency##2##5##(2009-9#2)
in the domain of##5##4##(2007-8#1)(2008-7#1)(2009-2#1)(2009-9#2)
in the domain##10##3##(1995-2#2)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#3)
in the domestic hen##2##4##(2008-12#2)
in the domestic##3##3##(2008-12#2)(2011-2#1)
in the donor##6##3##(2008-10#1)(2008-9#1)(2011-2#4)
in the dopaminergic##2##3##(1996-12#1)(2008-7#1)
in the dorsal and##2##4##(1996-12#2)
in the dorsal hippocampus##2##4##(1991-2#1)(1992-3#1)
in the dorsal horn of the##2##6##(1994-2#1)(2008-7#1)
in the dorsal horn of##3##5##(1994-2#1)(2008-7#1)(2011-2#1)
in the dorsal horn##8##4##(1990-7#2)(1994-2#1)(1995-12#1)(1997-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
in the dorsal raphe nucleus##2##5##(1992-3#1)(1995-5#1)
in the dorsal raphe of##2##5##(1994-2#1)(1997-6#1)
in the dorsal raphe##5##4##(1992-3#1)(1994-2#2)(1995-5#1)(1997-6#1)
in the dorsal root ganglion (DRG)##2##6##(1997-2#1)(2008-8#1)
in the dorsal root ganglion##4##5##(1995-12#1)(1997-2#2)(2008-8#1)
in the dorsal root##5##4##(1995-12#1)(1997-2#2)(2008-8#1)(2008-9#1)
in the dorsal striatum##2##4##(1996-2#1)(2010-2#1)
in the dorsal##39##3##(1990-7#2)(1991-2#1)(1992-10#1)(1992-3#2)(1993-12#2)(1993-3#1)(1994-2#3)(1994-8#1)(1995-12#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#3)(1997-3#2)(1997-6#1)(2007-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
in the dorsolateral##4##3##(2008-12#1)(2008-7#2)(2012-12#1)
in the dorsoventral plane##2##4##(1990-3#1)(1997-3#1)
in the dosage##2##3##(2008-10#1)(2010-5#1)
in the dose of##2##4##(2008-7#2)
in the dose range##2##4##(1994-8#1)(2008-7#1)
in the dose##5##3##(1994-8#1)(2008-10#1)(2008-7#3)
in the double##5##3##(1997-1#2)(2008-3#1)(2009-8#1)(2010-5#1)
in the downstream##4##3##(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
in the draining##2##3##(1997-3#1)(2008-10#1)
in the drinking water study##2##5##(2008-9#2)
in the drinking water##12##4##(1990-6#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-9#6)(2013-7#1)
in the drinking##13##3##(1990-6#1)(1995-12#2)(1995-3#1)(2008-10#2)(2008-9#6)(2013-7#1)
in the drop##2##3##(1991-5#1)(2008-10#1)
in the droplet##2##3##(1995-3#1)(2008-10#1)
in the drug substance##2##4##(1997-2#1)(2008-10#1)
in the drug##9##3##(1991-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-3#1)(2012-2#1)
in the dry period##2##4##(2013-7#2)
in the dry season##5##4##(2007-5#2)(2008-5#2)(2013-7#1)
in the dry##11##3##(2007-5#2)(2008-5#4)(2008-6#1)(2013-7#4)
in the drying##2##3##(2008-10#2)
in the dual##2##3##(1990-2#1)(2008-3#1)
in the ductal epithelium##2##4##(2008-5#1)(2011-2#1)
in the duodenum##4##3##(1995-11#1)(2011-2#1)(2013-1#2)
in the duplex oligomers containing##2##5##(2008-11#2)
in the duration of##5##4##(2008-6#1)(2008-9#1)(2009-6#2)(2012-2#1)
in the duration##7##3##(1993-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2012-2#1)
in the dye##3##3##(1990-12#1)(2008-2#1)(2010-4#1)
in the dynamic range##2##4##(2008-3#2)
in the dynamic##6##3##(2007-12#1)(2008-10#2)(2008-3#2)(2011-2#1)
in the dynamics of##3##4##(2008-9#3)
in the dynamics##5##3##(2008-10#1)(2008-8#1)(2008-9#3)
in the dyschondroplastic##2##3##(1991-9#2)
in the ear##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
in the earlier studies##2##4##(1991-6#1)(2008-2#1)
in the earlier##6##3##(1990-3#1)(1991-12#1)(1991-6#1)(1995-3#1)(2007-11#1)(2008-2#1)
in the earliest stages of##3##5##(2008-10#1)(2009-8#1)(2012-7#1)
in the earliest##6##3##(1994-3#1)(1995-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-7#1)
in the early 1900s##2##4##(2008-10#1)(2008-3#1)
in the early 1950s##2##4##(2008-9#1)(2010-1#1)
in the early 1960s##3##4##(1996-12#1)(2009-7#1)(2010-7#1)
in the early 1970s##3##4##(1992-4#1)(1996-3#1)(2008-12#1)
in the early 1980s##6##4##(1994-2#1)(1996-11#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)
in the early 1990s as##2##5##(1993-3#1)(2008-6#1)
in the early 1990s##8##4##(1993-3#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)
in the early and##2##4##(1996-5#1)(2008-10#1)
in the early detection of##4##5##(1991-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
in the early detection##5##4##(1991-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
in the early development of##2##5##(1992-12#1)(2010-12#1)
in the early diagnosis and##2##5##(2008-3#1)(2013-1#1)
in the early diagnosis of##4##5##(1990-9#1)(1993-3#1)(2008-7#1)(2009-5#1)
in the early diagnosis##6##4##(1990-9#1)(1993-3#1)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)
in the early embryo##5##4##(2007-12#2)(2009-3#1)(2009-8#1)(2012-3#1)
in the early hours##3##4##(1990-3#1)(2007-10#1)(2008-3#1)
in the early life##2##4##(2010-8#1)(2012-1#1)
in the early modern era]##2##5##(2008-10#2)
in the early modern##3##4##(2008-10#3)
in the early part of##2##5##(1991-8#1)(2008-9#1)
in the early period##2##4##(2008-11#1)(2010-11#1)
in the early phase of##5##5##(1992-12#1)(1994-11#1)(2007-8#1)(2008-8#1)(2010-1#1)
in the early phase##7##4##(1992-12#1)(1992-3#1)(1994-11#1)(2007-8#1)(2008-8#1)(2010-1#1)(2011-2#1)
in the early phases of##2##5##(1995-3#1)(2012-12#1)
in the early postoperative period after##2##6##(2007-8#2)
in the early postoperative period##6##5##(1991-5#1)(1994-3#1)(2007-7#1)(2007-8#2)(2011-2#1)
in the early postoperative##7##4##(1991-5#1)(1994-3#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-1#1)
in the early sixteenth century##2##5##(2008-11#1)(2012-2#1)
in the early stage of life##2##6##(1992-5#1)(1993-12#1)
in the early stage of the##2##6##(2008-9#1)(2012-3#1)
in the early stage of##12##5##(1992-12#1)(1992-5#1)(1993-12#2)(1994-3#1)(2008-10#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-3#1)
in the early stage##13##4##(1992-12#1)(1992-5#1)(1993-12#2)(1994-3#1)(1995-4#1)(2008-10#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-3#1)
in the early stages of development in##2##7##(1993-2#1)(2008-7#1)
in the early stages of development##3##6##(1993-2#1)(2008-7#1)(2011-2#1)
in the early stages of the##3##6##(2008-10#1)(2008-9#1)(2012-2#1)
in the early stages of##16##5##(1993-2#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#4)
in the early stages##24##4##(1993-2#1)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
in the early to##4##4##(2007-12#1)(2008-10#2)(2008-11#1)
in the early twentieth century##2##5##(2009-10#1)(2012-12#1)
in the early years of##2##5##(1992-2#1)(1992-3#1)
in the early years##3##4##(1992-2#1)(1992-3#1)(2010-12#1)
in the early##165##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-5#2)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
in the earth's crust##2##4##(2008-10#1)(2013-8#1)
in the earth's##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
in the east##4##3##(1992-2#1)(2008-10#3)
in the eastern United States##3##5##(2008-10#3)
in the eastern##11##3##(2007-5#1)(2008-1#1)(2008-10#7)(2009-8#1)(2012-3#1)
in the ecological##2##3##(2008-8#1)(2008-9#1)
in the economic and##2##4##(1990-12#1)(1993-2#1)
in the ecosystem##3##3##(1997-7#1)(2008-12#2)
in the ectoderm##2##3##(2007-12#1)(2008-7#1)
in the edge##3##3##(2013-7#2)(2013-8#1)
in the education of health##3##5##(1993-2#1)(2008-11#2)
in the education of##5##4##(1993-2#1)(2008-11#3)(2008-12#1)
in the education##6##3##(1993-2#1)(2006-10#1)(2008-11#3)(2008-12#1)
in the educational##2##3##(2008-12#1)(2010-9#1)
in the effect of##4##4##(1995-11#1)(1996-5#1)(2006-10#1)(2008-3#1)
in the effect##7##3##(1993-12#1)(1995-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
in the effective refractive index##2##5##(2007-11#2)
in the effective##8##3##(1995-1#1)(1996-6#1)(2007-11#2)(2008-2#2)(2008-3#1)(2013-8#1)
in the effectiveness of##4##4##(1991-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the effectiveness##5##3##(1991-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the effects of##7##4##(1991-12#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-7#1)(2008-9#1)
in the efficiency of the##3##5##(1997-2#2)(2008-3#1)
in the efficiency of##7##4##(1994-12#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
in the efficient##4##3##(1992-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
in the effluent##6##3##(2007-7#1)(2008-10#3)(2008-7#2)
in the effluents##2##3##(2007-7#1)(2008-10#1)
in the effort to##7##4##(1994-3#1)(1994-9#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
in the effort##8##3##(1991-3#1)(1994-3#1)(1994-9#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
in the efforts to##2##4##(1993-3#1)(1996-11#1)
in the egg##7##3##(2008-10#1)(2008-11#3)(2008-9#2)(2010-2#1)
in the eighties##2##3##(1994-11#1)(2012-12#1)
in the elaboration of##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
in the elaboration##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
in the elderly and in##2##5##(2007-8#1)(2012-3#1)
in the elderly and##8##4##(1995-1#1)(1997-8#1)(2007-7#2)(2007-8#1)(2011-1#2)(2012-3#1)
in the elderly patient##4##4##(1990-11#1)(1992-3#1)(2008-4#1)(2008-8#1)
in the elderly patients##4##4##(2008-10#1)(2008-7#3)
in the elderly population##7##4##(1993-3#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-3#1)
in the elderly with##3##4##(1991-6#1)(2008-7#2)
in the elderly##110##3##(1990-11#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#4)(1993-3#1)(1993-9#1)(1994-5#2)(1994-6#5)(1995-1#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#4)(2008-7#18)(2008-8#10)(2008-9#1)(2009-1#3)(2009-10#1)(2009-12#3)(2009-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#5)(2013-1#2)(2013-8#1)
in the elderly]##9##3##(1990-10#1)(1990-3#1)(1990-6#1)(1992-6#2)(1993-3#1)(1993-5#1)(1994-6#1)(2008-4#1)
in the electric field##3##4##(2007-11#2)(2008-10#1)
in the electrical activity of##2##5##(1994-2#1)(2010-8#1)
in the electrical##4##3##(1994-2#1)(2008-12#1)(2008-3#1)(2010-8#1)
in the electrochemical detection of##2##5##(2008-12#2)
in the electrochemical##4##3##(2008-10#2)(2008-12#2)
in the electrode potential##2##4##(2008-10#2)
in the electrode##7##3##(2008-10#7)
in the electrolyte##2##3##(2008-10#1)(2010-7#1)
in the electron##2##3##(2008-10#1)(2008-11#1)
in the electronic##7##3##(1997-5#1)(1997-7#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#2)
in the electrothermal atomizer##2##4##(2008-10#2)
in the elements##2##3##(1993-2#1)(2013-1#1)
in the elevated plus-maze test##3##5##(1993-3#1)(2008-11#1)(2013-1#1)
in the elevated plus-maze##6##4##(1993-3#2)(2008-11#3)(2013-1#1)
in the elimination of the##2##5##(1991-3#1)(2012-12#1)
in the elimination of##5##4##(1991-3#1)(1997-3#1)(2008-9#1)(2009-12#1)(2012-12#1)
in the elimination##7##3##(1991-3#1)(1997-3#1)(2008-9#1)(2009-12#1)(2012-12#2)(2013-1#1)
in the eluant##2##3##(2008-10#2)
in the eluate##2##3##(1990-8#1)(2008-10#1)
in the eluent##3##3##(1995-6#1)(2008-10#2)
in the elution##2##3##(1990-12#1)(1991-12#1)
in the embryo##6##3##(2007-12#2)(2008-10#1)(2008-11#2)(2008-7#1)
in the embryonal##2##3##(1993-6#1)(1994-11#1)
in the embryonic brain##2##4##(1997-6#1)(2007-12#1)
in the embryonic##6##3##(1993-6#1)(1997-4#1)(1997-6#2)(2007-12#2)
in the emergence of##6##4##(1991-4#1)(2008-1#1)(2008-11#3)(2008-3#1)
in the emergency department (ED)##2##5##(2009-6#1)(2010-8#1)
in the emergency department##30##4##(1991-12#1)(2006-5#2)(2007-5#5)(2008-11#2)(2008-3#6)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
in the emergency room##4##4##(1994-2#1)(2007-12#1)(2008-9#1)(2011-2#1)
in the emergency setting##4##4##(2006-5#2)(2007-5#1)(2012-2#1)
in the emergency ward##2##4##(1992-6#2)
in the emergency##44##3##(1991-12#1)(1992-3#1)(1992-6#2)(1994-2#1)(2006-5#4)(2007-12#1)(2007-5#6)(2008-10#2)(2008-11#2)(2008-3#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
in the emerging field##2##4##(2008-8#1)(2012-2#1)
in the emerging##3##3##(1995-12#1)(2008-8#1)(2012-2#1)
in the emission spectrum##2##4##(2008-3#1)(2008-7#1)
in the emission##6##3##(1990-5#1)(2008-10#3)(2008-3#1)(2008-7#1)
in the emulsion##3##3##(2008-10#1)(2008-5#2)
in the end of##2##4##(1994-2#1)(2009-7#1)
in the end##4##3##(1994-2#1)(2008-10#1)(2009-10#1)(2009-7#1)
in the endemic##4##3##(2007-12#1)(2008-8#1)(2011-2#2)
in the endocrine##2##3##(1990-11#1)(1994-8#1)
in the endometrial##2##3##(2008-9#1)(2013-8#1)
in the endometrium##6##3##(1994-9#1)(2008-4#1)(2008-9#2)(2011-1#1)(2012-3#1)
in the endoplasmic reticulum (ER)##4##5##(1995-2#1)(2008-11#1)(2009-8#1)(2012-2#1)
in the endoplasmic reticulum membrane##2##5##(1995-6#1)(1997-7#1)
in the endoplasmic reticulum##15##4##(1993-11#1)(1994-11#1)(1995-2#3)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
in the endoplasmic reticulum-Golgi##2##4##(1993-8#1)(1994-11#1)
in the endoplasmic##18##3##(1993-11#1)(1993-8#1)(1994-11#2)(1995-2#3)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)
in the endoscopic##2##3##(2007-11#1)(2012-2#1)
in the endosperm##3##3##(2008-10#2)(2009-12#1)
in the endothelial cell##2##4##(1993-6#1)(2011-2#1)
in the endothelial##3##3##(1993-6#1)(2007-12#1)(2011-2#1)
in the endothelium of##3##4##(2012-1#1)(2012-3#2)
in the endothelium##7##3##(1995-2#1)(2012-1#1)(2012-12#2)(2012-3#3)
in the energetic##3##3##(1994-11#1)(2008-8#2)
in the energy range of &gt##2##6##(2008-2#2)
in the energy range##3##4##(2008-2#3)
in the energy##6##3##(2008-10#2)(2008-2#3)(2009-8#1)
in the enhanced##2##3##(1992-12#1)(1992-8#1)
in the enhancement of##3##4##(1993-3#1)(2008-10#1)(2012-2#1)
in the enhancement##4##3##(1993-3#1)(1997-8#1)(2008-10#1)(2012-2#1)
in the enriched environment##2##4##(1992-11#2)
in the enriched##3##3##(1992-11#2)(2008-11#1)
in the enteric nervous system##2##5##(1992-6#1)(2008-7#1)
in the entire##14##3##(1990-6#1)(1996-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-7#1)(2013-1#1)
in the environment and##3##4##(2008-2#1)(2011-1#1)(2011-2#1)
in the environment at trace##2##5##(2008-10#2)
in the environment can##2##4##(2008-6#1)(2013-1#1)
in the environment##63##3##(1994-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(2007-2#1)(2008-10#26)(2008-11#7)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#4)(2009-8#1)(2010-5#1)(2010-8#4)(2011-1#5)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
in the environmental and##3##4##(2008-10#3)
in the environmental field##2##4##(2008-10#2)
in the environmental##17##3##(2008-10#13)(2008-8#2)(2009-8#1)(2010-2#1)
in the enzymatic hydrolysis of##2##5##(2008-10#1)(2008-7#1)
in the enzymatic hydrolysis##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
in the enzymatic reaction##3##4##(1991-5#1)(2008-10#2)
in the enzymatic##8##3##(1991-5#1)(2008-10#4)(2008-7#1)(2009-5#1)(2013-1#1)
in the enzyme active site##2##5##(1995-6#2)
in the enzyme activity##7##4##(1994-8#2)(1995-11#1)(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
in the enzyme##15##3##(1990-7#1)(1994-8#2)(1995-11#1)(1995-6#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)
in the epidemic##5##3##(2008-10#4)(2011-2#1)
in the epidemiology of dengue##2##5##(2007-10#1)(2011-3#1)
in the epidemiology of##10##4##(1991-8#1)(1995-9#1)(2007-10#1)(2008-10#5)(2011-2#1)(2011-3#1)
in the epidemiology##12##3##(1991-8#1)(1995-9#1)(2006-10#1)(2007-10#1)(2008-10#5)(2010-12#1)(2011-2#1)(2011-3#1)
in the epidermal##6##3##(1993-3#1)(2008-10#2)(2008-9#2)(2013-8#1)
in the epidermis and##5##4##(2008-10#3)(2008-5#2)
in the epidermis of##3##4##(1996-12#1)(2008-5#2)
in the epidermis or##2##4##(2008-10#1)(2010-6#1)
in the epidermis##16##3##(1995-11#1)(1996-12#3)(2008-1#1)(2008-10#4)(2008-5#5)(2010-6#1)(2010-7#1)
in the epidural space##3##4##(1993-10#2)(2010-7#1)
in the epithelial cells of the##2##6##(2008-10#1)(2008-8#1)
in the epithelial cells of##3##5##(1996-5#1)(2008-10#1)(2008-8#1)
in the epithelial cells##6##4##(1991-2#1)(1991-9#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-8#1)
in the epithelial##9##3##(1990-12#1)(1991-2#1)(1991-9#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
in the epithelium and in##2##5##(2013-1#2)
in the epithelium of the##2##5##(2008-12#1)(2010-11#1)
in the epithelium of##3##4##(2008-12#1)(2010-11#1)(2012-1#1)
in the epithelium##7##3##(2008-12#1)(2009-10#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#2)
in the equatorial##2##3##(1996-2#1)(1996-5#1)
in the equilibrium##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
in the equivalent##2##3##(1991-9#1)(1997-6#1)
in the era of health care reform##2##7##(2010-5#1)(2010-8#1)
in the era of health##3##5##(1996-1#1)(2010-5#1)(2010-8#1)
in the era of triple combination therapy##2##7##(2013-1#2)
in the era of##13##4##(1993-1#2)(1996-1#1)(2008-1#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#2)
in the eradication of##2##4##(1995-5#1)(2010-1#1)
in the eradication##3##3##(1995-5#1)(2008-10#1)(2010-1#1)
in the erythrocyte##5##3##(1990-2#1)(1990-7#1)(1993-11#1)(2008-8#1)(2012-2#1)
in the erythrocytes##2##3##(1990-2#1)(1994-9#1)
in the esophagus##3##3##(2007-8#1)(2008-11#1)(2010-12#1)
in the essential oil of##2##5##(2008-11#2)
in the established##3##3##(1991-12#1)(1996-9#1)(2013-1#1)
in the establishment of##8##4##(1992-1#1)(1992-3#1)(1994-9#1)(2008-10#2)(2008-2#2)(2009-12#1)
in the estimate##4##3##(1994-2#1)(2010-2#1)(2012-2#2)
in the estimated##3##3##(1995-2#1)(2008-11#1)(2008-3#1)
in the estimation of the##2##5##(1993-2#1)(2008-3#1)
in the estimation of##4##4##(1993-2#1)(2008-3#3)
in the estimation##6##3##(1993-2#1)(2008-3#5)
in the estuary##2##3##(2010-5#1)(2013-1#1)
in the etching solution##2##4##(2008-10#2)
in the ethnic population##3##4##(2010-8#3)
in the ethnic##5##3##(2008-1#1)(2010-8#4)
in the etiology and prognosis of##2##6##(2007-10#1)(2008-8#1)
in the etiology and##3##4##(1990-11#1)(2007-10#1)(2008-8#1)
in the etiology of many##2##5##(1990-8#1)(2008-5#1)
in the etiology of obesity##2##5##(2008-1#1)(2008-5#1)
in the etiology of the##2##5##(1991-9#1)(2008-10#1)
in the etiology of this##2##5##(1993-11#1)(2011-2#1)
in the etiology of##34##4##(1990-8#2)(1991-9#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-2#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the etiology##39##3##(1990-11#1)(1990-6#1)(1990-8#2)(1991-9#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-2#2)(2007-10#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the etiopathogenesis of##3##4##(1990-6#1)(2013-7#1)(2013-8#1)
in the eukaryotic##3##3##(1994-3#1)(2008-7#1)(2009-5#1)
in the euryarchaeal##2##3##(2011-2#2)
in the evaluated##2##3##(1990-12#1)(2008-3#1)
in the evaluation and treatment##2##5##(2008-9#1)(2009-1#1)
in the evaluation and##7##4##(1995-5#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-1#1)(2010-12#1)
in the evaluation of acute##2##5##(2011-2#1)(2013-1#1)
in the evaluation of patients with a##2##7##(2008-9#2)
in the evaluation of patients with##4##6##(2007-4#1)(2008-9#2)(2012-2#1)
in the evaluation of the##6##5##(1990-5#1)(1990-9#1)(1991-3#1)(2008-7#2)(2008-9#1)
in the evaluation of##47##4##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-2#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#5)(2012-2#4)(2013-1#4)
in the evaluation##54##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-2#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-1#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#5)(2012-2#4)(2013-1#4)
in the evening of##2##4##(2008-5#2)
in the evening##6##3##(1992-3#1)(1996-5#1)(1997-6#1)(2008-5#2)(2011-2#1)
in the event of an emergency##2##6##(1992-1#1)(2010-1#1)
in the event of##7##4##(1991-6#1)(1992-1#1)(2007-11#1)(2008-9#1)(2010-1#1)(2011-2#2)
in the event that##3##4##(1997-8#1)(2008-10#1)(2011-2#1)
in the event##11##3##(1991-6#1)(1992-1#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-2#3)
in the events that##2##4##(2008-11#2)
in the events##3##3##(1995-11#1)(2008-11#2)
in the everyday##2##3##(2008-5#1)(2012-2#1)
in the evidence##2##3##(2013-8#2)
in the evidence-based##2##3##(2008-8#1)(2012-1#1)
in the evolution of many##2##5##(2008-8#1)(2009-10#1)
in the evolution of the##6##5##(1992-11#1)(1996-4#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#1)
in the evolution of##34##4##(1990-7#1)(1992-11#1)(1995-8#1)(1996-4#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-8#1)(2010-3#3)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
in the evolutionary##5##3##(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)
in the examination of##2##4##(1995-11#1)(2008-12#1)
in the examination##4##3##(1995-11#2)(1995-6#1)(2008-12#1)
in the examples##2##3##(2008-10#1)(2010-7#1)
in the exchange process##2##4##(2008-12#1)(2010-3#1)
in the exchange##4##3##(2007-12#1)(2008-12#1)(2010-3#1)(2010-5#1)
in the excised##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
in the excitation##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
in the excited state##4##4##(1995-11#1)(2008-10#2)(2008-2#1)
in the excited##5##3##(1995-11#1)(2008-10#3)(2008-2#1)
in the execution##2##3##(1993-12#1)(2013-1#1)
in the exercise group##3##4##(1992-3#2)(2011-2#1)
in the exercise##6##3##(1992-3#3)(2007-6#1)(2008-11#1)(2011-2#1)
in the exhaled air##2##4##(1991-3#1)(2008-10#1)
in the exhaust duct##2##4##(2008-3#2)
in the exhaust region of##2##5##(2008-2#2)
in the exhaust##7##3##(2008-2#3)(2008-3#4)
in the existing literature on##2##5##(2008-5#1)(2012-12#1)
in the existing literature##3##4##(2008-5#1)(2008-7#1)(2012-12#1)
in the existing##11##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
in the exit##2##3##(2008-3#2)
in the exocarp##3##3##(2008-10#3)
in the exoskeleton##3##3##(2007-12#3)
in the expected##3##3##(1993-8#1)(2008-10#1)(2012-1#1)
in the experience of##4##4##(2008-6#1)(2009-7#1)(2010-4#1)(2012-1#1)
in the experiment##11##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)
in the experimental and control groups##2##6##(1991-12#1)(2011-2#1)
in the experimental and##3##4##(1991-12#1)(2011-2#1)(2013-8#1)
in the experimental conditions##3##4##(2006-4#1)(2008-10#2)
in the experimental field##2##4##(2008-10#1)(2010-1#1)
in the experimental group##16##4##(1992-9#1)(1993-6#1)(1995-1#1)(2007-11#2)(2008-11#3)(2008-12#3)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
in the experimental model of the brain ischemia/reperfusion in##2##9##(2013-1#2)
in the experimental model of##3##5##(2008-12#1)(2013-1#2)
in the experimental model##4##4##(1997-6#1)(2008-12#1)(2013-1#2)
in the experimental practices##2##4##(1993-12#2)
in the experimental than in the control##3##7##(1995-6#1)(2011-1#2)
in the experimental than##5##4##(1995-6#3)(2011-1#2)
in the experimental##44##3##(1990-6#1)(1991-12#1)(1992-9#1)(1993-12#2)(1993-6#1)(1995-1#2)(1995-6#3)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
in the experiments##15##3##(1990-11#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-7#1)(2008-9#1)(2013-7#1)
in the exploration of##3##4##(1990-3#1)(2009-10#1)(2009-12#1)
in the exploration##4##3##(1990-3#1)(2008-8#1)(2009-10#1)(2009-12#1)
in the exponential phase of##3##5##(1994-8#1)(2008-11#2)
in the exponential##5##3##(1994-8#1)(1995-9#1)(2008-11#2)(2008-7#1)
in the exposed##5##3##(1993-12#1)(1994-5#1)(2008-9#1)(2009-11#1)(2009-12#1)
in the exposure of##2##4##(1993-8#1)(1997-4#1)
in the exposure##4##3##(1990-5#1)(1991-12#1)(1993-8#1)(1997-4#1)
in the expression of a##2##5##(2008-5#1)(2008-7#1)
in the expression of genes##2##5##(2008-10#1)(2010-10#1)
in the expression of other genes##2##6##(2008-7#2)
in the expression of the##5##5##(1990-12#1)(1992-8#1)(1995-2#1)(2008-4#1)(2008-5#1)
in the expression of this##2##5##(1994-8#1)(1996-2#1)
in the expression of##42##4##(1990-12#1)(1992-3#3)(1992-8#2)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-8#3)
in the expression vector##3##4##(1990-5#1)(1997-6#1)(2008-10#1)
in the expression##50##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-3#3)(1992-8#2)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-8#3)
in the extended##2##3##(1990-8#1)(2009-4#1)
in the extent and##2##4##(2008-10#1)(2008-7#1)
in the extent of##8##4##(1994-11#1)(1995-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#1)
in the extent##12##3##(1994-11#1)(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2010-3#1)
in the external##9##3##(1993-12#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
in the extinction##2##3##(2008-10#1)(2008-8#1)
in the extra##2##3##(1991-5#1)(2008-1#1)
in the extracellular concentrations of acetylcholine in neostriatum##2##8##(1994-8#2)
in the extracellular domain of the##2##6##(1991-5#1)(1992-12#1)
in the extracellular domain##4##4##(1991-5#1)(1992-12#2)(1992-9#1)
in the extracellular environment and##2##5##(1991-9#1)(2008-4#1)
in the extracellular environment##4##4##(1991-9#1)(2008-4#1)(2010-10#1)(2012-1#1)
in the extracellular fluid##2##4##(2007-8#1)(2008-8#1)
in the extracellular matrix##7##4##(1991-9#1)(1993-9#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-5#1)(2011-1#1)
in the extracellular medium##3##4##(1990-2#1)(1991-2#1)(2008-4#1)
in the extracellular space##4##4##(1992-11#1)(1994-8#1)(2007-10#1)(2008-7#1)
in the extracellular##34##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-5#1)(1992-9#1)(1993-9#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#1)(1997-9#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-1#1)(2012-1#1)
in the extracorporeal circuit##2##4##(1992-1#1)(2008-10#1)
in the extracorporeal##3##3##(1991-11#1)(1992-1#1)(2008-10#1)
in the extract of##2##4##(1992-3#1)(2008-5#1)
in the extract##9##3##(1992-3#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-5#1)
in the extraction of##3##4##(2008-10#2)(2012-1#1)
in the extraction process##3##4##(2008-10#3)
in the extraction solution##2##4##(2008-10#2)
in the extraction time of IPB relative to##2##8##(2008-10#2)
in the extraction time of##3##5##(2008-10#3)
in the extraction vessel##2##4##(2008-10#2)
in the extraction##23##3##(2008-10#22)(2012-1#1)
in the extracts by##2##4##(2008-10#2)
in the extracts from##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
in the extracts of##3##4##(1990-2#1)(2008-10#2)
in the extracts were##2##4##(2008-10#2)
in the extracts##17##3##(1990-2#1)(1996-5#1)(2008-10#12)(2008-5#1)(2012-2#1)(2013-8#1)
in the extreme ultraviolet##8##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
in the extreme##12##3##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2012-3#1)
in the extreme-UV spectral region##2##5##(2008-2#1)(2008-3#1)
in the extreme-UV##3##3##(2008-2#1)(2008-3#2)
in the extreme-ultraviolet##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
in the extremely##2##3##(1995-6#1)(2008-11#1)
in the extremes of the##2##5##(2008-5#1)(2012-3#1)
in the extremities and##2##4##(2008-6#1)(2010-6#1)
in the extremities##4##3##(1990-12#1)(2008-6#1)(2009-3#1)(2010-6#1)
in the extremity##3##3##(1990-12#1)(2013-1#2)
in the eye of the##3##5##(1994-2#1)(2009-7#1)(2011-2#1)
in the eye##15##3##(1994-2#2)(2007-12#2)(2008-12#1)(2008-9#2)(2009-7#1)(2010-1#2)(2011-2#2)(2012-12#2)(2013-8#1)
in the eye-safe##2##3##(2007-11#1)(2008-3#1)
in the eyes of##5##4##(1994-3#1)(2008-6#1)(2010-8#1)(2012-1#1)(2013-1#1)
in the eyestalk##2##3##(2007-12#1)(2008-5#1)
in the fabrication of##11##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-7#1)
in the fabrication process##2##4##(2008-2#1)(2008-3#1)
in the fabrication##14##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-7#1)
in the face of limited resources##2##6##(1997-2#1)(2012-12#1)
in the face of##24##4##(1993-1#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-12#2)
in the face##27##3##(1993-1#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-12#2)
in the fact that##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)
in the factor##2##3##(1990-5#1)(2008-12#1)
in the faeces of##3##4##(1993-2#1)(2008-11#1)(2008-5#1)
in the failure of##2##4##(2008-11#2)
in the failure##3##3##(2008-11#2)(2013-8#1)
in the fall issue of Radiology Management##2##7##(1991-2#1)(1995-2#1)
in the fall issue##3##4##(1991-2#1)(1994-2#1)(1995-2#1)
in the fall of 1994##2##5##(2008-10#2)
in the fall of##5##4##(1996-1#1)(2008-10#4)
in the fall##12##3##(1991-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-8#1)
in the fallopian##2##3##(1994-7#1)(2008-7#1)
in the familial##2##3##(1990-3#1)(2007-10#1)
in the families##3##3##(1994-2#1)(2007-12#1)(2008-10#1)
in the family Cucurbitaceae##3##4##(2008-10#3)
in the family Thermoanaerobacteraceae##2##4##(2011-2#2)
in the family and##3##4##(2008-10#1)(2008-12#1)(2009-12#1)
in the family##37##3##(1990-11#1)(1991-6#1)(1992-3#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#2)(2011-2#11)(2012-3#2)
in the fan-beam##2##3##(2008-3#1)(2009-5#1)
in the far field are##2##5##(2007-11#1)(2008-3#1)
in the far field of a##3##6##(2007-11#2)(2007-12#1)
in the far field of##4##5##(2007-11#2)(2007-12#1)(2008-2#1)
in the far field##12##4##(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#3)
in the far##16##3##(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)
in the far-field##4##3##(2008-3#4)
in the far-infrared##2##3##(2007-12#1)(2008-3#1)
in the fast##4##3##(1996-5#1)(1997-2#1)(2008-10#1)(2011-1#1)
in the fasted state##3##4##(1991-3#2)(2008-3#1)
in the fasting##3##3##(1991-7#1)(2008-3#1)(2008-6#1)
in the fat##6##3##(1995-2#3)(1997-4#1)(2011-1#1)(2013-1#1)
in the fatty acid##2##4##(1996-3#1)(2010-4#1)
in the feces##4##3##(1990-6#1)(1991-12#1)(2007-10#1)(2009-4#1)
in the fed state##3##4##(1991-3#1)(1996-5#1)(2008-3#1)
in the fed-batch##2##3##(2008-11#2)
in the fee-for-service sector##2##4##(1993-1#1)(1993-3#1)
in the feed solution and##2##5##(2008-10#2)
in the feed solution##3##4##(2008-10#3)
in the feed##9##3##(1995-11#1)(1997-6#2)(2008-10#4)(2008-12#1)(2008-6#1)
in the feeder##2##3##(1997-3#2)
in the feeding##6##3##(1996-6#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#1)
in the female genital tract##2##5##(2009-2#1)(2011-2#1)
in the female genital##3##4##(2008-7#1)(2009-2#1)(2011-2#1)
in the female##20##3##(1990-6#1)(1991-11#1)(1992-12#1)(1992-3#4)(1995-6#1)(1995-8#1)(1996-12#2)(1997-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the females##8##3##(1993-12#1)(1994-2#1)(1995-3#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#1)
in the femoral neck##2##4##(2009-3#1)(2011-2#1)
in the femoral##5##3##(2009-3#2)(2011-2#3)
in the femtosecond regime##2##4##(2007-11#1)(2007-12#1)
in the femur##2##3##(2009-3#2)
in the femurs##2##3##(2007-11#1)(2013-1#1)
in the fermentation##4##3##(2008-10#1)(2008-6#2)(2008-7#1)
in the ferret##3##3##(2008-1#2)(2008-5#1)
in the fetal thymus##3##4##(2008-10#3)
in the fetal##14##3##(1992-6#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-5#3)(2008-1#1)(2008-10#5)(2013-1#1)
in the fetus##2##3##(2011-1#1)(2013-1#1)
in the fiber##18##3##(1991-12#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)(2008-6#1)
in the fibre##5##3##(2008-10#2)(2011-2#2)(2013-1#1)
in the fibrous matrix##2##4##(2008-11#2)
in the fibrous##4##3##(2008-11#3)(2008-5#1)
in the field and greenhouse##2##5##(2008-10#2)
in the field and provides##2##5##(2008-12#1)(2010-12#1)
in the field and##12##4##(2008-10#8)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
in the field are##2##4##(1992-3#1)(2008-4#1)
in the field at##2##4##(2008-10#2)
in the field by##2##4##(1995-12#1)(2008-3#1)
in the field experiments##2##4##(2008-10#1)(2008-9#1)
in the field for##4##4##(2008-10#2)(2008-8#1)(2011-2#1)
in the field have##2##4##(1997-4#1)(2009-10#1)
in the field in##6##4##(2008-10#5)(2008-5#1)
in the field is##2##4##(2008-10#2)
in the field of HIV##2##5##(1997-3#2)
in the field of Health Services Research in##2##8##(2012-2#2)
in the field of cancer##3##5##(2008-11#2)(2008-5#1)
in the field of dentistry##2##5##(2012-2#1)(2013-8#1)
in the field of environmental##2##5##(2008-10#2)
in the field of genomic##2##5##(2008-7#1)(2011-2#1)
in the field of health##2##5##(1992-3#1)(2011-2#1)
in the field of maxillofacial surgery##2##6##(2012-12#2)
in the field of medical##2##5##(2009-11#1)(2010-8#1)
in the field of mental health##2##6##(1992-1#1)(2013-8#1)
in the field of microbiology##4##5##(2008-10#2)(2008-9#2)
in the field of molecular biology##2##6##(2008-11#1)(2008-5#1)
in the field of oncology##2##5##(1991-8#1)(2010-5#1)
in the field of ophthalmology##2##5##(1995-9#1)(2011-7#1)
in the field of plant biotechnology##2##6##(2009-6#1)(2009-8#1)
in the field of##141##4##(1990-3#1)(1990-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-9#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#7)
in the field populations##2##4##(2008-10#2)
in the field ranged##2##4##(2008-9#1)(2012-8#1)
in the field since the##2##5##(2008-10#1)(2012-3#1)
in the field to##4##4##(1995-6#1)(2008-10#2)(2010-8#1)
in the field was##3##4##(2008-10#3)
in the field weekly##2##4##(2008-10#2)
in the field were##7##4##(2008-10#6)(2011-2#1)
in the field which##2##4##(2008-10#1)(2012-2#1)
in the field with##5##4##(2008-10#3)(2008-11#1)(2012-3#1)
in the field##350##3##(1990-3#1)(1990-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#4)(2007-7#1)(2007-8#1)(2008-10#148)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#15)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#5)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#4)(2012-8#1)(2013-1#4)(2013-8#7)
in the fields of##17##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
in the fields##19##3##(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
in the fifth##6##3##(1994-12#1)(1996-6#1)(2008-1#1)(2008-9#1)(2009-4#1)(2012-3#1)
in the fight against the##3##5##(1993-3#1)(2009-7#1)(2013-1#1)
in the fight against##12##4##(1993-12#1)(1993-3#1)(1995-1#1)(2008-3#1)(2009-2#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
in the figure##2##3##(1995-11#1)(2007-12#1)
in the figure-of-8 construct compared with 0##2##7##(2009-3#2)
in the figures##2##3##(2008-10#1)(2008-3#1)
in the film##9##3##(1997-2#2)(2008-10#3)(2008-2#2)(2008-3#1)(2010-4#1)
in the films##8##3##(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#1)(2013-1#1)
in the filters##2##3##(1992-5#1)(2008-10#1)
in the filtrate##5##3##(2008-10#5)
in the final analysis##3##4##(1992-3#1)(1997-6#1)(2008-4#1)
in the final model##2##4##(2008-10#1)(2009-7#1)
in the final product##2##4##(2008-10#1)(2008-3#1)
in the final solution##3##4##(2008-10#3)
in the final##43##3##(1990-5#1)(1992-3#1)(1992-6#1)(1995-1#2)(1997-3#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#3)
in the financial##2##3##(1997-1#1)(2010-5#1)
in the fine structure of##2##5##(1992-1#1)(2008-7#1)
in the fine structure##3##4##(1992-1#1)(2007-12#1)(2008-7#1)
in the fine##4##3##(1992-1#1)(1997-5#1)(2007-12#1)(2008-7#1)
in the fingerprint region##3##4##(2007-12#2)(2008-3#1)
in the finishing##2##3##(2010-2#1)(2010-7#1)
in the finite##3##3##(2008-3#1)(2010-11#1)(2013-1#1)
in the firing##4##3##(2007-8#1)(2008-10#1)(2008-11#2)
in the first 10##2##4##(2008-10#1)(2008-7#1)
in the first 2##3##4##(2007-8#1)(2008-7#2)
in the first 20##2##4##(1994-3#1)(2013-1#1)
in the first 24##3##4##(1991-10#1)(1992-5#1)(2008-7#1)
in the first 3 months of life##2##7##(2010-6#1)(2011-1#1)
in the first 3##4##4##(1991-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
in the first 30##2##4##(1991-8#1)(2008-7#1)
in the first 48##2##4##(1992-12#1)(2007-10#1)
in the first 5##2##4##(1993-12#1)(2008-3#1)
in the first 6 months after##2##6##(2011-2#1)(2013-8#1)
in the first 6 weeks##2##5##(2007-11#1)(2011-1#1)
in the first 6##4##4##(2007-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
in the first 7##2##4##(1994-5#1)(2010-4#1)
in the first and second##5##5##(1996-3#1)(1996-6#1)(2008-10#2)(2008-12#1)
in the first and##8##4##(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-9#1)
in the first branch##3##4##(2008-3#3)
in the first case and##2##5##(2008-5#1)(2010-12#1)
in the first case##6##4##(1993-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
in the first cell##2##4##(1990-11#1)(2008-11#1)
in the first dimension##3##4##(2008-10#1)(2008-4#2)
in the first exon of##2##5##(2009-5#1)(2012-1#1)
in the first exon##4##4##(1993-2#1)(1994-12#1)(2009-5#1)(2012-1#1)
in the first experiment##2##4##(2008-10#2)
in the first few days after##2##6##(1997-5#1)(2008-8#1)
in the first few hours after##2##6##(2008-11#1)(2008-6#1)
in the first few hours##3##5##(2008-11#1)(2008-6#1)(2011-2#1)
in the first few months of##2##6##(1996-9#1)(2012-2#1)
in the first few##11##4##(1996-9#2)(1997-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
in the first group (n =##2##6##(1991-5#1)(2012-3#1)
in the first group##9##4##(1990-2#1)(1991-5#1)(1994-12#1)(1997-3#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the first half of the twentieth century##2##8##(2009-7#1)(2010-1#1)
in the first half of the##5##6##(2008-11#1)(2008-12#1)(2009-7#1)(2010-1#2)
in the first half of##7##5##(1990-3#1)(1993-3#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-1#2)
in the first instance##3##4##(2012-3#1)(2013-1#2)
in the first intron of the##2##6##(1991-11#1)(1997-7#1)
in the first intron of##3##5##(1991-11#1)(1992-6#1)(1997-7#1)
in the first intron##8##4##(1991-11#1)(1991-6#1)(1992-6#1)(1993-2#2)(1994-12#1)(1997-7#1)(2012-3#1)
in the first month##3##4##(1996-8#2)(2007-7#1)
in the first period to##2##5##(2011-2#1)(2012-1#1)
in the first period##4##4##(1996-11#1)(2011-2#2)(2012-1#1)
in the first place##4##4##(2008-9#2)(2009-11#1)(2011-2#1)
in the first step of##2##5##(2008-12#1)(2011-2#1)
in the first study##2##4##(1994-3#1)(2012-3#1)
in the first ten##2##4##(1991-8#1)(2008-9#1)
in the first three##3##4##(2007-7#1)(2008-10#1)(2009-7#1)
in the first trimester of pregnancy##2##6##(1994-9#1)(1996-12#1)
in the first trimester of##3##5##(1990-6#1)(1994-9#1)(1996-12#1)
in the first trimester##6##4##(1990-6#1)(1993-3#2)(1994-9#1)(1996-12#1)(2011-1#1)
in the first two decades of life##2##7##(2008-8#2)
in the first two years##3##5##(2008-1#1)(2011-2#1)(2012-2#1)
in the first two##11##4##(1994-2#2)(1996-3#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
in the first upper true leaves at 14 dpi##2##9##(2008-10#2)
in the first upper##3##4##(2008-10#2)(2008-8#1)
in the first week of##2##5##(1997-6#1)(2007-11#1)
in the first week##3##4##(1990-12#1)(1997-6#1)(2007-11#1)
in the first year after##2##5##(2007-8#1)(2009-5#1)
in the first year of life##3##6##(2008-1#1)(2008-7#1)(2013-1#1)
in the first year of the##3##6##(1991-2#1)(1991-3#1)(2008-10#1)
in the first year of##7##5##(1991-2#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
in the first year##15##4##(1991-2#2)(1991-3#1)(1992-6#1)(1993-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
in the first years##2##4##(2007-8#1)(2013-1#1)
in the first##236##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#3)(2007-8#8)(2008-1#4)(2008-10#25)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#12)(2008-8#7)(2008-9#5)(2009-10#2)(2009-11#2)(2009-5#2)(2009-7#3)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#3)(2012-2#2)(2012-3#4)(2013-1#14)(2013-8#2)
in the first-round PCR##2##4##(1997-4#1)(2008-10#1)
in the fish##3##3##(2008-10#1)(2011-2#2)
in the fission yeast Schizosaccharomyces pombe##3##6##(1995-8#1)(1995-9#1)(1997-3#1)
in the fitness##2##3##(2008-10#1)(2008-11#1)
in the fitting##2##3##(2008-2#1)(2008-9#1)
in the five##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
in the flame##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
in the flames##2##3##(2008-3#2)
in the flashbackers##2##3##(1996-7#2)
in the flat##2##3##(1991-2#1)(2008-3#1)
in the flexed left lateral##3##5##(1993-10#3)
in the flexor##3##3##(2007-8#2)(2010-5#1)
in the floral##4##3##(2008-10#1)(2008-8#3)
in the flow cell and##2##5##(2008-10#2)
in the flow cell##7##4##(2008-10#7)
in the flow injection system##3##5##(2008-10#3)
in the flow injection##4##4##(2008-10#4)
in the flow of##2##4##(2007-8#1)(2008-7#1)
in the flow system##15##4##(2008-10#14)(2008-2#1)
in the flow##37##3##(1991-9#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#28)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)
in the flow-injection##2##3##(2008-10#2)
in the flow-through##2##3##(2008-10#2)
in the flower hypanthium##2##4##(2008-10#2)
in the flowing##2##3##(2008-10#2)
in the fluid##4##3##(2008-10#1)(2008-2#1)(2008-7#2)
in the fluorescence intensity of the##2##6##(1995-6#1)(2008-10#1)
in the fluorescence intensity of##3##5##(1995-6#1)(2008-10#1)(2009-11#1)
in the fluorescence intensity##6##4##(1995-6#1)(2008-10#3)(2008-2#1)(2009-11#1)
in the fluorescence of##2##4##(2007-12#1)(2008-10#1)
in the fluorescence##15##3##(1995-6#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2009-11#1)
in the flux##2##3##(1994-8#1)(2008-11#1)
in the fly##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
in the foam phase##2##4##(2008-6#2)
in the foam##4##3##(1992-5#1)(2008-6#3)
in the focal plane of the##2##6##(2008-3#2)
in the focal plane of##3##5##(2008-3#3)
in the focal plane##7##4##(2008-2#2)(2008-3#5)
in the focal region of a##4##6##(2007-11#1)(2007-12#1)(2008-3#2)
in the focal region of the##2##6##(2008-3#2)
in the focal region of##6##5##(2007-11#1)(2007-12#1)(2008-3#4)
in the focal region##8##4##(2007-11#1)(2007-12#1)(2008-3#6)
in the focal##19##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#12)(2012-2#1)
in the focus of##3##4##(2008-3#3)
in the focus##4##3##(2008-10#1)(2008-3#3)
in the focused spot##2##4##(2008-2#2)
in the focused##4##3##(2007-12#1)(2008-2#3)
in the foetal livers##2##4##(1990-5#2)
in the foetal##3##3##(1990-5#3)
in the folding and maturation of##2##6##(2009-6#2)
in the folding of##3##4##(1992-6#2)(2007-11#1)
in the folding##7##3##(1992-3#1)(1992-6#2)(2007-11#1)(2008-4#1)(2009-6#2)
in the foliage##2##3##(2008-10#2)
in the follicle cells##2##4##(1991-5#1)(2008-7#1)
in the follicle##3##3##(1991-5#1)(2008-7#1)(2008-8#1)
in the follow-up of patients with##2##6##(1990-6#1)(1997-8#1)
in the follow-up of patients##3##5##(1990-6#1)(1990-9#1)(1997-8#1)
in the follow-up of##9##4##(1990-6#1)(1990-9#1)(1991-3#1)(1994-11#1)(1997-8#2)(2008-1#1)(2010-6#1)(2011-2#1)
in the follow-up period##2##4##(1991-6#2)
in the follow-up##17##3##(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#2)(1994-11#1)(1997-3#1)(1997-8#3)(2007-8#1)(2008-1#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
in the following order##14##4##(1992-9#1)(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#8)(2008-11#1)(2010-3#1)
in the following way##2##4##(1996-5#1)(2011-2#1)
in the following##55##3##(1992-9#1)(1993-11#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-1#4)
in the food and##2##4##(2008-11#1)(2008-9#1)
in the food chain##5##4##(1994-3#1)(2008-10#3)(2011-2#1)
in the food industry##5##4##(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#2)
in the food##18##3##(1992-8#1)(1994-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-2#3)
in the foot and ankle##4##5##(2010-7#1)(2011-2#2)(2012-2#1)
in the foot##11##3##(1992-3#3)(2007-11#1)(2008-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
in the forearm##4##3##(1994-6#1)(2007-7#2)(2008-9#1)
in the forebrain##3##3##(1993-12#1)(1994-8#1)(1997-2#1)
in the foregut##2##3##(1991-8#1)(2008-10#1)
in the forensic##3##3##(2008-10#2)(2011-1#1)
in the foreseeable future##4##4##(2007-12#1)(2008-4#1)(2008-8#1)(2009-4#1)
in the forest##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
in the forests of this region##2##6##(1996-11#1)(2012-12#1)
in the forests##3##3##(1994-9#1)(1996-11#1)(2012-12#1)
in the form of a##30##5##(1991-12#1)(1995-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the form of acute##2##5##(1994-9#1)(2007-7#1)
in the form of an##6##5##(1994-5#1)(2008-10#3)(2010-5#2)
in the form of its##4##5##(1995-11#1)(2007-1#1)(2008-10#2)
in the form of the##3##5##(2007-11#1)(2008-10#1)(2008-12#1)
in the form of##142##4##(1990-12#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#4)(1996-12#2)(2007-1#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#37)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
in the form##147##3##(1990-12#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#4)(1996-12#3)(2007-1#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#37)(2008-11#8)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
in the formal##5##3##(1997-3#1)(2008-10#3)(2008-7#1)
in the formation of a##8##5##(1991-2#1)(1993-9#1)(1994-2#1)(2007-12#3)(2008-10#2)
in the formation of an##2##5##(1992-6#1)(2008-6#1)
in the formation of both##2##5##(1993-6#1)(2008-12#1)
in the formation of ion##2##5##(2008-10#1)(2008-9#1)
in the formation of oospores##2##5##(2008-10#2)
in the formation of the##12##5##(1990-11#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1996-5#2)(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#1)
in the formation of two##3##5##(1997-7#1)(2008-10#2)
in the formation of##80##4##(1990-11#2)(1990-12#3)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-6#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-2#1)(1996-2#1)(1996-5#5)(1997-2#1)(1997-7#2)(2007-12#3)(2007-5#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
in the formation##84##3##(1990-11#2)(1990-12#3)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-6#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-5#5)(1997-2#1)(1997-7#2)(2007-12#3)(2007-5#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
in the former group##2##4##(1993-8#1)(2008-7#1)
in the former##22##3##(1990-12#1)(1990-2#1)(1991-2#2)(1992-1#2)(1993-12#1)(1993-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#2)
in the forms of##2##4##(1991-3#1)(2013-1#1)
in the forms##3##3##(1991-3#1)(2008-10#1)(2013-1#1)
in the formula##2##3##(2008-2#1)(2008-5#1)
in the formulation of policies##2##5##(1996-1#1)(2007-7#1)
in the formulation of##11##4##(1990-8#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-1#1)
in the formulation##15##3##(1990-8#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-7#1)(2012-1#1)
in the formulations##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
in the forward direction##2##4##(2008-10#1)(2008-2#1)
in the forward##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
in the four##15##3##(1995-6#1)(1996-5#1)(2006-6#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-4#1)(2011-2#1)(2013-8#1)
in the fourth period##2##4##(2011-2#2)
in the fourth ventricle##3##4##(2008-7#2)(2013-1#1)
in the fourth##15##3##(1992-11#1)(1994-2#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
in the fraction of##2##4##(2008-11#1)(2008-8#1)
in the fraction were##3##4##(2008-11#3)
in the fraction##8##3##(1997-7#1)(2008-10#2)(2008-11#4)(2008-8#1)
in the fractional Fourier domain##2##5##(2007-12#2)
in the fractional Fourier##3##4##(2007-12#2)(2008-2#1)
in the fractional##6##3##(1990-4#1)(2007-12#2)(2008-2#2)(2008-7#1)
in the fractions of##2##4##(1992-6#1)(2008-10#1)
in the fractions##5##3##(1992-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
in the fracture##2##3##(2007-8#1)(2008-8#1)
in the frame of a##3##5##(2008-10#1)(2008-3#1)(2012-2#1)
in the frame of##5##4##(2008-10#1)(2008-3#2)(2012-2#1)(2013-1#1)
in the framework of a##3##5##(1990-12#1)(2007-12#1)(2007-7#1)
in the framework of the##5##5##(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
in the framework of##11##4##(1990-12#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
in the free stream of##2##5##(2007-11#1)(2008-3#1)
in the free##16##3##(1990-12#1)(1990-8#1)(1993-11#1)(1994-8#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-6#1)(2008-7#1)
in the free-running mode##2##4##(2008-2#1)(2008-3#1)
in the free-running regime##3##4##(2008-2#1)(2008-3#2)
in the free-running##5##3##(2008-2#2)(2008-3#3)
in the frequencies of##3##4##(2008-10#3)
in the frequency and the##2##5##(2008-3#2)
in the frequency and##5##4##(2007-8#1)(2008-11#1)(2008-3#2)(2009-11#1)
in the frequency domain##10##4##(1995-11#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#3)(2008-8#1)
in the frequency of##25##4##(1990-5#1)(1990-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-9#4)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the frequency##43##3##(1990-5#1)(1990-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1995-11#1)(1996-12#1)(1996-6#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the fresh egg##2##4##(2012-12#2)
in the fresh##4##3##(2008-11#1)(2008-5#1)(2012-12#2)
in the freshwater##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
in the fringe visibility##2##4##(2008-2#2)
in the fringe##4##3##(2008-2#4)
in the frog##3##3##(1990-5#1)(2008-7#1)(2010-3#1)
in the front meniscus region##2##5##(2009-6#2)
in the front##4##3##(1995-6#1)(2008-10#1)(2009-6#2)
in the frontal and parietal##2##5##(1992-8#1)(2011-1#1)
in the frontal and##3##4##(1992-8#1)(1996-12#1)(2011-1#1)
in the frontal cortex and in the hippocampus##2##8##(1994-6#2)
in the frontal cortex and in the##3##7##(1994-6#3)
in the frontal cortex of##3##5##(1995-2#2)(1995-3#1)
in the frontal cortex##7##4##(1994-6#3)(1995-2#2)(1995-3#1)(1997-2#1)
in the frontal lobe##2##4##(2008-1#1)(2008-7#1)
in the frontal lobes##2##4##(2008-6#1)(2008-7#1)
in the frontal plane during##2##5##(2007-10#2)
in the frontal plane of##2##5##(2007-10#1)(2010-8#1)
in the frontal plane##5##4##(2007-10#4)(2010-8#1)
in the frontal##24##3##(1992-8#1)(1994-6#3)(1995-2#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(2007-10#4)(2008-1#1)(2008-6#2)(2008-7#3)(2010-8#1)(2011-1#1)(2012-2#1)
in the fruit fly Drosophila melanogaster##2##6##(1997-7#1)(2008-7#1)
in the fruit of##2##4##(2008-10#1)(2013-8#1)
in the fruit##5##3##(1997-7#1)(2008-10#2)(2008-7#1)(2013-8#1)
in the fully##2##3##(2012-2#2)
in the function of the##4##5##(1992-6#2)(2007-10#1)(2011-2#1)
in the function of##8##4##(1991-12#1)(1992-6#2)(1997-2#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
in the function##9##3##(1991-12#1)(1992-6#2)(1996-2#1)(1997-2#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
in the functional phloem##2##4##(2008-10#2)
in the functional##16##3##(1994-8#1)(1995-11#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2009-10#1)(2011-2#3)(2012-1#1)
in the functioning of the##2##5##(1992-1#1)(2008-7#1)
in the functioning of##4##4##(1992-1#1)(2008-7#1)(2012-12#1)(2013-8#1)
in the fundamental##3##3##(1995-12#1)(2008-3#2)
in the fungal genome##2##4##(2008-10#1)(2011-1#1)
in the fungal##6##3##(2008-10#3)(2008-11#1)(2009-8#1)(2011-1#1)
in the further development of a##2##6##(1997-8#1)(2010-12#1)
in the further##7##3##(1993-3#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
in the fusion of##2##4##(2007-11#1)(2008-6#1)
in the fusion##4##3##(2007-11#1)(2008-5#1)(2008-6#1)(2012-2#1)
in the future a##2##4##(2009-5#1)(2009-7#1)
in the future and##2##4##(2008-12#1)(2011-1#1)
in the future as##3##4##(2009-6#1)(2010-11#1)(2012-6#1)
in the future of##4##4##(1994-1#1)(1996-12#1)(1996-3#1)(2008-11#1)
in the future on##2##4##(1995-2#1)(2008-1#1)
in the future this##2##4##(2008-4#1)(2010-7#1)
in the future##114##3##(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#3)(1997-3#3)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#1)
in the gain medium##2##4##(2008-3#2)
in the gain##4##3##(1996-3#1)(2008-12#1)(2008-3#2)
in the gallbladder wall##4##4##(1997-8#3)(2013-8#1)
in the gallbladder##9##3##(1990-9#1)(1996-6#1)(1997-8#3)(2008-1#1)(2013-8#3)
in the gamma##3##3##(1993-12#1)(2007-5#1)(2012-2#1)
in the gap##2##3##(2008-10#1)(2008-3#1)
in the garden##2##3##(2007-1#1)(2008-7#1)
in the gas and##2##4##(2008-10#1)(2008-6#1)
in the gas phase##9##4##(1996-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)
in the gas##12##3##(1996-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#2)(2010-7#1)
in the gastric mucosa##4##4##(1990-3#1)(1994-2#1)(1997-7#1)(2013-8#1)
in the gastric##13##3##(1990-3#1)(1990-7#1)(1991-6#1)(1992-12#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#1)(2010-12#1)(2012-1#2)(2013-8#1)
in the gastrocnemius##3##3##(2013-1#3)
in the gastrointestinal tract and##2##5##(1994-5#1)(2012-1#1)
in the gastrointestinal tract of##3##5##(2013-1#3)
in the gastrointestinal tract##15##4##(1994-12#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#6)
in the gastrointestinal##18##3##(1992-6#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#6)
in the gel and##2##4##(2008-10#1)(2008-4#1)
in the gel phase##2##4##(2008-10#1)(2010-5#1)
in the gel shift assay##2##5##(1993-8#2)
in the gel##13##3##(1993-8#2)(1996-12#1)(2008-1#1)(2008-10#5)(2008-4#1)(2010-5#1)(2011-2#2)
in the gel-state bilayer##2##4##(1990-7#2)
in the gelatin##3##3##(1995-5#1)(2011-2#2)
in the gender##2##3##(2010-7#1)(2011-2#1)
in the gene encoding the##6##5##(1994-12#1)(1997-3#2)(2009-10#1)(2009-9#1)(2013-1#1)
in the gene encoding##9##4##(1993-12#1)(1994-11#1)(1994-12#1)(1997-3#3)(2009-10#1)(2009-9#1)(2013-1#1)
in the gene expression of##2##5##(1991-5#1)(2013-7#1)
in the gene expression profiles of##2##6##(2012-1#1)(2013-7#1)
in the gene expression profiles##3##5##(2008-10#1)(2012-1#1)(2013-7#1)
in the gene expression##6##4##(1991-5#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-7#2)
in the gene##31##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1996-2#1)(1997-3#3)(2008-10#1)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2013-1#1)(2013-7#2)
in the genera##3##3##(2008-10#3)
in the general adult##3##4##(1993-11#1)(2012-12#2)
in the general population as well as##2##7##(2009-10#1)(2011-2#1)
in the general population by##2##5##(2007-10#1)(2013-1#1)
in the general population is##3##5##(1992-11#1)(2007-12#1)(2011-1#1)
in the general population of##3##5##(2007-12#1)(2008-1#1)(2008-7#1)
in the general population##45##4##(1990-11#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-1#1)(1997-3#1)(2007-10#1)(2007-12#4)(2008-1#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#5)
in the general public##2##4##(2008-7#1)(2012-3#1)
in the general##66##3##(1990-11#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#4)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)
in the generalized Shwartzman reaction##3##5##(1996-12#3)
in the generalized##6##3##(1996-12#3)(2008-2#1)(2008-3#1)(2009-12#1)
in the generation and##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
in the generation of moral##2##5##(2008-11#2)
in the generation of##26##4##(1991-5#1)(1991-9#1)(1992-9#1)(1996-4#1)(2007-11#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-9#2)(2013-8#1)
in the generation##30##3##(1991-5#1)(1991-9#1)(1992-9#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-9#2)(2011-2#1)(2013-8#1)
in the generic pharmaceutical industry##2##5##(2008-10#2)
in the genes encoding the##2##5##(1994-11#1)(2008-3#1)
in the genes encoding##4##4##(1994-11#1)(2008-1#1)(2008-3#1)(2008-4#1)
in the genes##9##3##(1994-11#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
in the genesis of many##2##5##(1991-4#1)(2008-10#1)
in the genesis of##9##4##(1991-12#1)(1991-4#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
in the genetic analysis of schizophrenia##2##6##(2010-1#2)
in the genetic analysis of##3##5##(1990-3#1)(2010-1#2)
in the genetic background of##3##5##(2008-10#2)(2009-10#1)
in the genetic code##2##4##(2012-2#2)
in the genetic##17##3##(1990-3#1)(1994-6#1)(1996-12#1)(1997-4#1)(1997-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-1#2)(2012-2#2)(2012-3#1)
in the genetically##2##3##(1991-12#1)(2013-7#1)
in the genetics of##2##4##(2008-8#1)(2012-3#1)
in the genital tract##2##4##(2007-12#1)(2011-2#1)
in the genital##3##3##(1996-12#1)(2007-12#1)(2011-2#1)
in the genome and##4##4##(1990-5#1)(2010-3#1)(2012-3#1)(2013-8#1)
in the genome of a##2##5##(2008-7#1)(2009-5#1)
in the genome of the##3##5##(1990-5#1)(1996-12#1)(2010-8#1)
in the genome of transgenic##2##5##(2008-8#1)(2008-9#1)
in the genome of##12##4##(1990-5#1)(1993-11#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-8#1)
in the genome that##2##4##(2008-9#1)(2009-6#1)
in the genome##34##3##(1990-5#2)(1992-11#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-6#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
in the genomes of fungal pathogens##2##6##(2009-6#2)
in the genomes of##4##4##(2008-10#2)(2009-6#2)
in the genomic DNA##4##4##(1992-6#1)(1993-8#1)(1994-12#1)(2010-7#1)
in the genomic region##2##4##(1997-2#2)
in the genomic##7##3##(1992-6#1)(1993-8#1)(1994-12#1)(1997-2#2)(2008-8#1)(2010-7#1)
in the genomics##3##3##(2008-2#1)(2008-4#1)(2011-2#1)
in the genus Solanum##3##4##(2008-10#3)
in the genus Tospovirus##3##4##(2008-10#3)
in the genus Trichoderma##2##4##(2008-10#2)
in the genus##29##3##(2008-10#20)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#2)(2011-2#2)(2013-1#1)
in the geographic populations and##2##5##(2008-10#2)
in the geographic populations##3##4##(2008-10#3)
in the geographic##5##3##(1997-3#1)(2008-10#4)
in the geometry of##2##4##(2008-11#1)(2008-2#1)
in the geriatric population##2##4##(1993-5#1)(2009-8#1)
in the geriatric##8##3##(1990-5#3)(1990-9#1)(1992-1#1)(1993-5#1)(2009-8#1)(2011-2#1)
in the germ line##3##4##(1995-2#2)(2009-3#1)
in the germ##4##3##(1995-2#2)(2008-10#1)(2009-3#1)
in the germline of##4##4##(1995-8#4)
in the germline##6##3##(1995-8#4)(2010-5#1)(2013-8#1)
in the giant grouper##2##4##(2010-5#2)
in the giant##3##3##(2008-8#1)(2010-5#2)
in the gill##3##3##(2008-7#3)
in the gills and##2##4##(2008-10#1)(2008-12#1)
in the gills##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
in the given##2##3##(2008-3#1)(2013-8#1)
in the gland##2##3##(1991-9#1)(2013-1#1)
in the glandular epithelium##2##4##(1995-6#1)(2007-12#1)
in the glandular##3##3##(1995-6#1)(2007-12#1)(2008-7#1)
in the glare##2##3##(2007-11#1)(2008-3#1)
in the glass##6##3##(2007-12#3)(2008-10#1)(2008-3#1)(2012-2#1)
in the glial##2##3##(2008-7#2)
in the global sense##2##4##(2008-2#1)(2009-5#1)
in the global##9##3##(1990-11#1)(1995-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2013-1#1)
in the globin##3##3##(1990-8#2)(2008-9#1)
in the globular domain##2##4##(1997-4#2)
in the globular##3##3##(1997-4#2)(2009-12#1)
in the glomerular##2##3##(2007-7#1)(2011-2#1)
in the glucose##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
in the glutamate##2##3##(2008-2#1)(2008-7#1)
in the gluteal region##2##4##(2009-9#1)(2011-2#1)
in the glycolytic pathway##2##4##(2008-11#1)(2008-7#1)
in the goldfish##6##3##(1991-2#5)(2011-2#1)
in the gradual##2##3##(2009-1#1)(2011-2#1)
in the graduate##2##3##(1995-1#1)(2008-11#1)
in the grafts##2##3##(2011-2#1)(2012-2#1)
in the grain##2##3##(1990-6#1)(2008-10#1)
in the granular##2##3##(1992-11#1)(1993-12#1)
in the granule neurons##2##4##(1995-8#2)
in the granule##4##3##(1992-6#1)(1995-12#1)(1995-8#2)
in the granulosa cells of##2##5##(2008-5#2)
in the granulosa cells##5##4##(2008-12#1)(2008-5#3)(2008-8#1)
in the granulosa layer of the##2##6##(2008-12#2)
in the granulosa##8##3##(2008-12#3)(2008-5#3)(2008-8#1)(2008-9#1)
in the graphite tube##4##4##(2008-10#4)
in the graphite##6##3##(2008-10#6)
in the great##4##3##(1997-6#2)(2011-2#1)(2012-1#1)
in the greater Milan area##2##5##(1990-12#1)(1990-8#1)
in the greater##3##3##(1990-12#1)(1990-8#1)(2007-12#1)
in the green##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
in the greenhouse and at##2##5##(2008-10#2)
in the greenhouse and in##3##5##(2008-10#3)
in the greenhouse and##9##4##(2008-10#9)
in the greenhouse for resistance to##2##6##(2008-10#2)
in the greenhouse for##4##4##(2008-10#4)
in the greenhouse in##2##4##(2008-10#1)(2011-2#1)
in the greenhouse or##2##4##(2008-10#2)
in the greenhouse##54##3##(2008-10#52)(2011-2#2)
in the groin area##2##4##(2008-7#2)
in the ground squirrel##3##4##(1990-5#1)(2008-8#2)
in the ground state##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
in the ground##11##3##(1990-5#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-8#3)(2013-1#1)
in the group TD##2##4##(2007-7#2)
in the group of patients with##2##6##(1990-10#1)(2011-1#1)
in the group of patients##5##5##(1990-10#1)(1992-8#1)(2011-1#1)(2011-2#2)
in the group of subjects with PD##3##7##(2008-7#3)
in the group of##22##4##(1990-10#1)(1990-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the group practice##3##4##(1991-1#1)(1994-3#2)
in the group treated with##6##5##(1991-2#1)(1993-2#1)(1993-9#1)(2007-11#1)(2008-8#1)(2013-1#1)
in the group treated##7##4##(1991-2#1)(1993-2#1)(1993-9#1)(2007-11#2)(2008-8#1)(2013-1#1)
in the group who##2##4##(1991-6#1)(1997-3#1)
in the group with##13##4##(1990-10#1)(1990-8#1)(1992-5#1)(1994-12#1)(1995-8#1)(1997-5#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
in the group without bone metastasis##2##6##(1994-12#2)
in the group without##5##4##(1992-5#1)(1994-12#2)(1994-7#1)(2008-3#1)
in the group##75##3##(1990-10#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-7#1)(1995-8#1)(1997-3#1)(1997-5#1)(2007-11#6)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#7)(2008-8#4)(2008-9#5)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
in the groups##3##3##(1993-6#1)(2008-6#1)(2011-1#1)
in the growing season##5##4##(2008-10#4)(2009-2#1)
in the growing##7##3##(1995-2#1)(2008-10#4)(2008-7#1)(2009-2#1)
in the growth and##5##4##(1993-5#1)(1993-9#1)(2008-4#1)(2009-6#1)(2013-8#1)
in the growth factor##2##4##(1990-8#1)(1997-4#1)
in the growth media##2##4##(2008-10#1)(2008-6#1)
in the growth medium##6##4##(1991-10#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-6#1)
in the growth of these##2##5##(1993-9#1)(1996-3#1)
in the growth of##10##4##(1992-3#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)
in the growth potential##2##4##(1990-3#1)(1991-12#1)
in the growth rate of##2##5##(2008-9#1)(2012-2#1)
in the growth rate##3##4##(2008-9#1)(2009-6#1)(2012-2#1)
in the growth rates of##2##5##(2008-11#2)
in the growth##41##3##(1990-11#1)(1990-3#2)(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-5#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-4#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-6#2)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
in the guided##2##3##(1990-9#1)(2008-3#1)
in the guidelines##4##3##(1990-6#1)(2009-6#1)(2010-9#1)(2013-1#1)
in the guiding##2##3##(2007-11#1)(2007-12#1)
in the guinea pig##4##4##(1990-9#1)(1992-3#1)(2008-10#1)(2008-7#1)
in the guinea##5##3##(1990-9#1)(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
in the gut of##2##4##(1993-8#1)(2008-10#1)
in the gut##12##3##(1992-6#1)(1993-6#1)(1993-8#1)(1995-6#1)(2008-10#4)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
in the hP2Y(1) receptor##2##4##(2008-4#2)
in the habitat##3##3##(2008-5#1)(2008-8#2)
in the haemolymph##2##3##(1991-5#2)
in the hair##6##3##(2008-5#5)(2008-8#1)
in the hairy##2##3##(1990-7#1)(1994-11#1)
in the hamster##4##3##(1990-7#1)(1995-12#1)(2008-9#2)
in the hand##4##3##(1992-6#1)(2008-12#1)(2008-9#1)(2012-2#1)
in the hands of##4##4##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
in the head and hemolymph##2##5##(1995-11#2)
in the head and neck region##7##6##(1992-5#1)(1992-9#1)(1997-6#1)(2007-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the head and neck##10##5##(1992-5#1)(1992-9#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
in the head and##12##4##(1992-5#1)(1992-9#1)(1995-11#2)(1995-8#1)(1997-6#1)(2007-12#1)(2008-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
in the head of the##4##5##(1991-3#1)(1995-11#1)(2007-12#1)(2013-1#1)
in the head of##5##4##(1991-3#1)(1995-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
in the head region##2##4##(1992-6#1)(2008-5#1)
in the head##28##3##(1990-5#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-11#4)(1995-3#1)(1995-8#1)(1997-6#1)(2007-12#5)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
in the headspace##5##3##(2008-10#4)(2008-11#1)
in the healing##4##3##(2008-1#2)(2008-9#1)(2011-2#1)
in the health administration curriculum##3##5##(1992-3#1)(1995-12#1)(1996-2#1)
in the health care environment##4##5##(1991-3#1)(1993-3#1)(1995-1#2)
in the health care field##5##5##(1993-12#1)(1994-2#2)(1995-2#1)(1996-2#1)
in the health care industry##7##5##(1992-3#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-11#1)
in the health care marketplace##2##5##(1996-3#1)(1997-2#1)
in the health care of older##2##6##(1995-3#1)(2010-8#1)
in the health care sector##4##5##(1992-1#1)(1994-2#1)(1996-2#1)(2010-7#1)
in the health care system and the##2##7##(1993-11#1)(1994-2#1)
in the health care system##14##5##(1991-2#1)(1991-3#2)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in the health care##50##4##(1991-2#1)(1991-3#3)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#4)(1994-3#3)(1995-1#2)(1995-2#3)(1995-3#2)(1996-2#5)(1996-3#2)(1997-2#2)(1997-3#2)(2008-1#1)(2008-11#4)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
in the health field##2##4##(1991-2#1)(2008-12#1)
in the health maintenance organization (HMO)##2##6##(1995-1#1)(1995-12#1)
in the health of##4##4##(1990-6#1)(1992-5#1)(2008-5#1)(2013-1#1)
in the health sciences##2##4##(2008-11#1)(2008-12#1)
in the health sector##3##4##(1995-3#1)(2011-2#1)(2012-3#1)
in the health services##3##4##(1991-6#1)(1992-12#1)(2011-2#1)
in the health system##3##4##(1993-12#1)(1994-3#1)(2013-1#1)
in the health##81##3##(1990-12#3)(1990-6#1)(1991-2#2)(1991-3#3)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#4)(1994-3#4)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#3)(1996-2#6)(1996-3#3)(1997-2#2)(1997-3#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)
in the health-care##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
in the healthcare environment##4##4##(1993-12#1)(2008-3#3)
in the healthcare industry##5##4##(1991-2#1)(1994-2#1)(1995-2#1)(2007-12#1)(2009-8#1)
in the healthcare setting##5##4##(1996-12#1)(1996-2#2)(2011-1#1)(2011-2#1)
in the healthcare system and##2##5##(1991-3#1)(2011-2#1)
in the healthcare system##4##4##(1991-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
in the healthcare##25##3##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-2#2)(1995-2#2)(1996-12#1)(1996-2#2)(2007-12#2)(2008-12#1)(2008-3#3)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
in the healthy population##3##4##(2008-1#3)
in the healthy##9##3##(1997-8#1)(2008-1#3)(2008-7#1)(2009-7#1)(2012-3#1)(2013-7#2)
in the heart and gastrocnemius##3##5##(2013-1#3)
in the heart and skeletal muscle##2##6##(2012-3#1)(2013-1#1)
in the heart and##7##4##(1991-5#1)(2012-3#1)(2013-1#5)
in the heart from vertebrate ectotherms##2##6##(1993-11#2)
in the heart of##3##4##(1993-11#1)(2008-9#1)(2013-1#1)
in the heart##31##3##(1990-12#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#3)(1994-3#1)(1994-9#1)(1996-12#1)(1996-9#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#9)
in the heat##4##3##(1994-11#1)(2008-3#1)(2013-8#2)
in the heavy##2##3##(2008-6#1)(2012-2#1)
in the height##3##3##(2008-3#3)
in the hemodialysis##3##3##(2007-7#1)(2008-1#2)
in the hemoglobin##2##3##(1997-2#1)(2012-12#1)
in the hemolymph after##2##4##(2008-10#2)
in the hemolymph and##2##4##(2008-10#1)(2008-6#1)
in the hemolymph of##2##4##(2008-10#2)
in the hemolymph##9##3##(2008-10#6)(2008-6#2)(2012-2#1)
in the hepatic##5##3##(1995-3#1)(1996-12#1)(2008-5#1)(2008-8#2)
in the hepatocyte##6##3##(1992-3#1)(2008-11#4)(2008-7#1)
in the hepatoma##2##3##(1992-3#1)(1992-8#1)
in the hepatopancreas##3##3##(2008-6#2)(2008-7#1)
in the hermaphrodite##2##3##(2007-12#2)
in the heterogeneous##2##3##(1996-6#1)(2008-10#1)
in the heterologous host##2##4##(1990-5#1)(1994-12#1)
in the heterologous##3##3##(1990-5#1)(1991-9#1)(1994-12#1)
in the hibernating##2##3##(2008-7#1)(2008-8#1)
in the hidden layer and the##3##6##(2008-10#1)(2010-8#2)
in the hidden layer and##4##5##(2008-10#1)(2010-8#3)
in the hidden layer##6##4##(2008-10#3)(2010-8#3)
in the hidden##12##3##(2008-1#1)(2008-10#8)(2010-8#3)
in the high elevations##2##4##(2008-10#2)
in the high risk group##2##5##(1994-11#1)(2009-8#1)
in the high salt##2##4##(1995-6#2)
in the high##24##3##(1992-3#1)(1993-8#1)(1994-11#1)(1995-6#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the high-risk##2##3##(2007-8#1)(2009-8#1)
in the higher##9##3##(1990-5#1)(1991-9#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2010-9#1)
in the highest##11##3##(1992-10#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2012-12#1)(2013-1#1)
in the highlands of##3##4##(1991-3#1)(2008-10#1)(2008-5#1)
in the highly metastatic##2##4##(1997-7#1)(2008-9#1)
in the highly susceptible##2##4##(1995-2#1)(2008-10#1)
in the highly##10##3##(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
in the hind##2##3##(1995-2#1)(2007-12#1)
in the hindgut epithelium##3##4##(2008-10#3)
in the hindgut##4##3##(2008-10#4)
in the hinge region##2##4##(1995-11#1)(1995-6#1)
in the hip joint##3##4##(2007-11#1)(2007-8#2)
in the hip##6##3##(1993-11#1)(2007-11#1)(2007-8#3)(2009-3#1)
in the hippocampal CA1 region##2##5##(1990-5#1)(1992-12#1)
in the hippocampal CA1##6##4##(1990-5#1)(1991-10#1)(1992-12#1)(2008-11#2)(2009-12#1)
in the hippocampal formation##4##4##(1995-12#1)(1996-2#1)(1997-6#2)
in the hippocampal##18##3##(1990-5#2)(1991-10#1)(1992-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-6#3)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)
in the hippocampi##2##3##(1995-12#2)
in the hippocampus CA1##2##4##(1990-7#2)
in the hippocampus and in##2##5##(1997-2#1)(2011-2#1)
in the hippocampus and##7##4##(1991-12#1)(1996-11#1)(1997-2#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
in the hippocampus of amygdala-kindled##2##5##(1996-12#2)
in the hippocampus of the##3##5##(1990-7#1)(1992-10#1)(1995-12#1)
in the hippocampus of##11##4##(1990-7#1)(1992-10#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-12#1)(1995-5#2)(1996-12#2)(2008-11#1)
in the hippocampus##65##3##(1990-7#4)(1991-10#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#4)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-12#4)(1995-5#3)(1996-11#1)(1996-12#6)(1997-2#3)(2007-8#1)(2008-10#2)(2008-11#7)(2008-7#6)(2009-3#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
in the histologic##2##3##(1990-3#1)(1995-4#1)
in the histological##2##3##(1994-9#1)(2008-2#1)
in the historical##3##3##(2008-5#1)(2010-8#1)(2011-2#1)
in the history of medicine##2##5##(1993-6#1)(2008-9#1)
in the history of the##2##5##(1990-11#1)(2008-10#1)
in the history of##11##4##(1990-11#1)(1993-6#1)(1995-1#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)
in the history##12##3##(1990-11#1)(1993-6#1)(1995-1#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)
in the holoenzyme##2##3##(1990-8#1)(1995-2#1)
in the holographic##2##3##(2008-2#1)(2008-3#1)
in the home and##2##4##(1991-1#1)(2007-12#1)
in the home setting##3##4##(2009-10#1)(2009-11#1)(2012-2#1)
in the home##19##3##(1991-1#2)(1991-12#1)(1991-8#2)(1994-2#1)(1995-2#1)(1995-8#1)(2007-10#1)(2007-12#3)(2009-10#1)(2009-11#1)(2011-2#3)(2012-2#2)
in the homeostasis of##2##4##(1994-12#1)(1995-12#1)
in the homes of##2##4##(1995-6#1)(2013-1#1)
in the homogeneous##2##3##(2008-2#1)(2008-3#1)
in the honey samples##2##4##(2008-10#2)
in the honey##3##3##(2008-10#2)(2008-5#1)
in the honeybee##3##3##(1994-8#2)(2008-8#1)
in the hope of##4##4##(1996-3#1)(2008-6#1)(2009-6#1)(2013-8#1)
in the hope that##2##4##(1992-12#1)(2008-11#1)
in the hope##6##3##(1992-12#1)(1996-3#1)(2008-11#1)(2008-6#1)(2009-6#1)(2013-8#1)
in the horizontal direction##3##4##(1996-5#1)(2008-3#2)
in the horizontal plane##8##4##(2007-11#2)(2008-3#3)(2008-9#1)(2012-2#2)
in the horizontal##14##3##(1996-5#1)(2007-11#2)(2008-3#6)(2008-9#1)(2009-7#1)(2012-2#2)(2013-8#1)
in the hormonal##3##3##(1990-2#1)(2008-3#1)(2010-7#1)
in the hospital and##3##4##(1992-2#1)(1995-2#1)(2008-3#1)
in the hospital environment##2##4##(2010-11#1)(2013-8#1)
in the hospital industry##3##4##(1994-12#1)(1995-12#1)(2008-11#1)
in the hospital sector##3##4##(1992-12#1)(1995-2#1)(1997-2#1)
in the hospital setting##4##4##(1991-1#1)(1991-12#1)(2008-11#1)(2008-3#1)
in the hospital##53##3##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#5)(2012-2#1)(2013-8#1)
in the host cells##2##4##(1994-3#1)(1994-6#1)
in the host plant##4##4##(2008-10#4)
in the host##38##3##(1990-2#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-6#2)(1997-4#1)(2008-10#19)(2008-12#1)(2008-4#2)(2008-9#1)(2009-2#1)(2010-10#3)(2011-2#3)(2013-8#1)
in the hours##2##3##(1992-8#1)(2013-8#1)
in the house##2##3##(2009-10#1)(2011-2#1)
in the household and##2##4##(1991-12#1)(1997-4#1)
in the household##5##3##(1991-12#1)(1997-4#1)(2008-11#1)(2012-2#1)(2013-8#1)
in the hprt gene##2##4##(1996-2#1)(1997-3#1)
in the human and##2##4##(2008-7#1)(2010-2#1)
in the human body and##2##5##(1991-9#1)(2013-1#1)
in the human body are##2##5##(2007-7#1)(2008-10#1)
in the human body##10##4##(1991-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
in the human brain##8##4##(1992-6#1)(1993-5#1)(1996-5#3)(1997-2#1)(2008-11#1)(2008-7#1)
in the human diet##4##4##(1992-8#1)(1993-11#1)(2008-10#1)(2011-2#1)
in the human eye##4##4##(2007-11#1)(2007-12#2)(2013-8#1)
in the human genome and##2##5##(1992-3#1)(2008-7#1)
in the human genome##15##4##(1990-12#1)(1991-6#2)(1992-3#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)
in the human knee##2##4##(2009-7#2)
in the human liver##2##4##(1993-3#1)(1994-6#1)
in the human lung##2##4##(1992-9#1)(1994-9#1)
in the human population##3##4##(2011-3#1)(2013-1#1)(2013-7#1)
in the human prefrontal cortex##2##5##(1994-8#2)
in the human retina##2##4##(1990-7#1)(2007-11#1)
in the human serum##2##4##(2008-10#2)
in the human services##2##4##(1992-1#1)(2008-11#1)
in the human skin##2##4##(2008-5#2)
in the human##127##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#5)(1997-1#1)(1997-2#1)(1997-5#1)(1997-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#9)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
in the humid##2##3##(2008-10#1)(2008-9#1)
in the hybrid##5##3##(1997-4#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
in the hybridization##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
in the hybrids##3##3##(1992-9#1)(2008-5#1)(2009-10#1)
in the hydraulic##2##3##(2008-10#1)(2009-8#1)
in the hydrocarbon chains##2##4##(1993-11#1)(1996-8#1)
in the hydrolysis of##2##4##(1992-3#1)(2011-1#1)
in the hydrolysis##3##3##(1992-3#1)(2008-5#1)(2011-1#1)
in the hydrophobic core of a protein##2##7##(1997-2#2)
in the hydrophobic core of##3##5##(1994-5#1)(1997-2#2)
in the hydrophobic##5##3##(1991-11#1)(1992-8#1)(1994-5#1)(1997-2#2)
in the hydrous##2##3##(1990-12#1)(2008-10#1)
in the hypertensive##2##3##(2012-2#1)(2012-3#1)
in the hypothalamic homogenate of the##2##6##(1994-8#2)
in the hypothalamic paraventricular##3##4##(1993-12#1)(1996-12#2)
in the hypothalamic##8##3##(1993-12#2)(1993-5#1)(1994-8#2)(1995-5#1)(1996-12#2)
in the hypothalamus and##3##4##(1990-7#1)(1997-3#1)(2013-1#1)
in the hypothalamus of##3##4##(1992-12#1)(1993-12#1)(1995-12#1)
in the hypothalamus##16##3##(1990-7#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#4)(1996-12#1)(1997-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#2)
in the hypothermic##3##3##(1996-12#2)(2007-10#1)
in the ideal condition##2##4##(2007-11#1)(2013-8#1)
in the ideal##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
in the identification of new##2##5##(2008-7#1)(2011-2#1)
in the identification of the##8##5##(1990-2#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#2)
in the identification of unknown corpses##2##6##(1995-2#2)
in the identification of##36##4##(1990-2#1)(1990-8#1)(1995-11#1)(1995-2#2)(1997-1#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)
in the identification##39##3##(1990-2#1)(1990-8#1)(1991-2#1)(1995-11#1)(1995-2#2)(1997-1#1)(1997-2#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-8#1)
in the ileal##2##3##(1996-12#1)(2009-12#1)
in the ileum##2##3##(1993-6#1)(1994-12#1)
in the iliac##2##3##(2008-3#1)(2010-3#1)
in the illness##2##3##(2008-6#1)(2011-1#1)
in the image of the##2##5##(2008-3#1)(2009-10#1)
in the image plane and##2##5##(2007-12#1)(2008-2#1)
in the image plane##7##4##(2007-12#1)(2008-2#3)(2008-3#3)
in the image##22##3##(1995-12#1)(2007-12#1)(2008-2#5)(2008-3#11)(2008-6#1)(2009-10#1)(2011-2#2)
in the images##9##3##(2007-12#1)(2008-2#1)(2008-3#5)(2010-1#1)(2010-8#1)
in the imaginary##2##3##(2008-3#2)
in the imaging of##2##4##(2008-3#1)(2012-2#1)
in the imaging##12##3##(1997-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the immediate loading group and##2##6##(2013-1#2)
in the immediate loading group##3##5##(2013-1#3)
in the immediate post-operative period and##2##6##(2007-11#1)(2012-2#1)
in the immediate post-operative period##3##5##(2007-11#1)(2012-2#2)
in the immediate postoperative period##3##5##(2008-8#1)(2009-3#1)(2009-4#1)
in the immediate vicinity of the##5##6##(1990-3#1)(2008-3#2)(2008-7#1)(2008-9#1)
in the immediate vicinity of##8##5##(1990-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)
in the immediate##23##3##(1990-3#1)(1996-2#1)(1996-9#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2012-2#2)(2013-1#4)
in the immobilized##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
in the immune response##3##4##(1991-2#1)(2007-2#1)(2008-10#1)
in the immune system of##2##5##(2008-11#1)(2008-7#1)
in the immune system##12##4##(1994-11#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#3)(2008-7#3)(2010-12#1)(2011-2#1)
in the immune##20##3##(1991-2#1)(1993-12#1)(1994-11#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#3)(2010-12#1)(2011-2#2)(2013-1#1)
in the immunoassay##2##3##(2008-10#2)
in the immunocompetent##2##3##(2010-12#2)
in the immunocompromised##4##3##(2007-12#1)(2008-12#1)(2010-5#1)(2012-3#1)
in the immunoglobulin##2##3##(1997-9#1)(2011-2#1)
in the immunological response##2##4##(2007-11#1)(2009-12#1)
in the immunopathogenesis of##2##4##(2008-10#1)(2008-7#1)
in the immunoprecipitates##2##3##(1993-8#1)(1997-6#1)
in the immunoprecipitation##2##3##(1992-9#1)(1994-2#1)
in the impact of##2##4##(1993-12#1)(1997-7#1)
in the impact##3##3##(1993-12#1)(1997-5#1)(1997-7#1)
in the impairment of##4##4##(1995-11#1)(1995-12#1)(2008-10#1)(2008-7#1)
in the implantation##2##3##(2012-3#1)(2013-8#1)
in the implementation of the##4##5##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
in the implementation of##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
in the implementation##7##3##(1996-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
in the importance of##3##4##(1996-1#1)(2008-8#1)(2009-11#1)
in the important##2##3##(2008-4#1)(2011-4#1)
in the improvement of the##2##5##(2006-6#1)(2008-7#1)
in the improvement of##7##4##(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-7#1)
in the in situ##2##4##(2008-3#1)(2009-12#1)
in the in vitro##11##4##(1991-9#1)(1992-12#1)(1992-3#1)(1995-2#1)(1995-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-8#1)
in the in vivo##3##4##(1991-4#1)(1994-9#1)(1995-12#1)
in the in##16##3##(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#2)(2013-8#1)
in the in-plane##2##3##(2009-11#1)(2012-2#1)
in the inactivation of##3##4##(1993-8#1)(1994-12#1)(1996-2#1)
in the inactivation##4##3##(1991-9#1)(1993-8#1)(1994-12#1)(1996-2#1)
in the incidence of acute intra-dialytic symptoms with the use of vitamin E-modified##4##13##(2007-7#2)(2008-1#2)
in the incidence of acute##5##5##(1996-6#1)(2007-7#2)(2008-1#2)
in the incidence of adverse##2##5##(1997-7#1)(2010-6#1)
in the incidence of breast cancer##2##6##(2008-7#1)(2013-7#1)
in the incidence of the disease##2##6##(1991-4#1)(1992-9#1)
in the incidence of##37##4##(1990-6#1)(1991-11#1)(1991-4#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-6#2)(1997-3#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#5)(2008-7#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-2#3)(2013-1#2)(2013-7#1)
in the incidence##39##3##(1990-6#1)(1991-11#1)(1991-4#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-6#2)(1997-3#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#6)(2008-7#2)(2008-9#1)(2010-10#1)(2010-6#1)(2011-2#3)(2013-1#2)(2013-7#1)
in the incident##2##3##(2007-12#1)(2008-3#1)
in the included studies##2##4##(2008-10#1)(2010-11#1)
in the included##4##3##(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
in the inclusion##2##3##(2008-10#2)
in the inclusions##2##3##(1997-3#1)(2008-10#1)
in the incomplete##2##3##(2008-7#1)(2010-8#1)
in the incorporation of##4##4##(1993-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
in the increase in##2##4##(2008-7#1)(2010-12#1)
in the increase of##2##4##(1990-5#1)(1994-2#1)
in the increase##4##3##(1990-5#1)(1994-2#1)(2008-7#1)(2010-12#1)
in the increased##9##3##(1991-1#1)(1995-2#1)(1996-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
in the incubation media##4##4##(1992-12#1)(1994-2#2)(2008-10#1)
in the incubation medium##5##4##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)
in the incubation mixture##2##4##(1990-2#1)(1994-5#1)
in the incubation##16##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#2)(1994-2#2)(1994-5#1)(1995-11#1)(1995-8#1)(2008-10#2)
in the index of refraction##5##5##(2007-12#1)(2008-2#1)(2008-3#3)
in the index##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
in the indirect##2##3##(2011-2#1)(2012-2#1)
in the individual##9##3##(1990-12#1)(1991-12#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)
in the induced##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
in the induction of DNA##2##5##(1997-4#2)
in the induction of LTP##2##5##(1995-12#1)(2008-7#1)
in the induction of the##2##5##(1992-8#2)
in the induction of##29##4##(1990-5#1)(1991-12#1)(1991-5#1)(1992-8#2)(1992-9#1)(1994-9#3)(1995-12#1)(1995-5#1)(1997-4#2)(1997-6#1)(2008-10#7)(2008-11#3)(2008-7#2)(2008-8#1)(2012-12#1)(2012-3#1)
in the induction trial##2##4##(2012-2#2)
in the induction##33##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-8#2)(1992-9#1)(1994-9#3)(1995-12#1)(1995-5#1)(1997-4#2)(1997-6#1)(2008-10#8)(2008-11#3)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#3)(2012-3#1)
in the inductively coupled plasma##2##5##(2008-10#2)
in the industrial##3##3##(2008-10#2)(2010-6#1)
in the industrialized##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
in the industry##8##3##(1990-4#1)(1995-3#1)(1996-2#2)(2007-8#1)(2008-11#2)(2008-6#1)
in the infant##2##3##(2008-10#1)(2012-2#1)
in the infarct##2##3##(2007-10#1)(2008-10#1)
in the infected individuals##2##4##(2010-12#1)(2011-1#1)
in the infected seed of##2##5##(2008-10#2)
in the infected##14##3##(1995-2#1)(1997-1#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
in the infection process##2##4##(2008-10#2)
in the infection##4##3##(2008-10#4)
in the inferior vena cava##3##5##(2007-8#3)
in the inferior##5##3##(1992-12#1)(2007-8#4)
in the inferred##2##3##(2008-2#2)
in the infertile##2##3##(2008-12#1)(2011-1#1)
in the infinite##2##3##(1994-9#1)(2008-3#1)
in the inflammatory##8##3##(1990-7#1)(1995-12#1)(2006-10#1)(2008-5#1)(2009-12#1)(2011-1#1)(2013-1#2)
in the information##4##3##(1994-1#1)(1996-11#1)(2008-11#1)(2008-3#1)
in the infrared is##2##4##(2007-11#1)(2008-2#1)
in the infrared spectral range##2##5##(2008-2#1)(2008-3#1)
in the infrared##15##3##(1991-1#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#7)
in the inguinal area##2##4##(1995-5#1)(2009-9#1)
in the inherent##2##3##(1994-12#1)(1995-11#1)
in the inhibition of cell##2##5##(1995-2#1)(1997-7#1)
in the inhibition of the##2##5##(1990-2#1)(1990-8#1)
in the inhibition of##15##4##(1990-2#2)(1990-8#2)(1991-8#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2012-2#1)
in the inhibition##17##3##(1990-2#2)(1990-8#2)(1991-8#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
in the inhibition/switching condition##2##4##(2013-1#2)
in the inhibitor##2##3##(1991-3#2)
in the inhibitory effects of##2##5##(1995-11#1)(2013-1#1)
in the inhibitory##5##3##(1990-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(2013-1#1)
in the initial period of##2##5##(2007-8#2)
in the initial phase of##2##5##(2007-7#1)(2008-2#1)
in the initial phase##3##4##(1990-6#1)(2007-7#1)(2008-2#1)
in the initial solution##2##4##(2008-10#2)
in the initial stage##2##4##(1994-3#1)(2013-1#1)
in the initial stages of the##2##6##(2008-10#1)(2011-2#1)
in the initial stages of##4##5##(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
in the initial stages##5##4##(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
in the initial step of##2##5##(1991-9#1)(2009-2#1)
in the initial##42##3##(1990-6#2)(1991-6#1)(1991-9#2)(1992-6#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
in the initiation and progression of##2##6##(1994-5#1)(2011-2#1)
in the initiation and##4##4##(1994-5#1)(2008-4#1)(2011-1#1)(2011-2#1)
in the initiation of##10##4##(1991-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
in the initiation##16##3##(1991-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
in the injection##6##3##(1993-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
in the inner city##2##4##(1996-8#1)(2008-10#1)
in the inner cortex and stele tissues##2##7##(2008-10#2)
in the inner ear##3##4##(1995-5#2)(2008-4#1)
in the inner mitochondrial##2##4##(1990-11#1)(1994-5#1)
in the inner nuclear##2##4##(1991-10#1)(2008-9#1)
in the inner##21##3##(1990-11#2)(1990-12#1)(1991-10#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#2)(2010-5#1)(2010-8#1)
in the inoculated cotyledonary leaves but##2##6##(2008-10#2)
in the inoculated leaf##2##4##(2008-10#2)
in the inoculated##9##3##(2008-10#8)(2008-8#1)
in the inoculum##2##3##(2008-10#1)(2008-11#1)
in the inpatient##2##3##(1993-2#1)(2013-1#1)
in the input and the##2##5##(2008-3#2)
in the input layer##3##4##(2008-10#2)(2010-8#1)
in the input##16##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#4)(2008-6#2)(2008-9#1)(2010-8#1)
in the insect##7##3##(1992-6#1)(1995-11#1)(2008-10#4)(2008-11#1)
in the inserted##2##3##(1990-5#1)(1997-2#1)
in the institution##2##3##(1993-6#1)(2011-2#1)
in the institutional##2##3##(1994-2#1)(2008-9#1)
in the instrument##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
in the insulin receptor##2##4##(1991-12#1)(1994-12#1)
in the insulin##4##3##(1991-12#1)(1993-6#1)(1994-12#1)(2008-11#1)
in the insulin-deficient##2##3##(1993-12#2)
in the insurance##2##3##(1991-12#1)(2008-11#1)
in the intact cells to the corresponding##2##7##(1993-9#2)
in the intact male rat##2##5##(1994-2#2)
in the intact##18##3##(1990-7#1)(1991-2#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-9#2)(1994-2#2)(1994-8#1)(1996-2#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)
in the integral##2##3##(1993-11#1)(1994-6#1)
in the integrated##2##3##(2008-11#1)(2012-2#1)
in the integration of##3##4##(1997-2#1)(2008-10#1)(2008-11#1)
in the integrative##2##3##(1992-2#1)(2012-2#1)
in the intended##2##3##(2008-10#1)(2010-6#1)
in the intensity and##2##4##(2008-10#1)(2008-7#1)
in the intensity of light##2##5##(1990-8#1)(2008-3#1)
in the intensity of the##3##5##(2008-3#2)(2013-8#1)
in the intensity of##13##4##(1990-8#1)(1992-12#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-3#4)(2010-8#1)(2011-1#1)(2013-8#1)
in the intensity##21##3##(1990-8#1)(1992-12#1)(1994-6#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-7#1)(2010-8#1)(2011-1#1)(2013-8#1)
in the intensive care unit (ICU) is##3##7##(2010-11#2)(2011-2#1)
in the intensive care unit (ICU)##6##6##(2007-8#1)(2008-3#1)(2010-11#2)(2011-2#1)(2012-3#1)
in the intensive care unit##18##5##(1991-2#1)(2006-10#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-8#1)(2010-11#5)(2010-12#1)(2011-2#3)(2012-3#1)
in the intensive care units##2##5##(2008-4#1)(2013-1#1)
in the intensive care##22##4##(1991-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2010-11#5)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
in the intensive##23##3##(1991-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2010-11#5)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
in the inter-war##2##3##(2008-12#2)
in the interaction between the##2##5##(1995-12#1)(2008-10#1)
in the interaction between##5##4##(1995-12#1)(2007-12#1)(2008-10#2)(2008-9#1)
in the interaction of##8##4##(1991-1#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(2008-10#2)(2008-8#1)
in the interaction with the##2##5##(1995-6#1)(2008-10#1)
in the interaction with##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
in the interaction##21##3##(1991-1#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
in the interactions between##4##4##(2009-11#1)(2013-1#2)(2013-8#1)
in the interactions##5##3##(1997-3#1)(2009-11#1)(2013-1#2)(2013-8#1)
in the intercellular##2##3##(2008-10#2)
in the interest##2##3##(2007-12#1)(2009-12#1)
in the interface##3##3##(1993-11#1)(2008-3#1)(2008-4#1)
in the interference pattern##3##4##(2008-2#2)(2008-3#1)
in the interference##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
in the interferogram##3##3##(2008-3#3)
in the interferometer##4##3##(2008-2#1)(2008-3#3)
in the interferometric isolator##2##4##(2008-3#2)
in the intergenic region##2##4##(1994-11#1)(1996-10#1)
in the intergenic spacer##2##4##(2008-10#2)
in the intergenic##4##3##(1994-11#1)(1996-10#1)(2008-10#2)
in the interior of fragments##2##5##(2013-7#2)
in the interior of the##3##5##(2008-10#1)(2008-6#1)(2010-10#1)
in the interior of##8##4##(1991-9#1)(1993-11#1)(2008-10#2)(2008-6#1)(2010-10#1)(2013-7#2)
in the interior##13##3##(1991-9#1)(1993-11#1)(1995-11#1)(1997-4#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-10#1)(2013-7#3)
in the intermediate lobe##2##4##(1992-12#1)(1993-5#1)
in the intermediate##7##3##(1992-12#1)(1992-6#1)(1993-5#2)(1995-5#1)(1996-5#1)(2010-8#1)
in the internal field##2##4##(2008-2#2)
in the internal##15##3##(1996-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2011-2#1)
in the international arena and##2##5##(2008-11#1)(2008-7#1)
in the international literature##6##4##(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-3#1)
in the international##11##3##(1990-12#1)(1991-3#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-7#1)(2011-1#1)(2011-3#1)
in the interphase##2##3##(1990-3#1)(2008-9#1)
in the interpretation of radiological images of the locomotor##2##9##(2007-11#2)
in the interpretation of the##4##5##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
in the interpretation of##17##4##(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1994-3#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#1)
in the interpretation##18##3##(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-3#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#1)
in the interstitial##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2012-7#1)
in the interstitium##3##3##(2009-10#2)(2012-7#1)
in the intertidal##2##3##(2008-10#1)(2008-5#1)
in the interval##4##3##(1996-3#1)(2008-10#2)(2008-7#1)
in the intervention group##5##4##(2007-5#1)(2010-4#3)(2013-1#1)
in the intervention##8##3##(1996-1#1)(2007-5#1)(2010-4#4)(2011-1#1)(2013-1#1)
in the interventions##2##3##(2008-10#1)(2008-11#1)
in the intervertebral foramen##2##4##(2013-8#2)
in the intervertebral##3##3##(2007-8#1)(2013-8#2)
in the interwar period##2##4##(2008-12#1)(2013-1#1)
in the intestinal Peyer's patches##2##5##(2012-1#2)
in the intestinal epithelium##2##4##(2008-10#1)(2011-1#1)
in the intestinal##13##3##(1990-2#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-1#2)
in the intestine and##4##4##(1995-5#1)(2008-10#2)(2008-11#1)
in the intestine##9##3##(1992-6#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-5#2)(2011-2#1)
in the intracellular accumulation of##2##5##(1995-6#1)(2008-7#1)
in the intracellular calcium##2##4##(1994-9#1)(2008-4#1)
in the intracellular##19##3##(1990-2#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(2007-11#1)(2008-11#3)(2008-4#2)(2008-7#3)(2010-10#1)
in the intracranial##2##3##(2007-10#1)(2012-2#1)
in the intramolecular##2##3##(1996-5#1)(2008-10#1)
in the intransitive motion construction##2##5##(2008-4#2)
in the intraoperative##4##3##(1993-1#1)(1996-1#1)(2011-7#1)(2013-1#1)
in the intravascular##2##3##(1997-3#1)(2010-8#1)
in the intrinsic fluorescence##2##4##(1995-5#1)(2008-10#1)
in the intrinsic##9##3##(1993-9#1)(1995-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
in the introduction of##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
in the introduction##5##3##(1991-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
in the introductory##2##3##(1993-12#1)(2008-10#1)
in the invasion of##3##4##(2008-11#2)(2012-2#1)
in the inversion##2##3##(2008-2#1)(2008-3#1)
in the investigated##2##3##(2008-10#2)
in the investigation of##13##4##(1990-12#1)(1991-1#1)(1995-11#1)(1996-6#1)(1997-8#2)(2008-12#2)(2008-2#1)(2008-9#2)(2010-1#1)(2012-8#1)
in the investigation##14##3##(1990-12#1)(1991-1#1)(1995-11#1)(1996-6#1)(1997-8#2)(2008-12#2)(2008-2#1)(2008-9#2)(2010-1#1)(2010-3#1)(2012-8#1)
in the investigational##2##3##(2006-7#1)(2012-12#1)
in the ion-pair extraction##2##4##(2008-10#2)
in the ionic##3##3##(2008-11#1)(2009-5#2)
in the ipsilateral##16##3##(1993-12#2)(1993-3#1)(1996-12#3)(1997-3#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)
in the iris/ciliary body##2##4##(1997-2#2)
in the iron##6##3##(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)
in the irradiance of##2##4##(2007-11#1)(2008-2#1)
in the irradiated##2##3##(2007-12#1)(2008-6#1)
in the ischemic##4##3##(1992-9#1)(1996-12#1)(2008-7#1)(2013-1#1)
in the islet##5##3##(1992-6#2)(1995-8#2)(2010-11#1)
in the islets and##2##4##(2010-11#2)
in the islets of##3##4##(1994-8#1)(1995-8#1)(2011-2#1)
in the islets##7##3##(1994-8#1)(1995-8#1)(2010-11#4)(2011-2#1)
in the isolated##13##3##(1990-11#1)(1990-5#1)(1991-9#1)(1993-6#1)(1994-8#1)(1996-12#1)(1997-6#1)(2007-10#2)(2008-6#1)(2008-8#2)(2008-9#1)
in the isolates##2##3##(1990-6#1)(2008-10#1)
in the isolation and##2##4##(2008-11#1)(2012-2#1)
in the isolation of##7##4##(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
in the isolation##9##3##(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)(2013-1#1)
in the isthmic##2##3##(1993-12#1)(1996-5#1)
in the iterative##2##3##(2007-11#1)(2008-2#1)
in the jejunum and##2##4##(2008-10#1)(2012-2#1)
in the jejunum##4##3##(2008-10#2)(2012-2#1)(2013-7#1)
in the jet nebulizer##2##4##(1991-1#2)
in the jet##3##3##(1991-1#2)(2007-12#1)
in the job##2##3##(1993-2#1)(2013-1#1)
in the joint analyses##2##4##(2008-10#2)
in the joint transform correlator##2##5##(2008-3#2)
in the joint##10##3##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
in the journal##3##3##(1996-3#1)(2012-12#1)(2013-1#1)
in the juice of##2##4##(2008-10#1)(2012-12#1)
in the juice sac area##4##5##(2008-10#4)
in the juice##7##3##(2008-10#6)(2012-12#1)
in the junctional foot protein##2##5##(1995-6#2)
in the karyoplasm##2##3##(2007-12#1)(2008-7#1)
in the kidney and intestine##2##5##(2007-7#1)(2008-11#1)
in the kidney and liver##3##5##(1990-7#1)(1994-5#1)(1995-3#1)
in the kidney and##9##4##(1990-11#1)(1990-7#1)(1994-5#1)(1995-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)
in the kidney in##2##4##(2008-7#1)(2012-12#1)
in the kidney of##3##4##(1995-12#1)(2009-12#1)(2009-6#1)
in the kidney##36##3##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-12#1)(1997-4#1)(2007-12#1)(2007-7#2)(2008-11#5)(2008-7#5)(2008-8#1)(2009-12#1)(2009-6#3)(2011-2#1)(2012-12#3)(2012-3#1)
in the kidneys of##6##4##(1990-7#1)(1994-5#1)(1997-6#1)(2008-5#1)(2009-6#1)(2010-6#1)
in the kidneys##9##3##(1990-7#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-6#1)(2008-5#2)(2009-6#1)(2010-6#1)
in the kinetic##7##3##(1995-11#1)(1995-2#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
in the kingdom of saudi arabia##2##6##(2008-1#2)
in the knee joint##2##4##(2007-8#1)(2009-10#1)
in the knee##13##3##(1990-6#1)(1991-6#1)(1995-3#1)(2007-11#1)(2007-8#3)(2008-12#1)(2009-10#1)(2011-2#3)(2013-1#1)
in the knockout##2##3##(2010-11#1)(2012-12#1)
in the knowledge of the##2##5##(2008-3#1)(2013-1#1)
in the knowledge of##4##4##(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
in the knowledge##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
in the labor market##2##4##(1994-3#1)(2013-1#1)
in the labor##3##3##(1994-3#1)(2007-2#1)(2013-1#1)
in the laboratories##2##3##(2007-10#1)(2011-1#1)
in the laboratory and##9##4##(1996-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)
in the laboratory by use of##2##6##(2008-3#2)
in the laboratory by##6##4##(2008-10#3)(2008-11#1)(2008-3#2)
in the laboratory for use in ecotoxicological testing##2##8##(2008-11#2)
in the laboratory for##4##4##(2008-10#1)(2008-11#2)(2013-8#1)
in the laboratory or##2##4##(2008-10#2)
in the laboratory population##2##4##(2008-10#2)
in the laboratory to##2##4##(2008-5#1)(2010-5#1)
in the laboratory using##4##4##(2008-10#3)(2012-2#1)
in the laboratory were##2##4##(2008-10#2)
in the laboratory with##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
in the laboratory##86##3##(1990-3#1)(1991-3#1)(1992-3#1)(1996-4#2)(1996-9#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#30)(2008-11#3)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#5)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
in the labour##2##3##(1993-3#1)(1993-6#1)
in the lack of##2##4##(1997-4#1)(2008-6#1)
in the lagoon##4##3##(2007-5#2)(2010-8#1)(2013-7#1)
in the lake sediments##2##4##(2008-10#2)
in the lamellar##3##3##(2008-5#1)(2012-2#2)
in the lamin##2##3##(2008-8#1)(2011-2#1)
in the lamina##4##3##(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
in the laminar##2##3##(1997-3#1)(2008-3#1)
in the lamprey##2##3##(1997-3#2)
in the land##2##3##(2008-11#1)(2013-8#1)
in the language##2##3##(2009-9#1)(2010-4#1)
in the large##9##3##(1995-10#1)(1997-3#1)(2007-12#1)(2008-3#1)(2008-4#2)(2012-2#2)(2013-8#1)
in the larger##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
in the largest##4##3##(1992-12#1)(1992-3#1)(1992-8#1)(2008-12#1)
in the larvae##2##3##(2008-7#2)
in the larval##3##3##(2007-12#1)(2008-12#1)(2008-9#1)
in the laser cavity##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
in the laser##20##3##(1992-12#1)(1993-3#1)(1994-12#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#9)
in the last 10 years##8##5##(1991-6#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
in the last 10##9##4##(1991-6#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
in the last 12 months##2##5##(1994-8#1)(2011-1#1)
in the last 15 years##2##5##(2008-10#1)(2012-2#1)
in the last 2 years##2##5##(1990-6#1)(2008-3#1)
in the last 2##4##4##(1990-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
in the last 20 years##3##5##(1994-3#1)(2007-8#1)(2010-11#1)
in the last 20##5##4##(1994-3#1)(2007-8#2)(2008-8#1)(2010-11#1)
in the last 3 months##2##5##(2008-10#1)(2013-1#1)
in the last 30 years##3##5##(2008-9#1)(2010-3#1)(2011-2#1)
in the last 30##4##4##(2007-12#1)(2008-9#1)(2010-3#1)(2011-2#1)
in the last 5 years##2##5##(2008-12#1)(2012-3#1)
in the last 5##3##4##(2008-12#1)(2010-2#1)(2012-3#1)
in the last 6 months##2##5##(1997-2#1)(2011-2#1)
in the last decade and##2##5##(2008-11#1)(2008-3#1)
in the last decade as##2##5##(2009-3#1)(2012-2#1)
in the last decade##27##4##(1990-12#2)(1990-8#1)(1991-6#1)(1992-1#1)(1992-12#1)(1994-3#2)(1995-3#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in the last decades##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
in the last few years##10##5##(1990-9#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)
in the last few##11##4##(1990-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)
in the last four weeks##2##5##(2011-1#2)
in the last four##3##4##(2008-5#1)(2011-1#2)
in the last one##2##4##(2007-8#1)(2012-1#1)
in the last phases of##2##5##(1990-6#1)(2008-11#1)
in the last several years##2##5##(1992-3#1)(2011-2#1)
in the last several##4##4##(1992-3#1)(1997-4#1)(2011-2#2)
in the last ten years##4##5##(1996-7#1)(2008-8#2)(2012-3#1)
in the last three##2##4##(2008-7#1)(2013-7#1)
in the last trimester##3##4##(1991-3#1)(1995-8#1)(2007-11#1)
in the last two decades##4##5##(1994-3#1)(1995-12#1)(2012-1#1)(2012-2#1)
in the last two##7##4##(1991-5#1)(1993-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(2012-1#1)(2012-2#1)
in the last years##4##4##(2008-11#1)(2010-12#1)(2011-1#2)
in the last##123##3##(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-7#1)(1994-8#1)(1995-12#3)(1995-3#2)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-10#8)(2008-11#5)(2008-12#4)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#6)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
in the late 1960s##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
in the late 1980s##4##4##(1992-2#1)(1994-3#1)(2008-1#1)(2008-7#1)
in the late 1990s##2##4##(2008-7#1)(2010-5#1)
in the late afternoon##2##4##(2011-2#1)(2012-6#1)
in the late nineteenth century##2##5##(2010-1#1)(2011-2#1)
in the late phase of##2##5##(1990-6#1)(1995-12#1)
in the late phase##3##4##(1990-6#1)(1995-11#1)(1995-12#1)
in the late##35##3##(1990-6#1)(1992-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#4)(2009-10#1)(2009-12#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-6#1)(2013-1#1)
in the late-preterm infant##2##4##(2012-2#2)
in the later part of##3##5##(2008-7#2)(2011-1#1)
in the later stages of##2##5##(2007-7#1)(2008-10#1)
in the later stages##3##4##(1993-9#1)(2007-7#1)(2008-10#1)
in the later##7##3##(1993-9#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-7#2)(2011-1#1)
in the lateral and##3##4##(1995-5#1)(1996-5#1)(2013-1#1)
in the lateral direction##3##4##(2007-12#2)(2008-2#1)
in the lateral hypothalamus##2##4##(1993-6#2)
in the lateral perforant path##2##5##(1993-12#2)
in the lateral##28##3##(1992-3#1)(1993-12#4)(1993-6#2)(1995-5#2)(1995-6#1)(1996-5#2)(1997-2#1)(1997-3#1)(2007-12#3)(2007-8#1)(2008-2#1)(2008-7#3)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2013-1#1)
in the latest##2##3##(2011-2#2)
in the latter case##6##4##(1990-2#1)(1991-5#1)(1995-6#1)(2008-10#3)
in the latter half of the##4##6##(1997-7#1)(2006-8#1)(2009-10#2)
in the latter##34##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
in the law##3##3##(1991-1#1)(1992-12#2)
in the layer of##2##4##(1997-6#1)(2008-10#1)
in the lead##6##3##(2008-10#5)(2008-5#1)
in the leader##3##3##(1991-9#1)(2008-8#1)(2008-9#1)
in the leaf##6##3##(2008-10#3)(2008-8#1)(2009-6#2)
in the learning environment##2##4##(2008-12#1)(2012-3#1)
in the learning##5##3##(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
in the least##2##3##(2008-7#1)(2008-8#1)
in the leather industry##2##4##(2008-10#2)
in the leather##4##3##(2008-10#3)(2009-12#1)
in the leaves and##2##4##(2008-10#2)
in the leaves of the##2##5##(2008-10#1)(2008-6#1)
in the leaves##8##3##(2008-10#4)(2008-12#2)(2008-6#1)(2011-10#1)
in the left and right##2##5##(2008-1#1)(2008-11#1)
in the left anterior##3##4##(2008-6#1)(2009-2#1)(2013-7#1)
in the left breast##3##4##(2007-7#1)(2008-10#2)
in the left colon##3##4##(1991-6#1)(1992-6#1)(2011-2#1)
in the left eye##3##4##(2010-10#1)(2013-1#2)
in the left internal##2##4##(2007-8#1)(2012-3#1)
in the left kidney##2##4##(2008-1#2)
in the left lateral##2##4##(1993-10#1)(2013-1#1)
in the left lobe##2##4##(1993-5#1)(2012-12#1)
in the left lower lid##2##5##(2010-11#2)
in the left lower lobe##5##5##(2007-8#2)(2008-1#1)(2008-6#2)
in the left lower##10##4##(2007-8#2)(2008-1#2)(2008-6#2)(2008-7#1)(2010-11#3)
in the left lung##4##4##(2008-1#2)(2011-2#1)(2013-8#1)
in the left pleural##2##4##(1990-5#2)
in the left temporal##2##4##(2008-1#1)(2010-7#1)
in the left upper lobe##2##5##(2008-1#2)
in the left upper##5##4##(2008-1#3)(2008-6#1)(2013-1#1)
in the left ventricle##3##4##(2008-10#1)(2009-12#1)(2013-1#1)
in the left ventricular##2##4##(2007-9#1)(2013-1#1)
in the left##91##3##(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#14)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#6)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#4)
in the leg##4##3##(1997-2#1)(2008-5#1)(2008-6#1)(2013-8#1)
in the legal##3##3##(1991-12#1)(1996-1#1)(2008-10#1)
in the legs##2##3##(2008-7#1)(2013-7#1)
in the length of the##2##5##(1991-2#1)(2009-2#1)
in the length of##5##4##(1991-2#1)(1991-6#1)(2008-4#1)(2009-2#1)(2013-8#1)
in the length##6##3##(1991-2#1)(1991-6#1)(2007-12#1)(2008-4#1)(2009-2#1)(2013-8#1)
in the lens and##2##4##(1991-9#1)(2008-11#1)
in the lens of##2##4##(1991-9#1)(1993-3#1)
in the lens##8##3##(1991-9#2)(1992-12#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-11#1)(2012-2#1)
in the lesion was##2##4##(2007-6#1)(2009-11#1)
in the lesion##12##3##(1990-5#1)(1993-3#1)(1994-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#2)
in the lesioned striatum##2##4##(2008-7#2)
in the lesioned##4##3##(1997-6#1)(2008-7#3)
in the less##3##3##(2008-9#1)(2009-12#1)(2012-3#1)
in the lesser curve##2##4##(2012-2#2)
in the lethal##2##3##(2008-10#1)(2008-7#1)
in the leukemic##2##3##(2008-11#1)(2012-12#1)
in the level of the##2##5##(1996-6#1)(1997-7#1)
in the level of##30##4##(1990-12#1)(1990-5#1)(1991-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#3)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
in the levels of the##2##5##(1997-4#1)(2013-8#1)
in the levels of##38##4##(1990-12#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#2)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#2)
in the levels##40##3##(1990-12#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#2)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#2)
in the liberation of##2##4##(1995-11#1)(2008-10#1)
in the lidar##3##3##(2008-2#1)(2008-3#2)
in the life cycle of##3##5##(1994-11#1)(2008-10#1)(2008-9#1)
in the life history of##2##5##(2009-10#1)(2013-7#1)
in the life history##3##4##(2008-8#1)(2009-10#1)(2013-7#1)
in the life of##3##4##(1995-5#1)(2010-8#1)(2012-3#1)
in the life sciences##2##4##(2008-9#1)(2010-7#1)
in the life span##2##4##(1994-5#2)
in the life##20##3##(1994-11#1)(1994-5#2)(1995-1#1)(1995-5#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-7#1)
in the lifetime##2##3##(2007-11#1)(2008-10#1)
in the ligand##5##3##(1990-8#1)(1996-5#1)(2008-10#3)
in the light and##2##4##(2008-10#1)(2009-8#1)
in the light of a##4##5##(1993-11#1)(1993-3#1)(2008-10#1)(2011-1#1)
in the light of published##2##5##(2008-2#1)(2008-9#1)
in the light of recent advances##2##6##(1990-9#1)(2008-5#1)
in the light of recent##5##5##(1990-9#1)(1991-4#1)(1991-6#1)(2008-5#1)(2009-8#1)
in the light of the literature##2##6##(1990-3#1)(2007-8#1)
in the light of the##22##5##(1990-3#2)(1990-8#1)(1993-3#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
in the light of these##2##5##(1990-12#1)(2008-7#1)
in the light of##65##4##(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-6#2)(1993-11#1)(1993-3#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#6)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)
in the light stage##2##4##(2009-6#2)
in the light##78##3##(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-8#1)(1993-11#2)(1993-3#3)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#6)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#2)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)
in the limb##4##3##(1990-6#1)(1992-8#1)(1993-12#2)
in the limit of negligible##2##5##(2007-12#1)(2008-3#1)
in the limit of##4##4##(1995-3#1)(2007-12#1)(2008-3#1)(2011-2#1)
in the limit##5##3##(1995-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
in the limited##2##3##(1990-2#1)(2013-7#1)
in the line RE714##2##4##(2008-10#2)
in the line of##2##4##(2007-10#1)(2008-3#1)
in the line##6##3##(1995-12#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)
in the linear range##4##4##(2008-10#4)
in the linear ranges of##2##5##(2008-10#1)(2011-1#1)
in the linear##14##3##(1991-5#1)(1992-6#1)(2007-12#1)(2008-10#8)(2008-5#1)(2008-6#1)(2011-1#1)
in the link##2##3##(2008-11#1)(2013-8#1)
in the lipid bilayer##3##4##(1990-11#1)(1992-6#1)(2008-11#1)
in the lipid phase##3##4##(1990-2#1)(1991-5#1)(1994-5#1)
in the lipid profiles##2##4##(1991-4#1)(2008-8#1)
in the lipid##19##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-3#1)(1992-6#1)(1994-3#2)(1994-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
in the lipophilic##2##3##(1994-11#1)(2008-5#1)
in the liposomes##2##3##(1990-2#1)(2008-5#1)
in the liquid phase##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
in the liquid##15##3##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the list of##3##4##(1997-3#2)(2012-12#1)
in the literature about##3##4##(1994-8#1)(1995-11#1)(2008-1#1)
in the literature and##15##4##(1993-1#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#1)
in the literature are##6##4##(1992-12#1)(1994-6#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-7#1)
in the literature as a##3##5##(2008-3#1)(2008-5#1)(2013-1#1)
in the literature as##9##4##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the literature could be##2##5##(2007-10#1)(2008-9#1)
in the literature could##3##4##(2007-10#1)(2008-3#1)(2008-9#1)
in the literature describing##2##4##(2008-3#1)(2009-10#1)
in the literature for the##2##5##(2008-10#1)(2008-11#1)
in the literature for##10##4##(1991-3#2)(1992-9#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)
in the literature in any##2##5##(1995-2#1)(2008-10#1)
in the literature in the##2##5##(1991-3#1)(1995-12#1)
in the literature in##5##4##(1991-3#1)(1995-12#1)(1995-2#1)(2008-10#1)(2013-1#1)
in the literature include##2##4##(2008-6#2)
in the literature is##2##4##(2008-10#1)(2008-3#1)
in the literature of##5##4##(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)
in the literature on##3##4##(1991-12#1)(2008-2#1)(2012-1#1)
in the literature regarding##4##4##(2008-5#1)(2012-2#3)
in the literature that##4##4##(2008-11#1)(2008-3#1)(2010-1#1)(2010-3#1)
in the literature to##2##4##(2008-6#1)(2008-7#1)
in the literature where##2##4##(2008-3#1)(2008-7#1)
in the literature which##2##4##(2012-3#1)(2013-8#1)
in the literature with##3##4##(1992-12#1)(2007-5#1)(2013-1#1)
in the literature##321##3##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-9#1)(1996-11#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#4)(2008-10#30)(2008-11#15)(2008-12#3)(2008-2#9)(2008-3#24)(2008-4#1)(2008-5#11)(2008-6#8)(2008-7#15)(2008-8#6)(2008-9#10)(2009-10#2)(2009-11#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#2)(2009-9#2)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#11)(2012-3#7)(2013-1#22)(2013-7#1)(2013-8#3)
in the literature)##2##3##(2008-2#1)(2008-3#1)
in the littoral##3##3##(2011-2#1)(2013-7#2)
in the liver and in##2##5##(1990-11#1)(2011-2#1)
in the liver and kidney##3##5##(1990-8#1)(1997-8#1)(2008-7#1)
in the liver and small intestine##2##6##(1992-11#2)
in the liver and the##2##5##(1994-7#1)(1995-3#1)
in the liver and##21##4##(1990-11#1)(1990-8#1)(1992-11#2)(1992-3#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
in the liver by##4##4##(1995-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
in the liver following##2##4##(2008-10#1)(2008-8#1)
in the liver is##2##4##(2008-9#1)(2010-7#1)
in the liver microsomes##2##4##(2011-3#2)
in the liver of female rats##2##6##(1995-3#1)(1995-8#1)
in the liver of rats##2##5##(1994-6#1)(2013-1#1)
in the liver of##13##4##(1990-12#1)(1990-3#2)(1991-8#1)(1993-11#1)(1994-6#1)(1995-3#2)(1995-8#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
in the liver under##2##4##(1990-11#1)(2012-12#1)
in the liver was##3##4##(1990-11#1)(1995-6#1)(2008-6#1)
in the liver with##2##4##(1991-6#1)(1996-12#1)
in the liver##120##3##(1990-11#9)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#4)(1991-8#1)(1992-11#4)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#3)(1994-7#1)(1994-8#3)(1995-2#2)(1995-3#7)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#4)(2010-7#4)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
in the livers of##3##4##(1992-11#1)(2008-10#2)
in the lives of##5##4##(2007-2#1)(2008-8#1)(2010-10#1)(2013-1#2)
in the living human retina##2##5##(2007-11#2)
in the living##7##3##(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)
in the local##22##3##(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-3#1)(2013-1#1)
in the locality##2##3##(2012-3#2)
in the localization of##4##4##(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)
in the localization##7##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#1)
in the location of##2##4##(2008-7#1)(2011-2#1)
in the location procedure##2##4##(2011-2#2)
in the location##5##3##(2007-4#1)(2008-7#1)(2011-2#3)
in the locomotor##2##3##(1993-6#1)(2007-8#1)
in the locus control region (LCR) of the human beta-like globin gene cluster##2##13##(2008-8#2)
in the locus##3##3##(2008-8#2)(2011-2#1)
in the locust##6##3##(1994-2#2)(2007-12#4)
in the log##2##3##(1995-3#1)(2008-8#1)
in the long bones##2##4##(2010-3#1)(2013-8#1)
in the long run##8##4##(1994-5#1)(1997-3#1)(1997-5#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
in the long term##13##4##(1993-11#1)(1994-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#3)(2013-8#1)
in the long##29##3##(1991-2#1)(1993-11#1)(1994-1#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-5#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#3)
in the long-run##2##3##(2010-12#1)(2012-12#1)
in the long-term increase##2##4##(2008-11#1)(2008-8#1)
in the long-term##9##3##(1991-12#1)(1994-12#1)(1996-7#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-3#1)(2011-2#1)
in the longer-term##2##3##(2008-1#1)(2008-11#1)
in the longitudinal direction##2##4##(2007-12#1)(2008-9#1)
in the longitudinal##5##3##(1997-3#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-11#1)
in the loop##4##3##(1993-11#1)(1993-8#1)(2008-8#1)(2008-9#1)
in the loss of##12##4##(1990-2#1)(1991-2#1)(1991-9#1)(1993-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the loss##15##3##(1990-2#1)(1991-2#1)(1991-9#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the low and the##2##5##(2008-3#2)
in the low back##2##4##(2008-12#1)(2013-8#1)
in the low dose##3##4##(1994-7#1)(2008-5#2)
in the low micromolar range##2##5##(1994-12#1)(2008-10#1)
in the low risk##2##4##(2007-8#1)(2010-11#1)
in the low salt buffer##2##5##(1995-6#2)
in the low##34##3##(1990-5#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in the lower chamber##2##4##(2008-11#2)
in the lower extremities##5##4##(1993-6#1)(1994-11#1)(2008-12#1)(2008-7#1)(2012-12#1)
in the lower extremity and##2##5##(2012-2#1)(2013-1#1)
in the lower extremity##7##4##(2008-12#1)(2008-6#2)(2009-1#1)(2009-10#1)(2012-2#1)(2013-1#1)
in the lower female##2##4##(1990-2#1)(1996-12#1)
in the lower fields of both lungs##2##7##(2008-1#2)
in the lower genital tract##2##5##(2011-2#2)
in the lower legs##2##4##(1997-8#1)(2007-2#1)
in the lower limb##2##4##(2011-2#2)
in the lower nanogram per liter range##2##7##(2008-10#2)
in the lower part##2##4##(1993-9#1)(2008-10#1)
in the lower reproductive tract##2##5##(1996-12#1)(2011-1#1)
in the lower stratosphere##2##4##(2008-3#2)
in the lower thoracic spinal cord##2##6##(1993-12#1)(2008-12#1)
in the lower thoracic##3##4##(1993-12#1)(2008-12#1)(2012-12#1)
in the lower troposphere##2##4##(2008-2#2)
in the lower##65##3##(1990-12#1)(1990-2#1)(1991-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
in the lowest excited singlet state##2##6##(2008-10#2)
in the lowest##7##3##(1991-12#1)(2008-10#4)(2009-2#1)(2009-3#1)
in the lumbar spine##4##4##(2007-8#1)(2008-4#1)(2012-12#1)(2012-2#1)
in the lumbar##14##3##(1996-3#1)(1997-2#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-7#2)(2011-2#3)(2012-12#2)(2012-2#1)
in the lumbosacral paravertebral muscle##2##5##(2013-8#2)
in the lumbosacral##5##3##(1997-2#1)(2008-12#1)(2013-8#3)
in the lumen of the##3##5##(1993-6#2)(2008-10#1)
in the lumen of##5##4##(1993-6#2)(2008-10#3)
in the lumen##11##3##(1993-12#1)(1993-6#2)(1996-12#1)(2007-8#1)(2008-10#3)(2008-7#3)
in the lung and##3##4##(1995-12#1)(2008-10#1)(2010-10#1)
in the lung homogenate##2##4##(2011-2#2)
in the lung may be##2##5##(1990-5#1)(2013-8#1)
in the lung##38##3##(1990-5#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#2)(1995-12#1)(1997-1#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-5#3)(2011-2#3)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#2)
in the lungs and##2##4##(1991-12#1)(1995-2#1)
in the lungs by##2##4##(2008-8#1)(2013-1#1)
in the lungs of##6##4##(1991-12#1)(1994-11#1)(1996-8#1)(2013-1#3)
in the lungs were##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
in the lungs##27##3##(1990-5#1)(1991-12#3)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-3#3)(1996-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-5#4)(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#4)
in the luteal phase##2##4##(1991-11#1)(2008-5#1)
in the lymph nodes##2##4##(1990-12#1)(2013-7#1)
in the lymphocyte##2##3##(2008-11#1)(2008-4#1)
in the lymphoid##3##3##(1992-12#1)(2008-4#1)(2008-9#1)
in the m =##2##4##(2008-2#1)(2008-3#1)
in the m/z##2##3##(2008-10#2)
in the mPFC and##3##4##(2008-6#2)(2008-7#1)
in the mPFC##5##3##(2008-6#2)(2008-7#3)
in the mRNA levels##2##4##(1991-12#1)(2008-4#1)
in the mRNA##6##3##(1991-12#1)(2008-11#1)(2008-4#1)(2010-1#1)(2012-2#1)(2013-1#1)
in the macroalbuminuric##2##3##(1992-9#2)
in the macrophage##2##3##(1994-8#1)(1995-6#1)
in the macrophages##2##3##(1990-7#1)(2011-2#1)
in the magnetization##2##3##(2009-6#1)(2012-12#1)
in the magnitude and direction of##2##6##(2010-8#1)(2013-1#1)
in the magnitude and##3##4##(2008-3#1)(2010-8#1)(2013-1#1)
in the magnitude of the##3##5##(1995-11#1)(2008-10#1)(2008-3#1)
in the magnitude of##11##4##(1995-11#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-10#1)(2012-3#1)
in the magnitude range##2##4##(1996-4#2)
in the magnitude##19##3##(1995-11#1)(1995-2#1)(1995-5#1)(1996-4#2)(2008-10#3)(2008-11#2)(2008-3#3)(2009-6#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the magnocellular##2##3##(1993-12#1)(1995-12#1)
in the magnoliids##2##3##(2008-10#2)
in the main study##2##4##(2007-10#1)(2010-3#1)
in the main##21##3##(1993-9#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-1#1)(2010-10#3)(2010-3#1)(2013-8#1)
in the mainland##2##3##(2008-10#1)(2011-1#1)
in the mainstream##2##3##(1995-1#1)(2012-2#1)
in the maintenance of a##4##5##(2008-5#2)(2010-12#1)(2013-1#1)
in the maintenance of glucose homeostasis##2##6##(2008-4#2)
in the maintenance of the##2##5##(1991-2#1)(2008-9#1)
in the maintenance of##27##4##(1991-2#1)(1995-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
in the maintenance##31##3##(1991-2#1)(1995-12#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
in the maize##3##3##(2008-10#3)
in the major groove of the##2##6##(1991-2#1)(1995-5#1)
in the major groove##3##4##(1991-2#1)(1992-6#1)(1995-5#1)
in the major##13##3##(1990-5#1)(1991-2#1)(1992-12#1)(1992-6#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
in the majority of cases##14##5##(1990-5#1)(1990-6#1)(1990-9#1)(1995-11#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in the majority of patients at##2##6##(2010-3#1)(2010-8#1)
in the majority of patients##7##5##(1994-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-8#1)(2011-2#1)
in the majority of samples##2##5##(2008-10#1)(2011-2#1)
in the majority of the##4##5##(1992-8#1)(1994-12#1)(1996-9#1)(2008-10#1)
in the majority of##41##4##(1990-5#1)(1990-6#1)(1990-9#2)(1992-12#1)(1992-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#3)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in the majority##42##3##(1990-5#1)(1990-6#1)(1990-9#2)(1992-12#1)(1992-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in the making of##2##4##(2008-6#1)(2013-1#1)
in the malaria##2##3##(2007-12#1)(2007-2#1)
in the male Fischer##2##4##(1993-12#1)(1994-3#1)
in the male genital##2##4##(1993-3#1)(2008-4#1)
in the male rats##4##4##(2008-7#1)(2013-1#3)
in the male reproductive##2##4##(1993-3#1)(2011-1#1)
in the male##24##3##(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-3#1)(2007-12#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#1)
in the males##4##3##(1994-2#1)(1995-3#2)(2008-10#1)
in the malignant##2##3##(2012-12#1)(2013-8#1)
in the mammalian and##2##4##(1995-3#1)(2009-3#1)
in the mammalian central nervous system##4##6##(1993-12#1)(2008-8#2)(2012-2#1)
in the mammalian thyroid gland##2##5##(1990-5#2)
in the mammalian##23##3##(1990-12#1)(1990-5#2)(1991-6#1)(1992-6#1)(1993-12#1)(1994-5#2)(1995-3#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-3#1)(2010-11#1)(2010-2#1)(2012-2#3)
in the mammary gland##4##4##(1990-12#1)(1994-12#1)(1995-9#1)(2008-8#1)
in the mammary##5##3##(1990-12#1)(1994-12#1)(1995-9#1)(2008-8#1)(2012-12#1)
in the managed care setting##3##5##(1992-2#2)(2009-11#1)
in the managed care##5##4##(1992-2#2)(1994-12#1)(1996-12#1)(2009-11#1)
in the managed##6##3##(1992-2#2)(1994-12#1)(1996-12#1)(2008-8#1)(2009-11#1)
in the management and##3##4##(1992-12#1)(2009-4#1)(2012-2#1)
in the management of a patient##2##6##(2008-12#2)
in the management of acute coronary syndromes##2##7##(2008-3#2)
in the management of acute##5##5##(1995-8#1)(2008-3#2)(2008-5#1)(2012-12#1)
in the management of breast##3##5##(2007-11#1)(2012-2#1)(2013-8#1)
in the management of children##2##5##(2008-10#1)(2008-9#1)
in the management of chronic##2##5##(1990-2#1)(2012-2#1)
in the management of end-stage##2##5##(2007-11#1)(2011-3#1)
in the management of locally advanced##2##6##(1990-6#1)(1993-9#1)
in the management of maxillofacial##2##5##(2007-12#2)
in the management of non-small cell lung cancer##2##8##(2007-5#1)(2008-1#1)
in the management of oral##2##5##(2013-1#2)
in the management of osteoporosis##2##5##(1993-11#1)(2008-6#1)
in the management of ovarian cancer##2##6##(1991-4#1)(2008-1#1)
in the management of ovarian masses##3##6##(1996-1#3)
in the management of ovarian##5##5##(1991-4#1)(1996-1#3)(2008-1#1)
in the management of pain##4##5##(2007-11#1)(2008-10#1)(2009-12#1)(2010-12#1)
in the management of patients with invasive mycoses##2##8##(2008-5#2)
in the management of patients with##17##6##(1990-8#1)(1996-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
in the management of patients##18##5##(1990-8#1)(1996-11#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
in the management of pediatric thyroid nodules##2##7##(2011-1#2)
in the management of pediatric##5##5##(2006-10#1)(2011-1#2)(2012-3#1)(2013-8#1)
in the management of post-operative chyle##2##6##(2007-8#2)
in the management of recurrent##2##5##(2007-12#1)(2009-4#1)
in the management of severe##3##5##(2007-12#1)(2008-11#1)(2008-9#1)
in the management of the##6##5##(1997-8#1)(2007-12#2)(2008-8#1)(2008-9#1)(2012-2#1)
in the management of these patients##4##6##(1991-2#1)(2008-3#1)(2010-9#1)(2011-2#1)
in the management of these##5##5##(1991-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)
in the management of this complex disorder##2##7##(2008-7#2)
in the management of this##5##5##(2008-7#3)(2010-8#2)
in the management of unstable angina pectoris and acute myocardial infarction##2##11##(1991-9#2)
in the management of various##2##5##(2008-2#1)(2009-10#1)
in the management of##197##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-3#2)(1993-11#1)(1993-9#2)(1994-3#1)(1995-11#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#10)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#7)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#9)(2013-8#2)
in the management##204##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1993-11#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#10)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#7)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#14)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#9)(2013-8#2)
in the mandible##6##3##(2007-5#1)(2011-7#1)(2013-1#4)
in the mandibular##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
in the mangrove##4##3##(2008-11#1)(2008-5#1)(2013-7#2)
in the manifestation of##4##4##(1994-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
in the manipulation category##2##4##(2008-12#2)
in the manipulation of##2##4##(2008-4#1)(2008-7#1)
in the manipulation##4##3##(2008-12#2)(2008-4#1)(2008-7#1)
in the manner of a##2##5##(2008-3#1)(2013-8#1)
in the manner##4##3##(1990-7#1)(1995-12#1)(2008-3#1)(2013-8#1)
in the manual##2##3##(2008-10#1)(2008-4#1)
in the manufacture of##7##4##(1994-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
in the manufacture##8##3##(1994-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
in the manufacturing process##2##4##(2008-10#1)(2008-3#1)
in the manufacturing##5##3##(1992-2#1)(2008-10#2)(2008-3#1)(2008-5#1)
in the manure##3##3##(2008-10#3)
in the marginal##4##3##(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
in the marine environment##4##4##(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)
in the marine##6##3##(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
in the market##10##3##(1991-3#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-5#2)(2012-12#2)
in the marketplace##5##3##(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-6#1)
in the mass media##2##4##(1992-2#1)(2012-12#1)
in the mass spectra##2##4##(2008-10#2)
in the mass##6##3##(1992-2#1)(1992-3#1)(2008-10#2)(2011-1#1)(2012-12#1)
in the massage group##2##4##(2008-10#1)(2008-12#1)
in the masseter muscle##4##4##(1993-12#1)(2008-4#3)
in the masseter##5##3##(1993-12#1)(2008-4#4)
in the mastoid##5##3##(1990-12#1)(2008-7#2)(2008-9#2)
in the material from##2##4##(1991-9#1)(2008-10#1)
in the material##8##3##(1991-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-7#1)(2012-2#1)(2013-1#1)
in the maternal circulation##2##4##(1994-6#2)
in the maternal##4##3##(1992-5#1)(1994-11#1)(1994-6#2)
in the maternally silenced##2##4##(2008-7#2)
in the matrix and##2##4##(2008-10#1)(2008-8#1)
in the matrix of##3##4##(1997-2#1)(2008-10#1)(2013-8#1)
in the matrix##12##3##(1990-2#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-8#2)(2009-7#1)(2013-7#1)(2013-8#1)
in the maturation of##2##4##(1996-5#1)(2013-8#1)
in the mature##8##3##(1992-3#2)(1993-2#1)(1994-12#1)(1995-12#1)(2008-5#1)(2009-12#1)(2009-8#1)
in the maxilla##3##3##(2008-12#1)(2010-3#1)(2013-1#1)
in the maxillary sinus##2##4##(2008-7#1)(2013-1#1)
in the maxillary##5##3##(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
in the maximal##2##3##(1994-9#1)(1996-2#1)
in the maximum##9##3##(1994-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)
in the mean arterial pressure##2##5##(2007-9#1)(2008-7#1)
in the mean number of##2##5##(1990-5#1)(2008-10#1)
in the mean##25##3##(1990-5#1)(1990-9#2)(1992-12#1)(1993-1#1)(1994-6#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the meaningful##2##3##(2009-10#1)(2011-1#1)
in the meantime##2##3##(2009-1#1)(2013-1#1)
in the measured data##2##4##(2008-2#1)(2008-3#1)
in the measured##20##3##(1992-3#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
in the measurement and##2##4##(2008-1#1)(2008-3#1)
in the measurement data##2##4##(2008-10#1)(2008-2#1)
in the measurement of the##2##5##(2007-12#1)(2008-3#1)
in the measurement of##12##4##(1993-2#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#3)(2012-3#1)(2013-1#2)
in the measurement system##2##4##(2008-3#2)
in the measurement##28##3##(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#8)(2012-3#1)(2013-1#2)
in the measurements##6##3##(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)
in the measuring##4##3##(2008-10#3)(2008-3#1)
in the meat##4##3##(2008-10#3)(2010-4#1)
in the mechanical properties##2##4##(2009-7#1)(2012-2#1)
in the mechanism by which##2##5##(1997-1#1)(2008-8#1)
in the mechanism of action of##3##6##(1997-2#1)(2008-6#1)(2013-8#1)
in the mechanism of##20##4##(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
in the mechanism##22##3##(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
in the mechanisms of##5##4##(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)
in the medaka fish##2##4##(1997-9#1)(2008-5#1)
in the medaka##3##3##(1997-9#1)(2008-5#2)
in the medfly Ceratitis capitata (Diptera##2##6##(2007-12#2)
in the media and##2##4##(2007-8#1)(2008-3#1)
in the media##18##3##(1991-9#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(2007-12#2)(2007-8#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-12#2)
in the medial perforant path##2##5##(1993-12#2)
in the medial prefrontal cortex##4##5##(2008-11#2)(2008-6#2)
in the medial prefrontal##5##4##(1993-12#1)(2008-11#2)(2008-6#2)
in the medial preoptic area (MPOA)##2##6##(1992-12#1)(1992-5#1)
in the medial superior olivary nucleus##2##6##(1997-3#2)
in the medial temporal lobe##4##5##(1991-10#1)(1992-11#1)(2010-7#2)
in the medial temporal##5##4##(1991-10#1)(1992-11#1)(2010-7#3)
in the medial##34##3##(1990-7#3)(1990-9#1)(1991-10#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#4)(1995-12#1)(1997-3#2)(1997-4#1)(2006-6#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#3)
in the median##4##3##(1993-12#1)(1995-12#1)(2007-8#1)(2011-2#1)
in the mediastinum##2##3##(1997-3#1)(2008-6#1)
in the mediation of##6##4##(1991-2#1)(1997-1#1)(1997-4#1)(2008-4#2)(2011-2#1)
in the medical and##2##4##(1991-11#1)(2008-10#1)
in the medical community##2##4##(1993-6#1)(2007-10#1)
in the medical curriculum]##2##4##(1990-9#1)(1992-6#1)
in the medical departments##2##4##(1992-6#1)(1993-6#1)
in the medical field##4##4##(1991-3#1)(1994-2#1)(2010-12#1)(2012-3#1)
in the medical literature##10##4##(1990-8#1)(1996-9#1)(2007-7#1)(2008-10#1)(2010-6#3)(2013-1#2)(2013-8#1)
in the medical##39##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-6#2)(1993-6#2)(1994-1#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#3)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
in the medium and##7##4##(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)(2013-1#1)
in the medium containing 5 mM aspirin##2##7##(2008-11#2)
in the medium containing##8##4##(2008-11#7)(2008-6#1)
in the medium term##3##4##(2008-10#1)(2010-5#1)(2013-7#1)
in the medium was##3##4##(1992-12#1)(2008-11#2)
in the medium with FGF-2##2##5##(2008-11#2)
in the medium with##3##4##(2008-11#3)
in the medium##68##3##(1990-6#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-8#2)(1996-2#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#24)(2008-12#1)(2008-2#6)(2008-3#1)(2008-6#3)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#2)
in the medium- and##2##4##(2008-10#1)(2011-2#1)
in the medulla##2##3##(2007-12#1)(2010-9#1)
in the melanogenic##3##3##(2008-11#1)(2008-5#2)
in the melt##2##3##(2007-12#2)
in the melting##2##3##(1994-3#1)(2013-8#1)
in the membrane and##2##4##(2008-10#2)
in the membrane fraction##2##4##(1990-2#1)(2008-11#1)
in the membrane of the##3##5##(1990-12#2)(2008-9#1)
in the membrane of##4##4##(1990-12#2)(1994-8#1)(2008-9#1)
in the membrane than##2##4##(1990-5#1)(1990-7#1)
in the membrane was##3##4##(1994-11#1)(2008-10#2)
in the membrane##46##3##(1990-12#3)(1990-2#2)(1990-5#1)(1990-7#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-8#2)(2008-10#14)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)
in the membranes##7##3##(1995-11#2)(1995-2#1)(1995-6#1)(2008-5#2)(2011-2#1)
in the memory##2##3##(2008-2#1)(2008-3#1)
in the mental and##2##4##(1996-9#1)(2011-1#1)
in the mental health field##5##5##(1994-1#1)(1995-1#1)(1997-3#2)(2008-11#1)
in the mental health##6##4##(1994-1#1)(1995-1#1)(1997-3#2)(2008-11#1)(2009-6#1)
in the mental##10##3##(1992-2#1)(1994-1#1)(1994-6#1)(1995-1#1)(1996-9#1)(1997-3#2)(2008-11#1)(2009-6#1)(2011-1#1)
in the mesangium##2##3##(1993-2#1)(2008-1#1)
in the mesophyll##2##3##(2008-10#2)
in the mesorectum##2##3##(2009-12#2)
in the mesosphere##3##3##(2008-3#3)
in the metabolic activation of##4##5##(1991-5#1)(1991-9#1)(1994-6#1)(2008-8#1)
in the metabolic syndrome is##2##5##(2008-1#1)(2008-6#1)
in the metabolic syndrome##10##4##(2008-1#1)(2008-3#3)(2008-6#5)(2012-5#1)
in the metabolic##19##3##(1990-5#1)(1991-5#1)(1991-9#1)(1994-5#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-6#5)(2008-8#2)(2012-5#2)
in the metabolism and##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
in the metabolism of domperidone##2##5##(2011-2#2)
in the metabolism of##11##4##(1992-12#1)(1994-8#2)(2008-10#1)(2008-3#2)(2009-6#1)(2011-2#3)(2013-1#1)
in the metabolism##14##3##(1992-12#1)(1994-8#2)(2008-10#2)(2008-3#2)(2008-7#1)(2009-6#1)(2011-2#3)(2013-1#2)
in the metal##3##3##(1990-9#1)(2008-10#2)
in the metapopulation##4##3##(2008-8#1)(2008-9#3)
in the metastatic process in##2##5##(1990-6#1)(2008-1#1)
in the metastatic process##4##4##(1990-6#1)(1993-9#1)(2008-1#1)(2008-4#1)
in the metastatic##7##3##(1990-6#1)(1991-4#1)(1993-9#1)(1994-12#1)(2008-1#1)(2008-4#1)(2010-3#1)
in the methanol extract##2##4##(2008-11#2)
in the method described here generalizes##2##6##(2009-4#2)
in the method##5##3##(1994-12#1)(2008-10#1)(2008-3#1)(2009-4#2)
in the methods of##3##4##(1992-2#1)(1993-11#1)(2009-7#1)
in the methods##7##3##(1992-2#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)
in the methylation##2##3##(1995-12#1)(2009-7#1)
in the methylotrophic yeast Pichia pastoris##4##6##(1994-11#1)(1994-3#1)(1997-4#1)(1997-7#1)
in the methylotrophic yeast##7##4##(1994-11#2)(1994-3#1)(1997-4#3)(1997-7#1)
in the metropolitan area of##2##5##(1991-6#1)(2011-1#1)
in the metropolitan##3##3##(1991-6#1)(2007-12#1)(2011-1#1)
in the mice##2##3##(2008-11#1)(2008-7#1)
in the micellar state have been##2##6##(2008-10#2)
in the micellar state##3##4##(2008-10#3)
in the micellar##9##3##(1990-5#1)(1996-5#2)(2008-10#6)
in the micelle##2##3##(1991-8#1)(2008-10#1)
in the microcrystalline##2##3##(2008-10#2)
in the micrometer range##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
in the micromolar range##4##4##(1994-5#1)(1995-5#1)(2008-10#1)(2008-4#1)
in the micromolar##6##3##(1990-2#1)(1994-5#1)(1995-5#1)(2008-10#2)(2008-4#1)
in the micron##2##3##(2008-10#1)(2009-5#1)
in the microsomal fraction of##3##5##(1990-11#1)(1994-11#1)(1997-3#1)
in the microsomal fraction##6##4##(1990-11#1)(1993-3#1)(1994-11#1)(1994-6#1)(1996-3#1)(1997-3#1)
in the microsomal membranes##3##4##(1991-12#1)(1993-11#1)(1993-3#1)
in the microsomal##12##3##(1990-11#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-6#1)(1996-3#1)(1997-3#1)(2011-2#1)
in the microsomes##2##3##(1994-11#1)(1994-8#1)
in the microstructure##2##3##(2007-11#2)
in the microwave##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2010-4#1)
in the mid IR##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
in the mid to##2##4##(2011-2#1)(2012-3#1)
in the mid##9##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#2)
in the mid- and##2##4##(2008-10#2)
in the mid-1970s##2##3##(1991-9#1)(1995-8#1)
in the mid-1980s##2##3##(1990-3#1)(2008-1#1)
in the mid-IR region##2##4##(2008-10#1)(2008-2#1)
in the mid-IR##5##3##(2007-12#2)(2008-10#2)(2008-2#1)
in the mid-infrared region##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
in the mid-infrared spectral##2##4##(2007-12#1)(2008-3#1)
in the mid-infrared##11##3##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#4)
in the mid-portion of the##2##5##(2008-12#1)(2008-5#1)
in the midbrain##4##3##(1996-12#1)(1997-3#1)(2008-7#2)
in the middle and##4##4##(1994-6#1)(2007-5#1)(2008-7#1)(2008-9#1)
in the middle atmosphere##2##4##(2008-3#2)
in the middle cerebral artery##4##5##(2007-10#2)(2007-8#1)(2010-11#1)
in the middle cerebral##5##4##(1996-2#1)(2007-10#2)(2007-8#1)(2010-11#1)
in the middle elevations##2##4##(2008-10#2)
in the middle infrared region##2##5##(2008-10#2)
in the middle of an##2##5##(1991-12#1)(1994-11#1)
in the middle of the 19th century##2##7##(2008-8#1)(2011-2#1)
in the middle of the##20##5##(1991-11#2)(1993-2#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#3)(2011-2#1)
in the middle of##25##4##(1991-11#2)(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#3)(2011-2#1)(2011-3#1)
in the middle part of the##2##6##(1996-2#1)(2012-12#1)
in the middle##63##3##(1990-11#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#3)(2010-11#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-8#2)
in the midface##2##3##(2007-12#2)
in the midgut and##2##4##(2008-6#1)(2013-1#1)
in the midgut epithelium##2##4##(2008-12#2)
in the midgut##9##3##(2007-12#2)(2008-10#3)(2008-12#2)(2008-6#1)(2013-1#1)
in the midline##2##3##(2007-12#1)(2013-1#1)
in the midsagittal plane##2##4##(1996-5#2)
in the midst of a##3##5##(1993-12#2)(2008-3#1)
in the midst of##9##4##(1993-12#3)(1993-2#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-3#1)(2011-1#1)
in the migration of##3##4##(1995-8#1)(2008-9#1)(2013-8#1)
in the migration##4##3##(1995-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
in the military##2##3##(1996-5#1)(2009-8#1)
in the milk and##3##4##(2008-12#1)(2009-8#1)(2013-1#1)
in the milk of##4##4##(2008-10#2)(2008-12#1)(2013-1#1)
in the milk##7##3##(2008-10#2)(2008-12#2)(2009-8#1)(2013-1#2)
in the millimeter##2##3##(2007-11#1)(2013-7#1)
in the millimeter-wave range##2##4##(2008-3#2)
in the millimolar range##2##4##(1994-5#1)(1995-5#1)
in the millisecond##2##3##(2008-2#2)
in the minicolumn##3##3##(2008-10#3)
in the minimal##2##3##(2008-10#1)(2011-2#1)
in the minimum##2##3##(2008-8#1)(2009-7#1)
in the minor groove of the##3##6##(1993-1#1)(1994-5#1)(1995-3#1)
in the minor groove of##5##5##(1992-3#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-3#1)
in the minor groove##9##4##(1990-7#1)(1992-3#1)(1993-1#2)(1994-5#2)(1995-3#1)(1995-8#1)(1996-3#1)
in the minor##14##3##(1990-7#1)(1992-3#1)(1993-1#2)(1994-5#3)(1994-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#2)(2008-4#1)
in the mitochondria##2##3##(1995-6#1)(1997-2#1)
in the mitochondrial genome##3##4##(1995-6#2)(1996-10#1)
in the mitochondrial matrix##2##4##(1994-11#1)(2010-12#1)
in the mitochondrial membrane##2##4##(1990-2#1)(2008-7#1)
in the mitochondrial##17##3##(1990-12#2)(1990-2#1)(1991-6#1)(1994-11#1)(1995-6#3)(1996-10#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-12#1)(2010-4#1)(2013-8#1)
in the mitotic spindle##2##4##(2008-1#1)(2011-2#1)
in the mitotic##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
in the mix of##2##4##(1992-4#1)(1996-12#1)
in the mixed cultures##3##4##(2013-1#3)
in the mixed inoculation##2##4##(2008-10#2)
in the mixed sample##4##4##(2008-10#4)
in the mixed solvents##4##4##(2008-10#4)
in the mixed##22##3##(1990-2#1)(1992-8#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-6#1)(2013-1#3)
in the mixing##2##3##(2008-10#1)(2008-2#1)
in the mixture of##5##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-12#1)
in the mixture##7##3##(1990-5#1)(2008-10#4)(2008-11#1)(2008-12#1)
in the mixtures##7##3##(2008-10#5)(2008-11#1)(2008-8#1)
in the mobile phase and##4##5##(2008-10#4)
in the mobile phase can be##2##6##(1996-5#2)
in the mobile phase was##3##5##(2008-10#3)
in the mobile phase##20##4##(1996-5#2)(2008-10#18)
in the mobile##21##3##(1996-5#2)(2008-10#19)
in the mode of##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
in the mode##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
in the model as a##2##5##(1990-8#1)(2013-1#1)
in the model as##3##4##(1990-8#1)(1996-3#1)(2013-1#1)
in the model by##2##4##(1995-9#1)(2008-10#1)
in the model##50##3##(1990-8#1)(1992-4#1)(1992-6#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-4#2)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#5)(2008-7#6)(2008-8#3)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
in the modeling of##3##4##(2008-2#1)(2008-3#2)
in the modelling of##2##4##(2008-11#1)(2009-12#1)
in the modelling##3##3##(2008-11#1)(2008-5#1)(2009-12#1)
in the models##4##3##(2008-11#1)(2008-4#1)(2009-8#1)(2013-8#1)
in the moderate##3##3##(2009-2#1)(2013-1#2)
in the modern##7##3##(2008-10#2)(2008-9#2)(2011-2#1)(2012-1#1)(2013-1#1)
in the modification of##2##4##(2008-10#1)(2010-12#1)
in the modified##5##3##(2008-10#2)(2008-9#1)(2009-10#2)
in the modulation of the##2##5##(1997-3#1)(2008-3#1)
in the modulation of##23##4##(1990-7#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-12#2)(1997-1#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
in the moiré##3##3##(2008-3#3)
in the molar##3##3##(2007-12#1)(2008-10#2)
in the molecular basis of##2##5##(1990-8#1)(1996-2#1)
in the molecular genetics of##2##5##(2008-4#1)(2008-7#1)
in the molecular layer of the dentate gyrus##2##8##(1995-12#2)
in the molecular layer##5##4##(1993-9#1)(1995-12#2)(1996-5#1)(2013-8#1)
in the molecular pathogenesis of##2##5##(2007-12#1)(2010-4#1)
in the molecular##21##3##(1990-7#1)(1990-8#1)(1991-5#1)(1993-9#1)(1995-12#2)(1996-2#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-4#2)(2013-8#1)
in the molecule##6##3##(1995-11#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
in the monitoring of##3##4##(1994-6#1)(1997-2#1)(2008-3#1)
in the monkey##8##3##(1991-2#1)(1992-11#1)(1993-6#1)(1995-12#1)(1997-2#1)(2008-8#3)
in the monoclinic space group##8##5##(1996-2#4)(1997-7#3)(2007-11#1)
in the monoclinic space##9##4##(1996-2#4)(1997-7#4)(2007-11#1)
in the monoclinic system##2##4##(1997-7#1)(2013-1#1)
in the monoclinic##11##3##(1996-2#4)(1997-7#5)(2007-11#1)(2013-1#1)
in the monolayer culture##2##4##(2008-11#2)
in the monolayer is##2##4##(1994-6#2)
in the monolayer##6##3##(1991-3#1)(1994-5#1)(1994-6#2)(2008-11#2)
in the monomer##2##3##(1995-5#1)(2008-8#1)
in the morbidity and mortality of the population##5##8##(2013-8#5)
in the morbidity##6##3##(1991-12#1)(2013-8#5)
in the more recent##2##4##(2008-5#1)(2008-7#1)
in the more resistant##3##4##(1990-2#1)(1996-12#1)(2008-10#1)
in the more##19##3##(1990-2#1)(1994-9#1)(1996-12#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-5#2)
in the morning and##2##4##(2008-10#1)(2008-5#1)
in the morning##12##3##(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#6)(2009-4#1)
in the morphological##4##3##(1994-12#1)(1994-8#1)(2007-12#1)(2008-5#1)
in the morphology of the##2##5##(2008-10#1)(2008-3#1)
in the morphology of##4##4##(1994-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
in the morphology##5##3##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
in the mortality rate##3##4##(1994-7#2)(2012-12#1)
in the mortality##5##3##(1994-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
in the moshavot##4##3##(2011-2#4)
in the most efficient manner##2##5##(2008-7#1)(2013-8#1)
in the most of##2##4##(1996-3#1)(2011-1#1)
in the most productive patches##2##5##(2008-9#2)
in the most productive##3##4##(1992-8#1)(2008-9#2)
in the most recent##4##4##(1996-11#1)(2010-8#1)(2011-2#2)
in the most severe##2##4##(1994-9#1)(2008-11#1)
in the most##38##3##(1992-8#1)(1993-12#1)(1993-5#2)(1994-2#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#1)
in the moth##2##3##(2007-12#1)(2009-8#1)
in the mother and##2##4##(2008-7#1)(2012-3#1)
in the mother##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
in the mothers##3##3##(2008-4#2)(2011-1#1)
in the motor cortex##3##4##(2008-7#2)(2010-7#1)
in the motor##4##3##(2008-7#2)(2010-7#2)
in the mountainous##2##3##(2008-1#1)(2008-10#1)
in the mouse brain##2##4##(1995-3#1)(1996-2#1)
in the mouse genome##4##4##(1993-6#1)(1995-2#1)(1995-6#1)(2012-2#1)
in the mouse tail-flick test##2##5##(1991-1#1)(1992-8#1)
in the mouse##45##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#4)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#6)(2008-7#1)(2008-8#2)(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
in the mouth and cervix##2##5##(2013-1#2)
in the mouth##8##3##(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#2)
in the mouths of##2##4##(2008-10#2)
in the mucosa##5##3##(1990-5#1)(2008-4#1)(2013-1#2)(2013-8#1)
in the mucosal##3##3##(1990-5#1)(1996-3#1)(2008-6#1)
in the multi-modality##2##3##(1990-6#1)(2010-3#1)
in the multidisciplinary##2##3##(2008-10#1)(2011-2#1)
in the multilayer##3##3##(2008-3#3)
in the multimode##2##3##(2007-11#1)(2008-3#1)
in the multiphoton##2##3##(1992-11#1)(2008-3#1)
in the multistage##2##3##(1994-8#1)(2013-1#1)
in the multivariate##3##3##(2008-10#1)(2008-6#1)(2010-8#1)
in the municipal##2##3##(2008-10#1)(2012-1#1)
in the municipality of##9##4##(1990-6#1)(1991-9#1)(1992-10#1)(1995-6#2)(1997-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
in the municipality##10##3##(1990-6#1)(1991-6#1)(1991-9#1)(1992-10#1)(1995-6#2)(1997-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
in the murine##3##3##(1991-2#1)(2012-2#1)(2013-8#1)
in the muscle and##3##4##(1992-11#1)(1997-4#1)(2012-2#1)
in the muscle##14##3##(1992-11#1)(1992-8#2)(1992-9#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the muscular##3##3##(2008-9#1)(2009-10#1)(2012-12#1)
in the musculoskeletal system and##2##5##(1990-6#1)(2012-12#1)
in the musculoskeletal system##4##4##(1990-6#1)(1997-6#1)(2012-12#2)
in the mushroom##2##3##(2007-12#1)(2011-2#1)
in the mutagenic##2##3##(1993-11#1)(2008-11#1)
in the mutant and##2##4##(1995-5#1)(2008-10#1)
in the mutant##15##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-11#1)(1994-5#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2011-1#1)
in the mutants##6##3##(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2012-12#1)
in the mutation frequency##2##4##(1997-3#2)
in the mutation##3##3##(1997-3#3)
in the myenteric##2##3##(2009-12#1)(2013-8#1)
in the myocardial##4##3##(1992-4#1)(1992-9#1)(2008-12#1)(2013-1#1)
in the myocardium##6##3##(1996-9#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-7#1)
in the myogenic##5##3##(1990-8#1)(1992-8#1)(1993-12#1)(2008-5#2)
in the myostatin gene##2##4##(2010-4#2)
in the nanocrystals##2##3##(2007-11#2)
in the nanomolar range##3##4##(1992-12#1)(1995-5#1)(2008-10#1)
in the nanomolar##5##3##(1992-12#1)(1995-5#1)(2008-10#2)(2008-4#1)
in the nasal airway##2##4##(2013-1#2)
in the nasal cavity##4##4##(1993-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
in the nasal##9##3##(1993-8#2)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#4)
in the nasopharynx##2##3##(1995-5#2)
in the nation's##3##3##(1992-2#1)(1996-2#1)(2008-7#1)
in the national##5##3##(1991-12#1)(1994-2#1)(2008-9#1)(2009-8#1)(2010-11#1)
in the native enzyme##2##4##(1990-5#1)(1994-8#1)
in the native##12##3##(1990-5#1)(1990-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-8#2)(1995-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-6#1)
in the natural environment##4##4##(2008-10#3)(2011-1#1)
in the natural sciences##2##4##(2008-4#1)(2009-10#1)
in the natural##16##3##(1991-6#1)(1993-1#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-5#1)(2011-1#1)
in the nature of##5##4##(1994-5#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-5#1)
in the nature##10##3##(1994-5#1)(2007-11#1)(2008-10#5)(2010-12#1)(2010-5#1)(2011-3#1)
in the near UV##2##4##(2007-11#1)(2008-10#1)
in the near and##2##4##(2008-2#1)(2008-3#1)
in the near field of a##2##6##(2008-3#1)(2013-8#1)
in the near field of##4##5##(2007-11#1)(2008-3#2)(2013-8#1)
in the near field##8##4##(2007-11#1)(2008-2#1)(2008-3#5)(2013-8#1)
in the near future##33##4##(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#4)(2013-1#1)
in the near infrared is##2##5##(2008-2#2)
in the near infrared##18##4##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#5)
in the near##71##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-5#1)(1997-8#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#13)(2008-5#2)(2008-6#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#4)(2013-1#2)(2013-8#1)
in the near-IR region##2##4##(2007-11#1)(2008-2#1)
in the near-IR##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
in the near-field##3##3##(2007-12#1)(2008-3#2)
in the near-infrared range##2##4##(2008-3#2)
in the near-infrared region##2##4##(2008-3#1)(2009-11#1)
in the near-infrared spectral region##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
in the near-infrared##12##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)(2009-11#1)
in the neck region##3##4##(1992-6#1)(2008-12#1)(2010-11#1)
in the neck##10##3##(1991-8#1)(1992-6#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-7#2)(2010-11#1)(2010-5#1)
in the necrotic##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
in the need for##3##4##(1997-1#1)(2007-7#2)
in the negative direction##2##4##(2008-10#1)(2008-12#1)
in the negative##11##3##(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2010-10#1)(2012-2#1)
in the neighborhood of a##2##5##(1996-3#1)(2008-2#1)
in the neighborhood of##5##4##(1996-3#1)(2007-12#1)(2008-2#1)(2008-3#2)
in the neighborhood##6##3##(1996-3#1)(2007-12#1)(2008-2#2)(2008-3#2)
in the neighbourhood##2##3##(1996-6#1)(1997-1#1)
in the nematode Caenorhabditis elegans##5##5##(1990-5#1)(1997-7#1)(2007-8#2)(2012-12#1)
in the nematode##10##3##(1990-5#1)(1993-12#1)(1994-12#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-10#2)(2012-12#1)
in the neoadjuvant##3##3##(1992-6#1)(1993-11#1)(2013-8#1)
in the neocortex##6##3##(1994-3#1)(1997-2#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-7#1)
in the neonatal age group##2##5##(1996-9#2)
in the neonatal intensive care unit##3##6##(1995-1#1)(1997-3#1)(2008-5#1)
in the neonatal intensive care##5##5##(1990-6#1)(1995-1#1)(1997-3#1)(2008-5#1)(2010-8#1)
in the neonatal period and##2##5##(1997-3#1)(2012-2#1)
in the neonatal period##7##4##(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
in the neonatal rat##2##4##(1997-2#2)
in the neonatal##20##3##(1990-6#1)(1992-8#1)(1995-1#1)(1996-3#1)(1996-9#2)(1997-2#2)(1997-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the neonate##4##3##(1992-6#1)(2008-4#1)(2011-1#1)(2012-3#1)
in the neoplastic##2##3##(1990-12#1)(1994-3#1)
in the nerve##4##3##(1990-5#1)(1991-10#1)(1996-5#1)(1997-3#1)
in the nervous system##25##4##(1992-12#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the nervous##26##3##(1992-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the nest##3##3##(2008-8#1)(2008-9#2)
in the net##6##3##(1997-7#1)(2007-11#2)(2008-10#2)(2013-8#1)
in the network##9##3##(1996-3#1)(2007-12#1)(2008-11#4)(2008-7#1)(2009-8#1)(2012-2#1)
in the neural control of##2##5##(1997-4#1)(2007-7#1)
in the neural##14##3##(1990-11#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-8#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-6#1)
in the neurobiology of##2##4##(2007-8#1)(2008-7#1)
in the neurointermediate##2##3##(1993-5#2)
in the neuromuscular##2##3##(1995-12#1)(2012-3#1)
in the neuronal and glial##2##5##(1990-7#2)
in the neuronal cell##2##4##(1993-8#2)
in the neuronal##7##3##(1990-7#2)(1993-8#2)(1995-12#1)(1997-2#1)(2008-11#1)
in the neurons of##2##4##(1997-2#1)(2008-7#1)
in the neuropeptide Y##2##4##(1995-12#1)(1997-2#1)
in the neurosciences##2##3##(2009-5#1)(2012-3#1)
in the neurosurgical##2##3##(2008-7#1)(2011-2#1)
in the neutral condition##2##4##(2008-4#1)(2012-2#1)
in the neutral pH##2##4##(1990-7#1)(2008-10#1)
in the neutral##7##3##(1990-7#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the new century##2##4##(2008-10#1)(2008-9#1)
in the new millennium##4##4##(2007-2#1)(2008-1#2)(2008-4#1)
in the new model##2##4##(1995-12#1)(2013-1#1)
in the new race##2##4##(2008-10#2)
in the new##31##3##(1991-3#1)(1992-1#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
in the newborn##8##3##(1990-11#1)(1990-9#1)(1993-12#1)(1995-8#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
in the newly described VCG##2##5##(2008-10#2)
in the newly described##3##4##(2008-10#2)(2011-1#1)
in the newly formed##2##4##(2008-10#1)(2008-8#1)
in the newly##9##3##(1994-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-1#1)(2013-8#1)
in the next century##3##4##(1995-12#1)(2008-4#2)
in the next few##2##4##(2008-10#1)(2008-7#1)
in the next issue of##2##5##(1992-3#1)(1993-2#1)
in the next issue##3##4##(1992-3#1)(1993-2#1)(2010-5#1)
in the next millennium##2##4##(2008-4#2)
in the next several years##2##5##(1995-1#1)(2008-5#1)
in the next year##3##4##(2009-6#1)(2011-1#2)
in the next##28##3##(1992-3#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-4#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#2)(2012-12#2)(2013-1#1)
in the nigrostriatal system##4##4##(2008-7#2)(2012-2#2)
in the nigrostriatal##6##3##(1992-10#1)(1996-12#1)(2008-7#2)(2012-2#2)
in the no tillage##2##4##(2008-10#2)
in the no##3##3##(2008-10#2)(2008-12#1)
in the nodose##4##3##(1996-5#4)
in the noise##4##3##(2007-7#1)(2008-2#1)(2008-3#2)
in the nominal absence of##2##5##(2008-8#2)
in the non##3##3##(1991-12#1)(2008-1#1)(2008-10#1)
in the non-coding##2##3##(2008-8#1)(2012-2#1)
in the non-ischaemic group (r = 0##2##7##(2008-10#2)
in the non-ischaemic group##3##4##(2008-10#3)
in the non-linear##2##3##(1997-2#1)(2008-10#1)
in the non-pregnant state##2##4##(1990-11#1)(1994-8#1)
in the non-pregnant##3##3##(1990-11#1)(1993-10#1)(1994-8#1)
in the nonlinear##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
in the nonobese##3##3##(2011-2#3)
in the nonprofit##2##3##(1993-1#1)(1994-2#1)
in the normal EF group##3##5##(2011-2#3)
in the normal and abnormal##2##5##(2008-7#1)(2008-9#1)
in the normal and##5##4##(1992-5#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
in the normal development of the##2##6##(1991-9#1)(2011-1#1)
in the normal development##3##4##(1991-9#1)(2009-4#1)(2011-1#1)
in the normal fimbrial epithelial cells##2##6##(2012-12#2)
in the normal group##3##4##(1990-12#1)(1996-7#2)
in the normal liver##2##4##(1990-5#2)
in the normal population##3##4##(1995-5#1)(1996-6#1)(2008-12#1)
in the normal range##4##4##(1992-9#2)(2007-8#1)(2008-9#1)
in the normal rat##3##4##(1996-2#1)(2008-8#1)(2008-9#1)
in the normal subjects##2##4##(1996-5#2)
in the normal##62##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#3)(1997-8#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-8#1)
in the normal-dispersion regime##3##4##(2007-11#1)(2007-12#2)
in the normal-dispersion region##2##4##(2007-11#1)(2007-12#1)
in the normal-dispersion##5##3##(2007-11#2)(2007-12#3)
in the normotensive##3##3##(1990-3#1)(1997-6#1)(2008-1#1)
in the normothermic##4##3##(1995-12#1)(1996-12#2)(2008-7#1)
in the north of##4##4##(2008-10#1)(2008-12#1)(2010-7#1)(2012-2#1)
in the north##10##3##(1992-8#1)(2008-10#3)(2008-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
in the north-central United States##3##5##(2008-10#3)
in the north-central region of the United States##3##8##(2008-10#3)
in the north-central##6##3##(2008-10#6)
in the north-west Pacific##4##4##(2010-8#4)
in the north-west##5##3##(1996-11#1)(2010-8#4)
in the north-western Pacific##2##4##(2010-8#2)
in the north-western##3##3##(2010-8#2)(2012-12#1)
in the northeast##2##3##(2008-10#1)(2009-2#1)
in the northeastern United States##3##5##(1996-1#1)(2008-10#1)(2011-2#1)
in the northeastern##8##3##(1993-3#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)
in the northern Great Plains##2##5##(2008-10#2)
in the northern hemisphere##2##4##(2008-10#1)(2008-5#1)
in the northern part of the##2##6##(1997-6#1)(2011-2#1)
in the northern part of##4##5##(1990-6#1)(1997-6#1)(2008-5#1)(2011-2#1)
in the northern part##5##4##(1990-6#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
in the northern region of##2##5##(2013-8#2)
in the northern##17##3##(1990-6#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#2)
in the northwest##2##3##(2007-5#1)(2008-10#1)
in the northwestern coast of Cuba##2##6##(2008-5#2)
in the northwestern region of##2##5##(1992-1#1)(2011-1#1)
in the northwestern##4##3##(1992-1#1)(2008-5#2)(2011-1#1)
in the ntra ntrb mutant##3##5##(2009-10#3)
in the ntra ntrb##4##4##(2009-10#4)
in the nu(4)##2##3##(2008-3#2)
in the nuclear genome##2##4##(1995-6#1)(2009-10#1)
in the nuclear##12##3##(1990-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-6#2)(1995-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)
in the nuclei of##8##4##(1990-11#2)(1992-3#1)(1994-6#2)(2008-4#1)(2008-7#1)(2009-12#1)
in the nuclei##13##3##(1990-11#2)(1990-3#1)(1992-3#1)(1994-6#2)(1996-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)
in the nucleolus and##2##4##(1991-2#2)
in the nucleolus##3##3##(1991-2#2)(1994-9#1)
in the nucleotide##3##3##(1990-5#1)(2013-8#2)
in the nucleus accumbens##16##4##(1991-1#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-8#2)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#3)(2008-4#2)(2008-7#1)
in the nucleus and##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
in the nucleus of the##3##5##(1991-2#1)(1993-12#1)(2008-11#1)
in the nucleus of##6##4##(1991-2#1)(1992-11#1)(1993-12#1)(1994-8#1)(2008-11#1)(2011-1#1)
in the nucleus##49##3##(1991-1#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-8#3)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-7#3)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
in the nude##2##3##(1992-2#1)(2008-6#1)
in the number and size of##3##6##(1995-8#1)(2008-10#1)(2010-12#1)
in the number and variety of##2##6##(1995-5#1)(1997-2#1)
in the number and##6##4##(1991-6#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2010-12#1)
in the number of cases of##2##6##(1991-8#1)(1992-11#1)
in the number of genes##3##5##(2008-4#1)(2008-7#1)(2009-5#1)
in the number of patients with##2##6##(1994-12#1)(2008-7#1)
in the number of patients##7##5##(1992-1#1)(1994-12#1)(1994-5#1)(1996-9#1)(2006-10#1)(2008-7#1)(2013-8#1)
in the number of propagules##2##5##(2008-10#2)
in the number of samples##2##5##(2008-10#2)
in the number of species##2##5##(2008-10#1)(2008-8#1)
in the number of tendons of APL##2##7##(2008-7#2)
in the number of the##2##5##(1992-6#1)(2012-3#1)
in the number of unmyelinated fibers in the##3##8##(1993-12#3)
in the number of##128##4##(1990-11#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#5)(1997-3#1)(1997-6#3)(1997-7#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-2#3)(2009-5#1)(2010-1#1)(2010-11#1)(2010-8#2)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
in the number##137##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#6)(1997-3#1)(1997-6#3)(1997-7#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#23)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-2#3)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
in the numbers of infected and susceptible roots over time##2##10##(2008-10#2)
in the numbers of##7##4##(1995-2#1)(1996-12#1)(2008-10#4)(2010-2#1)
in the numerical##3##3##(2008-2#1)(2008-3#2)
in the nursery##2##3##(2008-10#2)
in the nursing curricula##3##4##(2008-11#3)
in the nursing home##3##4##(1997-2#1)(2008-11#1)(2009-3#1)
in the nursing workforce##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
in the nursing##18##3##(1991-1#1)(1994-2#1)(1997-2#1)(2008-11#8)(2008-12#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#2)
in the nutrient media##2##4##(2013-1#2)
in the nutrient##3##3##(2008-7#1)(2013-1#2)
in the nutrition##2##3##(2008-10#1)(2008-5#1)
in the nutritional sciences##2##4##(2012-2#2)
in the nutritional##4##3##(1993-3#1)(2008-9#1)(2012-2#2)
in the obese subjects##2##4##(2012-2#2)
in the obese than the nonobese patients##2##7##(2011-2#2)
in the obese##9##3##(1996-12#1)(2009-11#1)(2011-1#2)(2011-2#3)(2012-2#2)
in the observation##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
in the observed##11##3##(1993-12#1)(1994-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
in the occipital lobe##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
in the occipital region##2##4##(1991-12#1)(1992-8#1)
in the occipital##8##3##(1991-12#1)(1992-8#2)(1995-12#1)(2008-7#2)(2011-1#1)(2011-2#1)
in the occupational health service##2##5##(1995-2#2)
in the occupational health##3##4##(1995-2#2)(2011-2#1)
in the occurrence of##10##4##(1990-8#1)(1991-11#1)(1996-7#1)(1997-3#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the occurrence##12##3##(1990-8#1)(1991-11#1)(1996-7#1)(1997-3#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the ocean##10##3##(2008-2#4)(2008-3#4)(2008-9#1)(2012-2#1)
in the oceans##2##3##(2012-2#1)(2013-8#1)
in the ocular##2##3##(2008-3#1)(2008-4#1)
in the odds##3##3##(1994-2#1)(2013-1#2)
in the oesophagus##2##3##(1990-6#1)(2011-1#1)
in the off-pump group##2##4##(2007-8#2)
in the off-pump##3##3##(2007-8#3)
in the office and##2##4##(1991-2#1)(2009-8#1)
in the office setting##2##4##(2008-4#1)(2011-1#1)
in the office##5##3##(1991-2#1)(1995-12#1)(2008-4#1)(2009-8#1)(2011-1#1)
in the offspring of##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#2)
in the offspring##7##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)
in the oil phase##2##4##(2008-5#2)
in the oil##5##3##(2008-12#1)(2008-5#3)(2011-1#1)
in the old##9##3##(1990-3#5)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)
in the older DS##3##4##(1991-1#3)
in the older adult population##2##5##(2009-12#2)
in the older##13##3##(1990-6#1)(1991-1#3)(1994-5#1)(2008-10#1)(2008-6#2)(2008-9#1)(2009-12#2)(2010-10#1)(2010-8#1)
in the oldest old in Sweden##2##6##(2010-3#2)
in the oldest old##5##4##(1994-5#1)(2007-10#1)(2010-3#3)
in the oldest##10##3##(1990-3#1)(1993-12#1)(1994-5#1)(2007-10#1)(2008-7#2)(2010-3#4)
in the olfactory bulb and##2##5##(1997-4#1)(2009-12#1)
in the olfactory bulb of SAMP8 and SAMR1##2##8##(2008-7#2)
in the olfactory bulb of##3##5##(2008-7#3)
in the olfactory bulb##11##4##(1990-7#1)(1997-3#1)(1997-4#1)(2008-6#2)(2008-7#4)(2009-12#1)(2012-2#1)
in the olfactory epithelium##2##4##(2008-5#2)
in the olfactory##19##3##(1990-7#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#3)(2008-5#2)(2008-6#2)(2008-7#4)(2009-12#2)(2012-2#1)
in the oligosaccharide##2##3##(1993-11#1)(2008-7#1)
in the on-blaze##2##3##(2008-2#2)
in the oncology##2##3##(2006-10#1)(2012-1#1)
in the one##4##3##(1992-4#1)(1995-12#1)(1997-3#1)(2008-10#1)
in the ongoing##3##3##(1991-12#1)(2008-11#1)(2013-8#1)
in the only##4##3##(1991-6#1)(1994-12#1)(1995-1#1)(2012-12#1)
in the onset of##8##4##(1990-8#1)(1994-5#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in the onset##10##3##(1990-8#1)(1994-5#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in the oocyte nucleus##2##4##(2007-12#2)
in the oocyte##7##3##(1993-6#1)(1994-9#1)(1997-2#1)(2007-12#3)(2008-8#1)
in the oocytes from##2##4##(2008-12#1)(2008-8#1)
in the oocytes of##2##4##(2007-12#1)(2008-8#1)
in the oocytes##5##3##(2007-12#1)(2008-12#1)(2008-8#3)
in the open environment was##2##5##(2013-8#2)
in the open field##5##4##(1993-3#4)(2008-10#1)
in the open reading frame##2##5##(1996-12#1)(1997-7#1)
in the open##27##3##(1990-11#1)(1993-3#4)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#3)(2011-2#1)(2013-8#3)
in the operated joint##3##4##(2007-8#3)
in the operating conditions##2##4##(2008-10#2)
in the operating room##12##4##(1991-1#1)(1996-3#1)(2007-8#2)(2007-9#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#1)
in the operating##19##3##(1991-1#1)(1996-3#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-4#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
in the operation of##5##4##(1997-3#2)(2008-12#1)(2008-2#1)(2010-8#1)
in the operation##6##3##(1994-3#1)(1997-3#2)(2008-12#1)(2008-2#1)(2010-8#1)
in the operational##2##3##(1995-6#1)(2008-10#1)
in the operative treatment of##2##5##(2007-11#1)(2008-10#1)
in the operative##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
in the opposite direction##7##4##(1991-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-7#1)(2012-2#1)
in the opposite##10##3##(1991-5#2)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-7#1)(2012-2#1)
in the optic tectum##2##4##(1990-5#1)(2008-6#1)
in the optic##7##3##(1990-5#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)
in the optical domain##5##4##(2007-11#2)(2008-2#1)(2008-3#2)
in the optical path of the##2##6##(2008-10#1)(2008-3#1)
in the optical path##5##4##(2007-12#1)(2008-10#3)(2008-3#1)
in the optical system##3##4##(2008-3#3)
in the optical##29##3##(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#14)
in the optimal##9##3##(1992-9#1)(1994-6#1)(1995-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2011-2#1)
in the optimisation##2##3##(2008-10#2)
in the optimization of##9##4##(2008-10#5)(2008-2#1)(2008-7#2)(2013-8#1)
in the optimization process##2##4##(2008-10#2)
in the optimization##19##3##(2008-10#13)(2008-2#1)(2008-3#1)(2008-7#3)(2013-8#1)
in the optimized medium##2##4##(2008-11#1)(2008-6#1)
in the optimized##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
in the oral cavity of##4##5##(2013-1#4)
in the oral cavity##19##4##(1990-7#1)(1990-9#1)(1995-8#2)(1997-4#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#7)
in the oral mucosal cells of##2##6##(2013-8#2)
in the oral##24##3##(1990-7#1)(1990-9#1)(1995-8#2)(1997-4#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#8)(2013-8#2)
in the orbit##2##3##(2008-7#1)(2013-1#1)
in the orchard and##2##4##(2008-10#2)
in the orchard##13##3##(2008-10#13)
in the order of 0##2##5##(2008-10#1)(2013-1#1)
in the order of the##2##5##(2008-10#1)(2010-1#1)
in the order of their##2##5##(2008-10#1)(2010-3#1)
in the order of##27##4##(1992-11#1)(1993-3#1)(1994-6#1)(1996-12#1)(2008-10#14)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2013-1#2)
in the order##54##3##(1990-5#1)(1990-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-6#2)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#27)(2008-5#5)(2008-6#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#2)(2013-1#2)
in the ordinary##3##3##(1992-6#2)(2008-10#1)
in the organic fraction##2##4##(2008-10#2)
in the organic is##2##4##(2008-7#2)
in the organic phase on##2##5##(2008-10#2)
in the organic phase##11##4##(2008-10#11)
in the organic solvent##2##4##(1992-3#1)(2008-10#1)
in the organic##23##3##(1992-3#1)(1994-8#1)(2008-10#17)(2008-5#1)(2008-6#1)(2008-7#2)
in the organisation##2##3##(1996-12#1)(2008-12#1)
in the organism##8##3##(1993-2#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-4#1)
in the organisms##2##3##(1992-6#1)(2007-7#1)
in the organization and##3##4##(1996-3#1)(1997-1#1)(2008-9#1)
in the organization of the##2##5##(1992-3#1)(2013-8#1)
in the organization of##4##4##(1992-3#1)(2008-2#1)(2008-7#1)(2013-8#1)
in the organization##11##3##(1992-2#1)(1992-3#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
in the orientation of##5##4##(1993-11#1)(1994-5#2)(2008-11#1)(2008-9#1)
in the orientation##6##3##(1993-11#1)(1994-5#2)(2008-11#1)(2008-9#1)(2012-2#1)
in the origin of##3##4##(2007-11#1)(2008-8#1)(2010-6#1)
in the origin##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-6#1)
in the original data##2##4##(1995-5#1)(2008-10#1)
in the original sample##4##4##(2008-10#1)(2008-11#2)(2008-12#1)
in the original samples##2##4##(2008-10#2)
in the original##28##3##(1990-2#1)(1994-8#1)(1995-5#2)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)
in the origins of##2##4##(1993-2#1)(2012-12#1)
in the orthogonal direction##2##4##(2007-11#1)(2007-12#1)
in the orthopaedic##2##3##(1990-9#1)(2013-8#1)
in the oscillation amplitude of the chemical system and the concentration of##2##12##(2008-10#2)
in the oscillation amplitude##4##4##(2008-10#4)
in the other 2##2##4##(1992-8#1)(2007-8#1)
in the other 4##2##4##(1994-7#1)(2008-10#1)
in the other countries##2##4##(2007-12#1)(2010-6#1)
in the other five##2##4##(1990-2#1)(2009-4#1)
in the other group##2##4##(2008-10#1)(2010-4#1)
in the other groups##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
in the other one##2##4##(2008-10#1)(2008-5#1)
in the other species##2##4##(2008-8#1)(2011-2#1)
in the other three##4##4##(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#1)
in the other two groups##4##5##(1991-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
in the other two##7##4##(1991-11#1)(1992-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
in the other##70##3##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-4#1)(1992-8#2)(1993-12#2)(1993-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2013-7#1)(2013-8#1)
in the other)##2##3##(1990-3#1)(2008-8#1)
in the others##3##3##(1992-12#1)(1992-5#1)(1997-2#1)
in the otherwise##2##3##(1990-7#1)(2008-1#1)
in the otoliths of##2##4##(2008-10#1)(2010-8#1)
in the out-of-plane##2##3##(2008-2#1)(2009-7#1)
in the outcome of##4##4##(1993-1#1)(1993-11#1)(2009-3#1)(2011-2#1)
in the outcomes##2##3##(1996-1#1)(2010-3#1)
in the outdoor##2##3##(2008-3#1)(2010-5#1)
in the outer membrane of##2##5##(1990-11#1)(2009-8#1)
in the outer membrane##4##4##(1990-11#1)(1994-12#1)(1994-8#1)(2009-8#1)
in the outer mitochondrial membrane##2##5##(2012-2#2)
in the outer##21##3##(1990-11#2)(1990-2#1)(1991-10#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#2)
in the outermost##2##3##(2008-5#2)
in the outpatient setting##3##4##(1995-2#1)(2006-10#1)(2008-3#1)
in the outpatient##11##3##(1991-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
in the output layer##3##4##(2008-10#2)(2010-8#1)
in the output of##3##4##(1993-9#1)(2007-12#2)
in the output##12##3##(1991-6#1)(1993-9#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)
in the outskirts of Madrid##2##5##(2008-10#1)(2008-11#1)
in the ovarian##2##3##(2008-12#1)(2008-5#1)
in the ovaries##2##3##(2008-5#1)(2008-7#1)
in the ovary and##3##4##(1993-3#1)(2008-6#2)
in the ovary##10##3##(1993-3#1)(1996-2#2)(2008-12#1)(2008-6#2)(2010-5#2)(2010-8#2)
in the overall QOL scores##2##5##(1995-4#2)
in the overall rate##2##4##(1993-11#2)
in the overall##22##3##(1991-12#1)(1992-12#1)(1993-11#2)(1994-6#1)(1995-4#2)(1995-5#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-3#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the overlapping##2##3##(2008-10#1)(2013-1#1)
in the oviduct##4##3##(2008-11#2)(2008-12#2)
in the oxidation of##4##4##(1994-5#2)(2008-10#1)(2008-9#1)
in the oxidation reaction##2##4##(2008-10#2)
in the oxidation##9##3##(1994-5#2)(2008-10#6)(2008-9#1)
in the oxidative burst##2##4##(1995-6#1)(2008-10#1)
in the oxidative##8##3##(1990-2#2)(1990-5#1)(1992-11#1)(1995-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
in the oxide##2##3##(2007-11#1)(2008-10#1)
in the oxygen##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
in the oxygenation##2##3##(1990-8#1)(2008-8#1)
in the ozone##4##3##(1996-1#1)(2008-2#1)(2008-3#2)
in the p53##3##3##(1996-6#1)(2008-9#1)(2010-10#1)
in the pH of##2##4##(2008-10#1)(2008-6#1)
in the pH range 2##3##5##(2008-10#3)
in the pH range 3##5##5##(2008-10#5)
in the pH range 4##4##5##(2008-10#4)
in the pH range 5##2##5##(2008-10#2)
in the pH range 6##2##5##(2008-10#2)
in the pH range 9##2##5##(2008-10#2)
in the pH range from 1##2##6##(2008-10#2)
in the pH range from##6##5##(2008-10#6)
in the pH range of 1##2##6##(2008-10#2)
in the pH range of 2##4##6##(2008-10#4)
in the pH range of 4##2##6##(2008-10#2)
in the pH range of 6##3##6##(2008-10#3)
in the pH range of fresh waters##2##7##(2008-10#2)
in the pH range of##18##5##(2008-10#17)(2008-4#1)
in the pH range##53##4##(2008-10#52)(2008-4#1)
in the pH ranges##2##4##(2008-10#2)
in the pH##60##3##(1995-5#1)(2008-10#57)(2008-4#1)(2008-6#1)
in the pacific northwest##3##4##(2008-10#2)(2013-1#1)
in the paediatric emergency department##4##5##(2008-11#4)
in the paediatric population##8##4##(1996-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2013-1#2)
in the paediatric##17##3##(1996-6#1)(2008-10#2)(2008-11#7)(2008-7#1)(2008-9#2)(2009-5#1)(2010-7#1)(2013-1#2)
in the pallidum##2##3##(1995-5#1)(2008-7#1)
in the pancreas and the##2##5##(1993-3#1)(2011-2#1)
in the pancreas of##3##4##(1990-2#1)(2008-10#1)(2008-7#1)
in the pancreas##16##3##(1990-2#1)(1992-8#1)(1993-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
in the pancreas]##2##3##(1991-3#1)(1992-2#1)
in the pancreatic##5##3##(1991-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
in the paper are##2##4##(1990-12#1)(2008-10#1)
in the paper##10##3##(1990-12#1)(2008-10#4)(2008-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
in the papillary dermis##2##4##(2010-6#2)
in the parallel wire construct##2##5##(2009-3#2)
in the parameter space##2##4##(2007-11#1)(2010-10#1)
in the parameter##3##3##(2007-11#1)(2008-10#1)(2010-10#1)
in the parasite##4##3##(1997-6#1)(2008-10#1)(2012-3#2)
in the paraventricular##4##3##(1993-12#1)(1995-12#1)(1996-12#2)
in the parental##5##3##(1995-8#1)(1997-7#1)(2008-11#1)(2008-9#1)(2009-11#1)
in the parents##6##3##(2007-7#1)(2008-10#5)
in the parietal lobe##2##4##(2007-10#1)(2008-7#1)
in the parietal##6##3##(1995-11#1)(2007-10#1)(2008-7#1)(2010-7#1)(2013-8#2)
in the parotid glands##2##4##(1993-12#1)(2007-10#1)
in the parotid##4##3##(1990-11#1)(1993-12#1)(2007-10#1)(2008-4#1)
in the part##2##3##(2008-5#1)(2011-1#1)
in the partial##2##3##(2008-10#2)
in the partially resistant##2##4##(2008-10#2)
in the partially##3##3##(1995-2#1)(2008-10#2)
in the particle size range##2##5##(2008-3#1)(2008-5#1)
in the particle size##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
in the particular##3##3##(2007-4#1)(2010-7#1)(2012-12#1)
in the particulate fraction##2##4##(1992-11#1)(1994-8#1)
in the particulate matter of emissions and##2##7##(2008-10#2)
in the particulate##4##3##(1992-11#1)(1994-8#1)(2008-10#2)
in the parturient##2##3##(1993-10#2)
in the parvocellular reticular##2##4##(1993-12#1)(1997-2#1)
in the passive section##2##4##(2007-12#1)(2008-3#1)
in the passive##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
in the past 10 years##6##5##(2008-10#1)(2008-11#1)(2009-1#1)(2009-4#1)(2010-8#1)(2013-7#1)
in the past 12 months##5##5##(1995-3#2)(2008-10#1)(2009-5#2)
in the past 15 years##2##5##(2010-12#1)(2011-2#1)
in the past 20 years##5##5##(1995-1#1)(2007-6#1)(2008-10#1)(2010-12#1)(2013-1#1)
in the past 30 days##2##5##(2013-1#2)
in the past 30##3##4##(2007-4#1)(2013-1#2)
in the past as##2##4##(1994-2#1)(2013-8#1)
in the past but##2##4##(1992-12#1)(2010-8#1)
in the past decade have##2##5##(2007-12#1)(2011-1#1)
in the past decade##9##4##(1993-3#1)(1994-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-1#1)
in the past few decades##3##5##(2008-10#2)(2008-7#1)
in the past few years##9##5##(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
in the past few##12##4##(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
in the past in##2##4##(2008-10#1)(2008-5#1)
in the past three decades##3##5##(1992-12#1)(1992-3#1)(2013-8#1)
in the past two decades##2##5##(1990-6#1)(2008-5#1)
in the past two##3##4##(1990-6#1)(2008-5#1)(2013-1#1)
in the past year##3##4##(1996-2#1)(2007-12#1)(2008-1#1)
in the past years##2##4##(2008-10#1)(2010-5#1)
in the past##121##3##(1990-11#1)(1990-6#2)(1991-12#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-3#2)(1996-2#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#4)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
in the paste##4##3##(2008-10#4)
in the patch##6##3##(1994-12#1)(1995-2#1)(2008-8#1)(2008-9#3)
in the path of the##2##5##(2007-11#1)(2008-2#1)
in the path of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
in the path##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
in the pathogen population##8##4##(2008-10#8)
in the pathogen##18##3##(1995-5#1)(2008-10#16)(2009-6#1)
in the pathogenesis and##6##4##(1991-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-8#1)
in the pathogenesis of AD##2##5##(1992-12#1)(2009-5#1)
in the pathogenesis of Alzheimer's disease (AD)##2##7##(1993-12#1)(1997-2#1)
in the pathogenesis of Alzheimer's disease##3##6##(1993-12#1)(1996-12#1)(1997-2#1)
in the pathogenesis of Alzheimer's##4##5##(1993-12#1)(1996-12#1)(1997-2#1)(2011-3#1)
in the pathogenesis of HAA##2##5##(1994-6#2)
in the pathogenesis of IBD##2##5##(2009-12#2)
in the pathogenesis of asthma##4##5##(1992-2#1)(2010-5#1)(2012-3#2)
in the pathogenesis of atherosclerosis##3##5##(1994-11#1)(1997-8#1)(2008-7#1)
in the pathogenesis of cancer##2##5##(2008-4#1)(2011-1#1)
in the pathogenesis of cardiovascular disease##2##6##(2008-3#1)(2013-3#1)
in the pathogenesis of cervical cancer##2##6##(2011-2#2)
in the pathogenesis of diabetic vascular##3##6##(2008-1#3)
in the pathogenesis of diabetic##4##5##(2008-1#4)
in the pathogenesis of the##7##5##(1990-11#1)(1991-5#1)(1992-6#1)(1995-5#1)(2008-1#1)(2008-7#2)
in the pathogenesis of these##2##5##(2008-1#1)(2008-7#1)
in the pathogenesis of##124##4##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#2)(2007-10#1)(2008-1#7)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#5)(2013-3#1)(2013-7#1)(2013-8#5)
in the pathogenesis##133##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#2)(2007-10#1)(2008-1#8)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#10)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-5#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#5)(2013-3#1)(2013-7#1)(2013-8#6)
in the pathogenic##2##3##(2008-10#2)
in the pathogenicity of##2##4##(2008-10#2)
in the pathogenicity##3##3##(2008-10#3)
in the pathological##4##3##(1992-6#1)(2008-12#1)(2011-2#1)(2012-3#1)
in the pathology of##4##4##(2008-10#1)(2009-4#1)(2009-8#1)(2011-2#1)
in the pathology##5##3##(2008-10#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
in the pathophysiology and treatment of##2##6##(2008-4#1)(2008-7#1)
in the pathophysiology of depression##2##5##(2008-7#1)(2013-1#1)
in the pathophysiology of neuropathic pain##2##6##(2008-6#1)(2008-8#1)
in the pathophysiology of this##2##5##(2009-8#1)(2012-2#1)
in the pathophysiology of##24##4##(1993-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#4)(2013-1#4)
in the pathophysiology##27##3##(1993-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#4)(2013-1#5)
in the pathotype##2##3##(2008-10#2)
in the pathway##7##3##(1994-11#1)(1997-2#1)(2008-11#1)(2008-9#1)(2011-3#3)
in the patient group were##2##5##(2011-1#1)(2011-2#1)
in the patient group##6##4##(1997-7#1)(1997-8#1)(2007-8#1)(2011-1#2)(2011-2#1)
in the patient with##4##4##(1991-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the patient##22##3##(1991-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the patient's best##4##4##(1997-8#2)(2008-10#1)(2012-2#1)
in the patient's serum##3##4##(1992-6#1)(1992-9#1)(1993-6#1)
in the patient's##22##3##(1992-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-10#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-8#1)(2013-1#1)
in the patients of##2##4##(2008-1#1)(2010-11#1)
in the patients suffering from##3##5##(2008-7#3)
in the patients than in the controls##3##7##(2008-7#2)(2011-2#1)
in the patients was##3##4##(1991-4#1)(1996-7#1)(2008-7#1)
in the patients with cancer of the##2##7##(2008-7#2)
in the patients with cutaneous##2##5##(2008-12#2)
in the patients with##22##4##(1990-3#1)(1990-6#1)(1991-4#1)(1994-2#1)(1997-8#1)(2008-11#1)(2008-12#2)(2008-7#7)(2009-6#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
in the patients##54##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-7#1)(1996-12#1)(1996-7#3)(1996-9#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#15)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
in the patients'##5##3##(1996-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-7#1)
in the pattern of##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
in the pattern##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
in the patterns of##4##4##(1993-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
in the pePOA of##3##4##(1992-3#3)
in the pePOA##5##3##(1992-3#5)
in the pea##2##3##(1993-8#1)(2008-10#1)
in the peak of##2##4##(2007-2#1)(2007-8#1)
in the peak##11##3##(1993-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)
in the peat mix but##2##5##(2008-10#2)
in the peat mix##4##4##(2008-10#4)
in the pectin layer of##2##5##(2008-10#2)
in the pediatric age group##2##5##(2008-4#1)(2013-1#1)
in the pediatric intensive care unit##2##6##(2012-2#2)
in the pediatric population##5##4##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#2)
in the pediatric##16##3##(1995-5#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
in the peer review process##2##5##(1992-12#1)(1993-1#1)
in the peer-reviewed literature##2##4##(2010-8#1)(2012-12#1)
in the pegfilgrastim and filgrastim groups##2##6##(2008-7#2)
in the pelvic cavity##2##4##(1992-3#1)(2008-12#1)
in the pelvic##4##3##(1992-3#1)(2008-12#1)(2011-2#1)(2012-1#1)
in the pelvis##3##3##(1991-11#1)(2009-12#1)(2011-2#1)
in the penumbra##2##3##(1997-2#2)
in the peptide##7##3##(1990-11#1)(1990-12#1)(1992-5#2)(1992-6#1)(1993-11#1)(2012-12#1)
in the peptidoglycan##2##3##(1995-2#1)(1997-4#1)
in the per##2##3##(1991-2#1)(2013-8#1)
in the perceived##2##3##(2008-11#1)(2009-4#1)
in the percentage of cells##2##5##(2008-10#2)
in the percentage of residents with##2##6##(2011-2#2)
in the percentage of residents##3##5##(2011-2#3)
in the percentage of##19##4##(1991-4#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-8#1)(2008-10#5)(2008-4#1)(2008-9#2)(2011-2#5)
in the percentage##21##3##(1991-4#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-8#1)(2008-10#7)(2008-4#1)(2008-9#2)(2011-2#5)
in the percentages of##3##4##(2008-10#2)(2012-1#1)
in the perception of##4##4##(1992-3#1)(1995-1#1)(2008-1#1)(2012-3#1)
in the percutaneous##2##3##(2008-12#1)(2011-2#1)
in the perennial##2##3##(2008-9#1)(2011-2#1)
in the performance of the##2##5##(2008-2#1)(2013-8#1)
in the performance of##7##4##(1994-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
in the performance##10##3##(1992-11#1)(1994-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2013-8#1)
in the perfusate##3##3##(1996-12#2)(2008-7#1)
in the perfused##3##3##(1990-11#1)(1993-11#1)(1995-3#1)
in the perfusion##2##3##(2008-11#1)(2009-11#1)
in the pericellular##2##3##(2008-4#1)(2011-2#1)
in the perinatal period##4##4##(1993-6#1)(1995-6#1)(2009-2#1)(2009-9#1)
in the perinatal##5##3##(1993-6#1)(1995-6#1)(2009-2#1)(2009-9#1)(2012-3#1)
in the perinuclear##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
in the period before##2##4##(2007-10#1)(2009-10#1)
in the period between##4##4##(1994-2#1)(1996-5#1)(2007-11#1)(2009-7#1)
in the period from##6##4##(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-3#1)
in the period of##5##4##(1991-11#1)(1992-8#1)(2007-11#1)(2011-1#1)(2013-1#1)
in the period##39##3##(1990-6#2)(1991-11#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-6#2)(1994-2#1)(1995-12#2)(1995-9#1)(1996-5#1)(1996-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
in the perioperative period##5##4##(2006-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the perioperative##9##3##(1992-5#1)(2006-7#1)(2008-10#1)(2008-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
in the peripheral blood##13##4##(1990-3#1)(1990-6#1)(1994-11#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
in the peripheral circulation##3##4##(2008-5#1)(2008-9#1)(2013-8#1)
in the peripheral nervous system (PNS)##2##6##(1993-6#1)(1996-12#1)
in the peripheral part##2##4##(1994-12#1)(1996-3#1)
in the peripheral tissues##2##4##(1995-12#2)
in the peripheral##26##3##(1990-3#1)(1990-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#2)
in the periphery##7##3##(1996-12#1)(1997-6#1)(2007-12#1)(2009-10#1)(2009-12#1)(2010-11#1)(2012-3#1)
in the periplasmic space##2##4##(1994-8#1)(2008-4#1)
in the periportal##2##3##(1991-12#1)(1996-2#1)
in the peritoneal cavity##2##4##(2008-1#1)(2008-10#1)
in the perivenous##2##3##(1990-11#2)
in the periventricular##2##3##(2007-10#1)(2009-10#1)
in the permanent calves##2##4##(1996-12#2)
in the permanent##3##3##(1996-12#2)(2010-12#1)
in the permeability of##3##4##(1990-5#1)(2008-10#1)(2008-6#1)
in the perpendicular##2##3##(2008-3#1)(2010-4#1)
in the petioles of inoculated leaves##2##6##(2008-10#2)
in the petioles of##3##4##(2008-10#3)
in the phantom##2##3##(2009-11#1)(2012-12#1)
in the pharmaceutical dosage forms##2##5##(2008-10#2)
in the pharmaceutical industry##10##4##(1995-5#1)(1997-1#1)(1997-4#1)(2008-11#3)(2009-11#2)(2010-11#1)(2012-2#1)
in the pharmaceutical##16##3##(1995-5#1)(1997-1#1)(1997-4#1)(2008-10#5)(2008-11#3)(2009-11#2)(2010-11#1)(2011-1#1)(2012-2#1)
in the pharmacokinetics and##2##4##(2008-8#2)
in the pharmacologic##2##3##(1991-1#1)(1996-9#1)
in the phase function##2##4##(2007-12#1)(2008-3#1)
in the phase##8##3##(2007-12#2)(2008-10#2)(2008-3#4)
in the phase-conjugate##2##3##(2008-3#2)
in the phase-shifting##2##3##(2007-11#1)(2008-3#1)
in the phenotype of##3##4##(1994-3#1)(2008-4#1)(2012-3#1)
in the pheromone##3##3##(1996-2#1)(2007-12#1)(2008-10#1)
in the phloem##4##3##(2008-10#3)(2008-11#1)
in the phonological and orthographic##2##5##(1991-2#2)
in the phospholipid##4##3##(1992-6#1)(1994-2#1)(2008-8#1)(2010-11#1)
in the phosphorylated##2##3##(1990-8#1)(1996-12#1)
in the phosphorylation state of KLC1 at##2##7##(2010-11#2)
in the phosphorylation##3##3##(1990-2#1)(2010-11#2)
in the photo-symbiotic clams##2##4##(2008-5#2)
in the photoacoustic##2##3##(2007-12#1)(2008-2#1)
in the photochemical reaction##2##4##(2008-10#1)(2008-8#1)
in the photochemical##3##3##(2008-10#2)(2008-8#1)
in the photonic##2##3##(2007-12#1)(2008-3#1)
in the photoreceptor##2##3##(1990-11#1)(1993-3#1)
in the phylogenetic##2##3##(2010-3#1)(2013-8#1)
in the phylum##5##3##(1994-12#1)(1996-5#2)(2011-2#2)
in the physical and##2##4##(2009-7#1)(2011-1#1)
in the physical##7##3##(1990-2#1)(1992-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
in the physician's##2##3##(1996-12#1)(2008-4#1)
in the physiological##5##3##(1994-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-6#1)
in the physiology of the##2##5##(1996-2#1)(2009-3#1)
in the physiology of##3##4##(1996-2#1)(1997-2#1)(2009-3#1)
in the physiopathology of##4##4##(1990-9#1)(1994-9#1)(2008-10#1)(2008-7#1)
in the phytopathogenic fungus##2##4##(1997-2#1)(2009-8#1)
in the pi-electron##2##3##(2007-11#2)
in the picosecond##2##3##(2007-12#1)(2008-2#1)
in the pig##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
in the pigeon##3##3##(1995-12#1)(2008-8#2)
in the pilot study##2##4##(2008-7#1)(2011-2#1)
in the pilot##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
in the pim1-d1ts mutant##2##4##(1995-2#2)
in the pineal gland##4##4##(1994-5#1)(1995-11#1)(2008-5#1)(2013-7#1)
in the piriform cortex##2##4##(1994-3#1)(2012-1#1)
in the pituitary gland##2##4##(1992-3#1)(1995-12#1)
in the pituitary##11##3##(1990-7#1)(1992-10#1)(1992-3#1)(1993-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(2008-4#4)
in the place##2##3##(2007-8#1)(2008-12#1)
in the placebo group##11##4##(1990-3#1)(2008-10#2)(2008-5#3)(2011-1#2)(2012-2#1)(2013-1#2)
in the placebo##12##3##(1990-3#1)(2008-10#2)(2008-5#3)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
in the placement of##2##4##(2007-8#1)(2008-12#1)
in the placement##3##3##(2007-8#1)(2008-11#1)(2008-12#1)
in the placenta##2##3##(1990-5#1)(1990-9#1)
in the plane of the##3##5##(1995-2#1)(2007-11#1)(2007-12#1)
in the plane##5##3##(1995-2#1)(2007-11#1)(2007-12#2)(2012-12#1)
in the planetary boundary layer##6##5##(2008-2#3)(2008-3#3)
in the planning and implementation of##2##6##(1993-3#1)(2008-10#1)
in the planning and##3##4##(1992-12#1)(1993-3#1)(2008-10#1)
in the planning##5##3##(1992-12#1)(1993-3#1)(1994-2#1)(2008-10#1)(2009-9#1)
in the plant kingdom and##2##5##(2008-10#1)(2009-12#1)
in the plant kingdom##5##4##(2008-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
in the plant sciences##2##4##(2008-7#1)(2011-10#1)
in the plant tissue##2##4##(2008-10#2)
in the plant##26##3##(1992-3#1)(2008-10#13)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-10#1)(2011-2#1)(2013-8#3)
in the plants##7##3##(2008-10#3)(2008-6#3)(2008-7#1)
in the plasma following##2##4##(2008-10#2)
in the plasma for##3##4##(2008-10#2)(2008-11#1)
in the plasma membrane and##2##5##(1992-9#1)(1994-12#1)
in the plasma membrane fraction##2##5##(1993-8#1)(1994-11#1)
in the plasma membrane of##6##5##(1990-12#1)(1994-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
in the plasma membrane##16##4##(1990-12#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-6#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
in the plasma of Luminal B##2##6##(2010-12#2)
in the plasma of aged##2##5##(1990-7#1)(2012-2#1)
in the plasma of patients##2##5##(1992-9#1)(2008-8#1)
in the plasma of##12##4##(1990-7#1)(1992-6#2)(1992-9#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2012-2#1)
in the plasma torch##3##4##(2008-10#3)
in the plasma##57##3##(1990-12#2)(1990-2#1)(1990-7#2)(1991-8#1)(1992-6#2)(1992-9#3)(1993-8#1)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#7)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
in the plasmid##4##3##(1990-5#1)(1994-12#1)(1995-8#1)(2008-8#1)
in the platelet##3##3##(1990-2#1)(1997-7#1)(2008-11#1)
in the pleural and ascitic fluid##2##6##(2007-12#2)
in the pleural##4##3##(2007-12#3)(2007-7#1)
in the plots##3##3##(2008-10#2)(2008-12#1)
in the plus-maze##4##3##(1992-7#1)(1993-3#1)(1994-2#1)(2008-11#1)
in the point##2##3##(2008-7#1)(2013-8#1)
in the polarization of##2##4##(2008-2#1)(2008-9#1)
in the polarization##3##3##(2008-2#2)(2008-9#1)
in the policy##2##3##(1995-2#1)(1997-2#1)
in the polymer matrix##2##4##(2008-10#1)(2008-7#1)
in the polymer##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
in the polymerase chain reaction##3##5##(1997-6#2)(1997-8#1)
in the polymeric matrix##3##4##(2008-10#2)(2008-2#1)
in the polymeric##4##3##(2008-10#2)(2008-2#2)
in the polymerized##2##3##(2007-11#1)(2008-3#1)
in the polyphosphate chain##2##4##(2009-2#2)
in the poor##3##3##(1991-4#1)(2009-5#1)(2011-2#1)
in the poorest parts of the world##2##7##(1990-2#1)(2008-9#1)
in the popular##2##3##(1995-12#1)(2008-5#1)
in the population are##2##4##(1996-3#1)(2010-8#1)
in the population being##2##4##(1997-2#1)(2012-12#1)
in the population between 2000 and 2010##4##7##(2013-8#4)
in the population from##2##4##(1991-12#1)(2008-10#1)
in the population is##2##4##(1991-9#1)(2011-2#1)
in the population of the##2##5##(2007-1#1)(2008-8#1)
in the population of##12##4##(2007-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the population structure of##2##5##(2008-10#2)
in the population##67##3##(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-2#1)(2007-1#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#6)(2009-3#1)(2009-4#1)(2010-10#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#6)
in the populations from four host genotypes##2##7##(2008-10#2)
in the populations of##2##4##(2008-8#2)
in the populations##5##3##(2008-10#3)(2008-8#2)
in the porcine pituitary##3##4##(1991-12#3)
in the porcine##8##3##(1991-12#3)(1993-3#1)(1995-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
in the pore region##2##4##(2008-8#2)
in the pore water at##2##5##(2008-10#1)(2013-8#1)
in the pore##6##3##(1991-9#1)(2008-10#1)(2008-8#3)(2013-8#1)
in the pores of the##2##5##(2008-10#2)
in the pores##4##3##(2008-10#4)
in the porous##2##3##(2008-3#1)(2012-2#1)
in the portal##2##3##(1994-7#1)(2010-12#1)
in the position of##3##4##(1990-12#1)(1997-3#1)(2008-8#1)
in the position##7##3##(1990-12#2)(1990-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
in the positioning##2##3##(1995-8#1)(2010-3#1)
in the positive ion mode##3##5##(2008-10#1)(2011-3#2)
in the positive##15##3##(1992-2#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-8#1)
in the positively##2##3##(1995-11#1)(2008-6#1)
in the possible##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
in the post##3##3##(2008-11#1)(2008-12#1)(2010-7#1)
in the post-I group##4##4##(2009-3#4)
in the post-genomic era##2##4##(2011-2#1)(2012-3#1)
in the post-operative##2##3##(1993-5#1)(2008-11#1)
in the post-translational##2##3##(1992-6#1)(2008-5#1)
in the post-transplant##2##3##(2007-11#1)(2010-6#1)
in the posterior fossa##8##4##(1996-6#2)(2008-7#4)(2011-2#2)
in the posterior lobe##2##4##(1992-9#2)
in the posterior mediastinum##3##4##(2007-8#1)(2010-12#1)(2011-2#1)
in the posterior##33##3##(1992-9#2)(1993-2#1)(1995-12#1)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#6)(2010-12#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
in the postnatal##4##3##(1990-5#1)(1996-5#1)(2009-8#1)(2009-9#1)
in the postoperative period##7##4##(1990-2#1)(1995-5#1)(2007-8#1)(2007-9#2)(2010-10#2)
in the postoperative setting##2##4##(2008-8#1)(2010-5#1)
in the postoperative##11##3##(1990-2#1)(1994-3#1)(1995-5#1)(2007-8#1)(2007-9#2)(2008-8#1)(2010-10#2)(2010-5#1)(2012-2#1)
in the postpartum period##4##4##(1995-8#1)(2011-2#1)(2012-2#2)
in the postpartum##5##3##(1995-8#1)(2010-6#1)(2011-2#1)(2012-2#2)
in the postsynaptic##2##3##(1996-12#2)
in the potency of##2##4##(1992-3#1)(2008-4#1)
in the potential##9##3##(1992-9#1)(2008-10#4)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
in the potentiation of##2##4##(1995-3#1)(2008-7#1)
in the potentiometric titration of Cu(2+)##3##6##(2008-10#3)
in the potentiometric titration of##11##5##(2008-10#11)
in the potentiometric##12##3##(2008-10#12)
in the pouch##2##3##(1994-9#1)(2008-10#1)
in the power##4##3##(2007-12#1)(2008-3#2)(2010-10#1)
in the practical use of##2##5##(2008-3#2)
in the practical##3##3##(2008-3#3)
in the practice of##18##4##(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
in the practice##22##3##(1990-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
in the pre- and##2##4##(2012-12#2)
in the pre-##3##3##(1994-9#1)(2012-12#2)
in the pre-I group##2##4##(2009-3#2)
in the preS2##2##3##(1993-8#1)(1997-6#1)
in the preceding##7##3##(1992-3#1)(1996-6#1)(1997-6#1)(2008-10#2)(2009-5#1)(2013-8#1)
in the precipitate##3##3##(2008-10#2)(2008-11#1)
in the precipitates##2##3##(2008-10#2)
in the precision##2##3##(2008-10#2)
in the preconcentration##2##3##(2008-10#2)
in the prediabetic##2##3##(2007-5#1)(2010-11#1)
in the predicted##4##3##(1991-6#1)(1994-11#1)(2008-10#2)
in the prediction of##9##4##(1990-5#1)(1995-8#1)(1996-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)
in the prediction##12##3##(1990-5#1)(1990-7#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)
in the predisposition to##2##4##(1991-12#1)(2009-5#1)
in the predisposition##4##3##(1991-12#1)(2008-4#1)(2009-10#1)(2009-5#1)
in the predominant##2##3##(2008-10#1)(2008-3#1)
in the preferred##2##3##(1993-12#1)(2013-8#1)
in the prefrontal cortex of##2##5##(1995-12#1)(2009-12#1)
in the prefrontal cortex##6##4##(1995-12#1)(1996-2#1)(1997-2#1)(2008-7#2)(2009-12#1)
in the prefrontal##7##3##(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-7#2)(2009-12#1)
in the preliminary##2##3##(1990-5#1)(2008-10#1)
in the premammillary##2##3##(1994-2#2)
in the premature##2##3##(2010-2#1)(2011-1#1)
in the prenatal##2##3##(1993-10#1)(2012-2#1)
in the preoperative##8##3##(1990-11#1)(1990-9#2)(1993-9#1)(1997-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
in the preoptic area (POA)##2##5##(1991-5#1)(2008-8#1)
in the preoptic area##4##4##(1991-5#1)(1992-1#1)(1992-3#1)(2008-8#1)
in the preoptic##5##3##(1991-5#1)(1992-1#1)(1992-3#1)(1993-12#1)(2008-8#1)
in the preparation and##2##4##(2008-10#2)
in the preparation of a##2##5##(1997-3#1)(2008-12#1)
in the preparation of##10##4##(1992-3#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
in the preparation##16##3##(1992-3#1)(1995-6#2)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)
in the prepubertal period##2##4##(2008-4#1)(2011-1#1)
in the prescription##2##3##(2008-9#1)(2009-3#1)
in the presence and absence of other##2##7##(2008-8#2)
in the presence and absence of the##5##7##(1990-5#1)(1992-3#1)(2008-10#2)(2011-1#1)
in the presence and absence of##42##6##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#11)(2008-11#2)(2008-7#1)(2008-8#3)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
in the presence and the absence of##2##7##(2008-10#2)
in the presence and##44##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#13)(2008-11#2)(2008-7#1)(2008-8#3)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
in the presence of 0##11##5##(1990-2#1)(1992-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(2008-10#2)(2008-11#1)
in the presence of 1 mM##2##6##(1993-6#1)(1995-12#1)
in the presence of 1 microM##5##6##(1990-12#1)(1991-12#1)(1995-11#1)(1997-7#1)(2009-12#1)
in the presence of 1 mol##2##6##(1994-5#1)(2008-10#1)
in the presence of 1##16##5##(1990-12#1)(1991-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#5)(2009-12#1)
in the presence of 10##3##5##(1995-11#1)(2010-11#1)(2012-12#1)
in the presence of 10% calf serum##2##7##(1991-5#1)(2008-11#1)
in the presence of 10%##4##5##(1991-5#1)(1995-3#1)(2008-10#1)(2008-11#1)
in the presence of 15 microM##2##6##(1990-5#1)(1992-6#1)
in the presence of 16##2##5##(1992-8#1)(2008-8#1)
in the presence of 2 mM##2##6##(1992-6#1)(1993-8#1)
in the presence of 2##7##5##(1990-8#2)(1992-6#1)(1993-8#1)(2008-10#3)
in the presence of 200##4##5##(1990-2#1)(1990-5#1)(2008-10#2)
in the presence of 5 mM##2##6##(1992-11#1)(1997-2#1)
in the presence of 5 microM##2##6##(1995-11#1)(1995-12#1)
in the presence of 5##7##5##(1992-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-7#1)
in the presence of 50##3##5##(1990-8#1)(2008-10#2)
in the presence of 8##2##5##(2008-10#2)
in the presence of ATP##11##5##(1990-7#2)(1991-12#1)(1993-11#1)(1993-6#4)(1995-2#1)(1995-3#1)(2008-4#1)
in the presence of B##2##5##(2008-10#2)
in the presence of Ba(2+)##2##5##(2008-10#2)
in the presence of CH##2##5##(2008-10#2)
in the presence of Ca(2+)##2##5##(2008-10#1)(2008-11#1)
in the presence of Ca2+ and phosphatidylserine##3##7##(1994-11#3)
in the presence of Ca2+ and##4##6##(1994-11#3)(1995-6#1)
in the presence of Ca2+##8##5##(1990-8#1)(1994-11#3)(1995-5#1)(1995-6#3)
in the presence of CaCl2##2##5##(1991-2#1)(1995-3#1)
in the presence of DNA using##2##6##(2008-10#2)
in the presence of DNA##5##5##(2008-10#5)
in the presence of EDTA##2##5##(1995-6#1)(2008-10#1)
in the presence of EGTA##5##5##(1990-10#2)(1990-2#1)(1990-8#1)(1994-6#1)
in the presence of FUTHAN was##2##6##(1990-5#2)
in the presence of Fe(II)##4##5##(2008-10#4)
in the presence of GSH##2##5##(1993-8#1)(2013-1#1)
in the presence of GTP##4##5##(1991-12#2)(1995-8#1)(2008-6#1)
in the presence of H(2)O(2)##3##5##(2008-10#3)
in the presence of H2O2##2##5##(1993-11#1)(1995-2#1)
in the presence of HGF##2##5##(2008-11#2)
in the presence of HS##4##5##(2008-10#4)
in the presence of MRS-2179##2##5##(2008-4#2)
in the presence of NADPH##5##5##(1990-12#2)(1991-5#2)(2009-9#1)
in the presence of NO (-) (3) N##2##8##(2008-10#2)
in the presence of RepK##2##5##(1997-6#2)
in the presence of Ru(bpy)(3)(2+)##2##5##(2008-10#2)
in the presence of T22##2##5##(2008-10#2)
in the presence of UA##2##5##(2008-10#2)
in the presence of UV##3##5##(2008-10#1)(2008-11#2)
in the presence of Z-D-Phe-L-PheGly##2##5##(1992-3#2)
in the presence of a cationic surfactant##2##7##(2008-10#2)
in the presence of a given##2##6##(2008-10#1)(2009-12#1)
in the presence of a high##2##6##(2008-10#2)
in the presence of a large##2##6##(2008-10#2)
in the presence of a transition metal##2##7##(1991-9#1)(1997-4#1)
in the presence of a##62##5##(1990-12#1)(1990-5#1)(1991-5#2)(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#3)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-6#1)(2008-8#1)(2009-11#2)(2009-12#1)(2009-6#2)(2010-4#1)
in the presence of aberrations##2##5##(2008-3#2)
in the presence of acetone##2##5##(2008-10#2)
in the presence of added##2##5##(1991-5#1)(1994-5#1)
in the presence of alcohol##2##5##(1996-12#1)(2010-5#1)
in the presence of alkali##2##5##(2008-10#2)
in the presence of alpha-##2##5##(1991-3#1)(2008-10#1)
in the presence of alpha-CD##2##5##(2008-10#2)
in the presence of ammonia##2##5##(2008-10#2)
in the presence of ammonium##3##5##(2008-10#3)
in the presence of an excess of sodium ion##2##9##(2008-10#2)
in the presence of an excess of##3##7##(2008-10#3)
in the presence of an exogenous##2##6##(2008-10#1)(2008-2#1)
in the presence of an##24##5##(1991-12#1)(1991-5#1)(1992-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-1#1)
in the presence of anions##2##5##(1990-8#1)(2008-10#1)
in the presence of ascorbate##2##5##(1993-8#1)(2013-1#1)
in the presence of ascorbic acid##9##6##(2008-10#8)(2011-1#1)
in the presence of atmospherical particulate matter sampled in a laboratory of the Department##2##14##(2008-10#2)
in the presence of atmospherical particulate matter sampled in a laboratory of the##3##13##(2008-10#3)
in the presence of atmospherical particulate matter##4##7##(2008-10#4)
in the presence of atropine (1 microM) and guanethidine (3 microM)##2##11##(1997-4#2)
in the presence of beta##2##5##(1994-9#1)(2008-10#1)
in the presence of beta-CD was##2##6##(2008-10#2)
in the presence of beta-CD##5##5##(1994-3#1)(2008-10#4)
in the presence of both neuropeptides##2##6##(2007-2#2)
in the presence of both##7##5##(1991-12#1)(1992-5#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-7#1)
in the presence of bovine serum albumin (2 mg/ml)##2##9##(1995-12#2)
in the presence of bovine serum albumin##5##7##(1993-8#1)(1995-12#2)(2008-10#2)
in the presence of bromate##2##5##(2008-10#2)
in the presence of calcium and##3##6##(1990-8#1)(1992-12#1)(1993-12#1)
in the presence of calcium##4##5##(1990-8#1)(1992-12#1)(1993-12#1)(2011-2#1)
in the presence of cardiolipin##2##5##(1991-5#2)
in the presence of cationic##2##5##(2008-10#2)
in the presence of cell walls from##3##7##(2008-10#3)
in the presence of cetylpyridinium chloride##4##6##(2008-10#4)
in the presence of cetyltrimethylammonium bromide (CTAB)##2##7##(2008-10#2)
in the presence of chloride ions##2##6##(1991-9#1)(2008-10#1)
in the presence of chloride##3##5##(1991-9#1)(2008-10#2)
in the presence of chronic##2##5##(2008-1#1)(2008-4#1)
in the presence of clouds with##2##6##(2008-3#2)
in the presence of copper by##2##6##(2008-10#2)
in the presence of copper##8##5##(2008-10#8)
in the presence of cycloheximide##2##5##(1991-12#1)(1994-12#1)
in the presence of cysteine##2##5##(2008-10#2)
in the presence of diagnostic uncertainty##2##6##(2008-12#2)
in the presence of different##10##5##(1990-5#1)(1991-5#1)(1992-5#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-4#1)
in the presence of each other##2##6##(2008-10#1)(2008-5#1)
in the presence of each##4##5##(1996-5#1)(2007-2#1)(2008-10#1)(2008-5#1)
in the presence of either##2##5##(1995-11#1)(1995-9#1)
in the presence of electromechanical##2##5##(1996-9#1)(2009-9#1)
in the presence of epicatechin##2##5##(2008-10#2)
in the presence of ethanol##3##5##(1991-5#1)(2008-10#2)
in the presence of excess of##3##6##(1994-12#1)(2008-10#2)
in the presence of excess##10##5##(1990-2#1)(1990-5#1)(1991-9#1)(1994-12#1)(2008-10#5)(2010-5#1)
in the presence of excitation-induced spectral diffusion##2##7##(2008-2#2)
in the presence of external##2##5##(1992-12#1)(2007-11#1)
in the presence of extrinsic phospholipid##2##6##(2008-9#2)
in the presence of ferrous ions##2##6##(1990-12#1)(2009-11#1)
in the presence of ferrous##3##5##(1990-12#1)(2008-5#1)(2009-11#1)
in the presence of folimycin##2##5##(1993-6#2)
in the presence of free##2##5##(2008-10#2)
in the presence of fructose 6-phosphate##2##6##(1990-7#2)
in the presence of genistein##3##5##(1997-7#2)(2008-11#1)
in the presence of glucose##4##5##(1995-8#2)(2008-10#2)
in the presence of glutathione##2##5##(1996-12#1)(2013-1#1)
in the presence of guanidine##2##5##(1995-5#1)(2008-4#1)
in the presence of heparin##2##5##(1992-5#1)(2010-8#1)
in the presence of high concentrations of##4##7##(1990-12#1)(1994-9#1)(2008-10#2)
in the presence of high levels of##2##7##(1990-8#1)(2008-10#1)
in the presence of high##12##5##(1990-12#1)(1990-8#1)(1991-9#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)
in the presence of horseradish peroxidase (HRP)##2##7##(2008-10#2)
in the presence of human##3##5##(1990-12#1)(2008-10#1)(2009-4#1)
in the presence of hydrogen peroxide##7##6##(2008-10#7)
in the presence of imidazole##2##5##(1994-5#2)
in the presence of inorganic##2##5##(2008-10#1)(2008-6#1)
in the presence of interferents##2##5##(2008-10#2)
in the presence of interfering##2##5##(2008-10#1)(2013-1#1)
in the presence of iron##4##5##(1991-5#1)(1995-3#1)(2008-10#1)(2013-1#1)
in the presence of large##9##5##(2007-11#3)(2007-12#1)(2008-10#5)
in the presence of liposomes##2##5##(2008-10#2)
in the presence of long##2##5##(1995-6#1)(2008-4#1)
in the presence of low##2##5##(1994-5#1)(2008-11#1)
in the presence of magnesium##2##5##(1997-3#1)(2008-4#1)
in the presence of males##3##5##(2009-9#3)
in the presence of maltotriose##2##5##(1990-12#2)
in the presence of many##2##5##(2008-10#1)(2012-3#1)
in the presence of metal##2##5##(1995-2#1)(2008-11#1)
in the presence of molybdate##3##5##(1990-11#1)(1992-3#1)(2008-10#1)
in the presence of nitrate##3##5##(1992-6#1)(2008-10#1)(2008-11#1)
in the presence of noise##8##5##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#2)(2010-10#1)(2011-1#1)
in the presence of nonionic##2##5##(2008-10#2)
in the presence of normal##2##5##(2008-1#1)(2011-2#1)
in the presence of one another##2##6##(2008-10#2)
in the presence of other risks##2##6##(1997-4#1)(2009-12#1)
in the presence of other##8##5##(1991-5#1)(1997-4#1)(2008-10#4)(2008-4#1)(2009-12#1)
in the presence of otherwise##2##5##(1994-8#1)(2007-12#1)
in the presence of oxygen##8##5##(1991-2#1)(1993-6#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-9#1)
in the presence of palmitic acid##2##6##(2008-5#1)(2009-6#1)
in the presence of phenol##4##5##(2008-10#4)
in the presence of polyethylene glycol##2##6##(1992-11#1)(2008-10#1)
in the presence of potassium##2##5##(2007-11#1)(2008-10#1)
in the presence of pyridine##3##5##(1996-2#1)(2007-11#1)(2008-10#1)
in the presence of random##2##5##(2007-11#1)(2008-3#1)
in the presence of rare variants##2##6##(2012-3#2)
in the presence of rare##3##5##(2012-3#3)
in the presence of reactive##2##5##(2008-10#1)(2009-8#1)
in the presence of relatively##2##5##(1991-9#1)(2008-10#1)
in the presence of saturating##2##5##(1997-2#1)(2008-8#1)
in the presence of several interfering##2##6##(2008-10#2)
in the presence of several substances##2##6##(2008-10#2)
in the presence of several##5##5##(2008-10#5)
in the presence of sodium chloride higher than 0##2##9##(2008-10#2)
in the presence of sodium dodecyl sulfate (SDS)##2##8##(1990-11#1)(2008-2#1)
in the presence of sodium dodecyl sulfate and##2##8##(1996-12#1)(2008-10#1)
in the presence of sodium dodecyl sulfate##4##7##(1990-11#1)(1996-12#1)(2008-10#1)(2008-2#1)
in the presence of sodium tartrate##2##6##(2008-10#2)
in the presence of sodium##21##5##(1990-11#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#14)(2008-2#1)(2008-6#1)(2008-9#1)
in the presence of some##2##5##(2008-10#2)
in the presence of strong##2##5##(2008-3#2)
in the presence of strongly##2##5##(2008-10#2)
in the presence of such##2##5##(1991-12#1)(2008-2#1)
in the presence of sufficient##2##5##(1995-2#1)(2008-10#1)
in the presence of sulphuric acid##2##6##(2008-10#2)
in the presence of surfactants##4##5##(2008-10#4)
in the presence of technology##3##5##(2007-10#3)
in the presence of the cation##2##6##(1992-3#1)(2008-8#1)
in the presence of the magnetic field##2##7##(2008-10#1)(2008-3#1)
in the presence of the neutral##2##6##(2008-10#2)
in the presence of the other##2##6##(2008-10#1)(2008-12#1)
in the presence of the##73##5##(1990-11#2)(1990-5#2)(1991-12#1)(1991-9#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#30)(2008-12#1)(2008-3#4)(2008-4#3)(2008-8#5)(2009-11#1)(2011-3#1)(2013-7#1)
in the presence of their degradates##2##6##(2008-10#2)
in the presence of these##2##5##(1991-8#1)(1995-2#1)
in the presence of this##4##5##(1993-8#1)(1997-2#1)(2008-10#2)
in the presence of trifluoroethanol##2##5##(1995-2#2)
in the presence of tunicamycin##3##5##(1993-6#1)(1994-8#1)(2008-11#1)
in the presence of two different##2##6##(2008-10#1)(2008-4#1)
in the presence of two##3##5##(2008-10#2)(2008-4#1)
in the presence of uric acid##2##6##(2008-10#2)
in the presence of various##7##5##(1994-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2008-10#1)(2012-3#1)
in the presence of varying##2##5##(2008-10#2)
in the presence of vitamin##2##5##(1992-12#1)(1993-6#1)
in the presence of zinc##2##5##(2008-10#1)(2010-10#1)
in the presence of##1213##4##(1990-10#4)(1990-11#5)(1990-12#12)(1990-2#10)(1990-5#15)(1990-7#6)(1990-8#15)(1991-12#14)(1991-2#4)(1991-3#1)(1991-5#15)(1991-8#2)(1991-9#8)(1992-11#6)(1992-12#7)(1992-2#3)(1992-3#11)(1992-4#1)(1992-5#5)(1992-6#9)(1992-7#1)(1992-8#5)(1992-9#4)(1993-11#8)(1993-12#1)(1993-3#3)(1993-6#17)(1993-8#16)(1993-9#4)(1994-11#11)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#13)(1994-6#9)(1994-8#6)(1994-9#4)(1995-11#10)(1995-12#8)(1995-2#18)(1995-3#7)(1995-5#8)(1995-6#8)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#16)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#8)(1997-8#3)(2007-10#5)(2007-11#22)(2007-12#16)(2007-2#3)(2007-7#1)(2008-1#4)(2008-10#475)(2008-11#47)(2008-12#6)(2008-2#16)(2008-3#41)(2008-4#25)(2008-5#10)(2008-6#9)(2008-7#8)(2008-8#18)(2008-9#10)(2009-10#1)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#15)(2013-7#2)(2013-8#1)
in the presence or absence of the##2##7##(1991-5#1)(1995-8#1)
in the presence or absence of##20##6##(1990-11#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-3#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#6)(2008-2#1)(2008-8#2)
in the presence or absence##21##5##(1990-11#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-3#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#2)
in the presence##1283##3##(1990-10#4)(1990-11#7)(1990-12#13)(1990-2#11)(1990-5#17)(1990-6#1)(1990-7#6)(1990-8#15)(1991-11#1)(1991-12#14)(1991-2#4)(1991-3#2)(1991-5#16)(1991-6#1)(1991-8#2)(1991-9#9)(1992-11#6)(1992-12#7)(1992-2#3)(1992-3#14)(1992-4#2)(1992-5#5)(1992-6#11)(1992-7#1)(1992-8#5)(1992-9#4)(1993-11#10)(1993-12#1)(1993-3#5)(1993-6#17)(1993-8#17)(1993-9#4)(1994-11#11)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#13)(1994-6#9)(1994-8#6)(1994-9#4)(1995-11#11)(1995-12#8)(1995-2#19)(1995-3#7)(1995-5#8)(1995-6#9)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#17)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#8)(1997-8#3)(2007-10#5)(2007-11#22)(2007-12#16)(2007-2#3)(2007-7#1)(2008-1#4)(2008-10#496)(2008-11#52)(2008-12#6)(2008-2#17)(2008-3#41)(2008-4#25)(2008-5#10)(2008-6#9)(2008-7#9)(2008-8#23)(2008-9#10)(2009-10#1)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#10)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#17)(2013-7#2)(2013-8#1)
in the presenilin-1##2##3##(1995-12#2)
in the present article##3##4##(1990-6#1)(2008-10#1)(2008-11#1)
in the present case the##2##5##(1990-5#1)(2011-2#1)
in the present case##8##4##(1990-5#1)(1995-4#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
in the present investigation##2##4##(2008-10#1)(2008-11#1)
in the present paper##9##4##(1996-4#1)(2008-10#5)(2008-11#1)(2013-8#2)
in the present series##2##4##(1990-12#1)(2008-7#1)
in the present study that##2##5##(1994-8#1)(1995-12#1)
in the present study we have##2##6##(1997-2#1)(2012-2#1)
in the present study we##3##5##(1997-2#1)(2011-2#1)(2012-2#1)
in the present study were##2##5##(1993-3#1)(2009-8#1)
in the present study##46##4##(1990-2#1)(1990-6#1)(1992-10#1)(1992-12#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1997-2#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-7#1)(2013-8#2)
in the present work we##3##5##(1990-12#1)(2008-10#1)(2008-8#1)
in the present work##10##4##(1990-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2013-8#1)
in the present##101##3##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-8#4)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#21)(2008-11#6)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#6)
in the presentation of##3##4##(1991-11#1)(2010-12#1)(2010-8#1)
in the presentation##4##3##(1991-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
in the preservation##2##3##(2008-10#1)(2008-11#1)
in the pressor response to##2##5##(1992-8#1)(1997-2#1)
in the pressure##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
in the presynaptic##4##3##(1993-3#1)(1994-8#1)(1996-2#2)
in the prevailing##2##3##(1993-6#1)(2008-10#1)
in the prevalence of 5##3##5##(1997-3#3)
in the prevalence of hypertension##2##5##(2008-1#2)
in the prevalence of##19##4##(1991-11#1)(1996-12#1)(1996-9#1)(1997-3#3)(2007-7#1)(2008-1#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
in the prevalence##21##3##(1991-11#1)(1996-12#1)(1996-9#1)(1997-3#3)(2007-7#1)(2008-1#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the prevention and treatment of acne vulgaris##2##8##(2008-5#2)
in the prevention and treatment of osteoporosis##3##7##(1993-11#2)(1997-6#1)
in the prevention and treatment of##13##6##(1993-11#2)(1997-6#1)(2006-10#2)(2008-10#1)(2008-5#3)(2008-7#1)(2010-3#1)(2012-12#1)(2013-8#1)
in the prevention and treatment##14##5##(1993-11#2)(1997-6#1)(2006-10#2)(2008-10#1)(2008-5#3)(2008-7#1)(2010-3#1)(2012-12#1)(2013-8#2)
in the prevention and##16##4##(1991-6#1)(1991-9#1)(1993-11#2)(1997-6#1)(2006-10#2)(2008-10#1)(2008-5#3)(2008-7#1)(2010-3#1)(2012-12#1)(2013-8#2)
in the prevention of acute##2##5##(1990-5#1)(2008-5#1)
in the prevention of mother-to-child transmission##2##6##(2009-4#1)(2009-7#1)
in the prevention of the##2##5##(1991-9#1)(2011-2#1)
in the prevention of this##2##5##(1990-3#1)(2007-4#1)
in the prevention of venous thromboembolism##2##6##(2007-10#1)(2010-11#1)
in the prevention of##35##4##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
in the prevention##53##3##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#2)(1992-5#1)(1992-9#1)(1993-11#4)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#5)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-8#2)
in the previous 12 months##4##5##(1994-12#1)(1997-3#1)(2010-8#1)(2013-1#1)
in the previous one year##3##5##(2011-2#3)
in the previous paper##3##4##(1994-5#1)(2008-10#1)(2008-2#1)
in the previous six months##3##5##(2011-1#3)
in the previous studies##3##4##(2008-10#1)(2011-1#2)
in the previous study##5##4##(1992-6#1)(1993-12#2)(1994-2#1)(2008-9#1)
in the previous year##4##4##(1994-12#1)(2007-5#1)(2008-10#2)
in the previous##40##3##(1992-3#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the previously sprayed##2##4##(2008-10#2)
in the previously##5##3##(1994-2#1)(2008-10#3)(2009-6#1)
in the prg pathogens##2##4##(2008-10#2)
in the primary afferent##2##4##(1995-12#1)(1995-5#1)
in the primary and##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
in the primary care setting##6##5##(2008-11#2)(2010-1#2)(2013-1#2)
in the primary care##7##4##(1995-11#1)(2008-11#2)(2010-1#2)(2013-1#2)
in the primary health##2##4##(1992-11#1)(2011-2#1)
in the primary structure of the##2##6##(1992-3#1)(2008-4#1)
in the primary structure of##4##5##(1990-11#1)(1992-3#1)(2008-4#1)(2011-2#1)
in the primary tumor and##2##5##(1992-6#1)(1993-1#1)
in the primary tumor##3##4##(1992-6#1)(1993-1#1)(2013-8#1)
in the primary visual cortex##2##5##(1995-11#1)(2008-8#1)
in the primary##52##3##(1990-11#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-11#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-5#2)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
in the primate brain##2##4##(1997-2#2)
in the primate##4##3##(1995-11#1)(1997-2#2)(2011-2#1)
in the principal##3##3##(2007-12#1)(2008-3#2)
in the prior##2##3##(1995-2#1)(2008-5#1)
in the private sector##5##4##(1991-1#1)(1993-2#1)(2006-10#1)(2008-1#1)(2008-6#1)
in the private##12##3##(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-6#1)(2012-2#1)
in the probability of##5##4##(1995-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
in the probability##7##3##(1995-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)
in the probe##2##3##(1992-11#1)(2008-10#1)
in the problems##3##3##(1995-3#1)(2006-10#1)(2008-3#1)
in the procedure is##2##4##(2008-10#1)(2012-3#1)
in the procedure##9##3##(1993-3#1)(2008-10#4)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
in the process and##4##4##(1994-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
in the process of the##3##5##(2007-11#1)(2008-8#1)(2012-3#1)
in the process of##72##4##(1990-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
in the process##90##3##(1990-5#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#4)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
in the processes of##7##4##(1993-8#1)(1997-3#1)(1997-4#1)(2008-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
in the processes##13##3##(1992-8#1)(1993-3#1)(1993-8#1)(1997-3#1)(1997-4#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-3#1)
in the processing of as many as 25 samples per hour##2##11##(2008-10#2)
in the processing of as many as 25##3##8##(2008-10#3)
in the processing of##12##4##(1992-10#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-2#1)(2013-8#1)
in the processing##14##3##(1992-10#1)(1993-5#1)(1994-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2009-2#1)(2013-8#1)
in the producing##2##3##(1992-9#2)
in the product##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
in the production and##2##4##(2006-6#1)(2007-4#1)
in the production of a##4##5##(1990-7#1)(2008-10#1)(2008-5#1)(2011-3#1)
in the production of different##2##5##(2008-10#1)(2008-2#1)
in the production of##49##4##(1990-7#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-4#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#4)
in the production##58##3##(1990-7#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-4#2)(2006-6#1)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#3)
in the productive##2##3##(1990-7#1)(2008-1#1)
in the profession##2##3##(2012-3#1)(2013-1#1)
in the professional##5##3##(1992-3#1)(1993-1#1)(2008-10#1)(2010-3#1)(2011-2#1)
in the profile of the##2##5##(1996-10#1)(2011-2#1)
in the profile of##3##4##(1995-11#1)(1996-10#1)(2011-2#1)
in the profile##4##3##(1995-11#1)(1996-10#1)(2008-3#1)(2011-2#1)
in the profiles##2##3##(2008-2#1)(2012-1#1)
in the progeny of damaged plants in##2##7##(2008-8#2)
in the progeny of##8##4##(2008-10#3)(2008-8#3)(2008-9#1)(2010-8#1)
in the progeny##10##3##(2008-10#4)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)
in the prognosis and##2##4##(2008-8#1)(2010-3#1)
in the prognosis##4##3##(2008-8#2)(2010-3#1)(2012-1#1)
in the program structure##2##4##(2008-3#1)(2008-9#1)
in the program##8##3##(1991-12#1)(1993-2#1)(1995-12#1)(1997-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
in the progression of gastric##2##5##(2011-2#2)
in the progression of##13##4##(1991-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2009-5#1)(2009-7#1)(2011-2#2)(2013-1#1)
in the project##7##3##(1995-11#1)(1997-3#1)(2007-12#1)(2008-11#2)(2009-7#1)(2013-1#1)
in the projected##2##3##(2008-10#1)(2008-3#1)
in the proliferating primary rat hepatocytes##2##6##(1993-8#2)
in the proliferation of##4##4##(1990-5#1)(1993-3#1)(2008-4#1)(2010-11#1)
in the proliferation rate##2##4##(1995-4#1)(2008-7#1)
in the proliferation##7##3##(1990-5#1)(1991-5#1)(1993-3#1)(1995-4#1)(2008-4#1)(2008-7#1)(2010-11#1)
in the proliferative##2##3##(1991-3#1)(1994-9#1)
in the prolonged##2##3##(2010-3#1)(2013-1#1)
in the promoter and##2##4##(1990-11#1)(1994-11#1)
in the promoter of the##4##5##(1995-2#1)(2008-11#1)(2009-7#1)(2012-12#1)
in the promoter of##6##4##(1995-2#1)(2008-11#1)(2008-9#2)(2009-7#1)(2012-12#1)
in the promoter or in##2##5##(2008-5#1)(2012-3#1)
in the promoter region of the##2##6##(1994-6#1)(1995-11#1)
in the promoter region of##3##5##(1994-6#1)(1995-11#1)(2011-2#1)
in the promoter region##7##4##(1991-6#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(2011-2#1)
in the promoter##20##3##(1990-11#1)(1991-6#2)(1993-3#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
in the promoters of##4##4##(1994-6#1)(2008-1#1)(2008-7#1)(2008-9#1)
in the promotion of##5##4##(1993-3#1)(1993-6#2)(2008-11#1)(2011-1#1)
in the prone position##5##4##(1992-11#3)(1992-4#1)(2008-7#1)
in the propagation of##2##4##(1990-5#1)(2008-10#1)
in the propagation##5##3##(1990-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
in the propensity##2##3##(2009-7#2)
in the proper##6##3##(1994-6#1)(2007-11#2)(2007-7#1)(2012-2#1)(2013-1#1)
in the prophylaxis and##2##4##(2008-5#1)(2010-8#1)
in the prophylaxis of##6##4##(1991-3#1)(1991-5#1)(2008-5#2)(2008-7#1)(2009-5#1)
in the prophylaxis##8##3##(1991-3#1)(1991-5#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-8#1)
in the proportion of##17##4##(1991-12#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#2)
in the proportional##2##3##(1997-8#1)(2011-2#1)
in the proportions of##2##4##(1991-9#1)(2009-7#1)
in the proposed method##2##4##(2008-10#2)
in the proposed system##2##4##(2008-10#2)
in the proposed##12##3##(1994-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)
in the propranolol group##2##4##(2009-8#2)
in the protected##3##3##(1990-11#1)(2008-10#1)(2008-3#1)
in the protection against the##2##5##(2008-10#1)(2013-8#1)
in the protection against##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
in the protection of##2##4##(2008-10#1)(2008-5#1)
in the protection##9##3##(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-1#1)(2013-8#1)
in the protective effect##2##4##(1995-12#1)(1996-12#1)
in the protective##4##3##(1994-2#1)(1995-12#1)(1996-12#1)(2013-7#1)
in the protein and##3##4##(1993-6#1)(1994-8#1)(2008-10#1)
in the protein sequence##2##4##(2008-7#1)(2010-11#1)
in the protein##29##3##(1990-12#1)(1990-5#1)(1990-8#1)(1993-6#2)(1994-8#1)(1995-2#2)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
in the proteins##3##3##(1993-6#1)(2008-10#2)
in the proteolytic processing of##2##5##(1990-8#1)(1991-9#1)
in the proteolytic##3##3##(1990-8#1)(1991-9#1)(2013-1#1)
in the protocerebrum##3##3##(2007-12#3)
in the protocol##3##3##(1992-3#1)(1997-5#1)(2011-2#1)
in the protonated##2##3##(1995-5#1)(2008-10#1)
in the province of Alberta##2##5##(2008-11#1)(2012-12#1)
in the province of Cordoba##2##5##(2009-7#2)
in the province of Corrientes##2##5##(2008-5#2)
in the province of Huelva##2##5##(1996-6#1)(2008-10#1)
in the province of Quebec##3##5##(2007-12#2)(2009-10#1)
in the province of Trento##2##5##(2008-8#2)
in the province of##21##4##(1994-9#2)(1996-3#1)(1996-6#1)(1997-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2009-10#2)(2009-7#2)(2012-12#1)(2013-1#1)
in the province##26##3##(1992-10#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2009-10#2)(2009-7#2)(2012-12#1)(2013-1#2)
in the provinces of##2##4##(2008-10#1)(2008-8#1)
in the provision of travel health advice and##2##8##(2007-2#2)
in the provision of##14##4##(1993-2#1)(1994-1#1)(1995-3#1)(1997-2#2)(1997-5#1)(2007-2#2)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#1)(2011-2#1)
in the provision##15##3##(1993-2#1)(1994-1#1)(1995-3#2)(1997-2#2)(1997-5#1)(2007-2#2)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#1)(2011-2#1)
in the proximal portion##2##4##(1995-12#1)(1997-4#1)
in the proximal tibia##3##4##(2009-3#1)(2012-1#2)
in the proximal tubular##2##4##(1994-5#1)(2011-2#1)
in the proximal##21##3##(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-3#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
in the proximity of a##2##5##(2008-7#1)(2008-8#1)
in the proximity##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
in the pseudogenes##2##3##(1990-8#1)(1991-6#1)
in the psychiatric setting##2##4##(1992-2#2)
in the psychiatric##3##3##(1991-12#1)(1992-2#2)
in the psychological##2##3##(1990-10#1)(2012-3#1)
in the pubertal period##2##4##(2011-1#2)
in the public and private##2##5##(1997-3#1)(2013-7#1)
in the public debate##2##4##(2008-11#1)(2010-11#1)
in the public domain##5##4##(1994-12#1)(1996-1#1)(1996-2#1)(2008-4#1)(2009-12#1)
in the public health##3##4##(2007-12#1)(2008-8#1)(2010-8#1)
in the public sector##3##4##(1996-12#1)(2010-3#1)(2012-12#1)
in the public##23##3##(1991-11#1)(1992-3#1)(1993-1#1)(1994-12#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2006-10#3)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#2)(2013-7#1)
in the publication##2##3##(2007-12#1)(2008-10#1)
in the published literature##2##4##(1991-3#1)(2012-12#1)
in the published##4##3##(1991-3#1)(1992-11#1)(2008-10#1)(2012-12#1)
in the pulmonary##11##3##(1990-5#1)(1991-9#1)(1994-12#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-6#2)(2010-8#1)(2013-1#1)
in the pulp##6##3##(1991-2#3)(2008-7#1)(2013-8#2)
in the pulse spectrum##2##4##(2008-3#2)
in the pulse##4##3##(2008-10#1)(2008-3#3)
in the purchase##2##3##(1995-2#1)(1996-12#1)
in the purification of##3##4##(1991-2#1)(1995-6#1)(2008-2#1)
in the purified##5##3##(1990-11#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)
in the purple##2##3##(1993-8#1)(1997-8#1)
in the pursuit of##3##4##(1993-2#1)(2008-12#2)
in the putamen##2##3##(2008-7#2)
in the putative promoter##2##4##(1992-6#1)(1996-10#1)
in the putative##9##3##(1990-11#1)(1990-8#1)(1991-2#2)(1992-6#1)(1995-5#1)(1996-10#1)(1997-9#1)(2008-10#1)
in the pyridine##2##3##(1992-1#1)(2008-10#1)
in the pyruvate kinase##2##4##(1990-8#1)(2008-7#1)
in the qualitative##2##3##(1997-3#1)(2008-10#1)
in the quality and##2##4##(2008-11#2)
in the quality control of different##2##6##(2008-10#2)
in the quality control of##5##5##(1994-1#1)(2008-10#3)(2010-4#1)
in the quality control##6##4##(1994-1#1)(2008-10#4)(2010-4#1)
in the quality of care##5##5##(1995-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(2008-7#1)
in the quality of each##2##5##(1991-12#1)(2009-12#1)
in the quality of the##3##5##(1996-3#1)(2008-3#1)(2011-2#1)
in the quality of##15##4##(1991-12#1)(1995-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-3#1)
in the quality##26##3##(1991-12#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)
in the quantification of##6##4##(2008-10#4)(2013-1#2)
in the quantitative##6##3##(1996-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
in the quantity of##5##4##(1992-12#1)(1994-8#1)(1996-12#1)(2008-10#1)(2009-9#1)
in the rAAV-antisense 6A8 cDNA-transduced SKW6 cells##2##7##(2008-8#2)
in the rAAV-antisense 6A8 cDNA-transduced SKW6##3##6##(2008-8#3)
in the rabbit retina in vivo##2##6##(2008-4#2)
in the rabbit##16##3##(1991-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#4)(2013-1#1)
in the race##2##3##(1991-12#1)(2008-10#1)
in the radial direction##3##4##(2008-2#2)(2008-7#1)
in the radial##8##3##(1990-11#1)(1990-8#1)(2008-10#1)(2008-2#2)(2008-7#2)(2009-7#1)
in the radiative transfer##2##4##(2008-2#1)(2008-3#1)
in the radio-frequency##2##3##(2007-11#1)(2008-3#1)
in the radiologic##2##3##(1996-1#1)(1997-8#1)
in the radiological##4##3##(1993-3#1)(1997-8#1)(2007-11#1)(2011-2#1)
in the radiology department##2##4##(1991-12#1)(2009-6#1)
in the radiology##3##3##(1991-12#1)(1995-3#1)(2009-6#1)
in the radiometric##5##3##(2008-3#5)
in the radiotherapy of##2##4##(2008-5#1)(2008-7#1)
in the radiotherapy##3##3##(1991-8#1)(2008-5#1)(2008-7#1)
in the rainbow trout##3##4##(2008-5#1)(2008-6#2)
in the rainbow##4##3##(2008-2#1)(2008-5#1)(2008-6#2)
in the rainy season##6##4##(2008-5#4)(2008-6#1)(2013-7#1)
in the random##2##3##(2008-9#1)(2013-8#1)
in the range 0##72##4##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#1)(2008-10#61)(2008-2#3)(2008-3#1)(2012-1#1)(2012-12#2)
in the range 0-5##2##4##(1996-2#1)(2008-10#1)
in the range 1##15##4##(2007-11#1)(2008-10#13)(2008-2#1)
in the range 10-100##2##4##(2007-12#1)(2008-10#1)
in the range 2##6##4##(2008-10#6)
in the range 3##4##4##(2008-10#4)
in the range 4##4##4##(2008-10#4)
in the range 5##3##4##(2008-10#3)
in the range 6##5##4##(2008-10#4)(2008-7#1)
in the range 7##2##4##(2008-10#2)
in the range 99##2##4##(2008-10#2)
in the range and##2##4##(2008-10#1)(2013-1#1)
in the range between 0##3##5##(2008-10#3)
in the range between 1##3##5##(2008-10#2)(2008-3#1)
in the range between##8##4##(2008-10#6)(2008-2#1)(2008-3#1)
in the range comprised between##2##5##(2008-10#2)
in the range expected for##2##5##(1992-3#2)
in the range from 0##11##5##(1990-12#1)(2008-10#5)(2008-3#3)(2010-4#2)
in the range from 1##3##5##(1990-2#1)(2007-11#1)(2008-10#1)
in the range from 10##2##5##(1990-8#1)(2008-2#1)
in the range from 91 to##2##6##(2008-10#2)
in the range from##36##4##(1990-12#1)(1990-2#1)(1990-8#3)(2007-11#2)(2008-10#17)(2008-2#4)(2008-3#5)(2010-4#2)(2011-2#1)
in the range of 0##68##5##(2008-10#64)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
in the range of 1##22##5##(1994-5#1)(1996-12#1)(1996-5#1)(2008-10#17)(2008-3#1)(2011-1#1)
in the range of 10(-4)##2##5##(2008-10#2)
in the range of 1x10(-7) to##2##6##(2008-10#2)
in the range of 2##9##5##(2008-10#9)
in the range of 3##6##5##(2008-10#5)(2010-3#1)
in the range of 4##6##5##(2008-10#5)(2013-1#1)
in the range of 5##9##5##(2008-10#9)
in the range of 7##4##5##(2008-10#3)(2010-5#1)
in the range of 9##2##5##(2008-10#2)
in the range of 95-105%##2##5##(2008-10#2)
in the range of 98##2##5##(2007-7#1)(2008-10#1)
in the range of 99##3##5##(2008-10#3)
in the range of pH##5##5##(1995-2#1)(2008-10#4)
in the range of##277##4##(1990-11#1)(1990-5#1)(1990-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-12#2)(1996-5#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#213)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2009-11#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#3)(2012-3#1)(2013-1#4)(2013-8#1)
in the range pH##2##4##(2008-10#2)
in the range##551##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#4)(1991-5#1)(1992-3#5)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#10)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#419)(2008-11#4)(2008-12#2)(2008-2#18)(2008-3#15)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#3)(2009-11#1)(2010-10#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#4)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
in the ranges from##2##4##(2008-10#1)(2013-8#1)
in the ranges of 0##2##5##(2008-10#1)(2011-1#1)
in the ranges of 1##6##5##(2007-12#1)(2008-10#4)(2013-8#1)
in the ranges of 2##2##5##(2008-10#2)
in the ranges of##15##4##(2007-12#1)(2008-10#11)(2008-2#1)(2011-1#1)(2013-8#1)
in the ranges##27##3##(2007-12#2)(2008-10#21)(2008-2#1)(2011-1#1)(2013-8#2)
in the raphe nuclei##5##4##(2008-7#5)
in the raphe##6##3##(2008-7#5)(2012-3#1)
in the rapid##11##3##(1991-2#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
in the rapidly growing##2##4##(1990-5#1)(1991-6#1)
in the rat SCN##2##4##(1993-12#2)
in the rat and mouse##2##5##(2008-4#2)
in the rat and##9##4##(1992-6#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-5#1)
in the rat aorta##2##4##(1991-9#2)
in the rat brain by##2##5##(1996-12#1)(2008-10#1)
in the rat brain##18##4##(1993-12#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-12#5)(1997-2#1)(2008-10#1)(2009-9#1)(2011-1#1)
in the rat but##2##4##(1992-12#1)(2008-8#1)
in the rat cerebral cortex##3##5##(1996-5#2)(1997-2#1)
in the rat dentate gyrus##3##5##(1990-5#1)(1995-12#1)(1997-6#1)
in the rat epididymis##2##4##(1992-3#1)(1992-8#1)
in the rat eye##4##4##(1992-6#1)(1997-2#2)(2008-4#1)
in the rat heart##3##4##(2008-7#1)(2013-1#1)(2013-7#1)
in the rat hippocampus after##2##5##(1990-5#1)(1995-12#1)
in the rat hippocampus##6##4##(1990-5#2)(1995-12#2)(1996-12#1)(1997-2#1)
in the rat hypothalamus##4##4##(1992-12#2)(1994-8#1)(1995-12#1)
in the rat kidney##6##4##(1993-3#1)(1994-5#2)(1994-6#1)(1995-12#1)(2012-2#1)
in the rat kindling model##2##5##(1994-2#2)
in the rat knee joint##2##5##(1992-6#2)
in the rat liver##4##4##(1994-6#1)(1996-5#1)(2008-10#1)(2009-8#1)
in the rat may##2##4##(1993-5#1)(1994-8#1)
in the rat model##2##4##(1995-12#1)(2008-7#1)
in the rat pituitary##4##4##(1992-12#2)(1992-6#1)(1993-11#1)
in the rat salivary gland##2##5##(1995-11#2)
in the rat striatum##3##4##(1996-2#1)(1996-5#2)
in the rat trigeminal##2##4##(1997-2#1)(2008-6#1)
in the rat were##2##4##(1994-2#1)(1996-5#1)
in the rat##235##3##(1990-12#2)(1990-3#1)(1990-5#7)(1990-7#3)(1991-1#1)(1991-12#2)(1991-2#5)(1991-5#5)(1991-6#2)(1991-9#3)(1992-12#9)(1992-3#2)(1992-6#8)(1992-8#4)(1993-1#2)(1993-11#2)(1993-12#15)(1993-3#7)(1993-5#2)(1993-6#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#5)(1995-11#4)(1995-12#23)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#2)(1996-12#11)(1996-2#7)(1996-5#12)(1997-2#11)(1997-6#1)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#1)
in the rat's##2##3##(1993-3#1)(2008-3#1)
in the rate and extent of##2##6##(2008-10#2)
in the rate and##3##4##(1992-8#1)(2008-10#2)
in the rate of##35##4##(1990-11#1)(1990-5#2)(1993-11#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-6#2)(1997-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#3)(2012-3#1)(2013-1#3)
in the rate##41##3##(1990-11#1)(1990-5#2)(1990-7#1)(1992-8#1)(1993-11#1)(1994-12#2)(1994-5#2)(1994-6#2)(1995-6#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#4)(2012-3#1)(2013-1#3)
in the rates and##2##4##(1990-8#1)(2011-2#1)
in the rates of primary and secondary infection##2##8##(2008-10#2)
in the rates of##16##4##(1990-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
in the rates##19##3##(1990-2#1)(1990-8#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
in the ratio 1##4##4##(2008-10#4)
in the ratio 2##2##4##(2008-10#2)
in the ratio of##13##4##(1991-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(2008-10#4)(2008-6#2)(2011-1#2)(2012-1#1)
in the ratio##26##3##(1991-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(2008-10#15)(2008-6#2)(2011-1#2)(2012-1#1)(2012-12#1)
in the rats##5##3##(1993-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2012-2#1)
in the raw beef patties with 15% flaxseed flour##2##9##(2010-4#2)
in the raw##4##3##(1992-5#1)(2010-2#1)(2010-4#2)
in the ray##2##3##(2008-2#1)(2008-3#1)
in the reaction center##2##4##(1993-11#1)(2008-8#1)
in the reaction mechanism##3##4##(1995-6#1)(2008-10#2)
in the reaction medium##6##4##(1996-5#1)(2008-10#5)
in the reaction mixture##4##4##(1991-12#1)(1994-5#1)(2008-10#2)
in the reaction of##5##4##(1994-6#2)(2008-10#3)
in the reaction system##2##4##(2008-10#2)
in the reaction##42##3##(1991-12#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#23)(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#1)(2013-1#2)
in the reactions of##2##4##(1992-6#1)(2008-10#1)
in the reactivation of##2##4##(2007-10#1)(2008-5#1)
in the reactive##2##3##(2008-11#1)(2013-1#1)
in the reactivity of##2##4##(1995-12#1)(2008-7#1)
in the reactor##3##3##(2008-6#1)(2008-7#2)
in the reagent##5##3##(2008-10#5)
in the real part##2##4##(2008-3#2)
in the real samples##3##4##(2008-10#3)
in the real world##5##4##(1994-12#1)(1996-4#1)(2008-10#1)(2009-12#1)(2009-9#1)
in the real##14##3##(1994-12#1)(1996-4#1)(2007-12#1)(2008-10#5)(2008-3#3)(2009-12#1)(2009-9#1)(2012-3#1)
in the realm of##3##4##(2007-12#1)(2009-5#1)(2010-2#1)
in the rear of##2##4##(2008-10#2)
in the rear##3##3##(1996-12#1)(2008-10#2)
in the receiver##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
in the recent literature##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
in the recent past##3##4##(2008-7#1)(2009-9#1)(2012-5#1)
in the recent years##3##4##(1997-4#1)(2007-7#1)(2013-1#1)
in the recent##13##3##(1993-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-9#1)(2012-3#1)(2012-5#1)(2013-1#2)
in the recently##6##3##(1996-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)
in the receptacle area##3##4##(2008-10#3)
in the reception##2##3##(1996-1#1)(2008-11#1)
in the receptor##3##3##(2006-6#1)(2008-5#1)(2008-8#1)
in the receptor-mediated##2##3##(1996-2#1)(1997-1#1)
in the recipient##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)
in the recipient's serum##2##4##(1992-12#1)(1997-5#1)
in the recognition of##7##4##(1995-2#1)(2007-12#1)(2008-1#1)(2008-5#2)(2009-1#1)(2009-3#1)
in the recognition process##2##4##(1994-3#1)(2008-10#1)
in the recognition##10##3##(1994-3#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-1#1)(2009-3#1)
in the recombinant##3##3##(1994-12#1)(2008-8#1)(2008-9#1)
in the recombination##2##3##(1995-8#1)(2013-1#1)
in the reconstituted##4##3##(1991-5#1)(1992-8#1)(1994-6#1)(2008-9#1)
in the reconstructed##8##3##(2007-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2012-12#1)
in the reconstruction of the##3##5##(1991-5#1)(2008-2#1)(2012-3#1)
in the reconstruction of##8##4##(1990-5#1)(1991-5#2)(2007-11#1)(2008-2#1)(2009-11#1)(2011-2#1)(2012-3#1)
in the reconstruction##12##3##(1990-5#1)(1991-5#2)(2007-11#3)(2008-2#1)(2008-3#2)(2009-11#1)(2011-2#1)(2012-3#1)
in the reconstructive##3##3##(2007-12#2)(2011-2#1)
in the record##2##3##(1997-5#1)(2013-7#1)
in the recording of##3##4##(1994-12#1)(2008-3#2)
in the recording##8##3##(1994-12#1)(2007-12#1)(2008-1#1)(2008-3#5)
in the recovery of the##2##5##(1990-7#1)(2008-11#1)
in the recovery of##7##4##(1990-7#1)(1993-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
in the recovery room##3##4##(2008-7#1)(2010-7#2)
in the recovery study##2##4##(2008-10#1)(2009-6#1)
in the recovery##14##3##(1990-7#1)(1993-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-7#2)(2011-2#2)
in the recruitment of##3##4##(2008-3#1)(2009-6#1)(2013-1#1)
in the recruitment##5##3##(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
in the rectus femoris##3##4##(2011-2#1)(2012-1#2)
in the red and the##2##5##(2008-3#2)
in the red and##3##4##(2008-10#1)(2008-3#2)
in the red nucleus##3##4##(1992-11#3)
in the red##15##3##(1992-11#3)(1994-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)
in the redox##3##3##(2008-10#3)
in the reduced##5##3##(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)
in the reducing##2##3##(1992-12#1)(2008-10#1)
in the reduction of the##2##5##(1995-6#1)(2009-7#1)
in the reduction of##17##4##(1990-5#1)(1991-1#1)(1992-1#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-3#1)(2009-7#1)(2011-1#1)
in the reduction##22##3##(1990-5#1)(1991-1#1)(1992-1#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-12#1)(2009-3#1)(2009-7#1)(2011-1#1)
in the reference arm##3##4##(2007-12#1)(2008-3#2)
in the reference beam##2##4##(2007-12#1)(2008-3#1)
in the reference##14##3##(1991-5#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2011-2#3)
in the reflection mode##2##4##(2008-2#2)
in the reflection##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
in the reflectivity##3##3##(2007-11#1)(2008-3#2)
in the reform of##2##4##(1997-2#1)(2008-8#1)
in the reform##4##3##(1994-12#1)(1997-2#1)(2008-2#1)(2008-8#1)
in the refractive index of the##3##6##(2007-11#2)(2008-3#1)
in the refractive index of##5##5##(2007-11#2)(2008-2#1)(2008-3#2)
in the refractive index##11##4##(2007-11#4)(2008-2#3)(2008-3#4)
in the regenerating##4##3##(1993-12#1)(1997-6#1)(2008-8#1)(2008-9#1)
in the region Middle East and North Africa##2##8##(1997-8#2)
in the region and##2##4##(2008-10#1)(2012-12#1)
in the region between##2##4##(1992-11#1)(1997-2#1)
in the region near##2##4##(2007-11#1)(2007-12#1)
in the region of chromosome##2##5##(2008-10#1)(2012-12#1)
in the region of the##13##5##(1990-7#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-6#1)(2012-12#1)(2013-1#1)
in the region of##26##4##(1990-7#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-11#1)(2007-12#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#2)(2013-1#1)
in the region were##2##4##(2007-10#1)(2008-10#1)
in the region##87##3##(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#4)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#1)
in the regional##4##3##(1991-12#1)(1996-4#1)(2008-5#1)(2010-6#1)
in the regions of the##3##5##(1990-12#1)(1991-12#1)(2008-8#1)
in the regions of##4##4##(1990-12#1)(1991-12#1)(2008-12#1)(2008-8#1)
in the regions##8##3##(1990-12#1)(1991-12#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2013-8#1)
in the register##4##3##(1995-8#4)
in the regulation of Ca2+##3##5##(1992-9#1)(1995-11#1)(1995-6#1)
in the regulation of cardiac##2##5##(1992-6#1)(2010-12#1)
in the regulation of cell growth##2##6##(1994-12#1)(2008-4#1)
in the regulation of cell##4##5##(1994-12#1)(1995-6#1)(2008-4#1)(2012-12#1)
in the regulation of cellular##2##5##(1991-5#1)(2008-9#1)
in the regulation of energy##3##5##(2008-4#1)(2008-7#1)(2009-8#1)
in the regulation of gene expression##6##6##(1991-6#1)(1997-4#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
in the regulation of glucagon secretion##3##6##(2010-11#3)
in the regulation of insulin##2##5##(2013-1#2)
in the regulation of muscle tone##3##6##(1995-2#3)
in the regulation of neuronal##2##5##(1995-11#1)(2010-8#1)
in the regulation of protein##2##5##(1990-5#1)(1990-8#1)
in the regulation of respiration##3##5##(2008-7#3)
in the regulation of the immune system##2##7##(2007-5#1)(2008-4#1)
in the regulation of the##20##5##(1992-11#1)(1993-12#1)(1993-5#1)(1993-6#2)(1995-12#1)(1995-2#1)(1995-8#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
in the regulation of thyroid##3##5##(1991-12#1)(1992-6#1)(1995-5#1)
in the regulation of##153##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-5#3)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#2)
in the regulation##156##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-5#3)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#2)
in the regulatory##10##3##(1994-8#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)
in the rehabilitation of elderly patients with chronic obstructive pulmonary disease##2##11##(2008-7#2)
in the rehabilitation of patients with##2##6##(2007-11#1)(2008-10#1)
in the rehabilitation of patients##3##5##(2007-11#1)(2007-8#1)(2008-10#1)
in the rehabilitation of the##2##5##(1992-12#1)(2010-3#1)
in the rehabilitation of##11##4##(1992-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-3#2)(2012-3#1)(2013-1#2)
in the rehabilitation process##2##4##(2007-11#1)(2010-10#1)
in the rehabilitation##15##3##(1992-12#1)(2007-11#2)(2007-8#2)(2008-10#2)(2008-7#2)(2010-10#1)(2010-3#2)(2012-3#1)(2013-1#2)
in the reinforcing##2##3##(1993-6#1)(1994-2#1)
in the related##2##3##(2008-10#2)
in the relationship between##14##4##(1991-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-12#1)
in the relationship##17##3##(1991-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)
in the relative risk##3##4##(1991-2#1)(1997-8#1)(2007-12#1)
in the relative strength of##2##5##(2008-7#1)(2008-8#1)
in the relative##22##3##(1990-3#2)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-9#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)
in the relatively##2##3##(2008-10#1)(2008-8#1)
in the release of the##2##5##(1995-11#1)(2009-8#1)
in the release of##12##4##(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-8#1)(2011-2#1)
in the remainder##2##3##(2008-12#1)(2012-2#1)
in the remaining 3##2##4##(2007-10#1)(2008-8#1)
in the remaining 4##3##4##(1993-9#1)(2007-10#1)(2008-7#1)
in the remaining two##2##4##(1993-5#1)(2009-2#1)
in the remaining##24##3##(1991-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(2007-10#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2009-2#2)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-4#1)(2013-1#1)
in the remnant solution##2##4##(1991-1#2)
in the removal of##6##4##(1997-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-8#1)
in the renal transplant##2##4##(2007-7#1)(2008-1#1)
in the renal##17##3##(1990-9#1)(1992-3#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#2)
in the repair of##5##4##(1992-5#1)(2008-11#1)(2011-2#2)(2013-8#1)
in the repair##6##3##(1992-5#1)(2008-11#1)(2008-9#1)(2011-2#2)(2013-8#1)
in the replacement of##2##4##(1997-7#1)(2008-10#1)
in the replication##5##3##(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
in the reported##3##3##(1991-2#1)(2010-1#1)(2011-2#1)
in the reporter constructs##2##4##(1994-2#2)
in the reporter##3##3##(1994-2#2)(2008-7#1)
in the reporting of##2##4##(2006-10#1)(2013-7#1)
in the reporting##3##3##(2006-10#1)(2008-1#1)(2013-7#1)
in the representation##2##3##(2008-11#1)(2009-10#1)
in the reproducibility##2##3##(2008-10#2)
in the reproduction##2##3##(2008-7#2)
in the reproductive##10##3##(1991-6#1)(1993-6#1)(1996-6#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
in the research of human##2##5##(2008-9#1)(2010-12#1)
in the research of##3##4##(2008-9#1)(2010-12#1)(2010-2#1)
in the research on##2##4##(2008-10#1)(2008-5#1)
in the research##11##3##(2008-10#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2013-8#2)
in the reservoir##3##3##(2008-10#1)(2008-5#2)
in the reservoirs##2##3##(2008-5#1)(2011-2#1)
in the resident##2##3##(1995-6#1)(2013-1#1)
in the residential construction industry##2##5##(1991-12#2)
in the residential##3##3##(1991-12#2)(1996-3#1)
in the residual##2##3##(2008-10#1)(2013-1#1)
in the residue at the##2##5##(1995-11#2)
in the resin phase##2##4##(2008-10#2)
in the resin was##2##4##(2008-10#2)
in the resin##4##3##(2008-10#4)
in the resistance of##3##4##(2008-10#1)(2008-9#2)
in the resistance to##2##4##(1993-8#1)(2008-10#1)
in the resistance##8##3##(1993-8#1)(2008-10#3)(2008-5#1)(2008-9#2)(2012-3#1)
in the resistant cactus##3##4##(2008-10#3)
in the resistant check##2##4##(2008-10#2)
in the resistant cultivar##3##4##(2008-10#2)(2011-10#1)
in the resistant cultivars##6##4##(2008-10#6)
in the resistant genotype##2##4##(2008-10#2)
in the resistant line##3##4##(1992-2#1)(2008-10#2)
in the resistant pepper##2##4##(2008-10#2)
in the resistant##37##3##(1990-5#1)(1992-2#2)(2008-10#33)(2011-10#1)
in the resolution##2##3##(1995-6#1)(2008-8#1)
in the resonance domain##3##4##(2007-12#2)(2008-3#1)
in the resonance##8##3##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
in the resonator##3##3##(2007-11#2)(2008-2#1)
in the respect of##2##4##(2008-10#2)
in the respective##10##3##(1992-10#1)(1993-12#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-2#1)
in the respiratory chain##3##4##(1990-11#1)(1994-11#1)(1995-2#1)
in the respiratory tract##5##4##(1992-3#1)(1992-9#1)(1996-1#2)(2008-11#1)
in the respiratory##13##3##(1990-11#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-2#1)(1996-1#2)(2008-10#1)(2008-11#1)(2008-7#1)
in the response of the##2##5##(1994-8#1)(2008-10#1)
in the response of##10##4##(1992-3#1)(1992-6#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-2#1)(2010-1#1)(2012-7#1)
in the response to inflammation and injury##2##7##(1990-5#2)
in the response to the##2##5##(1997-2#1)(2008-10#1)
in the response to##12##4##(1990-5#2)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#4)(2009-8#1)
in the response##26##3##(1990-5#3)(1990-6#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#9)(2008-2#1)(2009-8#1)(2010-1#1)(2012-7#1)
in the responsiveness##2##3##(1993-12#1)(1997-7#1)
in the rest of the patients##2##6##(2007-8#1)(2011-2#1)
in the rest of the##10##5##(1990-3#1)(1991-8#2)(2007-8#1)(2008-2#1)(2008-7#3)(2011-2#2)
in the rest of##12##4##(1990-3#1)(1991-8#2)(1992-9#1)(1994-2#1)(2007-8#1)(2008-2#1)(2008-7#3)(2011-2#2)
in the rest##15##3##(1990-3#1)(1991-8#2)(1992-9#1)(1994-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#3)(2011-2#2)
in the resting##5##3##(1994-3#1)(1994-6#1)(2011-2#1)(2013-8#2)
in the restoration of##4##4##(2008-7#1)(2008-9#2)(2011-1#1)
in the restored##2##3##(2007-12#1)(2008-3#1)
in the resultant##4##3##(1993-11#1)(1995-12#1)(2008-3#1)(2010-4#1)
in the resulting##11##3##(1993-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-4#1)
in the results of##2##4##(2008-2#1)(2012-2#1)
in the results##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
in the retention##3##3##(1995-11#1)(2008-10#2)
in the reticular##2##3##(1996-12#1)(1997-2#1)
in the reticuloendothelial system##2##4##(1991-9#1)(2010-2#1)
in the retina of##4##4##(1991-10#1)(1992-3#1)(2010-1#2)
in the retina##20##3##(1991-10#1)(1992-3#1)(1994-5#1)(2008-1#2)(2008-5#6)(2008-7#1)(2010-1#4)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
in the retinal##3##3##(2008-4#1)(2009-10#1)(2012-12#1)
in the retinas of##2##4##(1990-11#1)(2007-5#1)
in the retinol deficient group##2##5##(1994-8#2)
in the retinol deficient##3##4##(1994-8#3)
in the retrieval algorithm##2##4##(2008-2#2)
in the retrieval of##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
in the retrieval##8##3##(2007-12#1)(2008-2#3)(2008-3#4)
in the retroperitoneal##2##3##(2008-10#1)(2012-12#1)
in the retroperitoneum##3##3##(2008-6#1)(2009-1#1)(2009-9#1)
in the reverse direction##2##4##(1992-3#1)(2008-5#1)
in the reverse order##2##4##(2007-12#1)(2008-10#1)
in the reverse orientation##2##4##(1996-12#1)(1997-4#1)
in the reverse##7##3##(1992-3#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
in the reversed-phase##3##3##(2008-10#3)
in the revertants##2##3##(1995-11#2)
in the review##5##3##(2009-11#1)(2009-5#1)(2012-2#1)(2012-3#2)
in the revised##3##3##(1992-2#1)(1995-12#1)(2011-2#1)
in the revision##2##3##(2008-10#1)(2013-1#1)
in the rhesus monkey##2##4##(1991-1#1)(1993-5#1)
in the rhesus##3##3##(1991-1#1)(1993-5#1)(1995-11#1)
in the rheumatic diseases##2##4##(2008-8#1)(2012-1#1)
in the rheumatoid##2##3##(1991-5#1)(2010-3#1)
in the rhizosphere and##3##4##(2008-10#3)
in the rhizosphere of cantaloupe plants##2##6##(2008-10#2)
in the rhizosphere of##8##4##(2008-10#8)
in the rhizosphere##20##3##(2008-10#17)(2008-12#2)(2009-8#1)
in the rhizospheres of two##2##5##(2008-10#2)
in the rhizospheres of##3##4##(2008-10#3)
in the rice genome##5##4##(1996-8#2)(2008-9#1)(2009-10#2)
in the rice##7##3##(1996-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)
in the right and left##2##5##(1996-2#1)(2009-4#1)
in the right anterior##2##4##(2008-11#1)(2008-8#1)
in the right atrium and ventricle##2##6##(2010-8#1)(2012-3#1)
in the right atrium##3##4##(2007-8#1)(2010-8#1)(2012-3#1)
in the right breast##3##4##(1994-7#1)(1995-4#1)(2008-10#1)
in the right cerebellar hemisphere##2##5##(2008-7#1)(2012-3#1)
in the right cerebral hemisphere##2##5##(2011-1#1)(2013-8#1)
in the right colon##2##4##(2006-8#2)
in the right eye and##2##5##(2011-2#1)(2013-1#1)
in the right eye##4##4##(2011-1#1)(2011-2#1)(2013-1#2)
in the right femoral##2##4##(2006-10#1)(2012-1#1)
in the right frontal lobe##3##5##(2007-10#3)
in the right frontal##4##4##(2007-10#3)(2008-7#1)
in the right hemisphere##4##4##(1996-5#1)(1997-8#1)(2008-1#1)(2009-2#1)
in the right lobe of the liver and##2##8##(2009-8#1)(2012-2#1)
in the right lobe of##3##5##(2008-12#1)(2009-8#1)(2012-2#1)
in the right lobe##4##4##(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)
in the right lower lung field##2##6##(2008-1#2)
in the right lower##5##4##(1992-2#1)(2007-8#1)(2008-1#2)(2013-1#1)
in the right middle lobe and##2##6##(2008-1#2)
in the right middle##4##4##(2008-1#3)(2008-12#1)
in the right upper lobe##4##5##(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the right upper##8##4##(1990-9#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
in the right way##2##4##(1993-12#1)(2009-6#1)
in the right##98##3##(1990-3#1)(1990-5#1)(1990-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-7#1)(1994-8#3)(1995-4#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#5)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#1)(2008-11#2)(2008-12#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#2)
in the ring##5##3##(2007-11#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
in the risk group##3##4##(1992-9#1)(2012-12#2)
in the risk of##8##4##(1991-11#1)(1991-8#1)(2006-10#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
in the risk##19##3##(1990-6#1)(1991-11#1)(1991-8#1)(1992-9#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
in the river water##4##4##(2008-10#4)
in the river##7##3##(1997-4#1)(2008-10#5)(2010-8#1)
in the rod##4##3##(1997-4#1)(2007-11#1)(2008-2#2)
in the rodent and nonrodent test species used for drug safety assessments##2##12##(2010-11#2)
in the rodent and##3##4##(1995-9#1)(2010-11#2)
in the rodent##8##3##(1995-12#1)(1995-9#2)(1997-2#1)(2008-11#1)(2010-11#2)(2011-1#1)
in the role of the##3##5##(1991-1#1)(2008-10#1)(2012-3#1)
in the role of##7##4##(1991-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(2008-10#1)(2012-3#2)
in the role##9##3##(1990-12#1)(1991-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(1996-12#1)(2008-10#1)(2012-3#2)
in the room temperature ionic liquid##2##6##(2008-10#2)
in the room##3##3##(2008-10#3)
in the rooms of##2##4##(2008-10#1)(2008-5#1)
in the root zone##2##4##(2008-7#1)(2011-2#1)
in the root##16##3##(2008-10#8)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)
in the roots of##5##4##(2008-10#2)(2008-12#2)(2011-2#1)
in the roots##14##3##(2008-10#8)(2008-12#4)(2011-2#1)(2012-5#1)
in the rostral##2##3##(1992-8#1)(1997-2#1)
in the rotation##4##3##(2008-10#2)(2009-6#1)(2010-12#1)
in the rotational##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
in the routine analysis##2##4##(2008-10#1)(2008-11#1)
in the routine##12##3##(1992-5#1)(1993-12#1)(2007-10#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)
in the rules##2##3##(1995-6#1)(2008-8#1)
in the rumen##2##3##(2009-4#1)(2013-1#1)
in the rupture of##2##4##(2008-6#1)(2009-5#1)
in the rupture##3##3##(2008-6#1)(2009-5#1)(2009-9#1)
in the rural##7##3##(1994-1#1)(1997-6#1)(2007-10#1)(2009-10#1)(2009-7#1)(2010-4#1)(2011-1#1)
in the sacral##2##3##(2008-7#2)
in the safe##2##3##(1991-1#1)(1996-9#1)
in the safety of the##2##5##(2011-2#1)(2013-1#1)
in the safety of##3##4##(1996-9#1)(2011-2#1)(2013-1#1)
in the safety##4##3##(1996-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
in the sagittal plane##6##4##(2007-12#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-1#2)
in the sagittal##8##3##(1995-5#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-1#2)(2013-1#1)
in the saline##2##3##(1991-6#1)(2008-10#1)
in the salinity##2##3##(2008-10#1)(2011-2#1)
in the salivary glands of##4##5##(2008-10#3)(2013-1#1)
in the salivary glands##6##4##(2008-10#5)(2013-1#1)
in the salivary##9##3##(1993-12#1)(2008-10#7)(2013-1#1)
in the salt##2##3##(2008-10#1)(2008-9#1)
in the same age group##2##5##(1990-6#1)(2012-12#1)
in the same age##3##4##(1990-6#1)(2008-1#1)(2012-12#1)
in the same areas##2##4##(2008-10#1)(2010-5#1)
in the same array##2##4##(2008-10#2)
in the same breast##2##4##(1991-2#1)(1994-7#1)
in the same cell##6##4##(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2013-8#1)
in the same cells##3##4##(1994-12#1)(2008-4#1)(2013-1#1)
in the same city##2##4##(2008-1#1)(2012-12#1)
in the same clade as##2##5##(2008-10#1)(2008-6#1)
in the same clade##3##4##(2008-10#2)(2008-6#1)
in the same cluster##2##4##(2008-5#1)(2011-1#1)
in the same concentration range##2##5##(1993-12#1)(2008-10#1)
in the same conditions##3##4##(2008-10#3)
in the same day##2##4##(2008-10#1)(2013-1#1)
in the same direction as the##3##6##(1994-12#1)(2007-12#1)(2008-4#1)
in the same direction##9##4##(1992-4#1)(1994-12#1)(2007-12#2)(2008-4#1)(2008-8#2)(2008-9#1)(2012-2#1)
in the same dose##2##4##(1997-7#1)(2010-11#1)
in the same family##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
in the same fashion##2##4##(1996-2#1)(2008-3#1)
in the same fields##2##4##(2008-10#2)
in the same group##4##4##(1993-8#1)(1997-6#1)(2008-10#2)
in the same individual##3##4##(2007-7#1)(2008-8#1)(2012-3#1)
in the same interferogram##2##4##(2008-3#2)
in the same location as##2##5##(2008-2#1)(2008-3#1)
in the same manner as##2##5##(2008-1#1)(2008-10#1)
in the same manner##10##4##(1991-5#1)(1992-8#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-6#1)
in the same medium##2##4##(1992-6#1)(2008-10#1)
in the same order of##3##5##(1995-6#1)(2008-11#1)(2008-9#1)
in the same order##6##4##(1992-11#1)(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the same period##4##4##(1992-6#1)(1995-6#1)(2008-11#1)(2011-2#1)
in the same plane##2##4##(2008-10#1)(2010-8#1)
in the same population##3##4##(1997-3#1)(2008-10#1)(2012-12#1)
in the same position as##2##5##(1990-2#1)(2010-3#1)
in the same position##5##4##(1990-2#1)(1990-5#1)(1995-6#1)(2008-11#1)(2010-3#1)
in the same preparation##2##4##(1992-12#1)(1995-3#1)
in the same range as the##2##6##(1991-3#1)(2008-2#1)
in the same range as##5##5##(1990-11#1)(1991-3#1)(1992-2#1)(1993-8#1)(2008-2#1)
in the same range##8##4##(1990-11#1)(1991-3#1)(1992-2#1)(1993-8#1)(1995-6#1)(2007-10#1)(2008-2#1)(2010-8#1)
in the same region##4##4##(1991-3#1)(2008-10#2)(2011-1#1)
in the same sample##5##4##(2008-10#4)(2008-5#1)
in the same samples##2##4##(1993-6#1)(2008-10#1)
in the same scene##2##4##(2008-3#1)(2008-6#1)
in the same school##2##4##(1991-12#1)(2010-1#1)
in the same section##2##4##(1994-10#2)
in the same site##2##4##(1992-5#1)(1995-5#1)
in the same species##2##4##(2008-7#1)(2008-9#1)
in the same time##4##4##(1990-5#1)(1991-2#1)(2007-11#1)(2008-10#1)
in the same tissues##3##4##(1995-8#1)(2008-10#2)
in the same type of##2##5##(1992-9#1)(2009-5#1)
in the same way as for##2##6##(2007-12#1)(2008-2#1)
in the same way as samples##2##6##(2008-10#2)
in the same way as##11##5##(1991-9#2)(1993-3#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
in the same way that the##2##6##(1994-1#1)(2008-10#1)
in the same way that##4##5##(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
in the same way##22##4##(1990-8#1)(1991-9#2)(1993-3#1)(1994-1#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
in the same with##2##4##(2008-10#1)(2011-1#1)
in the same##313##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#76)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#10)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
in the sample and##5##4##(2008-10#5)
in the sample by##2##4##(2008-10#2)
in the sample chamber##4##4##(2008-10#1)(2008-11#2)(2008-9#1)
in the sample compartment of##2##5##(2008-10#1)(2008-3#1)
in the sample is##6##4##(2007-11#1)(2008-10#4)(2008-3#1)
in the sample solution was##2##5##(2008-10#2)
in the sample solution##12##4##(2008-10#12)
in the sample to##3##4##(2008-10#3)
in the sample using##3##4##(2008-10#3)
in the sample was##2##4##(2008-10#2)
in the sample were##3##4##(2008-10#2)(2012-12#1)
in the sample zone##3##4##(2008-10#3)
in the sample##96##3##(1990-5#1)(1990-8#1)(1991-9#1)(1992-6#1)(2007-11#5)(2007-7#1)(2008-1#1)(2008-10#66)(2008-11#2)(2008-3#5)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the sampled##2##3##(2008-10#1)(2008-5#1)
in the samples analyzed##2##4##(2008-10#2)
in the samples for##2##4##(2008-10#2)
in the samples was##3##4##(2008-10#2)(2013-1#1)
in the samples were in agreement with those obtained##2##9##(2008-10#2)
in the samples were in agreement with##3##7##(2008-10#3)
in the samples were##4##4##(2008-10#4)
in the samples##34##3##(1990-12#1)(1992-3#1)(2008-10#25)(2008-4#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the sampling##5##3##(2008-10#4)(2008-8#1)
in the sanctuary##2##3##(2013-7#2)
in the sand##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
in the sandy##2##3##(2008-10#1)(2013-7#1)
in the saturated##2##3##(1990-2#1)(2008-10#1)
in the saturation intensity##2##4##(2008-2#1)(2008-3#1)
in the scale of##2##4##(1994-2#1)(2008-11#1)
in the scale##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
in the scalp##2##3##(2010-5#1)(2012-3#1)
in the scan##2##3##(2007-11#1)(2012-1#1)
in the scanning##2##3##(2008-11#1)(2008-2#1)
in the scattered light##2##4##(2008-3#2)
in the scattered##3##3##(2008-3#3)
in the scattering medium##3##4##(2008-2#2)(2008-3#1)
in the scattering phase function##2##5##(2008-3#2)
in the scattering##13##3##(2007-11#1)(2008-2#7)(2008-3#5)
in the scheme##2##3##(1997-7#1)(2008-7#1)
in the schizophrenia##2##3##(1993-9#1)(2013-1#1)
in the schizophrenic group than in the normal group##2##9##(1996-7#2)
in the schizophrenic group##3##4##(1996-7#2)(2013-1#1)
in the schizophrenic##5##3##(1995-11#2)(1996-7#2)(2013-1#1)
in the school curriculum##2##4##(1996-4#1)(2008-1#1)
in the school setting##2##4##(1997-2#1)(2008-11#1)
in the school##6##3##(1991-12#1)(1996-4#1)(1997-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
in the schools in##2##4##(1991-12#2)
in the schools##4##3##(1991-1#1)(1991-12#2)(1993-8#1)
in the sciatic nerve##2##4##(1990-5#1)(1996-2#1)
in the science and##2##4##(1991-3#1)(1993-11#1)
in the scientific literature##7##4##(1993-12#1)(1997-2#1)(2008-5#2)(2010-7#1)(2011-1#1)(2011-2#1)
in the scientific process##2##4##(1996-1#1)(2012-2#1)
in the scientific##12##3##(1993-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-5#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
in the scores##2##3##(2010-3#2)
in the scorpion##2##3##(2007-12#2)
in the screening of##4##4##(1996-9#1)(1997-3#1)(2008-10#1)(2011-2#1)
in the screening##5##3##(1996-9#1)(1997-3#1)(2007-10#1)(2008-10#1)(2011-2#1)
in the scrotal##3##3##(1994-8#1)(2008-10#2)
in the scrotum##2##3##(2012-3#1)(2013-1#1)
in the sea pansy##2##4##(2008-7#2)
in the sea water samples##2##5##(2008-10#2)
in the sea##6##3##(2008-10#2)(2008-7#2)(2008-8#1)(2011-1#1)
in the search for new##2##5##(1997-7#1)(2010-7#1)
in the search for the ideal##3##6##(1994-3#1)(2008-5#1)(2008-6#1)
in the search for the##4##5##(1994-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
in the search for##22##4##(1991-12#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)
in the search##25##3##(1991-12#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-2#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)
in the season##8##3##(2008-10#5)(2008-8#2)(2012-6#1)
in the second and third##4##5##(1993-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
in the second and##6##4##(1990-12#1)(1990-3#1)(1993-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
in the second case##2##4##(2010-12#1)(2011-1#1)
in the second day##2##4##(2008-12#1)(2012-3#1)
in the second diffraction order##3##5##(2007-11#1)(2008-3#2)
in the second group##4##4##(1991-5#1)(2007-8#2)(2008-10#1)
in the second half of the 17th##2##7##(2008-10#2)
in the second half of the##4##6##(2007-11#1)(2008-10#2)(2011-2#1)
in the second half of##6##5##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
in the second half##7##4##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
in the second hour##2##4##(2010-5#1)(2012-2#1)
in the second intron##2##4##(1992-8#1)(1994-12#1)
in the second part of##2##5##(1997-6#1)(2007-8#1)
in the second step of##2##5##(2008-10#1)(2008-6#1)
in the second step##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
in the second trimester##5##4##(1990-2#1)(1991-6#1)(1993-3#1)(1994-3#1)(2012-2#1)
in the second week##3##4##(1992-3#2)(1997-2#1)
in the second year of life##2##6##(2007-8#1)(2008-9#1)
in the second year##6##4##(1996-12#1)(2007-8#1)(2008-6#2)(2008-9#1)(2011-2#1)
in the second##90##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-8#5)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
in the secondary##5##3##(1993-11#1)(1994-12#1)(2008-10#2)(2008-9#1)
in the secretion of##5##4##(1995-3#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-5#1)
in the secretion##6##3##(1995-3#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)
in the secretory cavity##2##4##(1997-6#2)
in the secretory pathway##2##4##(1992-9#1)(2008-11#1)
in the secretory##6##3##(1992-9#1)(1993-5#1)(1997-6#2)(2008-11#1)(2008-7#1)
in the sedentary group##2##4##(1992-3#1)(2013-1#1)
in the sediment##3##3##(2008-10#3)
in the sediments of##2##4##(2008-10#2)
in the sediments##5##3##(2007-5#1)(2008-10#3)(2008-5#1)
in the seed coat##2##4##(2008-10#2)
in the seed##9##3##(2007-12#1)(2008-10#6)(2009-6#1)(2013-8#1)
in the segments##2##3##(1995-12#1)(2008-8#1)
in the segregating##2##3##(2008-10#2)
in the selected ion monitoring (SIM) mode##2##7##(2008-10#2)
in the selected ion monitoring##4##5##(2008-10#4)
in the selected##10##3##(1994-5#1)(2008-10#6)(2008-12#1)(2009-6#1)(2010-11#1)
in the selection and##2##4##(2008-4#1)(2010-4#1)
in the selection of##9##4##(1992-8#1)(1997-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2010-11#1)(2012-12#1)
in the selection##13##3##(1992-8#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-11#1)(2010-4#1)(2012-12#1)
in the selective##3##3##(2008-10#2)(2008-11#1)
in the selectivity##2##3##(2008-10#2)
in the self-organizing neural network##3##5##(2008-3#3)
in the seminal##2##3##(2008-7#1)(2011-2#1)
in the seminiferous epithelium during##2##5##(2012-2#2)
in the seminiferous epithelium of##2##5##(2012-2#2)
in the seminiferous epithelium##9##4##(2009-10#4)(2012-2#5)
in the seminiferous tubules##2##4##(1995-6#1)(2009-10#1)
in the seminiferous##12##3##(1995-6#1)(2009-10#5)(2012-2#5)(2013-1#1)
in the senescent rat##2##4##(1994-6#1)(2013-7#1)
in the senescent##3##3##(1994-6#1)(2013-7#2)
in the sense of##6##4##(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)
in the sense that it##3##5##(2008-11#1)(2008-2#1)(2010-3#1)
in the sense that their##3##5##(2008-1#1)(2008-3#1)(2011-2#1)
in the sense that##12##4##(1994-11#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)
in the sense##19##3##(1994-11#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)
in the sensing##2##3##(2008-10#1)(2008-3#1)
in the sensitive determination of##2##5##(2008-10#1)(2008-2#1)
in the sensitive##5##3##(1991-12#1)(1992-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
in the sensitivity of the##7##5##(1991-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
in the sensitivity of##9##4##(1991-6#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
in the sensitivity##17##3##(1991-6#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-3#1)
in the sensor##3##3##(2007-11#1)(2008-10#2)
in the sensory##2##3##(1993-12#1)(2013-1#1)
in the separate##3##3##(2007-12#1)(2008-10#2)
in the separated fractions##3##4##(2008-10#3)
in the separation and preconcentration of##3##6##(2008-10#3)
in the separation and##4##4##(2008-10#4)
in the separation of##9##4##(1990-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-5#1)(2008-10#4)
in the separation##18##3##(1990-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-5#2)(2008-10#11)(2010-8#1)
in the septum##5##3##(1991-5#4)(1996-12#1)
in the sequence from##2##4##(1990-7#1)(1990-8#1)
in the sequence of the##3##5##(1993-11#1)(1997-3#1)(2008-10#1)
in the sequence of##6##4##(1993-11#1)(1997-3#1)(2007-11#1)(2008-10#3)
in the sequence##18##3##(1990-7#1)(1990-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-7#2)(2010-2#1)
in the sequencing of##2##4##(2008-10#1)(2008-7#1)
in the sequential##2##3##(2007-12#1)(2008-10#1)
in the sera from##3##4##(1994-3#2)(2013-8#1)
in the sera of patients with##3##6##(1990-12#1)(1992-8#1)(1993-2#1)
in the sera of patients##4##5##(1990-11#1)(1990-12#1)(1992-8#1)(1993-2#1)
in the sera of##8##4##(1990-11#1)(1990-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-3#2)(1997-4#1)
in the sera##13##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-3#4)(1997-4#1)(2013-8#1)
in the series of##3##4##(1997-7#1)(2007-11#1)(2008-8#1)
in the series##15##3##(1990-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-4#5)(2008-7#2)(2008-8#1)(2009-5#1)(2010-11#2)
in the serine##2##3##(1994-5#1)(1995-6#1)
in the serum and cerebrospinal fluid##2##6##(1997-8#1)(2009-6#1)
in the serum and urine##3##5##(1995-3#1)(2006-10#1)(2008-7#1)
in the serum and##7##4##(1992-6#1)(1995-3#1)(1997-8#2)(2006-10#1)(2008-7#1)(2009-6#1)
in the serum of patients with##2##6##(1992-9#1)(1994-8#1)
in the serum of the##2##5##(1995-3#1)(1997-4#1)
in the serum of##14##4##(1990-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-3#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
in the serum##44##3##(1990-2#1)(1990-8#1)(1991-12#2)(1991-4#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-2#2)(1994-8#2)(1995-2#1)(1995-3#2)(1997-4#2)(1997-8#2)(2006-10#1)(2007-2#1)(2008-10#5)(2008-12#2)(2008-5#2)(2008-7#4)(2009-6#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
in the serum-supplemented medium##3##4##(2008-11#3)
in the service of##4##4##(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)
in the service##6##3##(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
in the services##2##3##(1992-11#1)(2008-12#1)
in the set of##3##4##(2008-3#1)(2008-8#2)
in the set##5##3##(1990-11#2)(2008-3#1)(2008-8#2)
in the setting of I/R##2##5##(2010-8#2)
in the setting of a##4##5##(2007-5#1)(2008-4#1)(2010-10#1)(2013-8#1)
in the setting of acute##2##5##(2008-3#1)(2013-1#1)
in the setting of##33##4##(1996-2#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the setting##34##3##(1994-12#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the settlement##2##3##(1990-12#1)(1996-5#1)
in the seven##2##3##(1996-1#1)(2011-2#1)
in the seventh##2##3##(2011-2#1)(2013-8#1)
in the severity and##2##4##(1995-11#1)(2008-10#1)
in the severity of##2##4##(1991-8#1)(1997-3#1)
in the severity##4##3##(1991-8#1)(1995-11#1)(1997-3#1)(2008-10#1)
in the sex##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
in the shadow##2##3##(2008-2#1)(2008-3#1)
in the sham##2##3##(1995-11#1)(2013-1#1)
in the shampoo viscosity##2##4##(2008-5#2)
in the shape of a##3##5##(2008-3#2)(2009-4#1)
in the shape of the##2##5##(2008-10#1)(2008-2#1)
in the shape of##7##4##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-7#1)
in the shape##10##3##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-4#2)(2009-7#1)
in the shapes of##2##4##(1996-6#1)(2008-2#1)
in the share of##3##4##(1991-2#1)(1992-12#1)(1995-3#1)
in the sheep##4##3##(1996-12#1)(2008-10#1)(2008-8#1)(2012-1#1)
in the shell##2##3##(1995-2#1)(2008-12#1)
in the shock-probe burying test##2##5##(1993-3#2)
in the shock-probe##3##3##(1993-3#2)(1994-2#1)
in the short and the long terms##2##7##(2008-3#2)
in the short or##2##4##(1992-5#1)(2008-5#1)
in the short term##5##4##(2007-7#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-8#1)
in the short##17##3##(1990-11#1)(1990-9#1)(1992-5#1)(1993-11#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-2#1)
in the short- and long-term##2##5##(2010-5#1)(2011-2#1)
in the short-term##8##3##(1995-11#2)(2008-1#2)(2008-12#1)(2008-7#1)(2011-2#2)
in the short-wavelength##3##3##(2007-11#1)(2008-3#2)
in the shorter##2##3##(2007-11#1)(2008-3#1)
in the shortest##2##3##(2007-8#1)(2013-7#1)
in the shoulder surgery##2##4##(2007-11#2)
in the shoulder##5##3##(1990-5#1)(1996-9#1)(2007-11#2)(2013-1#1)
in the side##4##3##(2007-12#2)(2008-10#1)(2010-6#1)
in the signal to##2##4##(1991-3#1)(2008-10#1)
in the signal transduction pathway##3##5##(1991-12#1)(1994-11#1)(1994-3#1)
in the signal transduction##9##4##(1990-12#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-7#1)(2008-7#1)(2008-8#1)
in the signal##19##3##(1990-12#1)(1991-12#1)(1991-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-9#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)
in the signal-to-noise ratio##2##4##(2007-12#1)(2008-3#1)
in the signaling pathway of##3##5##(1992-12#1)(1994-11#1)(2008-11#1)
in the signaling pathways##2##4##(2008-10#1)(2008-11#1)
in the signaling##5##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#2)
in the significant##2##3##(1994-5#1)(2012-3#1)
in the silkworm head##2##4##(1995-11#2)
in the silkworm##3##3##(1995-11#3)
in the simple##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
in the simulated##2##3##(2008-10#1)(2008-11#1)
in the simulation##4##3##(1995-3#1)(2008-10#1)(2008-3#1)(2010-8#1)
in the simulations##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
in the simultaneous##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
in the single##11##3##(1994-7#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the single-crystal polymer##2##4##(2007-12#2)
in the single-mode##2##3##(2007-11#1)(2007-12#1)
in the sinus gland##3##4##(2008-5#1)(2008-6#2)
in the sinus##4##3##(2008-5#1)(2008-6#2)(2012-1#1)
in the site of##3##4##(1993-2#1)(2008-1#1)(2012-2#1)
in the sitting position##2##4##(1993-10#1)(2010-9#1)
in the six##5##3##(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
in the sixth and seventh decades##2##6##(1995-4#1)(2008-7#1)
in the sixth transmembrane domain##2##5##(1993-8#1)(1994-8#1)
in the sixth##5##3##(1993-8#1)(1994-8#1)(1995-4#1)(2008-7#1)(2010-9#1)
in the sixties##3##3##(1992-8#1)(1997-8#1)(2007-8#1)
in the size of the MTT volume##2##7##(2007-10#2)
in the size of the##10##5##(1991-8#1)(1995-11#1)(2007-10#2)(2008-1#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the size of##18##4##(1991-8#1)(1994-3#2)(1994-8#1)(1995-11#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in the size range of##2##5##(1995-3#1)(2008-7#1)
in the size range##5##4##(1995-3#1)(2008-7#4)
in the size##24##3##(1991-12#1)(1991-8#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-3#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in the skeletal and cardiac muscles##2##6##(2012-3#2)
in the skeletal##5##3##(1993-8#1)(2007-11#1)(2008-7#1)(2012-3#2)
in the skeletally immature patient##3##5##(2013-1#3)
in the skeleton##2##3##(1993-11#2)
in the skin and##5##4##(1992-6#2)(2012-2#2)(2013-8#1)
in the skin is##2##4##(2008-5#1)(2008-9#1)
in the skin of##3##4##(2008-5#2)(2012-3#1)
in the skin##28##3##(1991-6#1)(1992-6#2)(1992-8#1)(1995-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#10)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
in the skull##3##3##(2008-7#1)(2012-12#2)
in the sky##3##3##(2008-2#2)(2012-2#1)
in the slope##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
in the slot##2##3##(1996-2#1)(2007-8#1)
in the slow##5##3##(1992-2#1)(1995-2#1)(2007-11#1)(2008-9#1)(2009-12#1)
in the small bowel##2##4##(1991-6#1)(2010-12#1)
in the small intestine of finishing pigs##3##7##(2012-2#3)
in the small intestine of##5##5##(1991-12#1)(2012-2#3)(2013-1#1)
in the small intestine##13##4##(1991-12#1)(1992-11#1)(1994-8#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#5)
in the small##21##3##(1990-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1994-8#1)(1996-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#5)(2013-8#2)
in the smaller##3##3##(1994-3#1)(2011-1#1)(2011-2#1)
in the smallest##2##3##(1996-2#1)(2009-7#1)
in the smoking##2##3##(1991-1#1)(2008-2#1)
in the smooth muscle##3##4##(1993-2#1)(1993-8#1)(1997-3#1)
in the so-called##5##3##(1994-2#1)(1995-12#1)(2008-9#1)(2011-1#2)
in the social sciences##4##4##(1996-6#1)(2008-12#1)(2008-2#1)(2012-2#1)
in the social##14##3##(1991-3#1)(1991-6#1)(1995-12#1)(1996-6#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
in the society##3##3##(2008-7#2)(2012-2#1)
in the socket##2##3##(2008-10#1)(2013-1#1)
in the sodium##2##3##(1994-3#2)
in the soft tissue##4##4##(1997-4#1)(2007-7#1)(2007-8#1)(2008-12#1)
in the soft tissues##2##4##(2008-12#1)(2009-3#1)
in the soft##7##3##(1990-5#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-12#2)(2009-3#1)
in the soil and##4##4##(2008-10#3)(2008-7#1)
in the soil extracts##2##4##(2008-10#2)
in the soil microflora##2##4##(2008-10#2)
in the soil solution##3##4##(1992-3#2)(2008-10#1)
in the soil surface##2##4##(2008-6#2)
in the soil was##2##4##(2008-10#1)(2010-3#1)
in the soil##47##3##(1990-9#1)(1992-3#2)(1995-3#1)(2008-10#26)(2008-11#3)(2008-5#1)(2008-6#6)(2008-7#2)(2010-3#1)(2010-5#2)(2012-12#1)(2013-8#1)
in the soils##3##3##(2008-10#3)
in the solar##4##3##(2007-12#1)(2008-3#3)
in the solar-reflected spectrum##2##4##(2008-2#2)
in the sole##2##3##(1997-5#1)(2010-5#1)
in the solid phase##8##4##(1991-2#1)(2008-10#6)(2013-1#1)
in the solid sample##2##4##(2008-10#2)
in the solid state##7##4##(1993-3#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-3#1)
in the solid##25##3##(1991-2#1)(1993-3#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#14)(2008-11#1)(2008-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
in the solid-phase synthesis of##2##5##(2008-4#2)
in the solid-phase##4##3##(2008-1#1)(2008-4#3)
in the solubilized##2##3##(1991-5#1)(1993-11#1)
in the soluble fraction of##3##5##(1991-7#1)(1991-9#1)(1996-12#1)
in the soluble fraction##4##4##(1990-2#1)(1991-7#1)(1991-9#1)(1996-12#1)
in the soluble##7##3##(1990-2#1)(1991-7#1)(1991-9#1)(1996-12#1)(2008-10#2)(2008-4#1)
in the solution of##4##4##(2008-10#2)(2008-4#1)(2011-2#1)
in the solution phase##2##4##(2008-10#2)
in the solution structure##2##4##(1994-5#1)(1995-2#1)
in the solution was##3##4##(2008-10#3)
in the solution##35##3##(1992-5#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#21)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-7#1)
in the solutions##5##3##(2008-10#4)(2008-3#1)
in the solvent##3##3##(1994-11#1)(2008-10#1)(2013-8#1)
in the sorption of all the seven metal ions are reported##2##11##(2008-10#2)
in the sorption of all the##3##6##(2008-10#3)
in the sorption of##7##4##(2008-10#7)
in the sorption##11##3##(2008-10#11)
in the sorting of##2##4##(2008-9#1)(2011-2#1)
in the source##2##3##(1996-2#1)(2008-10#1)
in the sources##2##3##(1991-2#1)(2008-10#1)
in the south##6##3##(2007-1#1)(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
in the south-central and##2##4##(2008-10#2)
in the south-central##3##3##(2008-10#3)
in the southeastern United States##10##5##(1993-1#1)(1994-1#1)(2008-10#4)(2008-5#1)(2011-2#3)
in the southeastern part of##2##5##(2008-6#1)(2013-8#1)
in the southeastern##15##3##(1993-1#1)(1994-1#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#3)(2013-8#1)
in the southern Gulf of Mexico##2##6##(2008-5#2)
in the southern part of##3##5##(2008-1#1)(2008-8#1)(2010-8#1)
in the southern##15##3##(1990-6#1)(1993-6#1)(1996-8#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-8#2)(2012-3#1)
in the southwestern United States##3##5##(1990-8#2)(2008-10#1)
in the southwestern##4##3##(1990-8#2)(1992-7#1)(2008-10#1)
in the soybean##2##3##(1990-12#1)(2012-2#1)
in the space##8##3##(1996-2#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
in the space-time##2##3##(2007-12#1)(2008-8#1)
in the spatial beam##2##4##(2007-12#1)(2008-3#1)
in the spatial distribution of##2##5##(2008-11#1)(2008-2#1)
in the spatial domain##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
in the spatial##14##3##(1992-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2013-1#1)
in the spatially##2##3##(2008-8#1)(2009-9#1)
in the spawning##2##3##(1991-8#1)(2008-12#1)
in the specialty##3##3##(1993-1#1)(2008-9#2)
in the speciation of##3##4##(2008-10#3)
in the speciation##5##3##(2008-10#3)(2008-9#2)
in the species##6##3##(2008-10#4)(2012-3#1)(2013-7#1)
in the specific case of##2##5##(2008-10#1)(2012-2#1)
in the specific growth##2##4##(2008-11#1)(2008-7#1)
in the specific##17##3##(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
in the specimen##2##3##(2007-11#1)(2008-4#1)
in the spectra of##2##4##(1994-11#1)(2008-2#1)
in the spectra##4##3##(1994-11#1)(2008-10#2)(2008-2#1)
in the spectral domain##5##4##(2007-11#1)(2007-12#1)(2008-2#3)
in the spectral range from##4##5##(2007-12#2)(2008-10#1)(2008-3#1)
in the spectral range of##2##5##(2008-10#2)
in the spectral range##13##4##(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#5)
in the spectral region from##4##5##(2008-2#2)(2008-3#2)
in the spectral region##8##4##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)
in the spectral##34##3##(2007-11#2)(2007-12#6)(2008-10#6)(2008-2#9)(2008-3#11)
in the spectrometer##2##3##(2007-12#1)(2008-10#1)
in the spectrophotometric determination of##4##5##(2008-10#4)
in the spectrophotometric##6##3##(2008-10#6)
in the spectroscopic##3##3##(1997-2#1)(2008-1#1)(2008-2#1)
in the spectrum of the##2##5##(2007-11#1)(2007-12#1)
in the spectrum of##3##4##(1994-6#1)(2007-11#1)(2007-12#1)
in the spectrum##6##3##(1994-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)
in the specular direction##4##4##(2007-11#2)(2008-3#2)
in the specular##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
in the speech##2##3##(2008-9#1)(2013-8#1)
in the spent##2##3##(1995-6#1)(2008-11#1)
in the sperm##3##3##(2008-8#1)(2009-8#1)(2011-1#1)
in the spermatheca##3##3##(2008-6#1)(2008-8#1)(2012-12#1)
in the spermosphere##2##3##(2008-10#2)
in the sphere##2##3##(2008-2#1)(2008-3#1)
in the spider##2##3##(2007-12#2)
in the spike##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
in the spiked##2##3##(2008-10#2)
in the spinal canal##2##4##(2007-8#1)(2009-3#1)
in the spinal cord and##3##5##(1990-7#1)(1994-8#1)(1996-5#1)
in the spinal cord dorsal horn##2##6##(1993-12#1)(1994-8#1)
in the spinal cord##24##4##(1990-5#1)(1990-7#1)(1991-5#1)(1993-12#1)(1994-8#3)(1995-12#1)(1995-5#1)(1996-12#2)(1996-5#3)(1997-3#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-11#1)(2011-1#1)(2012-3#1)
in the spinal##28##3##(1990-5#1)(1990-7#1)(1991-5#1)(1993-12#1)(1994-8#3)(1995-12#1)(1995-5#1)(1996-12#2)(1996-5#3)(1997-3#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the spine and##2##4##(1993-11#1)(2010-5#1)
in the spine##4##3##(1993-11#1)(2007-11#1)(2010-5#1)(2011-2#1)
in the spleen and lung##3##5##(1990-12#2)(2008-10#1)
in the spleen and##5##4##(1990-12#2)(1997-6#1)(2008-10#2)
in the spleen were##2##4##(1995-12#1)(2008-10#1)
in the spleen##14##3##(1990-12#3)(1992-9#1)(1993-3#1)(1994-2#1)(1995-12#1)(1997-6#1)(2008-10#4)(2008-5#1)(2010-5#1)
in the sponges was##2##4##(1994-3#2)
in the spontaneous##2##3##(1990-7#1)(2008-1#1)
in the spontaneously hypertensive##2##4##(1997-2#1)(2009-9#1)
in the spore##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
in the spread of##3##4##(1997-6#1)(2008-10#2)
in the spring and##3##4##(2008-10#2)(2013-1#1)
in the spring of 1993##2##5##(2008-10#2)
in the spring of##11##4##(1992-4#1)(1994-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-9#1)(2012-3#1)
in the spring##17##3##(1992-4#1)(1994-12#1)(1995-2#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2011-9#1)(2012-3#1)(2013-1#1)
in the sputum##2##3##(2008-3#1)(2011-2#1)
in the square##2##3##(2007-12#1)(2008-10#1)
in the squid##2##3##(2008-7#1)(2013-8#1)
in the stability of the##5##5##(1994-11#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
in the stability of##6##4##(1994-11#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-3#1)
in the stabilization of the##2##5##(1991-6#1)(1992-5#1)
in the stabilization##4##3##(1991-6#1)(1992-5#1)(2008-12#2)
in the stable##3##3##(2008-10#1)(2011-2#2)
in the stage I and stage II hypertension groups as compared to those##2##13##(2013-8#2)
in the stage##4##3##(2008-1#1)(2013-8#3)
in the staging and##2##4##(2010-3#1)(2012-12#1)
in the staging of##4##4##(2007-4#1)(2008-2#2)(2012-12#1)
in the staging##6##3##(2007-4#1)(2008-2#2)(2010-3#1)(2012-12#2)
in the stained##2##3##(1995-4#1)(2007-12#1)
in the standard deviation##3##4##(2008-2#2)(2008-5#1)
in the standard##15##3##(1990-2#1)(1991-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#1)(2010-5#1)(2012-3#1)(2013-1#1)
in the standardization##3##3##(2006-6#1)(2008-10#2)
in the starch##2##3##(1995-6#1)(2008-10#1)
in the starfish##2##3##(1992-8#2)
in the starting material##2##4##(2008-10#2)
in the state of Bahia##2##5##(2008-8#1)(2009-10#1)
in the state of Minas Gerais##2##6##(2008-6#2)
in the state of Sao Paulo##3##6##(1993-8#3)
in the state of oral tolerance##2##6##(2008-11#2)
in the state of##20##4##(1993-6#1)(1993-8#3)(1996-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
in the state##28##3##(1991-8#1)(1993-6#1)(1993-8#3)(1995-12#1)(1996-12#1)(1996-4#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
in the stationary phase##2##4##(2008-7#2)
in the statistical analysis##3##4##(1996-7#1)(2008-8#1)(2013-8#1)
in the statistical##10##3##(1990-8#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
in the steady state##3##4##(1990-5#1)(1991-12#1)(2008-10#1)
in the steady-state level of##3##5##(1992-1#1)(1992-9#1)(1997-1#1)
in the steady-state##9##3##(1992-1#1)(1992-9#1)(1994-6#2)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
in the stem##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
in the stems and##2##4##(2008-10#2)
in the stenosis group than in the control group##2##9##(2007-10#2)
in the stent##2##3##(2008-7#2)
in the sterile anther##2##4##(2008-8#2)
in the sterile##3##3##(2008-12#1)(2008-8#2)
in the steroid binding domain##2##5##(1991-12#1)(1992-12#1)
in the steroid##5##3##(1991-12#1)(1991-5#2)(1992-12#1)(2008-4#1)
in the sterol##2##3##(1992-3#1)(2008-10#1)
in the still##2##3##(1996-11#1)(2009-7#1)
in the stimulation of##3##4##(1992-12#1)(1997-2#1)(1997-8#1)
in the stimulation##4##3##(1992-12#1)(1993-3#1)(1997-2#1)(1997-8#1)
in the stimulatory##2##3##(2008-11#2)
in the stirred##2##3##(2008-10#1)(2008-11#1)
in the stomach and##7##4##(1991-4#1)(1994-2#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-6#1)(2011-2#1)
in the stomach in##2##4##(1991-6#1)(1997-1#1)
in the stomach##23##3##(1991-4#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#3)(2012-2#4)(2013-1#1)(2013-7#1)
in the stools##2##3##(1991-6#1)(2009-1#1)
in the storage##4##3##(1991-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
in the strains##2##3##(2007-7#1)(2008-5#1)
in the strategic planning process##2##5##(1994-2#1)(1996-1#1)
in the stratigraphic##2##3##(1997-5#1)(2010-6#1)
in the stratosphere##4##3##(1991-6#1)(2008-2#2)(2008-3#1)
in the stratum corneum##6##4##(2008-10#1)(2008-5#4)(2012-2#1)
in the stratum##7##3##(1995-12#1)(2008-10#1)(2008-5#4)(2012-2#1)
in the stream of life##3##5##(2010-10#3)
in the strength of##4##4##(1993-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
in the strength##6##3##(1993-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
in the stress of##2##4##(2007-12#1)(2013-8#1)
in the stress response to DNA-damaging agents##2##7##(1995-8#2)
in the stress##5##3##(1995-8#2)(2007-12#1)(2008-9#1)(2013-8#1)
in the stretcher##2##3##(2007-11#1)(2008-2#1)
in the striatal##2##3##(1994-8#1)(1996-2#1)
in the striate cortex##2##4##(1994-8#1)(2008-11#1)
in the striatum and the nucleus accumbens##2##7##(1996-12#2)
in the striatum and the##3##5##(1996-12#2)(1996-5#1)
in the striatum and##5##4##(1996-12#2)(1996-5#2)(2008-7#1)
in the striatum of awake rats##2##6##(1995-12#2)
in the striatum of##6##4##(1995-12#2)(1996-5#1)(2008-10#1)(2008-7#1)(2009-8#1)
in the striatum##26##3##(1991-4#1)(1993-9#1)(1994-2#2)(1995-12#3)(1996-12#4)(1996-5#4)(1997-2#2)(2008-10#1)(2008-7#5)(2009-12#1)(2009-8#1)(2011-2#1)
in the stroma##3##3##(1994-2#1)(1997-3#1)(2008-11#1)
in the stromal##2##3##(1994-9#1)(1995-11#1)
in the strong##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
in the strongly##2##3##(2008-10#1)(2012-2#1)
in the structural##10##3##(1993-9#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#1)
in the structure and function of##4##6##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
in the structure and##5##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)
in the structure of the##8##5##(1990-11#1)(1990-5#1)(1993-8#1)(2007-12#2)(2008-10#1)(2008-5#2)
in the structure of##17##4##(1990-11#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-3#1)(1996-7#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)
in the structure##33##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-3#1)(1996-12#2)(1996-7#1)(2007-12#4)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)
in the structures of##3##4##(1994-8#1)(1996-5#1)(2008-8#1)
in the students'##2##3##(2008-11#2)
in the studied##15##3##(1991-6#1)(2008-10#8)(2008-2#1)(2010-3#1)(2010-8#1)(2013-1#2)(2013-8#1)
in the studies of##4##4##(2008-1#1)(2008-10#2)(2010-5#1)
in the studies on##2##4##(2012-1#1)(2013-7#1)
in the studies##17##3##(1992-3#1)(1993-11#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)
in the study and the##3##5##(1991-12#1)(1993-12#1)(2008-6#1)
in the study and##12##4##(1991-12#1)(1992-12#1)(1993-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)
in the study are##2##4##(1997-8#1)(2011-2#1)
in the study area##10##4##(1995-9#1)(2008-12#2)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
in the study group##8##4##(2007-7#1)(2009-10#4)(2011-1#2)(2013-1#1)
in the study of a##3##5##(1990-8#1)(2008-2#1)(2008-4#1)
in the study of human##2##5##(2008-10#1)(2008-4#1)
in the study of memory##2##5##(1994-3#1)(2013-8#1)
in the study of the##10##5##(1991-5#2)(1991-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-10#1)(2013-1#1)
in the study of##61##4##(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#2)(1991-9#1)(1994-3#1)(1995-6#1)(1996-3#4)(1997-5#1)(2007-10#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#2)(2011-3#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
in the study on##2##4##(2008-9#1)(2010-3#1)
in the study patients##2##4##(2008-1#2)
in the study period##4##4##(2006-8#4)
in the study population was##2##5##(2007-8#1)(2008-7#1)
in the study population##8##4##(1990-2#1)(1993-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
in the study protocol##2##4##(2008-8#1)(2013-1#1)
in the study sites##2##4##(2008-12#1)(2012-12#1)
in the study were##4##4##(1996-1#1)(2008-10#2)(2008-11#1)
in the study##256##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#5)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-8#6)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#12)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#3)(2008-9#5)(2009-10#4)(2009-3#2)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#14)(2011-10#1)(2011-2#13)(2011-3#3)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#17)(2013-7#2)(2013-8#3)
in the style##2##3##(2008-10#2)
in the sub-groups##2##3##(2007-7#1)(2008-2#1)
in the subacute##2##3##(2008-8#1)(2011-2#1)
in the subarachnoid space##6##4##(2008-7#6)
in the subarachnoid##7##3##(1995-11#1)(2008-7#6)
in the subcapsular area##2##4##(2012-2#1)(2012-3#1)
in the subcapsular##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
in the subcellular distribution of##2##5##(1993-9#1)(1994-10#1)
in the subcellular##4##3##(1992-6#1)(1993-9#1)(1994-10#1)(1996-9#1)
in the subcutaneous##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
in the subfamily Pooideae##2##4##(2008-10#1)(2008-8#1)
in the subfornical organ##2##4##(1994-2#1)(2008-4#1)
in the subgroup##2##3##(2008-7#1)(2008-8#1)
in the subjective##4##3##(1990-3#1)(1992-12#1)(2008-5#2)
in the subjects with##2##4##(2008-5#1)(2008-7#1)
in the subjects##4##3##(1994-12#1)(2008-5#1)(2008-7#2)
in the submicrometer##3##3##(2008-10#2)(2008-2#1)
in the submillimeter wave region##3##5##(2008-2#3)
in the subphase##4##3##(1994-3#1)(1994-6#1)(1997-2#2)
in the subsequent##6##3##(2008-2#1)(2008-4#1)(2008-7#2)(2011-2#2)
in the substantia nigra (SN)##2##5##(2008-7#1)(2012-2#1)
in the substantia nigra and the##3##6##(2008-7#3)
in the substantia nigra and##5##5##(2008-7#5)
in the substantia nigra are##2##5##(1995-12#1)(1995-2#1)
in the substantia nigra pars compacta##2##6##(1995-3#1)(2008-7#1)
in the substantia nigra##21##4##(1990-5#1)(1993-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-7#9)(2012-12#1)(2012-2#1)
in the substitution##2##3##(1993-3#1)(2008-10#1)
in the substrate are##2##4##(1992-3#1)(2008-2#1)
in the substrate binding pocket##2##5##(1994-5#1)(1995-5#1)
in the substrate binding##3##4##(1992-11#1)(1994-5#1)(1995-5#1)
in the substrate##11##3##(1990-5#1)(1992-11#1)(1992-3#1)(1994-5#1)(1995-5#1)(2008-10#3)(2008-2#2)(2008-5#1)
in the subsurface water##2##4##(2009-8#2)
in the subumbilical incision##2##4##(2011-2#2)
in the subunit##2##3##(1990-5#1)(2008-9#1)
in the success of##6##4##(1996-3#1)(2008-10#2)(2008-11#2)(2008-7#1)
in the successful implementation of##2##5##(1992-1#1)(2008-7#1)
in the successful##9##3##(1992-1#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)
in the successive##2##3##(2008-10#1)(2008-11#1)
in the sugar##3##3##(1992-3#1)(2008-11#1)(2008-5#1)
in the suicidal##2##3##(2010-6#2)
in the sulcal prefrontal cortex##3##5##(1994-3#3)
in the sulfate##3##3##(2008-10#2)(2008-7#1)
in the sum##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
in the summer of 1998##2##5##(2008-3#1)(2008-5#1)
in the summer of##6##4##(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)
in the summer##14##3##(1995-1#1)(1996-1#1)(2008-10#3)(2008-3#2)(2008-5#4)(2008-8#2)(2013-8#1)
in the superconducting##2##3##(2008-10#1)(2013-8#1)
in the superficial layers of the##2##6##(1997-2#1)(2008-5#1)
in the superficial layers of##3##5##(1997-2#1)(2008-11#1)(2008-5#1)
in the superficial layers##6##4##(1993-12#1)(1997-2#1)(2008-11#2)(2008-5#2)
in the superficial##12##3##(1993-12#2)(1994-2#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-5#3)(2011-2#2)
in the superior temporal sulcus##2##5##(2008-11#1)(2009-10#1)
in the superior##7##3##(1993-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-8#1)(2013-1#1)
in the supernatant and##2##4##(2008-11#2)
in the supernatant fraction##3##4##(1992-12#2)(1995-3#1)
in the supernatant of##2##4##(2008-11#1)(2008-9#1)
in the supernatant was##2##4##(2008-10#2)
in the supernatant##15##3##(1992-12#2)(1995-3#1)(2008-10#3)(2008-11#7)(2008-9#1)(2009-8#1)
in the supernatants of##4##4##(1991-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
in the supine position##3##4##(2010-3#1)(2011-2#1)(2012-3#1)
in the supine##4##3##(1992-4#1)(2010-3#1)(2011-2#1)(2012-3#1)
in the supplement##2##3##(2008-10#1)(2008-5#1)
in the supply of##2##4##(1996-3#1)(2008-10#1)
in the support protocol##2##4##(2008-4#2)
in the support##6##3##(1994-3#1)(2008-10#2)(2008-4#3)
in the suppression of antibody production by in vitro immunized##2##10##(2008-11#2)
in the suppression of##12##4##(1990-12#1)(2008-10#8)(2008-11#2)(2010-1#1)
in the suppression##13##3##(1990-12#1)(2008-10#8)(2008-11#3)(2010-1#1)
in the suppressive soil##2##4##(2008-10#2)
in the suppressive##3##3##(1996-5#1)(2008-10#2)
in the supraclavicular##2##3##(2008-7#2)
in the surface pressure##2##4##(1994-3#1)(1997-2#1)
in the surface##12##3##(1994-3#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#4)(2008-5#1)(2011-2#1)
in the surgical management of breast##2##6##(1994-12#1)(2008-1#1)
in the surgical management of##6##5##(1994-12#1)(2008-1#1)(2010-11#1)(2011-2#2)(2013-1#1)
in the surgical treatment of##6##5##(1990-3#1)(1991-3#1)(1992-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
in the surgical treatment##7##4##(1990-3#1)(1990-5#1)(1991-3#1)(1992-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
in the surgical##23##3##(1990-3#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-6#1)(1994-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
in the surrounding space##2##4##(2008-8#2)
in the surrounding##12##3##(1990-11#1)(1995-6#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#3)
in the surroundings of##2##4##(1995-2#1)(2009-7#1)
in the surveillance site##2##4##(2012-3#2)
in the surveillance##5##3##(1992-9#2)(2010-4#1)(2012-3#2)
in the survey##7##3##(1992-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(2008-12#1)(2008-5#1)(2010-10#1)
in the survival of##5##4##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)
in the survival##9##3##(1991-12#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)
in the surviving##4##3##(1992-3#1)(1994-3#1)(1994-5#1)(2010-4#1)
in the susceptibility of##2##4##(1995-3#1)(2008-10#1)
in the susceptibility to##2##4##(2008-10#1)(2011-2#1)
in the susceptibility##5##3##(1995-3#1)(1997-8#1)(2008-10#2)(2011-2#1)
in the susceptible cultivar##6##4##(2008-10#6)
in the susceptible cv##2##4##(2008-10#2)
in the susceptible genotype##3##4##(2008-10#3)
in the susceptible than in the resistant cultivars##2##8##(2008-10#2)
in the susceptible##25##3##(1994-9#1)(1996-12#1)(2008-10#22)(2011-10#1)
in the suspension culture##4##4##(2008-11#4)
in the suspension##7##3##(1990-12#1)(2008-11#5)(2008-6#1)
in the swimming##2##3##(1995-6#1)(2008-5#1)
in the swollen##2##3##(2008-10#1)(2012-12#1)
in the syllable##2##3##(2013-8#2)
in the sympathetic##2##3##(1994-5#1)(2008-2#1)
in the symptomatic##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
in the synaptic cleft##2##4##(1991-12#1)(2008-3#1)
in the synaptic##5##3##(1991-12#1)(1991-2#1)(1997-2#1)(2008-3#1)(2013-8#1)
in the synovial tissue##2##4##(1994-8#1)(2012-2#1)
in the synthesis and release of##2##6##(2008-9#1)(2013-7#1)
in the synthesis and##7##4##(1992-11#1)(1995-11#1)(2008-10#1)(2008-9#1)(2011-2#2)(2013-7#1)
in the synthesis of the##6##5##(1990-11#1)(1990-5#2)(1992-12#1)(2009-11#2)
in the synthesis of##26##4##(1990-11#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2011-1#1)(2012-3#1)
in the synthesis##36##3##(1990-11#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
in the synthesized##2##3##(2008-10#1)(2013-1#1)
in the synthetic##4##3##(1992-8#1)(1993-8#1)(2008-10#2)
in the system composed of##2##5##(2012-1#2)
in the system for##2##4##(2008-10#2)
in the system is##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
in the system of##12##4##(1990-5#1)(2008-10#1)(2013-8#10)
in the system##50##3##(1990-12#1)(1990-5#1)(1992-6#1)(1993-3#1)(1994-3#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-9#1)(2011-1#2)(2012-1#3)(2012-3#1)(2013-8#10)
in the systemic therapy##2##4##(2008-5#1)(2011-2#1)
in the systems##2##3##(2008-10#2)
in the tRNA of HIV-1 produced in##2##7##(1992-6#2)
in the table##3##3##(1993-2#1)(2008-10#1)(2008-6#1)
in the tail##6##3##(1995-3#1)(1997-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2011-1#1)
in the tangential##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
in the tank##2##3##(2008-8#1)(2009-9#1)
in the tapered##2##3##(2007-11#1)(2008-3#1)
in the target organ##2##4##(1990-8#1)(2008-11#1)
in the target region##2##4##(2008-10#1)(2011-2#1)
in the target##21##3##(1990-6#1)(1990-8#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#3)(2013-8#1)
in the targeting of##3##4##(1995-5#1)(1996-5#1)(2009-7#1)
in the targeting##4##3##(1995-5#1)(1996-5#1)(2008-9#1)(2009-7#1)
in the task##2##3##(1995-12#1)(2010-8#1)
in the teaching of##3##4##(2009-2#2)(2013-1#1)
in the telencephalon##8##3##(1996-5#6)(2008-6#1)(2012-3#1)
in the telescope##2##3##(2008-3#2)
in the telomeric region##2##4##(1995-2#1)(2010-8#1)
in the temperate##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
in the temperature of the##2##5##(2008-1#1)(2008-3#1)
in the temperature range of##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
in the temperature range##9##4##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
in the temperature##16##3##(1994-12#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-9#1)
in the temporal cortex##4##4##(1993-6#1)(1996-12#1)(1997-2#1)(2008-9#1)
in the temporal region##2##4##(2008-9#2)
in the temporal##14##3##(1993-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#5)
in the ten patients##2##4##(2008-6#1)(2008-7#1)
in the ten##3##3##(2008-6#1)(2008-7#1)(2013-8#1)
in the terminal ileum##2##4##(1992-5#1)(1997-1#1)
in the terminal##10##3##(1992-5#1)(1993-6#1)(1997-1#1)(2007-11#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
in the terminus region##2##4##(1995-2#2)
in the terms of##2##4##(1995-3#1)(2008-10#1)
in the ternary complex##2##4##(1994-5#1)(2008-3#1)
in the ternary##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
in the territory of the##2##5##(1992-2#1)(1996-3#1)
in the territory of##4##4##(1992-2#1)(1996-3#1)(2013-8#2)
in the test sample##2##4##(2008-10#2)
in the test##18##3##(1991-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)
in the tested##5##3##(2008-10#2)(2008-11#2)(2008-12#1)
in the testes##5##3##(2008-7#2)(2009-10#3)
in the testing of##3##4##(2008-3#1)(2008-4#1)(2010-2#1)
in the testing##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
in the testis and##2##4##(1991-1#1)(1992-12#1)
in the testis was##2##4##(1992-12#1)(2008-9#1)
in the testis##25##3##(1991-1#2)(1992-12#3)(1993-12#1)(1995-6#1)(1995-8#1)(2007-5#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#3)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#6)
in the tests##2##3##(2008-10#1)(2012-12#1)
in the tetramer##2##3##(1994-11#2)
in the tetraploid##2##3##(2008-5#1)(2009-9#1)
in the text##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
in the thalamic##3##3##(1993-12#1)(1997-2#2)
in the thalamus##2##3##(2008-7#1)(2012-3#1)
in the theoretical and##2##4##(1996-6#1)(2007-11#1)
in the theoretical framework of##2##5##(2009-11#1)(2011-2#1)
in the theoretical##10##3##(1991-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-11#1)(2009-6#1)(2011-2#1)
in the theory of##2##4##(2008-10#1)(2008-7#1)
in the theory##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
in the therapeutic approach of##2##5##(1991-6#1)(1997-7#1)
in the therapeutic milieu##2##4##(1993-2#1)(2010-5#1)
in the therapeutic##8##3##(1991-6#1)(1993-2#1)(1996-11#1)(1997-7#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
in the therapy of##16##4##(1990-2#1)(1990-3#1)(1991-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-7#2)(2011-3#1)(2012-12#1)
in the therapy##18##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-5#1)(2008-7#2)(2011-3#1)(2012-12#1)
in the thermal##4##3##(2008-3#4)
in the thickness of the##2##5##(2008-10#1)(2008-9#1)
in the thickness of##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
in the thickness##5##3##(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)
in the thin##2##3##(2007-12#1)(2008-10#1)
in the third and##2##4##(2011-1#1)(2011-2#1)
in the third month##2##4##(2007-11#1)(2011-1#1)
in the third part##2##4##(2008-7#1)(2013-8#1)
in the third position of##2##5##(1990-12#1)(1997-4#1)
in the third transmembrane domain##2##5##(1993-8#1)(2008-4#1)
in the third trimester##6##4##(1990-12#1)(1990-9#1)(1993-12#1)(1993-3#1)(2008-1#1)(2011-2#1)
in the third world##2##4##(1990-12#1)(2008-10#1)
in the third##34##3##(1990-12#3)(1990-9#1)(1991-8#1)(1993-12#2)(1993-3#1)(1993-8#2)(1995-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
in the thoracic region##2##4##(1996-3#1)(2008-11#1)
in the thoracic##6##3##(1993-12#1)(1996-3#1)(2007-8#1)(2008-11#1)(2010-8#2)
in the thoracolumbar##3##3##(1997-6#1)(2008-8#2)
in the thoracotomy group##2##4##(2007-8#2)
in the thorax##2##3##(1997-8#1)(2010-5#1)
in the three cases##2##4##(2007-12#1)(2008-5#1)
in the three castes##2##4##(2008-8#2)
in the three ethnic##2##4##(2011-1#1)(2011-2#1)
in the three fractions##2##4##(1993-8#1)(2008-10#1)
in the three groups##6##4##(1994-12#1)(1995-12#1)(1996-7#1)(1996-9#1)(2008-10#1)(2010-4#1)
in the three regions##2##4##(2013-1#2)
in the three##45##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-12#2)(1995-12#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
in the three-dimensional##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2009-3#1)
in the threshold##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
in the through-thickness direction##2##4##(2009-7#2)
in the thymic##2##3##(1995-5#1)(2008-8#1)
in the thymus and##3##4##(1993-3#2)(2008-10#1)
in the thymus##12##3##(1993-3#2)(1997-7#1)(1997-9#1)(2008-10#4)(2008-5#2)(2008-7#1)(2010-2#1)
in the thyroid gland##3##4##(1990-5#1)(2008-9#1)(2012-1#1)
in the thyroid hormone##2##4##(1994-11#1)(2008-1#1)
in the thyroid##10##3##(1990-2#2)(1990-5#1)(1994-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2012-1#1)(2013-8#1)
in the thyroids of##2##4##(2008-7#2)
in the tibia##8##3##(2007-11#2)(2007-12#1)(2009-3#3)(2009-7#1)(2010-3#1)
in the tibialis##2##3##(1995-12#1)(2008-5#1)
in the tight##2##3##(1990-7#1)(1997-8#1)
in the time and##2##4##(2007-11#1)(2007-12#1)
in the time domain by##2##5##(2008-2#1)(2008-3#1)
in the time domain##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
in the time of##2##4##(2007-8#1)(2013-1#1)
in the time period##2##4##(1991-4#1)(2006-8#1)
in the time required for##2##5##(2008-4#1)(2011-1#1)
in the time required##3##4##(2008-4#1)(2011-1#1)(2011-2#1)
in the time to##2##4##(2011-2#1)(2012-3#1)
in the time##21##3##(1991-12#1)(1991-4#1)(1992-8#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the timing of the##2##5##(1995-3#1)(2008-11#1)
in the timing of##10##4##(1993-12#1)(1995-3#1)(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2012-6#1)
in the timing##11##3##(1993-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2012-6#1)
in the tip of##2##4##(1990-9#1)(2008-5#1)
in the tip##4##3##(1990-9#1)(2008-10#1)(2008-5#2)
in the tissue phantom##2##4##(2008-3#2)
in the tissue##19##3##(1990-5#1)(1993-8#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-2#1)(2008-3#7)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
in the tissues and##2##4##(2008-11#1)(2008-3#1)
in the tissues of##2##4##(1993-12#1)(2008-12#1)
in the tissues##13##3##(1991-5#1)(1993-12#1)(1996-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
in the titration##2##3##(2008-10#2)
in the top##6##3##(1992-8#1)(1995-2#1)(2008-10#1)(2008-6#1)(2010-5#1)(2012-1#1)
in the topmost##2##3##(1990-4#1)(2007-12#1)
in the topsoil were##2##4##(2008-10#2)
in the total amount of energy##2##6##(2008-8#2)
in the total amount of##4##5##(1996-12#2)(2008-8#2)
in the total area of##2##5##(1995-12#1)(2008-6#1)
in the total biomass##2##4##(2008-7#2)
in the total hysterectomy group##2##5##(2011-2#2)
in the total ion##2##4##(2008-10#2)
in the total number of##5##5##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
in the total population between 2000 and 2010##2##8##(2013-8#2)
in the total population##4##4##(1994-3#1)(1996-5#1)(2013-8#2)
in the total##41##3##(1990-12#1)(1990-8#1)(1992-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-8#2)
in the town of Cabar##2##5##(2011-2#2)
in the town of##3##4##(2008-9#1)(2011-2#2)
in the town##4##3##(2008-9#1)(2011-2#2)(2012-12#1)
in the toxicity##2##3##(1995-5#1)(2008-10#1)
in the trace##2##3##(2008-10#1)(2013-1#1)
in the trachea and##2##4##(1993-8#1)(2008-9#1)
in the trachea##6##3##(1993-8#1)(1996-12#1)(1997-1#1)(2008-5#1)(2008-8#1)(2008-9#1)
in the tracheal##2##3##(1997-6#1)(2008-1#1)
in the traditional##11##3##(1994-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-2#1)
in the trafficking##2##3##(2008-7#1)(2008-8#1)
in the trained##2##3##(2013-1#2)
in the training and##3##4##(2007-11#1)(2008-12#1)(2009-10#1)
in the training of medical graduates##2##6##(1992-1#1)(2009-10#1)
in the training of medical##3##5##(1992-1#1)(1994-6#1)(2009-10#1)
in the training of residents##2##5##(1993-3#1)(1996-9#1)
in the training of##5##4##(1992-1#1)(1993-3#1)(1994-6#1)(1996-9#1)(2009-10#1)
in the training##12##3##(1992-1#1)(1993-3#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#2)(2009-6#1)
in the transcript##2##3##(1995-8#1)(2011-1#1)
in the transcription of the##3##5##(1992-8#1)(1994-9#1)(1995-11#1)
in the transcription of##4##4##(1992-8#1)(1994-9#1)(1995-11#1)(2008-10#1)
in the transcription##7##3##(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-9#1)(1995-11#1)(2008-10#1)
in the transcriptional activator##2##4##(2012-3#2)
in the transcriptional regulation of##3##5##(1996-12#1)(2008-11#1)(2011-2#1)
in the transcriptional regulation##4##4##(1992-12#1)(1996-12#1)(2008-11#1)(2011-2#1)
in the transcriptional##8##3##(1992-12#1)(1996-12#2)(2008-11#1)(2009-8#1)(2011-2#1)(2012-3#2)
in the transduction of##4##4##(1990-12#1)(1992-3#1)(1994-11#1)(1994-8#1)
in the transduction##5##3##(1990-12#1)(1992-3#1)(1994-11#2)(1994-8#1)
in the transfer##2##3##(1995-2#1)(2008-10#1)
in the transformant##2##3##(1991-9#1)(1995-12#1)
in the transformants##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
in the transformation of##6##4##(1990-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(2009-5#1)(2013-1#1)
in the transformation##7##3##(1990-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(2008-3#1)(2009-5#1)(2013-1#1)
in the transformed##2##3##(1994-11#1)(1995-2#1)
in the transgenic animals##2##4##(1992-11#1)(1992-8#1)
in the transgenic mice##2##4##(1992-11#1)(1995-2#1)
in the transgenic##9##3##(1992-11#2)(1992-8#1)(1993-12#1)(1995-2#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-5#1)
in the transit##2##3##(1996-10#1)(2008-7#1)
in the transition state for##3##5##(1995-2#2)(2009-5#1)
in the transition state##4##4##(1991-9#1)(1995-2#2)(2009-5#1)
in the transition to##6##4##(1991-12#1)(1997-2#1)(2008-11#2)(2012-2#1)(2013-1#1)
in the transition zone##3##4##(1990-7#2)(1991-5#1)
in the transition##16##3##(1990-7#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#2)(1995-2#2)(1997-2#1)(2007-11#1)(2008-11#2)(2009-5#1)(2012-2#1)(2013-1#1)
in the translation##2##3##(2007-11#1)(2008-9#1)
in the translocation of##6##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
in the transmembrane##4##3##(1991-2#1)(1994-12#1)(2008-7#1)(2012-2#1)
in the transmission and##2##4##(2007-12#1)(2008-3#1)
in the transmission mode##2##4##(2008-2#2)
in the transmission of hepatitis C##2##6##(2007-7#1)(2008-1#1)
in the transmission of##12##4##(1997-4#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-1#2)(2013-1#1)
in the transmission##21##3##(1997-4#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2010-1#2)(2013-1#1)
in the transmitted##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
in the transmitter##3##3##(2007-11#2)(2007-12#1)
in the transplanted kidney##2##4##(1992-2#2)
in the transport of##2##4##(2010-11#1)(2012-2#1)
in the transport##5##3##(1994-12#1)(2007-12#1)(2010-11#1)(2012-2#1)(2012-8#1)
in the transverse##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
in the trauma##2##3##(2007-8#1)(2013-1#1)
in the treated mice##2##4##(2008-9#2)
in the treated##14##3##(1991-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)(2012-3#1)
in the treatment and prevention of##4##6##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
in the treatment and##10##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#2)
in the treatment arm##2##4##(2008-5#1)(2010-12#1)
in the treatment group##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
in the treatment groups##2##4##(1991-8#1)(2012-12#1)
in the treatment of DDH##2##5##(2007-8#2)
in the treatment of OCD##2##5##(2008-3#1)(2008-6#1)
in the treatment of Parkinson's disease##5##6##(1992-3#1)(1995-12#1)(1996-3#2)(2008-10#1)
in the treatment of RA##2##5##(2008-5#1)(2013-8#1)
in the treatment of a##2##5##(1994-2#1)(2013-8#1)
in the treatment of acne vulgaris##4##6##(1997-8#1)(2007-7#1)(2010-8#2)
in the treatment of acute##10##5##(1990-5#1)(1991-3#1)(1992-3#1)(2007-10#2)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
in the treatment of advanced NSCLC##2##6##(2010-8#1)(2012-1#1)
in the treatment of advanced colorectal cancer##2##7##(1990-12#2)
in the treatment of advanced##10##5##(1990-12#3)(1991-4#1)(1993-6#1)(1996-3#1)(2007-8#1)(2008-6#1)(2010-8#1)(2012-1#1)
in the treatment of affective disorders##2##6##(1991-11#1)(1996-12#1)
in the treatment of alcoholism##2##5##(1994-5#1)(1995-11#1)
in the treatment of allergic rhinitis##4##6##(2007-11#3)(2011-2#1)
in the treatment of an##4##5##(2008-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
in the treatment of anxiety by##2##6##(2009-9#2)
in the treatment of anxiety##4##5##(2008-6#1)(2009-9#3)
in the treatment of arterial hypertension]##2##6##(1993-11#1)(1996-3#1)
in the treatment of asthma##4##5##(1992-2#1)(1997-1#1)(1997-5#1)(1997-7#1)
in the treatment of both##2##5##(1991-3#1)(2013-1#1)
in the treatment of breast cancer##5##6##(1992-5#1)(1993-11#2)(1995-11#1)(1996-11#1)
in the treatment of breast##6##5##(1992-5#1)(1993-11#2)(1993-6#1)(1995-11#1)(1996-11#1)
in the treatment of bronchial##2##5##(2008-1#1)(2013-8#1)
in the treatment of cancer##4##5##(1993-3#1)(2007-11#1)(2008-5#1)(2008-7#1)
in the treatment of cardiovascular##2##5##(2008-3#1)(2011-2#1)
in the treatment of cervical##4##5##(1991-1#1)(1994-12#1)(1996-3#1)(2007-10#1)
in the treatment of children with##2##6##(2006-10#1)(2011-2#1)
in the treatment of children##3##5##(2006-10#1)(2008-4#1)(2011-2#1)
in the treatment of chronic heart failure##2##7##(2008-7#1)(2012-3#1)
in the treatment of chronic inflammatory##2##6##(2008-4#1)(2008-5#1)
in the treatment of chronic##12##5##(1993-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the treatment of cognitive##2##5##(1991-6#1)(2008-7#1)
in the treatment of delusional depression##2##6##(2008-6#2)
in the treatment of developmental##3##5##(2007-8#3)
in the treatment of epilepsy##3##5##(2008-2#1)(2008-6#1)(2008-7#1)
in the treatment of female##2##5##(2007-9#1)(2010-11#1)
in the treatment of fractures of the distal##2##8##(2007-8#1)(2008-9#1)
in the treatment of fractures##3##5##(2007-8#2)(2008-9#1)
in the treatment of gout and##2##6##(1990-11#1)(1991-8#1)
in the treatment of heart failure##5##6##(1990-3#2)(1996-6#1)(2009-10#1)(2012-3#1)
in the treatment of hypertension##5##5##(1990-6#1)(1992-8#2)(1995-11#1)(2008-1#1)
in the treatment of infection##2##5##(1994-11#1)(2011-2#1)
in the treatment of inflammatory##2##5##(2008-3#1)(2009-1#1)
in the treatment of invasive##2##5##(2008-7#1)(2011-2#1)
in the treatment of ischemic##2##5##(2010-6#1)(2013-1#1)
in the treatment of locally advanced##2##6##(1995-9#1)(2009-5#1)
in the treatment of lumbar discopathy##2##6##(2007-8#2)
in the treatment of lumbar##3##5##(2007-8#2)(2008-8#1)
in the treatment of lung##2##5##(2007-8#1)(2008-11#1)
in the treatment of malignant pleural##3##6##(1991-6#1)(1992-12#2)
in the treatment of malignant##7##5##(1991-2#1)(1991-6#1)(1992-12#2)(1993-9#1)(1997-5#1)(2011-2#1)
in the treatment of many##3##5##(2008-3#1)(2008-9#1)(2011-3#1)
in the treatment of metastatic##2##5##(1990-2#1)(2012-3#1)
in the treatment of migraine##2##5##(1994-11#1)(2008-9#1)
in the treatment of mucormycosis##2##5##(2011-2#2)
in the treatment of multiple##2##5##(1994-12#1)(2008-3#1)
in the treatment of nasopharyngeal##2##5##(1993-9#1)(2008-8#1)
in the treatment of neuropathic pain##2##6##(2006-12#1)(2010-7#1)
in the treatment of osteomyelitis##2##5##(2010-6#2)
in the treatment of osteoporosis##4##5##(1997-6#1)(2007-11#1)(2008-7#1)(2008-8#1)
in the treatment of osteoporotic fractures of the##2##8##(2007-11#1)(2007-8#1)
in the treatment of osteoporotic vertebral##2##6##(2007-8#2)
in the treatment of osteoporotic##4##5##(2007-11#1)(2007-8#3)
in the treatment of osteosarcoma##2##5##(2010-3#2)
in the treatment of other##2##5##(2008-2#1)(2008-7#1)
in the treatment of pancreatic##3##5##(1990-9#1)(1991-8#1)(1993-6#1)
in the treatment of pathologic##2##5##(2008-9#1)(2009-3#1)
in the treatment of patients with advanced breast cancer##2##9##(1991-6#1)(1993-12#1)
in the treatment of patients with advanced##3##7##(1991-6#1)(1993-12#1)(2008-6#1)
in the treatment of patients with##12##6##(1990-12#1)(1991-6#1)(1993-12#1)(1995-9#1)(1996-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#3)(2011-2#1)
in the treatment of patients##14##5##(1990-12#1)(1991-6#1)(1993-12#1)(1995-9#1)(1996-11#1)(2008-5#2)(2008-6#1)(2009-5#1)(2011-1#3)(2011-2#2)
in the treatment of primary##3##5##(1990-3#1)(2013-1#2)
in the treatment of psoriasis##3##5##(2007-11#1)(2008-6#1)(2011-1#1)
in the treatment of recurrent##2##5##(1996-9#1)(2006-10#1)
in the treatment of renal##2##5##(2011-2#1)(2012-2#1)
in the treatment of respiratory##2##5##(2007-11#1)(2007-12#1)
in the treatment of rheumatoid arthritis##2##6##(2008-5#1)(2008-8#1)
in the treatment of schizophrenia and schizoaffective##2##7##(2008-8#2)
in the treatment of schizophrenia and##4##6##(2008-6#1)(2008-8#2)(2011-2#1)
in the treatment of schizophrenia##6##5##(2008-6#2)(2008-8#2)(2011-2#1)(2012-12#1)
in the treatment of sepsis##3##5##(2007-12#1)(2008-8#1)(2011-1#1)
in the treatment of several##2##5##(2007-4#1)(2010-11#1)
in the treatment of severe##6##5##(1990-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-9#1)(2013-1#1)
in the treatment of spinal##2##5##(2007-11#2)
in the treatment of stage III##2##6##(1994-8#1)(2007-11#1)
in the treatment of stage##4##5##(1994-8#1)(2007-11#1)(2007-8#1)(2009-10#1)
in the treatment of such##2##5##(1990-9#1)(2013-1#1)
in the treatment of systemic##2##5##(1997-2#1)(2008-11#1)
in the treatment of the##6##5##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)
in the treatment of these##3##5##(2007-11#1)(2007-8#1)(2011-2#1)
in the treatment of this disease##2##6##(2009-7#1)(2010-3#1)
in the treatment of this##5##5##(1991-9#1)(2007-9#1)(2009-10#1)(2009-7#1)(2010-3#1)
in the treatment of tuberculosis##2##5##(2008-10#1)(2008-8#1)
in the treatment of##474##4##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#5)(1990-5#1)(1990-6#7)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#5)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#4)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#2)(1995-11#4)(1995-12#3)(1995-5#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-11#3)(1996-12#1)(1996-3#5)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-12#3)(2007-10#4)(2007-11#25)(2007-12#9)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#23)(2007-9#4)(2008-1#4)(2008-10#7)(2008-11#7)(2008-2#5)(2008-3#9)(2008-4#6)(2008-5#16)(2008-6#18)(2008-7#14)(2008-8#10)(2008-9#6)(2009-1#3)(2009-10#4)(2009-3#2)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#2)(2009-9#5)(2010-10#2)(2010-11#6)(2010-12#3)(2010-3#7)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#27)(2011-3#5)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#14)(2013-1#24)(2013-8#7)
in the treatment##499##3##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#6)(1990-5#1)(1990-6#7)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#6)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#4)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#2)(1995-11#4)(1995-12#3)(1995-5#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-11#3)(1996-12#1)(1996-3#5)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-12#3)(2007-10#4)(2007-11#26)(2007-12#10)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#24)(2007-9#4)(2008-1#4)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#8)(2008-5#18)(2008-6#18)(2008-7#15)(2008-8#11)(2008-9#6)(2009-1#3)(2009-10#4)(2009-3#2)(2009-4#3)(2009-5#4)(2009-7#2)(2009-8#2)(2009-9#5)(2010-10#2)(2010-11#7)(2010-12#4)(2010-3#7)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#28)(2011-3#5)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#14)(2013-1#26)(2013-8#7)
in the treatments that##2##4##(2008-10#2)
in the tree##6##3##(2008-10#4)(2011-2#1)(2013-7#1)
in the trellis##2##3##(2008-10#1)(2008-3#1)
in the trial##8##3##(1990-2#1)(1997-7#1)(2007-7#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)
in the trials##2##3##(2008-2#1)(2010-12#1)
in the trigeminal ganglion##2##4##(1996-2#1)(2008-6#1)
in the trigeminal##5##3##(1996-2#1)(1997-2#2)(2008-6#1)(2008-9#1)
in the triggering of##2##4##(2008-8#2)
in the triradiate lumen##3##4##(2008-10#3)
in the trophic##2##3##(1993-3#1)(2013-7#1)
in the tropical and subtropical##2##5##(2008-10#1)(2008-5#1)
in the tropical and##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
in the tropical environment##2##4##(1996-12#1)(2008-10#1)
in the tropical forests of##2##5##(1991-12#1)(2013-7#1)
in the tropical##10##3##(1990-8#1)(1991-12#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-7#2)
in the tropics and subtropics##2##5##(2008-10#1)(2011-2#1)
in the tropics##10##3##(1995-12#1)(1996-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)
in the troposphere and lower stratosphere##3##6##(2008-3#3)
in the troposphere##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
in the true lumen##2##4##(2007-8#2)
in the true##3##3##(2007-8#2)(2013-7#1)
in the trunk##5##3##(1991-12#1)(1995-8#2)(2008-10#1)(2008-5#1)
in the trypsin-like##2##3##(2008-5#2)
in the tube##5##3##(2008-10#3)(2008-2#1)(2008-8#1)
in the tumor cells##3##4##(1993-8#1)(1994-5#1)(2012-2#1)
in the tumor microenvironment##2##4##(2011-1#2)
in the tumor tissue##2##4##(1992-9#2)
in the tumor was##2##4##(1990-5#1)(1993-11#1)
in the tumor##21##3##(1990-5#1)(1990-6#1)(1992-9#4)(1993-11#2)(1993-8#1)(1993-9#2)(1994-5#2)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
in the tumorigenic##2##3##(1992-9#2)
in the tumors##4##3##(1990-7#1)(1992-9#2)(1994-6#1)
in the tumour##3##3##(1990-5#1)(1997-3#1)(2008-7#1)
in the tunnel##2##3##(2007-12#1)(2009-10#1)
in the turbid##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
in the turbulent##2##3##(2007-12#1)(2008-8#1)
in the two cases##2##4##(2008-10#1)(2009-12#1)
in the two cell lines##3##5##(2008-11#1)(2008-7#1)(2011-2#1)
in the two groups of patients##3##6##(1990-11#1)(1990-12#1)(1990-5#1)
in the two groups of##5##5##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1995-5#1)
in the two groups was##3##5##(1996-5#1)(2008-1#1)(2008-7#1)
in the two groups were##3##5##(2009-11#1)(2009-12#1)(2013-8#1)
in the two groups##30##4##(1990-11#2)(1990-12#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-5#1)(1996-7#1)(2007-8#3)(2008-1#1)(2008-7#2)(2009-11#1)(2009-12#2)(2011-1#1)(2012-2#2)(2013-8#1)
in the two latter##2##4##(1996-2#1)(2008-5#1)
in the two species##4##4##(1996-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
in the two types of##2##5##(1993-12#1)(2008-7#1)
in the two##118##3##(1990-11#2)(1990-12#2)(1990-5#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-5#3)(1996-7#1)(1996-9#1)(1997-4#2)(2007-11#2)(2007-12#2)(2007-8#4)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#3)(2013-8#1)
in the two-dimensional##4##3##(1990-9#1)(2007-12#2)(2008-3#1)
in the two-phase systems##4##4##(2008-10#4)
in the two-phase##5##3##(2008-10#5)
in the tympanic membrane##2##4##(1991-3#2)
in the type of##6##4##(1993-12#1)(1997-1#1)(1997-6#1)(2008-10#2)(2010-5#1)
in the type##9##3##(1993-12#1)(1997-1#1)(1997-6#1)(2008-1#2)(2008-10#2)(2008-4#1)(2010-5#1)
in the typical##3##3##(1996-2#1)(2008-3#1)(2012-3#1)
in the tyrosine##3##3##(1992-3#1)(2008-8#1)(2013-1#1)
in the ubiquitin-dependent##3##3##(1995-6#1)(2009-7#2)
in the ulnar##2##3##(2008-9#2)
in the ultraendurance runners##3##4##(2013-8#3)
in the ultrasonic nebulizer##3##4##(1991-1#3)
in the ultrasonic##5##3##(1991-1#3)(2007-12#1)(2008-3#1)
in the ultrasonographic##2##3##(1990-9#1)(1993-12#1)
in the ultrastructure##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
in the ultraviolet region of the spectrum##2##7##(2008-2#2)
in the ultraviolet region##9##4##(1990-5#1)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#1)
in the ultraviolet##18##3##(1990-5#1)(2007-11#4)(2008-10#2)(2008-2#5)(2008-3#6)
in the umbilical cord##3##4##(1997-3#1)(2009-8#2)
in the umbilical##4##3##(1990-8#1)(1997-3#1)(2009-8#2)
in the undergraduate curriculum of##3##5##(2011-2#3)
in the undergraduate##5##3##(1991-1#1)(2008-12#1)(2011-2#3)
in the underlying##7##3##(1990-8#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
in the understanding and##2##4##(2008-11#1)(2011-2#1)
in the understanding of the molecular basis of##2##8##(2008-1#1)(2008-11#1)
in the understanding of the##15##5##(1991-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-6#1)(2012-12#1)
in the understanding of##18##4##(1991-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-6#1)(2012-12#1)(2012-2#1)
in the understanding##22##3##(1991-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the understory of##2##4##(2008-8#1)(2008-9#1)
in the understory##4##3##(2008-8#1)(2008-9#3)
in the unfolding##2##3##(2008-4#1)(2008-9#1)
in the unit##6##3##(1996-2#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)
in the universe##4##3##(2008-12#2)(2010-3#1)(2010-9#1)
in the university##3##3##(2007-7#1)(2008-11#1)(2008-12#1)
in the unprotected##2##3##(1996-8#1)(2008-3#1)
in the untreated##7##3##(1992-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#2)(2011-2#1)
in the upper Keys##3##4##(2007-5#3)
in the upper atmosphere##2##4##(2008-3#2)
in the upper crust##2##4##(1996-4#2)
in the upper explosive limit range##2##6##(2008-10#2)
in the upper extremity##2##4##(2007-7#1)(2011-2#1)
in the upper gastrointestinal tract##3##5##(2012-1#2)(2013-1#1)
in the upper layer##4##4##(2008-10#2)(2008-2#1)(2009-4#1)
in the upper limb##2##4##(1991-4#1)(2008-7#1)
in the upper ocean##2##4##(2008-2#1)(2008-3#1)
in the upper outer quadrant of the breast##2##8##(1994-7#2)
in the upper part of the##3##6##(1991-9#1)(2008-5#1)(2009-4#1)
in the upper part of##4##5##(1991-9#1)(2008-5#1)(2009-4#1)(2011-2#1)
in the upper troposphere and##2##5##(2008-2#1)(2008-3#1)
in the upper troposphere##3##4##(2008-2#1)(2008-3#2)
in the upper##63##3##(1991-4#1)(1991-6#1)(1991-9#2)(1993-2#1)(1993-9#1)(1994-5#1)(1994-7#3)(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#2)(2007-5#4)(2007-7#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#2)(2009-4#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#2)(2013-1#4)
in the upright body position##2##5##(2008-5#2)
in the uptake and##2##4##(2008-11#1)(2008-9#1)
in the uptake of##2##4##(1995-11#1)(2008-10#1)
in the uptake process##2##4##(1990-11#1)(2008-7#1)
in the uptake##6##3##(1990-11#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
in the urban area of Puerto Carreño##3##7##(2012-12#3)
in the urban area of Uberlândia##2##6##(2008-6#2)
in the urban area of##7##5##(2008-11#1)(2008-6#2)(2009-10#1)(2012-12#3)
in the urban area##9##4##(2008-11#1)(2008-6#3)(2009-10#1)(2012-12#3)(2012-3#1)
in the urban##14##3##(1990-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#3)(2009-10#1)(2012-12#3)(2012-3#1)
in the urinary bladder of a##2##6##(2007-7#1)(2012-2#1)
in the urinary bladder of##3##5##(2007-7#2)(2012-2#1)
in the urinary bladder##6##4##(2007-7#2)(2009-5#1)(2009-7#1)(2012-12#1)(2012-2#1)
in the urinary excretion of##5##5##(1991-12#1)(1994-5#3)(1995-3#1)
in the urinary##13##3##(1991-12#1)(1992-9#1)(1994-5#3)(1995-3#1)(1997-7#1)(2007-7#2)(2009-5#1)(2009-7#1)(2012-12#1)(2012-2#1)
in the urine and##3##4##(1990-12#1)(2008-12#1)(2012-2#1)
in the urine in##2##4##(1990-12#1)(1991-11#1)
in the urine is##2##4##(1995-3#1)(2009-7#1)
in the urine of patients##2##5##(1996-2#1)(1997-2#1)
in the urine of##9##4##(1990-12#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(2008-7#1)
in the urine were##2##4##(1992-5#1)(2013-1#1)
in the urine##40##3##(1990-12#5)(1990-2#1)(1991-11#1)(1992-3#2)(1992-5#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-3#2)(1996-12#2)(1996-2#1)(1997-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-7#3)(2009-7#2)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the urothelium##2##3##(2012-1#1)(2013-8#1)
in the use of cardiac##2##5##(1995-8#1)(2008-3#1)
in the use of flow##2##5##(2008-10#1)(2008-9#1)
in the use of information##2##5##(1996-12#1)(2008-10#1)
in the use of interventions to prevent infections##2##8##(2011-2#2)
in the use of medical devices##2##6##(2008-11#2)
in the use of medical##3##5##(2008-11#2)(2008-4#1)
in the use of the##5##5##(1993-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-6#1)
in the use of##72##4##(1991-3#2)(1991-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)
in the use##73##3##(1991-3#2)(1991-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
in the usual##3##3##(1991-1#1)(1992-6#1)(2007-11#1)
in the uterine##4##3##(1990-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the uterus are##3##4##(2007-11#2)(2012-2#1)
in the uterus##6##3##(2007-11#3)(2012-1#1)(2012-2#1)(2012-3#1)
in the utilization of##3##4##(1996-6#1)(2008-6#1)(2011-2#1)
in the vaccinated##5##3##(1994-2#3)(1995-5#1)(2008-11#1)
in the vaccine##2##3##(1994-2#1)(1995-5#1)
in the vagina##2##3##(1996-12#1)(1996-9#1)
in the vaginal##2##3##(2008-10#1)(2010-3#1)
in the validation##2##3##(2008-10#1)(2008-8#1)
in the valley##2##3##(2008-10#2)
in the value of the##2##5##(2008-10#1)(2008-3#1)
in the value of##9##4##(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)
in the value##11##3##(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
in the values of##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
in the variability of##3##4##(1990-11#1)(2008-11#1)(2011-1#1)
in the variable##2##3##(1993-11#1)(1993-6#1)
in the variables##2##3##(2008-10#1)(2008-5#1)
in the variation##2##3##(2008-10#1)(2008-3#1)
in the various cerebral subdivisions##2##5##(1997-2#2)
in the various systems##2##4##(2008-10#1)(2008-9#1)
in the various##14##3##(1991-12#1)(1991-5#1)(1995-3#1)(1996-12#1)(1997-2#2)(1997-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
in the vascular dementia##2##4##(2008-7#2)
in the vascular system##2##4##(2008-10#1)(2009-2#1)
in the vascular tissues##3##4##(2008-10#3)
in the vascular##14##3##(1991-2#1)(1997-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#3)(2009-2#1)(2012-1#1)
in the vasculature##3##3##(2008-3#1)(2009-2#1)(2013-8#1)
in the vast majority of patients##2##6##(1997-1#1)(2007-11#1)
in the vast majority of##4##5##(1997-1#1)(2007-11#1)(2008-11#1)(2008-12#1)
in the vault##2##3##(2007-11#1)(2008-5#1)
in the vector nematode Xiphinema americanum##2##6##(2008-10#2)
in the vector##7##3##(2008-10#7)
in the vegetative##2##3##(2008-8#1)(2009-12#1)
in the vehicle control##3##4##(2008-9#3)
in the vehicle controls##3##4##(2008-9#3)
in the vehicle##7##3##(2008-5#1)(2008-9#6)
in the venom##2##3##(1993-6#1)(2008-7#1)
in the venous##3##3##(1996-9#1)(2007-7#1)(2011-2#1)
in the ventral horn##2##4##(1990-7#1)(1995-5#1)
in the ventral tegmental area##3##5##(1997-7#1)(2008-4#1)(2008-7#1)
in the ventral##17##3##(1990-7#1)(1993-12#2)(1993-6#1)(1995-12#2)(1995-5#1)(1996-12#2)(1997-7#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-3#1)
in the ventricles##3##3##(2008-7#2)(2013-1#1)
in the ventricular zone##2##4##(1996-2#1)(2008-11#1)
in the ventricular##4##3##(1995-12#1)(1996-2#1)(2008-11#1)(2009-6#1)
in the ventrobasal complex##2##4##(1994-2#2)
in the ventrolateral region of the SCN##2##7##(1993-9#1)(1994-2#1)
in the ventrolateral##5##3##(1993-9#2)(1994-2#2)(1997-6#1)
in the ventromedial##3##3##(1994-2#2)(2008-11#1)
in the vertebral column##3##4##(2007-11#1)(2007-8#1)(2013-1#1)
in the vertebral##4##3##(1993-3#1)(2007-11#1)(2007-8#1)(2013-1#1)
in the vertebrate##5##3##(1990-5#1)(1994-12#1)(2008-1#1)(2008-4#1)(2008-7#1)
in the vertebrobasilar##2##3##(1991-3#1)(2008-7#1)
in the vertical##8##3##(1991-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#2)
in the vertically##2##3##(2008-3#1)(2010-8#1)
in the very early stage##2##5##(2007-11#1)(2009-7#1)
in the very early stages of##2##6##(2008-10#1)(2009-8#1)
in the very early##4##4##(2007-11#1)(2008-10#1)(2009-7#1)(2009-8#1)
in the very old##2##4##(1993-11#1)(2008-1#1)
in the very##11##3##(1993-11#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-3#1)
in the vesicles##3##3##(1991-2#1)(1995-12#1)(2008-8#1)
in the viability##2##3##(1994-5#1)(2008-11#1)
in the vicinity of a##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
in the vicinity of the##23##5##(1990-11#1)(1990-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-5#1)(1995-2#1)(1996-2#1)(2007-11#4)(2008-10#5)(2008-3#2)(2008-7#1)(2009-12#1)(2009-7#1)
in the vicinity of zero group-delay dispersion##2##7##(2008-3#2)
in the vicinity of##48##4##(1990-11#1)(1990-2#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)
in the vicinity##51##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-1#1)(2013-8#1)
in the village of##2##4##(2012-12#2)
in the vineyard##2##3##(2008-10#2)
in the viral##7##3##(1994-11#1)(1995-2#1)(2007-10#1)(2008-10#4)
in the virulence##2##3##(2007-12#1)(2008-10#1)
in the virus##5##3##(1990-2#1)(1991-5#1)(1997-6#1)(2008-10#1)(2008-12#1)
in the visible and the near infrared##2##7##(2008-3#2)
in the visible and the near-infrared##2##6##(2008-3#2)
in the visible and the##5##5##(2008-3#5)
in the visible and##9##4##(2007-12#1)(2008-3#8)
in the visible is##2##4##(2007-11#1)(2008-3#1)
in the visible or##2##4##(1997-7#1)(2008-2#1)
in the visible range##7##4##(1993-11#1)(2007-11#2)(2008-2#1)(2008-3#2)(2009-11#1)
in the visible region and##2##5##(2008-10#1)(2008-2#1)
in the visible region##12##4##(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#1)
in the visible spectral##2##4##(2008-3#1)(2013-8#1)
in the visible spectrum##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
in the visible wavelength range##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
in the visible wavelength##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
in the visible##66##3##(1993-11#1)(1997-7#1)(2007-11#6)(2007-12#8)(2008-10#9)(2008-2#11)(2008-3#27)(2009-11#1)(2009-12#1)(2013-8#1)
in the visual and olfactory systems##2##6##(2008-7#1)(2009-10#1)
in the visual and##3##4##(2008-3#1)(2008-7#1)(2009-10#1)
in the visual cortex##6##4##(1990-8#2)(1995-12#1)(1996-2#1)(2008-11#1)(2009-5#1)
in the visual field and optic nerve##2##7##(2011-2#2)
in the visual field##3##4##(2008-9#1)(2011-2#2)
in the visual##17##3##(1990-8#2)(1995-12#1)(1995-5#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-7#1)
in the vital##2##3##(2012-12#1)(2013-1#1)
in the voltage##2##3##(2007-11#1)(2008-11#1)
in the voltammetric##2##3##(2008-10#2)
in the volume of the##2##5##(2007-12#1)(2008-3#1)
in the volume of##6##4##(1996-5#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
in the volume##12##3##(1990-2#1)(1990-5#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-8#1)
in the volumetric##3##3##(2008-10#2)(2008-11#1)
in the volunteer##2##3##(1991-2#1)(1994-3#1)
in the volunteers##2##3##(1995-11#1)(1996-7#1)
in the vulnerability of the##2##5##(1995-11#1)(2009-4#1)
in the waiting##2##3##(2010-4#1)(2012-2#1)
in the wake of the##2##5##(2008-1#1)(2008-4#1)
in the wake of##4##4##(1991-3#1)(2008-1#1)(2008-4#1)(2011-2#1)
in the walking##2##3##(2007-12#2)
in the wall appositions##2##4##(2008-10#2)
in the wall normal##2##4##(2009-11#2)
in the wall of the##2##5##(2007-8#1)(2008-7#1)
in the wall##8##3##(2007-8#1)(2008-10#2)(2008-7#2)(2009-11#2)(2009-7#1)
in the walls of the##2##5##(1996-5#1)(2008-10#1)
in the walls of##3##4##(1996-5#1)(2008-10#2)
in the walls##4##3##(1996-5#2)(2008-10#2)
in the ward##2##3##(2007-11#1)(2008-11#1)
in the wards##3##3##(2010-3#1)(2013-1#2)
in the warmer##2##3##(2008-10#2)
in the wastewater##4##3##(2008-10#2)(2013-1#2)
in the water column##2##4##(2007-5#1)(2008-3#1)
in the water maze##5##4##(1993-12#1)(1993-3#1)(1997-2#1)(2008-9#2)
in the water rat Scapteromys aquaticus##2##6##(2008-5#2)
in the water samples##2##4##(2008-10#2)
in the water##31##3##(1991-5#2)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1997-2#2)(2007-5#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#4)(2008-9#2)(2011-1#1)(2013-7#1)
in the water-soluble##2##3##(1991-9#1)(1992-2#1)
in the waveguide##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
in the waveguides##2##3##(2008-2#2)
in the wavelength range 1##2##5##(2007-11#1)(2008-2#1)
in the wavelength range from##3##5##(2007-11#1)(2008-2#1)(2008-5#1)
in the wavelength range of##4##5##(2007-12#1)(2008-10#1)(2008-2#2)
in the wavelength range##21##4##(2007-11#8)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#5)(2008-5#1)
in the wavelength region##3##4##(2007-11#1)(2008-3#2)
in the wavelength##27##3##(1995-5#1)(2007-11#9)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-5#1)
in the wavelet domain##2##4##(2007-11#1)(2008-10#1)
in the way in which##2##5##(2009-5#1)(2011-2#1)
in the way of##5##4##(1997-8#1)(2008-11#1)(2008-12#1)(2010-5#1)(2013-8#1)
in the way that##4##4##(1997-5#1)(2008-11#2)(2008-4#1)
in the way the##3##4##(1997-4#1)(2008-3#1)(2008-6#1)
in the way##22##3##(1991-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
in the weak##2##3##(1995-2#1)(2008-7#1)
in the weakly acidic medium##2##5##(2008-10#2)
in the weakly##3##3##(1992-9#1)(2008-10#2)
in the weights##3##3##(1992-12#1)(1993-1#1)(1994-8#1)
in the west of##2##4##(1996-11#1)(2012-12#1)
in the west##3##3##(1996-11#1)(2008-10#1)(2012-12#1)
in the western United States##2##5##(2008-10#1)(2013-1#1)
in the western world##4##4##(1996-2#1)(2008-1#2)(2008-11#1)
in the western##13##3##(1996-2#1)(1997-7#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-2#1)(2013-1#1)
in the wet season##3##4##(2007-5#3)
in the wheat rhizosphere##4##4##(2008-10#4)
in the wheat##8##3##(2008-10#7)(2008-11#1)
in the white matter##4##4##(1995-12#1)(1995-5#1)(2008-6#1)(2010-12#1)
in the white##11##3##(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)
in the whole group##3##4##(2007-11#1)(2007-8#1)(2008-1#1)
in the whole troposphere##2##4##(2008-2#2)
in the whole##23##3##(1990-2#1)(1991-9#1)(1992-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
in the wide pH range of##2##6##(2008-10#2)
in the wide range##3##4##(2007-11#2)(2008-10#1)
in the wide##7##3##(1992-3#1)(2007-11#2)(2008-10#4)
in the wider##3##3##(1995-5#1)(2007-5#1)(2010-4#1)
in the wild and##2##4##(2010-5#1)(2012-3#1)
in the wild type strain##2##5##(1991-2#1)(2008-8#1)
in the wild type##3##4##(1991-2#1)(2008-8#1)(2009-6#1)
in the wild##12##3##(1991-2#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-4#2)(2010-5#1)(2012-3#1)
in the wild-type and##3##4##(1996-10#1)(2008-8#2)
in the wild-type strain##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
in the wild-type##14##3##(1992-6#1)(1995-5#1)(1996-10#1)(1997-3#1)(2008-10#1)(2008-7#2)(2008-8#3)(2009-6#3)(2012-2#1)
in the winter##9##3##(1995-2#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
in the wire##3##3##(2007-8#1)(2011-2#2)
in the work up##2##4##(2008-7#2)
in the work##13##3##(1991-12#2)(1991-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-7#2)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
in the workers##2##3##(2007-8#1)(2013-1#1)
in the workforce##2##3##(2008-10#1)(2012-2#1)
in the working of##3##4##(2008-10#3)
in the working range##2##4##(2008-10#2)
in the working##8##3##(1994-8#1)(2008-10#7)
in the workplace and##2##4##(2007-2#1)(2012-12#1)
in the workplace##30##3##(1991-12#2)(1991-5#1)(1992-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-6#2)(2008-9#2)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#2)
in the works of##2##4##(2007-8#1)(2008-12#1)
in the world and in##2##5##(2008-10#1)(2009-5#1)
in the world and##4##4##(2008-10#1)(2009-5#3)
in the world are##2##4##(1996-8#1)(2008-11#1)
in the world in##3##4##(2008-11#1)(2008-6#1)(2011-2#1)
in the world of managed##2##5##(1996-1#1)(1996-3#1)
in the world of##5##4##(1993-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-12#1)
in the world##60##3##(1991-3#1)(1993-1#1)(1994-2#1)(1994-9#3)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-10#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
in the world's##2##3##(1994-9#1)(2012-12#1)
in the world]##2##3##(1993-8#1)(2008-8#1)
in the worst##2##3##(1993-3#1)(2008-3#1)
in the wound##4##3##(2008-10#1)(2008-11#2)(2010-12#1)
in the writing##2##3##(2007-12#1)(2010-10#1)
in the wv/wv mice##2##4##(1996-12#2)
in the x and##2##4##(2007-12#1)(2008-3#1)
in the x##3##3##(2007-12#1)(2008-3#2)
in the xylem and##2##4##(2008-10#1)(2008-11#1)
in the xylem##6##3##(2007-12#1)(2008-10#4)(2008-11#1)
in the year 2000##7##4##(1992-3#1)(1994-9#1)(1996-2#1)(2008-1#1)(2010-5#1)(2011-1#1)(2012-2#1)
in the year following##2##4##(2008-10#1)(2008-6#1)
in the year of##2##4##(2008-10#2)
in the year##28##3##(1990-12#1)(1992-3#1)(1993-2#1)(1994-9#2)(1995-3#1)(1996-2#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
in the years ahead##3##4##(1992-2#1)(1994-3#1)(1996-9#1)
in the years following##2##4##(2008-12#1)(2010-5#1)
in the years to come##5##5##(1994-6#1)(1996-3#1)(2008-11#1)(2008-9#1)(2010-6#1)
in the years##25##3##(1992-2#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-6#2)(1996-3#1)(1996-9#2)(1997-8#1)(2007-11#3)(2007-8#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
in the yeast Saccharomyces cerevisiae##3##5##(1992-11#1)(1993-3#1)(1995-5#1)
in the yeast Saccharomyces##4##4##(1992-11#1)(1993-3#1)(1995-5#1)(1995-6#1)
in the yeast cell##2##4##(1994-11#1)(2008-8#1)
in the yeast genome and is##2##6##(1993-9#1)(1995-8#1)
in the yeast genome##5##4##(1990-5#1)(1993-9#1)(1995-8#1)(2008-11#1)(2008-7#1)
in the yeast##18##3##(1990-5#2)(1992-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the yields of##2##4##(2008-11#1)(2008-12#1)
in the yolk sac##2##4##(1997-4#1)(2008-9#1)
in the young adult##2##4##(1991-11#1)(1995-3#1)
in the young##12##3##(1990-7#1)(1991-11#2)(1994-5#1)(1995-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#1)(2013-7#1)
in the younger##5##3##(1991-1#1)(1992-8#1)(2008-6#1)(2008-7#1)(2010-8#1)
in the zebrafish##2##3##(1993-12#1)(2008-7#1)
in the zero order##2##4##(2008-2#1)(2008-3#1)
in the zero##3##3##(2008-2#1)(2008-3#2)
in the zigzag##2##3##(2008-3#2)
in the zinc##4##3##(1990-11#1)(2008-10#2)(2008-5#1)
in the zone of host sympatry##2##6##(2008-10#2)
in the zone of##4##4##(2008-10#4)
in the zone##6##3##(1996-2#1)(2008-10#5)
in the##37680##2##(1990-10#18)(1990-11#156)(1990-12#176)(1990-2#130)(1990-3#101)(1990-4#6)(1990-5#248)(1990-6#103)(1990-7#114)(1990-8#159)(1990-9#69)(1991-1#83)(1991-10#14)(1991-11#76)(1991-12#234)(1991-2#147)(1991-3#120)(1991-4#41)(1991-5#151)(1991-6#115)(1991-7#11)(1991-8#77)(1991-9#131)(1992-1#48)(1992-10#38)(1992-11#107)(1992-12#193)(1992-2#113)(1992-3#250)(1992-4#30)(1992-5#72)(1992-6#220)(1992-7#7)(1992-8#148)(1992-9#140)(1993-1#55)(1993-10#12)(1993-11#178)(1993-12#306)(1993-2#93)(1993-3#188)(1993-5#48)(1993-6#173)(1993-8#141)(1993-9#106)(1994-1#46)(1994-10#9)(1994-11#153)(1994-12#212)(1994-2#226)(1994-3#168)(1994-5#163)(1994-6#137)(1994-7#40)(1994-8#192)(1994-9#108)(1995-1#52)(1995-10#2)(1995-11#173)(1995-12#319)(1995-2#252)(1995-3#191)(1995-4#14)(1995-5#178)(1995-6#208)(1995-8#158)(1995-9#39)(1996-1#73)(1996-10#12)(1996-11#59)(1996-12#334)(1996-2#214)(1996-3#116)(1996-4#30)(1996-5#242)(1996-6#72)(1996-7#44)(1996-8#31)(1996-9#78)(1997-1#101)(1997-2#290)(1997-3#233)(1997-4#149)(1997-5#61)(1997-6#152)(1997-7#164)(1997-8#120)(1997-9#14)(2006-10#59)(2006-11#3)(2006-12#20)(2006-4#10)(2006-5#4)(2006-6#14)(2006-7#2)(2006-8#17)(2007-1#6)(2007-10#184)(2007-11#580)(2007-12#749)(2007-2#52)(2007-4#20)(2007-5#78)(2007-6#26)(2007-7#174)(2007-8#326)(2007-9#28)(2008-1#463)(2008-10#6741)(2008-11#1355)(2008-12#533)(2008-2#798)(2008-3#1547)(2008-4#531)(2008-5#992)(2008-6#456)(2008-7#1384)(2008-8#793)(2008-9#720)(2009-1#32)(2009-10#205)(2009-11#120)(2009-12#130)(2009-2#65)(2009-3#108)(2009-4#87)(2009-5#131)(2009-6#126)(2009-7#169)(2009-8#188)(2009-9#102)(2010-1#72)(2010-10#98)(2010-11#131)(2010-12#186)(2010-2#59)(2010-3#174)(2010-4#151)(2010-5#165)(2010-6#108)(2010-7#76)(2010-8#243)(2010-9#52)(2011-1#460)(2011-10#10)(2011-2#1254)(2011-3#54)(2011-4#1)(2011-7#19)(2011-9#1)(2012-1#172)(2012-12#416)(2012-2#596)(2012-3#448)(2012-4#2)(2012-5#9)(2012-6#13)(2012-7#15)(2012-8#6)(2012-9#3)(2013-1#1003)(2013-3#2)(2013-7#189)(2013-8#589)
in theabsence of##2##3##(2008-11#2)
in their BAL##2##3##(2008-10#2)
in their RR##2##3##(1995-5#1)(2008-10#1)
in their abilities to##5##4##(1996-12#1)(1996-2#1)(1997-7#1)(2008-9#1)(2009-12#1)
in their ability to transmit##2##5##(2008-10#2)
in their ability to##24##4##(1990-5#1)(1991-2#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
in their activation##3##3##(2007-10#1)(2007-8#1)(2010-8#1)
in their affinity##2##3##(1992-6#1)(1994-8#1)
in their anterior and##2##4##(2007-12#2)
in their apical cytoplasm##2##4##(2007-12#2)
in their apical##3##3##(2007-12#2)(2008-7#1)
in their association with##2##4##(1996-12#2)
in their association##3##3##(1996-12#2)(2008-6#1)
in their basal##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
in their binding##4##3##(1992-6#1)(1995-11#1)(1995-2#1)(1997-6#1)
in their body##2##3##(2007-12#1)(2008-7#1)
in their capacity to protect##2##5##(2008-10#1)(2008-5#1)
in their care##7##3##(1992-11#1)(2007-12#1)(2008-11#1)(2010-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
in their caring##2##3##(2009-5#1)(2011-1#1)
in their catalytic domains##2##4##(1992-6#1)(1992-7#1)
in their central##2##3##(1992-8#1)(2012-3#1)
in their children##2##3##(2010-9#2)
in their choice of##2##4##(1993-6#1)(2008-9#1)
in their clinical practice##2##4##(2009-11#1)(2012-2#1)
in their clinical##6##3##(1996-6#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-11#1)(2012-2#1)
in their communities##3##3##(1995-1#1)(1995-3#1)(2013-1#1)
in their countries##2##3##(2008-11#1)(2013-1#1)
in their daily work##4##4##(1997-3#1)(2008-1#1)(2010-10#1)(2013-1#1)
in their daily##5##3##(1997-3#1)(2008-1#1)(2010-10#1)(2010-7#1)(2013-1#1)
in their decision making##2##4##(1996-2#1)(2010-7#1)
in their design##2##3##(2009-2#1)(2011-2#1)
in their determination##2##3##(2008-10#2)
in their diet##5##3##(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)
in their dietary##2##3##(2008-1#1)(2010-6#1)
in their different##2##3##(2008-10#1)(2012-1#1)
in their differentiation##2##3##(2008-4#1)(2008-8#1)
in their disease##2##3##(1991-2#1)(2011-1#1)
in their drinking water for##2##5##(2008-10#2)
in their early stages##2##4##(2009-7#1)(2013-1#1)
in their effects on##8##4##(1990-5#1)(1993-6#1)(2008-12#1)(2008-8#2)(2008-9#2)(2012-3#1)
in their efforts to##5##4##(1995-3#1)(1996-3#2)(2009-4#1)(2012-3#1)
in their environment and##2##4##(2008-7#1)(2010-10#1)
in their environment##5##3##(1997-3#1)(2008-7#2)(2010-10#1)(2011-2#1)
in their etiology##2##3##(1997-8#1)(2011-2#1)
in their everyday##2##3##(1995-6#1)(2010-1#1)
in their expression of##2##4##(1995-12#1)(2012-2#1)
in their expression##5##3##(1995-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2012-2#1)
in their field of view##2##5##(2008-2#1)(2008-6#1)
in their first##5##3##(1990-3#1)(1992-1#2)(2008-9#1)(2012-12#1)
in their flowers##3##3##(2008-8#2)(2011-10#1)
in their functional##2##3##(1995-3#1)(2011-2#1)
in their general##2##3##(2008-10#1)(2008-2#1)
in their growth##2##3##(2008-10#1)(2009-10#1)
in their health##3##3##(1993-1#1)(1995-2#1)(2013-1#1)
in their home##2##3##(1990-12#1)(2008-11#1)
in their homes##5##3##(1995-1#1)(2008-9#2)(2012-2#2)
in their interaction with##2##4##(1995-2#1)(2008-8#1)
in their introduced##2##3##(2008-8#2)
in their learning##2##3##(2008-11#1)(2008-12#1)
in their level of##3##4##(1994-2#1)(2008-10#1)(2010-5#1)
in their levels of##2##4##(1996-12#1)(2008-10#1)
in their life##6##3##(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2013-1#2)
in their lifetime##2##3##(1990-6#1)(2009-5#1)
in their lives##2##3##(2007-12#1)(2008-11#1)
in their living##2##3##(2011-2#2)
in their metabolic##3##3##(1993-1#1)(2008-1#1)(2008-11#1)
in their mixture using##2##4##(2008-10#2)
in their mixture##3##3##(2008-10#3)
in their mixtures##3##3##(2008-10#3)
in their molecular##2##3##(1992-6#1)(2013-1#1)
in their native##9##3##(1995-2#1)(2008-10#1)(2008-2#2)(2008-8#2)(2010-9#1)(2011-2#1)(2013-8#1)
in their natural environment##2##4##(2007-10#1)(2008-3#1)
in their natural##3##3##(2007-10#1)(2008-3#2)
in their nontransgenic littermates##3##4##(1992-8#3)
in their normal##3##3##(1991-8#1)(1995-2#1)(1996-5#1)
in their nuclei##2##3##(1992-3#1)(2008-3#1)
in their optical##2##3##(1997-7#1)(2008-3#1)
in their organizations##2##3##(1996-3#2)
in their original positions##2##4##(1996-10#1)(2007-5#1)
in their original##3##3##(1996-10#1)(2007-5#1)(2008-5#1)
in their own homes following total hip replacement##2##8##(2010-10#2)
in their own homes##4##4##(1991-8#2)(2010-10#2)
in their own right##3##4##(1992-2#1)(2010-10#1)(2010-7#1)
in their own##25##3##(1991-8#2)(1992-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#3)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
in their patients##3##3##(2008-1#1)(2008-11#1)(2009-9#1)
in their patterns of##2##4##(2008-8#1)(2009-6#1)
in their perception##2##3##(1993-2#1)(2008-6#1)
in their performance##2##3##(1991-2#1)(2008-10#1)
in their personal##2##3##(1993-1#1)(2009-5#1)
in their pharmaceutical formulations##2##4##(2008-10#2)
in their pharmaceutical preparations##2##4##(2008-10#2)
in their pharmaceutical##5##3##(2008-10#5)
in their practice##4##3##(1995-3#1)(2008-11#2)(2010-8#1)
in their presence##2##3##(2008-8#1)(2009-9#1)
in their primary##2##3##(1992-6#1)(1997-9#1)
in their professional##2##3##(2010-10#1)(2013-1#1)
in their progenies##2##3##(2007-1#1)(2008-9#1)
in their programs##2##3##(1994-2#1)(1995-1#1)
in their promoter regions##2##4##(1994-11#1)(2008-8#1)
in their promoter##3##3##(1994-11#1)(1995-2#1)(2008-8#1)
in their purified forms as well as in the crude saps of infected##2##13##(2008-10#2)
in their quality of life##2##5##(2008-7#1)(2011-2#1)
in their quality of##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
in their reactions##2##3##(2008-10#2)
in their relationships##2##3##(1994-12#1)(2008-11#1)
in their relative##6##3##(1992-12#1)(2008-10#3)(2008-8#1)(2008-9#1)
in their reports of##2##4##(2008-9#1)(2010-10#1)
in their reports##3##3##(2008-11#1)(2008-9#1)(2010-10#1)
in their resistance to##3##4##(2008-10#2)(2008-8#1)
in their respective##11##3##(1992-12#1)(1994-12#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-4#1)(2012-12#1)
in their response to##4##4##(1997-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
in their response##5##3##(1997-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2012-3#1)
in their responses to##3##4##(1995-11#1)(2008-10#1)(2010-8#1)
in their rotational##2##3##(1990-2#1)(2008-10#1)
in their saprophytic##2##3##(2008-10#2)
in their sensitivity to##6##4##(1994-12#1)(1995-2#1)(2008-10#3)(2008-11#1)
in their social##2##3##(2008-11#2)
in their structures##2##3##(2008-3#1)(2009-7#1)
in their subsequent##2##3##(2008-10#1)(2008-5#1)
in their susceptibility to the virus##2##6##(2008-9#2)
in their susceptibility to the##3##5##(2008-8#1)(2008-9#2)
in their susceptibility to##5##4##(1994-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
in their toxicity##2##3##(2008-10#2)
in their treatment##2##3##(2007-8#1)(2011-2#1)
in their use of##3##4##(1990-9#1)(2008-11#1)(2008-8#1)
in their use##6##3##(1990-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
in their work##5##3##(1995-1#1)(1996-1#1)(2007-10#2)(2009-10#1)
in their workplace##4##3##(1991-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
in their##764##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#5)(1991-3#3)(1991-8#3)(1992-1#3)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#2)(1992-6#7)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#6)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#7)(1995-11#3)(1995-12#6)(1995-2#10)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#8)(1996-2#5)(1996-3#7)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#5)(1997-6#2)(1997-7#4)(1997-8#2)(1997-9#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#19)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#102)(2008-11#35)(2008-12#18)(2008-2#5)(2008-3#20)(2008-4#7)(2008-5#25)(2008-6#5)(2008-7#29)(2008-8#30)(2008-9#25)(2009-10#6)(2009-11#5)(2009-12#2)(2009-2#2)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#9)(2010-12#1)(2010-2#1)(2010-3#10)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#13)(2010-9#8)(2011-1#8)(2011-10#2)(2011-2#27)(2011-4#1)(2012-1#2)(2012-12#12)(2012-2#13)(2012-3#17)(2013-1#31)(2013-8#12)
in them##11##2##(1993-8#1)(1995-10#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
in themselves##5##2##(1990-3#1)(1991-6#1)(1992-3#1)(2008-7#1)(2013-1#1)
in theoretical##3##2##(1990-8#1)(2008-9#2)
in theory##6##2##(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
in thepresence of##3##3##(2008-11#3)
in thepresence##4##2##(2008-11#3)(2013-8#1)
in therapeutic doses##2##3##(1991-11#1)(2008-8#1)
in therapeutic trials##2##3##(1991-6#1)(2008-7#1)
in therapeutic##18##2##(1990-2#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
in therapeutically applied peat##2##4##(2008-10#2)
in therapies##2##2##(2008-1#1)(2010-5#1)
in therapy and##2##3##(1997-3#1)(2012-12#1)
in therapy by##2##3##(2008-6#1)(2013-8#1)
in therapy in##2##3##(1996-11#1)(2009-9#1)
in therapy of orthopaedic infections##2##5##(2007-11#2)
in therapy of##8##3##(1990-6#1)(1994-2#1)(1994-5#1)(2007-11#2)(2008-1#1)(2011-2#1)(2011-3#1)
in therapy##21##2##(1990-6#1)(1991-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-11#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-8#1)
in thermal##10##2##(1994-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
in thermally poled fused silica##2##5##(2007-12#2)
in thermally poled##3##3##(2007-11#1)(2007-12#2)
in thermally##4##2##(2007-11#1)(2007-12#2)(2008-6#1)
in thermodynamic##2##2##(1991-8#1)(2008-10#1)
in these adult rats##2##4##(1992-12#1)(1995-11#1)
in these analyses##2##3##(1997-4#1)(2008-10#1)
in these and other##3##4##(1992-9#1)(1995-12#1)(2008-6#1)
in these and##4##3##(1992-9#1)(1995-12#1)(2008-6#1)(2009-8#1)
in these animals##7##3##(1990-5#1)(1991-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(2008-5#1)(2008-9#1)
in these applications is##2##4##(2008-1#1)(2010-12#1)
in these areas are##2##4##(1994-1#1)(2008-8#1)
in these areas were##2##4##(2011-1#1)(2013-7#1)
in these areas##19##3##(1992-1#1)(1993-12#1)(1994-1#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
in these birds##2##3##(1997-3#1)(2008-5#1)
in these brain##3##3##(1994-3#1)(2007-8#1)(2008-6#1)
in these calculations##2##3##(2008-2#1)(2008-3#1)
in these case##2##3##(2008-11#1)(2008-12#1)
in these cases and##2##4##(1992-2#1)(2012-12#1)
in these cases the##2##4##(1994-9#1)(2013-8#1)
in these cases##14##3##(1992-2#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#2)(2011-2#2)(2012-12#1)(2013-8#1)
in these categories##2##3##(1991-2#1)(2012-3#1)
in these cell lines##2##4##(1993-9#1)(1994-6#1)
in these cell##3##3##(1993-9#1)(1994-6#1)(1995-2#1)
in these cells and##2##4##(1993-12#1)(1994-11#1)
in these cells by##2##4##(1994-11#1)(1995-8#1)
in these cells was##2##4##(1994-6#1)(1995-8#1)
in these cells##45##3##(1990-12#2)(1990-2#2)(1991-12#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#3)(1995-2#3)(1995-6#2)(1995-8#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-2#1)
in these cellular##2##3##(1992-11#1)(1995-2#1)
in these challenging##2##3##(2010-5#1)(2011-2#1)
in these children##3##3##(2008-6#1)(2011-2#2)
in these circumstances##3##3##(2008-3#1)(2011-1#1)(2012-12#1)
in these complexes##2##3##(1994-9#1)(1995-5#1)
in these compounds##2##3##(1994-11#2)
in these conditions##7##3##(1994-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)
in these countries and##2##4##(2008-10#1)(2008-7#1)
in these countries##8##3##(1991-4#1)(1993-9#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-2#1)
in these courses##3##3##(1994-12#1)(2013-1#2)
in these cultures##4##3##(1995-12#1)(2008-11#1)(2010-2#1)(2013-1#1)
in these data##2##3##(2008-7#1)(2012-3#1)
in these diseases##2##3##(2008-10#1)(2009-1#1)
in these disorders##6##3##(1990-11#1)(1997-5#1)(2008-1#1)(2012-2#2)(2013-8#1)
in these earlier##2##3##(1993-6#1)(2008-7#1)
in these eight##3##3##(1997-7#1)(2008-7#1)(2011-3#1)
in these environments can##2##4##(2008-8#1)(2008-9#1)
in these environments##4##3##(1996-12#1)(2008-8#1)(2008-9#2)
in these experiments##10##3##(1994-3#1)(2008-10#8)(2008-3#1)
in these experiments)##2##3##(2008-10#2)
in these facial pain patients##2##5##(1993-1#2)
in these families##3##3##(1997-5#1)(2008-5#1)(2009-8#1)
in these fibrotic conditions##2##4##(2008-9#2)
in these fibrotic##3##3##(2008-11#1)(2008-9#2)
in these fields##4##3##(2008-1#1)(2008-2#1)(2008-7#1)(2010-7#1)
in these four##2##3##(2008-5#1)(2013-1#1)
in these fractions##2##3##(1997-2#1)(2008-10#1)
in these genes##4##3##(2008-4#1)(2009-8#2)(2011-2#1)
in these groups##7##3##(2007-11#1)(2008-12#3)(2008-4#1)(2008-9#1)(2012-12#1)
in these highly##2##3##(2008-5#1)(2011-2#1)
in these hospitals##2##3##(1993-12#1)(2012-2#1)
in these individuals##2##3##(2008-3#1)(2012-3#1)
in these kinds of##2##4##(2008-11#1)(2012-2#1)
in these lines##2##3##(2008-10#2)
in these materials##2##3##(2008-10#1)(2008-3#1)
in these matrices##2##3##(2008-10#2)
in these media##4##3##(2008-12#2)(2008-2#1)(2009-10#1)
in these mice was##2##4##(2008-10#1)(2012-12#1)
in these mice##4##3##(1994-3#1)(2008-10#1)(2009-6#1)(2012-12#1)
in these models##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
in these neurons##3##3##(1991-12#1)(1995-5#1)(2008-7#1)
in these new##3##3##(1996-12#1)(2008-11#1)(2010-1#1)
in these organisms##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
in these organs##4##3##(1991-5#1)(1993-8#1)(1996-12#1)(2012-1#1)
in these parameters##3##3##(1991-8#1)(2006-8#1)(2011-1#1)
in these pathways##4##3##(1990-8#1)(2009-1#1)(2010-11#1)(2011-3#1)
in these patient##2##3##(2009-10#1)(2012-2#1)
in these patients and##3##4##(2008-1#1)(2009-9#1)(2011-2#1)
in these patients was##5##4##(1993-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
in these patients were##2##4##(1990-9#1)(2013-1#1)
in these patients##82##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#6)
in these plants##3##3##(2008-10#3)
in these populations##3##3##(1996-11#1)(2008-10#1)(2012-3#1)
in these procedures are##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
in these processes are##2##4##(1996-2#1)(2009-5#1)
in these processes##13##3##(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2013-1#3)
in these products##3##3##(1993-11#1)(2008-10#1)(2008-5#1)
in these programs##3##3##(1991-1#1)(1993-1#1)(1996-12#1)
in these reactions##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
in these regions were##2##4##(1997-5#1)(2011-1#1)
in these regions##12##3##(1991-10#1)(1997-5#1)(1997-6#2)(2006-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-1#1)
in these resistant##2##3##(1997-4#1)(2008-10#1)
in these responses##3##3##(1991-2#1)(2008-10#1)(2008-4#1)
in these same##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
in these samples were##2##4##(2008-10#2)
in these samples##7##3##(1994-11#1)(2008-10#6)
in these sediments##2##3##(1992-3#1)(2008-10#1)
in these settings##7##3##(1996-12#1)(1996-2#1)(2006-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-2#1)
in these situations##2##3##(1994-6#1)(2010-4#1)
in these societies##2##3##(2008-10#1)(2009-12#1)
in these solutions##2##3##(2008-10#2)
in these solvents##4##3##(2008-10#4)
in these species##6##3##(1996-6#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-2#1)
in these strains##3##3##(2008-10#2)(2012-3#1)
in these studies have##2##4##(1991-2#1)(2008-9#1)
in these studies##15##3##(1990-11#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#2)(2013-8#1)
in these subjects than##2##4##(1991-11#1)(2008-10#1)
in these subjects##9##3##(1991-11#1)(1995-4#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-2#1)
in these systems is##4##4##(2008-3#1)(2008-9#1)(2010-2#2)
in these systems##9##3##(1990-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2012-2#1)
in these tasks##2##3##(2008-11#1)(2012-12#1)
in these tests##2##3##(2008-10#1)(2009-8#1)
in these three##8##3##(1993-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2012-1#1)
in these tissues##7##3##(1990-12#1)(1991-1#1)(2008-10#1)(2008-8#2)(2012-12#1)(2012-2#1)
in these trials##2##3##(2012-2#1)(2013-1#1)
in these tumor##2##3##(2008-8#1)(2010-2#1)
in these two cases##2##4##(2009-10#1)(2010-2#1)
in these two groups##3##4##(1991-12#1)(2007-8#1)(2011-2#1)
in these two parameters##2##4##(2007-2#1)(2008-3#1)
in these two regions##2##4##(1993-11#1)(2008-7#1)
in these two systems##2##4##(2008-11#1)(2009-9#1)
in these two types of##2##5##(2008-9#2)
in these two##34##3##(1990-3#1)(1991-12#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#2)(1996-1#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
in these variables##2##3##(1994-6#1)(2013-8#1)
in these ways##2##3##(2008-10#1)(2008-7#1)
in these years##3##3##(1992-5#1)(2010-1#1)(2013-7#1)
in these##774##2##(1990-11#3)(1990-12#4)(1990-2#7)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#6)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#2)(1992-8#5)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#8)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#5)(1995-2#8)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#6)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#4)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#17)(2008-10#112)(2008-11#32)(2008-12#12)(2008-2#8)(2008-3#28)(2008-4#16)(2008-5#21)(2008-6#12)(2008-7#30)(2008-8#23)(2008-9#17)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#13)(2011-2#18)(2011-3#2)(2012-1#4)(2012-12#11)(2012-2#16)(2012-3#10)(2013-1#23)(2013-7#3)(2013-8#7)
in theta synchrony between the PFC and HC##2##8##(2013-8#2)
in theta##4##2##(2007-12#1)(2008-11#1)(2013-8#2)
in thick samples##2##3##(2008-2#1)(2011-1#1)
in thick##6##2##(2008-2#2)(2008-3#3)(2011-1#1)
in thickness##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
in thin films##7##3##(2008-10#3)(2008-3#3)(2011-2#1)
in thin sections##2##3##(2008-10#1)(2008-9#1)
in thin##19##2##(1990-8#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#4)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in thinking##3##2##(2008-11#1)(2008-12#1)(2012-12#1)
in third trimester##3##3##(2007-7#1)(2009-7#1)(2013-1#1)
in third##4##2##(2007-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
in thirteen patients##3##3##(1996-2#1)(1997-3#1)(2007-8#1)
in thirty##2##2##(1991-12#1)(2009-4#1)
in this action##2##3##(1993-5#1)(1995-12#1)
in this activity##2##3##(1996-3#1)(2008-7#1)
in this age group##10##4##(1991-8#1)(1995-12#1)(1997-1#4)(2007-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
in this age##12##3##(1991-8#1)(1995-12#1)(1997-1#4)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
in this agroecosystem##2##3##(2008-10#2)
in this analysis is##2##4##(2008-3#1)(2012-2#1)
in this analysis##9##3##(2007-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-11#1)(2010-12#1)(2012-2#1)
in this and##2##3##(2008-9#1)(2013-1#1)
in this animal model##3##4##(1992-12#1)(2008-4#1)(2011-2#1)
in this animal##6##3##(1992-12#1)(1997-4#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
in this application##3##3##(2007-7#1)(2008-10#1)(2010-6#1)
in this approach##2##3##(2008-11#1)(2012-3#1)
in this area and##6##4##(1994-2#1)(1995-3#1)(2008-11#1)(2008-12#1)(2009-3#1)(2013-8#1)
in this area are##2##4##(2008-10#1)(2012-12#1)
in this area by##2##4##(2010-10#1)(2013-8#1)
in this area in##4##4##(1993-8#1)(1995-2#1)(2008-2#1)(2008-7#1)
in this area is##7##4##(1994-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)
in this area may be##2##5##(1992-12#1)(2012-12#1)
in this area of research that##2##6##(2008-10#1)(2010-7#1)
in this area of research##4##5##(1997-8#1)(2008-10#1)(2008-2#1)(2010-7#1)
in this area of##12##4##(1995-6#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2010-7#1)(2012-1#1)
in this area to##2##4##(2009-3#1)(2013-1#1)
in this area will be##2##5##(1992-9#1)(2011-9#1)
in this area##112##3##(1990-11#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#9)(2008-11#9)(2008-12#5)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#3)(2013-1#4)(2013-7#2)(2013-8#3)
in this article and##2##4##(1992-2#1)(2008-2#1)
in this article are##5##4##(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2012-3#1)
in this article include##2##4##(1996-2#1)(2010-7#1)
in this article is##6##4##(1992-1#1)(1992-9#1)(1996-2#1)(2008-12#1)(2008-7#1)(2010-7#1)
in this article the##2##4##(2007-10#1)(2012-3#1)
in this article will##3##4##(2010-11#1)(2013-1#2)
in this article with##2##4##(1997-2#1)(2010-10#1)
in this article##87##3##(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1992-1#5)(1992-2#3)(1992-3#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-3#2)(1996-1#1)(1996-2#5)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-7#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
in this assay##2##3##(1991-2#1)(1995-5#1)
in this association##2##3##(2008-1#1)(2008-10#1)
in this capacity##2##3##(2009-5#1)(2010-2#1)
in this case because##2##4##(2008-8#1)(2012-2#1)
in this case report##4##4##(2008-12#2)(2010-6#1)(2012-3#1)
in this case study##3##4##(1994-1#2)(2012-12#1)
in this case the##6##4##(1992-6#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
in this case was##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
in this case##61##3##(1990-6#1)(1992-3#1)(1992-6#2)(1994-1#2)(1995-2#1)(1996-10#1)(1996-5#1)(1997-4#1)(2006-10#2)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in this case)##3##3##(2008-10#2)(2010-11#1)
in this category##2##3##(1991-3#1)(2012-1#1)
in this cell line##5##4##(1993-2#1)(1994-8#1)(1997-6#1)(2008-11#2)
in this chapter##8##3##(2008-4#4)(2008-9#2)(2011-1#1)(2013-1#1)
in this class##4##3##(1993-12#1)(2008-5#1)(2009-9#1)(2013-1#1)
in this clinical setting##2##4##(2010-7#1)(2012-2#1)
in this clinical##5##3##(1990-3#1)(2008-2#1)(2009-8#1)(2010-7#1)(2012-2#1)
in this communication##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
in this complex##6##3##(1990-7#1)(1994-6#1)(1995-2#1)(1996-2#1)(2008-10#2)
in this comprehensive##2##3##(2008-3#1)(2008-8#1)
in this concentration range##2##4##(1992-3#1)(2008-10#1)
in this condition##8##3##(1990-12#1)(1991-3#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)
in this configuration##2##3##(2007-12#1)(2008-2#1)
in this context##14##3##(1994-11#1)(1994-3#1)(1995-2#1)(2008-10#2)(2008-2#1)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in this contribution##2##3##(2008-10#2)
in this country##27##3##(1991-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#3)(2010-6#1)(2012-12#1)
in this crop##2##3##(2010-10#2)
in this cross##2##3##(2008-10#2)
in this devastating##2##3##(2008-1#1)(2008-11#1)
in this direction##6##3##(1997-6#1)(2007-7#1)(2008-3#2)(2009-4#1)(2010-3#1)
in this disease##13##3##(1990-12#1)(1991-12#1)(1992-11#1)(1992-5#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#2)(2011-2#2)
in this disorder##5##3##(1992-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)
in this domain##2##3##(1996-1#1)(2008-7#1)
in this endeavor##2##3##(1995-1#1)(2008-2#1)
in this environment##6##3##(1993-2#1)(1994-2#1)(2008-2#1)(2008-8#2)(2009-6#1)
in this era##2##3##(1994-3#1)(1995-2#1)
in this essay##2##3##(2007-5#1)(2012-12#1)
in this exciting##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
in this experiment is##2##4##(1995-3#1)(2008-2#1)
in this experiment##11##3##(1993-12#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)
in this experimental##2##3##(1993-2#1)(2009-2#1)
in this family of##3##4##(1992-5#1)(2008-6#1)(2009-9#1)
in this family##16##3##(1992-5#1)(1993-12#1)(1994-12#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
in this fashion##4##3##(1992-3#1)(1994-11#1)(1997-8#1)(2008-3#1)
in this field and##2##4##(2008-4#1)(2010-2#1)
in this field are##4##4##(2008-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
in this field for##3##4##(2008-11#1)(2008-12#1)(2012-12#1)
in this field has##2##4##(2010-8#1)(2011-2#1)
in this field is##8##4##(1992-9#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-2#1)(2010-11#1)(2010-12#1)(2012-12#1)
in this field of##3##4##(1995-5#1)(2008-10#1)(2010-11#1)
in this field that##2##4##(1996-2#1)(2008-12#1)
in this field##63##3##(1991-4#1)(1992-9#1)(1995-5#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#3)
in this first##4##3##(1992-12#1)(2012-2#1)(2013-1#2)
in this fish##2##3##(2008-10#1)(2012-3#1)
in this flow##2##3##(2007-8#1)(2011-2#1)
in this form of##2##4##(1997-3#1)(2008-1#1)
in this form##3##3##(1997-3#1)(2008-1#1)(2008-11#1)
in this fraction##2##3##(1992-3#1)(2013-7#1)
in this fragment##2##3##(2008-10#1)(2008-12#1)
in this framework##2##3##(2007-11#1)(2008-8#1)
in this friction##2##3##(2008-5#2)
in this fungus##5##3##(2008-10#4)(2008-8#1)
in this gene##6##3##(1992-3#1)(1994-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2013-1#1)
in this group had a##3##5##(2008-11#1)(2009-3#2)
in this group had##5##4##(1991-3#1)(2008-11#1)(2009-3#2)(2012-3#1)
in this group of patients##8##5##(1990-2#2)(1992-2#1)(1992-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-3#1)
in this group of##14##4##(1990-2#2)(1991-2#1)(1992-2#1)(1992-6#1)(1997-5#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-3#1)(2011-3#1)(2012-2#1)
in this group should be##2##5##(1992-9#1)(2013-1#1)
in this group was##2##4##(1990-9#1)(1995-2#1)
in this group##59##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-6#2)(1992-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-11#2)(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
in this grouping##2##3##(2009-4#1)(2010-12#1)
in this growing##2##3##(2008-3#1)(2010-6#1)
in this high-risk##2##3##(2007-8#1)(2010-3#1)
in this highly##2##3##(2008-4#1)(2011-2#1)
in this host population##2##4##(2009-2#2)
in this important field##2##4##(2008-11#1)(2013-1#1)
in this important##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
in this industry##3##3##(2008-11#2)(2008-6#1)
in this information##2##3##(1996-3#1)(2011-2#1)
in this initial##2##3##(1997-5#1)(2013-1#1)
in this investigation##7##3##(2007-8#1)(2008-10#4)(2008-11#1)(2008-8#1)
in this issue of the Health Care Financing Review##4##9##(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)
in this issue of the##6##5##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)
in this issue of##10##4##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-11#1)(2008-6#1)(2010-11#1)(2013-1#1)
in this issue##19##3##(1994-12#2)(1995-1#2)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(2008-11#1)(2008-6#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
in this journal##2##3##(1993-11#1)(2007-10#1)
in this kind of##5##4##(1992-6#1)(2007-10#1)(2008-10#3)
in this laboratory##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
in this large##6##3##(1996-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
in this laser##2##3##(2007-11#1)(2007-12#1)
in this latter##3##3##(2008-10#2)(2008-7#1)
in this location##2##3##(1996-9#1)(2008-10#1)
in this manner##11##3##(1991-3#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-1#1)
in this manual##8##3##(2008-4#3)(2008-9#5)
in this manuscript##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
in this market##3##3##(1995-3#1)(1997-3#1)(2010-4#1)
in this marketplace##2##3##(1995-3#1)(1996-3#1)
in this material##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
in this mechanism##4##3##(1992-8#1)(1994-6#1)(1995-12#1)(2008-12#1)
in this medium##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
in this method was##2##4##(2008-10#2)
in this method##9##3##(2008-10#6)(2008-11#2)(2008-4#1)
in this model##17##3##(1992-9#1)(1993-12#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-2#1)(2012-3#1)(2013-7#1)
in this molecular##2##3##(1992-3#1)(1994-3#1)
in this mouse model##3##4##(1997-4#1)(2011-2#1)(2012-12#1)
in this mouse##4##3##(1991-1#1)(1997-4#1)(2011-2#1)(2012-12#1)
in this new endeavor##2##4##(1996-12#2)
in this new##12##3##(1992-1#1)(1992-3#1)(1993-1#1)(1996-12#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
in this novel##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
in this order##3##3##(1995-11#1)(1997-8#1)(2008-10#1)
in this organism##8##3##(1991-9#1)(1993-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)
in this overview##4##3##(2008-4#3)(2011-2#1)
in this paper are consistent with##2##6##(2008-2#1)(2009-9#1)
in this paper are##6##4##(1992-9#1)(1997-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-9#1)
in this paper as##2##4##(2008-12#1)(2013-8#1)
in this paper for the##2##5##(2008-10#2)
in this paper for##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
in this paper in##2##4##(1990-2#1)(2008-11#1)
in this paper is##7##4##(1994-1#1)(2008-10#2)(2009-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
in this paper that##3##4##(2008-10#1)(2008-7#1)(2010-8#1)
in this paper the##3##4##(1995-1#1)(2009-8#1)(2013-1#1)
in this paper to##2##4##(1995-12#1)(2008-10#1)
in this paper was##4##4##(1991-9#1)(1994-9#1)(2008-10#2)
in this paper we##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
in this paper with##3##4##(2007-11#1)(2007-8#1)(2009-3#1)
in this paper##172##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#71)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#4)
in this paper)##2##3##(2008-10#1)(2013-1#1)
in this parameter##2##3##(2008-3#1)(2008-7#1)
in this particular##4##3##(1993-1#1)(1996-2#1)(2006-10#1)(2008-2#1)
in this pathogen##2##3##(2008-10#2)
in this pathology##4##3##(1991-11#1)(1993-6#1)(2008-7#1)(2011-2#1)
in this pathosystem##3##3##(2008-10#3)
in this pathovar##2##3##(2008-10#2)
in this pathway##4##3##(1994-11#1)(1994-8#1)(2008-8#1)(2010-2#1)
in this patient cannot be##2##5##(1997-3#1)(2012-2#1)
in this patient group##3##4##(1996-3#1)(2008-7#1)(2012-2#1)
in this patient is##2##4##(2011-1#1)(2012-12#1)
in this patient population have been##2##6##(2008-10#1)(2009-6#1)
in this patient population##12##4##(2008-10#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in this patient##35##3##(1993-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#6)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
in this period##7##3##(1995-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
in this phenomenon##4##3##(1993-12#1)(2007-11#1)(2012-2#1)(2013-8#1)
in this pilot study##3##4##(2007-7#1)(2008-9#1)(2010-3#1)
in this plot##2##3##(1994-5#1)(1995-5#1)
in this population and##2##4##(2008-3#1)(2010-2#1)
in this population have##2##4##(1994-6#1)(2009-4#1)
in this population is##3##4##(2008-7#1)(2011-1#1)(2013-1#1)
in this population will##2##4##(2008-7#1)(2010-8#1)
in this population##46##3##(1990-2#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-11#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#6)
in this position##4##3##(1995-8#2)(1997-3#1)(2008-1#1)
in this practice##3##3##(1991-6#1)(1992-1#1)(2013-8#1)
in this procedure##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
in this process has##2##4##(1995-8#1)(2008-1#1)
in this process is##2##4##(1994-6#1)(2010-3#1)
in this process##38##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#3)(2008-5#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
in this professional paper##2##4##(1997-1#2)
in this project##2##3##(2007-11#1)(2010-4#1)
in this prospective##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
in this province##2##3##(2007-12#1)(2008-12#1)
in this range##5##3##(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
in this rapidly##2##3##(1994-3#1)(2010-5#1)
in this rare##3##3##(1991-6#1)(2010-11#1)(2012-2#1)
in this reaction##2##3##(1990-7#1)(2008-10#1)
in this regard##15##3##(1992-12#1)(1993-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-4#1)(2009-11#1)(2009-8#1)(2010-5#2)(2010-9#1)(2011-2#1)
in this region and##3##4##(2007-7#1)(2008-10#1)(2013-7#1)
in this region are##2##4##(2008-7#1)(2012-2#1)
in this region during##2##4##(1992-10#1)(2008-10#1)
in this region has##2##4##(1994-8#1)(2012-12#1)
in this region in##2##4##(1996-1#1)(2008-10#1)
in this region is##2##4##(1993-11#1)(1993-12#1)
in this region of the protein##2##6##(1993-2#1)(1994-5#1)
in this region of the##3##5##(1993-2#1)(1993-3#1)(1994-5#1)
in this region of##4##4##(1993-2#1)(1993-3#1)(1994-5#1)(1997-5#1)
in this region##54##3##(1990-3#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-5#3)(1994-8#1)(1995-6#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#3)(1997-7#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
in this regulatory##2##3##(2008-11#1)(2011-1#1)
in this report is##2##4##(2007-7#1)(2011-2#1)
in this report##25##3##(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-2#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
in this research area##2##4##(2009-5#1)(2009-7#1)
in this research##11##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-2#1)
in this respect##11##3##(1992-5#1)(1992-9#1)(1994-9#1)(1995-12#2)(1995-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)
in this response##2##3##(1991-3#1)(1994-8#1)
in this retrospective analysis##2##4##(2008-1#1)(2011-1#1)
in this retrospective study##4##4##(2007-11#1)(2008-6#1)(2011-1#1)(2012-3#1)
in this retrospective##6##3##(2007-11#1)(2008-1#1)(2008-6#1)(2011-1#2)(2012-3#1)
in this review are##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
in this review include##3##4##(2008-10#1)(2012-1#1)(2012-12#1)
in this review##40##3##(1995-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#3)
in this same##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
in this sample of##3##4##(2008-7#1)(2009-5#1)(2013-1#1)
in this sample##9##3##(2008-10#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
in this sequence##5##3##(1992-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
in this series of##2##4##(1992-4#1)(2008-5#1)
in this series was##2##4##(2012-2#1)(2012-3#1)
in this series##17##3##(1992-2#1)(1992-4#1)(1995-11#1)(1995-3#2)(1997-7#1)(2008-1#1)(2008-5#2)(2008-6#2)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
in this setting##23##3##(1992-11#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#4)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
in this short##2##3##(1993-12#1)(2008-7#1)
in this single##2##3##(1996-12#1)(2013-1#1)
in this situation##4##3##(1991-7#1)(1993-12#1)(2008-11#1)(2008-7#1)
in this small##2##3##(2010-5#1)(2012-3#1)
in this special##4##3##(1994-3#1)(1997-1#1)(2008-1#1)(2008-6#1)
in this species and##2##4##(2007-12#1)(2008-10#1)
in this species is##2##4##(2008-8#1)(2009-8#1)
in this species##30##3##(1990-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1994-8#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#2)(2010-3#1)(2013-7#1)(2013-8#1)
in this specific##3##3##(2008-10#1)(2008-7#1)(2012-5#1)
in this spectral region##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
in this stage##2##3##(2007-12#1)(2013-1#1)
in this strain is##2##4##(2008-10#2)
in this strain##4##3##(2007-10#1)(2008-10#3)
in this study allowed##2##4##(2010-4#1)(2012-3#1)
in this study and##6##4##(2007-6#1)(2008-10#2)(2008-5#1)(2009-2#1)(2011-1#1)
in this study are##8##4##(1993-6#1)(2008-10#3)(2008-5#2)(2013-1#2)
in this study consisted of##2##5##(2008-11#1)(2011-2#1)
in this study could be##4##5##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
in this study could##5##4##(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
in this study followed##2##4##(1994-12#1)(2013-1#1)
in this study for##3##4##(1997-2#1)(2008-10#2)
in this study had##2##4##(1992-2#1)(2013-8#1)
in this study have##5##4##(2008-10#2)(2008-6#1)(2009-8#1)(2011-2#1)
in this study include##2##4##(2008-8#2)
in this study is the##3##5##(1994-6#1)(2008-5#1)(2012-2#1)
in this study is##14##4##(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-11#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)
in this study may be useful##2##6##(1996-2#1)(2008-10#1)
in this study may##4##4##(1996-2#1)(1997-3#1)(2008-10#1)(2010-12#1)
in this study provides##2##4##(2008-10#1)(2010-12#1)
in this study revealed that##2##5##(2008-10#2)
in this study should be##2##5##(1996-8#1)(2008-10#1)
in this study should##3##4##(1996-8#1)(2008-10#2)
in this study showed##3##4##(1997-4#1)(2008-12#1)(2013-8#1)
in this study such as##2##5##(2008-10#1)(2013-1#1)
in this study suggest that##2##5##(1992-6#1)(2008-10#1)
in this study suggests that##2##5##(1995-5#1)(2012-2#1)
in this study that##3##4##(2008-10#1)(2008-9#1)(2010-6#1)
in this study the##2##4##(2008-1#2)
in this study to determine##3##5##(2008-1#1)(2008-10#2)
in this study to evaluate the##2##6##(1990-2#1)(2007-7#1)
in this study to evaluate##3##5##(1990-2#2)(2007-7#1)
in this study to##10##4##(1990-2#2)(1996-12#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)
in this study was that##2##5##(2011-1#1)(2013-1#1)
in this study was##16##4##(1993-12#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-9#2)(2011-1#1)(2011-2#4)(2013-1#1)
in this study we##4##4##(2008-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
in this study were not##2##5##(2008-10#1)(2008-5#1)
in this study were##16##4##(1990-10#1)(1995-11#1)(1997-8#2)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-1#1)
in this study will be##2##5##(2008-5#1)(2010-11#1)
in this study will##4##4##(2008-10#1)(2008-5#1)(2010-1#1)(2010-11#1)
in this study##339##3##(1990-10#1)(1990-2#2)(1990-3#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#4)(2006-6#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#9)(2008-10#89)(2008-11#7)(2008-12#13)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#15)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#10)(2013-1#19)(2013-7#3)(2013-8#6)
in this subgroup##2##3##(2008-6#1)(2009-9#1)
in this system are##2##4##(2008-10#1)(2008-8#1)
in this system##30##3##(1990-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2012-3#1)
in this systematic review##2##4##(2008-6#1)(2013-1#1)
in this technique##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
in this test##2##3##(1992-7#1)(2008-2#1)
in this time##3##3##(2008-6#1)(2010-3#1)(2013-1#1)
in this tissue##5##3##(1990-5#1)(1993-3#1)(1994-6#1)(2013-1#2)
in this transition##3##3##(1994-2#1)(1996-12#1)(2010-8#1)
in this treatment##2##3##(1992-4#1)(2008-12#1)
in this trial##3##3##(1994-7#1)(2008-11#1)(2008-7#1)
in this tumor##3##3##(1990-10#1)(1992-9#1)(1997-7#1)
in this type of patients##2##5##(2011-2#1)(2013-1#1)
in this type of##12##4##(1991-5#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#3)(2013-1#1)
in this unit are##12##4##(2008-4#7)(2008-9#3)(2010-7#1)(2012-3#1)
in this unit can be used for##2##7##(2008-4#1)(2008-9#1)
in this unit can be used##4##6##(2008-4#3)(2008-9#1)
in this unit can##5##4##(2008-4#4)(2008-9#1)
in this unit cover##3##4##(2008-2#1)(2008-9#2)
in this unit describe the##4##5##(2008-2#1)(2008-9#3)
in this unit describe##6##4##(2008-2#1)(2008-4#2)(2008-9#3)
in this unit describes the##4##5##(2008-2#3)(2008-4#1)
in this unit describes##6##4##(2008-2#3)(2008-4#3)
in this unit for determining##2##5##(2008-4#2)
in this unit for##4##4##(2008-2#1)(2008-4#3)
in this unit include##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
in this unit is##8##4##(2008-2#1)(2008-4#5)(2008-9#1)(2010-8#1)
in this unit to##2##4##(2008-4#1)(2008-9#1)
in this unit##109##3##(2008-1#2)(2008-2#14)(2008-4#68)(2008-9#22)(2010-7#1)(2010-8#1)(2012-3#1)
in this very##2##3##(2007-10#1)(2008-5#1)
in this virus##2##3##(1992-6#2)
in this volume##4##3##(1990-3#1)(1992-6#1)(2008-11#1)(2008-2#1)
in this vulnerable population##2##4##(2009-5#1)(2009-9#1)
in this wavelength range##2##4##(2007-11#1)(2008-3#1)
in this way could##2##4##(2008-7#1)(2009-6#1)
in this way##38##3##(1991-5#1)(1992-2#1)(1992-5#1)(1993-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)
in this work are##2##4##(2008-10#1)(2011-2#1)
in this work for the##3##5##(2008-10#3)
in this work for##4##4##(2008-10#4)
in this work was##3##4##(2008-10#3)
in this work we##2##4##(2008-10#1)(2008-11#1)
in this work##58##3##(1992-12#1)(1993-8#1)(1994-8#1)(2007-11#1)(2008-10#45)(2008-11#1)(2008-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
in this##2415##2##(1990-10#3)(1990-11#6)(1990-12#4)(1990-2#7)(1990-3#4)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#8)(1991-2#12)(1991-3#6)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#7)(1992-1#13)(1992-10#4)(1992-11#4)(1992-12#10)(1992-2#10)(1992-3#13)(1992-4#2)(1992-5#5)(1992-6#12)(1992-7#1)(1992-8#3)(1992-9#11)(1993-1#8)(1993-11#5)(1993-12#20)(1993-2#7)(1993-3#6)(1993-5#3)(1993-6#9)(1993-8#5)(1994-1#5)(1994-11#8)(1994-12#15)(1994-2#8)(1994-3#12)(1994-5#4)(1994-6#9)(1994-7#1)(1994-8#12)(1994-9#4)(1995-1#10)(1995-11#10)(1995-12#15)(1995-2#16)(1995-3#14)(1995-5#8)(1995-6#8)(1995-8#4)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#15)(1996-2#16)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#11)(1997-2#17)(1997-3#20)(1997-4#8)(1997-5#9)(1997-6#4)(1997-7#10)(1997-8#12)(2006-10#7)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#13)(2007-11#38)(2007-12#29)(2007-2#4)(2007-5#5)(2007-6#1)(2007-7#18)(2007-8#14)(2008-1#38)(2008-10#400)(2008-11#92)(2008-12#56)(2008-2#62)(2008-3#52)(2008-4#100)(2008-5#71)(2008-6#37)(2008-7#86)(2008-8#55)(2008-9#65)(2009-10#10)(2009-11#10)(2009-12#7)(2009-2#10)(2009-3#9)(2009-4#7)(2009-5#12)(2009-6#7)(2009-7#7)(2009-8#19)(2009-9#10)(2010-1#3)(2010-10#10)(2010-11#15)(2010-12#14)(2010-2#10)(2010-3#15)(2010-4#12)(2010-5#10)(2010-6#9)(2010-7#13)(2010-8#27)(2010-9#5)(2011-1#28)(2011-2#72)(2011-3#4)(2011-7#1)(2011-9#1)(2012-1#9)(2012-12#25)(2012-2#37)(2012-3#37)(2012-5#1)(2013-1#83)(2013-2#1)(2013-7#15)(2013-8#37)
in thoracic and cardiovascular surgery##3##5##(2007-8#3)
in thoracic and##4##3##(2006-10#1)(2007-8#3)
in thoracic surgery##3##3##(2007-8#1)(2010-8#1)(2012-3#1)
in thoracic##13##2##(1990-2#1)(2006-10#2)(2007-11#1)(2007-8#4)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
in thoracoscopic##2##2##(2010-8#2)
in those aged##2##3##(1990-3#1)(1990-9#1)
in those animals##2##3##(2008-3#1)(2008-5#1)
in those at##2##3##(2008-7#2)
in those cases in which##3##5##(2007-11#1)(2007-8#1)(2008-8#1)
in those cases##6##3##(2006-12#1)(2007-11#2)(2007-8#1)(2008-5#1)(2008-8#1)
in those cells##2##3##(1997-3#1)(2008-10#1)
in those conditions##2##3##(1993-8#1)(2008-5#1)
in those countries##2##3##(2007-2#1)(2008-10#1)
in those fed##4##3##(1990-7#1)(2008-11#1)(2012-12#1)(2012-2#1)
in those in##2##3##(1996-6#1)(2008-7#1)
in those irrigated with fresh water (EC =##2##8##(2008-10#2)
in those of##6##3##(1994-6#1)(1997-4#1)(2008-10#2)(2008-5#1)(2013-1#1)
in those older than##2##4##(2007-12#1)(2013-8#1)
in those over##2##3##(1993-6#1)(2007-2#1)
in those patients with##2##4##(1995-3#1)(2013-8#1)
in those patients##12##3##(1990-12#1)(1995-3#1)(1996-12#1)(2007-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
in those presenting##3##3##(2008-1#1)(2008-12#1)(2011-2#1)
in those receiving##3##3##(1994-12#1)(2007-11#1)(2011-2#1)
in those returning from##2##4##(2007-2#1)(2012-3#1)
in those subjects##3##3##(1991-5#1)(1995-4#1)(1997-6#1)
in those treated with##4##4##(1993-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
in those treated##5##3##(1993-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
in those who had##6##4##(2007-7#1)(2012-3#2)(2013-1#3)
in those who received##3##4##(1990-6#1)(2008-11#1)(2008-6#1)
in those who were##3##4##(1990-2#1)(2011-2#1)(2013-1#1)
in those who##17##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#3)(2013-1#6)
in those whose##2##3##(1995-5#1)(2008-7#1)
in those with MR##3##4##(1995-3#3)
in those with a##3##4##(1997-8#1)(2008-9#1)(2012-2#1)
in those with higher baseline##2##5##(2008-1#1)(2008-7#1)
in those with##40##3##(1990-2#3)(1991-2#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-9#1)(1995-3#4)(1997-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
in those without##8##3##(1990-2#1)(1990-8#1)(1991-12#1)(1996-12#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
in those younger than##2##4##(2007-12#1)(2013-1#1)
in those##180##2##(1990-12#1)(1990-2#5)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#1)(1996-12#3)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#4)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#5)
in three (3##2##3##(2008-1#2)
in three and##4##3##(1997-3#1)(2007-7#1)(2008-6#1)(2011-2#1)
in three areas##4##3##(1992-2#1)(1993-12#1)(2008-12#1)(2008-9#1)
in three batches##2##3##(2008-11#1)(2013-1#1)
in three cases of##2##4##(1997-8#1)(2013-1#1)
in three cases##16##3##(1992-11#1)(1995-11#1)(1997-3#4)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
in three classes##2##3##(2008-10#1)(2008-7#1)
in three clusters##2##3##(2007-12#1)(2008-12#1)
in three commercial##2##3##(2008-10#2)
in three consecutive##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
in three different media##2##4##(2008-11#2)
in three different##30##3##(1995-6#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-8#2)
in three dimensions and##2##4##(2007-12#1)(2008-3#1)
in three dimensions##10##3##(2007-11#2)(2007-12#2)(2008-3#4)(2008-7#1)(2011-1#1)
in three distinct##2##3##(2008-10#2)
in three experimental groups##2##4##(1996-2#1)(1997-6#1)
in three groups according to the##4##6##(2007-6#1)(2008-10#2)(2011-2#1)
in three groups according##5##4##(2007-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
in three groups of##3##4##(1991-12#1)(2009-10#1)(2012-2#1)
in three groups##13##3##(1991-12#1)(1993-8#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in three hospitals##2##3##(2008-9#1)(2013-1#1)
in three independent##2##3##(1991-2#1)(2008-4#1)
in three lesions##2##3##(2008-6#2)
in three main##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2012-9#1)
in three model systems##3##4##(2008-11#1)(2012-12#2)
in three models##3##3##(2007-10#1)(2008-5#1)(2008-8#1)
in three mothers##2##3##(1994-3#1)(2007-2#1)
in three of four##4##4##(1992-11#1)(2008-10#2)(2011-2#1)
in three of six##2##4##(2008-10#1)(2008-3#1)
in three of the four##4##5##(1990-8#1)(1994-12#1)(2008-9#1)(2011-1#1)
in three of the patients##2##5##(1995-11#1)(2008-10#1)
in three of the##11##4##(1990-8#1)(1994-12#1)(1995-11#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-1#1)(2013-1#1)
in three of##19##3##(1990-5#1)(1990-8#1)(1992-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(2006-11#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
in three other##2##3##(2008-10#1)(2008-7#1)
in three patients with##4##4##(1993-8#1)(2007-8#1)(2012-1#1)(2012-2#1)
in three patients##18##3##(1990-8#1)(1993-8#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-8#2)(2008-5#2)(2008-6#2)(2008-7#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
in three phases##2##3##(1991-2#1)(2009-7#1)
in three randomized##2##3##(2008-8#1)(2012-12#1)
in three species of##2##4##(1997-4#1)(2008-2#1)
in three species##3##3##(1997-4#1)(2008-2#1)(2011-3#1)
in three steps from##3##4##(2008-10#1)(2008-4#1)(2010-6#1)
in three steps##5##3##(2008-10#2)(2008-4#2)(2010-6#1)
in three subjects##2##3##(2008-7#2)
in three tumours##2##3##(2008-7#2)
in three types of##2##4##(1996-2#1)(2008-10#1)
in three types##3##3##(1996-2#1)(2008-10#2)
in three ways##2##3##(1996-4#1)(2008-10#1)
in three zones##2##3##(2011-2#1)(2013-8#1)
in three##342##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#5)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#3)(1993-12#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#7)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#77)(2008-11#9)(2008-12#7)(2008-2#3)(2008-3#13)(2008-4#9)(2008-5#9)(2008-6#10)(2008-7#17)(2008-8#7)(2008-9#10)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#5)(2012-7#1)(2012-9#1)(2013-1#11)(2013-7#4)(2013-8#8)
in three-dimensional (3-D)##2##3##(2008-3#2)
in three-dimensional imaging and##2##4##(2007-12#2)
in three-dimensional imaging##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
in three-dimensional space##2##3##(2008-3#2)
in three-dimensional##22##2##(1995-9#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-8#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-8#1)
in thrombin##2##2##(1990-7#1)(1997-2#1)
in thrombogenesis##2##2##(2006-6#1)(2013-1#1)
in thulium-doped##2##2##(2007-11#1)(2008-3#1)
in thylakoid##2##2##(2009-10#2)
in thymic lymphosarcoma cells##2##4##(1992-8#2)
in thymic##3##2##(1992-8#2)(2008-8#1)
in thymocyte##4##2##(1991-12#1)(2008-10#3)
in thymocytes and##2##3##(1992-8#1)(1997-7#1)
in thymocytes##4##2##(1992-8#1)(1995-8#1)(1997-7#1)(2008-10#1)
in thymus and spleen##2##4##(1995-12#1)(2008-10#1)
in thymus##5##2##(1995-12#1)(2008-10#2)(2008-5#2)
in thyroid adenoma##2##3##(2012-1#2)
in thyroid cancer##2##3##(2012-1#1)(2013-1#1)
in thyroid cells##2##3##(1991-12#1)(1994-11#1)
in thyroid pathology##2##3##(2013-1#2)
in thyroid##18##2##(1990-5#1)(1991-12#1)(1991-5#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-1#4)(2013-1#6)(2013-8#1)
in thyroids of##2##3##(2008-7#1)(2013-8#1)
in thyroxine-treated rats (P&lt##3##4##(1995-12#3)
in thyroxine-treated rats##8##3##(1995-12#8)
in tibia##2##2##(2007-11#1)(2012-2#1)
in tibial##4##2##(1991-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
in tick##3##2##(2008-8#1)(2010-10#2)
in ticks##3##2##(2008-10#1)(2008-12#1)(2010-10#1)
in tight junction disruption##2##4##(2011-2#2)
in tight##4##2##(2008-10#1)(2011-10#1)(2011-2#2)
in tilled fields##2##3##(2008-10#2)
in tilled##5##2##(2008-10#5)
in time and space##5##4##(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
in time and##8##3##(1992-1#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2013-1#2)
in time average##2##3##(2008-3#2)
in time for##3##3##(2009-6#1)(2012-12#1)(2013-8#1)
in time in##2##3##(2008-10#1)(2008-11#1)
in time of##3##3##(1992-12#1)(2007-12#1)(2008-10#1)
in time to##9##3##(1991-2#2)(1997-7#1)(2007-10#1)(2007-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
in time with the##2##4##(2008-10#1)(2008-7#1)
in time with##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
in time##83##2##(1990-2#2)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1995-5#1)(1996-2#1)(1996-4#3)(1997-7#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#6)(2009-6#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
in time-dependent##3##2##(1994-5#1)(2008-11#1)(2008-3#1)
in time-resolved##2##2##(2007-11#1)(2008-3#1)
in times of##5##3##(2008-12#3)(2010-3#2)
in timing##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
in tinea cruris and##2##4##(2007-7#2)
in tinnitus##2##2##(1995-6#1)(2012-12#1)
in tissue and##5##3##(1991-12#1)(1997-2#1)(2008-10#1)(2008-9#1)(2013-7#1)
in tissue culture and##2##4##(1993-11#1)(1997-3#1)
in tissue culture##15##3##(1992-9#1)(1993-11#2)(1993-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#2)(2011-2#1)
in tissue engineering and regenerative medicine##4##6##(2008-5#1)(2009-7#1)(2010-10#1)(2012-5#1)
in tissue engineering and##5##4##(2008-5#1)(2009-7#1)(2010-10#2)(2012-5#1)
in tissue engineering##16##3##(2008-11#3)(2008-5#3)(2009-12#1)(2009-7#2)(2010-10#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-5#1)
in tissue extracts from##3##4##(1991-8#1)(1993-8#1)(2008-10#1)
in tissue extracts of##2##4##(1990-11#1)(1995-5#1)
in tissue extracts##8##3##(1990-11#2)(1991-8#1)(1993-8#1)(1995-5#1)(2008-10#2)(2008-11#1)
in tissue from##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
in tissue homogenates##2##3##(1996-12#1)(2008-4#1)
in tissue injury##2##3##(1990-2#2)
in tissue repair##2##3##(2008-9#1)(2013-1#1)
in tissue samples##2##3##(1995-12#1)(1996-12#1)
in tissue scaffold fabrication##2##4##(2010-9#2)
in tissue sections##4##3##(1991-5#1)(2008-4#2)(2008-5#1)
in tissue specimens##2##3##(2011-2#2)
in tissue##107##2##(1990-11#2)(1990-2#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#7)(2008-7#3)(2008-9#5)(2009-11#3)(2009-12#1)(2009-7#2)(2010-1#1)(2010-10#3)(2010-3#1)(2010-9#3)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
in tissue-culture##2##2##(1991-6#1)(1992-9#1)
in tissue-like phantoms##2##3##(2010-12#2)
in tissue-like##3##2##(2010-12#3)
in tissuelike##2##2##(2007-11#1)(2008-3#1)
in tissues and##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
in tissues from##5##3##(1990-11#1)(1996-9#2)(1997-3#1)(2008-10#1)
in tissues in##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
in tissues of##4##3##(1992-3#1)(2008-12#1)(2010-9#1)(2012-3#1)
in tissues or##2##3##(1991-11#1)(2008-7#1)
in tissues using##2##3##(1991-9#1)(2008-1#1)
in tissues with##2##3##(1993-12#1)(2007-11#1)
in tissues##47##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-12#1)(1995-12#2)(1996-5#1)(1996-9#2)(1997-3#1)(2007-11#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2009-10#1)(2010-9#1)(2012-3#2)(2013-1#1)
in titanium bearing minerals by potentiometric titration using##2##8##(2008-10#2)
in titanium##4##2##(2008-10#4)
in titrations##2##2##(1991-11#1)(2008-10#1)
in titrimetric##2##2##(2008-10#2)
in tits##2##2##(2008-5#2)
in to the##5##3##(2007-8#1)(2008-10#2)(2008-12#1)(2012-1#1)
in to##15##2##(2007-8#1)(2008-10#6)(2008-12#4)(2010-8#1)(2012-1#2)(2013-1#1)
in tobacco and tobacco smoke##2##5##(1993-11#1)(2011-1#1)
in tobacco and##5##3##(1993-11#1)(2008-10#3)(2011-1#1)
in tobacco plants##6##3##(1997-2#1)(2008-10#4)(2008-9#1)
in tobacco##37##2##(1993-11#1)(1997-1#1)(1997-2#2)(2008-10#23)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
in today's competitive##3##3##(1991-2#1)(1991-3#1)(1994-12#1)
in today's economic climate##2##4##(1992-12#1)(1994-1#1)
in today's health care environment##4##5##(1991-12#1)(1991-3#1)(2008-1#2)
in today's health care system##2##5##(1997-2#1)(1997-3#1)
in today's health care##8##4##(1991-12#1)(1991-3#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-11#1)
in today's healthcare##2##3##(1993-2#1)(1997-1#1)
in today's##33##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#2)
in tolerance##6##2##(1996-12#1)(2008-10#3)(2008-12#1)(2008-3#1)
in tolerant rats##3##3##(1996-2#3)
in tolerant##5##2##(1996-2#3)(2008-10#2)
in toluene as an extractant##2##5##(2008-10#2)
in toluene##17##2##(1991-7#1)(2007-12#1)(2008-10#11)(2009-9#4)
in tomato and##2##3##(2008-10#2)
in tomato fruits##3##3##(2008-10#1)(2011-2#2)
in tomato in##4##3##(2008-10#4)
in tomato leaves##2##3##(2008-10#2)
in tomato plants##9##3##(2008-10#8)(2008-9#1)
in tomato roots##4##3##(2008-10#4)
in tomato##47##2##(1993-12#1)(2008-10#42)(2008-9#1)(2011-2#3)
in tomographic##2##2##(2009-12#1)(2009-5#1)
in toothpastes##3##2##(2008-5#3)
in topical##2##2##(2008-10#1)(2008-5#1)
in total RNA##3##3##(1991-9#1)(2008-10#1)(2008-11#1)
in total cell number##2##4##(2008-5#1)(2012-12#1)
in total cell##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
in total cellular##2##3##(1992-11#1)(2008-7#1)
in total cholesterol##3##3##(1991-8#1)(1994-3#1)(2008-3#1)
in total competition intensity or##2##5##(2008-9#2)
in total darkness##2##3##(2008-10#1)(2008-4#1)
in total hip arthroplasty##4##4##(2008-8#1)(2011-2#2)(2012-2#1)
in total hip##5##3##(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)
in total knee arthroplasty (TKA)##2##5##(2008-8#1)(2013-1#1)
in total knee arthroplasty##3##4##(2008-8#1)(2011-1#1)(2013-1#1)
in total loss##2##3##(2008-3#1)(2010-3#1)
in total parenteral nutrition (TPN)##2##5##(1992-9#1)(2008-10#1)
in total plasma cholesterol##2##4##(1990-3#1)(1994-8#1)
in total plasma##3##3##(1990-3#1)(1992-11#1)(1994-8#1)
in total##95##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#6)(2008-9#4)(2009-4#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#4)
in total)##3##2##(1992-12#1)(2008-10#2)
in totally##2##2##(1996-1#1)(2008-2#1)
in touch with##2##3##(1993-6#1)(2008-11#1)
in touch##4##2##(1993-6#1)(2008-11#1)(2008-12#1)(2008-9#1)
in toxic##2##2##(1992-8#1)(1995-5#1)
in toxicological##3##2##(1996-5#1)(2008-10#2)
in toxicology##3##2##(1996-12#3)
in toxin##2##2##(2007-12#1)(2008-10#1)
in toys##2##2##(2011-1#2)
in trace DNA analysis##2##4##(2008-12#2)
in trace amounts in##2##4##(2008-10#1)(2008-11#1)
in trace amounts##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
in trace elements##2##3##(2008-10#2)
in trace quantities can be##2##5##(2008-10#2)
in trace##10##2##(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)
in trachea##5##2##(1990-8#1)(1992-3#1)(1995-12#1)(1997-6#2)
in tracking##2##2##(2008-11#1)(2008-7#1)
in traditional Chinese##5##3##(1992-2#1)(1997-2#1)(2008-10#3)
in traditional medicine##2##3##(2008-7#1)(2013-1#1)
in traditional##16##2##(1992-2#1)(1994-2#1)(1996-12#1)(1997-2#2)(1997-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
in traffic accidents##4##3##(1990-9#1)(1995-8#1)(2010-11#1)(2011-2#1)
in traffic##7##2##(1990-9#1)(1992-6#1)(1995-8#1)(2010-11#2)(2010-3#1)(2011-2#1)
in training and education##2##4##(1997-6#1)(2008-11#1)
in training and##5##3##(1997-6#1)(2007-11#2)(2008-11#1)(2010-12#1)
in training##14##2##(1994-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-11#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#3)
in traits##3##2##(1995-6#1)(2008-9#1)(2012-3#1)
in trans for##3##3##(1994-5#1)(2011-2#2)
in trans##9##2##(1991-12#1)(1993-12#1)(1994-5#1)(1995-6#2)(2008-10#1)(2011-2#3)
in transaminase##2##2##(1992-5#1)(2013-1#1)
in transcript##2##2##(2008-7#1)(2012-3#1)
in transcription of the##2##4##(1996-12#1)(2010-10#1)
in transcription##8##2##(1993-12#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)
in transcriptional enhancement and##2##4##(1995-6#2)
in transcriptional regulation and##2##4##(2008-10#1)(2008-7#1)
in transcriptional regulation of##2##4##(2008-8#1)(2011-2#1)
in transcriptional regulation##8##3##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#1)
in transcriptional##14##2##(1991-5#1)(1995-6#3)(1995-8#1)(1996-3#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#1)
in transcriptionally active##3##3##(1990-7#2)(2011-1#1)
in transendothelial migration##3##3##(2012-1#3)
in transfected Chinese hamster ovary##2##5##(1992-12#1)(1995-2#1)
in transfected Drosophila##2##3##(1994-8#1)(2008-11#1)
in transfected PC12 cells##2##4##(1990-5#1)(1992-9#1)
in transfected cells##8##3##(1990-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-11#1)(2010-5#1)
in transfected##22##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1997-4#1)(2008-11#2)(2008-4#1)(2010-5#1)
in transfection##5##2##(1994-8#1)(1995-6#1)(2008-11#2)(2008-7#1)
in transfer##5##2##(1993-1#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
in transferring##4##2##(1994-8#1)(1997-8#1)(2008-8#1)(2009-10#1)
in transformation##4##2##(1990-5#1)(1990-7#1)(1993-2#1)(1995-3#1)
in transformed cell and hairy root cultures##2##7##(1994-11#2)
in transformed cells##4##3##(1994-8#1)(1995-2#1)(2009-9#1)(2010-3#1)
in transformed##11##2##(1993-6#1)(1994-11#3)(1994-8#1)(1995-2#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-3#2)
in transformer-2##2##2##(2007-12#2)
in transforming growth factor-beta##2##4##(1994-11#1)(2008-9#1)
in transforming##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
in transfusion##5##2##(2008-10#3)(2008-7#1)(2011-2#1)
in transgene##3##2##(1995-2#1)(2008-8#1)(2011-1#1)
in transgenic Nicotiana##2##3##(2008-10#2)
in transgenic Petunia hybrida##2##4##(2008-9#2)
in transgenic animals##3##3##(1993-12#1)(1995-6#1)(2008-11#1)
in transgenic lines##3##3##(2008-10#2)(2008-9#1)
in transgenic maize plants and##2##5##(2008-8#2)
in transgenic mice and##2##4##(1990-8#1)(1992-11#1)
in transgenic mice##19##3##(1990-8#1)(1992-11#1)(1992-8#2)(1994-9#1)(1995-2#4)(1995-6#1)(1996-12#1)(1996-5#2)(1997-7#1)(2008-4#1)(2008-9#3)(2010-11#1)
in transgenic mouse embryos##2##4##(1997-6#2)
in transgenic mouse##4##3##(1994-8#1)(1997-6#2)(2008-9#1)
in transgenic plants##14##3##(1991-7#1)(2008-10#7)(2008-2#1)(2008-7#2)(2008-8#2)(2011-2#1)
in transgenic potato##4##3##(1997-4#2)(2008-8#2)
in transgenic rabbits##3##3##(1994-8#2)(2008-12#1)
in transgenic tobacco plants##7##4##(1997-6#2)(2008-10#2)(2008-8#1)(2008-9#1)(2011-10#1)
in transgenic tobacco##11##3##(1997-6#2)(2008-10#3)(2008-8#1)(2008-9#3)(2011-10#2)
in transgenic tobaccos##2##3##(2008-8#1)(2008-9#1)
in transgenic##84##2##(1990-11#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-8#2)(1993-12#3)(1994-8#4)(1994-9#1)(1995-2#4)(1995-6#3)(1996-12#1)(1996-5#2)(1997-4#2)(1997-6#4)(1997-7#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#8)(2008-9#17)(2009-10#1)(2010-11#1)(2010-7#1)(2011-10#2)(2011-2#1)
in transient expression assays##2##4##(1993-8#2)
in transient expression##4##3##(1993-8#2)(2008-11#1)(2008-8#1)
in transient transfection##2##3##(1992-8#1)(1993-3#1)
in transient transfections##2##3##(1993-6#1)(2008-1#1)
in transient##19##2##(1991-3#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-6#1)(2007-10#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
in transiently transfected##3##3##(1994-6#1)(1996-5#1)(2008-11#1)
in transit through##2##3##(1995-12#1)(2008-7#1)
in transit##5##2##(1994-7#1)(1994-9#1)(1995-12#1)(2008-7#1)(2012-2#1)
in transition##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
in transition-state##2##2##(1992-3#1)(2008-5#1)
in translating##4##2##(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#1)
in translation##4##2##(1993-9#1)(1995-6#1)(2008-10#1)(2010-1#1)
in translational research##2##3##(2008-8#1)(2012-12#1)
in translational##6##2##(1994-8#2)(2008-8#1)(2010-5#1)(2010-9#1)(2012-12#1)
in transmembrane signaling##2##3##(1993-6#1)(2008-9#1)
in transmembrane##8##2##(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#1)(2008-9#1)(2012-2#1)
in transmission by##3##3##(2008-10#3)
in transmission for##2##3##(2008-2#1)(2008-3#1)
in transmission laser##2##3##(2009-7#2)
in transmission mode##2##3##(2008-3#1)(2008-9#1)
in transmission of##2##3##(2007-7#1)(2012-3#1)
in transmission was##2##3##(2007-12#1)(2008-8#1)
in transmission##36##2##(2006-4#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-10#7)(2008-2#6)(2008-3#8)(2008-8#1)(2008-9#2)(2009-7#2)(2012-3#1)
in transmittance##2##2##(2008-3#2)
in transmitted##2##2##(2008-3#1)(2012-3#1)
in transparent and##2##3##(2007-11#1)(2007-12#1)
in transparent##6##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#3)
in transplant##3##2##(1991-3#1)(2007-12#1)(2008-8#1)
in transplantation##3##2##(1995-12#1)(2012-1#2)
in transplanted patients with ADPKD##2##5##(2013-1#2)
in transplanted patients##3##3##(2010-8#1)(2013-1#2)
in transplanted##7##2##(2008-1#1)(2008-9#1)(2009-3#1)(2010-8#1)(2013-1#2)(2013-7#1)
in transport of##2##3##(2007-7#1)(2011-1#1)
in transport##6##2##(1990-12#1)(1995-8#1)(2007-7#1)(2008-10#1)(2009-4#1)(2011-1#1)
in transposa and##2##3##(2008-10#2)
in transposition frequency##3##3##(2012-3#3)
in transposition##6##2##(2009-10#1)(2012-3#5)
in transradial##2##2##(2011-2#2)
in transverse##3##2##(2008-3#1)(2009-3#1)(2009-7#1)
in trapping##2##2##(2007-11#1)(2008-10#1)
in traps baited with##2##4##(2011-2#1)(2013-7#1)
in traps##3##2##(2011-2#2)(2013-7#1)
in trauma##2##2##(2009-4#1)(2012-2#1)
in traumatic brain injury##3##4##(2008-7#2)(2008-8#1)
in traumatic##5##2##(2007-11#1)(2008-7#2)(2008-8#1)(2012-2#1)
in travel medicine and##2##4##(2007-2#2)
in travel medicine##7##3##(2007-2#7)
in travel##8##2##(2007-2#7)(2008-8#1)
in travelers##5##2##(2007-2#2)(2011-2#3)
in traveling-wave##2##2##(2007-11#2)
in travellers##8##2##(2007-2#7)(2011-2#1)
in treated and##2##3##(1995-8#1)(2007-10#1)
in treated animals##3##3##(2006-6#1)(2011-2#2)
in treated patients##2##3##(2008-7#1)(2012-3#1)
in treated rats##2##3##(1994-6#1)(2008-10#1)
in treated than in##2##4##(1995-3#1)(2008-2#1)
in treated##24##2##(1992-11#1)(1992-9#1)(1994-6#1)(1995-3#1)(1995-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
in treating and##2##3##(1997-4#1)(2008-11#1)
in treating patients with##4##4##(1991-8#1)(2008-9#2)(2009-8#1)
in treating patients##6##3##(1991-8#1)(2008-10#1)(2008-9#2)(2009-8#1)(2012-3#1)
in treating prostate##2##3##(2008-10#1)(2008-4#1)
in treating severe##2##3##(1991-3#1)(2011-2#1)
in treating the##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2012-3#1)
in treating these##3##3##(1991-9#1)(2008-12#1)(2008-4#1)
in treating##61##2##(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#2)(1996-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#3)(2013-1#7)
in treatment (5)##2##3##(2013-1#2)
in treatment and##5##3##(1991-1#1)(1993-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
in treatment for severe depression##2##5##(2013-8#2)
in treatment for severe##3##4##(2013-8#3)
in treatment for##6##3##(2008-7#1)(2013-8#5)
in treatment of childhood##2##4##(1991-8#1)(2012-2#1)
in treatment of patients with##4##5##(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
in treatment of patients##5##4##(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
in treatment of resistant##2##4##(2007-7#1)(2011-2#1)
in treatment of the##2##4##(2007-11#2)
in treatment of unstable##2##4##(2007-8#2)
in treatment of vertebral##2##4##(2007-11#1)(2007-8#1)
in treatment of##50##3##(1990-6#1)(1990-9#1)(1991-8#1)(1991-9#1)(1995-11#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#8)(2007-7#1)(2007-8#6)(2008-10#2)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-3#1)(2009-9#1)(2010-4#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#3)
in treatment planning##2##3##(2008-7#1)(2010-8#1)
in treatment strategies##4##3##(2010-11#2)(2011-2#1)(2013-8#1)
in treatment with##2##3##(1996-2#1)(2012-3#1)
in treatment##104##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#9)(2007-12#1)(2007-7#2)(2007-8#6)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#3)(2009-1#1)(2009-3#1)(2009-9#1)(2010-11#3)(2010-4#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#6)
in treatment-resistant schizophrenic patients##4##4##(2008-12#3)(2008-6#1)
in treatment-resistant##5##2##(2008-12#3)(2008-6#2)
in treatments (1)##2##3##(2013-1#2)
in treatments of##2##3##(2008-10#1)(2009-11#1)
in treatments with##6##3##(2008-10#6)
in treatments##14##2##(2008-10#9)(2008-5#1)(2009-11#1)(2013-1#3)
in tree##2##2##(2008-10#2)
in trees##7##2##(2008-10#3)(2008-8#2)(2008-9#1)(2012-8#1)
in tremor at rest##4##4##(2008-7#4)
in tremor##6##2##(2008-7#6)
in trials##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
in triggering the##3##3##(1996-2#1)(2010-11#1)(2011-2#1)
in triggering##11##2##(1990-7#1)(1992-6#1)(1995-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#2)(2011-2#2)
in triglyceride##2##2##(1997-7#1)(2008-1#1)
in triglycerides##5##2##(1991-12#1)(2008-3#2)(2010-4#2)
in trimeric PEC##2##3##(2008-8#2)
in triplicate##2##2##(2008-12#1)(2013-7#1)
in triploid crucian carp##2##4##(2010-5#2)
in tropical Asia##4##3##(2008-10#4)
in tropical and sub-tropical regions##2##5##(1994-9#1)(2011-2#1)
in tropical and subtropical##2##4##(2008-10#2)
in tropical and##5##3##(1994-9#1)(2007-2#1)(2008-10#2)(2011-2#1)
in tropical areas##2##3##(1996-11#1)(2013-7#1)
in tropical countries##2##3##(2010-4#2)
in tropical regions##2##3##(1996-12#1)(2012-12#1)
in tropical##34##2##(1992-11#2)(1994-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(2007-2#1)(2008-10#10)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-7#4)
in troublesome##2##2##(2007-8#1)(2013-8#1)
in trying to##7##3##(1995-3#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-12#1)(2009-6#2)
in trypsin##2##2##(1992-3#2)
in tryptophan##3##2##(1992-3#1)(1993-11#1)(2008-10#1)
in tsetse##2##2##(2010-4#2)
in tubal##2##2##(1994-9#1)(2013-7#1)
in tuber##2##2##(2008-10#2)
in tuberculosis##8##2##(1996-3#2)(2008-12#1)(2008-7#2)(2010-5#1)(2010-8#1)(2013-1#1)
in tuberculous##2##2##(2007-8#1)(2011-2#1)
in tumor cell##2##3##(1991-8#1)(2012-12#1)
in tumor cells##18##3##(1992-2#1)(1994-5#2)(2008-11#6)(2008-9#2)(2009-3#1)(2010-1#1)(2010-2#3)(2012-1#1)(2012-12#1)
in tumor development##4##3##(1992-8#1)(2008-10#1)(2008-4#1)(2010-3#1)
in tumor growth and metastasis##2##5##(2008-8#1)(2013-8#1)
in tumor growth and##3##4##(2008-8#1)(2009-3#1)(2013-8#1)
in tumor growth##7##3##(1991-6#1)(1994-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#1)
in tumor immunotherapy trials##2##4##(2009-3#1)(2011-2#1)
in tumor immunotherapy##3##3##(2009-3#1)(2011-2#1)(2012-2#1)
in tumor invasion and metastasis##2##5##(1993-9#1)(2008-8#1)
in tumor progression and##2##4##(2009-3#2)
in tumor progression##4##3##(1993-9#1)(2009-3#2)(2012-12#1)
in tumor samples##2##3##(2008-9#1)(2012-12#1)
in tumor size##2##3##(1994-12#1)(2008-7#1)
in tumor tissue##3##3##(1994-2#1)(2008-4#1)(2008-9#1)
in tumor tissues##4##3##(1994-2#2)(2008-8#1)(2008-9#1)
in tumor##66##2##(1990-8#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-9#2)(1994-12#1)(1994-2#3)(1994-5#3)(1994-6#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#2)(2009-12#1)(2009-3#5)(2010-1#1)(2010-2#3)(2010-3#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#3)
in tumoral tissues##3##3##(2008-4#3)
in tumorigenesis##9##2##(1991-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#3)
in tumors of the##2##4##(1990-9#1)(2007-7#1)
in tumors of##4##3##(1990-9#1)(1997-7#1)(2007-7#1)(2009-4#1)
in tumors with##3##3##(2008-6#1)(2009-8#1)(2011-2#1)
in tumors##16##2##(1990-11#1)(1990-9#1)(1993-11#1)(1997-7#1)(2007-7#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-2#1)
in tumour##11##2##(1992-2#1)(1992-8#1)(1992-9#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-10#1)(2008-7#1)(2009-4#1)(2011-2#2)
in tumourigenesis##2##2##(2011-2#1)(2012-1#1)
in tumours##2##2##(1994-10#1)(2008-7#1)
in tunable##4##2##(2007-12#3)(2008-7#1)
in tunnels##2##2##(2009-10#2)
in turbid media are##2##4##(2008-3#1)(2011-2#1)
in turbid media by use of##2##6##(2007-12#1)(2008-3#1)
in turbid media by##3##4##(2007-12#1)(2008-3#2)
in turbid media is##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
in turbid media using##3##4##(1994-2#1)(2011-1#2)
in turbid media with##2##4##(2007-12#1)(2008-3#1)
in turbid media##36##3##(1994-2#1)(2007-11#3)(2007-12#8)(2008-2#3)(2008-3#18)(2011-1#2)(2011-2#1)
in turbid##41##2##(1994-2#1)(2007-11#5)(2007-12#8)(2008-2#3)(2008-3#20)(2011-1#2)(2011-2#2)
in turbidity##3##2##(2008-10#2)(2009-9#1)
in turbot##2##2##(2010-5#1)(2010-8#1)
in turbulent flow##2##3##(2008-2#1)(2008-9#1)
in turbulent flows##2##3##(2008-3#1)(2008-9#1)
in turbulent##6##2##(2008-2#1)(2008-3#2)(2008-9#3)
in turfgrass##2##2##(2008-10#2)
in turkey poults##3##3##(1997-6#2)(2008-5#1)
in turkey##4##2##(1997-6#2)(2007-8#1)(2008-5#1)
in turkeys in##2##3##(1997-6#1)(2013-1#1)
in turkeys##6##2##(1997-6#2)(2007-8#1)(2013-1#3)
in turn affects##3##3##(2008-8#1)(2009-11#1)(2010-11#1)
in turn allows##2##3##(2008-2#1)(2008-9#1)
in turn alter##2##3##(2008-10#1)(2008-5#1)
in turn are related to##2##5##(2008-10#1)(2008-8#1)
in turn are##6##3##(1992-1#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
in turn depends on##2##4##(1990-12#1)(2008-8#1)
in turn has##3##3##(1996-6#1)(2008-11#1)(2010-4#1)
in turn lead to##5##4##(2006-5#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
in turn leads to##4##4##(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)
in turn may##4##3##(1992-8#1)(1996-12#1)(2008-1#1)(2009-8#1)
in turn on##2##3##(2008-5#1)(2012-2#1)
in turn results in##2##4##(2008-10#1)(2008-5#1)
in turn suggests that##3##4##(1995-12#1)(2008-3#1)(2012-12#1)
in turn will##4##3##(1995-3#1)(1996-3#1)(1997-2#1)(2008-12#1)
in turn##185##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-6#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#3)
in turnover##2##2##(2007-12#1)(2010-2#1)
in turtles and##2##3##(2013-1#2)
in turtles##3##2##(2013-1#3)
in twelve healthy volunteers##2##4##(1996-5#1)(2008-3#1)
in twelve##6##2##(1993-2#1)(1995-2#1)(1996-5#1)(2008-3#1)(2008-8#1)(2013-1#1)
in twenty##3##2##(1993-3#1)(1997-3#1)(2008-10#1)
in twin gestations##2##3##(2012-3#2)
in twin pregnancies##2##3##(2007-11#2)
in twin##5##2##(2007-11#2)(2012-2#1)(2012-3#2)
in twins##2##2##(2008-11#1)(2011-1#1)
in twins?##2##2##(1995-8#1)(2009-5#1)
in two (10%)##5##3##(1996-9#3)(2008-5#1)(2011-1#1)
in two (2##2##3##(2008-1#2)
in two Canadian##3##3##(2008-10#2)(2008-12#1)
in two Italian provenances##2##4##(2012-5#2)
in two analytical##2##3##(2008-10#2)
in two and three##2##4##(2008-10#1)(2008-3#1)
in two and##6##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
in two areas##6##3##(1994-2#1)(1996-2#1)(2008-10#1)(2013-1#3)
in two cases and##6##4##(2007-12#1)(2007-8#2)(2008-7#3)
in two cases of##2##4##(1992-8#1)(2008-5#1)
in two cases was##2##4##(1993-2#1)(1995-6#1)
in two cases with pelvic##2##5##(2008-6#2)
in two cases##25##3##(1990-12#1)(1990-8#1)(1992-8#1)(1993-2#1)(1995-6#1)(1997-8#2)(2007-12#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#7)(2011-2#1)(2012-12#1)(2012-2#1)
in two children with##2##4##(2008-9#1)(2011-1#1)
in two children##4##3##(2008-10#1)(2008-9#1)(2009-3#1)(2011-1#1)
in two cities##2##3##(2008-11#1)(2012-12#1)
in two citrus orchards##2##4##(2008-10#1)(2008-6#1)
in two classes##2##3##(2008-7#1)(2011-2#1)
in two clinical##2##3##(2008-11#1)(2008-7#1)
in two configurations##2##3##(2007-11#1)(2008-2#1)
in two consecutive##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
in two copies##2##3##(1996-10#1)(2011-2#1)
in two different##27##3##(1990-6#1)(1992-11#1)(1993-12#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
in two dimensions##11##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)(2008-8#1)(2012-3#1)
in two directions##2##3##(2008-3#1)(2008-7#1)
in two distinct##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
in two environments##2##3##(2008-10#1)(2008-8#1)
in two experiments##5##3##(1993-12#1)(2008-10#1)(2008-4#1)(2008-6#2)
in two families##2##3##(1991-12#2)
in two field experiments##3##4##(2008-10#3)
in two field##6##3##(2008-10#6)
in two forms##5##3##(1991-12#1)(1991-5#1)(1993-8#1)(2008-10#1)(2009-9#1)
in two groups of##6##4##(1991-11#1)(1992-6#1)(2008-12#1)(2008-5#3)
in two groups##16##3##(1991-11#1)(1992-6#1)(1994-7#1)(1996-12#1)(2008-10#2)(2008-12#3)(2008-5#3)(2011-2#3)(2012-12#1)
in two high##2##3##(2008-11#1)(2011-2#1)
in two hospitals in##3##4##(2008-11#1)(2008-7#1)(2012-12#1)
in two human##2##3##(1992-9#1)(2008-8#1)
in two in##2##3##(1992-12#1)(1996-6#1)
in two key##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
in two large##2##3##(2008-1#1)(2008-8#1)
in two lesions##2##3##(2008-6#2)
in two locations in##2##4##(2008-10#2)
in two locations##6##3##(2008-10#5)(2012-12#1)
in two main##3##3##(1993-11#1)(2009-10#1)(2013-1#1)
in two maize cultivars##2##4##(2008-12#2)
in two of the four##4##5##(2008-10#2)(2008-5#1)(2008-7#1)
in two of the three##2##5##(2008-10#2)
in two of the##11##4##(1996-9#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
in two of three##4##4##(1992-2#1)(2008-10#3)
in two of##21##3##(1992-2#1)(1994-2#1)(1996-12#1)(1996-9#1)(1997-5#1)(2007-2#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-2#1)
in two or##2##3##(1996-12#1)(2008-9#1)
in two orthogonal directions##3##4##(2008-2#1)(2008-3#2)
in two other patients##2##4##(1997-3#1)(2007-7#1)
in two other##9##3##(1990-11#1)(1990-7#2)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2012-2#2)
in two out of##2##4##(2007-8#1)(2008-5#1)
in two parts##3##3##(1994-1#1)(1997-2#1)(2011-2#1)
in two patients with benign##2##5##(1990-9#1)(2013-1#1)
in two patients with##10##4##(1990-8#1)(1990-9#1)(1991-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2013-1#2)
in two patients without##2##4##(2008-5#1)(2013-1#1)
in two patients##32##3##(1990-8#1)(1990-9#1)(1991-3#1)(1993-1#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-9#1)(2007-11#1)(2007-7#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
in two periods##2##3##(1996-3#1)(2013-1#1)
in two perpendicular##2##3##(2008-3#2)
in two phases##3##3##(1993-9#1)(2008-10#1)(2013-1#1)
in two populations of##3##4##(2013-1#2)(2013-8#1)
in two populations##4##3##(2012-2#1)(2013-1#2)(2013-8#1)
in two positions##2##3##(2007-8#1)(2013-1#1)
in two rat strains##2##4##(1993-12#1)(2008-11#1)
in two regions of##4##4##(1996-2#1)(2007-8#2)(2008-7#1)
in two regions##7##3##(1992-9#1)(1995-2#1)(1996-2#1)(2007-8#2)(2008-7#2)
in two rural##2##3##(2008-3#1)(2009-6#1)
in two seasons##2##3##(2008-10#2)
in two separate##9##3##(1991-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
in two siblings with##2##4##(2008-7#1)(2009-3#1)
in two small##2##3##(1994-11#1)(1995-3#1)
in two species of##6##4##(1994-3#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)
in two species##10##3##(1994-3#1)(1995-5#1)(2007-12#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2013-7#1)
in two stages##5##3##(2008-10#1)(2008-11#2)(2010-8#2)
in two states##2##3##(1991-3#2)
in two steps##9##3##(1993-9#1)(2007-11#1)(2008-10#4)(2008-3#2)(2010-10#1)
in two strains of##4##4##(1990-3#1)(1991-5#1)(2008-10#1)(2008-11#1)
in two studies##3##3##(1993-9#1)(2009-1#1)(2010-6#1)
in two subgroups##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
in two time##2##3##(2008-12#1)(2012-2#1)
in two to##2##3##(2008-10#1)(2010-8#1)
in two townships of Jixian##2##5##(2011-1#2)
in two types of##2##4##(2008-10#1)(2008-3#1)
in two ways##9##3##(1992-11#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#2)
in two women##2##3##(1990-10#1)(2008-11#1)
in two years##3##3##(1996-3#1)(1997-8#1)(2013-1#1)
in two##591##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#4)(1991-5#3)(1991-9#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1996-9#5)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2006-8#1)(2007-11#7)(2007-12#12)(2007-2#1)(2007-7#9)(2007-8#11)(2008-1#9)(2008-10#102)(2008-11#24)(2008-12#18)(2008-2#4)(2008-3#23)(2008-4#8)(2008-5#24)(2008-6#17)(2008-7#26)(2008-8#13)(2008-9#19)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-6#3)(2010-7#2)(2010-8#7)(2011-1#10)(2011-2#18)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#6)(2012-5#3)(2013-1#21)(2013-7#3)(2013-8#5)
in two- or##2##3##(2008-10#1)(2008-3#1)
in two-##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
in two-component##2##2##(2008-10#2)
in two-dimensional photonic-crystal##2##3##(2007-11#2)
in two-dimensional space##3##3##(2008-11#3)
in two-dimensional##18##2##(1993-11#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-11#4)(2008-3#2)(2011-2#2)(2012-2#1)(2012-4#1)
in two-phase##2##2##(2008-10#1)(2010-4#1)
in two-photon excitation##2##3##(2008-3#2)
in two-photon##5##2##(2008-2#1)(2008-3#4)
in two-thirds of the##2##4##(1997-2#1)(2008-10#1)
in type 1 and type 2 diabetes##3##7##(2008-1#1)(2008-3#1)(2013-1#1)
in type 1 and type 2 diabetic patients##2##8##(1993-2#2)
in type 1 and type 2##5##6##(1993-2#2)(2008-1#1)(2008-3#1)(2013-1#1)
in type 1 and##6##4##(1993-2#2)(2008-1#2)(2008-3#1)(2013-1#1)
in type 1 diabetes mellitus##2##5##(1991-12#1)(2008-1#1)
in type 1 diabetes patients##4##5##(2008-1#1)(2013-1#3)
in type 1 diabetes##12##4##(1991-12#1)(2008-1#2)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#5)
in type 1 diabetic patients##2##5##(2010-12#1)(2012-4#1)
in type 1 diabetic##3##4##(2008-1#1)(2010-12#1)(2012-4#1)
in type 1##26##3##(1990-2#1)(1991-12#1)(1993-2#3)(1994-9#1)(1995-12#1)(2008-1#6)(2008-3#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-4#1)(2013-1#6)
in type 2 diabetes and##2##5##(2008-1#1)(2012-2#1)
in type 2 diabetes mellitus##3##5##(2011-1#1)(2012-1#1)(2012-5#1)
in type 2 diabetes patients##5##5##(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
in type 2 diabetes showed##2##5##(2008-8#2)
in type 2 diabetes##26##4##(2008-1#5)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2012-5#1)(2012-6#2)
in type 2 diabetic patients##3##5##(2011-2#3)
in type 2 diabetic##6##4##(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
in type 2##34##3##(1990-2#1)(1991-5#1)(2008-1#5)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2012-6#2)(2013-8#1)
in type I and type II##2##6##(1994-2#1)(2010-11#1)
in type I##6##3##(1994-2#1)(1995-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-11#1)
in type II##5##3##(1991-7#1)(1995-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
in type III##2##3##(2007-11#1)(2008-8#1)
in type and##2##3##(2008-1#1)(2008-4#1)
in type##80##2##(1990-2#2)(1991-12#1)(1991-5#1)(1991-7#1)(1993-2#3)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(2007-11#2)(2007-12#1)(2008-1#12)(2008-10#2)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#2)(2013-1#6)(2013-8#1)
in type-2 diabetes##2##3##(2012-2#1)(2012-3#1)
in type-2##4##2##(1994-6#1)(2012-2#1)(2012-3#2)
in typical situations##2##3##(1993-3#1)(2008-3#1)
in typical##7##2##(1993-3#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)
in ulcer##2##2##(1993-2#1)(2013-1#1)
in ulcerative colitis##6##3##(1992-9#2)(1995-10#1)(2012-12#1)(2013-8#2)
in ulcerative rectocolitis##2##3##(1990-3#1)(1992-3#1)
in ulcerative##9##2##(1990-3#1)(1990-6#1)(1992-3#1)(1992-9#2)(1995-10#1)(2012-12#1)(2013-8#2)
in ultrathin films##2##3##(2006-4#1)(2008-10#1)
in ultrathin polymer##2##3##(2008-10#2)
in ultrathin##6##2##(2006-4#1)(2008-10#5)
in ultraviolet region##3##3##(2008-10#3)
in ultraviolet##5##2##(2008-10#4)(2008-2#1)
in umbilical cord##3##3##(1990-12#1)(2009-8#1)(2011-1#1)
in umbilical##4##2##(1990-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
in unaffected##2##2##(1997-8#1)(2011-2#1)
in unanesthetized##7##2##(1997-2#1)(1997-6#3)(2007-10#2)(2008-4#1)
in unbuffered##2##2##(2008-10#1)(2009-12#1)
in uncontrolled##2##2##(2011-2#1)(2013-1#1)
in under##3##2##(2008-10#2)(2011-1#1)
in under-five mortality in Nigeria##2##5##(2009-6#1)(2009-7#1)
in under-five##3##2##(2009-6#1)(2009-7#2)
in undergraduate nursing curricula##2##4##(2008-12#1)(2012-3#1)
in undergraduate nursing##4##3##(2008-11#1)(2008-12#2)(2012-3#1)
in undergraduate##9##2##(1996-11#1)(2008-11#1)(2008-12#2)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
in underground##3##2##(2008-10#3)
in underserved communities##2##3##(2012-2#2)
in understanding and##3##3##(2010-11#1)(2010-9#1)(2012-2#1)
in understanding how##2##3##(1991-12#1)(2008-7#1)
in understanding mechanisms of change in##2##6##(2012-2#2)
in understanding mechanisms of##3##4##(2008-8#1)(2012-2#2)
in understanding of the##6##4##(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
in understanding of##8##3##(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
in understanding the mechanisms underlying##2##5##(2011-1#1)(2013-1#1)
in understanding the molecular basis of##2##6##(2008-11#1)(2008-9#1)
in understanding the molecular##3##4##(2008-11#2)(2008-9#1)
in understanding the nature of the##2##6##(1993-11#1)(2008-7#1)
in understanding the nature##3##4##(1993-11#1)(2008-4#1)(2008-7#1)
in understanding the pathophysiology of##4##5##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
in understanding the role of##4##5##(1991-3#1)(2008-10#1)(2010-11#1)(2012-2#1)
in understanding the role##5##4##(1991-3#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
in understanding the##46##3##(1991-3#1)(1993-11#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#5)(2013-1#2)(2013-8#1)
in understanding##91##2##(1991-12#1)(1991-3#1)(1993-11#1)(1996-12#1)(1997-3#1)(1997-8#3)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#11)(2013-1#3)(2013-8#1)
in undertaking##2##2##(1996-3#1)(2013-8#1)
in underweight##2##2##(1991-12#1)(2011-1#1)
in underwriting##3##2##(1992-3#1)(1993-12#2)
in undiagnosed##2##2##(2012-12#1)(2012-2#1)
in undifferentiated##5##2##(1992-3#1)(1997-2#1)(2008-4#1)(2011-2#1)(2012-1#1)
in undiluted human plasma by spectrofluorimetry##2##6##(2008-10#2)
in undiluted serum##3##3##(1993-12#3)
in undiluted##8##2##(1993-12#3)(2008-10#4)(2013-1#1)
in undoped YAG##2##3##(2008-2#1)(2008-3#1)
in undoped##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
in undrugged behavior##2##3##(1993-3#2)
in unexpected##2##2##(2008-10#1)(2009-1#1)
in unexposed##2##2##(1992-6#1)(2008-10#1)
in unfavourable##2##2##(2009-7#1)(2011-3#1)
in unfertilized human oocytes and##2##5##(1994-11#2)
in unfertilized##4##2##(1993-6#1)(1994-11#3)
in unhandled rats and##2##4##(1992-7#2)
in unhealthy##2##2##(2008-11#1)(2010-6#1)
in unilateral##4##2##(2006-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
in uninfected cells or cells infected with##2##7##(1993-6#2)
in uninfected insect##2##3##(2008-11#1)(2008-7#1)
in uninfected##8##2##(1990-12#1)(1993-6#2)(2008-10#3)(2008-11#1)(2008-7#1)
in unipolar##2##2##(2008-7#1)(2010-2#1)
in unique##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)
in unit dosage##2##3##(2008-10#1)(2010-5#1)
in unit##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
in units with##2##3##(2007-7#1)(2011-2#1)
in units##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
in univariate analyses##3##3##(1990-6#1)(1994-12#1)(1997-4#1)
in univariate##5##2##(1990-6#1)(1994-12#1)(1997-4#1)(2007-10#1)(2008-6#1)
in universal##2##2##(2007-7#1)(2008-10#1)
in universities##2##2##(1990-12#1)(2008-10#1)
in university##3##2##(1990-12#1)(2013-1#2)
in unknown samples##2##3##(2008-10#2)
in unpolluted##2##2##(2008-10#2)
in unprotected##6##2##(1996-5#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
in unraveling the##2##3##(1995-12#1)(1997-3#1)
in unraveling##3##2##(1995-12#1)(1997-3#1)(2008-5#1)
in unrelated individuals##2##3##(2012-3#2)
in unresolved##3##2##(2008-10#1)(2010-3#1)(2011-1#1)
in unsaturated systems##3##3##(2008-7#3)
in unsaturated##5##2##(2008-7#5)
in unsaturation##3##2##(2008-10#3)
in unselected consecutive patients with thyroid nodules##2##7##(2012-3#2)
in unselected##3##2##(2008-8#1)(2012-3#2)
in unstable resonators##3##3##(2007-11#1)(2008-3#2)
in unstable##4##2##(1991-9#1)(2007-11#1)(2008-3#2)
in unsupervised##2##2##(2008-10#1)(2009-7#1)
in untreated cells##2##3##(1993-6#1)(2008-9#1)
in untreated control plots##2##4##(2008-10#2)
in untreated control##3##3##(2008-10#3)
in untreated liver##2##3##(2008-2#2)
in untreated patients##2##3##(1995-12#1)(2010-6#1)
in untreated soil##2##3##(2008-10#2)
in untreated soils##2##3##(2008-10#2)
in untreated##27##2##(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-7#1)(1997-7#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-9#1)(2010-11#1)(2010-6#1)
in unusual locations##2##3##(2007-11#1)(2009-1#1)
in unusual##6##2##(1990-9#1)(1994-5#1)(2007-11#1)(2008-4#1)(2009-1#1)(2012-2#1)
in unvaccinated rural dogs##2##4##(2008-12#2)
in up to 20% of##2##5##(2008-7#1)(2009-6#1)
in up to 50% of##2##5##(2008-1#2)
in up to##18##3##(1991-9#1)(1994-11#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
in upland##2##2##(2008-10#2)
in upper and lower##2##4##(2007-11#1)(2011-2#1)
in upper##17##2##(1991-2#1)(2007-10#1)(2007-11#2)(2008-10#6)(2008-7#1)(2008-9#2)(2010-1#1)(2010-9#1)(2011-2#1)(2012-3#1)
in uppercase##2##2##(2008-11#1)(2008-6#1)
in upstream##2##2##(2010-8#1)(2013-1#1)
in uptake was observed##2##4##(1991-5#1)(1995-11#1)
in uptake##4##2##(1991-5#1)(1995-11#2)(2011-2#1)
in uranium##3##2##(2008-10#3)
in uranium-rich geological##2##3##(2008-10#2)
in urban Canadian##2##3##(2012-2#1)(2013-8#1)
in urban and rural areas##2##5##(1991-3#1)(1994-2#1)
in urban and rural##4##4##(1991-3#1)(1994-2#1)(2008-10#1)(2012-3#1)
in urban and##5##3##(1991-3#1)(1994-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
in urban area##2##3##(2008-6#1)(2011-1#1)
in urban areas and##3##4##(1994-2#1)(2008-5#1)(2009-4#1)
in urban areas of##2##4##(1997-4#1)(2008-6#1)
in urban areas##14##3##(1994-2#1)(1995-1#1)(1997-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-4#3)(2011-1#1)(2012-12#1)
in urban atmospheres##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
in urban hospitals has##2##4##(1992-12#2)
in urban settings##2##3##(2012-12#1)(2013-1#1)
in urban##63##2##(1991-1#1)(1991-3#1)(1992-12#3)(1994-2#2)(1995-1#1)(1996-3#1)(1997-4#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#3)(2009-10#1)(2009-4#5)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#4)
in urban/suburban##2##2##(1994-12#1)(1996-12#1)
in urea##7##2##(1993-11#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-4#2)
in uremic serum##3##3##(2008-10#3)
in uremic##6##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)
in ureteral##2##2##(1997-4#1)(2008-10#1)
in urethral##2##2##(2007-7#1)(2008-10#1)
in urgent##2##2##(2008-5#1)(2013-1#1)
in urinary tract infection##2##4##(1996-12#1)(2011-2#1)
in urinary tract infections]##2##4##(1993-11#1)(2013-8#1)
in urinary tract##6##3##(1993-11#1)(1996-12#1)(1997-2#1)(2007-7#1)(2011-2#1)(2013-8#1)
in urinary##17##2##(1991-12#2)(1993-11#1)(1996-12#3)(1996-7#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
in urine after##2##3##(2008-10#2)
in urine and serum##8##4##(1990-2#1)(1992-8#1)(1995-8#1)(2008-10#5)
in urine and##19##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-8#1)(1995-8#1)(2008-10#13)
in urine at##2##3##(2008-10#2)
in urine by a##2##4##(1996-12#1)(2008-10#1)
in urine by flow injection hydride generation##2##7##(2008-10#2)
in urine by flow injection##3##5##(1992-11#1)(2008-10#2)
in urine by##16##3##(1990-12#1)(1992-11#1)(1994-9#1)(1996-12#1)(2008-10#12)
in urine can be##2##4##(1992-3#1)(2008-12#1)
in urine cytology##2##3##(2012-2#1)(2013-8#1)
in urine has been developed##2##5##(2008-10#2)
in urine has been##3##4##(2008-10#3)
in urine in##3##3##(1994-9#1)(2008-10#1)(2012-12#1)
in urine is described##2##4##(1990-12#1)(2008-10#1)
in urine is##8##3##(1990-12#1)(1990-2#1)(1990-7#1)(1994-9#1)(1995-12#1)(2008-10#2)(2009-6#1)
in urine may##2##3##(1990-2#1)(2010-5#1)
in urine of patients##2##4##(1997-2#1)(2008-10#1)
in urine of the patients with cancer of the##2##9##(2008-7#2)
in urine of##11##3##(1992-3#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-7#3)(2013-8#2)
in urine sample##2##3##(2008-10#2)
in urine samples and##2##4##(2008-10#2)
in urine samples from##4##4##(1995-2#1)(2008-10#3)
in urine samples##27##3##(1995-2#1)(1995-6#1)(2008-10#25)
in urine using##4##3##(2008-10#4)
in urine was developed##2##4##(2008-10#2)
in urine was##8##3##(2008-10#8)
in urine were determined##3##4##(1990-8#1)(2008-10#2)
in urine were##5##3##(1990-8#1)(2008-10#4)
in urine with##2##3##(2008-10#2)
in urine##179##2##(1990-11#1)(1990-12#5)(1990-2#5)(1990-7#1)(1990-8#3)(1992-11#2)(1992-3#3)(1992-8#3)(1993-12#1)(1993-8#2)(1994-12#1)(1994-9#4)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#3)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#119)(2008-12#1)(2008-7#4)(2009-6#2)(2009-9#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-8#3)
in urology]##2##2##(1991-9#1)(2008-10#1)
in usage##2##2##(2008-1#1)(2008-8#1)
in use and##2##3##(1992-9#1)(2008-12#1)
in use for some##2##4##(2007-8#1)(2012-2#1)
in use for##4##3##(2007-8#1)(2008-10#2)(2012-2#1)
in use of##6##3##(1991-2#1)(1994-2#1)(2008-3#2)(2008-9#1)(2013-8#1)
in use##37##2##(1991-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-11#3)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in used rockwool##2##3##(2008-10#2)
in used##7##2##(2008-10#6)(2011-2#1)
in users##5##2##(1994-9#1)(1995-9#1)(2013-8#3)
in using a##2##3##(2007-11#1)(2008-7#1)
in using the##8##3##(1994-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
in using this##2##3##(2008-3#1)(2013-8#1)
in using##31##2##(1994-8#1)(1996-2#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
in usual##2##2##(1990-3#1)(2007-11#1)
in uterine##2##2##(1990-11#1)(1993-12#1)
in utero and##2##3##(2009-8#1)(2012-3#1)
in utero exposure to##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
in utero exposure##4##3##(1990-7#1)(2008-10#1)(2008-8#1)(2011-1#1)
in utero may##2##3##(1994-8#1)(2008-10#1)
in utero of a##2##4##(1990-5#1)(2008-10#1)
in utero##25##2##(1990-5#1)(1990-7#1)(1991-1#1)(1993-2#1)(1993-6#1)(1994-8#2)(1996-5#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-8#1)
in utilization and program##2##4##(1991-3#1)(1992-1#1)
in utilization review##2##3##(1992-1#2)
in utilization##9##2##(1991-3#1)(1992-1#3)(1993-1#1)(1996-1#1)(2007-4#1)(2008-11#1)(2011-2#1)
in utilizing##2##2##(1993-1#1)(2010-8#1)
in uveal##2##2##(2008-7#2)
in vaccinated##3##2##(1997-3#1)(2007-2#1)(2011-2#1)
in vaccinates##2##2##(1997-3#1)(2008-5#1)
in vaccine development##2##3##(1994-8#1)(1995-5#1)
in vaccine trials##2##3##(1994-9#1)(1995-5#1)
in vaccine##11##2##(1993-2#1)(1994-8#1)(1994-9#1)(1995-5#4)(2007-11#1)(2008-11#1)(2008-9#1)(2012-2#1)
in vaccines##2##2##(1990-12#1)(1995-5#1)
in vacuo##4##2##(1993-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
in vacuum##7##2##(1990-8#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2011-2#1)
in vaginal fluid and##2##4##(1996-12#2)
in vaginal fluid##5##3##(1996-12#5)
in vaginal##7##2##(1996-12#7)
in vain##2##2##(2008-10#1)(2008-7#1)
in validation of##2##3##(1995-3#1)(2008-8#1)
in values of##2##3##(1991-2#1)(2009-11#1)
in values##5##2##(1991-2#1)(2008-10#1)(2009-11#1)(2009-6#1)(2011-2#1)
in variable##7##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-7#1)
in variety##2##2##(2010-8#1)(2011-2#1)
in various animal species##3##4##(1990-6#1)(2011-1#1)(2013-7#1)
in various animal##5##3##(1990-6#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-7#1)
in various animals##2##3##(1992-8#1)(2008-7#1)
in various areas of##4##4##(1991-12#1)(2007-11#1)(2008-9#2)
in various aspects of##2##4##(2011-2#1)(2012-3#1)
in various biological##5##3##(1990-12#1)(1991-5#1)(1994-8#1)(1996-2#1)(1997-2#1)
in various bones##2##3##(2012-1#2)
in various buffer##2##3##(2008-10#2)
in various cancer##2##3##(1993-8#1)(2008-11#1)
in various cellular##2##3##(1995-11#1)(2009-8#1)
in various chemical##2##3##(1992-4#1)(2008-10#1)
in various chronic##3##3##(1991-3#1)(2008-8#1)(2009-12#1)
in various combinations with##2##4##(1993-11#1)(2008-10#1)
in various concentrations of##3##4##(2007-11#1)(2008-10#1)(2008-12#1)
in various countries##3##3##(1994-5#1)(2011-2#1)(2012-2#1)
in various crops##3##3##(2008-10#3)
in various disciplines##2##3##(1992-2#1)(2007-11#1)
in various disease states##4##4##(1992-12#1)(2006-10#1)(2008-9#1)(2011-2#1)
in various diseases##2##3##(2008-1#1)(2013-8#1)
in various environmental##3##3##(2008-10#3)
in various environments##2##3##(2008-10#1)(2008-2#1)
in various fields##2##3##(2008-10#1)(2008-3#1)
in various forms of##2##4##(1994-12#1)(2013-7#1)
in various forms##3##3##(1994-12#1)(2009-11#1)(2013-7#1)
in various functions##2##3##(2008-4#1)(2012-2#1)
in various host##2##3##(2008-10#1)(2011-2#1)
in various human tissues##5##4##(1990-12#1)(1993-6#1)(1995-6#1)(2008-8#2)
in various human##9##3##(1990-12#1)(1990-5#1)(1992-5#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-8#2)(2013-1#1)
in various in vitro##3##4##(2009-11#1)(2009-12#1)(2009-4#1)
in various in##4##3##(2008-10#1)(2009-11#1)(2009-12#1)(2009-4#1)
in various indications##2##3##(1990-8#1)(2008-8#1)
in various inflammatory##3##3##(1990-2#1)(2008-5#1)(2012-3#1)
in various natural##2##3##(1997-4#1)(2008-10#1)
in various organisms##2##3##(1995-2#1)(2009-8#1)
in various organs and##3##4##(2008-9#1)(2012-3#2)
in various organs of##2##4##(1992-9#1)(1996-12#1)
in various organs was##2##4##(1990-12#2)
in various organs##10##3##(1990-12#2)(1992-9#2)(1996-12#1)(2008-9#2)(2012-12#1)(2012-3#2)
in various other##2##3##(1991-9#1)(2007-11#1)
in various parts of the world##2##6##(2008-6#1)(2011-2#1)
in various parts of the##4##5##(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)
in various parts of##5##4##(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)
in various pathological conditions##2##4##(1992-2#1)(2012-2#1)
in various pathological##4##3##(1992-2#1)(2008-8#1)(2009-3#1)(2012-2#1)
in various pharmaceutical preparations##3##4##(2008-10#3)
in various plant species##2##4##(2008-10#2)
in various plant##4##3##(1995-6#1)(2008-10#3)
in various proportions##2##3##(2007-12#1)(2008-10#1)
in various psychiatric##2##3##(2009-10#1)(2012-2#1)
in various rat tissues##2##4##(1991-9#1)(1993-3#1)
in various real samples##2##4##(2008-10#2)
in various regions of the##2##5##(1994-12#1)(2008-7#1)
in various regions of##3##4##(1994-12#1)(2007-12#1)(2008-7#1)
in various regions##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
in various saline media##2##4##(2008-10#2)
in various samples after adsorption of its##2##7##(2008-10#2)
in various samples##5##3##(2008-10#5)
in various signaling pathways##2##4##(2009-8#1)(2012-2#1)
in various sites##2##3##(2007-8#1)(2011-2#1)
in various solvents##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
in various stages of##6##4##(1993-11#1)(1996-12#1)(1997-8#1)(2008-3#1)(2008-8#1)(2012-3#1)
in various standard alloys and environmental samples after##2##8##(2008-10#2)
in various standard alloys and environmental samples##3##7##(2008-10#3)
in various standard alloys and##4##5##(2008-10#4)
in various standard##5##3##(2008-10#5)
in various states##2##3##(2011-2#1)(2013-8#1)
in various tissues was##2##4##(1995-8#1)(2013-1#1)
in various tissues##14##3##(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
in various types of cells##2##5##(1993-3#1)(2008-4#1)
in various types of##11##4##(1992-8#1)(1993-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)
in various vertebrate##2##3##(1993-12#1)(2008-5#1)
in various ways##6##3##(1990-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-7#1)
in various##309##2##(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#3)(1991-3#2)(1991-5#2)(1991-9#4)(1992-12#2)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-8#3)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#67)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#12)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#3)(2012-2#13)(2012-3#7)(2013-1#5)(2013-7#3)(2013-8#2)
in varying degrees##3##3##(1993-1#1)(1993-11#1)(1994-12#1)
in varying stages of##2##4##(2008-4#1)(2012-2#1)
in varying##9##2##(1993-1#1)(1993-11#1)(1994-12#2)(2007-12#1)(2008-4#1)(2009-12#1)(2010-8#1)(2012-2#1)
in vascular endothelial cells##2##4##(1990-2#1)(1991-2#1)
in vascular malformations##2##3##(2012-1#2)
in vascular smooth muscle cells and fibroblasts##2##7##(1990-2#2)
in vascular smooth muscle cells from##2##6##(1990-2#1)(1995-11#1)
in vascular smooth muscle cells##10##5##(1990-2#3)(1992-12#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(2012-12#1)
in vascular smooth muscle##15##4##(1990-12#1)(1990-2#3)(1992-12#3)(1993-8#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(2011-2#1)(2012-12#1)
in vascular smooth muscles##2##4##(1995-12#2)
in vascular smooth##17##3##(1990-12#1)(1990-2#3)(1992-12#3)(1993-8#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#3)(2011-2#1)(2012-12#1)
in vascular##44##2##(1990-12#1)(1990-2#4)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#3)(1993-8#2)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#3)(1996-11#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#2)(2012-4#1)(2013-8#2)
in vasodilation##2##2##(1992-9#1)(2008-8#1)
in vast##2##2##(2008-2#1)(2012-12#1)
in vector##3##2##(2008-10#3)
in vegetable oils by##2##4##(2008-10#2)
in vegetable##7##2##(2008-10#7)
in vegetables and##2##3##(2008-10#1)(2008-7#1)
in vegetables by##2##3##(2008-10#2)
in vegetables is##2##3##(2008-10#2)
in vegetables##11##2##(2008-10#10)(2008-7#1)
in vegetation##2##2##(2008-10#1)(2013-8#1)
in vegetative compatibility##2##3##(2008-10#2)
in vegetative##7##2##(1997-3#1)(2008-10#3)(2008-5#1)(2012-8#1)(2013-8#1)
in vegetatively growing cells##2##4##(1993-6#1)(1997-6#1)
in veins##4##2##(1995-12#3)(2008-10#1)
in venous##10##2##(1990-5#2)(1996-3#2)(2008-1#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
in ventilation##2##2##(1992-12#1)(1996-2#1)
in ventilator##2##2##(2010-7#1)(2011-2#1)
in ventral##5##2##(1992-8#1)(1993-6#1)(1994-12#1)(2008-6#2)
in ventricular##2##2##(1992-6#1)(2008-7#1)
in verbal##3##2##(2007-8#1)(2008-7#1)(2008-9#1)
in vertebrae##3##2##(2007-8#3)
in vertebral body##2##3##(2007-11#1)(2007-8#1)
in vertebral##5##2##(1992-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-2#1)
in vertebrate and invertebrate##2##4##(1992-12#1)(2007-12#1)
in vertebrate evolution##2##3##(2008-8#1)(2011-2#1)
in vertebrate skeletal muscle##2##4##(1993-9#1)(2008-6#1)
in vertebrate##14##2##(1990-8#1)(1992-12#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)(2012-2#1)
in vertebrates and##2##3##(2008-1#1)(2009-7#1)
in vertebrates is##3##3##(1994-11#1)(2010-4#1)(2010-9#1)
in vertebrates##16##2##(1993-2#1)(1994-11#2)(1994-8#1)(1995-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-3#1)
in vertical##3##2##(1997-2#1)(2007-12#1)(2008-2#1)
in vertical-cavity surface-emitting lasers##6##4##(2007-11#5)(2007-12#1)
in vertical-cavity surface-emitting##7##3##(2007-11#5)(2007-12#2)
in very acid##2##3##(2008-10#2)
in very close proximity##2##4##(1993-11#1)(2008-10#1)
in very good agreement with the##2##6##(2008-9#1)(2011-2#1)
in very high##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
in very low##7##3##(1992-11#1)(1995-8#2)(1997-4#1)(2008-10#1)(2008-8#2)
in very low-density lipoprotein (VLDL)##2##5##(2008-10#1)(2008-7#1)
in very old age##3##4##(2008-7#3)
in very small##2##3##(2008-10#1)(2008-9#1)
in very young women##2##4##(1996-12#2)
in very young##5##3##(1995-3#1)(1996-12#2)(2008-11#1)(2008-9#1)
in very##37##2##(1992-10#1)(1992-11#1)(1993-11#1)(1995-3#1)(1995-8#2)(1996-12#2)(1997-4#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#5)(2008-8#3)(2008-9#3)(2010-12#1)(2011-2#2)
in vesicle transport and##2##4##(1993-9#1)(2008-11#1)
in vesicle##10##2##(1990-2#1)(1990-7#1)(1992-3#2)(1993-11#1)(1993-9#1)(1997-1#1)(2008-11#2)(2009-8#1)
in vesicles prepared from##2##4##(1991-5#1)(1994-6#1)
in vesicles##4##2##(1991-5#1)(1994-6#1)(1996-5#1)(2008-10#1)
in vesicular trafficking##4##3##(1996-5#1)(2009-10#2)(2009-7#1)
in vesicular##6##2##(1990-2#1)(1995-2#1)(1996-5#1)(2009-10#2)(2009-7#1)
in vessel walls##2##3##(1991-3#1)(2009-8#1)
in vessel##4##2##(1991-3#1)(2007-10#1)(2009-8#1)(2010-9#1)
in vessels##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
in vestibular##3##2##(1993-9#1)(2008-12#1)(2010-4#1)
in veterans##3##2##(2007-7#1)(2009-6#1)(2012-3#1)
in veterinary parasitology##5##3##(1997-7#2)(2008-8#3)
in veterinary practice##2##3##(1996-11#1)(1996-8#1)
in veterinary##14##2##(1990-9#1)(1996-11#1)(1996-8#1)(1997-7#2)(2008-10#1)(2008-8#3)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
in viability##6##2##(2008-10#2)(2008-11#2)(2009-4#1)(2012-3#1)
in viable cell number##3##4##(2008-11#3)
in viable##7##2##(2007-7#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)
in vibration##2##2##(2008-3#2)
in vibrational##2##2##(2008-3#1)(2008-8#1)
in video##2##2##(2008-6#1)(2012-2#1)
in view of a##2##4##(1991-3#1)(2008-7#1)
in view of its##3##4##(1990-12#1)(1990-5#1)(2008-11#1)
in view of realizing the amperometric ion-selective electrode##2##8##(2008-10#2)
in view of the fact that##2##6##(1997-1#1)(2008-10#1)
in view of the high##2##5##(2007-7#1)(2008-10#1)
in view of the##25##4##(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-7#2)(2009-8#1)(2012-2#1)(2013-1#1)
in view of their##3##4##(2008-5#1)(2008-7#1)(2010-12#1)
in view of##47##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#1)
in view##51##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
in villages##2##2##(2010-8#2)
in vinegar##3##2##(2008-10#3)
in vineyards##4##2##(2008-10#4)
in violation of the##2##4##(1993-3#1)(1994-2#1)
in violent##4##2##(1994-12#1)(1995-11#1)(2008-12#1)(2009-5#1)
in viral##14##2##(1990-5#1)(1991-5#1)(1994-11#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-5#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)
in virgin##3##2##(1992-9#1)(2007-12#1)(2008-5#1)
in virtual##3##2##(2008-6#1)(2009-3#1)(2012-3#1)
in virtually all##6##3##(1992-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)
in virtually every##2##3##(1996-12#1)(1997-1#1)
in virtually##9##2##(1992-3#1)(1993-11#1)(1996-12#2)(1997-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)
in virulence and##6##3##(1991-8#1)(2008-10#5)
in virulence of##4##3##(2008-10#4)
in virulence on##2##3##(2008-10#2)
in virulence were##3##3##(1991-8#1)(2008-10#2)
in virulence##30##2##(1991-8#3)(1995-2#1)(2008-10#25)(2012-2#1)
in virus replication##2##3##(1994-11#1)(2013-1#1)
in virus##16##2##(1992-6#1)(1994-11#1)(1994-8#3)(1995-2#1)(2008-10#4)(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
in virus-infected cells##2##3##(1995-2#1)(2009-11#1)
in virus-infected##4##2##(1995-2#1)(2008-10#2)(2009-11#1)
in viruses##2##2##(1995-9#1)(2008-10#1)
in visceral##6##2##(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
in visibly##2##2##(2008-10#2)
in vision##2##2##(2008-8#1)(2013-7#1)
in visual acuity##2##3##(2008-7#1)(2011-2#1)
in visual cortex##5##3##(1995-11#1)(2008-8#2)(2008-9#1)(2012-2#1)
in visual system##2##3##(2008-9#1)(2011-2#1)
in visual##23##2##(1994-8#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#3)(2012-2#3)(2012-3#1)
in visualizing##2##2##(2008-9#1)(2009-10#1)
in vital capacity##2##3##(2012-2#1)(2012-3#1)
in vital##3##2##(1996-1#1)(2012-2#1)(2012-3#1)
in vitamin A##2##3##(2011-1#1)(2012-1#1)
in vitamin C##2##3##(2008-10#1)(2011-1#1)
in vitamin D##3##3##(2008-4#1)(2011-1#1)(2013-1#1)
in vitamin##13##2##(1990-11#1)(1994-5#1)(2008-10#4)(2008-4#1)(2011-1#4)(2012-1#1)(2013-1#1)
in vitiligo was##2##3##(2013-1#2)
in vitreous humor##2##3##(2009-3#2)
in vitro AAA##2##3##(2009-7#2)
in vitro DNA##2##3##(1996-2#1)(2008-9#1)
in vitro RNA##3##3##(2008-10#1)(2008-7#2)
in vitro action##2##3##(2007-11#1)(2008-10#1)
in vitro activated T##2##4##(1990-12#1)(2008-9#1)
in vitro activation##4##3##(1996-2#1)(2008-7#1)(2008-9#2)
in vitro activities of##2##4##(1997-7#1)(2011-3#1)
in vitro activities##3##3##(1997-7#1)(2011-3#1)(2012-2#1)
in vitro activity against##4##4##(2007-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
in vitro activity and##2##4##(1993-1#1)(1995-3#1)
in vitro activity of##3##4##(1995-3#1)(2008-11#1)(2008-12#1)
in vitro activity##14##3##(1990-6#1)(1993-1#2)(1995-3#2)(1995-5#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
in vitro after##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
in vitro against a##2##4##(1994-5#1)(2008-5#1)
in vitro against##6##3##(1992-2#1)(1994-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
in vitro agar##2##3##(1995-2#1)(2008-10#1)
in vitro allergy reaction evaluation system using##2##7##(2008-11#2)
in vitro allergy reaction evaluation system##3##6##(2008-11#3)
in vitro and ex vivo effects of##2##7##(2008-10#1)(2008-11#1)
in vitro and ex vivo##7##5##(1991-8#1)(2008-10#1)(2008-11#4)(2008-9#1)
in vitro and following transplantation into the##2##7##(2008-7#1)(2012-12#1)
in vitro and in planta##5##5##(2008-10#4)(2009-12#1)
in vitro and in situ##3##5##(1996-12#1)(2008-10#2)
in vitro and in the rhizosphere##2##6##(2008-10#2)
in vitro and in the##5##5##(2008-10#2)(2008-11#2)(2008-3#1)
in vitro and in vivo activities##2##6##(1990-2#1)(1992-6#1)
in vitro and in vivo after##2##6##(2008-5#2)
in vitro and in vivo and##2##6##(1992-9#1)(2008-10#1)
in vitro and in vivo assays##3##6##(2008-10#2)(2008-11#1)
in vitro and in vivo by##2##6##(2008-10#1)(2008-11#1)
in vitro and in vivo data##3##6##(2008-10#1)(2008-3#1)(2008-5#1)
in vitro and in vivo determinations##2##6##(2008-5#2)
in vitro and in vivo evidence supporting##2##7##(2008-5#1)(2011-2#1)
in vitro and in vivo in##2##6##(1994-5#1)(1997-6#1)
in vitro and in vivo models##2##6##(2008-8#1)(2011-1#1)
in vitro and in vivo results##2##6##(1991-2#1)(2008-5#1)
in vitro and in vivo studies##4##6##(1992-11#1)(1996-12#1)(2008-5#1)(2011-2#1)
in vitro and in vivo study##3##6##(1993-1#2)(2013-1#1)
in vitro and in vivo were##2##6##(1996-5#1)(2008-9#1)
in vitro and in vivo##121##5##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#16)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#2)(2009-5#1)(2010-11#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
in vitro and in##142##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-8#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#8)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#17)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#3)(2009-5#1)(2010-11#3)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
in vitro and on the##2##5##(2008-10#1)(2008-5#1)
in vitro and on##5##4##(2008-10#3)(2008-5#2)
in vitro and that##2##4##(1994-5#1)(2008-10#1)
in vitro and their##2##4##(1994-6#1)(2008-4#1)
in vitro and whether##2##4##(1993-9#1)(1997-2#1)
in vitro and##210##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#2)(1996-12#4)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#14)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#20)(2008-7#6)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
in vitro antibody production##2##4##(2008-4#2)
in vitro antifungal activity of##2##5##(2008-5#1)(2010-5#1)
in vitro antifungal activity##4##4##(2008-10#1)(2008-5#1)(2010-5#2)
in vitro antifungal susceptibility##2##4##(2008-5#2)
in vitro antifungal##8##3##(2008-10#1)(2008-5#5)(2010-5#2)
in vitro antimicrobial activity of the##2##6##(2008-11#1)(2012-3#1)
in vitro antimicrobial activity of##3##5##(2008-11#1)(2008-5#1)(2012-3#1)
in vitro antimicrobial##5##3##(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
in vitro antioxidant activity and##2##5##(2008-10#1)(2008-5#1)
in vitro antioxidant activity##4##4##(2008-10#2)(2008-5#1)(2010-5#1)
in vitro antioxidant##5##3##(2008-10#2)(2008-5#1)(2010-5#1)(2011-1#1)
in vitro approaches##3##3##(2008-11#1)(2008-5#1)(2010-2#1)
in vitro are##4##3##(1997-4#1)(1997-6#2)(2008-4#1)
in vitro as well as##3##5##(1992-9#1)(2009-5#1)(2012-3#1)
in vitro as##6##3##(1991-6#1)(1992-9#1)(1995-2#1)(2008-3#1)(2009-5#1)(2012-3#1)
in vitro assay for##3##4##(1992-9#1)(1994-12#1)(2008-1#1)
in vitro assay systems##2##4##(2008-11#1)(2008-7#1)
in vitro assay##11##3##(1990-12#1)(1992-9#1)(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
in vitro assays##15##3##(1995-2#1)(1995-3#1)(1997-3#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-4#1)(2010-4#1)(2013-1#1)
in vitro assembled##3##3##(1993-8#2)(2008-1#1)
in vitro assessment##2##3##(2008-11#1)(2008-5#1)
in vitro based on the##2##5##(1997-6#1)(2013-8#1)
in vitro between##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
in vitro binding assay##2##4##(1995-6#1)(2008-9#1)
in vitro binding assays##3##4##(1993-12#1)(2008-10#1)(2010-5#1)
in vitro binding##7##3##(1991-11#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-9#1)(2010-5#2)
in vitro biological activity##3##4##(1993-8#1)(2008-8#2)
in vitro biological##4##3##(1993-8#1)(1993-9#1)(2008-8#2)
in vitro both##3##3##(1990-11#1)(1992-12#1)(1995-12#1)
in vitro but##2##3##(1992-9#1)(1995-11#1)
in vitro by a##2##4##(1992-12#1)(2008-1#1)
in vitro by the##2##4##(1991-9#1)(1994-8#1)
in vitro by using##2##4##(1991-3#1)(1997-7#1)
in vitro by##39##3##(1990-11#3)(1991-3#1)(1991-9#3)(1992-11#1)(1992-12#2)(1993-8#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-3#1)(2013-1#1)
in vitro can be##3##4##(1992-2#1)(1997-2#1)(2008-11#1)
in vitro can##4##3##(1992-12#1)(1992-2#1)(1997-2#1)(2008-11#1)
in vitro cell##3##3##(1992-2#1)(2008-11#1)(2008-9#1)
in vitro cellular##4##3##(1990-3#1)(1991-4#1)(2008-1#1)(2008-11#1)
in vitro closure time##3##4##(2011-1#3)
in vitro closure##5##3##(2011-1#5)
in vitro coculture system##2##4##(2008-11#2)
in vitro comparison##2##3##(2008-5#1)(2009-4#1)
in vitro conditions##5##3##(1993-2#1)(1996-5#1)(2008-11#1)(2008-5#1)(2011-1#1)
in vitro could##2##3##(1997-6#1)(2008-11#1)
in vitro crosses##2##3##(2008-10#2)
in vitro culture##10##3##(1995-3#2)(2006-6#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-11#1)(2009-6#1)(2013-1#1)
in vitro cultured##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
in vitro cytotoxic##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
in vitro cytotoxicity##2##3##(1995-3#2)
in vitro data##3##3##(1991-12#1)(1991-9#1)(2009-6#1)
in vitro determination of##2##4##(2008-10#1)(2008-5#1)
in vitro development of##3##4##(1996-2#1)(2008-11#2)
in vitro development##5##3##(1996-2#2)(2008-11#2)(2009-12#1)
in vitro differentiation of##4##4##(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
in vitro differentiation##5##3##(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#2)
in vitro dispersion time (approximately##2##5##(2010-3#2)
in vitro dispersion time##6##4##(2010-3#6)
in vitro dissolution##2##3##(2012-2#2)
in vitro drug release##8##4##(2010-3#4)(2010-5#2)(2011-1#1)(2012-2#1)
in vitro drug##9##3##(2010-3#4)(2010-5#2)(2011-1#2)(2012-2#1)
in vitro during##2##3##(2010-1#1)(2011-1#1)
in vitro effects of##5##4##(1995-12#2)(1997-1#1)(1997-4#1)(2011-1#1)
in vitro effects##8##3##(1995-12#2)(1995-5#2)(1997-1#1)(1997-4#1)(2008-10#1)(2011-1#1)
in vitro efficacy##3##3##(2008-5#3)
in vitro embryos##2##3##(2009-12#2)
in vitro evaluation of##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)
in vitro evidence of##2##4##(1993-11#1)(2008-10#1)
in vitro experiment##3##3##(1994-11#1)(1994-5#1)(1994-6#1)
in vitro experimental##3##3##(2008-5#2)(2012-3#1)
in vitro experiments with##2##4##(1993-12#1)(2007-10#1)
in vitro experiments##9##3##(1993-12#1)(1994-5#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-11#1)
in vitro exposure of##3##4##(1993-3#1)(2013-1#2)
in vitro expression##2##3##(2007-7#1)(2008-10#1)
in vitro fertilisation patients##2##4##(1992-9#2)
in vitro fertilisation##5##3##(1990-2#2)(1992-9#2)(1996-8#1)
in vitro fertilization and embryo transfer##2##6##(1996-9#1)(2013-1#1)
in vitro fertilization##17##3##(1991-11#1)(1993-1#1)(1994-9#1)(1995-6#4)(1996-9#1)(1997-2#1)(1997-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
in vitro findings##4##3##(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#1)
in vitro following##2##3##(1995-2#1)(2008-11#1)
in vitro for the##2##4##(1997-3#1)(2008-10#1)
in vitro for##12##3##(1991-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#2)
in vitro from a##2##4##(1994-11#1)(2008-11#1)
in vitro from the##2##4##(1990-11#1)(1992-11#1)
in vitro from##10##3##(1990-11#1)(1992-11#1)(1993-8#1)(1994-11#2)(2008-11#3)(2009-12#1)(2011-2#1)
in vitro germination of##2##4##(2008-10#2)
in vitro growth characteristics of##2##5##(1990-3#1)(1993-11#1)
in vitro growth of##5##4##(1992-8#2)(1993-8#1)(2008-10#2)
in vitro growth##9##3##(1990-3#1)(1992-8#2)(1993-11#1)(1993-8#1)(2008-10#4)
in vitro human##2##3##(2008-4#1)(2008-7#1)
in vitro immunization method##2##4##(2008-11#2)
in vitro immunization##11##3##(2008-11#11)
in vitro immunized PBMC##2##4##(2008-11#2)
in vitro immunized##4##3##(2008-11#4)
in vitro in a##2##4##(2008-4#1)(2012-2#1)
in vitro in rat##2##4##(1995-12#2)
in vitro in the presence of##2##6##(2008-4#1)(2012-2#1)
in vitro in the##4##4##(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
in vitro in##28##3##(1990-5#1)(1991-2#2)(1991-6#1)(1992-3#1)(1994-8#2)(1995-12#2)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-1#1)(2012-2#2)
in vitro infection of##2##4##(1996-12#1)(2008-9#1)
in vitro infection##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
in vitro inhibition of##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
in vitro inhibition##4##3##(1997-7#1)(2008-10#1)(2008-5#1)(2009-12#1)
in vitro invasion##3##3##(2008-11#2)(2008-8#1)
in vitro investigation##2##3##(2009-11#1)(2009-8#1)
in vitro investigations##2##3##(2008-4#1)(2008-5#1)
in vitro is a##2##4##(1990-5#1)(2008-7#1)
in vitro is##7##3##(1990-5#1)(1994-11#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
in vitro led##2##3##(1994-8#1)(1997-7#1)
in vitro long-term potentiation (LTP)##2##5##(2008-7#1)(2008-9#1)
in vitro maturation##2##3##(2013-1#2)
in vitro matured##2##3##(2008-11#1)(2013-1#1)
in vitro may##3##3##(1991-9#1)(1992-2#1)(1995-5#1)
in vitro metabolism of NNK##2##5##(1990-6#1)(1993-11#1)
in vitro method for##2##4##(1994-12#1)(2008-8#1)
in vitro method##3##3##(1994-12#1)(2008-5#1)(2008-8#1)
in vitro methods are##2##4##(2008-10#1)(2008-4#1)
in vitro methods were##2##4##(2008-10#1)(2008-5#1)
in vitro methods##12##3##(1995-11#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-8#1)(2012-12#1)
in vitro micronucleus assay##2##4##(2011-1#2)
in vitro model for the study of##2##7##(1994-9#1)(2008-9#1)
in vitro model for##4##4##(1994-9#1)(2008-11#2)(2008-9#1)
in vitro model of reconstructed##2##5##(2008-5#2)
in vitro model of##6##4##(1993-8#1)(1994-9#1)(2008-10#2)(2008-5#2)
in vitro model system##3##4##(1992-12#1)(2008-11#2)
in vitro model systems##2##4##(1997-6#1)(2008-5#1)
in vitro model##31##3##(1992-12#1)(1992-8#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-8#1)(1995-9#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#8)(2008-9#1)
in vitro models of##2##4##(1992-12#1)(2008-4#1)
in vitro models##14##3##(1992-12#1)(1994-9#1)(2008-11#1)(2008-4#2)(2008-5#5)(2008-7#2)(2011-1#1)(2012-1#1)
in vitro mycelial growth##2##4##(2008-10#2)
in vitro observations##2##3##(2013-1#1)(2013-8#1)
in vitro of##12##3##(1991-12#2)(1994-12#1)(1994-5#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
in vitro on the##2##4##(2008-11#1)(2008-5#1)
in vitro on##9##3##(1990-5#1)(1993-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)
in vitro or in vivo##4##5##(1992-6#1)(1992-9#1)(1997-4#1)(2008-11#1)
in vitro or in##5##4##(1992-6#1)(1992-9#1)(1997-4#1)(1997-7#1)(2008-11#1)
in vitro pathogen inhibitory activity##2##5##(2008-10#2)
in vitro permeation##2##3##(2008-10#1)(2008-5#1)
in vitro phosphorylation of the##2##5##(1995-6#1)(1997-2#1)
in vitro phosphorylation of##4##4##(1995-6#1)(1997-2#3)
in vitro phosphorylation##8##3##(1993-3#1)(1993-8#1)(1995-5#1)(1995-6#1)(1997-2#4)
in vitro porcine##2##3##(2008-2#1)(2008-5#1)
in vitro potency##2##3##(1990-12#1)(1995-3#1)
in vitro procedure##2##3##(2008-10#1)(2008-11#1)
in vitro production of##4##4##(1994-12#1)(1994-8#1)(2008-11#2)
in vitro proliferation of##2##4##(2008-11#2)
in vitro proliferation##3##3##(2008-11#3)
in vitro protein##2##3##(1995-11#1)(2011-2#1)
in vitro proton nuclear magnetic resonance##2##6##(2008-5#2)
in vitro reconstitution##3##3##(1995-2#1)(2008-4#1)(2009-9#1)
in vitro refolding of##2##4##(1995-8#1)(2009-3#1)
in vitro resistance to##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
in vitro screening##3##3##(1990-7#1)(2008-10#1)(2012-1#1)
in vitro selection using##2##4##(2008-4#2)
in vitro selection##11##3##(1990-8#1)(1997-6#1)(2008-11#1)(2008-4#5)(2010-5#1)(2012-12#1)(2013-8#1)
in vitro sepsis model##3##4##(2011-1#3)
in vitro showed that the##2##5##(1997-7#1)(2008-8#1)
in vitro skin##4##3##(2008-5#4)
in vitro studies have##2##4##(2009-11#1)(2013-1#1)
in vitro studies in##2##4##(1992-11#1)(2008-11#1)
in vitro studies of##2##4##(2008-10#1)(2008-11#1)
in vitro studies on##3##4##(1994-12#1)(2008-11#1)(2012-2#1)
in vitro studies##31##3##(1991-9#1)(1992-11#1)(1992-9#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-5#2)(2009-1#1)(2009-11#2)(2009-12#1)(2010-5#1)(2012-2#3)(2013-1#1)
in vitro study of the##2##5##(1990-5#1)(2012-1#1)
in vitro study of##5##4##(1990-5#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-8#1)
in vitro study##22##3##(1990-5#1)(1992-8#1)(1993-12#1)(1994-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#7)(2013-8#1)
in vitro susceptibility testing##2##4##(2011-2#2)
in vitro susceptibility##5##3##(2008-5#3)(2011-2#2)
in vitro synthesized##2##3##(1995-2#1)(2009-6#1)
in vitro system to study##2##5##(1990-3#1)(1996-2#1)
in vitro system to##6##4##(1990-3#1)(1993-3#1)(1994-6#1)(1996-2#1)(2008-11#1)(2013-8#1)
in vitro system##29##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-9#3)(1992-8#1)(1993-3#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-3#1)(1996-12#2)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-8#1)(2013-8#1)
in vitro systems for##2##4##(2008-10#1)(2008-11#1)
in vitro systems##8##3##(1991-9#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-3#1)
in vitro techniques##3##3##(1997-7#1)(2008-5#1)(2008-7#1)
in vitro test systems##2##4##(1991-12#1)(2008-10#1)
in vitro test using##2##4##(2008-5#2)
in vitro test##7##3##(1991-12#1)(2008-10#2)(2008-5#4)
in vitro tested##2##3##(1991-3#1)(2008-10#1)
in vitro testing of##2##4##(2008-5#2)
in vitro testing##7##3##(1994-2#1)(2008-5#3)(2008-8#1)(2009-7#1)(2011-2#1)
in vitro tests and##2##4##(2008-10#1)(2008-8#1)
in vitro tests##7##3##(2008-10#3)(2008-5#1)(2008-8#1)(2009-7#1)(2012-3#1)
in vitro the##3##3##(1995-12#1)(2008-5#1)(2008-9#1)
in vitro to##14##3##(1990-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-5#1)(2012-2#1)
in vitro transcribed mRNA sequence for protein D##2##8##(1992-8#2)
in vitro transcribed mRNA##3##4##(1992-8#2)(1993-8#1)
in vitro transcribed##4##3##(1992-8#3)(1993-8#1)
in vitro transcription of##3##4##(1990-12#1)(1991-12#1)(2008-9#1)
in vitro transcription##13##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-12#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#3)
in vitro transcription/translation##2##3##(1996-12#1)(1997-2#1)
in vitro transcripts of##3##4##(2008-10#3)
in vitro transcripts##8##3##(2008-10#7)(2008-9#1)
in vitro translation and##2##4##(1991-11#1)(2008-1#1)
in vitro translation of##4##4##(1995-2#1)(1995-6#1)(1997-3#1)(2008-9#1)
in vitro translation product##2##4##(2008-10#1)(2008-4#1)
in vitro translation##11##3##(1991-11#1)(1995-2#1)(1995-6#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-9#1)
in vitro transport##2##3##(2008-11#1)(2008-4#1)
in vitro treatment of##3##4##(1990-2#1)(1996-5#1)(2012-12#1)
in vitro treatment##5##3##(1990-2#1)(1996-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
in vitro using a##3##4##(1991-10#1)(1992-12#1)(2008-5#1)
in vitro using rabbit reticulocyte##2##5##(1990-11#1)(1994-8#1)
in vitro using the##2##4##(1994-12#1)(2008-10#1)
in vitro using##15##3##(1990-11#1)(1990-5#1)(1991-10#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(2008-10#1)(2008-5#1)(2009-10#1)(2012-12#1)(2013-1#1)
in vitro was measured##2##4##(1997-1#1)(2008-4#1)
in vitro was studied##3##4##(2008-10#1)(2010-3#1)(2011-3#1)
in vitro was##8##3##(1995-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-3#1)
in vitro were investigated##2##4##(1993-3#1)(2008-8#1)
in vitro were reduced##2##4##(2008-10#1)(2008-9#1)
in vitro were##10##3##(1992-11#1)(1993-11#1)(1993-3#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#2)
in vitro when##3##3##(1996-12#1)(1996-2#1)(2008-11#1)
in vitro with NF-kappa B##2##5##(1995-12#2)
in vitro with a##4##4##(1992-8#1)(1995-2#1)(1996-3#1)(2008-10#1)
in vitro with an##2##4##(1994-8#1)(2008-10#1)
in vitro with##20##3##(1991-2#1)(1992-8#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-3#1)
in vitro##1797##2##(1990-11#14)(1990-12#17)(1990-2#9)(1990-3#8)(1990-4#2)(1990-5#15)(1990-6#5)(1990-7#6)(1990-8#7)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#16)(1991-2#9)(1991-3#4)(1991-4#1)(1991-5#7)(1991-6#3)(1991-8#4)(1991-9#16)(1992-11#7)(1992-12#18)(1992-2#6)(1992-3#10)(1992-5#2)(1992-6#9)(1992-8#14)(1992-9#16)(1993-1#7)(1993-11#9)(1993-12#10)(1993-2#1)(1993-3#15)(1993-5#4)(1993-6#8)(1993-7#1)(1993-8#22)(1993-9#13)(1994-11#16)(1994-12#12)(1994-2#2)(1994-3#3)(1994-5#13)(1994-6#11)(1994-8#31)(1994-9#14)(1995-11#15)(1995-12#26)(1995-2#22)(1995-3#22)(1995-5#7)(1995-6#18)(1995-8#7)(1995-9#3)(1996-12#15)(1996-2#20)(1996-3#1)(1996-5#16)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#10)(1997-3#12)(1997-4#17)(1997-6#14)(1997-7#20)(1997-8#6)(2006-6#7)(2007-10#3)(2007-11#9)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#13)(2008-10#214)(2008-11#148)(2008-12#10)(2008-2#7)(2008-3#10)(2008-4#53)(2008-5#137)(2008-6#11)(2008-7#45)(2008-8#40)(2008-9#50)(2009-1#1)(2009-10#7)(2009-11#7)(2009-12#22)(2009-3#5)(2009-4#5)(2009-5#3)(2009-6#7)(2009-7#9)(2009-8#7)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#15)(2010-12#2)(2010-2#6)(2010-3#14)(2010-4#1)(2010-5#14)(2010-6#4)(2010-8#2)(2011-1#34)(2011-2#30)(2011-3#8)(2012-1#5)(2012-12#18)(2012-2#37)(2012-3#12)(2012-5#1)(2012-6#2)(2013-1#53)(2013-7#1)(2013-8#7)
in vitro)##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
in vitro-cultivated##2##2##(2008-10#1)(2008-9#1)
in vitro-transcribed##2##2##(1997-3#1)(2008-4#1)
in vitro/in##2##2##(2008-5#2)
in vitro]##10##2##(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#6)
in vivo DNA##2##3##(1990-5#1)(1991-9#1)
in vivo LTP##2##3##(2008-9#2)
in vivo SPF values##3##4##(2008-5#3)
in vivo a##2##3##(1997-3#1)(2007-11#1)
in vivo activity##7##3##(1990-8#1)(1992-6#1)(1993-1#1)(2007-11#1)(2008-7#3)
in vivo after##4##3##(1991-8#1)(2008-5#2)(2008-9#1)
in vivo analysis of##2##4##(1997-2#1)(2008-10#1)
in vivo analysis##3##3##(1997-2#1)(2008-10#1)(2009-12#1)
in vivo and clinical studies##2##5##(1993-6#1)(2009-11#1)
in vivo and in vitro as##2##6##(1991-6#1)(2012-3#1)
in vivo and in vitro effects##2##6##(1995-5#2)
in vivo and in vitro studies##6##6##(1991-9#1)(1992-11#1)(1994-8#1)(1995-9#1)(2009-1#1)(2010-5#1)
in vivo and in vitro##73##5##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
in vivo and in##74##4##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-5#2)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
in vivo and the##3##4##(1990-8#1)(2008-10#2)
in vivo and their##2##4##(2008-7#1)(2013-1#1)
in vivo and to##2##4##(2007-12#1)(2008-4#1)
in vivo and##104##3##(1990-11#2)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#2)(1994-8#4)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
in vivo application of##2##4##(2008-5#1)(2009-2#1)
in vivo applications##4##3##(1997-4#1)(2007-11#1)(2008-11#1)(2008-3#1)
in vivo approaches##2##3##(2008-10#1)(2010-2#1)
in vivo are##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
in vivo as##5##3##(1992-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(2008-4#1)
in vivo assay##8##3##(1990-5#1)(1991-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
in vivo assays are##2##4##(2008-10#2)
in vivo assays##9##3##(1995-3#1)(2008-10#6)(2008-11#1)(2011-2#1)
in vivo at##2##3##(1993-9#1)(1995-6#1)
in vivo behavior##2##3##(1990-8#2)
in vivo bioassay##2##3##(1991-6#1)(2008-11#1)
in vivo biological##2##3##(2008-9#1)(2011-1#1)
in vivo by a partial hepatectomy##2##6##(1990-12#1)(1994-6#1)
in vivo by a##5##4##(1990-12#1)(1994-6#1)(1995-3#1)(2007-12#1)(2008-10#1)
in vivo by directly##2##4##(1991-9#1)(1995-3#1)
in vivo by##16##3##(1990-12#1)(1991-9#1)(1994-6#1)(1994-8#1)(1995-3#2)(1996-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
in vivo can##2##3##(2008-7#1)(2011-1#1)
in vivo complement##2##3##(1991-9#1)(2008-4#1)
in vivo conditions##5##3##(1992-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-6#1)
in vivo confocal##2##3##(2008-2#1)(2008-3#1)
in vivo cytokine capture assay##2##5##(2008-4#2)
in vivo cytokine production##3##4##(2008-4#3)
in vivo cytokine secretion##2##4##(2008-4#2)
in vivo cytokine##7##3##(2008-4#7)
in vivo data##7##3##(1995-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
in vivo delivery##2##3##(1995-2#1)(2008-8#1)
in vivo detection##2##3##(1994-8#1)(2008-10#1)
in vivo determination of##2##4##(2008-10#2)
in vivo effects of lead on##2##6##(1995-3#2)
in vivo effects of##5##4##(1995-12#2)(1995-3#2)(2008-10#1)
in vivo effects##6##3##(1991-1#1)(1995-12#2)(1995-3#2)(2008-10#1)
in vivo efficacy in##2##4##(2008-5#1)(2012-2#1)
in vivo efficacy##5##3##(1995-3#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)
in vivo evaluation of##4##4##(1995-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
in vivo evaluation##5##3##(1995-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in vivo evaluations##2##3##(2008-11#1)(2010-11#1)
in vivo evidence for##2##4##(1992-10#1)(2012-12#1)
in vivo evidence that##3##4##(1994-11#1)(2008-10#1)(2008-11#1)
in vivo evidence##7##3##(1992-10#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
in vivo experimental##2##3##(2013-1#1)(2013-8#1)
in vivo experimentation##2##3##(2009-9#1)(2010-6#1)
in vivo experiments##8##3##(1993-8#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-5#2)(2010-11#1)(2010-2#1)
in vivo expression##3##3##(1990-8#1)(1994-12#1)(2008-7#1)
in vivo for##8##3##(1991-2#1)(1993-12#1)(1995-11#1)(1997-3#1)(1997-7#1)(2008-3#1)(2008-4#1)(2008-7#1)
in vivo from##2##3##(1993-8#1)(2007-12#1)
in vivo function of##5##4##(1996-2#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-2#1)
in vivo function##6##3##(1992-3#1)(1996-2#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-2#1)
in vivo gene delivery to##2##5##(1994-5#1)(2008-4#1)
in vivo gene transfer##3##4##(1994-5#3)
in vivo gene##7##3##(1994-12#1)(1994-5#5)(2008-4#1)
in vivo genotoxicity##4##3##(1996-12#2)(1996-2#2)
in vivo half-lives##2##3##(2008-4#1)(2013-1#1)
in vivo has##2##3##(2009-3#1)(2010-12#1)
in vivo have##3##3##(1995-9#1)(2009-5#1)(2010-11#1)
in vivo human skin##5##4##(2007-11#1)(2007-12#3)(2008-5#1)
in vivo human##6##3##(2007-11#1)(2007-12#3)(2008-5#1)(2013-1#1)
in vivo images##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
in vivo imaging##8##3##(2007-12#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-7#1)
in vivo immunization with##2##4##(2008-4#1)(2008-9#1)
in vivo immunization##4##3##(2008-4#3)(2008-9#1)
in vivo in mice##2##4##(1990-6#2)
in vivo in the hippocampal formation##2##6##(1996-2#1)(1997-6#1)
in vivo in the##3##4##(1996-2#1)(1997-6#1)(2006-6#1)
in vivo in##28##3##(1990-11#1)(1990-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-9#1)(2010-12#1)(2011-1#1)
in vivo induced##2##3##(1995-11#1)(2008-10#1)
in vivo is not##2##4##(1997-7#1)(2008-7#1)
in vivo is##12##3##(1992-10#1)(1994-11#2)(1997-7#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2012-12#2)
in vivo kinetics of the##2##5##(1992-12#1)(2010-6#1)
in vivo levels of##2##4##(1997-7#1)(2008-9#1)
in vivo measurements##2##3##(2008-2#1)(2011-1#1)
in vivo methods##4##3##(2008-10#3)(2008-5#1)
in vivo microdialysis##9##3##(1992-7#1)(1994-8#1)(1995-12#2)(1995-3#1)(1997-2#1)(1997-6#1)(2008-10#2)
in vivo model of##3##4##(1991-5#1)(1996-5#1)(2009-12#1)
in vivo model##5##3##(1991-5#1)(1996-2#1)(1996-5#1)(2008-10#1)(2009-12#1)
in vivo models##5##3##(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
in vivo monitoring of diffusible##2##5##(2008-10#2)
in vivo monitoring of##3##4##(1991-5#1)(2008-10#2)
in vivo of##2##3##(1995-5#1)(1996-12#1)
in vivo on##2##3##(1990-2#1)(2008-5#1)
in vivo optical##2##3##(2007-11#2)
in vivo or in vitro##5##5##(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2011-1#1)
in vivo or in##7##4##(1990-8#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#2)(2011-1#1)
in vivo or##9##3##(1990-8#1)(1992-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#2)(2010-11#1)(2011-1#1)
in vivo performance##3##3##(2008-5#1)(2012-2#2)
in vivo pharmacokinetics##2##3##(1997-4#2)
in vivo processing##2##3##(1991-12#1)(1997-1#1)
in vivo recombination##4##3##(1990-11#1)(1990-5#1)(2008-11#2)
in vivo regulation of##2##4##(1992-8#1)(2011-1#1)
in vivo results##4##3##(1991-2#1)(1992-11#1)(2008-5#1)(2012-12#1)
in vivo retinal##2##3##(2008-3#1)(2011-7#1)
in vivo screening##2##3##(2008-10#1)(2013-1#1)
in vivo situation##2##3##(2008-5#2)
in vivo skin##3##3##(2007-12#1)(2008-5#1)(2009-6#1)
in vivo studies demonstrate that##2##5##(2008-9#1)(2013-1#1)
in vivo studies of##2##4##(1996-12#1)(2010-7#1)
in vivo studies##16##3##(1992-11#1)(1993-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
in vivo study with##3##4##(1995-12#1)(2008-5#2)
in vivo study##14##3##(1990-5#1)(1993-1#2)(1995-12#1)(2008-5#4)(2008-8#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
in vivo system##5##3##(1995-2#1)(1996-12#2)(2008-11#1)(2009-3#1)
in vivo test##2##3##(2008-5#1)(2009-7#1)
in vivo testing##5##3##(2008-10#1)(2008-5#2)(2009-10#1)(2012-2#1)
in vivo tests##4##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)
in vivo that##3##3##(1994-2#1)(1994-5#1)(2012-2#1)
in vivo the##4##3##(1994-11#1)(2006-6#1)(2008-5#2)
in vivo to the##3##4##(1994-8#1)(2009-5#1)(2011-2#1)
in vivo to##13##3##(1990-5#2)(1991-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#2)(2009-5#1)(2011-2#1)
in vivo transfection##2##3##(1995-2#2)
in vivo treatment of##2##4##(1992-9#1)(1997-7#1)
in vivo treatment##4##3##(1992-9#1)(1997-1#1)(1997-7#1)(2009-9#1)
in vivo tumor growth##2##4##(1991-9#2)
in vivo tumor##5##3##(1991-4#1)(1991-9#2)(2011-2#1)(2012-3#1)
in vivo using a##2##4##(2008-5#1)(2012-2#1)
in vivo using an##2##4##(2010-6#1)(2012-12#1)
in vivo using##12##3##(1993-9#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
in vivo was##3##3##(1995-12#1)(1995-5#1)(2008-9#1)
in vivo were##3##3##(1996-5#1)(2008-9#1)(2010-8#1)
in vivo with the##2##4##(1993-9#1)(1995-5#1)
in vivo with##12##3##(1991-1#1)(1991-12#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(2008-2#3)(2008-5#1)(2008-8#1)
in vivo would##2##3##(1991-5#1)(2008-5#1)
in vivo##1158##2##(1990-11#13)(1990-12#5)(1990-2#4)(1990-4#2)(1990-5#11)(1990-6#3)(1990-7#3)(1990-8#8)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#5)(1991-4#3)(1991-5#13)(1991-6#3)(1991-8#4)(1991-9#15)(1992-10#3)(1992-11#9)(1992-12#10)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#6)(1993-1#4)(1993-11#6)(1993-12#6)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#4)(1993-8#11)(1993-9#8)(1994-11#12)(1994-12#10)(1994-2#5)(1994-3#5)(1994-5#19)(1994-6#7)(1994-8#14)(1994-9#5)(1995-10#1)(1995-11#14)(1995-12#24)(1995-2#24)(1995-3#19)(1995-5#11)(1995-6#9)(1995-8#2)(1995-9#3)(1996-12#13)(1996-2#15)(1996-5#12)(1996-8#1)(1997-1#2)(1997-2#8)(1997-3#8)(1997-4#13)(1997-6#5)(1997-7#10)(1997-8#4)(2006-12#2)(2006-6#7)(2007-11#15)(2007-12#11)(2007-7#1)(2007-8#3)(2008-1#8)(2008-10#68)(2008-11#55)(2008-12#3)(2008-2#20)(2008-3#27)(2008-4#43)(2008-5#89)(2008-6#7)(2008-7#41)(2008-8#15)(2008-9#33)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#20)(2009-2#3)(2009-3#6)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#1)(2009-9#5)(2010-1#5)(2010-10#1)(2010-11#15)(2010-12#2)(2010-2#6)(2010-3#1)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#20)(2011-2#21)(2011-3#1)(2011-7#2)(2012-12#17)(2012-2#28)(2012-3#8)(2013-1#30)(2013-7#3)(2013-8#3)
in vivo&quot##2##2##(1991-12#1)(2008-1#1)
in vocal dialects##2##3##(2009-9#2)
in vocal##4##2##(2008-6#1)(2008-9#1)(2009-9#2)
in vocational##2##2##(2008-11#1)(2010-1#1)
in vol##18##2##(2008-11#3)(2008-6#1)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in voltage-biased##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
in voltammetric##4##2##(2008-10#4)
in voltammetry##3##2##(2008-10#3)
in volume holographic##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
in volume##17##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
in volumetric##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
in volunteer administration##3##3##(1992-1#1)(1994-3#1)(1996-12#1)
in volunteer##8##2##(1992-1#1)(1993-1#1)(1994-3#1)(1996-12#1)(1996-3#2)(2008-10#2)
in volunteers##3##2##(1995-11#1)(2007-10#1)(2008-10#1)
in von##2##2##(2012-2#1)(2013-7#1)
in vulnerable##2##2##(2012-2#2)
in walk-off-compensated##2##2##(2007-12#2)
in walking##7##2##(1990-6#1)(2007-11#1)(2007-12#2)(2008-7#3)
in wall thickness##2##3##(2009-1#1)(2011-2#1)
in walls of##2##3##(2008-10#2)
in war and peace##2##4##(2007-7#1)(2008-10#1)
in ward##2##2##(2011-1#1)(2013-8#1)
in warm##4##2##(2008-10#2)(2012-12#2)
in warmer locations##2##3##(2008-10#2)
in wartime##2##2##(2007-7#1)(2011-2#1)
in washed platelets##2##3##(1991-12#1)(2008-7#1)
in washed##4##2##(1991-12#2)(2008-10#1)(2008-7#1)
in washing powder##2##3##(2008-10#2)
in washing##3##2##(2008-10#3)
in waste water and##3##4##(2008-10#3)
in waste water##8##3##(2008-10#8)
in waste waters##2##3##(2008-10#2)
in waste##13##2##(1996-1#1)(2008-10#12)
in waste-water##3##2##(2008-10#3)
in wastewater by##2##3##(2008-10#2)
in wastewater effluents##2##3##(2008-10#2)
in wastewater from an##2##4##(2008-10#2)
in wastewater from##4##3##(2008-10#4)
in wastewater samples##7##3##(2008-10#7)
in wastewater treatment##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
in wastewater with##2##3##(2008-10#2)
in wastewater##31##2##(2008-10#29)(2008-7#1)(2009-4#1)
in wastewaters##4##2##(2008-10#4)
in water (w) were determined potentiometrically at 25 degrees C##2##10##(2008-10#2)
in water after preconcentration##2##4##(2008-10#2)
in water after##5##3##(2008-10#5)
in water analysis##4##3##(2008-10#4)
in water and air by##2##5##(2008-10#2)
in water and air##5##4##(2008-10#4)(2008-3#1)
in water and biological samples by graphite furnace atomic##2##9##(2008-10#2)
in water and fruit juice##3##5##(2008-10#3)
in water and in##6##4##(1992-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
in water and sediment##2##4##(2008-10#2)
in water and sewage samples##2##5##(2008-10#2)
in water and the##2##4##(2008-10#2)
in water and vegetable samples##2##5##(2008-10#2)
in water and##53##3##(1992-12#1)(1994-12#1)(1995-3#1)(2008-10#44)(2008-3#4)(2011-2#1)(2013-8#1)
in water are##2##3##(2008-10#2)
in water as##7##3##(1991-6#1)(1995-3#1)(2008-10#4)(2008-3#1)
in water at##7##3##(1992-9#1)(1997-2#1)(2008-10#4)(2008-3#1)
in water by ICP-AES##3##4##(2008-10#3)
in water by##19##3##(2008-10#17)(2008-3#1)(2013-8#1)
in water can be##3##4##(2008-10#2)(2010-5#1)
in water can##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
in water containing##3##3##(2008-10#2)(2008-9#1)
in water for the##2##4##(2008-10#2)
in water for##3##3##(2008-10#2)(2008-12#1)
in water has been developed##2##5##(2008-10#2)
in water has been##4##4##(2008-10#4)
in water is reported##2##4##(2008-10#1)(2008-3#1)
in water is##8##3##(1995-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-7#1)
in water of##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
in water or in##2##4##(2008-10#2)
in water or##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
in water phase##4##3##(2008-10#2)(2013-8#2)
in water sample##2##3##(2008-10#2)
in water samples after cloud point extraction##2##7##(2008-10#2)
in water samples after##4##4##(2008-10#4)
in water samples and##4##4##(2008-10#4)
in water samples by flame##2##5##(2008-10#2)
in water samples by solid-phase microextraction coupled with##2##8##(2008-10#2)
in water samples by using a##2##6##(2008-10#2)
in water samples by using##3##5##(2008-10#3)
in water samples by##17##4##(2008-10#17)
in water samples digested##2##4##(2008-10#2)
in water samples in##2##4##(2008-10#2)
in water samples is described##3##5##(2008-10#3)
in water samples is##7##4##(2008-10#7)
in water samples on##2##4##(2008-10#2)
in water samples using##6##4##(2008-10#6)
in water samples was developed##3##5##(2008-10#3)
in water samples was performed##2##5##(2008-10#2)
in water samples was##8##4##(2008-10#8)
in water samples were##2##4##(2008-10#2)
in water samples with a##4##5##(2008-10#4)
in water samples with satisfactory results##4##6##(2008-10#4)
in water samples with##8##4##(2008-10#8)
in water samples##132##3##(2008-10#130)(2012-2#1)(2013-8#1)
in water solution were##2##4##(1991-5#1)(2008-3#1)
in water solution##6##3##(1991-5#1)(1995-2#1)(2008-10#2)(2008-3#2)
in water solutions##3##3##(2008-10#3)
in water striders##2##3##(2008-9#1)(2012-3#1)
in water to##3##3##(2008-10#3)
in water using##8##3##(2008-10#6)(2008-3#1)(2012-1#1)
in water was##5##3##(2008-10#4)(2012-2#1)
in water were##10##3##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)
in water with##7##3##(2008-10#6)(2008-5#1)
in water without##3##3##(2008-10#2)(2010-2#1)
in water##473##2##(1991-12#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2008-10#352)(2008-11#2)(2008-12#3)(2008-2#9)(2008-3#20)(2008-5#12)(2008-7#3)(2008-9#5)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#2)(2013-1#1)(2013-7#1)(2013-8#7)
in water)##3##2##(2008-10#1)(2010-3#1)(2011-1#1)
in water-ethanol##2##2##(2008-10#1)(2008-3#1)
in water-organic solvent mixtures##2##4##(2008-10#2)
in water-soluble organic##2##3##(2008-10#2)
in water-soluble##3##2##(2008-10#3)
in water-vapor##2##2##(2008-2#1)(2008-3#1)
in watermelon##2##2##(2008-10#2)
in waters after##2##3##(2008-10#2)
in waters and##3##3##(2008-10#3)
in waters by##7##3##(2008-10#7)
in waters of the Okavango Delta##2##6##(2008-10#2)
in waters using a##2##4##(2008-10#2)
in waters using##4##3##(2008-10#4)
in waters with##4##3##(2008-10#2)(2008-2#1)(2010-8#1)
in waters##34##2##(2008-10#32)(2008-2#1)(2010-8#1)
in wave 1##2##3##(2011-2#2)
in wave 2##3##3##(2011-2#3)
in wave mechanics##2##3##(2009-9#2)
in wave##8##2##(2008-2#1)(2009-9#2)(2011-2#5)
in waveguide##2##2##(2007-11#2)
in wavelength for##2##3##(2007-12#1)(2008-3#1)
in wavelength##9##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#4)
in wavelength-division multiplexing##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
in wavelength-division##7##2##(2007-11#2)(2007-12#3)(2008-3#2)
in waves##2##2##(2008-2#1)(2011-2#1)
in ways that are not##2##5##(1990-7#1)(1995-5#1)
in ways that are##4##4##(1990-7#1)(1995-5#1)(1997-7#1)(2012-2#1)
in ways that can##2##4##(2010-3#1)(2013-1#1)
in ways that cannot be##2##5##(2013-1#2)
in ways that##19##3##(1990-7#1)(1992-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
in ways##21##2##(1990-7#1)(1992-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
in weak##5##2##(2008-10#5)
in weakly##3##2##(2007-12#1)(2008-2#2)
in weaned##2##2##(1996-12#2)
in weaning##2##2##(1997-4#1)(2013-1#1)
in weanling rats##2##3##(1992-11#1)(2012-1#1)
in weanling##3##2##(1991-5#1)(1992-11#1)(2012-1#1)
in weed habitats##2##3##(2008-10#2)
in weed hosts##2##3##(2008-10#2)
in weed##4##2##(2008-10#4)
in weeds##2##2##(2008-10#2)
in weekly##2##2##(2011-2#2)
in weight gain##2##3##(1991-2#1)(1993-2#1)
in weight loss##2##3##(2008-5#1)(2008-7#1)
in weight management##2##3##(2008-10#1)(2012-2#1)
in weight of the##2##4##(1995-3#1)(2013-7#1)
in weight##24##2##(1990-11#1)(1991-2#3)(1992-12#1)(1993-2#1)(1995-3#1)(1996-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#3)(2013-8#1)
in weights##2##2##(2008-12#1)(2010-8#1)
in well##2##2##(1995-11#1)(2008-10#1)
in well-characterized hydrogen-air flames operated over a wide range of equivalence ratios##2##12##(2008-3#2)
in well-characterized##3##2##(2008-3#3)
in west of##2##3##(1997-8#1)(2009-6#1)
in west##5##2##(1997-8#1)(2008-10#2)(2008-6#1)(2009-6#1)
in western Canada##6##3##(1994-3#1)(2008-10#5)
in western Germany##3##3##(1992-1#1)(2008-11#1)(2013-1#1)
in western Kenya##2##3##(2008-10#1)(2012-12#1)
in western North America##2##4##(2008-10#2)
in western countries##6##3##(1990-3#1)(1992-9#1)(2007-10#1)(2009-2#3)
in western societies##2##3##(1995-11#1)(1996-11#1)
in western white pine (Pinus monticola)##3##6##(2008-10#3)
in western white pine##4##4##(2008-10#4)
in western##44##2##(1990-3#1)(1992-1#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-11#2)(1996-8#1)(2007-10#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#3)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
in wet##4##2##(1996-12#1)(2008-5#1)(2010-4#1)(2013-1#1)
in what is##7##3##(1992-6#1)(1997-1#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
in what##18##2##(1992-6#1)(1994-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#1)
in wheat (Triticum aestivum L##2##5##(2008-11#1)(2008-12#1)
in wheat and##3##3##(2008-10#3)
in wheat breeding programs##2##4##(2008-10#2)
in wheat cultivars##3##3##(2008-10#1)(2008-12#2)
in wheat farming##2##3##(2008-12#2)
in wheat fields##2##3##(2008-10#2)
in wheat flour by electrothermal atomic absorption spectrometry##2##8##(2008-10#2)
in wheat flour##7##3##(2008-10#7)
in wheat have been##2##4##(2008-10#1)(2011-2#1)
in wheat production##2##3##(2008-12#2)
in wheat to##3##3##(2008-10#1)(2011-2#2)
in wheat##67##2##(1992-3#1)(2008-10#45)(2008-11#1)(2008-12#9)(2008-5#1)(2008-8#2)(2008-9#1)(2011-10#1)(2011-2#6)
in where##4##2##(1991-3#1)(2008-10#1)(2012-1#1)(2013-8#1)
in whether##2##2##(1994-2#1)(2008-12#1)
in which 3##2##3##(2011-2#1)(2013-8#1)
in which B##2##3##(2008-10#1)(2008-4#1)
in which DNA##3##3##(1994-10#1)(1997-4#1)(2008-10#1)
in which HIV##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
in which I##4##3##(1995-2#1)(1995-8#1)(2008-11#1)(2013-8#1)
in which Leu##2##3##(1991-9#1)(1993-3#1)
in which Medicare##2##3##(1997-3#1)(2008-7#1)
in which NO is##2##4##(2008-10#1)(2011-2#1)
in which a carrier##2##4##(2008-10#1)(2008-2#1)
in which a chemical##3##4##(2008-5#3)
in which a product##2##4##(1991-9#1)(2008-5#1)
in which a radical serves as a hydrogen bond##2##9##(2010-7#2)
in which a single##4##4##(1990-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
in which a small##2##4##(2010-3#1)(2010-4#1)
in which a subject##3##4##(2008-4#1)(2010-8#1)(2012-3#1)
in which a##105##3##(1990-5#2)(1990-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-11#6)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#2)(2009-6#1)(2010-3#3)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
in which all the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
in which all##14##3##(1990-8#1)(1992-3#1)(1995-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#3)(2010-2#1)(2010-5#1)
in which alternating##2##3##(1995-6#1)(2008-7#1)
in which an internal##2##4##(1993-12#1)(2012-12#1)
in which an##29##3##(1990-11#1)(1990-7#1)(1990-8#2)(1991-12#1)(1993-12#1)(1996-11#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2009-9#1)(2010-11#1)(2011-2#2)(2011-8#1)(2012-12#1)(2013-1#2)
in which both the##5##4##(1995-6#1)(2007-12#1)(2008-10#2)(2011-2#1)
in which both##16##3##(1995-2#1)(1995-6#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)
in which cancer##2##3##(2009-11#1)(2013-1#1)
in which case##7##3##(1991-6#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2012-12#1)
in which cell proliferation##2##4##(2008-7#1)(2009-5#1)
in which changes##3##3##(1994-3#1)(2008-11#1)(2008-2#1)
in which chloride##2##3##(1994-5#1)(2008-10#1)
in which clinical##2##3##(1990-10#1)(2008-4#1)
in which complex##2##3##(1996-12#1)(2008-3#1)
in which conditions##2##3##(2008-10#1)(2008-3#1)
in which control##2##3##(1997-4#1)(2009-6#1)
in which data##3##3##(2008-3#1)(2009-11#1)(2012-12#1)
in which defects in##2##4##(2008-10#1)(2013-1#1)
in which different##6##3##(1997-7#1)(2008-2#2)(2008-8#2)(2011-2#1)
in which direct##2##3##(1994-5#1)(2008-10#1)
in which disease##4##3##(1997-3#1)(2008-10#2)(2008-9#1)
in which distraction##2##3##(2007-12#1)(2009-11#1)
in which each chip##2##4##(2008-3#2)
in which each of the##2##5##(1995-3#1)(2008-2#1)
in which each of##3##4##(1995-3#1)(2007-12#1)(2008-2#1)
in which each##14##3##(1995-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#1)
in which early successional species are able to persist##2##9##(2008-9#2)
in which either##5##3##(1994-6#1)(2008-8#2)(2010-3#1)(2011-2#1)
in which experimental##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
in which females##2##3##(2008-8#2)
in which femtosecond##2##3##(2007-11#1)(2007-12#1)
in which four##5##3##(1991-2#1)(1991-7#1)(2007-8#1)(2008-1#1)(2008-7#1)
in which hard rock and rap music were##2##8##(1993-1#2)
in which he##2##3##(1996-2#1)(2009-10#1)
in which hospital##2##3##(1991-2#1)(1994-3#1)
in which human##2##3##(2008-4#1)(2008-5#1)
in which in-line##2##3##(2008-10#2)
in which individual##2##3##(2008-7#1)(2008-9#1)
in which individuals have##2##4##(1993-12#1)(2008-9#1)
in which individuals##4##3##(1993-12#1)(1995-2#1)(2008-9#1)(2009-8#1)
in which insurers##2##3##(1994-12#1)(1995-6#1)
in which it can##3##4##(1994-3#1)(2008-8#1)(2012-3#1)
in which it is##7##4##(2008-10#1)(2008-4#2)(2011-1#2)(2012-12#1)(2013-8#1)
in which it was##2##4##(1995-3#1)(2010-8#1)
in which it##14##3##(1994-3#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
in which light##2##3##(2008-2#2)
in which loss of##2##4##(2008-3#1)(2009-5#1)
in which medicine##2##3##(2008-12#1)(2013-8#1)
in which molecular##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2012-12#1)
in which more than##3##4##(2008-10#1)(2011-2#1)(2011-3#1)
in which more##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)
in which most of the##2##5##(2008-11#1)(2011-1#1)
in which multiple##4##3##(2008-10#1)(2008-8#2)(2009-12#1)
in which new##2##3##(2008-1#1)(2008-2#1)
in which no##4##3##(1992-5#1)(1993-2#1)(2008-10#2)
in which normal##2##3##(2008-11#1)(2009-3#1)
in which one of the##2##5##(1991-9#1)(1997-3#1)
in which one##13##3##(1991-9#1)(1994-6#1)(1996-3#1)(1997-3#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)
in which only a##2##4##(2008-10#1)(2008-3#1)
in which only##7##3##(1991-4#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
in which parents##2##3##(1992-11#1)(2010-10#1)
in which participants discussed##2##4##(1994-7#1)(2008-6#1)
in which participants were##3##4##(2008-4#1)(2009-5#1)(2009-9#1)
in which participants##8##3##(1994-7#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-5#1)(2009-9#1)
in which patients##6##3##(1993-3#1)(1996-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-3#1)
in which pseudosclerotia##2##3##(2008-10#2)
in which public##2##3##(1996-3#1)(2008-12#1)
in which random##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
in which residues##2##3##(1994-5#1)(2008-10#1)
in which respondents##2##3##(2009-12#1)(2012-2#1)
in which root tissue included the soluble components##2##8##(2008-10#2)
in which samples are##3##4##(2008-10#1)(2008-4#2)
in which several##4##3##(1996-5#1)(2007-10#1)(2008-10#1)(2008-8#1)
in which signals##2##3##(2008-11#1)(2008-2#1)
in which significant##2##3##(2008-10#1)(2010-12#1)
in which single-mode##2##3##(2007-12#1)(2008-3#1)
in which small##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
in which some##2##3##(2008-8#1)(2009-10#1)
in which spatial##2##3##(2008-9#1)(2010-10#1)
in which strong##2##3##(2008-10#1)(2008-8#1)
in which students##4##3##(1996-1#1)(2008-11#2)(2012-1#1)
in which such##2##3##(2007-11#1)(2007-12#1)
in which symptoms were##2##4##(2008-1#1)(2008-10#1)
in which the C=C mode##2##5##(2007-1#2)
in which the N-terminal##2##4##(1991-10#1)(1997-2#1)
in which the alternative##2##4##(1995-12#1)(2009-8#1)
in which the analyte##2##4##(2008-10#2)
in which the animal##2##4##(2007-12#1)(2008-5#1)
in which the animals##2##4##(1994-3#1)(2008-8#1)
in which the carbonyl stretching frequencies are##2##7##(1995-5#2)
in which the cavity##2##4##(2007-12#1)(2008-3#1)
in which the cells##2##4##(1997-3#1)(2008-5#1)
in which the composition of##2##5##(1994-2#1)(2008-3#1)
in which the composition##3##4##(1994-2#1)(2008-10#1)(2008-3#1)
in which the crucial##2##4##(1992-3#1)(2013-8#1)
in which the effect of##2##5##(2011-2#1)(2012-1#1)
in which the energy of the optical field can be efficiently stored##2##12##(2007-11#2)
in which the enzyme##3##4##(1992-8#1)(1993-8#1)(2008-10#1)
in which the expression of the##2##6##(1997-6#1)(2013-1#1)
in which the expression##3##4##(1997-6#1)(2011-2#1)(2013-1#1)
in which the fibrils are##2##5##(1993-2#2)
in which the first##4##4##(1997-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
in which the gain##2##4##(2007-12#1)(2008-3#1)
in which the gene##2##4##(1996-2#1)(2008-4#1)
in which the hologram of a microscopic object##2##8##(2008-3#2)
in which the host##3##4##(2008-11#1)(2008-8#2)
in which the level of##3##5##(1990-12#1)(1996-3#1)(2008-10#1)
in which the maximum##2##4##(1993-8#1)(2008-10#1)
in which the microscopic##2##4##(2008-11#1)(2008-5#1)
in which the molecular##2##4##(2007-12#1)(2008-11#1)
in which the normal##2##4##(2008-2#1)(2008-4#1)
in which the nuclear envelope##2##5##(2011-2#2)
in which the object is##2##5##(2008-2#1)(2008-3#1)
in which the objective is##2##5##(2008-10#2)
in which the only##3##4##(1994-12#1)(1997-7#1)(2008-10#1)
in which the pathogen##2##4##(2008-10#2)
in which the patient did not##2##6##(2010-8#1)(2011-2#1)
in which the patient had##2##5##(1991-1#1)(2012-2#1)
in which the patient##5##4##(1991-1#1)(2010-8#1)(2011-2#2)(2012-2#1)
in which the presence of##2##5##(2007-7#1)(2008-8#1)
in which the presence##3##4##(2007-7#1)(2008-5#1)(2008-8#1)
in which the ratio##2##4##(1993-6#1)(2007-10#1)
in which the receiver is##2##5##(2008-2#2)
in which the refractive index is##2##6##(2007-11#1)(2008-2#1)
in which the refractive##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
in which the research##2##4##(1992-1#2)
in which the response##2##4##(2011-2#1)(2012-12#1)
in which the same##4##4##(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
in which the sample##3##4##(1992-12#1)(2008-10#2)
in which the second##3##4##(1995-6#1)(2008-3#1)(2009-4#1)
in which the sequence##2##4##(1993-11#1)(2007-12#1)
in which the set of##2##5##(2008-11#1)(2008-2#1)
in which the signal##2##4##(2008-2#1)(2008-3#1)
in which the spin##3##4##(1993-8#1)(2008-7#2)
in which the target##3##4##(2008-3#1)(2008-4#1)(2011-1#1)
in which the thickness##2##4##(2007-11#1)(2008-5#1)
in which the three##3##4##(2008-10#2)(2009-2#1)
in which the two##4##4##(2007-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
in which the use of##2##5##(2008-10#1)(2013-8#1)
in which the wild-type##2##4##(1994-8#1)(2008-7#1)
in which the##492##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#2)(1992-8#3)(1993-1#1)(1993-11#4)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#5)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#6)(1995-6#3)(1995-8#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#5)(1997-6#3)(1997-7#5)(1997-8#3)(2007-1#2)(2007-10#1)(2007-11#21)(2007-12#18)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#72)(2008-11#16)(2008-2#28)(2008-3#48)(2008-4#11)(2008-5#15)(2008-6#3)(2008-7#14)(2008-8#14)(2008-9#7)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#2)(2011-2#17)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#11)(2013-8#5)
in which their##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
in which there is a##3##5##(1995-2#1)(1997-3#1)(2007-12#1)
in which there is##11##4##(1990-3#1)(1995-2#2)(1997-3#1)(2007-12#2)(2008-6#1)(2008-8#2)(2009-8#1)(2012-12#1)
in which there##14##3##(1990-3#1)(1992-6#1)(1993-6#1)(1995-2#2)(1997-3#1)(2007-12#2)(2008-6#1)(2008-8#2)(2009-8#1)(2012-12#1)(2012-2#1)
in which these##9##3##(1990-6#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)
in which they are##2##4##(2008-8#1)(2010-5#1)
in which they practice##2##4##(1994-1#1)(2008-11#1)
in which they were##7##4##(1994-3#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)
in which they will##2##4##(1996-3#2)
in which they##36##3##(1991-12#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#3)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#3)(2009-10#1)(2009-5#2)(2010-11#1)(2010-5#2)(2011-2#4)(2012-2#2)
in which this##9##3##(1993-10#1)(1994-7#1)(1995-2#1)(1996-8#1)(2008-10#2)(2010-5#1)(2011-1#1)(2013-1#1)
in which three##4##3##(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
in which to study the##3##5##(1994-8#1)(1995-2#1)(1997-3#1)
in which to study##5##4##(1994-8#1)(1995-2#1)(1997-3#1)(2008-2#1)(2008-4#1)
in which to##19##3##(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#2)
in which treatment##2##3##(2008-6#1)(2009-11#1)
in which treatments##2##3##(1997-4#1)(2008-10#1)
in which two different##2##4##(1997-7#1)(2008-3#1)
in which two or more##2##5##(2008-10#1)(2010-12#1)
in which two##12##3##(1992-9#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
in which we have##2##4##(1991-12#1)(2012-3#1)
in which we identified##2##4##(1997-2#1)(2010-11#1)
in which we live##2##4##(2008-1#2)
in which we use##2##4##(2007-11#1)(2008-7#1)
in which we##21##3##(1991-12#1)(1994-2#1)(1995-9#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-9#1)(2012-2#1)(2012-3#2)
in which wheat##2##3##(2008-10#2)
in which women##2##3##(2008-11#1)(2008-3#1)
in which##1614##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#7)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#11)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#10)(1992-1#4)(1992-10#4)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#5)(1992-9#4)(1993-1#6)(1993-10#2)(1993-11#9)(1993-12#4)(1993-2#7)(1993-3#5)(1993-6#4)(1993-8#7)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#10)(1994-2#6)(1994-3#11)(1994-5#8)(1994-6#2)(1994-7#4)(1994-8#7)(1994-9#3)(1995-11#3)(1995-12#8)(1995-2#14)(1995-3#13)(1995-5#8)(1995-6#12)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#7)(1996-2#11)(1996-3#12)(1996-4#2)(1996-5#10)(1996-6#3)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#8)(1997-3#16)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#11)(1997-8#6)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#6)(2007-11#52)(2007-12#51)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#21)(2008-10#215)(2008-11#56)(2008-12#11)(2008-2#61)(2008-3#117)(2008-4#37)(2008-5#38)(2008-6#18)(2008-7#53)(2008-8#68)(2008-9#35)(2009-1#1)(2009-10#17)(2009-11#5)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#17)(2009-6#6)(2009-7#7)(2009-8#8)(2009-9#7)(2010-1#4)(2010-10#13)(2010-11#5)(2010-12#9)(2010-2#4)(2010-3#7)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#12)(2010-8#4)(2010-9#3)(2011-1#9)(2011-2#54)(2011-3#1)(2011-8#1)(2012-1#6)(2012-12#18)(2012-2#25)(2012-3#15)(2012-7#1)(2013-1#34)(2013-7#2)(2013-8#16)
in white and##3##3##(2008-10#2)(2008-3#1)
in white blood cells##3##4##(1992-5#1)(2011-1#1)(2013-8#1)
in white matter##2##3##(2008-6#1)(2010-12#1)
in white wine##4##3##(2008-10#4)
in white wines##2##3##(2008-10#2)
in white##19##2##(1991-3#1)(1992-5#1)(1996-3#1)(2008-10#9)(2008-3#1)(2008-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
in white-light##5##2##(2007-11#1)(2008-3#4)
in whiteflies##4##2##(2008-10#4)
in whitefly##2##2##(2008-10#2)
in whites##4##2##(1994-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
in whole blood from##2##4##(2008-10#2)
in whole blood killing##2##4##(1996-12#2)
in whole blood leukocytes and##2##5##(1996-2#2)
in whole blood samples##2##4##(2008-10#2)
in whole blood##29##3##(1991-2#1)(1993-2#1)(1996-12#2)(1996-2#2)(1996-5#1)(2006-6#4)(2007-11#1)(2008-10#13)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
in whole fish##2##3##(1997-4#2)
in whole mitochondria##2##3##(1994-12#1)(1995-2#1)
in whole mounts##2##3##(1992-8#1)(2007-12#1)
in whole##58##2##(1991-2#1)(1991-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#3)(1996-12#2)(1996-2#2)(1996-5#1)(1997-4#2)(2006-6#4)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#3)(2009-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
in whole-cell##5##2##(1991-9#1)(1993-12#1)(1995-11#1)(1997-3#1)(2012-3#1)
in whom a benign##2##4##(1990-3#1)(1991-2#1)
in whom a##7##3##(1990-3#1)(1991-2#1)(1993-2#1)(2008-1#1)(2008-7#1)(2010-8#1)(2013-1#1)
in whom an##2##3##(1990-12#1)(2013-1#1)
in whom it##6##3##(1990-3#1)(1991-11#1)(2008-1#2)(2008-7#1)(2010-7#1)
in whom no##2##3##(2010-6#1)(2013-8#1)
in whom the diagnosis of##2##5##(2007-8#1)(2013-1#1)
in whom the diagnosis##4##4##(1992-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
in whom the##16##3##(1990-12#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
in whom there##2##3##(2008-7#1)(2013-1#1)
in whom tumor##2##3##(1994-12#1)(2011-2#1)
in whom##86##2##(1990-12#2)(1990-3#4)(1990-9#1)(1991-11#5)(1991-2#3)(1991-9#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-7#1)(1996-5#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#9)(2009-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#8)(2013-8#1)
in wide range of##2##4##(2008-10#1)(2012-3#1)
in wide range##3##3##(2008-10#2)(2012-3#1)
in wide##6##2##(2008-10#3)(2009-5#1)(2012-3#1)(2013-7#1)
in widely##3##2##(1994-6#1)(1995-2#1)(2007-12#1)
in widespread use##4##3##(1991-12#1)(2007-12#1)(2008-4#1)(2012-2#1)
in widespread##6##2##(1991-12#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
in width##3##2##(2008-10#1)(2009-12#1)(2010-11#1)
in wild and##2##3##(1990-3#1)(2008-8#1)
in wild chimpanzees##2##3##(2007-12#1)(2012-2#1)
in wild populations##3##3##(2009-2#3)
in wild type (WT)##2##4##(2008-8#1)(2013-8#1)
in wild type mice##2##4##(2009-8#1)(2010-3#1)
in wild type##9##3##(2008-3#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2013-8#1)
in wild##29##2##(1990-3#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#1)(2009-2#3)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in wild-type (WT)##2##3##(2008-7#1)(2012-3#1)
in wild-type and##3##3##(1990-5#1)(2008-7#2)
in wild-type cells##2##3##(1995-2#1)(1995-9#1)
in wild-type##19##2##(1990-12#1)(1990-5#2)(1992-6#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-7#5)(2008-9#1)(2009-2#1)(2009-8#1)(2012-3#1)
in wildtype##2##2##(1992-12#1)(2012-2#1)
in wilt symptom##2##3##(2008-10#2)
in wilt##3##2##(2008-10#3)
in wind tunnel##2##3##(2008-10#1)(2009-6#1)
in wind##6##2##(2008-10#3)(2008-3#2)(2009-6#1)
in wine and cider##2##4##(2008-10#2)
in wine and##4##3##(2008-10#4)
in wine samples##5##3##(2008-10#5)
in wine using##2##3##(2008-10#2)
in wine##20##2##(2008-10#19)(2012-3#1)
in wines by##2##3##(2008-10#2)
in wines using##2##3##(2008-10#1)(2011-1#1)
in wines##14##2##(2008-10#12)(2011-1#2)
in wings##2##2##(2007-12#1)(2008-9#1)
in winter and spring##3##4##(2008-10#2)(2013-7#1)
in winter than in##2##4##(1995-11#1)(2008-3#1)
in winter wheat##6##3##(2008-10#6)
in winter##28##2##(1993-3#1)(1995-11#2)(1997-6#1)(2007-10#1)(2008-10#13)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
in wistar rats##2##3##(2007-4#1)(2013-1#1)
in witches'-broom##2##2##(2008-10#2)
in with the##2##3##(1994-11#1)(2008-10#1)
in with##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
in withdrawal##2##2##(1992-3#1)(1996-2#1)
in women (P##2##3##(2011-1#2)
in women aged over##2##4##(1993-2#1)(1994-2#1)
in women aged##3##3##(1993-2#1)(1994-2#1)(1994-9#1)
in women and##8##3##(1996-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
in women at high risk##3##5##(2007-2#3)
in women at##5##3##(2007-2#3)(2008-4#1)(2008-7#1)
in women but##2##3##(2009-8#1)(2012-12#1)
in women compared with men##2##5##(2008-4#1)(2009-11#1)
in women during##2##3##(1992-10#1)(2008-4#1)
in women in##8##3##(1991-11#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-5#2)(2012-3#1)(2013-1#1)
in women of reproductive age##2##5##(2011-1#2)
in women of##5##3##(1990-2#1)(1996-12#1)(2011-1#3)
in women over 50##2##4##(1990-6#1)(1993-2#1)
in women over##4##3##(1990-6#1)(1990-8#1)(1993-2#1)(2012-3#1)
in women than in men##5##5##(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#1)
in women than##6##3##(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
in women treated for breast##2##5##(1996-9#1)(2011-2#1)
in women undergoing##2##3##(2011-2#1)(2012-3#1)
in women were##3##3##(2011-1#2)(2012-12#1)
in women who##8##3##(1993-10#1)(1994-3#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-3#2)(2009-3#1)
in women with PCOS##3##4##(2008-4#2)(2010-11#1)
in women with and without##2##5##(1990-3#1)(1991-1#1)
in women with breast cancer and##2##6##(1990-12#1)(2008-7#1)
in women with breast cancer##4##5##(1990-12#1)(1992-2#1)(2008-7#1)(2013-1#1)
in women with early breast cancer treated##2##7##(2011-2#2)
in women with gestational diabetes mellitus##2##6##(1992-12#2)
in women with low obstetric risk##2##6##(2013-1#2)
in women with polycystic##2##4##(2008-11#1)(2008-3#1)
in women with the##2##4##(1994-5#1)(1995-9#1)
in women with##62##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1993-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-9#3)(1996-12#2)(1996-6#1)(1996-8#1)(2007-10#1)(2007-7#1)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-8#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)
in women##224##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#5)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#4)(1995-11#2)(1995-2#2)(1995-9#4)(1996-1#1)(1996-12#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-6#1)(1997-8#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#6)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#9)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#15)(2011-2#16)(2011-8#1)(2012-12#7)(2012-2#2)(2012-3#11)(2013-1#18)(2013-3#1)(2013-7#1)(2013-8#3)
in women's health##2##3##(1996-9#1)(2008-11#1)
in women's##9##2##(1995-12#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2011-2#1)
in women)##3##2##(1991-6#2)(2008-11#1)
in women]##3##2##(1991-2#1)(2008-12#1)(2012-3#1)
in wood##5##2##(2008-10#2)(2008-6#2)(2008-8#1)
in woody plants##2##3##(2008-10#1)(2009-8#1)
in woody##4##2##(2008-10#3)(2009-8#1)
in wool##3##2##(2008-10#3)
in word and##2##3##(1994-1#2)
in word##4##2##(1994-1#2)(2009-2#1)(2012-2#1)
in work##9##2##(1993-2#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
in workers exposed to##3##4##(2006-10#1)(2011-2#1)(2013-1#1)
in workers of##2##3##(2011-1#1)(2011-2#1)
in workers##19##2##(1994-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#5)(2008-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#3)
in working memory##5##3##(1992-8#1)(1994-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
in working with##3##3##(1992-3#1)(1995-12#1)(1995-2#1)
in working##17##2##(1992-3#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-5#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
in workplace drug testing##2##4##(2010-4#2)
in workplace##5##2##(2008-10#2)(2008-9#1)(2010-4#2)
in world##2##2##(2008-10#1)(2010-8#1)
in worldwide##4##2##(1993-11#1)(2008-10#2)(2010-12#1)
in wound healing##4##3##(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
in wound repair##3##3##(2011-2#1)(2012-12#2)
in wound##7##2##(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)
in wounded##3##2##(2008-10#2)(2008-7#1)
in wounds##3##2##(2008-10#3)
in writing##7##2##(1995-12#1)(1996-2#1)(2008-12#2)(2008-3#1)(2009-9#1)(2013-1#1)
in written##2##2##(1992-12#1)(2010-8#1)
in x-ray##2##2##(1993-5#1)(2008-3#1)
in xenograft models##4##3##(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in xenograft recipients##2##3##(2007-8#2)
in xenograft##6##2##(2007-8#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in xenon##2##2##(1991-9#1)(2007-11#1)
in xylem and phloem##2##4##(2012-8#2)
in xylem##6##2##(2009-8#1)(2012-5#1)(2012-8#4)
in xylene is used for the extractive separation of##2##9##(2008-10#2)
in xylene is used for##3##5##(2008-10#3)
in xylene##10##2##(2008-10#10)
in yaks##3##2##(2011-2#3)
in year##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
in years 1991##3##3##(2007-11#3)
in years##17##2##(2007-11#6)(2008-10#4)(2008-12#1)(2008-9#4)(2012-3#1)(2013-8#1)
in yeast DNA##2##3##(1990-5#1)(1993-2#1)
in yeast and mammalian cells##2##5##(1997-3#2)
in yeast and##7##3##(1997-3#2)(2008-9#1)(2009-12#2)(2009-5#1)(2012-2#1)
in yeast are##2##3##(1996-3#1)(2008-7#1)
in yeast by##4##3##(1990-8#1)(1993-8#1)(1995-6#1)(2008-10#1)
in yeast cell##2##3##(2008-10#1)(2008-9#1)
in yeast cells by##2##4##(1995-8#1)(2008-9#1)
in yeast cells##8##3##(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-9#3)
in yeast chromatin##2##3##(1997-3#2)
in yeast is##3##3##(1993-9#1)(2008-8#1)(2011-2#1)
in yeast strains##2##3##(1992-10#1)(2008-4#1)
in yeast##94##2##(1990-12#3)(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-6#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-3#7)(1997-7#3)(2008-10#10)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#2)
in yeasts##4##2##(1995-6#1)(2007-11#1)(2008-5#1)(2008-9#1)
in yellow##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
in yield and quality##2##4##(2008-10#2)
in yield##14##2##(2008-10#12)(2009-7#1)(2011-10#1)
in yields of##2##3##(1990-9#1)(1996-5#1)
in yields##6##2##(1990-9#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
in yoga##2##2##(2010-12#2)
in yoghurt##2##2##(2008-10#2)
in yolk sac##2##3##(1993-12#1)(2008-9#1)
in yolk##3##2##(1993-12#1)(2008-4#1)(2008-9#1)
in young (2 months)##2##4##(2008-3#1)(2013-7#1)
in young (3##2##3##(1994-6#1)(1997-9#1)
in young adult##3##3##(1995-9#1)(2008-6#1)(2008-8#1)
in young adults with##3##4##(1990-3#1)(1996-2#1)(2008-8#1)
in young adults##16##3##(1990-3#1)(1991-11#1)(1994-2#1)(1995-3#2)(1995-9#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
in young and adult##3##4##(2008-7#1)(2012-3#2)
in young and aged##2##4##(1994-6#1)(1995-5#1)
in young and by##2##4##(1990-3#1)(2008-7#1)
in young and middle-aged##2##4##(2008-7#2)
in young and old rats##4##5##(1991-12#2)(2008-7#2)
in young and old##8##4##(1991-12#2)(1994-5#2)(2008-7#2)(2009-12#1)(2010-11#1)
in young and older adults##2##5##(2008-11#1)(2009-10#1)
in young and##19##3##(1990-3#1)(1991-12#2)(1994-5#2)(1994-6#1)(1995-5#1)(2008-11#1)(2008-7#6)(2009-10#1)(2009-12#1)(2010-11#1)(2012-3#2)
in young animals##7##3##(1996-5#2)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)
in young athletes##8##3##(2010-1#3)(2010-10#1)(2012-3#4)
in young but##2##3##(1990-3#2)
in young children with##3##4##(2008-4#1)(2009-3#1)(2010-10#1)
in young children##19##3##(1991-8#1)(1997-1#2)(2007-12#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-9#3)(2009-3#1)(2010-10#2)(2010-6#2)(2011-2#1)(2012-2#1)(2013-8#1)
in young cirrhotics vs##4##4##(2012-3#4)
in young leaves##3##3##(2008-10#2)(2008-5#1)
in young male##4##3##(1990-6#1)(1996-3#1)(1996-8#1)(2008-7#1)
in young males with##2##4##(2011-2#2)
in young men with##2##4##(1994-2#1)(2011-2#1)
in young men##8##3##(1994-2#2)(2008-6#1)(2011-2#3)(2013-1#1)(2013-8#1)
in young or##2##3##(1997-6#1)(2012-3#1)
in young patients with##4##4##(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
in young patients##16##3##(1990-3#1)(1991-11#1)(1993-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
in young people##2##3##(2012-12#1)(2013-1#1)
in young population##2##3##(2007-11#1)(2012-2#1)
in young rats##8##3##(1990-3#1)(1992-11#2)(1994-6#1)(2008-7#2)(2011-1#1)(2013-7#1)
in young subjects##2##3##(1993-1#1)(2008-7#1)
in young women with##3##4##(2007-10#1)(2008-3#1)(2011-2#1)
in young women##12##3##(1994-5#4)(1996-3#1)(2007-10#1)(2007-12#2)(2008-3#1)(2011-2#1)(2013-1#2)
in young##200##2##(1990-3#8)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-2#3)(1994-5#6)(1994-6#3)(1995-3#2)(1995-5#2)(1995-9#2)(1996-10#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-9#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-6#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#4)(2009-7#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#21)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#16)(2013-1#6)(2013-7#3)(2013-8#4)
in younger adults##2##3##(2007-11#1)(2008-1#1)
in younger age##2##3##(2012-3#1)(2013-1#1)
in younger and older groups##2##5##(2008-6#2)
in younger and older##3##4##(2008-6#2)(2012-1#1)
in younger animals##2##3##(2008-3#2)
in younger dogs##2##3##(2012-3#2)
in younger men##3##3##(2008-3#1)(2008-4#1)(2009-5#1)
in younger patients##12##3##(1994-6#2)(1997-3#2)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
in younger rats##3##3##(1991-12#2)(2012-1#1)
in younger women##5##3##(1993-9#1)(1994-3#1)(2007-4#1)(2010-9#1)(2011-1#1)
in younger##44##2##(1990-12#1)(1991-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1997-3#3)(2007-11#2)(2007-4#1)(2008-1#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#4)(2013-1#2)
in your##20##2##(1991-2#1)(1993-1#3)(1994-3#2)(1995-12#1)(1995-3#1)(1996-1#1)(2008-11#2)(2008-8#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
in youth##14##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)
in zebrafish embryos/larvae##3##3##(2013-1#3)
in zebrafish##7##2##(1993-12#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#3)
in zinc##10##2##(1990-8#1)(1993-5#1)(1995-3#1)(1995-5#1)(2008-10#4)(2013-1#1)(2013-7#1)
in zones with##2##3##(2008-10#1)(2010-4#1)
in zones##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
in zooplankton##2##2##(2008-8#1)(2010-8#1)
in zucchini squash##2##3##(2008-10#2)
in zymogen granule membranes##2##4##(1991-5#2)
in zymogen##3##2##(1991-5#2)(2008-4#1)
in β-cell##2##2##(2010-11#1)(2012-2#1)
in β-cells##9##2##(2010-11#9)
in##156588##1##(1990-10#84)(1990-11#614)(1990-12#701)(1990-2#584)(1990-3#407)(1990-4#33)(1990-5#686)(1990-6#420)(1990-7#349)(1990-8#638)(1990-9#316)(1991-1#306)(1991-10#53)(1991-11#359)(1991-12#955)(1991-2#620)(1991-3#463)(1991-4#149)(1991-5#538)(1991-6#478)(1991-7#58)(1991-8#389)(1991-9#513)(1992-1#255)(1992-10#144)(1992-11#411)(1992-12#698)(1992-2#494)(1992-3#858)(1992-4#93)(1992-5#336)(1992-6#657)(1992-7#36)(1992-8#578)(1992-9#559)(1993-1#310)(1993-10#41)(1993-11#589)(1993-12#1110)(1993-2#488)(1993-3#704)(1993-5#197)(1993-6#628)(1993-7#2)(1993-8#574)(1993-9#473)(1994-1#205)(1994-10#52)(1994-11#687)(1994-12#868)(1994-2#784)(1994-3#705)(1994-5#559)(1994-6#630)(1994-7#125)(1994-8#827)(1994-9#448)(1995-1#248)(1995-10#18)(1995-11#666)(1995-12#1259)(1995-2#1036)(1995-3#763)(1995-4#44)(1995-5#626)(1995-6#722)(1995-8#540)(1995-9#160)(1996-1#307)(1996-10#47)(1996-11#269)(1996-12#1150)(1996-2#870)(1996-3#583)(1996-4#100)(1996-5#831)(1996-6#332)(1996-7#180)(1996-8#153)(1996-9#316)(1997-1#455)(1997-2#872)(1997-3#898)(1997-4#633)(1997-5#269)(1997-6#573)(1997-7#683)(1997-8#602)(1997-9#39)(2006-10#278)(2006-11#12)(2006-12#68)(2006-4#31)(2006-5#14)(2006-6#92)(2006-7#13)(2006-8#50)(2006-9#4)(2007-1#41)(2007-10#750)(2007-11#2584)(2007-12#2937)(2007-2#304)(2007-3#27)(2007-4#88)(2007-5#240)(2007-6#124)(2007-7#923)(2007-8#1273)(2007-9#99)(2008-1#2004)(2008-10#27818)(2008-11#5921)(2008-12#2544)(2008-2#2726)(2008-3#5311)(2008-4#2383)(2008-5#3933)(2008-6#1606)(2008-7#5442)(2008-8#3645)(2008-9#3512)(2009-1#122)(2009-10#754)(2009-11#439)(2009-12#579)(2009-2#285)(2009-3#444)(2009-4#430)(2009-5#695)(2009-6#528)(2009-7#661)(2009-8#905)(2009-9#459)(2010-1#344)(2010-10#516)(2010-11#669)(2010-12#812)(2010-2#361)(2010-3#718)(2010-4#693)(2010-5#706)(2010-6#419)(2010-7#405)(2010-8#1025)(2010-9#252)(2011-1#2045)(2011-10#52)(2011-2#5795)(2011-3#218)(2011-4#8)(2011-5#1)(2011-7#54)(2011-8#8)(2011-9#10)(2012-1#701)(2012-12#1988)(2012-2#3098)(2012-3#2489)(2012-4#23)(2012-5#54)(2012-6#28)(2012-7#63)(2012-8#50)(2012-9#18)(2013-1#4739)(2013-2#2)(2013-3#9)(2013-7#717)(2013-8#2318)
in&quot##3##1##(1992-11#1)(1997-3#1)(2008-10#1)
in)##2##1##(2008-8#1)(2012-12#1)
in- and##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
in-air##2##1##(2008-3#2)
in-atomizer trapping for##2##3##(2008-10#2)
in-cell&quot##2##1##(2010-4#2)
in-center hemodialysis patients##2##3##(1996-2#2)
in-center hemodialysis##3##2##(1996-2#2)(2010-5#1)
in-center##4##1##(1991-12#1)(1996-2#2)(2010-5#1)
in-class##2##1##(2007-12#2)
in-contact##2##1##(1997-3#2)
in-depth analysis##3##2##(2007-11#1)(2008-1#1)(2011-1#1)
in-depth case studies of##2##4##(1991-12#1)(2008-11#1)
in-depth exploration##2##2##(2009-7#1)(2013-8#1)
in-depth information##2##2##(1992-2#1)(1994-3#1)
in-depth interview##5##2##(1992-5#1)(1995-6#1)(2009-4#1)(2010-10#1)(2011-2#1)
in-depth interviews were conducted with##2##5##(1997-3#1)(2012-12#1)
in-depth interviews with##2##3##(2011-1#1)(2011-2#1)
in-depth interviews##11##2##(1997-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#4)
in-depth qualitative##3##2##(2010-5#1)(2013-1#2)
in-depth study of##2##3##(1994-2#1)(2008-10#1)
in-depth understanding of##2##3##(2007-12#1)(2009-9#1)
in-depth understanding##3##2##(1993-12#1)(2007-12#1)(2009-9#1)
in-depth##51##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#2)
in-fiber chirped moiré gratings##2##4##(2008-3#2)
in-fiber##7##1##(2007-11#1)(2008-2#2)(2008-3#4)
in-field##2##1##(2008-10#2)
in-flight fires##2##2##(1996-12#2)
in-flight##13##1##(1990-11#1)(1991-2#1)(1996-12#4)(2007-2#1)(2008-2#2)(2008-3#4)
in-focus##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
in-frame stop##4##2##(1990-11#1)(1992-11#1)(1993-11#1)(1993-12#1)
in-frame##15##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-11#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-8#1)(1997-4#3)
in-gel##4##1##(2008-10#1)(2008-4#2)(2008-9#1)
in-group##2##1##(2007-9#1)(2011-2#1)
in-home care##3##2##(1995-3#3)
in-home hospital care##2##3##(1991-2#2)
in-home respite##2##2##(1992-3#2)
in-home##11##1##(1991-2#2)(1992-3#2)(1995-3#3)(2008-12#1)(2010-6#1)(2011-2#2)
in-hospital and##2##2##(2008-3#1)(2011-2#1)
in-hospital cardiac##2##2##(1994-11#1)(2008-3#1)
in-hospital deaths##4##2##(2007-8#2)(2008-3#1)(2011-2#1)
in-hospital mortality##3##2##(2007-10#1)(2008-3#2)
in-hospital##28##1##(1991-12#2)(1992-1#1)(1992-6#1)(1994-11#1)(1996-2#1)(2007-10#1)(2007-8#4)(2008-10#1)(2008-3#7)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in-house developed##2##2##(1997-2#1)(2011-1#1)
in-house engineering##3##2##(1996-2#1)(2008-10#2)
in-house resources##2##2##(2008-10#2)
in-house##36##1##(1992-2#2)(1993-12#2)(1993-2#1)(1994-1#2)(1996-2#2)(1997-2#1)(1997-3#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
in-line Sagnac interferometer##2##3##(2008-3#2)
in-line complexation##3##2##(2008-10#3)
in-line digital holography##2##3##(2007-12#1)(2008-2#1)
in-line digital##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
in-line dilution##2##2##(2008-10#2)
in-line gas-diffusion##2##2##(2008-10#2)
in-line holograms##2##2##(2007-11#1)(2008-2#1)
in-line holography##2##2##(2008-3#2)
in-line nonlinear optical loop mirrors##2##5##(2007-12#2)
in-line preconcentration/separation##3##2##(2008-10#3)
in-line reaction column##2##3##(2008-10#2)
in-line with##2##2##(2008-1#1)(2008-10#1)
in-line##59##1##(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#36)(2008-2#8)(2008-3#7)
in-office##2##1##(2008-7#1)(2012-1#1)
in-orbit calibration of##2##3##(2008-2#2)
in-orbit##4##1##(2008-2#4)
in-patient pulmonary rehabilitation##2##3##(2011-2#2)
in-patient##14##1##(1991-11#1)(1991-3#1)(1991-9#1)(1995-11#2)(2007-7#1)(2008-11#1)(2008-3#2)(2011-2#5)
in-patients##6##1##(1990-6#1)(1992-9#1)(1993-8#1)(2008-11#1)(2008-3#1)(2009-10#1)
in-person interviews##2##2##(1997-1#1)(2009-7#1)
in-person##5##1##(1994-2#1)(1997-1#1)(2008-12#1)(2009-7#1)(2011-2#1)
in-phase and opposed-phase spoiled GRE imaging##2##6##(1997-8#2)
in-phase and opposed-phase##5##3##(1997-8#5)
in-phase and##8##2##(1997-8#5)(2007-11#2)(2008-3#1)
in-phase images##2##2##(1997-8#2)
in-phase imaging##2##2##(1997-8#2)
in-phase mode##2##2##(2008-3#2)
in-phase##21##1##(1995-5#1)(1997-8#12)(2007-11#2)(2007-12#2)(2008-3#3)(2009-3#1)
in-place ACBM##2##2##(1991-12#2)
in-place##3##1##(1991-12#3)
in-plane Young's relaxation modulus##2##4##(2009-7#2)
in-plane and out-of-plane##6##3##(2008-2#2)(2008-3#4)
in-plane deformations##2##2##(2007-11#1)(2008-3#1)
in-plane electronic speckle pattern interferometry##2##5##(2008-2#2)
in-plane laser##2##2##(2007-11#1)(2008-3#1)
in-plane light scattering##2##3##(2008-3#2)
in-plane rotation##2##2##(2008-3#2)
in-plane switching##2##2##(2008-3#2)
in-plane##46##1##(1993-11#1)(1996-2#1)(2007-11#4)(2008-10#1)(2008-2#7)(2008-3#23)(2009-11#1)(2009-6#1)(2009-7#3)(2012-2#3)(2013-8#1)
in-process##3##1##(2008-10#1)(2008-2#1)(2012-2#1)
in-row rotary cultivator##3##3##(2008-10#3)
in-service##7##1##(1992-2#1)(1996-1#1)(1996-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
in-silico##2##1##(2011-3#1)(2013-7#1)
in-situ at##2##2##(2008-10#1)(2012-12#1)
in-situ data##2##2##(2013-8#2)
in-situ hybridization (FISH)##2##3##(2009-10#1)(2012-3#1)
in-situ hybridization##5##2##(2008-8#2)(2008-9#1)(2009-10#1)(2012-3#1)
in-situ monitoring of##3##3##(2008-10#3)
in-situ remote sensing##2##3##(2008-10#1)(2013-8#1)
in-situ sampling##2##2##(2008-10#2)
in-situ##35##1##(2008-10#19)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-8#6)
in-stent restenosis##2##2##(2008-12#2)
in-stent##5##1##(2008-12#2)(2009-5#1)(2011-2#2)
in-tube SPME##3##2##(2008-10#3)
in-tube solid phase microextraction##2##4##(2008-10#2)
in-tube solid-phase microextraction##2##3##(2008-10#2)
in-tube##7##1##(2008-10#7)
in-use stocks##2##2##(2012-2#2)
in-use##4##1##(2008-5#2)(2012-2#2)
in-valve-mini-column##3##1##(2008-10#3)
in-vitro effects of##2##3##(1990-12#2)
in-vitro##20##1##(1990-12#3)(1991-11#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-3#1)
in-vivo optical##2##2##(2011-1#2)
in-vivo##16##1##(1994-11#3)(2008-10#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-5#2)(2010-6#1)(2011-1#3)(2012-1#1)
in-water light field##2##3##(2008-2#1)(2008-3#1)
in-water measurements##2##2##(2008-3#2)
in-water##11##1##(2008-2#4)(2008-3#7)
inAmaranthus caudatus seedlings##2##3##(2008-4#2)
inE##6##1##(2008-8#3)(2008-9#3)
inEscherichia coli##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
inH##2##1##(2008-8#2)
inMycobacterium##2##1##(2008-11#2)
inNocardia andRhodococcus##3##2##(2008-11#3)
inS##2##1##(2008-8#2)
ina##10##1##(1994-2#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2010-5#1)
inability of##13##2##(1990-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
inability to draw##2##3##(2007-7#2)
inability to##36##2##(1992-12#1)(1994-11#1)(1994-12#4)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
inability##49##1##(1990-8#1)(1992-12#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
inaccessibility##3##1##(1991-8#1)(2008-7#1)(2009-12#1)
inaccessible for##2##2##(1993-3#1)(2008-7#1)
inaccessible in##2##2##(1994-8#1)(2010-12#1)
inaccessible to##4##2##(1990-5#1)(1997-4#1)(2008-11#1)(2009-10#1)
inaccessible##16##1##(1990-2#1)(1990-5#1)(1992-3#1)(1993-3#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-6#1)
inaccuracies in##2##2##(2008-3#1)(2008-9#1)
inaccuracies##5##1##(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)
inaccuracy in the##2##3##(2008-3#2)
inaccuracy##9##1##(2008-10#3)(2008-3#4)(2008-4#1)(2009-5#1)
inaccurate information##2##2##(2008-11#1)(2008-7#1)
inaccurate##19##1##(1990-11#1)(1991-12#2)(1993-12#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
inaccurately##2##1##(2007-12#1)(2010-9#1)
inactions##2##1##(2013-8#2)
inactivate the antibiotics##2##3##(2008-10#2)
inactivate the enzyme##2##3##(1990-8#1)(1992-11#1)
inactivate the##6##2##(1990-8#1)(1992-11#1)(1995-2#1)(2008-10#2)(2009-11#1)
inactivate##26##1##(1990-8#1)(1991-9#1)(1992-11#1)(1993-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-3#2)(1997-4#1)(2008-10#8)(2008-6#1)(2008-8#1)(2009-11#1)(2012-2#3)(2013-1#1)
inactivated by##12##2##(1990-5#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
inactivated closed-states##3##2##(2008-8#3)
inactivated enzyme##4##2##(1991-5#1)(1992-9#1)(1997-2#1)(2008-5#1)
inactivated in##4##2##(1990-12#1)(1992-9#1)(1997-3#1)(2008-10#1)
inactivated poliovirus##2##2##(1995-5#2)
inactivated the##5##2##(1992-9#1)(1993-3#1)(1997-6#1)(2007-7#1)(2008-10#1)
inactivated vaccine against##2##3##(1991-3#1)(2008-5#1)
inactivated vaccine##6##2##(1991-3#1)(1996-12#1)(2008-4#1)(2008-5#2)(2013-8#1)
inactivated vaccines##2##2##(2009-8#1)(2011-2#1)
inactivated with##2##2##(1992-12#1)(1992-9#1)
inactivated##80##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#2)(1992-12#3)(1992-5#1)(1992-9#4)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#6)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#3)(1997-3#4)(1997-6#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
inactivates the##6##2##(1990-11#1)(1991-5#1)(1992-3#1)(1996-2#1)(2008-10#1)(2010-4#1)
inactivates##16##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-8#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)(2011-1#1)
inactivating##10##1##(1991-12#1)(1992-3#2)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-7#1)
inactivation and recovery##3##3##(2008-8#3)
inactivation and to##2##3##(1995-12#1)(2008-7#1)
inactivation and##11##2##(1990-5#1)(1993-6#1)(1995-12#1)(1995-6#1)(2008-3#1)(2008-7#1)(2008-8#3)(2011-3#1)(2013-7#1)
inactivation assay method##2##3##(1995-12#1)(2008-5#1)
inactivation by heat##2##3##(1991-5#1)(2007-12#1)
inactivation by the##2##3##(1995-11#1)(2011-2#1)
inactivation by##8##2##(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1995-11#1)(1997-7#1)(2007-12#1)(2011-2#1)
inactivation during##2##2##(2008-7#1)(2011-2#1)
inactivation from##2##2##(1991-9#1)(2008-8#1)
inactivation gate complex##2##3##(2008-8#2)
inactivation have##2##2##(2008-4#2)
inactivation in##5##2##(1994-6#1)(1997-2#1)(2007-12#1)(2008-12#1)(2012-12#1)
inactivation is the##2##3##(1992-3#1)(1993-11#1)
inactivation is##5##2##(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(2011-2#1)
inactivation kinetics##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
inactivation occurred##3##2##(1990-2#1)(1994-11#1)(1997-2#1)
inactivation of RDPR by##2##4##(1993-11#2)
inactivation of RDPR##3##3##(1993-11#3)
inactivation of a##2##3##(1993-12#1)(1994-12#1)
inactivation of the enzyme##6##4##(1990-8#1)(1991-5#1)(1993-6#1)(1993-8#1)(2008-5#1)(2011-2#1)
inactivation of the p53 function##2##5##(1994-12#2)
inactivation of the p53##3##4##(1994-12#2)(1994-8#1)
inactivation of the receptor##2##4##(1995-8#2)
inactivation of the##27##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#2)(2008-10#2)(2008-5#2)(2008-6#1)(2010-11#1)(2011-2#2)
inactivation of these##2##3##(1990-2#1)(2012-2#1)
inactivation of##91##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#3)(1995-8#3)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#3)(2011-3#2)(2012-2#5)(2012-3#1)(2013-1#1)
inactivation process##2##2##(1991-9#1)(1996-2#1)
inactivation rates of##2##3##(1990-5#1)(1995-2#1)
inactivation studies##2##2##(1990-5#1)(1991-6#1)
inactivation than##2##2##(1994-11#1)(1995-2#1)
inactivation was##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
inactivation which##2##2##(1991-12#1)(1991-9#1)
inactivation with##6##2##(1992-8#1)(1993-11#1)(1993-12#1)(1995-5#1)(2008-10#1)(2011-3#1)
inactivation##228##1##(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#8)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#7)(1991-6#1)(1991-9#7)(1992-11#3)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-11#10)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#6)(1993-8#5)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#7)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#7)(1995-5#3)(1995-6#8)(1995-8#5)(1996-2#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#18)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#7)(2011-3#5)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)
inactivation)##2##1##(1995-12#1)(1997-2#1)
inactivations##3##1##(2008-4#2)(2009-8#1)
inactivator of beta-glucosidases##2##3##(1991-5#2)
inactivator of the##2##3##(1992-11#1)(1995-2#1)
inactivator of##6##2##(1991-5#2)(1992-11#1)(1994-5#1)(1995-2#1)(1997-1#1)
inactivator##7##1##(1991-5#3)(1992-11#1)(1994-5#1)(1995-2#1)(1997-1#1)
inactivators of##5##2##(1991-9#1)(1992-11#1)(1994-6#1)(2007-11#1)(2013-1#1)
inactivators##7##1##(1991-9#1)(1992-11#1)(1994-6#1)(2007-11#2)(2008-3#1)(2013-1#1)
inactive GDP-bound##2##2##(1995-2#1)(1995-6#1)
inactive against##3##2##(1991-8#1)(1992-8#1)(2007-7#1)
inactive analogue##2##2##(1992-12#1)(1997-1#1)
inactive analogues##3##2##(1991-5#1)(2008-8#2)
inactive and active##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
inactive and could##2##3##(1994-5#1)(1995-3#1)
inactive and##7##2##(1994-5#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
inactive as##2##2##(1991-5#1)(1993-12#1)
inactive at##4##2##(1991-5#1)(1993-9#1)(1995-3#2)
inactive compounds##2##2##(2008-10#1)(2010-8#1)
inactive forms##2##2##(1995-2#1)(2008-4#1)
inactive in##2##2##(1992-12#1)(1992-3#1)
inactive intermediate##2##2##(1994-12#1)(2008-9#1)
inactive isomer##2##2##(1993-6#1)(1996-5#1)
inactive mutant##4##2##(1995-12#1)(1995-5#1)(1995-6#1)(2012-3#1)
inactive or##2##2##(1992-11#1)(2008-12#1)
inactive precursors##2##2##(2008-11#1)(2013-1#1)
inactive protein##2##2##(1991-10#1)(2010-6#1)
inactive when##4##2##(1995-12#1)(1996-5#3)
inactive##146##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#6)(1991-6#4)(1991-8#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#5)(1997-1#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#5)
inactivity of##2##2##(2007-2#1)(2008-8#1)
inactivity##16##1##(1993-6#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#1)(2011-2#2)(2013-1#4)(2013-8#1)
inadequacies##6##1##(1994-12#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
inadequacy of the##5##3##(1996-12#1)(2007-8#1)(2009-5#1)(2011-1#1)(2012-3#1)
inadequacy of##10##2##(1992-1#1)(1995-11#1)(1996-12#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
inadequacy##15##1##(1992-1#1)(1993-3#1)(1995-11#1)(1996-12#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
inadequate and that##5##3##(1994-3#1)(1996-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
inadequate and##12##2##(1994-12#1)(1994-3#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
inadequate care##3##2##(1992-2#1)(1993-3#1)(2008-10#1)
inadequate for their##2##3##(2008-10#1)(2008-7#1)
inadequate for##8##2##(1992-12#1)(1992-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)
inadequate growth##2##2##(2012-2#2)
inadequate in##2##2##(2008-10#1)(2011-2#1)
inadequate infection control##2##3##(1996-2#1)(2008-1#1)
inadequate initial##2##2##(2008-6#1)(2012-2#1)
inadequate knowledge##3##2##(2009-5#1)(2010-5#1)(2011-2#1)
inadequate nutritional intake##2##3##(2010-9#2)
inadequate or##2##2##(1990-12#1)(2008-7#1)
inadequate response##3##2##(2008-1#1)(2011-10#1)(2012-3#1)
inadequate samples##3##2##(1991-2#1)(1992-12#2)
inadequate screening##2##2##(2007-7#1)(2008-10#1)
inadequate to##9##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#2)(2013-7#1)
inadequate treatment##6##2##(1993-9#1)(1996-11#1)(2007-7#1)(2008-2#1)(2013-1#2)
inadequate##152##1##(1990-12#3)(1991-12#3)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#5)(1993-9#1)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#3)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#8)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
inadequately controlled by##2##3##(2008-7#1)(2011-10#1)
inadequately prepared##3##2##(2008-11#2)(2011-1#1)
inadequately treated##3##2##(2008-8#2)(2010-6#1)
inadequately##16##1##(1993-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#2)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2013-8#1)
inadvertent dural tap##2##3##(1993-10#2)
inadvertent dural##4##2##(1993-10#4)
inadvertent##13##1##(1992-3#2)(1993-10#4)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)(2013-8#1)
inadvertently##4##1##(1997-8#1)(2007-8#1)(2008-6#1)(2011-2#1)
inaequalis and##7##2##(2008-10#7)
inaequalis from##2##2##(2008-10#2)
inaequalis populations##2##2##(2008-10#2)
inaequalis was##4##2##(2008-10#4)
inaequalis were##2##2##(2008-10#2)
inaequalis##66##1##(2008-10#66)
inaequivalvis HbI##2##2##(1990-8#2)
inaequivalvis##4##1##(1990-8#4)
inanimate matter##2##2##(1997-6#1)(2008-12#1)
inanimate##7##1##(1991-2#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-2#1)
inaperisone (4 mg/kg i##3##4##(1992-3#3)
inaperisone##9##1##(1992-3#9)
inapplicable##3##1##(2008-10#2)(2008-2#1)
inappropriate and##3##2##(1994-3#1)(1996-1#1)(2008-1#1)
inappropriate behavior##2##2##(1993-1#2)
inappropriate for##2##2##(2008-1#1)(2008-7#1)
inappropriate in##3##2##(1992-2#1)(1996-5#1)(2008-10#1)
inappropriate rust species##4##3##(2008-10#4)
inappropriate rust##5##2##(2008-10#5)
inappropriate secretion of##2##3##(2007-8#1)(2008-1#1)
inappropriate to##3##2##(2007-11#1)(2008-5#1)(2009-5#1)
inappropriate treatment##2##2##(2008-10#1)(2010-5#1)
inappropriate use of##2##3##(1994-9#1)(1996-1#1)
inappropriate use##3##2##(1994-9#1)(1996-1#1)(2009-4#1)
inappropriate##82##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#4)(1993-12#1)(1993-3#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
inappropriately low or##2##3##(2008-4#1)(2013-8#1)
inappropriately treated##3##2##(2008-11#1)(2008-6#2)
inappropriately##11##1##(1994-3#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2013-8#1)
inasmuch as it##2##3##(2008-2#1)(2008-3#1)
inasmuch as##4##2##(1991-2#1)(2008-2#2)(2008-3#1)
inattention and##2##2##(2008-2#1)(2012-2#1)
inattention condition##3##2##(2008-8#3)
inattention##10##1##(1997-6#1)(2008-2#2)(2008-8#4)(2012-2#1)(2013-1#2)
inattentive##3##1##(2008-2#2)(2009-8#1)
inattentiveness##2##1##(2008-2#2)
inaugural meeting##2##2##(2008-5#1)(2008-7#1)
inaugural##7##1##(1992-5#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
inaugurated##3##1##(1993-12#1)(2009-10#1)(2009-7#1)
inauthentic feedback##2##2##(2009-9#2)
inauthentic##3##1##(2009-9#3)
inborn error of##2##3##(1990-8#1)(2013-8#1)
inborn error##3##2##(1990-8#1)(1992-9#1)(2013-8#1)
inborn errors of metabolism##3##4##(2008-4#3)
inborn errors of##4##3##(2008-4#3)(2012-2#1)
inborn errors##5##2##(2008-4#4)(2012-2#1)
inborn##9##1##(1990-8#1)(1992-9#1)(2008-4#4)(2012-2#1)(2012-3#1)(2013-8#1)
inboth##2##1##(2008-11#2)
inbound##4##1##(2008-1#1)(2008-2#1)(2010-5#2)
inbred Oh516##2##2##(2008-10#2)
inbred backcross lines##2##3##(2008-10#2)
inbred backcross##3##2##(2008-10#3)
inbred line##11##2##(1995-8#1)(2008-10#8)(2008-8#2)
inbred lines derived from the cross##2##6##(2008-10#1)(2012-3#1)
inbred lines derived from##3##4##(2008-10#2)(2012-3#1)
inbred lines of##5##3##(2008-10#3)(2008-5#1)(2012-3#1)
inbred lines that##2##3##(2008-10#1)(2008-5#1)
inbred lines##33##2##(1997-7#1)(2008-10#20)(2008-5#4)(2008-8#2)(2012-3#6)
inbred mice##3##2##(1993-12#1)(1994-5#1)(1994-8#1)
inbred strains of mice##3##4##(1991-12#2)(1996-5#1)
inbred strains##8##2##(1991-12#2)(1994-5#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-8#1)(2012-3#1)
inbred##95##1##(1991-12#2)(1993-12#1)(1994-5#2)(1994-8#3)(1995-8#1)(1996-5#1)(1997-7#3)(2008-1#1)(2008-10#51)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#5)(2009-10#2)(2009-2#1)(2009-5#2)(2012-3#13)
inbreds##16##1##(2008-10#13)(2008-5#1)(2008-9#1)(2012-3#1)
inbreeding as##2##2##(2012-3#2)
inbreeding avoidance##6##2##(2008-9#6)
inbreeding by##2##2##(2012-3#1)(2013-1#1)
inbreeding depression in##2##3##(2008-9#2)
inbreeding depression##18##2##(2008-8#10)(2008-9#7)(2009-2#1)
inbreeding##42##1##(2008-12#2)(2008-5#1)(2008-8#11)(2008-9#18)(2009-2#1)(2009-5#2)(2012-3#6)(2013-1#1)
incandescence as a##2##3##(2008-3#2)
incandescence##13##1##(2007-12#1)(2008-2#4)(2008-3#8)
incandescent##2##1##(2008-3#1)(2011-1#1)
incapable of##18##2##(1992-5#1)(1992-8#2)(1993-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-5#1)(1997-6#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
incapacitated##2##1##(1991-9#1)(1996-10#1)
incapacitating##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
incapacitation and##2##2##(1996-12#2)
incapacitation is##2##2##(1996-12#2)
incapacitation##8##1##(1996-12#8)
incapacity for Fas-mediated apoptosis##2##4##(1997-8#2)
incapacity of##2##2##(1995-5#1)(2009-4#1)
incapacity##6##1##(1994-12#1)(1995-5#1)(1997-8#2)(2009-4#2)
incarcerated juveniles##2##2##(2008-11#2)
incarcerated mothers and##2##3##(2009-11#2)
incarcerated women with substance use disorder##2##6##(2009-11#2)
incarcerated women##3##2##(1996-7#1)(2009-11#2)
incarcerated##17##1##(1994-2#1)(1996-7#1)(2008-11#3)(2009-11#6)(2011-1#1)(2012-12#3)(2013-1#2)
incarceration and##3##2##(2009-11#1)(2012-12#2)
incarceration of inguinal hernia##2##4##(2008-12#2)
incarceration of##7##2##(2008-11#1)(2008-12#3)(2009-11#1)(2011-2#2)
incarceration##17##1##(2008-11#1)(2008-12#3)(2008-9#1)(2009-11#4)(2010-6#1)(2011-2#3)(2012-12#3)(2012-2#1)
incarnata##4##1##(2008-10#4)
incentive for##4##2##(1992-1#2)(1996-2#1)(2012-12#1)
incentive motivation##2##2##(1993-6#1)(2008-4#1)
incentive program##5##2##(1992-2#1)(1992-3#2)(2008-9#1)(2011-1#1)
incentive to##5##2##(1992-12#1)(1993-3#1)(1994-3#1)(2008-10#1)(2008-7#1)
incentive##32##1##(1991-12#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1993-3#1)(1993-6#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-4#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
incentive&quot##2##1##(2008-8#2)
incentives among##2##2##(1996-12#1)(2008-1#1)
incentives and##4##2##(1991-2#1)(1997-1#1)(2008-7#1)(2011-2#1)
incentives are##3##2##(1996-12#1)(1997-2#1)(2008-7#1)
incentives as##2##2##(1993-12#1)(1996-12#1)
incentives for##12##2##(1991-12#1)(1991-3#1)(1993-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-8#1)
incentives in##4##2##(1992-3#1)(1993-12#1)(1994-1#1)(1996-12#1)
incentives that##4##2##(1994-2#1)(1997-1#2)(2009-6#1)
incentives to increase##2##3##(2008-6#1)(2012-3#1)
incentives to##10##2##(1993-3#1)(1994-2#1)(1994-3#2)(1995-2#1)(1997-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
incentives##71##1##(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1994-1#1)(1994-2#3)(1994-3#3)(1995-2#1)(1995-3#1)(1996-12#5)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#5)(1997-3#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#6)(2009-6#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)
inception cohort##2##2##(2008-3#1)(2009-2#1)
inception in 1990##2##3##(1995-12#1)(2008-1#1)
inception in##6##2##(1995-12#1)(1996-3#1)(2008-1#2)(2010-8#1)(2011-1#1)
inception##25##1##(1995-12#2)(1996-11#1)(1996-3#2)(1997-3#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)
incessant##2##1##(2010-1#1)(2013-1#1)
incessantly##2##1##(2008-5#1)(2008-7#1)
incest avoidance##2##2##(2008-9#2)
incest in Palau##4##3##(2008-1#4)
incest in the Palauan society##2##5##(2008-1#2)
incest in##6##2##(2008-1#6)
incest is defined vertically and horizontally##2##6##(2008-1#2)
incest is defined##4##3##(2008-1#4)
incest is##5##2##(2008-1#5)
incest##19##1##(1996-5#2)(2008-1#14)(2008-9#3)
inches##2##1##(2007-9#1)(2010-6#1)
incidence among##13##2##(1995-9#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
incidence and death##2##3##(2010-12#1)(2010-9#1)
incidence and incidence##2##3##(2008-11#1)(2008-2#1)
incidence and mortality in##2##4##(1996-3#1)(2009-5#1)
incidence and mortality##7##3##(1991-6#1)(1992-12#1)(1994-9#1)(1996-3#1)(2009-5#2)(2011-2#1)
incidence and on the##2##4##(1991-5#1)(2008-3#1)
incidence and prevalence of##9##4##(1992-2#1)(1996-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2010-6#1)(2011-1#1)
incidence and prevalence##14##3##(1992-2#2)(1996-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-12#1)(2010-6#1)(2011-1#1)(2011-2#3)
incidence and risk factors##2##4##(2009-9#1)(2012-2#1)
incidence and severity increased with##2##5##(2008-10#2)
incidence and severity of Fusarium ear rot and##2##8##(2008-10#2)
incidence and severity of##11##4##(2007-8#2)(2008-10#7)(2008-5#1)(2012-3#1)
incidence and severity on day##2##5##(2008-10#2)
incidence and severity on##3##4##(2008-10#3)
incidence and severity were##5##4##(2008-10#5)
incidence and severity##46##3##(2007-8#2)(2008-10#42)(2008-5#1)(2012-3#1)
incidence and significance##2##3##(1991-11#1)(2008-3#1)
incidence and sources of##2##4##(2008-11#1)(2011-2#1)
incidence and the##5##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
incidence and time##2##3##(1995-5#1)(2008-10#1)
incidence and treatment##2##3##(2008-6#1)(2011-2#1)
incidence and##137##2##(1990-11#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-11#1)(1994-9#3)(1995-5#2)(1996-11#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#63)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-5#2)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
incidence angle of##4##3##(2007-11#1)(2008-3#3)
incidence angle##17##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#10)
incidence angles of##3##3##(2007-11#1)(2008-3#2)
incidence angles##9##2##(2007-11#3)(2008-2#1)(2008-3#5)
incidence are##5##2##(1995-5#1)(2008-10#3)(2008-2#1)
incidence as##3##2##(1990-6#1)(2008-10#2)
incidence at the group scale and##2##6##(2008-10#2)
incidence at the scale of the individual tree##2##8##(2008-10#2)
incidence at the##12##3##(2008-10#12)
incidence at##22##2##(1996-12#1)(2008-10#20)(2008-2#1)
incidence between the##2##3##(2008-10#2)
incidence between##4##2##(2008-10#4)
incidence but##2##2##(1990-3#1)(2011-2#1)
incidence by##6##2##(2008-10#4)(2008-2#2)
incidence can be##2##3##(1994-9#1)(2008-10#1)
incidence can##3##2##(1994-9#1)(2008-10#2)
incidence data were##2##3##(1991-3#1)(2008-10#1)
incidence data##14##2##(1991-3#2)(1994-9#2)(2008-10#9)(2008-8#1)
incidence densities##3##2##(1994-2#3)
incidence density##4##2##(1994-2#1)(2008-11#2)(2011-1#1)
incidence during##2##2##(1996-11#1)(2008-10#1)
incidence for##4##2##(1993-9#1)(1994-2#1)(2008-4#1)(2009-5#1)
incidence from##6##2##(2008-10#4)(2008-3#1)(2009-8#1)
incidence function##3##2##(1997-4#1)(2008-9#2)
incidence had##2##2##(1994-9#1)(2008-10#1)
incidence has been##2##3##(1990-11#1)(1995-2#1)
incidence has##4##2##(1990-11#1)(1991-4#1)(1995-2#1)(1996-11#1)
incidence in a##6##3##(1991-4#1)(2008-10#4)(2012-1#1)
incidence in the population##2##4##(1993-2#1)(2011-2#1)
incidence in the##21##3##(1991-6#2)(1992-6#1)(1992-9#2)(1993-2#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
incidence in women##3##3##(1994-9#2)(2011-2#1)
incidence in##69##2##(1990-2#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-2#1)(1994-9#2)(1995-2#1)(1996-3#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2010-4#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#2)
incidence increased in the##2##4##(2006-8#1)(2008-10#1)
incidence increased##6##2##(1997-6#1)(2006-8#1)(2008-10#3)(2008-7#1)
incidence is estimated to be##2##5##(2012-1#1)(2013-7#1)
incidence is not##2##3##(1997-3#1)(2008-7#1)
incidence is##28##2##(1991-12#1)(1991-3#1)(1997-3#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#5)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
incidence may be##2##3##(2008-1#1)(2008-10#1)
incidence may##4##2##(2008-1#1)(2008-10#2)(2008-5#1)
incidence observed##2##2##(2008-10#1)(2011-2#1)
incidence of 0##5##3##(2008-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
incidence of 45##2##3##(2008-2#1)(2013-8#1)
incidence of 5##2##3##(2008-3#1)(2010-10#1)
incidence of AIDS##2##3##(1997-3#1)(1997-6#1)
incidence of AWR##2##3##(2008-10#2)
incidence of CBS in##2##4##(2011-2#2)
incidence of CSF##3##3##(2011-2#1)(2012-3#2)
incidence of EPS##2##3##(2011-2#2)
incidence of ESRD##3##3##(1991-3#1)(2007-7#1)(2008-4#1)
incidence of H##2##3##(1997-1#1)(2008-1#1)
incidence of RCC##3##3##(2008-1#2)(2011-2#1)
incidence of T2D##3##3##(2009-3#3)
incidence of TB in children##2##5##(2011-2#1)(2013-7#1)
incidence of TB##3##3##(2011-2#1)(2013-7#2)
incidence of TBE in Thurgau##2##5##(1996-11#2)
incidence of V##3##3##(1994-12#2)(2008-10#1)
incidence of a##4##3##(1993-12#1)(2007-12#1)(2008-7#2)
incidence of access site##2##4##(2011-2#2)
incidence of acute complications in children with diabetes##2##8##(1994-6#2)
incidence of acute##12##3##(1990-9#1)(1991-9#1)(1994-6#2)(1996-6#1)(2007-7#2)(2008-1#2)(2008-8#1)(2012-12#1)(2013-8#1)
incidence of adenocarcinoma##2##3##(2008-1#2)
incidence of aggression##2##3##(2008-7#1)(2012-3#1)
incidence of allergic##2##3##(1992-3#1)(2008-5#1)
incidence of apoptosis##3##3##(1996-12#1)(2008-7#1)(2013-1#1)
incidence of arterial##2##3##(1992-3#1)(2009-3#1)
incidence of autoimmune disease##2##4##(1996-11#1)(2008-10#1)
incidence of bacteremia##3##3##(1990-2#1)(2007-7#1)(2013-1#1)
incidence of bacterial##2##3##(2007-8#1)(2012-3#1)
incidence of blossom##2##3##(2008-10#2)
incidence of both##6##3##(1997-4#1)(2007-10#1)(2008-10#2)(2008-12#1)(2011-2#1)
incidence of breast##4##3##(1994-12#1)(2008-7#1)(2013-7#2)
incidence of brown stem rot##4##5##(2008-10#4)
incidence of calcium##2##3##(1992-9#1)(2009-12#1)
incidence of cancer##6##3##(1994-5#1)(2008-4#1)(2008-7#2)(2011-1#1)(2012-8#1)
incidence of cardiovascular##2##3##(2008-7#1)(2010-6#1)
incidence of central nervous system (CNS)##2##6##(2011-2#1)(2012-2#1)
incidence of certain##3##3##(1992-9#1)(1994-5#1)(2008-8#1)
incidence of chronic##3##3##(1992-2#1)(2008-1#1)(2008-7#1)
incidence of clinical mastitis##2##4##(1992-2#1)(1996-8#1)
incidence of complications was##3##4##(1991-8#1)(2008-1#1)(2008-9#1)
incidence of complications##10##3##(1991-8#1)(1993-11#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-9#2)(2012-2#1)(2013-1#1)
incidence of confirmed##2##3##(1991-11#1)(2008-1#1)
incidence of congenital##5##3##(1990-9#2)(2008-7#1)(2011-1#1)(2012-12#1)
incidence of coronary##2##3##(1996-3#1)(2010-9#1)
incidence of diffuse malignant mesothelioma##2##5##(1991-12#2)
incidence of disease##4##3##(2008-10#4)
incidence of distant metastases##3##4##(2008-6#2)(2010-3#1)
incidence of early##2##3##(1991-3#1)(2013-1#1)
incidence of elevated urinary Cd##2##5##(1997-4#2)
incidence of emergence##2##3##(2011-2#2)
incidence of errorless trials##2##4##(1992-12#2)
incidence of extraintestinal##2##3##(2013-8#2)
incidence of fever in the GM-CSF group##2##7##(2008-7#2)
incidence of fever##3##3##(2008-7#3)
incidence of fire blight##5##4##(2008-10#5)
incidence of flower infection##3##4##(2008-10#3)
incidence of flower##4##3##(2008-10#4)
incidence of flowers with ray##3##5##(2008-10#3)
incidence of fractures##3##3##(1995-11#1)(2007-8#1)(2010-10#1)
incidence of fruit brown rot##2##5##(2008-10#2)
incidence of fruit rot at##2##5##(2008-10#2)
incidence of fruit##6##3##(2008-10#6)
incidence of gastrointestinal##2##3##(2006-10#1)(2010-6#1)
incidence of heart##4##3##(2008-10#1)(2008-3#1)(2010-8#2)
incidence of hepatitis A##3##4##(2007-12#2)(2011-1#1)
incidence of hepatitis##4##3##(2007-12#2)(2007-7#1)(2011-1#1)
incidence of hepatocellular carcinoma##3##4##(2006-10#1)(2013-7#1)(2013-8#1)
incidence of hepatomas##2##3##(1990-6#2)
incidence of human##2##3##(1992-2#1)(2011-2#1)
incidence of infection and##3##4##(2007-7#1)(2008-10#1)(2008-7#1)
incidence of infection by##3##4##(2008-10#3)
incidence of infection in##2##4##(2008-10#2)
incidence of infection##12##3##(2007-12#1)(2007-7#1)(2008-10#7)(2008-7#1)(2010-10#1)(2011-2#1)
incidence of injury##2##3##(2007-8#1)(2013-1#1)
incidence of interstitial##2##3##(2007-4#1)(2008-8#1)
incidence of invasive##2##3##(1990-6#1)(1997-2#1)
incidence of ischemic##2##3##(2007-10#1)(2008-7#1)
incidence of isolation##3##3##(2008-10#3)
incidence of late##2##3##(2008-6#1)(2011-2#1)
incidence of latent fruit infection##2##5##(2008-10#2)
incidence of latent infection (ILI) of##2##6##(2008-10#2)
incidence of latent infection (ILI)##3##5##(2008-10#3)
incidence of latent infection##5##4##(2008-10#5)
incidence of latent##7##3##(2008-10#7)
incidence of lateral##2##3##(2008-8#1)(2013-1#1)
incidence of leaf blight##2##4##(2008-10#2)
incidence of leaf##3##3##(2008-10#3)
incidence of lettuce drop##2##4##(2008-10#2)
incidence of liver##2##3##(1990-6#1)(2012-12#1)
incidence of local##2##3##(1990-3#1)(2008-6#1)
incidence of lung cancer in##2##5##(1991-4#1)(2008-12#1)
incidence of lung cancer##3##4##(1991-4#1)(2008-12#1)(2010-5#1)
incidence of malaria##4##3##(2012-12#2)(2012-3#2)
incidence of malignant melanoma##3##4##(2007-10#1)(2011-2#2)
incidence of malignant##6##3##(1995-2#1)(2007-10#1)(2008-8#1)(2010-12#1)(2011-2#2)
incidence of melanoma##4##3##(2011-2#4)
incidence of metabolic syndrome##2##4##(2008-3#1)(2013-1#1)
incidence of morbidity and mortality##2##5##(2007-8#1)(2008-3#1)
incidence of mortality##2##3##(2008-7#1)(2012-3#1)
incidence of nausea##2##3##(2008-7#1)(2012-2#1)
incidence of new##2##3##(1991-8#1)(2012-2#1)
incidence of obesity##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
incidence of oesophageal and gastric##2##5##(2008-11#2)
incidence of other##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
incidence of pathological##2##3##(1990-11#1)(1993-3#1)
incidence of postoperative infections##2##4##(1990-11#1)(1991-5#1)
incidence of postoperative##6##3##(1990-11#1)(1991-11#2)(1991-5#1)(2007-8#2)
incidence of primary access failure##2##5##(2007-7#2)
incidence of primary##3##3##(1996-11#1)(2007-7#2)
incidence of prostate cancer##4##4##(2008-6#1)(2010-1#1)(2010-12#1)(2013-1#1)
incidence of pulmonary##2##3##(2008-10#1)(2008-9#1)
incidence of recurrent##2##3##(1990-2#1)(1997-4#1)
incidence of renal tumors##2##4##(1994-5#2)
incidence of renal##3##3##(1994-5#2)(2011-2#1)
incidence of respiratory##2##3##(1992-2#1)(1997-2#1)
incidence of rotavirus##2##3##(2009-5#1)(2011-2#1)
incidence of secondary##2##3##(1993-8#1)(2008-12#1)
incidence of serious##4##3##(1995-5#1)(1997-2#1)(2008-8#1)(2011-2#1)
incidence of severe##2##3##(1990-12#1)(2008-7#1)
incidence of side-effects##3##3##(2008-5#1)(2011-2#2)
incidence of spontaneous##2##3##(1990-8#1)(2008-7#1)
incidence of squamous cell##2##4##(2008-1#1)(2008-9#1)
incidence of stems with ray blight##5##6##(2008-10#5)
incidence of stems with##6##4##(2008-10#6)
incidence of strawberry##3##3##(2008-10#3)
incidence of stroke in the##2##5##(2007-8#2)
incidence of stroke in##4##4##(1995-5#1)(2007-8#3)
incidence of stroke##8##3##(1995-5#2)(2007-8#4)(2008-8#2)
incidence of sudden infant death syndrome##3##6##(1991-11#2)(1991-9#1)
incidence of sudden infant death##4##5##(1991-11#2)(1991-9#1)(1992-4#1)
incidence of surgical##3##3##(2008-9#1)(2012-3#2)
incidence of t-ESRD##2##3##(2008-4#2)
incidence of the disease in the##2##6##(1994-9#1)(2008-10#1)
incidence of the disease in##4##5##(1992-9#1)(1994-9#1)(2008-10#2)
incidence of the disease##9##4##(1991-4#1)(1992-9#1)(1994-9#1)(1997-6#1)(2007-7#1)(2008-10#3)(2011-2#1)
incidence of the##27##3##(1990-10#1)(1990-2#1)(1991-4#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
incidence of this complication##3##4##(1991-3#1)(2013-1#2)
incidence of this##7##3##(1990-6#1)(1991-3#1)(1993-3#1)(2008-11#1)(2010-5#1)(2013-1#2)
incidence of tuberculosis##4##3##(1996-3#1)(2008-1#1)(2009-7#1)(2013-1#1)
incidence of tumor-bearing mice with an average of##4##8##(1990-7#4)
incidence of varicocele##3##3##(1990-3#3)
incidence of vascular##2##3##(2011-2#1)(2013-1#1)
incidence of wound infections##2##4##(1990-3#1)(2007-8#1)
incidence of##830##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#7)(1990-5#1)(1990-6#11)(1990-7#4)(1990-8#3)(1990-9#4)(1991-10#1)(1991-11#8)(1991-12#4)(1991-2#4)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#2)(1991-8#6)(1991-9#2)(1992-10#1)(1992-12#4)(1992-2#7)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#3)(1992-9#5)(1993-10#1)(1993-11#2)(1993-12#6)(1993-3#4)(1993-8#4)(1993-9#4)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#5)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#7)(1996-12#2)(1996-3#4)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#5)(2006-8#1)(2007-10#7)(2007-11#7)(2007-12#10)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#18)(2007-8#24)(2008-1#23)(2008-10#141)(2008-11#12)(2008-12#8)(2008-2#6)(2008-3#12)(2008-4#11)(2008-5#5)(2008-6#9)(2008-7#43)(2008-8#20)(2008-9#20)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#59)(2012-1#5)(2012-12#11)(2012-2#10)(2012-3#17)(2012-8#1)(2013-1#47)(2013-7#7)(2013-8#13)
incidence on fruit in the tree##2##6##(2008-10#2)
incidence on the##4##3##(1995-12#1)(2007-11#1)(2010-3#1)(2011-2#1)
incidence on white fir##3##4##(2008-10#3)
incidence on##16##2##(1991-6#1)(1995-12#1)(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#1)(2010-3#1)(2011-2#1)
incidence or##7##2##(1994-2#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-7#1)
incidence over##3##2##(1993-11#1)(1994-9#1)(2008-10#1)
incidence ranged from##2##3##(2008-10#2)
incidence ranges from 0##2##4##(2010-6#1)(2013-1#1)
incidence ranging from 0##2##4##(2008-10#1)(2011-2#1)
incidence ranging from##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
incidence rate of##4##3##(1994-12#1)(2007-12#1)(2011-2#1)(2012-2#1)
incidence rate ratio##2##3##(2008-11#1)(2012-2#1)
incidence rate was 0##2##4##(2011-2#2)
incidence rate was##4##3##(1996-8#1)(2011-2#2)(2012-2#1)
incidence rate##24##2##(1992-10#1)(1993-2#1)(1994-11#1)(1994-12#3)(1995-5#1)(1996-3#1)(1996-8#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-2#4)(2012-2#4)(2012-3#1)
incidence rates and##3##3##(2008-7#1)(2010-3#1)(2012-2#1)
incidence rates for##2##3##(2008-7#1)(2012-2#1)
incidence rates of##4##3##(2008-7#1)(2010-3#1)(2010-8#1)(2013-1#1)
incidence rates##20##2##(1991-2#1)(1991-6#1)(1992-2#2)(1994-12#1)(1996-3#1)(2008-1#1)(2008-7#3)(2010-3#2)(2010-8#1)(2012-2#3)(2012-3#2)(2013-1#2)
incidence relationships##2##2##(2008-10#2)
incidence relative to##2##3##(2008-10#2)
incidence remained##2##2##(2008-10#2)
incidence shows a##2##3##(1997-3#1)(2007-10#1)
incidence studies##2##2##(2008-8#2)
incidence that##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
incidence to##5##2##(1990-3#1)(2008-10#4)
incidence trends##2##2##(1993-9#1)(1996-3#1)
incidence values##4##2##(2008-10#4)
incidence was 0##3##3##(2008-10#2)(2012-3#1)
incidence was found##2##3##(1990-6#1)(2007-7#1)
incidence was higher##2##3##(2008-10#2)
incidence was low in##3##4##(1992-10#1)(2008-10#2)
incidence was low##5##3##(1992-10#1)(2008-10#3)(2013-8#1)
incidence was not##6##3##(2008-10#5)(2013-8#1)
incidence was observed##2##3##(1990-6#1)(1996-8#1)
incidence was positively correlated with##3##5##(2008-10#3)
incidence was reduced by##2##4##(2008-10#2)
incidence was significantly higher##2##4##(1992-10#1)(1992-5#1)
incidence was significantly##3##3##(1992-10#1)(1992-5#1)(2008-10#1)
incidence was##56##2##(1990-3#2)(1990-6#2)(1991-8#1)(1992-10#2)(1992-5#1)(1994-2#1)(1996-11#1)(1996-8#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-10#37)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
incidence were##4##2##(2008-10#3)(2008-3#1)
incidence will##3##2##(1992-2#1)(1992-9#1)(1995-2#1)
incidence with a##2##3##(2007-10#1)(2007-12#1)
incidence with##9##2##(1990-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#4)(2012-12#1)
incidence would##2##2##(2008-10#1)(2008-7#1)
incidence##1646##1##(1990-10#1)(1990-11#7)(1990-12#2)(1990-2#8)(1990-3#11)(1990-5#1)(1990-6#14)(1990-7#4)(1990-8#3)(1990-9#4)(1991-10#1)(1991-11#11)(1991-12#7)(1991-2#7)(1991-3#9)(1991-4#8)(1991-5#4)(1991-6#11)(1991-8#7)(1991-9#2)(1992-10#4)(1992-12#6)(1992-2#14)(1992-3#5)(1992-4#3)(1992-5#7)(1992-6#4)(1992-8#1)(1992-9#14)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#2)(1993-3#5)(1993-5#1)(1993-8#5)(1993-9#9)(1994-11#5)(1994-12#11)(1994-2#10)(1994-3#3)(1994-5#5)(1994-6#3)(1994-7#1)(1994-9#14)(1995-11#1)(1995-12#8)(1995-2#4)(1995-5#13)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#13)(1996-12#3)(1996-3#11)(1996-5#1)(1996-6#3)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#18)(1997-4#7)(1997-5#4)(1997-6#7)(1997-7#1)(1997-8#2)(2006-10#5)(2006-8#3)(2007-10#11)(2007-11#15)(2007-12#24)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#21)(2007-8#27)(2007-9#1)(2008-1#32)(2008-10#465)(2008-11#24)(2008-12#10)(2008-2#34)(2008-3#80)(2008-4#14)(2008-5#8)(2008-6#14)(2008-7#70)(2008-8#29)(2008-9#24)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#7)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#3)(2010-12#7)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#2)(2010-6#8)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#16)(2011-2#92)(2011-3#2)(2012-1#7)(2012-12#17)(2012-2#18)(2012-3#29)(2012-8#1)(2013-1#66)(2013-7#8)(2013-8#16)
incidence) were##2##2##(2008-10#2)
incidence)##6##1##(2008-10#4)(2010-3#1)(2012-12#1)
incidence-angle##2##1##(2007-12#1)(2008-3#1)
incidence-density##2##1##(2008-10#2)
incidences and##3##2##(1997-6#1)(2008-9#2)
incidences and/or severities of cytoplasmic vacuolization of the hepatocyte##2##9##(2008-9#2)
incidences and/or severities of##3##4##(2008-9#3)
incidences and/or##4##2##(2008-9#4)
incidences at##2##2##(1997-6#1)(2008-10#1)
incidences in the##2##3##(2009-3#1)(2012-3#1)
incidences in##3##2##(2008-9#1)(2009-3#1)(2012-3#1)
incidences of epidermal hyperplasia##2##4##(2008-9#2)
incidences of epidermal##3##3##(2008-9#3)
incidences of infection##2##3##(2008-10#2)
incidences of minimal to##2##4##(2008-8#1)(2008-9#1)
incidences of neoplasms##4##3##(1995-11#1)(2008-9#3)
incidences of renal tubule degeneration in##2##6##(2008-9#2)
incidences of renal tubule##4##4##(2008-9#4)
incidences of squamous cell papilloma##4##5##(2008-9#4)
incidences of squamous cell##6##4##(2008-9#6)
incidences of thyroid gland##2##4##(2008-9#2)
incidences of##56##2##(1992-9#1)(1995-11#1)(1997-6#1)(1997-7#1)(2007-7#2)(2008-10#3)(2008-8#2)(2008-9#41)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
incidences were##2##2##(1992-2#1)(2011-2#1)
incidences##84##1##(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-6#3)(1997-7#1)(2007-11#1)(2007-7#2)(2008-10#7)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#49)(2009-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)
incident analysis##2##2##(2008-11#1)(2009-10#1)
incident and##7##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
incident angle of the##3##4##(2008-2#1)(2008-3#2)
incident angle of##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
incident angle##15##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#8)
incident angles of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
incident angles##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
incident beam are##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
incident beam##20##2##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#11)
incident beams##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
incident cases of##5##3##(1992-12#1)(1992-9#1)(1993-9#1)(2012-2#1)(2013-1#1)
incident cases##11##2##(1991-2#1)(1992-10#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-9#1)(1994-9#1)(1997-3#1)(2012-2#1)(2013-1#1)
incident distress##2##2##(2012-1#2)
incident energy##3##2##(2007-11#2)(2008-2#1)
incident field##3##2##(2007-11#1)(2008-2#2)
incident from##3##2##(2007-11#1)(2008-3#2)
incident fundamental##3##2##(2007-12#2)(2008-3#1)
incident illumination##2##2##(2008-3#2)
incident in##2##2##(1997-1#1)(2008-7#1)
incident intensities##2##2##(2007-12#1)(2008-3#1)
incident laser beam##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
incident laser power##2##3##(2007-11#1)(2008-11#1)
incident laser##13##2##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#4)(2011-1#1)
incident light and##4##3##(2008-2#2)(2008-3#2)
incident light is##4##3##(2007-12#3)(2008-3#1)
incident light##39##2##(2007-11#4)(2007-12#8)(2008-10#2)(2008-2#4)(2008-3#21)
incident on a##3##3##(2008-3#3)
incident on the##7##3##(2008-10#1)(2008-2#3)(2008-3#3)
incident on##12##2##(2008-10#1)(2008-2#3)(2008-3#8)
incident optical##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
incident photon##2##2##(2008-2#1)(2008-3#1)
incident plane wave##3##3##(2008-3#3)
incident plane##4##2##(2008-3#4)
incident polarization states##2##3##(2008-2#1)(2008-3#1)
incident polarization##3##2##(2008-2#1)(2008-3#2)
incident power##6##2##(2007-12#2)(2008-12#1)(2008-3#2)(2013-7#1)
incident pump power##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
incident pump##9##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2008-7#1)
incident radiation##10##2##(2008-2#5)(2008-3#5)
incident rain intensity##3##3##(2008-10#3)
incident reports and nurse's and patient's perspectives##2##7##(2010-10#2)
incident technique##2##2##(2010-10#2)
incident upon a##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
incident upon the##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
incident upon##13##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#4)
incident wave##6##2##(2008-2#1)(2008-3#5)
incident wavelength##8##2##(2008-2#3)(2008-3#4)(2013-8#1)
incident waves##2##2##(2007-11#1)(2008-2#1)
incident##295##1##(1990-6#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-9#3)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#3)(2007-11#23)(2007-12#30)(2007-2#2)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#51)(2008-3#111)(2008-5#1)(2008-6#1)(2008-7#3)(2009-1#1)(2009-10#5)(2010-10#6)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
incident-beam##2##1##(2008-3#2)
incidental detection##2##2##(2007-10#1)(2008-7#1)
incidental finding##11##2##(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(2007-8#2)(2008-12#1)(2008-7#1)(2011-2#2)(2013-8#1)
incidental findings in##2##3##(1990-9#1)(1993-9#1)
incidental findings##5##2##(1990-9#2)(1993-9#1)(2008-10#1)(2008-7#1)
incidental##36##1##(1990-9#2)(1991-3#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1995-11#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
incidentally detected##4##2##(2008-7#1)(2013-1#2)(2013-7#1)
incidentally discovered##2##2##(2008-5#1)(2009-3#1)
incidentally during##5##2##(1997-3#1)(2008-11#1)(2008-7#1)(2009-1#1)(2011-2#1)
incidentally or##2##2##(1991-5#1)(2013-1#1)
incidentally##26##1##(1991-5#1)(1995-8#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
incidentaloma##4##1##(2008-4#1)(2008-5#1)(2009-7#1)(2012-12#1)
incidents and##4##2##(1995-3#1)(2009-10#1)(2010-11#1)(2013-1#1)
incidents in##3##2##(1996-2#1)(2008-11#2)
incidents involving TB##3##3##(2010-5#3)
incidents involving tourists##6##3##(2007-2#6)
incidents involving##13##2##(1992-12#1)(2007-2#6)(2010-1#1)(2010-5#3)(2011-2#1)(2012-12#1)
incidents is##2##2##(2008-11#2)
incidents occur in##2##3##(1991-12#1)(1993-12#1)
incidents occurred##2##2##(2008-10#1)(2008-6#1)
incidents of##8##2##(1991-6#1)(1993-2#1)(1994-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
incidents##65##1##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(2007-2#14)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-6#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#4)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
incinerated bone##2##2##(1995-6#2)
incinerated##4##1##(1995-6#4)
incineration##6##1##(2008-10#5)(2008-6#1)
incinerator and##3##2##(1992-3#1)(2008-10#2)
incinerator##4##1##(1992-3#1)(2008-10#2)(2008-3#1)
incipient speciation##2##2##(2008-9#1)(2012-3#1)
incipient##14##1##(1994-2#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
incisal##3##1##(1993-12#1)(2010-3#1)(2012-2#1)
incised plate (TIP)##3##3##(2008-10#1)(2009-5#2)
incised plate urethroplasty##2##3##(2009-5#2)
incised plate##7##2##(2008-10#3)(2009-5#4)
incised##11##1##(2008-10#3)(2008-12#1)(2008-5#1)(2009-4#2)(2009-5#4)
incision and drainage of parapharyngeal abscess##2##6##(2009-7#2)
incision and drainage of##3##4##(2008-12#1)(2009-7#2)
incision and drainage##5##3##(2008-12#1)(2009-6#2)(2009-7#2)
incision and##12##2##(1994-9#1)(2008-10#1)(2008-12#2)(2009-6#2)(2009-7#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
incision at the##2##3##(1991-12#1)(2013-1#1)
incision below the left clavicle##2##5##(2012-12#2)
incision for##3##2##(2008-9#2)(2013-1#1)
incision in the##5##3##(1996-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
incision in##6##2##(1992-2#1)(1996-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
incision is##3##2##(2013-1#2)(2013-8#1)
incision of the##2##3##(2012-12#2)
incision was##2##2##(1992-2#1)(2008-12#1)
incision with##3##2##(1990-2#1)(2009-8#1)(2013-8#1)
incision##70##1##(1990-2#1)(1991-12#1)(1992-2#2)(1992-3#1)(1994-9#1)(1996-8#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#3)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#8)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
incisional biopsy##4##2##(1997-6#1)(2007-11#1)(2008-6#1)(2010-11#1)
incisional hernia repair##2##3##(2011-2#1)(2013-1#1)
incisional hernia##3##2##(2011-2#2)(2013-1#1)
incisional hernias##3##2##(2011-2#2)(2013-1#1)
incisional wound site pain##2##4##(2012-12#2)
incisional##17##1##(1994-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#2)
incisions and##2##2##(2007-8#1)(2011-2#1)
incisions##15##1##(1992-1#1)(1992-2#2)(2007-8#5)(2008-10#1)(2008-9#2)(2011-2#2)(2013-1#2)
incisor positioning##2##2##(2010-3#2)
incisor teeth reimplantation##2##3##(1990-10#2)
incisor teeth##5##2##(1990-10#2)(1996-3#3)
incisor were##2##2##(1993-12#1)(2008-12#1)
incisor with##3##2##(1990-3#1)(2012-12#2)
incisor##23##1##(1990-10#2)(1990-3#3)(1993-12#1)(1996-3#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#4)(2012-12#2)(2012-2#1)(2013-1#3)
incisors and##2##2##(2010-11#1)(2012-12#1)
incisors##19##1##(1990-6#1)(2008-11#1)(2008-12#1)(2009-7#2)(2009-8#2)(2010-11#1)(2012-12#3)(2012-2#1)(2013-1#7)
incited by##5##2##(2008-10#5)
incited significantly##2##2##(2008-10#2)
incited the##2##2##(2008-10#2)
incited##11##1##(2008-10#11)
inciting##3##1##(2008-10#3)
incl##2##1##(1995-5#2)
inclination and##2##2##(2008-11#1)(2008-12#1)
inclination angle##3##2##(2008-3#3)
inclination is##2##2##(2008-2#1)(2008-3#1)
inclination of the##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-7#1)
inclination##22##1##(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#14)(2009-7#2)(2012-12#1)
inclinations##3##1##(2007-11#1)(2008-10#1)(2008-3#1)
inclined to##6##2##(1994-3#1)(2007-11#1)(2008-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
inclined##19##1##(1990-3#1)(1993-12#1)(1994-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#7)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
inclines##2##1##(1994-5#1)(2013-1#1)
include (1)##5##2##(1991-12#1)(1992-9#1)(2008-12#1)(2008-3#1)(2012-2#1)
include (a)##2##2##(1994-1#1)(2012-2#1)
include (i)##2##2##(2008-1#1)(2008-10#1)
include DNA replication##2##3##(2008-7#1)(2011-2#1)
include a description##2##3##(1996-1#1)(1996-2#1)
include a low##2##3##(2008-2#1)(2010-5#1)
include a reduced##2##3##(1993-12#1)(2007-2#1)
include a##71##2##(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
include absorption##2##2##(2008-3#2)
include adequate##2##2##(2008-1#1)(2010-7#1)
include alcohol and##2##3##(1990-2#1)(2008-1#1)
include alignment of##2##3##(2008-3#1)(2008-4#1)
include all##6##2##(1991-11#1)(1993-12#1)(1997-3#1)(2008-10#1)(2010-3#1)(2011-2#1)
include also##2##2##(1995-5#1)(2008-7#1)
include an array of##2##4##(2008-4#1)(2009-12#1)
include an##15##2##(1991-12#1)(1995-1#1)(1996-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-12#1)(2010-10#1)
include any##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
include approaches##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
include automated##2##2##(1995-3#1)(2008-4#1)
include background##2##2##(1993-12#1)(2010-6#1)
include basic##2##2##(1993-12#1)(2008-4#1)
include bed rest##2##3##(2008-7#2)
include behavioral therapy##2##3##(2008-8#2)
include behavioral##3##2##(2008-8#2)(2008-9#1)
include behavioural##2##2##(2008-1#1)(2008-11#1)
include biological##2##2##(2008-10#1)(2008-7#1)
include both##21##2##(1992-3#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2011-2#2)(2012-12#1)
include cases of##2##3##(1991-9#1)(2008-1#1)
include cell##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
include changes in##2##3##(1993-1#1)(2009-7#1)
include commonly used##2##3##(2006-10#1)(2008-5#1)
include consideration of##2##3##(2008-12#1)(2011-2#1)
include cytokine##2##2##(1994-8#1)(2008-10#1)
include data##3##2##(1996-2#1)(2008-1#1)(2008-12#1)
include decreased##2##2##(2008-1#1)(2008-11#1)
include detailed##2##2##(2010-9#1)(2012-2#1)
include developing##2##2##(2009-5#1)(2010-5#1)
include developmental##2##2##(1995-8#1)(2009-3#1)
include direct##2##2##(2008-10#1)(2008-9#1)
include discussion of##2##3##(2011-2#1)(2012-2#1)
include early##2##2##(1995-3#1)(2008-3#1)
include education about##2##3##(2008-3#1)(2012-3#1)
include education##4##2##(1995-3#1)(2008-11#1)(2008-3#1)(2012-3#1)
include effects of##2##3##(2008-9#1)(2010-10#1)
include enhanced##4##2##(1992-2#1)(1996-1#1)(2007-7#1)(2010-7#1)
include evaluation of##2##3##(2008-2#1)(2010-12#1)
include evaluation##3##2##(1997-1#1)(2008-2#1)(2010-12#1)
include examining##2##2##(1996-2#1)(2008-9#1)
include features##2##2##(2008-9#1)(2011-2#1)
include four##2##2##(2008-12#1)(2012-3#1)
include genes##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
include genetic##3##2##(1993-9#1)(2008-3#1)(2008-8#1)
include good##2##2##(2007-12#1)(2008-11#1)
include greater##3##2##(2007-11#1)(2008-12#1)(2012-3#1)
include having##2##2##(2008-11#1)(2012-2#1)
include healthcare##2##2##(2011-2#1)(2012-12#1)
include heart##4##2##(2010-4#1)(2013-8#3)
include highly##2##2##(2009-11#1)(2013-1#1)
include hypertension##2##2##(2008-1#1)(2008-2#1)
include identification of##2##3##(2008-4#1)(2010-10#1)
include identification##3##2##(2008-4#1)(2010-10#1)(2010-7#1)
include improved##3##2##(1992-12#1)(2008-10#1)(2008-6#1)
include in##3##2##(1997-2#1)(2008-2#1)(2011-2#1)
include increased##6##2##(1990-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
include infection##4##2##(2008-10#3)(2012-2#1)
include information on##2##3##(1996-3#1)(2008-4#1)
include information##3##2##(1996-3#1)(2008-3#1)(2008-4#1)
include inhibition of##2##3##(2008-1#1)(2008-5#1)
include inhibitory##2##2##(1997-3#1)(2012-12#1)
include initial##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
include its ability to##2##4##(2007-11#1)(2011-7#1)
include its##6##2##(2007-11#2)(2008-2#1)(2010-7#1)(2011-1#1)(2011-7#1)
include known##2##2##(1995-12#1)(2012-2#1)
include lack of##3##3##(1996-1#1)(2009-11#1)(2012-3#1)
include lower##3##2##(1993-1#1)(1996-4#1)(2012-2#1)
include mainly##2##2##(2008-5#1)(2008-7#1)
include maintaining##2##2##(1997-2#1)(1997-3#1)
include management##2##2##(1994-12#1)(2008-8#1)
include modified##2##2##(1995-12#1)(2008-11#1)
include more##6##2##(1993-12#1)(1994-2#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)
include muscular##2##2##(2011-2#2)
include neurolysis##2##2##(2008-9#2)
include new##3##2##(1995-1#1)(2008-8#1)(2011-2#1)
include nonsteroidal anti-inflammatory drugs##2##4##(2010-1#1)(2012-3#1)
include nutrient##2##2##(2008-10#1)(2008-9#1)
include observation##2##2##(2006-12#1)(2007-12#1)
include one##2##2##(1997-4#1)(2008-4#1)
include only##2##2##(1992-9#1)(2007-11#1)
include patients with##2##3##(2008-2#1)(2011-2#1)
include patients##3##2##(1996-3#1)(2008-2#1)(2011-2#1)
include personal##2##2##(1997-3#1)(2008-11#1)
include previous##2##2##(2007-11#1)(2008-4#1)
include primary##3##2##(2007-7#1)(2012-3#2)
include problems with##2##3##(1992-3#1)(2008-11#1)
include proper##2##2##(2008-8#1)(2013-1#1)
include quality##2##2##(2008-6#1)(2008-7#1)
include reduced##2##2##(1992-8#1)(2008-10#1)
include screening##2##2##(2008-2#1)(2010-11#1)
include single##2##2##(2007-12#1)(2008-2#1)
include small##2##2##(2008-6#1)(2011-1#1)
include structural##2##2##(2008-5#1)(2010-11#1)
include studies of##2##3##(2007-12#1)(2008-4#1)
include studies##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2010-2#1)
include such##2##2##(2007-11#1)(2010-8#1)
include that##4##2##(1997-7#1)(2008-8#1)(2010-3#1)(2012-3#1)
include the ability to##3##4##(2008-1#1)(2008-10#1)(2009-6#1)
include the biologically##2##3##(1994-8#1)(2008-11#1)
include the concept of##2##4##(1990-3#1)(2008-10#1)
include the design and##2##4##(2008-10#1)(2010-11#1)
include the detection of##2##4##(2011-2#1)(2012-2#1)
include the effect of##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
include the effects of##3##4##(2008-10#1)(2008-9#1)(2010-6#1)
include the following##8##3##(1993-8#1)(1994-1#1)(2008-11#2)(2011-2#2)(2012-3#1)(2013-8#1)
include the high##2##3##(2008-7#1)(2009-2#1)
include the importance of##2##4##(1995-12#1)(2010-4#1)
include the need for##4##4##(2008-1#1)(2009-5#1)(2010-10#1)(2013-8#1)
include the possibility of##2##4##(2008-11#1)(2008-3#1)
include the role of##2##4##(2008-3#1)(2008-5#1)
include the study of##2##4##(2008-7#1)(2011-1#1)
include the use of##8##4##(1993-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-6#1)
include the##176##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#3)(1997-4#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#19)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#15)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#7)(2009-2#2)(2009-5#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#4)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#2)
include their##3##2##(2008-11#1)(2010-10#1)(2012-1#1)
include those that##2##3##(2007-2#1)(2008-9#1)
include those with##4##3##(2008-7#1)(2009-5#1)(2010-11#1)(2010-6#1)
include those##11##2##(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)
include three##4##2##(1993-2#1)(2007-5#1)(2010-12#1)(2012-2#1)
include total##2##2##(2007-11#1)(2007-12#1)
include treatment##2##2##(2008-11#1)(2010-3#1)
include two##4##2##(1990-8#1)(2008-10#1)(2008-12#1)(2013-7#1)
include urinary##2##2##(2007-7#1)(2012-12#1)
include use of##2##3##(2007-9#1)(2011-2#1)
include use##3##2##(2007-12#1)(2007-9#1)(2011-2#1)
include very##2##2##(2008-10#1)(2008-6#1)
include whether##2##2##(2008-4#1)(2008-5#1)
include working##2##2##(2008-11#1)(2013-1#1)
include##1190##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#5)(1991-5#2)(1991-7#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#10)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#4)(1993-11#2)(1993-12#10)(1993-2#3)(1993-3#7)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#10)(1994-2#6)(1994-3#3)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#9)(1995-5#4)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#11)(1996-3#13)(1996-4#3)(1996-5#1)(1996-6#3)(1997-1#8)(1997-2#4)(1997-3#14)(1997-4#4)(1997-5#4)(1997-7#3)(1997-8#2)(2006-10#4)(2006-12#3)(2006-5#1)(2007-10#4)(2007-11#17)(2007-12#31)(2007-2#6)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#13)(2007-8#4)(2007-9#2)(2008-1#29)(2008-10#108)(2008-11#55)(2008-12#24)(2008-2#32)(2008-3#60)(2008-4#40)(2008-5#22)(2008-6#22)(2008-7#46)(2008-8#32)(2008-9#38)(2009-11#11)(2009-12#7)(2009-2#3)(2009-3#2)(2009-5#6)(2009-6#7)(2009-7#7)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#10)(2010-11#8)(2010-12#10)(2010-2#3)(2010-3#10)(2010-4#7)(2010-5#10)(2010-6#7)(2010-7#13)(2010-8#12)(2010-9#1)(2011-1#15)(2011-2#60)(2011-3#2)(2011-4#1)(2011-7#2)(2012-1#3)(2012-12#11)(2012-2#30)(2012-3#28)(2013-1#36)(2013-7#2)(2013-8#15)
included &quot##2##2##(1992-2#1)(2011-2#1)
included (1)##3##2##(1992-2#1)(1994-3#1)(2013-1#1)
included (i)##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
included 1##6##2##(1991-6#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-7#1)(2009-10#1)
included 10##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
included 117##2##2##(2007-7#1)(2012-12#1)
included 12##3##2##(2008-10#1)(2008-5#1)(2010-7#1)
included 14##4##2##(1990-2#1)(2009-11#1)(2010-3#1)(2011-2#1)
included 15##2##2##(1997-8#1)(2009-8#1)
included 16##2##2##(2007-11#1)(2008-6#1)
included 2##2##2##(1997-4#1)(2008-7#1)
included 20##2##2##(1991-2#1)(2009-8#1)
included 21##3##2##(1992-9#1)(2008-1#1)(2010-3#1)
included 3##2##2##(2007-11#1)(2013-1#1)
included 30 patients with##2##4##(2009-8#1)(2013-8#1)
included 32 patients with##2##4##(2008-10#1)(2008-6#1)
included 40 patients##3##3##(2011-2#2)(2012-3#1)
included 50 patients##3##3##(2011-2#3)
included 6##2##2##(1997-7#1)(2009-7#1)
included 60##2##2##(2008-4#1)(2011-1#1)
included 9##2##2##(2007-11#1)(2013-1#1)
included a positive##2##3##(1992-3#1)(2008-12#1)
included a##42##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-8#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-10#2)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
included abdominal##2##2##(1992-2#1)(2008-11#1)
included about##2##2##(1991-8#1)(1992-12#1)
included age##5##2##(2007-7#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
included alcohol##2##2##(1993-12#1)(2009-9#1)
included all patients##2##3##(2007-10#1)(2007-8#1)
included all the patients##2##4##(2007-7#1)(2011-2#1)
included all##6##2##(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-2#1)
included among##2##2##(1991-8#1)(2013-7#1)
included an##7##2##(1993-1#1)(1993-2#1)(2008-1#1)(2008-10#3)(2013-1#1)
included and##7##2##(1990-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2011-2#1)
included anterior##2##2##(2008-8#1)(2012-1#1)
included are##6##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)
included as a##6##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-1#1)
included as an##4##3##(2008-10#2)(2008-12#1)(2008-4#1)
included as##16##2##(1996-1#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#2)
included at least##2##3##(1994-8#1)(2012-3#1)
included at##5##2##(1994-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
included because##2##2##(1990-9#1)(2008-10#1)
included bleeding##2##2##(1991-1#1)(2012-12#1)
included blood##2##2##(1995-12#1)(2008-7#1)
included body##2##2##(2008-5#1)(2010-4#1)
included both##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2012-3#1)
included children##2##2##(2008-12#1)(2009-10#1)
included chronic##2##2##(2007-7#1)(2008-9#1)
included clinical##2##2##(1992-3#1)(2008-5#1)
included data##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
included development of##2##3##(1994-12#1)(2010-8#1)
included diarrhea##2##2##(1992-8#1)(2011-2#1)
included epidermal hyperplasia##3##3##(2008-9#3)
included family planning services##2##4##(1994-8#2)
included five genes##2##3##(2008-10#2)
included five##3##2##(2008-10#2)(2011-2#1)
included for comparison##2##3##(1997-3#1)(2008-10#1)
included for the##7##3##(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#2)(2010-4#1)
included for##26##2##(1994-12#1)(1997-2#1)(1997-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#8)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)(2013-1#1)
included four##7##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
included headache##2##2##(2008-12#1)(2012-3#1)
included heart##2##2##(1992-6#1)(2012-2#1)
included history and physical examination##2##5##(2008-1#1)(2011-2#1)
included history##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
included hyperkeratosis##2##2##(2008-9#2)
included identifying the##2##3##(1996-3#1)(2013-8#1)
included identifying##3##2##(1996-3#1)(2007-4#1)(2013-8#1)
included in a study##2##4##(2007-7#1)(2011-2#1)
included in a##17##3##(1990-11#1)(1991-8#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)
included in an##3##3##(1993-2#1)(1996-12#1)(2008-10#1)
included in any##2##3##(1995-12#1)(2008-11#1)
included in beta-cyclodextrin in##2##4##(2008-10#2)
included in many##2##3##(2008-10#1)(2008-11#1)
included in our##2##3##(1991-6#1)(2008-10#1)
included in the analysis##6##4##(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
included in the array##2##4##(2008-10#2)
included in the calibration##2##4##(2008-10#2)
included in the current##3##4##(1993-12#1)(2011-2#1)(2013-1#1)
included in the differential diagnosis of##8##6##(1990-11#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
included in the differential diagnosis##11##5##(1990-11#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-11#1)(2013-1#1)(2013-8#1)
included in the formal##2##4##(2008-10#2)
included in the meta-analysis##2##4##(2009-9#1)(2012-3#1)
included in the model##7##4##(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)
included in the review##2##4##(2009-11#1)(2012-2#1)
included in the revised##2##4##(1995-12#1)(2011-2#1)
included in the same##3##4##(2008-10#1)(2008-6#1)(2009-8#1)
included in the studies##2##4##(2008-11#1)(2011-2#1)
included in the study##43##4##(1990-11#1)(1990-9#1)(1992-9#1)(1993-12#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#5)(2010-1#1)(2010-3#1)(2011-1#6)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
included in the##157##3##(1990-11#2)(1990-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#6)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
included in this study##27##4##(1994-3#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#4)
included in this unit##2##4##(2008-4#2)
included in this##45##3##(1993-12#1)(1994-12#1)(1994-3#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#5)(2013-8#1)
included in undergraduate##2##3##(1996-11#1)(2012-3#1)
included in##275##2##(1990-11#3)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#48)(2008-11#15)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#9)(2013-1#12)(2013-7#1)(2013-8#6)
included increased##4##2##(1996-1#1)(2008-1#1)(2008-12#1)(2012-12#1)
included individuals from##2##3##(2010-8#1)(2013-7#1)
included information##2##2##(1996-8#1)(2013-1#1)
included into the##4##3##(2007-11#1)(2008-10#2)(2008-12#1)
included is##6##2##(1992-1#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#2)
included isolates from##3##3##(2008-10#3)
included isolates of##3##3##(2008-10#3)
included isolates originating from##2##4##(2008-10#2)
included isolates##10##2##(2008-10#10)
included linear##2##2##(2008-10#2)
included loss of##2##3##(2008-10#1)(2012-1#1)
included many##2##2##(2009-11#1)(2010-12#1)
included medical##2##2##(2008-12#1)(2008-7#1)
included more##3##2##(2007-8#1)(2008-7#2)
included nausea/vomiting##2##2##(1990-12#1)(1991-6#1)
included one##3##2##(1994-12#1)(2007-11#1)(2011-2#1)
included only##7##2##(1997-5#3)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
included patient##2##2##(1997-8#1)(2011-2#1)
included patients with##2##3##(2007-10#1)(2012-2#1)
included patients##5##2##(2007-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
included questions##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
included representatives of##2##3##(2008-10#1)(2008-6#1)
included representatives##3##2##(2008-1#1)(2008-10#1)(2008-6#1)
included scales##2##2##(2008-5#1)(2013-1#1)
included several##2##2##(2008-10#2)
included six##3##2##(1994-9#1)(2008-11#1)(2008-9#1)
included some##2##2##(2008-10#2)
included strains##2##2##(2008-10#2)
included studies##6##2##(2008-10#2)(2010-11#1)(2011-2#2)(2013-8#1)
included subjects with A##2##4##(1997-5#2)
included the amount of##2##4##(2008-10#2)
included the following##4##3##(1996-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
included the introduction of##2##4##(2008-10#1)(2009-7#1)
included the use of##2##4##(2008-11#1)(2013-1#1)
included the##69##2##(1990-7#1)(1991-10#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#6)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
included those##3##2##(2008-9#1)(2011-2#2)
included three##5##2##(1996-7#1)(1997-8#1)(2008-10#2)(2008-11#1)
included to highlight##2##3##(1995-3#1)(2008-12#1)
included to##12##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-4#3)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
included tumors##4##2##(2007-8#4)
included two cases of##2##4##(2008-1#1)(2008-8#1)
included two main##2##3##(1992-9#1)(2008-10#1)
included two##14##2##(1992-9#1)(1993-2#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-6#2)(2008-8#2)(2009-9#1)
included urinary##2##2##(1994-5#1)(2007-8#1)
included weight##2##2##(2008-11#1)(2008-12#1)
included were##2##2##(2008-10#1)(2009-8#1)
included with##2##2##(2010-5#1)(2011-2#1)
included within the##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
included within##5##2##(1992-9#1)(2008-10#1)(2008-12#1)(2013-7#1)(2013-8#1)
included##1307##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#4)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#8)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#7)(1993-2#6)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#13)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-12#8)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#2)(1996-1#9)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#5)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#4)(1997-3#9)(1997-4#3)(1997-5#10)(1997-6#3)(1997-7#3)(1997-8#8)(2006-10#6)(2006-6#1)(2006-8#1)(2007-10#17)(2007-11#18)(2007-12#10)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#25)(2007-8#21)(2007-9#1)(2008-1#25)(2008-10#193)(2008-11#53)(2008-12#40)(2008-2#17)(2008-3#41)(2008-4#51)(2008-5#24)(2008-6#18)(2008-7#39)(2008-8#15)(2008-9#44)(2009-10#3)(2009-11#4)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#8)(2009-8#14)(2009-9#7)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#14)(2010-4#11)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#5)(2010-9#3)(2011-1#21)(2011-2#81)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#17)(2012-2#19)(2012-3#31)(2012-5#1)(2013-1#72)(2013-7#9)(2013-8#27)
included)##3##1##(1995-12#1)(2008-8#1)(2011-3#1)
includes 13##2##2##(2008-10#1)(2009-3#1)
includes a comparison of##2##4##(1992-2#1)(2008-3#1)
includes a discussion of##2##4##(2008-4#1)(2010-12#1)
includes a discussion on##2##4##(1996-3#1)(2008-9#1)
includes a discussion##4##3##(1996-3#1)(2008-4#1)(2008-9#1)(2010-12#1)
includes a list of##2##4##(1995-2#1)(1997-6#1)
includes a review of the##4##5##(1994-3#1)(2007-11#1)(2013-1#2)
includes a total of##2##4##(2010-3#1)(2011-2#1)
includes a treatment##2##3##(2008-10#1)(2011-1#1)
includes a variety of##2##4##(2012-2#1)(2012-3#1)
includes a##78##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1997-6#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#3)(2009-11#2)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)
includes acute##3##2##(1992-1#1)(2008-7#1)(2012-12#1)
includes all##4##2##(2007-12#1)(2008-11#1)(2010-3#1)(2011-2#1)
includes alleviation of##2##3##(2009-7#1)(2011-2#1)
includes also##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
includes an evaluation##2##3##(1993-2#1)(2012-3#1)
includes an##20##2##(1991-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-3#1)
includes approximately##2##2##(1995-3#1)(2011-2#1)
includes at least two##2##4##(2008-10#1)(2009-3#1)
includes at least##3##3##(1991-6#1)(2008-10#1)(2009-3#1)
includes both##11##2##(1990-8#1)(1994-12#1)(1994-2#1)(1997-3#1)(2007-1#1)(2008-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-3#1)
includes five##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
includes four##2##2##(1993-2#1)(2007-11#1)
includes health##2##2##(1993-3#1)(1997-3#1)
includes human##2##2##(2008-9#1)(2013-8#1)
includes information on##2##3##(1996-12#1)(1997-4#1)
includes information##4##2##(1995-12#1)(1996-12#1)(1997-4#1)(2008-9#1)
includes many##2##2##(1992-11#1)(2008-10#1)
includes modules##2##2##(2011-2#1)(2012-3#1)
includes more than##2##3##(2008-6#1)(2010-3#1)
includes nine##2##2##(1996-1#1)(2010-3#1)
includes numerous##2##2##(2011-1#1)(2011-2#1)
includes nurses##2##2##(1991-2#1)(1994-12#1)
includes only##2##2##(1994-1#1)(2007-11#1)
includes other##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
includes patients who##2##3##(2008-7#1)(2011-2#1)
includes procedures for##2##3##(2008-4#2)
includes protocols for##4##3##(2008-4#1)(2008-9#3)
includes questions on##2##3##(1991-9#1)(1994-3#1)
includes replacement of##2##3##(2008-10#1)(2013-1#1)
includes results for##2##3##(1994-3#1)(2008-3#1)
includes results##4##2##(1991-1#1)(1994-3#1)(1996-1#1)(2008-3#1)
includes several##5##2##(1992-9#1)(2010-1#1)(2010-9#1)(2011-3#1)(2012-8#1)
includes some of the most##2##5##(2009-2#1)(2010-10#1)
includes some##5##2##(1990-5#1)(1994-9#1)(2008-9#1)(2009-2#1)(2010-10#1)
includes specific##2##2##(1992-1#1)(2008-1#1)
includes surgery##2##2##(2007-11#1)(2011-2#1)
includes the abundance##2##3##(2008-3#1)(2008-7#1)
includes the analysis of##2##4##(2008-11#1)(2011-2#1)
includes the association of##2##4##(2008-10#2)
includes the development of##2##4##(2008-10#1)(2008-6#1)
includes the effect of##3##4##(2008-10#1)(2008-3#2)
includes the effects of##4##4##(2007-12#1)(2008-2#1)(2008-7#1)(2010-10#1)
includes the entire##2##3##(1995-6#1)(1997-6#1)
includes the following##4##3##(2008-1#1)(2008-2#1)(2010-6#1)(2013-1#1)
includes the patients##2##3##(2012-2#1)(2013-1#1)
includes the promotion of##2##4##(1991-3#1)(2008-12#1)
includes the use of##3##4##(1995-3#1)(2008-6#1)(2009-5#1)
includes the##96##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#2)(1997-3#2)(1997-6#1)(2007-12#6)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#5)(2009-3#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
includes three##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
includes two##11##2##(1990-12#1)(1993-2#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)
includes various##2##2##(2008-4#1)(2010-5#1)
includes##566##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#5)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#3)(1991-9#4)(1992-1#4)(1992-11#1)(1992-12#5)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#3)(1994-11#1)(1994-12#10)(1994-2#4)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-6#3)(1995-8#1)(1996-1#6)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#15)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#14)(2008-10#62)(2008-11#13)(2008-12#10)(2008-2#14)(2008-3#31)(2008-4#20)(2008-5#6)(2008-6#7)(2008-7#32)(2008-8#5)(2008-9#25)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#8)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#30)(2011-3#3)(2012-12#9)(2012-2#9)(2012-3#6)(2012-8#1)(2013-1#20)(2013-7#3)(2013-8#5)
including (a)##2##2##(2008-4#1)(2009-9#1)
including (i)##2##2##(2008-10#1)(2010-4#1)
including 1##4##2##(2008-10#2)(2008-8#1)(2009-8#1)
including 10##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
including 11##2##2##(2008-10#1)(2008-12#1)
including 13##5##2##(2007-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)
including 14##2##2##(2007-7#1)(2008-10#1)
including 16##2##2##(2008-1#1)(2011-2#1)
including 19##2##2##(2008-11#1)(2009-8#1)
including 2##4##2##(1991-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
including 22##2##2##(1993-3#1)(2008-11#1)
including 23##2##2##(2008-10#2)
including 25##2##2##(2007-2#1)(2013-1#1)
including 2D NMR##2##3##(2007-1#1)(2011-2#1)
including 2D##3##2##(2007-1#1)(2008-6#1)(2011-2#1)
including 4 cases of##2##4##(1994-12#1)(2007-11#1)
including 4##7##2##(1991-4#1)(1994-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2010-2#1)(2013-8#1)
including 5##2##2##(1991-11#1)(2008-10#1)
including 7##2##2##(1994-11#1)(1995-3#1)
including 73##2##2##(2008-5#1)(2010-1#1)
including 89##2##2##(2007-12#1)(2011-1#1)
including 9##2##2##(1990-8#1)(1996-11#1)
including A##2##2##(2006-10#1)(2008-9#1)
including ADP##2##2##(2008-4#1)(2008-8#1)
including Alzheimer's disease##2##3##(1995-12#1)(2007-8#1)
including B##3##2##(1997-2#1)(2008-10#1)(2010-5#1)
including Bacillus subtilis##2##3##(2008-10#1)(2011-2#1)
including CT##2##2##(2008-12#2)
including D##2##2##(2008-10#2)
including DNA and##2##3##(2008-3#1)(2012-2#1)
including DNA##5##2##(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2012-2#1)
including Fusarium##2##2##(2008-10#2)
including HIV##3##2##(1997-4#1)(2007-7#1)(2008-5#1)
including M##2##2##(2008-10#1)(2008-7#1)
including North##2##2##(1991-11#1)(2008-8#1)
including P##2##2##(2007-7#1)(2008-10#1)
including Pakistan##2##2##(2012-2#1)(2013-8#1)
including The National Institute for Nursing Research and Sigma Theta Tau International##2##12##(2013-1#2)
including a comparison##2##3##(2008-10#2)
including a decrease in the##2##5##(2007-11#1)(2008-5#1)
including a detailed##2##3##(2007-11#1)(2008-3#1)
including a history of##2##4##(1996-11#1)(2012-3#1)
including a large number##2##4##(1991-3#1)(2008-10#1)
including a large##5##3##(1991-3#1)(2008-1#1)(2008-10#2)(2012-3#1)
including a major##2##3##(2008-10#1)(2009-6#1)
including a new##2##3##(1991-5#1)(2008-3#1)
including a number of##2##4##(2009-10#1)(2010-9#1)
including a putative##3##3##(1990-12#1)(1993-3#1)(2009-2#1)
including a review of the##3##5##(2008-4#1)(2010-6#1)(2012-2#1)
including a small##2##3##(2008-9#1)(2010-8#1)
including a spatial##2##3##(2008-2#1)(2011-2#1)
including a variety of##3##4##(1996-5#1)(1997-7#1)(2008-3#1)
including a##115##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#1)(2006-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
including absorption##3##2##(2008-12#1)(2008-2#1)(2009-9#1)
including acute##4##2##(2008-3#1)(2008-7#1)(2011-2#2)
including age##5##2##(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
including aggregation##2##2##(2007-10#1)(2008-10#1)
including alkali##5##2##(2008-10#5)
including all##11##2##(1996-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
including also##3##2##(1997-6#1)(2009-10#1)(2011-2#1)
including alteration##2##2##(2008-10#1)(2008-9#1)
including amino acids##2##3##(2008-10#2)
including an assessment of##2##4##(2008-11#1)(2008-2#1)
including an##29##2##(1992-2#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
including anorexia##2##2##(1997-7#1)(2010-6#1)
including antioxidant and##2##3##(2008-10#1)(2012-2#1)
including antioxidant##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
including any##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
including apolipoprotein##2##2##(2008-4#1)(2013-1#1)
including apoptosis##2##2##(1994-12#1)(2012-2#1)
including asthma##2##2##(2008-11#1)(2009-1#1)
including at least one##4##4##(2008-10#1)(2012-3#2)(2013-1#1)
including at##6##2##(2008-10#2)(2012-3#2)(2013-1#2)
including atherosclerosis##4##2##(1993-3#1)(2008-2#1)(2011-2#1)(2012-3#1)
including bacterial and##2##3##(2008-10#1)(2008-9#1)
including bacterial##5##2##(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)
including basic##2##2##(2008-6#1)(2011-1#1)
including bilateral##2##2##(2007-10#1)(2007-8#1)
including binding sites for##2##4##(1993-12#1)(2008-7#1)
including biochemical##2##2##(2008-11#1)(2008-4#1)
including biomolecular systems##2##3##(2013-1#2)
including bladder##2##2##(2009-4#1)(2013-8#1)
including blood##7##2##(1990-5#1)(1995-2#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
including body##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
including bone marrow##4##3##(1994-5#1)(2008-11#2)(2008-9#1)
including bone##5##2##(1994-5#1)(2008-11#2)(2008-9#1)(2012-3#1)
including both##19##2##(1992-12#1)(1993-9#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#1)
including bovine##3##2##(1992-3#1)(2008-7#1)(2008-9#1)
including buffer pH##2##3##(2008-10#1)(2013-1#1)
including calcium##2##2##(2008-10#1)(2011-1#1)
including cancer and##2##3##(2008-8#1)(2012-2#1)
including cancer##9##2##(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
including cancers##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
including capillary##2##2##(2008-10#2)
including cardiac##2##2##(2007-8#1)(2010-11#1)
including cardiovascular disease##2##3##(2008-7#1)(2012-2#1)
including cell cycle##2##3##(2008-9#1)(2010-10#1)
including cell death##2##3##(2008-7#1)(2010-11#1)
including cell proliferation##2##3##(2007-12#1)(2013-8#1)
including cell##14##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2013-1#1)(2013-8#1)
including cellular##2##2##(2009-12#1)(2009-3#1)
including changes in##3##3##(1995-2#1)(2011-1#1)(2011-2#1)
including changing demographics##2##3##(2007-2#1)(2010-8#1)
including changing##3##2##(2007-12#1)(2007-2#1)(2010-8#1)
including chemical##2##2##(1990-8#1)(2008-10#1)
including chemotherapy##2##2##(2008-3#1)(2013-1#1)
including chronic##2##2##(2008-7#1)(2010-3#1)
including cisplatin##3##2##(1990-12#1)(1990-2#1)(1990-6#1)
including citrus##3##2##(2008-10#1)(2011-2#2)
including clinical chemistry##2##3##(1994-12#2)
including clinical##5##2##(1994-12#3)(2011-1#1)(2013-8#1)
including cognitive impairment##2##3##(2009-11#1)(2012-2#1)
including cognitive##4##2##(2007-12#1)(2009-11#1)(2012-2#2)
including column##2##2##(2008-10#1)(2011-2#1)
including common abbreviations##2##3##(2008-2#2)
including concentration##2##2##(2008-10#2)
including consideration of##2##3##(1991-2#1)(2013-8#1)
including control of##2##3##(2008-4#1)(2011-2#1)
including control##4##2##(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
including coronary##2##2##(2007-8#1)(2008-12#1)
including corticosteroids##2##2##(1993-2#1)(2012-3#1)
including cost##2##2##(2007-12#1)(2008-11#1)
including critical##2##2##(2008-11#1)(2008-8#1)
including current and##2##3##(2009-5#1)(2012-12#1)
including current##3##2##(2008-4#1)(2009-5#1)(2012-12#1)
including cutaneous##2##2##(1997-3#1)(2013-1#1)
including cyclophosphamide##4##2##(1990-12#1)(1991-6#1)(1995-4#1)(2008-10#1)
including death##3##2##(1997-1#1)(2008-11#1)(2012-12#1)
including decreased##2##2##(1995-2#1)(2008-6#1)
including dendritic##2##2##(2009-9#1)(2010-5#1)
including depression and##2##3##(2008-2#1)(2008-6#1)
including depression##3##2##(2008-11#1)(2008-2#1)(2008-6#1)
including determination of##2##3##(1992-3#1)(2013-1#1)
including development of##3##3##(1996-2#1)(2010-5#1)(2013-8#1)
including development##4##2##(1996-2#1)(2010-10#1)(2010-5#1)(2013-8#1)
including diabetes##6##2##(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#1)(2013-8#2)
including diabetic nephropathy##2##3##(2011-2#2)
including diabetic##4##2##(2010-10#1)(2011-2#2)(2012-12#1)
including diagnosis##2##2##(2008-1#1)(2012-12#1)
including diagnostic##2##2##(2007-4#1)(2011-2#1)
including diet##3##2##(1992-8#1)(2007-12#1)(2013-8#1)
including different##2##2##(2008-3#1)(2013-1#1)
including direct##2##2##(1995-5#1)(2012-3#1)
including discussion of##2##3##(2008-2#1)(2009-7#1)
including dopamine##2##2##(2008-7#1)(2009-8#1)
including drug##2##2##(2008-4#1)(2012-3#1)
including duplications##3##2##(2007-11#1)(2011-1#2)
including early##3##2##(2008-2#1)(2009-12#1)(2012-2#1)
including effects##3##2##(1995-11#1)(2007-12#1)(2008-7#1)
including eight##3##2##(1992-11#1)(2008-7#1)(2008-9#1)
including elevated##2##2##(1995-11#1)(2009-11#1)
including enhanced##2##2##(1992-1#1)(2012-3#1)
including environmental##2##2##(2008-7#1)(2009-11#1)
including epidermal##3##2##(2008-9#2)(2011-2#1)
including exercise##2##2##(2007-6#1)(2011-2#1)
including experimental##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
including extracellular##2##2##(2007-6#1)(2010-12#1)
including factors that##2##3##(1996-2#1)(2008-2#1)
including familial##2##2##(2012-3#2)
including financing of##2##3##(2012-12#1)(2013-8#1)
including five##2##2##(1993-8#1)(2008-9#1)
including flavonoids##2##2##(2008-10#1)(2009-8#1)
including forceful traction mobilizations##2##4##(2008-10#2)
including four##4##2##(1997-7#1)(2008-10#2)(2008-3#1)
including frequent##2##2##(2008-1#1)(2011-2#1)
including functional##3##2##(2008-7#2)(2010-9#1)
including gastrointestinal##2##2##(2008-6#2)
including gender##3##2##(2008-5#1)(2009-10#1)(2009-4#1)
including gene##3##2##(2008-10#1)(2009-11#1)(2010-6#1)
including genes##2##2##(1997-6#1)(2007-11#1)
including genetic##4##2##(1997-5#1)(2008-10#1)(2008-4#1)(2012-1#1)
including glucose and##2##3##(2008-10#1)(2008-11#1)
including glucose##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)
including glycosylation##2##2##(2008-11#1)(2013-1#1)
including good##2##2##(2008-10#1)(2008-5#1)
including growth on##2##3##(2008-10#1)(2008-9#1)
including growth##7##2##(1994-5#1)(1996-9#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-7#1)
including hardware##2##2##(2010-9#2)
including heart##4##2##(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)
including heat shock##2##3##(1994-8#1)(2008-10#1)
including heat##4##2##(1994-8#1)(2008-10#1)(2011-2#2)
including high##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
including higher##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
including histone##2##2##(2011-2#1)(2011-9#1)
including homologous recombination##2##3##(1995-6#1)(2013-1#1)
including host resistance##2##3##(2008-10#2)
including host##3##2##(2008-10#2)(2010-10#1)
including human##5##2##(1997-6#1)(2008-4#1)(2009-3#1)(2010-1#1)(2011-2#1)
including humans##5##2##(1995-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)
including hypertension##4##2##(2008-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
including immunomodulatory##2##2##(2008-10#1)(2008-5#1)
including improvements in##3##3##(1991-9#1)(1995-2#1)(2008-3#1)
including in the##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
including in##9##2##(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
including increased##3##2##(1994-1#1)(2008-10#1)(2008-12#1)
including individual##3##2##(1991-2#1)(1994-1#1)(2009-11#1)
including infections##2##2##(2012-12#1)(2012-3#1)
including inflammatory bowel disease##2##4##(2010-12#1)(2012-12#1)
including information about##2##3##(2007-12#1)(2013-1#1)
including information##6##2##(1994-3#1)(1997-3#1)(2007-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
including initiation##2##2##(2013-1#1)(2013-7#1)
including inoculum##2##2##(2008-10#1)(2008-5#1)
including insulin##2##2##(2010-11#1)(2010-5#1)
including interaction##2##2##(1994-8#1)(2011-2#1)
including intermediate##2##2##(1993-12#1)(2008-9#1)
including invasion and##2##3##(2010-3#1)(2013-1#1)
including ischemic##2##2##(1994-11#1)(2007-10#1)
including isolates##2##2##(2008-10#2)
including its##11##2##(1990-7#1)(1994-3#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-6#1)(2010-7#1)(2011-1#1)
including knee##2##2##(2011-2#2)
including labeling##2##2##(2008-4#1)(2008-9#1)
including large##2##2##(1992-8#1)(2009-9#1)
including learning##2##2##(2008-2#1)(2008-7#1)
including left ventricular##2##3##(1994-7#1)(2013-1#1)
including left##4##2##(1994-7#1)(1997-8#1)(2008-11#1)(2013-1#1)
including less##3##2##(1995-12#1)(2011-7#1)(2012-2#1)
including limited##3##2##(1992-11#1)(2008-12#1)(2013-1#1)
including liver##2##2##(1995-12#1)(2009-8#1)
including long##2##2##(2008-10#1)(2008-12#1)
including luminol##2##2##(2008-10#2)
including mammalian##2##2##(1991-1#1)(2008-11#1)
including many##9##2##(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)
including matrix##3##2##(2008-10#3)
including measures of##3##3##(2009-11#1)(2012-1#1)(2012-12#1)
including mechanical##4##2##(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
including medial##2##2##(2007-8#1)(2013-8#1)
including medical##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
including mesenchymal##2##2##(2008-9#2)
including metabolic##2##2##(2011-2#1)(2011-3#1)
including migration##2##2##(2011-2#1)(2012-12#1)
including model##2##2##(2008-7#1)(2008-9#1)
including molecular##4##2##(1992-4#1)(2008-4#1)(2008-7#1)(2011-1#1)
including mono-##2##2##(2008-6#2)
including more##2##2##(1993-2#1)(2011-2#1)
including multiple##3##2##(1995-5#1)(2008-7#1)(2011-2#1)
including muscle##2##2##(1990-12#1)(2013-1#1)
including mySQL sequence databases##2##4##(2008-4#2)
including myoglobin##2##2##(2008-10#2)
including neural##2##2##(2008-7#1)(2008-8#1)
including neurons##5##2##(1997-7#1)(2008-2#1)(2008-4#2)(2012-12#1)
including nitrogen##2##2##(2008-10#2)
including nonlinear##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
including normal##2##2##(2007-11#1)(2007-12#1)
including not only##5##3##(1995-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
including nucleic##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
including one with##2##3##(1990-3#1)(1995-11#1)
including one##13##2##(1990-3#1)(1993-12#2)(1995-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-12#1)
including only one##2##3##(2008-8#1)(2013-8#1)
including opioids##2##2##(2009-5#1)(2010-8#1)
including optical##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
including oral##2##2##(1996-3#1)(2008-7#1)
including osteotomy##2##2##(2007-12#1)(2008-8#1)
including other##2##2##(1992-5#1)(2008-5#1)
including our own##3##3##(2008-7#2)(2010-11#1)
including our##6##2##(2008-7#3)(2010-11#1)(2012-2#1)(2013-1#1)
including ours##2##2##(2008-4#1)(2011-2#1)
including pH##9##2##(2008-10#7)(2011-2#1)(2013-8#1)
including pain##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
including painful##2##2##(1991-4#1)(2008-7#1)
including patients with##2##3##(2007-12#1)(2008-3#1)
including patients##3##2##(2007-12#1)(2007-7#1)(2008-3#1)
including pediatric##2##2##(2007-12#1)(2009-9#1)
including peptides##2##2##(2008-10#1)(2008-4#1)
including percutaneous##2##2##(2008-10#1)(2010-8#1)
including phosphorylation of##2##3##(1993-8#1)(2009-6#1)
including physical##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
including physicians##3##2##(2007-12#1)(2007-8#1)(2012-3#1)
including platelet aggregation##2##3##(2008-4#2)
including polycyclic aromatic hydrocarbons##2##4##(2008-10#1)(2010-7#1)
including power##2##2##(2008-9#1)(2011-1#1)
including premature##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
including procedures to quickly determine conditions for successful amplification of the sequence and primer sets of interest##2##17##(2008-2#1)(2008-9#1)
including procedures##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
including professional##4##2##(1994-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
including proliferation##3##2##(1993-8#1)(2009-8#1)(2010-7#1)
including prospective##2##2##(1997-4#1)(2009-3#1)
including protein##2##2##(2008-7#1)(2011-2#1)
including psychological distress##2##3##(2009-12#1)(2013-1#1)
including psychotherapy##2##2##(2008-1#1)(2008-6#1)
including public##2##2##(2007-12#1)(2012-1#1)
including quantitative##2##2##(2008-4#1)(2010-5#1)
including rapid##2##2##(1991-7#1)(2008-7#1)
including reagent##3##2##(2008-10#3)
including recent##2##2##(2008-7#1)(2008-8#1)
including recombinant##2##2##(2010-7#1)(2012-2#1)
including recombination##2##2##(2008-10#1)(2008-8#1)
including reduced##4##2##(1990-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
including relative##3##2##(1997-4#1)(2008-10#1)(2011-2#1)
including renal##4##2##(1992-9#1)(1997-8#1)(2008-7#1)(2008-8#1)
including reproductive##2##2##(2008-7#1)(2012-12#1)
including research##2##2##(2008-5#1)(2013-1#1)
including resistant##2##2##(2008-10#1)(2013-8#1)
including response##2##2##(2008-10#1)(2008-9#1)
including retinal##2##2##(2008-8#1)(2011-7#1)
including right##2##2##(2007-8#1)(2008-11#1)
including risk##2##2##(2007-10#1)(2008-12#1)
including sample##3##2##(2008-10#3)
including samples##2##2##(2012-3#1)(2013-1#1)
including sampling and washing##4##4##(2008-10#4)
including sampling##5##2##(2008-10#4)(2009-4#1)
including searching##2##2##(2008-12#1)(2008-9#1)
including selection##2##2##(1996-12#1)(2008-10#1)
including sensory##2##2##(2007-12#1)(2009-9#1)
including separation##2##2##(2008-10#1)(2010-12#1)
including serum##3##2##(1996-2#1)(2010-12#1)(2013-1#1)
including seven##3##2##(1990-9#1)(2008-10#2)
including several##6##2##(2007-12#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-3#1)
including single##2##2##(2010-5#1)(2011-1#1)
including six##4##2##(1995-3#1)(2008-10#1)(2008-9#1)(2010-2#1)
including size##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
including skeletal##2##2##(1997-8#1)(2011-1#1)
including skin rash##2##3##(2010-3#1)(2012-2#1)
including skin##5##2##(1991-6#1)(2007-12#1)(2008-6#1)(2010-3#1)(2012-2#1)
including sleep##2##2##(2007-12#1)(2012-1#1)
including small##2##2##(2008-7#1)(2009-12#1)
including smoking##2##2##(1993-6#1)(2012-12#1)
including social##2##2##(2008-1#1)(2012-2#1)
including some of the##2##4##(2008-10#1)(2011-2#1)
including some##12##2##(1997-3#1)(2008-10#4)(2008-4#1)(2009-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
including specific##2##2##(1997-3#1)(2008-7#1)
including stability of##2##3##(2008-10#1)(2013-8#1)
including stability##3##2##(2008-10#2)(2013-8#1)
including statistical##2##2##(2008-3#1)(2008-8#1)
including stem cell##4##3##(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
including stigma##2##2##(2008-1#1)(2009-5#1)
including stimulation of##2##3##(2010-4#1)(2013-7#1)
including stroke##3##2##(2007-10#1)(2008-7#1)(2010-8#1)
including students##3##2##(2008-5#2)(2010-3#1)
including such##3##2##(1994-1#1)(2008-1#1)(2008-9#1)
including superoxide##2##2##(1990-2#1)(2008-1#1)
including surgery##3##2##(2010-5#1)(2010-8#1)(2011-2#1)
including survival##2##2##(2008-10#1)(2008-5#1)
including synthetic##2##2##(1990-5#1)(2010-6#1)
including systemic##2##2##(1993-2#1)(2008-1#1)
including testing##2##2##(2008-11#1)(2013-8#1)
including that of##4##3##(1993-6#1)(1994-8#1)(2007-10#1)(2008-10#1)
including that they##2##3##(2008-6#1)(2008-8#1)
including that##10##2##(1993-6#1)(1994-8#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2012-3#1)
including the 3##2##3##(2008-11#2)
including the age##2##3##(2008-5#1)(2011-2#1)
including the biosynthesis##2##3##(2008-10#1)(2009-7#1)
including the brain##3##3##(1997-4#1)(2010-5#1)(2012-2#1)
including the capacity to##2##4##(1991-11#1)(2011-1#1)
including the characterization##2##3##(2008-2#1)(2008-3#1)
including the common##2##3##(1994-8#1)(2008-8#1)
including the design##2##3##(2007-8#1)(2009-9#1)
including the development of##6##4##(1992-11#1)(1994-9#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-12#1)
including the effect of##5##4##(2008-2#1)(2008-3#2)(2009-6#1)(2011-1#1)
including the effects of##3##4##(2007-12#2)(2008-3#1)
including the effects##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
including the elderly##2##3##(1993-12#1)(2008-7#1)
including the following##2##3##(1997-4#1)(2008-10#1)
including the genes##2##3##(2008-10#1)(2008-8#1)
including the heart##2##3##(1995-8#1)(2008-11#1)
including the human##2##3##(1994-12#1)(1995-8#1)
including the influence of the##2##5##(1996-12#1)(2008-11#1)
including the liver##5##3##(1992-5#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-2#1)
including the maximum##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
including the most##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
including the novel##2##3##(2008-9#1)(2013-1#1)
including the nucleus##2##3##(1990-9#1)(1994-2#1)
including the physical##2##3##(2008-1#1)(2011-3#1)
including the polarized molecular orbital (PMO) model recently developed in our research group and other semiempirical molecular orbital methods##2##19##(2012-12#2)
including the possible##2##3##(1991-12#1)(2012-2#1)
including the potential##2##3##(1991-12#1)(2008-11#1)
including the presence of##8##4##(1993-5#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
including the prevention of##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
including the previously##2##3##(1991-6#1)(1996-6#1)
including the pump##2##3##(2007-11#1)(2008-10#1)
including the recently##3##3##(2008-10#3)
including the recording##2##3##(2008-3#1)(2010-7#1)
including the regulation of##2##4##(2007-12#1)(2008-7#1)
including the right##2##3##(1990-11#1)(2008-3#1)
including the role of##2##4##(2008-11#1)(2010-12#1)
including the social##2##3##(2008-8#1)(2010-4#1)
including the time needed##2##4##(1997-2#1)(2008-10#1)
including the type of##2##4##(1991-3#1)(2008-7#1)
including the type##4##3##(1991-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
including the use of##7##4##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-10#1)
including the##458##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#8)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#6)(1997-3#1)(1997-4#3)(1997-8#1)(1997-9#1)(2006-12#2)(2007-11#5)(2007-12#7)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#6)(2008-1#6)(2008-10#65)(2008-11#22)(2008-12#3)(2008-2#14)(2008-3#20)(2008-4#12)(2008-5#10)(2008-6#3)(2008-7#22)(2008-8#11)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#10)(2011-2#18)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#10)(2013-8#6)
including their purification##2##3##(2008-4#2)
including their##17##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
including therapeutic##2##2##(2008-11#1)(2009-3#1)
including thermal##2##2##(1995-2#1)(2008-3#1)
including these##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
including this##2##2##(2008-5#1)(2009-9#1)
including those from##4##3##(1992-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
including those in##2##3##(1996-1#1)(2010-1#1)
including those of the##3##4##(1992-11#1)(1993-2#1)(2008-7#1)
including those of##6##3##(1992-11#1)(1993-2#1)(1995-2#1)(2008-11#2)(2008-7#1)
including those related to##2##4##(2008-7#1)(2010-5#1)
including those related##3##3##(2008-7#2)(2010-5#1)
including those with##5##3##(1994-8#1)(2007-10#1)(2008-2#1)(2010-11#1)(2013-8#1)
including those##40##2##(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
including three##10##2##(1990-5#1)(1993-12#1)(1995-8#1)(1997-7#1)(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
including thyroid##2##2##(2011-2#1)(2013-1#1)
including total##3##2##(1991-12#1)(2008-8#1)(2010-11#1)
including toxic##2##2##(1997-2#1)(2008-10#1)
including trabecular##2##2##(2007-11#1)(2012-3#1)
including traditional##2##2##(1993-3#1)(1994-3#1)
including transcription factors##3##3##(1995-2#1)(2008-11#1)(2008-5#1)
including transcription##4##2##(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
including tuberculosis##2##2##(1997-3#1)(2008-9#1)
including two##17##2##(1990-8#1)(1992-8#1)(1993-3#1)(1993-6#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-7#2)(2010-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
including type##2##2##(2008-10#1)(2011-2#1)
including use of##3##3##(2011-2#2)(2012-3#1)
including various##4##2##(2008-10#1)(2008-3#1)(2009-8#1)(2010-3#1)
including vinblastine##2##2##(1991-6#1)(2008-5#1)
including visual##2##2##(2008-9#1)(2013-1#1)
including voltage and phase compensation##3##5##(2013-8#3)
including voltage##4##2##(1994-9#1)(2013-8#3)
including wall##2##2##(2008-10#1)(2010-9#1)
including weeds##3##2##(2008-10#3)
including weight##2##2##(2008-3#1)(2013-1#1)
including what##2##2##(2008-11#1)(2012-2#1)
including whether or not##2##4##(1996-1#1)(2010-10#1)
including women in labor##2##4##(1993-1#1)(1993-2#1)
including women in##3##3##(1993-1#1)(1993-2#1)(2009-8#1)
including##3011##1##(1990-11#4)(1990-12#11)(1990-2#8)(1990-3#2)(1990-5#8)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#4)(1991-1#6)(1991-11#5)(1991-12#15)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#7)(1991-7#3)(1991-8#1)(1991-9#7)(1992-1#4)(1992-10#2)(1992-11#11)(1992-12#9)(1992-2#7)(1992-3#15)(1992-4#3)(1992-5#4)(1992-6#3)(1992-8#13)(1992-9#6)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#11)(1993-2#11)(1993-3#12)(1993-5#1)(1993-6#7)(1993-8#8)(1993-9#6)(1994-1#8)(1994-10#3)(1994-11#5)(1994-12#14)(1994-2#11)(1994-3#17)(1994-5#4)(1994-6#5)(1994-7#1)(1994-8#13)(1994-9#7)(1995-1#4)(1995-11#10)(1995-12#13)(1995-2#21)(1995-3#10)(1995-4#2)(1995-5#8)(1995-6#10)(1995-8#6)(1995-9#1)(1996-1#9)(1996-10#1)(1996-11#4)(1996-12#18)(1996-2#18)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#4)(1996-8#1)(1996-9#4)(1997-1#6)(1997-2#17)(1997-3#14)(1997-4#12)(1997-5#3)(1997-6#5)(1997-7#11)(1997-8#7)(1997-9#1)(2006-10#9)(2006-12#2)(2007-1#1)(2007-10#14)(2007-11#36)(2007-12#46)(2007-2#10)(2007-4#2)(2007-5#4)(2007-6#6)(2007-7#10)(2007-8#29)(2007-9#3)(2008-1#40)(2008-10#443)(2008-11#121)(2008-12#49)(2008-2#60)(2008-3#87)(2008-4#96)(2008-5#79)(2008-6#34)(2008-7#141)(2008-8#72)(2008-9#84)(2009-1#2)(2009-10#13)(2009-11#17)(2009-12#18)(2009-2#4)(2009-3#13)(2009-4#12)(2009-5#17)(2009-6#7)(2009-7#8)(2009-8#27)(2009-9#17)(2010-1#12)(2010-10#12)(2010-11#16)(2010-12#26)(2010-2#9)(2010-3#18)(2010-4#16)(2010-5#22)(2010-6#17)(2010-7#13)(2010-8#26)(2010-9#11)(2011-1#65)(2011-2#153)(2011-3#8)(2011-7#2)(2011-8#1)(2011-9#1)(2012-1#12)(2012-12#51)(2012-2#71)(2012-3#74)(2012-7#1)(2013-1#103)(2013-7#11)(2013-8#58)
inclusion and exclusion criteria##8##4##(2007-11#1)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#2)
inclusion and##10##2##(2007-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#2)
inclusion bodies after##2##3##(2008-4#1)(2008-7#1)
inclusion bodies in Escherichia coli##3##5##(1991-7#1)(1997-4#1)(2009-3#1)
inclusion bodies in##6##3##(1991-7#1)(1997-3#1)(1997-4#1)(2008-10#1)(2009-3#1)(2011-2#1)
inclusion bodies##21##2##(1991-7#1)(1995-8#1)(1997-3#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#2)(2013-8#1)
inclusion body##2##2##(1992-2#1)(2008-7#1)
inclusion complex between##4##3##(2008-10#4)
inclusion complex modified carbon paste electrode##2##6##(2008-10#2)
inclusion complex of##4##3##(2008-10#4)
inclusion complex with##3##3##(2008-10#3)
inclusion complex##30##2##(2007-11#3)(2008-10#25)(2012-2#1)(2012-3#1)
inclusion complex-forming capacity##2##3##(1996-5#2)
inclusion complexation of##2##3##(2008-10#2)
inclusion complexation##4##2##(2008-10#3)(2013-1#1)
inclusion complexes with##3##3##(2008-10#2)(2010-12#1)
inclusion complexes##10##2##(1996-5#1)(2008-10#8)(2010-12#1)
inclusion constant##5##2##(2008-10#5)
inclusion criteria for##4##3##(2008-5#2)(2009-6#1)(2012-2#1)
inclusion criteria of##2##3##(2008-10#1)(2012-2#1)
inclusion criteria were##6##3##(1996-11#1)(2010-10#1)(2010-6#1)(2012-3#2)(2013-1#1)
inclusion criteria##36##2##(1996-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)
inclusion formation##4##2##(1996-5#1)(2008-10#3)
inclusion in a##3##3##(1996-1#1)(2008-2#1)(2008-3#1)
inclusion in the study and##2##5##(2007-8#1)(2013-1#1)
inclusion in the study##3##4##(2007-11#1)(2007-8#1)(2013-1#1)
inclusion in the##9##3##(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2009-8#1)(2013-1#1)
inclusion in this##2##3##(2008-5#1)(2008-6#1)
inclusion in##19##2##(1996-1#1)(1996-3#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
inclusion of a##5##3##(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
inclusion of additional##3##3##(1992-2#1)(2008-9#1)(2013-7#1)
inclusion of an##3##3##(1996-4#1)(2008-11#1)(2008-3#1)
inclusion of patients##2##3##(2006-10#1)(2008-11#1)
inclusion of the##4##3##(1990-11#1)(1992-5#1)(2007-11#1)(2013-8#1)
inclusion of these##4##3##(1992-9#1)(1997-3#1)(2008-8#1)(2012-2#1)
inclusion of##87##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#7)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
inclusion production##3##2##(2008-10#3)
inclusion proteins##2##2##(2008-10#2)
inclusion rate##4##2##(1994-9#4)
inclusion were##2##2##(2008-10#1)(2011-2#1)
inclusion##289##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#5)(1995-1#2)(1995-12#4)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1997-3#2)(1997-4#2)(1997-8#2)(2006-10#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#90)(2008-11#9)(2008-2#2)(2008-3#13)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#7)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-6#3)(2010-8#1)(2011-1#4)(2011-2#14)(2012-12#5)(2012-2#6)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#3)
inclusions are##4##2##(2008-2#1)(2008-3#1)(2008-7#2)
inclusions from##2##2##(2008-10#2)
inclusions in the##2##3##(2008-10#1)(2012-3#1)
inclusions in##13##2##(1992-11#1)(1992-9#1)(1993-12#1)(2008-10#7)(2008-3#1)(2008-7#1)(2012-3#1)
inclusions located##2##2##(2008-3#2)
inclusions may also##2##3##(2008-10#1)(2008-9#1)
inclusions of##2##2##(2008-10#1)(2008-7#1)
inclusions that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
inclusions to##2##2##(1993-6#1)(2008-10#1)
inclusions were present##2##3##(1994-9#1)(2006-12#1)
inclusions were##5##2##(1994-9#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#1)
inclusions##72##1##(1990-2#1)(1990-5#2)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-9#1)(1997-3#2)(1997-6#2)(2006-12#1)(2007-12#4)(2008-10#29)(2008-2#5)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2012-3#1)(2013-1#1)
inclusive fitness theory##2##3##(2008-10#2)
inclusive fitness##7##2##(2008-10#3)(2008-8#4)
inclusive of the##3##3##(2008-11#1)(2013-1#2)
inclusive of##10##2##(1996-12#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#4)
inclusive##36##1##(1990-4#2)(1993-3#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2010-2#2)(2010-3#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
inclusive-fitness model##2##2##(2008-8#2)
incognita J2##3##2##(2008-10#3)
incognita and the##2##3##(2008-10#1)(2011-2#1)
incognita and##4##2##(2008-10#3)(2011-2#1)
incognita second-stage juveniles (J2)##2##4##(2008-10#2)
incognita##31##1##(1994-12#2)(2008-10#28)(2011-2#1)
incognita-infested##2##1##(2008-10#2)
incoherence##3##1##(2008-3#2)(2009-9#1)
incoherent and##2##2##(2008-2#1)(2008-3#1)
incoherent backscattered spotlight##3##3##(2008-2#3)
incoherent beam##2##2##(2007-11#1)(2008-2#1)
incoherent feed-forward##3##2##(2008-11#3)
incoherent illumination##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
incoherent light are##2##3##(2007-11#2)
incoherent light##15##2##(2007-11#8)(2007-12#2)(2008-2#1)(2008-3#4)
incoherent optical frequency-domain reflectometer##2##4##(2008-3#2)
incoherent optical##4##2##(2007-11#2)(2008-3#2)
incoherent reflection model for##2##4##(2008-3#2)
incoherent reflection model##3##3##(2008-3#3)
incoherent reflection##4##2##(2008-2#1)(2008-3#3)
incoherent scattered##2##2##(2008-10#1)(2008-2#1)
incoherent scattering of##2##3##(2008-2#1)(2008-3#1)
incoherent scattering##3##2##(2008-2#1)(2008-3#2)
incoherent solitons##2##2##(2007-11#1)(2007-12#1)
incoherent source##7##2##(2007-12#4)(2008-3#3)
incoherent superposition of##2##3##(2008-3#2)
incoherent##97##1##(2007-11#16)(2007-12#21)(2008-10#1)(2008-11#3)(2008-2#15)(2008-3#40)(2010-8#1)
incoherent-to-coherent conversion and##2##3##(2008-2#1)(2008-3#1)
incoherent-to-coherent conversion##5##2##(2008-2#3)(2008-3#2)
incoherent-to-coherent optical##4##2##(2007-12#3)(2008-2#1)
incoherent-to-coherent##10##1##(2007-12#3)(2008-2#5)(2008-3#2)
incoherently illuminated##2##2##(2008-2#1)(2008-3#1)
incoherently interacting##2##2##(2007-12#2)
incoherently##9##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)
income and##10##2##(1993-1#1)(1993-3#1)(2008-8#2)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
income effects on##2##3##(1992-3#2)
income gamble##2##2##(2011-2#2)
income inequality##6##2##(2008-11#1)(2008-8#5)
income is##2##2##(2008-11#1)(2008-4#1)
income level##2##2##(2010-2#1)(2013-1#1)
income levels##2##2##(2009-7#1)(2011-2#1)
income tax##2##2##(1993-2#1)(2008-12#1)
income was##2##2##(2008-12#1)(2009-5#1)
income were##2##2##(2008-12#2)
income##120##1##(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#4)(2008-12#11)(2008-4#1)(2008-8#10)(2008-9#3)(2009-10#1)(2009-5#5)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
income-related inequalities in##2##3##(2013-1#2)
income-related##4##1##(2013-1#4)
income-to-needs##4##1##(2008-12#4)
income/education##2##1##(2011-2#2)
incomes##11##1##(1994-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-11#3)(2008-9#1)(2011-2#1)(2013-1#1)
incoming light##2##2##(2008-1#1)(2008-2#1)
incoming signals##2##2##(2008-7#2)
incoming wave front##2##3##(2008-3#2)
incoming wave##3##2##(2007-11#1)(2008-3#2)
incoming##33##1##(1995-3#1)(2007-11#4)(2007-12#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#7)(2008-7#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
incompatibilities between##2##2##(2009-2#1)(2011-2#1)
incompatibilities##4##1##(2009-2#2)(2011-2#2)
incompatibility between##2##2##(1992-6#1)(2008-8#1)
incompatibility with##4##2##(2008-10#3)(2009-12#1)
incompatibility##36##1##(1992-6#1)(1996-4#4)(2008-1#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
incompatible interaction##2##2##(2008-10#2)
incompatible interactions##2##2##(2008-10#2)
incompatible with the##6##3##(1991-11#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-8#1)
incompatible with##17##2##(1991-11#1)(1994-8#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
incompatible##43##1##(1991-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(1996-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#4)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
incompetence##7##1##(1992-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-7#1)(2011-1#1)(2013-1#1)
incompetent##6##1##(1991-2#1)(1993-3#1)(1995-9#4)
incomplete Freund's adjuvant##3##3##(1995-12#3)
incomplete and##7##2##(1990-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2012-2#1)
incomplete coverage of##2##3##(2008-10#1)(2008-7#1)
incomplete data##8##2##(1990-9#1)(1992-6#1)(2007-2#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
incomplete dominance##2##2##(2008-10#2)
incomplete in##2##2##(1993-6#1)(2008-10#1)
incomplete information##2##2##(1992-2#1)(1997-5#1)
incomplete lineage sorting##2##3##(2012-3#2)
incomplete medical##2##2##(2008-7#1)(2009-8#1)
incomplete or##3##2##(1992-11#1)(2010-8#1)(2012-2#1)
incomplete recovery of##2##3##(2008-10#1)(2008-7#1)
incomplete recovery##3##2##(2008-10#1)(2008-7#2)
incomplete removal##2##2##(1992-6#1)(2010-5#1)
incomplete replication##2##2##(1990-5#2)
incomplete resection##2##2##(1992-12#1)(2013-1#1)
incomplete right bundle branch block##2##5##(2008-12#1)(2012-12#1)
incomplete sampling##2##2##(2008-10#1)(2008-8#1)
incomplete tumor resection##2##3##(1997-7#1)(2009-4#1)
incomplete understanding of##2##3##(2012-2#1)(2012-3#1)
incomplete##146##1##(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#7)(2013-1#3)(2013-8#3)
incompletely defined##2##2##(1993-11#1)(1993-6#1)
incompletely dominant##5##2##(2008-10#4)(2012-3#1)
incompletely obliterated##2##2##(2008-7#2)
incompletely occluded##5##2##(1996-9#1)(2013-1#4)
incompletely resected##2##2##(1990-8#1)(2008-6#1)
incompletely##33##1##(1990-11#1)(1990-5#1)(1990-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-9#1)(2008-10#6)(2008-6#1)(2008-7#5)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)
inconclusive and##3##2##(1993-8#1)(1995-6#1)(2008-5#1)
inconclusive because##2##2##(2008-3#1)(2009-5#1)
inconclusive for a relationship between##3##5##(2013-8#3)
inconclusive for##7##2##(2008-11#1)(2013-8#6)
inconclusive##44##1##(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#7)
incongruence between the##2##3##(2008-10#1)(2012-3#1)
incongruence##7##1##(2007-8#5)(2008-10#1)(2012-3#1)
incongruent with##3##2##(2009-9#1)(2010-7#1)(2013-8#1)
incongruent##14##1##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-9#1)(2010-6#1)(2010-7#1)(2012-1#3)(2013-8#2)
inconsistencies in the##6##3##(1991-1#1)(2007-12#1)(2008-10#1)(2013-1#2)(2013-8#1)
inconsistencies in##9##2##(1991-1#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#3)(2013-8#1)
inconsistencies##22##1##(1991-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-4#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2013-1#3)(2013-8#1)
inconsistency between the##3##3##(2008-3#1)(2010-2#1)(2011-2#1)
inconsistency between##4##2##(1996-4#1)(2008-3#1)(2010-2#1)(2011-2#1)
inconsistency could be##2##3##(2008-5#1)(2010-11#1)
inconsistency in the##2##3##(2008-11#1)(2008-3#1)
inconsistency in##3##2##(1996-9#1)(2008-11#1)(2008-3#1)
inconsistency of##2##2##(2008-9#1)(2012-2#1)
inconsistency##18##1##(1996-4#1)(1996-9#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
inconsistent and##5##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)
inconsistent condom use##2##3##(2007-12#1)(2011-2#1)
inconsistent data##2##2##(2008-3#1)(2009-8#1)
inconsistent findings##5##2##(2008-11#1)(2009-10#1)(2012-12#2)(2013-1#1)
inconsistent gradient fields##2##3##(2008-2#2)
inconsistent results##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
inconsistent with a##2##3##(2008-10#1)(2013-1#1)
inconsistent with the##10##3##(1994-1#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
inconsistent with##20##2##(1990-8#1)(1994-1#1)(1994-3#1)(1995-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
inconsistent##74##1##(1990-8#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
inconsistently##3##1##(2007-12#1)(2008-10#1)(2009-9#1)
inconspicuous##5##1##(1990-8#1)(2008-10#2)(2008-11#1)(2009-6#1)
inconstant##3##1##(2008-10#1)(2008-9#2)
incontinence after##2##2##(2008-4#1)(2011-2#1)
incontinence and##4##2##(1992-8#1)(1996-11#1)(2008-3#1)(2008-4#1)
incontinence at##2##2##(2008-10#1)(2013-8#1)
incontinence in##10##2##(1994-5#1)(1997-5#1)(2008-10#4)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
incontinence is##2##2##(2008-4#1)(2011-1#1)
incontinence were##2##2##(1994-3#1)(2013-8#1)
incontinence##60##1##(1990-6#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-3#2)(1994-5#5)(1996-11#1)(1996-2#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-3#7)(2008-4#3)(2008-5#1)(2009-3#3)(2010-10#1)(2010-6#1)(2011-1#8)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
incontinence]##2##1##(1997-2#1)(2007-10#1)
incontinent##4##1##(2008-10#2)(2008-7#1)(2009-3#1)
inconvenience##8##1##(1994-3#1)(2008-10#1)(2008-11#4)(2009-3#1)(2009-6#1)
inconveniences of##2##2##(1995-5#1)(2007-8#1)
inconveniences##4##1##(1995-5#1)(2007-8#1)(2008-10#1)(2012-12#1)
inconvenient and##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
inconvenient to##2##2##(1991-3#1)(1997-4#1)
inconvenient##6##1##(1991-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-12#1)
incoordination was##2##2##(1997-2#1)(2011-1#1)
incoordination##12##1##(1992-12#1)(1997-2#7)(1997-8#1)(2011-1#3)
incorporate a##12##2##(1993-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
incorporate both##3##2##(1992-3#1)(2012-12#1)(2013-1#1)
incorporate knowledge##2##2##(2008-8#1)(2011-1#1)
incorporate such##2##2##(2007-11#1)(2011-1#1)
incorporate the##9##2##(1992-3#1)(1993-3#1)(1995-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-7#1)
incorporate them##2##2##(1995-3#1)(2008-10#1)
incorporate these##3##2##(2008-8#1)(2009-7#1)(2010-6#1)
incorporate##98##1##(1992-1#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#6)(2008-4#5)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#4)(2009-11#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
incorporated a##2##2##(1997-3#1)(2011-1#1)
incorporated and##3##2##(2008-11#1)(2008-5#1)(2010-8#1)
incorporated as a##2##3##(1991-12#1)(1992-11#1)
incorporated as##4##2##(1991-12#1)(1992-11#1)(1996-12#1)(2010-8#1)
incorporated at the##4##3##(1996-5#1)(2008-11#2)(2008-3#1)
incorporated at##7##2##(1990-2#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-3#1)
incorporated both##2##2##(1992-12#1)(1992-3#1)
incorporated by##2##2##(2008-10#1)(2008-11#1)
incorporated in a##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
incorporated in polyacrylate##2##3##(2008-5#2)
incorporated in the##16##3##(1990-2#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
incorporated in this##2##3##(2008-10#1)(2008-6#1)
incorporated in##54##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-6#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
incorporated into DNA##2##3##(2008-4#1)(2008-9#1)
incorporated into a##19##3##(1994-11#1)(1995-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-12#1)
incorporated into artificial planar##2##4##(1990-2#1)(1993-3#1)
incorporated into both##3##3##(1994-5#1)(2010-6#1)(2012-3#1)
incorporated into it##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
incorporated into its##2##3##(2010-2#1)(2011-1#1)
incorporated into our##2##3##(2008-2#1)(2008-8#1)
incorporated into solid lipid##2##4##(2008-5#2)
incorporated into the model##2##4##(1992-12#1)(2008-3#1)
incorporated into the##44##3##(1991-12#1)(1992-12#1)(1993-1#1)(1994-3#1)(1995-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#5)(2008-8#4)(2008-9#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
incorporated into this##2##3##(2008-11#1)(2008-8#1)
incorporated into##149##2##(1990-2#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#3)(1992-12#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#12)(2008-7#1)(2008-8#7)(2008-9#4)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
incorporated several##2##2##(2007-5#1)(2008-11#1)
incorporated the##5##2##(2008-10#1)(2008-3#1)(2008-9#2)(2010-1#1)
incorporated through the##2##3##(2010-2#1)(2011-1#1)
incorporated to##7##2##(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#2)
incorporated with##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2012-1#1)
incorporated within##2##2##(1994-9#1)(2008-10#1)
incorporated##307##1##(1990-2#3)(1990-5#3)(1990-7#1)(1991-12#4)(1991-5#2)(1991-9#2)(1992-10#4)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#3)(1993-1#1)(1993-11#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#2)(1997-7#3)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#62)(2008-11#17)(2008-12#5)(2008-2#3)(2008-3#16)(2008-4#6)(2008-5#21)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#9)(2009-1#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
incorporates a##15##2##(1992-6#1)(1994-2#1)(1995-2#1)(1996-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-3#3)(2008-7#1)(2012-3#1)
incorporates an##4##2##(1992-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
incorporates the##14##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#3)(2012-2#1)
incorporates##75##1##(1991-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-11#3)(2007-12#5)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
incorporating a##21##2##(1990-5#1)(1994-12#1)(1995-11#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-3#2)(2008-6#1)(2010-7#2)(2012-3#3)(2013-1#1)
incorporating an##11##2##(2008-10#8)(2008-5#1)(2009-6#1)(2010-4#1)
incorporating both##5##2##(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
incorporating different##2##2##(2008-4#1)(2010-3#1)
incorporating genetics into##2##3##(2008-12#2)
incorporating only##2##2##(2007-12#1)(2008-3#1)
incorporating such##2##2##(1996-6#1)(2008-10#1)
incorporating the##18##2##(1993-12#1)(1994-12#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
incorporating these##2##2##(2008-11#1)(2008-3#1)
incorporating this##4##2##(1992-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
incorporating two##3##2##(1994-1#1)(2008-10#2)
incorporating##162##1##(1990-5#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(2007-11#4)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#50)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#3)(2013-8#2)
incorporation after##2##2##(1994-3#1)(2009-10#1)
incorporation and##9##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-9#1)(1995-12#1)(1996-2#1)(2008-10#1)(2009-2#1)
incorporation as a##2##3##(2008-4#1)(2008-5#1)
incorporation at the##2##3##(1992-12#1)(1993-11#1)
incorporation at##3##2##(1992-12#1)(1992-3#1)(1993-11#1)
incorporation by##3##2##(1990-9#1)(1993-11#1)(1997-1#1)
incorporation in a##3##3##(1992-3#1)(2008-10#1)(2009-3#1)
incorporation in##12##2##(1991-12#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-12#1)(2008-10#3)(2009-3#2)(2012-2#1)
incorporation into DNA##7##3##(1991-12#2)(1994-11#1)(1994-3#1)(1994-5#2)(2010-11#1)
incorporation into serine##2##3##(1997-1#2)
incorporation into the##10##3##(1990-11#1)(1992-10#1)(1992-6#1)(1995-6#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-2#1)
incorporation into##47##2##(1990-11#1)(1990-7#2)(1991-12#2)(1991-6#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#3)(2007-11#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-11#1)(2010-5#1)
incorporation is##2##2##(1994-8#1)(2008-11#1)
incorporation occurred in##2##3##(1994-3#1)(2009-10#1)
incorporation of 3[H]-leucine into##2##4##(1994-8#2)
incorporation of D-alanine into LTA##2##5##(1995-6#2)
incorporation of [14C]arginine##2##3##(1995-12#2)
incorporation of [3H]-thymidine into DNA of##2##6##(1991-12#1)(1993-6#1)
incorporation of [3H]-thymidine##3##3##(1991-12#1)(1993-6#1)(2008-9#1)
incorporation of [3H]thymidine into##2##4##(1995-12#1)(2008-4#1)
incorporation of [3H]thymidine##6##3##(1995-12#1)(1995-2#3)(1997-1#1)(2008-4#1)
incorporation of a##13##3##(1990-7#1)(1991-9#1)(1992-9#1)(1993-1#1)(1995-3#2)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)
incorporation of an##5##3##(1993-8#1)(2007-11#1)(2008-10#2)(2009-2#1)
incorporation of both##3##3##(1991-9#1)(1995-2#1)(1996-3#1)
incorporation of cholesterol##2##3##(1990-2#1)(1992-6#1)
incorporation of radioactivity##2##3##(1990-11#1)(1994-5#1)
incorporation of radiolabeled##2##3##(1995-11#1)(2008-10#1)
incorporation of the##17##3##(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#1)(2010-3#1)(2012-2#1)
incorporation of these##5##3##(1990-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-4#1)
incorporation of this##2##3##(2008-10#1)(2008-3#1)
incorporation of##169##2##(1990-11#3)(1990-12#1)(1990-2#4)(1990-5#1)(1990-7#2)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#3)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#1)(2006-4#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#23)(2008-11#10)(2008-2#4)(2008-3#7)(2008-4#13)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
incorporation on the##2##3##(1993-8#1)(1995-11#1)
incorporation on##3##2##(1992-3#1)(1993-8#1)(1995-11#1)
incorporation procedure##2##2##(1995-8#1)(2008-10#1)
incorporation rates of##2##3##(1994-8#1)(2008-11#1)
incorporation rates##4##2##(1992-9#1)(1994-8#2)(2008-11#1)
incorporation studies##2##2##(1992-3#1)(2008-11#1)
incorporation to##3##2##(1990-7#1)(1992-12#1)(2008-10#1)
incorporation was##9##2##(1990-11#1)(1990-2#1)(1991-4#1)(1993-12#2)(1996-12#1)(2008-10#2)(2008-11#1)
incorporation##321##1##(1990-11#7)(1990-12#2)(1990-2#5)(1990-5#1)(1990-7#5)(1990-9#1)(1991-12#7)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-3#6)(1992-6#6)(1992-8#1)(1992-9#6)(1993-1#1)(1993-11#6)(1993-12#5)(1993-3#2)(1993-6#4)(1993-8#7)(1994-11#3)(1994-12#5)(1994-3#4)(1994-5#5)(1994-6#4)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#5)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#6)(1997-2#3)(1997-3#1)(2006-4#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#38)(2008-11#24)(2008-2#4)(2008-3#8)(2008-4#17)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
incorporation)##2##1##(1993-6#2)
incorrect at##2##2##(2007-8#1)(2008-7#1)
incorrect diagnosis##2##2##(2008-6#1)(2010-10#1)
incorrect total dose##2##3##(2011-2#2)
incorrect##34##1##(1990-6#1)(1991-6#2)(1991-9#2)(1996-11#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-7#3)(2009-5#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-3#1)
incorrectly##15##1##(1990-11#1)(1994-3#1)(1996-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2009-1#1)(2010-4#1)(2012-3#1)
increase &gt##4##2##(2008-7#4)
increase (P &lt##4##3##(1994-7#1)(2008-4#1)(2010-2#2)
increase (P##5##2##(1994-7#1)(2008-10#1)(2008-4#1)(2010-2#2)
increase (p&lt##4##2##(2008-11#1)(2008-12#1)(2013-1#2)
increase (r(m))##3##2##(2011-2#3)
increase PSD-95##2##2##(2012-3#2)
increase above the##2##3##(1996-5#1)(2011-2#1)
increase above##6##2##(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
increase access to##2##3##(1997-1#1)(2011-2#1)
increase access##3##2##(1994-2#1)(1997-1#1)(2011-2#1)
increase after light initiation##2##4##(2008-10#2)
increase after the initial##2##4##(2008-10#2)
increase after the##3##3##(1995-3#1)(2008-10#2)
increase after##13##2##(1990-7#1)(1995-12#2)(1995-3#1)(2008-10#5)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
increase all the##2##3##(2008-12#1)(2008-5#1)
increase all##3##2##(2008-12#2)(2008-5#1)
increase and decrease##2##3##(1996-12#1)(2008-10#1)
increase and subsequently##2##3##(1994-12#1)(2008-10#1)
increase and the##3##3##(2007-10#1)(2010-6#1)(2012-2#1)
increase and##26##2##(1992-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-9#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#2)(2009-2#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
increase are##2##2##(2008-10#1)(2009-11#1)
increase as a function of##3##5##(1991-2#1)(2008-8#2)
increase as a result of##2##5##(2007-11#1)(2008-12#1)
increase as a##5##3##(1991-2#1)(2007-11#1)(2008-12#1)(2008-8#2)
increase as##14##2##(1991-2#2)(1994-1#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#3)(2010-12#1)
increase at 10##2##3##(1992-7#1)(2009-12#1)
increase at pH##2##3##(2008-10#1)(2008-5#1)
increase at the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)
increase at##20##2##(1990-4#1)(1992-7#2)(1992-8#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-5#1)(2013-1#1)
increase awareness##4##2##(1997-1#1)(2007-2#1)(2008-1#1)(2008-8#1)
increase between##3##2##(1995-5#2)(2011-2#1)
increase blood##2##2##(1991-2#1)(2008-12#1)
increase bone density##2##3##(2008-4#1)(2008-8#1)
increase bone##3##2##(1993-11#1)(2008-4#1)(2008-8#1)
increase both in##2##3##(2008-3#1)(2012-2#1)
increase both the##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
increase both##11##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)
increase by the##3##3##(1993-6#1)(1997-6#1)(2008-2#1)
increase by##12##2##(1991-1#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-1#1)(1994-6#1)(1997-6#1)(2008-11#2)(2008-2#1)(2008-5#1)(2013-1#1)
increase cAMP##2##2##(1994-8#1)(1995-8#1)
increase cardiovascular##2##2##(2008-1#1)(2012-12#1)
increase cell##5##2##(1990-8#1)(1995-3#1)(2008-11#2)(2008-7#1)
increase compared to controls##2##4##(2008-10#1)(2011-2#1)
increase compared to##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
increase cytosolic calcium##2##3##(1993-12#1)(1995-11#1)
increase cytosolic##3##2##(1993-12#1)(1994-8#1)(1995-11#1)
increase diversity##2##2##(2010-2#2)
increase dramatically##4##2##(1994-2#1)(1995-3#1)(2008-2#1)(2008-9#1)
increase during aging##2##3##(1994-5#1)(2008-7#1)
increase during##12##2##(1990-12#1)(1994-5#1)(1994-6#2)(1995-6#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-7#1)
increase efficiency of##2##3##(1996-1#1)(2008-3#1)
increase efficiency##6##2##(1994-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
increase exercise##2##2##(2013-1#1)(2013-8#1)
increase expression##2##2##(1994-11#1)(2008-8#1)
increase followed##2##2##(2008-3#1)(2008-5#1)
increase food##2##2##(2011-1#1)(2012-12#1)
increase for a##3##3##(1992-12#1)(2008-2#1)(2008-3#1)
increase for##12##2##(1991-12#1)(1992-12#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-12#2)
increase from 5##2##3##(2008-3#1)(2012-2#1)
increase from a##2##3##(1997-6#1)(2007-12#1)
increase from baseline##3##3##(2011-2#1)(2013-1#2)
increase from the##2##3##(1994-6#1)(2013-8#1)
increase from##20##2##(1994-5#1)(1994-6#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-10#1)(2009-9#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
increase funding for##2##3##(1994-1#1)(2008-10#1)
increase has been##3##3##(2007-8#1)(2008-1#1)(2009-12#1)
increase health-span##2##2##(2008-11#2)
increase hemoglobin levels##2##3##(2010-11#1)(2010-9#1)
increase if##3##2##(2008-10#2)(2008-2#1)
increase in CAT activity##2##4##(1991-11#1)(1993-8#1)
increase in CMV##2##3##(2008-10#2)
increase in DNA content##2##4##(2008-11#2)
increase in DNA synthesis was##2##5##(1993-9#2)
increase in DNA synthesis##3##4##(1992-3#1)(1993-9#2)
increase in DNA##9##3##(1992-3#1)(1993-9#2)(1994-3#1)(1997-4#1)(2008-11#3)(2009-12#1)
increase in EC50##2##3##(1995-2#1)(1995-6#1)
increase in HDL##2##3##(2008-3#2)
increase in IL-2SA expression##2##4##(2008-11#2)
increase in IOP was obtained##2##5##(2013-1#2)
increase in IOP##3##3##(2013-1#3)
increase in IP3##2##3##(1990-12#1)(1991-12#1)
increase in IRS-I tyrosine phosphorylation##2##5##(1997-1#2)
increase in IRS-I##3##3##(1997-1#3)
increase in LDH##2##3##(1997-7#1)(2008-11#1)
increase in LDL metabolism##2##4##(1993-6#2)
increase in LDL##3##3##(1993-6#2)(1994-11#1)
increase in MnSOD##2##3##(1995-6#2)
increase in Na+##2##3##(1992-6#1)(2008-12#1)
increase in PKC activity##2##4##(1992-11#2)
increase in PKC##3##3##(1992-11#2)(1993-3#1)
increase in Pythium spp##2##4##(2008-10#2)
increase in ROS production##2##4##(2008-1#1)(2010-12#1)
increase in UTII concentration##2##4##(2008-7#2)
increase in Vmax##3##3##(1994-8#1)(1995-2#2)
increase in [3H]AMPA binding##2##4##(1996-5#2)
increase in [Ca2+]i and##2##4##(1990-7#1)(1997-1#1)
increase in [Ca2+]i in##3##4##(1992-6#1)(1994-2#1)(1997-2#1)
increase in [Ca2+]i was##3##4##(1994-3#1)(1994-6#1)(1994-9#1)
increase in [Ca2+]i##16##3##(1990-7#3)(1992-6#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1997-1#2)(1997-2#2)
increase in [Mg2+]i##3##3##(1993-11#1)(1994-6#2)
increase in [cAMP]i##2##3##(1991-3#2)
increase in a##3##3##(1995-3#1)(2008-9#1)(2012-2#1)
increase in absorbance##4##3##(1992-8#1)(2008-10#3)
increase in absorption##2##3##(2007-11#1)(2007-12#1)
increase in acetylcholine levels##2##4##(1994-8#2)
increase in activity##4##3##(1996-5#1)(2008-4#2)(2008-7#1)
increase in adhesion##2##3##(1992-12#1)(2012-2#1)
increase in alkaline phosphatase##2##4##(1990-6#1)(2008-11#1)
increase in all##2##3##(2008-10#1)(2012-2#1)
increase in apoptosis##3##3##(1997-7#1)(2008-7#2)
increase in apoptotic##2##3##(2008-11#1)(2008-6#1)
increase in average##4##3##(1992-12#1)(2008-12#1)(2008-5#1)(2012-1#1)
increase in basal##4##3##(1993-8#1)(1995-11#1)(1995-6#1)(2008-4#1)
increase in binding##2##3##(1992-6#1)(1995-3#1)
increase in blood flow velocity##2##5##(1996-3#2)
increase in blood flow##5##4##(1990-7#1)(1996-3#2)(2008-12#1)(2008-8#1)
increase in blood##11##3##(1990-7#1)(1991-5#1)(1995-12#1)(1996-3#2)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-1#1)
increase in body weight##4##4##(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
increase in body##5##3##(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
increase in bone mass##4##4##(1991-11#1)(1993-11#3)
increase in bone##5##3##(1991-11#1)(1993-11#3)(2008-8#1)
increase in both##12##3##(1990-7#2)(1992-11#1)(1993-8#1)(1995-3#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)
increase in brain##3##3##(1992-3#1)(1997-2#1)(2008-7#1)
increase in cAMP##4##3##(1993-3#2)(1994-9#1)(1995-12#1)
increase in cancer##2##3##(1993-8#1)(1995-5#1)
increase in cardiac##2##3##(1995-12#1)(2008-5#1)
increase in cell number##3##4##(1995-2#1)(1996-12#1)(1996-2#1)
increase in cell proliferation##2##4##(1990-8#1)(1995-11#1)
increase in cell size##2##4##(1995-12#1)(2008-11#1)
increase in cell##14##3##(1990-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)(2011-1#2)(2012-1#1)(2013-8#1)
increase in chickpea##2##3##(2008-10#2)
increase in children##2##3##(2008-8#1)(2011-1#1)
increase in chitinase and beta-1##2##5##(2008-10#2)
increase in chitinase##3##3##(2008-10#3)
increase in collagen##2##3##(2008-5#1)(2009-8#1)
increase in concentration of##3##4##(2008-1#1)(2008-11#1)(2010-3#1)
increase in concentration##4##3##(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#1)
increase in core temperature##2##4##(1992-3#2)
increase in coverage##2##3##(1994-3#1)(2008-11#1)
increase in crime##2##3##(1994-12#1)(1996-12#1)
increase in current##3##3##(1990-5#1)(2008-8#1)(2012-1#1)
increase in cytosolic Ca2+##3##4##(1992-4#1)(1994-6#1)(1995-12#1)
increase in cytosolic##7##3##(1992-4#1)(1994-6#1)(1995-11#2)(1995-12#1)(2008-10#1)(2008-7#1)
increase in disease severity##2##4##(2008-10#2)
increase in disease##5##3##(2008-10#5)
increase in dopamine##3##3##(1993-12#1)(1994-2#1)(2009-8#1)
increase in effluent##2##3##(2008-12#1)(2008-7#1)
increase in electrolyte leakage##3##4##(2008-10#3)
increase in electrolyte loss##2##4##(2008-10#2)
increase in electrolyte##5##3##(2008-10#5)
increase in enzyme activity was associated with##2##7##(1990-7#1)(1994-8#1)
increase in enzyme activity##3##4##(1990-11#1)(1990-7#1)(1994-8#1)
increase in expression##4##3##(1993-8#1)(1994-12#1)(1996-12#1)(2007-11#1)
increase in extracellular##5##3##(1991-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-6#1)
increase in fluctuation##2##3##(1996-3#2)
increase in fluorescence intensity and##2##5##(2008-10#2)
increase in fluorescence intensity##4##4##(2008-10#3)(2008-4#1)
increase in fluorescence##8##3##(2008-10#5)(2008-4#1)(2008-8#1)(2013-7#1)
increase in flux##2##3##(1991-3#1)(1995-6#1)
increase in force##2##3##(1997-7#1)(2013-8#1)
increase in frequencies##2##3##(2008-10#1)(2013-8#1)
increase in frequency of##2##4##(2008-10#2)
increase in frequency##3##3##(1992-3#1)(2008-10#2)
increase in glucose##3##3##(1991-5#1)(1994-6#1)(2010-2#1)
increase in growth rate##2##4##(2008-11#1)(2008-12#1)
increase in heart rate##3##4##(1993-2#1)(1995-12#1)(2012-3#1)
increase in high##2##3##(1990-12#1)(2010-5#1)
increase in homocysteine##2##3##(2008-3#1)(2010-5#1)
increase in hospital##4##3##(1991-12#1)(1996-12#1)(1997-5#1)(2013-8#1)
increase in incidence##2##3##(1990-11#1)(2010-8#1)
increase in inflammatory##2##3##(1997-1#1)(2008-3#1)
increase in informational entropy##2##4##(1993-12#2)
increase in inorganic##2##3##(1991-5#1)(1994-2#1)
increase in inositol phosphate##2##4##(1992-9#1)(1997-7#1)
increase in inositol##5##3##(1992-9#2)(1994-9#2)(1997-7#1)
increase in insulin##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
increase in insulinemia##2##3##(2008-10#1)(2008-4#1)
increase in intestinal##2##3##(2008-11#1)(2013-1#1)
increase in intracellular free Ca2+ concentration##2##6##(1993-12#1)(1995-8#1)
increase in intracellular##9##3##(1990-5#1)(1991-5#1)(1993-12#1)(1995-11#1)(1995-8#2)(2008-11#1)(2008-7#1)(2012-2#1)
increase in kcat/Km of the##2##5##(1995-2#2)
increase in labeling##2##3##(1990-7#1)(1997-3#1)
increase in lactate##3##3##(1994-2#1)(1994-6#1)(1995-12#1)
increase in late##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
increase in local##3##3##(1992-10#1)(2008-4#1)(2008-8#1)
increase in locomotor activity and##2##5##(2008-10#2)
increase in locomotor activity##4##4##(1993-3#1)(1996-12#1)(2008-10#2)
increase in loss##2##3##(2008-2#2)
increase in mRNA levels##2##4##(1993-5#1)(1994-11#1)
increase in mRNA##4##3##(1993-5#1)(1994-11#1)(2008-11#1)(2008-5#1)
increase in mass##2##3##(2008-10#1)(2010-3#1)
increase in maternal##2##3##(2008-8#1)(2012-3#1)
increase in maximal##2##3##(1990-6#1)(2008-11#1)
increase in maximum##2##3##(1994-3#1)(2011-2#1)
increase in mean##4##3##(1990-9#1)(1993-12#1)(2007-8#1)(2011-2#1)
increase in mice##2##3##(2008-11#1)(2012-2#1)
increase in micronucleated##2##3##(2008-8#1)(2008-9#1)
increase in mortality##7##3##(1991-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#2)
increase in muscle##2##3##(1993-11#1)(2012-12#1)
increase in mutations##2##3##(2008-7#1)(2008-9#1)
increase in nCDHA addition##2##4##(2012-2#2)
increase in nCDHA##3##3##(2012-2#3)
increase in number in##2##4##(2008-8#1)(2012-3#1)
increase in number of##4##4##(1991-2#1)(2007-11#1)(2010-8#1)(2012-3#1)
increase in number##7##3##(1991-2#1)(2007-11#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#2)
increase in numbers of##2##4##(1996-3#1)(2007-8#1)
increase in optical##2##3##(1994-11#1)(2008-3#1)
increase in other##2##3##(1993-6#1)(2007-7#1)
increase in pH of##2##4##(2008-12#1)(2008-5#1)
increase in paracellular permeability##2##4##(1994-6#2)
increase in percentage of##2##4##(1997-2#1)(2011-2#1)
increase in perfusion##2##3##(1993-3#2)
increase in photosensitivity##3##3##(2007-12#3)
increase in physical activity##2##4##(2010-1#1)(2012-12#1)
increase in plant growth##2##4##(2013-8#2)
increase in plasma##10##3##(1990-11#2)(1991-2#1)(1991-9#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-8#1)
increase in power by##2##4##(2007-11#1)(2008-3#1)
increase in power##3##3##(2007-11#1)(2008-3#2)
increase in pressure##2##3##(1997-7#1)(2008-7#1)
increase in prevalence##2##3##(2013-1#1)(2013-8#1)
increase in production##2##3##(1990-8#1)(2013-1#1)
increase in protein disulfide isomerase##2##5##(1990-7#1)(1993-6#1)
increase in protein kinase##2##4##(1994-5#1)(2010-12#1)
increase in protein synthesis##2##4##(2008-5#2)
increase in protein##9##3##(1990-12#1)(1990-7#1)(1993-6#1)(1994-5#1)(2008-5#3)(2008-7#1)(2010-12#1)
increase in rate##2##3##(1990-5#1)(2008-10#1)
increase in rates of##2##4##(1993-6#1)(2009-11#1)
increase in receptor phosphorylation##2##4##(1993-3#1)(1996-12#1)
increase in receptor##3##3##(1993-12#1)(1993-3#1)(1996-12#1)
increase in reflectance##2##3##(2008-2#1)(2008-3#1)
increase in renal##3##3##(1994-12#1)(1995-12#1)(2011-2#1)
increase in reported##2##3##(1991-9#1)(1992-2#1)
increase in response##2##3##(1993-12#1)(2008-8#1)
increase in rice##2##3##(2008-10#1)(2013-8#1)
increase in risk##7##3##(1990-6#2)(2008-7#2)(2009-12#1)(2009-8#1)(2011-2#1)
increase in secretion##2##3##(1990-11#1)(1991-6#1)
increase in seed yield##2##4##(2008-10#1)(2008-12#1)
increase in sensitivity##10##3##(1990-5#1)(1991-6#1)(2008-10#4)(2008-2#3)(2008-3#1)
increase in serum##12##3##(1993-12#2)(1996-9#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)
increase in size and intensity of the##2##7##(1993-12#2)
increase in size and##4##4##(1993-12#2)(2007-12#2)
increase in size##10##3##(1993-12#3)(2007-12#3)(2008-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
increase in skin##2##3##(1990-6#1)(2008-5#1)
increase in sleep##2##3##(1995-12#2)
increase in species##2##3##(2008-9#1)(2010-6#1)
increase in specific##4##3##(1993-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
increase in speed##2##3##(1995-2#1)(2008-3#1)
increase in strength with increasing##2##5##(2009-11#1)(2012-2#1)
increase in striatal##2##3##(1990-7#1)(1993-12#1)
increase in superoxide##2##3##(1994-11#1)(2012-2#1)
increase in surface area##3##4##(2010-10#3)
increase in surface##5##3##(1993-8#1)(2008-3#1)(2010-10#3)
increase in temperature##5##3##(1997-2#2)(2008-3#1)(2012-6#1)(2013-8#1)
increase in the activity of##6##5##(1992-5#1)(1994-5#1)(1995-2#1)(1997-1#1)(2008-11#2)
increase in the activity##7##4##(1992-5#1)(1994-5#1)(1995-2#1)(1997-1#1)(2008-11#2)(2008-7#1)
increase in the amount of the##3##6##(1992-3#1)(1992-6#1)(2009-8#1)
increase in the amount of##14##5##(1992-3#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)
increase in the apparent##2##4##(1995-5#1)(2011-1#1)
increase in the average##4##4##(2007-8#1)(2008-12#1)(2008-2#1)(2013-8#1)
increase in the binding##2##4##(1995-2#1)(1995-3#1)
increase in the bulk##2##4##(2008-10#1)(2011-1#1)
increase in the concentration of the##2##6##(1995-3#1)(2008-10#1)
increase in the concentration of##7##5##(1990-7#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-7#1)(2012-2#1)
increase in the concentration##8##4##(1990-7#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
increase in the density of##2##5##(1990-5#2)
increase in the diffraction##2##4##(2008-3#2)
increase in the effective##2##4##(1996-6#1)(2008-3#1)
increase in the excitation##2##4##(2008-10#1)(2008-2#1)
increase in the expression of##3##5##(1994-8#1)(2008-10#1)(2012-3#1)
increase in the fluorescence intensity##2##5##(1995-6#1)(2008-10#1)
increase in the fluorescence##3##4##(1995-6#1)(2008-10#2)
increase in the frequency of micronucleated erythrocytes was##3##8##(2008-9#3)
increase in the frequency of micronucleated##5##6##(1996-12#1)(2008-9#4)
increase in the frequency of##8##5##(1991-9#1)(1992-12#1)(1996-12#1)(2008-9#4)(2010-6#1)
increase in the growth##2##4##(2009-6#1)(2012-2#1)
increase in the incidence of##13##5##(1991-4#1)(1994-3#1)(1996-12#1)(1996-6#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-7#1)
increase in the intensity of##3##5##(1992-12#1)(1997-2#1)(2008-3#1)
increase in the intracellular##5##4##(1990-2#1)(1992-11#1)(1994-9#1)(2007-11#1)(2008-11#1)
increase in the level of##4##5##(1997-7#1)(2009-8#2)(2012-12#1)
increase in the levels of##9##5##(1992-12#1)(1994-2#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
increase in the mRNA##3##4##(2008-11#1)(2008-4#1)(2010-1#1)
increase in the magnitude of##2##5##(1995-2#1)(2010-10#1)
increase in the mean##5##4##(1990-9#1)(1993-1#1)(1994-6#1)(2008-11#1)(2008-9#1)
increase in the number of individuals##3##6##(2011-2#1)(2013-1#2)
increase in the number of papers##2##6##(1991-5#1)(2008-10#1)
increase in the number of patients##3##6##(1994-12#1)(2006-10#1)(2013-8#1)
increase in the number of people with##2##7##(2008-6#1)(2011-2#1)
increase in the number of people##3##6##(1992-2#1)(2008-6#1)(2011-2#1)
increase in the number of unmyelinated fibers in the##2##9##(1993-12#2)
increase in the number of##44##5##(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#2)(1994-12#2)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#2)(1997-6#2)(2006-10#2)(2008-10#9)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
increase in the number##48##4##(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#2)(1994-12#2)(1994-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#3)(1997-6#2)(2006-10#2)(2008-10#9)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
increase in the odds of##2##5##(2013-1#2)
increase in the order##2##4##(2008-10#2)
increase in the past##2##4##(1992-3#1)(1995-3#1)
increase in the peak##2##4##(2008-10#1)(2008-11#1)
increase in the population between 2000 and 2010##2##8##(2013-8#2)
increase in the population of##2##5##(2008-8#1)(2011-2#1)
increase in the population##4##4##(2008-8#1)(2011-2#1)(2013-8#2)
increase in the prevalence of##3##5##(1997-3#1)(2008-1#1)(2009-7#1)
increase in the prevalence##4##4##(1997-3#1)(2008-1#1)(2009-7#1)(2010-6#1)
increase in the production of##2##5##(1992-8#1)(2009-12#1)
increase in the proliferation##2##4##(1993-3#1)(1995-4#1)
increase in the proportion of APP##2##6##(1996-12#2)
increase in the proportion of##7##5##(1991-12#1)(1995-11#1)(1995-6#1)(1996-12#2)(2007-12#1)(2008-12#1)
increase in the rate of [3H]dTTP incorporation into DNA##2##9##(1994-5#2)
increase in the rate of##8##5##(1990-5#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-6#1)(2011-2#1)
increase in the ratio of##4##5##(1994-12#1)(2008-6#1)(2011-1#1)(2012-1#1)
increase in the ratio##5##4##(1993-2#1)(1994-12#1)(2008-6#1)(2011-1#1)(2012-1#1)
increase in the right##2##4##(2007-9#1)(2008-11#1)
increase in the risk of##2##5##(2006-10#1)(2008-10#1)
increase in the risk##3##4##(2006-10#1)(2008-10#1)(2011-2#1)
increase in the sensitivity of the##3##6##(2008-10#2)(2008-3#1)
increase in the sensitivity##4##4##(1995-2#1)(2008-10#2)(2008-3#1)
increase in the serum##2##4##(1992-3#1)(2010-4#1)
increase in the size of##2##5##(2009-6#1)(2011-1#1)
increase in the speed##2##4##(1993-12#1)(2008-3#1)
increase in the steady state##2##5##(1990-5#1)(1991-12#1)
increase in the steady-state level of##2##6##(1992-9#1)(1997-1#1)
increase in the steady-state levels of##2##6##(1994-6#2)
increase in the steady-state##4##4##(1992-9#1)(1994-6#2)(1997-1#1)
increase in the survival##2##4##(1991-12#1)(2008-11#1)
increase in the total number of##2##6##(2008-1#1)(2008-10#1)
increase in the total##7##4##(1994-5#1)(1994-9#1)(1997-1#1)(2008-1#2)(2008-10#2)
increase in the urine##2##4##(1990-12#2)
increase in the viscosity of##2##5##(2008-5#1)(2013-1#1)
increase in the##455##3##(1990-12#4)(1990-2#4)(1990-5#8)(1990-6#2)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#9)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#6)(1994-6#7)(1994-8#1)(1994-9#3)(1995-11#2)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#5)(1996-12#5)(1996-5#1)(1996-6#3)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-10#3)(2007-11#4)(2007-12#9)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#55)(2008-11#23)(2008-12#5)(2008-2#7)(2008-3#19)(2008-4#1)(2008-5#17)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#11)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#4)(2009-7#2)(2009-8#9)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#4)(2011-1#11)(2011-2#19)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#9)
increase in their##5##3##(1990-7#1)(1995-2#1)(2006-12#1)(2008-3#1)(2013-8#1)
increase in this##2##3##(2008-5#1)(2010-4#1)
increase in time##2##3##(1997-7#1)(2013-1#1)
increase in total##10##3##(1990-3#1)(1992-11#1)(1994-3#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)
increase in viral##2##3##(2008-5#1)(2011-2#1)
increase in virus##2##3##(2008-10#1)(2008-11#1)
increase in volumetric##2##3##(2008-11#1)(2008-7#1)
increase in water##3##3##(1994-8#1)(2008-5#2)
increase in weight##3##3##(1991-2#2)(2013-7#1)
increase in workload##2##3##(2008-1#1)(2012-2#1)
increase in yield##3##3##(2008-10#3)
increase in##1631##2##(1990-10#4)(1990-11#8)(1990-12#12)(1990-2#11)(1990-3#1)(1990-5#17)(1990-6#9)(1990-7#17)(1990-8#3)(1990-9#2)(1991-11#4)(1991-12#18)(1991-2#7)(1991-3#9)(1991-4#2)(1991-5#7)(1991-6#4)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#10)(1992-12#13)(1992-2#3)(1992-3#19)(1992-4#2)(1992-5#4)(1992-6#17)(1992-7#1)(1992-8#14)(1992-9#4)(1993-1#2)(1993-11#14)(1993-12#23)(1993-2#4)(1993-3#15)(1993-5#2)(1993-6#7)(1993-8#8)(1993-9#3)(1994-1#1)(1994-11#11)(1994-12#8)(1994-2#10)(1994-3#16)(1994-5#9)(1994-6#21)(1994-8#12)(1994-9#10)(1995-1#3)(1995-11#15)(1995-12#17)(1995-2#20)(1995-3#14)(1995-4#1)(1995-5#5)(1995-6#13)(1995-8#5)(1996-1#1)(1996-12#26)(1996-2#6)(1996-3#9)(1996-5#10)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#15)(1997-2#19)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#15)(1997-8#5)(2006-10#5)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#25)(2007-2#3)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#19)(2008-10#167)(2008-11#77)(2008-12#31)(2008-2#20)(2008-3#63)(2008-4#18)(2008-5#57)(2008-6#16)(2008-7#54)(2008-8#33)(2008-9#30)(2009-1#2)(2009-10#1)(2009-11#8)(2009-12#6)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#6)(2009-7#4)(2009-8#19)(2009-9#1)(2010-1#4)(2010-10#7)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#8)(2010-6#5)(2010-7#1)(2010-8#11)(2011-1#28)(2011-10#1)(2011-2#52)(2011-3#1)(2012-1#7)(2012-12#7)(2012-2#39)(2012-3#12)(2012-6#2)(2012-7#1)(2012-9#3)(2013-1#44)(2013-7#11)(2013-8#32)
increase induced by##2##3##(1992-3#1)(1995-5#1)
increase insulin##2##2##(1996-11#1)(2012-3#1)
increase intracellular##2##2##(1995-8#1)(1997-6#1)
increase is##26##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
increase its##6##2##(1994-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
increase levels of##2##3##(1997-7#1)(2009-8#1)
increase linearly with##3##3##(1996-5#1)(2008-3#1)(2010-8#1)
increase live##2##2##(2011-2#1)(2012-3#1)
increase may##2##2##(1994-11#1)(2008-7#1)
increase mean##2##2##(2008-8#1)(2009-5#1)
increase methane production##2##3##(2013-1#2)
increase microbial##2##2##(2008-10#1)(2010-4#1)
increase observed in##2##3##(1995-12#1)(2012-2#1)
increase observed##3##2##(1995-12#1)(2008-4#1)(2012-2#1)
increase occurs##2##2##(1993-11#1)(2007-12#1)
increase of 5##3##3##(1993-8#1)(1994-12#1)(2013-1#1)
increase of NBD fluorescence##2##4##(1994-2#2)
increase of NGFI-B mRNA##2##4##(1996-12#2)
increase of NO##2##3##(2008-2#1)(2008-9#1)
increase of NPC##2##3##(2011-2#2)
increase of [Ca2+]i##2##3##(1992-6#1)(2008-5#1)
increase of activity of##3##4##(2008-4#1)(2013-1#2)
increase of activity##4##3##(2008-11#1)(2008-4#1)(2013-1#2)
increase of blood##2##3##(2006-10#1)(2007-11#1)
increase of both free and membrane-bound ribosomes##2##7##(2008-7#2)
increase of both##4##3##(1993-12#1)(2008-10#1)(2008-7#2)
increase of cell##2##3##(1994-5#1)(2008-11#1)
increase of concentration of##2##4##(2013-1#2)
increase of corticostriatal EPSCs##2##4##(2009-12#2)
increase of cytoplasmic free calcium##2##5##(1992-6#2)
increase of cytosolic Ca2+##2##4##(1996-2#1)(2008-8#1)
increase of cytosolic##6##3##(1993-12#2)(1993-8#1)(1996-2#1)(2008-11#1)(2008-8#1)
increase of diastolic blood pressure##2##5##(2008-7#1)(2011-1#1)
increase of efficiency##2##3##(2008-10#1)(2008-8#1)
increase of final monoclonalantibody##2##4##(2008-11#2)
increase of fluorescence##3##3##(2008-10#3)
increase of free##3##3##(1990-7#1)(2008-11#1)(2013-8#1)
increase of holding current##2##4##(1993-12#2)
increase of inducible##2##3##(1995-12#1)(2013-1#1)
increase of interleukin##2##3##(2008-12#1)(2008-5#1)
increase of intracellular calcium##2##4##(1995-8#1)(2008-4#1)
increase of intracellular##4##3##(1995-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
increase of its##5##3##(1993-3#1)(2008-10#3)(2012-3#1)
increase of osmotic pressure from 300 mOsmol kg-1 to 366 mOsmol##2##11##(2008-11#2)
increase of osmotic pressure##6##4##(2008-11#6)
increase of plasma##2##3##(1991-12#1)(2010-4#1)
increase of serum##5##3##(1990-12#1)(1990-2#1)(1995-3#1)(2009-8#1)(2010-12#1)
increase of specific##2##3##(2008-11#1)(2008-7#1)
increase of surface potential##2##4##(2008-10#2)
increase of the cell##2##4##(1995-9#1)(2008-11#1)
increase of the intracellular##2##4##(2008-11#1)(2008-7#1)
increase of the mean##3##4##(2007-7#1)(2008-11#1)(2008-2#1)
increase of the signal in the##2##6##(2008-10#1)(2008-11#1)
increase of the signal##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
increase of the specific##2##4##(2008-11#1)(2008-7#1)
increase of the##82##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-6#1)(1993-8#1)(1994-3#2)(1994-6#2)(1995-12#1)(1995-3#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#19)(2008-11#10)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#2)
increase of their##3##3##(1994-9#1)(2009-5#1)(2009-7#1)
increase of these##2##3##(1990-5#1)(2007-8#1)
increase of total##2##3##(1996-11#1)(2008-12#1)
increase of tumor rate##2##4##(1992-8#2)
increase of##384##2##(1990-12#4)(1990-2#3)(1990-5#3)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-6#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#5)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-3#2)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#56)(2008-11#30)(2008-12#11)(2008-2#5)(2008-3#13)(2008-4#5)(2008-5#20)(2008-6#3)(2008-7#12)(2008-8#21)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#6)(2011-10#1)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#6)
increase on the##3##3##(2008-10#2)(2012-2#1)
increase on##5##2##(1997-8#1)(2008-10#2)(2009-11#1)(2012-2#1)
increase or decrease with##2##4##(2008-3#1)(2011-2#1)
increase or decrease##10##3##(1990-9#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)
increase or##14##2##(1990-9#1)(1996-2#1)(1997-1#2)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
increase organizational##2##2##(1994-12#1)(1996-1#1)
increase our understanding of the##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
increase our understanding of##8##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
increase our understanding##9##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
increase our##11##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
increase over the##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
increase over time##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
increase over##9##2##(1994-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2012-2#1)
increase overall##3##2##(1997-3#1)(2008-11#1)(2008-5#1)
increase paralleled##2##2##(1992-2#1)(2008-10#1)
increase patient##2##2##(2008-10#1)(2012-2#1)
increase physicians'##2##2##(2008-11#1)(2010-8#1)
increase positive##3##2##(2008-12#1)(2008-5#1)(2009-11#1)
increase product##2##2##(2008-10#1)(2008-5#1)
increase productivity##5##2##(1991-3#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-7#1)
increase proportionally to##2##3##(2008-2#1)(2012-2#1)
increase proportionally##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
increase public awareness of##2##4##(1994-1#1)(2008-10#1)
increase public awareness##3##3##(1994-1#1)(2008-1#1)(2008-10#1)
increase quality of care##2##4##(1996-2#1)(1997-3#1)
increase quality of##3##3##(1996-2#1)(1997-3#1)(2012-3#1)
increase rapidly##5##2##(1994-2#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-8#1)
increase rat platelet cAMP in porcine thyroid gland##2##8##(1993-3#2)
increase rates of##3##3##(2007-7#1)(2008-12#1)(2009-10#1)
increase reported##2##2##(1996-12#1)(2012-12#1)
increase risk of##4##3##(1990-8#1)(2008-11#1)(2008-3#1)(2009-12#1)
increase risk##6##2##(1990-8#1)(2008-11#1)(2008-3#1)(2009-12#2)(2012-12#1)
increase seen in##2##3##(1996-2#1)(2008-9#1)
increase sensitivity and selectivity##2##4##(2008-10#2)
increase sensitivity and##3##3##(2008-10#3)
increase sensitivity##7##2##(2007-11#1)(2008-10#6)
increase significantly in the##2##4##(1992-11#1)(2008-10#1)
increase significantly in##3##3##(1992-11#1)(1994-1#1)(2008-10#1)
increase significantly the##4##3##(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
increase significantly##13##2##(1992-11#1)(1994-1#1)(2008-10#5)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
increase smoothly##2##2##(2008-7#2)
increase students'##2##2##(2009-8#1)(2010-3#1)
increase surface##2##2##(2009-7#1)(2013-1#1)
increase that##2##2##(1996-3#1)(2008-9#1)
increase the accuracy in##2##4##(2007-10#1)(2008-3#1)
increase the accuracy of the##2##5##(2008-10#1)(2011-3#1)
increase the accuracy##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2011-3#1)
increase the activity of##2##4##(2012-1#1)(2013-8#1)
increase the amount of##2##4##(1997-3#1)(2013-8#1)
increase the availability of##2##4##(2008-9#1)(2011-1#1)
increase the bandwidth##2##3##(2007-11#1)(2008-2#1)
increase the binding of the##2##5##(1993-6#1)(1997-7#1)
increase the binding of##3##4##(1993-6#1)(1995-2#1)(1997-7#1)
increase the binding##4##3##(1991-12#1)(1993-6#1)(1995-2#1)(1997-7#1)
increase the bit error##2##4##(2008-3#2)
increase the concentration##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
increase the effectiveness of##2##4##(2012-1#1)(2013-1#1)
increase the efficacy##3##3##(2008-3#1)(2008-4#1)(2010-9#1)
increase the efficiency and##2##4##(2008-8#1)(2012-12#1)
increase the efficiency##6##3##(1993-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)
increase the frequency of##3##4##(2008-10#1)(2008-9#1)(2010-3#1)
increase the frequency##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
increase the incidence and severity of##2##6##(2008-10#1)(2012-3#1)
increase the incidence of##4##4##(1992-2#1)(1992-5#1)(2008-10#1)(2013-8#1)
increase the incidence##7##3##(1992-2#1)(1992-5#1)(2007-10#1)(2008-10#2)(2012-3#1)(2013-8#1)
increase the level of##7##4##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#1)
increase the levels of##2##4##(1997-1#1)(2010-6#1)
increase the likelihood of##9##4##(1992-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)
increase the likelihood##10##3##(1992-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#2)(2010-12#1)
increase the longevity of##2##4##(2008-10#1)(2008-11#1)
increase the number of patients##2##5##(2007-10#1)(2011-2#1)
increase the number of##14##4##(1993-11#1)(1993-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)
increase the number##15##3##(1993-11#1)(1993-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#1)(2011-2#1)
increase the odds of##2##4##(2007-10#1)(2013-1#1)
increase the overall##4##3##(1990-12#1)(1996-5#1)(2012-1#1)(2013-1#1)
increase the permeability of##2##4##(1992-6#1)(2008-5#1)
increase the potential##2##3##(2008-5#1)(2011-2#1)
increase the power##3##3##(2008-8#1)(2012-3#2)
increase the probability of##6##4##(1991-12#1)(1995-12#1)(2008-3#1)(2008-7#3)
increase the probability##7##3##(1991-12#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-7#3)
increase the proportion of##3##4##(1994-2#1)(2008-11#1)(2008-8#1)
increase the quality and##2##4##(2011-2#1)(2012-12#1)
increase the quality##3##3##(2011-2#1)(2011-7#1)(2012-12#1)
increase the range of##3##4##(1994-5#1)(2008-2#1)(2012-3#1)
increase the relative##2##3##(1990-7#1)(1994-2#1)
increase the resolution##2##3##(2008-11#1)(2008-3#1)
increase the response##2##3##(1990-11#1)(2012-12#1)
increase the risk for##4##4##(2008-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
increase the risk of breast cancer##2##6##(1994-2#1)(2009-4#1)
increase the risk of cancer##2##5##(2008-7#1)(2013-1#1)
increase the risk of##32##4##(1990-11#1)(1991-9#1)(1994-2#1)(1996-6#1)(2007-10#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
increase the risk##36##3##(1990-11#1)(1991-9#1)(1994-2#1)(1996-6#1)(2007-10#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)
increase the safety##2##3##(2011-2#1)(2013-1#1)
increase the sensitivity and##3##4##(1997-4#1)(2008-10#2)
increase the sensitivity of the##6##5##(1990-8#1)(1995-11#1)(2008-10#3)(2008-9#1)
increase the sensitivity of##11##4##(1990-8#2)(1995-11#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
increase the sensitivity##20##3##(1990-8#2)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#10)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
increase the size of the##2##5##(2008-3#1)(2008-5#1)
increase the solubility of##2##4##(2008-10#2)
increase the speed##2##3##(2008-10#1)(2008-3#1)
increase the stability of the##3##5##(1994-5#1)(2008-10#1)(2011-2#1)
increase the survival##2##3##(2008-10#1)(2008-7#1)
increase the total##2##3##(2008-11#1)(2011-1#1)
increase the visibility of##2##4##(1995-3#1)(2010-7#1)
increase the yield##2##3##(1996-12#1)(2008-2#1)
increase the##393##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#7)(1997-4#2)(1997-5#1)(1997-7#1)(2007-10#7)(2007-11#8)(2007-12#6)(2007-5#1)(2007-8#4)(2008-1#5)(2008-10#40)(2008-11#19)(2008-12#3)(2008-2#14)(2008-3#32)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#16)(2008-8#8)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#18)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#11)(2013-1#14)(2013-7#4)(2013-8#6)
increase their satisfaction##2##3##(1990-12#1)(2007-10#1)
increase their##28##2##(1990-12#1)(1990-3#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-1#2)(1994-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
increase this##2##2##(1991-12#1)(2008-10#1)
increase to##12##2##(1990-12#1)(1991-5#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)
increase tumor##2##2##(1994-6#1)(2008-6#1)
increase understanding of the##2##4##(1995-6#1)(2013-8#1)
increase understanding of##3##3##(1995-6#1)(2008-12#1)(2013-8#1)
increase understanding##4##2##(1995-6#1)(2008-12#2)(2013-8#1)
increase up to the##2##4##(1992-2#1)(2008-9#1)
increase up to##3##3##(1992-2#1)(2008-7#1)(2008-9#1)
increase urinary##2##2##(1991-12#2)
increase was detected##2##3##(2008-5#1)(2013-1#1)
increase was found in##3##4##(1992-12#1)(1993-12#1)(2008-7#1)
increase was not statistically significant##2##5##(2008-12#1)(2012-2#1)
increase was not##4##3##(2008-10#1)(2008-12#1)(2009-12#1)(2012-2#1)
increase was observed in the##2##5##(1992-8#1)(1996-2#1)
increase was observed in##6##4##(1990-7#1)(1991-11#1)(1992-8#1)(1996-2#1)(2007-11#1)(2008-12#1)
increase was observed##12##3##(1990-7#1)(1991-11#1)(1991-8#1)(1992-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
increase was only##2##3##(1994-3#1)(1996-5#1)
increase was significant##2##3##(1995-5#1)(2008-3#1)
increase was significantly##3##3##(1992-3#1)(1996-12#1)(2008-4#1)
increase was##58##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#2)(1992-12#2)(1992-3#2)(1992-8#2)(1993-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
increase when##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
increase with age##5##3##(1991-12#1)(1992-11#1)(1995-3#1)(1997-7#1)(2010-8#1)
increase with decreasing##2##3##(2008-2#1)(2008-5#1)
increase with increasing age##2##4##(1996-6#1)(2008-8#1)
increase with increasing concentration of##2##5##(1995-6#1)(2008-10#1)
increase with increasing##12##3##(1993-12#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)
increase with the##10##3##(1993-2#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-11#1)(2013-8#1)
increase with##52##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-11#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
increase within##2##2##(1996-2#1)(2008-5#1)
increase yields##2##2##(2008-11#2)
increase##3476##1##(1990-10#4)(1990-11#12)(1990-12#27)(1990-2#15)(1990-3#3)(1990-4#1)(1990-5#22)(1990-6#17)(1990-7#23)(1990-8#13)(1990-9#4)(1991-1#3)(1991-11#6)(1991-12#35)(1991-2#16)(1991-3#16)(1991-4#3)(1991-5#10)(1991-6#11)(1991-8#9)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#14)(1992-12#26)(1992-2#8)(1992-3#28)(1992-4#2)(1992-5#7)(1992-6#26)(1992-7#3)(1992-8#22)(1992-9#6)(1993-1#4)(1993-11#23)(1993-12#37)(1993-2#13)(1993-3#24)(1993-5#2)(1993-6#16)(1993-8#20)(1993-9#4)(1994-1#10)(1994-11#18)(1994-12#16)(1994-2#25)(1994-3#27)(1994-5#18)(1994-6#32)(1994-7#1)(1994-8#21)(1994-9#14)(1995-1#7)(1995-11#23)(1995-12#32)(1995-2#27)(1995-3#33)(1995-4#1)(1995-5#21)(1995-6#19)(1995-8#14)(1995-9#5)(1996-1#7)(1996-11#9)(1996-12#44)(1996-2#26)(1996-3#16)(1996-5#19)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#28)(1997-2#23)(1997-3#20)(1997-4#11)(1997-5#3)(1997-6#11)(1997-7#26)(1997-8#7)(2006-10#8)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#13)(2007-11#38)(2007-12#53)(2007-2#4)(2007-5#2)(2007-7#7)(2007-8#17)(2007-9#1)(2008-1#39)(2008-10#385)(2008-11#173)(2008-12#66)(2008-2#58)(2008-3#151)(2008-4#44)(2008-5#121)(2008-6#28)(2008-7#128)(2008-8#104)(2008-9#67)(2009-1#2)(2009-10#9)(2009-11#16)(2009-12#18)(2009-2#3)(2009-3#3)(2009-4#7)(2009-5#8)(2009-6#12)(2009-7#10)(2009-8#32)(2009-9#6)(2010-1#5)(2010-10#13)(2010-11#13)(2010-12#18)(2010-2#9)(2010-3#8)(2010-4#13)(2010-5#12)(2010-6#11)(2010-7#6)(2010-8#20)(2010-9#3)(2011-1#51)(2011-10#2)(2011-2#115)(2011-3#5)(2011-7#2)(2012-1#13)(2012-12#32)(2012-2#83)(2012-3#40)(2012-5#2)(2012-6#3)(2012-7#1)(2012-9#3)(2013-1#109)(2013-7#19)(2013-8#53)
increase) and##2##2##(1995-5#1)(2013-1#1)
increase) in the left eye (both significant at P &lt##2##9##(2013-1#2)
increase)##8##1##(1995-5#2)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#3)
increased (P &lt##5##3##(1992-12#1)(1993-12#1)(2010-2#1)(2011-3#2)
increased (P##6##2##(1992-12#1)(1993-12#1)(1995-8#1)(2010-2#1)(2011-3#2)
increased (P&lt##7##2##(2007-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-4#2)(2013-1#1)
increased (by##2##2##(2008-11#1)(2008-12#1)
increased (p &lt##4##3##(1994-6#1)(2008-12#1)(2013-1#1)(2013-8#1)
increased (p##5##2##(1994-6#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
increased 1 year after transplantation##2##5##(2011-2#2)
increased 1##3##2##(1990-5#1)(2011-2#2)
increased 10##2##2##(1994-1#1)(2012-3#1)
increased 10-fold##2##2##(2008-7#1)(2013-1#1)
increased 15##2##2##(1990-5#1)(1994-6#1)
increased 2-fold##2##2##(1997-6#1)(2011-3#1)
increased 3##4##2##(2008-8#1)(2010-8#1)(2011-2#1)(2011-3#1)
increased 3-fold in##2##3##(1990-12#1)(1995-6#1)
increased 4##2##2##(1995-3#1)(2008-10#1)
increased BDNF##2##2##(1997-2#1)(2012-2#1)
increased BMI##2##2##(2008-11#1)(2013-1#1)
increased Bmax##2##2##(1993-12#1)(1995-8#1)
increased CD4 cell##2##3##(2007-12#1)(2008-5#1)
increased CSF##2##2##(2011-2#1)(2012-3#1)
increased DNA damage##2##3##(2008-11#1)(2013-1#1)
increased DNA synthesis##2##3##(1990-11#2)
increased DNA##4##2##(1990-11#2)(2008-11#1)(2013-1#1)
increased GSH##2##2##(2008-10#1)(2010-5#1)
increased IBD sharing (P##2##4##(1997-5#2)
increased IL-6##2##2##(1995-12#1)(2008-11#1)
increased MnSOD##2##2##(1995-6#2)
increased NGF##2##2##(1996-12#1)(1996-2#1)
increased P##4##2##(2008-10#1)(2010-2#1)(2012-12#1)(2012-3#1)
increased RR##2##2##(1992-11#1)(2011-1#1)
increased VEGF##4##2##(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
increased [Ca2+]i in##3##3##(1992-6#2)(1994-6#1)
increased [Ca2+]i##5##2##(1992-6#3)(1994-6#2)
increased abdominal##2##2##(2008-3#1)(2008-6#1)
increased ability to##4##3##(1995-2#1)(1997-6#1)(2010-2#1)(2011-1#1)
increased ability##5##2##(1995-2#1)(1997-6#1)(2007-11#1)(2010-2#1)(2011-1#1)
increased about 2-fold##2##3##(1990-5#1)(1994-6#1)
increased about##10##2##(1990-5#2)(1991-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-4#2)(2008-10#1)(2013-8#1)
increased above##2##2##(1990-7#1)(1995-12#1)
increased access##2##2##(1996-1#1)(1997-1#1)
increased according to the##3##4##(2008-10#2)(2008-5#1)
increased according to##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
increased accumulation of##2##3##(1995-2#1)(2008-9#1)
increased accuracy##4##2##(2007-10#1)(2008-10#2)(2008-3#1)
increased activation in##3##3##(2008-11#2)(2009-6#1)
increased activation of the##3##4##(1993-6#1)(1996-6#1)(2013-7#1)
increased activation of##6##3##(1993-6#1)(1996-12#1)(1996-6#1)(2009-11#1)(2009-4#1)(2013-7#1)
increased activation##9##2##(1993-6#1)(1996-12#1)(1996-6#1)(2008-11#2)(2009-11#1)(2009-4#1)(2009-6#1)(2013-7#1)
increased activities of##2##3##(1994-6#1)(1994-8#1)
increased activity of the##3##4##(1991-9#1)(2008-7#1)(2009-4#1)
increased activity of##8##3##(1991-9#2)(1992-5#1)(1996-4#1)(1996-6#1)(2008-7#2)(2009-4#1)
increased activity was##2##3##(1990-11#1)(1993-12#1)
increased activity##15##2##(1990-11#1)(1991-9#2)(1992-5#1)(1993-12#1)(1995-2#1)(1996-4#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#1)
increased adhesion##3##2##(1992-12#1)(2008-11#2)
increased affinity for##5##3##(1990-2#1)(1991-12#1)(1992-6#1)(1995-2#1)(1995-6#1)
increased affinity##7##2##(1990-2#1)(1991-12#1)(1992-6#1)(1995-2#1)(1995-6#2)(2012-2#1)
increased after addition of##2##4##(1990-7#1)(1994-8#1)
increased after the##6##3##(1993-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)
increased after treatment##2##3##(2011-1#2)
increased after##38##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-3#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-12#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)
increased again##9##2##(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-7#1)(2013-8#1)
increased age##2##2##(1995-12#1)(2008-1#1)
increased aggressiveness##5##2##(2008-10#5)
increased alcohol##3##2##(2008-1#1)(2010-7#1)(2010-9#1)
increased allele sharing##3##3##(1997-5#3)
increased allocation of##2##3##(2008-9#2)
increased allocation##3##2##(2008-8#1)(2008-9#2)
increased along##2##2##(1992-12#1)(2008-9#1)
increased also##2##2##(2007-8#1)(2008-11#1)
increased among the##2##3##(1990-9#1)(2010-12#1)
increased among##3##2##(1990-9#1)(2006-10#1)(2010-12#1)
increased amount of##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
increased amounts of##4##3##(1990-12#1)(1991-5#1)(1993-3#1)(2012-2#1)
increased amounts##5##2##(1990-12#1)(1991-5#2)(1993-3#1)(2012-2#1)
increased an additional##2##3##(1994-11#1)(1995-2#1)
increased and reached##2##3##(2008-10#1)(2010-3#1)
increased and remained the same in##2##6##(2007-8#2)
increased and that##2##3##(1996-12#1)(2008-11#1)
increased and the##7##3##(1990-2#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
increased and their##2##3##(1996-6#1)(2008-5#1)
increased and##40##2##(1990-2#1)(1991-12#1)(1991-4#1)(1993-1#1)(1993-5#1)(1994-11#1)(1994-6#2)(1994-8#2)(1995-3#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
increased antioxidant##2##2##(1991-9#1)(2013-1#1)
increased anxiety##3##2##(1996-2#2)(2008-8#1)
increased apoA-I##2##2##(1991-12#2)
increased apoptosis##5##2##(2008-3#1)(2011-1#1)(2012-2#1)(2012-4#1)(2013-1#1)
increased approximately##4##2##(1995-8#1)(2008-10#1)(2008-11#2)
increased aromatase activity in##2##4##(1991-5#2)
increased around##2##2##(2010-8#1)(2013-8#1)
increased as a function of the##2##6##(1992-8#1)(2008-6#1)
increased as a function of##3##5##(1992-8#1)(2007-8#1)(2008-6#1)
increased as a saturation-type curve with##2##6##(2008-10#2)
increased as a##8##3##(1992-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-6#1)(2013-8#1)
increased as the level of##2##5##(2010-4#2)
increased as the number of##2##5##(2007-11#1)(2008-10#1)
increased as the range of decision thresholds decreased##2##8##(1997-3#2)
increased as the##22##3##(1997-3#2)(1997-8#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-4#2)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
increased as##45##2##(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#2)(2011-2#1)(2011-3#1)(2013-1#4)(2013-8#2)
increased at 24 h##2##4##(1997-7#1)(2008-10#1)
increased at a higher rate##2##5##(2008-10#1)(2008-11#1)
increased at a##4##3##(2008-10#2)(2008-11#2)
increased at an average annual growth rate of##2##8##(2011-2#2)
increased at an average annual rate of##2##7##(1993-1#1)(1993-3#1)
increased at an average annual##4##5##(1993-1#1)(1993-3#1)(2011-2#2)
increased at an##5##3##(1993-1#1)(1993-3#1)(2008-5#1)(2011-2#2)
increased at least##2##3##(1995-8#1)(1997-3#1)
increased at the site of application in##2##7##(2008-9#2)
increased at the##6##3##(1993-12#1)(1993-8#1)(2008-10#1)(2008-9#2)(2013-7#1)
increased at##32##2##(1991-2#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#3)(2011-2#2)(2013-1#1)(2013-7#1)
increased attention to##2##3##(1994-3#1)(2009-8#1)
increased attention was##2##3##(1994-3#1)(1995-12#1)
increased attention##12##2##(1992-1#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-5#1)(2012-3#1)
increased availability of##2##3##(2008-8#1)(2010-7#1)
increased availability##3##2##(2008-8#1)(2010-7#1)(2012-3#1)
increased average##2##2##(1991-6#1)(2012-12#1)
increased awareness of##7##3##(1991-3#1)(1997-1#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)
increased awareness##9##2##(1991-3#1)(1994-1#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)
increased bacterial##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
increased basal##3##2##(1995-3#1)(1997-1#2)
increased baseline risk##2##3##(2008-11#2)
increased baseline##3##2##(2008-1#1)(2008-11#2)
increased because##2##2##(2007-5#1)(2008-2#1)
increased between##4##2##(1996-12#1)(2008-10#2)(2011-2#1)
increased beyond##2##2##(2007-8#1)(2008-3#1)
increased binding of##2##3##(1993-1#1)(1995-5#1)
increased binding##7##2##(1993-1#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-7#1)
increased biosynthesis##2##2##(1990-11#1)(1990-12#1)
increased blood glucose##2##3##(1994-8#1)(2011-1#1)
increased blood loss##3##3##(2011-2#2)(2012-12#1)
increased blood pressure and##2##4##(2011-1#1)(2013-8#1)
increased blood pressure##3##3##(1992-3#1)(2011-1#1)(2013-8#1)
increased blood##13##2##(1992-3#1)(1992-6#1)(1994-5#1)(1994-8#1)(2008-11#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-8#1)
increased body mass index and##2##5##(2008-11#1)(2011-2#1)
increased body mass index##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
increased body weight##5##3##(1990-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
increased body##11##2##(1990-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#2)(2011-2#2)(2013-1#1)
increased bone resorption##2##3##(2008-11#1)(2008-8#1)
increased bone##4##2##(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
increased both the##2##3##(1997-1#1)(2008-10#1)
increased both##10##2##(1991-12#2)(1994-11#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
increased bronchial##2##2##(1992-5#1)(2010-5#1)
increased by 0##3##3##(1992-10#1)(1993-1#1)(1995-12#1)
increased by 1##2##3##(1991-5#1)(2008-10#1)
increased by 10%##2##3##(2008-3#1)(2013-8#1)
increased by 16##2##3##(2008-10#1)(2013-8#1)
increased by 18%##3##3##(1996-2#1)(2008-11#1)(2011-2#1)
increased by 2##2##3##(2008-10#1)(2008-7#1)
increased by 25%##2##3##(2008-11#1)(2013-1#1)
increased by 3##2##3##(2011-2#1)(2012-3#1)
increased by 40%##2##3##(2008-1#1)(2008-5#1)
increased by 7##2##3##(1991-8#1)(1994-9#1)
increased by MHT##2##3##(2011-2#2)
increased by a factor of 10##2##6##(1992-3#1)(2008-3#1)
increased by a factor of 30##2##6##(1993-9#1)(1995-3#1)
increased by a factor of##9##5##(1992-12#1)(1992-3#1)(1993-9#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
increased by a##14##3##(1992-12#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-3#4)(2008-6#1)(2008-7#1)
increased by an##2##3##(1995-3#1)(1997-4#1)
increased by as much as##2##5##(1990-3#1)(2008-3#1)
increased by interferon-gamma##2##3##(1997-1#2)
increased by more than 50%##2##5##(1995-5#1)(2008-7#1)
increased by more than##3##4##(1995-5#1)(1996-2#1)(2008-7#1)
increased by the addition of##3##5##(1993-11#1)(2008-10#1)(2008-3#1)
increased by the presence of##3##5##(1995-11#1)(2008-10#1)(2008-5#1)
increased by the##14##3##(1990-3#1)(1990-7#1)(1993-11#1)(1995-11#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
increased by two orders of magnitude##2##6##(2008-9#1)(2010-12#1)
increased by up to##4##4##(1996-2#1)(2008-11#2)(2008-3#1)
increased by##189##2##(1990-11#1)(1990-3#3)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#6)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-5#1)(1997-1#5)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#14)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#7)
increased cAMP content##2##3##(1995-8#1)(1996-5#1)
increased cAMP##4##2##(1995-8#3)(1996-5#1)
increased cancer latency and##2##4##(2008-7#2)
increased cancer risk##4##3##(1995-9#1)(2012-6#3)
increased cancer##8##2##(1995-9#1)(1997-1#1)(2008-7#2)(2011-3#1)(2012-6#3)
increased capacity for##2##3##(2008-10#1)(2008-7#1)
increased capacity##5##2##(1996-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
increased cardiac output##2##3##(2008-12#1)(2010-10#1)
increased cardiovascular risk and##2##4##(2008-6#1)(2009-10#1)
increased cardiovascular risk##4##3##(2008-3#1)(2008-6#1)(2009-10#1)(2012-3#1)
increased cardiovascular##5##2##(2008-1#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-3#1)
increased cell death in specific regions of##2##7##(1995-3#2)
increased cell death##5##3##(1994-2#1)(1995-3#3)(2008-10#1)
increased cell density##2##3##(1993-3#1)(2008-11#1)
increased cell proliferation##2##3##(1990-8#1)(2010-6#1)
increased cell##17##2##(1990-8#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-3#3)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-12#1)(2010-6#1)(2012-1#1)(2012-5#1)
increased cellular##5##2##(1991-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
increased cerebral##2##2##(2008-5#1)(2013-8#1)
increased chance of##3##3##(1994-12#1)(2011-2#2)
increased chitinase and beta-1##2##4##(2008-10#2)
increased clinical##3##2##(1991-12#1)(2008-5#1)(2012-12#1)
increased cobalamin production##2##3##(2011-1#2)
increased cognitive##2##2##(2012-2#2)
increased collagen##3##2##(1994-12#1)(2008-11#1)(2012-3#1)
increased compared to##3##3##(1992-12#1)(1995-12#1)(1995-2#1)
increased compared with##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
increased compared##6##2##(1992-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#1)(2011-2#1)
increased competition and##2##3##(1991-3#1)(1994-12#1)
increased competition for##2##3##(1993-2#1)(1996-1#1)
increased competition##5##2##(1991-3#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
increased complexity##2##2##(1996-2#1)(2012-1#1)
increased concentration of##4##3##(1994-2#1)(2008-11#1)(2008-7#2)
increased concentration##5##2##(1994-2#1)(2008-11#1)(2008-7#3)
increased concentrations of##5##3##(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
increased concentrations##6##2##(1990-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
increased concordance##2##2##(1995-12#1)(2012-3#1)
increased conidial##2##2##(2008-10#2)
increased consumer##2##2##(1993-12#1)(2010-7#1)
increased consumption of##3##3##(2008-1#1)(2011-1#1)(2012-12#1)
increased conversion##2##2##(2009-6#1)(2012-3#1)
increased coronary flow##2##3##(1992-6#1)(2008-4#1)
increased coronary##3##2##(1992-6#1)(2008-4#1)(2012-2#1)
increased cost##3##2##(1992-2#1)(1992-8#1)(2008-10#1)
increased costs##3##2##(2008-1#1)(2010-7#1)(2012-3#1)
increased cyclic AMP##2##3##(1994-2#1)(1994-6#1)
increased cyclic##3##2##(1994-2#1)(1994-6#1)(1995-8#1)
increased cytosolic calcium##2##3##(1995-11#2)
increased cytosolic##3##2##(1994-8#1)(1995-11#2)
increased daily efficiency##3##3##(2010-8#3)
increased daily##5##2##(1991-12#1)(1997-1#1)(2010-8#3)
increased demand for##4##3##(1996-2#1)(1997-3#1)(2010-5#1)(2010-8#1)
increased demand##6##2##(1990-6#1)(1996-2#1)(1997-3#1)(2010-5#1)(2010-8#1)(2013-7#1)
increased demands##3##2##(1996-2#1)(2008-1#1)(2008-10#1)
increased density of##2##3##(2008-11#1)(2012-5#1)
increased density##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2012-5#1)
increased developmental##2##2##(2008-10#1)(2008-8#1)
increased discussion##2##2##(2008-11#1)(2013-8#1)
increased disease severity##5##3##(2008-10#5)
increased disease##6##2##(2008-10#6)
increased dramatically in the##4##4##(2007-7#1)(2008-7#1)(2009-7#1)(2013-1#1)
increased dramatically in##6##3##(1993-8#1)(1997-2#1)(2007-7#1)(2008-7#1)(2009-7#1)(2013-1#1)
increased dramatically##17##2##(1993-8#1)(1994-11#1)(1995-12#2)(1995-6#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2013-1#1)
increased due to##4##3##(2008-10#3)(2008-5#1)
increased duration and##2##3##(2007-7#1)(2008-10#1)
increased during the first##3##4##(1990-10#1)(1991-12#1)(2008-10#1)
increased during the fruit development##2##5##(2008-9#2)
increased during the##25##3##(1990-10#1)(1991-12#2)(1992-12#1)(1992-4#1)(1993-8#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
increased during##50##2##(1990-10#1)(1991-10#2)(1991-12#3)(1991-5#1)(1992-12#3)(1992-4#1)(1993-6#1)(1993-8#1)(1995-5#1)(1996-12#1)(1997-2#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
increased earlier##2##2##(1994-8#1)(1996-3#1)
increased effectiveness##2##2##(2011-2#1)(2012-12#1)
increased efficiency of##2##3##(1993-2#1)(2008-9#1)
increased efficiency##7##2##(1993-2#1)(1995-1#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-9#1)
increased emergence by##2##3##(2008-10#2)
increased emotional##2##2##(2007-8#1)(2008-11#1)
increased emphasis on##5##3##(1994-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-7#1)
increased endothelial##2##2##(2009-11#1)(2010-12#1)
increased energy##2##2##(2008-11#1)(2013-8#1)
increased enrollment##3##2##(1997-3#1)(2007-4#1)(2008-12#1)
increased enzymatic##2##2##(2008-6#1)(2013-1#1)
increased enzyme##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
increased epidermal##2##2##(2008-5#1)(2008-9#1)
increased epsilon 4 allele frequency##2##5##(1995-12#2)
increased especially##2##2##(1995-4#1)(2008-8#1)
increased even after the##2##4##(2008-10#1)(2008-6#1)
increased even after##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
increased even##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
increased except at the highest##2##5##(2008-10#2)
increased excretion of##2##3##(1991-12#1)(1993-9#1)
increased exponentially with the increase of##2##6##(2008-10#1)(2008-3#1)
increased exponentially with##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
increased exponentially##7##2##(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)
increased exposure of##3##3##(1993-1#1)(1995-3#1)(2011-2#1)
increased exposure to##3##3##(2007-12#1)(2008-12#1)(2008-9#1)
increased exposure##6##2##(1993-1#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
increased expression of the##5##4##(1991-3#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
increased expression of##24##3##(1991-3#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-3#1)(1995-2#2)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
increased expression##30##2##(1991-3#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-2#2)(1996-12#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
increased extracellular##2##2##(2008-8#1)(2010-8#1)
increased fat##2##2##(1997-8#1)(2008-4#1)
increased fatty acid oxidation##2##4##(2008-1#2)
increased final##2##2##(2008-11#1)(2008-9#1)
increased firing##2##2##(1995-12#1)(1996-2#1)
increased first##2##2##(2008-11#1)(2008-8#1)
increased fitness##2##2##(2008-10#1)(2011-2#1)
increased fivefold##2##2##(1997-7#1)(2008-10#1)
increased flexibility of##2##3##(1992-6#1)(2008-3#1)
increased flexibility##6##2##(1992-6#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#2)
increased flexion angle##2##3##(2011-2#1)(2013-1#1)
increased focus on##2##3##(1991-3#1)(2008-1#1)
increased following##6##2##(1991-5#1)(1992-5#1)(1993-12#1)(2008-10#1)(2008-11#2)
increased food intake##5##3##(2009-12#3)(2012-12#2)
increased for##6##2##(1997-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
increased formation of##6##3##(1991-9#1)(1993-6#1)(2007-11#1)(2008-10#3)
increased free carnitine##2##3##(1995-12#1)(2008-7#1)
increased free fatty acid##2##4##(2008-3#1)(2012-2#1)
increased free##4##2##(1995-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
increased frequencies of##2##3##(2008-9#1)(2009-10#1)
increased frequency of##15##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-9#1)(1996-2#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-5#1)
increased from &lt##3##3##(1995-6#1)(2008-10#2)
increased from 0 to 1##2##5##(2008-10#2)
increased from 0 to##5##4##(1994-3#1)(2008-10#4)
increased from 0##15##3##(1991-2#1)(1994-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2010-10#1)(2010-4#1)
increased from 0% in##2##4##(1995-1#1)(2013-8#1)
increased from 0%##3##3##(1995-1#1)(2013-1#1)(2013-8#1)
increased from 1##6##3##(1993-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2013-1#1)
increased from 12 to##2##4##(2008-10#2)
increased from 2##2##3##(2007-11#1)(2007-8#1)
increased from 21##2##3##(2008-1#1)(2008-10#1)
increased from 23##2##3##(1995-3#1)(2008-10#1)
increased from 3##3##3##(1994-3#1)(2007-11#1)(2008-11#1)
increased from 5##2##3##(2007-8#1)(2008-10#1)
increased from 50##2##3##(1990-2#1)(1997-4#1)
increased from 8##3##3##(1994-9#1)(2008-11#1)(2008-3#1)
increased from day##2##3##(2011-2#1)(2012-3#1)
increased from the##3##3##(2008-9#1)(2010-5#1)(2012-12#1)
increased from##111##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-2#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-3#3)(1994-9#2)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#2)(1997-1#1)(1997-4#1)(1997-6#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#28)(2008-11#8)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#2)
increased functional##2##2##(1995-12#1)(1995-8#1)
increased funding for##2##3##(2008-8#1)(2009-7#1)
increased funding##4##2##(2008-7#2)(2008-8#1)(2009-7#1)
increased fungus##2##2##(2008-10#2)
increased further by##2##3##(1997-7#1)(2008-11#1)
increased further##5##2##(1997-7#1)(2008-10#1)(2008-11#2)(2012-1#1)
increased gap##2##2##(1994-3#1)(2008-10#1)
increased gene expression##2##3##(2008-10#1)(2012-1#1)
increased gene##4##2##(1992-12#1)(2008-10#1)(2012-1#1)(2012-2#1)
increased genetic##2##2##(1994-2#1)(2008-8#1)
increased ghrelin##2##2##(2012-3#1)(2013-8#1)
increased glucose##4##2##(1990-7#1)(1992-11#1)(1994-8#1)(1997-6#1)
increased glucose-6-phosphatase activity##2##3##(1994-11#1)(1997-7#1)
increased glycation##2##2##(1990-12#1)(2008-1#1)
increased gradually from##2##3##(2008-10#1)(2008-2#1)
increased gradually when##2##3##(2008-10#1)(2013-8#1)
increased gradually##13##2##(1992-6#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#4)
increased greatly in##2##3##(1992-12#1)(2008-12#1)
increased greatly##5##2##(1992-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
increased growth##4##2##(1992-8#2)(2008-10#2)
increased hair loss##3##3##(2008-5#2)(2012-3#1)
increased half-life##3##2##(2009-2#1)(2011-1#2)
increased health##5##2##(1996-1#1)(2008-1#2)(2008-10#1)(2009-6#1)
increased healthcare costs##2##3##(2008-3#1)(2010-12#1)
increased healthcare##3##2##(2008-3#1)(2010-12#1)(2013-1#1)
increased heat##3##2##(1993-12#1)(2010-2#1)(2010-4#1)
increased hepatic long-chain acyl-CoA##2##4##(1994-8#2)
increased hepatic##5##2##(1993-12#1)(1994-8#2)(2008-6#1)(2012-2#1)
increased hippocampal##3##2##(1992-11#1)(1992-8#1)(2013-1#1)
increased hospital##2##2##(1993-1#1)(2012-3#1)
increased host##2##2##(2008-10#1)(2008-9#1)
increased hydration##2##2##(2008-10#1)(2008-5#1)
increased if##3##2##(1996-3#1)(2007-7#1)(2008-10#1)
increased immediately after the##3##4##(1995-12#1)(2007-10#1)(2013-8#1)
increased immediately after##4##3##(1995-12#1)(2007-10#1)(2012-12#1)(2013-8#1)
increased immediately##5##2##(1995-12#1)(2007-10#1)(2008-9#1)(2012-12#1)(2013-8#1)
increased immunoreactivity##2##2##(1995-5#1)(2009-12#1)
increased immunostaining for##2##3##(1994-9#1)(1997-3#1)
increased in 1##2##3##(2008-9#1)(2012-3#1)
increased in 39##3##3##(2007-8#2)(2008-10#1)
increased in 400 and 800 mg/L##3##6##(2008-9#3)
increased in 400##4##3##(2008-9#4)
increased in 500 mg/kg males##2##5##(2008-9#2)
increased in a dose-dependent manner##3##5##(1993-12#1)(1997-7#1)(2008-1#1)
increased in a dose-related manner##3##5##(2008-6#1)(2008-9#2)
increased in a##12##3##(1992-6#1)(1993-12#1)(1994-9#1)(1997-7#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#3)
increased in abundance##2##3##(1993-6#1)(1995-8#1)
increased in all##10##3##(1990-5#1)(1995-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2012-12#1)(2013-1#1)
increased in an##2##3##(1991-9#1)(1994-8#1)
increased in both##8##3##(1994-11#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
increased in comparison to the##2##5##(1997-4#1)(2008-12#1)
increased in comparison##3##3##(1997-4#1)(2008-12#2)
increased in female##2##3##(2011-2#1)(2013-1#1)
increased in frequency with##2##4##(2008-5#1)(2008-7#1)
increased in frequency##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
increased in individuals with##2##4##(2008-7#1)(2009-10#1)
increased in males and females##3##5##(2008-9#3)
increased in males##4##3##(2008-9#4)
increased in number##6##3##(1993-12#1)(1996-2#1)(1996-5#1)(2008-11#2)(2011-2#1)
increased in parallel##2##3##(1996-2#1)(2008-12#1)
increased in patients with rheumatoid arthritis##2##6##(2008-5#1)(2008-7#1)
increased in patients with##6##4##(1995-12#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#1)
increased in patients##8##3##(1995-12#1)(1997-8#1)(2008-5#1)(2008-7#3)(2011-1#1)(2012-3#1)
increased in proportion to##2##4##(2008-11#1)(2008-7#1)
increased in recent years##3##4##(1993-1#1)(2008-10#1)(2013-8#1)
increased in response to##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
increased in size##6##3##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
increased in the final##2##4##(2011-7#1)(2013-1#1)
increased in the first##2##4##(2008-10#1)(2013-1#1)
increased in the following order##3##5##(2008-10#3)
increased in the kidney##2##4##(2008-11#1)(2008-7#1)
increased in the past##2##4##(1993-3#1)(2012-2#1)
increased in the presence of the##2##6##(1997-1#1)(2008-10#1)
increased in the presence of##8##5##(1990-5#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-1#1)(2008-10#3)
increased in the##80##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-11#1)(1996-12#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#2)(2006-8#1)(2008-10#18)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2011-1#1)(2011-7#1)(2012-2#1)(2012-6#1)(2013-1#5)(2013-8#1)
increased in vitro##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
increased in##329##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#3)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#6)(2008-1#4)(2008-10#45)(2008-11#21)(2008-12#10)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#18)(2008-8#5)(2008-9#31)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#8)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#6)(2012-6#1)(2012-8#1)(2013-1#8)(2013-8#5)
increased incidence in##3##3##(2008-9#2)(2012-3#1)
increased incidence of##24##3##(1990-11#1)(1992-3#1)(1994-5#2)(1996-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
increased incidence##27##2##(1990-11#1)(1992-3#1)(1994-5#2)(1996-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
increased incidences of epidermal##2##4##(2008-9#2)
increased incidences of squamous cell papillomas##2##6##(2008-9#2)
increased incidences of squamous cell##3##5##(2008-9#3)
increased incidences of##11##3##(2008-9#11)
increased incidences##14##2##(2008-9#14)
increased incubation time##2##3##(1993-8#1)(2008-10#1)
increased inflammation##2##2##(2008-3#1)(2011-2#1)
increased influx##2##2##(1993-8#1)(1994-8#1)
increased initially##2##2##(2008-10#1)(2008-3#1)
increased insulin secretion##2##3##(2010-11#2)
increased insulin##5##2##(1995-6#1)(2010-11#2)(2011-2#1)(2012-2#1)
increased intake##3##2##(2008-4#2)(2008-6#1)
increased intensity of##4##3##(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#1)
increased intensity##6##2##(1996-5#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#2)
increased interest in the##2##4##(2008-9#1)(2013-1#1)
increased interest in##6##3##(1995-2#1)(1996-3#1)(2008-9#1)(2010-11#1)(2010-8#1)(2013-1#1)
increased interest##7##2##(1995-2#1)(1996-3#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
increased intracellular levels of##2##4##(1997-2#2)
increased intracellular##8##2##(1993-8#1)(1997-2#2)(1997-8#1)(2008-10#3)(2008-11#1)
increased intracranial pressure (ICP)##2##4##(2006-7#1)(2008-12#1)
increased intracranial pressure##10##3##(1992-11#1)(1997-3#1)(2006-7#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#2)(2013-1#1)
increased it in##2##3##(1991-12#1)(2012-1#1)
increased it##5##2##(1990-2#1)(1991-12#1)(1992-7#1)(2008-10#1)(2012-1#1)
increased its##2##2##(1991-9#1)(1997-7#1)
increased knowledge of the##2##4##(2010-8#1)(2012-12#1)
increased knowledge of##7##3##(1994-1#1)(2008-7#1)(2008-9#2)(2010-8#2)(2012-12#1)
increased knowledge##10##2##(1994-1#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-6#1)(2010-8#2)(2012-12#1)
increased largely##2##2##(2008-10#2)
increased leaf##3##2##(2008-10#1)(2013-1#2)
increased left##2##2##(2008-1#1)(2011-2#1)
increased length of stay##2##4##(2012-2#1)(2013-1#1)
increased length of##5##3##(2008-6#1)(2009-7#2)(2012-2#1)(2013-1#1)
increased length##6##2##(2008-6#1)(2009-7#2)(2012-2#2)(2013-1#1)
increased level of##12##3##(1992-1#1)(1992-6#2)(1995-11#1)(2008-1#1)(2008-12#1)(2008-7#2)(2009-5#1)(2011-2#2)(2013-1#1)
increased level##13##2##(1992-1#1)(1992-6#2)(1995-11#1)(2008-1#1)(2008-12#2)(2008-7#2)(2009-5#1)(2011-2#2)(2013-1#1)
increased levels of both##2##4##(1994-6#1)(2008-10#1)
increased levels of the##3##4##(1992-9#1)(2008-10#1)(2013-1#1)
increased levels of transaminases##2##4##(1992-5#1)(2012-12#1)
increased levels of##36##3##(1990-11#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-6#2)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-6#1)(2013-1#3)
increased levels##37##2##(1990-11#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-6#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-6#1)(2013-1#3)
increased life expectancy##2##3##(2007-6#1)(2012-12#1)
increased life##5##2##(1992-9#1)(2007-6#1)(2008-8#1)(2012-12#2)
increased likelihood of##8##3##(1995-12#1)(1995-2#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
increased likelihood##9##2##(1992-1#1)(1995-12#1)(1995-2#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
increased linearly as##2##3##(2008-10#1)(2008-11#1)
increased linearly with the##3##4##(2008-10#2)(2008-11#1)
increased linearly with##13##3##(1990-5#1)(1995-3#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#1)
increased linearly##19##2##(1990-5#1)(1995-3#1)(2008-10#12)(2008-11#3)(2008-6#1)(2008-8#1)
increased lipid peroxidation##5##3##(1994-6#3)(2008-7#1)(2012-2#1)
increased lipid##7##2##(1994-6#3)(2008-5#1)(2008-7#2)(2012-2#1)
increased liver##3##2##(1995-11#1)(2012-3#2)
increased local##2##2##(2007-11#1)(2013-1#1)
increased locomotion##2##2##(1993-6#1)(2011-2#1)
increased losses##2##2##(2008-7#1)(2008-8#1)
increased lung##6##2##(1992-3#1)(1992-5#1)(1992-9#1)(1995-3#1)(2008-7#1)(2010-5#1)
increased markedly##4##2##(1992-3#1)(2008-10#2)(2008-4#1)
increased maternal##4##2##(2009-7#1)(2012-12#1)(2013-1#2)
increased mean##2##2##(2008-5#1)(2013-7#1)
increased melanin production##2##3##(2008-5#2)
increased melanin##4##2##(2008-5#2)(2010-6#1)(2011-2#1)
increased membrane##5##2##(1995-8#1)(1997-1#1)(2008-7#2)(2008-9#1)
increased metabolic activity##2##3##(1992-3#2)
increased metabolic load##4##3##(2008-11#4)
increased metabolic rate##3##3##(2008-7#3)
increased metabolic##13##2##(1992-3#2)(1994-8#1)(1996-3#1)(2008-11#4)(2008-7#3)(2008-9#1)(2010-12#1)
increased metabolism##2##2##(1993-12#1)(2012-3#1)
increased migration##2##2##(1996-12#1)(2008-8#1)
increased mobility of##2##3##(2007-11#1)(2008-7#1)
increased mobility##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
increased morbidity and mortality##5##4##(2006-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
increased morbidity##7##2##(2006-10#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
increased more than##5##3##(1996-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
increased more##9##2##(1995-5#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)
increased mortality and##2##3##(2008-10#1)(2008-11#1)
increased mortality due to##2##4##(1996-3#1)(2012-12#1)
increased mortality##17##2##(1990-6#1)(1994-7#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
increased much##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
increased muscle tone##2##3##(1995-2#1)(2008-12#1)
increased muscle##4##2##(1995-2#1)(2008-12#1)(2009-6#1)(2010-6#1)
increased nearly##4##2##(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
increased neck-shaft angle##2##3##(2007-8#2)
increased need to##4##3##(1995-3#1)(1996-9#1)(2008-7#2)
increased need##5##2##(1995-3#1)(1996-9#1)(2008-7#2)(2010-8#1)
increased negative##2##2##(1995-5#1)(2007-12#1)
increased neural##2##2##(2010-7#1)(2012-12#1)
increased neuronal##3##2##(1993-12#1)(1995-5#1)(2008-7#1)
increased neutrophil##2##2##(1994-3#1)(2008-9#1)
increased number of##20##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-6#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
increased number##22##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-6#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
increased numbers of##3##3##(1996-4#1)(1997-4#1)(2011-2#1)
increased nurse##2##2##(2008-12#1)(2010-10#1)
increased occurrence of##2##3##(1990-8#1)(2007-7#1)
increased odds##5##2##(2011-2#1)(2012-3#2)(2013-1#2)
increased on the##3##3##(1993-12#1)(1996-2#1)(2008-5#1)
increased on##10##2##(1993-12#2)(1994-5#2)(1996-2#1)(2008-10#3)(2008-5#1)(2012-12#1)
increased only by##2##3##(1990-12#1)(2011-2#1)
increased only slightly##2##3##(2007-12#1)(2007-7#1)
increased only##9##2##(1990-12#1)(1990-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-4#1)
increased or decreased##7##3##(1991-9#1)(2008-10#3)(2010-8#1)(2012-2#1)(2012-3#1)
increased or##10##2##(1991-9#1)(1997-1#1)(2008-10#5)(2010-8#1)(2012-2#1)(2012-3#1)
increased our knowledge of##2##4##(2008-11#1)(2013-1#1)
increased our understanding of the##5##5##(1995-5#1)(2008-7#1)(2009-4#1)(2013-1#2)
increased our##8##2##(1995-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2013-1#3)
increased over a##3##3##(1994-1#1)(2008-10#1)(2008-8#1)
increased over the past##4##4##(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)
increased over the##12##3##(1997-7#1)(2007-7#1)(2008-10#2)(2008-2#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
increased over time in##3##4##(2012-1#1)(2012-2#2)
increased over time##8##3##(1990-12#1)(2007-8#1)(2008-10#2)(2009-7#1)(2012-1#1)(2012-2#2)
increased over##28##2##(1990-12#1)(1994-1#1)(1994-11#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-8#1)(2009-7#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)
increased oxidative##2##2##(2008-1#1)(2009-9#1)
increased oxygen affinity##2##3##(1990-7#1)(1992-3#1)
increased pH##3##2##(1992-12#1)(2008-11#1)(2013-8#1)
increased pain##2##2##(1990-6#1)(1995-12#1)
increased participation of##2##3##(1997-2#1)(2012-3#1)
increased participation##4##2##(1997-2#1)(2008-9#1)(2012-12#1)(2012-3#1)
increased patient satisfaction##2##3##(2010-8#1)(2011-1#1)
increased patient##5##2##(1995-2#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#1)
increased performance##2##2##(2008-12#1)(2010-11#1)
increased peripheral##2##2##(1990-8#1)(1990-9#1)
increased personal##2##2##(2010-6#1)(2011-2#1)
increased phosphorylation of##4##3##(1992-12#1)(1994-8#1)(2009-6#1)(2012-2#1)
increased physical activity##2##3##(2012-12#1)(2012-2#1)
increased physical##3##2##(2008-6#1)(2012-12#1)(2012-2#1)
increased plant growth and##2##4##(2008-10#2)
increased plant growth##3##3##(2008-10#2)(2008-8#1)
increased plant##9##2##(2008-10#5)(2008-8#3)(2013-1#1)
increased plasma##10##2##(1993-6#1)(1994-12#1)(1996-5#1)(1997-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-1#1)
increased plasticity##4##2##(2008-8#4)
increased platelet##2##2##(1990-12#1)(2011-1#1)
increased postprandial##2##2##(2008-1#1)(2008-10#1)
increased postsynaptic##2##2##(1993-11#1)(1995-5#1)
increased potency##4##2##(1991-1#2)(1994-5#1)(2009-8#1)
increased precision##2##2##(2007-3#1)(2008-7#1)
increased prescription##2##2##(2008-11#2)
increased prevalence of this mutation in the Turkish population##2##9##(2008-2#2)
increased prevalence of##8##3##(1992-3#1)(1996-11#1)(2008-1#1)(2008-2#2)(2008-7#1)(2008-8#1)(2012-5#1)
increased prevalence##9##2##(1992-3#1)(1996-11#1)(2008-1#1)(2008-2#2)(2008-7#2)(2008-8#1)(2012-5#1)
increased probability##2##2##(1990-12#1)(2009-9#1)
increased production of##11##3##(1990-2#1)(1992-8#1)(1994-11#2)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-5#1)
increased production##13##2##(1990-2#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-5#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-5#1)
increased productivity##5##2##(1992-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
increased progressively from##2##3##(2008-10#1)(2008-7#1)
increased progressively with##3##3##(1990-9#1)(2008-10#1)(2010-2#1)
increased progressively##8##2##(1990-9#1)(1993-3#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-6#1)(2013-8#1)
increased proliferation and##2##3##(2011-2#2)
increased proliferation##5##2##(1993-8#1)(2008-11#1)(2008-5#1)(2011-2#2)
increased proportion of##5##3##(1994-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-4#1)
increased proportionally##2##2##(1991-12#1)(1995-12#1)
increased protein##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
increased proteinuria##2##2##(1994-5#1)(1996-6#1)
increased pulmonary blood flow##2##4##(1996-3#1)(2010-10#1)
increased pulmonary vascular resistance##3##4##(1990-11#1)(1991-9#1)(2010-10#1)
increased pulmonary##5##2##(1990-11#1)(1991-9#1)(1996-3#1)(2010-10#2)
increased quality of##2##3##(1994-3#1)(2012-3#1)
increased quantities of##2##3##(2008-11#1)(2012-2#1)
increased radiation exposure##2##3##(2008-7#2)
increased radiation##3##2##(2007-11#1)(2008-7#2)
increased rapidly and##2##3##(1997-2#1)(2008-10#1)
increased rapidly in##2##3##(1997-3#1)(2011-7#1)
increased rapidly with##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
increased rapidly##12##2##(1993-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-7#1)
increased rate of##13##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-6#1)(2008-10#2)(2008-9#1)(2012-12#1)
increased rate##15##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-6#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-12#1)
increased rates of infection##2##4##(2008-10#1)(2013-1#1)
increased rates of##8##3##(1994-7#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-2#1)(2010-5#1)(2013-1#1)
increased ratio of##2##3##(1995-12#1)(1997-6#1)
increased reactivity##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
increased recently##2##2##(1993-3#1)(1994-1#1)
increased recognition of the importance of##2##6##(1995-1#1)(2010-10#1)
increased regulatory##2##2##(1991-3#1)(2008-10#1)
increased relative risk##2##3##(1992-11#1)(2008-6#1)
increased relative##6##2##(1992-11#1)(1996-5#1)(2008-10#2)(2008-6#1)(2010-4#1)
increased relaxivity##2##2##(2008-7#2)
increased release of##2##3##(1996-12#1)(2008-5#1)
increased release##3##2##(1992-7#1)(1996-12#1)(2008-5#1)
increased remarkably in##2##3##(1994-11#1)(2008-8#1)
increased resistance to FHB##2##4##(2011-10#2)
increased resistance to##10##3##(1994-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2011-1#1)(2011-10#2)
increased resistance##12##2##(1994-8#1)(2008-10#5)(2008-6#1)(2008-7#1)(2011-1#1)(2011-10#2)(2011-2#1)
increased resources##2##2##(1990-6#1)(2008-9#1)
increased response to##4##3##(1990-11#1)(1992-9#1)(1995-5#1)(2010-8#1)
increased response##7##2##(1990-11#1)(1992-11#1)(1992-9#1)(1995-5#1)(2008-11#1)(2008-12#1)(2010-8#1)
increased risk for cardiovascular events##2##5##(2012-2#1)(2013-8#1)
increased risk for cardiovascular##3##4##(2008-3#1)(2012-2#1)(2013-8#1)
increased risk for complications##2##4##(1990-11#1)(2011-2#1)
increased risk for coronary##2##4##(1990-3#1)(1996-11#1)
increased risk for developing##3##4##(2009-3#2)(2012-3#1)
increased risk for lung##2##4##(2011-1#1)(2013-8#1)
increased risk for##49##3##(1990-11#1)(1990-3#1)(1990-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1996-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-10#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
increased risk of CP##2##4##(2011-2#2)
increased risk of HIV infection##2##5##(2007-7#1)(2011-2#1)
increased risk of PC##3##4##(1990-6#3)
increased risk of SBI##2##4##(2006-5#2)
increased risk of both##2##4##(2008-1#1)(2013-1#1)
increased risk of cardiovascular disease##2##5##(1992-8#1)(2008-3#1)
increased risk of complications##3##4##(1996-6#1)(2007-8#1)(2008-1#1)
increased risk of death##2##4##(2008-11#1)(2011-2#1)
increased risk of developing##12##4##(1990-11#2)(1990-12#1)(1990-9#1)(1992-9#1)(1994-9#1)(2007-5#1)(2011-2#2)(2012-2#1)(2012-3#2)
increased risk of diabetes and##2##5##(2008-1#1)(2013-8#1)
increased risk of disease##2##4##(2008-10#2)
increased risk of heart##2##4##(2010-8#1)(2013-1#1)
increased risk of mortality##2##4##(2008-9#1)(2011-2#1)
increased risk of type 2 diabetes##2##6##(2012-2#1)(2013-8#1)
increased risk of##111##3##(1990-11#2)(1990-12#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-9#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
increased risk with##2##3##(1990-6#1)(2009-12#1)
increased risk##175##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(1996-11#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-5#2)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#4)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#2)(2009-7#2)(2010-10#2)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#16)(2011-3#1)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#5)
increased risks of##4##3##(2008-1#1)(2008-8#2)(2013-1#1)
increased risks##5##2##(2008-1#1)(2008-11#1)(2008-8#2)(2013-1#1)
increased root##5##2##(2008-10#4)(2009-8#1)
increased saturation of##2##3##(2008-7#1)(2011-1#1)
increased scintigraphic activity##2##3##(2011-2#2)
increased secretion and##2##3##(1990-12#1)(2008-6#1)
increased secretion of##5##3##(1993-12#1)(1993-9#1)(1994-9#1)(2008-11#1)(2009-2#1)
increased secretion##10##2##(1990-12#2)(1993-12#1)(1993-9#1)(1994-9#1)(2008-11#2)(2008-6#1)(2009-2#1)(2009-5#1)
increased seedling emergence##2##3##(2008-10#2)
increased sensitivity of##8##3##(1991-1#1)(1992-11#1)(1992-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
increased sensitivity to##7##3##(1990-5#1)(1993-12#1)(2007-6#1)(2008-2#1)(2008-8#2)(2013-8#1)
increased sensitivity##19##2##(1990-5#1)(1991-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1996-12#1)(1997-7#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2012-3#1)(2013-1#1)(2013-8#2)
increased serum levels of##2##4##(1990-9#1)(2011-2#1)
increased serum##7##2##(1990-9#1)(1995-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
increased service##2##2##(1991-12#1)(1994-12#1)
increased severity of##4##3##(1997-6#1)(2008-10#1)(2009-4#1)(2012-3#1)
increased severity##5##2##(1997-6#1)(2008-10#2)(2009-4#1)(2012-3#1)
increased sexual##2##2##(2009-9#1)(2010-2#1)
increased sharply##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
increased signal##4##2##(2006-10#1)(2008-3#1)(2009-3#1)(2010-3#1)
increased significantly (P&lt##2##3##(2008-5#1)(2012-12#1)
increased significantly after the##2##4##(1996-8#1)(2011-1#1)
increased significantly after treatment##2##4##(2011-1#2)
increased significantly after##5##3##(1991-3#1)(1996-8#1)(2011-1#3)
increased significantly and the##2##4##(2008-8#1)(2008-9#1)
increased significantly as##2##3##(2008-12#1)(2008-6#1)
increased significantly at##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
increased significantly by##3##3##(1992-3#1)(2008-3#1)(2011-2#1)
increased significantly during the##2##4##(2008-10#1)(2008-9#1)
increased significantly during##7##3##(1991-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
increased significantly from a##2##4##(2008-1#1)(2008-10#1)
increased significantly from baseline to##2##5##(2012-3#2)
increased significantly from##11##3##(1994-3#1)(2008-1#2)(2008-10#1)(2008-12#2)(2009-2#1)(2011-1#1)(2012-3#2)(2013-1#1)
increased significantly in the##3##4##(1993-6#1)(2008-10#1)(2012-2#1)
increased significantly in##18##3##(1992-3#1)(1993-6#1)(1993-8#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-7#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-2#2)
increased significantly over##2##3##(2008-10#1)(2008-6#1)
increased significantly since##2##3##(2008-7#1)(2011-2#1)
increased significantly when##2##3##(2008-12#1)(2008-6#1)
increased significantly with##8##3##(1992-6#1)(1994-12#1)(1995-8#2)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
increased significantly##89##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#6)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
increased since the##2##3##(1997-8#1)(2008-7#1)
increased since##4##2##(1997-8#1)(2008-7#1)(2013-8#2)
increased size##3##2##(1996-3#1)(2008-8#1)(2012-3#1)
increased skin##3##2##(1997-3#1)(2008-5#2)
increased slowly##2##2##(2008-10#1)(2008-11#1)
increased smoking##2##2##(1996-8#1)(2009-5#1)
increased soil##2##2##(2008-10#2)
increased spatial##2##2##(2008-10#1)(2008-8#1)
increased specific activity##3##3##(1995-5#1)(2008-8#1)(2008-9#1)
increased specific##9##2##(1995-12#1)(1995-5#1)(2008-11#4)(2008-8#1)(2008-9#1)(2013-1#1)
increased spontaneous##2##2##(2008-8#1)(2010-8#1)
increased spore##2##2##(2008-10#2)
increased stability in##2##3##(1994-8#1)(2008-2#1)
increased stability of E6 and E7 mRNAs##2##7##(1995-2#2)
increased stability of##6##3##(1993-11#1)(1995-2#2)(1997-2#1)(1997-4#1)(2008-4#1)
increased stability##11##2##(1993-11#2)(1994-8#1)(1995-2#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
increased steadily from##2##3##(1992-4#1)(1994-12#1)
increased steadily##7##2##(1992-12#1)(1992-4#1)(1994-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
increased steady-state##2##2##(1992-10#1)(1995-2#1)
increased strength##2##2##(2007-11#1)(2007-8#1)
increased stroke risk##3##3##(2007-10#1)(2008-2#1)(2010-5#1)
increased stroke##4##2##(2007-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
increased substantially##6##2##(1994-6#2)(1997-8#1)(2008-3#1)(2008-7#2)
increased substrate##2##2##(2008-7#2)
increased success##2##2##(2008-9#1)(2012-2#1)
increased such that##2##3##(2007-10#1)(2008-8#1)
increased surface##4##2##(1994-5#1)(2008-3#1)(2008-5#1)(2009-11#1)
increased survival##5##2##(1990-5#1)(1994-12#1)(2008-11#1)(2011-2#2)
increased survivorship##2##2##(2008-9#1)(2011-2#1)
increased susceptibility of##5##3##(1994-6#1)(2008-10#2)(2008-5#1)(2012-1#1)
increased susceptibility to##12##3##(1991-9#2)(2007-2#1)(2008-10#5)(2009-12#1)(2010-11#1)(2012-3#1)(2013-7#1)
increased susceptibility##18##2##(1991-9#2)(1994-6#1)(2007-2#1)(2008-10#8)(2008-5#1)(2009-12#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-7#1)
increased symptom##2##2##(2008-10#2)
increased synthesis of##3##3##(1991-3#1)(1992-8#1)(2012-7#1)
increased synthesis##4##2##(1991-3#1)(1992-8#1)(2008-5#1)(2012-7#1)
increased temperature and##3##3##(1997-4#1)(2008-9#1)(2012-6#1)
increased temperature##7##2##(1997-4#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-1#1)(2012-6#1)
increased tendency to##2##3##(1993-12#1)(2011-2#1)
increased tendency##3##2##(1993-12#1)(2007-7#1)(2011-2#1)
increased that##2##2##(2008-10#1)(2010-2#1)
increased the MIMS response of all##2##6##(2008-10#2)
increased the amount of##2##4##(1997-6#1)(2008-11#1)
increased the analgesic##2##3##(1996-2#1)(2010-4#1)
increased the apparent viscosity of##2##5##(2008-5#2)
increased the apparent##4##3##(1990-7#1)(2008-10#1)(2008-5#2)
increased the binding of##2##4##(1993-6#2)
increased the binding##3##3##(1993-6#2)(1997-3#1)
increased the complexity of##2##4##(1993-3#1)(2008-7#1)
increased the degree of##2##4##(1992-3#1)(1995-8#1)
increased the duration of the##2##5##(1997-2#2)
increased the efficacy of##2##4##(2012-2#1)(2013-8#1)
increased the efficacy##3##3##(1997-4#1)(2012-2#1)(2013-8#1)
increased the energy##2##3##(2008-3#1)(2010-4#1)
increased the enzyme##2##3##(1994-11#1)(2013-1#1)
increased the expression of##10##4##(1991-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
increased the extent##2##3##(1996-2#1)(2008-5#1)
increased the extracellular##2##3##(1997-2#1)(1997-7#1)
increased the final##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
increased the fluorescence##3##3##(2008-10#2)(2008-11#1)
increased the frequency of##3##4##(1993-3#1)(1995-9#1)(2008-8#1)
increased the frequency##4##3##(1993-3#1)(1995-9#1)(2008-8#1)(2010-3#1)
increased the incidence of##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
increased the intensity of##3##4##(1995-12#1)(2008-5#2)
increased the intracellular##3##3##(1994-6#1)(1996-7#1)(2008-11#1)
increased the levels of##4##4##(1993-5#1)(1995-8#1)(2008-10#1)(2012-3#1)
increased the life span of##2##5##(1991-12#1)(2008-7#1)
increased the likelihood of##6##4##(1991-12#1)(2008-7#1)(2009-6#2)(2011-2#1)(2012-2#1)
increased the likelihood##7##3##(1991-12#1)(2007-12#1)(2008-7#1)(2009-6#2)(2011-2#1)(2012-2#1)
increased the mRNA##2##3##(2008-11#1)(2008-4#1)
increased the mean##2##3##(2007-9#1)(2008-5#1)
increased the metabolism##2##3##(2008-11#1)(2011-1#1)
increased the mortality##2##3##(2008-10#1)(2008-7#1)
increased the number of##13##4##(1990-2#1)(1990-3#1)(1991-5#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-5#1)(2008-6#2)(2012-3#1)
increased the odds##3##3##(1995-8#1)(2007-10#1)(2011-2#1)
increased the percentage of##5##4##(1991-11#1)(1995-12#1)(1996-3#1)(2009-9#1)(2012-4#1)
increased the phosphorylation of##2##4##(1990-11#1)(1994-8#1)
increased the phosphorylation##3##3##(1990-11#2)(1994-8#1)
increased the potency of##2##4##(1995-3#1)(2009-9#1)
increased the probability of##3##4##(1995-2#1)(2008-7#1)(2009-6#1)
increased the production of##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
increased the production##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
increased the rate of##3##4##(1990-12#1)(1995-6#1)(2010-11#1)
increased the ratio of##3##4##(1990-2#1)(2008-10#1)(2012-2#1)
increased the risk of ischemic stroke among##2##7##(2011-1#2)
increased the sensitivity for##2##4##(1991-12#1)(2008-10#1)
increased the sensitivity##4##3##(1991-12#1)(1997-3#1)(1997-4#1)(2008-10#1)
increased the stability##2##3##(2008-10#2)
increased the surface##2##3##(2008-10#1)(2010-4#1)
increased the survival of##2##4##(2008-10#1)(2009-12#1)
increased the survival##3##3##(2007-6#1)(2008-10#1)(2009-12#1)
increased the thermal stability##2##4##(1994-8#1)(2007-11#1)
increased the time##2##3##(2008-10#1)(2011-2#1)
increased the tissue##2##3##(1995-3#1)(1997-7#1)
increased the total##2##3##(1990-8#1)(1991-3#1)
increased the toxicity of Hg2+##2##5##(1992-11#2)
increased the##297##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#3)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#2)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1995-9#1)(1996-12#4)(1996-2#6)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#6)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#3)(2007-10#2)(2007-11#6)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#44)(2008-11#18)(2008-12#3)(2008-3#5)(2008-4#3)(2008-5#13)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2011-1#6)(2011-2#10)(2012-1#2)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#11)(2013-7#1)(2013-8#1)
increased their discharge rates##2##4##(1993-12#2)
increased their use of##2##4##(2007-11#1)(2011-2#1)
increased their##16##2##(1992-6#2)(1992-8#1)(1993-12#2)(1997-3#1)(2007-11#1)(2008-10#3)(2008-8#2)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
increased this##2##2##(1992-5#1)(1995-3#1)
increased through##6##2##(1995-12#1)(2008-10#2)(2009-6#1)(2012-2#1)(2013-1#1)
increased throughout the##2##3##(2008-10#2)
increased thymidine incorporation##2##3##(1994-3#2)
increased till the##2##3##(1991-2#1)(2008-7#1)
increased time##2##2##(1995-5#1)(2008-11#1)
increased tissue##2##2##(2008-10#2)
increased to 1##3##3##(1992-6#1)(1992-9#1)(2008-10#1)
increased to 13##2##3##(1992-12#1)(2008-7#1)
increased to 15##2##3##(1990-6#1)(2011-1#1)
increased to 6##3##3##(2008-10#2)(2012-1#1)
increased to a maximum##2##4##(1993-3#1)(2008-11#1)
increased to a##5##3##(1993-3#1)(1996-12#1)(2007-8#1)(2008-11#1)(2011-2#1)
increased to approximately##4##3##(2008-10#2)(2008-11#2)
increased to include##2##3##(1993-12#1)(2010-10#1)
increased to over##2##3##(2008-10#1)(2012-3#1)
increased to##88##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#6)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-3#2)(2013-1#4)
increased tolerance##2##2##(2008-10#1)(2008-8#1)
increased total##7##2##(1991-3#1)(1995-8#1)(2008-10#1)(2008-12#2)(2009-4#1)(2012-3#1)
increased toxicity##2##2##(1995-3#1)(2010-11#1)
increased training##2##2##(1991-11#1)(2012-3#1)
increased transcriptional##2##2##(1995-8#1)(1997-4#1)
increased tumor##2##2##(1996-12#1)(2009-9#1)
increased twofold and##2##3##(2008-10#2)
increased twofold##6##2##(2008-10#2)(2008-11#3)(2008-8#1)
increased tyrosine phosphorylation##2##3##(1997-1#1)(1997-6#1)
increased tyrosine##3##2##(1993-5#1)(1997-1#1)(1997-6#1)
increased under##3##2##(1995-12#1)(1997-2#2)
increased understanding of the##3##4##(2008-10#1)(2008-5#1)(2009-11#1)
increased understanding of##7##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2011-2#1)
increased understanding##9##2##(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2011-2#1)
increased until##4##2##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)
increased up to##9##3##(1997-3#1)(1997-8#1)(2008-10#3)(2008-5#1)(2011-2#2)(2013-1#1)
increased upon the##2##3##(1995-2#1)(1995-6#1)
increased upon##5##2##(1990-5#1)(1992-5#1)(1993-9#1)(1995-2#1)(1995-6#1)
increased uptake of##4##3##(1992-11#1)(1994-5#1)(1996-12#1)(2007-12#1)
increased uptake##6##2##(1992-11#1)(1994-5#2)(1996-12#1)(2006-10#1)(2007-12#1)
increased urethral##2##2##(2008-10#1)(2013-8#1)
increased urinary##3##2##(1991-12#1)(2008-5#1)(2012-3#1)
increased use of health care##2##5##(1993-12#1)(2008-1#1)
increased use of##20##3##(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-8#1)(2009-7#1)(2011-1#1)(2013-1#1)
increased use##22##2##(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
increased using an##2##3##(2008-10#1)(2013-8#1)
increased using the##2##3##(2008-4#1)(2013-1#1)
increased using##5##2##(2008-10#2)(2008-4#1)(2013-1#1)(2013-8#1)
increased values##4##2##(1993-8#1)(2007-8#2)(2012-3#1)
increased vascular permeability##5##3##(1990-12#1)(1992-6#1)(1994-8#1)(2008-1#1)(2012-12#1)
increased vascular risk##2##3##(2007-10#1)(2008-3#1)
increased vascular##8##2##(1990-12#1)(1992-6#1)(1994-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2012-12#1)(2013-8#1)
increased viability and##2##3##(2008-11#2)
increased viral load##2##3##(2008-5#1)(2012-2#1)
increased viral##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
increased visual##2##2##(1995-12#1)(2012-3#1)
increased vulnerability to##2##3##(1996-7#1)(2008-7#1)
increased vulnerability##5##2##(1996-7#1)(2007-2#1)(2008-7#3)
increased waist circumference##3##3##(2008-11#2)(2011-1#1)
increased weight##3##2##(2008-3#1)(2011-2#2)
increased wetness##3##2##(2008-10#3)
increased when the##8##3##(1992-12#1)(1993-3#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
increased when##19##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
increased whereas##2##2##(1994-8#1)(1995-12#1)
increased while##4##2##(2008-11#1)(2008-12#1)(2009-7#1)(2013-1#1)
increased with age in both##2##5##(2008-3#1)(2009-5#1)
increased with age in##3##4##(2008-3#1)(2008-7#1)(2009-5#1)
increased with age##14##3##(1991-11#1)(1991-12#1)(1993-2#1)(2007-12#1)(2008-3#1)(2008-7#3)(2009-5#1)(2010-12#1)(2011-1#3)(2013-3#1)
increased with aging##2##3##(2008-7#2)
increased with an increase in##2##5##(2008-10#1)(2008-6#1)
increased with an##3##3##(2008-10#2)(2008-6#1)
increased with colony size##2##4##(2008-9#2)
increased with decreasing pH and##2##5##(1995-2#1)(2013-1#1)
increased with decreasing##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
increased with each##2##3##(2008-10#1)(2011-2#1)
increased with enrichment##2##3##(2008-8#2)
increased with higher##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
increased with increased##5##3##(2008-10#3)(2010-2#1)(2013-8#1)
increased with increasing leaf wetness##2##5##(2008-10#2)
increased with increasing leaf##3##4##(2008-10#3)
increased with increasing temperature##2##4##(1990-9#1)(2008-11#1)
increased with increasing the number of##2##6##(2008-10#2)
increased with increasing the##4##4##(2008-10#3)(2008-5#1)
increased with increasing time of##2##5##(1990-12#1)(1997-4#1)
increased with increasing time##3##4##(1990-12#1)(1992-9#1)(1997-4#1)
increased with increasing##44##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-12#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
increased with longer##2##3##(2008-2#1)(2008-8#1)
increased with mean##2##3##(2008-10#1)(2008-9#1)
increased with temperature##2##3##(2011-2#1)(2013-7#1)
increased with the increase in the##2##6##(2008-11#1)(2012-2#1)
increased with the increase##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
increased with the severity of##2##5##(2008-10#1)(2008-4#1)
increased with the##28##3##(1990-8#1)(1990-9#1)(1992-6#1)(1994-11#2)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
increased with time##10##3##(1991-1#1)(1991-8#1)(1995-6#1)(2008-10#5)(2008-12#1)(2008-5#1)
increased with##165##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-12#4)(2007-7#1)(2008-10#47)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#5)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#3)(2013-3#1)(2013-7#4)(2013-8#3)
increased within the##2##3##(2007-1#1)(2013-8#1)
increased within##3##2##(2007-1#1)(2008-10#1)(2013-8#1)
increased yield##2##2##(2008-10#2)
increased##4511##1##(1990-10#2)(1990-11#21)(1990-12#26)(1990-2#19)(1990-3#12)(1990-5#26)(1990-6#12)(1990-7#17)(1990-8#8)(1990-9#9)(1991-1#6)(1991-10#6)(1991-11#7)(1991-12#49)(1991-2#11)(1991-3#18)(1991-4#1)(1991-5#17)(1991-6#4)(1991-7#2)(1991-8#8)(1991-9#21)(1992-1#5)(1992-10#4)(1992-11#14)(1992-12#28)(1992-2#11)(1992-3#27)(1992-4#4)(1992-5#10)(1992-6#25)(1992-7#4)(1992-8#28)(1992-9#17)(1993-1#14)(1993-11#8)(1993-12#43)(1993-2#11)(1993-3#28)(1993-5#3)(1993-6#13)(1993-8#21)(1993-9#13)(1994-1#9)(1994-10#1)(1994-11#31)(1994-12#14)(1994-2#17)(1994-3#25)(1994-5#21)(1994-6#32)(1994-7#2)(1994-8#34)(1994-9#13)(1995-1#5)(1995-11#17)(1995-12#57)(1995-2#33)(1995-3#31)(1995-4#1)(1995-5#18)(1995-6#22)(1995-8#25)(1995-9#3)(1996-1#7)(1996-11#5)(1996-12#33)(1996-2#39)(1996-3#18)(1996-4#2)(1996-5#19)(1996-6#5)(1996-7#2)(1996-8#5)(1996-9#7)(1997-1#27)(1997-2#38)(1997-3#33)(1997-4#25)(1997-5#6)(1997-6#26)(1997-7#24)(1997-8#13)(2006-10#13)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#21)(2007-11#39)(2007-12#35)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#21)(2007-8#39)(2007-9#3)(2008-1#62)(2008-10#620)(2008-11#261)(2008-12#74)(2008-2#37)(2008-3#94)(2008-4#41)(2008-5#108)(2008-6#54)(2008-7#188)(2008-8#118)(2008-9#146)(2009-1#2)(2009-10#11)(2009-11#17)(2009-12#19)(2009-2#10)(2009-3#7)(2009-4#13)(2009-5#14)(2009-6#14)(2009-7#22)(2009-8#19)(2009-9#12)(2010-1#4)(2010-10#18)(2010-11#22)(2010-12#15)(2010-2#21)(2010-3#7)(2010-4#28)(2010-5#16)(2010-6#13)(2010-7#6)(2010-8#28)(2010-9#5)(2011-1#71)(2011-10#3)(2011-2#200)(2011-3#12)(2011-7#2)(2012-1#25)(2012-12#60)(2012-2#80)(2012-3#70)(2012-4#6)(2012-5#6)(2012-6#7)(2012-7#2)(2012-8#1)(2013-1#157)(2013-3#1)(2013-7#19)(2013-8#70)
increasein the##2##2##(2008-11#2)
increasein##3##1##(2008-11#3)
increases activity##2##2##(2007-8#1)(2008-7#1)
increases after the##4##3##(2008-5#2)(2008-8#1)(2008-9#1)
increases after##7##2##(1994-9#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)
increases among##2##2##(2009-7#1)(2013-8#1)
increases and decreases in brain size in##2##7##(2012-3#2)
increases and decreases in##5##4##(1994-12#1)(2008-11#1)(2011-2#1)(2012-3#2)
increases and may##2##3##(1990-3#1)(2008-9#1)
increases and the##5##3##(1991-12#1)(1996-9#1)(2007-12#1)(2008-10#2)
increases and##20##2##(1990-3#1)(1991-12#1)(1994-12#1)(1996-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-3#2)
increases approximately##2##2##(1995-2#1)(1995-9#1)
increases are##3##2##(1995-11#1)(1997-8#1)(2008-10#1)
increases as a function of##2##5##(2008-9#1)(2011-2#1)
increases as the##8##3##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)
increases as##13##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
increases at##8##2##(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
increases blood##2##2##(1990-5#1)(2011-2#1)
increases bone##4##2##(1997-7#1)(1997-8#1)(2008-8#1)(2012-3#1)
increases both##3##2##(1991-9#1)(1993-12#1)(2008-4#1)
increases by a factor##2##4##(1994-12#1)(2008-3#1)
increases by##13##2##(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)(2011-3#1)
increases cell viability##2##3##(2009-12#2)
increases cell##3##2##(1996-5#1)(2009-12#2)
increases crop##2##2##(2008-10#2)
increases cytosolic##3##2##(1992-6#1)(1993-8#1)(1994-6#1)
increases during##6##2##(1992-6#1)(1997-7#1)(2008-12#1)(2008-3#2)(2008-7#1)
increases expected##2##2##(1991-2#1)(2008-8#1)
increases expression of##3##3##(1993-6#1)(1994-11#1)(2012-12#1)
increases for##6##2##(1997-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-1#1)(2011-1#1)
increases from 0##2##3##(1994-8#1)(2008-3#1)
increases from 2##2##3##(1995-2#1)(2009-12#1)
increases from the##2##3##(1992-2#1)(2008-2#1)
increases from##14##2##(1990-7#1)(1991-11#1)(1992-2#1)(1994-8#1)(1995-2#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)
increases glucose##2##2##(1993-8#1)(1994-6#1)
increases gradually##3##2##(1990-12#1)(1997-4#1)(2008-12#1)
increases in DNA synthesis and p53 phosphorylation##2##7##(1992-3#1)(1993-9#1)
increases in HIV##2##3##(1990-6#1)(1996-9#1)
increases in [Ca2+]i and##3##4##(1990-12#1)(1994-3#1)(1994-6#1)
increases in [Ca2+]i##5##3##(1990-12#1)(1994-3#1)(1994-6#1)(1995-11#2)
increases in blood pressure and##2##5##(1995-12#1)(2012-1#1)
increases in both##6##3##(1994-8#1)(1995-1#1)(1997-1#1)(1997-4#2)(2012-12#1)
increases in bronchoalveolar lavage fluid##2##5##(1992-3#2)
increases in costs##2##3##(2008-10#1)(2008-11#1)
increases in cyclic AMP##2##4##(1995-11#1)(2008-4#1)
increases in cytosolic##2##3##(2008-9#1)(2009-2#1)
increases in dopamine##2##3##(1993-6#1)(2008-4#1)
increases in fluorescence##2##3##(1995-5#1)(2008-11#1)
increases in frequency##2##3##(2008-10#1)(2010-4#1)
increases in heart rate##2##4##(1990-10#1)(1993-12#1)
increases in hepatic##4##3##(1994-8#3)(2008-10#1)
increases in homicide rates##2##4##(2008-12#2)
increases in intracellular Ca2+ concentrations##2##5##(1993-3#1)(1996-2#1)
increases in intracellular Ca2+##3##4##(1993-3#2)(1996-2#1)
increases in intracellular calcium##2##4##(1991-3#1)(1995-12#1)
increases in intracellular##9##3##(1991-3#1)(1993-3#2)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(2006-6#1)(2008-4#1)
increases in metabolic rate##3##4##(2008-3#1)(2010-4#2)
increases in muscle tone were##2##5##(1995-2#2)
increases in muscle##3##3##(1995-2#2)(2008-3#1)
increases in productivity##3##3##(1994-1#1)(1995-1#1)(2008-11#1)
increases in radiation-induced##2##3##(2008-11#2)
increases in the levels of##2##5##(1990-8#1)(2013-1#1)
increases in the number of letters##3##6##(2009-2#3)
increases in the number of older##2##6##(1997-2#1)(2008-7#1)
increases in the number of##5##5##(1997-2#1)(2008-7#1)(2009-2#3)
increases in the order##2##4##(2008-10#1)(2009-9#1)
increases in the rates of##2##5##(1994-3#1)(2010-3#1)
increases in the urinary excretion of protein##4##7##(1994-5#3)(1995-3#1)
increases in the##61##3##(1990-8#1)(1991-2#1)(1991-5#3)(1992-11#2)(1992-2#1)(1993-11#1)(1993-12#1)(1994-3#2)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#3)(2007-7#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#4)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2013-1#2)
increases in##297##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#4)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#5)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#5)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#8)(1994-9#2)(1995-1#2)(1995-11#6)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#2)(1996-1#1)(1996-12#9)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#8)(2008-12#7)(2008-3#3)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#5)(2009-2#5)(2009-5#1)(2009-9#3)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2011-1#2)(2011-10#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#7)
increases intracellular##2##2##(1996-2#1)(2008-9#1)
increases its##8##2##(1993-8#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)(2013-1#1)
increases levels of##2##3##(1993-9#1)(2008-11#1)
increases linearly with##5##3##(1996-4#1)(2008-10#2)(2008-5#1)(2013-1#1)
increases linearly##7##2##(1990-7#1)(1996-4#1)(2008-10#2)(2008-5#1)(2009-11#1)(2013-1#1)
increases mean##2##2##(1991-2#1)(1997-7#1)
increases metabolic##2##2##(1995-6#1)(2013-8#1)
increases more##2##2##(2008-10#1)(2011-2#1)
increases mortality##3##2##(2011-2#2)(2012-12#1)
increases of its##2##3##(1995-2#1)(1996-12#1)
increases of the##4##3##(1995-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
increases of##29##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-5#1)(1991-8#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
increases on##7##2##(1990-12#1)(1991-3#1)(1992-9#1)(1995-8#1)(1997-2#1)(2008-7#2)
increases or decreases##2##3##(1992-6#1)(2012-3#1)
increases or##3##2##(1991-2#1)(1992-6#1)(2012-3#1)
increases over time##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
increases oxidative stress##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
increases oxidative##4##2##(2008-8#1)(2009-5#2)(2011-2#1)
increases plasma##3##2##(1991-9#1)(1992-8#1)(1994-2#1)
increases postnatally##2##2##(1992-11#1)(1996-2#1)
increases rapidly##2##2##(2008-2#1)(2008-3#1)
increases relative to the##2##4##(2008-8#2)
increases resistance to##2##3##(2008-10#1)(2011-10#1)
increases sensitivity to##2##3##(1993-12#1)(2013-7#1)
increases sensitivity##3##2##(1993-12#1)(2008-10#1)(2013-7#1)
increases serum##2##2##(1995-3#1)(2008-10#1)
increases sharply##3##2##(1996-2#1)(2007-12#1)(2008-8#1)
increases significantly in the##2##4##(2008-8#1)(2008-9#1)
increases significantly with##2##3##(1991-9#1)(1992-3#1)
increases significantly##6##2##(1990-2#1)(1991-9#1)(1992-3#2)(2008-8#1)(2008-9#1)
increases slightly with##2##3##(2007-12#1)(2008-2#1)
increases slightly##3##2##(2007-12#1)(2008-12#1)(2008-2#1)
increases strongly##2##2##(2007-12#1)(2008-2#1)
increases survival##3##2##(1995-12#2)(2013-8#1)
increases susceptibility to##2##3##(2006-10#1)(2012-2#1)
increases the Vmax of##2##4##(1993-6#1)(1994-5#1)
increases the activity of##2##4##(1991-5#1)(2008-11#1)
increases the binding of##3##4##(1990-5#1)(1990-6#1)(1995-11#1)
increases the chance of##3##4##(2008-9#1)(2010-8#1)(2011-1#1)
increases the decay##2##3##(2007-11#1)(2009-8#1)
increases the expression of##3##4##(1993-3#1)(1994-12#1)(2012-12#1)
increases the field##2##3##(2007-11#1)(2008-3#1)
increases the incidence of##2##4##(1994-5#1)(1995-12#1)
increases the intracellular##2##3##(2008-11#1)(2009-3#1)
increases the levels of##2##4##(1990-7#1)(2009-12#1)
increases the life##2##3##(1994-6#1)(2009-9#1)
increases the likelihood of##3##4##(2008-7#1)(2008-8#1)(2009-7#1)
increases the need##2##3##(2007-10#1)(2008-11#1)
increases the number of cells##2##5##(1997-1#1)(2008-9#1)
increases the number of islets isolated from##2##7##(2010-11#2)
increases the number of##11##4##(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#2)
increases the number##12##3##(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)
increases the probability of##4##4##(1995-12#1)(1996-4#1)(2008-11#1)(2008-9#1)
increases the probability##5##3##(1995-12#1)(1996-4#1)(2008-11#1)(2008-8#1)(2008-9#1)
increases the production of##2##4##(1992-9#1)(1993-2#1)
increases the production##3##3##(1992-9#1)(1993-2#1)(2008-11#1)
increases the rate of##3##4##(1990-11#1)(1991-12#1)(2008-11#1)
increases the risk of developing##3##5##(2008-11#2)(2011-2#1)
increases the risk of infection##2##5##(2008-1#1)(2011-2#1)
increases the risk of##19##4##(1992-4#1)(1992-6#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#2)(2011-2#3)(2013-1#4)
increases the risk##21##3##(1992-4#1)(1992-6#1)(1994-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#2)(2011-2#3)(2013-1#4)
increases the sample##2##3##(2008-10#1)(2010-8#1)
increases the sensitivity by##2##4##(2008-10#2)
increases the sensitivity of##5##4##(1994-1#1)(1995-3#1)(2008-10#1)(2008-4#1)(2009-4#1)
increases the sensitivity##9##3##(1994-1#1)(1995-3#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-4#1)
increases the##187##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#9)(2008-9#8)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#2)
increases their##3##2##(1993-8#1)(1995-8#1)(2008-5#1)
increases through##2##2##(2008-11#1)(2010-5#1)
increases to the##5##3##(1990-5#1)(1993-12#1)(2008-8#1)(2009-2#2)
increases to##15##2##(1990-5#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#2)(2009-2#2)(2012-3#1)
increases total##2##2##(1997-8#1)(2008-9#1)
increases until maturity and##2##4##(2008-5#2)
increases upon##2##2##(1995-8#1)(2008-6#1)
increases were associated with a##2##5##(1992-10#1)(2011-2#1)
increases were observed##2##3##(2008-10#1)(2012-12#1)
increases were##8##2##(1992-10#1)(1993-12#1)(1993-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
increases when the##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
increases when##5##2##(1994-12#1)(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
increases while##2##2##(1993-8#1)(2009-8#1)
increases with age##16##3##(1996-5#1)(2007-1#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
increases with an increase in##2##5##(2008-3#1)(2008-8#1)
increases with decreasing##7##3##(1991-8#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
increases with increased##2##3##(1995-2#1)(2008-9#1)
increases with increasing pH##2##4##(1990-5#1)(2008-10#1)
increases with increasing the##3##4##(2008-9#1)(2013-8#2)
increases with increasing##14##3##(1990-5#1)(1990-7#1)(1991-11#1)(1992-4#1)(1997-2#1)(2008-10#3)(2008-9#1)(2009-7#2)(2012-12#1)(2013-8#2)
increases with the applied##2##4##(2008-3#1)(2009-5#1)
increases with the increase##2##4##(1993-8#1)(2013-8#1)
increases with the number of##3##5##(1996-12#1)(2008-8#1)(2009-5#1)
increases with the size of the##3##6##(2008-1#1)(2008-3#1)(2009-8#1)
increases with the##25##3##(1993-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-8#1)(2009-5#2)(2009-8#1)(2013-8#1)
increases with##90##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-8#2)(1992-4#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
increases##1132##1##(1990-10#3)(1990-11#1)(1990-12#8)(1990-2#4)(1990-3#3)(1990-5#7)(1990-6#4)(1990-7#8)(1990-8#4)(1990-9#1)(1991-11#4)(1991-12#8)(1991-2#6)(1991-3#5)(1991-5#10)(1991-8#5)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#6)(1992-2#4)(1992-3#11)(1992-4#2)(1992-6#7)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#16)(1993-2#1)(1993-3#7)(1993-6#5)(1993-8#10)(1993-9#4)(1994-1#2)(1994-11#3)(1994-12#7)(1994-2#8)(1994-3#9)(1994-5#8)(1994-6#10)(1994-8#12)(1994-9#4)(1995-1#4)(1995-11#10)(1995-12#20)(1995-2#13)(1995-3#12)(1995-5#4)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#15)(1996-2#16)(1996-3#5)(1996-4#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#9)(1997-3#5)(1997-4#8)(1997-5#3)(1997-6#1)(1997-7#10)(1997-8#4)(2006-10#3)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#5)(2007-11#12)(2007-12#24)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#13)(2008-10#107)(2008-11#40)(2008-12#14)(2008-2#23)(2008-3#52)(2008-4#16)(2008-5#31)(2008-6#11)(2008-7#33)(2008-8#53)(2008-9#36)(2009-11#10)(2009-12#6)(2009-2#7)(2009-3#1)(2009-4#1)(2009-5#8)(2009-6#7)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#3)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#10)(2011-10#2)(2011-2#36)(2011-3#3)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#15)(2013-1#26)(2013-7#3)(2013-8#21)
increasing BMI##2##2##(1994-12#1)(2008-6#1)
increasing Cd##2##2##(2013-1#2)
increasing D##2##2##(2008-10#1)(2008-3#1)
increasing IPC##2##2##(2010-1#2)
increasing RVUs##3##2##(2013-1#3)
increasing a##2##2##(2010-10#1)(2012-2#1)
increasing above##2##2##(1995-12#1)(2008-10#1)
increasing access to safe abortion in##2##6##(2011-1#2)
increasing access to##4##3##(2010-5#1)(2011-1#2)(2011-2#1)
increasing access##5##2##(2008-12#1)(2010-5#1)(2011-1#2)(2011-2#1)
increasing activity##2##2##(2008-10#1)(2008-11#1)
increasing age##36##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-6#2)(1994-11#1)(1994-6#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
increasing aggregation##3##2##(2008-10#3)
increasing agonists##2##2##(1995-11#2)
increasing altitude##3##2##(2009-5#3)
increasing among##2##2##(2008-12#1)(2012-2#1)
increasing amount of##5##3##(1996-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#1)
increasing amounts of##12##3##(1991-5#2)(1992-3#1)(1992-5#1)(1994-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-7#1)
increasing and##9##2##(1995-12#1)(1996-1#1)(1996-7#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-2#1)
increasing as the##2##3##(1991-2#1)(2013-1#1)
increasing at##2##2##(1995-3#1)(2008-8#1)
increasing atmospheric##2##2##(2012-12#1)(2013-8#1)
increasing attention as a##3##4##(2007-10#1)(2008-8#2)
increasing attention as##4##3##(2007-10#1)(2008-8#2)(2010-7#1)
increasing attention has been##2##4##(2008-6#1)(2010-9#1)
increasing attention in##2##3##(1992-12#1)(2008-1#1)
increasing attention##21##2##(1991-12#1)(1992-12#1)(1993-1#1)(1994-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#2)
increasing awareness##4##2##(1993-2#1)(2008-8#1)(2011-1#1)(2011-2#1)
increasing body of literature##2##4##(1991-12#1)(2009-6#1)
increasing bone##3##2##(1993-11#1)(2008-8#2)
increasing both##4##2##(2008-4#2)(2008-7#1)(2013-8#1)
increasing by##4##2##(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
increasing calcium##2##2##(2009-12#1)(2011-2#1)
increasing cell##4##2##(2008-11#1)(2009-8#1)(2012-1#1)(2013-8#1)
increasing challenge##2##2##(2010-3#1)(2011-2#1)
increasing competition##2##2##(1994-2#1)(2008-7#1)
increasing complexity##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
increasing concentration of##3##3##(1995-6#1)(2008-10#1)(2009-12#1)
increasing concentration##6##2##(1990-5#1)(1990-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-12#1)
increasing concentrations for##2##3##(2011-3#1)(2013-1#1)
increasing concentrations of##18##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-12#2)(1994-8#1)(1995-3#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-3#1)(2011-2#1)
increasing concentrations##23##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1992-12#2)(1994-8#1)(1995-3#1)(1996-12#1)(1997-4#1)(2008-10#5)(2008-11#4)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
increasing concern##5##2##(1996-3#1)(2008-10#1)(2009-5#1)(2010-8#1)(2012-12#1)
increasing consumption of##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
increasing content of##2##3##(1997-2#1)(2008-8#1)
increasing costs##4##2##(1991-9#1)(1995-3#1)(2008-7#1)(2013-8#1)
increasing crosslinking##2##2##(2008-10#1)(2010-6#1)
increasing delay##2##2##(2013-8#2)
increasing demand for##6##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)
increasing demand##11##2##(1992-1#1)(1992-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-7#1)
increasing demands##3##2##(2008-11#1)(2013-1#2)
increasing distances##2##2##(2008-10#1)(2008-8#1)
increasing dosage of carbachol##2##4##(1994-8#2)
increasing dose##4##2##(2008-10#1)(2008-7#2)(2009-7#1)
increasing doses of##3##3##(1997-4#1)(2007-10#1)(2008-7#1)
increasing doses##6##2##(1991-6#1)(1997-4#1)(2007-10#1)(2008-7#2)(2011-2#1)
increasing during the##2##3##(1996-7#1)(2008-9#1)
increasing dyspnoea on exertion##2##4##(2007-8#1)(2013-7#1)
increasing economic##2##2##(2008-10#1)(2010-12#1)
increasing either##2##2##(1990-2#1)(2008-10#1)
increasing evidence for##2##3##(1997-4#1)(2008-2#1)
increasing evidence that##13##3##(1992-9#1)(1995-12#1)(1996-7#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#2)
increasing evidence##19##2##(1992-9#1)(1995-12#1)(1996-7#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#2)(2013-1#1)
increasing exercise##2##2##(2010-10#1)(2013-8#1)
increasing experience##4##2##(2007-12#1)(2008-10#1)(2009-2#1)(2012-2#1)
increasing frequency and severity##2##4##(1991-12#1)(1995-5#1)
increasing frequency and##3##3##(1991-12#1)(1995-5#1)(2009-5#1)
increasing frequency of##2##3##(2007-7#1)(2008-8#1)
increasing frequency##13##2##(1991-12#1)(1992-4#1)(1993-9#1)(1994-5#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)
increasing from##4##2##(1992-3#1)(1994-8#1)(1996-7#1)(2008-12#1)
increasing genetic##2##2##(1993-12#1)(2008-3#1)
increasing health##2##2##(2008-1#1)(2011-1#1)
increasing impact##2##2##(1994-1#1)(2009-12#1)
increasing importance of##2##3##(1991-12#1)(2008-10#1)
increasing importance##5##2##(1991-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
increasing in number##2##3##(1994-2#1)(2011-2#1)
increasing in size##4##3##(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)
increasing in the##2##3##(2008-8#1)(2011-2#1)
increasing in##27##2##(1994-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-8#1)(2011-2#6)(2012-12#1)(2013-1#1)
increasing incidence in##2##3##(1991-6#1)(2011-2#1)
increasing incidence of##9##3##(1990-11#1)(1995-5#1)(1996-6#1)(1997-6#1)(2007-12#1)(2011-2#3)(2013-8#1)
increasing incidence##16##2##(1990-11#1)(1991-6#1)(1992-9#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-6#1)(1997-6#1)(2007-12#1)(2011-2#5)(2013-1#1)(2013-8#1)
increasing initial##3##2##(1995-5#1)(2008-11#1)(2008-8#1)
increasing inoculum densities##2##3##(2008-10#2)
increasing inoculum##3##2##(2008-10#3)
increasing interest in the potential##2##5##(2010-7#1)(2012-2#1)
increasing interest in the##8##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-8#1)
increasing interest in##16##3##(1991-2#1)(1992-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
increasing interest of##2##3##(2008-10#1)(2010-8#1)
increasing interest##26##2##(1991-2#1)(1992-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
increasing intracellular##2##2##(1995-12#1)(2008-4#1)
increasing involvement##2##2##(1991-6#1)(2011-2#1)
increasing ionic strength##3##3##(1991-9#2)(1997-6#1)
increasing ionic##4##2##(1991-9#2)(1997-6#1)(1997-7#1)
increasing its focus##2##3##(2007-4#1)(2008-7#1)
increasing its##4##2##(2007-4#1)(2008-11#1)(2008-7#1)(2013-1#1)
increasing knowledge of##2##3##(2008-1#1)(2010-12#1)
increasing knowledge##4##2##(2008-1#1)(2008-5#1)(2010-12#1)(2012-12#1)
increasing larval##3##2##(2008-9#1)(2009-10#2)
increasing length of the##3##4##(1992-11#1)(1992-6#1)(1992-8#1)
increasing length of##4##3##(1992-11#1)(1992-6#1)(1992-8#1)(2008-8#1)
increasing level of##5##3##(2008-12#3)(2008-6#1)(2008-8#1)
increasing levels of##11##3##(1993-8#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2013-1#1)
increasing life##2##2##(2012-1#1)(2013-8#1)
increasing light##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
increasing markedly##2##2##(2008-10#1)(2010-10#1)
increasing morbidity##2##2##(1993-9#1)(2012-12#1)
increasing national##2##2##(1993-12#1)(2009-5#1)
increasing number of children##2##4##(2007-11#1)(2010-6#1)
increasing number of patients##5##4##(1992-3#1)(1994-5#1)(2011-2#3)
increasing number of people with##2##5##(2009-10#1)(2011-1#1)
increasing number of people##3##4##(2006-12#1)(2009-10#1)(2011-1#1)
increasing number of studies##2##4##(2008-4#1)(2009-12#1)
increasing number of##50##3##(1990-7#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1993-2#2)(1993-3#2)(1994-3#2)(1994-5#1)(1995-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#5)
increasing numbers of##13##3##(1990-11#1)(1993-3#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-11#1)(2009-5#1)(2013-1#1)
increasing numbers##15##2##(1990-11#1)(1993-3#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2013-1#1)
increasing of the##4##3##(1992-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
increasing of##8##2##(1992-5#1)(2008-10#1)(2008-12#1)(2008-8#3)(2008-9#2)
increasing or decreasing##2##3##(1993-12#1)(1995-3#1)
increasing order of##2##3##(2008-10#1)(2008-5#1)
increasing our understanding of the##2##5##(2007-8#1)(2013-8#1)
increasing our understanding##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
increasing our##4##2##(2007-8#1)(2008-10#2)(2013-8#1)
increasing over the##5##3##(1990-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
increasing over time##2##3##(2008-10#1)(2012-1#1)
increasing over##8##2##(1990-11#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
increasing oxygen##2##2##(1995-6#1)(1996-3#1)
increasing pH##7##2##(1990-12#1)(1990-5#1)(1993-8#2)(1994-12#1)(2008-10#2)
increasing pain##2##2##(2007-12#1)(2009-3#1)
increasing participation##3##2##(1994-12#1)(2012-1#1)(2012-2#1)
increasing patch diameter##2##3##(2008-10#2)
increasing patch##3##2##(2008-10#3)
increasing patient##2##2##(1996-3#1)(2008-8#1)
increasing plant diversity##2##3##(2008-9#2)
increasing plant##4##2##(2008-10#1)(2008-9#2)(2012-1#1)
increasing popularity##2##2##(2008-5#1)(2011-2#1)
increasing population density##3##3##(2008-9#1)(2011-2#2)
increasing population##6##2##(1991-3#1)(2008-11#1)(2008-9#2)(2011-2#2)
increasing pressure on##2##3##(1992-6#1)(2008-5#1)
increasing pressure##8##2##(1992-6#1)(1993-12#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-5#1)
increasing prevalence of diabetes##2##4##(2007-12#1)(2008-1#1)
increasing prevalence of##12##3##(1990-6#1)(1991-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-3#2)
increasing prevalence##15##2##(1990-6#1)(1991-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-7#1)
increasing problem##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
increasing productivity##2##2##(1991-2#1)(2008-9#1)
increasing progressively##2##2##(2008-1#1)(2008-11#1)
increasing proportion of the##4##4##(1997-1#1)(2008-10#2)(2008-9#1)
increasing proportion of##5##3##(1990-3#1)(1997-1#1)(2008-10#2)(2008-9#1)
increasing protein##5##2##(1990-7#2)(2008-10#1)(2008-5#1)(2010-8#1)
increasing public##2##2##(1992-1#1)(2008-10#1)
increasing quadrat size##2##3##(2008-10#1)(2008-8#1)
increasing rapidly##5##2##(1992-11#1)(1997-7#1)(2008-10#2)(2011-1#1)
increasing rates of##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
increasing recognition##3##2##(1995-3#1)(2010-3#1)(2011-2#1)
increasing relative##2##2##(1997-3#1)(2008-8#1)
increasing reports##2##2##(1992-8#1)(1996-2#1)
increasing resident##2##2##(2012-12#1)(2012-3#1)
increasing resistance##2##2##(2008-5#1)(2010-6#1)
increasing risk of##3##3##(1996-2#1)(2007-1#1)(2008-5#1)
increasing risk##4##2##(1996-2#1)(2007-1#1)(2008-1#1)(2008-5#1)
increasing role of##4##3##(1994-3#1)(2006-5#1)(2009-5#1)(2011-2#1)
increasing role##8##2##(1994-3#1)(2006-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#2)
increasing salinity##4##2##(2008-12#2)(2009-8#1)(2013-1#1)
increasing sample##2##2##(2008-10#2)
increasing scrutiny from##2##3##(2008-10#1)(2008-12#1)
increasing seed##2##2##(2008-10#1)(2013-8#1)
increasing serum##2##2##(1993-8#1)(2008-10#1)
increasing severity##2##2##(1990-9#1)(2013-1#1)
increasing size of the##3##4##(1990-11#1)(1993-12#1)(2008-10#1)
increasing size of##4##3##(1990-11#1)(1993-12#1)(2008-10#1)(2008-11#1)
increasing size##6##2##(1990-11#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
increasing speed##3##2##(1994-8#2)(2008-9#1)
increasing support for##2##3##(1997-5#1)(2009-11#1)
increasing temperature##20##2##(1990-9#1)(1993-8#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#2)(2008-9#1)(2009-7#2)
increasing temperatures##5##2##(2008-10#4)(2012-8#1)
increasing tendency##2##2##(1991-6#1)(2008-5#1)
increasing the Km##3##3##(1990-5#1)(1994-5#1)(1995-2#1)
increasing the amount of##3##4##(1990-8#1)(1997-2#1)(2008-10#1)
increasing the availability of##2##4##(1991-9#1)(1995-12#1)
increasing the concentration of##8##4##(1992-6#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-9#2)
increasing the concentration##9##3##(1992-6#1)(1993-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#2)
increasing the contrast##2##3##(2007-11#1)(2008-3#1)
increasing the difficulty##2##3##(1991-9#1)(1997-2#1)
increasing the dynamic range##2##4##(2007-12#1)(2008-2#1)
increasing the efficiency of##3##4##(1991-2#1)(2011-2#1)(2012-2#1)
increasing the frequency of##3##4##(1993-12#1)(2008-10#1)(2008-8#1)
increasing the gas flow rate##2##5##(2013-8#2)
increasing the level of##2##4##(1995-6#1)(2010-7#1)
increasing the likelihood##2##3##(1995-1#1)(2010-2#1)
increasing the number of##16##4##(1995-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2012-12#1)
increasing the number##17##3##(1995-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-3#1)(2012-12#1)
increasing the oxygen##2##3##(2006-10#1)(2008-9#1)
increasing the plowing depth##2##4##(2008-12#2)
increasing the proportion of##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
increasing the range of##2##4##(2007-12#1)(2007-8#1)
increasing the rate of##2##4##(1995-6#1)(2008-10#1)
increasing the ratio of##3##4##(2008-10#2)(2013-1#1)
increasing the risk of##3##4##(2008-9#2)(2013-1#1)
increasing the risk##6##3##(1997-3#1)(2007-12#1)(2008-9#2)(2009-3#1)(2013-1#1)
increasing the sample##2##3##(2008-10#2)
increasing the size of##2##4##(2007-12#1)(2012-3#1)
increasing the stability of the##2##5##(2008-2#1)(2010-11#1)
increasing the stability of##3##4##(1997-2#1)(2008-2#1)(2010-11#1)
increasing the temperature##2##3##(2008-10#1)(2009-12#1)
increasing the##233##2##(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#2)(2008-1#2)(2008-10#42)(2008-11#8)(2008-12#5)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#10)(2008-9#12)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#11)(2013-8#3)
increasing their##9##2##(1991-5#1)(1991-9#1)(1992-1#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
increasing through##2##2##(1991-11#1)(2007-7#1)
increasing time##10##2##(1990-12#1)(1991-12#1)(1992-9#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
increasing to##7##2##(1990-11#1)(1994-9#1)(1995-12#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
increasing trend in##2##3##(1997-7#1)(2011-2#1)
increasing trend##9##2##(1993-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-6#1)(2011-2#1)
increasing use of the##2##4##(2007-8#1)(2008-11#1)
increasing use of##9##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-11#1)(2011-2#1)
increasing use##12##2##(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2011-2#1)
increasing variety of##2##3##(2011-2#1)(2013-8#1)
increasing while##2##2##(1993-12#1)(2007-7#1)
increasing with age##2##3##(2008-8#1)(2008-9#1)
increasing with##5##2##(1991-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
increasing worldwide##3##2##(2008-3#1)(2010-10#1)(2010-12#1)
increasing##1509##1##(1990-11#8)(1990-12#6)(1990-2#6)(1990-3#2)(1990-5#6)(1990-6#4)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#6)(1991-12#7)(1991-2#9)(1991-3#7)(1991-5#7)(1991-6#5)(1991-9#9)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#11)(1992-4#2)(1992-5#5)(1992-6#9)(1992-8#3)(1992-9#6)(1993-1#4)(1993-11#3)(1993-12#13)(1993-2#6)(1993-3#7)(1993-6#2)(1993-8#6)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#13)(1994-2#6)(1994-3#6)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#11)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#10)(1995-2#4)(1995-3#11)(1995-5#6)(1995-6#6)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#15)(1997-3#9)(1997-4#9)(1997-5#2)(1997-6#7)(1997-7#7)(1997-8#4)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#6)(2007-11#13)(2007-12#29)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#2)(2008-1#15)(2008-10#231)(2008-11#57)(2008-12#34)(2008-2#17)(2008-3#48)(2008-4#21)(2008-5#37)(2008-6#17)(2008-7#57)(2008-8#66)(2008-9#45)(2009-10#6)(2009-11#5)(2009-12#5)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#15)(2009-6#3)(2009-7#9)(2009-8#7)(2009-9#2)(2010-1#4)(2010-10#9)(2010-11#5)(2010-12#13)(2010-2#4)(2010-3#7)(2010-4#3)(2010-5#6)(2010-6#5)(2010-7#8)(2010-8#13)(2010-9#2)(2011-1#17)(2011-10#1)(2011-2#62)(2011-3#3)(2011-4#1)(2011-7#1)(2012-1#10)(2012-12#15)(2012-2#30)(2012-3#14)(2012-4#2)(2012-6#1)(2012-8#1)(2013-1#50)(2013-7#7)(2013-8#29)
increasingly adopted##4##2##(1990-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
increasingly apparent##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
increasingly are##2##2##(1997-3#1)(2008-11#1)
increasingly attractive##2##2##(1994-1#1)(2008-7#1)
increasingly aware of##2##3##(1994-6#1)(2008-8#1)
increasingly becoming##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
increasingly being##18##2##(1990-11#1)(1991-11#1)(1991-8#1)(1995-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#3)
increasingly by##2##2##(1995-3#1)(2006-6#1)
increasingly clear that##2##3##(1995-2#1)(2010-1#1)
increasingly common in##3##3##(1992-3#1)(2008-7#1)(2011-1#1)
increasingly common##10##2##(1992-3#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
increasingly competitive environment##3##3##(1994-12#1)(1994-2#1)(1996-1#1)
increasingly competitive##8##2##(1992-2#1)(1994-12#2)(1994-2#2)(1996-1#1)(2008-10#1)(2008-11#1)
increasingly complex##8##2##(1991-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#2)(2011-2#1)(2012-2#1)
increasingly difficult##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)
increasingly employed in##2##3##(2008-10#1)(2008-11#1)
increasingly expected to##2##3##(1996-12#1)(2008-11#1)
increasingly focused on##3##3##(1996-2#1)(2007-8#1)(2012-2#1)
increasingly gains##2##2##(2008-5#1)(2013-1#1)
increasingly important for##4##3##(1994-2#1)(2007-12#1)(2008-3#1)(2012-2#1)
increasingly important in##6##3##(1993-11#1)(1994-2#1)(1996-12#1)(2008-4#1)(2010-12#1)(2010-9#1)
increasingly important role in the##2##5##(2007-4#1)(2011-7#1)
increasingly important role in##4##4##(2007-4#1)(2010-12#1)(2011-2#1)(2011-7#1)
increasingly important to##5##3##(1994-3#1)(1995-1#1)(2007-11#1)(2007-5#1)(2007-8#1)
increasingly important##38##2##(1991-1#1)(1992-2#1)(1993-11#1)(1994-2#3)(1994-3#1)(1995-1#2)(1996-12#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
increasingly influenced by##2##3##(1993-2#1)(2008-9#1)
increasingly involved in##2##3##(1995-3#1)(2011-2#1)
increasingly popular and##2##3##(1995-2#1)(2008-11#1)
increasingly popular method for##2##4##(2008-11#1)(2008-6#1)
increasingly popular##13##2##(1994-9#1)(1995-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2011-2#1)
increasingly prevalent##3##2##(2008-3#1)(2009-6#1)(2013-8#1)
increasingly proposed as##2##3##(1992-6#1)(2006-7#1)
increasingly recognised as##2##3##(2008-4#1)(2009-5#1)
increasingly recognized as a##2##4##(2008-1#1)(2009-3#1)
increasingly recognized as##7##3##(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)
increasingly recognized that##2##3##(2008-4#1)(2012-3#1)
increasingly recognized##15##2##(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
increasingly relevant##2##2##(1995-5#1)(2007-11#1)
increasingly reported in##2##3##(2007-12#1)(2007-8#1)
increasingly reported##4##2##(2006-10#1)(2007-12#1)(2007-8#1)(2012-1#1)
increasingly significant##2##2##(2008-7#1)(2009-9#1)
increasingly smaller##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
increasingly sophisticated##4##2##(2008-11#2)(2008-9#1)(2013-1#1)
increasingly stringent##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
increasingly to##3##2##(2008-10#1)(2008-4#2)
increasingly used as a##3##4##(1992-3#1)(2008-7#1)(2008-9#1)
increasingly used for##7##3##(1993-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)
increasingly used in the##2##4##(2008-3#1)(2012-3#1)
increasingly used in##5##3##(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
increasingly used to##3##3##(1994-3#1)(2008-3#1)(2012-12#1)
increasingly used##19##2##(1992-3#1)(1993-11#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
increasingly useful##3##2##(2008-10#2)(2008-7#1)
increasingly younger##2##2##(1997-2#1)(2008-9#1)
increasingly##323##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1994-1#1)(1994-12#3)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#8)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#2)(1997-8#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#20)(2008-11#18)(2008-12#7)(2008-2#7)(2008-3#8)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#11)(2009-2#1)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#12)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#9)
incredibly##4##1##(2007-9#1)(2008-1#1)(2011-2#1)(2012-3#1)
increment in##10##2##(1990-11#1)(1990-5#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-10#2)(2010-11#1)(2013-7#1)(2013-8#1)
increment of 2##2##3##(2008-10#1)(2011-2#1)
increment of the##2##3##(2008-10#1)(2008-5#1)
increment of##20##2##(1990-8#1)(1992-12#1)(1993-9#2)(1994-12#1)(1994-9#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
increment##43##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-9#2)(1994-12#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#12)(2008-3#1)(2008-5#2)(2008-9#4)(2009-11#1)(2010-10#2)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
incremental cost-effectiveness ratio##3##3##(2011-2#1)(2012-12#2)
incremental cost-effectiveness##4##2##(2008-1#1)(2011-2#1)(2012-12#2)
incremental costs##2##2##(1997-1#1)(2008-7#1)
incremental cycling##3##2##(2011-2#3)
incremental increase in##3##3##(1992-3#1)(2008-8#1)(2011-2#1)
incremental scope##2##2##(2010-12#1)(2012-12#1)
incremental value##2##2##(2008-11#1)(2010-12#1)
incremental##39##1##(1991-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-2#5)(2012-12#3)(2013-1#7)
incrementalism##3##1##(1996-12#3)
incrementally##4##1##(1994-3#1)(1996-2#1)(2008-10#1)(2008-12#1)
increments in##3##2##(1993-11#1)(1997-2#1)(2013-7#1)
increments of##4##2##(1991-8#1)(1992-8#1)(2008-11#1)(2008-3#1)
increments##23##1##(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-9#1)(1997-2#1)(2007-5#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2011-2#2)(2013-7#3)
increments)##2##1##(2008-3#1)(2009-11#1)
incubate##3##1##(1990-12#1)(2008-8#1)(2010-8#1)
incubated as##2##2##(1994-5#1)(2008-10#1)
incubated at 15##2##3##(2008-10#2)
incubated at 23 degrees C##2##5##(1992-3#2)
incubated at 25 degrees C##3##5##(2008-10#2)(2008-5#1)
incubated at 33 degrees C##2##5##(1991-8#1)(2008-11#1)
incubated at 37 degrees C for##2##6##(1992-6#1)(1994-8#1)
incubated at 37 degrees C##7##5##(1992-6#1)(1994-3#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#2)
incubated at 5##2##3##(2008-10#2)
incubated at different##2##3##(2008-10#2)
incubated at##36##2##(1991-8#1)(1992-3#2)(1992-6#1)(1994-3#2)(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)
incubated for 24 h##3##4##(2008-11#1)(2008-12#1)(2009-6#1)
incubated for 24##4##3##(1992-11#1)(2008-11#1)(2008-12#1)(2009-6#1)
incubated for 48 h##2##4##(1990-11#1)(2008-10#1)
incubated for##19##2##(1990-11#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
incubated in a##5##3##(1993-11#1)(1995-11#1)(2008-10#2)(2008-8#1)
incubated in soil##2##3##(2008-10#2)
incubated in the presence of##7##5##(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(2008-11#1)
incubated in the##12##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
incubated in vitro##5##3##(1991-2#1)(2008-10#3)(2008-6#1)
incubated in##48##2##(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#19)(2008-11#6)(2008-6#1)(2008-8#2)(2013-1#1)
incubated on a##2##3##(2010-3#2)
incubated on##7##2##(2008-10#2)(2008-5#2)(2008-8#1)(2010-3#2)
incubated under controlled##2##3##(2008-10#2)
incubated under##7##2##(2008-10#4)(2008-11#3)
incubated with a##3##3##(1991-12#1)(1995-2#1)(1997-7#1)
incubated with bacterial components##2##4##(1996-12#2)
incubated with cells##3##3##(1997-7#2)(2008-7#1)
incubated with glucose##3##3##(1994-6#1)(2008-7#2)
incubated with the##10##3##(1990-12#3)(1990-2#1)(1990-8#1)(1991-2#1)(1993-8#1)(2008-11#2)(2008-4#1)
incubated with##98##2##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#2)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#3)(1991-5#1)(1992-10#1)(1992-12#5)(1992-3#3)(1992-8#1)(1993-11#3)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#8)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2010-11#1)(2010-3#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
incubated##236##1##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#2)(1990-5#2)(1990-8#1)(1991-12#4)(1991-2#6)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-3#5)(1992-6#4)(1992-8#1)(1993-11#5)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#4)(1997-8#1)(2008-10#59)(2008-11#19)(2008-12#2)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#11)(2008-8#5)(2008-9#1)(2009-6#1)(2010-11#1)(2010-3#5)(2011-1#3)(2012-3#2)(2013-1#3)(2013-8#1)
incubates##3##1##(1991-12#1)(2011-3#2)
incubating the##4##2##(1992-6#1)(2008-11#2)(2012-3#1)
incubating them at##2##3##(2008-10#2)
incubating them##3##2##(2008-10#3)
incubating##18##1##(1990-11#1)(1992-6#1)(1995-5#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-3#1)
incubation and##5##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
incubation at 18 degrees C##2##5##(1990-7#1)(2008-10#1)
incubation at 4 degrees C##2##5##(2008-10#2)
incubation at##16##2##(1990-7#2)(1991-2#1)(1992-3#1)(1994-8#1)(1995-3#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-5#1)
incubation conditions##5##2##(1992-6#1)(1994-6#1)(2008-10#2)(2008-7#1)
incubation distribution##5##2##(1992-9#5)
incubation for 30##2##3##(1994-3#1)(2008-10#1)
incubation for##8##2##(1990-11#1)(1994-3#1)(1996-2#1)(2008-10#2)(2010-6#1)(2010-8#1)(2012-12#1)
incubation in situ##2##3##(1995-3#2)
incubation in the dark##2##4##(2008-10#2)
incubation in the presence of##3##5##(1990-2#1)(1991-12#1)(1992-5#1)
incubation in the##7##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-5#1)(2008-10#2)(2008-11#1)
incubation in##16##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-5#1)(1995-3#2)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)
incubation medium##12##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1995-11#4)(1996-2#2)(2008-5#1)
incubation mixture##5##2##(1990-2#2)(1991-8#1)(1994-5#1)(2011-2#1)
incubation of cells with##3##4##(2008-11#2)(2008-5#1)
incubation of the##13##3##(1991-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)
incubation of##50##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
incubation on##4##2##(2008-10#2)(2008-5#1)(2009-6#1)
incubation period and##2##3##(2008-10#2)
incubation period from##2##3##(1992-6#1)(2008-10#1)
incubation period length##2##3##(2008-10#2)
incubation period of##3##3##(1991-12#1)(1992-8#1)(2008-10#1)
incubation period was##4##3##(1996-8#1)(2008-10#3)
incubation period##33##2##(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-8#2)(2008-10#20)(2008-11#1)(2008-9#2)(2011-2#2)(2013-1#1)
incubation periods##3##2##(2007-2#1)(2008-10#2)
incubation revealed##2##2##(2008-10#1)(2008-5#1)
incubation solution##3##2##(1994-6#1)(2008-10#2)
incubation temperature and batch##2##4##(2011-2#2)
incubation temperature and##6##3##(2008-10#1)(2008-12#1)(2011-2#4)
incubation temperature at##2##3##(2008-10#1)(2008-11#1)
incubation temperature of 37 degrees C##2##6##(2008-10#2)
incubation temperature of##3##3##(2008-10#2)(2011-2#1)
incubation temperature##24##2##(1996-12#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#6)(2013-1#1)
incubation temperatures##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
incubation time and the##2##4##(1991-5#1)(2008-10#1)
incubation time and##5##3##(1991-5#1)(2008-10#3)(2008-11#1)
incubation time of##6##3##(1996-2#2)(2008-10#2)(2008-9#1)(2013-1#1)
incubation time##37##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-12#1)(1996-2#4)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-3#1)(2012-6#1)(2013-1#1)
incubation times##5##2##(1990-12#1)(1992-3#1)(2008-10#3)
incubation under##2##2##(2008-10#1)(2008-11#1)
incubation was##3##2##(1997-7#1)(2008-10#1)(2009-4#1)
incubation were##2##2##(1991-5#1)(2008-5#1)
incubation with CdCl2##2##3##(1995-3#2)
incubation with LPL##2##3##(1991-12#1)(1993-8#1)
incubation with a##5##3##(1990-12#1)(1992-3#1)(1994-5#1)(2008-10#1)(2008-2#1)
incubation with the##5##3##(1990-12#1)(1992-5#1)(1993-8#1)(1994-3#1)(2008-11#1)
incubation with##69##2##(1990-12#3)(1990-2#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-3#4)(1992-5#2)(1992-8#1)(1993-11#3)(1993-12#1)(1993-6#1)(1993-8#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-3#3)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
incubation##415##1##(1990-11#4)(1990-12#12)(1990-2#8)(1990-5#4)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#5)(1991-8#1)(1991-9#1)(1992-12#6)(1992-2#3)(1992-3#7)(1992-5#3)(1992-6#3)(1992-8#4)(1992-9#6)(1993-11#7)(1993-12#1)(1993-3#3)(1993-6#4)(1993-8#5)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#7)(1995-11#7)(1995-2#3)(1995-3#9)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#8)(1996-5#2)(1996-8#2)(1997-1#4)(1997-2#1)(1997-4#4)(1997-7#3)(1997-8#2)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#101)(2008-11#25)(2008-12#9)(2008-2#2)(2008-4#7)(2008-5#20)(2008-6#1)(2008-7#6)(2008-8#12)(2008-9#9)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#6)(2013-8#1)
incubations of##3##2##(1990-12#1)(1994-8#1)(2010-11#1)
incubations##13##1##(1990-11#1)(1990-12#2)(1992-3#2)(1993-12#1)(1994-8#2)(1995-11#1)(1996-5#2)(2008-6#1)(2010-11#1)
incubator for##2##2##(2008-8#1)(2010-6#1)
incubator##12##1##(2008-10#1)(2008-11#4)(2008-5#2)(2008-8#2)(2009-6#1)(2010-6#1)(2013-1#1)
incubators##2##1##(2008-10#1)(2008-12#1)
incur##5##1##(1993-1#1)(1993-12#1)(2008-12#1)(2012-12#1)(2013-1#1)
incurable##4##1##(2008-10#2)(2008-6#1)(2011-1#1)
incurred by the##3##3##(1991-3#1)(1993-12#1)(2011-1#1)
incurred by##9##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-12#1)(1997-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
incurred during##2##2##(2010-8#2)
incurred in##2##2##(1996-11#1)(2008-3#1)
incurred##23##1##(1991-12#1)(1991-3#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-8#3)(2011-1#2)(2011-2#1)(2013-8#1)
incurring##2##1##(1992-12#1)(2013-1#1)
incursions##2##1##(1991-3#1)(2008-8#1)
ind##3##1##(2011-2#3)
ind/10 cm2)##2##2##(2008-5#2)
ind/m2 (2000)##2##2##(2008-5#2)
ind/m2 (2002) and##2##3##(2008-5#2)
ind/m2 (2003)##2##2##(2008-5#2)
ind/m2##12##1##(2008-5#12)
ind/m2)##4##1##(2008-5#4)
indapamide treatment##2##2##(2011-2#2)
indapamide##7##1##(2008-11#1)(2011-2#6)
indeed a##5##2##(1994-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
indeed able to##2##3##(1997-7#1)(2008-5#1)
indeed associated with##3##3##(1994-2#1)(2008-1#1)(2011-2#1)
indeed have##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
indeed present##2##2##(1992-3#1)(2008-8#1)
indeed the##3##2##(1994-3#1)(2008-8#1)(2010-6#1)
indeed##81##1##(1990-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#1)(2010-6#3)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
indefinite##6##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-3#1)
indefinitely##10##1##(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#2)(2013-8#1)
indel##2##1##(2008-10#1)(2012-3#1)
indels##2##1##(2010-3#1)(2013-8#1)
indemnification##3##1##(1993-3#3)
indemnity plans##2##2##(1991-3#1)(1997-1#1)
indemnity##4##1##(1991-12#1)(1991-3#1)(1997-1#1)(1997-5#1)
indeno(1##2##1##(2008-10#2)
indent##2##1##(2009-7#1)(2010-10#1)
indentation studies##2##2##(2007-7#2)
indentation was performed##2##3##(2012-2#2)
indentation##14##1##(2007-7#3)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#4)(2010-4#2)(2012-2#2)
indentations##4##1##(1997-2#1)(2008-3#1)(2008-7#2)
indenter##2##1##(2009-7#1)(2013-1#1)
indentified##2##1##(1995-3#1)(2011-2#1)
indents##2##1##(2009-7#1)(2010-10#1)
independence among##2##2##(2010-3#1)(2011-2#1)
independence and##8##2##(1991-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
independence at##2##2##(2007-10#1)(2010-1#1)
independence between##2##2##(1996-2#1)(1996-5#1)
independence in the##2##3##(2009-12#1)(2013-8#1)
independence in##5##2##(2007-11#2)(2007-7#1)(2009-12#1)(2013-8#1)
independence is##2##2##(2008-10#1)(2008-3#1)
independence of the##4##3##(1991-8#1)(1993-8#1)(2008-10#1)(2011-2#1)
independence of##11##2##(1991-8#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
independence structure of##2##3##(2011-2#2)
independence##62##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
independence)##3##1##(1995-5#1)(2008-10#1)(2008-8#1)
independent IRESes##2##2##(2008-9#2)
independent alkene##2##2##(2007-11#2)
independent analyses of##4##3##(1995-5#1)(2008-10#3)
independent analyses##6##2##(1995-3#1)(1995-5#1)(2008-10#4)
independent analysis by##2##3##(2008-10#2)
independent analysis of##3##3##(2008-10#2)(2011-1#1)
independent analysis##5##2##(2008-10#4)(2011-1#1)
independent analytical##3##2##(2008-10#3)
independent and additive##2##3##(1994-7#1)(2008-10#1)
independent and could be##2##4##(1991-9#2)
independent and##22##2##(1991-9#2)(1994-12#1)(1994-7#1)(1995-4#1)(1995-5#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
independent as##2##2##(2007-12#1)(2013-1#1)
independent association of##2##3##(1994-12#1)(2010-4#1)
independent association##3##2##(1994-12#1)(2010-4#1)(2010-5#1)
independent associations##3##2##(1990-3#1)(1993-9#1)(2013-7#1)
independent assortment of##2##3##(2008-4#1)(2008-8#1)
independent binding##2##2##(1995-2#1)(1997-2#1)
independent breeding##2##2##(2008-8#2)
independent cDNA clones##2##3##(1991-2#1)(2008-11#1)
independent calibration of##3##3##(2008-10#1)(2008-3#2)
independent cardiovascular risk factor##2##4##(1996-8#1)(2008-11#1)
independent clones##2##2##(1997-3#1)(2008-11#1)
independent coding##3##2##(1990-5#1)(2008-11#1)(2011-1#1)
independent cohort of##3##3##(2011-2#2)(2012-3#1)
independent cohort##4##2##(2007-10#1)(2011-2#2)(2012-3#1)
independent community dwelling older adults##3##5##(2008-12#3)
independent component analysis (ICA)##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
independent component analysis and##2##4##(2008-11#1)(2009-11#1)
independent component analysis##8##3##(2008-10#2)(2008-11#2)(2008-7#2)(2009-11#1)(2010-8#1)
independent component##9##2##(2008-10#3)(2008-11#2)(2008-7#2)(2009-11#1)(2010-8#1)
independent components##5##2##(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)
independent contractor##3##2##(1993-1#2)(2013-7#1)
independent contrasts##7##2##(1997-4#1)(2008-8#3)(2008-9#3)
independent contributions of##2##3##(1992-6#1)(1993-3#1)
independent control of the##3##4##(2007-12#3)
independent control of##4##3##(2007-12#3)(2008-3#1)
independent data sets##4##3##(1995-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
independent data##7##2##(1995-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
independent determinants of##2##3##(2009-9#1)(2010-4#1)
independent determination of##2##3##(2008-10#1)(2008-3#1)
independent determinations##4##2##(2008-10#3)(2010-11#1)
independent effect of##2##3##(2007-10#1)(2013-1#1)
independent effect##3##2##(2007-10#1)(2009-7#1)(2013-1#1)
independent effects of##2##3##(2007-10#1)(2008-7#1)
independent effects##3##2##(2007-10#1)(2008-7#1)(2008-9#1)
independent estimates of##2##3##(2008-10#1)(2008-2#1)
independent evolution##2##2##(2009-2#2)
independent evolutionary##2##2##(2007-12#1)(2008-10#1)
independent factors associated with##2##4##(2007-10#1)(2013-8#1)
independent factors##4##2##(2007-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
independent from its##2##3##(1996-5#1)(2009-8#1)
independent from the##4##3##(1990-2#1)(1991-9#1)(2008-5#1)(2012-12#1)
independent from##11##2##(1990-2#1)(1991-9#1)(1993-12#1)(1996-5#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
independent genes##2##2##(2008-10#1)(2008-11#1)
independent groups##4##2##(2008-3#1)(2008-7#1)(2009-8#1)(2010-6#1)
independent in##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
independent information##2##2##(2008-9#1)(2009-10#1)
independent introductions##2##2##(2008-8#2)
independent living##4##2##(2008-12#1)(2009-10#1)(2013-1#2)
independent manner##2##2##(2008-11#1)(2009-3#1)
independent markers##3##2##(2008-10#2)(2011-2#1)
independent measurements of##3##3##(2008-2#1)(2008-3#2)
independent measurements##8##2##(2008-10#1)(2008-2#3)(2008-3#4)
independent mechanism##3##2##(1990-8#1)(1994-3#1)(1995-6#1)
independent mechanisms##3##2##(1991-1#1)(1991-9#1)(2012-3#1)
independent method##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
independent monitoring of##2##3##(2008-10#1)(2008-3#1)
independent movement##2##2##(2007-11#2)
independent noise##2##2##(2008-3#1)(2008-8#1)
independent of Ca2+##3##3##(1990-7#1)(1994-11#1)(1996-2#1)
independent of PKC##3##3##(1991-2#1)(1993-6#1)(1997-7#1)
independent of a possible##2##4##(1993-3#2)
independent of a##4##3##(1993-3#2)(1995-6#1)(2010-8#1)
independent of all##3##3##(1992-8#1)(1995-3#1)(2008-3#1)
independent of any##5##3##(1991-12#1)(1993-11#1)(1993-3#1)(2008-3#1)(2008-5#1)
independent of both##2##3##(1994-11#1)(2008-3#1)
independent of clinical##2##3##(1995-2#1)(1996-9#1)
independent of each other##2##4##(2008-10#1)(2008-8#1)
independent of extracellular Na+##3##4##(1990-2#1)(1990-7#1)(1993-8#1)
independent of its##6##3##(1995-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2011-2#1)
independent of lesion density##2##4##(2008-10#2)
independent of maternal##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
independent of other##3##3##(2007-10#1)(2008-3#1)(2013-7#1)
independent of p53##2##3##(2009-4#1)(2011-2#1)
independent of pH##7##3##(1990-7#1)(1991-5#1)(2008-10#5)
independent of protein##4##3##(1991-2#1)(1993-3#1)(1993-6#1)(2008-7#1)
independent of sex and##2##4##(1990-2#1)(2008-5#1)
independent of temperature##3##3##(1990-2#1)(2008-10#1)(2008-3#1)
independent of that##2##3##(1997-2#1)(2008-10#1)
independent of the above##3##4##(1995-11#1)(2008-10#1)(2008-2#1)
independent of the clinical##2##4##(1995-12#1)(2008-6#1)
independent of the data size##2##5##(2008-3#2)
independent of the number of##2##5##(2008-10#1)(2008-8#1)
independent of the presence of##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
independent of the presence##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
independent of the pumping power and wavelength##2##7##(2007-12#2)
independent of the time##2##4##(1992-8#2)
independent of the type of##2##5##(1997-2#1)(2008-10#1)
independent of the##125##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-2#1)(1996-6#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-11#7)(2007-12#6)(2008-10#23)(2008-11#7)(2008-2#11)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#1)(2009-10#1)(2009-8#2)(2010-3#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
independent of their##2##3##(1992-9#1)(2009-8#1)
independent of##303##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-11#3)(1993-3#5)(1993-6#6)(1993-8#2)(1993-9#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-4#1)(1997-6#1)(1997-7#3)(2006-10#1)(2007-10#1)(2007-11#10)(2007-12#8)(2008-10#55)(2008-11#12)(2008-12#1)(2008-2#14)(2008-3#31)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#13)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-2#9)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#4)
independent on the##5##3##(1995-12#1)(2008-10#3)(2008-9#1)
independent on##7##2##(1990-12#1)(1995-12#1)(2008-10#3)(2008-9#1)(2011-1#1)
independent or##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
independent organization##2##2##(1997-3#1)(2007-12#1)
independent origins##2##2##(2010-3#2)
independent pathways##3##2##(1994-11#2)(2012-1#1)
independent patterns are simulated by randomly##2##6##(2008-10#2)
independent performance##2##2##(2008-7#2)
independent practice association##2##3##(1993-12#1)(1993-2#1)
independent practice##4##2##(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)
independent predictor of##2##3##(2008-3#1)(2011-2#1)
independent predictor##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
independent predictors of##4##3##(2008-7#1)(2011-2#1)(2012-3#2)
independent probands##2##2##(1991-12#1)(1992-9#1)
independent prognostic factor for##2##4##(2011-2#1)(2012-3#1)
independent prognostic factor in##2##4##(1995-4#1)(2008-7#1)
independent prognostic factor##4##3##(1995-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
independent prognostic##8##2##(1993-11#1)(1994-7#1)(1995-4#1)(1996-9#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
independent random##3##2##(2007-12#1)(2008-3#2)
independent reflections##2##2##(1997-4#1)(1997-7#1)
independent relationship between##2##3##(2007-10#1)(2013-1#1)
independent relationship##3##2##(1993-12#1)(2007-10#1)(2013-1#1)
independent reproduction##2##2##(2008-8#2)
independent resistance##2##2##(2008-10#2)
independent reviewers##8##2##(1997-8#1)(2012-12#6)(2013-1#1)
independent risk factor for##13##4##(1992-9#1)(1993-2#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
independent risk factor##17##3##(1992-9#1)(1993-2#1)(1994-12#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-6#1)(2008-8#3)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
independent risk factors for##6##4##(2007-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
independent risk factors##7##3##(2007-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
independent risk##26##2##(1992-9#1)(1993-2#1)(1994-12#1)(2007-10#2)(2007-8#2)(2008-1#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
independent samples of college##2##4##(2007-12#2)
independent samples of##5##3##(2007-12#2)(2008-10#1)(2011-1#1)(2013-1#1)
independent samples##6##2##(2007-12#2)(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
independent scattering##2##2##(2007-12#1)(2008-2#1)
independent selection of##2##3##(1994-12#1)(2008-10#1)
independent service##2##2##(1996-2#2)
independent set of standards##2##4##(2008-10#2)
independent set of##4##3##(2008-10#3)(2012-3#1)
independent speckle patterns##2##3##(2008-2#1)(2008-3#1)
independent studies##7##2##(1996-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
independent techniques##3##2##(1990-8#1)(2008-3#2)
independent test##2##2##(2008-10#1)(2008-6#1)
independent transgenic lines##2##3##(1995-8#1)(2008-8#1)
independent transgenic##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
independent validation##2##2##(2008-10#1)(2009-4#1)
independent variable##7##2##(2008-10#2)(2008-11#4)(2008-7#1)
independent variables were##2##3##(2008-10#1)(2009-8#1)
independent variables##20##2##(1990-3#1)(1992-1#1)(1993-8#1)(1994-12#1)(1995-9#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
independent walking##3##2##(1993-12#3)
independent##943##1##(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#5)(1993-1#6)(1993-11#6)(1993-12#7)(1993-2#3)(1993-3#11)(1993-5#1)(1993-6#6)(1993-8#7)(1993-9#3)(1994-11#6)(1994-12#13)(1994-2#1)(1994-3#7)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#4)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#3)(1995-4#3)(1995-5#6)(1995-6#8)(1995-8#2)(1995-9#3)(1996-1#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#6)(1997-6#2)(1997-7#6)(1997-8#3)(2006-10#1)(2007-10#10)(2007-11#34)(2007-12#23)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#159)(2008-11#30)(2008-12#14)(2008-2#31)(2008-3#72)(2008-4#8)(2008-5#12)(2008-6#9)(2008-7#38)(2008-8#41)(2008-9#18)(2009-10#4)(2009-11#6)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#11)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#6)(2010-6#2)(2010-8#4)(2011-1#9)(2011-2#33)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#12)(2012-3#17)(2012-9#1)(2013-1#24)(2013-7#4)(2013-8#10)
independent)##2##1##(2008-11#1)(2009-8#1)
independently and negatively associated with##2##5##(1992-9#1)(2010-5#1)
independently and##6##2##(1991-5#1)(1991-9#1)(1992-9#1)(1993-3#1)(2008-3#1)(2010-5#1)
independently associated with an increased odds ratio of VTE complication##2##10##(2012-3#2)
independently associated with poor##2##4##(2008-7#2)
independently associated with##23##3##(1992-4#1)(1995-8#2)(2007-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-3#3)(2013-1#10)
independently associated##24##2##(1992-4#1)(1995-8#2)(2007-8#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-3#3)(2013-1#10)
independently at##4##2##(2008-3#2)(2009-6#1)(2013-1#1)
independently but##3##2##(2008-1#1)(2008-10#1)(2009-10#1)
independently by two##4##3##(2007-11#1)(2008-6#1)(2010-2#1)(2013-1#1)
independently by##12##2##(2007-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-9#2)(2010-2#1)(2010-3#1)(2012-1#1)(2013-1#2)
independently controlled##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
independently correlated##2##2##(2007-7#1)(2007-8#1)
independently determined##4##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-2#1)
independently evolved##2##2##(2008-10#1)(2011-2#1)
independently for##3##2##(2008-10#1)(2012-1#2)
independently from the##4##3##(1992-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
independently from##8##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
independently in##5##2##(2008-10#4)(2008-9#1)
independently into##2##2##(1997-7#1)(2008-10#1)
independently is##2##2##(2008-7#1)(2012-2#1)
independently obtained##2##2##(2008-2#1)(2008-3#1)
independently of each other##4##4##(1994-12#1)(1997-6#1)(2008-10#1)(2008-8#1)
independently of how##2##3##(1990-11#1)(2007-12#1)
independently of the presence of##2##5##(1991-4#1)(2013-8#1)
independently of the##22##3##(1991-12#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-12#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
independently of##60##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-8#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#5)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#1)(2009-9#2)(2010-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
independently or##6##2##(1994-2#1)(1997-4#1)(2008-4#1)(2009-11#1)(2009-8#1)(2012-3#1)
independently predicted##2##2##(2007-12#1)(2012-3#1)
independently prepared##2##2##(2008-10#2)
independently regulated##3##2##(1992-6#1)(1993-5#1)(1993-8#1)
independently related to##2##3##(1991-3#1)(2007-10#1)
independently reviewed##3##2##(1992-8#1)(2011-2#1)(2012-12#1)
independently to tumor necrosis factor-alpha##2##5##(2009-9#2)
independently to##4##2##(2008-8#1)(2009-9#2)(2011-2#1)
independently tunable##4##2##(2007-11#1)(2008-3#2)(2012-2#1)
independently varying##2##2##(2008-10#1)(2008-11#1)
independently with##5##2##(1995-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
independently##263##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-8#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#37)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#12)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#6)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#18)(2013-8#4)
indeterminate##17##1##(1992-6#1)(1994-6#1)(1996-2#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
index &gt##4##2##(2006-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
index (0##2##2##(2008-3#1)(2013-7#1)
index (CI)##3##2##(1993-10#1)(2009-8#1)(2013-1#1)
index (GI)##3##2##(2008-1#2)(2008-12#1)
index (PI) was##2##3##(1996-1#1)(2008-5#1)
index (PI)##5##2##(1996-1#1)(1996-6#1)(2008-12#1)(2008-5#1)(2011-2#1)
index (RI) of the##2##4##(2007-11#1)(2013-8#1)
index (RI) of##3##3##(2007-11#1)(2008-1#1)(2013-8#1)
index (RI)##9##2##(1991-7#1)(1994-5#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2013-1#1)(2013-8#1)
index (SI)##4##2##(1993-10#1)(2008-5#1)(2011-2#2)
index (r = 0##3##4##(1991-3#1)(2008-8#1)(2010-4#1)
index (r =##4##3##(1991-3#2)(2008-8#1)(2010-4#1)
index (t##2##2##(2008-10#2)
index and a##3##3##(2008-3#1)(2010-8#1)(2012-3#1)
index and its related taxonomic traits were##2##7##(2008-8#2)
index and its related taxonomic traits##3##6##(2008-8#3)
index and its##5##3##(1993-9#1)(2007-11#1)(2008-8#3)
index and the##16##3##(2008-1#2)(2008-2#4)(2008-3#8)(2011-1#1)(2013-7#1)
index and##78##2##(1991-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1997-3#1)(2007-10#2)(2007-11#8)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#14)(2008-5#2)(2008-7#4)(2008-8#3)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
index and/or##2##2##(2008-5#2)
index are##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
index as a##3##3##(1993-12#1)(2007-11#1)(2007-12#1)
index as##9##2##(1993-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)(2013-1#1)
index at the##2##3##(2007-12#1)(2013-1#1)
index at##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
index based on##2##3##(1995-2#1)(2008-10#1)
index between##3##2##(2008-10#2)(2008-3#1)
index by##4##2##(2007-11#1)(2008-3#2)(2013-8#1)
index calculated##2##2##(2012-1#1)(2013-8#1)
index can be##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
index can##4##2##(1992-12#1)(2007-12#1)(2008-3#1)(2008-6#1)
index case##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
index cases##2##2##(1992-9#1)(1993-1#1)
index change##2##2##(2008-3#2)
index changes of the##2##4##(2007-12#1)(2008-3#1)
index changes of##3##3##(2007-12#2)(2008-3#1)
index changes##9##2##(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#2)
index decreased##5##2##(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
index did not##3##3##(2008-6#2)(2013-7#1)
index difference and the##2##4##(2008-2#1)(2008-3#1)
index during##3##2##(1994-5#1)(2008-7#1)(2012-12#1)
index finger##3##2##(1996-2#1)(2008-12#1)(2008-9#1)
index fingers##2##2##(2008-9#1)(2012-3#1)
index for each##2##3##(2008-10#1)(2008-3#1)
index for the##2##3##(2008-10#1)(2008-9#1)
index for##23##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-2#1)(1993-12#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-7#2)(2013-1#1)
index grating##2##2##(2007-11#2)
index gratings##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
index has##2##2##(2008-1#1)(2008-3#1)
index in the##6##3##(2007-10#2)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
index in##23##2##(1996-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
index increase##2##2##(2007-11#1)(2008-3#1)
index increased##2##2##(2011-2#1)(2012-1#1)
index is a##4##3##(1995-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
index is defined##2##3##(2008-2#1)(2008-3#1)
index is##37##2##(1993-11#1)(1995-2#1)(2007-11#6)(2007-12#3)(2007-8#1)(2008-2#5)(2008-3#14)(2008-6#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
index may##3##2##(1993-9#1)(2007-11#1)(2008-3#1)
index means##2##2##(2008-12#2)
index measurement##2##2##(2008-3#1)(2012-2#1)
index mismatch##4##2##(2008-2#1)(2008-3#3)
index modulation and##4##3##(2007-11#2)(2008-3#2)
index modulation##8##2##(2007-11#2)(2007-12#1)(2008-3#5)
index obtained##2##2##(2008-3#1)(2008-8#1)
index of IHI##2##3##(1994-3#2)
index of air##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
index of association##4##3##(2008-10#4)
index of dispersion (D)##3##4##(2008-10#3)
index of dispersion##9##3##(2008-10#9)
index of glucose##2##3##(1990-6#1)(1991-12#1)
index of hemolysis##2##3##(2008-7#1)(2013-1#1)
index of individuality##2##3##(1996-12#1)(2010-7#1)
index of lipid peroxidation##2##4##(1995-12#1)(2009-12#1)
index of non-elasticity##2##3##(2008-5#2)
index of oxidative damage##2##4##(1991-9#1)(2008-10#1)
index of patchiness##2##3##(2008-10#2)
index of refraction and the##3##5##(2007-12#1)(2008-2#2)
index of refraction and##10##4##(2007-12#1)(2008-2#5)(2008-3#4)
index of refraction as##2##4##(2008-3#2)
index of refraction for##2##4##(2008-3#2)
index of refraction in the##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
index of refraction in##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
index of refraction of the##4##5##(2008-2#1)(2008-3#3)
index of refraction of##7##4##(2008-2#3)(2008-3#4)
index of refraction that##3##4##(2007-12#1)(2008-3#2)
index of refraction##58##3##(1991-9#1)(2007-11#3)(2007-12#5)(2008-2#19)(2008-3#30)
index of suspicion for##3##4##(2006-10#1)(2008-11#1)(2013-8#1)
index of suspicion in##3##4##(2008-9#1)(2010-10#1)(2010-12#1)
index of suspicion##21##3##(2006-10#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#2)
index of the fiber##2##4##(2008-3#2)
index of the medium##5##4##(2007-11#1)(2008-3#3)(2010-2#1)
index of the##41##3##(1994-2#1)(1994-8#1)(2007-11#7)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#1)(2008-6#2)(2008-7#1)(2009-6#2)(2010-2#2)(2011-1#1)
index of ß-cell##2##3##(2011-2#2)
index of##274##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#4)(1994-8#1)(1995-12#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#14)(2007-12#12)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#30)(2008-11#8)(2008-12#2)(2008-2#36)(2008-3#70)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#8)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#3)
index on the##2##3##(2008-3#1)(2009-2#1)
index on##7##2##(2007-10#1)(2007-11#1)(2008-3#2)(2009-2#1)(2010-8#1)(2011-1#1)
index or##5##2##(1997-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
index over the##2##3##(2008-5#1)(2011-1#1)
index over##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
index pain##3##2##(2008-7#3)
index perturbation##2##2##(2008-3#2)
index profile##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
index profiles of##2##3##(2008-2#1)(2008-3#1)
index profiles##5##2##(2008-2#4)(2008-3#1)
index scores##2##2##(2010-8#1)(2012-1#1)
index showed##3##2##(2008-12#1)(2008-3#1)(2008-6#1)
index than##2##2##(1992-6#1)(2011-1#1)
index to evaluate##2##3##(1996-5#1)(2008-11#1)
index to##13##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2012-1#2)(2012-7#1)(2013-1#2)(2013-7#1)
index values##11##2##(1992-2#2)(1993-9#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)
index variation##2##2##(2007-11#1)(2008-3#1)
index was 1##2##3##(2008-10#1)(2013-7#1)
index was also##2##3##(2008-12#1)(2008-6#1)
index was calculated to##2##4##(1991-2#1)(2008-3#1)
index was calculated##6##3##(1991-2#1)(1992-3#2)(2008-3#1)(2008-9#1)(2012-3#1)
index was lower##2##3##(2008-10#1)(2011-2#1)
index was measured##2##3##(1993-9#1)(2008-2#1)
index was used to##2##4##(2008-10#2)
index was##45##2##(1991-2#1)(1992-3#2)(1992-6#1)(1993-6#1)(1993-9#2)(1995-6#1)(1997-7#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
index were##7##2##(1991-6#1)(2007-8#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
index with the##2##3##(2008-3#2)
index with##11##2##(1997-7#1)(2007-11#2)(2008-2#2)(2008-3#4)(2012-2#2)
index##1239##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#5)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#8)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#9)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#3)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#7)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#4)(2006-10#3)(2006-8#1)(2007-10#12)(2007-11#80)(2007-12#42)(2007-7#4)(2007-8#12)(2008-1#17)(2008-10#129)(2008-11#40)(2008-12#27)(2008-2#100)(2008-3#204)(2008-4#9)(2008-5#29)(2008-6#19)(2008-7#37)(2008-8#24)(2008-9#15)(2009-1#1)(2009-11#6)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#13)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#10)(2011-1#25)(2011-2#51)(2011-3#3)(2012-1#12)(2012-12#10)(2012-2#15)(2012-3#18)(2012-7#4)(2013-1#36)(2013-7#11)(2013-8#23)
index&quot##2##1##(2007-11#1)(2008-10#1)
index'##3##1##(2008-3#2)(2008-7#1)
index) was##2##2##(2008-7#2)
index)##14##1##(1993-11#1)(2007-11#1)(2008-10#4)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#1)
index-matching fluid##2##2##(2007-11#1)(2008-3#1)
index-of-refraction##3##1##(2008-2#2)(2008-3#1)
index]##2##1##(1996-3#1)(2012-3#1)
indexed by the##2##3##(1991-12#1)(2008-8#1)
indexed in the##4##3##(1996-12#1)(2011-4#1)(2012-3#1)(2013-8#1)
indexed in##7##2##(1996-12#1)(1996-2#1)(2009-5#1)(2011-4#1)(2012-3#1)(2013-8#2)
indexed##20##1##(1991-12#1)(1994-3#2)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#2)(2011-4#1)(2012-3#1)(2013-1#1)(2013-8#3)
indexes are##5##2##(1992-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
indexes in##3##2##(2006-10#1)(2008-10#1)(2011-1#1)
indexes of functional state of young people##2##7##(2011-1#2)
indexes of##15##2##(1991-12#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#3)(2011-2#3)(2011-3#1)(2013-8#1)
indexes used##2##2##(1992-1#1)(2008-6#1)
indexes was##2##2##(2008-10#1)(2010-11#1)
indexes were##8##2##(1990-9#1)(2008-5#1)(2011-2#1)(2011-3#2)(2012-2#3)
indexes##69##1##(1990-9#3)(1991-12#4)(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#4)(1995-12#1)(2006-10#1)(2008-10#9)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#3)(2010-3#1)(2010-4#1)(2011-1#5)(2011-2#6)(2011-3#3)(2012-2#8)(2012-3#2)(2013-7#1)(2013-8#2)
indexing hosts##2##2##(2008-10#2)
indexing##14##1##(1993-1#1)(1993-3#1)(1995-1#2)(1996-3#1)(2008-10#6)(2008-6#1)(2009-10#1)(2010-5#1)
india##2##1##(2008-9#1)(2013-7#1)
indians##3##1##(1991-12#1)(2008-3#2)
indica and T##3##3##(2008-10#3)
indica and japonica##3##3##(2008-10#2)(2008-8#1)
indica and##11##2##(2008-10#8)(2008-8#1)(2010-3#1)(2011-1#1)
indica cv##2##2##(1995-6#1)(2008-9#1)
indica is##3##2##(2008-10#3)
indica on germination and seedling growth of##2##7##(2008-12#2)
indica on##3##2##(2008-10#1)(2008-12#2)
indica possess potent##2##3##(2010-5#1)(2011-1#1)
indica rice##5##2##(2006-12#3)(2008-9#2)
indica were##2##2##(2008-10#2)
indica##67##1##(1995-6#1)(2006-12#3)(2007-7#1)(2008-10#39)(2008-12#4)(2008-8#2)(2008-9#7)(2010-3#1)(2010-5#3)(2011-1#4)(2011-2#1)(2012-3#1)
indica) and##2##2##(2008-8#1)(2008-9#1)
indica)##4##1##(2008-10#2)(2008-8#1)(2008-9#1)
indicate a close##2##3##(1992-8#1)(1996-5#1)
indicate a decrease in##3##4##(1991-2#1)(2009-12#1)(2012-2#1)
indicate a high prevalence of##2##5##(2008-12#1)(2012-2#1)
indicate a high##4##3##(1990-2#1)(1991-11#1)(2008-12#1)(2012-2#1)
indicate a major role for##2##5##(1990-5#1)(1996-2#1)
indicate a need for##3##4##(1996-2#1)(1996-6#2)
indicate a need##5##3##(1996-2#1)(1996-6#2)(2008-1#1)(2008-2#1)
indicate a poor prognosis##2##4##(1990-9#1)(1997-8#1)
indicate a positive##3##3##(2011-2#3)
indicate a role for##4##4##(1994-6#1)(1994-9#1)(2008-7#1)(2010-10#1)
indicate a significant##2##3##(2008-12#1)(2013-1#1)
indicate a strong##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
indicate a structure##2##3##(1996-2#1)(2008-3#1)
indicate a very##2##3##(1996-2#1)(2008-7#1)
indicate a##94##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#4)(1996-5#1)(1996-6#2)(1997-4#1)(1997-7#2)(1997-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
indicate an important##4##3##(1992-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
indicate an##17##2##(1990-6#1)(1990-8#1)(1992-5#1)(1993-1#1)(1994-12#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#2)(2012-2#1)
indicate contamination##2##2##(2007-5#1)(2008-10#1)
indicate differences in the##2##4##(2011-1#1)(2012-1#1)
indicate differences in##3##3##(2011-1#1)(2012-1#1)(2012-2#1)
indicate different##2##2##(2012-3#1)(2013-1#1)
indicate differential##2##2##(2008-10#1)(2011-2#1)
indicate excellent selectivity for##3##4##(2008-10#3)
indicate good selectivity for##2##4##(2008-10#2)
indicate good##5##2##(1991-3#1)(2008-10#3)(2010-4#1)
indicate how##4##2##(2008-4#1)(2009-7#1)(2011-2#1)(2012-12#1)
indicate involvement of##2##3##(1993-12#1)(2008-11#1)
indicate no##3##2##(2008-10#2)(2008-3#1)
indicate only##2##2##(1990-6#1)(1993-8#1)
indicate positive##2##2##(2008-11#2)
indicate potential##3##2##(1995-3#1)(2008-2#1)(2013-8#1)
indicate that (i) the##2##4##(1994-8#1)(2008-10#1)
indicate that (i)##3##3##(1994-5#1)(1994-8#1)(2008-10#1)
indicate that DAPI##2##3##(1992-3#2)
indicate that HTLV-I##2##3##(1994-6#1)(2008-8#1)
indicate that IL-1##2##3##(1993-8#1)(1995-12#1)
indicate that M##2##3##(2008-10#1)(2008-5#1)
indicate that P##2##3##(1992-12#1)(2008-10#1)
indicate that WSMV##2##3##(2008-10#2)
indicate that a high percentage##2##5##(1991-12#1)(2008-10#1)
indicate that a large##2##4##(2012-12#1)(2012-2#1)
indicate that a significant##2##4##(2008-3#1)(2008-4#1)
indicate that a single##4##4##(1993-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
indicate that a##34##3##(1990-6#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-8#3)(2009-3#1)(2012-12#2)(2012-2#2)(2013-1#2)
indicate that activation of##2##4##(1993-12#1)(1995-8#1)
indicate that additional##2##3##(1990-2#1)(1991-12#1)
indicate that adjunctive treatment with##4##5##(2008-6#4)
indicate that all##4##3##(2008-10#3)(2010-5#1)
indicate that although##2##3##(1992-1#1)(2011-1#1)
indicate that an##7##3##(1990-8#1)(1991-11#1)(1992-8#1)(1994-8#1)(1995-2#1)(2008-1#1)(2008-11#1)
indicate that approximately##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
indicate that at least##3##4##(1994-11#1)(2008-10#1)(2009-7#1)
indicate that at##7##3##(1994-11#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-7#1)(2009-7#1)
indicate that bacterial##2##3##(1991-3#1)(2008-10#1)
indicate that binding of##2##4##(1992-12#1)(2010-10#1)
indicate that both the##2##4##(1990-9#1)(1997-4#1)
indicate that both##23##3##(1990-9#1)(1991-12#1)(1991-5#2)(1992-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
indicate that cellular##2##3##(2009-2#1)(2009-6#1)
indicate that changes##2##3##(1990-7#1)(2008-7#1)
indicate that children who##2##4##(1995-1#1)(2011-1#1)
indicate that children##3##3##(1995-1#1)(1996-12#1)(2011-1#1)
indicate that chronic##2##3##(1996-12#1)(2010-2#1)
indicate that different##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
indicate that during##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
indicate that each of##2##4##(1991-9#1)(1994-8#1)
indicate that each##3##3##(1991-9#1)(1994-8#1)(2008-10#1)
indicate that early##2##3##(2008-10#1)(2008-12#1)
indicate that endogenous##2##3##(1990-2#1)(1996-2#1)
indicate that establishment##2##3##(2008-10#1)(2008-7#1)
indicate that higher##5##3##(2007-12#1)(2008-9#1)(2009-11#1)(2012-1#1)(2012-3#1)
indicate that if##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
indicate that in contrast to##2##5##(1995-2#1)(2008-3#1)
indicate that in hepatocytes##2##4##(1990-12#1)(1992-5#1)
indicate that in the##7##4##(1991-11#1)(1994-3#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
indicate that in##22##3##(1990-12#1)(1990-5#2)(1991-11#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-12#2)(1995-2#1)(1997-1#2)(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)
indicate that increased##4##3##(1994-8#1)(2012-6#1)(2013-1#1)(2013-8#1)
indicate that inhibition of##3##4##(1991-1#1)(1992-12#1)(2010-2#1)
indicate that it is possible to##2##6##(1992-8#1)(1996-5#1)
indicate that it is##7##4##(1990-12#1)(1992-12#1)(1992-8#1)(1996-5#1)(2008-10#2)(2010-12#1)
indicate that it may be possible to##2##7##(2008-3#1)(2009-4#1)
indicate that it may be##3##5##(2008-10#1)(2008-3#1)(2009-4#1)
indicate that it##13##3##(1990-12#1)(1992-12#1)(1992-8#1)(1996-5#1)(2008-10#4)(2008-3#2)(2008-4#1)(2009-4#1)(2010-12#1)
indicate that low doses of##2##5##(2008-7#2)
indicate that many of the##2##5##(1992-10#1)(2008-10#1)
indicate that many##4##3##(1992-10#1)(2008-10#2)(2012-12#1)
indicate that most of the##2##5##(2008-10#1)(2010-3#1)
indicate that most of##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
indicate that most patients##2##4##(1990-11#1)(2013-1#1)
indicate that most##8##3##(1990-11#1)(1990-8#1)(1996-2#1)(2008-10#2)(2008-5#1)(2010-3#1)(2013-1#1)
indicate that natural##2##3##(2010-2#1)(2013-1#1)
indicate that no##2##3##(1997-5#1)(2008-11#1)
indicate that nurses##2##3##(2010-7#1)(2013-1#1)
indicate that oncogenes##2##3##(1997-7#1)(2008-11#1)
indicate that one##4##3##(1991-8#1)(1992-3#1)(2008-5#1)(2012-1#1)
indicate that other##2##3##(2008-10#1)(2008-4#1)
indicate that oxidative##2##3##(1992-12#1)(1994-2#1)
indicate that parents##2##3##(1995-12#1)(2012-12#1)
indicate that patients##2##3##(2007-6#1)(2010-5#1)
indicate that plasma##4##3##(1991-9#1)(2008-4#1)(2008-7#1)(2011-2#1)
indicate that previous##2##3##(1997-3#1)(2010-5#1)
indicate that prolonged##2##3##(2008-8#1)(2013-1#1)
indicate that regulation of##3##4##(1997-1#1)(2008-7#2)
indicate that selection##2##3##(2008-9#1)(2013-1#1)
indicate that sensitivity to##2##4##(2008-10#1)(2008-11#1)
indicate that several##2##3##(1993-12#1)(2011-2#1)
indicate that some##7##3##(1990-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-5#2)
indicate that species##2##3##(1990-6#1)(2008-8#1)
indicate that the activation of##3##5##(1997-2#2)(2006-6#1)
indicate that the best##2##4##(2007-11#1)(2013-1#1)
indicate that the binding##3##4##(1990-11#1)(1990-8#1)(2008-8#1)
indicate that the conditions##2##4##(2008-10#1)(2008-8#1)
indicate that the conformation##2##4##(1992-6#1)(2008-10#1)
indicate that the derivative##2##4##(2008-10#2)
indicate that the effect of##3##5##(1995-8#1)(1996-2#1)(2012-2#1)
indicate that the effects of##3##5##(1996-3#1)(2008-12#1)(2011-2#1)
indicate that the effects##4##4##(1996-3#1)(2008-11#1)(2008-12#1)(2011-2#1)
indicate that the expression of##2##5##(1997-3#1)(2012-12#1)
indicate that the expression##3##4##(1993-6#1)(1997-3#1)(2012-12#1)
indicate that the fusion##2##4##(2008-8#2)
indicate that the incidence##2##4##(1997-3#1)(2010-6#1)
indicate that the increase in##2##5##(1995-6#1)(2008-10#1)
indicate that the interaction##2##4##(2008-10#2)
indicate that the main##4##4##(1995-12#1)(2008-10#1)(2008-11#2)
indicate that the major##3##4##(1993-3#1)(1997-8#1)(2008-9#1)
indicate that the method##3##4##(1996-12#1)(2008-10#2)
indicate that the neural##2##4##(1996-2#1)(2010-8#1)
indicate that the new##2##4##(1992-11#1)(2012-1#1)
indicate that the optical##2##4##(2008-3#1)(2013-8#1)
indicate that the performance of the##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
indicate that the presence of##4##5##(1992-6#1)(2007-11#1)(2008-10#1)(2008-12#1)
indicate that the present##2##4##(1994-2#1)(2010-6#1)
indicate that the prevalence of##2##5##(2007-7#1)(2012-12#1)
indicate that the procedure can eliminate##2##6##(2008-10#2)
indicate that the procedure##3##4##(2008-10#2)(2011-2#1)
indicate that the proposed##3##4##(2007-12#1)(2008-11#1)(2012-3#1)
indicate that the sensor##2##4##(2007-11#1)(2008-10#1)
indicate that the sequence##2##4##(1993-8#1)(1997-2#1)
indicate that the tilt angle of the##2##7##(2008-3#2)
indicate that the two##5##4##(1990-11#1)(1995-3#2)(2008-7#1)(2012-2#1)
indicate that the##369##3##(1990-11#7)(1990-12#7)(1990-2#1)(1990-7#3)(1990-8#4)(1991-11#1)(1991-12#4)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#6)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#5)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#9)(1995-8#5)(1996-12#1)(1996-2#8)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#6)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#59)(2008-11#11)(2008-12#6)(2008-2#8)(2008-3#15)(2008-4#4)(2008-5#12)(2008-6#5)(2008-7#10)(2008-8#12)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#5)(2010-11#2)(2010-2#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#6)
indicate that there are##3##4##(1990-11#1)(1992-1#1)(1993-3#1)
indicate that there is a##5##5##(1990-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
indicate that there is no##3##5##(1992-12#1)(1997-1#1)(2008-6#1)
indicate that there is##12##4##(1990-2#1)(1992-12#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)
indicate that there was no##2##5##(2012-12#1)(2013-1#1)
indicate that there was##3##4##(2008-5#1)(2012-12#1)(2013-1#1)
indicate that there##21##3##(1990-11#1)(1990-2#1)(1992-1#1)(1992-12#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)
indicate that these individuals often have pulmonary asbestos##2##8##(1991-12#2)
indicate that these species##2##4##(1997-7#1)(2008-10#1)
indicate that these two##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
indicate that these##18##3##(1990-7#1)(1991-12#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
indicate that they are##2##4##(2008-10#1)(2013-8#1)
indicate that they##7##3##(1992-3#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2013-8#1)
indicate that this new##2##4##(1992-8#1)(2008-10#1)
indicate that this##23##3##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2013-1#1)
indicate that two##2##3##(1990-11#1)(1996-12#1)
indicate that under##3##3##(2007-11#1)(2008-10#2)
indicate that visual##2##3##(1995-11#1)(2008-1#1)
indicate that when##2##3##(2008-7#1)(2013-1#1)
indicate that while##2##3##(1991-5#1)(1994-8#1)
indicate that##1359##2##(1990-10#1)(1990-11#12)(1990-12#18)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#3)(1990-7#10)(1990-8#9)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#19)(1991-2#1)(1991-3#3)(1991-5#10)(1991-6#2)(1991-8#4)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#11)(1992-2#2)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#9)(1992-7#1)(1992-8#17)(1992-9#6)(1993-1#1)(1993-11#10)(1993-12#14)(1993-2#4)(1993-3#11)(1993-5#3)(1993-6#12)(1993-8#15)(1993-9#7)(1994-11#10)(1994-12#4)(1994-2#7)(1994-3#5)(1994-5#10)(1994-6#12)(1994-8#18)(1994-9#2)(1995-1#2)(1995-11#9)(1995-12#27)(1995-2#16)(1995-3#11)(1995-5#7)(1995-6#14)(1995-8#14)(1996-1#4)(1996-12#12)(1996-2#23)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#4)(1996-9#1)(1997-1#10)(1997-2#14)(1997-3#5)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#12)(1997-8#4)(2006-6#1)(2006-8#1)(2007-10#6)(2007-11#17)(2007-12#15)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#10)(2008-10#213)(2008-11#41)(2008-12#21)(2008-2#21)(2008-3#45)(2008-4#20)(2008-5#39)(2008-6#16)(2008-7#42)(2008-8#40)(2008-9#19)(2009-10#5)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#10)(2009-8#5)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#4)(2010-2#9)(2010-3#5)(2010-4#3)(2010-5#6)(2010-6#4)(2010-7#5)(2010-8#6)(2011-1#9)(2011-10#1)(2011-2#30)(2012-1#4)(2012-12#14)(2012-2#24)(2012-3#8)(2012-5#1)(2012-6#1)(2013-1#37)(2013-7#3)(2013-8#14)
indicate the differential##2##3##(1990-7#1)(2008-4#1)
indicate the effectiveness of##2##4##(2008-7#1)(2012-2#1)
indicate the existence of an##2##5##(1990-5#1)(1997-6#1)
indicate the existence of##5##4##(1990-5#1)(1992-3#1)(1997-6#1)(2008-10#1)(2008-7#1)
indicate the importance of##3##4##(1990-10#1)(1990-12#1)(2010-6#1)
indicate the involvement of##4##4##(1992-6#1)(1993-12#1)(2008-12#1)(2008-8#1)
indicate the need for##5##4##(1994-3#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)
indicate the need to recognize##2##5##(1994-2#1)(2010-9#1)
indicate the need##7##3##(1994-2#1)(1994-3#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-9#1)
indicate the possibility of##3##4##(2008-3#3)
indicate the possibility##4##3##(2008-3#3)(2008-5#1)
indicate the potential##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
indicate the presence of a##4##5##(1990-11#1)(1993-3#1)(2007-12#1)(2008-10#1)
indicate the presence of two##2##5##(2008-10#1)(2008-7#1)
indicate the presence of##13##4##(1990-11#2)(1992-8#1)(1993-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)
indicate the usefulness of##2##4##(2008-11#1)(2013-1#1)
indicate the##97##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#10)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#2)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
indicate their##2##2##(2008-4#1)(2011-1#1)
indicate there##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
indicate this##2##2##(1994-2#1)(2009-5#1)
indicate two##2##2##(2008-10#1)(2008-11#1)
indicate what##2##2##(1997-7#1)(2012-3#1)
indicate where##2##2##(2008-11#1)(2008-2#1)
indicate which##2##2##(2013-1#2)
indicate##1728##1##(1990-10#3)(1990-11#15)(1990-12#20)(1990-2#5)(1990-3#1)(1990-5#9)(1990-6#6)(1990-7#11)(1990-8#10)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#21)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#11)(1991-6#4)(1991-8#6)(1991-9#7)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#12)(1992-2#3)(1992-3#12)(1992-4#2)(1992-5#5)(1992-6#14)(1992-7#1)(1992-8#19)(1992-9#7)(1993-1#2)(1993-11#11)(1993-12#18)(1993-2#5)(1993-3#13)(1993-5#3)(1993-6#14)(1993-8#16)(1993-9#8)(1994-11#13)(1994-12#5)(1994-2#10)(1994-3#7)(1994-5#10)(1994-6#13)(1994-8#20)(1994-9#4)(1995-1#3)(1995-11#11)(1995-12#28)(1995-2#17)(1995-3#13)(1995-5#8)(1995-6#15)(1995-8#14)(1995-9#1)(1996-1#5)(1996-12#14)(1996-2#27)(1996-3#4)(1996-4#3)(1996-5#8)(1996-6#6)(1996-8#1)(1996-9#2)(1997-1#11)(1997-2#14)(1997-3#5)(1997-4#6)(1997-5#5)(1997-6#7)(1997-7#15)(1997-8#5)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#8)(2007-11#19)(2007-12#18)(2007-2#4)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#14)(2008-10#262)(2008-11#61)(2008-12#37)(2008-2#25)(2008-3#62)(2008-4#28)(2008-5#49)(2008-6#19)(2008-7#51)(2008-8#46)(2008-9#26)(2009-10#6)(2009-11#2)(2009-12#6)(2009-2#5)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#5)(2009-7#13)(2009-8#7)(2009-9#1)(2010-1#4)(2010-10#6)(2010-11#5)(2010-12#5)(2010-2#9)(2010-3#8)(2010-4#5)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#2)(2011-1#14)(2011-10#1)(2011-2#41)(2012-1#8)(2012-12#20)(2012-2#31)(2012-3#14)(2012-5#3)(2012-6#1)(2013-1#55)(2013-7#4)(2013-8#19)
indicated TMSG-1##3##2##(2008-9#3)
indicated a competitive##2##3##(1993-3#1)(1995-12#1)
indicated a high degree of##2##5##(2008-10#2)
indicated a high level of##2##5##(1996-12#1)(2008-12#1)
indicated a high##8##3##(1992-2#1)(1996-12#1)(2008-10#3)(2008-12#1)(2011-1#2)
indicated a linear##2##3##(2008-10#2)
indicated a marked increase in##2##5##(1991-4#1)(1997-7#1)
indicated a marked##3##3##(1991-4#1)(1997-7#1)(2010-4#1)
indicated a need for##2##4##(2008-10#1)(2011-1#1)
indicated a need to##2##4##(1995-6#1)(2011-1#1)
indicated a need##4##3##(1995-6#1)(2008-10#1)(2011-1#2)
indicated a positive relationship between##2##5##(1995-3#1)(1996-12#1)
indicated a positive##3##3##(1995-3#1)(1996-12#1)(2008-6#1)
indicated a preference for##2##4##(2008-11#1)(2010-8#1)
indicated a rapid##2##3##(2008-10#1)(2011-2#1)
indicated a significant##2##3##(2008-10#1)(2011-2#1)
indicated a significantly##4##3##(1994-2#1)(2008-11#1)(2008-12#1)(2011-1#1)
indicated a similar##2##3##(1992-10#1)(1994-10#1)
indicated a strong##5##3##(1994-6#1)(2008-10#2)(2008-6#1)(2011-2#1)
indicated a##87##2##(1990-6#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-12#2)(1993-3#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#3)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#24)(2008-11#4)(2008-12#4)(2008-3#2)(2008-6#2)(2009-8#1)(2010-4#2)(2010-8#2)(2011-1#5)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
indicated above##3##2##(2008-10#2)(2008-3#1)
indicated aggregated patterns of disease incidence data##2##7##(2008-10#2)
indicated an increase##2##3##(1996-12#1)(1996-9#1)
indicated an overall##2##3##(1994-6#1)(2009-9#1)
indicated an##13##2##(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)
indicated and##3##2##(1996-11#1)(1997-6#1)(2008-12#1)
indicated as a##2##3##(1996-9#1)(2008-4#1)
indicated as the most##2##4##(2008-10#1)(2010-3#1)
indicated as##8##2##(1996-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-3#1)(2010-8#1)
indicated at##4##2##(1993-3#1)(1997-4#1)(2008-10#1)(2009-6#1)
indicated because##2##2##(2008-9#1)(2012-1#1)
indicated by a##7##3##(1994-5#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-7#1)
indicated by significant##2##3##(2008-10#1)(2008-8#1)
indicated by some##2##3##(1995-5#1)(2013-1#1)
indicated by the##29##3##(1990-2#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
indicated by their##5##3##(1990-5#1)(1994-9#1)(1995-3#2)(2008-10#1)
indicated by##89##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-7#1)(2012-9#1)(2013-1#2)(2013-8#1)
indicated close##2##2##(2008-10#1)(2013-8#1)
indicated considerable##2##2##(1992-3#1)(2008-10#1)
indicated enhanced##2##2##(2008-10#1)(2008-11#1)
indicated for patients with##2##4##(2008-10#1)(2008-3#1)
indicated for patients##3##3##(2008-10#2)(2008-3#1)
indicated for the treatment of chemotherapy-induced anemia##2##7##(2008-7#1)(2010-11#1)
indicated for the treatment of##3##5##(2008-7#1)(2010-11#1)(2012-2#1)
indicated for the##9##3##(2007-11#1)(2007-12#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
indicated for##29##2##(1994-9#1)(1996-11#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)
indicated greater##2##2##(1996-1#1)(2009-11#1)
indicated here##2##2##(1992-11#1)(1994-11#1)
indicated high##5##2##(1995-11#1)(2008-10#2)(2008-2#1)(2008-8#1)
indicated higher levels of##2##4##(2009-7#1)(2010-10#1)
indicated higher##7##2##(1994-6#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-10#1)(2011-2#2)
indicated in all##2##3##(2008-2#1)(2010-6#1)
indicated in patients with##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
indicated in the##5##3##(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
indicated in##29##2##(1990-6#1)(1994-3#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
indicated levels of##2##3##(2008-9#1)(2010-12#1)
indicated no interaction between##2##4##(1990-11#1)(2008-5#1)
indicated no significant changes##2##4##(2008-5#1)(2010-3#1)
indicated no significant##5##3##(1992-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
indicated no##9##2##(1990-11#1)(1992-11#1)(1992-9#1)(2008-10#1)(2008-5#2)(2008-9#2)(2010-3#1)
indicated or##2##2##(2008-10#1)(2008-5#1)
indicated promising results##2##3##(2008-10#1)(2008-5#1)
indicated relatively##2##2##(1997-4#1)(2008-10#1)
indicated significant differences in##2##4##(2008-10#1)(2013-7#1)
indicated significant##10##2##(1995-12#1)(2007-11#1)(2008-10#3)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
indicated some differences between##2##4##(2007-2#1)(2009-7#1)
indicated some##5##2##(1991-12#1)(2007-2#1)(2008-10#2)(2009-7#1)
indicated specific##2##2##(2008-10#1)(2008-5#1)
indicated that (1)##3##3##(1993-12#1)(1994-8#1)(1997-4#1)
indicated that P##2##3##(2008-10#1)(2008-5#1)
indicated that a high level of##2##6##(2008-10#1)(2008-11#1)
indicated that a single##5##4##(1997-3#1)(2008-10#4)
indicated that a##28##3##(1990-11#1)(1991-6#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2013-8#1)
indicated that additional##2##3##(1991-8#1)(2011-1#1)
indicated that all##2##3##(2008-10#1)(2012-12#1)
indicated that although##2##3##(1997-8#1)(2008-11#1)
indicated that an##3##3##(2008-10#2)(2012-2#1)
indicated that at##2##3##(1992-12#1)(1995-2#1)
indicated that both the##3##4##(2007-6#1)(2008-10#1)(2008-11#1)
indicated that both##9##3##(1990-2#1)(1991-6#1)(1992-6#1)(1995-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
indicated that cell##3##3##(1997-9#1)(2008-11#1)(2008-9#1)
indicated that certain##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
indicated that chromosome##2##3##(2008-10#2)
indicated that disease incidence was##2##5##(2008-10#2)
indicated that disease##4##3##(2008-10#4)
indicated that during##2##3##(1995-9#1)(2008-10#1)
indicated that each##3##3##(2008-10#2)(2008-9#1)
indicated that following##2##3##(1992-8#1)(1995-11#1)
indicated that in a##2##4##(1997-3#1)(2008-10#1)
indicated that in##9##3##(1993-12#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-9#1)
indicated that increased##2##3##(1993-12#1)(2009-7#1)
indicated that it is##5##4##(1992-8#1)(1994-8#1)(1996-12#1)(2008-10#2)
indicated that it##8##3##(1992-8#2)(1994-8#1)(1996-12#1)(2008-10#4)
indicated that mRNA##2##3##(1993-3#1)(1994-5#1)
indicated that metabolism##2##3##(1994-5#1)(2008-8#1)
indicated that more##3##3##(2007-7#1)(2008-10#1)(2009-7#1)
indicated that most of the##2##5##(2008-10#1)(2008-7#1)
indicated that most of these##2##5##(2011-3#1)(2012-3#1)
indicated that most of##4##4##(2008-10#1)(2008-7#1)(2011-3#1)(2012-3#1)
indicated that most##6##3##(1995-12#1)(2008-10#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
indicated that multiple##2##3##(2008-10#1)(2010-8#1)
indicated that one##2##3##(2008-10#2)
indicated that only the##2##4##(2008-10#1)(2008-4#1)
indicated that only##5##3##(1992-11#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
indicated that parental##2##3##(1996-2#1)(2007-12#1)
indicated that participants##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
indicated that patients with##2##4##(1991-5#1)(2008-6#1)
indicated that relative##2##3##(2007-12#1)(2013-8#1)
indicated that resistance to##2##4##(2008-10#2)
indicated that resistance##3##3##(2008-10#3)
indicated that sanA is##2##4##(2008-9#2)
indicated that some##3##3##(2008-10#1)(2008-12#1)(2012-1#1)
indicated that the addition of##2##5##(2008-10#1)(2008-11#1)
indicated that the best##2##4##(1996-3#1)(2007-11#1)
indicated that the cDNA##2##4##(1990-12#1)(1995-8#1)
indicated that the component giving##2##5##(1995-2#2)
indicated that the differential##2##4##(1993-12#1)(2008-10#1)
indicated that the expression of##4##5##(1991-9#1)(1997-2#1)(2008-8#1)(2008-9#1)
indicated that the gene##2##4##(2008-10#2)
indicated that the high##2##4##(2008-2#1)(2009-7#1)
indicated that the magnetic##2##4##(2008-12#1)(2008-8#1)
indicated that the major##4##4##(1994-11#1)(2008-1#1)(2010-8#1)(2011-3#1)
indicated that the majority of##2##5##(2008-5#1)(2008-9#1)
indicated that the majority##4##4##(1995-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
indicated that the management##3##4##(1996-3#1)(2010-3#1)(2012-3#1)
indicated that the method##2##4##(2008-10#1)(2013-8#1)
indicated that the modified##3##4##(1995-2#1)(2008-10#1)(2008-8#1)
indicated that the most##3##4##(1994-3#1)(2008-6#1)(2010-8#1)
indicated that the peptide##2##4##(1993-12#1)(1994-8#1)
indicated that the plant##2##4##(2008-6#1)(2013-1#1)
indicated that the presence of##3##5##(2008-10#2)(2008-7#1)
indicated that the protein##2##4##(1990-2#1)(1991-9#1)
indicated that the resistance##6##4##(2008-10#6)
indicated that the sequences##4##4##(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)
indicated that the translocation##2##4##(1996-6#1)(2008-8#1)
indicated that the two##6##4##(1990-2#2)(1991-8#1)(2008-10#1)(2008-9#1)(2013-7#1)
indicated that the virus##3##4##(2008-10#3)
indicated that the##314##3##(1990-11#3)(1990-12#2)(1990-2#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#105)(2008-11#10)(2008-12#9)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#17)(2008-9#12)(2009-1#1)(2009-11#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#2)(2011-3#5)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#2)
indicated that their##3##3##(1995-8#1)(2007-7#1)(2008-11#1)
indicated that there are no significant##2##6##(2008-11#1)(2010-3#1)
indicated that there are##4##4##(1993-2#1)(1994-3#1)(2008-11#1)(2010-3#1)
indicated that there was a##7##5##(2008-10#5)(2008-11#1)(2012-2#1)
indicated that there was##11##4##(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2012-2#1)
indicated that there were##4##4##(1994-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
indicated that there##22##3##(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
indicated that these two##2##4##(2008-10#1)(2012-2#1)
indicated that these##9##3##(1994-12#1)(2008-10#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
indicated that they are##4##4##(1993-3#1)(1994-6#1)(2008-10#1)(2008-5#1)
indicated that they##13##3##(1992-2#1)(1993-1#1)(1993-3#1)(1994-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2010-3#1)(2012-2#1)
indicated that this##15##3##(1993-12#1)(1994-5#1)(1997-4#1)(2008-10#6)(2008-5#3)(2008-8#3)
indicated that those##2##3##(1991-5#1)(2008-10#1)
indicated that tolerance##2##3##(1992-3#1)(2008-10#1)
indicated that two##3##3##(1990-5#1)(1990-9#1)(2008-10#1)
indicated that under##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
indicated that women##2##3##(2008-12#1)(2012-1#1)
indicated that##889##2##(1990-11#4)(1990-12#5)(1990-2#7)(1990-5#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#5)(1992-1#2)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#6)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#14)(1993-2#2)(1993-3#5)(1993-6#4)(1993-8#6)(1993-9#2)(1994-11#4)(1994-12#7)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#7)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#6)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#6)(1997-7#4)(1997-8#4)(1997-9#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-6#4)(2007-7#7)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#266)(2008-11#29)(2008-12#22)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#26)(2008-6#9)(2008-7#9)(2008-8#46)(2008-9#46)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#10)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#7)(2011-2#20)(2011-3#7)(2012-1#7)(2012-12#7)(2012-2#14)(2012-3#8)(2013-1#13)(2013-7#5)(2013-8#12)
indicated the existence of##3##4##(1992-12#1)(1997-7#1)(2008-10#1)
indicated the formation of##2##4##(1990-5#1)(2008-6#1)
indicated the high##2##3##(2008-10#1)(2011-1#1)
indicated the occurrence of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
indicated the oxidation of##2##4##(2008-10#2)
indicated the possibility##2##3##(2008-12#1)(2008-3#1)
indicated the possible action of##2##5##(1992-3#1)(2013-1#1)
indicated the possible##3##3##(1992-3#1)(1995-5#1)(2013-1#1)
indicated the presence of a##3##5##(1990-2#1)(1992-8#1)(1997-2#1)
indicated the presence of several##2##5##(2008-10#1)(2008-12#1)
indicated the presence of two classes of##2##7##(1994-3#1)(1994-8#1)
indicated the presence of two##5##5##(1993-8#1)(1994-3#1)(1994-8#1)(2008-10#1)(2010-2#1)
indicated the presence of##22##4##(1990-11#1)(1990-2#1)(1992-12#1)(1992-8#2)(1993-8#1)(1994-3#1)(1994-8#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
indicated the##76##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#27)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
indicated these##2##2##(2007-12#1)(2008-11#1)
indicated they would##2##3##(2007-2#1)(2012-12#1)
indicated they##4##2##(1995-1#1)(2007-11#1)(2007-2#1)(2012-12#1)
indicated three##2##2##(2008-12#1)(2008-2#1)
indicated to prevent##2##3##(1991-11#1)(2013-1#1)
indicated to##6##2##(1991-11#1)(2007-11#1)(2008-10#2)(2013-1#2)
indicated two##5##2##(1990-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
indicated##1487##1##(1990-10#1)(1990-11#9)(1990-12#6)(1990-2#11)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#1)(1991-11#4)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#4)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#8)(1992-12#8)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#10)(1992-8#8)(1992-9#6)(1993-1#6)(1993-11#4)(1993-12#19)(1993-2#2)(1993-3#13)(1993-6#4)(1993-8#8)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#10)(1994-2#5)(1994-3#8)(1994-5#6)(1994-6#5)(1994-8#10)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#7)(1995-2#10)(1995-3#7)(1995-5#3)(1995-6#10)(1995-8#9)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#13)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#7)(1996-6#2)(1996-9#5)(1997-1#3)(1997-2#8)(1997-3#9)(1997-4#9)(1997-6#2)(1997-7#8)(1997-8#6)(1997-9#1)(2006-8#1)(2007-10#2)(2007-11#13)(2007-12#18)(2007-2#3)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#402)(2008-11#48)(2008-12#39)(2008-2#13)(2008-3#19)(2008-4#13)(2008-5#41)(2008-6#15)(2008-7#25)(2008-8#58)(2008-9#63)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#14)(2009-8#6)(2009-9#2)(2010-10#4)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#1)(2010-8#14)(2010-9#1)(2011-1#16)(2011-2#47)(2011-3#7)(2012-1#11)(2012-12#13)(2012-2#22)(2012-3#13)(2012-7#1)(2012-9#2)(2013-1#31)(2013-7#8)(2013-8#21)
indicates a high risk##2##4##(2007-1#1)(2011-2#1)
indicates a high##3##3##(2007-1#1)(2011-2#1)(2012-3#1)
indicates a possible##2##3##(1992-6#1)(1996-12#1)
indicates a potential##2##3##(1997-8#1)(2013-8#1)
indicates a significant##2##3##(2008-10#1)(2013-8#1)
indicates a##31##2##(1992-11#1)(1992-6#3)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-8#2)
indicates an important##2##3##(2008-7#1)(2013-1#1)
indicates an increase in the probability to##2##7##(2011-2#2)
indicates an##8##2##(1990-12#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
indicates either##2##2##(2008-8#1)(2011-2#1)
indicates its##2##2##(2010-8#1)(2011-2#1)
indicates no##4##2##(1995-8#1)(2008-10#2)(2013-1#1)
indicates significant##3##2##(1994-5#1)(2008-10#1)(2011-2#1)
indicates that a##10##3##(1994-2#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2010-11#1)
indicates that although##2##3##(1993-12#1)(2008-11#1)
indicates that an##3##3##(1992-6#1)(1992-9#1)(2011-2#1)
indicates that both methods##2##4##(2008-10#2)
indicates that both##8##3##(1990-7#1)(1991-11#1)(1993-6#1)(1994-9#1)(1995-5#2)(2008-10#2)
indicates that during##2##3##(1991-5#1)(1996-2#1)
indicates that either##2##3##(1995-6#1)(2008-10#1)
indicates that higher##2##3##(1992-5#1)(2008-9#1)
indicates that in##3##3##(1994-11#1)(2012-12#2)
indicates that increased##2##3##(1992-6#1)(2010-2#1)
indicates that it is##3##4##(1993-12#1)(2007-12#1)(2008-10#1)
indicates that it##7##3##(1993-12#2)(1994-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)
indicates that many##3##3##(2008-10#1)(2008-8#2)
indicates that one##2##3##(1990-8#1)(2008-2#1)
indicates that other##2##3##(2008-1#1)(2008-10#1)
indicates that our##2##3##(1990-2#1)(2008-11#1)
indicates that some##2##3##(1996-4#1)(2008-10#1)
indicates that the RNA is##2##5##(1997-7#2)
indicates that the cytoplasm##2##4##(1991-11#1)(2008-5#1)
indicates that the effect of##2##5##(1994-8#1)(2008-10#1)
indicates that the method##2##4##(2008-10#2)
indicates that the reaction##2##4##(1996-5#1)(2008-10#1)
indicates that the three##2##4##(1994-8#1)(1996-12#1)
indicates that the##130##3##(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-2#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#3)(2007-11#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#9)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#5)(2011-3#1)(2013-1#4)(2013-8#2)
indicates that there is a##4##5##(1993-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
indicates that there is##6##4##(1993-12#1)(2008-4#1)(2008-5#2)(2009-7#1)(2013-1#1)
indicates that there##8##3##(1991-8#1)(1993-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-7#1)(2013-1#1)
indicates that these two##2##4##(1994-11#1)(2008-7#1)
indicates that these##8##3##(1994-11#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-9#1)
indicates that they are##2##4##(1996-6#1)(2008-7#1)
indicates that they##4##3##(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
indicates that this##7##3##(1990-12#1)(1993-6#1)(1994-12#1)(1995-6#1)(1997-3#1)(2007-11#1)(2008-11#1)
indicates that while##2##3##(1995-1#1)(2012-2#1)
indicates that##447##2##(1990-12#1)(1990-2#5)(1990-5#3)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#7)(1993-2#4)(1993-6#5)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#9)(1994-2#5)(1994-5#3)(1994-6#5)(1994-8#5)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#5)(1995-6#10)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#5)(1996-4#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#2)(1997-3#5)(1997-5#2)(1997-6#1)(1997-7#3)(2006-6#1)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#63)(2008-11#15)(2008-12#5)(2008-2#3)(2008-3#24)(2008-4#5)(2008-5#19)(2008-6#4)(2008-7#16)(2008-8#11)(2008-9#17)(2009-10#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2013-1#11)(2013-7#1)(2013-8#6)
indicates the importance of##3##4##(1992-8#1)(2008-11#1)(2008-9#1)
indicates the potential cross-linking site##2##5##(2008-11#2)
indicates the potential##3##3##(2008-11#2)(2009-4#1)
indicates the presence of a##2##5##(1994-2#1)(1995-2#1)
indicates the presence of##5##4##(1991-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-10#1)
indicates the presence##6##3##(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(2008-10#1)
indicates the significance of##2##4##(2009-7#1)(2011-1#1)
indicates the##49##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#3)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
indicates their##2##2##(2007-11#1)(2009-8#1)
indicates##610##1##(1990-12#2)(1990-2#6)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#9)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#4)(1993-6#6)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#6)(1994-3#3)(1994-5#4)(1994-6#6)(1994-8#5)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#5)(1995-6#13)(1995-8#4)(1996-1#1)(1996-12#5)(1996-2#5)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#9)(2007-12#8)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#87)(2008-11#22)(2008-12#8)(2008-2#8)(2008-3#28)(2008-4#6)(2008-5#25)(2008-6#6)(2008-7#24)(2008-8#14)(2008-9#18)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#8)(2011-1#4)(2011-2#25)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#18)(2013-7#2)(2013-8#10)
indicating a better accessibility of the chelating sites##2##8##(2008-10#2)
indicating a better accessibility of the##3##6##(2008-10#3)
indicating a better##4##3##(2008-10#3)(2008-6#1)
indicating a central##2##3##(1991-2#1)(2008-10#1)
indicating a common##2##3##(1990-11#1)(2009-5#1)
indicating a high##2##3##(1994-5#1)(2008-6#1)
indicating a large##2##3##(2008-8#1)(2011-2#1)
indicating a loss of##4##4##(1990-11#1)(1993-9#1)(2008-5#1)(2013-1#1)
indicating a more##2##3##(1997-7#1)(2012-5#1)
indicating a possible##3##3##(1997-3#1)(2007-6#1)(2008-6#1)
indicating a role of##2##4##(1997-1#1)(2009-8#1)
indicating a role##3##3##(1997-1#1)(2008-10#1)(2009-8#1)
indicating a shift##2##3##(1993-11#1)(1993-2#1)
indicating a significant##3##3##(2008-3#1)(2010-12#1)(2012-2#1)
indicating a very##2##3##(2008-10#2)
indicating a weakening##2##3##(2008-10#2)
indicating a##102##2##(1990-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#4)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#2)
indicating an increase in##2##4##(2008-10#2)
indicating an increased##3##3##(1996-5#1)(2008-5#1)(2008-7#1)
indicating an##18##2##(1991-10#1)(1996-5#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#2)
indicating both##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
indicating excellent##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
indicating frequent##2##2##(2008-10#2)
indicating future##2##2##(2008-10#1)(2008-11#1)
indicating good##2##2##(2008-10#1)(2008-11#1)
indicating heterogeneity of##2##3##(1992-3#1)(2008-10#1)
indicating high##4##2##(1993-8#1)(2007-12#1)(2008-8#1)(2011-1#1)
indicating increased##2##2##(2008-10#1)(2008-7#1)
indicating increasing##2##2##(1997-2#1)(2008-10#1)
indicating involvement of##2##3##(1992-9#1)(2009-4#1)
indicating its##8##2##(1990-5#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
indicating limited##3##2##(2008-10#3)
indicating low##3##2##(2008-10#2)(2011-1#1)
indicating minimal##2##2##(1990-12#1)(2011-2#1)
indicating moderate##2##2##(2008-10#1)(2008-5#1)
indicating no##6##2##(1990-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
indicating partial##2##2##(1994-12#1)(1995-6#1)
indicating potential##2##2##(2007-7#1)(2008-3#1)
indicating significant##4##2##(1996-9#1)(2008-11#1)(2008-2#1)(2008-3#1)
indicating some##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
indicating strong##2##2##(2008-5#1)(2008-8#1)
indicating that a##7##3##(1995-12#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-7#1)
indicating that additional##2##3##(1995-12#1)(2008-10#1)
indicating that both##5##3##(1992-3#1)(1993-3#1)(1995-5#1)(2008-10#1)(2012-1#1)
indicating that in##2##3##(1996-5#1)(2008-10#1)
indicating that it is a##5##5##(1993-3#1)(1997-4#1)(2008-10#2)(2013-1#1)
indicating that it is##7##4##(1993-3#1)(1997-4#1)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#1)
indicating that it may be a##2##6##(1990-2#1)(2008-10#1)
indicating that it was##2##4##(1990-5#1)(1995-12#1)
indicating that it##15##3##(1990-2#1)(1990-5#1)(1990-7#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2009-6#1)(2011-2#1)(2013-1#2)
indicating that its##2##3##(2008-10#2)
indicating that longicomin##2##3##(2008-8#2)
indicating that neither##2##3##(1995-5#1)(2008-4#1)
indicating that only##3##3##(1992-6#1)(1993-9#1)(1997-2#1)
indicating that other factors##2##4##(1997-7#1)(2013-1#1)
indicating that other##3##3##(1997-7#1)(2008-10#1)(2013-1#1)
indicating that resistance##2##3##(2008-10#2)
indicating that some##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
indicating that suppression was due to##2##6##(2008-10#2)
indicating that the active##2##4##(1990-5#1)(1991-11#1)
indicating that the effect##3##4##(1992-8#1)(2008-10#1)(2008-5#1)
indicating that the electrode renewal gives a good reproducible##2##9##(2008-10#2)
indicating that the expression of##3##5##(1996-12#1)(2008-9#2)
indicating that the latter is##2##5##(1995-8#1)(2008-10#1)
indicating that the normal##2##4##(2008-12#1)(2008-9#1)
indicating that the population##2##4##(2008-10#2)
indicating that the resistance##2##4##(2008-10#2)
indicating that the sites are of the##2##7##(1994-5#2)
indicating that the toxin is##2##5##(2008-10#2)
indicating that the two##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
indicating that the##147##3##(1990-11#2)(1990-2#1)(1990-5#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-12#2)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(2007-6#2)(2008-1#1)(2008-10#42)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
indicating that there is##3##4##(1990-7#1)(1994-12#1)(1996-2#1)
indicating that there was##2##4##(2008-10#1)(2008-11#1)
indicating that there##7##3##(1990-7#1)(1992-8#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
indicating that these two##2##4##(1993-12#1)(2008-11#1)
indicating that these##18##3##(1990-12#1)(1990-2#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#4)(2008-7#1)(2009-11#1)(2010-5#1)
indicating that they are##3##4##(1991-2#1)(1993-11#1)(2008-8#1)
indicating that they were##6##4##(1991-2#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
indicating that they##13##3##(1991-2#2)(1991-5#1)(1993-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2012-2#1)
indicating that this molecule##2##4##(1993-6#1)(2008-10#1)
indicating that this##16##3##(1990-11#1)(1990-8#1)(1993-6#2)(1993-8#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2009-4#1)(2013-1#1)
indicating that##453##2##(1990-11#4)(1990-12#2)(1990-2#4)(1990-5#5)(1990-7#2)(1990-8#3)(1991-11#2)(1991-12#3)(1991-2#5)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#5)(1993-6#8)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#5)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#2)(1995-5#8)(1995-6#5)(1995-8#3)(1995-9#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#5)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#7)(1997-3#4)(1997-4#3)(1997-6#3)(1997-7#2)(2007-1#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#2)(2008-1#3)(2008-10#121)(2008-11#22)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#14)(2008-6#5)(2008-7#11)(2008-8#16)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#2)
indicating the absence of##2##4##(2008-10#1)(2008-8#1)
indicating the degree of##2##4##(2008-2#1)(2008-3#1)
indicating the existence of a##2##5##(2008-10#1)(2008-8#1)
indicating the existence of##4##4##(1990-11#1)(1991-5#1)(2008-10#1)(2008-8#1)
indicating the formation of##2##4##(1994-2#1)(1995-5#1)
indicating the functional##2##3##(1995-2#1)(2011-3#1)
indicating the importance of##7##4##(1992-9#1)(1994-8#1)(1995-11#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
indicating the involvement of the ER##3##6##(2008-11#3)
indicating the involvement of the##4##5##(2008-10#1)(2008-11#3)
indicating the involvement of##10##4##(1990-2#1)(1991-3#1)(1991-5#1)(1993-11#1)(1994-5#1)(2008-10#1)(2008-11#3)(2011-2#1)
indicating the possibility of##5##4##(2007-10#1)(2008-10#3)(2012-2#1)
indicating the potential for##2##4##(2007-5#1)(2008-8#1)
indicating the potential##5##3##(1994-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2009-7#1)
indicating the presence of a single##2##6##(2008-10#2)
indicating the presence of a##3##5##(1990-11#1)(2008-10#2)
indicating the presence of##10##4##(1990-11#2)(1990-12#1)(1994-8#1)(1995-6#1)(2008-10#3)(2008-3#1)(2009-8#1)
indicating the usefulness of##2##4##(2008-10#1)(2010-5#1)
indicating the##102##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
indicating their##6##2##(1992-12#1)(1997-3#1)(2007-6#1)(2008-10#2)(2008-11#1)
indicating there##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
indicating##865##1##(1990-11#11)(1990-12#4)(1990-2#7)(1990-5#7)(1990-7#3)(1990-8#4)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#4)(1992-12#6)(1992-3#8)(1992-4#2)(1992-6#3)(1992-8#5)(1992-9#5)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#6)(1993-6#8)(1993-8#9)(1993-9#2)(1994-11#6)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#8)(1994-6#6)(1994-7#3)(1994-8#8)(1994-9#2)(1995-11#5)(1995-12#8)(1995-2#8)(1995-3#3)(1995-5#9)(1995-6#8)(1995-8#5)(1995-9#2)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#4)(1996-5#10)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-5#3)(2007-6#5)(2007-7#2)(2008-1#4)(2008-10#234)(2008-11#44)(2008-12#10)(2008-2#7)(2008-3#20)(2008-4#11)(2008-5#25)(2008-6#12)(2008-7#20)(2008-8#28)(2008-9#13)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#5)(2010-6#2)(2010-8#7)(2011-1#6)(2011-2#29)(2011-3#2)(2012-1#2)(2012-2#12)(2012-3#6)(2012-5#3)(2013-1#16)(2013-7#2)(2013-8#5)
indication and##4##2##(1997-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
indication by##2##2##(2008-3#1)(2010-12#1)
indication for RT##4##3##(2010-3#4)
indication for abatacept##2##3##(2012-3#2)
indication for surgery##2##3##(2007-11#1)(2011-1#1)
indication for surgical treatment##3##4##(1990-8#1)(1994-9#1)(2007-11#1)
indication for##48##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#4)(2007-7#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-3#4)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#8)(2013-8#1)
indication in both##2##3##(2008-10#1)(2010-3#1)
indication in##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
indication is the##2##3##(1992-6#1)(1996-3#1)
indication is##6##2##(1992-6#1)(1996-3#1)(1997-5#1)(2011-2#2)(2012-12#1)
indication of a##3##3##(1990-5#1)(1991-6#1)(1995-2#1)
indication of the##15##3##(1990-5#1)(1990-9#1)(1992-11#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
indication of##55##2##(1990-5#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-3#1)(1994-7#1)(1995-2#2)(2007-11#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
indication that the##5##3##(2008-10#5)
indication that this##2##3##(1994-2#1)(2008-12#1)
indication that##15##2##(1992-6#1)(1994-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)
indication to##3##2##(1992-8#1)(1993-9#1)(2008-1#1)
indication was##3##2##(1990-6#1)(1997-8#1)(2011-2#1)
indication##168##1##(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-2#2)(1995-9#1)(1996-11#2)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#3)(1997-8#2)(2007-11#7)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#18)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#6)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-3#6)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#3)
indications and applications##2##3##(2008-10#1)(2012-2#1)
indications and contraindications##4##3##(2007-11#1)(2007-8#1)(2011-2#2)
indications and results of##3##4##(1990-9#1)(2008-10#2)
indications and results##4##3##(1990-9#1)(1993-9#1)(2008-10#2)
indications and the##2##3##(2007-7#1)(2008-10#1)
indications and##27##2##(1990-9#2)(1992-9#1)(1993-11#1)(1993-9#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
indications are that##2##3##(1992-2#1)(2011-2#1)
indications are##6##2##(1992-2#1)(1992-5#1)(1993-8#1)(1997-2#1)(2011-2#1)(2011-3#1)
indications as##2##2##(1992-9#1)(2007-7#1)
indications for OPCAB##2##3##(2007-8#2)
indications for and##2##3##(1994-6#1)(2007-8#1)
indications for biopsy included##2##4##(2008-1#2)
indications for delivery and##2##4##(1996-11#2)
indications for each##2##3##(1991-5#1)(2008-7#1)
indications for imaging##2##3##(1990-11#2)
indications for prenatal##2##3##(2008-4#1)(2012-3#1)
indications for surgery are##2##4##(1991-5#1)(2008-7#1)
indications for surgery##6##3##(1990-3#1)(1990-9#1)(1991-5#1)(1992-9#1)(1997-2#1)(2008-7#1)
indications for surgical##2##3##(2007-11#1)(2012-3#1)
indications for the use of cortical allograft##2##7##(2011-2#2)
indications for the use of##5##5##(1990-9#2)(1991-2#1)(2011-2#2)
indications for the##11##3##(1990-11#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-6#1)(1994-3#1)(2010-6#1)(2011-2#3)
indications for this##4##3##(2007-8#1)(2008-7#1)(2008-8#1)(2013-8#1)
indications for treatment##2##3##(1992-6#1)(2011-2#1)
indications for use of##3##4##(2007-12#1)(2008-11#1)(2013-8#1)
indications for use##4##3##(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
indications for which##2##3##(1992-5#1)(1997-6#1)
indications for##101##2##(1990-11#3)(1990-3#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-2#1)(1991-3#2)(1991-5#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1994-11#1)(1994-3#1)(1994-6#2)(1996-11#2)(1996-9#1)(1997-2#2)(1997-6#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#10)(2008-8#2)(2009-10#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#3)(2011-10#2)(2011-2#10)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#4)
indications in the##3##3##(1991-9#1)(2008-9#1)(2010-9#1)
indications in##10##2##(1990-3#1)(1990-8#1)(1991-9#1)(1993-2#1)(1995-5#2)(2007-11#1)(2008-10#1)(2008-9#1)(2010-9#1)
indications of the##7##3##(1991-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
indications of##23##2##(1991-12#1)(1991-2#1)(1991-6#2)(1996-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#1)
indications pertaining to##2##3##(2010-12#2)
indications that it##2##3##(2008-10#1)(2008-8#1)
indications that this##2##3##(1990-12#1)(2006-6#1)
indications that##11##2##(1990-12#1)(1991-9#1)(1993-3#1)(1997-5#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
indications to##6##2##(1991-3#1)(1991-5#1)(1993-3#1)(2007-8#1)(2008-4#1)(2012-3#1)
indications were found for##2##4##(1997-1#1)(2008-10#1)
indications were##6##2##(1996-9#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
indications##267##1##(1990-11#3)(1990-12#1)(1990-3#6)(1990-6#1)(1990-8#2)(1990-9#9)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#3)(1991-6#2)(1991-9#2)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-5#2)(1996-11#3)(1996-3#4)(1996-9#3)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-12#1)(2006-6#1)(2006-7#2)(2007-11#13)(2007-12#2)(2007-7#2)(2007-8#11)(2008-1#8)(2008-10#16)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#14)(2008-8#7)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#1)(2009-8#5)(2010-12#8)(2010-3#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-10#2)(2011-2#24)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#4)(2013-8#5)
indicative for##2##2##(2009-2#1)(2010-7#1)
indicative literature values##2##3##(2008-10#2)
indicative of a more##2##4##(1993-11#1)(2009-4#1)
indicative of a##13##3##(1991-3#1)(1993-11#1)(1994-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2013-1#1)
indicative of an##4##3##(1994-3#1)(1997-3#1)(2008-4#1)(2009-9#1)
indicative of greater##2##3##(2008-11#1)(2009-11#1)
indicative of higher##2##3##(2008-12#1)(2011-2#1)
indicative of severe##2##3##(2010-10#1)(2012-12#1)
indicative of the degree of##2##5##(2008-5#1)(2008-8#1)
indicative of the##11##3##(1990-5#1)(1991-2#1)(1996-1#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
indicative of their##3##3##(1990-8#1)(2010-3#1)(2013-1#1)
indicative of##83##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-3#3)(1994-5#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#2)(1997-3#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#1)
indicative values##2##2##(2008-10#2)
indicative##94##1##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-3#3)(1994-5#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#2)(1997-3#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#7)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#1)
indicator and##4##2##(2008-10#3)(2008-5#1)
indicator dye##2##2##(2008-10#2)
indicator dyes##2##2##(2008-10#2)
indicator electrode for the##4##4##(2008-10#4)
indicator electrode for##6##3##(2008-10#6)
indicator electrode in potentiometric titration of##10##6##(2008-10#10)
indicator electrode in potentiometric titrations##2##5##(2008-10#2)
indicator electrode in potentiometric##12##4##(2008-10#12)
indicator electrode in##18##3##(2008-10#18)
indicator electrode##34##2##(2008-10#34)
indicator electrodes##2##2##(2008-10#2)
indicator for the##8##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)
indicator for##24##2##(1992-3#1)(1994-5#1)(1995-2#2)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#2)
indicator in the##2##3##(1991-12#1)(2008-10#1)
indicator in##7##2##(1991-12#1)(1994-12#1)(1995-11#1)(1997-4#1)(2008-10#2)(2012-2#1)
indicator is##2##2##(2008-10#1)(2013-1#1)
indicator latex##4##2##(1990-12#4)
indicator of DNA damage##2##4##(2008-9#1)(2009-5#1)
indicator of a##4##3##(2008-10#2)(2008-7#1)(2013-7#1)
indicator of lifestyle##2##3##(2008-1#2)
indicator of quality##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
indicator of the quality of##2##5##(2008-12#1)(2010-12#1)
indicator of the##18##3##(1990-9#1)(1993-12#1)(1995-12#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-12#1)(2013-7#1)
indicator of##91##2##(1990-3#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-1#3)(2008-10#21)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#8)(2008-7#7)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#3)
indicator plants##3##2##(1997-3#1)(2008-10#2)
indicator plates##2##2##(1990-5#1)(1991-9#1)
indicator project##2##2##(1992-2#1)(2012-12#1)
indicator reaction##9##2##(2008-10#9)
indicator species##2##2##(2011-2#1)(2013-7#1)
indicator strain##4##2##(2008-10#4)
indicator to the##2##3##(2010-11#1)(2013-1#1)
indicator to##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
indicator trait##5##2##(2008-9#5)
indicator##313##1##(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2006-6#1)(2007-10#2)(2007-12#1)(2008-1#6)(2008-10#139)(2008-11#7)(2008-12#4)(2008-3#6)(2008-4#6)(2008-5#9)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#11)(2013-7#4)(2013-8#1)
indicator&quot##2##1##(2008-9#2)
indicators and health##2##3##(2008-11#1)(2012-12#1)
indicators and##14##2##(1990-8#1)(1997-1#1)(1997-3#1)(2008-11#4)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-4#1)
indicators are used to##2##4##(1997-1#1)(2008-9#1)
indicators are##11##2##(1997-1#1)(2007-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#4)
indicators can be##2##3##(2008-11#1)(2012-12#1)
indicators for the##7##3##(1993-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-7#1)
indicators for##31##2##(1991-8#2)(1993-2#2)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-1#3)(1997-2#2)(1997-3#1)(2007-12#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#4)
indicators have##3##2##(2008-11#2)(2010-4#1)
indicators in the##3##3##(1994-2#1)(2009-10#1)(2010-12#1)
indicators in##15##2##(1991-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(2007-12#1)(2007-4#2)(2008-4#2)(2008-7#1)(2009-10#1)(2010-12#2)(2013-1#1)
indicators included##2##2##(1996-2#1)(2010-10#1)
indicators of a##2##3##(2008-12#1)(2011-2#1)
indicators of clinical##2##3##(1992-2#1)(2008-7#1)
indicators of health##2##3##(1994-3#1)(2008-12#1)
indicators of lung##2##3##(1992-9#1)(1996-7#1)
indicators of organic##2##3##(2008-5#2)
indicators of potential##2##3##(2008-12#1)(2008-8#1)
indicators of quality##3##3##(1996-2#2)(2013-1#1)
indicators of the##8##3##(1992-2#1)(1992-9#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
indicators of##81##2##(1990-3#1)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-9#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#5)(2008-5#5)(2008-7#2)(2008-8#2)(2009-8#2)(2010-11#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
indicators on##3##2##(1996-2#1)(2012-12#2)
indicators should be##2##3##(2007-4#1)(2008-11#1)
indicators show##2##2##(1994-9#1)(2010-6#1)
indicators such as##3##3##(2008-10#1)(2008-9#1)(2010-6#1)
indicators suggest that##3##3##(1993-11#1)(1994-3#1)(2010-10#1)
indicators suggest##4##2##(1993-11#1)(1994-3#2)(2010-10#1)
indicators that can be##3##4##(1992-12#1)(2008-9#1)(2012-12#1)
indicators that can##4##3##(1992-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
indicators that##9##2##(1992-12#1)(1992-9#1)(1993-11#1)(2008-9#1)(2009-2#1)(2012-12#3)(2013-1#1)
indicators to##9##2##(1994-2#2)(1995-3#1)(1996-12#1)(1997-1#1)(2008-11#3)(2008-5#1)
indicators was##2##2##(2011-2#1)(2012-12#1)
indicators were##7##2##(1991-5#1)(1996-2#1)(1996-9#1)(2008-10#2)(2012-3#1)(2012-4#1)
indicators which##2##2##(1992-11#1)(1992-12#1)
indicators will be##2##3##(1997-1#1)(2008-1#1)
indicators##320##1##(1990-3#1)(1990-8#1)(1991-1#3)(1991-12#3)(1991-2#2)(1991-5#6)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#9)(1994-3#5)(1994-5#3)(1994-7#1)(1994-9#1)(1995-12#6)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#4)(1996-2#11)(1996-3#3)(1996-7#1)(1996-9#2)(1997-1#10)(1997-2#3)(1997-3#8)(1997-7#1)(2007-12#4)(2007-2#1)(2007-4#6)(2007-7#2)(2008-1#4)(2008-10#21)(2008-11#23)(2008-12#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#2)(2009-2#1)(2009-6#2)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#9)(2012-1#2)(2012-12#24)(2012-2#3)(2012-3#5)(2012-4#3)(2013-1#22)(2013-7#1)(2013-8#2)
indicators'##2##1##(1991-5#2)
indicators]##2##1##(1996-9#1)(2013-1#1)
indicatrices of##2##2##(2008-3#2)
indicatrices##4##1##(2008-3#4)
indicatrix##2##1##(2008-3#2)
indices and the##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
indices and##29##2##(1993-3#1)(1995-3#1)(2007-11#4)(2007-7#1)(2008-10#2)(2008-2#10)(2008-3#4)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
indices are defined##2##3##(2007-11#1)(2009-8#1)
indices are##12##2##(2007-11#4)(2008-2#2)(2008-3#2)(2008-7#2)(2009-8#1)(2011-2#1)
indices at which##2##3##(2008-1#1)(2008-3#1)
indices at##5##2##(2008-1#1)(2008-12#1)(2008-3#2)(2012-12#1)
indices between##2##2##(1995-6#1)(2008-2#1)
indices by##4##2##(2007-11#1)(2008-10#2)(2008-8#1)
indices calculated from##4##3##(1992-9#1)(2008-10#3)
indices determined##2##2##(2008-11#1)(2008-6#1)
indices for the##6##3##(2007-11#2)(2008-10#4)
indices for##20##2##(1995-6#1)(2007-11#3)(2008-10#8)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-8#1)(2012-1#1)(2013-8#1)
indices from##4##2##(2007-11#1)(2008-3#2)(2012-2#1)
indices in the##5##3##(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
indices in##15##2##(1991-12#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
indices is presented##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
indices is##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
indices may##3##2##(1996-3#1)(2009-8#2)
indices of AUD severity##2##4##(2013-8#2)
indices of both##2##3##(2008-3#2)
indices of kidney in##2##4##(2008-12#2)
indices of lipid peroxidation##2##4##(1992-3#2)
indices of refraction##10##3##(2007-11#1)(2008-2#4)(2008-3#5)
indices of reproductive skew##2##4##(2008-8#2)
indices of the &quot##2##4##(2007-11#2)
indices of the humoral immunity##2##5##(2011-1#2)
indices of the##21##3##(1990-3#1)(1992-11#1)(1992-3#1)(1995-3#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2011-1#3)(2012-2#1)
indices of##102##2##(1990-3#1)(1992-11#2)(1992-3#3)(1992-9#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-7#1)(1997-5#1)(1997-6#1)(2007-11#6)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#20)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#3)(2010-7#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
indices on##4##2##(2008-2#1)(2008-3#2)(2009-11#1)
indices such as##2##3##(2008-10#1)(2009-8#1)
indices that##4##2##(2008-11#1)(2008-2#2)(2008-8#1)
indices to##5##2##(1995-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
indices were 0##2##3##(1996-2#1)(2008-10#1)
indices were measured##2##3##(2007-11#1)(2011-2#1)
indices were significantly higher in##2##5##(2008-6#1)(2011-2#1)
indices were##18##2##(1991-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2012-4#1)
indices##394##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-3#3)(1992-9#4)(1993-12#3)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#3)(1995-3#4)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-5#2)(1997-6#2)(2007-10#2)(2007-11#42)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#55)(2008-11#9)(2008-12#13)(2008-2#37)(2008-3#52)(2008-4#2)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#15)(2008-9#4)(2009-10#2)(2009-11#4)(2009-2#2)(2009-3#4)(2009-5#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#14)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#9)(2012-4#1)(2013-1#7)(2013-7#3)(2013-8#5)
indices)##3##1##(2008-10#1)(2008-2#1)(2008-6#1)
indices]##2##1##(1993-2#1)(2007-11#1)
indictment##2##1##(1991-6#1)(1996-5#1)
indicum##3##1##(2008-10#3)
indicus##2##1##(1991-5#1)(2012-3#1)
indifference##3##1##(1993-6#1)(2008-3#2)
indifferent to dose##2##3##(2012-3#2)
indifferent to the##2##3##(1994-3#1)(2008-10#1)
indifferent to##6##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#2)
indifferent##11##1##(1991-3#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-3#2)
indigenous and introduced##2##3##(2008-10#1)(2008-8#1)
indigenous bacterial epiphytes and##2##4##(2008-10#2)
indigenous bacterial epiphytes##3##3##(2008-10#3)
indigenous bacterial##4##2##(2008-10#4)
indigenous descent##2##2##(2013-1#2)
indigenous peoples of##2##3##(2008-1#1)(2010-4#1)
indigenous peoples##5##2##(2008-1#2)(2008-7#1)(2010-4#1)(2013-1#1)
indigenous pollens##2##2##(2013-1#2)
indigenous populations##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
indigenous practitioners##2##2##(1994-3#2)
indigenous surnames##3##2##(2013-1#3)
indigenous system of medicine##2##4##(2010-3#1)(2010-5#1)
indigenous to##3##2##(2008-10#1)(2011-2#2)
indigenous##83##1##(1991-12#1)(1994-3#3)(1997-7#1)(2007-7#1)(2008-1#5)(2008-10#26)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#5)(2013-1#18)(2013-8#2)
indigenously developed paclitaxel-eluting##2##3##(2008-11#2)
indigenously##3##1##(2007-7#1)(2008-11#2)
indigent care##2##2##(1992-3#1)(2008-11#1)
indigent patients##4##2##(1996-3#1)(2006-10#1)(2008-11#1)(2008-12#1)
indigent population##2##2##(1992-2#1)(1996-3#1)
indigent##14##1##(1992-2#2)(1992-3#1)(1995-2#1)(1996-3#4)(2006-10#1)(2008-11#3)(2008-12#1)(2010-2#1)
indigestion##2##1##(2008-10#1)(2008-7#1)
indigo blue##2##2##(1996-6#1)(2008-10#1)
indigo carmine##7##2##(1993-8#1)(2008-10#5)(2013-8#1)
indigo##10##1##(1993-8#1)(1996-6#1)(2008-10#7)(2013-8#1)
indinavir##12##1##(2007-1#1)(2008-10#1)(2008-5#8)(2008-8#2)
indirect ELISA format##2##3##(2008-10#2)
indirect ELISA##7##2##(1994-8#1)(2008-10#3)(2008-11#1)(2010-4#1)(2011-1#1)
indirect and direct##2##3##(2011-2#2)
indirect and##4##2##(1996-9#1)(2010-6#1)(2011-2#2)
indirect antiglobulin test##5##3##(1992-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)
indirect approach##3##2##(2008-4#2)(2008-7#1)
indirect benefit##3##2##(1994-2#1)(2008-8#2)
indirect competitive immunoassay##3##3##(2008-10#3)
indirect competitive##6##2##(2008-10#6)
indirect costs##4##2##(1996-1#2)(2008-11#1)(2009-6#1)
indirect detection##4##2##(2008-10#4)
indirect determination of the##2##4##(2008-10#2)
indirect determination of##9##3##(2008-10#9)
indirect determination##10##2##(2008-10#9)(2008-2#1)
indirect diagnosis of##2##3##(1994-2#1)(2011-2#1)
indirect disease markers##3##3##(1996-12#3)
indirect dopamine##2##2##(1994-3#1)(2009-7#1)
indirect double-antibody sandwich##2##3##(2008-10#2)
indirect effect##6##2##(1990-2#1)(1991-12#1)(1994-8#1)(2008-8#2)(2011-2#1)
indirect effects of predation##2##4##(2008-8#1)(2008-9#1)
indirect effects of the##2##4##(2008-11#1)(2010-8#1)
indirect effects of##8##3##(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)
indirect effects on##2##3##(2008-7#1)(2008-8#1)
indirect effects##21##2##(1991-12#1)(1992-11#1)(1997-1#1)(2008-11#1)(2008-7#3)(2008-8#5)(2008-9#4)(2010-8#2)(2011-1#1)(2012-2#2)
indirect enzyme immunoassay##2##3##(1996-12#2)
indirect enzyme-linked immunosorbent assay (ELISA)##2##5##(2008-10#1)(2010-4#1)
indirect enzyme-linked immunosorbent assay##5##4##(2008-10#4)(2010-4#1)
indirect enzyme-linked immunosorbent##6##3##(2008-10#5)(2010-4#1)
indirect evidence##8##2##(1990-3#1)(1991-9#1)(1992-12#1)(2007-11#1)(2007-12#1)(2011-1#3)
indirect format##2##2##(2008-10#1)(2008-9#1)
indirect genetic effects##5##3##(2008-8#4)(2012-3#1)
indirect genetic##6##2##(2008-8#4)(2008-9#1)(2012-3#1)
indirect haemagglutination assay##2##3##(1992-5#1)(2007-7#1)
indirect haemagglutination##3##2##(1992-5#1)(2007-7#1)(2008-7#1)
indirect immunoassay##2##2##(2008-10#1)(2008-2#1)
indirect immunofluorescence and##2##3##(1993-12#1)(2008-10#1)
indirect immunofluorescence using a##2##4##(2008-10#1)(2008-9#1)
indirect immunofluorescence##12##2##(1990-12#1)(1991-11#1)(1993-12#1)(1995-3#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-7#1)(2008-9#3)
indirect immunofluorescent assay##2##3##(2008-12#1)(2013-8#1)
indirect immunofluorescent##5##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-8#1)
indirect method##5##2##(1993-11#1)(1993-3#1)(2008-10#1)(2008-11#2)
indirect methods##7##2##(1993-2#1)(1997-4#1)(1997-5#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-3#1)
indirect paths mediated through##2##4##(2011-2#2)
indirect pathway##2##2##(2008-7#1)(2013-8#1)
indirect photoacoustic spectroscopy##2##3##(2008-3#2)
indirect photometric detection##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
indirect photometric##5##2##(1994-9#1)(1997-2#1)(2008-10#3)
indirect potentiometric##2##2##(2008-10#2)
indirect role##2##2##(1994-2#1)(2008-5#1)
indirect spectrophotometric method##5##3##(2008-10#5)
indirect spectrophotometric##6##2##(2008-10#6)
indirect tensammetric##2##2##(2008-10#2)
indirect##300##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-3#1)(1996-1#2)(1996-12#5)(1996-2#2)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#78)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#9)(2008-7#13)(2008-8#21)(2008-9#22)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#7)(2011-2#9)(2012-1#2)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#3)
indirect&quot##2##1##(1994-1#1)(1997-1#1)
indirectly affect##2##2##(1996-1#1)(2012-2#1)
indirectly affects##2##2##(2008-11#1)(2008-9#1)
indirectly and##2##2##(1992-9#1)(2011-1#1)
indirectly by a##2##3##(2008-10#1)(2008-9#1)
indirectly by##15##2##(1991-12#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-6#1)
indirectly determined##2##2##(2008-10#2)
indirectly from##2##2##(2008-3#1)(2008-8#1)
indirectly in##2##2##(1991-9#1)(1997-3#1)
indirectly related to grades through academic engagement##2##7##(2009-7#2)
indirectly related to grades through##3##5##(2009-7#3)
indirectly related to##5##3##(2009-7#4)(2012-3#1)
indirectly standardized##2##2##(1995-2#2)
indirectly through##3##2##(1994-8#1)(2008-11#1)(2012-3#1)
indirectly via##2##2##(1991-12#1)(2008-10#1)
indirectly with##3##2##(2008-4#2)(2008-9#1)
indirectly##109##1##(1991-1#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#3)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#2)(2009-5#2)(2009-7#4)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#3)(2012-6#1)
indirubin-3'-monoxime##6##1##(2008-10#6)
indiscriminate##6##1##(2008-12#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
indiscriminately##2##1##(1991-12#1)(1992-9#1)
indispensable for the##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
indispensable for##14##2##(1993-6#1)(1994-8#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)(2012-2#2)
indispensable to##7##2##(1991-5#1)(1994-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-8#1)
indispensable##43##1##(1990-3#1)(1991-5#3)(1993-6#1)(1994-2#2)(1994-8#1)(1996-2#2)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)
indispensible##3##1##(1992-5#1)(2008-2#1)(2013-3#1)
indistinct##5##1##(1994-3#1)(2008-7#2)(2010-8#1)(2012-2#1)
indistinguishable by##3##2##(1990-11#1)(1992-8#1)(2008-10#1)
indistinguishable from digoxin##2##3##(1990-12#2)
indistinguishable from that of native##2##5##(1992-8#1)(1995-2#1)
indistinguishable from that of##7##4##(1992-3#1)(1992-8#1)(1994-6#2)(1995-2#1)(1995-5#1)(2008-12#1)
indistinguishable from that##10##3##(1990-11#1)(1992-3#1)(1992-8#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#1)(2008-12#1)(2008-8#1)
indistinguishable from the##7##3##(1991-12#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
indistinguishable from those of##2##4##(1992-8#1)(2013-8#1)
indistinguishable from those##3##3##(1992-8#1)(2008-7#1)(2013-8#1)
indistinguishable from wild-type##2##3##(1993-12#1)(2008-10#1)
indistinguishable from##46##2##(1990-11#1)(1990-12#3)(1991-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-8#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
indistinguishable##67##1##(1990-11#2)(1990-12#3)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-8#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#3)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-8#1)
indistinguishably##2##1##(2008-2#1)(2011-2#1)
indium (III) and thallium (III)##2##5##(2008-10#2)
indium (III)##3##2##(2008-10#3)
indium and thallium with##2##4##(2008-10#2)
indium and thallium##4##3##(2008-10#4)
indium and##6##2##(2008-10#6)
indium gallium nitride##2##3##(2007-12#2)
indium in##7##2##(2008-1#1)(2008-10#6)
indium oxide##2##2##(2008-10#2)
indium tin oxide (ITO) coated glass##2##6##(2008-10#2)
indium tin oxide (ITO)##8##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-11#1)(2010-5#1)(2010-6#1)
indium tin oxide##12##3##(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2009-11#1)(2009-12#1)(2010-5#1)(2010-6#1)
indium tin##14##2##(1995-3#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#2)(2009-11#1)(2009-12#1)(2010-5#1)(2010-6#1)
indium##50##1##(1993-11#1)(1995-3#1)(2007-12#3)(2008-1#2)(2008-10#33)(2008-12#2)(2008-2#2)(2008-3#2)(2009-11#1)(2009-12#1)(2010-5#1)(2010-6#1)
individual Tom40 molecules##2##3##(2012-2#2)
individual YACs were##2##3##(1997-2#2)
individual YACs##3##2##(1996-10#1)(1997-2#2)
individual action##2##2##(1997-7#1)(2010-4#1)
individual amino acid##3##3##(1993-8#1)(1997-4#1)(1997-9#1)
individual amino##4##2##(1993-8#1)(1995-5#1)(1997-4#1)(1997-9#1)
individual anatomical variations##2##3##(1991-2#1)(2007-8#1)
individual anatomical##3##2##(1991-2#1)(2007-8#1)(2008-11#1)
individual and collective##2##3##(2008-9#2)
individual and contextual##2##3##(1995-1#1)(2010-10#1)
individual and family##5##3##(2007-7#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
individual and focus group interviews##2##5##(2008-11#1)(2008-12#1)
individual and group##4##3##(2008-8#1)(2009-11#2)(2013-1#1)
individual and social##2##3##(1994-5#1)(2008-10#1)
individual and##35##2##(1991-1#1)(1993-12#1)(1994-5#1)(1995-1#1)(1997-4#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
individual animals##3##2##(1995-5#1)(2008-10#1)(2010-4#1)
individual areas##2##2##(2007-10#1)(2008-7#1)
individual as##3##2##(1996-1#1)(1996-12#2)
individual at##2##2##(1990-3#1)(2008-10#1)
individual attitudes##2##2##(1994-12#1)(2010-10#1)
individual backbone and##2##3##(1992-3#1)(2008-9#1)
individual bands##2##2##(1991-9#1)(2008-10#1)
individual based##3##2##(1997-6#2)(2008-7#1)
individual basis##3##2##(1991-11#1)(1995-2#1)(2008-9#1)
individual calibration##3##2##(2008-10#2)(2008-3#1)
individual capacity##2##2##(1992-5#1)(2008-2#1)
individual case##12##2##(1990-3#1)(1990-6#1)(1991-2#1)(1992-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#2)(2012-1#1)(2012-12#1)
individual cases##4##2##(1993-12#1)(1997-8#1)(2007-8#1)(2012-1#1)
individual cell types##2##3##(2008-7#1)(2012-3#1)
individual cell##9##2##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-9#1)(2012-3#1)
individual cells can##2##3##(1995-5#1)(2009-9#1)
individual cells##21##2##(1994-6#1)(1995-5#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-9#2)(2011-1#1)
individual change##3##2##(2008-12#3)
individual characteristics##3##2##(1992-3#1)(2011-1#1)(2011-2#1)
individual chemical##3##2##(1995-6#1)(2008-10#1)(2008-4#1)
individual chicks##2##2##(1997-3#2)
individual chromosomes##2##2##(2008-1#1)(2008-9#1)
individual clinical##5##2##(1994-12#1)(1996-2#1)(2007-10#1)(2008-10#1)(2012-12#1)
individual clones##2##2##(1997-4#1)(2008-10#1)
individual component##3##2##(2008-3#1)(2009-11#1)(2013-1#1)
individual components in##2##3##(2008-10#2)
individual components of the##5##4##(1994-2#1)(1997-2#1)(2008-10#3)
individual components of##11##3##(1992-9#1)(1994-2#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-8#3)(2009-10#1)
individual components##19##2##(1992-9#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#1)
individual compounds##5##2##(2008-10#4)(2009-8#1)
individual counselling##2##2##(1991-11#1)(2013-8#1)
individual countries##4##2##(1990-12#3)(1994-9#1)
individual data##2##2##(2008-10#1)(2011-2#1)
individual decisions##2##2##(1992-2#1)(2008-7#1)
individual departments##2##2##(1994-3#1)(1996-3#1)
individual determinations##2##2##(1992-6#1)(2008-10#1)
individual difference##3##2##(2008-12#1)(2009-4#2)
individual differences and##2##3##(1993-5#1)(2008-7#1)
individual differences are##2##3##(2010-4#1)(2013-8#1)
individual differences in the recognition of##2##6##(2008-5#2)
individual differences in the requirement for IL-2 and IL-4##2##9##(2008-11#2)
individual differences in the##9##4##(1993-6#1)(2008-11#3)(2008-2#1)(2008-5#3)(2009-7#1)
individual differences in##17##3##(1993-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#5)(2008-2#1)(2008-5#3)(2009-7#1)(2009-8#1)(2012-1#1)(2012-3#1)
individual differences##24##2##(1992-7#1)(1993-5#1)(1993-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#5)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#2)
individual diseases##2##2##(2008-10#2)
individual domains##2##2##(1993-12#1)(2012-1#1)
individual element##2##2##(2008-10#2)
individual experiences##2##2##(2007-8#1)(2008-11#1)
individual faces##2##2##(2007-8#1)(2008-5#1)
individual factors##2##2##(2008-11#1)(2010-10#1)
individual features of##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
individual features##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)
individual female##3##2##(2008-3#1)(2009-9#1)(2012-3#1)
individual females##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
individual fibers##2##2##(2007-12#2)
individual fields##2##2##(2008-10#2)
individual fitness##4##2##(2008-8#2)(2008-9#2)
individual fragments##2##2##(1992-6#1)(2008-11#1)
individual gene##2##2##(1997-7#1)(2012-2#1)
individual genes##10##2##(1990-8#1)(1997-6#1)(2008-11#1)(2008-7#3)(2009-10#1)(2011-1#1)(2012-2#2)
individual genetic##2##2##(2008-10#1)(2008-6#1)
individual giant##2##2##(2008-10#1)(2012-2#1)
individual group##2##2##(2008-9#1)(2009-5#1)
individual growth and##2##3##(2008-5#1)(2008-8#1)
individual growth##3##2##(2008-5#1)(2008-8#2)
individual has##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
individual health care##2##3##(1994-1#1)(1995-12#1)
individual health##7##2##(1994-1#1)(1995-12#1)(1996-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-3#1)
individual hospital##3##2##(1992-2#1)(1993-1#1)(2008-11#1)
individual hospitals##2##2##(1997-1#1)(2008-11#1)
individual host##3##2##(1990-11#1)(2008-10#1)(2010-2#1)
individual identification##2##2##(1994-3#1)(1995-6#1)
individual identity##2##2##(2008-8#2)
individual images##2##2##(2008-2#1)(2008-3#1)
individual immune responses##2##3##(2008-11#2)
individual in the##4##3##(2007-12#1)(2008-12#1)(2008-8#1)(2010-2#1)
individual in##6##2##(2007-12#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#1)
individual information##2##2##(1997-3#1)(2011-7#1)
individual institutions##2##2##(1994-2#1)(1996-3#1)
individual interviews with##2##3##(2008-11#1)(2013-1#1)
individual interviews##6##2##(2008-11#2)(2010-3#1)(2013-1#3)
individual ionic currents##2##3##(2008-11#2)
individual ionic##3##2##(2008-11#3)
individual is##7##2##(1994-5#1)(1995-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
individual isolates##6##2##(2008-10#5)(2011-2#1)
individual kinetic##2##2##(1993-8#1)(2009-12#1)
individual larvae##2##2##(2008-11#2)
individual laser##2##2##(2007-11#1)(2008-2#1)
individual layers##2##2##(2007-12#2)
individual learning##2##2##(2008-11#2)
individual leg joints##2##3##(2007-12#2)
individual lesions##2##2##(2008-10#2)
individual level##10##2##(1996-8#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-8#3)(2009-4#1)(2011-9#1)(2012-2#1)
individual levels of##2##3##(2009-5#1)(2011-2#1)
individual life##2##2##(2008-3#1)(2008-8#1)
individual lives##2##2##(1997-5#1)(2008-1#1)
individual loci##2##2##(2008-10#2)
individual management##2##2##(1991-2#1)(2008-4#1)
individual mechanisms##2##2##(1990-2#1)(2008-9#1)
individual medical##3##2##(1991-12#1)(1994-11#1)(1994-6#1)
individual members of##2##3##(1994-2#1)(1997-7#1)
individual members##4##2##(1994-2#1)(1997-7#1)(2008-4#1)(2008-8#1)
individual metal##3##2##(1990-5#1)(2008-10#2)
individual molecules##4##2##(2008-7#4)
individual mutations##2##2##(2008-8#1)(2010-4#1)
individual needs##3##2##(1992-1#1)(2008-5#1)(2010-1#1)
individual nodules##2##2##(2008-5#2)
individual of##2##2##(2009-4#1)(2010-8#1)
individual or combined##2##3##(1993-8#1)(2009-2#1)
individual or small##2##3##(2008-10#1)(2008-5#1)
individual or##11##2##(1992-6#1)(1993-8#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-2#1)(2010-4#1)
individual particles##2##2##(2008-3#1)(2009-12#1)
individual patient and##3##3##(1993-1#1)(1996-8#1)(2013-8#1)
individual patient data##3##3##(1993-12#1)(2008-6#1)(2012-1#1)
individual patient##30##2##(1990-9#1)(1992-8#1)(1993-1#1)(1993-12#2)(1996-1#1)(1996-8#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#2)(2010-6#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
individual patient's##4##2##(2007-11#1)(2008-12#1)(2008-9#1)(2013-8#1)
individual patients and##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
individual patients with##5##3##(1991-3#1)(1996-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
individual patients##27##2##(1990-8#1)(1991-3#2)(1992-12#1)(1993-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-7#2)(2009-3#1)(2010-12#2)(2010-5#1)(2011-3#1)(2012-3#1)(2012-5#1)(2013-1#4)
individual plant was##2##3##(2008-10#1)(2008-9#1)
individual plant##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
individual plants in##3##3##(2008-10#2)(2008-9#1)
individual plants within##2##3##(2008-10#1)(2008-5#1)
individual plants##11##2##(2008-10#7)(2008-5#3)(2008-9#1)
individual populations##2##2##(2008-10#2)
individual protein bands##2##3##(1994-9#2)
individual proteins##5##2##(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#1)
individual provider##2##2##(1994-3#1)(1996-2#1)
individual reaction##2##2##(1990-5#1)(2008-10#1)
individual recovery values##2##3##(2008-10#2)
individual recovery##3##2##(2008-10#2)(2013-8#1)
individual response to##2##3##(2008-9#1)(2009-7#1)
individual response##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
individual risk assessment##2##3##(2012-3#1)(2013-8#1)
individual risk factors##2##3##(2008-6#1)(2008-8#1)
individual risk of##2##3##(1990-6#1)(2010-11#1)
individual risk##13##2##(1990-2#1)(1990-6#1)(2006-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#3)
individual sample##3##2##(2008-10#2)(2008-9#1)
individual scaling##2##2##(1995-9#2)
individual seed##2##2##(2008-10#1)(2008-8#1)
individual semi-structured interviews##2##3##(2007-10#1)(2008-12#1)
individual sensors##2##2##(2008-10#2)
individual separation of##4##3##(2008-10#4)
individual services##3##2##(1995-12#1)(1997-3#1)(2008-4#1)
individual should##2##2##(2008-5#1)(2008-7#1)
individual sites##2##2##(1990-8#1)(1996-4#1)
individual species##14##2##(1995-8#1)(2008-10#9)(2008-6#1)(2008-8#1)(2009-8#1)(2012-3#1)
individual spores##3##2##(2011-2#3)
individual steps##2##2##(2008-1#1)(2011-2#1)
individual strains##4##2##(2008-10#4)
individual students##2##2##(2008-12#2)
individual subunits##3##2##(1990-5#1)(1991-12#1)(2008-4#1)
individual supported employment program for##2##5##(1993-3#2)
individual surgeons##2##2##(2008-8#1)(2010-8#1)
individual survival##2##2##(1995-2#2)
individual susceptibility to##2##3##(1996-2#1)(2008-10#1)
individual susceptibility##4##2##(1996-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
individual test##2##2##(1991-12#1)(2008-9#1)
individual therapy##2##2##(1990-12#1)(2012-2#1)
individual to the##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
individual to##7##2##(1995-6#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
individual trabeculae##2##2##(2009-7#2)
individual treatment##4##2##(1995-6#1)(2009-11#1)(2009-3#1)(2013-1#1)
individual tree##5##2##(2008-10#5)
individual trees##5##2##(2008-10#4)(2008-5#1)
individual tumor##2##2##(2008-5#1)(2012-2#1)
individual tumour##2##2##(2008-11#1)(2011-2#1)
individual users##2##2##(1996-2#1)(2008-7#1)
individual variability in the##2##4##(1993-12#1)(2012-3#1)
individual variability in##3##3##(1993-12#1)(2008-7#1)(2012-3#1)
individual variability##5##2##(1993-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)
individual variables##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
individual variation in##3##3##(2008-8#1)(2012-3#1)(2013-1#1)
individual variation##4##2##(2007-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
individual vulnerability##2##2##(2009-10#1)(2010-7#1)
individual was##4##2##(1991-8#1)(1996-12#1)(2010-5#1)(2010-8#1)
individual were##2##2##(2008-9#1)(2012-12#1)
individual who##4##2##(1997-3#1)(2006-10#1)(2010-8#1)(2012-3#1)
individual with a##3##3##(1994-1#1)(2011-1#2)
individual with##14##2##(1994-1#1)(1994-12#1)(1994-9#1)(1995-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2011-1#3)(2013-1#1)
individual##1331##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#5)(1990-6#3)(1990-8#5)(1990-9#3)(1991-1#5)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#6)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#8)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#12)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#3)(1993-8#4)(1994-1#3)(1994-11#4)(1994-12#11)(1994-2#7)(1994-3#6)(1994-5#6)(1994-6#2)(1994-8#3)(1994-9#6)(1995-1#1)(1995-12#6)(1995-2#11)(1995-3#2)(1995-5#8)(1995-6#9)(1995-8#4)(1995-9#5)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#11)(1996-2#8)(1996-3#7)(1996-4#4)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#5)(1997-3#9)(1997-4#12)(1997-5#4)(1997-6#6)(1997-7#9)(1997-8#2)(1997-9#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#7)(2007-11#8)(2007-12#34)(2007-2#4)(2007-5#2)(2007-7#3)(2007-8#11)(2008-1#16)(2008-10#229)(2008-11#68)(2008-12#26)(2008-2#25)(2008-3#37)(2008-4#28)(2008-5#34)(2008-6#14)(2008-7#50)(2008-8#51)(2008-9#43)(2009-10#8)(2009-11#7)(2009-12#9)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#8)(2009-8#9)(2009-9#11)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#5)(2010-4#9)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#16)(2010-9#1)(2011-1#18)(2011-2#36)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#7)(2012-12#12)(2012-2#27)(2012-3#29)(2012-5#1)(2013-1#34)(2013-7#2)(2013-8#20)
individual&quot##2##1##(2008-2#1)(2008-3#1)
individual's genetic##4##2##(2008-3#1)(2008-4#1)(2010-4#1)(2012-3#1)
individual's##46##1##(1990-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#3)
individual- and community-level indicators##2##4##(2009-6#2)
individual-based model##6##2##(2008-8#3)(2008-9#3)
individual-based models##2##2##(2008-9#2)
individual-based##24##1##(2008-10#1)(2008-8#8)(2008-9#12)(2010-9#1)(2011-1#1)(2011-2#1)
individual-level estimates##2##2##(1992-6#2)
individual-level factors##2##2##(2010-10#1)(2010-7#1)
individual-level relation between income and##2##5##(2008-8#2)
individual-level##13##1##(1992-6#3)(1994-9#1)(2008-8#5)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)
individual-specific##2##1##(2008-7#1)(2009-7#1)
individualisation##2##1##(2008-11#1)(2008-6#1)
individualise##3##1##(2007-11#1)(2008-6#1)(2008-8#1)
individualised##7##1##(1995-5#1)(1997-6#1)(2007-10#1)(2007-7#1)(2011-3#2)(2013-1#1)
individualistic##5##1##(1995-3#1)(1996-2#1)(2008-5#1)(2010-12#1)(2010-2#1)
individuality##7##1##(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-7#1)
individualization of##4##2##(2008-1#1)(2008-5#1)(2010-9#1)(2011-2#1)
individualization##10##1##(1995-6#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-2#2)
individualize their##2##2##(1995-1#1)(2010-10#1)
individualize##6##1##(1991-1#1)(1992-8#1)(1995-1#1)(1997-4#1)(2007-2#1)(2010-10#1)
individualized and##3##2##(2007-12#1)(2008-9#1)(2009-10#1)
individualized approach##2##2##(2010-3#1)(2011-2#1)
individualized to##3##2##(2009-2#1)(2011-2#2)
individualized##40##1##(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#2)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-9#2)(2010-12#2)(2010-3#2)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
individualizing##2##1##(1991-1#1)(2010-12#1)
individually and as a##2##4##(2008-10#1)(2009-8#1)
individually and in combination##4##4##(1990-5#1)(2008-10#2)(2010-3#1)
individually and in##6##3##(1990-5#1)(1996-12#1)(2008-10#2)(2008-8#1)(2010-3#1)
individually and with##2##3##(2008-10#1)(2008-7#1)
individually and##16##2##(1990-5#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)
individually identified##2##2##(1994-2#1)(2008-3#1)
individually in their##2##3##(2008-10#1)(2008-12#1)
individually in##5##2##(2008-10#3)(2008-12#1)(2012-2#1)
individually into##2##2##(2008-10#1)(2008-7#1)
individually on##3##2##(2008-10#2)(2008-8#1)
individually or in combination##2##4##(1994-8#1)(2008-9#1)
individually or in##6##3##(1990-9#1)(1994-8#1)(1996-1#1)(2008-5#1)(2008-9#1)(2012-12#1)
individually or##8##2##(1990-9#1)(1994-8#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-12#1)
individually tailored##4##2##(1990-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
individually the##2##2##(2008-10#1)(2008-2#1)
individually to##2##2##(2008-10#1)(2008-3#1)
individually##133##1##(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
individuals (p##2##2##(2009-6#1)(2011-2#1)
individuals above##2##2##(1994-9#1)(2008-11#1)
individuals affected by##2##3##(1997-1#1)(1997-5#1)
individuals after##3##2##(1997-7#1)(2009-7#1)(2013-1#1)
individuals aged &gt##2##3##(2008-7#2)
individuals aged##9##2##(1995-6#1)(2007-7#1)(2008-7#2)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
individuals already##2##2##(2012-12#1)(2013-8#1)
individuals also##2##2##(2009-6#1)(2012-3#1)
individuals among##2##2##(2008-5#1)(2008-9#1)
individuals and a##2##3##(1992-12#1)(2008-6#1)
individuals and in##4##3##(1997-1#1)(2008-5#1)(2012-2#2)
individuals and the##5##3##(1995-3#1)(2007-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
individuals and their##3##3##(2008-1#1)(2008-9#1)(2010-8#1)
individuals and##68##2##(1990-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#2)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
individuals appear##2##2##(1995-3#1)(2007-10#1)
individuals are more likely to##2##5##(2008-8#2)
individuals are not##2##3##(2008-9#1)(2012-3#1)
individuals are removed at random##2##5##(1995-2#2)
individuals are##31##2##(1994-11#1)(1994-2#1)(1995-2#2)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-5#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
individuals as well as##2##4##(2010-8#1)(2012-12#1)
individuals as##4##2##(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
individuals at risk for##4##4##(1991-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
individuals at risk##7##3##(1990-3#1)(1991-1#1)(1997-5#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
individuals at the##4##3##(2008-10#2)(2009-7#1)(2013-8#1)
individuals at##23##2##(1990-3#1)(1991-1#1)(1997-5#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
individuals before the##2##3##(2008-7#1)(2013-7#1)
individuals before##3##2##(1994-12#1)(2008-7#1)(2013-7#1)
individuals being##2##2##(1990-8#1)(2009-10#1)
individuals but##2##2##(2008-5#1)(2008-8#1)
individuals by##8##2##(1991-6#1)(1992-3#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
individuals can##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
individuals carrying##2##2##(2008-10#1)(2008-5#1)
individuals collected##3##2##(2008-5#1)(2008-6#1)(2010-8#1)
individuals could##2##2##(1992-6#1)(2012-12#1)
individuals displayed##3##2##(1997-3#1)(2008-7#1)(2010-7#1)
individuals do##2##2##(1992-3#1)(1995-9#1)
individuals during##2##2##(2008-11#1)(2010-8#1)
individuals enrolled##2##2##(2008-1#1)(2008-9#1)
individuals examined##2##2##(1997-3#1)(1997-7#1)
individuals experience##2##2##(2008-12#1)(2013-8#1)
individuals for##7##2##(1995-3#1)(1996-3#1)(2007-1#1)(2008-10#1)(2008-4#1)(2012-3#2)
individuals frequently##3##2##(2007-10#1)(2009-9#1)(2011-2#1)
individuals from a##4##3##(1997-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
individuals from an##2##3##(1996-12#1)(2008-8#1)
individuals from the##8##3##(1997-7#1)(2008-10#1)(2008-12#4)(2008-5#1)(2011-2#1)
individuals from##35##2##(1990-7#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-12#2)(1997-5#3)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-12#10)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)
individuals had##8##2##(1990-12#1)(1992-4#1)(1996-11#1)(2008-12#2)(2008-5#1)(2009-2#1)(2012-12#1)
individuals has##3##2##(1993-11#1)(1994-12#1)(2008-9#1)
individuals have an##2##3##(2012-3#1)(2013-1#1)
individuals have been##2##3##(1997-8#1)(2008-8#1)
individuals have the##2##3##(1992-3#1)(2009-6#1)
individuals have##20##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-1#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
individuals in the experimental group##2##5##(2008-12#1)(2009-6#1)
individuals in the##8##3##(1992-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-12#1)
individuals in##34##2##(1990-3#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-1#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
individuals interact with##2##3##(2008-6#1)(2012-2#1)
individuals interact##4##2##(2008-6#1)(2008-9#2)(2012-2#1)
individuals into##2##2##(1997-8#1)(2010-4#1)
individuals is the##2##3##(2007-12#1)(2008-11#1)
individuals is##14##2##(1992-9#1)(1995-5#1)(1995-9#1)(1996-11#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
individuals living##3##2##(2007-12#1)(2013-1#2)
individuals may##8##2##(1992-11#1)(1996-12#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-6#1)
individuals move##2##2##(2008-8#2)
individuals of European##2##3##(2008-8#1)(2012-2#1)
individuals of M##2##3##(2008-10#1)(2008-11#1)
individuals of both sexes##2##4##(2008-11#1)(2009-5#1)
individuals of different##2##3##(2008-10#1)(2011-2#1)
individuals of species##3##3##(2008-8#2)(2008-9#1)
individuals of the same##3##4##(1991-11#1)(2008-7#1)(2012-12#1)
individuals of the##7##3##(1991-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
individuals of##36##2##(1991-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#4)
individuals often##3##2##(1991-12#2)(2008-10#1)
individuals older than 65 years of age##3##7##(2011-2#3)
individuals on##6##2##(1997-1#1)(2007-7#1)(2008-2#1)(2008-9#1)(2009-7#1)(2013-7#1)
individuals or##2##2##(1995-2#1)(2009-5#1)
individuals over a##2##3##(1991-12#1)(2013-8#1)
individuals over##5##2##(1991-12#1)(2008-5#1)(2008-9#2)(2013-8#1)
individuals participated##2##2##(2010-9#1)(2012-3#1)
individuals per##2##2##(2008-10#1)(2008-6#1)
individuals prefer##2##2##(1997-3#1)(2011-2#1)
individuals receiving##4##2##(1996-12#1)(1996-3#1)(2011-2#1)(2013-7#1)
individuals recruited from##2##3##(2008-12#1)(2008-7#1)
individuals residing in##2##3##(2013-8#2)
individuals revealed that##3##3##(1995-12#1)(2008-9#1)(2012-3#1)
individuals seeking##3##2##(1993-11#1)(2008-11#1)(2010-8#1)
individuals show##2##2##(1997-8#1)(2007-8#1)
individuals showed a##2##3##(1993-1#1)(2008-5#1)
individuals showed##5##2##(1993-1#1)(2008-3#1)(2008-5#1)(2010-3#1)(2013-8#1)
individuals showing##3##2##(2010-4#1)(2013-1#1)(2013-8#1)
individuals suffering from##2##3##(2008-8#1)(2010-1#1)
individuals tested##3##2##(1993-3#1)(1994-12#1)(2010-4#1)
individuals than##4##2##(2008-10#1)(2008-8#3)
individuals that are##2##3##(2008-2#1)(2008-5#1)
individuals that##9##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-3#1)
individuals throughout the##2##3##(2008-8#1)(2009-10#1)
individuals to develop##3##3##(1993-3#1)(2008-3#1)(2008-7#1)
individuals to learn##2##3##(1996-5#1)(2008-4#1)
individuals to##22##2##(1991-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
individuals under##2##2##(2011-2#1)(2012-2#1)
individuals using##2##2##(1995-12#1)(2008-8#1)
individuals was##5##2##(1991-5#1)(2008-5#2)(2008-9#1)(2009-10#1)
individuals were collected##2##3##(2008-5#1)(2009-5#1)
individuals were examined##2##3##(2006-10#1)(2007-2#1)
individuals were observed in##2##4##(2008-10#1)(2010-5#1)
individuals were observed##4##3##(2008-10#1)(2010-3#1)(2010-5#1)(2010-8#1)
individuals were##39##2##(1993-12#1)(1993-9#1)(1995-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-2#2)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#7)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2013-1#1)(2013-7#3)
individuals who are##7##3##(1991-12#1)(1992-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2009-6#1)(2013-8#1)
individuals who do##2##3##(1996-5#1)(2012-3#1)
individuals who had##2##3##(2007-8#1)(2008-12#1)
individuals who have##4##3##(2007-7#1)(2008-2#1)(2008-4#1)(2009-10#1)
individuals who were##3##3##(1992-3#1)(2008-12#1)(2012-3#1)
individuals who##36##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
individuals will be##2##3##(1992-6#1)(2012-2#1)
individuals will##5##2##(1992-6#1)(2008-5#1)(2009-10#2)(2012-2#1)
individuals with FXS##3##3##(2010-4#3)
individuals with MCI may##2##4##(2009-10#1)(2013-8#1)
individuals with a##6##3##(1992-2#1)(1994-12#2)(2007-5#1)(2008-12#1)(2008-5#1)
individuals with and without##4##4##(2008-3#2)(2012-12#1)(2012-2#1)
individuals with and##5##3##(1990-3#1)(2008-3#2)(2012-12#1)(2012-2#1)
individuals with aphasia##2##3##(2012-3#1)(2013-1#1)
individuals with autism##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
individuals with chronic##5##3##(1993-3#1)(1997-1#1)(2009-4#1)(2010-2#1)(2013-1#1)
individuals with clinical##2##3##(2009-10#1)(2013-1#1)
individuals with co-occurring substance abuse and mental health disorders##3##9##(2013-8#3)
individuals with co-occurring substance##4##4##(2013-8#4)
individuals with diabetes##5##3##(2007-7#1)(2012-3#1)(2013-1#3)
individuals with disabilities##2##3##(1994-2#1)(2010-12#1)
individuals with early psychosis##2##4##(2011-1#2)
individuals with early repolarization syndrome##2##5##(2012-3#2)
individuals with early##4##3##(2011-1#2)(2012-3#2)
individuals with higher##2##3##(2009-12#2)
individuals with intellectual disability##2##4##(2012-12#2)
individuals with known##2##3##(1996-12#1)(1997-3#1)
individuals with lesbian and gay parents##2##6##(2012-2#2)
individuals with mild##5##3##(1992-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)
individuals with no##6##3##(1994-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
individuals with other##3##3##(2008-4#2)(2008-8#1)
individuals with predisposing##2##3##(2007-12#1)(2011-2#1)
individuals with severe##4##3##(1994-12#1)(1997-2#1)(2008-4#1)(2008-8#1)
individuals with some##2##3##(1994-12#1)(2008-7#1)
individuals with sporadic##2##3##(1990-3#1)(1994-8#1)
individuals with the##10##3##(1992-6#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
individuals with type 2 diabetes##2##5##(2008-1#1)(2013-1#1)
individuals with##199##2##(1990-3#2)(1990-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#3)(1993-9#1)(1994-12#9)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-7#2)(2006-10#2)(2007-10#1)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#4)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#5)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#8)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#9)(2013-1#11)(2013-7#1)(2013-8#10)
individuals within a population##2##4##(2008-10#2)
individuals within a##3##3##(2008-10#2)(2011-1#1)
individuals within each##2##3##(2008-10#1)(2012-3#1)
individuals within the##3##3##(2008-12#1)(2008-8#1)(2009-5#1)
individuals within##13##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#3)(2009-5#1)(2011-1#2)(2012-3#1)(2012-7#1)
individuals without##10##2##(1997-3#1)(2007-10#1)(2008-5#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
individuals##1218##1##(1990-12#3)(1990-2#3)(1990-3#7)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#13)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#7)(1992-4#1)(1992-6#6)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#11)(1993-3#7)(1993-6#1)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#13)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#3)(1995-12#4)(1995-2#7)(1995-3#9)(1995-5#2)(1995-6#4)(1995-9#3)(1996-1#2)(1996-11#3)(1996-12#7)(1996-2#3)(1996-3#5)(1996-5#4)(1996-8#1)(1997-1#5)(1997-2#4)(1997-3#17)(1997-4#2)(1997-5#9)(1997-6#1)(1997-7#10)(1997-8#5)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#24)(2007-2#7)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#12)(2007-8#6)(2008-1#17)(2008-10#60)(2008-11#40)(2008-12#42)(2008-2#4)(2008-3#19)(2008-4#13)(2008-5#54)(2008-6#15)(2008-7#39)(2008-8#74)(2008-9#40)(2009-1#1)(2009-10#12)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#11)(2009-6#12)(2009-7#7)(2009-8#10)(2009-9#6)(2010-1#5)(2010-10#3)(2010-11#7)(2010-12#8)(2010-2#5)(2010-3#8)(2010-4#16)(2010-5#7)(2010-6#5)(2010-7#3)(2010-8#24)(2010-9#5)(2011-1#15)(2011-2#69)(2011-8#3)(2012-1#7)(2012-12#30)(2012-2#37)(2012-3#35)(2012-7#1)(2013-1#43)(2013-7#21)(2013-8#44)
individuals' own##2##2##(2007-10#1)(2009-6#1)
individuals'##16##1##(1995-6#1)(2007-10#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
individuals)##3##1##(1993-3#1)(1995-9#1)(2006-10#1)
individuals/m(2))##2##1##(2013-8#2)
individuals/m2)##2##1##(2008-5#2)
individuals]##3##1##(1990-5#1)(2013-1#1)(2013-7#1)
individuating##2##1##(2008-11#2)
individuation##2##1##(2008-11#1)(2013-1#1)
indocyanine green##5##2##(1992-2#1)(2009-12#1)(2012-2#1)(2013-1#2)
indocyanine##9##1##(1992-2#1)(2007-11#1)(2008-3#1)(2009-12#1)(2010-4#2)(2012-2#1)(2013-1#2)
indole##10##1##(1990-7#1)(1993-6#1)(1994-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#1)(2013-7#1)
indole-3-acetamide##2##1##(2008-10#2)
indole-3-acetic acid (IAA)##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
indole-3-acetic##8##1##(2008-10#6)(2008-11#1)(2008-12#1)
indole-3-butyric acid (IBA)##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
indole-3-carbinol##2##1##(1995-9#2)
indoleamine 2##4##2##(1992-11#2)(2008-11#2)
indoleamine##5##1##(1992-11#2)(1995-3#1)(2008-11#2)
indolecarboxylic acids and their regulation effects on##2##7##(2008-10#2)
indolence##2##1##(2008-12#2)
indolent growth##2##2##(2008-7#1)(2011-1#1)
indolent lymphoproliferative##2##2##(2009-2#1)(2009-8#1)
indolent##10##1##(2008-7#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
indolequinoline and quinolone alkaloids in coptis-evodia herb couple and the Chinese herbal preparations by##2##14##(2008-10#2)
indoles##6##1##(1995-12#1)(2010-3#1)(2012-3#4)
indolicidin##3##1##(1992-8#3)
indolylfulgimide##3##1##(2009-9#3)
indomethacin and##6##2##(1990-11#1)(1992-3#1)(1995-3#1)(2006-10#1)(2008-10#2)
indomethacin inhibited##2##2##(1991-5#1)(1996-2#1)
indomethacin##43##1##(1990-11#4)(1990-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1994-8#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#3)(2006-10#1)(2008-10#8)(2008-11#5)(2010-2#1)(2011-1#1)(2012-2#1)(2013-7#1)
indomethacin-induced enterocolitis##2##2##(2012-2#2)
indoor air pollution##3##3##(1991-3#1)(1994-9#1)(2008-7#1)
indoor air quality##3##3##(1993-2#1)(1995-6#1)(2012-1#1)
indoor air##14##2##(1991-3#1)(1993-2#1)(1994-9#2)(1995-6#2)(2008-10#3)(2008-7#1)(2010-5#3)(2012-1#1)
indoor and outdoor aeromicological##2##4##(2010-5#2)
indoor and outdoor air##7##4##(2008-10#6)(2010-5#1)
indoor and outdoor##19##3##(1997-4#1)(2008-10#11)(2008-11#1)(2008-6#1)(2010-5#5)
indoor and##20##2##(1997-4#1)(2008-10#11)(2008-11#1)(2008-6#1)(2010-5#6)
indoor environment##3##2##(1995-6#3)
indoor patients##2##2##(2007-7#1)(2013-8#1)
indoor pollution##3##2##(2008-10#3)
indoor sources##2##2##(2008-11#2)
indoor wireless##2##2##(2008-3#2)
indoor##65##1##(1991-3#3)(1993-2#2)(1993-6#1)(1994-9#3)(1995-11#1)(1995-6#5)(1997-4#1)(2007-7#1)(2008-10#19)(2008-11#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-5#11)(2012-1#1)(2013-1#4)(2013-8#1)
indoors and##5##2##(2008-10#1)(2010-5#1)(2012-12#2)(2013-8#1)
indoors##12##1##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#2)(2012-12#3)(2013-8#1)
indophenol blue##3##2##(2008-10#3)
indophenol##4##1##(2008-10#4)
indoxacarb##2##1##(2011-2#2)
induce Ca2+##2##2##(1995-3#1)(2010-11#1)
induce DNA damage in##2##4##(1997-4#2)
induce DNA damage##5##3##(1992-3#1)(1993-12#1)(1997-4#2)(2008-5#1)
induce DNA##11##2##(1992-3#1)(1993-12#1)(1995-11#1)(1996-2#1)(1997-4#2)(2008-11#3)(2008-3#1)(2008-5#1)
induce OVA-specific##2##2##(2008-11#2)
induce a sensitization response##3##4##(2008-10#3)
induce a significant##3##3##(1993-11#1)(1993-8#1)(2008-6#1)
induce a##55##2##(1990-12#2)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#3)
induce activation of##2##3##(1993-12#1)(1994-2#1)
induce activation##3##2##(1993-12#1)(1994-2#1)(1997-3#1)
induce acute##3##2##(1990-6#1)(2008-10#1)(2008-7#1)
induce aggregation##2##2##(1990-5#2)
induce an increase in##3##4##(1995-12#1)(2008-5#1)(2013-1#1)
induce an##17##2##(1990-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
induce and maintain mild hypothermia in unanesthetized##2##7##(2007-10#2)
induce and maintain mild##3##4##(2007-10#3)
induce and maintain##4##3##(2007-10#3)(2012-3#1)
induce and##6##2##(2007-10#3)(2008-4#1)(2008-8#1)(2012-3#1)
induce antibody##4##2##(1990-5#1)(1995-5#1)(2008-11#2)
induce any##4##2##(1992-11#1)(1992-9#1)(1996-2#1)(1997-4#1)
induce apoptosis in human quiescent peripheral blood mononuclear cells##2##9##(1994-6#2)
induce apoptosis in##8##3##(1993-8#1)(1994-10#1)(1994-6#2)(1996-12#1)(2008-10#1)(2008-8#2)
induce apoptosis of##3##3##(2008-8#1)(2008-9#1)(2009-3#1)
induce apoptosis when used as##2##5##(2009-12#2)
induce apoptosis##25##2##(1993-8#1)(1993-9#2)(1994-10#1)(1994-6#2)(1994-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#3)(2009-3#1)(2013-1#1)
induce both##6##2##(1992-8#1)(1995-5#1)(2008-10#2)(2010-8#1)(2013-8#1)
induce cell death##2##3##(1993-9#1)(2009-4#1)
induce cell differentiation and##2##4##(2008-11#1)(2008-4#1)
induce cell##10##2##(1993-9#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
induce cellular##4##2##(1994-2#1)(1994-6#1)(1994-8#1)(2011-2#1)
induce changes in the##4##4##(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
induce changes in##5##3##(1996-5#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
induce changes##7##2##(1996-5#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2012-2#1)
induce complete##2##2##(2008-8#1)(2011-2#1)
induce conformational##2##2##(1991-12#1)(1992-5#1)
induce contact##3##2##(2008-5#1)(2008-9#2)
induce different##4##2##(1995-12#1)(2008-11#2)(2012-3#1)
induce differentiation of##3##3##(2008-11#2)(2008-9#1)
induce differentiation##5##2##(1997-3#1)(2008-11#2)(2008-5#1)(2008-9#1)
induce dramatic##2##2##(2008-7#1)(2010-8#1)
induce early##3##2##(2007-2#1)(2013-1#2)
induce expression of##4##3##(1995-12#1)(2008-11#1)(2008-8#1)(2009-4#1)
induce expression##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)
induce fat##2##2##(2008-3#1)(2012-1#1)
induce formation of##4##3##(1990-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
induce glucose##3##2##(2008-11#1)(2008-3#2)
induce growth##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
induce higher##2##2##(2008-11#1)(2011-2#1)
induce in vitro##2##3##(2008-10#1)(2012-12#1)
induce in##3##2##(1994-6#1)(2008-10#1)(2012-12#1)
induce insulin-like##2##2##(2010-11#2)
induce long-term##2##2##(1991-12#1)(2012-1#1)
induce metabolic##3##2##(2008-12#2)(2008-3#1)
induce or##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
induce oxidative stress and chronic inflammation##2##6##(2012-5#2)
induce oxidative##3##2##(1995-6#1)(2012-5#2)
induce physical##3##2##(1991-12#1)(2008-3#1)(2011-2#1)
induce plant##2##2##(2008-10#1)(2011-10#1)
induce platelet##3##2##(1992-12#1)(2006-6#2)
induce potent##2##2##(1995-5#2)
induce proliferation of##3##3##(1993-3#1)(1993-6#1)(1997-3#1)
induce proliferation##4##2##(1993-3#1)(1993-6#1)(1997-3#1)(2008-4#1)
induce pulmonary##2##2##(1993-6#1)(2013-8#1)
induce rapid phospholipid flip-flop##2##4##(1994-5#2)
induce rapid##3##2##(1991-12#1)(1994-5#2)
induce resistance##6##2##(2008-10#6)
induce severe##4##2##(1993-11#1)(2008-10#2)(2011-1#1)
induce similar##5##2##(1995-2#1)(1995-5#1)(2008-10#2)(2013-8#1)
induce some##2##2##(1994-3#1)(2008-10#1)
induce strong##3##2##(1997-4#1)(2008-11#1)(2008-8#1)
induce substantial##2##2##(1997-1#1)(2008-10#1)
induce superficial##2##2##(2008-5#2)
induce systemic T cell##2##4##(2008-11#2)
induce systemic resistance in plants##3##5##(2008-10#3)
induce systemic resistance in##8##4##(2008-10#8)
induce systemic resistance to##2##4##(2008-10#1)(2013-8#1)
induce systemic resistance##11##3##(2008-10#10)(2013-8#1)
induce systemic##14##2##(2008-10#11)(2008-11#2)(2013-8#1)
induce the conformational change of##2##5##(1997-7#1)(2009-3#1)
induce the expression of##7##4##(1994-11#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#2)
induce the formation of##2##4##(1995-5#1)(2009-7#1)
induce the production of##6##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
induce the synthesis of##2##4##(1990-2#1)(2008-4#1)
induce the tyrosine phosphorylation##2##4##(1992-8#1)(1996-2#1)
induce the##60##2##(1990-10#1)(1990-2#2)(1990-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#3)(1994-5#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#2)(2009-7#2)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
induce these##4##2##(1990-2#1)(2008-10#2)(2012-12#1)
induce translocation of##2##3##(1993-8#1)(2008-11#1)
induce tumors in##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
induce##646##1##(1990-10#1)(1990-12#3)(1990-2#6)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#6)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-9#5)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#6)(1992-5#4)(1992-8#6)(1992-9#5)(1993-11#4)(1993-12#8)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#3)(1994-10#2)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#10)(1994-6#5)(1994-8#6)(1994-9#3)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#5)(1995-5#10)(1995-6#1)(1995-8#5)(1995-9#5)(1996-12#3)(1996-2#8)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#8)(1997-6#3)(1997-7#7)(1997-8#1)(2006-6#2)(2007-10#5)(2007-11#9)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#108)(2008-11#38)(2008-12#6)(2008-2#3)(2008-3#21)(2008-4#18)(2008-5#15)(2008-6#4)(2008-7#17)(2008-8#31)(2008-9#13)(2009-10#2)(2009-12#7)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#24)(2012-1#3)(2012-12#11)(2012-2#8)(2012-3#4)(2012-5#2)(2012-7#1)(2013-1#10)(2013-8#8)
induced DNA damage##4##3##(1993-12#1)(1997-4#2)(2012-12#1)
induced DNA synthesis##2##3##(1993-6#2)
induced DNA##9##2##(1991-12#1)(1993-12#1)(1993-6#2)(1994-11#1)(1995-6#1)(1997-4#2)(2012-12#1)
induced G1##2##2##(1991-9#1)(2011-2#1)
induced IFN-gamma production##2##3##(2008-11#2)
induced IW32##2##2##(1991-9#2)
induced MhNPR1 expression in##2##4##(2011-10#2)
induced P1-##2##2##(1990-3#2)
induced a biphasic##2##3##(1994-2#1)(1995-8#1)
induced a change##2##3##(2008-10#1)(2008-4#1)
induced a decrease in##2##4##(2008-10#2)
induced a dose-dependent increase in##4##5##(1993-3#1)(1994-11#1)(2008-10#1)(2008-5#1)
induced a dose-dependent suppression of##2##5##(1995-3#1)(1997-2#1)
induced a dose-dependent##7##3##(1993-3#1)(1994-11#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-11#1)
induced a local##2##3##(2008-10#2)
induced a marked##3##3##(1993-5#1)(1995-12#1)(2008-11#1)
induced a neutrophil count increase at 12 mg/kg that would be consistent with an inflammatory response related to the dermatitis observed histopathologically##2##22##(2008-9#2)
induced a neutrophil count increase##3##5##(2008-9#3)
induced a rapid increase##2##4##(1991-12#1)(2008-4#1)
induced a rapid##5##3##(1990-12#1)(1991-12#1)(1996-2#1)(2008-4#2)
induced a significant reduction##2##4##(2007-10#1)(2013-1#1)
induced a significant##8##3##(1993-3#1)(1996-5#1)(2007-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
induced a slow##3##3##(1990-7#1)(1994-2#1)(2008-10#1)
induced a small##2##3##(1995-8#1)(2009-6#1)
induced a##103##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#3)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1992-11#3)(1992-12#1)(1992-8#1)(1993-3#4)(1993-5#2)(1993-8#1)(1994-11#3)(1994-2#3)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#2)(1996-5#3)(1997-2#3)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#6)(2009-6#1)(2010-11#1)(2011-2#2)(2013-1#4)
induced abortion and##2##3##(1996-12#1)(2011-1#1)
induced abortion is##2##3##(1991-6#1)(2013-1#1)
induced abortion##8##2##(1991-6#4)(1996-12#1)(2011-1#1)(2013-1#2)
induced abortions##7##2##(1991-6#1)(1993-9#1)(2008-11#1)(2013-1#4)
induced absorption##4##2##(2007-12#2)(2008-3#2)
induced activity was##2##3##(1992-8#1)(1995-8#1)
induced after##3##2##(1995-11#1)(1997-7#1)(2008-10#1)
induced alterations in##2##3##(1991-6#1)(2008-11#1)
induced an increase in##6##4##(1993-3#1)(1993-5#1)(1993-8#1)(1994-9#1)(2008-10#1)(2008-8#1)
induced an increase of the##2##5##(2008-10#1)(2008-11#1)
induced an increase of##5##4##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#2)
induced an increase##12##3##(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#3)
induced an increased##2##3##(1993-6#1)(2008-11#1)
induced an##25##2##(1991-12#1)(1991-4#1)(1992-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#3)(2009-3#1)(2009-6#1)(2011-2#1)
induced and constitutive plant resistance##2##5##(2008-8#2)
induced and constitutive##3##3##(2008-8#3)
induced and maintained with##2##4##(1996-6#1)(2010-7#1)
induced and maintained##3##3##(1996-6#1)(2007-10#1)(2010-7#1)
induced and##11##2##(1994-6#1)(1996-6#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-8#3)(2009-8#1)(2010-7#1)
induced anxiety##3##2##(2007-6#2)(2012-2#1)
induced apoptosis in##5##3##(1993-9#1)(2008-11#1)(2011-2#2)(2013-1#1)
induced apoptosis of##2##3##(2008-8#1)(2011-2#1)
induced apoptosis##15##2##(1993-9#2)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#3)(2013-1#3)
induced artifacts##2##2##(2008-3#1)(2009-6#1)
induced as##2##2##(1994-11#1)(2009-8#1)
induced at the##2##3##(1992-12#1)(2008-10#1)
induced at##8##2##(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(2008-10#4)
induced average##2##2##(2007-12#1)(2013-1#1)
induced bilateral angle-closure glaucoma##2##4##(2008-7#2)
induced birefringence in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
induced birefringence##8##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
induced bone resorption##2##3##(1993-6#1)(2008-12#1)
induced bone##3##2##(1993-6#1)(2008-12#2)
induced both by##2##3##(2008-10#1)(2008-4#1)
induced both local and systemic##2##5##(2008-10#2)
induced both##8##2##(1993-6#1)(1993-8#1)(2008-10#4)(2008-4#1)(2008-8#1)
induced breakdown spectrometry##2##3##(2008-10#2)
induced breakdown spectroscopy##2##3##(2008-10#2)
induced breakdown##5##2##(1995-12#1)(2008-10#4)
induced bronchoconstriction##3##2##(1990-5#1)(1992-3#2)
induced by 1##2##3##(1993-6#1)(1994-9#1)
induced by 17 beta-estradiol##2##4##(1996-5#2)
induced by AAPH in the absence##2##6##(1995-6#2)
induced by AAPH##4##3##(1995-6#4)
induced by ACPD##4##3##(1995-12#4)
induced by Ach##2##3##(2011-2#2)
induced by Bothrops asper##2##4##(2008-5#2)
induced by H##2##3##(1997-1#1)(2008-12#1)
induced by HIV-1##2##3##(1991-2#1)(2008-11#1)
induced by IL-2##3##3##(1990-12#1)(2008-8#2)
induced by IPTG##2##3##(1994-8#1)(2013-1#1)
induced by LPS and IFN-gamma/LPS##2##5##(2008-8#2)
induced by LPS##4##3##(1993-8#1)(2008-8#3)
induced by M##2##3##(2008-10#2)
induced by NGF##2##3##(2008-11#2)
induced by PMA##3##3##(1994-8#1)(1995-6#1)(2008-4#1)
induced by TPA##3##3##(1990-12#1)(1990-2#1)(1990-8#1)
induced by UV light##3##4##(2007-12#2)(2008-4#1)
induced by a direct##2##4##(1993-3#1)(1995-6#1)
induced by a wide range of##2##6##(2008-11#1)(2008-7#1)
induced by a##35##3##(1990-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-2#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2012-2#1)(2012-5#1)
induced by acute##4##3##(1991-9#1)(1994-2#1)(2011-2#1)(2013-1#1)
induced by adding##2##3##(1994-12#1)(2008-10#1)
induced by an##9##3##(1990-7#1)(1993-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
induced by another##3##3##(1996-5#1)(1997-3#1)(2008-8#1)
induced by anti-IgE##3##3##(1991-12#3)
induced by anticancer##3##3##(2007-5#1)(2008-11#2)
induced by apomorphine##2##3##(1995-12#1)(2008-7#1)
induced by arachidonic acid##3##4##(1990-12#1)(1994-11#1)(1997-7#1)
induced by atrazine##2##3##(2013-1#2)
induced by binding of 3##2##5##(1993-8#2)
induced by bradykinin##3##3##(1992-3#1)(1997-1#2)
induced by carbachol##3##3##(1990-7#1)(1992-8#1)(1994-11#1)
induced by carrageenan##3##3##(2008-12#1)(2013-7#2)
induced by cationic##3##3##(2008-4#1)(2008-8#2)
induced by central##4##3##(1992-6#1)(1992-8#2)(2010-12#1)
induced by chemotherapy##3##3##(2008-8#1)(2010-12#1)(2013-7#1)
induced by chronic EtOH##2##4##(2008-10#2)
induced by chronic##4##3##(1995-12#1)(2008-10#2)(2013-1#1)
induced by colchicine##2##3##(1993-6#1)(1995-5#1)
induced by combined##2##3##(2011-2#2)
induced by compost##2##3##(2008-10#2)
induced by doxorubicin##5##3##(1991-6#1)(2011-2#4)
induced by either##5##3##(1990-7#1)(1996-5#1)(2008-4#1)(2008-7#1)(2010-5#1)
induced by electric fields in biological##2##6##(1997-6#2)
induced by endothelin-1##2##3##(1991-12#1)(1995-12#1)
induced by environmental##2##3##(2009-4#1)(2009-8#1)
induced by exogenous cGMP##2##4##(2008-4#2)
induced by exogenous##3##3##(2008-4#2)(2008-6#1)
induced by exposing##3##3##(1995-12#1)(2011-10#1)(2013-1#1)
induced by exposure to##5##4##(1992-5#1)(1995-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
induced by fMLP##2##3##(1995-6#1)(1996-2#1)
induced by fungal##2##3##(2008-10#2)
induced by galanin##2##3##(1993-3#2)
induced by glucose##2##3##(2008-1#1)(2008-11#1)
induced by glutamate##2##3##(1997-7#1)(2008-7#1)
induced by growth hormone##2##4##(1990-12#2)
induced by growth##4##3##(1990-12#2)(1991-9#1)(2010-10#1)
induced by harringtonine##2##3##(2008-8#2)
induced by heat shock##2##4##(1997-7#1)(2008-5#1)
induced by high dose##2##4##(2008-7#1)(2008-8#1)
induced by high##5##3##(1993-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
induced by i##2##3##(1995-12#1)(1997-4#1)
induced by infection with##2##4##(1996-11#1)(2011-2#1)
induced by injection of##3##4##(2008-8#1)(2008-9#1)(2013-1#1)
induced by intracellular##3##3##(1991-2#1)(1995-5#1)(2008-7#1)
induced by intraperitoneal (i##2##4##(1995-12#1)(1996-2#1)
induced by intraperitoneal##3##3##(1995-12#1)(1996-2#1)(2012-2#1)
induced by irradiation of##2##4##(2008-10#1)(2008-5#1)
induced by irradiation##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
induced by isoproterenol##2##3##(2008-4#2)
induced by ligand binding##2##4##(1993-8#1)(1995-2#1)
induced by lipopolysaccharide##2##3##(1994-12#1)(1994-8#1)
induced by low##2##3##(1991-5#1)(2008-7#1)
induced by lower##2##3##(1990-9#1)(2008-8#1)
induced by neonatal##2##3##(1992-5#1)(2008-1#1)
induced by nerve growth factor##2##5##(1996-12#1)(2008-11#1)
induced by nicotine##2##3##(1996-2#1)(2011-1#1)
induced by oxidative stress##2##4##(1994-2#1)(2008-4#1)
induced by permanent##3##3##(1997-2#2)(2007-10#1)
induced by phenylephrine##2##3##(1991-6#2)
induced by progesterone##2##3##(1991-12#1)(2008-8#1)
induced by pulsed##2##3##(2008-2#1)(2008-3#1)
induced by receptor##2##3##(1994-3#1)(1997-4#1)
induced by repeated##2##3##(1992-3#1)(1995-12#1)
induced by scopolamine##2##3##(1991-7#1)(1992-11#1)
induced by streptozotocin##3##3##(2011-2#1)(2012-3#2)
induced by stress##2##3##(2008-10#1)(2010-4#1)
induced by subcutaneous injection##2##4##(2008-11#1)(2013-1#1)
induced by subcutaneous##4##3##(2008-11#1)(2012-2#1)(2013-1#2)
induced by substance P##3##4##(1991-12#1)(1995-12#1)(1997-4#1)
induced by such##2##3##(1995-12#1)(2008-11#1)
induced by the addition of##2##5##(2008-11#1)(2008-4#1)
induced by the administration of##3##5##(1996-5#1)(2008-4#1)(2008-5#1)
induced by the endoplasmic reticulum##2##5##(2008-7#1)(2013-1#1)
induced by the increase##2##4##(1990-12#1)(2008-3#1)
induced by the laser##3##4##(2007-11#1)(2008-3#2)
induced by the presence##2##4##(2008-11#1)(2012-12#1)
induced by the##89##3##(1990-11#2)(1990-12#3)(1990-5#2)(1990-7#1)(1991-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-5#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#3)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
induced by these agents##2##4##(2008-10#1)(2008-11#1)
induced by these##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)
induced by this##2##3##(1990-5#1)(2008-4#1)
induced by thrombin##2##3##(1992-8#1)(1995-11#1)
induced by treatment of##2##4##(1994-11#1)(2008-10#1)
induced by treatment with##2##4##(1992-11#1)(2008-1#1)
induced by treatment##5##3##(1992-11#1)(1994-11#1)(2008-1#1)(2008-10#1)(2009-7#1)
induced by two##2##3##(1992-12#1)(2008-4#1)
induced by two-photon absorption##2##4##(2007-11#2)
induced by vaccination##2##3##(1995-2#1)(1995-9#1)
induced by various treatments##2##4##(1994-8#1)(2008-5#1)
induced by various##5##3##(1990-7#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-5#1)
induced by wounding##3##3##(1997-2#2)(2008-10#1)
induced by##869##2##(1990-11#7)(1990-12#15)(1990-2#6)(1990-3#3)(1990-5#9)(1990-6#5)(1990-7#12)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#15)(1991-2#5)(1991-3#1)(1991-5#4)(1991-6#7)(1991-7#1)(1991-8#4)(1991-9#9)(1992-11#6)(1992-12#10)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#11)(1992-9#4)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#10)(1993-6#4)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#11)(1994-12#9)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#7)(1994-8#17)(1994-9#3)(1995-11#7)(1995-12#37)(1995-2#6)(1995-3#3)(1995-5#11)(1995-6#13)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#2)(1996-4#1)(1996-5#11)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#6)(1997-6#7)(1997-7#13)(1997-8#4)(2007-10#2)(2007-11#24)(2007-12#19)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#72)(2008-11#35)(2008-12#4)(2008-2#10)(2008-3#26)(2008-4#36)(2008-5#17)(2008-6#7)(2008-7#22)(2008-8#30)(2008-9#11)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#3)(2010-10#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-10#3)(2011-2#26)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#15)(2012-3#6)(2012-5#1)(2013-1#18)(2013-7#6)(2013-8#5)
induced c-fos##3##2##(1990-12#1)(1997-2#1)(1997-3#1)
induced calcium##2##2##(1990-2#1)(1994-8#1)
induced cardiac##2##2##(1994-11#1)(2011-2#1)
induced cell apoptosis##2##3##(2008-9#2)
induced cell cycle##3##3##(1994-9#1)(2008-10#1)(2008-6#1)
induced cell death##7##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#3)(2013-1#1)
induced cell##13##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#3)(2009-12#3)(2012-2#1)(2013-1#1)
induced change in##2##3##(1991-1#1)(2008-3#1)
induced changes in##8##3##(1993-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2012-5#1)
induced changes##10##2##(1993-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-5#1)
induced chemical##2##2##(2009-10#1)(2011-1#1)
induced chromosomal aberrations##2##3##(1996-2#1)(2008-11#1)
induced chromosomal##3##2##(1992-8#1)(1996-2#1)(2008-11#1)
induced chromosome##3##2##(1995-6#1)(2008-11#2)
induced colon##2##2##(1990-6#2)
induced conditions##2##2##(2008-11#1)(2011-1#1)
induced conformational change of G(o)alpha##2##5##(2008-9#2)
induced conformational##4##2##(1990-8#1)(1992-6#1)(2008-9#2)
induced contractions##4##2##(1990-8#3)(2007-10#1)
induced contralateral head turns and rotations##2##6##(1995-12#2)
induced contralateral##3##2##(1995-12#2)(1996-2#1)
induced convection##2##2##(1992-8#1)(2008-10#1)
induced cytotoxicity##2##2##(1992-5#1)(2009-9#1)
induced damage##3##2##(2012-3#1)(2013-8#2)
induced decreases in##2##3##(1991-3#1)(2008-8#1)
induced diabetic##2##2##(2008-12#1)(2011-2#1)
induced differentiation in##2##3##(1990-6#1)(2008-11#1)
induced differentiation of murine erythroleukemia##2##5##(1991-2#2)
induced differentiation of##4##3##(1990-11#1)(1991-2#2)(2008-9#1)
induced differentiation##9##2##(1990-11#1)(1990-6#1)(1991-2#3)(1992-3#1)(1992-5#1)(2008-11#1)(2008-9#1)
induced disease##2##2##(2008-10#2)
induced dose-dependent increases##2##3##(1990-7#1)(1997-7#1)
induced dose-dependent##4##2##(1990-2#1)(1990-7#1)(1997-7#2)
induced during the##2##3##(1991-11#1)(2008-10#1)
induced during##8##2##(1991-11#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-7#1)
induced either by##4##3##(1994-8#1)(1997-1#1)(2007-12#1)(2012-1#1)
induced either##5##2##(1994-8#1)(1997-1#1)(2007-12#1)(2012-1#1)(2012-6#1)
induced eosinophilic##2##2##(2008-11#1)(2010-11#1)
induced experimentally##2##2##(1992-2#1)(1996-3#1)
induced expression of the##2##4##(1991-2#1)(2008-10#1)
induced expression of##8##3##(1991-2#1)(1994-11#1)(1997-7#1)(1997-9#1)(2008-10#2)(2010-3#1)(2012-2#1)
induced fluorescence detection##4##3##(1997-2#1)(2008-10#3)
induced fluorescence##17##2##(1997-2#1)(2008-10#16)
induced following##3##2##(1991-7#1)(1994-8#1)(2008-10#1)
induced for##2##2##(2008-8#1)(2008-9#1)
induced formation of##2##3##(2013-1#2)
induced from##6##2##(1990-5#1)(2008-12#1)(2008-8#3)(2013-1#1)
induced growth##4##2##(2007-11#1)(2009-10#1)(2011-2#1)(2013-8#1)
induced haematological##4##2##(2008-7#1)(2013-8#3)
induced hearing loss##2##3##(1992-2#1)(2008-8#1)
induced heat##2##2##(1994-3#1)(2013-8#1)
induced hepatotoxicity in##2##3##(2010-11#1)(2013-1#1)
induced hepatotoxicity##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
induced high##2##2##(1993-3#1)(2008-11#1)
induced hypothermia##2##2##(2007-10#1)(2008-7#1)
induced improvement##2##2##(2012-3#1)(2013-8#1)
induced in a##7##3##(1993-8#1)(2007-12#2)(2008-10#3)(2012-2#1)
induced in human##3##3##(1993-3#1)(1997-7#1)(2008-4#1)
induced in mice by##3##4##(1994-8#1)(1996-12#1)(2008-10#1)
induced in mice##7##3##(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#2)
induced in rat liver##2##4##(1990-12#1)(1994-8#1)
induced in rat##3##3##(1990-12#1)(1992-3#1)(1994-8#1)
induced in rats##2##3##(2008-4#1)(2011-3#1)
induced in response to##4##4##(1991-12#1)(1994-12#1)(2008-1#1)(2012-1#1)
induced in susceptible##2##3##(2008-10#2)
induced in the liver##2##4##(2010-5#1)(2012-12#1)
induced in the##24##3##(1990-2#1)(1990-7#1)(1991-5#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
induced in tomato roots##2##4##(2008-10#2)
induced in vitro by##3##4##(1997-3#1)(1997-4#1)(1997-7#1)
induced in vitro##5##3##(1997-3#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)
induced in##112##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#1)(1996-12#5)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#4)(2008-4#6)(2008-7#4)(2008-8#3)(2008-9#2)(2009-7#2)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
induced increases in##2##3##(1991-3#2)
induced inflammation##2##2##(2012-2#1)(2013-8#1)
induced inhibition of##3##3##(1991-5#1)(1993-3#1)(1997-2#1)
induced injury##3##2##(1995-11#1)(2008-9#1)(2013-8#1)
induced learning##2##2##(1991-7#1)(2010-1#1)
induced lensing##2##2##(2008-2#1)(2008-3#1)
induced lesions##2##2##(2008-1#1)(2008-10#1)
induced less##2##2##(2008-10#1)(2008-11#1)
induced liver damage##3##3##(1992-9#2)(2008-8#1)
induced local resistance by##2##4##(2008-10#2)
induced local##4##2##(1994-12#1)(2008-10#3)
induced lower##2##2##(2008-10#1)(2008-8#1)
induced mRNA##2##2##(1993-6#1)(2008-5#1)
induced mild##2##2##(2008-10#2)
induced modulational instability##2##3##(2007-11#1)(2007-12#1)
induced more##4##2##(2008-10#1)(2008-2#1)(2012-4#1)(2013-1#1)
induced murine##2##2##(1993-3#1)(2010-8#1)
induced mutations##3##2##(1991-9#1)(2008-4#1)(2008-7#1)
induced myoclonic jerks##2##3##(1995-12#2)
induced necrotic lesions##2##3##(2008-10#2)
induced no##3##2##(1992-3#1)(1994-2#1)(1995-12#1)
induced on the##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
induced on##7##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)
induced only##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
induced or##2##2##(1991-8#1)(1994-11#1)
induced ossicle##2##2##(2008-12#2)
induced oxidative##3##2##(2009-12#2)(2013-1#1)
induced pH change##2##3##(2009-12#2)
induced phase modulation##2##3##(2007-12#2)
induced phase##3##2##(2007-12#2)(2008-2#1)
induced plasma##5##2##(2008-10#4)(2008-4#1)
induced platelet##2##2##(1992-12#1)(2008-4#1)
induced pluripotent stem cells##5##4##(2010-10#1)(2012-12#1)(2012-2#2)(2012-5#1)
induced pluripotent##6##2##(2010-10#1)(2012-12#1)(2012-2#2)(2012-5#2)
induced pneumonitis##2##2##(2010-12#2)
induced protection##2##2##(2008-10#1)(2008-7#1)
induced rapid##5##2##(1990-12#1)(1994-9#1)(2008-10#1)(2009-8#1)(2010-6#1)
induced refractive-index change##2##3##(2007-12#2)
induced refractive-index##5##2##(2007-12#4)(2008-2#1)
induced release of##3##3##(1992-11#1)(1997-7#1)(2008-10#1)
induced renal##2##2##(2008-1#1)(2012-12#1)
induced reproduction in##2##3##(2008-7#2)
induced resistance against##2##3##(2008-10#2)
induced resistance and##3##3##(2008-10#3)
induced resistance in##3##3##(2008-10#3)
induced resistance is##5##3##(2008-10#5)
induced resistance to##2##3##(2008-10#2)
induced resistance##30##2##(2008-10#25)(2008-8#4)(2009-6#1)
induced resistant##2##2##(2008-10#1)(2008-11#1)
induced response##3##2##(2007-10#1)(2008-8#1)(2008-9#1)
induced responses##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
induced revenue##2##2##(1991-3#2)
induced severe##2##2##(1997-2#1)(2008-10#1)
induced significant changes in##2##4##(1996-5#1)(2011-2#1)
induced significant reductions in##2##4##(1997-2#1)(2008-5#1)
induced significant##9##2##(1995-12#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-5#2)(2010-12#1)(2010-5#1)(2011-2#1)
induced similar##5##2##(1990-8#1)(1992-10#1)(1992-12#1)(2008-10#1)(2008-11#1)
induced some##2##2##(1996-12#1)(2008-5#1)
induced sputum##3##2##(2008-3#2)(2008-7#1)
induced statistically##2##2##(1990-7#1)(1997-3#1)
induced stress##3##2##(1995-12#1)(2007-12#1)(2008-7#1)
induced strong##2##2##(2012-2#2)
induced substantial##2##2##(1990-12#1)(1994-6#1)
induced superresolution##3##2##(2008-2#3)
induced symptoms similar to those##2##5##(2008-10#2)
induced symptoms##6##2##(2008-10#6)
induced systemic resistance (ISR)##6##4##(2008-10#6)
induced systemic resistance and##2##4##(2008-10#1)(2013-8#1)
induced systemic resistance##14##3##(2008-10#13)(2013-8#1)
induced systemic##16##2##(2008-10#15)(2013-8#1)
induced the expression of##5##4##(1990-12#1)(2008-10#3)(2011-10#1)
induced the formation of##3##4##(1990-5#1)(2007-12#1)(2008-10#1)
induced the growth of lactic acid bacteria##2##7##(2008-11#2)
induced the growth##3##3##(2008-11#3)
induced the production of unusual cytoplasmic ribbon-like inclusions##2##8##(2008-10#2)
induced the production of##6##4##(1990-12#1)(1997-6#1)(2008-10#3)(2010-10#1)
induced the same##2##3##(1990-2#1)(1993-3#1)
induced the##49##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#2)(2011-3#1)
induced thrombocytopenia##3##2##(2007-8#1)(2013-1#2)
induced through the##3##3##(1994-9#1)(1995-3#1)(2008-9#1)
induced through##6##2##(1994-9#1)(1995-3#2)(2008-11#2)(2008-9#1)
induced to develop##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
induced to differentiate by treatment with##2##6##(1992-9#1)(1994-9#1)
induced to differentiate by##3##4##(1992-9#1)(1993-3#1)(1994-9#1)
induced to differentiate##5##3##(1992-9#1)(1993-3#1)(1994-9#1)(2008-11#2)
induced to undergo apoptosis##2##4##(1995-2#1)(2008-9#1)
induced to##25##2##(1991-5#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
induced toxicity in##2##3##(2008-10#1)(2013-1#1)
induced toxicity##4##2##(1995-11#1)(2008-10#1)(2013-1#2)
induced transcription of##2##3##(1994-8#1)(2008-10#1)
induced transcription##3##2##(1992-12#1)(1994-8#1)(2008-10#1)
induced transient##2##2##(1994-11#1)(1997-7#1)
induced transparency##8##2##(2007-11#2)(2007-12#4)(2008-3#2)
induced under##3##2##(1990-7#1)(2008-11#1)(2012-2#1)
induced upon A##2##3##(2008-10#2)
induced us to##2##3##(1990-10#1)(2008-10#1)
induced using##2##2##(2008-10#2)
induced when##2##2##(1994-3#1)(2012-12#1)
induced with thrombin##2##3##(1992-8#2)
induced with##20##2##(1990-5#1)(1992-8#3)(1995-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
induced within##2##2##(2007-11#1)(2008-10#1)
induced##2243##1##(1990-10#1)(1990-11#10)(1990-12#29)(1990-2#14)(1990-3#8)(1990-5#18)(1990-6#9)(1990-7#27)(1990-8#8)(1990-9#5)(1991-1#4)(1991-11#1)(1991-12#22)(1991-2#15)(1991-3#10)(1991-4#2)(1991-5#18)(1991-6#13)(1991-7#6)(1991-8#7)(1991-9#17)(1992-1#1)(1992-10#1)(1992-11#11)(1992-12#15)(1992-2#4)(1992-3#15)(1992-4#1)(1992-5#9)(1992-6#8)(1992-7#1)(1992-8#20)(1992-9#10)(1993-11#4)(1993-12#12)(1993-2#4)(1993-3#25)(1993-5#3)(1993-6#18)(1993-8#13)(1993-9#11)(1994-10#1)(1994-11#26)(1994-12#15)(1994-2#10)(1994-3#11)(1994-5#8)(1994-6#17)(1994-8#32)(1994-9#10)(1995-11#14)(1995-12#62)(1995-2#10)(1995-3#8)(1995-5#14)(1995-6#18)(1995-8#11)(1995-9#3)(1996-11#2)(1996-12#21)(1996-2#17)(1996-3#6)(1996-4#1)(1996-5#19)(1996-6#2)(1996-9#1)(1997-1#5)(1997-2#23)(1997-3#6)(1997-4#16)(1997-6#12)(1997-7#28)(1997-8#4)(1997-9#1)(2006-6#1)(2007-10#10)(2007-11#49)(2007-12#59)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#9)(2008-1#14)(2008-10#336)(2008-11#103)(2008-12#20)(2008-2#35)(2008-3#62)(2008-4#57)(2008-5#47)(2008-6#11)(2008-7#53)(2008-8#79)(2008-9#44)(2009-10#9)(2009-11#7)(2009-12#9)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#9)(2009-7#6)(2009-8#12)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#5)(2010-12#14)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#13)(2011-10#7)(2011-2#53)(2011-3#3)(2012-1#7)(2012-12#12)(2012-2#40)(2012-3#21)(2012-4#1)(2012-5#4)(2012-6#2)(2013-1#62)(2013-7#7)(2013-8#25)
induced)##4##1##(2007-12#1)(2007-7#1)(2008-5#1)(2012-3#1)
inducement and##2##2##(2009-6#1)(2011-2#1)
inducement##4##1##(2009-6#2)(2010-8#1)(2011-2#1)
inducements##4##1##(1991-1#2)(1994-3#1)(2009-6#1)
inducer and##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
inducer of apoptosis in##2##4##(2008-11#1)(2010-6#1)
inducer of erythroid differentiation##2##4##(1990-11#1)(1993-8#1)
inducer of##19##2##(1990-11#1)(1990-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
inducer##51##1##(1990-11#2)(1990-2#1)(1990-5#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-2#3)(1995-8#4)(1996-6#1)(1997-3#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
inducers include##2##2##(2008-10#2)
inducers of differentiation##2##3##(1992-2#2)
inducers of##8##2##(1992-2#2)(1994-11#1)(1996-6#1)(2008-10#4)
inducers##19##1##(1992-2#2)(1992-5#2)(1992-6#1)(1993-8#1)(1994-11#1)(1996-6#1)(2008-10#9)(2009-9#1)(2010-10#1)
induces DNA##2##2##(1993-6#1)(1997-4#1)
induces a conformational change in##2##5##(1992-9#1)(2008-5#1)
induces a conformational change##3##4##(1992-9#1)(1994-6#1)(2008-5#1)
induces a decrease##2##3##(1992-6#1)(1993-12#1)
induces a rapid##4##3##(1995-12#1)(1996-2#1)(2008-12#1)(2008-4#1)
induces a significant##3##3##(1993-11#1)(2008-5#1)(2011-2#1)
induces a similar##2##3##(1991-5#1)(2008-10#1)
induces a structural change in lac DNA##2##7##(1997-6#2)
induces a##68##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-2#2)(1997-4#2)(1997-6#3)(2007-11#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
induces acid-related symptoms##2##3##(2013-1#2)
induces an increase in##2##4##(1993-11#1)(1994-8#1)
induces an##8##2##(1990-12#1)(1992-6#2)(1993-11#1)(1994-8#1)(1997-2#1)(2008-3#1)(2009-8#1)
induces apoptosis and##2##3##(2011-2#1)(2013-1#1)
induces apoptosis in##3##3##(1993-9#1)(2011-2#1)(2012-2#1)
induces apoptosis##8##2##(1993-9#1)(2008-11#1)(2011-2#3)(2012-2#1)(2013-1#2)
induces c-fos##3##2##(1990-12#1)(1990-5#1)(1994-8#1)
induces cell##3##2##(2008-11#1)(2009-2#1)(2011-1#1)
induces developmental##2##2##(1995-3#2)
induces differentiation##3##2##(1992-12#1)(1993-11#1)(1993-3#1)
induces expression of##2##3##(2008-4#1)(2008-7#1)
induces ferritin##2##2##(1990-5#2)
induces generation of superoxide anion##2##5##(1993-6#2)
induces growth##2##2##(1990-2#1)(1995-2#1)
induces interleukin-6##2##2##(1994-6#1)(1995-12#1)
induces macrophage##2##2##(2013-1#2)
induces mainly##2##2##(2008-5#1)(2008-7#1)
induces meiotic maturation in##2##4##(1992-11#2)
induces negative##2##2##(2007-12#1)(2013-8#1)
induces neurite outgrowth##3##3##(2008-10#2)(2008-11#1)
induces obesity and##2##3##(2010-6#1)(2010-7#1)
induces protein##2##2##(2009-7#1)(2010-1#1)
induces release of##2##3##(1995-3#1)(2012-12#1)
induces resistance##3##2##(2008-10#2)(2009-6#1)
induces significant##4##2##(1996-12#1)(1997-4#1)(2008-10#1)(2011-1#1)
induces strong##3##2##(1994-11#1)(1995-2#1)(2008-10#1)
induces systemic resistance in##2##4##(2008-10#2)
induces systemic##4##2##(2008-10#4)
induces the formation of##4##4##(1990-5#1)(1994-6#1)(2008-10#1)(2008-9#1)
induces the production of##2##4##(1995-6#1)(2010-10#1)
induces the synthesis##2##3##(1994-9#1)(2008-8#1)
induces the##33##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
induces tolerance##2##2##(2012-3#1)(2013-1#1)
induces##324##1##(1990-12#4)(1990-2#3)(1990-5#7)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-5#5)(1991-9#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-3#7)(1993-6#6)(1993-9#1)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#4)(1994-8#7)(1994-9#2)(1995-10#1)(1995-12#6)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#1)(1997-2#4)(1997-3#1)(1997-4#5)(1997-6#4)(1997-7#3)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-7#1)(2008-10#35)(2008-11#17)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#6)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#3)(2011-1#3)(2011-10#1)(2011-2#9)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#4)
inducibility and##2##2##(1990-7#1)(1993-8#1)
inducibility of the##2##3##(1990-3#1)(1993-6#1)
inducibility of##7##2##(1990-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(2008-11#1)(2008-5#1)(2009-10#1)
inducibility##14##1##(1990-3#2)(1990-5#1)(1990-7#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
inducible HSP70##2##2##(1994-8#2)
inducible NO synthase##2##3##(1995-11#1)(2008-8#1)
inducible NO-synthase##4##2##(1995-12#4)
inducible NOS##3##2##(1993-3#1)(1994-11#1)(2009-10#1)
inducible and##2##2##(2008-2#1)(2008-9#1)
inducible by##7##2##(1990-5#1)(1991-12#1)(1992-6#2)(1992-8#1)(1993-9#1)(1995-2#1)
inducible expression of##6##3##(1990-12#1)(1993-12#1)(1993-9#1)(1995-5#1)(1996-2#1)(2010-11#1)
inducible expression##9##2##(1990-12#1)(1993-12#1)(1993-8#1)(1993-9#2)(1995-5#1)(1996-2#1)(1997-8#1)(2010-11#1)
inducible form of nitric oxide synthase##2##6##(1993-3#1)(1993-8#1)
inducible form of##3##3##(1993-3#1)(1993-8#1)(1995-12#1)
inducible gene expression##2##3##(2008-2#1)(2009-8#1)
inducible gene##5##2##(1994-12#1)(1994-9#2)(2008-2#1)(2009-8#1)
inducible genes##2##2##(1994-9#1)(2008-7#1)
inducible nitric oxide synthase (iNOS)##6##5##(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
inducible nitric oxide synthase and##2##5##(1995-12#1)(2008-5#1)
inducible nitric oxide synthase gene##2##5##(1993-3#1)(1993-8#1)
inducible nitric oxide synthase##14##4##(1993-3#1)(1993-8#1)(1995-12#2)(1996-12#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)
inducible nitric oxide##16##3##(1993-3#1)(1993-8#1)(1995-12#2)(1996-12#2)(1996-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
inducible promoter##4##2##(1992-12#1)(1992-3#1)(1993-9#1)(2008-10#1)
inducible transactivator##2##2##(2008-2#2)
inducible transcription##2##2##(1995-6#1)(1996-12#1)
inducible##110##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#5)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#2)(1994-12#1)(1994-8#4)(1994-9#3)(1995-11#3)(1995-12#9)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#3)(1997-7#2)(1997-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#6)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
inducing ACTH secretion##2##3##(2008-4#2)
inducing a##20##2##(1990-12#1)(1990-7#2)(1990-9#1)(1993-11#1)(1995-8#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
inducing activity##3##2##(1992-8#1)(1993-9#1)(2008-8#1)
inducing an##2##2##(2008-5#1)(2013-8#1)
inducing and maintaining clinical remission##2##5##(2008-8#1)(2012-2#1)
inducing and##4##2##(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
inducing apoptosis of##2##3##(2008-11#1)(2008-9#1)
inducing apoptosis##7##2##(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
inducing cell##3##2##(1991-9#1)(2008-11#1)(2011-2#1)
inducing effects of##2##3##(1990-5#1)(1992-3#1)
inducing expression of##2##3##(1997-3#1)(2012-2#1)
inducing expression##3##2##(1997-3#1)(2008-9#1)(2012-2#1)
inducing increased##2##2##(1991-9#1)(2008-4#1)
inducing pharmacologic preconditioning##2##3##(1996-9#2)
inducing remission##2##2##(1991-2#1)(2007-7#1)
inducing resistance##2##2##(2008-10#2)
inducing signal##2##2##(1996-2#1)(2008-10#1)
inducing systemic resistance##2##3##(2008-10#2)
inducing the##15##2##(1993-11#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-8#1)(2011-2#1)
inducing them to##2##3##(2008-7#1)(2009-7#1)
inducing##175##1##(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-9#5)(1992-12#1)(1992-3#1)(1992-8#3)(1993-11#3)(1993-12#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#6)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#1)
inductance##2##1##(1993-5#1)(2013-1#1)
inducted##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
induction and that##2##3##(1992-8#1)(2008-7#1)
induction and the##2##3##(1994-12#1)(2008-7#1)
induction and##26##2##(1991-12#2)(1992-8#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
induction are##3##2##(1991-5#1)(2008-1#1)(2008-11#1)
induction by phorbol##2##3##(1993-8#1)(1997-4#1)
induction by##30##2##(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-8#1)(1994-9#2)(1995-2#3)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#2)(2010-5#1)(2012-12#1)
induction can##2##2##(1997-2#1)(2008-11#1)
induction chemotherapy##13##2##(1990-6#4)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)
induction from##2##2##(1990-12#1)(2008-10#1)
induction in murine##2##3##(1992-8#1)(1995-11#1)
induction in the##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
induction in##24##2##(1990-3#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-9#2)(2009-8#1)(2013-1#1)
induction is##14##2##(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
induction medium in##2##3##(2008-11#2)
induction medium##7##2##(2008-11#6)(2012-7#1)
induction of CYP1A##2##3##(1996-12#2)
induction of DNA damage and##2##5##(1997-4#1)(2008-7#1)
induction of DNA damage##4##4##(1997-4#2)(2008-7#2)
induction of DNA single-strand breaks##2##5##(1994-8#1)(1997-4#1)
induction of DNA##11##3##(1991-12#1)(1994-8#1)(1995-2#2)(1997-4#4)(2008-7#3)
induction of HB-EGF##3##3##(1993-11#1)(1997-1#2)
induction of HSP70 mRNA##2##4##(1995-11#2)
induction of HSP70##5##3##(1995-11#3)(2008-10#2)
induction of IFN-gamma production##2##4##(2008-4#2)
induction of L-FABP##2##3##(1994-8#2)
induction of LTP##5##3##(1995-12#2)(1995-2#1)(2008-7#2)
induction of MnSOD##2##3##(1995-6#1)(2008-5#1)
induction of NO synthesis by##2##5##(1993-8#2)
induction of NO##3##3##(1991-3#1)(1993-8#2)
induction of a novel prostaglandin H synthase##2##7##(1992-8#2)
induction of a novel##3##4##(1992-8#3)
induction of a##8##3##(1992-8#3)(1995-2#1)(2008-10#3)(2012-12#1)
induction of acrosome reaction in##2##5##(2013-1#2)
induction of alpha Amy3##2##4##(1994-11#2)
induction of an##3##3##(1992-8#1)(1997-7#1)(2008-10#1)
induction of anaesthesia##4##3##(2010-7#1)(2011-2#3)
induction of anesthesia##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
induction of anti-inflammatory##2##3##(2008-12#1)(2012-2#1)
induction of apoptosis in##6##4##(1993-9#2)(1994-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
induction of apoptosis##23##3##(1993-8#1)(1993-9#2)(1994-10#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-12#1)(2011-2#3)(2012-12#1)
induction of c-fos and junB##3##5##(1994-8#3)
induction of c-fos by MK801 is##2##6##(1990-5#2)
induction of c-fos##6##3##(1990-12#1)(1990-5#2)(1994-8#3)
induction of c-jun##2##3##(1994-8#1)(1995-8#1)
induction of cell cycle##2##4##(2012-12#1)(2012-2#1)
induction of cell##4##3##(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
induction of chitinase##2##3##(2008-10#2)
induction of cytoglobin##2##3##(2010-11#2)
induction of defense##2##3##(2008-10#2)
induction of differentiation##6##3##(1992-9#1)(1993-12#1)(1994-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
induction of either##3##3##(1991-12#1)(1995-2#1)(1995-5#1)
induction of ethylene##2##3##(2008-10#2)
induction of ferritin H##2##4##(1990-5#2)
induction of hepatic microsomal##2##4##(1993-12#2)
induction of hepatic##3##3##(1993-12#3)
induction of host##2##3##(2008-10#2)
induction of human##5##3##(1994-8#1)(2008-11#1)(2008-8#1)(2012-1#2)
induction of labor##3##3##(1994-9#1)(2008-11#2)
induction of long-term potentiation in the##2##6##(1995-12#1)(2008-7#1)
induction of long-term potentiation##5##4##(1991-12#1)(1995-12#2)(2008-7#2)
induction of long-term synaptic##2##4##(1995-5#1)(2011-2#1)
induction of long-term##8##3##(1991-12#1)(1995-12#2)(1995-5#2)(2008-7#2)(2011-2#1)
induction of major histocompatibility##2##4##(1993-6#1)(1995-12#1)
induction of multiple##2##3##(2008-10#1)(2012-2#1)
induction of neutralizing##2##3##(1995-5#1)(2013-1#1)
induction of nitric oxide##2##4##(1993-3#1)(1995-11#1)
induction of osteogenic differentiation##2##4##(2008-11#1)(2012-1#1)
induction of other##2##3##(1992-10#1)(2013-1#1)
induction of oxidative stress##3##4##(2008-10#2)(2009-12#1)
induction of oxidative##4##3##(1994-6#1)(2008-10#2)(2009-12#1)
induction of peroxisome##2##3##(1993-9#1)(2012-12#1)
induction of programmed cell death##3##5##(1991-12#1)(1993-9#1)(1994-9#1)
induction of proliferation##4##3##(1991-3#2)(2006-10#1)(2013-1#1)
induction of resistance to##2##4##(2008-10#2)
induction of resistance##4##3##(2008-10#4)
induction of several##2##3##(2008-10#1)(2011-1#1)
induction of systemic resistance in##2##5##(2008-10#2)
induction of systemic resistance##6##4##(2008-10#6)
induction of systemic##7##3##(2008-10#7)
induction of the JE gene##2##5##(1994-9#2)
induction of the gene##2##4##(1992-9#1)(1996-5#1)
induction of the heat shock##2##5##(1994-11#1)(1994-8#1)
induction of the##29##3##(1990-7#1)(1991-12#1)(1991-9#2)(1992-12#1)(1992-8#2)(1992-9#1)(1993-9#1)(1994-11#2)(1994-8#2)(1994-9#2)(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
induction of these##2##3##(1994-6#1)(2008-10#1)
induction of this##4##3##(1992-12#2)(1996-2#1)(1997-2#1)
induction of tissue##2##3##(1994-9#1)(2008-10#1)
induction of##439##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#6)(1990-6#1)(1990-7#1)(1991-12#8)(1991-3#4)(1991-5#5)(1991-6#1)(1991-9#4)(1992-10#2)(1992-12#7)(1992-8#9)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#2)(1993-6#2)(1993-8#5)(1993-9#7)(1994-10#2)(1994-11#10)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#12)(1994-9#10)(1995-11#5)(1995-12#8)(1995-2#8)(1995-3#3)(1995-5#5)(1995-6#4)(1995-8#3)(1996-12#4)(1996-2#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#6)(1997-6#1)(1997-7#6)(1997-8#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#72)(2008-11#27)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#7)(2008-6#6)(2008-7#17)(2008-8#13)(2008-9#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#3)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#18)(2012-1#3)(2012-12#7)(2012-2#11)(2012-3#4)(2013-1#12)(2013-8#1)
induction on##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
induction period##4##2##(2008-10#4)
induction phase##3##2##(2008-10#3)
induction process##2##2##(1991-5#1)(1992-8#1)
induction profile##2##2##(1996-12#2)
induction showed##2##2##(2008-8#1)(2012-2#1)
induction therapy##5##2##(2008-1#1)(2008-10#2)(2010-3#1)(2011-2#1)
induction to##2##2##(1992-2#1)(2008-7#1)
induction treatment##3##2##(1994-5#1)(2011-2#2)
induction using##3##2##(1996-11#1)(2008-12#1)(2008-4#1)
induction was achieved##2##3##(1995-8#1)(2008-12#1)
induction was also##2##3##(1996-12#1)(2009-10#1)
induction was not##2##3##(1995-2#1)(2008-10#1)
induction was##18##2##(1990-5#2)(1992-8#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2012-2#1)
induction were##4##2##(1992-2#1)(1995-2#1)(1996-12#1)(2008-10#1)
induction with##7##2##(1990-5#1)(1995-11#1)(1995-12#2)(2007-7#1)(2008-8#1)(2011-3#1)
induction##773##1##(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#3)(1990-5#13)(1990-6#5)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#12)(1991-2#1)(1991-3#4)(1991-5#10)(1991-6#1)(1991-9#5)(1992-10#2)(1992-11#1)(1992-12#9)(1992-2#3)(1992-5#1)(1992-8#18)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#7)(1993-3#3)(1993-6#3)(1993-8#10)(1993-9#12)(1994-10#2)(1994-11#13)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#13)(1994-9#14)(1995-11#8)(1995-12#13)(1995-2#16)(1995-3#4)(1995-5#5)(1995-6#5)(1995-8#6)(1996-11#1)(1996-12#12)(1996-2#3)(1996-4#1)(1996-5#4)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-4#8)(1997-6#1)(1997-7#8)(1997-8#7)(2006-10#2)(2007-11#2)(2007-4#2)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#121)(2008-11#60)(2008-12#14)(2008-2#1)(2008-3#3)(2008-4#14)(2008-5#11)(2008-6#10)(2008-7#27)(2008-8#23)(2008-9#8)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#7)(2010-1#2)(2010-11#4)(2010-12#1)(2010-3#2)(2010-5#4)(2010-7#4)(2011-1#7)(2011-2#28)(2011-3#1)(2012-1#3)(2012-12#18)(2012-2#21)(2012-3#6)(2012-7#1)(2013-1#15)(2013-7#5)(2013-8#6)
inductions of##2##2##(1993-8#2)
inductions##4##1##(1993-8#2)(2008-11#2)
inductive approach##2##2##(2008-11#1)(2013-1#1)
inductive coupled plasma##2##3##(2008-10#1)(2012-2#1)
inductive qualitative##2##2##(2010-10#1)(2013-1#1)
inductive##22##1##(1991-5#1)(1992-8#1)(1993-5#1)(1994-12#2)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
inductively coulped plasma mass spectrometry##2##5##(2008-10#2)
inductively coupled argon##2##3##(2008-10#2)
inductively coupled mass spectrometry##2##4##(2008-10#2)
inductively coupled mass##3##3##(2008-10#3)
inductively coupled plasma (ICP)##3##4##(1992-3#1)(2008-10#2)
inductively coupled plasma atomic emission spectrometer (ICP-AES)##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectrometry (ICP-AES) and inductively coupled plasma mass spectrometry (ICP-MS)##2##14##(2008-10#2)
inductively coupled plasma atomic emission spectrometry (ICP-AES)##12##7##(2008-10#12)
inductively coupled plasma atomic emission spectrometry and##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectrometry determination of##2##8##(2008-10#2)
inductively coupled plasma atomic emission spectrometry##45##6##(1992-3#1)(2008-10#44)
inductively coupled plasma atomic emission spectroscopy technique##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectroscopy##4##6##(2008-10#4)
inductively coupled plasma atomic emission##57##5##(1992-3#1)(2008-10#56)
inductively coupled plasma atomic##59##4##(1992-3#1)(2008-10#58)
inductively coupled plasma emission##2##4##(2008-10#2)
inductively coupled plasma mass spectrometer (ICP-MS)##2##6##(2008-10#2)
inductively coupled plasma mass spectrometer##3##5##(2008-10#3)
inductively coupled plasma mass spectrometry (ICP-MS) using##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry (ICP-MS)##24##6##(2008-10#22)(2013-8#2)
inductively coupled plasma mass spectrometry (ICPMS)##3##6##(2008-10#2)(2010-11#1)
inductively coupled plasma mass spectrometry for the##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry for##4##6##(2008-10#4)
inductively coupled plasma mass spectrometry##64##5##(1993-9#1)(2008-10#58)(2010-11#3)(2013-8#2)
inductively coupled plasma mass##71##4##(1993-9#1)(2008-10#63)(2010-11#3)(2013-8#4)
inductively coupled plasma optical emission spectrometry (ICP-OES) after##2##8##(2008-10#2)
inductively coupled plasma optical emission spectrometry (ICP-OES)##8##7##(2008-10#8)
inductively coupled plasma optical emission spectrometry##20##6##(2008-10#20)
inductively coupled plasma optical emission##21##5##(2008-10#20)(2011-2#1)
inductively coupled plasma spectrometry of platinum group metals##2##8##(2008-10#2)
inductively coupled plasma spectrometry##3##4##(2008-10#3)
inductively coupled plasma##176##3##(1992-3#2)(1993-9#1)(2007-12#2)(2008-10#160)(2008-3#2)(2010-11#3)(2011-2#1)(2013-8#5)
inductively coupled plasma-atomic emission spectrometry (ICP-AES)##6##6##(2008-10#6)
inductively coupled plasma-atomic emission spectrometry##14##5##(2008-10#14)
inductively coupled plasma-atomic emission##19##4##(1995-2#1)(2008-10#18)
inductively coupled plasma-mass spectrometer##2##4##(2008-10#2)
inductively coupled plasma-mass spectrometry (ICP-MS)##6##5##(2008-10#6)
inductively coupled plasma-mass spectrometry##12##4##(2008-10#12)
inductively coupled plasma-mass##15##3##(2008-10#15)
inductively coupled plasma-optical emission spectrometry##3##5##(2008-10#3)
inductively coupled plasma-optical emission spectroscopy##2##5##(2008-10#2)
inductively coupled plasma-optical emission##6##4##(2008-10#6)
inductively coupled plasma-time of flight-mass spectrometry##2##6##(2008-10#2)
inductively coupled##224##2##(1992-3#2)(1993-9#1)(1995-2#1)(2007-12#2)(2008-10#207)(2008-3#2)(2010-11#3)(2011-2#1)(2013-8#5)
inductively##229##1##(1992-3#2)(1993-9#1)(1995-2#1)(2007-10#1)(2007-12#2)(2008-10#211)(2008-3#2)(2010-11#3)(2011-2#1)(2013-8#5)
inductor of##2##2##(2008-10#1)(2012-12#1)
inductor##3##1##(2007-12#1)(2008-10#1)(2012-12#1)
induration##5##1##(1990-11#1)(1990-6#1)(1997-2#1)(2007-11#1)(2011-2#1)
industrial CTW##2##2##(2008-12#2)
industrial and##11##2##(1993-3#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)
industrial application##6##2##(1991-5#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-2#1)
industrial applications##19##2##(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#2)
industrial area##2##2##(2008-10#1)(2012-3#1)
industrial development##2##2##(2008-10#1)(2008-2#1)
industrial effluent##3##2##(2008-10#3)
industrial effluents##4##2##(2008-10#4)
industrial engineering##2##2##(2008-10#2)
industrial environments##3##2##(2008-10#1)(2008-3#2)
industrial fermentation##3##2##(2012-3#2)(2013-1#1)
industrial furnaces##2##2##(2008-2#2)
industrial hygiene and safety##3##4##(2012-12#3)
industrial hygiene and##4##3##(2012-12#4)
industrial hygiene##5##2##(2008-10#1)(2012-12#4)
industrial importance##2##2##(1997-4#1)(2012-3#1)
industrial microbiology was##2##3##(2011-2#2)
industrial plant##2##2##(2008-10#1)(2008-6#1)
industrial process##4##2##(2008-10#3)(2011-2#1)
industrial processes##5##2##(1991-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
industrial production of##4##3##(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
industrial production##6##2##(1992-11#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
industrial products in clinical application##2##5##(2012-3#2)
industrial products##4##2##(2011-2#2)(2012-3#2)
industrial sample##2##2##(2008-10#2)
industrial samples##4##2##(2008-10#4)
industrial scale##6##2##(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)
industrial sectors##2##2##(2008-11#1)(2008-5#1)
industrial security##2##2##(2012-12#2)
industrial sludge##3##2##(2008-10#1)(2008-11#2)
industrial strain##2##2##(1996-6#1)(2013-1#1)
industrial waste water samples##2##4##(2008-10#2)
industrial waste water##4##3##(2008-10#4)
industrial waste waters##4##3##(2008-10#4)
industrial waste##9##2##(2008-10#9)
industrial wastewater samples##2##3##(2008-10#2)
industrial wastewaters##3##2##(2008-10#2)(2008-7#1)
industrial water##2##2##(2008-10#2)
industrial##245##1##(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-3#1)(1994-7#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#3)(1997-4#1)(2007-11#2)(2008-1#2)(2008-10#84)(2008-11#21)(2008-12#4)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#7)(2013-1#6)(2013-8#5)
industrialised##3##1##(2007-2#1)(2008-11#1)(2010-11#1)
industrialization##2##1##(2010-11#1)(2011-1#1)
industrialized countries for##2##3##(1990-6#1)(1994-2#1)
industrialized countries##15##2##(1990-6#1)(1991-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#2)
industrialized nations##6##2##(1995-3#1)(2008-10#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
industrialized societies##4##2##(2008-10#1)(2009-12#1)(2010-7#1)(2013-1#1)
industrialized##37##1##(1990-6#1)(1991-2#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-4#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-6#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#1)
industrially important##6##2##(2008-11#3)(2008-12#1)(2008-6#1)(2012-12#1)
industrially##12##1##(1993-12#1)(2008-11#5)(2008-12#1)(2008-6#2)(2008-7#1)(2011-1#1)(2012-12#1)
industries and##4##2##(1997-7#1)(2009-12#1)(2013-8#2)
industries are##3##2##(1995-1#1)(2009-8#2)
industries face##2##2##(1992-1#1)(2011-2#1)
industries in##2##2##(1996-5#1)(2008-10#1)
industries such as##2##3##(2008-11#1)(2011-2#1)
industries that##3##2##(1993-12#1)(2008-12#1)(2008-7#1)
industries##74##1##(1991-1#1)(1991-12#3)(1991-3#2)(1992-1#1)(1993-12#2)(1993-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#2)(1996-5#1)(1997-7#2)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-5#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
industry analysts##2##2##(1995-12#1)(2008-11#1)
industry and government##2##3##(2008-7#1)(2012-3#1)
industry and health care##3##4##(1993-12#1)(2007-2#1)(2008-7#1)
industry and health##4##3##(1991-3#1)(1993-12#1)(2007-2#1)(2008-7#1)
industry and that##2##3##(2008-11#1)(2010-7#1)
industry and the##2##3##(1991-1#1)(2009-12#1)
industry and to##2##3##(1991-3#1)(1995-2#1)
industry and##33##2##(1991-1#2)(1991-3#2)(1993-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
industry are##3##2##(2008-10#1)(2008-11#2)
industry as a##2##3##(2008-3#1)(2008-9#1)
industry as##4##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
industry changes##2##2##(1997-1#1)(1997-3#1)
industry for several##2##3##(2008-10#1)(2008-7#1)
industry for##5##2##(1994-12#1)(1995-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
industry has been##4##3##(1992-12#1)(1994-12#1)(2008-11#1)(2008-5#1)
industry has led##2##3##(2008-11#2)
industry has undergone##2##3##(2007-6#1)(2008-11#1)
industry has##12##2##(1992-12#1)(1994-12#1)(1995-5#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)
industry have been##2##3##(1995-1#1)(2008-10#1)
industry have##7##2##(1992-3#1)(1995-1#1)(2008-10#1)(2008-5#2)(2009-11#1)(2011-2#1)
industry in the##4##3##(2007-5#1)(2008-10#2)(2010-12#1)
industry in##15##2##(1991-3#1)(1997-7#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
industry is currently##2##3##(1994-2#1)(2011-1#1)
industry is##21##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(1994-2#1)(1994-5#1)(1996-11#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)
industry marketing##2##2##(1996-1#1)(2009-7#1)
industry practices##2##2##(2008-10#2)
industry regarding the##2##3##(1996-2#1)(2010-11#1)
industry representatives##2##2##(2008-4#1)(2008-5#1)
industry should##2##2##(1995-3#1)(2009-11#1)
industry since##2##2##(1993-3#1)(1994-12#1)
industry to make##2##3##(1993-11#1)(2008-5#1)
industry to##10##2##(1993-11#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-4#1)
industry uses##2##2##(1996-1#1)(2008-9#1)
industry was##2##2##(1997-3#1)(2008-11#1)
industry when##2##2##(2009-4#1)(2011-1#1)
industry workers##3##2##(1991-3#1)(2011-1#1)(2012-1#1)
industry##380##1##(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#9)(1991-6#3)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#4)(1993-1#1)(1993-11#1)(1993-12#11)(1993-2#2)(1993-3#1)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#1)(1995-1#6)(1995-12#7)(1995-2#5)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#3)(1997-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#54)(2008-11#35)(2008-12#12)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#27)(2008-6#3)(2008-7#16)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#6)(2009-12#3)(2009-4#3)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#19)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#5)
industry&quot##2##1##(1991-3#1)(2008-10#1)
industry's##4##1##(1990-4#1)(1993-3#1)(1996-5#1)(2008-10#1)
industry-driven##2##1##(2009-11#2)
industry-supported##2##1##(1991-1#1)(2009-4#1)
industry-wide##2##1##(1991-12#1)(1992-12#1)
industry]##4##1##(1990-3#1)(2011-1#1)(2011-3#2)
indwelling catheter##6##2##(1990-3#2)(1991-11#1)(1993-2#1)(2008-10#1)(2011-2#1)
indwelling catheters##3##2##(2008-1#3)
indwelling electrodes##5##2##(2012-2#5)
indwelling##23##1##(1990-11#1)(1990-3#2)(1991-11#1)(1993-2#1)(1996-5#1)(1997-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#3)(2012-2#7)
ineffective against the##2##3##(2008-10#1)(2011-2#1)
ineffective against##9##2##(1994-6#1)(2007-11#1)(2008-10#4)(2011-1#1)(2011-2#1)(2012-3#1)
ineffective approaches to##2##3##(2009-7#1)(2013-1#1)
ineffective as##2##2##(2008-11#1)(2011-10#1)
ineffective compression therapy##2##3##(2008-7#2)
ineffective in antagonizing##2##3##(1993-9#1)(1994-2#1)
ineffective in protecting##2##3##(2008-4#1)(2009-12#1)
ineffective in slowing##2##3##(2008-10#1)(2012-12#1)
ineffective in this respect##2##4##(1992-9#1)(1995-12#1)
ineffective in##19##2##(1992-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-6#1)(2012-12#1)(2013-8#1)
ineffective learning##2##2##(2013-1#2)
ineffective##100##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(2007-11#2)(2007-8#4)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
ineffective)##2##1##(1996-3#1)(1997-7#1)
ineffectiveness of##2##2##(1996-2#1)(2007-8#1)
ineffectiveness##3##1##(1996-2#1)(2007-8#1)(2013-1#1)
inefficiency of the##2##3##(1996-8#1)(2008-3#1)
inefficiency of##4##2##(1994-5#1)(1996-8#1)(2008-3#2)
inefficiency to##2##2##(1997-2#1)(2008-2#1)
inefficiency##10##1##(1992-2#1)(1994-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-2#1)(2008-3#2)(2010-8#1)(2013-8#1)
inefficient##30##1##(1990-11#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-4#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
inefficiently##2##1##(1991-10#1)(1995-5#1)
inelastic light##3##2##(2008-2#2)(2009-4#1)
inelastic neutron scattering##2##3##(1996-2#1)(2012-2#1)
inelastic scattering##4##2##(2008-2#3)(2008-3#1)
inelastic##17##1##(1995-3#1)(1996-2#1)(2007-12#1)(2008-2#7)(2008-3#5)(2009-4#1)(2012-2#1)
ineligible for##2##2##(1995-12#1)(2008-9#1)
ineligible##3##1##(1995-12#1)(2007-10#1)(2008-9#1)
inequalities among##4##2##(2008-1#1)(2011-2#1)(2013-1#2)
inequalities and##4##2##(1990-9#1)(2008-11#1)(2011-1#1)(2012-3#1)
inequalities can be##2##3##(2008-11#1)(2012-2#1)
inequalities in SRH##3##3##(2013-1#3)
inequalities in health##2##3##(2013-1#2)
inequalities in self-rated##2##3##(2013-1#2)
inequalities in the##2##3##(2010-11#1)(2013-1#1)
inequalities in##17##2##(1993-2#1)(1996-1#1)(2008-11#1)(2009-10#1)(2010-11#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#8)
inequalities##45##1##(1990-9#1)(1991-6#1)(1993-2#1)(1996-1#1)(1997-2#1)(2007-7#1)(2008-1#2)(2008-11#4)(2008-9#1)(2009-10#1)(2010-11#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#16)
inequality and##6##2##(2008-8#5)(2011-2#1)
inequality in##4##2##(1996-1#1)(2008-8#2)(2011-2#1)
inequality with##2##2##(2011-2#1)(2013-1#1)
inequality##34##1##(1996-1#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-3#1)(2008-8#10)(2009-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)
inequitable##2##1##(2007-7#1)(2008-7#1)
inequities in##3##2##(2009-6#2)(2011-1#1)
inequities##8##1##(1996-12#1)(2009-6#3)(2011-1#4)
inequity in##2##2##(2008-1#1)(2011-2#1)
inequity##6##1##(1996-1#1)(1997-5#1)(2008-1#1)(2009-7#1)(2011-2#1)(2013-1#1)
inequivalence##3##1##(1990-7#2)(1992-9#1)
inequivalent##2##1##(1996-2#2)
inermis##2##1##(2008-12#1)(2008-9#1)
inert gas##2##2##(2008-10#2)
inert gases##2##2##(1992-3#1)(1997-1#1)
inert support##2##2##(2008-10#2)
inert##42##1##(1990-7#1)(1992-3#3)(1992-6#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#3)(2013-1#1)
inertia of##2##2##(1995-1#1)(2012-2#1)
inertia##5##1##(1995-1#1)(1995-3#1)(1997-3#1)(2009-11#1)(2012-2#1)
inertial confinement fusion laser##2##4##(2008-3#2)
inertial confinement fusion##9##3##(1991-9#1)(2007-11#2)(2008-3#6)
inertial force##2##2##(2008-10#2)
inertial##16##1##(1991-9#1)(1996-4#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-3#6)(2010-8#1)
inertial-fusion##2##1##(2008-3#2)
inescapable stress##3##2##(1996-7#1)(2008-11#2)
inescapable##6##1##(1990-7#1)(1996-7#1)(2008-11#3)(2008-5#1)
inevitable##27##1##(1992-3#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
inevitably##24##1##(1991-5#1)(1993-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-5#1)(2012-8#1)
inexorable##4##1##(1993-3#1)(2007-7#1)(2010-10#1)(2013-1#1)
inexorably##3##1##(2008-7#1)(2009-9#2)
inexpensive alternative to##2##3##(2008-10#1)(2012-2#1)
inexpensive alternative##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
inexpensive and rapid##2##3##(2008-10#1)(2008-4#1)
inexpensive and##20##2##(2007-11#2)(2007-7#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-4#1)
inexpensive fabrication of##2##3##(2008-3#1)(2011-1#1)
inexpensive materials##2##2##(2008-10#2)
inexpensive method##3##2##(2008-10#2)(2010-5#1)
inexpensive spectrophotometric method##2##3##(2008-10#2)
inexpensive##109##1##(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-1#1)(2007-11#6)(2007-12#3)(2007-7#2)(2008-10#54)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
inexpensively##7##1##(1993-2#1)(1996-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)
inexpensiveness##2##1##(2008-11#1)(2008-9#1)
inexperienced##9##1##(1992-2#1)(2007-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
inexplicable##2##1##(1995-8#1)(2007-2#1)
inextricably linked##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
inf1##2##1##(2008-10#2)
infact##2##1##(2011-7#1)(2013-1#1)
infancy and early childhood##3##4##(2008-1#1)(2010-5#1)(2013-8#1)
infancy and early##4##3##(2008-1#1)(2010-5#1)(2013-8#2)
infancy and##15##2##(1996-8#1)(1996-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
infancy as##2##2##(2007-12#1)(2008-4#1)
infancy in##2##2##(1997-3#1)(2009-12#1)
infancy is##2##2##(2008-10#1)(2012-2#1)
infancy or##4##2##(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)
infancy was##3##2##(2008-1#1)(2008-10#2)
infancy##74##1##(1991-3#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-7#1)(2007-12#3)(2007-7#3)(2008-1#5)(2008-10#5)(2008-11#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#3)(2010-6#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
infant abductions##2##2##(1993-2#1)(1995-12#1)
infant and maternal##3##3##(1992-2#1)(1993-3#1)(2009-11#1)
infant and the##2##3##(2008-11#1)(2011-1#1)
infant and young child feeding##2##5##(2010-5#2)
infant and young##3##3##(2010-5#2)(2013-8#1)
infant and##12##2##(1992-2#1)(1993-3#1)(1994-3#1)(2007-8#2)(2008-11#1)(2009-11#1)(2010-5#2)(2011-1#1)(2013-1#1)(2013-8#1)
infant at##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
infant behavior##3##2##(1990-12#2)(1994-3#1)
infant birth weight##2##3##(1991-12#1)(2008-12#1)
infant brain##3##2##(1995-8#1)(2008-11#2)
infant by##2##2##(2009-12#1)(2013-1#1)
infant care practices##2##3##(2011-1#2)
infant death syndrome (SIDS) is##3##5##(1992-11#2)(1992-4#1)
infant death syndrome (SIDS)##9##4##(1991-11#3)(1992-11#2)(1992-4#1)(1993-12#1)(2011-1#1)(2013-1#1)
infant death syndrome##20##3##(1991-11#5)(1991-8#1)(1991-9#3)(1992-11#3)(1992-4#1)(1993-12#2)(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#2)
infant death##30##2##(1990-11#1)(1991-11#6)(1991-3#1)(1991-8#1)(1991-9#4)(1992-11#4)(1992-4#3)(1993-12#2)(1996-9#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-1#2)
infant death]##2##2##(1990-11#1)(1991-9#1)
infant deaths in##2##3##(2008-1#1)(2013-1#1)
infant deaths##4##2##(2008-1#1)(2010-9#1)(2013-1#2)
infant development##3##2##(1992-3#1)(2009-9#1)(2010-10#1)
infant feeding in the context of HIV##2##7##(2012-2#2)
infant feeding##4##2##(2007-11#1)(2012-2#3)
infant formula##3##2##(1996-8#1)(2008-10#2)
infant formulas##5##2##(2008-10#5)
infant group##2##2##(1995-3#1)(2012-2#1)
infant health and##3##3##(1992-3#1)(1994-3#1)(2010-5#1)
infant health##10##2##(1992-3#1)(1993-3#2)(1994-3#3)(2007-10#1)(2008-10#1)(2010-12#1)(2010-5#1)
infant in the##2##3##(2007-10#1)(2011-1#1)
infant in##4##2##(2007-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
infant massage##4##2##(2008-10#4)
infant mental##2##2##(1991-2#1)(2009-9#1)
infant mortality and##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
infant mortality in Cuba##2##4##(2013-1#2)
infant mortality in the##4##4##(1990-11#2)(1997-6#1)(2013-1#1)
infant mortality in##6##3##(1990-11#2)(1997-6#1)(2013-1#3)
infant mortality rate##6##3##(1990-12#1)(1993-2#1)(2013-1#4)
infant mortality rates##3##3##(2013-1#3)
infant mortality##25##2##(1990-11#3)(1990-12#1)(1993-2#4)(1993-3#1)(1994-3#1)(1995-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2012-3#1)(2013-1#10)
infant nutrition##4##2##(1991-6#3)(2012-2#1)
infant oral##3##2##(2008-11#1)(2011-2#2)
infant outcomes##2##2##(2007-2#1)(2008-11#1)
infant positional biases##2##3##(2007-12#2)
infant presented with##2##3##(2008-10#1)(2011-2#1)
infant presenting##2##2##(2007-8#1)(2009-9#1)
infant should##2##2##(1993-12#1)(2007-12#1)
infant stimuli##2##2##(2009-9#2)
infant undergoing##2##2##(2009-9#1)(2012-12#1)
infant vaccines##2##2##(1995-5#2)
infant was##6##2##(1991-11#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-1#1)(2012-12#1)
infant who was##3##3##(1994-12#1)(2008-12#1)(2012-3#1)
infant who##7##2##(1991-2#1)(1994-12#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
infant with a##2##3##(2012-2#1)(2013-1#1)
infant with bilateral##2##3##(2011-1#2)
infant with##24##2##(1991-3#2)(1994-6#1)(1995-6#1)(1997-3#2)(2007-7#2)(2007-8#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
infant##320##1##(1990-11#6)(1990-12#6)(1991-1#1)(1991-11#8)(1991-12#1)(1991-2#6)(1991-3#3)(1991-6#3)(1991-8#1)(1991-9#5)(1992-11#7)(1992-2#3)(1992-3#3)(1992-4#3)(1992-6#2)(1993-12#6)(1993-2#6)(1993-3#5)(1994-12#3)(1994-3#9)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#8)(2007-7#3)(2007-8#13)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#16)(2008-12#7)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#7)(2010-10#4)(2010-11#2)(2010-12#1)(2010-5#6)(2010-6#2)(2010-9#2)(2011-1#18)(2011-2#15)(2012-1#1)(2012-12#4)(2012-2#17)(2012-3#5)(2013-1#21)(2013-8#1)
infant's cue##2##2##(1990-12#2)
infant's##11##1##(1990-12#3)(1992-4#2)(1993-3#2)(2007-11#1)(2008-1#1)(2009-11#1)(2009-9#1)
infant]##2##1##(1990-9#1)(1991-6#1)
infantile Crohn's disease##2##3##(2010-12#2)
infantile autism##3##2##(1991-2#2)(1995-5#1)
infantile cerebral palsy##3##3##(2009-4#3)
infantile form of Pompe disease##2##5##(2012-12#2)
infantile form of##3##3##(2007-8#1)(2012-12#2)
infantile spasms##4##2##(1990-9#1)(2011-1#2)(2011-2#1)
infantile type##2##2##(1996-9#1)(2012-3#1)
infantile##37##1##(1990-9#2)(1991-2#2)(1992-11#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-4#3)(2010-12#3)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)
infantis##5##1##(2008-5#3)(2012-12#1)(2013-8#1)
infants after##2##2##(1992-2#1)(1995-6#1)
infants aged##3##2##(1992-11#1)(1997-4#1)(2010-6#1)
infants and children who received##2##5##(2008-11#2)
infants and children who##3##4##(1992-1#1)(2008-11#2)
infants and children with##4##4##(1991-12#1)(1995-6#1)(2008-9#1)(2009-5#1)
infants and children##16##3##(1991-12#2)(1992-1#1)(1992-3#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-5#3)(2011-2#1)
infants and families##3##3##(1991-12#3)
infants and those with##2##4##(2010-10#1)(2011-1#1)
infants and toddlers##7##3##(1992-12#2)(2012-2#5)
infants and young children with##2##5##(1997-1#1)(2013-1#1)
infants and young children##9##4##(1997-1#2)(2008-11#1)(2010-5#2)(2011-2#1)(2013-1#2)(2013-8#1)
infants and##53##2##(1990-3#1)(1991-12#5)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#1)(1995-3#1)(1995-6#1)(1997-1#3)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2009-5#3)(2010-10#2)(2010-5#2)(2011-1#1)(2011-2#6)(2012-2#6)(2013-1#3)(2013-8#1)
infants are at##2##3##(1990-5#1)(2008-11#1)
infants are##16##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-6#1)(2007-11#2)(2008-11#3)(2009-9#1)(2012-2#1)
infants as##2##2##(1991-2#1)(1992-11#1)
infants at##7##2##(1991-6#1)(1994-1#1)(1994-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
infants born at the border of viability##3##7##(2012-2#3)
infants born at##5##3##(1991-12#1)(2009-5#1)(2012-2#3)
infants born prematurely##3##3##(2009-6#1)(2013-1#1)(2013-8#1)
infants born##12##2##(1991-12#1)(2007-12#1)(2008-11#1)(2008-12#2)(2009-5#1)(2009-6#1)(2012-2#3)(2013-1#1)(2013-8#1)
infants by##3##2##(1995-12#1)(2009-11#2)
infants could sit without support##2##5##(1995-8#2)
infants could##3##2##(1995-8#3)
infants during the first##2##4##(1995-6#2)
infants during the##3##3##(1995-6#2)(2011-2#1)
infants during##4##2##(1995-6#2)(2010-10#1)(2011-2#1)
infants for##3##2##(1995-5#1)(2007-2#1)(2008-10#1)
infants from##2##2##(1993-2#1)(2011-1#1)
infants had##3##2##(1990-5#1)(2011-1#1)(2011-2#1)
infants have##2##2##(2007-11#1)(2007-2#1)
infants immunised##2##2##(1992-2#2)
infants in a##2##3##(1992-11#1)(2011-2#1)
infants in the##6##3##(1992-11#2)(1992-4#1)(1993-12#1)(2008-11#1)(2011-2#1)
infants in##16##2##(1990-11#1)(1992-11#3)(1992-2#1)(1992-4#1)(1993-12#1)(1995-12#1)(2008-11#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)
infants is##3##2##(2008-11#2)(2012-12#1)
infants of mothers with##2##4##(2011-1#2)
infants of##7##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(2008-11#1)(2011-1#2)
infants older than##3##3##(1994-6#2)(2012-2#1)
infants presented##2##2##(1996-3#1)(2008-12#1)
infants should be##2##3##(1990-11#1)(1994-6#1)
infants should##3##2##(1990-11#1)(1994-6#1)(1994-9#1)
infants the##3##2##(1990-8#1)(1991-6#1)(1993-12#1)
infants to##2##2##(1990-2#1)(1990-3#1)
infants treated with##2##3##(1990-9#1)(1994-6#1)
infants under##2##2##(1993-12#1)(1995-12#1)
infants was##3##2##(2010-4#1)(2011-1#1)(2012-12#1)
infants were treated with##2##4##(1994-6#1)(1995-5#1)
infants were##19##2##(1991-11#4)(1991-2#1)(1992-3#1)(1993-12#1)(1994-6#3)(1995-1#1)(1995-5#1)(1995-8#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
infants when##2##2##(1994-2#1)(1994-6#1)
infants who died##2##3##(1992-4#1)(2007-2#1)
infants who had##2##3##(1991-11#1)(1991-3#1)
infants who were##3##3##(1992-2#1)(1995-5#1)(2012-12#1)
infants who##15##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-4#1)(1995-5#2)(1997-4#2)(2007-2#1)(2007-5#1)(2011-1#1)(2012-12#2)
infants whose mothers did not have pre-eclampsia##2##7##(2011-2#2)
infants whose mothers##4##3##(2011-2#4)
infants whose##5##2##(1991-2#1)(2011-2#4)
infants with CHD##2##3##(2010-9#2)
infants with bronchopulmonary dysplasia##2##4##(2010-5#2)
infants with lower##2##3##(1991-12#1)(2008-12#1)
infants with severe respiratory##2##4##(1994-6#1)(1996-6#1)
infants with severe##3##3##(1994-6#1)(1996-3#1)(1996-6#1)
infants with very low birth##2##5##(1994-6#1)(1995-6#1)
infants with very low##3##4##(1994-6#1)(1995-5#1)(1995-6#1)
infants with very##4##3##(1992-3#1)(1994-6#1)(1995-5#1)(1995-6#1)
infants with##46##2##(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-3#2)(1994-6#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-3#1)(1996-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-5#3)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
infants##439##1##(1990-11#7)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-8#8)(1990-9#3)(1991-1#1)(1991-11#7)(1991-12#9)(1991-2#8)(1991-3#3)(1991-6#3)(1991-9#2)(1992-1#1)(1992-11#7)(1992-12#4)(1992-2#12)(1992-3#7)(1992-4#4)(1993-12#12)(1993-2#4)(1993-3#3)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#7)(1994-6#20)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#13)(1995-6#5)(1995-8#14)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#5)(1997-6#1)(1997-8#1)(2006-10#2)(2006-5#2)(2007-11#15)(2007-12#5)(2007-2#5)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#13)(2008-11#30)(2008-12#6)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#3)(2009-5#6)(2009-6#2)(2009-7#1)(2009-9#5)(2010-10#7)(2010-11#2)(2010-4#3)(2010-5#7)(2010-6#3)(2010-9#3)(2011-1#28)(2011-2#26)(2012-12#11)(2012-2#19)(2012-3#2)(2013-1#5)(2013-8#4)
infants'##9##1##(1991-12#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2011-1#1)
infants)##3##1##(1992-2#1)(1995-5#2)
infants]##7##1##(1990-11#2)(1990-8#1)(1994-6#2)(1996-11#1)(2013-1#1)
infantum##3##1##(2008-12#1)(2008-9#1)(2009-5#1)
infarct and##3##2##(1996-9#1)(2007-10#1)(2011-2#1)
infarct angioplasty##2##2##(2008-11#2)
infarct in the##3##3##(2007-10#1)(2008-6#1)(2013-8#1)
infarct in##8##2##(1990-3#1)(2007-10#5)(2008-6#1)(2013-8#1)
infarct site and##2##3##(1992-5#1)(2007-10#1)
infarct size and##8##3##(1990-12#1)(1992-5#3)(1996-9#1)(2011-2#2)(2012-2#1)
infarct size##17##2##(1990-12#1)(1991-9#1)(1992-5#3)(1996-9#3)(1997-6#1)(2007-10#1)(2011-2#4)(2012-2#2)(2013-1#1)
infarct territory##2##2##(2013-7#2)
infarct volume was##3##3##(1997-6#1)(2008-7#2)
infarct volume##8##2##(1997-6#1)(2007-10#3)(2008-2#1)(2008-7#3)
infarct was##2##2##(2007-10#1)(2008-11#1)
infarct##82##1##(1990-12#2)(1990-3#2)(1990-9#1)(1991-6#1)(1991-9#1)(1992-5#6)(1995-12#3)(1996-11#1)(1996-9#4)(1997-2#1)(1997-6#3)(2007-10#20)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#5)(2008-7#5)(2008-8#1)(2011-2#7)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#1)
infarcted cerebral volume##2##3##(1996-6#2)
infarcted myocardium##2##2##(2008-12#1)(2012-12#1)
infarcted##6##1##(1996-6#2)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
infarction -##3##2##(2008-1#1)(2008-11#2)
infarction after##2##2##(1991-4#1)(2006-10#1)
infarction and##37##2##(1990-2#1)(1990-5#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-5#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#3)(2008-8#1)(2009-9#5)(2010-11#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#2)
infarction are##3##2##(1994-11#1)(2007-10#1)(2008-3#1)
infarction as##2##2##(1993-12#1)(2011-2#1)
infarction at##2##2##(1990-8#1)(2008-3#1)
infarction due to##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
infarction during pregnancy##2##3##(1991-3#2)
infarction during##5##2##(1990-5#1)(1991-3#2)(1995-12#1)(2007-10#1)
infarction has been##3##3##(1990-12#1)(1993-11#1)(2008-3#1)
infarction in a 32-year-old##2##4##(2007-10#1)(2008-11#1)
infarction in a##5##3##(1997-6#1)(2007-10#1)(2007-8#1)(2008-11#1)(2013-8#1)
infarction in the right##2##4##(2008-12#2)
infarction in the##6##3##(1991-3#1)(1994-12#1)(1996-3#1)(2008-12#2)(2008-3#1)
infarction in##33##2##(1990-3#1)(1991-3#2)(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#2)(1996-3#1)(1997-6#1)(1997-8#3)(2006-8#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-7#2)(2009-4#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
infarction is##8##2##(1991-6#1)(1991-9#1)(1994-11#1)(1997-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
infarction may##2##2##(1997-2#1)(1997-5#1)
infarction or##4##2##(1992-9#1)(2008-3#1)(2009-6#1)(2013-7#1)
infarction presenting##2##2##(2007-7#1)(2008-3#1)
infarction risk score##4##3##(1994-11#4)
infarction treated##2##2##(1993-9#1)(2012-3#1)
infarction was##8##2##(1993-11#1)(1993-5#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-7#2)
infarction with left##2##3##(1997-3#1)(2011-2#1)
infarction with##9##2##(1990-5#1)(1990-9#1)(1997-3#1)(1997-5#1)(2008-11#1)(2010-5#1)(2011-2#2)(2013-8#1)
infarction##400##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#6)(1990-5#7)(1990-8#1)(1990-9#6)(1991-11#3)(1991-3#7)(1991-4#1)(1991-6#6)(1991-9#5)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#12)(1994-12#3)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-8#3)(1996-2#3)(1996-3#1)(1996-8#1)(1996-9#5)(1997-2#2)(1997-3#7)(1997-5#11)(1997-6#1)(1997-8#5)(2006-10#3)(2006-7#3)(2006-8#2)(2007-10#25)(2007-11#1)(2007-5#3)(2007-7#1)(2007-8#9)(2008-1#5)(2008-10#7)(2008-11#9)(2008-12#6)(2008-2#2)(2008-3#43)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#17)(2008-8#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#8)(2010-10#2)(2010-11#5)(2010-12#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#10)(2011-2#19)(2012-1#5)(2012-12#3)(2012-2#9)(2012-3#7)(2013-1#10)(2013-7#4)(2013-8#15)
infarction]##8##1##(1990-12#1)(1993-2#1)(1994-6#1)(1995-5#1)(2008-10#1)(2013-1#1)(2013-8#2)
infarctions in the##2##3##(2007-10#2)
infarctions in##3##2##(2007-10#2)(2007-8#1)
infarctions is##2##2##(2009-5#1)(2012-3#1)
infarctions##21##1##(1991-3#1)(1996-11#1)(1996-9#1)(1997-3#1)(2007-10#9)(2007-8#1)(2008-3#3)(2008-7#1)(2009-5#1)(2012-3#2)
infarcts and##6##2##(1991-11#1)(2007-10#1)(2008-8#1)(2010-12#1)(2011-2#2)
infarcts in ischaemic stroke patients##2##5##(2008-8#2)
infarcts in non-hypertensive patients##2##4##(2007-10#2)
infarcts in the##4##3##(2007-10#3)(2012-3#1)
infarcts in##10##2##(2007-10#7)(2008-8#2)(2012-3#1)
infarcts were##2##2##(1996-2#1)(2008-8#1)
infarcts##41##1##(1991-11#1)(1996-2#1)(2007-10#26)(2008-8#5)(2010-12#2)(2010-3#1)(2011-2#4)(2012-3#1)
infeasible##3##1##(2008-7#1)(2009-9#2)
infect a##7##2##(2008-10#4)(2008-8#1)(2013-1#2)
infect and cause##2##3##(2008-10#2)
infect and##5##2##(2008-10#4)(2008-4#1)
infect both##2##2##(2008-10#1)(2008-9#1)
infect different##3##2##(2008-10#3)
infect humans##3##2##(1994-11#1)(2008-5#1)(2008-9#1)
infect leaf##2##2##(2008-10#2)
infect lettuce##2##2##(2010-10#2)
infect plants##4##2##(1997-3#1)(2008-10#3)
infect rice##3##2##(2008-10#3)
infect susceptible##2##2##(2008-10#2)
infect the##9##2##(1991-6#1)(2008-10#5)(2008-8#1)(2013-1#2)
infect tobacco##2##2##(2008-10#2)
infect##102##1##(1990-5#1)(1991-6#1)(1994-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-5#1)(2008-10#69)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-10#2)(2012-2#3)(2013-1#6)(2013-8#2)
infectants##5##1##(1997-7#5)
infected A##3##2##(2008-10#3)
infected H9 cells##2##3##(1991-9#1)(1997-3#1)
infected N##2##2##(2008-10#2)
infected Nicotiana benthamiana##3##3##(1995-2#1)(2008-10#2)
infected Sf-9##2##2##(2008-11#2)
infected and non-infected##2##3##(2008-11#1)(2008-9#1)
infected and noninfected##2##3##(1995-2#1)(2008-10#1)
infected and uninfected##3##3##(1994-9#1)(2008-10#2)
infected and##23##2##(1991-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(2008-10#13)(2008-11#2)(2008-9#1)(2011-3#1)(2012-2#1)
infected animals##5##2##(1997-8#1)(2008-5#1)(2012-12#2)(2012-3#1)
infected at##7##2##(2007-6#1)(2008-10#4)(2008-11#2)
infected barley leaves##3##3##(2008-10#3)
infected barley##6##2##(2008-10#6)
infected bay laurel leaves##2##4##(2008-10#2)
infected blood##8##2##(1991-2#3)(1992-6#1)(2007-7#2)(2008-9#1)(2012-12#1)
infected but##2##2##(2008-10#1)(2013-1#1)
infected by HIV##3##3##(1993-6#1)(2008-12#1)(2012-2#1)
infected by P##3##3##(2008-10#3)
infected by both##2##3##(2008-10#2)
infected by subgroup##2##3##(2008-10#2)
infected by the same##2##4##(2008-10#2)
infected by the##8##3##(1996-11#1)(2008-10#5)(2008-5#1)(2012-2#1)
infected by##62##2##(1990-3#1)(1991-11#1)(1993-6#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2012-2#2)(2012-3#5)(2013-8#2)
infected calves##2##2##(1991-3#1)(1996-12#1)
infected cattle##2##2##(1996-12#2)
infected cell cultures##3##3##(2008-11#3)
infected cell lines##4##3##(1991-12#1)(1994-6#1)(2008-4#2)
infected cell##9##2##(1991-12#1)(1994-6#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#1)
infected cells and##3##3##(2009-2#1)(2009-5#1)(2012-12#1)
infected cells to##2##3##(1997-3#1)(2008-10#1)
infected cells were##2##3##(1997-3#1)(2009-8#1)
infected cells##37##2##(1990-7#1)(1997-1#2)(1997-3#3)(2007-10#1)(2008-10#6)(2008-11#7)(2008-4#4)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
infected chickpea##2##2##(2008-10#2)
infected children##4##2##(2007-12#1)(2010-3#1)(2010-9#1)(2013-8#1)
infected citrus##2##2##(2008-10#2)
infected cultures##3##2##(2008-11#2)(2008-9#1)
infected during##4##2##(2008-10#3)(2008-5#1)
infected epidermal cyst and gout##2##5##(2009-10#2)
infected female##3##2##(2008-10#2)(2012-3#1)
infected females##2##2##(2012-3#2)
infected fruit##8##2##(2008-10#8)
infected health care##2##3##(1996-2#1)(2007-12#1)
infected host##5##2##(2008-10#3)(2008-6#1)(2008-7#1)
infected hosts##3##2##(2008-9#1)(2013-8#2)
infected human##2##2##(1993-8#1)(1997-4#1)
infected implants of the hip##2##5##(2008-6#2)
infected in the##4##3##(1996-5#1)(2007-12#1)(2008-10#1)(2012-3#1)
infected in##11##2##(1991-12#1)(1991-7#1)(1993-8#2)(1996-11#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2012-3#2)
infected individuals##16##2##(1990-2#1)(1992-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)
infected infants##2##2##(1990-9#1)(2011-1#1)
infected insect cells##2##3##(1993-6#1)(1993-8#1)
infected leaf##4##2##(2008-10#4)
infected leaves and##2##3##(2008-10#2)
infected leaves or##2##3##(2008-10#2)
infected leaves##15##2##(2008-10#15)
infected lettuce##2##2##(2008-10#2)
infected macrophages##2##2##(2007-2#1)(2013-1#1)
infected maize##3##2##(2008-10#3)
infected male and female rats##4##5##(2008-12#4)
infected male and##6##3##(2008-10#2)(2008-12#4)
infected mammalian##2##2##(2008-11#1)(2011-2#1)
infected mice##5##2##(1992-8#1)(1996-12#1)(2008-4#1)(2012-12#1)(2012-2#1)
infected monkeys##2##2##(1990-2#2)
infected mouse tissues##2##3##(2008-9#2)
infected mouse##5##2##(1995-9#2)(2008-4#1)(2008-9#2)
infected necrosis##2##2##(2008-5#1)(2008-6#1)
infected or##4##2##(1993-8#1)(2007-6#1)(2008-5#1)(2010-3#1)
infected partners##2##2##(2011-2#2)
infected patient##2##2##(2008-5#1)(2012-3#1)
infected patients in##2##3##(1992-2#1)(2011-2#1)
infected patients is##2##3##(1990-2#1)(2007-12#1)
infected patients were##2##3##(2007-7#1)(2008-8#1)
infected patients##17##2##(1990-2#1)(1992-2#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-11#2)(2008-8#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
infected people##2##2##(2011-2#1)(2013-8#1)
infected person##2##2##(1993-12#1)(2007-2#1)
infected persons##5##2##(1997-1#1)(2008-10#1)(2009-11#1)(2013-8#2)
infected plant material##3##3##(2008-10#3)
infected plant tissue##3##3##(2008-10#3)
infected plant##13##2##(2008-10#13)
infected plants and##2##3##(2008-10#1)(2012-2#1)
infected plants in##4##3##(2008-10#4)
infected plants to##3##3##(2008-10#3)
infected plants was##2##3##(2008-10#2)
infected plants were##6##3##(2008-10#5)(2008-12#1)
infected plants##49##2##(2008-10#46)(2008-12#2)(2012-2#1)
infected pollen##3##2##(2008-10#3)
infected potato plants##2##3##(2008-10#2)
infected potato tubers##2##3##(2008-10#2)
infected potato##7##2##(2008-10#7)
infected psylla##2##2##(2008-10#2)
infected rat blood##2##3##(2013-1#2)
infected rats##2##2##(2008-12#2)
infected red blood cells##2##4##(1990-12#1)(2012-2#1)
infected resistant##2##2##(2008-10#2)
infected rhododendron##2##2##(2008-10#2)
infected root tissue##2##3##(2008-10#2)
infected roots in##2##3##(2008-10#2)
infected roots##8##2##(2008-10#8)
infected samples##3##2##(2008-10#2)(2008-9#1)
infected seed of##3##3##(2008-10#3)
infected seed##8##2##(2008-10#8)
infected seeds##4##2##(2008-10#3)(2008-12#1)
infected sites##2##2##(2008-10#1)(2008-6#1)
infected snails##2##2##(2012-3#2)
infected source plants at##2##4##(2008-10#2)
infected source plants##3##3##(2008-10#3)
infected soybean##4##2##(1997-6#1)(2008-10#3)
infected spikelets##4##2##(2008-10#4)
infected stands##3##2##(2008-10#3)
infected stem##2##2##(2008-10#2)
infected subdural hematoma##3##3##(2008-7#3)
infected the##4##2##(2008-10#4)
infected ticks##3##2##(1996-11#1)(1997-4#1)(2008-10#1)
infected tissue##12##2##(2008-10#8)(2008-8#1)(2008-9#1)(2011-2#2)
infected tissues##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
infected to##2##2##(2008-10#1)(2008-9#1)
infected tobacco##3##2##(2008-10#3)
infected tomato plants##5##3##(2008-10#5)
infected tomato##6##2##(2008-10#6)
infected trees##12##2##(2008-10#12)
infected trees)##2##2##(2008-10#2)
infected tubers##4##2##(2008-10#4)
infected via##2##2##(2008-10#2)
infected vines as##2##3##(2008-10#2)
infected vines##5##2##(2008-10#5)
infected was##3##2##(2008-10#3)
infected wheat##3##2##(2008-10#3)
infected when##2##2##(2008-10#1)(2010-3#1)
infected wild##2##2##(2008-10#2)
infected with AIDS##2##3##(1993-2#1)(1993-8#1)
infected with ALSV-YFP##2##3##(2008-10#2)
infected with B##3##3##(2008-10#1)(2010-6#2)
infected with C##4##3##(2008-10#4)
infected with CMV##2##3##(2008-10#2)
infected with E##2##3##(2008-10#1)(2008-11#1)
infected with F##6##3##(2008-10#4)(2008-12#1)(2011-10#1)
infected with HBV##2##3##(2013-1#2)
infected with HIV##15##3##(1991-11#1)(1993-1#1)(1993-6#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(2007-12#1)(2008-10#2)(2009-4#1)(2011-2#1)
infected with HIV-1##2##3##(1992-8#1)(2008-12#1)
infected with M##4##3##(1992-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
infected with PVX alone##2##4##(2008-10#2)
infected with PVX##3##3##(2008-10#3)
infected with R##5##3##(2008-10#4)(2009-6#1)
infected with S##5##3##(1996-12#1)(1996-8#1)(2008-10#1)(2012-3#2)
infected with Salmonella enterica serovar Enteritidis##2##6##(1997-3#2)
infected with Xanthomonas##2##3##(2008-10#2)
infected with a recombinant baculovirus##3##5##(1993-8#1)(2008-10#1)(2008-7#1)
infected with a recombinant##6##4##(1991-5#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
infected with a##17##3##(1991-5#1)(1993-8#1)(1994-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-7#1)(2011-2#1)(2012-2#1)
infected with both viruses##3##4##(2008-10#3)
infected with both##5##3##(2008-10#5)
infected with either the##2##4##(2008-10#2)
infected with either##5##3##(1994-6#1)(2007-2#1)(2008-10#2)(2008-7#1)
infected with human immunodeficiency virus (HIV)##2##6##(2006-10#1)(2008-11#1)
infected with human immunodeficiency virus##4##5##(2006-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
infected with human##7##3##(1991-12#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2011-2#1)
infected with isolates of a##2##5##(2008-10#2)
infected with isolates##3##3##(2008-10#3)
infected with mixtures##2##3##(2008-10#2)
infected with only##2##3##(2008-10#2)
infected with recombinant baculovirus containing##2##5##(1994-10#1)(1997-4#1)
infected with recombinant baculovirus##3##4##(1994-10#1)(1997-4#1)(2008-2#1)
infected with recombinant baculoviruses##2##4##(1992-8#1)(1997-8#1)
infected with recombinant##7##3##(1992-8#1)(1994-10#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-2#1)
infected with the apple proliferation phytoplasma##2##6##(2008-10#2)
infected with the pathogen##2##4##(2008-10#2)
infected with the recombinant##2##4##(2008-11#1)(2011-3#1)
infected with the virus##5##4##(1994-3#1)(1994-8#1)(1996-2#1)(2008-10#2)
infected with the##34##3##(1993-1#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-4#1)(1997-6#4)(2007-7#1)(2008-10#16)(2008-11#1)(2008-9#1)(2009-7#1)(2011-3#1)(2012-3#1)
infected with this##2##3##(2008-10#2)
infected with wild-type##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
infected with##262##2##(1991-11#2)(1991-12#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-8#3)(1993-1#2)(1993-2#1)(1993-6#7)(1993-8#3)(1994-10#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#8)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#119)(2008-11#10)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-6#2)(2011-1#1)(2011-10#1)(2011-2#6)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#9)(2013-1#6)
infected women##6##2##(1990-6#2)(1994-11#1)(1994-9#1)(1996-12#1)(2011-1#1)
infected wounds##4##2##(1991-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
infected##1045##1##(1990-12#1)(1990-2#6)(1990-3#2)(1990-6#4)(1990-7#1)(1990-9#3)(1991-11#4)(1991-12#5)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#6)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#9)(1993-8#13)(1994-10#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-12#4)(1995-2#5)(1995-6#1)(1995-9#6)(1996-11#5)(1996-12#14)(1996-2#2)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#10)(1997-4#9)(1997-5#5)(1997-6#11)(1997-8#2)(2006-10#2)(2007-10#3)(2007-12#12)(2007-2#3)(2007-6#4)(2007-7#12)(2007-8#4)(2008-1#3)(2008-10#523)(2008-11#44)(2008-12#21)(2008-2#2)(2008-4#12)(2008-5#21)(2008-6#7)(2008-7#11)(2008-8#11)(2008-9#24)(2009-10#3)(2009-11#2)(2009-2#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#22)(2011-3#9)(2012-1#1)(2012-12#10)(2012-2#10)(2012-3#28)(2013-1#16)(2013-8#10)
infected)##4##1##(2008-10#3)(2008-11#1)
infecting organism##2##2##(2007-12#1)(2008-8#1)
infecting organisms##3##2##(2007-12#2)(2008-5#1)
infecting species##3##2##(2008-10#3)
infecting the##2##2##(2008-10#2)
infecting tomato in##2##3##(2008-10#2)
infecting tomato##3##2##(2008-10#3)
infecting##50##1##(1991-11#1)(1991-3#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-12#3)(2008-10#33)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)(2013-1#2)
infection (20##2##2##(2007-7#1)(2008-10#1)
infection (27##2##2##(1994-12#1)(2008-8#1)
infection (8)##2##2##(1997-5#1)(2007-11#1)
infection (i##2##2##(2008-5#1)(2013-8#1)
infection (p##2##2##(2010-12#1)(2013-1#1)
infection acquired##3##2##(1990-9#1)(2007-2#1)(2009-8#1)
infection after##9##2##(1996-11#1)(1996-12#1)(2007-8#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
infection age##2##2##(2012-12#2)
infection almost##2##2##(1991-11#1)(2007-12#1)
infection also##2##2##(1991-6#1)(2011-2#1)
infection among the##3##3##(1990-3#1)(2007-7#2)
infection among##26##2##(1990-2#1)(1990-3#1)(1991-12#1)(1995-9#1)(1997-3#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#7)(2013-1#3)
infection amongst##2##2##(2007-7#2)
infection and a##2##3##(1993-12#1)(2012-2#1)
infection and aflatoxin##3##3##(2008-10#3)
infection and associated##2##3##(2008-11#1)(2009-6#1)
infection and cancer##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
infection and clinical##4##3##(1991-8#1)(2007-12#1)(2010-8#1)(2011-2#1)
infection and colonization by##2##4##(2008-10#2)
infection and colonization of##2##4##(2008-10#2)
infection and colonization##5##3##(2008-10#5)
infection and disease##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
infection and growth of##2##4##(2008-11#1)(2008-4#1)
infection and hepatitis##2##3##(1991-6#1)(2008-1#1)
infection and high##2##3##(2008-11#2)
infection and it##2##3##(2008-10#1)(2012-12#1)
infection and its##5##3##(2007-12#1)(2007-7#1)(2008-10#1)(2010-6#1)(2011-1#1)
infection and nodule##2##3##(2011-2#2)
infection and precancerous lesions##4##4##(2011-3#4)
infection and reproduction##2##3##(2008-10#1)(2008-8#1)
infection and risk of##3##4##(1994-2#2)(2008-10#1)
infection and sporulation##2##3##(2008-10#2)
infection and subsequent##2##3##(2008-10#2)
infection and suggest that##2##4##(1997-1#1)(2012-2#1)
infection and the##14##3##(1990-6#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
infection and to##5##3##(2008-12#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-2#1)
infection and##212##2##(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-2#3)(1994-5#1)(1996-11#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-4#2)(1997-6#2)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#5)(2008-1#4)(2008-10#53)(2008-11#10)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-6#2)(2010-8#3)(2011-1#10)(2011-2#15)(2011-3#7)(2012-12#11)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#2)
infection and/or##2##2##(2007-12#1)(2008-10#1)
infection are also##2##3##(2007-7#1)(2008-9#1)
infection are not##3##3##(2007-12#1)(2007-2#1)(2012-12#1)
infection are##24##2##(1995-12#1)(1995-3#1)(1996-11#1)(1997-4#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
infection as##7##2##(1991-3#1)(1995-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)
infection associated with##5##3##(1991-3#1)(1992-11#1)(1996-3#1)(2007-7#1)(2010-12#1)
infection at the##6##3##(2008-10#2)(2008-11#2)(2009-8#1)(2012-2#1)
infection at##17##2##(1991-2#1)(2008-10#9)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#2)
infection attending##2##2##(1996-2#1)(2007-2#1)
infection based on##2##3##(2008-10#2)
infection because##3##2##(2008-10#1)(2009-4#1)(2012-12#1)
infection between##2##2##(2008-10#2)
infection but##2##2##(2008-10#1)(2012-2#1)
infection by A##2##3##(2008-10#2)
infection by Botrytis cinerea was##2##5##(2008-10#2)
infection by F##3##3##(2008-10#3)
infection by Fusarium##2##3##(2008-10#2)
infection by M##8##3##(1990-12#1)(2008-10#7)
infection by P##4##3##(2008-10#4)
infection by Pythium##2##3##(2008-10#2)
infection by Rhizoctonia##2##3##(2008-10#2)
infection by Stagonospora nodorum##2##4##(2008-10#2)
infection by a##4##3##(1996-6#1)(2008-10#2)(2009-10#1)
infection by ascospores##3##3##(2008-10#3)
infection by species of##2##4##(2008-10#2)
infection by the pathogen##2##4##(2008-10#2)
infection by the##11##3##(1990-9#1)(1996-8#1)(2007-11#1)(2007-2#1)(2008-10#6)(2011-1#1)
infection by this pathogen##2##4##(2008-10#1)(2009-8#1)
infection by##127##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#85)(2008-12#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#5)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
infection can be##5##3##(1990-9#1)(1994-2#1)(1997-1#1)(2007-12#1)(2007-2#1)
infection can cause##2##3##(1992-5#1)(2013-1#1)
infection can result in##2##4##(2006-10#1)(2013-1#1)
infection can##12##2##(1990-9#1)(1992-5#1)(1994-2#1)(1997-1#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-8#1)(2013-1#2)
infection caused by Pseudomonas syringae pv##2##6##(2008-10#2)
infection caused by##14##3##(1990-3#1)(1995-8#1)(1996-3#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-10#1)(2010-12#1)
infection caused##15##2##(1990-3#1)(1995-8#1)(1996-3#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-10#1)(2010-12#1)
infection causes a##2##3##(1992-12#1)(1997-1#1)
infection compared to##3##3##(2007-7#1)(2011-10#1)(2011-2#1)
infection compared##4##2##(2007-7#2)(2011-10#1)(2011-2#1)
infection complications##2##2##(2011-2#1)(2013-1#1)
infection control link##3##3##(2008-11#3)
infection control measures was##2##4##(2008-1#2)
infection control measures##5##3##(2008-1#4)(2009-5#1)
infection control policies##3##3##(2007-2#2)(2008-10#1)
infection control practice in##2##4##(2012-12#2)
infection control practices in##2##4##(2011-2#1)(2012-12#1)
infection control precautions##3##3##(2007-7#3)
infection control procedures in the##2##5##(2008-1#1)(2008-11#1)
infection control strategies##4##3##(2007-12#1)(2007-7#1)(2010-11#1)(2011-2#1)
infection control was##3##3##(2006-10#1)(2007-11#2)
infection control##46##2##(1995-3#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#4)(2008-1#6)(2008-10#3)(2008-11#6)(2008-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#3)
infection could be##2##3##(2008-10#1)(2013-1#1)
infection could##7##2##(1990-3#1)(1994-2#1)(1997-6#1)(2008-10#3)(2013-1#1)
infection court##5##2##(2008-10#5)
infection courts##5##2##(2008-10#5)
infection cushions##2##2##(2008-10#2)
infection cycle##4##2##(2008-10#3)(2008-7#1)
infection cycles##2##2##(2008-10#2)
infection decreased##2##2##(2008-10#1)(2008-11#1)
infection density##3##2##(2008-10#2)(2008-11#1)
infection depends##2##2##(2007-2#1)(2008-10#1)
infection developed##2##2##(1991-6#1)(2012-12#1)
infection disease caused by##2##4##(2007-8#1)(2009-3#1)
infection due to Mycobacterium##2##4##(1991-11#1)(2007-12#1)
infection due to##9##3##(1990-8#1)(1991-11#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-9#1)(2010-12#1)(2013-1#1)
infection during pregnancy##3##3##(1990-9#1)(1992-4#1)(2007-7#1)
infection during the##4##3##(1996-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
infection during##10##2##(1990-9#2)(1992-4#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
infection dynamics##3##2##(2008-8#1)(2009-6#2)
infection early##2##2##(2008-10#1)(2011-2#1)
infection efficiency and##2##3##(2008-10#2)
infection efficiency as##2##3##(2008-10#2)
infection efficiency of##2##3##(2008-10#2)
infection efficiency##19##2##(2008-10#18)(2011-3#1)
infection events##2##2##(2008-10#2)
infection experiments##2##2##(2008-10#2)
infection following##3##2##(2007-6#1)(2007-7#1)(2009-6#1)
infection for the##5##3##(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
infection for##13##2##(1995-1#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#2)
infection found##2##2##(2008-10#1)(2012-3#1)
infection frequency##7##2##(2008-10#6)(2008-8#1)
infection from the##2##3##(2008-1#1)(2011-2#1)
infection from##11##2##(1995-12#1)(1996-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
infection had##3##2##(2008-10#3)
infection has been##4##3##(1994-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
infection has shown##2##3##(1990-3#1)(2013-8#1)
infection has##16##2##(1990-3#1)(1994-11#1)(1996-11#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#2)
infection have been##2##3##(2009-4#1)(2009-8#1)
infection have##6##2##(2009-4#1)(2009-8#3)(2010-10#1)(2011-1#1)
infection hypha##2##2##(2008-10#2)
infection hyphae##8##2##(2008-10#7)(2012-2#1)
infection in AIDS patients##2##4##(1991-3#1)(2008-5#1)
infection in Canada##5##3##(2007-12#5)
infection in a##17##3##(1990-3#1)(1991-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-5#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(2009-4#2)(2010-12#1)(2012-3#1)(2013-1#1)
infection in adults##2##3##(2007-12#1)(2010-8#1)
infection in an infant##2##4##(1995-6#1)(2008-10#1)
infection in an##6##3##(1992-12#1)(1995-6#2)(2008-10#1)(2009-6#1)(2010-12#1)
infection in both##3##3##(2008-10#2)(2012-2#1)
infection in cattle in##2##4##(1997-5#1)(2012-2#1)
infection in chickens##2##3##(1997-6#1)(2011-1#1)
infection in children##4##3##(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#1)
infection in chronic##2##3##(2009-8#1)(2011-1#1)
infection in commercial##2##3##(1990-3#1)(2008-10#1)
infection in diabetic patients and##2##5##(2008-1#2)
infection in diabetic##3##3##(2008-1#2)(2008-5#1)
infection in humans##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
infection in immunocompromised##2##3##(1996-6#1)(2009-11#1)
infection in kernels of maize##2##5##(2008-10#2)
infection in kernels##3##3##(2008-10#3)
infection in males##2##3##(1991-2#2)
infection in mice##3##3##(1996-12#1)(2012-2#1)(2013-1#1)
infection in patients undergoing##2##4##(2007-7#1)(2011-2#1)
infection in patients with##4##4##(2006-10#1)(2008-5#1)(2010-8#1)(2013-8#1)
infection in patients##6##3##(2006-10#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
infection in potato##2##3##(2008-10#1)(2009-6#1)
infection in pregnancy##3##3##(2008-11#1)(2009-8#1)(2012-3#1)
infection in pregnant women##3##4##(1994-6#1)(2007-12#1)(2007-7#1)
infection in the chicken##2##4##(2008-5#2)
infection in the hemodialysis (HD)##2##5##(2007-7#1)(2008-1#1)
infection in the newborn##2##4##(2012-12#1)(2013-1#1)
infection in the resistant##2##4##(2008-10#2)
infection in the##36##3##(1990-11#1)(1991-2#1)(1993-11#1)(1994-2#3)(1994-3#1)(1996-11#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-8#3)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#4)
infection in these##2##3##(2006-10#1)(2008-10#1)
infection in transplant##2##3##(1991-3#1)(2007-12#1)
infection in two##2##3##(1995-8#1)(2008-10#1)
infection in which##2##3##(2011-2#2)
infection in women##3##3##(1994-9#1)(2008-12#1)(2013-1#1)
infection in##253##2##(1990-11#1)(1990-3#4)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#4)(1991-3#4)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#2)(1993-11#3)(1993-5#1)(1994-2#3)(1994-3#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#3)(1996-12#2)(1996-3#3)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2006-10#2)(2007-11#1)(2007-12#11)(2007-6#1)(2007-7#12)(2007-8#1)(2008-1#6)(2008-10#49)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#7)(2011-2#19)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#10)(2013-8#2)
infection incidence to##2##3##(1990-3#1)(2008-10#1)
infection incidence was##2##3##(1990-3#1)(2008-10#1)
infection incidence##7##2##(1990-3#2)(1992-6#1)(2008-10#4)
infection included the##2##3##(2008-10#1)(2008-7#1)
infection increased##3##2##(2008-10#2)(2011-3#1)
infection intensities and##2##3##(1994-9#2)
infection intensities##3##2##(1994-9#3)
infection is a life-threatening complication##2##5##(2011-3#1)(2012-2#1)
infection is a major##2##4##(2007-7#1)(2008-2#1)
infection is a##8##3##(1995-5#1)(2007-7#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
infection is associated with##2##4##(2008-12#1)(2013-1#1)
infection is endemic##3##3##(1991-11#1)(2007-2#1)(2011-2#1)
infection is presented##2##3##(2008-12#1)(2012-3#1)
infection is the most common##2##5##(2008-11#2)
infection is the most##3##4##(2008-11#2)(2008-8#1)
infection is the##9##3##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2010-12#1)(2012-3#1)
infection is##63##2##(1990-6#2)(1990-9#2)(1991-11#1)(1991-3#1)(1992-4#1)(1993-6#1)(1995-5#1)(1996-6#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-7#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
infection level##4##2##(2008-10#4)
infection level)##2##2##(2008-10#2)
infection levels##6##2##(2008-10#2)(2009-5#3)(2010-8#1)
infection management##3##2##(2011-2#3)
infection may be an##2##4##(2007-10#1)(2008-10#1)
infection may be##8##3##(1990-6#1)(1991-2#1)(2007-10#1)(2008-10#2)(2008-7#1)(2012-2#2)
infection may##16##2##(1990-6#1)(1991-11#1)(1991-2#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-7#1)(2009-2#1)(2012-2#2)
infection might##2##2##(2009-6#1)(2009-8#1)
infection model##4##2##(2008-10#3)(2013-8#1)
infection models##2##2##(2008-10#1)(2012-2#1)
infection occurred##4##2##(1997-6#1)(2007-7#2)(2008-10#1)
infection occurs in##2##3##(2007-12#1)(2008-10#1)
infection occurs##3##2##(2007-12#1)(2008-10#2)
infection of 30##2##3##(1992-5#1)(2008-11#1)
infection of Arabidopsis thaliana##2##4##(2008-10#2)
infection of E##3##3##(1991-5#1)(1991-9#1)(1997-3#1)
infection of Nicotiana##2##3##(2008-10#2)
infection of a##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
infection of adult##2##3##(1993-2#1)(2008-9#1)
infection of an##2##3##(2007-8#1)(2009-4#1)
infection of apple##2##3##(2008-10#2)
infection of both##2##3##(2008-10#1)(2011-1#1)
infection of cells##2##3##(1992-12#1)(2008-9#1)
infection of human##2##3##(1991-2#1)(2011-1#1)
infection of maize##3##3##(2008-10#3)
infection of primary##3##3##(2008-2#1)(2008-4#2)
infection of susceptible##5##3##(2008-10#5)
infection of the brain##2##4##(1995-2#1)(2008-2#1)
infection of the central nervous system##5##6##(2007-12#1)(2008-7#2)(2010-12#1)(2011-2#1)
infection of the host##2##4##(2008-10#2)
infection of the lower genital tract##2##6##(1991-2#2)
infection of the respiratory##2##4##(1997-7#1)(2008-5#1)
infection of the upper##3##4##(1992-11#1)(1996-6#1)(2008-10#1)
infection of the##39##3##(1991-2#2)(1991-3#1)(1992-11#1)(1994-11#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#2)(2009-6#1)(2010-10#2)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
infection of this##2##3##(2008-10#1)(2012-12#1)
infection of tobacco with##3##4##(2008-10#2)(2012-2#1)
infection of tobacco##6##3##(2008-10#5)(2012-2#1)
infection of##164##2##(1990-9#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-11#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#4)(2008-10#64)(2008-11#4)(2008-12#2)(2008-2#3)(2008-4#5)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#5)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-10#1)(2011-2#7)(2011-3#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
infection often##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
infection on one hand##2##4##(2008-7#1)(2010-6#1)
infection on the##8##3##(1990-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-8#1)(2013-1#1)
infection on##33##2##(1990-2#1)(1991-5#1)(1992-9#2)(1995-9#1)(1997-1#1)(1997-3#1)(2006-5#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-1#2)(2013-8#1)
infection or##18##2##(1991-2#1)(1992-2#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
infection over##2##2##(2008-10#1)(2008-5#1)
infection peg##2##2##(2008-10#2)
infection period##2##2##(2008-10#2)
infection periods in##2##3##(2008-10#2)
infection periods##6##2##(2008-10#6)
infection phase##3##2##(2008-10#2)(2008-11#1)
infection prevalence##2##2##(2008-1#1)(2011-1#1)
infection prevention##5##2##(1993-6#3)(2008-8#1)(2013-8#1)
infection process and the##3##4##(2008-10#1)(2010-10#2)
infection process and##4##3##(2008-10#2)(2010-10#2)
infection process##15##2##(2008-10#7)(2010-10#6)(2011-10#2)
infection processes##2##2##(2008-10#2)
infection progress##2##2##(2008-10#2)
infection rate by##2##3##(2008-10#2)
infection rate for##2##3##(2007-7#1)(2012-2#1)
infection rate in##2##3##(2008-10#1)(2012-2#1)
infection rate of##6##3##(1996-8#1)(2008-10#3)(2012-3#2)
infection rate to##2##3##(2008-10#2)
infection rate was##3##3##(1991-9#1)(2008-10#2)
infection rate##30##2##(1990-3#1)(1991-9#1)(1996-12#1)(1996-8#1)(1997-3#1)(2007-7#1)(2008-10#19)(2008-8#1)(2012-2#2)(2012-3#2)
infection rates of##2##3##(2008-10#1)(2012-3#1)
infection rates##17##2##(1990-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2009-5#1)(2010-12#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
infection regardless of##2##3##(2008-10#1)(2012-2#1)
infection remains##2##2##(2007-11#1)(2011-2#1)
infection reported##2##2##(2007-12#1)(2008-10#1)
infection requires##2##2##(2008-10#1)(2008-8#1)
infection resulted in##3##3##(1992-12#1)(2008-10#2)
infection risk##5##2##(1991-6#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
infection severity##2##2##(2008-10#2)
infection should be##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
infection showed##3##2##(1992-12#1)(1992-2#1)(1996-8#1)
infection significantly increased##2##3##(2008-10#2)
infection site##5##2##(2008-10#5)
infection sites and##2##3##(2008-10#2)
infection sites##5##2##(2008-10#5)
infection sources##3##2##(2008-10#3)
infection status among##2##3##(2011-1#1)(2011-2#1)
infection status##5##2##(1993-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
infection structure##4##2##(2008-10#4)
infection structures##5##2##(2008-10#5)
infection such as##2##3##(1990-6#1)(2013-8#1)
infection than##3##2##(2008-10#2)(2012-12#1)
infection that can##3##3##(2007-2#1)(2008-9#1)(2012-3#1)
infection that##9##2##(1990-9#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
infection through##5##2##(2008-10#3)(2009-6#1)(2011-2#1)
infection times for ascospores##2##4##(2008-10#2)
infection times##5##2##(2008-10#5)
infection to occur##3##3##(2008-10#3)
infection to the##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
infection to##21##2##(1990-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1996-6#1)(2007-2#1)(2008-10#10)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)
infection transmission##2##2##(2008-8#1)(2011-3#1)
infection type data##2##3##(2008-10#2)
infection type##11##2##(2008-10#11)
infection types##3##2##(2008-10#3)
infection under##2##2##(2008-10#2)
infection until##2##2##(2008-10#1)(2011-2#1)
infection using##2##2##(2008-10#1)(2011-2#1)
infection vesicles and primary hyphae##2##5##(2008-10#2)
infection vesicles and##3##3##(2008-10#3)
infection vesicles##6##2##(2008-10#6)
infection was associated with##3##4##(2008-10#3)
infection was confirmed by##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
infection was detected##2##3##(2007-7#1)(2008-10#1)
infection was determined##2##3##(2008-10#2)
infection was diagnosed##2##3##(1996-12#1)(1997-5#1)
infection was due to##2##4##(1996-11#1)(2008-10#1)
infection was found to be##3##5##(2011-2#1)(2012-3#2)
infection was found##4##3##(1996-12#1)(2011-2#1)(2012-3#2)
infection was identified##2##3##(2008-10#2)
infection was investigated##2##3##(2007-8#1)(2008-10#1)
infection was not##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
infection was strongly##2##3##(2008-10#2)
infection was studied in##2##4##(1994-5#1)(2011-2#1)
infection was the##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
infection was##76##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-6#1)(1994-5#1)(1996-11#1)(1996-12#3)(1997-5#1)(1997-6#1)(2007-12#1)(2007-7#5)(2007-8#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-3#4)(2013-1#2)
infection were detected in##2##4##(2008-10#1)(2013-8#1)
infection were detected##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
infection were not##2##3##(2008-10#2)
infection were observed##2##3##(2008-10#2)
infection were obtained for##2##4##(2008-10#1)(2012-12#1)
infection were##32##2##(1992-2#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-5#2)(2008-7#2)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#1)
infection when the##2##3##(1994-2#1)(2008-10#1)
infection when##9##2##(1994-2#1)(1997-3#1)(2008-10#4)(2010-5#1)(2010-6#1)(2013-8#1)
infection with C##4##3##(2007-12#1)(2007-6#1)(2008-10#1)(2010-8#1)
infection with Chlamydia trachomatis##3##4##(1990-6#1)(1995-6#1)(2010-8#1)
infection with HIV##2##3##(1991-6#1)(2011-2#1)
infection with S##3##3##(2007-7#1)(2008-12#1)(2009-6#1)
infection with T##3##3##(2008-5#1)(2009-6#1)(2011-2#1)
infection with a##10##3##(1992-12#1)(1994-11#1)(1997-6#1)(2008-10#4)(2011-2#2)(2013-7#1)
infection with an##6##3##(2007-7#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
infection with chronic hepatitis B##2##5##(2009-8#2)
infection with chronic##4##3##(2008-5#2)(2009-8#2)
infection with different##2##3##(1990-6#1)(2013-8#1)
infection with hepatitis##3##3##(1990-3#1)(2007-2#1)(2013-8#1)
infection with high-risk##2##3##(2011-2#1)(2012-12#1)
infection with human##3##3##(1991-2#1)(1996-12#1)(2009-12#1)
infection with no##2##3##(2008-10#1)(2011-2#1)
infection with pathogenic##2##3##(2007-11#1)(2008-9#1)
infection with the##9##3##(1990-6#1)(1996-12#1)(1996-6#1)(1997-4#1)(2007-10#1)(2008-10#1)(2009-6#1)(2010-5#1)(2013-8#1)
infection with##119##2##(1990-3#1)(1990-5#1)(1990-6#3)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#7)(1996-6#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#4)(2009-8#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
infection within##5##2##(2007-11#1)(2008-10#4)
infection would##2##2##(1995-12#1)(2008-5#1)
infection##2667##1##(1990-11#2)(1990-12#5)(1990-2#6)(1990-3#15)(1990-5#1)(1990-6#17)(1990-8#4)(1990-9#14)(1991-1#3)(1991-11#8)(1991-12#2)(1991-2#12)(1991-3#11)(1991-4#1)(1991-5#3)(1991-6#8)(1991-7#1)(1991-8#8)(1991-9#9)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#7)(1992-3#3)(1992-4#3)(1992-5#6)(1992-6#7)(1992-8#2)(1992-9#6)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#4)(1994-11#8)(1994-12#3)(1994-2#12)(1994-3#1)(1994-5#5)(1994-6#7)(1994-8#2)(1994-9#5)(1995-1#3)(1995-12#8)(1995-2#8)(1995-3#3)(1995-5#3)(1995-6#6)(1995-8#3)(1995-9#8)(1996-11#18)(1996-12#19)(1996-2#2)(1996-3#9)(1996-5#3)(1996-6#10)(1996-8#8)(1996-9#2)(1997-1#15)(1997-2#2)(1997-3#21)(1997-4#9)(1997-5#9)(1997-6#13)(1997-7#5)(1997-8#2)(2006-10#20)(2006-12#1)(2006-5#1)(2007-10#15)(2007-11#14)(2007-12#72)(2007-2#21)(2007-6#7)(2007-7#81)(2007-8#17)(2008-1#41)(2008-10#826)(2008-11#67)(2008-12#35)(2008-2#24)(2008-3#2)(2008-4#26)(2008-5#60)(2008-6#9)(2008-7#55)(2008-8#44)(2008-9#50)(2009-10#7)(2009-11#1)(2009-12#5)(2009-2#4)(2009-3#4)(2009-4#12)(2009-5#25)(2009-6#18)(2009-7#3)(2009-8#26)(2009-9#1)(2010-10#21)(2010-11#6)(2010-12#27)(2010-3#6)(2010-4#8)(2010-5#9)(2010-6#15)(2010-7#2)(2010-8#20)(2011-1#41)(2011-10#9)(2011-2#153)(2011-3#24)(2012-1#2)(2012-12#65)(2012-2#61)(2012-3#42)(2013-1#90)(2013-7#1)(2013-8#45)
infection) and##4##2##(2008-10#3)(2011-3#1)
infection)##12##1##(1996-11#1)(2007-11#1)(2008-10#6)(2008-3#1)(2011-3#2)(2013-8#1)
infection-associated##2##1##(2008-10#1)(2011-1#1)
infection-inhibiting factor##2##2##(2008-10#2)
infection-related##3##1##(2008-10#1)(2008-7#1)(2009-8#1)
infection-type##2##1##(2008-10#2)
infection?##4##1##(2007-12#1)(2008-10#1)(2012-1#2)
infection]##23##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-6#2)(1992-2#2)(1993-2#1)(1993-5#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
infectionin##2##1##(2008-11#1)(2010-12#1)
infections after##5##2##(2007-8#1)(2008-7#1)(2011-2#3)
infections among the##3##3##(1992-11#1)(2008-10#1)(2008-12#1)
infections among##13##2##(1992-11#1)(2007-7#1)(2008-10#1)(2008-12#3)(2010-11#1)(2011-1#3)(2013-1#1)(2013-8#2)
infections and allergic##2##3##(1994-8#1)(2009-5#1)
infections and cancer##2##3##(1994-12#1)(2013-8#1)
infections and in##2##3##(1990-6#1)(1997-3#1)
infections and infectious complications##2##4##(2008-5#2)
infections and malignancies##2##3##(2011-2#1)(2011-3#1)
infections and risk##2##3##(1990-6#1)(1997-3#1)
infections and the##6##3##(1991-5#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
infections and use of##2##4##(1990-6#1)(2011-2#1)
infections and##67##2##(1990-12#1)(1990-3#1)(1990-6#3)(1991-11#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-11#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
infections are a##2##3##(2008-11#1)(2011-2#1)
infections are associated with##2##4##(2011-2#1)(2012-12#1)
infections are common##2##3##(2011-2#1)(2012-1#1)
infections are not##4##3##(1995-2#1)(1996-12#1)(2011-2#2)
infections are rare##2##3##(1991-11#1)(2010-12#1)
infections are still##2##3##(2008-12#1)(2011-2#1)
infections are the##2##3##(2011-2#1)(2011-3#1)
infections are##36##2##(1990-6#1)(1991-11#1)(1992-6#2)(1994-5#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-4#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#1)(2013-8#1)
infections as##3##2##(1990-5#1)(2011-2#1)(2013-8#1)
infections associated with##5##3##(2007-12#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
infections at the##2##3##(2008-10#1)(2011-2#1)
infections at##6##2##(1993-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#1)
infections both##2##2##(1990-10#1)(2012-3#1)
infections by the##2##3##(2007-6#1)(2010-3#1)
infections by##12##2##(1990-6#2)(2007-2#1)(2007-6#1)(2008-10#4)(2009-4#1)(2010-3#1)(2013-1#1)(2013-8#1)
infections can be##5##3##(2007-7#1)(2008-10#2)(2012-12#1)(2012-3#1)
infections can##7##2##(1990-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2012-12#1)(2012-3#1)
infections caused by##18##3##(1990-2#1)(1990-6#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
infections caused##19##2##(1990-2#1)(1990-6#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
infections could##2##2##(2008-10#2)
infections due to##8##3##(1990-6#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
infections during the##2##3##(2008-10#2)
infections during##3##2##(2008-10#2)(2010-8#1)
infections from##2##2##(2008-10#1)(2009-3#1)
infections has been##6##3##(2008-10#1)(2008-5#2)(2009-2#1)(2010-5#1)(2011-2#1)
infections has##9##2##(1990-2#1)(1997-2#1)(2008-10#1)(2008-5#2)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
infections have been##6##3##(1990-6#1)(1993-2#1)(2008-10#2)(2011-1#1)(2013-1#1)
infections have increased##2##3##(1997-6#1)(2008-10#1)
infections have##17##2##(1990-11#1)(1990-6#1)(1993-2#1)(1997-3#1)(1997-6#2)(2008-10#3)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
infections if##2##2##(2008-10#1)(2013-8#1)
infections in a##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
infections in all##2##3##(2008-5#1)(2012-3#1)
infections in both##2##3##(2008-10#2)
infections in children##5##3##(2007-12#1)(2008-11#1)(2009-5#2)(2012-12#1)
infections in children]##2##3##(1990-2#1)(2009-5#1)
infections in cystic fibrosis (CF)##2##5##(2007-12#1)(2008-5#1)
infections in humans##9##3##(1990-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
infections in patients undergoing##2##4##(2007-10#1)(2009-3#1)
infections in patients with##4##4##(2008-5#1)(2008-7#2)(2012-2#1)
infections in patients##9##3##(1990-9#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2012-12#1)(2012-2#1)
infections in the field##2##4##(2008-10#2)
infections in the##17##3##(1992-2#1)(1993-11#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#1)
infections in women##2##3##(2011-1#1)(2011-2#1)
infections in##137##2##(1990-2#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-2#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#4)(2008-5#8)(2008-7#7)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2010-10#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#3)
infections is discussed##2##3##(2008-10#1)(2011-2#1)
infections is##10##2##(1993-3#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-8#1)(2009-2#1)(2011-2#2)
infections lead to##2##3##(2008-10#1)(2013-1#1)
infections like##2##2##(2009-12#1)(2012-2#1)
infections make##2##2##(1997-4#1)(2008-10#1)
infections may also##2##3##(2008-10#1)(2011-2#1)
infections may##8##2##(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#2)(2013-8#1)
infections must be##2##3##(2007-12#1)(2007-8#1)
infections observed in##2##3##(1991-9#1)(2008-9#1)
infections occur##5##2##(2007-7#1)(2008-10#2)(2008-8#1)(2012-2#1)
infections occurred##4##2##(1992-9#1)(2007-8#1)(2008-10#1)(2012-3#1)
infections of plant##2##3##(2008-10#1)(2008-9#1)
infections of the upper##3##4##(1991-6#1)(1992-11#1)(2008-10#1)
infections of the##15##3##(1991-6#1)(1992-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
infections of##41##2##(1991-6#1)(1991-8#1)(1992-11#1)(1993-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
infections on##5##2##(2008-10#4)(2008-7#1)
infections or##8##2##(1990-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
infections over##2##2##(2007-2#1)(2008-10#1)
infections reported in##3##3##(1995-3#1)(2007-12#1)(2011-3#1)
infections requires##2##2##(2010-4#1)(2011-1#1)
infections such as##5##3##(2006-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
infections that are##2##3##(2007-11#1)(2011-2#1)
infections that have##2##3##(2008-5#1)(2009-6#1)
infections that##8##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#3)
infections to##3##2##(2007-11#1)(2008-12#2)
infections using##3##2##(2007-6#1)(2007-7#1)(2008-10#1)
infections was##7##2##(1990-3#1)(1992-11#1)(2007-2#1)(2008-10#2)(2011-2#1)(2012-3#1)
infections were detected in##3##4##(2008-10#1)(2012-3#2)
infections were detected##6##3##(2008-10#4)(2012-3#2)
infections were monitored##2##3##(2008-10#2)
infections were observed##2##3##(2008-10#2)
infections were treated with##2##4##(2007-8#1)(2011-2#1)
infections were##32##2##(1990-6#1)(1990-9#1)(1991-8#1)(1993-2#1)(1994-11#1)(1996-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#14)(2008-12#1)(2011-2#1)(2012-3#3)(2013-8#2)
infections which##2##2##(2011-1#1)(2012-2#1)
infections with B##2##3##(1991-11#1)(1996-12#1)
infections with a##2##3##(1992-5#1)(2008-10#1)
infections with the##4##3##(1996-12#1)(2008-1#1)(2008-10#2)
infections with##27##2##(1990-6#3)(1991-11#1)(1992-2#1)(1992-5#1)(1994-8#1)(1996-11#2)(1996-12#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2009-5#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-8#2)
infections within##3##2##(2008-10#3)
infections worldwide##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
infections##971##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#5)(1990-5#2)(1990-6#21)(1990-8#2)(1990-9#3)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#3)(1992-2#4)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#5)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#6)(1996-12#14)(1996-3#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#14)(1997-4#10)(1997-5#1)(1997-6#9)(1997-7#1)(2006-10#4)(2007-10#4)(2007-11#13)(2007-12#37)(2007-2#12)(2007-5#1)(2007-6#6)(2007-7#20)(2007-8#12)(2008-1#9)(2008-10#168)(2008-11#13)(2008-12#30)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#33)(2008-6#2)(2008-7#27)(2008-8#14)(2008-9#13)(2009-12#2)(2009-2#7)(2009-3#5)(2009-4#9)(2009-5#14)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#9)(2010-5#8)(2010-6#7)(2010-7#2)(2010-8#6)(2011-1#22)(2011-2#85)(2011-3#7)(2012-1#4)(2012-12#15)(2012-2#28)(2012-3#29)(2013-1#40)(2013-7#2)(2013-8#35)
infections)##5##1##(1990-6#1)(1993-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
infections?##2##1##(1997-4#1)(2008-10#1)
infections]##14##1##(1990-12#1)(1990-2#1)(1991-6#1)(1993-11#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
infectious HIV##3##2##(1997-3#1)(2008-4#1)(2012-12#1)
infectious RNA##3##2##(2008-10#2)(2008-9#1)
infectious SFV and SIN##2##4##(2008-4#2)
infectious agent and the##2##4##(1995-5#1)(2012-3#1)
infectious agent##9##2##(1992-2#1)(1995-2#1)(1995-5#2)(1996-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
infectious agents in##2##3##(1991-11#1)(2008-8#1)
infectious agents##17##2##(1991-11#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#3)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#3)
infectious and##5##2##(1997-8#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
infectious bovine##2##2##(2008-11#1)(2013-8#1)
infectious bronchitis (IB)##2##3##(1997-3#1)(2008-5#1)
infectious bronchitis virus (IBV)##7##4##(1997-3#1)(1997-6#2)(2008-5#4)
infectious bronchitis virus in##3##4##(1997-6#1)(2008-5#2)
infectious bronchitis virus##19##3##(1996-11#1)(1997-3#3)(1997-6#5)(2007-6#1)(2008-5#9)
infectious bronchitis##23##2##(1996-11#1)(1997-3#4)(1997-6#5)(2007-6#1)(2008-5#11)(2013-8#1)
infectious bursal disease virus##4##4##(2008-5#4)
infectious bursal disease##5##3##(1997-6#1)(2008-5#4)
infectious clone of##3##3##(2008-10#2)(2008-9#1)
infectious clone##6##2##(2008-10#4)(2008-9#2)
infectious clones of##4##3##(2008-10#3)(2008-9#1)
infectious colitis##2##2##(2010-12#1)(2011-2#1)
infectious complications in##2##3##(2007-7#1)(2008-5#1)
infectious complications##11##2##(1991-12#2)(1997-8#1)(2007-11#1)(2007-7#1)(2008-5#2)(2008-7#1)(2011-2#2)(2011-3#1)
infectious coryza##4##2##(1997-3#1)(1997-6#1)(2008-5#2)
infectious diarrhea##2##2##(2007-12#1)(2008-10#1)
infectious disease and##2##3##(2007-12#1)(2008-12#1)
infectious disease caused by##2##4##(2007-7#1)(2010-8#1)
infectious disease in##5##3##(1991-3#1)(1993-3#1)(2007-7#1)(2008-11#1)(2008-7#1)
infectious disease outbreaks##2##3##(2010-2#1)(2010-5#1)
infectious disease physicians##2##3##(2007-12#1)(2010-6#1)
infectious disease to##2##3##(1997-3#1)(2010-6#1)
infectious disease##38##2##(1990-12#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-9#2)(1995-11#1)(1995-5#1)(1997-3#1)(2007-12#5)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#3)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
infectious diseases and microbiology##2##4##(2008-11#2)
infectious diseases and the##2##4##(2008-1#1)(2013-8#1)
infectious diseases and##10##3##(1990-6#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
infectious diseases are##4##3##(1996-2#1)(2007-6#1)(2008-11#1)(2011-2#1)
infectious diseases as##2##3##(1994-6#1)(2008-7#1)
infectious diseases for##2##3##(2008-10#1)(2009-12#1)
infectious diseases in children##2##4##(1997-8#2)
infectious diseases in##4##3##(1990-9#1)(1997-8#2)(2008-1#1)
infectious diseases of##3##3##(1997-8#1)(2008-11#1)(2009-2#1)
infectious diseases such as##4##4##(2008-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
infectious diseases##79##2##(1990-6#3)(1990-9#1)(1992-3#1)(1994-11#1)(1994-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#3)(1997-6#1)(1997-8#3)(2007-12#4)(2007-2#5)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
infectious endocarditis]##2##2##(1997-2#1)(1997-8#1)
infectious exacerbations##2##2##(2008-7#2)
infectious in vitro transcripts##3##4##(2008-10#3)
infectious in##10##2##(1997-3#3)(2008-10#7)
infectious keratitis##2##2##(2011-2#1)(2012-2#1)
infectious laryngotracheitis##3##2##(1992-2#1)(1997-6#1)(2013-8#1)
infectious markers##2##2##(2007-7#2)
infectious mononucleosis##6##2##(1992-2#1)(1992-4#1)(2008-5#2)(2008-9#1)(2011-2#1)
infectious odontostomatitis##2##2##(1990-2#2)
infectious on##4##2##(1997-3#1)(2008-10#2)(2008-9#1)
infectious or##2##2##(1996-11#1)(2008-10#1)
infectious organisms##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
infectious particle##2##2##(1990-11#1)(2011-3#1)
infectious pathogens##3##2##(2008-12#1)(2008-4#1)(2012-3#1)
infectious period##3##2##(2008-10#2)(2011-2#1)
infectious potential of this##2##4##(2008-5#1)(2012-12#1)
infectious process##4##2##(2006-10#1)(2010-6#1)(2011-2#2)
infectious skin##2##2##(2008-12#2)
infectious to##2##2##(1997-3#2)
infectious transcripts##3##2##(2008-10#3)
infectious units/cell##4##2##(2008-11#4)
infectious virus titers##2##3##(2008-11#2)
infectious virus##6##2##(2007-12#1)(2008-11#2)(2008-4#1)(2012-2#2)
infectious when##2##2##(2008-10#2)
infectious yellows virus##4##3##(2008-10#4)
infectious##387##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-9#1)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#17)(1997-6#10)(1997-7#1)(1997-8#7)(2006-10#1)(2007-11#2)(2007-12#14)(2007-2#8)(2007-6#2)(2007-7#8)(2008-1#3)(2008-10#68)(2008-11#17)(2008-12#4)(2008-2#1)(2008-4#8)(2008-5#25)(2008-7#11)(2008-8#14)(2008-9#14)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#7)(2009-6#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#5)(2010-8#2)(2011-1#1)(2011-2#22)(2011-3#3)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#8)
infectiousness##2##1##(1990-8#1)(2010-5#1)
infective agent##2##2##(1997-1#1)(2009-8#1)
infective complications##2##2##(1991-5#1)(2012-12#1)
infective dose##5##2##(2009-6#4)(2011-2#1)
infective endocarditis (IE)##2##3##(2006-6#1)(2011-2#1)
infective endocarditis in##2##3##(2007-7#1)(2013-8#1)
infective endocarditis##16##2##(1992-2#1)(2006-6#2)(2007-12#1)(2007-7#2)(2007-8#3)(2010-5#1)(2011-1#1)(2011-2#3)(2013-8#2)
infective endocarditis?##2##2##(2011-2#2)
infective insects##4##2##(2008-10#4)
infective##47##1##(1991-11#1)(1991-5#1)(1992-2#1)(1992-4#1)(1997-1#1)(1997-3#1)(2006-6#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#10)(2009-5#1)(2009-6#4)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
infectivity by##2##2##(1992-9#1)(2008-11#1)
infectivity of the##2##3##(2008-10#2)
infectivity of##14##2##(1991-5#1)(2007-10#2)(2008-10#9)(2011-3#1)(2013-1#1)
infectivity##41##1##(1990-3#1)(1991-5#1)(1992-8#2)(1992-9#3)(1996-12#1)(1997-3#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
infectoria##5##1##(2008-10#5)
infects the##3##2##(2008-10#1)(2013-8#2)
infects##15##1##(2007-2#1)(2007-7#1)(2008-10#9)(2008-9#1)(2012-12#1)(2013-8#2)
infer a##4##2##(1990-2#1)(2008-2#1)(2009-10#1)(2011-1#1)
infer that##6##2##(1991-5#1)(1992-2#1)(1994-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
infer the temperature distribution##2##4##(2008-3#2)
infer the##16##2##(1994-3#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-8#1)(2008-9#1)(2010-8#2)(2013-1#1)
infer##52##1##(1990-2#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2010-8#3)(2011-1#4)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#5)(2013-8#1)
inference and##3##2##(2008-10#1)(2009-8#2)
inference for##5##2##(1997-4#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
inference from##4##2##(1991-8#1)(2007-7#1)(2008-6#1)(2012-3#1)
inference in##3##2##(2008-9#1)(2009-7#1)(2009-8#1)
inference is##2##2##(2008-10#1)(2010-5#1)
inference of protein##2##3##(2008-7#1)(2008-9#1)
inference of##10##2##(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#2)(2012-3#1)
inference on the##2##3##(2008-8#1)(2010-5#1)
inference##61##1##(1990-11#1)(1991-8#1)(1995-2#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#4)(2009-7#1)(2009-8#4)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#5)
inferences about mutation##2##3##(2008-12#2)
inferences about##6##2##(1993-1#1)(1997-4#1)(2008-12#2)(2008-8#1)(2010-5#1)
inferences and##2##2##(1997-4#1)(2009-12#1)
inferences based on##2##3##(1991-12#1)(2010-8#1)
inferences based##3##2##(1991-12#1)(1995-2#1)(2010-8#1)
inferences on##3##2##(2007-6#1)(2008-7#1)(2013-8#1)
inferences##38##1##(1991-12#2)(1993-1#1)(1994-11#1)(1995-2#1)(1997-3#2)(1997-4#2)(2007-6#1)(2008-10#1)(2008-11#9)(2008-12#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
inferential##7##1##(1997-8#1)(2008-1#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
inferior alveolar##2##2##(2012-12#2)
inferior cerebellar artery##4##3##(2008-7#4)
inferior cerebellar peduncle##3##3##(1996-5#3)
inferior cerebellar##7##2##(1996-5#3)(2008-7#4)
inferior competitor##8##2##(2008-8#8)
inferior competitors##5##2##(2008-8#5)
inferior frontal cortex##2##3##(1995-5#1)(2009-9#1)
inferior frontal gyrus##3##3##(2008-11#2)(2013-1#1)
inferior frontal##10##2##(1995-2#1)(1995-5#1)(2008-11#2)(2009-9#2)(2012-1#1)(2012-12#1)(2013-1#2)
inferior hip joint mobilization)##2##4##(2008-12#2)
inferior hip joint##3##3##(2008-12#3)
inferior mesenteric##3##2##(1990-6#1)(1992-12#1)(2008-7#1)
inferior mirage##3##2##(2008-2#3)
inferior pancreaticoduodenal artery##3##3##(2008-7#3)
inferior parietal lobule##2##3##(2008-11#2)
inferior parietal##3##2##(1996-5#1)(2008-11#2)
inferior temporal##3##2##(2007-8#2)(2009-10#1)
inferior to that of##3##4##(1990-11#1)(2008-1#1)(2008-7#1)
inferior to that##4##3##(1990-11#1)(2008-1#1)(2008-11#1)(2008-7#1)
inferior to the##4##3##(2008-11#1)(2012-2#1)(2013-1#2)
inferior to##12##2##(1990-11#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#2)
inferior vena cava (IVC) in##2##5##(2011-2#1)(2013-1#1)
inferior vena cava and##2##4##(2007-8#1)(2008-11#1)
inferior vena cava##22##3##(1991-8#1)(1992-9#2)(1993-5#1)(2007-8#7)(2008-11#3)(2008-7#3)(2011-2#3)(2013-1#2)
inferior vena##23##2##(1991-8#1)(1992-9#2)(1993-5#1)(2007-8#7)(2008-11#3)(2008-7#3)(2009-5#1)(2011-2#3)(2013-1#2)
inferior##131##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-5#2)(1993-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#4)(1997-2#1)(1997-3#1)(2007-11#2)(2007-8#11)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#6)(2008-2#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#14)(2008-8#16)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#10)(2013-7#1)
inferiorly##3##1##(2007-12#1)(2008-9#1)(2012-12#1)
inferolateral##3##1##(2008-11#1)(2009-9#1)(2012-3#1)
inferotemporal##6##1##(1993-12#1)(1993-6#1)(1997-2#3)(2006-12#1)
inferred a##2##2##(1995-12#1)(2013-1#1)
inferred based on##2##3##(2008-10#2)
inferred by##6##2##(1991-2#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
inferred from a##4##3##(1995-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
inferred from the##18##3##(1990-5#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-8#1)
inferred from##45##2##(1990-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
inferred phylogeny##2##2##(2008-10#1)(2009-10#1)
inferred that the##5##3##(1991-6#1)(1995-6#1)(2008-3#1)(2010-6#1)(2013-1#1)
inferred that##15##2##(1990-9#1)(1991-6#1)(1992-6#1)(1993-12#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-6#1)(2013-1#1)
inferred to be##5##3##(1992-3#1)(1995-3#1)(1995-6#1)(2007-12#1)(2010-8#1)
inferred to##6##2##(1992-3#1)(1995-3#1)(1995-6#1)(2007-12#1)(2010-8#1)(2013-8#1)
inferred##110##1##(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#5)(1996-4#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#4)(2008-2#11)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#6)(2009-10#1)(2009-2#1)(2010-10#2)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
inferring##15##1##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-2#1)
infers that##3##2##(2008-4#1)(2008-8#1)(2012-3#1)
infers##5##1##(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#2)
infertile males##2##2##(1997-4#2)
infertile men##2##2##(2008-12#2)
infertile patients with PCR##2##4##(2008-12#2)
infertile patients##5##2##(2008-12#4)(2011-1#1)
infertile samples##2##2##(1997-4#2)
infertile women with##2##3##(1996-12#1)(2013-1#1)
infertile women##3##2##(1996-12#1)(2011-1#1)(2013-1#1)
infertile##25##1##(1992-1#1)(1994-9#2)(1996-12#1)(1997-4#5)(2007-10#1)(2008-10#1)(2008-12#10)(2011-1#3)(2013-1#1)
infertility and##9##2##(1990-10#2)(1992-1#1)(1995-2#2)(2008-10#1)(2009-10#1)(2010-11#1)(2010-3#1)
infertility in##4##2##(1995-2#1)(2008-12#1)(2008-4#1)(2010-11#1)
infertility is##2##2##(1990-9#1)(2011-2#1)
infertility patients with severe##2##4##(1991-3#2)
infertility patients with##3##3##(1991-12#1)(1991-3#2)
infertility patients##6##2##(1990-2#1)(1991-12#1)(1991-3#3)(2013-8#1)
infertility treatment##4##2##(1994-7#1)(1997-3#1)(2008-12#1)(2012-3#1)
infertility were##2##2##(1991-12#1)(1991-2#1)
infertility##70##1##(1990-10#2)(1990-2#2)(1990-3#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-2#5)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-12#4)(2008-3#1)(2008-4#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-3#1)(2011-1#9)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#3)
infest##4##1##(2008-10#2)(2011-2#1)(2013-8#1)
infestans and##2##2##(2008-10#2)
infestans can##2##2##(2008-10#2)
infestans collected from##3##3##(2008-10#3)
infestans from potato##2##3##(2008-10#2)
infestans from##6##2##(2008-10#6)
infestans in the Toluca Valley##3##5##(2008-10#3)
infestans in the Toluca##4##4##(2008-10#4)
infestans in the##8##3##(2008-10#8)
infestans in##20##2##(2008-10#19)(2009-6#1)
infestans infection##2##2##(2008-8#1)(2009-6#1)
infestans isolates##4##2##(2008-10#4)
infestans on##6##2##(2008-10#6)
infestans population##3##2##(2008-10#3)
infestans populations from##2##3##(2008-10#2)
infestans populations##8##2##(2008-10#8)
infestans sensu lato in Ecuador##2##5##(2008-10#2)
infestans sensu lato in##3##4##(2008-10#3)
infestans sensu lato##5##3##(2008-10#5)
infestans sporangia##2##2##(2008-10#2)
infestans that##2##2##(2008-10#2)
infestans to##10##2##(2008-10#10)
infestans were##8##2##(2008-10#8)
infestans##153##1##(2007-12#2)(2008-10#145)(2008-8#2)(2009-6#4)
infestation and##4##2##(1990-3#1)(1996-12#2)(2008-10#1)
infestation by##9##2##(2008-10#8)(2011-2#1)
infestation compared with the##2##4##(1996-12#1)(2011-2#1)
infestation foci##3##2##(2008-10#3)
infestation for##3##2##(2008-10#1)(2011-2#2)
infestation in the##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
infestation in##8##2##(1996-12#2)(2008-10#3)(2008-5#1)(2011-2#2)
infestation is##2##2##(1997-3#1)(2008-10#1)
infestation of##8##2##(1996-6#1)(1997-3#2)(2008-10#1)(2008-2#1)(2010-10#2)(2011-2#1)
infestation was##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
infestation with##12##2##(1990-3#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
infestation##79##1##(1990-3#2)(1991-6#1)(1996-12#10)(1996-6#1)(1997-3#3)(2008-10#36)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-10#2)(2011-2#11)(2012-12#2)(2012-3#1)(2013-8#1)
infestations and##2##2##(1996-12#1)(1996-2#1)
infestations by##3##2##(2008-10#3)
infestations in##2##2##(2008-10#1)(2009-7#1)
infestations##15##1##(1996-12#3)(1996-2#1)(2008-10#6)(2009-7#1)(2011-2#3)(2013-8#1)
infested animals##2##2##(2008-12#2)
infested areas##3##2##(2008-10#3)
infested by##4##2##(2008-10#2)(2009-10#1)(2013-8#1)
infested herd was treated with##2##5##(1996-12#2)
infested seed and##2##3##(2008-10#2)
infested seed##3##2##(2008-10#3)
infested soil##10##2##(2008-10#10)
infested the##2##2##(1996-12#1)(2008-10#1)
infested with H##3##3##(2008-10#3)
infested with P##5##3##(2008-10#5)
infested with R##2##3##(2008-10#2)
infested with T##3##3##(2008-10#3)
infested with V##3##3##(2008-10#1)(2008-6#2)
infested with a##2##3##(2008-10#1)(2008-8#1)
infested with either##2##3##(1996-12#1)(2008-10#1)
infested with one##2##3##(1996-12#2)
infested with ten##2##3##(1996-12#2)
infested with the pathogen##2##4##(2008-10#2)
infested with the##4##3##(2008-10#3)(2008-6#1)
infested with##48##2##(1996-12#6)(2008-10#36)(2008-6#4)(2008-8#1)(2012-3#1)
infested##114##1##(1996-12#15)(2008-10#82)(2008-12#2)(2008-6#6)(2008-8#1)(2009-10#1)(2011-2#5)(2012-3#1)(2013-8#1)
infesting##7##1##(2008-10#3)(2011-1#1)(2011-2#2)(2013-8#1)
infiltrate in##3##2##(1991-2#1)(2008-9#1)(2009-8#1)
infiltrate into##2##2##(2008-10#1)(2013-1#1)
infiltrate with##3##2##(1990-11#1)(2007-7#1)(2008-5#1)
infiltrate##24##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-9#1)(1995-12#2)(1996-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
infiltrated by##2##2##(2008-5#1)(2009-1#1)
infiltrated into##5##2##(2007-11#1)(2008-10#3)(2012-1#1)
infiltrated with##6##2##(2008-10#5)(2009-7#1)
infiltrated##18##1##(1990-2#1)(2007-11#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2012-1#2)
infiltrates and##4##2##(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
infiltrates in##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
infiltrates of##2##2##(2008-5#1)(2011-2#1)
infiltrates was##2##2##(2013-1#2)
infiltrates with##2##2##(2009-8#1)(2010-11#1)
infiltrates##26##1##(1990-9#1)(2006-10#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#4)(2010-11#1)(2010-12#1)(2011-2#3)(2013-1#7)(2013-8#2)
infiltrating M/Ms##2##2##(1991-2#2)
infiltrating T##2##2##(1995-12#1)(2010-3#1)
infiltrating carcinomas##2##2##(1990-12#1)(1992-8#1)
infiltrating ductal##3##2##(2007-5#2)(2008-4#1)
infiltrating endometriosis##3##2##(1994-9#3)
infiltrating inflammatory cells##4##3##(2012-3#4)
infiltrating the##3##2##(2008-10#1)(2012-12#1)(2013-7#1)
infiltrating##41##1##(1990-12#2)(1991-2#2)(1992-8#6)(1993-9#2)(1994-9#4)(1995-12#1)(1995-4#1)(1997-3#1)(2007-5#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#1)
infiltration after partial wound closure##2##5##(2008-7#2)
infiltration and##12##2##(1990-3#1)(1990-9#1)(1991-3#1)(1994-9#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
infiltration by##3##2##(1995-3#1)(2008-7#1)(2012-3#1)
infiltration in the##5##3##(1997-3#1)(2008-1#1)(2008-10#1)(2010-1#1)(2011-2#1)
infiltration in##9##2##(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-1#2)(2011-2#2)
infiltration into the##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
infiltration into##5##2##(1995-4#1)(1997-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
infiltration of PMNLs and MPhi##3##5##(2010-1#3)
infiltration of PMNLs and##4##4##(2010-1#4)
infiltration of lymphocytes##2##3##(1992-9#1)(2012-12#1)
infiltration of mononuclear cells##2##4##(2008-1#1)(2008-10#1)
infiltration of the##10##3##(1990-3#1)(1992-2#1)(1995-12#1)(1996-7#1)(1996-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
infiltration of##39##2##(1990-3#1)(1991-3#2)(1992-2#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-7#1)(1996-9#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#5)(2010-12#1)(2010-6#2)(2011-2#4)(2012-12#3)(2013-7#1)
infiltration or##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
infiltration prior to wound closure##2##5##(2008-7#2)
infiltration were##2##2##(1995-2#1)(2008-7#1)
infiltration with##8##2##(2008-10#2)(2008-12#1)(2008-7#2)(2009-3#1)(2012-1#1)(2012-12#1)
infiltration##124##1##(1990-3#2)(1990-9#1)(1991-3#3)(1991-8#3)(1991-9#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-7#1)(1996-9#3)(1997-3#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#15)(2008-11#1)(2008-12#4)(2008-5#4)(2008-7#12)(2008-9#2)(2009-3#4)(2009-5#1)(2009-8#4)(2010-1#7)(2010-12#1)(2010-6#3)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)
infiltration)##2##1##(2009-3#2)
infiltrations##7##1##(1997-3#1)(1997-8#1)(2007-7#1)(2008-1#3)(2013-8#1)
infiltrative shadows##3##2##(2008-1#3)
infiltrative##13##1##(1990-8#1)(1991-12#1)(1994-9#1)(2008-1#3)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
infinite and##2##2##(2008-3#1)(2008-7#1)
infinite variance##2##2##(2008-8#2)
infinite##48##1##(1992-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-11#5)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2012-3#1)
infinitely##3##1##(2008-2#1)(2008-3#2)
infinitesimal##2##1##(2008-3#2)
infinitesimally small##2##2##(2007-11#1)(2008-3#1)
infinity##9##1##(1992-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-12#1)(2013-7#1)
infirm##3##1##(1991-11#1)(2011-2#1)(2013-8#1)
infirmary##9##1##(1993-8#1)(2008-10#8)
infl ovules##2##2##(2008-8#2)
inflamed tissues##3##2##(2008-3#2)(2012-3#1)
inflamed##22##1##(1990-6#1)(1993-2#1)(1995-11#3)(1995-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-9#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
inflammaging##2##1##(2010-1#2)
inflammation and a##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
inflammation and airway hyperresponsiveness##3##4##(2008-3#3)
inflammation and airway##4##3##(2008-3#3)(2010-5#1)
inflammation and associated##2##3##(1993-9#1)(2008-10#1)
inflammation and proteolysis##2##3##(2013-1#2)
inflammation and rheumatoid arthritis##3##4##(2008-5#3)
inflammation and the##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
inflammation and##83##2##(1990-5#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-6#2)(1993-9#1)(1994-11#2)(1994-2#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-2#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-3#4)(2008-5#8)(2008-7#2)(2008-9#3)(2009-11#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#3)(2012-8#1)(2013-1#7)(2013-8#7)
inflammation and/or##2##2##(1990-2#1)(2013-1#1)
inflammation are##2##2##(2011-2#1)(2013-8#1)
inflammation at the##2##3##(2008-9#1)(2012-3#1)
inflammation have##2##2##(2010-9#1)(2012-2#1)
inflammation in all##2##3##(2008-9#1)(2011-2#1)
inflammation in mice##2##3##(2008-12#1)(2011-1#1)
inflammation in prostate carcinoma patients##2##5##(2013-1#2)
inflammation in the##13##3##(1990-7#1)(1992-6#1)(1995-8#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
inflammation in these##2##3##(2008-10#1)(2008-3#1)
inflammation in##35##2##(1990-7#1)(1992-2#1)(1992-6#1)(1993-2#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
inflammation induced##2##2##(2009-10#1)(2012-3#1)
inflammation is a##2##3##(2008-8#1)(2009-11#1)
inflammation is##10##2##(1991-4#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#2)(2011-2#1)(2013-1#1)
inflammation occurred##2##2##(2008-10#1)(2008-9#1)
inflammation of the epidermis##2##4##(2008-9#2)
inflammation of the##18##3##(1991-9#1)(1992-3#1)(1996-3#1)(2008-12#1)(2008-4#1)(2008-9#10)(2009-1#1)(2009-10#1)(2011-2#1)
inflammation of##22##2##(1991-9#1)(1992-3#1)(1996-3#1)(1997-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#10)(2009-1#1)(2009-10#1)(2011-2#1)
inflammation or##3##2##(2007-7#1)(2009-11#1)(2013-8#1)
inflammation plays##2##2##(2008-10#1)(2008-3#1)
inflammation that##5##2##(1994-12#1)(2008-9#3)(2012-2#1)
inflammation to##2##2##(2011-2#1)(2013-7#1)
inflammation using##2##2##(2008-5#1)(2010-5#1)
inflammation was##5##2##(1990-7#3)(2011-2#1)(2013-1#1)
inflammation were##2##2##(2012-3#1)(2013-1#1)
inflammation with##4##2##(1997-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
inflammation##401##1##(1990-2#4)(1990-3#3)(1990-5#3)(1990-7#7)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#3)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#6)(1992-8#1)(1993-11#2)(1993-2#4)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#24)(2008-11#2)(2008-12#6)(2008-2#3)(2008-3#18)(2008-4#14)(2008-5#21)(2008-7#13)(2008-8#4)(2008-9#33)(2009-1#3)(2009-10#7)(2009-11#4)(2009-2#1)(2009-6#2)(2009-8#2)(2010-1#5)(2010-10#2)(2010-12#4)(2010-2#1)(2010-5#6)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#28)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#28)(2012-3#11)(2012-5#2)(2012-8#1)(2013-1#22)(2013-7#2)(2013-8#13)
inflammation)##4##1##(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
inflammation-associated##2##1##(1991-12#1)(2009-8#1)
inflammation-related##2##1##(1995-5#1)(2009-6#1)
inflammation]##2##1##(2008-10#1)(2008-4#1)
inflammatory DSP##3##2##(2010-6#3)
inflammatory acne##2##2##(2007-7#2)
inflammatory activity in##2##3##(2013-8#2)
inflammatory activity##7##2##(2008-7#1)(2011-1#1)(2013-8#5)
inflammatory and chronic pain##2##4##(2008-7#2)
inflammatory and immune responses##3##4##(1994-9#2)(2008-11#1)
inflammatory and immune##5##3##(1994-9#2)(1997-8#1)(2008-1#1)(2008-11#1)
inflammatory and infectious conditions##2##4##(2012-2#1)(2013-8#1)
inflammatory and infectious##5##3##(2007-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
inflammatory and neuropathic##2##3##(2008-7#1)(2009-12#1)
inflammatory and proliferative##2##3##(2013-1#2)
inflammatory and##27##2##(1991-3#1)(1991-8#1)(1994-9#2)(1997-8#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2010-11#1)(2012-2#3)(2013-1#3)(2013-8#2)
inflammatory arthritis##8##2##(1990-6#2)(1994-8#1)(2006-10#1)(2008-5#2)(2008-8#2)
inflammatory bowel disease (IBD)##7##4##(2008-11#1)(2010-12#3)(2011-1#1)(2011-2#1)(2013-8#1)
inflammatory bowel disease and##3##4##(1992-6#1)(2010-12#1)(2012-12#1)
inflammatory bowel disease patients##2##4##(2010-12#2)
inflammatory bowel disease##45##3##(1991-8#1)(1992-6#2)(1994-2#3)(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-12#16)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
inflammatory bowel diseases is##2##4##(2010-12#2)
inflammatory bowel diseases##14##3##(1996-2#3)(2008-10#2)(2010-12#7)(2012-2#2)
inflammatory bowel##62##2##(1991-8#1)(1992-6#2)(1994-2#3)(1994-6#1)(1996-2#3)(1997-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-12#23)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
inflammatory breast cancer##2##3##(1991-12#1)(2011-2#1)
inflammatory carcinoma##3##2##(1991-8#1)(1993-12#2)
inflammatory cascade##3##2##(2007-11#1)(2009-12#1)(2010-2#1)
inflammatory cell infiltrates##3##3##(2013-1#3)
inflammatory cell infiltration##2##3##(1991-8#1)(2011-2#1)
inflammatory cell##10##2##(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#3)
inflammatory cells and##2##3##(1997-1#1)(2008-7#1)
inflammatory cells in##3##3##(1997-1#1)(1997-8#1)(2008-3#1)
inflammatory cells##25##2##(1991-12#1)(1992-2#2)(1992-5#1)(1996-7#1)(1997-1#4)(1997-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-3#6)(2013-8#1)
inflammatory cellular##2##2##(2007-9#1)(2012-12#1)
inflammatory changes##6##2##(1990-8#1)(1992-11#1)(2007-11#1)(2008-1#1)(2008-7#2)
inflammatory characteristics##2##2##(1991-8#1)(2008-10#1)
inflammatory complications##2##2##(1996-3#1)(2013-1#1)
inflammatory component##3##2##(1991-8#2)(2008-3#1)
inflammatory condition##5##2##(1990-12#1)(1994-11#1)(2008-1#1)(2009-7#1)(2012-12#1)
inflammatory conditions and##2##3##(1994-11#1)(2013-1#1)
inflammatory conditions##18##2##(1993-3#2)(1994-11#1)(1995-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
inflammatory cytokine and##2##3##(1991-8#1)(2009-9#1)
inflammatory cytokine production##3##3##(1991-8#2)(2012-2#1)
inflammatory cytokine##9##2##(1990-5#1)(1991-8#3)(2007-11#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-2#1)
inflammatory cytokines in##3##3##(1996-12#1)(2008-10#1)(2012-12#1)
inflammatory cytokines##16##2##(1994-11#1)(1996-12#1)(1996-2#2)(1997-1#1)(2007-11#3)(2008-10#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
inflammatory damage##4##2##(2007-12#1)(2008-10#1)(2012-2#2)
inflammatory demyelinating polyneuropathy##6##3##(1995-5#1)(2008-1#1)(2008-7#2)(2012-3#1)(2013-1#1)
inflammatory demyelinating polyradiculoneuropathy##4##3##(1995-5#2)(2008-2#1)(2008-7#1)
inflammatory demyelinating##13##2##(1995-12#1)(1995-5#3)(2008-1#1)(2008-2#1)(2008-7#3)(2012-2#1)(2012-3#1)(2013-1#2)
inflammatory disease and##2##3##(1996-2#1)(2007-7#1)
inflammatory disease involving##2##3##(1990-11#1)(2012-12#1)
inflammatory disease##16##2##(1990-11#3)(1992-4#1)(1994-3#1)(1996-2#1)(1996-7#1)(2007-7#3)(2008-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
inflammatory diseases (IMID)##4##3##(2011-2#4)
inflammatory diseases has##2##3##(2008-11#1)(2010-5#1)
inflammatory diseases of##4##3##(1995-12#2)(2012-3#1)(2013-1#1)
inflammatory diseases such as atherosclerosis##2##5##(2008-10#1)(2012-12#1)
inflammatory diseases such as##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
inflammatory diseases##34##2##(1991-2#1)(1992-12#1)(1995-12#2)(2008-10#4)(2008-11#1)(2009-6#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
inflammatory disorder of the##4##4##(2008-9#1)(2012-3#1)(2013-1#2)
inflammatory disorder##7##2##(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#2)
inflammatory disorders of the CNS##2##5##(1994-9#1)(2010-12#1)
inflammatory disorders##7##2##(1994-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
inflammatory factors##2##2##(2008-3#2)
inflammatory genes##2##2##(2008-7#1)(2010-5#1)
inflammatory illness##2##2##(2011-2#1)(2013-1#1)
inflammatory in##3##2##(2006-10#2)(2009-8#1)
inflammatory infiltrate with##2##3##(1990-11#1)(2008-5#1)
inflammatory infiltrate##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
inflammatory infiltrates##4##2##(2006-10#1)(2008-7#1)(2009-8#1)(2013-1#1)
inflammatory joint diseases##5##3##(2010-5#5)
inflammatory joint##8##2##(1993-2#2)(2010-5#5)(2012-2#1)
inflammatory lesions in the##2##4##(1995-12#1)(2008-12#1)
inflammatory lesions in##4##3##(1995-12#1)(2007-11#1)(2008-12#1)(2008-4#1)
inflammatory lesions##7##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
inflammatory marker##2##2##(2007-10#1)(2012-2#1)
inflammatory markers##8##2##(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#3)
inflammatory mechanisms##3##2##(1992-2#1)(1997-8#1)(2010-6#1)
inflammatory mediator##3##2##(2008-3#1)(2008-6#1)(2010-1#1)
inflammatory mediators and##4##3##(2008-12#1)(2008-7#1)(2010-1#1)(2013-1#1)
inflammatory mediators that##2##3##(2008-7#1)(2013-1#1)
inflammatory mediators##18##2##(2008-1#1)(2008-12#1)(2008-7#7)(2009-10#1)(2009-11#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
inflammatory myopathy and pulmonary fibrosis##2##5##(2006-10#2)
inflammatory myopathy and##3##3##(2006-10#3)
inflammatory myopathy in##2##3##(2006-10#1)(2013-1#1)
inflammatory myopathy##7##2##(2006-10#5)(2008-7#1)(2013-1#1)
inflammatory pain##4##2##(1996-5#1)(2008-5#2)(2008-7#1)
inflammatory pathways##2##2##(2008-3#1)(2011-2#1)
inflammatory polyps##2##2##(2013-1#2)
inflammatory process and##3##3##(2006-10#1)(2008-4#1)(2010-12#1)
inflammatory process in the##2##4##(1993-1#1)(2008-5#1)
inflammatory process in##4##3##(1993-1#1)(2008-1#1)(2008-5#1)(2008-8#1)
inflammatory process of the##3##4##(2008-10#1)(2008-3#1)(2010-6#1)
inflammatory process of##4##3##(1997-8#1)(2008-10#1)(2008-3#1)(2010-6#1)
inflammatory process##26##2##(1992-2#1)(1992-6#3)(1993-1#2)(1995-5#1)(1997-8#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
inflammatory processes are##2##3##(2011-2#2)
inflammatory processes##15##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
inflammatory pseudotumor##2##2##(2009-3#1)(2010-12#1)
inflammatory pseudotumour##2##2##(2008-7#1)(2013-1#1)
inflammatory reaction and##3##3##(1992-3#1)(2008-7#1)(2013-1#1)
inflammatory reaction in##2##3##(2007-10#1)(2007-12#1)
inflammatory reaction involving##2##3##(2010-3#1)(2013-8#1)
inflammatory reaction of the##2##4##(1990-7#1)(2007-8#1)
inflammatory reaction##15##2##(1990-7#1)(1992-3#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
inflammatory reactions##2##2##(1995-2#1)(2008-5#1)
inflammatory renal disease##3##3##(2013-8#3)
inflammatory response and neurodegeneration##2##4##(2010-2#2)
inflammatory response and the##2##4##(1997-7#1)(2008-10#1)
inflammatory response and##6##3##(1997-7#1)(2008-10#1)(2008-7#1)(2010-2#3)
inflammatory response in##4##3##(1994-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
inflammatory response initiated##2##3##(2008-10#1)(2008-8#1)
inflammatory response to##5##3##(1994-5#1)(2006-10#1)(2007-2#1)(2008-12#1)(2012-1#1)
inflammatory response##56##2##(1990-8#1)(1991-8#1)(1993-3#2)(1994-5#2)(1994-6#1)(1995-12#2)(1997-7#2)(2006-10#1)(2007-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-2#3)(2010-5#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
inflammatory responses and##2##3##(1995-2#1)(2011-2#1)
inflammatory responses in##4##3##(2008-10#3)(2013-8#1)
inflammatory responses of##3##3##(1992-3#1)(2008-5#1)(2013-1#1)
inflammatory responses that##2##3##(2008-10#2)
inflammatory responses##21##2##(1991-8#2)(1992-3#1)(1995-2#1)(2008-10#6)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
inflammatory rheumatic##2##2##(1994-8#1)(2008-7#1)
inflammatory signs##2##2##(2008-7#1)(2011-2#1)
inflammatory skin disorders##2##3##(2008-3#2)
inflammatory skin##7##2##(2008-10#1)(2008-3#2)(2008-5#2)(2008-9#1)(2012-2#1)
inflammatory state##4##2##(1994-5#1)(1997-8#2)(2008-1#1)
inflammatory syndrome##6##2##(2008-10#1)(2009-7#1)(2009-8#1)(2010-5#2)(2012-2#1)
inflammatory thickening of##2##3##(1996-3#1)(2012-2#1)
inflammatory tissue##7##2##(1990-2#2)(1994-5#1)(2008-6#2)(2009-5#1)(2011-2#1)
inflammatory vaginitis##2##2##(2011-2#2)
inflammatory##667##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#8)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#15)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#4)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#5)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#7)(1995-2#2)(1995-5#4)(1996-12#2)(1996-2#6)(1996-3#4)(1996-5#1)(1996-7#2)(1997-1#7)(1997-3#3)(1997-5#1)(1997-7#2)(1997-8#9)(2006-10#15)(2006-12#1)(2007-10#4)(2007-11#8)(2007-12#5)(2007-2#1)(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#36)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#22)(2008-4#8)(2008-5#17)(2008-6#3)(2008-7#46)(2008-8#7)(2008-9#13)(2009-1#2)(2009-10#6)(2009-11#4)(2009-12#7)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#31)(2010-2#4)(2010-3#2)(2010-5#13)(2010-6#10)(2010-7#1)(2010-8#5)(2011-1#10)(2011-2#43)(2011-7#1)(2012-1#1)(2012-12#17)(2012-2#27)(2012-3#25)(2013-1#42)(2013-7#1)(2013-8#20)
inflate the##2##2##(2008-10#1)(2009-4#1)
inflate##3##1##(2008-10#1)(2009-4#1)(2010-5#1)
inflated##9##1##(1997-3#2)(1997-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
inflates##2##1##(1996-3#1)(2011-1#1)
inflation and##4##2##(1991-2#1)(1996-12#1)(2008-10#1)(2008-7#1)
inflation in##2##2##(1992-2#1)(1996-2#1)
inflation of##3##2##(1997-3#1)(2008-7#2)
inflation##17##1##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-3#1)(1994-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#3)
inflected##3##1##(1996-2#1)(2009-10#1)(2012-1#1)
inflection point (M)##2##3##(2008-10#2)
inflection point of the##2##4##(2008-10#1)(2008-8#1)
inflection point of##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
inflection point##9##2##(2008-10#7)(2008-8#1)(2013-8#1)
inflection##19##1##(2008-10#12)(2008-8#2)(2009-8#1)(2012-1#3)(2013-8#1)
inflectional##2##1##(2008-10#1)(2013-1#1)
inflections##3##1##(2008-10#1)(2009-8#1)(2012-1#1)
inflexibility##2##1##(1992-8#1)(2007-8#1)
inflexible##3##1##(1997-6#1)(2007-10#1)(2010-5#1)
inflicted by##3##2##(1995-3#1)(2012-1#1)(2012-12#1)
inflicted on##2##2##(2008-8#2)
inflicted##9##1##(1995-3#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-8#2)(2012-1#1)(2012-12#1)(2013-8#1)
inflicting##2##1##(2008-11#1)(2011-2#1)
infliximab and##3##2##(2012-3#1)(2013-8#2)
infliximab for##3##2##(2006-10#1)(2010-12#1)(2011-2#1)
infliximab in##3##2##(2010-12#2)(2013-8#1)
infliximab therapy for##2##3##(2010-12#1)(2012-2#1)
infliximab therapy in##2##3##(2010-12#2)
infliximab therapy##6##2##(2010-12#4)(2012-2#1)(2012-3#1)
infliximab##34##1##(2006-10#3)(2008-7#1)(2010-12#12)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#5)(2013-8#6)
inflorescence of##2##2##(1996-2#1)(2008-11#1)
inflorescence##15##1##(1996-2#5)(2008-10#5)(2008-11#1)(2008-9#2)(2009-10#1)(2009-5#1)
inflorescences were##2##2##(2008-10#1)(2008-8#1)
inflorescences##9##1##(2008-10#2)(2008-8#4)(2008-9#2)(2011-10#1)
inflow and outflow##2##3##(1995-12#1)(1997-3#1)
inflow and##3##2##(1995-12#1)(1997-3#1)(2008-3#1)
inflow from the##2##3##(1997-3#1)(2008-7#1)
inflow##13##1##(1991-11#1)(1994-6#1)(1995-12#1)(1997-3#2)(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)
influence DNA##2##2##(1995-11#1)(1995-5#1)
influence a##6##2##(1994-3#2)(1995-12#1)(2008-11#1)(2008-9#1)(2012-12#1)
influence an##2##2##(1997-1#1)(2007-11#1)
influence and##8##2##(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
influence bone##2##2##(2009-10#1)(2011-2#1)
influence both##5##2##(1994-12#1)(2006-10#2)(2008-10#1)(2010-8#1)
influence by##2##2##(2010-11#1)(2012-3#1)
influence cardiovascular##2##2##(2008-3#1)(2012-2#1)
influence cell growth##2##3##(1992-8#1)(2008-11#1)
influence cell##5##2##(1992-8#1)(1993-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
influence children's##2##2##(1992-3#1)(2009-9#1)
influence clinical##2##2##(2008-9#1)(2011-2#1)
influence diagrams##2##2##(2010-8#2)
influence disease##3##2##(2008-10#2)(2009-8#1)
influence during##2##2##(2008-7#1)(2013-1#1)
influence each##2##2##(2011-2#1)(2012-2#1)
influence exerted##3##2##(2008-10#3)
influence food intake and##2##4##(2008-4#2)
influence food intake##3##3##(2008-4#3)
influence for##2##2##(2008-10#1)(2011-1#1)
influence from the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
influence from##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#2)
influence gene##2##2##(2008-10#1)(2013-1#1)
influence health##3##2##(1990-12#1)(1994-3#1)(1996-3#1)
influence how##3##2##(1997-1#1)(2008-12#1)(2010-2#1)
influence human##2##2##(2008-4#1)(2008-5#1)
influence in discriminating##2##3##(2008-10#2)
influence in the##2##3##(2008-10#1)(2011-1#1)
influence in##14##2##(1990-3#1)(1993-9#1)(1996-3#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-5#2)(2009-7#1)(2010-2#1)(2011-1#1)
influence is##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
influence its##2##2##(2008-12#1)(2013-1#1)
influence later alcohol use and##2##5##(2008-12#2)
influence later##3##2##(1991-12#1)(2008-12#2)
influence levels of##2##3##(1995-12#1)(2011-1#1)
influence levels##3##2##(1995-12#1)(2008-6#1)(2011-1#1)
influence negative##2##2##(1995-1#1)(2010-10#1)
influence of American##2##3##(1993-2#1)(2011-2#1)
influence of KCl##2##3##(1990-5#1)(2008-12#1)
influence of a cream containing 20% glycerin##2##7##(2008-5#2)
influence of a novel##2##4##(1997-7#1)(2008-7#1)
influence of a##25##3##(1990-12#1)(1990-6#1)(1993-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
influence of age and##3##4##(2008-3#1)(2008-9#1)(2010-9#1)
influence of age at##2##4##(2010-10#1)(2012-2#1)
influence of age on##6##4##(1990-3#1)(1995-8#1)(2008-8#2)(2008-9#2)
influence of age##14##3##(1990-3#1)(1994-8#1)(1995-8#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-10#1)(2010-9#1)(2012-2#1)
influence of airpollution##2##3##(1990-8#2)
influence of alpha-ketoglutarate##2##3##(2007-8#2)
influence of body##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)
influence of both##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
influence of changes in##2##4##(2007-11#1)(2008-2#1)
influence of childhood community##2##4##(2010-7#2)
influence of climate##2##3##(2008-10#1)(2008-11#1)
influence of coherent population trapping##2##5##(2007-12#2)
influence of complex##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
influence of curvature##2##3##(2008-7#2)
influence of decorrelation##2##3##(2008-2#2)
influence of dental amalgam fillings and fish eating##2##8##(1993-8#2)
influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide##2##11##(2011-2#2)
influence of diabetes on the##3##5##(2008-1#1)(2011-2#2)
influence of diabetes on##4##4##(2008-1#1)(2011-2#2)(2012-3#1)
influence of diabetes##5##3##(2008-1#1)(2008-4#1)(2011-2#2)(2012-3#1)
influence of dietary##4##3##(1991-6#2)(2008-11#1)(2009-6#1)
influence of different parameters##3##4##(2008-10#3)
influence of different##24##3##(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-2#1)(2012-3#1)
influence of dispersal##2##3##(2008-9#2)
influence of dispersion##2##3##(2008-2#2)
influence of each##2##3##(2008-5#1)(2008-8#1)
influence of environmental##2##3##(1997-6#1)(2008-7#1)
influence of ethanol##2##3##(2008-10#2)
influence of experimental##2##3##(2008-10#1)(2011-2#1)
influence of film##2##3##(2008-2#2)
influence of flow rates of##3##5##(2008-10#3)
influence of food##2##3##(1997-1#1)(2008-9#1)
influence of foreign##4##3##(2008-10#4)
influence of high##3##3##(1993-11#1)(1997-4#1)(2011-2#1)
influence of increased##2##3##(1997-3#1)(2012-3#1)
influence of increasing##2##3##(2008-10#1)(2008-7#1)
influence of inoculum##3##3##(2008-10#3)
influence of laser##2##3##(2011-1#1)(2013-8#1)
influence of media##2##3##(2008-11#2)
influence of mixing##2##3##(1997-2#1)(2008-8#1)
influence of moisture in##2##4##(2008-10#2)
influence of moisture##4##3##(2008-10#4)
influence of molecular##2##3##(1990-2#1)(2008-2#1)
influence of multiple##2##3##(2008-3#2)
influence of music##2##3##(2007-6#2)
influence of noise on the##2##5##(2008-3#2)
influence of nutrition##2##3##(1996-8#1)(2013-1#1)
influence of other##3##3##(2008-10#2)(2008-4#1)
influence of pH and##2##4##(2008-10#1)(2013-8#1)
influence of pH##7##3##(2008-10#5)(2011-2#1)(2013-8#1)
influence of palmitic acid on##2##5##(2008-5#2)
influence of parents##2##3##(1990-2#1)(2012-1#1)
influence of particle##2##3##(2008-10#1)(2008-3#1)
influence of sample matrix##2##4##(2008-10#2)
influence of sample##4##3##(2008-10#3)(2013-8#1)
influence of several##10##3##(2008-10#9)(2008-11#1)
influence of some##6##3##(1995-6#1)(2008-10#5)
influence of stress##2##3##(2008-7#2)
influence of such##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
influence of temperature and##3##4##(1992-5#1)(2008-10#1)(2008-3#1)
influence of temperature on the##2##5##(2008-10#2)
influence of temperature on##4##4##(1990-11#1)(2008-10#3)
influence of temperature##8##3##(1990-11#1)(1992-5#1)(2008-10#4)(2008-3#2)
influence of the formation of##2##5##(2008-10#2)
influence of the lunar cycle##2##5##(2011-1#2)
influence of the mesocortical DA system##2##6##(1996-5#2)
influence of the presence of##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
influence of the system nonuniformity##2##5##(2008-3#2)
influence of the type and##2##5##(2008-10#2)
influence of the variable##2##4##(2008-10#1)(2012-12#1)
influence of the##154##3##(1990-12#2)(1990-2#1)(1990-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#41)(2008-11#5)(2008-12#1)(2008-2#18)(2008-3#25)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-9#1)(2013-1#1)(2013-7#1)
influence of these factors on##2##5##(2008-10#1)(2008-3#1)
influence of these factors##3##4##(2008-10#1)(2008-3#2)
influence of these##12##3##(1994-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
influence of this##2##3##(1996-11#1)(2006-6#1)
influence of tumor##2##3##(1993-9#1)(2009-3#1)
influence of two##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
influence of ultraviolet##2##3##(2008-5#1)(2011-2#1)
influence of various##7##3##(2008-10#7)
influence of visual##3##3##(2008-5#1)(2009-2#1)(2010-9#1)
influence of##822##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#2)(2007-10#4)(2007-11#16)(2007-12#12)(2007-6#2)(2007-8#6)(2008-1#4)(2008-10#204)(2008-11#34)(2008-12#8)(2008-2#47)(2008-3#65)(2008-4#7)(2008-5#36)(2008-6#6)(2008-7#30)(2008-8#18)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#8)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#1)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#4)(2010-7#2)(2010-9#4)(2011-1#16)(2011-2#29)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#9)(2012-3#8)(2012-6#2)(2012-9#2)(2013-1#15)(2013-7#4)(2013-8#15)
influence on a##4##3##(2008-10#2)(2011-1#2)
influence on analytical##2##3##(2008-10#2)
influence on body##2##3##(2007-12#1)(2013-1#1)
influence on cardiovascular##2##3##(2009-9#1)(2010-1#1)
influence on development of##2##4##(2011-2#2)
influence on development##3##3##(2011-2#2)(2013-1#1)
influence on heart rate##2##4##(2010-5#2)
influence on his##2##3##(1996-1#1)(2008-7#1)
influence on prognosis##2##3##(1991-6#1)(1991-8#1)
influence on sensitivity##2##3##(2008-10#2)
influence on survival##4##3##(1990-12#1)(1995-2#2)(2008-10#1)
influence on the amount##2##4##(1992-3#1)(2008-10#1)
influence on the clinical##2##4##(1994-5#1)(2008-12#1)
influence on the degree of##2##5##(2008-10#2)
influence on the nature of##2##5##(1995-2#1)(1996-4#1)
influence on the origin of##2##5##(1990-8#2)
influence on the reaction##2##4##(1994-5#1)(1996-5#1)
influence on the selectivity##2##4##(2008-10#2)
influence on the treatment##3##4##(1996-7#1)(2007-11#1)(2011-2#1)
influence on the##96##3##(1990-2#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-2#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2009-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#3)
influence on their##6##3##(2007-11#1)(2008-11#2)(2009-7#1)(2009-9#1)(2013-8#1)
influence on this##4##3##(1995-2#1)(2007-10#1)(2008-11#2)
influence on##232##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#39)(2008-11#13)(2008-12#3)(2008-2#2)(2008-3#11)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#2)(2009-7#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#15)(2011-3#1)(2012-1#1)(2012-2#7)(2012-3#2)(2012-8#1)(2013-1#6)(2013-8#5)
influence or##4##2##(1996-3#1)(2008-12#1)(2010-4#1)(2011-1#1)
influence over the##3##3##(1993-8#1)(2009-8#1)(2013-1#1)
influence over##4##2##(1993-8#1)(2008-11#1)(2009-8#1)(2013-1#1)
influence partner selection##2##3##(2009-5#2)
influence patient##3##2##(1996-12#1)(1996-3#1)(2010-12#1)
influence performance##2##2##(2008-11#1)(2012-3#1)
influence protein##2##2##(1997-4#1)(2011-2#1)
influence return##2##2##(1993-1#2)
influence social##2##2##(2008-8#1)(2013-1#1)
influence some##2##2##(2009-5#1)(2009-9#1)
influence strongly##2##2##(2008-10#1)(2008-5#1)
influence survival##5##2##(1991-2#1)(1991-4#1)(2007-11#1)(2008-6#1)(2012-3#1)
influence susceptibility to##2##3##(1997-8#1)(2011-1#1)
influence targets##2##2##(2012-3#2)
influence test##2##2##(2008-10#1)(2008-2#1)
influence that is due to##2##5##(2008-2#1)(2008-3#1)
influence that##8##2##(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)
influence the ability of##2##4##(1997-2#1)(2008-9#1)
influence the acquisition of##2##4##(2010-4#1)(2013-8#1)
influence the aging process##3##4##(1994-6#1)(2008-11#1)(2009-12#1)
influence the complex##2##3##(2008-10#1)(2008-3#1)
influence the course of##2##4##(1994-2#1)(2008-5#1)
influence the development of##7##4##(1992-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(2007-10#1)(2008-9#1)(2009-9#1)
influence the direction##2##3##(2007-8#1)(2012-3#1)
influence the distribution of##5##4##(1997-1#2)(2008-10#1)(2008-9#2)
influence the effectiveness of##3##4##(1996-1#1)(2007-12#1)(2008-11#1)
influence the evolution of##4##4##(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)
influence the expression of##3##4##(2008-11#1)(2008-7#1)(2011-1#1)
influence the extent##2##3##(1992-3#1)(2013-8#1)
influence the final##2##3##(1995-11#1)(2008-10#1)
influence the frequency of##2##4##(1993-11#1)(1994-8#1)
influence the growth##2##3##(2008-10#1)(2009-8#1)
influence the level of##4##4##(1997-4#1)(2008-12#1)(2008-6#1)(2012-3#1)
influence the magnitude of the##2##5##(2008-10#1)(2008-2#1)
influence the magnitude of##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
influence the mating behaviors##2##4##(2008-6#2)
influence the outcome of##5##4##(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
influence the outcome##6##3##(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
influence the pattern of##2##4##(1997-6#1)(2008-8#1)
influence the peak##2##3##(2008-10#1)(2013-8#1)
influence the performance of##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
influence the process of##3##4##(2008-5#2)(2011-1#1)
influence the progression of##3##4##(2008-1#1)(2010-8#1)(2011-2#1)
influence the progression##4##3##(2008-1#1)(2010-8#1)(2011-2#1)(2013-8#1)
influence the quality of##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
influence the quality##5##3##(1994-2#1)(1995-1#1)(2008-11#1)(2008-12#1)(2011-1#1)
influence the relative##2##3##(1995-2#1)(2012-6#1)
influence the results##3##3##(2008-10#2)(2010-6#1)
influence the risk##2##3##(1992-10#1)(2008-4#1)
influence the sensitivity of##3##4##(2008-11#2)(2008-2#1)
influence the sexual##2##3##(1990-9#1)(2008-7#1)
influence the success of##3##4##(1994-12#1)(2008-10#1)(2008-11#1)
influence the success##4##3##(1994-12#1)(2008-10#2)(2008-11#1)
influence the use of##2##4##(2007-10#1)(2008-1#1)
influence the##249##2##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-10#3)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#1)(1995-5#1)(1995-9#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#30)(2008-11#10)(2008-12#8)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#12)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#2)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#6)
influence their usefulness##2##3##(2008-11#1)(2011-1#1)
influence their##17##2##(1991-12#1)(1996-2#1)(1997-1#1)(2008-11#2)(2008-8#3)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#1)
influence them##4##2##(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
influence therapeutic##2##2##(1994-9#1)(2008-9#1)
influence these##4##2##(1995-8#1)(1997-7#1)(2008-10#1)(2010-9#1)
influence this##4##2##(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
influence treatment##2##2##(2008-2#1)(2008-7#1)
influence vascular##2##2##(1997-6#1)(2008-3#1)
influence was##5##2##(2008-10#2)(2008-5#2)(2013-8#1)
influence whether##2##2##(1993-12#1)(2008-3#1)
influence##1732##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#7)(1990-3#3)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#8)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#6)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#7)(1992-5#3)(1992-6#7)(1992-8#3)(1992-9#7)(1993-1#4)(1993-11#4)(1993-12#15)(1993-2#4)(1993-3#2)(1993-6#6)(1993-8#6)(1993-9#6)(1994-11#2)(1994-12#9)(1994-2#6)(1994-3#9)(1994-5#6)(1994-6#5)(1994-8#8)(1994-9#6)(1995-1#4)(1995-11#7)(1995-12#15)(1995-2#10)(1995-3#4)(1995-5#4)(1995-6#5)(1995-8#7)(1995-9#2)(1996-1#7)(1996-11#1)(1996-12#10)(1996-2#8)(1996-3#7)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#14)(1997-3#6)(1997-4#5)(1997-6#5)(1997-7#5)(1997-8#3)(2006-10#3)(2006-6#3)(2007-10#10)(2007-11#26)(2007-12#23)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#12)(2008-1#9)(2008-10#321)(2008-11#74)(2008-12#33)(2008-2#67)(2008-3#91)(2008-4#25)(2008-5#69)(2008-6#21)(2008-7#62)(2008-8#45)(2008-9#40)(2009-1#2)(2009-10#8)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#7)(2009-4#3)(2009-5#12)(2009-6#6)(2009-7#12)(2009-8#14)(2009-9#10)(2010-1#11)(2010-10#6)(2010-11#5)(2010-12#3)(2010-2#5)(2010-3#6)(2010-4#9)(2010-5#4)(2010-6#6)(2010-7#5)(2010-8#11)(2010-9#9)(2011-1#32)(2011-2#58)(2011-3#4)(2012-1#11)(2012-12#11)(2012-2#36)(2012-3#24)(2012-6#3)(2012-8#1)(2012-9#2)(2013-1#48)(2013-7#9)(2013-8#34)
influenced and##4##2##(1992-12#1)(2008-5#1)(2008-9#1)(2010-7#1)
influenced by a number of##3##5##(1997-2#1)(2008-5#1)(2008-7#1)
influenced by a##7##3##(1995-3#1)(1997-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)
influenced by aging##2##3##(1994-2#1)(1997-2#1)
influenced by both##3##3##(1992-12#1)(1995-3#1)(1996-2#1)
influenced by crop rotation##2##4##(2008-10#2)
influenced by environmental##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
influenced by factors such as##2##5##(1995-3#1)(2012-12#1)
influenced by genetic##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
influenced by high##2##3##(2011-2#1)(2012-2#1)
influenced by many##3##3##(2008-12#1)(2011-1#1)(2012-3#1)
influenced by maternal##2##3##(2008-8#1)(2010-8#1)
influenced by multiple##3##3##(2008-10#2)(2008-4#1)
influenced by sex##2##3##(2010-6#1)(2011-2#1)
influenced by soil##2##3##(2008-10#1)(2013-7#1)
influenced by the amount of##2##5##(1996-12#1)(2008-10#1)
influenced by the nature and##2##5##(1992-8#1)(2008-7#1)
influenced by the nature of##2##5##(1996-4#1)(2010-3#1)
influenced by the nature##4##4##(1992-8#1)(1996-4#1)(2008-7#1)(2010-3#1)
influenced by the presence of##6##5##(1993-8#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-9#1)(2010-8#1)
influenced by the shape of the##2##6##(2008-2#2)
influenced by the type of the##2##6##(2008-10#1)(2008-5#1)
influenced by the type of##5##5##(1995-11#1)(2008-10#2)(2008-5#1)(2010-6#1)
influenced by the##105##3##(1990-11#3)(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#3)(1995-11#1)(1996-12#4)(1996-4#1)(1996-6#1)(1997-2#1)(1997-7#2)(2007-8#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
influenced by their##5##3##(1994-1#1)(1995-5#1)(2009-5#1)(2011-3#1)(2012-2#1)
influenced by this##2##3##(2008-4#1)(2013-7#1)
influenced by various factors##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
influenced by whether##2##3##(1994-2#1)(2008-9#1)
influenced by wind direction##2##4##(2008-10#2)
influenced by##281##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#3)(1995-11#1)(1995-2#3)(1995-3#4)(1995-5#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-7#3)(2007-10#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#48)(2008-11#19)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#13)(2008-9#8)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#16)(2011-3#2)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#1)
influenced disease##2##2##(2008-10#2)
influenced hemodynamic less##2##3##(2012-3#2)
influenced how##2##2##(2008-12#1)(2010-1#1)
influenced male behaviors##2##3##(2008-6#2)
influenced middle##2##2##(2010-7#2)
influenced not only by the##3##5##(1990-3#1)(2008-2#1)(2008-3#1)
influenced outcomes##2##2##(2011-1#2)
influenced significantly by##2##3##(2008-10#1)(2009-11#1)
influenced the extent##2##3##(2008-10#1)(2008-11#1)
influenced the final##2##3##(2009-11#1)(2013-1#1)
influenced the risk of##2##4##(2008-10#1)(2013-8#1)
influenced the subsequent##2##3##(1993-6#1)(2008-9#1)
influenced the##56##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-11#1)(1995-5#2)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
influenced their##4##2##(1996-5#1)(2007-10#1)(2008-7#1)(2013-1#1)
influenced##431##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-9#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#4)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#6)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#3)(1994-6#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#4)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#3)(2007-10#4)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#68)(2008-11#23)(2008-12#10)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#8)(2008-8#16)(2008-9#15)(2009-10#1)(2009-11#4)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#20)(2011-3#2)(2012-12#7)(2012-2#15)(2012-3#6)(2012-9#1)(2013-1#11)(2013-7#5)(2013-8#4)
influences and##4##2##(1997-1#1)(1997-6#1)(2008-5#1)(2009-7#1)
influences are##2##2##(1993-5#1)(2011-2#1)
influences during##2##2##(1990-8#1)(2013-1#1)
influences in the##3##3##(1991-4#1)(1995-2#1)(2012-12#1)
influences in##9##2##(1991-4#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-12#1)
influences of age##4##3##(1997-6#1)(2007-12#1)(2013-8#2)
influences of childhood community adversity##2##5##(2010-7#2)
influences of different##3##3##(2008-10#2)(2011-2#1)
influences of the##7##3##(1992-2#1)(2008-10#5)(2008-2#1)
influences of##43##2##(1990-7#1)(1992-2#1)(1994-2#1)(1994-9#2)(1997-6#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#3)(2009-5#1)(2009-7#2)(2010-11#1)(2010-7#2)(2011-2#1)(2013-8#2)
influences on adolescent##2##3##(2007-12#1)(2013-1#1)
influences on growth##2##3##(2007-11#1)(2010-6#1)
influences on the##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)
influences on young adult achievement##2##5##(2010-7#2)
influences on##50##2##(1990-2#1)(1991-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#3)(1997-2#1)(1997-3#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#2)(2013-1#3)
influences perception of##2##3##(2008-11#2)
influences such##2##2##(2008-11#1)(2012-3#1)
influences that##3##2##(1995-3#1)(2008-9#1)(2012-12#1)
influences the development of##2##4##(2009-5#1)(2011-2#1)
influences the##48##2##(1993-11#1)(1993-3#2)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#4)
influences their##4##2##(2007-2#1)(2008-12#1)(2008-2#1)(2008-8#1)
influences upon##2##2##(1993-12#1)(2008-11#1)
influences##272##1##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#4)(1991-4#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#4)(1997-1#1)(1997-2#1)(1997-3#5)(1997-6#2)(1997-7#2)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#5)(2008-10#29)(2008-11#17)(2008-12#7)(2008-2#8)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#15)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#10)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#12)(2013-8#3)
influencing cell##2##2##(2008-9#1)(2009-8#1)
influencing drug##2##2##(1997-1#1)(2008-7#1)
influencing factor##2##2##(2008-10#1)(2008-9#1)
influencing factors##9##2##(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#3)(2012-2#1)(2013-1#1)
influencing length of##2##3##(1993-2#1)(2007-5#1)
influencing parameters##2##2##(2008-10#1)(2008-3#1)
influencing the choice of##2##4##(1994-3#1)(2008-10#1)
influencing the decision##3##3##(1994-3#1)(2012-3#2)
influencing the determination of##3##4##(2008-10#3)
influencing the development of##3##4##(1992-6#1)(1995-11#1)(2008-10#1)
influencing the outcome of##2##4##(1994-12#1)(1995-1#1)
influencing the outcome##3##3##(1994-12#1)(1995-1#1)(2010-3#1)
influencing the performance of the##2##5##(2008-10#1)(2008-7#1)
influencing the process of##2##4##(2008-1#1)(2009-11#1)
influencing the##70##2##(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-3#2)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-1#2)
influencing their##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
influencing these##2##2##(1996-2#1)(2008-4#1)
influencing this##4##2##(1991-6#1)(1996-2#1)(2007-10#1)(2011-2#1)
influencing treatment##2##2##(2010-11#1)(2010-4#1)
influencing##186##1##(1990-7#1)(1991-1#2)(1991-12#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-3#4)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#36)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#10)(2008-8#10)(2008-9#7)(2009-10#3)(2009-11#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#1)
influent##10##1##(2008-10#8)(2008-11#1)(2008-7#1)
influential and##2##2##(1992-3#1)(2008-8#1)
influential data##2##2##(2008-10#2)
influential factor##2##2##(2013-1#1)(2013-8#1)
influential factors##3##2##(2008-10#1)(2010-10#1)(2010-12#1)
influential in##4##2##(1992-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
influential parameters##2##2##(2008-10#2)
influential points##2##2##(2008-10#2)
influential##40##1##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-3#2)(1996-1#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
influents and effluents##2##3##(2008-10#2)
influenza A (H1N1) virus##2##4##(2011-1#1)(2012-12#1)
influenza A (H1N1)##6##3##(2011-1#2)(2011-2#3)(2012-12#1)
influenza A and B##3##4##(2011-2#2)(2013-1#1)
influenza A and##4##3##(2011-2#2)(2012-2#1)(2013-1#1)
influenza A infection##2##3##(1991-8#1)(2011-2#1)
influenza A outbreak##2##3##(1991-8#1)(2007-12#1)
influenza A virus##9##3##(1992-9#2)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
influenza A viruses of the H1 and H3 subtypes##2##9##(1992-9#2)
influenza A viruses of the##3##5##(1992-9#3)
influenza A viruses##12##3##(1992-9#3)(1994-8#3)(1996-6#2)(2007-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
influenza A##51##2##(1991-8#4)(1992-6#2)(1992-9#5)(1994-8#3)(1996-6#2)(2007-12#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#2)(2011-1#2)(2011-2#11)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#3)
influenza A(H1N1) 2009 virus##2##4##(2011-2#2)
influenza A(H1N1) 2009##4##3##(2011-2#4)
influenza A(H1N1) epidemic##2##3##(2012-12#2)
influenza A(H1N1)##8##2##(1994-9#1)(2011-2#4)(2012-12#3)
influenza A(H3N2) viruses##3##3##(2013-8#3)
influenza A(H3N2)##5##2##(1994-9#1)(2013-8#4)
influenza A/H1##2##2##(2011-2#2)
influenza A/H1N1 and A/H3N2##3##4##(2011-2#3)
influenza A/H1N1##5##2##(2011-2#4)(2012-2#1)
influenza A/H3N2 and##2##3##(1996-6#2)
influenza A/H3N2##3##2##(1996-6#3)
influenza B virus##3##3##(2011-2#3)
influenza B viruses##5##3##(1994-9#2)(1996-6#3)
influenza B##11##2##(1992-6#2)(1994-9#2)(1996-6#3)(2011-2#4)
influenza activity##4##2##(1992-6#2)(1994-9#2)
influenza and##4##2##(1991-8#1)(1997-6#1)(2011-2#2)
influenza circulation seasons##2##3##(2012-12#2)
influenza disease##4##2##(2009-5#1)(2012-3#2)(2013-1#1)
influenza epidemic##2##2##(1996-6#1)(2011-1#1)
influenza haemagglutinin##2##2##(2007-11#1)(2008-8#1)
influenza hemagglutinin##2##2##(1992-9#1)(2012-2#1)
influenza illness##2##2##(2009-12#1)(2011-2#1)
influenza in East and##2##4##(2009-5#2)
influenza in the##3##3##(2009-5#1)(2011-9#1)(2013-1#1)
influenza in##12##2##(1996-6#1)(2009-12#1)(2009-5#4)(2010-4#1)(2010-5#1)(2011-9#1)(2012-3#2)(2013-1#1)
influenza infection##3##2##(2009-5#1)(2013-1#2)
influenza infections##2##2##(2007-6#1)(2013-1#1)
influenza isolates##2##2##(1997-6#1)(2011-2#1)
influenza mortality##2##2##(2011-2#2)
influenza or##2##2##(1997-7#1)(2013-8#1)
influenza outbreak##2##2##(2007-2#1)(2009-7#1)
influenza pandemic in##4##3##(2009-7#1)(2011-1#1)(2011-2#2)
influenza pandemic##15##2##(2008-11#2)(2009-5#1)(2009-7#2)(2010-4#1)(2011-1#3)(2011-2#6)
influenza season##3##2##(1992-6#2)(2011-2#1)
influenza strains##5##2##(2012-12#2)(2012-2#2)(2013-1#1)
influenza surveillance##2##2##(1996-6#1)(2011-9#1)
influenza testing##3##2##(2011-2#3)
influenza vaccination coverage##3##3##(2008-9#1)(2011-2#2)
influenza vaccination##14##2##(1995-6#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-12#2)(2010-4#1)(2011-2#6)(2012-3#1)
influenza vaccinations##3##2##(2012-3#3)
influenza vaccine effectiveness##2##3##(2010-4#2)
influenza vaccine in##3##3##(1991-8#1)(1994-6#1)(2010-4#1)
influenza vaccine##18##2##(1991-8#1)(1992-6#2)(1994-6#1)(2007-11#5)(2009-12#1)(2009-5#1)(2010-4#4)(2011-2#1)(2012-3#1)(2013-8#1)
influenza vaccines##4##2##(2009-12#2)(2011-2#2)
influenza virus A##2##3##(2008-10#1)(2010-5#1)
influenza virus and##3##3##(2012-12#1)(2012-2#1)(2013-8#1)
influenza virus##35##2##(1990-5#2)(1992-6#1)(1994-6#1)(1995-5#1)(1997-6#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
influenza viruses (SIVs)##2##3##(2013-1#1)(2013-8#1)
influenza viruses from##3##3##(2008-9#1)(2011-2#2)
influenza viruses in##8##3##(2009-5#1)(2011-2#2)(2013-1#4)(2013-8#1)
influenza viruses##24##2##(1992-6#1)(1997-6#1)(2008-9#1)(2009-5#1)(2011-2#5)(2011-3#1)(2013-1#8)(2013-8#6)
influenza viruses]##2##2##(2010-4#1)(2013-8#1)
influenza##313##1##(1990-5#2)(1991-3#1)(1991-8#6)(1992-4#1)(1992-6#15)(1992-9#6)(1994-6#2)(1994-8#3)(1994-9#7)(1995-5#1)(1995-6#1)(1996-6#11)(1997-6#5)(1997-7#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-6#3)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#9)(2009-4#1)(2009-5#13)(2009-6#1)(2009-7#3)(2010-2#1)(2010-4#13)(2010-5#3)(2010-8#1)(2011-1#10)(2011-2#75)(2011-3#3)(2011-9#2)(2012-12#14)(2012-2#7)(2012-3#13)(2013-1#22)(2013-8#21)
influenza-associated mortality was##2##3##(1992-6#2)
influenza-associated##5##1##(1992-6#2)(2009-5#3)
influenza-like illness (ILI)##2##3##(2011-2#1)(2011-9#1)
influenza-like illness##4##2##(2011-2#3)(2011-9#1)
influenza-like symptoms##2##2##(1992-4#1)(1996-8#1)
influenza-like##7##1##(1990-2#1)(1992-4#1)(1996-8#1)(2011-2#3)(2011-9#1)
influenzae and##2##2##(2008-7#1)(2011-1#1)
influenzae type b conjugate vaccines##2##5##(2007-11#1)(2008-10#1)
influenzae type b##15##3##(1990-12#2)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2009-5#1)(2012-12#1)
influenzae type##20##2##(1990-12#2)(1992-9#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-5#2)(2012-12#1)
influenzae##40##1##(1990-12#2)(1992-11#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#7)(1997-3#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#5)(2009-5#5)(2011-1#1)(2011-2#4)(2012-12#1)
influx and efflux of##2##4##(1994-8#1)(2008-5#1)
influx and efflux##7##3##(1990-2#1)(1994-8#4)(2008-5#1)(2012-12#1)
influx and##15##2##(1990-12#2)(1990-2#1)(1993-11#2)(1994-8#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-12#1)
influx by##3##2##(1991-1#1)(1992-8#1)(1994-11#1)
influx in##7##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(1996-2#1)
influx into##4##2##(1991-5#2)(1995-5#1)(2010-8#1)
influx is##5##2##(1992-6#1)(1993-8#1)(1994-2#1)(1996-2#1)(1996-5#1)
influx occurs##2##2##(1990-7#1)(1993-12#1)
influx of Ca2+ through the##2##5##(1991-12#1)(1994-6#1)
influx of Ca2+##6##3##(1990-5#2)(1991-12#1)(1994-2#1)(1994-6#1)(1995-11#1)
influx of T-lymphocytes##2##3##(1996-12#2)
influx of extracellular##3##3##(1991-9#1)(1994-2#1)(1996-12#1)
influx of##24##2##(1990-5#2)(1991-1#1)(1991-12#1)(1991-9#1)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-12#3)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#2)
influx rate##2##2##(1995-5#1)(1996-8#1)
influx stimulating##2##2##(1992-12#2)
influx through##3##2##(1993-12#1)(1993-8#1)(1994-11#1)
influx##95##1##(1990-11#1)(1990-12#7)(1990-2#2)(1990-5#2)(1990-7#2)(1991-1#3)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#4)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#2)(1994-8#10)(1994-9#1)(1995-11#1)(1995-5#3)(1996-12#3)(1996-2#2)(1996-5#4)(1996-8#1)(1996-9#2)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-3#2)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
infolding system##4##2##(2008-7#4)
inform and##3##2##(1994-1#1)(2009-4#1)(2012-3#1)
inform clinical##3##2##(2008-12#1)(2010-7#1)(2011-10#1)
inform current##2##2##(2010-2#1)(2010-8#1)
inform future##4##2##(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
inform on the##2##3##(2008-10#1)(2009-8#1)
inform policy##2##2##(1994-2#1)(2011-1#1)
inform policymakers##2##2##(1994-1#1)(2009-4#1)
inform practice##4##2##(2007-10#1)(2008-11#1)(2009-8#2)
inform strategies for##2##3##(2010-5#1)(2012-2#1)
inform the##17##2##(1991-9#1)(1992-1#1)(1994-3#1)(1994-8#1)(2007-10#1)(2008-11#2)(2009-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
inform us##2##2##(2008-12#1)(2008-8#1)
inform##89##1##(1991-11#1)(1991-9#1)(1992-1#2)(1992-12#2)(1994-1#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#3)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#2)(2008-10#2)(2008-11#8)(2008-12#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#4)(2013-8#2)
informal and##2##2##(1994-3#1)(2008-7#1)
informal caregivers##2##2##(1992-1#2)
informal economy##2##2##(2013-1#2)
informal interviews##2##2##(2008-11#1)(2010-8#1)
informal settlement in##2##3##(1997-4#1)(2013-8#1)
informal support##2##2##(1996-3#1)(2009-5#1)
informal work##2##2##(2013-1#2)
informal##34##1##(1992-1#3)(1992-12#2)(1992-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-3#3)(1997-4#2)(2007-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2009-5#4)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#4)(2013-8#1)
informally by##2##2##(1994-2#1)(1995-9#1)
informally##5##1##(1993-2#1)(1994-2#1)(1995-9#1)(2008-12#1)(2009-5#1)
informant reports of##2##3##(2009-9#2)
informant##10##1##(1994-2#1)(2008-12#1)(2008-6#1)(2009-9#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
informants were##2##2##(2013-1#2)
informants##16##1##(1994-1#1)(1996-3#1)(2007-10#1)(2008-1#1)(2010-12#2)(2011-2#3)(2012-3#3)(2013-1#4)
informants'##2##1##(2012-3#2)
informatics and##2##2##(2008-10#1)(2008-7#1)
informatics in##2##2##(2008-10#2)
informatics##19##1##(1992-12#1)(1994-12#2)(1994-2#1)(1994-3#3)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#4)(2008-9#1)
information (see##2##2##(2008-4#2)
information (such as the##2##4##(2007-12#2)
information a##2##2##(1996-3#1)(1997-3#1)
information about Arabidopsis genes##2##4##(2008-4#2)
information about HIV##2##3##(1996-5#1)(2009-5#1)
information about a##3##3##(2007-12#1)(2008-4#1)(2010-7#1)
information about an individual's##2##4##(1997-3#1)(2008-4#1)
information about an##3##3##(1997-3#1)(2008-4#1)(2008-9#1)
information about different##2##3##(2010-8#1)(2011-3#1)
information about her##2##3##(2011-2#2)
information about his HIV status##2##5##(1996-5#2)
information about how the##2##4##(1992-12#1)(2008-10#1)
information about how to##2##4##(1996-5#1)(2008-5#1)
information about how##5##3##(1992-12#1)(1996-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
information about individual##2##3##(2008-7#1)(2013-1#1)
information about its##2##3##(1992-2#1)(2008-9#1)
information about object##2##3##(1992-11#1)(2008-7#1)
information about patients##2##3##(1990-3#1)(1997-1#1)
information about sexual##2##3##(1996-11#1)(2008-7#1)
information about the effects of##2##5##(1991-5#1)(2008-5#1)
information about the nature of##2##5##(2010-8#1)(2012-2#1)
information about the nature##3##4##(2010-8#1)(2011-2#1)(2012-2#1)
information about the risks##2##4##(2007-12#1)(2013-1#1)
information about the sensory##2##4##(2008-10#1)(2009-8#1)
information about the##128##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#2)(1995-12#3)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#7)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#8)(2012-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
information about their child's##2##4##(1993-12#1)(2008-11#1)
information about their##9##3##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#2)(2013-1#1)(2013-8#1)
information about these##2##3##(2008-9#1)(2011-2#1)
information about this group##2##4##(2013-7#2)
information about tissue##3##3##(2008-3#1)(2011-1#1)(2012-2#1)
information about##263##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#4)(1995-3#4)(1995-5#2)(1996-1#2)(1996-11#3)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#13)(2007-2#1)(2008-1#2)(2008-10#19)(2008-11#10)(2008-12#1)(2008-2#12)(2008-3#18)(2008-4#17)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#3)(2009-8#2)(2010-10#4)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#14)(2011-3#2)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
information accessible##3##2##(1995-12#1)(1996-1#1)(1997-2#1)
information age##6##2##(1994-1#1)(1996-3#2)(2008-1#1)(2009-5#2)
information alone##4##2##(1995-12#1)(1995-3#1)(2008-12#1)(2008-4#1)
information along with##2##3##(2012-12#1)(2013-1#1)
information along##3##2##(2009-8#1)(2012-12#1)(2013-1#1)
information among##3##2##(1996-12#1)(2008-10#1)(2009-4#1)
information and a##6##3##(1992-3#1)(1993-2#1)(1995-9#1)(2008-2#1)(2008-7#1)(2012-2#1)
information and communication##4##3##(1996-4#1)(2012-12#2)(2013-1#1)
information and is##3##3##(2008-11#2)(2012-12#1)
information and knowledge##3##3##(1993-2#1)(2008-7#1)(2012-12#1)
information and management systems##2##4##(1993-3#1)(1995-1#1)
information and resources##2##3##(2007-2#1)(2013-1#1)
information and support##2##3##(2009-5#1)(2012-12#1)
information and the##7##3##(1992-12#1)(1995-3#1)(1996-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
information and to##6##3##(1995-8#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
information and tools##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
information and##122##2##(1990-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#3)(2011-1#6)(2011-2#6)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#3)
information are available##4##3##(1997-6#1)(1997-8#1)(2009-12#1)(2011-2#1)
information are communicated##2##3##(1991-5#1)(2008-1#1)
information are discussed##2##3##(1997-3#1)(2008-5#1)
information are used##2##3##(2008-8#1)(2012-3#1)
information are##21##2##(1991-5#1)(1993-2#1)(1995-12#1)(1997-3#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
information as a##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
information as##12##2##(1990-2#1)(1991-3#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
information at the point of##2##5##(1996-1#1)(2008-11#1)
information at the##6##3##(1992-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
information at##9##2##(1992-1#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
information available for##2##3##(2008-4#1)(2013-1#1)
information available in##2##3##(2011-2#1)(2013-1#1)
information available on the##2##4##(2008-10#1)(2008-4#1)
information available to##4##3##(1997-3#1)(2008-11#1)(2009-5#1)(2013-7#1)
information available##16##2##(1991-11#1)(1995-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
information based on##2##3##(2008-3#1)(2008-4#1)
information being##3##2##(1993-12#1)(1995-1#1)(1996-2#1)
information between##10##2##(1992-11#1)(1992-12#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
information but##2##2##(1995-10#1)(2008-1#1)
information by use of##2##4##(2008-3#2)
information by##12##2##(1993-1#1)(1995-3#1)(1996-11#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2012-1#1)
information can also be##2##4##(2008-6#1)(2012-3#1)
information can be obtained##4##4##(1992-4#1)(1992-5#1)(2008-9#1)(2013-1#1)
information can be recovered from##2##5##(2007-11#1)(2008-3#1)
information can be used##3##4##(1996-3#1)(2010-4#1)(2013-1#1)
information can be##27##3##(1992-4#1)(1992-5#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#8)(2008-9#3)(2010-1#1)(2010-4#1)(2010-5#1)(2013-1#2)
information can then be##2##4##(2008-3#1)(2011-2#1)
information can then##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
information can##41##2##(1992-4#1)(1992-5#1)(1992-9#1)(1995-11#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
information cannot be##3##3##(2008-2#2)(2013-8#1)
information carried by the##3##4##(2007-11#1)(2009-8#1)(2013-8#1)
information carried##4##2##(2007-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
information collected##7##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#2)(2013-1#1)
information coming##2##2##(1991-5#1)(1994-12#1)
information concerning the##15##3##(1992-8#1)(1994-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-3#1)
information concerning their##2##3##(1995-12#1)(1997-6#1)
information concerning##34##2##(1990-8#1)(1991-2#3)(1992-11#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#2)(2011-2#1)(2012-3#2)(2013-8#2)
information contained in the##2##4##(2008-10#1)(2008-3#1)
information contained in##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
information contained##7##2##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
information content of the##5##4##(1997-6#1)(2008-2#1)(2008-3#2)(2011-2#1)
information content of##7##3##(1997-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#1)
information content##10##2##(1997-6#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2010-10#1)(2011-2#1)
information could be##3##3##(2008-10#1)(2009-11#1)(2011-2#1)
information could##4##2##(2008-10#2)(2009-11#1)(2011-2#1)
information criteria##2##2##(2008-3#1)(2012-3#1)
information criterion##3##2##(2008-10#1)(2011-1#2)
information decoding##2##2##(2008-3#2)
information demands##2##2##(1997-3#1)(2008-10#1)
information density##4##2##(2008-3#4)
information derived from##4##3##(1994-3#1)(2007-4#1)(2008-4#1)(2008-8#1)
information differently##2##2##(2010-11#1)(2010-9#1)
information directly##2##2##(1994-12#1)(2008-7#1)
information dissemination##3##2##(1990-3#1)(2008-10#1)(2011-1#1)
information do##2##2##(2008-11#1)(2010-11#1)
information during the##2##3##(1993-5#1)(2010-4#1)
information during##4##2##(1990-12#1)(1993-5#1)(2008-4#1)(2010-4#1)
information entropy##4##2##(2007-11#1)(2013-8#3)
information even##2##2##(2007-11#1)(2008-7#1)
information exchange##6##2##(1992-2#2)(1995-12#1)(1996-1#1)(1996-2#1)(2011-1#1)
information exists regarding##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2012-5#1)
information exists##8##2##(1992-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-5#1)
information extraction method of spectral images based on 3D spectral angle##2##11##(2013-8#2)
information extraction##4##2##(2008-10#1)(2008-7#1)(2013-8#2)
information facilitates##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
information flow##2##2##(2010-4#1)(2012-2#1)
information for accurate##2##3##(2008-1#1)(2008-10#1)
information for each##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
information for further##2##3##(2008-10#1)(2013-1#1)
information for medical##2##3##(1997-1#1)(2008-10#1)
information for other##2##3##(2008-11#2)
information for planning##2##3##(1990-12#1)(2008-9#1)
information for quality improvement##2##4##(1996-12#1)(2012-2#1)
information for the##22##3##(1990-8#1)(1994-3#1)(1995-3#1)(1997-4#1)(1997-8#2)(2006-6#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-9#2)(2010-5#1)(2011-1#1)(2011-7#1)(2013-8#2)
information for young people##2##4##(2008-7#2)
information for##104##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-6#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#5)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#7)(2009-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
information found in the##2##4##(1991-2#1)(2011-3#1)
information found in##3##3##(1991-2#1)(2010-5#1)(2011-3#1)
information found on##2##3##(2011-1#2)
information found##5##2##(1991-2#1)(2010-5#1)(2011-1#2)(2011-3#1)
information from a cDNA##2##4##(1997-7#1)(2011-2#1)
information from a variety of##2##5##(1995-1#1)(2008-12#1)
information from a##10##3##(1993-2#1)(1995-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)(2011-2#1)
information from biological##2##3##(2008-4#1)(2010-7#1)
information from complex##2##3##(2008-10#2)
information from different##2##3##(2007-8#1)(2011-2#1)
information from managed care##2##4##(1993-12#1)(1997-2#1)
information from one##2##3##(2008-1#1)(2008-3#1)
information from patients##4##3##(1992-12#1)(1997-3#2)(2008-11#1)
information from silent amino acid substitutions##3##6##(2008-4#3)
information from the##26##3##(1991-12#1)(1991-2#1)(1992-12#1)(1995-8#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)
information from their##2##3##(2007-12#1)(2008-7#1)
information from##92##2##(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(2007-12#4)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-8#2)
information gap##2##2##(2007-5#2)
information gathered##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
information generated##2##2##(1993-12#1)(2008-3#1)
information given##5##2##(1993-6#1)(1996-3#1)(2007-8#1)(2008-11#1)(2011-1#1)
information gleaned from##4##3##(1996-3#1)(2007-6#1)(2009-9#1)(2010-2#1)
information had##4##2##(1993-2#1)(1993-9#1)(2008-5#1)(2013-1#1)
information has become##2##3##(2008-5#1)(2008-7#1)
information has been##7##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2013-1#1)
information has##16##2##(1995-12#1)(1995-3#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
information have##2##2##(1996-11#1)(2013-7#1)
information in a timely fashion##2##5##(1994-2#1)(1995-12#1)
information in a##8##3##(1991-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
information in addition to##4##4##(1997-8#1)(2008-3#1)(2009-2#1)(2010-4#1)
information in patients##2##3##(1995-3#1)(1997-8#1)
information in predicting##3##3##(2008-7#1)(2009-8#1)(2013-1#1)
information in rice##2##3##(1996-10#1)(2009-10#1)
information in the literature##3##4##(1992-2#1)(2007-5#1)(2008-1#1)
information in the##29##3##(1992-10#1)(1992-2#2)(1993-3#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
information in this##3##3##(1992-12#1)(2006-5#1)(2011-2#1)
information in##89##2##(1991-11#1)(1992-10#1)(1992-12#1)(1992-2#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#3)(2009-2#1)(2009-8#1)(2010-11#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
information includes##3##2##(1994-3#2)(2008-10#1)
information infrastructure##5##2##(1994-12#1)(1997-3#3)(2010-8#1)
information into a coherent##2##4##(2008-11#1)(2008-4#1)
information into account##2##3##(2008-3#1)(2009-10#1)
information into the##2##3##(1990-11#1)(1997-2#1)
information into##14##2##(1990-11#1)(1990-5#2)(1993-12#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)
information is a##3##3##(1996-1#1)(1996-3#1)(2012-12#1)
information is also##2##3##(2008-9#1)(2010-7#1)
information is available about the##2##5##(2008-10#1)(2013-7#1)
information is available about##3##4##(2007-10#1)(2008-10#1)(2013-7#1)
information is available concerning the##3##5##(2008-10#2)(2008-12#1)
information is available for##4##4##(2007-12#1)(2008-8#1)(2009-4#1)(2013-1#1)
information is available from##2##4##(2008-10#1)(2008-8#1)
information is available on the##7##5##(2008-10#4)(2008-5#2)(2012-3#1)
information is available on##9##4##(1993-1#1)(2008-10#4)(2008-5#2)(2008-6#1)(2012-3#1)
information is available##26##3##(1993-1#1)(1994-12#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2012-3#1)(2013-1#2)(2013-7#1)
information is being##3##3##(2007-7#1)(2010-5#1)(2013-1#1)
information is contained in the##2##5##(2008-3#2)
information is crucial for##2##4##(2009-12#1)(2013-7#1)
information is crucial##3##3##(2008-9#1)(2009-12#1)(2013-7#1)
information is discussed##2##3##(1990-12#1)(2008-3#1)
information is extracted##3##3##(2007-11#1)(2008-3#2)
information is not##4##3##(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)
information is obtained from##3##4##(2008-3#2)(2010-9#1)
information is obtained##4##3##(2008-3#3)(2010-9#1)
information is presented##4##3##(1994-2#1)(2007-8#1)(2008-1#1)(2010-11#1)
information is processed in##3##4##(1995-12#1)(2012-2#1)(2013-8#1)
information is provided##4##3##(2008-10#1)(2008-4#2)(2008-5#1)
information is required for##3##4##(1990-8#1)(2008-10#1)(2010-4#1)
information is required##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)
information is still##2##3##(2008-12#1)(2008-5#1)
information is the##2##3##(1997-3#1)(2012-12#1)
information is then##2##3##(2008-3#1)(2008-9#1)
information is to##2##3##(1992-3#1)(2008-4#1)
information is##125##2##(1990-12#1)(1990-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#2)(1996-4#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
information leaflets##4##2##(1996-1#1)(2010-5#3)
information like##2##2##(1996-12#1)(2008-11#1)
information malpractice##2##2##(1992-2#2)
information management environment##2##3##(1995-2#2)
information management in##2##3##(1995-2#1)(2010-8#1)
information management system##2##3##(1992-2#1)(2008-11#1)
information management##18##2##(1992-2#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#6)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-8#1)
information may be useful in##2##5##(2010-5#1)(2013-1#1)
information may be##5##3##(1994-5#1)(1995-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
information may##13##2##(1992-5#1)(1994-5#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
information more##2##2##(2007-9#1)(2008-7#1)
information necessary to##4##3##(1994-1#2)(1996-3#1)(2013-1#1)
information necessary##5##2##(1993-2#1)(1994-1#2)(1996-3#1)(2013-1#1)
information needed for##2##3##(1997-1#1)(2007-2#1)
information needed to##9##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#3)
information needed##12##2##(1994-2#1)(1994-3#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)
information needs during a##2##4##(1995-12#1)(2010-8#1)
information needs for##2##3##(1997-3#1)(2012-12#1)
information needs in##3##3##(1993-12#1)(1997-3#2)
information needs of the##2##4##(1991-12#1)(1997-3#1)
information needs of##8##3##(1991-12#1)(1994-12#1)(1995-1#1)(1997-3#4)(2010-8#1)
information needs##20##2##(1991-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-3#10)(2008-3#1)(2010-8#2)(2012-12#1)
information networks##4##2##(1993-2#1)(1996-1#2)(2010-8#1)
information not##5##2##(1996-1#1)(2008-1#1)(2008-10#2)(2009-11#1)
information obtainable##2##2##(2008-7#1)(2012-2#1)
information obtained from a##3##4##(1994-3#1)(2008-10#1)(2008-12#1)
information obtained from the##2##4##(1991-3#1)(1993-2#1)
information obtained from##12##3##(1990-2#1)(1991-3#1)(1993-2#1)(1994-3#1)(2008-10#5)(2008-12#1)(2012-12#1)(2013-1#1)
information obtained in this##2##4##(1997-8#1)(2011-2#1)
information obtained in##3##3##(1997-3#1)(1997-8#1)(2011-2#1)
information obtained##23##2##(1990-2#1)(1991-12#1)(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
information of a##3##3##(2008-3#2)(2013-8#1)
information of both##3##3##(1994-8#1)(2008-10#1)(2011-1#1)
information of interest##2##3##(1995-2#1)(2008-9#1)
information of the##17##3##(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-6#1)(2011-2#1)(2013-8#2)
information of##54##2##(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#9)(2008-7#3)(2008-8#2)(2008-9#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-8#4)
information on a##6##3##(1991-1#1)(1995-6#1)(1997-1#1)(2008-3#1)(2008-7#1)(2013-1#1)
information on all##3##3##(2008-4#1)(2008-6#1)(2011-2#1)
information on an##2##3##(2008-3#1)(2013-7#1)
information on both the##2##4##(2007-11#1)(2008-2#1)
information on conducting a waste audit and negotiating with a hauler##2##11##(1996-12#1)(1996-3#1)
information on future##2##3##(1991-5#1)(2008-7#1)
information on gene##2##3##(2008-7#2)
information on heart function##2##4##(2013-1#2)
information on heart##3##3##(1991-3#1)(2013-1#2)
information on how to##4##4##(1993-12#1)(1997-5#1)(2008-4#2)
information on how##6##3##(1993-12#1)(1997-5#1)(1997-7#1)(2008-4#2)(2008-7#1)
information on natural##2##3##(1997-3#1)(2013-7#1)
information on platelet-leukocyte conjugate formation in whole blood and on factors that##2##12##(2006-6#2)
information on quality##2##3##(1996-2#1)(1997-3#1)
information on radioactivity and the safe use of radioisotopes and other hazardous chemicals##2##13##(2008-2#2)
information on regulation of##2##4##(1992-11#1)(2008-7#1)
information on smoking##3##3##(1991-12#1)(1992-6#1)(1995-6#1)
information on the Internet##5##4##(1996-2#1)(2007-2#1)(2008-11#3)
information on the actual##2##4##(1993-12#1)(2008-11#1)
information on the anatomy##2##4##(2007-8#1)(2013-1#1)
information on the behaviour of##2##5##(2008-5#2)
information on the causes of##3##5##(2008-10#2)(2008-11#1)
information on the effects of##2##5##(2008-10#2)
information on the efficacy of##2##5##(1996-3#1)(2011-2#1)
information on the health care context##2##6##(1997-3#2)
information on the health##3##4##(1991-3#1)(1997-3#2)
information on the impact of##2##5##(1995-6#1)(2008-11#1)
information on the mechanisms##2##4##(1993-6#1)(2013-1#1)
information on the number of##3##5##(2007-10#1)(2008-10#1)(2008-3#1)
information on the number##6##4##(1994-6#2)(2007-10#1)(2008-10#1)(2008-3#2)
information on the spatial##2##4##(2007-12#1)(2008-10#1)
information on the##156##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#3)(1996-3#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-8#1)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2008-9#4)(2009-2#1)(2009-5#2)(2010-12#4)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#4)(2013-1#6)(2013-8#2)
information on their##8##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
information on this##5##3##(1991-6#1)(1993-3#1)(2008-4#1)(2008-7#1)(2013-7#1)
information on using##2##3##(2008-12#1)(2008-9#1)
information on variables##2##3##(2008-3#1)(2011-1#1)
information on which##2##3##(1992-12#1)(2008-5#1)
information on##340##2##(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#3)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1994-1#1)(1994-11#2)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#3)(1996-1#4)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#4)(2007-8#2)(2008-1#2)(2008-10#38)(2008-11#15)(2008-12#3)(2008-2#10)(2008-3#16)(2008-4#14)(2008-5#11)(2008-6#5)(2008-7#17)(2008-8#5)(2008-9#8)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#16)(2013-7#3)(2013-8#2)
information or##9##2##(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#2)(2012-3#1)
information over a##2##3##(2008-10#1)(2008-11#1)
information over the##2##3##(2008-2#1)(2008-7#1)
information over##5##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
information present in the##2##4##(2008-4#1)(2008-6#1)
information presented here##2##3##(2008-4#1)(2008-5#1)
information presented##3##2##(2008-4#1)(2008-5#2)
information processing by the##3##4##(2008-11#1)(2009-3#2)
information processing in##4##3##(1992-8#1)(2008-2#1)(2008-5#1)(2012-1#1)
information processing to##2##3##(2008-11#1)(2012-12#1)
information processing##30##2##(1992-8#1)(1993-5#1)(1996-2#2)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-3#3)(2012-1#1)(2012-12#2)
information produced##2##2##(1995-2#1)(2008-11#1)
information provided by a##3##4##(1993-2#1)(2008-11#1)(2008-8#1)
information provided by the##5##4##(1992-12#1)(1997-1#1)(2008-10#1)(2010-3#1)(2010-8#1)
information provided by##15##3##(1992-12#1)(1993-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-2#1)
information provided to##2##3##(2007-10#1)(2008-11#1)
information provided##19##2##(1992-12#1)(1993-2#1)(1997-1#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-8#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
information provides##4##2##(1994-2#1)(2007-12#1)(2007-7#1)(2008-6#1)
information regarding the##18##3##(1990-6#1)(1993-12#1)(1993-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-9#1)(2013-1#3)
information regarding their##2##3##(2008-4#2)
information regarding##34##2##(1990-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
information related to the##2##4##(1995-12#1)(2008-5#1)
information related to##11##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
information relative to the##2##4##(2008-10#1)(2008-5#1)
information relative to##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
information relevant to the##3##4##(1990-2#1)(2008-3#1)(2009-6#1)
information relevant to##7##3##(1990-2#2)(1995-8#1)(1997-1#1)(2008-3#1)(2008-7#1)(2009-6#1)
information required for##2##3##(1997-3#1)(2008-11#1)
information required##5##2##(1997-3#1)(2008-11#2)(2008-7#1)(2009-10#1)
information resource that can be##5##5##(2008-4#3)(2008-9#1)(2010-11#1)
information resource##7##2##(1993-2#1)(1997-2#1)(2008-4#3)(2008-9#1)(2010-11#1)
information resources for##3##3##(1996-2#1)(1997-2#1)(2008-4#1)
information resources##7##2##(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)
information retrieval##12##2##(1991-8#1)(1992-1#2)(1994-8#2)(1996-12#2)(2007-12#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#1)
information search and retrieval skills##2##5##(2008-11#2)
information search##4##2##(1997-3#1)(2008-11#2)(2010-8#1)
information security##2##2##(2010-8#2)
information services##7##2##(1991-2#1)(1993-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)
information sharing##3##2##(1995-2#1)(2008-11#1)(2011-9#1)
information should be useful##3##4##(1994-1#1)(2008-10#2)
information should be##4##3##(1994-1#1)(2008-10#2)(2010-12#1)
information should##8##2##(1993-11#1)(1994-1#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-12#1)
information significantly##2##2##(2007-12#1)(2010-3#1)
information sources##6##2##(1991-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2011-2#1)(2012-12#1)
information storage##3##2##(2007-8#2)(2008-3#1)
information stored in##2##3##(1993-1#1)(2008-7#1)
information stored##3##2##(1993-1#1)(2008-2#1)(2008-7#1)
information such as##5##3##(2008-2#1)(2008-4#1)(2009-11#1)(2011-2#1)(2011-3#1)
information superhighway##4##2##(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)
information supporting##2##2##(2008-10#1)(2010-5#1)
information system as##2##3##(2012-12#1)(2012-3#1)
information system can be##2##4##(1992-12#1)(1994-2#1)
information system for##5##3##(1993-12#1)(1995-12#1)(1996-3#1)(2007-4#1)(2010-8#1)
information system in##3##3##(1991-9#1)(2012-12#1)(2012-3#1)
information system is##3##3##(1992-3#1)(1994-2#1)(2010-8#1)
information system to##2##3##(1996-3#1)(1997-1#1)
information system using##2##3##(1996-12#1)(2008-8#1)
information system will##3##3##(1992-11#1)(1994-12#1)(1997-1#1)
information system##60##2##(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#2)(1995-12#3)(1996-12#4)(1996-2#1)(1996-3#8)(1997-1#2)(1997-3#2)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-8#3)(2010-8#4)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#1)
information systems and remote sensing##3##5##(2008-8#3)
information systems and##11##3##(1993-1#1)(1993-3#1)(1994-2#2)(1995-1#1)(1996-3#1)(2008-10#1)(2008-8#3)(2012-12#1)
information systems are being##2##4##(1996-12#1)(1997-3#1)
information systems are##4##3##(1996-12#2)(1997-1#1)(1997-3#1)
information systems for##4##3##(1994-2#1)(1994-3#1)(2011-2#1)(2012-12#1)
information systems in##6##3##(1995-12#1)(1996-12#1)(2008-8#2)(2012-12#2)
information systems into##2##3##(1997-3#2)
information systems management##2##3##(1992-12#2)
information systems manager##2##3##(1994-3#2)
information systems that##4##3##(1993-2#1)(1995-12#1)(1996-3#2)
information systems to support##3##4##(1993-3#1)(1994-12#1)(1996-12#1)
information systems to##7##3##(1992-12#1)(1993-3#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2009-11#1)
information systems will##4##3##(1994-12#1)(1995-12#1)(1996-3#1)(1997-3#1)
information systems##121##2##(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#2)(1993-12#4)(1993-2#6)(1993-3#5)(1994-12#3)(1994-2#6)(1994-3#5)(1995-1#5)(1995-12#3)(1995-2#1)(1996-1#2)(1996-12#8)(1996-2#2)(1996-3#7)(1997-1#3)(1997-2#2)(1997-3#10)(2007-10#1)(2008-1#1)(2008-10#10)(2008-7#2)(2008-8#6)(2009-11#1)(2010-8#3)(2011-2#3)(2012-12#13)(2012-3#1)
information technologies for##2##3##(1997-2#1)(2013-1#1)
information technologies##8##2##(1995-1#1)(1996-1#2)(1997-2#1)(2009-5#1)(2010-8#1)(2013-1#2)
information technology (IT)##2##3##(2007-12#1)(2008-1#1)
information technology and##3##3##(2008-11#2)(2008-7#1)
information technology for##2##3##(1997-1#1)(2008-11#1)
information technology in##6##3##(1993-2#1)(1994-12#1)(2008-10#2)(2010-8#1)(2013-1#1)
information technology to##3##3##(1995-3#1)(2008-11#2)
information technology##40##2##(1993-2#3)(1994-12#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-1#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-5#1)(2008-7#4)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
information than##3##2##(2008-2#1)(2008-4#2)
information that can be##6##4##(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
information that can##7##3##(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#2)
information that could##3##3##(2007-12#1)(2008-5#1)(2009-3#1)
information that is available in##2##5##(1992-9#1)(2008-2#1)
information that is available##4##4##(1992-9#1)(2008-2#1)(2008-9#1)(2013-8#1)
information that is##11##3##(1992-9#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
information that was##4##3##(2007-5#1)(2008-11#1)(2008-2#1)(2009-3#1)
information that will##2##3##(1997-3#1)(2010-10#1)
information that##54##2##(1991-12#1)(1992-2#1)(1992-9#1)(1995-12#3)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#2)(2009-8#1)(2010-10#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
information the##4##2##(1997-7#1)(1997-8#1)(2012-12#2)
information theory##4##2##(2008-1#1)(2010-8#2)(2011-3#1)
information they##6##2##(1993-6#1)(1995-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-5#1)
information through##3##2##(2007-2#1)(2008-2#1)(2008-3#1)
information to a##2##3##(2007-12#1)(2013-1#1)
information to assist in##2##4##(1995-1#1)(2008-4#1)
information to be##5##3##(1996-2#1)(2008-11#1)(2009-11#1)(2011-10#1)(2011-2#1)
information to consumers##2##3##(1996-2#1)(1997-3#1)
information to develop##2##3##(1993-12#1)(2008-7#1)
information to enhance##2##3##(1996-2#1)(2008-10#1)
information to establish##2##3##(1995-12#1)(2012-12#1)
information to evaluate##2##3##(2008-9#1)(2013-7#1)
information to guide##3##3##(1993-2#1)(1996-2#1)(2008-7#1)
information to help identify##2##4##(1991-2#1)(2012-3#1)
information to improve##3##3##(1993-12#1)(1996-1#1)(2008-7#1)
information to minimize##2##3##(2008-3#1)(2008-9#1)
information to rural physiotherapists##2##4##(1993-2#2)
information to the##13##3##(1990-2#1)(1994-2#1)(1996-1#1)(2008-1#2)(2008-10#3)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
information to##96##2##(1990-2#3)(1990-6#1)(1991-2#2)(1991-3#1)(1992-12#1)(1993-12#2)(1993-2#4)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-1#2)(1996-2#7)(1996-6#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#4)(2007-2#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
information transfer##3##2##(2008-1#1)(2008-9#1)(2010-10#1)
information transmission##4##2##(2007-12#1)(2008-3#1)(2011-2#2)
information used##3##2##(1994-2#1)(1997-3#1)(2008-10#1)
information useful##2##2##(1997-3#1)(2008-5#1)
information using a##2##3##(2010-3#1)(2011-1#1)
information using##4##2##(2008-10#1)(2010-3#1)(2011-1#1)(2011-3#1)
information via##3##2##(2008-7#1)(2010-4#1)(2010-5#1)
information was available##4##3##(1991-12#1)(1992-11#1)(2008-10#1)(2008-7#1)
information was collected from##2##4##(1994-1#1)(2008-8#1)
information was collected##5##3##(1994-1#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-9#1)
information was obtained by##2##4##(2008-10#1)(2008-3#1)
information was obtained from##2##4##(2007-10#1)(2011-2#1)
information was obtained##6##3##(1991-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
information was used##2##3##(1992-2#1)(2008-11#1)
information was##39##2##(1990-3#2)(1991-12#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-9#1)(2013-1#3)
information were also##2##3##(1997-3#1)(2011-2#1)
information were##7##2##(1992-2#1)(1993-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2011-2#2)
information when##2##2##(1992-2#1)(2007-8#1)
information which is##2##3##(1996-3#1)(1997-6#1)
information which##4##2##(1996-3#1)(1997-6#1)(2008-12#1)(2008-8#1)
information will be useful##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
information will be##5##3##(1993-2#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-2#1)
information will provide##2##3##(2008-4#1)(2010-5#1)
information will##9##2##(1993-2#1)(1994-11#1)(1994-2#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
information with regard to##2##4##(1994-3#1)(1997-4#1)
information with respect to##2##4##(2008-7#1)(2012-1#1)
information with##17##2##(1994-3#1)(1995-12#1)(1995-3#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-8#2)(2012-1#1)(2013-1#1)
information within##2##2##(1995-1#1)(1996-12#1)
information without##4##2##(1996-1#1)(2008-3#1)(2010-8#1)(2012-12#1)
information would##3##2##(1994-5#1)(1997-3#1)(2008-11#1)
information##3000##1##(1990-11#5)(1990-12#5)(1990-2#12)(1990-3#4)(1990-5#4)(1990-6#4)(1990-8#9)(1991-1#6)(1991-11#4)(1991-12#15)(1991-2#13)(1991-3#12)(1991-5#5)(1991-6#6)(1991-8#3)(1991-9#2)(1992-1#8)(1992-10#2)(1992-11#11)(1992-12#23)(1992-2#26)(1992-3#11)(1992-4#2)(1992-5#4)(1992-6#3)(1992-8#4)(1992-9#5)(1993-1#11)(1993-11#2)(1993-12#28)(1993-2#42)(1993-3#16)(1993-5#2)(1993-6#5)(1993-8#1)(1993-9#2)(1994-1#9)(1994-11#4)(1994-12#23)(1994-2#37)(1994-3#25)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#10)(1994-9#2)(1995-1#24)(1995-10#1)(1995-11#8)(1995-12#35)(1995-2#24)(1995-3#24)(1995-4#1)(1995-5#5)(1995-6#8)(1995-8#4)(1995-9#3)(1996-1#42)(1996-10#1)(1996-11#14)(1996-12#32)(1996-2#36)(1996-3#59)(1996-4#3)(1996-5#8)(1996-6#8)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#28)(1997-2#13)(1997-3#84)(1997-4#7)(1997-5#8)(1997-6#13)(1997-7#10)(1997-8#10)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#3)(2007-10#13)(2007-11#24)(2007-12#72)(2007-2#15)(2007-4#5)(2007-5#7)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#2)(2008-1#51)(2008-10#212)(2008-11#147)(2008-12#39)(2008-2#80)(2008-3#170)(2008-4#110)(2008-5#48)(2008-6#35)(2008-7#133)(2008-8#46)(2008-9#74)(2009-10#9)(2009-11#10)(2009-12#13)(2009-2#4)(2009-3#9)(2009-4#8)(2009-5#18)(2009-6#2)(2009-7#1)(2009-8#10)(2009-9#6)(2010-1#2)(2010-10#11)(2010-11#12)(2010-12#12)(2010-2#4)(2010-3#15)(2010-4#14)(2010-5#20)(2010-6#4)(2010-7#5)(2010-8#56)(2010-9#6)(2011-1#52)(2011-10#1)(2011-2#99)(2011-3#8)(2011-7#1)(2011-9#2)(2012-1#9)(2012-12#70)(2012-2#61)(2012-3#39)(2012-5#1)(2013-1#79)(2013-7#13)(2013-8#47)
information) and##2##2##(2008-7#1)(2010-1#1)
information)##7##1##(1995-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)
information--and##2##1##(1993-12#1)(1996-12#1)
information-based##2##1##(2008-3#2)
information-integration task##2##2##(2009-5#2)
information-limiting##2##1##(1995-1#2)
information-processing##4##1##(2007-12#1)(2007-8#1)(2008-4#1)(2010-8#1)
information-rich##3##1##(2008-7#1)(2010-5#2)
information-seeking questions##2##2##(2013-8#2)
information-seeking##7##1##(1995-1#3)(1995-2#1)(2013-8#3)
information-signal processing##2##2##(2012-2#2)
information-signal##3##1##(2012-2#3)
information-theoretic approach##2##2##(2008-7#1)(2010-10#1)
information-theoretic criteria##2##2##(2008-7#2)
information-theoretic method##2##2##(2008-7#2)
information-theoretic##8##1##(2008-3#1)(2008-7#5)(2010-10#1)(2012-2#1)
information?##2##1##(2009-5#1)(2013-8#1)
informational entropy##3##2##(1993-12#3)
informational processing architecture##2##3##(1997-1#2)
informational##17##1##(1992-12#1)(1993-12#3)(1995-1#1)(1997-1#2)(1997-3#3)(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#2)
informations on##2##2##(2006-8#1)(2008-10#1)
informations##10##1##(1990-5#1)(1992-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
informative about##2##2##(2008-7#1)(2013-1#1)
informative and##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
informative campaign##3##2##(2008-12#3)
informative data##2##2##(2008-11#1)(2008-9#1)
informative for##4##2##(1997-5#1)(2008-1#1)(2008-12#1)(2013-8#1)
informative genes##2##2##(2008-10#2)
informative material##2##2##(2008-11#1)(2008-3#1)
informative regarding##2##2##(2008-12#1)(2008-6#1)
informative to##2##2##(2008-10#1)(2010-12#1)
informative##61##1##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#8)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#2)(2009-9#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#1)
informed about the##7##3##(1995-12#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-9#1)(2012-1#1)
informed about##12##2##(1991-6#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-6#2)(2008-10#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-2#1)
informed by a##4##3##(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)
informed by the##6##3##(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)
informed by##14##2##(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
informed choices##3##2##(1997-3#1)(2008-11#1)(2008-12#1)
informed consent are##2##3##(1993-2#1)(1995-1#1)
informed consent from##2##3##(2008-12#1)(2012-1#1)
informed consent is##2##3##(2008-7#1)(2010-11#1)
informed consent of##3##3##(1992-3#1)(2007-11#1)(2011-2#1)
informed consent process##3##3##(2008-4#1)(2010-7#1)(2012-2#1)
informed consent to participate in##2##5##(2010-11#1)(2012-1#1)
informed consent##44##2##(1992-3#2)(1993-2#3)(1995-1#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-9#1)(1997-6#1)(2007-11#4)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-4#3)(2009-6#3)(2010-11#3)(2010-7#1)(2011-2#2)(2012-1#4)(2012-2#1)(2012-3#1)
informed decisions about##2##3##(1993-12#1)(2008-1#1)
informed decisions##5##2##(1991-2#1)(1993-12#1)(2008-1#1)(2008-12#1)(2013-1#1)
informed his##2##2##(1995-6#1)(2008-12#1)
informed of the##5##3##(1996-1#1)(1997-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
informed purchasing##2##2##(1991-2#1)(2008-11#1)
informed the##6##2##(1990-2#1)(1991-7#2)(1996-11#1)(1997-5#1)(2008-11#1)
informed##130##1##(1990-2#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-12#1)(1993-2#5)(1994-2#1)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-6#3)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#3)(2007-10#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#4)(2009-6#4)(2009-8#1)(2009-9#2)(2010-11#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
informing the##2##2##(1990-2#1)(2008-4#1)
informing their##2##2##(1994-2#1)(2011-2#1)
informing##8##1##(1990-2#1)(1994-2#1)(1996-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-2#1)
informs about the##2##3##(1997-6#1)(2011-3#1)
informs##7##1##(1993-2#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-8#1)(2011-3#1)(2012-3#1)
infra red##2##2##(2008-10#1)(2012-2#1)
infra-red##9##1##(1991-2#2)(2008-10#4)(2009-5#1)(2009-6#1)(2013-1#1)
infra-renal aortic dissection##2##3##(2012-1#2)
infra-renal aortic##3##2##(2012-1#3)
infra-umbilical##2##1##(1990-2#1)(2008-12#1)
infrabony##2##1##(2009-5#1)(2010-5#1)
infrabuccal cavity##4##2##(2007-12#4)
infrabuccal##5##1##(2007-12#5)
infraction##3##1##(2007-11#1)(2008-1#1)(2008-4#1)
infragranular##2##1##(1993-12#1)(1997-2#1)
inframammary fold##2##2##(2013-1#2)
inframammary##4##1##(2006-10#1)(2011-2#1)(2013-1#2)
infraorbital sinuses##2##2##(2008-5#2)
infraorbital##3##1##(1997-3#1)(2008-5#2)
infrared (ATR-FTIR)##2##2##(2008-10#2)
infrared (FT-IR)##8##2##(2007-12#4)(2008-10#3)(2013-1#1)
infrared (FTIR) spectroscopy##7##3##(1994-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)
infrared (FTIR)##19##2##(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)
infrared (IR) spectra##2##3##(2008-10#2)
infrared (IR) spectroscopy##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
infrared (IR)##12##2##(2007-12#3)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2011-2#1)
infrared (NIR) spectroscopy##3##3##(2008-10#2)(2011-1#1)
infrared (NIR)##5##2##(2008-10#3)(2010-1#1)(2011-1#1)
infrared Fourier transform##5##3##(2008-1#1)(2008-10#4)
infrared Fourier##6##2##(2008-1#1)(2008-10#5)
infrared absorption spectroscopy##5##3##(2008-11#2)(2008-3#1)(2013-8#2)
infrared absorption##10##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2013-8#2)
infrared and near-infrared##2##3##(2007-12#1)(2008-2#1)
infrared and##12##2##(1993-11#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
infrared antennas##2##2##(2008-2#1)(2008-3#1)
infrared atmospheric sounding interferometer##2##4##(2008-3#2)
infrared atmospheric##3##2##(2008-3#3)
infrared attenuated total reflection##2##4##(1990-2#1)(2008-5#1)
infrared band##3##2##(2008-2#1)(2008-3#2)
infrared bands##2##2##(2007-11#1)(2007-12#1)
infrared beam splitter##2##3##(2008-2#2)
infrared data##2##2##(2008-2#1)(2008-3#1)
infrared detection##4##2##(2007-11#2)(2008-10#1)(2008-2#1)
infrared detectors##3##2##(2007-11#2)(2008-3#1)
infrared determination of##3##3##(2008-10#3)
infrared distance sensing##2##3##(2013-8#2)
infrared drying##2##2##(2008-10#2)
infrared emission##3##2##(2008-10#1)(2008-2#2)
infrared emissivity##2##2##(2008-3#2)
infrared evolved gas##3##3##(2008-10#3)
infrared femtosecond laser pulses##4##4##(2007-12#4)
infrared femtosecond laser##5##3##(2007-12#5)
infrared imagery##2##2##(2008-3#2)
infrared images##2##2##(2008-2#1)(2008-3#1)
infrared imaging spectroscopy##2##3##(2008-8#2)
infrared imaging##9##2##(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)
infrared interferometer##2##2##(2008-2#1)(2008-3#1)
infrared interferometers##2##2##(2008-2#1)(2008-3#1)
infrared is##4##2##(2007-11#1)(2008-2#3)
infrared laser pulses##2##3##(2007-11#1)(2007-12#1)
infrared laser##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
infrared lasers##2##2##(2008-3#1)(2008-7#1)
infrared light##4##2##(2008-2#1)(2008-3#3)
infrared limb spectra##2##3##(2008-3#2)
infrared microspectroscopy##2##2##(2008-5#2)
infrared optical##4##2##(2008-2#1)(2008-3#1)(2011-1#2)
infrared radiation spectra##2##3##(2008-3#2)
infrared radiation##12##2##(2007-11#3)(2008-10#2)(2008-2#2)(2008-3#4)(2013-1#1)
infrared radiometer for measuring the air-sea temperature difference##2##8##(2008-3#2)
infrared radiometer for##3##3##(2008-3#3)
infrared radiometer##4##2##(2008-3#4)
infrared reflection##3##2##(1991-5#2)(2008-2#1)
infrared region of the spectrum##2##5##(2008-10#2)
infrared region##4##2##(2008-10#4)
infrared sensors##3##2##(2008-10#1)(2008-3#2)
infrared spectra of the##2##4##(1995-5#1)(2013-8#1)
infrared spectra of##9##3##(1995-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2013-8#2)
infrared spectra##21##2##(1991-5#1)(1995-5#1)(1996-2#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-3#1)(2009-9#1)(2010-5#1)(2013-8#3)
infrared spectral radiance from water##2##5##(2008-3#2)
infrared spectral radiance##3##3##(2008-2#1)(2008-3#2)
infrared spectral regions##2##3##(2008-3#2)
infrared spectral##11##2##(2008-2#2)(2008-3#9)
infrared spectrometer##9##2##(2008-10#3)(2008-3#4)(2013-8#2)
infrared spectrometers##2##2##(2008-3#2)
infrared spectrometry (FT-IR)##3##3##(1997-2#1)(2008-10#2)
infrared spectrometry and##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
infrared spectrometry##20##2##(1992-8#1)(1997-2#2)(1997-4#1)(2008-10#14)(2008-3#1)(2008-5#1)
infrared spectroscopic determination of##2##4##(2008-10#1)(2012-2#1)
infrared spectroscopic##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-8#1)
infrared spectroscopy (ATR-FTIR)##3##3##(2008-10#2)(2008-5#1)
infrared spectroscopy (FTIR)##8##3##(2008-10#5)(2008-5#1)(2013-8#2)
infrared spectroscopy (NIRS)##2##3##(2008-10#2)
infrared spectroscopy analysis##2##3##(2008-10#1)(2008-6#1)
infrared spectroscopy and its##2##4##(2007-12#1)(2012-2#1)
infrared spectroscopy and multivariate##3##4##(2008-10#2)(2013-8#1)
infrared spectroscopy and##11##3##(2007-12#1)(2008-10#6)(2008-6#1)(2010-5#1)(2012-2#1)(2013-8#1)
infrared spectroscopy is##2##3##(2008-10#2)
infrared spectroscopy to##2##3##(1994-11#1)(2008-10#1)
infrared spectroscopy##66##2##(1992-6#2)(1994-11#2)(1994-6#1)(2007-10#1)(2007-12#3)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2009-10#1)(2010-2#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-8#3)
infrared spectrum of##2##3##(1990-8#1)(1996-2#1)
infrared spectrum##9##2##(1990-8#1)(1996-2#1)(2008-10#3)(2013-8#4)
infrared systems##3##2##(2008-2#1)(2008-3#2)
infrared thermograph technique##2##3##(2008-3#2)
infrared thermography##3##2##(2008-10#2)(2011-1#1)
infrared wavelength region##2##3##(2008-2#1)(2008-3#1)
infrared wavelength##4##2##(2008-2#2)(2008-3#1)(2011-1#1)
infrared wavelengths##4##2##(2008-2#2)(2008-3#1)(2010-2#1)
infrared##512##1##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#3)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#3)(1994-6#1)(1995-5#1)(1996-2#5)(1996-7#2)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#22)(2007-12#46)(2008-1#3)(2008-10#151)(2008-11#4)(2008-2#49)(2008-3#127)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#5)(2009-10#2)(2009-9#1)(2010-1#1)(2010-2#2)(2010-4#3)(2010-5#3)(2011-1#6)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#25)
infrared)##5##1##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
infrared-sensitive photorefractive##2##2##(2008-2#1)(2008-3#1)
infrared-sensitive##3##1##(2008-2#2)(2008-3#1)
infrared-transmitting##2##1##(2007-12#1)(2008-3#1)
infrarenal##8##1##(1991-8#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
infraspinatus##5##1##(2008-12#2)(2010-4#1)(2012-12#2)
infrastructural##2##1##(2008-11#1)(2008-4#1)
infrastructure and##9##2##(1995-12#1)(1996-1#1)(2008-1#1)(2008-11#1)(2010-8#2)(2012-12#1)(2012-2#2)
infrastructure for data-based cancer control planning and##2##7##(1997-1#2)
infrastructure for##6##2##(1996-3#1)(1997-1#3)(2008-7#1)(2010-9#1)
infrastructure in##2##2##(2008-1#1)(2008-10#1)
infrastructure of##3##2##(1992-12#1)(1995-12#1)(2008-10#1)
infrastructure that##2##2##(1996-3#1)(2008-11#1)
infrastructure to ensure##2##3##(1995-1#1)(2010-3#1)
infrastructure to support##3##3##(2007-2#1)(2008-10#1)(2012-2#1)
infrastructure to##8##2##(1995-1#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
infrastructure##65##1##(1991-6#1)(1992-12#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-3#2)(1997-1#4)(1997-3#5)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-5#1)(2008-6#2)(2008-7#5)(2010-12#1)(2010-3#1)(2010-8#6)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#1)
infrastructures##3##1##(1994-12#1)(1996-3#1)(1997-3#1)
infratemporal fossa and##2##3##(2011-2#1)(2012-3#1)
infratemporal fossa##4##2##(2011-2#2)(2012-3#2)
infratemporal##5##1##(2006-12#1)(2011-2#2)(2012-3#2)
infratentorial##5##1##(2008-7#3)(2012-12#2)
infrequent and##5##2##(1992-5#1)(1995-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
infrequent cause of##2##3##(1991-3#1)(2012-3#1)
infrequent disease##2##2##(1990-12#1)(2011-2#1)
infrequent in##2##2##(1990-2#1)(2008-10#1)
infrequent shortenings##2##2##(1995-5#2)
infrequent##37##1##(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#2)(1993-10#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-5#2)(1995-6#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
infrequently encountered##2##2##(2011-2#1)(2012-2#1)
infrequently reported##3##2##(2007-8#1)(2008-1#1)(2010-6#1)
infrequently##19##1##(1994-8#2)(1995-2#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#1)
infundibulum and##2##2##(2007-8#1)(2008-12#1)
infundibulum##5##1##(1992-6#1)(2007-8#2)(2008-12#2)
infuse##3##1##(1997-3#1)(2009-5#1)(2010-8#1)
infused in the##2##3##(1992-8#1)(1997-2#1)
infused into the medial##3##4##(1993-12#3)
infused into the##7##3##(1993-12#4)(2007-11#1)(2007-12#1)(2011-2#1)
infused into##8##2##(1993-12#4)(2007-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
infused per##2##2##(1991-5#1)(2011-2#1)
infused with##4##2##(1994-9#1)(1997-2#1)(2008-7#1)(2012-2#1)
infused##30##1##(1991-1#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-8#1)(1993-12#4)(1993-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-3#2)(2011-2#2)(2012-2#1)
infusing##5##1##(1992-10#1)(1993-1#1)(1996-12#1)(1997-2#1)(2011-2#1)
infusion and a##2##3##(1990-12#1)(2008-7#1)
infusion and##6##2##(1990-12#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-7#2)
infusion in terminal cancer]##2##4##(1992-5#2)
infusion in terminal##3##3##(1990-3#1)(1992-5#2)
infusion in the##2##3##(1995-12#1)(1995-9#1)
infusion in##11##2##(1990-3#1)(1992-5#2)(1993-12#1)(1995-12#1)(1995-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
infusion increased##2##2##(1994-3#1)(2008-5#1)
infusion is##3##2##(1992-5#1)(2008-5#1)(2012-2#1)
infusion may##2##2##(1991-9#1)(1994-11#1)
infusion of CCK##2##3##(1993-6#2)
infusion of FGFs##2##3##(2008-7#2)
infusion of a##2##3##(1995-11#1)(2008-6#1)
infusion of amino##2##3##(2010-7#2)
infusion of drugs##2##3##(1992-5#2)
infusion of either##3##3##(1993-6#1)(1995-11#1)(2008-1#1)
infusion of saline into the epidural space##3##7##(1993-10#3)
infusion of saline##5##3##(1993-10#4)(2008-1#1)
infusion of the##3##3##(1993-12#1)(1995-12#1)(1997-2#1)
infusion of##75##2##(1990-12#2)(1990-8#1)(1991-3#3)(1991-8#1)(1992-11#1)(1992-5#3)(1992-7#1)(1992-9#1)(1993-10#4)(1993-12#7)(1993-3#3)(1993-6#5)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#5)(1996-11#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#7)(2009-4#1)(2010-11#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
infusion on##5##2##(1995-12#1)(2007-10#2)(2012-12#1)(2013-8#1)
infusion only##2##2##(1991-6#1)(2008-5#1)
infusion or##4##2##(1990-2#1)(2007-8#2)(2008-8#1)
infusion period##2##2##(1994-8#1)(1995-12#1)
infusion pump##6##2##(2008-1#1)(2008-4#1)(2009-11#2)(2011-2#2)
infusion pumps may##2##3##(2011-2#2)
infusion pumps##9##2##(1990-8#1)(2010-9#2)(2011-1#1)(2011-2#5)
infusion rate##3##2##(1993-1#1)(1994-12#1)(2008-11#1)
infusion therapy##7##2##(1991-11#1)(1995-2#1)(2007-8#1)(2008-3#2)(2008-7#1)(2012-3#1)
infusion was##6##2##(1992-10#1)(1997-3#1)(2007-10#2)(2008-4#1)(2013-1#1)
infusion were##2##2##(1994-11#1)(1995-3#1)
infusion with##3##2##(1992-10#1)(2010-7#1)(2011-2#1)
infusion##227##1##(1990-10#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#5)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#3)(1992-11#1)(1992-5#7)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#6)(1993-12#9)(1993-3#3)(1993-6#5)(1994-11#3)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#3)(1995-11#3)(1995-12#10)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#4)(1997-8#1)(2007-10#9)(2007-11#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#17)(2008-8#2)(2008-9#1)(2009-11#3)(2009-4#2)(2009-9#1)(2010-11#2)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#15)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#1)(2013-8#3)
infusion]##2##1##(1992-11#1)(1997-5#1)
infusions and##2##2##(1992-5#1)(1993-12#1)
infusions during##2##2##(1992-5#1)(2011-2#1)
infusions into##2##2##(1990-5#1)(1992-8#1)
infusions of chlordiazepoxide##2##3##(1993-12#2)
infusions of β-lactam##2##3##(2013-1#2)
infusions of##19##2##(1992-8#1)(1993-12#5)(1993-6#2)(1994-10#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-12#1)(2007-7#1)(2012-12#2)(2013-1#2)
infusions were##2##2##(1992-6#1)(2011-2#1)
infusions##43##1##(1990-10#1)(1990-5#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#6)(1993-6#2)(1994-10#1)(1994-2#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#3)(2012-12#4)(2013-1#2)
ing##3##1##(2008-11#3)
ingenious##3##1##(2008-9#2)(2012-2#1)
ingentis##3##1##(2007-12#3)
ingest##8##1##(1990-2#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#2)(2011-2#1)
ingested SLCV##2##2##(2008-10#2)
ingested amounts##2##2##(2008-11#1)(2012-2#1)
ingested by##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
ingested either##2##2##(2008-5#1)(2013-1#1)
ingested food##2##2##(2008-2#1)(2011-2#1)
ingested through##2##2##(2008-5#2)
ingested##31##1##(1993-12#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#7)(2008-7#4)(2009-10#1)(2010-1#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#2)
ingesting##8##1##(1991-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2013-8#1)
ingestion and##4##2##(1994-11#1)(2008-5#1)(2008-6#1)(2010-1#1)
ingestion exposure##2##2##(2008-7#2)
ingestion of a##6##3##(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)
ingestion of contaminated##2##3##(2008-6#1)(2008-7#1)
ingestion of the##5##3##(1992-2#1)(2008-10#1)(2008-7#2)(2013-8#1)
ingestion of##36##2##(1990-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-11#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
ingestion on##2##2##(2012-2#1)(2013-1#1)
ingestion or inhalation of##2##4##(1992-8#1)(2007-12#1)
ingestion or##3##2##(1992-8#1)(2007-12#1)(2008-1#1)
ingestion was##2##2##(2008-10#1)(2010-11#1)
ingestion##83##1##(1990-9#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#5)(1996-12#1)(1997-4#3)(2007-12#3)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-2#3)(2010-6#2)(2010-8#1)(2011-2#5)(2012-2#3)(2013-1#5)(2013-8#1)
ingestions##3##1##(2007-8#1)(2008-7#1)(2010-5#1)
ingestive##2##1##(1993-12#1)(2009-8#1)
ingredient in##6##2##(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
ingredient is##2##2##(2008-5#2)
ingredient of##5##2##(1991-6#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-9#1)
ingredient to##4##2##(2007-2#1)(2008-5#2)(2011-2#1)
ingredient within##3##2##(2008-10#1)(2008-5#2)
ingredient##63##1##(1991-1#1)(1991-6#1)(1994-8#1)(1995-1#2)(1997-3#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-5#32)(2008-8#2)(2008-9#2)(2010-4#4)(2011-2#4)(2012-2#4)(2012-3#1)(2013-8#1)
ingredient)##2##1##(2008-5#2)
ingredients and##10##2##(1994-6#1)(2007-7#1)(2008-10#2)(2008-5#3)(2008-8#1)(2011-2#1)(2012-2#1)
ingredients are##6##2##(2008-5#2)(2009-7#1)(2012-12#1)(2012-2#2)
ingredients for##8##2##(2008-5#4)(2010-7#2)(2011-2#1)(2012-2#1)
ingredients from##3##2##(2008-5#2)(2009-12#1)
ingredients in##9##2##(2008-10#6)(2008-8#1)(2010-9#2)
ingredients of##3##2##(1996-4#1)(2008-5#2)
ingredients on##2##2##(2009-12#1)(2010-4#1)
ingredients that##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
ingredients was##2##2##(2008-5#1)(2012-2#1)
ingredients were##3##2##(2008-10#1)(2008-5#2)
ingredients##93##1##(1990-3#1)(1994-3#1)(1994-6#1)(1996-4#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#39)(2008-7#1)(2008-8#2)(2009-12#2)(2009-7#3)(2010-4#2)(2010-7#4)(2010-9#3)(2011-2#7)(2012-12#1)(2012-2#9)
ingredients'##3##1##(2008-5#3)
ingress in##2##2##(2008-10#2)
ingress into the##2##3##(2008-10#2)
ingress of##3##2##(1996-2#1)(2008-10#2)
ingress##16##1##(1996-2#1)(2008-10#14)(2008-9#1)
ingression##2##1##(2008-10#2)
ingroup and outgroup##6##3##(2008-11#2)(2009-11#4)
ingroup preference##2##2##(2009-11#2)
ingroup##10##1##(2008-11#2)(2009-11#6)(2012-3#2)
ingrowth##9##1##(2008-10#2)(2008-11#3)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#1)
ingrowths##2##1##(2007-12#1)(2011-2#1)
inguinal area##3##2##(1995-5#1)(2008-5#1)(2009-9#1)
inguinal hernia repair##3##3##(2011-2#3)
inguinal hernia with incarceration of urinary bladder diverticulum in a##2##10##(2011-2#2)
inguinal hernia##17##2##(1992-5#1)(1993-9#1)(1996-3#1)(1996-9#1)(2008-10#2)(2008-12#3)(2011-2#7)(2012-12#1)
inguinal hernia]##2##2##(1990-6#1)(1994-3#1)
inguinal hernias##2##2##(1990-6#2)
inguinal herniorrhaphy##3##2##(2011-2#3)
inguinal herniotomy in##2##3##(2008-10#1)(2008-7#1)
inguinal lymph nodes##2##3##(1994-12#1)(2013-1#1)
inguinal lymph##3##2##(1994-12#1)(2007-5#1)(2013-1#1)
inguinal region##2##2##(2009-2#1)(2011-2#1)
inguinal##52##1##(1990-6#3)(1992-5#2)(1993-9#2)(1994-12#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-9#2)(2007-5#1)(2008-10#6)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-9#3)(2010-11#1)(2011-2#14)(2012-12#2)(2012-4#1)(2013-1#1)
inguinoscrotal hernia##2##2##(2008-12#2)
inguinoscrotal##3##1##(1992-5#1)(2008-12#2)
inhabit##4##1##(2009-5#1)(2011-2#2)(2013-1#1)
inhabitants and##2##2##(1992-9#1)(2008-10#1)
inhabitants of##7##2##(1991-3#1)(1992-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#2)
inhabitants were##2##2##(2008-7#1)(2013-1#1)
inhabitants##34##1##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#2)(1992-2#1)(1992-9#1)(1994-11#2)(1994-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
inhabitants)##3##1##(1991-2#1)(1993-9#1)(2011-2#1)
inhabited by the##2##3##(2008-5#1)(2008-8#1)
inhabited by##3##2##(2008-5#1)(2008-8#2)
inhabited##5##1##(2008-12#1)(2008-5#1)(2008-8#2)(2012-3#1)
inhabiting a##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
inhabiting the same##2##3##(2008-10#2)
inhabiting the##3##2##(2008-10#3)
inhabiting##16##1##(1994-9#1)(2008-10#4)(2008-5#2)(2008-8#3)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
inhabits##2##1##(2008-10#1)(2008-5#1)
inhalant allergens##2##2##(2007-7#1)(2012-3#1)
inhalation and dermal##2##3##(2008-12#1)(2008-5#1)
inhalation and##5##2##(1996-2#1)(2008-12#1)(2008-5#2)(2012-3#1)
inhalation challenge##2##2##(2008-10#2)
inhalation devices##2##2##(1997-1#1)(1997-2#1)
inhalation exposure##2##2##(2008-10#2)
inhalation in##2##2##(1993-2#1)(1996-2#1)
inhalation is##2##2##(1996-3#1)(2013-8#1)
inhalation method##2##2##(1995-5#1)(2008-7#1)
inhalation of##14##2##(1990-12#1)(1990-9#1)(1992-8#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#1)
inhalation or##3##2##(1997-1#1)(2008-5#1)(2008-7#1)
inhalation products##2##2##(1997-2#2)
inhalation technique##2##2##(1992-3#1)(1997-1#1)
inhalation##73##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-2#2)(1994-2#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-1#3)(1996-2#3)(1996-3#4)(1997-1#5)(1997-2#6)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
inhalational##8##1##(1991-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#3)
inhalative##2##1##(1992-6#1)(2013-8#1)
inhale##3##1##(1992-3#2)(1996-1#1)
inhaled aerosols to##2##3##(1994-12#1)(1997-2#1)
inhaled aerosols##4##2##(1994-12#1)(1997-2#1)(2013-1#2)
inhaled air##3##2##(1990-8#2)(2008-11#1)
inhaled and intranasal corticosteroids##3##4##(2007-11#3)
inhaled and##4##2##(2007-11#3)(2008-11#1)
inhaled as##2##2##(2010-4#2)
inhaled bradykinin##2##2##(1992-3#2)
inhaled corticosteroid##7##2##(1996-1#1)(2008-1#3)(2008-11#1)(2009-6#1)(2012-1#1)
inhaled corticosteroids##13##2##(1996-7#1)(2007-11#4)(2008-11#4)(2011-2#2)(2012-1#1)(2013-8#1)
inhaled dose of##2##3##(1992-3#1)(2008-5#1)
inhaled drugs##3##2##(1997-1#2)(2010-10#1)
inhaled insulin##9##2##(2008-8#9)
inhaled nitric oxide##3##3##(1997-1#1)(2008-12#2)
inhaled or##2##2##(2007-11#1)(2010-5#1)
inhaled salbutamol##2##2##(1990-9#1)(2007-2#1)
inhaled steroids##3##2##(1992-5#1)(1995-6#1)(2008-11#1)
inhaled tritiated##2##2##(1993-8#2)
inhaled##106##1##(1990-5#2)(1990-8#2)(1990-9#1)(1991-12#2)(1991-4#1)(1992-3#9)(1992-5#1)(1993-8#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#2)(1997-1#8)(1997-2#1)(2007-11#9)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#9)(2009-6#1)(2010-10#2)(2010-2#1)(2010-4#2)(2010-5#3)(2011-2#2)(2012-1#3)(2012-3#1)(2013-1#5)(2013-8#4)
inhaler (MDI)##8##2##(1992-3#2)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#2)
inhaler is##2##2##(1994-2#1)(1996-2#1)
inhaler with a spacer##2##4##(2007-11#1)(2008-8#1)
inhaler##33##1##(1992-3#2)(1993-2#3)(1994-2#4)(1996-1#2)(1996-2#9)(1997-1#3)(1997-2#4)(2007-11#2)(2008-8#2)(2010-11#1)(2010-6#1)
inhalers (MDIs)##10##2##(1992-3#2)(1996-1#5)(1996-2#1)(1997-1#1)(2008-3#1)
inhalers have##2##2##(1992-3#2)
inhalers##36##1##(1992-2#5)(1992-3#12)(1993-2#1)(1996-1#10)(1996-2#5)(1997-1#1)(2008-3#1)(2011-2#1)
inherent differences in the##2##4##(1991-12#1)(2008-5#1)
inherent heterogeneity##2##2##(2008-10#2)
inherent high##2##2##(2008-3#1)(2010-3#1)
inherent immune##2##2##(2010-1#1)(2012-3#1)
inherent in a##2##3##(2008-2#1)(2008-7#1)
inherent in the use of##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
inherent in the##13##3##(1990-8#1)(1991-1#1)(1991-12#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-6#2)(2008-7#1)(2010-12#1)
inherent in this##2##3##(1992-3#1)(2008-10#1)
inherent in##38##2##(1990-8#2)(1991-1#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
inherent incentives##2##2##(1991-12#1)(1991-2#1)
inherent limitations of##2##3##(2008-10#1)(2008-7#1)
inherent limitations##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
inherent optical properties of seawater##2##5##(2008-2#1)(2008-3#1)
inherent optical properties of##7##4##(2008-2#2)(2008-3#5)
inherent optical properties##17##3##(2008-2#6)(2008-3#11)
inherent optical property models##2##4##(2008-2#1)(2008-3#1)
inherent optical property##5##3##(2008-2#2)(2008-3#3)
inherent optical##24##2##(2008-2#9)(2008-3#15)
inherent problems that##2##3##(2008-10#1)(2008-12#1)
inherent problems##5##2##(2008-10#2)(2008-12#2)(2009-9#1)
inherent properties of##2##3##(2008-11#1)(2008-3#1)
inherent properties##4##2##(2008-11#1)(2008-3#2)(2010-12#1)
inherent reactivity##2##2##(1994-12#2)
inherent resistance to##2##3##(2008-10#2)
inherent resistance##3##2##(1991-2#1)(2008-10#2)
inherent sensitivity##2##2##(2008-10#1)(2012-3#1)
inherent stability and##2##3##(2008-10#1)(2008-4#1)
inherent stability##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
inherent to the##4##3##(1996-11#1)(2008-10#2)(2009-6#1)
inherent to this##2##3##(2008-6#1)(2009-5#1)
inherent to##15##2##(1992-3#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-12#1)
inherent##202##1##(1990-2#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1992-3#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-11#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#6)(2008-1#3)(2008-10#29)(2008-11#9)(2008-12#7)(2008-2#16)(2008-3#35)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-5#2)(2009-6#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#2)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
inherently complex##3##2##(2008-7#1)(2010-4#1)(2012-1#1)
inherently conducting##2##2##(2008-10#1)(2008-9#1)
inherently discrete##2##2##(1996-4#2)
inherently faster##2##2##(2008-10#1)(2008-3#1)
inherently limited##2##2##(2008-7#1)(2009-5#1)
inherently noisy##2##2##(2008-3#2)
inherently unstable##2##2##(2008-2#1)(2008-9#1)
inherently##44##1##(1992-1#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-4#2)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#12)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-6#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
inherit dominance##2##2##(2008-8#2)
inherit##7##1##(2008-7#1)(2008-8#5)(2012-3#1)
inheritable##3##1##(2012-12#2)(2013-1#1)
inheritance and##2##2##(2008-10#1)(2009-3#1)
inheritance are##2##2##(2008-5#1)(2008-7#1)
inheritance has been##2##3##(2008-7#1)(2011-1#1)
inheritance has##3##2##(2008-7#2)(2011-1#1)
inheritance is##3##2##(1997-3#1)(2007-7#1)(2011-2#1)
inheritance of EBS is linked to##2##6##(1991-12#2)
inheritance of resistance to leprosis##2##5##(2008-10#2)
inheritance of resistance to##9##4##(2008-10#8)(2012-3#1)
inheritance of resistance##13##3##(2008-10#12)(2012-3#1)
inheritance of the##9##3##(1994-11#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-9#1)(2013-8#1)
inheritance of these##2##3##(1993-6#1)(2008-11#1)
inheritance of##56##2##(1991-12#2)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-12#1)(2007-1#2)(2008-10#29)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2012-3#1)(2013-8#1)
inheritance pattern##5##2##(1994-8#2)(2007-7#1)(2008-7#1)(2012-3#1)
inheritance were##2##2##(2008-10#1)(2008-8#1)
inheritance##111##1##(1991-12#2)(1991-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-8#3)(1994-9#2)(1996-12#1)(1997-3#1)(2007-1#2)(2007-7#6)(2007-8#1)(2008-1#4)(2008-10#38)(2008-11#2)(2008-12#4)(2008-4#4)(2008-5#3)(2008-7#8)(2008-8#8)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-3#4)(2013-8#1)
inherited and the##2##3##(1997-3#1)(2008-9#1)
inherited and##5##2##(1997-3#1)(2008-6#1)(2008-9#2)(2012-12#1)
inherited ataxias##3##2##(2008-7#3)
inherited autosomal##2##2##(2008-1#1)(2012-12#1)
inherited bleeding disorders##2##3##(1997-7#1)(2011-2#1)
inherited by##2##2##(1994-11#1)(2009-8#1)
inherited defects##2##2##(2008-10#1)(2008-9#1)
inherited diseases##7##2##(1995-12#1)(1995-8#1)(1996-8#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
inherited disorders of##2##3##(1997-7#1)(2008-10#1)
inherited disorders##8##2##(1991-11#1)(1994-11#1)(1994-2#1)(1994-9#1)(1997-7#1)(2008-10#2)(2008-5#1)
inherited factors##2##2##(1996-2#1)(2008-12#1)
inherited form of##2##3##(1992-11#1)(2008-10#1)
inherited from P##3##3##(2008-10#3)
inherited from the##4##3##(2008-10#3)(2011-2#1)
inherited from##11##2##(1997-4#1)(2008-10#6)(2009-6#1)(2010-9#1)(2011-2#2)
inherited in a##2##3##(2008-7#1)(2011-2#1)
inherited in##3##2##(1992-6#1)(2008-7#1)(2011-2#1)
inherited metabolic diseases##2##3##(1990-8#1)(2010-12#1)
inherited metabolic disorders##2##3##(2008-10#1)(2011-2#1)
inherited metabolic##5##2##(1990-8#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
inherited the##2##2##(1990-11#1)(1997-3#1)
inherited##117##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-2#2)(1996-8#2)(1997-3#5)(1997-4#1)(1997-7#5)(2007-10#1)(2007-12#1)(2007-7#4)(2008-1#3)(2008-10#18)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
inherits##2##1##(2008-11#1)(2009-3#1)
inhibin A##2##2##(1992-6#1)(1992-8#1)
inhibin subunits##3##2##(2008-8#3)
inhibin##11##1##(1992-6#1)(1992-8#2)(1996-5#2)(2008-10#1)(2008-8#5)
inhibit DNA##5##2##(1994-8#1)(1995-2#1)(1997-3#1)(2008-5#1)(2008-9#1)
inhibit HIV-1 protease##2##3##(1991-12#1)(2011-3#1)
inhibit HIV-1##3##2##(1991-12#1)(1994-6#1)(2011-3#1)
inhibit a##4##2##(1992-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
inhibit actomyosin ATPase activity##2##4##(1992-9#2)
inhibit adenosine kinase activity##2##4##(1997-7#2)
inhibit all##2##2##(2008-4#1)(2009-7#1)
inhibit binding##2##2##(1992-5#1)(1995-3#1)
inhibit both##6##2##(1990-2#1)(1991-11#1)(1991-9#1)(2006-10#1)(2008-1#1)(2008-9#1)
inhibit cathepsin##2##2##(1990-2#1)(1990-5#1)
inhibit cell growth##3##3##(1994-8#1)(2008-11#2)
inhibit cell##4##2##(1994-3#1)(1994-8#1)(2008-11#2)
inhibit collagen##2##2##(1997-3#1)(2008-8#1)
inhibit cyclooxygenase##2##2##(2008-5#1)(2012-2#1)
inhibit gene expression##2##3##(1997-4#1)(2009-5#1)
inhibit glucose##2##2##(2009-10#1)(2010-2#1)
inhibit growth of##6##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
inhibit growth##9##2##(1990-2#1)(1993-1#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
inhibit iNOS##2##2##(2008-10#1)(2011-2#1)
inhibit in vitro##3##3##(1991-9#1)(1997-3#1)(2008-10#1)
inhibit insulin secretion##2##3##(1993-3#1)(1994-8#1)
inhibit insulin##4##2##(1990-12#1)(1993-3#1)(1994-8#1)(1997-1#1)
inhibit its##4##2##(1994-6#1)(1995-2#1)(2011-2#1)(2011-3#1)
inhibit or##3##2##(1993-8#1)(1996-12#1)(2008-10#1)
inhibit pepsinogen secretion##3##3##(1995-8#3)
inhibit phagocytosis##2##2##(2008-4#1)(2008-6#1)
inhibit platelet aggregation##2##3##(1993-8#1)(2006-6#1)
inhibit platelet##3##2##(1991-11#1)(1993-8#1)(2006-6#1)
inhibit proliferation##3##2##(1997-3#1)(2011-2#1)(2013-7#1)
inhibit protein synthesis##4##3##(1990-11#1)(1994-2#1)(1994-5#1)(2011-1#1)
inhibit protein##6##2##(1990-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(2011-1#1)
inhibit release of##2##3##(1991-8#1)(2008-7#1)
inhibit replication of##2##3##(1994-6#2)
inhibit some##2##2##(1995-2#1)(2011-3#1)
inhibit superprecipitation##2##2##(1992-9#2)
inhibit the activation of##2##4##(1992-9#1)(1994-11#1)
inhibit the activity of the##2##5##(1995-11#1)(2009-6#1)
inhibit the activity of##3##4##(1995-11#1)(2008-1#1)(2009-6#1)
inhibit the binding##6##3##(1990-5#2)(1991-9#1)(1994-8#1)(1995-11#1)(2009-2#1)
inhibit the cell##2##3##(2008-11#1)(2008-8#1)
inhibit the development of##3##4##(1991-1#1)(2008-10#1)(2010-4#1)
inhibit the effect of##2##4##(1994-6#1)(2008-5#1)
inhibit the enzyme##4##3##(1990-7#1)(1996-2#1)(2008-11#1)(2013-1#1)
inhibit the expression of##9##4##(1993-3#1)(1995-11#1)(1997-6#1)(2008-5#1)(2008-9#3)(2010-1#1)(2013-1#1)
inhibit the expression##10##3##(1993-3#1)(1993-6#1)(1995-11#1)(1997-6#1)(2008-5#1)(2008-9#3)(2010-1#1)(2013-1#1)
inhibit the formation of##5##4##(1994-5#1)(1994-8#1)(1996-3#1)(2008-5#1)(2008-8#1)
inhibit the growth of##12##4##(1990-8#1)(2008-10#6)(2008-8#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#1)
inhibit the induction of##2##4##(1994-9#2)
inhibit the metabolism of##2##4##(1995-11#1)(2008-9#1)
inhibit the pathogen##2##3##(2008-10#2)
inhibit the production of##2##4##(1994-11#1)(1996-2#1)
inhibit the proliferation of##3##4##(1994-6#1)(1997-1#1)(2011-2#1)
inhibit the replication of AZT-resistant##2##5##(1994-6#2)
inhibit the replication of##4##4##(1994-6#2)(2008-5#1)(2011-3#1)
inhibit the splicing##2##3##(1991-9#2)
inhibit the synthesis of##3##4##(1990-2#1)(1993-8#1)(2008-10#1)
inhibit the tyrosine##2##3##(1991-11#1)(2011-2#1)
inhibit the##153##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#6)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#3)(1995-11#6)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-8#7)(2008-9#5)(2009-2#2)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)
inhibit their##2##2##(2008-11#1)(2010-5#1)
inhibit these##2##2##(1992-3#1)(1993-11#1)
inhibit this##4##2##(1995-11#1)(1995-5#1)(2008-11#1)(2009-12#1)
inhibit thrombin##5##2##(1990-7#1)(1991-9#1)(1994-5#3)
inhibit transcription of##2##3##(2008-7#1)(2010-4#1)
inhibit transcription##3##2##(2008-7#1)(2008-9#1)(2010-4#1)
inhibit tumor growth##5##3##(1993-11#1)(1994-6#1)(2008-8#2)(2008-9#1)
inhibit tumor##7##2##(1993-11#1)(1994-6#1)(2008-11#2)(2008-8#2)(2008-9#1)
inhibit##458##1##(1990-11#4)(1990-12#2)(1990-2#6)(1990-4#1)(1990-5#6)(1990-7#8)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#10)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#4)(1993-3#4)(1993-6#2)(1993-8#8)(1993-9#2)(1994-11#7)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#7)(1994-6#12)(1994-7#1)(1994-8#12)(1994-9#4)(1995-11#10)(1995-12#8)(1995-2#10)(1995-3#4)(1995-5#3)(1995-6#5)(1995-8#8)(1995-9#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#1)(1997-1#5)(1997-2#1)(1997-3#5)(1997-4#4)(1997-6#2)(1997-7#3)(2006-10#2)(2006-6#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#34)(2008-11#18)(2008-12#1)(2008-3#4)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#11)(2008-8#19)(2008-9#16)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#5)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#11)(2011-3#4)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#2)
inhibited Ca2+##2##2##(1995-12#1)(1995-6#1)
inhibited DNA synthesis##2##3##(1990-7#1)(1997-4#1)
inhibited DNA##3##2##(1990-7#1)(1995-2#1)(1997-4#1)
inhibited ET-1-induced##2##2##(1993-8#2)
inhibited HIV-1 strain##2##3##(2011-3#2)
inhibited HL-60##2##2##(1995-3#2)
inhibited O2-##3##2##(1992-5#1)(1994-8#1)(1996-2#1)
inhibited TRH-induced##2##2##(1993-11#1)(1996-2#1)
inhibited U937##2##2##(1995-3#1)(2012-2#1)
inhibited [3H]5-HT release in##3##4##(1995-12#3)
inhibited acetylcholinesterase##2##2##(1997-7#1)(2008-11#1)
inhibited after##3##2##(2008-10#3)
inhibited almost##2##2##(1990-5#1)(1992-4#1)
inhibited and the##2##3##(1995-12#1)(2008-9#1)
inhibited and##9##2##(1990-2#1)(1994-5#1)(1995-12#2)(1997-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
inhibited angiogenesis##2##2##(1991-12#1)(2008-10#1)
inhibited angiotensin II-induced##2##3##(1995-11#1)(1995-12#1)
inhibited angiotensin##3##2##(1995-11#1)(1995-12#2)
inhibited antigen-induced##2##2##(1992-3#1)(1997-7#1)
inhibited apoptosis##2##2##(2008-8#1)(2012-2#1)
inhibited appressorium formation##2##3##(2008-10#2)
inhibited as##2##2##(1997-4#1)(2010-11#1)
inhibited at high##2##3##(1992-9#1)(2009-3#1)
inhibited at##12##2##(1990-7#1)(1992-5#1)(1992-9#2)(1993-9#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-3#1)
inhibited binding##2##2##(1995-11#1)(1996-12#1)
inhibited both the##3##3##(1990-2#1)(1991-12#1)(2008-11#1)
inhibited both##16##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2011-3#1)
inhibited by 10 mM##2##4##(1990-11#1)(1995-6#1)
inhibited by 10##3##3##(1990-11#1)(1995-3#1)(1995-6#1)
inhibited by EDTA##3##3##(1991-9#1)(1992-8#1)(1994-5#1)
inhibited by OxLDL##2##3##(1995-2#2)
inhibited by RA##2##3##(2008-11#2)
inhibited by a##6##3##(1990-7#1)(1992-6#1)(1995-2#1)(1996-2#1)(2008-5#1)(2008-8#1)
inhibited by about##2##3##(1993-3#1)(1995-12#1)
inhibited by an##3##3##(1990-5#1)(1991-2#1)(1993-9#1)
inhibited by approximately##2##3##(1993-3#1)(1993-8#1)
inhibited by both##3##3##(1990-2#1)(1993-6#1)(1994-5#1)
inhibited by cycloheximide##2##3##(1991-12#1)(1993-12#1)
inhibited by dexamethasone##2##3##(1993-3#1)(1997-1#1)
inhibited by diphenyleneiodonium##2##3##(1993-6#1)(2008-10#1)
inhibited by indomethacin and##3##4##(1990-11#1)(1992-3#1)(1995-3#1)
inhibited by indomethacin##6##3##(1990-11#1)(1990-2#1)(1991-3#1)(1992-3#1)(1995-3#1)(1997-1#1)
inhibited by other##3##3##(1990-8#1)(1994-6#1)(1994-8#1)
inhibited by pertussis toxin##2##4##(1990-8#1)(1994-9#1)
inhibited by phorbol##2##3##(1991-5#1)(1994-11#1)
inhibited by pretreatment of##2##4##(1992-8#1)(2008-11#1)
inhibited by pretreatment##3##3##(1992-8#1)(1994-3#1)(2008-11#1)
inhibited by rat##2##3##(1990-8#1)(1993-11#1)
inhibited by the active principle##2##5##(1992-3#2)
inhibited by the addition of 20##2##6##(2008-8#1)(2012-2#1)
inhibited by the addition of##6##5##(1992-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(2008-8#1)(2012-2#1)
inhibited by the presence of##2##5##(1991-1#1)(1995-3#1)
inhibited by the protein##2##4##(1994-11#1)(2013-1#1)
inhibited by the##37##3##(1990-11#1)(1990-2#1)(1990-7#2)(1991-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#2)(2012-2#1)(2013-1#2)
inhibited by these##2##3##(1992-8#1)(2008-11#1)
inhibited by treatment with##3##4##(1991-2#1)(1994-11#1)(2008-8#1)
inhibited by treatment##4##3##(1991-2#1)(1994-11#1)(2008-10#1)(2008-8#1)
inhibited by wortmannin##2##3##(1994-11#1)(1995-8#1)
inhibited by##302##2##(1990-10#1)(1990-11#10)(1990-12#9)(1990-2#11)(1990-5#5)(1990-7#4)(1990-8#6)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-11#2)(1992-12#7)(1992-3#13)(1992-6#2)(1992-8#6)(1992-9#5)(1993-11#2)(1993-12#4)(1993-3#9)(1993-6#4)(1993-8#10)(1993-9#4)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#5)(1994-8#9)(1994-9#6)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#3)(1995-6#6)(1995-8#4)(1996-12#4)(1996-2#7)(1996-5#1)(1997-1#4)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#20)(2008-11#15)(2008-3#2)(2008-4#9)(2008-5#5)(2008-7#3)(2008-8#11)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
inhibited cell division##2##3##(1993-8#1)(1995-2#1)
inhibited cell growth and##2##4##(2013-1#2)
inhibited cell growth##8##3##(1991-9#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-11#2)(2013-1#2)
inhibited cell proliferation in##2##4##(1992-5#1)(2011-2#1)
inhibited cell proliferation##5##3##(1992-5#2)(2009-9#1)(2011-2#1)(2013-1#1)
inhibited cell##18##2##(1991-9#1)(1992-5#2)(1993-8#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-9#1)(2011-2#2)(2013-1#3)
inhibited compared with##2##3##(2008-8#2)
inhibited disseminated candidiasis##2##3##(2008-5#2)
inhibited enzyme##2##2##(1995-6#1)(2008-10#1)
inhibited expression of##3##3##(2008-8#2)(2012-2#1)
inhibited for##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
inhibited forskolin##2##2##(1990-12#1)(1995-11#1)
inhibited forskolin-stimulated##2##2##(1993-3#1)(1997-1#1)
inhibited from##3##2##(1994-11#2)(2012-3#1)
inhibited fungal##2##2##(2008-10#2)
inhibited germination of##3##3##(2008-10#3)
inhibited glisoxepide##2##2##(1992-3#2)
inhibited growth in##2##3##(1990-6#1)(1993-11#1)
inhibited growth of##4##3##(1993-9#1)(1994-8#1)(2008-10#2)
inhibited growth##10##2##(1990-6#1)(1993-11#1)(1993-9#1)(1994-8#1)(2008-10#3)(2008-11#2)(2011-2#1)
inhibited high KCl-stimulated##2##3##(1996-2#2)
inhibited high##4##2##(1995-11#1)(1996-2#3)
inhibited histamine-induced bronchoconstriction##2##3##(1994-11#1)(1997-7#1)
inhibited in a##3##3##(1992-6#1)(1993-9#1)(2012-2#1)
inhibited in the presence of##5##5##(1993-11#1)(1994-11#1)(2008-10#2)(2008-11#1)
inhibited in the##9##3##(1992-3#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
inhibited in vitro##2##3##(1993-8#1)(1995-6#1)
inhibited in##27##2##(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)
inhibited its##4##2##(1990-5#1)(1993-3#1)(1994-5#1)(2008-10#1)
inhibited markedly by##3##3##(1991-8#1)(1995-8#1)(2008-8#1)
inhibited nematode##3##2##(2008-10#3)
inhibited only##2##2##(1997-4#1)(2008-10#1)
inhibited or##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
inhibited over##2##2##(2011-2#1)(2013-8#1)
inhibited partially##2##2##(1991-8#1)(2008-11#1)
inhibited peaks##2##2##(2008-10#2)
inhibited phorbol ester##2##3##(1992-12#1)(1994-8#1)
inhibited phosphorylation of##3##3##(1991-12#1)(1993-11#1)(1995-6#1)
inhibited platelet aggregation##3##3##(1991-12#1)(1992-4#1)(2008-5#1)
inhibited proliferation and##2##3##(2008-11#1)(2011-2#1)
inhibited proliferation##4##2##(1997-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
inhibited rat##2##2##(1992-3#1)(1994-11#1)
inhibited secretion##4##2##(1993-3#1)(1995-11#1)(2008-11#2)
inhibited specifically##2##2##(1993-6#1)(1994-8#1)
inhibited spore germination and##2##4##(1997-6#1)(2008-10#1)
inhibited spore germination##3##3##(1997-6#1)(2008-10#2)
inhibited stimulated release in##2##4##(1995-12#2)
inhibited syncytium formation##2##3##(1991-2#1)(1993-6#1)
inhibited systemic candidiasis of endogenous origin##2##6##(2008-5#2)
inhibited telomerase##2##2##(2008-11#2)
inhibited the activation of##3##4##(1993-6#1)(1996-2#1)(2008-8#1)
inhibited the activity of##3##4##(1995-12#1)(1997-6#1)(2011-2#1)
inhibited the amidolytic activity of##2##5##(1995-5#1)(1995-6#1)
inhibited the binding of##7##4##(1990-11#1)(1990-12#1)(1991-6#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)
inhibited the binding##8##3##(1990-11#1)(1990-12#1)(1991-6#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#2)
inhibited the degradation of##3##4##(1992-12#1)(1997-1#1)(2012-2#1)
inhibited the development of##2##4##(2008-11#1)(2012-3#1)
inhibited the effects of##2##4##(1993-8#1)(2008-4#1)
inhibited the enzyme by##2##4##(1994-11#1)(1995-6#1)
inhibited the enzyme##4##3##(1990-9#1)(1991-2#1)(1994-11#1)(1995-6#1)
inhibited the expression of##2##4##(2012-12#1)(2012-3#1)
inhibited the formation of##8##4##(1992-2#1)(1992-3#1)(1993-11#1)(2006-6#1)(2008-10#2)(2009-8#1)(2013-1#1)
inhibited the fungal growth##2##4##(1997-4#1)(2012-2#1)
inhibited the generation##2##3##(1991-12#1)(2008-4#1)
inhibited the growth of all##2##5##(2008-8#2)
inhibited the growth of human##2##5##(2008-11#1)(2010-6#1)
inhibited the growth of the##3##5##(1992-8#1)(1992-9#1)(2008-10#1)
inhibited the growth of##17##4##(1990-11#1)(1992-8#1)(1992-9#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-6#1)(2012-3#1)
inhibited the growth##19##3##(1990-11#1)(1992-8#1)(1992-9#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2010-6#1)(2012-3#1)
inhibited the in vitro##3##4##(1995-12#1)(2008-10#2)
inhibited the increase##2##3##(1993-12#1)(1996-2#1)
inhibited the invasion##2##3##(2008-11#2)
inhibited the phosphorylation of##2##4##(2008-4#1)(2012-3#1)
inhibited the production of##4##4##(1992-9#1)(1994-8#1)(2008-10#2)
inhibited the proliferation of##2##4##(1993-9#1)(2008-11#1)
inhibited the proliferation##3##3##(1993-9#1)(2008-11#1)(2013-8#1)
inhibited the rate of##2##4##(1992-6#1)(2008-11#1)
inhibited the responses##2##3##(1990-7#1)(1991-6#1)
inhibited the slow##2##3##(1991-2#1)(1995-12#1)
inhibited the tumor##2##3##(1994-12#1)(2008-9#1)
inhibited the##194##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#8)(1995-2#3)(1995-5#2)(1995-6#7)(1995-8#2)(1996-12#1)(1996-2#5)(1996-5#1)(1997-1#3)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#21)(2008-11#11)(2008-12#1)(2008-4#7)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#6)(2008-9#5)(2009-8#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#2)(2013-8#1)
inhibited these##2##2##(1992-3#1)(1994-3#1)
inhibited this##5##2##(1995-12#3)(2008-10#1)(2008-5#1)
inhibited to a##2##3##(1995-12#1)(2008-8#1)
inhibited to##3##2##(1991-12#1)(1995-12#1)(2008-8#1)
inhibited tumor growth in##2##4##(1990-11#1)(2011-1#1)
inhibited tumor growth##4##3##(1990-11#1)(2008-6#1)(2010-1#1)(2011-1#1)
inhibited under##2##2##(1991-5#1)(1997-2#1)
inhibited when the##2##3##(1993-11#1)(1997-7#1)
inhibited when##6##2##(1990-11#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1997-7#1)
inhibited with the##2##3##(2008-8#1)(2009-10#1)
inhibited with##9##2##(1990-2#1)(1991-8#1)(1993-6#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-10#1)
inhibited##1043##1##(1990-10#1)(1990-11#22)(1990-12#15)(1990-2#20)(1990-3#1)(1990-5#16)(1990-6#1)(1990-7#11)(1990-8#7)(1990-9#1)(1991-1#1)(1991-12#17)(1991-2#8)(1991-3#1)(1991-4#1)(1991-5#11)(1991-6#3)(1991-8#10)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#13)(1992-2#3)(1992-3#27)(1992-4#2)(1992-5#5)(1992-6#5)(1992-7#1)(1992-8#10)(1992-9#12)(1993-11#13)(1993-12#10)(1993-3#16)(1993-6#17)(1993-8#23)(1993-9#11)(1994-11#23)(1994-12#8)(1994-2#3)(1994-3#8)(1994-5#13)(1994-6#11)(1994-8#28)(1994-9#9)(1995-11#19)(1995-12#34)(1995-2#21)(1995-3#11)(1995-5#5)(1995-6#24)(1995-8#11)(1996-12#7)(1996-2#20)(1996-4#1)(1996-5#2)(1997-1#10)(1997-2#9)(1997-3#1)(1997-4#11)(1997-6#7)(1997-7#15)(1997-8#2)(2006-6#4)(2007-11#1)(2007-12#1)(2008-10#115)(2008-11#53)(2008-12#8)(2008-2#3)(2008-3#3)(2008-4#21)(2008-5#24)(2008-6#9)(2008-7#14)(2008-8#33)(2008-9#12)(2009-10#4)(2009-12#4)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#16)(2011-3#6)(2012-12#2)(2012-2#14)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#4)
inhibiting DNA##2##2##(1992-9#1)(1997-2#1)
inhibiting [3H]imipramine binding##2##3##(1990-5#2)
inhibiting activity##3##2##(1997-3#1)(2008-11#2)
inhibiting bacterial##2##2##(2008-5#1)(2010-4#1)
inhibiting bud##2##2##(2012-4#2)
inhibiting by##2##2##(2008-4#1)(2008-6#1)
inhibiting cell##2##2##(1992-8#1)(2008-4#1)
inhibiting cellular##2##2##(1990-2#1)(2008-2#1)
inhibiting effect on##2##3##(2008-11#1)(2008-8#1)
inhibiting effect##5##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
inhibiting effects of##2##3##(2008-10#1)(2008-8#1)
inhibiting inflammation##2##2##(1994-2#1)(2008-7#1)
inhibiting the development##2##3##(1995-6#1)(2008-11#1)
inhibiting the expression of##2##4##(1994-5#1)(2010-1#1)
inhibiting the growth of Rhizoctonia solani##2##6##(2008-10#2)
inhibiting the growth of##3##4##(2008-10#3)
inhibiting the growth##4##3##(2008-10#3)(2008-11#1)
inhibiting the##40##2##(1990-11#1)(1990-5#1)(1991-8#1)(1992-3#3)(1992-5#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-6#1)(2010-1#1)(2011-3#1)(2012-3#2)(2013-8#1)
inhibiting tumor##4##2##(2008-4#1)(2009-2#1)(2009-3#1)(2013-8#1)
inhibiting viral##2##2##(2006-10#1)(2008-8#1)
inhibiting##148##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1991-12#2)(1991-8#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#19)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#4)(2012-4#2)(2013-1#3)(2013-7#1)(2013-8#2)
inhibition (Ki##2##2##(1992-6#1)(1994-6#1)
inhibition (PPI) of##2##3##(2008-11#1)(2008-4#1)
inhibition (PPI)##3##2##(1997-4#1)(2008-11#1)(2008-4#1)
inhibition (which results in##2##4##(2008-11#2)
inhibition ELISA##2##2##(1992-3#1)(2008-5#1)
inhibition action of##2##3##(2008-10#2)
inhibition activity##4##2##(1994-5#1)(2008-10#1)(2008-4#1)(2009-6#1)
inhibition against##2##2##(2008-5#1)(2010-11#1)
inhibition and##32##2##(1990-4#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-3#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#2)(1997-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
inhibition as##2##2##(1992-3#1)(1994-8#1)
inhibition assay##2##2##(1993-2#1)(1997-4#1)
inhibition assays##4##2##(1995-6#2)(2009-12#1)(2011-2#1)
inhibition associated with##2##3##(1991-10#1)(2008-5#1)
inhibition at higher##3##3##(1990-5#1)(1992-12#1)(1995-6#1)
inhibition at the##2##3##(2008-5#1)(2008-6#1)
inhibition at##13##2##(1990-5#2)(1992-12#1)(1992-3#1)(1993-11#3)(1995-2#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-6#1)
inhibition by the##5##3##(1992-3#1)(1992-8#1)(1994-2#1)(1994-9#1)(2008-9#1)
inhibition by these##2##3##(1990-2#1)(1992-6#1)
inhibition by##75##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-12#2)(1992-11#1)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-9#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
inhibition due to##2##3##(2011-2#1)(2013-1#1)
inhibition during diapause##2##3##(2013-1#2)
inhibition during##3##2##(1990-11#1)(2013-1#2)
inhibition effect of##4##3##(2008-10#3)(2008-11#1)
inhibition effect##10##2##(2008-10#7)(2008-11#1)(2009-10#2)
inhibition effects in##2##3##(1995-6#1)(2008-11#1)
inhibition effects were##2##3##(2008-10#1)(2008-11#1)
inhibition effects##8##2##(1995-6#1)(2008-10#2)(2008-11#4)(2013-1#1)
inhibition efficiency##2##2##(2013-1#2)
inhibition factor##5##2##(1991-12#4)(2008-10#1)
inhibition for##3##2##(1994-8#1)(2008-10#1)(2010-10#1)
inhibition grouping##2##2##(2008-10#2)
inhibition has been##2##3##(2008-5#1)(2009-5#1)
inhibition has##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2009-5#1)
inhibition in a##2##3##(1992-3#1)(2008-7#1)
inhibition in the Vmax##2##4##(1992-6#2)
inhibition in the rat visual cortex##2##6##(2011-2#2)
inhibition in the##13##3##(1991-5#1)(1992-6#4)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
inhibition in vitro##3##3##(1994-8#1)(1995-3#1)(1997-7#1)
inhibition in##38##2##(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-6#4)(1993-11#1)(1993-3#1)(1993-8#2)(1994-8#2)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
inhibition induced by##2##3##(1990-8#1)(1994-8#1)
inhibition is##18##2##(1990-11#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
inhibition kinetics##3##2##(1992-3#1)(1994-6#2)
inhibition may play a role##2##5##(1993-12#1)(2008-7#1)
inhibition may result##2##3##(1997-2#2)
inhibition may##5##2##(1993-12#1)(1997-2#2)(2008-7#1)(2008-8#1)
inhibition measurements##2##2##(1992-12#1)(2008-10#1)
inhibition mechanism##4##2##(1990-11#1)(1992-6#1)(2008-10#1)(2013-1#1)
inhibition method##4##2##(2008-10#4)
inhibition observed##3##2##(1991-2#1)(1993-8#1)(2008-6#1)
inhibition obtained##2##2##(1991-12#1)(1993-6#1)
inhibition occurred when##3##3##(1994-8#1)(2008-10#2)
inhibition occurred##6##2##(1990-5#1)(1993-3#1)(1994-8#1)(2008-10#3)
inhibition of AH109A invasion##2##4##(2008-11#2)
inhibition of BIM expression##3##4##(2008-8#3)
inhibition of CYP3A4##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
inhibition of Ca2+ influx##2##4##(1991-1#2)
inhibition of DNA biosynthesis##2##4##(1990-2#1)(1991-4#1)
inhibition of DNA replication##2##4##(1997-3#1)(2012-2#1)
inhibition of DNA synthesis and inhibition of insulin secretion##2##9##(1997-4#2)
inhibition of DNA synthesis##6##4##(1991-2#1)(1997-2#1)(1997-4#2)(2008-3#1)(2009-3#1)
inhibition of DNA##13##3##(1990-2#1)(1991-2#1)(1991-4#2)(1993-8#1)(1994-10#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-3#1)(2009-3#1)(2012-2#1)
inhibition of DSB repair##2##4##(2011-2#1)(2013-1#1)
inhibition of ENOX2##2##3##(2009-9#2)
inhibition of HIV-1##2##3##(1992-12#1)(1996-5#1)
inhibition of ICSS produced by the##2##6##(1996-2#2)
inhibition of Kir2##2##3##(2008-8#2)
inhibition of TNF-alpha##2##3##(2008-10#1)(2008-11#1)
inhibition of [3H]D-aspartate transport##3##4##(1995-11#3)
inhibition of a##2##3##(1992-12#1)(1994-3#1)
inhibition of activity##2##3##(1995-2#1)(1995-8#1)
inhibition of adenylate cyclase##3##4##(1995-3#1)(1995-6#1)(2008-4#1)
inhibition of aggregation##2##3##(2008-8#2)
inhibition of bacteria##2##3##(2008-10#2)
inhibition of bacterial growth##2##4##(1997-8#1)(2008-5#1)
inhibition of binding##2##3##(1990-5#1)(2009-2#1)
inhibition of bone##2##3##(1993-11#1)(2013-1#1)
inhibition of both the##2##4##(2008-4#1)(2011-1#1)
inhibition of both##7##3##(1991-8#1)(1992-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
inhibition of brain##2##3##(2012-2#2)
inhibition of cAMP formation##2##4##(1992-4#1)(1995-6#1)
inhibition of cAMP##3##3##(1992-4#1)(1993-9#1)(1995-6#1)
inhibition of cell cycle progression##2##5##(1997-7#1)(2012-3#1)
inhibition of cell growth and##3##5##(1990-2#1)(1993-12#1)(2008-1#1)
inhibition of cell growth##8##4##(1990-2#1)(1990-8#1)(1993-12#1)(1995-2#1)(2008-1#1)(2008-11#3)
inhibition of cell proliferation##6##4##(1992-3#1)(1993-9#1)(1995-2#1)(2008-11#1)(2008-4#1)(2012-12#1)
inhibition of cell##17##3##(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-2#2)(1997-7#1)(2008-1#1)(2008-11#4)(2008-4#1)(2012-12#1)(2012-3#1)
inhibition of cellular proliferation in##2##5##(1991-5#1)(2008-1#1)
inhibition of cellular##5##3##(1990-5#1)(1991-5#2)(1994-3#1)(2008-1#1)
inhibition of cholate uptake##2##4##(1992-3#2)
inhibition of colony##2##3##(1992-9#1)(1993-9#1)
inhibition of cyclic AMP##2##4##(1993-3#1)(1995-11#1)
inhibition of cytochrome P450##2##4##(2008-3#2)
inhibition of different##2##3##(1992-8#1)(2008-11#1)
inhibition of elastase##2##3##(2008-5#2)
inhibition of enzyme##2##3##(1990-5#1)(2012-2#1)
inhibition of estrogen stimulated##2##4##(2008-11#2)
inhibition of ethanol absorption in the##2##6##(2008-11#2)
inhibition of evoked##2##3##(1990-5#1)(1991-1#1)
inhibition of fungal growth##2##4##(2008-10#2)
inhibition of fungal##3##3##(2008-10#3)
inhibition of gastric emptying and intestinal transit in male rats##2##10##(2013-1#2)
inhibition of gastric emptying and intestinal transit##4##7##(2013-1#4)
inhibition of gastric emptying##6##4##(1997-4#1)(2013-1#5)
inhibition of gastric##7##3##(1997-4#1)(2008-11#1)(2013-1#5)
inhibition of gene expression##2##4##(1992-12#1)(2008-11#1)
inhibition of glucose##2##3##(2008-10#1)(2008-11#1)
inhibition of glycosylation##2##3##(1994-11#1)(1995-2#1)
inhibition of growth##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
inhibition of hepatic##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
inhibition of human##8##3##(1992-8#1)(1993-8#2)(1994-8#1)(1995-2#1)(2008-4#1)(2010-6#1)(2013-7#1)
inhibition of iNOS##2##3##(2008-10#1)(2008-8#1)
inhibition of insulin release##2##4##(1990-12#2)
inhibition of insulin secretion##3##4##(1997-4#2)(2011-1#1)
inhibition of insulin##6##3##(1990-12#2)(1994-11#1)(1997-4#2)(2011-1#1)
inhibition of intracellular##2##3##(1990-8#1)(1994-3#1)
inhibition of lysosomal##2##3##(1990-5#1)(1992-9#1)
inhibition of mitochondrial##2##3##(1990-5#1)(1996-5#1)
inhibition of mushroom tyrosinase activity##2##5##(2008-5#2)
inhibition of neutrophil elastase##2##4##(1995-2#1)(2008-5#1)
inhibition of neutrophil##3##3##(1991-2#1)(1995-2#1)(2008-5#1)
inhibition of p38##2##3##(2008-7#2)
inhibition of pancreatic##3##3##(1990-12#1)(1992-8#2)
inhibition of phagocytosis##3##3##(1994-6#3)
inhibition of phosphatidylcholine##2##3##(1995-3#2)
inhibition of phosphorylation and cytoplasmic translocation of##2##7##(1992-3#2)
inhibition of phosphorylation##3##3##(1992-3#2)(1993-12#1)
inhibition of platelet aggregation##3##4##(1990-5#1)(1997-7#1)(2008-5#1)
inhibition of platelet##4##3##(1990-5#1)(1997-7#1)(2008-5#1)(2008-7#1)
inhibition of prostaglandin##2##3##(1993-3#1)(1995-5#1)
inhibition of prostanoid synthesis##2##4##(1994-3#2)
inhibition of protein kinase C##3##5##(1994-8#1)(1997-4#1)(2008-8#1)
inhibition of protein phosphatase 1##2##5##(1995-8#1)(1997-4#1)
inhibition of protein phosphatase##3##4##(1995-8#2)(1997-4#1)
inhibition of protein synthesis##5##4##(1991-2#1)(1992-11#1)(1992-8#1)(1994-11#1)(1995-11#1)
inhibition of protein##14##3##(1990-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#2)(1997-4#2)(2008-8#1)
inhibition of rat##2##3##(1994-11#1)(1994-8#1)
inhibition of release##2##3##(1995-12#2)
inhibition of serine##2##3##(1992-6#1)(1993-6#1)
inhibition of smooth muscle cell##2##5##(1995-12#1)(2008-10#1)
inhibition of sphingosine kinase##2##4##(2009-9#2)
inhibition of the activation of##2##5##(1996-2#1)(2008-10#1)
inhibition of the cell proliferation##2##5##(1997-2#2)
inhibition of the enzyme activity##2##5##(1990-5#1)(1992-11#1)
inhibition of the enzyme##7##4##(1990-5#1)(1990-8#2)(1992-11#1)(1993-6#1)(1995-3#1)(2008-10#1)
inhibition of the formation of##2##5##(1992-3#1)(1995-12#1)
inhibition of the specific##2##4##(1994-5#1)(1995-12#1)
inhibition of the tail-flick##2##4##(1992-3#2)
inhibition of the##89##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#6)(1995-12#2)(1995-3#3)(1995-6#1)(1996-2#1)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#2)(2013-7#2)
inhibition of these##2##3##(1992-3#1)(1997-3#1)
inhibition of this pathway##2##4##(2009-12#1)(2011-2#1)
inhibition of this##3##3##(2008-5#1)(2009-12#1)(2011-2#1)
inhibition of translation##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
inhibition of tumor necrosis##2##4##(1997-7#1)(2008-5#1)
inhibition of tumor##5##3##(1991-12#1)(1993-1#1)(1997-7#1)(2008-11#1)(2008-5#1)
inhibition of type##2##3##(1995-5#1)(2008-7#1)
inhibition of tyrosinase##3##3##(2008-10#1)(2008-5#2)
inhibition of ubiquitin-proteasome pathway##5##4##(2008-9#5)
inhibition of viral##4##3##(1992-3#1)(2008-10#2)(2008-8#1)
inhibition of##646##2##(1990-11#5)(1990-12#7)(1990-2#6)(1990-5#15)(1990-7#1)(1990-8#7)(1991-1#4)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#3)(1991-5#10)(1991-8#7)(1991-9#4)(1992-10#1)(1992-11#3)(1992-12#14)(1992-2#2)(1992-3#15)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#7)(1992-9#5)(1993-1#2)(1993-11#5)(1993-12#5)(1993-3#3)(1993-6#10)(1993-8#8)(1993-9#4)(1994-10#2)(1994-11#13)(1994-12#2)(1994-2#1)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#13)(1994-9#2)(1995-11#16)(1995-12#12)(1995-2#14)(1995-3#10)(1995-5#8)(1995-6#7)(1995-8#4)(1996-12#3)(1996-2#6)(1996-5#2)(1996-6#2)(1997-1#5)(1997-2#8)(1997-3#4)(1997-4#15)(1997-6#1)(1997-7#6)(1997-8#1)(2006-6#2)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#52)(2008-11#35)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#14)(2008-5#22)(2008-6#1)(2008-7#15)(2008-8#28)(2008-9#13)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#6)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#11)(2011-3#3)(2012-1#1)(2012-12#7)(2012-2#16)(2012-3#6)(2012-7#1)(2013-1#21)(2013-7#6)(2013-8#1)
inhibition on##12##2##(1994-3#3)(1995-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
inhibition or##2##2##(1992-8#1)(2008-7#1)
inhibition produced by##3##3##(2008-10#2)(2008-8#1)
inhibition produced through extinction##2##4##(2008-5#2)
inhibition produced##5##2##(2008-10#2)(2008-5#2)(2008-8#1)
inhibition rate##3##2##(2008-12#2)(2012-12#1)
inhibition rates of##3##3##(1991-3#1)(2008-12#1)(2008-8#1)
inhibition signal##2##2##(1995-2#1)(2008-11#1)
inhibition studies revealed##2##3##(2008-4#1)(2009-3#1)
inhibition studies##5##2##(1991-12#1)(1991-9#1)(2008-11#1)(2008-4#1)(2009-3#1)
inhibition test##4##2##(1991-12#1)(1997-6#1)(2008-11#2)
inhibition to##4##2##(1992-5#1)(1992-8#1)(1993-11#1)(2008-11#1)
inhibition up to 10##2##4##(1995-3#1)(2008-11#1)
inhibition was approximately##2##3##(1994-11#1)(1995-6#1)
inhibition was competitive##3##3##(1992-3#1)(1992-8#1)(2008-11#1)
inhibition was measured##2##3##(2013-1#2)
inhibition was not##4##3##(1991-9#1)(1992-8#1)(1995-2#1)(2008-6#1)
inhibition was observed at##4##4##(1992-8#1)(1994-11#1)(2008-10#1)(2008-6#1)
inhibition was observed in##2##4##(1996-12#1)(2008-10#1)
inhibition was observed##9##3##(1992-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-6#1)(2010-3#1)
inhibition was related##2##3##(2008-10#1)(2008-11#1)
inhibition was relieved##2##3##(1991-12#1)(1991-5#1)
inhibition was##47##2##(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2012-7#1)(2013-1#2)(2013-7#1)
inhibition were##3##2##(1994-8#1)(2008-3#1)(2008-5#1)
inhibition with##12##2##(1990-5#2)(1992-3#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
inhibition within##2##2##(2008-1#1)(2013-8#1)
inhibition zone##4##2##(2008-5#1)(2008-8#2)(2013-1#1)
inhibition zones##4##2##(2008-10#1)(2012-2#3)
inhibition##1262##1##(1990-11#16)(1990-12#10)(1990-2#10)(1990-4#1)(1990-5#24)(1990-7#7)(1990-8#10)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#23)(1991-2#10)(1991-3#2)(1991-4#3)(1991-5#13)(1991-7#1)(1991-8#8)(1991-9#10)(1992-10#1)(1992-11#5)(1992-12#21)(1992-2#4)(1992-3#32)(1992-4#1)(1992-5#4)(1992-6#19)(1992-8#21)(1992-9#8)(1993-1#3)(1993-11#10)(1993-12#8)(1993-2#1)(1993-3#12)(1993-6#12)(1993-8#17)(1993-9#6)(1994-10#2)(1994-11#20)(1994-12#2)(1994-2#2)(1994-3#9)(1994-5#5)(1994-6#11)(1994-8#31)(1994-9#3)(1995-11#30)(1995-12#17)(1995-2#23)(1995-3#14)(1995-5#15)(1995-6#16)(1995-8#12)(1996-12#6)(1996-2#8)(1996-5#5)(1996-6#2)(1997-1#7)(1997-2#20)(1997-3#7)(1997-4#18)(1997-6#6)(1997-7#12)(1997-8#1)(2006-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#122)(2008-11#68)(2008-12#6)(2008-2#1)(2008-3#11)(2008-4#27)(2008-5#46)(2008-6#9)(2008-7#37)(2008-8#50)(2008-9#24)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#2)(2009-9#10)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#28)(2011-3#4)(2012-1#1)(2012-12#11)(2012-2#23)(2012-3#6)(2012-7#3)(2013-1#40)(2013-7#10)(2013-8#7)
inhibition) in##2##2##(1991-12#1)(2008-10#1)
inhibition) or##2##2##(2007-8#1)(2008-11#1)
inhibition)##12##1##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(2007-8#1)(2008-10#3)(2008-11#3)
inhibitions and##2##2##(2010-5#1)(2012-3#1)
inhibitions of##2##2##(1997-7#1)(2008-11#1)
inhibitions##7##1##(1992-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-6#1)(2010-5#1)(2012-3#1)
inhibitor (PPI)##2##2##(2012-2#1)(2013-1#1)
inhibitor (TIMP)##2##2##(1990-8#1)(1992-6#1)
inhibitor (serpin)##2##2##(1995-6#1)(2008-7#1)
inhibitor 2##3##2##(1990-11#1)(2008-7#1)(2010-12#1)
inhibitor GF109203X##2##2##(2008-4#1)(2013-1#1)
inhibitor H-7##2##2##(1994-11#1)(1997-2#1)
inhibitor PD98059##2##2##(2011-2#1)(2013-1#1)
inhibitor action##3##2##(1992-9#1)(2012-12#2)
inhibitor activity##2##2##(1992-9#1)(1995-5#1)
inhibitor and a##2##3##(1990-5#1)(1991-5#1)
inhibitor and the##4##3##(1991-3#1)(1993-11#1)(2009-11#1)(2009-7#1)
inhibitor and##27##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-8#2)(1994-8#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
inhibitor as##2##2##(2009-6#1)(2012-2#1)
inhibitor can##2##2##(1990-11#1)(2010-12#1)
inhibitor complex##2##2##(1996-12#1)(2010-3#1)
inhibitor domain##5##2##(1991-11#2)(1991-2#1)(1994-11#2)
inhibitor for DNA ligase I##2##5##(1993-3#2)
inhibitor for food##2##3##(2009-11#2)
inhibitor for the treatment of##2##5##(2009-11#1)(2010-11#1)
inhibitor for the##5##3##(1991-12#1)(1995-12#1)(2008-4#1)(2009-11#1)(2010-11#1)
inhibitor for##12##2##(1991-11#1)(1991-12#1)(1993-3#2)(1995-12#1)(2008-10#1)(2008-4#1)(2009-11#3)(2009-12#1)(2010-11#1)
inhibitor from##4##2##(1992-8#1)(1994-3#1)(1995-3#1)(2010-2#1)
inhibitor has##3##2##(1990-11#1)(2008-5#1)(2008-7#1)
inhibitor hydroxyurea##2##2##(1994-8#1)(2010-2#1)
inhibitor in the##3##3##(1996-12#1)(2010-6#1)(2011-2#1)
inhibitor in##16##2##(1990-12#1)(1992-5#2)(1992-6#1)(1992-9#1)(1994-8#1)(1996-12#1)(2006-6#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
inhibitor is a##2##3##(1991-2#1)(1991-9#1)
inhibitor is able to##2##4##(1994-2#1)(2008-5#1)
inhibitor is not##2##3##(1991-3#1)(2008-10#1)
inhibitor is##11##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#2)(1994-2#1)(1996-12#1)(2008-10#1)(2008-5#1)
inhibitor known to##2##3##(1992-6#1)(2008-11#1)
inhibitor model##2##2##(1990-2#1)(1992-8#1)
inhibitor of DNA methylation##2##4##(2013-8#2)
inhibitor of DNA##4##3##(1990-2#1)(2008-11#1)(2013-8#2)
inhibitor of HIV-1##4##3##(1990-5#1)(1991-12#2)(2011-3#1)
inhibitor of NADPH oxidase##2##4##(1993-8#1)(2008-10#1)
inhibitor of NF-kappa B activation##2##5##(1992-12#1)(1993-3#1)
inhibitor of NO synthase##2##4##(1997-2#1)(2008-7#1)
inhibitor of NO##3##3##(1997-2#1)(2008-7#1)(2011-2#1)
inhibitor of both##5##3##(1991-8#1)(1994-8#1)(2008-11#2)(2008-4#1)
inhibitor of calcium oxalate##2##4##(1991-12#1)(1993-3#1)
inhibitor of cytochrome##2##3##(1995-8#1)(2008-10#1)
inhibitor of deoxyhypusine synthase##2##4##(1997-1#2)
inhibitor of endothelium##2##3##(1991-9#1)(1997-7#1)
inhibitor of glutathione##2##3##(1995-11#1)(2009-10#1)
inhibitor of histone##2##3##(2010-6#1)(2013-8#1)
inhibitor of human##4##3##(1992-8#1)(1994-11#1)(1995-2#1)(2008-10#1)
inhibitor of myosin-based activities in plant##2##6##(2008-11#2)
inhibitor of nitric oxide (NO)##2##5##(1995-12#1)(1995-2#1)
inhibitor of nitric oxide##5##4##(1995-12#2)(1995-2#1)(2008-4#1)(2009-4#1)
inhibitor of protein kinase A##2##5##(1993-8#1)(1996-12#1)
inhibitor of protein kinase C (PKC)##2##6##(1996-12#1)(1997-7#1)
inhibitor of protein kinase C##8##5##(1990-11#1)(1993-8#1)(1994-6#2)(1995-12#1)(1996-12#1)(1997-7#1)(2008-11#1)
inhibitor of protein kinase##10##4##(1990-11#1)(1993-8#2)(1994-6#2)(1995-12#1)(1996-12#2)(1997-7#1)(2008-11#1)
inhibitor of protein##16##3##(1990-11#1)(1992-12#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-6#2)(1995-12#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-8#2)
inhibitor of several##2##3##(2008-5#1)(2012-12#1)
inhibitor of the vacuolar##2##4##(1994-6#2)
inhibitor of the##32##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-6#3)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2012-12#1)(2013-1#1)
inhibitor of tyrosinase##2##3##(1992-3#1)(2008-5#1)
inhibitor of von Willebrand##2##4##(1994-11#2)
inhibitor of##252##2##(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#5)(1990-7#2)(1990-8#4)(1991-12#3)(1991-6#1)(1991-8#3)(1991-9#2)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#9)(1992-5#4)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#7)(1993-6#3)(1993-8#6)(1994-11#8)(1994-3#2)(1994-5#3)(1994-6#7)(1994-8#6)(1994-9#2)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#6)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#3)(2006-10#1)(2008-10#6)(2008-11#16)(2008-4#11)(2008-5#7)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#2)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-4#2)(2010-6#2)(2011-2#6)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
inhibitor on the##2##3##(1990-11#1)(1992-3#1)
inhibitor on##5##2##(1990-11#1)(1990-2#1)(1992-3#1)(2008-4#1)(2009-11#1)
inhibitor p21 and##2##3##(2008-11#1)(2010-6#1)
inhibitor p21##3##2##(2008-11#1)(2010-6#1)(2012-3#1)
inhibitor protein##3##2##(1992-6#2)(2008-10#1)
inhibitor species##2##2##(1993-11#2)
inhibitor staurosporine##3##2##(1992-12#1)(1992-9#1)(1993-3#1)
inhibitor than##2##2##(1991-8#1)(1994-8#1)
inhibitor that##7##2##(1992-12#1)(1992-9#1)(1994-6#1)(1995-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
inhibitor therapy##5##2##(2007-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
inhibitor to##6##2##(1991-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
inhibitor treatment##2##2##(2012-12#1)(2013-1#1)
inhibitor use##2##2##(2013-1#2)
inhibitor was##9##2##(1990-5#1)(1991-3#1)(1993-3#1)(1996-12#1)(1996-3#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
inhibitor which##4##2##(1991-12#1)(1995-3#1)(1997-7#2)
inhibitor with a##3##3##(1991-12#1)(2008-11#1)(2010-4#1)
inhibitor with an##2##3##(2008-11#1)(2012-2#1)
inhibitor with##7##2##(1990-12#1)(1991-12#1)(2008-11#2)(2008-6#1)(2010-4#1)(2012-2#1)
inhibitor wortmannin##2##2##(2008-11#1)(2013-7#1)
inhibitor##881##1##(1990-11#12)(1990-12#8)(1990-2#12)(1990-3#1)(1990-5#15)(1990-7#5)(1990-8#10)(1991-1#1)(1991-11#5)(1991-12#15)(1991-2#3)(1991-3#6)(1991-5#7)(1991-6#1)(1991-8#8)(1991-9#9)(1992-1#1)(1992-10#2)(1992-11#10)(1992-12#14)(1992-2#4)(1992-3#17)(1992-5#7)(1992-6#9)(1992-7#2)(1992-8#15)(1992-9#12)(1993-11#9)(1993-12#2)(1993-2#1)(1993-3#18)(1993-6#4)(1993-8#23)(1993-9#1)(1994-11#22)(1994-12#1)(1994-2#3)(1994-3#6)(1994-5#8)(1994-6#18)(1994-8#16)(1994-9#6)(1995-11#8)(1995-12#13)(1995-2#17)(1995-3#8)(1995-5#6)(1995-6#8)(1995-8#9)(1996-10#2)(1996-11#1)(1996-12#11)(1996-2#5)(1996-3#4)(1996-5#6)(1996-6#1)(1996-9#2)(1997-1#6)(1997-2#7)(1997-3#2)(1997-4#7)(1997-5#2)(1997-6#1)(1997-7#6)(2006-10#1)(2006-6#3)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#40)(2008-11#37)(2008-12#4)(2008-3#10)(2008-4#32)(2008-5#26)(2008-6#6)(2008-7#16)(2008-8#18)(2008-9#4)(2009-10#2)(2009-11#8)(2009-12#3)(2009-4#4)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#6)(2010-2#9)(2010-3#1)(2010-4#6)(2010-6#5)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#19)(2011-3#5)(2012-1#4)(2012-12#20)(2012-2#16)(2012-3#11)(2013-1#34)(2013-7#3)(2013-8#5)
inhibitor) and##4##2##(1992-3#1)(1994-5#1)(2011-2#1)(2012-3#1)
inhibitor) treatment##2##2##(1996-2#1)(2008-11#1)
inhibitor)##26##1##(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#2)(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#3)(2008-9#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-3#1)
inhibitor-1##15##1##(1993-12#1)(1994-9#1)(1995-8#2)(1997-1#1)(1997-7#1)(2008-3#1)(2008-4#2)(2009-8#2)(2011-2#2)(2013-1#2)
inhibitor/##3##1##(2009-9#3)
inhibitors (AIs) are##2##3##(2011-1#1)(2013-8#1)
inhibitors (SSRIs)##9##2##(1996-7#1)(2008-11#1)(2008-6#2)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
inhibitors (e##2##2##(1992-8#1)(2011-2#1)
inhibitors against the##2##3##(2012-2#1)(2012-3#1)
inhibitors against##7##2##(2008-11#1)(2010-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
inhibitors also##2##2##(1990-10#1)(1992-8#1)
inhibitors and the##5##3##(1995-2#1)(1995-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
inhibitors and their therapeutic##2##4##(2008-1#1)(2011-1#1)
inhibitors and their##3##3##(2008-1#1)(2011-1#1)(2012-2#1)
inhibitors and##47##2##(1990-12#2)(1990-3#1)(1994-10#1)(1995-2#1)(1995-3#2)(1997-7#2)(1997-8#3)(2006-6#1)(2008-1#4)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#7)
inhibitors are active##2##3##(2009-11#1)(2012-12#1)
inhibitors are useful##3##3##(1996-6#1)(2008-2#1)(2008-4#1)
inhibitors are##24##2##(1990-2#1)(1995-6#1)(1996-6#1)(2006-10#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-5#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#2)
inhibitors as##4##2##(1994-11#1)(2008-5#1)(2009-9#2)
inhibitors at the##2##3##(1991-5#1)(1994-8#1)
inhibitors at##3##2##(1991-5#1)(1992-12#1)(1994-8#1)
inhibitors but##2##2##(1991-2#1)(2008-10#1)
inhibitors by##4##2##(1997-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
inhibitors can##6##2##(1994-11#1)(1994-3#1)(2011-2#1)(2011-3#1)(2012-12#2)
inhibitors cycloheximide and##2##3##(1995-12#1)(1997-7#1)
inhibitors did not##2##3##(2008-10#1)(2013-1#1)
inhibitors for the treatment of schizophrenia##2##6##(2011-1#2)
inhibitors for the treatment of##4##5##(2008-1#1)(2008-5#1)(2011-1#2)
inhibitors for the##7##3##(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#2)
inhibitors for##16##2##(1994-12#1)(1995-2#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-5#1)(2010-6#1)(2011-1#2)
inhibitors from##4##2##(1992-8#1)(2008-10#1)(2011-1#2)
inhibitors has been##3##3##(2008-4#1)(2008-5#1)(2012-3#1)
inhibitors has##4##2##(2008-4#1)(2008-5#2)(2012-3#1)
inhibitors have been##4##3##(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)
inhibitors have shown##2##3##(2007-11#1)(2011-2#1)
inhibitors have##12##2##(2006-6#1)(2007-11#1)(2008-7#2)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
inhibitors in the treatment of##4##5##(2008-5#2)(2012-1#1)(2012-3#1)
inhibitors in the##13##3##(1995-3#1)(2007-4#1)(2008-1#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
inhibitors in##34##2##(1991-12#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-4#2)(2008-1#3)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#2)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
inhibitors including##2##2##(1990-5#1)(1994-6#1)
inhibitors induce##2##2##(2010-8#1)(2012-2#1)
inhibitors is##6##2##(1992-3#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-3#1)(2013-1#1)
inhibitors like##3##2##(1991-9#2)(2012-2#1)
inhibitors may##4##2##(1994-6#1)(2010-10#1)(2012-2#2)
inhibitors of DNA##2##3##(1995-2#1)(1997-4#1)
inhibitors of HIV-1##2##3##(1991-9#1)(2013-1#1)
inhibitors of cyclooxygenase-2 possess little potential for decreasing in vitro phagocytosis by rat macrophages or canine neutrophils##2##17##(2008-10#2)
inhibitors of human##9##3##(1991-5#1)(1992-8#1)(1994-8#1)(1995-3#4)(2008-10#1)(2013-1#1)
inhibitors of insulin##2##3##(1997-4#1)(2010-11#1)
inhibitors of phosphatidylinositol 3-kinase##2##4##(1994-6#1)(1995-8#1)
inhibitors of protein##6##3##(1990-12#1)(1992-12#1)(1993-8#1)(2008-11#1)(2009-9#1)(2012-2#1)
inhibitors of the NADH##2##4##(1994-11#1)(1995-3#1)
inhibitors of the enzyme##2##4##(1993-11#1)(2009-9#1)
inhibitors of the monoamine##2##4##(1994-8#1)(2008-7#1)
inhibitors of the##33##3##(1990-12#2)(1990-5#1)(1991-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#3)(2009-6#1)(2009-9#1)(2010-12#1)
inhibitors of this enzyme##2##4##(1997-7#1)(2010-2#1)
inhibitors of tyrosine kinases##3##4##(1992-12#2)(2013-1#1)
inhibitors of##171##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#4)(1991-9#3)(1992-12#5)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#4)(1993-11#4)(1993-3#2)(1993-8#2)(1994-11#4)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#4)(1995-2#3)(1995-3#10)(1995-5#4)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-4#4)(1997-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#4)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)
inhibitors on##8##2##(1991-2#1)(1994-11#1)(1995-2#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)
inhibitors or angiotensin II receptor blockers##2##6##(1996-6#1)(2008-11#1)
inhibitors or angiotensin II receptor##3##5##(1995-12#1)(1996-6#1)(2008-11#1)
inhibitors or##6##2##(1993-6#1)(1995-12#1)(1996-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
inhibitors should block##2##3##(1997-7#2)
inhibitors should##3##2##(1997-7#2)(2008-2#1)
inhibitors showed##2##2##(1991-5#1)(2013-1#1)
inhibitors such as##6##3##(1991-8#1)(1992-8#1)(2008-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
inhibitors targeting##2##2##(2008-5#1)(2011-3#1)
inhibitors that##6##2##(1990-11#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)
inhibitors to the##2##3##(1995-11#1)(2013-1#1)
inhibitors to##10##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
inhibitors used##2##2##(1996-5#1)(2008-10#1)
inhibitors was also##2##3##(1996-2#1)(2008-3#1)
inhibitors was##7##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-6#1)(1996-2#1)(2008-11#1)(2008-3#1)
inhibitors were##4##2##(1992-10#1)(1996-5#1)(2008-10#1)(2012-2#1)
inhibitors with improved##2##3##(1994-2#1)(2007-11#1)
inhibitors with the##2##3##(1992-6#1)(1994-8#1)
inhibitors with##10##2##(1990-5#2)(1991-3#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(2007-11#1)(2012-2#1)(2013-1#1)
inhibitors##808##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#5)(1990-3#1)(1990-5#7)(1990-7#3)(1990-8#4)(1991-11#2)(1991-12#2)(1991-2#10)(1991-3#1)(1991-5#13)(1991-6#3)(1991-8#2)(1991-9#9)(1992-10#3)(1992-11#1)(1992-12#14)(1992-3#5)(1992-6#10)(1992-7#1)(1992-8#21)(1992-9#8)(1993-1#1)(1993-11#7)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#11)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#11)(1994-7#3)(1994-8#10)(1994-9#4)(1995-11#12)(1995-12#2)(1995-2#7)(1995-3#17)(1995-5#6)(1995-6#4)(1995-8#3)(1996-11#1)(1996-12#4)(1996-2#7)(1996-5#4)(1996-6#3)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#8)(1997-6#1)(1997-7#8)(1997-8#3)(2006-10#4)(2006-12#1)(2006-6#6)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#24)(2008-10#42)(2008-11#29)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#13)(2008-5#52)(2008-6#10)(2008-7#14)(2008-8#15)(2008-9#12)(2009-10#3)(2009-11#6)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#14)(2011-2#32)(2011-3#17)(2012-1#4)(2012-12#17)(2012-2#16)(2012-3#20)(2013-1#42)(2013-7#2)(2013-8#4)
inhibitors)##9##1##(1992-3#1)(1993-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2013-1#3)
inhibitors]##4##1##(1997-3#1)(2011-3#3)
inhibitory ability##2##2##(1992-7#1)(2007-8#1)
inhibitory action of the##5##4##(1990-11#1)(1994-8#1)(1995-2#1)(2008-10#2)
inhibitory action of##9##3##(1990-11#2)(1992-12#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-10#2)
inhibitory action on##2##3##(1993-5#1)(2013-7#1)
inhibitory action##17##2##(1990-11#2)(1990-2#2)(1992-12#1)(1992-8#1)(1993-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(2008-10#4)(2008-12#1)(2013-7#1)
inhibitory actions of##2##3##(1990-2#1)(1991-5#1)
inhibitory actions##3##2##(1990-2#1)(1991-5#2)
inhibitory activities against##2##3##(1994-12#1)(2011-3#1)
inhibitory activities of##2##3##(2008-5#1)(2011-3#1)
inhibitory activities on##3##3##(1995-3#1)(2011-3#2)
inhibitory activities##17##2##(1990-10#1)(1990-7#1)(1991-9#1)(1992-6#3)(1994-12#1)(1995-3#1)(1997-4#1)(2008-5#1)(2010-2#2)(2011-3#5)
inhibitory activity against##10##3##(1991-8#1)(1992-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-10#1)(2012-2#1)
inhibitory activity in##3##3##(2008-4#1)(2008-8#1)(2010-2#1)
inhibitory activity of##16##3##(1990-12#1)(1990-7#1)(1991-12#1)(1992-3#2)(1994-11#2)(1994-6#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)
inhibitory activity on##3##3##(1990-5#1)(1991-8#1)(2013-1#1)
inhibitory activity towards##4##3##(1992-8#1)(1994-12#2)(2011-1#1)
inhibitory activity was##3##3##(1990-5#1)(1991-1#1)(2008-10#1)
inhibitory activity were##3##3##(1994-3#2)(2008-10#1)
inhibitory activity##71##2##(1990-12#1)(1990-5#4)(1990-7#1)(1991-1#1)(1991-12#3)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#3)(1992-8#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-6#2)(1995-12#1)(1995-3#4)(1996-12#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#2)(2010-2#4)(2010-8#1)(2011-1#2)(2011-10#1)(2011-3#2)(2012-2#3)(2012-3#2)(2013-1#2)
inhibitory and activating##2##3##(2006-10#1)(2012-2#1)
inhibitory and##8##2##(1992-3#1)(1993-5#1)(1997-3#1)(2006-10#1)(2008-11#1)(2012-2#1)(2013-1#2)
inhibitory avoidance training##2##3##(1997-2#2)
inhibitory avoidance##5##2##(1993-12#1)(1994-3#1)(1997-2#3)
inhibitory capacity##2##2##(1991-12#2)
inhibitory compounds##5##2##(2008-10#4)(2011-2#1)
inhibitory concentration (MIC) of##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
inhibitory concentration (MIC)##10##3##(1991-8#1)(1994-12#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
inhibitory concentration of##3##3##(1991-5#1)(2008-11#2)
inhibitory concentration values##2##3##(2010-5#1)(2013-1#1)
inhibitory concentration##20##2##(1991-5#1)(1991-8#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-5#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
inhibitory concentrations (MIC)##2##3##(2008-5#1)(2010-2#1)
inhibitory concentrations (MICs) of##2##4##(2008-10#1)(2008-5#1)
inhibitory concentrations (MICs)##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
inhibitory concentrations##11##2##(1992-6#1)(1994-5#1)(2008-10#1)(2008-5#3)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
inhibitory connections##2##2##(1996-2#1)(2008-11#1)
inhibitory control##4##2##(1993-12#1)(2008-7#1)(2013-8#2)
inhibitory dysfunction##3##2##(2013-1#3)
inhibitory effect of DEPC##2##4##(1992-6#2)
inhibitory effect of RC-160##2##4##(1995-2#2)
inhibitory effect of captopril on##2##5##(2008-10#2)
inhibitory effect of the##4##4##(1993-11#1)(1995-6#1)(2008-9#1)(2010-5#1)
inhibitory effect of##66##3##(1990-11#2)(1990-7#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1997-4#3)(2007-11#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
inhibitory effect on lipid##2##4##(2008-4#1)(2010-4#1)
inhibitory effect on the growth of##2##6##(1992-8#1)(2012-2#1)
inhibitory effect on the##15##4##(1992-2#1)(1992-5#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
inhibitory effect on##48##3##(1990-12#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1996-2#1)(1997-4#2)(1997-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-7#1)
inhibitory effect was##7##3##(1990-11#1)(1990-7#1)(1991-9#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
inhibitory effect##142##2##(1990-11#3)(1990-12#1)(1990-7#4)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#2)(1992-2#2)(1992-5#2)(1992-6#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-8#4)(1995-11#4)(1995-12#5)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-5#1)(1997-4#5)(1997-7#1)(2007-11#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-4#8)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
inhibitory effects against##2##3##(1997-4#1)(2008-10#1)
inhibitory effects in##2##3##(2008-10#1)(2008-11#1)
inhibitory effects of high##2##4##(1990-11#1)(1993-11#1)
inhibitory effects of some dipeptides##2##5##(2008-10#2)
inhibitory effects of the##3##4##(1992-12#1)(2008-11#1)(2008-5#1)
inhibitory effects of##43##3##(1990-11#2)(1990-6#1)(1991-12#3)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-6#1)(1997-3#2)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#4)
inhibitory effects on platelet function##2##5##(1991-12#2)
inhibitory effects on platelet##3##4##(1991-12#3)
inhibitory effects on##21##3##(1990-7#1)(1991-12#3)(1991-5#1)(1993-1#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#4)
inhibitory effects##79##2##(1990-11#2)(1990-6#1)(1990-7#1)(1991-12#6)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#5)(1995-12#3)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-3#2)(1997-4#1)(2008-10#10)(2008-11#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#8)
inhibitory elements##2##2##(2008-11#2)
inhibitory factor (LIF)##9##3##(1991-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2009-3#1)
inhibitory factor for##2##3##(1991-12#1)(2008-8#1)
inhibitory factor##30##2##(1991-12#2)(1992-9#6)(1994-9#1)(1995-11#1)(1995-2#2)(1996-2#8)(1996-5#1)(1997-7#2)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-6#1)(2012-2#1)
inhibitory factors##2##2##(1997-4#1)(2010-4#1)
inhibitory function##4##2##(2008-7#1)(2013-1#3)
inhibitory interneurons##2##2##(1994-2#1)(2008-7#1)
inhibitory junction potential##3##3##(1996-5#2)(1997-4#1)
inhibitory mechanisms##3##2##(1993-8#1)(1995-6#1)(2009-7#1)
inhibitory motoneurons##5##2##(2007-12#5)
inhibitory neurons##3##2##(1993-12#1)(2007-12#1)(2010-7#1)
inhibitory neurotransmitter##3##2##(1991-5#2)(2008-11#1)
inhibitory neurotransmitters##2##2##(1996-12#1)(1997-2#1)
inhibitory on##2##2##(1993-8#1)(1994-11#1)
inhibitory peptide##4##2##(1997-1#1)(2008-11#2)(2009-10#1)
inhibitory peptides##2##2##(1995-5#1)(2010-2#1)
inhibitory postsynaptic##3##2##(1995-2#1)(2007-12#1)(2011-2#1)
inhibitory potencies##2##2##(1990-5#1)(1994-8#1)
inhibitory potency##6##2##(1990-5#1)(2008-10#1)(2010-11#2)(2011-2#1)(2012-3#1)
inhibitory potential of##2##3##(1994-6#1)(2008-11#1)
inhibitory potential##4##2##(1991-9#1)(1994-6#1)(1997-3#1)(2008-11#1)
inhibitory processes##7##2##(1995-12#1)(2008-7#3)(2009-10#1)(2012-12#1)(2013-1#1)
inhibitory protein##2##2##(1995-6#1)(2008-10#1)
inhibitory receptors##2##2##(2008-9#1)(2010-5#1)
inhibitory regulation of acid invertase##2##5##(2008-9#2)
inhibitory regulation of##3##3##(2008-2#1)(2008-9#2)
inhibitory regulation##4##2##(1995-11#1)(2008-2#1)(2008-9#2)
inhibitory response##3##2##(1992-2#1)(1997-4#1)(2008-6#1)
inhibitory role in##2##3##(1995-12#1)(2009-6#1)
inhibitory role of##3##3##(1990-2#1)(1991-2#1)(1996-5#1)
inhibitory role##6##2##(1990-2#1)(1991-2#1)(1995-12#1)(1996-5#1)(2009-6#1)(2013-1#1)
inhibitory signals##3##2##(1995-11#1)(2008-7#1)(2008-8#1)
inhibitory spectrum##2##2##(2008-11#2)
inhibitory substances##4##2##(2008-11#3)(2008-6#1)
inhibitory synapses##3##2##(1993-12#1)(2009-8#2)
inhibitory than the##3##3##(1997-1#1)(2008-10#2)
inhibitory than##6##2##(1997-1#1)(2008-10#4)(2008-11#1)
inhibitory to a##2##3##(2008-10#1)(2008-11#1)
inhibitory to##13##2##(1994-2#1)(1997-1#1)(2008-10#9)(2008-11#2)
inhibitory##631##1##(1990-10#1)(1990-11#8)(1990-12#3)(1990-2#7)(1990-5#7)(1990-6#1)(1990-7#7)(1991-1#1)(1991-12#15)(1991-2#4)(1991-5#6)(1991-6#1)(1991-8#3)(1991-9#8)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#6)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#8)(1992-9#9)(1993-1#2)(1993-11#4)(1993-12#10)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#8)(1994-12#6)(1994-2#3)(1994-3#7)(1994-5#3)(1994-6#3)(1994-8#10)(1994-9#1)(1995-11#15)(1995-12#13)(1995-2#7)(1995-3#8)(1995-5#2)(1995-6#8)(1995-8#1)(1996-12#2)(1996-2#14)(1996-5#10)(1996-6#1)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#13)(1997-7#4)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#10)(2007-7#1)(2007-8#4)(2008-10#72)(2008-11#45)(2008-12#5)(2008-2#1)(2008-4#11)(2008-5#19)(2008-6#12)(2008-7#19)(2008-8#10)(2008-9#6)(2009-10#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#3)(2010-12#2)(2010-2#8)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#10)(2011-3#8)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#9)(2013-1#25)(2013-7#2)(2013-8#4)
inhibitory)##2##1##(1994-8#1)(2008-4#1)
inhibits Ca2+##2##2##(1993-11#1)(1997-7#1)
inhibits DNA##2##2##(1993-6#1)(1993-8#1)
inhibits a##2##2##(1995-12#1)(2008-11#1)
inhibits apoptosis##3##2##(2008-5#1)(2009-2#1)(2012-12#1)
inhibits autophosphorylation##2##2##(1990-11#1)(1991-12#1)
inhibits by##2##2##(1994-11#1)(2008-10#1)
inhibits cell##2##2##(1993-8#1)(1994-8#1)
inhibits growth of##3##3##(1993-9#1)(2011-2#2)
inhibits high##2##2##(1996-2#1)(2011-2#1)
inhibits iNOS##2##2##(1993-3#1)(2011-2#1)
inhibits induction of##2##3##(1991-12#1)(1993-3#1)
inhibits insulin secretion and##2##4##(1993-3#1)(1994-8#1)
inhibits insulin##3##2##(1993-3#1)(1994-8#2)
inhibits ion##2##2##(1990-12#1)(1992-6#1)
inhibits it##3##2##(2008-8#3)
inhibits its##2##2##(1994-11#1)(2010-10#1)
inhibits myelination##2##2##(2008-5#1)(2008-7#1)
inhibits phospholipase action under##2##4##(1994-3#2)
inhibits platelet aggregation##2##3##(1990-12#1)(2006-6#1)
inhibits proliferation of##3##3##(1993-11#1)(1995-12#1)(2013-7#1)
inhibits proliferation##4##2##(1993-11#1)(1995-12#1)(2011-2#1)(2013-7#1)
inhibits protein kinase C##2##4##(1993-12#1)(1994-2#1)
inhibits protein##4##2##(1991-5#1)(1993-12#1)(1994-2#1)(2011-3#1)
inhibits rat##2##2##(1990-7#1)(1992-8#1)
inhibits signal transduction in##2##4##(1993-6#1)(2010-1#1)
inhibits the activation of##2##4##(1992-9#1)(2008-4#1)
inhibits the effects of##3##4##(1995-11#1)(2008-4#1)(2008-5#1)
inhibits the formation of##4##4##(1992-5#1)(1995-2#1)(2008-5#1)(2011-2#1)
inhibits the growth of##6##4##(1992-9#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
inhibits the infectivity and hemagglutinating activity of influenza A viruses of the##2##12##(1992-9#2)
inhibits the onset of##2##4##(1994-5#1)(2006-6#1)
inhibits the proliferation of##4##4##(1996-2#1)(1997-1#1)(2010-1#1)(2011-1#1)
inhibits the##80##2##(1990-11#2)(1990-12#1)(1990-7#2)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#7)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#3)(1996-2#2)(1997-1#3)(1997-6#1)(1997-7#2)(2006-6#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
inhibits their##2##2##(1993-8#1)(2011-2#1)
inhibits this##3##2##(1990-2#1)(1993-11#1)(2008-10#1)
inhibits translation##2##2##(1997-6#1)(2008-10#1)
inhibits tumor##2##2##(2008-11#1)(2012-2#1)
inhibits##276##1##(1990-11#6)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#5)(1990-8#1)(1991-1#3)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#10)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#8)(1993-11#4)(1993-12#2)(1993-3#6)(1993-5#1)(1993-6#5)(1993-8#7)(1993-9#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#8)(1995-11#6)(1995-12#10)(1995-2#6)(1995-6#3)(1995-8#1)(1996-2#4)(1996-5#1)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#5)(2006-6#2)(2007-11#2)(2008-1#1)(2008-10#17)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#13)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-7#2)(2009-8#5)(2010-1#4)(2010-10#1)(2011-1#2)(2011-2#9)(2011-3#3)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#2)(2013-8#1)
inhomogeneities and##2##2##(2008-2#1)(2008-3#1)
inhomogeneities are##3##2##(2008-2#2)(2008-3#1)
inhomogeneities at the##2##3##(2007-10#1)(2008-3#1)
inhomogeneities in##2##2##(2007-11#1)(2008-8#1)
inhomogeneities of##5##2##(1996-4#2)(2008-2#1)(2008-3#2)
inhomogeneities on##4##2##(1996-4#1)(2008-3#3)
inhomogeneities##40##1##(1996-4#4)(2007-10#3)(2007-11#1)(2007-12#2)(2008-2#8)(2008-3#18)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
inhomogeneity in##2##2##(2008-3#2)
inhomogeneity of the##5##3##(2008-3#4)(2013-7#1)
inhomogeneity of##9##2##(2008-2#2)(2008-3#4)(2008-7#1)(2013-7#2)
inhomogeneity on##2##2##(1996-4#1)(2008-3#1)
inhomogeneity##26##1##(1991-5#1)(1996-4#1)(2007-10#1)(2007-4#1)(2008-2#4)(2008-3#11)(2008-7#3)(2013-7#4)
inhomogeneous medium##2##2##(2008-11#1)(2008-2#1)
inhomogeneous regions##2##2##(2008-3#2)
inhomogeneous spectral broadening of stimulated Brillouin scattering##2##7##(2007-11#2)
inhomogeneous spheres##2##2##(2008-2#2)
inhomogeneous##51##1##(1990-9#2)(1996-4#2)(2007-11#5)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#9)(2008-3#21)(2009-7#3)(2009-8#2)(2011-2#1)(2012-3#1)
inhomogeneously broadened##2##2##(2007-11#1)(2007-12#1)
inhomogeneously##7##1##(2007-11#2)(2007-12#3)(2008-2#1)(2009-5#1)
inhospitable##3##1##(2008-10#1)(2011-2#1)(2013-7#1)
initial 12##2##2##(1990-2#1)(2008-11#1)
initial F0##3##2##(2013-8#3)
initial GCS score##2##3##(2013-8#2)
initial SCr level of##2##4##(2008-1#2)
initial acidification##2##2##(1990-2#2)
initial acquisition and##2##3##(1991-2#1)(2008-5#1)
initial acquisition##3##2##(1991-2#1)(1993-3#1)(2008-5#1)
initial activity##3##2##(1990-2#1)(2008-10#1)(2012-2#1)
initial aggregation##2##2##(2008-10#2)
initial amplitude##2##2##(1995-12#1)(2011-1#1)
initial analysis##3##2##(2008-10#2)(2008-3#1)
initial and final measurements##2##4##(2007-7#1)(2008-8#1)
initial and final##4##3##(1996-9#1)(2007-7#1)(2008-8#1)(2013-1#1)
initial and terminal##3##3##(1993-11#2)(2010-8#1)
initial and##16##2##(1992-6#1)(1993-11#2)(1995-12#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
initial angle##2##2##(2008-2#1)(2008-3#1)
initial anti-HBs##2##2##(2013-1#2)
initial appearance##2##2##(2008-10#1)(2011-2#1)
initial application##2##2##(2008-10#1)(2013-8#1)
initial aspect ratio##2##3##(2008-2#2)
initial assessment and##3##3##(2007-1#1)(2008-7#1)(2011-2#1)
initial assessment of##3##3##(1993-11#1)(2008-4#1)(2013-8#1)
initial assessment##12##2##(1992-12#1)(1993-11#1)(1993-2#2)(2007-1#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
initial attempt##2##2##(1995-5#1)(2009-8#1)
initial cell concentration##2##3##(1994-5#1)(2008-11#1)
initial cell##9##2##(1994-5#1)(2008-10#2)(2008-11#5)(2008-9#1)
initial characterization of the##2##4##(2008-3#1)(2008-9#1)
initial characterization of##8##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
initial cleavage of##3##3##(1990-7#1)(1990-9#1)(2008-8#1)
initial clinical experience with##2##4##(2012-12#1)(2012-3#1)
initial clinical presentation##2##3##(2008-1#1)(2008-9#1)
initial clinical##9##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-3#1)
initial colonization##2##2##(2008-10#2)
initial complexes##2##2##(1995-6#1)(2008-10#1)
initial concentration of the##3##4##(1995-11#1)(2008-10#2)
initial concentration of##9##3##(1995-11#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-2#1)
initial concentration##13##2##(1995-11#1)(2008-10#7)(2008-5#2)(2008-7#2)(2011-2#1)
initial condition##6##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-8#1)
initial conditions and quadrat size##2##5##(2008-10#2)
initial conditions and##4##3##(2008-10#4)
initial conditions##17##2##(2007-12#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
initial configuration##2##2##(2008-3#1)(2008-8#1)
initial contact##2##2##(1995-11#1)(2008-10#1)
initial contamination##2##2##(1997-4#1)(2008-12#1)
initial culture##2##2##(2008-12#1)(2013-1#1)
initial data##5##2##(1994-6#1)(1995-8#1)(1997-5#1)(2008-10#1)(2008-3#1)
initial days of##2##3##(1993-6#1)(2013-7#1)
initial decrease in##4##3##(1991-9#1)(1996-11#1)(2008-11#1)(2008-5#1)
initial decrease##7##2##(1991-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
initial delay##3##2##(1995-8#1)(2011-2#2)
initial development of##5##3##(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
initial diagnosis and##2##3##(2007-11#1)(2008-6#1)
initial diagnosis of a##3##4##(2008-7#1)(2010-6#1)(2011-2#1)
initial diagnosis of##5##3##(1991-7#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-2#1)
initial diagnosis was##3##3##(1992-6#1)(1996-3#1)(2008-11#1)
initial diagnosis##17##2##(1991-7#2)(1992-6#1)(1996-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#3)(2013-8#1)
initial disease##4##2##(2008-10#4)
initial distribution of##2##3##(2007-11#1)(2008-3#1)
initial distribution##3##2##(2007-11#1)(2008-3#2)
initial dose##5##2##(1994-12#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-6#1)
initial down-regulation##2##2##(1996-12#1)(1997-7#1)
initial drug##3##2##(1992-1#1)(1993-12#1)(1995-3#1)
initial energetic level##2##3##(2008-8#2)
initial enzyme##2##2##(2011-1#1)(2013-1#1)
initial epidemic conditions##3##3##(2008-10#3)
initial episode of##2##3##(2008-7#1)(2013-1#1)
initial episode##3##2##(1995-3#1)(2008-7#1)(2013-1#1)
initial estimates of the##2##4##(2008-2#1)(2008-8#1)
initial estimates##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
initial evaluation of##3##3##(1992-1#1)(2008-11#1)(2008-5#1)
initial evaluation##11##2##(1992-1#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#2)
initial examination##2##2##(2007-8#1)(2010-10#1)
initial experience in##2##3##(2008-7#1)(2012-12#1)
initial experience##11##2##(1992-2#1)(1996-12#1)(2008-7#1)(2010-6#1)(2011-2#3)(2012-12#3)(2013-8#1)
initial experiments with##2##3##(2008-10#1)(2008-2#1)
initial experiments##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
initial exposure to##3##3##(1991-6#1)(2008-10#2)
initial exposure##4##2##(1991-6#1)(2008-10#2)(2011-2#1)
initial fear##3##2##(2012-1#1)(2012-2#2)
initial focus##3##2##(2008-3#1)(2008-7#2)
initial formation of a##3##4##(1990-11#1)(1993-8#1)(2011-2#1)
initial fumaric acid##2##3##(2008-6#2)
initial genome##3##2##(1997-5#3)
initial genomic##2##2##(1997-5#1)(2008-10#1)
initial glucose concentration##4##3##(2008-5#1)(2008-6#2)(2008-7#1)
initial glucose##6##2##(1995-2#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)
initial growth##3##2##(1992-2#1)(1997-8#1)(2007-12#1)
initial guess of the##2##4##(2008-3#2)
initial guess##5##2##(2007-7#1)(2008-3#4)
initial headspace or dissolved O(2)##2##5##(2011-2#2)
initial headspace##4##2##(2011-2#4)
initial hydrolysis##2##2##(2008-10#2)
initial immune##2##2##(2007-12#1)(2011-2#1)
initial implementation of##2##3##(1995-2#1)(2008-7#1)
initial implementation##3##2##(1995-2#1)(1996-12#1)(2008-7#1)
initial increase after##2##3##(1990-7#1)(2008-10#1)
initial increase in##3##3##(1990-5#2)(2009-8#1)
initial increase##6##2##(1990-5#2)(1990-7#1)(1995-5#1)(2008-10#1)(2009-8#1)
initial infection##8##2##(2008-10#8)
initial injury##2##2##(1995-5#1)(2007-8#1)
initial inocula##4##2##(2008-10#4)
initial inoculum and##2##3##(2008-10#2)
initial inoculum##11##2##(2008-10#11)
initial interviews##2##2##(2008-6#1)(2013-1#1)
initial investigation##2##2##(1997-8#1)(2007-11#1)
initial isolates##3##2##(2008-10#3)
initial lesion##2##2##(2008-10#1)(2010-6#1)
initial leukocytosis over 50 000/mm3##3##5##(2011-2#3)
initial leukocytosis##4##2##(2011-2#4)
initial level of anxiety that##2##5##(2009-7#2)
initial level of##3##3##(2008-7#1)(2009-7#2)
initial level##4##2##(2008-7#1)(2008-8#1)(2009-7#2)
initial levels of##3##3##(1993-8#1)(2008-11#1)(2011-2#1)
initial levels##5##2##(1993-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
initial location##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
initial management of##3##3##(2007-10#1)(2007-12#1)(2010-9#1)
initial management##9##2##(1995-11#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-8#1)
initial manifestation of##4##3##(1991-3#1)(1991-6#1)(2006-10#1)(2008-10#1)
initial manifestation##5##2##(1991-3#1)(1991-6#1)(1993-2#1)(2006-10#1)(2008-10#1)
initial medical##2##2##(2007-8#1)(2012-2#1)
initial model##3##2##(2008-4#1)(2008-8#2)
initial mortality rate##2##3##(2008-9#2)
initial mortality##4##2##(1995-3#1)(2008-9#3)
initial observations##2##2##(1994-11#1)(1996-12#1)
initial operation##9##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#4)(2012-3#1)(2013-1#1)
initial pH##6##2##(2008-5#1)(2008-6#4)(2013-8#1)
initial parameter##2##2##(2008-10#1)(2008-3#1)
initial particle##2##2##(1996-1#1)(1996-12#1)
initial performance##4##2##(2007-12#1)(2008-10#3)
initial period of##6##3##(2007-8#3)(2008-7#1)(2008-8#2)
initial period##7##2##(2007-8#3)(2008-7#1)(2008-8#2)(2011-2#1)
initial phase of##8##3##(2007-7#2)(2008-10#2)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
initial phase shift between##2##4##(2008-3#2)
initial phase##18##2##(1990-6#1)(1990-7#1)(1994-5#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2012-3#1)(2013-8#1)
initial plating##3##2##(1990-7#1)(1996-5#1)(2009-6#1)
initial population##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
initial position##2##2##(2007-8#1)(2008-9#1)
initial postspawning##2##2##(2010-8#2)
initial presentation and##4##3##(1991-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
initial presentation of##9##3##(2006-10#1)(2007-5#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
initial presentation##19##2##(1991-2#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-6#2)(2009-3#2)(2009-8#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
initial problems##2##2##(2007-7#1)(2011-1#1)
initial procedure##3##2##(2007-8#1)(2013-1#1)(2013-7#1)
initial procedures##2##2##(2007-8#1)(2012-12#1)
initial pulse is##2##3##(2007-12#2)
initial pulse##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
initial quality##2##2##(1990-3#1)(2008-3#1)
initial random##2##2##(1995-2#1)(2008-3#1)
initial rate of Ca2+ influx##2##5##(1990-12#2)
initial rate of the##5##4##(1990-12#1)(2008-10#4)
initial rate of##17##3##(1990-11#1)(1990-12#4)(1992-6#3)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#6)
initial rate##29##2##(1990-11#1)(1990-12#4)(1992-6#3)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#17)(2008-7#1)
initial rates of##4##3##(1990-12#1)(1990-2#1)(1992-6#1)(1994-5#1)
initial rates##6##2##(1990-12#1)(1990-2#1)(1992-6#1)(1994-5#1)(2008-7#2)
initial reaction rates##3##3##(2008-7#3)
initial reaction##5##2##(2008-7#4)(2013-1#1)
initial reduction in dimensionality is##2##5##(2010-7#2)
initial reduction in##3##3##(2009-11#1)(2010-7#2)
initial reduction of##2##3##(1995-6#1)(2007-3#1)
initial reduction##6##2##(1995-6#1)(2007-3#1)(2009-11#1)(2010-7#2)(2011-2#1)
initial research##2##2##(1992-6#1)(2011-2#1)
initial response to##3##3##(1997-7#1)(2007-7#1)(2010-4#1)
initial response##5##2##(1992-2#1)(1997-7#1)(2007-7#1)(2008-10#1)(2010-4#1)
initial results are##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
initial results of##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
initial results suggest that##2##4##(2008-10#1)(2008-3#1)
initial results##14##2##(1996-1#1)(1996-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
initial screening of##3##3##(1991-1#1)(2013-1#2)
initial screening##11##2##(1991-1#1)(1995-12#1)(2008-10#5)(2008-4#1)(2011-2#1)(2013-1#2)
initial seed size##2##3##(2008-9#2)
initial seed##3##2##(2008-10#1)(2008-9#2)
initial sensitivity after##2##3##(2008-10#2)
initial set##2##2##(2008-11#1)(2008-12#1)
initial signal##3##2##(1993-6#1)(2008-4#1)(2008-8#1)
initial signaling##2##2##(1994-8#1)(1995-2#1)
initial single##2##2##(1996-5#1)(2008-11#1)
initial slope##3##2##(2008-10#2)(2008-3#1)
initial solution##3##2##(2008-10#3)
initial spatial##2##2##(2008-10#1)(2009-8#1)
initial spore##2##2##(2008-10#2)
initial stage but##2##3##(1994-3#1)(2010-8#1)
initial stage of##8##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)
initial stage##10##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#2)(2013-1#1)
initial stages of##14##3##(2006-12#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
initial stages##16##2##(1991-12#1)(2006-12#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
initial stem##2##2##(2008-7#1)(2010-1#1)
initial step in the##2##4##(2007-11#1)(2010-4#1)
initial step in##3##3##(2007-11#1)(2008-1#1)(2010-4#1)
initial step toward##3##3##(2008-10#2)(2008-5#1)
initial step##11##2##(1991-9#1)(1992-12#1)(1997-2#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-2#1)(2010-4#1)
initial stress##5##2##(1996-4#1)(2008-5#3)(2008-7#1)
initial studies have##3##3##(1997-4#1)(2008-10#1)(2012-2#1)
initial studies suggest##3##3##(1995-11#1)(2008-11#1)(2008-3#1)
initial studies##11##2##(1995-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2011-2#1)(2012-2#1)
initial study##3##2##(1994-3#2)(2008-6#1)
initial surgery##2##2##(2007-5#1)(2009-1#1)
initial survey##2##2##(1995-9#1)(2008-9#1)
initial symptom##4##2##(1990-9#1)(2008-1#1)(2008-10#1)(2008-8#1)
initial symptoms##6##2##(1990-6#1)(1991-6#1)(2008-10#3)(2008-7#1)
initial therapeutic##3##2##(1993-11#1)(2008-11#1)(2008-9#1)
initial training##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
initial translation##2##2##(1991-11#1)(2007-8#1)
initial transmission of##2##3##(2008-12#1)(2008-3#1)
initial treatment of##4##3##(1990-9#1)(1993-6#1)(2013-8#2)
initial treatment##15##2##(1990-9#1)(1992-3#1)(1993-3#1)(1993-6#1)(2007-10#1)(2008-3#1)(2008-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#2)(2013-8#2)
initial trigger for##2##3##(1992-11#1)(2008-9#1)
initial trigger##3##2##(1992-11#1)(2008-1#1)(2008-9#1)
initial validation##2##2##(2012-1#1)(2013-1#1)
initial value of##2##3##(1990-3#1)(2008-10#1)
initial value##8##2##(1990-12#1)(1990-3#2)(1993-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
initial values##5##2##(1990-7#1)(1993-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
initial vectors##2##2##(2008-10#2)
initial velocity##2##2##(1990-7#1)(2008-6#1)
initial weight loss##2##3##(1991-12#1)(2008-5#1)
initial weight##3##2##(1991-12#1)(2008-5#1)(2011-2#1)
initial work##3##2##(2009-3#1)(2011-2#1)(2012-12#1)
initial##1210##1##(1990-10#1)(1990-11#5)(1990-12#11)(1990-2#9)(1990-3#4)(1990-5#5)(1990-6#4)(1990-7#10)(1990-9#4)(1991-1#4)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#4)(1991-7#3)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#10)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#4)(1993-6#5)(1993-8#4)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#8)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#8)(1995-12#6)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#5)(1997-4#3)(1997-5#7)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#3)(2006-12#1)(2007-1#2)(2007-10#9)(2007-11#18)(2007-12#29)(2007-3#1)(2007-5#3)(2007-7#10)(2007-8#18)(2007-9#3)(2008-1#17)(2008-10#212)(2008-11#54)(2008-12#13)(2008-2#21)(2008-3#54)(2008-4#14)(2008-5#28)(2008-6#28)(2008-7#58)(2008-8#30)(2008-9#28)(2009-1#3)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#1)(2009-6#6)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#10)(2011-2#67)(2011-3#2)(2012-1#3)(2012-12#13)(2012-2#18)(2012-3#9)(2012-8#1)(2013-1#45)(2013-7#4)(2013-8#27)
initial-rate potentiometric##2##2##(2008-10#2)
initial-rate##3##1##(2008-10#3)
initialization##3##1##(2008-2#1)(2008-3#1)(2010-8#1)
initialized##5##1##(1992-7#1)(1997-2#1)(2008-10#2)(2012-3#1)
initially a##4##2##(2007-8#1)(2008-10#2)(2009-1#1)
initially and##3##2##(1993-2#1)(2010-1#1)(2013-1#1)
initially as a##4##3##(1995-8#1)(2006-10#2)(2007-7#1)
initially as##7##2##(1995-8#1)(2006-10#2)(2007-7#1)(2008-1#1)(2011-1#1)(2013-7#1)
initially be##4##2##(1990-11#1)(1990-3#1)(2009-3#1)(2011-2#1)
initially but##2##2##(1991-8#1)(2008-3#1)
initially by##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
initially classified as##2##3##(2008-10#1)(2009-8#1)
initially classified##4##2##(2008-10#1)(2008-12#2)(2009-8#1)
initially considered##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
initially demonstrated using##2##3##(2008-10#1)(2008-7#1)
initially demonstrated##3##2##(2008-10#2)(2008-7#1)
initially described##2##2##(1991-2#1)(2009-8#1)
initially designed##2##2##(2007-11#1)(2008-7#1)
initially developed##2##2##(2008-8#1)(2012-2#1)
initially diagnosed as##3##3##(2007-7#1)(2007-8#1)(2008-7#1)
initially diagnosed##6##2##(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
initially followed by##2##3##(2008-11#1)(2008-5#1)
initially for##2##2##(1993-11#1)(2012-2#1)
initially formed##5##2##(1991-9#1)(1996-5#2)(2008-10#1)(2008-7#1)
initially found##2##2##(2008-11#1)(2009-7#1)
initially fumigated##2##2##(2008-10#2)
initially identified as a##2##4##(2011-2#1)(2012-3#1)
initially identified as##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
initially identified##6##2##(2007-2#1)(2008-12#1)(2009-10#1)(2011-2#2)(2012-3#1)
initially in excess over##2##4##(1991-5#2)
initially in the##4##3##(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)
initially in##10##2##(1990-5#1)(1991-5#2)(1995-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-7#1)
initially increased##3##2##(2008-10#2)(2008-8#1)
initially infested with##2##3##(1996-12#1)(2008-10#1)
initially measured##2##2##(2008-10#1)(2008-4#1)
initially not##4##2##(1990-6#1)(1997-3#1)(2007-12#1)(2008-9#1)
initially on the##2##3##(2008-10#2)
initially on##3##2##(2008-10#2)(2013-1#1)
initially only##2##2##(1992-3#1)(1996-11#1)
initially plane##2##2##(2008-2#1)(2008-3#1)
initially presented with##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
initially presented##6##2##(2008-10#1)(2008-2#1)(2008-7#2)(2009-7#1)(2011-2#1)
initially received##2##2##(2009-10#1)(2013-1#1)
initially respond to##2##3##(1996-9#1)(2010-7#1)
initially set##2##2##(1996-2#1)(2009-10#1)
initially showed a##2##3##(1996-6#1)(2011-1#1)
initially showed##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-1#1)
initially tested##4##2##(1992-8#1)(1994-8#1)(1995-3#1)(2008-10#1)
initially the##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
initially thought to be##3##4##(1995-3#1)(2008-10#1)(2013-1#1)
initially thought##5##2##(1995-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2013-1#1)
initially to##6##2##(1992-9#1)(1994-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)
initially treated with##6##3##(1991-3#1)(2008-7#2)(2011-2#1)(2013-8#2)
initially treated##9##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-8#2)
initially underwent a##2##3##(2007-10#1)(2011-2#1)
initially underwent##3##2##(2007-10#1)(2011-2#1)(2012-2#1)
initially was##2##2##(2008-10#2)
initially were S(T)R(V)##2##3##(2008-10#2)
initially with##9##2##(1992-12#1)(1995-3#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-10#1)(2011-2#1)
initially##338##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#5)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#3)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#1)(2007-7#4)(2007-8#7)(2008-1#3)(2008-10#64)(2008-11#10)(2008-12#12)(2008-2#10)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#15)(2008-8#12)(2008-9#5)(2009-1#1)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#2)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#9)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#5)
initials##3##1##(2008-10#2)(2008-8#1)
initiate a##9##2##(1992-12#3)(1992-9#1)(1993-8#1)(1995-11#1)(2008-10#1)(2009-9#1)(2012-2#1)
initiate and##2##2##(2008-4#2)
initiate its##3##2##(1996-2#1)(1997-4#1)(2013-7#1)
initiate the##18##2##(1990-7#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#3)(2012-12#1)
initiate##98##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-6#2)(1992-12#3)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-2#3)(1997-1#1)(1997-2#2)(1997-4#1)(2007-11#1)(2008-1#4)(2008-10#8)(2008-11#10)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#2)
initiated a phase II trial##2##5##(2008-5#2)
initiated a study of##3##4##(1993-3#1)(1993-9#1)(1995-11#1)
initiated a##19##2##(1991-2#1)(1992-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#2)(1995-11#1)(1996-3#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
initiated an##3##2##(1991-8#1)(1995-2#1)(1997-6#1)
initiated and the##2##3##(2008-8#1)(2013-8#1)
initiated and##5##2##(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
initiated as early as possible##2##5##(1997-3#1)(2008-8#1)
initiated as##3##2##(1997-3#1)(2008-7#1)(2008-8#1)
initiated at the##8##3##(1990-5#1)(1991-3#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
initiated at##14##2##(1990-5#3)(1991-3#3)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
initiated before##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
initiated by a##5##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
initiated by the##10##3##(1990-11#2)(1990-12#1)(1990-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-9#1)(2013-1#1)
initiated by##48##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1992-4#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#2)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
initiated cells##2##2##(1995-2#1)(1995-9#1)
initiated during##2##2##(2008-12#1)(2008-9#1)
initiated early##2##2##(1994-1#1)(2008-7#1)
initiated from the##2##3##(1995-8#1)(2011-2#1)
initiated from##5##2##(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
initiated in the##7##3##(1991-1#1)(1992-11#1)(1994-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
initiated in##23##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
initiated injury##2##2##(1995-11#2)
initiated on the##2##3##(1996-5#1)(2008-8#1)
initiated on##10##2##(1994-6#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#3)
initiated studies##2##2##(1993-12#1)(2008-10#1)
initiated the##5##2##(1992-2#1)(1993-3#1)(1995-12#1)(2008-7#1)(2010-7#1)
initiated to determine##2##3##(1992-12#1)(2011-2#1)
initiated to##14##2##(1992-12#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)
initiated when##2##2##(2008-10#1)(2011-2#1)
initiated with##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
initiated##245##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#4)(1991-1#1)(1991-2#2)(1991-3#3)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#4)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#6)(2008-12#3)(2008-3#5)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#16)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#2)
initiates DNA##3##2##(1997-6#1)(2008-5#1)(2012-3#1)
initiates a##4##2##(1990-12#1)(1996-5#1)(2008-2#1)(2010-5#1)
initiates an##2##2##(2008-3#1)(2012-12#1)
initiates the##5##2##(1991-5#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#1)
initiates##26##1##(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
initiating a##9##2##(2008-1#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
initiating activity##2##2##(1990-7#1)(1994-2#1)
initiating and##7##2##(1992-2#1)(1994-8#1)(1995-3#1)(2008-3#1)(2010-7#1)(2011-1#2)
initiating epidemics##2##2##(2008-10#2)
initiating events##2##2##(2008-10#1)(2009-10#1)
initiating or maintaining##2##3##(1990-5#1)(2008-7#1)
initiating or##3##2##(1990-5#1)(2008-7#1)(2011-2#1)
initiating the##9##2##(1991-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-2#1)(2011-2#2)
initiating this##2##2##(2008-8#1)(2009-8#1)
initiating treatment##2##2##(1992-6#1)(2008-10#1)
initiating##78##1##(1990-5#1)(1990-7#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-6#1)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2009-10#1)(2009-2#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
initiation among##2##2##(2013-1#2)
initiation and beam quality evolution in##2##6##(2008-2#2)
initiation and elongation##2##3##(1994-8#1)(2008-8#1)
initiation and execution of##2##4##(2011-1#2)
initiation and execution##4##3##(1991-6#2)(2011-1#2)
initiation and growth##2##3##(2008-8#1)(2011-2#1)
initiation and progression##5##3##(1994-5#1)(2008-10#1)(2008-7#1)(2011-2#2)
initiation and propagation##5##3##(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-1#1)
initiation and suppression of promotion##2##5##(1995-2#2)
initiation and the##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
initiation and##52##2##(1991-6#2)(1992-5#1)(1993-12#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-2#2)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-7#4)(2008-8#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#2)
initiation and/or advice&quot##2##3##(2011-2#2)
initiation at##4##2##(1991-12#1)(1995-2#1)(2008-10#1)(2008-4#1)
initiation but##2##2##(2010-4#1)(2013-1#1)
initiation codon##9##2##(1992-11#2)(1993-3#2)(1994-11#1)(1996-8#1)(1997-6#3)
initiation codons##5##2##(1991-12#1)(1996-8#4)
initiation complex and##2##3##(2008-11#1)(2008-8#1)
initiation factor##10##2##(1991-12#2)(1993-12#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
initiation factors##2##2##(1994-3#1)(2010-4#1)
initiation from the##2##3##(1991-9#1)(2008-8#1)
initiation from##3##2##(1991-9#1)(1992-12#1)(2008-8#1)
initiation in the##2##3##(2008-5#1)(2011-2#1)
initiation in##10##2##(1993-12#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
initiation into drug use##2##4##(2013-8#2)
initiation of DNA replication##3##4##(1990-11#1)(2009-2#2)
initiation of DNA##4##3##(1990-11#2)(2009-2#2)
initiation of HAART##3##3##(2009-7#1)(2010-5#1)(2011-2#1)
initiation of PD+HD therapy##3##4##(2011-2#3)
initiation of a##3##3##(1994-5#1)(2008-6#1)(2012-2#1)
initiation of an##2##3##(1991-1#1)(1997-8#1)
initiation of antiretroviral therapy##4##4##(2006-10#1)(2009-4#1)(2011-2#1)(2012-2#1)
initiation of apoptosis##2##3##(2008-12#1)(2008-8#1)
initiation of appropriate##2##3##(2006-10#1)(2013-1#1)
initiation of breastfeeding##2##3##(2010-5#1)(2011-1#1)
initiation of cardiovascular protective therapies##2##5##(2008-3#2)
initiation of disease##3##3##(2008-10#3)
initiation of peritoneal dialysis##2##4##(2007-7#1)(2011-2#1)
initiation of renal replacement therapy##2##5##(2008-1#1)(2008-3#1)
initiation of the heart's diastolic dysfunction##2##6##(2011-1#2)
initiation of the reaction##3##4##(2008-10#3)
initiation of the treatment##2##4##(1991-11#1)(2012-3#1)
initiation of the##18##3##(1991-11#1)(1992-3#1)(1996-3#1)(2007-7#1)(2008-10#7)(2008-3#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#1)
initiation of therapy##6##3##(1996-11#1)(2007-7#1)(2008-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
initiation of translation##2##3##(1991-1#1)(1994-6#1)
initiation of treatment##8##3##(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
initiation of##138##2##(1990-11#2)(1990-5#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#3)(1994-9#1)(1996-11#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-8#4)(2011-1#7)(2011-2#13)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)
initiation or##5##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
initiation polymerization##5##2##(2008-10#5)
initiation site of##3##3##(1990-12#1)(2008-6#2)
initiation site was##3##3##(1991-9#1)(1997-7#2)
initiation site##16##2##(1990-12#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#3)(2008-6#2)
initiation sites were##6##3##(1993-3#1)(1996-5#1)(1996-8#1)(1997-6#3)
initiation sites##23##2##(1993-3#1)(1993-8#1)(1996-5#2)(1996-8#5)(1997-2#5)(1997-6#9)
initiation were##2##2##(1991-12#1)(1997-3#1)
initiation with##3##2##(1992-9#1)(1995-11#2)
initiation##379##1##(1990-11#3)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#7)(1991-6#3)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#7)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#8)(1995-6#5)(1996-11#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#10)(1997-1#1)(1997-2#8)(1997-3#4)(1997-4#1)(1997-6#13)(1997-7#7)(1997-8#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#42)(2008-11#13)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#16)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#1)(2010-8#4)(2011-1#11)(2011-2#24)(2012-1#4)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#14)(2013-7#3)(2013-8#7)
initiation)##3##1##(2008-10#2)(2013-1#1)
initiation-promotion##2##1##(1992-2#2)
initiation/termination##3##1##(2010-3#1)(2011-1#2)
initiative and##3##2##(1991-12#1)(2008-11#1)(2012-2#1)
initiative are discussed##2##3##(2009-3#1)(2013-1#1)
initiative are##3##2##(1995-3#1)(2009-3#1)(2013-1#1)
initiative at a##2##3##(1995-2#1)(1995-3#1)
initiative at the##2##3##(1995-2#1)(2008-11#1)
initiative at##4##2##(1995-2#2)(1995-3#1)(2008-11#1)
initiative by##2##2##(2008-4#1)(2012-2#1)
initiative can##2##2##(1995-2#1)(1996-1#1)
initiative for##4##2##(1994-12#1)(1995-1#1)(1997-1#1)(2008-10#1)
initiative has##4##2##(2007-2#1)(2013-1#3)
initiative in the##2##3##(1997-8#1)(2008-6#1)
initiative in which##2##3##(1995-6#1)(1996-12#1)
initiative in##8##2##(1994-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-8#1)(2008-3#1)(2008-6#1)(2013-1#1)
initiative is the##3##3##(1991-12#1)(2013-1#2)
initiative is##10##2##(1991-12#1)(1993-3#1)(1994-3#1)(2008-1#1)(2013-1#5)(2013-8#1)
initiative of the##4##3##(1995-3#2)(2008-10#1)(2010-11#1)
initiative of##8##2##(1995-3#2)(2007-11#1)(2008-10#1)(2008-5#2)(2010-1#1)(2010-11#1)
initiative on##2##2##(2008-1#1)(2008-3#1)
initiative that##2##2##(1993-3#1)(1996-1#1)
initiative to develop##2##3##(1997-7#1)(2008-11#1)
initiative to##12##2##(1992-11#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
initiative was##2##2##(2009-3#1)(2011-2#1)
initiative##161##1##(1990-12#1)(1991-12#4)(1992-11#1)(1992-2#1)(1993-3#2)(1994-1#2)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#4)(1994-9#1)(1995-1#5)(1995-12#2)(1995-2#5)(1995-3#5)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#3)(2009-7#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#2)(2011-1#2)(2011-2#5)(2011-8#1)(2011-9#1)(2012-2#4)(2013-1#27)(2013-8#3)
initiative's##2##1##(2013-1#2)
initiatives and##8##2##(1995-1#1)(1996-1#1)(1996-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
initiatives are##3##2##(1993-12#1)(1996-1#1)(2010-12#1)
initiatives as##2##2##(1994-12#1)(1997-1#1)
initiatives at##2##2##(1992-12#1)(2013-1#1)
initiatives by##2##2##(1995-2#1)(2010-8#1)
initiatives carried out in Spain##2##5##(2013-1#2)
initiatives carried out in##3##4##(1996-12#1)(2013-1#2)
initiatives for##3##2##(2008-11#1)(2008-12#1)(2012-1#1)
initiatives have##4##2##(1994-1#1)(1996-12#1)(1997-2#1)(2011-2#1)
initiatives implemented by##2##3##(1992-2#1)(2011-2#1)
initiatives in the##2##3##(1997-1#1)(2010-9#1)
initiatives in##16##2##(1992-1#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-1#3)(1997-2#2)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)
initiatives is##3##2##(1992-1#2)(2013-1#1)
initiatives may##3##2##(1994-12#1)(1996-3#1)(1997-2#1)
initiatives of##2##2##(1995-2#1)(2008-10#1)
initiatives related to childhood obesity and physical inactivity in Canada##2##10##(2008-12#2)
initiatives such as##4##3##(1995-12#1)(1997-2#1)(2008-12#1)(2012-2#1)
initiatives that##3##2##(1997-3#1)(2009-5#1)(2011-2#1)
initiatives to##7##2##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#1)
initiatives undertaken##2##2##(1996-1#1)(2008-10#1)
initiatives will##2##2##(1995-2#1)(2008-11#1)
initiatives##141##1##(1991-1#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-1#4)(1995-12#6)(1995-2#6)(1995-3#3)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#8)(1997-1#4)(1997-2#5)(1997-3#5)(2007-5#1)(2008-10#3)(2008-11#7)(2008-12#9)(2008-3#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2010-12#6)(2010-2#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#10)(2013-8#1)
initiator codon##2##2##(1991-1#1)(2008-8#1)
initiator dose##5##2##(1990-7#5)
initiator in##2##2##(2008-12#1)(2008-9#1)
initiator of##4##2##(1994-11#1)(1994-9#1)(2008-10#1)(2009-8#1)
initiator or a##2##3##(1995-9#2)
initiator protein##3##2##(1990-11#1)(1997-6#2)
initiator surface densities##2##3##(2009-10#2)
initiator##45##1##(1990-11#1)(1990-5#1)(1990-7#7)(1990-8#1)(1991-1#2)(1991-12#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-9#2)(1997-4#1)(1997-6#2)(2008-10#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-4#1)(2012-12#3)
initiators##2##1##(1992-9#1)(2008-9#1)
initio##23##1##(1991-5#1)(1996-2#4)(1996-5#3)(1997-7#3)(2006-4#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#3)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)
inject effector proteins into##2##4##(2011-2#1)(2013-8#1)
inject##8##1##(1990-8#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#3)(2013-8#1)
injectable drug##2##2##(1996-4#2)
injectable nonsteroidal anti-inflammatory##2##3##(2008-9#2)
injectable##28##1##(1991-1#1)(1996-4#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#4)(2013-1#3)
injected CCK-8##2##2##(1994-2#2)
injected MTEC1 cells##2##3##(2008-8#2)
injected and##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-1#1)
injected animals##5##2##(2008-5#5)
injected as a##2##3##(2008-10#1)(2011-2#1)
injected as##3##2##(2008-10#2)(2011-2#1)
injected at the same site##2##5##(1995-12#1)(2011-2#1)
injected at##7##2##(1995-12#2)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
injected by##7##2##(1994-9#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#3)
injected directly into a GC##2##5##(2008-10#2)
injected directly into a##3##4##(2008-10#3)
injected directly into the##4##4##(1990-8#1)(2008-10#3)
injected directly into##9##3##(1990-8#1)(1991-12#1)(2008-10#7)
injected directly##10##2##(1990-8#2)(1991-12#1)(2008-10#7)
injected during the early phase##2##5##(2012-2#2)
injected i##6##2##(1994-11#1)(1994-2#1)(1997-4#2)(2010-1#2)
injected in the lateral##2##4##(1993-12#1)(2010-2#1)
injected in the striatum##2##4##(1996-5#2)
injected in the##8##3##(1993-12#1)(1996-5#2)(1997-2#1)(2008-10#2)(2010-2#1)(2010-8#1)
injected in##16##2##(1992-11#1)(1993-12#1)(1996-5#2)(1997-2#1)(2007-11#1)(2008-10#7)(2010-2#1)(2010-8#1)(2011-1#1)
injected into a carrier stream of##3##6##(2008-10#3)
injected into a carrier stream##4##5##(2008-10#4)
injected into a carrier##6##4##(2008-10#6)
injected into a##29##3##(1990-8#1)(1993-8#1)(1994-2#1)(2007-12#1)(2008-10#22)(2008-2#2)(2010-8#1)
injected into an##3##3##(2008-10#3)
injected into rats##2##3##(1991-9#1)(2008-10#1)
injected into syngeneic##2##3##(2008-4#1)(2013-1#1)
injected into the carrier##3##4##(2008-10#3)
injected into the flow line##3##5##(2008-10#3)
injected into the nucleus accumbens##3##5##(1991-2#2)(1993-6#1)
injected into the##56##3##(1990-8#1)(1991-2#3)(1993-12#1)(1993-6#1)(1995-12#4)(1996-9#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
injected into##115##2##(1990-8#2)(1991-2#3)(1991-9#1)(1992-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#5)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#55)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
injected intraperitoneally with##5##3##(1992-11#2)(1995-3#1)(2008-11#1)(2008-5#1)
injected intraperitoneally##8##2##(1992-11#2)(1995-3#1)(1997-2#1)(2008-11#2)(2008-5#1)(2010-5#1)
injected intratumorally##2##2##(1993-11#2)
injected intravenously##5##2##(1993-12#1)(1997-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
injected mice##2##2##(2008-7#1)(2013-1#1)
injected on##2##2##(1990-12#1)(2008-10#1)
injected onto the##4##3##(1992-3#1)(2008-10#2)(2008-11#1)
injected onto##7##2##(1992-3#1)(2008-10#5)(2008-11#1)
injected per hour##2##3##(2008-10#1)(2011-1#1)
injected sample##6##2##(2008-10#6)
injected semiconductor lasers##2##3##(2007-12#2)
injected semiconductor##4##2##(2007-11#2)(2007-12#2)
injected subcutaneously with##2##3##(1995-11#1)(2012-3#1)
injected subcutaneously##5##2##(1994-6#1)(1995-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
injected the##2##2##(2008-10#1)(2010-1#1)
injected to the##2##3##(2008-10#2)
injected to##5##2##(2008-10#5)
injected volume##4##2##(2008-10#4)
injected with 0##3##3##(1994-5#1)(2008-12#1)(2008-9#1)
injected with a##6##3##(1993-3#1)(1995-12#1)(2008-10#3)(2010-1#1)
injected with hFIX##2##3##(2008-8#2)
injected with mycoplasma##2##3##(1997-3#2)
injected with saline##4##3##(1994-2#1)(1995-12#1)(2008-12#1)(2008-8#1)
injected with the##5##3##(1993-3#1)(1993-8#1)(1994-5#1)(1996-7#1)(2008-4#1)
injected with##65##2##(1990-7#2)(1991-2#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#2)(1994-2#1)(1994-5#4)(1995-12#2)(1995-2#1)(1996-7#2)(1997-2#1)(1997-3#2)(1997-7#1)(2008-10#8)(2008-11#1)(2008-12#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
injected##401##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#4)(1991-12#4)(1991-2#4)(1991-5#4)(1991-9#1)(1992-11#4)(1992-3#3)(1992-9#1)(1993-11#6)(1993-12#6)(1993-3#4)(1993-5#2)(1993-6#2)(1993-8#5)(1994-11#1)(1994-2#5)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#15)(1995-2#2)(1995-3#1)(1995-5#1)(1996-5#4)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#142)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#12)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-1#5)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#11)(2012-1#3)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#4)(2013-8#3)
injecting drug users##2##3##(2007-7#2)
injecting drug##3##2##(2007-7#2)(2013-1#1)
injecting insulin##2##2##(1993-12#2)
injecting the sample into##2##4##(2008-10#2)
injecting the##9##2##(1992-11#1)(1993-6#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-8#1)
injecting##55##1##(1991-9#1)(1992-11#1)(1993-10#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-8#3)(1994-9#1)(1995-2#2)(1997-2#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-10#21)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
injection (0##2##2##(1990-5#1)(2008-11#1)
injection (FI) system##15##3##(2008-10#15)
injection (FI) was##3##3##(2008-10#3)
injection (FI)##60##2##(2008-10#60)
injection amperometric##3##2##(2008-10#3)
injection analysis (BIA)##5##3##(2008-10#5)
injection analysis (SIA)##29##3##(2008-10#29)
injection analysis and##8##3##(2008-10#8)
injection analysis for the determination of##3##6##(2008-10#3)
injection analysis for##10##3##(2008-10#9)(2008-11#1)
injection analysis is##3##3##(2008-10#3)
injection analysis method for the determination of##2##7##(2008-10#2)
injection analysis method##3##3##(2008-10#3)
injection analysis of trace##2##4##(2008-10#2)
injection analysis of##25##3##(2008-10#25)
injection analysis system for##4##4##(2008-10#4)
injection analysis system with##2##4##(2008-10#2)
injection analysis system##16##3##(2008-10#16)
injection analysis technique##3##3##(2008-10#3)
injection analysis using##4##3##(2008-10#4)
injection analysis with##18##3##(2008-10#18)
injection analysis##238##2##(1992-11#1)(2008-10#234)(2008-11#2)(2008-9#1)
injection and sexual##2##3##(2013-8#2)
injection and##36##2##(1990-12#1)(1990-5#1)(1992-11#1)(1993-11#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
injection approach##7##2##(2008-10#6)(2010-5#1)
injection are##3##2##(1994-9#1)(2008-4#1)(2010-1#1)
injection as a##2##3##(2008-1#1)(2009-9#1)
injection assay##2##2##(2008-10#2)
injection at a##3##3##(2008-10#2)(2012-2#1)
injection at##10##2##(1994-5#1)(2008-10#2)(2008-6#2)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
injection by##4##2##(1993-12#1)(1994-9#1)(2008-10#1)(2012-3#1)
injection catalytic spectrophotometric##3##3##(2008-10#3)
injection catalytic##4##2##(2008-10#4)
injection chemiluminescence##15##2##(2008-10#15)
injection chromatographic##3##2##(2008-10#3)
injection combined with##2##3##(2011-2#1)(2012-3#1)
injection current##4##2##(2007-12#3)(2008-3#1)
injection determination of cobalt##2##4##(2008-10#2)
injection determination of##22##3##(2008-10#22)
injection determination##26##2##(2008-10#26)
injection did not##2##3##(2008-9#1)(2012-1#1)
injection drug use initiation##2##4##(2013-1#2)
injection drug use##5##3##(2007-4#2)(2012-1#1)(2013-1#2)
injection drug users##5##3##(1996-3#1)(2007-4#1)(2008-10#1)(2013-8#2)
injection drug##10##2##(1996-3#1)(2007-4#3)(2008-10#1)(2012-1#1)(2013-1#2)(2013-8#2)
injection electrogenerated##2##2##(2008-10#2)
injection electrospray mass spectrometry##2##4##(2008-7#2)
injection electrospray mass##3##3##(2008-7#3)
injection experiments##3##2##(1996-12#1)(2008-10#2)
injection flow rate##2##3##(2008-7#2)
injection flow##3##2##(2008-10#1)(2008-7#2)
injection fluorimetric determination##2##3##(2008-10#2)
injection fluorimetric##3##2##(2008-10#3)
injection for##8##2##(1991-3#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#2)
injection from##2##2##(2008-10#1)(2011-2#1)
injection groups##2##2##(2007-4#2)
injection hydride generation atomic absorption spectrometry##2##6##(2008-10#2)
injection hydride generation atomic absorption##3##5##(2008-10#3)
injection hydride generation atomic fluorescence spectrometry##2##6##(2008-10#2)
injection hydride generation atomic##5##4##(2008-10#5)
injection hydride generation##10##3##(2008-10#10)
injection in a##2##3##(2008-10#1)(2012-3#1)
injection in children##2##3##(2008-10#1)(2011-2#1)
injection in the##4##3##(1991-6#1)(1993-1#1)(1997-3#1)(2008-9#1)
injection in treatment of##2##4##(2008-7#1)(2013-1#1)
injection in##21##2##(1991-6#2)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1995-12#1)(1995-2#1)(1997-2#2)(1997-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#2)
injection inductively coupled plasma mass##2##5##(2008-10#2)
injection inductively coupled plasma##4##4##(2008-10#4)
injection initiation##4##2##(2013-1#4)
injection into a##4##3##(1990-4#1)(2008-10#3)
injection into the##11##3##(1994-12#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)
injection into##20##2##(1990-4#1)(1991-12#1)(1994-12#1)(1995-12#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2010-8#1)
injection is described##4##3##(2008-10#4)
injection is##10##2##(1992-10#1)(1994-9#1)(2008-10#6)(2011-2#2)
injection lab-on-valve##5##2##(2008-10#5)
injection liquid-liquid extraction##2##3##(2008-10#2)
injection loop##2##2##(2008-10#2)
injection manifold##8##2##(2008-10#8)
injection may##2##2##(2008-10#2)
injection method for the determination of##2##6##(2008-10#2)
injection method for the##7##4##(2008-10#7)
injection method for##9##3##(2008-10#9)
injection method has been developed for the##2##7##(2008-10#2)
injection method has been##3##4##(2008-10#3)
injection method is##6##3##(2008-10#5)(2011-2#1)
injection method##35##2##(1990-8#1)(1992-2#1)(1994-9#1)(2007-11#1)(2008-10#30)(2011-2#1)
injection methodology##2##2##(2008-10#2)
injection modalities##3##2##(2008-10#3)
injection mode##6##2##(2008-10#6)
injection model##4##2##(2007-10#4)
injection of 0##3##3##(1992-3#2)(2011-2#1)
injection of 10##2##3##(1990-2#1)(1994-12#1)
injection of 2##3##3##(1991-5#1)(1992-5#1)(2008-3#1)
injection of 200##2##3##(1995-3#1)(1995-5#1)
injection of 400##2##3##(2008-10#1)(2008-12#1)
injection of 5##3##3##(1992-3#1)(1997-6#1)(2008-4#1)
injection of 50 mg##2##4##(2008-10#2)
injection of 50##3##3##(1990-7#1)(2008-10#2)
injection of 500##2##3##(1995-12#1)(2008-10#1)
injection of 6-hydroxydopamine##4##3##(1992-10#1)(1995-12#1)(1995-5#1)(2008-7#1)
injection of AuTM (0##2##4##(1994-5#1)(1995-3#1)
injection of CCK-8##2##3##(1994-2#2)
injection of Cd##2##3##(2008-10#1)(2008-7#1)
injection of DNA##2##3##(1994-5#1)(2008-2#1)
injection of PGE2 at##3##4##(1997-2#3)
injection of a##13##3##(1990-6#1)(1992-12#1)(1993-1#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-6#1)(2013-8#1)
injection of bacterial##2##3##(1995-12#1)(2012-1#1)
injection of beta-AP(1-40) into NBM##2##5##(2008-8#2)
injection of beta-AP(1-40)##3##3##(2008-8#3)
injection of blood##3##3##(1990-8#1)(1993-10#1)(2011-2#1)
injection of botulinum toxin##2##4##(2008-10#1)(2012-3#1)
injection of butylated hydroxytoluene (BHT)##2##5##(1994-5#1)(1995-3#1)
injection of cells##2##3##(2008-1#1)(2011-1#1)
injection of corticosteroids##3##3##(1997-5#2)(2011-2#1)
injection of either 0##2##4##(1993-1#1)(1997-4#1)
injection of either##4##3##(1991-8#1)(1993-1#1)(1993-12#1)(1997-4#1)
injection of fluorescein##5##3##(2008-12#5)
injection of idazoxan##2##3##(1997-4#2)
injection of lipopolysaccharide##3##3##(1996-12#1)(1997-2#1)(2009-12#1)
injection of morphine##2##3##(1996-2#1)(1997-2#1)
injection of plasmid DNA##3##4##(1997-8#2)(2008-4#1)
injection of procaine##2##3##(1993-9#2)
injection of recombinant##2##3##(1990-12#1)(2008-7#1)
injection of sample##2##3##(2008-10#1)(2013-1#1)
injection of samples##2##3##(2008-10#2)
injection of segments of##2##4##(2008-10#2)
injection of substance P##2##4##(1994-8#2)
injection of the cells##2##4##(2008-1#1)(2008-11#1)
injection of the sample##3##4##(1994-9#1)(2008-10#1)(2009-8#1)
injection of the##25##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#3)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#2)(2009-8#1)(2011-1#1)
injection of thrombin##2##3##(2009-12#2)
injection of triamcinolone##2##3##(1992-5#1)(2010-12#1)
injection of##312##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#5)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#6)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#7)(1994-5#7)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#12)(1995-2#1)(1995-3#5)(1995-5#6)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#2)(1997-2#11)(1997-3#1)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#5)(2007-10#8)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#4)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#11)(2008-9#12)(2009-12#4)(2009-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#5)
injection on the##4##3##(2008-10#1)(2008-9#1)(2010-12#1)(2013-8#1)
injection on##6##2##(1993-11#1)(2008-10#2)(2008-9#1)(2010-12#1)(2013-8#1)
injection on-line dilution##2##3##(2008-10#2)
injection on-line solid phase##2##4##(2008-10#2)
injection on-line##12##2##(2008-10#12)
injection or##7##2##(1992-9#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
injection port##6##2##(2008-10#6)
injection potentiometric##4##2##(2008-10#4)
injection potentiometry by a##2##4##(2008-10#2)
injection potentiometry##9##2##(2008-10#9)
injection practices##2##2##(2007-4#2)
injection procedure##7##2##(2008-10#5)(2011-2#2)
injection protocols for multiple detector-row##2##5##(2008-7#2)
injection protocols##3##2##(2008-7#3)
injection rate##3##2##(2008-10#2)(2008-7#1)
injection resulted in a##2##4##(1993-6#1)(2013-7#1)
injection sample was##2##3##(2008-10#2)
injection samples##4##2##(2008-10#4)
injection seeded##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
injection significantly##2##2##(2008-10#1)(2008-8#1)
injection site reactions##2##3##(1996-8#1)(2008-8#1)
injection site##16##2##(1990-6#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#2)(2007-11#1)(2008-12#1)(2008-8#2)(2009-9#2)(2011-2#2)
injection sites##5##2##(1993-1#1)(2008-11#1)(2008-8#2)(2010-4#1)
injection spectrofluorimetry##2##2##(2008-10#2)
injection spectrophotometric assay of##2##4##(2008-10#2)
injection spectrophotometric determination of ritodrine hydrochloride##2##6##(2008-10#2)
injection spectrophotometric determination of trace amounts of##2##7##(2008-10#2)
injection spectrophotometric determination of trace##3##5##(2008-10#3)
injection spectrophotometric determination of##19##4##(2008-10#19)
injection spectrophotometric method for the determination of##4##7##(2008-10#4)
injection spectrophotometric method for the##6##5##(2008-10#6)
injection spectrophotometric method for##8##4##(2008-10#8)
injection spectrophotometric method##10##3##(2008-10#10)
injection spectrophotometric procedure##2##3##(2008-10#2)
injection spectrophotometric##35##2##(2008-10#35)
injection spectrophotometry##5##2##(2008-10#5)
injection studies##2##2##(1991-12#1)(2008-10#1)
injection system and##10##3##(2008-10#9)(2008-7#1)
injection system for the determination of##5##6##(2008-10#5)
injection system for the spectrophotometric determination of##2##7##(2008-10#2)
injection system for the##11##4##(2008-10#11)
injection system for##23##3##(2008-10#23)
injection system is##9##3##(2008-10#9)
injection system was##4##3##(2008-10#4)
injection system with in-line##2##4##(2008-10#2)
injection system with##17##3##(2008-10#17)
injection system##102##2##(2008-10#101)(2008-7#1)
injection systems##8##2##(2008-10#7)(2008-3#1)
injection technique for##4##3##(2008-10#4)
injection technique##15##2##(2008-10#13)(2008-7#1)(2009-4#1)
injection techniques##5##2##(1997-7#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
injection therapy with##2##3##(2013-1#2)
injection therapy##5##2##(1994-6#1)(2008-1#1)(2010-12#1)(2013-1#2)
injection throughput##3##2##(2008-10#3)
injection time##5##2##(2008-10#5)
injection titration##6##2##(2008-10#6)
injection to##6##2##(2008-10#2)(2008-8#1)(2011-2#2)(2012-1#1)
injection using##3##2##(2008-10#2)(2011-2#1)
injection valve and##2##3##(2008-10#2)
injection valve##9##2##(2008-10#9)
injection vapor generation##2##3##(2007-12#1)(2008-10#1)
injection volume of##11##3##(2008-10#10)(2008-5#1)
injection volume was##2##3##(2011-1#1)(2012-3#1)
injection volume##26##2##(1990-8#1)(1994-9#1)(2008-10#19)(2008-5#1)(2011-1#2)(2012-1#1)(2012-3#1)
injection volumes and##2##3##(2008-4#1)(2008-7#1)
injection volumes of##2##3##(2008-10#2)
injection volumes##5##2##(2008-10#3)(2008-4#1)(2008-7#1)
injection was##11##2##(1994-5#1)(1995-5#1)(2008-10#4)(2008-8#1)(2011-2#4)
injection were##2##2##(2008-10#1)(2011-2#1)
injection wetting film extraction##2##4##(2008-10#2)
injection wetting film##3##3##(2008-10#3)
injection with##17##2##(2008-10#13)(2008-11#1)(2008-8#1)(2008-9#2)
injection##1680##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#10)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#4)(1991-8#2)(1992-10#4)(1992-11#3)(1992-12#7)(1992-2#1)(1992-3#3)(1992-5#6)(1992-6#3)(1992-8#1)(1992-9#5)(1993-1#6)(1993-10#1)(1993-11#7)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#9)(1994-3#1)(1994-5#19)(1994-6#3)(1994-8#6)(1994-9#9)(1995-11#1)(1995-12#18)(1995-2#3)(1995-3#9)(1995-5#12)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#18)(1997-3#4)(1997-4#8)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#6)(2007-10#12)(2007-11#15)(2007-12#10)(2007-4#7)(2007-7#1)(2007-8#3)(2008-1#9)(2008-10#987)(2008-11#16)(2008-12#14)(2008-2#8)(2008-3#10)(2008-4#14)(2008-5#8)(2008-6#8)(2008-7#35)(2008-8#25)(2008-9#26)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#1)(2011-1#10)(2011-2#48)(2011-3#5)(2012-1#8)(2012-12#8)(2012-2#7)(2012-3#16)(2013-1#30)(2013-7#3)(2013-8#21)
injection)##8##1##(1992-5#2)(2008-10#4)(2008-3#1)(2011-1#1)
injection-chemiluminescence##2##1##(2008-10#2)
injection-current##3##1##(2007-12#2)(2008-2#1)
injection-hydride##6##1##(2008-10#6)
injection-locked diode laser##2##3##(2007-11#1)(2008-2#1)
injection-locked lasers##2##2##(2008-3#2)
injection-locked##9##1##(2007-11#1)(2008-2#2)(2008-3#6)
injection-seeded solid dye laser##2##4##(2007-12#2)
injection-seeded terahertz-wave parametric generator##2##4##(2007-11#2)
injection-seeded##6##1##(2007-11#2)(2007-12#2)(2008-3#2)
injection-site##2##1##(2008-11#2)
injection]##2##1##(1997-5#1)(2012-3#1)
injections (0##2##2##(1993-6#1)(1994-8#1)
injections and##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
injections at##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
injections during##2##2##(2008-10#1)(2008-5#1)
injections for##4##2##(2007-10#1)(2007-2#1)(2008-10#1)(2009-9#1)
injections from##2##2##(1997-6#1)(2008-10#1)
injections given##3##2##(1993-6#1)(1994-8#1)(2007-7#1)
injections h(-1) can be##2##4##(2008-10#2)
injections h(-1)##4##2##(2008-10#4)
injections had##2##2##(1994-8#1)(2011-1#1)
injections in the##4##3##(1996-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
injections in##11##2##(1991-2#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
injections into the##4##3##(1991-2#1)(1993-12#1)(1995-12#1)(1996-5#1)
injections into##8##2##(1990-9#1)(1991-2#2)(1992-10#1)(1993-12#1)(1995-12#1)(1996-5#1)(2008-11#1)
injections is##2##2##(1991-2#1)(2011-2#1)
injections of 0##2##3##(1992-5#1)(2008-10#1)
injections of 1##3##3##(1990-11#1)(1992-5#1)(2008-10#1)
injections of 10##3##3##(2008-10#3)
injections of 2##2##3##(2008-10#1)(2008-4#1)
injections of 5##2##3##(2008-10#2)
injections of Bevacizumab##2##3##(2011-2#2)
injections of a##9##3##(1994-8#1)(2008-10#6)(2013-1#2)
injections of botulinum toxin##2##4##(2009-3#1)(2012-3#1)
injections of bradykinin##2##3##(1990-7#2)
injections of cis-flupenthixol##2##3##(1993-6#2)
injections of cocaine##2##3##(2008-10#2)
injections of d-amphetamine facilitated retention##2##5##(1994-8#2)
injections of d-amphetamine##6##3##(1994-8#6)
injections of either##3##3##(1993-11#1)(1993-12#1)(1996-5#1)
injections of morphine sulfate##2##4##(1993-12#1)(1996-2#1)
injections of morphine##7##3##(1993-12#6)(1996-2#1)
injections of recombinant##2##3##(1990-12#1)(1995-12#1)
injections of saline##2##3##(1994-8#1)(2008-10#1)
injections of the##3##3##(1993-6#1)(1996-5#1)(1997-2#1)
injections of##111##2##(1990-11#1)(1990-12#2)(1990-7#2)(1991-12#3)(1991-2#1)(1992-10#1)(1992-11#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#10)(1993-3#1)(1993-6#3)(1993-9#1)(1994-5#1)(1994-8#9)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#3)(1997-2#3)(2006-10#1)(2007-11#1)(2008-10#26)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
injections per h##4##3##(2008-10#4)
injections per hour##3##3##(2008-10#3)
injections per##8##2##(2008-10#8)
injections to##2##2##(1994-8#1)(1996-7#1)
injections was##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
injections were##8##2##(1993-1#1)(1993-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2011-2#3)
injections with##2##2##(2008-7#1)(2008-9#1)
injections##252##1##(1990-11#1)(1990-12#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#7)(1992-10#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#14)(1993-3#2)(1993-5#1)(1993-6#6)(1993-9#1)(1994-5#2)(1994-6#1)(1994-8#16)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#4)(1996-7#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#2)(2007-11#4)(2007-2#1)(2007-4#3)(2007-7#1)(2008-10#65)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#6)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-1#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#20)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#5)
injections)##8##1##(1994-5#1)(2007-11#1)(2008-10#3)(2008-8#1)(2013-1#2)
injectisome##3##1##(2013-8#3)
injectisomes##4##1##(2013-8#4)
injector and the##2##3##(1995-6#1)(2008-10#1)
injector and##8##2##(1995-6#1)(2008-10#7)
injector##22##1##(1991-5#1)(1995-6#1)(2008-10#18)(2008-7#1)(2011-2#1)
injector-commutator##2##1##(2008-10#2)
injectors##5##1##(2007-4#3)(2011-2#2)
injunction against enforcement of##2##4##(1997-6#1)(1997-7#1)
injunction##4##1##(1995-6#2)(1997-6#1)(1997-7#1)
injunctive relief##2##2##(1995-12#2)
injunctive##3##1##(1995-12#2)(2012-12#1)
injure the##2##2##(2008-7#1)(2009-8#1)
injure##6##1##(1995-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
injured (n = 9) and sham-injured##2##6##(1993-12#2)
injured (n =##3##3##(1993-12#3)
injured and##2##2##(1997-6#1)(2010-1#1)
injured brain##2##2##(2008-5#1)(2008-7#1)
injured by##9##2##(1992-1#1)(1992-6#1)(1995-3#1)(2008-1#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)
injured cells##3##2##(2008-10#2)(2009-6#1)
injured in##6##2##(1990-9#1)(1995-8#1)(2007-2#1)(2012-3#1)(2013-1#2)
injured nerve##3##2##(1996-5#1)(1997-3#1)(2008-9#1)
injured or##2##2##(2008-4#2)
injured patient##2##2##(2008-7#1)(2013-8#1)
injured patients##4##2##(1990-9#1)(1996-1#1)(2008-7#1)(2012-12#1)
injured peripheral nerves##3##3##(2008-7#1)(2011-2#2)
injured resulted from##4##3##(2007-2#4)
injured site##2##2##(1993-12#1)(2008-7#1)
injured test nerve##2##3##(1997-3#2)
injured tissue##2##2##(2008-9#1)(2013-1#1)
injured tissues##2##2##(2008-9#2)
injured were##5##2##(1990-6#1)(1992-6#1)(2007-2#3)
injured##110##1##(1990-6#2)(1990-9#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#3)(1992-9#3)(1993-12#6)(1993-5#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#3)(1997-6#1)(2007-11#4)(2007-12#1)(2007-2#8)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#5)(2010-1#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#3)
injures##6##1##(1995-8#1)(2007-8#4)(2008-9#1)
injuries after blunt##2##3##(1990-9#2)
injuries among##5##2##(1992-6#1)(2008-12#2)(2011-2#1)(2013-1#1)
injuries and illnesses##3##3##(1993-12#1)(1993-3#2)
injuries and other##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
injuries and##29##2##(1990-6#1)(1991-6#3)(1992-6#1)(1993-12#1)(1993-3#2)(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#2)(2008-5#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
injuries are discussed##2##3##(2008-8#1)(2013-8#1)
injuries are##18##2##(1990-9#2)(1995-9#1)(2007-11#2)(2008-11#1)(2008-8#1)(2008-9#3)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
injuries associated with##4##3##(1994-5#2)(2007-11#1)(2012-2#1)
injuries at work##2##3##(2008-11#2)
injuries at##3##2##(2007-11#1)(2008-11#2)
injuries by##3##2##(1993-3#1)(2007-8#1)(2010-9#1)
injuries can##5##2##(1994-3#2)(2008-8#2)(2010-9#1)
injuries caused by##6##3##(1991-7#1)(1992-4#1)(1992-6#1)(1995-5#1)(1995-8#1)(1997-6#1)
injuries due to##2##3##(2008-8#1)(2012-12#1)
injuries during##3##2##(1990-6#1)(1996-2#1)(2007-8#1)
injuries from##6##2##(1991-3#1)(1992-2#1)(1992-6#2)(2008-1#2)
injuries has been##2##3##(1990-6#1)(1994-5#1)
injuries have been##2##3##(2011-2#1)(2013-1#1)
injuries have##5##2##(1996-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
injuries in a##2##3##(2008-7#1)(2009-10#1)
injuries in children##5##3##(1992-4#1)(2008-10#1)(2008-11#1)(2013-1#2)
injuries in health care##2##4##(1996-1#1)(2007-7#1)
injuries in the##8##3##(1994-8#1)(2007-8#1)(2008-8#2)(2009-7#1)(2013-1#3)
injuries in##35##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-4#4)(1992-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-7#2)(2011-2#1)(2013-1#9)
injuries involving the##2##3##(2010-1#1)(2013-1#1)
injuries is not##2##3##(2008-7#1)(2008-9#1)
injuries is##9##2##(1990-6#1)(1990-9#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
injuries may##2##2##(2011-2#1)(2012-12#1)
injuries occur##4##2##(1990-6#1)(2008-9#2)(2012-12#1)
injuries of the##8##3##(2007-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#4)
injuries of##9##2##(1991-6#1)(2007-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#4)
injuries or##3##2##(1993-12#1)(1995-3#1)(2007-8#1)
injuries per 1##2##3##(1990-6#1)(1995-8#1)
injuries per##3##2##(1990-6#1)(1995-8#1)(2008-6#1)
injuries such as##2##3##(2007-12#1)(2012-2#1)
injuries that##4##2##(2008-9#1)(2009-7#1)(2011-2#2)
injuries to the##11##3##(1992-6#1)(1995-9#3)(2007-8#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#2)
injuries to##19##2##(1990-6#1)(1992-6#1)(1994-11#1)(1995-9#3)(2007-4#1)(2007-8#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
injuries were identified##3##3##(1995-3#1)(2010-1#1)(2012-12#1)
injuries were##9##2##(1990-2#2)(1990-6#1)(1995-3#1)(1997-6#1)(2008-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
injuries##389##1##(1990-2#6)(1990-3#1)(1990-6#16)(1990-9#8)(1991-11#1)(1991-12#2)(1991-3#4)(1991-6#9)(1991-7#1)(1992-2#2)(1992-4#7)(1992-6#16)(1992-9#1)(1993-12#2)(1993-3#4)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#4)(1995-5#1)(1995-8#4)(1995-9#5)(1996-1#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#3)(1997-2#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-11#11)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#22)(2008-1#8)(2008-10#8)(2008-11#10)(2008-12#9)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#19)(2009-10#2)(2009-3#3)(2009-6#2)(2009-7#4)(2010-1#6)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#7)(2011-1#7)(2011-2#27)(2012-1#3)(2012-12#13)(2012-2#14)(2012-3#2)(2013-1#33)(2013-7#1)(2013-8#8)
injuries)##2##1##(2008-4#1)(2010-9#1)
injuries--a##2##1##(1996-3#1)(2008-10#1)
injuries]##12##1##(1990-2#2)(1990-6#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-8#1)
injurious##5##1##(1991-9#1)(1993-12#1)(1996-9#1)(2008-7#1)(2012-3#1)
injury (CCI)##3##2##(1996-5#2)(1997-2#1)
injury after##9##2##(1995-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
injury among##3##2##(1991-8#1)(2008-8#1)(2012-12#1)
injury and disease##3##3##(1997-3#1)(2008-1#1)(2008-7#1)
injury and dysfunction##2##3##(2008-8#1)(2010-8#1)
injury and ill-health and the##2##5##(2008-11#2)
injury and ill-health in##3##4##(2008-11#3)
injury and ill-health##5##3##(2008-11#5)
injury and illness##2##3##(1993-12#1)(1993-3#1)
injury and in the##4##4##(1995-2#1)(1997-8#1)(2007-8#1)(2013-8#1)
injury and in##5##3##(1995-2#1)(1997-8#1)(2007-8#1)(2013-1#1)(2013-8#1)
injury and repair##2##3##(2008-10#1)(2008-4#1)
injury and small animals##2##4##(2011-2#2)
injury and stroke##2##3##(2008-8#1)(2011-2#1)
injury and the##7##3##(1991-9#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-1#2)
injury and to##2##3##(1994-11#1)(2013-1#1)
injury and##74##2##(1991-9#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-3#3)(1997-7#2)(1997-8#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-4#1)(2008-7#6)(2008-8#4)(2009-7#1)(2010-1#2)(2010-4#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#7)(2013-8#2)
injury appears to##3##3##(1994-5#1)(2008-9#1)(2012-3#1)
injury are##4##2##(1993-12#1)(2008-12#1)(2010-11#1)(2011-7#1)
injury as a##6##3##(1994-3#2)(2008-11#1)(2008-7#2)(2011-2#1)
injury as well as##3##4##(2010-3#1)(2011-2#1)(2013-8#1)
injury as well##4##3##(1995-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
injury as##11##2##(1994-3#2)(1995-11#1)(1995-12#1)(2008-11#1)(2008-7#2)(2010-3#1)(2011-2#2)(2013-8#1)
injury associated with##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
injury associated##4##2##(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
injury at##3##2##(1991-11#1)(2011-2#1)(2013-1#1)
injury but##2##2##(2008-7#1)(2009-3#1)
injury by##9##2##(1991-9#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-9#2)(1997-8#1)(2008-11#1)(2013-1#1)
injury can be##2##3##(1991-9#1)(2013-1#1)
injury can##4##2##(1991-9#1)(2011-2#2)(2013-1#1)
injury caused by##4##3##(2008-1#1)(2008-7#1)(2013-1#1)(2013-8#1)
injury caused##7##2##(1991-9#1)(2008-1#1)(2008-7#2)(2013-1#2)(2013-8#1)
injury compensation##2##2##(2008-9#2)
injury due to##5##3##(2007-8#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
injury during a##2##3##(2010-5#1)(2012-12#1)
injury during the##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
injury during##9##2##(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
injury following##6##2##(1991-9#2)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
injury from##6##2##(1995-11#2)(2006-10#1)(2007-10#1)(2008-10#1)(2008-9#1)
injury has##3##2##(1992-6#1)(1994-12#1)(2010-3#1)
injury in a rat model##2##5##(1995-12#1)(2012-2#1)
injury in a##8##3##(1995-12#1)(2007-12#1)(2008-9#1)(2012-2#2)(2013-1#3)
injury in diabetic##2##3##(2010-12#1)(2012-12#1)
injury in human##2##3##(2013-1#1)(2013-8#1)
injury in man##2##3##(1990-3#1)(1993-12#1)
injury in patients##2##3##(2006-10#1)(2007-10#1)
injury in rats##6##3##(1993-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-7#1)
injury in the rat##3##4##(1995-12#2)(2012-2#1)
injury in the##8##3##(1995-11#1)(1995-12#2)(1996-12#1)(2007-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
injury in these##2##3##(1995-11#1)(2010-8#1)
injury in##75##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-12#2)(1994-5#1)(1995-11#4)(1995-12#3)(1996-12#1)(1996-6#3)(1996-9#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#8)(2013-8#1)
injury induced by##6##3##(1995-12#3)(2008-9#1)(2010-12#1)(2012-2#1)
injury is a##7##3##(1995-12#2)(2007-8#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)
injury is an##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
injury is associated with##2##4##(2009-9#1)(2012-2#1)
injury is not##2##3##(1995-11#1)(2008-11#1)
injury is##31##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-9#2)(1994-2#1)(1995-11#2)(1995-12#2)(1997-8#1)(2007-8#2)(2008-11#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)
injury leading to##2##3##(2007-8#1)(2010-4#1)
injury level of##2##3##(2008-8#1)(2011-2#1)
injury level##4##2##(2008-8#1)(2011-2#2)(2013-1#1)
injury may be associated with##2##5##(2011-2#2)
injury may be##4##3##(2008-12#1)(2008-7#1)(2011-2#2)
injury may##6##2##(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
injury mechanisms##4##2##(1990-6#1)(2010-1#3)
injury mediated by##2##3##(1991-9#1)(1995-11#1)
injury mediated##3##2##(1991-9#1)(1995-11#1)(2008-9#1)
injury models##2##2##(2008-7#1)(2012-3#1)
injury occurred##4##2##(1991-12#1)(1993-12#1)(2008-10#1)(2013-1#1)
injury occurs##2##2##(1992-9#1)(2010-8#1)
injury of his##2##3##(2008-7#1)(2010-8#1)
injury of the##8##3##(2007-8#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
injury of##18##2##(1991-12#1)(1991-9#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-3#1)(2010-11#1)(2010-8#2)(2012-2#2)(2013-1#2)
injury on the##2##3##(1990-7#1)(1993-12#1)
injury on##8##2##(1990-7#1)(1991-12#1)(1993-12#1)(2007-11#1)(2008-9#3)(2012-2#1)
injury or##4##2##(1993-12#1)(1993-5#1)(2009-2#1)(2011-2#1)
injury overall##2##2##(2008-7#1)(2012-2#1)
injury patient##2##2##(2008-10#1)(2012-2#1)
injury patients##2##2##(2008-8#1)(2012-2#1)
injury pattern##2##2##(2013-1#2)
injury prevention##6##2##(1995-12#1)(2007-11#1)(2008-11#1)(2008-12#3)
injury rate among##2##3##(1997-2#1)(2012-12#1)
injury rate##6##2##(1997-2#1)(2008-11#3)(2012-12#2)
injury rehabilitation##3##2##(1992-3#1)(1994-12#1)(2011-1#1)
injury remains a##2##3##(2010-12#1)(2011-2#1)
injury remains##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
injury require##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
injury resulting in##2##3##(2007-11#1)(2011-2#1)
injury resulting##3##2##(2007-11#1)(2011-2#1)(2012-1#1)
injury secondary to##2##3##(2008-7#1)(2013-8#1)
injury severity##2##2##(2010-1#1)(2011-2#1)
injury showed##2##2##(2007-11#1)(2008-9#1)
injury such as##2##3##(2008-1#1)(2008-8#1)
injury such##3##2##(2008-1#1)(2008-8#2)
injury surveillance##3##2##(2007-11#2)(2008-12#1)
injury than##3##2##(1996-5#2)(2013-8#1)
injury that is seen##2##4##(1992-4#1)(2013-1#1)
injury that is##3##3##(1992-4#1)(2007-8#1)(2013-1#1)
injury that##9##2##(1992-4#1)(1992-6#1)(1995-12#1)(2007-8#1)(2008-9#2)(2013-1#2)(2013-8#1)
injury through##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
injury to the brain##2##4##(1995-5#1)(2009-10#1)
injury to the##21##3##(1990-9#1)(1994-2#1)(1995-12#2)(1995-5#1)(2007-8#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#3)
injury to##38##2##(1990-9#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-12#3)(1995-5#1)(1996-2#1)(1996-8#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
injury using the##2##3##(1990-7#1)(2008-12#1)
injury using##3##2##(1990-7#1)(2008-12#1)(2008-8#1)
injury was induced##2##3##(2007-8#1)(2008-7#1)
injury was not##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
injury was observed in##2##4##(1994-7#1)(1995-2#1)
injury was observed##3##3##(1992-12#1)(1994-7#1)(1995-2#1)
injury was##30##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-6#2)(1994-7#1)(1995-2#1)(1996-11#1)(1996-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#3)(2008-9#1)(2009-3#1)(2012-2#3)(2013-1#3)
injury were##4##2##(1994-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
injury which##2##2##(1996-2#1)(2010-7#1)
injury while##2##2##(1992-2#1)(2013-1#1)
injury who##2##2##(2008-7#1)(2013-8#1)
injury with a##2##3##(1996-6#1)(2012-2#1)
injury with the##2##3##(1992-6#1)(2009-11#1)
injury with##15##2##(1991-6#1)(1992-6#1)(1995-11#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
injury##981##1##(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#5)(1990-9#2)(1991-11#3)(1991-12#10)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#2)(1991-9#19)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#11)(1992-9#7)(1993-10#3)(1993-12#14)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#16)(1994-6#2)(1994-7#2)(1995-1#3)(1995-10#1)(1995-11#19)(1995-12#23)(1995-2#6)(1995-3#5)(1995-5#4)(1995-6#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#8)(1996-6#6)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#9)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#5)(2007-10#11)(2007-11#20)(2007-12#4)(2007-7#2)(2007-8#27)(2007-9#2)(2008-1#11)(2008-10#25)(2008-11#23)(2008-12#24)(2008-2#4)(2008-4#11)(2008-5#7)(2008-6#4)(2008-7#78)(2008-8#33)(2008-9#52)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#10)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#16)(2010-10#2)(2010-11#3)(2010-12#8)(2010-3#7)(2010-4#3)(2010-5#7)(2010-6#1)(2010-7#6)(2010-8#14)(2010-9#4)(2011-1#5)(2011-10#1)(2011-2#49)(2011-7#3)(2012-1#6)(2012-12#21)(2012-2#44)(2012-3#30)(2012-7#2)(2012-9#1)(2013-1#83)(2013-7#3)(2013-8#22)
injury-related##3##1##(1993-9#1)(1997-3#1)(2009-9#1)
injury]##3##1##(1993-3#1)(2012-2#1)(2012-3#1)
injustice in##2##2##(2009-6#2)
injustice##4##1##(2009-6#2)(2010-12#1)(2010-7#1)
ink##10##1##(2008-10#8)(2008-5#1)(2013-8#1)
inkpads##2##1##(2008-10#2)
inks and##3##2##(2008-10#1)(2008-9#2)
inks##14##1##(2008-10#10)(2008-5#1)(2008-9#3)
inland and##2##2##(2008-2#1)(2008-3#1)
inland cultivated sites##2##3##(2008-10#2)
inland population##2##2##(2013-1#2)
inland populations##2##2##(2013-7#2)
inland##20##1##(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#4)(2010-6#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#3)(2013-8#1)
inlay##2##1##(2008-10#1)(2009-5#1)
inlet and outlet##2##3##(2008-10#1)(2009-11#1)
inlet and##7##2##(1990-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)
inlet##23##1##(1990-3#1)(1990-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2011-2#1)
inlet)##3##1##(2008-11#2)(2013-1#1)
inmates in##2##2##(2008-9#1)(2012-3#1)
inmates##11##1##(1992-2#2)(1997-5#5)(2008-9#1)(2009-11#2)(2012-3#1)
innate and adaptive immune responses##3##5##(2010-10#1)(2010-5#1)(2013-8#1)
innate and adaptive responses##2##4##(2006-10#2)
innate and adaptive##7##3##(2006-10#2)(2008-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2013-8#1)
innate and##11##2##(2006-10#3)(2008-10#1)(2008-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2013-7#1)(2013-8#2)
innate antiviral##2##2##(2013-1#2)
innate immune defense##2##3##(2009-6#1)(2012-3#1)
innate immune response to##2##4##(2010-1#1)(2013-7#1)
innate immune response##5##3##(2008-3#1)(2010-1#2)(2013-7#1)(2013-8#1)
innate immune responses##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
innate immune system and##2##4##(2006-10#1)(2010-8#1)
innate immune system##13##3##(2006-10#1)(2008-10#2)(2008-4#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
innate immune##28##2##(2006-10#1)(2008-10#4)(2008-3#1)(2008-4#2)(2009-3#1)(2009-6#2)(2010-1#3)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
innate immunity and##3##3##(2008-9#1)(2012-3#2)
innate immunity##12##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#2)(2012-3#3)(2013-1#1)
innate mechanisms##2##2##(2008-5#1)(2013-1#1)
innate##72##1##(2006-10#4)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#5)(2010-10#1)(2010-5#1)(2010-8#3)(2011-10#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#7)(2013-1#6)(2013-7#2)(2013-8#5)
innately##3##1##(1996-11#1)(2008-6#1)(2011-2#1)
inner and outer##6##3##(1990-11#2)(1991-10#1)(1996-5#1)(2011-2#1)(2013-8#1)
inner and##7##2##(1990-11#2)(1991-10#1)(1996-5#1)(2011-2#2)(2013-8#1)
inner arm##3##2##(1991-2#2)(2008-5#1)
inner cell mass##4##3##(2008-5#1)(2008-9#2)(2013-8#1)
inner cell##6##2##(2008-10#1)(2008-5#1)(2008-9#2)(2010-11#1)(2013-8#1)
inner city##7##2##(1991-1#1)(1996-8#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
inner contacts##3##2##(2008-10#3)
inner core##9##2##(1995-3#4)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#2)
inner cortex and stele tissues##3##5##(2008-10#3)
inner diameter of##4##3##(2007-12#2)(2008-2#1)(2012-2#1)
inner diameter##9##2##(1994-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2012-2#1)
inner ear malformations##2##3##(2011-1#2)
inner ear##19##2##(1993-9#1)(1994-9#2)(1995-5#4)(2006-12#1)(2008-4#2)(2008-9#2)(2009-9#1)(2011-1#3)(2011-2#1)(2013-1#2)
inner layer##6##2##(2008-10#2)(2008-12#2)(2008-8#1)(2010-2#1)
inner layers##3##2##(2008-10#1)(2010-8#2)
inner membrane proteins##2##3##(2008-4#1)(2011-2#1)
inner membrane##17##2##(1990-2#2)(1991-10#1)(1992-6#1)(1992-7#2)(1994-5#1)(1994-8#2)(1995-2#1)(1997-8#1)(2008-4#1)(2009-6#1)(2010-2#1)(2011-2#2)(2013-8#1)
inner membranes##2##2##(1994-5#1)(1995-12#1)
inner mitochondrial membranes##3##3##(1994-5#1)(1995-12#2)
inner mitochondrial##9##2##(1990-11#1)(1993-6#2)(1994-5#1)(1995-12#2)(1995-2#1)(1996-2#1)(2012-2#1)
inner monolayer##2##2##(1990-11#1)(1992-6#1)
inner nuclear membrane##4##3##(2007-12#1)(2008-9#1)(2011-2#2)
inner nuclear##6##2##(1991-10#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#2)
inner or outer##2##3##(1994-12#1)(2010-5#1)
inner preputial##2##2##(2008-10#2)
inner retina##2##2##(1990-11#1)(2008-9#1)
inner sensillum-lymph##2##2##(2007-12#2)
inner shell capsid##2##3##(2008-8#2)
inner shell##3##2##(2008-8#3)
inner structure##2##2##(1995-8#1)(2007-12#1)
inner surface##12##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#1)
inner volume##2##2##(2008-10#2)
inner wall of##5##3##(2007-8#1)(2008-10#4)
inner wall##10##2##(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-9#1)(2009-6#1)
inner##235##1##(1990-11#8)(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-10#4)(1991-2#4)(1991-5#4)(1992-3#1)(1992-6#2)(1992-7#2)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#2)(1994-5#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-12#3)(1995-2#2)(1995-3#6)(1995-5#4)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#13)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#47)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#5)(2008-4#5)(2008-5#6)(2008-8#14)(2008-9#8)(2009-6#4)(2009-9#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#12)(2012-2#3)(2013-1#3)(2013-8#5)
inner-city minority children##2##3##(2009-11#2)
inner-city minority##4##2##(2009-11#2)(2011-1#2)
inner-city##9##1##(1991-1#1)(1995-2#1)(2007-10#1)(2008-10#1)(2009-11#3)(2011-1#2)
inner-edge polarization can##2##3##(2008-2#2)
inner-edge polarization##4##2##(2008-2#4)
inner-sphere##2##1##(1993-11#1)(1997-7#1)
innermost chorionic layer is##2##4##(2007-12#2)
innermost chorionic layer##4##3##(2007-12#4)
innermost##11##1##(1990-3#2)(1994-5#1)(2007-12#4)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
innervate##4##1##(1994-2#1)(1997-7#1)(2008-2#1)(2013-1#1)
innervated by the##6##3##(1997-3#2)(2007-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
innervated by##12##2##(1994-9#1)(1996-2#1)(1997-3#3)(2007-12#4)(2008-12#1)(2008-9#1)(2011-2#1)
innervated##18##1##(1991-12#1)(1994-9#2)(1996-2#1)(1996-5#1)(1997-3#3)(1997-4#1)(2007-12#5)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
innervating the##5##2##(1992-12#1)(1997-2#1)(2007-12#3)
innervating##10##1##(1992-12#1)(1996-2#1)(1997-2#2)(2007-12#5)(2008-8#1)
innervation and##3##2##(1991-12#1)(1992-6#1)(2012-2#1)
innervation density##2##2##(1996-6#2)
innervation from##3##2##(1993-12#1)(1996-5#1)(2007-12#1)
innervation in the##2##3##(1994-12#1)(2007-12#1)
innervation in##4##2##(1994-12#1)(1995-12#1)(2007-12#1)(2008-7#1)
innervation is##2##2##(1994-5#1)(2008-5#1)
innervation of NXIIts##2##3##(2008-8#2)
innervation of the guinea pig extraocular muscles##2##7##(1997-3#2)
innervation of the##14##3##(1990-7#1)(1992-6#2)(1994-5#1)(1996-5#2)(1996-6#1)(1997-3#2)(2007-12#3)(2012-1#1)(2013-8#1)
innervation of##21##2##(1990-7#1)(1992-6#3)(1993-5#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-5#2)(1996-6#1)(1997-3#2)(2007-12#3)(2008-8#2)(2012-1#1)(2013-8#2)
innervation pattern of the##2##4##(2007-12#2)
innervation pattern of##3##3##(2007-12#2)(2013-1#1)
innervation##63##1##(1990-7#1)(1991-12#1)(1992-6#5)(1993-12#1)(1993-5#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#5)(1994-9#1)(1995-12#2)(1995-3#1)(1996-5#4)(1996-6#4)(1997-3#2)(2007-12#12)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
innervations##2##1##(2008-7#1)(2012-3#1)
innexins##2##1##(2008-7#2)
innocent##3##1##(1995-6#1)(1997-1#1)(2009-9#1)
innocuous or##2##2##(2008-4#1)(2011-2#1)
innocuous##11##1##(1991-12#2)(1996-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#3)
innovate##3##1##(1995-12#1)(2008-12#1)(2011-2#1)
innovated##2##1##(2012-3#1)(2013-1#1)
innovating##2##1##(1995-1#1)(2010-10#1)
innovation and##8##2##(1994-1#1)(1994-12#1)(1995-1#2)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
innovation at##3##2##(1996-1#1)(2008-12#1)(2008-9#1)
innovation in##9##2##(1991-1#1)(1995-1#2)(2008-1#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-3#1)
innovation of##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
innovation that##2##2##(2008-11#1)(2008-12#1)
innovation##66##1##(1991-1#5)(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#8)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
innovations and##3##2##(2008-7#1)(2013-8#2)
innovations are##2##2##(2007-12#1)(2008-3#1)
innovations have##2##2##(1992-2#1)(1995-1#1)
innovations in##7##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-8#1)
innovations that are##2##3##(2009-12#1)(2010-8#1)
innovations that##4##2##(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
innovations##32##1##(1992-2#1)(1992-3#1)(1995-1#2)(1997-2#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
innovative and##9##2##(1991-12#1)(1992-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
innovative approach to##4##3##(1992-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
innovative approach##9##2##(1992-1#1)(1992-12#1)(1992-8#1)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
innovative approaches to##4##3##(1996-1#1)(1996-3#1)(2008-4#1)(2012-2#1)
innovative developments##2##2##(2010-11#1)(2011-2#1)
innovative features##2##2##(2008-11#1)(2009-12#1)
innovative health##2##2##(1994-2#1)(1996-1#1)
innovative items##2##2##(2010-3#2)
innovative medical##2##2##(2010-11#1)(2012-3#1)
innovative method for##2##3##(2007-11#1)(2008-4#1)
innovative method##3##2##(1991-2#1)(2007-11#1)(2008-4#1)
innovative methods##2##2##(2008-11#1)(2008-2#1)
innovative new##2##2##(2008-5#1)(2012-12#1)
innovative paediatric##2##2##(2012-12#2)
innovative project##2##2##(2008-12#2)
innovative responses##2##2##(1994-2#1)(2012-2#1)
innovative revenue generation##2##3##(1991-12#2)
innovative strategies##2##2##(2010-3#1)(2012-3#1)
innovative technique##3##2##(2007-11#1)(2008-7#1)(2010-6#1)
innovative way to##2##3##(2009-8#1)(2010-3#1)
innovative way##3##2##(1992-5#1)(2009-8#1)(2010-3#1)
innovative##145##1##(1991-12#3)(1991-2#2)(1992-1#2)(1992-12#3)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#10)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#9)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)
innovator##2##1##(1995-1#1)(2010-5#1)
inocula of##4##2##(2008-10#2)(2008-5#2)
inocula to##2##2##(2008-10#2)
inocula##30##1##(1995-2#2)(2008-10#22)(2008-5#5)(2008-7#1)
inoculant##6##1##(2008-10#4)(2011-2#1)(2012-2#1)
inoculants##6##1##(2008-10#3)(2012-2#3)
inoculate plants##2##2##(2008-10#2)
inoculate##11##1##(2008-10#8)(2008-11#1)(2008-9#2)
inoculated 10##2##2##(2008-10#2)
inoculated 4##2##2##(2008-10#2)
inoculated after##3##2##(2008-10#3)
inoculated and uninoculated##3##3##(2008-10#3)
inoculated and##14##2##(2008-10#13)(2011-10#1)
inoculated artificially with##3##3##(1997-4#1)(2008-10#2)
inoculated at 2 million##2##4##(2008-11#2)
inoculated at bloom##2##3##(2008-10#2)
inoculated at the##6##3##(2008-10#6)
inoculated at##23##2##(2007-6#1)(2008-10#19)(2008-11#3)
inoculated by##5##2##(2008-10#5)
inoculated controls##2##2##(2008-10#2)
inoculated fruit were##2##3##(2008-10#2)
inoculated in the greenhouse##3##4##(2008-10#3)
inoculated in the##4##3##(2008-10#4)
inoculated in##14##2##(1997-4#1)(2008-10#10)(2008-5#3)
inoculated into the##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
inoculated into##7##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
inoculated intradermally##2##2##(1991-8#1)(2008-12#1)
inoculated intramuscularly##2##2##(1991-8#1)(2008-5#1)
inoculated isolates##7##2##(2008-10#7)
inoculated leaf##8##2##(2008-10#8)
inoculated leaves and##3##3##(2008-10#2)(2008-5#1)
inoculated leaves were##2##3##(2008-10#2)
inoculated leaves##19##2##(2008-10#16)(2008-5#1)(2008-8#2)
inoculated on the##3##3##(2008-10#3)
inoculated on##8##2##(1994-9#1)(2008-10#7)
inoculated one##2##2##(2008-10#2)
inoculated only with##2##3##(2008-10#1)(2012-3#1)
inoculated onto a##3##3##(2008-10#3)
inoculated onto##12##2##(2007-12#1)(2008-10#8)(2008-8#1)(2011-2#1)(2012-2#1)
inoculated or##2##2##(2008-10#2)
inoculated plant##2##2##(2008-10#2)
inoculated plants and##2##3##(2008-10#2)
inoculated plants to##2##3##(2008-10#2)
inoculated plants##18##2##(2008-10#17)(2008-5#1)
inoculated plots##4##2##(2008-10#4)
inoculated seedlings##3##2##(2008-10#3)
inoculated separately##2##2##(2008-10#2)
inoculated to##5##2##(2008-10#5)
inoculated trees##4##2##(2008-10#4)
inoculated with 1##2##3##(2008-10#2)
inoculated with A##2##3##(2008-10#2)
inoculated with B##2##3##(2008-10#2)
inoculated with C##2##3##(2008-10#1)(2013-1#1)
inoculated with E##2##3##(2008-10#2)
inoculated with Fusarium##2##3##(2008-10#2)
inoculated with GINV##2##3##(2008-10#2)
inoculated with M##4##3##(2008-10#4)
inoculated with P##6##3##(2008-10#6)
inoculated with R##3##3##(2008-10#3)
inoculated with Trichoderma hamatum 382##2##5##(2008-10#2)
inoculated with V##2##3##(2008-10#2)
inoculated with a mixture of##3##5##(2008-10#3)
inoculated with a##16##3##(2008-10#14)(2008-12#1)(2011-2#1)
inoculated with an##3##3##(2008-10#3)
inoculated with conidia of##3##4##(2008-10#3)
inoculated with conidial suspensions##3##4##(2008-10#3)
inoculated with either##4##3##(2008-10#4)
inoculated with in vitro transcripts##2##5##(2008-10#2)
inoculated with isolates of morphotype A##2##6##(2008-10#2)
inoculated with isolates of##3##4##(2008-10#3)
inoculated with isolates##4##3##(2008-10#4)
inoculated with one of##3##4##(1997-3#1)(2008-10#2)
inoculated with one##4##3##(1997-3#1)(2008-10#3)
inoculated with race##2##3##(2008-10#2)
inoculated with the nematode##2##4##(2008-10#2)
inoculated with the pathogen##3##4##(2008-10#3)
inoculated with the##24##3##(1995-12#1)(2008-10#19)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)
inoculated with two##4##3##(2008-10#4)
inoculated with urediniospores##2##3##(2008-10#2)
inoculated with wild-type isolates##2##4##(2008-10#2)
inoculated with##180##2##(1991-3#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-6#2)(2008-10#151)(2008-11#1)(2008-12#5)(2008-5#5)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
inoculated within##2##2##(2008-10#2)
inoculated##478##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-2#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-3#2)(1997-4#2)(1997-6#4)(2007-12#1)(2007-6#1)(2008-10#396)(2008-11#6)(2008-12#7)(2008-5#20)(2008-7#2)(2008-8#4)(2008-9#1)(2009-6#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)
inoculating detached##2##2##(2008-10#2)
inoculating the##3##2##(1997-8#1)(2008-10#2)
inoculating##19##1##(1997-8#1)(2008-10#12)(2008-2#2)(2008-8#1)(2008-9#2)(2012-2#1)
inoculation access period##3##3##(2008-10#3)
inoculation access##4##2##(2008-10#4)
inoculation and##19##2##(2008-10#16)(2008-9#2)(2013-1#1)
inoculation assays##3##2##(2008-10#3)
inoculation at##3##2##(2008-10#3)
inoculation by##5##2##(1997-3#1)(2008-10#4)
inoculation date##2##2##(2008-10#2)
inoculation dates##2##2##(2008-10#2)
inoculation developed##2##2##(2008-10#2)
inoculation did not##2##3##(2008-10#2)
inoculation experiments in##3##3##(2008-10#3)
inoculation experiments##5##2##(2008-10#5)
inoculation in the##2##3##(2008-10#1)(2012-3#1)
inoculation in##14##2##(2007-10#1)(2008-10#12)(2012-3#1)
inoculation method##4##2##(2008-10#3)(2008-8#1)
inoculation methods##10##2##(2008-10#10)
inoculation of leaves##4##3##(2008-10#4)
inoculation of plants##2##3##(2008-10#2)
inoculation of the##8##3##(2008-10#7)(2008-5#1)
inoculation of##53##2##(1997-3#1)(1997-6#1)(2008-10#41)(2008-11#1)(2008-5#4)(2008-8#2)(2008-9#2)(2013-1#1)
inoculation on the##3##3##(2008-10#3)
inoculation on##10##2##(2008-10#10)
inoculation onto##2##2##(2008-10#2)
inoculation or##3##2##(2008-10#3)
inoculation period##4##2##(2008-10#4)
inoculation pressure##3##2##(2008-10#3)
inoculation rate##4##2##(2008-4#1)(2012-12#3)
inoculation resulted in##3##3##(2008-10#2)(2008-11#1)
inoculation site##6##2##(2007-2#1)(2008-10#5)
inoculation sites##4##2##(1992-2#1)(2008-10#3)
inoculation studies##4##2##(2008-10#4)
inoculation technique##4##2##(2008-10#4)
inoculation tests##5##2##(2008-10#5)
inoculation time##5##2##(2008-10#1)(2008-5#4)
inoculation times##2##2##(2008-10#1)(2008-5#1)
inoculation to##10##2##(2008-10#9)(2008-11#1)
inoculation was##9##2##(2008-10#9)
inoculation were##5##2##(2008-10#4)(2008-5#1)
inoculation with B##3##3##(2008-10#3)
inoculation with C##2##3##(2008-10#2)
inoculation with V##2##3##(2008-10#2)
inoculation with a##2##3##(2008-10#2)
inoculation with nonpathogenic spores##2##4##(2008-10#2)
inoculation with the pathogen##7##4##(2008-10#7)
inoculation with the##12##3##(1991-3#1)(2008-10#11)
inoculation with##57##2##(1991-3#1)(1997-6#3)(2008-10#52)(2011-2#1)
inoculation zones and##2##3##(2008-10#2)
inoculation##493##1##(1991-3#1)(1992-2#2)(1993-8#2)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#2)(1997-6#4)(2007-10#1)(2007-2#1)(2008-10#431)(2008-11#7)(2008-12#2)(2008-4#2)(2008-5#13)(2008-8#7)(2008-9#7)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
inoculation) will detect##2##3##(2008-10#2)
inoculation)##11##1##(2008-10#11)
inoculations demonstrated that##3##3##(2008-10#3)
inoculations of##8##2##(2008-10#8)
inoculations per##2##2##(2008-10#2)
inoculations were##4##2##(2008-10#4)
inoculations with##8##2##(2008-10#7)(2008-5#1)
inoculations##42##1##(2008-10#41)(2008-5#1)
inoculative##2##1##(2008-10#2)
inoculum and weather variables##2##4##(2008-10#2)
inoculum and weather##3##3##(2008-10#3)
inoculum and##16##2##(2008-10#16)
inoculum associated with##2##3##(2008-10#2)
inoculum at##2##2##(2008-10#1)(2008-11#1)
inoculum availability##5##2##(2008-10#4)(2008-12#1)
inoculum concentration##9##2##(1994-5#1)(2008-10#8)
inoculum concentrations were##2##3##(2008-10#2)
inoculum concentrations##5##2##(2008-10#5)
inoculum consisted of##2##3##(2008-10#2)
inoculum decay##2##2##(2008-10#2)
inoculum densities of the pathogen##2##5##(2008-10#2)
inoculum densities##10##2##(2008-10#10)
inoculum density and the##2##4##(2008-10#2)
inoculum density and##3##3##(2008-10#3)
inoculum density on infection##2##4##(1997-6#2)
inoculum density on##5##3##(1997-6#2)(2008-10#3)
inoculum density treatments##2##3##(2008-10#2)
inoculum density was low##2##4##(2008-10#2)
inoculum density was##3##3##(2008-10#3)
inoculum density##40##2##(1997-6#3)(2008-10#37)
inoculum dispersal##4##2##(2008-10#4)
inoculum doses##2##2##(2008-10#2)
inoculum during the period##2##4##(2008-10#2)
inoculum during the##3##3##(2008-10#3)
inoculum during##4##2##(2008-10#4)
inoculum dynamics##2##2##(2008-10#2)
inoculum for infection##3##3##(2008-10#3)
inoculum for the##3##3##(2008-10#3)
inoculum for##15##2##(2008-10#15)
inoculum from##8##2##(2008-10#7)(2008-5#1)
inoculum in the##5##3##(2008-10#5)
inoculum in##15##2##(2008-10#15)
inoculum is##7##2##(2008-10#5)(2008-7#2)
inoculum level##3##2##(2008-10#3)
inoculum levels in##2##3##(2008-10#1)(2011-2#1)
inoculum levels of##2##3##(2008-10#2)
inoculum levels##10##2##(2008-10#9)(2011-2#1)
inoculum moved##2##2##(2008-10#2)
inoculum movement to roots##3##4##(2008-10#3)
inoculum of P##3##3##(2008-10#3)
inoculum of##13##2##(1994-8#1)(1997-4#1)(2008-10#11)
inoculum on##4##2##(2008-10#4)
inoculum only##2##2##(2008-10#2)
inoculum or##4##2##(2008-10#4)
inoculum potential##3##2##(2008-10#3)
inoculum pressure##4##2##(2008-10#4)
inoculum produced##2##2##(2008-10#2)
inoculum reservoir##2##2##(2008-10#2)
inoculum size##4##2##(2008-11#1)(2008-5#1)(2008-6#2)
inoculum source and##2##3##(2008-10#2)
inoculum source for##3##3##(2008-10#3)
inoculum source##14##2##(2008-10#14)
inoculum sources for##3##3##(2008-10#3)
inoculum sources of##3##3##(2008-10#3)
inoculum sources##17##2##(2008-10#17)
inoculum to##5##2##(2008-10#5)
inoculum virulent to##2##3##(2008-10#2)
inoculum was used##2##3##(2008-10#1)(2013-8#1)
inoculum was##13##2##(2008-10#12)(2013-8#1)
inoculum##358##1##(1991-11#1)(1994-5#2)(1994-8#1)(1997-4#1)(1997-6#3)(2008-10#326)(2008-11#8)(2008-12#2)(2008-5#5)(2008-6#2)(2008-7#4)(2011-2#1)(2013-8#2)
inoculum)##2##1##(2008-10#2)
inoculums##4##1##(2008-5#3)(2008-8#1)
inoperable or##2##2##(2008-6#1)(2009-10#1)
inoperable patients##2##2##(2011-2#2)
inoperable##28##1##(1991-2#2)(1992-10#2)(1993-2#1)(1993-6#3)(1994-11#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
inophyllum##2##1##(2008-5#2)
inordinately##2##1##(2008-12#1)(2012-3#1)
inorganic As##3##2##(2008-10#3)
inorganic P##2##2##(2010-2#2)
inorganic Se##4##2##(2008-10#4)
inorganic analyses##2##2##(1997-4#1)(2008-10#1)
inorganic and methyl mercury##3##4##(2008-10#3)
inorganic and organic anions##2##4##(2008-10#2)
inorganic and organic ligands##2##4##(2008-10#2)
inorganic and organic mercury##3##4##(2008-10#3)
inorganic and organic##16##3##(2008-10#13)(2008-12#1)(2008-6#1)(2011-2#1)
inorganic and##25##2##(2008-10#21)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)
inorganic anions in##4##3##(2008-10#4)
inorganic anions##17##2##(2008-10#17)
inorganic antimony##2##2##(2008-10#2)
inorganic arsenic in water##3##4##(2008-10#3)
inorganic arsenic in##6##3##(2008-10#6)
inorganic arsenic is##2##3##(2008-10#2)
inorganic arsenic species##5##3##(2008-10#5)
inorganic arsenic##30##2##(1995-11#1)(2008-10#29)
inorganic beryllium species##2##3##(2008-10#2)
inorganic beryllium##3##2##(2008-10#3)
inorganic carbon##3##2##(2008-10#3)
inorganic cations and anions##2##4##(2008-10#2)
inorganic cations##11##2##(2008-10#11)
inorganic compounds##2##2##(2008-10#1)(2008-7#1)
inorganic constituents##2##2##(2008-10#1)(2008-5#1)
inorganic contaminants in##3##3##(2008-10#1)(2008-11#2)
inorganic elements in##2##3##(2008-10#1)(2013-8#1)
inorganic filler weight##2##3##(2011-2#2)
inorganic forms of phosphorus##3##4##(2008-10#3)
inorganic ions and##2##3##(2008-10#2)
inorganic ions in##2##3##(2008-10#1)(2008-11#1)
inorganic ions##12##2##(1994-2#1)(2008-10#10)(2008-11#1)
inorganic iron##4##2##(2008-10#4)
inorganic lead##2##2##(1995-11#1)(2008-10#1)
inorganic mercury in##2##3##(2008-10#2)
inorganic mercury##18##2##(1993-12#1)(2008-10#17)
inorganic metal##2##2##(2008-10#2)
inorganic nanoparticles##2##2##(2010-12#2)
inorganic or##2##2##(2008-10#2)
inorganic oxyanions of As and Se##2##6##(2008-10#2)
inorganic oxyanions of As##3##4##(2008-10#3)
inorganic phosphate and##2##3##(1993-11#1)(2008-10#1)
inorganic phosphate##11##2##(1991-5#2)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#2)(2008-10#3)(2010-8#1)
inorganic phosphates##7##2##(1990-5#1)(2008-10#6)
inorganic phosphorus in##2##3##(2008-10#2)
inorganic phosphorus##4##2##(1994-2#2)(2008-10#2)
inorganic pigments##2##2##(2008-10#2)
inorganic pyrophosphatase##2##2##(1997-6#2)
inorganic redox partners##2##3##(1990-5#2)
inorganic redox##3##2##(1990-5#2)(2008-10#1)
inorganic salt##4##2##(2008-10#4)
inorganic salts##11##2##(1990-5#1)(1991-9#1)(1994-5#1)(2008-10#4)(2008-11#3)(2013-1#1)
inorganic selenium species##4##3##(2008-10#4)
inorganic selenium##11##2##(2008-10#10)(2010-11#1)
inorganic species##10##2##(2008-10#9)(2008-7#1)
inorganic sulfur##2##2##(2008-10#2)
inorganic sulphide##2##2##(1996-7#2)
inorganic support##2##2##(2008-10#2)
inorganic##319##1##(1990-5#4)(1990-7#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#3)(1993-3#2)(1994-2#3)(1994-5#1)(1995-11#3)(1995-3#2)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-10#235)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#7)(2008-8#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#3)(2013-8#1)
inorganic-organic##2##1##(2009-7#1)(2010-4#1)
inorganic/organic##2##1##(2008-10#2)
inorganics##2##1##(2008-10#2)
inosinate##2##1##(1990-10#1)(1994-8#1)
inosine 5'-monophosphate dehydrogenase##3##3##(1994-11#3)
inosine and##2##2##(1993-12#1)(1994-8#1)
inosine for guanosine##2##3##(1992-3#2)
inosine in##2##2##(2008-10#1)(2010-9#1)
inosine monophosphate dehydrogenase type II##3##5##(1995-3#3)
inosine monophosphate##4##2##(1995-12#1)(1995-3#3)
inosine##31##1##(1991-7#1)(1992-3#2)(1993-12#4)(1994-11#3)(1994-8#1)(1995-12#2)(1995-3#3)(1997-2#1)(2008-10#9)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
inositol (1##3##2##(1990-12#1)(1990-7#2)
inositol 1##32##2##(1990-12#2)(1990-8#1)(1991-12#4)(1991-6#1)(1991-8#1)(1992-11#3)(1992-5#2)(1992-9#1)(1993-6#1)(1993-8#4)(1994-8#2)(1995-11#2)(1995-2#1)(1997-1#1)(1997-8#1)(2008-8#2)(2009-7#1)(2012-12#1)(2013-1#1)
inositol derivatives##5##2##(2008-11#5)
inositol glycans##2##2##(2010-4#2)
inositol hexaphosphate##2##2##(1990-8#2)
inositol lipid cycle##2##3##(1993-8#2)
inositol lipid##3##2##(1990-12#1)(1993-8#2)
inositol mono-##3##2##(1990-7#1)(1997-1#2)
inositol phosphate accumulation##3##3##(1997-1#1)(2008-4#2)
inositol phosphate formation##2##3##(1990-7#1)(1997-7#1)
inositol phosphate metabolism in melanotrope cells of Xenopus laevis##2##9##(1993-5#2)
inositol phosphate metabolism##3##3##(1993-5#3)
inositol phosphate production in##2##4##(1990-11#1)(1997-1#1)
inositol phosphate production##6##3##(1990-11#2)(1992-9#1)(1993-5#1)(1997-1#2)
inositol phosphate##17##2##(1990-11#2)(1990-7#2)(1992-3#1)(1992-9#1)(1993-5#4)(1995-11#1)(1997-1#3)(1997-7#1)(2008-4#2)
inositol phosphates in##2##3##(1993-6#1)(2008-4#1)
inositol phosphates was##3##3##(1990-12#1)(1993-5#1)(1993-6#1)
inositol phosphates##17##2##(1990-12#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-9#1)(1993-5#4)(1993-6#5)(2008-4#2)
inositol tetrakisphosphate##4##2##(1992-11#1)(1993-6#1)(1997-1#2)
inositol tetrakisphosphates##2##2##(1992-11#1)(1997-1#1)
inositol triphosphate##4##2##(1993-11#1)(1995-11#1)(2008-11#1)(2012-12#1)
inositol trisphosphate production in##3##4##(1991-12#1)(1993-3#2)
inositol trisphosphate production##4##3##(1990-8#1)(1991-12#1)(1993-3#2)
inositol trisphosphate was##2##3##(1990-8#2)
inositol trisphosphate##16##2##(1990-8#5)(1991-12#2)(1992-12#1)(1993-3#3)(1993-6#3)(1994-9#1)(1995-2#1)
inositol##140##1##(1990-11#2)(1990-12#5)(1990-7#7)(1990-8#10)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#7)(1992-12#2)(1992-3#1)(1992-5#3)(1992-9#4)(1993-11#1)(1993-3#3)(1993-5#10)(1993-6#10)(1993-8#9)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-11#4)(1995-2#3)(1996-12#1)(1997-1#10)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#6)(2008-4#4)(2008-8#5)(2009-7#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
inositol(1##5##1##(1990-12#1)(1994-11#4)
inositol-1##2##1##(1993-1#1)(2011-1#1)
inositol-phosphates##2##1##(1996-5#2)
inositolphosphate##2##1##(1991-12#2)
inotrope and vasopressor use##2##4##(2009-8#2)
inotrope##3##1##(1994-8#1)(2009-8#2)
inotropic agent##2##2##(2008-5#1)(2009-8#1)
inotropic effect of##3##3##(1995-12#2)(2008-5#1)
inotropic effect##4##2##(1995-12#2)(2008-5#2)
inotropic effects of##5##3##(1995-12#2)(1997-7#3)
inotropic effects##6##2##(1995-12#2)(1997-7#4)
inotropic support##6##2##(2007-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
inotropic##24##1##(1995-12#4)(1996-3#1)(1997-7#7)(2007-8#1)(2008-5#3)(2009-2#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
inpatient admission##2##2##(2008-6#2)
inpatient and outpatient##9##3##(1992-12#2)(1993-12#1)(1995-2#1)(1996-3#3)(2007-10#1)(2013-1#1)
inpatient and##11##2##(1992-12#2)(1993-12#1)(1995-2#1)(1996-3#4)(1997-1#1)(2007-10#1)(2013-1#1)
inpatient beds##4##2##(1992-12#1)(1997-2#1)(2008-8#1)(2009-6#1)
inpatient care in##4##3##(1991-1#1)(1992-2#1)(2008-7#1)(2012-12#1)
inpatient care is##2##3##(1993-1#1)(1993-3#1)
inpatient care##19##2##(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#3)(1993-1#1)(1993-12#2)(1993-3#2)(1995-2#2)(2008-7#1)(2008-8#1)(2012-12#1)
inpatient case##3##2##(1994-12#1)(1995-2#1)(2008-12#1)
inpatient cost##2##2##(1992-12#2)
inpatient diabetes care##2##3##(2009-11#1)(2012-2#1)
inpatient diabetes##5##2##(2009-11#4)(2012-2#1)
inpatient diagnoses##2##2##(1997-1#2)
inpatient hospital services##2##3##(1992-1#1)(1994-3#1)
inpatient hospital##7##2##(1991-3#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-7#1)
inpatient hospitalization##3##2##(1992-1#1)(1993-12#1)(1997-3#1)
inpatient management##2##2##(2008-3#1)(2010-12#1)
inpatient or##3##2##(1991-2#1)(1994-2#1)(2008-4#1)
inpatient physician##2##2##(1993-12#2)
inpatient population##2##2##(1991-2#1)(1995-2#1)
inpatient providers##2##2##(1991-3#1)(2011-1#1)
inpatient psychiatric treatment##4##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)
inpatient psychiatric##7##2##(1991-2#3)(1992-2#1)(1992-3#2)(1993-1#1)
inpatient ratesetting##2##2##(1993-12#2)
inpatient rehabilited patients##2##3##(2007-11#2)
inpatient services##7##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#2)(1996-3#1)(2008-11#1)
inpatient stay##2##2##(1993-2#1)(2011-2#1)
inpatient to##7##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1996-2#1)(2008-3#1)
inpatient treatment of##3##3##(1991-2#1)(1992-3#2)
inpatient treatment with##2##3##(1992-3#1)(1993-2#1)
inpatient treatment##11##2##(1991-2#1)(1992-1#1)(1992-3#5)(1993-2#2)(1995-11#1)(2008-4#1)
inpatient unit##4##2##(1992-3#1)(1993-2#1)(2009-9#1)(2010-2#1)
inpatient units##4##2##(1993-1#2)(1993-12#1)(1995-11#1)
inpatient##163##1##(1991-1#7)(1991-11#2)(1991-12#2)(1991-2#8)(1991-3#5)(1992-1#6)(1992-12#5)(1992-2#8)(1992-3#8)(1993-1#5)(1993-12#13)(1993-2#6)(1993-3#5)(1994-12#3)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#1)(1996-2#3)(1996-3#5)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#3)(2008-6#3)(2008-7#4)(2008-8#2)(2009-11#6)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
inpatients and outpatients##5##3##(2007-7#2)(2011-2#3)
inpatients and##8##2##(1996-7#1)(2007-7#2)(2008-11#1)(2011-2#4)
inpatients are##2##2##(1993-12#1)(1996-3#1)
inpatients of##2##2##(2007-1#1)(2011-2#1)
inpatients or##2##2##(2007-12#1)(2012-1#1)
inpatients were##2##2##(2011-2#1)(2013-1#1)
inpatients with##5##2##(1994-2#1)(1995-11#1)(2008-11#2)(2013-8#1)
inpatients##47##1##(1990-2#1)(1992-1#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#2)(1995-11#1)(1995-2#1)(1996-3#1)(1996-7#3)(2007-1#1)(2007-12#2)(2007-7#2)(2008-11#4)(2008-7#2)(2010-12#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
inpatients]##2##1##(1995-3#1)(2012-12#1)
inplace##2##1##(1991-12#1)(2008-11#1)
input Stokes##2##2##(2008-3#2)
input and output data##2##4##(2010-8#2)
input and output##12##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2010-8#2)
input and the##13##3##(1992-9#1)(2007-12#2)(2008-2#2)(2008-3#8)
input and##32##2##(1990-5#1)(1992-9#1)(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#13)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-8#2)(2013-1#1)
input angle##3##2##(2008-2#3)
input angles##2##2##(2007-12#1)(2008-3#1)
input aperture##2##2##(2008-2#1)(2008-3#1)
input beam##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
input by##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
input cases##2##2##(2012-3#2)
input channel is##2##3##(2007-12#1)(2008-2#1)
input channel##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
input data##11##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-8#1)(2013-8#1)
input end and##2##3##(2008-3#2)
input facet##2##2##(2007-11#2)
input for the##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
input for##8##2##(1993-12#1)(1994-8#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
input from the##7##3##(1991-5#1)(1993-12#1)(1993-2#1)(1994-3#1)(2007-12#1)(2009-4#1)(2012-2#1)
input from##20##2##(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-11#2)(2008-3#1)(2008-7#3)(2009-4#1)(2011-8#1)(2012-12#1)(2012-2#2)
input function##2##2##(1991-6#1)(2008-2#1)
input image is##2##3##(2008-2#1)(2008-3#1)
input image##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
input images##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
input in a##2##3##(2008-2#1)(2008-3#1)
input in##8##2##(1991-2#4)(2008-11#1)(2008-2#1)(2008-3#2)
input intensity##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
input into the##2##3##(1994-8#1)(2008-3#1)
input into##7##2##(1994-8#1)(1996-8#1)(2007-12#1)(2008-3#2)(2008-4#1)(2008-7#1)
input is##9##2##(1991-2#2)(1993-12#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)
input laser beam##2##3##(2008-2#1)(2008-3#1)
input laser##3##2##(2008-2#1)(2008-3#2)
input noise##4##2##(2007-12#1)(2008-2#3)
input object##3##2##(2008-2#1)(2008-3#2)
input of the##2##3##(1990-5#1)(2008-2#1)
input of##10##2##(1990-5#1)(1993-2#1)(2008-10#1)(2008-2#1)(2009-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
input on##3##2##(1996-5#1)(1997-3#1)(2007-12#1)
input or##4##2##(1997-3#1)(2008-2#2)(2008-3#1)
input parameters for##2##3##(2008-10#1)(2008-3#1)
input parameters##7##2##(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)(2013-1#1)
input pathways##2##2##(2008-11#2)
input pattern##2##2##(2008-3#1)(2012-2#1)
input plane of##2##3##(2008-3#2)
input plane##6##2##(2007-11#1)(2008-3#5)
input polarization##3##2##(2007-12#2)(2008-2#1)
input power of##2##3##(2007-12#1)(2008-3#1)
input power##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
input price##6##2##(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#2)
input prices##3##2##(1992-1#1)(1992-2#2)
input pulse##9##2##(2007-11#6)(2007-12#3)
input pulses and##2##3##(2007-12#1)(2008-2#1)
input pulses with##2##3##(2007-11#1)(2008-2#1)
input pulses##14##2##(2007-11#2)(2007-12#6)(2008-2#4)(2008-3#2)
input resistance##4##2##(1992-3#1)(1993-12#2)(2013-1#1)
input scene##6##2##(2008-2#3)(2008-3#3)
input scenes the##2##3##(2008-2#2)
input signal##7##2##(2007-12#1)(2008-11#2)(2008-3#3)(2013-7#1)
input signals and##2##3##(2012-2#2)
input signals##4##2##(2007-12#1)(2010-4#1)(2012-2#2)
input spatial##2##2##(2007-11#1)(2008-2#1)
input spectrum##2##2##(2008-3#2)
input state##2##2##(2007-12#1)(2008-3#1)
input surface##3##2##(2008-3#3)
input than##2##2##(1996-2#1)(2008-11#1)
input to the##11##3##(1991-2#2)(1991-5#1)(1992-10#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
input to this##2##3##(1995-1#1)(2008-3#1)
input to##20##2##(1991-2#2)(1991-5#1)(1992-10#1)(1992-8#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2010-3#1)(2013-8#1)
input variables to##3##3##(2008-10#2)(2013-8#1)
input variables were##3##3##(2008-10#3)
input variables##12##2##(1992-2#1)(2008-10#10)(2013-8#1)
input was##2##2##(1992-2#1)(1993-12#1)
input wavelengths##2##2##(2008-2#1)(2008-3#1)
input##460##1##(1990-5#4)(1990-7#1)(1991-12#1)(1991-2#8)(1991-3#1)(1991-5#3)(1991-6#1)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#7)(1993-2#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#3)(1996-8#1)(1997-3#6)(2007-11#29)(2007-12#52)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#21)(2008-12#1)(2008-2#66)(2008-3#98)(2008-4#7)(2008-5#5)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#9)(2011-1#1)(2011-2#2)(2011-3#1)(2011-8#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
input-image illumination##2##2##(2008-3#2)
input-output##20##1##(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#8)(2008-8#3)(2012-2#1)
input-outputs##3##1##(2008-2#2)(2008-3#1)
inputs and outputs##3##3##(1992-2#2)(2008-2#1)
inputs and the##2##3##(2008-3#1)(2008-9#1)
inputs and##12##2##(1992-2#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
inputs are##8##2##(1992-1#1)(1992-2#1)(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
inputs at##2##2##(2007-11#1)(2007-12#1)
inputs between##2##2##(2008-8#2)
inputs can be##3##3##(2007-8#1)(2008-3#1)(2008-4#1)
inputs can##4##2##(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)
inputs for##4##2##(2008-10#3)(2008-2#1)
inputs from the##2##3##(1993-12#1)(2013-8#1)
inputs from##10##2##(1993-12#2)(1994-2#2)(2008-9#1)(2009-12#1)(2010-9#1)(2012-2#2)(2013-8#1)
inputs in##2##2##(2007-12#1)(2008-3#1)
inputs on the##3##3##(1992-2#1)(1997-7#1)(2008-9#1)
inputs on##4##2##(1992-2#1)(1997-7#1)(2008-9#2)
inputs to the##6##3##(1993-6#1)(1994-8#1)(1996-5#1)(2008-2#2)(2013-8#1)
inputs to##15##2##(1993-6#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-10#2)(2010-10#1)(2012-12#2)(2012-2#1)(2013-8#1)
inputs##110##1##(1992-1#1)(1992-2#6)(1992-3#2)(1993-12#3)(1993-6#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#7)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#11)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#7)(2013-1#2)(2013-8#5)
inquiline##2##1##(2009-2#2)
inquired about##2##2##(2011-2#1)(2012-12#1)
inquired##3##1##(2011-2#1)(2012-12#1)(2012-2#1)
inquiries##4##1##(2008-12#2)(2008-7#1)(2013-1#1)
inquiry and##3##2##(1993-2#2)(2008-12#1)
inquiry into the##2##3##(2009-5#1)(2011-2#1)
inquiry on##3##2##(1993-3#1)(1993-6#1)(1995-8#1)
inquiry##33##1##(1990-6#1)(1991-8#4)(1992-12#1)(1993-2#5)(1993-3#1)(1993-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
inquisitiveness##2##1##(1993-12#1)(2008-11#1)
ins/del##2##1##(1993-9#1)(2013-8#1)
insane##4##1##(1994-1#1)(2008-7#2)(2011-2#1)
insanity defense##7##2##(2011-1#7)
insanity##9##1##(2009-10#1)(2011-1#8)
insatiable##2##1##(2007-7#1)(2009-10#1)
inscribed in##2##2##(2007-11#2)
inscribed with##2##2##(2007-12#2)
inscribed##7##1##(2007-11#3)(2007-12#2)(2008-3#1)(2012-2#1)
inscription##4##1##(2007-11#2)(2008-2#1)(2011-3#1)
inscriptions##3##1##(2008-10#1)(2009-9#1)(2010-5#1)
insect abundances##6##2##(2008-8#6)
insect and vertebrate##2##3##(2007-12#2)
insect and##5##2##(2007-12#2)(2008-10#1)(2008-8#1)(2009-6#1)
insect bites##2##2##(2007-2#1)(2011-1#1)
insect brain##4##2##(2007-12#4)
insect cell culture##3##3##(2008-11#3)
insect cell cultures at the##2##5##(2008-7#2)
insect cell cultures##8##3##(1992-8#1)(2008-11#2)(2008-2#2)(2008-7#3)
insect cell growth##2##3##(2008-11#2)
insect cell line##8##3##(2008-11#5)(2008-7#3)
insect cell lines##10##3##(1997-8#1)(2008-11#4)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#2)
insect cell##37##2##(1992-8#1)(1993-6#1)(1997-8#1)(2008-11#21)(2008-2#2)(2008-7#7)(2008-9#1)(2012-2#1)(2013-8#2)
insect cells and##7##3##(1994-8#1)(1997-4#3)(2008-11#2)(2008-2#1)
insect cells by##2##3##(2008-10#1)(2008-9#1)
insect cells infected with a recombinant baculovirus##2##7##(1993-8#1)(2008-7#1)
insect cells infected with a##3##5##(1993-8#1)(2008-11#1)(2008-7#1)
insect cells infected with##4##4##(1993-6#1)(1993-8#1)(2008-11#1)(2008-7#1)
insect cells or##2##3##(2008-4#1)(2011-2#1)
insect cells with a##2##4##(1993-6#1)(2008-11#1)
insect cells with##5##3##(1993-6#1)(2008-11#2)(2008-2#1)(2008-7#1)
insect cells##53##2##(1991-2#1)(1992-10#1)(1992-3#1)(1993-6#6)(1993-8#4)(1994-10#1)(1994-8#6)(1995-2#2)(1997-4#4)(2008-1#1)(2008-10#1)(2008-11#13)(2008-2#3)(2008-4#2)(2008-7#5)(2008-9#1)(2011-2#1)
insect communities##3##2##(2008-8#2)(2008-9#1)
insect cuticle##3##2##(2007-12#2)(2011-2#1)
insect density##2##2##(2008-10#1)(2011-2#1)
insect feeding medium##3##3##(2008-10#3)
insect feeding##7##2##(2008-10#3)(2009-8#4)
insect genomes##3##2##(2008-10#2)(2012-2#1)
insect glycoproteins##2##2##(2008-10#2)
insect growth##2##2##(2007-11#1)(2011-2#1)
insect herbivore##3##2##(2008-8#1)(2013-7#2)
insect herbivores and##2##3##(2008-8#1)(2008-9#1)
insect herbivores##7##2##(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-7#2)
insect herbivory##3##2##(2008-8#2)(2009-8#1)
insect larvae##6##2##(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)
insect mushroom bodies##3##3##(2007-12#3)
insect orders##5##2##(2007-12#2)(2008-6#1)(2008-7#1)(2008-8#1)
insect pest of##2##3##(2008-10#1)(2013-8#1)
insect pest##6##2##(2008-10#3)(2009-8#1)(2011-2#1)(2013-8#1)
insect pests##6##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#3)
insect populations##5##2##(2008-9#3)(2011-2#1)(2012-12#1)
insect proteins##2##2##(2008-10#2)
insect resistance##3##2##(1995-6#1)(2010-10#1)(2011-2#1)
insect species richness and##2##4##(2008-9#1)(2013-7#1)
insect species richness##3##3##(2008-8#1)(2008-9#1)(2013-7#1)
insect species##12##2##(2007-12#4)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2013-7#1)
insect taxa##2##2##(2007-12#1)(2008-9#1)
insect transmission##2##2##(2008-10#2)
insect vector##7##2##(2008-10#4)(2008-5#1)(2008-9#2)
insect vectors have##2##3##(2008-10#2)
insect vectors##9##2##(2007-7#1)(2008-10#8)
insect was##2##2##(2007-12#1)(2013-1#1)
insect##322##1##(1990-7#2)(1991-2#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#7)(1993-8#4)(1994-10#1)(1994-8#6)(1995-11#1)(1995-2#2)(1995-6#3)(1997-2#1)(1997-4#5)(1997-8#1)(2007-11#2)(2007-12#36)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#54)(2008-11#41)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#20)(2008-8#27)(2008-9#18)(2009-6#1)(2009-8#8)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#17)(2012-12#2)(2012-2#6)(2013-1#4)(2013-7#6)(2013-8#4)
insect's head##2##2##(2008-10#2)
insect's##4##1##(2008-10#4)
insect-borne##2##1##(2008-10#1)(2010-8#1)
insect-plant##3##1##(2008-1#2)(2009-6#1)
insecticidal activity##2##2##(2008-11#2)
insecticidal crystal##2##2##(1993-12#1)(1995-6#1)
insecticidal##8##1##(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2013-8#1)
insecticide applications##2##2##(2008-10#1)(2011-2#1)
insecticide in##2##2##(2009-3#1)(2011-2#1)
insecticide resistance##5##2##(2011-2#5)
insecticide use##2##2##(2008-10#1)(2011-2#1)
insecticide##41##1##(1992-2#1)(1992-8#1)(1993-8#1)(1995-3#2)(1996-12#1)(1997-7#2)(2008-10#5)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#2)(2011-2#16)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
insecticide-treated##2##1##(1997-4#1)(2013-1#1)
insecticides and their analogs##2##4##(2008-10#2)
insecticides and##3##2##(2008-10#2)(2012-12#1)
insecticides in##3##2##(2007-10#1)(2008-10#1)(2010-5#1)
insecticides was##2##2##(2007-10#1)(2011-2#1)
insecticides were##2##2##(1992-11#1)(2012-12#1)
insecticides##51##1##(1992-11#1)(1997-7#1)(2007-10#3)(2008-10#15)(2008-11#3)(2008-12#5)(2008-5#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#12)(2012-12#4)(2013-7#2)
insectivorous##2##1##(2007-12#1)(2008-5#1)
insects and vertebrates##7##3##(2007-12#7)
insects and##22##2##(1990-5#1)(1995-11#1)(2007-12#11)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2011-2#1)
insects from##3##2##(2008-5#3)
insects have been##2##3##(2010-1#2)
insects in##5##2##(2007-12#2)(2008-10#1)(2008-5#1)(2010-6#1)
insects is##6##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
insects of the##2##3##(2007-12#1)(2010-1#1)
insects of##5##2##(2007-12#1)(2008-10#2)(2010-1#2)
insects on##3##2##(2008-8#1)(2010-10#1)(2011-2#1)
insects or##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
insects that##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
insects to##2##2##(2008-6#1)(2009-8#1)
insects was##2##2##(2008-10#2)
insects were##4##2##(2008-10#3)(2008-5#1)
insects with##3##2##(2007-12#1)(2008-8#1)(2010-4#1)
insects##173##1##(1990-5#1)(1990-7#1)(1991-5#1)(1992-6#2)(1993-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(1997-4#1)(2006-12#4)(2007-12#40)(2008-10#38)(2008-11#1)(2008-12#3)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#16)(2008-9#18)(2009-10#1)(2009-8#8)(2010-1#6)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
insects' bodies##2##2##(2008-10#2)
insects)##3##1##(2007-12#3)
insecure attachment##2##2##(2012-1#2)
insecurity and##3##2##(2009-10#1)(2011-2#1)(2012-1#1)
insecurity on##2##2##(2009-10#1)(2012-1#1)
insecurity with##2##2##(2007-11#1)(2008-1#1)
insecurity##20##1##(1993-3#1)(1994-12#1)(2007-11#1)(2008-1#3)(2009-10#4)(2010-8#2)(2011-2#2)(2012-1#5)(2012-12#1)
inseminate wild females##2##3##(2011-2#1)(2012-12#1)
inseminated with##2##2##(2012-2#1)(2013-1#1)
inseminated##4##1##(2008-8#1)(2012-2#1)(2013-1#2)
insemination pocket##2##2##(2007-12#2)
insemination##18##1##(1991-11#2)(1993-6#1)(1996-9#2)(2007-10#1)(2007-12#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
insensitive and##3##2##(1995-12#1)(2007-11#1)(2008-10#1)
insensitive for##2##2##(2010-5#1)(2013-8#1)
insensitive genotypes##2##2##(2008-10#2)
insensitive isolates##3##2##(2008-10#3)
insensitive mutants##4##2##(2008-10#2)(2009-6#2)
insensitive to amiloride##2##3##(1990-2#1)(1991-5#1)
insensitive to changes in the##2##5##(2007-12#1)(2008-3#1)
insensitive to inhibition by##2##4##(1992-3#1)(1995-8#1)
insensitive to metalaxyl##2##3##(2008-10#2)
insensitive to the input##2##4##(2008-2#2)
insensitive to the toxin##3##4##(2008-10#3)
insensitive to the##24##3##(1990-5#1)(1992-7#1)(1995-11#1)(1995-2#1)(2006-6#1)(2008-10#6)(2008-2#4)(2008-3#4)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)
insensitive to variations in##3##4##(1990-2#2)(2007-11#1)
insensitive to##93##2##(1990-2#3)(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-12#2)(1992-3#2)(1992-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1997-9#1)(2006-6#1)(2007-11#4)(2007-12#3)(2008-10#19)(2008-11#2)(2008-2#10)(2008-3#14)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)
insensitive##135##1##(1990-12#2)(1990-2#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-5#1)(1992-12#2)(1992-3#2)(1992-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-11#5)(2007-12#3)(2008-10#37)(2008-11#2)(2008-2#13)(2008-3#15)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-5#1)(2012-5#1)(2013-1#1)(2013-8#1)
insensitivity in the##4##3##(2008-10#4)
insensitivity in##6##2##(2008-10#6)
insensitivity may##2##2##(2008-10#2)
insensitivity of##2##2##(2007-12#1)(2008-7#1)
insensitivity to Ptr ToxA##2##4##(2008-10#2)
insensitivity to the##3##3##(1997-3#1)(2008-10#1)(2009-8#1)
insensitivity to##23##2##(1990-11#1)(1992-3#1)(1992-8#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-2#4)(2008-3#1)(2009-8#2)(2010-7#1)(2012-12#1)
insensitivity was##2##2##(2008-10#2)
insensitivity##51##1##(1990-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1995-5#1)(1997-3#1)(2007-12#2)(2008-10#30)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-7#1)(2012-12#1)
inseparable from##2##2##(2007-11#1)(2013-1#1)
inseparably##2##1##(2007-8#1)(2010-12#1)
insert DNA##4##2##(1997-2#1)(2008-4#2)(2008-8#1)
insert and##3##2##(1993-11#1)(1996-12#1)(2008-8#1)
insert contains##2##2##(1991-2#1)(1994-8#1)
insert in the##3##3##(1992-8#1)(1996-12#1)(2013-8#1)
insert in##7##2##(1992-8#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
insert into the bacterial cytoplasmic membrane##2##6##(1990-11#2)
insert into the##3##3##(1990-11#2)(1995-2#1)
insert of##3##2##(1990-11#1)(1994-12#1)(1995-2#1)
insert revealed##2##2##(1995-11#1)(2008-8#1)
insert sizes##3##2##(1997-2#2)(2008-5#1)
insert was##2##2##(1991-12#1)(2008-8#1)
insert##73##1##(1990-11#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#3)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1996-10#2)(1996-12#3)(1996-2#1)(1997-2#4)(1997-6#3)(2007-12#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
inserted DNA fragment##2##3##(2008-11#1)(2008-8#1)
inserted DNA##3##2##(2008-11#2)(2008-8#1)
inserted a##2##2##(1996-2#1)(2008-10#1)
inserted after##2##2##(1992-10#1)(2008-11#1)
inserted and##2##2##(2008-3#1)(2008-7#1)
inserted as##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)
inserted at the##4##3##(1993-2#1)(1996-12#1)(1997-6#1)(2009-3#1)
inserted at##6##2##(1990-7#1)(1993-2#1)(1996-12#1)(1997-6#1)(2007-12#1)(2009-3#1)
inserted between the##3##3##(1997-4#2)(2008-6#1)
inserted between##4##2##(1997-4#2)(2008-5#1)(2008-6#1)
inserted by##2##2##(1996-3#1)(2008-11#1)
inserted downstream of the##2##4##(1994-6#1)(2008-8#1)
inserted downstream##3##2##(1990-8#1)(1994-6#1)(2008-8#1)
inserted flapless with##2##3##(2013-1#2)
inserted for##3##2##(1996-3#1)(2008-12#1)(2012-12#1)
inserted in a##5##3##(1991-7#1)(2008-10#2)(2011-2#1)(2013-8#1)
inserted in front of the##2##5##(1991-2#1)(2011-1#1)
inserted in front of##3##4##(1991-2#1)(1991-6#1)(2011-1#1)
inserted in the##11##3##(1990-8#1)(1994-2#1)(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#5)(2009-4#1)
inserted in##25##2##(1990-8#1)(1991-2#1)(1991-6#1)(1991-7#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#7)(2009-4#2)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#2)(2013-8#1)
inserted into a##14##3##(1993-11#2)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)
inserted into the cavity##2##4##(2008-2#1)(2008-3#1)
inserted into the chromosome##2##4##(1991-5#1)(1993-9#1)
inserted into the inner membrane##2##5##(1990-2#1)(2011-2#1)
inserted into the needle##2##4##(2008-10#1)(2010-8#1)
inserted into the##44##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-9#2)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#4)(2008-9#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
inserted into##76##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#3)(1993-3#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#3)(2010-11#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
inserted percutaneously##2##2##(2008-10#1)(2012-3#1)
inserted the##3##2##(1992-3#1)(2008-6#1)(2008-9#1)
inserted through##3##2##(1991-12#1)(2007-12#1)(2009-3#1)
inserted to##4##2##(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
inserted under##3##2##(1991-12#1)(2008-9#1)(2011-2#1)
inserted until##2##2##(1997-6#1)(2012-2#1)
inserted with a##4##3##(2008-10#1)(2013-1#3)
inserted with the##3##3##(1993-10#1)(1993-8#1)(1997-2#1)
inserted with##11##2##(1993-10#1)(1993-8#1)(1997-2#1)(2008-10#2)(2009-10#1)(2013-1#5)
inserted without##2##2##(2008-9#1)(2012-2#1)
inserted##204##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#5)(1997-8#6)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#28)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#4)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#15)(2013-8#1)
inserting a##7##2##(1992-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)
inserting or deleting##3##3##(2009-7#3)
inserting the##2##2##(2007-11#1)(2008-8#1)
inserting##21##1##(1990-7#1)(1992-11#1)(1993-12#1)(1995-8#1)(2007-11#3)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#3)(2010-8#1)(2011-2#1)
insertion and##7##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)(2012-12#1)
insertion as well as##2##4##(2008-8#1)(2008-9#1)
insertion at the##2##3##(2008-12#1)(2010-6#1)
insertion at##3##2##(2008-12#1)(2008-8#1)(2010-6#1)
insertion attempts##2##2##(1992-12#1)(2012-2#1)
insertion events##2##2##(1997-4#1)(2009-10#1)
insertion for##5##2##(2007-10#2)(2008-12#1)(2012-2#1)(2013-8#1)
insertion has##2##2##(2008-12#1)(2009-7#1)
insertion in the##6##3##(1990-5#1)(1990-7#1)(1991-12#1)(1993-11#1)(1994-9#1)(2008-1#1)
insertion in##12##2##(1990-5#1)(1990-7#1)(1991-12#1)(1993-11#1)(1993-6#1)(1994-9#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-6#1)(2012-3#1)
insertion into the##6##3##(1990-8#1)(1991-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
insertion into##11##2##(1990-8#1)(1991-6#1)(1994-2#2)(1995-5#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
insertion is##7##2##(2008-1#2)(2008-8#1)(2010-12#2)(2010-9#1)(2013-1#1)
insertion loss is##2##3##(2008-3#2)
insertion loss of##6##3##(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#3)
insertion loss was##2##3##(2008-2#1)(2009-5#1)
insertion loss##16##2##(2007-11#2)(2007-9#2)(2008-2#3)(2008-3#8)(2009-5#1)
insertion losses and##2##3##(2008-2#1)(2008-3#1)
insertion losses##3##2##(2008-2#1)(2008-3#2)
insertion method##2##2##(2010-12#1)(2010-6#1)
insertion mutations##2##2##(1990-11#1)(1993-9#1)
insertion occurred within an##2##4##(1995-9#1)(2008-10#1)
insertion occurred##3##2##(1995-9#1)(2008-10#2)
insertion of CTrach and ETT##2##5##(2010-7#2)
insertion of a##28##3##(1990-11#2)(1991-10#1)(1991-12#1)(1991-9#1)(1993-2#1)(1993-8#1)(1994-12#2)(1995-2#1)(1995-9#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
insertion of an##4##3##(1993-10#1)(1993-2#1)(2007-8#1)(2008-10#1)
insertion of foreign genes##2##4##(2008-11#1)(2008-8#1)
insertion of implantable cardioverter-defibrillators##2##4##(2008-12#2)
insertion of peptides into##2##4##(1994-2#1)(2010-5#1)
insertion of the needle##3##4##(1992-12#1)(2007-8#2)
insertion of the##24##3##(1990-8#1)(1992-12#1)(1995-11#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2012-2#2)(2013-1#2)
insertion of##97##2##(1990-11#3)(1990-5#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-12#3)(1994-2#2)(1995-11#3)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
insertion or deletion of##3##4##(1997-3#1)(2008-9#1)(2011-1#1)
insertion or deletion##5##3##(1997-3#1)(2008-10#1)(2008-9#2)(2011-1#1)
insertion or##7##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-1#1)
insertion site##3##2##(1990-11#1)(1995-8#1)(2013-1#1)
insertion sites##6##2##(1991-5#2)(2008-10#2)(2008-11#1)(2009-3#1)
insertion success##2##2##(2012-2#2)
insertion torque##3##2##(2013-1#3)
insertion was##9##2##(1990-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
insertion##303##1##(1990-11#6)(1990-5#2)(1990-7#1)(1990-8#3)(1991-10#3)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#4)(1994-2#4)(1994-8#1)(1994-9#4)(1995-11#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#4)(1995-9#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#3)(2006-10#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#28)(2008-11#8)(2008-12#6)(2008-2#9)(2008-3#13)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#20)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#6)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#7)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#15)(2012-3#8)(2013-1#16)(2013-8#5)
insertion/deletion##2##1##(2008-10#1)(2010-5#1)
insertional Achilles tendinosis##2##3##(2010-3#2)
insertional inactivation of##2##3##(1993-12#1)(2008-6#1)
insertional inactivation##3##2##(1993-12#1)(1995-8#1)(2008-6#1)
insertional mutagenesis##9##2##(1991-5#1)(2008-10#7)(2008-9#1)
insertional##20##1##(1991-5#1)(1993-12#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#2)
insertions and##2##2##(2009-10#1)(2012-3#1)
insertions in##2##2##(1994-7#1)(1997-3#1)
insertions of##2##2##(1997-2#1)(1997-3#1)
insertions or##2##2##(2008-4#1)(2011-1#1)
insertions were##4##2##(1993-10#1)(1997-3#1)(2008-10#1)(2012-3#1)
insertions##31##1##(1990-8#1)(1991-5#1)(1993-10#1)(1993-3#1)(1994-7#1)(1995-2#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-10#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)
inserts as##2##2##(1997-4#1)(2008-5#1)
inserts of##4##2##(1991-2#1)(1997-3#1)(2008-10#1)(2008-8#1)
inserts to##2##2##(1991-5#1)(1992-12#1)
inserts was##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
inserts##28##1##(1991-2#1)(1991-5#1)(1992-12#1)(1994-12#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2013-8#1)
inshore##3##1##(2007-5#1)(2010-8#1)(2013-7#1)
inside Au##2##2##(2008-10#2)
inside a Fabry-Perot##2##3##(2008-3#2)
inside a dielectric sphere##2##4##(2008-2#1)(2010-12#1)
inside a glass block##2##4##(2007-11#2)
inside a glass##3##3##(2007-11#2)(2008-10#1)
inside a photorefractive##2##3##(2007-12#1)(2008-2#1)
inside a protein##2##3##(1997-2#2)
inside a scattering medium##4##4##(2008-3#4)
inside a standard##2##3##(2007-11#1)(2010-5#1)
inside a volume##2##3##(2007-11#1)(2007-12#1)
inside a waveguide##2##3##(2008-3#2)
inside a##55##2##(1996-3#1)(1997-2#2)(2007-11#7)(2007-12#8)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#19)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
inside an##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-3#1)
inside and outside the body##2##5##(2010-9#1)(2011-2#1)
inside and outside the##4##4##(1997-2#1)(2008-2#1)(2010-9#1)(2011-2#1)
inside and outside##7##3##(1997-2#1)(2008-2#2)(2010-9#2)(2011-2#1)(2012-2#1)
inside and##10##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-6#1)(2010-9#2)(2011-2#1)(2012-2#1)
inside artificial##2##2##(2007-12#1)(2008-7#1)
inside each##2##2##(2007-12#1)(2008-7#1)
inside it##2##2##(2007-11#1)(2008-10#1)
inside living##3##2##(2008-8#1)(2008-9#1)(2011-1#1)
inside microparticles##2##2##(2008-3#2)
inside microsomes##2##2##(1997-7#2)
inside of a##3##3##(2008-2#2)(2008-8#1)
inside of the##8##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
inside of##16##2##(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
inside or outside of##3##4##(1996-3#1)(2008-8#1)(2012-12#1)
inside or outside##4##3##(1995-8#1)(1996-3#1)(2008-8#1)(2012-12#1)
inside order##2##2##(2008-2#1)(2008-3#1)
inside plant##2##2##(2008-10#2)
inside scattering##2##2##(2007-11#2)
inside silica glass##3##3##(2007-11#1)(2007-12#2)
inside surface of the##2##4##(2008-10#2)
inside the body##3##3##(2008-3#1)(2008-8#1)(2009-7#1)
inside the cavity##5##3##(2007-11#1)(2007-12#4)
inside the cell##4##3##(1993-6#1)(2008-11#1)(2008-7#1)(2012-12#1)
inside the cells##3##3##(1991-9#1)(1993-8#1)(2008-9#1)
inside the crystal##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
inside the droplet##2##3##(2008-2#2)
inside the female##2##3##(2008-5#2)
inside the glass##4##3##(2007-11#1)(2007-12#3)
inside the microcavity##2##3##(2007-12#2)
inside the optical##2##3##(2007-11#2)
inside the particles##2##3##(2008-3#2)
inside the tree canopy##2##4##(2008-10#2)
inside the volume##2##3##(2007-11#1)(2007-12#1)
inside the waveguide##2##3##(2008-3#2)
inside the##158##2##(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-12#2)(1996-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#11)(2007-12#21)(2007-9#2)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#27)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
inside turbid media##2##3##(2007-11#2)
inside##356##1##(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#3)(1997-6#1)(1997-7#4)(1997-8#2)(2007-11#28)(2007-12#39)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#57)(2008-11#11)(2008-12#3)(2008-2#18)(2008-3#63)(2008-5#10)(2008-6#2)(2008-7#14)(2008-8#9)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#5)
inside-out membrane patches##3##3##(1995-5#1)(2008-8#2)
inside-out membrane vesicles##3##3##(1997-8#3)
inside-out membrane##6##2##(1995-5#1)(1997-8#3)(2008-8#2)
inside-out patch##5##2##(1994-12#1)(1995-11#3)(2008-8#1)
inside-out patches##2##2##(1990-11#1)(1995-5#1)
inside-out##16##1##(1990-11#2)(1994-12#2)(1995-11#3)(1995-5#2)(1997-8#3)(2008-8#3)(2012-2#1)
insidious##5##1##(1995-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
insight about the##2##3##(2008-10#1)(2010-4#1)
insight about##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
insight and##6##2##(1996-3#1)(1996-8#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
insight can be##2##3##(2008-11#2)
insight for##4##2##(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)
insight from the##2##3##(2009-11#1)(2009-12#1)
insight from##3##2##(2009-11#1)(2009-12#1)(2013-7#1)
insight in the##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
insight in##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-9#1)(2010-8#1)(2013-8#1)
insight into both the##2##4##(2008-10#1)(2012-2#1)
insight into how##8##3##(1997-7#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-12#1)(2013-1#1)
insight into its##2##3##(1997-4#1)(2008-10#1)
insight into possible##2##3##(2008-10#1)(2008-7#1)
insight into the current state##2##5##(2008-10#1)(2012-2#1)
insight into the evolutionary##2##4##(1994-8#1)(1997-9#1)
insight into the interaction of##2##5##(2008-10#1)(2010-3#1)
insight into the mechanism of##4##5##(2008-10#2)(2008-11#1)(2013-1#1)
insight into the mechanism##7##4##(1990-5#1)(2008-10#3)(2008-11#1)(2009-5#1)(2013-1#1)
insight into the mechanisms of##3##5##(2007-8#1)(2008-11#1)(2008-4#1)
insight into the mechanisms##5##4##(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
insight into the nature of##2##5##(2008-1#1)(2008-10#1)
insight into the origin of##2##5##(1995-11#1)(1997-3#1)
insight into the origin##3##4##(1995-11#1)(1997-3#1)(2008-2#1)
insight into the physiological##2##4##(1995-3#1)(2008-9#1)
insight into the potential##3##4##(2009-8#1)(2012-2#1)(2013-1#1)
insight into the quality##2##4##(1991-6#1)(1993-2#1)
insight into the relationship between##2##5##(2008-3#1)(2010-6#1)
insight into the role of##4##5##(1991-10#1)(1992-6#1)(2008-11#1)(2009-8#1)
insight into the roles of##3##5##(2008-7#1)(2011-2#1)(2012-12#1)
insight into the structure##2##4##(2007-7#1)(2008-9#1)
insight into the unique##4##4##(1993-12#1)(1994-3#1)(2010-6#1)(2011-2#1)
insight into the##118##3##(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-6#3)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-3#3)(1997-9#2)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#16)(2008-11#8)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#4)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)
insight into their##8##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-7#1)
insight into this##7##3##(1993-8#1)(1995-5#1)(1996-5#1)(1997-3#1)(2008-7#1)(2009-12#1)(2010-12#1)
insight into whether##2##3##(2009-5#1)(2011-1#1)
insight into##205##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-7#1)(1997-9#2)(2007-11#1)(2007-12#9)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#23)(2008-11#15)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
insight of##2##2##(2008-7#1)(2012-1#1)
insight on how##2##3##(2008-10#1)(2008-11#1)
insight on the##6##3##(1993-2#1)(1993-9#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
insight on##8##2##(1993-2#1)(1993-9#1)(2008-10#2)(2008-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
insight that##2##2##(2008-11#1)(2012-12#1)
insight to##2##2##(1990-2#1)(2012-2#1)
insight##266##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#3)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-7#1)(1997-9#2)(2007-11#2)(2007-12#9)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#29)(2008-11#21)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#1)(2008-6#6)(2008-7#14)(2008-8#6)(2008-9#9)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#5)
insights about the##2##3##(1992-2#1)(2011-2#1)
insights about##6##2##(1992-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
insights and##7##2##(1992-3#1)(1993-12#2)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
insights are##3##2##(1992-3#1)(2008-7#1)(2009-3#1)
insights can be##2##3##(1993-12#1)(1996-1#1)
insights for the##2##3##(2008-7#1)(2013-1#1)
insights for##5##2##(2007-12#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
insights from##10##2##(1994-12#1)(1994-2#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#2)
insights gained from##2##3##(1991-5#1)(2012-2#1)
insights in the##6##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
insights in##15##2##(2006-10#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#2)
insights into cardiovascular##2##3##(2008-10#1)(2012-2#1)
insights into how this##2##4##(1994-8#1)(2010-3#1)
insights into how##6##3##(1994-8#1)(2007-12#2)(2008-11#1)(2009-3#1)(2010-3#1)
insights into molecular##2##3##(2008-10#1)(2008-9#1)
insights into the basic##2##4##(1994-9#1)(2010-3#1)
insights into the complex##2##4##(2008-10#1)(2012-3#1)
insights into the contributions of##2##5##(2012-12#1)(2013-8#1)
insights into the development##2##4##(2008-4#1)(2010-11#1)
insights into the evolution of##5##5##(1993-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)
insights into the evolutionary##2##4##(2007-12#1)(2008-9#1)
insights into the kinetic##2##4##(2008-1#1)(2008-11#1)
insights into the mechanisms by which##2##6##(2008-7#1)(2010-5#1)
insights into the mechanisms##3##4##(2008-11#1)(2008-7#1)(2010-5#1)
insights into the molecular##4##4##(1992-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
insights into the nature##3##4##(2012-3#1)(2013-1#2)
insights into the pathogenesis of##3##5##(2007-10#1)(2008-7#1)(2010-12#1)
insights into the potential##2##4##(1994-3#1)(2010-1#1)
insights into the role of##2##5##(2008-10#1)(2013-8#1)
insights into the role##3##4##(2008-10#1)(2012-12#1)(2013-8#1)
insights into the structure##2##4##(2008-4#1)(2012-12#1)
insights into the understanding of##2##5##(1997-3#1)(2010-7#1)
insights into the##102##3##(1992-11#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#2)
insights into their##4##3##(1993-11#1)(2008-4#1)(2008-6#1)(2013-1#1)
insights into this relationship##2##4##(2012-12#1)(2012-2#1)
insights into this##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
insights into underlying##2##3##(1991-3#1)(2008-7#1)
insights into##172##2##(1991-3#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#15)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#9)(2012-12#5)(2012-2#11)(2012-3#6)(2013-1#14)(2013-8#2)
insights may##3##2##(2012-3#1)(2013-1#2)
insights of##4##2##(1992-3#1)(2008-1#1)(2008-11#1)(2010-1#1)
insights on the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
insights on##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
insights provided by##2##3##(2008-6#1)(2013-8#1)
insights that can be##2##4##(2008-9#1)(2013-8#1)
insights that can##3##3##(2008-9#1)(2012-1#1)(2013-8#1)
insights that##6##2##(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2012-1#1)(2013-8#1)
insights to##4##2##(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
insights##266##1##(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#20)(2008-8#9)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#5)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#5)(2010-10#2)(2010-11#5)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#18)(2012-1#1)(2012-12#7)(2012-2#17)(2012-3#8)(2013-1#23)(2013-8#4)
insignificant bias##2##2##(2008-10#2)
insignificant change in##2##3##(1992-5#1)(2008-10#1)
insignificant effect##2##2##(1993-6#1)(2008-2#1)
insignificant in##2##2##(2008-10#2)
insignificant##42##1##(1990-2#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-3#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
insignificantly##6##1##(1993-11#1)(2007-7#4)(2008-7#1)
insipidus (DI)##2##2##(1997-8#1)(2007-10#1)
insipidus##22##1##(1993-6#2)(1994-11#2)(1994-8#3)(1997-3#2)(1997-8#2)(2007-10#2)(2008-4#2)(2008-7#1)(2011-1#3)(2012-3#1)(2013-1#2)
insist on a##2##3##(2008-11#2)
insist on##4##2##(1995-12#1)(2008-11#2)(2009-7#1)
insist##6##1##(1995-12#1)(2008-11#2)(2009-5#1)(2009-7#1)(2012-3#1)
insisted##2##1##(2008-10#1)(2011-2#1)
insisting##4##1##(2008-4#3)(2013-8#1)
insists on##2##2##(1992-3#1)(2010-4#1)
insists##4##1##(1992-2#1)(1992-3#1)(2010-4#1)(2010-8#1)
insofar as they##4##3##(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
insofar as##6##2##(1991-12#1)(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
insolens Y1##3##2##(2013-1#3)
insolubility in##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
insolubility of##3##2##(1994-8#1)(1995-11#1)(2008-10#1)
insolubility##11##1##(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
insoluble A beta##3##3##(1994-11#3)
insoluble Cr(VI)##3##2##(2008-10#3)
insoluble amyloid deposits##2##3##(1994-11#2)
insoluble amyloid##3##2##(1994-11#2)(1994-8#1)
insoluble and##2##2##(1991-11#1)(1997-4#1)
insoluble cell fraction##2##3##(1990-5#2)
insoluble complexes##2##2##(2008-10#2)
insoluble compounds##3##2##(2008-10#3)
insoluble in the##2##3##(1996-1#1)(1997-4#1)
insoluble in water##2##3##(2008-11#1)(2012-2#1)
insoluble in##7##2##(1996-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2012-2#1)
insoluble lignin##2##2##(2008-6#2)
insoluble matrix##2##2##(2008-1#1)(2010-5#1)
insoluble monolayer##4##2##(2008-10#4)
insoluble polymer##2##2##(2008-6#1)(2013-1#1)
insoluble precipitates##2##2##(1994-11#1)(1996-12#1)
insoluble protein##3##2##(1990-5#1)(1990-8#1)(2011-2#1)
insoluble##90##1##(1990-12#2)(1990-2#2)(1990-5#3)(1990-8#1)(1991-11#2)(1991-7#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-11#8)(1994-12#1)(1994-3#2)(1994-8#1)(1996-1#2)(1996-12#1)(1997-4#3)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#2)(2009-7#2)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
insolubles##3##1##(2008-10#3)
insolvent##2##1##(1991-1#1)(2008-11#1)
insomnia and##2##2##(1997-4#1)(2008-7#1)
insomnia may be##2##3##(2013-1#1)(2013-7#1)
insomnia##26##1##(1994-6#2)(1996-9#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#3)(2008-7#2)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#7)(2013-7#2)(2013-8#1)
insonation##3##1##(2008-10#2)(2008-8#1)
inspect the##3##2##(2007-12#1)(2008-7#1)(2011-1#1)
inspect##5##1##(1997-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-1#1)
inspected for##2##2##(2008-10#1)(2011-2#1)
inspected in##2##2##(2007-12#1)(2008-4#1)
inspected##10##1##(1993-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-8#1)(2011-2#2)(2013-8#2)
inspecting##4##1##(2007-12#1)(2008-10#1)(2008-6#1)(2009-3#1)
inspection after tooth separation was##2##5##(2008-12#2)
inspection and##6##2##(1995-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
inspection for##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
inspection of engine cylinder walls##2##5##(2008-3#2)
inspection of the##9##3##(1994-12#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)(2012-2#1)
inspection of##23##2##(1992-9#1)(1993-2#1)(1994-12#1)(1995-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-6#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)
inspection requirements for outpatient imaging centers##2##6##(1993-2#2)
inspection##70##1##(1992-2#1)(1992-9#1)(1993-2#4)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#15)(2008-4#1)(2008-6#2)(2008-9#1)(2009-8#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
inspections and##2##2##(1993-2#1)(2011-1#1)
inspections##10##1##(1993-12#1)(1993-2#1)(1996-3#1)(1996-5#1)(2008-3#1)(2010-4#3)(2011-1#1)(2013-8#1)
inspectorates##2##1##(2008-7#2)
inspiration and##2##2##(2007-12#1)(2008-1#1)
inspiration to##3##2##(2007-2#1)(2008-12#1)(2008-5#1)
inspiration##15##1##(1990-9#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-11#1)(2011-2#1)(2012-3#2)
inspiratory and expiratory##3##3##(1991-11#1)(1996-2#1)(1996-3#1)
inspiratory flow rate##2##3##(1997-2#1)(2012-2#1)
inspiratory flow##9##2##(1992-3#2)(1995-3#4)(1997-2#1)(2012-1#1)(2012-2#1)
inspiratory or##2##2##(1996-5#2)
inspiratory##28##1##(1991-11#1)(1992-3#2)(1994-2#1)(1995-3#5)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#1)(2008-11#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-7#1)
inspire##2##1##(1995-1#1)(2012-2#1)
inspired a##2##2##(2008-1#1)(2008-8#1)
inspired by##5##2##(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
inspired oxygen##2##2##(2007-12#1)(2007-8#1)
inspired the##4##2##(2007-12#1)(2008-12#1)(2008-7#1)(2009-5#1)
inspired##19##1##(1992-2#1)(1992-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
inspiring##2##1##(1994-1#1)(2008-5#1)
instabilities are##2##2##(2007-12#2)
instabilities can##2##2##(2008-2#1)(2012-1#1)
instabilities in the output##2##4##(2007-12#1)(2008-3#1)
instabilities in the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
instabilities in##9##2##(2007-11#4)(2007-12#3)(2008-11#1)(2008-3#1)
instabilities that##2##2##(2007-11#2)
instabilities##33##1##(2007-11#9)(2007-12#10)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#2)(2012-3#1)(2013-1#3)
instability (MI)##2##2##(2007-11#2)
instability analysis##3##2##(2008-10#2)(2013-8#1)
instability and##22##2##(1993-11#1)(1994-8#1)(1995-6#1)(2007-11#4)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
instability are##3##2##(2008-4#1)(2010-2#1)(2011-2#1)
instability during##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
instability for##2##2##(1995-2#1)(2007-8#1)
instability in a##3##3##(1994-2#1)(2007-11#1)(2007-12#1)
instability in the##4##3##(2007-11#1)(2008-7#2)(2008-9#1)
instability in##24##2##(1992-8#1)(1994-2#1)(1994-6#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
instability induced by##2##3##(1992-5#1)(2007-11#1)
instability is##6##2##(2007-11#1)(2007-12#2)(2008-7#2)(2011-2#1)
instability of a##2##3##(2008-3#1)(2013-1#1)
instability of the##12##3##(1990-5#1)(1991-12#1)(1992-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-9#2)(2011-7#1)(2012-3#1)
instability of##33##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-6#1)(2007-11#4)(2007-12#7)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
instability or##2##2##(2008-12#1)(2013-1#1)
instability that##4##2##(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
instability was##5##2##(1994-6#1)(2008-10#1)(2008-3#1)(2012-1#2)
instability were##4##2##(2008-4#1)(2008-8#1)(2013-1#2)
instability##229##1##(1990-5#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#4)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-3#1)(2007-11#33)(2007-12#23)(2007-8#2)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#1)(2010-2#3)(2011-1#2)(2011-10#1)(2011-2#15)(2011-7#1)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#16)(2012-9#1)(2013-1#19)(2013-7#1)(2013-8#2)
instability)##3##1##(1993-12#1)(2008-4#1)(2008-9#1)
instable##4##1##(1990-11#2)(2008-10#1)(2013-8#1)
install the##3##2##(1996-1#1)(2008-10#1)(2009-9#1)
install##6##1##(1996-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)
installation and use of##2##4##(2008-4#1)(2013-1#1)
installation of a##4##3##(1990-10#1)(1996-2#1)(2008-10#2)
installation of the##4##3##(1990-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
installation of##14##2##(1990-10#2)(1990-3#1)(1992-11#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-10#1)
installation##30##1##(1990-10#2)(1990-3#1)(1992-11#2)(1992-2#1)(1992-6#1)(1994-3#3)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-10#1)(2012-2#1)(2013-1#1)
installations##6##1##(1991-3#2)(2008-10#2)(2008-2#1)(2009-10#1)
installed and##2##2##(1991-12#1)(2008-11#1)
installed at the##3##3##(2008-2#1)(2008-3#2)
installed in##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
installed on a##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
installed on##5##2##(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)
installed with##2##2##(2008-10#1)(2010-4#1)
installed##30##1##(1991-12#1)(1992-12#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2013-1#5)
installing a##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
installing dust control devices##3##4##(2009-12#3)
installing##10##1##(1994-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#3)
instance of a##6##3##(1993-11#1)(1993-6#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
instance of##12##2##(1992-6#1)(1993-11#2)(1993-6#2)(1996-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
instance the##2##2##(2008-10#2)
instance##77##1##(1992-12#1)(1992-6#1)(1993-11#3)(1993-6#2)(1994-6#1)(1995-8#2)(1996-12#1)(1997-3#1)(1997-7#3)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
instances and##2##2##(2008-10#1)(2008-7#1)
instances due to##2##3##(1997-3#1)(2012-3#1)
instances for##2##2##(2008-12#2)
instances in the##2##3##(2008-10#1)(2013-8#1)
instances in which##2##3##(2008-3#2)
instances in##4##2##(2008-10#1)(2008-3#2)(2013-8#1)
instances of##14##2##(1991-12#1)(1995-1#1)(1995-6#1)(1997-5#1)(2008-4#1)(2008-7#4)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
instances the##3##2##(1995-5#1)(1997-2#1)(1997-5#1)
instances where##4##2##(1993-2#1)(1994-11#1)(2008-4#1)(2008-8#1)
instances##85##1##(1990-11#2)(1990-8#1)(1991-12#4)(1991-6#2)(1992-1#1)(1992-5#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#3)
instant and lasting relief of dentin hypersensitivity##2##7##(2011-2#2)
instant and lasting relief of##3##5##(2011-2#3)
instant and lasting##4##3##(2011-2#4)
instant powders##2##2##(2008-10#2)
instant##21##1##(1992-6#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#3)(2011-2#6)(2012-2#1)
instantaneous information##2##2##(2008-3#1)(2011-1#1)
instantaneous measurements of##2##3##(2008-3#2)
instantaneous##42##1##(1990-11#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#12)(2008-9#1)(2009-9#3)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
instantaneously##7##1##(1997-4#1)(2008-10#4)(2008-3#1)(2012-2#1)
instantiated##2##1##(2008-7#1)(2012-1#1)
instantly##7##1##(1992-3#1)(1997-2#1)(2008-1#1)(2008-10#4)
instar larva##3##2##(2008-10#1)(2008-6#2)
instar larvae of##5##3##(1997-8#1)(2007-12#1)(2010-10#1)(2013-1#2)
instar larvae##17##2##(1992-6#4)(1995-11#1)(1996-5#1)(1997-8#1)(2007-12#5)(2008-12#1)(2010-10#1)(2013-1#2)(2013-8#1)
instar of##2##2##(2007-12#1)(2008-12#1)
instar##35##1##(1992-6#6)(1995-11#1)(1996-5#1)(1997-8#1)(2007-12#12)(2008-10#2)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-11#1)(2013-1#2)(2013-8#1)
instars of A##2##3##(2008-5#1)(2008-6#1)
instars of##4##2##(2008-10#1)(2008-5#2)(2008-6#1)
instars##11##1##(2007-12#2)(2008-10#1)(2008-5#4)(2008-6#1)(2008-7#1)(2011-2#2)
instationary batch##2##2##(2008-11#2)
instead a##2##2##(1992-12#1)(2012-3#1)
instead is##2##2##(2008-4#1)(2008-7#1)
instead of &quot##2##3##(2008-10#1)(2008-12#1)
instead of 60##2##3##(2008-10#2)
instead of a single##2##4##(1997-8#1)(2008-3#1)
instead of a##17##3##(1992-3#1)(1996-2#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-6#1)
instead of an##4##3##(1993-8#1)(1994-2#1)(1995-8#1)(2008-4#1)
instead of being##4##3##(1991-6#1)(2008-11#1)(2008-4#1)(2013-8#1)
instead of employing##2##3##(2008-10#1)(2012-12#1)
instead of just##2##3##(2008-3#1)(2010-7#1)
instead of on##2##3##(1990-11#1)(2008-10#1)
instead of the conventional##2##4##(1990-8#1)(2008-2#1)
instead of the typical##2##4##(2007-11#1)(2008-10#1)
instead of the usual##4##4##(1992-3#1)(1994-2#1)(2007-12#1)(2008-10#1)
instead of the##38##3##(1990-11#1)(1990-7#2)(1990-8#2)(1992-12#1)(1992-3#1)(1994-2#1)(2007-11#5)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-9#3)(2009-5#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
instead of using##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
instead of##183##2##(1990-11#2)(1990-12#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-8#1)(2007-10#1)(2007-11#14)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#33)(2008-11#8)(2008-12#2)(2008-2#12)(2008-3#15)(2008-4#6)(2008-6#5)(2008-7#2)(2008-8#5)(2008-9#7)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#2)
instead the##2##2##(1992-5#1)(2008-7#1)
instead to##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
instead##245##1##(1990-11#2)(1990-12#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#14)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#41)(2008-11#10)(2008-12#2)(2008-2#13)(2008-3#20)(2008-4#8)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#9)(2008-9#13)(2009-11#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#2)
instigated a##2##2##(2011-1#1)(2011-2#1)
instigated##3##1##(2011-1#2)(2011-2#1)
instillation in##2##2##(2008-11#1)(2012-3#1)
instillation of a##2##3##(2011-2#1)(2013-1#1)
instillation of the##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
instillation of##13##2##(1990-11#1)(1993-11#1)(1994-12#1)(1996-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2010-10#1)(2011-2#2)(2013-1#1)
instillation##28##1##(1990-11#1)(1993-11#1)(1994-12#1)(1995-12#3)(1996-8#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#3)(2010-10#1)(2010-12#1)(2011-2#5)(2012-3#1)(2013-1#1)
instilled mice at 8 weeks##2##5##(2008-10#2)
instilled mice##4##2##(2008-10#4)
instilled##18##1##(1992-11#1)(1993-11#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#9)(2010-10#1)(2010-3#1)(2012-12#1)(2012-3#1)
instilling##2##1##(1992-11#1)(1993-12#1)
institute of##2##2##(2007-7#1)(2008-1#1)
institute##19##1##(1992-1#1)(1992-5#1)(1993-9#1)(1994-3#1)(1995-5#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#3)
instituted a##3##2##(1996-3#1)(1997-2#2)
instituted in##3##2##(1994-12#1)(2007-8#1)(2008-12#1)
instituted##23##1##(1991-1#1)(1991-12#2)(1992-1#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2013-8#1)
institutes and##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
institutes##12##1##(1993-3#1)(1994-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
instituting##2##1##(1992-11#1)(1992-3#1)
institution and##8##2##(1992-12#1)(1994-1#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2013-1#2)
institution for the##2##3##(1992-12#1)(2008-12#1)
institution for##4##2##(1991-6#1)(1992-12#1)(2008-12#1)(2008-6#1)
institution has been##2##3##(2007-11#1)(2008-8#1)
institution has##3##2##(2007-11#1)(2008-8#1)(2009-11#1)
institution in##6##2##(1991-3#1)(1993-12#1)(1994-12#1)(2007-11#1)(2011-3#1)(2012-2#1)
institution is##2##2##(1995-1#1)(2007-8#1)
institution of appropriate##2##3##(2011-2#1)(2013-8#1)
institution of##12##2##(1996-12#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-8#1)
institution to##3##2##(1993-1#1)(1994-2#1)(2012-12#1)
institution with##6##2##(1990-6#1)(2007-8#1)(2008-12#1)(2008-8#2)(2013-1#1)
institution##138##1##(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#2)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#1)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#6)(2008-1#1)(2008-11#5)(2008-12#5)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#4)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#2)
institution's##14##1##(1990-11#1)(1991-3#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-2#3)(1996-3#1)(2008-8#2)(2009-11#1)(2011-2#1)(2013-1#1)
institution-based##2##1##(1995-1#1)(2008-11#1)
institutional and##4##2##(1991-12#1)(1991-6#1)(2008-7#1)(2009-11#1)
institutional care##6##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(2008-12#1)
institutional commitment##2##2##(1996-3#1)(2009-3#1)
institutional experience##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
institutional level##3##2##(2008-7#1)(2009-4#1)(2013-1#1)
institutional review board##4##3##(1993-2#1)(2010-9#1)(2012-3#1)(2013-8#1)
institutional review##5##2##(1993-2#1)(1995-1#1)(2010-9#1)(2012-3#1)(2013-8#1)
institutional setting##3##2##(1993-1#1)(2008-7#1)(2008-9#1)
institutional support##2##2##(1991-2#1)(2013-8#1)
institutional##87##1##(1991-1#4)(1991-12#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#4)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-7#6)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#3)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
institutionalisation##2##1##(1997-6#1)(2008-9#1)
institutionalised elderly##2##2##(2008-7#1)(2012-12#1)
institutionalised##13##1##(2008-10#3)(2008-7#3)(2011-2#6)(2012-12#1)
institutionalization at follow-up##2##3##(2009-9#2)
institutionalization of the##2##3##(1992-12#1)(2009-7#1)
institutionalization of##7##2##(1992-12#1)(1996-2#1)(2009-7#1)(2010-1#2)(2013-1#2)
institutionalization##24##1##(1990-5#1)(1992-1#1)(1992-12#1)(1993-1#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-9#5)(2010-1#2)(2010-9#1)(2012-2#1)(2013-1#4)
institutionalized elderly home residents##2##4##(2008-1#2)
institutionalized elderly##5##2##(1994-6#1)(2008-1#3)(2008-7#1)
institutionalized##13##1##(1991-6#1)(1994-12#2)(1994-6#1)(1997-3#2)(1997-8#1)(2007-10#1)(2008-1#3)(2008-7#2)
institutions across##2##2##(1993-12#1)(2013-1#1)
institutions and community-based##2##3##(1992-3#1)(2012-2#1)
institutions and sex ratios in India##2##6##(2011-2#2)
institutions and##21##2##(1990-6#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#3)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
institutions are##5##2##(1994-12#1)(1995-2#1)(2010-10#1)(2010-12#1)(2010-3#1)
institutions as##4##2##(1993-1#1)(1994-3#1)(1995-1#1)(2008-11#1)
institutions for the##2##3##(1990-6#1)(1991-11#1)
institutions for##7##2##(1990-6#1)(1991-11#1)(1993-3#1)(1995-5#1)(2008-10#1)(2008-12#1)(2012-12#1)
institutions from##2##2##(1991-3#1)(2013-1#1)
institutions have##4##2##(1997-1#1)(2008-6#2)(2012-2#1)
institutions in the area##2##4##(1992-2#1)(2012-12#1)
institutions in the##3##3##(1992-2#1)(2012-12#1)(2013-8#1)
institutions in##17##2##(1991-6#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-1#2)(2009-7#2)(2010-12#1)(2010-3#2)(2012-12#1)(2012-3#2)(2013-8#2)
institutions involved in##2##3##(1992-3#1)(2011-2#1)
institutions of##3##2##(1997-2#1)(2007-8#1)(2012-3#1)
institutions should##2##2##(1994-3#1)(2008-6#1)
institutions such as##2##3##(1991-3#1)(2012-12#1)
institutions that##5##2##(1993-12#1)(1995-12#1)(2008-12#1)(2012-12#2)
institutions to##8##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#1)
institutions were##4##2##(1993-12#1)(1995-11#1)(2009-8#1)(2012-3#1)
institutions with##3##2##(2007-10#1)(2008-9#1)(2011-2#1)
institutions##209##1##(1990-6#3)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#5)(1992-3#4)(1992-5#1)(1993-1#4)(1993-12#9)(1993-2#4)(1993-3#3)(1994-1#4)(1994-12#2)(1994-2#3)(1994-3#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#6)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#2)(1997-7#1)(2007-10#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#7)(2008-2#1)(2008-6#4)(2008-7#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#4)(2009-5#1)(2009-7#6)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#7)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#9)(2012-12#11)(2012-2#3)(2012-3#7)(2013-1#7)(2013-8#6)
instruct##2##1##(1995-4#1)(1995-5#1)
instructed that the##2##3##(2008-11#1)(2012-12#1)
instructed that##4##2##(2008-11#3)(2012-12#1)
instructed to##11##2##(1991-2#1)(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
instructed##22##1##(1991-2#1)(1994-2#1)(1994-8#1)(1995-5#2)(1996-2#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
instructing##3##1##(1992-2#1)(1995-3#1)(2009-2#1)
instruction and training##2##3##(2007-2#1)(2012-12#1)
instruction and##6##2##(1993-1#1)(2007-2#1)(2008-12#2)(2012-12#1)(2013-1#1)
instruction as##2##2##(2011-2#2)
instruction in the##2##3##(1995-3#1)(2013-1#1)
instruction in##7##2##(1993-12#2)(1995-3#2)(1995-6#2)(2013-1#1)
instruction on the topic##2##4##(1994-2#2)
instruction on##6##2##(1994-2#2)(1996-11#1)(2013-1#3)
instruction set##2##2##(2008-3#2)
instruction to##2##2##(1993-3#1)(1993-8#1)
instruction was##2##2##(1994-2#1)(2008-12#1)
instruction##68##1##(1991-12#5)(1992-12#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-3#5)(1995-6#2)(1996-11#1)(1997-5#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-12#8)(2008-3#2)(2008-4#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2013-1#9)(2013-8#2)
instructional method##2##2##(1996-1#2)
instructional technique in##2##3##(1993-1#1)(2011-2#1)
instructional##16##1##(1990-3#1)(1993-1#1)(1995-1#1)(1996-1#2)(2008-12#3)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
instructions and##8##2##(1993-12#1)(2008-12#1)(2009-11#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
instructions for the##2##3##(2008-4#1)(2008-9#1)
instructions for##8##2##(2007-10#1)(2008-10#1)(2008-4#4)(2008-9#1)(2012-12#1)
instructions in##3##2##(1994-1#1)(2008-8#1)(2011-2#1)
instructions on how to##3##4##(1990-2#2)(2009-11#1)
instructions on##7##2##(1990-2#2)(1991-2#1)(1992-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
instructions to##7##2##(1994-3#1)(1995-12#1)(2008-11#2)(2008-7#1)(2009-4#1)(2011-1#1)
instructions##50##1##(1990-2#2)(1991-2#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#2)(1995-12#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
instructive##9##1##(1996-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-7#1)
instructor##5##1##(1994-7#2)(2007-6#3)
instructors who normally teach##2##4##(2011-2#2)
instructors##6##1##(1993-1#1)(2008-10#1)(2008-12#1)(2011-2#3)
instructs the##2##2##(2012-12#2)
instrument and a##2##3##(2008-3#2)
instrument and the##5##3##(2008-10#1)(2008-3#4)
instrument and##20##2##(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-3#12)(2008-7#1)(2011-2#1)(2012-1#1)
instrument applied##2##2##(2012-2#1)(2013-1#1)
instrument are reported##2##3##(2008-10#2)
instrument are##6##2##(2008-10#2)(2008-3#3)(2008-9#1)
instrument artifacts##2##2##(1997-2#1)(2011-2#1)
instrument at##3##2##(2008-3#2)(2008-9#1)
instrument based on##3##3##(2008-2#1)(2008-3#2)
instrument by##2##2##(2008-10#1)(2008-2#1)
instrument calibration##3##2##(2008-10#2)(2008-3#1)
instrument can be##3##3##(2008-3#3)
instrument can##7##2##(2008-3#5)(2011-2#2)
instrument configuration##2##2##(2008-10#1)(2008-3#1)
instrument design and##2##3##(2008-10#1)(2008-3#1)
instrument design##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
instrument detection##2##2##(2008-10#2)
instrument for air monitoring at submillimeter wavelengths##2##7##(2007-12#2)
instrument for measuring##4##3##(1996-3#1)(2008-3#1)(2012-2#1)(2013-1#1)
instrument for the##6##3##(2008-10#1)(2008-12#1)(2008-3#2)(2012-2#1)(2013-1#1)
instrument for use in##2##4##(1992-3#1)(2010-11#1)
instrument for##45##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#8)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
instrument from##2##2##(2008-10#1)(2008-2#1)
instrument function##4##2##(2008-3#4)
instrument has a##2##3##(2008-2#1)(2008-3#1)
instrument has been developed##2##4##(2008-2#1)(2008-3#1)
instrument has been##6##3##(2007-11#1)(2008-2#2)(2008-3#1)(2012-12#2)
instrument has potential##2##3##(2008-3#1)(2008-5#1)
instrument has##10##2##(2007-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2012-12#2)
instrument in the##2##3##(2008-8#1)(2012-2#1)
instrument in##6##2##(1997-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-2#1)
instrument included##2##2##(1993-2#1)(2008-10#1)
instrument is based on##3##4##(2008-3#3)
instrument is capable of##2##4##(2008-3#2)
instrument is demonstrated##2##3##(2007-11#1)(2008-10#1)
instrument is designed##3##3##(2008-2#1)(2008-3#2)
instrument is##31##2##(1994-3#1)(1997-8#1)(2007-11#2)(2008-10#7)(2008-2#2)(2008-3#15)(2008-9#1)(2010-12#1)(2012-12#1)
instrument line##2##2##(2008-3#2)
instrument line-shape distortions##2##3##(2008-2#2)
instrument measures the##2##3##(2008-3#2)
instrument measures##4##2##(1993-2#1)(2007-8#1)(2008-3#2)
instrument of##3##2##(2009-4#1)(2009-9#1)(2013-8#1)
instrument on the##2##3##(2008-10#1)(2008-3#1)
instrument operating##2##2##(2008-10#1)(2008-3#1)
instrument or##3##2##(1991-3#1)(1996-2#1)(2012-3#1)
instrument outputs##2##2##(2008-3#2)
instrument package##2##2##(2008-3#2)
instrument parameters##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
instrument performance##5##2##(2008-3#4)(2008-4#1)
instrument polarization sensitivity##2##3##(2008-2#2)
instrument provides##3##2##(2007-11#1)(2007-12#1)(2010-10#1)
instrument response##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
instrument sensitivity##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
instrument should be##2##3##(2008-10#1)(2008-3#1)
instrument that is capable of##2##5##(2007-11#1)(2008-3#1)
instrument that is##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
instrument that uses a##2##4##(2008-3#1)(2012-2#1)
instrument that uses##3##3##(2008-3#2)(2012-2#1)
instrument that##16##2##(1992-1#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#7)(2010-10#1)(2012-2#1)
instrument to assess##2##3##(2008-11#1)(2013-1#1)
instrument to measure##6##3##(1993-3#1)(1997-1#1)(2008-3#2)(2008-7#1)(2010-11#1)
instrument to##19##2##(1993-3#1)(1997-1#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2012-12#1)(2013-1#2)
instrument using##2##2##(2008-10#1)(2008-12#1)
instrument was developed##3##3##(1996-1#1)(2009-12#1)(2012-1#1)
instrument was evaluated##2##3##(1993-3#1)(1997-2#1)
instrument was used for##2##4##(2008-10#1)(2008-2#1)
instrument was##18##2##(1993-1#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-10#1)(2012-1#1)(2012-12#1)
instrument were##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
instrument with a##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
instrument with##12##2##(1990-11#1)(1993-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-6#1)(2012-3#1)
instrument within primary health care for##2##6##(2010-10#2)
instrument##498##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-2#4)(1993-3#3)(1994-2#1)(1994-3#4)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-1#4)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#14)(2007-12#8)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#95)(2008-11#10)(2008-12#6)(2008-2#39)(2008-3#149)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#20)(2009-12#8)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#7)(2010-11#4)(2010-12#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#9)(2012-2#8)(2012-3#3)(2013-1#15)(2013-8#8)
instrument's calibration##2##2##(2007-11#1)(2008-3#1)
instrument's##11##1##(2007-11#2)(2008-10#1)(2008-3#7)(2012-12#1)
instrument-limited##2##1##(2008-2#1)(2008-7#1)
instrumental activities of daily living##2##5##(2008-1#1)(2012-12#1)
instrumental analysis##6##2##(2008-10#5)(2008-5#1)
instrumental and chemical variables##2##4##(2008-10#2)
instrumental and##11##2##(2008-10#6)(2008-4#1)(2008-5#2)(2011-1#1)(2012-12#1)
instrumental approaches##3##2##(2008-10#3)
instrumental assessments##2##2##(2008-5#2)
instrumental conditions##3##2##(2008-10#3)
instrumental design##2##2##(2008-10#1)(2008-3#1)
instrumental detection##5##2##(2008-10#4)(2008-3#1)
instrumental error##2##2##(2007-11#1)(2008-2#1)
instrumental errors##2##2##(2008-3#2)
instrumental evaluations##2##2##(2008-5#2)
instrumental factors##3##2##(2008-10#3)
instrumental for the##3##3##(1993-11#1)(2009-8#1)(2011-2#1)
instrumental in the##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2012-1#1)
instrumental in##20##2##(1990-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
instrumental limit of detection##2##4##(2008-10#2)
instrumental line shape##2##3##(2008-3#2)
instrumental methods##4##2##(2008-10#2)(2008-5#2)
instrumental music##3##2##(2007-6#2)(2008-5#1)
instrumental neutron activation analysis##2##4##(2008-10#2)
instrumental noise##2##2##(2008-10#1)(2008-3#1)
instrumental operation##2##2##(2008-10#1)(2008-4#1)
instrumental or##2##2##(2008-6#1)(2010-5#1)
instrumental parameter##2##2##(2008-10#2)
instrumental parameters such as##2##4##(2008-10#2)
instrumental parameters were##4##3##(2008-10#4)
instrumental parameters##10##2##(1990-3#1)(2008-10#9)
instrumental requirements##2##2##(2008-10#1)(2009-12#1)
instrumental setup##2##2##(2007-12#1)(2008-3#1)
instrumental technique##3##2##(2008-10#3)
instrumental test##2##2##(1991-5#1)(2008-5#1)
instrumental tests##3##2##(1991-6#2)(2008-5#1)
instrumental texture##3##2##(2010-4#2)(2011-2#1)
instrumental to##3##2##(1997-3#1)(2009-8#1)(2012-2#1)
instrumental variables##6##2##(2008-10#6)
instrumental##185##1##(1990-3#2)(1990-6#1)(1990-8#1)(1991-3#3)(1991-5#1)(1991-6#2)(1992-5#1)(1993-11#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#3)(2008-1#1)(2008-10#80)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#19)(2008-4#4)(2008-5#17)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#3)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)
instrumentalization##4##1##(2012-3#4)
instrumentally##3##1##(2006-4#1)(2008-10#1)(2008-5#1)
instrumentation and fusion##2##3##(2012-12#1)(2012-3#1)
instrumentation and##21##2##(2007-8#3)(2008-10#7)(2008-3#3)(2008-8#4)(2010-11#1)(2012-12#1)(2012-3#2)
instrumentation are##5##2##(2008-10#2)(2008-3#1)(2009-2#1)(2011-2#1)
instrumentation for the##3##3##(2008-10#2)(2008-11#1)
instrumentation for##9##2##(2008-10#3)(2008-11#1)(2008-2#2)(2008-8#2)(2013-1#1)
instrumentation has been##2##3##(2008-3#2)
instrumentation has##4##2##(2008-10#2)(2008-3#2)
instrumentation have##2##2##(2008-10#2)
instrumentation hyphenation##2##2##(2008-10#2)
instrumentation in##2##2##(1997-3#1)(2008-4#1)
instrumentation is##2##2##(2007-12#1)(2008-10#1)
instrumentation of##2##2##(2008-11#1)(2008-3#1)
instrumentation system##2##2##(2008-10#2)
instrumentation that##2##2##(2008-3#1)(2008-8#1)
instrumentation to##4##2##(2008-2#1)(2008-8#2)(2012-2#1)
instrumentation used##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
instrumentation with##5##2##(2008-10#2)(2008-11#2)(2008-2#1)
instrumentation##119##1##(1992-11#1)(1994-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-10#44)(2008-11#7)(2008-2#4)(2008-3#13)(2008-4#1)(2008-7#1)(2008-8#13)(2008-9#1)(2009-2#2)(2010-11#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
instrumented fusions##2##2##(2012-3#2)
instrumented##9##1##(1994-3#1)(2008-11#2)(2012-12#1)(2012-3#3)(2013-1#2)
instruments and techniques##2##3##(1993-12#1)(2008-9#1)
instruments and the##2##3##(2008-10#1)(2008-7#1)
instruments and##20##2##(1991-9#1)(1993-12#1)(1993-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(2008-10#6)(2008-7#1)(2008-9#2)(2010-9#1)(2013-1#4)
instruments are used##3##3##(2008-3#1)(2008-5#2)
instruments are##10##2##(1997-8#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)
instruments as well as##2##4##(1992-3#1)(2008-9#1)
instruments as##3##2##(1992-3#1)(2008-2#1)(2008-9#1)
instruments can##2##2##(2006-10#1)(2008-10#1)
instruments could##2##2##(2008-9#1)(2012-3#1)
instruments designed to##2##3##(2008-10#1)(2008-9#1)
instruments developed##2##2##(2008-10#2)
instruments for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
instruments for##14##2##(1991-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
instruments had##3##2##(2008-10#1)(2013-1#2)
instruments have been##4##3##(2008-10#1)(2008-3#1)(2010-1#1)(2010-10#1)
instruments have##6##2##(1991-3#1)(2008-10#1)(2008-3#2)(2010-1#1)(2010-10#1)
instruments in the##2##3##(1996-4#1)(2013-1#1)
instruments in##7##2##(1996-4#1)(2007-8#1)(2010-1#1)(2012-2#1)(2013-1#3)
instruments into the##2##3##(2007-11#1)(2007-8#1)
instruments is##5##2##(1991-6#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#1)
instruments may##3##2##(2011-2#1)(2013-1#2)
instruments measuring##2##2##(2010-4#1)(2010-5#1)
instruments on##2##2##(2008-10#1)(2008-2#1)
instruments present##2##2##(2008-3#1)(2009-12#1)
instruments simultaneously##2##2##(2008-3#2)
instruments that have##2##3##(1996-3#1)(2008-3#1)
instruments that##10##2##(1991-1#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#1)(2010-9#1)
instruments to##3##2##(2007-6#1)(2008-5#1)(2010-12#1)
instruments used for##2##3##(2008-10#1)(2008-5#1)
instruments used##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#2)(2013-8#1)
instruments was##2##2##(2008-9#2)
instruments were designed##2##3##(2008-3#1)(2010-3#1)
instruments were in good agreement##2##5##(2008-10#1)(2008-3#1)
instruments were in##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
instruments were##15##2##(1990-2#1)(1992-2#1)(1993-2#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2013-1#4)
instruments will##2##2##(2008-10#1)(2008-3#1)
instruments##274##1##(1990-2#1)(1990-8#1)(1991-1#4)(1991-3#2)(1991-6#4)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1997-4#1)(1997-8#3)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#3)(2007-8#4)(2008-10#35)(2008-11#4)(2008-12#3)(2008-2#16)(2008-3#45)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#24)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#4)(2010-7#1)(2010-9#4)(2011-1#4)(2011-2#7)(2011-7#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#30)(2013-8#2)
insufficiency and the##2##3##(1990-9#1)(2008-7#1)
insufficiency and##17##2##(1990-9#1)(1992-5#1)(1993-11#1)(1996-11#1)(1996-3#1)(2008-1#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-3#1)(2012-3#1)
insufficiency are##2##2##(2006-10#1)(2012-3#1)
insufficiency associated with high##2##4##(1992-5#1)(2011-2#1)
insufficiency due to##2##3##(1990-3#1)(1990-9#1)
insufficiency in##8##2##(1995-8#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#2)
insufficiency is##2##2##(2009-9#1)(2013-1#1)
insufficiency of the lower limbs##2##5##(1990-3#1)(1997-3#1)
insufficiency of the##3##3##(1990-3#1)(1990-9#1)(1997-3#1)
insufficiency of##7##2##(1990-3#1)(1990-9#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-5#1)(2013-1#1)
insufficiency with##5##2##(2007-12#1)(2008-4#2)(2008-7#1)(2011-3#1)
insufficiency##123##1##(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-9#4)(1991-3#1)(1991-6#2)(1991-9#1)(1992-5#2)(1993-11#1)(1993-3#3)(1993-5#1)(1994-12#1)(1994-3#2)(1995-8#2)(1996-11#3)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-10#6)(2007-10#1)(2007-12#3)(2007-7#5)(2007-8#3)(2008-1#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-9#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#3)(2012-2#4)(2012-3#12)(2013-1#11)
insufficiency]##6##1##(1991-6#1)(1992-5#1)(1995-2#1)(1995-3#1)(2007-10#1)(2007-6#1)
insufficient and##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
insufficient control##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
insufficient data##2##2##(2008-10#1)(2011-2#1)
insufficient documentation##2##2##(1997-4#1)(2008-7#1)
insufficient evidence to##4##3##(1994-5#1)(2011-2#1)(2013-1#2)
insufficient evidence##6##2##(1994-5#1)(2006-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
insufficient for##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
insufficient in##3##2##(2007-2#1)(2011-1#1)(2012-2#1)
insufficient information##3##2##(1993-8#1)(2007-12#1)(2008-10#1)
insufficient intake of calcium##2##4##(1997-8#2)
insufficient time##2##2##(1990-2#1)(2011-1#1)
insufficient to explain the##2##4##(2008-11#1)(2012-2#1)
insufficient to explain##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
insufficient to##19##2##(1990-2#1)(1995-5#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2011-2#2)(2012-2#1)(2012-3#1)
insufficient##117##1##(1990-2#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#1)
insufficiently##10##1##(1990-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-6#1)(2008-10#2)(2011-2#1)(2012-2#1)
insufflating##2##1##(2007-8#2)
insufflation gas##3##2##(1992-12#3)
insufflation of##2##2##(2011-2#1)(2012-3#1)
insufflation##10##1##(1992-12#3)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)
insula was##2##2##(2008-11#2)
insula##9##1##(1995-8#1)(2008-11#6)(2012-12#2)
insular##5##1##(1996-4#1)(1997-2#1)(2008-11#1)(2008-9#1)(2010-3#1)
insulated##2##1##(2008-10#1)(2011-1#1)
insulating##13##1##(2008-10#3)(2008-7#2)(2009-11#1)(2009-5#2)(2010-2#1)(2012-2#2)(2013-8#2)
insulation workers##3##2##(1991-12#3)
insulation##10##1##(1991-12#3)(1992-3#1)(2008-10#3)(2009-11#1)(2011-2#2)
insulator##2##1##(2008-10#1)(2013-8#1)
insulators##4##1##(1995-2#1)(2008-10#1)(2008-7#1)(2010-9#1)
insulin (group##2##2##(2012-4#2)
insulin (p =##2##3##(2008-3#1)(2013-8#1)
insulin +##3##2##(1991-12#2)(1993-6#1)
insulin A chain##2##3##(1990-12#1)(1992-3#1)
insulin action and##2##3##(2009-12#1)(2012-7#1)
insulin action##10##2##(1991-7#1)(1992-11#1)(1993-8#1)(1994-8#1)(1996-2#2)(2008-10#1)(2009-12#2)(2012-7#1)
insulin administration##4##2##(1990-11#1)(1996-2#1)(2007-10#1)(2008-3#1)
insulin aerosol##2##2##(1996-3#2)
insulin analog##4##2##(1992-6#2)(2008-4#2)
insulin analogs##2##2##(2008-1#1)(2012-2#1)
insulin analogues##2##2##(1990-12#1)(1992-3#1)
insulin and IGF-1 receptors##3##4##(1994-11#3)
insulin and IGF-1##7##3##(1994-11#5)(1996-2#1)(2008-9#1)
insulin and glucagon##3##3##(1994-11#1)(2008-11#1)(2008-3#1)
insulin and insulin##2##3##(2008-4#1)(2013-1#1)
insulin and insulin-like##2##3##(2008-10#1)(2009-11#1)
insulin and its##2##3##(2008-9#2)
insulin and leptin levels as compared to##2##7##(2013-1#2)
insulin and leptin##4##3##(2008-4#1)(2012-1#1)(2013-1#2)
insulin and phorbol##3##3##(1995-6#2)(1996-2#1)
insulin and transferrin##2##3##(1990-8#1)(2008-11#1)
insulin and##57##2##(1990-8#1)(1991-8#2)(1992-6#1)(1994-11#6)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#3)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#4)
insulin as##2##2##(2008-12#1)(2009-9#1)
insulin at##3##2##(1991-12#1)(1995-11#1)(2010-11#1)
insulin autoantibodies (IAA)##2##3##(1994-12#2)
insulin autoimmune syndrome##2##3##(1997-8#2)
insulin binding and glucose utilization in##2##6##(1990-7#2)
insulin binding and##4##3##(1990-7#2)(1993-8#1)(1997-1#1)
insulin binding##9##2##(1990-7#2)(1991-12#1)(1993-8#1)(1995-11#2)(1997-1#3)
insulin but##3##2##(1991-8#1)(1994-11#1)(1996-2#1)
insulin by##3##2##(1990-11#1)(2008-4#1)(2008-8#1)
insulin cells##3##2##(2010-11#3)
insulin concentration##5##2##(2008-3#1)(2008-8#1)(2010-10#2)(2012-2#1)
insulin concentrations##4##2##(1994-11#1)(2010-10#1)(2010-8#2)
insulin deficiency##5##2##(2008-3#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
insulin degradation##3##2##(1990-11#1)(1991-12#1)(1997-1#1)
insulin delivery##2##2##(2008-1#1)(2008-8#1)
insulin dependent diabetes mellitus##6##4##(1992-11#1)(1992-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2012-12#1)
insulin dependent diabetes##8##3##(1990-9#1)(1992-11#1)(1992-5#1)(1997-5#1)(2008-1#1)(2008-11#2)(2012-12#1)
insulin dosing##2##2##(2008-1#2)
insulin effects##2##2##(1995-11#1)(2008-3#1)
insulin exocytosis##3##2##(2010-11#3)
insulin expression and secretion##2##4##(2010-11#2)
insulin fibril formation##2##3##(2010-11#2)
insulin for##2##2##(1993-12#1)(2008-8#1)
insulin gene expression##3##3##(2008-1#2)(2010-11#1)
insulin gene##8##2##(2008-1#3)(2008-11#1)(2008-4#1)(2010-11#3)
insulin genes##2##2##(1993-3#2)
insulin growth factor-1##2##3##(2007-7#1)(2013-1#1)
insulin growth##3##2##(2007-7#1)(2008-11#1)(2013-1#1)
insulin immunoreactive cells##2##3##(2010-11#2)
insulin in patients with##2##4##(2008-3#1)(2008-4#1)
insulin in patients##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
insulin in response to a##2##5##(1990-8#1)(1992-6#1)
insulin in response to##3##4##(1990-8#1)(1992-6#1)(2010-11#1)
insulin in the##8##3##(1990-11#1)(1991-8#1)(1997-6#2)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
insulin in##23##2##(1990-11#1)(1990-8#1)(1991-8#1)(1992-6#1)(1993-12#1)(1996-2#1)(1997-6#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-8#2)(2010-11#4)(2011-1#4)(2011-2#1)
insulin increased the##2##3##(1991-12#1)(1992-12#1)
insulin independence##3##2##(2010-10#2)(2010-11#1)
insulin infusion pump##2##3##(2008-1#1)(2009-11#1)
insulin infusion##6##2##(2008-1#1)(2008-3#1)(2008-7#1)(2009-11#2)(2012-3#1)
insulin injections##2##2##(1994-6#1)(2008-11#1)
insulin is##6##2##(2008-1#1)(2008-3#3)(2008-4#1)(2008-5#1)
insulin level##6##2##(1994-12#2)(2011-1#4)
insulin levels and##3##3##(2008-5#2)(2013-1#1)
insulin levels in##4##3##(1991-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
insulin levels##19##2##(1990-5#3)(1991-7#2)(1992-6#1)(1994-8#1)(2008-1#1)(2008-3#1)(2008-5#4)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
insulin like growth factor I##2##5##(2008-8#1)(2008-9#1)
insulin mRNA stability##3##3##(2008-1#3)
insulin mRNA##6##2##(2008-1#6)
insulin may be##2##3##(1997-8#1)(2008-3#1)
insulin may##6##2##(1990-8#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-3#2)
insulin mixed DG##2##3##(2011-1#2)
insulin mixed##3##2##(2011-1#3)
insulin on##6##2##(1991-7#1)(1995-6#1)(1996-2#1)(1997-2#1)(2009-10#1)(2010-11#1)
insulin or phorbol##3##3##(1995-6#3)
insulin or##6##2##(1994-11#1)(1995-6#3)(1997-3#1)(2013-1#1)
insulin preparations##2##2##(1991-8#1)(2008-8#1)
insulin production##2##2##(1996-11#1)(2008-11#1)
insulin pump therapy##5##3##(2008-1#5)
insulin pump##7##2##(2008-1#6)(2008-7#1)
insulin receptor and IRS-1##2##4##(1997-6#2)
insulin receptor and##3##3##(1997-6#2)(2008-4#1)
insulin receptor autophosphorylation##3##3##(1992-10#1)(1994-6#2)
insulin receptor by##2##3##(1991-12#1)(1995-6#1)
insulin receptor gene##5##3##(1991-12#1)(1994-12#4)
insulin receptor kinase##3##3##(1991-12#2)(1992-12#1)
insulin receptor phosphorylation by##2##4##(1995-6#2)
insulin receptor signaling in β-cells##2##5##(2010-11#2)
insulin receptor signaling##3##3##(2010-11#3)
insulin receptor substrate##2##3##(1991-12#1)(2010-12#1)
insulin receptor substrate-1##3##3##(1995-8#1)(2013-1#2)
insulin receptor tyrosine kinase##2##4##(1992-12#1)(1995-11#1)
insulin receptor##52##2##(1990-11#2)(1991-12#9)(1992-10#2)(1992-12#3)(1993-8#3)(1994-11#1)(1994-12#5)(1994-5#1)(1994-6#2)(1995-11#1)(1995-6#5)(1995-8#1)(1997-1#1)(1997-6#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-9#1)(2010-11#4)(2010-12#1)(2013-1#2)
insulin receptors and##2##3##(1994-12#1)(2008-12#1)
insulin receptors from##2##3##(1994-6#2)
insulin receptors in##2##3##(2008-1#1)(2010-11#1)
insulin receptors##20##2##(1993-8#5)(1994-12#1)(1994-6#4)(1995-6#2)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2010-11#2)
insulin reduction##2##2##(2009-9#2)
insulin regulation of##2##3##(1995-6#1)(1996-2#1)
insulin release from##4##3##(1990-12#2)(1990-8#1)(1996-5#1)
insulin release in##3##3##(1995-8#1)(2010-11#2)
insulin release##23##2##(1990-12#7)(1990-8#4)(1994-11#1)(1995-8#3)(1996-5#1)(2008-1#1)(2008-11#1)(2010-11#4)(2011-1#1)
insulin resistance (HOMA-IR)##5##3##(2008-3#1)(2011-1#3)(2013-8#1)
insulin resistance (IR)##4##3##(2008-3#1)(2010-4#1)(2013-1#1)(2013-8#1)
insulin resistance and hyperinsulinemia##2##4##(1990-2#1)(2008-4#1)
insulin resistance and insulin insufficiency##2##5##(2008-1#2)
insulin resistance and obesity##2##4##(2011-1#1)(2013-1#1)
insulin resistance and the##3##4##(2008-3#1)(2008-4#1)(2012-2#1)
insulin resistance and##40##3##(1990-2#1)(1994-11#2)(1997-7#1)(2008-1#7)(2008-3#10)(2008-4#4)(2008-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
insulin resistance as##5##3##(1992-8#1)(2008-1#1)(2008-3#2)(2009-11#1)
insulin resistance in the##2##4##(2011-1#2)
insulin resistance in##20##3##(1990-9#1)(1993-11#1)(1997-7#1)(2008-1#5)(2008-3#3)(2008-9#2)(2011-1#2)(2012-2#2)(2012-5#1)(2013-1#2)
insulin resistance index##2##3##(2012-3#1)(2013-1#1)
insulin resistance is##4##3##(1994-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
insulin resistance on##2##3##(2008-3#1)(2011-1#1)
insulin resistance or##2##3##(2008-1#1)(2008-3#1)
insulin resistance syndrome##3##3##(2008-3#1)(2009-7#1)(2013-1#1)
insulin resistance was##3##3##(2008-3#2)(2011-1#1)
insulin resistance with##3##3##(1994-12#1)(2008-3#1)(2010-7#1)
insulin resistance##180##2##(1990-2#2)(1990-9#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-12#2)(1996-2#1)(1996-5#1)(1997-7#2)(2008-1#29)(2008-3#45)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-11#2)(2009-3#1)(2009-7#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#22)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2012-5#3)(2013-1#12)(2013-7#1)(2013-8#6)
insulin resistant individuals##2##3##(2008-1#1)(2008-10#1)
insulin resistant rats##4##3##(2008-1#1)(2012-3#3)
insulin resistant##10##2##(2008-1#3)(2008-10#1)(2008-3#2)(2012-3#3)(2012-5#1)
insulin response to##2##3##(1990-12#1)(2008-1#1)
insulin response was##2##3##(1994-12#1)(1995-8#1)
insulin response##5##2##(1990-12#1)(1994-12#1)(1995-8#1)(2008-1#1)(2010-10#1)
insulin responses to##2##3##(2010-10#1)(2010-11#1)
insulin responses##3##2##(1995-8#1)(2010-10#1)(2010-11#1)
insulin secretaguage action of##2##4##(2011-1#2)
insulin secreting cells##2##3##(2008-11#1)(2010-11#1)
insulin secreting##3##2##(1997-1#1)(2008-11#1)(2010-11#1)
insulin secretion (GSIS)##2##3##(2010-11#1)(2012-2#1)
insulin secretion and##13##3##(1991-7#1)(1993-3#1)(1994-8#1)(2008-1#2)(2008-4#1)(2009-12#1)(2010-10#1)(2010-11#2)(2011-1#3)
insulin secretion by##6##3##(1990-12#2)(1993-3#1)(1997-4#1)(2008-4#1)(2010-11#1)
insulin secretion from isolated mouse islets##2##6##(1994-8#2)
insulin secretion from##6##3##(1990-12#2)(1994-8#2)(2008-1#1)(2010-11#1)
insulin secretion in glucose-free medium##2##5##(1995-8#2)
insulin secretion in vivo##2##4##(2010-11#2)
insulin secretion in##17##3##(1990-12#2)(1990-8#1)(1994-12#1)(1995-8#6)(2008-1#1)(2008-4#1)(2010-11#4)(2013-1#1)
insulin secretion is not dependent on##2##6##(1990-12#1)(1994-8#1)
insulin secretion is##4##3##(1990-12#1)(1994-12#1)(1994-8#1)(2010-11#1)
insulin secretion was##2##3##(1994-8#1)(2008-4#1)
insulin secretion##88##2##(1990-12#9)(1990-8#1)(1991-7#3)(1993-3#2)(1994-11#1)(1994-12#3)(1994-8#5)(1995-8#9)(1996-5#3)(1997-4#5)(2008-1#6)(2008-11#5)(2008-4#6)(2009-12#1)(2010-10#1)(2010-11#19)(2011-1#5)(2011-2#1)(2012-2#2)(2013-1#1)
insulin secretory function##3##3##(2010-10#3)
insulin secretory response##2##3##(1990-12#1)(1990-8#1)
insulin secretory##5##2##(1990-12#1)(1990-8#1)(2010-10#3)
insulin sensitive##2##2##(2008-1#1)(2012-5#1)
insulin sensitivity and secretion##2##4##(2011-2#2)
insulin sensitivity and##9##3##(1993-2#1)(2008-4#1)(2010-10#2)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
insulin sensitivity in healthy individuals with##3##6##(2008-3#3)
insulin sensitivity in##6##3##(2008-3#4)(2008-4#1)(2013-1#1)
insulin sensitivity index##2##3##(1997-7#1)(2011-2#1)
insulin sensitivity was##2##3##(2008-3#1)(2012-3#1)
insulin sensitivity##46##2##(1990-2#1)(1992-6#1)(1993-2#2)(1994-12#4)(1997-1#2)(1997-7#2)(2008-1#4)(2008-11#1)(2008-3#9)(2008-4#2)(2008-7#1)(2008-9#1)(2010-10#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
insulin sensitizers##2##2##(2008-3#1)(2013-1#1)
insulin sensitizing##2##2##(2008-3#1)(2010-11#1)
insulin signal##4##2##(1992-10#1)(1993-6#1)(2008-3#1)(2010-4#1)
insulin signaling pathway##6##3##(2008-11#2)(2010-12#4)
insulin signaling##14##2##(1995-6#1)(2008-1#3)(2008-11#2)(2010-11#1)(2010-12#5)(2012-2#1)(2013-1#1)
insulin stimulation of##4##3##(1992-10#1)(1994-11#3)
insulin stimulation##8##2##(1992-10#2)(1994-11#3)(2008-11#1)(2008-6#2)
insulin therapy has##2##3##(2010-12#2)
insulin therapy in##3##3##(1993-12#1)(2008-1#1)(2011-1#1)
insulin therapy##23##2##(1993-12#7)(1997-4#3)(2008-1#2)(2008-8#1)(2009-11#1)(2010-12#3)(2011-1#4)(2012-5#2)
insulin to##10##2##(1992-3#1)(1992-6#1)(1997-4#1)(2008-1#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-11#1)(2012-2#1)
insulin treatment in##3##3##(1990-11#1)(1997-6#1)(2011-2#1)
insulin treatment was##2##3##(1993-12#1)(2011-1#1)
insulin treatment##16##2##(1990-11#1)(1991-8#2)(1993-12#1)(1993-8#1)(1995-5#1)(1997-6#1)(1997-8#3)(2008-1#1)(2010-4#1)(2011-1#2)(2011-2#2)
insulin use##2##2##(2009-11#1)(2011-1#1)
insulin was##9##2##(1996-3#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2013-8#1)
insulin were##5##2##(1991-2#1)(1991-5#1)(2008-7#1)(2010-8#1)(2012-2#1)
insulin##1095##1##(1990-11#8)(1990-12#26)(1990-2#3)(1990-5#3)(1990-7#5)(1990-8#13)(1990-9#2)(1991-1#1)(1991-12#17)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#8)(1991-8#12)(1992-10#6)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#15)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#13)(1993-2#2)(1993-3#4)(1993-6#12)(1993-8#15)(1994-11#24)(1994-12#25)(1994-5#2)(1994-6#9)(1994-8#10)(1995-11#7)(1995-2#1)(1995-5#1)(1995-6#21)(1995-8#19)(1996-10#1)(1996-11#10)(1996-12#2)(1996-2#14)(1996-3#6)(1996-5#8)(1997-1#8)(1997-2#1)(1997-3#1)(1997-4#15)(1997-5#1)(1997-6#8)(1997-7#4)(1997-8#8)(2007-10#3)(2007-12#1)(2007-7#1)(2008-1#92)(2008-10#6)(2008-11#35)(2008-12#5)(2008-3#94)(2008-4#35)(2008-5#11)(2008-6#6)(2008-7#12)(2008-8#25)(2008-9#24)(2009-10#1)(2009-11#18)(2009-12#3)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#10)(2010-10#23)(2010-11#79)(2010-12#14)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#66)(2011-2#17)(2012-1#1)(2012-12#4)(2012-2#19)(2012-3#12)(2012-4#2)(2012-5#8)(2012-7#2)(2013-1#32)(2013-7#3)(2013-8#14)
insulin) was##3##2##(1990-8#2)(2008-7#1)
insulin)##9##1##(1990-8#2)(1991-8#1)(1996-11#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-7#1)
insulin-deficient##3##1##(1993-12#2)(2010-11#1)
insulin-degrading##2##1##(1995-6#1)(1997-1#1)
insulin-dependent diabetes mellitus (IDDM)##3##4##(1995-3#1)(2007-5#1)(2011-2#1)
insulin-dependent diabetes mellitus##14##3##(1990-11#1)(1990-5#1)(1993-9#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2010-11#1)(2011-2#1)
insulin-dependent diabetes##20##2##(1990-11#1)(1990-5#2)(1991-8#1)(1992-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
insulin-dependent type##2##2##(2009-3#1)(2013-1#1)
insulin-dependent##26##1##(1990-11#1)(1990-5#2)(1991-8#2)(1992-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#3)
insulin-independent##2##1##(1995-6#2)
insulin-induced##10##1##(1991-12#1)(1995-2#1)(1995-8#3)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-2#1)
insulin-like effect##2##2##(2008-11#2)
insulin-like effects on##2##3##(2008-11#1)(2010-11#1)
insulin-like growth factor (IGF)##2##4##(2008-4#1)(2009-11#1)
insulin-like growth factor (IGF)-I##3##4##(1993-9#1)(2008-11#1)(2013-1#1)
insulin-like growth factor (IGF-I)##2##4##(1995-11#1)(2008-8#1)
insulin-like growth factor 1##5##4##(2008-4#1)(2008-9#3)(2010-10#1)
insulin-like growth factor I (IGF-I)##2##5##(1991-5#1)(2012-12#1)
insulin-like growth factor II (IGF-II)##2##5##(1990-11#1)(1992-3#1)
insulin-like growth factor II##4##4##(1990-11#1)(1992-3#2)(1996-10#1)
insulin-like growth factor binding proteins##2##5##(1992-4#1)(1993-3#1)
insulin-like growth factor binding##4##4##(1992-4#1)(1993-3#2)(1993-8#1)
insulin-like growth factor system##2##4##(2008-5#1)(2008-6#1)
insulin-like growth factor##32##3##(1990-11#1)(1990-9#1)(1991-5#1)(1991-7#2)(1992-3#2)(1992-4#1)(1993-3#2)(1993-8#1)(1993-9#1)(1995-11#1)(1996-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
insulin-like growth factor-1 (IGF-1) and##2##5##(1992-12#1)(2011-1#1)
insulin-like growth factor-1 (IGF-1)##3##4##(1990-12#1)(1992-12#1)(2011-1#1)
insulin-like growth factor-I (IGF-I) gene##2##5##(1992-9#1)(2010-8#1)
insulin-like growth factor-I (IGF-I)##9##4##(1991-12#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-11#2)(2010-8#1)
insulin-like growth factor-I receptor##2##4##(2008-8#2)
insulin-like growth factor-I##16##3##(1991-12#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-11#2)(2008-8#2)(2010-8#2)
insulin-like growth factor-binding proteins##2##4##(1991-12#1)(2008-4#1)
insulin-like growth factor-binding##4##3##(1991-12#1)(1993-2#2)(2008-4#1)
insulin-like growth factors I##2##4##(1996-5#1)(2010-5#1)
insulin-like growth factors##5##3##(1990-5#1)(1996-5#2)(2010-5#2)
insulin-like growth##61##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-5#2)(1997-1#1)(2007-11#1)(2008-11#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
insulin-like##73##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#1)(1993-9#3)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-5#2)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#6)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2010-10#1)(2010-11#3)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
insulin-mimetic activity##4##2##(2008-11#1)(2010-11#3)
insulin-mimetic##5##1##(2008-11#2)(2010-11#3)
insulin-producing cells##2##2##(2010-11#2)
insulin-producing##7##1##(1993-3#1)(1994-8#1)(2010-11#4)(2011-2#1)
insulin-receptor interactions##2##2##(1992-3#2)
insulin-receptor##5##1##(1992-3#2)(1995-11#2)(1997-1#1)
insulin-related processes##2##2##(1995-11#2)
insulin-related##3##1##(1995-11#2)(1995-8#1)
insulin-resistant##2##1##(2008-3#1)(2012-3#1)
insulin-responsive##4##1##(1994-11#2)(2008-11#1)(2009-12#1)
insulin-secreting cells##4##2##(1997-4#1)(2008-11#3)
insulin-secreting##8##1##(1997-1#2)(1997-4#3)(2008-11#3)
insulin-sensitive cells in##2##3##(1994-8#1)(2010-4#1)
insulin-sensitive##5##1##(1990-8#1)(1994-8#1)(2008-1#1)(2010-11#1)(2010-4#1)
insulin-sensitizing##3##1##(2008-3#1)(2008-7#1)(2013-1#1)
insulin-stimulated glucose##3##2##(1992-11#1)(2008-3#1)(2008-9#1)
insulin-stimulated##14##1##(1991-12#2)(1992-10#1)(1992-11#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
insulin-treated##3##1##(1997-6#3)
insulinemia##3##1##(2008-10#1)(2008-4#2)
insulinlike growth factor##2##3##(2008-4#2)
insulinlike growth##3##2##(2008-4#3)
insulinoma##13##1##(1993-3#1)(1995-8#1)(1997-5#1)(2007-5#3)(2008-11#3)(2008-2#1)(2009-4#3)
insulinomas##3##1##(1997-8#1)(2007-5#1)(2008-3#1)
insulinopenia##2##1##(1993-12#1)(2008-1#1)
insulinotropic##2##1##(1995-11#1)(2012-2#1)
insulins##5##1##(1990-12#2)(1991-8#1)(1997-4#1)(2008-1#1)
insulitis and##2##2##(2010-11#2)
insult##36##1##(1990-5#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-5#1)(1996-12#2)(1996-5#2)(1997-2#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
insults##25##1##(1994-2#2)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
insurable##2##1##(1995-1#2)
insurance and health##2##3##(1995-2#1)(2011-2#1)
insurance and the##2##3##(1992-12#1)(1994-1#1)
insurance and##15##2##(1992-12#1)(1992-3#1)(1994-1#2)(1995-1#1)(1995-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-4#1)(2011-2#2)
insurance applicants##4##2##(1995-1#4)
insurance at##2##2##(1992-3#1)(2011-2#1)
insurance benefits##3##2##(1992-1#1)(1996-5#1)(1997-5#1)
insurance can be##2##3##(1992-2#1)(2010-5#1)
insurance carriers##3##2##(1994-2#1)(1996-5#1)(2012-2#1)
insurance claims##2##2##(1995-1#1)(1995-3#1)
insurance companies##13##2##(1993-1#1)(1993-12#1)(1994-3#3)(1996-1#1)(1996-3#1)(1997-5#2)(2007-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
insurance company##4##2##(1993-1#1)(1993-12#1)(1996-2#1)(1997-1#1)
insurance costs##2##2##(2008-11#1)(2008-6#1)
insurance coverage among disabled Medicare enrollees##2##6##(1992-2#2)
insurance coverage and##3##3##(1992-2#1)(1993-3#1)(2010-4#1)
insurance coverage are##2##3##(1991-12#1)(2011-2#1)
insurance coverage for##5##3##(1995-12#2)(1996-1#1)(1996-12#1)(2008-12#1)
insurance coverage were##2##3##(1994-3#1)(2009-5#1)
insurance coverage##34##2##(1991-12#2)(1991-2#1)(1992-2#4)(1993-12#1)(1993-3#3)(1994-1#1)(1994-2#3)(1994-3#2)(1995-12#3)(1996-1#1)(1996-12#1)(2007-2#1)(2008-11#3)(2008-12#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
insurance for##9##2##(1991-1#1)(1991-2#2)(1992-2#1)(1992-3#1)(1993-1#1)(1995-3#1)(2011-2#1)(2013-1#1)
insurance in the##2##3##(1992-3#1)(1995-2#1)
insurance in##10##2##(1992-12#1)(1992-3#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-11#1)(2010-8#1)(2012-12#1)
insurance industry##9##2##(1992-3#2)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-7#2)
insurance information##2##2##(1991-2#1)(1991-3#1)
insurance is##7##2##(1992-12#3)(1992-2#2)(1992-5#1)(1993-3#1)
insurance management##2##2##(1992-3#1)(1995-12#1)
insurance market##3##2##(1995-12#1)(1997-2#1)(1997-3#1)
insurance medicine##2##2##(1995-1#1)(1996-2#1)
insurance of##2##2##(2013-1#1)(2013-8#1)
insurance or##3##2##(1993-12#1)(1995-12#1)(2012-1#1)
insurance plan##2##2##(1991-2#1)(1992-2#1)
insurance policies##2##2##(1993-3#1)(1996-3#1)
insurance policy##7##2##(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#3)
insurance premium rates##2##3##(2009-11#2)
insurance premiums##2##2##(2008-12#1)(2008-7#1)
insurance program##4##2##(1993-1#2)(1993-12#2)
insurance programs##5##2##(1993-1#1)(1995-3#1)(1996-2#1)(1997-5#1)(2010-5#1)
insurance risk##2##2##(1991-12#1)(1994-12#1)
insurance scheme##5##2##(1995-11#1)(1996-12#1)(1997-2#1)(2008-7#1)(2013-8#1)
insurance schemes##3##2##(2008-7#2)(2010-5#1)
insurance status##5##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(2012-3#1)
insurance subsidies##2##2##(1996-1#1)(2010-5#1)
insurance system##3##2##(1992-12#1)(1995-5#1)(1996-8#1)
insurance to##4##2##(1992-12#3)(1996-5#1)
insurance##337##1##(1991-1#2)(1991-12#7)(1991-2#12)(1991-3#7)(1992-1#7)(1992-12#13)(1992-2#13)(1992-3#9)(1992-5#1)(1993-1#12)(1993-12#11)(1993-2#1)(1993-3#18)(1994-1#9)(1994-12#2)(1994-2#15)(1994-3#7)(1994-8#1)(1995-1#14)(1995-11#1)(1995-12#10)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#10)(1996-2#7)(1996-3#10)(1996-5#3)(1996-8#1)(1997-1#3)(1997-2#6)(1997-3#5)(1997-5#5)(1997-8#1)(2007-12#1)(2007-2#3)(2007-3#1)(2008-1#2)(2008-11#14)(2008-12#2)(2008-4#3)(2008-6#2)(2008-7#19)(2008-8#1)(2009-11#2)(2009-5#1)(2010-4#1)(2010-5#5)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#3)
insurance-based##2##1##(1993-2#1)(2008-8#1)
insurance?##2##1##(1993-3#1)(2008-7#1)
insure that##2##2##(1993-2#1)(2008-8#1)
insure the##2##2##(2008-4#1)(2008-9#1)
insure##11##1##(1991-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
insured##16##1##(1991-12#2)(1992-2#2)(1993-1#1)(1994-12#1)(1994-2#2)(1995-12#1)(1997-3#4)(2008-11#1)(2011-2#1)(2012-2#1)
insureds##2##1##(1992-1#1)(1996-12#1)
insurer##13##1##(1993-1#2)(1993-3#1)(1994-3#1)(1995-12#1)(1997-5#6)(2008-7#1)(2011-1#1)
insurers and##4##2##(1997-1#1)(1997-2#1)(1997-5#1)(2008-11#1)
insurers##29##1##(1991-1#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-8#1)(2012-12#1)
insurmountable##2##1##(2007-8#1)(2012-3#1)
int-1##2##1##(1994-7#2)
int-2##2##1##(1994-7#2)
intact DNA##2##2##(1992-3#1)(1995-2#1)
intact F29W and##2##3##(1995-5#2)
intact POU domain##2##3##(1992-6#2)
intact and the##2##3##(1996-12#1)(2011-1#1)
intact and triton-treated##2##3##(1994-11#2)
intact and unloaded erythrocytes##2##4##(1990-11#2)
intact and unloaded##3##3##(1990-11#3)
intact and##22##2##(1990-11#3)(1990-12#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
intact brain##2##2##(2008-4#1)(2008-7#1)
intact breast##2##2##(1994-8#1)(2013-1#1)
intact cell##3##2##(1994-11#1)(2008-4#1)(2008-9#1)
intact cells and##3##3##(1990-11#1)(1992-11#1)(1995-12#1)
intact cells of##2##3##(1990-11#1)(1996-6#1)
intact cells##28##2##(1990-11#3)(1991-12#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
intact cortical bone index (ICBI)##2##5##(2007-11#2)
intact foliage##3##2##(2008-10#3)
intact ganglia##2##2##(1996-12#1)(1997-6#1)
intact hepatocytes##2##2##(1990-12#2)
intact human erythrocytes##3##3##(1990-12#1)(1992-8#2)
intact human##5##2##(1990-12#1)(1992-8#2)(2008-5#1)(2008-8#1)
intact in all##2##3##(1997-7#1)(2008-8#1)
intact in##5##2##(1997-7#1)(2008-10#1)(2008-5#2)(2008-8#1)
intact islets##2##2##(1990-12#1)(1990-2#1)
intact leaves##2##2##(2008-10#1)(2008-7#1)
intact male##3##2##(1994-2#2)(2008-11#1)
intact males##2##2##(1993-8#1)(1995-2#1)
intact membrane##2##2##(1997-8#1)(2008-9#1)
intact molecular##2##2##(2008-4#2)
intact muscle##2##2##(1997-2#1)(2008-9#1)
intact myelinated##2##2##(1997-3#2)
intact on##2##2##(2008-10#1)(2012-12#1)
intact or##5##2##(1993-8#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#1)
intact organisms##3##2##(1993-12#2)(2009-5#1)
intact pancreas##2##2##(1995-11#2)
intact pathogens##2##2##(2009-5#2)
intact plants##10##2##(1997-3#1)(2008-10#3)(2008-11#6)
intact protein##2##2##(1994-5#1)(2008-5#1)
intact proteins##7##2##(2008-2#2)(2008-4#5)
intact pulp fibers##2##3##(2008-3#2)
intact rat##2##2##(1990-7#1)(1996-2#1)
intact rats##4##2##(1990-12#1)(1993-12#1)(1996-2#1)(2008-7#1)
intact receptor##2##2##(1992-4#1)(2007-12#1)
intact red cells##2##3##(1992-9#1)(1993-12#1)
intact salivary gland##2##3##(2007-11#1)(2008-11#1)
intact tissues##3##2##(1994-8#1)(2008-10#2)
intact type VI collagen microfibrils##3##5##(1993-3#3)
intact type VI collagen##5##4##(1993-3#5)
intact uterus##2##2##(1993-11#1)(1994-8#1)
intact with##2##2##(1997-2#1)(2008-2#1)
intact##384##1##(1990-10#1)(1990-11#6)(1990-12#8)(1990-2#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#5)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#4)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#13)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#9)(1995-5#5)(1995-6#6)(1995-8#1)(1996-12#5)(1996-2#9)(1996-5#2)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#5)(2008-1#2)(2008-10#45)(2008-11#17)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#21)(2008-5#13)(2008-6#3)(2008-7#10)(2008-8#13)(2008-9#14)(2009-12#1)(2009-3#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
intaglio surfaces##2##2##(2009-8#2)
intake (DMI)##2##2##(2012-2#2)
intake and blood##2##3##(1996-11#1)(2011-1#1)
intake and body weight##2##4##(1997-3#1)(2008-5#1)
intake and body##3##3##(1997-3#1)(2008-1#1)(2008-5#1)
intake and cancer have##2##4##(2012-2#2)
intake and energy expenditure##2##4##(2008-10#1)(2008-4#1)
intake and energy##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
intake and fat##2##3##(2008-10#1)(2008-2#1)
intake and nitrogen##2##3##(2012-2#2)
intake and risk##2##3##(1996-3#1)(2012-2#1)
intake and the##2##3##(1993-9#1)(2008-5#1)
intake and##50##2##(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-9#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#6)(2013-8#5)
intake as well as##3##4##(2008-11#1)(2008-5#1)(2010-1#1)
intake as##9##2##(1992-12#1)(1993-12#1)(1996-2#1)(1997-8#2)(2008-11#1)(2008-5#2)(2010-1#1)
intake by##5##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
intake can##3##2##(1997-8#1)(2008-11#2)
intake compared##2##2##(2008-5#1)(2010-6#1)
intake during##4##2##(1994-12#1)(2008-7#1)(2008-9#1)(2010-2#1)
intake for##4##2##(1992-12#1)(2008-5#1)(2010-3#1)(2010-9#1)
intake from food##5##3##(1992-12#4)(2008-5#1)
intake from##7##2##(1992-12#4)(2008-10#1)(2008-5#1)(2010-1#1)
intake group##2##2##(1992-10#1)(2008-11#1)
intake in the##3##3##(2008-5#1)(2010-5#1)(2011-1#1)
intake in##20##2##(1990-8#1)(1993-12#1)(1994-12#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
intake is associated with##2##4##(2010-1#1)(2011-2#1)
intake is##12##2##(1990-8#1)(1991-5#1)(1991-6#1)(1997-4#1)(2008-11#1)(2008-3#1)(2010-1#1)(2011-2#2)(2012-2#3)
intake levels##2##2##(2011-2#1)(2012-2#1)
intake may##3##2##(2008-4#1)(2009-12#2)
intake of a##2##3##(1993-12#2)
intake of each##2##3##(2008-1#1)(2011-1#1)
intake of energy##2##3##(1994-12#1)(2013-1#1)
intake of fresh##2##3##(2008-1#1)(2012-3#1)
intake of fruits and vegetables##2##5##(2012-2#1)(2013-1#1)
intake of nutrients##2##3##(2011-1#2)
intake of saturated fatty acids and cholesterol##2##7##(1992-8#2)
intake of saturated fatty acids##3##5##(1990-2#1)(1992-8#2)
intake of the##8##3##(1991-2#1)(1993-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
intake of these##2##3##(1992-10#1)(1994-9#1)
intake of vitamin##2##3##(1992-9#1)(1996-8#1)
intake of##91##2##(1990-2#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-10#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#4)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#1)
intake on##10##2##(1991-11#1)(2008-3#1)(2008-5#2)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#2)
intake or##3##2##(1993-11#1)(2010-8#1)(2013-1#1)
intake relative to##2##3##(2008-5#1)(2012-2#1)
intake to##2##2##(2008-4#1)(2009-11#1)
intake was also##2##3##(2011-1#1)(2013-1#1)
intake was not significantly##2##4##(2008-12#1)(2013-1#1)
intake was not##3##3##(1993-8#1)(2008-12#1)(2013-1#1)
intake was##19##2##(1991-2#2)(1993-8#1)(1994-12#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-8#2)
intake were##5##2##(1997-3#1)(2007-11#1)(2008-4#1)(2010-2#1)(2013-8#1)
intake when##3##2##(1993-12#1)(1997-4#2)
intake with##3##2##(2008-1#2)(2013-1#1)
intake##431##1##(1990-10#1)(1990-2#3)(1990-8#8)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#4)(1991-5#2)(1991-6#1)(1992-10#3)(1992-12#8)(1992-3#1)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#19)(1993-8#3)(1993-9#5)(1994-12#6)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#6)(1997-5#1)(1997-8#6)(2007-11#4)(2007-12#3)(2007-7#3)(2008-1#13)(2008-10#15)(2008-11#13)(2008-12#4)(2008-2#12)(2008-3#9)(2008-4#15)(2008-5#21)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#3)(2009-11#3)(2009-12#3)(2009-4#4)(2009-5#2)(2009-8#7)(2009-9#2)(2010-1#5)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#8)(2010-8#2)(2010-9#3)(2011-1#18)(2011-2#20)(2012-1#7)(2012-12#9)(2012-2#29)(2012-3#4)(2013-1#21)(2013-7#1)(2013-8#23)
intake)##3##1##(1997-3#1)(2008-2#1)(2013-1#1)
intakes are##3##2##(1992-9#1)(2008-7#2)
intakes for##2##2##(1993-9#1)(1995-2#1)
intakes in##2##2##(2013-1#2)
intakes of energy##2##3##(2008-1#1)(2010-6#1)
intakes of##10##2##(2008-1#1)(2008-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
intakes were##4##2##(2008-3#1)(2010-6#1)(2013-1#2)
intakes##38##1##(1992-9#1)(1993-9#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#4)(2010-1#1)(2010-6#5)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#9)
intangible##3##1##(1993-12#1)(1995-3#1)(2008-9#1)
inteferometer##2##1##(2007-11#1)(2008-3#1)
inteferometry##2##1##(2007-11#1)(2008-3#1)
integer and##2##2##(2012-2#2)
integer wavelet transforms##2##3##(2008-3#2)
integer wavelet##3##2##(2008-3#2)(2008-6#1)
integer##14##1##(2007-12#2)(2008-2#2)(2008-3#4)(2008-6#3)(2010-9#1)(2012-2#2)
integerrima and##2##2##(2008-10#2)
integerrima##4##1##(2008-10#4)
integral and peripheral##2##3##(1995-5#1)(2011-2#1)
integral and##4##2##(1995-5#1)(1996-12#1)(2011-2#1)(2013-1#1)
integral currents##2##2##(2013-1#2)
integral equation for##2##3##(2007-12#1)(2009-10#1)
integral equation is solved##3##4##(2008-2#1)(2008-3#2)
integral equation is##4##3##(2008-2#1)(2008-3#2)(2009-10#1)
integral equation method##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
integral equation of the first kind##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
integral equation of the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
integral equation that##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
integral equation##23##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#6)(2009-10#4)(2009-2#1)(2012-3#1)
integral equations##5##2##(2008-10#1)(2009-2#1)(2009-7#1)(2012-3#2)
integral imaging by##3##3##(2007-11#3)
integral imaging scheme for displaying three-dimensional images##2##7##(2007-11#2)
integral imaging system##2##3##(2007-11#2)
integral imaging##13##2##(2007-11#13)
integral is##4##2##(2008-3#3)(2012-1#1)
integral membrane protein##15##3##(1990-11#1)(1990-12#1)(1993-11#3)(1993-6#1)(1994-12#3)(1994-2#1)(2008-10#1)(2009-7#2)(2011-2#1)(2013-7#1)
integral membrane proteins##8##3##(1990-5#1)(1991-2#1)(1992-8#1)(1994-12#1)(1995-8#1)(2008-4#2)(2008-8#1)
integral membrane##26##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-12#4)(1994-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2009-7#2)(2011-2#1)(2013-7#1)
integral of [Ca2+]i##2##3##(1994-6#2)
integral of##3##2##(1994-6#2)(2008-7#1)
integral part of health##2##4##(1992-1#1)(2008-1#1)
integral part of the##14##4##(1991-2#1)(1992-6#1)(1993-12#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#2)
integral part of##39##3##(1991-2#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
integral part##41##2##(1991-2#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
integral photography##6##2##(2008-3#6)
integral protein##2##2##(1994-12#1)(2012-2#1)
integral reflectance##2##2##(2008-3#2)
integral to the##2##3##(2012-3#1)(2013-1#1)
integral to##14##2##(1992-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-11#4)(2009-5#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#2)
integral value##2##2##(1994-9#1)(1996-2#1)
integral##217##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#7)(1994-2#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#17)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#8)(2008-2#16)(2008-3#32)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#5)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#5)(2013-7#1)
integrally##3##1##(2008-1#1)(2008-12#1)(2013-1#1)
integrals is##3##2##(2008-2#1)(2008-3#2)
integrals that##2##2##(2008-2#1)(2012-1#1)
integrals##13##1##(1994-2#1)(2008-10#1)(2008-2#3)(2008-3#5)(2009-12#1)(2012-1#2)
integrase (IN) is##2##3##(2009-11#1)(2011-3#1)
integrase inhibitors##2##2##(2011-2#1)(2011-3#1)
integrase is##2##2##(1992-6#2)
integrase protein##2##2##(1994-9#1)(1997-3#1)
integrase##29##1##(1992-6#3)(1994-9#4)(1996-6#1)(1997-3#5)(2009-11#1)(2010-5#3)(2011-2#1)(2011-3#8)(2012-2#1)(2012-3#1)(2013-1#1)
integrate a##3##2##(1992-2#1)(2008-3#1)(2010-10#1)
integrate and##6##2##(1994-12#1)(1995-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-6#1)
integrate as a single copy##2##5##(1995-5#1)(2008-10#1)
integrate into##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
integrate multiple##2##2##(2009-8#1)(2011-3#1)
integrate shade and hormone##2##4##(2009-8#2)
integrate the##22##2##(1992-1#1)(1993-2#2)(1994-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-8#1)(2009-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
integrate their##4##2##(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#1)
integrate them##2##2##(2008-12#1)(2010-3#1)
integrate these##3##2##(2008-7#1)(2010-1#1)(2012-12#1)
integrate##111##1##(1991-6#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#3)(2006-5#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#7)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#10)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#2)
integrate-and-fire##3##1##(2008-11#3)
integrated AlGaAs##2##2##(2007-12#2)
integrated TB and HIV treatment##2##5##(2010-4#2)
integrated TB and HIV##3##4##(2010-4#3)
integrated a##2##2##(2008-10#2)
integrated absorbance##4##2##(2008-10#4)
integrated analytic framework##2##3##(1992-3#1)(1994-3#1)
integrated and organic apple##2##4##(2008-10#2)
integrated and##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
integrated approach to##12##3##(1993-12#2)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-4#1)(2012-1#1)
integrated approach##20##2##(1993-12#2)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-8#1)(2009-4#1)(2009-6#1)(2012-1#1)(2012-3#2)
integrated arrays of##2##3##(2008-10#1)(2008-3#1)
integrated assessment of##2##3##(2009-4#1)(2010-11#1)
integrated at a single##2##4##(2008-10#1)(2008-11#1)
integrated at##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
integrated by##2##2##(2008-2#2)
integrated care##4##2##(2008-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
integrated chemometric approach##3##3##(2008-10#3)
integrated circuit##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-9#1)
integrated circuits with##2##3##(2007-12#1)(2008-2#1)
integrated circuits##12##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#4)(2012-2#1)
integrated component##5##2##(2007-11#1)(2008-2#2)(2012-2#1)(2012-3#1)
integrated control of##2##3##(1997-7#1)(2008-10#1)
integrated control##3##2##(1997-7#2)(2008-10#1)
integrated data##3##2##(2008-7#2)(2010-6#1)
integrated delivery network##3##3##(1996-12#1)(1997-1#1)(2008-11#1)
integrated delivery system##9##3##(1996-1#4)(1996-3#2)(1997-3#2)(2008-1#1)
integrated delivery systems##9##3##(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)
integrated delivery##23##2##(1996-1#9)(1996-12#2)(1996-2#1)(1996-3#4)(1997-1#2)(1997-3#2)(2008-1#1)(2008-11#1)(2010-8#1)
integrated devices##2##2##(2008-7#2)
integrated disease management##2##3##(2008-10#2)
integrated electro-optic lens and##2##4##(2008-2#1)(2008-3#1)
integrated firms##2##2##(1994-2#2)
integrated functional and##2##3##(2007-12#1)(2007-7#1)
integrated gas-liquid##2##2##(2008-10#2)
integrated health and##2##3##(1991-3#1)(2008-11#1)
integrated health care delivery system##2##5##(1996-1#2)
integrated health care delivery systems##2##5##(1996-1#1)(1996-3#1)
integrated health care delivery##6##4##(1996-1#4)(1996-3#1)(2008-1#1)
integrated health care organizations##2##4##(1997-2#2)
integrated health care systems##6##4##(1995-12#2)(1997-1#3)(1997-2#1)
integrated health care##23##3##(1994-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#4)(1996-12#2)(1996-3#1)(1997-1#3)(1997-2#3)(1997-3#1)(2008-1#1)
integrated health delivery##2##3##(1995-3#1)(1997-3#1)
integrated health services##2##3##(2007-12#1)(2012-2#1)
integrated health systems##2##3##(1997-3#1)(2008-7#1)
integrated health##39##2##(1991-3#1)(1994-1#2)(1994-2#1)(1995-12#3)(1995-2#2)(1995-3#2)(1996-1#4)(1996-12#2)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#6)(2007-12#2)(2008-1#3)(2008-11#1)(2008-7#1)(2012-2#1)
integrated healthcare##3##2##(1996-3#1)(1997-3#1)(2008-12#1)
integrated in a##9##3##(1993-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
integrated in the undergraduate curriculum of##2##6##(2011-2#2)
integrated in the##10##3##(1992-12#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-8#2)(2011-2#2)
integrated in##31##2##(1992-12#1)(1993-12#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
integrated information system##2##3##(1995-12#1)(1997-3#1)
integrated information systems that##2##4##(1996-3#2)
integrated information systems##3##3##(1995-12#1)(1996-3#2)
integrated information##5##2##(1995-12#2)(1996-3#2)(1997-3#1)
integrated intensity##3##2##(2008-2#1)(2008-3#2)
integrated into a##7##3##(1994-12#1)(1996-1#1)(1996-8#1)(2008-10#2)(2009-11#1)(2012-1#1)
integrated into one##2##3##(1994-12#1)(2008-4#1)
integrated into the##18##3##(1991-6#1)(1992-3#1)(1992-5#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-7#1)(2013-1#1)
integrated into##44##2##(1991-6#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
integrated light##3##2##(2008-10#2)(2008-3#1)
integrated management##5##2##(2008-10#3)(2008-6#1)(2011-2#1)
integrated medical##3##2##(1995-3#3)
integrated microchip##2##2##(2008-10#2)
integrated model for##2##3##(2008-3#1)(2010-4#1)
integrated model##4##2##(1994-12#1)(1997-2#1)(2008-3#1)(2010-4#1)
integrated networks##3##2##(1996-3#3)
integrated on a##5##3##(2007-11#1)(2007-8#1)(2008-10#3)
integrated on##6##2##(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)
integrated on-line to##2##3##(2008-10#2)
integrated onto##3##2##(2008-10#1)(2008-2#1)(2009-9#1)
integrated optical displacement sensor based on triangulation and optical beam deflection##2##11##(2008-2#2)
integrated optical interferometer##2##3##(2008-2#1)(2008-3#1)
integrated optical sensor##2##3##(2007-11#2)
integrated optical waveguide##2##3##(2008-10#1)(2008-3#1)
integrated optical waveguides##3##3##(2007-11#2)(2008-3#1)
integrated optical##24##2##(2007-11#7)(2008-10#3)(2008-2#5)(2008-3#8)(2011-1#1)
integrated optics##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
integrated organ system-based curriculum##3##4##(2012-3#3)
integrated organ##4##2##(2012-3#4)
integrated over the##3##3##(2008-10#2)(2008-3#1)
integrated over##5##2##(2008-10#2)(2008-3#2)(2009-9#1)
integrated pest management (IPM)##4##4##(2008-10#3)(2011-2#1)
integrated pest management systems##2##4##(2008-10#2)
integrated pest management##16##3##(1997-7#1)(2008-10#10)(2008-9#1)(2011-2#2)(2013-8#2)
integrated pest##17##2##(1997-7#1)(2008-10#11)(2008-9#1)(2011-2#2)(2013-8#2)
integrated photoelasticity##4##2##(2008-3#4)
integrated platform of a##2##4##(2008-10#2)
integrated platform of##4##3##(2008-10#4)
integrated platform##5##2##(2008-10#5)
integrated program##2##2##(2007-8#1)(2011-2#1)
integrated public health information##3##4##(1995-12#2)(1996-3#1)
integrated public##4##2##(1995-12#2)(1996-3#1)(2008-6#1)
integrated pulsed##4##2##(2008-10#2)(2008-7#2)
integrated regional##2##2##(1995-3#1)(1996-3#1)
integrated research##2##2##(1993-3#1)(2011-2#1)
integrated review of##2##3##(2008-3#1)(2013-1#1)
integrated scattering##5##2##(2008-2#2)(2008-3#3)
integrated speckle##2##2##(2008-2#2)
integrated system of##5##3##(1995-2#1)(1997-1#2)(2008-10#1)(2008-2#1)
integrated system##11##2##(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-3#1)(2008-10#2)(2008-2#1)(2011-1#2)
integrated systems##8##2##(1992-12#1)(1996-3#1)(1997-3#3)(2008-10#1)(2009-12#1)(2013-8#1)
integrated the expression##2##3##(2008-11#2)
integrated the##4##2##(2008-11#2)(2008-3#1)(2008-7#1)
integrated theoretical##2##2##(1994-3#1)(2012-3#1)
integrated thin-film heaters##2##3##(2008-3#2)
integrated to##10##2##(1995-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
integrated treatment intervention##2##3##(2012-3#2)
integrated treatment##13##2##(2008-6#1)(2008-7#1)(2012-12#2)(2012-3#9)
integrated units##2##2##(2006-10#1)(2008-8#1)
integrated upon a##2##3##(2007-12#2)
integrated use of##4##3##(1997-7#1)(2008-10#1)(2011-2#2)
integrated view of the##2##4##(2008-7#2)
integrated view of##4##3##(2008-7#3)(2010-4#1)
integrated viral##2##2##(1995-2#1)(2012-12#1)
integrated with a##6##3##(1994-1#1)(2008-11#1)(2008-3#3)(2012-12#1)
integrated with other##2##3##(2008-7#1)(2011-2#1)
integrated with the##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
integrated with##31##2##(1994-1#1)(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#3)(2009-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
integrated##689##1##(1990-11#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#1)(1993-12#5)(1993-3#1)(1993-6#2)(1994-1#5)(1994-12#7)(1994-2#6)(1994-3#4)(1995-1#1)(1995-12#10)(1995-2#9)(1995-3#7)(1995-6#2)(1996-1#16)(1996-12#7)(1996-2#3)(1996-3#18)(1996-5#1)(1996-8#1)(1997-1#7)(1997-2#6)(1997-3#18)(1997-4#1)(1997-7#8)(1997-8#3)(2006-10#1)(2006-9#1)(2007-11#24)(2007-12#18)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#105)(2008-11#25)(2008-12#9)(2008-2#35)(2008-3#77)(2008-4#8)(2008-5#5)(2008-6#8)(2008-7#27)(2008-8#15)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#10)(2011-2#20)(2012-1#4)(2012-12#7)(2012-2#12)(2012-3#24)(2013-1#8)(2013-8#8)
integrated-circuit##5##1##(2008-2#1)(2008-3#4)
integrated-optic##3##1##(2008-2#2)(2008-3#1)
integrates a##2##2##(2011-1#1)(2012-12#1)
integrates the##6##2##(2007-12#2)(2008-8#1)(2009-10#1)(2010-8#2)
integrates these##3##2##(2008-11#1)(2010-6#1)(2012-2#1)
integrates two##2##2##(2007-12#1)(2008-3#1)
integrates##45##1##(1992-12#1)(1993-3#1)(1994-2#2)(1995-12#1)(1996-1#1)(1997-3#1)(1997-7#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)
integrating NT-proBNP testing##2##3##(2008-3#2)
integrating a##2##2##(2008-10#1)(2008-11#1)
integrating and##2##2##(1997-2#1)(2009-12#1)
integrating breastfeeding##2##2##(2010-5#2)
integrating data##2##2##(1997-3#1)(2010-12#1)
integrating health##4##2##(1994-1#1)(1997-3#1)(2012-12#1)(2012-2#1)
integrating multiple##3##2##(2007-8#1)(2008-10#1)(2010-7#1)
integrating sphere##4##2##(2008-3#4)
integrating surveillance##2##2##(1997-3#2)
integrating the##16##2##(1993-1#1)(1994-3#1)(1996-3#2)(2006-5#1)(2008-1#2)(2008-3#2)(2008-6#2)(2009-11#1)(2009-2#1)(2011-2#2)(2012-3#1)
integrating them with##2##3##(1996-12#1)(2008-4#1)
integrating them##3##2##(1996-12#1)(2008-4#1)(2012-2#1)
integrating these##6##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-10#1)
integrating this##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
integrating##112##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#4)(2006-5#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
integration activity##2##2##(1992-6#2)
integration among##2##2##(1996-3#1)(2009-6#1)
integration and genetic instability##3##4##(2008-4#3)
integration and##28##2##(1991-3#1)(1996-12#1)(1997-1#2)(1997-2#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-11#1)(2012-2#2)
integration between##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
integration capabilities##2##2##(2008-3#2)
integration events##3##2##(2008-10#2)(2008-11#1)
integration for##2##2##(2008-3#1)(2011-3#1)
integration has a##2##3##(2008-9#1)(2009-8#1)
integration has##5##2##(1996-12#1)(2008-7#1)(2008-9#1)(2009-8#2)
integration in the##4##3##(1994-7#1)(1996-12#1)(2008-10#1)(2008-3#1)
integration in##17##2##(1991-3#1)(1993-1#1)(1994-2#1)(1994-7#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-1#1)
integration into the##3##3##(1996-6#1)(2008-2#2)
integration into##10##2##(1994-7#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-9#1)(2013-1#2)
integration is##9##2##(1995-2#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)
integration loci##2##2##(2008-11#2)
integration method and that of the##2##6##(2008-3#2)
integration method and##3##3##(2008-3#3)
integration method##7##2##(2008-3#7)
integration methods##3##2##(2007-11#2)(2008-10#1)
integration of a##4##3##(1994-2#1)(2008-3#2)(2008-7#1)
integration of all these##2##4##(2008-10#1)(2010-10#1)
integration of both##2##3##(2006-12#1)(2008-10#1)
integration of chemical##3##3##(2008-10#3)
integration of different##2##3##(1994-12#1)(2013-1#1)
integration of health##2##3##(2008-2#1)(2011-1#1)
integration of information##3##3##(1995-1#1)(1996-12#1)(2008-4#1)
integration of mental health into##2##5##(1993-2#1)(2010-4#1)
integration of microfluidic channels and optical waveguides##2##7##(2008-3#2)
integration of organic##3##3##(2008-7#2)(2010-5#1)
integration of plasmid DNA##2##4##(2008-10#1)(2008-2#1)
integration of primary##2##3##(1997-1#1)(1997-3#1)
integration of public health and medicine##2##6##(1995-2#2)
integration of services##2##3##(1991-2#1)(1997-1#1)
integration of several##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
integration of strategic##2##3##(1997-3#2)
integration of such a##2##4##(2008-3#1)(2008-8#1)
integration of the introduced##2##4##(1994-9#1)(2008-5#1)
integration of the medical##2##4##(1992-2#1)(2008-12#1)
integration of the##44##3##(1990-5#1)(1992-2#1)(1993-6#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2011-2#2)
integration of theory to practice##2##5##(2008-11#2)
integration of these##5##3##(1996-12#1)(1997-8#1)(2008-2#1)(2008-7#1)(2009-6#1)
integration of this##2##3##(2007-12#1)(2008-11#1)
integration of viral##2##3##(2008-11#1)(2009-11#1)
integration of##180##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#8)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#11)(2008-12#1)(2008-2#9)(2008-3#17)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#1)
integration over##4##2##(1991-5#1)(1997-5#1)(2008-2#2)
integration process##4##2##(1997-1#4)
integration site##2##2##(2008-11#1)(2013-7#1)
integration sites##5##2##(1997-3#1)(2008-10#2)(2011-1#1)(2012-12#1)
integration time and##2##3##(2008-2#1)(2008-3#1)
integration time##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
integration time)##2##2##(2008-10#2)
integration times##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
integration to##4##2##(2008-11#1)(2008-2#2)(2008-3#1)
integration was##2##2##(2009-8#1)(2012-3#1)
integration with other##2##3##(1997-7#1)(2008-10#1)
integration with the##3##3##(1996-2#1)(2009-7#1)(2012-2#1)
integration with##13##2##(1991-2#1)(1994-2#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-9#1)(2012-2#1)
integration within##2##2##(1994-8#1)(2008-1#1)
integration##446##1##(1990-11#1)(1990-5#1)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#4)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-7#3)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#8)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#7)(1996-2#5)(1996-3#5)(1996-6#2)(1997-1#9)(1997-2#5)(1997-3#12)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#49)(2008-11#26)(2008-12#3)(2008-2#26)(2008-3#58)(2008-4#13)(2008-5#5)(2008-6#4)(2008-7#18)(2008-8#6)(2008-9#6)(2009-11#5)(2009-12#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#13)(2009-9#6)(2010-10#3)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#3)(2011-3#1)(2011-7#1)(2011-9#1)(2012-12#5)(2012-2#7)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#1)
integration)##2##1##(2007-12#1)(2008-10#1)
integration-##2##1##(2008-3#2)
integrations##6##1##(1994-7#1)(1997-7#1)(2008-3#3)(2011-1#1)
integrative analyses##2##2##(2008-7#1)(2008-8#1)
integrative biology##2##2##(1997-6#1)(2008-7#1)
integrative literature##2##2##(2009-12#1)(2012-3#1)
integrative medicine##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
integrative pharmacology on-target##2##3##(2012-2#2)
integrative properties##2##2##(2009-3#1)(2012-2#1)
integrative research review##3##3##(1992-2#2)(2009-6#1)
integrative review of##3##3##(2008-4#1)(2010-10#1)(2013-1#1)
integrative review##8##2##(1992-2#1)(2008-4#1)(2010-10#2)(2012-3#1)(2013-1#2)(2013-8#1)
integrative view##2##2##(1994-5#1)(2009-6#1)
integrative##55##1##(1991-2#1)(1992-2#3)(1994-2#3)(1994-3#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#2)(2011-2#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#4)
integrator##9##1##(1996-1#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#3)
integrators##2##1##(1993-1#1)(2008-11#1)
integrifolia##2##1##(1994-12#1)(2008-10#1)
integrin alpha(IIb)beta3##2##2##(2008-11#2)
integrin alpha(v)beta(3) and##3##3##(2010-6#3)
integrin alpha(v)beta(3)##5##2##(2010-6#5)
integrin alphaIIbbeta3##2##2##(1997-7#1)(2006-6#1)
integrin and##4##2##(1991-5#1)(1994-9#1)(1996-2#1)(2010-6#1)
integrin cluster##3##2##(2010-10#3)
integrin clusters in a population of##2##6##(2010-10#2)
integrin clusters in##3##3##(2010-10#3)
integrin clusters##5##2##(2010-10#5)
integrin expression##2##2##(2010-7#1)(2012-12#1)
integrin receptor##2##2##(1995-6#2)
integrin receptors##4##2##(1992-12#1)(1994-12#1)(1995-6#1)(2006-6#1)
integrin signaling##2##2##(2010-3#1)(2010-6#1)
integrin signalling##3##2##(2010-10#3)
integrin α(v) β(3)##3##3##(2010-12#3)
integrin##66##1##(1991-5#1)(1992-12#1)(1992-2#2)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-6#3)(1996-2#1)(1997-2#1)(1997-7#1)(2006-6#3)(2008-1#3)(2008-11#5)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#4)(2010-10#12)(2010-12#3)(2010-3#1)(2010-6#8)(2010-7#1)(2012-12#3)
integrin-dependent##2##1##(2008-1#1)(2012-12#1)
integrin-mediated##2##1##(2010-1#1)(2010-6#1)
integrins and##3##2##(1994-6#1)(2012-12#1)(2013-1#1)
integrins are involved##2##3##(2006-6#1)(2008-1#1)
integrins are##3##2##(2006-6#1)(2008-1#1)(2008-7#1)
integrins##23##1##(1994-6#2)(1995-2#2)(1997-7#1)(2006-6#1)(2008-1#2)(2008-4#1)(2008-7#2)(2009-1#2)(2009-3#1)(2010-11#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
integrity and blood pressure##2##4##(1997-7#2)
integrity and function##2##3##(1996-2#1)(2010-5#1)
integrity and##21##2##(1991-9#1)(1996-2#1)(1997-4#1)(1997-7#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#3)
integrity as well as the##2##5##(2008-5#1)(2008-7#1)
integrity as well as##3##4##(2008-5#1)(2008-7#1)(2008-9#1)
integrity as##5##2##(2008-5#1)(2008-7#1)(2008-9#2)(2010-9#1)
integrity during##2##2##(1996-9#1)(2012-2#1)
integrity in the medial temporal##3##5##(2010-7#3)
integrity in the##4##3##(2010-7#4)
integrity in##7##2##(1990-12#1)(2008-10#1)(2010-7#4)(2013-8#1)
integrity is##5##2##(1992-1#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-12#1)
integrity of a##2##3##(2007-12#1)(2008-4#1)
integrity of mammalian##2##3##(1990-7#1)(2008-9#1)
integrity of the##31##3##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1994-5#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
integrity of these##2##3##(1995-2#1)(2008-10#1)
integrity of this##2##3##(1995-2#1)(2008-10#1)
integrity of##71##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-3#1)(1997-4#2)(1997-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)
integrity plays a key role in##2##6##(2011-2#1)(2012-2#1)
integrity testing##3##2##(2008-9#1)(2012-2#2)
integrity to##2##2##(2008-5#1)(2010-10#1)
integrity when##2##2##(2009-10#1)(2010-8#1)
integrity##187##1##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-7#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#12)(2012-3#6)(2013-1#12)(2013-8#1)
integrodifference##2##1##(2008-9#2)
integument of##2##2##(2007-12#1)(2012-3#1)
integument##6##1##(1991-2#1)(2007-12#3)(2012-2#1)(2012-3#1)
integumentary##4##1##(2007-12#3)(2011-2#1)
intein##8##1##(2009-7#2)(2011-1#1)(2011-2#1)(2011-3#2)(2013-1#2)
inteins##3##1##(2013-1#3)
intellectual and##2##2##(1997-3#1)(2010-10#1)
intellectual disabilities##3##2##(2009-2#1)(2012-12#1)(2012-2#1)
intellectual disability##6##2##(2010-12#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
intellectual functioning##4##2##(1995-11#2)(2006-10#1)(2008-2#1)
intellectual impairment##2##2##(1993-3#1)(2006-12#1)
intellectual property##7##2##(1994-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#3)
intellectual##47##1##(1993-12#2)(1993-3#2)(1994-3#1)(1995-11#2)(1996-1#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)
intellectuals##4##1##(1994-7#1)(2010-1#2)(2011-2#1)
intelligence (EI)##2##2##(2013-1#2)
intelligence and##6##2##(2007-12#1)(2008-11#1)(2008-7#1)(2010-1#2)(2012-3#1)
intelligence in##2##2##(2008-1#1)(2012-12#1)
intelligence of##2##2##(1990-9#1)(2013-1#1)
intelligence techniques##3##2##(2008-4#1)(2010-8#2)
intelligence##44##1##(1990-9#1)(1994-2#1)(1996-3#2)(1997-3#5)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#2)(2008-9#1)(2009-8#2)(2009-9#1)(2010-1#5)(2010-3#1)(2010-8#2)(2012-12#1)(2012-3#3)(2013-1#3)
intelligent design##2##2##(2010-3#1)(2012-3#1)
intelligent use of##2##3##(1996-3#2)
intelligent##20##1##(1991-2#1)(1992-2#1)(1994-3#1)(1996-3#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-3#1)
intelligentsia in the##2##3##(2008-12#2)
intelligentsia in##3##2##(2008-12#3)
intelligentsia##8##1##(2008-12#8)
intelligibility##5##1##(2008-9#4)(2009-2#1)
intelligible##2##1##(2009-2#1)(2012-2#1)
intend to give##2##3##(1994-3#1)(2011-2#1)
intend to show##2##3##(2010-1#1)(2012-12#1)
intend to use##2##3##(1995-3#1)(2008-7#1)
intend to##21##2##(1994-3#1)(1995-12#1)(1995-3#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)
intend##22##1##(1994-3#1)(1995-12#1)(1995-3#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#1)
intended and##2##2##(2008-6#1)(2010-1#1)
intended as##5##2##(1991-2#1)(1992-12#1)(1994-6#1)(1997-3#1)(2012-2#1)
intended for a##2##3##(2008-3#2)
intended for dry-cured ham production##2##5##(2013-1#2)
intended for use##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
intended for##21##2##(2008-10#3)(2008-2#2)(2008-3#7)(2010-4#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
intended meaning of##2##3##(2008-11#2)
intended meaning##3##2##(2008-11#2)(2012-3#1)
intended to assist##2##3##(2010-7#1)(2013-1#1)
intended to be used as##2##5##(2008-2#1)(2011-1#1)
intended to be##4##3##(2008-2#1)(2008-4#1)(2011-1#1)(2013-8#1)
intended to evaluate the##2##4##(2008-10#1)(2008-7#1)
intended to help##4##3##(1993-6#1)(2008-8#1)(2009-4#1)(2009-7#1)
intended to identify##4##3##(1992-1#1)(1993-5#1)(1996-12#1)(2009-7#1)
intended to improve##2##3##(1990-11#1)(2011-1#1)
intended to protect the##2##4##(2008-5#1)(2008-8#1)
intended to provide a##2##4##(2008-10#1)(2008-11#1)
intended to provide an##2##4##(2008-2#1)(2008-5#1)
intended to provide##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)
intended to reduce##2##3##(1992-12#1)(1996-1#1)
intended to##59##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-5#1)(1993-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
intended use##4##2##(1997-1#1)(2007-11#1)(2010-6#1)(2011-2#1)
intended##122##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#2)(2007-11#3)(2008-10#9)(2008-11#6)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
intending to##3##2##(2007-12#1)(2008-12#1)(2010-2#1)
intends to##9##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#2)(2012-3#1)
intenpecies##3##1##(2008-9#3)
intense UV##2##2##(2008-10#1)(2008-3#1)
intense X-ray##2##2##(2006-4#1)(2008-10#1)
intense and##6##2##(1992-5#1)(2008-10#3)(2008-5#1)(2008-7#1)
intense but##2##2##(2008-10#2)
intense debate##3##2##(1997-1#1)(2010-12#1)(2010-3#1)
intense emotional##2##2##(1993-12#1)(2013-1#1)
intense exposure##2##2##(1992-3#1)(2008-10#1)
intense femtosecond##3##2##(2007-11#1)(2007-12#2)
intense fluorescence##2##2##(2008-10#1)(2008-2#1)
intense in##6##2##(1991-5#1)(1993-11#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-7#1)
intense inoculation pressure##2##3##(2008-10#2)
intense laser##2##2##(2007-11#1)(2007-12#1)
intense light##4##2##(2007-12#2)(2008-1#1)(2008-10#1)
intense pain##4##2##(2008-3#1)(2008-7#2)(2009-3#1)
intense pulsed##2##2##(2010-6#2)
intense research##5##2##(1994-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2010-9#1)
intense scrutiny##2##2##(2008-7#1)(2009-3#1)
intense signal##2##2##(2006-10#1)(2008-10#1)
intense staining of##2##3##(2008-7#1)(2008-9#1)
intense when the##2##3##(1994-5#1)(2008-11#1)
intense##201##1##(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1997-1#2)(1997-2#1)(1997-7#1)(2006-10#2)(2006-4#3)(2007-11#9)(2007-12#19)(2007-5#1)(2008-1#1)(2008-10#37)(2008-11#5)(2008-2#9)(2008-3#7)(2008-5#9)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#4)(2009-3#4)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#2)(2013-1#2)(2013-7#1)(2013-8#4)
intensely expressed in the##3##4##(1997-2#1)(1997-4#1)(2012-3#1)
intensely expressed##4##2##(1990-11#1)(1997-2#1)(1997-4#1)(2012-3#1)
intensely labeled##2##2##(1990-11#1)(1995-12#1)
intensely pumped Nd##2##3##(2008-3#2)
intensely pumped##3##2##(2008-3#3)
intensely stained##2##2##(1997-2#1)(2008-7#1)
intensely##29##1##(1990-11#2)(1990-7#1)(1993-3#1)(1995-1#1)(1995-12#2)(1995-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
intensification of the##2##3##(1996-11#1)(2008-10#1)
intensification of##11##2##(1994-8#1)(1996-11#1)(1996-4#1)(2008-10#2)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#3)
intensification time##2##2##(2008-10#2)
intensification##18##1##(1993-9#1)(1994-8#1)(1996-11#1)(1996-4#1)(2008-10#4)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#3)(2012-12#1)(2013-1#3)
intensified CCD camera##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
intensified CCD##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
intensified camera##2##2##(2008-3#2)
intensified charge-coupled device##2##3##(2008-10#2)
intensified in the##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
intensified insulin therapy##2##3##(1997-4#1)(2008-1#1)
intensified##38##1##(1991-3#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
intensifies##5##1##(1992-3#1)(1995-12#1)(2008-1#1)(2008-10#2)
intensifying##7##1##(2007-8#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
intensities and potentials##2##3##(2008-10#2)
intensities and##10##2##(1994-9#2)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#2)
intensities are##9##2##(2007-12#1)(2008-10#1)(2008-3#6)(2010-2#1)
intensities at two##2##3##(2008-2#2)
intensities at##4##2##(2007-12#1)(2008-2#3)
intensities by a##2##3##(1994-9#1)(2008-3#1)
intensities by##4##2##(1994-9#1)(2007-12#1)(2008-3#1)(2008-9#1)
intensities could be##2##3##(2008-10#1)(2008-11#1)
intensities for the##2##3##(2008-10#2)
intensities for##3##2##(2008-10#3)
intensities from a##3##3##(2008-10#3)
intensities from##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
intensities in the##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
intensities in##9##2##(1992-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2012-12#1)
intensities is##2##2##(2008-3#1)(2008-6#1)
intensities measured##2##2##(2006-6#1)(2008-2#1)
intensities of a##2##3##(2007-12#1)(2008-3#1)
intensities of the##20##3##(2007-11#3)(2007-12#1)(2008-10#8)(2008-3#2)(2008-8#2)(2012-3#1)(2013-8#3)
intensities of these##2##3##(1994-12#1)(2008-10#1)
intensities of##50##2##(1990-7#1)(1992-3#3)(1993-12#1)(1993-8#1)(1994-12#1)(1994-7#1)(2007-11#4)(2007-12#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#3)(2012-3#1)(2013-1#1)(2013-8#3)
intensities on##3##2##(2008-7#2)(2009-11#1)
intensities ranging from 0##2##4##(2008-10#1)(2008-11#1)
intensities ranging from##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
intensities that are##2##3##(2007-11#1)(2008-3#1)
intensities that##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
intensities the##2##2##(2008-3#2)
intensities were##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
intensities with the##2##3##(2007-12#1)(2008-10#1)
intensities with##6##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
intensities##179##1##(1990-7#1)(1992-3#4)(1992-8#2)(1993-12#4)(1993-8#1)(1994-12#1)(1994-7#1)(1994-9#3)(1995-12#1)(1996-2#1)(1997-5#1)(2006-6#1)(2007-11#8)(2007-12#11)(2008-10#44)(2008-11#4)(2008-12#3)(2008-2#17)(2008-3#39)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#8)
intensity (incidence and severity)##2##4##(2008-10#2)
intensity =##2##2##(2008-10#1)(2008-6#1)
intensity across the##2##3##(2008-3#2)
intensity and a##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
intensity and deoxynivalenol##2##3##(2008-10#2)
intensity and duration of##2##4##(1994-2#1)(2009-3#1)
intensity and duration##3##3##(1994-2#1)(2008-10#1)(2009-3#1)
intensity and energy density##2##4##(2007-11#2)
intensity and frequency of##2##4##(1990-8#1)(2007-8#1)
intensity and frequency##3##3##(1990-8#1)(2007-8#1)(2013-1#1)
intensity and phase##2##3##(2007-11#1)(2007-12#1)
intensity and polarization##3##3##(2007-12#1)(2008-2#2)
intensity and the concentration of##2##5##(2008-10#2)
intensity and the phase of##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
intensity and the##26##3##(1990-12#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-11#3)(2010-4#1)
intensity and unpleasantness##4##3##(2008-10#3)(2008-5#1)
intensity and##112##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1996-2#1)(1996-3#1)(2007-11#7)(2007-12#6)(2007-8#1)(2008-10#31)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2010-11#3)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)(2013-8#3)
intensity are observed##2##3##(2007-12#1)(2008-3#1)
intensity are##8##2##(2007-12#3)(2008-10#1)(2008-3#4)
intensity as a function of##2##5##(2008-10#1)(2008-3#1)
intensity as a##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
intensity as low as##3##4##(2007-12#2)(2009-5#1)
intensity as##11##2##(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)(2009-5#1)(2013-8#1)
intensity at 1##3##3##(2008-3#1)(2013-8#2)
intensity at the##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
intensity at##32##2##(1992-6#3)(1995-5#3)(2007-11#3)(2007-12#4)(2008-10#8)(2008-2#3)(2008-3#4)(2009-11#2)(2013-8#2)
intensity autocorrelation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
intensity based##2##2##(2008-7#1)(2013-1#1)
intensity between##3##2##(2008-8#2)(2011-2#1)
intensity by##4##2##(1990-12#1)(2008-10#1)(2008-3#2)
intensity can##2##2##(2008-10#1)(2008-3#1)
intensity change in##2##3##(1995-5#1)(2008-7#1)
intensity change##6##2##(1992-12#1)(1995-5#1)(2008-10#1)(2008-3#2)(2008-7#1)
intensity changes in##3##3##(2008-10#1)(2008-3#2)
intensity changes with##2##3##(2008-10#1)(2008-3#1)
intensity changes##11##2##(1996-2#1)(2008-10#4)(2008-3#4)(2008-4#1)(2011-2#1)
intensity correlation function of##2##4##(2007-12#1)(2008-2#1)
intensity correlation function##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
intensity correlations##2##2##(2007-12#1)(2008-3#1)
intensity data obtained##2##3##(2008-2#1)(2008-7#1)
intensity data##7##2##(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#2)
intensity decreases##3##2##(2008-10#1)(2008-2#1)(2012-1#1)
intensity dependence##2##2##(2007-12#1)(2008-3#1)
intensity differences##3##2##(1993-11#1)(2008-10#1)(2011-1#1)
intensity distribution and the##2##4##(2008-2#1)(2008-3#1)
intensity distribution and##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
intensity distribution in the##5##4##(2008-2#2)(2008-3#3)
intensity distribution is##2##3##(2007-12#1)(2008-3#1)
intensity distribution of a##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
intensity distribution of the##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
intensity distribution of##14##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)
intensity distribution that is##2##4##(2007-12#1)(2008-3#1)
intensity distribution##44##2##(2007-11#6)(2007-12#8)(2008-10#2)(2008-2#7)(2008-3#21)
intensity distributions##10##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2010-12#1)
intensity during##4##2##(1994-12#1)(2012-12#1)(2013-8#2)
intensity emitted##2##2##(2008-10#1)(2013-8#1)
intensity enhancement##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)
intensity fluctuations and##2##3##(2008-2#1)(2008-3#1)
intensity fluctuations in##2##3##(2007-11#1)(2007-12#1)
intensity fluctuations of##3##3##(2007-11#1)(2008-3#2)
intensity fluctuations##17##2##(2007-11#4)(2007-12#4)(2008-2#4)(2008-3#5)
intensity for##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
intensity from a##2##3##(2007-12#1)(2008-5#1)
intensity from the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
intensity from##15##2##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2013-8#2)
intensity has##4##2##(2008-3#2)(2008-9#2)
intensity heat-evoked tail-flick response##2##4##(1992-3#2)
intensity in a##4##3##(2008-10#1)(2008-3#2)(2010-1#1)
intensity in all##2##3##(2009-10#1)(2009-3#1)
intensity in the range of##2##5##(2008-10#2)
intensity in the##19##3##(1990-7#1)(1991-11#2)(1991-5#1)(1996-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-3#2)(2008-7#2)(2009-3#1)(2011-1#1)
intensity in##37##2##(1990-7#1)(1991-11#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#1)(1995-12#1)(1996-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#6)(2008-7#2)(2009-10#1)(2009-3#2)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#2)
intensity increase##2##2##(2007-12#1)(2009-11#1)
intensity increased##6##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#2)
intensity increases##3##2##(2007-12#1)(2008-9#1)(2013-8#1)
intensity information##4##2##(2008-3#2)(2010-9#1)(2013-8#1)
intensity inside##4##2##(2008-3#3)(2008-7#1)
intensity is a linear function of##2##6##(2008-10#2)
intensity is proportional to the concentration of##3##7##(2008-10#2)(2008-12#1)
intensity is proportional to the##4##5##(2008-10#2)(2008-12#1)(2008-3#1)
intensity is proportional to##5##4##(2008-10#3)(2008-12#1)(2008-3#1)
intensity is the##2##3##(2008-3#2)
intensity is##35##2##(2007-11#3)(2007-12#1)(2008-10#19)(2008-12#1)(2008-3#7)(2008-5#1)(2008-7#2)(2011-1#1)
intensity levels##2##2##(1995-12#1)(2011-2#1)
intensity measured##3##2##(2008-10#1)(2008-3#2)
intensity measurements in the##2##4##(2007-11#1)(2008-2#1)
intensity measurements##9##2##(1994-3#1)(2007-11#1)(2008-2#3)(2008-3#4)
intensity measures##2##2##(2008-10#1)(2008-7#1)
intensity modulation in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
intensity modulation is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
intensity modulation##13##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#9)
intensity modulations as##2##3##(2008-3#2)
intensity modulations##4##2##(2008-2#1)(2008-3#3)
intensity modulator##2##2##(2007-11#1)(2008-3#1)
intensity noise##15##2##(2007-11#1)(2007-12#8)(2008-2#1)(2008-3#5)
intensity nonuniformity of##2##3##(2008-2#2)
intensity nonuniformity##3##2##(2008-2#2)(2008-3#1)
intensity obtained from##2##3##(2008-2#2)
intensity obtained##3##2##(2008-10#1)(2008-2#2)
intensity of 1##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
intensity of 200##2##3##(2008-3#1)(2008-6#1)
intensity of a##6##3##(1992-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
intensity of aggregation##2##3##(1990-5#1)(2008-10#1)
intensity of an##3##3##(1992-12#1)(2008-2#1)(2008-4#1)
intensity of both##2##3##(2009-11#1)(2013-8#1)
intensity of care provided##2##4##(1992-1#2)
intensity of care##5##3##(1992-1#3)(1994-3#1)(2012-2#1)
intensity of each##3##3##(2007-12#1)(2008-3#2)
intensity of fluorescence##4##3##(2008-10#3)(2008-11#1)
intensity of infection##2##3##(2011-1#2)
intensity of light##5##3##(1990-8#1)(2008-3#4)
intensity of pain##5##3##(1995-12#1)(2007-11#2)(2007-8#1)(2013-1#1)
intensity of reflectance##4##3##(2008-10#4)
intensity of scattered light##2##4##(2008-2#1)(2008-3#1)
intensity of service##2##3##(1995-3#1)(1996-1#1)
intensity of sexual selection on##2##5##(2008-8#2)
intensity of sexual selection##5##4##(2008-8#3)(2008-9#2)
intensity of sexual##6##3##(2008-8#3)(2008-9#3)
intensity of stimulation##3##3##(1997-3#1)(2008-7#2)
intensity of symptoms##2##3##(2008-10#1)(2013-1#1)
intensity of the blue##2##4##(2007-12#1)(2008-10#1)
intensity of the complex##2##4##(2008-10#2)
intensity of the laser##2##4##(2008-2#1)(2008-3#1)
intensity of the light##2##4##(2007-12#1)(2008-2#1)
intensity of the probe##2##4##(1995-11#1)(2007-12#1)
intensity of the##116##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1992-11#2)(1992-3#2)(1993-12#2)(1993-3#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#5)(2008-10#35)(2008-11#3)(2008-2#13)(2008-3#13)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#5)
intensity of these##2##3##(2008-10#2)
intensity of this##4##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
intensity of treatment##3##3##(1993-1#1)(2009-11#1)(2011-2#1)
intensity of##334##2##(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1992-1#4)(1992-11#2)(1992-12#1)(1992-3#4)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-6#2)(1995-8#3)(1996-1#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#14)(2007-12#12)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#82)(2008-11#9)(2008-12#6)(2008-2#21)(2008-3#32)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#5)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#12)
intensity on the optical##2##4##(2007-12#1)(2008-3#1)
intensity on the##8##3##(2007-12#2)(2008-2#1)(2008-3#4)(2009-10#1)
intensity on two##2##3##(2007-11#1)(2011-2#1)
intensity on##26##2##(1991-11#2)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2009-10#1)(2009-11#2)(2011-2#4)(2012-2#1)
intensity or the##2##3##(2008-10#1)(2008-3#1)
intensity or##5##2##(2008-10#1)(2008-3#2)(2008-9#2)
intensity pattern in the##2##4##(2007-11#1)(2008-3#1)
intensity pattern##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
intensity patterns of##4##3##(2008-2#1)(2008-3#3)
intensity patterns##11##2##(2007-12#2)(2008-2#1)(2008-3#8)
intensity peak##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
intensity produced by##2##3##(2008-10#1)(2008-4#1)
intensity produced##4##2##(2008-10#3)(2008-4#1)
intensity profile and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
intensity profile is##2##3##(2007-11#1)(2008-3#1)
intensity profile pump beam##2##4##(2008-3#2)
intensity profile##18##2##(2007-11#4)(2008-2#4)(2008-3#10)
intensity profiles are##2##3##(2007-12#1)(2008-3#1)
intensity profiles of##2##3##(2007-11#1)(2007-12#1)
intensity profiles##10##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)(2008-5#1)
intensity progression##2##2##(2010-1#2)
intensity projection##2##2##(2008-7#1)(2012-2#1)
intensity ratio in##2##3##(2008-2#1)(2008-3#1)
intensity ratio of the##2##4##(1992-6#1)(2008-3#1)
intensity ratio of##5##3##(1992-6#1)(2008-10#1)(2008-3#3)
intensity ratio##24##2##(1992-6#1)(2007-12#3)(2008-10#6)(2008-2#5)(2008-3#9)
intensity ratios##4##2##(2008-10#1)(2008-2#3)
intensity response##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
intensity showed##2##2##(2008-10#2)
intensity significantly affected##2##3##(1992-2#1)(2008-10#1)
intensity spectrum##3##2##(2007-12#2)(2008-3#1)
intensity statistics of the##2##4##(2007-12#1)(2008-2#1)
intensity than the##2##3##(2008-10#1)(2008-2#1)
intensity than##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
intensity that is##3##3##(2007-11#1)(2008-2#1)(2008-9#1)
intensity that##12##2##(1990-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2013-8#1)
intensity threshold##2##2##(2008-3#2)
intensity to##6##2##(1990-7#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
intensity transformations##2##2##(2008-2#2)
intensity using##2##2##(2008-10#1)(2012-12#1)
intensity values##3##2##(2007-12#1)(2008-10#2)
intensity variation##8##2##(2007-12#2)(2008-3#6)
intensity variations##7##2##(2007-12#1)(2008-2#2)(2008-3#3)(2010-10#1)
intensity versus##3##2##(2008-10#1)(2008-3#2)
intensity was found##2##3##(2008-10#1)(2008-2#1)
intensity was linear over a nitrite concentration of##2##8##(2008-10#2)
intensity was linear over a##3##5##(2008-10#3)
intensity was linear with the##4##5##(2008-10#4)
intensity was linear with##7##4##(2008-10#7)
intensity was linear##14##3##(2008-10#14)
intensity was measured at##2##4##(2008-10#2)
intensity was measured##4##3##(2008-10#4)
intensity was proportional to the##2##5##(2008-10#1)(2008-3#1)
intensity was##50##2##(1991-12#1)(1992-1#1)(1992-10#1)(1995-12#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#34)(2008-2#3)(2008-3#1)(2008-6#3)(2008-7#1)(2010-7#1)
intensity were investigated##2##3##(2008-10#2)
intensity were measured##2##3##(1992-12#1)(2008-3#1)
intensity were##11##2##(1992-12#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
intensity when##4##2##(1992-12#1)(1994-6#1)(2008-10#1)(2013-8#1)
intensity with the##3##3##(1992-12#1)(2008-10#1)(2008-6#1)
intensity with##11##2##(1992-12#1)(1996-5#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2013-1#1)
intensity within##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
intensity without##2##2##(2007-12#2)
intensity x##2##2##(2008-10#1)(2008-2#1)
intensity##1428##1##(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#2)(1991-11#7)(1991-12#4)(1991-2#4)(1991-5#3)(1991-6#1)(1992-1#5)(1992-10#3)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#8)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-3#4)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#6)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#12)(1995-3#1)(1995-5#6)(1995-6#2)(1995-8#3)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#5)(2007-10#3)(2007-11#91)(2007-12#117)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#304)(2008-11#15)(2008-12#15)(2008-2#123)(2008-3#276)(2008-4#7)(2008-5#18)(2008-6#18)(2008-7#40)(2008-8#15)(2008-9#33)(2009-1#1)(2009-10#3)(2009-11#10)(2009-12#5)(2009-2#1)(2009-3#7)(2009-4#2)(2009-5#2)(2009-7#1)(2010-1#6)(2010-10#1)(2010-11#5)(2010-12#5)(2010-3#1)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#28)(2012-1#3)(2012-12#11)(2012-2#10)(2012-3#6)(2012-8#1)(2013-1#15)(2013-7#3)(2013-8#36)
intensity) and##2##2##(2007-12#1)(2008-3#1)
intensity)##7##1##(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-11#1)
intensity-correlation functions##2##2##(2008-3#2)
intensity-dependent polarization##3##2##(2007-11#1)(2007-12#2)
intensity-dependent##9##1##(2007-11#3)(2007-12#6)
intensity-modulated radiotherapy (IMRT)##2##3##(2008-2#1)(2011-2#1)
intensity-modulated radiotherapy##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
intensity-modulated##18##1##(1995-5#1)(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#5)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
intensity-validation scheme##3##2##(2008-3#3)
intensive and require a##2##4##(1993-12#1)(2008-10#1)
intensive and##9##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#2)
intensive care and##2##3##(2008-11#1)(2012-12#1)
intensive care for##2##3##(1997-3#1)(2013-8#1)
intensive care in##3##3##(2006-10#2)(2009-4#1)
intensive care management of##2##4##(2008-9#1)(2010-7#1)
intensive care management##3##3##(2008-9#1)(2010-10#1)(2010-7#1)
intensive care medicine##2##3##(1997-1#1)(1997-2#1)
intensive care nursery experience##2##4##(1995-1#2)
intensive care nursery##3##3##(1995-1#2)(2011-1#1)
intensive care patients##6##3##(1990-2#3)(2007-11#1)(2007-12#1)(2008-7#1)
intensive care setting##2##3##(2007-11#1)(2008-11#1)
intensive care unit (ICU) and##2##5##(1992-2#1)(2008-4#1)
intensive care unit (ICU)##11##4##(1992-2#1)(1995-12#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2010-11#2)(2011-2#1)(2012-3#1)
intensive care unit and##4##4##(2006-10#1)(2007-8#1)(2009-5#1)(2012-3#1)
intensive care unit for##2##4##(1991-11#1)(2010-12#1)
intensive care unit of##4##4##(2009-3#1)(2010-11#1)(2010-8#1)(2013-1#1)
intensive care unit patients##4##4##(2007-7#1)(2009-11#2)(2011-2#1)
intensive care unit##64##3##(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-8#2)(2009-11#2)(2009-3#1)(2009-5#3)(2010-10#1)(2010-11#5)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)
intensive care unit]##3##3##(1990-6#1)(1991-3#1)(2011-2#1)
intensive care units (ICUs)##4##4##(2007-11#1)(2007-7#1)(2008-8#1)(2011-2#1)
intensive care units and##3##4##(2006-10#1)(2008-11#1)(2008-4#1)
intensive care units is##2##4##(2007-11#1)(2010-8#1)
intensive care units##33##3##(1991-12#1)(1991-2#1)(1992-3#1)(1994-3#2)(1995-1#1)(1995-5#1)(1996-3#1)(1996-9#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#2)(2009-5#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
intensive care units]##3##3##(1993-8#1)(1996-9#1)(2011-2#1)
intensive care##165##2##(1990-11#1)(1990-2#3)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#13)(1991-2#2)(1991-3#3)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#5)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#2)(2006-10#5)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#14)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#8)(2010-10#2)(2010-11#5)(2010-12#2)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#1)
intensive chemotherapy##4##2##(1990-3#1)(1994-5#1)(2008-10#1)(2011-2#1)
intensive computation##2##2##(2008-2#1)(2008-3#1)
intensive efforts##4##2##(1993-3#1)(2008-10#1)(2008-9#1)(2011-2#1)
intensive exercise##2##2##(2007-8#1)(2012-3#1)
intensive insulin therapy##2##3##(2010-12#1)(2011-1#1)
intensive investigation##3##2##(2011-2#1)(2011-3#1)(2013-8#1)
intensive management##2##2##(1994-12#1)(2008-10#1)
intensive medical##2##2##(1995-5#1)(2012-3#1)
intensive regimens##2##2##(2007-10#1)(2008-7#1)
intensive rehabilitation##2##2##(2007-10#1)(2009-4#1)
intensive research##6##2##(1990-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-2#1)
intensive screening##2##2##(2008-5#2)
intensive studies##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
intensive therapeutic##2##2##(2008-4#1)(2012-2#1)
intensive therapy##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
intensive therapy]##2##2##(1991-2#1)(1992-3#1)
intensive training in##2##3##(1993-3#1)(2008-12#1)
intensive treatment for##3##3##(2012-2#3)
intensive treatment with##2##3##(1994-12#1)(2013-1#1)
intensive treatment##13##2##(1993-9#1)(1994-12#1)(1996-11#1)(2008-3#1)(2010-5#1)(2011-2#3)(2012-2#3)(2013-1#2)
intensive treatments##4##2##(2008-10#3)(2008-3#1)
intensive use of##3##3##(2008-10#2)(2008-3#1)
intensive##328##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#14)(1991-2#3)(1991-3#3)(1992-1#1)(1992-2#1)(1992-3#4)(1992-5#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#6)(1997-1#2)(1997-2#1)(1997-3#2)(2006-10#5)(2007-10#3)(2007-11#11)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#19)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#2)(2009-5#9)(2010-10#2)(2010-11#5)(2010-12#4)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#7)(2011-2#27)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#4)
intensively sampled##2##2##(2008-10#2)
intensively studied for##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
intensively studied##8##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#2)(2013-1#1)
intensively##29##1##(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
intent and##3##2##(2008-4#1)(2008-6#1)(2012-3#1)
intent of the##5##3##(1994-2#1)(1997-1#1)(2007-4#1)(2009-4#1)(2011-2#1)
intent of##11##2##(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2007-4#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#1)
intent on##2##2##(1997-3#1)(2008-11#1)
intent to complain##2##3##(1993-12#2)
intent to use condoms##3##4##(2008-4#3)
intent to##10##2##(1993-12#2)(1996-3#1)(2007-10#1)(2008-4#4)(2009-2#1)(2010-12#1)
intent##44##1##(1992-1#2)(1992-12#1)(1993-12#2)(1994-1#1)(1994-2#3)(1994-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)
intent-to-treat##4##1##(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
intention and##5##2##(2008-1#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
intention is to##3##3##(2008-10#1)(2008-2#2)
intention of##7##2##(1995-3#2)(1997-4#1)(2008-10#2)(2008-5#1)(2009-9#1)
intention to##14##2##(1993-12#2)(2007-12#2)(2008-4#1)(2009-5#1)(2011-1#6)(2013-8#2)
intention##38##1##(1992-6#1)(1993-12#4)(1994-3#1)(1995-3#2)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#6)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
intentional and automatic retrieval##2##4##(2009-10#2)
intentional and##3##2##(2009-10#2)(2013-1#1)
intentional inferences##2##2##(2008-11#2)
intentional tort##2##2##(1994-1#2)
intentional##34##1##(1990-3#1)(1992-3#1)(1994-1#2)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#7)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2010-2#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
intentionally##10##1##(1995-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
intentions and##4##2##(1991-3#1)(2008-11#1)(2009-12#1)(2013-7#1)
intentions are##3##2##(1995-3#1)(2009-12#2)
intentions to##6##2##(1991-3#1)(1994-3#1)(1996-3#1)(2008-12#2)(2009-10#1)
intentions##30##1##(1990-11#1)(1991-3#2)(1994-3#2)(1995-3#2)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2009-10#2)(2009-12#8)(2010-2#3)(2011-1#1)(2013-7#1)
inter alia##2##2##(2008-11#1)(2008-3#1)
inter and##2##2##(2008-10#1)(2008-7#1)
inter atrial septum##4##3##(2012-3#4)
inter##17##1##(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2012-3#4)(2013-1#1)(2013-7#1)
inter- and intracellular##2##3##(2008-10#2)
inter- and intraspecific##3##3##(2008-8#2)(2008-9#1)
inter- and##15##2##(1992-3#1)(1996-12#1)(2008-10#7)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)
inter-##17##1##(1991-2#1)(1992-3#1)(1996-12#1)(2008-10#8)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)
inter-annual##2##1##(2012-6#1)(2013-7#1)
inter-assay##12##1##(1990-11#1)(1990-12#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-7#1)(2010-5#1)(2011-3#1)
inter-day##14##1##(2008-10#12)(2011-2#1)(2011-3#1)
inter-dialytic weight gains##2##3##(2007-7#2)
inter-disciplinary##3##1##(2008-11#1)(2008-9#1)(2009-7#1)
inter-dot##2##1##(2012-2#2)
inter-individual variability##2##2##(2008-3#1)(2011-1#1)
inter-individual##10##1##(1993-5#1)(1996-12#2)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#2)
inter-item correlation##2##2##(2013-1#2)
inter-laboratory comparison##3##2##(2008-10#3)
inter-laboratory##12##1##(2008-10#12)
inter-observer variation##2##2##(2007-8#1)(2008-11#1)
inter-observer##5##1##(2007-8#2)(2008-11#1)(2008-6#1)(2012-3#1)
inter-professional education##4##2##(2008-11#2)(2008-12#2)
inter-professional learning##2##2##(2008-11#2)
inter-professional##11##1##(2008-11#5)(2008-12#3)(2008-3#1)(2010-10#1)(2011-1#1)
inter-rater reliability of the##2##4##(2008-11#1)(2008-9#1)
inter-rater reliability of##6##3##(1993-12#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
inter-rater reliability##13##2##(1993-12#3)(2008-10#1)(2008-11#1)(2008-9#3)(2010-10#2)(2011-2#1)(2012-12#2)
inter-rater##14##1##(1993-12#3)(2008-10#2)(2008-11#1)(2008-9#3)(2010-10#2)(2011-2#1)(2012-12#2)
inter-related##2##1##(2008-5#1)(2010-11#1)
inter-relationships##3##1##(1990-9#1)(1991-2#1)(1992-9#1)
inter-session reliability##2##2##(2013-7#2)
inter-simple sequence repeats##2##3##(2008-10#2)
inter-simple sequence##3##2##(2008-10#3)
inter-spawning##3##1##(2010-8#3)
inter-species differences##3##2##(2008-10#1)(2011-3#2)
inter-species##4##1##(2008-10#1)(2008-11#1)(2011-3#2)
inter-strain hybrids##2##2##(2008-12#2)
inter-tetramer positive cooperativity##3##3##(1997-2#3)
interact and##3##2##(1993-11#1)(2008-5#1)(2010-6#1)
interact at the##2##3##(2008-9#1)(2009-7#1)
interact at##4##2##(1992-3#1)(2008-10#1)(2008-9#1)(2009-7#1)
interact differently##2##2##(2009-12#1)(2013-8#1)
interact directly or indirectly with##2##5##(2008-4#1)(2008-9#1)
interact directly with the##4##4##(1995-6#2)(1996-2#2)
interact directly with##6##3##(1993-8#1)(1995-6#2)(1996-2#2)(2008-5#1)
interact directly##8##2##(1993-8#1)(1995-6#2)(1996-2#2)(2008-4#1)(2008-5#1)(2008-9#1)
interact in a complex manner##2##5##(2007-11#1)(2008-11#1)
interact in a##5##3##(1992-10#1)(1993-8#1)(2007-11#2)(2008-11#1)
interact in determining##2##3##(2008-8#1)(2009-8#1)
interact in the##5##3##(1992-8#1)(1992-9#1)(1993-6#1)(1995-2#1)(2008-7#1)
interact in vitro##2##3##(1995-12#1)(1995-2#1)
interact in##18##2##(1992-10#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#2)(2007-11#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#1)
interact strongly with##4##3##(1994-2#1)(1994-5#1)(2007-12#1)(2009-10#1)
interact strongly##5##2##(1994-2#1)(1994-5#1)(2007-12#1)(2008-10#1)(2009-10#1)
interact through##2##2##(2008-8#2)
interact to affect sexual trait##2##5##(2012-3#2)
interact to affect##3##3##(2008-4#1)(2012-3#2)
interact to form##2##3##(1992-6#1)(1995-2#1)
interact to produce##2##3##(2007-11#1)(2012-3#1)
interact to##11##2##(1991-9#1)(1992-6#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2012-3#3)
interact with DNA##2##3##(1992-11#1)(1997-3#1)
interact with NifA##2##3##(2008-4#1)(2008-9#1)
interact with a##6##3##(1991-9#1)(1993-8#1)(1995-2#1)(2008-4#1)(2009-3#1)(2012-2#1)
interact with antithrombin III##2##4##(1995-2#2)
interact with both##3##3##(1990-7#1)(1992-11#1)(1995-5#1)
interact with each other and##2##5##(2008-10#1)(2008-5#1)
interact with each other##8##4##(1994-12#1)(1995-2#2)(2008-10#1)(2008-5#2)(2008-7#1)(2009-6#1)
interact with host##2##3##(1995-9#1)(2013-1#1)
interact with one another##4##4##(1997-7#1)(2007-11#1)(2010-12#1)(2011-1#1)
interact with other##5##3##(1991-3#1)(2008-12#1)(2009-3#1)(2011-2#2)
interact with several##2##3##(1993-11#1)(2008-11#1)
interact with the active site##2##5##(2008-8#2)
interact with the drug##2##4##(1990-2#1)(1995-5#1)
interact with the environment##2##4##(2010-4#1)(2010-5#1)
interact with the##33##3##(1990-11#1)(1990-2#2)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-2#2)(1995-5#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-3#2)
interact with their environment##2##4##(2008-11#1)(2012-2#1)
interact with them##2##3##(2008-1#1)(2009-9#1)
interact with various##2##3##(2008-7#1)(2010-5#1)
interact with##160##2##(1990-11#1)(1990-2#4)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#2)(1993-11#2)(1993-3#2)(1993-8#4)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#1)(1995-2#9)(1995-5#5)(1995-6#3)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#3)(2009-3#4)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#4)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
interact##243##1##(1990-11#1)(1990-2#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#2)(1993-6#1)(1993-8#6)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#6)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#13)(1995-5#5)(1995-6#5)(1995-9#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#9)(2009-10#4)(2009-12#1)(2009-3#4)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#9)(2013-1#4)(2013-8#4)
interacted directly with##2##3##(1993-6#1)(2008-11#1)
interacted significantly with##2##3##(1996-6#1)(2008-10#1)
interacted specifically##2##2##(1994-6#1)(2008-8#1)
interacted with antibodies to M##2##5##(1992-12#2)
interacted with the##5##3##(1994-5#1)(1994-6#1)(1995-8#1)(2008-2#1)(2008-5#1)
interacted with##20##2##(1991-5#1)(1992-12#2)(1992-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#2)(2010-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
interacted##35##1##(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-6#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-8#1)(1996-6#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
interacting components##2##2##(1996-12#1)(1997-7#1)
interacting factors##3##2##(1997-7#1)(2008-10#1)(2008-3#1)
interacting genetic and environmental factors##2##5##(2012-1#1)(2012-3#1)
interacting loci##2##2##(2008-8#1)(2011-2#1)
interacting molecules##3##2##(2008-1#1)(2008-11#1)(2010-12#1)
interacting phenotypes##5##2##(2008-8#5)
interacting protein##4##2##(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
interacting proteins##7##2##(2008-1#1)(2008-4#1)(2008-9#3)(2009-8#1)(2011-2#1)
interacting system##3##2##(2008-2#2)(2009-12#1)
interacting waves##5##2##(2007-11#3)(2007-12#2)
interacting with Caenorhabditis elegans Galpha subunits##2##6##(2008-7#2)
interacting with a##2##3##(2007-12#1)(2008-3#1)
interacting with high risk patients##2##5##(2010-3#2)
interacting with the##13##3##(1990-4#1)(1990-5#1)(1991-2#1)(1992-11#2)(1994-11#1)(1995-12#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
interacting with##56##2##(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#4)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
interacting##142##1##(1990-12#2)(1990-4#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#4)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#4)(1997-7#2)(2007-11#4)(2007-12#9)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#13)(2008-9#7)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
interaction (i##2##2##(1997-2#1)(2008-9#1)
interaction among the##2##3##(2007-11#1)(2008-10#1)
interaction among##10##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#1)(2009-8#1)(2010-6#1)
interaction analysis##3##2##(2008-10#1)(2008-4#2)
interaction and the##2##3##(2008-4#1)(2009-12#1)
interaction and##33##2##(1990-8#2)(1992-12#1)(1995-2#2)(1996-11#1)(1997-2#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-6#1)(2012-2#1)(2012-3#2)
interaction are discussed##2##3##(2008-11#1)(2009-11#1)
interaction are##9##2##(1991-3#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-1#1)
interaction assays##3##2##(2009-10#2)(2012-2#1)
interaction at the##2##3##(1990-5#1)(1993-11#1)
interaction at##7##2##(1990-5#1)(1990-8#2)(1993-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
interaction became##2##2##(2008-10#2)
interaction between ADAM22 and 14-3-3beta##2##5##(2008-9#2)
interaction between P##3##3##(2008-10#3)
interaction between RIPs and rRNA##2##5##(2008-8#2)
interaction between RIPs and##3##4##(2008-8#3)
interaction between a probe##2##4##(2007-11#1)(2009-6#1)
interaction between a##9##3##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-6#2)
interaction between an##3##3##(2007-11#3)
interaction between drug and##2##4##(2008-10#1)(2010-5#1)
interaction between host##2##3##(1994-11#1)(2008-10#1)
interaction between intestinal epithelial cells##2##5##(2008-11#2)
interaction between muscarinic M2 receptors and beta-adrenoceptors in##2##8##(1995-12#2)
interaction between muscarinic##3##3##(1995-12#3)
interaction between proteins and##3##4##(1997-2#1)(2008-10#1)(2009-2#1)
interaction between proteins##5##3##(1997-2#1)(2008-10#1)(2008-4#1)(2009-2#1)(2011-2#1)
interaction between the analyte and##2##5##(2008-10#1)(2010-7#1)
interaction between the fungal##2##4##(2008-10#1)(2011-10#1)
interaction between the receptor##2##4##(2008-3#1)(2008-7#1)
interaction between the two##11##4##(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-3#1)
interaction between the##62##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-10#1)(2012-2#1)(2012-3#2)(2013-1#1)
interaction between these two##3##4##(2008-7#1)(2009-6#1)(2013-1#1)
interaction between these##5##3##(2008-11#1)(2008-7#2)(2009-6#1)(2013-1#1)
interaction between two##6##3##(1990-11#1)(2008-10#3)(2008-8#2)
interaction between zolpidem and ciprofloxacin in healthy volunteers##2##8##(2011-2#2)
interaction between##286##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#5)(1995-2#3)(1995-5#2)(1995-6#2)(1996-2#3)(1996-5#3)(1997-1#2)(1997-2#2)(1997-6#3)(1997-7#1)(2006-6#2)(2007-11#7)(2007-12#5)(2008-1#1)(2008-10#84)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#20)(2008-9#11)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#5)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#2)
interaction by##6##2##(1990-12#1)(1997-2#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
interaction can be##2##3##(1994-3#1)(2008-8#1)
interaction chromatography##12##2##(1991-5#4)(2008-10#7)(2011-1#1)
interaction data are##2##3##(2008-4#1)(2008-7#1)
interaction data from##2##3##(2008-4#1)(2010-10#1)
interaction data##7##2##(2008-4#4)(2008-7#2)(2010-10#1)
interaction depends##2##2##(1990-2#1)(2007-11#1)
interaction domains##2##2##(2008-7#1)(2009-7#1)
interaction effect##8##2##(2008-4#2)(2008-6#1)(2010-2#2)(2013-1#1)(2013-8#2)
interaction effects of##4##3##(2008-10#2)(2008-4#1)(2009-9#1)
interaction effects##9##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)
interaction energies##2##2##(1991-6#1)(1991-8#1)
interaction energy of##2##3##(1990-8#1)(2008-10#1)
interaction energy##4##2##(1990-8#1)(2008-10#3)
interaction events##2##2##(2009-7#1)(2011-1#1)
interaction exists between##2##3##(2007-8#1)(2008-7#1)
interaction for##7##2##(1993-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-11#1)
interaction geometry##2##2##(2007-12#1)(2008-3#1)
interaction had##2##2##(2008-10#2)
interaction has also been##2##4##(2008-10#1)(2013-8#1)
interaction has been##2##3##(1995-12#1)(2011-10#1)
interaction has##4##2##(1995-12#1)(2008-10#1)(2011-10#1)(2013-8#1)
interaction in RNA##3##3##(1992-3#1)(1993-1#1)(1997-2#1)
interaction in isotropic##2##3##(2007-12#1)(2008-2#1)
interaction in the regulation of##2##5##(1991-7#1)(2012-1#1)
interaction in the##15##3##(1991-7#1)(1992-12#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-8#2)(2012-1#1)(2012-2#1)
interaction in##52##2##(1990-12#3)(1990-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-3#1)(1995-11#2)(1995-5#2)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#2)(2013-8#1)
interaction information##3##2##(2008-4#1)(2011-3#1)(2012-2#1)
interaction is mediated by##2##4##(1992-3#1)(1994-12#1)
interaction is negligible##2##3##(2008-10#1)(2010-5#1)
interaction is##25##2##(1990-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2008-10#9)(2008-3#1)(2008-4#2)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
interaction length of##4##3##(2007-12#2)(2008-3#2)
interaction length##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
interaction maps##2##2##(2011-2#1)(2012-2#1)
interaction mating##2##2##(2008-9#2)
interaction may##2##2##(1995-12#1)(1997-4#1)
interaction medium##2##2##(2007-12#1)(2008-2#1)
interaction model##2##2##(2008-10#1)(2012-2#1)
interaction networks##9##2##(2008-4#3)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
interaction occurs##2##2##(1994-8#1)(2007-11#1)
interaction of Gdn##2##3##(1993-6#2)
interaction of a##10##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-8#1)(2009-6#1)(2010-11#1)
interaction of biological control##2##4##(2008-6#2)
interaction of dietary proteins##2##4##(2012-1#2)
interaction of genetic and environmental factors##2##6##(1990-6#1)(2009-10#1)
interaction of genetic##3##3##(1990-6#1)(2009-10#1)(2013-1#1)
interaction of guanidine hydrochloride with##3##5##(1993-3#2)(1993-6#1)
interaction of guanine nucleotides with the##2##6##(1991-5#1)(1995-5#1)
interaction of histone with nucleic acids##2##6##(2008-10#2)
interaction of natural##3##3##(1994-8#1)(2008-10#2)
interaction of protein##4##3##(1990-12#1)(1994-5#2)(2008-10#1)
interaction of the##37##3##(1990-2#1)(1991-12#1)(1992-12#2)(1992-6#1)(1994-2#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
interaction of these##4##3##(1990-2#1)(1992-6#1)(1994-12#1)(2008-10#1)
interaction of this##2##3##(1991-1#1)(1994-8#1)
interaction of two##5##3##(1994-6#1)(2008-10#3)(2008-8#1)
interaction of vitamin##2##3##(1992-9#1)(1993-12#1)
interaction of##286##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-6#1)(1990-8#4)(1991-1#2)(1991-12#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#4)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#8)(1993-8#4)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#5)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#7)(1995-6#4)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#85)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#8)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
interaction on the##3##3##(1994-2#1)(2008-10#2)
interaction on##8##2##(1994-2#1)(2008-10#7)
interaction or##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
interaction parameters for the##2##4##(2008-10#2)
interaction parameters##3##2##(2008-10#3)
interaction partners##6##2##(2008-4#2)(2008-8#2)(2008-9#1)(2010-5#1)
interaction pathways##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)
interaction patterns##3##2##(2012-2#1)(2012-3#2)
interaction phenotypes##2##2##(2008-10#2)
interaction plays a##2##3##(1995-2#1)(2008-9#1)
interaction plays##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
interaction rates##2##2##(2008-8#1)(2008-9#1)
interaction screens##2##2##(2008-7#1)(2012-3#1)
interaction site##2##2##(2010-7#1)(2012-3#1)
interaction sites for##2##3##(1990-5#1)(2008-8#1)
interaction sites##4##2##(1990-5#1)(2008-10#2)(2008-8#1)
interaction studies##2##2##(2008-4#1)(2012-2#1)
interaction terms##2##2##(2010-5#1)(2011-2#1)
interaction that was##2##3##(1997-2#1)(2008-10#1)
interaction that##7##2##(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
interaction time##2##2##(2008-8#1)(2012-2#1)
interaction to##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
interaction trap##3##2##(2008-2#1)(2008-9#2)
interaction was detected##2##3##(1992-12#1)(2012-2#1)
interaction was found between##4##4##(2008-10#1)(2009-2#1)(2009-7#1)(2011-2#1)
interaction was found##5##3##(1993-6#1)(2008-10#1)(2009-2#1)(2009-7#1)(2011-2#1)
interaction was significant##2##3##(2008-10#2)
interaction was##34##2##(1990-12#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-9#1)(1995-2#2)(1995-6#2)(1997-2#2)(2007-10#1)(2008-10#15)(2008-2#1)(2008-9#2)(2009-2#1)(2009-7#1)(2011-2#1)(2012-2#1)
interaction were##4##2##(1994-6#1)(1996-10#1)(2008-10#2)
interaction with DNA##5##3##(1992-11#1)(1992-3#1)(1995-5#1)(2008-10#2)
interaction with a##9##3##(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-2#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
interaction with an##4##3##(1992-12#1)(1994-11#1)(1996-2#1)(2013-1#1)
interaction with beta-CD##2##3##(2008-10#2)
interaction with cysteine##2##3##(1995-2#1)(2008-10#1)
interaction with double##2##3##(2007-11#1)(2008-10#1)
interaction with heparin##2##3##(1995-5#1)(1997-4#1)
interaction with human##2##3##(2012-8#1)(2013-1#1)
interaction with other molecules##2##4##(1995-2#1)(2008-5#1)
interaction with other##6##3##(1995-2#1)(1997-8#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
interaction with phospholipid##2##3##(1990-2#1)(1997-2#1)
interaction with the estrogen receptor##2##5##(2008-11#2)
interaction with the host##2##4##(2008-10#1)(2011-2#1)
interaction with the##44##3##(1990-4#1)(1990-8#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#4)(1996-5#1)(1997-1#2)(1997-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
interaction with their##3##3##(2008-7#1)(2010-10#1)(2011-2#1)
interaction with two##2##3##(1994-2#1)(1995-8#1)
interaction with##208##2##(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#3)(1991-1#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#3)(1995-6#5)(1995-8#3)(1996-2#5)(1996-5#3)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#42)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2009-8#2)(2010-10#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#8)(2013-8#1)
interaction##1446##1##(1990-11#4)(1990-12#14)(1990-2#10)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#16)(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#12)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#8)(1992-3#13)(1992-5#3)(1992-6#9)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#6)(1993-12#4)(1993-3#7)(1993-5#1)(1993-6#12)(1993-8#14)(1993-9#1)(1994-11#10)(1994-12#5)(1994-2#6)(1994-3#7)(1994-5#13)(1994-6#8)(1994-8#11)(1994-9#2)(1995-11#12)(1995-12#12)(1995-2#22)(1995-3#2)(1995-5#17)(1995-6#17)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#10)(1996-4#1)(1996-5#11)(1996-9#1)(1997-1#5)(1997-2#18)(1997-3#5)(1997-4#5)(1997-6#6)(1997-7#8)(1997-8#3)(2006-10#1)(2006-6#3)(2007-10#4)(2007-11#26)(2007-12#28)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#377)(2008-11#42)(2008-12#13)(2008-2#22)(2008-3#27)(2008-4#41)(2008-5#20)(2008-6#7)(2008-7#39)(2008-8#55)(2008-9#48)(2009-10#8)(2009-11#12)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#8)(2009-7#12)(2009-8#12)(2009-9#3)(2010-1#1)(2010-10#9)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#12)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#9)(2011-10#3)(2011-2#43)(2011-3#4)(2012-1#6)(2012-12#5)(2012-2#30)(2012-3#16)(2012-4#1)(2012-6#6)(2012-8#2)(2013-1#20)(2013-7#4)(2013-8#14)
interaction(s)##3##1##(1990-8#1)(1995-2#1)(2008-7#1)
interaction)##4##1##(1990-8#2)(2008-10#2)
interactional patterns##3##2##(2008-6#2)(2010-10#1)
interactional##8##1##(1992-1#1)(1994-2#1)(2008-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2013-8#1)
interactions (e##2##2##(2008-6#1)(2008-8#1)
interactions act##2##2##(1993-11#1)(2008-8#1)
interactions also were##2##3##(2008-10#2)
interactions also##3##2##(2008-10#3)
interactions among the##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2009-8#1)
interactions among##27##2##(1992-6#2)(1993-1#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#2)(2010-5#1)(2012-2#1)
interactions amongst##2##2##(2009-8#1)(2010-2#1)
interactions and a##2##3##(1992-6#1)(2010-4#1)
interactions and for##2##3##(1992-3#1)(2008-10#1)
interactions and on##2##3##(1991-10#1)(2008-10#1)
interactions and the##10##3##(1993-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
interactions and their##2##3##(2008-1#1)(2013-1#1)
interactions and##62##2##(1991-10#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-2#2)(1997-5#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
interactions are crucial##2##3##(1993-3#1)(2008-7#1)
interactions are described##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
interactions are not##2##3##(1991-8#1)(2008-10#1)
interactions are responsible for##2##4##(1995-5#1)(2008-10#1)
interactions are the##2##3##(1994-5#1)(2008-6#1)
interactions are##42##2##(1991-8#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#4)(1995-5#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-4#3)(2011-1#1)(2012-2#1)(2012-3#1)
interactions as well as the##2##5##(1991-9#1)(2008-10#1)
interactions as##3##2##(1991-9#1)(2008-10#1)(2012-3#1)
interactions at both##2##3##(2008-9#1)(2009-10#1)
interactions at multiple levels##3##4##(2008-1#1)(2008-10#1)(2010-7#1)
interactions at the cell surface##2##5##(2008-4#2)
interactions at the##4##3##(1996-12#1)(2008-11#1)(2008-4#2)
interactions at##14##2##(1992-8#2)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-7#1)
interactions based on##2##3##(2008-12#1)(2009-11#1)
interactions because##2##2##(1996-12#1)(2010-10#1)
interactions between HBV##2##3##(2008-8#1)(2013-8#1)
interactions between HIV##2##3##(2007-7#1)(2008-4#1)
interactions between a##2##3##(2008-10#1)(2013-1#1)
interactions between an##2##3##(2007-12#1)(2008-10#1)
interactions between genes##3##3##(2012-3#2)(2013-7#1)
interactions between host##2##3##(2008-10#1)(2008-12#1)
interactions between plants and##3##4##(2008-8#2)(2009-8#1)
interactions between proteins and##2##4##(2008-10#1)(2008-2#1)
interactions between proteins of##2##4##(2008-4#1)(2013-1#1)
interactions between proteins##5##3##(2008-10#1)(2008-2#1)(2008-4#2)(2013-1#1)
interactions between subunits##2##3##(1992-8#1)(2011-1#1)
interactions between the host and##2##5##(2008-10#2)
interactions between the two##4##4##(1993-6#1)(1997-2#1)(2008-10#2)
interactions between the##44##3##(1991-2#1)(1993-6#2)(1993-9#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-8#1)
interactions between these##5##3##(2007-12#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
interactions between##222##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-8#4)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#54)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#13)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#7)(2012-4#3)(2012-6#2)(2013-1#5)(2013-7#1)(2013-8#6)
interactions but also##2##3##(2008-11#1)(2010-4#1)
interactions by the##2##3##(1997-2#1)(2006-10#1)
interactions by##15##2##(1994-12#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-4#4)(2008-7#3)(2008-8#1)(2013-1#1)
interactions can be##9##3##(2007-12#1)(2008-4#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-11#1)(2011-2#1)
interactions can##15##2##(1990-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#4)(2009-10#1)(2009-9#1)(2010-11#1)(2011-2#1)
interactions caused from##2##3##(2008-10#2)
interactions caused##3##2##(1992-3#1)(2008-10#2)
interactions control##2##2##(2007-11#1)(2008-7#1)
interactions could##3##2##(1991-5#1)(2008-3#1)(2012-1#1)
interactions did not##2##3##(2008-10#1)(2008-8#1)
interactions do not##2##3##(1997-2#1)(2008-8#1)
interactions due to##2##3##(2008-5#1)(2012-6#1)
interactions during##6##2##(1991-3#1)(1997-4#1)(2008-7#2)(2011-1#1)(2013-1#1)
interactions for the##3##3##(1997-2#1)(2008-2#1)(2008-7#1)
interactions for##5##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#2)
interactions has been##2##3##(1992-9#1)(2008-9#1)
interactions has led to the##2##5##(2008-10#2)
interactions has##9##2##(1992-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2013-1#1)
interactions have been##2##3##(1997-2#1)(2008-4#1)
interactions have recently been developed##3##5##(2008-4#1)(2013-1#2)
interactions have##10##2##(1997-2#1)(2007-12#1)(2008-4#2)(2008-8#1)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#2)
interactions in a##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
interactions in biological systems##2##4##(1997-2#1)(2008-4#1)
interactions in chronic##2##3##(1997-2#1)(1997-6#1)
interactions in immediate##2##3##(2010-11#2)
interactions in living cells##4##4##(2008-1#1)(2008-4#3)
interactions in natural##2##3##(2008-9#1)(2010-4#1)
interactions in proteins##2##3##(1997-2#1)(2008-7#1)
interactions in the##23##3##(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#5)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)
interactions in vitro##2##3##(1995-11#1)(2008-9#1)
interactions in##98##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(2006-4#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-4#10)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#2)
interactions into##3##2##(2008-10#1)(2009-9#1)(2013-8#1)
interactions involved in##5##3##(1993-11#1)(1995-6#1)(2008-4#1)(2009-3#1)(2012-2#1)
interactions involving##6##2##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
interactions is##15##2##(1992-8#1)(1993-1#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
interactions made##2##2##(1993-8#1)(1995-5#1)
interactions may be##3##3##(2007-11#1)(2008-11#1)(2008-9#1)
interactions may##9##2##(1990-12#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-2#1)(2013-1#1)
interactions mediated by##2##3##(2007-12#1)(2012-2#1)
interactions might be##2##3##(2008-10#1)(2009-3#1)
interactions might##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
interactions must##3##2##(1993-8#1)(2008-10#1)(2008-9#1)
interactions occur between##2##3##(2008-10#2)
interactions occur##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
interactions occurring##3##2##(1992-6#1)(2008-10#1)(2009-11#1)
interactions of ATP and ADP with rubisco activase##2##8##(1991-9#2)
interactions of ATP##3##3##(1991-9#2)(2008-8#1)
interactions of C5a##2##3##(2008-10#2)
interactions of a##2##3##(1995-6#1)(2008-9#1)
interactions of endothelin##2##3##(2008-1#2)
interactions of leukocytes##2##3##(1997-3#1)(2008-1#1)
interactions of porcine##2##3##(2013-1#2)
interactions of quantitative trait loci##2##5##(2008-10#2)
interactions of quantitative trait##3##4##(2008-10#3)
interactions of the molecules##2##4##(1992-9#1)(2009-5#1)
interactions of the two##2##4##(2008-10#1)(2010-12#1)
interactions of the##26##3##(1990-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)
interactions of these##3##3##(1990-7#1)(2008-4#1)(2012-3#1)
interactions of this##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
interactions of##104##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-6#1)(1993-8#4)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#22)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)
interactions often##2##2##(2008-10#2)
interactions on the##2##3##(2008-7#1)(2008-8#1)
interactions on##12##2##(1993-6#1)(1995-11#1)(2008-10#4)(2008-7#1)(2008-8#3)(2009-6#1)(2010-3#1)
interactions or##5##2##(2008-10#1)(2008-4#2)(2008-9#1)(2013-8#1)
interactions play a critical role in##2##6##(2008-2#1)(2008-9#1)
interactions play a role in##2##5##(2007-12#1)(2009-7#1)
interactions play a significant role in##2##6##(2008-4#1)(2010-1#1)
interactions play a##6##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#1)
interactions play##9##2##(1993-9#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#1)
interactions should be##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
interactions such as##3##3##(1991-9#1)(2008-4#1)(2008-6#1)
interactions take place##2##3##(2008-7#1)(2008-9#1)
interactions than##2##2##(2007-12#1)(2011-2#1)
interactions that are##2##3##(1991-8#1)(2007-11#1)
interactions that may##2##3##(1992-9#1)(2011-2#1)
interactions that occur##2##3##(1996-3#1)(2009-7#1)
interactions that they##2##3##(2008-8#1)(2008-9#1)
interactions that##21##2##(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#2)
interactions to##9##2##(2008-10#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-3#1)(2012-12#1)
interactions using##8##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-4#3)(2008-5#1)(2012-2#1)
interactions was##3##2##(2007-11#1)(2008-10#1)(2009-8#1)
interactions were observed##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
interactions were##21##2##(2007-11#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-6#1)(2013-1#2)(2013-8#1)
interactions when they##2##3##(2008-7#1)(2008-8#1)
interactions which##3##2##(1990-8#1)(1992-4#1)(1994-9#1)
interactions with a##3##3##(1992-11#1)(1995-3#1)(2008-9#1)
interactions with host##2##3##(2006-6#1)(2008-10#1)
interactions with its##2##3##(2008-10#1)(2008-8#1)
interactions with other##7##3##(1990-2#1)(2007-8#1)(2012-2#1)(2012-3#2)(2013-1#2)
interactions with position##2##3##(2008-8#2)
interactions with specific##3##3##(1994-9#1)(2008-7#1)(2008-9#1)
interactions with the##20##3##(1990-11#1)(1993-11#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-6#1)(2008-7#2)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-1#1)
interactions with three##2##3##(1993-6#1)(2008-9#1)
interactions with##121##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-11#3)(1992-3#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#4)(1997-7#3)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#7)(2009-11#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
interactions within the##5##3##(1991-5#1)(1992-4#1)(1993-6#1)(1995-5#1)(2008-4#1)
interactions within##9##2##(1991-5#1)(1992-4#1)(1992-9#1)(1993-6#1)(1995-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
interactions##1374##1##(1990-11#4)(1990-12#5)(1990-2#2)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#5)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#4)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#18)(1992-4#4)(1992-5#1)(1992-6#10)(1992-8#12)(1992-9#10)(1993-1#3)(1993-11#10)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#7)(1993-8#12)(1993-9#5)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#12)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#11)(1995-3#1)(1995-5#9)(1995-6#7)(1995-8#4)(1996-12#6)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#22)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#8)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#2)(2007-10#4)(2007-11#30)(2007-12#24)(2007-2#2)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#11)(2008-10#256)(2008-11#35)(2008-12#11)(2008-2#11)(2008-3#19)(2008-4#92)(2008-5#27)(2008-6#10)(2008-7#72)(2008-8#89)(2008-9#64)(2009-10#6)(2009-11#10)(2009-12#6)(2009-2#2)(2009-3#8)(2009-4#2)(2009-5#4)(2009-6#12)(2009-7#11)(2009-8#13)(2009-9#10)(2010-1#2)(2010-10#9)(2010-11#12)(2010-12#6)(2010-2#6)(2010-3#4)(2010-4#12)(2010-5#4)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#21)(2011-3#3)(2011-7#1)(2012-1#5)(2012-12#8)(2012-2#35)(2012-3#23)(2012-4#4)(2012-6#4)(2013-1#36)(2013-7#2)(2013-8#15)
interactions)##5##1##(1990-5#1)(1993-12#1)(2006-12#1)(2008-10#1)(2011-2#1)
interactions?##4##1##(1991-9#1)(2008-11#2)(2012-2#1)
interactive VR##2##2##(2010-4#2)
interactive effects of##3##3##(2008-10#1)(2012-3#2)
interactive effects##7##2##(2008-10#1)(2012-12#1)(2012-3#4)(2013-8#1)
interactive learning##2##2##(2008-11#1)(2012-3#1)
interactive multimedia##3##2##(2008-11#3)
interactive nature of##4##3##(2007-8#1)(2010-11#2)(2012-2#1)
interactive practices##2##2##(2008-12#2)
interactive process##2##2##(1994-1#1)(2012-3#1)
interactive processes##2##2##(2008-5#2)
interactive strategy##4##2##(2008-12#4)
interactive##85##1##(1991-1#1)(1994-1#1)(1995-2#2)(1997-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#8)(2008-2#3)(2008-4#3)(2008-5#2)(2008-6#10)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#1)(2013-8#3)
interactively##7##1##(2008-11#1)(2008-3#2)(2008-6#2)(2012-1#1)(2013-7#1)
interactivity##2##1##(2010-4#1)(2013-1#1)
interactome##10##1##(2008-7#5)(2012-12#1)(2012-2#1)(2013-1#3)
interactors of##2##2##(2008-7#1)(2009-10#1)
interactors##4##1##(2008-7#2)(2008-8#1)(2009-10#1)
interacts directly with##2##3##(1992-11#1)(2008-10#1)
interacts in##2##2##(1995-12#1)(2012-2#1)
interacts specifically with the##2##4##(1992-8#1)(2008-4#1)
interacts specifically with##3##3##(1992-8#1)(1993-12#1)(2008-4#1)
interacts specifically##4##2##(1992-8#1)(1993-12#1)(1993-8#1)(2008-4#1)
interacts with a##4##3##(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#1)
interacts with other##3##3##(1993-8#1)(2009-11#1)(2013-8#1)
interacts with the##24##3##(1992-3#1)(1992-9#1)(1994-2#1)(1995-5#1)(1996-2#2)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#4)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)
interacts with##83##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-8#2)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1996-2#2)(1997-2#4)(1997-3#1)(1997-4#3)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-7#1)(2010-2#3)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
interacts##99##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#3)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1996-2#2)(1997-2#4)(1997-3#1)(1997-4#3)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-2#3)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
interagency##2##1##(1991-12#1)(2007-11#1)
interampatte##3##1##(2010-10#3)
interampatteness##2##1##(2010-10#2)
interannual##4##1##(2010-8#1)(2012-2#3)
interband##3##1##(2007-12#2)(2008-3#1)
interbody fusion##8##2##(2008-11#3)(2008-7#2)(2011-2#3)
interbreeding##4##1##(2008-10#2)(2008-8#1)(2010-8#1)
interbulbar##2##1##(1993-3#2)
intercalary##4##1##(2007-12#2)(2011-2#1)(2012-9#1)
intercalate into##2##2##(1991-6#1)(1994-5#1)
intercalate##7##1##(1991-6#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-6#1)(2013-1#1)
intercalated in double helix DNA##2##5##(2008-10#2)
intercalated into the##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
intercalated into##5##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)
intercalated##19##1##(1993-11#1)(1994-5#2)(1997-4#1)(1997-7#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#2)(2010-4#3)
intercalates into##3##2##(2008-10#2)(2008-2#1)
intercalates##6##1##(1995-2#1)(1997-7#2)(2008-10#2)(2008-2#1)
intercalating agents##2##2##(2008-11#1)(2008-4#1)
intercalating##5##1##(1992-11#1)(2008-10#2)(2008-11#1)(2008-4#1)
intercalation and##2##2##(1994-5#1)(2008-10#1)
intercalation complex##2##2##(1992-3#2)
intercalation complexes##2##2##(1990-7#2)
intercalation compounds##2##2##(2010-4#2)
intercalation of##5##2##(1993-8#2)(2008-10#2)(2009-6#1)
intercalation##25##1##(1990-7#3)(1992-3#6)(1993-8#3)(1994-5#3)(2006-4#1)(2008-10#4)(2008-2#1)(2008-6#1)(2009-6#1)(2010-4#2)
intercalative##2##1##(1991-12#1)(2008-6#1)
intercalator##5##1##(1991-12#1)(2007-11#1)(2008-10#1)(2008-4#2)
intercalibration##6##1##(2008-10#1)(2008-3#5)
intercanine distance##2##2##(2012-3#2)
intercellular adhesion molecule 1##2##4##(1993-8#1)(1995-2#1)
intercellular adhesion molecule##4##3##(1993-8#1)(1995-2#2)(2013-1#1)
intercellular adhesion molecule-1 (ICAM-1)##3##4##(1995-12#1)(2009-10#1)(2010-1#1)
intercellular adhesion molecule-1##5##3##(1993-8#1)(1995-12#1)(2008-5#1)(2009-10#1)(2010-1#1)
intercellular adhesion##12##2##(1993-8#2)(1995-12#1)(1995-2#2)(2008-5#1)(2009-10#2)(2010-1#1)(2013-1#1)(2013-7#2)
intercellular cohesion are##2##3##(2008-5#2)
intercellular communication (GJIC)##3##3##(2008-11#1)(2008-8#1)(2010-9#1)
intercellular communication##14##2##(1990-7#3)(1994-11#2)(1994-9#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-9#1)(2013-8#1)
intercellular communications##2##2##(1997-2#1)(2012-1#1)
intercellular fluid from infected leaves##2##5##(2008-10#2)
intercellular fluid##5##2##(2008-10#5)
intercellular hyphae##2##2##(2008-10#2)
intercellular junctions##3##2##(2009-10#3)
intercellular lipid##3##2##(2008-5#3)
intercellular lipids##2##2##(2008-5#2)
intercellular space##4##2##(2008-10#2)(2008-5#1)(2009-7#1)
intercellular spaces of the##4##4##(2008-10#4)
intercellular spaces of##6##3##(2008-10#6)
intercellular spaces##12##2##(2008-10#11)(2008-7#1)
intercellular##86##1##(1990-12#1)(1990-7#3)(1993-8#2)(1994-11#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1997-2#2)(2007-12#1)(2008-10#25)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#10)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#6)(2009-7#1)(2010-1#1)(2010-9#1)(2012-1#2)(2013-1#3)(2013-7#2)(2013-8#1)
intercellularly and##2##2##(2008-10#1)(2008-8#1)
intercept of the##3##3##(2008-10#3)
intercept of##6##2##(2008-10#5)(2009-8#1)
intercept were significantly##2##3##(2008-10#2)
intercept were##4##2##(2008-10#4)
intercept##28##1##(1991-12#1)(1995-2#1)(1997-8#1)(2008-10#24)(2009-8#1)
intercepted by##3##2##(1996-5#2)(2008-3#1)
intercepted##5##1##(1996-5#2)(2008-11#1)(2008-3#1)(2010-8#1)
interception##6##1##(2007-12#1)(2008-10#4)(2008-5#1)
intercepts 3##2##2##(2008-10#2)
intercepts were##2##2##(2008-10#2)
intercepts##6##1##(2008-10#4)(2008-9#2)
interchain disulfide bonds##3##3##(1990-5#1)(2008-4#2)
interchain disulfide##4##2##(1990-5#1)(1993-6#1)(2008-4#2)
interchain immonium ions##2##3##(2008-10#2)
interchain##9##1##(1990-5#2)(1992-6#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-4#2)
interchange##14##1##(1990-8#3)(1993-3#1)(1994-11#1)(1994-8#1)(1997-1#1)(2007-12#3)(2008-10#1)(2009-9#3)
interchangeability between##2##2##(2011-1#1)(2013-1#1)
interchangeability of##3##2##(1990-2#1)(2012-2#1)(2013-1#1)
interchangeability##6##1##(1990-2#1)(2011-1#1)(2012-2#1)(2013-1#3)
interchangeable##2##1##(2007-12#1)(2013-1#1)
interchanged##3##1##(2010-8#1)(2013-1#2)
interchannel collisions##2##2##(2007-12#2)
interchannel cross talk##4##3##(2008-2#2)(2008-3#2)
interchannel##9##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
interchip free-space##2##2##(2008-3#2)
interchip##6##1##(2007-12#1)(2008-3#5)
interchiral mating##2##2##(2008-9#2)
interchiral##3##1##(2008-9#3)
intercomparison##10##1##(1997-4#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)
intercomparisons##3##1##(2008-2#2)(2008-3#1)
intercondylar fractures of the distal humerus##2##6##(2012-2#2)
intercondylar##5##1##(2007-8#1)(2012-2#2)(2013-1#2)
interconnect networks##3##2##(2008-2#2)(2008-3#1)
interconnect system##8##2##(2007-12#1)(2008-2#3)(2008-3#4)
interconnect systems##4##2##(2008-2#1)(2008-3#3)
interconnect to##2##2##(2008-2#1)(2009-5#1)
interconnect was##2##2##(2008-2#2)
interconnect##49##1##(2007-11#1)(2007-12#2)(2008-2#22)(2008-3#21)(2009-5#2)(2013-1#1)
interconnected by##3##2##(1992-8#1)(2007-12#1)(2008-3#1)
interconnected cylindrical##2##2##(2008-10#2)
interconnected with##6##2##(1994-3#1)(2008-3#2)(2010-8#1)(2010-9#1)(2012-1#1)
interconnected##29##1##(1991-10#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#2)
interconnecting##4##1##(1997-6#1)(2008-1#1)(2008-5#1)(2010-6#1)
interconnection and##2##2##(2007-11#1)(2008-3#1)
interconnection applications##2##2##(2008-2#2)
interconnection approach##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
interconnection approaches##2##2##(2008-2#2)
interconnection cross talk##2##3##(2008-2#2)
interconnection densities##2##2##(2008-2#1)(2008-3#1)
interconnection density##3##2##(2008-3#3)
interconnection network##7##2##(2008-2#5)(2008-3#1)(2010-8#1)
interconnection networks##3##2##(2008-2#1)(2008-3#2)
interconnection of##4##2##(1995-3#1)(2008-2#1)(2008-3#1)(2008-7#1)
interconnection system##8##2##(2008-2#2)(2008-3#6)
interconnection weights##2##2##(2008-3#2)
interconnection with##2##2##(2008-2#1)(2008-3#1)
interconnection##68##1##(1995-3#1)(2007-11#1)(2007-12#2)(2008-2#32)(2008-3#30)(2008-7#1)(2010-8#1)
interconnections are##3##2##(2008-2#1)(2008-3#2)
interconnections based on diffractive optical elements for##2##7##(2008-2#2)
interconnections between##2##2##(1994-3#1)(2008-2#1)
interconnections by##2##2##(2008-3#2)
interconnections of##2##2##(1994-3#1)(2008-3#1)
interconnections##32##1##(1994-3#2)(2007-11#1)(2008-11#2)(2008-2#11)(2008-3#16)
interconnects is##2##2##(2008-3#2)
interconnects##34##1##(1992-8#1)(2008-2#10)(2008-3#22)(2012-2#1)
intercontinental migration of##2##3##(2008-10#2)
intercontinental##3##1##(2008-10#2)(2012-3#1)
interconversion between the##4##3##(2008-10#4)
interconversion of##5##2##(1990-9#1)(1992-10#1)(1992-11#1)(1994-8#1)(2008-10#1)
interconversion##13##1##(1990-9#1)(1992-10#1)(1992-11#1)(1994-8#1)(1997-1#3)(2008-10#6)
interconversions##2##1##(1993-6#1)(1995-2#1)
interconvert##2##1##(1997-2#1)(1997-7#1)
interconvertible##2##1##(1990-8#1)(1993-12#1)
intercorrelated##2##1##(1996-12#1)(2008-10#1)
intercostal space##3##2##(1990-2#2)(2007-12#1)
intercostal veins##3##2##(2011-2#3)
intercostal##19##1##(1990-2#2)(1991-6#1)(1997-1#1)(2007-12#1)(2007-8#5)(2008-10#4)(2008-7#1)(2011-2#4)
intercourse (median = 10)##2##4##(2011-1#2)
intercourse (median = 3)##2##4##(2011-1#2)
intercourse (median =##5##3##(2011-1#5)
intercourse among##2##2##(1990-9#1)(2012-2#1)
intercourse is##2##2##(1990-9#1)(2007-8#1)
intercourse with a##3##3##(1997-5#1)(2008-12#2)
intercourse with##9##2##(1993-8#1)(1997-5#1)(2008-12#4)(2011-2#2)(2012-2#1)
intercourse##44##1##(1990-9#6)(1992-6#1)(1993-2#1)(1993-8#1)(1994-7#1)(1996-12#1)(1996-6#1)(1997-5#3)(2007-12#1)(2007-8#1)(2008-12#6)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#3)(2012-12#1)(2012-2#2)
intercross##3##1##(2008-8#1)(2010-4#1)(2012-3#1)
intercrossed and##2##2##(2008-10#2)
intercurrent##2##1##(2008-5#1)(2012-2#1)
interday precision##2##2##(2008-10#2)
interday##4##1##(2008-10#4)
interdepartmental##2##1##(1994-1#2)
interdependence and##2##2##(1994-12#1)(2009-8#1)
interdependence between##4##2##(1992-3#1)(2009-8#2)(2009-9#1)
interdependence of##5##2##(1992-12#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
interdependence##16##1##(1991-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(2008-2#1)(2009-8#6)(2009-9#3)(2011-2#1)(2012-2#1)
interdependencies##5##1##(2008-11#1)(2008-7#1)(2009-11#2)(2010-1#1)
interdependency##2##1##(2008-11#1)(2010-8#1)
interdependent##13##1##(1991-5#1)(1995-3#2)(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#2)(2009-9#2)(2011-1#1)(2013-1#1)
interdialytic##7##1##(2008-1#5)(2010-3#2)
interdiffused quantum wells##2##3##(2008-2#2)
interdiffused quantum##3##2##(2008-2#3)
interdiffusion##4##1##(2008-2#4)
interdigitated array##3##2##(2008-10#3)
interdigitated contacts##2##2##(2007-12#2)
interdigitated electrodes##6##2##(2008-10#3)(2008-3#2)(2008-7#1)
interdigitated gel phase in##2##4##(1993-8#1)(2008-8#1)
interdigitated gel phase##3##3##(1993-8#2)(2008-8#1)
interdigitated microelectrode array##2##3##(2008-10#2)
interdigitated##26##1##(1990-7#1)(1992-4#1)(1992-6#1)(1993-8#4)(2007-12#4)(2008-10#9)(2008-3#3)(2008-7#1)(2008-8#2)
interdigitations##2##1##(2008-12#1)(2008-7#1)
interdimer mechanism##2##2##(2008-10#2)
interdimer mechanisms##3##2##(2008-10#3)
interdimer##5##1##(2008-10#5)
interdisciplinary approach in##3##3##(1995-5#1)(1997-8#1)(2008-4#1)
interdisciplinary approach to##3##3##(1992-2#1)(2006-10#1)(2007-12#1)
interdisciplinary approach##11##2##(1992-2#1)(1994-3#1)(1995-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
interdisciplinary approaches##2##2##(2012-12#1)(2012-3#1)
interdisciplinary assessment##4##2##(1995-1#2)(2013-1#2)
interdisciplinary collaboration##3##2##(1992-1#1)(1992-12#1)(1996-1#1)
interdisciplinary community service-learning##2##3##(2008-1#2)
interdisciplinary connections##2##2##(2011-2#2)
interdisciplinary group of##2##3##(1992-1#1)(2010-10#1)
interdisciplinary palliative care team##2##4##(2009-9#2)
interdisciplinary project##2##2##(2008-8#1)(2009-3#1)
interdisciplinary research##3##2##(1993-2#1)(1997-3#1)(2011-2#1)
interdisciplinary team of##2##3##(1994-12#1)(1995-5#1)
interdisciplinary team##7##2##(1994-12#2)(1995-5#1)(2008-10#1)(2010-10#1)(2010-3#1)(2011-2#1)
interdisciplinary##81##1##(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-5#4)(1996-1#3)(1996-2#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-12#4)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-3#2)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)
interdomain linker##2##2##(2009-7#1)(2013-8#1)
interdomain##3##1##(1993-2#1)(2009-7#1)(2013-8#1)
interelement spacing##2##2##(2008-3#2)
interelement##3##1##(2008-10#1)(2008-3#2)
interest (e##2##2##(1995-6#1)(2008-11#1)
interest among##4##2##(1990-6#1)(1992-6#1)(1993-12#1)(2010-12#1)
interest and excitement##2##3##(2008-11#1)(2009-3#1)
interest and participation in##2##4##(2010-3#1)(2012-2#1)
interest and research##2##3##(2009-1#1)(2010-6#1)
interest and the##3##3##(1992-3#1)(2008-4#1)(2009-5#1)
interest and##37##2##(1991-3#2)(1992-3#2)(1992-6#1)(1993-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#1)
interest are presented##2##3##(2008-10#1)(2008-12#1)
interest are the##2##3##(1995-2#1)(2008-3#1)
interest are##17##2##(1991-5#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2013-8#1)
interest as it##2##3##(2011-2#2)
interest as##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)
interest at##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
interest because it is##6##4##(2011-2#6)
interest because it##10##3##(1990-8#1)(1996-6#1)(2008-10#1)(2011-2#7)
interest because of its isolated##2##5##(2011-2#2)
interest because of its##8##4##(2011-2#8)
interest because of the##5##4##(1990-12#1)(1997-3#1)(2008-3#1)(2011-2#2)
interest because of their##3##4##(2010-4#1)(2011-2#1)(2013-1#1)
interest because of##19##3##(1990-12#1)(1993-1#1)(1997-3#1)(2008-3#1)(2010-4#1)(2010-5#1)(2011-2#12)(2013-1#1)
interest because they##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
interest because##34##2##(1990-12#1)(1990-8#1)(1993-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)(2011-2#21)(2013-1#1)
interest both for##2##3##(2008-10#1)(2008-7#1)
interest by##2##2##(1990-8#1)(2008-10#1)
interest can be##6##3##(1996-6#2)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
interest due to##2##3##(2007-11#1)(2008-8#1)
interest for a##2##3##(2008-11#1)(2010-7#1)
interest for further##3##3##(1991-5#1)(1997-5#1)(2008-5#1)
interest for its##2##3##(2011-2#1)(2012-2#1)
interest for the##9##3##(1995-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-12#1)(2013-8#1)
interest for their##3##3##(1993-9#1)(2011-2#2)
interest for##56##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-6#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#8)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#3)(2013-8#1)
interest from##6##2##(1995-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
interest group##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
interest groups##6##2##(1992-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2008-8#1)(2012-2#1)
interest had##2##2##(1995-12#1)(2011-2#1)
interest has been##4##3##(1996-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
interest has##9##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-1#1)
interest have been##2##3##(1994-8#1)(2008-4#1)
interest in a##4##3##(1992-12#1)(1992-9#1)(2008-5#1)(2008-9#1)
interest in casual sex##4##4##(2010-8#4)
interest in clinical##2##3##(2011-3#1)(2013-1#1)
interest in colorectal##2##3##(1991-3#1)(2013-1#1)
interest in developing strategies to##2##5##(2009-12#1)(2010-10#1)
interest in developing##8##3##(1994-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-10#1)(2011-3#1)
interest in finding##2##3##(2008-7#1)(2009-11#1)
interest in its##2##3##(1994-11#1)(1995-1#1)
interest in medical##3##3##(2007-4#1)(2008-7#1)(2008-8#1)
interest in order to##2##4##(2008-10#1)(2009-5#1)
interest in research##3##3##(1992-6#1)(1994-3#1)(2013-1#1)
interest in the detection of##2##5##(2008-10#1)(2008-4#1)
interest in the development of##4##5##(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)
interest in the effects of##2##5##(1995-2#1)(2008-7#1)
interest in the potential##3##4##(1992-9#1)(2010-7#1)(2012-2#1)
interest in the prevention##2##4##(2008-5#2)
interest in the use of##5##5##(1995-5#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
interest in the##67##3##(1990-2#1)(1990-5#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-7#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#2)
interest in their##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
interest in these##3##3##(2008-11#1)(2008-3#1)(2010-1#1)
interest in this field##2##4##(2008-10#1)(2010-8#1)
interest in this##9##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#2)
interest in understanding the##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
interest in using##4##3##(1996-2#1)(2008-8#1)(2008-9#1)(2009-3#1)
interest in##220##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-7#1)(1996-9#3)(1997-3#1)(1997-7#5)(2006-10#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#20)(2008-11#11)(2008-12#3)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#8)(2008-9#6)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#6)
interest include##3##2##(1990-2#1)(2007-7#1)(2010-7#1)
interest is growing in##2##4##(2008-7#1)(2013-1#1)
interest is in##2##3##(1992-9#1)(2010-2#1)
interest is the##10##3##(1994-9#1)(1995-2#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-4#1)
interest is whether##2##3##(1994-2#1)(1997-2#1)
interest is##42##2##(1990-8#1)(1991-9#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#2)(2008-9#3)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
interest of A(2A)R##2##3##(2008-4#2)
interest of a##3##3##(2008-5#1)(2009-10#1)(2009-7#1)
interest of health##2##3##(2010-8#1)(2011-2#1)
interest of our##2##3##(2008-6#1)(2013-1#1)
interest of the##6##3##(1991-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-8#1)
interest of##29##2##(1990-2#1)(1991-7#1)(1992-12#1)(1993-2#1)(1994-1#2)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
interest on the##2##3##(2008-1#1)(2008-11#1)
interest on##7##2##(1990-8#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-9#1)
interest or##2##2##(2008-7#2)
interest over##2##2##(2008-9#2)
interest regarding##4##2##(2007-5#1)(2010-12#1)(2011-3#2)
interest since the discovery of##2##5##(1996-5#1)(2008-4#1)
interest since the##4##3##(1992-8#1)(1996-5#1)(2008-10#1)(2008-4#1)
interest since##7##2##(1991-12#1)(1992-8#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
interest to clinical##2##3##(1993-11#1)(2010-11#1)
interest to the##9##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)
interest to##48##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(2007-10#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-5#1)(2010-11#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)
interest was the finding##2##4##(1996-12#1)(2008-7#1)
interest was the##3##3##(1993-12#1)(1996-12#1)(2008-7#1)
interest was##8##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-7#1)
interest were##5##2##(1995-12#1)(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
interest when##3##2##(2007-10#1)(2008-10#1)(2013-7#1)
interest with##3##2##(1994-8#1)(1995-3#1)(2008-10#1)
interest##854##1##(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#5)(1993-1#5)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#9)(1995-3#5)(1995-5#3)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#5)(1996-5#1)(1996-6#5)(1996-7#2)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#3)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#6)(2008-1#6)(2008-10#84)(2008-11#40)(2008-12#10)(2008-2#23)(2008-3#35)(2008-4#37)(2008-5#25)(2008-6#5)(2008-7#40)(2008-8#19)(2008-9#38)(2009-1#2)(2009-10#6)(2009-11#2)(2009-12#5)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#2)(2010-3#5)(2010-4#2)(2010-5#9)(2010-6#3)(2010-7#4)(2010-8#10)(2010-9#4)(2011-1#44)(2011-2#47)(2011-3#5)(2012-1#7)(2012-12#9)(2012-2#20)(2012-3#11)(2013-1#23)(2013-7#3)(2013-8#12)
interest?##5##1##(1996-12#1)(1996-2#1)(2007-4#1)(2012-12#1)(2012-2#1)
interested and##3##2##(1996-3#1)(2007-2#1)(2013-1#1)
interested in developing their##2##4##(2008-11#1)(2008-12#1)
interested in developing##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
interested in investigating##2##3##(1992-2#1)(2008-11#1)
interested in the##8##3##(1990-9#1)(1995-5#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
interested in this##2##3##(2007-11#1)(2010-10#1)
interested in##47##2##(1990-9#1)(1991-3#1)(1992-2#1)(1992-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-3#1)(2013-8#1)
interested to##2##2##(1995-3#1)(2013-1#1)
interested##62##1##(1990-9#1)(1991-3#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2011-9#1)(2012-3#1)(2013-1#4)(2013-8#1)
interesting alternative to##2##3##(2008-2#1)(2012-2#1)
interesting alternative##4##2##(2008-10#1)(2008-2#1)(2010-11#1)(2012-2#1)
interesting and novel##2##3##(2008-8#1)(2010-12#1)
interesting and##8##2##(1992-5#1)(1994-6#1)(1996-9#1)(2007-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2013-1#1)
interesting case of a##2##4##(2008-10#1)(2012-2#1)
interesting case of bladder##2##4##(2008-10#2)
interesting case of##9##3##(2007-2#1)(2008-10#3)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
interesting case##13##2##(2007-2#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
interesting clinical##2##2##(1992-5#1)(2010-11#1)
interesting clues##2##2##(1990-8#1)(2013-1#1)
interesting correlation##2##2##(2008-10#1)(2010-8#1)
interesting data##2##2##(2008-3#1)(2008-4#1)
interesting effects##2##2##(2008-2#1)(2008-7#1)
interesting elements##3##2##(2008-10#3)
interesting example of##3##3##(2008-10#2)(2010-11#1)
interesting example##4##2##(1991-4#1)(2008-10#2)(2010-11#1)
interesting feature of##3##3##(1996-2#1)(2010-6#1)(2011-2#1)
interesting feature##5##2##(1996-2#1)(1997-5#1)(2010-3#1)(2010-6#1)(2011-2#1)
interesting features##3##2##(1996-2#1)(2008-2#1)(2011-2#1)
interesting finding is##2##3##(2008-10#1)(2008-2#1)
interesting for the##3##3##(1990-10#1)(2008-10#1)(2008-3#1)
interesting for##8##2##(1990-10#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-7#1)
interesting functional##2##2##(1997-4#1)(2008-8#1)
interesting in##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
interesting inhibitory effect##2##3##(2008-10#1)(2012-2#1)
interesting properties##3##2##(2007-12#1)(2008-2#1)(2008-5#1)
interesting results##4##2##(1995-5#1)(1997-8#1)(2008-10#1)(2008-3#1)
interesting similarities##2##2##(1991-6#1)(1995-9#1)
interesting since##2##2##(2008-3#1)(2010-11#1)
interesting targets for##2##3##(2008-10#1)(2013-8#1)
interesting that the##2##3##(2008-11#1)(2008-9#1)
interesting that##6##2##(1992-12#1)(2008-11#3)(2008-12#1)(2008-9#1)
interesting to explore##2##3##(2013-1#2)
interesting to##5##2##(1994-5#1)(2009-8#1)(2012-2#1)(2013-1#2)
interesting##213##1##(1990-10#1)(1990-5#2)(1990-8#2)(1991-4#1)(1991-6#3)(1992-1#1)(1992-12#1)(1992-5#3)(1992-8#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#33)(2008-11#9)(2008-12#3)(2008-2#12)(2008-3#7)(2008-4#1)(2008-5#13)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#5)(2010-10#3)(2010-11#7)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
interestingly##5##1##(2007-7#1)(2008-11#2)(2008-8#1)(2010-11#1)
interests and##11##2##(1991-2#1)(1992-1#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#2)(2010-2#1)(2012-12#1)
interests in##6##2##(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#2)
interests of the##9##3##(1991-12#1)(1992-3#1)(1993-2#1)(1997-1#1)(2008-8#1)(2009-10#1)(2010-9#2)(2012-12#1)
interests of##23##2##(1991-12#1)(1991-2#1)(1992-3#3)(1993-2#3)(1994-2#1)(1995-2#3)(1997-1#2)(1997-3#2)(2008-10#1)(2008-8#1)(2009-10#1)(2010-9#2)(2012-12#1)(2013-1#1)
interests to##2##2##(2008-8#1)(2009-7#1)
interests##77##1##(1990-6#2)(1991-12#1)(1991-2#3)(1991-6#2)(1992-1#2)(1992-2#1)(1992-3#5)(1993-2#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-11#3)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#3)(1997-7#1)(1997-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#3)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-9#2)(2012-12#2)(2012-2#1)(2013-1#4)
interet pour##2##2##(2008-5#2)
interface and##10##2##(1990-8#1)(1993-9#1)(1994-5#1)(2008-10#5)(2008-9#1)(2010-2#1)
interface applications##3##2##(2008-10#2)(2009-5#1)
interface are##2##2##(1990-7#1)(2009-9#1)
interface as##4##2##(1993-8#1)(2008-3#1)(2010-8#1)(2013-1#1)
interface between the##10##3##(1995-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
interface between two##5##3##(2007-11#1)(2008-10#2)(2008-3#2)
interface between##32##2##(1990-7#1)(1990-8#2)(1995-2#1)(1996-2#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-10#1)
interface by##4##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
interface can be used##2##4##(2008-10#1)(2008-4#1)
interface concept##2##2##(2008-10#2)
interface could##2##2##(2008-10#2)
interface detection##2##2##(2008-10#2)
interface for a##2##3##(1996-12#1)(2009-5#1)
interface for the##2##3##(1993-11#1)(2008-10#1)
interface for##11##2##(1993-11#1)(1996-12#1)(2008-10#4)(2008-4#1)(2009-10#1)(2009-5#1)(2010-8#2)
interface has been##3##3##(2007-12#1)(2008-10#2)
interface has##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
interface have been##2##3##(1995-5#1)(2008-10#1)
interface in order to##2##4##(2008-10#1)(2010-8#1)
interface in##10##2##(1990-12#1)(1991-5#2)(1992-3#2)(2007-11#1)(2008-10#2)(2008-8#1)(2010-8#1)
interface is##12##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#5)(2008-4#1)(2008-5#1)(2012-2#1)
interface of human##2##3##(1994-9#1)(2013-1#1)
interface of the##11##3##(1991-12#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-8#1)(2012-3#1)
interface of##27##2##(1991-12#1)(1994-9#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-3#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
interface on##4##2##(1995-2#2)(2008-2#1)(2008-8#1)
interface positions##2##2##(1993-11#1)(2012-2#1)
interface profiles##2##2##(2008-2#2)
interface roughness##3##2##(2007-12#1)(2008-3#2)
interface that may be##2##4##(2012-2#1)(2013-8#1)
interface that##8##2##(1997-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#3)(2013-8#1)
interface to##13##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#3)(2010-10#1)
interface was##11##2##(1994-5#1)(2008-10#6)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#1)
interface were##2##2##(1995-5#1)(2008-11#1)
interface where##2##2##(2008-10#2)
interface with the##4##3##(1994-8#1)(2008-2#1)(2009-6#1)(2010-10#1)
interface with##13##2##(1994-8#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2009-6#1)(2010-10#1)(2013-1#1)
interface##373##1##(1990-11#1)(1990-12#2)(1990-7#2)(1990-8#4)(1991-12#1)(1991-3#4)(1991-5#2)(1992-12#1)(1992-3#3)(1993-11#3)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#5)(1994-5#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#3)(1996-12#2)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(2007-11#12)(2007-12#19)(2007-9#1)(2008-1#2)(2008-10#108)(2008-11#4)(2008-12#1)(2008-2#16)(2008-3#38)(2008-4#9)(2008-5#12)(2008-7#12)(2008-8#7)(2008-9#3)(2009-10#4)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#4)(2010-10#6)(2010-2#2)(2010-4#3)(2010-8#10)(2011-1#5)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#9)(2013-8#2)
interface]##2##1##(2009-10#1)(2011-1#1)
interfaced to a##3##3##(1997-2#1)(2007-12#1)(2008-10#1)
interfaced to##6##2##(1997-2#2)(2007-12#1)(2008-10#2)(2008-3#1)
interfaced with##5##2##(2008-1#1)(2008-10#3)(2008-3#1)
interfaced##13##1##(1997-2#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-3#2)
interfaces and##7##2##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)
interfaces are##2##2##(2007-12#1)(2008-3#1)
interfaces based on##2##3##(2007-12#1)(2008-7#1)
interfaces for##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
interfaces in##5##2##(1990-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-2#1)
interfaces of a##2##3##(2008-3#1)(2008-7#1)
interfaces of##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
interfaces often##2##2##(2008-7#2)
interfaces were##2##2##(2008-10#1)(2012-2#1)
interfaces with##5##2##(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)
interfaces##88##1##(1990-4#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-3#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#15)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#16)(2008-4#5)(2008-7#14)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#1)
interfacial area##4##2##(1994-3#2)(2008-10#1)(2008-7#1)
interfacial pressure detector##2##3##(2008-10#2)
interfacial pressure##7##2##(1994-9#1)(2008-10#6)
interfacial region##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
interfacial roughnesses##2##2##(2008-3#2)
interfacial tension##4##2##(1997-1#1)(2008-10#1)(2008-3#1)(2010-4#1)
interfacial tensions##3##2##(2008-6#1)(2008-7#1)(2010-4#1)
interfacial transport##4##2##(1991-5#2)(2008-10#1)(2008-3#1)
interfacial##75##1##(1990-2#3)(1990-8#2)(1991-3#1)(1991-5#3)(1991-8#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-9#1)(1995-5#3)(1997-1#1)(1997-4#1)(2007-12#2)(2008-10#24)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#5)(2009-11#3)(2009-3#1)(2009-7#1)(2010-4#2)(2012-1#2)(2012-2#2)(2013-1#1)
interfacing of a##4##3##(2008-10#4)
interfacing of##6##2##(1997-2#1)(2008-10#5)
interfacing##13##1##(1994-12#1)(1994-6#1)(1997-2#1)(2008-10#8)(2008-3#1)(2009-10#1)
interferants##3##1##(2008-10#3)
interfere and##2##2##(2008-10#2)
interfere destructively##2##2##(2007-12#2)
interfere in the##11##3##(2008-10#10)(2008-5#1)
interfere in##15##2##(2008-10#13)(2008-5#1)(2010-5#1)
interfere the##6##2##(2008-10#6)
interfere with fungal growth##2##4##(2008-10#1)(2010-7#1)
interfere with normal##2##3##(2008-12#1)(2008-7#1)
interfere with other##4##3##(2008-10#3)(2012-1#1)
interfere with platelet aggregation##2##4##(1991-12#1)(2008-5#1)
interfere with the activity of##3##5##(2008-2#1)(2012-1#1)(2012-3#1)
interfere with the determination of##6##5##(2008-10#6)
interfere with the determination##10##4##(2008-10#10)
interfere with the effects of##2##5##(1990-5#1)(1997-7#1)
interfere with the##55##3##(1990-12#3)(1990-5#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-1#2)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-3#2)
interfere with wound healing##2##4##(2007-12#1)(2010-6#1)
interfere with##126##2##(1990-12#3)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#42)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
interfere##178##1##(1990-12#3)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#86)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
interfered by##2##2##(2008-10#2)
interfered with its##2##3##(2008-10#1)(2013-1#1)
interfered with the##6##3##(1992-3#2)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
interfered with##16##2##(1990-5#1)(1992-3#2)(1993-3#1)(1993-6#1)(1995-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2010-5#1)(2013-1#2)
interfered##21##1##(1990-5#1)(1992-3#2)(1993-3#1)(1993-6#1)(1995-12#1)(1996-6#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-6#1)(2010-5#1)(2013-1#2)
interference among the##2##3##(2007-11#1)(2007-12#1)
interference and##14##2##(1995-8#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#4)(2013-1#1)
interference are##2##2##(2007-11#1)(2008-10#1)
interference arising from##2##3##(2008-10#1)(2008-3#1)
interference at##2##2##(2007-11#1)(2008-12#1)
interference between a lasing field and##2##6##(2007-11#1)(2007-12#1)
interference between a##3##3##(2007-11#1)(2007-12#2)
interference between the##7##3##(2007-11#2)(2008-2#1)(2008-3#3)(2013-8#1)
interference between two##2##3##(2007-11#1)(2008-10#1)
interference between##21##2##(2007-11#5)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#6)(2008-8#1)(2009-5#1)(2013-8#1)
interference by##20##2##(1990-2#1)(2007-12#1)(2008-10#16)(2008-2#1)(2010-11#1)
interference can be##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
interference caused by the##2##4##(2008-10#2)
interference caused by##11##3##(2008-10#10)(2008-5#1)
interference coatings with##2##3##(2008-3#2)
interference coatings##7##2##(2007-11#2)(2008-3#5)
interference condition##2##2##(2007-11#1)(2008-3#1)
interference contrast microscopy##2##3##(2008-2#1)(2008-3#1)
interference contrast##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)
interference device##3##2##(2008-7#2)(2013-8#1)
interference due to##3##3##(2008-10#3)
interference effect of several##2##4##(2008-10#2)
interference effect of##4##3##(2008-10#4)
interference effect on the##4##4##(2008-10#4)
interference effect##10##2##(2007-12#1)(2008-10#9)
interference effects of the##2##4##(2008-10#1)(2008-2#1)
interference effects of##5##3##(2008-10#4)(2008-2#1)
interference effects##22##2##(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#6)(2008-2#5)(2008-3#6)
interference filter##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
interference filters##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
interference for##2##2##(2008-10#1)(2008-2#1)
interference free##4##2##(2008-10#4)
interference fringe##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
interference fringes formed by##2##4##(2007-11#1)(2008-3#1)
interference fringes to##2##3##(2008-3#2)
interference fringes were##3##3##(2007-12#1)(2008-3#2)
interference fringes##19##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#14)(2013-8#1)
interference from dissolved##2##3##(2008-10#2)
interference from endogenous##2##3##(1990-2#1)(2008-10#1)
interference from excipients##3##3##(2008-10#3)
interference from many##3##3##(2008-10#3)
interference from other##6##3##(1993-9#1)(2008-10#4)(2008-3#1)
interference from oxidizable species##2##4##(2008-10#2)
interference from several common##2##4##(2008-10#2)
interference from silicate##2##3##(2008-10#2)
interference from some##3##3##(2008-10#3)
interference from surfactants##2##3##(2008-10#2)
interference from the##8##3##(1996-6#1)(2008-10#4)(2008-2#1)(2010-5#1)(2010-6#1)
interference from water-vapor lines##2##4##(2008-3#2)
interference from##75##2##(1990-2#1)(1990-8#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#58)(2008-2#1)(2008-3#5)(2010-5#1)(2010-6#1)(2011-2#2)
interference have##2##2##(2007-11#1)(2008-10#1)
interference hyperspectral image##2##3##(2013-8#2)
interference image##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
interference in a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
interference in the determination of##5##5##(2008-10#5)
interference in the##12##3##(1990-12#1)(1997-7#1)(2007-12#1)(2008-10#8)(2010-5#1)
interference in##34##2##(1990-12#1)(1992-11#2)(1993-2#2)(1995-6#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#3)(2009-9#1)(2010-5#1)(2010-6#1)
interference is caused by##2##4##(2007-12#1)(2008-3#1)
interference is##10##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2012-12#1)
interference lithography##4##2##(2007-11#1)(2008-2#1)(2008-7#2)
interference method##10##2##(2008-10#6)(2008-3#3)(2012-1#1)
interference microscope for##2##3##(2007-12#1)(2008-3#1)
interference microscope with##2##3##(2008-3#2)
interference microscope##9##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)
interference modulation##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
interference noise##2##2##(2008-2#2)
interference occurs##2##2##(2008-10#1)(2008-3#1)
interference of Cu on##2##4##(2008-10#2)
interference of a large number of##6##6##(2008-10#6)
interference of a##12##3##(2008-10#10)(2008-3#2)
interference of almost all##2##4##(2008-10#2)
interference of four noncoplanar beams##2##5##(2007-11#2)
interference of light##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
interference of multiply reflected##2##4##(2008-1#1)(2008-3#1)
interference of organic##2##3##(2008-10#2)
interference of other##4##3##(2008-10#3)(2008-6#1)
interference of the##19##3##(2007-10#1)(2008-10#9)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
interference of two##7##3##(2007-11#1)(2008-2#3)(2008-3#2)(2008-6#1)
interference of##113##2##(1990-12#1)(1995-12#1)(2007-10#1)(2007-11#5)(2007-12#8)(2008-1#1)(2008-10#67)(2008-2#6)(2008-3#11)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
interference on the##4##3##(2008-10#4)
interference on##9##2##(1994-6#1)(2008-10#7)(2012-2#1)
interference pattern is formed##2##4##(2008-3#2)
interference pattern is##5##3##(2008-2#2)(2008-3#3)
interference pattern of the##2##4##(2008-3#2)
interference pattern of##3##3##(2008-2#1)(2008-3#2)
interference pattern on the##2##4##(2008-3#2)
interference pattern produced by##2##4##(2007-11#2)
interference pattern##26##2##(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#5)(2008-3#16)
interference patterns generated##2##3##(2008-3#2)
interference patterns in##2##3##(2007-12#1)(2008-2#1)
interference patterns##13##2##(1993-9#1)(2007-12#1)(2008-2#1)(2008-3#10)
interference phenomena##2##2##(2008-3#2)
interference problems##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
interference screw##2##2##(2009-10#2)
interference signal##7##2##(2007-11#1)(2007-12#1)(2008-3#4)(2011-1#1)
interference signals##2##2##(2008-2#1)(2008-3#1)
interference studies##2##2##(2008-10#2)
interference study of##2##3##(2008-10#2)
interference study##6##2##(2008-10#6)
interference system##2##2##(2013-8#2)
interference technique##2##2##(2007-11#1)(2008-3#1)
interference that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
interference to##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
interference was found##4##3##(2008-10#4)
interference was observed for##2##4##(2008-10#2)
interference was observed from##6##4##(2008-10#6)
interference was observed##13##3##(2008-10#12)(2008-3#1)
interference was##26##2##(1991-12#1)(2008-10#23)(2008-3#1)(2013-1#1)
interference were##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
interference while##2##2##(2007-11#1)(2008-1#1)
interference will##2##2##(2008-3#2)
interference with calcium-mediated##2##3##(1997-4#2)
interference with the##9##3##(1994-11#1)(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-7#1)(2013-8#1)
interference with##25##2##(1991-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#2)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
interference##748##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-12#2)(1993-2#4)(1993-9#2)(1994-11#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-7#1)(2007-10#1)(2007-11#44)(2007-12#44)(2008-1#10)(2008-10#313)(2008-11#4)(2008-12#2)(2008-2#49)(2008-3#142)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#17)
interference)##2##1##(2008-10#1)(2008-2#1)
interference-contrast microscopy##3##2##(2008-3#3)
interferences and has been successfully applied to the determination of##2##10##(2008-10#2)
interferences and##12##2##(2008-10#12)
interferences are caused by##2##4##(2008-10#2)
interferences are##10##2##(2008-10#9)(2013-1#1)
interferences as##2##2##(1991-7#1)(2008-10#1)
interferences between##2##2##(2008-10#2)
interferences by##2##2##(2008-10#2)
interferences can be##4##3##(2008-10#2)(2008-11#2)
interferences can##5##2##(2008-10#3)(2008-11#2)
interferences caused by alkali and alkaline earth##2##7##(2008-10#2)
interferences caused by the##4##4##(2008-10#4)
interferences caused by##10##3##(2008-10#10)
interferences due to##3##3##(2008-10#3)
interferences from common##2##3##(2008-10#2)
interferences from other##2##3##(2008-10#2)
interferences from surface-active compounds##2##4##(2008-10#2)
interferences from the##3##3##(2008-10#3)
interferences from##23##2##(2008-10#23)
interferences in the determination of##2##5##(2008-10#2)
interferences in the##6##3##(2008-10#5)(2013-1#1)
interferences in##13##2##(2008-10#11)(2008-2#1)(2013-1#1)
interferences may##2##2##(2008-10#2)
interferences of other##3##3##(2008-10#2)(2008-2#1)
interferences of the##3##3##(2008-10#3)
interferences of##22##2##(1990-2#1)(2008-10#20)(2008-2#1)
interferences on percent recovery of##3##5##(2008-10#3)
interferences on the##7##3##(2008-10#6)(2011-1#1)
interferences on##12##2##(2008-10#11)(2011-1#1)
interferences was##5##2##(2008-10#5)
interferences were investigated##3##3##(2008-10#3)
interferences were observed##4##3##(2008-10#4)
interferences were##12##2##(2008-10#11)(2010-5#1)
interferences with##2##2##(2008-10#2)
interferences##203##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-7#1)(1993-1#1)(2008-10#185)(2008-11#2)(2008-2#3)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
interferent in##3##2##(2008-10#3)
interferent ions##2##2##(2008-10#2)
interferent##14##1##(2008-10#14)
interferential##6##1##(1995-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-1#1)(2012-3#1)
interferents are##3##2##(2008-10#3)
interferents in##3##2##(2008-10#3)
interferents such as##2##3##(2008-10#2)
interferents were##2##2##(2008-10#2)
interferents##34##1##(2008-10#34)
interferes in the##3##3##(2008-10#3)
interferes with the detection of##2##5##(2008-9#1)(2013-1#1)
interferes with the##11##3##(1993-12#1)(1994-11#1)(2006-6#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
interferes with##30##2##(1990-5#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-5#1)(1997-6#1)(2006-6#2)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
interferes##38##1##(1990-5#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-5#1)(1997-6#1)(2006-6#2)(2007-12#1)(2007-6#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
interfering RNA (siRNA)##4##3##(2008-2#1)(2009-3#1)(2010-2#1)(2012-3#1)
interfering RNA##6##2##(2008-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
interfering RNAs##8##2##(1994-8#2)(2008-10#2)(2008-2#2)(2011-2#1)(2012-2#1)
interfering anions##2##2##(2008-10#2)
interfering cations##7##2##(2008-10#7)
interfering compounds##8##2##(2008-10#8)
interfering effect##6##2##(2008-10#6)
interfering effects of##4##3##(2008-10#4)
interfering effects##8##2##(2008-10#8)
interfering elements in##2##3##(2008-10#2)
interfering elements##5##2##(2008-10#5)
interfering ions and##2##3##(2008-10#2)
interfering ions are##2##3##(2008-10#2)
interfering ions on the recovery of the analytes##3##8##(2008-10#3)
interfering ions on the recovery of the##5##7##(2008-10#5)
interfering ions on the##9##4##(2008-10#9)
interfering ions on##10##3##(2008-10#10)
interfering ions was##4##3##(2008-10#4)
interfering ions were##4##3##(2008-10#4)
interfering ions##38##2##(2008-10#38)
interfering metal ions##2##3##(2008-10#2)
interfering particles##2##2##(1994-8#2)
interfering peaks##6##2##(1997-2#6)
interfering species for##2##3##(2008-10#2)
interfering species to be##2##4##(2008-10#1)(2008-2#1)
interfering species##11##2##(2008-10#8)(2008-2#2)(2008-3#1)
interfering substances##5##2##(2008-10#5)
interfering with the generation of##2##5##(2010-7#1)(2011-2#1)
interfering with the##7##3##(1990-12#1)(1990-7#1)(1994-6#1)(2010-11#1)(2010-7#1)(2011-2#2)
interfering with their##2##3##(2008-8#1)(2010-3#1)
interfering with##20##2##(1990-12#1)(1990-7#1)(1992-3#1)(1994-6#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)
interfering##167##1##(1990-12#1)(1990-7#1)(1991-12#1)(1992-3#1)(1992-6#1)(1994-6#1)(1994-8#5)(1995-3#1)(1997-2#7)(2006-6#1)(2007-11#3)(2007-12#1)(2008-10#109)(2008-11#1)(2008-2#9)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)
interferogram by##3##2##(2007-11#1)(2008-3#2)
interferogram demodulation##2##2##(2008-2#1)(2008-3#1)
interferogram is##6##2##(2008-2#2)(2008-3#4)
interferogram will##2##2##(2007-11#1)(2008-3#1)
interferogram##53##1##(2007-11#2)(2007-12#2)(2008-2#16)(2008-3#30)(2013-8#3)
interferograms and##2##2##(2008-3#2)
interferograms are##8##2##(2008-2#4)(2008-3#4)
interferograms at##2##2##(2007-12#1)(2008-2#1)
interferograms can be##2##3##(2007-11#1)(2008-2#1)
interferograms have##2##2##(2008-2#1)(2008-3#1)
interferograms is##2##2##(2008-3#2)
interferograms of##2##2##(2008-2#1)(2008-3#1)
interferograms that##2##2##(2008-2#1)(2008-3#1)
interferograms with a##2##3##(2008-2#1)(2008-3#1)
interferograms with##4##2##(2008-2#1)(2008-3#3)
interferograms##45##1##(2007-11#3)(2007-12#2)(2008-2#15)(2008-3#25)
interferometer and a##3##3##(2007-11#1)(2008-3#2)
interferometer and an##2##3##(2008-3#1)(2011-1#1)
interferometer and compared##2##3##(2008-3#2)
interferometer and##14##2##(2007-11#3)(2008-2#1)(2008-3#9)(2011-1#1)
interferometer are##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
interferometer arms##3##2##(2008-3#3)
interferometer as##2##2##(2007-12#1)(2008-3#1)
interferometer based on a##2##4##(2007-11#1)(2008-3#1)
interferometer based on##8##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#2)
interferometer but##2##2##(2007-12#1)(2008-3#1)
interferometer concept##3##2##(2008-3#3)
interferometer for a##3##3##(2007-12#1)(2008-3#2)
interferometer for measuring##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
interferometer for the##3##3##(2007-11#1)(2008-3#2)
interferometer for##29##2##(2007-11#5)(2007-12#2)(2008-2#3)(2008-3#19)
interferometer has been developed##2##4##(2007-11#1)(2008-3#1)
interferometer has been##3##3##(2007-11#1)(2008-3#2)
interferometer has##5##2##(2007-11#1)(2008-3#4)
interferometer illuminated by a##2##4##(2008-3#2)
interferometer in which##2##3##(2007-12#2)
interferometer in##5##2##(2007-12#2)(2008-2#3)
interferometer is applied to the##2##5##(2008-3#2)
interferometer is built##2##3##(2008-3#2)
interferometer is described##2##3##(2008-3#2)
interferometer is presented##2##3##(2008-2#1)(2008-3#1)
interferometer is##23##2##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#14)
interferometer operating at##2##3##(2007-11#1)(2008-3#1)
interferometer operating##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
interferometer or the##2##3##(2007-11#1)(2008-3#1)
interferometer technique##2##2##(2007-11#1)(2008-2#1)
interferometer that makes use of an##2##6##(2007-12#2)
interferometer that uses an##2##4##(2008-3#2)
interferometer that uses##4##3##(2008-3#4)
interferometer that##14##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#7)
interferometer through##2##2##(2008-2#1)(2008-3#1)
interferometer to measure the##2##4##(2008-2#2)
interferometer to##11##2##(2007-11#4)(2008-2#4)(2008-3#3)
interferometer under##2##2##(2007-12#1)(2008-3#1)
interferometer was constructed##2##3##(2007-11#1)(2008-3#1)
interferometer was used in##2##4##(2007-12#1)(2008-3#1)
interferometer was used##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
interferometer was##9##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2013-8#1)
interferometer with a laser diode##2##5##(2008-2#1)(2008-3#1)
interferometer with a self-pumped phase-conjugate mirror##2##6##(2008-3#2)
interferometer with a##21##3##(2007-11#7)(2007-12#1)(2008-2#3)(2008-3#10)
interferometer with resonant sideband extraction##2##5##(2008-2#2)
interferometer with##42##2##(2007-11#9)(2007-12#6)(2008-2#7)(2008-3#19)(2013-8#1)
interferometer##376##1##(2006-4#1)(2007-11#62)(2007-12#42)(2008-10#1)(2008-2#68)(2008-3#197)(2010-4#1)(2011-1#1)(2013-8#3)
interferometer-based##2##1##(2007-11#1)(2008-3#1)
interferometers and##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
interferometers for##3##2##(2008-2#1)(2008-3#2)
interferometers have##2##2##(2008-2#1)(2008-3#1)
interferometers is##2##2##(2007-11#1)(2008-3#1)
interferometers with##2##2##(2008-3#2)
interferometers##34##1##(2007-11#5)(2007-12#4)(2008-2#9)(2008-3#16)
interferometric configuration##2##2##(2007-11#1)(2012-2#1)
interferometric detection##2##2##(2007-11#1)(2008-3#1)
interferometric determination of##2##3##(2008-2#1)(2008-3#1)
interferometric four-wave mixing##2##3##(2007-11#2)
interferometric fringe patterns##2##3##(2008-2#1)(2008-3#1)
interferometric gravitational-wave detectors##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
interferometric gravitational-wave##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
interferometric heterodyne vibrometer##2##3##(2008-3#2)
interferometric imaging system##2##3##(2007-12#1)(2008-3#1)
interferometric imaging##3##2##(2007-12#1)(2008-3#2)
interferometric length##3##2##(2008-3#3)
interferometric lithography##6##2##(2007-12#3)(2008-3#3)
interferometric measurements##5##2##(2007-11#2)(2008-3#3)
interferometric method##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
interferometric methods##2##2##(2007-12#1)(2008-3#1)
interferometric microscopy##2##2##(2011-1#2)
interferometric monitor for greenhouse gases##3##5##(2008-3#3)
interferometric noise##2##2##(2008-2#2)
interferometric optical##4##2##(2007-11#2)(2008-3#2)
interferometric phase##2##2##(2008-2#1)(2011-1#1)
interferometric photothermal spectroscopy##2##3##(2008-2#2)
interferometric reflectometry##2##2##(2008-3#2)
interferometric sensors based on highly birefringent fibers##3##7##(2008-2#1)(2008-3#2)
interferometric stellar coronagraph##2##3##(2007-11#2)
interferometric system for##2##3##(2008-2#2)
interferometric system is##2##3##(2008-2#1)(2008-3#1)
interferometric system##4##2##(2008-2#3)(2008-3#1)
interferometric technique for##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
interferometric technique##7##2##(2007-11#3)(2007-12#2)(2008-3#2)
interferometric techniques##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
interferometric testing##4##2##(2008-3#4)
interferometric tomography##2##2##(2008-2#1)(2008-3#1)
interferometric##127##1##(2007-11#22)(2007-12#15)(2008-10#1)(2008-2#28)(2008-3#56)(2008-5#1)(2011-1#3)(2012-2#1)
interferometrically##2##1##(2007-12#1)(2008-3#1)
interferometry (DSPI)##4##2##(2008-2#2)(2008-3#1)(2008-8#1)
interferometry (ESPI)##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
interferometry and optical##2##3##(2007-11#2)
interferometry and##11##2##(2007-11#3)(2008-2#5)(2008-3#3)
interferometry are compared##2##3##(2008-3#2)
interferometry are##12##2##(2008-2#1)(2008-3#11)
interferometry at##3##2##(2008-3#3)
interferometry data##2##2##(2008-2#1)(2008-3#1)
interferometry for direct electric-field reconstruction##7##5##(2007-12#7)
interferometry for direct##8##3##(2007-11#1)(2007-12#7)
interferometry for##13##2##(2007-11#4)(2007-12#7)(2008-2#1)(2008-3#1)
interferometry images##3##2##(2008-3#3)
interferometry in the##2##3##(2007-11#1)(2008-3#1)
interferometry in##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
interferometry is a##4##3##(2008-2#1)(2008-3#3)
interferometry is applied##2##3##(2008-3#2)
interferometry is proposed that##2##4##(2007-11#1)(2008-2#1)
interferometry is##16##2##(2007-11#1)(2008-2#3)(2008-3#12)
interferometry of a plasma with a tabletop##2##7##(2007-12#2)
interferometry of a##3##3##(2007-12#2)(2008-3#1)
interferometry of##10##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#5)
interferometry system##2##2##(2008-2#2)
interferometry technique##4##2##(2008-2#2)(2008-3#2)
interferometry techniques##2##2##(2008-3#2)
interferometry that##5##2##(2008-2#2)(2008-3#3)
interferometry to##5##2##(2008-2#1)(2008-3#4)
interferometry with a##3##3##(2008-2#1)(2008-3#2)
interferometry with probe-to-droplet size ratios less than unity##2##8##(2008-3#2)
interferometry with##19##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#13)(2008-5#1)
interferometry##233##1##(1992-8#1)(1994-11#2)(1995-5#2)(2007-11#24)(2007-12#18)(2008-2#50)(2008-3#131)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#2)
interferon (IFN)##3##2##(1993-2#1)(2009-8#1)(2013-7#1)
interferon (IFN)-gamma##5##2##(1994-8#1)(1996-12#2)(2008-10#1)(2008-11#1)
interferon alpha and ribavirin##2##4##(2008-6#1)(2010-4#1)
interferon alpha and##3##3##(1997-3#1)(2008-6#1)(2010-4#1)
interferon alpha##11##2##(1997-1#3)(1997-3#3)(1997-5#1)(2008-6#1)(2009-10#1)(2010-4#1)(2012-12#1)
interferon and ribavirin##3##3##(2011-2#2)(2013-7#1)
interferon and##6##2##(1990-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-7#1)
interferon at##2##2##(1990-12#1)(1991-6#1)
interferon for##3##2##(1991-6#1)(1993-12#1)(1995-8#1)
interferon gamma (IFN-gamma)##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
interferon gamma##11##2##(1993-9#1)(1994-8#1)(1995-12#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
interferon has been##2##3##(1991-6#1)(1997-1#1)
interferon has##3##2##(1991-6#1)(1997-1#2)
interferon in##3##2##(1990-8#1)(1991-6#1)(1993-6#1)
interferon production in##2##3##(1994-6#1)(2010-4#1)
interferon regulatory factor##2##3##(2008-10#1)(2012-3#1)
interferon regulatory factor-1##2##3##(1994-11#1)(2012-3#1)
interferon regulatory##5##2##(1994-11#1)(2008-10#1)(2012-3#2)(2013-1#1)
interferon therapy##4##2##(2006-10#2)(2009-3#1)(2013-1#1)
interferon treatment##4##2##(2007-8#1)(2008-8#1)(2009-3#1)(2010-11#1)
interferon use##2##2##(2013-8#2)
interferon β##2##2##(2012-3#1)(2013-8#1)
interferon β-1a##2##2##(2013-8#2)
interferon##103##1##(1990-12#4)(1990-5#1)(1990-6#2)(1990-8#3)(1991-2#1)(1991-6#4)(1991-8#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#6)(1997-3#3)(1997-4#3)(1997-5#1)(2006-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#5)
interferon-alpha (IFN-alpha)##2##2##(1994-3#1)(2009-5#1)
interferon-alpha and##2##2##(2007-11#1)(2008-6#1)
interferon-alpha in##2##2##(1990-3#1)(1997-5#1)
interferon-alpha therapy##3##2##(1992-10#2)(2008-6#1)
interferon-alpha treatment##2##2##(1992-10#1)(2007-11#1)
interferon-alpha##16##1##(1990-3#1)(1990-5#1)(1992-10#3)(1993-12#1)(1993-2#1)(1994-3#1)(1997-5#1)(2007-11#3)(2008-6#3)(2009-5#1)
interferon-alpha-2a##3##1##(1990-2#2)(2010-6#1)
interferon-based therapy for##2##3##(2009-7#1)(2011-2#1)
interferon-based therapy##3##2##(2009-7#2)(2011-2#1)
interferon-beta##12##1##(1990-5#1)(1994-6#1)(2008-11#10)
interferon-gamma (IFN-gamma)##6##2##(1993-12#1)(1994-6#1)(2008-11#2)(2008-3#1)(2008-7#1)
interferon-gamma were##2##2##(1993-6#1)(2008-11#1)
interferon-gamma##28##1##(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-2#1)(1997-1#3)(2008-10#2)(2008-11#7)(2008-3#1)(2008-4#1)(2008-7#3)(2013-1#1)
interferon-induced thyroid##2##2##(2008-6#2)
interferon-induced##3##1##(2008-6#2)(2008-7#1)
interferon-γ gene##2##2##(2011-1#1)(2013-1#1)
interferons and##3##2##(1993-2#1)(1996-2#1)(1997-1#1)
interferons##14##1##(1990-2#1)(1990-5#1)(1991-3#2)(1993-2#1)(1994-8#1)(1995-12#2)(1996-2#1)(1997-1#4)(2008-4#1)
interferons-beta##2##1##(1994-6#2)
interfertile##4##1##(2008-10#3)(2008-8#1)
interfertility##3##1##(2008-8#3)
interfood##3##1##(2008-5#3)
interfragmentary contact area##2##3##(2013-1#2)
interfragmentary contact surface##2##3##(2013-1#2)
interfragmentary contact##4##2##(2013-1#4)
intergenerational##4##1##(1997-5#1)(2008-5#1)(2008-9#1)(2010-12#1)
intergeneric##5##1##(2008-10#1)(2008-5#2)(2008-8#1)(2010-3#1)
intergenic region of##3##3##(2008-10#2)(2008-8#1)
intergenic region separating##2##3##(1994-11#1)(2008-10#1)
intergenic region##17##2##(1994-11#1)(1996-10#2)(1996-6#2)(2008-10#7)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)
intergenic regions##7##2##(1993-2#1)(1996-3#1)(2008-10#1)(2008-4#1)(2012-3#3)
intergenic sequences##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
intergenic spacer (IGS) region of the nuclear ribosomal RNA gene##2##10##(2008-10#2)
intergenic spacer (IGS) region of##3##5##(2008-10#3)
intergenic spacer (IGS)##6##3##(2008-10#6)
intergenic spacer region##4##3##(2008-10#3)(2011-2#1)
intergenic spacer##19##2##(1995-8#2)(2008-10#15)(2008-5#1)(2011-2#1)
intergenic spacers##2##2##(2008-5#2)
intergenic##53##1##(1993-2#1)(1994-11#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-6#3)(2008-10#28)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#3)(2012-3#3)
intergenomic##2##1##(2008-7#1)(2010-3#1)
intergovernmental##3##1##(1993-3#1)(1996-1#1)(2012-2#1)
intergroup##7##1##(1990-6#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#1)(2013-8#1)
interhelical##2##1##(1994-5#1)(1994-6#1)
interhemispheric or##2##2##(1994-3#1)(2008-7#1)
interhemispheric##9##1##(1992-8#1)(1994-3#3)(2008-7#1)(2011-2#2)(2013-1#2)
interhospital##2##1##(1991-12#1)(1995-9#1)
interhyoid muscle in##2##3##(2011-2#2)
interhyoid muscle##7##2##(2011-2#7)
interhyoid##8##1##(2011-2#8)
interictal and preseizure##2##3##(2013-8#2)
interictal##4##1##(1990-5#1)(2010-8#1)(2013-8#2)
interim analysis of##2##3##(1997-8#1)(2008-5#1)
interim analysis##6##2##(1997-8#3)(2008-5#1)(2012-2#2)
interim report##3##2##(1991-1#1)(1995-3#1)(1996-12#1)
interim solution##2##2##(1996-3#1)(2008-10#1)
interim##36##1##(1991-1#1)(1992-12#1)(1992-8#2)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-8#3)(2007-7#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#6)
interindividual and##2##2##(2008-10#1)(2008-5#1)
interindividual differences in##5##3##(1993-12#1)(2007-10#2)(2008-11#1)(2008-5#1)
interindividual differences##6##2##(1993-12#1)(1995-11#1)(2007-10#2)(2008-11#1)(2008-5#1)
interindividual variability in 24-h urinary excretion of##2##7##(1995-11#2)
interindividual variability in response##2##4##(2009-5#2)
interindividual variability in##5##3##(1995-11#2)(2008-8#1)(2009-5#2)
interindividual variability of##2##3##(1995-11#1)(2008-10#1)
interindividual variability##8##2##(1995-11#3)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#2)
interindividual variation in##4##3##(1996-8#1)(2008-12#1)(2008-8#1)(2010-10#1)
interindividual##21##1##(1992-9#1)(1993-12#1)(1995-11#4)(1996-8#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2009-5#2)(2010-10#1)
interior and exterior##2##3##(2008-9#1)(2010-4#1)
interior and##3##2##(2008-9#1)(2010-4#1)(2013-7#1)
interior of the##9##3##(2007-11#3)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-8#1)
interior of##18##2##(1991-9#1)(1993-11#1)(1994-11#1)(2007-11#3)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-6#1)(2013-7#3)(2013-8#1)
interior region##2##2##(2008-8#1)(2010-8#1)
interior##55##1##(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#3)(1995-2#2)(1996-12#3)(1997-4#1)(2007-11#4)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#5)(2013-8#1)
interior)##2##1##(1996-12#1)(2013-7#1)
interketosidic linkages##2##2##(1994-11#2)
interlaboratory comparison of##2##3##(2008-10#1)(2008-5#1)
interlaboratory comparison##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
interlaboratory reproducibility##2##2##(2008-5#2)
interlaboratory study##7##2##(2008-10#5)(2008-5#2)
interlaboratory##18##1##(2008-10#12)(2008-4#1)(2008-5#5)
interlaced##6##1##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
interlacing technique##2##2##(2008-2#1)(2008-3#1)
interlacing##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
interlaminar##2##1##(1993-12#1)(2011-2#1)
interlayer separation##2##2##(1996-2#2)
interlayer##9##1##(1991-5#1)(1991-9#1)(1994-5#2)(1996-2#2)(1997-7#1)(2008-10#1)(2008-6#1)
interleaved pulse sequences##2##3##(2009-9#2)
interleaved##4##1##(2008-3#1)(2009-9#3)
interleavers##2##1##(2007-11#1)(2007-12#1)
interleaving##3##1##(2008-2#3)
interlesion gaps##2##2##(2010-6#2)
interleukin (IL)-10##2##2##(2008-11#1)(2008-5#1)
interleukin (IL)-6##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
interleukin 1 (IL-1)##3##3##(1990-11#1)(1990-2#1)(1995-2#1)
interleukin 1##7##2##(1990-11#1)(1990-2#2)(1990-7#1)(1995-2#1)(1996-2#1)(2012-2#1)
interleukin 10##2##2##(1993-8#1)(1994-8#1)
interleukin 12##2##2##(2008-11#1)(2008-4#1)
interleukin 2 (IL-2)##3##3##(2008-11#1)(2008-4#2)
interleukin 2##10##2##(1990-12#1)(1990-6#1)(1995-12#1)(2008-11#3)(2008-4#4)
interleukin 3##6##2##(1990-12#1)(1991-12#2)(1991-5#1)(1992-3#1)(1994-5#1)
interleukin 4##4##2##(1993-2#1)(1994-8#2)(2008-9#1)
interleukin 5 (IL-5)##2##3##(1990-12#1)(1992-3#1)
interleukin 5##4##2##(1990-12#1)(1992-3#1)(2008-4#2)
interleukin 6 (IL-6)##2##3##(1995-2#1)(2008-11#1)
interleukin 6##7##2##(1995-2#2)(2008-11#2)(2008-4#1)(2011-1#1)(2011-2#1)
interleukin 7 (IL-7)##4##3##(1995-2#1)(2008-11#2)(2008-4#1)
interleukin 7##8##2##(1995-2#2)(2008-11#3)(2008-4#2)(2008-9#1)
interleukin 8 (IL-8)##3##3##(1994-12#1)(1994-5#1)(2009-10#1)
interleukin 8##4##2##(1994-12#1)(1994-5#2)(2009-10#1)
interleukin 9##2##2##(2008-4#2)
interleukin##76##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#3)(1994-8#3)(1995-12#1)(1995-2#5)(1996-12#2)(1996-2#1)(2007-11#1)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
interleukin-1 (IL-1) production##2##3##(1991-8#2)
interleukin-1 (IL-1)##3##2##(1991-8#2)(1995-6#1)
interleukin-1 alpha##4##2##(1992-6#1)(1993-8#1)(1994-6#1)(1994-8#1)
interleukin-1 and##3##2##(1994-6#1)(2008-7#1)(2012-2#1)
interleukin-1 beta (IL-1 beta)##2##4##(1994-11#1)(1995-12#1)
interleukin-1 beta mutant##2##3##(1993-8#2)
interleukin-1 beta##16##2##(1990-10#3)(1990-12#3)(1990-2#3)(1993-8#2)(1994-11#1)(1995-12#1)(1996-12#1)(1997-5#2)
interleukin-1 receptor antagonist (IL-1ra)##3##4##(2007-11#1)(2008-5#1)(2011-1#1)
interleukin-1 receptor antagonist##6##3##(1992-3#2)(1995-12#1)(2007-11#1)(2008-5#1)(2011-1#1)
interleukin-1##42##1##(1990-10#4)(1990-12#7)(1990-2#3)(1991-8#2)(1992-3#2)(1992-6#1)(1993-8#3)(1994-11#2)(1994-6#5)(1994-8#1)(1995-12#2)(1995-6#2)(1996-12#1)(1997-5#2)(2007-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
interleukin-10##2##1##(2011-1#2)
interleukin-12 (IL-12)##2##2##(2008-11#2)
interleukin-13##2##1##(2008-4#2)
interleukin-1beta (IL-1beta)##2##2##(2007-8#1)(2008-10#1)
interleukin-1beta##10##1##(1997-1#6)(2007-8#1)(2008-10#1)(2008-6#1)(2010-8#1)
interleukin-1β (IL-1β)##2##2##(2011-1#1)(2013-1#1)
interleukin-2 (IL-2) and##3##3##(1993-8#1)(2008-11#1)(2008-5#1)
interleukin-2 (IL-2)##12##2##(1990-2#1)(1991-6#1)(1993-6#1)(1993-8#1)(1995-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
interleukin-2 and LAK##2##3##(1991-8#1)(1994-6#1)
interleukin-2 and##5##2##(1991-8#1)(1992-12#2)(1994-6#1)(2008-11#1)
interleukin-2 beta-chain##2##2##(1992-5#2)
interleukin-2 by##2##2##(1990-12#1)(1990-5#1)
interleukin-2 levels##2##2##(1990-2#1)(2008-7#1)
interleukin-2 plus##4##2##(1993-12#2)(1993-6#1)(1994-12#1)
interleukin-2 receptor beta chain##2##4##(1997-5#2)
interleukin-2 receptor##8##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-9#1)(1997-5#2)(2011-1#1)
interleukin-2##61##1##(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#8)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#2)(1997-5#2)(2008-11#4)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2012-2#2)
interleukin-2-stimulated##2##1##(1994-5#1)(2008-4#1)
interleukin-3 receptor alpha##2##3##(1993-12#2)
interleukin-3 receptor##3##2##(1993-12#2)(1994-11#1)
interleukin-3##4##1##(1993-12#2)(1994-11#1)(2008-7#1)
interleukin-4 (IL-4)##3##2##(1992-5#1)(1992-8#1)(2009-12#1)
interleukin-4##12##1##(1992-5#2)(1992-8#2)(1997-1#5)(2008-11#1)(2008-3#1)(2009-12#1)
interleukin-5##6##1##(1994-6#4)(1995-6#1)(2008-1#1)
interleukin-6 (IL-6) and##2##3##(1990-5#1)(2008-11#1)
interleukin-6 (IL-6)##16##2##(1990-5#2)(1994-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
interleukin-6 and##6##2##(1994-6#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)
interleukin-6 in##4##2##(1990-5#1)(2008-5#1)(2008-6#1)(2011-2#1)
interleukin-6 receptor##4##2##(1990-5#1)(1994-2#1)(2008-8#2)
interleukin-6##48##1##(1990-5#4)(1992-8#4)(1994-2#1)(1994-3#1)(1994-6#6)(1995-12#5)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
interleukin-8 (IL-8)##4##2##(1994-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
interleukin-8##10##1##(1993-6#1)(1994-11#1)(2008-10#3)(2008-4#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
interleukins##7##1##(1990-9#2)(1991-3#1)(1996-10#1)(1996-12#1)(1996-5#1)(2008-4#1)
interlibrary loan##2##2##(1992-2#1)(1995-2#1)
interlibrary##3##1##(1992-2#1)(1995-2#1)(1996-1#1)
interline transfer CCD##3##3##(2008-3#3)
interline##4##1##(2008-3#4)
interlinked in##2##2##(2008-8#1)(2012-2#1)
interlinked##3##1##(2008-8#1)(2010-10#1)(2012-2#1)
interlobular septa##2##2##(2010-10#1)(2012-12#1)
interlocked##2##1##(2008-10#1)(2010-12#1)
interlocking detachable##2##2##(1997-3#2)
interlocking nail##2##2##(2013-1#1)(2013-8#1)
interlocking screws##2##2##(2009-3#2)
interlocking##15##1##(1997-3#2)(2008-7#2)(2009-11#1)(2009-3#2)(2010-2#1)(2011-2#1)(2013-1#5)(2013-8#1)
intermarker interval##3##2##(1997-5#3)
intermaxillipedal process##2##2##(2008-5#2)
intermedia##8##1##(2007-11#1)(2007-12#2)(2008-5#2)(2013-1#3)
intermediaries##5##1##(1992-1#1)(1996-12#2)(1997-8#1)(2010-5#1)
intermediary conducting polymer layer##2##4##(2008-10#2)
intermediary metabolites##2##2##(2008-10#1)(2008-11#1)
intermediary oxidised sulphur##2##3##(2008-10#2)
intermediary selfing##2##2##(2008-8#2)
intermediary##16##1##(1991-11#1)(1995-12#2)(1995-3#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#3)(2013-1#1)
intermediate adsorbate##2##2##(2007-12#2)
intermediate and caudal parts of the caudate-putamen##2##7##(1995-12#2)
intermediate and##17##2##(1990-12#1)(1990-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-12#2)(1995-6#1)(2007-12#1)(2008-10#2)(2008-7#3)(2008-9#1)(2010-11#1)
intermediate as##2##2##(2008-11#1)(2010-2#1)
intermediate at##2##2##(1993-8#1)(1995-5#1)
intermediate basic##2##2##(1990-7#2)
intermediate between that of##3##4##(1990-8#2)(1991-8#1)
intermediate between the##2##3##(2008-10#1)(2010-4#1)
intermediate between those##2##3##(1990-11#1)(1995-5#1)
intermediate between##13##2##(1990-11#1)(1990-8#2)(1991-6#1)(1991-8#1)(1995-5#1)(2008-10#4)(2008-5#1)(2009-8#1)(2010-4#1)
intermediate cardiovascular phenotypes##2##3##(2009-9#2)
intermediate cardiovascular##3##2##(2009-9#2)(2012-3#1)
intermediate care facilities##2##3##(1991-2#1)(1992-2#1)
intermediate care##3##2##(1991-1#1)(1991-2#1)(1992-2#1)
intermediate density lipoproteins##3##3##(1993-12#1)(1994-8#2)
intermediate density##5##2##(1993-12#1)(1994-8#2)(1995-6#1)(2008-11#1)
intermediate distribution##2##2##(2008-10#1)(2013-7#1)
intermediate doses##2##2##(2013-1#2)
intermediate during##2##2##(1995-5#1)(2008-10#1)
intermediate filament##7##2##(1991-12#1)(1993-8#1)(1996-5#1)(1997-2#1)(2008-5#2)(2011-2#1)
intermediate filaments in##3##3##(2008-8#1)(2009-10#2)
intermediate filaments##12##2##(1992-9#1)(2008-5#1)(2008-8#5)(2009-10#4)(2009-8#1)
intermediate for 'Florunner'##2##3##(2008-10#2)
intermediate for##6##2##(1992-6#1)(1995-2#1)(1997-8#1)(2008-10#3)
intermediate found in##2##3##(1991-5#1)(1994-6#1)
intermediate frequencies##2##2##(2008-10#1)(2012-3#1)
intermediate frequency##2##2##(2008-3#1)(2010-4#1)
intermediate host snail##2##3##(2008-8#2)
intermediate host##3##2##(2008-8#2)(2013-8#1)
intermediate hosts##6##2##(2008-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
intermediate image##2##2##(2008-2#1)(2008-3#1)
intermediate in large artery##2##4##(2007-10#2)
intermediate in the synthesis of##3##5##(1992-12#1)(1994-3#1)(2011-1#1)
intermediate in the##10##3##(1990-7#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-6#1)(2008-5#1)(2009-7#1)(2011-1#1)
intermediate in##23##2##(1990-7#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#1)(2007-10#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)
intermediate is##4##2##(1990-5#1)(1991-12#1)(1995-6#1)(2009-8#1)
intermediate layer between the##2##4##(1993-12#1)(2008-10#1)
intermediate layer##4##2##(1993-12#1)(2008-10#1)(2008-12#2)
intermediate leaves##2##2##(2008-10#2)
intermediate length##2##2##(2008-11#1)(2008-7#1)
intermediate level of##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)
intermediate level##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)
intermediate levels of##13##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
intermediate lobe##4##2##(1992-12#1)(1993-5#3)
intermediate of the##4##3##(1990-11#2)(1990-7#1)(2008-10#1)
intermediate of##10##2##(1990-11#2)(1990-7#1)(1992-6#1)(1994-12#1)(1995-5#2)(1996-5#1)(2008-10#1)(2008-11#1)
intermediate or resistant##2##3##(1997-3#1)(2008-5#1)
intermediate or##4##2##(1997-3#1)(2007-10#1)(2008-10#1)(2008-5#1)
intermediate pituitary##3##2##(1993-5#3)
intermediate points##2##2##(2008-3#2)
intermediate position between##2##3##(1990-3#1)(1997-6#1)
intermediate productivity##2##2##(2008-9#1)(2011-2#1)
intermediate products##4##2##(2008-11#1)(2008-3#3)
intermediate rates##2##2##(1993-9#1)(2009-7#1)
intermediate region##3##2##(1990-3#2)(2010-8#1)
intermediate risk##2##2##(2010-12#1)(2013-1#1)
intermediate sensitivity##4##2##(1990-12#1)(2007-7#1)(2008-10#2)
intermediate size##2##2##(1995-5#1)(2008-11#1)
intermediate species##3##2##(1994-6#1)(2008-8#1)(2012-1#1)
intermediate stages of##2##3##(1995-3#1)(2009-8#1)
intermediate state##5##2##(1993-11#1)(1995-5#3)(2008-11#1)
intermediate states##3##2##(1991-6#1)(1995-5#1)(2007-11#1)
intermediate step in the##2##4##(1990-5#1)(2008-9#1)
intermediate step##5##2##(1990-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-1#1)
intermediate steps of##3##3##(1991-2#1)(2008-3#1)(2010-3#1)
intermediate structures from##2##3##(2007-12#1)(2010-10#1)
intermediate structures##4##2##(1995-2#1)(2007-12#1)(2010-10#1)(2012-12#1)
intermediate than##2##2##(1995-5#1)(1995-6#1)
intermediate that##4##2##(1995-3#1)(1995-5#1)(2007-11#1)(2009-9#1)
intermediate to high CBS concentrations##2##5##(1993-8#2)
intermediate to high##8##3##(1993-8#2)(1996-6#3)(2008-6#1)(2008-7#1)(2011-2#1)
intermediate to those of the##3##5##(1993-2#1)(2013-8#2)
intermediate to those of##5##4##(1993-2#1)(1995-5#1)(2008-12#1)(2013-8#2)
intermediate to##13##2##(1993-2#1)(1993-8#2)(1995-5#1)(1996-6#3)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#2)
intermediate values##2##2##(2008-10#1)(2008-8#1)
intermediate was##5##2##(1994-6#1)(1995-5#1)(1995-6#1)(2008-9#1)(2009-9#1)
intermediate which##3##2##(1996-5#2)(2010-2#1)
intermediate with the##2##3##(1992-3#1)(2009-2#1)
intermediate with##3##2##(1992-3#1)(2008-10#1)(2009-2#1)
intermediate##473##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#7)(1990-5#6)(1990-6#1)(1990-7#7)(1990-8#8)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#1)(1993-11#7)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#7)(1993-8#7)(1993-9#1)(1994-12#2)(1994-3#3)(1994-6#8)(1994-8#4)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#6)(1995-5#20)(1995-6#5)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#10)(1996-6#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-10#3)(2007-11#8)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#56)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#14)(2008-4#7)(2008-5#13)(2008-6#5)(2008-7#11)(2008-8#26)(2008-9#14)(2009-10#8)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#5)(2009-7#2)(2009-8#8)(2009-9#5)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#6)
intermediate-##2##1##(2007-8#1)(2008-3#1)
intermediate-like properties##2##2##(1993-8#2)
intermediate-scale##2##1##(2008-6#2)
intermediate-term##4##1##(1992-1#2)(1996-4#1)(2007-8#1)
intermediately##2##1##(2008-10#1)(2011-2#1)
intermediates and##3##2##(1991-5#1)(1991-6#1)(1996-5#1)
intermediates are##3##2##(1991-9#1)(2009-9#2)
intermediates by##4##2##(1991-9#1)(1994-9#1)(1997-2#1)(1997-7#1)
intermediates from##2##2##(2008-4#1)(2008-9#1)
intermediates in oxidative hair dyes##2##5##(2008-10#2)
intermediates in the##8##3##(1990-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(2008-10#2)(2008-5#1)(2009-9#1)
intermediates in##17##2##(1990-11#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-4#1)(2008-10#4)(2008-5#1)(2009-9#1)
intermediates of the##3##3##(1992-6#2)(1994-11#1)
intermediates of##10##2##(1990-5#1)(1992-3#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-4#1)
intermediates or##2##2##(1995-3#1)(2008-4#1)
intermediates that would##2##3##(1995-8#1)(2009-2#1)
intermediates that##4##2##(1992-11#1)(1993-8#1)(1995-8#1)(2009-2#1)
intermediates to the##2##3##(1997-4#1)(2008-10#1)
intermediates were##2##2##(1990-8#1)(1994-9#1)
intermediates##116##1##(1990-11#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#2)(1992-3#3)(1992-6#3)(1993-11#3)(1993-8#1)(1994-11#3)(1994-12#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#6)(1996-6#2)(1997-1#3)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#2)(2007-11#3)(2007-12#1)(2008-10#13)(2008-11#2)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#4)(2010-7#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
intermediates)##4##1##(1996-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
intermediolateral##3##1##(1991-7#1)(1993-12#1)(1995-12#1)
intermedium chromosome##2##2##(2008-10#1)(2008-5#1)
intermedium in##2##2##(2008-8#1)(2008-9#1)
intermedium plants##2##2##(2008-10#2)
intermedium translocation##2##2##(2008-10#1)(2008-8#1)
intermedium was##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
intermedium##21##1##(2008-10#8)(2008-5#4)(2008-8#4)(2008-9#5)
intermedium-derived resistance##2##2##(2008-10#2)
intermembrane space##2##2##(1993-2#1)(2009-6#1)
intermembrane transfer##3##2##(1992-3#1)(1992-6#2)
intermembrane##9##1##(1992-3#1)(1992-6#2)(1993-2#1)(1994-12#1)(1995-12#1)(2008-10#1)(2009-6#1)(2013-8#1)
intermetatarsal angle##2##2##(2009-10#1)(2012-2#1)
intermetatarsal##3##1##(2009-10#1)(2012-2#2)
intermingled with##3##2##(1991-4#1)(1995-12#1)(1996-8#1)
intermingled##6##1##(1991-4#1)(1995-12#1)(1996-8#1)(2007-8#1)(2008-8#1)(2013-8#1)
intermingling##3##1##(2008-10#1)(2008-2#1)(2010-8#1)
intermittency##3##1##(1993-5#1)(2007-12#2)
intermittent agitation##2##2##(2008-11#2)
intermittent asthma##2##2##(1996-7#1)(2013-1#1)
intermittent claudication##6##2##(1995-2#3)(1997-3#2)(2008-8#1)
intermittent clean##2##2##(2008-7#2)
intermittent dynamics##2##2##(2008-3#2)
intermittent exercise##4##2##(2013-8#4)
intermittent fever##4##2##(2011-2#2)(2012-2#1)(2012-3#1)
intermittent flow##2##2##(2011-2#2)
intermittent high glucose##2##3##(2012-4#2)
intermittent high##3##2##(1992-4#1)(2012-4#2)
intermittent morphine##2##2##(1995-12#2)
intermittent ozone theraphy in##2##4##(2007-8#2)
intermittent ozone##3##2##(2007-8#3)
intermittent##93##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-4#3)(1993-11#1)(1993-2#2)(1993-9#3)(1994-2#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-7#1)(2006-10#1)(2007-12#2)(2007-8#4)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#8)(2012-2#3)(2012-3#1)(2012-4#2)(2013-1#1)(2013-8#5)
intermittently##10##1##(1991-12#2)(1993-11#1)(1994-9#1)(1995-9#2)(2008-11#2)(2008-5#1)(2009-9#1)
intermixed with##2##2##(2008-9#1)(2013-7#1)
intermixed##3##1##(2008-9#1)(2009-1#1)(2013-7#1)
intermolecular forces##2##2##(1992-5#1)(1992-6#1)
intermolecular hydrogen bonding and##2##4##(2008-10#1)(2008-5#1)
intermolecular hydrogen bonding##6##3##(1993-8#1)(2008-10#2)(2008-5#2)(2012-2#1)
intermolecular hydrogen bonds##3##3##(2008-10#2)(2008-11#1)
intermolecular hydrogen##10##2##(1993-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2012-2#1)
intermolecular interaction##2##2##(1996-5#1)(2007-12#1)
intermolecular interactions##10##2##(1992-4#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)
intermolecular recombination##2##2##(1995-8#1)(2008-10#1)
intermolecular##49##1##(1991-5#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#16)(2008-11#1)(2008-4#3)(2008-5#4)(2008-8#1)(2008-9#2)(2009-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
intermoult##2##1##(1995-8#2)
intern##3##1##(1992-2#2)(1993-3#1)
interna##4##1##(1995-12#2)(1995-8#1)(2007-8#1)
internal Ca2+ stores##2##3##(1991-12#1)(1992-11#1)
internal Ca2+##3##2##(1990-7#1)(1991-12#1)(1992-11#1)
internal amplification control##2##3##(2008-10#2)
internal and external factors##2##4##(1996-1#1)(2009-10#1)
internal and external imagery##2##4##(1992-12#2)
internal and external##29##3##(1990-2#1)(1991-5#1)(1992-12#3)(1993-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-8#1)(2012-2#2)(2012-3#1)
internal and##35##2##(1990-2#1)(1991-5#1)(1992-12#3)(1993-2#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-8#1)(2012-2#2)(2012-3#1)
internal as well as external##3##5##(1995-1#1)(2008-10#1)(2008-12#1)
internal audit##5##2##(1996-12#1)(1996-2#1)(2007-9#2)(2012-2#1)
internal auditory canal##6##3##(2006-12#2)(2008-7#2)(2008-9#2)
internal auditory##7##2##(2006-12#2)(2008-7#2)(2008-9#3)
internal audits##4##2##(2012-2#3)(2012-3#1)
internal boll damage##2##3##(2011-2#2)
internal buffer##2##2##(2008-10#2)
internal calcium##2##2##(1994-11#2)
internal calibration##2##2##(2008-10#2)
internal capsule##6##2##(1996-12#1)(1996-5#3)(2008-7#2)
internal carotid arteries were##2##4##(2006-12#1)(2008-7#1)
internal carotid arteries##4##3##(1991-5#1)(2006-12#1)(2008-7#2)
internal carotid artery (ICA)##6##4##(2006-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
internal carotid artery disease##3##4##(2008-7#1)(2008-8#2)
internal carotid artery dissection##3##4##(2011-2#3)
internal carotid artery in##5##4##(1995-12#1)(2007-10#1)(2008-3#1)(2008-7#2)
internal carotid artery occlusion by atherosclerosis and by cervical dissection##2##10##(2007-10#2)
internal carotid artery stenosis##3##4##(2008-7#1)(2008-8#1)(2013-1#1)
internal carotid artery##40##3##(1995-12#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#13)(2008-8#3)(2010-3#1)(2011-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
internal carotid occlusion##5##3##(1996-6#1)(2007-10#3)(2008-7#1)
internal carotid##55##2##(1991-5#1)(1995-12#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-6#1)(2006-12#2)(2007-10#6)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#17)(2008-8#3)(2010-3#1)(2011-2#6)(2011-3#3)(2012-3#4)(2013-1#2)(2013-8#1)
internal coding exons##2##3##(2008-9#2)
internal combustion##3##2##(2008-2#2)(2008-3#1)
internal communication##2##2##(2008-12#2)
internal compartment##2##2##(2008-7#2)
internal compartments##2##2##(1994-11#1)(2010-4#1)
internal concentration##2##2##(2008-3#1)(2008-7#1)
internal consistency and##6##3##(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#2)
internal consistency for the##2##4##(1996-3#2)
internal consistency of##2##3##(1996-3#1)(2012-12#1)
internal consistency reliability##2##3##(2007-12#1)(2013-1#1)
internal consistency##24##2##(1996-3#3)(1996-7#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-11#1)(2010-7#1)(2011-1#1)(2012-12#3)(2013-1#5)(2013-8#1)
internal contact##3##2##(2008-10#3)
internal contradictions##2##2##(2008-12#1)(2008-8#1)
internal control##8##2##(1996-12#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-8#1)
internal conversion efficiency of##2##4##(2007-11#1)(2007-12#1)
internal conversion efficiency##3##3##(2007-11#1)(2007-12#2)
internal conversion##7##2##(2007-1#2)(2007-11#1)(2007-12#2)(2010-2#2)
internal damage was##2##3##(2011-2#2)
internal damage##6##2##(2011-2#6)
internal defects##3##2##(1996-12#1)(2007-11#2)
internal deletions##4##2##(1993-9#1)(1995-6#1)(1997-4#1)(2011-2#1)
internal diameter of##3##3##(2008-10#2)(2013-1#1)
internal diameter##8##2##(2007-8#2)(2007-9#1)(2008-10#4)(2013-1#1)
internal disease##2##2##(2007-7#1)(2008-10#1)
internal distraction##2##2##(2011-2#2)
internal features##2##2##(2007-12#1)(2008-1#1)
internal field intensity##2##3##(2008-3#2)
internal field##8##2##(2007-11#1)(2008-2#5)(2008-3#2)
internal fixation and##4##3##(1991-6#1)(2008-8#1)(2010-5#1)(2012-2#1)
internal fixation of##5##3##(2008-12#1)(2008-9#1)(2010-12#1)(2010-3#1)(2013-1#1)
internal fixation techniques##2##3##(2008-12#1)(2010-12#1)
internal fixation##25##2##(1991-6#1)(2006-10#1)(2007-12#1)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2010-12#3)(2010-3#2)(2010-5#1)(2012-2#4)(2013-1#2)
internal flow##3##2##(2008-5#3)
internal focus##2##2##(2007-12#1)(2013-1#1)
internal furnace gas##3##3##(2008-10#3)
internal iliac artery##2##3##(2008-12#2)
internal iliac##4##2##(2008-12#2)(2008-7#2)
internal imagery##5##2##(1992-12#5)
internal intensity##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
internal jugular and subclavian vein rupture##2##6##(2008-12#2)
internal jugular and##3##3##(2008-12#2)(2012-3#1)
internal jugular vein##7##3##(1992-12#2)(2008-1#1)(2011-2#1)(2012-3#3)
internal jugular##14##2##(1992-12#3)(2008-1#2)(2008-12#2)(2011-2#1)(2012-3#6)
internal light##3##2##(2008-10#1)(2008-3#2)
internal loop##2##2##(1991-8#2)
internal loops##3##2##(1991-8#3)
internal lumen##2##2##(2007-12#2)
internal malignancy##2##2##(2007-7#1)(2008-8#1)
internal mammary artery (IMA) harvesting##2##5##(2007-8#2)
internal mammary artery##9##3##(1993-8#2)(2007-8#6)(2011-2#1)
internal mammary##15##2##(1993-8#2)(1994-12#1)(2007-10#1)(2007-7#2)(2007-8#7)(2011-2#1)(2013-1#1)
internal marketing##4##2##(2008-12#4)
internal matrix##2##2##(2012-12#2)
internal medical##2##2##(1992-12#1)(2012-3#1)
internal medicine and##3##3##(1994-12#1)(2008-9#1)(2009-12#1)
internal medicine##11##2##(1992-5#2)(1993-6#1)(1994-12#1)(1996-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)
internal membranes##5##2##(1990-5#5)
internal migration##2##2##(1992-8#2)
internal milieu##3##2##(1990-2#1)(2011-1#1)(2013-8#1)
internal modulation##3##2##(2008-1#3)
internal morphology##3##2##(2007-12#1)(2008-5#1)(2013-7#1)
internal motions##2##2##(1993-11#1)(1995-2#1)
internal necrosis than##2##3##(2008-10#2)
internal necrosis##4##2##(2008-10#4)
internal operations##2##2##(1993-3#1)(1996-3#1)
internal or external calcium##4##4##(1990-2#4)
internal or external##7##3##(1990-2#4)(2008-7#1)(2009-10#1)(2010-5#1)
internal organ##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
internal organs##8##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-3#3)
internal osteosynthesis and bone cement application##2##6##(2007-11#2)
internal osteosynthesis only##2##3##(2007-11#2)
internal osteosynthesis##4##2##(2007-11#4)
internal phase##3##2##(2008-3#1)(2008-5#1)(2010-5#1)
internal population sizes##2##3##(2008-10#2)
internal population##3##2##(2008-10#2)(2009-7#1)
internal positions##2##2##(1995-12#1)(2008-4#1)
internal postural##2##2##(2013-1#2)
internal quality##5##2##(1994-3#1)(1996-12#1)(2007-7#1)(2008-9#1)(2011-2#1)
internal reference##3##2##(2008-10#3)
internal reflection fluorescence microscopy##2##4##(2008-1#2)
internal reflection in the##2##4##(2007-12#1)(2008-3#1)
internal reflection in##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
internal reflection##38##2##(2007-11#4)(2007-12#7)(2008-1#2)(2008-10#3)(2008-2#9)(2008-3#13)
internal reflections within the##2##4##(2007-12#1)(2008-3#1)
internal reflections##9##2##(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#2)
internal regions##2##2##(2010-4#1)(2013-1#1)
internal ribosomal entry site##2##4##(1993-6#1)(2008-9#1)
internal ribosomal entry sites##2##4##(2008-11#1)(2008-9#1)
internal ribosomal entry##4##3##(1993-6#1)(2008-11#1)(2008-9#2)
internal ribosome entry site (IRES)##2##5##(1997-8#1)(2008-10#1)
internal ribosome entry site##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
internal root##2##2##(2008-10#1)(2013-1#1)
internal rotation of the##3##4##(1997-7#1)(2007-8#1)(2009-3#1)
internal rotation##5##2##(1997-7#1)(2007-8#1)(2009-3#3)
internal rotational##2##2##(2007-12#2)
internal sequence of##2##3##(2008-10#2)
internal sequence##5##2##(1994-8#1)(1995-8#1)(2008-10#2)(2012-3#1)
internal site##2##2##(1995-5#1)(2008-4#1)
internal solution##3##2##(1995-12#1)(2008-10#2)
internal spermatic##2##2##(1990-9#2)
internal stakeholder##2##2##(1996-12#2)
internal standard (IS)##5##3##(2008-10#5)
internal standard and##5##3##(2008-10#4)(2011-3#1)
internal standard for the##3##4##(2008-10#2)(2008-12#1)
internal standard for##5##3##(2008-10#4)(2008-12#1)
internal standard in##2##3##(2008-1#1)(2008-10#1)
internal standard method##6##3##(1993-3#1)(2008-10#5)
internal standard to##6##3##(2008-1#1)(2008-10#5)
internal standard was used##2##4##(1992-12#1)(2008-10#1)
internal standard was##6##3##(1992-12#1)(2008-10#5)
internal standard were##4##3##(1992-8#1)(1996-5#1)(2008-10#2)
internal standard##101##2##(1992-12#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-9#1)(1995-12#1)(1996-5#2)(1997-2#1)(2008-1#3)(2008-10#72)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
internal standard)##4##2##(1995-2#1)(1996-5#1)(2008-10#2)
internal standardization for##2##3##(2008-10#2)
internal standardization##6##2##(2008-10#6)
internal standards and##2##3##(2008-10#2)
internal standards##15##2##(1990-8#3)(1991-5#1)(1997-2#1)(2008-10#7)(2008-9#2)(2011-1#1)
internal state##3##2##(1993-12#1)(2007-12#1)(2012-12#1)
internal states##2##2##(1993-12#1)(2007-12#1)
internal stores##2##2##(2007-11#1)(2009-3#1)
internal structure of the##5##4##(1991-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
internal structure of##6##3##(1991-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#1)
internal structure##13##2##(1991-2#1)(2007-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
internal structures##4##2##(1994-11#1)(1995-6#1)(2008-12#1)(2010-8#1)
internal surface reversed-phase high-performance liquid chromatography##2##6##(1991-5#2)
internal surface reversed-phase##4##3##(1991-5#4)
internal surface##6##2##(1991-5#4)(2008-6#1)(2008-8#1)
internal symptoms of##2##3##(2008-10#1)(2011-2#1)
internal tandem##2##2##(2008-5#1)(2010-4#1)
internal thoracic artery with##2##4##(2007-8#2)
internal thoracic artery##9##3##(2007-8#8)(2011-2#1)
internal thoracic##10##2##(2007-8#8)(2010-8#1)(2011-2#1)
internal three-dimensional##2##2##(2008-3#2)
internal to the##2##3##(2008-10#1)(2008-2#1)
internal to##4##2##(1990-5#1)(1996-3#1)(2008-10#1)(2008-2#1)
internal transcribed spacer (ITS) 2##2##5##(2008-10#2)
internal transcribed spacer (ITS) of##2##5##(2008-10#2)
internal transcribed spacer (ITS) region of the ribosomal##3##8##(2008-10#2)(2008-5#1)
internal transcribed spacer (ITS) region of the##4##7##(2008-10#3)(2008-5#1)
internal transcribed spacer (ITS) region of##8##6##(2008-10#7)(2008-5#1)
internal transcribed spacer (ITS) region##16##5##(2008-10#15)(2008-5#1)
internal transcribed spacer (ITS) regions of##4##6##(2008-10#4)
internal transcribed spacer (ITS) regions##7##5##(2008-10#7)
internal transcribed spacer (ITS) sequence data##2##6##(2008-10#2)
internal transcribed spacer (ITS) sequence##4##5##(2008-10#4)
internal transcribed spacer (ITS) sequences##2##5##(2008-10#1)(2008-9#1)
internal transcribed spacer (ITS)##38##4##(2008-10#35)(2008-5#1)(2008-9#1)(2010-10#1)
internal transcribed spacer 1 (ITS1) region##2##6##(2008-10#2)
internal transcribed spacer 1 (ITS1)##3##5##(2008-10#3)
internal transcribed spacer 1##7##4##(2008-10#7)
internal transcribed spacer region and##2##5##(2008-10#2)
internal transcribed spacer region##14##4##(2008-10#13)(2008-9#1)
internal transcribed spacer regions of##3##5##(2008-10#3)
internal transcribed spacer regions##4##4##(2008-10#4)
internal transcribed spacer##78##3##(2008-10#72)(2008-12#1)(2008-5#1)(2008-9#2)(2010-10#2)
internal transcribed spacers##3##3##(2008-10#2)(2008-8#1)
internal transcribed##83##2##(2008-10#75)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-10#2)
internal validity of##2##3##(1991-1#1)(1995-12#1)
internal validity##4##2##(1991-1#1)(1995-12#1)(2008-11#1)(2010-10#1)
internal vertebral venous plexus##4##4##(2011-2#4)
internal volume of the##2##4##(2008-10#1)(2009-6#1)
internal volume##3##2##(2008-10#2)(2009-6#1)
internal wall##2##2##(2007-11#1)(2008-10#1)
internal##1019##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#5)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#9)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#16)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#5)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#7)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#7)(1995-2#3)(1995-3#4)(1995-5#6)(1995-6#6)(1995-8#3)(1996-1#3)(1996-12#10)(1996-2#8)(1996-3#8)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#1)(2006-10#1)(2006-12#4)(2007-1#2)(2007-10#8)(2007-11#25)(2007-12#37)(2007-4#1)(2007-7#6)(2007-8#22)(2007-9#5)(2008-1#18)(2008-10#243)(2008-11#14)(2008-12#28)(2008-2#35)(2008-3#41)(2008-4#6)(2008-5#16)(2008-6#6)(2008-7#35)(2008-8#16)(2008-9#25)(2009-10#7)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#6)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#42)(2011-3#4)(2012-12#7)(2012-2#12)(2012-3#23)(2013-1#24)(2013-7#3)(2013-8#10)
internal-reflection element##2##2##(2008-2#2)
internal-reflection##3##1##(2008-2#2)(2008-3#1)
internalisation and degradation##2##3##(1993-3#2)
internalisation and##3##2##(1993-3#3)
internalisation is##2##2##(1990-11#1)(2009-8#1)
internalisation of##2##2##(1993-3#1)(1994-6#1)
internalisation##7##1##(1990-11#1)(1993-3#4)(1994-6#1)(2009-8#1)
internalization and##4##2##(1994-6#1)(1995-11#2)(2007-12#1)
internalization in##2##2##(1997-1#1)(2013-1#1)
internalization into##2##2##(1991-2#1)(2008-11#1)
internalization levels##2##2##(2007-12#1)(2009-5#1)
internalization of angiotensin II##2##4##(1994-8#2)
internalization of sociocultural attitudes##3##4##(2007-12#3)
internalization of the##3##3##(1994-11#1)(2007-12#1)(2011-2#1)
internalization of this##2##3##(1990-11#1)(2008-11#1)
internalization of##22##2##(1990-11#1)(1993-5#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-2#1)(1997-1#2)(2007-12#6)(2008-11#3)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
internalization process##2##2##(1994-8#1)(1995-11#1)
internalization sequence##2##2##(1990-11#2)
internalization sequences##2##2##(1990-11#2)
internalization##60##1##(1990-11#10)(1991-2#1)(1991-9#1)(1993-5#1)(1994-11#1)(1994-6#2)(1994-8#5)(1995-11#4)(1995-2#2)(1995-6#2)(1996-2#1)(1997-1#3)(2007-12#8)(2008-11#4)(2008-5#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
internalize and##2##2##(1991-12#1)(1995-8#1)
internalize##5##1##(1991-12#1)(1991-9#1)(1992-12#1)(1995-6#1)(1995-8#1)
internalized and##3##2##(1991-12#1)(1994-6#1)(2011-1#1)
internalized by##6##2##(1994-8#1)(1995-8#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#1)
internalized in##2##2##(1993-6#1)(1994-8#1)
internalized into##2##2##(1995-6#1)(1997-7#1)
internalized stigma##3##2##(2011-1#3)
internalized##30##1##(1990-11#1)(1991-12#2)(1992-5#1)(1993-6#1)(1994-6#2)(1994-8#4)(1995-11#1)(1995-6#2)(1995-8#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-8#3)(2011-1#5)(2011-2#1)
internalizing and externalizing##7##3##(1995-2#1)(2008-12#1)(2012-12#4)(2013-1#1)
internalizing or externalizing behavior##2##4##(2008-12#2)
internalizing problems##2##2##(2008-2#2)
internalizing##21##1##(1992-3#1)(1995-2#2)(2008-12#3)(2008-2#2)(2008-9#1)(2009-7#2)(2009-9#2)(2012-12#7)(2013-1#1)
internally and##2##2##(2008-10#1)(2008-11#1)
internally coherent##3##2##(2008-3#1)(2013-8#2)
internally deleted##2##2##(1991-5#1)(2008-10#1)
internally displaced##2##2##(2008-7#1)(2013-1#1)
internally generated##2##2##(1994-8#1)(2013-1#1)
internally infested##2##2##(2008-10#2)
internally reflected rays##2##3##(2008-2#2)
internally stored##2##2##(1994-8#2)
internally transcribed spacer##2##3##(2008-10#2)
internally with##2##2##(2008-10#2)
internally##34##1##(1990-11#1)(1991-12#1)(1991-5#1)(1994-8#3)(1995-2#1)(1996-1#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2013-1#2)(2013-8#2)
international agencies##2##2##(2012-12#2)
international aid##2##2##(1997-7#1)(2008-10#1)
international alliances##2##2##(2008-10#2)
international and##4##2##(1997-7#1)(2008-12#1)(2012-3#1)(2013-1#1)
international classification##2##2##(1991-9#1)(2011-2#1)
international collaboration##6##2##(1993-2#1)(2007-7#2)(2008-10#1)(2010-1#1)(2012-12#1)
international collaborative##2##2##(2011-2#1)(2012-3#1)
international comparison##4##2##(1990-6#1)(1993-2#2)(2012-12#1)
international comparisons##2##2##(1993-2#1)(2009-7#1)
international conference##4##2##(1994-8#1)(1995-9#1)(2008-10#1)(2008-12#1)
international congress on##2##3##(2006-10#1)(2011-2#1)
international cooperation##3##2##(2007-8#1)(2008-8#1)(2010-4#1)
international data##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
international databases##2##2##(2011-4#1)(2012-12#1)
international development##4##2##(1991-5#1)(2008-11#2)(2010-9#1)
international differential groups##2##3##(2008-10#2)
international experience##2##2##(1992-4#1)(2011-2#1)
international experts##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
international group##2##2##(2009-12#1)(2011-10#1)
international guidelines##4##2##(1997-7#1)(2009-1#1)(2011-2#1)(2012-3#1)
international health care##2##3##(1996-2#1)(2008-12#1)
international health##6##2##(1996-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-1#1)
international infant mortality##2##3##(1993-2#2)
international journals##3##2##(1993-6#1)(1994-12#1)(1997-3#1)
international law##2##2##(1996-11#1)(2008-1#1)
international level##7##2##(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
international levels##2##2##(2010-4#1)(2011-2#1)
international literature##11##2##(1991-11#1)(1992-10#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
international medical##3##2##(1991-8#1)(2009-7#1)(2010-2#1)
international meeting##2##2##(2008-5#1)(2010-5#1)
international migration##3##2##(2010-5#1)(2011-2#2)
international multicenter##2##2##(2008-7#1)(2008-8#1)
international multicentre##2##2##(2008-10#1)(2008-8#1)
international normalized ratio##4##3##(2007-10#3)(2011-1#1)
international organizations##2##2##(1994-12#1)(2013-1#1)
international project##5##2##(1991-9#1)(1995-12#1)(1997-7#1)(2008-4#1)(2010-3#1)
international public health##2##3##(1993-12#1)(2010-3#1)
international public##3##2##(1993-12#1)(2008-10#1)(2010-3#1)
international reach##2##2##(2011-2#1)(2012-2#1)
international recommendations##3##2##(2008-1#1)(2009-4#1)(2013-1#1)
international reference##2##2##(1991-12#1)(2008-10#1)
international regulatory##2##2##(2008-10#1)(2008-11#1)
international research##3##2##(2006-10#1)(2009-6#2)
international scientific societies##3##3##(2007-8#2)(2008-10#1)
international scientific##4##2##(2007-8#2)(2008-10#1)(2008-12#1)
international security##2##2##(1992-12#2)
international standard##5##2##(1993-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
international standards##7##2##(1996-8#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-7#1)(2011-1#1)(2013-8#1)
international student##2##2##(1993-1#1)(2010-3#1)
international study##2##2##(1995-1#1)(2010-3#1)
international survey##3##2##(1997-8#1)(2008-10#1)(2011-10#1)
international travel##4##2##(2007-12#2)(2007-2#1)(2010-3#1)
international travellers##3##2##(1995-8#1)(2007-2#2)
international validation of##2##3##(2008-10#1)(2008-11#1)
international validation##3##2##(2008-10#2)(2008-11#1)
international workshop##2##2##(1993-1#1)(2012-2#1)
international##342##1##(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#2)(1992-4#1)(1992-5#2)(1993-1#3)(1993-12#1)(1993-2#9)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#3)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#8)(2007-5#1)(2007-7#2)(2007-8#7)(2008-1#7)(2008-10#44)(2008-11#25)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#8)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#4)(2010-8#3)(2010-9#5)(2011-1#4)(2011-10#2)(2011-2#24)(2011-3#1)(2011-4#1)(2012-1#1)(2012-12#12)(2012-2#6)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#6)
internationalisation of the nursing curriculum##2##5##(2008-12#2)
internationalisation##4##1##(2008-11#2)(2008-12#2)
internationalism and##2##2##(1992-5#1)(2010-1#1)
internationalism##3##1##(1992-5#2)(2010-1#1)
internationally accepted##2##2##(1993-8#1)(1995-6#1)
internationally and in##2##3##(1990-12#1)(1993-3#1)
internationally and##3##2##(1990-12#1)(1993-3#1)(2012-3#1)
internationally as##2##2##(2012-1#1)(2012-12#1)
internationally##29##1##(1990-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#2)(2008-10#3)(2008-11#2)(2008-12#6)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
interned##2##1##(1993-3#2)
internet obesity prevention programs##2##4##(2013-1#2)
internet use##2##2##(2009-7#1)(2013-8#1)
internet##30##1##(1994-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
internet-based##7##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-8#1)
interneuron subtypes##2##2##(2012-2#2)
interneuron##3##1##(2012-2#3)
interneuronal##2##1##(1990-5#1)(2009-9#1)
interneurons and##3##2##(1997-3#3)
interneurons are##5##2##(1990-5#1)(2008-1#1)(2008-7#1)(2012-2#2)
interneurons in##3##2##(1990-5#2)(1993-12#1)
interneurons may##2##2##(1995-12#1)(1995-2#1)
interneurons##36##1##(1990-5#3)(1993-12#2)(1994-2#1)(1995-12#1)(1995-2#2)(1997-3#7)(2007-12#4)(2008-1#2)(2008-11#2)(2008-7#2)(2009-8#1)(2012-2#7)(2013-8#2)
internist##3##1##(1993-12#1)(1996-11#1)(2013-7#1)
internists##5##1##(1992-5#1)(1993-12#1)(1995-11#1)(1995-3#1)(2008-1#1)
internode##3##1##(2008-10#1)(2008-8#1)(2012-5#1)
internodes in all##2##3##(2011-2#2)
internodes##10##1##(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#4)
interns in##2##2##(1995-2#1)(1995-6#1)
interns##10##1##(1992-11#1)(1992-2#1)(1995-2#4)(1995-6#2)(1997-5#1)(2010-2#1)
internship appointments in##2##3##(1992-2#2)
internship##20##1##(1992-2#5)(1993-3#4)(1994-12#2)(1995-6#6)(1996-1#1)(2008-5#1)(2011-2#1)
internships##2##1##(1997-3#1)(2008-5#1)
internuclear##2##1##(2008-7#1)(2009-9#1)
internucleosomal DNA degradation##2##3##(1991-12#1)(1994-10#1)
internucleosomal DNA fragmentation##4##3##(1993-3#1)(1993-8#1)(1995-12#1)(2008-8#1)
internucleosomal DNA##7##2##(1991-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1995-12#1)(1995-8#1)(2008-8#1)
internucleosomal##8##1##(1991-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-10#1)(1995-12#1)(1995-8#1)(2008-8#1)
internucleotide linkages##2##2##(2008-4#2)
internucleotide##3##1##(2008-4#3)
interobserver difference##2##2##(2008-8#1)(2012-12#1)
interobserver reproducibility##3##2##(1997-8#3)
interobserver variability in##2##3##(2009-11#2)
interobserver variability##7##2##(1991-12#1)(2008-3#1)(2008-8#1)(2009-11#2)(2009-2#2)
interobserver##18##1##(1991-12#1)(1997-8#4)(2008-3#1)(2008-7#4)(2008-8#3)(2009-11#2)(2009-2#2)(2012-12#1)
interoceptive##2##1##(1992-10#1)(2013-8#1)
interoperability##2##1##(2008-7#1)(2010-8#1)
interorganizational##2##1##(1992-1#1)(1992-12#1)
interosseous##8##1##(1990-6#1)(1991-6#1)(2008-9#5)(2012-3#1)
interosseus##2##1##(2008-9#1)(2012-1#1)
interpage##2##1##(2008-2#1)(2008-3#1)
interparental conflict##6##2##(2010-1#6)
interpartner conflict##5##2##(2009-9#5)
interpatient##2##1##(2008-7#1)(2008-8#1)
interpenetrating##3##1##(2008-8#1)(2009-12#1)(2012-2#1)
interpenetration##2##1##(2008-3#1)(2010-4#1)
interpersonal (e##2##2##(2008-12#1)(2009-4#1)
interpersonal and##5##2##(1992-2#1)(1993-2#1)(1997-7#1)(2008-11#1)(2008-9#1)
interpersonal communication and##3##3##(1994-2#1)(2008-11#1)(2009-3#1)
interpersonal communication##6##2##(1994-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-3#2)
interpersonal conflict##2##2##(2007-1#1)(2008-9#1)
interpersonal difficulties##2##2##(2008-11#2)
interpersonal distance##2##2##(1996-1#2)
interpersonal problems##3##2##(1996-8#1)(2010-7#1)(2011-2#1)
interpersonal relations##2##2##(1990-12#1)(2010-10#1)
interpersonal relationship##3##2##(2008-1#1)(2008-4#1)(2012-3#1)
interpersonal relationships##3##2##(1993-12#1)(2012-12#1)(2012-3#1)
interpersonal skills##3##2##(1996-2#1)(2008-11#2)
interpersonal##64##1##(1990-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-3#1)(1996-1#3)(1996-2#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-11#8)(2008-12#4)(2008-4#2)(2008-9#6)(2009-11#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-3#6)(2013-1#2)
interpersonal/collaborative##2##1##(2008-1#2)
interphalangeal joint##5##2##(2008-9#4)(2010-11#1)
interphalangeal motion##2##2##(2008-9#2)
interphalangeal##12##1##(2008-9#9)(2010-11#1)(2011-2#1)(2012-3#1)
interphase FISH##2##2##(1997-3#2)
interphase cells##4##2##(1990-3#1)(1992-6#2)(2011-2#1)
interphase nuclei##6##2##(1990-3#1)(2008-4#4)(2008-9#1)
interphase##33##1##(1990-11#2)(1990-2#1)(1990-3#4)(1992-6#2)(1997-3#3)(2008-3#2)(2008-4#6)(2008-9#3)(2009-3#1)(2009-6#5)(2009-8#1)(2011-2#3)
interphotoreceptor retinoid-binding protein##2##3##(1994-9#2)
interphotoreceptor##3##1##(1994-9#2)(2010-4#1)
interpixel##2##1##(2007-11#1)(2008-3#1)
interplay among genetic##2##3##(2008-10#1)(2009-3#1)
interplay among##4##2##(2008-10#1)(2009-3#1)(2010-7#1)(2012-12#1)
interplay between genetic##2##3##(2008-1#1)(2008-6#1)
interplay between the##6##3##(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-12#1)
interplay between##40##2##(1995-5#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)
interplay in##3##2##(1995-8#1)(2008-8#1)(2012-3#1)
interplay of##12##2##(1990-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
interplay##65##1##(1990-11#1)(1995-5#1)(1995-8#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-7#2)
interploidy crosses##2##2##(2009-12#2)
interpolated total number of##2##4##(2008-10#2)
interpolated##8##1##(1992-11#1)(2008-10#4)(2008-5#2)(2008-8#1)
interpolation and##3##2##(2007-5#1)(2008-8#1)(2009-5#1)
interpolation for##2##2##(2008-3#2)
interpolation functions##3##2##(2007-10#3)
interpolation is##3##2##(2007-11#1)(2008-3#2)
interpolation method##2##2##(2008-11#1)(2008-3#1)
interpolation of the##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
interpolation of##5##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
interpolation##34##1##(2007-10#3)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-7#1)(2012-2#3)
interpopulation##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
interposed between##2##2##(2007-12#1)(2011-2#1)
interposed##6##1##(1990-3#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
interposition and##2##2##(2008-1#1)(2009-10#1)
interposition arthroplasty##5##2##(2008-9#2)(2010-11#1)(2011-2#2)
interposition material##3##2##(2007-8#2)(2011-2#1)
interposition of##2##2##(2008-10#1)(2011-3#1)
interposition##19##1##(2007-8#3)(2008-1#3)(2008-10#1)(2008-9#5)(2009-10#1)(2010-11#1)(2011-2#3)(2011-3#1)(2013-8#1)
interpositional##3##1##(2007-12#1)(2010-11#2)
interpower power cords##2##3##(2011-2#2)
interpractice variation in repeat prescribing##3##5##(2008-11#3)
interpractice variation##4##2##(2008-11#4)
interpractice##5##1##(1993-12#1)(2008-11#4)
interpret and##5##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
interpret as##2##2##(2007-12#1)(2012-3#1)
interpret results##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
interpret the##23##2##(1995-3#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-9#5)(2009-10#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
interpret these results##2##3##(1993-8#1)(2008-3#1)
interpret this##2##2##(1993-12#1)(2008-3#1)
interpret##76##1##(1991-11#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#7)(2009-1#1)(2009-10#2)(2009-7#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)
interpretability##4##1##(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
interpretable##9##1##(1991-3#1)(1992-12#1)(2008-10#1)(2008-7#1)(2009-8#2)(2010-6#1)(2012-1#1)(2013-1#1)
interpretation and limitations##2##3##(2008-10#1)(2009-11#1)
interpretation and##13##2##(1993-12#2)(1993-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
interpretation are##2##2##(1995-6#1)(2008-9#1)
interpretation by##3##2##(1993-3#1)(1994-6#1)(2008-9#1)
interpretation due to##2##3##(2008-4#1)(2013-1#1)
interpretation for##4##2##(2007-2#1)(2008-12#1)(2008-2#1)(2009-8#1)
interpretation in##6##2##(1991-1#1)(1992-12#2)(1997-8#1)(2007-12#1)(2008-10#1)
interpretation is##5##2##(1997-7#1)(2007-11#1)(2008-10#2)(2013-1#1)
interpretation of both##2##3##(2008-10#1)(2008-3#1)
interpretation of data##2##3##(2008-7#1)(2011-2#1)
interpretation of laboratory##2##3##(1994-12#1)(2008-10#1)
interpretation of postmortem carboxyhemoglobin##2##4##(1996-12#2)
interpretation of radiological##3##3##(2007-11#2)(2013-1#1)
interpretation of results from##3##4##(1995-3#1)(1997-5#1)(2008-1#1)
interpretation of results##8##3##(1995-3#1)(1996-12#1)(1997-5#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2009-8#1)
interpretation of the MS/MS spectrum##2##5##(2008-4#1)(2008-8#1)
interpretation of the data##5##4##(1994-3#1)(1994-5#1)(1995-11#1)(2008-4#1)(2008-5#1)
interpretation of the findings##2##4##(1993-6#1)(2009-10#1)
interpretation of the obtained##3##4##(2007-11#1)(2008-10#2)
interpretation of the results is##2##5##(1991-12#1)(2008-4#1)
interpretation of the results##6##4##(1991-12#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-4#1)
interpretation of the##70##3##(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#3)(1994-5#1)(1995-11#1)(1996-11#1)(2007-10#1)(2007-11#4)(2007-5#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#4)
interpretation of these results##2##4##(1994-5#1)(2008-4#1)
interpretation of##182##2##(1990-9#1)(1991-11#3)(1991-12#3)(1991-5#1)(1991-6#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-12#3)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#11)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#11)(2008-4#9)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-2#1)(2010-8#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#6)
interpretation that##3##2##(1997-6#1)(1997-9#1)(2008-11#1)
interpretation to##4##2##(1995-11#1)(1996-4#2)(2007-12#1)
interpretation was##2##2##(1994-6#1)(1995-11#1)
interpretation##297##1##(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#5)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#3)(1996-4#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2007-10#1)(2007-11#13)(2007-12#3)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#35)(2008-11#8)(2008-12#9)(2008-2#8)(2008-3#14)(2008-4#15)(2008-5#3)(2008-6#6)(2008-7#10)(2008-8#5)(2008-9#10)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#10)(2013-8#3)
interpretations and##2##2##(1994-3#1)(2008-11#1)
interpretations of the##5##3##(1993-1#1)(1993-2#1)(2008-10#2)(2008-11#1)
interpretations of##14##2##(1991-11#1)(1993-1#1)(1993-2#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2012-3#1)
interpretations##28##1##(1991-11#1)(1991-12#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-3#2)(1996-2#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
interpretative##7##1##(1991-12#1)(1993-2#1)(2007-8#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
interpreted and##4##2##(1996-11#1)(1997-2#1)(2008-10#1)(2010-1#1)
interpreted as a##6##3##(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-7#1)
interpreted as an##2##3##(1993-6#1)(2008-3#1)
interpreted as being##2##3##(2008-10#1)(2008-3#1)
interpreted as due to##3##4##(1995-5#2)(2008-2#1)
interpreted as evidence that##3##4##(1991-5#1)(1993-9#1)(2012-3#1)
interpreted as evidence##5##3##(1991-5#1)(1993-9#1)(1994-5#1)(1996-2#1)(2012-3#1)
interpreted as indicating that##2##4##(2007-12#1)(2008-5#1)
interpreted as the##4##3##(1992-8#1)(1995-1#1)(2008-3#1)(2008-7#1)
interpreted as##53##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-5#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
interpreted by the##3##3##(1993-8#1)(1997-6#1)(2008-10#1)
interpreted by##8##2##(1993-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
interpreted from##2##2##(2007-5#1)(2008-8#1)
interpreted in terms of a##7##5##(1990-11#1)(1993-11#2)(1994-11#1)(1994-5#1)(1996-5#1)(2009-10#1)
interpreted in terms of the##4##5##(1993-11#1)(2008-10#2)(2008-2#1)
interpreted in terms of##22##4##(1990-11#1)(1990-7#1)(1991-9#1)(1992-6#1)(1993-11#3)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2009-10#1)
interpreted in the##2##3##(1991-6#1)(2012-3#1)
interpreted in##27##2##(1990-11#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#3)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#1)
interpreted on the basis of##4##5##(1992-6#1)(1994-5#1)(2008-10#1)(2008-5#1)
interpreted to be##4##3##(1992-12#1)(1996-2#1)(2008-10#2)
interpreted to indicate that##2##4##(2008-10#2)
interpreted to indicate##3##3##(2008-10#2)(2009-10#1)
interpreted to mean##3##3##(1996-5#1)(2008-10#2)
interpreted to##13##2##(1990-12#1)(1992-12#1)(1996-2#1)(1996-5#1)(2008-10#6)(2008-3#1)(2009-10#1)(2010-8#1)
interpreted using##4##2##(1995-2#1)(2007-8#1)(2008-7#1)(2010-7#1)
interpreted with caution##4##3##(1994-12#1)(1997-1#1)(2011-1#1)(2011-2#1)
interpreted with##7##2##(1994-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
interpreted##151##1##(1990-11#2)(1990-12#1)(1990-7#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#4)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#8)(2008-5#7)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#1)
interpreter##2##1##(2008-11#1)(2010-8#1)
interpreters to##2##2##(1997-5#1)(2013-8#1)
interpreters##8##1##(1991-12#1)(1997-5#3)(2010-8#1)(2013-8#3)
interpreting and##2##2##(1993-12#1)(2010-11#1)
interpreting research##3##2##(2010-5#1)(2013-1#2)
interpreting results##5##2##(2008-4#2)(2008-8#1)(2011-1#1)(2012-3#1)
interpreting statistical evidence##2##3##(2011-2#2)
interpreting the resulting##2##3##(1995-5#1)(2009-12#1)
interpreting the##15##2##(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-2#2)(2012-3#1)
interpreting this##2##2##(1995-12#1)(2012-3#1)
interpreting##57##1##(1991-2#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#4)
interpretive##6##1##(1993-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-9#1)
interprofessional education##11##2##(2008-11#6)(2008-12#3)(2012-2#1)(2013-1#1)
interprofessional learning##2##2##(2008-11#1)(2008-12#1)
interprofessional workers##2##2##(2008-11#2)
interprofessional##25##1##(2008-11#13)(2008-12#7)(2012-12#1)(2012-2#2)(2013-1#2)
interproton distances##2##2##(1993-11#2)
interproton##4##1##(1992-4#1)(1993-11#2)(1995-5#1)
interpulse##2##1##(2007-12#1)(2008-3#1)
interquartile range 1##2##3##(2013-1#2)
interrater reliability##2##2##(1996-7#2)
interrater##3##1##(1996-7#2)(2009-2#1)
interrelated and##3##2##(1992-2#1)(1995-3#1)(2008-11#1)
interrelated##21##1##(1991-6#1)(1992-12#1)(1992-2#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
interrelation between##3##2##(1993-2#1)(2008-11#1)(2011-1#1)
interrelation##7##1##(1990-5#1)(1993-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#2)
interrelations##3##1##(1993-12#1)(1993-6#1)(2008-3#1)
interrelationship between nutrition and##2##4##(2008-12#2)
interrelationship between the##2##3##(1994-9#1)(1995-2#1)
interrelationship between##6##2##(1994-9#1)(1995-2#1)(2008-12#2)(2011-2#1)(2013-1#1)
interrelationship of##3##2##(1992-12#1)(2007-11#1)(2013-1#1)
interrelationship##14##1##(1992-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-12#2)(2011-2#1)(2013-1#2)
interrelationships among subjective well-being##2##4##(2008-7#2)
interrelationships among##6##2##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)
interrelationships between the##2##3##(1994-1#1)(2013-1#1)
interrelationships between##6##2##(1994-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
interrelationships of##3##2##(2007-7#1)(2008-4#1)(2008-7#1)
interrelationships##17##1##(1994-1#1)(1994-8#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2013-1#1)(2013-8#1)
interrogans##4##1##(1991-8#3)(2008-9#1)
interrogate the##2##2##(2008-11#1)(2011-2#1)
interrogate##8##1##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
interrogated by##3##2##(2007-11#1)(2008-3#2)
interrogated using##2##2##(2008-10#1)(2008-7#1)
interrogated##10##1##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-12#1)(2012-3#1)
interrogating the##2##2##(2009-12#1)(2010-2#1)
interrogating##5##1##(2008-2#1)(2008-3#2)(2009-12#1)(2010-2#1)
interrogation of##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-9#1)
interrogation##20##1##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#6)
interrupt the##2##2##(2011-2#1)(2011-3#1)
interrupt##3##1##(2008-8#1)(2011-2#1)(2011-3#1)
interrupted amperometry##2##2##(2008-10#2)
interrupted anastomoses##2##2##(2007-7#2)
interrupted and##3##2##(2008-8#1)(2010-5#1)(2013-8#1)
interrupted by a##4##3##(1990-8#1)(1995-2#1)(1997-3#1)(2008-10#1)
interrupted by three introns of##2##5##(1993-3#1)(1994-12#1)
interrupted by three introns##4##4##(1993-3#1)(1993-6#1)(1994-12#2)
interrupted by three short introns##2##5##(1997-4#1)(1997-6#1)
interrupted by three##6##3##(1993-3#1)(1993-6#1)(1994-12#2)(1997-4#1)(1997-6#1)
interrupted by two introns##3##4##(1991-9#1)(1993-6#1)(1995-9#1)
interrupted by##26##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#1)
interrupted in##2##2##(1991-3#1)(2012-3#1)
interrupted stitch is##2##3##(1991-2#2)
interrupted stitch##3##2##(1991-2#3)
interrupted suture##2##2##(1992-1#1)(2007-7#1)
interrupted##56##1##(1990-12#1)(1990-8#2)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#3)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-7#4)(2008-10#7)(2008-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#2)
interrupter technique##2##2##(2008-1#2)
interrupter##3##1##(1995-3#1)(2008-1#2)
interrupting the##5##2##(1993-12#1)(2007-12#1)(2008-7#3)
interrupting##9##1##(1992-10#1)(1993-12#2)(2007-12#1)(2008-4#1)(2008-7#3)(2011-2#1)
interruption and Swiss-cheese ventricular septal defect (VSD)##2##7##(2007-8#2)
interruption and##4##2##(1994-6#1)(2007-8#2)(2008-10#1)
interruption in##2##2##(2008-10#1)(2008-3#1)
interruption of hemodialysis##2##3##(2013-1#2)
interruption of pregnancy##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
interruption of the moist##2##4##(2008-10#2)
interruption of the##11##3##(1990-5#1)(1991-2#1)(1991-3#1)(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-12#1)
interruption of##23##2##(1990-5#1)(1991-2#1)(1991-3#2)(1993-3#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
interruption##42##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-5#1)(1993-3#1)(1994-6#1)(1995-2#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-4#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
interruptions and##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
interruptions in##2##2##(2010-5#2)
interruptions of##4##2##(2008-10#1)(2008-3#1)(2010-8#2)
interruptions##14##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#5)(2010-8#2)(2011-2#1)
interrupts##4##1##(1991-6#1)(1993-2#1)(1994-12#1)(2010-8#1)
intersatellite optical communication##2##3##(2008-2#2)
intersatellite##3##1##(2008-2#2)(2008-3#1)
interscapular brown adipose tissue##2##4##(2011-2#2)
interscapular##5##1##(1992-2#1)(1993-10#1)(2007-8#1)(2011-2#2)
interscience##2##1##(2008-7#1)(2011-2#1)
intersect at##2##2##(2008-2#1)(2008-7#1)
intersect##6##1##(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
intersecting##6##1##(1992-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
intersection between##2##2##(2008-7#1)(2013-1#1)
intersection in##2##2##(2007-11#1)(2008-3#1)
intersection of##12##2##(2007-11#2)(2008-11#1)(2008-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
intersection##22##1##(1995-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-7#1)(2009-5#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
intersections with##3##2##(2007-11#2)(2008-6#1)
intersections##12##1##(2007-11#3)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#3)(2013-7#1)
intersectorial##3##1##(2011-2#2)(2012-3#1)
intersects##2##1##(2008-8#1)(2010-2#1)
intersex disorders##3##2##(2008-10#2)(2009-5#1)
intersex##7##1##(1991-6#1)(2008-10#4)(2009-5#1)(2013-8#1)
intersexual##3##1##(2008-8#1)(2008-9#1)(2010-5#1)
interspecies##10##1##(1991-9#1)(1992-6#1)(1993-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#2)(2013-8#2)
interspecific competition and##2##3##(2008-8#2)
interspecific competition##12##2##(2007-7#1)(2008-8#9)(2008-9#1)(2012-2#1)
interspecific crosses and##2##3##(2008-10#2)
interspecific crosses##8##2##(2008-10#8)
interspecific differences in##2##3##(2007-12#1)(2008-8#1)
interspecific hybrid poplar##2##3##(2008-10#2)
interspecific hybrid##6##2##(1995-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
interspecific hybridization events##2##3##(2008-10#2)
interspecific hybridization in##2##3##(2008-10#2)
interspecific hybridization was##3##3##(2008-10#1)(2008-9#2)
interspecific hybridization##10##2##(1996-4#1)(2008-10#5)(2008-9#4)
interspecific hybrids##8##2##(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#2)
interspecific interactions##3##2##(2008-8#2)(2008-9#1)
interspecific level##2##2##(2008-6#1)(2012-3#1)
interspecific nest parasitism##2##3##(2008-9#2)
interspecific transmission of dsRNA##2##4##(2008-10#2)
interspecific variation in##2##3##(2008-8#2)
interspecific##75##1##(1993-12#1)(1995-8#1)(1996-4#1)(2007-12#3)(2007-7#1)(2008-10#29)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#18)(2008-9#11)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
interspersed with##3##2##(1991-2#1)(1991-9#1)(2007-8#1)
interspersed##11##1##(1991-2#1)(1991-9#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-5#1)
interspinous ratio and##2##3##(2012-12#2)
interspinous ratio##4##2##(2012-12#4)
interspinous##5##1##(2012-12#5)
interstate##5##1##(1995-12#2)(1997-3#3)
interstellar dust##2##2##(1997-5#2)
intersterility group##2##2##(2008-10#2)
intersterility##4##1##(2008-10#2)(2010-10#2)
interstimulus interval##2##2##(2008-9#2)
interstimulus##3##1##(1996-5#1)(2008-9#2)
interstitial and##2##2##(2008-9#1)(2013-8#1)
interstitial brachytherapy##5##2##(1991-8#1)(1994-2#1)(2008-6#3)
interstitial cell##3##2##(2008-5#3)
interstitial cells of Cajal##3##4##(2008-6#1)(2009-12#1)(2012-12#1)
interstitial cells##6##2##(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#1)
interstitial changes##3##2##(1991-12#1)(1993-2#2)
interstitial deletion of a##2##4##(1996-12#1)(2012-12#1)
interstitial deletion of##3##3##(1996-12#1)(1997-3#1)(2012-12#1)
interstitial deletion##4##2##(1996-12#2)(1997-3#1)(2012-12#1)
interstitial fibrosis in##2##3##(2008-5#1)(2008-7#1)
interstitial fibrosis##5##2##(1990-9#1)(1991-9#1)(2008-5#1)(2008-7#2)
interstitial fluid##3##2##(2008-8#1)(2009-11#1)(2009-12#1)
interstitial hernia##3##2##(2012-12#3)
interstitial implants in##2##3##(2007-11#2)
interstitial implants##3##2##(2007-11#3)
interstitial liquid##2##2##(1997-1#1)(2008-3#1)
interstitial lung disease in##4##4##(2006-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
interstitial lung disease##13##3##(1997-3#1)(1997-8#1)(2006-10#2)(2008-8#2)(2011-2#2)(2012-12#3)(2012-2#2)
interstitial lung##16##2##(1991-12#1)(1991-2#2)(1997-3#1)(1997-8#1)(2006-10#2)(2008-8#2)(2011-2#2)(2012-12#3)(2012-2#2)
interstitial matrix and##2##3##(2008-4#2)
interstitial matrix##4##2##(2008-4#2)(2008-5#2)
interstitial nephritis and##2##3##(2007-6#1)(2008-4#1)
interstitial nephritis##13##2##(1992-5#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#2)
interstitial nephropathy##3##2##(1997-3#1)(2007-7#2)
interstitial pneumonia##4##2##(2008-1#2)(2011-2#2)
interstitial shadows##3##2##(2008-1#3)
interstitial tissue##3##2##(1996-5#1)(1997-3#1)(2008-7#1)
interstitial##131##1##(1990-9#1)(1991-12#3)(1991-2#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-5#1)(1993-2#3)(1994-2#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#7)(1997-6#1)(1997-8#1)(2006-10#3)(2007-11#5)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#2)(2009-11#2)(2009-12#2)(2011-2#7)(2012-1#1)(2012-12#13)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#2)
interstitium##5##1##(1997-3#1)(2007-7#1)(2009-10#2)(2012-7#1)
interstrain##5##1##(2008-10#2)(2008-5#1)(2012-1#2)
interstrand cross-links##2##2##(1993-11#1)(2008-11#1)
interstrand##7##1##(1992-3#2)(1992-6#1)(1993-11#2)(2008-11#2)
intersubband transitions##2##2##(2007-11#1)(2007-12#1)
intersubband##3##1##(2007-11#1)(2007-12#2)
intersubject variability##4##2##(2008-11#3)(2011-2#1)
intersubjective##2##1##(1997-1#1)(2007-10#1)
intersubunit hydrogen##2##2##(1992-3#2)
intersubunit##4##1##(1991-10#1)(1992-3#2)(1995-6#1)
intersymbol interference##2##2##(2007-11#1)(2008-3#1)
intertap intervals##2##2##(1994-3#2)
intertidal barnacles##2##2##(2013-7#2)
intertidal##11##1##(2007-5#2)(2008-10#1)(2008-5#4)(2008-9#2)(2013-7#2)
intertrochanteric femoral##2##2##(2010-11#1)(2011-2#1)
intertrochanteric fractures of the femur##2##5##(2007-8#2)
intertrochanteric fractures of the##3##4##(2007-8#2)(2013-1#1)
intertrochanteric fractures##6##2##(2007-8#2)(2009-3#1)(2013-1#3)
intertrochanteric##11##1##(2007-8#2)(2009-3#4)(2010-11#1)(2011-2#1)(2013-1#3)
intertwined##3##1##(1990-7#1)(2008-12#2)
interval (CI)##18##2##(1992-10#1)(1993-9#2)(1994-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
interval 0##8##2##(1990-6#1)(1991-11#1)(1991-8#2)(2008-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
interval 4##2##2##(1997-3#1)(2011-2#1)
interval 6##2##2##(1993-12#2)
interval analysis##3##2##(2008-10#3)
interval and circadian timing##2##4##(2009-7#2)
interval and high plasma digoxin level in##2##7##(1994-6#2)
interval and##11##2##(1993-12#1)(1994-5#2)(1994-6#2)(1994-8#1)(2008-10#1)(2008-3#1)(2009-7#3)
interval at##2##2##(2008-10#1)(2013-8#1)
interval between 0##4##3##(2008-10#4)
interval between first##2##3##(1992-5#1)(1992-9#1)
interval between the##7##3##(1993-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#2)(2011-2#1)
interval between##26##2##(1992-5#1)(1992-9#1)(1993-6#1)(1994-7#1)(1994-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#4)(2010-5#1)(2011-1#1)(2011-2#1)
interval censored##3##2##(1992-9#2)(1995-12#1)
interval compared with##2##3##(1996-3#1)(2012-12#1)
interval encompassing the##2##3##(2008-10#1)(2008-3#1)
interval estimates of##2##3##(1994-9#1)(2011-2#1)
interval estimates##5##2##(1994-9#2)(2008-11#1)(2011-2#1)(2012-1#1)
interval for each##2##3##(1994-2#1)(2008-10#1)
interval for##15##2##(1991-2#1)(1991-5#1)(1994-2#1)(1996-3#5)(2008-10#2)(2008-6#1)(2009-12#1)(2011-1#1)(2013-8#2)
interval from the##2##3##(2008-3#1)(2013-1#1)
interval from##8##2##(1994-3#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#3)
interval in a##2##3##(2008-6#1)(2009-9#1)
interval in the##3##3##(1994-6#1)(1995-6#1)(2013-8#1)
interval in##14##2##(1991-8#1)(1992-9#1)(1994-6#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
interval is##6##2##(1991-5#1)(1996-9#1)(1997-7#1)(2008-10#1)(2010-8#1)(2011-2#1)
interval mapping was##2##3##(2008-10#2)
interval mapping##13##2##(2008-10#10)(2008-12#1)(2008-5#1)(2012-3#1)
interval of 16##2##3##(2011-2#2)
interval of 6##2##3##(1992-10#1)(1994-3#1)
interval of 95%##4##3##(2008-10#3)(2013-1#1)
interval of less than##2##4##(1994-3#1)(2008-6#1)
interval of the##7##3##(1994-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2011-1#1)
interval of##44##2##(1990-8#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-10#2)(1993-11#1)(1994-3#2)(1994-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#2)(2008-10#9)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
interval on the##3##3##(2008-7#2)(2012-2#1)
interval on##4##2##(1994-9#1)(2008-7#2)(2012-2#1)
interval or##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
interval the##2##2##(2008-10#2)
interval to##2##2##(2008-10#1)(2010-12#1)
interval was 0##2##3##(2008-10#2)
interval was##16##2##(1990-10#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-12#1)(1997-5#1)(2008-10#4)(2008-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
interval were##3##2##(1994-11#1)(2007-8#1)(2008-10#1)
interval##405##1##(1990-10#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#5)(1992-10#7)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#4)(1993-6#3)(1993-9#3)(1994-11#3)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#4)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#8)(1996-8#1)(1996-9#2)(1997-3#2)(1997-4#2)(1997-5#5)(1997-7#3)(1997-8#1)(1997-9#1)(2006-10#4)(2007-10#6)(2007-11#5)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#67)(2008-11#4)(2008-12#7)(2008-2#5)(2008-3#20)(2008-5#8)(2008-6#9)(2008-7#13)(2008-8#5)(2008-9#12)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#6)(2010-4#5)(2010-5#2)(2010-6#2)(2010-8#4)(2011-1#5)(2011-2#15)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#10)
interval)##4##1##(2007-12#1)(2008-3#1)(2010-8#1)(2012-2#1)
intervals (0##2##2##(1992-5#1)(2010-2#1)
intervals 1##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
intervals across the DEJ##2##4##(2010-10#2)
intervals after##8##2##(1994-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-10#1)
intervals and##13##2##(1991-10#1)(1992-2#1)(1992-3#1)(2008-10#6)(2008-2#1)(2009-9#1)(2010-5#1)(2010-7#1)
intervals are not##2##3##(2008-10#1)(2012-3#1)
intervals are##6##2##(1990-8#1)(1994-11#1)(2008-10#3)(2012-3#1)
intervals at##2##2##(2008-3#2)
intervals between##12##2##(1992-11#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2010-8#1)
intervals by##2##2##(2008-3#1)(2012-3#1)
intervals computed##2##2##(2008-10#1)(2008-3#1)
intervals during##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
intervals following##2##2##(2008-9#1)(2011-2#1)
intervals for the##7##3##(1992-8#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
intervals for##21##2##(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-9#1)(1997-7#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
intervals from##8##2##(2007-10#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
intervals in##4##2##(1992-2#1)(1994-3#1)(2008-10#1)(2008-3#1)
intervals of 2##3##3##(2008-10#2)(2008-5#1)
intervals of 5##4##3##(1992-11#1)(2007-7#1)(2008-10#2)
intervals of the##8##3##(2008-10#4)(2008-3#1)(2008-9#3)
intervals of time##2##3##(1996-4#1)(2008-10#1)
intervals of##38##2##(1990-5#1)(1990-6#1)(1992-11#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-4#2)(1997-2#1)(2007-7#1)(2008-1#2)(2008-10#16)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2010-3#1)(2011-1#1)
intervals on the##2##3##(2008-5#2)
intervals on##4##2##(1994-7#1)(2008-12#1)(2008-5#2)
intervals over a##4##3##(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
intervals over##6##2##(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
intervals than##2##2##(1993-3#1)(2008-10#1)
intervals to##2##2##(1997-4#1)(2008-2#1)
intervals was##3##2##(1991-10#1)(2007-11#1)(2007-7#1)
intervals were##5##2##(1994-11#1)(1996-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
intervals where##2##2##(2008-3#1)(2008-8#1)
intervals with the##3##3##(1990-8#1)(2008-10#2)
intervals with##7##2##(1990-8#1)(1992-6#1)(2007-12#1)(2008-10#4)
intervals##297##1##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-10#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-11#3)(1994-2#3)(1994-3#5)(1994-7#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#3)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#5)(2008-10#74)(2008-11#4)(2008-12#8)(2008-2#4)(2008-3#17)(2008-4#4)(2008-5#16)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#9)(2009-12#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#2)
intervals)##7##1##(1993-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2013-1#1)
intervene in the##3##3##(1995-6#1)(2013-1#2)
intervene in##6##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-12#1)(2013-1#2)
intervene##18##1##(1993-3#1)(1995-6#1)(1997-7#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#2)
intervened and control##3##3##(2012-3#1)(2013-1#2)
intervened##10##1##(2007-11#1)(2009-7#1)(2012-3#2)(2013-1#5)(2013-8#1)
intervenes##2##1##(1997-7#1)(2011-1#1)
intervening sequence##3##2##(1992-8#1)(2008-11#1)(2008-8#1)
intervening variables##2##2##(1994-2#1)(2008-12#1)
intervening##23##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-8#2)(1994-1#1)(1994-2#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
intervention after##3##2##(1995-1#1)(2007-11#2)
intervention against##2##2##(1994-11#1)(2008-1#1)
intervention among##2##2##(2012-2#1)(2012-3#1)
intervention and at##2##3##(2008-10#1)(2010-12#1)
intervention and evaluation##2##3##(1997-2#1)(2008-8#1)
intervention and its##2##3##(2008-1#1)(2009-12#1)
intervention and prevention##2##3##(1991-6#1)(2008-1#1)
intervention and the development of##2##5##(2008-5#1)(2009-4#1)
intervention and the##8##3##(1995-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)
intervention and treatment##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
intervention and##43##2##(1990-8#1)(1991-12#1)(1991-6#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-11#2)(1997-2#2)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
intervention approach##2##2##(1993-1#1)(2013-1#1)
intervention approaches##2##2##(2010-12#1)(2012-2#1)
intervention are discussed##2##3##(1995-12#1)(2008-12#1)
intervention are still##2##3##(1990-8#1)(2007-8#1)
intervention are##14##2##(1990-8#1)(1992-4#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
intervention as well as##2##4##(1991-8#1)(2013-1#1)
intervention as##3##2##(1991-8#1)(2011-1#1)(2013-1#1)
intervention at##3##2##(1997-2#2)(2011-2#1)
intervention based on##3##3##(2008-7#1)(2009-9#1)(2011-2#1)
intervention by##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
intervention can be##2##3##(1993-11#1)(2008-11#1)
intervention can reduce##2##3##(2007-7#1)(2012-3#1)
intervention can##9##2##(1993-11#1)(1993-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
intervention conditions##2##2##(2012-2#2)
intervention could##2##2##(1993-12#1)(2011-2#1)
intervention design##2##2##(1994-1#2)
intervention designed to improve##2##4##(2008-8#1)(2010-10#1)
intervention designed to##5##3##(1992-2#1)(2007-10#1)(2008-8#1)(2009-11#1)(2010-10#1)
intervention due to##2##3##(2008-12#1)(2008-7#1)
intervention followed by##3##3##(2008-7#1)(2011-1#2)
intervention for adults##2##3##(2008-8#1)(2009-2#1)
intervention for children##2##3##(1993-1#1)(2009-9#1)
intervention for the treatment##2##4##(2007-11#1)(2008-1#1)
intervention for the##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
intervention for##42##2##(1990-12#1)(1992-1#1)(1993-1#2)(1995-1#1)(1997-4#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#3)(2008-4#1)(2008-6#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
intervention from##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
intervention group and##2##3##(2008-12#1)(2010-4#1)
intervention group showed##2##3##(2008-12#1)(2008-8#1)
intervention group##13##2##(2007-5#2)(2008-12#4)(2008-8#1)(2008-9#1)(2010-4#3)(2012-3#1)(2013-1#1)
intervention had##2##2##(2008-12#1)(2013-1#1)
intervention has been##2##3##(1991-12#1)(2011-2#1)
intervention has##3##2##(1991-12#1)(1997-5#1)(2011-2#1)
intervention have##2##2##(2007-12#1)(2009-6#1)
intervention implementation##2##2##(1997-1#1)(2012-2#1)
intervention in a##2##3##(2008-8#1)(2013-1#1)
intervention in patients with##3##4##(2007-10#1)(2010-10#1)(2011-2#1)
intervention in primary care##2##4##(2008-11#1)(2008-12#1)
intervention in the treatment of##2##5##(1991-5#1)(2010-8#1)
intervention in the##9##3##(1991-5#1)(1994-1#1)(1994-6#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2010-8#1)
intervention in these patients##2##4##(2008-1#1)(2008-11#1)
intervention in this##2##3##(1996-9#1)(2013-1#1)
intervention in##52##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-5#1)(1994-1#1)(1994-6#2)(1994-8#1)(1995-3#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#8)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#3)(2010-10#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
intervention is essential##2##3##(1995-5#1)(2010-10#1)
intervention is##19##2##(1990-9#1)(1991-3#1)(1993-1#1)(1994-1#2)(1995-5#2)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#3)(2013-8#2)
intervention may##3##2##(2008-6#1)(2008-8#1)(2011-1#1)
intervention must##2##2##(1992-12#1)(2012-3#1)
intervention of##12##2##(1997-7#1)(2008-2#1)(2008-5#2)(2009-9#1)(2010-12#2)(2010-9#1)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
intervention on body##2##3##(2007-12#1)(2009-6#1)
intervention on the##4##3##(1990-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
intervention on##17##2##(1990-6#1)(1994-6#1)(1996-1#1)(2007-10#1)(2007-12#1)(2008-3#1)(2009-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)
intervention or##6##2##(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
intervention period##5##2##(1991-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
intervention program for##2##3##(1991-12#1)(2008-11#1)
intervention program participation and##2##4##(2008-12#2)
intervention program##16##2##(1991-12#1)(1991-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#4)(2010-10#1)(2012-12#2)
intervention programme##2##2##(1991-6#1)(1994-2#1)
intervention programs that##2##3##(2008-8#1)(2009-7#1)
intervention programs##8##2##(1992-12#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
intervention research##8##2##(2008-2#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
intervention services##8##2##(1991-12#1)(1992-1#1)(1993-12#1)(1994-1#4)(2010-12#1)
intervention should be##2##3##(1990-9#1)(2012-1#1)
intervention significantly increased##2##3##(2008-7#1)(2012-3#1)
intervention strategies to##2##3##(1994-12#1)(2010-7#1)
intervention strategies##18##2##(1990-10#1)(1993-3#1)(1994-12#2)(1997-2#1)(2007-12#1)(2007-5#2)(2008-12#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#1)
intervention strategy##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
intervention studies##10##2##(1992-9#1)(2008-12#1)(2009-5#2)(2010-4#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
intervention study to##2##3##(2010-5#1)(2012-3#1)
intervention study was##2##3##(2008-11#1)(2012-2#1)
intervention study##10##2##(1991-8#1)(2008-11#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#2)
intervention subjects##3##2##(2009-11#3)
intervention techniques##2##2##(1991-1#1)(1995-1#1)
intervention that##2##2##(1993-11#1)(2008-3#1)
intervention they focused on##2##4##(2013-1#2)
intervention through##4##2##(2008-6#1)(2011-2#1)(2013-1#2)
intervention to help##2##3##(2011-2#1)(2013-8#1)
intervention to improve##3##3##(2008-3#1)(2008-6#1)(2010-4#1)
intervention to prevent##2##3##(1995-12#1)(2010-4#1)
intervention to reduce##2##3##(2012-3#2)
intervention to the##3##3##(1993-5#1)(2008-12#1)(2013-8#1)
intervention to##30##2##(1993-5#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
intervention trial##3##2##(1995-9#1)(2009-12#1)(2010-12#1)
intervention vs##3##2##(2008-11#1)(2012-3#2)
intervention was delivered##2##3##(2008-4#1)(2008-8#1)
intervention was initiated##2##3##(2007-12#1)(2011-1#1)
intervention was performed##2##3##(2007-8#1)(2008-7#1)
intervention was##23##2##(1993-5#1)(1996-6#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#5)(2013-8#1)
intervention were more likely to##2##5##(2013-1#2)
intervention were##8##2##(2008-12#2)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
intervention which##2##2##(2011-2#2)
intervention with##18##2##(1991-12#1)(1991-9#1)(1992-12#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
intervention without##2##2##(1995-5#1)(2008-7#1)
intervention zones was##2##3##(2008-12#2)
intervention zones##3##2##(2008-12#3)
intervention##834##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#9)(1991-2#5)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#5)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#3)(1994-1#11)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#8)(1994-6#3)(1994-8#1)(1995-1#7)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-9#1)(1996-1#7)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#17)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2007-10#8)(2007-11#10)(2007-12#13)(2007-2#1)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#9)(2008-1#17)(2008-10#15)(2008-11#35)(2008-12#48)(2008-2#9)(2008-3#23)(2008-4#21)(2008-5#6)(2008-6#11)(2008-7#23)(2008-8#22)(2008-9#10)(2009-10#1)(2009-11#15)(2009-12#8)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#11)(2009-6#6)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#20)(2010-11#1)(2010-12#9)(2010-3#3)(2010-4#11)(2010-5#3)(2010-7#9)(2010-8#4)(2010-9#4)(2011-1#22)(2011-2#59)(2011-3#2)(2011-9#1)(2012-1#7)(2012-12#19)(2012-2#32)(2012-3#16)(2013-1#80)(2013-7#3)(2013-8#16)
intervention) or##2##2##(2011-1#1)(2011-2#1)
intervention)##5##1##(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
intervention?##2##1##(2010-12#1)(2012-2#1)
intervention]##3##1##(1992-3#1)(1996-3#1)(1997-2#1)
interventional approach##2##2##(2008-3#1)(2011-2#1)
interventional cardiologists##3##2##(1993-12#1)(2008-11#1)(2008-3#1)
interventional cardiology##5##2##(2006-10#1)(2007-8#1)(2008-11#1)(2013-8#2)
interventional methods##2##2##(1994-3#1)(2013-1#1)
interventional neuroradiology##2##2##(1991-3#1)(1997-6#1)
interventional procedure##2##2##(2011-2#1)(2012-12#1)
interventional procedures and##2##3##(2011-2#1)(2012-2#1)
interventional procedures##9##2##(2006-10#1)(2006-8#1)(2009-12#1)(2010-12#1)(2011-2#4)(2012-2#1)
interventional radiologist##2##2##(2008-1#1)(2008-3#1)
interventional radiologists##2##2##(2012-2#1)(2012-3#1)
interventional radiology in##3##3##(2008-1#2)(2012-2#1)
interventional radiology##14##2##(1993-3#2)(2008-1#4)(2012-2#8)
interventional techniques##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
interventional treatment##2##2##(2008-7#1)(2008-8#1)
interventional vascular imaging##2##3##(2011-1#2)
interventional##72##1##(1991-3#2)(1993-12#1)(1993-3#2)(1994-3#2)(1995-1#1)(1995-11#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#4)(2013-8#2)
interventionist##4##1##(2008-10#2)(2008-12#1)(2011-2#1)
interventionists##3##1##(2011-1#1)(2011-2#2)
interventions and appropriate##2##3##(2008-11#1)(2010-10#1)
interventions and outcomes##2##3##(1995-3#1)(2008-1#1)
interventions and programs##2##3##(2008-11#1)(2012-2#1)
interventions and##28##2##(1993-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#4)(2013-1#2)
interventions are a##2##3##(2009-9#1)(2013-7#1)
interventions are also##2##3##(2008-6#1)(2011-2#1)
interventions are discussed##2##3##(2009-12#1)(2009-9#1)
interventions are needed to##2##4##(1995-6#1)(2012-2#1)
interventions are not##2##3##(2008-3#1)(2011-2#1)
interventions are##28##2##(1991-12#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#3)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
interventions at the##2##3##(2010-8#1)(2011-2#1)
interventions because##2##2##(2010-8#1)(2011-1#1)
interventions by##2##2##(1993-3#1)(2012-2#1)
interventions can enhance##2##3##(2008-2#1)(2013-1#1)
interventions can ensue##2##3##(2008-12#2)
interventions can##7##2##(2008-12#2)(2008-2#1)(2008-8#2)(2010-6#1)(2013-1#1)
interventions carried out##2##3##(2008-10#2)
interventions could##2##2##(2007-10#1)(2008-11#1)
interventions designed to##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
interventions designed##4##2##(2008-4#1)(2012-2#1)(2013-1#2)
interventions focused on##2##3##(2011-2#1)(2012-2#1)
interventions focused##3##2##(2011-2#1)(2012-2#2)
interventions for acute##2##3##(2007-10#1)(2010-8#1)
interventions for adolescents##2##3##(1996-12#1)(2008-7#1)
interventions for smoking cessation##3##4##(2007-12#1)(2013-1#2)
interventions for the##5##3##(1994-1#1)(1994-6#1)(1997-2#1)(2011-2#1)(2013-1#1)
interventions for##47##2##(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#7)(2013-1#9)
interventions has##2##2##(2009-7#1)(2012-2#1)
interventions have been##3##3##(1994-5#1)(2008-1#1)(2012-3#1)
interventions have shown that the##2##5##(2008-11#1)(2013-8#1)
interventions have##10##2##(1994-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
interventions in a##4##3##(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)
interventions in low##2##3##(2008-10#1)(2012-2#1)
interventions in secondary education##2##4##(2011-2#2)
interventions in the United States##3##5##(2011-2#2)(2012-3#1)
interventions in the context of##2##5##(2008-2#1)(2012-2#1)
interventions in the##10##3##(1993-3#1)(1994-5#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)
interventions in this##2##3##(2008-7#1)(2008-9#1)
interventions in##40##2##(1991-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-11#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#5)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#7)(2012-3#1)(2013-1#2)
interventions included##2##2##(1997-8#1)(2013-1#1)
interventions into##2##2##(2010-5#1)(2013-1#1)
interventions is##5##2##(2008-1#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
interventions may need to##2##4##(2007-12#1)(2008-12#1)
interventions may##6##2##(2007-12#1)(2008-12#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
interventions must##2##2##(2007-12#1)(2009-11#1)
interventions need to##2##3##(1996-6#1)(2008-12#1)
interventions of##5##2##(2008-10#2)(2012-3#1)(2013-1#2)
interventions on the##5##3##(1992-9#1)(1993-5#1)(2009-5#1)(2013-1#2)
interventions on##14##2##(1992-9#1)(1993-5#1)(1995-3#1)(1996-9#1)(2008-12#1)(2009-11#1)(2009-4#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
interventions or##2##2##(1993-12#1)(2012-3#1)
interventions regarding##2##2##(1990-2#1)(2011-2#1)
interventions should be##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
interventions should##4##2##(2008-11#1)(2008-4#1)(2011-1#1)(2013-8#1)
interventions such as##4##3##(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
interventions targeting##2##2##(2007-12#1)(2013-1#1)
interventions testing program##2##3##(2009-5#2)
interventions than##2##2##(2011-2#1)(2012-2#1)
interventions that are##4##3##(1995-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
interventions that can##2##3##(2008-11#1)(2013-1#1)
interventions that could##2##3##(2010-9#1)(2011-2#1)
interventions that improve##2##3##(2008-11#1)(2013-1#1)
interventions that involve##2##3##(2007-12#1)(2008-2#1)
interventions that promote##2##3##(1992-12#1)(2009-6#1)
interventions that will##2##3##(2010-3#1)(2011-1#1)
interventions that##33##2##(1991-3#1)(1992-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
interventions to address the##2##4##(2011-2#1)(2013-8#1)
interventions to address##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
interventions to be##2##3##(2008-11#1)(2013-1#1)
interventions to collect##2##3##(2013-1#2)
interventions to improve##6##3##(1996-12#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
interventions to prevent infections after knee arthroplasty##3##7##(2011-2#3)
interventions to prevent infections in knee arthroplasty##2##7##(2011-2#2)
interventions to prevent infections##5##4##(2011-2#5)
interventions to prevent##6##3##(2011-2#6)
interventions to reduce##6##3##(2008-10#1)(2010-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
interventions to##44##2##(1992-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#1)
interventions was##2##2##(1995-3#1)(2012-2#1)
interventions were performed##2##3##(2007-8#1)(2012-2#1)
interventions were##12##2##(1990-8#1)(2007-12#1)(2007-8#1)(2009-6#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
interventions which are##2##3##(2008-7#1)(2013-1#1)
interventions which##5##2##(1994-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
interventions with a##2##3##(2011-1#1)(2011-2#1)
interventions with different##2##3##(2010-8#1)(2013-8#1)
interventions with the##2##3##(1991-12#1)(2008-11#1)
interventions with##12##2##(1991-12#1)(1992-3#1)(2008-11#2)(2009-11#1)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
interventions##584##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-9#2)(1995-1#4)(1995-12#3)(1995-2#4)(1995-3#7)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-10#3)(2007-11#3)(2007-12#9)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#9)(2008-10#22)(2008-11#32)(2008-12#12)(2008-2#5)(2008-3#2)(2008-4#14)(2008-5#3)(2008-6#11)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#3)(2009-11#14)(2009-12#2)(2009-4#4)(2009-5#9)(2009-6#12)(2009-7#6)(2009-8#2)(2009-9#5)(2010-1#4)(2010-10#9)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#9)(2010-9#3)(2011-1#21)(2011-2#49)(2012-1#2)(2012-12#10)(2012-2#56)(2012-3#12)(2013-1#69)(2013-7#7)(2013-8#9)
interventions?##4##1##(2011-2#1)(2013-1#3)
interventricular##6##1##(1993-12#2)(1996-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
intervertebral disc degeneration##3##3##(2007-11#2)(2012-3#1)
intervertebral disc##20##2##(2007-11#9)(2007-8#4)(2008-11#1)(2008-7#1)(2009-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
intervertebral discs##8##2##(2007-11#2)(2007-8#6)
intervertebral disk##2##2##(1992-5#1)(2010-9#1)
intervertebral foramen##6##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#3)
intervertebral##41##1##(1992-5#1)(1996-8#1)(1996-9#1)(2006-12#1)(2007-11#13)(2007-8#11)(2008-11#1)(2008-7#2)(2009-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
interview and##7##2##(1992-3#1)(2007-11#1)(2008-12#2)(2010-8#1)(2011-2#1)(2012-12#1)
interview at##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
interview data and##2##3##(2013-1#2)
interview data##5##2##(2008-11#1)(2013-1#4)
interview findings##2##2##(2007-12#2)
interview for##3##2##(1993-6#1)(2011-1#1)(2012-12#1)
interview guide##3##2##(2008-4#1)(2010-9#1)(2011-1#1)
interview in the##2##3##(1993-9#1)(1995-6#1)
interview in##4##2##(1993-9#1)(1995-6#1)(2008-7#1)(2013-8#1)
interview is##3##2##(2010-6#1)(2010-8#1)(2011-2#1)
interview method##2##2##(2007-11#1)(2010-6#1)
interview questions##3##2##(2007-10#1)(2008-11#1)(2011-8#1)
interview schedule##2##2##(2010-8#1)(2011-2#1)
interview study of##2##3##(1997-4#1)(2010-10#1)
interview study##7##2##(1997-4#1)(2008-3#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#2)
interview survey##3##2##(1992-11#1)(1992-5#1)(2008-7#1)
interview that##2##2##(2010-3#1)(2010-7#1)
interview the##2##2##(1996-3#1)(2010-3#1)
interview to##2##2##(2008-11#1)(2012-12#1)
interview transcripts##6##2##(1993-3#1)(2007-4#2)(2008-12#1)(2009-5#1)(2013-1#1)
interview was##8##2##(1990-12#1)(1992-5#1)(1996-3#1)(2006-10#1)(2011-1#2)(2012-3#2)
interview with Peter##2##3##(1994-1#1)(2010-5#1)
interview with Richard##2##3##(1996-8#1)(2009-8#1)
interview with##18##2##(1992-2#1)(1994-1#1)(1996-8#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
interview##160##1##(1990-11#1)(1990-12#3)(1990-6#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#3)(1993-12#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#3)(2008-11#8)(2008-12#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#4)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#11)(2011-8#1)(2012-12#5)(2012-2#2)(2012-3#7)(2013-1#9)(2013-8#5)
interviewed and##3##2##(1990-12#1)(1995-1#1)(2008-12#1)
interviewed by##4##2##(1997-3#1)(2008-12#1)(2009-5#1)(2011-2#1)
interviewed for the##2##3##(1996-2#1)(2008-7#1)
interviewed for##4##2##(1991-6#1)(1996-2#1)(2008-7#1)(2011-2#1)
interviewed in##5##2##(1990-12#1)(1992-3#1)(2008-1#1)(2009-6#1)(2011-1#1)
interviewed using the##5##3##(1992-2#1)(2007-7#1)(2008-7#1)(2011-1#1)(2013-1#1)
interviewed using##16##2##(1992-2#1)(1995-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)
interviewed##101##1##(1990-12#3)(1990-8#3)(1991-3#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#5)(2009-6#2)(2009-9#2)(2010-10#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#2)
interviewees##5##1##(1990-8#1)(2008-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
interviewer-administered questionnaire##2##2##(2008-11#1)(2011-1#1)
interviewer-administered##3##1##(2008-11#1)(2010-11#1)(2011-1#1)
interviewing##11##1##(1992-2#1)(1993-1#1)(1997-1#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#1)(2013-1#1)
interviews among##2##2##(2008-11#1)(2009-12#1)
interviews and##10##2##(1994-2#1)(2007-10#2)(2010-1#1)(2010-10#2)(2010-3#2)(2012-12#1)(2013-8#1)
interviews conducted at##2##3##(2008-9#1)(2013-8#1)
interviews conducted with##3##3##(1991-12#1)(1996-12#1)(2007-12#1)
interviews conducted##7##2##(1991-12#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#1)
interviews of key##2##3##(1991-1#1)(2013-1#1)
interviews of##6##2##(1991-1#1)(1992-10#1)(2009-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
interviews revealed that##2##3##(2010-5#1)(2012-3#1)
interviews that were##2##3##(2012-12#1)(2013-1#1)
interviews to##5##2##(1997-2#1)(2008-6#1)(2008-8#1)(2013-1#2)
interviews using a##3##3##(2009-10#1)(2010-3#1)(2013-8#1)
interviews was##5##2##(2008-11#2)(2012-3#1)(2013-1#2)
interviews were analyzed##2##3##(2011-1#1)(2013-1#1)
interviews were carried out##2##4##(2007-7#1)(2012-3#1)
interviews were conducted and##3##4##(2008-11#1)(2010-3#1)(2012-3#1)
interviews were conducted using##2##4##(2008-8#1)(2013-1#1)
interviews were conducted with a##2##5##(2008-12#1)(2010-4#1)
interviews were conducted with##15##4##(1995-1#1)(1997-3#1)(2007-12#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
interviews were conducted##24##3##(1993-9#2)(1995-1#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
interviews were performed##3##3##(2010-10#1)(2010-6#1)(2013-1#1)
interviews were transcribed verbatim and##2##5##(2008-11#1)(2011-1#1)
interviews were transcribed##3##3##(2008-11#1)(2010-3#1)(2011-1#1)
interviews were undertaken with##2##4##(2008-9#1)(2010-10#1)
interviews were used to collect data##4##6##(2008-11#2)(2012-3#2)
interviews were used##5##3##(2008-11#3)(2012-3#2)
interviews were##53##2##(1993-9#2)(1995-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#7)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#3)(2010-11#1)(2010-3#3)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#5)(2013-1#7)
interviews with 24##2##3##(1997-3#1)(2011-2#1)
interviews with a##4##3##(1997-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
interviews with key##2##3##(1996-3#1)(2008-12#1)
interviews with men##2##3##(2008-11#2)
interviews with the##2##3##(2011-1#1)(2013-1#1)
interviews with##59##2##(1990-12#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#3)(1997-4#1)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#2)
interviews##246##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#1)(2007-10#5)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#5)(2008-11#23)(2008-12#13)(2008-2#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#6)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#12)(2010-11#2)(2010-12#1)(2010-3#8)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#3)(2012-12#9)(2012-2#2)(2012-3#11)(2013-1#40)(2013-7#2)(2013-8#8)
interviews)##3##1##(2009-4#1)(2009-7#1)(2009-9#1)
intestinal Caco-2 cells##3##3##(2008-11#3)
intestinal I/R##3##2##(2010-5#3)
intestinal absorption of##2##3##(1994-8#1)(2008-11#1)
intestinal absorption##6##2##(1991-8#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-11#1)
intestinal and##6##2##(1990-2#1)(1992-12#1)(1993-2#1)(1994-11#1)(2008-10#1)(2013-8#1)
intestinal bacteria and##2##3##(1991-12#1)(2010-11#1)
intestinal bacteria in##2##3##(2008-11#1)(2008-5#1)
intestinal bacteria##20##2##(1991-12#1)(1995-3#2)(2008-11#10)(2008-5#2)(2008-8#1)(2010-10#1)(2010-11#1)(2012-2#2)
intestinal bacterial metabolite##2##3##(2008-11#1)(2012-2#1)
intestinal bacterial##4##2##(2008-11#2)(2010-6#1)(2012-2#1)
intestinal bleeding##6##2##(1992-5#2)(1992-6#2)(2007-8#2)
intestinal brush-border membrane##4##3##(1992-6#2)(1994-8#1)(2006-12#1)
intestinal carcinogenesis##3##2##(1991-6#1)(1992-9#2)
intestinal cell##6##2##(1994-6#2)(1996-5#1)(2008-11#2)(2008-8#1)
intestinal cestodes##2##2##(2008-12#2)
intestinal content of##3##3##(1995-3#1)(2011-2#2)
intestinal continuity##2##2##(1990-2#1)(1991-6#1)
intestinal digestion for##2##3##(2008-10#2)
intestinal digestion##3##2##(2008-10#3)
intestinal diseases##2##2##(2008-7#1)(2012-2#1)
intestinal epithelial Caco-2 cells##2##4##(2008-11#2)
intestinal epithelial Caco-2##3##3##(2008-11#3)
intestinal epithelial cell monolayers##2##4##(2008-11#2)
intestinal epithelial cell##5##3##(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)
intestinal epithelial cells##10##3##(1990-12#1)(1990-2#1)(2008-11#6)(2008-6#1)(2008-8#1)
intestinal epithelial##21##2##(1990-12#1)(1990-2#1)(2008-10#2)(2008-11#12)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
intestinal fluid##3##2##(1994-12#1)(1996-6#1)(2008-11#1)
intestinal glucose absorption##2##3##(1997-6#2)
intestinal glucose##3##2##(1991-12#1)(1997-6#2)
intestinal hemorrhage##4##2##(1992-6#1)(1997-8#2)(2007-8#1)
intestinal immune##4##2##(2008-11#2)(2009-12#1)(2012-2#1)
intestinal inflammation in mdr1a (-/-) mice##2##6##(2008-10#2)
intestinal inflammation##5##2##(2008-10#4)(2012-2#1)
intestinal injury##3##2##(2013-1#3)
intestinal intraepithelial lymphocytes##2##3##(1996-12#1)(2008-11#1)
intestinal ischemia##6##2##(1993-5#4)(2009-8#1)(2013-1#1)
intestinal lymphoid patches##2##3##(1992-12#2)
intestinal manifestation of UC##2##4##(2011-2#2)
intestinal membrane##2##2##(2008-10#1)(2008-5#1)
intestinal metaplasia##4##2##(1994-2#1)(1997-1#3)
intestinal microbiota##4##2##(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#1)
intestinal microflora##2##2##(2008-11#2)
intestinal microvillus membrane##2##3##(1990-7#2)
intestinal motility##3##2##(2008-5#2)(2010-8#1)
intestinal mucin##10##2##(1990-8#2)(1991-12#5)(1992-11#1)(1993-8#1)(2008-7#1)
intestinal mucosa and##2##3##(1990-3#1)(1996-6#1)
intestinal mucosa##10##2##(1990-2#1)(1990-3#2)(1992-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
intestinal mucosal cells##2##3##(1994-8#1)(1996-5#1)
intestinal mucosal mast##2##3##(1995-12#2)
intestinal mucosal##5##2##(1994-8#1)(1995-12#2)(1996-5#1)(2008-4#1)
intestinal mucus film##2##3##(2008-5#2)
intestinal mucus##3##2##(2008-5#3)
intestinal obstruction##11##2##(1990-5#1)(1992-5#1)(2008-12#3)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
intestinal occlusion##4##2##(1990-3#1)(1990-5#1)(1990-6#1)(2010-1#1)
intestinal or##2##2##(1990-6#1)(1991-7#1)
intestinal parasites among##2##3##(2012-3#1)(2013-1#1)
intestinal parasites##6##2##(1996-12#1)(1997-3#1)(2008-10#1)(2009-10#1)(2012-3#1)(2013-1#1)
intestinal parasitism##3##2##(1991-12#1)(2012-12#2)
intestinal pathogens##2##2##(1995-2#1)(2011-2#1)
intestinal peptide (VIP)##4##3##(1994-11#1)(1994-3#1)(1995-5#1)(2012-3#1)
intestinal peptide##8##2##(1994-11#1)(1994-3#3)(1994-8#1)(1995-5#2)(2012-3#1)
intestinal perforations##3##2##(2011-2#3)
intestinal permeability##3##2##(1990-2#1)(2006-10#1)(2008-7#1)
intestinal polyps are##2##3##(2009-12#2)
intestinal polyps##3##2##(1993-9#1)(2009-12#2)
intestinal protein##2##2##(1994-11#1)(2011-2#1)
intestinal protozoa##4##2##(2009-10#4)
intestinal resection##3##2##(1992-5#1)(1995-12#1)(2013-1#1)
intestinal segments##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
intestinal strains##3##2##(1993-2#3)
intestinal tissue and##2##3##(2008-4#1)(2012-2#1)
intestinal tissue##3##2##(1995-12#1)(2008-4#1)(2012-2#1)
intestinal tract##7##2##(1992-5#1)(1993-2#1)(1993-9#1)(2007-6#1)(2011-2#2)(2013-1#1)
intestinal transit##7##2##(2013-1#7)
intestinal type##7##2##(1990-2#6)(2013-8#1)
intestinal uptake##3##2##(1995-3#2)(2008-8#1)
intestinal villi##3##2##(1993-6#3)
intestinal##415##1##(1990-11#6)(1990-12#3)(1990-2#14)(1990-3#5)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-12#9)(1991-6#2)(1991-7#1)(1991-8#4)(1992-11#1)(1992-12#6)(1992-5#5)(1992-6#8)(1992-8#1)(1992-9#4)(1993-11#1)(1993-2#6)(1993-3#1)(1993-5#5)(1993-6#3)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#11)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#7)(1995-5#2)(1996-12#3)(1996-3#1)(1996-5#4)(1996-6#4)(1997-1#4)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#4)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#25)(2008-11#42)(2008-12#9)(2008-4#5)(2008-5#14)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#7)(2009-12#3)(2009-2#1)(2009-5#1)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#5)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#24)(2011-3#4)(2012-1#3)(2012-12#3)(2012-2#12)(2012-3#10)(2013-1#24)(2013-8#5)
intestinal-type##4##1##(1990-6#1)(1997-1#1)(2013-1#1)(2013-8#1)
intestinalis and##2##2##(2010-12#1)(2012-2#1)
intestinalis is##2##2##(2012-2#2)
intestinalis##18##1##(2007-5#3)(2008-11#1)(2009-10#5)(2010-12#1)(2011-1#2)(2012-2#6)
intestine and kidney##2##3##(1992-9#1)(2008-5#1)
intestine and the##3##3##(1995-2#1)(2008-5#1)(2010-12#1)
intestine and##25##2##(1990-2#2)(1991-12#1)(1992-9#1)(1994-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
intestine are##2##2##(2008-5#1)(2011-2#1)
intestine associated with##2##3##(2007-8#1)(2009-1#1)
intestine in##5##2##(1990-11#2)(1995-12#1)(2007-2#1)(2007-8#1)
intestine is##3##2##(1991-6#1)(1992-6#1)(2009-1#1)
intestine of the##3##3##(2008-5#2)(2008-7#1)
intestine of##12##2##(1991-12#1)(1995-9#1)(2008-12#1)(2008-5#2)(2008-7#2)(2011-3#1)(2012-2#3)(2013-1#1)
intestine or##2##2##(1992-11#1)(2008-11#1)
intestine was##4##2##(1991-12#1)(1993-2#1)(2008-5#2)
intestine were examined##2##3##(1993-6#1)(1994-11#1)
intestine with##3##2##(1990-11#1)(1992-6#1)(2008-5#1)
intestine##168##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#5)(1991-5#5)(1991-6#1)(1991-8#2)(1992-11#5)(1992-5#3)(1992-6#5)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#8)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#20)(2008-7#5)(2008-8#2)(2009-1#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
intestine)##2##1##(2008-12#1)(2009-8#1)
intestine]##4##1##(1990-11#1)(1990-3#1)(1992-5#2)
intestines and##2##2##(2008-10#1)(2008-8#1)
intestines of##2##2##(2006-12#1)(2009-6#1)
intestines##17##1##(1992-11#1)(1993-11#1)(1993-6#2)(1993-9#4)(1997-3#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
inthe##11##1##(2008-11#7)(2008-2#1)(2009-8#3)
intima media##2##2##(2013-1#2)
intima##8##1##(1997-8#2)(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#2)
intima-media thickness (IMT)##2##3##(2011-1#1)(2011-2#1)
intima-media thickness and##4##3##(2008-1#1)(2008-11#2)(2009-1#1)
intima-media thickness in##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
intima-media thickness##16##2##(2008-1#1)(2008-11#5)(2008-7#2)(2008-8#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
intima-media##17##1##(2008-1#1)(2008-11#5)(2008-7#2)(2008-8#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
intimacy##2##1##(2008-6#1)(2010-5#1)
intimal flap##2##2##(2011-2#2)
intimal hyperplasia##13##2##(1996-8#2)(2006-6#5)(2008-4#4)(2009-11#1)(2011-3#1)
intimal lesion##2##2##(1997-6#1)(1997-8#1)
intimal thickening and##2##3##(1995-12#2)
intimal thickening##5##2##(1995-12#4)(1995-8#1)
intimal##31##1##(1995-12#4)(1995-8#1)(1996-2#1)(1996-8#2)(1997-6#1)(1997-8#3)(2006-6#5)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#4)(2009-11#1)(2010-4#2)(2011-2#3)(2011-3#1)
intimate and##2##2##(2008-11#1)(2009-10#1)
intimate contact##4##2##(2008-10#1)(2010-10#1)(2010-5#1)(2012-3#1)
intimate partner violence (IPV)##4##4##(2008-12#1)(2009-5#1)(2010-11#1)(2013-1#1)
intimate partner violence##13##3##(2008-12#2)(2008-6#1)(2009-5#2)(2010-11#2)(2010-3#1)(2012-12#4)(2013-1#1)
intimate partner##14##2##(2008-12#2)(2008-6#1)(2009-5#2)(2010-11#2)(2010-3#1)(2012-12#4)(2012-2#1)(2013-1#1)
intimate relationships##3##2##(2009-11#1)(2012-2#2)
intimate##42##1##(1992-2#1)(1993-12#1)(1996-2#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#1)
intimately connected##2##2##(2010-10#1)(2012-12#1)
intimately involved in##3##3##(1996-2#1)(2007-12#1)(2008-4#1)
intimately linked to##4##3##(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
intimately linked##5##2##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
intimately##17##1##(1993-8#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
into 1##9##2##(2007-11#1)(2008-10#6)(2008-12#1)(2011-1#1)
into 10##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
into 100##2##2##(2008-10#1)(2011-3#1)
into 11##4##2##(2008-10#2)(2008-4#1)(2011-1#1)
into 14##2##2##(2008-10#1)(2008-5#1)
into 16##3##2##(2007-11#1)(2008-12#1)(2013-8#1)
into 17##2##2##(1992-12#1)(2009-10#1)
into 2 groups##7##3##(1990-2#1)(1994-6#1)(2007-10#1)(2009-7#1)(2010-4#1)(2012-2#1)(2012-3#1)
into 2##8##2##(1990-2#1)(1994-6#1)(2007-10#1)(2007-11#1)(2009-7#1)(2010-4#1)(2012-2#1)(2012-3#1)
into 3 groups##9##3##(2007-10#2)(2007-11#1)(2008-10#2)(2008-12#1)(2012-4#1)(2013-1#2)
into 3##17##2##(1991-9#1)(2007-10#3)(2007-11#2)(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)(2012-3#1)(2012-4#1)(2013-1#3)
into 30##2##2##(2009-4#1)(2013-1#1)
into 4##10##2##(1992-9#1)(1996-10#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-8#1)
into 4M5NC##2##2##(2008-10#2)
into 6 groups##3##3##(1996-6#1)(2013-1#1)(2013-7#1)
into 6##4##2##(1996-6#1)(2008-10#1)(2013-1#1)(2013-7#1)
into 7##2##2##(2008-6#1)(2011-2#1)
into A beta##2##3##(1995-12#1)(1996-2#1)
into A##3##2##(1995-12#1)(1996-2#1)(2008-9#1)
into Andean and##2##3##(2008-10#2)
into B##4##2##(1997-1#3)(2008-10#1)
into BL21##2##2##(1997-7#1)(2010-6#1)
into CER vesicles##2##3##(2008-5#2)
into CHO cells##3##3##(1990-8#1)(2008-11#2)
into Chinese hamster ovary##3##4##(1994-3#1)(2008-11#1)(2008-4#1)
into Chinese##4##2##(1992-9#1)(1994-3#1)(2008-11#1)(2008-4#1)
into DNA by##2##3##(1994-11#1)(1995-5#1)
into DNA in##2##3##(1997-7#1)(2008-9#1)
into DNA of##4##3##(1991-12#3)(1993-6#1)
into DNA##23##2##(1991-12#3)(1991-6#2)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#1)(1997-7#1)(2008-4#4)(2008-9#1)(2010-11#1)(2012-2#1)
into Drosophila##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
into E##2##2##(1994-12#1)(1997-2#1)
into ES cells##2##3##(1997-8#1)(2008-9#1)
into Escherichia coli DH5 alpha##2##5##(1992-9#1)(1994-8#1)
into Escherichia coli##7##3##(1991-9#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-8#1)(1997-4#1)
into HeLa cells##3##3##(1993-3#1)(2008-9#2)
into HepG2 cells##3##3##(1994-6#1)(1995-6#1)(2008-8#1)
into ICP##2##2##(2008-10#2)
into L##2##2##(1991-5#1)(2008-6#1)
into M##2##2##(2007-12#1)(2010-9#1)
into Malaysia##2##2##(2011-1#2)
into N##2##2##(2008-10#1)(2008-9#1)
into NBM##3##2##(2008-8#3)
into North America##3##3##(2008-10#3)
into OLs##2##2##(2008-7#2)
into P29##2##2##(2008-10#2)
into PC12 cells##2##3##(1990-5#1)(1993-12#1)
into PG##2##2##(1994-9#1)(2008-8#1)
into PI##2##2##(1992-10#2)
into Polish##2##2##(2012-12#1)(2013-1#1)
into RNA##2##2##(2008-10#1)(2008-9#1)
into ROS##3##2##(1993-3#1)(1995-5#1)(2009-8#1)
into S phase##3##3##(1992-10#2)(1993-8#1)
into S##6##2##(1992-10#2)(1993-8#1)(1994-3#1)(1997-7#1)(2008-2#1)
into SF-CO(2)##3##2##(2008-10#3)
into SLN##4##2##(2008-5#4)
into Spain##2##2##(2008-10#2)
into Tf##3##2##(2010-11#3)
into Xenopus##2##2##(1991-12#1)(1992-11#1)
into a &quot##2##3##(2007-8#1)(2008-11#1)
into a 1##2##3##(2008-10#1)(2008-3#1)
into a Raman##2##3##(2007-12#1)(2008-10#1)
into a baculovirus##2##3##(1993-6#1)(2008-11#1)
into a beam##2##3##(2008-2#2)
into a broader##2##3##(1996-1#1)(2008-1#1)
into a carrier stream of##4##5##(2008-10#4)
into a carrier stream to be stacked inside a holding coil and flow reversed through a reaction coil##2##18##(2008-10#2)
into a carrier stream##7##4##(2008-10#7)
into a carrier##9##3##(2008-10#9)
into a cell##2##3##(2008-11#1)(2008-9#1)
into a circular##2##3##(2008-2#2)
into a coherent##6##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#2)
into a common clade##2##4##(2008-10#2)
into a common##5##3##(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)
into a community-based gynecology practice##2##5##(1996-2#2)
into a deterministic##2##3##(2008-7#2)
into a different##2##3##(1995-5#1)(2008-10#1)
into a distinct actin network##2##5##(2008-11#1)(2008-9#1)
into a distinct##3##3##(2008-11#2)(2008-9#1)
into a donor stream of##2##5##(2008-10#2)
into a flow injection system##2##5##(2008-10#2)
into a flow injection##3##4##(2008-10#3)
into a flow##6##3##(2008-10#6)
into a flow-through##2##3##(2008-10#2)
into a flowing##3##3##(2008-10#2)(2008-9#1)
into a full##3##3##(2008-12#2)(2008-3#1)
into a gas chromatograph##2##4##(2008-10#2)
into a gas##3##3##(2008-10#3)
into a given##3##3##(1991-1#1)(1995-2#1)(2008-10#1)
into a graphite furnace##2##4##(2008-10#2)
into a group##3##3##(1994-6#1)(2007-8#1)(2012-2#1)
into a high-performance liquid##2##4##(1990-8#1)(2008-10#1)
into a home-made##2##3##(2008-10#2)
into a hot##3##3##(2008-10#2)(2008-5#1)
into a large##4##3##(1995-5#1)(1997-2#1)(2008-10#2)
into a local##2##3##(2008-10#1)(2008-8#1)
into a major##2##3##(2008-10#2)
into a matrix of##2##4##(2008-10#1)(2008-5#1)
into a more##3##3##(1991-5#1)(2008-11#1)(2010-1#1)
into a multilayer##2##3##(2008-3#2)
into a nearly Gaussian beam##2##5##(2007-11#2)
into a nearly##3##3##(2007-11#3)
into a new##7##3##(1997-3#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)
into a novel##3##3##(1997-4#1)(2008-2#1)(2010-6#1)
into a number of##3##4##(2008-10#1)(2008-12#1)(2010-10#1)
into a nursing##2##3##(1995-2#1)(2008-11#1)
into a photonic crystal##3##4##(2007-11#1)(2007-12#2)
into a plasticized poly(vinyl chloride)##2##5##(2008-10#2)
into a product##2##3##(2008-10#1)(2008-5#1)
into a protein##4##3##(1990-11#1)(1992-3#1)(1995-12#1)(2013-8#1)
into a regular##2##3##(1994-12#1)(2008-3#1)
into a rigorous##2##3##(1991-2#1)(2008-7#1)
into a ring##2##3##(2007-12#2)
into a section##2##3##(2007-11#1)(2008-10#1)
into a series of##4##4##(2008-10#4)
into a set of##5##4##(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)
into a short##2##3##(2008-10#1)(2009-9#1)
into a single##18##3##(1993-8#1)(1994-3#1)(1995-9#1)(1997-3#1)(2007-12#2)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#1)
into a single-mode##2##3##(2007-12#2)
into a small##9##3##(1990-5#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)
into a solid##2##3##(2008-2#1)(2008-6#1)
into a solution of##2##4##(2008-10#1)(2008-2#1)
into a solution##3##3##(2008-10#1)(2008-2#1)(2009-12#1)
into a specific##2##3##(1995-9#1)(2008-7#1)
into a stream of##3##4##(2008-10#3)
into a system of##2##4##(1995-2#1)(2008-7#1)
into a thin##2##3##(2008-10#1)(2008-3#1)
into a three-dimensional##2##3##(2008-3#2)
into a training set##2##4##(1995-9#1)(2008-10#1)
into a turbid medium##2##4##(2008-3#2)
into a two-dimensional##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
into a uniform##2##3##(2007-12#1)(2008-3#1)
into a variety of cell types##3##6##(2008-11#2)(2008-9#1)
into a variety of cell##4##5##(1991-6#1)(2008-11#2)(2008-9#1)
into a variety of##8##4##(1991-6#1)(2007-11#1)(2008-11#2)(2008-9#1)(2009-11#1)(2009-12#1)(2013-1#1)
into a versatile##2##3##(2010-2#1)(2011-1#1)
into a very##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
into a wide range of##2##5##(1996-2#1)(2008-5#1)
into a wide##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
into a##579##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#2)(1996-12#1)(1996-2#4)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#22)(2007-12#29)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#6)(2008-10#154)(2008-11#23)(2008-12#5)(2008-2#25)(2008-3#42)(2008-4#4)(2008-5#16)(2008-6#8)(2008-7#23)(2008-8#8)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#5)(2012-12#2)(2012-2#4)(2013-1#7)(2013-8#2)
into absolute##2##2##(2007-11#1)(2010-7#1)
into academic##2##2##(1997-2#1)(2008-7#1)
into account a##4##3##(1997-6#1)(2007-12#1)(2008-3#1)(2008-8#1)
into account all the##2##4##(1996-5#1)(2008-9#1)
into account all##4##3##(1996-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
into account and##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
into account both##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
into account by##9##3##(1992-6#1)(1993-12#1)(2008-10#3)(2008-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
into account different physiological##2##4##(2008-8#1)(2009-12#1)
into account different##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
into account during##2##3##(2007-7#1)(2008-8#1)
into account is##2##3##(1994-3#1)(2013-8#1)
into account of the##2##4##(2008-10#1)(2008-8#1)
into account of##3##3##(1996-10#1)(2008-10#1)(2008-8#1)
into account possible##2##3##(2008-3#1)(2012-12#1)
into account the absorption##2##4##(2008-2#1)(2008-3#1)
into account the changes##2##4##(2007-11#1)(2008-10#1)
into account the coherent and the incoherent scattering##2##8##(2008-3#2)
into account the differences in the##2##6##(1997-2#1)(2008-3#1)
into account the different##2##4##(2007-11#1)(2008-10#1)
into account the patient's##2##4##(1991-4#1)(1996-6#1)
into account the sensitivity##2##4##(2008-10#2)
into account the##83##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-5#2)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#4)(2007-12#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)
into account this##2##3##(2008-11#1)(2011-2#1)
into account to##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)
into account when##8##3##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
into account##274##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#8)(2007-12#8)(2007-6#1)(2007-7#1)(2008-10#43)(2008-11#11)(2008-12#1)(2008-2#26)(2008-3#40)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#4)(2013-8#4)
into action##4##2##(1991-12#1)(1995-1#1)(1995-6#1)(2010-12#1)
into activated##2##2##(1994-12#1)(2009-8#1)
into active##4##2##(1993-8#1)(1997-4#1)(2007-12#1)(2012-3#1)
into adipocytes##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-4#1)
into adjacent woodlands##2##3##(2010-6#2)
into adjacent##5##2##(2008-10#2)(2010-6#2)(2011-2#1)
into adult##4##2##(1992-11#1)(1994-2#1)(2008-12#1)(2009-5#1)
into adulthood##7##2##(1996-5#1)(2008-2#2)(2008-4#1)(2010-10#1)(2011-2#1)(2013-7#1)
into all##5##2##(1995-6#1)(2008-10#1)(2008-11#2)(2012-2#1)
into alpha##3##2##(1990-7#1)(1992-3#1)(2010-11#1)
into alternative##2##2##(2008-4#1)(2008-9#1)
into an OAH##2##3##(2008-7#2)
into an acidic carrier stream and##2##6##(2008-10#2)
into an acidic##3##3##(1994-11#1)(2008-10#2)
into an active##2##3##(1993-6#1)(1994-11#1)
into an adult##2##3##(2007-12#2)
into an aqueous solution##2##4##(2008-10#1)(2009-12#1)
into an aqueous##4##3##(1994-12#1)(2008-10#2)(2009-12#1)
into an array of##4##4##(2007-12#1)(2008-3#2)(2009-8#1)
into an array##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-8#1)
into an effective##2##3##(1990-5#1)(2009-5#1)
into an energy##2##3##(2008-3#1)(2008-5#1)
into an integrated system##2##4##(1997-1#1)(1997-3#1)
into an integrated##5##3##(1993-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
into an intensively fluorescent compound##2##5##(2008-10#2)
into an oligonucleotide##2##3##(1993-11#1)(2008-4#1)
into an organic##2##3##(2008-10#2)
into an osteoblastic tendency##2##4##(2008-11#2)
into an osteoblastic##3##3##(2008-11#2)(2010-3#1)
into an unstable##2##3##(2007-12#1)(2008-10#1)
into an##120##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#4)(1994-3#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2006-7#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#29)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
into and out of##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
into and##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
into animal##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
into animals##2##2##(2008-8#1)(2008-9#1)
into another##3##2##(2007-12#1)(2008-1#1)(2008-4#1)
into any##7##2##(1994-3#1)(1997-3#1)(1997-4#1)(2008-4#3)(2008-9#1)
into appropriate##2##2##(1991-3#1)(2008-9#1)
into aqueous##4##2##(2008-10#3)(2009-12#1)
into area CA1##2##3##(2008-9#2)
into area##3##2##(2008-9#3)
into areas of##4##3##(2008-2#1)(2008-9#1)(2010-5#2)
into areas##5##2##(2008-2#1)(2008-9#1)(2010-4#1)(2010-5#2)
into astrocytes##6##2##(2008-11#5)(2012-12#1)
into at least two##2##4##(1995-11#1)(2012-2#1)
into at least##7##3##(1993-9#1)(1995-11#1)(2007-7#1)(2008-10#3)(2012-2#1)
into atrial fibrillation##2##3##(2007-8#2)
into atrial##3##2##(1996-2#1)(2007-8#2)
into baby hamster kidney (BHK) cells##2##6##(1994-9#1)(2011-3#1)
into baby hamster kidney##3##4##(1994-9#1)(2008-4#1)(2011-3#1)
into barley cultivars##2##3##(2008-10#2)
into barley##3##2##(2008-10#3)
into basic##2##2##(1994-12#1)(2009-8#1)
into benzene##4##2##(2008-10#4)
into bile by##2##3##(2008-11#2)
into bile##5##2##(1994-8#1)(2008-11#4)
into biological##4##2##(1994-2#1)(2007-12#1)(2008-3#1)(2010-6#1)
into blastocysts##2##2##(1995-2#1)(1997-8#1)
into blood##4##2##(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
into bone marrow##3##3##(1994-5#1)(1995-9#1)(2010-8#1)
into both the##6##3##(1990-11#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
into both##12##2##(1990-11#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
into building##2##2##(1997-1#1)(2006-4#1)
into cardiac##2##2##(1992-10#1)(2007-8#1)
into cartilage cells##2##3##(2007-8#1)(2008-9#1)
into categories##2##2##(2010-8#1)(2012-2#1)
into cell##6##2##(1991-5#1)(1997-3#1)(2008-11#1)(2010-10#1)(2010-6#1)(2012-7#1)
into cells by##2##3##(2008-4#1)(2011-1#1)
into cells from##3##3##(1990-5#2)(2008-8#1)
into cells##30##2##(1990-5#2)(1991-11#1)(1991-9#1)(1992-12#2)(1993-3#1)(1993-8#1)(1994-6#2)(1996-9#1)(1997-7#2)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2011-1#1)(2013-1#1)
into cellular protein was measured as an##2##7##(2008-11#2)
into cellular##7##2##(1994-9#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-5#1)(2013-1#1)
into central##4##2##(1992-10#1)(1997-4#1)(2008-11#1)(2011-1#1)
into changes in##2##3##(2008-1#1)(2009-10#1)
into chloroform by##2##3##(2008-10#2)
into chloroform##12##2##(2008-10#12)
into chondrocytes##3##2##(1991-11#1)(2008-11#1)(2008-9#1)
into chromium##2##2##(2008-10#2)
into circulation##2##2##(2011-2#1)(2012-12#1)
into classes##2##2##(2008-10#1)(2013-1#1)
into classical##2##2##(2007-10#1)(2008-10#1)
into clinical practice##13##3##(1993-12#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#1)
into clinical##20##2##(1993-12#1)(1996-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
into close proximity##2##3##(1994-5#2)
into close##4##2##(1994-5#2)(2008-4#1)(2010-5#1)
into cochlear##2##2##(2009-5#1)(2012-2#1)
into commercial##4##2##(2008-10#4)
into community##2##2##(1996-2#1)(2010-5#1)
into complex##3##2##(1995-6#1)(1996-12#1)(2008-7#1)
into conscious##2##2##(1990-5#1)(1996-12#1)
into consideration for##3##3##(2008-1#1)(2008-10#1)(2010-11#1)
into consideration the##14##3##(1995-9#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-3#1)(2012-1#1)
into consideration##50##2##(1990-6#1)(1991-11#1)(1992-4#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-11#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
into contact with##10##3##(1990-3#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#2)(2010-1#1)(2012-12#1)
into contact##11##2##(1990-11#1)(1990-3#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#2)(2010-1#1)(2012-12#1)
into contiguous##2##2##(2008-10#1)(2008-3#1)
into continuous##3##2##(1996-5#1)(2008-3#1)(2011-1#1)
into contributing factors##2##3##(2010-8#1)(2013-1#1)
into control##5##2##(1995-12#1)(2008-12#1)(2008-4#1)(2010-4#1)(2012-2#1)
into coordinated##2##2##(2009-9#1)(2012-12#1)
into cortical##2##2##(2008-10#1)(2008-11#1)
into cosmetic##3##2##(2008-5#3)
into courses##2##2##(1996-1#1)(2008-12#1)
into crystals of##2##3##(2007-12#1)(2010-12#1)
into crystals##3##2##(2007-12#1)(2009-8#1)(2010-12#1)
into cultured cells##2##3##(1990-11#1)(1994-9#1)
into cultured##4##2##(1990-11#1)(1994-9#1)(2007-11#1)(2008-4#1)
into current##2##2##(1992-12#1)(2008-10#1)
into deeper water##2##3##(2008-10#1)(2008-5#1)
into deeper##6##2##(1993-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-1#1)
into developing##2##2##(2008-10#1)(2013-1#1)
into diamond by use of##2##5##(2007-12#2)
into dichloromethane##4##2##(2008-10#4)
into different groups##5##3##(1992-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
into different##18##2##(1992-2#1)(1996-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#2)(2013-1#1)
into digital##2##2##(2008-3#2)
into dimers##4##2##(1994-8#1)(1997-2#1)(2008-8#1)(2008-9#1)
into direct contact##2##3##(1990-8#1)(2008-10#1)
into disaccharides##2##2##(2008-7#2)
into discrete##5##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
into disease##3##2##(2008-10#2)(2008-7#1)
into distinct groups##3##3##(2008-10#2)(2008-9#1)
into distinct##11##2##(1994-8#1)(1996-4#1)(1996-9#1)(2007-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-2#1)
into each of##2##3##(1997-6#1)(2008-1#1)
into each##6##2##(1994-12#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
into early##2##2##(2012-12#1)(2012-3#1)
into effect##3##2##(2007-8#1)(2008-2#1)(2012-1#1)
into eight groups##2##3##(1992-9#1)(2010-4#1)
into eight##6##2##(1991-3#1)(1992-9#1)(1997-3#1)(2008-12#1)(2008-5#1)(2010-4#1)
into either an##2##3##(2007-11#1)(2008-3#1)
into either##10##2##(1990-7#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)
into embryos##2##2##(1993-3#1)(2008-4#1)
into enucleated rabbit##2##3##(2008-9#2)
into equal##3##2##(2007-11#1)(2008-12#1)(2008-7#1)
into ethanol##3##2##(2008-6#1)(2011-1#1)(2013-1#1)
into ethyl acetate##2##3##(2008-10#2)
into eukaryotic##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
into events##2##2##(2008-7#1)(2008-9#1)
into existing##6##2##(1996-3#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-4#1)
into families##2##2##(2008-5#1)(2009-5#1)
into fewer##2##2##(1993-12#1)(2008-10#1)
into filaments##2##2##(2008-8#2)
into fine##2##2##(2008-1#1)(2008-3#1)
into five categories##2##3##(1995-3#1)(2008-9#1)
into five groups##7##3##(1990-12#1)(2008-10#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)
into five##31##2##(1990-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)
into focus##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
into force##3##2##(2008-11#1)(2010-5#1)(2013-1#1)
into four categories##6##3##(1997-8#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-1#1)
into four distinct##3##3##(1994-11#1)(2008-10#2)
into four grades##2##3##(2010-3#1)(2011-2#1)
into four groups based on their##2##6##(2008-9#1)(2011-2#1)
into four groups depending on the##2##6##(2008-7#1)(2010-1#1)
into four groups##23##3##(1991-2#1)(1992-1#1)(1993-5#1)(1996-7#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#5)(2013-8#1)
into four main##3##3##(2008-12#1)(2008-7#1)(2011-1#1)
into four phylogenetic##2##3##(2008-10#2)
into four sections##2##3##(2008-10#1)(2012-2#1)
into four subgroups##3##3##(1997-6#1)(2008-10#1)(2009-8#1)
into four##68##2##(1991-2#1)(1992-1#1)(1992-4#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-12#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
into fractions##3##2##(2008-10#3)
into free##2##2##(2008-10#2)
into functional##3##2##(1997-7#1)(2008-7#1)(2008-8#1)
into functionally##3##2##(1994-3#1)(2007-12#1)(2008-11#1)
into furfural##2##2##(2013-1#2)
into fused silica##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
into future##2##2##(2008-5#1)(2010-1#1)
into gaseous##3##2##(2008-10#3)
into general##6##2##(1991-6#1)(1994-2#1)(1997-3#1)(2007-11#1)(2008-6#1)(2010-4#1)
into genetic linkage##2##3##(2008-10#1)(2008-4#1)
into genetic##4##2##(2008-10#3)(2008-4#1)
into geographic##2##2##(2008-10#1)(2011-2#1)
into global##2##2##(2008-3#1)(2009-6#1)
into group##2##2##(1995-1#1)(2008-1#1)
into groups based on##2##4##(2008-3#1)(2009-7#1)
into groups##7##2##(1993-2#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-8#1)
into growth##2##2##(2008-10#1)(2012-12#1)
into health and##2##3##(1993-2#1)(2013-8#1)
into health care##5##3##(1991-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-12#1)
into health management##2##3##(1994-3#1)(1995-12#1)
into health##12##2##(1991-2#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-12#1)(2013-8#1)
into healthy##3##2##(2008-10#2)(2008-9#1)
into hepatic cells##2##3##(1994-5#1)(2008-8#1)
into hepatocyte-like cells##2##3##(2008-9#2)
into hepatocytes##2##2##(1992-3#1)(2012-2#1)
into hepatoma##2##2##(1995-2#1)(2008-8#1)
into her##2##2##(2008-12#1)(2011-2#1)
into high##2##2##(1991-12#1)(2010-12#1)
into high-quality##3##2##(2007-11#1)(2009-11#1)(2010-5#1)
into high-value##2##2##(2011-1#2)
into higher##2##2##(2008-10#1)(2010-5#1)
into highly##2##2##(2008-10#1)(2008-4#1)
into his##3##2##(2007-8#1)(2008-12#1)(2010-12#1)
into holes##2##2##(2008-2#1)(2011-2#1)
into hospital##2##2##(1995-1#1)(2008-1#1)
into host##5##2##(2008-4#1)(2008-7#1)(2011-2#3)
into how##14##2##(1994-8#1)(1997-7#1)(2007-12#2)(2008-11#4)(2008-6#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
into human skin from##2##4##(2008-5#2)
into human skin##5##3##(2007-2#1)(2008-5#4)
into human##18##2##(1993-8#1)(1997-7#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#3)(2009-4#1)(2011-2#1)
into hydrated##2##2##(1992-6#1)(2008-10#1)
into immature##2##2##(1992-12#2)
into immunodeficient mice##2##3##(1990-7#1)(2009-12#1)
into improved##4##2##(2008-10#2)(2008-9#1)(2009-3#1)
into independent##2##2##(2008-10#1)(2008-2#1)
into information that##2##3##(1995-12#1)(2008-2#1)
into information##4##2##(1995-12#1)(2008-2#1)(2008-7#1)(2012-12#1)
into injured##5##2##(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
into inpatient##3##2##(1992-12#1)(1995-12#1)(1997-2#1)
into integrated##2##2##(1997-2#1)(1997-3#1)
into internal##2##2##(2008-4#1)(2011-2#1)
into interventions##3##2##(2009-11#1)(2010-12#1)(2012-2#1)
into intestinal##2##2##(2008-10#1)(2008-11#1)
into intracellular organelles##2##3##(1993-11#1)(2012-2#1)
into intracellular##3##2##(1993-11#1)(2011-2#1)(2012-2#1)
into irradiated##2##2##(2008-8#1)(2013-1#1)
into isobutyl methyl ketone (IBMK)##2##5##(2008-10#2)
into isolated##4##2##(1992-3#1)(1994-6#1)(2008-4#1)(2008-7#1)
into issues##3##2##(1992-1#1)(2007-10#1)(2009-5#1)
into it##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
into its component##2##3##(1993-8#2)
into its##22##2##(1991-7#1)(1993-8#2)(1994-2#1)(1997-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)
into ketones##2##2##(2007-11#2)
into key##2##2##(2008-10#1)(2008-2#1)
into large##6##2##(1992-6#1)(2008-10#3)(2008-11#1)(2008-4#1)
into larger##3##2##(1994-5#1)(1996-1#1)(2008-11#1)
into late##3##2##(2008-11#1)(2009-5#1)(2010-1#1)
into law in##2##3##(1996-5#1)(2008-11#1)
into law##8##2##(1991-12#2)(1991-3#1)(1993-1#1)(1994-3#1)(1996-5#2)(2008-11#1)
into left##2##2##(2007-12#1)(2008-7#1)
into lethally irradiated##3##3##(1997-4#1)(2010-11#1)(2011-2#1)
into life##2##2##(1991-2#1)(2013-1#1)
into light##2##2##(2008-2#1)(2013-8#1)
into line##2##2##(1992-1#1)(1996-3#1)
into lipid bilayers##2##3##(2008-10#1)(2010-5#1)
into lipid##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
into liposomes##6##2##(1995-2#2)(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
into liver##3##2##(1995-6#1)(1997-4#1)(1997-7#1)
into local##5##2##(1991-12#1)(1992-12#1)(2007-7#1)(2008-7#1)(2013-1#1)
into long##2##2##(1997-8#1)(2008-8#1)
into long-term##2##2##(1995-12#1)(2011-2#1)
into low##2##2##(2008-12#1)(2013-8#1)
into lymphatic##3##2##(1995-4#1)(2008-1#1)(2011-1#1)
into maize##2##2##(2008-8#2)
into male##2##2##(1992-11#1)(2007-12#1)
into mammalian cells##6##3##(1992-8#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)
into mammalian##8##2##(1991-9#1)(1992-8#1)(1994-11#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)
into mammary##2##2##(2008-8#2)
into managed care##2##3##(1991-3#1)(1993-12#1)
into many##7##2##(2007-11#1)(2008-10#1)(2008-7#2)(2011-2#2)(2012-12#1)
into mature##10##2##(1990-5#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-5#1)(2012-12#1)
into meaningful##2##2##(1994-3#1)(1996-1#1)
into mechanisms##2##2##(2010-8#1)(2011-2#1)
into medical education in the##2##5##(2008-12#2)
into medical eye care##2##4##(2012-12#2)
into medical##10##2##(1991-1#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-12#2)(2009-11#1)(2010-1#1)(2012-12#2)
into membrane##3##2##(1990-2#1)(1993-3#1)(2008-10#1)
into methyl isobutyl ketone (MIBK)##2##5##(2008-10#2)
into methyl##3##2##(2008-10#3)
into mice##4##2##(1995-3#1)(1997-4#1)(2008-4#1)(2013-1#1)
into microbial##2##2##(2008-9#1)(2011-2#1)
into milk from the##2##4##(1992-3#1)(2008-10#1)
into milk from##3##3##(1992-3#2)(2008-10#1)
into milk##5##2##(1992-3#4)(2008-10#1)
into mitochondria##6##2##(1990-2#2)(1994-6#2)(1994-8#1)(2012-2#1)
into mixed##2##2##(1990-7#1)(2008-10#1)
into more##6##2##(1991-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-9#1)
into motor##4##2##(1990-5#1)(1995-12#1)(2007-12#1)(2009-2#1)
into mouse##8##2##(1994-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)
into multilayer##2##2##(2007-12#1)(2008-10#1)
into multinucleated##3##2##(2008-11#3)
into multiple##8##2##(1991-2#1)(1993-2#1)(2008-11#1)(2008-3#3)(2010-6#1)(2013-8#1)
into murine##2##2##(1994-5#1)(1997-4#1)
into muscle##5##2##(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#1)
into myotubes##3##2##(1993-3#1)(2008-11#1)(2008-4#1)
into nascent##3##2##(1993-6#1)(1995-8#1)(2008-9#1)
into national plans##2##3##(1995-12#1)(2007-11#1)
into natural##2##2##(2008-8#1)(2011-1#1)
into networks##2##2##(2008-8#1)(2009-9#1)
into neuronal and##2##3##(1993-8#1)(2008-11#1)
into neurons##5##2##(1994-11#1)(1995-12#1)(2008-7#2)(2012-12#1)
into new therapeutic##2##3##(2009-4#1)(2013-1#1)
into new##11##2##(1990-4#1)(1994-2#1)(1996-11#2)(1997-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-4#1)(2013-1#1)
into newly##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
into nine##2##2##(1993-9#1)(2009-10#1)
into normal##6##2##(1990-2#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)
into nuclei##2##2##(2008-8#2)
into nude##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
into old##2##2##(2010-2#1)(2012-3#1)
into oligodendrocytes##2##2##(1991-5#1)(2008-7#1)
into oligomers##2##2##(1992-11#1)(1994-8#1)
into one cluster##2##3##(2008-10#1)(2009-5#1)
into one of the##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
into one of these##2##4##(1993-8#1)(2008-11#1)
into one of three##3##4##(2008-10#2)(2010-3#1)
into one of##12##3##(1992-7#1)(1993-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)
into one##36##2##(1992-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
into optical##3##2##(2007-12#2)(2008-3#1)
into organic solvent##2##3##(2008-10#2)
into organic##3##2##(2008-10#3)
into orthogonal##2##2##(2007-12#2)
into osteoblasts and##2##3##(2008-11#1)(2012-2#1)
into osteoblasts##4##2##(2008-11#2)(2008-9#1)(2012-2#1)
into other##4##2##(1991-2#1)(2008-11#1)(2010-8#1)(2013-1#1)
into our##10##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#4)(2009-11#1)
into pUC18##2##2##(1992-3#1)(1994-12#1)
into particular##2##2##(2008-10#1)(2012-2#1)
into patient care##3##3##(1993-3#1)(1997-3#1)(2008-12#1)
into patient##4##2##(1990-12#1)(1993-3#1)(1997-3#1)(2008-12#1)
into perinatal education##2##3##(2007-2#2)
into peripheral##2##2##(2010-12#1)(2011-2#1)
into perspective the##2##3##(1990-11#1)(2008-3#1)
into phenotypic##2##2##(2008-10#1)(2009-6#1)
into phosphatidylcholine##2##2##(1990-11#1)(2013-1#1)
into phosphatidylinositol##2##2##(1994-11#1)(1994-6#1)
into phospholipid##3##2##(1994-2#1)(1994-5#1)(1995-11#1)
into phylogenetic##2##2##(2008-8#1)(2010-3#1)
into plant cells##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
into plant##6##2##(2008-10#3)(2008-9#1)(2009-8#1)(2011-2#1)
into plants##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
into plasma##4##2##(1994-12#1)(2008-10#3)
into plasmid pUC19##2##3##(2008-4#1)(2008-8#1)
into plasmid##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
into plasmids##2##2##(1990-11#1)(2008-10#1)
into plasticized##3##2##(2008-10#3)
into plots##2##2##(2008-10#2)
into polyaniline-polyacrylonitrile composite matrix##2##4##(2008-10#2)
into polymer##2##2##(2008-10#1)(2009-9#1)
into possible##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)
into potential##2##2##(2008-10#1)(2008-7#1)
into practical##2##2##(1995-3#1)(2008-6#1)
into practice in##2##3##(1990-5#1)(2010-10#1)
into practice is##2##3##(2008-11#1)(2008-4#1)
into practice##19##2##(1990-5#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-5#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-10#2)(2011-1#1)(2013-1#2)
into primary rat##4##3##(1993-2#1)(2008-9#3)
into primary##8##2##(1991-6#1)(1993-2#2)(2008-9#3)(2009-12#1)(2011-1#1)
into processes##2##2##(1996-2#1)(2013-1#1)
into protein##3##2##(1990-5#1)(2008-4#1)(2011-1#1)
into proteins##6##2##(2008-4#4)(2008-8#1)(2009-11#1)
into proteoliposomes##2##2##(1995-8#2)
into pure DPPC liposomes##3##4##(2008-10#3)
into pure##5##2##(2008-10#4)(2008-5#1)
into quality##2##2##(1993-3#1)(1993-6#1)
into question the##3##3##(1995-3#1)(1995-5#1)(2008-10#1)
into question##6##2##(1992-12#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2009-9#1)
into rabbits##2##2##(1990-2#1)(2008-10#1)
into rat##6##2##(1992-3#1)(1993-8#2)(1995-12#1)(1995-2#1)(2008-10#1)
into rats##7##2##(1990-11#1)(1991-9#1)(1992-11#1)(1993-6#1)(1993-8#1)(1995-2#1)(2008-10#1)
into red blood cells##2##4##(1996-7#1)(2008-9#1)
into red blood##3##3##(1994-12#1)(1996-7#1)(2008-9#1)
into regions##2##2##(1993-11#1)(2007-11#1)
into regular##2##2##(1992-12#1)(2008-11#1)
into regulatory##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
into reliable##2##2##(2008-2#1)(2010-11#1)
into remission##2##2##(1991-9#1)(2010-10#1)
into research##2##2##(2010-10#1)(2010-3#1)
into resonance##2##2##(2007-11#1)(2008-3#1)
into risk factors##3##3##(2008-8#1)(2009-2#1)(2011-2#1)
into risk groups##2##3##(2007-10#1)(2011-2#1)
into risk##6##2##(1995-12#1)(2007-10#1)(2008-8#1)(2009-2#1)(2011-2#2)
into routine clinical##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
into routine oncological care##2##4##(2012-3#2)
into routine##7##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#2)
into secondary structures is##2##4##(1997-6#1)(2006-12#1)
into secondary##3##2##(1997-6#1)(2006-12#1)(2008-10#1)
into self-schemas##2##2##(2010-8#2)
into separate##2##2##(1992-6#1)(1993-8#1)
into serine##4##2##(1991-8#1)(1997-1#3)
into seven lineages##2##3##(2008-10#2)
into seven##8##2##(1997-2#1)(1997-6#1)(2006-8#1)(2008-10#4)(2008-5#1)
into several##16##2##(1990-5#1)(1991-5#1)(1992-6#1)(1993-11#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-5#1)
into sexual##2##2##(2008-8#1)(2010-12#1)
into short##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
into single##2##2##(2008-2#1)(2012-3#1)
into six classes##2##3##(2008-10#1)(2012-12#1)
into six groups##2##3##(2008-11#1)(2011-2#1)
into six variants based on differences in pathogenicity to##2##9##(2008-10#2)
into six##24##2##(1990-12#1)(1991-12#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
into skeletal muscle##3##3##(1997-7#1)(2008-1#1)(2008-3#1)
into small##7##2##(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)
into smaller units##2##3##(2012-3#2)
into smaller##5##2##(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#2)
into smoking##3##2##(1997-4#2)(2009-7#1)
into soil##2##2##(2008-10#2)
into solid##3##2##(2007-12#1)(2008-5#2)
into solution##5##2##(2008-10#4)(2011-2#1)
into some##2##2##(1996-3#1)(2008-8#1)
into specific##5##2##(1991-1#1)(1995-12#1)(2008-11#1)(2008-8#1)(2011-1#1)
into spontaneously##2##2##(1994-11#1)(1994-5#1)
into stable##3##2##(1994-8#1)(2007-11#1)(2008-2#1)
into standard##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
into student##2##2##(2011-2#1)(2013-1#1)
into subcutaneous tissues##2##3##(2010-2#1)(2012-3#1)
into subcutaneous##3##2##(1997-3#1)(2010-2#1)(2012-3#1)
into subgroups##2##2##(2008-10#1)(2013-8#1)
into subpopulations##2##2##(2008-4#1)(2009-4#1)
into subtypes##3##2##(1995-6#1)(2008-9#1)(2012-3#1)
into such##5##2##(1994-1#1)(2007-2#1)(2008-11#1)(2010-11#1)(2010-7#1)
into supercritical carbon dioxide##2##4##(2008-10#2)
into supercritical##3##2##(2008-10#3)
into supported##2##2##(2008-10#1)(2008-4#1)
into syngeneic mice##2##3##(1990-8#1)(2008-4#1)
into syngeneic##4##2##(1990-8#1)(2008-4#2)(2013-1#1)
into synthetic saliva##2##3##(2008-10#2)
into synthetic##4##2##(2008-10#3)(2008-4#1)
into taiwanin##2##2##(1996-5#2)
into target cells##2##3##(1991-2#1)(2011-3#1)
into ten##2##2##(2007-11#1)(2008-12#1)
into that##2##2##(2008-11#1)(2008-5#1)
into the (1##2##3##(1991-8#2)
into the 21st century##7##4##(1991-12#1)(1994-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#1)
into the CNS##2##3##(1992-8#1)(2008-7#1)
into the Caco-2 cell monolayers##2##5##(2008-11#2)
into the DNA##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
into the ER##2##3##(1991-2#2)
into the GC##2##3##(2008-10#2)
into the HPLC system##3##4##(1990-8#1)(2008-10#2)
into the L(2) phase region##2##5##(2008-5#2)
into the Medicare##2##3##(1992-2#1)(1994-12#1)
into the NTS##3##3##(1997-2#3)
into the North##2##3##(2008-10#1)(2013-7#1)
into the Palau##2##3##(2008-1#2)
into the S##3##3##(1991-9#1)(2008-10#2)
into the SNpr##2##3##(1993-12#2)
into the United States##3##4##(2008-10#3)
into the VTA or##2##4##(1993-12#2)
into the abdomen##2##3##(1995-3#1)(2007-12#1)
into the abdominal##3##3##(1995-3#1)(1997-8#1)(2011-2#1)
into the active##3##3##(1990-7#1)(2008-11#1)(2008-8#1)
into the adult##2##3##(1991-12#1)(2008-7#1)
into the affected##2##3##(2008-8#1)(2013-1#1)
into the agar##2##3##(2008-8#2)
into the air##4##3##(2007-11#1)(2008-11#1)(2008-12#1)(2013-1#1)
into the amygdala##3##3##(1992-8#2)(1994-8#1)
into the analysis of##2##4##(2008-10#1)(2008-3#1)
into the analysis##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
into the anterior##4##3##(1994-8#1)(1995-2#1)(1996-5#1)(1997-2#1)
into the appropriate##2##3##(1992-9#1)(2008-12#1)
into the aqueous##2##3##(1991-5#1)(2008-10#1)
into the atmosphere##8##3##(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)
into the atomizer##3##3##(2008-10#3)
into the avian##3##3##(1996-5#2)(2012-12#1)
into the basal##4##3##(1992-10#1)(1994-11#1)(2008-10#1)(2009-10#1)
into the basolateral amygdala##2##4##(1993-12#1)(1997-7#1)
into the behavior of##2##4##(2007-12#1)(2008-7#1)
into the biology of##2##4##(2008-4#1)(2008-5#1)
into the biology##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
into the bladder##5##3##(1992-12#1)(1992-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
into the blood##4##3##(1991-12#1)(2008-11#1)(2008-7#1)(2009-9#1)
into the body##5##3##(1997-3#1)(2008-12#1)(2008-7#1)(2009-11#2)
into the brain##14##3##(1990-3#1)(1993-12#1)(1994-5#1)(1994-8#1)(1997-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-8#3)(2013-1#1)
into the bulk##3##3##(2007-12#1)(2008-10#2)
into the carrier stream##3##4##(2008-10#3)
into the carrier##4##3##(2008-10#4)
into the caudal##3##3##(1993-12#1)(1996-5#2)
into the causes##2##3##(2008-10#1)(2009-3#1)
into the cavity of##2##4##(2008-10#1)(2008-3#1)
into the cavity##8##3##(1995-2#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#3)
into the cell##9##3##(1990-11#1)(1991-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
into the cells of##2##4##(2011-3#1)(2013-8#1)
into the cells##7##3##(1990-2#2)(2008-11#1)(2009-7#1)(2010-11#1)(2011-3#1)(2013-8#1)
into the center of##2##4##(1991-2#1)(2008-11#1)
into the central nervous system##2##5##(1992-4#1)(2008-4#1)
into the central##4##3##(1992-4#1)(2008-11#1)(2008-4#1)(2008-6#1)
into the cervical neck##2##4##(2007-8#2)
into the chromatographic system##2##4##(2008-10#1)(2010-11#1)
into the chromatographic##3##3##(2008-10#2)(2010-11#1)
into the chromosome of##2##4##(1993-9#1)(2008-10#1)
into the chromosome##3##3##(1991-5#1)(1993-9#1)(2008-10#1)
into the circulation during##2##4##(1991-8#1)(1993-11#1)
into the circulation##9##3##(1991-8#2)(1993-11#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2013-8#1)
into the clinical##7##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
into the coding region of##2##5##(1997-3#1)(1997-7#1)
into the community##3##3##(1991-2#1)(1992-5#1)(2007-2#1)
into the conduits of##2##4##(2008-10#2)
into the contributions of##3##4##(2009-11#1)(2012-12#1)(2013-8#1)
into the control##2##3##(2008-10#1)(2009-2#1)
into the core##2##3##(2008-10#1)(2010-2#1)
into the corresponding##7##3##(1992-6#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
into the crop##2##3##(1991-11#1)(2008-10#1)
into the culture media##2##4##(1992-8#1)(2008-11#1)
into the culture medium##14##4##(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#1)(1996-2#1)(1997-1#1)(1997-4#2)(2008-11#1)(2008-7#1)
into the culture supernatant##2##4##(2008-11#2)
into the culture##21##3##(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-1#1)(1994-11#1)(1996-2#1)(1997-1#1)(1997-4#2)(2008-11#5)(2008-7#2)
into the current##3##3##(1994-2#1)(2008-10#1)(2012-2#1)
into the cytoplasm of##3##4##(1994-11#1)(1995-5#1)(2008-10#1)
into the cytoplasm##8##3##(1994-11#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)
into the cytoplasmic##2##3##(1990-11#1)(1992-6#1)
into the cytosol##6##3##(1990-5#1)(1994-5#1)(2009-11#1)(2009-2#2)(2011-2#1)
into the database##3##3##(1995-1#1)(2008-7#1)(2011-1#1)
into the decision making process##2##5##(1996-6#2)
into the degree##2##3##(2008-12#1)(2011-2#1)
into the delivery system##2##4##(1996-1#1)(1997-2#1)
into the dermis##2##3##(1996-12#1)(2008-5#1)
into the design and##2##4##(1995-12#1)(1996-6#1)
into the design##3##3##(1995-12#1)(1996-6#1)(2008-8#1)
into the detector##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
into the detrusor##3##3##(2008-10#3)
into the developing##3##3##(2007-12#2)(2010-12#1)
into the development and##2##4##(2008-4#1)(2010-6#1)
into the development of##6##4##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)
into the development##8##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-6#1)(2011-2#1)
into the device##2##3##(2008-10#1)(2008-2#1)
into the different##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
into the diversity##2##3##(2008-10#1)(2011-1#1)
into the dorsal raphe##2##4##(1991-2#1)(1992-3#1)
into the dorsal##3##3##(1991-2#1)(1992-3#1)(1993-6#1)
into the duodenal##2##3##(1991-6#1)(2008-12#1)
into the dynamics of##2##4##(1994-3#1)(2008-11#1)
into the effect of##4##4##(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
into the effects of##3##4##(1990-11#1)(2008-8#1)(2011-7#1)
into the effluent##2##3##(2008-10#1)(2008-11#1)
into the eggs##2##3##(1993-6#1)(2008-5#1)
into the ejaculatory duct##2##4##(2008-7#2)
into the embryo sac##3##4##(2009-8#3)
into the embryo##4##3##(1994-12#1)(2009-8#3)
into the emulsion##2##3##(2008-10#2)
into the endoplasmic reticulum##4##4##(1991-10#1)(1991-2#2)(1996-3#1)
into the environment##7##3##(1990-7#1)(1991-12#1)(1992-1#1)(1997-2#1)(2008-10#3)
into the enzyme##3##3##(1991-12#1)(1994-11#1)(2008-7#1)
into the epidural space##4##4##(1993-10#3)(2009-3#1)
into the etiology of##2##4##(2008-7#1)(2010-6#1)
into the etiology##3##3##(2008-6#1)(2008-7#1)(2010-6#1)
into the evolution of the##2##5##(1993-2#1)(2008-7#1)
into the evolution of##7##4##(1993-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-5#1)
into the evolutionary##4##3##(1994-8#1)(1997-9#1)(2007-12#1)(2008-9#1)
into the expression##3##3##(1994-5#2)(2008-3#1)
into the extracellular medium##2##4##(1990-11#1)(1994-11#1)
into the extracellular space##2##4##(2008-8#1)(2012-3#1)
into the extracellular##4##3##(1990-11#1)(1994-11#1)(2008-8#1)(2012-3#1)
into the fiber##2##3##(2008-3#2)
into the field##3##3##(2008-10#2)(2010-12#1)
into the first##4##3##(1990-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
into the flame of an atomic##2##6##(2008-10#2)
into the flame##8##3##(2008-10#8)
into the flow line##5##4##(2008-10#5)
into the flow system##3##4##(2008-10#3)
into the flow##13##3##(2008-10#12)(2008-9#1)
into the follicular##2##3##(2008-5#1)(2012-3#1)
into the following 3 types based on##2##7##(2007-10#2)
into the following categories##2##4##(2011-3#1)(2012-12#1)
into the following##6##3##(2007-10#2)(2008-6#1)(2010-6#1)(2011-3#1)(2012-12#1)
into the food##4##3##(2008-12#1)(2008-5#1)(2009-8#1)(2012-1#1)
into the form##2##3##(1997-2#1)(2007-7#1)
into the frontal##3##3##(2011-2#3)
into the functional##3##3##(2008-7#1)(2009-1#1)(2009-7#1)
into the furnace##2##3##(2008-10#2)
into the future##9##3##(1991-12#1)(1993-2#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#1)
into the gain medium##2##4##(2007-11#1)(2008-2#1)
into the gaseous##3##3##(2008-10#3)
into the genome##2##3##(1990-7#1)(2008-4#1)
into the glass##2##3##(2008-10#1)(2008-3#1)
into the graphite tube and##2##5##(2008-10#2)
into the graphite tube##8##4##(2008-10#8)
into the graphite##11##3##(2008-10#11)
into the gut##2##3##(1990-5#1)(2007-12#1)
into the hands of##2##4##(1996-11#1)(1997-2#1)
into the health care system##2##5##(1994-2#1)(1995-2#1)
into the health##3##3##(1994-2#1)(1995-2#2)
into the heart##2##3##(2008-5#1)(2013-1#1)
into the hepatic##2##3##(1995-11#1)(1997-8#1)
into the heterogeneity of##2##4##(2010-12#1)(2012-3#1)
into the host cell##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
into the host chromosome##2##4##(1995-2#1)(2008-2#1)
into the host cytoplasm##2##4##(1996-12#2)
into the host##12##3##(1995-2#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#1)(2009-11#1)(2013-1#1)
into the human##4##3##(1995-2#1)(1997-7#1)(2008-9#1)(2013-1#1)
into the importance of##2##4##(1996-12#1)(1997-9#1)
into the inner membrane##3##4##(1990-2#1)(1992-6#1)(2011-2#1)
into the inner##5##3##(1990-2#1)(1992-6#1)(2007-11#1)(2007-12#1)(2011-2#1)
into the insect##2##3##(1993-6#1)(2008-10#1)
into the intercellular spaces of the##2##6##(2008-10#2)
into the intermediate##2##3##(1995-12#1)(2010-3#1)
into the internal##2##3##(1995-12#1)(2008-7#1)
into the intestinal lumen##2##4##(2011-2#2)
into the joint##2##3##(1996-9#1)(2008-5#1)
into the laser cavity##2##4##(2007-11#1)(2008-3#1)
into the laser diode##2##4##(2008-2#1)(2008-3#1)
into the laser##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
into the lateral ventricle##3##4##(1991-12#1)(1992-8#1)(1995-12#1)
into the lateral##4##3##(1991-12#1)(1992-8#1)(1995-12#1)(1997-2#1)
into the left##7##3##(1997-3#2)(1997-6#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-3#1)
into the lesioned spinal cord##2##5##(2008-7#2)
into the lipid bilayer##2##4##(1994-2#1)(2008-10#1)
into the lipid##5##3##(1994-2#1)(1994-3#1)(1994-5#1)(2008-10#1)(2012-1#1)
into the local##4##3##(1997-8#1)(2008-8#2)(2011-1#1)
into the long-term effects of##2##5##(2009-1#1)(2012-2#1)
into the lower##2##3##(1996-4#1)(2007-7#1)
into the lumen of the##4##5##(1997-1#1)(2007-8#1)(2008-7#1)(2011-2#1)
into the lumen of##5##4##(1997-1#1)(2007-8#1)(2008-7#2)(2011-2#1)
into the lumen##9##3##(1991-12#1)(1993-12#1)(1997-1#1)(2007-8#1)(2008-5#1)(2008-7#2)(2011-2#2)
into the lung##3##3##(1994-12#1)(2008-10#2)
into the lungs##2##3##(1997-1#1)(2007-8#1)
into the main##2##3##(2007-12#1)(2011-2#1)
into the mainstream##2##3##(1994-3#1)(1994-8#1)
into the marketplace##2##3##(1994-1#1)(2008-3#1)
into the maternal##2##3##(1990-12#1)(2010-8#1)
into the measurement##2##3##(2008-3#2)
into the mechanical##3##3##(2010-6#1)(2010-8#1)(2012-12#1)
into the mechanism of action of##2##6##(2008-11#1)(2008-9#1)
into the mechanism of##6##4##(2008-10#2)(2008-11#1)(2008-9#2)(2013-1#1)
into the mechanism##10##3##(1990-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-5#1)(2013-1#1)
into the mechanisms of##5##4##(2007-8#1)(2008-11#2)(2008-4#1)(2009-8#1)
into the mechanisms##9##3##(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)
into the media##2##3##(1994-11#1)(1995-3#1)
into the medial forebrain bundle##3##5##(1992-10#1)(1993-12#1)(1995-12#1)
into the medial pontine reticular formation##2##6##(1990-7#2)
into the medial##10##3##(1990-7#2)(1992-10#1)(1993-12#4)(1994-2#1)(1995-12#1)(1996-2#1)
into the median raphe nucleus##2##5##(1991-2#1)(1993-12#1)
into the medical##2##3##(2008-11#1)(2010-12#1)
into the medium and##2##4##(1994-9#1)(2012-4#1)
into the medium was##3##4##(1990-2#1)(1993-6#1)(1995-2#1)
into the medium##30##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-9#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-4#1)(2013-7#1)
into the membrane##9##3##(1991-10#2)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-5#1)(2009-5#1)
into the membranes##2##3##(1992-6#1)(2008-8#1)
into the middle phase##2##4##(2008-10#2)
into the middle##3##3##(2008-10#2)(2008-7#1)
into the model##3##3##(1992-12#1)(2008-3#1)(2008-9#1)
into the molecular##7##3##(1992-9#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-2#2)
into the mouse##2##3##(1995-12#1)(2008-10#1)
into the movement##2##3##(2009-2#2)
into the mutant conformation##2##4##(1991-5#2)
into the mycobacterial##2##3##(1995-5#2)
into the myocardium##2##3##(2007-8#1)(2010-6#1)
into the natural##2##3##(2008-10#1)(2012-3#1)
into the nature of##4##4##(2008-1#1)(2008-10#1)(2013-1#2)
into the nature##5##3##(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#2)
into the nebulizer##2##3##(2008-10#2)
into the nebulizer-burner system##2##4##(2008-10#2)
into the needle##3##3##(2008-10#2)(2010-8#1)
into the new##2##3##(1995-2#1)(2011-2#1)
into the next millennium##2##4##(2008-10#1)(2008-4#1)
into the next##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
into the normal##2##3##(1996-11#1)(2006-10#1)
into the novel##2##3##(2008-10#1)(2011-2#1)
into the nucleus accumbens##7##4##(1991-2#5)(1993-12#1)(1993-6#1)
into the nucleus and##2##4##(1994-9#1)(1996-12#1)
into the nucleus##24##3##(1991-2#5)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-12#2)(1997-2#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#3)(2012-2#1)
into the nursing curriculum##2##4##(2008-11#1)(2008-12#1)
into the nursing##3##3##(1991-1#1)(2008-11#1)(2008-12#1)
into the oil##2##3##(2008-10#1)(2008-5#1)
into the optical system##3##4##(2007-11#1)(2008-3#2)
into the optical##7##3##(2007-11#2)(2008-3#5)
into the organic phase##6##4##(1994-8#1)(2008-10#4)(2008-7#1)
into the organic solvent##2##4##(2008-10#2)
into the organic##8##3##(1994-8#1)(2008-10#6)(2008-7#1)
into the origin and##2##4##(2008-2#1)(2011-2#1)
into the origin##4##3##(1995-11#1)(1997-3#1)(2008-2#1)(2011-2#1)
into the pathogenesis of MVD##2##5##(2010-12#2)
into the pathogenesis of##5##4##(2007-10#1)(2008-7#1)(2010-12#3)
into the pathophysiology of##2##4##(2008-1#1)(2009-7#1)
into the pathophysiology##3##3##(2007-7#1)(2008-1#1)(2009-7#1)
into the patient's##4##3##(1990-10#1)(1995-3#1)(2008-11#1)(2012-2#1)
into the pericardial cavity##3##4##(2007-8#3)
into the periplasmic space##3##4##(1990-8#1)(1993-6#1)(1997-3#1)
into the peritoneal cavity##4##4##(2008-12#2)(2011-2#1)(2012-12#1)
into the phage##2##3##(1991-6#1)(1995-2#1)
into the phase##2##3##(2007-12#1)(2008-10#1)
into the phenomenon##2##3##(2008-9#1)(2009-5#1)
into the phloem##2##3##(2008-10#2)
into the plasma for##2##4##(2008-10#2)
into the plasma##6##3##(2008-10#5)(2013-8#1)
into the plasmid##5##3##(1992-3#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
into the polymer##7##3##(2008-10#5)(2008-8#1)(2010-2#1)
into the polymeric matrix##2##4##(2008-10#1)(2010-4#1)
into the polypyrrole##2##3##(2008-10#2)
into the population##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
into the pores of##2##4##(2008-10#1)(2008-11#1)
into the posterior fossa##2##4##(1996-9#1)(2011-2#1)
into the posterior##3##3##(1996-9#1)(2007-8#1)(2011-2#1)
into the potential##7##3##(1994-2#1)(1994-3#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
into the previously##2##3##(1993-2#1)(2008-10#1)
into the problem##2##3##(2007-12#1)(2008-7#1)
into the proposed##2##3##(2008-10#1)(2009-10#1)
into the protein##4##3##(1990-8#2)(1995-2#1)(1995-5#1)
into the pulmonary circulation##2##4##(1992-3#1)(1994-8#1)
into the pulmonary##5##3##(1992-2#1)(1992-3#1)(1994-8#1)(2010-5#1)(2010-8#1)
into the quality of##2##4##(1991-6#1)(1995-6#1)
into the quality##3##3##(1991-6#1)(1993-2#1)(1995-6#1)
into the rat##3##3##(1991-9#1)(1995-12#1)(2008-4#1)
into the reaction##3##3##(2008-10#1)(2009-8#1)(2010-4#1)
into the receiver##2##3##(2008-2#1)(2008-3#1)
into the rectum##2##3##(1993-9#1)(2012-1#1)
into the region##2##3##(1997-3#1)(2007-12#1)
into the regulation of##3##4##(1994-10#1)(2009-6#1)(2012-12#1)
into the relationship between##3##4##(2008-11#1)(2008-3#1)(2010-6#1)
into the renal##2##3##(1994-5#1)(2007-10#1)
into the right atrium##9##4##(2007-8#3)(2008-11#1)(2012-2#1)(2013-1#2)(2013-2#2)
into the right##15##3##(1990-12#1)(1995-12#1)(1996-9#1)(1997-1#1)(2007-8#3)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-2#2)
into the role of##8##4##(1991-1#1)(1991-10#1)(1992-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-8#1)
into the role##9##3##(1991-1#1)(1991-10#1)(1992-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
into the roles of these##2##5##(2010-12#1)(2012-12#1)
into the roles of##5##4##(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
into the same##12##3##(1995-11#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-1#1)(2010-5#1)(2013-8#1)
into the sample##8##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-1#1)
into the sea##2##3##(2008-11#1)(2008-8#1)
into the second##2##3##(2008-2#1)(2008-7#1)
into the secretory pathway and##2##5##(2012-2#2)
into the sensor##2##3##(2008-10#2)
into the sequence##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
into the setup##2##3##(2007-11#1)(2008-3#1)
into the skin##8##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#5)
into the small intestine##2##4##(2008-5#1)(2008-8#1)
into the small##5##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
into the soil##7##3##(2008-10#4)(2008-11#1)(2008-7#1)(2012-12#1)
into the soils##2##3##(2008-10#2)
into the solution##4##3##(1994-3#1)(2008-10#3)
into the source##3##3##(2008-10#2)(2008-11#1)
into the spatial and temporal##2##5##(2008-2#1)(2009-8#1)
into the spermatheca##2##3##(2008-6#1)(2012-12#1)
into the spermathecal##2##3##(2008-5#1)(2008-8#1)
into the sphenoid sinus##2##4##(2011-2#2)
into the spleen##3##3##(1991-6#1)(1995-12#1)(2008-7#1)
into the standard of##2##4##(2007-2#1)(2009-12#1)
into the strategic##2##3##(1994-2#1)(1997-1#1)
into the stream##2##3##(2008-10#1)(2012-12#1)
into the striatum##2##3##(1995-12#1)(2008-7#1)
into the structural##5##3##(1991-6#1)(2008-10#1)(2008-4#1)(2008-8#2)
into the structure and function of##2##6##(2008-4#1)(2010-12#1)
into the structure of##3##4##(2007-11#1)(2008-9#1)(2012-12#1)
into the structure##8##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)
into the study##7##3##(1992-3#1)(1992-5#1)(2008-1#1)(2008-4#1)(2009-6#1)(2011-1#2)
into the subadventitial layer of the##2##6##(2011-2#2)
into the subadventitial##3##3##(2008-7#1)(2011-2#2)
into the subarachnoid##2##3##(2007-10#1)(2008-7#1)
into the surfactant-rich phase##3##4##(2008-10#1)(2008-7#2)
into the surrounding##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
into the sweat glands##2##4##(2008-5#2)
into the synovial##2##3##(1993-2#1)(2008-5#1)
into the system##12##3##(1990-12#1)(2007-12#1)(2008-10#7)(2008-6#1)(2010-6#2)
into the target cells##2##4##(2008-11#1)(2008-5#1)
into the target##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
into the third##2##3##(1990-7#1)(2008-10#1)
into the three##3##3##(1997-4#1)(1997-6#1)(2009-10#1)
into the thymus##2##3##(1994-5#2)
into the tissue##2##3##(1994-2#1)(2008-5#1)
into the treatment##2##3##(2009-9#1)(2012-3#1)
into the tumor##3##3##(1990-2#1)(2013-1#2)
into the tumour bed##2##4##(2008-7#2)
into the underlying##3##3##(2008-11#1)(2008-7#1)(2010-4#1)
into the unknown##2##3##(1991-3#1)(2008-10#1)
into the upper phase##4##4##(2008-10#4)
into the upper##7##3##(1994-9#1)(2008-10#6)
into the use of##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
into the vas##2##3##(1994-8#2)
into the vascular wall##2##4##(1990-8#1)(2010-5#1)
into the vascular##4##3##(1990-8#1)(1997-1#1)(2008-10#1)(2010-5#1)
into the vector##5##3##(1991-6#1)(1994-12#1)(2008-11#1)(2008-8#1)(2010-5#1)
into the ventral hippocampus##2##4##(1995-12#2)
into the ventral tegmental area (VTA)##2##6##(1993-12#2)
into the ventral tegmental area##3##5##(1993-12#3)
into the ventral##6##3##(1993-12#3)(1995-12#2)(2011-2#1)
into the vertebral body##2##4##(2007-11#1)(2007-8#1)
into the water##2##3##(2008-10#1)(2008-3#1)
into the waveguide##4##3##(2007-11#2)(2008-3#2)
into the work##2##3##(1997-3#1)(2009-7#1)
into the world of##2##4##(1994-2#1)(2010-8#1)
into the yeast##2##3##(1995-2#1)(1997-7#1)
into the##1890##2##(1990-10#1)(1990-11#11)(1990-12#7)(1990-2#7)(1990-3#1)(1990-5#9)(1990-7#10)(1990-8#13)(1990-9#4)(1991-1#3)(1991-10#5)(1991-11#1)(1991-12#13)(1991-2#14)(1991-3#2)(1991-5#7)(1991-6#6)(1991-8#6)(1991-9#7)(1992-1#4)(1992-10#4)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#10)(1992-8#8)(1992-9#2)(1993-1#3)(1993-10#3)(1993-11#1)(1993-12#28)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#12)(1993-8#3)(1993-9#8)(1994-1#3)(1994-10#1)(1994-11#11)(1994-12#15)(1994-2#12)(1994-3#13)(1994-5#11)(1994-6#2)(1994-8#12)(1994-9#12)(1995-1#2)(1995-11#5)(1995-12#16)(1995-2#17)(1995-3#11)(1995-5#7)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#13)(1996-2#11)(1996-3#2)(1996-4#3)(1996-5#10)(1996-6#4)(1996-9#6)(1997-1#10)(1997-2#22)(1997-3#21)(1997-4#9)(1997-6#6)(1997-7#10)(1997-8#12)(1997-9#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#7)(2007-11#29)(2007-12#45)(2007-2#2)(2007-4#2)(2007-5#5)(2007-7#7)(2007-8#18)(2008-1#19)(2008-10#362)(2008-11#78)(2008-12#19)(2008-2#37)(2008-3#70)(2008-4#37)(2008-5#60)(2008-6#15)(2008-7#71)(2008-8#50)(2008-9#30)(2009-1#2)(2009-10#5)(2009-11#10)(2009-12#2)(2009-2#8)(2009-3#4)(2009-4#2)(2009-5#6)(2009-6#9)(2009-7#8)(2009-8#18)(2009-9#5)(2010-1#3)(2010-11#9)(2010-12#10)(2010-2#2)(2010-3#6)(2010-4#7)(2010-5#10)(2010-6#13)(2010-7#1)(2010-8#12)(2010-9#3)(2011-1#19)(2011-10#1)(2011-2#52)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#15)(2012-2#32)(2012-3#21)(2012-4#1)(2012-7#1)(2013-1#41)(2013-2#2)(2013-7#6)(2013-8#15)
into their physiological##2##3##(2008-4#1)(2008-7#1)
into their respective##2##3##(1991-5#1)(2008-10#1)
into their##44##2##(1990-5#1)(1991-5#1)(1992-8#1)(1993-11#1)(1995-3#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#3)(2008-8#2)(2009-11#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
into these cells##3##3##(1991-12#1)(1991-5#1)(2010-11#1)
into these##18##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#2)(2008-10#4)(2008-4#1)(2008-8#2)(2009-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
into this area##2##3##(1995-2#1)(2008-11#1)
into this process##2##3##(2008-11#1)(2008-7#1)
into this puzzle##2##3##(2009-7#1)(2013-1#1)
into this##29##2##(1993-12#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
into those of##2##3##(1994-12#1)(2008-10#1)
into those##7##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-2#1)(2009-12#1)(2010-12#1)
into three broad##2##3##(1991-2#1)(1997-1#1)
into three categories##6##3##(2008-10#1)(2008-6#1)(2010-12#2)(2011-2#2)
into three classes##2##3##(2007-12#1)(2008-7#1)
into three different##4##3##(1997-8#1)(2008-10#2)(2013-1#1)
into three distinct groups##2##4##(2008-10#1)(2011-2#1)
into three distinct##7##3##(1994-3#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#1)
into three fractions##2##3##(1991-5#1)(1995-6#1)
into three groups according to the##2##6##(1996-6#1)(2011-1#1)
into three groups depending##2##4##(2007-8#1)(2008-5#1)
into three groups##31##3##(1994-6#1)(1995-1#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#3)
into three levels##2##3##(2010-11#1)(2010-8#1)
into three major##3##3##(2008-6#1)(2009-7#1)(2012-3#1)
into three separate##3##3##(2008-8#1)(2009-10#1)(2012-2#1)
into three stages##4##3##(2008-10#1)(2008-4#3)
into three subgroups##2##3##(2008-5#1)(2013-8#1)
into three types of##2##4##(2008-4#1)(2008-5#1)
into three types##5##3##(1990-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
into three##116##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#5)
into thyroid##3##2##(1994-11#1)(1994-6#1)(2013-1#1)
into tissue culture##2##3##(1993-9#1)(2008-11#1)
into tissue##5##2##(1993-12#1)(1993-9#1)(2008-11#1)(2011-2#1)(2011-3#1)
into tissues##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
into to##2##2##(2008-12#1)(2011-2#1)
into tobacco##7##2##(1997-2#1)(1997-6#2)(2008-10#1)(2008-7#1)(2008-9#2)
into toluene##3##2##(2008-10#3)
into tomato##2##2##(2008-10#2)
into total##2##2##(1994-8#2)
into treatment##3##2##(2007-10#1)(2008-9#1)(2011-1#1)
into triglycerides##2##2##(2013-1#2)
into tumors##3##2##(1994-5#2)(2010-7#1)
into two beams##3##3##(2007-12#2)(2008-3#1)
into two categories##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
into two classes##3##3##(1994-12#1)(1995-11#1)(2010-8#1)
into two components##2##3##(2008-3#1)(2008-5#1)
into two distinct groups##5##4##(2008-10#5)
into two distinct##15##3##(1990-5#1)(1995-12#1)(2007-12#1)(2008-10#10)(2008-5#1)(2008-7#1)
into two equal groups##6##4##(2007-7#2)(2007-9#1)(2008-1#1)(2008-12#1)(2012-2#1)
into two groupings##2##3##(2007-12#1)(2008-10#1)
into two groups according to the##3##6##(1997-2#1)(1997-7#1)(2008-10#1)
into two groups according to##5##5##(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#2)
into two groups and##3##4##(1993-2#1)(1994-2#1)(2012-3#1)
into two groups by##2##4##(1995-12#1)(2008-10#1)
into two groups that##3##4##(2008-10#2)(2013-1#1)
into two groups##71##3##(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#2)(2007-11#1)(2007-6#1)(2007-8#5)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
into two main categories##2##4##(2008-8#1)(2011-2#1)
into two main clusters##2##4##(2008-10#1)(2008-5#1)
into two main##6##3##(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
into two major groups##2##4##(2008-10#2)
into two major##8##3##(1993-6#1)(2008-10#5)(2008-11#1)(2009-11#1)
into two parts##4##3##(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)
into two phases##4##3##(2008-10#1)(2008-4#1)(2008-5#2)
into two sections##2##3##(2008-10#1)(2008-4#1)
into two separate##5##3##(1993-6#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
into two subfamilies##3##3##(2008-4#1)(2008-8#2)
into two subgroups##5##3##(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
into two subpopulations##2##3##(2008-10#1)(2008-11#1)
into two types##4##3##(1997-2#1)(2007-12#1)(2008-10#2)
into two##210##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#4)(1995-3#2)(1995-4#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#4)(2007-11#1)(2007-12#9)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#57)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#13)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#8)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
into type##2##2##(2007-12#2)
into types##2##2##(1997-8#1)(2008-7#1)
into underlying##5##2##(1991-3#1)(1991-5#1)(1996-3#1)(2008-4#1)(2008-7#1)
into uninoculated leaves##3##3##(2008-10#3)
into units##2##2##(2008-1#1)(2008-2#1)
into unlabelled cells##2##3##(1991-5#2)
into urine##5##2##(1990-12#1)(1993-9#2)(1995-3#1)(2008-10#1)
into use##2##2##(1990-2#1)(2010-8#1)
into various diluents##3##3##(2008-10#3)
into various organic solvents##3##4##(2008-10#3)
into various types##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
into various##21##2##(1991-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#3)(2010-3#1)(2012-12#1)(2013-1#2)
into vector##3##2##(1995-12#1)(2007-12#1)(2008-9#1)
into very##4##2##(1990-11#1)(1991-5#1)(1993-11#1)(2008-11#1)
into volatile odorous products##2##4##(2008-5#2)
into waste##2##2##(2008-10#1)(2008-5#1)
into water##5##2##(1990-2#1)(2008-10#3)(2013-8#1)
into wheat ceramides##2##3##(2008-5#2)
into wheat##7##2##(2008-10#2)(2008-5#2)(2008-8#2)(2011-10#1)
into whether##3##2##(2008-8#1)(2009-5#1)(2011-1#1)
into which the##5##3##(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-5#1)
into which##16##2##(1993-8#1)(1995-2#1)(1995-3#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-12#1)
into widespread use##2##3##(2010-8#1)(2012-12#1)
into wild-type##3##2##(1995-8#1)(2008-10#1)(2013-1#1)
into xylene##4##2##(2008-10#4)
into yeast##4##2##(1997-4#1)(2008-4#2)(2008-8#1)
into young##2##2##(1994-5#1)(2008-9#1)
into your##2##2##(1991-1#1)(1994-3#1)
into zeolites##2##2##(2008-10#2)
into##6253##1##(1990-10#1)(1990-11#30)(1990-12#18)(1990-2#17)(1990-3#5)(1990-4#4)(1990-5#37)(1990-6#2)(1990-7#21)(1990-8#29)(1990-9#6)(1991-1#8)(1991-10#6)(1991-11#6)(1991-12#34)(1991-2#30)(1991-3#11)(1991-4#1)(1991-5#34)(1991-6#15)(1991-7#2)(1991-8#7)(1991-9#19)(1992-1#9)(1992-10#12)(1992-11#15)(1992-12#30)(1992-2#5)(1992-3#30)(1992-4#4)(1992-5#8)(1992-6#20)(1992-7#1)(1992-8#17)(1992-9#16)(1993-1#8)(1993-10#3)(1993-11#21)(1993-12#59)(1993-2#15)(1993-3#20)(1993-5#2)(1993-6#30)(1993-8#24)(1993-9#19)(1994-1#10)(1994-10#1)(1994-11#27)(1994-12#48)(1994-2#28)(1994-3#40)(1994-5#35)(1994-6#22)(1994-7#4)(1994-8#42)(1994-9#23)(1995-1#10)(1995-11#15)(1995-12#53)(1995-2#44)(1995-3#30)(1995-4#2)(1995-5#21)(1995-6#26)(1995-8#14)(1995-9#6)(1996-1#13)(1996-10#2)(1996-11#5)(1996-12#20)(1996-2#34)(1996-3#17)(1996-4#4)(1996-5#27)(1996-6#12)(1996-7#2)(1996-8#4)(1996-9#10)(1997-1#29)(1997-2#52)(1997-3#50)(1997-4#33)(1997-5#3)(1997-6#27)(1997-7#34)(1997-8#25)(1997-9#2)(2006-10#6)(2006-12#9)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#22)(2007-11#99)(2007-12#169)(2007-2#9)(2007-4#3)(2007-5#8)(2007-6#4)(2007-7#23)(2007-8#42)(2007-9#3)(2008-1#54)(2008-10#1184)(2008-11#301)(2008-12#80)(2008-2#139)(2008-3#253)(2008-4#152)(2008-5#185)(2008-6#61)(2008-7#227)(2008-8#198)(2008-9#162)(2009-1#2)(2009-10#22)(2009-11#26)(2009-12#22)(2009-2#14)(2009-3#14)(2009-4#20)(2009-5#28)(2009-6#16)(2009-7#28)(2009-8#42)(2009-9#27)(2010-1#14)(2010-10#18)(2010-11#28)(2010-12#34)(2010-2#11)(2010-3#26)(2010-4#33)(2010-5#31)(2010-6#29)(2010-7#11)(2010-8#41)(2010-9#8)(2011-1#73)(2011-10#2)(2011-2#152)(2011-3#13)(2011-7#2)(2012-1#22)(2012-12#57)(2012-2#92)(2012-3#56)(2012-4#3)(2012-5#1)(2012-7#3)(2013-1#149)(2013-2#2)(2013-7#15)(2013-8#51)
intolerable##3##1##(1996-3#1)(2008-10#1)(2008-9#1)
intolerance to##4##2##(1990-3#1)(1992-6#1)(2007-12#1)(2012-3#1)
intolerance with onset or first recognition##2##6##(2008-1#1)(2009-3#1)
intolerance##32##1##(1990-3#1)(1991-5#1)(1992-6#1)(1994-3#1)(1997-6#2)(2007-12#1)(2008-1#4)(2008-12#1)(2008-3#4)(2008-4#1)(2009-11#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
intolerant to##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
intolerant##6##1##(2008-5#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
intonation development##3##2##(2010-10#3)
intonation in##2##2##(2010-10#2)
intonation##8##1##(2010-10#6)(2013-8#2)
intonational##4##1##(2013-8#4)
intoxicated by##2##2##(1990-9#1)(1991-11#1)
intoxicated with 20% ethanol##2##4##(1994-7#2)
intoxicated with ethanol##3##3##(1994-7#1)(2009-8#2)
intoxicated with##11##2##(1992-3#3)(1994-6#1)(1994-7#4)(1995-3#1)(2009-8#2)
intoxicated##19##1##(1990-9#1)(1991-11#1)(1992-3#3)(1994-2#1)(1994-6#1)(1994-7#4)(1995-3#1)(1997-2#1)(2008-10#1)(2009-8#2)(2010-1#1)(2011-1#1)(2013-1#1)
intoxication and##3##2##(1990-5#1)(1995-3#1)(2008-6#1)
intoxication in mice##3##3##(1990-5#3)
intoxication in##7##2##(1990-5#3)(1992-7#1)(1995-12#1)(2012-3#1)(2013-8#1)
intoxication with##5##2##(1992-3#1)(1995-11#1)(1997-3#1)(2008-5#1)(2013-1#1)
intoxication##47##1##(1990-5#4)(1990-9#1)(1991-11#3)(1992-3#2)(1992-7#1)(1993-8#1)(1995-11#4)(1995-12#3)(1995-3#2)(1996-5#3)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-12#3)(2009-8#2)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
intoxications##2##1##(1990-3#1)(2013-8#1)
intra abdominal##2##2##(2008-11#2)
intra and##4##2##(2008-10#1)(2009-5#1)(2012-3#1)(2013-1#1)
intra operative##5##2##(2007-9#1)(2012-2#4)
intra##18##1##(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2010-7#1)(2012-2#5)(2012-3#1)(2013-1#1)
intra- and extracellular##6##3##(1994-8#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
intra- and extracranially##2##3##(2008-7#1)(2011-2#1)
intra- and inter-assay precision##2##4##(1995-2#1)(2008-10#1)
intra- and inter-assay##5##3##(1990-12#1)(1995-2#1)(2008-10#2)(2011-3#1)
intra- and inter-day precision##2##4##(2011-2#1)(2011-3#1)
intra- and inter-day##5##3##(2008-10#3)(2011-2#1)(2011-3#1)
intra- and inter-laboratory##2##3##(2008-10#2)
intra- and intermolecular##5##3##(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#2)
intra- and interobserver reproducibility##2##4##(1997-8#2)
intra- and interspecies##2##3##(1992-6#1)(2009-6#1)
intra- and##46##2##(1990-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#2)(2007-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-3#2)(2012-2#2)(2013-7#1)(2013-8#3)
intra- nor##2##2##(1996-2#1)(2008-5#1)
intra-##52##1##(1990-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#3)(1997-2#1)(1997-7#1)(1997-8#2)(2007-11#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
intra-Golgi##4##1##(1997-1#2)(2008-11#1)(2009-7#1)
intra-MR##2##1##(1993-12#2)
intra-NAS D-amphetamine##2##2##(1993-12#2)
intra-NAS injections of##2##3##(1993-12#2)
intra-NAS##5##1##(1993-12#5)
intra-abdominal abscesses in##2##3##(2013-8#2)
intra-abdominal abscesses##3##2##(2013-8#3)
intra-abdominal pressure##3##2##(1996-11#1)(2008-10#1)(2011-2#1)
intra-abdominal testis##2##2##(1997-3#1)(2008-10#1)
intra-abdominal##13##1##(1996-11#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#2)(2013-8#3)
intra-accumbens infusions of D-amphetamine##2##4##(1993-6#2)
intra-accumbens##3##1##(1993-6#3)
intra-amygdala##3##1##(1993-12#2)(1997-7#1)
intra-aneurysmal##3##1##(1997-3#2)(1997-6#1)
intra-aortic balloon pump##3##3##(2010-5#1)(2013-1#2)
intra-aortic balloon##4##2##(2010-5#1)(2011-2#1)(2013-1#2)
intra-aortic##5##1##(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#2)
intra-arterial and intravenous##2##3##(2007-10#1)(2008-8#1)
intra-arterial calcium stimulation##3##3##(2007-5#3)
intra-arterial calcium##4##2##(1997-5#1)(2007-5#3)
intra-arterial chemotherapy in##2##3##(1997-3#1)(2013-1#1)
intra-arterial thrombolysis##7##2##(1994-11#1)(2007-10#4)(2007-9#2)
intra-arterial##21##1##(1994-11#1)(1994-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#5)(2007-5#3)(2007-9#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2013-1#1)
intra-arthricular##2##1##(2007-11#2)
intra-articular calcaneal fracture##3##3##(2012-2#3)
intra-articular effusion##2##2##(2011-2#2)
intra-articular fractures of##2##3##(2009-8#1)(2012-2#1)
intra-articular injections of a hyaluronic acid preparation##2##7##(2013-1#2)
intra-articular injections of##3##3##(2013-1#3)
intra-articular injections##4##2##(2013-1#4)
intra-articular##26##1##(1996-9#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#1)
intra-assay and inter-assay##2##3##(2008-10#2)
intra-assay##9##1##(1996-12#2)(1996-5#2)(2008-10#5)
intra-atrial##3##1##(2007-8#2)(2009-10#1)
intra-axial##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
intra-cardiac ultrasound##3##2##(2007-8#3)
intra-cardiac##8##1##(2007-8#8)
intra-cellular##3##1##(1993-11#2)(2008-11#1)
intra-class##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
intra-cochlear##2##1##(2008-9#2)
intra-cranial pressure##3##2##(2009-6#3)
intra-cranial##5##1##(1992-7#1)(2009-6#4)
intra-day and inter-day##2##3##(2008-10#2)
intra-day and##3##2##(2008-10#3)
intra-day##7##1##(2008-10#6)(2013-8#1)
intra-dialytic symptoms##8##2##(2007-7#4)(2008-1#4)
intra-epithelial##3##1##(1993-8#3)
intra-hepatic and##2##2##(2008-10#1)(2008-11#1)
intra-individual and inter-individual variations##2##4##(1996-12#2)
intra-individual variability##2##2##(1990-8#1)(2008-10#1)
intra-individual##7##1##(1990-8#2)(1996-12#2)(2008-10#1)(2008-5#2)
intra-laboratory##4##1##(2008-10#2)(2013-1#2)
intra-nasally with##2##2##(1997-6#1)(2008-5#1)
intra-operative##15##1##(2007-7#1)(2007-8#4)(2008-6#2)(2008-9#2)(2009-12#1)(2010-8#2)(2012-12#2)(2013-1#1)
intra-operatively##7##1##(2007-7#1)(2008-9#3)(2012-2#1)(2013-1#2)
intra-oral##3##1##(2010-5#1)(2013-8#2)
intra-peritoneal##3##1##(2008-12#2)(2008-6#1)
intra-peritoneally with##2##2##(1995-12#1)(2008-2#1)
intra-professional education##2##2##(2008-12#2)
intra-professional##3##1##(2008-12#2)(2011-1#1)
intra-rater##2##1##(1995-3#1)(2008-10#1)
intra-species biodiversity of spore-forming bacteria##2##5##(2011-2#2)
intra-species##5##1##(1997-7#1)(2008-11#1)(2008-7#1)(2011-2#2)
intra-specific##3##1##(2008-10#1)(2011-2#2)
intra-tetramer negative cooperativity and##2##4##(1997-2#2)
intra-tetramer negative cooperativity##3##3##(1997-2#3)
intra-thoracic##2##1##(2010-4#1)(2011-1#1)
intra-uterine insemination##2##2##(1991-11#1)(1996-9#1)
intra-uterine##4##1##(1991-11#1)(1996-5#1)(1996-9#1)(2009-6#1)
intra-vascular ultrasound##2##2##(2007-8#2)
intra-vascular##3##1##(2007-8#2)(2008-6#1)
intraabdominal viscera##2##2##(1990-2#1)(2011-2#1)
intraabdominal##12##1##(1990-2#2)(1990-9#1)(1991-3#2)(1994-5#1)(2008-12#1)(2011-2#4)(2013-8#1)
intraamygdala injections of d-amphetamine##2##4##(1994-8#2)
intraaortic axial##2##2##(2008-8#2)
intraaortic balloon pumping##2##3##(2007-8#1)(2010-8#1)
intraaortic balloon##3##2##(2007-8#1)(2008-3#1)(2010-8#1)
intraaortic##6##1##(2007-8#1)(2008-3#1)(2008-8#3)(2010-8#1)
intraarterial thrombolysis##3##2##(1996-6#3)
intraarterial##7##1##(1993-8#1)(1994-11#2)(1994-3#1)(1996-6#3)
intraarticular injection of corticosteroids##2##4##(1997-5#2)
intraarticular injection##3##2##(1997-5#3)
intraarticular##9##1##(1990-6#1)(1997-5#3)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-3#1)
intraband##2##1##(2007-11#1)(2007-12#1)
intracanal##4##1##(2008-7#1)(2012-3#2)(2013-1#1)
intracanalicular##2##1##(2006-12#1)(2011-2#1)
intracapsular##2##1##(2008-11#1)(2008-8#1)
intracardiac##7##1##(2007-8#2)(2008-11#1)(2008-5#1)(2009-3#1)(2013-1#1)(2013-8#1)
intracarpal pathology##3##2##(2008-9#3)
intracaudate##2##1##(1994-8#2)
intracaval##3##1##(1991-6#1)(2008-1#1)(2011-2#1)
intracavitary##5##1##(1995-9#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-3#1)
intracavity Bragg##2##2##(2007-11#2)
intracavity KTP##2##2##(2007-11#1)(2008-3#1)
intracavity absorption##2##2##(2007-12#1)(2008-3#1)
intracavity diffractive##2##2##(2008-3#2)
intracavity dispersion##8##2##(2007-11#4)(2007-12#4)
intracavity doubling##3##2##(2007-12#1)(2008-2#2)
intracavity etalon##2##2##(2007-12#1)(2008-3#1)
intracavity etalons##2##2##(2007-11#1)(2008-2#1)
intracavity filter##2##2##(2007-11#2)
intracavity frequency doubling of a##3##5##(2007-12#1)(2008-3#2)
intracavity frequency doubling of##4##4##(2007-12#2)(2008-3#2)
intracavity frequency doubling with a##2##5##(2007-11#1)(2007-12#1)
intracavity frequency doubling##9##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)
intracavity frequency##11##2##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#2)
intracavity frequency-doubled##3##2##(2007-12#1)(2008-2#2)
intracavity frequency-doubling##2##2##(2007-12#2)
intracavity inspection##2##2##(2008-3#2)
intracavity intensity fluctuations##2##3##(2007-12#2)
intracavity intensity##3##2##(2007-12#3)
intracavity laser absorption spectroscopy with##2##5##(2007-12#2)
intracavity laser intensity##2##3##(2007-11#2)
intracavity laser spectroscopy##2##3##(2008-2#2)
intracavity laser##7##2##(2007-11#2)(2007-12#3)(2008-2#2)
intracavity lens##2##2##(2008-3#2)
intracavity nonlinear##2##2##(2007-11#1)(2007-12#1)
intracavity phase##2##2##(2008-3#2)
intracavity polarization##2##2##(2008-2#1)(2008-3#1)
intracavity prism##2##2##(2007-11#1)(2008-2#1)
intracavity pumped##2##2##(2008-3#2)
intracavity second-harmonic generation##4##3##(2007-12#3)(2008-3#1)
intracavity second-harmonic##5##2##(2007-12#4)(2008-3#1)
intracavity spatial##2##2##(2007-12#1)(2008-3#1)
intracavity sum-frequency mixing##2##3##(2007-11#2)
intracavity tripled Ti##2##3##(2007-11#2)
intracavity##131##1##(2007-11#33)(2007-12#48)(2008-10#1)(2008-2#14)(2008-3#35)
intracavity-doubled Nd##2##2##(2007-12#1)(2008-3#1)
intracavity-doubled lasers##2##2##(2008-3#2)
intracavity-doubled##4##1##(2007-12#1)(2008-3#3)
intracellular APP##2##2##(1992-9#1)(1994-9#1)
intracellular ATP##3##2##(2008-11#3)
intracellular Ca(2+) concentration##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
intracellular Ca(2+) increase##2##3##(2008-4#1)(2009-10#1)
intracellular Ca(2+) signals##2##3##(2008-8#1)(2009-8#1)
intracellular Ca(2+)##18##2##(2006-6#3)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-8#2)(2012-2#1)
intracellular Ca++ level##4##3##(1991-9#4)
intracellular Ca++##6##2##(1990-12#1)(1991-9#5)
intracellular Ca2+ chelator##2##3##(1994-3#1)(1996-2#1)
intracellular Ca2+ concentration##6##3##(1990-2#1)(1990-7#2)(1992-8#2)(1994-6#1)
intracellular Ca2+ concentrations##3##3##(1993-3#1)(1995-8#1)(1996-2#1)
intracellular Ca2+ in the##2##4##(1993-3#1)(1993-8#1)
intracellular Ca2+ levels##5##3##(1993-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-4#1)
intracellular Ca2+ stores##2##3##(1994-6#1)(1996-5#1)
intracellular Ca2+##42##2##(1990-12#1)(1990-2#2)(1990-7#3)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-12#2)(1992-8#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#4)(1996-5#1)(1997-4#2)(2008-9#1)
intracellular GSH##2##2##(1990-2#1)(2009-6#1)
intracellular H(2)O(2)##2##2##(2008-11#2)
intracellular KChIP2b##2##2##(2008-8#2)
intracellular RNA from##2##3##(1997-3#2)
intracellular RNA##3##2##(1997-3#3)
intracellular ROS level##2##3##(2008-11#2)
intracellular ROS##6##2##(2008-11#5)(2012-2#1)
intracellular ZDV##2##2##(2008-7#2)
intracellular accumulation of##10##3##(1990-8#1)(1993-3#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-11#2)(2008-7#1)(2009-7#1)(2013-1#1)
intracellular accumulation##12##2##(1990-8#1)(1993-3#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-11#4)(2008-7#1)(2009-7#1)(2013-1#1)
intracellular adhesion molecule-1##2##3##(2006-7#1)(2012-3#1)
intracellular alkalinization##2##2##(1992-12#1)(2013-8#1)
intracellular amino acid pool##2##4##(1990-12#2)
intracellular amino acid##4##3##(1990-12#4)
intracellular amino##5##2##(1990-12#5)
intracellular and extracellular##3##3##(1994-12#1)(1996-8#1)(2008-10#1)
intracellular and intercellular##2##3##(2008-2#1)(2012-1#1)
intracellular and##12##2##(1990-12#1)(1994-12#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-3#1)(2012-1#1)(2013-1#1)
intracellular antibody##2##2##(2008-11#1)(2008-8#1)
intracellular antigen##3##2##(1990-5#1)(2008-9#2)
intracellular antigens##4##2##(1990-12#2)(2008-4#1)(2008-9#1)
intracellular apoB##2##2##(1992-3#1)(1994-8#1)
intracellular bacteria that##2##3##(2008-8#1)(2008-9#1)
intracellular bacteria##3##2##(1994-8#1)(2008-8#1)(2008-9#1)
intracellular bacterium##3##2##(1994-12#1)(1996-12#1)(2008-9#1)
intracellular cAMP levels##3##3##(1995-8#1)(2008-10#2)
intracellular cAMP##9##2##(1990-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#2)(2008-10#2)(2008-11#1)
intracellular cGMP##4##2##(1995-8#3)(2008-4#1)
intracellular calcium and pH in##2##5##(1990-2#1)(1993-5#1)
intracellular calcium and##5##3##(1990-2#2)(1993-5#1)(1994-2#1)(1997-8#1)
intracellular calcium concentration##6##3##(1992-9#1)(1995-2#1)(1995-8#2)(2008-4#1)(2008-8#1)
intracellular calcium concentrations##2##3##(1994-2#1)(2008-8#1)
intracellular calcium for##2##3##(2008-4#1)(2008-8#1)
intracellular calcium mobilization##5##3##(1993-6#1)(1995-2#1)(2008-4#2)(2008-8#1)
intracellular calcium signaling##2##3##(2008-11#1)(2009-7#1)
intracellular calcium stores##3##3##(1994-8#1)(1995-11#1)(2008-4#1)
intracellular calcium##54##2##(1990-2#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#3)(1996-2#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#6)(2008-7#1)(2008-8#6)(2008-9#1)(2009-7#1)(2010-8#1)
intracellular cholesterol##3##2##(1990-8#1)(1994-3#1)(1995-3#1)
intracellular compartment##4##2##(1990-2#1)(1990-7#1)(1993-6#1)(2010-10#1)
intracellular compartments##2##2##(2010-10#1)(2010-11#1)
intracellular concentration of##2##3##(1990-5#1)(2013-1#1)
intracellular concentration sites##2##3##(1990-5#2)
intracellular concentration##6##2##(1990-5#3)(2007-11#1)(2008-7#1)(2013-1#1)
intracellular concentrations of cAMP##2##4##(1994-9#1)(2008-11#1)
intracellular concentrations of##6##3##(1992-6#1)(1994-9#1)(1996-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
intracellular cyclic AMP##5##3##(1995-11#3)(1997-6#1)(2008-10#1)
intracellular delivery##2##2##(1994-12#2)
intracellular distribution##5##2##(1990-2#1)(1991-11#1)(1991-5#1)(2008-11#2)
intracellular domain##5##2##(1991-12#1)(1993-8#3)(2008-8#1)
intracellular drug distribution##2##3##(2008-11#2)
intracellular energy##2##2##(1993-6#1)(2008-4#1)
intracellular environment##2##2##(2008-7#1)(2012-2#1)
intracellular enzyme##2##2##(1990-8#1)(2008-6#1)
intracellular events##3##2##(1990-12#1)(2008-4#1)(2008-7#1)
intracellular expression of##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
intracellular free Ca2+ concentration##3##4##(1993-12#1)(1995-8#2)
intracellular free Ca2+##4##3##(1993-12#1)(1995-8#2)(2008-9#1)
intracellular free calcium mobilization##2##4##(1993-11#2)
intracellular free calcium##4##3##(1992-12#1)(1993-11#2)(1994-6#1)
intracellular free magnesium concentration##2##4##(1993-11#1)(2008-7#1)
intracellular free magnesium##3##3##(1993-11#2)(2008-7#1)
intracellular free##14##2##(1991-9#1)(1992-12#1)(1993-11#4)(1993-12#1)(1994-6#2)(1995-8#2)(2008-4#1)(2008-7#1)(2008-9#1)
intracellular glutathione##2##2##(2008-10#1)(2008-7#1)
intracellular histamine##3##2##(1991-9#2)(2008-11#1)
intracellular hyphae##2##2##(2008-10#2)
intracellular immunoglobulin##3##2##(2008-11#2)(2008-9#1)
intracellular immunoglobulins##2##2##(2008-11#2)
intracellular infection##2##2##(2006-10#1)(2008-9#1)
intracellular ionized calcium##2##3##(2008-4#1)(2008-9#1)
intracellular ions##5##2##(1991-11#1)(2008-4#1)(2008-9#1)(2010-4#2)
intracellular levels of##7##3##(1990-8#1)(1993-8#1)(1995-11#1)(1997-2#2)(2008-4#1)(2009-3#1)
intracellular lipid##2##2##(1996-2#1)(2012-2#1)
intracellular lipolysis from##2##3##(2008-1#2)
intracellular localization of##4##3##(1993-2#1)(1993-8#1)(1994-6#1)(2012-12#1)
intracellular localization##7##2##(1993-2#1)(1993-8#1)(1994-6#1)(1995-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
intracellular location##2##2##(1990-8#1)(2013-1#1)
intracellular markers##2##2##(2008-10#1)(2008-9#1)
intracellular mechanisms##2##2##(2008-3#1)(2013-1#1)
intracellular membranes##2##2##(1992-3#1)(1994-12#1)
intracellular messenger for##2##3##(1992-9#1)(1994-6#1)
intracellular messenger##4##2##(1992-9#1)(1993-3#1)(1994-6#1)(2008-10#1)
intracellular metabolic##2##2##(2008-11#2)
intracellular molecules##2##2##(2008-4#1)(2010-7#1)
intracellular nanosurgery##3##2##(2011-1#3)
intracellular nucleotide##5##2##(2008-11#5)
intracellular organelle##2##2##(1991-8#1)(1992-5#1)
intracellular organelles##6##2##(1993-11#1)(2008-1#1)(2008-7#1)(2008-9#2)(2012-2#1)
intracellular oxidative stress##2##3##(2008-11#1)(2008-9#1)
intracellular oxygen##2##2##(2010-11#2)
intracellular pH (pHi)##4##3##(1994-6#1)(2007-10#1)(2010-8#2)
intracellular pH and##2##3##(2008-11#1)(2008-9#1)
intracellular pH measurements in##2##4##(2008-10#1)(2010-8#1)
intracellular pH##24##2##(1990-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-6#2)(1994-8#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-9#4)(2010-8#4)
intracellular partner(s)##2##2##(1996-2#2)
intracellular pathogen##5##2##(1991-8#1)(1995-2#1)(2009-8#2)(2011-2#1)
intracellular pathogens##5##2##(1995-2#1)(1995-5#1)(2006-10#1)(2009-8#1)(2012-3#1)
intracellular pathways##5##2##(1991-12#1)(1995-5#1)(2008-5#1)(2008-7#1)(2011-2#1)
intracellular phosphoepitopes##2##2##(2008-9#2)
intracellular polyamines##2##2##(1992-8#1)(2008-10#1)
intracellular processes##2##2##(1994-6#1)(2008-1#1)
intracellular processing of##2##3##(1990-8#1)(2010-10#1)
intracellular processing##5##2##(1990-8#1)(1993-8#3)(2010-10#1)
intracellular protein delivery##2##3##(2008-11#2)
intracellular protein##12##2##(1990-5#1)(1990-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-3#1)(2008-11#5)(2008-9#1)
intracellular proteins##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
intracellular reactive oxygen species (ROS)##4##5##(2008-11#1)(2008-9#1)(2009-8#1)(2012-2#1)
intracellular receptors##4##2##(1991-9#1)(2008-4#1)(2011-2#1)(2013-1#1)
intracellular recordings##2##2##(1994-2#1)(2008-11#1)
intracellular second messengers##2##3##(1995-8#1)(2008-7#1)
intracellular second##3##2##(1992-3#1)(1995-8#1)(2008-7#1)
intracellular secretory vesicles##2##3##(2008-7#1)(2008-8#1)
intracellular signal transduction##4##3##(1995-11#1)(2008-8#1)(2009-12#1)(2012-12#1)
intracellular signal##7##2##(1990-7#1)(1995-11#1)(1997-3#1)(2008-3#1)(2008-8#1)(2009-12#1)(2012-12#1)
intracellular signaling molecules##2##3##(1994-12#1)(2009-8#1)
intracellular signaling pathways and##2##4##(1996-12#1)(2008-11#1)
intracellular signaling pathways##9##3##(1994-8#1)(1996-12#1)(2008-11#3)(2008-7#1)(2009-12#2)(2012-2#1)
intracellular signaling##22##2##(1994-12#1)(1994-8#2)(1995-11#1)(1996-12#1)(1997-4#1)(2008-11#4)(2008-4#1)(2008-7#2)(2009-12#2)(2009-8#1)(2010-9#1)(2012-12#2)(2012-2#3)
intracellular signalling processes##2##3##(2008-7#2)
intracellular signalling##10##2##(1994-11#1)(1996-2#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
intracellular signals and##2##3##(2008-4#1)(2011-2#1)
intracellular signals##4##2##(1994-6#1)(2008-4#1)(2008-9#1)(2011-2#1)
intracellular sodium concentration##2##3##(1992-11#1)(1994-3#1)
intracellular sodium##5##2##(1992-11#1)(1994-3#4)
intracellular storage##3##2##(1991-12#1)(2007-12#1)(2009-5#1)
intracellular stores is##2##3##(1994-8#1)(2008-4#1)
intracellular stores##12##2##(1990-12#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(2008-4#2)(2008-7#1)(2012-2#1)
intracellular targets##2##2##(2008-4#1)(2011-2#1)
intracellular thiols##2##2##(1991-9#1)(2008-9#1)
intracellular trafficking and##2##3##(1994-8#1)(2008-11#1)
intracellular trafficking##5##2##(1993-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(2008-11#1)
intracellular transport of##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
intracellular transport##10##2##(1992-5#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
intracellular vanadyl##2##2##(1990-2#2)
intracellular zinc##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
intracellular##757##1##(1990-12#15)(1990-2#13)(1990-5#6)(1990-7#7)(1990-8#12)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#2)(1991-9#15)(1992-11#2)(1992-12#9)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#4)(1992-9#8)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#9)(1993-5#1)(1993-6#5)(1993-8#11)(1994-10#2)(1994-11#16)(1994-12#12)(1994-2#7)(1994-3#10)(1994-5#1)(1994-6#20)(1994-8#13)(1994-9#5)(1995-11#17)(1995-12#2)(1995-2#6)(1995-3#3)(1995-5#8)(1995-6#3)(1995-8#19)(1996-12#6)(1996-2#13)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-7#1)(2008-1#7)(2008-10#33)(2008-11#80)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#33)(2008-5#6)(2008-6#2)(2008-7#37)(2008-8#27)(2008-9#35)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#7)(2009-7#4)(2009-8#9)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#9)(2012-1#3)(2012-12#9)(2012-2#13)(2012-3#3)(2012-6#1)(2013-1#15)(2013-8#3)
intracellulare##3##1##(2008-1#3)
intracellularly and##2##2##(2013-1#1)(2013-8#1)
intracellularly applied##2##2##(1992-8#2)
intracellularly in the##3##3##(1992-12#1)(1993-6#1)(1994-11#1)
intracellularly in##5##2##(1992-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(2008-10#1)
intracellularly##28##1##(1990-8#1)(1991-12#2)(1992-12#2)(1992-8#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
intracerebellar##5##1##(1997-2#5)
intracerebral and##2##2##(2008-5#1)(2012-1#1)
intracerebral haematoma##2##2##(2008-7#2)
intracerebral haemorrhage and##2##3##(2008-7#2)
intracerebral haemorrhage##9##2##(2008-7#6)(2008-8#3)
intracerebral hematoma##3##2##(2008-12#3)
intracerebral hemorrhage (ICH)##3##3##(2007-10#1)(2008-8#1)(2012-3#1)
intracerebral hemorrhage in##2##3##(2007-10#1)(2012-12#1)
intracerebral hemorrhage##22##2##(1995-5#1)(2007-10#13)(2007-9#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
intracerebral infusion of neurotrophic factors##2##5##(2008-7#2)
intracerebral infusion of##3##3##(2008-7#3)
intracerebral infusion##5##2##(2008-7#5)
intracerebral lesions##2##2##(2008-7#2)
intracerebral##58##1##(1992-12#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-6#1)(1997-3#1)(2007-10#13)(2007-9#1)(2008-12#4)(2008-5#1)(2008-7#18)(2008-8#5)(2009-11#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
intracerebrally##2##1##(1994-8#1)(1996-5#1)
intracerebroventricular (i##6##2##(1992-3#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)
intracerebroventricular administration##3##2##(1992-3#1)(1993-12#1)(1995-12#1)
intracerebroventricular injection of##3##3##(1995-12#1)(1997-2#1)(2008-8#1)
intracerebroventricular injection##4##2##(1995-12#1)(1997-2#1)(2008-8#1)(2010-2#1)
intracerebroventricular##17##1##(1992-3#3)(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#3)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-8#1)(2010-2#1)
intracerebroventricularly (i##5##2##(1992-3#2)(1996-2#1)(1997-4#2)
intracerebroventricularly##6##1##(1991-9#1)(1992-3#2)(1996-2#1)(1997-4#2)
intrachain disulfide bonds##3##3##(1990-5#3)
intrachain##4##1##(1990-5#4)
intrachannel interactions in a transmission system with strong periodic dispersion management##2##11##(2007-11#1)(2007-12#1)
intrachannel interactions in##3##3##(2007-11#1)(2007-12#2)
intrachannel##6##1##(2007-11#4)(2007-12#2)
intrachip##2##1##(2008-3#2)
intrachromosomal gene conversion and pop-out recombination##2##6##(1990-5#2)
intrachromosomal insertion##2##2##(2012-3#2)
intrachromosomal recombination in##3##3##(1993-12#1)(1995-6#1)(1996-2#1)
intrachromosomal recombination##4##2##(1993-12#1)(1995-6#1)(1996-2#2)
intrachromosomal##8##1##(1990-5#2)(1993-12#1)(1995-6#1)(1996-2#2)(2012-3#2)
intraclass correlation coefficient##4##3##(2007-10#1)(2008-12#1)(2008-7#1)(2013-7#1)
intraclass correlation##8##2##(2007-10#1)(2008-10#3)(2008-12#2)(2008-7#1)(2013-7#1)
intracochlear trauma##3##2##(2012-2#3)
intracochlear##7##1##(2008-9#4)(2012-2#3)
intracore##2##1##(2007-12#2)
intracoronary OFDI##2##2##(2011-1#2)
intracoronary delivery##2##2##(2012-2#2)
intracoronary stents##2##2##(1994-11#2)
intracoronary##20##1##(1990-12#1)(1994-11#4)(2007-8#4)(2008-10#1)(2008-7#1)(2011-1#4)(2012-1#1)(2012-2#4)
intracortical##3##1##(1994-8#1)(1996-2#1)(2008-11#1)
intracranial and##4##2##(1991-6#1)(2008-7#1)(2011-2#2)
intracranial aneurysm##6##2##(1995-5#1)(2007-10#3)(2008-7#1)(2011-2#1)
intracranial aneurysms##10##2##(1995-11#1)(1997-3#1)(2006-7#1)(2008-2#1)(2008-7#3)(2009-7#1)(2009-9#1)(2011-2#1)
intracranial arterial##3##2##(1991-5#1)(1997-6#2)
intracranial arteries##2##2##(2012-3#1)(2013-8#1)
intracranial arteriovenous malformations##2##3##(1991-2#1)(2008-9#1)
intracranial arteriovenous##3##2##(1991-2#2)(2008-9#1)
intracranial atherosclerosis##7##2##(2008-12#4)(2008-7#1)(2008-8#2)
intracranial complications of##2##3##(2012-8#2)
intracranial complications##4##2##(1991-6#1)(2012-2#1)(2012-8#2)
intracranial extension##2##2##(1997-3#1)(2008-7#1)
intracranial haemorrhage and need##2##4##(1992-6#2)
intracranial haemorrhage and##3##3##(1992-6#3)
intracranial haemorrhage##10##2##(1992-6#4)(2007-10#2)(2008-7#2)(2011-2#2)
intracranial hemorrhage##4##2##(2007-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
intracranial hypertension##11##2##(1995-11#1)(2008-7#5)(2009-5#1)(2010-5#2)(2011-2#2)
intracranial hypotension##4##2##(2008-7#3)(2010-11#1)
intracranial meningioma##3##2##(2008-7#3)
intracranial meningiomas##2##2##(1995-9#1)(2011-2#1)
intracranial metastases##2##2##(1997-4#2)
intracranial metastasis##2##2##(2011-2#1)(2012-2#1)
intracranial pressure (ICP)##7##3##(1993-1#1)(2006-7#1)(2008-12#1)(2008-7#2)(2010-5#1)(2011-2#1)
intracranial pressure and##3##3##(1993-1#1)(2011-2#2)
intracranial pressure##20##2##(1992-11#1)(1993-1#2)(1997-3#1)(2006-7#1)(2008-1#1)(2008-12#2)(2008-7#4)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#4)(2013-1#1)
intracranial saccular aneurysms##2##3##(1995-11#1)(2010-9#1)
intracranial self-stimulation (ICSS)##2##3##(1991-2#1)(1996-2#1)
intracranial self-stimulation##3##2##(1991-2#2)(1996-2#1)
intracranial skull base##2##3##(2006-12#2)
intracranial space##2##2##(2008-9#1)(2011-2#1)
intracranial stenosis##2##2##(2008-8#2)
intracranial stenting##2##2##(2008-12#1)(2009-7#1)
intracranial surgery##3##2##(2008-7#3)
intracranial tumor##5##2##(2008-12#1)(2008-7#1)(2011-2#2)(2012-2#1)
intracranial tumour##2##2##(2008-7#2)
intracranial##178##1##(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-6#4)(1993-1#2)(1993-12#1)(1993-9#1)(1994-8#2)(1995-11#5)(1995-5#2)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(2006-12#2)(2006-7#2)(2007-10#9)(2007-9#1)(2008-1#2)(2008-12#9)(2008-2#2)(2008-7#41)(2008-8#4)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#21)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-8#3)(2013-1#3)(2013-7#1)(2013-8#6)
intracranialis##2##1##(1990-12#2)
intracranially##2##1##(1992-3#1)(2011-2#1)
intractable asthma##2##2##(2012-2#2)
intractable epilepsy##3##2##(1996-3#1)(2008-7#1)(2009-9#1)
intractable facial pain##2##3##(1993-1#2)
intractable nausea and vomiting##4##4##(2008-7#1)(2013-8#3)
intractable##32##1##(1993-1#2)(1994-3#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#5)(2008-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
intracutaneous##4##1##(2007-10#2)(2007-7#2)
intracystic breast cancer##2##3##(1994-7#2)
intracystic papillary carcinoma##2##3##(1992-2#1)(2011-2#1)
intracystic##11##1##(1992-2#1)(1993-1#1)(1994-7#5)(2008-12#1)(2008-4#1)(2011-2#2)
intracytoplasmic sperm injection##3##3##(2009-5#1)(2012-3#2)
intracytoplasmic##13##1##(1991-8#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2012-1#2)(2012-3#2)
intraday and##2##2##(2008-10#2)
intradermal injection of##2##3##(1995-12#1)(2008-9#1)
intradermal injection##5##2##(1992-12#1)(1992-6#1)(1995-12#1)(2008-9#1)(2012-2#1)
intradermal reaction##2##2##(1990-6#1)(1993-3#1)
intradermal##17##1##(1990-6#1)(1990-7#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-12#1)(1995-5#1)(1997-8#2)(2008-4#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
intradermally##4##1##(1990-6#1)(1991-8#1)(1995-11#1)(2008-12#1)
intradialytic##3##1##(2008-1#3)
intradiscal aspiration of##2##3##(2012-2#2)
intradiscal injections of##2##3##(1996-3#2)
intradiscal thermoablation##2##2##(2007-8#2)
intradiscal##8##1##(1992-5#1)(1996-3#2)(2007-10#1)(2007-8#2)(2012-2#2)
intradiskal electrothermal annuloplasty (IDET)##2##4##(2008-8#2)
intradiskal electrothermal annuloplasty##3##3##(2008-8#3)
intraductal papilloma##3##2##(1991-2#3)
intraductal pathology##2##2##(1990-11#2)
intraductal##12##1##(1990-11#2)(1990-12#1)(1991-2#3)(1992-8#1)(1994-12#1)(1994-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
intradural extramedullary##2##2##(2008-7#1)(2012-12#1)
intradural spinal surgery##2##3##(2012-3#2)
intradural spinal##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
intradural spine surgery##3##3##(2012-3#3)
intradural##17##1##(2008-12#1)(2008-7#3)(2008-9#1)(2009-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#5)
intraepidermal nerve fibers##2##3##(2013-1#1)(2013-8#1)
intraepithelial lesions##3##2##(1994-1#1)(1994-12#1)(2008-11#1)
intraepithelial neoplasia and##3##3##(1991-2#1)(2011-1#1)(2013-1#1)
intraepithelial neoplasia##32##2##(1991-2#7)(1992-8#1)(1993-9#2)(1994-12#2)(1994-2#3)(2011-1#5)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
intraepithelial neoplasias##2##2##(2008-11#1)(2011-1#1)
intraepithelial##43##1##(1991-2#7)(1992-8#1)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#3)(1996-12#1)(1996-8#1)(2008-11#3)(2010-3#1)(2011-1#7)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
intrafloral integration##3##2##(2009-8#3)
intragastric balloon##2##2##(2008-5#2)
intragastric pH##2##2##(1993-12#2)
intragastric##13##1##(1991-12#1)(1993-12#4)(1996-12#2)(1997-4#1)(2008-10#2)(2008-5#2)(2013-1#1)
intragastrically##4##1##(1995-3#1)(1996-2#1)(2008-11#1)(2008-7#1)
intragenic##8##1##(1990-5#1)(1993-12#1)(1995-6#1)(1997-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
intragenomic##2##1##(1996-6#1)(2008-7#1)
intraglomerular pressure##2##2##(1992-8#1)(2008-1#1)
intraglomerular##3##1##(1992-8#1)(1996-6#1)(2008-1#1)
intragroup##2##1##(2008-10#1)(2008-5#1)
intraguild predation and##3##3##(2007-7#1)(2008-8#2)
intraguild predation##4##2##(2007-7#1)(2008-8#3)
intragyral##4##1##(1994-8#4)
intrahepatic biliary lithiasis##2##3##(1990-3#2)
intrahepatic or##2##2##(1997-8#1)(2012-2#1)
intrahepatic portal##2##2##(2009-8#2)
intrahepatic##12##1##(1990-3#2)(1991-12#1)(1997-8#1)(2008-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
intrahippocampal injection of##2##3##(1997-6#1)(2009-12#1)
intrahippocampal##6##1##(1993-12#1)(1994-8#3)(1997-6#1)(2009-12#1)
intrahippocampally##2##1##(1993-9#2)
intrahost##2##1##(2012-2#1)(2013-8#1)
intraindividual##5##1##(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
intralesional steroid##2##2##(2007-7#2)
intralesional triamcinolone acetonide##2##3##(2007-7#2)
intralesional##9##1##(2007-7#4)(2008-6#2)(2010-3#1)(2012-12#1)(2013-8#1)
intralimb##2##1##(2011-2#2)
intraluminal thrombus##2##2##(2008-7#2)
intraluminal tonometry##2##2##(2012-3#2)
intraluminal##21##1##(1990-12#2)(1992-6#1)(1992-9#1)(1994-5#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-7#3)(2009-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
intralysosomal##2##1##(1993-8#1)(1995-2#1)
intramammary infections##8##2##(1990-6#3)(2012-3#5)
intramedullarly nailing##2##2##(2008-6#2)
intramedullary AVM##3##2##(1997-6#2)(2008-7#1)
intramedullary Gamma nail osteosynthesis##2##4##(2007-11#2)
intramedullary fixation of pathological fractures in the terminal period of##2##10##(2007-11#2)
intramedullary fixation##4##2##(2007-11#2)(2013-1#2)
intramedullary nail fixation##2##3##(2012-2#1)(2013-1#1)
intramedullary nail##10##2##(2007-11#1)(2009-3#2)(2011-2#2)(2012-2#1)(2013-1#4)
intramedullary nailing for##2##3##(2009-3#1)(2012-2#1)
intramedullary nailing in##2##3##(2013-8#2)
intramedullary nailing with##2##3##(2007-11#1)(2012-2#1)
intramedullary nailing##10##2##(2007-11#5)(2009-3#1)(2012-2#2)(2013-8#2)
intramedullary##50##1##(1997-6#2)(2007-11#15)(2007-8#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#3)(2010-3#1)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#4)
intramembrane##3##1##(1992-9#1)(1994-12#1)(2008-10#1)
intramicellar##2##1##(2008-10#1)(2010-2#1)
intramitochondrial##4##1##(1991-12#1)(1994-8#1)(1996-5#1)(2008-4#1)
intramolecular and intermolecular hydrogen bonds##2##5##(2008-10#2)
intramolecular and intermolecular##4##3##(2008-10#4)
intramolecular base pairing##2##3##(1991-5#1)(2008-4#1)
intramolecular charge-transfer character##2##3##(2008-10#2)
intramolecular cyclization of##2##3##(1994-8#1)(1996-5#1)
intramolecular fluorescence energy transfer##2##4##(1996-12#2)
intramolecular hydrogen##2##2##(1992-12#1)(1993-3#1)
intramolecular interactions##2##2##(1993-11#1)(2008-5#1)
intramolecular isotope effects##2##3##(1992-11#2)
intramolecular lactonization##2##2##(2010-7#2)
intramolecular nucleophilic##2##2##(1996-5#1)(2010-2#1)
intramolecular proton transfer##2##3##(1994-8#1)(2008-10#1)
intramolecular##70##1##(1991-5#2)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-3#5)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#7)(2007-1#1)(2007-11#2)(2008-10#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#2)(2013-1#1)
intramolecularly##2##1##(1992-6#1)(1995-3#1)
intramucosal##2##1##(1992-2#1)(2010-12#1)
intramural fibroids##2##2##(1994-2#2)
intramural hematoma##2##2##(2011-2#2)
intramural schwannoma of the oesophagus##2##5##(2007-8#2)
intramural spread##2##2##(1991-12#2)
intramural##15##1##(1990-3#1)(1990-9#1)(1991-12#2)(1994-2#2)(2007-8#3)(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
intramuscular administration##2##2##(1992-5#1)(2008-8#1)
intramuscular connective tissue and##2##4##(2010-2#1)(2013-1#1)
intramuscular connective tissue##4##3##(2010-2#2)(2013-1#2)
intramuscular fat##4##2##(2010-4#4)
intramuscular haemangioma##2##2##(2010-5#2)
intramuscular implantation of##2##3##(2012-1#2)
intramuscular injection of nalbuphine##2##4##(1992-5#2)
intramuscular injection of the##2##4##(1997-4#1)(2008-4#1)
intramuscular injection of##18##3##(1990-6#1)(1992-5#2)(1995-3#1)(1997-4#2)(1997-8#3)(2008-10#2)(2008-4#1)(2008-8#3)(2011-2#1)(2012-3#1)(2013-7#1)
intramuscular injection##20##2##(1990-6#1)(1991-3#1)(1992-5#2)(1995-3#1)(1997-4#2)(1997-8#3)(2008-10#2)(2008-4#1)(2008-8#4)(2011-2#1)(2012-3#1)(2013-7#1)
intramuscular injections of##2##3##(1995-12#1)(2008-7#1)
intramuscular injections##5##2##(1995-12#1)(1995-8#1)(2007-4#1)(2008-7#1)(2008-8#1)
intramuscular##65##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-5#3)(1995-12#1)(1995-3#1)(1995-8#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#7)(2009-9#1)(2010-2#2)(2010-4#8)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
intramuscularly##10##1##(1990-2#1)(1990-6#1)(1991-8#1)(1993-9#1)(1997-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)
intramyocardial electrograms##3##2##(2009-3#3)
intramyocardial##5##1##(2009-3#3)(2011-2#1)(2012-12#1)
intramyocardially##3##1##(2007-8#1)(2009-10#1)(2012-12#1)
intranasal corticosteroid is##2##3##(2007-11#2)
intranasal corticosteroid##3##2##(2007-11#2)(2012-12#1)
intranasal corticosteroids are##2##3##(2007-11#2)
intranasal corticosteroids on##2##3##(2007-11#1)(2012-12#1)
intranasal corticosteroids##7##2##(2007-11#6)(2012-12#1)
intranasal instillation##2##2##(2008-10#2)
intranasal methamphetamine##2##2##(2007-10#2)
intranasal mometasone furoate##2##3##(2007-11#2)
intranasal##32##1##(1995-2#1)(1995-9#1)(2007-10#3)(2007-11#12)(2008-10#7)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
intranasally##7##1##(1991-8#1)(1995-2#2)(2007-11#1)(2008-10#1)(2008-5#2)
intraneural##2##1##(2008-7#1)(2011-2#1)
intraneuronal##4##1##(1991-1#1)(1992-3#1)(1996-5#1)(2008-9#1)
intranuclear binding##4##2##(1994-11#4)
intranuclear coccidian parasite##2##3##(2013-1#2)
intranuclear staining##2##2##(1995-6#1)(2010-3#1)
intranuclear##14##1##(1990-5#1)(1991-12#1)(1994-11#4)(1995-6#1)(2007-12#1)(2008-5#1)(2010-3#2)(2013-1#3)
intraobserver##3##1##(1997-8#2)(2008-8#1)
intraocular foreign##2##2##(2009-12#2)
intraocular infections##2##2##(2008-12#2)
intraocular lens implantation##5##3##(2010-9#1)(2011-2#3)(2013-1#1)
intraocular lens##10##2##(1991-2#1)(2008-3#1)(2010-9#1)(2011-2#6)(2013-1#1)
intraocular lenses##3##2##(1991-2#1)(2008-3#1)(2011-2#1)
intraocular microsurgery##3##2##(2008-3#3)
intraocular pressure (IOP)##5##3##(2009-7#1)(2011-2#3)(2013-1#1)
intraocular pressure in##2##3##(1993-1#1)(2008-7#1)
intraocular pressure##11##2##(1990-11#1)(1993-1#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-2#3)(2012-12#1)(2013-1#2)
intraocular retinoblastoma##3##2##(2011-2#3)
intraocular tumor recurrence at the##2##5##(2011-1#2)
intraocular##50##1##(1990-11#1)(1991-2#2)(1993-1#1)(2008-1#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-7#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-9#1)(2011-1#6)(2011-2#14)(2012-12#1)(2013-1#4)
intraoperative MEP mapping##2##3##(2010-7#2)
intraoperative analgesic##2##2##(2010-7#2)
intraoperative and postoperative##5##3##(1994-9#1)(2006-10#1)(2008-9#2)(2013-1#1)
intraoperative and##6##2##(1994-9#1)(2006-10#1)(2008-10#1)(2008-9#2)(2013-1#1)
intraoperative assessment of##2##3##(1992-9#1)(2013-1#1)
intraoperative biopsy##2##2##(1990-3#1)(1993-5#1)
intraoperative bleeding##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
intraoperative blood loss##4##3##(1994-3#3)(1996-1#1)
intraoperative blood##5##2##(1994-3#3)(1996-1#1)(2011-2#1)
intraoperative complications or##3##3##(2007-11#2)(2008-10#1)
intraoperative complications##9##2##(1993-12#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)
intraoperative contamination##2##2##(1992-6#1)(2011-2#1)
intraoperative diagnosis##3##2##(1990-10#1)(1990-6#1)(2010-8#1)
intraoperative findings##4##2##(2007-11#3)(2013-8#1)
intraoperative hemodialysis##2##2##(2007-8#2)
intraoperative imaging of##2##3##(2011-7#2)
intraoperative imaging##4##2##(2011-7#2)(2012-2#1)(2013-1#1)
intraoperative mediastinoscopy##5##2##(2007-8#5)
intraoperative monitoring of##2##3##(2008-10#1)(2012-3#1)
intraoperative monitoring##3##2##(2008-10#1)(2012-3#2)
intraoperative periprosthetic femoral##2##3##(2013-1#2)
intraoperative transesophageal##2##2##(2007-8#1)(2008-10#1)
intraoperative ultrasonography##2##2##(1992-9#1)(2007-5#1)
intraoperative ultrasound##2##2##(2008-9#1)(2010-12#1)
intraoperative##133##1##(1990-10#2)(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#4)(1994-9#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-11#8)(2007-5#1)(2007-8#13)(2008-10#8)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#7)(2009-1#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#8)(2010-8#3)(2011-2#12)(2011-3#1)(2011-7#4)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#1)
intraoperatively and##3##2##(1994-1#1)(2008-6#1)(2013-8#1)
intraoperatively##16##1##(1991-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-3#1)(2008-6#1)(2009-4#1)(2010-7#1)(2012-3#1)(2013-8#2)
intraoral intake of##2##3##(1993-12#2)
intraoral##16##1##(1990-6#1)(1993-1#1)(1993-12#3)(2007-12#3)(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
intraorbital hematoma##3##2##(2011-2#3)
intraorbital##7##1##(2008-7#1)(2011-1#2)(2011-2#3)(2012-3#1)
intraosseous meningioma##2##2##(2008-10#2)
intraosseous##11##1##(2008-10#2)(2008-9#1)(2009-3#2)(2010-3#5)(2012-3#1)
intrapage##2##1##(2008-2#1)(2008-3#1)
intraparenchymal hemorrhage##2##2##(2008-9#1)(2012-3#1)
intraparenchymal##12##1##(1990-3#1)(1991-6#1)(1996-5#1)(2008-12#1)(2008-7#4)(2008-9#1)(2012-12#1)(2012-3#2)
intraparenchymatous##2##1##(1996-6#1)(1996-9#1)
intrapartum##5##1##(1994-3#2)(2011-2#2)(2013-1#1)
intrapelvic##4##1##(2008-7#1)(2008-8#2)(2009-3#1)
intrapericardial bronchogenic cyst##2##3##(2007-8#2)
intrapericardial bronchogenic##3##2##(2007-8#3)
intrapericardial##4##1##(2007-8#4)
intraperitoneal (i##11##2##(1994-5#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#3)(2008-10#1)(2013-1#2)
intraperitoneal Ringer's lactate instillation##2##4##(1995-12#2)
intraperitoneal accumulation of leukocytes##2##4##(2008-12#2)
intraperitoneal accumulation of##3##3##(2008-12#3)
intraperitoneal administration of##8##3##(1994-8#1)(1995-12#3)(2012-1#1)(2012-2#2)(2013-1#1)
intraperitoneal administration##9##2##(1992-2#1)(1994-8#1)(1995-12#3)(2012-1#1)(2012-2#2)(2013-1#1)
intraperitoneal chemotherapy##2##2##(1994-6#1)(2010-12#1)
intraperitoneal fluid##2##2##(2007-5#1)(2008-1#1)
intraperitoneal injection of the##2##4##(1995-12#1)(2008-10#1)
intraperitoneal injection of##16##3##(1990-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)
intraperitoneal injection##18##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#2)(2011-3#2)(2012-1#1)
intraperitoneal injections of##2##3##(1992-5#1)(2008-4#1)
intraperitoneal injections##3##2##(1992-5#1)(2008-4#1)(2008-7#1)
intraperitoneal or##2##2##(1993-12#1)(1997-4#1)
intraperitoneal transplantation##2##2##(1997-4#2)
intraperitoneal##76##1##(1990-12#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#10)(1996-12#1)(1996-2#3)(1997-2#1)(1997-4#4)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-12#3)(2008-4#2)(2008-7#2)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-1#2)(2012-2#3)(2013-1#3)
intraperitoneal)##3##1##(2008-6#2)(2012-3#1)
intraperitoneally (i##4##2##(1992-12#1)(1994-7#1)(2010-1#1)(2010-5#1)
intraperitoneally administered##4##2##(1990-7#1)(1993-3#1)(2008-11#1)(2013-1#1)
intraperitoneally in##2##2##(2008-12#1)(2011-2#1)
intraperitoneally injected##3##2##(1993-8#1)(1994-5#1)(2009-5#1)
intraperitoneally into##2##2##(1993-8#1)(1997-4#1)
intraperitoneally with##6##2##(1992-11#2)(1995-3#1)(1997-8#1)(2008-11#1)(2008-5#1)
intraperitoneally##31##1##(1990-5#1)(1990-7#1)(1991-6#1)(1992-11#2)(1992-12#1)(1993-3#1)(1993-8#3)(1994-5#1)(1994-7#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
intrapersonal##2##1##(2007-12#1)(2012-12#1)
intrapineal##2##1##(1994-5#2)
intraplaque##3##1##(2007-10#3)
intraplatelet magnesium concentrations##2##3##(2008-7#2)
intraplatelet##3##1##(2008-7#2)(2011-1#1)
intrapopulation##2##1##(2008-10#1)(2008-8#1)
intraportal islet grafts##2##3##(2010-11#2)
intrapulmonary lymph nodes##5##3##(2008-1#5)
intrapulmonary##10##1##(1992-5#2)(1996-3#1)(1997-1#1)(2008-1#5)(2010-8#1)
intraradices in##2##2##(2008-10#2)
intraradices##5##1##(2008-10#4)(2008-12#1)
intrarectal##2##1##(2008-7#1)(2013-1#1)
intrarectally##2##1##(2008-4#1)(2011-1#1)
intrarenal neuroblastoma##3##2##(2008-10#3)
intrarenal##9##1##(2008-1#4)(2008-10#3)(2008-11#1)(2011-2#1)
intrarticular##3##1##(2007-8#2)(2013-1#1)
intraseptal infusion of##2##3##(1993-12#2)
intraseptal infusions of##3##3##(1993-12#3)
intraseptal##6##1##(1993-12#6)
intraspecific competition##5##2##(2008-8#4)(2012-2#1)
intraspecific crosses##2##2##(2008-10#2)
intraspecific genetic##2##2##(2008-10#1)(2009-2#1)
intraspecific nest parasitism##2##3##(2008-9#2)
intraspecific polymorphisms were##2##3##(2008-10#1)(2008-5#1)
intraspecific variability##2##2##(2008-10#2)
intraspecific variation in##3##3##(2008-10#1)(2012-2#2)
intraspecific variation##5##2##(2008-10#2)(2008-8#1)(2012-2#2)
intraspecific##39##1##(1995-11#1)(2008-10#16)(2008-5#2)(2008-8#8)(2008-9#4)(2009-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
intraspinal##5##1##(1997-3#1)(2008-12#1)(2008-7#1)(2010-5#2)
intrastrand##3##1##(1992-3#3)
intrastriatal injection of##3##3##(1995-5#3)
intrastriatal injections of##2##3##(1993-12#1)(1995-5#1)
intrastriatal injections##3##2##(1993-12#1)(1995-5#1)(1997-7#1)
intrastriatal##12##1##(1993-12#1)(1995-12#2)(1995-5#4)(1997-2#1)(1997-7#1)(2008-7#3)
intrasubunit hydrogen##2##2##(1992-3#2)
intratesticular##4##1##(2007-8#1)(2008-4#1)(2011-5#1)(2013-7#1)
intrathecal TCA##2##2##(2010-12#2)
intrathecal baclofen##4##2##(2011-2#4)
intrathecal injection of fluorescein##4##4##(2008-12#4)
intrathecal space of the spinal cord##2##6##(2007-10#2)
intrathecal##25##1##(1991-1#1)(1991-4#1)(1992-11#1)(1993-8#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-12#4)(2009-3#1)(2010-12#3)(2011-2#7)(2012-3#1)
intrathecally##7##1##(1992-3#2)(1995-12#2)(2011-2#3)
intrathoracic (more than##2##3##(1993-5#2)
intrathoracic defects##2##2##(2012-2#2)
intrathoracic goiter##2##2##(2013-1#2)
intrathoracic goitre##4##2##(1993-5#4)
intrathoracic growth##2##2##(2007-8#2)
intrathoracic lesion##2##2##(1991-3#1)(2007-8#1)
intrathoracic##26##1##(1991-3#1)(1993-5#7)(1997-6#1)(2007-11#1)(2007-8#7)(2008-11#1)(2010-12#1)(2012-2#2)(2013-1#5)
intrathymic##2##1##(2008-4#1)(2008-8#1)
intratracheal inoculation of##2##3##(2008-5#2)
intratracheal inoculation##3##2##(2008-5#2)(2008-9#1)
intratracheal##4##1##(1996-3#1)(2008-5#2)(2008-9#1)
intratracheally into##2##2##(1992-11#2)
intratracheally##5##1##(1992-11#2)(2008-10#2)(2008-5#1)
intratubular##2##1##(2008-10#1)(2011-2#1)
intratumor heterogeneity##2##2##(2013-1#2)
intratumor##3##1##(2013-1#3)
intratumoral drug##2##2##(1995-10#1)(2013-1#1)
intratumoral##8##1##(1993-11#1)(1994-5#1)(1995-10#1)(1995-9#1)(2008-5#1)(2011-2#1)(2013-1#2)
intratumorally##4##1##(1993-11#2)(2008-5#1)(2011-1#1)
intratumoural##2##1##(2008-7#1)(2011-2#1)
intraurethral##2##1##(1991-2#1)(1991-9#1)
intrauterine HI##3##2##(1996-5#3)
intrauterine contraceptive device##3##3##(1993-2#1)(2007-7#1)(2013-1#1)
intrauterine device##2##2##(1992-4#1)(2013-1#1)
intrauterine devices##3##2##(1993-12#2)(2007-7#1)
intrauterine fetal##3##2##(1992-5#1)(2008-11#1)(2010-8#1)
intrauterine growth restriction##3##3##(2008-11#2)(2011-2#1)
intrauterine growth retardation and low birth weight##2##7##(2013-1#2)
intrauterine growth retardation##5##3##(1995-8#2)(2010-3#1)(2013-1#2)
intrauterine growth##8##2##(1995-8#2)(2008-11#2)(2010-3#1)(2011-2#1)(2013-1#2)
intrauterine insemination##3##2##(2007-10#1)(2011-1#1)(2012-3#1)
intrauterine pregnancy##3##2##(1994-12#2)(2011-1#1)
intrauterine vascular insufficiency and##2##4##(2008-9#2)
intrauterine##61##1##(1990-11#1)(1990-8#1)(1991-2#2)(1991-6#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-8#1)(1993-12#2)(1993-2#1)(1994-12#3)(1994-3#1)(1994-9#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#4)(2007-10#1)(2007-7#2)(2008-10#1)(2008-11#3)(2008-9#2)(2009-11#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-3#2)(2013-1#8)
intravaginal##4##1##(1990-10#1)(1994-3#1)(1995-8#1)(2008-12#1)
intravascular bone marrow##2##3##(2010-8#2)
intravascular catheters##3##2##(1991-3#1)(1991-8#1)(1994-5#1)
intravascular coagulation##10##2##(1992-9#1)(2006-10#1)(2007-10#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-3#3)
intravascular hemolysis##3##2##(1992-9#1)(2008-4#1)(2011-2#1)
intravascular space##2##2##(1997-3#1)(2013-8#1)
intravascular treatment##2##2##(1996-6#1)(2008-7#1)
intravascular ultrasound catheter##2##3##(2008-11#2)
intravascular ultrasound for##2##3##(2007-8#1)(2009-5#1)
intravascular ultrasound##12##2##(2007-8#2)(2008-10#2)(2008-11#3)(2008-6#1)(2009-5#4)
intravascular##57##1##(1990-3#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-9#2)(1993-2#1)(1994-5#2)(1995-11#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-4#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#4)(2010-3#2)(2010-8#2)(2011-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
intravenous (IV)##5##2##(1993-1#1)(2006-10#1)(2008-1#1)(2012-12#1)(2012-2#1)
intravenous (i##6##2##(1992-8#1)(1993-12#1)(1995-12#1)(2006-12#1)(2007-10#1)(2008-1#1)
intravenous N-acetylcysteine##2##2##(1991-9#2)
intravenous administration of##11##3##(1991-2#1)(1995-11#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-4#1)(2012-12#1)(2012-3#1)
intravenous administration##22##2##(1990-6#1)(1991-2#1)(1991-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#3)(2012-12#1)(2012-3#1)
intravenous amiodarone##3##2##(1993-6#1)(2006-10#1)(2012-3#1)
intravenous and oral administration##2##4##(2011-1#1)(2011-2#1)
intravenous and oral##6##3##(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
intravenous and##9##2##(1992-5#1)(2008-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)
intravenous anesthesia##6##2##(2008-6#1)(2009-4#1)(2011-2#3)(2012-3#1)
intravenous antibiotic prophylaxis##3##3##(2011-2#2)(2012-12#1)
intravenous antibiotic therapy##2##3##(1997-7#1)(2009-3#1)
intravenous antibiotic##5##2##(1997-7#1)(2009-3#1)(2011-2#2)(2012-12#1)
intravenous antibiotics##6##2##(2006-10#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
intravenous bisphosphonates##2##2##(2007-11#1)(2009-12#1)
intravenous bolus injection of##2##4##(1992-5#1)(2007-10#1)
intravenous bolus##7##2##(1991-12#1)(1992-12#1)(1992-5#1)(2007-10#1)(2007-12#1)(2008-6#1)(2008-7#1)
intravenous calcium and##2##3##(1991-6#1)(2008-3#1)
intravenous calcium##3##2##(1991-6#1)(1995-8#1)(2008-3#1)
intravenous catheter##2##2##(1993-6#1)(2012-2#1)
intravenous chemotherapy##2##2##(2007-7#1)(2008-7#1)
intravenous cocaine##3##2##(1991-1#2)(1993-6#1)
intravenous contrast##2##2##(2009-3#1)(2010-12#1)
intravenous cyclophosphamide##2##2##(2006-10#1)(2007-7#1)
intravenous dose##2##2##(1993-9#1)(2009-3#1)
intravenous doses of##2##3##(2007-11#1)(2007-8#1)
intravenous drug abuse##3##3##(2007-7#1)(2008-5#1)(2009-7#1)
intravenous drug abusers (IVDAs)##2##4##(1991-1#2)
intravenous drug abusers##3##3##(1990-3#1)(1991-1#2)
intravenous drug self-administration in large primates##2##6##(2008-4#1)(2012-3#1)
intravenous drug self-administration in##4##4##(2008-4#3)(2012-3#1)
intravenous drug use##4##3##(1996-11#1)(2007-12#1)(2012-1#1)(2013-1#1)
intravenous drug users (IDU)##2##4##(2008-5#1)(2013-8#1)
intravenous drug users and##2##4##(1992-9#1)(2012-1#1)
intravenous drug users##10##3##(1991-1#1)(1991-12#1)(1992-9#3)(1997-6#1)(2007-7#1)(2008-5#1)(2012-1#1)(2013-8#1)
intravenous drug##30##2##(1990-3#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-5#1)(1992-9#3)(1996-11#1)(1997-6#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-4#3)(2008-5#3)(2009-6#1)(2009-7#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#2)
intravenous fluid##3##2##(1991-6#1)(2008-4#1)(2012-3#1)
intravenous glucose##4##2##(1990-12#1)(1994-12#1)(2010-10#1)(2012-7#1)
intravenous heparin##2##2##(1997-8#1)(2007-10#1)
intravenous hydralazine##2##2##(2008-4#2)
intravenous immunoglobulin (IVIG)##3##3##(2007-12#1)(2012-2#1)(2012-3#1)
intravenous immunoglobulin for##2##3##(1990-3#1)(2007-12#1)
intravenous immunoglobulin##13##2##(1990-3#1)(1992-8#1)(1995-5#1)(2007-12#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
intravenous immunoglobulins##3##2##(1997-2#1)(2012-3#2)
intravenous infusion of sodium##2##4##(2008-4#2)
intravenous infusion of##11##3##(1990-12#1)(1990-8#1)(1991-3#2)(1991-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)
intravenous infusion over##2##3##(2008-1#1)(2008-6#1)
intravenous infusion##18##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#2)(1991-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#1)(2010-11#1)(2012-3#1)
intravenous infusions of##2##3##(1994-10#1)(1995-12#1)
intravenous infusions##5##2##(1990-10#1)(1992-6#1)(1994-10#1)(1995-12#1)(2012-12#1)
intravenous injection of##10##3##(1991-12#1)(1992-12#1)(1992-3#2)(1992-5#1)(1994-5#1)(1995-12#1)(2007-10#1)(2013-1#1)(2013-8#1)
intravenous injection##16##2##(1991-12#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-11#2)(1994-5#1)(1995-12#1)(2007-10#1)(2008-7#1)(2009-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
intravenous injections##3##2##(1991-2#1)(2007-4#1)(2009-5#1)
intravenous inoculation##2##2##(1997-3#1)(2013-1#1)
intravenous iron saccharate##3##3##(2007-7#2)(2008-1#1)
intravenous mannitol##3##2##(2008-1#3)
intravenous midazolam##3##2##(1993-1#3)
intravenous prophylaxis##3##2##(2011-2#3)
intravenous self-administration##4##2##(1993-6#3)(2008-4#1)
intravenous therapy##2##2##(2007-10#1)(2012-2#1)
intravenous treatment with##2##3##(2008-10#1)(2008-9#1)
intravenous treatment##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
intravenous unfractionated heparin##2##3##(2008-3#2)
intravenous urography##3##2##(1990-9#1)(2011-2#2)
intravenous##309##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#5)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#5)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#6)(1993-11#2)(1993-12#1)(1993-6#6)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-5#1)(1995-11#2)(1995-12#5)(1995-5#2)(1995-8#1)(1996-11#3)(1996-8#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#9)(2007-11#5)(2007-12#8)(2007-4#1)(2007-7#9)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#4)(2008-4#10)(2008-5#4)(2008-6#6)(2008-7#12)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#4)(2010-8#5)(2011-1#6)(2011-2#18)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#13)(2012-7#1)(2013-1#9)(2013-8#4)
intravenously (i##2##2##(1990-2#1)(2008-10#1)
intravenously administered##3##2##(1995-12#1)(1996-2#1)(2008-7#1)
intravenously at##5##2##(1991-6#1)(1994-8#1)(2008-11#1)(2010-3#1)(2013-1#1)
intravenously every##2##2##(2008-10#1)(2008-6#1)
intravenously for##2##2##(2007-10#1)(2012-2#1)
intravenously in##3##2##(1997-4#1)(2007-7#1)(2008-1#1)
intravenously infused##2##2##(1991-9#2)
intravenously on##2##2##(1991-5#1)(2008-1#1)
intravenously##47##1##(1990-12#1)(1990-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1993-11#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#3)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#4)
intravenously)##2##1##(1992-5#1)(1994-9#1)
intraventricular asynchrony##2##2##(2008-10#2)
intraventricular haemorrhage (IVH)##2##3##(2008-7#2)
intraventricular haemorrhage##4##2##(2008-7#4)
intraventricular hemorrhage and##3##3##(2011-2#3)
intraventricular hemorrhage##6##2##(2007-10#1)(2011-2#3)(2012-3#2)
intraventricular injection of##2##3##(1991-12#1)(2008-7#1)
intraventricular injection##4##2##(1991-12#3)(2008-7#1)
intraventricular or##2##2##(2007-10#1)(2009-3#1)
intraventricular urokinase##2##2##(2007-10#2)
intraventricular##37##1##(1991-12#4)(1991-8#1)(1992-9#1)(1993-12#2)(1995-1#1)(1997-3#1)(1997-7#1)(2007-10#7)(2008-10#2)(2008-7#7)(2008-8#1)(2009-3#1)(2011-2#4)(2012-2#1)(2012-3#3)
intraventricular-germinal matrix hemorrhage##2##3##(2011-2#2)
intraventricularly##2##1##(1991-12#1)(1995-12#1)
intravesical chemotherapy##3##2##(2008-1#2)(2011-2#1)
intravesical part##2##2##(1997-4#1)(2008-10#1)
intravesical ureter##4##2##(1997-4#3)(2008-10#1)
intravesical##17##1##(1991-11#1)(1993-11#2)(1997-4#4)(1997-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2009-2#1)(2011-2#1)
intravesically##2##1##(1993-11#2)
intravesicular##2##1##(1992-6#1)(1994-12#1)
intravital microscopy##4##2##(1995-12#1)(2008-9#1)(2009-11#1)(2011-2#1)
intravital##7##1##(1995-12#1)(2008-1#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#2)
intravitreal bevacizumab##2##2##(2011-1#1)(2011-2#1)
intravitreal injections of##2##3##(2011-2#1)(2012-3#1)
intravitreal ranibizumab##2##2##(2010-9#1)(2011-1#1)
intravitreal##11##1##(2008-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#3)
intricacy of##2##2##(2011-2#1)(2012-3#1)
intricate##16##1##(1993-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-8#1)(2012-2#2)(2013-1#2)
intricately##3##1##(2008-4#1)(2009-10#1)(2011-2#1)
intrigue##2##1##(2008-11#2)
intriguing##34##1##(1990-11#1)(1992-2#1)(1994-12#2)(1994-5#1)(1996-2#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
intrinsic ATPase activity of##3##4##(1992-6#3)
intrinsic GTPase activity of##2##4##(1993-8#1)(1994-12#1)
intrinsic GTPase activity##3##3##(1992-11#1)(1993-8#1)(1994-12#1)
intrinsic activity##8##2##(1990-5#1)(1991-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(2008-10#1)(2012-2#1)
intrinsic affinity##2##2##(1990-11#1)(2008-10#1)
intrinsic and extrinsic work values##2##5##(2010-10#2)
intrinsic and extrinsic work##3##4##(1996-1#1)(2010-10#2)
intrinsic and extrinsic##8##3##(1996-1#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#2)(2011-2#1)(2013-1#1)
intrinsic and##10##2##(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#2)(2011-2#1)(2013-1#1)
intrinsic apoptosis##3##2##(2011-2#3)
intrinsic apoptotic pathway##2##3##(2009-12#1)(2011-2#1)
intrinsic cavity loss and the##2##5##(2007-12#2)
intrinsic complexation constants##3##3##(2008-10#3)
intrinsic complexation##4##2##(2008-10#4)
intrinsic constants##2##2##(2008-10#2)
intrinsic defects##3##2##(1997-8#1)(2007-12#1)(2008-1#1)
intrinsic drug resistance##2##3##(1994-2#1)(1997-7#1)
intrinsic effects##3##2##(1991-9#1)(1994-2#1)(1996-2#1)
intrinsic factor##3##2##(1990-11#2)(2013-1#1)
intrinsic factors##3##2##(1990-6#1)(2008-11#1)(2011-2#1)
intrinsic feature of##2##3##(2008-11#1)(2008-7#1)
intrinsic feature##3##2##(2008-11#2)(2008-7#1)
intrinsic feedback##2##2##(2009-12#1)(2010-11#1)
intrinsic fiber##2##2##(1991-12#1)(2007-11#1)
intrinsic fluorescence of the##4##4##(1990-5#1)(2008-10#2)(2008-8#1)
intrinsic fluorescence of tryptophan##2##4##(1992-6#1)(2008-8#1)
intrinsic fluorescence of##9##3##(1990-5#1)(1992-6#1)(1995-6#1)(2008-10#4)(2008-8#2)
intrinsic fluorescence##23##2##(1990-5#1)(1992-6#2)(1994-6#2)(1995-5#3)(1995-6#2)(1997-2#1)(2008-1#1)(2008-10#4)(2008-3#5)(2008-8#2)
intrinsic frequency##2##2##(2007-11#1)(2007-12#1)
intrinsic growth rates##2##3##(2008-6#2)
intrinsic link##2##2##(2008-8#2)
intrinsic mechanisms to##2##3##(2008-11#1)(2009-10#1)
intrinsic mechanisms##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
intrinsic membrane##2##2##(1993-3#1)(2008-2#1)
intrinsic motivation##3##2##(2008-11#3)
intrinsic nature of##2##3##(2007-11#1)(2007-12#1)
intrinsic noise##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
intrinsic optical##2##2##(2010-2#1)(2010-4#1)
intrinsic or##2##2##(2008-1#1)(2008-11#1)
intrinsic physical##2##2##(2008-5#1)(2010-2#1)
intrinsic properties##5##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
intrinsic protein##3##2##(1990-5#1)(1993-2#2)
intrinsic rate of natural increase (r(m))##2##6##(2011-2#2)
intrinsic rate of##8##3##(2008-10#4)(2008-8#2)(2011-2#2)
intrinsic rates of##2##3##(2008-8#1)(2011-2#1)
intrinsic resistance##4##2##(1993-9#2)(2007-12#1)(2008-7#1)
intrinsic resolution##2##2##(1994-5#1)(2011-2#1)
intrinsic sensitivity##2##2##(2008-10#1)(2008-3#1)
intrinsic skin aging##3##3##(2008-5#3)
intrinsic skin##4##2##(2008-5#4)
intrinsic tissue##2##2##(2008-3#1)(2011-1#1)
intrinsic to the##5##3##(2007-11#1)(2007-12#1)(2010-12#1)(2010-4#1)(2011-2#1)
intrinsic to##6##2##(1996-2#1)(2007-11#1)(2007-12#1)(2010-12#1)(2010-4#1)(2011-2#1)
intrinsic upregulation of##2##3##(1992-8#2)
intrinsic value for math and English##3##6##(2009-7#3)
intrinsic vector##3##2##(2008-3#3)
intrinsic viscosity of poly(ethylene terephthalate)##2##5##(2008-10#2)
intrinsic viscosity of##3##3##(2008-10#3)
intrinsic##317##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#7)(1992-7#1)(1992-8#2)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#6)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#3)(1997-3#1)(1997-7#2)(1997-8#1)(2006-10#3)(2007-11#12)(2007-12#17)(2007-8#1)(2008-1#3)(2008-10#37)(2008-11#12)(2008-2#9)(2008-3#28)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#11)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-5#2)(2009-7#4)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#3)(2010-2#4)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#16)(2012-12#1)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#1)
intrinsically related with the##2##4##(2008-10#2)
intrinsically##33##1##(1992-1#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-8#2)(1994-9#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)
introduce a method##2##3##(2008-3#1)(2010-8#1)
introduce a model for##2##4##(2008-8#1)(2011-1#1)
introduce a new##11##3##(1997-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-8#1)(2013-8#2)
introduce a simple##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
introduce a##52##2##(1991-11#1)(1993-2#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#6)(2008-2#4)(2008-3#9)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
introduce an##9##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)
introduce and##3##2##(2008-2#2)(2010-3#1)
introduce concepts##2##2##(1996-12#1)(2008-1#1)
introduce foreign##2##2##(2008-11#1)(2008-4#1)
introduce some##2##2##(2008-7#2)
introduce the concept of##4##4##(1991-12#1)(2007-11#1)(2008-11#1)(2012-12#1)
introduce the new##2##3##(1995-12#1)(2007-11#1)
introduce the use of a##2##5##(2008-3#1)(2013-1#1)
introduce the##25##2##(1991-12#1)(1995-12#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2009-1#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
introduce##166##1##(1991-11#1)(1991-12#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#12)(2007-12#9)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#20)(2008-4#10)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#4)(2009-1#1)(2009-11#2)(2009-2#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
introduced 2##3##2##(2008-10#3)
introduced H##2##2##(2008-10#2)
introduced a method##2##3##(1993-11#1)(2008-7#1)
introduced a##19##2##(1991-12#1)(1993-11#1)(1993-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#2)(2010-6#1)(2013-8#1)
introduced an##4##2##(1992-1#1)(1994-6#1)(1995-2#1)(2008-8#1)
introduced and##24##2##(1990-8#2)(1992-9#1)(1994-2#1)(1997-6#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2010-9#1)(2011-7#1)(2012-3#1)(2013-1#2)
introduced antagonists##2##2##(2008-10#2)
introduced as a##13##3##(1993-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#2)
introduced as an alternative to##2##5##(1996-9#1)(2008-2#1)
introduced as an##6##3##(1996-9#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
introduced as##28##2##(1993-12#1)(1995-8#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
introduced at the##6##3##(1992-5#1)(2008-4#2)(2010-6#1)(2010-9#1)(2011-2#1)
introduced at##10##2##(1990-8#1)(1992-5#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#1)
introduced between##2##2##(2008-10#1)(2011-2#1)
introduced by a##2##3##(2007-11#1)(2008-3#1)
introduced by an##2##3##(2008-3#2)
introduced by means of##2##4##(2008-10#1)(2008-3#1)
introduced by the##15##3##(1992-6#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-8#1)(2009-5#1)
introduced by##50##2##(1992-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-11#3)(2007-12#3)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#11)(2008-8#3)(2008-9#3)(2009-5#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
introduced directly into the##4##4##(1993-12#1)(2008-10#3)
introduced directly into##5##3##(1993-12#1)(2008-10#4)
introduced directly##6##2##(1993-12#2)(2008-10#4)
introduced during the##2##3##(2008-1#1)(2011-3#1)
introduced during##3##2##(2008-1#1)(2008-11#1)(2011-3#1)
introduced early##2##2##(2011-1#1)(2011-3#1)
introduced for the##5##3##(1990-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
introduced for use##2##3##(2008-3#1)(2012-12#1)
introduced for##25##2##(1990-5#1)(1990-6#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2012-12#2)(2013-7#1)
introduced here##7##2##(1993-8#1)(2008-2#1)(2008-3#2)(2010-11#1)(2011-2#1)(2013-7#1)
introduced in a##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
introduced in order to##2##4##(2008-11#2)
introduced in the same##2##4##(1995-5#1)(2012-2#1)
introduced in the treatment of##2##5##(1993-3#1)(2008-5#1)
introduced in the##23##3##(1990-5#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#2)
introduced in this paper##3##4##(2008-10#3)
introduced in this work##2##4##(2007-11#1)(2008-10#1)
introduced in this##9##3##(1994-12#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-2#1)
introduced in##65##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
introduced into a##14##3##(1993-12#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-9#1)
introduced into an##3##3##(1994-12#1)(1994-3#1)(2008-10#1)
introduced into clinical practice##2##4##(2007-8#1)(2008-10#1)
introduced into the flame##3##4##(2008-10#3)
introduced into the flow line##2##5##(2008-10#2)
introduced into the flow system##2##5##(2008-10#2)
introduced into the flow##6##4##(2008-10#6)
introduced into the graphite furnace##3##5##(2008-10#3)
introduced into the graphite##4##4##(2008-10#4)
introduced into the source##2##4##(2008-10#2)
introduced into the system##2##4##(2008-10#2)
introduced into the##66##3##(1990-8#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-3#2)(1997-6#2)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#2)
introduced into tobacco plants##3##4##(1997-2#1)(1997-6#2)
introduced into tobacco##4##3##(1997-2#1)(1997-6#2)(2008-9#1)
introduced into##147##2##(1990-12#1)(1990-5#1)(1990-8#2)(1992-12#3)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-8#2)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1997-2#2)(1997-3#2)(1997-6#6)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#54)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#5)(2009-8#2)(2010-8#1)(2011-1#3)(2011-2#3)
introduced isolate of##3##3##(2008-10#3)
introduced new##2##2##(2007-9#1)(2010-10#1)
introduced on a##2##3##(2007-12#1)(2013-1#1)
introduced on the##4##3##(1990-3#1)(2007-8#1)(2008-10#1)(2008-6#1)
introduced on##6##2##(1990-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
introduced over##3##2##(2008-10#2)(2008-2#1)
introduced pathogens##2##2##(2008-10#2)
introduced population##2##2##(2008-10#1)(2012-3#1)
introduced recently##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
introduced species##3##2##(2007-7#1)(2008-6#1)(2008-9#1)
introduced that##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
introduced the concept of##4##4##(1990-8#1)(2008-11#1)(2008-7#1)(2010-3#1)
introduced the##14##2##(1990-11#1)(1990-8#1)(1993-11#1)(1993-3#1)(1996-12#1)(1996-3#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
introduced through a##2##3##(1990-2#1)(1992-1#1)
introduced through the##3##3##(1992-3#1)(2008-10#2)
introduced through##6##2##(1990-2#1)(1992-1#1)(1992-3#1)(1996-3#1)(2008-10#2)
introduced to a##2##3##(1991-3#1)(2009-6#1)
introduced to account for##2##4##(2008-3#1)(2010-11#1)
introduced to facilitate##2##3##(2008-9#1)(2010-5#1)
introduced to quantify the##2##4##(2008-10#1)(2010-3#1)
introduced to the##10##3##(1994-1#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-5#1)(2011-2#1)(2013-7#1)
introduced to##45##2##(1990-11#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-1#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
introduced together##3##2##(1993-12#1)(1993-3#1)(2008-10#1)
introduced using a##2##3##(2008-10#2)
introduced using##3##2##(1994-7#1)(2008-10#2)
introduced via a##2##3##(2008-4#1)(2010-3#1)
introduced via##5##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-3#1)
introduced which##2##2##(2008-11#1)(2013-1#1)
introduced with an##2##3##(2007-11#1)(2008-3#1)
introduced with##3##2##(2007-11#1)(2008-3#1)(2010-6#1)
introduced within##2##2##(2008-4#1)(2008-7#1)
introduced##725##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#7)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#7)(1993-3#3)(1993-8#4)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-2#7)(1995-3#2)(1995-5#4)(1995-6#6)(1995-8#4)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#6)(2007-10#1)(2007-11#22)(2007-12#13)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#170)(2008-11#34)(2008-12#8)(2008-2#32)(2008-3#68)(2008-4#8)(2008-5#9)(2008-6#6)(2008-7#14)(2008-8#33)(2008-9#16)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#4)(2010-8#7)(2010-9#2)(2011-1#9)(2011-2#24)(2011-3#2)(2011-7#1)(2012-12#4)(2012-2#9)(2012-3#8)(2013-1#10)(2013-7#3)(2013-8#8)
introducer##2##1##(2007-7#1)(2009-8#1)
introduces a new##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)
introduces a systematic##2##3##(1996-12#1)(2008-3#1)
introduces a##24##2##(1990-7#1)(1990-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
introduces an##2##2##(2008-4#1)(2008-6#1)
introduces and##2##2##(2008-10#1)(2010-7#1)
introduces the possibility##2##3##(2008-10#1)(2012-2#1)
introduces the##18##2##(1991-2#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)
introduces two##2##2##(2008-5#1)(2013-8#1)
introduces##72##1##(1990-7#1)(1990-8#1)(1991-2#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#6)(2009-12#1)(2009-5#3)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
introducing a new##4##3##(1993-1#1)(1997-3#1)(2008-10#1)(2008-3#1)
introducing a##20##2##(1992-6#1)(1993-1#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2010-10#1)(2011-2#1)(2012-2#3)
introducing an##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
introducing feedback##2##2##(2010-10#2)
introducing into the##2##3##(2007-8#1)(2008-3#1)
introducing it##2##2##(1995-12#1)(1995-2#1)
introducing new##3##2##(2008-5#1)(2009-11#1)(2011-3#1)
introducing the concept of##2##4##(2008-9#1)(2012-3#1)
introducing the##8##2##(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
introducing them##2##2##(1997-1#1)(2008-10#1)
introducing##107##1##(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2010-1#2)(2010-10#4)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#4)
introduction and development of##2##4##(2008-11#1)(2008-12#1)
introduction and spread of##4##4##(1990-3#1)(2008-10#2)(2010-8#1)
introduction and##16##2##(1990-3#1)(1991-4#1)(1994-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2010-8#1)(2011-1#2)(2012-2#1)
introduction effort was##2##3##(2008-8#2)
introduction in the##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
introduction in##8##2##(2007-7#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-12#1)
introduction into the##7##3##(1990-7#1)(1991-11#1)(2008-10#3)(2013-1#2)
introduction into##10##2##(1990-7#1)(1991-11#1)(2008-10#4)(2008-4#1)(2008-8#1)(2013-1#2)
introduction of 2##3##3##(2008-10#2)(2009-9#1)
introduction of a medical##2##4##(2008-6#1)(2011-2#1)
introduction of a new##3##4##(1997-3#1)(2007-11#1)(2011-1#1)
introduction of a##39##3##(1992-12#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-3#3)(1997-4#1)(2007-11#3)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#2)
introduction of an##9##3##(1990-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)
introduction of drug-eluting stents##3##4##(2008-11#2)(2011-2#1)
introduction of effective chemotherapy##2##4##(2010-3#2)
introduction of effective##4##3##(2008-7#1)(2010-3#3)
introduction of foreign##2##3##(1997-7#1)(2008-1#1)
introduction of highly active##2##4##(2008-1#1)(2008-3#1)
introduction of highly##3##3##(1991-5#1)(2008-1#1)(2008-3#1)
introduction of modern##2##3##(1990-12#1)(2011-2#1)
introduction of new##11##3##(1990-2#1)(1991-3#1)(1993-1#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
introduction of other##2##3##(1990-2#1)(2007-11#1)
introduction of the pathogen into##2##5##(2008-10#2)
introduction of the pathogen##3##4##(2008-10#3)
introduction of the##58##3##(1990-10#1)(1991-9#2)(1992-3#1)(1993-12#2)(1994-6#2)(1995-6#1)(1997-5#2)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
introduction of these##3##3##(1993-12#1)(1995-11#1)(2008-11#1)
introduction of this##5##3##(1995-2#1)(1997-7#1)(2008-10#2)(2012-8#1)
introduction of two##2##3##(2007-11#1)(2008-11#1)
introduction of ultrasonography in##2##4##(2007-8#2)
introduction of##319##2##(1990-10#1)(1990-12#3)(1990-2#3)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#10)(2007-12#6)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#7)(2008-1#7)(2008-10#48)(2008-11#24)(2008-12#9)(2008-2#6)(2008-3#13)(2008-4#8)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-3#6)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#2)
introduction on the##2##3##(1992-1#1)(2008-10#1)
introduction or##2##2##(1996-3#1)(2007-11#1)
introduction success##2##2##(2008-8#2)
introduction systems##2##2##(2008-10#1)(2010-7#1)
introduction techniques##5##2##(2008-10#3)(2008-11#2)
introduction to a new##2##4##(2008-7#1)(2008-8#1)
introduction to a##3##3##(1993-3#1)(2008-7#1)(2008-8#1)
introduction to modeling structure from##2##5##(2008-4#2)
introduction to the feature issue##9##5##(2008-2#3)(2008-3#6)
introduction to the##23##3##(1991-12#1)(1992-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
introduction to##60##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#3)(1995-3#2)(1996-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#10)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
introduction within##2##2##(1995-6#1)(2008-11#1)
introduction##495##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-6#2)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-11#13)(2007-12#8)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#7)(2008-1#8)(2008-10#107)(2008-11#31)(2008-12#12)(2008-2#10)(2008-3#20)(2008-4#19)(2008-5#8)(2008-6#6)(2008-7#20)(2008-8#12)(2008-9#7)(2009-11#3)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#6)(2010-3#6)(2010-4#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#19)(2013-7#1)(2013-8#3)
introductions of the same species##2##5##(2008-8#2)
introductions of##9##2##(1990-7#1)(2008-10#6)(2008-8#2)
introductions##19##1##(1990-7#1)(2008-10#8)(2008-8#7)(2009-4#1)(2011-2#2)
introductory part##3##2##(2008-10#2)(2011-1#1)
introductory physics lab##2##3##(2012-2#2)
introductory physics##3##2##(2012-2#3)
introductory##19##1##(1992-1#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
introgressed from##3##2##(2008-10#3)
introgressed into##6##2##(2008-10#6)
introgressed##14##1##(2008-10#10)(2008-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
introgressing##2##1##(2008-10#1)(2008-5#1)
introgression of##2##2##(2009-2#1)(2009-9#1)
introgression was##2##2##(2008-10#1)(2009-2#1)
introgression##14##1##(2008-10#2)(2008-8#5)(2009-2#5)(2009-9#1)(2012-3#1)
intromissions preceding ejaculation and in time to ejaculation##2##8##(1991-2#2)
intromissions##3##1##(1991-2#3)
intron 1 of##4##3##(1995-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
intron 1##8##2##(1995-5#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
intron 2##2##2##(1993-2#1)(1995-8#1)
intron 3##3##2##(1995-6#1)(2010-4#1)(2011-1#1)
intron A##2##2##(1991-1#2)
intron alleles##2##2##(2008-10#2)
intron and genome##2##3##(2008-8#2)
intron and##6##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2011-1#1)
intron can##2##2##(1991-9#1)(1995-8#1)
intron content##3##2##(2008-7#3)
intron in the##3##3##(1993-8#1)(1997-8#1)(2008-10#1)
intron in##4##2##(1993-8#1)(1995-6#1)(1997-8#1)(2008-10#1)
intron of the gene##2##4##(1993-8#2)
intron of the rat##2##4##(1991-11#1)(1991-6#1)
intron of the##14##3##(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-8#2)(1995-6#1)(1997-7#1)(2008-10#3)(2012-3#2)
intron of##22##2##(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-8#2)(1995-6#1)(1997-7#1)(2008-10#5)(2008-9#2)(2012-3#2)
intron removal##2##2##(2007-12#2)
intron sequence##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
intron sequences##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
intron size##4##2##(2008-8#4)
intron that##2##2##(1995-6#1)(2008-10#1)
intron was##2##2##(2008-9#2)
intron with##2##2##(1991-9#1)(1994-12#1)
intron##127##1##(1990-7#1)(1991-1#3)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#4)(1991-9#7)(1992-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#8)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#5)(1995-5#2)(1995-6#4)(1995-8#3)(1997-2#3)(1997-7#1)(1997-8#2)(2007-12#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#6)(2008-8#10)(2008-9#11)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-3#4)(2013-1#1)
intron-containing##6##1##(1991-9#1)(1993-6#1)(2008-10#2)(2013-8#2)
intron-encoded##2##1##(1995-6#1)(1997-7#1)
intron-exon structure##2##2##(1993-12#1)(1993-6#1)
intron-exon##5##1##(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-8#1)
intron/exon organization##2##2##(1993-8#1)(1995-8#1)
intron/exon##7##1##(1993-11#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-4#1)
intronic sequences of##2##3##(1993-2#1)(1997-7#1)
intronic##9##1##(1993-12#3)(1993-2#1)(1996-2#1)(1997-7#1)(2008-5#1)(2011-1#1)(2012-3#1)
intronless gene##2##2##(1991-9#1)(1997-7#1)
intronless genes##4##2##(1993-2#1)(1993-8#1)(2008-7#1)(2008-9#1)
intronless##12##1##(1991-9#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)
introns 1 and##2##3##(1995-8#1)(2008-7#1)
introns and encodes a protein of##2##6##(1993-6#1)(1996-6#1)
introns and encodes a##3##4##(1993-6#1)(1996-10#1)(1996-6#1)
introns and the##3##3##(1994-11#1)(1996-10#1)(2008-10#1)
introns and##15##2##(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-9#1)(1996-10#2)(1996-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-9#1)
introns are embedded molecular switches regulated by##2##7##(2013-8#2)
introns are##3##2##(1995-8#1)(2013-8#2)
introns in the##6##3##(1992-3#1)(1994-8#2)(1995-8#1)(2008-10#1)(2010-5#1)
introns in##8##2##(1992-3#1)(1994-8#2)(1995-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2013-8#1)
introns of##8##2##(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-11#1)
introns were##2##2##(2010-5#2)
introns##90##1##(1990-12#1)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#6)(1993-3#1)(1993-6#4)(1993-8#3)(1994-11#3)(1994-12#4)(1994-5#1)(1994-8#2)(1995-6#3)(1995-8#5)(1995-9#1)(1996-10#2)(1996-6#1)(1997-2#2)(1997-4#2)(1997-6#5)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#4)
introspection##3##1##(1993-2#1)(2009-4#1)(2012-3#1)
introverted##3##1##(1996-3#1)(2009-7#2)
intrude##2##1##(2007-12#1)(2007-9#1)
intrusion##9##1##(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#3)(2012-3#2)(2013-1#1)
intrusions and##2##2##(2009-11#2)
intrusions##7##1##(1994-2#1)(2008-3#1)(2008-8#1)(2009-11#4)
intrusive memories##2##2##(2009-11#2)
intrusive##11##1##(1994-12#1)(2008-10#2)(2008-4#1)(2009-11#4)(2009-12#1)(2010-8#1)(2013-8#1)
intubated and##2##2##(1996-3#1)(2011-2#1)
intubated##8##1##(1996-3#1)(2008-11#1)(2009-4#1)(2010-10#2)(2010-7#2)(2011-2#1)
intubation and##3##2##(1991-11#1)(2010-7#1)(2013-1#1)
intubation for##2##2##(2012-12#1)(2012-2#1)
intubation in##2##2##(1996-6#1)(2013-1#1)
intubation or##2##2##(2007-8#1)(2011-2#1)
intubation was##3##2##(2007-5#1)(2010-7#2)
intubation##35##1##(1990-2#1)(1991-11#1)(1991-12#1)(1993-6#4)(1996-6#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2009-5#1)(2010-7#6)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
intuition##3##1##(2009-8#1)(2010-12#2)
intuitions##3##1##(2008-11#1)(2012-2#2)
intuitive and##2##2##(1994-11#1)(2008-8#1)
intuitive physical##2##2##(2008-2#1)(2010-7#1)
intuitive##22##1##(1994-11#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
intuitively##4##1##(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
intussusception##10##1##(1993-9#1)(2007-2#1)(2009-2#2)(2011-2#1)(2013-1#5)
inulin and##4##2##(2008-1#1)(2010-4#2)(2011-1#1)
inulin was##3##2##(2011-1#3)
inulin##20##1##(1992-1#1)(1994-6#1)(2008-1#1)(2008-10#3)(2008-6#1)(2010-4#5)(2011-1#6)(2012-2#2)
inulinase##5##1##(2008-6#2)(2011-1#3)
inundated with##2##2##(1993-12#1)(2008-7#1)
inundated##4##1##(1993-12#1)(2008-5#2)(2008-7#1)
invade agar##2##2##(2008-8#2)
invade and##2##2##(2008-9#1)(2011-2#1)
invade the seed##2##3##(2008-10#2)
invade the##12##2##(1991-7#1)(2008-1#1)(2008-10#6)(2008-5#1)(2009-5#1)(2009-7#1)(2011-2#1)
invade##30##1##(1991-7#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-5#2)(2008-8#2)(2008-9#5)(2009-5#1)(2009-7#1)(2011-2#3)(2012-2#2)(2013-8#1)
invaded by the##4##3##(2006-12#1)(2008-10#2)(2008-6#1)
invaded by##8##2##(1990-3#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
invaded the##9##2##(1991-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
invaded##33##1##(1990-3#1)(1991-12#1)(1992-1#1)(1995-6#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
invaders##6##1##(2006-10#1)(2008-11#2)(2008-8#3)
invades the##2##2##(2008-10#1)(2013-1#1)
invades##5##1##(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
invading hyphae##5##2##(2008-10#5)
invading the##7##2##(1993-12#1)(1993-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
invading##33##1##(1990-2#1)(1990-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(2007-12#1)(2008-10#12)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
invadopodia##3##1##(2011-2#2)(2012-12#1)
invadopodia/podosomes##2##1##(2011-2#2)
invaginated##4##1##(2007-12#1)(2008-10#2)(2008-5#1)
invaginating##2##1##(2007-12#1)(2008-7#1)
invagination of the##2##3##(2008-10#1)(2008-6#1)
invagination##11##1##(1990-3#2)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#2)(2013-1#1)
invaginations of the##3##3##(1995-2#1)(2007-12#1)(2008-7#1)
invaginations of##4##2##(1994-8#1)(1995-2#1)(2007-12#1)(2008-7#1)
invaginations##7##1##(1994-8#1)(1995-2#1)(2007-12#4)(2008-7#1)
invalid for##2##2##(2008-3#1)(2008-9#1)
invalid##12##1##(1995-2#1)(1997-1#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
invalidate the##2##2##(2009-3#1)(2010-4#1)
invalidate##5##1##(1995-6#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)
invalidated##2##1##(2008-10#1)(2012-2#1)
invalidates the##2##2##(2008-10#1)(2008-7#1)
invaluable in##4##2##(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
invaluable information##2##2##(2008-10#1)(2012-3#1)
invaluable to##2##2##(1995-1#1)(1995-12#1)
invaluable tools##2##2##(2008-11#2)
invaluable##28##1##(1992-2#1)(1995-1#1)(1995-12#2)(1996-1#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#6)(2011-2#1)(2012-2#1)(2012-3#2)
invariable##4##1##(1994-2#1)(2008-7#1)(2008-9#1)(2010-1#1)
invariably be##2##2##(1992-11#1)(1997-7#1)
invariably fatal##2##2##(2008-7#1)(2009-2#1)
invariably##29##1##(1992-11#1)(1993-5#1)(1995-12#1)(1995-8#1)(1995-9#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
invariance are##2##2##(1995-2#1)(2008-3#1)
invariance of##2##2##(2008-3#2)
invariance##15##1##(1991-9#1)(1993-9#1)(1994-2#1)(1995-2#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-11#1)(2012-2#2)
invariant NK T cell clones##2##5##(2008-4#2)
invariant NK T##3##3##(2008-4#3)
invariant across##2##2##(2008-10#1)(2008-5#1)
invariant and##3##2##(2008-3#1)(2012-2#2)
invariant chain##2##2##(1990-12#1)(1995-11#1)
invariant for##2##2##(2008-10#1)(2008-3#1)
invariant in##2##2##(2008-3#1)(2009-8#1)
invariant item##2##2##(2012-2#2)
invariant representations##2##2##(2009-10#2)
invariant surface glycoprotein##2##3##(2013-1#2)
invariant to##5##2##(2008-2#2)(2008-3#2)(2008-6#1)
invariant under the##2##3##(1996-3#1)(2013-8#1)
invariant under##4##2##(1996-3#1)(2008-3#1)(2008-6#1)(2013-8#1)
invariant with respect to##2##4##(2008-3#1)(2009-10#1)
invariant with##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
invariant##55##1##(1990-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#2)(1995-2#2)(1995-9#2)(1996-3#1)(1996-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#1)(2008-6#2)(2009-10#3)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#5)(2013-1#2)(2013-8#1)
invasibility##2##1##(2008-10#1)(2008-8#1)
invasion and angiogenesis##3##3##(2008-11#3)
invasion and metastasis##13##3##(1992-9#1)(1993-6#1)(1993-9#1)(2007-10#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)
invasion and metastatic##4##3##(1990-11#1)(1993-9#1)(2011-2#1)(2013-1#1)
invasion and migration##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
invasion and proliferation##3##3##(2008-11#2)(2012-12#1)
invasion and spread of##3##4##(1990-11#1)(2008-10#1)(2010-3#1)
invasion and spread##4##3##(1990-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
invasion and subsequent##2##3##(2008-10#1)(2008-8#1)
invasion and the##2##3##(1995-12#1)(2009-4#1)
invasion and##49##2##(1990-11#3)(1990-9#1)(1992-2#1)(1992-9#1)(1993-6#1)(1993-9#2)(1995-12#1)(2007-10#2)(2008-10#7)(2008-11#7)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)
invasion as##2##2##(2011-2#1)(2012-12#1)
invasion assay##4##2##(2008-11#2)(2013-8#2)
invasion by##9##2##(1990-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
invasion can##2##2##(2008-8#2)
invasion depth of##2##3##(2013-1#2)
invasion depth##3##2##(2013-1#3)
invasion in vivo##2##3##(1992-9#1)(1994-9#1)
invasion in##7##2##(1992-9#1)(1994-9#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
invasion into the##2##3##(2008-8#1)(2011-2#1)
invasion into##6##2##(1997-3#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
invasion is##5##2##(2007-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
invasion of AH109A cells across##2##5##(2008-11#2)
invasion of AH109A cells##6##4##(2008-11#6)
invasion of AH109A##7##3##(2008-11#7)
invasion of a rat ascites hepatoma cell line of AH109A##2##10##(2008-11#2)
invasion of a rat ascites hepatoma cell line##3##8##(2008-11#3)
invasion of a##7##3##(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
invasion of cancer cells##4##4##(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
invasion of hepatoma cells in culture##3##6##(2008-11#3)
invasion of hepatoma cells in##4##5##(1991-5#1)(2008-11#3)
invasion of hepatoma cells##5##4##(1991-5#1)(2008-11#4)
invasion of hepatoma##6##3##(1991-5#1)(2008-11#4)(2013-8#1)
invasion of host##2##3##(2008-10#1)(2008-9#1)
invasion of privacy##2##3##(1995-12#1)(1996-5#1)
invasion of rat ascites hepatoma##2##5##(2008-11#2)
invasion of the##21##3##(1990-9#1)(1991-12#1)(1991-6#1)(1994-9#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-7#2)(2009-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
invasion of##72##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#20)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#5)
invasion process##3##2##(1994-9#1)(2007-12#1)(2008-10#1)
invasion site##2##2##(2008-10#1)(2009-8#1)
invasion suggest##2##2##(1994-9#1)(2008-6#1)
invasion to##6##2##(1994-9#2)(2008-8#1)(2009-3#1)(2010-10#1)(2012-2#1)
invasion was##6##2##(1990-8#1)(1990-9#2)(1994-9#1)(2008-10#1)(2008-5#1)
invasion were##2##2##(1994-9#1)(2012-1#1)
invasion##296##1##(1990-10#2)(1990-11#3)(1990-8#2)(1990-9#5)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-9#2)(1993-6#1)(1993-9#3)(1994-9#18)(1995-12#2)(1996-5#1)(1997-3#1)(2006-4#1)(2007-10#4)(2007-12#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#38)(2008-11#50)(2008-12#2)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#16)(2008-9#10)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#2)(2010-3#5)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#24)(2012-1#1)(2012-12#11)(2012-2#8)(2012-3#4)(2013-1#11)(2013-8#18)
invasions by##2##2##(2007-7#2)
invasions##9##1##(2007-7#3)(2008-10#1)(2008-8#4)(2010-3#1)
invasive activity##5##2##(2008-11#5)
invasive and metastatic##4##3##(1992-9#1)(2008-1#1)(2008-11#1)(2012-2#1)
invasive and noninvasive species##2##4##(2008-8#2)
invasive and noninvasive##3##3##(2008-8#3)
invasive and##23##2##(1992-9#2)(1997-6#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
invasive approach##7##2##(2008-12#1)(2010-11#1)(2011-2#4)(2013-1#1)
invasive approaches to incisional##2##4##(2011-2#2)
invasive approaches to##6##3##(2011-2#4)(2013-1#2)
invasive approaches##10##2##(2008-10#1)(2011-2#5)(2013-1#4)
invasive aspergillosis##6##2##(2008-7#2)(2009-3#3)(2013-8#1)
invasive bladder cancer was##2##4##(1993-9#2)
invasive bladder cancer##6##3##(1993-9#3)(2013-8#3)
invasive bladder tumours##3##3##(1991-6#2)(1991-9#1)
invasive bladder##9##2##(1991-6#2)(1991-9#1)(1993-9#3)(2013-8#3)
invasive breast cancer##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
invasive breast##6##2##(1993-11#1)(2008-10#1)(2008-7#1)(2013-1#3)
invasive cancer patients##3##3##(1992-8#3)
invasive cancer##11##2##(1991-2#1)(1992-10#1)(1992-8#4)(1995-2#1)(1997-8#1)(2009-11#1)(2011-2#2)
invasive candidiasis##2##2##(2008-5#1)(2011-2#1)
invasive capacity##3##2##(2008-11#2)(2008-9#1)
invasive carcinoma##7##2##(1990-6#2)(1994-1#1)(1994-2#1)(1997-7#2)(2008-1#1)
invasive carcinomas##3##2##(1994-12#1)(1997-8#2)
invasive cervical cancer##4##3##(1990-12#1)(1992-8#1)(2011-3#1)(2012-3#1)
invasive cervical##6##2##(1990-12#1)(1992-8#1)(2011-3#1)(2012-3#1)(2013-1#2)
invasive coronary##2##2##(2008-10#1)(2008-11#1)
invasive diagnostic##3##2##(1992-11#1)(2008-7#1)(2011-2#1)
invasive direct coronary artery bypass##3##5##(1997-8#1)(2007-8#2)
invasive direct coronary artery##5##4##(1997-8#1)(2007-8#4)
invasive disease##6##2##(1994-2#1)(2008-11#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
invasive ductal carcinoma##3##3##(1994-12#1)(1995-4#1)(2008-10#1)
invasive ductal carcinomas##2##3##(1994-12#1)(1994-2#1)
invasive ductal##8##2##(1992-8#1)(1994-12#2)(1994-2#1)(1995-4#1)(2008-10#1)(2011-2#1)(2012-12#1)
invasive fungal infections##5##3##(2008-7#2)(2011-2#2)(2012-2#1)
invasive fungal##7##2##(2008-7#2)(2011-2#2)(2012-2#3)
invasive growth and##3##3##(1990-11#1)(2007-8#1)(2008-11#1)
invasive growth of##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
invasive growth##11##2##(1990-11#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-11#5)(2011-1#1)(2013-1#1)
invasive infection##2##2##(2007-12#1)(2008-11#1)
invasive infections in##2##3##(1996-12#1)(2007-12#1)
invasive infections##5##2##(1993-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-5#1)
invasive lobular carcinoma##2##3##(1994-12#1)(1997-3#1)
invasive lobular##4##2##(1994-12#1)(1997-3#2)(2011-2#1)
invasive malignancy##2##2##(1997-1#1)(2009-12#1)
invasive management##2##2##(1996-3#1)(2010-11#1)
invasive medical procedures##2##3##(2008-11#1)(2011-1#1)
invasive medical##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
invasive meningococcal disease##7##3##(2007-12#2)(2008-11#2)(2009-5#1)(2013-1#2)
invasive meningococcal##8##2##(2007-12#2)(2008-11#2)(2009-5#1)(2010-10#1)(2013-1#2)
invasive method##4##2##(2007-11#1)(2007-8#1)(2008-8#2)
invasive methods for##2##3##(1995-8#1)(2013-1#1)
invasive methods in##2##3##(1996-9#1)(2007-8#1)
invasive methods of##2##3##(2011-2#1)(2012-3#1)
invasive methods##10##2##(1991-11#1)(1995-8#1)(1996-9#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
invasive monitoring##2##2##(2008-8#1)(2012-3#1)
invasive mosquitoes##3##2##(2007-7#3)
invasive or##2##2##(1994-2#1)(2011-3#1)
invasive papillary thyroid##3##3##(2013-1#3)
invasive periodontal##2##2##(2012-3#2)
invasive potential of##2##3##(2008-10#1)(2008-4#1)
invasive prenatal##2##2##(2013-1#2)
invasive procedure##9##2##(1996-12#1)(2007-7#2)(2007-8#1)(2010-8#2)(2012-12#1)(2012-2#2)
invasive procedures in##6##3##(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
invasive procedures such as##2##4##(2007-4#1)(2008-9#1)
invasive procedures##18##2##(1990-2#1)(1996-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
invasive pulmonary aspergillosis##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
invasive species##5##2##(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)
invasive squamous cell carcinoma##2##4##(1996-12#1)(2013-8#1)
invasive strategies##2##2##(2010-12#1)(2011-2#1)
invasive strategy##3##2##(2008-3#3)
invasive surgery##13##2##(2007-8#2)(2008-10#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
invasive surgical techniques for##2##4##(2007-8#1)(2011-2#1)
invasive surgical techniques##5##3##(2007-8#1)(2007-9#1)(2008-8#1)(2011-2#2)
invasive surgical##13##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
invasive technique##6##2##(2011-2#4)(2012-2#1)(2013-1#1)
invasive techniques and##2##3##(1993-2#1)(2007-8#1)
invasive techniques##10##2##(1993-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
invasive test##3##2##(2012-3#1)(2013-1#2)
invasive than##4##2##(1997-3#1)(2008-4#1)(2009-3#1)(2011-2#1)
invasive therapy##4##2##(1997-2#1)(2008-3#2)(2009-12#1)
invasive transitional cell##2##3##(2007-10#1)(2008-10#1)
invasive treatment for##3##3##(1994-11#1)(1997-3#1)(2013-1#1)
invasive treatment##5##2##(1994-11#1)(1997-3#1)(2008-10#1)(2013-1#2)
invasive tumors up to 10 mm in size##2##8##(1990-2#2)
invasive##447##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#3)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-6#1)(1992-8#8)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#6)(1997-6#1)(1997-7#3)(1997-8#7)(2007-10#3)(2007-11#3)(2007-12#8)(2007-4#1)(2007-7#11)(2007-8#18)(2007-9#1)(2008-1#7)(2008-10#23)(2008-11#26)(2008-12#3)(2008-3#7)(2008-4#4)(2008-5#7)(2008-7#19)(2008-8#15)(2008-9#7)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#8)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#6)(2011-1#5)(2011-2#50)(2011-3#2)(2012-1#5)(2012-12#13)(2012-2#12)(2012-3#19)(2013-1#42)(2013-7#1)(2013-8#10)
invasive)##2##1##(1991-2#1)(2008-3#1)
invasively##4##1##(1990-9#1)(2008-12#1)(2009-4#1)(2011-2#1)
invasiveness and##6##2##(1997-3#2)(2006-10#1)(2010-3#1)(2010-8#1)(2012-12#1)
invasiveness in##2##2##(1993-2#1)(2010-3#1)
invasiveness of the##2##3##(1990-6#1)(2011-2#1)
invasiveness of##6##2##(1990-6#1)(1991-2#1)(1994-9#1)(1995-6#1)(2007-11#1)(2011-2#1)
invasiveness##25##1##(1990-6#1)(1991-2#1)(1993-2#1)(1994-9#1)(1995-6#1)(1997-3#2)(2006-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-8#2)(2010-3#4)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
inventariseren##2##1##(2012-12#2)
invented##6##1##(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-2#1)
invention of##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
invention##6##1##(2007-12#1)(2008-2#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-1#1)
inventions##4##1##(2010-7#1)(2011-1#3)
inventories##3##1##(2007-12#1)(2008-11#1)(2008-7#1)
inventory and##4##2##(1996-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
inventory management##4##2##(2008-10#1)(2008-7#2)(2011-2#1)
inventory of the##3##3##(1997-3#1)(2008-5#1)(2013-1#1)
inventory of##13##2##(1992-3#1)(1996-12#1)(1997-3#1)(2008-1#2)(2008-5#2)(2008-7#4)(2012-2#1)(2013-1#1)
inventory##47##1##(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#3)(2008-7#11)(2009-3#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
inverse Fourier transformation of##2##4##(2008-1#1)(2008-2#1)
inverse Monte Carlo method##2##4##(2008-3#2)
inverse Monte Carlo##4##3##(2008-3#4)
inverse PCR with highly overlapped primers##3##6##(1997-2#3)
inverse agonists##3##2##(1995-11#1)(2008-11#1)(2009-8#1)
inverse association##3##2##(2008-3#1)(2008-4#1)(2012-12#1)
inverse correlation between##5##3##(1993-9#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-7#1)
inverse correlation##12##2##(1991-12#1)(1992-2#1)(1993-9#1)(2008-7#4)(2008-8#1)(2011-2#1)(2012-12#2)(2012-7#1)
inverse distance##2##2##(2008-10#1)(2009-7#1)
inverse filter##3##2##(2007-12#1)(2008-3#2)
inverse growth associated##5##3##(2008-11#5)
inverse growth##6##2##(2008-11#6)
inverse least squares##2##3##(2007-12#1)(2008-10#1)
inverse least-squares##2##2##(2008-10#2)
inverse linear relationship##3##3##(2008-10#2)(2009-4#1)
inverse linear##4##2##(1991-12#1)(2008-10#2)(2009-4#1)
inverse photon migration problems in heterogeneous##2##6##(2007-12#2)
inverse polymerase chain reaction##2##4##(1993-9#1)(2008-10#1)
inverse power##3##2##(2008-10#3)
inverse problem of##2##3##(2007-12#1)(2008-2#1)
inverse problem##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2009-7#1)
inverse problems in##2##3##(2008-2#1)(2008-3#1)
inverse problems##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
inverse procedure is##2##3##(2008-3#2)
inverse procedure##3##2##(2008-3#3)
inverse proportion to the##4##4##(1990-8#1)(2008-10#1)(2008-3#2)
inverse relation between##2##3##(2008-4#1)(2008-8#1)
inverse relation##4##2##(1991-5#1)(1994-5#1)(2008-4#1)(2008-8#1)
inverse relationship between##17##3##(1991-5#1)(1994-6#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#3)
inverse relationship with the##2##4##(1993-2#1)(2008-7#1)
inverse relationship with##4##3##(1993-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
inverse relationship##23##2##(1991-5#1)(1993-12#1)(1993-2#1)(1994-6#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#3)
inverse sampling##6##2##(1995-9#3)(1996-3#3)
inverse spectral theory##4##3##(2008-2#2)(2008-3#2)
inverse technique is##2##3##(2008-3#2)
inverse technique##3##2##(2008-3#3)
inverse transform##2##2##(2008-3#1)(2013-8#1)
inverse##177##1##(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-9#3)(1996-3#3)(1996-7#1)(1997-2#3)(1997-8#1)(2007-11#2)(2007-12#9)(2008-1#2)(2008-10#19)(2008-11#9)(2008-12#1)(2008-2#13)(2008-3#36)(2008-4#2)(2008-5#8)(2008-7#7)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2012-7#1)(2013-7#1)(2013-8#4)
inverse-kinematic model of##2##3##(2007-12#2)
inverse-kinematic##3##1##(2007-12#3)
inverse-probability##2##1##(2012-3#2)
inverse-scattering problem##3##2##(2007-12#1)(2008-2#2)
inverse-scattering##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
inversely associated with##4##3##(1991-3#1)(2009-3#1)(2009-9#2)
inversely associated##5##2##(1991-3#1)(2008-10#1)(2009-3#1)(2009-9#2)
inversely correlated with the##5##4##(1990-2#1)(1993-8#1)(1997-4#1)(2009-5#1)(2011-2#1)
inversely correlated with##19##3##(1990-2#1)(1993-8#1)(1995-2#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#2)
inversely correlated##21##2##(1990-2#1)(1991-12#1)(1993-8#1)(1995-2#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#2)
inversely proportional to the##10##4##(1990-11#1)(1990-12#1)(1990-9#1)(1993-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2012-3#1)
inversely proportional to##15##3##(1990-11#1)(1990-12#1)(1990-9#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-3#1)
inversely related to ration##2##4##(2010-8#2)
inversely related to the degree of heterogeneity##2##7##(2008-10#2)
inversely related to the degree of##3##6##(1990-5#1)(2008-10#2)
inversely related to the##13##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-9#2)(2009-3#1)(2009-8#1)
inversely related to##22##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-6#1)(1994-6#1)(1995-12#1)(2008-10#3)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#2)(2010-8#2)(2011-2#1)
inversely related##23##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-6#1)(1994-6#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#2)(2010-8#2)(2011-2#1)
inversely to##2##2##(1992-8#1)(2013-1#1)
inversely with metastatic potential##2##4##(1993-9#1)(2010-3#1)
inversely with the square##2##4##(2008-2#1)(2008-9#1)
inversely with the##6##3##(1992-11#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)
inversely with##14##2##(1992-11#1)(1993-9#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2012-2#1)
inversely##88##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-8#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#8)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
inversion accuracy##2##2##(2008-2#1)(2013-8#1)
inversion algorithm for estimating the absorption and backscattering coefficients of natural waters##2##12##(2008-2#1)(2008-3#1)
inversion algorithm for##3##3##(2008-2#2)(2008-3#1)
inversion algorithm is##4##3##(2008-3#4)
inversion algorithm that##3##3##(2008-3#3)
inversion algorithm##22##2##(2008-2#5)(2008-3#17)
inversion and the##2##3##(1994-8#1)(2007-12#1)
inversion and##6##2##(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#2)
inversion by##2##2##(2008-3#2)
inversion effect##2##2##(2007-8#1)(2008-3#1)
inversion events in##2##3##(1995-8#2)
inversion for##2##2##(1996-2#1)(2008-2#1)
inversion in##7##2##(1993-1#1)(1995-8#1)(2007-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
inversion is##3##2##(2008-3#3)
inversion method##3##2##(2008-2#1)(2008-3#2)
inversion methods##2##2##(2008-3#2)
inversion model##2##2##(2008-3#2)
inversion of a##2##3##(2008-2#1)(2008-3#1)
inversion of atmospheric##2##3##(2008-3#2)
inversion of configuration at##2##4##(1996-5#2)
inversion of reflectometric and ellipsometric data##3##6##(2008-3#3)
inversion of the##12##3##(1991-12#1)(1994-2#1)(1996-2#1)(2007-12#1)(2008-3#7)(2010-4#1)
inversion of##40##2##(1991-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-2#1)(2007-12#3)(2008-11#1)(2008-2#4)(2008-3#20)(2008-6#1)(2010-4#1)(2012-1#1)(2013-1#1)
inversion on##2##2##(1997-5#1)(2008-3#1)
inversion problem##2##2##(2008-3#2)
inversion procedure that##2##3##(2009-5#1)(2011-2#1)
inversion procedure##6##2##(2008-2#1)(2008-3#3)(2009-5#1)(2011-2#1)
inversion recovery##3##2##(2008-7#1)(2011-2#2)
inversion results##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
inversion scheme that##2##3##(2008-3#2)
inversion scheme##5##2##(2008-3#5)
inversion system##3##2##(2013-1#3)
inversion technique##3##2##(2008-3#3)
inversion techniques##4##2##(2008-3#4)
inversion to##2##2##(2008-3#2)
inversion with regularization##4##3##(2008-3#4)
inversion with##6##2##(2008-3#6)
inversion##206##1##(1991-12#1)(1992-7#1)(1993-1#1)(1994-2#1)(1994-8#3)(1995-3#1)(1995-8#4)(1996-2#3)(1996-5#2)(1997-2#2)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#11)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#30)(2008-3#100)(2008-6#1)(2008-7#5)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#7)(2012-1#3)(2013-1#10)(2013-8#4)
inversions are##2##2##(2008-3#2)
inversions in##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
inversions##22##1##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#8)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-2#2)(2013-1#3)
inversus is##2##2##(2008-7#1)(2009-8#1)
inversus with dextrocardia##3##3##(2008-7#3)
inversus##11##1##(1993-9#2)(2008-7#4)(2009-8#5)
invertase from##2##2##(1997-2#2)
invertase in##2##2##(2008-12#1)(2008-9#1)
invertase oligosaccharides##2##2##(2008-7#2)
invertase##32##1##(1996-3#1)(1997-2#3)(1997-3#1)(2008-10#7)(2008-12#3)(2008-7#7)(2008-9#10)
invertebrate LDH##2##2##(1994-11#2)
invertebrate and##2##2##(1996-6#1)(2010-7#1)
invertebrate glial cell migration##2##4##(2008-7#2)
invertebrate hosts##2##2##(2008-9#2)
invertebrate lectins##2##2##(1990-5#2)
invertebrate model##2##2##(2007-12#1)(2009-8#1)
invertebrate species##3##2##(1990-11#1)(2009-4#1)(2013-7#1)
invertebrate##38##1##(1990-11#1)(1990-5#3)(1992-12#1)(1994-11#3)(1994-8#1)(1995-12#2)(1996-6#1)(1997-7#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-4#2)(2009-6#2)(2009-8#1)(2010-7#1)(2013-1#1)(2013-7#1)
invertebrates and vertebrates##3##3##(2008-9#3)
invertebrates and##4##2##(2008-9#3)(2009-6#1)
invertebrates have##2##2##(2008-10#1)(2008-9#1)
invertebrates was##2##2##(2008-11#1)(2013-1#1)
invertebrates##32##1##(1990-5#1)(1991-1#1)(1991-12#1)(1994-9#1)(1996-2#1)(2007-5#3)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-2#1)(2009-4#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
inverted Maxwell-Garnett##2##2##(2008-3#2)
inverted U-shaped##2##2##(2008-5#2)
inverted and unprocessed digitized radiographic imaging in periodontal bone loss measurements##2##11##(2008-12#2)
inverted and unprocessed digitized radiographic##3##5##(2008-12#3)
inverted and unprocessed digitized##4##4##(2008-12#4)
inverted and##9##2##(2008-11#3)(2008-12#4)(2008-2#2)
inverted by##4##2##(1995-8#1)(2008-3#1)(2013-8#2)
inverted exclamation##2##2##(2008-10#2)
inverted extinction##3##2##(2008-3#3)
inverted hexagonal (HII)##2##3##(1990-2#1)(1994-3#1)
inverted papilloma##2##2##(2008-7#1)(2013-1#1)
inverted repeat##7##2##(1993-12#1)(1995-8#1)(2008-10#2)(2008-8#2)(2011-1#1)
inverted repeats##5##2##(1993-12#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-2#1)
inverted terminal repeats##2##3##(1995-8#1)(2008-8#1)
inverted to obtain the##2##4##(2008-2#1)(2008-3#1)
inverted to##3##2##(2008-2#2)(2008-3#1)
inverted##77##1##(1990-2#1)(1993-1#1)(1993-12#2)(1994-12#3)(1994-3#1)(1995-8#4)(1996-6#1)(1997-2#3)(1997-9#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-2#8)(2008-3#14)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
inverting profiles of##2##3##(2008-2#1)(2008-3#1)
inverting the##5##2##(2007-11#1)(2008-3#2)(2009-5#1)(2012-3#1)
inverting##11##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2009-5#1)(2010-11#1)(2012-3#1)
invest in##6##2##(1993-12#1)(1995-2#1)(2007-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
invest more in##2##3##(2008-8#1)(2010-5#1)
invest##12##1##(1992-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(2007-2#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)
invested in##9##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#5)
invested their##2##2##(2009-3#1)(2011-2#1)
invested##14##1##(1993-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#6)(2013-1#1)
investigate a##8##2##(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#2)
investigate and##3##2##(1993-5#1)(2008-10#1)(2011-2#1)
investigate any##4##2##(2008-11#1)(2009-5#1)(2010-5#1)(2010-8#1)
investigate both the##2##3##(1990-5#1)(2007-11#1)
investigate both##3##2##(1990-5#1)(2007-11#1)(2008-5#1)
investigate cellular##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
investigate different##2##2##(1997-3#1)(2008-2#1)
investigate effect of##2##3##(2008-12#1)(2008-9#1)
investigate factors##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
investigate further##5##2##(1995-6#1)(1996-2#1)(2008-5#1)(2010-2#1)(2012-2#1)
investigate genetic factors##2##3##(1996-5#1)(1997-8#1)
investigate genetic##3##2##(1996-5#1)(1997-8#1)(2008-10#1)
investigate how##25##2##(1993-6#1)(1994-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#2)
investigate if the##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
investigate if##7##2##(1990-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#1)
investigate its##10##2##(1991-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
investigate mechanisms of##2##3##(2008-11#1)(2008-8#1)
investigate new##4##2##(2007-11#1)(2008-7#1)(2010-11#1)(2012-2#1)
investigate other##2##2##(2008-4#1)(2008-6#1)
investigate possible##7##2##(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-6#1)
investigate potential##2##2##(1994-12#1)(1994-5#1)
investigate quantitatively the##2##3##(1995-5#1)(2008-10#1)
investigate since##2##2##(2008-1#2)
investigate the applicability of##2##4##(1995-9#1)(2008-10#1)
investigate the applicability##3##3##(1995-9#1)(2008-10#1)(2008-2#1)
investigate the association between##5##4##(2008-3#1)(2011-2#2)(2013-1#2)
investigate the association##6##3##(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
investigate the biomechanical##2##3##(2008-9#1)(2013-1#1)
investigate the changes in##3##4##(2010-4#1)(2011-1#1)(2012-12#1)
investigate the characteristics of##5##4##(2008-2#1)(2008-3#3)(2011-3#1)
investigate the contribution of##2##4##(1995-8#1)(2009-6#1)
investigate the correlation between##3##4##(2007-10#1)(2008-5#1)(2013-8#1)
investigate the distribution of##5##4##(1992-11#1)(1993-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
investigate the dynamics of##4##4##(2007-11#1)(2007-12#1)(2008-11#1)(2009-6#1)
investigate the effect of a##3##5##(1997-7#1)(2008-2#1)(2009-12#1)
investigate the effect of the##5##5##(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
investigate the effect of##50##4##(1992-2#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-3#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#5)(2008-12#6)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
investigate the effect##51##3##(1992-2#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#5)(2008-12#6)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
investigate the effects of##32##4##(1990-3#1)(1990-7#1)(1990-9#1)(1992-2#1)(1995-12#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
investigate the effects##34##3##(1990-3#1)(1990-7#1)(1990-9#1)(1992-2#1)(1995-12#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
investigate the efficacy of##5##4##(1997-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
investigate the efficiency of##2##4##(2007-11#1)(2008-12#1)
investigate the extent to which##2##5##(2007-11#1)(2009-7#1)
investigate the extent##3##3##(2007-11#1)(2009-7#1)(2012-3#1)
investigate the feasibility of the##3##5##(2008-2#2)(2008-3#1)
investigate the feasibility of##8##4##(2008-10#1)(2008-2#4)(2008-3#1)(2010-5#1)(2012-3#1)
investigate the feasibility##9##3##(2008-10#1)(2008-2#4)(2008-3#1)(2010-5#1)(2010-8#1)(2012-3#1)
investigate the formation##2##3##(2007-12#1)(2010-4#1)
investigate the function of##2##4##(2008-6#1)(2008-9#1)
investigate the genetic##4##3##(2007-10#1)(2008-10#1)(2008-8#1)(2013-8#1)
investigate the impact of##5##4##(2008-2#1)(2008-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
investigate the influence of##18##4##(1995-12#1)(1995-6#1)(1996-12#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#3)
investigate the intensity##2##3##(2007-11#1)(2007-12#1)
investigate the interaction between##2##4##(1993-6#1)(2008-10#1)
investigate the mechanism for##2##4##(2008-11#1)(2008-3#1)
investigate the mechanism of##10##4##(1992-8#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
investigate the mechanism##16##3##(1991-11#1)(1992-8#1)(1994-8#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
investigate the metabolic##2##3##(1996-12#1)(2012-1#1)
investigate the molecular##10##3##(1990-5#1)(1990-8#1)(1992-3#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-9#1)(2012-1#1)
investigate the nature of the##2##5##(1992-9#1)(1995-3#1)
investigate the nature of##3##4##(1992-9#1)(1993-9#1)(1995-3#1)
investigate the neural##4##3##(1993-5#1)(2008-11#1)(2008-9#1)(2012-2#1)
investigate the performance of the##3##5##(1997-3#1)(2008-2#1)(2012-3#1)
investigate the performance of##4##4##(1997-3#1)(2008-2#1)(2012-3#2)
investigate the possibility##6##3##(1994-6#1)(1994-8#2)(2008-11#2)(2012-3#1)
investigate the possible association##2##4##(1992-12#1)(2011-1#1)
investigate the possible##8##3##(1992-12#1)(1992-9#1)(1994-5#1)(1996-2#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
investigate the potential of##3##4##(1992-9#1)(1995-2#1)(2008-7#1)
investigate the potential##7##3##(1992-9#1)(1995-2#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)
investigate the presence of the##2##5##(1995-5#1)(2008-4#1)
investigate the presence of##5##4##(1995-12#1)(1995-2#1)(1995-5#1)(2008-2#1)(2008-4#1)
investigate the prevalence of##2##4##(2007-2#1)(2008-7#1)
investigate the prevalence##4##3##(2007-2#1)(2008-7#1)(2011-1#1)(2012-1#1)
investigate the relationship between the##9##5##(1991-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)
investigate the relationship between##21##4##(1991-2#1)(1991-9#1)(1993-8#1)(1994-3#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
investigate the relationship of##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
investigate the relationship##25##3##(1990-8#1)(1991-2#1)(1991-9#1)(1993-8#1)(1994-3#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-7#2)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
investigate the robustness##2##3##(1995-11#1)(2008-11#1)
investigate the role of the##3##5##(2008-10#3)
investigate the role of##28##4##(1990-11#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)
investigate the role##29##3##(1990-11#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)
investigate the sensitivity of the##2##5##(2007-12#1)(2008-3#1)
investigate the sensitivity of##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
investigate the significance of##2##4##(1995-5#1)(2008-10#1)
investigate the structure##3##3##(1996-6#1)(2008-4#1)(2008-5#1)
investigate the use of##4##4##(2007-12#1)(2008-2#2)(2011-1#1)
investigate the vertical##2##3##(2008-11#2)
investigate the##603##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#6)(1995-11#1)(1995-12#7)(1995-2#5)(1995-3#3)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-6#2)(1997-7#2)(1997-8#3)(2007-10#4)(2007-11#17)(2007-12#14)(2007-2#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#69)(2008-11#20)(2008-12#14)(2008-2#28)(2008-3#39)(2008-4#7)(2008-5#13)(2008-6#10)(2008-7#18)(2008-8#18)(2008-9#22)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#6)(2009-7#7)(2009-8#2)(2009-9#4)(2010-11#4)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#23)(2011-3#4)(2012-1#5)(2012-12#3)(2012-2#14)(2012-3#16)(2013-1#16)(2013-7#3)(2013-8#10)
investigate their##16##2##(1990-12#1)(1992-1#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
investigate theoretically##3##2##(2008-3#2)(2008-8#1)
investigate these phenomena and##2##4##(2008-2#1)(2013-1#1)
investigate these##5##2##(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
investigate this hypothesis##2##3##(2008-10#1)(2008-11#1)
investigate this mechanism##2##3##(1990-12#1)(2010-3#1)
investigate this phenomenon##3##3##(1996-5#1)(2008-11#1)(2013-8#1)
investigate this##18##2##(1990-12#1)(1992-2#1)(1994-3#1)(1996-1#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-8#1)(2010-3#1)(2013-8#1)
investigate what##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
investigate whether a##4##3##(2008-11#1)(2008-5#2)(2012-3#1)
investigate whether##48##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-12#2)(1995-12#1)(1995-6#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#1)
investigate##953##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#6)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#4)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#8)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#9)(1995-2#7)(1995-3#3)(1995-5#6)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#2)(1996-5#6)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#6)(2006-10#1)(2006-8#1)(2007-10#6)(2007-11#27)(2007-12#20)(2007-2#3)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#102)(2008-11#51)(2008-12#22)(2008-2#35)(2008-3#53)(2008-4#12)(2008-5#27)(2008-6#15)(2008-7#29)(2008-8#33)(2008-9#31)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#6)(2009-7#7)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#6)(2010-2#10)(2010-3#9)(2010-4#2)(2010-5#9)(2010-6#4)(2010-8#9)(2010-9#1)(2011-1#20)(2011-10#1)(2011-2#36)(2011-3#4)(2012-1#7)(2012-12#6)(2012-2#25)(2012-3#27)(2012-5#1)(2013-1#29)(2013-7#7)(2013-8#15)
investigated a##6##2##(1996-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-1#1)
investigated according to##2##3##(2006-8#1)(2011-2#1)
investigated after##2##2##(1993-3#1)(2008-11#1)
investigated along##3##2##(1990-12#1)(2008-10#1)(2008-12#1)
investigated among##2##2##(2008-10#1)(2013-1#1)
investigated and a##2##3##(2008-10#1)(2009-3#1)
investigated and are##2##3##(1995-11#1)(2008-10#1)
investigated and compared with those predicted##2##6##(2007-11#1)(2008-2#1)
investigated and compared with##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
investigated and compared##11##3##(1990-11#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-6#1)(2013-1#1)
investigated and discussed##2##3##(2008-10#2)
investigated and found to be##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
investigated and found to##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
investigated and found##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)
investigated and it was found that the##2##7##(1990-8#1)(2008-10#1)
investigated and it##3##3##(1990-11#1)(1990-8#1)(2008-10#1)
investigated and optimized##7##3##(2008-10#4)(2008-3#1)(2010-4#1)(2012-1#1)
investigated and the##18##3##(2008-10#14)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
investigated and used to##2##4##(2008-10#1)(2011-2#1)
investigated and used##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
investigated and##81##2##(1990-11#2)(1990-8#1)(1995-11#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#41)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2013-1#3)
investigated are##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
investigated as a function of the##3##6##(1997-7#1)(2008-10#1)(2008-3#1)
investigated as a function of##8##5##(1995-5#1)(1997-7#2)(2008-10#1)(2008-3#4)
investigated as a method of##2##5##(2007-11#1)(2008-10#1)
investigated as a##21##3##(1995-5#1)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#6)(2008-3#6)(2008-7#1)(2009-5#1)(2010-1#1)(2010-7#1)
investigated as an##2##3##(1993-11#1)(2008-12#1)
investigated as potential##3##3##(2008-10#2)(2009-5#1)
investigated as selective##2##3##(2008-10#2)
investigated as well##5##3##(2008-10#4)(2008-5#1)
investigated as##57##2##(1992-8#1)(1993-11#1)(1995-5#1)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#28)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-7#1)(2012-2#1)(2012-5#1)
investigated at 25 degrees C##2##5##(2008-10#2)
investigated at different##2##3##(2008-10#2)
investigated at pH##2##3##(2008-10#2)
investigated at the##2##3##(1995-3#1)(2008-3#1)
investigated at##22##2##(1990-5#1)(1993-9#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-3#1)
investigated based on##2##3##(2008-10#1)(2013-1#1)
investigated because##2##2##(2008-10#1)(2010-11#1)
investigated between##2##2##(1990-8#1)(1993-12#1)
investigated both theoretically and experimentally##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
investigated both##10##2##(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)
investigated by a##8##3##(1991-6#1)(1992-5#1)(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)
investigated by analysis of the##2##5##(2008-10#1)(2008-2#1)
investigated by atomic force microscopy##2##5##(2008-10#1)(2008-3#1)
investigated by capillary##2##3##(1994-9#1)(2008-10#1)
investigated by comparisons with##2##4##(2008-3#2)
investigated by conducting##2##3##(2008-10#1)(2008-11#1)
investigated by cyclic voltammetry (CV)##2##5##(2008-10#2)
investigated by cyclic voltammetry and##2##5##(2008-10#2)
investigated by cyclic voltammetry##5##4##(2008-10#5)
investigated by cyclic##8##3##(2008-10#8)
investigated by determining the##2##4##(1995-5#1)(2008-10#1)
investigated by electrochemical##2##3##(2008-10#1)(2013-1#1)
investigated by electron microscopy##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
investigated by evaluating##2##3##(1994-9#1)(2008-5#1)
investigated by fluorescence##2##3##(1990-5#1)(2008-10#1)
investigated by in vivo##2##4##(1994-2#1)(2008-8#1)
investigated by means of a##3##5##(1990-8#1)(2008-3#1)(2008-9#1)
investigated by means of the##2##5##(2008-5#1)(2008-6#1)
investigated by means of##19##4##(1990-12#1)(1990-8#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
investigated by measuring the##6##4##(1994-3#1)(2008-10#3)(2008-5#1)(2013-7#1)
investigated by measuring##8##3##(1991-9#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-7#1)
investigated by potentiometry##2##3##(2008-10#2)
investigated by testing##2##3##(2008-10#2)
investigated by the##4##3##(2008-10#1)(2008-11#2)(2008-2#1)
investigated by time-resolved##3##3##(1992-6#1)(2008-10#1)(2008-2#1)
investigated by transmission electron microscopy and##2##6##(2008-10#1)(2009-11#1)
investigated by transmission electron microscopy##4##5##(2008-10#2)(2008-7#1)(2009-11#1)
investigated by two-dimensional##2##3##(1993-11#2)
investigated by use of a##3##5##(2007-11#2)(2008-10#1)
investigated by use of##11##4##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)
investigated by using a##3##4##(2008-10#2)(2008-7#1)
investigated by using the##4##4##(2008-10#3)(2009-9#1)
investigated by using##19##3##(1990-7#1)(1991-9#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)
investigated by##220##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#6)(2007-12#9)(2008-10#84)(2008-11#7)(2008-2#5)(2008-3#11)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
investigated compounds with##2##3##(2008-10#2)
investigated compounds##10##2##(1996-2#1)(2007-11#1)(2008-10#8)
investigated drugs##7##2##(2008-10#5)(2008-11#1)(2008-7#1)
investigated during the##3##3##(2008-10#2)(2013-1#1)
investigated during##9##2##(1995-12#1)(1996-5#1)(1996-7#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
investigated employing##3##2##(1990-8#1)(2008-10#2)
investigated experimentally and theoretically##2##4##(2008-10#1)(2008-3#1)
investigated experimentally and##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
investigated experimentally in##4##3##(2007-12#2)(2008-2#1)(2008-9#1)
investigated experimentally the##2##3##(2008-2#1)(2011-2#1)
investigated experimentally##17##2##(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-9#1)(2009-10#1)(2011-2#1)
investigated for a wide##2##4##(2010-12#2)
investigated for a##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#2)
investigated for different##2##3##(2008-10#1)(2008-2#1)
investigated for meningitis##2##3##(2007-8#2)
investigated for optimum##2##3##(2008-10#2)
investigated for the determination of##2##5##(2008-10#2)
investigated for the first time##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
investigated for the presence of##2##5##(2007-11#1)(2012-3#1)
investigated for the simultaneous determination of##2##6##(2008-10#2)
investigated for the##22##3##(1993-8#1)(2007-11#2)(2008-10#12)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)
investigated for their##7##3##(1997-4#1)(2008-7#2)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
investigated for various##5##3##(2008-10#1)(2008-2#3)(2008-5#1)
investigated for##91##2##(1993-8#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-8#2)(2008-10#35)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#5)(2008-5#3)(2008-7#5)(2009-12#1)(2009-2#1)(2010-12#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
investigated from the##2##3##(2007-12#1)(2008-11#1)
investigated from##7##2##(1994-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)
investigated further##6##2##(2008-10#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
investigated gene##2##2##(2007-8#1)(2008-7#1)
investigated group##2##2##(2008-7#1)(2012-3#1)
investigated have##2##2##(2008-10#1)(2008-7#1)
investigated here##9##2##(1991-8#1)(1994-6#1)(1994-9#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-3#2)
investigated how the##2##3##(2007-11#1)(2009-8#1)
investigated how##11##2##(1994-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#2)(2011-2#1)
investigated if the##2##3##(2008-1#1)(2008-10#1)
investigated if##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
investigated in 27##2##3##(1991-4#1)(1997-3#1)
investigated in a series of##5##5##(1990-12#1)(1991-8#1)(2008-10#3)
investigated in a##28##3##(1990-12#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-8#1)
investigated in adult male and female rats##2##7##(1995-3#1)(2008-11#1)
investigated in aqueous##4##3##(2008-10#3)(2008-3#1)
investigated in both##4##3##(1992-11#1)(1992-8#1)(2008-10#1)(2008-3#1)
investigated in controlled##2##3##(2008-10#2)
investigated in detail and##5##4##(2008-10#5)
investigated in detail the##2##4##(2008-3#1)(2011-2#1)
investigated in detail##36##3##(1994-5#1)(2008-10#27)(2008-3#4)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
investigated in four##2##3##(2008-10#1)(2011-1#1)
investigated in healthy##2##3##(1996-1#1)(2011-2#1)
investigated in human##8##3##(1990-12#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-7#1)(2011-3#1)(2013-1#1)
investigated in isolated rat##2##4##(1992-3#1)(1996-5#1)
investigated in male##3##3##(1992-3#1)(1996-2#1)(2008-4#1)
investigated in mice##3##3##(1996-2#1)(2008-7#1)(2013-8#1)
investigated in normal and##2##4##(1994-8#1)(2010-11#1)
investigated in normal##3##3##(1994-8#1)(2008-10#1)(2010-11#1)
investigated in order to optimize##2##5##(2008-10#2)
investigated in order to##10##4##(1994-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
investigated in order##11##3##(1994-6#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)
investigated in patients with##3##4##(1990-3#1)(2011-1#1)(2012-4#1)
investigated in rat##2##3##(1990-12#1)(1997-1#1)
investigated in rats##6##3##(1994-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-7#1)
investigated in relation to the##2##5##(2008-2#1)(2008-3#1)
investigated in relation##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
investigated in several##2##3##(1994-6#1)(2011-2#1)
investigated in terms of##9##4##(1994-8#1)(1996-2#1)(2008-10#4)(2008-3#2)(2010-6#1)
investigated in the adult male cricket##2##6##(2008-5#2)
investigated in the concentration##2##4##(2008-10#2)
investigated in the context of##2##5##(1993-12#1)(2009-10#1)
investigated in the present##3##4##(1992-12#1)(2008-11#1)(2009-10#1)
investigated in the##35##3##(1990-12#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-3#1)(2011-1#1)(2012-3#1)
investigated in this paper##3##4##(2008-10#2)(2008-5#1)
investigated in this study##5##4##(1997-4#1)(2008-10#1)(2008-12#2)(2008-8#1)
investigated in this work##3##4##(1993-8#1)(2008-10#1)(2011-2#1)
investigated in this##14##3##(1993-8#1)(1997-4#1)(2008-10#5)(2008-12#3)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
investigated in various##2##3##(2008-11#1)(2008-8#1)
investigated in vitro and in vivo##2##6##(2008-10#1)(2008-5#1)
investigated in vitro##8##3##(1990-11#1)(1992-11#1)(1994-9#1)(1996-12#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-5#1)
investigated in vivo##7##3##(1990-11#1)(1990-5#1)(1993-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-5#1)
investigated in##331##2##(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#5)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#7)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#5)(1997-6#2)(1997-7#4)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#99)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2012-4#2)(2013-1#3)(2013-8#2)
investigated include##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
investigated its##8##2##(1991-12#1)(1992-3#1)(1993-8#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
investigated mainly##2##2##(1995-11#1)(2008-10#1)
investigated methods##2##2##(2008-10#1)(2012-3#1)
investigated on the##4##3##(1992-3#1)(2008-10#3)
investigated on##19##2##(1990-5#1)(1991-2#1)(1992-3#1)(1995-12#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-6#1)(2008-9#1)(2010-4#1)(2010-7#1)(2013-1#1)
investigated over the##8##3##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)
investigated over##11##2##(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#2)(2011-2#1)
investigated parameters##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
investigated phase##2##2##(2008-3#1)(2008-9#1)
investigated possible##2##2##(2008-1#1)(2008-12#1)
investigated potential##2##2##(2008-10#1)(2012-3#1)
investigated potentiometrically in##2##3##(2008-10#2)
investigated relationships##2##2##(1995-12#1)(2007-12#1)
investigated samples##3##2##(2008-10#3)
investigated several##3##2##(1996-3#1)(1997-8#1)(2012-12#1)
investigated species##6##2##(2007-12#4)(2008-5#1)(2012-3#1)
investigated spectrophotometrically##3##2##(2008-10#3)
investigated successive##2##2##(2007-10#1)(2008-11#1)
investigated systematically##2##2##(2008-10#1)(2010-4#1)
investigated that##2##2##(2008-2#1)(2011-2#1)
investigated the ability of##3##4##(2008-10#1)(2008-8#1)(2010-11#1)
investigated the accuracy and inter-rater reliability of##2##7##(1993-12#2)
investigated the association between##3##4##(1995-2#1)(2008-4#1)(2008-9#1)
investigated the association##5##3##(1995-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
investigated the binding##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
investigated the degree##2##3##(1990-3#1)(2012-3#1)
investigated the different##2##3##(1991-5#1)(2008-10#1)
investigated the distribution of##2##4##(1997-2#1)(2008-8#1)
investigated the distribution##3##3##(1997-2#1)(2007-10#1)(2008-8#1)
investigated the effect of a##2##5##(1992-3#1)(2012-3#1)
investigated the effect of the##3##5##(1994-11#1)(1996-2#1)(2011-2#1)
investigated the effect of##40##4##(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-2#2)(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#4)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)
investigated the effect##41##3##(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-2#2)(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#4)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)
investigated the effects of##38##4##(1991-12#1)(1991-9#2)(1993-11#1)(1993-8#1)(1994-10#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-7#1)(2013-1#1)
investigated the effects##40##3##(1991-12#1)(1991-9#2)(1993-11#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-7#1)(2013-1#1)
investigated the efficacy of##5##4##(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#2)
investigated the experience of##2##4##(2007-10#1)(2008-11#1)
investigated the expression and##2##4##(2008-5#1)(2012-3#1)
investigated the expression of##6##4##(1996-12#1)(1996-5#1)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
investigated the expression##11##3##(1996-12#1)(1996-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
investigated the extent to which the##2##6##(2009-9#1)(2011-2#1)
investigated the feasibility of##4##4##(1996-2#1)(2008-11#1)(2008-5#1)(2013-1#1)
investigated the function##2##3##(1992-9#1)(2013-1#1)
investigated the functional##2##3##(2011-2#2)
investigated the impact of##3##4##(2008-7#1)(2008-9#1)(2011-2#1)
investigated the impact##4##3##(1993-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
investigated the influence of dietary##2##5##(1991-6#1)(2008-11#1)
investigated the influence of the##2##5##(1994-11#1)(2008-2#1)
investigated the influence of##13##4##(1991-6#1)(1994-11#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-2#1)
investigated the influence##14##3##(1991-6#1)(1994-11#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-2#1)
investigated the interactions of##2##4##(1997-2#1)(2009-10#1)
investigated the involvement of protein##2##5##(1991-2#1)(1997-1#1)
investigated the involvement of##3##4##(1991-2#1)(1992-8#1)(1997-1#1)
investigated the mechanism of##3##4##(1991-2#1)(2008-11#1)(2008-2#1)
investigated the mechanism##6##3##(1991-2#1)(1993-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
investigated the modulation of##2##4##(1994-6#1)(2008-7#1)
investigated the neural##4##3##(1995-12#1)(2008-8#1)(2009-2#1)(2013-8#1)
investigated the performance of##2##4##(2007-11#1)(2008-10#1)
investigated the possible##9##3##(1994-11#1)(1995-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
investigated the potential##4##3##(1995-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
investigated the presence of##4##4##(1995-11#1)(2007-7#1)(2008-12#1)(2013-1#1)
investigated the prevalence of##2##4##(1997-4#1)(2008-7#1)
investigated the properties of##3##4##(2008-10#1)(2012-2#2)
investigated the regulation of##3##4##(1993-5#1)(1996-12#1)(2010-11#1)
investigated the regulation##4##3##(1993-5#1)(1996-12#1)(2008-11#1)(2010-11#1)
investigated the relation between##2##4##(1994-2#1)(2009-2#1)
investigated the relationship between tyrosine phosphorylation and##2##7##(1994-6#1)(1996-12#1)
investigated the relationship between##8##4##(1994-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
investigated the relationship of##2##4##(1996-12#1)(2008-5#1)
investigated the relationship##10##3##(1994-6#1)(1996-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
investigated the relationships##2##3##(1996-2#1)(2008-8#1)
investigated the response##3##3##(1995-12#1)(1995-2#1)(2009-8#1)
investigated the risk##2##3##(2008-11#2)
investigated the role of the##3##5##(1995-12#1)(1997-2#1)(2008-12#1)
investigated the role of##19##4##(1993-3#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
investigated the sequence##2##3##(1996-6#1)(2008-11#1)
investigated the spectral##2##3##(2007-11#1)(2007-12#1)
investigated the temporal##2##3##(1997-2#1)(2008-3#1)
investigated the time course##2##4##(1995-12#1)(2013-1#1)
investigated the use of##10##4##(1991-5#1)(1992-1#1)(1997-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#2)
investigated the##392##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#4)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#12)(1995-2#4)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#39)(2008-11#26)(2008-12#10)(2008-2#7)(2008-3#19)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#20)(2008-8#9)(2008-9#8)(2009-10#1)(2009-12#3)(2009-2#3)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#5)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#3)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#7)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#4)
investigated their##4##2##(1993-8#1)(1997-4#1)(2008-7#1)(2010-6#1)
investigated theoretically and experimentally##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
investigated theoretically##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
investigated these##2##2##(2008-11#1)(2011-2#1)
investigated this phenomenon##2##3##(1990-11#1)(1993-11#1)
investigated this##9##2##(1990-11#1)(1993-11#1)(1995-2#2)(1996-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)
investigated through a##3##3##(2008-10#2)(2008-3#1)
investigated through the##4##3##(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
investigated through##12##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-8#1)
investigated to determine the##3##4##(2008-10#2)(2013-1#1)
investigated to determine##5##3##(1996-4#1)(2008-10#2)(2009-11#1)(2013-1#1)
investigated to develop##2##3##(2008-10#1)(2009-11#1)
investigated to find##4##3##(2008-10#4)
investigated to improve the##3##4##(2008-10#2)(2008-2#1)
investigated to obtain##2##3##(2008-5#1)(2012-2#1)
investigated to##40##2##(1991-12#1)(1996-4#1)(1996-5#1)(2008-10#21)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#3)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
investigated under the##2##3##(1996-6#1)(2008-7#1)
investigated under##11##2##(1994-5#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
investigated using a##11##3##(1990-2#1)(1993-12#1)(2008-10#5)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)
investigated using an##4##3##(1990-7#1)(1991-5#1)(1992-12#1)(1993-6#1)
investigated using cyclic voltammetry##2##4##(2008-10#2)
investigated using human##2##3##(1993-3#1)(2011-2#1)
investigated using the##12##3##(1990-12#1)(1992-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-8#1)(2012-1#1)(2012-3#1)
investigated using##91##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
investigated was##2##2##(1990-9#1)(1996-12#1)
investigated were##6##2##(1991-1#1)(2008-10#3)(2008-3#1)(2010-6#1)
investigated when##2##2##(2008-3#1)(2009-8#1)
investigated whether a##3##3##(1992-6#1)(2007-12#1)(2007-4#1)
investigated whether such##2##3##(2009-8#1)(2013-1#1)
investigated whether the##10##3##(1994-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(2008-6#2)(2009-11#1)(2010-12#1)(2011-2#1)
investigated whether this##3##3##(1994-8#1)(1996-2#1)(2008-10#1)
investigated whether##59##2##(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#3)(1997-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)
investigated which##3##2##(1993-12#1)(2008-10#1)(2008-8#1)
investigated with a##9##3##(1991-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)
investigated with an##3##3##(2008-10#2)(2008-3#1)
investigated with fluorescence##2##3##(2008-10#1)(2008-2#1)
investigated with regard to##5##4##(1995-5#1)(2008-10#3)(2013-1#1)
investigated with respect to the##2##5##(2007-12#1)(2008-10#1)
investigated with respect to##6##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
investigated with the##11##3##(1994-6#1)(1996-5#1)(2008-10#6)(2008-2#1)(2012-1#1)(2013-8#1)
investigated with two##2##3##(2008-10#1)(2008-2#1)
investigated with##60##2##(1990-5#1)(1991-12#1)(1991-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#3)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
investigated within##2##2##(2008-3#1)(2010-6#1)
investigated##2763##1##(1990-11#9)(1990-12#12)(1990-2#5)(1990-3#6)(1990-5#11)(1990-7#6)(1990-8#9)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#10)(1991-2#9)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#12)(1992-4#1)(1992-5#4)(1992-6#7)(1992-8#6)(1992-9#6)(1993-1#1)(1993-11#14)(1993-12#14)(1993-2#2)(1993-3#14)(1993-5#2)(1993-6#7)(1993-8#17)(1993-9#5)(1994-10#1)(1994-11#14)(1994-12#6)(1994-2#6)(1994-3#8)(1994-5#8)(1994-6#22)(1994-7#1)(1994-8#11)(1994-9#11)(1995-11#17)(1995-12#25)(1995-2#13)(1995-3#11)(1995-5#6)(1995-6#7)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#20)(1996-2#26)(1996-3#2)(1996-4#2)(1996-5#15)(1996-6#2)(1996-7#2)(1997-1#6)(1997-2#17)(1997-3#8)(1997-4#16)(1997-5#1)(1997-6#4)(1997-7#16)(1997-8#6)(2006-10#2)(2006-6#4)(2006-8#1)(2007-10#10)(2007-11#41)(2007-12#62)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#8)(2007-8#7)(2007-9#2)(2008-1#12)(2008-10#912)(2008-11#115)(2008-12#40)(2008-2#89)(2008-3#168)(2008-4#22)(2008-5#72)(2008-6#32)(2008-7#80)(2008-8#48)(2008-9#31)(2009-10#9)(2009-11#5)(2009-12#11)(2009-2#6)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#6)(2009-7#14)(2009-8#18)(2009-9#10)(2010-1#2)(2010-10#3)(2010-11#11)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#19)(2010-5#8)(2010-6#9)(2010-7#5)(2010-8#8)(2010-9#3)(2011-1#33)(2011-10#2)(2011-2#61)(2011-3#3)(2012-1#16)(2012-12#13)(2012-2#28)(2012-3#30)(2012-4#2)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#53)(2013-7#2)(2013-8#24)
investigates a##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
investigates how##2##2##(2008-5#1)(2009-10#1)
investigates the effect of##6##4##(1991-2#1)(1996-12#1)(2007-12#1)(2008-11#1)(2010-5#1)(2011-2#1)
investigates the effects of##4##4##(1991-12#1)(2008-8#1)(2011-1#1)(2013-8#1)
investigates the impact of##2##4##(2008-7#1)(2009-7#1)
investigates the relationship between##2##4##(2008-8#1)(2008-9#1)
investigates the relationship of##2##4##(1994-2#1)(2008-7#1)
investigates the relationship##4##3##(1994-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
investigates the##43##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
investigates whether##5##2##(1995-12#1)(1995-2#1)(1997-4#1)(2011-2#1)(2013-1#1)
investigates##72##1##(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
investigating a##2##2##(2008-6#1)(2010-12#1)
investigating and##2##2##(2008-2#1)(2008-3#1)
investigating its##3##2##(1991-12#1)(2007-7#1)(2008-10#1)
investigating mechanisms of##2##3##(1996-5#1)(2008-11#1)
investigating such##2##2##(1997-6#1)(2012-3#1)
investigating the effect of##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
investigating the effects of##4##4##(1997-2#1)(1997-7#1)(2010-2#1)(2010-7#1)
investigating the efficacy of##2##4##(2008-10#1)(2009-12#1)
investigating the influence of##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
investigating the mechanism of##2##4##(1993-8#1)(2008-11#1)
investigating the mechanism##3##3##(1993-8#1)(1995-12#1)(2008-11#1)
investigating the relationship between##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
investigating the role of##4##4##(1993-11#1)(2008-8#1)(2010-12#1)(2011-1#1)
investigating the underlying##3##3##(2007-10#1)(2013-1#2)
investigating the##69##2##(1991-2#1)(1992-5#1)(1993-11#1)(1993-8#1)(1995-12#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-12#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
investigating these##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
investigating whether##3##2##(1990-6#1)(1993-2#1)(2008-1#1)
investigating##150##1##(1990-6#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#3)(2008-1#7)(2008-10#13)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#7)(2013-8#4)
investigation about##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
investigation aimed at##2##3##(2008-2#1)(2011-2#1)
investigation aimed##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
investigation also##2##2##(1996-12#1)(1997-6#1)
investigation and intervention##2##3##(1992-12#1)(2013-8#1)
investigation and management of##3##4##(2007-12#1)(2007-8#1)(2008-11#1)
investigation and treatment of##3##4##(2007-12#1)(2008-3#1)(2010-3#1)
investigation and treatment##4##3##(2007-12#1)(2008-3#1)(2010-12#1)(2010-3#1)
investigation and##34##2##(1990-2#1)(1992-12#2)(1993-11#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-8#3)
investigation are##5##2##(1991-3#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-8#1)
investigation at##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
investigation before##2##2##(2008-10#1)(2008-9#1)
investigation by##2##2##(2008-3#1)(2011-1#1)
investigation can##2##2##(2008-9#2)
investigation confirmed##2##2##(2012-3#1)(2013-1#1)
investigation examined##3##2##(2007-10#1)(2007-12#1)(2008-2#1)
investigation for the##2##3##(2008-10#1)(2011-1#1)
investigation for##10##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
investigation has been##2##3##(1993-11#1)(2011-2#1)
investigation has##4##2##(1993-11#2)(1995-11#1)(2011-2#1)
investigation in the##7##3##(1992-1#1)(1993-12#1)(1996-9#1)(2009-6#1)(2009-7#1)(2010-2#1)(2013-1#1)
investigation in this##2##3##(2008-10#1)(2011-9#1)
investigation in##24##2##(1991-3#3)(1992-1#1)(1993-12#1)(1993-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-9#1)(2012-2#2)(2013-1#1)
investigation include##3##2##(1992-9#1)(2008-3#1)(2008-9#1)
investigation included a##2##3##(2008-10#1)(2011-2#1)
investigation included##4##2##(1997-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
investigation indicate##2##2##(2008-12#1)(2013-1#1)
investigation into a seated unloading movement strategy for the lumbar spine##2##11##(2010-3#2)
investigation into the##16##3##(1990-11#1)(1991-1#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-9#2)(2009-6#1)(2013-1#1)
investigation into##19##2##(1990-11#1)(1991-1#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#2)(2013-1#1)
investigation is necessary##3##3##(1991-8#1)(2008-10#1)(2010-10#1)
investigation is required to##2##4##(2009-6#1)(2012-1#1)
investigation is to##2##3##(2011-2#1)(2012-2#1)
investigation is##14##2##(1991-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#2)
investigation it was##2##3##(1990-6#1)(2008-10#1)
investigation it##3##2##(1990-6#1)(2008-10#1)(2011-1#1)
investigation may##2##2##(2008-5#1)(2013-8#1)
investigation of a##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
investigation of abuse##2##3##(1995-11#1)(2010-12#1)
investigation of all##3##3##(1992-12#1)(2008-4#1)(2012-2#1)
investigation of biological##3##3##(1992-5#1)(2008-3#1)(2013-1#1)
investigation of choice in##2##4##(1996-9#1)(2007-11#1)
investigation of choice##3##3##(1996-9#1)(2007-11#1)(2012-2#1)
investigation of compounds##2##3##(2008-4#1)(2012-8#1)
investigation of different##2##3##(2008-10#1)(2008-8#1)
investigation of its##3##3##(1990-11#1)(2008-10#1)(2012-8#1)
investigation of large##3##3##(2008-11#1)(2008-7#1)(2010-12#1)
investigation of other##3##3##(1995-12#1)(2008-10#1)(2010-3#1)
investigation of potential##2##3##(2008-12#1)(2013-1#1)
investigation of specific##2##3##(2011-2#2)
investigation of the behavior of a##2##6##(2008-10#1)(2008-9#1)
investigation of the chemical##2##4##(2008-10#1)(2013-8#1)
investigation of the effect of##5##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
investigation of the effects of##2##5##(2008-3#2)
investigation of the effects##3##4##(2008-10#1)(2008-3#2)
investigation of the interaction##2##4##(2008-10#2)
investigation of the mechanism##2##4##(2008-3#1)(2010-12#1)
investigation of the performance of a##2##6##(2008-10#1)(2008-3#1)
investigation of the phase-matching properties of sum- and difference-frequency generation##2##10##(2008-3#2)
investigation of the polarization##2##4##(2007-12#1)(2008-2#1)
investigation of the propagation##2##4##(2007-11#1)(2007-12#1)
investigation of the relationship between##2##5##(2008-10#1)(2009-4#1)
investigation of the relationship##3##4##(2008-10#1)(2008-3#1)(2009-4#1)
investigation of the role of##3##5##(1997-8#1)(2008-3#1)(2008-4#1)
investigation of the role##4##4##(1997-8#1)(2008-3#1)(2008-4#1)(2010-12#1)
investigation of the use of##2##5##(2008-3#1)(2013-1#1)
investigation of the##109##3##(1990-5#2)(1990-9#1)(1991-5#1)(1992-5#1)(1995-11#2)(1995-12#1)(1995-9#1)(1997-8#1)(2007-11#3)(2007-12#7)(2008-10#26)(2008-11#1)(2008-2#6)(2008-3#22)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#4)
investigation of these##4##3##(1991-12#1)(1997-8#1)(2008-5#1)(2008-9#1)
investigation of this##6##3##(1992-11#1)(1992-2#1)(2008-10#2)(2011-2#2)
investigation of##311##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-4#1)(2007-11#8)(2007-12#9)(2007-7#1)(2008-1#1)(2008-10#70)(2008-11#9)(2008-12#4)(2008-2#11)(2008-3#35)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2012-8#2)(2013-1#11)(2013-8#7)
investigation on the##12##3##(1990-12#1)(1993-5#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-3#2)(2012-3#1)
investigation on##25##2##(1990-12#1)(1993-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#1)
investigation performed##2##2##(1997-8#1)(2008-5#1)
investigation period##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
investigation provide##2##2##(1995-3#1)(2008-10#1)
investigation revealed##6##2##(1990-5#1)(1993-8#1)(1994-6#1)(2006-10#1)(2006-12#1)(2010-2#1)
investigation should##2##2##(1995-11#1)(1996-12#1)
investigation showed##3##2##(2007-11#1)(2008-10#2)
investigation shows that##3##3##(1993-6#1)(1994-2#1)(2007-11#1)
investigation shows##5##2##(1993-6#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#1)
investigation sought to##2##3##(1993-12#1)(2008-12#1)
investigation that##2##2##(2008-11#1)(2008-4#1)
investigation times of the 3-month animals##2##6##(1994-3#2)
investigation times##3##2##(1994-3#3)
investigation to determine##2##3##(2008-11#1)(2013-1#1)
investigation to##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
investigation tool##2##2##(2013-8#2)
investigation using##4##2##(1992-6#1)(2007-10#1)(2008-5#2)
investigation was carried out##3##4##(2007-11#1)(2008-12#1)(2008-3#1)
investigation was conducted##4##3##(1990-3#1)(1991-5#1)(2008-12#1)(2012-3#1)
investigation was done##2##3##(2008-6#1)(2012-2#1)
investigation was performed to##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
investigation was performed##5##3##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
investigation was to determine##2##4##(2008-10#1)(2013-8#1)
investigation was to##12##3##(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-8#1)(2011-1#1)(2013-8#1)
investigation was undertaken to##3##4##(1993-2#1)(1995-12#1)(2008-10#1)
investigation was undertaken##4##3##(1990-12#1)(1993-2#1)(1995-12#1)(2008-10#1)
investigation was##37##2##(1990-12#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-2#1)(1995-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
investigation we##2##2##(1994-12#1)(2007-11#1)
investigation with##4##2##(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
investigation without##2##2##(2008-3#1)(2011-2#1)
investigation##803##1##(1990-11#4)(1990-12#7)(1990-2#2)(1990-3#4)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#4)(1991-5#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-9#1)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#3)(1995-9#2)(1996-1#7)(1996-11#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-9#4)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#5)(1997-8#7)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-10#4)(2007-11#17)(2007-12#21)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#128)(2008-11#31)(2008-12#16)(2008-2#20)(2008-3#50)(2008-4#14)(2008-5#18)(2008-6#13)(2008-7#34)(2008-8#16)(2008-9#24)(2009-10#4)(2009-11#3)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#8)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#34)(2011-3#4)(2011-9#1)(2012-1#3)(2012-12#5)(2012-2#19)(2012-3#12)(2012-7#1)(2012-8#2)(2013-1#31)(2013-7#1)(2013-8#21)
investigational agents##2##2##(2008-12#1)(2011-3#1)
investigational drugs##2##2##(2008-10#1)(2009-12#1)
investigational##16##1##(1996-12#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-8#1)
investigations among##2##2##(2007-2#1)(2011-2#1)
investigations and##11##2##(1992-3#1)(1996-12#1)(2008-10#2)(2008-12#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
investigations are expected to##2##4##(1993-11#1)(2012-12#1)
investigations are necessary to##2##4##(2007-12#1)(2008-10#1)
investigations are needed##5##3##(1992-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
investigations are##19##2##(1990-6#1)(1992-11#1)(1992-8#1)(1993-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
investigations by##2##2##(1997-6#1)(2008-11#1)
investigations carried out##2##3##(2008-1#1)(2008-10#1)
investigations concerning##2##2##(2008-10#1)(2008-7#1)
investigations failed to reveal##2##4##(2008-7#1)(2012-12#1)
investigations failed to##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
investigations for##5##2##(1991-8#1)(1995-11#1)(2007-7#1)(2008-3#1)(2013-8#1)
investigations have highlighted##2##3##(2007-12#1)(2013-1#1)
investigations have revealed that##2##4##(2008-7#1)(2012-2#1)
investigations have revealed##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
investigations have shown that##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
investigations have shown##4##3##(1992-3#1)(2008-10#2)(2008-11#1)
investigations have##18##2##(1991-4#1)(1992-3#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-11#1)(2012-2#1)(2013-1#1)
investigations in patients##2##3##(2010-3#1)(2013-1#1)
investigations in the##3##3##(1995-9#1)(2008-6#1)(2012-2#1)
investigations in this area##3##4##(1994-2#1)(2008-2#1)(2013-1#1)
investigations in this##5##3##(1994-2#1)(2008-2#1)(2008-8#1)(2010-6#1)(2013-1#1)
investigations in which##2##3##(1993-12#1)(2007-12#1)
investigations in##23##2##(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
investigations indicated that##2##3##(2008-7#1)(2008-8#1)
investigations into peptides##2##3##(2006-12#2)
investigations into the##4##3##(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#1)
investigations into##12##2##(2006-12#2)(2007-9#1)(2008-10#2)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)
investigations is##2##2##(1996-1#1)(2012-2#1)
investigations it is##2##3##(2008-6#1)(2011-1#1)
investigations of a##2##3##(2007-10#1)(2007-12#1)
investigations of citrus samples##2##4##(2008-10#2)
investigations of new##2##3##(2007-8#1)(2008-11#1)
investigations of the##24##3##(1990-11#1)(1991-5#1)(1994-11#2)(1995-3#2)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
investigations of this##2##3##(1995-11#1)(2008-10#1)
investigations of##81##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-1#1)(1992-5#2)(1993-1#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#5)(2010-10#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
investigations on the##5##3##(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-1#1)
investigations on##8##2##(1993-1#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)
investigations performed##4##2##(1991-8#1)(1997-8#1)(2007-11#1)(2013-7#1)
investigations relating to the##2##4##(2008-8#1)(2012-12#1)
investigations reveal##2##2##(2008-2#1)(2011-1#1)
investigations revealed a##3##3##(1990-12#1)(1991-11#1)(2008-10#1)
investigations revealed that##4##3##(2008-10#3)(2013-1#1)
investigations revealed##11##2##(1990-12#1)(1991-11#1)(1993-11#1)(2008-10#5)(2010-11#1)(2011-2#1)(2013-1#1)
investigations should examine##2##3##(2008-7#1)(2009-9#1)
investigations should##3##2##(2008-7#1)(2008-9#1)(2009-9#1)
investigations show##4##2##(1990-11#1)(2010-10#1)(2010-5#1)(2013-8#1)
investigations to##5##2##(1994-5#1)(1996-12#1)(2008-10#2)(2012-12#1)
investigations used##3##2##(1996-5#2)(2011-2#1)
investigations using##4##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
investigations were carried out##3##4##(2008-5#2)(2011-2#1)
investigations were performed##5##3##(1990-9#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
investigations were used to investigate##2##5##(2008-8#1)(2010-5#1)
investigations were##22##2##(1990-9#1)(1994-12#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#2)
investigations where##2##2##(1992-11#1)(2008-12#1)
investigations will be needed##2##4##(1990-6#1)(2008-10#1)
investigations will be##3##3##(1990-6#2)(2008-10#1)
investigations will##5##2##(1990-6#2)(2008-10#2)(2012-3#1)
investigations with##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
investigations##400##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-3#2)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#2)(2006-10#2)(2006-12#2)(2007-10#3)(2007-11#2)(2007-12#11)(2007-2#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#61)(2008-11#17)(2008-12#9)(2008-2#11)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#7)(2008-7#18)(2008-8#17)(2008-9#4)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2011-1#6)(2011-2#13)(2012-12#10)(2012-2#9)(2012-3#10)(2013-1#10)(2013-7#3)(2013-8#4)
investigative##9##1##(1990-5#1)(1990-6#1)(1993-8#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)
investigator and##2##2##(2009-4#1)(2012-3#1)
investigator in##2##2##(1992-1#1)(2013-1#1)
investigator to##3##2##(2008-1#1)(2010-11#1)(2010-7#1)
investigator##22##1##(1992-1#1)(1994-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-4#2)(2010-11#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
investigator's##3##1##(1992-12#1)(2008-9#1)(2010-8#1)
investigator-based##2##1##(1993-12#1)(2012-12#1)
investigators and##7##2##(1995-6#1)(2007-8#1)(2008-4#3)(2009-4#1)(2012-12#1)
investigators are##2##2##(2007-11#1)(2009-9#1)
investigators can##2##2##(1991-12#1)(2009-6#1)
investigators have attempted to##2##4##(2012-12#1)(2012-3#1)
investigators have##11##2##(1991-12#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
investigators in##2##2##(2008-1#1)(2009-10#1)
investigators interested in##2##3##(2008-4#2)
investigators of##3##2##(1996-12#1)(2008-12#1)(2008-4#1)
investigators or##3##2##(1993-11#1)(1993-12#1)(2008-10#1)
investigators that##2##2##(1994-8#1)(2008-4#1)
investigators to study##2##3##(2008-11#1)(2010-6#1)
investigators to use##2##3##(2008-1#1)(2012-3#1)
investigators to##20##2##(1990-8#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#3)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
investigators use##2##2##(1991-12#1)(1992-6#1)
investigators who##2##2##(2008-2#1)(2008-4#1)
investigators with##2##2##(2008-10#1)(2008-2#1)
investigators##104##1##(1990-3#1)(1990-8#1)(1991-12#3)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#15)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)
investigators'##2##1##(2009-4#1)(2011-2#1)
investing in##5##2##(1992-1#1)(1997-6#1)(2008-2#1)(2008-8#1)(2010-12#1)
investing##8##1##(1992-1#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)
investment and##7##2##(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-8#1)(2013-8#1)
investment by##3##2##(2008-8#3)
investment for##3##2##(2008-1#1)(2008-7#1)(2010-12#1)
investment from##2##2##(2008-8#2)
investment in sexual##3##3##(2012-3#3)
investment in the##4##3##(2008-10#1)(2008-8#1)(2009-11#1)(2011-1#1)
investment in workers##5##3##(2008-8#5)
investment in##33##2##(1993-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-8#11)(2008-9#1)(2009-11#1)(2011-1#1)(2012-3#6)(2013-1#1)
investment is##5##2##(2007-9#1)(2008-8#2)(2008-9#1)(2012-12#1)
investment of the##3##3##(1994-12#1)(1994-3#2)
investment of##6##2##(1992-12#1)(1994-12#1)(1994-3#2)(1995-1#1)(2008-9#1)
investment per##3##2##(2008-9#2)(2010-8#1)
investment that##2##2##(2008-9#2)
investment##130##1##(1991-12#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-5#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#31)(2008-9#17)(2009-11#1)(2009-5#1)(2010-12#3)(2010-5#3)(2010-8#7)(2011-1#1)(2012-12#3)(2012-3#8)(2013-1#3)(2013-8#1)
investments are##2##2##(1995-1#1)(2008-8#1)
investments can##2##2##(1994-2#1)(2008-8#1)
investments in##6##2##(1993-2#1)(1994-2#1)(1996-1#1)(1997-6#1)(2008-8#1)(2008-9#1)
investments may##2##2##(1992-2#1)(2008-8#1)
investments required to##2##3##(1993-11#1)(1994-2#1)
investments to##2##2##(2008-8#1)(2011-1#1)
investments##36##1##(1991-9#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#2)(1996-1#2)(1997-6#2)(2008-11#1)(2008-5#1)(2008-8#8)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)
investor##3##1##(1992-1#2)(2008-10#1)
investor-owned##2##1##(1993-2#1)(1996-12#1)
investors##5##1##(1992-1#1)(1993-1#1)(2008-5#1)(2008-9#1)(2011-1#1)
invests##2##1##(1994-1#1)(2012-2#1)
invisibility cloak has##2##3##(2012-2#2)
invisibility cloak##3##2##(2012-2#3)
invisible to##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
invisible##20##1##(1991-6#1)(1993-12#1)(2007-10#1)(2007-11#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2010-5#1)(2011-1#1)(2011-2#1)
invitation##4##1##(1992-3#1)(2008-11#2)(2008-4#1)
invitations to##2##2##(2007-8#1)(2012-2#1)
invitations##5##1##(2007-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
invite##3##1##(1993-1#1)(1994-2#1)(2012-3#1)
invited for##2##2##(2010-11#1)(2012-1#1)
invited to participate in##2##4##(2008-11#1)(2012-12#1)
invited to participate##6##3##(2007-10#1)(2008-11#2)(2011-1#1)(2012-12#2)
invited to take part in##2##5##(1997-6#1)(2008-10#1)
invited to##21##2##(1991-6#1)(1992-5#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-9#1)(2010-6#2)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
invited##39##1##(1990-2#1)(1991-6#2)(1992-5#1)(1993-11#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
invites##6##1##(1991-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)
invitro##2##1##(2008-11#2)
invivo##4##1##(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
invoke an##2##2##(2008-3#1)(2008-8#1)
invoke##5##1##(1997-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)
invoked by##2##2##(2008-9#1)(2011-9#1)
invoked in##2##2##(1996-6#1)(2009-11#1)
invoked##7##1##(1994-8#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2011-9#1)
invoking##4##1##(1992-12#1)(1996-6#1)(2008-10#1)(2008-6#1)
involucrin antigenicity##2##2##(2008-5#2)
involuntarily##3##1##(1992-12#1)(1995-1#1)(1997-2#1)
involuntary bladder contractions##2##3##(2008-7#2)
involuntary movements of the##2##4##(2009-6#1)(2011-1#1)
involuntary movements##3##2##(2008-7#1)(2009-6#1)(2011-1#1)
involuntary##13##1##(1993-12#1)(1993-6#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-7#3)(2009-11#1)(2009-6#2)(2011-1#2)
involuted##2##1##(1991-11#2)
involution day##4##2##(1997-6#4)
involution was##2##2##(1993-12#1)(2008-10#1)
involution##21##1##(1990-12#2)(1993-12#2)(1997-6#5)(2008-10#3)(2008-7#2)(2011-2#2)(2012-1#1)(2013-7#4)
involutive and/or secretory histomorphological and ultrastructural changes##2##7##(1994-5#2)
involve DNA##2##2##(2008-11#1)(2012-12#1)
involve a variety of##2##4##(1992-9#1)(2008-10#1)
involve a##23##2##(1990-7#1)(1991-1#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-3#1)(2012-1#1)
involve all##3##2##(1993-3#1)(2008-1#1)(2009-10#1)
involve an##7##2##(1991-5#1)(1992-8#1)(1996-12#1)(1996-8#1)(2008-11#1)(2008-12#1)(2013-8#1)
involve any##4##2##(1995-8#1)(2008-3#2)(2013-8#1)
involve at least##2##3##(1992-11#1)(2008-10#1)
involve changes in the##3##4##(2008-10#1)(2008-9#2)
involve community##2##2##(1991-2#1)(2010-8#1)
involve complex##2##2##(2007-12#1)(2008-6#1)
involve de novo##2##3##(1990-5#1)(2008-11#1)
involve high##2##2##(1992-2#1)(2008-10#1)
involve in##2##2##(2008-11#1)(2008-12#1)
involve more##3##2##(2009-2#1)(2010-12#1)(2012-1#1)
involve multiple##2##2##(2008-1#1)(2010-9#1)
involve not only##2##3##(1995-5#1)(1996-5#1)
involve other##2##2##(1992-3#1)(2012-3#1)
involve regulation of##2##3##(1996-2#1)(2009-8#1)
involve several##2##2##(2008-8#2)
involve significant##2##2##(1993-12#1)(2009-2#1)
involve the activation of##2##4##(1990-7#1)(1994-2#1)
involve the determination of##2##4##(2008-10#1)(2008-2#1)
involve the use of##4##4##(2007-11#1)(2008-10#1)(2008-9#2)
involve the##61##2##(1990-12#2)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-8#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#4)(2009-11#1)(2009-4#2)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)
involve their##3##2##(1992-12#1)(1994-2#1)(2008-7#1)
involve##301##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-3#3)(1997-4#4)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#7)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#25)(2008-11#9)(2008-12#7)(2008-2#6)(2008-3#4)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#5)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#5)
involved a retrospective analysis of##2##5##(2008-9#1)(2011-1#1)
involved a##15##2##(1994-11#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
involved an##4##2##(1993-1#1)(2008-10#1)(2008-8#1)(2012-4#1)
involved and the##5##3##(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
involved and their##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
involved and##25##2##(1990-6#1)(1994-3#1)(1995-11#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
involved are discussed##2##3##(1996-9#1)(2010-5#1)
involved are not##6##3##(1993-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
involved are the##2##3##(2008-7#1)(2013-1#1)
involved are##12##2##(1993-12#1)(1996-9#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#2)(2010-5#1)(2013-1#1)
involved area##4##2##(1990-8#1)(2007-12#1)(2007-5#1)(2009-10#1)
involved as a##2##3##(1994-9#1)(2008-10#1)
involved as well as##2##4##(2008-12#1)(2008-3#1)
involved as##6##2##(1993-5#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
involved at##3##2##(1990-5#1)(1994-11#1)(2007-12#1)
involved by the##2##3##(2008-7#2)
involved by##7##2##(1990-3#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-3#1)
involved during##3##2##(2007-6#1)(2008-10#2)
involved eyes)##2##2##(2011-2#2)
involved for##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
involved have been##3##3##(1995-2#1)(1997-3#1)(2010-3#1)
involved have##5##2##(1995-2#1)(1997-3#1)(2008-7#1)(2010-3#1)(2011-1#1)
involved in Ca2+##2##3##(1990-2#1)(1995-11#1)
involved in DNA repair##2##4##(1993-12#1)(2007-7#1)
involved in DNA##5##3##(1993-12#1)(1993-2#1)(2007-7#1)(2009-8#1)(2010-10#1)
involved in DNA-DNA interactions##2##4##(1995-12#2)
involved in HIV##2##3##(2009-5#1)(2013-8#1)
involved in PD##2##3##(2012-12#2)
involved in RNA splicing##4##4##(1995-6#3)(2008-9#1)
involved in a large##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
involved in a nosocomial cluster of##2##6##(2010-11#2)
involved in a number of cellular functions##2##7##(2008-11#1)(2010-11#1)
involved in a number of cellular##3##6##(2008-11#1)(2010-11#2)
involved in a variety of##3##5##(1997-1#1)(2008-5#1)(2012-12#1)
involved in a##33##3##(1991-9#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-10#2)(2010-11#4)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
involved in acetylcholine##2##3##(2008-8#2)
involved in activation of##2##4##(1990-5#1)(2012-3#1)
involved in activation##3##3##(1990-5#1)(2008-8#1)(2012-3#1)
involved in active##2##3##(1996-9#1)(2008-10#1)
involved in acute##2##3##(1997-7#1)(2008-4#1)
involved in adult##3##3##(1992-8#2)(2008-1#1)
involved in all##2##3##(1995-2#1)(2012-3#1)
involved in an##4##3##(1993-1#1)(1993-3#1)(1996-8#1)(2008-10#1)
involved in any##2##3##(1992-12#1)(2008-9#1)
involved in apoptosis##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
involved in assessing##2##3##(1994-1#1)(1995-3#1)
involved in at least##2##4##(1995-8#1)(2008-11#1)
involved in binding to the##3##5##(1993-11#1)(1995-6#2)
involved in binding to##5##4##(1993-11#1)(1993-3#1)(1995-6#2)(1997-7#1)
involved in binding##9##3##(1991-8#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-6#2)(1996-12#1)(1997-7#1)(2008-9#1)
involved in biological##2##3##(1994-5#1)(2008-10#1)
involved in blood##2##3##(1991-6#1)(2008-6#1)
involved in both##8##3##(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
involved in cancer##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
involved in cell growth and##2##5##(2008-10#1)(2013-7#1)
involved in cell wall##2##4##(2008-10#1)(2012-2#1)
involved in cell##15##3##(1992-3#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-7#1)
involved in cellular##4##3##(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#1)
involved in cholinergic##2##3##(1997-2#1)(2008-5#1)
involved in choosing##2##3##(2006-7#1)(2008-4#1)
involved in ciliary##2##3##(1997-1#1)(2008-3#1)
involved in cleavage##2##3##(1995-8#1)(1997-7#1)
involved in cognitive##2##3##(2008-7#1)(2013-8#1)
involved in complex##2##3##(1992-6#1)(2007-11#1)
involved in controlling flowering time##2##5##(1997-2#1)(1997-8#1)
involved in controlling the##4##4##(1997-2#1)(2008-8#2)(2010-10#1)
involved in controlling##7##3##(1994-11#1)(1997-2#2)(1997-8#1)(2008-8#2)(2010-10#1)
involved in depression##2##3##(2008-4#1)(2013-8#1)
involved in determining the##5##4##(1990-12#1)(1990-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
involved in determining##6##3##(1990-12#1)(1990-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
involved in development##2##3##(2007-11#1)(2008-7#1)
involved in differentiation##2##3##(2008-8#1)(2013-7#1)
involved in disease resistance##3##4##(1997-6#1)(2008-10#2)
involved in disease##4##3##(1997-5#1)(1997-6#1)(2008-10#2)
involved in diverse biological processes##2##5##(2008-4#1)(2009-7#1)
involved in each##2##3##(2008-2#1)(2009-3#1)
involved in early##6##3##(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-1#1)
involved in establishing##3##3##(1990-5#1)(1992-3#1)(2008-4#1)
involved in ethanol##2##3##(2008-11#1)(2012-3#1)
involved in feeding##2##3##(2007-12#1)(2010-11#1)
involved in gene expression##2##4##(1993-12#1)(2013-1#1)
involved in gene##3##3##(1993-12#1)(2009-7#1)(2013-1#1)
involved in generating##4##3##(1995-2#1)(2008-11#2)(2008-9#1)
involved in glucose##3##3##(2008-1#1)(2008-11#1)(2013-7#1)
involved in head##2##3##(1997-6#1)(2008-1#1)
involved in host##3##3##(1992-12#1)(1997-4#1)(2008-10#1)
involved in human##8##3##(1994-11#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-9#1)(2009-5#2)(2011-2#1)
involved in immune##2##3##(1995-12#1)(2010-12#1)
involved in induction of##2##4##(1991-12#1)(2008-8#1)
involved in inflammatory##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
involved in information##2##3##(1994-8#1)(2009-3#1)
involved in initiating the##2##4##(1994-11#1)(2008-10#1)
involved in initiating##3##3##(1994-11#1)(1995-3#1)(2008-10#1)
involved in insulin##3##3##(1994-6#1)(2010-12#1)(2010-4#1)
involved in interaction with the##2##5##(1990-4#1)(1995-8#1)
involved in interactions##2##3##(1990-8#1)(2008-8#1)
involved in intercellular communication##2##4##(1994-9#1)(2008-7#1)
involved in intracellular##4##3##(1991-12#1)(1995-3#1)(2008-5#1)(2012-1#1)
involved in its pathogenesis##2##4##(2008-2#1)(2012-1#1)
involved in its##8##3##(1995-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-1#1)
involved in learning##2##3##(2008-11#1)(2008-7#1)
involved in lipid##3##3##(1990-11#1)(1996-3#1)(2008-10#1)
involved in long##2##3##(2008-10#1)(2008-7#1)
involved in maintaining the##2##4##(1995-6#1)(1995-9#1)
involved in maintaining##3##3##(1995-6#1)(1995-9#1)(2008-1#1)
involved in making##2##3##(1996-2#2)
involved in many aspects##2##4##(2008-11#1)(2011-2#1)
involved in many important##2##4##(2008-10#1)(2008-8#1)
involved in many##14##3##(1991-9#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-8#2)
involved in mate##2##3##(2008-8#1)(2008-9#1)
involved in mediating the##3##4##(1996-12#1)(2006-6#1)(2008-9#1)
involved in mediating##5##3##(1995-12#1)(1996-12#1)(2006-6#1)(2008-4#1)(2008-9#1)
involved in melanoma##2##3##(2008-11#1)(2009-4#1)
involved in membrane##2##3##(2008-7#1)(2012-2#1)
involved in metabolic##2##3##(2008-10#1)(2012-2#1)
involved in modulating##4##3##(1994-6#1)(2008-4#1)(2008-9#1)(2009-10#1)
involved in myeloid leukemogenesis##2##4##(2010-4#2)
involved in normal##3##3##(2008-4#1)(2009-3#1)(2011-1#1)
involved in numerous##3##3##(1995-2#1)(2008-11#1)(2008-5#1)
involved in nursing##2##3##(1997-2#1)(2008-1#1)
involved in nutrient absorption##2##4##(2007-12#2)
involved in oral##2##3##(2008-11#1)(2013-1#1)
involved in other##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
involved in oxidative##2##3##(2008-10#1)(2010-12#1)
involved in pathogenicity of X##3##5##(2008-10#3)
involved in pathogenicity of##4##4##(2008-10#4)
involved in pathogenicity##5##3##(2008-10#5)
involved in patient care##3##4##(1995-2#1)(2007-12#1)(2013-1#1)
involved in plant##5##3##(1990-12#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-2#1)
involved in pore formation##2##4##(1994-2#2)
involved in post-translational##2##3##(1992-8#1)(2013-1#1)
involved in processing##2##3##(2008-4#1)(2012-2#1)
involved in protein##4##3##(1995-2#1)(1996-2#1)(2008-5#1)(2011-2#1)
involved in receptor-mediated##2##3##(1993-9#1)(2008-4#1)
involved in recombination##2##3##(1995-8#1)(2008-11#1)
involved in regulating the##3##4##(1993-5#1)(2008-10#1)(2008-8#1)
involved in regulating##8##3##(1993-5#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)
involved in regulation of##5##4##(1991-7#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-10#1)
involved in resistance to##2##4##(1994-8#1)(2008-10#1)
involved in resistance##4##3##(1994-8#1)(2008-10#2)(2008-5#1)
involved in response to##3##4##(2008-7#2)(2010-4#1)
involved in ribosome##2##3##(2011-2#2)
involved in several##2##3##(2008-7#1)(2008-8#1)
involved in signal transduction##4##4##(1993-11#1)(1995-5#1)(1995-6#1)(2008-11#1)
involved in signaling##2##3##(2008-1#1)(2009-6#1)
involved in skin##2##3##(2008-5#2)
involved in specific##3##3##(1992-9#1)(1993-12#1)(1995-8#1)
involved in sports##2##3##(2007-11#2)
involved in starch##2##3##(2008-10#1)(2008-9#1)
involved in stress##3##3##(1995-12#1)(2013-1#1)(2013-7#1)
involved in such a##2##4##(2008-10#1)(2008-11#1)
involved in such##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
involved in suppression of##3##4##(2008-10#2)(2012-12#1)
involved in synaptic##2##3##(1997-7#1)(2008-7#1)
involved in teaching##2##3##(1994-2#1)(2008-11#1)
involved in the DNA##2##4##(1995-5#1)(2012-12#1)
involved in the activation of##4##5##(1992-6#1)(1994-2#1)(2008-5#1)(2008-7#1)
involved in the activation##5##4##(1992-6#1)(1993-6#1)(1994-2#1)(2008-5#1)(2008-7#1)
involved in the acute##2##4##(1991-9#1)(1995-12#1)
involved in the aetiology of##2##5##(2008-7#1)(2009-8#1)
involved in the binding and##2##5##(1993-11#1)(1994-5#1)
involved in the binding of the##2##6##(1990-8#1)(1991-11#1)
involved in the binding of##3##5##(1990-8#2)(1991-11#1)
involved in the binding##5##4##(1990-8#2)(1991-11#1)(1993-11#1)(1994-5#1)
involved in the biosynthesis of the##2##6##(1992-8#1)(2008-10#1)
involved in the biosynthesis of##8##5##(1990-5#1)(1992-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)
involved in the catabolism of##2##5##(1994-8#1)(2008-11#1)
involved in the catalytic##2##4##(1992-6#1)(1993-11#1)
involved in the cell cycle##2##5##(2008-11#1)(2011-2#1)
involved in the cell##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
involved in the clinical##2##4##(2009-5#1)(2012-2#1)
involved in the collection##2##4##(1994-2#1)(2008-10#1)
involved in the complex##3##4##(1997-2#1)(2007-10#1)(2008-7#1)
involved in the control of cell##3##6##(1990-5#1)(2008-4#1)(2008-9#1)
involved in the control of the##2##6##(2008-4#1)(2009-8#1)
involved in the control of##11##5##(1990-5#1)(1993-12#1)(1993-9#1)(1997-3#1)(2008-4#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)
involved in the control##12##4##(1990-5#1)(1993-12#1)(1993-9#1)(1997-3#1)(2008-4#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)
involved in the conversation##2##4##(2007-11#2)
involved in the defense response of western white pine##2##9##(2008-10#2)
involved in the defense##3##4##(1994-6#1)(2008-10#2)
involved in the development and progression of##2##7##(2008-1#1)(2011-2#1)
involved in the development of##12##5##(1992-3#1)(1996-5#1)(1997-8#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
involved in the development##16##4##(1992-3#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-8#1)
involved in the differentiation of##2##5##(1992-8#1)(2008-4#1)
involved in the early phase of##2##6##(1992-12#1)(2010-1#1)
involved in the early##3##4##(1992-12#1)(2010-1#1)(2010-12#1)
involved in the enzymatic##2##4##(2008-10#1)(2009-5#1)
involved in the epidemic##2##4##(2008-10#2)
involved in the establishment of##3##5##(2008-10#1)(2008-2#2)
involved in the etiology of##6##5##(1991-9#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
involved in the etiology##7##4##(1991-9#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
involved in the expression of##3##5##(1995-12#1)(2008-5#1)(2013-8#1)
involved in the formation of granules##2##6##(2010-11#1)(2013-1#1)
involved in the formation of##8##5##(1990-12#2)(1992-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-1#1)(2013-1#1)
involved in the formation##11##4##(1990-12#2)(1992-6#1)(2008-10#4)(2008-9#1)(2010-11#1)(2012-1#1)(2013-1#1)
involved in the generation of##3##5##(1996-4#1)(2008-8#1)(2010-9#1)
involved in the host##3##4##(2008-10#1)(2010-10#2)
involved in the immune##2##4##(2007-2#1)(2011-2#1)
involved in the inactivation##2##4##(1991-9#1)(1996-2#1)
involved in the induction of ascospore germination##2##7##(2008-10#2)
involved in the induction of##5##5##(1992-9#1)(2008-10#3)(2008-7#1)
involved in the induction##6##4##(1992-9#1)(2008-10#4)(2008-7#1)
involved in the inflammatory##2##4##(1990-7#1)(2009-12#1)
involved in the inhibitory##2##4##(1995-2#1)(1995-6#1)
involved in the initial##2##4##(1991-9#1)(2013-1#1)
involved in the initiation of##3##5##(1992-3#1)(1994-12#1)(2008-7#1)
involved in the interaction##3##4##(2008-10#2)(2008-4#1)
involved in the intracellular##2##4##(1994-8#1)(2008-7#1)
involved in the invasion of##2##5##(2008-11#1)(2012-2#1)
involved in the maintenance of a##2##6##(2010-12#1)(2013-1#1)
involved in the maintenance of##7##5##(1995-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)
involved in the maintenance##8##4##(1995-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2013-1#1)
involved in the mechanism of##2##5##(1993-8#1)(2011-2#1)
involved in the mechanism##3##4##(1993-8#1)(2008-8#1)(2011-2#1)
involved in the mechanisms of##2##5##(2008-7#1)(2013-1#1)
involved in the mediation of##3##5##(1997-1#1)(2008-4#2)
involved in the metabolism of##2##5##(2011-2#1)(2013-1#1)
involved in the modulation of##5##5##(1990-7#1)(1997-3#1)(1997-6#1)(2008-7#1)(2012-12#1)
involved in the observed##3##4##(1995-12#1)(2008-10#1)(2008-9#1)
involved in the oxidative##3##4##(1990-2#2)(2008-10#1)
involved in the pathogenesis of the##3##6##(1995-5#1)(2008-7#2)
involved in the pathogenesis of##17##5##(1993-12#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-9#1)(2010-10#1)(2011-2#2)(2013-8#1)
involved in the pathophysiology of##2##5##(1993-3#1)(2008-7#1)
involved in the pathophysiology##3##4##(1993-3#1)(2008-7#2)
involved in the patient's##2##4##(1997-3#1)(2012-8#1)
involved in the process of##8##5##(1995-5#1)(1996-12#1)(2008-1#2)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
involved in the process##11##4##(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-8#1)(2011-1#1)(2012-2#1)
involved in the progression of##2##5##(1996-6#1)(2008-1#1)
involved in the proliferation of the##2##6##(2008-4#1)(2010-11#1)
involved in the protection##2##4##(1995-12#1)(2013-8#1)
involved in the provision of##2##5##(1993-2#1)(2007-2#1)
involved in the regulation of gene expression##2##7##(2008-4#1)(2008-7#1)
involved in the regulation of muscle tone##2##7##(1995-2#2)
involved in the regulation of the##6##6##(1993-12#1)(1993-5#1)(1993-6#2)(1995-12#1)(2010-12#1)
involved in the regulation of these##2##6##(2009-8#1)(2012-12#1)
involved in the regulation of##37##5##(1990-12#1)(1992-11#2)(1992-6#1)(1993-12#2)(1993-5#2)(1993-6#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#3)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#2)(2010-12#2)(2012-12#1)(2013-1#2)
involved in the replication##2##4##(1997-2#1)(2008-11#1)
involved in the resistance of##2##5##(2008-9#2)
involved in the resistance##3##4##(1993-8#1)(2008-9#2)
involved in the response to##3##5##(1994-12#1)(1995-5#1)(2008-10#1)
involved in the response##4##4##(1992-3#1)(1994-12#1)(1995-5#1)(2008-10#1)
involved in the reversible##2##4##(1994-11#1)(2009-5#1)
involved in the signal##2##4##(1991-3#1)(1994-11#1)
involved in the spread of##2##5##(1997-6#1)(2008-10#1)
involved in the structural##2##4##(1993-9#1)(2008-7#1)
involved in the study##4##4##(1991-4#1)(2007-7#1)(2008-5#1)(2011-1#1)
involved in the substrate-binding site of##2##6##(1992-8#2)
involved in the suppression of##3##5##(2008-10#3)
involved in the synthesis and##2##5##(2008-10#1)(2011-2#1)
involved in the synthesis of##3##5##(1990-11#1)(1990-5#1)(2008-10#1)
involved in the synthesis##5##4##(1990-11#1)(1990-5#1)(2008-10#2)(2011-2#1)
involved in the transmission##2##4##(2008-10#1)(2008-5#1)
involved in the treatment of##2##5##(1993-5#1)(2010-3#1)
involved in the uptake##3##4##(1990-11#1)(1995-11#1)(2008-11#1)
involved in the use of##2##5##(2008-10#1)(2011-2#1)
involved in the##530##3##(1990-11#4)(1990-12#3)(1990-2#4)(1990-5#4)(1990-7#2)(1990-8#5)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#3)(1991-7#1)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-3#9)(1992-6#6)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#3)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#5)(1995-11#3)(1995-12#11)(1995-2#7)(1995-3#1)(1995-5#5)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#6)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#5)(1997-6#3)(1997-7#3)(1997-8#4)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#70)(2008-11#18)(2008-2#4)(2008-3#6)(2008-4#17)(2008-5#10)(2008-6#4)(2008-7#27)(2008-8#14)(2008-9#21)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#6)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#19)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#6)(2012-5#1)(2012-8#1)(2013-1#13)(2013-8#7)
involved in their care##2##4##(2007-12#1)(2008-11#1)
involved in their metabolism##2##4##(1994-3#1)(2006-10#1)
involved in their##6##3##(1994-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#2)
involved in these procedures are##2##5##(2007-8#1)(2008-10#1)
involved in these processes##2##4##(2008-11#1)(2008-9#1)
involved in these reactions##2##4##(2008-10#1)(2008-4#1)
involved in these responses##2##4##(1991-2#1)(2008-10#1)
involved in these##17##3##(1990-8#1)(1991-2#1)(1992-3#1)(1993-2#1)(1996-5#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-9#1)(2010-12#1)(2011-1#1)
involved in this phenomenon##2##4##(1993-12#1)(2012-2#1)
involved in this process##12##4##(1993-1#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-11#1)
involved in this type of##2##5##(1994-6#1)(2013-1#1)
involved in this##41##3##(1991-3#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
involved in three##2##3##(1995-11#1)(2007-8#1)
involved in transcriptional regulation##2##4##(2008-10#1)(2010-10#1)
involved in triggering the##2##4##(1996-2#1)(2011-2#1)
involved in using##2##3##(2008-3#1)(2008-7#1)
involved in various##2##3##(2008-4#1)(2012-3#1)
involved in vesicle##2##3##(1993-9#1)(1997-1#1)
involved in vesicular trafficking##2##4##(1996-5#1)(2009-10#1)
involved in##1443##2##(1990-11#6)(1990-12#5)(1990-2#5)(1990-4#1)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#8)(1991-1#1)(1991-11#2)(1991-12#9)(1991-2#4)(1991-3#4)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#10)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#7)(1992-3#15)(1992-6#10)(1992-8#12)(1992-9#7)(1993-1#3)(1993-11#6)(1993-12#14)(1993-2#5)(1993-3#7)(1993-5#6)(1993-6#9)(1993-8#8)(1993-9#7)(1994-1#1)(1994-11#14)(1994-12#7)(1994-2#14)(1994-3#6)(1994-5#8)(1994-6#11)(1994-8#14)(1994-9#3)(1995-1#2)(1995-11#11)(1995-12#22)(1995-2#19)(1995-3#7)(1995-5#10)(1995-6#19)(1995-8#12)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#10)(1996-2#16)(1996-3#5)(1996-4#1)(1996-5#7)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#17)(1997-3#10)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#11)(1997-8#7)(1997-9#1)(2006-10#2)(2006-6#4)(2006-7#1)(2007-10#3)(2007-11#10)(2007-12#20)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#24)(2008-10#164)(2008-11#67)(2008-12#9)(2008-2#9)(2008-3#14)(2008-4#51)(2008-5#27)(2008-6#11)(2008-7#79)(2008-8#39)(2008-9#53)(2009-1#2)(2009-10#10)(2009-11#5)(2009-12#8)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#12)(2009-6#6)(2009-7#6)(2009-8#13)(2009-9#3)(2010-1#4)(2010-10#9)(2010-11#16)(2010-12#13)(2010-2#1)(2010-3#6)(2010-4#8)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#14)(2011-2#47)(2011-3#2)(2012-1#5)(2012-12#19)(2012-2#29)(2012-3#23)(2012-5#1)(2012-8#1)(2013-1#36)(2013-7#4)(2013-8#19)
involved include##2##2##(2008-7#1)(2010-10#1)
involved liver##2##2##(1990-8#1)(2008-10#1)
involved lymph nodes were on##2##5##(2011-2#2)
involved lymph nodes##4##3##(1993-9#1)(2008-10#1)(2011-2#2)
involved may be##2##3##(1997-1#1)(2008-9#1)
involved may##3##2##(1997-1#1)(2008-6#1)(2008-9#1)
involved more##2##2##(1990-5#1)(2008-11#1)
involved most##2##2##(2008-7#1)(2013-1#1)
involved multiple##2##2##(1991-2#1)(2012-12#1)
involved on the##3##3##(2008-10#2)(2008-3#1)
involved placing##2##2##(2008-10#1)(2012-2#1)
involved the development of##2##4##(2011-1#2)
involved the formation of##2##4##(1995-5#1)(2008-10#1)
involved the##34##2##(1990-6#1)(1990-9#1)(1992-5#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#4)(2009-10#2)(2009-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
involved was##2##2##(2008-10#2)
involved were##4##2##(1990-8#1)(1997-8#1)(2008-12#1)(2010-1#1)
involved when##2##2##(1996-12#1)(2012-12#1)
involved will##3##2##(1997-8#1)(2008-10#1)(2009-5#1)
involved with a##3##3##(1996-9#1)(2009-3#1)(2013-1#1)
involved with maintaining##2##3##(1995-3#1)(2009-10#1)
involved with the##4##3##(1992-8#1)(1995-5#1)(2008-10#1)(2008-8#1)
involved with##30##2##(1990-11#1)(1992-2#1)(1992-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-7#1)(2010-11#1)(2011-3#1)(2013-1#3)(2013-8#1)
involved##1961##1##(1990-11#7)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#10)(1990-6#5)(1990-7#4)(1990-8#12)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#11)(1991-2#7)(1991-3#4)(1991-4#4)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#12)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#9)(1992-2#1)(1992-3#17)(1992-5#2)(1992-6#10)(1992-7#1)(1992-8#15)(1992-9#7)(1993-1#5)(1993-11#9)(1993-12#16)(1993-2#5)(1993-3#8)(1993-5#8)(1993-6#9)(1993-8#10)(1993-9#8)(1994-1#5)(1994-11#16)(1994-12#11)(1994-2#16)(1994-3#9)(1994-5#8)(1994-6#12)(1994-7#1)(1994-8#18)(1994-9#4)(1995-1#4)(1995-11#13)(1995-12#27)(1995-2#21)(1995-3#8)(1995-5#16)(1995-6#22)(1995-8#14)(1995-9#3)(1996-1#5)(1996-10#1)(1996-12#12)(1996-2#17)(1996-3#7)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#8)(1997-1#8)(1997-2#20)(1997-3#13)(1997-4#5)(1997-5#5)(1997-6#6)(1997-7#12)(1997-8#9)(1997-9#1)(2006-10#3)(2006-6#5)(2006-7#1)(2007-10#4)(2007-11#17)(2007-12#27)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#14)(2008-1#34)(2008-10#242)(2008-11#94)(2008-12#22)(2008-2#16)(2008-3#22)(2008-4#63)(2008-5#36)(2008-6#13)(2008-7#103)(2008-8#49)(2008-9#69)(2009-1#2)(2009-10#18)(2009-11#8)(2009-12#8)(2009-2#3)(2009-3#7)(2009-4#3)(2009-5#16)(2009-6#7)(2009-7#8)(2009-8#15)(2009-9#5)(2010-1#7)(2010-10#11)(2010-11#19)(2010-12#15)(2010-2#1)(2010-3#9)(2010-4#12)(2010-5#6)(2010-6#8)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#23)(2011-2#72)(2011-3#3)(2012-1#8)(2012-12#25)(2012-2#36)(2012-3#26)(2012-4#2)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#55)(2013-7#7)(2013-8#26)
involved-field radiotherapy##2##2##(2011-2#2)
involved-field##3##1##(2007-5#1)(2011-2#2)
involvement among##2##2##(2006-10#1)(2009-7#1)
involvement and the##2##3##(1996-3#1)(1997-3#1)
involvement and##28##2##(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
involvement are often##2##3##(1996-2#1)(1997-8#1)
involvement are##6##2##(1996-2#1)(1997-3#2)(1997-8#1)(2008-12#1)(2008-2#1)
involvement as first##2##3##(1993-12#1)(1997-8#1)
involvement as##3##2##(1993-12#1)(1997-8#1)(2011-2#1)
involvement associated with##2##3##(1993-2#1)(2013-1#1)
involvement at##4##2##(2008-12#1)(2009-7#1)(2011-2#2)
involvement but##2##2##(2008-9#1)(2011-2#1)
involvement by##12##2##(1990-6#1)(1990-8#1)(1993-2#1)(1993-8#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-9#1)(2012-3#2)(2013-8#1)
involvement developed##2##2##(2008-6#1)(2012-12#1)
involvement during##3##2##(1996-2#1)(2010-12#1)(2013-1#1)
involvement for##2##2##(1994-2#1)(2008-11#1)
involvement from##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)
involvement has been##3##3##(2006-10#1)(2008-12#1)(2013-1#1)
involvement has##4##2##(2006-10#2)(2008-12#1)(2013-1#1)
involvement in a##4##3##(1992-2#1)(1993-12#1)(1994-11#1)(2010-10#1)
involvement in cellular##2##3##(2011-2#2)
involvement in health##4##3##(2010-3#4)
involvement in nonprescription medicine purchase decisions##2##6##(1995-2#2)
involvement in primary##2##3##(1991-11#1)(2011-2#1)
involvement in such##2##3##(1993-1#1)(2008-7#1)
involvement in the##21##3##(1990-6#1)(1991-1#2)(1991-3#1)(1994-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
involvement in##113##2##(1990-11#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#2)(1993-1#1)(1993-12#4)(1994-1#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1997-3#2)(1997-5#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#5)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
involvement is rare##2##3##(2007-8#1)(2013-1#1)
involvement is##14##2##(1992-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
involvement may be##2##3##(2008-7#1)(2011-2#1)
involvement may##3##2##(2008-7#2)(2011-2#1)
involvement occurred##3##2##(1997-8#2)(2013-1#1)
involvement of a##11##3##(1990-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-2#1)(2012-2#1)
involvement of an##4##3##(1991-10#1)(1993-12#1)(1995-2#1)(1997-3#1)
involvement of beta3 integrin in##2##5##(2009-9#2)
involvement of both##3##3##(1991-5#1)(1995-8#1)(2008-11#1)
involvement of cyclic##2##3##(1990-12#1)(1992-3#1)
involvement of heat##2##3##(1994-11#2)
involvement of histidine residues and sulfhydryl groups in the##2##9##(1992-6#2)
involvement of myosin##2##3##(1992-6#1)(2008-11#1)
involvement of phospholipase A(2) and cyclooxygenase in##2##7##(2008-11#2)
involvement of phospholipase##3##3##(2008-11#3)
involvement of prostaglandin##2##3##(1990-12#2)
involvement of protein kinase C##3##5##(1991-2#1)(1992-8#1)(2008-11#1)
involvement of protein##4##3##(1991-2#1)(1992-8#1)(1997-1#1)(2008-11#1)
involvement of reactive oxygen species (ROS) in##2##7##(1992-12#1)(2011-2#1)
involvement of reactive oxygen species##3##5##(1992-12#1)(2009-4#1)(2011-2#1)
involvement of service users in##2##5##(2008-12#2)
involvement of singlet oxygen in the##2##6##(1990-11#2)
involvement of somatotropes##2##3##(1992-6#1)(1994-9#1)
involvement of speech##2##3##(2007-10#2)
involvement of the carotid artery##2##5##(1993-3#1)(2011-2#1)
involvement of the right##2##4##(2007-7#1)(2013-8#1)
involvement of the##63##3##(1990-10#1)(1990-11#2)(1990-6#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-8#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
involvement of these##6##3##(1990-12#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-2#1)
involvement of this##5##3##(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-3#1)
involvement of transition metals##2##4##(2008-5#1)(2011-1#1)
involvement of##311##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#5)(1992-11#3)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#5)(1994-2#3)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#2)(1996-12#5)(1996-2#2)(1996-5#3)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#23)(2008-11#29)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#2)(2008-6#5)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#3)
involvement on##2##2##(2008-12#1)(2008-4#1)
involvement policies##2##2##(2008-7#2)
involvement requires##2##2##(2008-6#1)(2013-1#1)
involvement suggests##2##2##(1994-12#1)(1995-2#1)
involvement that##2##2##(2007-12#1)(2008-8#1)
involvement to##2##2##(1995-2#1)(2009-7#1)
involvement was found##2##3##(1990-12#1)(2011-2#1)
involvement was seen in##2##4##(2007-7#1)(2012-3#1)
involvement was seen##4##3##(1996-6#1)(2007-7#1)(2012-3#2)
involvement was##18##2##(1990-12#1)(1990-2#1)(1991-4#1)(1991-6#1)(1994-9#2)(1996-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2011-2#4)(2012-2#2)(2012-3#2)
involvement were associated with##2##4##(1994-2#1)(2009-5#1)
involvement were##5##2##(1994-2#1)(1997-8#1)(2007-7#1)(2009-5#1)(2013-8#1)
involvement with##8##2##(1991-9#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-1#1)(2013-7#1)
involvement##729##1##(1990-10#1)(1990-11#7)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#8)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#7)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#13)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#7)(1994-12#3)(1994-2#7)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#6)(1995-10#1)(1995-11#2)(1995-12#8)(1995-2#10)(1995-3#7)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#9)(1996-2#8)(1996-3#5)(1996-5#5)(1996-6#3)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#9)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#15)(2006-10#12)(2006-5#1)(2006-6#2)(2007-10#5)(2007-11#9)(2007-12#10)(2007-2#1)(2007-7#9)(2007-8#9)(2008-1#9)(2008-10#32)(2008-11#40)(2008-12#18)(2008-2#3)(2008-3#5)(2008-4#13)(2008-5#7)(2008-6#7)(2008-7#33)(2008-8#7)(2008-9#7)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#4)(2009-7#9)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#11)(2010-4#2)(2010-6#5)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#51)(2012-1#1)(2012-12#6)(2012-2#16)(2012-3#16)(2013-1#37)(2013-7#6)(2013-8#8)
involvement]##2##1##(1991-9#1)(2009-5#1)
involvements##2##1##(2007-8#1)(2012-2#1)
involves a combination of##2##4##(2008-10#1)(2011-3#1)
involves a complex##2##3##(2008-11#1)(2008-5#1)
involves a number of##2##4##(2007-10#1)(2008-7#1)
involves a reactive##2##3##(1992-12#1)(2013-1#1)
involves a relatively##2##3##(2010-12#1)(2013-1#1)
involves a sequence of##2##4##(2008-10#1)(2011-2#1)
involves a series of##3##4##(1995-8#1)(1996-5#1)(2008-7#1)
involves a site that is##2##5##(1994-5#2)
involves a##77##2##(1990-12#1)(1990-2#2)(1991-1#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
involves an##7##2##(1993-6#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
involves at least##2##3##(1990-7#1)(2009-5#1)
involves binding##2##2##(1990-12#1)(1990-5#1)
involves both##4##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
involves complex##3##2##(2008-4#2)(2013-8#1)
involves direct##3##2##(1991-5#1)(2008-3#1)(2009-11#1)
involves dry heating to 60 degrees C and higher##2##9##(2008-10#2)
involves four##3##2##(1994-2#1)(1997-8#1)(2008-10#1)
involves gene mutation that causes the##2##6##(2008-10#2)
involves laboratory##2##2##(2008-10#1)(2008-7#1)
involves many##2##2##(1992-2#1)(2013-8#1)
involves measurements##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
involves more than##2##3##(2008-2#1)(2010-8#1)
involves more##3##2##(2008-12#1)(2008-2#1)(2010-8#1)
involves multiple##2##2##(1992-12#1)(2012-2#1)
involves no##2##2##(1994-8#1)(2008-10#1)
involves one##2##2##(1994-5#1)(2011-2#1)
involves only##2##2##(2008-3#1)(2008-4#1)
involves patients##2##2##(2008-5#1)(2012-3#1)
involves rapid##2##2##(1994-9#1)(2011-1#1)
involves release of##2##3##(1991-9#1)(2012-12#1)
involves sample##2##2##(2008-10#2)
involves several##2##2##(1995-9#1)(2008-7#1)
involves specific##2##2##(1992-6#1)(2012-2#1)
involves stable##2##2##(1992-3#1)(1996-2#1)
involves the action of##2##4##(1990-2#1)(1995-2#1)
involves the activation of##2##4##(1994-8#1)(2008-7#1)
involves the administration of##2##4##(1994-6#1)(2008-8#1)
involves the combined use of##2##5##(2008-10#1)(2008-7#1)
involves the conversion of##2##4##(1991-5#1)(2009-11#1)
involves the development of##2##4##(2008-5#1)(2010-11#1)
involves the extraction of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
involves the formation of a##2##5##(1993-6#1)(2008-9#1)
involves the immobilization of##2##4##(2008-10#1)(2009-3#1)
involves the induction##2##3##(2008-11#1)(2011-1#1)
involves the injection of##2##4##(2008-10#2)
involves the participation of##3##4##(1991-5#1)(1994-3#1)(2010-2#1)
involves the use of a##3##5##(2008-10#2)(2013-1#1)
involves the use of##12##4##(1991-3#1)(1992-8#1)(2008-10#6)(2008-11#1)(2009-11#1)(2012-3#1)(2013-1#1)
involves the##111##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-5#2)(2008-10#27)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#3)(2009-3#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)
involves three##4##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
involves two steps##2##3##(2008-10#2)
involves two##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
involves various##2##2##(2007-10#1)(2012-3#1)
involves##462##1##(1990-12#5)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#1)(1995-5#3)(1995-8#3)(1995-9#1)(1996-2#1)(1996-5#5)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#13)(2007-2#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#80)(2008-11#12)(2008-12#7)(2008-2#6)(2008-3#24)(2008-4#20)(2008-5#15)(2008-6#5)(2008-7#19)(2008-8#10)(2008-9#11)(2009-1#2)(2009-10#4)(2009-11#4)(2009-12#2)(2009-3#2)(2009-5#4)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#12)(2011-3#3)(2011-8#1)(2012-1#3)(2012-12#11)(2012-2#9)(2012-3#6)(2012-7#1)(2013-1#13)(2013-8#3)
involving 1##2##2##(1996-1#1)(2007-10#1)
involving 58##2##2##(1992-4#1)(2008-10#1)
involving a high##2##3##(1994-5#1)(2012-2#1)
involving a total of##3##4##(2008-5#1)(2009-2#1)(2011-2#1)
involving a total##4##3##(2008-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
involving a##33##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-12#2)(1994-5#1)(1994-6#1)(1995-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
involving all##7##2##(1994-2#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#1)(2010-3#1)(2013-1#1)
involving amino acids##2##3##(1993-3#1)(2008-10#1)
involving amino##3##2##(1993-3#1)(1997-6#1)(2008-10#1)
involving an##8##2##(1990-8#1)(1992-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
involving bilateral nasal cavity##2##4##(2011-1#2)
involving bilateral##3##2##(2008-12#1)(2011-1#2)
involving both the##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
involving both##13##2##(1990-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
involving children##2##2##(1995-3#2)
involving choline##2##2##(2008-10#1)(2008-11#1)
involving control and##2##3##(2009-11#1)(2009-8#1)
involving different##7##2##(1990-8#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#2)
involving either##4##2##(1997-7#1)(2007-11#1)(2008-6#1)(2010-11#1)
involving exercise##2##2##(2008-12#1)(2008-5#1)
involving family##3##2##(2011-2#2)(2013-1#1)
involving five##2##2##(1995-3#1)(2008-5#1)
involving four##2##2##(1995-3#1)(2008-10#1)
involving highly##2##2##(2007-11#1)(2012-3#1)
involving invasion##2##2##(1996-5#1)(2009-4#1)
involving larger##2##2##(2008-1#1)(2012-3#1)
involving major##3##2##(1994-9#1)(2008-10#1)(2008-7#1)
involving more than##2##3##(2007-12#1)(2013-1#1)
involving more##4##2##(2007-12#1)(2008-3#1)(2008-6#1)(2013-1#1)
involving multiple##4##2##(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)
involving negative##2##2##(2010-10#1)(2010-3#1)
involving nonlinear##2##2##(2007-12#1)(2008-7#1)
involving one##2##2##(2007-8#1)(2008-7#1)
involving only##4##2##(1997-7#1)(2007-12#1)(2008-10#2)
involving other##2##2##(1993-8#1)(2008-2#1)
involving oxidation of##2##3##(1992-12#1)(2008-10#1)
involving pathways##2##2##(2008-7#1)(2008-8#1)
involving patients in##2##3##(2008-11#1)(2008-12#1)
involving patients##4##2##(2008-11#1)(2008-12#1)(2008-6#1)(2012-3#1)
involving primarily##2##2##(1996-5#1)(2007-11#1)
involving protein##4##2##(1991-9#1)(1994-11#1)(2008-11#1)(2009-11#1)
involving radiation##2##2##(2008-7#1)(2013-1#1)
involving repeated##2##2##(1994-2#1)(1996-6#1)
involving repetitive##3##2##(2008-9#2)(2013-1#1)
involving several##2##2##(2010-10#1)(2010-12#1)
involving small numbers of##2##4##(2010-4#1)(2012-2#1)
involving the anterior part of the annulus##2##7##(1996-6#2)
involving the carina##3##3##(2010-7#2)(2012-1#1)
involving the celiac axis##2##4##(2008-12#2)
involving the celiac##3##3##(2008-12#3)
involving the community##2##3##(1995-2#1)(2012-12#1)
involving the endometrium##2##3##(2011-2#2)
involving the face##3##3##(2013-1#3)
involving the gastrointestinal tract##2##4##(1990-11#1)(2013-1#1)
involving the hand##2##3##(2008-6#1)(2008-9#1)
involving the head and neck##2##5##(1994-6#1)(2008-8#1)
involving the head##3##3##(1994-6#1)(2008-6#1)(2008-8#1)
involving the left##4##3##(2008-11#1)(2008-7#2)(2012-12#1)
involving the lower##2##3##(2009-3#1)(2013-1#1)
involving the middle##2##3##(1996-9#1)(2013-1#1)
involving the orbit##2##3##(2011-2#1)(2013-8#1)
involving the participation of##2##4##(1994-1#1)(2007-8#1)
involving the proximal##3##3##(1997-3#1)(2008-11#1)(2010-12#1)
involving the right##3##3##(1996-9#1)(2007-7#2)
involving the same##2##3##(2008-10#2)
involving the skull##3##3##(2008-1#1)(2010-12#2)
involving the upper##2##3##(2009-5#1)(2013-8#1)
involving the use of a##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
involving the use of##12##4##(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-5#1)(2010-6#1)
involving the##187##2##(1990-11#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#2)(1996-9#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#27)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#12)(2013-8#2)
involving three##2##2##(1993-11#1)(2010-12#1)
involving tissue##2##2##(1994-3#1)(2008-9#1)
involving two or##2##3##(2007-8#1)(2008-10#1)
involving two##8##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-8#1)
involving zinc##2##2##(2008-10#2)
involving##693##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#6)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#7)(1996-6#4)(1996-9#7)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#4)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#10)(2007-12#13)(2007-2#9)(2007-5#2)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#111)(2008-11#22)(2008-12#17)(2008-2#12)(2008-3#18)(2008-4#15)(2008-5#9)(2008-6#13)(2008-7#32)(2008-8#8)(2008-9#14)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#6)(2010-2#4)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#28)(2012-1#3)(2012-12#12)(2012-2#12)(2012-3#12)(2012-7#1)(2013-1#36)(2013-7#1)(2013-8#9)
invulnerability and optimism bias##2##4##(2010-7#2)
invulnerability and##3##2##(2010-7#3)
invulnerability##10##1##(2010-7#10)
invulnerable##3##1##(2008-8#3)
inward K(+)##5##2##(2008-8#5)
inward current at##2##3##(1990-7#1)(2009-12#1)
inward current which##2##3##(1993-12#1)(1993-3#1)
inward current##19##2##(1990-7#3)(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#1)(1995-11#2)(1995-12#3)(1997-2#1)(2008-8#3)(2009-12#2)
inward currents##11##2##(1993-8#1)(1995-11#4)(1995-12#1)(1995-2#1)(1996-5#1)(2008-8#2)(2009-12#1)
inward rectification##3##2##(1996-2#3)
inward rectified##2##2##(2008-8#2)
inward rectifier##4##2##(1993-3#1)(2008-8#2)(2013-7#1)
inward##51##1##(1990-7#3)(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#2)(1993-8#1)(1995-11#6)(1995-12#5)(1995-2#1)(1996-2#3)(1996-5#1)(1997-2#2)(2008-4#1)(2008-7#1)(2008-8#14)(2009-1#1)(2009-12#3)(2011-2#1)(2013-7#1)(2013-8#1)
inward-rectifying K+ channels##2##3##(1994-12#1)(1996-2#1)
inward-rectifying K+##3##2##(1994-12#2)(1996-2#1)
inward-rectifying##4##1##(1994-12#3)(1996-2#1)
inwardly rectifying##3##2##(1996-2#1)(2008-6#1)(2008-8#1)
in vitro scratch##2##2##(2013-8#2)
in vitro##6##1##(2012-3#1)(2013-1#3)(2013-8#2)
iodate and iodide in table salts##2##6##(2008-10#2)
iodate and iodide in table##3##5##(2008-10#3)
iodate and iodide##4##3##(2008-10#4)
iodate and##9##2##(2008-10#9)
iodate by##2##2##(2008-10#2)
iodate in##7##2##(2008-10#7)
iodate was##3##2##(2008-10#3)
iodate with a##2##3##(2008-10#2)
iodate with##4##2##(2008-10#4)
iodate##40##1##(2006-4#1)(2008-10#39)
iodate-bromate##4##1##(2008-10#4)
iodide and nitrite##2##3##(2008-10#2)
iodide and the##2##3##(2008-10#1)(2009-11#1)
iodide and##12##2##(1993-3#1)(2008-10#10)(2009-11#1)
iodide at##2##2##(2008-10#2)
iodide by##4##2##(2008-10#4)
iodide concentration##2##2##(2008-10#2)
iodide contents in##2##3##(1990-2#1)(2008-10#1)
iodide during##2##2##(2008-10#1)(2008-11#1)
iodide from 5##2##3##(1996-2#1)(2008-10#1)
iodide in acidic##3##3##(2008-10#3)
iodide in the presence of##2##5##(2008-10#2)
iodide in the##3##3##(2008-10#3)
iodide in##15##2##(2008-10#15)
iodide ion in a photographic developing solution was##2##8##(2008-10#2)
iodide ion in a photographic developing solution##5##7##(2008-10#5)
iodide ion in##7##3##(2008-10#7)
iodide ion##13##2##(2008-10#13)
iodide ion-selective electrode detector##2##4##(2008-10#2)
iodide ion-selective electrode##3##3##(2008-10#3)
iodide ions##2##2##(2008-10#2)
iodide is##3##2##(2008-10#3)
iodide on##3##2##(2008-10#2)(2010-12#1)
iodide to##4##2##(2008-10#3)(2008-11#1)
iodide was##5##2##(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#1)
iodide were##3##2##(2008-10#3)
iodide with##2##2##(2008-10#2)
iodide##146##1##(1990-2#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-2#3)(1997-7#2)(2007-12#1)(2007-7#3)(2008-10#103)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#6)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#3)(2012-1#1)(2013-1#1)
iodide)##4##1##(1990-12#2)(2008-10#1)(2008-5#1)
iodide-selective##3##1##(2008-10#3)
iodides##3##1##(2008-10#2)(2010-5#1)
iodimetric##4##1##(2008-10#4)
iodinated##10##1##(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#2)
iodination of soluble##2##3##(2008-4#2)
iodination of tyrosine##2##3##(1990-5#2)
iodination of##7##2##(1990-5#2)(1995-12#1)(2007-11#2)(2008-4#2)
iodination##11##1##(1990-5#2)(1995-12#1)(2007-11#6)(2008-4#2)
iodine and##8##2##(1997-8#1)(2007-12#1)(2008-10#6)
iodine as##2##2##(2008-10#2)
iodine at##2##2##(2008-10#1)(2008-3#1)
iodine concentration of the contrast medium##2##6##(2008-7#2)
iodine concentration##4##2##(2008-3#1)(2008-7#3)
iodine in##5##2##(1997-8#2)(2008-10#2)(2012-3#1)
iodine intake##2##2##(1990-8#2)
iodine is determined##2##3##(2008-10#2)
iodine is##3##2##(2008-10#3)
iodine laser##3##2##(2007-11#1)(2008-3#2)
iodine lines##2##2##(2008-3#2)
iodine or gadolinium##2##3##(2013-1#2)
iodine or##3##2##(1990-8#1)(2013-1#2)
iodine solution##3##2##(2008-10#3)
iodine to##3##2##(2008-10#2)(2008-5#1)
iodine was##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
iodine##114##1##(1990-3#1)(1990-8#4)(1992-2#2)(1997-8#9)(2007-11#8)(2007-12#2)(2008-10#56)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#3)
iodine-125-labeled GNRs##2##2##(2012-12#2)
iodine-containing##2##1##(2013-1#1)(2013-8#1)
iodine-deficiency##2##1##(1990-8#1)(2007-11#1)
iodine-stabilized laser##2##2##(2007-12#1)(2008-2#1)
iodine-stabilized##4##1##(2007-12#3)(2008-2#1)
iodization##3##1##(2007-11#3)
iodized salt##3##2##(2007-11#2)(2008-10#1)
iodized##7##1##(1990-3#1)(1997-8#1)(2007-11#2)(2008-10#3)
iodo##2##1##(2007-12#1)(2008-4#1)
iodoacetamide##9##1##(1994-11#1)(1994-6#5)(2008-4#1)(2008-5#1)(2010-11#1)
iodoacetic acid##3##2##(1991-5#1)(1992-5#1)(2008-7#1)
iodometric determination of##4##3##(2008-10#4)
iodometric determination##5##2##(2008-10#5)
iodometric method##2##2##(2007-8#1)(2008-10#1)
iodometric titration##4##2##(2008-10#4)
iodometric##13##1##(2007-7#1)(2007-8#1)(2008-10#11)
iodometry##3##1##(2008-10#2)(2008-5#1)
iodonium##3##1##(1990-2#1)(1991-2#2)
iodophor##2##1##(1990-6#1)(1992-2#1)
iodothyronine 5'-deiodinase from rat liver microsomes##2##6##(1990-11#2)
iodothyronine 5'-deiodinase##5##2##(1990-11#2)(1990-12#3)
iodothyronine deiodinase##5##2##(1992-12#2)(1995-12#2)(2011-1#1)
iodothyronine##10##1##(1990-11#2)(1990-12#3)(1992-12#2)(1995-12#2)(2011-1#1)
iodotyrosines and iodothyronines##3##3##(2008-10#3)
iodotyrosines##4##1##(1995-12#1)(2008-10#3)
ion accumulation##2##2##(1994-5#1)(2008-5#1)
ion activity##2##2##(2008-10#2)
ion adsorption##4##2##(2008-10#4)
ion against##2##2##(2008-10#2)
ion amperometry at##2##3##(2008-10#2)
ion and is##2##3##(1992-12#1)(1992-6#1)
ion and solvent##2##3##(2008-10#2)
ion and the##2##3##(1997-7#1)(2008-10#1)
ion and##35##2##(1992-12#1)(1992-6#2)(1993-8#1)(1995-6#1)(1997-7#1)(2007-12#2)(2008-10#23)(2008-2#1)(2008-7#2)(2009-8#1)
ion are described##3##3##(2008-10#3)
ion are##5##2##(1991-5#1)(2008-10#4)
ion as a##2##3##(2008-10#2)
ion as##5##2##(2008-10#3)(2012-12#1)(2012-2#1)
ion associate formation##2##3##(2008-10#2)
ion associate of##2##3##(2008-10#2)
ion associate##14##2##(2008-10#14)
ion associates are##2##3##(2008-10#2)
ion associates of##5##3##(2008-10#5)
ion associates with##2##3##(2008-10#2)
ion associates##14##2##(2008-10#14)
ion association complex [Fe(bipy)(3)](2+)[(FinBr(4))(2)](2-)##2##4##(2008-10#2)
ion association complex##5##3##(2008-10#5)
ion association constants##3##3##(2008-10#3)
ion association reagent and##2##4##(2008-10#2)
ion association##20##2##(2008-10#20)
ion at##4##2##(2008-10#4)
ion based on N##2##4##(2008-10#2)
ion based on##5##3##(2008-10#5)
ion beam is##2##3##(2008-3#2)
ion beam##9##2##(2008-10#2)(2008-2#1)(2008-3#4)(2008-8#1)(2009-10#1)
ion binding##6##2##(1992-3#1)(1997-2#1)(2008-10#4)
ion by##7##2##(2008-10#7)
ion can##4##2##(2008-10#3)(2008-8#1)
ion capturing##2##2##(2008-10#2)
ion carrier##4##2##(1990-2#1)(2008-10#3)
ion carriers in##2##3##(2008-10#2)
ion chamber##3##2##(2009-11#3)
ion channel and##2##3##(1995-8#1)(2013-8#1)
ion channel families##2##3##(2008-8#2)
ion channel function and##2##4##(1995-8#1)(2008-4#1)
ion channel function##3##3##(1995-8#1)(2008-4#2)
ion channel##31##2##(1990-11#1)(1992-6#2)(1994-12#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-8#2)(2008-11#2)(2008-4#3)(2008-8#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
ion channel-related##2##2##(2013-1#2)
ion channels activated##2##3##(2008-7#1)(2013-1#1)
ion channels and##2##3##(2008-6#1)(2008-8#1)
ion channels by##2##3##(1993-12#1)(2008-4#1)
ion channels in the##2##4##(2008-8#1)(2013-1#1)
ion channels in##8##3##(1990-8#1)(1997-7#2)(2008-8#2)(2009-12#1)(2013-1#1)(2013-7#1)
ion channels that##2##3##(2008-9#2)
ion channels was##2##3##(2009-12#1)(2013-1#1)
ion channels##48##2##(1990-8#1)(1993-12#1)(1993-9#1)(1995-2#2)(1995-5#1)(1997-7#2)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#17)(2008-9#2)(2009-12#3)(2012-3#1)(2013-1#6)(2013-7#1)
ion chelation##2##2##(1993-8#1)(2008-10#1)
ion chemistry##4##2##(2008-10#4)
ion chromatograph##3##2##(2008-10#3)
ion chromatographic analyses##2##3##(2008-10#1)(2010-4#1)
ion chromatographic##9##2##(1994-9#1)(2008-10#6)(2008-6#1)(2010-4#1)
ion chromatography (IC) with##5##4##(2008-10#5)
ion chromatography (IC)##10##3##(2008-10#10)
ion chromatography and##4##3##(2008-10#4)
ion chromatography for the determination of##2##6##(1994-9#1)(2008-10#1)
ion chromatography for##4##3##(1994-9#1)(2008-10#3)
ion chromatography is##2##3##(2008-10#1)(2010-5#1)
ion chromatography with series bulk acoustic wave detection##2##8##(2008-10#2)
ion chromatography with##5##3##(2008-10#5)
ion chromatography##46##2##(1991-2#1)(1994-9#1)(2008-10#43)(2010-5#1)
ion complexation by##3##3##(2008-10#3)
ion complexation##5##2##(2008-10#5)
ion complexes##2##2##(2008-10#2)
ion concentration and##2##3##(1994-12#1)(2008-10#1)
ion concentration in the##3##4##(1995-8#1)(2008-10#2)
ion concentration in##5##3##(1990-12#1)(1995-8#1)(2008-10#3)
ion concentration range##3##3##(2008-10#3)
ion concentration##21##2##(1990-12#1)(1994-12#1)(1995-12#1)(1995-8#1)(2008-10#16)(2009-12#1)
ion concentrations in##2##3##(2008-10#2)
ion concentrations##8##2##(1994-8#1)(2008-10#4)(2008-5#1)(2010-11#1)(2012-12#1)
ion conductances##2##2##(2008-8#2)
ion current##2##2##(2008-10#2)
ion currents##3##2##(2008-10#1)(2008-7#2)
ion cyclotron resonance mass spectrometry##2##5##(2008-10#1)(2008-7#1)
ion cyclotron resonance##4##3##(2008-10#2)(2008-7#2)
ion determination##5##2##(2008-10#5)
ion due to the##2##4##(2008-10#2)
ion electrophoresis##3##2##(1994-9#2)(1997-2#1)
ion electrospray ionization##2##3##(2008-10#2)
ion electrospray##3##2##(2008-10#2)(2011-1#1)
ion exchange and##8##3##(1993-9#1)(1997-7#1)(2008-10#6)
ion exchange chromatography on##3##4##(1997-4#1)(2008-4#1)(2009-9#1)
ion exchange chromatography##6##3##(1994-8#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)
ion exchange column##2##3##(2008-10#2)
ion exchange columns##3##3##(1991-5#1)(2008-10#2)
ion exchange in##4##3##(1990-8#1)(2008-2#2)(2008-3#1)
ion exchange membranes##2##3##(2008-10#1)(2013-1#1)
ion exchange resin##10##3##(2008-10#10)
ion exchange resins##5##3##(2008-10#5)
ion exchange selectivity##3##3##(2008-10#3)
ion exchange##73##2##(1990-8#1)(1991-5#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#54)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
ion exchanger and##2##3##(2008-10#2)
ion exchanger was##3##3##(1994-5#2)(2008-10#1)
ion exchanger##21##2##(1990-8#1)(1994-5#2)(2008-10#18)
ion exchangers and##2##3##(1997-2#1)(2008-10#1)
ion exchangers##7##2##(1990-5#1)(1997-2#1)(2008-10#5)
ion exchanges##2##2##(2008-10#1)(2008-2#1)
ion exclusion##3##2##(1990-8#2)(2008-10#1)
ion fluxes##4##2##(1992-6#1)(2008-10#2)(2008-8#1)
ion for##2##2##(2008-10#2)
ion formation##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)
ion formed##4##2##(2008-10#3)(2010-4#1)
ion forms a##2##3##(2008-10#2)
ion from aqueous solutions##3##4##(2008-10#2)(2008-6#1)
ion from aqueous##4##3##(2008-10#3)(2008-6#1)
ion from##6##2##(2008-10#4)(2008-6#2)
ion has been identified as##2##5##(2010-5#2)
ion has been##7##3##(1996-2#1)(2008-10#4)(2010-5#2)
ion has##8##2##(1993-8#1)(1996-2#1)(2008-10#4)(2010-5#2)
ion homeostasis##4##2##(1994-5#1)(2008-4#1)(2009-8#1)(2010-3#1)
ion implantation##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
ion imprinted polymer (IIP) particles##2##5##(2008-10#2)
ion in a##20##3##(1993-5#1)(1993-8#1)(2008-10#17)(2008-11#1)
ion in aqueous media##2##4##(2008-10#2)
ion in aqueous samples##3##4##(2008-10#3)
ion in aqueous solution##4##4##(2008-10#4)
ion in aqueous##10##3##(2008-10#10)
ion in basic##2##3##(2008-10#2)
ion in comparison to##2##4##(2008-10#2)
ion in comparison with some##2##5##(2008-10#2)
ion in comparison with##3##4##(2008-10#3)
ion in comparison##5##3##(2008-10#5)
ion in natural waters##2##4##(2008-10#2)
ion in natural##3##3##(2008-10#3)
ion in solution##2##3##(2008-10#2)
ion in the sample##2##4##(2008-10#2)
ion in the##16##3##(1993-11#1)(1995-6#1)(1997-2#1)(2008-10#12)(2008-3#1)
ion in water##4##3##(2008-10#4)
ion in##90##2##(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-5#2)(1995-6#3)(1997-2#1)(2008-10#77)(2008-11#1)(2008-3#1)(2010-5#1)
ion induced##3##2##(1995-2#1)(2008-10#1)(2009-10#1)
ion influx##2##2##(1993-12#1)(2013-8#1)
ion interactions##2##2##(2008-10#2)
ion intermediate##2##2##(2009-8#1)(2010-2#1)
ion is described##2##3##(2008-10#2)
ion is increased##2##3##(2008-10#2)
ion is observed##2##3##(2008-10#2)
ion is##24##2##(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-3#1)(2008-6#1)(2010-6#2)
ion leakage##2##2##(1990-12#2)
ion mass spectrometry##13##3##(2008-10#6)(2008-2#3)(2008-5#1)(2009-2#1)(2012-12#2)
ion mass##16##2##(2008-10#8)(2008-2#3)(2008-4#1)(2008-5#1)(2009-2#1)(2012-12#2)
ion measurements##2##2##(2008-10#2)
ion mobility spectra of##3##4##(2008-10#3)
ion mobility spectrometer##7##3##(2008-10#7)
ion mobility spectrometry (IMS) was##2##5##(2008-10#1)(2010-9#1)
ion mobility spectrometry (IMS)##8##4##(2008-10#7)(2010-9#1)
ion mobility spectrometry##23##3##(2008-10#22)(2010-9#1)
ion mobility##38##2##(2008-10#36)(2010-8#1)(2010-9#1)
ion mode##5##2##(2008-10#3)(2011-3#2)
ion monitoring (SIM)##7##3##(2008-10#7)
ion monitoring mode##9##3##(2008-10#8)(2008-11#1)
ion monitoring##22##2##(2008-10#21)(2008-11#1)
ion motion process##2##3##(2008-10#2)
ion motion##3##2##(2008-10#3)
ion of##2##2##(2007-12#1)(2008-10#1)
ion on a##2##3##(2008-10#2)
ion on the##4##3##(1990-5#1)(1992-3#1)(2008-10#2)
ion on##8##2##(1990-5#1)(1992-3#1)(2008-10#4)(2008-5#1)(2012-7#1)
ion or##2##2##(2008-10#1)(2008-3#1)
ion over a wide concentration range##3##6##(2008-10#3)
ion over a wide variety of other##2##7##(2008-10#2)
ion over a wide variety of##4##6##(2008-10#4)
ion over a wide##8##4##(2008-10#8)
ion over a##9##3##(2008-10#9)
ion over alkali##4##3##(2008-10#4)
ion over other##2##3##(2008-10#2)
ion over the concentration range of##2##6##(2008-10#2)
ion over the concentration range##3##5##(2008-10#3)
ion over wide concentration##2##4##(2008-10#2)
ion over##21##2##(2008-10#21)
ion pair as an electroactive material##2##6##(2008-10#2)
ion pair as an##3##4##(2008-10#3)
ion pair formation##3##3##(2008-10#2)(2008-5#1)
ion pair formed##2##3##(2008-10#2)
ion pair in##2##3##(2008-10#2)
ion pair of##5##3##(2008-10#5)
ion pair with##2##3##(2008-10#2)
ion pair##25##2##(1995-6#1)(2008-10#22)(2008-5#2)
ion pairing reversed phase and cation exchange##2##7##(2008-10#2)
ion pairing##8##2##(1993-11#1)(2008-10#3)(2008-11#1)(2008-5#3)
ion pairs with##2##3##(2008-10#2)
ion pairs##9##2##(2008-10#8)(2008-2#1)
ion peaks##2##2##(1990-12#1)(2008-10#1)
ion per##2##2##(2008-10#2)
ion permeability of##3##3##(1992-6#1)(2008-10#1)(2008-8#1)
ion permeability##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
ion present##2##2##(1997-2#1)(2008-10#1)
ion release##4##2##(2008-5#2)(2010-3#2)
ion released by##2##3##(2008-10#2)
ion selective PVC membrane electrode##2##5##(2008-10#2)
ion selective PVC membrane##3##4##(2008-10#3)
ion selective electrode based on##3##5##(2008-10#3)
ion selective electrode##16##3##(2008-10#15)(2008-5#1)
ion selective electrodes##13##3##(2008-10#12)(2008-6#1)
ion selective##37##2##(2008-10#35)(2008-5#1)(2008-6#1)
ion selectivity and thermodynamic properties##2##5##(1991-5#2)
ion selectivity and##4##3##(1991-5#2)(1994-6#1)(2008-10#1)
ion selectivity##9##2##(1991-5#2)(1994-6#1)(1995-5#1)(2007-8#1)(2008-10#4)
ion sensing##3##2##(2008-10#3)
ion sensitive##3##2##(2008-10#3)
ion sensor based on##2##4##(2008-10#2)
ion sensor##3##2##(2008-10#3)
ion sensors##3##2##(2008-10#3)
ion solution##5##2##(2008-10#5)
ion sorption##5##2##(2008-10#5)
ion source##4##2##(2007-11#1)(2008-3#1)(2009-2#1)(2011-3#1)
ion species##3##2##(1990-11#1)(2008-10#2)
ion spray##3##2##(1992-12#1)(2008-10#2)
ion such as##2##3##(2008-10#2)
ion to the##3##3##(2008-10#3)
ion to##11##2##(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#8)
ion transfer##2##2##(2008-10#2)
ion transport in the##3##4##(2008-1#1)(2008-12#2)
ion transport in##4##3##(2008-1#2)(2008-12#2)
ion transport##13##2##(1991-8#1)(1992-6#2)(1997-1#2)(1997-6#1)(2008-1#3)(2008-10#1)(2008-12#2)(2010-7#1)
ion trap mass spectrometer##3##4##(2008-10#3)
ion trap mass spectrometry##4##4##(2008-10#1)(2008-8#2)(2010-11#1)
ion trap mass##8##3##(2008-10#5)(2008-8#2)(2010-11#1)
ion trap##14##2##(2008-10#8)(2008-11#1)(2008-8#2)(2010-11#1)(2010-7#2)
ion traps##2##2##(2010-4#1)(2010-7#1)
ion using a##2##3##(2008-10#2)
ion using##5##2##(2008-10#5)
ion was found to be##3##5##(2008-10#3)
ion was##16##2##(1995-2#1)(2008-10#13)(2008-6#1)(2013-1#1)
ion were##4##2##(2008-10#4)
ion with a##4##3##(2008-10#4)
ion with##12##2##(1996-2#1)(2008-10#11)
ion##1282##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#2)(1990-8#7)(1991-2#1)(1991-3#1)(1991-5#4)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#8)(1992-9#3)(1993-11#3)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#6)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#10)(1994-9#4)(1995-11#3)(1995-12#2)(1995-2#5)(1995-5#4)(1995-6#11)(1995-8#4)(1996-2#5)(1996-5#1)(1996-7#2)(1997-1#3)(1997-2#9)(1997-4#5)(1997-6#2)(1997-7#6)(2007-11#3)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#876)(2008-11#12)(2008-12#2)(2008-2#13)(2008-3#25)(2008-4#13)(2008-5#17)(2008-6#11)(2008-7#14)(2008-8#32)(2008-9#4)(2009-10#2)(2009-11#6)(2009-12#7)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#4)(2012-12#13)(2012-2#1)(2012-3#4)(2012-7#2)(2013-1#16)(2013-7#1)(2013-8#4)
ion)##4##1##(1990-8#1)(2008-10#3)
ion-assisted deposition##2##2##(2008-2#1)(2008-3#1)
ion-assisted electron-beam evaporation##2##3##(2008-2#2)
ion-assisted##8##1##(2008-2#3)(2008-3#5)
ion-associate of##2##2##(2008-10#2)
ion-associate##5##1##(2008-10#5)
ion-associated complexes##2##2##(2008-10#2)
ion-association complex##4##2##(2008-10#4)
ion-association complexes##2##2##(2008-10#2)
ion-association##8##1##(2008-10#8)
ion-beam etching##4##2##(2007-11#4)
ion-beam##11##1##(2007-11#4)(2008-3#7)
ion-beam-deposited##7##1##(2008-2#4)(2008-3#3)
ion-channel sensor based on self-assembled monolayer of thioctic acid##2##9##(2008-10#2)
ion-channel##6##1##(2008-10#3)(2010-8#1)(2012-2#1)(2013-1#1)
ion-chromatographic##3##1##(2008-10#3)
ion-chromatography with##2##2##(2008-10#2)
ion-chromatography##5##1##(2008-10#5)
ion-conducting##2##1##(1994-2#1)(2013-1#1)
ion-cycle##3##1##(2008-8#3)
ion-etched plane laminar holographic grating##2##5##(2008-3#2)
ion-etched##3##1##(2008-3#3)
ion-etching##2##1##(2008-3#2)
ion-exchange HPLC method##2##3##(1997-2#1)(2008-10#1)
ion-exchange HPLC##3##2##(1997-2#2)(2008-10#1)
ion-exchange adsorption##2##2##(2008-10#1)(2008-7#1)
ion-exchange and potentiometric selectivity##2##4##(2008-10#2)
ion-exchange and##5##2##(1993-8#1)(2008-10#3)(2013-1#1)
ion-exchange chromatographic##2##2##(1990-8#1)(1996-12#1)
ion-exchange chromatography and##5##3##(1990-12#1)(1990-5#1)(1993-8#1)(1997-1#1)(1997-2#1)
ion-exchange chromatography on##2##3##(1990-8#1)(1992-8#1)
ion-exchange chromatography##17##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-6#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)
ion-exchange column##2##2##(1990-5#1)(2008-10#1)
ion-exchange membranes##2##2##(2008-7#2)
ion-exchange or##3##2##(2008-10#2)(2008-6#1)
ion-exchange reaction##2##2##(2008-10#1)(2009-11#1)
ion-exchange resin##4##2##(2008-10#2)(2008-6#2)
ion-exchange resins modified with##2##4##(2008-10#2)
ion-exchange resins##4##2##(2008-10#3)(2008-6#1)
ion-exchange##70##1##(1990-12#1)(1990-5#2)(1990-8#3)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-8#2)(1994-5#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-2#6)(2008-10#31)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#4)(2008-7#3)(2008-8#2)(2009-11#1)(2013-1#3)
ion-exchanged channel##2##2##(2008-2#2)
ion-exchanged waveguides##3##2##(2008-2#2)(2008-3#1)
ion-exchanged##7##1##(2008-2#5)(2008-3#2)
ion-exchanger##11##1##(2008-10#11)
ion-exclusion##6##1##(2008-10#6)
ion-implanted##5##1##(2007-11#1)(2008-3#4)
ion-imprinted polymer##2##2##(2008-10#2)
ion-imprinted##3##1##(2008-10#3)
ion-interaction##2##1##(2008-10#2)
ion-molecule##2##1##(2008-10#2)
ion-pair HPLC##3##2##(2008-10#3)
ion-pair chromatography##4##2##(1995-6#1)(1996-5#1)(2008-10#2)
ion-pair complex as selective##2##4##(2008-10#2)
ion-pair complex reaction##2##3##(2008-10#2)
ion-pair complex##8##2##(2008-10#8)
ion-pair extraction##7##2##(2008-10#7)
ion-pair formation between##2##3##(2008-10#2)
ion-pair formation##10##2##(2008-10#10)
ion-pair formed##3##2##(2008-10#3)
ion-pair high-performance liquid chromatography##2##4##(2008-10#2)
ion-pair liquid chromatography##3##3##(2008-10#3)
ion-pair liquid##5##2##(2008-10#5)
ion-pair of##2##2##(2008-10#2)
ion-pair reversed phase chromatographic system##2##5##(2008-10#2)
ion-pair reversed phase chromatography##3##4##(2008-10#3)
ion-pair reversed phase high performance liquid chromatography##2##7##(2008-10#2)
ion-pair reversed phase high performance liquid##3##6##(2008-10#3)
ion-pair reversed phase##8##3##(2008-10#8)
ion-pair reversed-phase##4##2##(2008-10#4)
ion-pair##72##1##(1995-6#1)(1996-5#1)(2008-10#70)
ion-paired##2##1##(2008-10#1)(2010-3#1)
ion-pairing agent##2##2##(1994-9#1)(2008-10#1)
ion-pairing reagent##5##2##(2008-10#4)(2010-3#1)
ion-pairing reversed phase##2##3##(2008-10#1)(2010-11#1)
ion-pairing##15##1##(1994-9#1)(2008-10#11)(2008-11#1)(2010-11#1)(2010-3#1)
ion-pairs with the##2##3##(2008-10#2)
ion-pairs##6##1##(2008-10#6)
ion-selective PVC membrane electrode based on##2##6##(2008-10#2)
ion-selective PVC membrane sensor based on##3##6##(2008-10#3)
ion-selective PVC membrane##6##3##(2008-10#6)
ion-selective electrode (ISE) based on##2##5##(2008-10#2)
ion-selective electrode (ISE) can be calibrated in##2##7##(2008-10#2)
ion-selective electrode (ISE)##12##3##(2008-10#12)
ion-selective electrode based on##5##4##(2008-10#5)
ion-selective electrode detector##5##3##(2008-10#5)
ion-selective electrode for the determination of##3##6##(2008-10#3)
ion-selective electrode for##5##3##(2008-10#5)
ion-selective electrode has been##2##4##(2008-10#2)
ion-selective electrode in##2##3##(2008-10#2)
ion-selective electrode##57##2##(2008-10#57)
ion-selective electrodes (ISEs) can be##2##5##(2008-10#2)
ion-selective electrodes (ISEs) is##3##4##(2008-10#3)
ion-selective electrodes (ISEs)##9##3##(2008-10#8)(2010-5#1)
ion-selective electrodes based on##4##4##(2008-10#4)
ion-selective electrodes for##2##3##(2008-10#2)
ion-selective electrodes in##2##3##(2008-10#2)
ion-selective electrodes were##2##3##(2008-10#2)
ion-selective electrodes##36##2##(2008-10#34)(2010-5#2)
ion-selective membrane electrodes based on##2##5##(2008-10#2)
ion-selective membrane electrodes##3##3##(2008-10#3)
ion-selective membrane##5##2##(2008-10#5)
ion-selective piezoelectric##2##2##(2008-10#2)
ion-selective poly(vinyl chloride)##2##3##(2008-10#2)
ion-selective polymeric membrane electrode##2##4##(2008-10#2)
ion-selective polymeric membrane sensor based on##2##6##(2008-10#2)
ion-selective polymeric membrane##4##3##(2008-10#4)
ion-selective##123##1##(2007-8#1)(2008-10#120)(2010-5#2)
ion-sensing capillaries are##2##3##(2007-8#2)
ion-sensing##3##1##(2007-8#2)(2008-10#1)
ion-sensitive field-effect##2##2##(1995-8#1)(2008-10#1)
ion-sensitive membrane##2##2##(2008-10#2)
ion-sensitive##5##1##(1995-8#1)(2008-10#4)
ion-spray mass spectrometry##4##3##(1994-5#3)(2008-10#1)
ion-transporting filaments##2##2##(2008-7#2)
ion-transporting##4##1##(2008-7#4)
ionic additive##2##2##(2008-10#2)
ionic and##4##2##(1997-7#1)(2008-5#1)(2008-7#1)(2013-1#1)
ionic complexes of##2##3##(1995-5#2)
ionic composition and##2##3##(1990-2#1)(1995-5#1)
ionic concentration##3##2##(1996-12#1)(2008-10#2)
ionic conditions##2##2##(1994-5#1)(2008-6#1)
ionic conduction##5##2##(2008-10#3)(2010-7#2)
ionic content##2##2##(2008-10#1)(2013-1#1)
ionic currents##7##2##(1995-12#2)(2008-11#4)(2013-1#1)
ionic dipolar interactions##2##3##(2010-4#2)
ionic dyes##2##2##(2008-10#2)
ionic dyskinesia##2##2##(2008-7#2)
ionic environment##2##2##(2008-9#1)(2010-4#1)
ionic forms##2##2##(1993-11#1)(2008-10#1)
ionic homeostasis##2##2##(1995-12#1)(2008-4#1)
ionic interaction##3##2##(1991-5#1)(1992-6#1)(2012-3#1)
ionic interactions between##3##3##(1995-5#2)(2007-11#1)
ionic interactions##6##2##(1990-7#1)(1992-3#1)(1995-5#2)(1997-4#1)(2007-11#1)
ionic liquid as##2##3##(2008-10#1)(2013-1#1)
ionic liquid##14##2##(2008-10#11)(2011-1#1)(2013-1#2)
ionic liquids (ILs)##3##3##(2008-10#2)(2010-7#1)
ionic liquids as##3##3##(2008-10#3)
ionic liquids##13##2##(1995-3#1)(2008-10#6)(2010-7#1)(2011-1#2)(2012-1#3)
ionic media##3##2##(2008-10#3)
ionic medium of##2##3##(2008-10#2)
ionic medium##9##2##(2008-10#9)
ionic radii##3##2##(2008-10#3)
ionic radius##2##2##(1995-5#1)(2008-10#1)
ionic release##2##2##(2012-2#2)
ionic species of##2##3##(2008-10#2)
ionic species##6##2##(2007-12#1)(2008-10#5)
ionic strength (1##2##3##(1995-2#1)(2008-10#1)
ionic strength 0##2##3##(2008-10#2)
ionic strength adjustment buffer##2##4##(2008-10#2)
ionic strength and pH of##2##5##(2008-10#2)
ionic strength and pH on their chromatographic behavior was investigated##2##10##(2008-10#2)
ionic strength and pH##5##4##(1990-12#1)(2008-10#4)
ionic strength and##21##3##(1990-12#1)(1990-2#1)(1993-3#1)(1997-2#1)(2008-10#13)(2008-4#1)(2009-5#1)(2012-1#1)(2013-1#1)
ionic strength buffer##2##3##(1990-5#1)(1992-8#1)
ionic strength buffers##2##3##(1992-8#1)(1994-12#1)
ionic strength in##2##3##(1997-6#1)(2008-10#1)
ionic strength of 0##7##4##(1995-2#1)(1997-7#1)(2008-10#4)(2008-5#1)
ionic strength of the solution##2##5##(1990-5#1)(2008-10#1)
ionic strength of the##8##4##(1990-5#1)(1994-3#1)(1997-2#1)(2008-10#4)(2008-5#1)
ionic strength of##19##3##(1990-12#1)(1990-5#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-5#2)
ionic strength on the##2##4##(2008-10#2)
ionic strength on##3##3##(2008-10#3)
ionic strength or##2##3##(1994-9#1)(2008-10#1)
ionic strength was##4##3##(1997-2#2)(2008-10#1)(2008-7#1)
ionic strength were##3##3##(2008-10#3)
ionic strength##148##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#3)(1990-7#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-8#3)(1993-11#3)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-9#1)(1995-2#6)(1995-5#1)(1997-2#5)(1997-6#1)(1997-7#1)(2008-10#86)(2008-4#3)(2008-5#3)(2008-7#2)(2009-5#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#3)
ionic strength) and##2##3##(2008-10#2)
ionic strength)##5##2##(1992-3#1)(1992-8#1)(2008-10#2)(2010-4#1)
ionic strengths in NaClO(4)##2##4##(2008-10#2)
ionic strengths in##3##3##(2008-10#3)
ionic strengths of##2##3##(1995-2#1)(2008-10#1)
ionic strengths##19##2##(1992-5#1)(1994-5#1)(1995-2#4)(1997-7#2)(2008-10#10)(2008-7#1)
ionic##339##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#4)(1990-7#2)(1990-8#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-11#5)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#7)(1994-9#1)(1995-12#3)(1995-2#11)(1995-3#2)(1995-5#7)(1996-12#1)(1996-2#1)(1997-2#6)(1997-4#1)(1997-6#1)(1997-7#4)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#176)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#8)(2008-9#2)(2009-12#1)(2009-5#3)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#7)(2011-1#3)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#10)
ionisation constant of ketoprofen##2##4##(2008-10#2)
ionisation constant of##3##3##(2008-10#3)
ionisation mass spectrometry##4##3##(1995-5#1)(2008-10#3)
ionisation of a##2##3##(2008-10#2)
ionisation of##5##2##(2008-10#5)
ionisation##21##1##(1995-5#1)(2008-10#19)(2008-11#1)
ionising radiation##2##2##(2010-4#1)(2012-2#1)
ionizable compounds##3##2##(1990-8#1)(1994-9#1)(2008-10#1)
ionizable group##2##2##(1993-8#1)(1997-2#1)
ionizable##13##1##(1990-5#1)(1990-8#1)(1992-6#2)(1993-8#1)(1994-9#1)(1997-2#2)(2008-10#3)(2008-5#1)(2013-7#1)
ionization (ESI)##3##2##(2008-10#3)
ionization and##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
ionization by##2##2##(2007-12#1)(2011-2#1)
ionization constants were##2##3##(2008-10#2)
ionization constants##6##2##(2008-10#5)(2008-9#1)
ionization detection##4##2##(2008-10#2)(2008-5#2)
ionization detector (FID)##3##3##(2008-10#3)
ionization detector##9##2##(2008-10#7)(2008-11#1)(2012-1#1)
ionization ion-trap mass spectrometry##2##4##(2011-1#2)
ionization mass spectrometry##19##3##(1990-12#2)(1992-3#1)(1992-7#1)(1995-2#1)(1997-4#1)(2008-10#11)(2010-6#1)(2011-2#1)
ionization mass##22##2##(1990-12#2)(1992-3#1)(1992-7#1)(1995-2#1)(1997-4#1)(2008-10#14)(2010-6#1)(2011-2#1)
ionization methods##2##2##(2010-7#2)
ionization of##11##2##(1992-11#1)(1993-11#2)(1994-5#1)(1995-5#1)(2008-10#5)(2008-3#1)
ionization on##2##2##(2007-12#1)(2011-1#1)
ionization process##2##2##(2008-10#1)(2008-3#1)
ionization source##7##2##(2008-10#6)(2011-3#1)
ionization spectroscopy##3##2##(2008-3#3)
ionization tandem mass spectrometry##6##4##(2008-10#3)(2011-1#1)(2011-2#2)
ionization tandem mass##7##3##(2008-10#3)(2011-1#2)(2011-2#2)
ionization tandem##8##2##(2008-10#3)(2008-9#1)(2011-1#2)(2011-2#2)
ionization technique##2##2##(2008-10#1)(2008-11#1)
ionization##154##1##(1990-12#2)(1990-8#3)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-12#10)(2008-1#2)(2008-10#81)(2008-11#2)(2008-3#12)(2008-5#2)(2008-9#2)(2009-6#1)(2010-11#3)(2010-6#1)(2010-7#5)(2011-1#8)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
ionization-mass spectrometry##5##2##(2008-10#2)(2008-5#1)(2011-1#2)
ionization-mass##6##1##(2008-10#2)(2008-5#1)(2011-1#2)(2012-3#1)
ionized by a##2##3##(2007-11#1)(2008-3#1)
ionized by##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
ionized calcium##5##2##(1990-2#2)(1990-8#1)(2008-4#1)(2008-9#1)
ionized filaments##2##2##(2007-11#2)
ionized##26##1##(1990-2#2)(1990-8#1)(1991-5#1)(1996-5#1)(2007-11#4)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2011-1#2)(2013-1#1)
ionizes##2##1##(2008-3#1)(2008-7#1)
ionizing radiation and##4##3##(1990-7#1)(2008-11#1)(2008-7#2)
ionizing radiation in##2##3##(1995-6#1)(1997-8#1)
ionizing radiation is##3##3##(1997-4#1)(2008-7#2)
ionizing radiation or##3##3##(1995-8#1)(2008-7#1)(2008-9#1)
ionizing radiation##56##2##(1990-7#2)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#3)(1995-8#2)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-11#3)(2008-2#1)(2008-7#22)(2008-8#1)(2008-9#4)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#5)
ionizing radiation-induced##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
ionizing radiation?##2##2##(2008-7#2)
ionizing radiations##3##2##(2008-7#2)(2013-1#1)
ionizing##72##1##(1990-7#2)(1994-12#1)(1994-8#1)(1995-12#3)(1995-5#2)(1995-6#3)(1995-8#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2008-11#4)(2008-2#1)(2008-7#27)(2008-8#1)(2008-9#4)(2009-10#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#7)
iono-neuronal dynamics##4##2##(2009-5#4)
iono-neuronal##7##1##(2009-5#7)
ionome##2##1##(2009-8#2)
ionomer cements##3##2##(2008-10#1)(2012-2#2)
ionomer liner##2##2##(1990-2#2)
ionomer##16##1##(1990-2#3)(2008-10#3)(2008-12#2)(2009-8#1)(2010-3#1)(2010-4#2)(2012-2#2)(2013-1#2)
ionomycin##21##1##(1990-2#1)(1990-8#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-8#4)(1997-1#1)(1997-2#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-12#2)
ionomycin-induced##2##1##(1992-6#2)
ionophor##2##1##(1993-11#2)
ionophore A23187##6##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(2008-10#1)(2008-8#1)
ionophore and##6##2##(1994-3#1)(2008-10#5)
ionophore for##9##2##(2008-10#9)
ionophore in##7##2##(2008-10#7)
ionophore showed##2##2##(2008-10#2)
ionophore to##2##2##(2008-10#2)
ionophore was##8##2##(2008-10#8)
ionophore##109##1##(1990-12#1)(1990-2#7)(1990-5#1)(1991-5#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#2)(1995-11#4)(1995-12#1)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#75)(2008-11#1)(2008-8#2)(2008-9#1)(2009-12#1)(2012-12#1)
ionophore)##2##1##(2008-10#2)
ionophore-based ISEs##2##2##(2008-10#2)
ionophore-based##4##1##(2008-10#4)
ionophore-immobilized##2##1##(2008-10#2)
ionophores and##3##2##(2008-10#3)
ionophores are##2##2##(2008-10#2)
ionophores containing dithiocarbamoyl##2##3##(2008-10#2)
ionophores containing##4##2##(2008-10#4)
ionophores have been##2##3##(2008-10#2)
ionophores in##6##2##(2008-10#6)
ionophores to##2##2##(2008-10#2)
ionophores were##3##2##(2008-10#3)
ionophores##44##1##(1990-12#1)(1992-8#1)(1995-2#1)(1996-4#1)(2008-10#40)
ionotropic and metabotropic receptors##2##4##(2008-7#2)
ionotropic and metabotropic##4##3##(2008-7#4)
ionotropic glutamate receptors##3##3##(1995-11#3)
ionotropic glutamate##4##2##(1995-11#3)(1996-5#1)
ionotropic receptors##2##2##(2008-7#2)
ionotropic support##2##2##(2007-8#1)(2013-1#1)
ionotropic##15##1##(1995-11#3)(1996-5#1)(2007-8#1)(2008-4#2)(2008-7#7)(2013-1#1)
ions (detection at##2##3##(2008-10#2)
ions (e##4##2##(2008-10#3)(2008-9#1)
ions Cu(II)##3##2##(2008-10#3)
ions across##2##2##(2008-10#1)(2012-2#1)
ions also##2##2##(1992-11#1)(2009-8#1)
ions and a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
ions and common##2##3##(2008-10#2)
ions and could be used##5##5##(2008-10#5)
ions and could##6##3##(1995-12#1)(2008-10#5)
ions and in##2##3##(1995-6#1)(2008-10#1)
ions and organic compounds##2##4##(2008-10#2)
ions and other##3##3##(2008-10#3)
ions and the##6##3##(1997-7#2)(2008-10#4)
ions and was##2##3##(1995-2#1)(2008-10#1)
ions and##81##2##(1990-12#2)(1990-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#2)(2008-10#59)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#2)(2010-12#1)(2010-5#1)(2013-1#1)
ions are adsorbed##3##3##(2008-10#3)
ions are described##3##3##(2008-10#3)
ions are determined##2##3##(2008-10#2)
ions are reported##6##3##(2008-10#6)
ions are then stripped from the disk##2##7##(2008-10#2)
ions are tolerated##2##3##(2008-10#2)
ions are##59##2##(1991-8#1)(1992-11#1)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-7#3)(2008-10#45)(2008-4#1)(2008-7#2)
ions arising from##2##3##(1991-11#1)(2008-10#1)
ions as well as##2##4##(2007-12#1)(2008-10#1)
ions as##11##2##(2007-12#1)(2008-10#7)(2008-4#1)(2012-12#1)(2012-2#1)
ions at pH 10##2##4##(2008-10#2)
ions at pH##4##3##(2008-10#4)
ions at the##2##3##(2008-10#1)(2008-8#1)
ions at##15##2##(2007-12#1)(2008-10#12)(2008-8#2)
ions based on##5##3##(2008-10#5)
ions being##2##2##(1997-7#1)(2008-9#1)
ions bound to##2##3##(1990-11#1)(2008-10#1)
ions bound##3##2##(1990-11#1)(1991-8#1)(2008-10#1)
ions by atomic absorption##2##4##(2008-10#2)
ions by flow cytometry##2##4##(2008-4#1)(2008-9#1)
ions by the##2##3##(2008-10#2)
ions by##31##2##(2008-10#27)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
ions can be quantitatively##3##4##(2008-10#3)
ions can be##11##3##(2008-10#9)(2008-3#1)(2012-12#1)
ions commonly##4##2##(2008-10#4)
ions could be##5##3##(2008-10#4)(2008-4#1)
ions could##7##2##(1994-6#1)(2008-10#5)(2008-4#1)
ions detected##2##2##(2008-10#2)
ions determination##4##2##(2008-10#4)
ions did not interfere with the##2##6##(2008-10#2)
ions did not##4##3##(2008-10#3)(2008-11#1)
ions do not interfere with the determination##2##7##(2008-10#2)
ions do not##6##3##(2008-10#5)(2009-10#1)
ions except##2##2##(2008-10#2)
ions extraction and the EN 12341 standard##2##7##(2008-10#2)
ions extraction and##3##3##(2008-10#3)
ions extraction##4##2##(2008-10#4)
ions for##7##2##(2008-1#1)(2008-10#6)
ions formed##4##2##(2008-10#4)
ions from aqueous solutions##5##4##(2008-10#5)
ions from aqueous##7##3##(2008-10#7)
ions from solution samples##3##4##(2008-10#3)
ions from synthetic##2##3##(2008-10#2)
ions from the##6##3##(1990-12#1)(1994-6#1)(1995-11#1)(2008-10#3)
ions from water##4##3##(2008-10#4)
ions from##39##2##(1990-12#1)(1994-6#1)(1995-11#1)(2008-10#35)(2010-3#1)
ions has been investigated in##2##5##(2008-10#2)
ions has been investigated##4##4##(2008-10#4)
ions has been##8##3##(2008-10#8)
ions has##10##2##(1997-4#1)(2008-10#9)
ions have been investigated##4##4##(2008-10#4)
ions have been##11##3##(2008-10#11)
ions have##18##2##(1996-7#2)(2008-10#15)(2010-6#1)
ions in a##5##3##(2008-10#5)
ions in airborne##3##3##(2008-10#3)
ions in aqueous solution##5##4##(2008-10#4)(2010-2#1)
ions in aqueous##8##3##(2008-10#7)(2010-2#1)
ions in concentrations##2##3##(2008-10#2)
ions in its##2##3##(1995-8#1)(2008-10#1)
ions in lithium niobate##2##4##(2008-2#2)
ions in natural waters##2##4##(2008-10#2)
ions in natural##4##3##(2008-10#4)
ions in physiological##2##3##(2008-10#1)(2009-6#1)
ions in real##3##3##(2008-10#3)
ions in river and##3##4##(2008-10#3)
ions in synthetic samples##2##4##(2008-10#2)
ions in the aqueous##2##4##(2008-10#2)
ions in the concentration range##4##5##(2008-10#4)
ions in the presence of##5##5##(1994-12#1)(2008-10#4)
ions in the presence##6##4##(1994-12#1)(2008-10#5)
ions in the solution##3##4##(2008-10#2)(2008-6#1)
ions in the##46##3##(1993-8#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#35)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
ions in water samples##3##4##(2008-10#3)
ions in water were##2##4##(2008-10#2)
ions in water##7##3##(2008-10#7)
ions in##145##2##(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#112)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
ions including##2##2##(2008-10#1)(2010-11#1)
ions increased##3##2##(1991-5#1)(2008-10#1)(2013-7#1)
ions into the##2##3##(2007-11#1)(2009-8#1)
ions into##3##2##(2007-11#1)(2008-11#1)(2009-8#1)
ions investigated here##2##3##(1991-8#1)(1996-7#1)
ions investigated##3##2##(1991-8#1)(1996-7#1)(2008-10#1)
ions is described##2##3##(2007-11#1)(2008-10#1)
ions is##20##2##(1996-2#1)(1997-4#1)(2007-11#2)(2008-10#13)(2008-3#2)(2010-7#1)
ions may##2##2##(2008-10#2)
ions measured##2##2##(2008-10#1)(2008-3#1)
ions of the same##2##4##(1991-8#1)(2008-7#1)
ions of the##6##3##(1990-12#1)(1991-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
ions of##18##2##(1990-12#1)(1991-8#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-7#1)
ions on a##3##3##(2008-10#3)
ions on the determination of##13##5##(2008-10#13)
ions on the extraction##2##4##(2008-10#2)
ions on the sorption##2##4##(2008-10#2)
ions on the##43##3##(1994-5#1)(2007-12#1)(2008-10#40)(2008-2#1)
ions on##59##2##(1991-9#1)(1994-5#1)(2007-12#1)(2008-10#53)(2008-2#1)(2010-11#2)
ions onto a column##2##4##(2008-10#2)
ions onto a##3##3##(2008-10#3)
ions onto the##3##3##(2008-10#3)
ions onto##12##2##(2008-10#12)
ions or##7##2##(1990-12#1)(2008-10#5)(2009-12#1)
ions over a large number of##3##6##(2008-10#3)
ions over a wide concentration range##6##6##(2008-10#6)
ions over a##10##3##(2008-10#10)
ions over the concentration range##2##5##(2008-10#2)
ions over##15##2##(2008-10#15)
ions produced in##2##3##(2008-10#2)
ions released##2##2##(1997-8#1)(2008-10#1)
ions should##2##2##(2008-10#2)
ions showed that##3##3##(2008-10#2)(2013-8#1)
ions studied##5##2##(2008-10#5)
ions such as Cu(II)##3##4##(2008-10#3)
ions such as##16##3##(1995-3#1)(2008-10#14)(2010-7#1)
ions than those##2##3##(2008-1#1)(2008-10#1)
ions than##3##2##(2008-1#1)(2008-10#2)
ions that do not##2##4##(2008-10#2)
ions that##5##2##(1997-4#1)(2008-10#4)
ions through a bulk liquid membrane##2##6##(2008-10#2)
ions through a##4##3##(2008-10#4)
ions through##8##2##(1997-7#1)(2008-10#6)(2011-2#1)
ions to form##2##3##(1990-2#1)(2008-10#1)
ions to the##3##3##(1994-11#1)(2008-1#1)(2008-10#1)
ions to##10##2##(1990-2#1)(1994-11#2)(2008-1#1)(2008-10#5)(2009-11#1)
ions under##2##2##(2008-10#1)(2008-7#1)
ions using a##2##3##(2008-10#2)
ions using##8##2##(2008-10#8)
ions via##2##2##(2008-10#2)
ions was also carried out##2##5##(2008-10#2)
ions was also##4##3##(2008-10#4)
ions was developed##2##3##(2008-10#2)
ions was investigated in##2##4##(2008-10#1)(2008-3#1)
ions was investigated##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
ions was prepared by using##2##5##(2008-10#2)
ions was studied##5##3##(2008-10#5)
ions was##39##2##(2008-10#36)(2008-2#1)(2008-3#1)(2011-2#1)
ions were adsorbed##2##3##(2008-10#2)
ions were also investigated##3##4##(2008-10#3)
ions were also##5##3##(2008-10#4)(2009-8#1)
ions were bound to##2##4##(1990-2#1)(2008-10#1)
ions were described##2##3##(2008-10#2)
ions were desorbed##2##3##(2008-10#2)
ions were determined by##3##4##(2008-10#3)
ions were determined##6##3##(2008-10#6)
ions were evaluated##2##3##(2008-10#2)
ions were exchanged for the single-charged##2##6##(2008-10#2)
ions were investigated##4##3##(2008-10#4)
ions were measured##2##3##(1995-2#1)(2008-10#1)
ions were observed##2##3##(1994-3#1)(2008-10#1)
ions were obtained##3##3##(1994-3#1)(2008-10#2)
ions were quantitatively retained on the##2##6##(2008-10#2)
ions were removed##2##3##(2008-10#2)
ions were sorbed in the minicolumn##2##6##(2008-10#2)
ions were studied##7##3##(2008-10#7)
ions were##82##2##(1990-2#1)(1994-3#2)(1995-2#1)(2008-10#70)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#3)(2012-12#1)
ions when##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
ions which##2##2##(2008-10#2)
ions with EDTA##3##3##(2008-10#3)
ions with a##4##3##(2008-10#4)
ions with respect to##2##4##(1996-7#1)(2008-10#1)
ions with the##4##3##(2008-10#4)
ions with##39##2##(1996-7#1)(2007-11#1)(2008-10#34)(2008-3#1)(2008-5#1)(2008-7#1)
ions##1331##1##(1990-11#3)(1990-12#5)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-11#1)(1991-5#1)(1991-8#6)(1991-9#3)(1992-11#3)(1992-3#3)(1992-4#1)(1992-9#4)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#5)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#5)(1995-8#3)(1996-2#2)(1996-5#1)(1996-7#7)(1997-2#2)(1997-4#5)(1997-6#1)(1997-7#12)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#14)(2008-1#5)(2008-10#1040)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#20)(2008-4#12)(2008-5#6)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#3)(2009-12#2)(2009-6#1)(2009-7#2)(2009-8#7)(2010-11#6)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#3)(2011-1#4)(2011-2#6)(2012-12#4)(2012-2#4)(2013-1#5)(2013-7#3)(2013-8#2)
ions)##2##1##(1991-8#1)(2008-10#1)
iontophoresis##5##1##(2008-5#2)(2009-12#1)(2011-2#2)
iontophoretic##3##1##(1995-5#2)(1997-7#1)
iontophoretically##2##1##(1994-2#1)(2008-4#1)
iowae##4##1##(2008-5#4)
ipomoeae##4##1##(2008-10#4)
iprodione was##2##2##(2008-10#2)
iprodione##14##1##(2008-10#14)
iprodione-tolerant##2##1##(2008-10#2)
ipsative method##3##2##(1992-3#3)
ipsi- and contralateral##2##3##(1993-3#1)(2007-12#1)
ipsilateral SHM##2##2##(2011-2#2)
ipsilateral and contralateral##4##3##(1992-8#2)(2007-12#1)(2008-7#1)
ipsilateral and##5##2##(1992-8#2)(1996-5#1)(2007-12#1)(2008-7#1)
ipsilateral areas##2##2##(2008-5#2)
ipsilateral breast##3##2##(1991-2#1)(1994-12#1)(2013-1#1)
ipsilateral fibular##2##2##(2008-6#2)
ipsilateral hippocampus##2##2##(1996-12#2)
ipsilateral recurrence##3##2##(1990-12#1)(1991-11#1)(2008-10#1)
ipsilateral to the lesion##6##4##(1993-3#1)(1996-2#1)(1996-5#2)(1997-3#1)(2008-7#1)
ipsilateral to the##10##3##(1990-9#1)(1992-10#1)(1993-3#1)(1996-2#1)(1996-5#3)(1997-3#1)(2008-7#2)
ipsilateral##91##1##(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#2)(1992-10#1)(1992-3#1)(1992-8#5)(1993-12#8)(1993-3#5)(1994-12#2)(1995-12#2)(1996-12#5)(1996-2#1)(1996-5#9)(1997-3#2)(2006-12#2)(2007-10#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
ipsiversive circling##5##2##(1993-3#5)
iralukast##2##1##(2008-5#2)
iran##26##1##(2007-10#1)(2008-10#1)(2011-2#1)(2012-2#9)(2013-1#14)
iraqi##2##1##(2007-7#1)(2011-2#1)
ire1a/ire1b##3##1##(2012-2#3)
iridescence##3##1##(2008-2#2)(2008-3#1)
iridescent##5##1##(2008-2#4)(2008-3#1)
iridium in##3##2##(2008-10#3)
iridium oxide##4##2##(2008-10#4)
iridium##24##1##(1991-8#1)(1996-2#1)(1997-5#2)(2008-10#20)
iridium(III)##2##1##(1996-2#1)(2008-10#1)
iridium-192##2##1##(1995-9#2)
iridoid glycosides##2##2##(2013-1#2)
iridophores are##3##2##(2008-5#3)
iridophores##7##1##(2008-5#7)
iridovirus##3##1##(2009-5#3)
irinotecan##8##1##(2008-5#2)(2008-8#5)(2009-5#1)
irinotecan-based chemotherapy##2##2##(2008-8#1)(2010-8#1)
iris and macular##2##3##(2011-2#2)
iris and##7##2##(1996-2#1)(1997-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
iris is##2##2##(1996-5#1)(2008-8#1)
iris phenotypes##2##2##(2008-8#2)
iris yellow spot virus (IYSV)##2##5##(2008-10#2)
iris yellow spot virus##3##4##(2008-10#3)
iris##28##1##(1990-11#1)(1991-3#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#2)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#3)(2011-2#4)
iron (Fe(III))##2##2##(2008-5#2)
iron (Fe)##3##2##(1995-3#1)(1996-2#1)(2008-10#1)
iron (II)##5##2##(2008-10#4)(2009-9#1)
iron (III) in natural waters##2##5##(2008-10#2)
iron (III)##9##2##(2008-10#8)(2013-8#1)
iron absorption##3##2##(1997-7#1)(2013-8#2)
iron accumulation##2##2##(1992-8#1)(2013-8#1)
iron acquisition##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
iron administration##2##2##(2008-1#1)(2013-8#1)
iron and aluminum##2##3##(2008-10#2)
iron and boron in soil extracts##2##6##(2008-10#2)
iron and chromium##4##3##(2008-10#4)
iron and copper were##2##4##(2008-10#2)
iron and copper##3##3##(2008-10#3)
iron and lead in lubricating oils##2##6##(2008-10#2)
iron and lead##3##3##(2008-10#3)
iron and manganese in##2##4##(2008-10#2)
iron and manganese##7##3##(1995-3#1)(2008-10#6)
iron and other##2##3##(1995-3#1)(2008-10#1)
iron and the##2##3##(1995-2#1)(1995-3#1)
iron and vanadium by H-point standard addition method##2##8##(2008-10#2)
iron and vanadium##5##3##(2008-10#5)
iron and zinc by##2##4##(2008-10#2)
iron and zinc##10##3##(1995-3#1)(2008-10#8)(2013-8#1)
iron and##73##2##(1992-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-2#1)(2008-10#53)(2008-3#1)(2008-8#1)(2011-2#4)(2012-2#2)(2013-7#1)(2013-8#2)
iron are discussed##2##3##(2008-10#2)
iron are##3##2##(1995-3#1)(2008-10#2)
iron as Fe(II) in##2##4##(2008-10#2)
iron as##5##2##(2008-10#5)
iron at the##2##3##(1990-12#1)(2008-10#1)
iron bioavailability##4##2##(2008-10#1)(2012-2#3)
iron by the##2##3##(1994-8#1)(2008-10#1)
iron by##10##2##(1994-8#1)(2008-10#9)
iron can##2##2##(2008-10#2)
iron center##2##2##(1997-7#1)(2012-12#1)
iron chalcogenide glass ion-selective electrode##2##5##(2008-10#2)
iron chalcogenide glass##3##3##(2008-10#3)
iron chalcogenide##5##2##(2008-10#5)
iron chelates##2##2##(2008-10#1)(2009-9#1)
iron chelating##3##2##(2009-10#1)(2009-6#1)(2010-5#1)
iron chelation##2##2##(2009-6#1)(2010-5#1)
iron chelator##8##2##(1990-11#1)(1990-12#1)(1991-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
iron chelators##3##2##(1991-9#1)(2008-11#1)(2013-8#1)
iron compounds##2##2##(2011-2#2)
iron concentration in##2##3##(1992-8#1)(1996-12#1)
iron concentration of##4##3##(1996-2#3)(2008-10#1)
iron concentration##9##2##(1992-8#1)(1996-12#1)(1996-2#3)(2008-10#3)(2011-2#1)
iron concentrations##2##2##(2008-10#2)
iron content in##3##3##(2008-10#2)(2012-2#1)
iron content##7##2##(1992-3#1)(2008-10#5)(2012-2#1)
iron could##3##2##(1996-2#2)(2008-1#1)
iron deficiency and##2##3##(2008-1#1)(2009-10#1)
iron deficiency##19##2##(1990-11#1)(1991-6#1)(1995-6#1)(1997-7#1)(2008-1#3)(2009-10#1)(2011-1#10)(2012-12#1)
iron deposition##2##2##(2013-1#1)(2013-8#1)
iron determination in##2##3##(2008-10#2)
iron determination##9##2##(2008-10#9)
iron dissolution##2##2##(2008-10#2)
iron enrichment in##3##3##(1996-5#3)
iron enrichment##6##2##(1996-5#6)
iron from##8##2##(2008-10#5)(2008-5#3)
iron garnet films##2##3##(2008-3#2)
iron has been##2##3##(2008-10#1)(2013-8#1)
iron homeostasis and##2##3##(2008-10#1)(2013-8#1)
iron homeostasis##6##2##(1990-5#1)(2008-10#1)(2010-12#2)(2013-8#2)
iron hydroxide phase##2##3##(2008-10#2)
iron hydroxide precipitates##2##3##(2008-10#2)
iron hydroxide##8##2##(2008-10#8)
iron hydroxides##2##2##(2008-10#2)
iron in beer##3##3##(2008-10#3)
iron in natural waters##2##4##(2008-10#2)
iron in natural##3##3##(2008-10#3)
iron in tap##3##3##(2008-10#3)
iron in the##12##3##(1993-2#1)(1996-5#2)(2008-10#7)(2013-1#1)(2013-8#1)
iron in water samples##4##4##(2008-10#4)
iron in##57##2##(1993-2#2)(1996-5#2)(1996-8#1)(1997-8#1)(2008-10#46)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
iron ion##3##2##(1993-8#1)(1995-2#2)
iron ions##6##2##(1993-8#4)(2008-10#2)
iron is##12##2##(1992-6#1)(1992-8#3)(2008-10#5)(2008-11#2)(2013-8#1)
iron levels##3##2##(2008-10#2)(2012-12#1)
iron limitation##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
iron matrix##2##2##(2008-10#2)
iron metabolism in##2##3##(1993-11#1)(2013-8#1)
iron metabolism##8##2##(1992-5#1)(1993-11#2)(2008-10#1)(2010-12#1)(2013-8#3)
iron on the##3##3##(1994-5#2)(2008-10#1)
iron on##4##2##(1994-5#2)(2008-10#2)
iron or manganese##2##3##(2008-10#2)
iron or##5##2##(1997-5#1)(2008-10#2)(2008-2#1)(2008-6#1)
iron overload and##2##3##(2008-10#1)(2012-2#1)
iron overload in the##2##4##(2013-8#2)
iron overload in##3##3##(2012-2#1)(2013-8#2)
iron overload##11##2##(1992-8#1)(1995-8#3)(2008-10#1)(2009-8#1)(2012-2#2)(2013-8#3)
iron oxide (SPIO)##2##3##(2009-6#1)(2013-1#1)
iron oxide nanoparticles##9##3##(2008-10#1)(2009-8#2)(2012-12#2)(2012-2#1)(2013-1#3)
iron oxide##20##2##(2008-10#5)(2008-11#1)(2009-6#1)(2009-8#2)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#5)
iron phosphide##3##2##(2008-11#3)
iron phthalocyanine##2##2##(2008-10#2)
iron production process##2##3##(2008-10#2)
iron production##3##2##(2008-10#3)
iron reduction##3##2##(1992-6#1)(2008-10#1)(2009-8#1)
iron replacement##2##2##(2011-2#1)(2012-2#1)
iron saccharate on the##2##4##(2007-7#1)(2008-1#1)
iron saccharate##9##2##(2007-7#2)(2008-1#7)
iron samples##3##2##(2008-10#2)(2008-11#1)
iron speciation##4##2##(2008-10#4)
iron species##2##2##(2008-10#2)
iron stores in##2##3##(2008-1#2)
iron stores##4##2##(2008-1#3)(2008-5#1)
iron supplementation in##4##3##(2007-11#1)(2007-7#1)(2008-1#2)
iron supplementation##6##2##(2007-11#1)(2007-7#1)(2008-1#4)
iron than hull-less soybean flour##2##5##(2012-2#2)
iron transfer##2##2##(1992-6#1)(2008-10#1)
iron transport##4##2##(1993-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
iron uptake by##2##3##(1995-11#1)(1996-2#1)
iron uptake system##3##3##(1996-8#1)(1997-7#1)(2011-2#1)
iron uptake##7##2##(1995-11#2)(1996-2#1)(1996-8#1)(1997-7#2)(2011-2#1)
iron was##7##2##(1992-8#2)(1996-5#1)(2007-7#1)(2008-10#2)(2013-8#1)
iron were##6##2##(2008-10#5)(2010-2#1)
iron##662##1##(1990-11#2)(1990-12#5)(1990-3#6)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#3)(1992-3#2)(1992-5#1)(1992-6#6)(1992-8#14)(1993-11#7)(1993-2#3)(1993-6#1)(1993-8#6)(1994-5#8)(1994-8#2)(1995-11#8)(1995-2#3)(1995-3#7)(1995-6#3)(1995-8#3)(1996-12#4)(1996-2#10)(1996-5#12)(1996-8#2)(1997-5#2)(1997-7#7)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#5)(2008-1#27)(2008-10#317)(2008-11#15)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-11#2)(2009-2#2)(2009-6#3)(2009-8#8)(2009-9#5)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#1)(2011-1#11)(2011-2#13)(2012-12#7)(2012-2#32)(2013-1#10)(2013-7#3)(2013-8#26)
iron(II) and##5##2##(2008-10#4)(2008-5#1)
iron(II) in##4##2##(2008-10#4)
iron(II) phthalocyanine##2##2##(2008-10#2)
iron(II) with##2##2##(2008-10#2)
iron(II)##37##1##(2008-10#35)(2008-5#1)(2012-12#1)
iron(II)/iron(III)##3##1##(2008-10#3)
iron(III) and##23##2##(2008-10#23)
iron(III) at the##2##3##(2008-10#2)
iron(III) by##3##2##(2008-10#3)
iron(III) in the##4##3##(2008-10#4)
iron(III) in##7##2##(2008-10#7)
iron(III) oxide##3##2##(2008-10#3)
iron(III) solution##2##2##(2008-10#2)
iron(III) using##2##2##(2008-10#2)
iron(III) was##3##2##(2008-10#3)
iron(III) were##2##2##(2008-10#2)
iron(III) with##2##2##(2008-10#2)
iron(III)##99##1##(1997-7#5)(2008-10#94)
iron) and##2##2##(2008-10#2)
iron)##5##1##(1995-11#1)(2008-10#4)
iron-containing##4##1##(1990-12#2)(1996-12#2)
iron-deficiency anaemia##4##2##(1994-6#2)(2009-10#2)
iron-deficiency##6##1##(1993-5#1)(1994-6#2)(1996-10#1)(2009-10#2)
iron-doped lithium niobate##2##3##(2007-12#2)
iron-doped lithium##3##2##(2007-12#3)
iron-enriched##2##1##(1996-5#1)(2013-8#1)
iron-poor##2##1##(1996-12#2)
iron-rich##3##1##(1996-12#1)(2008-10#2)
iron-sulfur protein##4##2##(1990-5#1)(1991-5#1)(1995-11#2)
iron-sulfur proteins##4##2##(1993-11#2)(1995-11#2)
iron-sulfur##12##1##(1990-5#1)(1991-5#1)(1993-11#4)(1995-11#4)(1995-2#1)(2008-11#1)
iron-sulphur cluster##3##2##(2008-7#3)
ironic process theory##2##3##(2007-6#1)(2009-11#1)
ironic remark##2##2##(2008-11#2)
ironic##6##1##(1994-9#1)(2007-6#1)(2008-11#3)(2009-11#1)
irony##3##1##(2008-11#1)(2009-5#2)
irradiance (K(d))##2##2##(2008-2#2)
irradiance and the##2##3##(2008-3#1)(2008-8#1)
irradiance and##12##2##(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
irradiance are##3##2##(2008-2#1)(2008-3#2)
irradiance at the##2##3##(2008-2#1)(2008-3#1)
irradiance for##2##2##(2008-3#2)
irradiance in the##3##3##(2008-2#2)(2008-3#1)
irradiance is##3##2##(2008-2#1)(2008-3#2)
irradiance measurements at a##2##4##(2008-2#1)(2008-3#1)
irradiance measurements in the##2##4##(2007-11#1)(2008-3#1)
irradiance measurements##13##2##(2007-11#1)(2008-2#7)(2008-3#5)
irradiance of the##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
irradiance of##9##2##(2007-11#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#3)
irradiance profile beam on the##2##5##(2008-3#2)
irradiance profile##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
irradiance profiles##3##2##(2008-3#3)
irradiance responsivity##3##2##(2008-2#1)(2008-3#2)
irradiance spectrum##2##2##(2008-2#1)(2008-3#1)
irradiance standards##2##2##(2008-3#2)
irradiance threshold##2##2##(2008-3#2)
irradiance values##4##2##(2008-2#1)(2008-3#3)
irradiance with##2##2##(2008-2#2)
irradiance##138##1##(1993-3#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#45)(2008-3#73)(2008-5#1)(2008-7#4)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
irradiances to##3##2##(2008-2#1)(2008-3#2)
irradiances##24##1##(2008-12#1)(2008-2#9)(2008-3#14)
irradiated area##2##2##(2008-2#2)
irradiated at##6##2##(1991-2#1)(2008-10#2)(2008-7#2)(2010-1#1)
irradiated bone##2##2##(2007-11#1)(2008-6#1)
irradiated by a##4##3##(2008-11#2)(2008-3#2)
irradiated by##18##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
irradiated cells##7##2##(1995-6#1)(2011-2#6)
irradiated during##3##2##(1992-9#1)(2008-10#1)(2011-1#1)
irradiated fibroblasts##2##2##(1993-9#2)
irradiated food##4##2##(1997-4#4)
irradiated for##2##2##(1997-3#1)(2013-1#1)
irradiated human##2##2##(1993-9#1)(2011-2#1)
irradiated in##2##2##(2008-6#1)(2011-1#1)
irradiated males##2##2##(2012-12#2)
irradiated mice##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
irradiated mouse embryonic fibroblast feeder cells##2##6##(2008-8#2)
irradiated on##2##2##(1992-9#2)
irradiated samples##3##2##(2008-10#2)(2013-7#1)
irradiated with UV light##2##4##(2008-11#2)
irradiated with UV##3##3##(2008-11#2)(2008-9#1)
irradiated with a dose of##2##5##(2007-11#1)(2011-2#1)
irradiated with a##6##3##(2007-11#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-3#1)
irradiated with femtosecond laser pulses##2##5##(2008-3#2)
irradiated with##29##2##(1993-9#1)(1994-8#1)(1996-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
irradiated##157##1##(1991-2#1)(1992-9#3)(1993-2#1)(1993-8#1)(1993-9#5)(1994-12#1)(1994-8#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#6)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#7)(2008-10#21)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#12)(2008-5#5)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#6)(2009-7#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#14)(2012-12#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
irradiating the##2##2##(2007-11#1)(2008-9#1)
irradiating##6##1##(2007-11#1)(2008-3#2)(2008-5#2)(2008-9#1)
irradiation and##20##2##(1995-2#2)(1995-6#1)(1995-9#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)
irradiation are##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
irradiation as well as##2##4##(2010-11#1)(2013-1#1)
irradiation at the same##2##4##(2008-8#1)(2012-2#1)
irradiation at the##4##3##(2007-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
irradiation at##14##2##(1992-9#1)(1993-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
irradiation by##5##2##(1994-11#1)(2008-10#2)(2008-3#2)
irradiation conditions##2##2##(2007-11#1)(2008-11#1)
irradiation cycles##2##2##(2008-10#1)(2008-3#1)
irradiation dose##6##2##(2008-10#3)(2008-5#2)(2011-2#1)
irradiation followed##2##2##(1990-12#1)(2008-10#1)
irradiation for##10##2##(1993-9#2)(1994-8#2)(1997-4#1)(2007-12#1)(2008-7#2)(2013-1#2)
irradiation from the##2##3##(2008-11#1)(2008-8#1)
irradiation from##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
irradiation had##3##2##(2008-10#2)(2008-8#1)
irradiation has##2##2##(1996-6#1)(2008-10#1)
irradiation in the treatment of##3##5##(1995-11#1)(1995-8#1)(2012-3#1)
irradiation in the##5##3##(1994-12#1)(1995-11#1)(1995-8#1)(2008-10#1)(2012-3#1)
irradiation in##12##2##(1994-12#2)(1995-11#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-7#2)(2009-2#1)(2011-2#2)(2012-3#1)
irradiation induced##2##2##(2008-8#2)
irradiation is##10##2##(1990-9#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-5#1)(2012-2#1)
irradiation of a##3##3##(2007-11#1)(2010-12#1)(2012-2#1)
irradiation of cefazolin sodium##2##4##(2008-10#2)
irradiation of the##7##3##(1992-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(2007-11#1)(2008-9#1)(2010-4#1)
irradiation of##39##2##(1990-10#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#2)(1996-2#2)(1996-3#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#2)(2010-4#1)(2012-2#2)(2013-1#1)
irradiation on##5##2##(2007-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#1)
irradiation or##7##2##(1992-10#2)(2007-11#1)(2008-5#2)(2008-7#1)(2011-2#1)
irradiation power and##3##3##(2008-10#3)
irradiation power##5##2##(2008-10#4)(2012-1#1)
irradiation prior to##3##3##(2007-4#1)(2008-10#1)(2009-7#1)
irradiation time and##2##3##(2008-10#2)
irradiation time of##3##3##(2008-10#3)
irradiation time##19##2##(2008-10#13)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#2)
irradiation times##5##2##(2008-10#4)(2008-7#1)
irradiation to##8##2##(1993-3#1)(2007-11#1)(2008-10#4)(2008-7#1)(2009-7#1)
irradiation using##3##2##(1993-9#1)(1995-9#1)(2012-2#1)
irradiation was used##2##3##(2008-10#2)
irradiation was##14##2##(1990-8#1)(1994-11#1)(1994-12#1)(1995-6#2)(1995-8#3)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)
irradiation were##3##2##(2008-10#2)(2008-9#1)
irradiation with a##2##3##(1995-9#1)(2008-8#1)
irradiation with the##2##3##(1995-9#1)(2007-12#1)
irradiation with##29##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-3#1)(1995-9#2)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)
irradiation##418##1##(1990-10#4)(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-3#2)(1993-8#1)(1993-9#7)(1994-11#4)(1994-12#5)(1994-3#2)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#10)(1995-8#8)(1995-9#7)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#3)(1997-3#2)(1997-4#7)(1997-7#1)(2007-10#2)(2007-11#19)(2007-12#16)(2007-4#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#86)(2008-11#12)(2008-12#2)(2008-2#9)(2008-3#28)(2008-4#1)(2008-5#25)(2008-6#3)(2008-7#22)(2008-8#11)(2008-9#7)(2009-11#1)(2009-2#3)(2009-3#4)(2009-7#4)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#7)(2012-3#2)(2013-1#12)(2013-8#7)
irradiation)##5##1##(1990-12#1)(1992-5#1)(1995-8#1)(2008-2#1)(2010-6#1)
irradiation-hydride##3##1##(2008-10#3)
irradiation-induced##2##1##(2008-3#1)(2010-10#1)
irradiations##7##1##(1997-4#1)(2008-3#1)(2008-5#2)(2013-1#2)(2013-7#1)
irrational beliefs##5##2##(2010-5#5)
irrational##12##1##(1990-5#1)(1991-11#2)(1996-11#1)(2008-11#1)(2008-9#1)(2010-5#6)
irreducible##4##1##(2008-10#1)(2009-8#1)(2011-2#2)
irregular and##3##2##(1994-3#1)(2008-7#1)(2009-5#1)
irregular bleeding##2##2##(2007-7#1)(2011-2#1)
irregular domains##2##2##(2008-2#2)
irregular shape##2##2##(2007-12#1)(2008-3#1)
irregular surface##2##2##(1996-12#1)(2008-9#1)
irregular##60##1##(1991-2#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#4)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#4)
irregulare group I##2##3##(2008-10#2)
irregulare group IV##2##3##(2008-10#2)
irregulare group##4##2##(2008-10#4)
irregulare sensu stricto##2##3##(2008-10#2)
irregulare sensu##3##2##(2008-10#3)
irregulare##19##1##(2008-10#17)(2010-10#2)
irregularities and##2##2##(2008-10#1)(2008-4#1)
irregularities in the##3##3##(1995-3#1)(2009-5#1)(2011-3#1)
irregularities of##2##2##(1996-4#1)(2008-2#1)
irregularities##14##1##(1995-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-5#1)(2011-3#1)
irregularity and##2##2##(2008-7#1)(2008-8#1)
irregularity##7##1##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-8#1)
irregularly distributed##2##2##(1991-6#1)(2008-10#1)
irregularly shaped##6##2##(2008-10#4)(2008-3#1)(2008-5#1)
irregularly##15##1##(1991-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
irrelevant to the##3##3##(1992-5#1)(2008-11#1)(2010-5#1)
irrelevant to##8##2##(1992-5#1)(1994-8#1)(2007-8#1)(2008-11#2)(2010-12#1)(2010-5#1)(2012-1#1)
irrelevant##28##1##(1990-12#1)(1991-2#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-5#3)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-8#1)
irreproducible##2##1##(2008-10#2)
irresistible##2##1##(1991-3#2)
irrespective of age##3##3##(1993-9#1)(2008-6#1)(2013-7#1)
irrespective of geographical##2##3##(2008-10#1)(2011-2#1)
irrespective of its##3##3##(1991-11#1)(2008-10#1)(2013-1#1)
irrespective of site##2##3##(2008-7#1)(2013-1#1)
irrespective of the age##2##4##(1992-10#1)(2012-2#1)
irrespective of the fungal inoculum density##4##6##(2008-10#4)
irrespective of the type of##2##5##(2008-10#1)(2011-2#1)
irrespective of the##38##3##(1991-11#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-9#1)(1997-4#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#2)
irrespective of their##10##3##(1992-3#1)(1994-1#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-5#1)(2012-4#1)(2013-1#1)
irrespective of whether it was##2##5##(2008-10#1)(2008-11#1)
irrespective of whether##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)(2013-1#1)
irrespective of##98##2##(1990-12#1)(1990-9#1)(1991-11#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-4#1)(2013-1#4)(2013-7#1)
irresponsible behavior##2##2##(1996-2#1)(2007-11#1)
irresponsible##3##1##(1996-2#1)(1997-6#1)(2007-11#1)
irreversibility of the##2##3##(1991-5#1)(2008-10#1)
irreversibility##3##1##(1991-5#1)(1995-2#1)(2008-10#1)
irreversible adsorption##2##2##(1997-2#1)(2008-10#1)
irreversible and##11##2##(1991-4#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-9#1)(2008-10#5)
irreversible binding of##3##3##(1991-3#1)(2006-6#1)(2011-2#1)
irreversible cell##2##2##(2008-4#1)(2011-2#1)
irreversible changes##2##2##(2008-10#1)(2010-1#1)
irreversible cyclic voltammograms and##2##4##(2008-10#2)
irreversible cyclic voltammograms##3##3##(2008-10#3)
irreversible damage##3##2##(1992-4#1)(2008-11#1)(2008-5#1)
irreversible inactivation of##3##3##(1990-7#1)(1992-8#1)(1994-5#1)
irreversible inactivation##4##2##(1990-7#1)(1992-8#1)(1993-11#1)(1994-5#1)
irreversible inhibitor of the##2##4##(1990-11#1)(1990-2#1)
irreversible inhibitor of##5##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-3#1)(1992-8#1)
irreversible inhibitor##6##2##(1990-11#1)(1990-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1997-6#1)
irreversible inhibitors of##2##3##(1994-6#1)(1996-5#1)
irreversible inhibitors##4##2##(1992-8#1)(1994-6#1)(1996-5#1)(2008-6#1)
irreversible oxidation##3##2##(2008-10#3)
irreversible photochromic##2##2##(2008-3#2)
irreversible renal failure##2##3##(2008-1#1)(2013-1#1)
irreversible vegetation##3##2##(2008-8#3)
irreversible##128##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#3)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
irreversibly##17##1##(1990-7#1)(1991-2#1)(1991-4#3)(1991-5#1)(1993-12#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-10#5)(2009-12#1)(2011-1#1)
irrigants to##2##2##(2012-3#1)(2013-1#1)
irrigants##6##1##(2012-3#1)(2013-1#5)
irrigated with saline water##3##4##(2008-10#3)
irrigated with saline##4##3##(2008-10#3)(2013-1#1)
irrigated with##9##2##(2008-10#7)(2013-1#2)
irrigated##15##1##(2008-10#13)(2013-1#2)
irrigation and##8##2##(2008-10#7)(2012-12#1)
irrigation in##2##2##(2008-10#2)
irrigation intervals##2##2##(2008-12#2)
irrigation method##2##2##(2008-10#2)
irrigation methods##6##2##(2008-10#6)
irrigation of##2##2##(2012-3#1)(2013-8#1)
irrigation on##2##2##(2008-10#2)
irrigation regime##3##2##(2008-10#3)
irrigation regimes##3##2##(2008-10#1)(2008-12#2)
irrigation season##3##2##(2008-10#3)
irrigation system##2##2##(2008-10#2)
irrigation systems##6##2##(2008-10#6)
irrigation than under##3##3##(2008-10#3)
irrigation water at##2##3##(2008-10#1)(2008-12#1)
irrigation water during##2##3##(2008-10#1)(2008-12#1)
irrigation water in##2##3##(2008-10#2)
irrigation water##25##2##(2008-10#18)(2008-12#7)
irrigation were##3##2##(2008-10#2)(2013-8#1)
irrigation with##6##2##(2008-10#4)(2012-2#1)(2012-3#1)
irrigation##122##1##(2008-10#98)(2008-12#14)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#2)
irrigation)##4##1##(2008-10#3)(2012-9#1)
irrigations##2##1##(2008-10#1)(2012-2#1)
irritability##10##1##(1993-2#1)(2008-11#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
irritable bowel syndrome (IBS)##2##4##(1997-6#1)(2010-6#1)
irritable bowel syndrome and##2##4##(1995-10#1)(2007-10#1)
irritable bowel syndrome##10##3##(1995-10#1)(1997-6#2)(2007-10#1)(2010-12#1)(2010-6#2)(2012-12#1)(2013-1#2)
irritable bowel##12##2##(1995-10#1)(1997-6#2)(2007-10#1)(2008-4#1)(2010-12#1)(2010-6#2)(2012-12#1)(2013-1#3)
irritable##18##1##(1995-10#1)(1995-6#1)(1997-6#2)(2007-10#1)(2007-7#1)(2008-4#2)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
irritancy and##2##2##(2008-10#1)(2008-5#1)
irritancy##6##1##(1996-12#1)(2008-10#1)(2008-5#2)(2008-9#2)
irritant capacity of##2##3##(2008-5#2)
irritant capacity##4##2##(2008-5#4)
irritant dermatitis##3##2##(2007-7#1)(2008-5#2)
irritant gas##2##2##(1996-12#2)
irritant##19##1##(1992-3#1)(1992-5#1)(1995-6#2)(1996-12#3)(2007-7#1)(2008-5#10)(2011-1#1)
irritants##8##1##(1994-3#1)(1996-12#3)(2008-5#4)
irritated##4##1##(2008-3#1)(2008-5#3)
irritating##5##1##(2007-7#1)(2008-5#2)(2008-9#2)
irritation and##4##2##(2008-10#1)(2008-5#2)(2011-3#1)
irritation are##2##2##(2008-5#2)
irritation at the##3##3##(2008-10#1)(2008-9#2)
irritation at##4##2##(2008-10#1)(2008-5#1)(2008-9#2)
irritation is##3##2##(2008-11#1)(2008-5#2)
irritation of the##2##3##(1996-12#1)(2012-2#1)
irritation of##4##2##(1992-6#1)(1996-12#1)(2008-5#1)(2012-2#1)
irritation or##4##2##(1991-5#1)(2008-10#2)(2008-5#1)
irritation potential of##6##3##(2008-5#6)
irritation potential##10##2##(2008-5#8)(2009-6#2)
irritation to the##2##3##(1996-1#1)(2011-1#1)
irritation##57##1##(1991-5#1)(1992-6#1)(1993-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#31)(2008-9#2)(2009-11#1)(2009-6#2)(2011-1#1)(2011-3#3)(2012-2#2)
irritative##2##1##(2007-11#1)(2011-2#1)
is &gt##8##2##(1993-11#1)(1993-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2013-1#1)
is &lt##12##2##(1996-9#1)(2008-10#6)(2008-2#3)(2008-3#1)(2013-1#1)
is &quot##18##2##(1990-11#1)(1991-3#1)(1994-2#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-7#1)(2012-12#1)
is (2##2##2##(1992-6#1)(1995-2#1)
is (6##2##2##(2008-10#2)
is (MY(2-))##2##2##(2008-10#2)
is (partly)##2##2##(1991-6#1)(2012-1#1)
is -0##3##2##(2008-10#2)(2008-2#1)
is -1##3##2##(2008-10#2)(2008-3#1)
is 0##158##2##(1990-2#1)(1991-3#1)(1992-4#2)(1993-8#2)(1994-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-5#2)(1996-7#1)(2007-11#3)(2007-12#1)(2008-10#108)(2008-11#2)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2011-3#3)(2013-1#1)(2013-8#8)
is 1 order of magnitude##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is 1##88##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1996-2#1)(1996-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#51)(2008-2#2)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#3)
is 10 times##2##3##(2008-3#1)(2008-7#1)
is 10##12##2##(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-7#1)
is 10-fold more##2##3##(1990-12#1)(1995-3#1)
is 100 times##2##3##(2007-11#1)(2008-10#1)
is 100##4##2##(2007-11#1)(2008-10#3)
is 100% identical to the##2##5##(1995-9#2)
is 100%##5##2##(1990-9#1)(1995-9#2)(2008-10#1)(2010-9#1)
is 1000##2##2##(2008-10#1)(2010-1#1)
is 11##3##2##(1993-3#1)(1994-1#1)(2008-11#1)
is 12##10##2##(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2013-1#1)
is 120##2##2##(1991-5#1)(1992-11#1)
is 13##3##2##(1992-8#1)(2008-10#1)(2013-1#1)
is 15 s##2##3##(2008-10#2)
is 15##7##2##(1994-2#1)(2007-12#1)(2008-10#4)(2011-2#1)
is 16##2##2##(2008-8#1)(2013-8#1)
is 17##2##2##(2007-11#1)(2008-10#1)
is 2 ng ml(-1)##2##4##(2008-10#2)
is 2 orders of magnitude higher##2##6##(2007-11#1)(2007-12#1)
is 2 orders of magnitude##5##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
is 2##65##2##(1991-6#1)(1992-3#1)(1992-4#2)(1992-6#1)(1993-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#41)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
is 2-6##2##2##(2008-10#2)
is 20##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
is 21##4##2##(1990-7#1)(1997-5#1)(2008-1#1)(2008-11#1)
is 22##2##2##(2008-2#1)(2008-8#1)
is 23##2##2##(1996-10#1)(2008-10#1)
is 24##3##2##(2008-10#1)(2008-12#2)
is 25##2##2##(2007-12#1)(2008-10#1)
is 27##2##2##(2011-1#1)(2011-2#1)
is 29##2##2##(1994-3#1)(1995-6#1)
is 3##38##2##(1992-12#1)(1992-6#1)(1994-12#1)(1996-2#1)(1996-5#1)(2007-12#3)(2008-10#22)(2008-3#3)(2008-7#2)(2008-8#2)(2010-8#1)
is 3%##2##2##(1995-8#1)(2008-3#1)
is 30##4##2##(1997-5#1)(2008-10#3)
is 34##2##2##(2008-3#1)(2008-9#1)
is 35##2##2##(2008-10#1)(2008-11#1)
is 38##2##2##(1995-6#1)(2008-10#1)
is 39##2##2##(2008-10#1)(2008-12#1)
is 4##30##2##(1990-8#1)(1993-2#1)(1994-12#1)(1996-6#1)(1997-7#1)(2008-10#17)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)
is 40##5##2##(1991-12#1)(1993-3#1)(2008-3#2)(2011-2#1)
is 430##2##2##(2008-10#1)(2008-3#1)
is 44##2##2##(2008-3#1)(2010-4#1)
is 45##3##2##(2008-10#2)(2008-6#1)
is 5##29##2##(1993-8#1)(1994-9#1)(2008-10#18)(2008-3#2)(2008-5#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is 5%##3##2##(1996-11#1)(2011-2#1)(2013-8#1)
is 5-6 times##2##3##(1991-6#1)(2008-8#1)
is 50##5##2##(2007-12#1)(2008-10#2)(2008-8#1)(2013-8#1)
is 50%##2##2##(2007-12#1)(2008-9#1)
is 500 nm##2##3##(2007-11#1)(2008-3#1)
is 500##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
is 52##3##2##(1990-2#1)(1995-5#1)(2008-6#1)
is 6##20##2##(1990-6#1)(1990-7#1)(1996-3#1)(1997-9#1)(2007-11#2)(2008-10#9)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
is 6%##2##2##(2008-10#1)(2008-2#1)
is 60##2##2##(2008-10#1)(2008-7#1)
is 62##2##2##(2008-10#1)(2008-8#1)
is 68##2##2##(1994-12#1)(2008-10#1)
is 7 times##2##3##(1995-4#1)(2009-6#1)
is 7##10##2##(1991-5#1)(1995-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)
is 76%##2##2##(1992-5#1)(2008-3#1)
is 78##3##2##(2007-12#1)(2011-3#1)(2012-12#1)
is 79##2##2##(1992-5#1)(1994-12#1)
is 8##9##2##(1990-5#1)(1993-3#1)(2008-10#6)(2008-8#1)
is 80##3##2##(2008-10#2)(2008-8#1)
is 81##2##2##(1993-3#1)(2008-2#1)
is 9##8##2##(1994-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
is 90%##3##2##(1997-4#1)(2008-5#1)(2010-11#1)
is 92##2##2##(1990-12#1)(1994-5#1)
is 92%##2##2##(2008-10#1)(2008-9#1)
is 96%##2##2##(1994-12#1)(2008-4#1)
is 98##2##2##(1990-9#1)(2013-1#1)
is 99%##2##2##(2008-5#1)(2013-1#1)
is ?0##2##2##(2008-3#2)
is A##3##2##(2008-10#2)(2008-8#1)
is April 29##10##3##(2011-2#5)(2012-1#5)
is Associated##2##2##(2012-12#1)(2013-1#1)
is Ca(2+)-dependent##2##2##(1995-11#1)(2008-8#1)
is FDA##2##2##(2008-11#1)(2008-12#1)
is Gram-negative##2##2##(2008-6#1)(2011-2#1)
is HIV positive##2##3##(1993-8#1)(2010-12#1)
is IT##2##2##(1993-2#1)(1996-3#1)
is March##19##2##(2011-1#15)(2011-2#2)(2012-1#2)
is May##4##2##(2011-2#1)(2012-1#3)
is Pseudomonas syringae##2##3##(2008-10#1)(2009-8#1)
is US$##2##2##(2007-7#1)(2011-2#1)
is a &quot##4##3##(1990-6#1)(2007-11#1)(2007-7#1)(2008-10#1)
is a 1##2##3##(1997-3#1)(2008-5#1)
is a 13-year-old boy##2##4##(2007-7#1)(2013-1#1)
is a DNA##2##3##(1995-5#1)(1997-4#1)
is a Fourier##2##3##(2008-2#1)(2008-3#1)
is a Gram-positive##5##3##(2011-2#4)(2012-12#1)
is a T-cell##2##3##(1995-1#1)(1995-12#1)
is a bacterial##2##3##(2008-12#1)(2013-8#1)
is a barrier to##2##4##(1994-3#1)(1996-3#1)
is a barrier##4##3##(1994-3#1)(1996-3#1)(2011-2#2)
is a basic##9##3##(1993-3#1)(1995-1#1)(1996-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-2#1)
is a beneficial##2##3##(1993-6#1)(2013-1#1)
is a benign condition##2##4##(2008-7#1)(2013-8#1)
is a benign lesion occurring##2##5##(1990-12#1)(2008-4#1)
is a benign##10##3##(1990-12#2)(1991-11#1)(1991-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
is a better predictor##2##4##(1991-2#1)(2012-3#1)
is a better##12##3##(1991-2#1)(1994-11#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
is a bibliographic##3##3##(1991-12#1)(2012-3#2)
is a bifunctional##3##3##(1990-8#1)(2008-10#2)
is a bioactive##2##3##(2008-10#1)(2009-3#1)
is a biochemical marker for##2##5##(1990-8#1)(2007-12#1)
is a biochemical##3##3##(1990-8#1)(1993-8#1)(2007-12#1)
is a biocontrol agent of##2##5##(2008-10#2)
is a biocontrol agent##3##4##(2008-10#3)
is a biological##4##3##(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
is a brief discussion of##2##5##(2008-10#1)(2009-9#1)
is a brief introduction to##2##5##(2008-9#1)(2009-9#1)
is a brief##4##3##(2008-10#1)(2008-9#1)(2009-9#2)
is a broad spectrum##2##4##(2008-3#1)(2012-2#1)
is a broad##8##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#2)
is a by-product of##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
is a candidate for##6##4##(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-8#1)
is a candidate##13##3##(1992-6#1)(1993-11#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-6#1)(2008-10#3)(2008-8#2)(2011-2#1)
is a case study of a##2##6##(1992-2#1)(2008-6#1)
is a case study of##4##5##(1992-2#1)(1996-9#1)(2007-11#1)(2008-6#1)
is a case study##5##4##(1992-2#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-6#1)
is a case##17##3##(1992-2#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
is a causative##2##3##(2008-12#1)(2008-7#1)
is a cause of##4##4##(1994-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
is a cause##6##3##(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#1)
is a cell##2##3##(1992-12#1)(2008-11#1)
is a cellular##2##3##(1997-2#1)(2008-8#1)
is a central component##2##4##(1994-8#1)(2008-8#1)
is a central theme in##2##5##(2008-11#1)(2009-7#1)
is a central##9##3##(1994-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
is a certain##2##3##(2008-2#1)(2009-8#1)
is a challenge##7##3##(1994-11#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#2)
is a challenging problem##2##4##(1994-3#1)(2008-3#1)
is a challenging task##4##4##(2008-10#1)(2008-5#1)(2009-12#1)(2012-12#1)
is a challenging##10##3##(1994-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#2)
is a change in the##2##5##(2006-10#1)(2007-12#1)
is a characteristic##5##3##(1993-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
is a cheap##2##3##(1993-3#1)(2008-10#1)
is a chemical##2##3##(2008-11#1)(2010-9#1)
is a chronic debilitating disease##2##5##(2007-7#1)(2013-1#1)
is a chronic disease##3##4##(1997-8#1)(2008-3#1)(2012-3#1)
is a chronic inflammatory autoimmune##2##5##(2012-2#1)(2012-3#1)
is a chronic inflammatory##6##4##(1997-8#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
is a chronic multisystem##2##4##(2011-2#1)(2012-3#1)
is a chronic##34##3##(1990-3#1)(1995-12#1)(1997-8#4)(2007-12#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#3)
is a classic##3##3##(2008-10#1)(2009-11#1)(2010-7#1)
is a classical##2##3##(2008-10#1)(2011-2#1)
is a clear advantage##2##4##(2008-7#1)(2011-2#1)
is a clear need for##3##5##(2007-8#1)(2008-10#1)(2009-11#1)
is a clear##9##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
is a clinical condition characterized by##2##6##(2008-1#1)(2011-2#1)
is a clinical condition##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
is a clinical reality##2##4##(2010-5#1)(2011-2#1)
is a clinical syndrome##2##4##(2008-10#1)(2012-3#1)
is a clinical##17##3##(1991-1#1)(1991-6#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#4)(2012-3#3)(2013-8#1)
is a clonal##5##3##(2008-1#1)(2009-2#1)(2010-1#1)(2010-4#1)(2012-12#1)
is a close relationship between##2##5##(2008-8#1)(2011-2#1)
is a close##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
is a collaborative##2##3##(1991-2#1)(1996-12#1)
is a collection of##5##4##(1994-12#1)(1996-2#1)(2008-4#1)(2008-9#1)(2010-8#1)
is a combination of##8##4##(1993-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-11#1)
is a common and essential##2##5##(2008-2#1)(2012-2#1)
is a common and often##2##5##(2008-9#1)(2010-8#1)
is a common and##7##4##(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#2)(2010-8#1)(2012-2#1)
is a common cause of morbidity##2##6##(2009-8#1)(2011-2#1)
is a common cause of##8##5##(1990-6#1)(2007-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
is a common cause##10##4##(1990-6#1)(2007-11#2)(2007-7#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
is a common clinical entity##2##5##(1993-10#1)(2011-2#1)
is a common complication in##2##5##(1996-9#1)(2008-3#1)
is a common complication##3##4##(1991-6#1)(1996-9#1)(2008-3#1)
is a common component of##2##5##(2011-2#1)(2012-2#1)
is a common condition in##2##5##(1991-5#1)(2011-2#1)
is a common disease in##2##5##(2008-10#1)(2012-2#1)
is a common disease##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
is a common disorder in##3##5##(1995-2#1)(2008-1#1)(2011-1#1)
is a common disorder##7##4##(1995-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-1#2)
is a common event in##2##5##(2008-7#1)(2010-11#1)
is a common feature of##5##5##(1991-3#1)(1993-12#1)(2008-5#1)(2009-5#1)(2010-12#1)
is a common feature##6##4##(1991-3#1)(1993-12#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)
is a common finding in patients with##2##7##(1996-6#1)(2013-8#1)
is a common finding in##4##5##(1992-9#1)(1996-6#1)(2008-7#1)(2013-8#1)
is a common law##2##4##(1990-11#1)(2007-11#1)
is a common occurrence in##2##5##(1993-3#1)(2008-6#1)
is a common occurrence##6##4##(1993-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#1)
is a common phenomenon##2##4##(2008-7#1)(2008-8#1)
is a common practice##2##4##(2008-10#1)(2008-2#1)
is a common presentation to##2##5##(2009-8#1)(2010-5#1)
is a common problem in##7##5##(1993-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
is a common problem##13##4##(1993-2#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2013-8#1)
is a common procedure##2##4##(2008-10#1)(2011-2#1)
is a common symptom##2##4##(2007-7#1)(2008-5#1)
is a common target##2##4##(1991-9#1)(1997-4#1)
is a common theme##2##4##(2008-5#1)(2009-8#1)
is a common##140##3##(1990-11#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#8)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#4)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#6)(2013-8#6)
is a commonly used##6##4##(1997-2#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
is a commonly##9##3##(1997-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
is a compact##2##3##(2008-3#2)
is a companion to##2##4##(1992-2#1)(1997-1#1)
is a comparative##3##3##(2008-7#3)
is a complete##3##3##(1993-8#1)(1994-9#1)(2011-2#1)
is a completely##2##3##(2008-11#1)(2012-3#1)
is a complex and##8##4##(1997-3#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
is a complex disease##3##4##(2008-1#1)(2008-7#1)(2012-3#1)
is a complex mixture##2##4##(2008-11#1)(2008-8#1)
is a complex of##3##4##(1992-9#1)(2008-10#2)
is a complex problem##3##4##(2008-5#1)(2009-4#1)(2012-2#1)
is a complex process and##3##5##(1996-8#1)(2008-10#1)(2008-7#1)
is a complex process in which##3##6##(2008-5#1)(2008-8#1)(2011-2#1)
is a complex process involving##2##5##(2008-8#1)(2012-2#1)
is a complex process##11##4##(1996-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
is a complex##55##3##(1991-12#1)(1992-9#1)(1994-1#1)(1994-12#1)(1996-8#1)(1997-3#2)(2007-10#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#3)(2009-11#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
is a complicated process##4##4##(1993-12#1)(2008-7#2)(2012-2#1)
is a complicated##8##3##(1993-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-2#1)
is a component of a##2##5##(1990-8#1)(2008-10#1)
is a component of the##9##5##(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-5#1)(2011-2#1)
is a component of##16##4##(1990-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)
is a component##19##3##(1990-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-5#2)(2011-2#1)(2013-1#1)
is a composite##2##3##(2008-10#1)(2013-1#1)
is a comprehensive##4##3##(1996-3#1)(2007-8#1)(2008-4#1)(2008-7#1)
is a concept that##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
is a concept##5##3##(2008-10#1)(2008-11#1)(2010-10#1)(2010-8#1)(2012-3#1)
is a concern##5##3##(1993-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
is a condition characterised by##2##5##(2013-1#1)(2013-8#1)
is a condition in which##3##5##(2010-1#1)(2010-12#1)(2010-5#1)
is a condition of##3##4##(2008-5#1)(2011-1#1)(2012-3#1)
is a condition##13##3##(1997-5#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is a conditionally essential##2##4##(2008-5#2)
is a consensus##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
is a consequence of##7##4##(1991-3#1)(1995-2#1)(2006-10#1)(2008-10#2)(2010-6#1)(2011-2#1)
is a conserved##4##3##(1994-11#1)(1994-12#1)(2007-12#1)(2008-7#1)
is a considerable##8##3##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-9#1)(2012-3#1)
is a constant##10##3##(1991-9#1)(1996-4#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
is a contiguous##2##3##(1997-3#1)(2013-1#1)
is a continued##2##3##(2008-9#1)(2010-12#1)
is a continuing##2##3##(1992-1#1)(1992-3#1)
is a continuous process##2##4##(1995-2#1)(1995-3#1)
is a continuous##5##3##(1995-2#1)(1995-3#1)(1997-2#1)(2008-2#1)(2011-2#1)
is a contributory factor##2##4##(2008-11#1)(2008-12#1)
is a convenient##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
is a core##2##3##(2008-11#1)(2012-3#1)
is a cost##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
is a cost-effective way##2##4##(1995-2#1)(2008-3#1)
is a cost-effective##4##3##(1991-1#1)(1995-2#1)(2008-3#1)(2012-12#1)
is a critical component of##2##5##(2007-12#1)(2008-7#1)
is a critical component##4##4##(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
is a critical element in##2##5##(1995-2#1)(2008-4#1)
is a critical factor in##2##5##(1993-1#1)(2008-10#1)
is a critical factor##3##4##(1993-1#1)(2008-10#1)(2008-8#1)
is a critical parameter##2##4##(1997-4#1)(2008-5#1)
is a critical step in the##2##6##(2008-10#1)(2008-9#1)
is a critical step in##5##5##(1993-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
is a critical step##6##4##(1993-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
is a critical##40##3##(1992-2#1)(1993-1#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
is a crucial factor for##2##5##(2009-10#1)(2012-3#1)
is a crucial factor in##2##5##(2008-3#1)(2009-12#1)
is a crucial factor##4##4##(2008-3#1)(2009-10#1)(2009-12#1)(2012-3#1)
is a crucial part of##3##5##(2008-10#1)(2008-12#1)(2008-6#1)
is a crucial##13##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
is a cumulative process##2##4##(2008-10#1)(2011-2#1)
is a cumulative##3##3##(2008-10#2)(2011-2#1)
is a current##2##3##(2012-12#1)(2012-2#1)
is a cytokine that##3##4##(1993-8#1)(1995-6#1)(2009-7#1)
is a cytokine##4##3##(1993-8#1)(1994-11#1)(1995-6#1)(2009-7#1)
is a damaging disease of##2##5##(2008-10#2)
is a database of##2##4##(2008-4#2)
is a dearth of##4##4##(2008-11#2)(2008-12#1)(2008-4#1)
is a debilitating and##3##4##(2007-10#1)(2013-1#2)
is a debilitating condition##2##4##(2010-1#1)(2011-2#1)
is a debilitating##7##3##(2007-10#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
is a decrease in##5##4##(1990-11#1)(1990-6#1)(2008-10#1)(2011-2#2)
is a definite##2##3##(2008-3#1)(2008-7#1)
is a degenerative##2##3##(2008-12#1)(2008-9#1)
is a demanding##3##3##(1991-2#1)(2008-3#1)(2008-9#1)
is a description of the##2##5##(1992-1#1)(2012-12#1)
is a description of##5##4##(1992-1#1)(1996-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
is a descriptive##4##3##(2008-11#1)(2010-10#1)(2010-9#1)(2013-1#1)
is a desirable goal##2##4##(1997-2#1)(2010-12#1)
is a desirable##3##3##(1992-1#1)(1997-2#1)(2010-12#1)
is a desire to##2##4##(2012-12#1)(2013-1#1)
is a destructive disease of##5##5##(2008-10#5)
is a destructive disease##6##4##(2008-10#6)
is a destructive##7##3##(2008-10#6)(2013-8#1)
is a detailed##3##3##(1991-5#1)(2007-12#1)(2013-8#1)
is a devastating complication##3##4##(2008-8#1)(2011-2#1)(2012-1#1)
is a devastating disease of##2##5##(2008-10#1)(2012-2#1)
is a devastating disease##3##4##(2008-10#2)(2012-2#1)
is a devastating##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
is a development of##2##4##(2008-10#1)(2009-11#1)
is a developmental##2##3##(2009-4#1)(2013-1#1)
is a diagnostic##7##3##(1991-6#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)
is a different##4##3##(1990-11#1)(2008-10#2)(2008-8#1)
is a difficult problem##5##4##(2007-12#1)(2007-2#1)(2008-10#2)(2010-6#1)
is a difficult task##4##4##(1990-9#1)(2008-3#1)(2008-5#1)(2008-7#1)
is a difficult##12##3##(1990-9#1)(1993-1#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)
is a diffractive optical element##2##5##(2008-3#2)
is a dimeric##3##3##(1992-3#1)(1993-3#1)(1994-11#1)
is a direct consequence of the##2##6##(1997-7#1)(2008-11#1)
is a direct consequence##3##4##(1997-7#1)(2008-11#1)(2011-1#1)
is a direct measure of##3##5##(2008-10#1)(2008-3#2)
is a direct result of##3##5##(1994-6#1)(2007-11#1)(2008-10#1)
is a direct##21##3##(1992-8#1)(1994-6#1)(1996-2#1)(1996-4#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#1)(2013-1#3)
is a disabling##2##3##(1996-9#1)(2009-3#1)
is a discussion of##4##4##(1991-2#1)(2008-9#3)
is a discussion##5##3##(1991-2#1)(2008-12#1)(2008-9#3)
is a disease of##6##4##(1991-6#1)(2007-7#2)(2008-10#2)(2011-2#1)
is a disease that is##2##5##(2008-7#1)(2013-1#1)
is a disease that##4##4##(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
is a disease which##2##4##(1992-9#1)(1996-6#1)
is a disease with##2##4##(1994-9#1)(2008-7#1)
is a disease##26##3##(1991-12#1)(1991-6#1)(1992-9#1)(1994-9#3)(1995-8#1)(1996-6#1)(2006-10#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
is a disorder characterized by##2##5##(1995-8#1)(2008-1#1)
is a disorder of##2##4##(2008-7#1)(2012-12#1)
is a disorder##4##3##(1995-8#1)(2008-1#1)(2008-7#1)(2012-12#1)
is a distinct entity##3##4##(1997-3#1)(2006-10#1)(2011-2#1)
is a distinct member##2##4##(2008-10#2)
is a distinct possibility##2##4##(1991-3#1)(2008-10#1)
is a distinct species##2##4##(2008-10#2)
is a distinct##15##3##(1990-12#1)(1991-3#1)(1991-5#1)(1997-3#1)(2006-10#1)(2008-10#6)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
is a distinctive##2##3##(2007-7#1)(2008-7#1)
is a distribution of##2##4##(2008-2#2)
is a distribution##3##3##(2008-2#2)(2009-11#1)
is a diverse##2##3##(2008-10#1)(2010-3#1)
is a doctor##2##3##(1994-1#1)(2013-1#1)
is a domain##2##3##(2011-1#1)(2013-1#1)
is a dominant##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
is a dopamine##2##3##(2008-10#1)(2008-7#1)
is a dose-limiting##2##3##(2008-7#2)
is a double##2##3##(2008-1#1)(2008-3#1)
is a downstream##3##3##(1994-8#1)(1995-2#1)(2008-6#1)
is a drug with##2##4##(2008-10#1)(2012-2#1)
is a drug##4##3##(2007-11#1)(2008-10#2)(2012-2#1)
is a dynamic process##2##4##(2008-3#1)(2008-9#1)
is a dynamic##7##3##(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#2)(2013-8#1)
is a eukaryotic##2##3##(1997-4#1)(2008-9#1)
is a factor##2##3##(2008-3#1)(2013-7#1)
is a fairly##2##3##(1995-3#1)(1996-6#1)
is a family of##2##4##(2008-8#1)(2009-10#1)
is a family##3##3##(2008-8#1)(2009-10#1)(2013-1#1)
is a fascinating and##2##4##(2008-5#1)(2009-10#1)
is a fascinating##3##3##(2008-5#1)(2008-8#1)(2009-10#1)
is a fast and##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
is a fast##7##3##(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2012-3#1)
is a favorable##2##3##(1992-3#1)(2008-10#1)
is a feasible##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-12#1)
is a few times##2##4##(2007-12#1)(2008-10#1)
is a finite##3##3##(1990-8#1)(2008-7#1)(2008-9#1)
is a first step toward##5##5##(1997-7#1)(2007-11#2)(2010-12#1)(2010-9#1)
is a first step##6##4##(1997-2#1)(1997-7#1)(2007-11#2)(2010-12#1)(2010-9#1)
is a first##11##3##(1994-2#1)(1997-2#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-9#1)(2013-1#1)
is a flavoprotein##2##3##(1992-3#1)(1994-8#1)
is a flexible##2##3##(1996-12#1)(2008-9#1)
is a focus of##2##4##(1991-1#1)(2009-3#1)
is a form of##9##4##(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-8#1)(2013-8#1)
is a free##2##3##(2008-10#1)(2008-4#1)
is a free-living##3##3##(2008-5#1)(2011-2#2)
is a frequent and##2##4##(1993-12#1)(2013-1#1)
is a frequent cause of##3##5##(1991-8#1)(1992-4#1)(2006-10#1)
is a frequent complication in##2##5##(2008-5#1)(2012-3#1)
is a frequent complication of##2##5##(2008-1#1)(2009-9#1)
is a frequent complication##5##4##(2008-1#2)(2008-5#1)(2009-9#1)(2012-3#1)
is a frequent site##2##4##(2007-7#1)(2008-5#1)
is a frequent##24##3##(1991-8#1)(1992-4#1)(1993-12#1)(1995-10#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-5#3)(2008-7#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
is a frequently##5##3##(2007-11#1)(2007-2#1)(2008-1#1)(2011-2#1)(2013-8#1)
is a function of charges involved in the formation reaction##3##10##(2008-10#3)
is a function of income##2##5##(2010-2#2)
is a function of the density of##2##7##(2008-10#2)
is a function of the##14##5##(1991-9#1)(1992-6#1)(1994-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
is a function of time##2##5##(1996-4#1)(2008-10#1)
is a function of##31##4##(1991-9#1)(1992-6#1)(1994-12#1)(1996-4#1)(1997-7#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#2)(2012-2#1)(2013-8#1)
is a functional##2##3##(1994-6#1)(2008-4#1)
is a fundamental component of##3##5##(2008-10#1)(2008-11#1)(2008-9#1)
is a fundamental component##4##4##(2008-10#1)(2008-11#2)(2008-9#1)
is a fundamental##20##3##(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#4)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
is a fungal##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
is a general feature of##3##5##(1997-3#1)(1997-7#1)(2011-1#1)
is a general phenomenon##2##4##(2007-11#1)(2008-10#1)
is a general##20##3##(1992-12#1)(1994-11#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
is a generalized##2##3##(2008-4#1)(2008-9#1)
is a generally##2##3##(2008-5#1)(2008-9#1)
is a generic##2##3##(2008-10#1)(2008-11#1)
is a genetic cardiac disease##2##5##(2010-4#1)(2012-12#1)
is a genetic disease##3##4##(2007-7#1)(2008-2#1)(2009-4#1)
is a genetic disorder##2##4##(2007-7#1)(2008-2#1)
is a genetic##10##3##(1997-5#1)(2007-7#2)(2008-12#1)(2008-2#2)(2009-4#1)(2010-4#1)(2010-7#1)(2012-12#1)
is a genetically##5##3##(1991-8#1)(2008-11#2)(2009-3#1)(2013-1#1)
is a global##6##3##(2008-1#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a glutamate##2##3##(1995-5#1)(2012-2#1)
is a glycoprotein and##4##4##(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)
is a glycoprotein##5##3##(1991-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)
is a glycosylated##2##3##(1992-10#1)(1993-6#1)
is a goal##2##3##(2011-1#1)(2012-12#1)
is a good alternative to traditional##2##6##(1994-9#1)(2010-4#1)
is a good alternative to##3##5##(1994-9#1)(2010-4#1)(2013-1#1)
is a good alternative##4##4##(1994-9#1)(2010-4#1)(2013-1#2)
is a good candidate for##5##5##(1992-6#1)(1993-9#1)(1996-12#1)(2008-2#1)(2008-5#1)
is a good candidate##7##4##(1992-6#1)(1993-9#1)(1996-12#1)(2008-2#1)(2008-5#1)(2010-5#1)(2013-8#1)
is a good example of##2##5##(2008-2#1)(2009-3#1)
is a good indicator of##4##5##(2007-10#1)(2008-10#1)(2008-12#1)(2010-3#1)
is a good model for##2##5##(1993-11#1)(2009-2#1)
is a good model##3##4##(1993-11#1)(2008-10#1)(2009-2#1)
is a good predictor of##3##5##(2007-10#1)(2008-8#1)(2013-1#1)
is a good substrate for the##3##6##(1990-5#1)(1995-6#1)(2008-10#1)
is a good way to##2##5##(2008-9#1)(2013-8#1)
is a good##51##3##(1990-3#1)(1990-5#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
is a great need to##3##5##(2008-10#1)(2008-6#1)(2009-11#1)
is a great need##4##4##(1994-9#1)(2008-10#1)(2008-6#1)(2009-11#1)
is a great##12##3##(1994-9#1)(1995-6#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-8#2)(2011-2#1)
is a greater##2##3##(2008-9#1)(2012-12#1)
is a group of##5##4##(2008-1#1)(2008-10#1)(2010-12#1)(2010-4#1)(2012-3#1)
is a growing interest in##4##5##(2008-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
is a growing problem##2##4##(2009-5#1)(2010-11#1)
is a growing recognition##2##4##(1996-7#1)(2008-7#1)
is a growing##26##3##(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-7#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
is a hallmark of##3##4##(1991-2#1)(1992-2#1)(2008-6#1)
is a hallmark##6##3##(1991-2#1)(1992-2#1)(2008-11#1)(2008-6#1)(2009-8#1)(2013-8#1)
is a helpful##2##3##(2008-12#1)(2012-3#1)
is a hematopoietic##2##3##(2008-11#1)(2008-8#1)
is a hereditary##2##3##(1994-12#1)(2006-6#1)
is a heritable##2##3##(2012-3#1)(2013-1#1)
is a heterodimer##2##3##(1993-11#1)(1994-8#1)
is a heterogeneous disorder##3##4##(2008-1#2)(2013-8#1)
is a heterogeneous##10##3##(1995-2#1)(2008-1#3)(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
is a high prevalence of##3##5##(2008-6#1)(2013-1#2)
is a high priority##2##4##(1994-2#1)(2008-1#1)
is a high##21##3##(1992-2#1)(1994-2#1)(1995-8#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
is a high-throughput method##2##4##(2008-7#1)(2010-11#1)
is a higher incidence##2##4##(1991-6#1)(1996-3#1)
is a higher##5##3##(1991-6#1)(1996-3#1)(2008-10#1)(2009-1#1)(2011-2#1)
is a highly conserved and##2##5##(1994-11#1)(1997-4#1)
is a highly conserved##6##4##(1991-9#1)(1994-11#1)(1994-2#1)(1997-4#1)(2009-7#1)(2010-3#1)
is a highly effective##2##4##(2011-2#1)(2012-3#1)
is a highly malignant##2##4##(2008-11#1)(2008-6#1)
is a highly prevalent##5##4##(2008-1#1)(2008-12#1)(2009-5#2)(2013-8#1)
is a highly promising##3##4##(1991-2#1)(2008-10#1)(2012-3#1)
is a highly sensitive##4##4##(1991-5#1)(2008-10#1)(2008-3#1)(2010-5#1)
is a highly variable##2##4##(2008-10#1)(2010-5#1)
is a highly##47##3##(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-11#2)(1994-2#1)(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-3#3)(2013-8#1)
is a homologue of##2##4##(1995-2#1)(1997-7#1)
is a hormone##2##3##(2008-5#1)(2013-8#1)
is a host##2##3##(2008-10#2)
is a huge##5##3##(1995-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
is a human##4##3##(1995-2#1)(1997-3#1)(2008-5#1)(2009-7#1)
is a hybrid##4##3##(1991-9#1)(1994-5#1)(2007-11#1)(2012-12#1)
is a joint effort of the##2##6##(1991-2#1)(1991-3#1)
is a keen##2##3##(2007-12#1)(2008-10#1)
is a key challenge##3##4##(2008-7#2)(2012-12#1)
is a key determinant of##2##5##(2008-11#1)(2012-12#1)
is a key determinant##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
is a key enzyme in the##2##6##(1992-3#1)(2008-9#1)
is a key enzyme in##3##5##(1990-2#1)(1992-3#1)(2008-9#1)
is a key enzyme##5##4##(1990-2#1)(1992-3#1)(1993-6#1)(2008-11#1)(2008-9#1)
is a key factor for the##2##6##(2008-10#2)
is a key factor in the##3##6##(2008-10#1)(2013-1#1)(2013-8#1)
is a key factor in##7##5##(1996-1#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
is a key factor##11##4##(1996-1#1)(2008-1#1)(2008-10#4)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
is a key feature of##2##5##(1991-9#1)(2008-11#1)
is a key feature##3##4##(1991-9#1)(2008-11#1)(2008-5#1)
is a key issue##2##4##(2007-11#1)(2008-10#1)
is a key process in##2##5##(2010-8#1)(2012-12#1)
is a key process##3##4##(2008-10#1)(2010-8#1)(2012-12#1)
is a key regulator of##2##5##(2008-11#1)(2012-2#1)
is a key regulatory component##2##5##(1993-12#1)(2008-10#1)
is a key regulatory##3##4##(1990-4#1)(1993-12#1)(2008-10#1)
is a key step in##4##5##(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)
is a key technique##2##4##(1993-6#1)(2008-4#1)
is a key to##2##4##(2008-3#1)(2011-1#1)
is a key##75##3##(1990-2#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1996-1#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#2)
is a kind of##3##4##(2007-11#1)(2008-3#1)(2012-2#1)
is a known complication of##3##5##(2008-12#1)(2012-2#1)(2013-1#1)
is a known##14##3##(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is a lack of data##4##5##(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)
is a lack of##21##4##(1994-6#1)(1995-2#1)(2007-10#1)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
is a large body of##3##5##(2008-10#1)(2008-5#1)(2010-5#1)
is a large##14##3##(1992-11#1)(1997-3#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)
is a largely##2##3##(2007-10#1)(2008-5#1)
is a late##2##3##(1991-2#1)(2011-2#1)
is a leading cause of blindness##2##6##(2008-1#1)(2010-10#1)
is a leading cause of death##2##6##(2008-10#1)(2011-2#1)
is a leading cause of disability##3##6##(1995-12#1)(2008-1#1)(2013-1#1)
is a leading cause of morbidity and mortality in##2##9##(1993-3#1)(2008-8#1)
is a leading cause of##17##5##(1993-3#1)(1995-12#1)(2008-1#3)(2008-10#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#3)(2013-1#3)
is a leading risk factor for##2##6##(2011-2#1)(2012-3#1)
is a leading##21##3##(1993-3#1)(1995-12#1)(1996-8#1)(2008-1#3)(2008-10#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#3)
is a learning##2##3##(2009-5#1)(2011-2#1)
is a less##4##3##(1993-3#1)(2007-7#1)(2011-2#1)(2013-8#1)
is a lethal##3##3##(1993-3#1)(2010-4#1)(2010-7#1)
is a life threatening##2##4##(2007-2#1)(2007-8#1)
is a life##3##3##(1990-6#1)(2007-2#1)(2007-8#1)
is a life-threatening complication of##3##5##(2007-8#1)(2010-10#1)(2011-2#1)
is a life-threatening complication##5##4##(2007-8#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
is a life-threatening disease##3##4##(2008-11#1)(2010-5#1)(2011-2#1)
is a life-threatening##14##3##(1993-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-2#1)
is a ligand for the##2##5##(1991-5#1)(2008-9#1)
is a ligand for##3##4##(1990-5#1)(1991-5#1)(2008-9#1)
is a ligand##4##3##(1990-5#1)(1991-5#1)(1992-3#1)(2008-9#1)
is a likely##3##3##(1995-5#1)(2007-10#1)(2008-7#1)
is a limited##3##3##(2008-4#2)(2011-2#1)
is a limiting factor##2##4##(1996-3#1)(2009-12#1)
is a linear function of the##2##6##(2008-10#1)(2008-4#1)
is a linear function of##5##5##(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
is a linear##9##3##(2007-11#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-8#1)
is a list of##2##4##(2008-4#1)(2011-1#1)
is a little##5##3##(2008-10#1)(2008-12#1)(2009-5#1)(2010-8#1)(2013-8#1)
is a locally##2##3##(2007-7#1)(2010-3#1)
is a long process##3##4##(1996-2#1)(2008-11#1)(2008-8#1)
is a long##6##3##(1996-2#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
is a long-standing##2##3##(2008-8#1)(2011-1#1)
is a low##2##3##(1995-6#1)(2008-7#1)
is a main source of##2##5##(2008-12#1)(2013-1#1)
is a main##3##3##(2008-12#1)(2008-9#1)(2013-1#1)
is a major advance##2##4##(2007-12#1)(2008-8#1)
is a major advantage##2##4##(2007-8#1)(2008-10#1)
is a major cause for##2##5##(2008-11#1)(2010-3#1)
is a major cause of end-stage renal##2##7##(2008-1#2)
is a major cause of morbidity and mortality in##3##9##(2007-12#1)(2008-12#1)(2009-12#1)
is a major cause of morbidity and mortality##6##8##(2007-12#1)(2008-12#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-3#1)
is a major cause of morbidity and##7##7##(2007-12#1)(2008-12#1)(2009-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
is a major cause of morbidity in##2##7##(2008-2#1)(2013-8#1)
is a major cause of morbidity##9##6##(2007-12#1)(2008-12#1)(2008-2#1)(2009-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
is a major cause of##21##5##(1994-2#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
is a major cause##23##4##(1994-2#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
is a major challenge##2##4##(2007-7#1)(2012-3#1)
is a major component in##2##5##(1992-6#1)(2008-12#1)
is a major component of the##6##6##(1990-9#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-3#1)(2013-1#1)
is a major component of##9##5##(1990-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
is a major component##12##4##(1990-9#1)(1992-6#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
is a major concern in##4##5##(2007-7#1)(2008-10#1)(2009-2#1)(2012-3#1)
is a major concern##7##4##(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-3#1)
is a major constituent of##2##5##(1992-12#1)(1995-6#1)
is a major contributor to##2##5##(2008-1#1)(2011-9#1)
is a major determinant of##2##5##(1994-8#1)(2008-10#1)
is a major disease of##2##5##(2008-10#2)
is a major disease##5##4##(2008-10#5)
is a major environmental##2##4##(2009-3#1)(2011-2#1)
is a major factor in the##2##6##(1997-7#1)(2008-3#1)
is a major factor in##4##5##(1996-3#1)(1997-7#1)(2007-11#1)(2008-3#1)
is a major factor limiting##2##5##(2008-8#1)(2009-12#1)
is a major factor##8##4##(1994-5#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)
is a major global##2##4##(2012-2#1)(2013-8#1)
is a major goal##2##4##(1991-6#1)(1996-1#1)
is a major health problem in##3##6##(2007-7#1)(2010-8#1)(2013-1#1)
is a major health problem##5##5##(1993-11#1)(2007-7#1)(2008-3#1)(2010-8#1)(2013-1#1)
is a major health##6##4##(1993-11#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
is a major mechanism##2##4##(2008-11#1)(2008-4#1)
is a major problem in the treatment##2##7##(1991-9#1)(2007-2#1)
is a major problem in the##3##6##(1991-9#1)(2007-2#1)(2007-7#1)
is a major problem in##4##5##(1991-9#1)(2007-2#1)(2007-7#1)(2008-10#1)
is a major problem##9##4##(1991-9#1)(1993-3#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-6#1)(2009-3#1)(2010-12#1)
is a major public health concern##2##6##(2008-11#1)(2013-1#1)
is a major public health problem in the world##2##9##(2009-5#1)(2012-3#1)
is a major public health problem in##4##7##(1992-9#1)(2007-11#1)(2009-5#1)(2012-3#1)
is a major public health problem##6##6##(1992-9#1)(2007-11#1)(2007-7#2)(2009-5#1)(2012-3#1)
is a major public health##12##5##(1992-9#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
is a major risk factor for##4##6##(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
is a major site of##3##5##(1994-11#1)(2008-1#1)(2008-7#1)
is a major source of##3##5##(1995-5#1)(2008-1#1)(2008-10#1)
is a major##161##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-7#7)(2007-8#2)(2008-1#5)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#2)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#5)(2011-3#1)(2011-9#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#2)
is a management##2##3##(1996-12#1)(1996-2#1)
is a marked##4##3##(1992-3#1)(1997-7#1)(2008-8#1)(2008-9#1)
is a marker of##3##4##(1994-2#1)(2012-2#1)(2013-1#1)
is a matter of debate##2##5##(2008-7#1)(2009-12#1)
is a matter of##5##4##(1996-9#1)(2007-2#1)(2008-7#1)(2009-12#1)(2009-5#1)
is a matter##6##3##(1996-9#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-5#1)
is a measure of the##2##5##(2008-10#2)
is a measure of##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)
is a measure##8##3##(2008-10#4)(2008-11#1)(2008-5#1)(2009-3#1)(2009-6#1)
is a mechanism for##2##4##(2008-7#1)(2010-12#1)
is a mechanism##4##3##(2008-7#1)(2010-12#1)(2010-9#1)(2013-8#1)
is a mediator of##5##4##(1991-12#1)(1993-8#1)(1995-2#1)(2008-11#1)(2010-5#1)
is a medical emergency##2##4##(2007-12#1)(2010-12#1)
is a medical##5##3##(1996-5#1)(2007-12#1)(2008-2#1)(2010-12#1)(2012-3#1)
is a member of a family of##2##7##(1992-3#1)(1995-8#1)
is a member of a##7##5##(1991-2#1)(1992-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-11#1)(2009-9#1)
is a member of the##26##5##(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#3)(1994-9#2)(1995-6#1)(1996-12#2)(1997-7#2)(2008-10#3)(2008-8#1)(2009-5#1)(2011-2#3)(2012-3#1)
is a member of##34##4##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-9#2)(1995-6#1)(1995-8#1)(1996-12#3)(1997-7#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-3#1)
is a membrane-bound##4##3##(1992-6#1)(1995-12#1)(2007-11#1)(2008-7#1)
is a metabolically##2##3##(2008-10#2)
is a metabolite of##2##4##(2008-3#1)(2009-12#1)
is a method for##4##4##(2008-2#1)(2008-3#2)(2008-4#1)
is a method of choice in##3##6##(2007-8#2)(2011-2#1)
is a method of##8##4##(1995-3#1)(1997-6#1)(2007-8#2)(2008-5#1)(2010-6#1)(2011-2#1)(2012-1#1)
is a method##14##3##(1995-3#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-1#1)
is a minimal##2##3##(2011-2#1)(2012-3#1)
is a mixed##3##3##(1992-12#1)(2010-2#1)(2013-8#1)
is a mixture of##8##4##(1992-11#1)(1992-6#1)(1996-12#1)(2008-10#2)(2009-12#1)(2010-2#1)(2013-1#1)
is a model for##3##4##(1990-5#1)(1995-12#1)(2010-8#1)
is a model of##2##4##(2008-9#1)(2011-2#1)
is a model system for##2##5##(2008-10#1)(2012-3#1)
is a model system##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
is a model##12##3##(1990-5#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)
is a modification of the method##2##6##(2008-11#1)(2008-4#1)
is a modification of the##4##5##(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
is a modification of##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
is a modification##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
is a modified##3##3##(1997-2#1)(2008-3#2)
is a monophyletic group##2##4##(1996-4#1)(2007-12#1)
is a moral##2##3##(1993-2#1)(2012-2#1)
is a more appropriate##2##4##(2008-11#1)(2012-1#1)
is a more efficient##2##4##(1990-11#1)(2008-10#1)
is a more important##2##4##(2008-12#1)(2008-9#1)
is a more potent##3##4##(1991-12#1)(1991-5#1)(1993-8#1)
is a more##32##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
is a much more##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
is a much##7##3##(1993-3#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
is a multi-step process##2##4##(2008-11#1)(2008-7#1)
is a multi-step##3##3##(2008-11#1)(2008-7#2)
is a multidisciplinary##3##3##(1995-3#1)(2010-5#1)(2011-2#1)
is a multidomain##2##3##(1994-5#1)(2009-6#1)
is a multifunctional##5##3##(1995-8#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
is a multimeric##2##3##(1990-5#1)(1990-8#1)
is a multistep process##3##4##(1992-2#1)(1993-8#1)(2008-12#1)
is a multistep##4##3##(1992-2#1)(1993-8#1)(2007-10#1)(2008-12#1)
is a multisystem##3##3##(1997-8#1)(2008-9#1)(2012-3#1)
is a must##6##3##(1995-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
is a mutation##2##3##(1990-5#1)(2008-9#1)
is a narrow##2##3##(2008-10#1)(2008-11#1)
is a national##2##3##(1997-1#1)(2012-12#1)
is a natural##14##3##(1993-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#2)(2013-1#2)
is a naturally occurring##3##4##(1990-11#1)(2008-5#1)(2008-7#1)
is a nearly##2##3##(1994-2#1)(2008-7#1)
is a necessary element of##2##5##(2007-11#1)(2008-11#1)
is a necessary step for##2##5##(1994-1#1)(2012-2#1)
is a necessary step##4##4##(1993-11#1)(1994-1#1)(1994-11#1)(2012-2#1)
is a necessary##12##3##(1993-11#1)(1994-1#1)(1994-11#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-4#1)(2012-2#1)
is a necessity##4##3##(2007-12#1)(2008-11#1)(2010-12#1)(2011-3#1)
is a necrotrophic##3##3##(2008-10#3)
is a need for a##2##5##(1997-6#1)(2011-2#1)
is a need for an##2##5##(1997-3#1)(2008-10#1)
is a need for development of##2##6##(2009-8#1)(2011-1#1)
is a need for further##2##5##(2007-10#1)(2011-1#1)
is a need for greater##2##5##(2008-7#1)(2011-1#1)
is a need for more##4##5##(1995-2#1)(2008-1#1)(2008-12#1)(2008-4#1)
is a need for##36##4##(1993-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#2)
is a need to develop##4##5##(2008-10#1)(2008-5#1)(2012-2#2)
is a need to improve##2##5##(2010-5#1)(2011-2#1)
is a need to increase##3##5##(2008-1#1)(2012-3#1)(2013-1#1)
is a need to##31##4##(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
is a need##70##3##(1993-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#4)
is a negative##9##3##(1993-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
is a neurodegenerative##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
is a neurological disorder characterized by##2##6##(1991-5#1)(2009-10#1)
is a neurological disorder##3##4##(1991-5#1)(2008-9#1)(2009-10#1)
is a neurological##6##3##(1991-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)
is a neuropeptide##2##3##(1996-2#1)(2008-5#1)
is a neutral##2##3##(1994-8#1)(2008-9#1)
is a new analysis##2##4##(2008-3#2)
is a new and##4##4##(2008-6#1)(2009-11#1)(2011-2#1)(2012-3#1)
is a new approach##2##4##(2008-5#1)(2009-12#1)
is a new area of##2##5##(1995-8#1)(2008-9#1)
is a new chemoattractant for##2##5##(1993-6#2)
is a new class of##2##5##(1991-9#1)(2008-10#1)
is a new concept##2##4##(1996-12#1)(1997-6#1)
is a new member of the genus##2##7##(2008-10#2)
is a new member of the##3##6##(2008-10#2)(2009-3#1)
is a new model##2##4##(1990-8#1)(2008-8#1)
is a new species in the genus##2##7##(2008-10#2)
is a new technique for##2##5##(1991-9#1)(2008-3#1)
is a new technique##5##4##(1991-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
is a new therapeutic##2##4##(1993-11#1)(2013-8#1)
is a new type of##2##5##(1995-5#1)(2008-3#1)
is a new##89##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#14)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
is a newly discovered##2##4##(1992-8#1)(2007-11#1)
is a newly##5##3##(1992-8#1)(2007-11#1)(2008-10#2)(2011-2#1)
is a non##3##3##(2007-7#1)(2008-1#1)(2013-1#1)
is a non-contact##2##3##(2009-7#1)(2013-1#1)
is a non-inflammatory##2##3##(2009-7#1)(2013-1#1)
is a non-invasive method##2##4##(1992-5#1)(2010-6#1)
is a non-invasive##4##3##(1992-5#1)(1997-8#1)(2010-6#1)(2013-1#1)
is a non-nucleoside reverse transcriptase inhibitor##2##6##(2008-5#1)(2011-2#1)
is a non-receptor tyrosine kinase that##2##6##(1995-8#1)(2012-12#1)
is a noncompetitive##2##3##(1991-5#1)(1992-3#1)
is a noncontact##2##3##(2008-3#2)
is a noninvasive##5##3##(1993-1#1)(1993-11#1)(2008-3#1)(2010-9#1)(2011-2#1)
is a nonlinear function of##2##5##(2008-8#1)(2008-9#1)
is a nonlinear function##3##4##(2008-3#1)(2008-8#1)(2008-9#1)
is a normal component of##2##5##(2008-10#1)(2008-11#1)
is a normal##7##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
is a notable##3##3##(1996-3#1)(2008-1#1)(2008-3#1)
is a novel apoptosis-inducing gene##2##5##(2008-8#1)(2008-9#1)
is a novel approach to##2##5##(2008-3#1)(2008-4#1)
is a novel approach##3##4##(2008-3#1)(2008-4#1)(2011-2#1)
is a novel gene##2##4##(2008-10#1)(2008-9#1)
is a novel member of the##2##6##(2008-10#1)(2013-1#1)
is a novel technique##4##4##(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
is a novel##66##3##(1991-12#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
is a nuclear##5##3##(1994-9#1)(1996-2#1)(2008-1#1)(2008-11#1)(2012-2#1)
is a one##4##3##(1995-10#1)(1997-5#1)(2012-2#2)
is a parasitic##4##3##(2007-2#1)(2008-10#1)(2008-2#1)(2010-11#1)
is a part of an##2##5##(2008-10#1)(2009-11#1)
is a part of the##26##5##(2008-10#1)(2010-6#1)(2010-8#1)(2011-2#22)(2013-8#1)
is a part of##28##4##(2008-10#2)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#22)(2013-8#1)
is a part##29##3##(2008-1#1)(2008-10#2)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#22)(2013-8#1)
is a partial##3##3##(1993-3#1)(1995-11#1)(2008-4#1)
is a particular##3##3##(1994-9#1)(1996-1#1)(2009-10#1)
is a particularly powerful##2##4##(2008-2#1)(2008-4#1)
is a particularly##8##3##(1993-5#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#1)
is a pathogen##2##3##(2008-10#1)(2010-3#1)
is a pathological##2##3##(1996-6#1)(2007-11#1)
is a paucity of data##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
is a paucity of studies##2##5##(2010-5#1)(2013-1#1)
is a paucity of##14##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
is a perception##2##3##(1994-3#1)(2009-2#1)
is a perennial##2##3##(2008-10#2)
is a pervasive##3##3##(2008-12#1)(2009-8#1)(2013-1#1)
is a phenomenon##3##3##(2008-11#1)(2010-4#1)(2013-7#1)
is a phospholipid##2##3##(1992-11#1)(2008-11#1)
is a physiological##2##3##(1995-2#1)(2008-10#1)
is a pivotal##2##3##(1994-1#1)(2011-2#1)
is a plant##4##3##(1993-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
is a plasma##2##3##(1995-2#1)(2009-10#1)
is a plastic##2##3##(2008-8#1)(2013-7#1)
is a pleiotropic##2##3##(2008-4#1)(2008-9#1)
is a polygenic##2##3##(2010-5#1)(2012-3#1)
is a polymorphic##2##3##(1990-6#1)(1990-8#1)
is a polypeptide##3##3##(1990-2#1)(1996-2#1)(2008-8#1)
is a poor##2##3##(2010-6#1)(2011-2#1)
is a popular##4##3##(1996-3#1)(2008-2#1)(2008-5#2)
is a population-based##2##3##(2008-12#1)(2011-2#1)
is a porous##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
is a positive##3##3##(1993-12#1)(2008-11#1)(2008-8#1)
is a possibility##6##3##(2007-6#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
is a possible##8##3##(1992-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2013-1#2)
is a potent activator of##2##5##(1990-2#1)(2010-6#1)
is a potent and##3##4##(1990-8#1)(1991-9#1)(1995-12#1)
is a potent angiogenic factor##3##5##(1992-9#1)(1994-11#1)(1995-12#1)
is a potent free radical scavenger##2##6##(1995-8#1)(2012-2#1)
is a potent immunosuppressive compound##2##5##(1993-8#1)(1995-3#1)
is a potent inducer of##4##5##(1992-8#1)(1993-3#1)(2008-11#1)(2011-2#1)
is a potent inhibitor of##10##5##(1991-12#1)(1992-12#2)(1993-8#1)(1994-11#1)(1997-1#1)(1997-4#2)(2010-6#1)(2012-12#1)
is a potent stimulator of##2##5##(1992-3#1)(2008-6#1)
is a potent vasoconstrictor##2##4##(1993-3#1)(2009-10#1)
is a potent##65##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#3)(1993-8#3)(1994-11#4)(1994-2#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2010-2#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a potential candidate for##2##5##(2008-5#1)(2012-2#1)
is a potential cause of##2##5##(1997-6#1)(2008-7#1)
is a potential inducer of##2##5##(1992-3#1)(2008-10#1)
is a potential##28##3##(1992-3#1)(1992-9#1)(1993-3#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
is a potentially fatal##2##4##(2009-11#1)(2011-2#1)
is a potentially lethal##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
is a potentially life-threatening##2##4##(2009-7#1)(2013-1#1)
is a potentially serious##2##4##(2010-8#1)(2011-2#1)
is a potentially useful technique for##2##6##(2007-11#1)(2008-2#1)
is a potentially useful##4##4##(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)
is a potentially##20##3##(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
is a powerful and##4##4##(2007-2#1)(2007-7#1)(2008-2#1)(2009-10#1)
is a powerful predictor##2##4##(2008-12#1)(2012-2#1)
is a powerful technique for developing##2##6##(1993-3#1)(2008-6#1)
is a powerful technique for##5##5##(1993-3#1)(1994-2#1)(2008-2#1)(2008-6#1)(2008-7#1)
is a powerful technique to##2##5##(2008-10#2)
is a powerful technique##10##4##(1991-5#1)(1993-3#1)(1994-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
is a powerful tool for the##2##6##(2008-10#1)(2008-4#1)
is a powerful tool for##9##5##(1996-10#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)
is a powerful tool in##2##5##(2008-1#1)(2008-10#1)
is a powerful tool to##6##5##(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
is a powerful tool##19##4##(1996-10#1)(1997-3#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
is a powerful##50##3##(1991-5#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-3#2)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#3)
is a practical and##2##4##(1993-8#1)(2008-12#1)
is a practical##7##3##(1991-2#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)
is a precursor of##2##4##(1990-7#1)(2007-11#1)
is a precursor##4##3##(1990-7#1)(1992-6#1)(2007-11#1)(2013-8#1)
is a predictor of##3##4##(1992-4#1)(2008-12#1)(2011-2#1)
is a predictor##4##3##(1992-4#1)(2008-12#1)(2010-10#1)(2011-2#1)
is a predominant##2##3##(2008-11#1)(2010-11#1)
is a predominantly##2##3##(1991-12#1)(2009-7#1)
is a prerequisite for##10##4##(1990-2#1)(1991-11#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)
is a prerequisite##12##3##(1990-2#1)(1991-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-8#1)(2012-2#1)
is a pressing need##4##4##(1990-9#1)(2008-12#1)(2008-8#1)(2013-1#1)
is a presynaptic##2##3##(1995-6#1)(1997-2#1)
is a prevalent##5##3##(1994-2#1)(2008-12#1)(2009-9#1)(2012-12#1)(2013-1#1)
is a previously undescribed##2##4##(2008-10#2)
is a previously##3##3##(2008-10#3)
is a primary##16##3##(1990-12#1)(1991-2#1)(1994-2#2)(1995-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
is a prime##3##3##(1990-4#1)(1990-5#1)(2008-4#1)
is a priority##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
is a probable##2##3##(1993-3#1)(2009-11#1)
is a problem in##2##4##(2008-10#1)(2008-11#1)
is a problem##13##3##(1991-9#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)
is a procedure in which a##3##6##(2008-4#1)(2008-5#1)(2012-3#1)
is a procedure##7##3##(2007-11#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
is a process of##3##4##(1991-9#1)(2008-2#1)(2008-9#1)
is a process that##2##4##(2011-2#2)
is a process which##4##4##(1995-2#1)(1996-12#1)(1996-2#1)(2011-2#1)
is a process##12##3##(1991-9#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(2008-2#1)(2008-9#1)(2010-5#1)(2011-2#3)
is a product of##2##4##(1993-3#1)(1995-2#1)
is a prognostic##2##3##(2008-6#1)(2009-9#1)
is a program##2##3##(2008-4#2)
is a progressive disorder##2##4##(2008-7#1)(2008-9#1)
is a progressive##10##3##(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2013-7#1)
is a project##2##3##(2010-8#1)(2013-1#1)
is a proliferative##2##3##(1990-12#1)(2013-1#1)
is a prominent##6##3##(1991-12#1)(1994-11#1)(1996-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
is a promising approach for the##3##6##(1992-8#1)(2010-4#1)(2012-2#1)
is a promising approach for##6##5##(1992-8#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-7#1)
is a promising approach##7##4##(1992-8#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-7#1)
is a promising cancer##2##4##(2008-11#1)(2012-2#1)
is a promising material for##2##5##(2007-11#1)(2008-10#1)
is a promising method for##5##5##(2008-10#2)(2008-3#2)(2012-3#1)
is a promising method to##2##5##(2008-7#1)(2009-5#1)
is a promising method##9##4##(1991-9#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
is a promising technique for##6##5##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
is a promising technique##8##4##(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#2)(2013-1#1)
is a promising tool for##3##5##(1994-12#1)(2008-10#2)
is a promising##55##3##(1991-9#2)(1992-8#1)(1994-12#1)(1997-3#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#4)
is a proper##2##3##(2008-12#1)(2008-7#1)
is a property of the##2##5##(2008-5#1)(2008-7#1)
is a property##3##3##(1991-5#1)(2008-5#1)(2008-7#1)
is a prospective##9##3##(1995-2#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#3)
is a protective##2##3##(1996-12#1)(2011-2#1)
is a protein kinase##2##4##(1993-12#1)(2009-7#1)
is a protein of##2##4##(1994-11#1)(2008-8#1)
is a protein tyrosine phosphatase##2##5##(1993-11#1)(2009-7#1)
is a protein##12##3##(1990-11#1)(1990-7#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#2)
is a pseudogene##2##3##(1993-12#1)(1993-2#1)
is a public health problem##2##5##(2012-12#1)(2013-1#1)
is a public health##3##4##(2010-7#1)(2012-12#1)(2013-1#1)
is a public##4##3##(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#1)
is a putative##7##3##(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#2)
is a qualitative and##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
is a qualitative##4##3##(2012-2#1)(2012-3#2)(2013-1#1)
is a quality##3##3##(1995-3#1)(1997-1#1)(2012-3#1)
is a question##2##3##(1991-1#1)(1992-5#1)
is a quite##2##3##(1996-12#1)(2008-9#1)
is a rapid and##4##4##(1991-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
is a rapid##10##3##(1991-12#1)(1993-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
is a rapidly emerging##2##4##(2008-10#2)
is a rapidly expanding field##2##5##(2008-5#1)(2008-7#1)
is a rapidly expanding##3##4##(2008-5#1)(2008-7#1)(2008-9#1)
is a rapidly##9##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)
is a rare and##8##4##(1993-6#1)(2007-5#1)(2007-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is a rare autosomal dominant##3##5##(2011-1#2)(2013-1#1)
is a rare autosomal recessive##5##5##(1997-8#1)(2007-7#1)(2011-1#2)(2012-2#1)
is a rare autosomal##9##4##(1997-8#1)(2007-7#1)(2008-1#1)(2011-1#4)(2012-2#1)(2013-1#1)
is a rare benign tumour of the##2##7##(2008-10#1)(2008-7#1)
is a rare benign##6##4##(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-6#1)(2013-8#1)
is a rare but potentially life-threatening##2##6##(2008-8#1)(2013-8#1)
is a rare but serious##2##5##(2007-7#1)(2008-11#1)
is a rare but##12##4##(1992-12#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
is a rare case of##2##5##(1990-5#1)(2012-2#1)
is a rare case##3##4##(1990-5#1)(2010-3#1)(2012-2#1)
is a rare cause of##5##5##(2007-12#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
is a rare clinical entity##2##5##(2012-1#1)(2012-2#1)
is a rare clinical##3##4##(2012-1#1)(2012-2#2)
is a rare complication after##3##5##(2007-8#1)(2008-12#1)(2012-12#1)
is a rare complication of##15##5##(1993-5#1)(2007-8#1)(2008-6#1)(2009-1#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#3)
is a rare complication##21##4##(1992-11#1)(1993-5#1)(2007-8#2)(2008-12#1)(2008-6#1)(2009-1#1)(2009-11#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
is a rare condition that##2##5##(2009-1#1)(2013-1#1)
is a rare condition with##2##5##(1992-9#1)(2012-3#1)
is a rare condition##15##4##(1990-12#1)(1992-9#1)(1993-3#1)(2006-10#1)(2007-8#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#3)
is a rare congenital anomaly##4##5##(1991-8#1)(2008-11#1)(2010-11#1)(2010-5#1)
is a rare congenital malformation##3##5##(2008-11#2)(2013-8#1)
is a rare congenital##9##4##(1991-8#1)(2008-10#1)(2008-11#3)(2010-11#2)(2010-5#1)(2013-8#1)
is a rare disease in##2##5##(2008-1#1)(2008-7#1)
is a rare disease of##2##5##(1996-3#1)(2013-8#1)
is a rare disease##17##4##(1992-12#1)(1992-4#1)(1993-6#2)(1996-3#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
is a rare disorder characterized by##3##6##(2010-1#1)(2010-7#1)(2012-3#1)
is a rare disorder##4##4##(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
is a rare entity and##3##5##(2007-8#1)(2011-1#1)(2013-1#1)
is a rare entity with##2##5##(2008-10#1)(2010-12#1)
is a rare entity##16##4##(1993-8#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-7#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
is a rare event##6##4##(2008-10#2)(2009-10#1)(2009-9#1)(2010-10#1)(2011-2#1)
is a rare form of##3##5##(2011-2#1)(2012-3#1)(2013-7#1)
is a rare form##4##4##(1994-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
is a rare hereditary disorder##2##5##(1994-8#1)(2013-8#1)
is a rare inflammatory##2##4##(2011-1#1)(2013-1#1)
is a rare injury##2##4##(2007-8#1)(2010-7#1)
is a rare malignant tumor##3##5##(2007-5#1)(2008-10#1)(2013-1#1)
is a rare neoplasm##4##4##(2007-5#1)(2008-4#1)(2008-7#1)(2010-3#1)
is a rare occurrence##2##4##(2009-10#1)(2013-1#1)
is a rare phenomenon##2##4##(2008-10#1)(2011-2#1)
is a rare presentation of##2##5##(2007-7#1)(2010-12#1)
is a rare primary##2##4##(1993-3#1)(2010-6#1)
is a rare subcutaneous##2##4##(2007-7#1)(2009-5#1)
is a rare subtype of##3##5##(2008-12#1)(2009-12#1)(2012-3#1)
is a rare tumor and##2##5##(2010-3#1)(2013-1#1)
is a rare tumor##7##4##(2007-5#1)(2008-6#1)(2010-3#1)(2012-2#1)(2013-1#3)
is a rare variant of##4##5##(2008-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
is a rare##251##3##(1990-12#2)(1990-5#2)(1991-11#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#3)(2006-10#2)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#6)(2007-7#8)(2007-8#13)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#7)(2008-4#1)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#2)(2009-1#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#4)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#10)(2011-2#21)(2012-1#3)(2012-12#8)(2012-2#12)(2012-3#10)(2013-1#26)(2013-7#3)(2013-8#7)
is a rate-limiting enzyme in##3##5##(1994-12#1)(1994-6#2)
is a rate-limiting enzyme##4##4##(1994-12#1)(1994-6#2)(2008-11#1)
is a rate-limiting##6##3##(1990-2#1)(1994-12#1)(1994-6#2)(1995-2#1)(2008-11#1)
is a rational approach##2##4##(1995-5#1)(2009-7#1)
is a readily##2##3##(1995-2#1)(2013-1#1)
is a real##3##3##(1995-12#1)(2007-11#1)(2008-11#1)
is a reasonable##7##3##(1991-1#1)(1991-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)
is a recent addition to##2##5##(2008-4#1)(2008-6#1)
is a recent development##2##4##(1995-2#1)(2010-6#1)
is a recent##6##3##(1995-2#1)(2008-4#1)(2008-6#1)(2010-6#1)(2012-12#1)(2013-8#1)
is a recently developed##3##4##(2007-8#1)(2008-2#1)(2008-4#1)
is a recently discovered##2##4##(1995-3#1)(2008-4#1)
is a recently identified##3##4##(1993-11#1)(1997-1#1)(2009-10#1)
is a recently##15##3##(1993-11#1)(1995-3#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2013-1#1)
is a receptor##3##3##(1997-7#1)(2008-4#1)(2010-4#1)
is a recessive autosomal disorder##2##5##(1992-5#1)(2008-1#1)
is a recessive##3##3##(1992-5#1)(2007-7#1)(2008-1#1)
is a recognized##3##3##(2009-7#1)(2012-12#1)(2012-3#1)
is a red##2##3##(2008-8#1)(2013-1#1)
is a reference##2##3##(2008-10#1)(2008-7#1)
is a reflection##2##3##(1996-5#1)(2013-1#1)
is a relative##2##3##(2011-2#1)(2012-2#1)
is a relatively common##4##4##(1991-4#1)(2009-6#1)(2011-2#2)
is a relatively frequent##2##4##(1991-12#1)(2010-5#1)
is a relatively new approach##2##5##(1992-8#1)(2007-12#1)
is a relatively new method for##2##6##(1992-5#1)(2007-11#1)
is a relatively new technique##2##5##(2008-10#1)(2010-3#1)
is a relatively new##14##4##(1992-5#1)(1992-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-2#1)
is a relatively rare##8##4##(2007-7#1)(2008-3#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a relatively simple##2##4##(1990-11#1)(2011-2#1)
is a relatively uncommon##4##4##(1994-11#1)(2008-1#1)(2013-1#1)(2013-8#1)
is a relatively##49##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is a relevant##2##3##(1993-9#1)(2008-3#1)
is a reliable and valid measure of##2##7##(2010-9#1)(2013-1#1)
is a reliable and valid##3##5##(2010-10#1)(2010-9#1)(2013-1#1)
is a reliable and##6##4##(1992-12#1)(1994-6#1)(2008-12#1)(2010-10#1)(2010-9#1)(2013-1#1)
is a reliable method to##2##5##(2006-10#1)(2013-7#1)
is a reliable##17##3##(1991-3#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#2)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#2)
is a remarkably##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
is a report of##4##4##(1991-12#1)(2008-10#2)(2012-12#1)
is a report##8##3##(1990-9#1)(1991-12#1)(1993-2#1)(2008-10#3)(2009-4#1)(2012-12#1)
is a representative of the##3##5##(2011-1#1)(2011-2#2)
is a representative of##5##4##(1991-9#1)(2011-1#1)(2011-2#3)
is a representative##6##3##(1991-9#1)(2010-8#1)(2011-1#1)(2011-2#3)
is a requirement##3##3##(2008-11#1)(2008-8#1)(2009-4#1)
is a result of the##6##5##(1993-8#1)(1996-11#1)(1996-8#1)(2008-10#2)(2008-5#1)
is a result of##22##4##(1990-12#1)(1991-12#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(2007-8#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
is a result##23##3##(1990-12#1)(1991-12#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(2007-8#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
is a retrospective analysis of two##2##6##(2007-8#1)(2011-2#1)
is a retrospective analysis of##3##5##(2007-8#1)(2011-2#1)(2012-2#1)
is a retrospective study##4##4##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
is a retrospective##14##3##(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-2#2)(2013-1#1)
is a reverse##2##3##(2010-5#1)(2013-8#1)
is a reversible##4##3##(1991-9#1)(1992-6#1)(2008-3#1)(2011-2#1)
is a review of the literature##2##6##(1991-1#1)(2011-2#1)
is a review of the##6##5##(1991-1#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-12#1)
is a review of##9##4##(1991-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
is a rich source of##2##5##(2008-5#1)(2008-9#1)
is a risk factor for##14##5##(1992-4#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#3)
is a risk factor##15##4##(1992-4#1)(1992-9#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#3)
is a risk##21##3##(1992-4#1)(1992-9#1)(1996-6#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-8#1)
is a robust##3##3##(2008-10#1)(2010-12#1)(2010-3#1)
is a routine##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
is a safe and effective treatment for##2##7##(2008-2#1)(2008-9#1)
is a safe and effective##13##5##(1993-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#2)
is a safe and efficacious##2##5##(1993-1#1)(2008-10#1)
is a safe and##19##4##(1993-1#1)(1993-12#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
is a safe procedure##2##4##(2007-8#1)(2008-10#1)
is a safe##25##3##(1993-1#1)(1993-12#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
is a safer##2##3##(2007-7#1)(2008-7#1)
is a scanning##2##3##(2008-3#1)(2008-7#1)
is a scientific##2##3##(2008-7#1)(2010-7#1)
is a secondary##2##3##(2008-9#1)(2009-8#1)
is a secreted##2##3##(1992-8#1)(2010-11#1)
is a selective##7##3##(1993-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-2#1)
is a selenoenzyme##2##3##(1990-12#1)(1992-12#1)
is a sensitive diagnostic##2##4##(2007-10#1)(2012-12#1)
is a sensitive##7##3##(1995-1#1)(1996-5#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
is a serious and##2##4##(2012-3#1)(2013-8#1)
is a serious complication##4##4##(1995-11#1)(2011-2#1)(2013-1#2)
is a serious disease of##7##5##(2008-10#7)
is a serious disease##10##4##(2008-10#8)(2010-6#1)(2011-2#1)
is a serious fungal disease##2##5##(2008-10#2)
is a serious fungal##3##4##(2008-10#3)
is a serious health problem##2##5##(2013-1#2)
is a serious problem that##2##5##(2008-10#1)(2008-3#1)
is a serious problem##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
is a serious risk##2##4##(2011-2#1)(2013-1#1)
is a serious threat to##2##5##(2008-10#2)
is a serious##48##3##(1991-6#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-11#1)(2010-6#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
is a set of##8##4##(1991-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
is a severe disease##4##4##(2008-10#3)(2008-4#1)
is a severe##13##3##(1994-8#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
is a sharp##4##3##(1992-3#1)(1995-6#1)(2009-4#1)(2010-12#1)
is a shift##2##3##(1996-2#1)(2010-12#1)
is a signal##2##3##(1994-12#1)(2008-5#1)
is a significant and##2##4##(2007-12#1)(2010-5#1)
is a significant cause of morbidity##3##6##(2008-7#1)(2012-3#1)(2013-8#1)
is a significant cause of##4##5##(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
is a significant challenge##2##4##(2007-11#1)(2011-2#1)
is a significant change in##2##5##(2008-11#1)(2008-3#1)
is a significant factor in##2##5##(2008-4#1)(2008-7#1)
is a significant health##2##4##(2011-1#1)(2011-2#1)
is a significant predictor##2##4##(2008-7#1)(2011-2#1)
is a significant public health##2##5##(2008-11#1)(2010-8#1)
is a significant risk factor for##4##6##(1997-3#1)(2011-2#1)(2012-5#1)(2013-1#1)
is a significant step##2##4##(2008-3#1)(2009-6#1)
is a significant time##2##4##(2008-9#1)(2010-5#1)
is a significant##54##3##(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#2)(1997-1#1)(1997-3#2)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#2)(2009-8#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#1)
is a simple and accurate method for##2##7##(2007-12#1)(2008-2#1)
is a simple and fast##2##5##(2008-6#1)(2008-7#1)
is a simple and rapid method##2##6##(2008-10#1)(2008-4#1)
is a simple and##11##4##(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2013-8#1)
is a simple method##2##4##(2008-10#1)(2008-2#1)
is a simple##33##3##(1990-8#1)(1993-2#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2011-1#1)(2012-2#2)(2013-8#2)
is a simpler##2##3##(2008-10#2)
is a single copy gene and##2##6##(1997-4#1)(2009-10#1)
is a single##8##3##(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-10#1)
is a single-copy gene##3##4##(1993-12#1)(1994-12#1)(1996-6#1)
is a sinusoidal##2##3##(2008-3#2)
is a site##2##3##(1995-11#1)(2012-2#1)
is a situation##2##3##(2008-10#1)(2013-1#1)
is a slight##2##3##(2008-12#1)(2008-9#1)
is a slow##4##3##(1992-5#1)(1993-11#1)(2008-10#1)(2010-3#1)
is a slowly##2##3##(2007-11#1)(2011-2#1)
is a small country##2##4##(2008-1#1)(2008-8#1)
is a small##16##3##(1991-7#1)(1992-3#1)(1994-5#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
is a socially##2##3##(1995-11#1)(2010-7#1)
is a software package##2##4##(2008-4#2)
is a soil-inhabiting##2##3##(2008-10#1)(2011-2#1)
is a soilborne pathogen##2##4##(2008-10#2)
is a soilborne##4##3##(2008-10#4)
is a solid##3##3##(1992-12#1)(2008-11#1)(2010-9#1)
is a solution of##2##4##(2007-12#1)(2008-10#1)
is a sophisticated##2##3##(2008-9#1)(2010-8#1)
is a source of##6##4##(2008-3#1)(2008-7#2)(2013-1#2)(2013-8#1)
is a special case##2##4##(2008-3#1)(2008-8#1)
is a special##6##3##(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)(2012-3#1)
is a specialized##4##3##(1995-5#1)(2008-7#2)(2009-10#1)
is a species of##2##4##(1992-8#1)(2010-3#1)
is a species##4##3##(1992-8#1)(1995-12#1)(2010-3#1)(2013-7#1)
is a specific inhibitor of##2##5##(1990-2#1)(1992-12#1)
is a specific##20##3##(1990-11#1)(1990-2#2)(1991-2#1)(1992-12#1)(1992-8#1)(1995-11#1)(1997-2#1)(1997-6#1)(2007-5#1)(2008-11#4)(2008-7#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-8#1)
is a spectrum##2##3##(2010-10#1)(2013-8#1)
is a spherical##2##3##(1990-8#1)(2010-11#1)
is a spinal##2##3##(1994-2#1)(2008-11#1)
is a stable##4##3##(1991-5#1)(2007-12#1)(2008-10#1)(2013-1#1)
is a standard##9##3##(1991-12#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)
is a statistical##3##3##(2008-9#1)(2011-3#1)(2012-3#1)
is a statistically##2##3##(1992-11#1)(2013-1#1)
is a step toward##2##4##(1995-2#1)(2007-12#1)
is a step##3##3##(1995-2#1)(2007-12#1)(2012-2#1)
is a straightforward and##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
is a straightforward##4##3##(2007-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
is a strategy##3##3##(1995-12#1)(2011-1#1)(2012-1#1)
is a strictly##2##3##(2008-10#1)(2008-9#1)
is a strong correlation between##3##5##(1997-1#1)(1997-3#1)(2011-2#1)
is a strong function of##2##5##(2007-12#1)(2008-3#1)
is a strong##25##3##(1991-2#1)(1991-9#1)(1993-2#1)(1994-11#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
is a study##2##3##(2011-1#1)(2012-2#1)
is a subjective##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
is a subset##2##3##(2007-12#1)(2008-10#1)
is a substance##2##3##(1990-2#1)(1991-9#1)
is a substantial problem##2##4##(1997-7#1)(2011-1#1)
is a substantial public health##2##5##(2011-2#1)(2013-8#1)
is a substantial##6##3##(1997-7#1)(2008-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
is a substrate for##4##4##(1991-5#1)(1992-7#2)(2009-3#1)
is a successful##2##3##(2008-3#1)(2008-4#1)
is a suitable alternative##2##4##(1996-1#1)(2008-3#1)
is a suitable material for##2##5##(2008-10#1)(2008-2#1)
is a suitable method for##2##5##(2008-10#2)
is a suitable method##3##4##(2008-10#3)
is a suitable tool for studying##2##6##(1993-6#1)(2008-8#1)
is a suitable##18##3##(1992-5#1)(1993-6#1)(1995-2#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)
is a summary of the##2##5##(1991-3#1)(2009-10#1)
is a superior##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
is a supportive##2##3##(1994-6#1)(2012-3#1)
is a surgical##2##3##(2007-12#1)(2008-9#1)
is a surrogate##2##3##(1992-8#1)(1995-1#1)
is a susceptibility##2##3##(1997-5#1)(2008-8#1)
is a syndrome characterized by##2##5##(2010-3#1)(2012-3#1)
is a syndrome##5##3##(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
is a synthetic##4##3##(1993-3#1)(2008-12#1)(2008-2#1)(2008-5#1)
is a system##2##3##(1993-3#1)(2008-11#1)
is a systemic disease which affects##2##6##(2008-10#1)(2012-12#1)
is a systemic disease##7##4##(1991-12#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
is a systemic disorder##2##4##(2011-2#1)(2012-12#1)
is a systemic##11##3##(1991-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
is a target for##2##4##(2008-1#1)(2011-1#1)
is a target##6##3##(1991-2#1)(1991-5#1)(2008-1#1)(2008-11#1)(2011-1#2)
is a technique for##3##4##(2008-10#1)(2008-4#2)
is a technique that##2##4##(2008-10#1)(2008-3#1)
is a technique used##2##4##(2008-7#1)(2012-2#1)
is a technique which##2##4##(2007-11#1)(2010-12#1)
is a technique##11##3##(2007-11#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
is a technology##2##3##(2008-5#1)(2008-9#1)
is a tendency##4##3##(2008-7#1)(2011-2#2)(2013-7#1)
is a term that##2##4##(2007-11#1)(2008-9#1)
is a term##6##3##(1996-12#1)(2007-11#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
is a therapeutic challenge##2##4##(1995-11#1)(2010-5#1)
is a therapeutic##5##3##(1995-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-1#1)
is a thin##2##3##(2008-5#1)(2008-8#1)
is a third##2##3##(1991-1#1)(2008-5#1)
is a threat to##2##4##(1997-3#1)(2010-4#1)
is a time##3##3##(1990-3#1)(1993-12#2)
is a tool to##2##4##(2008-10#1)(2008-12#1)
is a tool##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2012-1#1)
is a transcription factor##2##4##(2006-8#1)(2013-1#1)
is a transcriptional activator##2##4##(1997-3#1)(2008-9#1)
is a transcriptional##4##3##(1997-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
is a transient##2##3##(2012-3#1)(2013-1#1)
is a transmembrane protein##2##4##(1993-12#1)(2007-7#1)
is a transmembrane##4##3##(1993-12#2)(1996-12#1)(2007-7#1)
is a treatment option##2##4##(2012-3#1)(2013-1#1)
is a tree##2##3##(2007-1#1)(2008-5#1)
is a tremendous##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
is a trimeric##2##3##(1994-8#1)(2008-1#1)
is a true##2##3##(2010-6#1)(2012-2#1)
is a tumor##4##3##(1993-9#1)(1995-6#1)(2008-6#1)(2012-3#1)
is a two-dimensional##2##3##(1996-4#1)(2008-2#1)
is a two-stage##5##3##(1991-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
is a type of##5##4##(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
is a type##7##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
is a typical##9##3##(1990-3#1)(2008-10#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
is a ubiquitous##9##3##(1992-10#1)(1992-6#1)(1993-9#1)(1994-9#1)(2008-1#1)(2008-7#1)(2010-10#1)(2013-1#1)(2013-8#1)
is a unique feature##2##4##(2008-10#1)(2008-7#1)
is a unique##21##3##(1991-3#1)(1993-8#1)(1995-2#1)(1996-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
is a useful approach for##2##5##(1995-8#1)(2008-10#1)
is a useful approach##3##4##(1990-6#1)(1995-8#1)(2008-10#1)
is a useful clinical##3##4##(1993-12#2)(2008-12#1)
is a useful diagnostic##2##4##(2007-11#1)(2007-7#1)
is a useful marker of##2##5##(2008-3#1)(2010-5#1)
is a useful method for##2##5##(1990-12#1)(2012-3#1)
is a useful procedure##2##4##(2008-4#1)(2012-3#1)
is a useful strategy for##2##5##(2008-10#1)(2010-10#1)
is a useful technique for##2##5##(2008-9#1)(2013-8#1)
is a useful technique##4##4##(2007-12#1)(2008-9#1)(2010-7#1)(2013-8#1)
is a useful tool for##7##5##(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
is a useful tool in the##2##6##(1996-12#1)(2008-7#1)
is a useful tool in##4##5##(1994-2#1)(1996-12#1)(2008-7#1)(2013-8#1)
is a useful tool to##4##5##(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
is a useful tool##16##4##(1993-3#1)(1994-2#1)(1995-11#1)(1996-12#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
is a useful##66##3##(1990-12#1)(1990-5#2)(1990-6#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#3)(2013-7#1)(2013-8#2)
is a vaginal##2##3##(1996-9#1)(2007-7#1)
is a valid alternative to##2##5##(1990-2#1)(1992-5#1)
is a valid alternative##5##4##(1990-2#1)(1992-5#1)(2007-8#1)(2008-10#1)(2008-7#1)
is a valid treatment for##2##5##(2011-3#1)(2013-1#1)
is a valid##13##3##(1990-2#1)(1992-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
is a valuable source for##2##5##(2008-10#1)(2012-3#1)
is a valuable supplement to##2##5##(2007-11#1)(2007-8#1)
is a valuable tool for##5##5##(2008-3#1)(2008-6#1)(2008-9#3)
is a valuable tool in the##3##6##(2008-1#2)(2009-11#1)
is a valuable tool##10##4##(2008-1#2)(2008-3#1)(2008-6#1)(2008-9#3)(2009-11#1)(2010-11#1)(2011-1#1)
is a valuable##27##3##(1991-3#1)(1992-12#1)(1993-12#1)(1994-7#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-3#1)
is a variable##2##3##(2008-3#1)(2008-4#1)
is a variant of##4##4##(1990-11#1)(1992-2#1)(1995-11#1)(2010-7#1)
is a vascular disease##2##4##(2008-10#2)
is a vascular##8##3##(1997-3#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-1#1)
is a vehicle##2##3##(1993-3#1)(2008-8#1)
is a versatile and##2##4##(2007-12#1)(2008-9#1)
is a versatile##4##3##(2007-12#1)(2008-4#2)(2008-9#1)
is a vertex shared with the##2##6##(2008-6#2)
is a very attractive##2##4##(1992-12#1)(2012-2#1)
is a very broad##2##4##(2008-11#2)
is a very challenging##2##4##(2008-10#1)(2012-3#1)
is a very common##6##4##(1996-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
is a very complex process that##2##6##(2011-2#1)(2013-1#1)
is a very complex process##3##5##(1992-9#1)(2011-2#1)(2013-1#1)
is a very complex##4##4##(1992-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
is a very effective##2##4##(1992-8#1)(1992-9#1)
is a very good##2##4##(2008-10#2)
is a very important##8##4##(1991-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a very powerful##2##4##(2008-7#1)(2012-1#1)
is a very rapid##2##4##(2008-10#1)(2009-6#1)
is a very rare and##2##5##(2008-11#1)(2010-12#1)
is a very rare benign##2##5##(1992-2#1)(2013-7#1)
is a very rare complication##2##5##(2007-10#1)(2011-2#1)
is a very rare condition##2##5##(1997-8#1)(2007-8#1)
is a very rare entity##2##5##(2010-5#1)(2013-1#1)
is a very rare##20##4##(1990-10#1)(1992-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
is a very sensitive##2##4##(2008-10#1)(2012-3#1)
is a very serious##3##4##(1995-3#1)(2012-12#1)(2012-3#1)
is a very useful tool##2##5##(1991-2#1)(2012-2#1)
is a very useful##7##4##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
is a very##86##3##(1990-10#1)(1990-3#1)(1990-8#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-8#2)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
is a viable alternative##2##4##(2008-3#1)(2009-7#1)
is a viable option##3##4##(2008-10#1)(2009-10#1)(2013-1#1)
is a viable treatment option##2##5##(2012-12#1)(2012-2#1)
is a viable treatment##3##4##(2008-8#1)(2012-12#1)(2012-2#1)
is a viable##15##3##(2008-10#5)(2008-3#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
is a viral disease##2##4##(2008-10#2)
is a viral##4##3##(1992-9#1)(1996-11#1)(2008-10#2)
is a vital element##2##4##(1992-1#1)(2009-7#1)
is a vital##7##3##(1992-1#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-2#1)
is a way of##3##4##(1995-1#1)(2008-5#2)
is a way to##3##4##(1994-3#1)(2008-11#1)(2010-11#1)
is a way##7##3##(1994-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)
is a weak##3##3##(2008-11#1)(2009-5#1)(2010-3#1)
is a web-based##2##3##(2008-10#1)(2008-7#1)
is a well established##4##4##(1994-11#1)(2007-7#1)(2008-11#1)(2012-12#1)
is a well known##7##4##(1993-11#1)(1995-11#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#1)(2013-1#1)
is a well##13##3##(1993-11#1)(1994-11#1)(1995-11#1)(1996-12#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a well-documented##3##3##(1997-2#1)(2007-12#1)(2010-3#1)
is a well-established technique for##2##5##(2008-2#1)(2008-3#1)
is a well-established technique##3##4##(2008-2#1)(2008-3#2)
is a well-established##8##3##(2008-2#1)(2008-3#4)(2008-9#1)(2010-4#1)(2012-1#1)
is a well-known problem##2##4##(2011-1#1)(2012-3#1)
is a well-known technique for##2##5##(2008-2#1)(2008-3#1)
is a well-known##16##3##(1991-3#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is a well-recognized##4##3##(1992-6#1)(2008-7#1)(2010-7#1)(2012-3#1)
is a well-tolerated##2##3##(1995-4#1)(2013-1#1)
is a wide range of##2##5##(2007-8#1)(2008-5#1)
is a wide range##3##4##(1991-4#1)(2007-8#1)(2008-5#1)
is a wide##8##3##(1991-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2013-1#1)
is a widely studied##2##4##(1997-3#1)(2012-3#1)
is a widely used technique##3##5##(1996-8#1)(2008-3#1)(2012-12#1)
is a widely used##14##4##(1992-2#1)(1995-8#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
is a widely##17##3##(1992-2#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
is a widespread disease##2##4##(2008-10#2)
is a widespread##10##3##(2008-10#6)(2008-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
is a work in progress##2##5##(2008-7#1)(2011-1#1)
is a working##2##3##(1994-1#1)(2008-3#1)
is a worldwide problem##2##4##(2008-6#1)(2011-1#1)
is a worldwide##4##3##(2008-4#1)(2008-6#1)(2010-6#1)(2011-1#1)
is a zinc##2##3##(1991-9#1)(1994-9#1)
is a zoonotic##2##3##(2008-10#1)(2013-7#1)
is a##5236##2##(1990-10#1)(1990-11#12)(1990-12#15)(1990-2#15)(1990-3#6)(1990-4#2)(1990-5#11)(1990-6#9)(1990-7#6)(1990-8#16)(1990-9#6)(1991-1#9)(1991-11#5)(1991-12#31)(1991-2#25)(1991-3#12)(1991-4#2)(1991-5#21)(1991-6#11)(1991-7#1)(1991-8#7)(1991-9#30)(1992-1#6)(1992-10#4)(1992-11#10)(1992-12#22)(1992-2#11)(1992-3#23)(1992-4#6)(1992-5#8)(1992-6#13)(1992-7#3)(1992-8#17)(1992-9#16)(1993-1#7)(1993-10#1)(1993-11#21)(1993-12#33)(1993-2#13)(1993-3#39)(1993-5#3)(1993-6#18)(1993-8#20)(1993-9#9)(1994-1#8)(1994-11#31)(1994-12#26)(1994-2#24)(1994-3#20)(1994-5#14)(1994-6#11)(1994-7#2)(1994-8#20)(1994-9#17)(1995-1#10)(1995-10#2)(1995-11#17)(1995-12#22)(1995-2#42)(1995-3#12)(1995-4#2)(1995-5#16)(1995-6#17)(1995-8#16)(1995-9#2)(1996-1#13)(1996-10#1)(1996-11#7)(1996-12#32)(1996-2#24)(1996-3#19)(1996-4#6)(1996-5#8)(1996-6#11)(1996-7#2)(1996-8#7)(1996-9#7)(1997-1#14)(1997-2#19)(1997-3#29)(1997-4#22)(1997-5#8)(1997-6#15)(1997-7#21)(1997-8#21)(2006-10#14)(2006-12#3)(2006-6#4)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#29)(2007-11#73)(2007-12#75)(2007-2#18)(2007-4#1)(2007-5#11)(2007-6#1)(2007-7#56)(2007-8#54)(2007-9#5)(2008-1#96)(2008-10#555)(2008-11#197)(2008-12#81)(2008-2#88)(2008-3#212)(2008-4#124)(2008-5#140)(2008-6#59)(2008-7#211)(2008-8#136)(2008-9#141)(2009-1#8)(2009-10#29)(2009-11#25)(2009-12#21)(2009-2#9)(2009-3#21)(2009-4#14)(2009-5#28)(2009-6#15)(2009-7#25)(2009-8#29)(2009-9#18)(2010-1#12)(2010-10#25)(2010-11#30)(2010-12#37)(2010-2#14)(2010-3#26)(2010-4#19)(2010-5#42)(2010-6#30)(2010-7#21)(2010-8#50)(2010-9#9)(2011-1#72)(2011-2#287)(2011-3#9)(2011-7#1)(2011-8#1)(2011-9#1)(2012-1#20)(2012-12#92)(2012-2#154)(2012-3#123)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#224)(2013-7#26)(2013-8#103)
is able to achieve##2##4##(1995-5#1)(2008-11#1)
is able to bind##2##4##(1990-2#1)(1995-8#1)
is able to deliver##2##4##(2007-12#1)(2011-1#1)
is able to detect##4##4##(2008-11#1)(2008-3#2)(2010-11#1)
is able to form##2##4##(1997-6#1)(2008-8#1)
is able to generate##4##4##(1994-3#1)(2008-2#1)(2008-3#1)(2008-6#1)
is able to identify##4##4##(2008-3#1)(2013-8#3)
is able to induce the##2##5##(2008-1#1)(2008-9#1)
is able to induce##5##4##(1994-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)
is able to inhibit##2##4##(1991-6#1)(1994-6#1)
is able to interact##2##4##(1994-5#1)(2009-8#1)
is able to modulate##2##4##(1995-6#1)(2008-5#1)
is able to predict##2##4##(2008-5#1)(2010-8#1)
is able to produce a##2##5##(1997-6#1)(2008-10#1)
is able to produce##4##4##(1997-6#1)(2007-12#1)(2008-10#1)(2013-8#1)
is able to reach##2##4##(2008-10#1)(2009-12#1)
is able to recognize##3##4##(1995-8#1)(2009-8#1)(2010-6#1)
is able to recover a##2##5##(2008-3#1)(2012-12#1)
is able to reproduce the##3##5##(2008-2#1)(2008-3#1)(2008-8#1)
is able to reproduce##6##4##(1995-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)
is able to rescue the##2##5##(1993-9#1)(2008-11#1)
is able to reveal##2##4##(2007-11#1)(2008-10#1)
is able to stimulate##4##4##(1990-2#1)(1992-11#1)(1992-9#1)(2008-5#1)
is able to support##2##4##(2008-7#2)
is able to##138##3##(1990-11#1)(1990-2#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#3)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#4)(2007-6#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#5)(2009-11#2)(2009-12#3)(2009-5#3)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#4)
is able##140##2##(1990-11#1)(1990-2#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#3)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#4)(2007-6#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#5)(2009-11#2)(2009-12#3)(2009-5#3)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#4)
is abnormal##3##2##(1990-6#1)(1993-12#1)(2010-6#1)
is abolished##3##2##(1990-11#2)(1995-2#1)
is about 0##6##3##(1993-8#1)(1996-5#2)(2008-10#2)(2013-8#1)
is about 1##9##3##(1992-5#1)(1992-8#1)(1993-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-8#1)
is about 10##4##3##(2008-10#4)
is about 100##2##3##(2007-12#1)(2008-10#1)
is about 13##2##3##(1990-2#1)(2010-8#1)
is about 15%##2##3##(2008-8#1)(2012-1#1)
is about 2 months##2##4##(2008-10#2)
is about 2##7##3##(1992-8#1)(1995-5#1)(2008-10#3)(2008-8#1)(2013-8#1)
is about 3-fold##2##3##(1990-11#1)(1994-12#1)
is about 30##2##3##(1992-3#1)(2013-1#1)
is about 4##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
is about 40##2##3##(2008-10#1)(2008-12#1)
is about 5%##2##3##(2008-10#1)(2008-5#1)
is about 6%##2##3##(2008-10#1)(2008-7#1)
is about 7##2##3##(1992-2#1)(2008-10#1)
is about 90%##2##3##(1991-2#1)(2008-10#1)
is about an##2##3##(2008-7#1)(2012-3#1)
is about ten times##2##4##(2008-7#1)(2009-5#1)
is about the##2##3##(1994-5#1)(2013-8#1)
is about three##2##3##(1990-2#1)(2008-10#1)
is about to##2##3##(1995-3#1)(2007-9#1)
is about twice##2##3##(1995-12#1)(2007-12#1)
is about##103##2##(1990-11#3)(1990-12#1)(1990-2#3)(1991-2#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#5)(1993-11#1)(1993-8#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#34)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#4)
is above 0##2##3##(2008-10#1)(2013-1#1)
is above the##5##3##(1990-9#1)(2007-11#2)(2007-12#1)(2008-3#1)
is above##10##2##(1990-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2013-1#1)
is absent from the##2##4##(1990-12#1)(1994-12#1)
is absent from##3##3##(1990-12#1)(1994-12#1)(2008-10#1)
is absent in other##2##4##(2008-10#1)(2008-3#1)
is absent in the##4##4##(1993-2#1)(2008-8#1)(2009-7#1)(2010-3#1)
is absent in##10##3##(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
is absent##19##2##(1990-11#1)(1990-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-7#1)(2010-3#1)(2012-2#2)(2013-8#1)
is absolutely##4##2##(1995-3#1)(1997-1#2)(2008-3#1)
is absorbed by##2##3##(2008-3#1)(2010-12#1)
is absorbed in##2##3##(2008-10#1)(2011-1#1)
is absorbed##7##2##(2007-11#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
is abundant and##2##3##(1995-2#1)(2008-9#1)
is abundant in##2##3##(1992-11#1)(1995-2#1)
is abundant##5##2##(1992-11#1)(1995-2#2)(2008-4#1)(2008-9#1)
is accelerated by##3##3##(1991-9#1)(1993-5#1)(2008-6#1)
is accelerated##6##2##(1991-9#1)(1993-5#1)(2008-10#1)(2008-6#2)(2008-9#1)
is acceptable in the##2##4##(2008-10#1)(2008-2#1)
is acceptable in##4##3##(1996-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
is acceptable only##2##3##(2008-3#1)(2011-2#1)
is acceptable##17##2##(1990-9#1)(1991-8#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
is accepted as a##2##4##(1993-2#1)(2008-10#1)
is accepted as##4##3##(1993-2#1)(1994-9#1)(2007-6#1)(2008-10#1)
is accepted##8##2##(1993-2#1)(1994-9#1)(2007-6#1)(2008-10#1)(2008-11#3)(2011-2#1)
is accessed##2##2##(2008-12#1)(2009-5#1)
is accessible and##2##3##(1993-11#1)(2008-7#1)
is accessible to##2##3##(2008-12#1)(2008-7#1)
is accessible##8##2##(1992-2#1)(1993-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-8#1)
is accompanied by a change##2##5##(1997-7#1)(2008-2#1)
is accompanied by a decrease in##2##6##(2008-10#1)(2010-8#1)
is accompanied by a##18##4##(1992-11#1)(1994-5#1)(1994-8#1)(1997-7#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#3)(2013-1#1)
is accompanied by an increase in##3##6##(1992-9#1)(2008-3#1)(2010-5#1)
is accompanied by an##7##4##(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-5#1)
is accompanied by changes in##4##5##(1993-8#1)(1995-3#1)(2008-4#1)(2008-7#1)
is accompanied by increased##4##4##(1992-12#1)(1992-6#1)(1994-3#1)(2009-9#1)
is accompanied by numerous##2##4##(1990-9#1)(1992-11#1)
is accompanied by the##5##4##(1994-12#1)(2007-12#1)(2008-10#1)(2009-8#1)(2012-3#1)
is accompanied by##64##3##(1990-4#1)(1990-7#1)(1990-9#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#6)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
is accompanied##66##2##(1990-4#1)(1990-7#1)(1990-9#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-9#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#6)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
is accomplished by a##2##4##(2008-10#1)(2008-9#1)
is accomplished by##21##3##(1996-12#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-9#2)(2009-5#1)(2009-8#1)
is accomplished in a##2##4##(2008-2#1)(2008-3#1)
is accomplished in##4##3##(2008-2#2)(2008-3#2)
is accomplished with a##3##4##(2007-11#1)(2008-4#1)(2009-6#1)
is accomplished with##5##3##(2007-11#1)(2008-10#2)(2008-4#1)(2009-6#1)
is accomplished##36##2##(1994-2#1)(1996-12#2)(1997-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)
is accounted for by##2##4##(2008-1#1)(2008-10#1)
is accounted for##4##3##(2008-1#1)(2008-10#2)(2008-3#1)
is accumulated in the##2##4##(2008-12#1)(2008-7#1)
is accumulated in##3##3##(2007-11#1)(2008-12#1)(2008-7#1)
is accumulated##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
is accumulating evidence##2##3##(1994-12#1)(2008-7#1)
is accumulating that##2##3##(2008-7#1)(2009-3#1)
is accumulating##8##2##(1994-12#1)(1997-3#1)(2008-11#1)(2008-7#3)(2009-3#1)(2011-2#1)
is accurate and precise##3##4##(2008-10#2)(2012-2#1)
is accurate and##7##3##(2008-10#4)(2008-4#1)(2010-3#1)(2012-2#1)
is accurate to##3##3##(2008-2#1)(2008-3#2)
is accurate##23##2##(1997-2#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-2#1)
is accurately##3##2##(2007-11#1)(2008-2#1)(2013-1#1)
is achievable in##2##3##(2007-12#1)(2012-2#1)
is achievable with##2##3##(2007-11#1)(2007-12#1)
is achievable##7##2##(1994-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2012-2#2)
is achieved and##2##3##(2008-11#1)(2008-9#1)
is achieved at a##2##4##(2007-11#1)(2008-10#1)
is achieved at##7##3##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)
is achieved by a##4##4##(2008-2#1)(2008-3#3)
is achieved by employment of a##2##6##(2007-11#1)(2007-12#1)
is achieved by exploiting the##2##5##(2007-12#1)(2008-10#1)
is achieved by means of a##2##6##(1991-12#1)(2008-3#1)
is achieved by means of##6##5##(1991-12#1)(2008-10#2)(2008-12#1)(2008-3#2)
is achieved by the##8##4##(1992-1#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-6#1)
is achieved by use of a##4##6##(2007-11#1)(2007-12#3)
is achieved by use of##8##5##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)
is achieved by##71##3##(1990-2#1)(1991-12#1)(1992-1#1)(1994-3#1)(1994-5#1)(1997-7#1)(2007-11#9)(2007-12#13)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
is achieved for##6##3##(2007-12#1)(2008-10#2)(2008-3#2)(2013-1#1)
is achieved from the##2##4##(2010-3#1)(2010-7#1)
is achieved from##4##3##(2008-10#1)(2008-5#1)(2010-3#1)(2010-7#1)
is achieved in##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
is achieved only##2##3##(1994-11#1)(2008-2#1)
is achieved over the##2##4##(1990-2#1)(2013-8#1)
is achieved through a##2##4##(2007-12#1)(2008-4#1)
is achieved through the##2##4##(1994-9#1)(2008-9#1)
is achieved through##9##3##(1994-9#1)(2007-12#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
is achieved under##3##3##(2007-12#1)(2008-6#1)(2010-1#1)
is achieved using##3##3##(2008-10#2)(2008-11#1)
is achieved when##4##3##(2007-11#1)(2008-3#2)(2008-7#1)
is achieved with a##6##4##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
is achieved with an##3##4##(2007-11#1)(2008-2#2)
is achieved with the##3##4##(2008-10#1)(2008-3#2)
is achieved with##23##3##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2012-2#1)
is achieved without##2##3##(2007-11#1)(2013-8#1)
is achieved##189##2##(1990-11#1)(1990-2#2)(1991-12#1)(1992-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#2)(2007-11#18)(2007-12#27)(2007-8#1)(2008-10#39)(2008-11#5)(2008-12#1)(2008-2#21)(2008-3#30)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-3#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
is acid##2##2##(1996-2#1)(1997-1#1)
is acidic##2##2##(2008-10#1)(2008-12#1)
is acknowledged by##2##3##(1991-3#1)(2012-3#1)
is acknowledged##7##2##(1991-3#1)(1992-1#1)(2008-11#2)(2008-12#1)(2012-3#2)
is acquired and##2##3##(2007-8#1)(2008-3#1)
is acquired during##2##3##(1990-9#1)(2011-1#1)
is acquired in##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
is acquired##13##2##(1990-9#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-3#6)(2009-3#1)(2011-1#1)
is acquiring Cantonese##2##3##(2008-9#2)
is acquiring##3##2##(2008-9#2)(2013-1#1)
is acting as##2##3##(1990-7#1)(2008-6#1)
is acting##4##2##(1990-7#1)(1996-5#1)(2008-11#1)(2008-6#1)
is activated by a##3##4##(1991-2#1)(1995-6#1)(2008-10#1)
is activated by the##2##4##(1992-3#1)(2008-4#1)
is activated by##25##3##(1990-11#2)(1990-2#1)(1991-2#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-11#2)(1994-5#1)(1995-6#2)(1996-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)
is activated during##2##3##(1993-3#1)(2008-11#1)
is activated in##9##3##(1991-9#1)(1992-12#1)(1992-8#1)(2008-11#1)(2008-7#2)(2010-11#2)(2013-1#1)
is activated through phosphorylation##2##4##(1995-2#1)(2011-2#1)
is activated through##3##3##(1995-2#1)(2008-4#1)(2011-2#1)
is activated when##3##3##(1995-11#1)(1995-8#1)(2008-10#1)
is activated with##2##3##(2008-10#1)(2008-8#1)
is activated##55##2##(1990-11#2)(1990-2#1)(1991-2#1)(1991-3#1)(1991-9#4)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-7#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
is activation of the##2##4##(1996-2#1)(2012-12#1)
is activation of##3##3##(1996-2#1)(2008-8#1)(2012-12#1)
is active against##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
is active in##9##3##(1990-11#1)(1991-9#1)(1992-10#1)(1992-12#1)(1994-2#1)(1997-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
is active##22##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1994-2#1)(1997-4#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-4#1)(2012-3#1)(2013-8#1)
is actively involved in##3##4##(1994-11#1)(2007-12#1)(2010-5#1)
is actively##12##2##(1990-5#2)(1994-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
is actual##2##2##(1995-9#1)(2012-3#1)
is actually##8##2##(1992-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
is acute##2##2##(1993-9#1)(2009-10#1)
is acutely##3##2##(1993-5#1)(1994-11#1)(2008-7#1)
is adaptable to##2##3##(1992-12#1)(2010-8#1)
is adapted to##6##3##(1997-4#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2013-8#1)
is adapted##7##2##(1997-4#1)(2007-12#1)(2008-3#2)(2008-6#1)(2009-10#1)(2013-8#1)
is adaptive##2##2##(1996-6#1)(2010-3#1)
is added at##2##3##(2007-11#1)(2008-8#1)
is added to the solution##2##5##(2008-10#2)
is added to the##10##4##(1990-11#1)(1991-3#1)(1992-12#1)(2007-12#1)(2008-10#5)(2008-5#1)
is added to##16##3##(1990-11#1)(1991-3#1)(1992-12#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-5#1)
is added##34##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-11#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2010-12#1)
is additive to##2##3##(1990-2#1)(1992-11#1)
is additive##3##2##(1990-2#1)(1991-5#1)(1992-11#1)
is addressed by##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
is addressed in##2##3##(2010-9#1)(2012-2#1)
is addressed##20##2##(1992-2#1)(1992-3#1)(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#2)(2009-5#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
is adequate for the##2##4##(2008-10#2)
is adequate for##8##3##(1991-6#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-9#1)
is adequate match of the screw diameter up with the pedicle diameter##2##12##(2007-11#2)
is adequate##16##2##(1991-6#2)(2007-11#2)(2007-7#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)
is adequately##2##2##(2008-3#1)(2008-5#1)
is adiabatically##2##2##(2007-12#1)(2012-2#1)
is adjacent to##2##3##(1995-6#1)(2008-10#1)
is adjusted##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
is administered in##3##3##(1991-6#1)(2008-10#2)
is administered##9##2##(1991-6#1)(1993-6#1)(2008-10#3)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
is admixed##2##2##(2008-11#1)(2011-2#1)
is adopted and##2##3##(2007-12#1)(2008-10#1)
is adopted for##2##3##(2008-10#1)(2013-8#1)
is adopted to##2##3##(2008-2#1)(2009-7#1)
is adopted##11##2##(1994-2#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2009-7#1)(2011-2#1)(2013-8#1)
is adsorbed##6##2##(1994-5#1)(2008-10#4)(2008-6#1)
is advanced##4##2##(1990-3#1)(1994-8#1)(1995-8#1)(2008-11#1)
is advantageous as it##2##4##(2008-2#1)(2008-7#1)
is advantageous because##3##3##(1997-6#1)(2008-4#1)(2013-1#1)
is advantageous for##2##3##(1995-12#1)(2008-2#1)
is advantageous in##3##3##(2008-10#1)(2009-10#1)(2010-9#1)
is advantageous##16##2##(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-9#1)(2013-1#1)
is adversely##2##2##(2008-11#1)(2012-2#1)
is advisable for##2##3##(2008-8#1)(2011-2#1)
is advisable in##2##3##(1990-9#1)(2011-2#1)
is advisable##15##2##(1990-9#1)(1992-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
is advised##8##2##(1992-5#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
is advocated for##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
is advocated##14##2##(1990-9#1)(1993-2#1)(1994-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)
is affected and##2##3##(2008-11#1)(2010-7#1)
is affected by a##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
is affected by the##13##4##(1991-12#1)(1993-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)
is affected by##45##3##(1990-11#1)(1990-9#1)(1991-12#1)(1993-12#1)(1995-1#1)(1995-5#1)(1996-12#2)(1997-4#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
is affected in##3##3##(1995-6#2)(1996-6#1)
is affected only##2##3##(2008-2#1)(2008-3#1)
is affected##68##2##(1990-11#2)(1990-9#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
is again##5##2##(1992-11#1)(1992-6#2)(2006-6#1)(2009-11#1)
is age at##2##3##(2010-8#2)
is age##4##2##(2007-6#1)(2008-8#1)(2010-8#2)
is aggressive##3##2##(2007-12#1)(2009-5#1)(2011-2#1)
is aggressively##2##2##(1995-12#1)(1996-12#1)
is aimed at investigating##2##4##(2008-7#1)(2009-1#1)
is aimed at the##3##4##(2008-10#1)(2010-12#1)(2012-3#1)
is aimed at##14##3##(1996-1#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is aimed to##2##3##(2011-3#1)(2013-7#1)
is aimed##16##2##(1996-1#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-12#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is alive and##2##3##(1991-6#1)(1995-1#1)
is alive##6##2##(1990-2#1)(1990-9#1)(1991-6#1)(1995-1#1)(2007-5#1)(2010-9#1)
is all the more##4##4##(1991-3#1)(1992-3#1)(2008-10#1)(2008-3#1)
is all##7##2##(1991-3#1)(1992-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
is allelic to##2##3##(1995-6#1)(2008-10#1)
is allocated to##2##3##(2008-4#1)(2011-10#1)
is allocated##3##2##(1992-2#1)(2008-4#1)(2011-10#1)
is allowed in the##2##4##(2008-12#1)(2008-3#1)
is allowed to##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
is allowed##10##2##(1992-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#1)
is almost a##2##3##(2008-3#1)(2008-5#1)
is almost always##6##3##(1992-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-6#1)
is almost certainly##2##3##(1995-11#1)(2013-1#1)
is almost complete in##2##4##(2008-10#2)
is almost complete##3##3##(2008-10#2)(2008-7#1)
is almost completely##2##3##(2008-2#1)(2011-1#1)
is almost entirely##2##3##(1994-8#1)(2007-11#1)
is almost identical to the##2##5##(1995-9#1)(2009-8#1)
is almost identical to##3##4##(1995-9#1)(2007-12#1)(2009-8#1)
is almost inevitable##2##3##(2009-3#1)(2012-12#1)
is almost the same as##2##5##(1995-12#1)(2008-2#1)
is almost totally##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
is almost##48##2##(1991-2#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
is alpha##2##2##(1995-5#1)(1996-5#1)
is already a##2##3##(2008-10#1)(2010-7#1)
is already available##2##3##(2007-10#1)(2007-7#1)
is already being##2##3##(1994-2#1)(2008-1#1)
is already in##2##3##(2008-11#1)(2013-8#1)
is already the##2##3##(2010-3#1)(2011-2#1)
is already##29##2##(1990-12#1)(1991-12#1)(1992-11#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#2)
is also a convenient##2##4##(1994-6#1)(2008-3#1)
is also a major##2##4##(2008-10#2)
is also a need##3##4##(2007-7#1)(2008-1#1)(2008-11#1)
is also a very##3##4##(2007-7#1)(2008-10#1)(2012-12#1)
is also a##47##3##(1990-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-5#1)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
is also able to##3##4##(2008-3#1)(2008-9#1)(2009-6#1)
is also active##2##3##(1994-5#1)(2008-5#1)
is also addressed##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
is also affected##2##3##(2008-10#1)(2012-12#1)
is also an effective treatment##2##5##(2007-11#1)(2012-2#1)
is also an ideal##2##4##(2008-9#1)(2012-2#1)
is also an important##2##4##(2008-5#1)(2008-8#1)
is also an increase in the##3##6##(1990-7#1)(2007-12#1)(2011-2#1)
is also an##16##3##(1990-7#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-5#2)(2008-8#2)(2008-9#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
is also analyzed##2##3##(2008-3#2)
is also apparent that##2##4##(1995-3#1)(2011-1#1)
is also applicable to other##2##5##(2008-11#1)(2008-3#1)
is also applicable to##7##4##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)
is also applicable##8##3##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)
is also applied to the##2##5##(1993-12#1)(1996-5#1)
is also applied to##3##4##(1993-12#1)(1996-5#1)(2008-3#1)
is also associated with an##2##5##(2008-6#1)(2011-2#1)
is also associated with increased##2##5##(1996-12#1)(2013-1#1)
is also associated with##16##4##(1991-11#1)(1991-12#2)(1992-2#1)(1993-9#1)(1995-11#1)(1996-12#1)(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
is also associated##17##3##(1991-11#1)(1991-12#2)(1992-2#1)(1993-9#1)(1995-11#1)(1996-12#1)(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
is also available##2##3##(1991-12#1)(2008-11#1)
is also being evaluated##2##4##(2008-5#2)
is also being##3##3##(1992-10#1)(2008-5#2)
is also briefly##2##3##(2008-11#1)(2008-3#1)
is also capable of detecting##2##5##(2008-10#1)(2008-3#1)
is also capable of##6##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)
is also capable##7##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
is also carried out##2##4##(2008-10#2)
is also carried##3##3##(2008-10#3)
is also characterized by##2##4##(2008-1#1)(2008-5#1)
is also common##4##3##(1995-9#1)(1997-1#1)(1997-8#1)(2008-1#1)
is also commonly##2##3##(1996-8#1)(2008-8#1)
is also compared with##4##4##(2008-2#2)(2008-3#2)
is also confirmed by##3##4##(1997-4#1)(2008-10#1)(2008-6#1)
is also considered##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
is also consistent with the##3##5##(2008-5#1)(2008-8#1)(2013-1#1)
is also consistent with##5##4##(1991-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
is also critical to##2##4##(2008-4#1)(2011-2#1)
is also critical##3##3##(2008-4#2)(2011-2#1)
is also demonstrated in the##2##5##(2007-12#1)(2008-10#1)
is also demonstrated in##3##4##(2007-12#1)(2008-10#2)
is also demonstrated to##2##4##(1995-2#1)(2008-3#1)
is also demonstrated with##2##4##(2007-12#1)(2008-3#1)
is also demonstrated##17##3##(1990-7#1)(1995-2#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-3#7)
is also dependent on##3##4##(1996-12#1)(2008-2#1)(2008-5#1)
is also dependent##4##3##(1994-8#1)(1996-12#1)(2008-2#1)(2008-5#1)
is also derived##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
is also described that##2##4##(1996-2#1)(2008-4#1)
is also described##26##3##(1992-1#1)(1996-2#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-2#4)(2008-3#1)(2008-4#5)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
is also designed##2##3##(1994-1#1)(2010-8#1)
is also detected in the##2##5##(1996-12#1)(2008-10#1)
is also detected##3##3##(1996-12#1)(1997-2#1)(2008-10#1)
is also determined##4##3##(1992-9#1)(2007-11#1)(2008-10#2)
is also discussed in the##2##5##(1993-11#1)(1997-6#1)
is also discussed in##3##4##(1993-11#1)(1997-6#1)(2008-6#1)
is also discussed##57##3##(1991-2#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#16)(2008-2#3)(2008-3#7)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
is also effective in##3##4##(1994-8#1)(2008-2#1)(2008-3#1)
is also effective##5##3##(1990-10#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-3#1)
is also essential for the##2##5##(1995-6#1)(2012-1#1)
is also essential for##3##4##(1995-6#1)(2008-7#1)(2012-1#1)
is also essential##5##3##(1995-6#1)(1997-1#1)(2008-7#1)(2010-7#1)(2012-1#1)
is also evaluated##4##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-11#1)
is also evidence##7##3##(1992-4#1)(1995-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
is also examined##5##3##(1996-2#1)(2008-10#1)(2008-2#2)(2009-11#1)
is also expected##2##3##(2008-10#1)(2010-8#1)
is also expressed in##4##4##(1994-10#1)(1995-2#1)(2008-4#1)(2012-12#1)
is also expressed##6##3##(1992-12#1)(1994-10#1)(1995-2#1)(2008-2#1)(2008-4#1)(2012-12#1)
is also faster##2##3##(2007-12#1)(2008-10#1)
is also found##8##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)
is also given to##2##4##(1992-9#1)(2008-9#1)
is also given##8##3##(1992-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
is also growing in##2##4##(1992-11#1)(2008-12#1)
is also growing##5##3##(1992-11#1)(2006-10#1)(2008-12#1)(2008-7#1)(2010-5#1)
is also highly conserved##2##4##(1990-8#1)(2012-2#1)
is also highly##7##3##(1990-2#1)(1990-8#1)(1995-2#1)(2008-1#1)(2009-10#1)(2011-2#1)(2012-2#1)
is also identified##2##3##(2007-11#1)(2010-2#1)
is also illustrated##3##3##(1994-2#1)(2007-7#1)(2008-3#1)
is also impaired##2##3##(1991-7#1)(2008-1#1)
is also implicated in the##2##5##(1994-9#1)(2008-4#1)
is also implicated in##3##4##(1994-9#1)(2008-10#1)(2008-4#1)
is also important for##6##4##(1994-5#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
is also important in##3##4##(2008-6#1)(2008-7#1)(2009-6#1)
is also important to##4##4##(1993-6#1)(2008-10#1)(2008-7#2)
is also important##18##3##(1992-3#1)(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-8#1)
is also improved##2##3##(2008-10#1)(2008-3#1)
is also in##2##3##(2008-10#1)(2009-10#1)
is also included##13##3##(1997-3#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-9#1)(2009-8#1)
is also increased##2##3##(2008-3#2)
is also increasing##5##3##(1995-11#1)(1995-3#1)(2007-7#1)(2008-8#1)(2013-1#1)
is also induced by##3##4##(1991-9#1)(1997-7#1)(2008-11#1)
is also influenced by##3##4##(1994-5#1)(2008-6#1)(2012-12#1)
is also inhibited by##2##4##(1995-8#1)(1997-7#1)
is also insensitive to##2##4##(2008-3#2)
is also introduced##2##3##(2008-5#1)(2012-3#1)
is also investigated and##2##4##(2008-10#1)(2008-12#1)
is also investigated##14##3##(1994-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#4)(2010-4#1)
is also involved in the##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
is also involved in##6##4##(1997-2#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#2)
is also known to induce##2##5##(1993-8#1)(2012-12#1)
is also known to##5##4##(1990-5#1)(1993-8#1)(1994-6#1)(2010-3#1)(2012-12#1)
is also known##8##3##(1990-5#1)(1993-8#1)(1994-6#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-6#1)(2012-12#1)
is also likely to be##2##5##(2010-2#1)(2012-2#1)
is also likely to##3##4##(2008-5#1)(2010-2#1)(2012-2#1)
is also likely##4##3##(2008-5#1)(2009-8#1)(2010-2#1)(2012-2#1)
is also made##2##3##(2008-10#1)(2008-5#1)
is also necessary for##2##4##(2008-9#1)(2009-8#1)
is also necessary to##3##4##(2009-2#1)(2009-6#1)(2011-2#1)
is also necessary##5##3##(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-2#1)
is also needed on##2##4##(1994-2#1)(2013-8#1)
is also needed##3##3##(1994-2#1)(1994-5#1)(2013-8#1)
is also not##2##3##(2008-3#1)(2013-1#1)
is also observed in the##4##5##(1992-8#1)(1994-6#1)(2008-2#1)(2008-7#1)
is also observed in##8##4##(1992-8#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
is also observed##10##3##(1992-8#1)(1994-6#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
is also obtained##2##3##(2008-2#1)(2008-3#1)
is also of##6##3##(1990-2#1)(1993-11#1)(1994-2#1)(2008-9#1)(2011-2#2)
is also outlined##2##3##(2008-4#1)(2011-1#1)
is also particularly##2##3##(2008-12#1)(2010-3#1)
is also placed##2##3##(2008-2#1)(2010-3#1)
is also possible that##3##4##(1994-9#1)(2007-10#1)(2013-1#1)
is also possible to##5##4##(1997-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
is also possible via##2##4##(2008-6#1)(2009-2#1)
is also possible##13##3##(1994-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-2#1)(2013-1#1)
is also present in##4##4##(1992-8#1)(1997-3#1)(1997-7#1)(2008-4#1)
is also present##7##3##(1992-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-4#2)(2011-2#1)
is also presented and##2##4##(2008-3#2)
is also presented that##3##4##(1993-6#1)(1995-6#1)(2007-12#1)
is also presented##43##3##(1990-5#1)(1991-5#1)(1993-6#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#3)(2008-6#2)(2008-9#2)(2010-3#1)
is also proposed##11##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-5#1)
is also provided for##3##4##(2008-1#1)(2008-4#2)
is also provided##20##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#7)(2008-5#1)(2008-7#1)(2008-9#3)
is also quite##2##3##(1993-6#1)(2008-9#1)
is also recorded##2##3##(2007-11#1)(2008-2#1)
is also reduced##2##3##(1994-8#1)(2010-12#1)
is also reflected##2##3##(1990-5#1)(1991-12#1)
is also regulated##2##3##(1993-11#1)(2008-9#1)
is also relatively##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
is also reported##11##3##(1991-5#1)(1992-9#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#1)
is also required for the##2##5##(1990-11#1)(2013-7#1)
is also required for##5##4##(1990-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2013-7#1)
is also required##11##3##(1990-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
is also responsible for##4##4##(1990-8#1)(1996-1#1)(2008-10#1)(2010-5#1)
is also reviewed##3##3##(2008-2#1)(2010-12#1)(2011-1#1)
is also seen in##3##4##(2008-1#1)(2009-12#1)(2009-9#1)
is also seen##4##3##(2007-8#1)(2008-1#1)(2009-12#1)(2009-9#1)
is also shown and##2##4##(2008-3#2)
is also shown to be##2##5##(2008-10#1)(2008-3#1)
is also shown to##4##4##(1995-2#1)(1997-5#1)(2008-10#1)(2008-3#1)
is also shown##23##3##(1990-2#1)(1990-8#1)(1992-5#1)(1995-2#2)(1996-5#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-4#1)(2009-7#1)
is also significantly##3##3##(1990-8#1)(1993-3#1)(2008-2#1)
is also still##2##3##(2007-8#1)(2012-3#1)
is also stressed##2##3##(2008-10#1)(2008-4#1)
is also studied##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
is also suggested##7##3##(1990-12#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
is also suitable for the##2##5##(1996-5#1)(2008-10#1)
is also suitable for##5##4##(1996-5#1)(2008-10#3)(2008-6#1)
is also suitable##6##3##(1996-5#1)(2007-12#1)(2008-10#3)(2008-6#1)
is also summarized##2##3##(2008-12#1)(2008-3#1)
is also supported by##5##4##(1994-12#1)(2008-1#1)(2008-10#2)(2008-7#1)
is also taken into account##2##5##(2008-2#1)(2008-3#1)
is also the first##2##4##(2008-10#1)(2009-1#1)
is also the major##3##4##(1995-6#1)(2008-1#1)(2012-2#1)
is also the possibility of##2##5##(2007-2#1)(2008-10#1)
is also the##13##3##(1995-6#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-2#1)
is also thought to##2##4##(2012-3#1)(2013-8#1)
is also under##2##3##(2008-10#1)(2008-11#1)
is also used as an##3##5##(2008-11#1)(2008-3#1)(2008-9#1)
is also used as##4##4##(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)
is also used for##2##4##(1994-3#1)(2009-8#1)
is also used in##3##4##(1995-6#1)(2008-9#2)
is also used to treat##2##5##(2008-3#1)(2013-1#1)
is also used to##4##4##(2008-10#1)(2008-3#1)(2010-3#1)(2013-1#1)
is also used##16##3##(1992-5#1)(1994-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#3)(2009-8#1)(2010-3#2)(2013-1#1)
is also useful for##3##4##(1994-11#1)(2008-1#1)(2008-2#1)
is also useful in##3##4##(1992-3#1)(2010-8#1)(2012-2#1)
is also useful to##2##4##(1997-1#1)(2007-2#1)
is also useful##8##3##(1992-3#1)(1994-11#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-2#1)(2010-8#1)(2012-2#1)
is also very##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
is also well##6##3##(1990-3#1)(1996-3#1)(2008-2#1)(2008-3#2)(2008-9#1)
is also##877##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#5)(1990-7#4)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#4)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#5)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#2)(1995-5#3)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#5)(1996-8#3)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#24)(2007-12#23)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#20)(2008-10#117)(2008-11#19)(2008-12#10)(2008-2#57)(2008-3#89)(2008-4#45)(2008-5#21)(2008-6#12)(2008-7#20)(2008-8#22)(2008-9#30)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#5)(2010-2#3)(2010-3#6)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#11)(2010-9#1)(2011-1#9)(2011-2#29)(2012-1#2)(2012-12#9)(2012-2#10)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#6)
is altered and##2##3##(1994-9#1)(2008-8#1)
is altered by the##3##4##(1992-5#1)(2008-7#1)(2008-9#1)
is altered by##7##3##(1992-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-7#1)(2008-9#1)
is altered in a##2##4##(2008-11#1)(2012-2#1)
is altered in##9##3##(1990-3#1)(1991-9#1)(1992-6#1)(1994-8#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-1#1)(2012-2#1)
is altered##27##2##(1990-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
is alternative##2##2##(2007-11#1)(2009-6#1)
is altruistic##2##2##(2011-2#2)
is always a##3##3##(1991-3#1)(2008-3#1)(2008-6#1)
is always associated with##2##4##(2008-10#1)(2013-1#1)
is always larger than##2##4##(1995-9#1)(2007-12#1)
is always necessary##2##3##(2007-11#1)(2008-7#1)
is always present##2##3##(2008-10#1)(2008-3#1)
is always the##3##3##(1994-1#1)(2008-9#2)
is always##40##2##(1990-7#1)(1991-11#1)(1991-3#1)(1992-8#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-9#1)(1997-1#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is amenable to##8##3##(1996-2#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#2)(2012-2#1)
is amenable##9##2##(1996-2#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-2#1)(2011-2#2)(2012-2#1)
is among one of the##2##5##(2012-12#1)(2013-7#1)
is among the most##5##4##(1995-5#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
is among the##17##3##(1992-12#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)
is among##23##2##(1992-12#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
is ample evidence##3##3##(1991-5#1)(2008-3#1)(2008-7#1)
is amplified and##2##3##(1992-9#1)(2008-2#1)
is amplified by##4##3##(1997-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
is amplified in##2##3##(2008-10#1)(2009-7#1)
is amplified##10##2##(1990-6#1)(1992-9#1)(1997-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)
is amyloid##2##2##(1992-12#1)(2013-8#1)
is an 18-year old##2##4##(2007-7#1)(2008-10#1)
is an EU-funded##2##3##(2008-7#2)
is an X-linked disorder##2##4##(2007-7#1)(2011-2#1)
is an X-linked##6##3##(2007-7#2)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#1)
is an abnormal##5##3##(2007-10#1)(2010-5#1)(2011-1#1)(2013-1#2)
is an absolute requirement for##2##5##(1990-11#1)(1994-11#1)
is an absolute requirement##3##4##(1990-11#1)(1994-11#1)(2008-10#1)
is an absolute##8##3##(1990-11#1)(1994-11#1)(2008-10#3)(2008-4#1)(2010-3#1)(2011-2#1)
is an abundant##4##3##(1991-2#1)(1995-2#2)(2010-4#1)
is an acceptable treatment##2##4##(2007-8#1)(2008-11#1)
is an acceptable##4##3##(1996-12#1)(2007-8#1)(2008-11#1)(2009-11#1)
is an accepted##2##3##(2008-12#1)(2013-8#1)
is an account of the##2##5##(1995-2#1)(2008-7#1)
is an accurate##3##3##(1993-3#1)(2008-2#1)(2010-1#1)
is an active and##2##4##(1992-10#1)(2010-3#1)
is an active component of##2##5##(1994-8#1)(2012-3#1)
is an active process##2##4##(1992-7#1)(2012-3#1)
is an active##19##3##(1991-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#3)
is an activity##2##3##(2008-10#1)(2013-7#1)
is an acute##9##3##(1995-5#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-2#2)
is an adaptation of##2##4##(2012-2#1)(2013-1#1)
is an adaptive##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
is an additional##3##3##(1991-1#1)(1993-3#1)(2008-10#1)
is an adequate##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
is an advanced##3##3##(2008-3#1)(2008-4#1)(2010-2#1)
is an advantage in##2##4##(2008-2#1)(2008-3#1)
is an advantage##4##3##(1995-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
is an aerobic##2##3##(2011-2#2)
is an age-related##2##3##(2008-7#2)
is an aggressive neoplasm##2##4##(2010-3#1)(2012-1#1)
is an aggressive##6##3##(2008-10#2)(2010-3#2)(2012-1#1)(2012-12#1)
is an alkaline##2##3##(2008-10#1)(2008-11#1)
is an allele of##2##4##(1995-9#1)(1997-4#1)
is an altered##2##3##(2009-12#1)(2013-7#1)
is an alternative and##2##4##(2008-6#1)(2013-8#1)
is an alternative to##11##4##(1994-9#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
is an alternative##23##3##(1990-8#1)(1994-9#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#3)
is an analysis of##2##4##(1990-8#1)(2010-11#1)
is an analytical##2##3##(2008-2#1)(2012-2#1)
is an ancient##2##3##(2009-8#2)
is an angiogenic##2##3##(1994-6#1)(2008-9#1)
is an apparent##4##3##(1991-12#1)(2008-3#1)(2008-7#1)(2010-1#1)
is an appealing##2##3##(2008-10#1)(2008-8#1)
is an approach##2##3##(2008-10#1)(2012-3#1)
is an appropriate##9##3##(1995-1#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)
is an approximately##2##3##(2008-3#1)(2008-6#1)
is an area in which##2##5##(2008-10#2)
is an area in##3##4##(1991-12#1)(2008-10#2)
is an area of intense investigation##2##6##(2008-11#1)(2008-7#1)
is an area of##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
is an area that has##2##5##(2008-11#1)(2009-8#1)
is an area that##3##4##(2008-11#1)(2008-5#1)(2009-8#1)
is an area##10##3##(1991-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)
is an artificial sweetener used throughout the world in food and beverages##2##12##(2008-8#1)(2008-9#1)
is an attempt to review##2##5##(1990-12#1)(2012-2#1)
is an attempt to##6##4##(1990-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2012-2#1)(2013-8#1)
is an attempt##8##3##(1990-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-3#1)(2009-9#1)(2012-2#1)(2013-8#1)
is an attractive alternative##2##4##(1997-8#1)(2012-2#1)
is an attractive technique##3##4##(2008-10#3)
is an attractive##13##3##(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-2#1)
is an autoimmune disease##7##4##(1990-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
is an autoimmune##10##3##(1990-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
is an autosomal dominant disorder caused by##2##7##(2012-3#1)(2013-1#1)
is an autosomal dominant disorder characterized by##3##7##(2008-8#1)(2010-3#1)(2010-9#1)
is an autosomal dominant disorder##8##5##(2007-10#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#2)
is an autosomal dominant##20##4##(1993-12#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
is an autosomal recessive disorder##5##5##(1991-8#1)(1991-9#1)(2008-7#1)(2010-3#1)(2011-1#1)
is an autosomal recessive##11##4##(1990-8#1)(1991-8#1)(1991-9#1)(1995-6#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
is an autosomal##31##3##(1990-8#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-6#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#2)(2008-8#1)(2010-3#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
is an early event##2##4##(2007-4#1)(2010-3#1)
is an early##7##3##(1992-3#1)(2007-4#1)(2008-8#1)(2010-3#2)(2010-5#1)(2012-2#1)
is an easily##4##3##(1994-12#1)(2008-10#1)(2009-9#1)(2013-1#1)
is an easy and##2##4##(1990-8#1)(2010-3#1)
is an easy##3##3##(1990-8#1)(2008-9#1)(2010-3#1)
is an economical and##2##4##(2008-10#2)
is an economical##3##3##(2008-10#2)(2011-1#1)
is an economically important disease of##3##6##(2007-2#1)(2008-10#2)
is an economically important##5##4##(2007-2#1)(2008-10#4)
is an effect##2##3##(2008-3#1)(2013-8#1)
is an effective alternative##2##4##(2010-8#1)(2013-8#1)
is an effective and well tolerated##2##6##(1990-12#1)(1991-6#1)
is an effective and##7##4##(1990-12#1)(1991-12#1)(1991-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)
is an effective approach for##2##5##(2007-8#1)(2013-1#1)
is an effective means of##2##5##(2008-10#2)
is an effective method of##3##5##(1993-12#1)(2008-12#1)(2011-2#1)
is an effective method to##3##5##(2008-10#1)(2012-12#1)(2013-1#1)
is an effective method##9##4##(1993-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-1#1)
is an effective strategy for##3##5##(2008-5#1)(2010-7#1)(2013-1#1)
is an effective strategy##4##4##(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
is an effective tool for##2##5##(1997-3#1)(2008-11#1)
is an effective tool##4##4##(1994-3#1)(1996-3#1)(1997-3#1)(2008-11#1)
is an effective treatment for##2##5##(2007-9#1)(2008-6#1)
is an effective treatment##3##4##(2007-8#1)(2007-9#1)(2008-6#1)
is an effective way to##2##5##(2008-11#1)(2012-3#1)
is an effective##59##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
is an efficient approach##2##4##(2010-12#1)(2010-5#1)
is an efficient method to##2##5##(1997-8#1)(2011-2#1)
is an efficient method##4##4##(1997-8#1)(2007-11#1)(2008-4#1)(2011-2#1)
is an efficient##14##3##(1992-9#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
is an effort to##2##4##(2008-8#1)(2012-3#1)
is an emerging pathogen##2##4##(2011-2#1)(2013-1#1)
is an emerging##13##3##(1996-12#1)(2007-8#1)(2008-10#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#3)
is an endangered##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
is an endemic##4##3##(1991-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
is an endogenous##3##3##(1992-8#1)(1996-2#1)(2008-7#1)
is an endonuclease##2##3##(1994-8#1)(1995-6#1)
is an enigmatic##2##3##(2008-8#1)(2012-2#1)
is an enormous##3##3##(1997-5#1)(2008-10#1)(2010-7#1)
is an entirely##2##3##(2007-8#1)(2008-5#1)
is an environmental##2##3##(1992-12#1)(2008-10#1)
is an environmentally##2##3##(2008-10#2)
is an enzyme##2##3##(2008-11#1)(2010-12#1)
is an essential component in the##2##6##(2010-1#1)(2012-1#1)
is an essential component of the##3##6##(1995-2#1)(1997-3#1)(2012-2#1)
is an essential component of##10##5##(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2007-7#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-8#1)
is an essential component##14##4##(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
is an essential element##3##4##(2008-10#2)(2012-2#1)
is an essential enzyme for##3##5##(2009-6#1)(2009-7#1)(2011-3#1)
is an essential micronutrient##3##4##(1993-11#1)(2012-2#2)
is an essential part of##2##5##(2008-2#1)(2008-7#1)
is an essential prerequisite to##2##5##(1995-12#1)(2013-7#1)
is an essential prerequisite##3##4##(1995-12#1)(2007-8#1)(2013-7#1)
is an essential step in##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
is an essential step to##2##5##(1995-6#1)(2008-10#1)
is an essential step##6##4##(1995-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
is an essential trace element##3##5##(2008-10#2)(2012-2#1)
is an essential##58##3##(1991-11#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#3)
is an established treatment##2##4##(1992-9#1)(2011-2#1)
is an established##17##3##(1991-1#1)(1992-9#1)(1994-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2011-2#3)(2011-3#1)(2013-8#1)
is an evaluation of the##3##5##(1997-6#1)(2012-3#2)
is an evaluation of##4##4##(1992-2#1)(1997-6#1)(2012-3#2)
is an evaluation##5##3##(1992-2#1)(1997-6#1)(2008-10#1)(2012-3#2)
is an ever##2##3##(2008-5#1)(2011-1#1)
is an evolving##2##3##(1991-12#1)(1996-6#1)
is an examination##2##3##(1994-2#1)(2011-1#1)
is an example of a##2##5##(1990-8#1)(2008-10#1)
is an example of##7##4##(1990-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-5#1)
is an excellent candidate for##2##5##(2008-10#2)
is an excellent candidate##3##4##(2008-10#2)(2009-7#1)
is an excellent method##2##4##(2008-1#2)
is an excellent tool for##3##5##(2008-1#1)(2008-10#2)
is an excellent way##2##4##(1992-3#1)(2008-12#1)
is an excellent##30##3##(1991-12#1)(1992-11#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-1#4)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
is an exciting##5##3##(1992-9#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
is an expanding##2##3##(2007-7#1)(2011-2#1)
is an explicit##2##3##(2008-10#1)(2011-2#1)
is an expression of##2##4##(2008-10#2)
is an extension of a##2##5##(2008-10#2)
is an extension of the##6##5##(1995-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-5#1)
is an extension of##12##4##(1991-2#1)(1995-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2010-5#1)(2013-8#1)
is an extremely complex process##2##5##(2008-11#1)(2009-3#1)
is an extremely large##2##4##(1992-8#1)(2008-10#1)
is an extremely rare and##2##5##(2008-10#1)(2013-1#1)
is an extremely rare condition##3##5##(2007-8#1)(2008-10#2)
is an extremely rare##19##4##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#3)(2008-7#1)(2010-11#1)(2011-1#1)(2012-12#2)(2013-1#2)
is an extremely##32##3##(1991-9#1)(1992-2#1)(1992-8#1)(1995-2#1)(1995-5#1)(1996-6#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#2)(2013-1#2)
is an iatrogenic complication##2##4##(1993-1#1)(1996-3#1)
is an iatrogenic##3##3##(1993-1#1)(1996-3#1)(2007-7#1)
is an ideal imaging##2##4##(2008-10#1)(2011-2#1)
is an ideal technique for##2##5##(2007-11#1)(2008-10#1)
is an ideal way to##2##5##(2007-12#1)(2010-3#1)
is an ideal##14##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-2#1)(2010-3#1)(2011-2#1)
is an imaging##2##3##(2010-9#1)(2012-2#1)
is an imbalance between##3##4##(1993-2#1)(2008-7#1)(2011-2#1)
is an immune##2##3##(2007-7#1)(2012-2#1)
is an immunologically##2##3##(2009-10#2)
is an important addition to the##2##6##(2008-11#1)(2008-9#1)
is an important advantage of##2##5##(1994-2#1)(2008-3#1)
is an important and##6##4##(1993-1#1)(1997-4#1)(2008-8#1)(2009-10#1)(2011-7#1)(2013-8#1)
is an important area##2##4##(1991-9#1)(2008-12#1)
is an important aspect of##6##5##(1991-11#1)(1994-11#1)(2007-9#1)(2008-10#2)(2012-2#1)
is an important aspect##9##4##(1991-11#1)(1994-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
is an important cause of##14##5##(2007-2#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-8#3)(2008-9#1)(2011-2#3)(2012-12#1)
is an important challenge##2##4##(2010-6#1)(2012-12#1)
is an important component in the##2##6##(2008-4#2)
is an important component of the##3##6##(1996-2#1)(2007-12#1)(2008-10#1)
is an important component of##5##5##(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#2)
is an important component##8##4##(1996-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-4#2)
is an important concern##2##4##(1994-3#1)(2013-8#1)
is an important consideration##4##4##(1993-1#1)(1994-11#1)(2010-11#1)(2013-1#1)
is an important contributor to##2##5##(2008-10#1)(2008-7#1)
is an important determinant of the##4##6##(1992-2#1)(1993-3#1)(1996-3#1)(1997-8#1)
is an important determinant of##11##5##(1992-2#1)(1993-3#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
is an important determinant##12##4##(1992-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
is an important disease of barley in many production areas##2##10##(2008-10#2)
is an important disease of barley in many##3##8##(2008-10#3)
is an important disease of##6##5##(2008-10#6)
is an important disease##8##4##(2008-10#7)(2008-11#1)
is an important element of##2##5##(2008-4#1)(2012-2#1)
is an important element##4##4##(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
is an important etiological agent of##2##6##(2008-9#1)(2011-2#1)
is an important factor in the##3##6##(2008-3#2)(2012-2#1)
is an important factor in##7##5##(1996-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-9#1)(2012-2#1)
is an important factor that##2##5##(1994-7#1)(2008-10#1)
is an important factor##13##4##(1991-12#1)(1992-10#1)(1994-7#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2010-9#1)(2012-2#1)(2013-1#1)
is an important feature of the##3##6##(1992-4#1)(2009-4#1)(2013-1#1)
is an important feature of##5##5##(1992-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is an important feature##6##4##(1992-4#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
is an important first step##2##5##(2008-3#1)(2013-8#1)
is an important function##2##4##(2008-12#1)(2012-2#1)
is an important health problem in##2##6##(2007-2#1)(2011-2#1)
is an important health problem##3##5##(2007-2#1)(2011-2#1)(2012-2#1)
is an important human pathogen##2##5##(2008-7#1)(2008-9#1)
is an important independent##2##4##(2008-11#1)(2008-8#1)
is an important issue in##2##5##(2008-3#1)(2011-2#1)
is an important issue##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
is an important means of##2##5##(1993-1#1)(2008-10#1)
is an important mechanism for tolerance##2##6##(2008-4#1)(2008-6#1)
is an important mechanism of##4##5##(2008-10#2)(2008-5#1)(2008-9#1)
is an important mechanism##6##4##(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
is an important milestone in the##2##6##(2008-10#1)(2009-10#1)
is an important natural##2##4##(2008-5#1)(2013-8#1)
is an important outcome##2##4##(2010-5#1)(2011-2#1)
is an important parameter##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
is an important part of the##4##6##(1996-3#1)(1996-6#1)(2008-7#1)(2011-2#1)
is an important part of##6##5##(1996-3#1)(1996-6#1)(2008-4#1)(2008-7#1)(2011-2#2)
is an important pathogen of##2##5##(2008-10#2)
is an important phenomenon in##2##5##(2008-9#1)(2012-3#1)
is an important problem in##2##5##(2011-1#1)(2013-1#1)
is an important process##2##4##(2010-4#1)(2012-1#1)
is an important prognostic factor##2##5##(2011-2#1)(2013-8#1)
is an important public health problem##2##6##(2011-2#1)(2012-2#1)
is an important public health##4##5##(1991-6#1)(2010-3#1)(2011-2#1)(2012-2#1)
is an important regulator of##2##5##(1995-2#1)(1997-4#1)
is an important risk factor for##2##6##(2012-12#1)(2012-3#1)
is an important risk factor##3##5##(2006-10#1)(2012-12#1)(2012-3#1)
is an important signal molecule##2##5##(1996-5#1)(2008-10#1)
is an important source##2##4##(2008-3#1)(2013-1#1)
is an important step in the##2##6##(2008-5#1)(2009-7#1)
is an important step in##3##5##(1994-9#1)(2008-5#1)(2009-7#1)
is an important step##6##4##(1994-9#1)(2008-1#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-3#1)
is an important structural##3##4##(1994-11#1)(2008-9#1)(2009-7#1)
is an important task for##2##5##(2008-3#2)
is an important task##4##4##(2008-3#2)(2008-5#1)(2010-2#1)
is an important tool for##6##5##(1996-3#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)(2013-8#1)
is an important tool in the##4##6##(1992-2#1)(2007-12#1)(2010-12#1)(2010-3#1)
is an important tool##14##4##(1992-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
is an important##286##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-3#2)(1994-11#4)(1994-2#3)(1994-3#1)(1994-7#1)(1994-9#2)(1995-2#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#42)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#11)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#11)(2008-9#11)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-9#1)(2011-1#4)(2011-2#17)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#7)
is an in vitro##2##4##(1997-3#1)(2009-11#1)
is an in##3##3##(1997-3#1)(2008-1#1)(2009-11#1)
is an inappropriate##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
is an incomplete##2##3##(2008-1#1)(2008-11#1)
is an increase in the amount of##2##7##(2008-11#1)(2009-6#1)
is an increase in the##4##5##(2007-8#1)(2008-11#1)(2009-6#1)(2010-12#1)
is an increase in##5##4##(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#1)
is an increase##7##3##(1992-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)
is an increased risk of##4##5##(2007-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
is an increased##7##3##(1994-5#1)(2007-7#1)(2009-12#1)(2010-8#2)(2011-1#1)(2011-2#1)
is an increasing role of##2##5##(2006-5#1)(2009-5#1)
is an increasing##15##3##(1991-12#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-1#1)
is an increasingly important##2##4##(2008-9#1)(2013-1#1)
is an increasingly popular##3##4##(2008-10#1)(2008-11#2)
is an increasingly##6##3##(2008-10#1)(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)
is an independent risk factor for##3##6##(1992-9#1)(2008-1#1)(2013-1#1)
is an independent risk factor##5##5##(1992-9#1)(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#1)
is an independent risk##6##4##(1992-9#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-1#1)
is an independent##11##3##(1992-9#1)(1993-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-5#1)(2012-2#2)(2013-1#1)
is an index of##2##4##(1996-5#1)(2008-10#1)
is an indication of the##2##5##(2008-3#1)(2009-5#1)
is an indication of##3##4##(2008-3#1)(2009-5#1)(2013-8#1)
is an indication##5##3##(2008-3#1)(2009-5#1)(2010-3#1)(2013-8#2)
is an indicator of##4##4##(1991-11#1)(2008-10#2)(2008-3#1)
is an indicator##5##3##(1991-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
is an indispensable##4##3##(1991-5#2)(2006-10#1)(2008-10#1)
is an inducible##3##3##(1990-11#1)(1994-12#1)(2010-10#1)
is an ineffective##2##3##(1992-12#1)(2008-10#1)
is an inert##2##3##(2007-12#1)(2008-4#1)
is an infection##2##3##(2007-8#1)(2008-7#1)
is an infinite##2##3##(2008-10#1)(2008-3#1)
is an inflammatory##7##3##(1990-6#1)(2008-7#1)(2011-7#1)(2012-12#3)(2012-2#1)
is an infrequent##3##3##(2008-9#1)(2011-2#2)
is an infrequently##3##3##(1996-9#1)(2008-1#1)(2012-2#1)
is an inherited##3##3##(1990-5#1)(1997-3#1)(2010-6#1)
is an inhibitor of the##2##5##(2008-7#1)(2009-8#1)
is an initial##5##3##(1994-1#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-4#1)
is an innate##2##3##(2006-10#1)(2008-10#1)
is an innovative##6##3##(1991-2#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-6#1)(2010-7#1)
is an insect##2##3##(2008-10#1)(2012-2#1)
is an insufficient##2##3##(2008-9#1)(2009-5#1)
is an integral component of##3##5##(2007-11#1)(2012-2#1)(2012-3#1)
is an integral part of the##3##6##(1996-3#1)(2007-7#1)(2012-2#1)
is an integral part of##10##5##(1994-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-2#2)
is an integral##19##3##(1991-2#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2012-2#4)(2012-3#1)(2013-1#1)
is an integrated##2##3##(1997-3#1)(2012-2#1)
is an interdisciplinary##2##3##(1996-1#1)(2013-1#1)
is an interesting tool##2##4##(2010-10#1)(2012-12#1)
is an interesting##9##3##(1991-4#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)(2012-12#1)(2013-1#1)
is an intermediate##2##3##(1995-11#1)(2008-9#1)
is an international##4##3##(1996-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
is an intracellular##8##3##(1990-7#1)(1996-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
is an intriguing##3##3##(2008-4#1)(2011-2#1)(2012-12#1)
is an intrinsic part of the##2##6##(2008-3#1)(2008-5#1)
is an intrinsic##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
is an invasive##3##3##(2007-7#1)(2009-5#1)(2011-2#1)
is an inverse##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
is an investigation##2##3##(2008-10#1)(2008-2#1)
is an irreversible##2##3##(2008-10#1)(2013-8#1)
is an island##2##3##(1992-1#1)(2008-1#1)
is an issue##3##3##(1992-3#1)(2008-5#1)(2011-2#1)
is an iterative##2##3##(2008-3#1)(2011-8#1)
is an obligate##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
is an obligately##2##3##(2008-10#1)(2011-2#1)
is an obligatory##2##3##(1996-5#1)(2013-1#1)
is an observational##3##3##(1996-3#1)(2011-1#1)(2012-3#1)
is an ongoing challenge for##2##5##(2008-7#1)(2011-2#1)
is an ongoing##6##3##(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
is an open##4##3##(1996-11#1)(2008-10#1)(2008-8#1)(2009-12#1)
is an opportunistic infection##3##4##(2007-7#1)(2012-3#1)(2013-8#1)
is an opportunistic pathogen that##2##5##(2010-10#1)(2012-3#1)
is an opportunistic##6##3##(2007-7#1)(2009-9#1)(2010-10#1)(2012-3#2)(2013-8#1)
is an opportunity##3##3##(2008-12#2)(2013-1#1)
is an optimized##2##3##(2008-2#1)(2011-1#1)
is an option##2##3##(1994-12#1)(2011-2#1)
is an oral##2##3##(1995-6#1)(2013-1#1)
is an orally-active##2##3##(2008-5#2)
is an order of magnitude##3##5##(2007-11#1)(2008-3#2)
is an organ##2##3##(2007-12#1)(2008-5#1)
is an organelle##3##3##(2007-12#1)(2011-2#2)
is an original##2##3##(2008-8#1)(2011-2#1)
is an outgrowth of##3##4##(1992-1#1)(2008-3#1)(2008-4#1)
is an overall##2##3##(2008-10#1)(2012-1#1)
is an overview of##6##4##(1992-1#1)(1994-2#1)(1996-2#1)(1997-3#1)(2010-12#1)(2012-2#1)
is an ubiquitous##3##3##(2008-5#1)(2008-8#1)(2010-10#1)
is an uncommon benign##2##4##(1990-5#1)(2010-6#1)
is an uncommon but well##2##5##(2008-10#1)(2008-7#1)
is an uncommon but##4##4##(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
is an uncommon cause of##5##5##(1992-6#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
is an uncommon cause##6##4##(1992-6#1)(2008-12#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
is an uncommon clinical entity##3##5##(2007-8#1)(2011-1#1)(2011-2#1)
is an uncommon clinical##4##4##(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
is an uncommon complication##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
is an uncommon condition that##2##5##(2006-10#1)(2011-2#1)
is an uncommon condition##3##4##(2006-10#1)(2008-7#1)(2011-2#1)
is an uncommon disease##2##4##(2008-1#1)(2009-5#1)
is an uncommon disorder##2##4##(2007-7#1)(2010-1#1)
is an uncommon finding##2##4##(2010-5#1)(2010-8#1)
is an uncommon malignancy##2##4##(1992-3#1)(2013-8#1)
is an uncommon type of##2##5##(2011-3#1)(2013-1#1)
is an uncommon##54##3##(1990-5#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(2006-10#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#6)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
is an unusual complication of##2##5##(2006-10#1)(2011-2#1)
is an unusual form of##2##5##(2007-10#1)(2009-6#1)
is an unusual##17##3##(1990-5#1)(1991-8#1)(1994-6#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#1)
is an update of an##2##5##(1994-3#1)(2012-2#1)
is an update of##3##4##(1994-3#1)(2012-2#2)
is an urgent need for##3##5##(2008-10#1)(2008-11#1)(2009-4#1)
is an urgent need to##5##5##(1996-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2012-1#1)
is an urgent need##8##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-5#1)(2012-1#1)
is an urgent##11##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-4#1)(2009-5#1)(2012-1#1)(2013-7#1)
is an useful##2##3##(2006-10#1)(2013-1#1)
is an##1519##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#7)(1990-9#1)(1991-1#2)(1991-11#5)(1991-12#9)(1991-2#4)(1991-4#3)(1991-5#8)(1991-6#3)(1991-8#3)(1991-9#6)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#7)(1992-2#6)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#8)(1993-1#5)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#9)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#7)(1994-12#7)(1994-2#6)(1994-3#7)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#13)(1995-3#3)(1995-5#4)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#10)(1996-2#6)(1996-3#11)(1996-4#1)(1996-5#3)(1996-6#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#13)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2006-10#7)(2006-12#1)(2006-5#1)(2007-10#6)(2007-11#14)(2007-12#17)(2007-2#7)(2007-4#1)(2007-5#2)(2007-7#19)(2007-8#17)(2007-9#4)(2008-1#22)(2008-10#179)(2008-11#60)(2008-12#35)(2008-2#25)(2008-3#53)(2008-4#45)(2008-5#41)(2008-6#12)(2008-7#62)(2008-8#35)(2008-9#37)(2009-10#7)(2009-11#4)(2009-12#7)(2009-2#2)(2009-3#9)(2009-4#2)(2009-5#12)(2009-6#8)(2009-7#10)(2009-8#14)(2009-9#10)(2010-1#7)(2010-10#11)(2010-11#5)(2010-12#9)(2010-2#5)(2010-3#14)(2010-4#5)(2010-5#9)(2010-6#14)(2010-7#6)(2010-8#8)(2010-9#4)(2011-1#23)(2011-2#78)(2011-3#4)(2011-7#3)(2011-8#1)(2012-1#7)(2012-12#26)(2012-2#59)(2012-3#29)(2012-9#1)(2013-1#61)(2013-7#7)(2013-8#32)
is analogous to a##2##4##(2008-3#1)(2011-2#1)
is analogous to that##3##4##(1991-5#2)(2007-11#1)
is analogous to the##4##4##(1990-2#1)(1994-9#1)(2007-11#1)(2010-7#1)
is analogous to##10##3##(1990-2#1)(1991-5#2)(1994-9#1)(2007-11#2)(2008-12#1)(2008-3#1)(2010-7#1)(2011-2#1)
is analysed by##2##3##(2007-12#1)(2008-11#1)
is analysed to##2##3##(2008-11#1)(2008-8#1)
is analysed##15##2##(1993-6#1)(1996-11#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-5#2)(2008-8#1)(2013-8#1)
is analytically##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
is analyzed and##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-4#1)(2013-8#1)
is analyzed by means of##2##5##(1992-6#1)(2008-3#1)
is analyzed by use of the##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
is analyzed by##9##3##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
is analyzed for the##2##4##(2008-3#2)
is analyzed for##4##3##(2008-3#4)
is analyzed in the##2##4##(2008-3#2)
is analyzed in##4##3##(1995-1#1)(2008-3#2)(2009-5#1)
is analyzed on the basis of##2##6##(2007-11#1)(2008-9#1)
is analyzed quantitatively##2##3##(1991-8#1)(2008-3#1)
is analyzed theoretically by##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is analyzed using##3##3##(2008-10#1)(2009-11#1)(2009-8#1)
is analyzed with a##2##4##(2008-2#1)(2008-3#1)
is analyzed with##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2009-6#1)
is analyzed##82##2##(1991-8#1)(1992-6#1)(1994-11#1)(1995-1#1)(1996-1#1)(2007-11#8)(2007-12#9)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#32)(2008-4#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2013-1#2)(2013-8#1)
is anchored on##2##3##(1990-2#1)(2011-1#1)
is and##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
is another factor##2##3##(1991-5#1)(2008-5#1)
is another important##2##3##(2008-1#1)(2008-11#1)
is another key##2##3##(2008-11#1)(2012-2#1)
is another##21##2##(1991-5#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
is antagonized by##5##3##(1990-2#1)(1991-9#1)(1993-8#2)(2008-5#1)
is anticipated that this##2##4##(2008-4#1)(2009-2#1)
is anticipated that##6##3##(1991-2#1)(1997-7#1)(2007-5#1)(2008-4#1)(2009-2#1)(2009-5#1)
is anticipated to##3##3##(2011-1#1)(2011-7#1)(2012-2#1)
is anticipated##14##2##(1991-2#1)(1995-12#1)(1996-9#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-7#1)
is any##4##2##(1996-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
is apparent in##2##3##(1995-5#1)(2008-11#1)
is apparent that##9##3##(1995-12#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2009-6#1)(2011-1#1)(2012-2#1)
is apparent##17##2##(1990-5#1)(1991-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
is apparently a##2##3##(2008-10#1)(2012-1#1)
is apparently not##4##3##(1991-8#1)(1994-8#1)(2008-10#1)(2013-1#1)
is apparently##21##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-8#2)(1992-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#3)(2009-5#1)(2010-3#1)(2012-1#1)(2013-1#1)
is appealing##2##2##(2008-9#1)(2011-2#1)
is applicable for##11##3##(1995-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-2#2)
is applicable in##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
is applicable only##2##3##(2006-5#1)(2008-8#1)
is applicable to a##2##4##(1994-6#1)(2008-11#1)
is applicable to all##3##4##(1996-6#1)(2008-10#1)(2008-7#1)
is applicable to any##2##4##(1997-2#1)(2008-3#1)
is applicable to the##11##4##(2008-10#9)(2008-2#1)(2011-1#1)
is applicable to##39##3##(1991-8#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)
is applicable##61##2##(1991-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#23)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)
is applied and##3##3##(2008-10#1)(2008-12#1)(2010-7#1)
is applied during##2##3##(2008-11#1)(2012-2#1)
is applied for the determination of##2##6##(2008-10#2)
is applied for the##3##4##(2008-10#3)
is applied for##11##3##(2008-10#7)(2008-3#4)
is applied in##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
is applied on the##2##4##(2008-10#1)(2010-8#1)
is applied to a##16##4##(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2010-10#1)(2012-1#1)(2013-8#1)
is applied to an##2##4##(2009-12#1)(2011-2#1)
is applied to analysis of##2##5##(2007-12#1)(2008-10#1)
is applied to calculate the##2##5##(2007-12#1)(2008-3#1)
is applied to data##4##4##(1995-5#1)(1997-7#1)(2008-2#1)(2008-3#1)
is applied to detect the##2##5##(2008-2#1)(2009-10#1)
is applied to determine the##4##5##(2008-10#2)(2008-3#2)
is applied to determine##5##4##(2008-10#3)(2008-3#2)
is applied to experimental##2##4##(2008-2#1)(2008-3#1)
is applied to measure##3##4##(2007-12#1)(2008-3#2)
is applied to simulated##2##4##(2008-2#1)(2008-3#1)
is applied to the analysis of##4##6##(2008-10#3)(2008-6#1)
is applied to the design of a##2##7##(2008-2#1)(2008-3#1)
is applied to the design of##3##6##(2008-2#1)(2008-3#2)
is applied to the determination of##9##6##(2008-10#8)(2008-3#1)
is applied to the measurement of the##2##7##(2008-3#2)
is applied to the study of##3##6##(2008-2#1)(2008-3#2)
is applied to the##49##4##(1991-12#2)(1992-3#1)(2007-11#3)(2007-12#2)(2008-10#18)(2008-2#6)(2008-3#13)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
is applied to two##2##4##(2008-10#1)(2008-7#1)
is applied to##135##3##(1991-12#2)(1992-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#7)(2008-10#33)(2008-11#2)(2008-2#19)(2008-3#37)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#2)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
is applied with##2##3##(2008-10#1)(2008-3#1)
is applied##190##2##(1991-12#2)(1992-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-11#7)(2007-12#10)(2007-8#1)(2008-10#56)(2008-11#5)(2008-12#1)(2008-2#22)(2008-3#47)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#1)(2013-8#2)
is appraised##2##2##(2008-10#1)(2011-2#1)
is appreciated##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
is approached##3##2##(1997-6#1)(2007-12#1)(2009-12#1)
is approaching##4##2##(2007-4#1)(2008-1#1)(2008-11#1)(2009-6#1)
is appropriate and##2##3##(2011-2#1)(2013-8#1)
is appropriate for a##2##4##(2008-4#1)(2008-6#1)
is appropriate for##13##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-3#1)
is appropriate in##2##3##(2008-10#1)(2010-6#1)
is appropriate to##8##3##(1993-1#1)(1993-2#1)(1997-1#1)(2008-10#3)(2008-5#1)(2009-12#1)
is appropriate##31##2##(1991-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-2#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
is approximated by a Gaussian##2##5##(2008-3#2)
is approximated by a##3##4##(2008-3#3)
is approximated by##4##3##(1992-2#1)(2008-3#3)
is approximated##5##2##(1992-2#1)(2008-3#3)(2008-8#1)
is approximately 0##6##3##(1996-2#1)(2008-3#4)(2012-3#1)
is approximately 1##9##3##(1996-10#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
is approximately 1%##3##3##(2008-1#1)(2008-3#1)(2009-3#1)
is approximately 10##2##3##(1997-6#1)(2008-3#1)
is approximately 100##2##3##(2008-2#1)(2008-3#1)
is approximately 2##9##3##(1992-3#1)(1994-11#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
is approximately 3##5##3##(1992-5#1)(2008-11#1)(2008-2#2)(2008-3#1)
is approximately 3%##2##3##(2008-10#2)
is approximately 30 percent##2##4##(2010-12#1)(2013-1#1)
is approximately 30##3##3##(2007-11#1)(2010-12#1)(2013-1#1)
is approximately 40##2##3##(1994-2#1)(2008-3#1)
is approximately 40%##2##3##(2008-4#1)(2008-7#1)
is approximately 5##2##3##(1993-2#1)(2008-2#1)
is approximately 50%##2##3##(2011-1#1)(2011-3#1)
is approximately 60##2##3##(2008-3#1)(2008-7#1)
is approximately a##2##3##(2008-10#1)(2008-2#1)
is approximately constant##2##3##(1995-2#1)(2007-11#1)
is approximately equal to the##2##5##(2008-11#1)(2008-3#1)
is approximately equal to##4##4##(1991-11#1)(1996-5#1)(2008-11#1)(2008-3#1)
is approximately proportional to the##2##5##(2008-10#1)(2008-3#1)
is approximately the##2##3##(2007-11#1)(2008-2#1)
is approximately twice as##3##4##(1993-1#1)(2008-3#1)(2008-6#1)
is approximately twice the##3##4##(2007-10#1)(2008-3#2)
is approximately twice##6##3##(1993-1#1)(2007-10#1)(2008-3#3)(2008-6#1)
is approximately two times higher##2##5##(2008-2#1)(2010-9#1)
is approximately two##3##3##(2008-2#1)(2008-7#1)(2010-9#1)
is approximately##107##2##(1991-11#2)(1991-3#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-5#3)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#23)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
is arbitrarily##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
is arguably the##2##3##(2010-5#1)(2013-1#1)
is arguably##4##2##(2008-9#1)(2010-5#1)(2012-1#1)(2013-1#1)
is argued in this paper##2##5##(2008-7#1)(2010-6#1)
is argued that the##8##4##(1990-7#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-3#1)
is argued that this##3##4##(1991-3#1)(2008-10#1)(2009-2#1)
is argued that##28##3##(1990-7#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2013-1#2)(2013-8#2)
is argued##32##2##(1990-7#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-6#1)(2013-1#2)(2013-8#2)
is around 0##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
is around 1##2##3##(2008-10#1)(2009-11#1)
is around 3%##2##3##(2008-10#2)
is around 5% for the analytes##2##6##(2008-10#2)
is around##17##2##(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-11#1)(2013-1#1)
is arranged##4##2##(1992-6#1)(1993-1#2)(2013-8#1)
is arrested in##3##3##(2008-8#1)(2009-10#1)(2011-1#1)
is arrested##4##2##(1993-6#1)(2008-8#1)(2009-10#1)(2011-1#1)
is as a##2##3##(1996-1#1)(2008-5#1)
is as effective as##3##4##(1994-3#1)(1995-9#1)(2011-2#1)
is as effective##4##3##(1994-3#2)(1995-9#1)(2011-2#1)
is as expected##3##3##(1995-11#1)(2010-11#1)(2013-1#1)
is as follows##5##3##(1990-2#1)(1992-11#1)(1995-8#1)(2008-2#1)(2008-3#1)
is as good as##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
is as high as##10##4##(1991-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-1#1)
is as large as##3##4##(1993-12#1)(2007-12#1)(2008-2#1)
is as low as##9##4##(2007-11#1)(2008-10#6)(2008-9#1)(2011-3#1)
is as much as##3##4##(2008-3#3)
is as much##5##3##(2008-1#1)(2008-3#3)(2009-4#1)
is as sensitive as##2##4##(1992-3#1)(2008-10#1)
is as true##2##3##(1993-2#1)(2013-7#1)
is as yet no##2##4##(1991-11#1)(2012-12#1)
is as yet##3##3##(1990-12#1)(1991-11#1)(2012-12#1)
is as##70##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
is ascribed to##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2009-6#1)
is ascribed##5##2##(1996-5#1)(1997-2#1)(2008-10#1)(2008-2#1)(2009-6#1)
is asked to##2##3##(1992-11#1)(2009-9#1)
is aspirated##2##2##(2008-10#1)(2008-9#1)
is assayed##3##2##(2008-10#2)(2008-9#1)
is assembled by##3##3##(2008-10#3)
is assembled in##2##3##(1990-2#1)(2008-10#1)
is assembled##7##2##(1990-2#1)(2008-10#4)(2008-2#1)(2008-8#1)
is assessed as##3##3##(2008-10#1)(2013-8#2)
is assessed by##5##3##(1990-11#1)(2008-10#1)(2008-3#2)(2008-8#1)
is assessed in##3##3##(1997-4#1)(2008-1#1)(2008-10#1)
is assessed using##2##3##(2008-10#1)(2008-8#1)
is assessed with##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
is assessed##30##2##(1990-11#1)(1993-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#7)(2008-7#1)(2008-8#3)(2009-10#1)(2012-2#2)(2013-8#2)
is assigned a##3##3##(1991-8#1)(2008-1#1)(2012-2#1)
is assigned to##2##3##(2007-12#1)(2010-5#1)
is assigned##8##2##(1991-8#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-8#2)(2010-5#1)(2012-2#1)
is assisted by##2##3##(2007-12#1)(2008-2#1)
is assisted##3##2##(2007-12#1)(2008-2#1)(2011-3#1)
is associated to a##2##4##(2008-10#1)(2009-5#1)
is associated to the##2##4##(2009-10#1)(2012-12#1)
is associated to##7##3##(1991-2#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-5#1)(2012-12#1)
is associated with a decrease in##2##6##(1996-2#1)(2008-7#1)
is associated with a decreased##2##5##(1990-2#1)(2007-4#1)
is associated with a distinct##2##5##(1991-1#1)(2008-10#1)
is associated with a high##4##5##(2007-10#1)(2010-11#1)(2012-2#1)(2013-8#1)
is associated with a low##2##5##(2008-6#1)(2012-2#1)
is associated with a lower##2##5##(2007-5#1)(2013-1#1)
is associated with a more##2##5##(2008-6#2)
is associated with a number of##2##6##(1990-8#1)(1994-3#1)
is associated with a progressive##2##5##(1994-8#1)(2009-12#1)
is associated with a range of##2##6##(2013-1#2)
is associated with a reduction in##3##6##(2008-3#1)(2011-2#1)(2012-2#1)
is associated with a reduction of##2##6##(2008-4#1)(2009-7#1)
is associated with a reduction##5##5##(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-2#1)
is associated with a significant##4##5##(1997-4#1)(2007-8#1)(2008-1#1)(2012-2#1)
is associated with a substantial##2##5##(1993-11#1)(1997-3#1)
is associated with a variety of##2##6##(2008-10#1)(2012-3#1)
is associated with a##66##4##(1990-2#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#2)(1996-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#6)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#2)(2009-12#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
is associated with advanced##2##4##(2009-4#1)(2012-12#1)
is associated with adverse##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
is associated with an increase in##2##6##(2008-9#1)(2009-8#1)
is associated with an increase##3##5##(1990-8#1)(2008-9#1)(2009-8#1)
is associated with an increased incidence of##2##7##(2008-10#1)(2013-7#1)
is associated with an increased risk for##5##7##(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
is associated with an increased risk of##8##7##(1992-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
is associated with an increased risk##13##6##(1992-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
is associated with an increased##18##5##(1992-8#1)(1995-12#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
is associated with an##34##4##(1990-5#2)(1990-8#1)(1992-8#1)(1993-8#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-10#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
is associated with better##3##4##(2008-5#1)(2008-7#1)(2009-11#1)
is associated with both##2##4##(2010-4#1)(2012-2#1)
is associated with cellular proliferation##2##5##(1994-11#1)(1994-3#1)
is associated with conditions##2##4##(2008-6#1)(2011-2#1)
is associated with decreased##4##4##(2008-7#1)(2009-1#1)(2010-10#1)(2012-1#1)
is associated with greater##3##4##(2008-7#1)(2009-7#1)(2012-2#1)
is associated with high morbidity and mortality##3##7##(2008-1#1)(2009-7#1)(2013-1#1)
is associated with high morbidity##4##5##(2007-7#1)(2008-1#1)(2009-7#1)(2013-1#1)
is associated with high##9##4##(2007-7#1)(2008-1#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
is associated with higher##7##4##(1993-6#1)(1995-12#1)(1996-6#1)(2008-11#1)(2009-12#1)(2013-1#2)
is associated with improved outcomes##2##5##(2008-12#1)(2008-3#1)
is associated with improved##3##4##(2008-12#1)(2008-3#1)(2008-7#1)
is associated with increased risk for##3##6##(1993-12#2)(2008-4#1)
is associated with increased risk of##3##6##(2008-11#1)(2011-2#1)(2013-1#1)
is associated with increased risk##6##5##(1993-12#2)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
is associated with increased##23##4##(1991-12#1)(1993-12#2)(1994-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)
is associated with ischemic stroke##2##5##(2007-10#2)
is associated with less##3##4##(2009-2#1)(2013-1#2)
is associated with loss of the##2##6##(1997-3#1)(2008-10#1)
is associated with loss of##3##5##(1997-3#1)(2008-10#1)(2011-2#1)
is associated with lower##3##4##(1996-12#1)(1996-3#1)(2012-2#1)
is associated with metabolic##2##4##(2013-1#1)(2013-8#1)
is associated with poor outcomes##2##5##(2009-1#1)(2013-8#1)
is associated with poor##3##4##(2008-5#1)(2009-1#1)(2013-8#1)
is associated with rapid##3##4##(2007-7#1)(2010-6#1)(2012-2#1)
is associated with reduced##4##4##(2008-12#1)(2010-1#2)(2012-3#1)
is associated with reductions in##2##5##(2012-2#1)(2013-1#1)
is associated with serious##2##4##(2009-6#1)(2013-1#1)
is associated with several##2##4##(2011-2#1)(2012-2#1)
is associated with significant morbidity and mortality##3##7##(2006-10#1)(2008-7#1)(2013-8#1)
is associated with significant morbidity##5##5##(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2013-8#1)
is associated with significant##8##4##(1995-1#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-7#1)(2012-3#1)(2013-8#1)
is associated with some##2##4##(1994-3#1)(2008-7#1)
is associated with specific##4##4##(1990-6#1)(2010-12#1)(2011-2#2)
is associated with spontaneous##2##4##(2008-10#1)(2012-2#1)
is associated with substantial##2##4##(2011-2#1)(2013-8#1)
is associated with the development of##4##6##(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
is associated with the development##5##5##(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
is associated with the increase in##2##6##(2008-11#1)(2011-2#1)
is associated with the metabolic syndrome and##2##7##(2010-4#2)
is associated with the metabolic syndrome##3##6##(2010-4#2)(2012-2#1)
is associated with the risk of##2##6##(2008-11#1)(2010-12#1)
is associated with the##49##4##(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-5#1)(1997-7#1)(2006-6#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-2#5)(2012-2#2)(2013-1#3)(2013-8#1)
is associated with vascular##2##4##(2009-4#1)(2013-1#1)
is associated with##418##3##(1990-12#1)(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-6#2)(2007-10#7)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#3)(2007-8#1)(2008-1#14)(2008-10#27)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#5)(2008-6#10)(2008-7#18)(2008-8#5)(2008-9#1)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#9)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#1)(2011-1#6)(2011-2#33)(2012-1#3)(2012-12#7)(2012-2#20)(2012-3#9)(2012-5#1)(2013-1#33)(2013-7#4)(2013-8#12)
is associated##435##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-6#2)(2007-10#7)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#3)(2007-8#1)(2008-1#14)(2008-10#31)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#9)(2008-5#6)(2008-6#10)(2008-7#18)(2008-8#5)(2008-9#2)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#9)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#1)(2011-1#6)(2011-2#33)(2012-1#3)(2012-12#8)(2012-2#20)(2012-3#9)(2012-5#1)(2013-1#33)(2013-7#4)(2013-8#13)
is assumed for##2##3##(1996-6#1)(2008-2#1)
is assumed that a##2##4##(2007-11#1)(2008-10#1)
is assumed that the##4##4##(1990-3#1)(1993-3#1)(2008-3#1)(2009-8#1)
is assumed that##18##3##(1990-3#1)(1992-4#1)(1993-3#1)(1994-3#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#2)
is assumed to be a##4##5##(1991-12#1)(2008-11#1)(2008-2#2)
is assumed to be##12##4##(1991-12#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-9#1)
is assumed to##20##3##(1991-12#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#2)(2008-9#1)
is assumed##53##2##(1990-3#1)(1991-12#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-6#2)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#11)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#2)
is asymmetric##3##2##(1997-3#1)(2006-4#1)(2008-2#1)
is asymptomatic##2##2##(1990-6#1)(2010-11#1)
is asymptotically at a nominal level##2##6##(2012-1#2)
is asymptotically##5##2##(1996-3#1)(2008-10#1)(2008-3#1)(2012-1#2)
is at a wavelength##2##4##(2008-3#2)
is at a##4##3##(1996-3#1)(2008-2#1)(2008-3#2)
is at best##3##3##(1990-5#1)(2009-10#1)(2013-8#1)
is at high risk##2##4##(2011-2#1)(2012-2#1)
is at its lowest level##2##5##(1993-2#1)(1996-8#1)
is at its##5##3##(1993-2#1)(1996-8#1)(2008-12#1)(2010-5#1)(2011-2#1)
is at least 3 months##2##5##(2008-10#2)
is at least as##4##4##(1990-8#1)(1991-9#1)(2008-2#2)
is at least in part mediated by##2##7##(1991-5#1)(2011-2#1)
is at least in part##3##5##(1991-5#1)(2008-11#1)(2011-2#1)
is at least##22##3##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#1)(2008-9#1)(2011-2#1)
is at once##2##3##(2008-7#2)
is at risk##2##3##(2010-8#1)(2012-12#1)
is at the intersection of##2##5##(2008-11#1)(2011-2#1)
is at the same time##3##5##(2007-12#1)(2009-10#1)(2013-1#1)
is at the##29##3##(1990-11#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
is at##100##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
is atraumatic##2##2##(2006-10#1)(2007-8#1)
is attached to an##2##4##(2008-12#1)(2008-4#1)
is attached to the##5##4##(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)
is attached to##12##3##(1990-12#2)(1996-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#2)
is attached##16##2##(1990-11#1)(1990-12#2)(1994-8#1)(1996-6#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)
is attainable in##2##3##(2008-2#1)(2008-3#1)
is attainable##3##2##(2008-2#1)(2008-3#2)
is attained##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-5#1)
is attempted by##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
is attempted##8##2##(1991-11#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2012-12#1)
is attempting to##2##3##(1995-3#1)(2008-5#1)
is attenuated by the##2##4##(1994-11#1)(2008-11#1)
is attenuated by##3##3##(1994-11#1)(2008-11#1)(2012-2#1)
is attenuated in##2##3##(1996-2#1)(1996-5#1)
is attenuated##6##2##(1994-11#1)(1996-2#1)(1996-5#1)(2008-11#1)(2010-12#1)(2012-2#1)
is attracting##2##2##(2008-1#1)(2011-1#1)
is attributable to the##3##4##(2008-10#1)(2008-5#2)
is attributable to##10##3##(1990-12#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2011-1#1)
is attributable##12##2##(1990-12#1)(1994-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-2#1)
is attributed to a##5##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
is attributed to an##2##4##(1994-5#1)(2008-10#1)
is attributed to differential##2##4##(2008-10#1)(2008-2#1)
is attributed to the##21##4##(1990-12#1)(1990-5#1)(1992-3#1)(1996-2#1)(1996-4#1)(1997-4#1)(2007-11#3)(2008-10#5)(2008-3#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-8#1)(2012-2#1)
is attributed to##44##3##(1990-12#1)(1990-5#1)(1992-3#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2007-11#5)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#2)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
is attributed##45##2##(1990-12#1)(1990-5#1)(1992-3#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2007-11#5)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#2)(2010-12#1)(2010-4#2)(2010-8#1)(2012-2#1)
is augmented by##4##3##(1993-3#1)(2006-10#1)(2008-2#1)(2008-6#1)
is augmented##5##2##(1993-3#1)(1993-6#1)(2006-10#1)(2008-2#1)(2008-6#1)
is authentic##2##2##(1994-8#1)(2008-2#1)
is automated##2##2##(1993-12#1)(2010-8#1)
is automatic##2##2##(2008-10#1)(2008-9#1)
is automatically##10##2##(1991-5#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
is autosomal dominant##2##3##(1997-3#2)
is autosomal##3##2##(1997-3#2)(2008-4#1)
is available about the##3##4##(2007-12#1)(2008-10#1)(2013-7#1)
is available about##4##3##(2007-10#1)(2007-12#1)(2008-10#1)(2013-7#1)
is available and##4##3##(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)
is available as a##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
is available as##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
is available for free download##2##5##(2010-5#1)(2011-1#1)
is available for free##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
is available for further##2##4##(2008-9#1)(2010-1#1)
is available for##19##3##(1990-10#1)(1991-12#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
is available from##5##3##(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#2)
is available in a##2##4##(2008-10#1)(2010-8#1)
is available in the##2##4##(2008-2#1)(2009-7#1)
is available in##9##3##(1990-6#2)(1992-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-8#1)
is available on the##10##4##(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2012-3#1)
is available on##16##3##(1993-1#1)(1994-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#2)(2012-12#3)(2012-3#1)
is available through the##2##4##(1996-3#1)(2008-2#1)
is available through##4##3##(1992-3#1)(1996-3#1)(2008-2#1)(2008-7#1)
is available to the##2##4##(1992-5#1)(2008-2#1)
is available to##22##3##(1992-5#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#6)(2012-3#2)(2013-1#1)
is available##143##2##(1990-10#1)(1990-6#2)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
is averaged over##3##3##(1993-11#1)(2008-3#2)
is averaged##4##2##(1993-11#1)(2008-3#3)
is avirulent##3##2##(2008-10#3)
is avoided by##2##3##(2008-10#1)(2008-2#1)
is avoided##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
is bad##2##2##(1994-2#1)(2008-2#1)
is balanced by##4##3##(1991-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
is balanced##5##2##(1991-9#1)(1995-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
is banned##2##2##(1994-7#1)(2008-7#1)
is based in the##5##4##(2008-10#2)(2008-3#1)(2009-7#2)
is based in##10##3##(1992-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-7#2)(2013-1#1)(2013-8#1)
is based mainly on##3##4##(2008-3#1)(2011-2#1)(2013-1#1)
is based on a combination of##2##6##(2008-2#1)(2013-1#1)
is based on a model that##2##6##(2007-6#1)(2008-3#1)
is based on a modified##3##5##(2007-11#1)(2008-3#2)
is based on a number of##2##6##(2010-1#1)(2011-2#1)
is based on a periodic##2##5##(2007-12#2)
is based on a review of##3##6##(1996-2#1)(1997-2#1)(2011-2#1)
is based on a set of##2##6##(2008-10#1)(2008-3#1)
is based on a simple##2##5##(2007-11#1)(2008-3#1)
is based on a single##2##5##(2008-10#1)(2008-3#1)
is based on a two-dimensional##3##5##(2007-11#2)(2008-2#1)
is based on a##117##4##(1990-12#1)(1990-6#1)(1991-2#1)(1992-2#1)(1996-1#1)(1996-2#1)(1997-2#2)(2007-11#11)(2007-12#7)(2007-6#1)(2008-10#22)(2008-11#1)(2008-2#11)(2008-3#33)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
is based on an analysis of##2##6##(1990-11#1)(1993-12#1)
is based on an##17##4##(1990-11#1)(1993-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-9#1)(2010-1#1)(2010-5#1)
is based on both##2##4##(2012-1#1)(2013-1#1)
is based on clinical##5##4##(1994-5#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
is based on combining##2##4##(2008-3#1)(2008-7#1)
is based on controlled##2##4##(2008-10#2)
is based on data##3##4##(1991-12#1)(1996-12#1)(2011-2#1)
is based on detection of##2##5##(2008-3#1)(2010-7#1)
is based on diffusion##2##4##(2008-10#1)(2008-2#1)
is based on direct##2##4##(2008-10#2)
is based on evaluation of the##2##6##(1992-12#1)(2008-10#1)
is based on fitting the##2##5##(2008-2#1)(2008-3#1)
is based on highly##2##4##(2008-2#1)(2008-3#1)
is based on immobilized##2##4##(2008-10#2)
is based on interference##3##4##(2007-12#1)(2008-3#2)
is based on its catalytic effect on the oxidation##3##9##(2008-10#3)
is based on its catalytic effect on the##4##8##(2008-10#4)
is based on its##7##4##(2008-10#7)
is based on many factors##2##5##(1993-2#1)(2011-2#1)
is based on measurement of the##2##6##(2008-3#2)
is based on measurements of##2##5##(1996-12#1)(2008-3#1)
is based on measurements##3##4##(1996-12#1)(2008-3#2)
is based on measuring the##2##5##(2007-12#1)(2008-10#1)
is based on mortality##2##4##(1992-2#1)(2008-8#1)
is based on multiple##2##4##(1996-3#1)(2008-3#1)
is based on observations##2##4##(2008-2#1)(2008-9#1)
is based on one##2##4##(2007-10#1)(2008-8#1)
is based on periodically poled lithium niobate##3##7##(2007-12#2)(2008-3#1)
is based on personal##2##4##(1996-2#1)(2010-5#1)
is based on phase##2##4##(2008-10#1)(2008-3#1)
is based on recent##3##4##(1996-1#1)(2008-11#1)(2008-3#1)
is based on reflectance##2##4##(2008-10#1)(2008-3#1)
is based on results of##2##5##(2008-2#1)(2010-10#1)
is based on simple##2##4##(2008-2#1)(2008-6#1)
is based on simultaneous##2##4##(2007-12#1)(2008-10#1)
is based on solid phase##2##5##(2008-10#2)
is based on that##2##4##(2008-10#1)(2011-2#1)
is based on the CL reaction##3##6##(2008-10#3)
is based on the ability of IL-9 to stimulate the proliferation of the##2##13##(2008-4#2)
is based on the ability of##5##6##(1995-5#1)(2008-10#1)(2008-4#3)
is based on the ability to##2##6##(2008-6#1)(2012-1#1)
is based on the ability##7##5##(1995-5#1)(2008-10#1)(2008-4#3)(2008-6#1)(2012-1#1)
is based on the accumulation of##2##6##(2008-10#2)
is based on the analysis of##2##6##(2008-2#1)(2008-3#1)
is based on the application of a##2##7##(2008-10#1)(2008-3#1)
is based on the application of##4##6##(2008-10#2)(2008-11#1)(2008-3#1)
is based on the assumption that the##2##7##(1992-6#1)(2008-9#1)
is based on the assumption that##4##6##(1992-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
is based on the assumption##5##5##(1992-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
is based on the author's##2##5##(1991-1#1)(2008-12#1)
is based on the catalytic effect of manganese (II) on the oxidation of##2##13##(2008-10#2)
is based on the catalytic effect of##11##7##(2008-10#11)
is based on the catalytic##12##5##(2008-10#12)
is based on the changes in##2##6##(2008-10#2)
is based on the chemical sorption of##2##7##(2008-10#2)
is based on the chemical##3##5##(2008-10#3)
is based on the clinical##2##5##(2007-12#1)(2010-6#1)
is based on the combination of##2##6##(2008-10#2)
is based on the combined##3##5##(2008-10#2)(2008-2#1)
is based on the complex##3##5##(2008-10#2)(2008-3#1)
is based on the complexation##3##5##(2008-10#3)
is based on the concept of##2##6##(2008-10#1)(2008-3#1)
is based on the coupling##2##5##(2008-10#2)
is based on the development of##3##6##(2008-10#2)(2008-5#1)
is based on the difference between the##3##7##(2008-10#2)(2008-5#1)
is based on the difference##6##5##(2008-10#5)(2008-5#1)
is based on the differential##3##5##(2008-3#1)(2008-9#1)(2010-7#1)
is based on the diffusion##2##5##(2008-10#1)(2008-3#1)
is based on the effective##2##5##(2008-10#1)(2008-3#1)
is based on the efficient##2##5##(2008-10#1)(2008-2#1)
is based on the employment of##2##6##(2008-10#2)
is based on the enhancement of##2##6##(2008-10#2)
is based on the estimation of the##2##7##(2007-11#1)(2008-10#1)
is based on the exposed##2##5##(2008-10#1)(2010-4#1)
is based on the expression##2##5##(2008-10#1)(2008-9#1)
is based on the fact that the##3##7##(1992-9#1)(2008-10#2)
is based on the fact that##11##6##(1990-11#1)(1992-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)
is based on the finding##2##5##(1995-6#1)(2008-1#1)
is based on the fluorescence quenching of##2##7##(2008-10#2)
is based on the fluorescence##5##5##(2008-10#5)
is based on the following##3##5##(1996-12#1)(2008-10#2)
is based on the formation of a##5##7##(2008-10#5)
is based on the formation of##14##6##(2008-10#13)(2010-5#1)
is based on the inhibition effect of##3##7##(2008-10#3)
is based on the inhibition##4##5##(2008-10#3)(2008-3#1)
is based on the injection of##2##6##(2008-10#2)
is based on the injection##3##5##(2008-10#3)
is based on the interaction of##4##6##(2008-10#3)(2008-3#1)
is based on the measurement of the##5##7##(2008-10#4)(2008-3#1)
is based on the measurement of##8##6##(1997-4#1)(2008-10#6)(2008-3#1)
is based on the observations##2##5##(1995-3#1)(2008-3#1)
is based on the on-line##4##5##(2008-10#4)
is based on the optical##2##5##(2008-3#2)
is based on the oxidation of##7##6##(2008-10#7)
is based on the oxidation reaction of##2##7##(2008-10#2)
is based on the oxidation##9##5##(2008-10#9)
is based on the premise that##2##6##(2008-9#1)(2013-1#1)
is based on the presence of##2##6##(2007-12#1)(2008-10#1)
is based on the presence##3##5##(1990-5#1)(2007-12#1)(2008-10#1)
is based on the principle of##2##6##(2008-3#1)(2008-7#1)
is based on the principle##3##5##(2008-3#1)(2008-4#1)(2008-7#1)
is based on the reaction between##10##6##(2008-10#10)
is based on the reaction of##11##6##(2008-10#11)
is based on the reaction##22##5##(2008-10#22)
is based on the separation and##2##6##(2008-10#2)
is based on the separation##3##5##(2008-10#3)
is based on the simultaneous##4##5##(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
is based on the solid-phase extraction of##2##7##(2008-10#2)
is based on the sorption of##4##6##(2008-10#4)
is based on the spatial##2##5##(2007-12#1)(2008-3#1)
is based on the use of the##4##7##(1995-5#1)(2008-10#1)(2008-2#1)(2010-5#1)
is based on the use of##16##6##(1990-12#2)(1995-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2010-5#1)
is based on the utilization of##2##6##(2008-10#2)
is based on the well-known##2##5##(2008-10#1)(2008-2#1)
is based on the##436##4##(1990-11#1)(1990-12#4)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#9)(2007-12#10)(2007-2#1)(2008-1#2)(2008-10#251)(2008-11#8)(2008-12#3)(2008-2#13)(2008-3#54)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#8)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
is based on their##3##4##(2008-10#2)(2008-11#1)
is based on this##2##4##(1994-3#1)(2008-2#1)
is based on three##2##4##(2008-10#1)(2008-11#1)
is based on two##3##4##(1991-6#1)(1997-6#1)(2008-3#1)
is based on using##2##4##(2008-2#1)(2008-3#1)
is based on##888##3##(1990-11#2)(1990-12#5)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#5)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#31)(2007-12#39)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#352)(2008-11#20)(2008-12#4)(2008-2#53)(2008-3#140)(2008-4#14)(2008-5#10)(2008-6#8)(2008-7#12)(2008-8#10)(2008-9#17)(2009-10#1)(2009-11#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#5)(2011-10#1)(2011-2#14)(2011-3#2)(2012-1#3)(2012-2#6)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#5)
is based only on##3##4##(2007-6#1)(2007-8#1)(2012-3#1)
is based primarily on##2##4##(1992-4#1)(2008-8#1)
is based upon the##7##4##(1990-12#1)(1996-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)
is based upon##17##3##(1990-12#1)(1991-3#2)(1991-5#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
is based##933##2##(1990-11#2)(1990-12#6)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#5)(1996-2#2)(1996-3#4)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#32)(2007-12#40)(2007-2#2)(2007-6#2)(2007-8#5)(2008-1#6)(2008-10#359)(2008-11#22)(2008-12#4)(2008-2#53)(2008-3#142)(2008-4#14)(2008-5#12)(2008-6#9)(2008-7#12)(2008-8#12)(2008-9#18)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#6)(2011-10#1)(2011-2#17)(2011-3#2)(2012-1#3)(2012-2#6)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#6)
is basically##4##2##(1996-12#1)(2008-5#2)(2011-1#1)
is because of the##2##4##(2012-1#1)(2013-8#1)
is because of##4##3##(1997-6#1)(2007-2#1)(2012-1#1)(2013-8#1)
is because##14##2##(1996-4#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
is becoming a more##2##4##(2008-10#1)(2008-7#1)
is becoming a##7##3##(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-7#1)
is becoming an important topic##2##5##(2008-10#1)(2008-12#1)
is becoming an important##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
is becoming an increasingly common##2##5##(2013-1#2)
is becoming an increasingly important##3##5##(1994-2#1)(2006-6#1)(2010-10#1)
is becoming an increasingly##5##4##(1994-2#1)(2006-6#1)(2010-10#1)(2013-1#2)
is becoming an##9##3##(1994-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#2)
is becoming increasingly evident##2##4##(2008-7#1)(2010-6#1)
is becoming increasingly important in##2##5##(1993-11#1)(1996-12#1)
is becoming increasingly important to##2##5##(2007-11#1)(2007-8#1)
is becoming increasingly important##6##4##(1993-11#1)(1996-12#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-2#1)
is becoming increasingly##11##3##(1992-3#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
is becoming more and more##2##5##(2010-7#1)(2013-8#1)
is becoming more popular in##2##5##(1995-2#1)(2008-8#1)
is becoming more##10##3##(1992-9#1)(1993-3#1)(1994-1#1)(1995-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
is becoming##53##2##(1990-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#3)(1994-1#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-4#3)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#2)
is beginning to emerge##2##4##(1995-9#1)(2011-2#1)
is beginning to shift##2##4##(2008-11#1)(2008-5#1)
is beginning to##11##3##(1995-1#1)(1995-9#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#2)
is being applied to##2##4##(2008-10#1)(2010-4#1)
is being assessed##2##3##(2008-11#1)(2008-7#1)
is being carried out##2##4##(2008-5#1)(2011-2#1)
is being challenged##2##3##(1994-2#1)(2013-1#1)
is being conducted##4##3##(2008-10#1)(2008-5#1)(2009-7#1)(2010-8#1)
is being considered##2##3##(1990-9#1)(1997-1#1)
is being developed##7##3##(1994-5#1)(1995-12#1)(1997-5#2)(2008-2#1)(2008-3#1)(2010-4#1)
is being driven##2##3##(1997-4#1)(2009-3#1)
is being employed##2##3##(2008-10#1)(2008-4#1)
is being given##3##3##(1992-3#1)(1993-1#1)(2007-11#1)
is being implemented##2##3##(1994-3#1)(2013-1#1)
is being increasingly recognized##2##4##(2009-3#1)(2009-9#1)
is being increasingly used for##2##5##(1993-11#1)(2008-3#1)
is being increasingly##9##3##(1993-11#1)(2006-10#1)(2007-7#1)(2008-3#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-2#2)
is being investigated##2##3##(2008-10#1)(2008-3#1)
is being measured##2##3##(1993-1#1)(2008-3#1)
is being observed##2##3##(1996-2#1)(2008-7#1)
is being reported##9##3##(1996-9#1)(2007-7#5)(2007-8#1)(2008-1#1)(2013-1#1)
is being studied##3##3##(1997-4#1)(2008-4#1)(2011-2#1)
is being tested##4##3##(1997-6#1)(2008-5#2)(2008-7#1)
is being treated with##3##4##(1993-2#1)(2007-7#1)(2008-7#1)
is being used as a##2##5##(1994-6#1)(2008-11#1)
is being used as##3##4##(1994-6#1)(2008-11#2)
is being used in the##2##5##(2008-11#1)(2011-2#1)
is being used in##4##4##(2007-7#1)(2008-11#2)(2011-2#1)
is being used to##8##4##(2008-10#2)(2008-11#2)(2008-3#1)(2010-10#1)(2010-5#1)(2010-8#1)
is being used##23##3##(1994-3#1)(1994-6#1)(1996-2#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
is being##146##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-9#1)(1997-1#1)(1997-4#4)(1997-5#3)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#11)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#10)(2008-9#1)(2009-3#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
is believed that the##3##4##(1994-8#1)(2012-1#1)(2012-12#1)
is believed that this##4##4##(2007-2#1)(2008-10#1)(2008-3#2)
is believed that##19##3##(1991-3#1)(1994-8#1)(1995-1#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
is believed to be a##12##5##(1991-9#1)(1994-11#1)(1994-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#3)(2008-9#1)(2011-2#1)(2012-2#1)
is believed to be an##2##5##(1994-11#1)(1995-3#1)
is believed to be involved in the##2##7##(2010-3#1)(2013-8#1)
is believed to be the first##33##6##(2007-11#17)(2007-12#15)(2008-3#1)
is believed to be the##36##5##(1992-4#1)(1992-9#1)(2007-11#18)(2007-12#15)(2008-3#1)
is believed to be##63##4##(1990-8#1)(1991-9#1)(1992-4#1)(1992-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-11#20)(2007-12#15)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#2)
is believed to contribute to the##2##6##(2008-5#1)(2012-3#1)
is believed to encode##2##4##(1991-12#1)(1992-4#1)
is believed to occur##3##4##(1990-5#1)(1996-1#1)(2012-12#1)
is believed to play an important role in##2##8##(1995-12#1)(2010-12#1)
is believed to play##4##4##(1995-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
is believed to represent##2##4##(2008-10#1)(2011-2#1)
is believed to result from##3##5##(1995-11#1)(1997-4#1)(2008-10#1)
is believed to result##4##4##(1995-11#1)(1997-4#1)(2008-10#1)(2008-4#1)
is believed to##94##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-4#2)(1992-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#21)(2007-12#15)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
is believed##115##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-4#2)(1992-9#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#21)(2007-12#15)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
is below approximately##2##3##(2008-3#2)
is below the threshold##2##4##(2008-10#2)
is below the##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
is below##15##2##(1993-9#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-8#1)(2009-11#1)(2013-1#1)
is beneficial for the##3##4##(1993-3#1)(2007-11#1)(2012-2#1)
is beneficial for##7##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#1)
is beneficial in##5##3##(2007-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
is beneficial to##8##3##(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
is beneficial##26##2##(1993-3#1)(1995-5#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
is bent##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)
is best achieved##2##3##(2010-3#1)(2010-7#1)
is best described as a##2##5##(1996-2#1)(2008-10#1)
is best described as##3##4##(1996-2#1)(2008-1#1)(2008-10#1)
is best described##5##3##(1996-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
is best explained by##3##4##(1997-6#1)(2008-4#2)
is best for##2##3##(1991-3#1)(1992-2#1)
is best known as##2##4##(1995-2#1)(2008-10#1)
is best known##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
is best suited for##2##4##(2008-10#1)(2011-2#1)
is best suited##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
is best understood by##2##4##(2008-4#2)
is best##35##2##(1991-3#2)(1992-2#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#6)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#3)
is better suited##2##3##(2008-10#1)(2008-3#1)
is better than 0##2##4##(2008-10#1)(2008-2#1)
is better than that of the##2##6##(2008-3#1)(2009-7#1)
is better than that of##5##5##(2007-11#1)(2008-3#2)(2008-8#1)(2009-7#1)
is better than that##6##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-7#1)
is better than the##4##4##(2008-2#1)(2010-8#1)(2012-3#1)(2013-8#1)
is better than##30##3##(1993-3#1)(1995-9#1)(2007-11#2)(2008-10#6)(2008-2#3)(2008-3#8)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is better to##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
is better tolerated##2##3##(1991-9#1)(2008-5#1)
is better##56##2##(1990-9#1)(1991-9#1)(1993-3#1)(1995-9#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#4)(2008-3#10)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
is between 0##2##3##(2008-10#2)
is between 1 and 20##2##5##(2008-10#1)(2008-11#1)
is between 2 and##2##4##(2008-5#1)(2009-4#1)
is between the##2##3##(2007-12#1)(2008-8#1)
is between##20##2##(1990-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)(2013-8#1)
is beyond doubt##2##3##(2011-2#1)(2013-1#1)
is beyond the scope of this##2##6##(2008-5#1)(2013-7#1)
is beyond the scope of##3##5##(2008-5#1)(2008-9#1)(2013-7#1)
is beyond the##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-7#1)
is beyond##8##2##(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
is biased##2##2##(1997-5#1)(2010-3#1)
is biologically active##3##3##(1993-6#1)(2008-10#2)
is biologically##6##2##(1993-6#1)(1993-9#1)(2008-10#3)(2013-1#1)
is blended##2##2##(2008-12#1)(2012-3#1)
is blocked by the##2##4##(2008-11#1)(2010-7#1)
is blocked by##12##3##(1991-1#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-8#1)
is blocked in##2##3##(1990-11#1)(1994-6#1)
is blocked with##2##3##(1991-5#1)(2008-8#1)
is blocked##18##2##(1990-11#1)(1991-1#1)(1991-5#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-7#1)(2013-8#1)
is born##2##2##(1993-12#1)(1995-12#1)
is both a##3##3##(1991-3#1)(1993-2#1)(1994-2#1)
is both complex and##2##4##(2008-7#1)(2009-7#1)
is both necessary and sufficient for##4##6##(1991-2#2)(2009-10#1)(2012-3#1)
is both##42##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
is bound by##3##3##(1991-5#1)(1992-10#1)(1995-2#1)
is bound to the##2##4##(1991-5#1)(2008-4#1)
is bound to##6##3##(1990-12#1)(1991-5#1)(1993-12#1)(1994-8#1)(1996-2#1)(2008-4#1)
is bound##18##2##(1990-12#2)(1991-5#2)(1992-10#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-3#1)(2010-4#1)(2010-6#1)
is briefly described##5##3##(2007-12#1)(2008-11#2)(2008-2#1)(2008-7#1)
is briefly discussed##5##3##(1992-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)
is briefly presented##2##3##(1995-8#1)(2013-1#1)
is briefly reviewed##2##3##(1997-8#1)(2013-8#1)
is briefly##17##2##(1990-8#1)(1992-10#1)(1995-8#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-3#1)(2013-1#1)(2013-8#1)
is bright##3##2##(2007-11#1)(2009-4#1)(2009-5#1)
is broad##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
is broadband##2##2##(2007-11#1)(2008-3#1)
is broadened##2##2##(2007-12#1)(2008-2#1)
is broadly##2##2##(2008-3#1)(2009-8#1)
is broken##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)
is brought##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)
is built around##3##3##(1997-3#1)(2007-12#1)(2012-3#1)
is built in##2##3##(2008-5#1)(2012-3#1)
is built of##2##3##(2008-3#1)(2008-7#1)
is built on##2##3##(2007-10#1)(2008-11#1)
is built to##2##3##(2008-3#1)(2008-7#1)
is built with##2##3##(2008-3#2)
is built##18##2##(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#2)
is buried##2##2##(1992-6#1)(2008-2#1)
is by a##2##3##(2007-12#1)(2008-10#1)
is by far the##2##4##(1993-1#1)(2010-12#1)
is by no means a##2##5##(1990-12#1)(2009-3#1)
is by no means##4##4##(1990-12#1)(1995-1#1)(2008-9#1)(2009-3#1)
is by##21##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-1#1)(1995-1#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-3#2)(2009-5#1)(2010-12#1)(2010-7#1)(2013-8#2)
is ca##2##2##(2008-10#2)
is calcium##3##2##(1993-8#1)(2008-4#1)(2010-12#1)
is calculated and compared with##2##5##(2008-3#2)
is calculated and##3##3##(2008-10#1)(2008-3#2)
is calculated as a function of##2##6##(2008-10#1)(2008-2#1)
is calculated as the##3##4##(2008-10#2)(2008-3#1)
is calculated as##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
is calculated by use of a##2##6##(2007-12#2)
is calculated by use of the##2##6##(2008-2#1)(2008-3#1)
is calculated by use of##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
is calculated by##9##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-8#1)
is calculated for##8##3##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#4)
is calculated from the difference##2##5##(2008-10#2)
is calculated from the##13##4##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-9#1)(2009-12#1)(2010-5#1)
is calculated from##18##3##(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-9#1)(2009-12#1)(2010-5#1)
is calculated in##2##3##(2008-2#2)
is calculated to be 0##2##5##(2008-10#2)
is calculated to be##6##4##(1990-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
is calculated##80##2##(1990-6#1)(1992-6#1)(1996-2#1)(2007-11#2)(2007-12#6)(2008-10#18)(2008-2#14)(2008-3#28)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#2)(2010-5#1)(2013-8#1)
is called for##2##3##(1991-11#1)(2010-6#1)
is called the##5##3##(1995-3#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
is called##25##2##(1991-1#1)(1991-11#1)(1993-12#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-7#3)(2008-8#2)(2009-1#1)(2009-10#1)(2010-6#2)(2010-8#2)(2011-2#2)(2012-3#1)
is capable of a##2##4##(2007-12#1)(2008-10#1)
is capable of achieving##2##4##(2007-12#1)(2008-10#1)
is capable of being##3##4##(2008-2#1)(2008-7#1)(2009-6#1)
is capable of binding##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
is capable of causing##2##4##(2007-12#1)(2013-8#1)
is capable of converting##2##4##(1992-12#1)(2010-1#1)
is capable of detecting##6##4##(1995-3#1)(2008-10#2)(2008-3#2)(2008-9#1)
is capable of determining the##2##5##(2008-2#1)(2008-3#1)
is capable of direct##2##4##(1995-2#1)(2011-2#1)
is capable of directly##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
is capable of generating##4##4##(2008-10#1)(2008-3#3)
is capable of identifying the##2##5##(2008-10#1)(2008-3#1)
is capable of identifying##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
is capable of imaging##2##4##(2007-11#1)(2008-3#1)
is capable of increasing the##2##5##(1990-2#1)(1995-12#1)
is capable of inducing##5##4##(1991-12#1)(1992-12#1)(1994-11#1)(1995-12#1)(2008-10#1)
is capable of measuring##3##4##(2008-2#2)(2008-3#1)
is capable of mediating the electron transfer to##2##8##(2008-10#2)
is capable of modeling##2##4##(2008-2#1)(2013-1#1)
is capable of operating##2##4##(2008-3#2)
is capable of potentiating##2##4##(1995-3#1)(2010-11#1)
is capable of producing##5##4##(1991-9#1)(1994-5#1)(2008-10#1)(2008-3#2)
is capable of recording##2##4##(2008-2#1)(2008-3#1)
is capable of resolving##2##4##(2008-2#1)(2008-3#1)
is capable of scanning##2##4##(2008-3#2)
is capable of supporting##2##4##(2008-3#2)
is capable of taking##2##4##(2007-11#1)(2008-3#1)
is capable of undergoing##2##4##(1996-5#1)(2007-12#1)
is capable of##134##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#2)(1992-12#2)(1992-3#1)(1993-12#1)(1994-11#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#7)(2007-12#11)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#31)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-7#1)(2013-1#2)(2013-8#2)
is capable to##2##3##(1996-2#1)(2008-11#1)
is capable##137##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#2)(1992-12#2)(1992-3#1)(1993-12#1)(1994-11#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2007-11#7)(2007-12#11)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#31)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-7#1)(2013-1#2)(2013-8#2)
is captured##2##2##(2008-3#1)(2008-4#1)
is carbon##2##2##(2008-10#1)(2008-9#1)
is carcinogenic##3##2##(1991-12#1)(1994-2#1)(2007-10#1)
is carefully controlled##2##3##(2008-10#1)(2008-5#1)
is carefully##5##2##(1994-1#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
is carried by##3##3##(1995-5#1)(1997-2#1)(2008-10#1)
is carried out by a##2##5##(2008-10#1)(2008-4#1)
is carried out by complexation with##2##6##(2008-10#2)
is carried out by use of##2##6##(2008-2#2)
is carried out by##13##4##(2007-11#1)(2008-10#5)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-9#1)
is carried out in a closed##2##6##(2008-10#2)
is carried out in a##5##5##(2007-11#1)(2008-10#4)
is carried out in an on-line system##2##7##(2008-10#2)
is carried out in the##3##5##(1991-6#1)(2008-10#2)
is carried out in##14##4##(1991-6#1)(2007-11#1)(2008-10#9)(2008-7#1)(2008-9#1)(2010-3#1)
is carried out on##4##4##(2008-10#3)(2010-5#1)
is carried out through##2##4##(2008-4#1)(2012-12#1)
is carried out using##5##4##(2008-10#3)(2008-7#1)(2013-8#1)
is carried out with##7##4##(1990-5#1)(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
is carried out within##2##4##(1995-11#1)(2007-11#1)
is carried out##73##3##(1990-5#1)(1991-11#1)(1991-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-5#1)(2007-11#3)(2007-7#1)(2008-10#33)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
is carried##79##2##(1990-5#1)(1991-11#1)(1991-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-5#2)(1996-5#1)(1997-2#1)(2007-11#3)(2007-7#1)(2008-10#34)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
is carrying out##2##3##(2008-11#1)(2008-6#1)
is catalytically##2##2##(1990-7#1)(2008-11#1)
is catalyzed at the active site##2##6##(1992-6#2)
is catalyzed by a##3##4##(1990-10#1)(1995-2#1)(2012-2#1)
is catalyzed by##9##3##(1990-10#1)(1994-8#1)(1995-2#2)(2008-10#1)(2008-4#2)(2012-2#1)(2013-8#1)
is catalyzed##12##2##(1990-10#1)(1992-6#2)(1994-8#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-4#2)(2012-2#1)(2013-8#1)
is categorized##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
is causally##2##2##(1994-6#1)(2012-2#1)
is cause of##2##3##(2007-8#1)(2013-1#1)
is cause##3##2##(1990-7#1)(2007-8#1)(2013-1#1)
is caused by Phytophthora##2##4##(2008-10#2)
is caused by Puccinia striiformis f##2##6##(2008-10#2)
is caused by a complex##2##5##(2008-10#1)(2009-6#1)
is caused by a gene##2##5##(1994-8#1)(1997-8#1)
is caused by a mutation in##2##6##(2007-8#1)(2008-12#1)
is caused by a##21##4##(1990-11#1)(1994-8#2)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)
is caused by an##2##4##(2008-10#1)(2013-8#1)
is caused by at least##2##5##(2008-10#1)(2008-6#1)
is caused by increased##2##4##(1991-6#1)(1995-5#1)
is caused by mutations in##3##5##(2007-7#1)(2013-1#1)(2013-8#1)
is caused by mutations of##2##5##(1995-2#1)(2007-7#1)
is caused by mutations##5##4##(1995-2#1)(2007-7#2)(2013-1#1)(2013-8#1)
is caused by the phase difference##2##6##(2008-3#2)
is caused by the##23##4##(1993-3#2)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
is caused by their##2##4##(2008-11#1)(2008-8#1)
is caused by this##2##4##(1990-11#1)(2008-5#1)
is caused by##113##3##(1990-11#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-6#1)(1993-3#2)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#3)(2007-8#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
is caused largely by##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
is caused not##2##3##(1995-6#1)(2008-10#1)
is caused primarily by##3##4##(2008-10#2)(2011-1#1)
is caused##124##2##(1990-11#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-6#2)(1993-3#2)(1994-11#1)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-2#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#3)(2007-8#1)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
is causing##2##2##(2008-10#1)(2013-8#1)
is cell##2##2##(1994-11#1)(2008-2#1)
is centered around the##2##4##(1996-1#1)(2007-12#1)
is centered##5##2##(1996-1#1)(2007-12#2)(2009-10#1)(2011-1#1)
is central to the##10##4##(1997-1#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
is central to##20##3##(1991-4#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
is central##22##2##(1991-4#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
is certain##2##2##(2008-11#1)(2008-2#1)
is certainly the case in##2##5##(2008-7#1)(2010-11#1)
is certainly##6##2##(1991-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)
is challenged by##2##3##(2008-11#1)(2008-5#1)
is challenged##6##2##(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-1#1)
is challenging and##3##3##(2008-11#1)(2008-8#1)(2010-12#1)
is challenging because of the##2##5##(2008-3#1)(2011-1#1)
is challenging because of##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
is challenging because##4##3##(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
is challenging##18##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2010-12#2)(2010-6#1)(2011-1#1)(2013-1#4)(2013-8#1)
is changed to##2##3##(1995-5#1)(1997-3#1)
is changed##9##2##(1994-12#1)(1995-5#1)(1997-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2013-8#1)
is changing##14##2##(1992-9#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-3#2)(2007-12#1)(2007-4#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-7#1)(2013-8#1)
is characterised by measuring the##2##5##(1994-12#1)(2008-10#1)
is characterised by the##3##4##(1993-3#1)(2007-8#1)(2008-7#1)
is characterised by##15##3##(1993-3#1)(1994-12#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-10#2)(2012-12#2)(2013-7#1)
is characterised##19##2##(1991-2#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-10#2)(2012-12#2)(2013-7#1)(2013-8#1)
is characteristic for##2##3##(2008-11#1)(2011-2#1)
is characteristic of a##2##4##(1997-7#1)(2007-7#1)
is characteristic of many##2##4##(1991-11#1)(2008-4#1)
is characteristic of##21##3##(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)
is characteristic##25##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2011-2#1)
is characteristics##2##2##(2008-8#1)(2011-2#1)
is characterized as##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
is characterized by a high##3##5##(1995-8#1)(2010-3#1)(2010-8#1)
is characterized by a##35##4##(1990-8#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
is characterized by an##9##4##(1994-12#1)(1995-12#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
is characterized by cortical##2##4##(2008-7#2)
is characterized by high##4##4##(1995-11#1)(2006-10#1)(2008-6#1)(2012-3#1)
is characterized by inflammatory##2##4##(2008-4#1)(2010-12#1)
is characterized by its##7##4##(1990-2#1)(2007-12#1)(2008-10#3)(2008-4#1)(2013-1#1)
is characterized by loss of##2##5##(1996-3#1)(1997-1#1)
is characterized by normal##2##4##(1992-9#1)(2008-10#1)
is characterized by recurrent##2##4##(2013-1#1)(2013-8#1)
is characterized by the formation of##2##6##(1992-12#1)(2010-6#1)
is characterized by the presence of##4##6##(2006-10#1)(2008-5#1)(2010-6#2)
is characterized by the presence##5##5##(1993-2#1)(2006-10#1)(2008-5#1)(2010-6#2)
is characterized by the##26##4##(1992-12#1)(1993-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(2006-10#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-6#6)(2011-2#2)(2012-3#1)
is characterized by use of##3##5##(2007-12#1)(2008-3#2)
is characterized by##185##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#5)(2008-10#20)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#9)(2010-8#2)(2011-1#5)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
is characterized in##2##3##(2007-11#1)(2008-2#1)
is characterized with##2##3##(2008-10#2)
is characterized##203##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#2)(2008-1#5)(2008-10#24)(2008-11#2)(2008-12#6)(2008-2#9)(2008-3#10)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#9)(2010-8#2)(2011-1#5)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
is charged with##2##3##(1994-5#1)(1995-12#1)
is charged##3##2##(1990-5#1)(1994-5#1)(1995-12#1)
is cheap and simple##2##4##(2008-10#1)(2008-12#1)
is cheap and##4##3##(1993-11#1)(2008-10#2)(2008-12#1)
is cheap##8##2##(1990-2#1)(1993-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-2#1)
is checked##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
is chemically##3##2##(1992-3#1)(1993-6#1)(2008-10#1)
is chemotactic for##2##3##(1992-6#1)(2008-9#1)
is chosen as the##2##4##(2008-2#1)(2008-3#1)
is chosen for##2##3##(2008-3#2)
is chosen so that the##2##5##(2008-2#1)(2008-3#1)
is chosen such that the grating is moved approximately along the##2##11##(2008-3#2)
is chosen##11##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#7)
is chromosomal##2##2##(2008-12#1)(2008-7#1)
is chronic##2##2##(2007-12#1)(2013-8#1)
is circulating##3##2##(2007-2#1)(2008-3#2)
is cited##2##2##(1991-1#1)(2007-4#1)
is claimed##2##2##(1997-4#1)(2008-5#1)
is clarified##2##2##(2007-12#1)(2008-3#1)
is classically##2##2##(2008-7#1)(2012-2#1)
is classified according to the##3##5##(1990-6#1)(1997-8#1)(2013-1#1)
is classified as##5##3##(2007-5#1)(2008-10#1)(2008-6#1)(2010-8#1)(2013-8#1)
is classified into##5##3##(1997-6#1)(1997-8#1)(2008-12#1)(2009-5#1)(2012-2#1)
is classified##16##2##(1990-6#1)(1995-3#1)(1997-6#1)(1997-8#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is cleaned##2##2##(2008-10#1)(2008-4#1)
is clear that the##8##4##(1990-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
is clear that this##2##4##(2008-3#1)(2008-9#1)
is clear that##34##3##(1990-3#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
is clear##53##2##(1990-3#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
is cleared##2##2##(1994-5#1)(1997-1#1)
is clearly demonstrated##3##3##(2008-10#1)(2008-11#2)
is clearly identified##2##3##(1995-5#1)(2008-3#1)
is clearly needed to##2##4##(2010-10#1)(2011-1#1)
is clearly not##2##3##(1996-12#1)(2008-10#1)
is clearly observed##2##3##(2008-2#1)(2008-3#1)
is clearly##37##2##(1992-1#1)(1993-11#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)
is cleaved in the##2##4##(1991-9#1)(1996-12#1)
is cleaved##10##2##(1991-9#1)(1992-12#1)(1993-11#1)(1995-2#1)(1996-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-3#1)
is clinical##2##2##(1995-5#1)(2007-8#1)
is clinically important##2##3##(1994-9#1)(2013-1#1)
is clinically relevant because of##2##5##(2007-8#1)(2010-7#1)
is clinically##16##2##(1992-2#1)(1994-9#1)(1996-12#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
is cloned and##2##3##(1997-7#1)(2008-8#1)
is cloned##5##2##(1995-8#1)(1997-7#1)(2008-2#1)(2008-8#1)(2008-9#1)
is close to that of##2##5##(2007-11#1)(2008-10#1)
is close to the##9##4##(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#4)
is close to##21##3##(1994-5#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#6)(2008-7#1)(2011-2#1)(2013-8#1)
is closed to##2##3##(1995-8#1)(2008-6#1)
is closed##3##2##(1995-8#1)(2008-1#1)(2008-6#1)
is closely associated with the##3##5##(1993-8#1)(2012-2#2)
is closely associated with##8##4##(1992-12#1)(1993-8#1)(2008-8#3)(2008-9#1)(2012-2#2)
is closely correlated##2##3##(1994-6#1)(2007-8#1)
is closely interrelated##2##3##(1995-3#1)(2011-3#1)
is closely linked to##3##4##(2008-10#2)(2012-5#1)
is closely linked##4##3##(2008-10#2)(2008-11#1)(2012-5#1)
is closely related to M##2##5##(2008-10#1)(2008-9#1)
is closely related to the##4##5##(1990-11#1)(1991-7#1)(2008-3#1)(2008-4#1)
is closely related to##19##4##(1990-11#1)(1991-7#1)(1994-12#1)(1996-12#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)
is closely related##22##3##(1990-11#1)(1991-7#1)(1994-12#1)(1996-12#2)(1997-2#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#1)
is closely similar to##3##4##(1994-5#1)(1994-6#1)(2008-6#1)
is closely##46##2##(1990-11#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-5#1)(2009-7#1)(2011-3#1)(2012-2#2)(2012-5#1)
is closer to the##5##4##(1990-2#2)(2008-2#2)(2008-7#1)
is closer##6##2##(1990-2#2)(2008-2#2)(2008-7#1)(2008-8#1)
is co-localized##2##2##(1992-6#1)(2008-7#1)
is coated by a thin##2##5##(1997-4#1)(2009-6#1)
is coated with a##3##4##(2008-10#2)(2008-2#1)
is coated with##5##3##(2008-10#2)(2008-2#1)(2010-5#1)(2012-2#1)
is coated##7##2##(1997-4#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-5#1)(2012-2#1)
is coded by the##2##4##(2007-8#1)(2009-9#1)
is collected and##4##3##(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
is collected at##2##3##(2008-3#1)(2008-9#1)
is collected by a##2##4##(2008-3#2)
is collected by##4##3##(2007-11#1)(2008-3#2)(2012-2#1)
is collected in a##3##4##(2008-10#3)
is collected in##4##3##(2008-10#4)
is collected##19##2##(1995-2#1)(2007-11#1)(2008-10#8)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
is combined with the##2##4##(2007-11#1)(2008-3#1)
is combined with##15##3##(1995-3#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#2)
is combined##18##2##(1995-3#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
is coming to##2##3##(1995-8#1)(2007-12#1)
is coming##4##2##(1992-12#1)(1993-6#1)(1995-8#1)(2007-12#1)
is commenced##2##2##(2007-11#1)(2007-8#1)
is commercially available##4##3##(2008-10#2)(2008-4#1)(2012-3#1)
is commercially##5##2##(2008-10#2)(2008-4#1)(2010-4#1)(2012-3#1)
is committed to##2##3##(1991-2#1)(1995-2#1)
is common among##3##3##(2007-10#1)(2010-12#1)(2011-1#1)
is common and##7##3##(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
is common during##2##3##(2008-12#1)(2010-5#1)
is common for##2##3##(2008-3#1)(2008-8#1)
is common in developing countries##2##5##(2008-7#2)
is common in patients with##2##5##(2008-7#1)(2008-8#1)
is common in the literature##2##5##(1993-12#1)(2008-3#1)
is common in the##10##4##(1990-3#1)(1993-12#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)(2012-3#2)(2013-1#1)
is common in##36##3##(1990-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-1#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#4)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)
is common practice##2##3##(1996-11#1)(2007-11#1)
is common to all##3##4##(1990-2#1)(1995-6#1)(1996-1#1)
is common to both##2##4##(2007-12#1)(2008-2#1)
is common to the##2##4##(1997-7#1)(2008-9#1)
is common to##10##3##(1990-2#1)(1991-5#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-3#1)
is common with##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
is common##77##2##(1990-2#1)(1990-3#1)(1991-5#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#3)
is commonly associated with##2##4##(1991-4#1)(2009-10#1)
is commonly assumed to##2##4##(2008-3#1)(2012-3#1)
is commonly assumed##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
is commonly employed for##2##4##(2008-10#2)
is commonly found in##6##4##(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)
is commonly found##8##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2013-8#1)
is commonly observed in##2##4##(2011-1#1)(2011-2#1)
is commonly performed##5##3##(1996-8#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-2#1)
is commonly seen##3##3##(2008-3#1)(2010-8#1)(2013-1#1)
is commonly used as a##2##5##(1992-11#1)(2008-10#1)
is commonly used for##3##4##(2008-10#3)
is commonly used in##7##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
is commonly used to##3##4##(1990-11#1)(2008-4#1)(2008-8#1)
is commonly used##16##3##(1990-11#1)(1992-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
is commonly##68##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
is commonplace in##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
is commonplace##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
is compact and##2##3##(2007-11#1)(2008-3#1)
is compact##9##2##(1993-8#1)(2007-11#2)(2008-10#1)(2008-3#5)
is comparable to that in##2##5##(2008-10#1)(2010-3#1)
is comparable to that of##3##5##(1995-2#1)(1996-5#1)(2007-12#1)
is comparable to that##9##4##(1991-12#1)(1992-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-3#1)
is comparable to the##9##4##(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
is comparable to those##2##4##(2008-10#1)(2008-6#1)
is comparable to##26##3##(1991-12#1)(1992-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-2#1)
is comparable with or##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
is comparable with that of the##4##6##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is comparable with that of##7##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
is comparable with that##8##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)
is comparable with the wavelength of##2##6##(2008-2#1)(2008-3#1)
is comparable with the wavelength##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is comparable with the##9##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2010-5#1)
is comparable with##24##3##(1990-2#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#2)(2010-3#1)(2010-5#1)
is comparable##55##2##(1990-2#1)(1991-12#1)(1992-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-9#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
is comparatively##3##2##(1992-9#1)(2008-9#1)(2012-2#1)
is compared to that of the##2##6##(1994-2#1)(2008-6#1)
is compared to that of##3##5##(1994-2#1)(2008-12#1)(2008-6#1)
is compared to that##7##4##(1994-2#1)(2007-12#1)(2008-12#1)(2008-6#2)(2009-12#1)(2010-8#1)
is compared to the##5##4##(1993-12#1)(1995-8#1)(2008-10#1)(2008-7#1)(2010-3#1)
is compared to##20##3##(1993-12#1)(1994-2#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#2)(2008-7#2)(2009-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
is compared with a##3##4##(1995-11#1)(2007-12#1)(2008-3#1)
is compared with an##2##4##(2008-2#2)
is compared with experimental##3##4##(2007-11#1)(2008-2#1)(2009-12#1)
is compared with that of a##3##6##(2008-2#1)(2008-3#2)
is compared with that##5##4##(1991-3#1)(2008-2#1)(2008-3#3)
is compared with the result of a##2##7##(2007-12#1)(2008-2#1)
is compared with the##16##4##(1993-2#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#7)
is compared with##54##3##(1991-3#1)(1992-5#1)(1993-2#1)(1995-11#1)(1996-3#1)(1997-7#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#5)(2008-2#11)(2008-3#17)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-8#1)
is compared##81##2##(1991-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#7)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#13)(2008-3#19)(2008-5#3)(2008-6#2)(2008-7#3)(2009-12#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-2#1)
is compatible with a##3##4##(2008-3#1)(2008-5#1)(2011-1#1)
is compatible with all##2##4##(2008-10#1)(2008-9#1)
is compatible with an##2##4##(1997-1#1)(2008-1#1)
is compatible with the hypothesis##2##5##(2008-5#1)(2011-2#1)
is compatible with the##4##4##(1990-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
is compatible with##21##3##(1990-12#1)(1993-8#1)(1995-6#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2013-1#1)
is compatible##22##2##(1990-12#1)(1993-8#1)(1995-6#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2013-1#1)
is compelling and##2##3##(1992-9#1)(2011-2#1)
is compelling##5##2##(1992-9#1)(2008-7#1)(2008-8#1)(2011-2#2)
is compensated by##2##3##(2011-2#1)(2013-1#1)
is compensated for##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
is compensated in##2##3##(2008-3#1)(2008-9#1)
is compensated##10##2##(2007-11#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
is competitive with the##2##4##(1996-5#1)(2008-3#1)
is competitive with##3##3##(1994-5#1)(1996-5#1)(2008-3#1)
is competitive##7##2##(1990-11#1)(1992-12#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-2#1)
is compiled##2##2##(2006-10#1)(2008-3#1)
is complementary to##2##3##(1995-1#1)(2008-6#1)
is complemented by##2##3##(2008-1#1)(2011-2#1)
is complemented##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
is complete##7##2##(1990-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)
is completed by##2##3##(1996-2#1)(2009-8#1)
is completed##10##2##(1994-3#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-8#1)
is completely blocked##3##3##(1993-11#1)(1997-7#1)(2008-9#1)
is completely buried##2##3##(1994-5#1)(2012-2#1)
is completely eluted##2##3##(2008-10#2)
is completely inhibited##4##3##(1990-7#1)(1993-8#1)(1995-12#1)(1995-6#1)
is completely removed##2##3##(2008-2#1)(2008-3#1)
is completely stable##3##3##(2008-4#3)
is completely##31##2##(1990-7#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-7#2)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
is complex and##16##3##(1991-9#1)(1992-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)
is complex##34##2##(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
is complexed with##2##3##(1994-6#1)(1994-8#1)
is complexed##4##2##(1994-6#1)(1994-8#1)(2008-10#2)
is complicated and##2##3##(2008-2#1)(2008-7#1)
is complicated by the##5##4##(1997-4#1)(2008-11#1)(2008-3#2)(2008-8#1)
is complicated by##15##3##(1990-12#1)(1994-1#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2013-1#1)(2013-8#1)
is complicated##25##2##(1990-12#1)(1994-1#2)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
is composed mainly of##3##4##(1994-5#1)(2010-2#1)(2010-8#1)
is composed of a##9##4##(1992-1#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)
is composed of an##2##4##(2008-10#1)(2011-2#1)
is composed of four exons##2##5##(1993-6#1)(1994-12#1)
is composed of four##5##4##(1993-6#1)(1994-12#1)(1995-6#1)(2008-5#1)(2013-1#1)
is composed of seven##2##4##(1997-2#1)(2008-10#1)
is composed of the##2##4##(1990-5#1)(2008-6#1)
is composed of three##5##4##(2008-8#1)(2009-2#1)(2009-7#1)(2010-8#2)
is composed of two##9##4##(1993-11#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-8#1)(2013-1#2)
is composed of##73##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-8#2)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
is composed##78##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#3)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#3)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
is compounded##4##2##(1994-2#1)(2008-10#1)(2008-9#1)(2010-7#1)
is compressed##2##2##(2007-11#1)(2008-2#1)
is comprised of a##2##4##(1990-12#1)(2011-2#1)
is comprised of##10##3##(1990-12#1)(1990-8#1)(1995-3#1)(2008-10#2)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
is compromised in##2##3##(2009-8#1)(2012-2#1)
is compromised##8##2##(2007-8#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-2#1)
is computationally##2##2##(2008-3#2)
is computed##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)
is conceivable that##5##3##(1995-12#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-10#1)
is conceived##2##2##(2010-4#1)(2013-8#1)
is concentrated in the##3##4##(1992-3#1)(2008-12#1)(2008-8#1)
is concentrated in##5##3##(1990-11#1)(1992-3#1)(1992-6#1)(2008-12#1)(2008-8#1)
is concentrated##11##2##(1990-11#1)(1992-3#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-10#1)
is concentration dependent##2##3##(2008-10#1)(2009-8#1)
is concentration-dependent##2##2##(1990-7#1)(1994-11#1)
is conceptualized##2##2##(2008-2#1)(2008-6#1)
is concern##4##2##(1992-2#1)(1994-9#1)(2008-7#1)(2008-8#1)
is concerned with the##6##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
is concerned with##11##3##(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#3)
is concerned##21##2##(1992-11#1)(1996-5#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#4)
is concluded that both##3##4##(1990-2#1)(1993-2#1)(1995-11#1)
is concluded that the number of##2##6##(1991-11#1)(1991-2#1)
is concluded that the##33##4##(1990-7#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2013-1#2)
is concluded that these##2##4##(1992-11#1)(2008-1#1)
is concluded that this##4##4##(1991-12#1)(2008-3#1)(2008-5#1)(2009-7#1)
is concluded that##151##3##(1990-12#2)(1990-2#2)(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#3)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(1997-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#1)(2009-7#2)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
is concluded to be##2##4##(1993-11#1)(2008-10#1)
is concluded##162##2##(1990-12#2)(1990-2#2)(1990-3#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#3)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(1997-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#1)(2009-7#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
is conditioned by the##3##4##(2008-10#3)
is conditioned by##4##3##(2008-10#4)
is conditioned##5##2##(2008-10#5)
is conducive to##2##3##(1993-2#1)(2011-2#1)
is conducted by##5##3##(1993-3#1)(1997-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
is conducted in##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
is conducted on##2##3##(2008-10#1)(2010-2#1)
is conducted to##2##3##(2008-12#1)(2008-3#1)
is conducted##21##2##(1992-2#1)(1993-3#1)(1994-12#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is conducting##4##2##(2008-5#3)(2010-3#1)
is conferred by the##2##4##(2008-10#2)
is conferred by##4##3##(2008-10#3)(2010-12#1)
is conferred##5##2##(1995-5#1)(2008-10#3)(2010-12#1)
is configured##2##2##(1991-5#1)(2008-10#1)
is confined in##2##3##(2007-12#2)
is confined to##2##3##(1997-3#1)(2008-7#1)
is confined##5##2##(1997-3#1)(2007-12#2)(2008-7#1)(2010-2#1)
is confirmed by the##5##4##(1990-11#1)(1993-11#1)(2008-10#2)(2008-11#1)
is confirmed by##16##3##(1990-11#1)(1993-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2012-12#1)
is confirmed experimentally##2##3##(2008-10#1)(2008-3#1)
is confirmed that##4##3##(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
is confirmed##35##2##(1990-11#2)(1990-3#1)(1990-6#1)(1993-11#1)(2007-11#2)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-7#1)
is conformationally##2##2##(1992-11#1)(1996-2#1)
is confronted with the##3##4##(1992-1#1)(1993-11#1)(2007-7#1)
is connected to the##5##4##(1992-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
is connected to##7##3##(1992-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
is connected with##4##3##(2007-11#1)(2008-10#1)(2011-2#1)(2013-7#1)
is connected##11##2##(1992-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
is consensus##2##2##(1997-7#1)(2008-1#1)
is consequently##2##2##(2008-1#1)(2008-3#1)
is conservative##2##2##(1992-9#1)(2008-8#1)
is conserved among the##2##4##(1992-11#1)(2008-10#1)
is conserved among##4##3##(1992-11#1)(1993-9#1)(2007-12#1)(2008-10#1)
is conserved between##4##3##(1995-2#1)(1996-5#1)(2009-5#1)(2012-3#1)
is conserved in all known##2##5##(1993-11#1)(2008-4#1)
is conserved in all##5##4##(1993-11#1)(1993-9#1)(1995-2#2)(2008-4#1)
is conserved in##11##3##(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-6#1)(2008-4#1)(2008-8#2)(2010-10#1)
is conserved within##2##3##(1992-6#1)(1994-8#1)
is conserved##29##2##(1990-12#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2012-3#1)
is considerable and##2##3##(2009-7#1)(2012-12#1)
is considerable evidence that##3##4##(2008-5#1)(2008-9#1)(2009-10#1)
is considerable interest in##3##4##(1997-7#1)(2008-4#1)(2008-5#1)
is considerable scope for##2##4##(2008-10#1)(2010-12#1)
is considerable variation##4##3##(1991-11#1)(2011-2#1)(2013-1#2)
is considerable##31##2##(1991-11#1)(1992-9#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
is considerably higher##2##3##(2008-11#1)(2011-2#1)
is considerably lower than that of the##2##7##(1991-8#1)(1997-5#1)
is considerably lower##3##3##(1991-8#1)(1997-5#1)(2007-11#1)
is considerably more##2##3##(1992-12#1)(2012-3#1)
is considerably##19##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
is considered a major##4##4##(2008-1#2)(2008-4#1)(2013-8#1)
is considered a##29##3##(1990-10#1)(1992-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-2#2)(2013-8#2)
is considered an essential##2##4##(2008-10#1)(2011-2#1)
is considered an##7##3##(2008-10#3)(2011-2#2)(2012-2#1)(2013-7#1)
is considered and##7##3##(1992-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-12#1)
is considered as a##8##4##(1994-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
is considered as an##4##4##(1992-9#1)(2008-10#1)(2008-11#1)(2010-8#1)
is considered as the##2##4##(2007-8#1)(2008-10#1)
is considered as##19##3##(1992-9#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
is considered by##3##3##(1993-11#1)(2007-11#1)(2008-2#1)
is considered for a##2##4##(2008-2#1)(2013-8#1)
is considered for##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
is considered in terms of##2##5##(2008-11#1)(2008-2#1)
is considered in##8##3##(1991-9#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-3#1)
is considered more##2##3##(1992-1#1)(2009-6#1)
is considered one of the most##3##6##(2008-10#1)(2010-12#1)(2010-2#1)
is considered one of the##5##5##(2008-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
is considered safe##2##3##(1992-11#1)(2010-12#1)
is considered that the##3##4##(2008-10#2)(2008-6#1)
is considered that##7##3##(2008-10#3)(2008-6#1)(2008-9#2)(2009-7#1)
is considered the##10##3##(1997-1#1)(2007-8#1)(2008-1#2)(2008-10#3)(2010-4#1)(2012-3#1)(2013-1#1)
is considered to be a major##2##6##(2008-12#1)(2008-5#1)
is considered to be a##13##5##(1990-12#1)(1994-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#2)(2013-8#1)
is considered to be due to a##2##7##(1991-12#1)(1995-3#1)
is considered to be due to##3##6##(1991-12#2)(1995-3#1)
is considered to be of##2##5##(2007-2#1)(2013-8#1)
is considered to be one of the##2##7##(2008-8#1)(2013-8#1)
is considered to be the##5##5##(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
is considered to be##45##4##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
is considered to have##4##4##(1993-2#1)(1996-9#1)(2008-5#1)(2013-1#1)
is considered to play##2##4##(1996-12#1)(2008-7#1)
is considered to##60##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#6)
is considered##223##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-11#2)(1991-12#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#26)(2008-11#8)(2008-12#6)(2008-2#14)(2008-3#17)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#15)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#11)
is considering##3##2##(1993-1#1)(1994-2#1)(1996-1#1)
is consistent with a role for##2##6##(1993-12#1)(1996-12#1)
is consistent with a role##3##5##(1993-12#1)(1996-12#1)(2010-10#1)
is consistent with a##17##4##(1991-3#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-12#1)(2010-10#1)(2011-1#1)
is consistent with current##2##4##(2008-10#1)(2008-3#1)
is consistent with experimental##2##4##(2008-12#1)(2010-10#1)
is consistent with its##3##4##(1992-11#1)(2008-10#1)(2008-3#1)
is consistent with previous##3##4##(1991-8#1)(2008-7#1)(2008-9#1)
is consistent with previously published##2##5##(2007-12#1)(2010-2#1)
is consistent with that of##2##5##(2008-10#2)
is consistent with that##3##4##(1994-2#1)(2008-10#2)
is consistent with the hypothesis that##5##6##(1990-7#1)(1993-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
is consistent with the hypothesis##6##5##(1990-7#1)(1993-6#1)(2008-10#2)(2008-6#1)(2008-8#1)
is consistent with the low##2##5##(2008-9#1)(2011-2#1)
is consistent with the observation that##2##6##(2008-10#2)
is consistent with the##43##4##(1990-7#1)(1991-10#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-6#2)(1997-8#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-8#1)(2011-2#2)(2013-1#2)
is consistent with this##2##4##(2008-11#1)(2008-7#1)
is consistent with##110##3##(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#3)(2013-1#4)
is consistent##119##2##(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#4)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#6)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2013-1#4)
is consistently better##2##3##(2008-10#1)(2012-3#1)
is consistently higher##2##3##(2008-11#1)(2012-3#1)
is consistently##12##2##(1990-5#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#2)(2012-3#2)
is constant##9##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-9#2)(2012-3#1)
is constantly evolving##2##3##(1997-3#1)(2010-8#1)
is constantly##6##2##(1997-3#1)(2008-8#1)(2008-9#1)(2010-6#2)(2010-8#1)
is constituted by##6##3##(2008-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
is constituted##7##2##(2008-10#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
is constitutively activated##2##3##(1994-12#1)(2011-2#1)
is constitutively expressed in the##2##5##(2007-12#1)(2010-3#1)
is constitutively expressed in##3##4##(1995-6#1)(2007-12#1)(2010-3#1)
is constitutively expressed##6##3##(1993-3#1)(1995-6#1)(2007-12#1)(2008-8#1)(2010-2#1)(2010-3#1)
is constitutively##9##2##(1993-3#1)(1994-12#1)(1995-6#1)(2007-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
is constrained##2##2##(2008-8#1)(2008-9#1)
is constructed and##2##3##(2008-10#1)(2008-3#1)
is constructed by##6##3##(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)
is constructed for##4##3##(1995-9#1)(2007-12#1)(2008-11#1)(2012-12#1)
is constructed from a##2##4##(2008-10#2)
is constructed from##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
is constructed that##2##3##(2008-2#1)(2008-3#1)
is constructed using##2##3##(2009-2#1)(2012-1#1)
is constructed##27##2##(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
is consumed in the##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
is consumed in##4##3##(1993-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
is consumed##9##2##(1993-6#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)
is contained in the##3##4##(2008-2#1)(2008-3#2)
is contained in##5##3##(1992-12#1)(2008-2#1)(2008-3#3)
is contained within a##3##4##(1995-2#1)(1995-5#1)(2009-10#1)
is contained within contig##2##4##(1994-11#2)
is contained within##6##3##(1994-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(2009-10#1)
is contained##11##2##(1992-12#1)(1994-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(2008-2#1)(2008-3#3)(2009-10#1)
is contaminated with##2##3##(1991-12#1)(1992-12#1)
is contaminated##3##2##(1991-12#1)(1992-12#1)(2008-3#1)
is contended that##5##3##(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#1)
is contended##6##2##(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#2)
is contentious##3##2##(2008-11#1)(2008-8#1)(2010-10#1)
is continually being##2##3##(1996-2#1)(1996-3#1)
is continuing to##3##3##(2008-6#1)(2011-2#1)(2012-3#1)
is continuing##5##2##(1994-9#1)(2006-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
is continuous with##2##3##(2007-12#1)(2008-10#1)
is continuous##9##2##(1991-9#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-8#1)(2011-2#1)
is continuously circulated##2##3##(2008-10#2)
is continuously increasing##2##3##(2008-3#1)(2010-11#1)
is continuously tunable##2##3##(2007-11#1)(2008-2#1)
is continuously##17##2##(1991-3#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#2)(2010-12#1)
is contradictory##2##2##(1997-8#1)(2012-2#1)
is contraindicated in##2##3##(1991-9#1)(1992-5#1)
is contraindicated or##2##3##(2007-8#1)(2012-12#1)
is contraindicated##9##2##(1991-9#1)(1992-5#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
is contributed##2##2##(2008-3#1)(2013-1#1)
is contributing to##2##3##(2009-6#1)(2011-2#1)
is controlled at##3##3##(1991-6#1)(1997-1#1)(2008-11#1)
is controlled by a microcomputer##2##5##(2008-10#2)
is controlled by a single recessive gene##3##7##(2008-10#1)(2008-5#1)(2008-9#1)
is controlled by a single recessive##4##6##(2008-10#2)(2008-5#1)(2008-9#1)
is controlled by a single##7##5##(2008-10#5)(2008-5#1)(2008-9#1)
is controlled by a##16##4##(1994-12#1)(1995-2#2)(2008-10#9)(2008-3#2)(2008-5#1)(2008-9#1)
is controlled by the##16##4##(1990-11#1)(1994-2#1)(1995-8#1)(1996-5#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-4#2)(2009-11#1)(2009-12#1)(2009-7#1)(2011-2#1)
is controlled by two##2##4##(2008-10#1)(2010-4#1)
is controlled by##52##3##(1990-11#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-5#1)(2007-11#3)(2007-12#5)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
is controlled in##2##3##(2008-3#1)(2012-12#1)
is controlled through##2##3##(2007-5#1)(2008-10#1)
is controlled via##2##3##(2008-12#1)(2012-2#1)
is controlled##69##2##(1990-11#2)(1991-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-2#3)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-11#3)(2007-12#5)(2007-5#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
is controversial and##5##3##(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
is controversial##26##2##(1992-10#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#3)(2009-6#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-1#5)
is convenient and##2##3##(2008-10#1)(2012-2#1)
is convenient to##4##3##(2008-2#1)(2008-3#3)
is convenient##8##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
is conventionally##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-9#1)
is converted in vivo to##2##5##(1994-2#1)(2008-4#1)
is converted in##4##3##(1993-11#1)(1994-2#1)(2008-4#1)(2008-8#1)
is converted into a##5##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
is converted into the##2##4##(2008-3#1)(2008-4#1)
is converted into##11##3##(1995-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
is converted to a##4##4##(1992-8#2)(2008-10#2)
is converted to an##2##4##(1992-12#1)(2008-3#1)
is converted to##16##3##(1992-12#1)(1992-8#3)(1995-5#1)(2008-10#7)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#1)
is converted##37##2##(1992-12#1)(1992-6#1)(1992-8#3)(1993-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-2#1)(2008-3#3)(2008-4#3)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
is conveyed##2##2##(2008-1#1)(2010-8#1)
is cooperative##2##2##(1995-2#1)(1997-2#1)
is coordinated by##2##3##(1991-3#1)(2007-11#1)
is correct##4##2##(2008-2#1)(2008-9#1)(2009-8#1)(2010-8#1)
is corrected for##2##3##(1990-8#1)(1995-3#1)
is corrected##5##2##(1990-8#1)(1995-3#1)(2008-2#1)(2008-3#1)(2013-1#1)
is correctly predicted##2##3##(1997-7#1)(2008-3#1)
is correctly##4##2##(1994-8#1)(1997-7#1)(2008-3#1)(2008-8#1)
is correlated to the##5##4##(1992-12#1)(2007-12#1)(2008-10#3)
is correlated to##6##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#3)
is correlated with a##4##4##(1992-9#1)(1997-7#1)(2008-3#1)(2008-8#1)
is correlated with the##7##4##(1992-8#1)(1997-8#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-3#1)(2012-2#1)
is correlated with##30##3##(1990-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#2)(2010-3#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is correlated##37##2##(1990-7#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#3)(2009-5#2)(2010-3#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is correspondingly##2##2##(2008-10#1)(2010-3#1)
is corroborated by##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is corrupted##2##2##(2008-2#1)(2008-3#1)
is cosmetically##2##2##(2008-5#2)
is cost effective##4##3##(1996-8#1)(2008-12#1)(2010-3#1)(2012-12#1)
is cost##5##2##(1994-2#1)(1996-8#1)(2008-12#1)(2010-3#1)(2012-12#1)
is cost-effective##3##2##(1993-12#1)(2008-8#1)(2012-3#1)
is costly and##2##3##(2008-8#1)(2011-2#1)
is costly##3##2##(2008-8#2)(2011-2#1)
is counterbalanced by##4##3##(1992-12#1)(1995-12#1)(2007-11#1)(2009-5#1)
is coupled back into the##2##5##(2008-2#2)
is coupled into##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is coupled to##12##3##(1990-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-2#1)
is coupled with a##2##4##(2008-2#2)
is coupled with the##2##4##(2008-10#2)
is coupled with##11##3##(1993-3#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-9#1)(2012-2#1)
is coupled##31##2##(1990-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-2#2)
is covalently##2##2##(1992-8#1)(2008-10#1)
is covered by the##2##4##(1991-8#1)(2008-2#1)
is covered by##9##3##(1991-8#1)(1992-11#1)(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
is covered with a##2##4##(2008-10#1)(2008-12#1)
is covered with##4##3##(2007-12#1)(2008-10#1)(2008-12#2)
is covered##14##2##(1991-8#1)(1992-11#1)(1993-12#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2011-2#2)
is created and##3##3##(1994-3#1)(1995-3#1)(2011-2#1)
is created by##2##3##(2007-12#1)(2008-3#1)
is created for##2##3##(2008-11#1)(2008-7#1)
is created that##2##3##(1994-5#1)(2008-3#1)
is created via##2##3##(2008-10#1)(2013-1#1)
is created##17##2##(1994-3#1)(1994-5#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#2)
is credible##2##2##(1994-1#1)(1994-2#1)
is critical because##2##3##(1995-12#1)(2011-2#1)
is critical for both##2##4##(2008-6#1)(2010-10#1)
is critical for effective##2##4##(2009-2#1)(2009-8#1)
is critical for its##2##4##(1995-2#1)(2008-9#1)
is critical for the##9##4##(1990-3#1)(2008-10#3)(2009-10#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
is critical for##52##3##(1990-3#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#1)
is critical if##2##3##(2008-10#2)
is critical in##9##3##(1994-8#1)(1995-2#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
is critical that##6##3##(1996-4#1)(2007-5#1)(2008-3#1)(2010-11#1)(2010-6#1)(2013-1#1)
is critical to effective##3##4##(1995-5#1)(2010-5#1)(2013-1#1)
is critical to identify##2##4##(2008-3#1)(2011-2#1)
is critical to numerous##2##4##(1994-8#1)(2010-7#1)
is critical to the success of##4##6##(1994-12#1)(2007-12#1)(2011-2#2)
is critical to the##14##4##(1990-7#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#3)
is critical to##38##3##(1990-7#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2013-1#1)
is critical##131##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#2)(2007-12#4)(2007-5#2)(2008-10#14)(2008-11#7)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#3)
is critically dependent on the##2##5##(1990-8#1)(2007-11#1)
is critically evaluated##2##3##(2007-12#1)(2009-8#1)
is critically important##4##3##(1990-11#1)(1996-4#1)(2008-7#1)(2010-7#1)
is critically##15##2##(1990-11#1)(1990-7#1)(1990-8#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)
is crossed##2##2##(2008-3#2)
is crucial for obtaining a better understanding of the physiological events that distinguish normal and diseased states##2##17##(2008-2#1)(2008-4#1)
is crucial for obtaining##3##4##(1995-2#1)(2008-2#1)(2008-4#1)
is crucial for successful##2##4##(2008-7#1)(2012-12#1)
is crucial for survival##2##4##(2008-12#1)(2010-3#1)
is crucial for the##11##4##(1994-12#1)(1994-2#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
is crucial for understanding##2##4##(2008-6#1)(2009-12#1)
is crucial for##39##3##(1991-2#2)(1992-5#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
is crucial in the##3##4##(2007-12#1)(2011-2#1)(2012-1#1)
is crucial in##9##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
is crucial that##5##3##(1995-5#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
is crucial to provide##2##4##(1991-12#1)(2010-11#1)
is crucial to the##7##4##(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2011-2#1)
is crucial to understand##2##4##(2008-9#1)(2012-2#1)
is crucial to##26##3##(1991-12#1)(1997-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)
is crucial when##2##3##(2008-7#1)(2011-2#1)
is crucial##93##2##(1991-12#1)(1991-2#2)(1992-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
is cured##2##2##(1994-9#2)
is currently a##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)
is currently available on##2##4##(1994-3#1)(2008-7#1)
is currently available to##2##4##(1994-2#1)(2013-1#1)
is currently available##8##3##(1994-2#1)(1994-3#2)(2008-7#1)(2010-6#1)(2012-2#2)(2013-1#1)
is currently being evaluated##2##4##(1997-1#1)(2008-6#1)
is currently being used##2##4##(2008-10#1)(2010-6#1)
is currently being##12##3##(1992-3#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-6#1)(2013-1#1)
is currently considered as a##2##5##(1991-12#1)(2007-11#1)
is currently considered to be##2##5##(2008-1#1)(2008-10#1)
is currently considered##8##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)
is currently in the##3##4##(1994-2#1)(2008-3#1)(2008-6#1)
is currently in##7##3##(1994-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#1)
is currently known about##4##4##(2007-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
is currently known##5##3##(2007-11#1)(2008-7#1)(2009-8#2)(2013-1#1)
is currently limited##4##3##(2007-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
is currently not known##2##4##(1990-2#1)(1992-12#1)
is currently not##6##3##(1990-2#1)(1992-12#1)(2008-1#1)(2008-3#1)(2011-2#1)(2011-3#1)
is currently occurring##2##3##(2008-10#1)(2008-7#1)
is currently of##2##3##(1997-7#1)(2008-5#1)
is currently one of the##2##5##(2008-6#1)(2008-7#1)
is currently performed##2##3##(2008-2#1)(2010-8#1)
is currently regarded as a##2##5##(1996-2#1)(2011-2#1)
is currently the mainstay of##2##5##(2010-5#1)(2013-1#1)
is currently the most widely used##2##6##(1991-3#1)(1996-1#1)
is currently the most##5##4##(1991-3#1)(1995-3#1)(1996-1#2)(2008-10#1)
is currently the only##2##4##(2007-9#1)(2011-2#1)
is currently the##13##3##(1991-3#1)(1995-3#1)(1996-1#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#3)(2013-1#1)
is currently under development##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
is currently under evaluation in##2##5##(2008-2#1)(2013-1#1)
is currently under evaluation##3##4##(2008-2#1)(2011-3#1)(2013-1#1)
is currently under way##2##4##(2008-2#1)(2008-4#1)
is currently under##12##3##(1991-9#1)(1996-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2011-3#1)(2013-1#1)
is currently undergoing clinical##2##4##(1995-3#1)(1996-9#1)
is currently unknown##8##3##(1992-12#1)(1995-6#1)(2007-8#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-6#1)(2012-2#1)
is currently used as a##2##5##(1991-2#1)(1997-3#1)
is currently used for##4##4##(2008-10#1)(2010-11#1)(2010-7#1)(2010-8#1)
is currently used to##2##4##(2008-10#1)(2008-7#1)
is currently used##11##3##(1991-2#1)(1997-3#1)(2008-10#4)(2008-7#1)(2009-2#1)(2010-11#1)(2010-7#1)(2010-8#1)
is currently##158##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-3#2)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#6)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#13)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)
is cycled##3##2##(2008-2#1)(2008-9#1)(2009-9#1)
is cytotoxic##2##2##(1995-12#1)(2013-8#1)
is dangerous##4##2##(1994-6#1)(1996-11#1)(2008-1#1)(2008-11#1)
is dead##2##2##(2007-12#1)(2008-8#1)
is dealing with an##2##4##(1994-3#1)(2008-10#1)
is dealing with##7##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
is dealing##8##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)
is dealt with##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
is debatable##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
is debate##2##2##(2008-11#1)(2009-10#1)
is debated##4##2##(1992-8#1)(1993-3#1)(2008-11#1)(2008-8#1)
is decided by##2##3##(2007-11#1)(2008-4#1)
is decided##3##2##(2007-11#1)(2008-4#1)(2013-1#1)
is decisive for the##2##4##(2007-8#1)(2008-3#1)
is decomposed into##3##3##(1992-12#1)(2008-3#2)
is decomposed##4##2##(1992-12#1)(2008-3#3)
is decreased by approximately##2##4##(2008-3#2)
is decreased by##7##3##(1992-1#1)(1994-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-9#1)
is decreased in##3##3##(1995-12#1)(2008-1#1)(2008-3#1)
is decreased to##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
is decreased##23##2##(1992-1#1)(1994-10#1)(1995-12#1)(1995-2#2)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#4)(2008-9#2)(2009-9#1)(2010-2#1)(2012-2#1)
is decreasing##5##2##(2007-11#1)(2007-7#1)(2008-2#1)(2008-8#1)(2010-6#1)
is dedicated to##4##3##(2008-10#1)(2008-5#1)(2009-9#2)
is dedicated##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#2)
is deduced from the##3##4##(1990-11#1)(2008-3#2)
is deduced from##4##3##(1990-11#1)(2008-11#1)(2008-3#2)
is deduced that##2##3##(1993-8#1)(2008-3#1)
is deduced to##2##3##(1994-6#1)(2008-3#1)
is deduced##13##2##(1990-11#1)(1993-8#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#1)
is deemed##2##2##(2008-2#1)(2012-2#1)
is deeper##2##2##(2008-2#1)(2012-3#1)
is deeply##3##2##(1992-8#1)(1997-1#1)(2012-12#1)
is deficient in##4##3##(2008-10#2)(2009-8#1)(2012-3#1)
is deficient##5##2##(2008-10#2)(2008-11#1)(2009-8#1)(2012-3#1)
is defined and##6##3##(1990-12#1)(2007-11#1)(2008-1#2)(2008-3#1)(2009-9#1)
is defined as a situation in which##2##7##(2008-11#1)(2008-5#1)
is defined as a##13##4##(1991-4#1)(1992-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
is defined as an##3##4##(1996-12#1)(2008-7#1)(2011-2#1)
is defined as the average##2##5##(2008-10#1)(2008-2#1)
is defined as the##19##4##(1991-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-9#1)(2012-2#1)(2013-1#2)
is defined as##48##3##(1990-9#1)(1991-11#1)(1991-4#1)(1992-2#1)(1992-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
is defined by the##8##4##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-1#1)
is defined by##14##3##(1991-5#1)(1993-11#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2013-1#1)
is defined here##2##3##(2008-3#1)(2008-6#1)
is defined in##4##3##(1993-3#1)(1997-3#1)(1997-6#1)(2008-8#1)
is defined##85##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#15)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
is definitely##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
is degraded##4##2##(1993-3#1)(1994-11#1)(2008-3#2)
is delayed##7##2##(1991-9#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-2#1)(2013-1#1)
is deleted##3##2##(1995-8#1)(2008-8#1)(2012-12#1)
is delivered into##2##3##(2007-12#1)(2009-8#1)
is delivered##9##2##(1993-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
is demanded and##2##3##(1991-2#1)(2008-10#1)
is demanded##3##2##(1991-2#1)(1997-7#1)(2008-10#1)
is demethylated##2##2##(1995-2#2)
is demonstrated and##6##3##(2008-10#2)(2008-3#1)(2008-9#1)(2009-11#1)(2011-1#1)
is demonstrated as an##2##4##(2007-11#1)(2008-10#1)
is demonstrated as##3##3##(2007-11#2)(2008-10#1)
is demonstrated at##6##3##(1992-4#1)(2008-2#2)(2008-3#2)(2009-2#1)
is demonstrated both##2##3##(2007-11#1)(2008-3#1)
is demonstrated by application to##2##5##(2008-10#1)(2008-3#1)
is demonstrated by applying it to##2##6##(2008-10#2)
is demonstrated by computer simulation##2##5##(2007-11#1)(2008-3#1)
is demonstrated by means of##2##5##(2008-2#1)(2008-3#1)
is demonstrated by measurement of the##3##6##(2007-11#1)(2008-3#2)
is demonstrated by measurement of##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
is demonstrated by the##10##4##(1992-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#1)
is demonstrated by their##2##4##(2008-10#1)(2010-3#1)
is demonstrated by use of a##3##6##(2007-11#2)(2008-3#1)
is demonstrated by use of##6##5##(2007-11#4)(2008-3#2)
is demonstrated by##52##3##(1992-2#1)(1995-2#2)(2007-11#9)(2007-12#7)(2008-10#13)(2008-2#1)(2008-3#14)(2008-5#1)(2008-6#1)(2010-3#1)(2012-2#1)(2012-3#1)
is demonstrated experimentally for##2##4##(2007-11#1)(2008-2#1)
is demonstrated experimentally##12##3##(2007-11#4)(2007-12#1)(2008-2#3)(2008-3#3)(2011-1#1)
is demonstrated for a##2##4##(2008-2#2)
is demonstrated for both##2##4##(2007-12#1)(2008-2#1)
is demonstrated for the first time to the authors' knowledge##2##10##(2007-11#2)
is demonstrated for the first time to##3##7##(2007-11#3)
is demonstrated for the first time##7##6##(2007-11#3)(2008-10#2)(2008-2#2)
is demonstrated for the##10##4##(1994-12#1)(2007-11#3)(2008-10#3)(2008-2#3)
is demonstrated for what is##2##5##(2007-12#1)(2008-2#1)
is demonstrated for##31##3##(1994-12#1)(1997-2#1)(2007-11#5)(2007-12#5)(2008-10#5)(2008-2#11)(2008-3#3)
is demonstrated from##2##3##(2007-12#2)
is demonstrated here##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
is demonstrated how##2##3##(2008-11#1)(2008-3#1)
is demonstrated in a##7##4##(1995-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-9#1)
is demonstrated in an##2##4##(2008-3#1)(2010-6#1)
is demonstrated in the present##2##5##(2008-10#1)(2008-11#1)
is demonstrated in the##7##4##(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)
is demonstrated in this##3##4##(1995-3#1)(2008-10#1)(2013-1#1)
is demonstrated in##24##3##(1995-11#1)(1995-3#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2009-6#1)(2009-9#1)(2010-6#1)(2013-1#2)
is demonstrated on a##3##4##(2007-11#1)(2008-3#2)
is demonstrated on##7##3##(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#3)(2010-2#1)
is demonstrated over##2##3##(2008-10#2)
is demonstrated that the##13##4##(1992-12#1)(1992-9#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2013-1#1)
is demonstrated that this laser##2##5##(2008-2#1)(2008-3#1)
is demonstrated that##46##3##(1990-12#2)(1992-12#1)(1992-9#1)(1993-8#1)(1996-4#1)(2007-11#4)(2007-12#6)(2008-10#6)(2008-2#6)(2008-3#12)(2008-5#2)(2008-8#2)(2013-1#2)
is demonstrated through the##2##4##(2008-3#1)(2009-5#1)
is demonstrated through##4##3##(2008-3#2)(2008-7#1)(2009-5#1)
is demonstrated to be a##3##5##(2008-10#1)(2008-6#1)(2012-2#1)
is demonstrated to be the##2##5##(2008-10#1)(2008-3#1)
is demonstrated to be##9##4##(1992-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
is demonstrated to promote the electrochemical##2##6##(2008-10#2)
is demonstrated to##18##3##(1992-1#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#2)
is demonstrated using##8##3##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
is demonstrated with a##5##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
is demonstrated with an##2##4##(2007-12#1)(2008-3#1)
is demonstrated with the##3##4##(2008-10#2)(2008-8#1)
is demonstrated with##22##3##(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#6)(2008-8#2)(2010-12#1)
is demonstrated##381##2##(1990-12#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-11#56)(2007-12#59)(2007-5#1)(2007-7#1)(2008-10#66)(2008-11#2)(2008-2#52)(2008-3#82)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#3)(2012-2#5)(2012-3#1)(2013-1#4)
is dependent on a##3##4##(1996-6#1)(1997-2#1)(2010-8#1)
is dependent on activation of##2##5##(1997-2#1)(2008-4#1)
is dependent on both##2##4##(1995-3#1)(1995-5#1)
is dependent on pH##2##4##(2008-10#2)
is dependent on the concentration of##2##6##(2008-10#2)
is dependent on the nature of##2##6##(2008-10#1)(2008-3#1)
is dependent on the size of the##2##7##(2008-3#1)(2008-5#1)
is dependent on the##42##4##(1990-11#1)(1990-2#1)(1995-8#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is dependent on two##2##4##(1993-12#1)(2008-3#1)
is dependent on##91##3##(1990-11#4)(1990-2#1)(1991-5#2)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is dependent upon a##3##4##(1990-5#1)(2008-8#2)
is dependent upon the##13##4##(1990-11#1)(1990-3#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)
is dependent upon##27##3##(1990-11#1)(1990-3#1)(1990-5#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#1)
is dependent##122##2##(1990-11#5)(1990-2#1)(1990-3#1)(1990-5#1)(1991-5#2)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#17)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is depleted##5##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
is deposited as##2##3##(2008-10#2)
is deposited by##3##3##(2008-3#3)
is deposited on##3##3##(2008-10#2)(2008-3#1)
is deposited##12##2##(2007-12#1)(2008-10#4)(2008-3#5)(2008-7#2)
is deprotonated##2##2##(1992-3#1)(2008-10#1)
is derepressed##2##2##(1990-5#1)(2008-6#1)
is derived and shown to be##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
is derived and##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
is derived as##2##3##(1995-9#1)(2008-2#1)
is derived by the##2##4##(2008-2#1)(2008-3#1)
is derived by use of##3##5##(2007-11#1)(2008-3#2)
is derived by##7##3##(1992-12#1)(2007-11#1)(2008-2#2)(2008-3#3)
is derived for the##7##4##(2007-11#2)(2008-2#2)(2008-3#3)
is derived for##13##3##(2007-11#3)(2008-2#3)(2008-3#6)(2011-2#1)
is derived from a##7##4##(1991-9#1)(1992-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
is derived from the##12##4##(1992-3#1)(1992-6#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2012-3#1)
is derived from##33##3##(1990-6#1)(1991-11#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
is derived in##3##3##(1992-8#1)(2007-11#1)(2008-2#1)
is derived that##3##3##(2007-12#1)(2008-2#2)
is derived to##4##3##(1997-8#1)(2008-3#2)(2013-1#1)
is derived##97##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-2#1)(1995-9#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-11#13)(2007-12#5)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#15)(2008-3#22)(2008-4#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
is described along with##4##4##(2008-2#2)(2008-4#1)(2008-9#1)
is described and an##2##4##(2008-12#1)(2008-4#1)
is described and discussed##2##4##(2008-10#1)(2008-8#1)
is described and evaluated for##2##5##(2008-10#1)(2008-3#1)
is described and evaluated##3##4##(2008-10#2)(2008-3#1)
is described and illustrated##2##4##(1996-12#1)(2008-5#1)
is described and tested##2##4##(2008-2#2)
is described and the##2##4##(1995-9#1)(2008-12#1)
is described and used##2##4##(1996-2#1)(2008-3#1)
is described and##29##3##(1990-9#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)
is described as &quot##2##4##(2008-5#1)(2012-12#1)
is described as a##7##4##(1991-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
is described as an example##3##5##(1996-12#1)(2008-4#2)
is described as an##4##4##(1996-12#1)(2008-3#1)(2008-4#2)
is described as well as the##2##6##(2008-10#1)(2013-1#1)
is described as well as##5##5##(2008-10#3)(2008-3#1)(2013-1#1)
is described as well##6##4##(2008-10#3)(2008-3#2)(2013-1#1)
is described as##22##3##(1991-3#1)(1996-12#1)(2008-10#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
is described based on the##3##5##(2008-10#3)
is described based on##5##4##(2008-10#5)
is described by a##5##4##(1991-5#1)(1994-5#1)(2007-12#1)(2008-2#1)(2012-2#1)
is described by means of##2##5##(2008-3#1)(2008-6#1)
is described by the##4##4##(2008-1#1)(2008-10#2)(2008-7#1)
is described by##16##3##(1991-5#1)(1994-5#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
is described for a##3##4##(2007-11#1)(2008-3#2)
is described for application##2##4##(1993-11#1)(2007-8#1)
is described for detecting##2##4##(1990-12#1)(2008-10#1)
is described for measuring##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
is described for the determination of hydrazine##2##7##(2008-10#2)
is described for the determination of trace##5##7##(2008-10#5)
is described for the determination of##48##6##(1991-5#1)(2008-10#47)
is described for the first time##2##6##(2008-10#2)
is described for the identification of##2##6##(2008-10#2)
is described for the selective##2##5##(2008-10#2)
is described for the sequential determination of##2##7##(2008-10#2)
is described for the simultaneous determination of##3##7##(2008-10#3)
is described for the##73##4##(1991-5#1)(1993-11#1)(2008-10#68)(2008-2#2)(2012-2#1)
is described for##120##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#79)(2008-11#3)(2008-2#7)(2008-3#6)(2008-4#10)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
is described from the##3##4##(2008-5#2)(2013-1#1)
is described here##6##3##(1991-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-6#1)
is described herein##2##3##(2008-10#1)(2008-11#1)
is described in a patient##2##5##(1992-11#1)(2008-11#1)
is described in a support protocol##2##6##(2008-2#1)(2008-4#1)
is described in a##11##4##(1992-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)
is described in detail and##2##5##(2008-3#1)(2008-6#1)
is described in detail##8##4##(1994-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
is described in more detail##2##5##(1991-2#1)(2008-4#1)
is described in the second##2##5##(1997-6#1)(2010-11#1)
is described in the##5##4##(1997-6#1)(2008-10#1)(2008-4#2)(2010-11#1)
is described in this paper##8##5##(1996-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-8#1)
is described in this unit##7##5##(2008-2#2)(2008-4#5)
is described in this work##2##5##(2008-10#1)(2013-1#1)
is described in this##24##4##(1996-12#1)(2007-12#1)(2008-10#8)(2008-2#4)(2008-4#5)(2008-5#1)(2010-4#1)(2010-8#1)(2013-1#2)
is described in which the##3##5##(1994-5#1)(2008-7#1)(2010-3#1)
is described in which##7##4##(1994-12#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)
is described in##66##3##(1991-2#1)(1992-11#1)(1994-12#2)(1994-5#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-2#7)(2008-3#4)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#2)
is described of##5##3##(1991-3#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-12#1)
is described that allows##4##4##(2008-3#3)(2008-4#1)
is described that is##6##4##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
is described that uses##2##4##(2008-2#1)(2008-3#1)
is described that##21##3##(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#9)(2008-4#2)
is described to##3##3##(2008-12#1)(2008-2#1)(2011-2#1)
is described using##2##3##(1991-9#1)(2008-4#1)
is described where a##2##4##(2008-10#2)
is described which allows##2##4##(1992-9#1)(2011-2#1)
is described which includes##2##4##(1997-3#1)(2010-11#1)
is described which is##2##4##(1990-2#1)(2008-10#1)
is described which##12##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-2#1)(1997-3#1)(2008-10#3)(2010-11#1)(2011-2#1)
is described with##5##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
is described##902##2##(1990-11#3)(1990-12#9)(1990-2#2)(1990-6#2)(1990-8#5)(1990-9#4)(1991-12#2)(1991-2#6)(1991-3#2)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-8#2)(1992-9#3)(1993-11#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-12#2)(1994-5#3)(1995-12#9)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#21)(2007-12#28)(2007-2#1)(2007-7#3)(2007-8#9)(2008-1#3)(2008-10#354)(2008-11#14)(2008-12#6)(2008-2#66)(2008-3#98)(2008-4#49)(2008-5#9)(2008-6#9)(2008-7#8)(2008-8#6)(2008-9#11)(2009-10#2)(2009-11#3)(2009-12#4)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#14)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#2)
is designated as##7##3##(1992-3#1)(2008-10#3)(2008-8#1)(2008-9#2)
is designated##13##2##(1992-3#1)(2008-10#6)(2008-8#2)(2008-9#3)(2012-2#1)
is designed and##5##3##(2008-10#1)(2008-3#3)(2008-6#1)
is designed by use of##2##5##(2008-3#2)
is designed by##3##3##(2008-3#3)
is designed for##9##3##(1991-1#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-9#1)
is designed in such a way to##2##7##(1990-12#1)(2011-1#1)
is designed in##4##3##(1990-12#1)(2008-10#1)(2011-1#1)(2012-3#1)
is designed to be##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
is designed to evaluate##2##4##(2007-10#1)(2008-11#1)
is designed to facilitate##2##4##(2008-10#1)(2008-3#1)
is designed to measure##3##4##(2007-11#1)(2008-3#2)
is designed to produce##2##4##(2008-3#1)(2011-1#1)
is designed to provide##4##4##(1995-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
is designed to##58##3##(1991-12#2)(1992-1#1)(1994-2#1)(1995-1#1)(1996-2#2)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#15)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#2)
is designed with an##2##4##(2008-3#2)
is designed with##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
is designed##88##2##(1990-12#1)(1991-1#1)(1991-12#2)(1992-1#1)(1994-2#1)(1995-1#1)(1996-2#2)(1997-3#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#26)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
is desirable and##2##3##(1995-2#1)(1996-6#1)
is desirable for##2##3##(2008-2#1)(2011-1#1)
is desirable to optimize##2##4##(2007-11#1)(2008-2#1)
is desirable to##9##3##(1991-5#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
is desirable##22##2##(1991-5#1)(1992-8#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#2)(2008-9#2)(2009-5#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
is desired##6##2##(1995-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
is destabilized by##5##3##(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
is detailed##5##2##(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-1#1)
is detectable in the##2##4##(1994-3#1)(1994-6#1)
is detectable in##6##3##(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-5#1)
is detectable##12##2##(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-5#1)(2009-5#2)(2012-3#1)
is detected and##2##3##(2008-10#1)(2008-3#1)
is detected as##3##3##(2008-10#2)(2008-3#1)
is detected at the##2##4##(2008-10#1)(2012-12#1)
is detected at##6##3##(1996-12#1)(2008-10#3)(2009-5#1)(2012-12#1)
is detected by a##2##4##(2008-3#2)
is detected by measuring the##3##5##(2008-10#1)(2008-4#1)(2010-2#1)
is detected by##15##3##(1995-3#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#3)(2010-2#1)
is detected either by##3##4##(1990-11#1)(2008-2#1)(2008-4#1)
is detected if##2##3##(2008-10#1)(2008-4#1)
is detected in the##3##4##(1994-11#1)(2008-10#1)(2008-4#1)
is detected in##13##3##(1990-11#1)(1992-11#1)(1994-11#1)(1994-8#1)(1996-12#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)
is detected on glassy carbon electrode##2##6##(2008-10#2)
is detected using a##2##4##(2008-10#2)
is detected using##3##3##(2008-10#2)(2008-9#1)
is detected when##2##3##(2008-10#1)(2008-9#1)
is detected with a##2##4##(2008-10#1)(2008-3#1)
is detected with##4##3##(1992-6#1)(1993-2#1)(2008-10#1)(2008-3#1)
is detected##79##2##(1990-11#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-12#3)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#29)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#4)(2008-9#6)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
is detection##3##2##(1992-1#1)(2008-3#1)(2010-3#1)
is determined after##2##3##(2008-10#2)
is determined analytically##2##3##(2008-2#1)(2008-3#1)
is determined and##2##3##(2008-1#1)(2009-5#1)
is determined as##2##3##(2008-10#1)(2008-2#1)
is determined at pH##2##4##(2008-10#2)
is determined by a##4##4##(1996-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
is determined by differential pulse polarography##2##6##(2008-10#2)
is determined by integration of##2##5##(2008-2#1)(2008-3#1)
is determined by means of##2##5##(2008-3#2)
is determined by measuring the##2##5##(2008-10#1)(2008-4#1)
is determined by multiple##2##4##(1991-12#1)(2008-6#1)
is determined by the diffraction##2##5##(2007-12#1)(2008-3#1)
is determined by the##39##4##(1990-8#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-3#1)(2007-12#2)(2008-10#11)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#2)(2009-8#1)(2010-2#2)(2012-3#1)(2013-1#1)
is determined by##88##3##(1990-8#3)(1991-11#1)(1991-12#1)(1993-6#1)(1994-8#3)(1995-12#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#5)(2008-10#26)(2008-2#3)(2008-3#14)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-2#2)(2012-3#2)(2013-1#2)
is determined directly in##2##4##(2008-10#2)
is determined directly##3##3##(2008-10#3)
is determined for##4##3##(2008-10#1)(2008-3#3)
is determined from the##2##4##(2008-10#2)
is determined from##4##3##(1994-6#1)(2008-10#2)(2008-3#1)
is determined in the##2##4##(2007-11#1)(2008-10#1)
is determined in##7##3##(1991-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
is determined on##2##3##(2008-10#1)(2009-3#1)
is determined primarily by##2##4##(2008-8#2)
is determined solely by##2##4##(1993-2#1)(2008-2#1)
is determined that##2##3##(2008-3#2)
is determined to be##4##4##(2007-12#2)(2008-3#1)(2009-11#1)
is determined to##6##3##(2007-12#2)(2008-3#2)(2008-4#1)(2009-11#1)
is determined using##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
is determined with##4##3##(1990-2#1)(2007-11#1)(2008-11#1)(2008-2#1)
is determined##174##2##(1990-2#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-11#3)(2007-12#7)(2008-1#2)(2008-10#51)(2008-11#1)(2008-2#11)(2008-3#37)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#4)(2009-8#1)(2010-12#1)(2010-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
is determining##2##2##(2008-7#1)(2008-8#1)
is deterministic##2##2##(2008-2#1)(2011-2#1)
is detrimental to the##2##4##(2008-5#1)(2012-1#1)
is detrimental##3##2##(2008-5#1)(2011-1#1)(2012-1#1)
is developed and applied to##2##5##(2008-2#1)(2008-3#1)
is developed and implemented##2##4##(2008-3#2)
is developed and used##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
is developed and##12##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)
is developed as a##2##4##(2007-12#1)(2008-12#1)
is developed as##3##3##(2007-12#1)(2008-12#1)(2008-3#1)
is developed based on##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
is developed based##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
is developed by##6##3##(2008-10#5)(2008-3#1)
is developed due to##2##4##(2009-6#1)(2013-1#1)
is developed for determination of##3##5##(2008-10#3)
is developed for quantitative##2##4##(2007-11#1)(2008-3#1)
is developed for the determination of##4##6##(2008-10#4)
is developed for the##15##4##(2008-10#10)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)
is developed for##44##3##(1992-5#1)(1993-12#1)(1994-9#1)(2007-11#2)(2008-10#20)(2008-2#5)(2008-3#9)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)
is developed from a##3##4##(1990-8#1)(2008-2#1)(2008-3#1)
is developed from##6##3##(1990-8#1)(2008-2#1)(2008-3#3)(2011-1#1)
is developed in order to##2##5##(2008-10#2)
is developed in the##2##4##(2008-10#1)(2012-3#1)
is developed in this paper##3##5##(2008-10#3)
is developed in##8##3##(2008-10#6)(2008-3#1)(2012-3#1)
is developed on the##2##4##(2011-1#2)
is developed that##9##3##(2008-10#1)(2008-2#3)(2008-3#3)(2008-9#1)(2012-2#1)
is developed to describe the##3##5##(1992-6#1)(2008-3#1)(2010-5#1)
is developed to solve the radiative transfer##2##7##(2008-3#2)
is developed to solve##3##4##(2008-3#3)
is developed to##29##3##(1992-6#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#16)(2008-6#1)(2009-5#1)(2010-5#1)(2010-7#1)(2013-8#1)
is developed using##2##3##(2008-10#2)
is developed##189##2##(1990-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-6#1)(1997-4#1)(2007-11#6)(2007-12#2)(2008-10#62)(2008-12#1)(2008-2#21)(2008-3#53)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
is developing##13##2##(1992-1#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-5#8)(2009-5#1)
is developmentally regulated in##3##4##(1990-11#1)(1991-11#1)(1994-11#1)
is developmentally regulated##4##3##(1990-11#1)(1991-11#1)(1994-11#1)(2008-10#1)
is developmentally##5##2##(1990-11#1)(1991-11#1)(1994-11#1)(1997-3#1)(2008-10#1)
is devised to##3##3##(2008-3#1)(2009-11#1)(2011-1#1)
is devised##5##2##(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-1#1)
is devoid of##8##3##(1991-12#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-1#1)
is devoted to the##2##4##(2011-1#2)
is devoted to##10##3##(1990-8#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-1#2)(2012-1#1)(2012-3#1)
is devoted##11##2##(1990-8#1)(1991-12#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-1#2)(2012-1#1)(2012-3#1)
is diagnosed by##3##3##(1994-5#1)(2011-2#2)
is diagnosed of##2##3##(2009-8#1)(2013-1#1)
is diagnosed when##2##3##(2008-1#1)(2008-11#1)
is diagnosed##20##2##(1990-6#1)(1992-12#1)(1994-5#1)(2006-10#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-1#1)(2013-1#2)
is diagnostic##3##2##(1996-2#1)(2011-1#2)
is dictated##3##2##(1996-12#1)(2008-3#1)(2011-2#1)
is different for different##2##4##(2008-3#1)(2012-2#1)
is different for##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
is different from all other##2##5##(2008-10#1)(2011-2#1)
is different from all the##2##5##(1993-12#1)(2008-10#1)
is different from all##5##4##(1993-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
is different from that in##3##5##(1993-8#1)(2008-8#1)(2013-1#1)
is different from that of the##2##6##(1995-6#1)(2008-3#1)
is different from that of##6##5##(1992-4#1)(1993-2#1)(1995-3#1)(1995-6#1)(2008-3#1)(2008-9#1)
is different from that##11##4##(1992-4#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
is different from the##4##4##(1991-1#1)(1995-10#1)(2010-8#2)
is different from##28##3##(1991-1#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-8#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#2)(2011-2#1)(2013-1#1)
is different in##4##3##(1993-5#1)(2008-11#1)(2008-8#1)(2009-7#1)
is different to##3##3##(1994-6#1)(2011-1#1)(2013-1#1)
is different##55##2##(1991-1#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#2)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
is differentially expressed in##2##4##(1991-2#1)(1995-3#1)
is differentially expressed##3##3##(1991-2#1)(1992-3#1)(1995-3#1)
is differentially regulated by##2##4##(1993-3#1)(1993-5#1)
is differentially regulated##3##3##(1990-7#1)(1993-3#1)(1993-5#1)
is differentially##9##2##(1990-7#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-3#1)
is differentiated##2##2##(1994-3#1)(2008-10#1)
is difficult and is##2##4##(2007-2#1)(2013-1#1)
is difficult and the##2##4##(1996-12#1)(2012-2#1)
is difficult and##10##3##(1991-3#1)(1996-12#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
is difficult as##2##3##(1992-11#1)(2008-12#1)
is difficult because of the##5##5##(1995-2#1)(2008-2#1)(2008-3#2)(2010-12#1)
is difficult because of##8##4##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-12#1)(2011-1#1)(2012-12#1)
is difficult because the##2##4##(2008-3#2)
is difficult because##17##3##(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-1#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
is difficult in##3##3##(2008-3#1)(2008-8#1)(2010-11#1)
is difficult or impossible to##2##5##(1997-3#1)(2008-4#1)
is difficult to achieve##4##4##(1994-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
is difficult to assess##2##4##(2008-8#1)(2012-3#1)
is difficult to determine##2##4##(1995-12#1)(2008-2#1)
is difficult to diagnose##5##4##(2009-12#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-8#1)
is difficult to explain##3##4##(1992-5#1)(1993-12#1)(2008-9#1)
is difficult to predict##4##4##(1996-2#1)(2008-5#1)(2010-5#1)(2011-2#1)
is difficult to treat##3##4##(2008-6#1)(2008-7#1)(2011-2#1)
is difficult to##71##3##(1991-12#1)(1991-2#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-12#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
is difficult##133##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#8)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#2)
is diffuse##2##2##(1996-1#1)(2007-7#1)
is diffusely##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
is digested and##2##3##(1990-12#1)(2008-10#1)
is digested##3##2##(1990-12#1)(1993-8#1)(2008-10#1)
is digital##2##2##(2008-3#1)(2009-8#1)
is digitized##2##2##(1991-2#1)(2008-3#1)
is diluted##3##2##(2008-10#2)(2008-5#1)
is diminished##9##2##(1991-12#1)(1991-9#1)(1992-9#1)(1994-8#1)(1996-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2009-6#1)
is direct##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
is directed against the##2##4##(1994-5#1)(2008-3#1)
is directed by##3##3##(1990-11#2)(2012-2#1)
is directed through##2##3##(1995-3#1)(2013-1#1)
is directed to the##3##4##(2006-6#1)(2007-11#1)(2007-12#1)
is directed to##8##3##(1991-6#1)(1992-5#1)(1995-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
is directed toward##3##3##(2008-3#1)(2011-2#1)(2011-7#1)
is directed towards the##2##4##(2008-6#2)
is directed towards##3##3##(1994-11#1)(2008-6#2)
is directed##26##2##(1990-11#2)(1991-6#1)(1992-5#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
is directly applicable##2##3##(2008-10#1)(2008-11#1)
is directly correlated with the##2##5##(2008-10#1)(2008-2#1)
is directly correlated with##4##4##(1993-11#1)(2008-10#1)(2008-2#1)(2010-7#1)
is directly coupled with##2##4##(2008-10#2)
is directly coupled##3##3##(2008-10#2)(2008-4#1)
is directly implicated in##2##4##(1990-8#1)(2011-2#1)
is directly involved in the##2##5##(1990-11#1)(1992-11#1)
is directly involved in##3##4##(1990-11#1)(1992-11#1)(1993-11#1)
is directly involved##4##3##(1990-11#1)(1992-11#1)(1993-11#1)(2011-2#1)
is directly linked to##2##4##(2008-5#1)(2011-2#1)
is directly performed on the##2##5##(2008-10#2)
is directly proportional to the concentration of##4##7##(2008-10#4)
is directly proportional to the##8##5##(1994-12#1)(2008-10#5)(2008-7#1)(2008-9#1)
is directly proportional to##10##4##(1994-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
is directly related to the##11##5##(1995-12#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)
is directly related to##19##4##(1994-12#1)(1995-12#1)(1996-6#1)(2006-4#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2013-1#1)(2013-8#1)
is directly responsible for the##2##5##(1995-3#1)(2009-3#1)
is directly##80##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-11#1)(1993-11#2)(1993-8#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-6#1)(1997-2#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#28)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#1)
is disagreement##3##2##(1996-11#1)(1997-7#1)(2009-3#1)
is discharged##2##2##(2008-10#1)(2008-11#1)
is discouraged because##2##3##(1996-3#1)(2008-8#1)
is discouraged##5##2##(1996-3#1)(1997-5#1)(2008-10#2)(2008-8#1)
is discovered in##2##3##(1990-10#1)(2008-9#1)
is discovered##8##2##(1990-10#1)(1994-2#1)(1996-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-1#2)
is discussed along with##4##4##(1992-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
is discussed and compared with the##2##6##(1993-12#1)(1994-11#1)
is discussed and compared##3##4##(1993-12#1)(1994-11#1)(2008-3#1)
is discussed and the##4##4##(1996-2#1)(2008-7#2)(2012-12#1)
is discussed and##13##3##(1993-12#1)(1994-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#3)(2010-9#1)(2012-12#1)
is discussed as a##4##4##(1995-3#1)(2007-11#1)(2008-10#1)(2009-6#1)
is discussed as well##3##4##(2007-11#1)(2008-2#1)(2011-2#1)
is discussed as##9##3##(1990-5#1)(1995-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2009-6#1)(2010-10#1)(2011-2#1)
is discussed both##2##3##(1996-1#1)(2008-3#1)
is discussed by##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
is discussed for##4##3##(1996-5#1)(1997-7#1)(2007-12#1)(2008-3#1)
is discussed in connection with##2##5##(2008-3#2)
is discussed in detail##7##4##(1991-4#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#2)
is discussed in light of the##3##6##(1993-11#1)(1997-6#1)(2008-5#1)
is discussed in light of##5##5##(1993-11#1)(1997-6#1)(2008-3#1)(2008-5#1)(2011-2#1)
is discussed in order to##2##5##(1994-11#1)(2008-8#1)
is discussed in relation to the##6##6##(1990-12#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-11#1)
is discussed in relation to##12##5##(1990-12#1)(1990-7#1)(1995-12#1)(1996-4#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-6#1)
is discussed in some detail##2##5##(1992-4#1)(2008-5#1)
is discussed in terms of##6##5##(1990-5#1)(2008-11#1)(2008-3#2)(2009-8#1)(2011-2#1)
is discussed in the context of##9##6##(1990-7#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)
is discussed in the light of the##3##7##(1993-3#1)(1997-7#1)(2008-5#1)
is discussed in the light of##6##6##(1990-12#1)(1993-3#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)
is discussed in the##17##4##(1990-12#1)(1990-7#1)(1992-6#1)(1993-3#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-1#1)
is discussed in this article##3##5##(2008-8#1)(2010-2#1)(2013-1#1)
is discussed in this paper##3##5##(1997-3#1)(2008-10#1)(2008-12#1)
is discussed in this##7##4##(1997-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)(2013-1#1)
is discussed in##65##3##(1990-12#2)(1990-5#1)(1990-7#2)(1991-4#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-4#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-1#1)(2010-2#1)(2011-2#2)(2013-1#1)
is discussed that##3##3##(1994-8#1)(2008-7#2)
is discussed with respect to the##2##6##(2007-12#1)(2008-3#1)
is discussed with respect to##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
is discussed with respect##4##4##(1993-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
is discussed with##9##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-11#1)
is discussed within the context of##2##6##(2008-11#1)(2008-2#1)
is discussed##440##2##(1990-12#4)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#5)(1995-3#3)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#4)(1997-7#2)(2007-11#12)(2007-12#20)(2007-2#2)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#85)(2008-11#14)(2008-12#7)(2008-2#26)(2008-3#59)(2008-4#12)(2008-5#10)(2008-6#5)(2008-7#18)(2008-8#5)(2008-9#3)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#8)(2013-7#1)(2013-8#2)
is dispensable for##4##3##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)
is dispersed##4##2##(1997-2#1)(2008-10#2)(2009-11#1)
is displaced##8##2##(1995-3#1)(2007-8#1)(2008-2#1)(2008-3#4)(2009-3#1)
is displayed##2##2##(1994-3#1)(2013-1#1)
is disrupted by##5##3##(1993-2#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-5#1)
is disrupted##7##2##(1993-2#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-4#1)(2011-2#1)
is dissipated##2##2##(2008-4#1)(2009-7#1)
is dissociated##2##2##(2008-10#1)(2010-7#1)
is dissolved in##5##3##(2008-10#5)
is dissolved with##2##3##(2008-10#2)
is dissolved##9##2##(2008-10#8)(2008-4#1)
is distinct from other##2##4##(2008-10#2)
is distinct from that of##2##5##(2007-12#1)(2008-10#1)
is distinct from that##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
is distinct from the##6##4##(1992-8#1)(1993-11#1)(1995-11#1)(1997-2#1)(2007-12#1)(2010-3#1)
is distinct from##22##3##(1991-5#1)(1992-8#1)(1993-11#1)(1995-11#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2013-1#1)
is distinct##23##2##(1991-5#1)(1992-8#1)(1993-11#1)(1995-11#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2012-1#1)(2013-1#1)
is distinctly different##2##3##(1996-1#1)(2008-3#1)
is distinguishable##2##2##(2008-5#1)(2012-3#1)
is distinguished by##3##3##(1996-2#1)(2008-5#1)(2012-3#1)
is distinguished from##3##3##(2013-7#3)
is distinguished##8##2##(1996-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-7#3)
is distorted##3##2##(1997-7#2)(2008-3#1)
is distributed on the##2##4##(2008-5#1)(2008-6#1)
is distributed on##3##3##(1994-12#1)(2008-5#1)(2008-6#1)
is distributed##16##2##(1994-12#2)(1994-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)
is disturbed##3##2##(1994-8#2)(2008-11#1)
is diverse##4##2##(2007-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
is diverted##2##2##(2008-10#1)(2008-3#1)
is divided into the##2##4##(2008-10#1)(2010-6#1)
is divided into three##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
is divided into two phases##2##5##(2008-4#1)(2008-5#1)
is divided into two##8##4##(1995-11#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)
is divided into##21##3##(1995-11#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-6#1)(2013-8#1)
is divided on##2##3##(1996-8#1)(2008-8#1)
is divided##25##2##(1995-11#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-6#1)(2011-2#1)(2013-8#1)
is documented and##2##3##(2008-11#1)(2008-2#1)
is documented##10##2##(1990-12#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#1)
is doing well##6##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#1)(2013-7#1)
is doing?##2##2##(2008-11#1)(2008-12#1)
is dominant and##2##3##(2008-10#1)(2009-8#1)
is dominant##11##2##(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)
is dominated by the##6##4##(2008-11#1)(2008-3#2)(2008-5#1)(2010-2#1)(2011-2#1)
is dominated by##24##3##(1990-8#1)(1992-12#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#7)(2008-5#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#1)
is done by##7##3##(1997-2#1)(2008-10#2)(2008-2#2)(2011-2#1)(2013-1#1)
is done in##4##3##(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
is done on a##2##4##(1990-6#1)(2012-2#1)
is done on##4##3##(1990-6#1)(2007-7#1)(2010-7#1)(2012-2#1)
is done to##2##3##(2008-12#1)(2013-1#1)
is done with##2##3##(2007-11#1)(2007-12#1)
is done##32##2##(1990-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-7#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-7#1)
is doped with a##2##4##(2007-11#1)(2008-10#1)
is doped with##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
is dose dependent##2##3##(2007-11#2)
is dose##3##2##(1992-3#1)(2007-11#2)
is dose-dependent##4##2##(1990-5#1)(1994-9#1)(1995-5#1)(2008-7#1)
is doubled##2##2##(2007-12#1)(2009-5#1)
is doubtful##5##2##(1990-6#1)(1994-7#1)(1994-8#1)(2008-10#1)(2008-12#1)
is down regulated##2##3##(1993-3#1)(2008-9#1)
is down##6##2##(1993-3#1)(1994-9#1)(2008-10#2)(2008-9#1)(2013-1#1)
is down-regulated##3##2##(1992-9#1)(1995-12#1)(1995-8#1)
is downregulated by##2##3##(2008-4#1)(2012-12#1)
is downregulated in##2##3##(2011-2#1)(2012-3#1)
is downregulated##7##2##(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
is dramatically enhanced by##2##4##(2008-10#1)(2008-11#1)
is dramatically##8##2##(1993-2#1)(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
is drastically##2##2##(2007-11#1)(2008-10#1)
is drawn between##2##3##(1991-1#1)(1996-3#1)
is drawn to##4##3##(1990-9#1)(1994-3#1)(1996-8#1)(2008-5#1)
is drawn##11##2##(1990-9#1)(1991-1#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
is driven by a##4##4##(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#1)
is driven by the##6##4##(1990-2#1)(1993-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
is driven by##22##3##(1990-2#1)(1993-12#1)(1993-9#1)(1994-6#1)(1996-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
is driven to a##2##4##(2008-10#1)(2008-7#1)
is driven to##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
is driven##31##2##(1990-2#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-9#1)(1996-11#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#3)(2008-9#3)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
is driving##2##2##(2008-10#1)(2008-11#1)
is due in part to the##2##6##(2007-12#1)(2008-10#1)
is due in part to##3##5##(2007-12#1)(2008-10#2)
is due in##5##3##(2007-12#1)(2008-10#2)(2008-6#1)(2009-12#1)
is due mainly to##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
is due only to##2##4##(1997-2#1)(2012-3#1)
is due primarily to##2##4##(2008-3#1)(2009-10#1)
is due to a single##2##5##(2008-10#1)(2011-2#1)
is due to a##20##4##(1990-5#1)(1990-7#1)(1993-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-2#1)
is due to an##7##4##(1993-12#1)(1997-3#1)(1997-7#1)(2008-10#4)
is due to another##2##4##(2008-5#1)(2009-10#1)
is due to be##2##4##(1996-1#1)(2008-3#1)
is due to both##3##4##(2008-1#1)(2008-3#1)(2008-7#1)
is due to different##2##4##(2008-2#1)(2012-3#1)
is due to its##5##4##(1991-6#1)(1992-9#1)(1995-2#1)(2008-1#1)(2013-1#1)
is due to mutations in##2##5##(2008-11#2)
is due to the fact that##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
is due to the formation of##2##6##(1994-2#1)(2008-11#1)
is due to the formation##3##5##(1994-2#1)(2008-11#1)(2008-3#1)
is due to the influence of##2##6##(2006-10#1)(2008-3#1)
is due to the interaction of Lr13##2##7##(2008-10#2)
is due to the interference##2##5##(2007-12#1)(2008-10#1)
is due to the presence of##4##6##(1992-3#1)(1997-6#1)(1997-7#1)(2008-3#1)
is due to the strong##2##5##(1996-5#1)(2008-2#1)
is due to the temperature##2##5##(2008-3#2)
is due to the##83##4##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-10#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#8)(2007-12#7)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#7)(2008-3#20)(2008-4#1)(2008-5#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
is due to##221##3##(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1991-12#2)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#15)(2007-12#13)(2007-7#1)(2008-1#6)(2008-10#25)(2008-11#4)(2008-2#20)(2008-3#46)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#2)
is due##243##2##(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#6)(1991-12#2)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#16)(2007-12#15)(2007-7#1)(2008-1#6)(2008-10#28)(2008-11#4)(2008-2#21)(2008-3#48)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#4)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#2)
is duplicated##3##2##(1993-8#1)(1995-8#1)(2008-3#1)
is dynamic##2##2##(1996-3#1)(2008-10#1)
is dynamically##3##2##(1995-2#1)(2007-11#1)(2008-6#1)
is early detection and##2##4##(1995-12#1)(2013-1#1)
is early##7##2##(1992-12#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
is easier and##3##3##(1991-3#1)(2008-12#1)(2008-2#1)
is easier to##8##3##(2008-10#4)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)
is easier##13##2##(1990-11#1)(1991-3#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-7#1)(2013-1#1)
is easiest##2##2##(2008-8#1)(2012-3#1)
is easily converted##2##3##(2008-10#1)(2008-4#1)
is easily implemented##2##3##(2008-3#2)
is easily overlooked##2##3##(1997-6#1)(2007-8#1)
is easily performed##2##3##(2008-10#1)(2008-3#1)
is easily##33##2##(1994-7#1)(1996-1#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#2)(2010-3#1)(2012-2#1)
is easy and##2##3##(2007-11#1)(2008-10#1)
is easy for##2##3##(2008-10#1)(2008-5#1)
is easy to implement##3##4##(1997-7#1)(2008-2#1)(2008-3#1)
is easy to perform##2##4##(2008-10#1)(2012-2#1)
is easy to use##4##4##(1991-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
is easy to##27##3##(1991-11#1)(1994-12#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-10#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)
is easy##34##2##(1991-11#1)(1994-12#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2009-10#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)
is economically##2##2##(1994-2#1)(1996-3#1)
is edge enhanced##2##3##(2008-2#1)(2008-3#1)
is effected##2##2##(2008-10#1)(2010-12#1)
is effective against##5##3##(1990-3#1)(1990-6#1)(2008-10#2)(2008-3#1)
is effective and safe in##2##5##(2008-1#1)(2010-12#1)
is effective and well-tolerated##2##4##(1994-8#1)(2012-2#1)
is effective and##8##3##(1994-8#1)(1997-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
is effective as a##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
is effective as##4##3##(1990-2#1)(2008-11#1)(2008-3#1)(2012-2#1)
is effective at##2##3##(2008-7#1)(2013-1#1)
is effective for the##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
is effective for##14##3##(1996-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#2)
is effective in improving##2##4##(2008-5#1)(2008-7#1)
is effective in preventing the##2##5##(2008-1#1)(2011-2#1)
is effective in reducing##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
is effective in the treatment of##4##6##(1994-9#1)(2007-11#1)(2013-1#2)
is effective in the treatment##5##5##(1994-9#1)(2007-11#2)(2013-1#2)
is effective in the##10##4##(1994-9#1)(2007-11#2)(2008-10#1)(2009-12#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
is effective in##39##3##(1990-5#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
is effective treatment##2##3##(1994-3#1)(2007-8#1)
is effective##96##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#7)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#10)(2008-11#7)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
is effectively a##2##3##(2008-9#2)
is effectively##7##2##(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)
is efficacious and##2##3##(2008-2#1)(2008-6#1)
is efficacious in##3##3##(1991-3#1)(1992-1#1)(2008-5#1)
is efficacious##8##2##(1991-3#1)(1992-1#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)
is efficient and##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
is efficient for##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
is efficient in the##2##4##(2008-5#1)(2010-5#1)
is efficient in##4##3##(1990-8#1)(2008-5#1)(2009-11#1)(2010-5#1)
is efficient##13##2##(1990-8#1)(1994-1#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
is efficiently##4##2##(1995-5#1)(2008-10#1)(2008-2#1)(2012-12#1)
is either incomplete or##2##4##(2010-8#1)(2012-2#1)
is either##20##2##(1991-9#1)(1993-11#1)(1994-6#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is elaborated##5##2##(1990-2#1)(2008-10#2)(2008-12#1)(2013-1#1)
is elevated in##4##3##(1991-7#1)(1996-5#1)(2008-12#1)(2011-2#1)
is elevated##10##2##(1991-7#1)(1993-3#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#1)
is eliminated by a##2##4##(2008-10#1)(2008-3#1)
is eliminated by the addition of EDTA##2##7##(2008-10#2)
is eliminated by the addition of##3##6##(2008-10#3)
is eliminated by##11##3##(1991-5#1)(1997-3#1)(2008-10#5)(2008-3#3)(2012-2#1)
is eliminated##15##2##(1991-5#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#3)(2012-2#1)
is eluted by##2##3##(2008-10#2)
is eluted with 0##2##4##(2008-10#2)
is eluted with##8##3##(2008-10#6)(2008-5#1)(2008-6#1)
is eluted##11##2##(2008-10#9)(2008-5#1)(2008-6#1)
is embedded in the##2##4##(2008-1#1)(2008-2#1)
is embedded in##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
is embedded within##2##3##(2011-2#1)(2013-1#1)
is embedded##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#1)
is emerging as a common##2##5##(2008-1#1)(2008-7#1)
is emerging as a promising##2##5##(2010-5#1)(2011-1#1)
is emerging as a##11##4##(2008-1#2)(2008-12#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
is emerging as an##3##4##(1992-1#1)(2011-2#2)
is emerging as the##2##4##(2008-1#2)
is emerging as##16##3##(1992-1#1)(2008-1#4)(2008-12#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)
is emerging evidence##4##3##(1994-5#1)(2008-4#1)(2009-6#1)(2011-2#1)
is emerging from##2##3##(2008-6#1)(2010-6#1)
is emerging in##3##3##(2008-7#1)(2011-2#2)
is emerging##26##2##(1992-1#1)(1994-5#1)(2008-1#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-6#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#1)
is emphasised that##2##3##(2007-8#1)(2008-11#1)
is emphasised##7##2##(1996-6#1)(2007-11#1)(2007-8#1)(2008-11#3)(2008-7#1)
is emphasized##23##2##(1991-11#2)(1991-12#1)(1991-3#1)(1992-11#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
is empirically##2##2##(2008-10#1)(2008-2#1)
is employed as a##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
is employed as the##2##4##(2008-3#1)(2008-4#1)
is employed as##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
is employed for##2##3##(2008-3#1)(2011-2#1)
is employed in a##2##4##(2007-11#2)
is employed in##7##3##(1991-11#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-6#1)
is employed to calculate##2##4##(2008-2#1)(2008-3#1)
is employed to generate##2##4##(2008-2#1)(2008-3#1)
is employed to perform##2##4##(2008-2#1)(2008-3#1)
is employed to##19##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#6)(2010-5#1)(2011-1#1)
is employed##51##2##(1990-8#1)(1991-11#1)(1991-3#1)(1994-12#1)(1994-2#1)(1997-1#1)(2007-11#5)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#12)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
is enclosed##2##2##(2008-3#1)(2010-11#1)
is encoded by a single gene##2##6##(1990-11#1)(1995-6#1)
is encoded by a single##6##5##(1990-11#1)(1991-6#1)(1992-12#1)(1995-6#1)(1995-8#1)(2008-3#1)
is encoded by a##10##4##(1990-11#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(2008-3#1)(2008-8#1)
is encoded by one gene##2##5##(1992-3#1)(1993-3#1)
is encoded by the##10##4##(1990-5#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-3#1)(2009-7#1)(2013-8#1)
is encoded by two##3##4##(1991-6#1)(1993-9#1)(1997-7#1)
is encoded by##27##3##(1990-11#1)(1990-5#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#2)(1995-8#1)(1997-7#2)(2008-1#1)(2008-3#2)(2008-8#1)(2009-7#1)(2013-8#1)
is encoded in##2##3##(2007-11#1)(2008-7#1)
is encoded##35##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#2)(1995-8#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-1#1)(2013-8#1)
is encountered in##2##3##(1990-8#1)(2007-11#1)
is encountered on the skin##2##5##(2008-5#2)
is encountered##7##2##(1990-8#2)(1994-11#1)(1995-5#1)(2007-11#1)(2008-5#2)
is encouraged##4##2##(1997-1#1)(2007-10#1)(2008-10#1)(2008-11#1)
is encouraging and##2##3##(2008-12#1)(2012-3#1)
is encouraging##4##2##(2006-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
is endemic for##3##3##(2008-5#1)(2012-12#2)
is endemic in South##2##4##(1991-11#1)(2007-7#1)
is endemic in##9##3##(1991-11#3)(2007-2#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is endemic to##2##3##(2008-10#1)(2009-2#1)
is endemic##20##2##(1991-11#3)(1992-8#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-5#2)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is endoscopic##3##2##(1992-2#2)(2013-1#1)
is endowed with##2##3##(2008-4#1)(2008-9#1)
is energetically disfavored for the AAA sequence##2##7##(2012-12#2)
is enforced by##4##3##(2008-3#1)(2008-8#1)(2011-2#2)
is engaged in##2##3##(2012-2#1)(2013-8#1)
is enhanced because##2##3##(2007-11#1)(2011-2#1)
is enhanced by a factor of##2##6##(2007-12#2)
is enhanced by a##3##4##(2007-12#2)(2012-3#1)
is enhanced by the##4##4##(1996-3#1)(2008-10#2)(2009-8#1)
is enhanced by##24##3##(1991-5#1)(1993-6#1)(1994-8#1)(1996-3#2)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2012-2#2)(2012-3#1)
is enhanced during##2##3##(2008-11#1)(2008-7#1)
is enhanced in the presence of##2##6##(2008-10#1)(2013-1#1)
is enhanced in the##3##4##(2008-10#1)(2009-8#1)(2013-1#1)
is enhanced in##11##3##(1994-12#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
is enhanced is##2##3##(2008-3#1)(2010-11#1)
is enhanced when##3##3##(1994-1#1)(2008-10#2)
is enhanced with##2##3##(1992-11#1)(1994-12#1)
is enhanced##59##2##(1991-5#2)(1992-11#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-8#2)(1995-2#2)(1996-3#2)(1996-5#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
is enlarged##2##2##(2007-11#1)(2008-10#1)
is enough for##2##3##(2008-10#1)(2012-12#1)
is enough to cause##2##4##(1997-6#1)(2008-5#1)
is enough to##7##3##(1991-12#1)(1997-6#1)(2008-10#1)(2008-5#2)(2012-12#1)(2012-2#1)
is enough##13##2##(1991-12#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-8#1)(2012-12#2)(2012-2#1)
is enough?##2##2##(1992-12#1)(2008-5#1)
is enriched in##3##3##(1990-7#1)(1997-3#1)(2013-1#1)
is enriched##4##2##(1990-7#1)(1992-9#1)(1997-3#1)(2013-1#1)
is ensured by the##2##4##(2007-11#1)(2008-3#1)
is ensured by##4##3##(2007-11#1)(2008-3#3)
is ensured##5##2##(2007-11#1)(2008-3#3)(2008-8#1)
is entirely consistent with##2##4##(1990-11#1)(1993-12#1)
is entirely##10##2##(1990-11#1)(1990-12#1)(1991-11#1)(1993-12#1)(1995-3#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-3#1)(2011-1#1)
is entrapped##2##2##(2008-10#2)
is environmentally##2##2##(2007-12#1)(2008-9#1)
is envisaged##5##2##(2008-10#2)(2008-9#1)(2009-11#1)(2012-2#1)
is envisioned##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
is enzootic in##2##3##(2008-10#1)(2011-2#1)
is enzymatically##3##2##(2008-10#2)(2013-7#1)
is epidemic##3##2##(1995-3#1)(2009-11#1)(2009-4#1)
is equal or##2##3##(1992-1#1)(2008-1#1)
is equal to the##8##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)
is equal to##17##3##(2007-11#3)(2008-10#4)(2008-2#2)(2008-3#7)(2008-6#1)
is equal##24##2##(1992-1#1)(2007-11#3)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#7)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)
is equally important##2##3##(2010-2#1)(2010-8#1)
is equally##8##2##(1992-3#1)(1994-11#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-8#1)
is equipped with##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)
is equivalent to 1##2##4##(1991-8#1)(2008-10#1)
is equivalent to the##9##4##(1991-3#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is equivalent to##21##3##(1991-3#1)(1991-8#2)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)
is equivalent##24##2##(1991-3#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)
is equivocal##2##2##(2008-1#1)(2008-9#1)
is especially advantageous for##2##4##(2008-10#1)(2008-2#1)
is especially difficult##3##3##(2008-10#1)(2012-2#1)(2013-7#1)
is especially important for##2##4##(1994-3#1)(2012-3#1)
is especially important in##3##4##(2008-1#1)(2008-9#1)(2011-2#1)
is especially important to##2##4##(2008-5#1)(2010-1#1)
is especially important##10##3##(1991-6#1)(1994-11#1)(1994-3#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
is especially prone to##2##4##(2008-10#1)(2008-8#1)
is especially relevant in##2##4##(1996-5#1)(2013-1#1)
is especially relevant##3##3##(1996-5#1)(2009-6#1)(2013-1#1)
is especially suited##2##3##(1990-8#1)(2008-2#1)
is especially the##2##3##(1991-8#1)(1995-2#1)
is especially true##12##3##(1990-12#1)(1992-2#1)(1994-2#1)(2007-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
is especially useful for the##2##5##(2008-10#1)(2008-5#1)
is especially useful for##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
is especially useful in##2##4##(1995-11#1)(2007-12#1)
is especially useful##6##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)
is especially##63##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#7)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
is essential before##2##3##(1994-12#1)(2008-7#1)
is essential for appropriate##4##4##(2007-11#1)(2007-8#1)(2011-2#2)
is essential for control of##3##5##(2008-10#1)(2008-9#1)(2009-2#1)
is essential for efficient##3##4##(1990-5#1)(1991-9#1)(2008-10#1)
is essential for globin##2##4##(1994-8#2)
is essential for its##2##4##(1991-5#1)(2008-8#1)
is essential for normal##2##4##(2009-10#1)(2011-2#1)
is essential for nuclear##2##4##(1991-5#1)(1994-9#1)
is essential for predicting##2##4##(2009-2#2)
is essential for protein##2##4##(1994-6#1)(2008-7#1)
is essential for successful##3##4##(1992-6#1)(1995-8#1)(2011-2#1)
is essential for the design of##2##6##(1993-11#1)(2008-7#1)
is essential for the development of##5##6##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
is essential for the development##6##5##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-1#1)
is essential for the function of##2##6##(1993-12#1)(2008-11#1)
is essential for the##41##4##(1990-2#1)(1991-12#1)(1993-11#1)(1993-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#5)
is essential for understanding##2##4##(2008-10#1)(2012-2#1)
is essential for##143##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-9#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#9)(2008-9#5)(2009-10#2)(2009-2#6)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)
is essential if##2##3##(1993-12#1)(2013-1#1)
is essential in order to##2##5##(2007-8#1)(2010-12#1)
is essential in the##6##4##(1994-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-8#1)
is essential in##18##3##(1993-3#1)(1994-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#3)(2010-9#1)(2011-1#1)
is essential not only##2##4##(2008-7#1)(2012-3#1)
is essential that the##2##4##(2008-4#1)(2009-11#1)
is essential that##7##3##(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
is essential to allow##2##4##(2008-12#1)(2011-2#1)
is essential to control##2##4##(2008-5#1)(2011-2#1)
is essential to determine##2##4##(2008-11#1)(2010-12#1)
is essential to ensure##4##4##(2008-11#2)(2008-12#2)
is essential to identify##3##4##(2009-5#1)(2011-2#1)(2012-2#1)
is essential to prevent##4##4##(2008-1#1)(2008-2#1)(2010-8#1)(2013-1#1)
is essential to the##8##4##(1993-12#1)(1995-2#1)(2008-12#2)(2008-9#2)(2010-5#1)(2013-1#1)
is essential to##72##3##(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#2)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
is essential when##3##3##(1991-9#1)(1992-9#1)(2008-10#1)
is essential##285##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#5)(1991-6#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#2)(1992-9#3)(1993-11#1)(1993-12#4)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-5#3)(1995-6#3)(1995-8#5)(1995-9#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#26)(2008-11#12)(2008-12#8)(2008-2#6)(2008-3#4)(2008-4#6)(2008-5#4)(2008-7#12)(2008-8#10)(2008-9#12)(2009-10#2)(2009-11#1)(2009-2#6)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#3)(2010-5#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-2#21)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#12)(2013-8#2)
is essentially a benign##2##4##(2007-11#1)(2010-5#1)
is essentially a##4##3##(2007-11#1)(2008-11#1)(2008-4#1)(2010-5#1)
is essentially dependent on the##2##5##(1994-12#1)(1995-8#1)
is essentially identical to that##2##5##(1991-5#1)(1992-8#1)
is essentially the same in##2##5##(1991-2#1)(2008-2#1)
is essentially the same##3##4##(1991-2#1)(1994-6#1)(2008-2#1)
is essentially##23##2##(1991-2#1)(1991-5#1)(1992-11#2)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-8#1)
is established as##2##3##(2008-10#2)
is established between the##2##4##(2007-11#1)(2008-10#1)
is established between##6##3##(1990-9#1)(2007-11#1)(2008-10#3)(2013-1#1)
is established by##5##3##(1991-11#1)(1993-3#1)(2007-11#1)(2008-11#1)(2008-7#1)
is established in a##2##4##(2008-3#1)(2008-9#1)
is established in the##3##4##(2008-10#1)(2008-5#1)(2009-1#1)
is established in##10##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2013-1#1)
is established that##2##3##(2011-2#1)(2013-1#1)
is established with the##2##4##(2008-10#1)(2012-2#1)
is established with##3##3##(2008-10#2)(2012-2#1)
is established##54##2##(1990-12#1)(1990-9#1)(1991-11#1)(1992-5#1)(1993-3#1)(1994-1#1)(1996-6#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#8)
is esterified##2##2##(1992-3#1)(2012-2#1)
is estimated at 1##2##4##(2008-1#1)(2009-7#1)
is estimated at##6##3##(2008-1#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
is estimated based on##2##4##(2008-1#1)(2008-11#1)
is estimated by use of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is estimated by##8##3##(1995-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)
is estimated for##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
is estimated from##2##3##(2008-10#1)(2008-3#1)
is estimated that approximately##2##4##(2012-12#1)(2013-1#1)
is estimated that the##4##4##(1991-6#1)(1993-8#1)(1995-6#1)(2008-5#1)
is estimated that##18##3##(1990-2#1)(1991-6#1)(1993-8#1)(1995-6#1)(1996-2#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
is estimated to be 1##2##5##(2008-10#1)(2012-1#1)
is estimated to be##19##4##(1990-7#2)(1994-8#1)(1994-9#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
is estimated to range from##2##5##(2012-2#1)(2013-1#1)
is estimated to##27##3##(1990-7#2)(1994-8#1)(1994-9#1)(1995-5#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#4)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
is estimated##74##2##(1990-2#1)(1990-7#2)(1991-1#1)(1991-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#5)(2008-3#9)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#1)
is evaluated and##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
is evaluated as a function of##2##6##(2008-2#1)(2008-8#1)
is evaluated as a##3##4##(2008-2#2)(2008-8#1)
is evaluated as##4##3##(2008-2#3)(2008-8#1)
is evaluated by use of##2##5##(2008-2#1)(2008-3#1)
is evaluated by##14##3##(1990-8#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2013-8#1)
is evaluated for##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)
is evaluated from##2##3##(2008-10#1)(2008-3#1)
is evaluated in a##2##4##(2008-10#1)(2008-4#1)
is evaluated in terms of##4##5##(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)
is evaluated in##9##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2013-1#1)
is evaluated numerically##3##3##(2008-2#1)(2008-3#2)
is evaluated through##3##3##(1990-3#1)(2008-2#1)(2008-3#1)
is evaluated using##5##3##(2008-10#2)(2008-6#1)(2009-11#1)(2010-8#1)
is evaluated via##2##3##(1997-2#1)(2008-6#1)
is evaluated with##2##3##(2008-10#2)
is evaluated##76##2##(1990-3#1)(1990-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-2#13)(2008-3#16)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
is even more rare##2##4##(1991-11#1)(2013-1#1)
is even more##8##3##(1991-11#1)(1995-11#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2013-1#2)
is even rarer##6##3##(2007-7#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
is even##27##2##(1991-11#1)(1991-12#1)(1995-11#1)(1995-2#1)(1996-7#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
is ever##4##2##(1992-1#1)(2008-8#2)(2012-12#1)
is every##3##2##(1991-5#1)(2008-10#2)
is evidence for##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
is evidence from##2##3##(1994-3#1)(1994-9#1)
is evidence of##12##3##(1996-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
is evidence suggesting##2##3##(1993-3#1)(2008-10#1)
is evidence that high##2##4##(2010-1#1)(2010-9#1)
is evidence that the##4##4##(1992-7#1)(2006-10#1)(2010-1#1)(2010-5#1)
is evidence that these##2##4##(2009-5#1)(2010-11#1)
is evidence that##30##3##(1991-12#2)(1992-7#1)(1995-11#1)(1995-12#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-5#1)(2010-1#2)(2010-11#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
is evidence to suggest that##3##5##(1994-9#1)(2008-9#1)(2010-2#1)
is evidence to support a##3##5##(1996-9#1)(2007-12#1)(2008-2#1)
is evidence to support##4##4##(1996-9#1)(2007-12#2)(2008-2#1)
is evidence to##7##3##(1994-9#1)(1996-9#1)(2007-12#2)(2008-2#1)(2008-9#1)(2010-2#1)
is evidence##61##2##(1991-12#2)(1992-7#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-5#2)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
is evidenced by the##2##4##(1991-5#1)(1996-2#1)
is evidenced by##3##3##(1991-5#1)(1996-2#1)(2011-2#1)
is evidenced##5##2##(1991-5#1)(1996-2#1)(1997-4#1)(2011-2#2)
is evident from##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
is evident in##5##3##(2008-1#1)(2012-12#2)(2013-1#2)
is evident that the##5##4##(1993-1#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-3#1)
is evident that these##2##4##(2012-1#1)(2012-3#1)
is evident that##18##3##(1992-1#1)(1993-1#1)(1993-12#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
is evident##31##2##(1992-1#1)(1993-1#1)(1993-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
is evolutionarily stable##2##3##(2008-9#2)
is evolutionarily##7##2##(1994-11#1)(1995-6#1)(2008-8#1)(2008-9#2)(2010-6#1)(2012-3#1)
is evolved by##2##3##(2008-3#2)
is evolving##4##2##(1991-2#1)(2008-1#1)(2010-12#1)(2010-3#1)
is exacerbated in##3##3##(2008-8#1)(2009-9#1)(2013-1#1)
is exactly what##3##3##(2008-3#1)(2008-9#1)(2009-10#1)
is examined and shown to##2##5##(2008-10#1)(2008-3#1)
is examined and##4##3##(1990-3#1)(2008-10#2)(2008-3#1)
is examined by##4##3##(2008-10#1)(2008-3#2)(2009-11#1)
is examined for its##2##4##(2008-11#1)(2008-3#1)
is examined for the##2##4##(2008-3#2)
is examined for##8##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
is examined from##2##3##(1992-3#1)(1993-3#1)
is examined in detail##2##4##(1991-12#1)(2009-12#1)
is examined in relation to the##2##6##(2008-10#1)(2009-8#1)
is examined in this##2##4##(1995-2#1)(2008-7#1)
is examined in##13##3##(1991-12#1)(1991-3#1)(1992-3#1)(1995-2#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)
is examined with##3##3##(1993-1#1)(2008-1#1)(2008-3#1)
is examined##72##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-3#2)(1994-2#1)(1995-2#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#20)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)
is exceedingly rare in##2##4##(2009-1#1)(2013-1#1)
is exceedingly rare##7##3##(2008-11#1)(2009-1#1)(2010-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
is exceedingly##8##2##(2008-11#1)(2009-1#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#2)
is excellent##13##2##(1992-12#1)(1996-9#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-9#1)(2011-2#1)
is exceptionally##4##2##(1994-8#1)(1997-8#1)(2007-12#1)(2008-10#1)
is exchanged##2##2##(2007-11#1)(2008-4#1)
is excised from##2##3##(1993-12#1)(1996-2#1)
is excised##3##2##(1993-12#1)(1996-2#1)(2008-4#1)
is excited at##2##3##(2008-10#2)
is excited by the##2##4##(1992-12#1)(2008-3#1)
is excited by##5##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
is excited##11##2##(1992-12#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)
is excluded from the##3##4##(1994-6#1)(1995-3#1)(2007-11#1)
is excluded##4##2##(1994-6#1)(1995-3#1)(2007-11#1)(2010-4#1)
is exclusively expressed in##3##4##(2008-5#1)(2008-8#1)(2012-2#1)
is exclusively expressed##4##3##(1994-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
is exclusively##7##2##(1994-8#1)(1996-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
is excreted##3##2##(2008-10#2)(2012-2#1)
is exemplified by the##3##4##(1997-8#1)(2008-8#1)(2008-9#1)
is exemplified by##5##3##(1997-8#1)(2008-8#2)(2008-9#1)(2011-2#1)
is exemplified through##2##3##(2008-3#1)(2008-4#1)
is exemplified##9##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2011-2#1)
is exerted##4##2##(1994-9#1)(2008-11#1)(2008-4#1)(2009-8#1)
is exhibited by##2##3##(1994-5#1)(2007-12#1)
is exhibited##3##2##(1994-5#1)(1995-6#1)(2007-12#1)
is expanded to##3##3##(1995-11#1)(2008-3#2)
is expanded##6##2##(1995-11#1)(2008-3#2)(2008-5#2)(2008-6#1)
is expanding##4##2##(1991-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
is expected in##5##3##(1993-1#1)(2008-11#2)(2008-5#1)(2008-9#1)
is expected that it##2##4##(2008-10#1)(2008-11#1)
is expected that##18##3##(1991-1#1)(1994-5#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-7#2)(2010-12#1)(2012-2#1)(2012-3#1)
is expected to be a##5##5##(1992-12#1)(2007-7#1)(2008-11#2)(2010-6#1)
is expected to be useful for##2##6##(2008-10#1)(2008-3#1)
is expected to be##17##4##(1992-12#1)(1993-11#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
is expected to grow##2##4##(1991-1#1)(2012-2#1)
is expected to have a##3##5##(2008-11#1)(2008-3#1)(2011-2#1)
is expected to have##6##4##(2008-11#1)(2008-3#3)(2010-8#1)(2011-2#1)
is expected to improve##2##4##(1997-6#1)(2008-10#1)
is expected to increase##4##4##(1991-12#1)(1994-9#1)(2008-9#1)(2012-3#1)
is expected to lower the##2##5##(2008-7#1)(2010-11#1)
is expected to yield##2##4##(2008-11#1)(2011-2#1)
is expected to##64##3##(1991-1#2)(1991-12#1)(1992-12#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#6)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#3)
is expected##100##2##(1991-1#3)(1991-12#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#13)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)
is expensive and##4##3##(1994-3#1)(2012-3#1)(2013-1#2)
is expensive##5##2##(1993-3#1)(1994-3#1)(2012-3#1)(2013-1#2)
is experienced##6##2##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
is experiencing##2##2##(1992-2#1)(2008-11#1)
is experimental##2##2##(1992-9#1)(2012-1#1)
is experimentally and theoretically##2##4##(2007-11#1)(2008-2#1)
is experimentally demonstrated by use of a##2##7##(2008-3#2)
is experimentally demonstrated by use of##3##6##(2008-3#3)
is experimentally demonstrated in##2##4##(1997-6#1)(2008-3#1)
is experimentally demonstrated##12##3##(1997-6#1)(2007-11#1)(2007-12#3)(2008-3#7)
is experimentally investigated##3##3##(2007-12#1)(2008-3#2)
is experimentally observed in##2##4##(2007-12#2)
is experimentally observed##4##3##(2007-12#4)
is experimentally shown##2##3##(2007-12#2)
is experimentally studied##3##3##(2007-12#2)(2008-3#1)
is experimentally verified by##2##4##(2007-11#1)(2008-3#1)
is experimentally verified##6##3##(2007-11#2)(2008-10#2)(2008-3#2)
is experimentally##37##2##(1997-6#1)(2007-11#5)(2007-12#13)(2008-10#3)(2008-2#2)(2008-3#12)(2012-3#1)
is explained and compared with##2##5##(2008-10#1)(2008-3#1)
is explained as##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
is explained by the##6##4##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2013-1#1)
is explained by##13##3##(1993-12#1)(1995-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
is explained on the basis of##2##6##(2008-10#1)(2008-3#1)
is explained with##2##3##(1994-3#1)(2008-3#1)
is explained##38##2##(1993-12#1)(1994-3#1)(1995-12#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#7)(2008-7#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2013-1#1)
is explicitly considered##2##3##(2008-10#1)(2008-9#1)
is explicitly##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
is exploited in##2##3##(2008-10#2)
is exploited to detect##2##4##(2008-3#2)
is exploited to##4##3##(1995-2#1)(2008-3#3)
is exploited##7##2##(1995-2#1)(2008-10#2)(2008-3#4)
is explored and##4##3##(1992-1#1)(1994-2#1)(2008-11#1)(2009-10#1)
is explored in##5##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-5#1)
is explored##24##2##(1992-1#1)(1992-9#1)(1994-2#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#2)(2010-9#1)(2011-1#1)(2013-1#2)
is exploring##2##2##(2010-5#1)(2012-1#1)
is exposed to a##2##4##(2007-12#1)(2008-7#1)
is exposed to the##4##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
is exposed to##12##3##(1990-5#1)(1994-5#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)
is exposed##15##2##(1990-5#1)(1994-5#1)(1997-8#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
is expressed as a##7##4##(1993-2#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
is expressed as##10##3##(1993-2#1)(1996-6#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)(2012-2#1)
is expressed at high levels in##3##6##(1991-9#1)(1995-2#1)(1997-6#1)
is expressed at##8##3##(1991-9#1)(1993-2#1)(1994-10#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-7#1)(2009-10#1)
is expressed by a##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
is expressed by##13##3##(1991-2#1)(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-8#1)
is expressed exclusively in the##2##5##(1993-9#1)(1994-8#1)
is expressed in a##3##4##(1993-3#1)(2008-1#1)(2008-5#1)
is expressed in all##2##4##(1993-6#1)(1996-12#1)
is expressed in many##2##4##(1992-3#1)(2013-8#1)
is expressed in the##10##4##(1993-12#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-7#2)(2008-4#1)(2010-11#1)(2013-1#1)
is expressed in tissues##2##4##(1992-11#1)(1993-12#1)
is expressed in##52##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-9#3)(1995-2#2)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#3)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#2)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
is expressed on##2##3##(1993-12#1)(2012-2#1)
is expressed specifically in the##2##5##(1993-12#1)(1995-2#1)
is expressed specifically in##4##4##(1993-12#1)(1993-8#1)(1995-2#1)(2008-8#1)
is expressed ubiquitously##3##3##(1992-12#1)(1995-6#1)(1997-7#1)
is expressed##116##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#7)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
is exquisitely sensitive to##2##4##(2008-9#1)(2012-2#1)
is extended by##2##3##(2007-11#1)(2008-10#1)
is extended for##2##3##(2008-10#1)(2008-2#1)
is extended to cover##2##4##(2008-2#1)(2008-3#1)
is extended to the case of##2##6##(2008-2#1)(2008-3#1)
is extended to the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
is extended to##19##3##(1992-6#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
is extended with##2##3##(1997-8#1)(2009-12#1)
is extended##32##2##(1992-11#1)(1992-6#1)(1997-8#2)(2007-11#3)(2008-10#5)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2012-2#1)
is extensive##5##2##(1993-12#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
is extensively##4##2##(1992-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
is extracted by##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
is extracted from the##2##4##(2007-11#1)(2010-3#1)
is extracted from##4##3##(2007-11#1)(2008-10#1)(2009-4#1)(2010-3#1)
is extracted with##3##3##(2008-10#3)
is extracted##25##2##(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#2)(2009-4#1)(2010-3#1)
is extrapolated##2##2##(2008-3#1)(2009-5#1)
is extremely attractive##2##3##(2008-10#1)(2008-3#1)
is extremely challenging##2##3##(2010-5#1)(2012-3#1)
is extremely common in##2##4##(2008-1#1)(2008-5#1)
is extremely common##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
is extremely complex and##2##4##(2008-7#1)(2013-1#1)
is extremely complex##3##3##(2008-7#1)(2010-9#1)(2013-1#1)
is extremely difficult##2##3##(2008-2#1)(2012-2#1)
is extremely effective for##2##4##(2008-11#1)(2009-3#1)
is extremely effective##3##3##(2008-11#1)(2009-3#1)(2011-3#1)
is extremely important##6##3##(1995-9#2)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#1)
is extremely rare and##5##4##(2008-12#1)(2008-6#2)(2013-1#1)(2013-8#1)
is extremely rare in##5##4##(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
is extremely rare##29##3##(1991-9#1)(1993-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
is extremely sensitive to##5##4##(1990-3#1)(1996-4#1)(2008-3#1)(2009-5#1)(2009-8#1)
is extremely sensitive##7##3##(1990-3#1)(1994-8#1)(1996-4#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)
is extremely stable##2##3##(2007-11#1)(2008-10#1)
is extremely useful for##5##4##(2007-12#2)(2008-10#1)(2008-4#2)
is extremely useful##6##3##(1997-7#1)(2007-12#2)(2008-10#1)(2008-4#2)
is extremely variable##2##3##(1991-2#1)(2013-1#1)
is extremely##87##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-6#1)(1995-9#2)(1996-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
is fabricated by a##2##4##(2007-11#1)(2008-10#1)
is fabricated by##5##3##(1994-2#1)(2007-11#1)(2007-12#2)(2008-10#1)
is fabricated with a##2##4##(2007-11#1)(2008-3#1)
is fabricated with##3##3##(2007-11#2)(2008-3#1)
is fabricated##11##2##(1994-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#3)(2008-7#1)
is faced with the##2##4##(1995-5#1)(2012-2#1)
is faced with##3##3##(1995-5#1)(2008-11#1)(2012-2#1)
is facilitated by the##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
is facilitated by##6##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-8#1)
is facilitated##9##2##(1990-2#1)(2008-10#1)(2008-11#2)(2008-4#2)(2012-1#1)(2012-3#1)(2013-8#1)
is fairly##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)
is far from##6##3##(1993-3#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
is far higher than##2##4##(1992-3#1)(2008-7#1)
is far more##3##3##(2008-10#1)(2008-3#1)(2009-12#1)
is far too##2##3##(1995-6#1)(2012-3#1)
is far##21##2##(1991-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#2)(2009-12#1)(2009-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is fast and##5##3##(1996-12#1)(2008-10#2)(2008-4#1)(2010-4#1)
is fast becoming a##2##4##(1995-2#1)(2010-5#1)
is fast##18##2##(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-4#1)(2010-5#1)
is faster and##3##3##(2008-10#2)(2008-11#1)
is faster in##2##3##(1993-11#1)(2007-11#1)
is faster than##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
is faster when##2##3##(1997-4#1)(2008-9#1)
is faster##13##2##(1993-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
is favorable for##2##3##(2007-12#1)(2008-10#1)
is favorable##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
is favored by##2##3##(2008-6#1)(2008-8#1)
is favored##9##2##(2008-10#1)(2008-6#1)(2008-8#5)(2008-9#2)
is favourable##3##2##(1991-8#1)(1997-6#1)(2007-11#1)
is favoured##5##2##(2008-11#1)(2008-4#1)(2012-3#1)(2012-7#1)(2013-1#1)
is feasible and safe##2##4##(2011-2#1)(2012-2#1)
is feasible and##8##3##(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
is feasible for##2##3##(2007-8#1)(2013-8#1)
is feasible in##6##3##(1991-2#1)(2008-1#1)(2008-3#1)(2010-3#1)(2013-1#1)(2013-8#1)
is feasible with##3##3##(1997-6#1)(2010-5#1)(2012-3#1)
is feasible##56##2##(1991-2#1)(1992-10#1)(1995-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#7)
is fed back##2##3##(2007-12#1)(2008-2#1)
is fed##5##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
is filamentous##2##2##(1995-2#1)(2008-7#1)
is filled with a##2##4##(2007-12#1)(2008-3#1)
is filled with##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2012-1#1)
is filled##6##2##(2007-12#2)(2008-10#2)(2008-3#1)(2012-1#1)
is finally##3##2##(1990-11#1)(2008-10#1)(2008-9#1)
is financed and##2##3##(1997-2#1)(1997-5#1)
is financed##3##2##(1996-2#1)(1997-2#1)(1997-5#1)
is finished##2##2##(2008-10#2)
is firmly##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
is first given##2##3##(2008-10#1)(2008-2#1)
is first mapped##2##3##(2008-10#1)(2008-3#1)
is first order##2##3##(2008-10#1)(2010-5#1)
is first presented##2##3##(2007-12#1)(2012-2#1)
is first##33##2##(1995-11#2)(1997-7#1)(2007-12#2)(2007-7#2)(2008-10#10)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
is firstly##2##2##(2007-12#1)(2012-3#1)
is fit to##2##3##(2008-2#1)(2010-3#1)
is fit##3##2##(1997-4#1)(2008-2#1)(2010-3#1)
is fitted to a##2##4##(2008-2#2)
is fitted to##4##3##(1996-2#1)(2008-2#3)
is fitted##5##2##(1992-6#1)(1996-2#1)(2008-2#3)
is five times##4##3##(1994-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
is five##5##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-3#1)(2012-2#1)
is fixed and##2##3##(2008-2#2)
is fixed##12##2##(1992-9#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)
is flanked by##3##3##(1994-12#1)(1997-4#1)(1997-7#1)
is flanked##4##2##(1994-12#1)(1997-4#1)(1997-7#2)
is flat##2##2##(2008-3#2)
is flexible and##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
is flexible##6##2##(1992-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
is focused in##2##3##(2008-3#1)(2008-7#1)
is focused on the##11##4##(1990-8#1)(1992-5#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#2)
is focused on##26##3##(1990-8#1)(1991-3#1)(1992-5#1)(1992-6#1)(1994-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)
is focused onto##2##3##(2008-2#2)
is focused to##2##3##(2007-11#1)(2007-12#1)
is focused##39##2##(1990-8#1)(1991-3#1)(1992-5#1)(1992-6#1)(1994-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#5)(2008-4#2)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
is focussed on##3##3##(2008-10#1)(2010-9#2)
is followed by a discussion of the##2##7##(2009-12#1)(2010-12#1)
is followed by a discussion of##6##6##(1994-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-12#1)
is followed by a##15##4##(1990-5#1)(1991-6#1)(1994-12#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)
is followed by an##3##4##(1992-12#1)(1994-11#1)(1995-8#1)
is followed by the##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
is followed by##43##3##(1990-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-8#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
is followed for##2##3##(2008-3#2)
is followed in the##3##4##(2008-10#2)(2009-11#1)
is followed in##4##3##(1994-12#1)(2008-10#2)(2009-11#1)
is followed##53##2##(1990-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
is for a##2##3##(1993-12#2)
is for one##2##3##(2008-2#1)(2008-9#1)
is for the##5##3##(1994-12#1)(1995-1#1)(2008-10#2)(2008-4#1)
is for##34##2##(1991-5#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-6#1)(2008-9#3)(2009-11#2)(2011-2#1)(2012-12#2)(2013-1#1)
is forbidden##2##2##(1991-6#1)(2008-10#1)
is forced to##2##3##(2008-3#1)(2009-3#1)
is forcing##2##2##(1992-1#1)(1993-2#1)
is formed and##5##3##(1991-9#1)(1993-3#1)(2008-10#2)(2008-3#1)
is formed as##2##3##(2008-10#1)(2008-4#1)
is formed at##2##3##(2008-10#1)(2009-7#1)
is formed between##3##3##(2008-10#2)(2008-4#1)
is formed by an##2##4##(2008-10#1)(2011-2#1)
is formed by rotation of the##3##6##(2008-3#3)
is formed by the##7##4##(1990-11#1)(1992-4#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
is formed by##22##3##(1990-11#1)(1992-4#1)(1993-11#1)(1994-2#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#5)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#2)
is formed during##2##3##(2008-3#1)(2009-7#1)
is formed from##4##3##(1990-5#1)(1993-11#1)(2008-10#1)(2008-6#1)
is formed in a##2##4##(2008-10#1)(2008-11#1)
is formed in the##2##4##(1994-5#1)(2008-3#1)
is formed in##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
is formed on the##2##4##(2008-12#1)(2008-5#1)
is formed with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
is formed##77##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#1)(2007-11#2)(2007-12#6)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#3)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
is formulated as##2##3##(2007-12#1)(2008-2#1)
is formulated##9##2##(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2013-8#1)
is found among##2##3##(2012-2#1)(2013-1#1)
is found as a##3##4##(1996-6#2)(2008-3#1)
is found as##4##3##(1996-6#2)(2008-10#1)(2008-3#1)
is found at##2##3##(2007-12#1)(2008-2#1)
is found between the##3##4##(2007-12#1)(2008-2#2)
is found between##7##3##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)(2013-1#1)
is found by##4##3##(2008-2#1)(2008-3#1)(2008-4#2)
is found for a##2##4##(2007-11#1)(2007-12#1)
is found for the##3##4##(1994-12#1)(2008-2#1)(2008-3#1)
is found for##12##3##(1994-12#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2009-4#1)(2011-2#1)
is found in a##3##4##(1993-9#1)(1994-8#1)(2012-2#1)
is found in an##2##4##(1990-3#1)(2008-5#1)
is found in approximately##2##4##(1995-11#1)(2008-7#1)
is found in the##11##4##(1990-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-5#1)(2010-8#2)
is found in##43##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-9#2)(1992-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#4)(2009-6#1)(2009-8#3)(2010-3#1)(2010-5#1)(2010-8#3)(2012-2#1)(2013-8#1)
is found not##2##3##(2008-10#2)
is found on##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
is found that it is##2##5##(2008-2#1)(2008-3#1)
is found that the##44##4##(1990-2#1)(1990-8#3)(1992-6#1)(2007-11#4)(2007-12#4)(2008-10#6)(2008-2#7)(2008-3#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-1#2)(2013-8#1)
is found that this##2##4##(2008-10#1)(2008-3#1)
is found that##80##3##(1990-2#1)(1990-3#1)(1990-8#3)(1992-6#1)(1994-9#1)(1996-4#1)(1996-5#1)(2007-11#5)(2007-12#6)(2008-10#14)(2008-2#13)(2008-3#21)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-3#1)(2013-1#2)(2013-8#1)
is found to be 2##2##5##(2008-10#2)
is found to be a##6##5##(1991-5#2)(1995-8#1)(2008-10#2)(2009-7#1)
is found to be associated with##2##6##(2012-12#1)(2012-3#1)
is found to be better than##2##6##(2008-10#2)
is found to be independent of##2##6##(2007-11#2)
is found to be less than##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
is found to be linear##3##5##(2008-10#3)
is found to be more##2##5##(2008-10#1)(2008-3#1)
is found to be significantly##2##5##(2007-11#1)(2009-2#1)
is found to be the##6##5##(1996-2#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
is found to be##79##4##(1990-7#1)(1991-5#2)(1995-8#1)(1996-2#3)(1996-5#2)(2007-11#10)(2007-12#3)(2008-10#24)(2008-11#1)(2008-2#9)(2008-3#13)(2008-7#1)(2009-2#3)(2009-7#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
is found to decrease with##2##5##(1996-3#1)(2008-3#1)
is found to depend##2##4##(2007-12#2)
is found to enhance the##2##5##(2008-3#1)(2012-2#1)
is found to exist##2##4##(1996-12#1)(2008-2#1)
is found to have a##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
is found to have##6##4##(2008-10#1)(2008-2#4)(2008-3#1)
is found to increase##3##4##(2007-12#1)(2008-5#1)(2009-11#1)
is found to limit the##2##5##(2007-11#1)(2008-2#1)
is found to##117##3##(1990-7#1)(1991-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(2007-11#11)(2007-12#7)(2008-10#29)(2008-11#2)(2008-2#17)(2008-3#20)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#3)(2009-7#2)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
is found when a##2##4##(2008-2#1)(2009-10#1)
is found when##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)
is found within##3##3##(1991-11#1)(1996-6#1)(2008-5#1)
is found##323##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-5#2)(1991-9#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#4)(1997-1#1)(1997-3#1)(2007-11#20)(2007-12#22)(2008-1#1)(2008-10#53)(2008-11#3)(2008-2#46)(2008-3#56)(2008-4#3)(2008-5#5)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-11#1)(2010-3#3)(2010-5#1)(2010-8#5)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#3)
is founded##2##2##(1996-6#1)(2008-8#1)
is four times##2##3##(1992-9#1)(2008-3#1)
is framed##2##2##(1990-7#1)(2008-1#1)
is fraught with##4##3##(2008-11#2)(2008-9#2)
is free from matrix##3##4##(2008-10#3)
is free from the interference of##2##6##(2008-10#2)
is free from the##3##4##(1990-12#1)(2008-10#2)
is free from##17##3##(1990-12#1)(1991-12#1)(2007-12#2)(2008-10#10)(2008-11#2)(2011-2#1)
is free of##4##3##(1991-2#1)(1991-8#1)(2008-10#1)(2008-3#1)
is free##26##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
is freely available##4##3##(2008-9#2)(2009-2#1)(2012-1#1)
is freely##5##2##(2008-10#1)(2008-9#2)(2009-2#1)(2012-1#1)
is frequency doubled##2##3##(2007-11#1)(2008-3#1)
is frequency##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
is frequent in##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
is frequent##6##2##(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
is frequently an##2##3##(2008-10#1)(2008-5#1)
is frequently associated with the##2##5##(2008-3#1)(2012-1#1)
is frequently associated with##9##4##(1993-2#1)(1993-9#1)(1996-7#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-12#1)
is frequently associated##10##3##(1993-2#1)(1993-9#1)(1996-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-12#1)
is frequently cited##2##3##(1993-1#1)(2008-12#1)
is frequently compromised by##2##4##(2008-11#1)(2009-12#1)
is frequently described in##2##4##(1992-8#1)(2008-9#1)
is frequently due to##2##4##(1993-11#1)(2008-5#1)
is frequently misdiagnosed##3##3##(2006-10#1)(2008-11#1)(2013-8#1)
is frequently observed in##2##4##(2008-10#1)(2013-1#1)
is frequently observed##4##3##(1995-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
is frequently performed##2##3##(1990-9#1)(2008-7#1)
is frequently recognized##2##3##(2008-11#1)(2008-5#1)
is frequently seen in##3##4##(1994-11#1)(2008-1#1)(2008-11#1)
is frequently the##2##3##(2008-5#1)(2010-3#1)
is frequently used in##3##4##(2008-11#2)(2008-3#1)
is frequently used to##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
is frequently used##9##3##(1991-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
is frequently##84##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
is from 0##2##3##(2008-10#2)
is from the##4##3##(2007-12#1)(2008-11#1)(2008-8#1)(2013-1#1)
is from##23##2##(1992-12#1)(1993-12#1)(1997-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2013-1#3)
is fueling##3##2##(1993-12#1)(1993-2#1)(1994-1#1)
is full##2##2##(1995-5#1)(2013-8#1)
is fully automated##2##3##(2008-3#2)
is fully computerized and##2##4##(2008-10#1)(2008-3#1)
is fully determined by the##2##5##(2007-12#1)(2008-9#1)
is fully exploited##2##3##(2008-2#1)(2008-3#1)
is fully operational##2##3##(1992-3#1)(2007-11#1)
is fully reversible and##2##4##(1992-12#1)(2008-10#1)
is fully reversible##4##3##(1992-12#1)(2008-10#3)
is fully##25##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#4)(2008-9#1)(2011-2#1)
is functional in##4##3##(1993-3#1)(1996-3#2)(2008-2#1)
is functional##8##2##(1992-10#1)(1993-3#1)(1993-9#1)(1996-3#2)(2008-10#1)(2008-2#1)(2012-3#1)
is functionally active##2##3##(1992-12#1)(1996-12#1)
is functionally##13##2##(1990-8#1)(1991-2#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
is functioning##2##2##(2008-1#1)(2008-9#1)
is fundamental for##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
is fundamental to the##3##4##(2008-1#1)(2008-10#1)(2008-6#1)
is fundamental to##9##3##(1994-12#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-9#1)(2010-5#1)
is fundamental##17##2##(1994-12#1)(1996-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
is funded##2##2##(1994-3#1)(2012-12#1)
is further applied to##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
is further complicated by##3##4##(1997-1#1)(2008-1#1)(2008-4#1)
is further complicated##4##3##(1997-1#1)(2008-1#1)(2008-4#1)(2010-5#1)
is further confirmed##2##3##(2007-12#1)(2010-8#1)
is further improved by##2##4##(2008-10#1)(2008-3#1)
is further increased##2##3##(1994-10#1)(1996-3#1)
is further supported by the##2##5##(2008-8#1)(2009-9#1)
is further supported by##4##4##(1990-7#1)(1997-3#1)(2008-8#1)(2009-9#1)
is further##50##2##(1990-7#1)(1990-9#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#5)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-5#1)(2010-8#2)(2013-1#3)(2013-8#1)
is fused to##2##3##(1992-12#1)(2008-4#1)
is fused##5##2##(1992-12#1)(2008-10#2)(2008-4#1)(2008-6#1)
is gaining momentum in##2##4##(1994-2#1)(2008-7#1)
is gaining popularity##4##3##(2008-12#1)(2009-11#1)(2010-7#1)(2013-1#1)
is gaining##12##2##(1994-2#1)(1997-4#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2013-1#3)
is gathered and##2##3##(1992-12#1)(1995-12#1)
is gay##2##2##(1996-5#1)(2008-12#1)
is general agreement that##4##4##(1994-8#1)(2007-8#1)(2008-11#1)(2008-6#1)
is general enough to##2##4##(1991-1#1)(2008-4#1)
is general##12##2##(1991-1#1)(1994-11#1)(1994-8#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#2)(2010-3#1)
is generalized for##2##3##(2007-11#1)(2008-3#1)
is generalized to##6##3##(1992-9#1)(1994-3#1)(2008-3#3)(2008-6#1)
is generalized##10##2##(1992-9#1)(1994-3#1)(2007-11#1)(2008-3#4)(2008-6#3)
is generally a##4##3##(1991-6#1)(1992-6#1)(2008-11#1)(2013-1#1)
is generally accepted as##2##4##(1994-12#1)(2008-9#1)
is generally accepted that##8##4##(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2012-3#2)
is generally accepted##12##3##(1990-12#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#2)
is generally associated with##2##4##(2008-11#1)(2008-7#1)
is generally assumed that##3##4##(1994-11#1)(2008-3#1)(2013-8#1)
is generally believed that##2##4##(2010-7#1)(2011-10#1)
is generally believed##4##3##(1990-2#1)(1996-5#1)(2010-7#1)(2011-10#1)
is generally considered a##2##4##(2009-10#1)(2012-7#1)
is generally considered##8##3##(1996-3#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-7#1)(2013-1#1)
is generally determined by##2##4##(2008-7#1)(2008-9#1)
is generally excellent##2##3##(2008-3#1)(2009-5#1)
is generally good##2##3##(1991-12#1)(2008-3#1)
is generally lacking##2##3##(1993-3#1)(2009-5#1)
is generally more##5##3##(1995-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
is generally not a##2##4##(2007-5#1)(2008-10#1)
is generally not##5##3##(1996-5#1)(2007-5#1)(2008-10#2)(2008-3#1)
is generally observed##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
is generally regarded as##2##4##(2008-10#2)
is generally similar to that##2##5##(2007-12#1)(2008-11#1)
is generally similar##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
is generally smaller##2##3##(2008-10#1)(2008-4#1)
is generally suboptimal##2##3##(2008-10#1)(2008-2#1)
is generally thought##2##3##(1997-2#1)(2008-11#1)
is generally used##2##3##(1990-5#1)(2012-2#1)
is generally##125##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#9)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-2#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#4)(2013-8#1)
is generated at##3##3##(2007-12#1)(2008-10#2)
is generated by a##3##4##(1994-6#1)(2007-11#1)(2008-3#1)
is generated by frequency doubling of the output of##2##9##(2007-12#2)
is generated by frequency doubling of##3##6##(2007-12#3)
is generated by the##6##4##(1992-6#1)(1995-6#2)(1997-3#1)(1997-6#1)(2008-3#1)
is generated by##19##3##(1992-6#1)(1993-6#1)(1994-6#1)(1995-6#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-3#2)(2008-8#2)
is generated for##2##3##(2008-3#1)(2008-9#1)
is generated in a##2##4##(2008-10#1)(2008-2#1)
is generated in##8##3##(1995-2#1)(1996-11#1)(2008-10#2)(2008-12#1)(2008-2#3)
is generated only##2##3##(2007-12#1)(2008-3#1)
is generated primarily##2##3##(2008-3#1)(2013-1#1)
is generated##55##2##(1992-6#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-11#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-7#1)(2013-1#1)
is generic##2##2##(2008-10#2)
is genetic##3##2##(2008-10#2)(2008-4#1)
is genetically determined##4##3##(1990-2#1)(2008-12#1)(2008-7#1)(2012-3#1)
is genetically regulated##2##3##(2008-10#1)(2013-1#1)
is genetically##17##2##(1990-2#2)(1994-8#1)(1996-2#1)(2007-11#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
is getting##3##2##(2007-11#1)(2009-9#1)(2011-1#1)
is given and##2##3##(2008-10#2)
is given as##5##3##(1992-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#1)
is given by a##3##4##(2007-11#2)(2007-12#1)
is given by the##8##4##(2007-12#1)(2008-10#1)(2008-3#4)(2010-10#1)(2010-2#1)
is given by##15##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#6)(2010-10#1)(2010-2#1)(2010-4#1)
is given for the##11##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)
is given for##15##3##(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-9#1)(2013-8#1)
is given in which##2##4##(2008-3#1)(2008-4#1)
is given in##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2011-1#1)
is given of how##2##4##(2008-3#2)
is given of the##7##4##(1997-7#1)(2006-4#2)(2007-2#1)(2008-2#3)
is given of##11##3##(1992-6#1)(1997-7#1)(2006-4#2)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#2)
is given on the##4##4##(1990-10#1)(2007-2#1)(2008-10#1)(2008-2#1)
is given on##6##3##(1990-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
is given that##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
is given to the##15##4##(1991-6#2)(1992-3#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-3#3)(2008-9#2)(2010-10#1)(2010-6#1)(2013-8#1)
is given to##30##3##(1990-12#1)(1991-6#2)(1992-3#1)(1994-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-3#5)(2008-5#1)(2008-6#1)(2008-9#2)(2010-10#1)(2010-6#1)(2012-2#1)(2013-8#1)
is given##160##2##(1990-10#1)(1990-12#1)(1991-3#2)(1991-6#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2006-4#2)(2007-11#8)(2007-12#6)(2007-2#2)(2008-1#2)(2008-10#22)(2008-11#5)(2008-2#19)(2008-3#38)(2008-4#6)(2008-5#3)(2008-6#1)(2008-9#3)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
is giving##2##2##(1996-5#1)(2011-2#1)
is globally##2##2##(2008-7#1)(2013-8#1)
is going through##2##3##(1996-2#1)(2013-1#1)
is going to be##2##4##(1990-11#1)(2008-11#1)
is going to##4##3##(1990-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
is going##9##2##(1990-11#1)(1991-2#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
is good agreement##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
is good and##2##3##(2007-11#1)(2009-4#1)
is good evidence that##3##4##(2008-7#1)(2009-6#1)(2010-12#1)
is good evidence##4##3##(2008-7#2)(2009-6#1)(2010-12#1)
is good if the##3##4##(1996-9#1)(2008-3#1)(2008-4#1)
is good if##4##3##(1996-8#1)(1996-9#1)(2008-3#1)(2008-4#1)
is good##30##2##(1991-6#1)(1992-11#1)(1992-3#1)(1996-8#1)(1996-9#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#6)(2009-4#1)(2009-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is governed by a single##2##5##(1990-7#1)(2008-10#1)
is governed by a##4##4##(1990-7#1)(2008-10#3)
is governed by the##9##4##(1990-9#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-2#1)
is governed by##17##3##(1990-7#1)(1990-9#1)(1992-3#1)(2007-11#2)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)
is gradually diminished towards the##2##5##(1994-9#2)
is gradually##6##2##(1994-9#2)(2007-7#1)(2008-10#1)(2008-4#1)(2012-3#1)
is great interest in##3##4##(2007-8#1)(2008-11#1)(2009-7#1)
is great##11##2##(1994-12#1)(1994-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-11#4)(2009-7#1)(2010-10#1)
is greater for##5##3##(1996-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
is greater in the##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
is greater in##5##3##(1990-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
is greater than 20##2##4##(2008-11#1)(2008-3#1)
is greater than four##2##4##(2008-10#1)(2008-8#1)
is greater than that##5##4##(1991-12#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-5#1)
is greater than the##4##4##(2006-10#1)(2008-3#1)(2008-8#1)(2009-4#1)
is greater than##36##3##(1991-12#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#8)(2008-5#2)(2008-8#4)(2009-4#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
is greater with##2##3##(2012-3#1)(2013-1#1)
is greater##55##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-9#2)(1993-11#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#10)(2008-5#2)(2008-8#5)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
is greatest in##2##3##(2008-5#1)(2008-7#1)
is greatest##5##2##(1990-12#1)(1990-9#1)(2008-5#2)(2008-7#1)
is greatly affected by##2##4##(1990-12#1)(2008-10#1)
is greatly diminished in##2##4##(1993-12#1)(1996-5#1)
is greatly enhanced by##2##4##(2007-11#1)(2008-10#1)
is greatly enhanced##6##3##(2007-11#2)(2008-10#4)
is greatly increased in the##2##5##(1992-8#1)(2008-10#1)
is greatly increased in##3##4##(1992-8#1)(1995-8#1)(2008-10#1)
is greatly increased##5##3##(1992-8#1)(1994-2#1)(1995-8#1)(2008-10#2)
is greatly reduced by##2##4##(2008-10#1)(2008-3#1)
is greatly##27##2##(1990-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#1)
is grounded in##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
is grounded on##2##3##(2008-9#2)
is grounded##5##2##(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)
is growing concern##2##3##(1997-3#1)(2008-11#1)
is growing evidence that##7##4##(1991-12#1)(2006-6#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
is growing evidence##10##3##(1991-12#1)(2006-6#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
is growing in##4##3##(2007-12#1)(2008-7#1)(2010-11#1)(2013-1#1)
is growing interest##5##3##(1996-3#1)(1997-7#1)(2010-1#1)(2010-12#1)(2011-3#1)
is growing##40##2##(1991-12#1)(1991-3#1)(1993-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-7#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is grown##4##2##(1992-6#1)(2008-10#3)
is growth##2##2##(2008-11#1)(2008-3#1)
is guaranteed##5##2##(1992-2#1)(1994-3#1)(1996-11#1)(2007-7#1)(2008-2#1)
is guided by##3##3##(1997-7#1)(2007-12#1)(2008-2#1)
is half the##2##3##(2007-11#1)(2009-9#1)
is half##3##2##(2007-11#1)(2008-3#1)(2009-9#1)
is halted##2##2##(1996-3#1)(2008-10#1)
is hampered by the lack of##3##6##(2008-5#1)(2008-9#1)(2013-1#1)
is hampered by the##4##4##(1996-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
is hampered by##8##3##(1990-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
is hampered##9##2##(1990-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
is handled##3##2##(1995-11#1)(1995-3#1)(1996-12#1)
is hard to believe that##2##5##(1996-4#1)(2008-9#1)
is hard to##5##3##(1996-4#1)(2008-12#2)(2008-9#1)(2011-2#1)
is hardly an##2##3##(1994-1#1)(2008-7#1)
is hardly surprising##2##3##(2008-10#1)(2013-8#1)
is hardly##10##2##(1993-11#1)(1994-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#2)(2012-2#1)(2013-8#1)
is harmful##2##2##(2008-10#1)(2009-11#1)
is harvested##2##2##(2008-11#1)(2008-4#1)
is has been##2##3##(2008-7#1)(2011-2#1)
is having on##2##3##(1991-12#1)(2008-12#1)
is having##6##2##(1991-12#1)(1991-3#1)(1993-5#1)(2008-12#1)(2008-7#1)(2010-8#1)
is headed##2##2##(1990-10#1)(2008-11#1)
is health care##2##3##(1997-2#1)(2013-1#1)
is heated##6##2##(1992-6#1)(2008-10#3)(2008-2#2)
is heavily concentrated in##2##4##(1994-3#1)(2012-2#1)
is heavily##8##2##(1994-3#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
is held in##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
is held##5##2##(2008-10#2)(2008-3#1)(2010-11#1)(2012-3#1)
is helpful for##2##3##(2007-8#1)(2012-2#1)
is helpful in##8##3##(1991-2#1)(2007-11#1)(2007-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)
is helpful to##2##3##(2007-11#1)(2011-1#1)
is helpful##13##2##(1991-2#1)(2007-11#2)(2007-8#2)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-2#1)
is here described##2##3##(2008-10#2)
is here##8##2##(1997-3#1)(2008-10#6)(2013-8#1)
is hereby##2##2##(2008-10#1)(2011-2#1)
is herein##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
is heterogeneous and##2##3##(2008-2#1)(2013-8#1)
is heterogeneous##8##2##(1992-11#1)(1993-5#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2013-8#1)
is heterothallic and##2##3##(2008-10#2)
is high and may##2##4##(2006-10#1)(2008-1#1)
is high and##6##3##(2006-10#1)(2007-11#1)(2008-1#1)(2010-8#1)(2012-12#1)(2013-1#1)
is high but##2##3##(1992-5#1)(2008-8#1)
is high enough##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
is high in patients with##2##5##(1994-9#1)(1995-10#1)
is high in the##2##4##(1995-8#1)(2010-8#1)
is high in##9##3##(1993-6#1)(1994-9#1)(1995-10#1)(1995-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#2)
is high or##2##3##(2008-3#1)(2011-1#1)
is high##79##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-7#2)(2008-1#4)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#3)
is higher among##2##3##(1996-6#1)(2008-9#1)
is higher and the##2##4##(1992-9#1)(2008-10#1)
is higher and##4##3##(1992-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
is higher for##2##3##(1995-12#1)(2008-2#1)
is higher in the##4##4##(1992-11#1)(1994-2#1)(2008-10#2)
is higher in##13##3##(1991-6#1)(1992-11#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#2)(2009-11#1)(2012-12#1)
is higher than 0##2##4##(2013-1#1)(2013-8#1)
is higher than in##5##4##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
is higher than other##3##4##(2008-10#1)(2008-12#1)(2010-7#1)
is higher than that of the##3##6##(1997-4#1)(2008-3#2)
is higher than that of##9##5##(1990-8#1)(1997-4#1)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
is higher than that reported##2##5##(2007-7#1)(2008-10#1)
is higher than that##14##4##(1990-8#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#2)(2008-9#2)(2011-2#1)(2013-8#1)
is higher than the##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
is higher than with##2##4##(2008-3#2)
is higher than##43##3##(1990-8#1)(1994-3#1)(1995-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#3)
is higher when the##2##4##(1991-3#1)(2009-5#1)
is higher##81##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
is highest in##4##3##(1990-9#1)(1991-5#1)(1994-3#1)(2012-3#1)
is highest##6##2##(1990-9#1)(1991-5#1)(1994-3#1)(1997-3#1)(2012-1#1)(2012-3#1)
is highlighted as an##2##4##(2008-10#2)
is highlighted by the##3##4##(2008-10#1)(2009-4#1)(2013-1#1)
is highlighted by##6##3##(2008-10#1)(2008-3#1)(2009-4#2)(2010-2#1)(2013-1#1)
is highlighted in##3##3##(2009-9#1)(2010-10#1)(2013-7#1)
is highlighted through##2##3##(1996-5#1)(2008-7#1)
is highlighted##32##2##(1993-12#1)(1994-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#5)(2008-9#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
is highly conserved among##3##4##(1990-8#1)(1994-11#1)(2007-12#1)
is highly conserved and##3##4##(1993-8#1)(2011-2#1)(2013-8#1)
is highly conserved in evolution##2##5##(1991-5#1)(1991-6#1)
is highly conserved in the##2##5##(1994-12#2)
is highly conserved in##6##4##(1991-5#1)(1991-6#1)(1994-12#2)(2007-12#1)(2008-4#1)
is highly conserved##21##3##(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(2007-12#2)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
is highly correlated##3##3##(2008-9#2)(2010-10#1)
is highly dependent on the##6##5##(1992-11#1)(1997-1#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
is highly dependent on##7##4##(1992-11#1)(1997-1#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
is highly desirable##4##3##(2008-11#2)(2008-7#1)(2011-2#1)
is highly effective##4##3##(2008-10#1)(2008-3#1)(2010-4#1)(2013-8#1)
is highly efficient and##2##4##(2008-3#1)(2009-12#1)
is highly efficient##5##3##(2008-2#1)(2008-3#2)(2008-6#1)(2009-12#1)
is highly expressed in the##3##5##(1993-8#1)(1995-8#1)(2008-11#1)
is highly expressed in##11##4##(1991-9#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
is highly expressed##13##3##(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
is highly homologous to the##4##5##(1990-11#1)(1993-6#1)(1994-9#1)(1995-8#1)
is highly homologous to those of##2##6##(1991-6#1)(1997-2#1)
is highly homologous to##10##4##(1990-11#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#1)
is highly immunogenic##2##3##(2008-7#1)(2009-6#1)
is highly increased##2##3##(1993-8#1)(1995-12#1)
is highly influenced by the##4##5##(2008-10#2)(2009-7#1)(2013-1#1)
is highly phosphorylated##2##3##(1995-2#1)(2008-8#1)
is highly polymorphic##2##3##(2008-12#1)(2008-9#1)
is highly prevalent in##8##4##(2008-1#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#2)(2013-1#1)
is highly prevalent##9##3##(2008-1#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#3)(2013-1#1)
is highly recommended to##2##4##(2008-9#1)(2009-2#1)
is highly recommended##6##3##(2008-9#1)(2009-2#1)(2011-2#3)(2013-8#1)
is highly relevant for##2##4##(2008-10#1)(2008-4#1)
is highly relevant##3##3##(2007-5#1)(2008-10#1)(2008-4#1)
is highly reproducible and##2##4##(1996-9#1)(2008-10#1)
is highly reproducible##3##3##(1996-9#1)(2008-10#1)(2009-12#1)
is highly resistant to##3##4##(1992-8#1)(2008-10#2)
is highly selective and##3##4##(2008-10#3)
is highly selective for##3##4##(2008-10#3)
is highly selective to##4##4##(2008-10#4)
is highly selective##12##3##(2008-10#11)(2012-12#1)
is highly sensitive to both##2##5##(1992-4#1)(2009-7#1)
is highly sensitive to the##2##5##(2007-11#1)(2008-3#1)
is highly sensitive to##8##4##(1992-12#1)(1992-4#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-7#1)
is highly sensitive##12##3##(1992-12#1)(1992-4#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
is highly significant##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
is highly specific and##2##4##(1991-9#1)(2012-2#1)
is highly specific##6##3##(1990-12#1)(1991-9#1)(1992-12#1)(1994-8#1)(2008-12#1)(2012-2#1)
is highly stimulated by##2##4##(1993-3#1)(2009-8#1)
is highly susceptible to##3##4##(2008-10#3)
is highly susceptible##4##3##(2008-10#4)
is highly variable##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
is highly##220##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#3)(1992-12#5)(1992-3#2)(1992-4#2)(1992-8#2)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#3)(1994-11#3)(1994-12#5)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-9#1)(2007-11#5)(2007-12#7)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#37)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#9)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#5)
is hindered by##3##3##(1995-6#1)(2008-10#1)(2012-2#1)
is hindered##4##2##(1991-11#1)(1995-6#1)(2008-10#1)(2012-2#1)
is homogenous##2##2##(2008-10#1)(2010-10#1)
is homologous to bacterial##2##4##(1993-11#1)(1997-7#1)
is homologous to mammalian##2##4##(1996-6#1)(2008-11#1)
is homologous to the##2##4##(1996-3#1)(2008-9#1)
is homologous to##11##3##(1990-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-7#1)(2008-11#1)(2008-9#1)
is homologous##13##2##(1990-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
is homothallic##2##2##(2008-10#1)(2010-3#1)
is hoped that the##9##4##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2013-1#2)
is hoped that##23##3##(1991-1#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#3)
is hoped##30##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#2)(2012-2#1)(2013-1#3)
is host##2##2##(2008-10#2)
is how to##7##3##(1991-1#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-11#2)(2008-6#1)
is how##19##2##(1991-1#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-12#1)
is however##10##2##(1990-3#1)(1992-3#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-1#1)(2012-2#1)
is huge##2##2##(2008-3#1)(2008-7#1)
is human##2##2##(1995-2#1)(2011-2#1)
is hybridized##3##2##(2008-10#2)(2008-2#1)
is hydrogen##2##2##(1995-2#1)(2008-10#1)
is hydrolyzed by##2##3##(1995-6#1)(2008-10#1)
is hydrolyzed to##2##3##(1995-5#1)(2008-6#1)
is hydrolyzed##6##2##(1990-8#1)(1992-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-6#1)
is hyperglycemia##2##2##(2007-5#1)(2008-10#1)
is hypothesised that##2##3##(1990-6#1)(2006-6#1)
is hypothesised##4##2##(1990-6#1)(2006-6#1)(2009-4#1)(2011-2#1)
is hypothesized that the##6##4##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)
is hypothesized that this##6##4##(1995-11#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-8#1)(2013-1#1)
is hypothesized that##19##3##(1992-3#1)(1992-8#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
is hypothesized to be##3##4##(1995-3#1)(2008-9#1)(2010-11#1)
is hypothesized to##5##3##(1995-3#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-1#1)
is hypothesized##27##2##(1992-12#1)(1992-3#1)(1992-8#1)(1995-11#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
is ideal for##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)
is ideal##6##2##(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2012-3#1)(2013-8#1)
is ideally suited to##2##4##(1990-9#1)(2008-9#1)
is ideally##6##2##(1990-9#1)(1991-11#1)(2007-12#1)(2008-10#1)(2008-9#2)
is identical to that of##2##5##(1995-6#1)(2008-10#1)
is identical to that##3##4##(1991-11#1)(1995-6#1)(2008-10#1)
is identical to the##7##4##(1992-3#1)(1992-8#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
is identical to those##2##4##(1996-12#1)(2008-10#1)
is identical to##25##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
is identical with##3##3##(1990-7#1)(1993-6#1)(1997-4#1)
is identical##33##2##(1990-5#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2013-1#1)
is identified and##2##3##(2008-10#1)(2008-4#1)
is identified as##5##3##(1991-5#1)(1993-1#1)(1993-11#1)(2007-12#1)(2008-6#1)
is identified by##4##3##(1993-3#1)(2008-5#1)(2010-5#1)(2011-3#1)
is identified in##3##3##(2007-11#1)(2007-12#1)(2012-3#1)
is identified##26##2##(1991-12#1)(1991-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-5#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-3#1)(2012-3#1)
is ill##2##2##(1991-8#1)(2008-3#1)
is illuminated by a##4##4##(1991-2#1)(2008-3#3)
is illuminated by##5##3##(1991-2#1)(2007-12#1)(2008-3#3)
is illuminated with##3##3##(2007-12#1)(2008-3#2)
is illuminated##11##2##(1991-2#1)(2007-12#2)(2008-3#7)(2012-2#1)
is illustrated by a number of practically relevant applications##2##9##(2008-10#2)
is illustrated by a##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
is illustrated by an##3##4##(2007-11#1)(2008-11#1)(2008-3#1)
is illustrated by comparison##2##4##(2008-2#2)
is illustrated by experiment##2##4##(2008-3#2)
is illustrated by the##6##4##(2008-10#4)(2008-3#1)(2012-3#1)
is illustrated by two case studies##2##6##(2008-10#2)
is illustrated by two##3##4##(2008-10#2)(2008-3#1)
is illustrated by##33##3##(1992-2#1)(1997-2#1)(2007-11#2)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#8)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
is illustrated for##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2010-5#1)
is illustrated in a##2##4##(2008-10#1)(2011-1#1)
is illustrated in the##3##4##(2008-2#1)(2010-5#1)(2012-1#1)
is illustrated in##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2010-5#1)(2011-1#1)(2012-1#1)
is illustrated through a##2##4##(1991-1#1)(2009-4#1)
is illustrated through##4##3##(1991-1#1)(2008-7#1)(2009-4#1)(2010-6#1)
is illustrated using##6##3##(1992-9#1)(1994-11#1)(2009-7#1)(2012-1#2)(2013-8#1)
is illustrated with a##2##4##(2007-11#1)(2008-3#1)
is illustrated with data from##2##5##(1990-12#1)(2009-9#1)
is illustrated with##17##3##(1990-12#1)(1994-2#1)(1995-12#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
is illustrated##86##2##(1990-12#1)(1991-1#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-10#21)(2008-11#5)(2008-2#6)(2008-3#15)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-3#3)(2013-1#2)(2013-8#1)
is imaged through##2##3##(2008-2#1)(2008-3#1)
is imaged##5##2##(2008-2#1)(2008-3#4)
is immediately adjacent to the##2##5##(1994-12#1)(1995-6#1)
is immediately followed by##2##4##(2007-12#1)(2013-8#1)
is immediately##6##2##(1994-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
is immense##2##2##(2008-1#1)(2008-11#1)
is immersed in##2##3##(2008-10#2)
is immobile##2##2##(1991-5#1)(2008-10#1)
is immobilised##2##2##(1991-12#1)(2008-10#1)
is immobilized on a##4##4##(2008-10#3)(2008-4#1)
is immobilized on the##3##4##(2008-10#3)
is immobilized on##8##3##(2008-10#7)(2008-4#1)
is immobilized##12##2##(2008-10#9)(2008-4#3)
is immune to##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
is immune##6##2##(1991-8#1)(2008-10#1)(2008-3#2)(2012-2#1)(2013-8#1)
is immunologically##2##2##(1991-2#1)(2013-1#1)
is impacted by##2##3##(2012-12#1)(2012-2#1)
is impaired and##2##3##(2007-10#1)(2013-1#1)
is impaired by##2##3##(1992-1#1)(1993-6#1)
is impaired in##6##3##(1994-11#1)(2008-1#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)
is impaired##20##2##(1991-9#1)(1992-1#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is imperative for##4##3##(2008-4#1)(2009-11#1)(2010-11#1)(2013-8#1)
is imperative that##12##3##(1992-1#1)(1993-12#1)(1995-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-3#1)(2011-1#1)
is imperative to##8##3##(1997-2#1)(2008-3#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
is imperative##29##2##(1992-1#2)(1993-12#1)(1995-3#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
is implemented by use of a##2##6##(2008-2#1)(2008-3#1)
is implemented by##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
is implemented in a##2##4##(2008-10#1)(2008-3#1)
is implemented in the##4##4##(1995-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
is implemented in##9##3##(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2012-3#1)
is implemented on##2##3##(2008-3#1)(2011-1#1)
is implemented to##2##3##(2007-7#1)(2008-3#1)
is implemented##29##2##(1993-2#1)(1995-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#10)(2008-9#2)(2011-1#1)(2012-3#2)
is implicated as##3##3##(1995-3#1)(2008-11#1)(2013-1#1)
is implicated in the pathophysiology##2##5##(2013-1#2)
is implicated in the##6##4##(1995-11#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#2)
is implicated in##13##3##(1995-11#1)(1995-2#2)(1995-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#3)
is implicated##17##2##(1994-12#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#4)
is implied##2##2##(1996-9#1)(2008-8#1)
is important and##2##3##(2010-3#1)(2011-1#1)
is important as the##3##4##(1997-4#1)(2008-10#1)(2008-12#1)
is important because it##4##4##(1993-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
is important because the##5##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-8#1)
is important because this##2##4##(2008-2#1)(2008-7#1)
is important because##15##3##(1993-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)
is important both##2##3##(2008-10#2)
is important for an##2##4##(2008-10#1)(2009-10#1)
is important for clinicians to##2##5##(2011-2#1)(2012-3#1)
is important for control##2##4##(1996-12#1)(2012-2#1)
is important for early diagnosis and##2##6##(1993-6#1)(2011-2#1)
is important for early##3##4##(1993-6#1)(2009-8#1)(2011-2#1)
is important for medical##3##4##(1993-1#1)(2008-10#1)(2013-1#1)
is important for normal##2##4##(2008-9#1)(2009-8#1)
is important for social##2##4##(2008-11#1)(2008-8#1)
is important for the long-term##2##5##(2008-10#1)(2010-2#1)
is important for the##20##4##(1990-2#1)(1991-2#1)(1992-12#1)(1992-6#2)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
is important for their##2##4##(2008-10#1)(2008-9#1)
is important for understanding the##4##5##(1995-2#1)(2008-10#2)(2008-9#1)
is important for##108##3##(1990-2#2)(1991-1#1)(1991-2#3)(1991-3#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
is important from##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
is important in assessing##2##4##(2008-10#1)(2010-12#1)
is important in determining the##2##5##(2007-8#1)(2008-8#1)
is important in order to##2##5##(1996-3#1)(2010-2#1)
is important in predicting##3##4##(2008-12#1)(2009-11#1)(2012-3#1)
is important in the development of##2##6##(1995-3#1)(2010-12#1)
is important in the##12##4##(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2007-10#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-2#1)
is important in their##2##4##(2008-5#1)(2012-3#1)
is important in##42##3##(1992-3#1)(1993-12#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-6#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
is important not to##2##4##(2008-1#1)(2008-8#1)
is important since it can be##2##6##(1992-2#1)(2013-8#1)
is important since##6##3##(1992-2#1)(1993-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is important that the##5##4##(1995-6#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-8#1)
is important that##23##3##(1991-1#1)(1992-1#1)(1992-6#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-8#1)(2013-1#2)(2013-8#1)
is important to a##3##4##(2012-3#1)(2013-1#2)
is important to assess##4##4##(2008-10#1)(2009-11#1)(2011-2#1)(2013-1#1)
is important to avoid##6##4##(1997-5#1)(2007-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
is important to be##5##4##(1991-1#1)(1993-12#1)(1995-2#1)(2008-2#1)(2009-11#1)
is important to consider##5##4##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is important to determine whether##3##5##(2008-4#1)(2008-8#1)(2010-6#1)
is important to determine##6##4##(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-2#1)
is important to develop##3##4##(1992-9#1)(2008-6#1)(2010-8#1)
is important to ensure##3##4##(1993-6#1)(2010-10#1)(2010-3#1)
is important to establish##8##4##(1993-1#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
is important to evaluate##3##4##(2008-1#1)(2008-9#1)(2012-2#1)
is important to examine##3##4##(1992-11#1)(2008-8#1)(2012-2#1)
is important to have##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
is important to help##2##4##(2008-7#1)(2010-10#1)
is important to identify##3##4##(1996-3#1)(2010-11#1)(2012-2#1)
is important to keep##4##4##(2008-1#1)(2009-12#1)(2009-6#1)(2011-1#1)
is important to know##7##4##(1992-4#1)(1993-12#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)
is important to prevent##2##4##(2007-10#1)(2009-3#1)
is important to realize that##4##5##(1991-2#1)(1994-9#1)(2008-10#1)(2011-2#1)
is important to recognise##2##4##(1997-7#1)(2007-7#1)
is important to recognize the##3##5##(2008-6#1)(2011-2#1)(2013-1#1)
is important to remember that##2##5##(1991-11#1)(2013-1#1)
is important to remember##3##4##(1991-11#1)(1995-3#1)(2013-1#1)
is important to the##2##4##(2007-9#1)(2012-2#1)
is important to understand the##6##5##(1994-3#2)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
is important to understand##13##4##(1994-3#2)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is important to##159##3##(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#13)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#10)(2013-8#2)
is important when##2##3##(2008-5#1)(2009-1#1)
is important##408##2##(1990-2#2)(1990-7#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-12#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-5#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#27)(2008-11#9)(2008-12#7)(2008-2#13)(2008-3#13)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#8)(2011-1#7)(2011-2#30)(2012-1#2)(2012-12#4)(2012-2#16)(2012-3#8)(2013-1#24)(2013-7#1)(2013-8#6)
is imported from##2##3##(2007-12#1)(2008-10#1)
is imported##3##2##(1997-3#1)(2007-12#1)(2008-10#1)
is imposed##5##2##(1993-3#1)(1997-5#1)(2007-12#1)(2008-3#2)
is impossible to##11##3##(1990-8#2)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
is impossible##17##2##(1990-11#1)(1990-8#2)(1994-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
is impractical##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
is impregnated with##3##3##(2008-10#3)
is improved by a##2##4##(2007-12#1)(2008-2#1)
is improved by##7##3##(1996-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
is improved considerably##2##3##(2007-12#1)(2008-3#1)
is improved to##2##3##(2008-3#2)
is improved using##2##3##(2008-10#1)(2008-4#1)
is improved##22##2##(1993-5#1)(1996-3#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2009-6#1)(2012-3#1)
is improving##2##2##(2008-1#1)(2011-2#1)
is in a good##2##4##(2007-12#1)(2013-1#1)
is in a##16##3##(1995-2#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-5#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
is in accord with the##2##5##(1991-9#1)(2008-9#1)
is in accord with##4##4##(1991-9#1)(2008-10#1)(2008-2#1)(2008-9#1)
is in accordance with the##5##5##(1996-11#1)(2008-10#1)(2008-5#2)(2011-2#1)
is in accordance with##6##4##(1996-11#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-12#1)
is in agreement with a##2##5##(1990-7#1)(2008-10#1)
is in agreement with experimental##2##5##(2008-2#1)(2008-3#1)
is in agreement with the current##2##6##(1996-5#1)(2007-8#1)
is in agreement with the##8##5##(1991-5#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)
is in agreement with##21##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1993-6#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)
is in an##2##3##(1995-6#1)(2008-12#1)
is in constant##2##3##(2008-9#1)(2011-2#1)
is in contact with##3##4##(1994-5#1)(2008-10#1)(2008-5#1)
is in contrast to the##9##5##(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
is in contrast to##16##4##(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-7#1)
is in contrast with the##3##5##(1992-12#1)(2008-10#2)
is in contrast with##6##4##(1992-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-3#1)
is in contrast##22##3##(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-7#1)
is in direct##2##3##(1990-6#1)(2008-10#1)
is in excellent agreement with##3##5##(1993-11#1)(2008-3#1)(2009-9#1)
is in fact##10##3##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-3#1)(2012-12#1)(2012-3#1)
is in favor of##2##4##(1994-9#1)(2008-8#1)
is in general##2##3##(1993-8#1)(2007-10#1)
is in good agreement with the theoretical prediction##2##8##(2007-11#1)(2008-2#1)
is in good agreement with the##12##6##(1993-9#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2009-12#1)
is in good agreement with theoretical##2##6##(2007-12#1)(2011-1#1)
is in good agreement with##19##5##(1993-9#1)(1995-11#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#4)(2008-8#1)(2009-12#1)(2011-1#1)
is in good agreement##20##4##(1993-9#1)(1995-11#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#4)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
is in good##25##3##(1993-9#1)(1995-11#2)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-1#1)(2013-8#2)
is in great##2##3##(2008-6#2)
is in its infancy##3##4##(1997-7#1)(2008-7#1)(2012-2#1)
is in its##5##3##(1990-2#1)(1997-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
is in large##2##3##(2007-4#1)(2011-2#1)
is in line with##5##4##(1991-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)
is in many##2##3##(2007-12#1)(2007-8#1)
is in most##2##3##(1996-3#1)(1996-9#1)
is in need of##2##4##(2007-2#1)(2009-9#1)
is in nuclear-transferred embryos supported by the transgenic F(4)##2##9##(2008-8#2)
is in part due to##2##5##(2008-10#1)(2008-11#1)
is in part##6##3##(1995-2#1)(1996-6#1)(2006-8#1)(2008-10#2)(2008-11#1)
is in phase II clinical trials##4##6##(2008-5#4)
is in phase II clinical##5##5##(2008-5#5)
is in phase II trials##2##5##(2008-5#2)
is in phase II##7##4##(2008-5#7)
is in phase III##2##4##(2008-5#2)
is in phase##10##3##(2008-5#10)
is in progress##6##3##(1990-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
is in proportion to the concentration of proteins##2##8##(2008-10#2)
is in proportion to the concentration of##4##7##(2008-10#4)
is in strong contrast with##2##5##(1992-3#1)(2007-11#1)
is in the midst of##2##5##(1996-12#1)(2007-7#1)
is in the order of##3##5##(1994-6#1)(2008-10#1)(2013-1#1)
is in the process of##2##5##(1996-1#1)(2008-7#1)
is in the range 1##2##5##(2008-10#2)
is in the range of##4##5##(1996-5#1)(2008-10#1)(2008-2#2)
is in the range##16##4##(1992-3#1)(1993-9#1)(1996-5#1)(2008-10#9)(2008-2#2)(2008-3#1)(2011-1#1)
is in the##69##3##(1990-11#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-9#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-5#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is in these##2##3##(1992-11#1)(2012-12#1)
is in this##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
is in your##2##3##(1995-12#1)(2008-8#1)
is in##320##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#54)(2008-11#5)(2008-12#5)(2008-2#16)(2008-3#16)(2008-4#2)(2008-5#23)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
is inactivated by##3##3##(1992-12#1)(1993-6#1)(2008-4#1)
is inactivated##8##2##(1990-12#1)(1992-12#3)(1993-6#1)(1997-3#1)(2008-4#2)
is inactive##2##2##(1992-11#1)(1992-3#1)
is inadequate and that##2##4##(2011-2#1)(2012-2#1)
is inadequate and##5##3##(1994-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
is inadequate for##4##3##(2007-7#1)(2007-8#1)(2008-3#2)
is inadequate to##2##3##(1997-2#1)(2011-2#1)
is inadequate##14##2##(1993-12#1)(1994-12#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
is inappropriate to##2##3##(2007-11#1)(2008-5#1)
is inappropriate##6##2##(1992-6#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
is incapable of##5##3##(1993-12#1)(1995-6#1)(1997-6#1)(2008-4#1)(2008-6#1)
is incident on##3##3##(2008-3#3)
is incident upon##4##3##(2007-12#2)(2008-3#2)
is incident##9##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
is included at the##2##4##(2008-3#1)(2008-4#1)
is included for##5##3##(2008-4#4)(2008-9#1)
is included in the##6##4##(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2011-2#1)
is included in##12##3##(1997-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
is included to##2##3##(2008-4#2)
is included##43##2##(1992-12#1)(1993-3#1)(1995-1#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#12)(2008-5#3)(2008-7#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
is incompatible with##3##3##(1991-11#1)(2013-1#2)
is incomplete##6##2##(1993-6#1)(2008-3#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
is incompletely##2##2##(2008-6#1)(2008-7#1)
is inconclusive##3##2##(2008-6#2)(2010-6#1)
is inconsistent with the##2##4##(2008-12#1)(2013-1#1)
is inconsistent with##4##3##(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
is inconsistent##6##2##(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#3)
is inconvenient##2##2##(1991-3#1)(2008-10#1)
is incorporated in##2##3##(1992-6#1)(2010-3#1)
is incorporated into the##4##4##(2007-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
is incorporated into##6##3##(2007-11#1)(2008-3#1)(2008-4#2)(2010-6#1)(2013-8#1)
is incorporated with##2##3##(2008-11#1)(2008-3#1)
is incorporated##15##2##(1992-6#1)(1993-6#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2013-8#1)
is increased and##2##3##(1991-4#1)(2008-10#1)
is increased as##2##3##(1993-12#1)(2008-3#1)
is increased by the##4##4##(1990-3#1)(1990-7#1)(2008-2#1)(2008-5#1)
is increased by##15##3##(1990-11#1)(1990-3#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
is increased during##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
is increased in patients with##2##5##(1995-12#1)(2008-7#1)
is increased in subjects with##2##5##(2008-1#1)(2008-7#1)
is increased in the##4##4##(1992-3#1)(1992-9#1)(1997-2#1)(2008-5#1)
is increased in##18##3##(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-12#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-12#1)
is increased or decreased##2##4##(2010-8#1)(2012-3#1)
is increased significantly##2##3##(1990-12#1)(2008-5#1)
is increased through##2##3##(1995-12#1)(2008-10#1)
is increased to##3##3##(1992-6#1)(2007-11#1)(2008-2#1)
is increased##96##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#3)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-2#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
is increasing and##6##3##(1995-12#1)(1996-7#1)(2007-2#1)(2010-3#1)(2011-1#1)(2012-2#1)
is increasing evidence that a##2##5##(1992-9#1)(2008-7#1)
is increasing evidence that##12##4##(1992-9#1)(1995-12#1)(1996-7#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)
is increasing evidence to suggest that##2##6##(2008-7#1)(2008-8#1)
is increasing evidence##15##3##(1992-9#1)(1995-12#1)(1996-7#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#1)
is increasing in##9##3##(1997-3#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is increasing interest in developing##2##5##(2008-4#1)(2010-10#1)
is increasing interest in the##2##5##(2008-11#1)(2010-7#1)
is increasing interest in##4##4##(2008-11#1)(2008-4#1)(2010-10#1)(2010-7#1)
is increasing pressure##2##3##(1993-12#1)(2008-5#1)
is increasing rapidly##4##3##(1992-11#1)(1997-7#1)(2008-10#1)(2011-1#1)
is increasing worldwide##2##3##(2010-10#1)(2010-12#1)
is increasing##102##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#2)(2007-7#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2011-4#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
is increasingly becoming an##2##4##(2008-10#1)(2008-11#1)
is increasingly being used to##2##5##(2008-1#1)(2008-11#1)
is increasingly being used##4##4##(1991-11#1)(2008-1#1)(2008-11#1)(2013-8#1)
is increasingly being##12##3##(1991-11#1)(1991-8#1)(1997-1#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-6#1)(2012-1#1)(2013-8#3)
is increasingly important for##2##4##(1994-2#1)(2007-12#1)
is increasingly recognized##2##3##(2008-7#1)(2012-3#1)
is increasingly reported##2##3##(2007-12#1)(2012-1#1)
is increasingly used as a##2##5##(1992-3#1)(2008-7#1)
is increasingly used for##2##4##(2008-3#1)(2008-9#1)
is increasingly used##5##3##(1992-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
is increasingly##42##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-6#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#4)
is incubated with yeast##2##4##(1993-11#2)
is incubated with##4##3##(1993-11#2)(2008-10#1)(2008-7#1)
is incubated##5##2##(1993-11#2)(2008-10#1)(2008-11#1)(2008-7#1)
is indeed a##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
is indeed##17##2##(1991-9#1)(1994-3#1)(1994-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-8#3)(2008-9#1)(2010-11#1)(2010-6#1)
is independent of PKC##2##4##(1991-2#1)(1993-6#1)
is independent of a##2##4##(1995-6#1)(2010-8#1)
is independent of extracellular Na+##2##5##(1990-7#1)(1993-8#1)
is independent of pH in the range of##2##8##(2008-10#2)
is independent of pH##3##4##(2008-10#3)
is independent of protein kinase C##2##6##(1991-2#1)(1993-3#1)
is independent of protein##3##4##(1991-2#1)(1993-3#1)(1993-6#1)
is independent of the orientation of the##2##7##(2007-11#1)(2008-3#1)
is independent of the##31##4##(1992-8#1)(1995-11#1)(1996-6#1)(1997-2#1)(2007-11#6)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-8#2)(2009-10#1)(2012-3#1)
is independent of##72##3##(1990-6#1)(1990-7#1)(1991-2#3)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#2)(2007-11#6)(2007-12#3)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#4)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is independent##74##2##(1990-6#1)(1990-7#1)(1991-2#3)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#2)(2007-11#6)(2007-12#3)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#4)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
is independently associated with a##2##5##(2008-8#1)(2013-1#1)
is independently associated with##3##4##(2008-8#1)(2013-1#2)
is independently##4##2##(1993-8#1)(2008-8#1)(2013-1#2)
is indexed in##2##3##(2011-4#1)(2013-8#1)
is indexed##3##2##(2008-11#1)(2011-4#1)(2013-8#1)
is indicated as##2##3##(2008-2#1)(2008-4#1)
is indicated by##5##3##(1993-3#1)(1993-8#1)(1994-9#1)(2008-9#1)(2011-2#1)
is indicated for the control of##2##6##(2007-12#1)(2011-2#1)
is indicated for the##3##4##(2007-12#1)(2008-7#1)(2011-2#1)
is indicated for##9##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#4)
is indicated from the##2##4##(1990-2#1)(2008-10#1)
is indicated in patients with##2##5##(2008-10#1)(2008-3#1)
is indicated in##10##3##(1990-6#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-12#1)(2012-2#1)
is indicated only##4##3##(1991-11#1)(1992-9#1)(2011-2#1)(2013-1#1)
is indicated that##5##3##(2008-10#1)(2008-2#1)(2012-3#2)(2013-8#1)
is indicated to##2##3##(1991-11#1)(2008-10#1)
is indicated##53##2##(1990-2#1)(1990-6#1)(1991-11#3)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-3#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
is indicative of a##3##4##(1991-3#1)(1993-11#1)(2008-11#1)
is indicative of an underlying##2##5##(2008-4#1)(2009-9#1)
is indicative of##9##3##(1991-3#1)(1993-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-9#1)(2013-8#1)
is indirect##2##2##(1992-9#1)(2006-10#1)
is indispensable for the##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
is indispensable for##7##3##(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#2)
is indispensable to##4##3##(1991-5#1)(2008-4#1)(2008-5#1)(2012-8#1)
is indispensable##13##2##(1990-3#1)(1991-5#1)(1996-2#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2012-8#1)
is indistinguishable from##4##3##(1993-11#1)(1993-12#1)(2008-7#1)(2008-8#1)
is induced and##2##3##(1997-7#1)(2008-1#1)
is induced by an##2##4##(2008-3#1)(2010-4#1)
is induced by the##3##4##(2007-12#1)(2008-7#1)(2008-8#1)
is induced by##32##3##(1990-11#4)(1990-5#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-12#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
is induced in##8##3##(1990-12#1)(1994-11#1)(1994-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2011-10#1)
is induced##52##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-8#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
is inducible##2##2##(1995-12#1)(1995-2#1)
is ineffective in##3##3##(1992-9#1)(2008-4#1)(2008-6#1)
is ineffective##7##2##(1991-12#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-2#1)(2008-4#1)(2008-6#1)
is inevitable that##2##3##(2008-5#1)(2009-2#1)
is inevitable##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)
is inexpensive##4##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
is inextricably linked##2##3##(1996-3#1)(2008-10#1)
is infectious##2##2##(2008-10#1)(2008-9#1)
is inferior##2##2##(1992-2#1)(2008-1#1)
is inferred from the##2##4##(2008-2#2)
is inferred from##3##3##(2008-2#2)(2008-3#1)
is inferred that##2##3##(1990-9#1)(1991-6#1)
is inferred to be##2##4##(1992-3#1)(2007-12#1)
is inferred##7##2##(1990-9#1)(1991-6#1)(1992-3#1)(2007-12#1)(2008-2#2)(2008-3#1)
is inflammation##2##2##(2008-3#1)(2008-5#1)
is influenced by a number of##2##6##(1997-2#1)(2008-7#1)
is influenced by a##3##4##(1997-2#1)(2008-3#1)(2008-7#1)
is influenced by the##19##4##(1990-11#1)(1993-12#1)(1994-6#2)(1996-6#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-12#1)
is influenced by##46##3##(1990-11#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-6#2)(1996-6#1)(1997-2#2)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#2)(2009-8#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#1)
is influenced not only by the##2##6##(2008-2#1)(2008-3#1)
is influenced##51##2##(1990-11#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-6#2)(1996-6#1)(1997-2#2)(1997-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#2)(2009-8#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#1)
is information##2##2##(2007-10#1)(2010-12#1)
is infrequent##3##2##(1996-3#1)(1997-8#1)(2008-10#1)
is infrequently##4##2##(2007-8#1)(2010-1#1)(2011-2#2)
is ingested##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
is inherent in##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-3#1)
is inherently complex##2##3##(2010-4#1)(2012-1#1)
is inherently##13##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-4#1)(2010-7#1)(2012-1#1)
is inherited and##2##3##(1997-3#1)(2012-12#1)
is inherited from P##2##4##(2008-10#2)
is inherited##5##2##(1997-3#2)(2008-10#2)(2012-12#1)
is inhibited by the##4##4##(1990-7#1)(1995-2#1)(2008-3#1)(2012-2#1)
is inhibited by vanadate##2##4##(1994-12#2)
is inhibited by##40##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
is inhibited in##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
is inhibited or##2##3##(2008-11#1)(2008-7#1)
is inhibited##54##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1997-1#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is inhomogeneous##2##2##(2007-11#1)(2009-7#1)
is initially##12##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-5#1)(2012-2#1)
is initiated and##2##3##(2008-7#1)(2011-2#1)
is initiated at the##3##4##(1991-3#1)(2008-3#1)(2008-6#1)
is initiated at##5##3##(1990-5#2)(1991-3#1)(2008-3#1)(2008-6#1)
is initiated before##2##3##(2008-10#1)(2008-7#1)
is initiated by the##2##4##(1990-2#1)(2007-12#1)
is initiated by##10##3##(1990-2#1)(1995-2#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-7#2)(2013-1#1)
is initiated##32##2##(1990-2#1)(1990-5#2)(1991-3#1)(1994-1#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#2)(2010-3#1)(2011-2#3)(2013-1#1)
is injected into a carrier stream of##2##7##(2008-10#2)
is injected into a carrier##3##5##(2008-10#3)
is injected into a##7##4##(2008-10#6)(2008-2#1)
is injected into the##6##4##(2007-12#1)(2008-10#5)
is injected into##14##3##(2007-12#1)(2008-10#12)(2008-2#1)
is injected##17##2##(1997-1#1)(2007-12#1)(2008-10#14)(2008-2#1)
is injection seeded##2##3##(2008-2#1)(2008-3#1)
is innervated by a##2##4##(2007-12#2)
is innervated by the##2##4##(2007-12#1)(2011-2#1)
is innervated by##4##3##(2007-12#3)(2011-2#1)
is input##2##2##(1992-3#1)(2008-2#1)
is insensitive to the##6##4##(1995-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-8#1)
is insensitive to##18##3##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#4)(2008-8#2)(2009-8#1)
is insensitive##19##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#4)(2008-8#2)(2009-8#1)(2013-8#1)
is inserted in##2##3##(1997-8#1)(2008-10#1)
is inserted into the##6##4##(1995-2#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)
is inserted into##9##3##(1995-2#1)(2008-2#1)(2008-3#3)(2008-8#2)(2010-11#1)(2010-8#1)
is inserted##20##2##(1991-12#2)(1993-2#1)(1995-2#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-8#2)(2010-11#1)(2010-8#1)(2013-1#1)
is insignificant##2##2##(2008-10#2)
is inspired by##2##3##(2008-3#1)(2008-7#1)
is instead##2##2##(2008-10#1)(2012-12#1)
is instructive##2##2##(1997-6#1)(2013-7#1)
is instrumental in##3##3##(2009-8#1)(2012-3#1)(2013-7#1)
is instrumental to##2##3##(1997-3#1)(2009-8#1)
is instrumental##5##2##(1997-3#1)(2009-8#2)(2012-3#1)(2013-7#1)
is insufficient to predict##2##4##(1995-5#1)(2008-3#1)
is insufficient to##5##3##(1995-5#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
is insufficient##14##2##(1995-12#1)(1995-5#1)(1995-6#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
is intact##3##2##(1994-3#1)(1995-2#1)(2011-2#1)
is integral to##3##3##(1997-3#1)(2009-5#1)(2013-1#1)
is integral##4##2##(1997-3#1)(2008-10#1)(2009-5#1)(2013-1#1)
is integrally linked##2##3##(2008-1#1)(2008-12#1)
is integrated##3##2##(2007-12#1)(2008-3#2)
is intended as a##2##4##(1991-2#1)(1997-3#1)
is intended as an##2##4##(1992-12#1)(1994-6#1)
is intended as##4##3##(1991-2#1)(1992-12#1)(1994-6#1)(1997-3#1)
is intended for##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
is intended to be##2##4##(2008-4#1)(2011-1#1)
is intended to facilitate##2##4##(2008-3#1)(2008-7#1)
is intended to provide##2##4##(2008-2#1)(2010-8#1)
is intended to##20##3##(1990-12#1)(1991-5#1)(1995-5#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2009-4#1)(2010-8#3)(2011-1#1)(2013-1#2)(2013-7#1)
is intended##30##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-7#2)(2009-4#1)(2010-8#3)(2011-1#1)(2013-1#2)(2013-7#1)
is intensely expressed in the##2##5##(1997-2#1)(1997-4#1)
is intensely##3##2##(1997-2#1)(1997-4#1)(2010-12#1)
is intercalated##2##2##(1994-5#1)(2008-10#1)
is intercepted by the adjacent keto group to produce an##2##10##(1996-5#2)
is interesting##9##2##(1992-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)
is intermediate between##2##3##(2008-10#2)
is intermediate##4##2##(1990-6#1)(2008-10#3)
is interpreted as evidence for##2##5##(1994-5#1)(1996-2#1)
is interpreted as##6##3##(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-11#1)
is interpreted##9##2##(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-10#1)
is interrogated by##2##3##(2008-3#2)
is interrupted by three##2##4##(1993-6#1)(1997-6#1)
is interrupted by two introns of##2##6##(1991-9#1)(1993-6#1)
is interrupted by##6##3##(1990-12#1)(1991-7#1)(1991-9#1)(1993-6#2)(1997-6#1)
is interrupted##7##2##(1990-12#1)(1991-7#1)(1991-9#1)(1993-6#2)(1997-6#1)(2008-10#1)
is intimately related to##2##4##(2008-11#1)(2012-12#1)
is intimately##6##2##(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#2)
is intriguing##3##2##(1996-2#1)(2008-2#1)(2008-8#1)
is intrinsic to the##2##4##(2007-11#1)(2007-12#1)
is intrinsically##8##2##(1994-8#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-6#1)(2011-1#1)
is introduced and##6##3##(1994-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-7#1)
is introduced as an##2##4##(2008-2#1)(2008-3#1)
is introduced as##4##3##(2008-2#1)(2008-3#3)
is introduced at the##2##4##(2010-6#1)(2011-2#1)
is introduced based on the##2##5##(2008-10#1)(2008-3#1)
is introduced by##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
is introduced for##9##3##(1994-8#1)(1996-4#1)(2007-11#1)(2008-2#2)(2008-3#3)(2008-7#1)
is introduced here##3##3##(1993-8#1)(2008-3#2)
is introduced in this paper##2##5##(2008-10#2)
is introduced in this##3##4##(2008-10#3)
is introduced in##5##3##(2008-10#4)(2009-8#1)
is introduced into a##2##4##(2008-10#1)(2008-2#1)
is introduced into the##7##4##(1993-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
is introduced into##11##3##(1993-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#1)
is introduced that##4##3##(2007-11#1)(2008-3#3)
is introduced through the##2##4##(2008-10#2)
is introduced to describe##2##4##(2007-11#1)(2008-2#1)
is introduced to##8##3##(1992-1#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#2)(2010-11#1)
is introduced via##2##3##(1995-2#1)(2008-4#1)
is introduced with##2##3##(2007-11#1)(2010-6#1)
is introduced##114##2##(1990-8#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-8#1)(2007-11#12)(2007-12#6)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#11)(2008-3#29)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is intuitive##2##2##(1994-11#1)(1997-1#1)
is invaluable##3##2##(1995-12#1)(2007-4#1)(2011-2#1)
is invariant under##3##3##(1996-3#1)(2008-3#1)(2008-6#1)
is invariant##5##2##(1996-3#1)(2008-3#3)(2008-6#1)
is invasive##2##2##(2007-7#1)(2008-12#1)
is inversely proportional to the##3##5##(2008-2#1)(2008-3#1)(2012-3#1)
is inversely proportional to##5##4##(1997-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
is inversely related to the##4##5##(1991-12#1)(2008-10#1)(2008-9#2)
is inversely related to##6##4##(1991-12#1)(1994-6#1)(2008-10#1)(2008-9#2)(2009-8#1)
is inversely##13##2##(1991-12#1)(1991-3#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-8#1)(2012-3#1)
is inverted##2##2##(2008-10#1)(2008-2#1)
is investigated and compared##2##4##(2008-3#1)(2008-6#1)
is investigated and##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)
is investigated as a function of##3##6##(2008-3#3)
is investigated as a##4##4##(2008-3#4)
is investigated both experimentally and##2##5##(2007-12#1)(2008-3#1)
is investigated both theoretically and experimentally##2##6##(2008-10#1)(2008-2#1)
is investigated both##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is investigated by use of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
is investigated by##12##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#4)(2009-7#1)
is investigated experimentally in##2##4##(2007-12#1)(2008-2#1)
is investigated experimentally##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
is investigated for a##2##4##(2008-10#1)(2008-3#1)
is investigated for the##2##4##(2008-2#1)(2008-3#1)
is investigated for##7##3##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)
is investigated in a##2##4##(1994-11#1)(2011-1#1)
is investigated in##8##3##(1994-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)
is investigated numerically##2##3##(2008-3#2)
is investigated over the##2##4##(2007-11#1)(2008-2#1)
is investigated theoretically##4##3##(2008-2#1)(2008-3#3)
is investigated to##3##3##(1996-4#1)(2008-10#1)(2008-3#1)
is investigated with##3##3##(2008-10#1)(2008-2#2)
is investigated##111##2##(1994-11#1)(1994-6#1)(1995-12#2)(1996-4#2)(1996-5#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#26)(2008-3#32)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)
is invisible##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
is involved and the##2##4##(2008-10#1)(2011-1#1)
is involved and##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
is involved in a variety of##2##6##(1997-1#1)(2008-5#1)
is involved in a##8##4##(1991-9#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)
is involved in cell##2##4##(1994-9#1)(2009-7#1)
is involved in male##2##4##(1995-12#1)(2008-9#1)
is involved in many##6##4##(1991-9#1)(2008-10#2)(2010-11#1)(2011-2#1)(2013-8#1)
is involved in numerous##2##4##(1995-2#1)(2008-5#1)
is involved in the activation of##2##6##(1992-6#1)(1994-2#1)
is involved in the early##2##5##(2010-1#1)(2010-12#1)
is involved in the maintenance of##3##6##(1995-12#1)(2008-4#1)(2009-11#1)
is involved in the regulation of##10##6##(1990-12#1)(1992-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
is involved in the##67##4##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#2)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#2)
is involved in their##2##4##(2007-10#1)(2008-11#1)
is involved in these##2##4##(1991-2#1)(2008-11#1)
is involved in this process##4##5##(1994-11#1)(1995-12#1)(1996-5#1)(2008-4#1)
is involved in this##6##4##(1991-3#1)(1993-12#1)(1994-11#1)(1995-12#1)(1996-5#1)(2008-4#1)
is involved in##160##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(2007-10#1)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#1)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#6)(2009-10#3)(2009-11#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#5)
is involved with##2##3##(2009-3#1)(2013-1#1)
is involved##182##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#14)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#6)(2009-10#3)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
is irrelevant to##2##3##(2008-11#1)(2010-12#1)
is irrelevant##3##2##(2008-11#1)(2008-4#1)(2010-12#1)
is irreversible and##3##3##(1991-9#1)(2008-10#2)
is irreversible##5##2##(1991-9#1)(1997-2#1)(2008-10#2)(2008-8#1)
is is##2##2##(2007-8#1)(2013-1#1)
is isolated from##3##3##(2008-2#1)(2008-8#2)
is isolated##7##2##(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#2)
is it a##6##3##(1991-3#1)(1994-1#1)(2008-10#1)(2008-3#1)(2008-7#2)
is it anyway?##2##3##(1996-1#1)(2007-11#1)
is it like##2##3##(2008-8#1)(2008-9#1)
is it##48##2##(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)
is it?##4##2##(1991-1#1)(1993-9#1)(2008-1#1)(2008-2#1)
is its ability to##4##4##(2008-10#1)(2008-2#3)
is its high##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
is its lack of##2##4##(1996-3#1)(2008-8#1)
is its low sensitivity##2##4##(2008-3#1)(2010-5#1)
is its sensitivity##2##3##(2008-10#1)(2008-4#1)
is its##39##2##(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
is itself##7##2##(1996-3#1)(1997-8#1)(2008-10#1)(2009-1#1)(2011-2#1)(2013-1#2)
is judged##2##2##(2010-7#1)(2012-2#1)
is just##8##2##(1994-2#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-8#1)
is justified in##2##3##(2012-3#1)(2013-1#1)
is justified##10##2##(1990-8#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
is kept constant##2##3##(2008-2#2)
is kept in##2##3##(1992-4#1)(2008-10#1)
is kept within##2##3##(2008-3#1)(2008-8#1)
is kept##14##2##(1992-4#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2013-8#1)
is key in the development of##2##6##(2008-10#1)(2011-1#1)
is key in##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
is key to the##2##4##(2008-10#1)(2008-7#1)
is key to##7##3##(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-11#1)(2013-8#1)
is key##12##2##(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
is known about how to##2##5##(1997-1#1)(2010-11#1)
is known about how##9##4##(1997-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
is known about its##5##4##(1994-6#1)(2008-5#1)(2008-7#1)(2013-8#2)
is known about the diversity##2##5##(2008-10#1)(2009-8#1)
is known about the early##2##5##(2008-8#1)(2012-2#1)
is known about the effect of##2##6##(2008-12#1)(2012-2#1)
is known about the effects of##3##6##(2008-10#1)(2008-8#1)(2013-7#1)
is known about the mechanism##3##5##(1991-12#1)(2008-7#1)(2008-8#1)
is known about the mechanisms##2##5##(2008-11#1)(2013-1#1)
is known about the molecular##2##5##(1991-2#1)(2012-2#1)
is known about the relationship##2##5##(2008-10#1)(2008-4#1)
is known about the role of##2##6##(2010-4#1)(2010-9#1)
is known about the##82##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-5#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
is known about their##7##4##(1992-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
is known about##131##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#7)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#6)
is known and##2##3##(2008-3#1)(2010-8#1)
is known as a potent##2##5##(2008-5#1)(2009-12#1)
is known as a##6##4##(1992-3#1)(2007-8#1)(2008-5#2)(2009-12#1)(2010-7#1)
is known as the##4##4##(2008-2#2)(2008-4#1)(2013-7#1)
is known as##16##3##(1991-12#1)(1992-3#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-7#1)(2010-8#1)(2013-7#1)
is known for its##4##4##(2008-10#2)(2009-9#1)(2011-2#1)
is known for##10##3##(1991-12#1)(1997-7#1)(2008-10#2)(2008-2#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)
is known from##2##3##(2008-2#1)(2010-3#1)
is known in the##4##4##(1996-11#2)(2008-12#1)(2009-3#1)
is known in##9##3##(1992-2#1)(1995-1#1)(1996-11#2)(2008-12#2)(2008-5#1)(2009-3#1)(2010-12#1)
is known of the role##2##5##(1996-6#1)(2008-4#1)
is known of the##5##4##(1996-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
is known of##11##3##(1992-10#1)(1993-1#1)(1993-6#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
is known on##3##3##(2007-8#1)(2008-8#1)(2013-1#1)
is known or##2##3##(2008-2#1)(2009-5#1)
is known since##2##3##(2008-10#1)(2008-5#1)
is known that the##4##4##(1990-6#1)(2008-2#1)(2008-7#1)(2012-1#1)
is known that##18##3##(1990-6#1)(1991-3#1)(1991-9#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#2)(2012-1#2)(2012-12#1)
is known to affect the##3##5##(2007-7#1)(2008-10#1)(2012-3#1)
is known to affect##6##4##(1991-5#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
is known to alter##2##4##(1992-12#1)(2008-7#1)
is known to be a key##2##6##(2008-11#1)(2010-8#1)
is known to be a##11##5##(1994-11#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
is known to be associated with##3##6##(2007-8#1)(2008-11#1)(2011-2#1)
is known to be influenced by##2##6##(2008-10#1)(2008-7#1)
is known to be involved in the##2##7##(2008-4#1)(2009-8#1)
is known to be involved in##4##6##(2008-4#2)(2009-8#1)(2010-11#1)
is known to be responsible for the##2##7##(2008-3#1)(2011-1#1)
is known to be responsible for##3##6##(1997-8#1)(2008-3#1)(2011-1#1)
is known to be##44##4##(1990-8#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
is known to bind##3##4##(1991-12#1)(1992-8#1)(2013-1#1)
is known to cause##5##4##(1993-8#1)(2007-12#1)(2007-8#1)(2009-6#1)(2012-2#1)
is known to contain##2##4##(1992-3#1)(1993-6#1)
is known to depend on##2##5##(2008-10#1)(2008-8#1)
is known to enhance##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
is known to exert its##2##5##(2012-2#2)
is known to form##2##4##(2008-10#1)(2010-11#1)
is known to have##8##4##(1994-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
is known to increase##2##4##(2008-1#1)(2012-12#1)
is known to induce an##2##5##(1990-2#1)(2008-5#1)
is known to induce##8##4##(1990-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-5#2)
is known to influence##2##4##(2007-7#1)(2008-9#1)
is known to occur in a##2##6##(1997-7#1)(2009-8#1)
is known to occur in##3##5##(1997-7#1)(2008-6#1)(2009-8#1)
is known to occur with##2##5##(2007-7#1)(2008-5#1)
is known to occur##8##4##(1997-7#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2009-8#1)(2013-1#1)
is known to play a role in##2##7##(1996-2#1)(2012-2#1)
is known to play a##4##5##(1993-8#1)(1996-2#1)(2008-11#1)(2012-2#1)
is known to play an important role in##2##8##(1996-12#1)(2011-2#1)
is known to play##6##4##(1993-8#1)(1996-12#1)(1996-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
is known to produce##4##4##(1991-12#1)(1995-12#1)(2008-10#1)(2009-2#1)
is known to reduce##3##4##(2008-5#1)(2011-2#1)(2012-1#1)
is known to regulate##3##4##(2008-8#1)(2009-5#1)(2010-11#1)
is known to##148##3##(1990-2#1)(1990-8#1)(1991-12#4)(1991-3#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#4)(1996-5#2)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#4)
is known##389##2##(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#8)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#4)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-10#2)(2007-12#6)(2007-2#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#36)(2008-11#17)(2008-12#8)(2008-2#16)(2008-3#8)(2008-4#9)(2008-5#17)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#5)(2009-9#2)(2010-1#2)(2010-11#5)(2010-12#5)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#6)(2011-2#12)(2011-3#1)(2012-1#7)(2012-12#9)(2012-2#17)(2012-3#5)(2013-1#12)(2013-7#4)(2013-8#6)
is known)##3##2##(2008-3#3)
is labeled upon modification of##3##5##(1995-6#3)
is labeled##6##2##(1992-5#1)(1995-2#1)(1995-6#3)(2008-4#1)
is laborious and##2##3##(2008-10#1)(2008-11#1)
is lack of##4##3##(2008-3#1)(2008-5#1)(2010-12#1)(2011-10#1)
is lacking in many centers##2##5##(2007-7#1)(2008-1#1)
is lacking in##4##3##(1995-11#1)(2007-7#1)(2008-1#1)(2008-8#1)
is lacking##25##2##(1993-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#2)(2010-9#1)(2012-12#1)(2012-2#2)
is laid on the importance of##3##6##(1990-3#2)(2007-7#1)
is laid on the##7##4##(1990-3#2)(2007-7#1)(2008-2#2)(2008-3#1)(2010-5#1)
is laid on##8##3##(1990-3#3)(2007-7#1)(2008-2#2)(2008-3#1)(2010-5#1)
is laid##9##2##(1990-3#3)(2007-7#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#1)
is large and##2##3##(1994-9#1)(2008-5#1)
is large enough##2##3##(2008-3#1)(2011-2#1)
is large relative to the##2##5##(2008-8#1)(2011-2#1)
is large##19##2##(1991-3#1)(1993-11#1)(1994-2#1)(1994-9#1)(2007-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#2)(2012-1#1)(2013-8#1)
is largely a##3##3##(1997-3#1)(2007-7#1)(2009-5#1)
is largely composed of##2##4##(2010-5#1)(2011-2#1)
is largely dependent on##2##4##(2008-10#1)(2011-2#1)
is largely due to the##3##5##(1994-12#1)(2012-2#1)(2013-7#1)
is largely not##2##3##(1997-3#1)(2012-3#1)
is largely responsible for##3##4##(1996-3#1)(2009-11#1)(2012-2#1)
is largely unknown##6##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2013-8#2)
is largely##63##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
is larger by##2##3##(2008-2#1)(2008-3#1)
is larger for nonspherical##2##4##(2008-2#2)
is larger for##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
is larger in##2##3##(2008-8#1)(2012-3#1)
is larger than that of##2##5##(2008-3#1)(2008-7#1)
is larger than the##3##4##(2008-10#1)(2008-3#2)
is larger than##13##3##(1991-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
is larger##23##2##(1991-8#1)(2007-11#2)(2008-10#4)(2008-2#4)(2008-3#4)(2008-7#1)(2008-8#3)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
is largest##2##2##(1992-3#1)(2008-11#1)
is lasting##2##2##(2008-5#1)(2011-2#1)
is late##2##2##(2009-7#1)(2013-8#1)
is later##6##2##(1995-6#1)(1995-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
is launched by##2##3##(2007-11#1)(2013-8#1)
is launched##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
is layered##2##2##(2008-4#1)(2008-9#1)
is leading to the##3##4##(1994-8#1)(2008-11#1)(2013-8#1)
is leading to##6##3##(1993-6#1)(1994-8#1)(2008-11#1)(2008-6#1)(2012-12#1)(2013-8#1)
is leading##7##2##(1993-6#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-6#1)(2012-12#1)(2013-8#1)
is least##2##2##(2008-3#1)(2008-7#1)
is led into##2##3##(2008-10#2)
is left untreated##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
is left##6##2##(2008-3#1)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
is legal##5##2##(1994-7#1)(2008-11#1)(2010-12#1)(2013-1#2)
is less affected by##2##4##(2008-10#1)(2008-11#1)
is less clear##8##3##(1991-12#1)(1997-8#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
is less common in##3##4##(2008-1#1)(2008-9#1)(2010-6#1)
is less common##5##3##(2007-8#1)(2008-1#1)(2008-9#1)(2010-6#1)(2013-1#1)
is less complex##2##3##(1995-3#1)(2010-5#1)
is less important##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
is less invasive and##2##4##(2008-7#2)
is less invasive##3##3##(2008-7#2)(2011-2#1)
is less likely to##3##4##(2008-8#2)(2011-2#1)
is less likely##4##3##(2008-1#1)(2008-8#2)(2011-2#1)
is less risky##2##3##(1990-2#1)(2013-1#1)
is less sensitive for##2##4##(2008-3#1)(2011-2#1)
is less sensitive to##7##4##(2007-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)
is less sensitive##10##3##(2007-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)
is less than 0##9##4##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-7#1)(2013-8#1)
is less than 1##9##4##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
is less than 1%##2##4##(1996-5#1)(2008-3#1)
is less than 2##2##4##(2008-10#1)(2008-2#1)
is less than 2%##2##4##(2007-12#1)(2008-3#1)
is less than 20##2##4##(2007-12#1)(2008-10#1)
is less than 20%##2##4##(2008-2#1)(2008-8#1)
is less than 3##4##4##(2007-12#2)(2008-10#2)
is less than one##2##4##(2008-10#1)(2008-2#1)
is less than that##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
is less than the##7##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-9#1)(2013-1#1)
is less than##80##3##(1991-6#1)(1992-3#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#11)(2008-3#14)(2008-7#5)(2008-8#1)(2008-9#2)(2009-7#1)(2012-2#1)(2013-1#2)(2013-8#3)
is less well understood##3##4##(1995-8#1)(2011-2#1)(2013-1#1)
is less well##7##3##(1992-3#1)(1993-11#1)(1995-8#1)(2008-7#1)(2011-2#2)(2013-1#1)
is less##176##2##(1990-2#2)(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#2)(2007-11#5)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#2)(2008-2#15)(2008-3#20)(2008-4#1)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#5)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#6)
is liberated##3##2##(1993-8#1)(2008-10#2)
is like##2##2##(1997-1#2)
is likely a##4##3##(2007-8#1)(2008-8#1)(2011-2#1)(2012-2#1)
is likely an##2##3##(1992-6#1)(2008-7#1)
is likely because##2##3##(2008-11#1)(2008-8#1)
is likely conserved in##2##4##(2008-8#1)(2012-2#1)
is likely due to a##2##5##(2008-3#1)(2008-5#1)
is likely due to##4##4##(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
is likely involved##2##3##(1993-5#1)(1995-8#1)
is likely not##2##3##(2008-10#1)(2008-9#1)
is likely responsible for the##2##5##(1993-3#1)(2009-8#1)
is likely that many##2##4##(1995-6#1)(2007-12#1)
is likely that some of##2##5##(2007-11#1)(2008-7#1)
is likely that some##3##4##(2007-11#2)(2008-7#1)
is likely that the##15##4##(1990-12#1)(1992-12#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#1)(2013-1#1)
is likely that this##9##4##(1990-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1995-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
is likely that##57##3##(1990-11#1)(1990-12#1)(1992-12#3)(1992-5#1)(1993-11#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
is likely the##6##3##(1993-8#1)(2008-10#3)(2008-3#1)(2010-7#1)
is likely to achieve##2##4##(1992-2#1)(2011-2#1)
is likely to be a##4##5##(1994-8#1)(1997-6#1)(2008-8#1)(2010-10#1)
is likely to be an##3##5##(1990-2#1)(1995-6#1)(2011-2#1)
is likely to be due to a##3##7##(2008-11#1)(2008-3#1)(2009-7#1)
is likely to be due to##5##6##(1994-9#1)(2008-11#1)(2008-3#1)(2009-7#1)(2011-2#1)
is likely to be important##2##5##(1996-2#1)(2009-6#1)
is likely to be involved in##4##6##(1991-7#1)(2008-7#1)(2010-10#2)
is likely to be involved##5##5##(1991-7#1)(2008-10#1)(2008-7#1)(2010-10#2)
is likely to be more##3##5##(2008-10#1)(2008-9#1)(2010-12#1)
is likely to be the##3##5##(1993-2#1)(1994-3#1)(2011-2#1)
is likely to be##57##4##(1990-12#1)(1990-2#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-5#2)(2011-2#6)(2012-2#1)
is likely to continue##2##4##(2007-7#1)(2008-11#1)
is likely to develop##2##4##(1997-8#1)(2013-8#1)
is likely to expand##2##4##(2008-5#1)(2008-7#1)
is likely to have a##3##5##(2007-10#1)(2008-10#1)(2009-4#1)
is likely to have##8##4##(1991-12#2)(2007-10#1)(2008-1#1)(2008-10#1)(2009-4#2)(2013-1#1)
is likely to influence the##2##5##(1996-12#1)(2008-10#1)
is likely to influence##3##4##(1996-12#1)(2008-10#1)(2008-7#1)
is likely to occur##3##4##(1997-1#1)(2007-10#1)(2008-8#1)
is likely to play##2##4##(1997-7#1)(2008-9#1)
is likely to result from##2##5##(1994-3#1)(1996-6#1)
is likely to result##3##4##(1994-3#1)(1996-6#1)(2008-10#1)
is likely to reveal##2##4##(1996-2#1)(2008-1#1)
is likely to##122##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-5#3)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#7)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#8)(2012-2#1)(2013-1#4)(2013-8#1)
is likely##229##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#5)(1995-5#4)(1995-6#4)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#18)(2008-8#15)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#10)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#1)
is limited and##6##3##(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2012-1#1)
is limited at##2##3##(2008-10#1)(2008-8#1)
is limited because##2##3##(2008-2#1)(2008-7#1)
is limited but##2##3##(2007-8#1)(2009-5#1)
is limited by a##4##4##(1997-2#1)(2007-11#1)(2008-12#1)(2008-3#1)
is limited by donor##2##4##(2007-8#1)(2008-9#1)
is limited by its##2##4##(1994-9#1)(2012-2#1)
is limited by the number of##2##6##(2008-3#1)(2012-3#1)
is limited by the pixel##2##5##(2007-11#1)(2008-3#1)
is limited by the##25##4##(1991-3#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#2)(2013-1#1)
is limited by their##2##4##(2008-10#1)(2011-1#1)
is limited by##47##3##(1991-3#1)(1994-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
is limited due to##2##4##(2008-10#1)(2008-6#1)
is limited in##4##3##(2008-3#1)(2008-9#1)(2011-2#2)
is limited information##5##3##(2007-11#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
is limited only by the##4##5##(1993-12#1)(2008-3#3)
is limited to a##2##4##(1994-9#1)(2007-10#1)
is limited to the##5##4##(1991-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
is limited to##25##3##(1991-9#1)(1994-9#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-3#6)(2008-4#2)(2008-9#2)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
is limited##147##2##(1991-3#1)(1991-9#2)(1992-1#1)(1993-12#2)(1993-6#1)(1994-10#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-8#2)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#6)(2008-3#20)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#1)
is limiting##2##2##(1990-2#1)(2008-10#1)
is linear from 0##2##4##(2008-10#2)
is linear from##6##3##(2008-10#6)
is linear in the concentration range##3##6##(2008-10#3)
is linear in the range 0##3##6##(2008-10#3)
is linear in the range of 0##4##7##(2008-10#4)
is linear in the range of##8##6##(2008-10#8)
is linear in the range##12##5##(2008-10#12)
is linear in the##18##4##(2007-11#1)(2008-10#16)(2008-3#1)
is linear in##20##3##(2007-11#1)(2008-10#17)(2008-2#1)(2008-3#1)
is linear over 0##2##4##(2008-10#2)
is linear over the concentration range##6##6##(2008-10#6)
is linear over the range of##2##6##(2008-10#2)
is linear over the range##4##5##(2008-10#4)
is linear over the##11##4##(2008-10#11)
is linear over##18##3##(2008-10#18)
is linear up to##7##4##(2008-10#7)
is linear with the concentration of##3##6##(2008-10#3)
is linear with the concentration##4##5##(2008-10#4)
is linear with the##5##4##(2008-10#5)
is linear with##9##3##(2008-10#9)
is linear##69##2##(2007-11#1)(2007-12#1)(2008-10#62)(2008-2#1)(2008-3#2)(2008-8#2)
is linearly dependent on the##2##5##(2008-10#1)(2008-9#1)
is linearly proportional to the##5##5##(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
is linearly proportional to##6##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
is linearly related to the##3##5##(2008-10#2)(2010-8#1)
is linearly##15##2##(1991-9#1)(1997-2#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-8#1)
is linked by##2##3##(1990-2#1)(1992-12#1)
is linked to numerous##2##4##(2008-10#1)(2013-1#1)
is linked to the##12##4##(1991-12#1)(1992-3#1)(1994-6#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-5#1)(2011-2#1)(2013-1#1)
is linked to##32##3##(1991-12#2)(1992-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-3#2)(1997-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
is linked with a##2##4##(1994-12#1)(2008-10#1)
is linked with##6##3##(1994-12#1)(1994-9#1)(2008-10#2)(2008-2#1)(2012-2#1)
is linked##42##2##(1990-2#1)(1991-12#2)(1992-12#1)(1992-3#2)(1994-12#2)(1994-6#1)(1994-9#2)(1996-3#2)(1997-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
is listed as##2##3##(2011-2#2)
is little affected by##4##4##(2008-10#3)(2011-1#1)
is little doubt##2##3##(2008-1#1)(2012-2#1)
is little evidence that##3##4##(1993-3#1)(2008-7#1)(2012-1#1)
is little evidence##9##3##(1993-3#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-3#1)
is little information on##2##4##(2008-10#1)(2009-4#1)
is little information##3##3##(2007-10#1)(2008-10#1)(2009-4#1)
is little or no##4##4##(1993-8#1)(2008-8#1)(2011-2#1)(2013-8#1)
is little##55##2##(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
is loaded##3##2##(2008-7#1)(2009-7#1)(2011-2#1)
is local##2##2##(2008-10#1)(2008-8#1)
is localized at the##2##4##(1991-5#1)(2008-3#1)
is localized in the##4##4##(1991-9#1)(1992-5#1)(1997-8#1)(2008-4#1)
is localized in##7##3##(1990-11#1)(1991-9#1)(1992-5#1)(1994-12#1)(1997-8#1)(2008-12#1)(2008-4#1)
is localized to the Golgi##2##5##(1995-2#1)(2009-8#1)
is localized to the nucleus##2##5##(1990-11#1)(1995-8#1)
is localized to the##4##4##(1990-11#1)(1995-2#1)(1995-8#1)(2009-8#1)
is localized to##6##3##(1990-11#1)(1995-11#1)(1995-2#1)(1995-8#1)(2009-8#2)
is localized##21##2##(1990-11#2)(1991-5#1)(1991-9#2)(1992-5#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-8#2)(2012-2#1)
is locally##2##2##(1997-7#1)(2011-2#1)
is located at the##5##4##(1991-1#1)(1995-12#1)(2008-12#1)(2008-7#1)(2009-12#1)
is located at##12##3##(1990-12#1)(1990-7#1)(1991-1#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
is located between##5##3##(1997-2#1)(1997-6#1)(2008-4#1)(2008-8#1)(2012-12#1)
is located immediately downstream of the##2##6##(1992-9#1)(1997-2#1)
is located in a##4##4##(2008-3#1)(2008-5#2)(2008-9#1)
is located in an##2##4##(1991-12#1)(1994-5#1)
is located in the central##2##5##(2008-8#1)(2008-9#1)
is located in the##21##4##(1990-12#1)(1992-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
is located in##29##3##(1990-12#1)(1991-12#1)(1992-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
is located near the##5##4##(1993-11#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-8#1)
is located on chromosome##6##4##(1991-6#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-8#1)(2008-9#1)
is located on the left arm of chromosome##2##8##(1993-9#1)(1995-6#1)
is located on the##10##4##(1993-9#1)(1995-6#2)(1996-10#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-8#1)
is located on##17##3##(1991-6#1)(1993-9#1)(1994-6#1)(1995-5#1)(1995-6#2)(1996-10#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#2)(2008-9#1)
is located outside##2##3##(1995-2#1)(2008-10#1)
is located upstream##2##3##(1993-6#1)(1995-6#1)
is located within a##4##4##(1990-12#1)(1992-4#1)(1992-6#1)(1995-6#1)
is located within the##2##4##(1993-11#1)(1993-8#1)
is located within##9##3##(1990-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-9#1)
is located##108##2##(1990-12#3)(1990-7#1)(1991-1#1)(1991-12#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#5)(1996-10#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#7)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#5)(2009-12#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
is locked##2##2##(2007-12#2)
is long enough##2##3##(2008-10#1)(2013-7#1)
is long##5##2##(1994-3#1)(2008-10#1)(2008-9#1)(2013-7#1)(2013-8#1)
is longer than##4##3##(1994-12#1)(1996-4#1)(2007-12#1)(2008-10#1)
is longer##5##2##(1994-12#1)(1996-4#1)(2007-12#1)(2008-10#2)
is lost after##2##3##(2008-10#1)(2010-11#1)
is lost from##2##3##(1992-3#1)(2013-1#1)
is lost in##2##3##(2008-1#1)(2008-2#1)
is lost##15##2##(1992-3#1)(1992-6#1)(1993-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
is low and##6##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)
is low because##2##3##(2007-11#1)(2007-12#1)
is low but##3##3##(1996-8#1)(1997-5#1)(2007-11#1)
is low compared##2##3##(2008-8#1)(2012-3#1)
is low for##2##3##(2007-2#1)(2011-2#1)
is low in##7##3##(1993-2#1)(1994-2#1)(1994-9#1)(2007-11#2)(2008-9#1)(2011-2#1)
is low or##4##3##(1994-3#1)(2008-10#2)(2008-9#1)
is low##77##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2008-10#9)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-1#1)(2010-10#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
is low-cost##2##2##(1997-3#1)(2008-10#1)
is lower and##2##3##(1990-8#1)(2011-1#1)
is lower in##4##3##(1995-12#1)(2007-10#1)(2011-2#2)
is lower than expected##2##4##(1991-2#1)(2007-7#1)
is lower than in##2##4##(1994-11#1)(1996-5#1)
is lower than that of##4##5##(1994-5#1)(2007-12#1)(2008-10#1)(2011-3#1)
is lower than that##7##4##(1994-5#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-3#1)(2012-3#1)
is lower than the##4##4##(1992-6#1)(2008-11#1)(2008-12#1)(2012-12#1)
is lower than##22##3##(1991-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
is lower##35##2##(1990-11#1)(1990-8#1)(1991-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is lowered##4##2##(1997-7#1)(2008-10#1)(2008-8#1)(2012-1#1)
is m(o)=2##2##2##(2008-10#2)
is made available##2##3##(2008-1#1)(2008-3#1)
is made between the##5##4##(1990-6#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
is made between##8##3##(1990-6#1)(1992-5#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
is made by##7##3##(1991-5#1)(1992-11#1)(1994-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
is made for##3##3##(1992-2#1)(1997-5#1)(2008-3#1)
is made from##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#2)
is made in the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
is made in##8##3##(1991-12#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2013-1#1)
is made more##2##3##(1992-11#1)(2008-10#1)
is made of a##2##4##(2008-2#1)(2009-7#1)
is made of the##9##4##(1992-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-3#1)
is made of##17##3##(1992-1#1)(1993-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
is made on the##2##4##(1991-3#1)(2008-2#1)
is made on##6##3##(1991-3#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
is made possible by a##2##5##(1994-6#1)(2007-12#1)
is made possible by the##3##5##(1994-12#1)(2007-11#1)(2007-12#1)
is made possible by##9##4##(1994-12#1)(1994-6#1)(2007-11#1)(2007-12#3)(2008-3#2)(2012-2#1)
is made that##3##3##(1990-11#1)(1995-5#1)(2009-10#1)
is made to develop##2##4##(1991-3#1)(2008-10#1)
is made to react with##2##5##(2008-10#2)
is made to the##4##4##(1994-2#1)(1996-9#1)(2007-6#1)(2011-1#1)
is made to##20##3##(1990-3#1)(1991-3#1)(1994-2#1)(1996-6#1)(1996-9#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-1#1)
is made up of a##2##5##(1993-6#1)(2008-9#1)
is made up of many##2##5##(2007-12#1)(2008-3#1)
is made up of##10##4##(1991-3#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)
is made with the##3##4##(2007-12#1)(2008-5#1)(2010-7#1)
is made with##11##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)(2013-1#2)
is made##153##2##(1990-11#1)(1990-3#2)(1990-6#1)(1991-12#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#11)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#4)(2008-2#10)(2008-3#24)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#8)
is mainly a##2##3##(2007-11#1)(2008-5#1)
is mainly based on##4##4##(1996-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
is mainly because##2##3##(2008-3#1)(2008-5#1)
is mainly caused by##4##4##(1994-9#1)(1997-4#1)(2008-11#1)(2008-7#1)
is mainly due to the##6##5##(1992-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-7#1)
is mainly due to##11##4##(1992-1#1)(1994-5#1)(1994-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-3#1)
is mainly influenced by the##2##5##(2008-10#1)(2012-2#1)
is mainly mediated by##3##4##(2008-11#1)(2008-9#1)(2009-10#1)
is mainly observed##2##3##(2008-3#1)(2013-1#1)
is mainly present in##2##4##(1993-8#1)(1994-2#1)
is mainly reflected##2##3##(2008-12#1)(2013-1#1)
is mainly regulated##2##3##(2008-4#1)(2013-1#1)
is mainly related to##2##4##(2008-3#1)(2012-2#1)
is mainly responsible for##7##4##(1992-11#1)(1992-6#1)(1994-12#1)(1997-7#1)(2008-3#1)(2011-1#1)(2012-2#1)
is mainly used##2##3##(2008-2#1)(2008-3#1)
is mainly##79##2##(1992-1#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#4)
is maintained as an##2##4##(1995-2#2)
is maintained between##2##3##(1996-2#1)(2008-10#1)
is maintained by##10##3##(1990-7#1)(1992-7#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-8#1)(2013-1#1)
is maintained even##2##3##(1990-8#1)(2008-3#1)
is maintained for##5##3##(1994-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2011-3#1)
is maintained in the concentration range##4##6##(2008-10#4)
is maintained in the concentration##5##5##(2008-10#5)
is maintained in the##7##4##(1990-5#1)(2008-10#6)
is maintained in##14##3##(1990-5#1)(1994-11#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-10#6)(2008-4#2)(2010-12#1)
is maintained throughout the##2##4##(2007-12#1)(2009-2#1)
is maintained throughout##3##3##(2007-12#1)(2009-2#1)(2013-8#1)
is maintained##59##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-8#1)(1991-9#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
is major concern##2##3##(2008-7#1)(2012-2#1)
is making##5##2##(1996-2#1)(1997-7#1)(2008-7#2)(2009-5#1)
is male##3##2##(1995-2#1)(2007-2#1)(2012-3#1)
is managed by##2##3##(2007-12#1)(2008-10#1)
is managed##6##2##(1992-12#1)(2007-12#1)(2008-10#3)(2008-7#1)
is mandatory for##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
is mandatory if##2##3##(1990-9#1)(2008-10#1)
is mandatory to maintain the##2##5##(1994-5#1)(2011-2#1)
is mandatory to##4##3##(1994-5#1)(1997-6#1)(2011-2#2)
is mandatory##24##2##(1990-10#1)(1990-9#1)(1994-5#1)(1996-11#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#3)(2009-10#1)(2009-4#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)
is manifested by a##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
is manifested by the##2##4##(2008-3#1)(2008-4#1)
is manifested by##10##3##(1990-5#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
is manifested in##2##3##(1997-6#1)(2008-3#1)
is manifested##12##2##(1990-5#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2012-2#1)
is manipulated##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
is many##2##2##(1996-2#1)(2007-12#1)
is marked by##6##3##(1995-6#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-5#1)
is marked##7##2##(1995-6#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-5#1)
is markedly inhibited##3##3##(1992-1#1)(1994-2#1)(1995-3#1)
is markedly##11##2##(1991-12#1)(1991-2#1)(1992-1#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#1)(2012-3#1)
is matched by##2##3##(1995-2#1)(2008-2#1)
is matched##3##2##(1995-2#1)(2008-2#2)
is maternally##2##2##(1993-1#1)(1995-8#1)
is mathematically##2##2##(2008-3#1)(2012-2#1)
is maximal at##2##3##(2008-8#1)(2013-8#1)
is maximal##6##2##(1990-12#1)(1991-5#1)(1995-3#1)(2008-8#1)(2011-3#1)(2013-8#1)
is maximized in##2##3##(1994-3#1)(2008-2#1)
is maximized when the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
is maximized##9##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#2)
is maximum in##2##3##(2009-6#1)(2012-3#1)
is maximum##7##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-6#1)(2012-3#1)
is meant to be##2##4##(1996-2#1)(2007-12#1)
is meant to##5##3##(1996-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-6#1)
is meant##10##2##(1994-9#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-1#1)
is measurable##2##2##(2008-10#1)(2008-12#1)
is measured and##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is measured as##3##3##(1993-3#1)(2007-11#1)(2008-4#1)
is measured at 525 nm##2##5##(2008-10#2)
is measured at a##2##4##(2007-11#1)(2008-10#1)
is measured at##24##3##(2007-11#1)(2008-10#22)(2008-3#1)
is measured by a##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
is measured by an##2##4##(1991-2#1)(2008-10#1)
is measured by the##4##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
is measured by##22##3##(1991-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#2)
is measured for##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
is measured from the##2##4##(2008-8#1)(2008-9#1)
is measured from##4##3##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
is measured in a##2##4##(2007-11#1)(2008-10#1)
is measured in##7##3##(1992-3#1)(2007-11#1)(2007-12#2)(2008-10#3)
is measured spectrophotometrically at##3##4##(1993-12#1)(2008-10#2)
is measured to be 0##2##5##(2007-11#1)(2008-3#1)
is measured to be##7##4##(2007-11#3)(2007-12#1)(2008-3#3)
is measured to##9##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#4)
is measured using##4##3##(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
is measured with a##3##4##(2007-12#1)(2008-3#2)
is measured with##6##3##(2007-12#1)(2008-10#1)(2008-3#3)(2010-2#1)
is measured##120##2##(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(2007-11#9)(2007-12#9)(2007-9#1)(2008-1#1)(2008-10#43)(2008-11#1)(2008-2#11)(2008-3#21)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#7)(2009-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#2)
is mechanically##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
is mediated at least##2##4##(1992-6#1)(2008-9#1)
is mediated by a cis-acting##2##5##(1994-12#1)(1995-6#1)
is mediated by a protein##2##5##(1991-12#1)(1995-6#1)
is mediated by a##17##4##(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#2)(1996-2#1)(1997-9#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)
is mediated by activation of##2##5##(1996-2#1)(2008-4#1)
is mediated by an##5##4##(1993-3#1)(1995-11#1)(1995-8#1)(2008-5#1)(2013-1#1)
is mediated by both##4##4##(1994-8#1)(2008-10#1)(2008-4#1)(2008-6#1)
is mediated by protein kinase C##2##6##(1993-11#1)(1993-3#1)
is mediated by the##13##4##(1992-6#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#2)(2009-3#1)(2009-8#1)(2010-10#1)(2012-2#1)
is mediated by##78##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#4)(1992-6#1)(1993-11#1)(1993-3#5)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#3)(1996-5#2)(1997-2#2)(1997-4#1)(1997-7#2)(1997-9#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
is mediated primarily##2##3##(2008-7#1)(2011-2#1)
is mediated through a novel##2##5##(1993-5#1)(2012-3#1)
is mediated through the##5##4##(1994-6#1)(1996-2#1)(2008-8#1)(2010-8#1)(2012-3#1)
is mediated through##9##3##(1993-5#1)(1994-6#1)(1996-2#2)(2008-4#1)(2008-8#1)(2010-8#1)(2012-3#2)
is mediated via##4##3##(1993-6#2)(1995-12#1)(2008-8#1)
is mediated##101##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#5)(1992-6#2)(1993-11#2)(1993-3#5)(1993-5#1)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#5)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-9#1)(2008-10#6)(2008-11#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
is medically##2##2##(2007-10#1)(2012-2#1)
is membrane##2##2##(1994-6#1)(2009-5#1)
is membrane-bound##2##2##(2008-4#1)(2008-7#1)
is mental##2##2##(2012-1#1)(2013-8#1)
is mentioned##2##2##(1992-6#1)(2008-10#1)
is merged with a##2##4##(2008-10#2)
is merged with##3##3##(2008-10#3)
is met by##2##3##(2010-3#1)(2012-2#1)
is met##4##2##(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
is metabolized by##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
is metabolized to##3##3##(1990-5#1)(1991-2#1)(2010-11#1)
is metabolized##10##2##(1990-11#1)(1990-5#1)(1991-2#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-11#1)(2012-12#1)
is mild##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
is mimicked by##2##3##(1990-7#1)(2012-2#1)
is minimal##15##2##(1991-4#1)(1992-5#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
is minimised##2##2##(2007-11#1)(2008-10#1)
is minimized by##5##3##(2008-10#2)(2008-3#2)(2011-2#1)
is minimized##14##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#6)(2011-2#2)(2013-8#1)
is misleading##2##2##(2008-10#1)(2008-11#1)
is missing##5##2##(1995-11#1)(1995-12#1)(2007-12#1)(2013-1#1)(2013-8#1)
is mitogenic##3##2##(1990-12#1)(1994-11#1)(1997-7#1)
is mixed with##4##3##(1995-3#1)(2008-10#3)
is mixed##7##2##(1995-3#1)(2008-10#5)(2008-11#1)
is mode locked by##3##4##(2007-11#2)(2008-3#1)
is mode locked##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
is mode##8##2##(2007-11#3)(2007-12#1)(2008-3#3)(2013-1#1)
is modeled as a##5##4##(1996-4#1)(2008-10#2)(2008-3#1)(2008-8#1)
is modeled as an##2##4##(2008-2#1)(2008-3#1)
is modeled as##7##3##(1996-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
is modeled by a##3##4##(2008-3#3)
is modeled by##5##3##(2007-12#1)(2008-3#3)(2008-6#1)
is modeled using##3##3##(2008-10#1)(2008-7#2)
is modeled with##2##3##(2008-2#1)(2010-3#1)
is modeled##22##2##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)
is modest##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
is modestly##2##2##(1990-11#1)(2008-3#1)
is modified by##6##3##(1991-9#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
is modified in##2##3##(1996-12#1)(2008-4#1)
is modified to##3##3##(2008-3#2)(2008-9#1)
is modified with##2##3##(1994-6#1)(2009-5#1)
is modified##20##2##(1991-9#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2013-1#1)
is modular##2##2##(2008-10#1)(2008-3#1)
is modulated at##2##3##(1992-10#1)(2008-2#1)
is modulated by a##3##4##(1990-7#1)(2008-5#1)(2009-9#1)
is modulated by phosphorylation##2##4##(1994-11#1)(1996-2#1)
is modulated by the##5##4##(1990-8#1)(1994-11#1)(1994-2#1)(2008-11#1)(2008-4#1)
is modulated by##21##3##(1990-7#1)(1990-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-2#1)(1995-9#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-9#1)(2011-1#1)(2013-8#1)
is modulated in response to##2##5##(1994-5#1)(2007-12#1)
is modulated##31##2##(1990-7#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-8#1)
is monitored and##2##3##(1993-12#1)(2008-10#1)
is monitored at##8##3##(2008-10#8)
is monitored by##7##3##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)
is monitored spectrophotometrically at##3##4##(2008-10#3)
is monitored spectrophotometrically##6##3##(2008-10#6)
is monitored with a##2##4##(2008-10#1)(2008-3#1)
is monitored##36##2##(1993-12#1)(1994-12#1)(2008-1#1)(2008-10#26)(2008-3#3)(2008-4#1)(2008-5#2)(2009-4#1)
is monoclinic##4##2##(1996-2#1)(1996-5#1)(1997-7#2)
is more accurate than##2##4##(2008-10#1)(2012-3#1)
is more accurate##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
is more applicable to##2##4##(2007-12#1)(2008-5#1)
is more appropriate##5##3##(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)
is more closely related to##3##5##(2008-4#1)(2008-9#2)
is more closely related##4##4##(2008-4#1)(2008-9#3)
is more common and##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
is more common in##6##4##(2006-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-8#1)
is more common than##2##4##(2007-11#1)(2008-8#1)
is more common##13##3##(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is more commonly seen in##2##5##(2008-8#1)(2009-1#1)
is more commonly##3##3##(2008-7#1)(2008-8#1)(2009-1#1)
is more complex than##5##4##(1994-6#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-8#1)
is more complex##10##3##(1994-2#1)(1994-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
is more complicated##2##3##(1992-8#1)(2008-8#1)
is more critical##2##3##(2008-10#1)(2008-2#1)
is more difficult to##6##4##(1990-9#1)(1992-6#1)(2008-11#1)(2008-8#1)(2010-6#2)
is more difficult##9##3##(1990-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#2)
is more effective for##2##4##(2008-10#1)(2008-4#1)
is more effective in##2##4##(1992-9#1)(2013-1#1)
is more effective than the##3##5##(1995-2#1)(1995-9#1)(2008-12#1)
is more effective than##6##4##(1990-2#1)(1995-2#1)(1995-9#1)(2007-12#1)(2008-12#1)(2008-4#1)
is more effective##16##3##(1990-2#1)(1991-9#1)(1992-9#2)(1995-2#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2013-1#1)
is more efficient in##2##4##(2008-3#1)(2012-2#1)
is more efficient than the##2##5##(2008-10#1)(2009-9#1)
is more efficient than##5##4##(1993-9#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#1)
is more efficient##10##3##(1993-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-9#1)(2012-2#1)(2013-1#1)
is more frequent##2##3##(1990-2#1)(2011-2#1)
is more frequently##2##3##(2007-12#1)(2013-1#1)
is more important than##2##4##(1993-1#1)(1994-7#1)
is more important##4##3##(1993-1#1)(1994-7#1)(1996-12#1)(2007-12#1)
is more intense##2##3##(2007-12#1)(2012-7#1)
is more likely that##2##4##(1994-12#1)(2008-5#1)
is more likely to be##7##5##(2007-12#1)(2007-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
is more likely to occur##2##5##(1990-6#1)(1996-11#1)
is more likely to##14##4##(1990-6#1)(1996-11#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
is more likely##19##3##(1990-6#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
is more often##4##3##(2011-2#2)(2013-1#2)
is more open to##2##4##(1994-1#1)(2013-1#1)
is more persistent than##2##4##(1996-5#1)(2008-7#1)
is more potent##3##3##(1991-12#1)(1996-2#1)(2008-3#1)
is more precise and accurate##2##5##(2008-10#2)
is more precise and##3##4##(1995-2#1)(2008-10#2)
is more precise##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
is more prevalent in##2##4##(2007-7#1)(2008-5#1)
is more prevalent##5##3##(1991-6#1)(1993-3#1)(2007-7#1)(2008-5#1)(2012-12#1)
is more pronounced at##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
is more pronounced in the##2##5##(1995-12#1)(2010-12#1)
is more pronounced in##5##4##(1993-2#1)(1995-12#1)(2009-6#1)(2010-12#1)(2012-1#1)
is more pronounced##8##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-1#1)
is more rarely##2##3##(2010-12#1)(2012-12#1)
is more reactive##2##3##(2008-5#1)(2008-6#1)
is more readily##2##3##(2008-10#1)(2008-9#1)
is more related to##2##4##(2008-10#1)(2012-12#1)
is more reliable##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
is more robust##2##3##(2007-12#1)(2008-3#1)
is more selective##2##3##(1995-6#1)(2008-10#1)
is more sensitive than the##2##5##(2008-7#1)(2008-8#1)
is more sensitive than##12##4##(1991-8#1)(1996-8#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)
is more sensitive to the##3##5##(1991-5#1)(1992-5#1)(2012-2#1)
is more sensitive to##13##4##(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-2#1)
is more sensitive##27##3##(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#1)
is more severe##2##3##(2008-3#1)(2008-5#1)
is more specific##2##3##(1990-2#1)(1995-2#1)
is more stable than##2##4##(2008-10#2)
is more stable##4##3##(2008-10#3)(2008-5#1)
is more suitable for##3##4##(2008-10#1)(2010-4#2)
is more than twice##2##4##(2008-10#1)(2008-9#1)
is more than##21##3##(1990-6#1)(1993-11#1)(1994-5#1)(1996-9#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)
is more to##4##3##(1995-1#1)(1997-8#1)(2008-7#1)(2012-3#1)
is more useful for##3##4##(2008-10#1)(2008-3#1)(2009-8#1)
is more useful##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
is more widespread##2##3##(1991-12#1)(2007-11#1)
is more##320##2##(1990-2#3)(1990-6#2)(1990-9#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#3)(2007-12#14)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#36)(2008-11#5)(2008-12#6)(2008-2#6)(2008-3#11)(2008-4#6)(2008-5#14)(2008-6#3)(2008-7#8)(2008-8#15)(2008-9#17)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#18)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#13)(2013-8#2)
is morphologically similar to##3##4##(1997-4#1)(2008-5#2)
is morphologically##4##2##(1997-4#1)(2008-5#2)(2010-3#1)
is most closely related to PFBV##2##6##(2008-10#2)
is most closely##3##3##(1993-2#1)(2008-10#2)
is most common in##2##4##(2008-10#1)(2008-5#1)
is most common##5##3##(1992-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-8#1)
is most commonly caused by##2##5##(2008-1#1)(2011-2#1)
is most commonly##9##3##(2007-11#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
is most effective in the##2##5##(1992-2#1)(2008-10#1)
is most effective in##3##4##(1992-2#1)(1997-6#1)(2008-10#1)
is most effective when##2##4##(1994-1#1)(2008-9#1)
is most effective##8##3##(1992-2#1)(1994-1#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
is most evident##2##3##(2009-2#1)(2011-1#1)
is most frequent in##2##4##(1996-12#1)(2011-2#1)
is most frequent##3##3##(1996-12#1)(2007-11#1)(2011-2#1)
is most frequently associated with##2##5##(2006-10#1)(2012-3#1)
is most frequently##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2012-3#1)
is most important for##2##4##(1994-6#1)(2008-10#1)
is most important##4##3##(1994-3#1)(1994-6#1)(2008-10#1)(2011-2#1)
is most likely a##4##4##(1995-11#1)(2008-4#1)(2009-8#1)(2011-1#1)
is most likely due to##3##5##(2008-7#1)(2011-1#1)(2012-2#1)
is most likely the##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
is most likely to be##2##5##(2008-12#1)(2012-2#1)
is most likely to occur##2##5##(2008-10#1)(2008-8#1)
is most likely to##6##4##(2008-10#1)(2008-12#1)(2008-8#2)(2010-5#1)(2012-2#1)
is most likely##28##3##(1991-12#1)(1992-3#2)(1995-11#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-5#1)(2011-1#2)(2012-2#2)
is most often seen##2##4##(1992-5#1)(2008-10#1)
is most often##13##3##(1992-5#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
is most probably the##2##4##(1992-8#1)(2006-6#1)
is most probably##5##3##(1992-8#1)(1995-8#1)(1996-8#1)(2006-6#1)(2008-3#1)
is most pronounced##3##3##(1994-5#1)(2007-5#1)(2008-8#1)
is most sensitive##2##3##(2008-10#1)(2008-3#1)
is most severe in##2##4##(2006-10#1)(2008-10#1)
is most similar to the##2##5##(1995-5#1)(1995-8#1)
is most similar to##4##4##(1995-5#1)(1995-8#1)(2008-10#2)
is most useful in the##2##5##(2008-2#1)(2010-6#1)
is most widely used##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
is most##123##2##(1990-12#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-5#1)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
is mostly based on##2##4##(2010-7#1)(2011-2#1)
is mostly due to##2##4##(2008-10#1)(2009-12#1)
is mostly found in the##2##5##(2008-12#1)(2011-2#1)
is mostly similar##2##3##(2008-7#1)(2011-2#1)
is mostly##26##2##(1996-11#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#2)
is motivated by the##2##4##(2008-2#1)(2008-3#1)
is motivated by##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
is mounted on a##2##4##(2008-2#1)(2008-3#1)
is mounted on##3##3##(2008-2#1)(2008-3#2)
is mounted##4##2##(2008-2#1)(2008-3#3)
is moved##3##2##(2008-3#3)
is moving##3##2##(1997-3#1)(2008-3#1)(2009-10#1)
is much better than that obtained with##2##7##(2008-10#1)(2008-3#1)
is much better than that##3##5##(2008-10#2)(2008-3#1)
is much better than##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
is much better##6##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
is much faster than##2##4##(2008-3#1)(2012-3#1)
is much faster##8##3##(2007-12#1)(2008-10#2)(2008-3#3)(2010-6#1)(2012-3#1)
is much greater than that##2##5##(2008-10#1)(2008-8#1)
is much greater than##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
is much greater##4##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
is much higher in##3##4##(2008-10#2)(2008-9#1)
is much higher than in##2##5##(1990-11#1)(2008-10#1)
is much higher than that of##4##6##(2007-11#1)(2008-10#2)(2008-8#1)
is much higher than##10##4##(1990-11#1)(1994-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
is much higher##17##3##(1990-11#1)(1993-8#1)(1994-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
is much larger than the##4##5##(2007-12#1)(2008-3#2)(2012-2#1)
is much larger than##6##4##(2007-11#1)(2007-12#1)(2008-3#3)(2012-2#1)
is much larger##8##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2012-2#1)
is much less##12##3##(1993-2#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
is much lower than that##2##5##(2008-5#1)(2010-8#1)
is much lower than##5##4##(2008-10#1)(2008-5#2)(2010-8#1)(2012-1#1)
is much lower##8##3##(1997-7#1)(2008-10#1)(2008-5#2)(2010-8#1)(2012-1#2)(2012-12#1)
is much more effective##3##4##(2008-1#1)(2008-3#2)
is much more rapid##2##4##(2008-10#1)(2008-7#1)
is much more sensitive##2##4##(1994-5#1)(1996-8#1)
is much more stable##2##4##(2008-11#1)(2008-3#1)
is much more##24##3##(1991-1#1)(1994-1#1)(1994-5#1)(1995-6#1)(1996-8#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
is much rarer##3##3##(2009-1#1)(2010-11#1)(2010-12#1)
is much shorter##2##3##(2008-10#1)(2010-10#1)
is much slower than##2##4##(1992-6#1)(2008-2#1)
is much slower##3##3##(1992-6#1)(2008-2#1)(2009-2#1)
is much smaller than the##4##5##(2008-2#1)(2008-3#3)
is much smaller than##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
is much smaller##7##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
is much##127##2##(1990-11#1)(1991-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-10#1)(2007-11#4)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#21)(2008-11#6)(2008-2#4)(2008-3#19)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
is multi-factorial##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
is multifactorial##9##2##(1992-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
is multimodal##2##2##(2012-2#1)(2012-3#1)
is multiple##2##2##(2009-8#1)(2012-3#1)
is multiplied by##2##3##(2007-11#1)(2012-2#1)
is multiplied##3##2##(2007-11#1)(2012-2#2)
is mutated##3##2##(1991-5#1)(1992-12#1)(1992-9#1)
is mutually exclusive##2##3##(1992-3#1)(1995-3#1)
is my##2##2##(1994-2#1)(2008-11#1)
is myosin##2##2##(1992-2#1)(2008-5#1)
is myotonic dystrophy##2##3##(2013-1#2)
is named##3##2##(2008-10#2)(2008-8#1)
is narrow##3##2##(1995-1#1)(2008-10#1)(2008-2#1)
is narrower than##3##3##(2008-10#1)(2008-3#2)
is native to the##2##4##(2008-10#1)(2008-11#1)
is native##4##2##(1997-2#2)(2008-10#1)(2008-11#1)
is naturally##5##2##(1992-6#1)(1995-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
is near the##3##3##(1992-3#1)(2008-2#1)(2013-8#1)
is near##5##2##(1992-3#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
is nearly independent of the##2##5##(2007-12#1)(2008-3#1)
is nearly independent of##3##4##(2007-12#1)(2008-3#2)
is nearly the same##2##4##(2007-11#2)
is nearly##20##2##(1991-3#1)(1994-12#2)(1996-2#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#4)(2008-6#2)(2008-8#1)(2009-11#1)(2013-7#1)
is necessarily##4##2##(1993-1#1)(2008-3#1)(2008-7#1)(2009-2#1)
is necessary and sufficient to##3##5##(1997-2#1)(1997-3#1)(2008-7#1)
is necessary and sufficient##5##4##(1997-2#1)(1997-3#1)(2008-7#1)(2009-8#1)(2012-3#1)
is necessary and##9##3##(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
is necessary as##2##3##(2008-10#1)(2008-2#1)
is necessary because of the##2##5##(2008-2#1)(2011-1#1)
is necessary even##2##3##(2013-1#1)(2013-8#1)
is necessary for diagnosis##2##4##(1996-6#1)(2009-5#1)
is necessary for effective##2##4##(2008-11#1)(2010-7#1)
is necessary for environmental##2##4##(2008-10#2)
is necessary for optimal##3##4##(2008-10#1)(2008-2#1)(2012-12#1)
is necessary for the##14##4##(1990-2#1)(1991-11#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-11#1)(2010-7#1)(2012-2#1)
is necessary for their##2##4##(1993-3#1)(2010-12#1)
is necessary for##74##3##(1990-11#2)(1990-2#1)(1990-8#2)(1990-9#1)(1991-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#5)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#3)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-7#3)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)
is necessary in order to##8##5##(1992-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2011-1#1)
is necessary in##15##3##(1991-11#1)(1992-5#1)(1996-3#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
is necessary to achieve##2##4##(1993-3#1)(2007-5#1)
is necessary to assess##2##4##(2008-10#1)(2011-2#1)
is necessary to carry out##2##5##(2008-11#1)(2013-1#1)
is necessary to carry##3##4##(1991-9#1)(2008-11#1)(2013-1#1)
is necessary to consider##4##4##(1992-9#1)(1996-11#1)(2008-3#1)(2008-5#1)
is necessary to define the##2##5##(1992-6#1)(2013-1#1)
is necessary to determine##3##4##(1991-8#1)(2008-3#1)(2009-8#1)
is necessary to develop##5##4##(2008-1#1)(2008-10#1)(2008-9#2)(2012-2#1)
is necessary to ensure the##2##5##(2008-4#1)(2013-7#1)
is necessary to examine the##2##5##(1996-12#1)(2008-3#1)
is necessary to examine##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
is necessary to extend##2##4##(2011-2#1)(2012-3#1)
is necessary to find##2##4##(2011-2#2)
is necessary to identify##6##4##(1990-6#1)(1995-5#1)(2008-10#2)(2010-5#1)(2013-8#1)
is necessary to maintain##5##4##(1990-2#1)(1991-1#1)(1994-12#1)(1996-12#1)(2008-7#1)
is necessary to minimise##2##4##(2010-3#1)(2012-2#1)
is necessary to minimize##2##4##(1993-1#1)(2009-7#1)
is necessary to obtain quantitative recoveries for##2##7##(2008-10#2)
is necessary to obtain##3##4##(2008-10#2)(2013-8#1)
is necessary to overcome the##2##5##(1995-5#1)(2008-3#1)
is necessary to perform a##2##5##(2009-3#1)(2013-8#1)
is necessary to protect##2##4##(1995-2#1)(2010-7#1)
is necessary to reduce##3##4##(2008-4#2)(2013-1#1)
is necessary to strengthen the##2##5##(2013-7#1)(2013-8#1)
is necessary to understand the##3##5##(2007-8#1)(2008-9#1)(2013-1#1)
is necessary to understand##10##4##(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2013-1#2)
is necessary to##139##3##(1990-2#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1994-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#1)(1997-3#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#5)
is necessary when##2##3##(2008-2#1)(2008-3#1)
is necessary]##3##2##(1994-3#1)(1995-8#1)(1996-3#1)
is need##3##2##(2009-6#1)(2010-8#1)(2012-2#1)
is needed and##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
is needed at##2##3##(1993-6#1)(2009-11#1)
is needed before##2##3##(1993-3#1)(2010-10#1)
is needed for the##2##4##(2008-10#2)
is needed for##16##3##(1995-2#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-7#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)
is needed from##2##3##(1997-1#1)(2010-11#1)
is needed in order to##4##5##(2008-10#1)(2009-3#1)(2012-3#1)(2013-1#1)
is needed in the##3##4##(1995-3#1)(1995-6#1)(2008-1#1)
is needed in##14##3##(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
is needed is##3##3##(1992-3#1)(1994-1#1)(1994-2#1)
is needed on##5##3##(1990-9#1)(1993-1#1)(1995-11#1)(2008-11#1)(2012-2#1)
is needed to address the##3##5##(1993-1#1)(1994-12#1)(2008-11#1)
is needed to address##4##4##(1993-1#1)(1994-12#1)(2008-11#1)(2008-7#1)
is needed to assess the##2##5##(2007-8#1)(2008-11#1)
is needed to assess##3##4##(2007-8#1)(2008-11#1)(2010-10#1)
is needed to confirm these##2##5##(2009-7#1)(2011-2#1)
is needed to confirm##3##4##(2009-7#1)(2011-2#2)
is needed to determine if##2##5##(1994-12#1)(2008-10#1)
is needed to determine the##6##5##(1996-12#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
is needed to determine whether##2##5##(2008-10#2)
is needed to determine##12##4##(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
is needed to ensure##2##4##(2013-1#2)
is needed to evaluate##5##4##(1994-2#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-7#1)
is needed to further##3##4##(2008-11#1)(2012-2#2)
is needed to identify##9##4##(1992-11#1)(1994-9#1)(2007-10#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
is needed to uncover the##2##5##(2008-8#1)(2008-9#1)
is needed to understand##4##4##(2010-2#2)(2012-3#1)(2013-1#1)
is needed to verify the##2##5##(2007-12#1)(2008-9#1)
is needed to verify##3##4##(2007-12#1)(2008-10#1)(2008-9#1)
is needed to##87##3##(1990-2#1)(1992-11#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-10#2)(2007-12#5)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#2)(2009-7#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
is needed##225##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#3)(1993-11#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#29)(2008-11#16)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#2)(2010-10#5)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#14)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#9)(2013-8#1)
is negative##10##2##(1993-2#1)(1995-11#2)(1997-7#1)(2008-10#1)(2008-3#2)(2009-9#1)(2011-2#1)(2012-2#1)
is negatively affected by##2##4##(1993-3#2)
is negatively controlled by##2##4##(1990-11#1)(2011-1#1)
is negatively correlated with the##4##5##(2008-10#1)(2008-3#1)(2008-8#2)
is negatively correlated with##9##4##(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#3)(2012-3#1)(2013-8#1)
is negatively regulated by##2##4##(1995-8#1)(2007-12#1)
is negatively regulated##3##3##(1995-6#1)(1995-8#1)(2007-12#1)
is negatively related to the##2##5##(2008-5#1)(2008-7#1)
is negatively related to##3##4##(2007-12#1)(2008-5#1)(2008-7#1)
is negatively related##4##3##(2007-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
is negatively##20##2##(1990-11#1)(1993-3#2)(1995-6#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2011-1#1)(2012-3#2)(2013-8#1)
is negligible for##2##3##(2008-10#1)(2008-3#1)
is negligible in##2##3##(1990-12#1)(2008-10#1)
is negligible##20##2##(1990-12#1)(1991-3#2)(1992-6#1)(2008-10#7)(2008-2#2)(2008-3#5)(2010-5#1)(2010-7#1)
is neither a substrate##2##4##(1993-3#1)(1993-8#1)
is neither a##3##3##(1993-3#1)(1993-8#1)(2011-2#1)
is neither related to the##2##5##(1990-5#1)(2013-1#1)
is neither##19##2##(1990-5#1)(1991-1#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#2)
is neuroprotective against##2##3##(1995-12#1)(2011-2#1)
is neurotoxic to##2##3##(1994-2#1)(1997-2#1)
is neutralized##2##2##(1996-12#1)(2008-5#1)
is never an##2##3##(2008-10#1)(2008-6#1)
is never##6##2##(1992-9#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
is nevertheless##3##2##(1992-6#1)(1997-1#1)(2009-8#1)
is new in##2##3##(2009-5#1)(2009-8#1)
is new##7##2##(1993-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-5#1)(2009-8#1)(2010-5#1)
is newly##2##2##(2008-2#2)
is no a##2##3##(2008-12#1)(2008-7#1)
is no alternative##2##3##(2007-10#1)(2008-7#1)
is no convincing evidence that##2##5##(1995-11#1)(2007-8#1)
is no convincing evidence##4##4##(1992-2#1)(1995-11#1)(2007-8#1)(2009-5#1)
is no correlation between##3##4##(1992-10#1)(1994-5#1)(2011-2#1)
is no cure##3##3##(2010-11#2)(2012-1#1)
is no difference##3##3##(2007-2#1)(2008-6#1)(2011-1#1)
is no different##2##3##(2006-10#1)(2011-2#1)
is no doubt that the##2##5##(1995-4#1)(2011-2#1)
is no doubt that##5##4##(1992-6#1)(1995-4#1)(2009-12#1)(2011-2#2)
is no doubt##6##3##(1992-6#1)(1995-4#1)(2008-7#1)(2009-12#1)(2011-2#2)
is no evidence for##7##4##(1991-8#1)(1995-5#1)(2007-6#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
is no evidence of##9##4##(1990-2#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
is no evidence that##7##4##(1993-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-6#1)(2012-12#1)
is no evidence##27##3##(1990-2#1)(1991-8#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-5#1)(1997-3#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is no exception##2##3##(2008-9#1)(2010-10#1)
is no functional data system to identify##2##7##(2013-8#2)
is no functional data system##5##5##(2013-8#5)
is no information on the##2##5##(2008-10#1)(2008-5#1)
is no information on##3##4##(2008-10#1)(2008-5#2)
is no information##5##3##(2008-10#2)(2008-5#2)(2013-7#1)
is no interference##2##3##(2008-10#2)
is no longer a##2##4##(1996-2#1)(2008-8#1)
is no longer an##2##4##(2010-8#1)(2011-3#1)
is no longer confined to##2##5##(2008-11#1)(2008-9#1)
is no longer considered##3##4##(1991-2#1)(2008-10#1)(2008-11#1)
is no longer stable##2##4##(2008-8#1)(2008-9#1)
is no longer the##2##4##(1992-1#1)(2010-9#1)
is no longer##30##3##(1991-2#1)(1992-1#1)(1992-5#1)(1992-9#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-2#2)(1996-7#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-8#1)(2010-9#1)(2011-3#1)(2013-1#1)
is no more##2##3##(1996-11#1)(1996-12#1)
is no need to##4##4##(1994-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
is no need##6##3##(1994-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
is no objective##2##3##(2007-8#1)(2013-1#1)
is no phase##2##3##(2008-2#1)(2008-3#1)
is no proof##2##3##(1990-6#1)(1997-4#1)
is no reason to##2##4##(1993-11#1)(1997-5#1)
is no significant difference in##2##5##(1996-6#1)(2008-10#1)
is no significant difference##5##4##(1996-6#1)(2008-10#2)(2008-9#2)
is no significant##9##3##(1990-2#1)(1990-6#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-9#2)(2009-5#1)
is no simple##4##3##(1995-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
is no single##2##3##(2009-11#1)(2012-12#1)
is no specific treatment for##2##5##(1994-9#1)(2013-1#1)
is no specific treatment##5##4##(1994-9#1)(2007-2#1)(2011-2#2)(2013-1#1)
is no universal##3##3##(1996-6#1)(2007-11#1)(2013-1#1)
is no##316##2##(1990-11#1)(1990-2#3)(1990-6#3)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#30)(2008-11#7)(2008-12#5)(2008-2#5)(2008-3#9)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#11)(2008-8#10)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-5#7)(2009-6#2)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#16)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#12)
is non##2##2##(1995-1#1)(2008-10#1)
is non-specific and##2##3##(1990-5#1)(1997-4#1)
is non-specific##4##2##(1990-5#1)(1997-4#1)(2008-10#1)(2008-9#1)
is non-toxic and##3##3##(2008-5#1)(2009-12#1)(2012-2#1)
is non-toxic##4##2##(2008-10#1)(2008-5#1)(2009-12#1)(2012-2#1)
is noncompetitive##3##2##(1990-11#1)(1992-3#1)(1995-3#1)
is noninterferometric##2##2##(2008-2#2)
is nonlinear##5##2##(1990-8#1)(2007-11#2)(2008-3#1)(2008-8#1)
is nonpathogenic##2##2##(2008-10#2)
is normal##13##2##(1990-12#1)(1991-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-8#2)(2007-8#1)(2008-10#1)(2009-7#1)(2010-2#1)(2011-2#1)
is normalized by##2##3##(1996-2#1)(2008-3#1)
is normalized##3##2##(1994-8#1)(1996-2#1)(2008-3#1)
is normally expressed in##3##4##(1997-7#1)(1997-8#1)(2008-11#1)
is normally expressed##6##3##(1994-11#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-12#1)
is normally not##3##3##(1993-1#1)(2008-10#1)(2009-11#1)
is normally##31##2##(1990-5#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1994-11#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#2)(2009-11#1)(2009-12#1)(2010-8#1)(2012-12#1)
is not a consequence of##2##5##(1991-5#1)(2008-10#1)
is not a constant##2##4##(1993-12#1)(2011-1#1)
is not a contraindication for##2##5##(1993-9#1)(2013-8#1)
is not a decisive factor##2##5##(2013-1#2)
is not a genetic##2##4##(2008-11#2)
is not a good##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
is not a limiting factor##2##5##(2008-1#1)(2008-10#1)
is not a new##2##4##(2008-11#1)(2008-4#1)
is not a panacea##2##4##(1994-2#1)(1997-3#1)
is not a prerequisite for##2##5##(1995-11#1)(1996-5#1)
is not a proximal##2##4##(1994-2#2)
is not a question##2##4##(1990-2#1)(2010-8#1)
is not a rare##2##4##(1990-5#1)(1990-6#1)
is not a single disease but a##2##7##(2010-3#1)(2013-1#1)
is not a single##3##4##(2009-10#1)(2010-3#1)(2013-1#1)
is not a substrate##2##4##(1995-2#1)(2009-2#1)
is not a sufficient##2##4##(1993-1#1)(2007-12#1)
is not a##104##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#4)(1995-11#3)(1995-2#1)(1995-6#4)(1996-3#1)(1996-5#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
is not able to##5##4##(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
is not absolutely required for##2##5##(1990-8#1)(2008-4#1)
is not absolutely##3##3##(1990-8#1)(1997-3#1)(2008-4#1)
is not achieved##2##3##(2007-8#1)(2008-7#1)
is not activated by##3##4##(1995-5#2)(2008-4#1)
is not adequate for##2##4##(1997-8#1)(2007-7#1)
is not adequate##4##3##(1993-3#1)(1997-8#1)(2007-7#1)(2008-3#1)
is not affected by the##11##5##(1992-8#1)(1994-11#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
is not affected by##17##4##(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-8#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)
is not affected##24##3##(1990-11#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)
is not altered by##2##4##(2008-11#1)(2008-8#1)
is not altered in##2##4##(1994-12#1)(1997-2#1)
is not altered##4##3##(1994-12#1)(1997-2#1)(2008-11#1)(2008-8#1)
is not always easy to##2##5##(1997-3#1)(2008-11#1)
is not always easy##5##4##(1991-3#1)(1997-3#1)(2008-11#1)(2008-9#1)(2010-9#1)
is not always possible##3##4##(2009-3#1)(2011-2#2)
is not always##28##3##(1991-2#1)(1991-3#1)(1992-3#1)(1994-12#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-9#1)(2011-2#4)(2013-8#1)
is not an absolute##3##4##(1995-2#1)(1996-11#1)(2008-7#1)
is not an important##2##4##(1992-2#1)(2011-3#1)
is not an inherent##2##4##(2008-11#1)(2008-3#1)
is not an uncommon cause of##2##6##(2008-1#1)(2008-8#1)
is not an uncommon##4##4##(2007-7#1)(2008-1#2)(2008-8#1)
is not an##28##3##(1990-5#1)(1992-2#1)(1992-3#1)(1995-2#2)(1996-11#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)
is not apparent##3##3##(1994-3#1)(1994-8#1)(1995-11#1)
is not applicable to##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
is not applicable##6##3##(1995-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-12#1)
is not applied to##2##4##(2008-10#1)(2010-5#1)
is not appropriate for##2##4##(2008-3#1)(2008-6#1)
is not appropriate##5##3##(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
is not as good##2##4##(1996-11#1)(2010-7#1)
is not as##16##3##(1990-12#1)(1990-6#1)(1996-1#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#2)
is not assessed##3##3##(1996-3#1)(2007-7#1)(2008-4#1)
is not associated with##15##4##(1990-7#1)(1991-9#1)(1992-8#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#2)
is not available in##2##4##(2008-9#1)(2012-12#1)
is not available##16##3##(1993-2#1)(1993-3#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#2)(2012-12#2)
is not based on##3##4##(1994-2#1)(2008-11#1)(2008-2#1)
is not based##4##3##(1994-2#1)(1996-6#1)(2008-11#1)(2008-2#1)
is not being##2##3##(1994-1#1)(2010-8#1)
is not caused by##4##4##(1996-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
is not changed by##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
is not changed##5##3##(1992-3#1)(2008-10#2)(2008-11#1)(2012-12#1)
is not clear whether these##3##5##(1995-12#1)(2008-11#2)
is not clear whether##11##4##(1990-6#1)(1995-12#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-8#1)(2012-1#1)
is not clear##37##3##(1990-10#1)(1990-6#1)(1991-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
is not clearly##4##3##(1995-12#1)(2007-11#1)(2010-5#1)(2011-1#1)
is not closely##2##3##(1991-11#1)(1991-4#1)
is not common##2##3##(2008-10#1)(2013-8#1)
is not commonly##2##3##(2007-7#1)(2008-9#1)
is not complete##4##3##(1995-9#1)(2008-10#2)(2008-4#1)
is not completely understood##7##4##(1995-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-8#1)
is not completely##13##3##(1990-7#1)(1995-2#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2013-8#1)
is not compromised by##2##4##(1993-1#1)(2007-11#1)
is not compromised##3##3##(1993-1#1)(2007-10#1)(2007-11#1)
is not confined to##2##4##(1994-12#1)(2007-12#1)
is not considered##4##3##(1997-1#1)(1997-8#1)(2008-10#1)(2013-1#1)
is not consistent with the##5##5##(1993-12#1)(1993-9#1)(1996-5#1)(2008-5#1)(2010-11#1)
is not consistent with##6##4##(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2008-5#1)(2010-11#1)
is not consistent##7##3##(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2008-5#1)(2010-11#1)(2013-8#1)
is not constant##2##3##(2008-2#1)(2008-3#1)
is not controlled by##4##4##(1994-2#1)(2008-10#2)(2011-2#1)
is not controlled##6##3##(1994-2#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-2#1)
is not correlated##2##3##(1995-12#1)(2008-10#1)
is not coupled##3##3##(1992-6#1)(1995-11#1)(2008-8#1)
is not currently available##2##4##(1994-12#1)(2013-7#1)
is not currently##3##3##(1994-12#1)(2008-8#1)(2013-7#1)
is not degraded by##2##4##(1992-3#1)(1993-6#1)
is not dependent on the##4##5##(1994-12#1)(1995-6#1)(2007-8#1)(2012-12#1)
is not dependent on##15##4##(1990-12#1)(1990-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
is not dependent upon##2##4##(1995-6#1)(2008-7#1)
is not dependent##17##3##(1990-12#1)(1990-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-12#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
is not detectable##3##3##(2007-11#1)(2010-12#1)(2012-2#1)
is not detected##5##3##(1990-8#1)(1992-6#1)(1996-12#1)(2007-5#1)(2012-12#1)
is not determined##2##3##(1991-12#1)(1995-11#1)
is not directly involved in##2##5##(1993-5#1)(1995-5#1)
is not directly involved##3##4##(1992-8#1)(1993-5#1)(1995-5#1)
is not directly##7##3##(1992-8#1)(1993-5#1)(1994-11#1)(1995-5#1)(2008-3#1)(2008-5#1)(2010-9#1)
is not disrupted by##2##4##(1994-12#1)(2008-2#1)
is not disrupted##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
is not due to a##4##5##(1992-12#1)(1995-12#1)(2008-10#1)(2008-4#1)
is not due to an##2##5##(1992-9#1)(1993-6#1)
is not due to the##2##5##(2008-6#1)(2013-1#1)
is not due to##21##4##(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-2#1)(1995-12#1)(1995-8#2)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2011-1#1)(2013-1#1)
is not easily##7##3##(1995-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-6#2)(2010-8#1)
is not easy to##2##4##(1994-1#1)(2008-10#1)
is not easy##6##3##(1994-1#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-7#1)
is not enough##4##3##(1990-12#1)(2007-7#1)(2008-3#1)(2011-2#1)
is not entirely##3##3##(2008-5#1)(2009-10#1)(2011-2#1)
is not essential for the##3##5##(1993-12#1)(1995-5#1)(2008-10#1)
is not essential for viability##2##5##(1993-9#1)(1997-3#1)
is not essential for##13##4##(1990-12#1)(1990-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-3#1)(2008-10#2)
is not established##3##3##(1990-12#1)(1996-7#1)(2008-7#1)
is not exactly##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
is not expressed during##2##4##(1992-5#1)(1995-6#1)
is not expressed in##2##4##(2012-12#1)(2013-1#1)
is not expressed##5##3##(1992-5#1)(1994-11#1)(1995-6#1)(2012-12#1)(2013-1#1)
is not feasible for##2##4##(2011-2#1)(2013-1#1)
is not feasible##7##3##(1990-10#1)(1995-11#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
is not followed by##2##4##(1995-5#1)(2009-8#1)
is not for##2##3##(1992-12#1)(2008-1#1)
is not formed##2##3##(1993-9#1)(2008-10#1)
is not found in##6##4##(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
is not frequent##2##3##(2008-10#1)(2012-6#1)
is not fully understood##11##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2012-3#2)(2013-8#1)
is not fully##16##3##(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#2)(2013-8#1)
is not generally##3##3##(1991-12#1)(2007-2#1)(2008-4#1)
is not going##2##3##(1991-3#1)(2008-7#1)
is not identical##2##3##(1990-5#1)(2008-2#1)
is not immediately##2##3##(1994-12#1)(2007-8#1)
is not important##3##3##(2008-10#1)(2008-8#2)
is not in the##3##4##(1994-12#1)(1997-8#1)(2008-10#1)
is not in##5##3##(1990-5#1)(1994-12#2)(1997-8#1)(2008-10#1)
is not increased##4##3##(1990-2#1)(1995-12#1)(2008-8#1)(2011-2#1)
is not indicated for##3##4##(1994-9#1)(1996-9#1)(2010-6#1)
is not induced by##2##4##(1993-8#1)(1996-12#1)
is not induced##3##3##(1993-8#1)(1996-12#1)(2008-11#1)
is not influenced by the##2##5##(1991-12#1)(2010-10#1)
is not influenced##3##3##(1991-12#1)(1994-12#1)(2010-10#1)
is not inhibited by##3##4##(1992-9#1)(1993-8#1)(2008-11#1)
is not inhibited##5##3##(1992-9#1)(1993-8#1)(1994-11#1)(1995-12#1)(2008-11#1)
is not intended to##2##4##(1991-1#1)(2008-3#1)
is not involved in the##2##5##(1992-9#1)(1993-3#1)
is not involved in##5##4##(1992-6#1)(1992-9#1)(1993-3#1)(1995-8#1)(2008-10#1)
is not involved##8##3##(1991-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-8#1)(1996-9#1)(2008-10#1)(2008-11#1)
is not just a##3##4##(1996-2#1)(2008-7#1)(2012-12#1)
is not just##5##3##(1996-2#1)(2008-11#1)(2008-7#2)(2012-12#1)
is not justified##3##3##(1992-2#1)(1992-6#1)(2008-10#1)
is not known at present##2##5##(1990-11#1)(2007-2#1)
is not known how##2##4##(1997-7#1)(2012-2#1)
is not known if##3##4##(1996-2#1)(2008-10#1)(2008-5#1)
is not known whether##4##4##(1990-5#1)(2008-11#1)(2008-5#1)(2008-7#1)
is not known##50##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-7#2)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#8)(2009-11#1)(2010-5#1)(2012-2#4)(2012-3#1)(2013-1#1)
is not large##2##3##(1992-6#1)(2007-5#1)
is not likely to be##2##5##(1995-5#1)(1995-8#1)
is not likely##3##3##(1995-5#1)(1995-8#1)(2011-2#1)
is not limited to##7##4##(1994-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#1)(2013-1#1)
is not limited##8##3##(1994-8#1)(2008-10#1)(2008-2#3)(2008-7#1)(2011-2#1)(2013-1#1)
is not linear##2##3##(1992-5#1)(1996-5#1)
is not linked to##2##4##(1995-2#1)(2008-10#1)
is not mediated by##7##4##(1991-9#1)(1994-3#1)(1994-8#2)(1995-5#1)(1996-12#1)(2009-7#1)
is not mediated##9##3##(1991-9#1)(1994-3#1)(1994-8#3)(1995-5#1)(1996-12#1)(2008-5#1)(2009-7#1)
is not more than##2##4##(2008-3#1)(2008-8#1)
is not more##3##3##(2008-3#1)(2008-8#2)
is not necessarily related to##2##5##(2008-5#1)(2012-1#1)
is not necessarily the##5##4##(1996-3#1)(1997-5#1)(2007-11#1)(2008-10#2)
is not necessarily##16##3##(1996-3#1)(1996-6#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#2)
is not necessary for##5##4##(1994-2#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
is not necessary to##5##4##(1997-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
is not necessary##17##3##(1990-2#1)(1990-9#1)(1991-11#1)(1992-11#1)(1994-2#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#2)
is not needed##4##3##(1995-3#1)(2008-3#1)(2008-5#1)(2011-2#1)
is not negligible##2##3##(1990-9#1)(2008-2#1)
is not observed in##5##4##(1992-9#1)(1994-10#1)(1996-2#1)(2007-11#1)(2008-7#1)
is not observed##10##3##(1992-9#1)(1993-11#1)(1994-10#1)(1994-5#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)
is not obtainable##2##3##(2007-12#1)(2010-8#1)
is not of##3##3##(2007-11#1)(2008-4#1)(2009-6#1)
is not on##3##3##(1993-2#1)(1997-1#1)(2010-12#1)
is not one##2##3##(1996-12#1)(2010-12#1)
is not only a##5##4##(1990-11#1)(1990-6#1)(2008-11#1)(2008-7#1)(2009-5#1)
is not only an##2##4##(1994-2#1)(2008-9#1)
is not only the##2##4##(1995-1#1)(2013-7#1)
is not only to##4##4##(2008-4#1)(2009-5#1)(2010-3#1)(2011-2#1)
is not only##35##3##(1990-11#2)(1990-6#1)(1991-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
is not oriented##2##3##(2008-10#1)(2008-8#1)
is not palmitoylated##2##3##(1993-11#1)(2008-7#1)
is not part of the##2##5##(1993-12#1)(2011-2#1)
is not perpendicular to the##2##5##(2007-11#1)(2008-3#1)
is not phosphorylated##2##3##(1990-11#1)(1994-8#1)
is not possible for##2##4##(1996-9#1)(2008-10#1)
is not possible to##11##4##(1990-5#1)(1993-9#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
is not possible with##3##4##(2008-6#1)(2011-1#1)(2011-2#1)
is not possible##27##3##(1990-5#1)(1993-9#1)(1994-12#1)(1996-11#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#2)(2011-2#4)(2012-12#1)
is not practical##2##3##(2007-12#1)(2008-11#1)
is not present in the##3##5##(2008-10#1)(2008-7#1)(2012-3#1)
is not present in##4##4##(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
is not present##5##3##(1993-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
is not prevented by##2##4##(1992-3#1)(1997-4#1)
is not quite##2##3##(1991-6#1)(2008-9#1)
is not rare##4##3##(1990-2#1)(1997-7#1)(2009-5#1)(2013-7#1)
is not reached##2##3##(2007-12#1)(2008-4#1)
is not readily##4##3##(1990-5#1)(1995-12#1)(2008-2#1)(2009-8#1)
is not recommended because##2##4##(1993-8#1)(2008-2#1)
is not recommended##12##3##(1993-8#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#1)(2010-2#1)(2011-2#4)(2013-1#1)
is not reflected##2##3##(2008-11#1)(2009-7#1)
is not regulated by##2##4##(1994-8#1)(1995-12#1)
is not related to the##5##5##(1990-2#1)(1990-5#1)(1991-12#1)(1994-6#1)(1995-8#1)
is not related to##16##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
is not removed##2##3##(1992-3#1)(1993-8#1)
is not reported##2##3##(1991-6#1)(2012-2#1)
is not required for the##3##5##(1991-5#1)(1994-8#1)(1995-6#1)
is not required for##8##4##(1991-5#1)(1993-12#1)(1993-6#1)(1994-8#2)(1995-6#1)(1997-7#1)(2008-9#1)
is not required to obtain##2##5##(2008-10#1)(2008-2#1)
is not required to##4##4##(1993-9#1)(1995-2#1)(2008-10#1)(2008-2#1)
is not required##23##3##(1991-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-2#1)(1995-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-9#1)(2009-5#1)
is not responsible for##2##4##(1994-8#1)(1995-2#1)
is not restricted to##8##4##(1991-1#1)(1992-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
is not retained##2##3##(2008-10#2)
is not reversible##2##3##(1996-5#1)(2012-3#1)
is not routinely##2##3##(2011-2#1)(2012-12#1)
is not satisfactory##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
is not seen##2##3##(1990-12#1)(2008-3#1)
is not sensitive to the##4##5##(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
is not sensitive to##8##4##(1991-6#1)(1992-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
is not sensitive##11##3##(1991-6#1)(1992-8#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-2#1)(2013-8#1)
is not significant##3##3##(1996-8#1)(2008-10#1)(2009-8#1)
is not significantly affected by##3##5##(1993-3#1)(1995-8#1)(2008-2#1)
is not significantly different from##2##5##(1992-5#1)(2008-8#1)
is not significantly different##5##4##(1990-6#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
is not significantly##13##3##(1990-6#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2010-10#1)
is not simply##2##3##(2008-7#1)(2009-7#1)
is not so##6##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
is not solely##2##3##(2008-10#1)(2013-1#1)
is not specific for##2##4##(1993-8#1)(1994-11#1)
is not specific##3##3##(1993-8#1)(1994-11#1)(2008-5#1)
is not standardized##2##3##(2008-11#1)(2011-2#1)
is not statistically significant##3##4##(1992-4#1)(2008-10#1)(2013-1#1)
is not straightforward and##2##4##(2008-10#1)(2010-3#1)
is not straightforward##6##3##(1990-12#1)(1994-5#1)(2008-10#1)(2009-9#1)(2010-3#1)(2010-5#1)
is not strictly##3##3##(1995-9#1)(2008-11#1)(2010-5#1)
is not strong enough to##2##5##(1997-7#1)(2008-3#1)
is not subject to##4##4##(1995-12#1)(1997-3#1)(2008-11#1)(2012-3#1)
is not sufficient for##5##4##(1992-3#1)(1994-8#1)(2008-10#2)(2008-7#1)
is not sufficient in##2##4##(1994-3#1)(2011-2#1)
is not sufficient to##10##4##(1992-12#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2012-12#1)
is not sufficient##21##3##(1992-12#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)
is not suitable for##3##4##(2008-10#2)(2010-4#1)
is not suitable##4##3##(2008-10#3)(2010-4#1)
is not superior to##3##4##(2007-8#1)(2008-6#1)(2008-8#1)
is not surprising because##2##4##(2008-5#1)(2010-1#1)
is not surprising that##4##4##(1997-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
is not surprising##8##3##(1997-6#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
is not susceptible to##2##4##(2008-10#1)(2010-5#1)
is not the case for##2##5##(2008-10#1)(2008-11#1)
is not the case##6##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)
is not the cause of##2##5##(2008-10#1)(2012-3#1)
is not the most##2##4##(1996-7#1)(2008-3#1)
is not the only##5##4##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
is not the result of##3##5##(1995-11#2)(2008-8#1)
is not the same as##2##5##(2008-10#1)(2008-3#1)
is not the same##4##4##(2008-10#2)(2008-3#1)(2013-8#1)
is not the sole##2##4##(1993-3#1)(1994-8#1)
is not the##43##3##(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#2)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
is not time##2##3##(1990-12#1)(2008-10#1)
is not to##8##3##(1994-1#1)(1996-2#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
is not too great##2##4##(2008-8#2)
is not too##5##3##(1994-3#1)(2008-3#1)(2008-8#3)
is not totally##2##3##(2008-10#1)(2012-3#1)
is not transmitted##2##3##(2008-10#2)
is not true for##2##4##(2008-10#1)(2008-2#1)
is not true##3##3##(1992-9#1)(2008-10#1)(2008-2#1)
is not uncommon in##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
is not uncommon to##2##4##(2008-4#1)(2013-8#1)
is not uncommon##8##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-3#1)(2013-8#1)
is not understood##5##3##(1992-9#1)(1997-3#1)(2008-10#1)(2009-4#1)(2013-1#1)
is not uniform##3##3##(2008-10#2)(2009-4#1)
is not unique##2##3##(2007-12#1)(2008-11#1)
is not until##2##3##(1995-2#1)(1996-3#1)
is not unusual##2##3##(1993-12#1)(2012-2#1)
is not used here##2##4##(2008-10#2)
is not used##3##3##(2008-10#2)(2008-7#1)
is not useful##3##3##(2008-7#2)(2008-9#1)
is not valid##2##3##(1990-11#1)(2008-4#1)
is not very sensitive to##2##5##(1994-8#1)(2009-8#1)
is not very##6##3##(1994-3#1)(1994-8#1)(2008-10#2)(2009-8#1)(2013-1#1)
is not warranted##2##3##(1996-12#1)(2008-7#1)
is not well defined##3##4##(1990-11#1)(1990-12#1)(2008-7#1)
is not well described##2##4##(2008-9#1)(2009-11#1)
is not well documented##4##4##(1997-4#1)(2008-10#1)(2008-4#1)(2012-3#1)
is not well established##2##4##(1996-11#1)(2009-10#1)
is not well known##4##4##(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
is not well suited for##2##5##(2007-12#1)(2008-10#1)
is not well understood##19##4##(1993-9#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#3)(2009-11#1)(2010-10#1)(2010-11#1)(2010-2#2)(2011-1#1)(2013-1#2)
is not well##38##3##(1990-11#1)(1990-12#1)(1993-9#1)(1996-11#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#2)(2010-10#1)(2010-11#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is not widely used in the##2##6##(2010-6#1)(2010-8#1)
is not widely used##3##4##(2010-6#1)(2010-8#1)(2013-1#1)
is not widely##5##3##(2008-10#1)(2008-6#1)(2010-6#1)(2010-8#1)(2013-1#1)
is not without its##3##4##(2008-12#2)(2010-11#1)
is not without##7##3##(1996-1#1)(2008-12#2)(2009-10#1)(2010-10#1)(2010-11#1)(2013-8#1)
is not yet available##3##4##(2007-11#1)(2011-1#1)(2011-2#1)
is not yet clear##3##4##(1994-3#1)(1994-5#1)(2013-8#1)
is not yet established##2##4##(1993-12#1)(2008-1#1)
is not yet fully##4##4##(1991-2#1)(1997-8#1)(2009-7#1)(2011-1#1)
is not yet included in##2##5##(1993-12#1)(2008-7#1)
is not yet understood##3##4##(1991-11#1)(2008-7#1)(2013-1#1)
is not yet well##2##4##(2008-1#1)(2013-1#1)
is not yet##41##3##(1990-2#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
is not##1460##2##(1990-10#3)(1990-11#9)(1990-12#12)(1990-2#8)(1990-3#1)(1990-5#12)(1990-6#9)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#5)(1991-11#3)(1991-12#11)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#8)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#4)(1992-3#9)(1992-4#2)(1992-5#6)(1992-6#9)(1992-8#7)(1992-9#11)(1993-1#2)(1993-11#7)(1993-12#17)(1993-2#6)(1993-3#5)(1993-5#2)(1993-6#3)(1993-8#7)(1993-9#8)(1994-1#5)(1994-10#3)(1994-11#10)(1994-12#17)(1994-2#12)(1994-3#8)(1994-5#3)(1994-6#3)(1994-8#16)(1994-9#4)(1995-1#1)(1995-11#10)(1995-12#15)(1995-2#13)(1995-3#6)(1995-5#12)(1995-6#12)(1995-8#8)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#11)(1996-2#9)(1996-3#6)(1996-5#8)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#2)(1997-3#13)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#10)(1997-8#7)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#23)(2007-12#25)(2007-2#5)(2007-5#3)(2007-7#14)(2007-8#11)(2007-9#1)(2008-1#26)(2008-10#161)(2008-11#54)(2008-12#14)(2008-2#29)(2008-3#64)(2008-4#31)(2008-5#35)(2008-6#15)(2008-7#65)(2008-8#37)(2008-9#28)(2009-10#9)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#6)(2009-6#1)(2009-7#6)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#6)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#2)(2010-5#12)(2010-6#4)(2010-7#3)(2010-8#14)(2010-9#4)(2011-1#16)(2011-2#59)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#20)(2012-2#24)(2012-3#20)(2012-6#1)(2013-1#35)(2013-7#4)(2013-8#18)
is notably##6##2##(1997-4#1)(2007-11#1)(2008-7#1)(2008-8#2)(2013-8#1)
is noted in##4##3##(1994-8#1)(1997-1#1)(2008-3#2)
is noted##7##2##(1994-8#1)(1997-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-2#1)
is noteworthy that the##2##4##(1993-2#1)(2009-2#1)
is noteworthy that##10##3##(1992-12#1)(1993-2#1)(1995-8#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2012-2#1)
is noteworthy##12##2##(1992-12#1)(1993-2#1)(1995-8#1)(2007-7#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-2#1)
is nothing##2##2##(2008-10#1)(2008-3#1)
is notoriously difficult to##3##4##(2008-8#1)(2008-9#1)(2010-12#1)
is notoriously difficult##5##3##(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
is novel and##3##3##(2008-10#2)(2010-5#1)
is novel##8##2##(2008-10#3)(2008-11#2)(2008-9#1)(2010-5#1)(2012-2#1)
is now a##14##3##(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is now accepted as a##3##5##(1990-9#1)(1996-11#1)(2010-8#1)
is now accepted as##4##4##(1990-12#1)(1990-9#1)(1996-11#1)(2010-8#1)
is now accepted that##3##4##(1997-7#1)(2007-12#1)(2008-5#1)
is now accepted##8##3##(1990-12#1)(1990-9#1)(1996-11#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-8#1)
is now an##2##3##(1994-12#1)(2010-8#1)
is now applied to##2##4##(2008-10#1)(2008-12#1)
is now applied##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
is now available##10##3##(1990-2#1)(1991-3#1)(1992-12#1)(1995-5#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-4#1)(2011-2#1)
is now becoming##4##3##(1993-11#1)(2008-7#2)(2009-3#1)
is now being used to##3##5##(1990-11#1)(1994-5#1)(2008-7#1)
is now being used##5##4##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-7#1)
is now being##10##3##(1990-11#1)(1994-5#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
is now clear that##5##4##(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)
is now clear##6##3##(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#2)
is now considered a##6##4##(2006-7#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-3#1)
is now considered the##2##4##(2008-4#1)(2010-12#1)
is now considered to be##2##5##(2007-6#1)(2008-4#1)
is now considered##13##3##(1996-8#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-3#1)
is now established##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
is now feasible##2##3##(2008-10#1)(2008-7#1)
is now frequently used##2##4##(1992-5#1)(2011-1#1)
is now generally##3##3##(2007-11#2)(2012-1#1)
is now in##3##3##(1997-2#1)(1997-8#1)(2012-2#1)
is now known that##3##4##(2009-4#1)(2011-2#1)(2013-1#1)
is now known to be##2##5##(2008-6#1)(2010-7#1)
is now known to##3##4##(1993-6#1)(2008-6#1)(2010-7#1)
is now known##7##3##(1993-6#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
is now of##2##3##(2008-7#1)(2011-2#1)
is now possible to##9##4##(1990-12#1)(1991-1#1)(1993-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#1)
is now possible##10##3##(1990-12#1)(1991-1#1)(1993-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
is now recognised##3##3##(2008-11#1)(2008-12#1)(2010-12#1)
is now recognized as##3##4##(2007-7#1)(2008-12#1)(2008-5#1)
is now recognized to be##2##5##(1990-6#1)(2008-7#1)
is now recognized to##3##4##(1990-6#1)(2008-7#2)
is now recognized##8##3##(1990-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#3)(2012-1#1)
is now recommended##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
is now strong evidence that##2##5##(1990-2#1)(2008-8#1)
is now the time##2##4##(2008-12#1)(2013-1#1)
is now the##10##3##(1992-11#1)(1992-12#1)(1992-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2013-1#1)
is now thought to be##2##5##(1997-8#1)(2008-6#1)
is now thought##3##3##(1997-8#1)(2008-5#1)(2008-6#1)
is now used##3##3##(1993-1#1)(2008-10#1)(2008-7#1)
is now well established##5##4##(1994-11#1)(1996-2#1)(1997-1#1)(2007-6#1)(2011-2#1)
is now well understood##2##4##(2008-9#1)(2013-1#1)
is now well##9##3##(1994-11#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-6#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
is now widely accepted that##3##5##(2008-11#1)(2011-2#1)(2012-3#1)
is now widely accepted##4##4##(2008-11#2)(2011-2#1)(2012-3#1)
is now widely##6##3##(1997-4#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-3#1)
is now##214##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-3#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#20)(2008-8#4)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#7)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#12)(2013-8#1)
is nowadays##7##2##(1992-3#1)(1993-3#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-2#1)
is numerically##8##2##(2007-12#3)(2008-3#5)
is obeyed in the##10##4##(2008-10#10)
is obeyed in##12##3##(2008-10#12)
is obeyed over the range##3##5##(2008-10#3)
is obeyed over the##10##4##(2008-10#10)
is obeyed##28##2##(2008-10#28)
is objective and##2##3##(1990-11#1)(2007-11#1)
is obscure##4##2##(1993-3#1)(2008-9#1)(2010-12#1)(2010-8#1)
is obscured by##2##3##(1990-2#1)(2008-10#1)
is observable##2##2##(2008-10#1)(2008-11#1)
is observed across a wide range of##2##7##(2007-12#1)(2008-3#1)
is observed across##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
is observed after##2##3##(2008-3#1)(2011-2#1)
is observed and##7##3##(1990-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
is observed as##4##3##(2008-1#1)(2008-10#2)(2013-1#1)
is observed at room temperature##2##5##(2007-12#1)(2008-10#1)
is observed at##10##3##(1990-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)
is observed between the##2##4##(1993-11#1)(2008-7#1)
is observed between##7##3##(1992-4#1)(1993-11#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
is observed by##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
is observed following##2##3##(2010-5#1)(2012-3#1)
is observed for both##2##4##(2008-10#1)(2008-3#1)
is observed for the##3##4##(1993-11#1)(2008-10#1)(2008-3#1)
is observed for##12##3##(1993-11#1)(1996-5#1)(2008-10#7)(2008-3#2)(2008-4#1)
is observed in all##2##4##(1990-5#1)(1995-2#1)
is observed in many##2##4##(2008-10#1)(2013-8#1)
is observed in the presence of##2##6##(2008-10#1)(2008-8#1)
is observed in the range##2##5##(2008-10#2)
is observed in the##16##4##(1990-5#1)(1990-8#1)(1991-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-11#1)
is observed in##40##3##(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-5#1)(2007-11#3)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#2)(2009-11#1)(2009-8#1)(2012-2#2)(2013-8#1)
is observed on the##2##4##(2008-10#1)(2008-12#1)
is observed on##4##3##(1990-7#1)(2008-10#2)(2008-12#1)
is observed only##5##3##(1990-11#1)(1991-12#1)(1993-8#1)(2008-10#1)(2013-8#1)
is observed over##2##3##(2007-12#1)(2008-10#1)
is observed that the##4##4##(2008-10#2)(2008-3#1)(2009-8#1)
is observed that##6##3##(2008-10#3)(2008-3#1)(2009-8#1)(2011-2#1)
is observed to be##3##4##(1991-5#1)(2008-10#1)(2009-11#1)
is observed to##7##3##(1990-8#2)(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-11#1)
is observed when##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
is observed with##8##3##(1992-3#1)(1993-11#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)
is observed##188##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#3)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#10)(2007-12#14)(2008-1#5)(2008-10#51)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2012-8#1)(2013-1#3)(2013-8#2)
is obtainable##2##2##(1992-3#1)(2007-11#1)
is obtained and##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
is obtained as a##3##4##(1991-11#1)(2007-12#1)(2008-3#1)
is obtained as##4##3##(1991-11#1)(2007-12#1)(2008-3#2)
is obtained at a##2##4##(2007-11#1)(2007-12#1)
is obtained at##5##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#2)
is obtained between the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
is obtained between##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
is obtained by means of##3##5##(2007-12#1)(2008-3#2)
is obtained by measurement of##2##5##(2008-3#2)
is obtained by the##3##4##(2008-3#2)(2008-5#1)
is obtained by use of a##2##6##(2008-2#1)(2008-3#1)
is obtained by use of##3##5##(2008-2#2)(2008-3#1)
is obtained by using##2##4##(2008-10#2)
is obtained by##35##3##(1990-9#1)(2007-11#2)(2007-12#4)(2008-10#7)(2008-2#3)(2008-3#13)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#2)
is obtained for a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is obtained for the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
is obtained for##11##3##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#3)
is obtained from a##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
is obtained from the##6##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
is obtained from##17##3##(2007-11#3)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2010-9#1)
is obtained in a##2##4##(2007-12#1)(2008-4#1)
is obtained in the##2##4##(1991-6#1)(2008-10#1)
is obtained in##7##3##(1991-6#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-4#1)
is obtained on##4##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
is obtained only##2##3##(1995-2#1)(2008-10#1)
is obtained over the##2##4##(2008-10#2)
is obtained over##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
is obtained that##2##3##(2008-2#1)(2008-4#1)
is obtained through##3##3##(2007-11#1)(2008-2#1)(2010-4#1)
is obtained under##3##3##(2008-10#3)
is obtained up to an##2##5##(2008-10#1)(2008-3#1)
is obtained up to##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
is obtained when the##7##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
is obtained when##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)
is obtained with a##8##4##(1993-12#1)(2007-11#2)(2008-2#2)(2008-3#3)
is obtained with an##2##4##(2007-12#1)(2008-3#1)
is obtained with the##2##4##(2008-2#1)(2008-3#1)
is obtained with##18##3##(1993-12#1)(1993-8#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#5)(2008-4#1)
is obtained within##3##3##(2007-12#1)(2008-10#2)
is obtained##198##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-11#17)(2007-12#22)(2008-10#54)(2008-11#1)(2008-2#23)(2008-3#48)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)
is obvious##3##2##(1994-12#1)(2007-12#1)(2008-10#1)
is obviously lower than##2##4##(2008-10#2)
is obviously##7##2##(1992-3#1)(2008-10#3)(2008-11#1)(2010-5#1)(2013-1#1)
is occasionally##3##2##(1995-12#1)(1995-6#1)(2007-7#1)
is occurring in##4##3##(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#1)
is occurring##13##2##(1994-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#2)
is of 1##2##3##(2008-10#2)
is of a##7##3##(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
is of concern##6##3##(1994-2#1)(2008-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
is of considerable importance##2##4##(2008-11#1)(2008-7#1)
is of considerable interest##2##4##(2008-10#1)(2008-5#1)
is of considerable##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)
is of critical importance##3##4##(1991-1#1)(1995-8#1)(2008-10#1)
is of crucial importance##5##4##(2007-10#1)(2008-10#1)(2008-7#2)(2010-5#1)
is of fundamental importance in##2##5##(2007-11#1)(2008-7#1)
is of fundamental importance to##3##5##(2008-10#1)(2010-7#1)(2012-1#1)
is of fundamental importance##5##4##(2007-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-1#1)
is of fundamental##7##3##(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-1#1)
is of general##4##3##(1994-2#1)(2007-11#1)(2008-11#2)
is of great importance for##4##5##(2006-10#1)(2008-2#1)(2011-1#1)(2013-1#1)
is of great importance in##4##5##(1991-9#1)(1997-1#1)(2008-10#1)(2012-2#1)
is of great importance##16##4##(1990-11#1)(1991-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
is of great interest because##2##5##(2011-2#1)(2013-1#1)
is of great interest for##3##5##(2007-12#1)(2008-11#1)(2012-2#1)
is of great interest##7##4##(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
is of great value##2##4##(1996-11#1)(2010-8#1)
is of great##31##3##(1990-11#1)(1991-9#1)(1992-6#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-7#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
is of growing##2##3##(2008-11#1)(2008-8#1)
is of high##3##3##(1994-11#1)(2008-2#1)(2012-3#1)
is of importance for the##2##5##(1994-3#1)(2010-3#1)
is of importance for##6##4##(1992-12#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)
is of importance in the##3##5##(1997-8#1)(2007-11#1)(2008-5#1)
is of importance in##5##4##(1990-12#1)(1992-3#1)(1997-8#1)(2007-11#1)(2008-5#1)
is of importance##16##3##(1990-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-3#1)
is of increasing concern##2##4##(2009-5#1)(2012-12#1)
is of increasing##3##3##(2008-8#1)(2009-5#1)(2012-12#1)
is of interest as##2##4##(2008-1#1)(2011-2#1)
is of interest because it is an##2##7##(2011-2#2)
is of interest because it is##4##6##(2011-2#4)
is of interest because it##6##5##(1990-8#1)(2011-2#5)
is of interest because of its##3##6##(2011-2#3)
is of interest because of##4##5##(2010-5#1)(2011-2#3)
is of interest because##10##4##(1990-8#1)(2010-5#1)(2011-2#8)
is of interest for##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
is of interest to##4##4##(1993-12#1)(1995-11#1)(2008-7#2)
is of interest##23##3##(1990-8#1)(1993-12#1)(1995-11#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#10)
is of large interest because of##2##6##(2011-2#2)
is of limited value##2##4##(1995-3#1)(2008-7#1)
is of major importance for##2##5##(1991-6#1)(2008-11#1)
is of major importance in##2##5##(2008-5#1)(2011-2#1)
is of major importance##5##4##(1991-6#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
is of major##8##3##(1991-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)
is of no##2##3##(2008-10#1)(2008-7#1)
is of paramount importance##5##4##(1991-5#1)(1994-12#1)(2007-10#1)(2008-10#1)(2008-12#1)
is of particular concern in##3##5##(2008-10#1)(2008-3#1)(2012-3#1)
is of particular concern##6##4##(1991-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-3#1)
is of particular importance in##3##5##(1992-5#1)(2008-6#1)(2013-1#1)
is of particular importance##4##4##(1992-5#1)(1997-7#1)(2008-6#1)(2013-1#1)
is of particular interest because##3##5##(1990-12#1)(2008-10#1)(2008-2#1)
is of particular interest to##2##5##(2008-8#1)(2008-9#1)
is of particular interest##9##4##(1990-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)
is of particular relevance##2##4##(2007-12#1)(2008-11#1)
is of particular significance##2##4##(1992-8#1)(2008-10#1)
is of particular##24##3##(1990-12#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-8#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
is of phylogenetic interest because of its##2##7##(2011-2#2)
is of phylogenetic interest because of##3##6##(2011-2#3)
is of phylogenetic interest because##4##5##(2011-2#4)
is of potential##2##3##(2008-10#2)
is of practical importance##2##4##(2008-12#1)(2013-1#1)
is of practical significance##2##4##(2008-10#1)(2008-3#1)
is of practical##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
is of primary importance##3##4##(1992-3#1)(1994-11#1)(2012-3#1)
is of prime importance for the##2##6##(2008-9#2)
is of prime importance##3##4##(2008-10#1)(2008-9#2)
is of prognostic value##2##4##(1996-9#1)(2011-2#1)
is of significant##2##3##(1994-9#1)(2008-10#1)
is of special interest because of its##2##7##(2011-2#2)
is of special interest because##3##5##(2011-2#3)
is of special interest##6##4##(2011-2#6)
is of the order of 1##2##6##(2007-12#1)(2008-3#1)
is of the order of##11##5##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)
is of the same##2##4##(2007-11#1)(2008-11#1)
is of the##16##3##(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2013-7#1)
is of theoretical##2##3##(1990-12#1)(1992-5#1)
is of utmost importance for##2##5##(2008-11#1)(2011-1#1)
is of utmost importance in the##2##6##(2008-10#1)(2013-8#1)
is of utmost importance to##2##5##(1991-6#1)(2011-1#1)
is of utmost importance##8##4##(1991-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-8#1)
is of utmost##10##3##(1991-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
is of value for##2##4##(2008-1#1)(2008-10#1)
is of value##3##3##(2008-1#2)(2008-10#1)
is of vital##2##3##(2008-10#1)(2008-5#1)
is of##281##2##(1990-11#1)(1990-12#5)(1990-8#1)(1991-1#1)(1991-3#2)(1991-5#2)(1991-6#4)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#8)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#43)(2008-11#16)(2008-12#7)(2008-2#10)(2008-3#10)(2008-5#7)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#36)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#1)
is off##2##2##(1994-3#1)(2008-3#1)
is offered by the##2##4##(2008-4#1)(2013-1#1)
is offered by##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
is offered##15##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-9#1)(2007-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-5#1)(2013-1#1)
is offering##3##2##(1992-2#1)(2008-5#1)(2008-7#1)
is often a##16##3##(1993-1#1)(1993-11#1)(1995-1#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
is often accompanied by##3##4##(2008-11#1)(2008-2#1)(2008-5#1)
is often accompanied##4##3##(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
is often addressed##2##3##(2008-2#1)(2009-9#1)
is often associated with a##2##5##(2007-10#1)(2012-2#1)
is often associated with##21##4##(1993-11#1)(1993-12#1)(1995-12#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#2)
is often asymptomatic##2##3##(2010-7#1)(2013-1#1)
is often based on##4##4##(1990-6#1)(2008-2#1)(2010-5#1)(2012-2#1)
is often complicated by##4##4##(1994-11#1)(1997-2#1)(2009-7#1)(2012-12#1)
is often considered##2##3##(2008-12#1)(2008-4#1)
is often delayed##2##3##(1997-8#1)(2009-8#1)
is often desirable to##3##4##(2008-1#1)(2008-2#1)(2008-9#1)
is often desirable##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)
is often determined by##2##4##(2008-1#1)(2010-6#1)
is often determined##3##3##(2008-1#1)(2008-3#1)(2010-6#1)
is often diagnosed##2##3##(1993-3#1)(1997-8#1)
is often difficult and##2##4##(1997-3#1)(2012-3#1)
is often difficult to##4##4##(2008-10#1)(2008-3#2)(2010-5#1)
is often difficult##12##3##(1993-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-7#1)
is often downregulated in##2##4##(2011-2#1)(2013-1#1)
is often extremely##2##3##(2008-4#1)(2010-12#1)
is often fatal##2##3##(2006-7#1)(2008-10#1)
is often found##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
is often hampered by the##2##5##(1990-12#1)(2011-3#1)
is often hampered by##3##4##(1990-12#1)(1992-9#1)(2011-3#1)
is often highly##2##3##(1991-3#1)(2008-2#1)
is often inadequate##2##3##(2010-10#1)(2013-7#1)
is often limited by##2##4##(2008-8#1)(2009-11#1)
is often limited to##2##4##(1996-12#1)(2013-1#1)
is often limited##5##3##(1996-12#1)(2008-10#1)(2008-8#1)(2009-11#1)(2013-1#1)
is often linked##2##3##(1996-6#1)(2009-7#1)
is often missed##3##3##(2008-7#1)(2010-4#1)(2011-2#1)
is often more##3##3##(1995-11#1)(2008-8#1)(2010-10#1)
is often necessary in##2##4##(2008-10#2)
is often necessary to##4##4##(1994-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
is often necessary##7##3##(1994-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#1)
is often not##6##3##(1994-3#1)(2008-11#2)(2008-5#1)(2009-9#1)(2011-2#1)
is often observed in##2##4##(2011-2#1)(2013-1#1)
is often observed##3##3##(2011-2#1)(2013-1#2)
is often one of##2##4##(2008-8#1)(2011-2#1)
is often overlooked##3##3##(1993-12#1)(2008-2#1)(2013-8#1)
is often poor##2##3##(2008-11#1)(2010-1#1)
is often relegated##2##3##(2008-12#1)(2008-5#1)
is often required in##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
is often required##7##3##(1994-3#1)(2007-2#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
is often seen as##2##4##(2008-11#1)(2013-8#1)
is often seen##3##3##(2008-11#1)(2010-7#1)(2013-8#1)
is often suggested##2##3##(1997-3#1)(2011-2#1)
is often the case##3##4##(1995-1#1)(2008-4#1)(2011-2#1)
is often the first##5##4##(1993-2#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)
is often the##12##3##(1993-2#1)(1995-1#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#2)(2011-2#2)
is often thought##2##3##(2009-8#1)(2010-8#1)
is often to##2##3##(2008-3#1)(2013-1#1)
is often underestimated##3##3##(1997-3#1)(2012-12#1)(2013-8#1)
is often unknown##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
is often used as a##4##5##(1996-3#1)(2008-2#1)(2008-6#1)(2013-1#1)
is often used as the##2##5##(2007-12#1)(2010-12#1)
is often used as##6##4##(1996-3#1)(2007-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2013-1#1)
is often used in##4##4##(2008-10#2)(2008-7#1)(2009-7#1)
is often used to##6##4##(1993-2#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
is often used##17##3##(1993-2#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#2)
is often##297##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#4)(1997-7#1)(1997-8#3)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#12)(2008-12#6)(2008-2#12)(2008-3#11)(2008-4#11)(2008-5#8)(2008-6#2)(2008-7#14)(2008-8#10)(2008-9#7)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#18)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#8)
is omitted##2##2##(2008-10#1)(2008-2#1)
is on a##2##3##(2008-10#2)
is on an##3##3##(2008-10#1)(2008-12#2)
is on average##4##3##(1996-2#1)(2008-5#3)
is on the increase##3##4##(1995-11#1)(2008-1#2)
is on the rise##3##4##(2008-11#1)(2010-8#1)(2013-1#1)
is on the##27##3##(1992-12#1)(1994-2#1)(1995-11#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
is on##62##2##(1991-2#1)(1992-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#2)(1997-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-8#1)(2008-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
is on-line##3##2##(2008-10#3)
is once again##2##3##(2008-6#1)(2010-1#1)
is one example of##2##4##(2006-4#1)(2008-4#1)
is one example##4##3##(2006-4#1)(2007-12#1)(2008-4#1)(2008-5#1)
is one in which the##2##5##(2009-7#1)(2012-12#1)
is one mechanism##2##3##(1995-5#1)(2008-8#1)
is one method##2##3##(1996-12#1)(2008-11#1)
is one of a##3##4##(1995-12#1)(1995-5#1)(2008-11#1)
is one of several##7##4##(1994-12#1)(1995-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-2#1)
is one of the best##3##5##(1991-6#1)(1995-8#1)(2008-12#1)
is one of the common##4##5##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
is one of the commonly##2##5##(2008-10#1)(2008-8#1)
is one of the components of the##2##7##(1991-2#1)(2008-10#1)
is one of the factors##3##5##(1992-12#1)(2008-10#1)(2008-7#1)
is one of the fastest growing##2##6##(2008-1#1)(2008-11#1)
is one of the few##5##5##(1993-11#1)(1993-12#1)(1994-5#1)(2008-10#1)(2009-9#1)
is one of the first##3##5##(1996-12#1)(1996-3#1)(2012-3#1)
is one of the fundamental##3##5##(1995-8#1)(2008-8#1)(2013-8#1)
is one of the hallmarks of cancer##2##7##(2011-2#1)(2012-2#1)
is one of the hallmarks of##3##6##(2009-5#1)(2011-2#1)(2012-2#1)
is one of the important##11##5##(1992-12#1)(1993-3#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#2)
is one of the key enzymes##2##6##(1994-12#1)(2008-9#1)
is one of the key##3##5##(1994-12#1)(2008-8#1)(2008-9#1)
is one of the leading causes of##6##7##(2007-12#1)(2008-1#1)(2010-8#1)(2011-2#2)(2013-8#1)
is one of the leading##7##5##(2007-12#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
is one of the main causes of##2##7##(2008-1#1)(2011-2#1)
is one of the main causes##3##6##(2008-1#1)(2011-2#1)(2012-3#1)
is one of the main##15##5##(1991-6#1)(1992-12#1)(1994-12#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#2)(2012-3#2)(2013-8#1)
is one of the major causes of##3##7##(2008-11#2)(2009-12#1)
is one of the major complications##3##6##(2008-10#1)(2011-2#1)(2013-1#1)
is one of the major factors##2##6##(2008-1#1)(2008-10#1)
is one of the major health##2##6##(2011-2#1)(2013-1#1)
is one of the major##28##5##(1994-2#1)(1995-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#3)
is one of the mechanisms##2##5##(2008-10#1)(2012-3#1)
is one of the more##2##5##(1994-5#1)(2008-9#1)
is one of the most aggressive##2##6##(2008-1#1)(2011-3#1)
is one of the most challenging conditions##2##7##(1991-12#1)(2011-2#1)
is one of the most challenging##3##6##(1991-12#1)(2011-2#2)
is one of the most common and##2##7##(2008-11#1)(2008-3#1)
is one of the most common autosomal##2##7##(2008-7#1)(2012-12#1)
is one of the most common cancers##2##7##(2008-4#1)(2008-8#1)
is one of the most common complications##2##7##(2008-1#1)(2010-8#1)
is one of the most common sites##2##7##(2013-1#1)(2013-8#1)
is one of the most common##33##6##(1990-8#1)(1990-9#1)(1995-3#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#6)(2013-8#2)
is one of the most destructive diseases of##2##8##(2008-10#2)
is one of the most destructive##3##6##(2008-10#3)
is one of the most devastating diseases of##2##8##(1997-7#1)(2011-2#1)
is one of the most devastating##3##6##(1997-7#1)(2008-10#1)(2011-2#1)
is one of the most difficult##2##6##(2009-3#1)(2013-1#1)
is one of the most effective##4##6##(2007-11#1)(2009-11#1)(2009-3#1)(2013-8#1)
is one of the most frequent##4##6##(2008-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
is one of the most important and##3##7##(2008-10#1)(2010-10#1)(2010-7#1)
is one of the most important diseases of wheat##2##9##(2008-10#1)(2011-10#1)
is one of the most important diseases of##4##8##(2008-10#3)(2011-10#1)
is one of the most important part of##2##8##(1996-7#1)(2007-11#1)
is one of the most important##30##6##(1993-6#1)(1996-7#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-1#1)(2013-7#2)(2013-8#1)
is one of the most intensely studied##2##7##(1995-5#1)(2010-10#1)
is one of the most interesting##2##6##(2008-2#1)(2009-8#1)
is one of the most potent##3##6##(2008-4#1)(2010-4#1)(2010-8#1)
is one of the most powerful##2##6##(1995-3#1)(2008-10#1)
is one of the most prevalent##2##6##(2008-10#1)(2008-7#1)
is one of the most prominent##2##6##(2008-5#1)(2008-8#1)
is one of the most rapidly##2##6##(2008-12#1)(2011-10#1)
is one of the most sensitive##3##6##(2008-10#2)(2008-7#1)
is one of the most serious##2##6##(1991-3#1)(2008-10#1)
is one of the most widely distributed##2##7##(2008-10#2)
is one of the most widely used##5##7##(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
is one of the most widely##9##6##(2006-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
is one of the most##146##5##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#25)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-10#2)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#9)(2013-7#2)(2013-8#4)
is one of the parameters##2##5##(2008-10#1)(2008-3#1)
is one of the primary##3##5##(1993-1#1)(2008-10#1)(2008-8#1)
is one of the rare##3##5##(1992-11#1)(2010-5#1)(2012-12#1)
is one of the simplest##2##5##(2008-10#2)
is one of the##319##4##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#6)(2007-12#3)(2007-7#4)(2007-8#1)(2008-1#8)(2008-10#54)(2008-11#10)(2008-12#9)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#10)(2008-6#3)(2008-7#12)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#5)(2011-1#2)(2011-10#2)(2011-2#23)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#10)
is one of three##2##4##(2008-3#1)(2011-2#1)
is one of##348##3##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#8)(2008-10#55)(2008-11#14)(2008-12#9)(2008-2#4)(2008-3#8)(2008-4#9)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#9)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#5)(2011-1#3)(2011-10#2)(2011-2#24)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#10)(2012-3#9)(2013-1#15)(2013-7#3)(2013-8#10)
is one step##2##3##(1994-12#1)(1996-2#1)
is one such##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
is one system##2##3##(1994-2#1)(2008-1#1)
is one that##6##3##(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)
is one the##2##3##(1995-2#1)(2013-8#1)
is one way##3##3##(2007-11#1)(2011-1#2)
is one##414##2##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#11)(2008-10#55)(2008-11#18)(2008-12#11)(2008-2#9)(2008-3#11)(2008-4#11)(2008-5#11)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#6)(2011-1#5)(2011-10#2)(2011-2#24)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#11)(2012-3#9)(2013-1#15)(2013-7#3)(2013-8#12)
is ongoing##7##2##(1994-3#1)(2008-5#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
is only a##9##3##(1994-12#1)(1994-6#1)(1996-4#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
is only active##2##3##(2008-10#1)(2008-9#1)
is only effective##2##3##(2007-11#1)(2007-12#1)
is only expressed##2##3##(1993-9#1)(2008-11#1)
is only observed##2##3##(1993-6#2)
is only one factor##2##4##(2008-11#2)
is only one of##2##4##(1996-3#1)(2009-8#1)
is only one##14##3##(1993-8#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#2)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
is only partially##4##3##(1991-3#1)(1991-8#1)(1995-2#1)(2011-2#1)
is only possible##3##3##(1994-12#1)(1996-6#1)(2008-10#1)
is only recently##2##3##(2008-4#1)(2013-1#1)
is only slightly##6##3##(1992-1#1)(1994-6#1)(2007-11#1)(2008-2#2)(2008-8#1)
is only the beginning##3##4##(1994-2#1)(1996-1#1)(2008-11#1)
is only the second##5##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
is only the##13##3##(1994-2#1)(1996-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#4)(2012-2#1)(2012-3#1)
is only weakly##4##3##(1990-8#1)(1991-5#1)(2007-11#1)(2008-3#1)
is only##127##2##(1990-12#1)(1990-6#2)(1990-8#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-6#2)(1994-7#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
is open to the##2##4##(2008-3#1)(2008-7#1)
is open to##14##3##(1995-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#6)(2013-1#1)
is open##15##2##(1995-5#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#6)(2013-1#1)
is opening##2##2##(2008-7#1)(2011-3#1)
is operated in##2##3##(2008-2#2)
is operated##5##2##(1992-1#1)(1994-12#1)(2008-2#2)(2008-6#1)
is operating##3##2##(2008-2#1)(2009-5#2)
is operationally##2##2##(2008-10#1)(2008-7#1)
is opposed by NaCl##2##4##(1997-2#2)
is opposite that##2##3##(2007-11#1)(2008-3#1)
is opposite to##2##3##(2007-11#1)(2008-10#1)
is opposite##5##2##(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#1)
is optical##2##2##(2008-3#1)(2010-7#1)
is optically##6##2##(2007-12#2)(2008-3#4)
is optimal for the##2##4##(1996-5#1)(2008-8#1)
is optimal for##6##3##(1992-12#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
is optimal in the##2##4##(2007-12#1)(2008-2#1)
is optimal in##3##3##(2007-12#1)(2008-2#2)
is optimal##9##2##(1992-12#1)(1996-5#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-8#1)
is optimistic##2##2##(1995-1#1)(2007-8#1)
is optimized by##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
is optimized for##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
is optimized##16##2##(1994-9#1)(2007-12#2)(2008-10#4)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
is optimum##2##2##(1993-3#1)(2008-10#1)
is orders of magnitude##4##4##(1990-11#1)(1992-8#1)(2007-11#1)(2008-3#1)
is organised##2##2##(1994-3#1)(1996-12#1)
is organized by##2##3##(2007-12#1)(2011-2#1)
is organized in##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
is organized into##4##3##(1992-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
is organized##15##2##(1991-2#1)(1992-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#2)
is oriented perpendicular to the plane of the##2##8##(1994-12#1)(1995-5#1)
is oriented to##2##3##(1995-2#1)(2008-2#1)
is oriented toward the##2##4##(1990-2#1)(1991-12#1)
is oriented##11##2##(1990-2#1)(1991-12#1)(1994-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
is otherwise##7##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-7#1)
is our best##2##3##(1996-2#1)(2010-9#1)
is our##13##2##(1992-2#1)(1994-1#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-3#1)(2007-9#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
is outlined as##2##3##(2008-10#1)(2011-2#1)
is outlined for##3##3##(1991-8#1)(2007-12#1)(2008-4#1)
is outlined##21##2##(1990-9#1)(1991-8#1)(1992-1#2)(1994-1#1)(1994-12#1)(1994-3#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-5#1)(2011-2#1)
is over##10##2##(1996-2#1)(2007-5#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
is over-expressed in##3##3##(2009-3#1)(2010-8#1)(2012-2#1)
is overcome by##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
is overcome with##2##3##(2008-7#1)(2012-1#1)
is overcome##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
is overestimated in the##2##4##(1997-3#1)(2008-10#1)
is overexpressed in##5##3##(1992-9#1)(2008-10#1)(2008-11#2)(2010-2#1)
is overexpressed##6##2##(1992-9#1)(1994-7#1)(2008-10#1)(2008-11#2)(2010-2#1)
is oxidised##3##2##(2008-10#3)
is oxidized by the##2##4##(2008-10#2)
is oxidized to iodine##2##4##(2008-10#2)
is oxidized to sulfate and##2##5##(2008-10#2)
is oxidized to##10##3##(1990-2#1)(1991-12#1)(1993-12#1)(2008-10#7)
is oxidized##16##2##(1990-2#1)(1991-12#1)(1993-12#1)(1994-5#1)(2008-10#12)
is oxygenated##2##2##(1995-5#2)
is pH dependent##2##3##(1994-12#1)(2008-10#1)
is pH##3##2##(1994-12#1)(2008-10#2)
is packaged##2##2##(1991-5#1)(1993-6#1)
is paid for##2##3##(1991-8#1)(1995-11#1)
is paid to##14##3##(1990-6#1)(1991-5#1)(1992-3#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-9#1)(2011-3#1)
is paid##16##2##(1990-6#1)(1991-5#1)(1991-8#1)(1992-3#1)(1995-11#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-9#1)(2011-3#1)
is pain##2##2##(2007-11#1)(2009-10#1)
is paired with a##3##4##(1997-8#2)(2008-4#1)
is parallel to the##2##4##(1996-4#1)(2008-3#1)
is paralleled by a##3##4##(1996-12#1)(1996-5#1)(2007-5#1)
is paralleled by##4##3##(1996-12#1)(1996-5#1)(2007-5#1)(2008-7#1)
is paralleled##5##2##(1996-12#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-7#1)
is parameterized##2##2##(2008-10#1)(2008-6#1)
is paramount##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
is part of a new##2##5##(2008-3#1)(2012-12#1)
is part of a##12##4##(1990-7#1)(1992-1#1)(1994-1#1)(1997-7#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-12#1)
is part of the Genomic Encyclopedia of Bacteria and Archaea project##19##11##(2011-2#19)
is part of the normal##2##5##(2007-6#1)(2008-9#1)
is part of the##41##4##(1990-10#1)(1990-7#1)(1991-12#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#22)(2012-2#2)(2012-3#1)
is part of##57##3##(1990-10#1)(1990-7#2)(1991-12#1)(1992-1#1)(1994-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-2#1)(2007-5#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#24)(2012-12#1)(2012-2#2)(2012-3#1)
is part##58##2##(1990-10#1)(1990-7#2)(1991-12#1)(1992-1#1)(1994-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-2#1)(2007-5#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#24)(2012-12#1)(2012-2#2)(2012-3#1)
is partial##3##2##(2008-10#2)(2008-8#1)
is partially compensated##2##3##(2007-11#1)(2008-3#1)
is partially due to##2##4##(1991-12#1)(2010-5#1)
is partially##14##2##(1991-11#1)(1991-12#1)(1991-9#1)(1995-8#1)(1997-2#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2012-1#1)
is particularly acute##2##3##(1991-12#1)(2008-2#1)
is particularly applicable for##2##4##(1992-6#1)(2008-3#1)
is particularly attractive##2##3##(2008-10#1)(2008-2#1)
is particularly challenging##4##3##(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
is particularly convenient for##2##4##(2007-12#1)(2008-10#1)
is particularly critical##2##3##(1992-6#1)(2008-8#1)
is particularly efficient##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
is particularly high##3##3##(1990-5#1)(2007-2#1)(2012-2#1)
is particularly important because##2##4##(1993-11#1)(2010-4#1)
is particularly important for the##2##5##(2008-2#1)(2012-2#1)
is particularly important for##4##4##(1997-7#1)(2008-2#1)(2008-9#1)(2012-2#1)
is particularly important in##6##4##(1992-11#1)(1992-5#1)(1993-12#1)(1996-8#1)(2009-4#1)(2011-2#1)
is particularly important##15##3##(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
is particularly relevant##2##3##(2008-5#1)(2012-12#1)
is particularly suitable for##4##4##(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)
is particularly suited to##3##4##(1991-5#1)(2007-11#1)(2008-9#1)
is particularly suited##4##3##(1991-5#1)(1991-9#1)(2007-11#1)(2008-9#1)
is particularly useful for analyzing the##2##6##(1997-6#1)(2008-4#1)
is particularly useful for##7##4##(1991-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-4#1)
is particularly useful in##5##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)
is particularly useful when##3##4##(2008-2#1)(2008-4#2)
is particularly useful##18##3##(1991-1#1)(1991-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-8#1)(2010-6#1)
is particularly valuable##2##3##(2008-11#1)(2008-9#1)
is particularly well suited for##2##5##(1997-6#1)(2008-3#1)
is particularly well suited to the##2##6##(1991-5#1)(2008-3#1)
is particularly well suited##4##4##(1991-5#1)(1997-6#1)(2008-3#2)
is particularly well##6##3##(1991-5#1)(1997-6#1)(2008-10#1)(2008-3#2)(2012-3#1)
is particularly##103##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
is partitioned##2##2##(2008-10#1)(2008-8#1)
is partly dependent on##4##4##(2007-11#1)(2008-11#1)(2010-5#1)(2013-8#1)
is partly due to the presence of##2##7##(1997-7#1)(2007-2#1)
is partly due to the##3##5##(1997-7#1)(2007-2#1)(2008-10#1)
is partly due to##8##4##(1992-12#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
is partly##21##2##(1991-2#1)(1992-12#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-7#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#2)
is passed through the device##2##5##(2008-10#1)(2008-3#1)
is passed through the##4##4##(2008-10#3)(2008-3#1)
is passed through##6##3##(1996-8#1)(2007-12#1)(2008-10#3)(2008-3#1)
is passed##10##2##(1996-8#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)
is pathogenic to##3##3##(2008-10#2)(2010-3#1)
is pathogenic##4##2##(2008-10#3)(2010-3#1)
is pathognomonic##2##2##(2009-7#1)(2013-7#1)
is pathological##2##2##(1990-6#1)(2007-11#1)
is paucity of##2##3##(2012-2#1)(2013-1#1)
is peer##2##2##(1997-3#1)(2013-1#1)
is perceived as a##2##4##(2010-12#2)
is perceived as high##2##4##(2008-8#1)(2010-3#1)
is perceived as##8##3##(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#3)(2010-3#1)(2012-2#1)
is perceived by##3##3##(2008-1#1)(2008-12#1)(2012-1#1)
is perceived to be##2##4##(1993-3#1)(2009-4#1)
is perceived##13##2##(1993-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#3)(2010-3#1)(2012-1#1)(2012-2#1)
is percutaneous##2##2##(1990-2#1)(1991-3#1)
is perfectly suited##2##3##(2007-12#1)(2008-10#1)
is perfectly##6##2##(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
is performed and##2##3##(2008-2#1)(2008-3#1)
is performed at a##2##4##(2008-10#2)
is performed at##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
is performed by a##4##4##(2007-12#1)(2008-10#3)
is performed by the##6##4##(2008-10#2)(2008-3#3)(2009-12#1)
is performed by##29##3##(1991-2#1)(1991-3#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#6)(2009-12#1)(2009-5#1)(2010-11#1)
is performed during##2##3##(2007-12#1)(2008-10#1)
is performed electronically##2##3##(2007-12#2)
is performed for##3##3##(2008-2#2)(2013-8#1)
is performed in a##5##4##(2008-10#4)(2008-2#1)
is performed in##12##3##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2013-1#1)
is performed on a##3##4##(2008-10#1)(2008-9#1)(2009-11#1)
is performed on the##2##4##(1997-2#1)(2008-10#1)
is performed on##10##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)
is performed through##3##3##(1991-6#1)(2007-12#1)(2008-2#1)
is performed to##9##3##(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
is performed using a##2##4##(2008-10#1)(2008-7#1)
is performed using##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
is performed with a##2##4##(2008-3#1)(2011-1#1)
is performed with an##3##4##(1990-9#1)(2007-11#1)(2008-2#1)
is performed with the##2##4##(2008-3#1)(2010-2#1)
is performed with##11##3##(1990-9#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2010-2#1)(2011-1#1)
is performed##126##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2007-11#6)(2007-12#8)(2007-8#2)(2008-10#35)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#16)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
is performing##2##2##(2007-8#1)(2008-7#1)
is perhaps most##2##3##(2008-4#1)(2012-2#1)
is perhaps the most##4##4##(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
is perhaps##10##2##(1992-3#1)(1992-9#1)(1994-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)
is periodic##4##2##(2007-11#2)(2008-10#1)(2008-2#1)
is permanent##2##2##(2007-11#1)(2007-12#1)
is permitted##2##2##(2007-12#1)(2008-2#1)
is perpendicular to the##3##4##(2007-12#1)(2008-3#2)
is perpendicular to##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
is perturbed##2##2##(1990-8#1)(2008-11#1)
is pharmacologically##2##2##(1992-3#1)(1997-2#1)
is phase matchable##2##3##(2007-12#2)
is phase##8##2##(2007-12#5)(2008-2#3)
is phosphorylated at##2##3##(2008-7#1)(2010-12#1)
is phosphorylated by##3##3##(1991-2#1)(1993-8#1)(2008-11#1)
is phosphorylated in##3##3##(1994-6#2)(1995-6#1)
is phosphorylated##8##2##(1991-2#1)(1993-8#1)(1994-6#2)(1995-6#1)(2008-11#1)(2008-7#1)(2010-12#1)
is photobleached##2##2##(2008-1#1)(2008-9#1)
is phylogenetically related to##2##4##(1997-4#1)(2011-2#1)
is phylogenetically##4##2##(1997-4#1)(2008-10#2)(2011-2#1)
is physically linked to##3##4##(1993-6#1)(1996-10#1)(2008-4#1)
is physically##6##2##(1993-6#1)(1996-10#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-7#1)
is pivotal to##3##3##(1995-11#1)(1995-2#1)(2008-1#1)
is pivotal##5##2##(1995-11#1)(1995-2#1)(2008-1#1)(2012-2#1)(2013-7#1)
is placed at the##2##4##(2007-11#1)(2008-10#1)
is placed at##6##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
is placed in the##7##4##(1994-7#1)(2008-3#5)(2008-5#1)
is placed in##10##3##(1994-7#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#1)
is placed inside a##2##4##(2008-10#1)(2008-3#1)
is placed on the##3##4##(2009-10#1)(2010-10#1)(2010-3#1)
is placed on##22##3##(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#1)(2010-3#1)(2012-3#1)
is placed##50##2##(1990-10#1)(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-7#1)(1996-3#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#14)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
is plagued##2##2##(1995-5#1)(2008-3#1)
is planned to##2##3##(1994-12#1)(2011-1#1)
is planned##10##2##(1994-12#1)(1994-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#2)(2010-12#1)(2011-1#1)
is planning##2##2##(1996-12#1)(2008-5#1)
is plausible that##4##3##(2008-11#1)(2009-6#1)(2009-7#1)(2009-8#1)
is plausible##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)
is played by##2##3##(1996-2#1)(2008-10#1)
is plentiful##2##2##(2008-6#1)(2009-4#1)
is plotted##2##2##(1997-6#1)(2008-11#1)
is pointed out##4##3##(1996-3#1)(2008-2#3)
is poor in##2##3##(2007-10#1)(2013-8#1)
is poor##25##2##(1992-6#1)(1996-9#1)(2007-10#2)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is poorly documented##3##3##(1990-12#1)(1995-5#1)(2012-1#1)
is poorly known##3##3##(1997-5#1)(2008-10#1)(2008-5#1)
is poorly soluble in##2##4##(2008-10#1)(2010-3#1)
is poorly understood##26##3##(1996-11#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
is poorly##45##2##(1990-12#1)(1991-3#1)(1995-5#1)(1996-11#1)(1997-5#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
is popular##2##2##(2008-10#1)(2008-5#1)
is porous##2##2##(2008-11#1)(2008-5#1)
is portable##3##2##(2008-10#2)(2008-9#1)
is positioned at the##2##4##(1995-8#1)(2008-10#1)
is positioned at##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
is positioned##6##2##(1991-12#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-3#1)
is positive and##2##3##(1995-2#1)(2008-11#1)
is positive for##2##3##(1990-6#1)(2008-10#1)
is positive##11##2##(1990-6#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-9#1)(2012-2#1)
is positively associated with##3##4##(1995-8#1)(2008-7#1)(2012-1#1)
is positively correlated with the##2##5##(1991-7#1)(2008-5#1)
is positively correlated with##3##4##(1991-7#1)(2008-5#1)(2012-3#1)
is positively related to##5##4##(1991-12#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-3#1)
is positively related##6##3##(1991-12#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-3#1)
is positively##14##2##(1991-12#1)(1991-7#1)(1993-6#1)(1995-8#1)(2007-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-3#2)
is possible after##2##3##(1990-12#1)(2007-11#1)
is possible and safe##2##4##(1990-12#1)(2012-3#1)
is possible and the##2##4##(2008-10#1)(2008-11#1)
is possible and##9##3##(1990-12#1)(1993-3#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2012-3#1)
is possible at##2##3##(2008-10#1)(2008-2#1)
is possible by the##2##4##(1996-5#1)(2008-10#1)
is possible by use of##2##5##(2007-11#1)(2008-3#1)
is possible by##13##3##(1990-9#1)(1993-12#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-3#1)(2008-5#1)(2013-8#1)
is possible for##6##3##(1995-5#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-6#1)
is possible if the##2##4##(2008-4#1)(2008-8#1)
is possible if##6##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#3)
is possible in the##4##4##(2008-1#1)(2008-10#2)(2013-1#1)
is possible in##11##3##(1991-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2013-1#1)
is possible only if##2##4##(2008-10#1)(2008-8#1)
is possible only##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
is possible that future##2##4##(1992-8#1)(2008-4#1)
is possible that low##2##4##(2008-7#1)(2012-2#1)
is possible that the##13##4##(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#2)
is possible that they##3##4##(1994-5#1)(2008-11#1)(2011-2#1)
is possible that this##3##4##(1995-5#1)(1997-1#1)(2008-9#1)
is possible that##55##3##(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
is possible to achieve##3##4##(2007-11#1)(2008-2#2)
is possible to detect a##2##5##(1990-3#1)(2008-10#1)
is possible to detect##5##4##(1990-3#1)(2008-10#2)(2008-3#1)(2008-4#1)
is possible to determine the##7##5##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
is possible to determine##11##4##(1997-2#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
is possible to extract##5##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
is possible to identify##3##4##(1996-3#1)(2006-4#1)(2008-11#1)
is possible to produce##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
is possible to##157##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#8)(2007-8#2)(2008-1#2)(2008-10#33)(2008-11#10)(2008-12#3)(2008-2#13)(2008-3#20)(2008-4#6)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#1)(2009-4#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
is possible when##2##3##(2008-2#1)(2008-3#1)
is possible with a##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
is possible with##17##3##(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)
is possible without##2##3##(2008-3#1)(2011-2#1)
is possible##338##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#3)(1994-5#5)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#4)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-10#1)(2007-11#16)(2007-12#17)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#59)(2008-11#18)(2008-12#4)(2008-2#19)(2008-3#35)(2008-4#9)(2008-5#13)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#9)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#3)
is possibly a##3##3##(1994-8#1)(1996-12#1)(2007-12#1)
is possibly##13##2##(1990-11#1)(1991-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)
is postulated that##9##3##(1992-12#1)(1992-2#1)(1995-8#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)
is postulated to be a##2##5##(1994-2#1)(2008-5#1)
is postulated to be##4##4##(1994-2#1)(2008-10#1)(2008-5#1)(2011-1#1)
is postulated to##6##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)
is postulated##19##2##(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-1#1)
is potentially life-threatening##2##3##(1997-5#1)(2008-7#1)
is potentially reversible##2##3##(2008-1#1)(2008-7#1)
is potentially useful for##2##4##(2008-10#1)(2012-2#1)
is potentially useful in##2##4##(1992-12#1)(1994-11#1)
is potentially useful##4##3##(1992-12#1)(1994-11#1)(2008-10#1)(2012-2#1)
is potentially##29##2##(1990-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#3)(2008-7#3)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)
is potentiated by##5##3##(1994-12#1)(1994-6#1)(2008-4#1)(2008-5#1)(2008-8#1)
is potentiated##6##2##(1994-12#1)(1994-6#1)(1996-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
is practical##4##2##(1994-3#1)(2008-10#1)(2008-3#2)
is practically##3##2##(1994-12#1)(2008-10#2)
is practiced##4##2##(1995-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
is preceded by a##4##4##(1990-2#1)(1991-11#1)(1994-12#1)(1994-2#1)
is preceded by##9##3##(1990-2#1)(1991-11#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#2)(2008-5#1)(2012-3#1)
is preceded##13##2##(1990-2#1)(1991-11#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-3#1)
is precise and##2##3##(1992-12#1)(2008-10#1)
is precise##3##2##(1992-12#1)(2007-11#1)(2008-10#1)
is precisely##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
is preconcentrated##4##2##(2008-10#4)
is predicated on##3##3##(2008-11#1)(2008-2#1)(2009-4#1)
is predicted by the##2##4##(2008-3#2)
is predicted by##7##3##(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
is predicted in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is predicted to be##9##4##(1991-2#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2012-2#1)
is predicted to encode a protein of##2##7##(1990-8#1)(1996-6#1)
is predicted to encode a##5##5##(1990-8#1)(1996-6#1)(2008-10#2)(2008-6#1)
is predicted to increase##2##4##(1995-12#1)(2008-9#1)
is predicted to##23##3##(1990-7#1)(1990-8#1)(1991-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2012-2#1)(2013-8#2)
is predicted##46##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-6#1)(2007-11#1)(2007-12#7)(2008-10#4)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2011-2#1)(2012-2#1)(2013-8#2)
is predictive of increased liver enzymes and##2##7##(2012-3#2)
is predictive of##8##3##(1992-12#1)(1994-8#1)(1996-6#1)(2009-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
is predictive##10##2##(1992-12#1)(1994-8#1)(1996-6#1)(2009-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
is predominant in##2##3##(1995-3#1)(2012-1#1)
is predominant##6##2##(1995-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
is predominantly expressed in the##2##5##(1995-8#1)(1997-2#1)
is predominantly expressed in##4##4##(1995-8#2)(1997-2#1)(2009-8#1)
is predominantly expressed##5##3##(1990-12#1)(1995-8#2)(1997-2#1)(2009-8#1)
is predominantly localized in the##2##5##(1994-12#1)(2008-10#1)
is predominantly used to##2##4##(2008-4#1)(2008-7#1)
is predominantly##19##2##(1990-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-8#2)(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
is preferable that##2##3##(2007-12#1)(2008-11#1)
is preferable to use##2##4##(2008-10#2)
is preferable to##8##3##(1990-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-3#1)(2013-1#1)
is preferable##15##2##(1990-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-3#1)(2013-1#2)
is preferentially##4##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#1)
is preferred for##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
is preferred in##3##3##(1997-3#1)(2008-3#1)(2010-5#1)
is preferred##12##2##(1990-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-5#1)(2013-8#1)
is prepared by##6##3##(2008-10#6)
is prepared in##3##3##(1996-2#1)(2008-4#2)
is prepared##17##2##(1995-2#1)(1996-2#1)(2008-10#11)(2008-4#4)
is preparing##2##2##(1996-5#1)(2008-5#1)
is prerequisite for##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
is prescribed##3##2##(1991-11#1)(1996-2#1)(1996-4#1)
is present and##2##3##(2009-6#1)(2011-2#1)
is present as a single copy##2##6##(1993-2#1)(1997-4#1)
is present as a##6##4##(1993-2#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-6#1)(2012-1#1)
is present as##9##3##(1990-8#1)(1993-2#1)(1994-11#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-1#1)
is present at the##3##4##(1992-8#1)(1994-6#1)(2008-10#1)
is present at##9##3##(1990-5#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(2008-10#3)
is present in a##4##4##(1990-11#1)(1992-2#1)(1993-6#1)(1995-2#1)
is present in about##2##4##(2008-1#1)(2011-2#1)
is present in all##2##4##(1991-2#1)(2011-2#1)
is present in different##2##4##(2008-9#1)(2013-1#1)
is present in high##2##4##(1992-6#1)(2008-10#1)
is present in large##2##4##(1992-6#1)(1994-8#1)
is present in most##4##4##(1992-12#1)(2008-10#1)(2009-2#1)(2010-6#1)
is present in several##2##4##(1992-9#1)(2008-7#1)
is present in the sample##2##5##(2008-10#2)
is present in the soluble##2##5##(1991-7#1)(2008-10#1)
is present in the##29##4##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#2)(1991-7#1)(1992-3#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-5#2)(1994-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-6#1)(2009-8#1)(2012-7#1)
is present in these##2##4##(1991-5#1)(2008-10#1)
is present in this##2##4##(1995-2#2)
is present in##90##3##(1990-11#2)(1990-12#1)(1990-2#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-5#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#4)(1993-6#3)(1993-8#2)(1993-9#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-2#3)(1997-2#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
is present is##2##3##(2008-10#1)(2009-10#1)
is present on##6##3##(1990-11#1)(1992-6#1)(1993-9#1)(1997-7#1)(2008-10#1)(2011-2#1)
is present only in##3##4##(1993-12#1)(2008-6#1)(2008-7#1)
is present only##4##3##(1993-12#1)(2008-6#2)(2008-7#1)
is present throughout##2##3##(1994-2#1)(2008-10#1)
is present to##2##3##(1994-5#1)(2008-10#1)
is present within the##2##4##(1991-9#1)(1994-6#1)
is present##157##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#3)(1995-2#4)(1995-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-12#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#2)(2013-8#2)
is present)##2##2##(1995-2#1)(2008-10#1)
is presented along with##4##4##(2007-12#1)(2007-5#1)(2008-3#2)
is presented and applied to the##3##6##(1994-12#1)(2008-3#2)
is presented and compared with##2##5##(2008-10#1)(2008-3#1)
is presented and compared##3##4##(1993-6#1)(2008-10#1)(2008-3#1)
is presented and discussed##3##4##(1990-8#1)(2008-3#1)(2009-3#1)
is presented and the##7##4##(1990-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#1)(2011-7#1)
is presented and##32##3##(1990-12#1)(1990-3#1)(1990-8#1)(1992-11#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2009-11#1)(2009-3#1)(2011-1#2)(2011-7#1)(2013-8#1)
is presented as a new##2##5##(2007-12#1)(2008-10#1)
is presented as a##21##4##(1993-1#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-8#1)(2012-2#1)
is presented as an alternative##2##5##(2008-10#1)(2008-3#1)
is presented as an example##2##5##(2008-2#1)(2009-8#1)
is presented as an##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2009-8#1)
is presented as##32##3##(1993-1#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
is presented based on##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
is presented by##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
is presented for a##2##4##(2008-11#1)(2008-3#1)
is presented for calculating##2##4##(2007-12#1)(2008-2#1)
is presented for determination of##2##5##(2008-10#2)
is presented for measuring##2##4##(2008-3#1)(2008-4#1)
is presented for the analysis of polycyclic aromatic hydrocarbons##2##9##(2008-10#2)
is presented for the analysis of##3##6##(1992-8#1)(2008-10#2)
is presented for the determination of##6##6##(2008-10#6)
is presented for the##33##4##(1990-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#15)(2008-2#2)(2008-3#7)(2008-4#1)(2008-7#1)
is presented for##64##3##(1990-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#1)(2008-2#7)(2008-3#14)(2008-4#5)(2008-7#1)(2010-8#1)(2013-1#2)
is presented from a##2##4##(2007-10#1)(2008-1#1)
is presented from##4##3##(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)
is presented here##13##3##(1990-5#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
is presented in detail##4##4##(1992-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
is presented in the context of##2##6##(2007-12#1)(2008-2#1)
is presented in the##8##4##(2007-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-10#2)(2011-1#1)
is presented in this paper##13##5##(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-7#1)
is presented in this work##3##5##(2008-10#3)
is presented in this##21##4##(1992-1#1)(1995-1#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)
is presented in which the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
is presented in which##10##4##(1990-2#1)(1991-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
is presented in##50##3##(1990-2#1)(1991-2#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#2)(2011-1#1)
is presented of a##4##4##(1992-2#1)(1993-2#1)(2008-10#1)(2013-7#1)
is presented of an##2##4##(1996-7#1)(2010-3#1)
is presented of the##3##4##(1992-3#1)(2007-12#1)(2008-2#1)
is presented of##13##3##(1990-8#1)(1992-2#2)(1992-3#1)(1993-2#1)(1996-7#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-7#1)
is presented on the##4##4##(1992-1#1)(2008-1#1)(2008-10#2)
is presented on##5##3##(1992-1#1)(2008-1#1)(2008-10#2)(2008-11#1)
is presented that allows##2##4##(2008-2#1)(2008-3#1)
is presented that can##2##4##(2007-12#1)(2008-3#1)
is presented that combines the##2##5##(2008-2#1)(2008-3#1)
is presented that is based##2##5##(1997-1#1)(2008-2#1)
is presented that is##4##4##(1997-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
is presented that provides##2##4##(2008-2#2)
is presented that##38##3##(1990-2#1)(1992-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(2007-12#3)(2008-10#3)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#1)(2011-2#1)
is presented to characterize the performance of##2##7##(2008-2#1)(2008-3#1)
is presented to demonstrate##2##4##(1990-8#1)(2008-7#1)
is presented to determine##2##4##(2008-2#1)(2008-3#1)
is presented to explain##2##4##(2008-2#1)(2009-2#1)
is presented to show the##2##5##(2008-10#1)(2008-5#1)
is presented to show##5##4##(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
is presented to##34##3##(1990-12#1)(1990-8#1)(1995-2#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#2)(2013-1#1)
is presented together with a##2##5##(2008-3#1)(2013-7#1)
is presented together with##7##4##(2008-10#1)(2008-2#1)(2008-3#4)(2013-7#1)
is presented using##2##3##(1991-5#1)(2008-4#1)
is presented where##2##3##(1994-11#1)(2008-9#1)
is presented which##4##3##(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
is presented with the##3##4##(1990-6#1)(2008-10#1)(2008-3#1)
is presented with##10##3##(1990-6#1)(2007-10#1)(2008-10#4)(2008-3#3)(2008-9#1)
is presented within##2##3##(1992-1#1)(2010-11#1)
is presented##896##2##(1990-12#3)(1990-2#2)(1990-3#4)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-8#2)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#3)(1995-11#3)(1995-2#5)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#36)(2007-12#35)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#5)(2008-10#184)(2008-11#21)(2008-12#3)(2008-2#81)(2008-3#226)(2008-4#25)(2008-5#12)(2008-6#5)(2008-7#28)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#5)(2013-7#5)(2013-8#4)
is presently insufficient##2##3##(1994-5#1)(2008-3#1)
is presently the##2##3##(2007-8#1)(2013-7#1)
is presently unclear##2##3##(1993-11#1)(1993-6#1)
is presently##16##2##(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-4#1)(1997-4#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-3#1)(2013-7#1)
is preserved in the##2##4##(2008-2#1)(2008-7#1)
is preserved in##3##3##(1993-12#1)(2008-2#1)(2008-7#1)
is preserved##8##2##(1993-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-12#1)(2011-1#1)
is presumably##10##2##(1993-6#1)(1994-11#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)
is presumed that##5##3##(1993-8#1)(1995-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
is presumed to be##2##4##(1994-5#1)(2010-5#1)
is presumed to##8##3##(1991-12#1)(1993-6#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)
is presumed##15##2##(1991-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
is prevalent among##2##3##(2008-9#1)(2012-3#1)
is prevalent in##6##3##(2008-10#1)(2008-2#1)(2009-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
is prevalent##11##2##(1996-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
is preventable##2##2##(1993-11#1)(2013-8#1)
is prevented by##3##3##(1990-10#1)(1990-11#1)(1992-3#1)
is prevented##6##2##(1990-10#1)(1990-11#1)(1992-3#1)(1992-8#1)(1994-6#1)(2008-3#1)
is prevention##2##2##(1996-12#1)(2010-1#1)
is primarily a##4##3##(1992-3#1)(1997-2#1)(2008-3#1)(2012-12#1)
is primarily based on##3##4##(2008-8#1)(2010-11#1)(2011-2#1)
is primarily controlled by##2##4##(1993-8#1)(1994-5#1)
is primarily driven by##2##4##(2008-10#1)(2012-2#1)
is primarily due to##4##4##(2008-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
is primarily in the##2##4##(1994-9#1)(1997-8#1)
is primarily responsible for the##4##5##(1990-12#1)(2008-11#1)(2008-5#1)(2009-12#1)
is primarily responsible for##5##4##(1990-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)
is primarily##47##2##(1990-12#2)(1992-10#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
is primary##5##2##(1991-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-6#1)
is principally##2##2##(2008-10#1)(2008-11#1)
is printed##2##2##(1992-3#1)(2008-3#1)
is probable that##4##3##(1991-1#1)(1995-8#1)(2007-12#1)(2008-12#1)
is probable##7##2##(1991-1#1)(1995-8#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-12#1)(2012-12#1)
is probably a major##2##4##(2008-10#1)(2012-12#1)
is probably a##6##3##(1990-6#1)(1995-11#1)(1995-5#1)(1997-6#1)(2008-10#1)(2012-12#1)
is probably an##5##3##(1992-4#1)(1994-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
is probably associated with##2##4##(2009-7#1)(2011-2#1)
is probably due to a##2##5##(1991-11#1)(1992-6#1)
is probably due to##7##4##(1991-11#1)(1991-2#1)(1991-9#1)(1992-6#1)(1994-2#1)(2008-10#1)(2008-3#1)
is probably involved in##3##4##(1990-5#1)(1992-9#1)(2008-7#1)
is probably mediated by##2##4##(1996-2#1)(1997-2#1)
is probably more##2##3##(2008-2#1)(2009-11#1)
is probably much##2##3##(1991-12#1)(2008-10#1)
is probably not##5##3##(1992-12#1)(1994-5#1)(2008-10#2)(2010-3#1)
is probably one of the##3##5##(2008-7#1)(2008-9#1)(2013-1#1)
is probably related to the##2##5##(1997-2#1)(2008-7#1)
is probably related to##4##4##(1996-2#1)(1997-2#1)(2008-7#1)(2011-1#1)
is probably related##5##3##(1996-2#1)(1997-2#1)(2008-7#1)(2010-8#1)(2011-1#1)
is probably responsible for##2##4##(1997-1#1)(2008-10#1)
is probably the most##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
is probably the reason for the##2##6##(2008-5#1)(2009-8#1)
is probably the##14##3##(1991-12#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
is probably##92##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-2#3)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-6#1)(2007-11#2)(2008-1#3)(2008-10#15)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is probed with##2##3##(2007-12#1)(2008-1#1)
is probed##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
is problematic in##2##3##(2008-10#1)(2011-2#1)
is problematic##8##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#2)(2013-1#1)
is processed by##2##3##(2008-2#1)(2008-3#1)
is processed in a##2##4##(1995-12#1)(2008-11#1)
is processed in the##2##4##(2008-12#1)(2013-8#1)
is processed in##5##3##(1995-12#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
is processed##10##2##(1994-11#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2012-2#1)(2013-8#1)
is processing##2##2##(2007-7#1)(2008-3#1)
is produced and##3##3##(1993-3#1)(2007-12#1)(2008-10#1)
is produced as##3##3##(1994-9#1)(2008-5#1)(2009-5#1)
is produced at##4##3##(1992-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
is produced by a##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
is produced by the##6##4##(1991-12#1)(1992-9#1)(2008-10#2)(2008-7#1)(2009-12#1)
is produced by two##2##4##(2008-2#1)(2008-3#1)
is produced by##36##3##(1991-12#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-3#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#1)
is produced during##2##3##(2007-12#1)(2008-4#1)
is produced from##2##3##(2008-2#1)(2009-3#1)
is produced in the##2##4##(1992-5#1)(2008-10#1)
is produced in##15##3##(1990-8#1)(1992-5#1)(1992-7#1)(1994-11#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-6#1)(2009-7#1)
is produced through##2##3##(2007-12#1)(2009-8#1)
is produced when##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
is produced##89##2##(1990-8#1)(1991-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#5)(2008-3#12)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
is producing##5##2##(1991-6#1)(1994-12#2)(2008-10#1)(2008-9#1)
is progressing rapidly##3##3##(1995-2#1)(2008-7#1)(2009-11#1)
is progressive##3##2##(1993-6#1)(2008-1#1)(2008-7#1)
is progressively##3##2##(1993-8#1)(2008-3#1)(2013-8#1)
is projected onto##5##3##(2007-12#1)(2008-3#4)
is projected to##3##3##(1994-3#1)(1994-9#1)(2012-12#1)
is projected##13##2##(1992-2#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#6)(2012-12#1)
is prominent##2##2##(1992-12#1)(2006-10#1)
is promising for##5##3##(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#1)
is promising to##2##3##(1992-12#1)(2013-1#1)
is promising##10##2##(1992-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is promoted by##7##3##(1993-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#2)
is prompt##2##2##(1990-11#1)(2008-10#1)
is prone to##4##3##(1995-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
is propagating##2##2##(2007-12#2)
is properly##8##2##(1993-12#1)(1994-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-12#1)
is proportional to the CL intensity##2##6##(2008-10#2)
is proportional to the concentration of the##2##7##(1996-12#1)(2008-10#1)
is proportional to the concentration of##12##6##(1991-2#1)(1996-12#1)(2008-10#9)(2008-12#1)
is proportional to the product of the##2##7##(2008-3#2)
is proportional to the square of the pulse width##2##9##(2008-3#2)
is proportional to the square of the##3##7##(2007-11#1)(2008-3#2)
is proportional to the square root of##2##7##(2007-12#1)(2008-3#1)
is proportional to the square##5##5##(2007-11#1)(2007-12#1)(2008-3#3)
is proportional to the##44##4##(1991-2#1)(1996-12#1)(1996-3#1)(2007-11#4)(2007-12#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#16)(2008-7#1)
is proportional to##64##3##(1991-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#6)(2007-12#4)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#16)(2008-7#4)(2008-8#2)
is proportional##65##2##(1991-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#6)(2007-12#4)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#16)(2008-7#4)(2008-8#2)
is proposed and a##2##4##(2008-10#2)
is proposed and analyzed##3##4##(2008-2#1)(2008-3#2)
is proposed and applied to##3##5##(2008-10#2)(2008-3#1)
is proposed and demonstrated##16##4##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#8)
is proposed and discussed##2##4##(1994-9#1)(2008-3#1)
is proposed and experimentally demonstrated##5##5##(2007-12#5)
is proposed and experimentally##7##4##(1997-2#1)(2007-12#5)(2008-2#1)
is proposed and##44##3##(1994-9#1)(1997-2#1)(2007-11#3)(2007-12#10)(2008-10#9)(2008-2#4)(2008-3#16)
is proposed as a new##2##5##(2008-10#1)(2008-3#1)
is proposed as a##10##4##(1990-5#1)(1993-12#1)(1995-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)
is proposed as an alternative##2##5##(1995-1#1)(2013-7#1)
is proposed as an##5##4##(1991-5#1)(1995-1#1)(2008-10#2)(2013-7#1)
is proposed as the standard##2##5##(2008-2#2)
is proposed as the##4##4##(1990-11#1)(2008-2#2)(2013-1#1)
is proposed as##21##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-12#1)(1995-1#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-8#1)(2013-1#1)(2013-7#1)
is proposed based on the##2##5##(2008-10#2)
is proposed based on##6##4##(2008-10#4)(2008-11#1)(2009-5#1)
is proposed by##3##3##(1990-5#1)(2008-10#1)(2010-8#1)
is proposed for determination of##2##5##(2007-11#1)(2008-10#1)
is proposed for determining##3##4##(2008-10#2)(2008-11#1)
is proposed for estimating##2##4##(2008-3#1)(2010-11#1)
is proposed for measuring the##3##5##(2008-3#3)
is proposed for measuring##4##4##(2008-3#4)
is proposed for simultaneous determination of##3##6##(2008-10#3)
is proposed for spectrophotometric determination of##2##6##(2008-10#2)
is proposed for spectrophotometric##3##4##(2008-10#3)
is proposed for the determination of thiamine##2##7##(2008-10#2)
is proposed for the determination of trace amounts of##3##9##(2008-10#3)
is proposed for the determination of trace##4##7##(2008-10#4)
is proposed for the determination of##31##6##(2008-10#31)
is proposed for the extraction of##3##6##(2008-10#2)(2008-3#1)
is proposed for the extraction##5##5##(2008-10#4)(2008-3#1)
is proposed for the resolution of##2##6##(2008-10#2)
is proposed for the simultaneous determination of##6##7##(2008-10#6)
is proposed for the simultaneous##7##5##(2008-10#7)
is proposed for the spectrophotometric determination of##4##7##(2008-10#4)
is proposed for the##84##4##(1995-6#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#69)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-6#1)
is proposed for##135##3##(1990-5#1)(1990-8#1)(1995-6#1)(1996-2#1)(1996-4#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#92)(2008-11#2)(2008-2#6)(2008-3#17)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-6#1)
is proposed here##2##3##(2008-10#1)(2008-3#1)
is proposed in the##3##4##(2008-10#1)(2010-5#1)(2013-8#1)
is proposed in this paper##5##5##(2008-10#4)(2008-6#1)
is proposed in this##7##4##(2008-10#5)(2008-6#1)(2008-7#1)
is proposed in which the##2##5##(1991-5#1)(2008-3#1)
is proposed in which##4##4##(1991-5#1)(1991-9#1)(2007-12#1)(2008-3#1)
is proposed in##16##3##(1991-5#1)(1991-9#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2013-8#1)
is proposed that combines##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
is proposed that is based on the##2##7##(2008-3#2)
is proposed that is##3##4##(2008-3#2)(2008-6#1)
is proposed that the##15##4##(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-6#1)(2010-10#1)(2013-8#2)
is proposed that this##2##4##(2008-10#1)(2012-12#1)
is proposed that uses##2##4##(2007-12#1)(2010-5#1)
is proposed that##59##3##(1990-12#1)(1990-7#1)(1991-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#3)
is proposed to account for##2##5##(1996-5#1)(2008-9#1)
is proposed to be##6##4##(1995-5#2)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
is proposed to explain the##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
is proposed to improve##2##4##(2008-3#2)
is proposed to increase the##2##5##(2007-11#1)(2008-2#1)
is proposed to involve the Fe((III))Pc/Fe((II))Pc redox process##2##8##(2008-10#2)
is proposed to occur##2##4##(1994-8#1)(2008-10#1)
is proposed to reduce##2##4##(2007-11#1)(2008-2#1)
is proposed to retrieve##2##4##(2008-3#2)
is proposed to select##2##4##(2008-10#2)
is proposed to##50##3##(1994-3#1)(1994-8#2)(1995-5#2)(1996-2#1)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is proposed using##4##3##(2008-10#3)(2010-8#1)
is proposed when##2##3##(1991-2#1)(2008-10#1)
is proposed whereby##2##3##(1994-2#1)(2011-2#1)
is proposed with##2##3##(1991-5#1)(2008-10#1)
is proposed##661##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-9#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#2)(1997-2#1)(1997-7#2)(2006-6#1)(2007-11#25)(2007-12#33)(2007-8#2)(2008-1#4)(2008-10#285)(2008-11#9)(2008-12#2)(2008-2#40)(2008-3#118)(2008-4#2)(2008-5#6)(2008-6#12)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-11#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#10)
is protected##3##2##(1992-1#1)(1994-3#1)(2008-11#1)
is protective##3##2##(1995-5#1)(2008-5#1)(2009-5#1)
is protein##2##2##(1994-8#1)(2010-2#1)
is proteolytically##2##2##(1992-12#2)
is protonated##3##2##(1991-9#1)(1995-2#1)(1996-2#1)
is proved by##2##3##(2008-10#1)(2008-3#1)
is proved that the##2##4##(2008-3#1)(2011-1#1)
is proved that##3##3##(2008-3#1)(2011-1#1)(2011-2#1)
is proved to be##5##4##(2008-10#2)(2008-8#2)(2009-7#1)
is proved to##6##3##(2008-10#2)(2008-2#1)(2008-8#2)(2009-7#1)
is proved##12##2##(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)
is proven to be##2##4##(2008-11#1)(2013-8#1)
is proven##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
is provided and##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
is provided by a##5##4##(1997-2#1)(1997-6#1)(2008-10#1)(2008-3#2)
is provided by the##4##4##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
is provided by##17##3##(1994-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#1)
is provided for a##2##4##(2008-3#1)(2008-7#1)
is provided for measuring##2##4##(2008-4#2)
is provided for the##2##4##(2008-2#1)(2008-5#1)
is provided for##22##3##(1994-1#1)(1994-2#1)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#2)(2008-7#2)(2010-3#1)(2013-8#1)
is provided herein##2##3##(1992-1#1)(2008-5#1)
is provided in this study##3##5##(2008-10#3)
is provided in this##4##4##(2008-10#3)(2008-11#1)
is provided in##9##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2012-3#1)(2013-8#1)
is provided that##4##3##(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#1)
is provided to##9##3##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2012-12#1)(2013-7#1)
is provided with##3##3##(1992-1#1)(1996-1#1)(2008-2#1)
is provided##135##2##(1992-1#3)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-12#5)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#28)(2008-5#6)(2008-7#6)(2008-8#1)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
is providing##5##2##(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-5#1)
is prudent##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
is publicly available on the##2##5##(2008-3#1)(2008-4#1)
is publicly available##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
is published##2##2##(2008-11#1)(2010-8#1)
is pumped by a diode-pumped##2##5##(2007-11#1)(2007-12#1)
is pumped by a##8##4##(2007-11#4)(2007-12#3)(2008-2#1)
is pumped by##11##3##(2007-11#4)(2007-12#4)(2008-2#3)
is pumped with##2##3##(2007-11#2)
is pumped##18##2##(2007-11#6)(2007-12#5)(2008-10#4)(2008-2#3)
is pure##2##2##(2007-12#1)(2013-8#1)
is purified##2##2##(2008-4#1)(2008-8#1)
is put forward##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
is put##7##2##(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-1#1)
is puzzling##2##2##(1997-7#1)(2012-3#1)
is qualified##2##2##(2007-12#1)(2012-2#1)
is qualitatively different##2##3##(2008-12#1)(2008-9#1)
is qualitatively similar to##2##4##(2008-4#1)(2008-8#1)
is qualitatively##8##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
is quantified by the##2##4##(2008-1#1)(2008-9#1)
is quantified by##7##3##(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)
is quantified##13##2##(1990-8#1)(1992-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-8#1)
is quantitated##2##2##(2008-10#2)
is quantitative and##2##3##(2007-11#1)(2008-10#1)
is quantitative##6##2##(2007-11#1)(2008-10#5)
is quantitatively adsorbed on##2##4##(2008-10#2)
is quantitatively described by##2##4##(1990-5#1)(2009-11#1)
is quantitatively retained by##2##4##(2008-10#2)
is quantitatively retained on##3##4##(2008-10#3)
is quantitatively retained##5##3##(2008-10#5)
is quantitatively the##2##3##(1993-12#1)(2008-1#1)
is quantitatively##17##2##(1990-5#2)(1993-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-3#1)(2009-11#1)
is questionable whether this##2##4##(1996-9#1)(2008-10#1)
is questionable##10##2##(1990-12#1)(1991-2#1)(1991-6#1)(1995-2#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-2#1)(2012-3#1)
is questioned by##2##3##(1992-9#2)
is questioned##5##2##(1992-3#1)(1992-9#2)(2008-10#1)(2008-9#1)
is quick and##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
is quick##10##2##(1992-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
is quicker and##2##3##(2008-10#2)
is quicker##3##2##(1996-1#1)(2008-10#2)
is quickly##6##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#1)
is quite common in##4##4##(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
is quite common##6##3##(1995-3#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
is quite different from##3##4##(1996-2#1)(2008-8#1)(2008-9#1)
is quite different##5##3##(1994-12#1)(1996-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
is quite difficult##3##3##(2008-10#1)(2008-9#1)(2009-1#1)
is quite high##3##3##(1991-12#1)(2007-11#1)(2008-2#1)
is quite insensitive to##2##4##(2007-11#1)(2007-12#1)
is quite limited##3##3##(2008-9#1)(2010-6#1)(2011-2#1)
is quite low##3##3##(1996-2#1)(2008-12#1)(2012-3#1)
is quite sensitive##2##3##(2008-10#1)(2008-9#1)
is quite similar##2##3##(2007-12#1)(2008-5#1)
is quite simple and##2##4##(1994-2#1)(2008-10#1)
is quite small##2##3##(1992-1#1)(2008-3#1)
is quite variable##2##3##(1997-3#1)(2008-10#1)
is quite##64##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#3)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#12)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#5)(2009-1#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is radical##2##2##(2008-7#1)(2011-2#1)
is raised##7##2##(1995-2#2)(1996-9#1)(2008-11#1)(2008-6#1)(2010-8#2)
is random##2##2##(1997-2#1)(1997-7#1)
is rapid and simple##4##4##(2008-10#3)(2008-11#1)
is rapid and##12##3##(1993-3#1)(1994-3#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-3#1)
is rapid with##2##3##(2008-10#2)
is rapid##41##2##(1990-12#1)(1991-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-12#1)(2010-3#1)(2010-6#1)(2011-1#2)
is rapidly becoming the##2##4##(2008-4#1)(2012-2#1)
is rapidly becoming##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
is rapidly evolving##2##3##(2008-4#1)(2013-1#1)
is rapidly gaining##2##3##(1997-5#1)(2012-3#1)
is rapidly induced by##2##4##(1994-12#1)(1996-12#1)
is rapidly induced##3##3##(1994-12#1)(1996-12#1)(2008-1#1)
is rapidly phosphorylated on##2##4##(1991-5#1)(1995-8#1)
is rapidly##29##2##(1991-5#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is rare and is##3##4##(1990-8#1)(2010-12#1)(2011-2#1)
is rare and mostly##2##4##(2009-8#1)(2013-7#1)
is rare and when##2##4##(2008-7#1)(2011-2#1)
is rare and##21##3##(1990-8#1)(1991-11#1)(1991-6#1)(1992-8#1)(1997-1#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
is rare but##3##3##(2008-12#1)(2010-12#1)(2011-2#1)
is rare entity##2##3##(2009-7#1)(2012-3#1)
is rare in children##2##4##(2008-8#1)(2012-3#1)
is rare in the##5##4##(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)
is rare in##15##3##(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is rare##104##2##(1990-11#1)(1990-8#2)(1991-11#1)(1991-6#2)(1992-10#1)(1992-8#1)(1995-10#1)(1995-9#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#4)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#9)(2012-12#6)(2012-2#4)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#3)
is rarely associated with##2##4##(1995-1#1)(2012-12#1)
is rarely encountered in##2##4##(2010-10#1)(2011-2#1)
is rarely encountered##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
is rarely found in##3##4##(1994-12#1)(2008-5#1)(2008-8#1)
is rarely reported in the##2##5##(2010-12#1)(2011-2#1)
is rarely reported##3##3##(2006-10#1)(2010-12#1)(2011-2#1)
is rarely seen in##3##4##(1992-11#1)(2011-2#1)(2013-8#1)
is rarely seen##5##3##(1992-11#1)(2008-11#2)(2011-2#1)(2013-8#1)
is rarely##39##2##(1990-6#1)(1992-11#1)(1992-2#1)(1992-4#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
is rarer##2##2##(2008-7#2)
is rate limiting##3##3##(1993-9#1)(1995-2#1)(2008-10#1)
is rate##4##2##(1993-9#1)(1995-2#1)(2008-10#1)(2009-8#1)
is rather limited##2##3##(2008-12#1)(2008-2#1)
is rather low##2##3##(2008-5#1)(2008-6#1)
is rather##22##2##(1990-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-2#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2011-2#1)(2013-1#2)
is rationalized in terms of##2##5##(2008-10#1)(2011-1#1)
is reached and##2##3##(2008-10#1)(2008-2#1)
is reached at##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
is reached when##2##3##(2008-8#1)(2013-8#1)
is reached##19##2##(1993-11#2)(1993-8#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
is reaching epidemic proportions##2##4##(2013-1#1)(2013-8#1)
is reaching##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
is reacted with##3##3##(2008-10#3)
is read out by##2##4##(2008-3#2)
is read out##3##3##(2008-2#1)(2008-3#2)
is read##8##2##(1990-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
is readily achieved##2##3##(2007-11#1)(2008-6#1)
is readily applicable##2##3##(1997-6#1)(2008-10#1)
is readily available##2##3##(1995-9#1)(2013-1#1)
is readily##23##2##(1990-7#1)(1991-5#1)(1992-8#1)(1995-2#1)(1995-9#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
is ready##2##2##(2008-2#1)(2008-7#1)
is real##4##2##(1994-1#1)(1996-3#1)(2008-7#1)(2009-4#1)
is realized by use of a##2##6##(2007-12#2)
is realized by use of##3##5##(2007-12#3)
is realized by##11##3##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#2)(2012-2#1)(2013-1#1)
is realized##18##2##(2007-11#2)(2007-12#5)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
is really a##2##3##(1996-8#1)(2008-10#1)
is really##7##2##(1996-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)
is reasonable to assume that##2##5##(1991-6#2)
is reasonable to##12##3##(1991-6#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
is reasonable##16##2##(1991-6#2)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-3#1)
is reasonably##3##2##(2008-12#1)(2008-3#1)(2011-2#1)
is received by##2##3##(1995-8#1)(2008-3#1)
is received##3##2##(1995-8#1)(2008-3#2)
is receiving##4##2##(1995-1#1)(2010-5#1)(2013-1#2)
is recent##2##2##(2008-8#1)(2012-12#1)
is recently##3##2##(1992-3#1)(2007-7#1)(2008-7#1)
is reciprocally##2##2##(1994-3#1)(1996-5#1)
is recognised as a major##2##5##(2008-11#1)(2012-2#1)
is recognised as a##3##4##(2008-11#1)(2012-2#2)
is recognised as##5##3##(2007-10#1)(2008-11#1)(2012-1#1)(2012-2#2)
is recognised by##2##3##(2008-10#1)(2012-12#1)
is recognised##10##2##(2007-10#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
is recognized as a##4##4##(1990-9#1)(2008-2#1)(2008-4#1)(2012-12#1)
is recognized as an##2##4##(2008-1#1)(2008-6#1)
is recognized as the##4##4##(2007-10#1)(2008-10#1)(2009-10#1)(2010-9#1)
is recognized as##10##3##(1990-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-9#1)(2012-12#1)
is recognized by a##2##4##(1995-6#1)(2008-5#1)
is recognized by several##2##4##(1994-6#1)(2011-2#1)
is recognized by the##2##4##(1992-6#1)(1995-6#1)
is recognized by##10##3##(1992-11#1)(1992-6#1)(1993-11#1)(1994-6#1)(1995-6#2)(2008-11#2)(2008-5#1)(2011-2#1)
is recognized##31##2##(1990-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-6#2)(1996-6#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
is recommended and##2##3##(1994-1#1)(2007-6#1)
is recommended as a##4##4##(1990-10#1)(2008-10#1)(2008-4#1)(2013-1#1)
is recommended as an##4##4##(1991-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
is recommended as the##3##4##(1990-6#1)(2008-10#1)(2008-4#1)
is recommended as##14##3##(1990-10#1)(1990-6#1)(1991-3#1)(2007-10#1)(2008-10#4)(2008-4#2)(2009-6#1)(2011-1#1)(2013-1#2)
is recommended by the##2##4##(1991-9#1)(2008-3#1)
is recommended by##3##3##(1991-9#1)(2007-2#1)(2008-3#1)
is recommended for all##3##4##(2008-12#1)(2009-12#1)(2011-2#1)
is recommended for the##2##4##(2007-12#1)(2008-10#1)
is recommended for##22##3##(1990-12#1)(1992-6#1)(1993-1#1)(1996-3#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is recommended in##7##3##(1990-2#1)(1990-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
is recommended that the use of##2##6##(1994-3#1)(2012-12#1)
is recommended that the##7##4##(1994-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-12#3)
is recommended that this##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
is recommended that##27##3##(1991-3#2)(1994-11#1)(1994-3#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)
is recommended to##11##3##(1992-11#1)(1994-2#1)(1995-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
is recommended##144##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
is reconstructed by##3##3##(2007-11#1)(2008-3#2)
is reconstructed from##3##3##(2008-3#3)
is reconstructed##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
is recorded as an##2##4##(2007-12#1)(2008-6#1)
is recorded as##3##3##(2007-12#2)(2008-6#1)
is recorded by##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is recorded##18##2##(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#2)
is recovered##4##2##(1991-5#1)(2008-2#1)(2010-7#1)(2011-2#1)
is recovering##2##2##(1997-6#1)(2007-8#1)
is recycled##4##2##(1990-8#1)(1996-12#1)(1996-3#1)(2008-7#1)
is reduced and the##2##4##(2007-11#1)(2008-5#1)
is reduced and##6##3##(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-6#1)
is reduced approximately 50% with##2##5##(1994-11#1)(2006-10#1)
is reduced but##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
is reduced by a factor of 2##2##7##(2007-11#1)(2008-10#1)
is reduced by a factor of##5##6##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
is reduced by approximately##2##4##(1992-11#1)(2008-6#1)
is reduced by more than##2##5##(1997-2#1)(2008-10#1)
is reduced by##20##3##(1991-5#1)(1992-11#1)(1994-11#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#4)(2008-6#1)(2008-8#1)(2013-8#1)
is reduced compared##2##3##(2008-3#1)(2008-7#1)
is reduced considerably##2##3##(2007-11#1)(2008-2#1)
is reduced from##5##3##(1993-8#1)(2007-11#2)(2008-10#1)(2008-7#1)
is reduced if##3##3##(2008-10#3)
is reduced in##16##3##(1991-11#1)(1991-2#1)(1993-9#2)(1994-5#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-2#1)
is reduced or##2##3##(2007-11#1)(2008-6#1)
is reduced to Fe(II)##2##4##(2008-10#2)
is reduced to a##3##4##(1993-12#1)(2007-11#1)(2008-10#1)
is reduced to the##5##4##(2008-10#3)(2008-3#1)(2009-10#1)
is reduced to##21##3##(1993-12#2)(1993-6#1)(2007-11#2)(2008-10#9)(2008-2#1)(2008-3#4)(2008-7#1)(2009-10#1)
is reduced when the##2##4##(2007-11#1)(2008-3#1)
is reduced when##4##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-3#1)
is reduced with##2##3##(1997-2#1)(2008-10#1)
is reduced##124##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#10)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
is reduction of##2##3##(1992-8#1)(2007-8#1)
is reduction##3##2##(1992-8#1)(2007-8#1)(2008-5#1)
is reexamined##2##2##(1997-1#1)(2007-12#1)
is referred to as the##4##5##(1992-6#1)(2008-11#1)(2008-2#1)(2008-3#1)
is referred to as##8##4##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-4#1)
is referred to##9##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)
is referred##11##2##(1992-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-3#1)
is refined##2##2##(1992-2#1)(2008-10#1)
is reflected by a mirror##2##5##(2008-10#1)(2008-2#1)
is reflected by the##3##4##(1995-9#1)(2009-10#1)(2010-8#1)
is reflected by##8##3##(1994-12#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-8#1)(2011-2#1)
is reflected from a##3##4##(2007-11#1)(2008-2#2)
is reflected from##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
is reflected in an##2##4##(1996-12#1)(2008-10#1)
is reflected in the##5##4##(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#2)
is reflected in##11##3##(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-11#1)(2012-12#2)
is reflected##27##2##(1994-12#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-11#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#2)
is reformulated in##2##3##(2008-3#2)
is refractory to##2##3##(2008-9#1)(2012-3#1)
is regained##2##2##(1992-11#1)(2008-10#1)
is regarded as a##6##4##(1996-3#1)(2008-1#1)(2008-3#3)(2013-1#1)
is regarded as an##3##4##(2008-11#1)(2009-12#1)(2010-3#1)
is regarded as the##4##4##(1994-3#1)(2008-10#2)(2010-8#1)
is regarded as##21##3##(1991-6#1)(1992-9#1)(1993-2#1)(1994-3#1)(1996-11#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
is registered##3##2##(2008-10#1)(2008-6#1)(2013-8#1)
is regular##3##2##(1992-3#1)(2007-8#1)(2011-3#1)
is regularized##2##2##(2008-3#1)(2008-6#1)
is regularly##4##2##(1993-11#1)(2011-2#2)(2012-1#1)
is regulated at##3##3##(2009-6#1)(2009-8#1)(2013-1#1)
is regulated by a balance##2##5##(2007-10#1)(2013-1#1)
is regulated by a complex##2##5##(2010-8#1)(2012-2#1)
is regulated by a##6##4##(1990-9#1)(1993-3#1)(2007-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
is regulated by both##2##4##(1993-12#1)(2008-11#1)
is regulated by the##9##4##(1990-5#1)(1993-6#1)(1994-10#1)(1994-12#2)(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#1)
is regulated by##63##3##(1990-11#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#5)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)
is regulated in a##2##4##(1991-12#1)(1993-8#1)
is regulated in response to##3##5##(2009-8#1)(2011-1#1)(2011-2#1)
is regulated in##11##3##(1991-12#1)(1993-8#1)(1994-11#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)
is regulated##96##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#7)(2010-11#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#6)
is reinforced by the##2##4##(1996-2#1)(2008-5#1)
is reinforced by##6##3##(1996-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)
is reinforced##8##2##(1996-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)
is rejected##2##2##(2008-2#1)(2008-8#1)
is related by##2##3##(1991-12#1)(1993-8#1)
is related to a##4##4##(2008-10#2)(2008-6#1)(2008-7#1)
is related to better##2##4##(2007-12#1)(2010-2#1)
is related to both##2##4##(1992-9#1)(2009-11#1)
is related to differences in##2##5##(1994-5#1)(2008-11#1)
is related to financial##2##4##(2010-10#2)
is related to the level##2##5##(2008-11#1)(2008-5#1)
is related to the optical##2##5##(2007-12#2)
is related to the previously##2##5##(1992-12#1)(1993-12#1)
is related to the specific energy dissipation rate##2##8##(2008-7#2)
is related to the##65##4##(1990-12#1)(1991-12#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1997-2#1)(2007-12#3)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
is related to their##4##4##(1993-9#1)(2008-5#1)(2008-8#1)(2013-7#1)
is related to##145##3##(1990-12#3)(1990-8#1)(1991-12#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-5#3)(1994-6#3)(1994-9#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
is related with##3##3##(2008-10#1)(2011-2#2)
is related##154##2##(1990-12#3)(1990-8#1)(1991-12#2)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-2#2)(1994-5#3)(1994-6#3)(1994-9#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
is relatively common##2##3##(2008-10#1)(2009-9#1)
is relatively easy to##3##4##(1991-3#1)(2011-1#1)(2012-12#1)
is relatively easy##5##3##(1991-3#1)(1997-3#1)(2008-8#1)(2011-1#1)(2012-12#1)
is relatively high##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
is relatively homogeneous##2##3##(2008-10#1)(2010-3#1)
is relatively insensitive to##3##4##(1992-3#1)(1995-2#1)(2008-3#1)
is relatively insensitive##4##3##(1992-3#1)(1995-2#1)(2008-2#1)(2008-3#1)
is relatively less##5##3##(1990-12#1)(2008-8#2)(2008-9#1)(2009-6#1)
is relatively low##6##3##(1990-8#1)(1994-2#1)(2008-3#1)(2009-11#1)(2010-4#1)(2011-2#1)
is relatively new##3##3##(1995-3#1)(2008-10#1)(2010-11#1)
is relatively rare##7##3##(2007-7#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
is relatively short##2##3##(2009-12#1)(2010-8#1)
is relatively simple and##2##4##(2008-3#2)
is relatively simple##3##3##(2007-12#1)(2008-3#2)
is relatively small##2##3##(2008-8#1)(2009-5#1)
is relatively stable##2##3##(2008-10#1)(2008-5#1)
is relatively uncommon##3##3##(1992-4#1)(2013-1#2)
is relatively unstable##2##3##(1990-5#1)(2008-9#1)
is relatively weak##2##3##(1996-2#1)(1997-1#1)
is relatively##89##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-4#2)(1992-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#15)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#7)
is released as##2##3##(2008-7#1)(2011-1#1)
is released by##2##3##(2007-12#1)(2010-4#1)
is released during the##2##4##(1990-5#1)(1992-6#1)
is released from the##3##4##(1990-7#1)(2008-3#1)(2008-4#1)
is released from##13##3##(1990-2#1)(1990-7#1)(1992-3#1)(1992-6#2)(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)
is released##30##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-8#1)(1992-3#1)(1992-6#3)(1995-11#2)(1995-2#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2010-4#1)(2011-1#1)
is relevant for the##2##4##(2008-8#1)(2010-12#1)
is relevant for##6##3##(2007-12#2)(2008-3#2)(2008-8#1)(2010-12#1)
is relevant to the##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
is relevant to##11##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)
is relevant##23##2##(1992-11#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-3#1)
is reliable and##3##3##(1990-8#1)(2008-10#1)(2010-11#1)
is reliable for##4##3##(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
is reliable##9##2##(1990-8#1)(1993-12#1)(1995-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)
is reliably##2##2##(2008-2#1)(2012-2#1)
is relieved##5##2##(1990-9#2)(1995-8#1)(2008-3#2)
is remarkable##12##2##(1991-11#1)(1991-6#1)(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#3)
is remarkably##7##2##(1992-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#2)
is reminiscent of that##2##4##(1993-8#1)(2008-3#1)
is reminiscent of the##6##4##(1993-3#1)(1995-2#1)(1996-10#1)(1997-2#1)(2007-12#1)(2009-6#1)
is reminiscent of##9##3##(1993-3#1)(1993-8#1)(1995-2#1)(1996-10#1)(1997-2#1)(2007-12#2)(2008-3#1)(2009-6#1)
is removed by precipitation##2##4##(2008-10#2)
is removed by the##2##4##(2008-3#1)(2011-1#1)
is removed by##8##3##(1994-12#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-1#1)
is removed from the##3##4##(2008-5#1)(2010-8#1)(2011-2#1)
is removed from##4##3##(1995-9#1)(2008-5#1)(2010-8#1)(2011-2#1)
is removed in##2##3##(1990-8#1)(2010-6#1)
is removed to##2##3##(1997-7#1)(2008-10#1)
is removed##29##2##(1990-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-9#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
is rendered##4##2##(1991-2#1)(2007-11#1)(2008-3#1)(2012-2#1)
is repeatable##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
is repeated##6##2##(1992-3#1)(1994-9#1)(1997-2#1)(2007-12#1)(2008-11#1)(2010-5#1)
is repeatedly##2##2##(1997-5#1)(2008-1#1)
is replaced by a##6##4##(1991-2#1)(1995-5#1)(2008-10#1)(2008-3#2)(2008-4#1)
is replaced by##14##3##(1990-11#1)(1991-2#1)(1992-3#1)(1994-12#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-1#1)
is replaced with a##3##4##(2008-10#1)(2008-3#2)
is replaced with##8##3##(1994-5#1)(1997-7#1)(2008-10#2)(2008-3#3)(2013-1#1)
is replaced##24##2##(1990-11#1)(1991-2#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-8#1)(2009-1#1)(2013-1#1)
is reported and##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
is reported as a##2##4##(1995-3#1)(2008-10#1)
is reported as an##2##4##(2008-10#1)(2012-2#1)
is reported as##7##3##(1991-8#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2012-2#1)
is reported between##2##3##(1992-6#1)(1994-5#1)
is reported for the determination of##3##6##(2008-10#3)
is reported for the first time to our knowledge##2##9##(2007-11#1)(2008-3#1)
is reported for the first time##9##6##(1994-11#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-6#1)(2010-10#1)
is reported for the simultaneous##2##5##(2008-10#2)
is reported for the##19##4##(1994-11#1)(2007-11#1)(2008-10#12)(2008-3#2)(2008-6#1)(2010-10#1)(2010-5#1)
is reported for##24##3##(1994-11#1)(2007-11#1)(2008-10#13)(2008-2#2)(2008-3#3)(2008-6#1)(2010-10#1)(2010-11#1)(2010-5#1)
is reported here##10##3##(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-2#1)
is reported if the##2##4##(1997-5#1)(2008-10#1)
is reported in a##6##4##(1990-6#1)(2007-12#1)(2007-8#2)(2009-5#1)(2010-3#1)
is reported in this##3##4##(2008-10#3)
is reported in which##3##4##(1995-3#1)(2007-11#1)(2008-10#1)
is reported in##16##3##(1990-6#2)(1992-9#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-9#1)(2009-5#1)(2010-3#1)(2012-12#1)
is reported of##4##3##(1990-6#2)(1991-3#1)(2008-2#1)
is reported on the##2##4##(1990-8#1)(1996-12#1)
is reported that the##2##4##(2008-1#1)(2008-12#1)
is reported that##9##3##(1990-11#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#2)
is reported to be##8##4##(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
is reported to decrease##2##4##(2011-2#1)(2013-1#1)
is reported to have a##2##5##(2010-11#1)(2011-1#1)
is reported to have##6##4##(1991-5#1)(1996-2#1)(2008-10#1)(2010-11#1)(2011-1#1)(2013-1#1)
is reported to##26##3##(1991-5#1)(1992-2#1)(1992-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#2)
is reported who##2##3##(2008-7#1)(2009-5#1)
is reported with##3##3##(1997-8#1)(2008-10#1)(2011-1#1)
is reported##344##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#5)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#5)(1992-9#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(2007-10#3)(2007-11#16)(2007-12#14)(2007-7#8)(2007-8#5)(2008-1#1)(2008-10#101)(2008-11#3)(2008-12#2)(2008-2#17)(2008-3#28)(2008-5#8)(2008-6#2)(2008-7#19)(2008-8#2)(2008-9#5)(2009-12#4)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-12#4)(2012-2#5)(2013-1#3)(2013-8#1)
is reportedly##2##2##(2008-11#1)(2013-8#1)
is representative of the##2##4##(1993-6#1)(2008-5#1)
is representative of##4##3##(1991-2#1)(1993-6#1)(1996-2#1)(2008-5#1)
is represented by a##7##4##(1990-12#1)(1990-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
is represented by the##3##4##(2009-1#1)(2011-2#2)
is represented by##17##3##(1990-12#1)(1990-7#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-1#1)(2011-2#3)(2013-1#1)
is represented##21##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-3#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-1#1)(2009-9#1)(2011-2#3)(2013-1#2)
is repressed by##2##3##(1995-6#1)(1995-8#1)
is repressed in##2##3##(1993-3#1)(1997-7#1)
is repressed##5##2##(1990-11#1)(1993-3#1)(1995-6#1)(1995-8#1)(1997-7#1)
is reproduced by##3##3##(1990-6#1)(2008-10#1)(2010-2#1)
is reproduced##5##2##(1990-6#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#1)
is reproducible and##3##3##(1997-2#1)(2008-10#2)
is reproducible##11##2##(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#8)
is reproducibly##2##2##(1997-2#1)(2008-10#1)
is required and##2##3##(1994-12#1)(2008-10#1)
is required at##2##3##(1994-8#1)(2009-8#1)
is required because##2##3##(1995-2#1)(2008-10#1)
is required before##3##3##(1992-3#1)(2008-11#1)(2010-4#1)
is required for a##2##4##(2008-3#1)(2010-4#1)
is required for accurate##3##4##(2008-10#2)(2010-4#1)
is required for both##3##4##(1992-3#1)(1993-12#1)(1995-2#1)
is required for effective##2##4##(2011-2#1)(2013-1#1)
is required for expression of##2##5##(2008-5#1)(2010-3#1)
is required for full##2##4##(1995-12#1)(2007-11#1)
is required for insulin##3##4##(1994-11#1)(1995-6#2)
is required for its##4##4##(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
is required for maintaining##2##4##(2008-7#1)(2008-9#1)
is required for normal development of##2##6##(2008-9#1)(2009-3#1)
is required for normal##5##4##(2008-9#1)(2009-3#1)(2010-9#1)(2012-2#1)(2012-3#1)
is required for optimal##2##4##(1995-3#1)(1995-5#1)
is required for pollen fertility##2##5##(2009-10#2)
is required for proper##4##4##(1995-11#1)(2008-10#1)(2009-3#1)(2012-12#1)
is required for the regulation of##3##6##(1995-6#2)(1996-2#1)
is required for the##35##4##(1990-11#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-2#2)(1996-8#2)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2012-3#2)(2013-1#2)(2013-7#1)
is required for##148##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#6)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#5)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-7#3)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#2)(2008-9#6)(2009-10#4)(2009-11#1)(2009-2#3)(2009-3#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#3)
is required in order to##3##5##(1994-12#1)(2010-11#1)(2010-6#1)
is required in the##5##4##(1991-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
is required in this##2##4##(1992-11#1)(2008-10#1)
is required in##18##3##(1990-11#1)(1991-5#1)(1992-11#1)(1994-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)
is required of##2##3##(2008-3#1)(2011-2#1)
is required on the##2##4##(2008-12#1)(2010-11#1)
is required to achieve##5##4##(1996-2#1)(2008-1#2)(2008-10#1)(2010-12#1)
is required to clarify##2##4##(2008-7#1)(2011-2#1)
is required to determine##2##4##(1997-7#1)(2007-11#1)
is required to develop##2##4##(2008-7#1)(2013-1#1)
is required to diagnose##3##4##(1997-8#1)(2007-7#1)(2012-12#1)
is required to drive##2##4##(1994-6#1)(2008-5#1)
is required to ensure that##2##5##(2008-3#1)(2008-5#1)
is required to ensure##3##4##(2008-3#1)(2008-5#1)(2012-3#1)
is required to establish##2##4##(2007-12#1)(2008-1#1)
is required to identify##3##4##(1990-9#1)(1996-5#1)(2008-1#1)
is required to improve the##2##5##(2008-10#1)(2011-1#1)
is required to improve##4##4##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
is required to obtain##4##4##(1992-11#1)(1992-12#1)(2007-12#1)(2011-2#1)
is required to optimize##2##4##(2008-11#1)(2011-2#1)
is required to prevent##3##4##(1991-8#1)(2009-1#1)(2010-1#1)
is required to protect##2##4##(1993-11#1)(2008-11#1)
is required to reduce the##2##5##(1997-4#1)(2013-8#1)
is required to##72##3##(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-12#1)(1993-11#1)(1994-1#1)(1994-6#1)(1995-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
is required when##2##3##(1992-6#1)(1995-8#1)
is required##341##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-6#1)(1994-8#8)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#1)(1996-2#5)(1996-3#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#9)(2008-10#32)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#16)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#17)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#6)(2009-11#2)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#20)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#3)(2013-8#5)
is required]##2##2##(1990-2#1)(1997-4#1)
is reserved for##5##3##(1992-5#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
is resistance to##2##3##(2008-4#1)(2011-3#1)
is resistant to most##2##4##(2008-10#1)(2013-1#1)
is resistant to##19##3##(1991-5#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(2008-10#7)(2008-12#1)(2008-9#1)(2011-2#2)(2013-1#1)
is resolved by##2##3##(1991-9#1)(1995-3#1)
is resolved in##2##3##(2008-3#1)(2011-2#1)
is resolved into##2##3##(2008-11#1)(2008-3#1)
is resolved##8##2##(1991-9#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)
is resorbed##3##2##(2008-12#1)(2009-3#1)(2012-12#1)
is responsible for D-alanine##2##4##(1995-6#2)
is responsible for a##5##4##(1996-2#1)(2008-2#1)(2008-9#1)(2009-2#1)(2012-2#1)
is responsible for considerable morbidity##2##5##(2007-12#1)(2008-7#1)
is responsible for considerable##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
is responsible for inducing##2##4##(1996-5#1)(2008-3#1)
is responsible for more than##2##5##(2010-3#1)(2013-1#1)
is responsible for significant##2##4##(2008-10#1)(2013-1#1)
is responsible for the##47##4##(1990-12#2)(1990-5#3)(1990-7#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#1)
is responsible for their##2##4##(1993-11#1)(2010-4#1)
is responsible for this##3##4##(1991-5#1)(1994-5#1)(2008-7#1)
is responsible for widespread##2##4##(2008-10#2)
is responsible for##116##3##(1990-12#2)(1990-5#3)(1990-7#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#2)(2006-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)
is responsible##117##2##(1990-12#2)(1990-5#3)(1990-7#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#2)(2006-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)
is responsible?##2##2##(1995-1#1)(1995-12#1)
is responsive to##5##3##(1993-6#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)
is restored##3##2##(1990-2#1)(2008-3#1)(2012-2#1)
is restricted by##2##3##(1992-2#1)(2011-3#1)
is restricted to a##3##4##(1994-2#1)(2008-2#1)(2008-5#1)
is restricted to high##2##4##(2008-2#1)(2009-3#1)
is restricted to the##9##4##(1990-11#1)(1990-5#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
is restricted to##28##3##(1990-11#1)(1990-5#2)(1991-6#1)(1992-1#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2012-12#1)
is restricted##32##2##(1990-11#1)(1990-5#2)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2011-3#1)(2012-12#1)
is retained and##2##3##(2008-10#1)(2008-3#1)
is retained on a##2##4##(2008-10#2)
is retained##14##2##(1992-9#1)(1997-2#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)
is retrieved by##3##3##(2008-2#1)(2008-3#2)
is retrieved##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
is returned to the##2##4##(2007-12#1)(2008-8#1)
is reused##2##2##(2008-10#2)
is revealed by the##2##4##(2008-3#2)
is revealed by##3##3##(1991-2#1)(2008-3#2)
is revealed##13##2##(1991-2#1)(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#5)(2010-2#1)(2013-1#1)
is reverse biased##2##3##(2008-10#2)
is reversed by the##3##4##(1991-1#1)(1994-12#1)(1994-9#1)
is reversed##7##2##(1991-1#2)(1994-11#1)(1994-12#1)(1994-9#1)(2007-11#1)(2008-4#1)
is reversible and##5##3##(1994-9#1)(1996-9#1)(1997-2#1)(2008-10#2)
is reversible##13##2##(1994-9#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#3)(2013-7#1)
is reversibly##3##2##(1990-11#1)(1996-2#1)(2008-10#1)
is reviewed and the##3##4##(1991-6#1)(1993-8#1)(2008-7#1)
is reviewed and##10##3##(1991-6#1)(1993-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2013-1#1)
is reviewed for##3##3##(1996-3#1)(2007-7#1)(2008-9#1)
is reviewed from##3##3##(1995-6#1)(2008-11#1)(2011-1#1)
is reviewed here##2##3##(1990-8#1)(2010-8#1)
is reviewed in##3##3##(1992-1#1)(1994-2#1)(2011-2#1)
is reviewed to##2##3##(1991-3#1)(1993-1#1)
is reviewed with particular##2##4##(2008-11#1)(2011-2#1)
is reviewed with##5##3##(1991-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
is reviewed##97##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
is revised##2##2##(2007-12#1)(2013-8#1)
is revisited##4##2##(2007-11#1)(2008-3#3)
is rich in##6##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-1#1)
is rife with##2##3##(1996-2#1)(2012-2#1)
is right##2##2##(1992-9#1)(1996-3#1)
is ripe##3##2##(2008-7#1)(2009-5#1)(2013-1#1)
is rising in##2##3##(1991-6#1)(2012-3#1)
is rising##7##2##(1991-12#1)(1991-6#1)(2011-1#1)(2012-2#1)(2012-3#3)
is robust against##2##3##(2008-3#1)(2008-8#1)
is robust and##6##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
is robust to##7##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)
is robust##22##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-2#1)(2012-3#1)
is robustly##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
is rooted in the##2##4##(1993-11#1)(2008-11#1)
is rooted in##3##3##(1993-11#1)(2008-11#1)(2010-8#1)
is rotated##10##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)(2008-5#1)
is rough##2##2##(2008-3#1)(2008-9#1)
is roughly proportional to##2##4##(1992-12#1)(2008-3#1)
is roughly##4##2##(1992-12#1)(1994-8#1)(1996-4#1)(2008-3#1)
is routine##2##2##(1997-8#1)(2008-9#1)
is routinely used to##2##4##(2008-11#1)(2008-9#1)
is routinely used##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
is routinely##7##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2012-12#1)
is rugged and##2##3##(2007-11#1)(2008-10#1)
is rugged##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
is ruled out##2##3##(1990-8#1)(2012-1#1)
is ruled##3##2##(1990-8#1)(2012-1#1)(2012-2#1)
is rushed##2##2##(1996-2#1)(2008-7#1)
is safe and effective for##2##5##(2008-11#1)(2008-7#1)
is safe and effective when##2##5##(1996-12#1)(2010-12#1)
is safe and effective##7##4##(1991-11#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)
is safe and##24##3##(1991-11#1)(1994-11#1)(1994-3#1)(1996-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#4)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
is safe in##2##3##(2007-8#1)(2008-6#1)
is safe to##3##3##(1993-9#1)(2007-11#1)(2008-12#1)
is safe##40##2##(1990-8#1)(1991-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
is safer to use##2##4##(2012-3#2)
is safer##3##2##(2011-2#1)(2012-3#2)
is said to##2##3##(1993-9#1)(1995-6#1)
is said##4##2##(1993-9#1)(1995-6#1)(2007-10#1)(2009-3#1)
is sampled##3##2##(2008-2#1)(2008-3#2)
is satisfactory for##2##3##(2008-10#1)(2008-3#1)
is satisfactory##11##2##(1990-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2012-2#1)
is satisfying##2##2##(1991-12#1)(2007-8#1)
is saturable and##2##3##(1990-11#1)(1995-2#1)
is saturable##3##2##(1990-11#1)(1994-12#1)(1995-2#1)
is scalable to##2##3##(2007-12#1)(2008-3#1)
is scalable##6##2##(2007-12#2)(2008-3#3)(2010-8#1)
is scaled##2##2##(2008-2#1)(2008-8#1)
is scanned##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
is scarce##8##2##(1995-11#1)(2008-10#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#2)
is scattered##2##2##(2007-11#1)(2007-12#1)
is scheduled for##2##3##(1995-11#1)(2010-4#1)
is scheduled##5##2##(1995-11#1)(2010-12#1)(2010-4#1)(2011-4#1)(2012-2#1)
is scope for##2##3##(1995-2#1)(2012-12#1)
is sealed##2##2##(1996-1#1)(2012-12#1)
is second##2##2##(1997-1#1)(2008-8#1)
is secondary to##5##3##(1994-8#1)(1995-8#1)(1997-2#1)(2008-7#1)(2008-9#1)
is secondary##8##2##(1994-8#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-1#1)
is secreted as a##2##4##(1992-12#1)(2008-12#1)
is secreted as##3##3##(1991-8#1)(1992-12#1)(2008-12#1)
is secreted by##3##3##(1997-6#1)(2008-12#1)(2010-10#1)
is secreted from the##2##4##(2008-4#1)(2008-8#1)
is secreted from##3##3##(1994-5#1)(2008-4#1)(2008-8#1)
is secreted into the##3##4##(1997-2#1)(2008-5#2)
is secreted upon##2##3##(1991-2#1)(1992-12#1)
is secreted##16##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#2)(1994-5#1)(1997-2#1)(1997-6#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-10#1)
is seemingly##3##2##(1992-6#1)(1995-11#1)(2008-7#1)
is seen as a##10##4##(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2011-1#1)(2012-1#3)(2013-1#1)
is seen as##14##3##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
is seen by##2##3##(2008-11#1)(2008-12#1)
is seen for##3##3##(2008-10#1)(2008-8#1)(2009-9#1)
is seen in about##2##4##(2007-10#1)(2008-7#1)
is seen in the##3##4##(1994-8#1)(1996-9#1)(2012-3#1)
is seen in##11##3##(1994-8#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
is seen more##3##3##(1991-9#1)(2008-8#1)(2013-1#1)
is seen most commonly after##2##5##(2008-11#1)(2011-2#1)
is seen that the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
is seen that##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
is seen to be##4##4##(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
is seen to##8##3##(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
is seen with##5##3##(1992-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
is seen##63##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#2)(1996-1#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#3)
is seldom##7##2##(1990-9#1)(1992-5#1)(2007-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
is selected and##2##3##(2007-11#1)(2008-7#1)
is selected as its##2##4##(2008-10#1)(2011-2#1)
is selected as##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
is selected##17##2##(1990-11#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
is selective and##2##3##(1995-3#1)(2010-4#1)
is selective for##4##3##(1992-12#1)(1995-6#1)(2008-10#2)
is selective##11##2##(1990-8#1)(1992-12#1)(1995-3#1)(1995-6#1)(2008-10#5)(2010-4#1)(2012-3#1)
is selectively and##2##3##(1990-12#1)(2008-10#1)
is selectively detected by AFS in a Ar/H(2) miniaturized flame after sodium borohydride reduction to##2##15##(2008-10#2)
is selectively##13##2##(1990-12#1)(1994-5#1)(1997-7#1)(2008-10#8)(2008-2#1)(2008-8#1)
is sensitive and##6##3##(1995-11#1)(2007-7#1)(2008-10#3)(2008-3#1)
is sensitive enough to##3##4##(1995-12#1)(1996-2#1)(2008-3#1)
is sensitive to change##2##4##(2007-7#1)(2009-11#1)
is sensitive to changes in##2##5##(1995-3#1)(1996-2#1)
is sensitive to its##2##4##(1997-2#1)(2008-4#1)
is sensitive to protein##2##4##(1991-2#1)(1993-12#1)
is sensitive to the##15##4##(1994-2#1)(1994-5#2)(1995-3#1)(2007-12#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)
is sensitive to##50##3##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-3#1)
is sensitive##76##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1997-2#1)(2007-11#1)(2007-12#4)(2007-7#3)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-3#1)
is sent##2##2##(2007-12#1)(2008-3#1)
is separated by##4##3##(2008-10#3)(2008-4#1)
is separated from the liquid phase using a##2##8##(2008-10#2)
is separated from the liquid##3##5##(2008-10#3)
is separated from the solution##2##5##(2008-10#2)
is separated from the##7##4##(1990-8#1)(2008-10#6)
is separated from##10##3##(1990-8#1)(2008-10#8)(2008-3#1)
is separated##17##2##(1990-8#1)(2008-10#13)(2008-3#2)(2008-4#1)
is sequestered by##2##3##(1990-2#1)(1997-6#1)
is sequestered##3##2##(1990-2#1)(1992-6#1)(1997-6#1)
is seriously##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
is served by##2##3##(2008-3#1)(2011-1#1)
is serving##2##2##(1996-1#1)(2013-1#1)
is set at##2##3##(1996-12#1)(2008-10#1)
is set by the##3##4##(2008-11#1)(2008-3#2)
is set equal to zero##2##5##(2008-3#2)
is set to##2##3##(2008-9#2)
is set up##3##3##(2007-11#1)(2008-10#2)
is set##14##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-9#2)
is several times##3##3##(1992-6#1)(2008-3#1)(2011-2#1)
is several##4##2##(1992-6#1)(2008-11#1)(2008-3#1)(2011-2#1)
is severe##4##2##(1995-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
is severely affected##2##3##(1997-6#1)(2008-7#1)
is severely impaired##3##3##(2008-1#1)(2008-4#1)(2012-2#1)
is severely limited by the##3##5##(1996-2#1)(2010-11#1)(2011-1#1)
is severely##11##2##(1990-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
is sexually transmitted##3##3##(2011-2#3)
is sexually##4##2##(1993-8#1)(2011-2#3)
is shaken##3##2##(1997-6#1)(2008-10#2)
is shallow##2##2##(2008-9#1)(2011-2#1)
is shared by##8##3##(1994-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
is shared##9##2##(1994-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#1)
is shifted by##2##3##(2007-11#1)(2008-2#1)
is shifted to more##2##4##(2008-10#2)
is shifted to##4##3##(1994-5#1)(2007-11#1)(2008-10#2)
is shifted toward##2##3##(2008-10#1)(2008-9#1)
is shifted##10##2##(1994-5#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)
is short##7##2##(1993-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2012-3#1)(2013-8#1)
is shortened##2##2##(2007-11#1)(2008-3#1)
is shorter than##2##3##(2007-11#1)(2008-5#1)
is shorter##4##2##(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
is showing##3##2##(2008-9#1)(2009-4#1)(2010-6#1)
is shown as a##2##4##(1996-12#1)(2008-3#1)
is shown as an example##2##5##(2007-11#1)(2008-10#1)
is shown as an##3##4##(2007-11#1)(2008-10#1)(2012-1#1)
is shown as##5##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-1#1)
is shown by##6##3##(1991-5#1)(1994-8#1)(2007-12#1)(2008-10#2)(2012-3#1)
is shown experimentally##2##3##(2007-11#1)(2008-3#1)
is shown for##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
is shown here that##4##4##(1992-3#1)(2008-10#1)(2008-3#2)
is shown here to be##2##5##(1993-8#1)(2008-10#1)
is shown here to##3##4##(1991-9#1)(1993-8#1)(2008-10#1)
is shown here##7##3##(1991-9#1)(1992-3#1)(1993-8#1)(2008-10#2)(2008-3#2)
is shown how the##4##4##(2008-3#1)(2008-6#2)(2008-8#1)
is shown how##9##3##(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)
is shown in##2##3##(1997-2#1)(2008-3#1)
is shown not##2##3##(2008-2#1)(2008-3#1)
is shown that a simple##2##5##(2008-3#1)(2008-8#1)
is shown that a##19##4##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#8)(2008-5#1)(2008-8#1)(2010-12#1)
is shown that an##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
is shown that if the##2##5##(2008-3#2)
is shown that in a##2##5##(2007-11#1)(2008-10#1)
is shown that in##7##4##(2007-11#2)(2008-10#3)(2008-2#2)
is shown that it is possible##2##6##(2007-12#1)(2008-3#1)
is shown that it is##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
is shown that spectral##2##4##(2008-10#1)(2008-2#1)
is shown that the presence of##2##6##(1995-6#1)(2008-3#1)
is shown that the system##2##5##(2008-2#1)(2008-3#1)
is shown that the##102##4##(1991-9#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-6#3)(1996-2#1)(1997-2#2)(2007-11#8)(2007-12#9)(2008-10#13)(2008-11#1)(2008-2#18)(2008-3#31)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2013-1#1)
is shown that these##5##4##(1990-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
is shown that this method can be##2##7##(2008-3#2)
is shown that this##8##4##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#5)
is shown that##282##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#2)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#3)(1996-2#1)(1997-2#2)(2007-11#20)(2007-12#24)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#54)(2008-3#92)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
is shown the##2##3##(2008-10#1)(2013-1#1)
is shown theoretically and##2##4##(2007-11#1)(2007-12#1)
is shown theoretically##3##3##(2007-11#2)(2007-12#1)
is shown to arise from##3##5##(1997-7#1)(2007-11#1)(2008-3#1)
is shown to be a powerful##3##6##(1994-9#1)(2008-3#2)
is shown to be a useful tool in##2##8##(2010-7#1)(2012-2#1)
is shown to be a##14##5##(1992-6#1)(1994-9#1)(1995-2#1)(2007-12#2)(2008-2#2)(2008-3#4)(2009-10#1)(2010-7#1)(2012-2#1)
is shown to be an efficient##2##6##(2007-11#1)(2008-2#1)
is shown to be an##3##5##(1992-1#1)(2007-11#1)(2008-2#1)
is shown to be effective##2##5##(2008-2#1)(2013-1#1)
is shown to be in##2##5##(2007-12#1)(2008-3#1)
is shown to be related to the##2##7##(1994-5#1)(2008-2#1)
is shown to be similar##2##5##(2008-3#1)(2011-1#1)
is shown to be useful for##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
is shown to be useful in##2##6##(2007-12#1)(2008-2#1)
is shown to be useful##5##5##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
is shown to be##75##4##(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-1#1)(1997-4#1)(2007-11#4)(2007-12#8)(2008-10#7)(2008-2#14)(2008-3#19)(2008-5#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
is shown to depend on##2##5##(2008-10#1)(2008-2#1)
is shown to depend##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
is shown to exhibit##2##4##(1990-11#1)(2010-5#1)
is shown to have##3##4##(2008-3#2)(2008-8#1)
is shown to improve the##2##5##(2008-3#1)(2008-6#1)
is shown to increase the##2##5##(2010-10#1)(2012-3#1)
is shown to increase##4##4##(2007-12#2)(2010-10#1)(2012-3#1)
is shown to inhibit the##2##5##(1990-11#1)(1991-9#1)
is shown to inhibit##3##4##(1990-11#1)(1991-9#1)(1994-2#1)
is shown to occur##2##4##(1990-7#1)(2008-8#1)
is shown to produce##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
is shown to reduce to##2##5##(2007-11#1)(2008-3#1)
is shown to reduce##4##4##(1994-9#1)(2007-11#1)(2008-3#2)
is shown to result##2##4##(1994-5#1)(1995-2#1)
is shown to yield##2##4##(2008-10#1)(2008-3#1)
is shown to##138##3##(1990-11#2)(1990-2#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#10)(2007-12#16)(2008-10#12)(2008-2#20)(2008-3#33)(2008-5#3)(2008-6#1)(2008-8#2)(2009-10#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is shown with##2##3##(2008-3#1)(2008-8#1)
is shown##508##2##(1990-11#3)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#3)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#2)(1994-9#6)(1995-2#3)(1995-3#1)(1995-6#4)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#1)(2007-11#36)(2007-12#48)(2008-1#1)(2008-10#62)(2008-11#6)(2008-12#1)(2008-2#84)(2008-3#151)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#4)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
is significant correlation between##2##4##(2011-2#2)
is significant for##2##3##(1991-12#1)(2011-2#1)
is significant in##4##3##(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)
is significant##31##2##(1991-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#1)
is significantly affected by##3##4##(2007-11#1)(2008-12#1)(2010-2#1)
is significantly associated with increased##2##5##(2008-4#1)(2009-7#1)
is significantly associated with##4##4##(2008-4#1)(2009-7#1)(2010-11#1)(2012-3#1)
is significantly better than##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
is significantly better##5##3##(1991-8#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
is significantly correlated with the##2##5##(1993-3#1)(2010-2#1)
is significantly correlated with##3##4##(1992-12#1)(1993-3#1)(2010-2#1)
is significantly decreased in##3##4##(1993-3#1)(2007-11#1)(2010-8#1)
is significantly decreased##4##3##(1993-3#1)(1994-8#1)(2007-11#1)(2010-8#1)
is significantly different##3##3##(1993-8#1)(2008-10#1)(2013-8#1)
is significantly enhanced##3##3##(1992-12#1)(1994-8#1)(2008-8#1)
is significantly greater than the##2##5##(1995-1#1)(1996-3#1)
is significantly greater than##4##4##(1993-3#1)(1995-1#1)(1996-3#1)(2008-4#1)
is significantly greater##5##3##(1993-3#1)(1995-1#1)(1996-3#1)(2008-4#1)(2013-1#1)
is significantly high##2##3##(2008-10#1)(2010-8#1)
is significantly higher for##2##4##(2008-10#1)(2008-9#1)
is significantly higher in##6##4##(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#1)
is significantly higher than##3##4##(1994-6#1)(2008-10#1)(2008-12#1)
is significantly higher##11##3##(1994-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
is significantly increased##3##3##(1992-12#1)(2008-11#1)(2008-3#1)
is significantly larger than that##2##5##(2008-2#1)(2008-9#1)
is significantly less##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
is significantly lower in##2##4##(2007-11#1)(2009-11#1)
is significantly lower than the##2##5##(1990-7#1)(1991-11#1)
is significantly lower than##5##4##(1990-7#1)(1991-11#1)(2008-12#1)(2008-2#1)(2011-1#1)
is significantly lower##9##3##(1990-7#1)(1991-11#1)(2007-11#1)(2008-12#1)(2008-2#2)(2009-11#1)(2011-1#2)
is significantly more##2##3##(1991-9#1)(2011-2#1)
is significantly perturbed##2##3##(1993-11#1)(2008-3#1)
is significantly reduced in##2##4##(2007-12#1)(2008-7#1)
is significantly reduced##6##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
is significantly smaller than the##2##5##(2008-3#1)(2013-7#1)
is significantly smaller than##3##4##(2008-11#1)(2008-3#1)(2013-7#1)
is significantly##93##2##(1990-7#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-12#4)(1992-6#1)(1993-11#1)(1993-3#3)(1993-8#1)(1994-6#1)(1994-8#2)(1995-1#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
is silent##2##2##(1991-9#1)(2008-6#1)
is similar for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
is similar in the##2##4##(1991-11#1)(1992-2#1)
is similar in##12##3##(1990-5#1)(1991-11#1)(1992-2#1)(1992-4#1)(1994-11#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)
is similar to a##5##4##(1997-3#1)(2008-10#1)(2008-3#3)
is similar to but##2##4##(1991-5#1)(2009-10#1)
is similar to other##2##4##(1990-11#1)(1990-7#1)
is similar to that in##3##5##(1995-9#1)(2008-7#1)(2010-11#1)
is similar to that observed in##2##6##(1996-6#1)(2013-1#1)
is similar to that observed##3##5##(1996-6#1)(2009-5#1)(2013-1#1)
is similar to that obtained##2##5##(2008-10#1)(2008-5#1)
is similar to that of other##3##6##(1990-11#1)(2007-12#1)(2008-10#1)
is similar to that of the##4##6##(1991-9#2)(1997-2#2)
is similar to that of##19##5##(1990-11#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-7#1)(2013-1#1)
is similar to that seen in##3##6##(1994-5#1)(2008-10#1)(2012-3#1)
is similar to that with##2##5##(1993-11#1)(2008-10#1)
is similar to that##37##4##(1990-11#1)(1990-2#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#2)(2007-12#1)(2008-10#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#2)
is similar to the difference##2##5##(2008-7#1)(2011-1#1)
is similar to the##21##4##(1990-11#1)(1990-5#1)(1992-3#1)(1993-2#1)(1993-6#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#2)(2009-8#1)(2011-1#1)(2012-3#1)
is similar to those for##2##5##(2008-3#1)(2011-1#1)
is similar to those##3##4##(1995-5#1)(2008-3#1)(2011-1#1)
is similar to what##2##4##(1995-12#1)(2008-11#1)
is similar to##89##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(2006-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-3#2)(2013-1#3)
is similar##116##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#5)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-3#2)(2013-1#4)
is similarly##3##2##(1991-5#1)(1995-8#1)(2011-2#1)
is simple and consists of##2##5##(2008-2#1)(2008-6#1)
is simple and fast##2##4##(2008-10#1)(2008-3#1)
is simple and inexpensive##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
is simple and##30##3##(1990-8#1)(1991-5#1)(1992-3#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
is simple to construct##2##4##(2007-11#1)(2008-10#1)
is simple to perform and##2##5##(1990-2#1)(2009-10#1)
is simple to perform##3##4##(1990-2#1)(1993-6#1)(2009-10#1)
is simple to prepare and##3##5##(1997-6#1)(2008-10#2)
is simple to##12##3##(1990-2#1)(1993-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#4)(2009-10#1)
is simple##95##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#41)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#3)(2011-1#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
is simpler and##2##3##(1993-9#1)(2008-10#1)
is simpler than##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2009-8#1)
is simpler##6##2##(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)
is simplified by##2##3##(1997-6#1)(2008-10#1)
is simplified##8##2##(1997-6#1)(2008-10#2)(2008-3#4)(2008-6#1)
is simply##6##2##(1992-3#1)(1995-1#1)(1996-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
is simulated by##2##3##(2007-11#1)(2008-2#1)
is simulated##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
is simultaneously##11##2##(1992-6#1)(1995-3#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2009-6#1)(2012-1#1)(2012-12#1)
is single##2##2##(2008-3#1)(2013-8#1)
is situated in the##3##4##(1990-6#1)(1993-8#1)(2010-6#1)
is situated##5##2##(1990-6#1)(1993-8#1)(2007-11#1)(2010-6#1)(2011-2#1)
is slightly favored##2##3##(1997-2#1)(2009-11#1)
is slightly greater##2##3##(2008-10#1)(2009-4#1)
is slightly higher than the##2##5##(1993-6#1)(1995-2#1)
is slightly higher than##3##4##(1993-6#1)(1995-2#1)(2013-1#1)
is slightly higher##4##3##(1993-6#1)(1995-2#1)(2013-1#2)
is slightly less##2##3##(1994-5#1)(2008-3#1)
is slightly more##3##3##(1996-2#1)(2006-10#1)(2008-3#1)
is slightly##23##2##(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2009-11#1)(2009-4#1)(2009-7#1)(2012-3#1)(2013-1#2)
is slow to##2##3##(2007-12#1)(2008-8#1)
is slow##7##2##(1994-2#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)
is slowed##4##2##(1991-12#1)(2007-11#1)(2008-1#1)(2012-2#1)
is slower than the##2##4##(1993-11#1)(2010-10#1)
is slower than##3##3##(1992-3#1)(1993-11#1)(2010-10#1)
is slower##4##2##(1992-3#1)(1993-11#1)(2010-10#1)(2010-4#1)
is small and##3##3##(1995-9#1)(2007-11#1)(2013-8#1)
is small compared to the##2##5##(2008-2#1)(2008-8#1)
is small compared with the##3##5##(2007-11#1)(2008-3#2)
is small compared with##4##4##(1995-3#1)(2007-11#1)(2008-3#2)
is small compared##6##3##(1995-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
is small enough to##3##4##(2008-10#1)(2008-3#2)
is small enough##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
is small for##2##3##(2008-2#1)(2008-3#1)
is small in comparison##2##4##(2008-10#1)(2008-7#1)
is small in##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
is small##38##2##(1990-12#1)(1990-8#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-9#2)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#8)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
is smaller in##2##3##(1996-2#1)(2011-2#1)
is smaller than 1##2##4##(2007-12#1)(2008-10#1)
is smaller than that of##2##5##(1995-6#1)(2008-3#1)
is smaller than the##3##4##(2007-11#1)(2008-3#1)(2013-1#1)
is smaller than##20##3##(1991-8#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-6#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2013-1#2)
is smaller##23##2##(1991-8#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-2#2)(1996-6#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
is smoother##2##2##(1993-3#1)(2008-5#1)
is so expensive##2##3##(2008-11#1)(2010-8#1)
is so far inconclusive##2##4##(1991-12#1)(2012-12#1)
is so far##4##3##(1991-12#1)(1992-8#1)(2012-12#1)(2013-1#1)
is so##23##2##(1991-12#1)(1992-8#1)(1996-3#1)(1997-5#1)(1997-9#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-6#2)(2010-8#1)(2012-12#1)(2013-1#1)
is social##2##2##(1995-12#1)(2010-3#1)
is solitary##2##2##(1997-1#1)(2011-2#1)
is soluble##2##2##(1993-12#1)(2008-9#1)
is solved by##2##3##(2008-10#1)(2008-2#1)
is solved with##2##3##(2008-11#1)(2008-7#1)
is solved##12##2##(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-7#2)(2008-9#1)
is solvent##2##2##(1992-3#1)(2008-10#1)
is some evidence of##4##4##(1991-1#1)(1995-5#1)(2007-2#1)(2011-2#1)
is some evidence that the##2##5##(1996-2#1)(2008-5#1)
is some evidence that##5##4##(1993-1#1)(1996-2#1)(1996-6#1)(2007-2#1)(2008-5#1)
is some evidence##12##3##(1991-1#1)(1993-1#1)(1995-5#1)(1996-2#1)(1996-6#1)(2007-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
is some##25##2##(1990-8#1)(1991-1#1)(1992-11#1)(1992-2#1)(1993-1#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#3)
is sometime##2##2##(1990-3#1)(2013-1#1)
is sometimes associated with##2##4##(2008-10#1)(2008-3#1)
is sometimes##15##2##(1991-11#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2012-2#1)
is somewhat different##3##3##(1994-5#1)(1994-9#1)(2008-2#1)
is somewhat higher than that##2##5##(2008-10#1)(2008-2#1)
is somewhat##12##2##(1994-5#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
is sorbed onto##2##3##(2008-10#2)
is sorted##2##2##(1990-5#1)(1992-12#1)
is sought##2##2##(2011-2#1)(2012-3#1)
is space##2##2##(2008-3#1)(2008-9#1)
is sparse##8##2##(1993-12#1)(1993-2#1)(1993-9#1)(2008-12#1)(2008-8#1)(2009-11#1)(2012-12#1)(2013-1#1)
is spatially and temporally regulated##2##5##(1994-2#1)(2011-2#1)
is spatially##11##2##(1994-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)
is specialized for processing##2##4##(2008-11#2)
is specialized for##3##3##(2008-11#3)
is specialized##4##2##(2008-11#4)
is specially##3##2##(2007-12#1)(2008-10#2)
is specific and##2##3##(1993-9#1)(2008-4#1)
is specific for the##7##4##(1990-8#1)(1995-2#1)(2008-10#2)(2008-4#1)(2011-1#1)(2013-8#1)
is specific for##15##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-4#1)(2011-1#1)(2013-8#1)
is specific of##2##3##(1991-8#1)(2009-2#1)
is specific to##7##3##(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
is specific##28##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#1)(2013-8#1)
is specifically associated##2##3##(1990-8#1)(2008-2#1)
is specifically designed to##2##4##(1996-12#1)(2012-2#1)
is specifically designed##3##3##(1996-12#1)(2007-12#1)(2012-2#1)
is specifically expressed##2##3##(1991-9#1)(2008-8#1)
is specifically##17##2##(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#2)
is specified by a##2##4##(1994-11#1)(1995-6#1)
is specified by##3##3##(1994-11#1)(1994-12#1)(1995-6#1)
is specified##5##2##(1994-11#1)(1994-12#1)(1995-6#1)(2009-5#1)(2010-11#1)
is spectrally##2##2##(2008-2#2)
is spectrophotometrically determined##2##3##(2008-10#2)
is spectroscopically##2##2##(1992-8#1)(1994-5#1)
is speculated that the##2##4##(1996-2#1)(2008-3#1)
is speculated that##10##3##(1992-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
is speculated##11##2##(1992-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
is split into two##5##4##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
is split into##9##3##(1996-8#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)
is split##15##2##(1995-6#1)(1996-8#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-8#1)
is sponsored by##3##3##(1994-1#1)(2008-11#1)(2009-6#1)
is spread##5##2##(1993-6#1)(2007-12#1)(2008-10#2)(2008-5#1)
is spreading##2##2##(2008-10#1)(2012-3#1)
is stabilized by a##2##4##(2007-12#1)(2011-2#1)
is stabilized by##11##3##(1990-5#1)(1991-3#1)(1992-10#1)(1995-6#2)(1997-2#1)(2007-12#2)(2008-3#1)(2008-8#1)(2011-2#1)
is stabilized##15##2##(1990-5#1)(1991-3#1)(1992-10#1)(1992-12#1)(1994-9#1)(1995-6#2)(1997-2#1)(2007-12#2)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#2)
is stable and##5##3##(1994-8#1)(2008-12#1)(2008-6#1)(2011-2#2)
is stable for at least##3##5##(2008-10#2)(2008-8#1)
is stable for more than##2##5##(2008-10#2)
is stable for##12##3##(2008-10#9)(2008-8#1)(2012-1#1)(2012-3#1)
is stable in##2##3##(1991-5#1)(1994-3#1)
is stable##35##2##(1991-5#1)(1992-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(2007-12#1)(2008-10#16)(2008-12#1)(2008-2#3)(2008-6#1)(2008-8#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
is stained with##2##3##(1990-12#1)(2008-4#1)
is stained##3##2##(1990-12#1)(2008-4#1)(2008-7#1)
is standard for##2##3##(2008-3#1)(2008-5#1)
is standard treatment for##2##4##(2007-8#1)(2010-8#1)
is standard##4##2##(2007-8#1)(2008-3#1)(2008-5#1)(2010-8#1)
is started##3##2##(1995-5#1)(2009-7#1)(2011-2#1)
is stated that the##2##4##(1992-11#1)(1995-6#1)
is stated that##4##3##(1992-11#1)(1993-6#1)(1995-2#1)(1995-6#1)
is stated##5##2##(1992-11#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-2#1)
is statistically significant##6##3##(1991-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
is statistically##13##2##(1991-1#1)(1992-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#2)
is steadily increasing##4##3##(1991-11#1)(1997-6#1)(2008-3#1)(2011-2#1)
is steadily##5##2##(1991-11#1)(1997-6#1)(2008-3#1)(2011-2#2)
is steady##2##2##(2008-8#1)(2013-8#1)
is steroid##2##2##(2007-7#1)(2012-2#1)
is still a major##2##4##(1993-6#1)(2009-2#1)
is still a matter of##2##5##(2008-1#1)(2008-5#1)
is still a matter##3##4##(1997-7#1)(2008-1#1)(2008-5#1)
is still a significant##3##4##(1996-6#1)(2009-5#1)(2010-12#1)
is still a subject of##3##5##(1990-6#1)(2009-5#1)(2010-11#1)
is still a##42##3##(1990-6#1)(1991-12#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-5#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
is still alive##2##3##(1992-9#1)(2008-7#1)
is still an underestimated##2##4##(1992-9#1)(2012-2#1)
is still an##6##3##(1992-9#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
is still being##2##3##(2008-11#1)(2008-7#1)
is still clearly##2##3##(2008-10#1)(2008-11#1)
is still controversial and##2##4##(1990-12#1)(2013-1#1)
is still controversial##8##3##(1990-12#1)(1992-8#1)(1995-2#1)(2007-8#2)(2008-11#1)(2008-7#1)(2013-1#1)
is still controversy about the##2##5##(2008-10#1)(2013-8#1)
is still debatable##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
is still debated##4##3##(1992-8#2)(2011-2#2)
is still developing##2##3##(1994-1#1)(2010-4#1)
is still extremely##2##3##(2008-1#1)(2010-11#1)
is still fragmentary##2##3##(2007-12#2)
is still high##2##3##(2007-8#1)(2008-1#1)
is still higher than##2##4##(2008-7#1)(2010-12#1)
is still in its early stages##2##6##(2007-7#1)(2011-2#1)
is still in its infancy##3##5##(1995-5#1)(1996-4#1)(2008-10#1)
is still in its##5##4##(1995-5#1)(1996-4#1)(2007-7#1)(2008-10#1)(2011-2#1)
is still in##10##3##(1992-5#1)(1995-3#1)(1995-5#1)(1996-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-7#1)(2011-2#1)
is still incomplete##2##3##(2008-10#1)(2012-2#1)
is still incompletely##2##3##(1993-6#1)(2008-7#1)
is still increasing##2##3##(1997-8#1)(2013-7#1)
is still lacking##7##3##(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-2#1)(2012-3#1)
is still largely##2##3##(1994-12#1)(2009-7#1)
is still limited##9##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
is still more##2##3##(1994-1#1)(2008-5#1)
is still needed##4##3##(2007-9#1)(2008-10#1)(2009-2#1)(2010-12#1)
is still no##5##3##(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
is still not a##2##4##(2008-7#1)(2011-2#1)
is still not clear##6##4##(2007-5#1)(2008-11#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-7#1)
is still not completely understood##2##5##(2008-2#1)(2011-1#1)
is still not completely##3##4##(2008-2#1)(2009-12#1)(2011-1#1)
is still not established##2##4##(2008-8#1)(2012-2#1)
is still not fully understood##5##5##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
is still not##29##3##(1993-6#1)(1994-11#1)(1997-8#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
is still of##2##3##(2011-2#1)(2011-3#1)
is still one of the##2##5##(2010-9#1)(2011-1#1)
is still poorly understood##4##4##(1991-11#1)(2008-8#1)(2012-12#1)(2012-3#1)
is still poorly##6##3##(1991-11#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
is still possible##2##3##(1996-1#1)(2008-10#1)
is still present in the##2##5##(1995-2#1)(2008-10#1)
is still present in##3##4##(1995-2#1)(2007-12#1)(2008-10#1)
is still present##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2010-2#1)
is still questionable##2##3##(2008-10#1)(2008-8#1)
is still required for##2##4##(2008-8#1)(2011-2#1)
is still required to##2##4##(2009-10#1)(2011-2#1)
is still required##7##3##(1997-1#1)(1997-4#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#2)
is still significant##2##3##(2008-8#1)(2009-8#1)
is still somewhat##2##3##(2008-2#1)(2009-3#1)
is still the major##2##4##(1996-8#1)(2010-10#1)
is still the##10##3##(1990-5#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-11#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
is still uncertain##2##3##(2013-1#2)
is still unclear##19##3##(1992-2#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
is still under investigation##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
is still under##6##3##(1992-5#1)(2008-10#1)(2008-7#2)(2009-3#1)(2011-2#1)
is still unknown##19##3##(1991-3#1)(1991-6#1)(1993-6#1)(1993-9#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
is still used##2##3##(2008-3#1)(2013-1#1)
is still valid##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#2)
is still very low in the nature##2##7##(2008-10#2)
is still very##5##3##(1994-2#1)(2008-10#2)(2010-3#1)(2011-2#1)
is still##347##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-6#5)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#6)(2006-10#2)(2006-6#1)(2007-11#8)(2007-12#5)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#23)(2008-11#16)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#20)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#24)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#10)(2013-1#13)(2013-7#4)(2013-8#6)
is stimulated by a##2##4##(1995-8#1)(2008-5#1)
is stimulated by the##2##4##(1994-3#1)(2008-10#1)
is stimulated by##18##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
is stimulated##23##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-6#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-2#1)
is stimulating##2##2##(1996-12#1)(2008-7#1)
is stimulation of##3##3##(1994-8#1)(2008-5#1)(2008-8#1)
is stopped##2##2##(2007-11#1)(2008-10#1)
is stored in the##2##4##(1994-8#1)(2008-2#1)
is stored in##3##3##(1994-8#1)(1997-6#1)(2008-2#1)
is stored##9##2##(1994-8#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2011-2#1)
is straightened##2##2##(2009-5#1)(2009-7#1)
is straightforward to##2##3##(2008-3#1)(2008-4#1)
is straightforward##7##2##(1992-9#1)(1995-9#1)(2007-11#1)(2008-3#1)(2008-4#2)(2010-10#1)
is strain-specific##3##2##(2008-10#3)
is strengthened##3##2##(1996-8#1)(2008-11#1)(2013-8#1)
is stress##2##2##(1994-2#1)(2008-10#1)
is stressed of##3##3##(1991-2#1)(1992-6#1)(2008-9#1)
is stressed that##5##3##(1990-9#1)(1991-5#1)(1994-9#1)(2008-11#1)(2009-10#1)
is stressed##21##2##(1990-5#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-5#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-7#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-10#1)(2012-2#1)
is stretched##2##2##(2011-2#1)(2012-2#1)
is strictly dependent on the##4##5##(1990-9#1)(1993-5#1)(2008-10#1)(2010-11#1)
is strictly related to##2##4##(2011-1#1)(2013-7#1)
is strictly##13##2##(1990-9#1)(1992-11#1)(1993-5#1)(1995-2#1)(1997-6#1)(2008-10#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
is strikingly similar to the##2##5##(1994-12#1)(2008-5#1)
is strikingly##5##2##(1993-2#1)(1994-12#1)(2008-12#1)(2008-5#1)(2013-8#1)
is stripped from##2##3##(2008-10#2)
is strong evidence that##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
is strong evidence##6##3##(2008-1#1)(2008-10#1)(2008-8#2)(2012-2#1)(2013-1#1)
is strong##19##2##(1993-11#1)(1995-11#1)(1995-5#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#3)(2008-8#4)(2009-8#1)(2012-2#1)(2013-1#1)
is stronger and##2##3##(1990-5#1)(2008-3#1)
is stronger than##2##3##(2008-10#1)(2008-3#1)
is stronger##8##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-8#1)
is strongly affected by the##2##5##(1990-11#1)(2007-11#1)
is strongly associated with##6##4##(1996-1#1)(1997-8#1)(2007-11#1)(2008-1#1)(2011-2#1)(2011-7#1)
is strongly dependent on the##10##5##(1995-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)(2011-2#1)
is strongly dependent on##15##4##(1995-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#5)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
is strongly dependent##16##3##(1995-8#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
is strongly enhanced by##2##4##(1995-3#1)(2008-3#1)
is strongly enhanced##4##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
is strongly influenced by##2##4##(2008-10#1)(2008-11#1)
is strongly inhibited by##2##4##(1990-12#1)(1992-12#1)
is strongly recommended##5##3##(2008-11#1)(2008-7#2)(2010-8#1)(2011-2#1)
is strongly reduced##2##3##(2007-11#1)(2008-8#1)
is strongly related to the##4##5##(2008-10#2)(2008-3#1)(2011-2#1)
is strongly related to##6##4##(2007-10#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#1)
is strongly##72##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#2)(1993-8#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-7#3)(2008-8#4)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#2)(2012-2#1)(2013-8#1)
is structurally related to the##2##5##(1994-8#1)(1997-2#1)
is structurally related to##5##4##(1994-8#1)(1997-2#2)(2008-11#1)(2008-4#1)
is structurally##12##2##(1991-6#1)(1994-8#2)(1995-6#1)(1997-2#2)(2007-12#2)(2008-11#1)(2008-4#2)(2008-8#1)
is structured##4##2##(1991-1#1)(2008-7#1)(2010-5#1)(2012-3#1)
is studied and utilized##2##4##(2008-2#1)(2008-3#1)
is studied and##10##3##(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#1)(2009-11#1)
is studied as a##2##4##(1993-11#1)(2008-3#1)
is studied as##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
is studied by the batch equilibrium technique and##2##8##(2008-10#2)
is studied by##12##3##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#3)
is studied experimentally##2##3##(2008-2#2)
is studied for##4##3##(1995-12#1)(2007-12#2)(2008-3#1)
is studied from##2##3##(2008-2#1)(2008-3#1)
is studied in detail##3##4##(1992-3#1)(2007-11#1)(2008-11#1)
is studied in##6##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2011-1#1)
is studied using##3##3##(2008-10#1)(2008-12#1)(2010-6#1)
is studied with a##2##4##(2007-12#1)(2008-3#1)
is studied with##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
is studied##79##2##(1992-3#1)(1993-11#1)(1994-8#1)(1995-12#1)(1996-8#1)(1997-4#1)(2007-11#5)(2007-12#8)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#15)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#3)(2010-6#1)(2011-1#1)(2013-8#1)
is subdivided into an##2##4##(1991-5#1)(2007-12#1)
is subdivided into##3##3##(1991-5#1)(1994-3#1)(2007-12#1)
is subject to##10##3##(1990-2#1)(1992-12#1)(1993-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-1#1)(2013-7#1)
is subject##11##2##(1990-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-1#1)(2013-7#1)
is subjected to##9##3##(1994-5#1)(1995-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
is subjected##10##2##(1994-5#1)(1995-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2013-1#1)
is subsequently eluted with##2##4##(2008-10#2)
is subsequently##23##2##(1990-2#1)(1993-9#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2009-7#1)(2010-8#1)(2012-2#1)
is substantial##13##2##(1991-3#1)(1992-12#1)(1992-2#1)(1994-3#2)(1997-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-2#1)
is substantially different##2##3##(2007-11#1)(2009-12#1)
is substantially##13##2##(1990-12#1)(1991-12#1)(1991-5#1)(1993-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-5#1)(2012-2#1)
is substantiated##2##2##(2007-12#1)(2008-3#1)
is substituted for##3##3##(2008-2#2)(2011-2#1)
is substituted to##2##3##(1993-12#1)(1995-11#1)
is substituted with##2##3##(1995-3#1)(2009-5#1)
is substituted##9##2##(1993-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(2008-2#3)(2009-5#1)(2011-2#1)
is subtracted##2##2##(2008-2#1)(2008-3#1)
is successful and##2##3##(2008-3#1)(2012-2#1)
is successful##10##2##(1994-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2012-2#1)(2013-8#1)
is successfully applied to the determination of##4##7##(2008-10#4)
is successfully applied to the##6##5##(2008-10#5)(2008-5#1)
is successfully applied to##13##4##(2008-10#11)(2008-3#1)(2008-5#1)
is successfully applied##16##3##(2008-10#14)(2008-3#1)(2008-5#1)
is successfully demonstrated##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is successfully used for the##2##5##(2008-10#1)(2008-5#1)
is successfully used##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
is successfully##28##2##(1990-9#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)
is such a##2##3##(1993-3#1)(2009-9#1)
is such that##2##3##(1997-3#1)(2008-10#1)
is such##5##2##(1993-11#1)(1993-3#1)(1997-3#1)(2008-10#1)(2009-9#1)
is suffering from##2##3##(1992-3#1)(2007-12#1)
is suffering##3##2##(1992-3#1)(2007-12#1)(2008-9#1)
is sufficient for the##2##4##(1995-2#1)(2008-10#1)
is sufficient for##15##3##(1990-11#1)(1993-9#1)(1994-5#1)(1995-2#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#2)
is sufficient to account for##2##5##(2008-3#1)(2008-7#1)
is sufficient to confer##2##4##(1994-12#1)(1997-3#1)
is sufficient to explain the##3##5##(2007-11#1)(2008-11#2)
is sufficient to explain##4##4##(2007-11#1)(2008-11#2)(2008-8#1)
is sufficient to induce##3##4##(1994-2#1)(2008-10#1)(2008-6#1)
is sufficient to obtain##2##4##(2008-3#1)(2008-9#1)
is sufficient to##34##3##(1990-8#1)(1993-12#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-7#1)
is sufficient##56##2##(1990-11#2)(1990-8#1)(1991-12#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#4)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2010-7#1)(2011-2#1)(2013-1#2)
is sufficiently high##2##3##(2008-3#1)(2008-8#1)
is sufficiently large##4##3##(2008-2#2)(2008-8#2)
is sufficiently##21##2##(1995-5#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#3)(2010-4#1)(2012-2#1)(2013-1#1)
is suggested as a possible##2##5##(2008-10#2)
is suggested as a##9##4##(2007-8#1)(2008-10#7)(2012-2#1)
is suggested as the##3##4##(2007-12#1)(2008-7#1)(2012-3#1)
is suggested as##14##3##(2007-12#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
is suggested by the##3##4##(1991-8#1)(1997-5#1)(2009-9#1)
is suggested by##10##3##(1991-8#1)(1992-3#1)(1994-11#1)(1997-5#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
is suggested for the##3##4##(2008-10#2)(2008-11#1)
is suggested for##10##3##(1990-6#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)
is suggested in##2##3##(2012-2#1)(2013-1#1)
is suggested that a##6##4##(1993-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
is suggested that an increase##2##5##(1994-3#1)(2008-1#1)
is suggested that an##4##4##(1994-3#1)(2008-1#1)(2008-7#1)(2008-8#1)
is suggested that the##43##4##(1990-12#1)(1990-5#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)
is suggested that there may##2##5##(1996-12#1)(2008-8#1)
is suggested that there##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
is suggested that these##3##4##(1991-12#1)(1992-3#1)(1992-8#1)
is suggested that this##9##4##(1990-2#1)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#2)(2008-12#2)(2008-8#1)
is suggested that##143##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#6)(1992-3#3)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#9)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)
is suggested to be##9##4##(1990-11#2)(1993-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
is suggested to##18##3##(1990-11#2)(1993-1#1)(1994-11#1)(1994-9#2)(2008-10#4)(2008-11#3)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
is suggested##237##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#7)(1992-3#4)(1992-5#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-6#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-8#2)(2008-1#4)(2008-10#33)(2008-11#18)(2008-12#5)(2008-2#6)(2008-3#8)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#11)(2008-9#3)(2009-12#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#2)
is suggestive of a##4##4##(1990-11#1)(1993-9#1)(1995-12#1)(2008-10#1)
is suggestive of##8##3##(1990-11#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#2)
is suitable as##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
is suitable for a##2##4##(2008-3#1)(2008-4#1)
is suitable for application##2##4##(2008-10#2)
is suitable for clinical##2##4##(2008-10#1)(2008-4#1)
is suitable for measuring##2##4##(2008-10#1)(2008-2#1)
is suitable for real-time##2##4##(2007-11#1)(2008-3#1)
is suitable for routine analysis##2##5##(2008-10#2)
is suitable for routine##4##4##(1996-12#1)(2008-10#2)(2008-5#1)
is suitable for screening##2##4##(2008-10#1)(2011-1#1)
is suitable for the analysis of##4##6##(1996-2#1)(2008-10#1)(2011-1#2)
is suitable for the determination of##7##6##(1991-5#1)(2008-10#5)(2011-1#1)
is suitable for the simultaneous##3##5##(2008-10#3)
is suitable for the##24##4##(1991-5#1)(1996-2#1)(2007-12#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#3)(2013-1#1)
is suitable for use##3##4##(1996-12#1)(2008-10#2)
is suitable for##101##3##(1991-2#1)(1991-5#2)(1993-2#1)(1994-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#41)(2008-11#1)(2008-2#9)(2008-3#12)(2008-4#5)(2008-5#2)(2008-6#1)(2008-9#2)(2010-12#1)(2010-8#2)(2011-1#5)(2012-3#1)(2013-1#1)
is suitable to##2##3##(2007-7#1)(2013-8#1)
is suitable##112##2##(1991-2#1)(1991-5#2)(1993-2#1)(1994-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#44)(2008-11#1)(2008-2#9)(2008-3#12)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#2)(2010-8#3)(2011-1#5)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is suitably##2##2##(2007-12#1)(2008-10#1)
is suited for##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
is suited##5##2##(1990-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
is summarised##3##2##(2008-11#1)(2011-2#1)(2011-3#1)
is summarized in##2##3##(2008-10#1)(2008-5#1)
is summarized##11##2##(1993-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#2)
is superimposed##2##2##(1995-2#1)(2008-9#1)
is superior in terms of##2##5##(2008-11#1)(2011-2#1)
is superior in##5##3##(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is superior or##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
is superior over##2##3##(2008-10#2)
is superior to aluminum##2##4##(1991-5#1)(2008-10#1)
is superior to conventional##2##4##(2008-10#1)(2008-2#1)
is superior to other##3##4##(2008-10#1)(2008-5#1)(2010-6#1)
is superior to that of##2##5##(1995-2#1)(2008-10#1)
is superior to that##3##4##(1995-2#1)(2008-10#2)
is superior to the##11##4##(1992-10#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
is superior to##39##3##(1990-12#1)(1991-5#1)(1992-10#1)(1995-12#1)(1995-2#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
is superior##50##2##(1990-12#1)(1991-5#1)(1992-10#1)(1993-12#1)(1995-12#1)(1995-2#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
is supplemented by##2##3##(1990-5#1)(1996-11#1)
is supplemented with##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
is supplemented##5##2##(1990-5#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
is supplied##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
is support##2##2##(2008-10#1)(2008-11#1)
is supported by a recent##2##5##(1992-3#1)(2008-7#1)
is supported by a##5##4##(1992-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
is supported by the##13##4##(1990-2#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2011-2#1)(2013-8#1)
is supported by##31##3##(1990-2#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
is supported##38##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
is supposed to be##3##4##(1994-10#1)(2008-8#1)(2013-1#1)
is supposed to##5##3##(1994-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is supposed##7##2##(1990-11#1)(1994-10#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is suppressed and##2##3##(2008-9#1)(2012-3#1)
is suppressed by##8##3##(1990-11#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
is suppressed in##2##3##(2008-7#1)(2008-8#1)
is suppressed##19##2##(1990-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#2)
is surely##2##2##(1993-12#1)(1994-1#1)
is surface##2##2##(2008-10#1)(2008-5#1)
is surgery##2##2##(2010-12#1)(2013-1#1)
is surgical treatment##2##3##(1992-9#1)(2008-10#1)
is surgical##8##2##(1992-9#1)(1993-3#1)(2007-11#1)(2008-10#2)(2011-1#1)(2013-1#2)
is surgically##2##2##(2008-10#1)(2008-5#1)
is surprising##5##2##(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2012-3#1)
is surprisingly##8##2##(1990-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)
is surrounded by an##2##4##(2007-12#1)(2008-7#1)
is surrounded by##7##3##(1993-9#1)(1994-12#1)(2007-12#2)(2008-5#1)(2008-7#2)
is surrounded##8##2##(1993-9#1)(1994-12#1)(2007-12#3)(2008-5#1)(2008-7#2)
is surveyed##3##2##(1990-8#1)(1991-12#1)(1995-2#1)
is susceptible to all##2##4##(2008-10#2)
is susceptible to##12##3##(1991-12#1)(1994-12#1)(1995-9#1)(2008-10#8)(2011-2#1)
is susceptible##16##2##(1991-12#1)(1994-12#1)(1995-9#1)(2008-10#11)(2011-2#2)
is suspected in##2##3##(1996-12#1)(2009-3#1)
is suspected to be##2##4##(2008-5#1)(2008-6#1)
is suspected to##3##3##(2008-5#2)(2008-6#1)
is suspended in##2##3##(2008-11#1)(2008-5#1)
is suspended##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
is sustained##5##2##(1992-2#1)(1995-5#1)(2007-10#1)(2011-2#1)(2013-1#1)
is switched off##2##3##(1992-11#1)(1992-3#1)
is switched##3##2##(1992-11#1)(1992-3#1)(2010-12#1)
is symmetric##3##2##(1997-7#1)(2007-12#1)(2008-12#1)
is symmetrical##2##2##(1991-5#1)(2010-3#1)
is symptom##2##2##(2011-2#1)(2012-12#1)
is synchronized to##2##3##(2007-11#1)(2008-3#1)
is synchronously pumped##2##3##(2007-11#1)(2007-12#1)
is synonymous with##3##3##(1997-8#1)(2008-7#1)(2010-4#1)
is synthesised in##2##3##(1991-3#1)(1992-8#1)
is synthesised##3##2##(1991-3#1)(1992-8#1)(2013-7#1)
is synthesized and##5##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
is synthesized as a preproenzyme##2##5##(1991-11#2)
is synthesized as a##5##4##(1990-12#1)(1991-11#2)(2008-10#1)(2012-12#1)
is synthesized by the##2##4##(1995-2#1)(1996-2#1)
is synthesized by##7##3##(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-4#1)(2008-9#1)(2009-10#1)
is synthesized from##2##3##(2008-4#1)(2012-2#1)
is synthesized in the body and##2##6##(2007-7#1)(2008-10#1)
is synthesized in the##4##4##(1993-12#1)(1994-11#1)(2007-7#1)(2008-10#1)
is synthesized in##7##3##(1993-11#1)(1993-12#1)(1994-11#1)(1995-6#1)(2007-7#1)(2008-10#1)(2009-7#1)
is synthesized simply and rapidly from##2##6##(2008-10#2)
is synthesized##37##2##(1990-12#1)(1990-5#1)(1991-11#3)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#4)(2008-9#1)(2009-10#2)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
is systematically##6##2##(1995-11#1)(1997-7#1)(2008-3#3)(2010-4#1)
is tackled by means of##2##5##(2007-11#1)(2008-2#1)
is tailored to##2##3##(1995-1#1)(2009-9#1)
is taken as an##2##4##(2007-11#1)(2008-10#1)
is taken as##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
is taken from##2##3##(2008-7#1)(2010-8#1)
is taken into account by##2##5##(2008-2#1)(2012-3#1)
is taken into account##13##4##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
is taken into consideration##3##4##(1995-5#1)(2008-12#1)(2008-3#1)
is taken into##17##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
is taken to be##3##4##(2008-2#1)(2008-3#2)
is taken to##7##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-3#1)
is taken up by a##2##5##(1990-2#1)(1995-11#1)
is taken up by##3##4##(1990-2#1)(1995-11#1)(1995-6#1)
is taken up##6##3##(1990-2#1)(1994-12#1)(1995-11#1)(1995-6#1)(2007-10#1)(2008-12#1)
is taken##53##2##(1990-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#11)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
is taking place##3##3##(1993-6#1)(1995-3#1)(2011-2#1)
is taking##10##2##(1993-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
is tantamount to the##2##4##(1992-2#1)(2012-3#1)
is targeted to##4##3##(1995-11#1)(2008-1#1)(2008-9#1)(2013-1#1)
is targeted##8##2##(1995-11#1)(2008-1#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#1)
is targeting##2##2##(1997-6#1)(2010-11#1)
is taxonomically##2##2##(2011-2#1)(2012-3#1)
is technically demanding and##2##4##(1996-9#1)(2008-12#1)
is technically simple##2##3##(2008-10#1)(2010-3#1)
is technically##13##2##(1990-5#1)(1994-9#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-12#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
is tedious##2##2##(2008-9#1)(2012-2#1)
is temperature##4##2##(1994-8#1)(2007-11#1)(2008-10#2)
is temporally##2##2##(1991-11#1)(2008-10#1)
is temporarily##2##2##(1991-2#1)(2008-9#1)
is ten times more##2##4##(1992-2#1)(2008-10#1)
is ten times##3##3##(1992-2#2)(2008-10#1)
is termed a##2##3##(2008-10#1)(2008-3#1)
is termed##6##2##(1995-2#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
is tested and##2##3##(2008-3#1)(2009-12#1)
is tested for##2##3##(2008-2#1)(2008-4#1)
is tested in##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
is tested on the##2##4##(2012-2#1)(2012-3#1)
is tested on##8##3##(2008-3#3)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
is tested with##3##3##(2008-3#3)
is tested##31##2##(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
is that a##10##3##(1990-7#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#2)(2012-3#1)
is that an##3##3##(2008-2#1)(2008-3#2)
is that cell##2##3##(1992-9#1)(2008-2#1)
is that different##2##3##(2007-12#1)(2013-8#1)
is that even##2##3##(2008-3#1)(2008-7#1)
is that in##6##3##(1990-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
is that it can##5##4##(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)
is that it is##7##4##(1994-3#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
is that it provides##2##4##(2008-1#1)(2009-8#1)
is that it requires##2##4##(2008-10#1)(2008-4#1)
is that it##32##3##(1994-3#1)(1994-9#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
is that most##2##3##(1995-1#1)(2007-8#1)
is that no##3##3##(2008-10#2)(2008-11#1)
is that of a##2##4##(1995-2#2)
is that of the##4##4##(1995-2#1)(2009-10#1)(2013-1#1)(2013-8#1)
is that of##20##3##(1990-6#1)(1992-3#1)(1993-1#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
is that only##2##3##(1993-8#1)(2008-10#1)
is that people with##2##4##(1996-1#1)(2008-12#1)
is that sexual##2##3##(1993-9#1)(2008-10#1)
is that such##4##3##(1997-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
is that the theoretical##2##4##(2008-11#1)(2008-2#1)
is that the##88##3##(1991-3#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#3)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#6)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
is that there is##2##4##(1996-1#1)(2007-11#1)
is that there##3##3##(1996-1#1)(2007-11#1)(2008-4#1)
is that these##9##3##(1995-2#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)
is that they do##2##4##(1991-2#1)(2008-4#1)
is that they usually##2##4##(2011-2#2)
is that they##6##3##(1991-2#2)(2008-4#1)(2011-2#3)
is that this##5##3##(1993-12#1)(2008-11#1)(2008-12#1)(2013-8#2)
is that which##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
is that##354##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2006-10#1)(2006-6#1)(2007-11#6)(2007-12#5)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#32)(2008-11#15)(2008-12#4)(2008-2#19)(2008-3#27)(2008-4#11)(2008-5#7)(2008-6#6)(2008-7#16)(2008-8#19)(2008-9#16)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#5)(2013-8#8)
is the &quot##5##3##(1996-6#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-12#1)
is the ability of##4##4##(1997-6#1)(2009-1#1)(2010-5#2)
is the ability to##5##4##(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
is the ability##9##3##(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-5#2)(2010-8#1)
is the absence of the##2##5##(1991-9#1)(2008-10#1)
is the absence of##5##4##(1990-5#1)(1991-9#1)(2008-10#2)(2013-1#1)
is the absolute##2##3##(1990-8#1)(2007-12#1)
is the access##2##3##(1996-3#1)(2007-7#1)
is the accumulation of##2##4##(1996-5#1)(2008-7#1)
is the activation of##2##4##(1994-8#1)(2008-1#1)
is the active##3##3##(1992-3#1)(1996-12#1)(2013-8#1)
is the actual##3##3##(1992-9#1)(1995-8#1)(2008-3#1)
is the aerosol##2##3##(2008-2#2)
is the alternative##2##3##(1990-6#1)(1997-3#1)
is the amount of##2##4##(2008-5#1)(2010-8#1)
is the analogous parent molecule##2##5##(2010-7#2)
is the analysis of##2##4##(2007-8#1)(2010-11#1)
is the appearance of##2##4##(1991-3#1)(2008-3#1)
is the application of##3##4##(2008-10#1)(2008-9#1)(2009-3#1)
is the area##2##3##(1992-9#1)(1995-1#1)
is the association##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
is the asymmetry##4##3##(2008-2#3)(2010-9#1)
is the availability of##2##4##(1994-2#1)(2008-5#1)
is the average cosine of##2##5##(2008-3#2)
is the average##3##3##(1992-12#1)(2008-3#2)
is the avian##2##3##(1993-6#1)(1995-2#1)
is the basic##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
is the basis for a##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
is the basis for the##4##5##(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
is the basis for##8##4##(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
is the basis of this##2##5##(2008-10#1)(2011-2#1)
is the basis of##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
is the basis##13##3##(1997-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
is the beginning of a##2##5##(1991-12#1)(2007-11#1)
is the beginning of##3##4##(1991-12#1)(2007-11#1)(2008-12#1)
is the belief that##2##4##(1996-1#1)(2008-4#1)
is the best approach##2##4##(2008-10#2)
is the best available##2##4##(2011-2#2)
is the best known##2##4##(2007-11#1)(2008-10#1)
is the best regimen##2##4##(1991-11#1)(1993-11#1)
is the best way to##2##5##(2008-9#1)(2011-2#1)
is the best way##3##4##(2008-9#1)(2010-12#1)(2011-2#1)
is the best##34##3##(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-11#1)(1994-7#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#7)(2013-1#1)(2013-8#1)
is the beta value for##2##5##(2008-10#2)
is the case for##7##4##(1990-5#1)(1991-6#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-2#1)(2013-1#1)
is the case in##7##4##(1991-9#1)(1993-11#1)(1994-9#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
is the case of##6##4##(1992-6#1)(1997-2#1)(2008-10#2)(2008-2#1)(2012-3#1)
is the case with##7##4##(1990-5#1)(1992-5#1)(2006-10#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-7#1)
is the case##38##3##(1990-5#2)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
is the catalytic##4##3##(2008-11#1)(2008-4#2)(2008-5#1)
is the causal agent of a##2##6##(2008-10#2)
is the causal agent of##11##5##(2008-10#11)
is the causative agent of##5##5##(1992-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
is the cause of##6##4##(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-12#1)
is the cause##7##3##(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-12#1)(2013-7#1)
is the cell##2##3##(2008-4#2)
is the cellular##3##3##(1993-6#1)(1996-2#1)(2008-11#1)
is the center##2##3##(2008-7#1)(2008-8#1)
is the central##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
is the chemical##2##3##(1996-12#1)(2008-4#1)
is the chief##2##3##(1993-11#1)(2008-10#1)
is the clinical##3##3##(2007-11#1)(2012-2#1)(2012-3#1)
is the combination of two##2##5##(2008-10#1)(2008-4#1)
is the combination of##4##4##(2008-10#1)(2008-4#1)(2009-1#1)(2010-4#1)
is the combination##5##3##(2008-1#1)(2008-10#1)(2008-4#1)(2009-1#1)(2010-4#1)
is the common##2##3##(2012-3#1)(2013-1#1)
is the commonest primary##2##4##(2008-1#1)(2010-11#1)
is the commonest##14##3##(1992-4#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-3#1)(2013-8#2)
is the comprehensive##2##3##(1993-8#1)(2007-5#1)
is the concentration##2##3##(2008-10#1)(2012-2#1)
is the concurrent##2##3##(2006-10#1)(2008-12#1)
is the consequence of##2##4##(2008-4#1)(2008-7#1)
is the construction##2##3##(2008-10#1)(2011-2#1)
is the contribution of##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
is the core##2##3##(2008-1#2)
is the cornerstone of any##2##5##(1995-3#1)(2012-12#1)
is the cornerstone of##3##4##(1995-3#1)(2011-2#1)(2012-12#1)
is the critical##4##3##(1994-2#1)(2008-8#1)(2012-1#1)(2012-12#1)
is the current##6##3##(1991-2#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
is the definitive##2##3##(2007-8#1)(2010-6#1)
is the degree##2##3##(1996-3#1)(2008-3#1)
is the delivery##2##3##(1996-1#1)(2008-5#1)
is the deposition of##2##4##(1991-9#1)(2008-10#1)
is the determination of the##2##5##(2008-7#1)(2011-2#1)
is the determination of##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
is the development of a##3##5##(2007-6#1)(2008-10#1)(2009-8#1)
is the development of##10##4##(2007-11#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is the development##11##3##(2007-11#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is the difference between##2##4##(1990-5#1)(2008-2#1)
is the difference##4##3##(1990-5#1)(2008-2#1)(2008-3#2)
is the difficulty in##2##4##(2007-8#1)(2012-3#1)
is the difficulty of##2##4##(1994-11#1)(2010-8#1)
is the difficulty##4##3##(1994-11#1)(2007-8#1)(2010-8#1)(2012-3#1)
is the diffusion coefficient##2##4##(2007-10#1)(2008-11#1)
is the diffusion##3##3##(2007-10#1)(2008-11#1)(2008-8#1)
is the dimensionless##2##3##(2007-10#1)(2008-2#1)
is the discovery##2##3##(1994-5#1)(2010-12#1)
is the distance between the##2##5##(2008-3#2)
is the dominant##8##3##(1996-4#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
is the dominating##2##3##(2007-11#1)(2008-8#1)
is the driving##3##3##(1993-1#1)(1994-8#1)(2013-8#1)
is the drug##2##3##(1993-2#1)(2013-1#1)
is the earliest##2##3##(2008-7#1)(2010-5#1)
is the easiest##2##3##(1990-3#1)(2007-8#1)
is the effect of##3##4##(2008-12#1)(2008-8#1)(2012-2#1)
is the effect##5##3##(1993-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
is the effectiveness of multilevel##2##5##(2012-12#2)
is the eighth##2##3##(2008-1#1)(2008-3#1)
is the endogenous##2##3##(1993-9#1)(2012-12#1)
is the environment##2##3##(2007-12#1)(2008-8#1)
is the essential##5##3##(1995-3#1)(1996-12#1)(1997-3#1)(2008-5#1)(2008-6#1)
is the establishment of a##2##5##(1991-12#1)(2008-10#1)
is the etiologic agent of##2##5##(2007-2#1)(2008-9#1)
is the etiological agent of##2##5##(1997-4#1)(2007-12#1)
is the evaluation of the##2##5##(2007-11#1)(2008-7#1)
is the evidence##2##3##(2008-7#1)(2013-1#1)
is the evolutionarily##3##3##(2008-10#1)(2011-2#2)
is the extension of##2##4##(1995-9#1)(2008-2#1)
is the extensive##2##3##(1992-1#1)(1994-8#1)
is the extent to which the##2##6##(2008-10#1)(2008-11#1)
is the extent to which##3##5##(2008-10#1)(2008-11#1)(2009-9#1)
is the fact that the##3##5##(1996-9#1)(2011-2#1)(2012-1#1)
is the fact that##9##4##(1990-3#1)(1996-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)
is the failure to##2##4##(2008-11#1)(2012-2#1)
is the field##2##3##(1991-1#1)(1996-2#1)
is the fifth##4##3##(1997-3#1)(2008-5#1)(2009-1#1)(2013-1#1)
is the final step##2##4##(1992-12#1)(2008-2#1)
is the final##4##3##(1991-9#1)(1992-12#1)(1994-3#1)(2008-2#1)
is the first application of##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
is the first attempt to##2##5##(2008-11#1)(2013-8#1)
is the first attempt##3##4##(2008-11#1)(2010-2#1)(2013-8#1)
is the first case of##9##5##(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-5#1)(2010-3#1)(2012-3#2)
is the first case report##3##5##(2008-6#1)(2009-2#1)(2012-3#1)
is the first case reported##2##5##(2007-10#1)(2007-7#1)
is the first case##14##4##(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2012-3#3)
is the first choice##3##4##(2007-7#1)(2008-1#1)(2012-2#1)
is the first comprehensive##2##4##(2008-10#1)(2013-1#1)
is the first demonstration of##10##5##(1990-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-8#1)(2013-1#1)
is the first demonstration##11##4##(1990-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-8#1)(2013-1#1)
is the first described##2##4##(1994-3#1)(2008-10#1)
is the first description of the##2##6##(2008-10#1)(2009-7#1)
is the first description of##4##5##(1997-5#1)(2008-10#2)(2009-7#1)
is the first documented##3##4##(2008-12#1)(2008-9#1)(2012-2#1)
is the first example of a##3##6##(1991-2#1)(1996-3#1)(2012-3#1)
is the first example of##5##5##(1991-2#1)(1996-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
is the first in a series of##2##7##(1996-3#1)(2008-4#1)
is the first in a series##4##6##(1993-2#1)(1993-3#1)(1996-3#1)(2008-4#1)
is the first instance of##2##5##(2008-11#1)(2008-12#1)
is the first known##2##4##(2011-2#1)(2013-1#1)
is the first line of##3##5##(1993-12#1)(2008-7#1)(2013-1#1)
is the first major##2##4##(2008-10#2)
is the first member of##2##5##(2008-10#1)(2008-8#1)
is the first observation##2##4##(1991-5#1)(1993-6#1)
is the first of a##3##5##(1994-12#1)(1995-5#1)(2008-9#1)
is the first of##5##4##(1994-12#1)(1994-5#1)(1995-5#1)(2006-10#1)(2008-9#1)
is the first published##3##4##(1990-12#1)(2008-10#1)(2012-2#1)
is the first record of##2##5##(1997-4#1)(2008-10#1)
is the first report confirming the##2##6##(2011-2#2)
is the first report describing##4##5##(1994-12#1)(2008-10#2)(2008-11#1)
is the first report in##2##5##(2008-5#1)(2013-8#1)
is the first report of a##16##6##(1992-2#1)(1995-5#1)(1995-9#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
is the first report of an##4##6##(1991-9#1)(1992-10#1)(2007-8#1)(2013-1#1)
is the first report of successful treatment of##2##8##(1991-4#1)(2008-10#1)
is the first report of such##3##6##(2007-10#1)(2007-12#1)(2011-1#1)
is the first report of the effects of##2##8##(2008-11#1)(2013-1#1)
is the first report of the isolation##2##7##(1990-7#1)(2008-10#1)
is the first report of the##13##6##(1990-7#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is the first report of##76##5##(1990-7#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-5#2)(1995-6#1)(1995-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#24)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
is the first report on the##12##6##(2008-10#9)(2008-12#1)(2008-9#2)
is the first report on##21##5##(1994-3#1)(2007-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-6#1)(2011-2#2)
is the first report that##10##5##(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
is the first report to show##2##6##(1990-5#1)(2009-12#1)
is the first report to##3##5##(1990-5#1)(2009-12#1)(2012-2#1)
is the first report##131##4##(1990-5#1)(1990-7#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
is the first reported case of such##2##7##(2008-10#1)(2010-7#1)
is the first reported case of##17##6##(2007-10#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-7#4)(2008-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
is the first reported case##18##5##(1991-9#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-7#4)(2008-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
is the first reported##22##4##(1991-9#1)(1992-8#1)(2007-10#1)(2007-6#1)(2008-10#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
is the first species##2##4##(2008-12#1)(2008-5#1)
is the first step in##5##5##(1994-3#1)(1996-1#1)(2008-10#1)(2010-9#1)(2011-2#1)
is the first step to##3##5##(1992-12#1)(2011-2#2)
is the first step toward##2##5##(2008-6#1)(2009-4#1)
is the first step##14##4##(1992-12#1)(1994-3#2)(1996-1#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-2#3)(2013-1#1)(2013-8#1)
is the first study showing that##2##6##(1995-12#1)(2011-2#1)
is the first study to examine##2##6##(2008-10#1)(2008-8#1)
is the first study to##5##5##(2008-10#3)(2008-12#1)(2008-8#1)
is the first study##11##4##(1995-12#1)(2008-10#6)(2008-12#1)(2008-8#1)(2011-2#2)
is the first time in##2##5##(1991-11#1)(2008-3#1)
is the first time that##9##5##(1991-3#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
is the first time the##2##5##(1995-6#1)(2007-11#1)
is the first time to our knowledge##2##7##(2007-12#1)(2008-2#1)
is the first time to##4##5##(2007-12#1)(2008-2#1)(2008-9#2)
is the first time##26##4##(1991-11#1)(1991-3#1)(1995-6#1)(1997-2#2)(2007-11#1)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#3)(2011-2#1)(2012-2#1)
is the first to demonstrate##3##5##(1990-11#1)(1994-11#1)(2009-12#1)
is the first to##13##4##(1990-11#1)(1993-1#1)(1994-11#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-12#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-3#1)
is the first treatment of##2##5##(1993-8#1)(2008-1#1)
is the first##399##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#3)(1994-3#4)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#11)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#81)(2008-11#17)(2008-12#5)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#8)(2008-6#9)(2008-7#12)(2008-8#6)(2008-9#12)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#7)(2011-2#44)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#9)(2013-1#11)(2013-3#1)(2013-8#5)
is the first-line treatment##2##4##(2010-12#1)(2013-8#1)
is the first-line##4##3##(2010-12#3)(2013-8#1)
is the focal point of##2##5##(1992-3#1)(2008-10#1)
is the focus of this##2##5##(2008-12#1)(2010-6#1)
is the focus of##6##4##(1993-1#1)(1997-2#1)(1997-4#1)(2008-12#1)(2010-6#1)(2010-7#1)
is the following##3##3##(1993-8#1)(2008-8#1)(2009-4#1)
is the formation of##4##4##(1994-8#1)(1997-1#1)(2008-1#1)(2008-11#1)
is the foundation##2##3##(2008-10#1)(2008-5#1)
is the fourth case of##2##5##(2007-7#1)(2011-2#1)
is the fourth in a series##2##6##(1994-1#1)(2008-5#1)
is the fourth##6##3##(1994-1#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#1)
is the fraction of##2##4##(1990-8#1)(1997-3#1)
is the function of the##2##5##(2008-10#2)
is the functional##3##3##(2008-4#1)(2008-9#1)(2009-10#1)
is the future##3##3##(1991-1#1)(2008-11#2)
is the generation of##3##4##(2008-10#1)(2008-6#2)
is the generation##5##3##(2008-10#1)(2008-2#1)(2008-6#2)(2008-8#1)
is the goal##3##3##(1997-1#1)(2007-8#1)(2012-12#1)
is the gold standard for##3##5##(2007-12#1)(2008-11#1)(2013-8#1)
is the gold standard##8##4##(1996-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2009-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
is the hallmark of##2##4##(2011-2#1)(2012-2#1)
is the health##2##3##(1995-12#1)(1996-12#1)
is the highest incidence of##2##5##(1990-3#1)(2008-4#1)
is the highest value##2##4##(2007-11#1)(2008-12#1)
is the highest##12##3##(1990-3#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)
is the human##3##3##(1997-7#1)(2008-4#1)(2008-5#1)
is the ideal##2##3##(2007-8#1)(2013-1#1)
is the identification of##3##4##(2008-4#1)(2010-12#1)(2010-4#1)
is the identification##5##3##(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2012-3#1)
is the imaging##3##3##(2009-3#1)(2012-12#1)(2012-2#1)
is the impact of##2##4##(1994-3#1)(1995-2#1)
is the impact on##2##4##(1992-2#1)(1994-3#1)
is the impact##5##3##(1992-2#1)(1994-3#2)(1995-2#1)(2008-7#1)
is the importance of##3##4##(2008-11#2)(2011-1#1)
is the increased##2##3##(1991-3#1)(2008-3#1)
is the influence of the##2##5##(2008-2#1)(2011-2#1)
is the influence of##3##4##(1996-4#1)(2008-2#1)(2011-2#1)
is the initial##5##3##(2007-10#1)(2007-7#1)(2011-1#2)(2011-2#1)
is the interaction between##2##4##(1992-8#1)(1997-6#1)
is the investigation of##2##4##(1996-9#1)(2008-7#1)
is the joint##2##3##(2008-2#1)(2011-1#1)
is the key element##2##4##(2007-11#1)(2008-7#1)
is the key enzyme##2##4##(2008-8#1)(2013-1#1)
is the key factor in##2##5##(2008-10#1)(2008-3#1)
is the key factor##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
is the key step##2##4##(2007-8#1)(2008-11#1)
is the key to the##3##5##(1990-8#1)(1992-2#1)(2007-8#1)
is the key to understanding the##2##6##(2008-1#1)(2008-9#1)
is the key to##16##4##(1990-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)
is the key##37##3##(1990-8#1)(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-2#2)(1996-1#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
is the lack of##7##4##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2012-2#2)
is the largest##11##3##(1991-5#1)(1993-11#1)(1995-6#1)(1997-5#1)(2008-1#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
is the last in a##2##5##(1995-2#1)(1996-2#1)
is the last##6##3##(1991-12#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2010-3#1)
is the lead##2##3##(2008-5#1)(2008-7#1)
is the leading cause of death and disability in##2##9##(2008-8#1)(2011-2#1)
is the leading cause of death##4##6##(1990-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
is the leading cause of visual##2##6##(2011-2#1)(2012-2#1)
is the leading cause of##15##5##(1990-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
is the leading##18##3##(1990-6#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
is the least##3##3##(1992-5#1)(2007-11#1)(2012-3#1)
is the level of##2##4##(2008-1#1)(2009-5#1)
is the light source##2##4##(2008-10#1)(2008-3#1)
is the limiting step##2##4##(1993-6#1)(1994-11#1)
is the limiting##3##3##(1993-6#1)(1994-11#1)(2008-2#1)
is the log10##2##3##(2008-10#2)
is the logical##2##3##(2008-7#1)(2009-9#1)
is the loss of##3##4##(1993-6#1)(2008-10#1)(2008-3#1)
is the low##3##3##(1996-3#1)(2008-10#1)(2008-5#1)
is the lowest##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
is the magnetic##2##3##(2008-3#1)(2008-7#1)
is the main cause of##6##5##(2008-1#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#1)
is the main factor##2##4##(2007-11#1)(2012-12#1)
is the main mechanism of##2##5##(2007-11#1)(2008-12#1)
is the main mechanism##6##4##(1996-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
is the main problem##2##4##(1995-3#1)(2007-8#1)
is the main route of##2##5##(2007-7#1)(2013-8#1)
is the main species##3##4##(2008-10#3)
is the main therapeutic##2##4##(2008-3#1)(2008-4#1)
is the main##47##3##(1990-7#1)(1991-9#1)(1994-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-3#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
is the mainstay of treatment for##2##6##(2010-4#1)(2011-1#1)
is the mainstay of treatment##5##5##(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
is the mainstay of##8##4##(1997-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
is the mainstay##9##3##(1997-1#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
is the major cause of death in##2##7##(2008-3#1)(2013-8#1)
is the major determinant of##3##5##(2008-11#1)(2008-3#1)(2008-8#1)
is the major##43##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
is the major)##2##3##(2008-11#2)
is the management of##2##4##(2008-12#1)(2012-12#1)
is the maximum##4##3##(1991-8#1)(2008-10#2)(2008-7#1)
is the means by which##2##5##(1996-1#1)(2008-10#1)
is the measurement of##2##4##(1996-12#1)(2009-4#1)
is the mechanism##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
is the median##2##3##(1995-3#2)
is the method of choice for##4##6##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
is the method of choice##5##5##(1992-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
is the method of##7##4##(1990-11#1)(1992-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
is the method##10##3##(1990-11#1)(1992-9#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
is the minimal##2##3##(2006-8#1)(2009-7#1)
is the modulation##2##3##(2007-12#1)(2010-2#1)
is the mole fraction of##2##5##(2008-10#2)
is the more##5##3##(1995-2#1)(2008-10#2)(2009-10#1)(2009-8#1)
is the most abundant##3##4##(2008-10#2)(2011-2#1)
is the most accurate##3##4##(1991-6#1)(1993-11#2)
is the most active##3##4##(1992-2#1)(1992-9#1)(2008-11#1)
is the most apparent##2##4##(1995-1#1)(2008-5#1)
is the most appropriate way to##2##6##(2008-10#2)
is the most appropriate##7##4##(1990-6#1)(1993-6#1)(1996-2#1)(2008-10#2)(2011-2#1)(2013-1#1)
is the most common and##4##5##(2008-7#1)(2010-5#1)(2013-1#2)
is the most common causative##2##5##(2008-1#1)(2012-12#1)
is the most common cause of chronic##2##7##(2007-7#1)(2009-7#1)
is the most common cause of##12##6##(1993-9#1)(2007-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is the most common cause##13##5##(1993-9#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is the most common chronic##2##5##(2008-9#1)(2011-1#1)
is the most common complication of##2##6##(1991-6#1)(2007-11#1)
is the most common congenital##4##5##(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
is the most common form of##8##6##(1992-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
is the most common malignancy##2##5##(2009-2#1)(2013-1#1)
is the most common malignant##2##5##(1995-11#1)(2012-2#1)
is the most common method##2##5##(2008-4#1)(2012-2#1)
is the most common neoplasm##2##5##(2010-6#1)(2012-3#1)
is the most common primary##2##5##(2010-3#1)(2013-1#1)
is the most common site of##2##6##(2007-11#1)(2011-2#1)
is the most common type of##3##6##(2010-6#1)(2011-2#1)(2013-1#1)
is the most common##101##4##(1991-12#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-9#1)(1995-11#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#3)(2010-6#3)(2010-8#3)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#10)(2013-8#3)
is the most commonly used##2##5##(2008-7#1)(2008-9#1)
is the most commonly##9##4##(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-7#1)
is the most cost-effective##3##4##(2011-1#2)(2011-2#1)
is the most critical##3##4##(2008-10#1)(2008-3#2)
is the most destructive##2##4##(2008-10#1)(2013-8#1)
is the most difficult##2##4##(2008-2#1)(2011-2#1)
is the most dimorphic##2##4##(1995-6#2)
is the most economical and##2##5##(2008-3#1)(2009-10#1)
is the most effective inhibitor of Na(+)-H+ exchange in##2##9##(1992-5#2)
is the most effective means to control##2##7##(2008-10#2)
is the most effective##13##4##(1991-3#1)(1992-5#2)(1995-2#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-7#1)(2012-2#1)
is the most efficacious##2##4##(2010-12#1)(2011-2#1)
is the most frequent##13##4##(1990-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-3#1)(2011-2#2)(2013-1#3)
is the most frequently##3##4##(2008-8#1)(2011-2#1)(2012-12#1)
is the most important##18##4##(1992-5#1)(1994-5#1)(1995-2#1)(1995-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)
is the most likely##6##4##(1992-8#1)(1994-2#1)(1995-6#1)(2008-10#2)(2011-2#1)
is the most popular##3##4##(2009-6#1)(2009-8#1)(2010-8#1)
is the most potent##5##4##(1993-8#1)(1994-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
is the most powerful##2##4##(1996-3#1)(2011-2#1)
is the most prevalent##3##4##(2006-10#1)(2008-5#1)(2013-8#1)
is the most probable##3##4##(1991-12#1)(1994-5#1)(2013-1#1)
is the most recently##2##4##(1993-11#1)(2008-8#1)
is the most sensitive method##2##5##(2008-10#1)(2010-12#1)
is the most sensitive##5##4##(2008-10#2)(2010-12#1)(2010-6#1)(2011-2#1)
is the most serious complication of##2##6##(1991-11#1)(2009-2#1)
is the most serious##5##4##(1991-11#1)(2008-10#2)(2009-2#1)(2012-2#1)
is the most severe##4##4##(1994-9#1)(2007-8#1)(2008-10#1)(2013-8#1)
is the most significant##3##4##(1995-3#1)(2012-12#1)(2012-3#1)
is the most suitable##6##4##(1995-8#1)(2008-10#2)(2010-8#1)(2013-1#2)
is the most useful##2##4##(2008-2#1)(2012-2#1)
is the most widely used##6##5##(2008-3#1)(2008-4#2)(2008-8#1)(2010-8#1)(2011-1#1)
is the most widely##8##4##(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#2)(2010-8#1)(2011-1#1)
is the most widespread##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
is the most##302##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#5)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#39)(2008-11#7)(2008-2#5)(2008-3#10)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#3)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#8)(2011-1#4)(2011-2#27)(2012-1#1)(2012-12#6)(2012-2#16)(2012-3#3)(2013-1#21)(2013-8#8)
is the mutation##2##3##(2007-10#1)(2010-3#1)
is the natural##2##3##(2008-10#2)
is the necessary##2##3##(1991-12#1)(1994-12#1)
is the need for a##2##5##(1992-1#1)(1996-3#1)
is the need for##8##4##(1992-1#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-2#1)
is the need to##6##4##(1991-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
is the need##16##3##(1991-1#1)(1992-1#1)(1993-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2011-1#1)(2012-12#1)
is the new##2##3##(2012-12#1)(2013-1#1)
is the next best##2##4##(2007-7#1)(2011-1#1)
is the next##3##3##(2007-7#1)(2008-1#1)(2011-1#1)
is the normal##2##3##(2007-5#1)(2008-10#1)
is the notion of##2##4##(2008-12#1)(2009-3#1)
is the number of##11##4##(1991-8#1)(1993-12#1)(2007-11#1)(2008-8#2)(2009-12#2)(2009-3#1)(2010-2#2)(2010-8#1)
is the number one cause of death##2##7##(2011-2#1)(2012-2#1)
is the number##14##3##(1991-8#1)(1993-12#1)(2007-11#1)(2008-8#2)(2009-12#2)(2009-3#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is the occurrence of##2##4##(1997-4#1)(2007-7#1)
is the one##2##3##(2008-10#1)(2010-5#1)
is the only effective##2##4##(1992-6#1)(2009-11#1)
is the only known##4##4##(1997-1#1)(2008-10#1)(2008-5#1)(2009-12#1)
is the only one##3##4##(1997-7#1)(2008-6#1)(2011-2#1)
is the only species##2##4##(2011-2#2)
is the only treatment##2##4##(2008-10#1)(2010-5#1)
is the only way to##2##5##(1991-11#1)(1997-5#1)
is the only way##5##4##(1991-11#1)(1994-9#1)(1997-5#1)(2010-6#1)(2010-7#1)
is the only##61##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#7)(2012-2#1)(2013-1#2)(2013-8#1)
is the operation of##2##4##(1993-9#1)(2009-12#1)
is the optimal treatment for##2##5##(2007-8#1)(2008-6#1)
is the optimal treatment##3##4##(2007-8#1)(2008-6#1)(2010-4#1)
is the optimal##8##3##(2007-8#3)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)
is the optimum##2##3##(2008-3#1)(2010-3#1)
is the outcome of##3##4##(1994-1#2)(2008-7#1)
is the outcome##4##3##(1990-12#1)(1994-1#2)(2008-7#1)
is the overall##2##3##(2007-11#2)
is the percentage of##2##4##(1993-12#1)(2013-1#1)
is the possibility of##5##4##(1990-8#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
is the possibility##6##3##(1990-8#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
is the potential for the##2##5##(1997-6#1)(2008-10#1)
is the potential of##2##4##(2008-11#1)(2009-12#1)
is the potential##6##3##(1997-6#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-4#1)
is the precise##2##3##(2009-4#1)(2011-2#1)
is the predominant mechanism##2##4##(2007-11#1)(2008-10#1)
is the predominant##7##3##(1992-12#1)(1993-11#1)(2007-11#1)(2008-10#3)(2008-11#1)
is the preferred method of##2##5##(1994-1#1)(2010-7#1)
is the preferred method##3##4##(1994-1#1)(2007-12#1)(2010-7#1)
is the preferred treatment##2##4##(1996-3#1)(2010-3#1)
is the preferred##10##3##(1994-1#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-3#1)(2010-7#1)(2013-8#1)
is the preparation of##3##4##(2007-11#1)(2008-11#1)(2008-4#1)
is the presence of##10##4##(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-3#1)
is the prevention of##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
is the primary cause of##2##5##(2008-11#1)(2012-2#1)
is the primary focus of this review##2##7##(2008-1#1)(2008-7#1)
is the primary focus##3##4##(2008-1#1)(2008-7#1)(2009-5#1)
is the primary force behind##2##5##(1995-12#1)(2011-2#1)
is the primary site of##2##5##(1991-2#1)(2008-10#1)
is the primary site##3##4##(1991-2#1)(1992-12#1)(2008-10#1)
is the primary##37##3##(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-3#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
is the prime##3##3##(1991-3#1)(1991-9#1)(2010-3#1)
is the principal##7##3##(1990-2#1)(1991-11#1)(1993-11#1)(1994-6#1)(1994-8#1)(2008-10#1)(2009-8#1)
is the principle##2##3##(2008-1#1)(2008-10#1)
is the problem of##4##4##(1991-4#1)(2007-11#1)(2010-3#1)(2011-1#1)
is the procedure of choice in##2##6##(2009-5#1)(2011-2#1)
is the procedure of choice##4##5##(2007-8#1)(2009-5#1)(2010-3#1)(2011-2#1)
is the process by which##2##5##(2008-1#1)(2008-4#1)
is the process of##5##4##(1996-12#1)(2008-10#1)(2008-3#1)(2008-9#2)
is the process##8##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2013-8#1)
is the product of##3##4##(1995-5#1)(2008-10#1)(2008-7#1)
is the product##6##3##(1990-7#2)(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
is the production of##2##4##(1992-10#1)(2008-3#1)
is the prototype of a##2##5##(1996-7#1)(2008-9#1)
is the prototype of##5##4##(1996-5#1)(1996-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
is the provision of##3##4##(1994-2#1)(1995-1#1)(2008-10#1)
is the pulse##2##3##(2007-11#1)(2008-2#1)
is the purpose of##4##4##(2007-7#1)(2010-12#3)
is the quality##3##3##(1996-2#1)(2008-7#1)(2012-12#1)
is the question##3##3##(1993-3#1)(1994-3#1)(1996-1#1)
is the rate of##2##4##(2008-3#1)(2008-8#1)
is the rate-limiting enzyme in##2##5##(1991-9#1)(1994-11#1)
is the rate-limiting##4##3##(1991-9#2)(1994-11#1)(2008-1#1)
is the reason for##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
is the reason that##2##4##(2008-10#1)(2011-2#1)
is the reason##6##3##(1997-6#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)
is the recognition##2##3##(1991-6#1)(1995-6#1)
is the reduced##2##3##(1990-2#1)(2008-7#1)
is the reduction in##2##4##(2008-11#1)(2008-9#1)
is the region##2##3##(1993-11#1)(2010-1#1)
is the relationship between##3##4##(1995-11#1)(1996-2#1)(2008-7#1)
is the relationship##4##3##(1993-11#1)(1995-11#1)(1996-2#1)(2008-7#1)
is the relative##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
is the relatively high##2##4##(2008-1#1)(2008-10#1)
is the relatively##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
is the requirement for##2##4##(1993-11#1)(2008-1#1)
is the responsibility of the##2##5##(1995-9#1)(2012-12#1)
is the responsibility of##4##4##(1995-9#1)(1996-3#1)(2008-11#1)(2012-12#1)
is the result of a##5##5##(2007-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
is the result of decreased##3##5##(2007-2#1)(2008-1#1)(2013-7#1)
is the result of the##5##5##(1993-11#1)(1994-5#1)(2008-3#1)(2008-8#1)(2013-8#1)
is the result of##39##4##(1993-11#1)(1994-1#1)(1994-12#1)(1994-5#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#4)(2013-8#1)
is the reverse##2##3##(2008-9#1)(2010-7#1)
is the risk of##3##4##(2007-5#1)(2008-11#1)(2008-7#1)
is the role of the##3##5##(1995-12#1)(2007-12#1)(2008-11#1)
is the role of##10##4##(1993-11#2)(1995-12#1)(2007-12#2)(2008-11#2)(2008-8#1)(2012-12#1)(2012-2#1)
is the role##11##3##(1993-11#2)(1995-1#1)(1995-12#1)(2007-12#2)(2008-11#2)(2008-8#1)(2012-12#1)(2012-2#1)
is the rule##2##3##(2008-6#1)(2011-3#1)
is the same as in##2##5##(1990-5#1)(1991-8#1)
is the same as that of the##2##7##(1990-12#1)(2008-2#1)
is the same as that of##3##6##(1990-12#1)(1990-7#1)(2008-2#1)
is the same as that##7##5##(1990-12#1)(1990-7#1)(1993-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-1#1)
is the same as the##5##5##(1991-5#1)(1995-6#1)(2008-10#3)
is the same as##16##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1993-8#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-8#1)(2010-1#1)
is the same for all##2##5##(1994-5#1)(2008-8#1)
is the same for##5##4##(1994-5#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-3#1)
is the same in##4##4##(1993-6#1)(1994-6#1)(1996-9#1)(2008-9#1)
is the same virus##2##4##(2008-10#1)(2008-8#1)
is the same##39##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
is the second case of##2##5##(2007-8#1)(2013-1#1)
is the second completed genome sequence of##5##7##(2011-2#5)
is the second in a series of##2##7##(1996-12#1)(2007-11#1)
is the second in a series##3##6##(1993-3#1)(1996-12#1)(2007-11#1)
is the second in a##5##5##(1993-3#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#1)
is the second largest##3##4##(1992-3#1)(1996-2#1)(2008-10#1)
is the second leading cause of cancer-related##3##7##(2008-1#1)(2011-1#1)(2011-2#1)
is the second leading cause of##4##6##(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
is the second leading##5##4##(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
is the second most common cancer in##2##7##(2008-5#1)(2013-1#1)
is the second most common##9##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
is the second most##10##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#2)
is the second reported case of##2##6##(2008-10#1)(2008-7#1)
is the second##47##3##(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#8)(2013-1#4)(2013-8#1)
is the secreted form of##2##5##(1991-2#1)(1992-12#1)
is the selection##3##3##(2008-10#2)(2008-3#1)
is the seventh##2##3##(2012-2#1)(2013-8#1)
is the shape of the##2##5##(1997-3#1)(2008-3#1)
is the significant##2##3##(2008-7#1)(2011-3#1)
is the simultaneous##4##3##(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)
is the single most important##2##5##(2008-8#1)(2011-1#1)
is the single most##5##4##(1996-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)
is the site of##2##4##(2007-12#1)(2008-11#1)
is the site##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
is the size of##2##4##(2008-3#1)(2008-4#1)
is the smallest##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
is the sole##6##3##(1990-5#1)(1992-5#1)(2008-10#2)(2011-2#2)
is the source of all##2##5##(1990-2#1)(2010-5#1)
is the source of##5##4##(1990-2#1)(1994-7#1)(2010-5#1)(2011-2#1)(2013-7#1)
is the spatial##2##3##(2008-3#2)
is the stability of##2##4##(1995-1#1)(2008-10#1)
is the standard deviation of##2##5##(2008-10#2)
is the standard method##2##4##(2007-8#1)(2008-3#1)
is the standard##9##3##(1993-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-7#1)(2012-1#1)
is the standardized##2##3##(2008-8#2)
is the strength of##2##4##(2008-8#1)(2013-8#1)
is the strongest##5##3##(1991-5#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-3#1)
is the structural##2##3##(1993-9#1)(1995-2#1)
is the study of the##2##5##(2008-10#2)
is the study of##5##4##(2008-10#4)(2013-8#1)
is the study##6##3##(2008-10#4)(2008-7#1)(2013-8#1)
is the subject of ongoing##2##5##(2008-7#1)(2009-8#1)
is the subject of the present##2##6##(1993-6#1)(2011-1#1)
is the subject of the##3##5##(1992-2#1)(1993-6#1)(2011-1#1)
is the subject of##8##4##(1992-2#1)(1993-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)
is the successful##2##3##(2008-10#1)(2008-3#1)
is the target##3##3##(1992-9#1)(2008-3#1)(2008-9#1)
is the term used to describe##2##6##(2008-9#1)(2013-1#1)
is the therapeutic##2##3##(1994-9#1)(2008-4#1)
is the third in a series##2##6##(1993-12#1)(2008-5#1)
is the third leading cause of##2##6##(2007-7#1)(2010-10#1)
is the third most common##2##5##(2007-4#1)(2012-2#1)
is the third most##4##4##(2007-4#1)(2008-8#1)(2012-2#1)(2013-8#1)
is the third##11##3##(1993-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
is the time##3##3##(1992-3#1)(2008-12#1)(2008-8#1)
is the total##5##3##(1991-3#1)(1994-5#1)(2007-7#1)(2008-3#2)
is the treatment of choice for symptomatic##2##7##(2008-8#1)(2009-3#1)
is the treatment of choice for##6##6##(1991-9#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#2)
is the treatment of choice in##4##6##(1990-9#1)(1992-12#1)(2009-4#1)(2010-6#1)
is the treatment of choice##20##5##(1990-6#2)(1990-9#1)(1991-9#1)(1992-12#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#1)(2013-1#2)
is the treatment of##21##4##(1990-6#2)(1990-9#1)(1991-9#1)(1992-12#1)(1995-8#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#1)(2013-1#2)
is the true##2##3##(1990-8#1)(2012-3#1)
is the type genus of the family##2##7##(2011-2#2)
is the type species of the genus##23##7##(2011-2#23)
is the type species of the##25##6##(2011-2#25)
is the type species##26##4##(2008-10#1)(2011-2#25)
is the type strain of the genus##2##7##(2011-2#2)
is the type strain of the##3##6##(2011-2#3)
is the type strain of##4##5##(2011-2#4)
is the type##36##3##(2008-10#1)(2011-2#33)(2012-1#1)(2013-1#1)
is the use of a##6##5##(2008-10#2)(2008-2#1)(2008-6#2)(2012-3#1)
is the use of##32##4##(1990-8#1)(1992-11#1)(1994-12#1)(1997-4#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2009-2#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is the value of##2##4##(1997-7#1)(1997-8#1)
is the value##3##3##(1997-7#1)(1997-8#1)(2008-10#1)
is the wavelength##3##3##(2008-10#1)(2008-3#2)
is the way in which##2##5##(2008-12#1)(2008-4#1)
is the way##3##3##(2008-12#1)(2008-4#1)(2008-7#1)
is the well-known##2##3##(2008-3#1)(2008-9#1)
is the widespread##2##3##(2008-12#1)(2008-8#1)
is the wild-type##2##3##(1990-10#1)(1991-9#1)
is the world's largest##2##4##(2007-5#1)(2008-5#1)
is the world's##4##3##(1995-2#1)(2007-5#1)(2008-12#1)(2008-5#1)
is the##2753##2##(1990-10#1)(1990-11#5)(1990-12#8)(1990-2#4)(1990-3#5)(1990-5#12)(1990-6#7)(1990-7#7)(1990-8#7)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#7)(1991-12#12)(1991-2#5)(1991-3#11)(1991-4#2)(1991-5#9)(1991-6#6)(1991-8#5)(1991-9#15)(1992-1#4)(1992-10#3)(1992-11#5)(1992-12#12)(1992-2#10)(1992-3#13)(1992-4#2)(1992-5#11)(1992-6#4)(1992-8#10)(1992-9#10)(1993-1#4)(1993-10#1)(1993-11#17)(1993-12#11)(1993-2#5)(1993-3#11)(1993-6#11)(1993-8#11)(1993-9#8)(1994-1#9)(1994-11#11)(1994-12#14)(1994-2#7)(1994-3#11)(1994-5#15)(1994-6#9)(1994-7#2)(1994-8#13)(1994-9#8)(1995-1#7)(1995-11#9)(1995-12#11)(1995-2#20)(1995-3#11)(1995-4#1)(1995-5#7)(1995-6#16)(1995-8#7)(1995-9#5)(1996-1#8)(1996-11#3)(1996-12#16)(1996-2#16)(1996-3#13)(1996-4#4)(1996-5#7)(1996-6#8)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#10)(1997-2#16)(1997-3#19)(1997-4#11)(1997-5#6)(1997-6#10)(1997-7#8)(1997-8#10)(2006-10#7)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#16)(2007-11#49)(2007-12#43)(2007-2#2)(2007-4#3)(2007-5#5)(2007-6#2)(2007-7#19)(2007-8#35)(2007-9#1)(2008-1#58)(2008-10#353)(2008-11#97)(2008-12#40)(2008-2#63)(2008-3#119)(2008-4#55)(2008-5#72)(2008-6#28)(2008-7#90)(2008-8#70)(2008-9#66)(2009-1#6)(2009-10#12)(2009-11#5)(2009-12#14)(2009-2#5)(2009-3#8)(2009-4#9)(2009-5#14)(2009-6#8)(2009-7#5)(2009-8#14)(2009-9#4)(2010-1#4)(2010-10#8)(2010-11#10)(2010-12#26)(2010-2#7)(2010-3#20)(2010-4#10)(2010-5#14)(2010-6#17)(2010-7#10)(2010-8#23)(2010-9#6)(2011-1#32)(2011-10#1)(2011-2#186)(2011-3#6)(2012-1#11)(2012-12#42)(2012-2#65)(2012-3#39)(2012-5#1)(2013-1#90)(2013-3#1)(2013-7#9)(2013-8#46)
is their ability to##2##4##(1994-5#1)(2009-3#1)
is their##19##2##(1994-5#1)(1995-11#1)(1995-5#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)
is then added to##2##4##(2008-8#2)
is then analyzed##2##3##(2008-10#1)(2008-4#1)
is then applied to a##2##5##(1992-12#1)(2008-6#1)
is then applied to the##5##5##(2008-3#2)(2008-4#1)(2009-11#1)(2010-3#1)
is then applied to##9##4##(1992-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2009-11#1)(2010-3#1)
is then carried out##3##4##(2008-10#1)(2009-6#1)(2010-4#1)
is then compared##2##3##(2008-3#1)(2008-9#1)
is then described##3##3##(2008-3#1)(2008-4#2)
is then determined by##2##4##(2008-10#1)(2008-4#1)
is then determined##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
is then developed##2##3##(2008-11#1)(2008-2#1)
is then discussed##2##3##(1991-12#1)(2008-3#1)
is then eluted##2##3##(2008-10#2)
is then extracted##2##3##(2008-10#1)(2008-3#1)
is then generated##2##3##(2007-11#1)(2008-2#1)
is then incorporated into##2##4##(2007-11#1)(2008-3#1)
is then merged with##2##4##(2008-10#2)
is then monitored##2##3##(2008-10#2)
is then performed##2##3##(1997-7#1)(2008-4#1)
is then presented##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
is then reconstructed##4##3##(2008-2#1)(2008-3#3)
is then shown##2##3##(2008-10#1)(2008-3#1)
is then used to refine the##2##6##(2008-6#1)(2009-10#1)
is then used to##14##4##(1992-12#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)
is then used##16##3##(1992-12#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)
is then##133##2##(1990-12#1)(1990-5#2)(1991-12#2)(1992-12#4)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#2)(2007-11#6)(2007-12#4)(2008-1#1)(2008-10#29)(2008-11#3)(2008-2#8)(2008-3#24)(2008-4#15)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
is theoretically analyzed##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is theoretically and experimentally##2##4##(2008-3#2)
is theoretically and##3##3##(2008-3#3)
is theoretically derived by##2##4##(2007-12#1)(2008-3#1)
is theoretically derived##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is theoretically##16##2##(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#2)(2008-3#6)(2008-7#1)(2011-1#1)
is therapeutic##2##2##(1994-12#1)(1994-3#1)
is there a need for##2##5##(2008-10#1)(2009-4#1)
is there a need##3##4##(1991-3#1)(2008-10#1)(2009-4#1)
is there a##15##3##(1990-10#1)(1991-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2009-4#1)(2012-12#1)
is there##25##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-2#1)(1991-3#2)(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
is thereby##2##2##(2008-10#1)(2008-2#1)
is therefore a##11##3##(1993-11#1)(1993-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
is therefore an##3##3##(1994-3#1)(2008-2#1)(2009-8#1)
is therefore considered##2##3##(1990-7#1)(2008-5#1)
is therefore crucial to##2##4##(2008-7#1)(2008-8#1)
is therefore highly##2##3##(1995-11#1)(2008-3#1)
is therefore important##14##3##(1994-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
is therefore necessary##6##3##(1990-2#1)(1990-3#1)(1990-8#1)(2008-10#1)(2010-4#1)(2012-3#1)
is therefore needed##2##3##(1995-12#1)(2008-10#1)
is therefore not##5##3##(1997-7#1)(2007-12#2)(2008-1#1)(2009-3#1)
is therefore of great##2##4##(2009-1#1)(2011-1#1)
is therefore of##4##3##(2009-1#1)(2009-10#1)(2011-1#1)(2012-1#1)
is therefore possible that##2##4##(2011-2#1)(2013-8#1)
is therefore possible##4##3##(1993-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
is therefore recommended##3##3##(1992-6#1)(1994-3#1)(2010-2#1)
is therefore required to##2##4##(2008-2#1)(2012-2#1)
is therefore required##3##3##(2008-2#1)(2011-2#1)(2012-2#1)
is therefore##120##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-4#3)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
is thick and##2##3##(2008-5#1)(2008-7#1)
is thick##3##2##(2008-5#1)(2008-7#2)
is thicker##2##2##(2008-5#1)(2009-6#1)
is this possible?##2##3##(2007-10#1)(2010-5#1)
is this##9##2##(1991-11#1)(1995-1#1)(1995-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-5#1)
is thought as##2##3##(2010-8#1)(2012-3#1)
is thought that##8##3##(1990-3#1)(1990-6#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-6#1)
is thought to act as##2##5##(1990-7#1)(2012-2#1)
is thought to arise##2##4##(2013-1#1)(2013-7#1)
is thought to be a##6##5##(1992-11#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-11#1)(2009-12#1)
is thought to be an##3##5##(1993-3#1)(2011-2#1)(2012-12#1)
is thought to be associated with##2##6##(1994-11#1)(2008-11#1)
is thought to be generated##2##5##(1991-5#1)(1995-2#1)
is thought to be important for##2##6##(1997-4#1)(2008-7#1)
is thought to be important##3##5##(1997-4#1)(2008-7#1)(2008-8#1)
is thought to be located##2##5##(2008-10#1)(2008-5#1)
is thought to be the##6##5##(1990-11#1)(1991-8#1)(1994-9#1)(2008-11#1)(2010-12#1)(2012-12#1)
is thought to be unable to synthesize##2##7##(1992-12#2)
is thought to be##47##4##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1993-3#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
is thought to contribute to##3##5##(2008-5#1)(2008-7#2)
is thought to have an##2##5##(1993-9#1)(1995-3#1)
is thought to have##3##4##(1993-9#1)(1995-3#1)(2012-3#1)
is thought to involve##2##4##(1991-12#1)(2013-8#1)
is thought to occur##3##4##(1994-3#1)(2008-11#1)(2010-6#1)
is thought to originate##2##4##(2008-10#1)(2008-3#1)
is thought to play a major role##2##7##(1992-8#1)(2007-7#1)
is thought to play a##5##5##(1992-8#1)(1993-3#1)(1994-9#1)(2007-7#1)(2011-2#1)
is thought to play##7##4##(1992-8#1)(1993-3#1)(1994-9#1)(1995-8#1)(2007-7#1)(2009-2#1)(2011-2#1)
is thought to reflect the##2##5##(2008-2#1)(2009-9#1)
is thought to represent##2##4##(2008-11#1)(2013-1#1)
is thought to result from the##2##6##(2008-9#1)(2009-3#1)
is thought to result from##3##5##(2008-6#1)(2008-9#1)(2009-3#1)
is thought to##100##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
is thought##111##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#7)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
is threatened##6##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
is three times greater##2##4##(1990-9#1)(2008-2#1)
is three times##3##3##(1990-9#1)(2008-2#2)
is three##5##2##(1990-9#1)(2008-1#1)(2008-2#2)(2013-1#1)
is three-fold##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
is through a##2##3##(1994-12#1)(2008-10#1)
is through the##6##3##(1990-11#1)(1994-1#1)(2007-11#1)(2007-12#1)(2009-12#1)(2011-2#1)
is through##13##2##(1990-11#1)(1994-1#1)(1994-12#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-1#1)
is thus a##8##3##(1996-6#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)(2012-12#1)
is thus an##3##3##(1996-5#1)(2008-3#1)(2008-9#1)
is thus avoided##3##3##(2008-10#3)
is thus likely##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
is thus useful##2##3##(1992-11#1)(2008-10#1)
is thus##48##2##(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
is tied to##3##3##(1996-5#1)(2008-3#1)(2011-2#1)
is tightly associated with##2##4##(1992-3#1)(2008-7#1)
is tightly bound##2##3##(1993-11#1)(1995-2#1)
is tightly correlated with##2##4##(2012-2#1)(2013-1#1)
is tightly coupled to##2##4##(1994-11#1)(2012-3#1)
is tightly linked to the##2##5##(2008-10#1)(2013-8#1)
is tightly linked to##3##4##(2008-10#2)(2013-8#1)
is tightly regulated by##2##4##(2008-9#1)(2013-1#1)
is tightly regulated##4##3##(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
is tightly##18##2##(1992-3#1)(1993-11#1)(1994-11#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
is tilted with respect to the##2##6##(2008-2#1)(2008-3#1)
is tilted##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
is time consuming and##3##4##(2008-10#2)(2008-2#1)
is time consuming##7##3##(1993-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)
is time dependent and##2##4##(2008-10#1)(2008-7#1)
is time dependent##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
is time to##2##3##(1993-1#1)(1995-1#1)
is time##19##2##(1991-3#1)(1993-1#1)(1993-8#1)(1995-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-12#1)
is time-consuming and##4##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
is time-consuming##7##2##(1993-9#1)(1995-1#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
is time-dependent##2##2##(1995-11#1)(1995-12#1)
is timely##3##2##(1994-3#1)(2008-11#2)
is tissue dependent##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
is titrated##2##2##(1991-8#1)(1997-2#1)
is to a large##2##4##(2008-9#1)(2011-2#1)
is to a##3##3##(1990-8#1)(2008-9#1)(2011-2#1)
is to achieve a##3##4##(1994-8#1)(2007-11#1)(2008-7#1)
is to achieve##7##3##(1994-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
is to add##2##3##(1997-1#1)(2010-8#1)
is to aid the##2##4##(2008-9#2)
is to alert##2##3##(2008-2#1)(2008-7#1)
is to allow the##2##4##(1995-12#1)(2012-3#1)
is to allow##3##3##(1995-12#1)(2012-12#1)(2012-3#1)
is to analyze the##5##4##(2007-8#1)(2009-10#1)(2010-8#1)(2011-7#1)(2013-1#1)
is to analyze##13##3##(2007-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-7#1)(2013-1#2)
is to apply##3##3##(1995-2#1)(2008-11#1)(2008-8#1)
is to assess the relationship between##2##6##(2008-6#1)(2008-9#1)
is to assess the##16##4##(1994-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
is to assess##19##3##(1994-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-8#1)
is to avoid##5##3##(1997-2#1)(2008-3#1)(2008-4#2)(2011-2#1)
is to base##2##3##(1992-11#1)(2010-5#1)
is to be a##2##4##(2012-3#1)(2013-8#1)
is to be achieved##2##4##(1994-8#1)(1995-2#1)
is to be avoided##2##4##(2013-1#1)(2013-8#1)
is to be considered##3##4##(2008-7#1)(2008-8#1)(2012-1#1)
is to be expected##4##4##(1990-8#1)(1994-3#1)(1996-6#1)(2008-3#1)
is to be performed##2##4##(1993-11#1)(2010-5#1)
is to be preferred##2##4##(1992-11#1)(1993-11#1)
is to be used##4##4##(1996-12#1)(2008-3#1)(2008-4#2)
is to be##48##3##(1990-8#3)(1991-11#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
is to become##2##3##(2010-11#1)(2013-8#1)
is to briefly##3##3##(1993-1#1)(2010-3#1)(2011-3#1)
is to bring##2##3##(1996-11#1)(2012-3#1)
is to calculate the##2##4##(2008-10#1)(2008-7#1)
is to characterize##3##3##(2008-9#1)(2009-9#1)(2011-2#1)
is to clarify the##3##4##(1994-9#1)(2008-4#2)
is to clarify##5##3##(1994-9#1)(2008-4#2)(2008-5#1)(2011-2#1)
is to collect##2##3##(2008-3#1)(2008-8#1)
is to combine##3##3##(2007-10#1)(2007-11#1)(2009-12#1)
is to compare the##5##4##(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
is to compare##11##3##(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
is to connect##2##3##(2007-8#1)(2009-8#1)
is to construct##2##3##(1997-2#1)(2013-8#1)
is to continue##2##3##(2009-7#1)(2011-2#1)
is to control the##3##4##(1997-2#1)(2008-11#1)(2010-12#1)
is to create awareness##2##4##(2007-12#1)(2008-7#1)
is to create##6##3##(1991-1#1)(1992-2#1)(2007-12#1)(2008-6#1)(2008-7#2)
is to critically##3##3##(2008-2#1)(2009-5#1)(2013-1#1)
is to define##4##3##(1996-2#1)(2008-11#1)(2008-7#2)
is to deliver##2##3##(2008-3#1)(2008-9#1)
is to demonstrate that##2##4##(2008-2#1)(2008-3#1)
is to demonstrate the##5##4##(2008-11#2)(2008-7#1)(2009-8#1)(2013-1#1)
is to demonstrate##8##3##(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
is to derive##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
is to describe a##5##4##(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
is to describe the##21##4##(1992-1#1)(1992-2#1)(1993-1#1)(1994-1#1)(1995-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#2)(2010-7#1)(2010-9#1)(2011-2#4)(2012-2#1)
is to describe##40##3##(1992-1#1)(1992-2#2)(1993-1#1)(1994-1#1)(1995-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-2#3)(2012-3#1)
is to design##4##3##(2008-10#3)(2008-2#1)
is to detect the##2##4##(2008-7#1)(2010-8#1)
is to detect##6##3##(1997-5#1)(2007-12#2)(2008-7#1)(2010-8#1)(2012-3#1)
is to determine if##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
is to determine the##8##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
is to determine whether##4##4##(2008-5#1)(2011-2#1)(2013-1#2)
is to determine##18##3##(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-7#1)
is to develop a##7##4##(1991-12#1)(1996-2#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-8#1)
is to develop and##2##4##(2008-10#1)(2010-7#1)
is to develop##13##3##(1991-12#1)(1993-2#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-8#1)
is to discover##4##3##(1993-11#1)(2008-11#1)(2012-1#1)(2012-3#1)
is to discuss the role of##2##6##(2008-8#1)(2013-8#1)
is to discuss the##13##4##(2007-4#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
is to discuss##19##3##(1995-1#1)(1996-2#1)(2007-4#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is to distinguish##3##3##(1993-2#1)(2012-2#1)(2013-1#1)
is to do##3##3##(2007-12#1)(2008-9#1)(2013-8#1)
is to draw##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
is to eliminate##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
is to elucidate the##2##4##(2008-11#1)(2008-9#1)
is to elucidate##3##3##(2008-11#1)(2008-9#1)(2010-5#1)
is to enable##2##3##(2008-10#1)(2008-11#1)
is to enhance##4##3##(2007-11#1)(2007-12#1)(2010-8#1)(2011-1#1)
is to ensure that##5##4##(1993-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
is to ensure##9##3##(1993-3#1)(1994-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
is to establish a##3##4##(1994-2#1)(1995-12#1)(2007-10#1)
is to estimate the##4##4##(1992-12#1)(1995-6#1)(2008-3#1)(2011-2#1)
is to evaluate the##20##4##(1991-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-7#1)(2010-8#3)(2011-2#5)(2012-2#1)(2013-1#2)
is to evaluate whether the##2##5##(2008-4#1)(2013-1#1)
is to evaluate whether##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
is to evaluate##32##3##(1991-4#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#3)(2011-2#7)(2012-2#2)(2013-1#4)
is to examine the##6##4##(1991-2#1)(2008-10#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#1)
is to examine##13##3##(1991-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
is to expand##2##3##(2008-3#1)(2012-2#1)
is to explain the##2##4##(2012-1#1)(2012-2#1)
is to explore the##6##4##(2008-10#2)(2008-11#1)(2010-10#1)(2011-3#1)(2012-12#1)
is to explore##8##3##(2008-10#2)(2008-11#1)(2010-10#1)(2011-3#1)(2012-1#1)(2012-12#2)
is to facilitate the growth and development of##2##8##(1994-1#1)(1996-3#1)
is to facilitate##5##3##(1994-1#1)(1996-1#1)(1996-3#1)(2007-10#1)(2013-8#1)
is to familiarize the##2##4##(2008-8#1)(2012-3#1)
is to familiarize##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
is to find the##2##4##(2008-3#1)(2008-6#1)
is to find##8##3##(1992-9#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-6#1)
is to focus on##3##4##(1994-1#1)(1996-2#1)(2007-10#1)
is to focus##5##3##(1994-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2012-2#1)
is to follow##2##3##(1997-2#1)(2008-7#1)
is to function##2##3##(1992-11#1)(1994-2#1)
is to further##2##3##(2008-12#1)(2012-2#1)
is to gather##2##3##(2008-1#1)(2010-4#1)
is to go beyond##2##4##(2008-10#1)(2008-7#1)
is to guide##2##3##(2008-9#1)(2010-3#1)
is to have a##2##4##(2010-10#1)(2011-2#1)
is to have##3##3##(2010-10#1)(2011-2#1)(2012-3#1)
is to highlight the current##2##5##(2011-2#1)(2012-12#1)
is to highlight the##6##4##(2006-6#1)(2007-5#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-12#1)
is to identify and##2##4##(2008-12#1)(2013-1#1)
is to identify factors##2##4##(2009-4#1)(2013-8#1)
is to identify the##5##4##(1996-3#1)(2008-12#1)(2010-12#1)(2013-1#2)
is to identify##17##3##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
is to illustrate the##6##4##(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
is to illustrate##9##3##(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
is to implement##2##3##(1993-12#1)(2008-4#1)
is to improve survival##2##4##(1994-6#1)(2012-3#1)
is to improve the quality of##2##6##(2007-11#1)(2013-1#1)
is to improve the##6##4##(2007-11#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-1#1)(2013-1#1)
is to improve##14##3##(1991-12#1)(1993-12#1)(1994-6#1)(1996-2#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
is to increase the##4##4##(1990-8#1)(2008-7#1)(2011-1#1)(2011-2#1)
is to increase##6##3##(1990-8#1)(1996-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)
is to inform##2##3##(1992-1#1)(2012-3#1)
is to introduce##4##3##(1996-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
is to investigate the effect of##2##6##(2008-10#1)(2011-3#1)
is to investigate the##12##4##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-3#2)(2012-2#1)
is to investigate##22##3##(2007-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-3#2)(2012-2#1)(2012-3#1)
is to link##2##3##(2007-8#1)(2008-10#1)
is to look for##2##4##(1996-4#1)(2008-5#1)
is to maintain##2##3##(2008-11#1)(2011-2#1)
is to make##4##3##(1991-12#1)(1994-9#1)(1995-5#1)(2008-10#1)
is to measure##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
is to meet##3##3##(1992-1#1)(1994-2#1)(2008-11#1)
is to offer##2##3##(1993-2#1)(2010-7#1)
is to our knowledge the first observation of a##2##9##(2007-11#2)
is to our knowledge the first observation of##3##8##(2007-11#3)
is to our knowledge the first##34##6##(2007-11#12)(2007-12#16)(2008-2#3)(2008-3#3)
is to our knowledge the highest##2##6##(2007-11#2)
is to our knowledge the##39##5##(2007-11#15)(2007-12#18)(2008-2#3)(2008-3#3)
is to our knowledge##41##4##(2007-11#15)(2007-12#20)(2008-2#3)(2008-3#3)
is to overcome##2##3##(2007-12#1)(2008-5#1)
is to perform##2##3##(2008-10#1)(2010-8#1)
is to play a##2##4##(1992-3#1)(2008-7#1)
is to play##3##3##(1992-3#1)(1993-12#1)(2008-7#1)
is to predict##2##3##(1992-3#1)(2008-8#1)
is to prepare##2##3##(2008-5#1)(2011-3#1)
is to present a case of a##2##7##(2012-12#2)
is to present a case of##3##6##(2011-2#1)(2012-12#2)
is to present a##11##4##(1993-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
is to present preliminary##2##4##(2007-8#1)(2008-4#1)
is to present the##7##4##(1997-3#1)(2007-11#1)(2008-3#1)(2011-2#2)(2013-1#2)
is to present##32##3##(1993-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#3)
is to prevent and##2##4##(1992-2#1)(2012-3#1)
is to prevent##7##3##(1992-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-8#1)
is to produce##5##3##(2008-11#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
is to promote the##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
is to promote##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
is to propose##3##3##(2007-11#1)(2008-3#1)(2010-8#1)
is to protect##3##3##(1995-3#1)(2008-11#1)(2008-8#1)
is to provide a general##2##5##(1997-3#1)(2008-6#1)
is to provide a##19##4##(1996-2#2)(1996-3#1)(1997-3#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is to provide an overview of how##2##7##(2007-4#1)(2008-11#1)
is to provide an overview of the##4##7##(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#1)
is to provide an overview of##9##6##(1995-3#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
is to provide an overview##10##5##(1995-3#1)(2007-4#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
is to provide an##13##4##(1994-2#1)(1995-3#1)(1997-8#1)(2007-4#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
is to provide insight into##2##5##(1994-3#1)(1996-12#1)
is to provide the reader with##2##6##(2008-5#1)(2010-9#1)
is to provide the##5##4##(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#1)
is to provide##62##3##(1992-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-4#2)(2008-10#1)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#4)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#3)
is to publish peer-reviewed##3##4##(2010-12#3)
is to reduce the##4##4##(2007-8#1)(2008-2#1)(2008-3#1)(2009-9#1)
is to reduce##9##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-9#1)
is to relate the##2##4##(2008-5#1)(2012-2#1)
is to remain##3##3##(1994-5#1)(1997-3#1)(1997-6#1)
is to report on a##2##5##(2008-11#1)(2013-1#1)
is to report on##4##4##(2008-11#2)(2010-3#1)(2013-1#1)
is to report the experience##2##5##(2008-7#1)(2012-3#1)
is to report the##4##4##(2008-7#1)(2012-3#1)(2013-1#2)
is to report##11##3##(2008-11#3)(2008-7#1)(2009-10#1)(2010-3#1)(2012-3#1)(2013-1#4)
is to represent##2##3##(2010-5#1)(2012-3#1)
is to result##2##3##(1991-3#1)(2008-9#1)
is to review recent##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
is to review the literature##2##5##(1993-5#1)(2010-3#1)
is to review the##18##4##(1993-5#1)(1994-11#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
is to review##32##3##(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
is to select##2##3##(1992-8#1)(2008-10#1)
is to set##2##3##(1996-2#1)(2009-6#1)
is to show that##4##4##(1994-2#1)(2008-10#1)(2013-1#2)
is to show the##3##4##(2008-10#2)(2009-9#1)
is to show##10##3##(1994-2#1)(2007-10#1)(2008-10#3)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
is to stimulate##3##3##(1994-12#1)(2008-1#1)(2011-2#1)
is to study the##5##4##(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#2)
is to study##6##3##(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#2)
is to successfully##2##3##(1993-2#1)(2012-2#1)
is to suggest a##2##4##(2007-12#1)(2008-11#1)
is to suggest##3##3##(2007-12#1)(2008-11#1)(2008-6#1)
is to summarise##2##3##(2008-8#1)(2012-12#1)
is to summarize recent##2##4##(2008-10#1)(2008-7#1)
is to summarize the##3##4##(2008-5#1)(2009-4#1)(2010-1#1)
is to summarize##7##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#1)
is to support##2##3##(1992-2#1)(2008-11#1)
is to suppress##2##3##(2008-5#1)(2011-2#1)
is to take##2##3##(1996-4#1)(2009-2#1)
is to test the##2##4##(1996-2#1)(2009-3#1)
is to the authors' knowledge the first##2##7##(2007-11#1)(2007-12#1)
is to the##8##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2010-2#1)
is to treat##4##3##(1992-2#1)(1992-5#1)(2007-11#1)(2008-10#1)
is to understand the##4##4##(2007-12#1)(2008-2#1)(2008-9#1)(2009-12#1)
is to understand##7##3##(1994-2#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-12#1)
is to use the##3##4##(1994-3#1)(2008-4#1)(2010-5#1)
is to use these##2##4##(1994-2#1)(2008-10#1)
is to use##14##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-5#1)(2012-2#1)
is to##995##2##(1990-11#1)(1990-12#1)(1990-8#5)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#4)(1992-11#4)(1992-12#3)(1992-2#8)(1992-3#5)(1992-5#1)(1992-8#1)(1992-9#4)(1993-1#4)(1993-11#3)(1993-12#5)(1993-2#5)(1993-3#5)(1993-5#2)(1993-6#1)(1994-1#5)(1994-11#3)(1994-12#6)(1994-2#7)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#15)(1996-3#6)(1996-4#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#7)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-6#1)(2007-10#9)(2007-11#34)(2007-12#36)(2007-2#2)(2007-4#4)(2007-5#2)(2007-7#6)(2007-8#10)(2008-1#17)(2008-10#61)(2008-11#50)(2008-12#11)(2008-2#23)(2008-3#35)(2008-4#20)(2008-5#25)(2008-6#16)(2008-7#43)(2008-8#26)(2008-9#26)(2009-10#7)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#7)(2009-6#8)(2009-7#6)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#7)(2010-11#6)(2010-12#12)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#10)(2010-6#2)(2010-7#3)(2010-8#16)(2010-9#3)(2011-1#9)(2011-2#53)(2011-3#9)(2011-7#1)(2012-1#8)(2012-12#19)(2012-2#34)(2012-3#30)(2013-1#42)(2013-7#2)(2013-8#22)
is today##5##2##(1994-12#1)(2007-8#1)(2008-1#2)(2008-7#1)
is too costly to##2##4##(2008-3#1)(2008-9#1)
is too expensive##2##3##(1996-5#1)(1997-6#1)
is too high##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
is too large##3##3##(1993-12#1)(2007-7#1)(2008-3#1)
is too late##2##3##(1996-8#1)(2008-11#1)
is too low##4##3##(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
is too narrow##2##3##(2008-11#1)(2013-1#1)
is too small##2##3##(1990-8#1)(2007-7#1)
is too##32##2##(1990-8#1)(1991-8#1)(1992-6#1)(1993-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is totally##4##2##(1990-11#1)(2008-10#1)(2008-3#2)
is toxic to##5##3##(1995-8#1)(1997-2#1)(2008-10#2)(2008-5#1)
is toxic##9##2##(1992-12#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)
is traced##4##2##(1995-1#1)(2007-10#1)(2007-5#1)(2008-10#1)
is traditionally##7##2##(1991-11#1)(1992-12#1)(1994-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
is trained on the##2##4##(2010-8#2)
is trained to##2##3##(1997-7#1)(2008-3#1)
is trained##5##2##(1997-7#1)(2008-3#1)(2010-8#3)
is transcribed as##2##3##(1994-12#1)(2008-8#1)
is transcribed by##2##3##(1993-12#1)(1997-2#1)
is transcribed from##2##3##(1995-6#1)(2008-7#1)
is transcribed in##2##3##(1996-6#1)(1997-3#1)
is transcribed into##2##3##(1993-2#1)(2008-11#1)
is transcribed##13##2##(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-7#1)(2008-8#2)
is transcriptionally##4##2##(1990-11#1)(1994-12#1)(2008-9#1)(2009-7#1)
is transferred directly##2##3##(2008-2#1)(2008-9#1)
is transferred from the##2##4##(1991-5#1)(1993-3#1)
is transferred from##4##3##(1991-5#1)(1993-3#1)(2008-4#2)
is transferred to a##2##4##(2007-11#1)(2008-5#1)
is transferred to the##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
is transferred to##8##3##(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
is transferred##19##2##(1991-5#1)(1993-3#1)(1994-2#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
is transformed into a##2##4##(2008-2#1)(2008-7#1)
is transformed into##6##3##(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
is transformed to##2##3##(1997-7#2)
is transformed##9##2##(1994-12#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)
is translated into##4##3##(1990-7#1)(2007-11#1)(2008-2#1)(2008-7#1)
is translated to the##2##4##(2007-12#1)(2008-3#1)
is translated##7##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
is translocated to the##3##4##(1993-8#1)(1994-6#1)(2011-1#1)
is translocated##4##2##(1992-6#1)(1993-8#1)(1994-6#1)(2011-1#1)
is transmitted by mosquitoes##2##4##(2007-2#1)(2011-2#1)
is transmitted by the##4##4##(2008-10#4)
is transmitted by##9##3##(1992-6#1)(2007-2#1)(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#1)
is transmitted from##2##3##(1997-6#1)(2008-10#1)
is transmitted through##2##3##(2007-12#1)(2008-3#1)
is transmitted to##2##3##(1994-5#1)(2007-12#1)
is transmitted with##2##3##(1997-6#1)(2009-10#1)
is transmitted##23##2##(1992-6#1)(1994-5#1)(1997-6#2)(2007-12#2)(2007-2#2)(2008-10#9)(2008-3#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
is transparent in the##2##4##(2007-12#1)(2013-1#1)
is transported in##2##3##(1994-8#1)(2011-1#1)
is transported into the##2##4##(1993-12#1)(2012-2#1)
is transported into##4##3##(1993-12#1)(1993-8#2)(2012-2#1)
is transported##9##2##(1993-12#1)(1993-8#2)(1994-8#1)(2008-10#2)(2009-8#1)(2011-1#1)(2012-2#1)
is transposition##2##2##(1990-9#1)(2010-5#1)
is trapped in the##2##4##(2008-10#2)
is trapped in##4##3##(2008-10#3)(2008-11#1)
is treatable with##2##3##(2009-11#1)(2011-1#1)
is treatable##3##2##(2009-11#1)(2011-1#1)(2012-2#1)
is treated as a##3##4##(1992-5#1)(2008-3#1)(2008-9#1)
is treated as##4##3##(1992-5#1)(2007-11#1)(2008-3#1)(2008-9#1)
is treated with##10##3##(1990-7#1)(1992-9#1)(2008-10#5)(2008-2#1)(2009-11#1)(2009-7#1)
is treated##24##2##(1990-7#1)(1992-5#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2013-7#1)
is triggered by##7##3##(1994-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-7#1)(2009-5#1)(2012-3#1)
is triggered##12##2##(1994-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-3#1)
is true for the##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
is true for##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2010-11#1)(2012-2#1)
is true##13##2##(1995-5#1)(1996-4#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
is truly##7##2##(1992-9#1)(1995-5#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#1)(2012-2#1)
is truncated##3##2##(1996-12#1)(1997-2#1)(2008-3#1)
is tunable from 1##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
is tunable from##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
is tunable in the##2##4##(2007-11#1)(2007-12#1)
is tunable##8##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
is tuned##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
is twice as##2##3##(2008-4#1)(2009-3#1)
is twice##4##2##(1990-3#1)(2008-3#1)(2008-4#1)(2009-3#1)
is two to##2##3##(1996-8#1)(2008-2#1)
is two##7##2##(1994-2#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
is two-dimensional##2##2##(1991-5#2)
is twofold##4##2##(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
is typical for patients##2##4##(2011-1#1)(2013-1#1)
is typical for##8##3##(2007-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2011-1#1)(2013-1#2)
is typical of##11##3##(1991-3#1)(1993-8#1)(1994-6#1)(1996-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2010-10#1)
is typical##21##2##(1991-3#1)(1993-8#1)(1994-6#1)(1996-1#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-12#2)(2008-2#2)(2008-4#1)(2010-10#1)(2011-1#2)(2013-1#2)
is typically a##2##3##(1995-12#1)(2011-2#1)
is typically low##2##3##(2008-11#1)(2008-8#1)
is typically observed in young women##2##6##(2013-1#2)
is typically##36##2##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#3)(2010-2#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
is ubiquitous in##5##3##(2008-9#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
is ubiquitous##8##2##(1993-8#1)(1994-8#1)(2007-2#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
is ubiquitously expressed##2##3##(1997-7#1)(2011-2#1)
is ubiquitously##3##2##(1997-7#1)(2011-2#1)(2013-8#1)
is ultimately##4##2##(1994-9#1)(1995-8#1)(1996-3#1)(2008-10#1)
is unable to grow##2##4##(1995-2#1)(2008-6#1)
is unable to##17##3##(1990-11#1)(1990-8#1)(1992-9#1)(1993-6#1)(1995-2#2)(1995-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-1#1)
is unaffected by the##2##4##(1990-11#1)(1992-8#1)
is unaffected by##9##3##(1990-11#1)(1992-8#1)(1993-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)
is unaffected##10##2##(1990-11#1)(1992-8#1)(1993-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-2#1)
is unaltered##2##2##(1991-1#1)(2008-11#1)
is unambiguous##2##2##(2007-12#1)(2013-8#1)
is unavailable##5##2##(1997-8#1)(2007-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
is unavoidable##3##2##(2007-11#1)(2008-2#1)(2008-4#1)
is unbiased##2##2##(2008-5#1)(2008-7#1)
is uncertain##20##2##(1993-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#2)
is unchanged##5##2##(1992-2#1)(2008-3#2)(2009-2#1)(2009-6#1)
is unclear and##2##3##(2007-6#1)(2010-4#1)
is unclear to##2##3##(1993-2#1)(2007-10#1)
is unclear what##3##3##(1994-12#1)(2009-8#1)(2012-12#1)
is unclear whether the##3##4##(2008-8#2)(2012-3#1)
is unclear whether these##2##4##(2008-6#1)(2008-7#1)
is unclear whether this##2##4##(1996-1#1)(2008-11#1)
is unclear whether##12##3##(1991-2#1)(1996-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
is unclear##66##2##(1990-5#2)(1991-2#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
is uncommon and##3##3##(1990-8#1)(1994-11#1)(2007-8#1)
is uncommon in children##2##4##(2007-8#1)(2008-10#1)
is uncommon in##6##3##(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-10#1)(2013-1#1)
is uncommon##21##2##(1990-8#1)(1992-6#1)(1994-11#1)(1996-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
is undefined##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
is under control of##2##4##(1994-5#1)(1997-7#1)
is under development by##3##4##(2008-5#3)
is under development##6##3##(2008-10#1)(2008-5#3)(2009-9#1)(2010-8#1)
is under investigation##2##3##(2008-10#1)(2008-6#1)
is under phase##2##3##(2007-2#1)(2008-5#1)
is under study##2##3##(1990-8#1)(2012-3#1)
is under the control of the##3##6##(1991-12#1)(1993-6#1)(2008-7#1)
is under the control of##8##5##(1990-5#1)(1991-12#1)(1993-6#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#2)
is under the##9##3##(1990-5#1)(1991-12#1)(1993-6#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#2)(2012-12#1)
is under##44##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-6#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
is underdeveloped##2##2##(1997-5#1)(2010-5#1)
is underestimated##3##2##(1997-3#1)(2007-2#1)(2008-8#1)
is undergoing a major##2##4##(1992-1#1)(1994-3#1)
is undergoing##8##2##(1992-1#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
is underlined##7##2##(1990-6#1)(1991-6#1)(1992-1#1)(1993-5#1)(2008-10#1)(2008-8#2)
is underpinned by##2##3##(2008-10#1)(2008-12#1)
is understood as##3##3##(2008-10#2)(2011-2#1)
is understood##8##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
is undertaken to##2##3##(2009-3#1)(2010-8#1)
is undertaken##7##2##(1991-3#1)(1996-2#1)(2008-10#2)(2009-3#1)(2010-8#1)(2012-12#1)
is underway from##2##3##(2008-2#2)
is underway##6##2##(1994-1#1)(1994-5#1)(2008-1#1)(2008-2#2)(2010-12#1)
is undesirable##2##2##(2008-3#1)(2008-9#1)
is undetectable in##3##3##(2012-2#1)(2013-1#2)
is undetectable##6##2##(1994-8#1)(1995-2#1)(2008-8#1)(2012-2#1)(2013-1#2)
is undoubtedly##4##2##(1992-3#1)(2007-12#1)(2010-1#1)(2010-12#1)
is unfavorable##2##2##(1995-5#1)(2012-2#1)
is unfit##2##2##(2008-11#1)(2013-8#1)
is unfortunately##2##2##(1992-5#1)(2008-9#1)
is unhelpful##2##2##(1997-8#1)(2009-11#1)
is uniform##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
is uniformly distributed##2##3##(1990-5#1)(2008-3#1)
is uniformly##5##2##(1990-5#1)(2007-10#1)(2008-3#2)(2010-4#1)
is unimodal##2##2##(2008-8#1)(2012-2#1)
is unique among##6##3##(1992-10#1)(1995-8#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
is unique and cannot be##2##5##(1997-4#1)(2008-3#1)
is unique and##3##3##(1997-4#1)(2008-3#1)(2011-3#1)
is unique in that it can##2##6##(1995-9#1)(2013-8#1)
is unique in that it##3##5##(1993-6#1)(1995-9#1)(2013-8#1)
is unique in that##4##4##(1993-6#1)(1995-9#1)(2008-10#1)(2013-8#1)
is unique in##8##3##(1990-5#1)(1992-6#1)(1993-6#1)(1995-9#1)(1997-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
is unique to the##4##4##(2008-1#1)(2009-10#1)(2009-8#1)(2011-2#1)
is unique to##9##3##(1992-6#1)(1993-2#1)(1995-6#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
is unique##37##2##(1990-12#1)(1990-5#2)(1992-10#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#2)
is uniquely positioned##2##3##(2007-12#1)(2010-4#1)
is uniquely##8##2##(1990-5#1)(1994-8#1)(1996-12#1)(2007-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
is unity##2##2##(2008-2#1)(2008-3#1)
is universal##2##2##(2008-11#1)(2008-7#1)
is universally##2##2##(2007-11#1)(2008-7#1)
is unknown and##2##3##(1995-12#1)(2011-2#1)
is unknown at##2##3##(1992-9#1)(2008-11#1)
is unknown but##4##3##(1990-12#1)(1990-3#1)(1993-11#1)(2013-8#1)
is unknown how##2##3##(1990-9#1)(2008-10#1)
is unknown if##2##3##(2010-5#1)(2013-1#1)
is unknown whether##6##3##(1995-5#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-7#1)
is unknown##98##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-11#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#2)(1997-3#3)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
is unlikely that the##2##4##(2007-12#1)(2007-5#1)
is unlikely that##20##3##(1990-2#1)(1990-7#1)(1990-8#1)(1993-9#1)(1995-12#2)(1995-5#2)(1996-12#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)
is unlikely to be a##3##5##(2007-2#1)(2009-7#1)(2010-1#1)
is unlikely to be due to##2##6##(2008-11#1)(2012-12#1)
is unlikely to be##12##4##(1992-6#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-12#1)(2013-8#1)
is unlikely to##22##3##(1990-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-3#1)(1997-2#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2012-12#1)(2013-8#1)
is unlikely##52##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-7#1)(2010-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
is unlimited##2##2##(1992-2#1)(1996-3#1)
is unnecessary to##2##3##(1991-5#1)(2012-3#1)
is unnecessary##7##2##(1991-5#1)(1996-11#1)(2008-10#2)(2008-7#1)(2010-3#1)(2012-3#1)
is unpredictable##2##2##(2011-1#1)(2011-2#1)
is unrelated to##4##3##(1991-3#1)(2008-7#1)(2009-12#1)(2010-12#1)
is unreliable##5##2##(1990-8#1)(1994-12#1)(2007-2#1)(2008-9#2)
is unresponsive to##3##3##(1994-12#1)(1996-9#1)(2007-8#1)
is unsettled##2##2##(2011-2#2)
is unstable##6##2##(1990-7#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
is unsuitable for##2##3##(2008-10#1)(2008-7#1)
is unsuitable##3##2##(2008-10#2)(2008-7#1)
is unusual among##2##3##(2007-12#1)(2010-4#1)
is unusual in##2##3##(1996-2#1)(2012-1#1)
is unusual##17##2##(1995-12#1)(1996-2#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-7#1)
is unusually##3##2##(1991-5#1)(2008-1#1)(2008-10#1)
is up to the##3##4##(1994-3#1)(2008-5#1)(2011-2#1)
is up to##11##3##(1992-8#1)(1994-3#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2011-2#1)
is up##12##2##(1992-8#1)(1994-3#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
is up-regulated in##4##3##(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
is up-regulated##6##2##(1995-8#2)(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
is upregulated by##4##3##(1997-7#1)(2007-12#1)(2008-5#1)(2009-8#1)
is upregulated in##5##3##(1995-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
is upregulated##11##2##(1995-5#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-12#1)(2013-1#2)
is urgent to##2##3##(2012-3#1)(2013-1#1)
is urgent##4##2##(1994-12#1)(1997-4#1)(2012-3#1)(2013-1#1)
is urgently needed##3##3##(1995-2#1)(2008-3#1)(2011-2#1)
is used and##3##3##(2008-3#2)(2009-10#1)
is used as a framework##2##5##(2008-11#1)(2008-3#1)
is used as a light source##2##6##(2007-12#1)(2008-2#1)
is used as a model##4##5##(1992-5#1)(2008-10#1)(2008-7#1)(2009-9#1)
is used as a novel ionophore in plasticized##2##8##(2008-10#2)
is used as a novel##3##5##(2008-10#3)
is used as a##43##4##(1991-6#1)(1992-5#1)(1993-3#2)(1996-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#2)(2013-7#1)
is used as an example of the##2##7##(1992-11#1)(1994-2#1)
is used as an example##4##5##(1992-11#1)(1994-2#1)(2007-11#1)(2008-11#1)
is used as an indicator of the##3##7##(2008-10#2)(2012-12#1)
is used as an indicator of##4##6##(2008-1#1)(2008-10#2)(2012-12#1)
is used as an##15##4##(1992-11#1)(1994-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
is used as the light source##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
is used as the##16##4##(2007-11#1)(2008-10#7)(2008-2#4)(2008-3#2)(2008-8#1)(2009-2#1)
is used as##99##3##(1991-6#1)(1992-11#1)(1992-5#1)(1993-3#2)(1994-2#1)(1996-6#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#39)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
is used at##4##3##(2008-10#1)(2008-3#1)(2010-1#1)(2010-2#1)
is used because##3##3##(1997-2#1)(2007-12#1)(2008-5#1)
is used by##10##3##(1990-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
is used extensively##2##3##(2008-6#1)(2010-5#1)
is used for both##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
is used for determining the##2##5##(2008-3#2)
is used for direct##3##4##(2008-10#1)(2008-4#1)(2010-8#1)
is used for measuring the##3##5##(2008-3#3)
is used for measuring##4##4##(2008-3#4)
is used for quantitative##2##4##(2008-10#2)
is used for the determination of##3##6##(2008-10#3)
is used for the##21##4##(2007-12#2)(2008-10#14)(2008-11#2)(2008-2#1)(2013-1#2)
is used for this##3##4##(2008-2#1)(2008-3#2)
is used for treatment of##2##5##(2010-5#1)(2010-8#1)
is used for##95##3##(1993-2#1)(1997-6#1)(2007-11#4)(2007-12#7)(2008-10#38)(2008-11#2)(2008-2#6)(2008-3#18)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2013-1#3)
is used here to##3##4##(2008-12#1)(2008-3#1)(2008-5#1)
is used in a##10##4##(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)
is used in conjunction with##6##5##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-1#1)
is used in the production of ultraviolet-curable inks##2##8##(2008-9#2)
is used in the study of##2##6##(2008-10#1)(2008-3#1)
is used in the treatment of Parkinson's disease##2##8##(1992-3#1)(2008-10#1)
is used in the##23##4##(1990-11#1)(1992-3#1)(1992-6#1)(1995-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
is used in this##2##4##(2008-10#1)(2008-4#1)
is used in which the##2##5##(2008-2#1)(2008-3#1)
is used in##73##3##(1990-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-9#2)(1997-3#2)(2007-11#2)(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#5)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#3)
is used instead of the##2##5##(2008-3#1)(2011-2#1)
is used instead of##6##4##(2008-10#1)(2008-3#3)(2011-2#2)
is used is##2##3##(2008-2#2)
is used more##2##3##(2008-4#1)(2009-12#1)
is used on a##2##4##(2008-3#1)(2013-7#1)
is used on##4##3##(2008-10#2)(2008-3#1)(2013-7#1)
is used that##5##3##(2008-1#1)(2008-2#3)(2008-3#1)
is used throughout##3##3##(2008-10#2)(2011-2#1)
is used to achieve##2##4##(2008-3#2)
is used to analyze the##3##5##(2008-3#1)(2010-2#1)(2010-8#1)
is used to analyze##6##4##(2008-3#3)(2009-10#1)(2010-2#1)(2010-8#1)
is used to assess##2##4##(2008-10#1)(2009-10#1)
is used to calculate the##8##5##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
is used to calculate##11##4##(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)
is used to characterize the##5##5##(1995-12#1)(2007-11#1)(2007-12#2)(2012-12#1)
is used to characterize##7##4##(1995-12#1)(2007-11#2)(2007-12#3)(2012-12#1)
is used to compare the##5##5##(1990-7#1)(2008-2#2)(2008-3#1)(2009-7#1)
is used to compare##6##4##(1990-7#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)
is used to compensate for the##2##6##(2008-3#2)
is used to compute a##2##5##(2008-2#1)(2008-6#1)
is used to compute the##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
is used to compute##8##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#2)(2010-2#1)(2012-3#1)
is used to control##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
is used to correct##2##4##(2007-11#1)(2008-9#1)
is used to create##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
is used to demonstrate the##2##5##(2008-3#1)(2008-9#1)
is used to derive##4##4##(1992-12#1)(2007-11#1)(2008-3#2)
is used to describe the##3##5##(2008-11#1)(2008-2#1)(2008-3#1)
is used to describe##7##4##(1990-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
is used to detect the##4##5##(2007-12#1)(2008-10#1)(2008-3#2)
is used to detect##11##4##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#3)(2008-4#1)(2008-9#1)
is used to determine the##10##5##(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-4#1)
is used to determine##17##4##(1993-3#1)(1995-2#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-4#1)(2010-11#1)
is used to develop##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is used to distinguish##2##4##(2008-10#1)(2008-4#1)
is used to enhance the##2##5##(2008-3#2)
is used to estimate the##7##5##(2008-10#1)(2008-3#3)(2008-4#1)(2010-6#1)(2011-1#1)
is used to estimate##8##4##(2008-10#1)(2008-3#4)(2008-4#1)(2010-6#1)(2011-1#1)
is used to evaluate the##3##5##(2008-11#1)(2008-7#1)(2010-8#1)
is used to expand##2##4##(2008-10#1)(2008-3#1)
is used to explain the##3##5##(2008-10#1)(2008-3#2)
is used to extract the##2##5##(2008-10#1)(2008-3#1)
is used to extract##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
is used to fit the##2##5##(2007-12#1)(2008-3#1)
is used to follow the##2##5##(2008-1#1)(2008-10#1)
is used to form a##4##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
is used to form##5##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
is used to generate##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-4#1)
is used to guide##2##4##(2007-12#1)(2008-10#1)
is used to identify the##2##5##(2008-9#1)(2010-4#1)
is used to identify##5##4##(1997-3#1)(2008-4#2)(2008-9#1)(2010-4#1)
is used to image##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is used to implement an##2##5##(2008-3#2)
is used to implement##5##4##(2007-11#1)(2008-10#1)(2008-3#3)
is used to improve the##2##5##(2008-2#1)(2013-1#1)
is used to improve##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
is used to induce##2##4##(2007-11#1)(2008-11#1)
is used to introduce##2##4##(2008-10#1)(2009-11#1)
is used to investigate the##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
is used to isolate##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
is used to make##2##4##(2008-3#1)(2008-5#1)
is used to measure the##10##5##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2012-1#1)
is used to measure##16##4##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-9#1)(2009-7#1)(2012-1#1)
is used to model the##4##5##(2008-3#1)(2009-11#1)(2009-9#1)(2010-5#1)
is used to model##6##4##(1992-6#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-5#1)
is used to modulate the##3##5##(2007-11#2)(2008-3#1)
is used to obtain the##2##5##(2007-11#2)
is used to obtain##5##4##(2007-11#2)(2008-2#2)(2008-3#1)
is used to optimize the##2##5##(2007-11#2)
is used to perform##3##4##(2008-2#1)(2008-3#2)
is used to predict the##3##5##(1992-6#1)(2008-11#1)(2010-8#1)
is used to predict##5##4##(1992-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)
is used to present the##2##5##(1996-3#1)(2008-10#1)
is used to prevent##2##4##(2008-10#1)(2013-1#1)
is used to probe##3##4##(2007-11#1)(2008-3#2)
is used to produce##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
is used to provide a##2##5##(2008-2#1)(2010-4#1)
is used to provide##4##4##(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
is used to quantify##6##4##(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
is used to quantitate##3##4##(1991-9#1)(1994-6#1)(2008-9#1)
is used to reconstruct the##4##5##(2008-3#3)(2008-9#1)
is used to record the##2##5##(2008-3#1)(2009-4#1)
is used to record##3##4##(2008-3#2)(2009-4#1)
is used to recover the##2##5##(2007-11#1)(2008-3#1)
is used to reduce the##2##5##(2007-11#1)(2008-10#1)
is used to remove##2##4##(1991-6#1)(2007-11#1)
is used to represent##3##4##(2007-12#1)(2008-4#1)(2008-7#1)
is used to sample##3##4##(2008-10#3)
is used to select##3##4##(1994-12#1)(2008-3#1)(2012-12#1)
is used to separate##3##4##(2008-10#1)(2008-2#2)
is used to show that##2##5##(2007-11#1)(2008-2#1)
is used to simulate the##2##5##(2008-3#2)
is used to simulate##3##4##(2008-3#3)
is used to solve the##2##5##(2008-2#1)(2011-1#1)
is used to study the##4##5##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
is used to study##10##4##(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-7#1)
is used to treat##2##4##(1991-9#1)(2012-3#1)
is used to validate the##2##5##(2008-3#2)
is used to##353##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-3#1)(2007-11#33)(2007-12#21)(2008-1#7)(2008-10#43)(2008-11#10)(2008-12#1)(2008-2#44)(2008-3#90)(2008-4#11)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#14)(2009-10#2)(2009-11#2)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
is used when##2##3##(2008-4#1)(2010-12#1)
is used widely in##2##4##(1994-11#1)(2008-3#1)
is used widely##3##3##(1994-11#1)(2008-10#1)(2008-3#1)
is used with a##2##4##(2008-3#2)
is used with##9##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)
is used##786##2##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-2#2)(1993-3#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#2)(2007-11#51)(2007-12#39)(2007-4#1)(2007-8#1)(2008-1#10)(2008-10#162)(2008-11#24)(2008-12#3)(2008-2#78)(2008-3#168)(2008-4#20)(2008-5#10)(2008-6#12)(2008-7#14)(2008-8#7)(2008-9#23)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#9)(2011-1#7)(2011-2#8)(2012-1#4)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#5)
is useful as a##3##4##(1995-8#1)(2008-10#1)(2010-12#1)
is useful as##4##3##(1995-8#1)(2007-12#1)(2008-10#1)(2010-12#1)
is useful because##2##3##(1996-9#1)(2008-2#1)
is useful for a##3##4##(1990-12#1)(2008-11#1)(2008-4#1)
is useful for assessing##2##4##(2008-6#1)(2008-9#1)
is useful for examining##2##4##(2008-4#2)
is useful for studies##2##4##(1995-12#1)(2008-1#1)
is useful for the##7##4##(1990-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)
is useful for##55##3##(1990-12#1)(1990-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
is useful in detecting the##2##5##(2010-8#1)(2012-2#1)
is useful in studies on the##2##6##(1991-12#1)(1992-6#1)
is useful in the diagnosis of##2##6##(2007-10#1)(2011-2#1)
is useful in the diagnosis##3##5##(2007-10#1)(2008-12#1)(2011-2#1)
is useful in the##9##4##(1990-3#1)(1991-11#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
is useful in##32##3##(1990-3#1)(1991-11#1)(1991-12#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-6#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
is useful to improve##2##4##(2008-11#1)(2009-5#1)
is useful to##12##3##(1990-12#1)(1991-1#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-11#3)(2009-5#1)(2013-1#1)
is useful##118##2##(1990-12#2)(1990-3#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#3)(1996-9#1)(1997-4#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
is useless in##2##3##(1991-6#1)(2011-2#1)
is useless##3##2##(1991-6#1)(1992-2#1)(2011-2#1)
is using##4##2##(2007-12#1)(2008-9#1)(2009-10#1)(2009-3#1)
is usually a##5##3##(1990-9#1)(1991-4#1)(1994-2#1)(1997-3#1)(2008-7#1)
is usually associated with##8##4##(2008-1#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is usually assumed##2##3##(1992-3#1)(2008-9#1)
is usually based on##2##4##(1995-12#1)(2011-2#1)
is usually based##3##3##(1990-8#1)(1995-12#1)(2011-2#1)
is usually carried out by##2##5##(2008-1#1)(2008-5#1)
is usually caused by##4##4##(1990-12#1)(2007-12#1)(2008-1#2)
is usually confined to the##2##5##(1990-5#1)(1991-11#1)
is usually considered a##2##4##(2008-10#1)(2009-7#1)
is usually considered to be##2##5##(2008-4#1)(2008-7#1)
is usually considered##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)
is usually described##2##3##(2008-9#1)(2010-5#1)
is usually determined##3##3##(2008-3#2)(2012-2#1)
is usually diagnosed##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
is usually favorable##2##3##(1996-11#1)(2006-10#1)
is usually found in the##2##5##(2007-8#1)(2013-8#1)
is usually found in##3##4##(2007-8#1)(2013-7#1)(2013-8#1)
is usually found##4##3##(1991-6#1)(2007-8#1)(2013-7#1)(2013-8#1)
is usually located##2##3##(2010-12#1)(2012-12#1)
is usually made##6##3##(1995-12#1)(2008-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
is usually mild##2##3##(2008-1#1)(2010-12#1)
is usually much##2##3##(2008-3#1)(2008-8#1)
is usually necessary for a##2##5##(2008-10#1)(2010-11#1)
is usually normal##2##3##(2010-12#1)(2013-1#1)
is usually not##6##3##(1990-12#1)(1997-3#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
is usually performed by##2##4##(2008-3#1)(2008-5#1)
is usually performed when##2##4##(1990-9#1)(1992-9#1)
is usually performed##8##3##(1990-9#1)(1992-9#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)
is usually recognized##2##3##(2007-10#1)(2008-8#1)
is usually regarded as##2##4##(1990-8#1)(1995-11#1)
is usually required to##2##4##(1995-5#1)(2010-9#1)
is usually required##3##3##(1995-5#1)(2008-10#1)(2010-9#1)
is usually secondary##2##3##(2008-10#1)(2013-8#1)
is usually seen in adults##2##5##(2008-10#1)(2011-2#1)
is usually seen##4##3##(1997-5#1)(2008-10#1)(2009-11#1)(2011-2#1)
is usually the##2##3##(2008-6#1)(2012-2#1)
is usually treated##2##3##(1991-8#1)(2008-9#1)
is usually##181##2##(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#3)(1997-4#4)(1997-5#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#14)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#5)
is utilized as an##2##4##(2008-10#1)(2008-2#1)
is utilized by##2##3##(2009-2#1)(2012-1#1)
is utilized for##3##3##(2008-1#1)(2008-10#2)
is utilized in##4##3##(1993-3#1)(2008-10#1)(2010-5#1)(2011-2#1)
is utilized to##8##3##(2007-11#2)(2008-10#2)(2008-3#2)(2008-4#1)(2013-8#1)
is utilized##22##2##(1993-3#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
is valid and##2##3##(2008-3#1)(2010-10#1)
is valid for a##2##4##(2007-11#1)(2008-2#1)
is valid for the##2##4##(2008-10#2)
is valid for##11##3##(1995-3#1)(2007-11#1)(2008-10#3)(2008-2#5)(2008-6#1)
is valid only##3##3##(2008-3#3)
is valid##23##2##(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#5)(2008-3#6)(2008-6#1)(2008-9#2)(2010-10#1)
is validated against##2##3##(2008-3#1)(2008-7#1)
is validated by comparison with##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is validated by comparison##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
is validated by##11##3##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)
is validated experimentally##3##3##(2008-2#1)(2008-3#2)
is validated##19##2##(2007-11#2)(2008-10#5)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#2)
is valuable for##4##3##(1993-2#1)(1994-7#1)(1996-5#1)(2008-10#1)
is valuable to##2##3##(2008-9#2)
is valuable##12##2##(1991-3#1)(1993-2#1)(1994-7#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#2)(2012-2#1)
is variable and##2##3##(1994-11#1)(2009-4#1)
is variable##15##2##(1991-6#1)(1994-11#1)(1995-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
is variably##2##2##(1996-12#1)(2007-7#1)
is varied in##2##3##(2008-3#2)
is varied within##2##3##(2008-10#1)(2008-2#1)
is varied##15##2##(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)
is varying##2##2##(1990-9#1)(2007-11#1)
is vascular##2##2##(2011-2#1)(2013-8#1)
is verified by a##2##4##(2008-10#1)(2011-1#1)
is verified by the##3##4##(2008-2#2)(2008-3#1)
is verified by##15##3##(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#1)(2011-1#1)
is verified experimentally##2##3##(2008-3#1)(2008-7#1)
is verified to##2##3##(2007-12#1)(2008-3#1)
is verified with##3##3##(2008-2#1)(2008-3#2)
is verified##30##2##(1994-2#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#10)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)
is very attractive##2##3##(2008-1#1)(2008-10#1)
is very challenging##2##3##(1992-3#1)(2010-7#1)
is very characteristic##2##3##(1995-5#1)(2007-11#1)
is very close to the##4##5##(2007-11#1)(2008-10#1)(2012-3#2)
is very close to##5##4##(1990-8#1)(2007-11#1)(2008-10#1)(2012-3#2)
is very common in##2##4##(2007-11#1)(2008-1#1)
is very common##6##3##(1991-6#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)
is very convenient##2##3##(2008-10#2)
is very difficult to##11##4##(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2010-6#1)(2013-1#1)(2013-8#1)
is very difficult##13##3##(1990-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
is very effective##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
is very essential##2##3##(2008-10#1)(2010-11#1)
is very frequent##2##3##(2009-10#1)(2009-6#1)
is very helpful##2##3##(2007-11#1)(2012-12#1)
is very high in##3##4##(1992-5#1)(1997-4#1)(2011-1#1)
is very high##11##3##(1991-6#1)(1992-5#1)(1993-6#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)
is very important for the##3##5##(2008-10#1)(2008-7#1)(2012-2#1)
is very important for##12##4##(1992-12#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
is very important in order to##2##6##(1992-11#1)(2008-10#1)
is very important in##3##4##(1992-11#1)(2008-10#2)
is very important to investigate the##3##6##(2008-10#2)(2008-11#1)
is very important to##11##4##(1991-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-8#1)
is very important##31##3##(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#2)(1996-11#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is very large##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
is very likely a##2##4##(2008-3#1)(2008-5#1)
is very likely##6##3##(1990-5#1)(1992-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
is very limited and##2##4##(2008-10#2)
is very limited##5##3##(1993-1#1)(2008-10#2)(2008-7#1)(2009-12#1)
is very little##7##3##(1991-11#1)(2007-8#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-7#1)
is very low##10##3##(1990-8#1)(1994-12#1)(1996-6#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)
is very much##3##3##(2008-1#1)(2008-8#1)(2009-3#1)
is very poor##2##3##(1993-11#1)(1993-8#1)
is very rare and the##2##5##(2007-8#1)(2013-1#1)
is very rare and##7##4##(2007-8#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
is very rare in Japan##2##5##(2009-8#1)(2013-1#1)
is very rare##32##3##(1991-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#5)(2008-8#1)(2009-7#1)(2009-8#1)(2010-6#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
is very selective##2##3##(2008-10#2)
is very sensitive to##3##4##(1992-6#1)(2008-1#1)(2008-12#1)
is very sensitive##9##3##(1992-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#1)
is very short##2##3##(2008-10#1)(2008-5#1)
is very similar in##2##4##(1994-11#1)(2007-10#1)
is very similar to that of the##2##7##(1997-4#1)(2008-8#1)
is very similar to that of##5##6##(1993-2#1)(1993-8#1)(1997-4#1)(2008-2#1)(2008-8#1)
is very similar to that##7##5##(1993-2#1)(1993-8#1)(1994-5#2)(1997-4#1)(2008-2#1)(2008-8#1)
is very similar to the##2##5##(1994-12#1)(2009-8#1)
is very similar to##14##4##(1992-12#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-5#2)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)
is very similar##20##3##(1992-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1995-6#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-11#1)
is very simple and##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
is very simple##14##3##(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)
is very small##2##3##(2007-11#1)(2008-9#1)
is very specific##2##3##(1995-5#1)(1997-2#1)
is very stable##2##3##(2008-10#1)(2013-8#1)
is very strong##2##3##(2008-10#2)
is very suitable for##2##4##(2007-12#1)(2011-2#1)
is very unusual##3##3##(1991-6#1)(1997-8#1)(2011-2#1)
is very useful for##5##4##(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)
is very useful in##3##4##(2007-11#1)(2012-2#2)
is very useful##9##3##(1991-5#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#2)
is very versatile and##2##4##(2008-3#1)(2008-4#1)
is very weak##3##3##(2008-10#1)(2008-7#2)
is very well##2##3##(2007-11#1)(2008-10#1)
is very##287##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#5)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#14)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#10)(2008-10#52)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#11)(2008-7#17)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#4)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#7)
is via##5##2##(1992-3#1)(2008-11#2)(2010-1#1)(2011-2#1)
is viable##2##2##(1996-9#1)(2011-2#1)
is viewed as a##3##4##(1992-3#1)(2008-4#1)(2012-3#1)
is viewed as##4##3##(1992-3#1)(2008-11#1)(2008-4#1)(2012-3#1)
is viewed##9##2##(1992-3#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
is violated##2##2##(1994-11#1)(2008-1#1)
is virion-associated and##2##3##(1994-8#1)(1997-3#1)
is virtually absent in##2##4##(1990-2#1)(2008-10#1)
is virtually absent##3##3##(1990-2#1)(2008-10#1)(2012-1#1)
is virtually##12##2##(1990-2#1)(1991-6#1)(1993-8#1)(1995-12#1)(1995-3#1)(2008-10#4)(2008-3#1)(2011-1#1)(2012-1#1)
is virulent on##2##3##(2008-10#2)
is virulent to##2##3##(2008-10#2)
is virulent##4##2##(2008-10#4)
is vital for##8##3##(1994-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-5#1)(2013-8#1)
is vital that##5##3##(1997-1#1)(2007-11#1)(2012-2#1)(2013-1#2)
is vital to develop##2##4##(2008-11#1)(2013-8#1)
is vital to the##5##4##(1993-9#1)(1995-3#1)(2008-10#1)(2010-4#1)(2013-8#1)
is vital to##14##3##(1993-9#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#3)
is vital##37##2##(1992-12#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#4)
is vitally important##2##3##(1993-2#1)(2008-4#1)
is vulnerable to the##2##4##(2008-8#1)(2013-1#1)
is vulnerable to##5##3##(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
is warranted and##3##3##(1991-12#1)(2008-11#1)(2011-2#1)
is warranted for##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
is warranted to##5##3##(2007-7#1)(2008-4#1)(2008-7#1)(2009-4#1)(2013-1#1)
is warranted##32##2##(1990-12#1)(1991-12#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#5)(2009-4#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#5)
is washed and##3##3##(2008-10#1)(2008-4#2)
is washed##5##2##(2008-10#1)(2008-4#2)(2008-8#2)
is weak and##3##3##(2008-3#1)(2009-8#1)(2012-1#1)
is weak##13##2##(1992-6#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
is weakened##2##2##(1995-5#1)(2008-8#1)
is weaker##4##2##(1994-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
is weakly related to##2##4##(2008-9#1)(2010-12#1)
is weakly##8##2##(1994-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-12#1)(2013-7#1)
is well accepted by##2##4##(1991-6#1)(2010-2#1)
is well accepted##5##3##(1991-6#1)(2008-10#2)(2010-2#1)(2013-8#1)
is well adapted to##2##4##(2008-12#1)(2012-2#1)
is well approximated##2##3##(1992-9#1)(2008-2#1)
is well below##2##3##(1995-12#1)(2008-3#1)
is well conserved in##2##4##(1996-12#1)(2008-7#1)
is well described by a##2##5##(2007-12#1)(2008-3#1)
is well described by the##2##5##(2008-2#2)
is well described by##6##4##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-4#1)
is well described in##3##4##(1991-6#1)(2008-1#1)(2013-1#1)
is well described##10##3##(1991-6#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-4#1)(2013-1#1)
is well documented and##3##4##(2008-11#1)(2009-6#1)(2011-2#1)
is well documented as##2##4##(1996-8#1)(2011-7#1)
is well documented in##2##4##(1991-4#1)(2009-6#1)
is well documented that##2##4##(2008-7#1)(2011-2#1)
is well documented##14##3##(1991-4#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)
is well established in the##2##5##(2008-5#1)(2013-1#1)
is well established in##3##4##(1996-9#1)(2008-5#1)(2013-1#1)
is well established that the##2##5##(2008-5#1)(2009-9#1)
is well established that##5##4##(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)
is well established##22##3##(1991-11#1)(1991-12#1)(1992-6#1)(1995-2#1)(1996-7#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2009-9#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
is well known in the##2##5##(2008-12#1)(2009-10#1)
is well known that the##5##5##(1993-3#1)(1997-2#1)(2008-3#3)
is well known that##29##4##(1992-6#1)(1993-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
is well known to be a##2##6##(2008-5#1)(2008-7#1)
is well known to be##3##5##(2008-5#1)(2008-7#1)(2013-8#1)
is well known to##5##4##(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
is well known##43##3##(1992-6#1)(1993-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
is well recognised##2##3##(2008-6#1)(2012-2#1)
is well recognized##5##3##(1990-9#1)(1995-6#1)(2006-10#1)(2011-2#1)(2012-12#1)
is well studied##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
is well suited for##11##4##(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2010-9#1)(2011-1#1)
is well suited to the##3##5##(2007-12#1)(2008-3#1)(2008-6#1)
is well suited to##6##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-1#1)
is well suited##17##3##(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-9#1)(2011-1#1)(2012-1#1)
is well tolerated and##2##4##(2008-10#1)(2013-1#1)
is well tolerated by patients##2##5##(2008-2#1)(2010-6#1)
is well tolerated by##3##4##(2008-2#1)(2009-4#1)(2010-6#1)
is well tolerated with##2##4##(2008-6#1)(2011-2#1)
is well tolerated##12##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
is well under##2##3##(2007-11#1)(2008-2#1)
is well understood##3##3##(2008-3#1)(2010-12#1)(2010-7#1)
is well##166##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#7)(2008-12#2)(2008-2#10)(2008-3#14)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
is well-documented##2##2##(1997-3#2)
is well-established##2##2##(2011-1#1)(2012-3#1)
is well-known that##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)
is well-known##6##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)
is well-tolerated by patients##2##4##(2007-11#1)(2007-8#1)
is what is##2##3##(2007-11#1)(2008-2#1)
is what##7##2##(1993-11#1)(1994-2#1)(2007-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-8#1)
is when the##2##3##(1991-3#1)(2008-3#1)
is when##5##2##(1991-3#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-4#1)
is whether the##7##3##(1994-2#1)(1997-2#1)(2007-8#1)(2009-10#1)(2009-5#1)(2010-2#2)
is whether##19##2##(1991-1#1)(1994-2#2)(1995-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-2#2)(2011-2#1)
is wholly##2##2##(1990-6#1)(2007-11#1)
is why the##2##3##(2008-10#1)(2011-2#1)
is why##10##2##(1991-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
is wide##3##2##(1997-5#1)(2008-10#1)(2012-2#1)
is widely accepted##9##3##(1991-3#1)(1994-9#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)
is widely believed##2##3##(1995-12#1)(2009-7#1)
is widely distributed in##6##4##(1993-11#1)(1993-3#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-7#1)
is widely expressed##2##3##(1993-12#1)(2012-12#1)
is widely known##3##3##(1994-3#1)(2007-11#1)(2007-6#1)
is widely recognized##4##3##(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
is widely regarded as##2##4##(2008-8#1)(2012-2#1)
is widely used as a model##2##6##(2008-9#1)(2009-9#1)
is widely used as a##5##5##(1997-4#1)(2008-10#1)(2008-9#1)(2009-9#1)(2011-2#1)
is widely used as an##2##5##(1996-8#1)(2010-8#1)
is widely used as##7##4##(1996-8#1)(1997-4#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)
is widely used for the##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
is widely used for##8##4##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
is widely used in Japan##2##5##(2008-10#1)(2010-6#1)
is widely used in##22##4##(1990-6#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-7#1)
is widely used to##4##4##(1994-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
is widely used##45##3##(1990-6#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
is widely utilized##2##3##(2008-10#1)(2008-9#1)
is widely##96##2##(1990-6#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(2007-11#3)(2007-2#1)(2007-6#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#3)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#1)
is wider##2##2##(2008-10#1)(2008-8#1)
is widespread among##2##3##(1994-8#1)(1995-8#1)
is widespread in Malawi##2##4##(2012-2#2)
is widespread in##5##3##(2012-1#1)(2012-2#2)(2013-1#2)
is widespread##18##2##(1992-3#1)(1994-8#1)(1995-8#1)(2008-10#3)(2008-7#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
is with the##3##3##(1994-8#1)(2008-12#1)(2008-3#1)
is with##7##2##(1994-8#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-3#3)
is within the physiological##2##4##(1993-8#1)(1995-5#1)
is within the range of##2##5##(1990-7#1)(1995-2#1)
is within the##14##3##(1990-5#1)(1990-7#1)(1991-9#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#3)
is within##20##2##(1990-5#1)(1990-7#1)(1991-9#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#6)(2010-12#1)
is without##7##2##(1990-8#1)(1991-5#1)(1996-3#1)(1997-6#1)(2008-11#1)(2008-6#1)(2013-8#1)
is working to improve##2##4##(2013-8#2)
is working to##3##3##(1996-2#1)(2013-8#2)
is working with##2##3##(1994-9#1)(2010-9#1)
is working##10##2##(1994-9#1)(1996-2#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-8#2)
is worse than##3##3##(1991-5#1)(1995-8#1)(2008-11#1)
is worse##6##2##(1991-5#1)(1995-8#1)(2008-11#2)(2008-4#1)(2009-10#1)
is worsened by##2##3##(1993-8#1)(2009-4#1)
is worsened##3##2##(1993-8#1)(2008-7#1)(2009-4#1)
is worth##6##2##(1993-11#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-12#1)
is worthwhile##3##2##(1991-11#1)(1996-4#1)(2008-4#1)
is written in##2##3##(2007-11#1)(2008-6#1)
is written##8##2##(2007-11#2)(2008-1#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-8#1)
is yet to be##5##4##(2007-7#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
is yet##8##2##(1990-2#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is your diagnosis?##4##3##(1992-6#1)(1993-11#1)(1994-5#1)(2007-12#1)
is your##9##2##(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1996-12#1)(2007-12#1)(2012-3#2)(2013-7#1)
is zero##5##2##(2007-10#1)(2008-10#2)(2008-3#1)(2008-8#1)
is ~0##8##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
is ~2##2##2##(2007-12#1)(2008-3#1)
is##54672##1##(1990-10#26)(1990-11#194)(1990-12#210)(1990-2#152)(1990-3#64)(1990-4#7)(1990-5#175)(1990-6#112)(1990-7#114)(1990-8#202)(1990-9#85)(1991-1#76)(1991-10#5)(1991-11#113)(1991-12#261)(1991-2#188)(1991-3#152)(1991-4#25)(1991-5#188)(1991-6#137)(1991-7#14)(1991-8#73)(1991-9#189)(1992-1#89)(1992-10#35)(1992-11#122)(1992-12#253)(1992-2#123)(1992-3#261)(1992-4#47)(1992-5#106)(1992-6#206)(1992-7#10)(1992-8#132)(1992-9#179)(1993-1#76)(1993-10#6)(1993-11#219)(1993-12#256)(1993-2#139)(1993-3#234)(1993-5#28)(1993-6#160)(1993-7#1)(1993-8#182)(1993-9#115)(1994-1#87)(1994-10#16)(1994-11#229)(1994-12#308)(1994-2#237)(1994-3#202)(1994-5#205)(1994-6#131)(1994-7#23)(1994-8#232)(1994-9#176)(1995-1#77)(1995-10#6)(1995-11#154)(1995-12#257)(1995-2#375)(1995-3#189)(1995-4#8)(1995-5#212)(1995-6#244)(1995-8#159)(1995-9#60)(1996-1#101)(1996-10#13)(1996-11#85)(1996-12#244)(1996-2#292)(1996-3#203)(1996-4#65)(1996-5#195)(1996-6#112)(1996-7#24)(1996-8#59)(1996-9#84)(1997-1#159)(1997-2#253)(1997-3#263)(1997-4#174)(1997-5#82)(1997-6#153)(1997-7#224)(1997-8#171)(1997-9#9)(2006-10#99)(2006-12#19)(2006-4#9)(2006-5#6)(2006-6#24)(2006-7#6)(2006-8#4)(2007-1#7)(2007-10#179)(2007-11#1444)(2007-12#1678)(2007-2#107)(2007-4#34)(2007-5#70)(2007-6#31)(2007-7#303)(2007-8#385)(2007-9#23)(2008-1#741)(2008-10#8429)(2008-11#1749)(2008-12#628)(2008-2#2239)(2008-3#4558)(2008-4#1155)(2008-5#1238)(2008-6#578)(2008-7#1816)(2008-8#1337)(2008-9#1225)(2009-1#56)(2009-10#223)(2009-11#171)(2009-12#174)(2009-2#95)(2009-3#149)(2009-4#122)(2009-5#255)(2009-6#153)(2009-7#193)(2009-8#321)(2009-9#140)(2010-1#91)(2010-10#200)(2010-11#214)(2010-12#312)(2010-2#127)(2010-3#253)(2010-4#185)(2010-5#262)(2010-6#187)(2010-7#161)(2010-8#377)(2010-9#76)(2011-1#552)(2011-10#8)(2011-2#2019)(2011-3#89)(2011-4#5)(2011-7#16)(2011-8#2)(2011-9#1)(2012-1#215)(2012-12#593)(2012-2#1049)(2012-3#748)(2012-4#2)(2012-5#5)(2012-6#3)(2012-7#8)(2012-8#4)(2012-9#4)(2013-1#1486)(2013-3#1)(2013-7#180)(2013-8#771)
is/is not##6##2##(2011-2#6)
isatin derivatives##2##2##(2011-1#2)
isatin##4##1##(2008-11#1)(2011-1#3)
ischaemia after##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
ischaemia and##8##2##(1991-2#1)(1992-5#1)(1995-8#1)(1996-2#1)(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
ischaemia because##2##2##(1995-11#1)(2013-8#1)
ischaemia by##2##2##(2008-7#1)(2011-2#1)
ischaemia has##2##2##(2008-10#1)(2012-1#1)
ischaemia in##6##2##(1990-9#1)(1993-9#1)(2008-7#2)(2009-11#1)(2011-2#1)
ischaemia##61##1##(1990-3#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-9#2)(1992-5#1)(1993-9#5)(1994-11#1)(1995-11#2)(1995-5#3)(1995-8#1)(1996-2#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-3#4)(2008-7#16)(2009-11#1)(2011-2#3)(2012-1#3)(2012-2#3)(2013-8#3)
ischaemia)##2##1##(1993-9#1)(1996-9#1)
ischaemia-reperfusion injury in the##2##4##(2007-9#1)(2012-2#1)
ischaemia-reperfusion injury##4##2##(1995-12#1)(2007-9#1)(2011-2#1)(2012-2#1)
ischaemia-reperfusion##10##1##(1995-12#1)(2007-9#1)(2008-7#3)(2011-2#1)(2012-2#2)(2013-7#2)
ischaemic and##2##2##(1994-11#1)(2012-2#1)
ischaemic cardiomyopathy##3##2##(2008-10#3)
ischaemic events##3##2##(1991-11#2)(2012-2#1)
ischaemic heart disease and##3##4##(1995-12#1)(2008-7#1)(2008-8#1)
ischaemic heart disease##15##3##(1990-6#1)(1990-9#1)(1995-12#2)(1997-8#3)(2007-7#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2012-2#1)
ischaemic heart##16##2##(1990-6#1)(1990-9#1)(1995-12#2)(1997-8#3)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2012-2#1)
ischaemic stroke and##2##3##(2008-8#1)(2009-11#1)
ischaemic stroke patients##4##3##(2008-8#4)
ischaemic stroke##25##2##(1992-2#2)(1997-5#1)(1997-8#1)(2008-7#3)(2008-8#14)(2009-11#1)(2012-2#3)
ischaemic##85##1##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#4)(1992-2#3)(1993-9#2)(1994-11#2)(1995-12#2)(1996-8#1)(1997-5#1)(1997-8#4)(2007-7#1)(2007-8#3)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#10)(2008-8#20)(2009-10#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-2#6)(2013-7#2)(2013-8#1)
ischemia (P &lt##3##3##(2007-10#2)(2008-3#1)
ischemia (i##2##2##(1994-2#1)(1996-11#1)
ischemia and cardiac##2##3##(2007-10#1)(2008-3#1)
ischemia and infarction##2##3##(2006-10#1)(2008-3#1)
ischemia and reperfusion##7##3##(1991-9#2)(1996-9#2)(2009-12#1)(2010-1#1)(2013-7#1)
ischemia and##21##2##(1990-8#1)(1991-9#2)(1994-9#1)(1996-9#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-7#1)
ischemia are##2##2##(2006-7#1)(2010-4#1)
ischemia at##2##2##(1997-2#1)(2006-12#1)
ischemia but##2##2##(1996-9#1)(2008-3#1)
ischemia by##5##2##(1990-7#1)(1995-12#1)(2007-10#2)(2008-7#1)
ischemia could##2##2##(1994-11#1)(1996-9#1)
ischemia due to##2##3##(1992-6#1)(2007-8#1)
ischemia during##4##2##(1994-2#1)(2008-4#1)(2008-7#1)(2010-8#1)
ischemia for 30 min##2##4##(2010-1#1)(2013-1#1)
ischemia in the##5##3##(1991-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2012-2#1)
ischemia in##17##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-5#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-9#2)(1997-2#2)(2007-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#1)
ischemia induced oxidative damage in##2##5##(2009-12#2)
ischemia induced##3##2##(1993-6#1)(2009-12#2)
ischemia is a##2##3##(2008-11#1)(2008-2#1)
ischemia is##5##2##(1996-12#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-12#1)
ischemia may##2##2##(1991-9#2)
ischemia of the##4##3##(2008-10#1)(2008-7#1)(2010-1#1)(2012-1#1)
ischemia of##5##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-1#1)
ischemia on##5##2##(1990-5#1)(1997-2#1)(2006-12#2)(2008-12#1)
ischemia or##2##2##(1997-3#1)(2007-5#1)
ischemia reperfusion##2##2##(2010-3#1)(2013-8#1)
ischemia was induced##2##3##(2007-10#1)(2008-10#1)
ischemia was##4##2##(2007-10#2)(2008-10#1)(2011-1#1)
ischemia which##2##2##(2008-7#1)(2010-8#1)
ischemia with##2##2##(1996-9#1)(2007-10#1)
ischemia##234##1##(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#1)(1991-3#1)(1991-5#4)(1991-9#6)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-5#4)(1993-6#2)(1994-11#4)(1994-2#10)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#8)(1996-11#1)(1996-12#7)(1996-5#1)(1996-9#15)(1997-2#6)(1997-3#1)(1997-6#4)(1997-8#1)(2006-10#2)(2006-12#5)(2006-7#2)(2007-10#15)(2007-5#1)(2007-8#8)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#2)(2009-1#1)(2009-12#5)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#3)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#5)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
ischemia)##6##1##(1990-3#1)(1994-2#1)(1996-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
ischemia-induced##2##1##(2011-1#1)(2013-7#1)
ischemia-reperfusion (I/R) injury##2##3##(2008-10#1)(2008-12#1)
ischemia-reperfusion damage##2##2##(1996-9#1)(1997-4#1)
ischemia-reperfusion in##6##2##(1991-9#1)(1995-12#2)(2008-10#1)(2008-7#1)(2013-7#1)
ischemia-reperfusion injury##5##2##(1991-9#2)(1995-12#1)(1996-9#1)(2012-3#1)
ischemia-reperfusion renal injury in##2##4##(1995-12#2)
ischemia-reperfusion##27##1##(1991-9#6)(1995-12#7)(1996-12#2)(1996-9#4)(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-3#2)(2013-7#1)
ischemia/reperfusion (I/R) injury##2##3##(2010-5#1)(2010-8#1)
ischemia/reperfusion injury in##6##3##(1996-9#1)(2008-7#1)(2010-11#1)(2010-12#3)
ischemia/reperfusion injury##10##2##(1996-9#2)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2011-2#1)
ischemia/reperfusion of##2##2##(2010-12#2)
ischemia/reperfusion##18##1##(1996-9#2)(2008-10#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-5#2)(2010-8#2)(2011-2#1)(2013-1#2)
ischemia]##2##1##(1990-3#1)(1994-11#1)
ischemic and reperfused##2##3##(1991-9#1)(1996-9#1)
ischemic and##8##2##(1991-9#1)(1992-9#1)(1995-12#1)(1996-9#1)(2007-10#1)(2008-10#1)(2010-8#1)(2011-2#1)
ischemic attack in##2##3##(2007-10#1)(2012-12#1)
ischemic attack##11##2##(1991-3#1)(1992-6#1)(1997-2#1)(2007-10#4)(2008-8#2)(2012-12#1)(2013-8#1)
ischemic attacks##8##2##(1991-11#1)(1991-3#1)(1994-6#2)(2007-10#1)(2007-7#1)(2007-8#1)(2012-3#1)
ischemic bowel##2##2##(2008-10#1)(2008-7#1)
ischemic brain damage##2##3##(2008-4#1)(2011-2#1)
ischemic brain injury##3##3##(1994-11#1)(2007-10#1)(2007-9#1)
ischemic brain##8##2##(1994-11#1)(1994-2#1)(1995-12#1)(2007-10#1)(2007-9#1)(2008-4#1)(2011-2#1)(2013-1#1)
ischemic brains##5##2##(1995-12#5)
ischemic cardiomyopathy##2##2##(2008-7#1)(2010-6#1)
ischemic cardiopathy##3##2##(1997-5#1)(2008-10#2)
ischemic cascade##3##2##(2008-2#2)(2009-10#1)
ischemic cerebral##5##2##(1990-3#1)(1996-12#1)(2007-10#2)(2008-7#1)
ischemic cerebrovascular##2##2##(2006-7#1)(2007-8#1)
ischemic colitis##6##2##(1990-6#1)(2013-1#5)
ischemic cortical##2##2##(2011-2#1)(2012-1#1)
ischemic damage##5##2##(1995-12#1)(1996-9#1)(2008-11#2)(2012-2#1)
ischemic events##3##2##(1994-11#1)(2009-5#1)(2011-2#1)
ischemic heart disease (IHD) have been studied##2##7##(2012-3#2)
ischemic heart disease (IHD)##4##4##(2008-3#2)(2012-3#2)
ischemic heart disease and##5##4##(1992-9#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-8#1)
ischemic heart disease in##5##4##(1994-3#1)(2007-8#1)(2011-2#3)
ischemic heart disease or##2##4##(2008-7#1)(2010-8#1)
ischemic heart disease were##2##4##(2011-2#2)
ischemic heart disease##48##3##(1992-9#1)(1994-3#1)(1996-3#1)(1996-6#1)(1996-9#5)(1997-8#2)(2007-10#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#4)(2008-7#5)(2008-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-8#2)(2011-2#7)(2012-3#4)
ischemic heart##54##2##(1992-9#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-9#5)(1997-8#2)(2007-10#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-3#4)(2008-7#5)(2008-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-8#2)(2011-2#7)(2012-12#1)(2012-3#5)(2013-1#2)
ischemic injury##4##2##(1997-2#1)(2010-4#1)(2013-1#2)
ischemic insult##7##2##(1990-5#1)(1993-3#1)(1994-11#1)(1996-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
ischemic insults##3##2##(2008-7#2)(2011-2#1)
ischemic lesion##2##2##(2008-8#1)(2010-5#1)
ischemic lesions##3##2##(2007-10#2)(2007-9#1)
ischemic myocardium##6##2##(1996-9#2)(2008-10#3)(2008-7#1)
ischemic necrosis##2##2##(2007-10#1)(2007-8#1)
ischemic nephropathy##5##2##(2007-7#3)(2008-1#1)(2008-12#1)
ischemic neuronal##2##2##(2009-12#2)
ischemic or##2##2##(2007-10#1)(2010-6#1)
ischemic pain##2##2##(1997-3#1)(2013-8#1)
ischemic preconditioning and##2##3##(2007-8#1)(2008-10#1)
ischemic preconditioning in the##2##4##(1996-9#1)(2013-7#1)
ischemic preconditioning##13##2##(1996-9#4)(2007-8#5)(2008-10#1)(2010-12#1)(2013-7#2)
ischemic reperfusion injury##3##3##(2013-1#3)
ischemic stress##4##2##(1994-11#1)(1996-12#1)(1996-9#1)(2008-10#1)
ischemic stroke and##8##3##(2007-10#6)(2008-10#1)(2009-11#1)
ischemic stroke at##2##3##(2007-10#2)
ischemic stroke can##2##3##(2008-12#1)(2008-8#1)
ischemic stroke cases##2##3##(2009-9#1)(2011-1#1)
ischemic stroke caused by##2##4##(2007-10#1)(2008-12#1)
ischemic stroke in young##3##4##(2007-10#1)(2011-1#1)(2012-3#1)
ischemic stroke in##7##3##(2007-10#2)(2011-1#4)(2012-3#1)
ischemic stroke is##2##3##(2006-7#1)(2009-11#1)
ischemic stroke of##2##3##(2007-10#1)(2008-8#1)
ischemic stroke patients##6##3##(2007-10#4)(2008-3#1)(2012-12#1)
ischemic stroke remains##3##3##(2007-10#1)(2008-8#2)
ischemic stroke secondary to##2##4##(2009-6#1)(2013-8#1)
ischemic stroke within##2##3##(2007-10#1)(2007-9#1)
ischemic stroke##126##2##(2006-7#5)(2007-10#63)(2007-9#1)(2008-10#2)(2008-12#3)(2008-3#3)(2008-8#9)(2008-9#4)(2009-11#5)(2009-6#1)(2009-9#2)(2010-4#1)(2011-1#12)(2011-2#2)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
ischemic strokes##4##2##(2007-10#3)(2008-7#1)
ischemic symptoms##2##2##(2007-8#1)(2008-8#1)
ischemic time##2##2##(2008-1#1)(2011-2#1)
ischemic##391##1##(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#3)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-6#3)(1994-11#4)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#9)(1995-5#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#16)(1997-2#5)(1997-3#2)(1997-5#1)(1997-8#3)(2006-7#6)(2007-10#86)(2007-7#4)(2007-8#15)(2007-9#3)(2008-1#3)(2008-10#25)(2008-11#2)(2008-12#6)(2008-2#5)(2008-3#11)(2008-4#2)(2008-7#14)(2008-8#15)(2008-9#4)(2009-10#2)(2009-11#5)(2009-12#3)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-8#5)(2011-1#14)(2011-2#21)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#4)(2012-3#7)(2013-1#18)(2013-7#4)(2013-8#4)
ischiorectal fossa##2##2##(2009-3#1)(2012-3#1)
ischiorectal##3##1##(1997-8#1)(2009-3#1)(2012-3#1)
ischium##2##1##(2013-1#2)
isdiscussed##2##1##(2008-11#1)(2008-2#1)
isethionate##2##1##(2008-10#2)
ishikariensis##6##1##(2008-10#6)
island countries##3##2##(2008-1#3)
island films##6##2##(2008-10#2)(2008-3#2)(2013-8#2)
island flap##2##2##(2008-10#1)(2008-6#1)
island nation##2##2##(2008-1#1)(2012-12#1)
island of Rab##2##3##(2011-2#2)
island of##10##2##(1995-6#1)(1997-4#1)(2008-10#3)(2008-5#1)(2011-1#2)(2011-2#2)
island was##2##2##(1996-10#2)
island within the##2##3##(1996-10#1)(2007-11#1)
island##78##1##(1991-6#4)(1992-1#1)(1994-11#1)(1995-6#1)(1996-10#3)(1996-6#7)(1997-4#2)(2007-11#2)(2007-5#2)(2008-1#12)(2008-10#10)(2008-11#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#3)(2010-3#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#5)
islands and##4##2##(1990-6#1)(2008-1#2)(2008-8#1)
islands are##2##2##(1996-6#1)(2008-9#1)
islands has##4##2##(1996-6#1)(2008-8#3)
islands have##2##2##(1995-8#1)(1996-4#1)
islands in the##3##3##(1992-11#1)(1994-9#1)(2008-10#1)
islands in##5##2##(1992-11#1)(1994-9#1)(1996-6#1)(2008-10#1)(2013-1#1)
islands of##4##2##(1995-3#1)(2008-3#1)(2011-2#1)(2013-8#1)
islands were##4##2##(1993-6#1)(1996-6#1)(2008-10#2)
islands which##2##2##(1990-5#1)(1996-10#1)
islands##78##1##(1990-5#2)(1990-6#1)(1991-4#2)(1992-11#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-10#2)(1996-4#1)(1996-6#9)(2007-11#2)(2007-12#1)(2008-1#6)(2008-10#6)(2008-3#5)(2008-7#2)(2008-8#12)(2008-9#6)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#4)
islands)##3##1##(2007-11#3)
islet amyloid polypeptide##2##3##(1992-6#1)(1994-8#1)
islet amyloid##6##2##(1992-6#2)(1993-8#1)(1994-8#3)
islet antigens##2##2##(2007-5#2)
islet cell surface antibodies (ICSA)##2##5##(1994-12#2)
islet cell tumours##4##3##(2008-1#1)(2008-2#3)
islet cell##16##2##(1994-12#2)(1996-12#1)(1996-2#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-2#3)(2010-11#5)(2012-2#1)
islet cells##9##2##(1990-2#2)(1995-11#1)(2008-1#1)(2010-11#5)
islet dysfunction##2##2##(1991-7#2)
islet engraftment in##2##3##(2010-11#2)
islet function and diabetes development##2##5##(2010-11#2)
islet function and##3##3##(2010-11#3)
islet function##4##2##(1991-7#1)(2010-11#3)
islet grafts##4##2##(2010-11#4)
islet insulin##3##2##(1995-8#1)(2010-11#2)
islet isolation procedure is##2##4##(2008-11#2)
islet isolation##11##2##(2008-11#6)(2010-10#2)(2010-11#2)(2010-12#1)
islet perifusion##2##2##(2010-11#2)
islet structure is##2##3##(2010-11#2)
islet survival and function##2##4##(2010-11#2)
islet survival##3##2##(2010-11#3)
islet transplantation is##2##3##(2010-11#1)(2012-12#1)
islet transplantation##14##2##(1997-8#1)(2008-11#1)(2010-10#3)(2010-11#5)(2010-12#3)(2012-12#1)
islet yield##4##2##(2008-11#3)(2010-11#1)
islet##133##1##(1990-12#1)(1990-2#2)(1991-7#5)(1992-6#5)(1993-8#1)(1994-12#2)(1994-8#3)(1995-11#1)(1995-8#7)(1996-12#1)(1996-2#1)(1997-5#1)(1997-8#1)(2007-5#6)(2008-1#2)(2008-10#1)(2008-11#10)(2008-2#3)(2008-3#1)(2009-8#1)(2010-10#6)(2010-11#60)(2010-12#5)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
islets and in##2##3##(1995-8#2)
islets and β-cells##2##3##(2010-11#2)
islets and##13##2##(1995-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#5)(2012-2#2)
islets can##2##2##(1994-8#1)(2010-12#1)
islets from##4##2##(1994-8#1)(2008-4#1)(2010-11#2)
islets in##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
islets isolated from##4##3##(2010-11#4)
islets of Langerhans##7##3##(1994-8#1)(1995-8#2)(1997-4#1)(2009-8#1)(2010-11#1)(2010-12#1)
islets of the organ were##2##5##(2008-5#2)
islets of##12##2##(1994-8#3)(1995-8#2)(1997-4#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
islets or##2##2##(1994-8#1)(1995-11#1)
islets pretreated##2##2##(1995-8#2)
islets to##3##2##(1995-2#1)(2008-11#1)(2010-11#1)
islets was##3##2##(1990-12#1)(1995-8#1)(2008-5#1)
islets were##2##2##(1995-8#1)(2010-11#1)
islets with##3##2##(1990-12#1)(2008-10#1)(2010-11#1)
islets##115##1##(1990-12#5)(1990-2#1)(1994-8#11)(1995-11#3)(1995-2#1)(1995-8#22)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#3)(2008-5#8)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#39)(2010-12#3)(2011-2#2)(2012-2#2)(2013-1#1)
isn't##8##1##(1992-11#1)(1993-1#1)(1993-3#1)(1995-12#1)(2007-9#1)(2008-4#2)(2012-12#1)
iso I##7##2##(1992-8#7)
iso##8##1##(1992-8#8)
iso-##2##1##(2008-7#1)(2011-1#1)
iso-1-cytochrome c in##2##3##(1995-5#2)
iso-1-cytochrome c##3##2##(1995-5#3)
iso-amylase##3##1##(1993-12#3)
iso-butylamine##3##1##(2008-10#3)
iso-chronous##2##1##(2008-5#2)
iso-electric point##2##2##(1994-11#1)(2008-10#1)
iso-osmotically##2##1##(1997-1#2)
isoacceptors##2##1##(2008-4#1)(2008-8#1)
isoamyl##2##1##(2008-10#1)(2008-7#1)
isoamylase gene##2##2##(1990-11#2)
isoamylase##5##1##(1990-11#5)
isoarecolone##2##1##(1995-5#2)
isoasparagine##2##1##(1993-6#2)
isobaric ropivacain##2##2##(2012-3#2)
isobaric##9##1##(2008-10#1)(2008-3#1)(2012-12#2)(2012-3#5)
isobolograms##2##1##(1994-11#2)
isobutyl methyl ketone (IBMK)##6##4##(2008-10#6)
isobutyl methyl ketone##7##3##(2008-10#7)
isobutyl methyl##8##2##(2008-10#7)(2008-11#1)
isobutyl##18##1##(2008-10#17)(2008-11#1)
isobutylmethylxanthine##2##1##(1991-12#1)(2008-5#1)
isobutyric##3##1##(2008-10#3)
isocaine##3##1##(2008-10#3)
isocaloric##2##1##(2008-3#1)(2010-6#1)
isocenter position##3##2##(2009-2#3)
isocenter##4##1##(2008-3#1)(2009-2#3)
isochromatic phase##2##2##(2008-2#2)
isochromatic##6##1##(2008-2#2)(2008-3#4)
isochromatics of photoelastic fringe patterns##2##5##(2008-2#2)
isochromatics##5##1##(2008-2#2)(2008-3#3)
isochronal and isothermal decays of##2##5##(2008-3#2)
isochronal##4##1##(2008-3#4)
isochrone maps##2##2##(2008-7#2)
isochrone##3##1##(2008-7#3)
isochrones##2##1##(2008-7#2)
isocitrate dehydrogenase and##2##3##(2009-11#1)(2013-1#1)
isocitrate dehydrogenase##12##2##(1990-8#3)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#2)(2010-12#2)(2013-1#1)
isocitrate lyase##2##2##(2008-10#2)
isocitrate##21##1##(1990-8#4)(2008-10#9)(2008-11#2)(2008-7#1)(2009-11#2)(2010-12#2)(2013-1#1)
isoclinics##4##1##(2008-2#2)(2008-3#2)
isocortex##3##1##(1994-8#3)
isocoumarin derivatives##2##2##(2012-2#2)
isocoumarin##5##1##(1991-3#3)(2012-2#2)
isocratic HPLC##3##2##(1996-5#1)(2008-10#2)
isocratic conditions##2##2##(1996-5#1)(2008-10#1)
isocratic elution with##5##3##(1996-5#1)(2008-10#4)
isocratic elution##9##2##(1990-8#1)(1996-5#1)(1997-2#1)(2008-10#5)(2009-8#1)
isocratic mode##5##2##(2008-10#3)(2010-11#1)(2010-3#1)
isocratic reversed-phase high-performance liquid chromatographic##2##5##(1996-5#1)(2008-10#1)
isocratic reversed-phase high-performance liquid##3##4##(1991-5#1)(1996-5#1)(2008-10#1)
isocratic reversed-phase##4##2##(1991-5#1)(1996-5#1)(2008-10#2)
isocratic##39##1##(1990-8#1)(1991-5#2)(1996-5#4)(1997-2#1)(2008-10#25)(2008-5#2)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)
isocratically##2##1##(2008-10#2)
isocyanate##6##1##(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
isocyanuric##3##1##(2008-10#3)
isodomoic acid A##2##3##(1992-8#2)
isodose##2##1##(2008-11#1)(2009-11#1)
isoelectric focusing (IEF)##3##3##(1993-8#1)(2008-11#1)(2008-4#1)
isoelectric focusing and##2##3##(2008-10#1)(2008-11#1)
isoelectric focusing gels##2##3##(1992-8#1)(2008-10#1)
isoelectric focusing##16##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-11#3)(2008-4#3)(2010-7#1)
isoelectric point (pI)##5##3##(1995-12#1)(1996-5#1)(2008-4#3)
isoelectric point of the##2##4##(2008-11#1)(2008-8#1)
isoelectric point of##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
isoelectric point##25##2##(1990-11#2)(1990-5#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-4#3)(2008-7#3)(2008-8#1)
isoelectric points##6##2##(1991-2#1)(1994-5#1)(2008-10#2)(2008-11#1)(2009-9#1)
isoelectric precipitation##2##2##(2008-7#2)
isoelectric##51##1##(1990-11#2)(1990-5#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-4#6)(2008-7#5)(2008-8#1)(2009-9#1)(2010-7#1)
isoelectrofocusing##5##1##(1991-12#1)(1992-3#1)(2008-10#1)(2008-4#2)
isoenergetic##2##1##(1997-7#1)(2008-10#1)
isoenzyme distribution##2##2##(1993-12#2)
isoenzyme forms##2##2##(1990-12#1)(1991-5#1)
isoenzyme in##3##2##(1992-6#2)(1993-12#1)
isoenzyme is##2##2##(1990-12#1)(2008-7#1)
isoenzyme of##4##2##(1992-6#1)(1993-2#1)(1994-9#1)(2013-1#1)
isoenzyme##30##1##(1990-12#3)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#3)(1993-12#4)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#2)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2013-1#2)
isoenzymes (alpha##2##2##(1993-3#1)(1994-8#1)
isoenzymes could be##2##3##(1991-5#1)(1994-11#1)
isoenzymes in##4##2##(1992-6#1)(1993-12#1)(1993-3#1)(2008-6#1)
isoenzymes##29##1##(1990-12#1)(1990-2#1)(1991-5#4)(1992-3#2)(1992-6#1)(1993-12#2)(1993-3#2)(1994-11#2)(1994-2#2)(1994-8#2)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-11#1)(2013-1#1)
isoeugenol##2##1##(2008-5#2)
isofemale lines##2##2##(2008-8#1)(2011-2#1)
isofemale##3##1##(2008-8#1)(2011-2#2)
isoflavone aglycones##3##2##(2008-10#3)
isoflavone daidzein##2##2##(2008-10#2)
isoflavone glucoside##3##2##(2008-11#3)
isoflavone##16##1##(1992-3#1)(1993-12#1)(2008-10#6)(2008-11#5)(2010-10#1)(2012-2#2)
isoflavones in##2##2##(1993-12#2)
isoflavones##19##1##(1993-12#7)(2008-10#4)(2008-2#1)(2008-7#1)(2010-1#1)(2010-3#4)(2011-2#1)
isoflavonoid metabolites##3##2##(1993-12#3)
isoflavonoids##2##1##(2011-1#2)
isoflurane in##2##2##(2011-2#1)(2012-3#1)
isoflurane##8##1##(1991-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#3)
isoform and##5##2##(1993-6#1)(1996-12#1)(2008-10#1)(2009-10#1)(2010-12#1)
isoform content##4##2##(1993-6#1)(1994-8#1)(2008-10#1)(2013-8#1)
isoform expressed in##2##3##(1993-6#1)(2008-8#1)
isoform in##2##2##(1995-12#1)(2008-10#1)
isoform is##2##2##(1995-2#1)(2008-10#1)
isoform of PKA##2##3##(1994-8#2)
isoform of protein##2##3##(1993-12#1)(1993-6#1)
isoform of the##4##3##(1991-2#1)(1995-11#1)(1995-12#1)(1996-12#1)
isoform of##18##2##(1991-2#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(2008-11#1)(2008-5#1)(2012-12#2)
isoform patterns##2##2##(1992-3#1)(2008-10#1)
isoform usage##2##2##(2012-3#2)
isoform was detected##2##3##(1993-6#1)(2008-10#1)
isoform was##6##2##(1993-6#1)(1995-8#1)(2008-10#4)
isoform which##2##2##(1992-3#1)(1995-8#1)
isoform##96##1##(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#5)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#5)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#4)(1995-11#4)(1995-12#5)(1995-2#1)(1995-8#3)(1996-12#6)(1996-2#2)(1996-6#1)(1996-9#1)(2008-10#14)(2008-11#6)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-8#1)
isoform) were##2##2##(1995-11#1)(2008-4#1)
isoform)##3##1##(1995-11#1)(2008-4#2)
isoform-specific##4##1##(1994-8#1)(1996-6#2)(2010-11#1)
isoforms and the##4##3##(1995-12#1)(1995-6#1)(2010-12#1)(2012-12#1)
isoforms and##11##2##(1993-3#1)(1995-12#1)(1995-6#2)(1996-5#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
isoforms are##8##2##(1991-5#1)(1994-8#1)(1995-12#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-7#1)
isoforms by##2##2##(1994-9#1)(2008-10#1)
isoforms during##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
isoforms for##2##2##(1992-3#1)(1994-8#1)
isoforms from##6##2##(1993-12#1)(1995-12#1)(2008-10#3)(2013-1#1)
isoforms has been##2##3##(2008-4#1)(2008-7#1)
isoforms have been##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
isoforms have##6##2##(1990-12#2)(1992-8#1)(1995-2#1)(2008-10#1)(2008-8#1)
isoforms in rat##2##3##(1992-12#1)(2008-10#1)
isoforms in the##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
isoforms in##18##2##(1992-12#1)(1993-8#2)(1994-8#2)(1994-9#1)(1995-2#1)(1996-5#2)(2008-10#2)(2008-11#1)(2009-5#1)(2010-12#2)(2011-2#2)(2013-8#1)
isoforms is##3##2##(1991-12#1)(1992-3#1)(2010-12#1)
isoforms may##2##2##(1994-6#1)(2010-2#1)
isoforms of PKC in##3##4##(1994-6#2)(1995-11#1)
isoforms of PKC##5##3##(1994-6#2)(1995-11#3)
isoforms of SNAP-25##2##3##(1995-2#2)
isoforms of mouse liver cytosol##2##5##(2008-10#2)
isoforms of porcine aromatase##2##4##(1995-8#2)
isoforms of the##7##3##(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#1)(2010-7#1)(2013-1#1)
isoforms of##53##2##(1991-12#4)(1992-12#1)(1992-3#2)(1993-12#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#5)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
isoforms was##3##2##(1993-3#1)(1993-6#1)(1994-8#1)
isoforms were##4##2##(1995-8#1)(1997-2#1)(2008-10#2)
isoforms which##4##2##(1991-12#1)(1992-8#1)(1993-6#1)(2008-4#1)
isoforms with##5##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
isoforms##215##1##(1990-11#1)(1990-12#5)(1990-5#1)(1991-12#9)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#5)(1992-8#3)(1993-11#2)(1993-12#3)(1993-3#5)(1993-6#2)(1993-8#7)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#7)(1994-8#8)(1994-9#4)(1995-11#5)(1995-12#5)(1995-2#11)(1995-3#2)(1995-6#4)(1995-8#5)(1996-12#4)(1996-2#1)(1996-5#4)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#5)(2009-5#4)(2009-9#3)(2010-11#1)(2010-12#7)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
isoforms)##2##1##(2009-10#2)
isofraxidin and##5##2##(2008-10#5)
isogenic yeast strains##2##3##(1993-8#1)(1995-6#1)
isogenic##12##1##(1993-3#1)(1993-8#1)(1995-6#1)(1996-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)
isoheight##2##1##(2008-3#2)
isoindole##2##1##(2008-10#2)
isoindoline class##2##2##(2012-3#2)
isokinetic##2##1##(1990-7#1)(1996-6#1)
isolable##4##1##(1992-9#1)(2008-10#1)(2010-2#1)(2010-5#1)
isolate (pathogenic on##8##3##(2008-10#8)
isolate 10343##3##2##(2008-5#3)
isolate 78-62##3##2##(2008-10#3)
isolate Bangalore##2##2##(2008-10#2)
isolate C##3##2##(2008-10#2)(2008-5#1)
isolate EN-4##3##2##(2008-10#3)
isolate IPO323##3##2##(2008-10#3)
isolate N-1##3##2##(2008-10#3)
isolate ND90Pr##3##2##(2008-10#3)
isolate Sh12B of S##2##4##(2008-10#2)
isolate Sh12B of##3##3##(2008-10#3)
isolate Sh12B was##3##3##(2008-10#3)
isolate Sh12B##10##2##(2008-10#10)
isolate Sn2000##3##2##(2008-10#3)
isolate ZJ1##2##2##(2008-9#2)
isolate a##6##2##(1991-5#2)(1994-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
isolate after##2##2##(2008-10#2)
isolate and a laboratory##2##4##(2008-10#1)(2011-2#1)
isolate and a##4##3##(2008-10#1)(2010-10#2)(2011-2#1)
isolate and##22##2##(1990-2#1)(1993-8#1)(1997-2#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#2)(2011-2#1)
isolate as##4##2##(1997-7#1)(2008-10#2)(2009-6#1)
isolate collected from##3##3##(2008-10#2)(2008-12#1)
isolate did not##2##3##(2008-10#2)
isolate each##2##2##(2008-10#2)
isolate from a##2##3##(2008-10#1)(2009-12#1)
isolate from the##5##3##(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
isolate from##31##2##(1995-3#2)(1997-6#2)(2008-10#19)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2011-2#1)(2013-1#1)
isolate gene##2##2##(1993-9#1)(1996-2#1)
isolate had a##3##3##(2008-10#3)
isolate had##4##2##(2008-10#4)
isolate in the##2##3##(2008-10#2)
isolate in##12##2##(2007-7#1)(2008-10#10)(2008-4#1)
isolate induced##3##2##(2008-10#3)
isolate is##7##2##(2007-12#1)(2008-10#6)
isolate of BBSV##2##3##(2008-10#2)
isolate of F##3##3##(2008-10#3)
isolate of P##2##3##(2008-10#2)
isolate of R##2##3##(2008-10#2)
isolate of Rhizoctonia solani##3##4##(2008-10#3)
isolate of T##2##3##(2008-10#2)
isolate of each##2##3##(2008-10#2)
isolate of the fungus##2##4##(2008-10#2)
isolate of the##10##3##(2008-10#9)(2011-2#1)
isolate of##61##2##(1994-8#1)(1997-2#2)(1997-6#2)(2007-6#1)(2008-10#49)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#2)
isolate on##4##2##(2008-10#3)(2011-2#1)
isolate revealed##2##2##(2008-10#2)
isolate showed##2##2##(1997-8#1)(2011-2#1)
isolate tested##2##2##(2008-10#2)
isolate that##2##2##(2008-10#1)(2011-2#1)
isolate the##24##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-6#1)(1994-12#1)(1995-1#1)(1997-2#2)(2006-10#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#2)(2011-2#1)(2012-2#1)
isolate to##3##2##(2008-10#3)
isolate used##3##2##(2008-10#3)
isolate was composed of##2##4##(2008-10#2)
isolate was composed##3##3##(2008-10#3)
isolate was identified as##2##4##(2007-7#1)(2012-2#1)
isolate was identified##3##3##(2007-7#1)(2012-2#2)
isolate was##26##2##(2007-6#1)(2007-7#1)(2008-10#18)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#2)
isolate were determined##2##3##(2008-10#2)
isolate were inoculated on S##2##5##(2008-10#2)
isolate were inoculated##3##3##(2008-10#3)
isolate were##8##2##(2008-10#8)
isolate##550##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#3)(1991-8#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#3)(1995-1#2)(1995-2#2)(1995-3#2)(1996-2#1)(1996-6#1)(1997-2#7)(1997-3#2)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-6#9)(2007-7#3)(2008-1#3)(2008-10#367)(2008-11#6)(2008-12#8)(2008-2#5)(2008-3#5)(2008-4#8)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#9)(2008-9#9)(2009-10#1)(2009-12#2)(2009-6#3)(2010-10#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#14)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#2)
isolate)##8##1##(1997-6#1)(2008-10#6)(2013-1#1)
isolate-plant##2##1##(2008-10#2)
isolate-specific and##2##2##(2008-10#2)
isolate-specific resistance genes##3##3##(2008-10#3)
isolate-specific resistance##4##2##(2008-10#4)
isolate-specific##10##1##(2008-10#10)
isolated AVR##2##2##(2007-8#2)
isolated Bacillus##2##2##(2008-8#1)(2013-1#1)
isolated HS##2##2##(2008-10#2)
isolated MS-ATP##2##2##(2008-3#2)
isolated MS-WHO##2##2##(2008-3#2)
isolated a cDNA clone encoding##2##5##(1993-12#1)(1994-12#1)
isolated a cDNA clone##3##4##(1993-12#1)(1994-12#1)(1997-4#1)
isolated a cDNA##4##3##(1993-12#1)(1994-12#1)(1995-12#1)(1997-4#1)
isolated a##26##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-4#3)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)
isolated adult##3##2##(1994-6#2)(2008-12#1)
isolated after specific##2##3##(1991-9#1)(1993-11#1)
isolated after##10##2##(1990-2#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-5#1)
isolated an##2##2##(2008-11#2)
isolated and characterised##4##3##(1990-11#1)(1993-2#1)(2008-11#2)
isolated and characterized a human##2##5##(1991-2#1)(1994-8#1)
isolated and characterized a##4##4##(1991-2#1)(1993-11#1)(1994-8#1)(1997-6#1)
isolated and characterized as##2##4##(1991-5#1)(2008-11#1)
isolated and characterized from##2##4##(2008-11#1)(2008-8#1)
isolated and characterized##31##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-6#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-8#1)
isolated and cloned##3##3##(1990-12#1)(2008-8#2)
isolated and cultured in##2##4##(1995-8#1)(2008-4#1)
isolated and identified##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
isolated and partially sequenced##2##4##(1990-12#1)(1996-10#1)
isolated and partially##3##3##(1990-12#1)(1992-6#1)(1996-10#1)
isolated and purified by##3##4##(1990-12#1)(1995-11#1)(2008-9#1)
isolated and purified from multiple-step chromatographies including##2##7##(1992-8#1)(1994-6#1)
isolated and purified from##7##4##(1992-8#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-12#1)(2011-1#1)
isolated and purified##12##3##(1990-11#1)(1990-12#1)(1992-8#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)
isolated and sequenced the##3##4##(1991-2#1)(1994-12#1)(1995-11#1)
isolated and sequenced##17##3##(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1992-4#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-8#1)(1997-1#1)(2008-10#1)
isolated and the##3##3##(1992-3#1)(1997-4#1)(2007-7#1)
isolated and was##2##3##(1997-5#1)(2008-10#1)
isolated and##116##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-7#3)(1990-8#2)(1991-11#1)(1991-2#3)(1991-5#3)(1991-6#5)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-8#1)
isolated areas##2##2##(2008-10#1)(2009-9#1)
isolated as a##4##3##(1990-2#1)(1992-8#1)(1995-8#1)(2011-2#1)
isolated as##6##2##(1990-2#1)(1990-9#1)(1992-8#1)(1995-8#1)(2008-11#1)(2011-2#1)
isolated at a##2##3##(2008-10#1)(2008-5#1)
isolated at##9##2##(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-3#1)
isolated atrial flutter##2##3##(2010-11#2)
isolated bacteria##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
isolated but were##2##3##(1992-9#1)(1995-8#1)
isolated but##4##2##(1992-9#1)(1995-8#1)(2008-12#1)(2008-5#1)
isolated by RT-PCR##3##3##(1993-3#1)(2008-7#1)(2008-8#1)
isolated by a##3##3##(1993-3#1)(1994-12#1)(2008-10#1)
isolated by column chromatography##2##4##(2009-6#1)(2010-5#1)
isolated by density gradient centrifugation##2##5##(1994-8#1)(2008-9#1)
isolated by gel filtration##2##4##(1993-11#1)(2008-6#1)
isolated by screening a human##3##5##(1991-6#1)(1996-10#1)(2008-8#1)
isolated by screening##4##3##(1990-5#1)(1991-6#1)(1996-10#1)(2008-8#1)
isolated by semi-preparative##2##3##(1990-8#1)(2008-10#1)
isolated by##65##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-8#3)(1995-11#1)(1995-6#2)(1996-10#1)(1996-12#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
isolated cDNA clones##4##3##(1990-12#1)(1993-6#1)(1995-2#1)(2008-5#1)
isolated cDNA##7##2##(1990-12#2)(1991-2#1)(1993-6#1)(1995-2#1)(1996-10#1)(2008-5#1)
isolated cells and##3##3##(1990-12#1)(1995-11#1)(2008-11#1)
isolated cells##8##2##(1990-12#1)(1994-9#1)(1995-11#2)(2008-11#3)(2008-8#1)
isolated chicken##3##2##(1990-2#1)(1992-9#1)(2008-12#1)
isolated clones##5##2##(1991-6#1)(1993-6#1)(1995-2#1)(1996-10#2)
isolated compounds were##3##3##(2008-11#2)(2013-1#1)
isolated compounds##5##2##(2008-10#1)(2008-11#2)(2013-1#2)
isolated conidia##2##2##(1992-8#1)(2008-10#1)
isolated coronary arteries##2##3##(1994-11#1)(2007-8#1)
isolated coronary##5##2##(1994-11#1)(2007-8#3)(2012-3#1)
isolated directly from##3##3##(2008-11#1)(2008-5#2)
isolated directly##4##2##(2008-11#1)(2008-5#3)
isolated during the period##2##4##(2008-5#1)(2008-7#1)
isolated during the##4##3##(2008-10#1)(2008-5#2)(2008-7#1)
isolated during##7##2##(1990-6#1)(1995-3#1)(2008-10#2)(2008-5#2)(2008-7#1)
isolated elements##2##2##(2008-10#1)(2013-1#1)
isolated ferric low-spin siroheme-CN is##2##5##(1993-8#2)
isolated for the first time from the##2##7##(2007-11#1)(2013-1#1)
isolated for the first time##3##5##(2007-11#1)(2008-5#1)(2013-1#1)
isolated for the##5##3##(2007-11#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
isolated for##8##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
isolated form##5##2##(1992-5#1)(1997-3#1)(2009-10#2)(2013-8#1)
isolated four##3##2##(1991-5#1)(1995-8#1)(1997-8#1)
isolated frequently##2##2##(2008-10#1)(2008-5#1)
isolated from 15##2##3##(2008-10#2)
isolated from 18##2##3##(2008-11#1)(2008-5#1)
isolated from 2##2##3##(1997-9#1)(2008-10#1)
isolated from 37##2##3##(2007-7#1)(2008-12#1)
isolated from Brazilian soil##2##4##(2008-6#2)
isolated from Brazilian##3##3##(2008-6#3)
isolated from CSF##2##3##(2007-8#2)
isolated from Candida##3##3##(1995-8#1)(1996-3#1)(1997-4#1)
isolated from Chinese##2##3##(2008-8#2)
isolated from EBs##2##3##(2008-11#2)
isolated from M##2##3##(2008-10#1)(2011-10#1)
isolated from Phyllomedusa##2##3##(1993-3#1)(1994-5#1)
isolated from Spanish##2##3##(2008-10#1)(2008-5#1)
isolated from Streptomyces##2##3##(2008-8#1)(2009-6#1)
isolated from a Korean##2##4##(1997-2#1)(2008-10#1)
isolated from a cDNA library derived from##2##7##(1990-11#1)(1994-12#1)
isolated from a cDNA library##3##5##(1990-11#1)(1994-12#1)(1995-8#1)
isolated from a field population##2##5##(2011-2#2)
isolated from a genomic library of##2##6##(1990-5#1)(2008-10#1)
isolated from a genomic library##4##5##(1990-5#1)(1992-8#1)(1993-6#1)(2008-10#1)
isolated from a human brain cDNA library##2##7##(1993-8#2)
isolated from a human##10##4##(1992-8#1)(1993-8#2)(1994-11#2)(1994-9#1)(1995-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
isolated from a lambda gt##2##5##(1991-6#1)(2008-11#1)
isolated from a lambda##4##4##(1991-12#1)(1991-6#1)(1993-2#1)(2008-11#1)
isolated from a library of##2##5##(1990-5#1)(2008-10#1)
isolated from a rat##3##4##(1991-12#1)(1992-10#1)(1996-12#1)
isolated from a##76##3##(1990-11#1)(1990-12#3)(1990-5#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-6#1)(2011-2#11)(2012-12#1)(2012-2#2)
isolated from an offshore oil##2##5##(2011-2#2)
isolated from an##12##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1997-7#1)(2011-2#3)
isolated from birds##2##3##(1997-3#1)(1997-6#1)
isolated from blighted##2##3##(2008-10#2)
isolated from blood cultures##2##4##(2008-7#1)(2013-8#1)
isolated from blood##3##3##(1995-3#1)(2008-7#1)(2013-8#1)
isolated from bone marrow##2##4##(1997-6#1)(2013-1#1)
isolated from both##5##3##(1995-11#1)(2007-7#1)(2008-1#1)(2008-10#2)
isolated from bovine##3##3##(1990-7#1)(1993-3#1)(1993-6#1)
isolated from cases of##3##4##(2007-7#1)(2008-12#1)(2008-7#1)
isolated from children with##2##4##(2007-10#1)(2013-1#1)
isolated from clinical specimens##2##4##(2008-12#1)(2008-7#1)
isolated from clinical##4##3##(2008-12#1)(2008-7#1)(2013-8#2)
isolated from culture##2##3##(1991-11#1)(2008-11#1)
isolated from different##4##3##(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
isolated from diseased##8##3##(2008-10#8)
isolated from dog##2##3##(1991-11#1)(1991-6#1)
isolated from dying##2##3##(1996-12#1)(2008-10#1)
isolated from each other##2##4##(2008-9#1)(2009-2#1)
isolated from each##3##3##(2008-10#1)(2008-9#1)(2009-2#1)
isolated from fasted animals##2##4##(1994-8#2)
isolated from fasted##3##3##(1994-8#2)(1995-6#1)
isolated from fetal##2##3##(1994-11#1)(1996-5#1)
isolated from field##2##3##(2008-10#2)
isolated from healthy##4##3##(2008-10#2)(2008-12#2)
isolated from human and##3##4##(1991-12#1)(1991-5#1)(2012-12#1)
isolated from human feces##2##4##(2008-11#1)(2012-2#1)
isolated from human placenta##2##4##(1991-12#1)(1997-1#1)
isolated from human term##2##4##(1994-9#1)(1995-11#1)
isolated from human umbilical##2##4##(1993-3#1)(2013-8#1)
isolated from human##32##3##(1990-3#1)(1990-7#2)(1991-12#3)(1991-2#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-11#3)(2008-8#2)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
isolated from immature##2##3##(1997-4#1)(2008-6#1)
isolated from infected##4##3##(1991-3#1)(2008-10#3)
isolated from lettuce##2##3##(2008-10#2)
isolated from marine##2##3##(2011-2#2)
isolated from minute##2##3##(1990-11#2)
isolated from mouse##2##3##(1994-11#1)(2010-11#1)
isolated from normal##2##3##(1991-9#1)(1992-3#1)
isolated from onion##3##3##(2008-10#3)
isolated from other##4##3##(2008-10#4)
isolated from patient##3##3##(1994-8#2)(2011-2#1)
isolated from patients with##3##4##(1994-6#1)(2011-1#1)(2012-2#1)
isolated from patients##8##3##(1994-5#1)(1994-6#1)(2007-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#2)
isolated from peripheral blood##3##4##(1993-6#1)(1997-4#1)(2008-4#1)
isolated from plant##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
isolated from rabbit##2##3##(1992-12#1)(1992-6#1)
isolated from rainbow trout##2##4##(1994-5#1)(1997-9#1)
isolated from rat##7##3##(1991-12#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-11#1)(1996-2#1)(2008-11#1)
isolated from rats##4##3##(1991-12#1)(1992-11#1)(1997-1#1)(2008-11#1)
isolated from roots##2##3##(2008-10#2)
isolated from samples##2##3##(1996-6#1)(2010-4#1)
isolated from six##2##3##(1995-12#1)(2008-10#1)
isolated from soil and##3##4##(1993-11#1)(2008-10#1)(2013-1#1)
isolated from soil samples##3##4##(2008-5#1)(2008-6#1)(2008-8#1)
isolated from soil##8##3##(1993-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
isolated from soybean##4##3##(2008-10#4)
isolated from strawberry##3##3##(2008-10#3)
isolated from sweet orange##2##4##(2008-10#2)
isolated from symptomatic##3##3##(2008-10#3)
isolated from symptomless##2##3##(2008-10#2)
isolated from systemically infected##2##4##(2008-10#2)
isolated from the cells##2##4##(1994-3#1)(2008-11#1)
isolated from the fruit of##2##5##(2008-9#1)(2013-1#1)
isolated from the leaves of##4##5##(2008-8#1)(2010-2#1)(2011-2#1)(2011-3#1)
isolated from the plant##2##4##(2011-1#1)(2011-2#1)
isolated from the reaction##2##4##(1996-5#1)(2008-8#1)
isolated from the roots##2##4##(2008-10#1)(2008-11#1)
isolated from the same orchard##2##5##(2008-10#2)
isolated from the same##4##4##(1991-9#1)(1992-8#1)(2008-10#2)
isolated from the skin of##2##5##(1994-11#1)(1994-5#1)
isolated from the soil##2##4##(2008-10#2)
isolated from the venom of##2##5##(1994-11#1)(1995-5#1)
isolated from the##121##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#3)(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#5)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-10#22)(2008-11#8)(2008-12#1)(2008-5#9)(2008-7#1)(2008-8#6)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
isolated from these##8##3##(1997-3#1)(2008-10#4)(2008-2#1)(2008-9#1)(2011-1#1)
isolated from this plant##2##4##(1994-11#1)(2011-3#1)
isolated from this##6##3##(1990-8#1)(1994-11#1)(1995-6#1)(2008-10#2)(2011-3#1)
isolated from three##2##3##(2012-2#1)(2013-8#1)
isolated from tobacco##4##3##(2008-10#3)(2008-8#1)
isolated from tomato##2##3##(2008-10#2)
isolated from traditional fermented milk 'Dahi'##2##6##(2010-2#2)
isolated from traditional fermented##3##4##(2010-2#2)(2010-4#1)
isolated from two##3##3##(1990-8#1)(2008-8#1)(2011-2#1)
isolated from urine##3##3##(1991-12#1)(2007-7#2)
isolated from various##5##3##(1994-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-6#1)
isolated from wheat##2##3##(1992-8#1)(2008-9#1)
isolated from young##2##3##(1994-11#1)(1994-6#1)
isolated from##734##2##(1990-11#9)(1990-12#8)(1990-2#3)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#13)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#2)(1991-9#8)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#8)(1992-6#5)(1992-7#1)(1992-8#6)(1992-9#4)(1993-11#6)(1993-12#6)(1993-2#5)(1993-3#4)(1993-6#8)(1993-8#4)(1993-9#3)(1994-11#14)(1994-12#10)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#4)(1994-8#5)(1994-9#4)(1995-11#8)(1995-12#5)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#7)(1997-6#3)(1997-7#4)(1997-8#4)(1997-9#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#3)(2007-7#11)(2007-8#2)(2008-1#1)(2008-10#186)(2008-11#24)(2008-12#13)(2008-2#3)(2008-4#4)(2008-5#27)(2008-6#9)(2008-7#7)(2008-8#24)(2008-9#19)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-11#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2011-1#7)(2011-10#1)(2011-2#39)(2011-3#4)(2012-12#3)(2012-2#21)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#12)
isolated genomic clones of the##2##5##(1993-6#1)(1994-12#1)
isolated genomic##3##2##(1991-7#1)(1993-6#1)(1994-12#1)
isolated guinea pig##3##3##(1994-9#1)(1995-3#1)(1997-7#1)
isolated guinea-pig##2##2##(1995-12#1)(1997-7#1)
isolated hepatocytes was##3##3##(1990-11#1)(1990-8#1)(1994-8#1)
isolated hepatocytes##12##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#4)(1994-8#1)(1995-11#1)(1996-2#1)
isolated human##8##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-9#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
isolated hydronephrosis##3##2##(2008-10#3)
isolated in Guangzhou##2##3##(2013-8#2)
isolated in a##3##3##(1997-3#1)(2008-10#1)(2012-2#1)
isolated in peninsular Malaysia##2##4##(2008-12#2)
isolated in the##10##3##(1990-2#1)(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
isolated in##51##2##(1990-2#1)(1991-11#1)(1992-6#1)(1997-3#4)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#11)(2008-12#5)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
isolated islets##3##2##(2008-10#1)(2010-11#1)(2012-2#1)
isolated liver##2##2##(1995-11#1)(2013-8#1)
isolated lymphocytes##2##2##(1990-12#1)(2008-11#1)
isolated membrane##3##2##(1991-2#1)(1993-8#1)(2008-11#1)
isolated membranes##2##2##(1992-3#1)(1993-3#1)
isolated microorganisms##2##2##(1996-12#1)(2011-1#1)
isolated mitochondria##7##2##(1990-7#2)(1991-3#2)(1994-6#1)(1995-11#1)(2008-5#1)
isolated more##2##2##(1997-3#1)(2008-10#1)
isolated natural product Amavadin##2##4##(2008-10#2)
isolated neonatal##3##2##(1992-3#1)(2008-10#1)(2010-11#1)
isolated nerve terminals##2##3##(1995-11#1)(1997-7#1)
isolated nuclei##5##2##(1991-12#1)(1994-8#1)(2008-2#1)(2008-5#1)(2008-8#1)
isolated on##3##2##(1996-5#1)(2008-9#1)(2011-2#1)
isolated only from##2##3##(1992-9#1)(2008-10#1)
isolated or associated##2##3##(1996-12#1)(2011-2#1)
isolated or##6##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#2)(2011-2#1)
isolated organelles##2##2##(1994-6#1)(2008-2#1)
isolated organic matter was##2##4##(2008-10#2)
isolated over##2##2##(1996-12#1)(2008-10#1)
isolated pancreatic##3##2##(1994-11#1)(2010-1#1)(2013-1#1)
isolated patches##3##2##(2008-9#3)
isolated perfused rat liver##5##4##(1993-3#1)(1996-12#2)(1996-5#1)(2008-11#1)
isolated perfused rat pancreas##2##4##(1990-12#2)
isolated perfused rat##10##3##(1990-12#2)(1991-9#1)(1993-3#1)(1995-3#1)(1996-12#3)(1996-5#1)(2008-11#1)
isolated perfused##12##2##(1990-12#2)(1991-9#2)(1993-3#1)(1995-3#1)(1996-12#4)(1996-5#1)(2008-11#1)
isolated peripheral##2##2##(1990-12#1)(2008-9#1)
isolated phylogenetic##2##2##(2011-2#2)
isolated pituitary##3##2##(1993-5#1)(2013-1#2)
isolated populations##10##2##(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#5)(2010-8#1)
isolated power earthing during##2##4##(2012-3#2)
isolated previously##2##2##(1991-12#1)(2012-3#1)
isolated protein##3##2##(1993-8#1)(2008-2#1)(2008-4#1)
isolated proteins and##3##3##(1992-3#1)(1994-5#1)(1996-12#1)
isolated proteins##5##2##(1992-3#1)(1993-6#1)(1994-5#1)(1996-12#1)(2008-4#1)
isolated protoplasts##2##2##(1994-11#1)(1997-3#1)
isolated pulmonary##2##2##(2008-11#2)
isolated rabbit##6##2##(1990-7#1)(1991-9#1)(1992-6#1)(1995-12#3)
isolated rat heart##2##3##(1996-9#1)(2011-1#1)
isolated rat hepatocytes##9##3##(1990-5#1)(1992-3#2)(1993-3#1)(1994-6#1)(1995-11#1)(1996-2#2)(1996-5#1)
isolated rat liver mitochondria##3##4##(1990-2#1)(1994-12#1)(2013-1#1)
isolated rat liver##5##3##(1990-2#1)(1994-12#1)(1994-6#1)(1995-8#1)(2013-1#1)
isolated rat##34##2##(1990-2#1)(1990-5#1)(1991-2#2)(1991-8#1)(1992-3#5)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-2#3)(1996-5#2)(1996-9#1)(1997-1#2)(2010-12#1)(2011-1#1)(2013-1#1)
isolated relapse##3##2##(2011-2#3)
isolated retroperitoneal##2##2##(1994-6#2)
isolated right##2##2##(2008-10#1)(2011-2#1)
isolated rural##2##2##(1993-12#1)(1996-3#1)
isolated segments##2##2##(1995-12#2)
isolated several##2##2##(1991-12#1)(1992-9#1)
isolated skin relapse##2##3##(1991-4#2)
isolated species##2##2##(2007-10#1)(2010-3#1)
isolated strain##5##2##(1994-12#1)(2008-10#2)(2011-2#2)
isolated strains##5##2##(1991-3#2)(2007-10#1)(2008-12#1)(2008-5#1)
isolated system##2##2##(2008-1#1)(2008-3#1)
isolated systems##2##2##(2008-5#2)
isolated that##5##2##(1990-11#1)(1990-8#1)(1994-11#1)(2007-8#1)(2008-10#1)
isolated the##4##2##(1990-5#1)(1993-3#1)(1993-8#1)(2008-10#1)
isolated three##2##2##(1991-9#1)(2008-11#1)
isolated to##5##2##(1991-8#1)(1993-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
isolated trees##2##2##(2008-5#2)
isolated two##3##2##(1990-8#1)(1994-12#1)(1994-2#1)
isolated under##2##2##(1994-5#1)(2008-10#1)
isolated using##10##2##(1990-2#1)(1990-7#1)(1991-6#1)(1993-8#1)(1995-12#2)(1997-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
isolated were##5##2##(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)
isolated with the##2##3##(1994-11#2)
isolated with##7##2##(1992-8#1)(1994-11#2)(1994-8#1)(2008-10#1)(2011-1#2)
isolated yields##3##2##(2008-12#1)(2010-7#2)
isolated zygotes##2##2##(2009-12#2)
isolated##1831##1##(1990-11#16)(1990-12#22)(1990-2#14)(1990-3#2)(1990-5#21)(1990-6#2)(1990-7#13)(1990-8#12)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#23)(1991-2#11)(1991-3#5)(1991-4#2)(1991-5#10)(1991-6#11)(1991-7#1)(1991-8#8)(1991-9#16)(1992-10#2)(1992-11#5)(1992-12#12)(1992-2#3)(1992-3#28)(1992-4#1)(1992-5#1)(1992-6#16)(1992-7#1)(1992-8#16)(1992-9#17)(1993-1#1)(1993-11#15)(1993-12#12)(1993-2#13)(1993-3#16)(1993-5#1)(1993-6#24)(1993-8#21)(1993-9#6)(1994-11#27)(1994-12#27)(1994-2#2)(1994-3#4)(1994-5#12)(1994-6#22)(1994-8#20)(1994-9#7)(1995-11#21)(1995-12#19)(1995-2#15)(1995-3#12)(1995-5#8)(1995-6#8)(1995-8#13)(1995-9#2)(1996-10#7)(1996-11#1)(1996-12#16)(1996-2#10)(1996-3#3)(1996-5#11)(1996-6#5)(1996-8#1)(1996-9#3)(1997-1#6)(1997-2#7)(1997-3#16)(1997-4#15)(1997-5#2)(1997-6#7)(1997-7#13)(1997-8#9)(1997-9#2)(2006-10#1)(2007-1#1)(2007-10#13)(2007-11#8)(2007-12#4)(2007-6#3)(2007-7#21)(2007-8#19)(2008-1#8)(2008-10#298)(2008-11#72)(2008-12#35)(2008-2#11)(2008-3#9)(2008-4#18)(2008-5#75)(2008-6#17)(2008-7#21)(2008-8#63)(2008-9#51)(2009-10#5)(2009-11#4)(2009-12#9)(2009-2#4)(2009-3#3)(2009-5#6)(2009-6#5)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#8)(2010-12#4)(2010-2#7)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#5)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#26)(2011-10#1)(2011-2#71)(2011-3#5)(2012-1#1)(2012-12#6)(2012-2#35)(2012-3#17)(2013-1#37)(2013-7#3)(2013-8#30)
isolates (besides##2##2##(2008-10#2)
isolates (n =##3##3##(2008-10#3)
isolates Pti2##2##2##(2008-10#2)
isolates after##3##2##(2008-10#3)
isolates against##2##2##(2008-10#1)(2008-12#1)
isolates all were##2##3##(2008-10#2)
isolates all##3##2##(2008-10#2)(2008-8#1)
isolates also were tested for##3##5##(2008-10#3)
isolates also were##7##3##(2008-10#7)
isolates also##10##2##(2008-10#10)
isolates among##2##2##(2008-10#2)
isolates analyzed##4##2##(2008-10#4)
isolates and a##3##3##(2008-10#2)(2008-5#1)
isolates and also##2##3##(2008-10#1)(2008-7#1)
isolates and isolates from##2##4##(2008-10#2)
isolates and isolates##3##3##(2008-10#3)
isolates and the##6##3##(2008-10#6)
isolates and were not##2##4##(2008-10#2)
isolates and##65##2##(2007-6#1)(2008-10#53)(2008-12#2)(2008-5#3)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
isolates appeared##2##2##(2008-10#2)
isolates are##12##2##(2008-10#12)
isolates as C##4##3##(2008-10#4)
isolates as##16##2##(1997-4#1)(2008-10#13)(2008-11#1)(2012-2#1)
isolates associated with##2##3##(2008-10#2)
isolates at##4##2##(2008-10#3)(2011-1#1)
isolates averaged##2##2##(2008-10#2)
isolates based on##5##3##(2008-10#5)
isolates being##2##2##(2008-10#2)
isolates belonged to the same##2##5##(2008-10#1)(2008-12#1)
isolates belonged to##9##3##(2008-10#7)(2008-12#1)(2008-9#1)
isolates belonging to NA-VCG2 and NA-VCG5##2##6##(2008-10#2)
isolates belonging to race##2##4##(2008-10#2)
isolates belonging to the##6##4##(2008-10#5)(2010-6#1)
isolates belonging to three##2##4##(2008-10#1)(2010-10#1)
isolates belonging to##19##3##(1996-12#1)(2008-10#16)(2010-10#1)(2010-6#1)
isolates between##3##2##(2008-10#3)
isolates but also##3##3##(2008-10#3)
isolates but##5##2##(2008-10#5)
isolates by##4##2##(1995-12#1)(1997-6#1)(2008-10#2)
isolates came from##2##3##(2008-10#2)
isolates can be##2##3##(2008-10#2)
isolates can##4##2##(2008-10#3)(2011-2#1)
isolates capable of causing##2##4##(2008-10#2)
isolates caused##4##2##(2008-10#4)
isolates causing##4##2##(2007-12#1)(2008-10#3)
isolates classified##3##2##(2008-10#3)
isolates clustered into##2##3##(2008-10#2)
isolates clustered together##3##3##(2008-10#3)
isolates clustered##9##2##(2008-10#9)
isolates collected during##4##3##(2008-10#4)
isolates collected from Australian cereal growing regions##2##7##(2008-10#2)
isolates collected from durum wheat##2##5##(2008-10#2)
isolates collected from one##2##4##(2008-10#2)
isolates collected from potato##3##4##(2008-10#3)
isolates collected from the##2##4##(2008-10#2)
isolates collected from##31##3##(2008-10#31)
isolates collected in##10##3##(2008-10#9)(2011-1#1)
isolates collected##49##2##(2008-10#47)(2011-1#1)(2012-3#1)
isolates common to##2##3##(2008-10#2)
isolates compared##2##2##(2008-10#2)
isolates confirmed##2##2##(2008-10#2)
isolates contained##6##2##(1997-3#1)(2008-10#5)
isolates could be##10##3##(1997-6#1)(2008-10#7)(2008-5#1)(2012-3#1)
isolates could not be##3##4##(2008-10#3)
isolates could##13##2##(1997-6#1)(2008-10#10)(2008-5#1)(2012-3#1)
isolates demonstrated##2##2##(2008-10#2)
isolates derived from the same##2##5##(2008-10#2)
isolates derived from the##3##4##(2008-10#3)
isolates derived from##7##3##(2008-10#7)
isolates did not produce##2##4##(2008-10#2)
isolates did not##8##3##(2008-10#8)
isolates differed##3##2##(2008-10#3)
isolates displayed##2##2##(2008-10#2)
isolates do not##2##3##(2008-10#2)
isolates during##2##2##(2008-10#1)(2008-5#1)
isolates each##2##2##(2008-10#2)
isolates evaluated##2##2##(2008-10#2)
isolates examined##5##2##(2008-10#4)(2008-5#1)
isolates exhibited##2##2##(2008-10#2)
isolates exhibiting##2##2##(2008-10#1)(2013-8#1)
isolates for##11##2##(2008-10#10)(2008-7#1)
isolates formed a##2##3##(2008-10#2)
isolates formed##6##2##(2008-10#6)
isolates from 15##2##3##(2008-10#2)
isolates from 2003##2##3##(2008-10#2)
isolates from Africa and##2##4##(2008-10#2)
isolates from Africa##5##3##(2008-10#5)
isolates from California were##2##4##(2008-10#2)
isolates from California##4##3##(2008-10#4)
isolates from Dermacentor marginatus##2##4##(1995-12#2)
isolates from East Azarbaijan province##2##5##(2008-12#2)
isolates from Ethiopia##3##3##(2008-10#3)
isolates from Europe##3##3##(2008-10#3)
isolates from Israel##4##3##(2008-10#4)
isolates from Japan belonged to lineage##2##6##(2008-10#2)
isolates from MIN##2##3##(2008-10#2)
isolates from Malus##2##3##(2008-10#2)
isolates from North America##2##4##(2008-10#2)
isolates from North##3##3##(2008-10#3)
isolates from Ontario##2##3##(2008-10#2)
isolates from South America and##2##5##(2008-10#2)
isolates from Spain##2##3##(2008-10#2)
isolates from a##9##3##(2008-10#7)(2010-10#1)(2011-2#1)
isolates from all##2##3##(2008-10#2)
isolates from almond##4##3##(2008-10#4)
isolates from artichoke##6##3##(2008-10#6)
isolates from bell pepper##2##4##(2008-10#2)
isolates from cacao##2##3##(2008-10#2)
isolates from coffee##3##3##(2008-10#3)
isolates from common wheat##2##4##(2008-10#2)
isolates from cotton##2##3##(2008-10#2)
isolates from cruciferous##2##3##(2008-10#2)
isolates from different geographical##2##4##(2008-10#1)(2011-2#1)
isolates from different hosts##2##4##(2008-10#2)
isolates from different##12##3##(1997-6#1)(2008-10#10)(2011-2#1)
isolates from durum wheat##4##4##(2008-10#4)
isolates from each host##2##4##(2008-10#2)
isolates from each##8##3##(2008-10#8)
isolates from forage legumes##2##4##(2008-10#2)
isolates from four different##2##4##(2008-10#2)
isolates from four##3##3##(2008-10#2)(2009-5#1)
isolates from grass pea##2##4##(2011-2#2)
isolates from infected##2##3##(2008-10#2)
isolates from native##2##3##(2008-10#2)
isolates from ornamental asparagus##2##4##(2008-10#2)
isolates from other hosts##3##4##(2008-10#3)
isolates from other##6##3##(2008-10#6)
isolates from patients with##3##4##(1992-2#2)(2007-7#1)
isolates from prg##2##3##(2008-10#2)
isolates from rice and##2##4##(2008-10#2)
isolates from rice##3##3##(2008-10#3)
isolates from seven field populations##2##5##(2008-10#2)
isolates from soybean##2##3##(2008-10#2)
isolates from strawberry##2##3##(2008-10#2)
isolates from the United States and##2##6##(2008-10#2)
isolates from the United States were##2##6##(2008-10#2)
isolates from the United States##10##5##(2008-10#10)
isolates from the same##2##4##(2008-10#2)
isolates from the wild##2##4##(2008-10#2)
isolates from the##31##3##(1992-5#1)(2008-10#27)(2008-5#2)(2012-12#1)
isolates from three##2##3##(2008-10#2)
isolates from tomato##3##3##(2008-10#3)
isolates from various hosts and##2##5##(2008-10#2)
isolates from various##3##3##(2008-10#3)
isolates from wheat##3##3##(2008-10#3)
isolates from wild##2##3##(2008-10#2)
isolates from##292##2##(1991-8#3)(1992-2#2)(1992-5#1)(1995-12#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#2)(2007-12#2)(2007-6#1)(2007-7#2)(2008-10#249)(2008-12#2)(2008-4#1)(2008-5#5)(2008-9#1)(2009-5#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#1)(2013-8#1)
isolates grouped##7##2##(2008-10#6)(2012-3#1)
isolates had a##3##3##(1992-2#1)(1997-8#1)(2008-10#1)
isolates had the##2##3##(2008-10#2)
isolates had##16##2##(1992-2#1)(1997-8#1)(2007-6#1)(2008-10#12)(2008-5#1)
isolates harboured##2##2##(2011-2#2)
isolates has been##3##3##(1997-6#1)(2008-10#2)
isolates has##4##2##(1996-12#1)(1997-6#1)(2008-10#2)
isolates have a##2##3##(2008-10#2)
isolates have also been##2##4##(1995-5#1)(2008-10#1)
isolates have been##3##3##(2007-12#2)(2008-10#1)
isolates have##10##2##(1995-5#1)(2007-12#2)(2008-10#4)(2008-12#3)
isolates having##2##2##(2008-10#2)
isolates highly##2##2##(2008-10#2)
isolates identical##3##2##(2008-10#3)
isolates identified as##3##3##(2008-10#3)
isolates identified##5##2##(2008-10#4)(2011-2#1)
isolates in RG##2##3##(2008-10#2)
isolates in VCG##6##3##(2008-10#6)
isolates in each##4##3##(1991-8#2)(2008-10#2)
isolates in lineages##3##3##(2008-10#3)
isolates in the collection##2##4##(2008-10#1)(2008-5#1)
isolates in the inoculated plots##2##5##(2008-10#2)
isolates in the same AG##2##5##(2008-10#2)
isolates in the same##3##4##(2008-10#3)
isolates in the##17##3##(2008-10#16)(2008-5#1)
isolates in these##2##3##(2008-10#2)
isolates in##61##2##(1990-6#1)(1991-8#2)(2007-7#2)(2007-8#1)(2008-10#50)(2008-12#2)(2008-5#1)(2011-1#1)(2012-3#1)
isolates included##5##2##(2008-10#4)(2008-12#1)
isolates increased##2##2##(2008-10#2)
isolates indicated that they##2##4##(2008-10#2)
isolates induced##2##2##(2008-10#2)
isolates infected##2##2##(2008-10#2)
isolates into four##2##3##(2008-10#2)
isolates into three##2##3##(2008-10#2)
isolates into##13##2##(2008-10#12)(2008-5#1)
isolates is##4##2##(2007-12#1)(2008-10#3)
isolates may be##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
isolates may have##2##3##(2007-12#1)(2008-10#1)
isolates may##9##2##(2007-12#1)(2008-10#6)(2008-5#1)(2012-2#1)
isolates obtained from the##3##4##(2007-6#1)(2008-10#1)(2011-2#1)
isolates obtained from##13##3##(2007-6#1)(2007-7#1)(2008-10#9)(2011-2#2)
isolates obtained in##2##3##(2008-10#2)
isolates obtained##18##2##(1997-3#1)(2007-6#1)(2007-7#1)(2008-10#12)(2008-5#1)(2011-2#2)
isolates of A##10##3##(1996-12#1)(2008-10#8)(2013-1#1)
isolates of AG-12##3##3##(2008-10#3)
isolates of AG-13 were##2##4##(2008-10#2)
isolates of AG-13##4##3##(2008-10#4)
isolates of ARF18##3##3##(2008-10#3)
isolates of Alternaria alternata##2##4##(2008-10#2)
isolates of Aphanomyces euteiches##2##4##(2008-10#2)
isolates of B##7##3##(2008-10#5)(2008-12#1)(2008-6#1)
isolates of Bipolaris##2##3##(2008-10#2)
isolates of C##31##3##(2008-10#28)(2008-5#2)(2013-1#1)
isolates of Cercospora kikuchii##2##4##(2008-10#2)
isolates of Colletotrichum##3##3##(2008-10#3)
isolates of D##3##3##(1991-8#1)(2008-10#2)
isolates of E##2##3##(2007-7#1)(2012-2#1)
isolates of Escherichia coli##2##4##(1996-12#1)(2012-3#1)
isolates of F##24##3##(2008-10#24)
isolates of Fusarium oxysporum f##3##5##(2008-10#3)
isolates of Fusarium oxysporum##5##4##(2008-10#5)
isolates of Fusarium spp##2##4##(2008-10#2)
isolates of Fusarium##10##3##(2008-10#10)
isolates of G##10##3##(2008-10#10)
isolates of H##3##3##(1995-2#1)(1997-3#1)(2008-10#1)
isolates of Haemophilus paragallinarum from##2##5##(1997-3#2)
isolates of L##4##3##(2008-10#3)(2008-5#1)
isolates of M##10##3##(2008-10#9)(2008-6#1)
isolates of Mycosphaerella graminicola##4##4##(2008-10#4)
isolates of P##28##3##(2008-10#27)(2012-3#1)
isolates of Phytophthora infestans collected from##2##6##(2008-10#2)
isolates of Phytophthora infestans##6##4##(2008-10#6)
isolates of Phytophthora##9##3##(2008-10#9)
isolates of Plum pox virus (PPV)##2##6##(2008-10#2)
isolates of Puccinia triticina##2##4##(2008-10#2)
isolates of Puccinia##4##3##(2008-10#4)
isolates of Pyricularia grisea##2##4##(2008-10#2)
isolates of Pyricularia##3##3##(2008-10#3)
isolates of Pythium##2##3##(2008-10#2)
isolates of R##8##3##(2008-10#8)
isolates of Rhizoctonia##2##3##(2008-10#1)(2008-12#1)
isolates of S##6##3##(2007-12#1)(2008-10#3)(2011-2#1)(2012-3#1)
isolates of SYSV##2##3##(2008-10#2)
isolates of Salmonella##2##3##(2008-8#1)(2013-8#1)
isolates of Sclerotinia##3##3##(2008-10#3)
isolates of T##7##3##(2008-10#7)
isolates of US-8##2##3##(2008-10#2)
isolates of Ustilago##2##3##(2008-10#2)
isolates of V##12##3##(2008-10#12)
isolates of VCG1A##3##3##(2008-10#3)
isolates of Verticillium spp##2##4##(2008-10#2)
isolates of Verticillium##5##3##(2008-10#5)
isolates of Xanthomonas##2##3##(2008-10#1)(2008-9#1)
isolates of a##7##3##(2008-10#6)(2008-9#1)
isolates of all##2##3##(2008-10#2)
isolates of both##5##3##(2008-10#3)(2008-12#1)(2012-2#1)
isolates of different##3##3##(2008-10#2)(2008-5#1)
isolates of each of##2##4##(2008-10#2)
isolates of each##5##3##(2008-10#5)
isolates of either##4##3##(2008-10#4)
isolates of group##2##3##(2008-10#2)
isolates of morphotype A##5##4##(2008-10#5)
isolates of nonpathogenic Fusarium##2##4##(2008-10#2)
isolates of nonpathogenic##4##3##(2008-10#4)
isolates of other##3##3##(2008-10#3)
isolates of potato##2##3##(2008-10#2)
isolates of race 1##2##4##(2008-10#2)
isolates of race##4##3##(2008-10#4)
isolates of races##3##3##(2008-10#3)
isolates of the A##2##4##(2008-10#2)
isolates of the most##2##4##(2008-10#2)
isolates of the other##2##4##(2008-10#2)
isolates of the pathogen collected in##2##6##(2008-10#2)
isolates of the pathogen##4##4##(2008-10#4)
isolates of the same##4##4##(2008-10#4)
isolates of the##39##3##(1995-12#1)(1995-8#1)(2008-10#36)(2013-8#1)
isolates of this##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
isolates of three##2##3##(2008-10#2)
isolates of##454##2##(1990-6#1)(1991-8#2)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#4)(1997-3#3)(1997-6#3)(1997-8#1)(2007-12#1)(2007-6#2)(2007-7#4)(2008-10#374)(2008-12#11)(2008-5#12)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#2)
isolates on the basis of##2##5##(2008-10#2)
isolates on the##3##3##(2008-10#3)
isolates on##12##2##(2008-10#10)(2008-5#1)(2008-6#1)
isolates or##5##2##(2008-10#5)
isolates originated from##4##3##(2008-10#4)
isolates originating from##6##3##(2007-6#1)(2008-10#5)
isolates parasitic on##2##3##(2008-10#2)
isolates parasitized##5##2##(2008-10#5)
isolates pathogenic to##3##3##(2008-10#3)
isolates possessing##2##2##(2008-10#2)
isolates produced a##2##3##(2008-10#2)
isolates produced##16##2##(2008-10#16)
isolates proved##2##2##(2008-5#1)(2008-7#1)
isolates reacting##2##2##(2008-10#2)
isolates recovered from diseased##2##4##(2008-10#2)
isolates recovered from noncultivated hosts##2##5##(2008-10#2)
isolates recovered from the##2##4##(2008-10#2)
isolates recovered from##12##3##(2008-10#12)
isolates recovered##15##2##(2008-10#15)
isolates recovered)##3##2##(2008-10#3)
isolates referred to##2##3##(2008-10#2)
isolates represent##3##2##(2008-10#3)
isolates representative of the##2##4##(2008-10#2)
isolates representative of##3##3##(2008-10#3)
isolates representing the##2##3##(2008-10#2)
isolates representing##10##2##(2008-10#10)
isolates resistant to##4##3##(1995-3#1)(2008-10#3)
isolates revealed a##2##3##(2008-10#2)
isolates revealed that the##3##4##(2008-10#2)(2011-2#1)
isolates revealed that##6##3##(2008-10#4)(2011-1#1)(2011-2#1)
isolates revealed two##2##3##(1997-7#1)(2008-10#1)
isolates revealed##12##2##(1997-7#1)(2008-10#9)(2011-1#1)(2011-2#1)
isolates sampled from different##3##4##(2008-10#3)
isolates sampled from##11##3##(2008-10#11)
isolates sampled##16##2##(2007-6#1)(2008-10#15)
isolates showed a##5##3##(2008-10#3)(2010-4#1)(2011-1#1)
isolates showed greater##2##3##(2008-10#2)
isolates showed that##2##3##(2008-10#2)
isolates showed##17##2##(2007-12#1)(2007-6#1)(2008-10#10)(2008-5#2)(2010-4#1)(2011-1#1)(2012-3#1)
isolates showing##3##2##(2008-10#3)
isolates studied##5##2##(2008-10#5)
isolates tested in this study##2##5##(2008-10#1)(2008-12#1)
isolates tested in##5##3##(2008-10#4)(2008-12#1)
isolates tested were##5##3##(1992-6#1)(2008-10#3)(2008-5#1)
isolates tested##29##2##(1991-8#1)(1992-6#1)(2008-10#25)(2008-12#1)(2008-5#1)
isolates than##6##2##(1997-3#1)(2008-10#5)
isolates that can##2##3##(2008-10#2)
isolates that did not belong to any of the##2##9##(2008-10#2)
isolates that express the##2##4##(2008-10#2)
isolates that had##2##3##(2008-10#2)
isolates that were identified as##2##5##(2008-10#1)(2013-8#1)
isolates that were##10##3##(2008-10#9)(2013-8#1)
isolates that##36##2##(2008-10#33)(2010-10#1)(2011-1#1)(2013-8#1)
isolates to species##2##3##(2008-10#2)
isolates to their##2##3##(2008-10#2)
isolates to various##2##3##(2008-10#1)(2011-1#1)
isolates to##18##2##(2007-12#1)(2008-10#16)(2011-1#1)
isolates used in this study##2##5##(1997-8#1)(2008-12#1)
isolates used in##3##3##(1997-8#1)(2008-10#1)(2008-12#1)
isolates used##4##2##(1997-8#1)(2008-10#2)(2008-12#1)
isolates using##7##2##(1995-12#1)(1997-6#1)(2008-10#3)(2008-12#1)(2011-1#1)
isolates was assessed##2##3##(2008-10#2)
isolates was confirmed by##2##4##(2008-10#2)
isolates was determined by##2##4##(2008-10#1)(2012-3#1)
isolates was determined##5##3##(2007-6#1)(2008-10#3)(2012-3#1)
isolates was examined##2##3##(2008-10#1)(2008-5#1)
isolates was studied by##2##4##(2007-7#1)(2008-10#1)
isolates was studied##3##3##(2007-7#1)(2008-10#2)
isolates was tested##2##3##(2008-10#2)
isolates was##39##2##(2007-6#1)(2007-7#1)(2008-10#34)(2008-5#2)(2012-3#1)
isolates were able to##7##4##(2008-10#4)(2008-6#1)(2011-2#2)
isolates were also##4##3##(2008-10#2)(2008-5#1)(2013-7#1)
isolates were amplified##2##3##(2008-10#1)(2013-8#1)
isolates were analyzed for##2##4##(2008-10#2)
isolates were analyzed##3##3##(2008-10#3)
isolates were associated with##2##4##(2008-10#1)(2010-4#1)
isolates were characterized by##5##4##(2008-10#5)
isolates were characterized##8##3##(2008-10#7)(2013-7#1)
isolates were classified into##2##4##(2008-10#2)
isolates were collected from##4##4##(2008-10#4)
isolates were collected##6##3##(2008-10#6)
isolates were compared##2##3##(1997-4#1)(2008-12#1)
isolates were consistently##2##3##(2008-10#2)
isolates were detected##3##3##(1997-4#1)(2008-10#2)
isolates were determined##7##3##(2008-10#6)(2008-9#1)
isolates were distinct##2##3##(2008-10#2)
isolates were distinguished##2##3##(2008-10#2)
isolates were divided into two groups##2##6##(2008-10#2)
isolates were divided into two##3##5##(2008-10#3)
isolates were divided into##4##4##(2008-10#4)
isolates were evaluated on##2##4##(2008-10#2)
isolates were evaluated##4##3##(2008-10#4)
isolates were examined##4##3##(2008-10#3)(2012-2#1)
isolates were found in##2##4##(2008-10#2)
isolates were found to be##2##5##(2008-10#1)(2010-8#1)
isolates were found##7##3##(2007-7#1)(2008-10#4)(2008-5#1)(2010-8#1)
isolates were from##2##3##(2008-10#2)
isolates were grouped##2##3##(2008-10#2)
isolates were identical##2##3##(2008-10#1)(2012-3#1)
isolates were identified as T##2##5##(2008-10#2)
isolates were identified as##8##4##(2008-10#7)(2008-5#1)
isolates were identified by##3##4##(2007-7#1)(2008-10#1)(2013-8#1)
isolates were identified##17##3##(2007-7#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-8#1)
isolates were inoculated##4##3##(2008-10#4)
isolates were isolated##2##3##(2007-12#1)(2008-6#1)
isolates were less##2##3##(2008-10#2)
isolates were more closely related to##2##6##(2008-10#2)
isolates were more##4##3##(2008-10#4)
isolates were nonpathogenic on##2##4##(2008-10#2)
isolates were nonpathogenic##5##3##(2008-10#5)
isolates were not significantly more pathogenic on##2##7##(2008-10#2)
isolates were not##4##3##(2008-10#4)
isolates were obtained from##2##4##(2007-7#1)(2008-10#1)
isolates were obtained##5##3##(2007-7#1)(2008-10#1)(2008-5#2)(2011-2#1)
isolates were pathogenic on##5##4##(2008-10#5)
isolates were pathogenic to##2##4##(2008-10#2)
isolates were pathogenic##7##3##(2008-10#7)
isolates were recovered from diseased##2##5##(2008-10#2)
isolates were recovered from##5##4##(2008-10#5)
isolates were recovered##8##3##(2008-10#7)(2012-2#1)
isolates were represented by##2##4##(2008-10#2)
isolates were resistant to both##2##5##(2008-10#2)
isolates were resistant to fluconazole##2##5##(2008-5#2)
isolates were resistant to##10##4##(2007-7#1)(2008-10#2)(2008-5#3)(2011-2#1)(2012-3#1)(2013-8#2)
isolates were resistant##12##3##(2007-7#1)(2008-10#3)(2008-5#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
isolates were sampled from##2##4##(2008-10#2)
isolates were sampled##3##3##(2008-10#3)
isolates were screened for##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
isolates were screened##4##3##(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
isolates were selected from##2##4##(2008-10#1)(2013-8#1)
isolates were selected##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
isolates were sensitive to##2##4##(2008-10#1)(2008-12#1)
isolates were shown##2##3##(2008-10#2)
isolates were similar##2##3##(1997-8#1)(2011-2#1)
isolates were subjected to##3##4##(2008-10#2)(2008-12#1)
isolates were tested for antimicrobial##2##5##(2007-8#1)(2009-10#1)
isolates were tested for pathogenicity on##2##6##(2008-10#2)
isolates were tested for##4##4##(2007-8#1)(2008-10#2)(2009-10#1)
isolates were tested##7##3##(2007-8#1)(2008-10#5)(2009-10#1)
isolates were the##5##3##(1991-8#1)(2008-10#4)
isolates were used##3##3##(2008-10#2)(2008-11#1)
isolates were vegetatively self-incompatible##2##4##(2008-10#2)
isolates were vegetatively##3##3##(2008-10#3)
isolates were very##2##3##(2008-10#2)
isolates were##271##2##(1991-8#2)(1996-12#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-12#4)(2007-6#1)(2007-7#6)(2007-8#1)(2008-10#188)(2008-11#1)(2008-12#6)(2008-5#16)(2008-6#4)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2010-4#2)(2010-8#3)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#2)(2013-8#5)
isolates when##2##2##(1997-3#1)(2008-10#1)
isolates which##3##2##(2008-12#2)(2008-5#1)
isolates with##18##2##(2007-7#1)(2007-8#1)(2008-10#16)
isolates within a##5##3##(2008-10#5)
isolates within each##2##3##(2008-10#2)
isolates within populations##2##3##(2008-10#2)
isolates within the species C##2##5##(2008-10#2)
isolates within the##5##3##(2008-10#5)
isolates within##20##2##(2008-10#20)
isolates would##2##2##(2008-10#1)(2008-5#1)
isolates##2468##1##(1990-6#2)(1991-3#3)(1991-8#11)(1992-2#4)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#8)(1996-8#1)(1997-2#1)(1997-3#14)(1997-4#4)(1997-6#11)(1997-7#1)(1997-8#7)(2007-12#15)(2007-6#14)(2007-7#24)(2007-8#4)(2008-1#1)(2008-10#2026)(2008-11#2)(2008-12#41)(2008-4#3)(2008-5#78)(2008-6#10)(2008-7#10)(2008-8#4)(2008-9#9)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-10#7)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-6#1)(2010-8#6)(2011-1#19)(2011-2#39)(2012-12#3)(2012-2#17)(2012-3#16)(2013-1#6)(2013-7#2)(2013-8#13)
isolates) and##4##2##(2008-10#4)
isolates) showed##2##2##(2008-10#2)
isolates) were##3##2##(2008-10#3)
isolates)##34##1##(2008-10#33)(2008-5#1)
isolating a##2##2##(1994-1#1)(1994-11#1)
isolating and##2##2##(2008-10#1)(2008-4#1)
isolating barriers##2##2##(2008-10#1)(2012-3#1)
isolating mechanism##2##2##(2008-8#2)
isolating mechanisms##2##2##(2009-2#1)(2012-3#1)
isolating specific##2##2##(1994-12#1)(1996-12#1)
isolating the##10##2##(1996-6#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#1)(2011-2#1)
isolating##55##1##(1990-5#1)(1990-7#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#11)(2008-2#4)(2008-4#10)(2008-5#1)(2008-8#3)(2008-9#6)(2009-2#1)(2011-2#1)(2012-3#2)(2013-1#1)
isolation after a founder event##2##5##(2008-9#2)
isolation among##2##2##(2008-9#1)(2009-2#1)
isolation and a##2##3##(2008-10#1)(2011-2#1)
isolation and characterization of a##6##5##(1990-12#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-11#1)
isolation and characterization of the##2##5##(1992-8#1)(1993-5#1)
isolation and characterization of##11##4##(1990-12#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-11#1)(1995-8#1)(2008-4#1)
isolation and characterization##15##3##(1990-12#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-11#1)(1995-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)
isolation and identification of##4##4##(1991-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
isolation and preconcentration of##2##4##(2008-10#2)
isolation and purification of##4##4##(2008-10#2)(2008-11#1)(2011-1#1)
isolation and purification##8##3##(2008-10#5)(2008-11#1)(2011-1#1)(2011-3#1)
isolation and sequencing of##3##4##(1991-6#1)(1994-11#1)(1997-7#1)
isolation and##76##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#18)(2008-11#6)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#4)(2009-2#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
isolation between Aquilegia formosa and Aquilegia pubescens##2##7##(2008-8#2)
isolation between populations##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
isolation between species##2##3##(2008-8#1)(2008-9#1)
isolation between the##2##3##(2008-8#1)(2008-9#1)
isolation between##12##2##(2008-10#1)(2008-5#1)(2008-8#5)(2008-9#4)(2012-3#1)
isolation but##2##2##(2009-5#1)(2011-2#1)
isolation by distance (IBD)##2##4##(2008-9#1)(2013-1#1)
isolation by distance##9##3##(2008-10#2)(2008-9#2)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
isolation by##11##2##(2006-12#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
isolation calling response##2##3##(2008-4#2)
isolation for##3##2##(2008-10#2)(2008-4#1)
isolation from interfering##2##3##(2008-3#2)
isolation from the##2##3##(1996-12#1)(2008-11#1)
isolation from##17##2##(1996-12#3)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-9#1)(2010-11#1)(2012-2#1)
isolation in##8##2##(1991-2#1)(1993-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)
isolation is##10##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#3)
isolation may##2##2##(2008-10#1)(2008-12#1)
isolation method##2##2##(2008-10#1)(2008-4#1)
isolation methods##3##2##(2008-10#2)(2010-10#1)
isolation of Cryptococcus neoformans##2##4##(2008-5#2)
isolation of Helicobacter pylori##2##4##(2008-12#2)
isolation of P##3##3##(2008-10#3)
isolation of a cDNA clone##2##5##(1990-12#1)(1994-8#1)
isolation of a cDNA##4##4##(1990-12#1)(1994-11#1)(1994-8#1)(1995-2#1)
isolation of a##16##3##(1990-12#1)(1990-9#1)(1994-11#2)(1994-8#3)(1995-12#1)(1995-2#1)(1996-6#2)(2008-11#2)(2008-8#1)(2009-10#1)(2011-1#1)
isolation of an##2##3##(1990-7#1)(2011-2#1)
isolation of differentially expressed##2##4##(2008-2#1)(2008-7#1)
isolation of highly##2##3##(2008-10#2)
isolation of human##3##3##(2008-9#2)(2010-12#1)
isolation of influenza##2##3##(1994-9#1)(2008-9#1)
isolation of other##2##3##(2008-11#1)(2008-8#1)
isolation of proteins##2##3##(1990-5#1)(2008-9#1)
isolation of rhein from##2##4##(2010-3#2)
isolation of rhein##4##3##(2010-3#4)
isolation of specific##2##3##(1997-4#1)(2008-11#1)
isolation of the analyte##2##4##(2008-10#1)(2009-8#1)
isolation of the compounds##2##4##(2008-10#1)(2008-12#1)
isolation of the##33##3##(1990-5#1)(1991-11#1)(1991-2#1)(1993-5#1)(1993-9#1)(1994-12#2)(1996-12#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#1)(2009-7#2)(2009-8#1)(2011-2#1)
isolation of these##3##3##(2008-11#1)(2008-4#1)(2013-7#1)
isolation of this##2##3##(1991-2#1)(2008-5#1)
isolation of trypsin##2##3##(2008-7#2)
isolation of two##5##3##(1990-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)
isolation of various##3##3##(2008-10#1)(2008-2#1)(2010-11#1)
isolation of##197##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#29)(2008-11#13)(2008-12#8)(2008-2#9)(2008-3#4)(2008-4#11)(2008-5#7)(2008-7#4)(2008-8#4)(2008-9#13)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2011-1#4)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
isolation on the##2##3##(2007-7#1)(2008-8#1)
isolation on##5##2##(2007-7#2)(2008-11#1)(2008-8#2)
isolation or##4##2##(1994-6#1)(2010-5#1)(2011-2#2)
isolation procedure is##3##3##(1994-5#1)(2008-11#2)
isolation procedure##7##2##(1992-11#1)(1994-5#1)(2008-11#3)(2010-3#2)
isolation procedures##6##2##(2008-1#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
isolation rate and##2##3##(2007-7#1)(2012-3#1)
isolation rate of Campylobacter##2##4##(2008-10#2)
isolation rate of##3##3##(2008-10#2)(2008-12#1)
isolation rate##7##2##(1991-8#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2012-3#1)
isolation techniques##3##2##(2008-10#3)
isolation to##5##2##(1992-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
isolation using##2##2##(2008-4#1)(2008-9#1)
isolation was not##2##3##(2008-12#1)(2013-1#1)
isolation was performed##2##3##(2008-11#1)(2013-8#1)
isolation was##7##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
isolation##522##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-5#3)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#4)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#6)(1996-2#1)(1996-5#1)(1996-6#5)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#5)(2007-12#2)(2007-2#3)(2007-7#9)(2007-8#4)(2008-1#12)(2008-10#81)(2008-11#47)(2008-12#12)(2008-2#14)(2008-3#14)(2008-4#27)(2008-5#16)(2008-6#2)(2008-7#10)(2008-8#31)(2008-9#44)(2009-10#2)(2009-12#4)(2009-2#4)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#17)(2011-3#1)(2011-7#1)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#5)
isolations and##2##2##(2008-10#1)(2012-2#1)
isolations of##5##2##(1992-8#1)(2007-10#2)(2008-10#1)(2009-12#1)
isolations were##2##2##(1997-6#1)(2008-10#1)
isolations##12##1##(1992-6#1)(1992-8#1)(1997-6#1)(2007-10#2)(2008-10#5)(2009-12#1)(2012-2#1)
isolator##12##1##(2007-6#1)(2008-3#9)(2012-2#2)
isolators##3##1##(2007-6#1)(2008-3#1)(2012-2#1)
isolectin##4##1##(1990-7#2)(1993-8#1)(1997-2#1)
isolegs##3##1##(2008-8#3)
isoleucine and valine##3##3##(1995-11#3)
isoleucine residue##2##2##(2008-10#1)(2013-8#1)
isoleucine##22##1##(1990-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-11#6)(2008-10#7)(2008-11#1)(2010-6#1)(2013-8#1)
isoleucyl##2##1##(1990-2#1)(1993-6#1)
isoline##5##1##(2008-10#2)(2011-2#3)
isolines of##2##2##(2008-10#2)
isolines##8##1##(2008-10#8)
isomenthone##2##1##(2008-10#2)
isomer is##5##2##(1992-4#1)(1993-8#1)(1994-5#1)(1996-2#1)(2007-12#1)
isomer of the##2##3##(1991-5#1)(2008-9#1)
isomer of##8##2##(1990-12#1)(1991-5#1)(1993-1#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-2#1)
isomer while this##2##3##(2012-12#2)
isomer with##2##2##(1996-2#1)(2008-10#1)
isomer##42##1##(1990-12#1)(1990-7#1)(1991-5#5)(1992-4#2)(1992-8#3)(1993-1#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-2#1)(1995-3#1)(1996-2#3)(1996-5#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-2#4)(2012-12#3)(2012-2#1)
isomerase activity##2##2##(1990-9#1)(1993-6#1)
isomerase and##6##2##(2008-10#5)(2010-10#1)
isomerase gene##5##2##(1990-11#1)(1990-7#2)(1997-8#1)(2012-3#1)
isomerase##34##1##(1990-11#2)(1990-7#3)(1990-9#1)(1993-6#6)(1993-8#1)(1995-3#2)(1997-6#2)(1997-8#1)(2008-10#9)(2008-7#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
isomeric end-labeled -SH deoxyoligonucleotides on##2##5##(2008-10#2)
isomeric ethyl##2##2##(2008-10#2)
isomeric glycosylfructoses##2##2##(1992-12#2)
isomeric##22##1##(1990-8#1)(1991-9#1)(1992-12#3)(1994-5#2)(1996-2#1)(1996-5#3)(2008-10#11)
isomerically pure##2##2##(1996-2#2)
isomerically##3##1##(1996-2#2)(2010-5#1)
isomerisation effects on##2##3##(2008-10#2)
isomerisation##3##1##(1990-3#1)(2008-10#2)
isomerised##2##1##(2008-11#1)(2012-1#1)
isomerization of the##2##3##(1992-6#2)
isomerization of##4##2##(1992-6#2)(1993-11#1)(2007-12#1)
isomerization reaction##3##2##(1992-6#3)
isomerization##19##1##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#6)(1993-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-2#2)
isomerized C*I##3##2##(1992-6#3)
isomerized to##2##2##(1995-6#1)(2011-1#1)
isomerized##6##1##(1992-6#3)(1995-6#1)(2007-11#1)(2011-1#1)
isomerizes to##2##2##(1992-6#1)(2008-10#1)
isomers and##5##2##(1993-6#1)(1995-6#1)(2007-11#1)(2008-8#1)(2012-2#1)
isomers by high-performance##2##3##(2008-10#2)
isomers by##5##2##(1991-5#1)(2008-10#4)
isomers in##2##2##(2008-10#1)(2008-9#1)
isomers of a##3##3##(1995-8#1)(2010-2#2)
isomers of the##8##3##(1992-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2010-2#4)
isomers of##34##2##(1990-9#1)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#6)(2010-2#13)
isomers on##2##2##(2008-10#2)
isomers was##2##2##(1990-9#1)(2011-1#1)
isomers were##2##2##(1990-7#1)(2008-10#1)
isomers##87##1##(1990-11#1)(1990-7#2)(1990-9#2)(1991-5#5)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-2#4)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-10#18)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#15)(2010-5#1)(2011-1#2)(2011-10#1)(2012-2#3)(2013-1#1)
isometamidium##2##1##(1997-4#2)
isometamidium- and##2##2##(1997-4#2)
isometric contract-relax technique on hamstring extensibility##3##6##(2007-11#3)
isometric contract-relax##5##2##(2007-11#5)
isometric contraction##3##2##(1993-12#2)(1994-11#1)
isometric exercises of the##2##4##(2007-11#1)(2007-8#1)
isometric exercises##4##2##(2007-11#2)(2007-8#1)(2013-1#1)
isometric force##2##2##(1995-12#1)(1995-2#1)
isometric particles##2##2##(2008-10#2)
isometric quadriceps muscle strengthening exercise##3##5##(2011-2#3)
isometric shoulder flexion with##2##4##(2010-9#2)
isometric shoulder flexion##4##3##(2010-9#4)
isometric##41##1##(1993-12#3)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(2007-11#7)(2007-8#3)(2008-10#6)(2008-12#1)(2008-8#1)(2010-7#1)(2010-9#4)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#2)
isometrically##4##1##(2007-12#2)(2008-8#1)(2011-2#1)
isomorphous replacement methods##2##3##(1992-8#1)(1995-3#1)
isomorphous replacement##4##2##(1992-8#2)(1995-3#1)(1997-4#1)
isomorphous with##2##2##(1990-8#1)(1995-2#1)
isomorphous##7##1##(1990-8#1)(1992-8#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-4#1)
isomorphy was##2##2##(2008-8#2)
isomorphy##9##1##(2008-8#9)
isoniazid (INH)##2##2##(2008-1#1)(2008-10#1)
isoniazid and iproniazid phosphate##2##4##(2008-11#2)
isoniazid and##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
isoniazid in pharmaceutical preparations##2##4##(2008-10#2)
isoniazid in##4##2##(1997-7#1)(2008-10#3)
isoniazid with##2##2##(2008-10#1)(2008-5#1)
isoniazid##32##1##(1991-11#1)(1997-7#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#2)(2011-2#1)
isoniazide##2##1##(1990-6#1)(2008-10#1)
isonimy##3##1##(2012-12#3)
isooctane##3##1##(2008-10#2)(2013-1#1)
isoosmotic##2##1##(2008-1#1)(2008-4#1)
isopenicillin N##5##2##(2011-1#5)
isopentenol##2##1##(1991-12#2)
isopentenyl##2##1##(2008-8#1)(2010-10#1)
isopeptidase activity##2##2##(1994-11#2)
isoperistaltic##2##1##(2008-10#2)
isoplanatic angle##3##2##(2008-2#1)(2008-3#2)
isoprenaline (10##2##2##(1995-12#1)(1997-2#1)
isoprenaline and forskolin##2##3##(1997-2#2)
isoprenaline and##3##2##(1997-2#2)(2008-10#1)
isoprenaline##7##1##(1995-12#2)(1997-2#4)(2008-10#1)
isoprene##2##1##(1993-3#1)(1996-2#1)
isoprenoid metabolism in land plants##2##5##(2012-2#2)
isoprenoid metabolism in##3##3##(2012-2#3)
isoprenoid metabolism##5##2##(1990-12#2)(2012-2#3)
isoprenoid##11##1##(1990-12#3)(1994-11#3)(2008-10#1)(2008-5#1)(2012-2#3)
isoprenoids##2##1##(2012-2#2)
isoprenylation##3##1##(1993-11#1)(1994-11#2)
isopropanol was##2##2##(2008-11#1)(2008-5#1)
isopropanol##19##1##(1991-5#6)(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#1)
isopropanol)##2##1##(2008-2#1)(2008-3#1)
isopropyl alcohol##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
isopropyl beta-D-thiogalactopyranoside (IPTG)##2##3##(1993-8#1)(1995-2#1)
isopropyl beta-D-thiogalactopyranoside##3##2##(1990-5#1)(1993-8#1)(1995-2#1)
isopropyl beta-D-thiogalactoside##2##2##(1993-11#1)(2008-7#1)
isopropyl##12##1##(1990-5#1)(1991-12#1)(1993-11#1)(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
isopropylantipyrine##2##1##(2013-1#2)
isoprotein (pI 4##2##3##(1990-8#2)
isoprotein (pI##3##2##(1990-8#3)
isoprotein##5##1##(1990-8#4)(1997-2#1)
isoproteins##7##1##(1990-8#3)(1991-8#4)
isoproterenol##17##1##(1990-3#1)(1991-12#1)(1993-3#1)(1994-11#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2009-2#1)(2010-8#1)(2011-2#2)
isoproterenol-stimulated lipolysis##2##2##(1991-12#1)(1994-8#1)
isoproterenol-stimulated##3##1##(1991-12#1)(1994-8#2)
isoproturon and diuron##2##3##(2008-10#2)
isoproturon and##4##2##(2008-10#4)
isoproturon##10##1##(2008-10#10)
isopycnic##2##1##(1990-11#1)(2008-11#1)
isoquinoline alkaloid##2##2##(2008-11#2)
isoquinoline derivatives##4##2##(1995-5#4)
isoquinoline##10##1##(1995-5#4)(1996-2#1)(2007-11#1)(2008-11#3)(2008-5#1)
isosbestic point##4##2##(2008-10#3)(2008-3#1)
isosbestic##5##1##(2008-10#4)(2008-3#1)
isosceles triangle##3##2##(1996-2#1)(2008-3#2)
isosceles##5##1##(1996-2#1)(2007-12#1)(2008-3#3)
isosorbide dinitrate in##2##3##(2008-10#1)(2008-3#1)
isosorbide dinitrate##3##2##(1996-9#1)(2008-10#1)(2008-3#1)
isosporosis##5##1##(1996-12#5)
isostere##4##1##(1992-8#3)(2012-3#1)
isosteric heat of##2##3##(2010-4#2)
isosteric heat##3##2##(2010-4#3)
isosteric##5##1##(2008-7#1)(2010-4#4)
isostericity matrices##2##2##(2008-7#2)
isostericity##3##1##(2008-7#3)
isostructural##3##1##(1997-7#2)(2007-11#1)
isosurface##2##1##(2008-6#2)
isosurfaces##2##1##(2008-6#2)
isotachophoresis (cITP)##3##2##(2008-10#3)
isotachophoresis##13##1##(2008-10#13)
isotachophoretic##2##1##(2008-10#2)
isotherm and isobar##2##3##(1990-2#2)
isotherm and##3##2##(1990-2#2)(2008-10#1)
isotherm approach##4##2##(2008-10#4)
isotherm behaviour##2##2##(2008-10#2)
isotherm model##2##2##(2008-10#2)
isotherm of##4##2##(1992-5#1)(1994-5#1)(2008-10#1)(2013-1#1)
isotherm##34##1##(1990-2#2)(1991-3#1)(1992-5#1)(1994-5#1)(1997-2#1)(2008-10#24)(2010-5#1)(2013-1#1)(2013-8#2)
isothermal adsorption behaviour##2##3##(1997-2#2)
isothermal adsorption##3##2##(1997-2#3)
isothermal amplification (LAMP)##2##3##(2009-6#2)
isothermal amplification reactions##2##3##(1997-6#2)
isothermal amplification##4##2##(1997-6#2)(2009-6#2)
isothermal and##2##2##(2008-10#1)(2009-7#1)
isothermal conditions##2##2##(2008-3#1)(2009-7#1)
isothermal decays##3##2##(2008-3#3)
isothermal titration calorimetry##2##3##(1994-5#1)(1997-2#1)
isothermal##30##1##(1994-5#1)(1997-2#6)(1997-6#2)(2008-10#6)(2008-2#1)(2008-3#6)(2008-7#2)(2009-6#2)(2009-7#3)(2011-2#1)
isotherms and##4##2##(2008-10#2)(2009-11#1)(2010-4#1)
isotherms are##2##2##(2008-10#2)
isotherms for##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
isotherms in##2##2##(1997-2#1)(2008-6#1)
isotherms of the##2##3##(1994-5#1)(1996-5#1)
isotherms of##8##2##(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-5#1)(2008-10#2)(2010-4#1)
isotherms show##2##2##(1994-5#2)
isotherms were##6##2##(1997-2#1)(2008-10#2)(2008-6#2)(2010-5#1)
isotherms##46##1##(1990-8#2)(1992-6#2)(1993-8#1)(1994-3#1)(1994-5#4)(1996-5#1)(1997-2#3)(2008-10#19)(2008-3#2)(2008-6#4)(2009-11#1)(2010-4#4)(2010-5#1)(2011-2#1)
isothiocyanate (FITC)##2##2##(2008-10#2)
isothiocyanate and##3##2##(2008-10#3)
isothiocyanate##23##1##(1990-12#1)(1990-8#1)(1995-11#1)(2008-10#15)(2008-2#1)(2008-4#3)(2008-5#1)
isothiocyanate-conjugated##2##1##(1994-9#1)(2008-10#1)
isothiocyanates against##2##2##(2008-10#2)
isothiocyanates##5##1##(1990-8#1)(2008-10#4)
isotonic resealing##2##2##(1990-11#1)(1993-8#1)
isotonic##15##1##(1990-11#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-3#1)(2008-10#6)(2008-12#1)(2010-2#1)(2011-1#1)(2013-7#1)
isotope analysis of##2##3##(2008-10#1)(2012-9#1)
isotope analysis##4##2##(2008-10#2)(2012-9#1)(2013-8#1)
isotope bone##2##2##(2007-11#1)(2011-2#1)
isotope dilution (ID)##2##3##(2008-10#2)
isotope dilution mass spectrometry (IDMS)##2##5##(2008-10#2)
isotope dilution method##4##3##(2008-10#4)
isotope dilution##21##2##(1990-11#1)(1991-5#2)(2008-10#18)
isotope effect on its##2##4##(1991-3#1)(1995-2#1)
isotope effect on the##2##4##(1993-8#1)(1995-2#1)
isotope effect on##5##3##(1991-3#1)(1993-8#1)(1995-2#3)
isotope effect##16##2##(1991-3#2)(1992-3#3)(1992-6#1)(1993-11#1)(1993-8#3)(1995-2#3)(1995-6#1)(1996-5#1)(2009-6#1)
isotope effects on##6##3##(1992-3#4)(1995-2#2)
isotope effects were##2##3##(1991-9#1)(2008-10#1)
isotope effects##17##2##(1991-9#2)(1992-11#2)(1992-3#7)(1995-2#3)(1995-6#1)(2008-10#1)(2009-9#1)
isotope exchange##3##2##(1991-9#2)(1995-6#1)
isotope in the##2##3##(1992-12#1)(2008-10#1)
isotope injection##2##2##(1994-5#2)
isotope labeling##2##2##(2008-4#1)(2008-8#1)
isotope of##2##2##(1990-5#1)(2013-8#1)
isotope pair##2##2##(2008-10#2)
isotope ratio analysis##2##3##(2008-10#2)
isotope ratio measurements##2##3##(2008-10#1)(2008-2#1)
isotope ratio##11##2##(2008-10#10)(2008-2#1)
isotope ratios in##5##3##(1992-3#2)(2008-10#3)
isotope ratios of##2##3##(1992-3#1)(2008-10#1)
isotope ratios##17##2##(1992-3#7)(2008-10#9)(2008-2#1)
isotope selection effects##2##3##(1991-3#2)
isotope tracers##2##2##(1993-8#1)(2008-6#1)
isotope##136##1##(1990-11#1)(1990-5#1)(1991-3#4)(1991-5#2)(1991-9#4)(1992-11#2)(1992-12#2)(1992-3#17)(1992-6#1)(1993-11#1)(1993-8#4)(1994-2#1)(1994-5#2)(1995-2#6)(1995-6#3)(1996-5#1)(2007-11#1)(2008-10#53)(2008-2#4)(2008-3#2)(2008-4#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#5)(2012-9#1)(2013-8#2)
isotope-dilution##3##1##(2008-10#3)
isotopes in##4##2##(2008-10#4)
isotopes of##2##2##(2008-10#1)(2008-4#1)
isotopes were##3##2##(2008-10#3)
isotopes##23##1##(1990-12#1)(2007-2#1)(2008-1#1)(2008-10#12)(2008-4#2)(2008-9#1)(2010-6#1)(2010-8#3)(2012-2#1)
isotopic abundance##2##2##(1990-12#1)(2011-2#1)
isotopic analysis##6##2##(2008-10#5)(2013-8#1)
isotopic composition in##2##3##(2013-8#2)
isotopic composition of##6##3##(1992-3#2)(2008-10#2)(2013-8#2)
isotopic composition##9##2##(1992-3#2)(2008-10#3)(2013-8#4)
isotopic compositions in##2##3##(2008-10#1)(2013-8#1)
isotopic dilution##2##2##(2008-10#2)
isotopic in situ##2##3##(2008-4#1)(2013-8#1)
isotopic labeling##2##2##(1994-5#1)(2008-4#1)
isotopic labels##2##2##(2008-4#2)
isotopic reference materials##2##3##(2008-10#2)
isotopic##43##1##(1990-12#1)(1992-3#2)(1994-5#1)(2007-10#1)(2008-10#18)(2008-3#2)(2008-4#5)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#8)
isotopically labeled##4##2##(1993-11#1)(1994-11#1)(1994-8#1)(2008-10#1)
isotopically##7##1##(1993-11#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
isotopomer distribution##3##2##(2008-7#3)
isotopomer distributions##2##2##(2008-7#2)
isotopomer model##2##2##(2008-7#2)
isotopomer##13##1##(1997-1#1)(2008-7#12)
isotretinoin in##2##2##(2011-1#1)(2013-1#1)
isotretinoin##4##1##(2011-1#1)(2013-1#3)
isotropic and anisotropic scattering media##4##5##(2008-2#1)(2008-3#3)
isotropic and anisotropic scattering##5##4##(2008-2#1)(2008-3#4)
isotropic and anisotropic##6##3##(2008-2#2)(2008-3#4)
isotropic and##9##2##(2008-2#2)(2008-3#7)
isotropic medium##5##2##(2007-11#3)(2008-2#1)(2008-3#1)
isotropic phase##2##2##(1997-2#1)(2008-2#1)
isotropic scaling##3##2##(2008-3#3)
isotropic scattering##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
isotropic substrate##3##2##(2008-3#3)
isotropic to biphasic##2##3##(2008-10#2)
isotropic##73##1##(1990-2#1)(1993-11#1)(1994-12#1)(1996-4#1)(1997-2#1)(2007-11#5)(2007-12#4)(2008-10#4)(2008-2#12)(2008-3#37)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-2#1)(2013-1#1)
isotropy##3##1##(2008-2#1)(2008-3#2)
isotype of##3##2##(1990-12#2)(1993-6#1)
isotype##9##1##(1990-12#3)(1991-12#1)(1993-6#1)(1995-5#1)(1996-12#1)(2008-4#1)(2008-8#1)
isotypes and##2##2##(2011-2#2)
isotypes##9##1##(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2011-2#4)
isovaleric##3##1##(1994-9#1)(2008-10#1)(2008-5#1)
isovolemic##2##1##(1992-3#1)(1994-12#1)
isozyme I##3##2##(1991-2#3)
isozyme II##3##2##(1991-2#2)(1994-5#1)
isozyme banding##2##2##(2008-10#2)
isozyme electrophoresis##2##2##(2008-10#1)(2008-8#1)
isozyme in##4##2##(1992-11#1)(1993-12#1)(1995-3#1)(1997-2#1)
isozyme is##2##2##(1997-2#1)(2008-1#1)
isozyme of##2##2##(2008-10#1)(2008-4#1)
isozyme patterns##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
isozyme was##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
isozyme##55##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#6)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#3)(1993-12#1)(1993-6#4)(1994-11#2)(1994-5#1)(1995-3#3)(1997-2#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#1)(2012-5#1)
isozymes are##3##2##(1991-2#1)(1992-10#1)(1992-6#1)
isozymes in##4##2##(1992-6#1)(1993-6#1)(1993-8#1)(2008-10#1)
isozymes was##2##2##(1997-2#1)(2008-10#1)
isozymes were##2##2##(1996-9#1)(2008-10#1)
isozymes##50##1##(1990-12#2)(1990-7#2)(1991-12#1)(1991-2#4)(1992-10#2)(1992-11#2)(1992-3#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#3)(1995-2#1)(1996-6#1)(1996-9#4)(1997-2#2)(1997-4#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2012-2#1)
isradipine##3##1##(1994-9#2)(2012-3#1)
israelensis##2##1##(1993-12#2)
issuance of a DNR order##3##5##(1992-12#1)(1992-3#2)
issuance of##5##2##(1992-12#2)(1992-3#3)
issuance##6##1##(1992-12#2)(1992-3#4)
issue 1 of 2010##2##4##(2011-2#2)
issue a##2##2##(2008-10#1)(2008-11#1)
issue and the##3##3##(1991-3#1)(2008-11#1)(2013-1#1)
issue and##9##2##(1991-3#1)(1992-1#1)(1994-1#1)(2007-10#2)(2008-11#1)(2012-2#2)(2013-1#1)
issue are##2##2##(2008-11#1)(2013-1#1)
issue as##4##2##(1994-2#1)(1995-8#1)(2008-1#1)(2008-7#1)
issue became##2##2##(1991-6#1)(1997-7#1)
issue dedicated to##5##3##(1990-8#1)(1993-6#1)(2008-7#1)(2009-4#1)(2012-3#1)
issue for the##5##3##(1991-12#1)(1992-11#1)(1996-1#1)(2008-10#1)(2009-12#1)
issue for##19##2##(1991-12#1)(1992-11#1)(1996-1#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-9#1)(2010-9#1)(2012-2#1)
issue from a##2##3##(2008-2#1)(2010-10#1)
issue has not been##2##4##(2007-11#1)(2008-11#1)
issue in the##5##3##(1996-5#1)(1996-9#1)(2008-10#1)(2008-8#1)(2009-9#1)
issue in##26##2##(1992-5#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
issue is to##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
issue is whether the##3##4##(2009-5#1)(2010-2#2)
issue is whether##6##3##(1997-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-2#2)
issue is##19##2##(1991-2#1)(1992-1#2)(1996-2#1)(1997-1#2)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#3)(2010-2#2)(2013-8#1)
issue of Applied Optics##7##4##(2008-2#2)(2008-3#5)
issue of Radiology Management##5##4##(1991-2#1)(1995-1#1)(1995-2#2)(1996-1#1)
issue of the Health Care Financing Review##5##7##(1994-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)
issue of the Journal of Pediatric Urology##3##7##(2008-10#3)
issue of the Journal of##5##5##(2008-10#3)(2008-3#1)(2009-8#1)
issue of the Journal##6##4##(1994-3#1)(2008-10#3)(2008-3#1)(2009-8#1)
issue of the##25##3##(1991-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
issue of this##3##3##(1992-3#1)(1996-2#1)(2008-9#1)
issue of whether##3##3##(1992-2#1)(1994-1#1)(2010-6#1)
issue of##122##2##(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
issue on##4##2##(2008-8#2)(2008-9#1)(2013-1#1)
issue relevant to##2##3##(1992-3#1)(2008-1#1)
issue that is##2##3##(2008-11#1)(2008-12#1)
issue that##4##2##(2008-11#1)(2008-12#2)(2011-2#1)
issue the##3##2##(1991-2#1)(1991-3#1)(2008-4#1)
issue was##3##2##(1992-12#1)(1996-3#1)(2008-1#1)
issue will##2##2##(2010-3#1)(2012-2#1)
issue with##5##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
issue##413##1##(1990-11#2)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-6#2)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#6)(1993-12#2)(1993-2#3)(1993-6#2)(1994-1#7)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#5)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#6)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#21)(2008-11#32)(2008-12#10)(2008-2#13)(2008-3#22)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#16)(2008-8#10)(2008-9#11)(2009-10#3)(2009-12#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#5)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#20)(2012-1#1)(2012-12#10)(2012-2#7)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#8)
issue)##2##1##(2009-9#2)
issue?##2##1##(1995-2#1)(2008-8#1)
issue]##3##1##(1991-11#1)(1997-4#1)(2008-7#1)
issued a##5##2##(1994-2#1)(1995-12#1)(1997-6#1)(2008-5#1)(2013-8#1)
issued by the##5##3##(1994-3#1)(1996-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
issued by##7##2##(1994-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
issued for##2##2##(1991-2#1)(1993-3#1)
issued from the##2##3##(2008-5#2)
issued from##4##2##(2008-10#2)(2008-5#2)
issued its##2##2##(1996-12#2)
issued on##2##2##(2008-7#1)(2010-7#1)
issued recommendations##4##2##(2007-12#1)(2008-5#1)(2009-11#1)(2011-2#1)
issued to##3##2##(1992-6#1)(1996-9#1)(2011-2#1)
issued##43##1##(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#2)(2008-9#2)(2009-11#1)(2010-7#2)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#2)
issues about the##2##3##(1996-12#1)(2009-10#1)
issues about##3##2##(1996-12#1)(2009-10#1)(2011-2#1)
issues addressed##3##2##(1991-3#1)(1996-1#1)(2008-7#1)
issues affecting the##2##3##(2008-11#1)(2008-9#1)
issues affecting##4##2##(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)
issues among##2##2##(2009-5#1)(2012-12#1)
issues and challenges for##3##4##(2008-10#1)(2010-8#1)(2012-12#1)
issues and challenges that##2##4##(2007-10#2)
issues and challenges##8##3##(1996-1#1)(2007-10#2)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#2)
issues and concerns##2##3##(1992-2#1)(2008-1#1)
issues and evidence##2##3##(1992-1#1)(1994-3#1)
issues and how to##2##4##(1995-2#1)(2008-6#1)
issues and in##2##3##(1995-3#1)(2008-10#1)
issues and needs##3##3##(2008-7#1)(2013-8#2)
issues and options##2##3##(1997-1#2)
issues and problems##5##3##(2013-8#5)
issues and the##5##3##(2008-11#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
issues and trends are##2##4##(2008-1#2)
issues and trends##3##3##(2008-1#3)
issues and##96##2##(1990-2#1)(1991-1#2)(1991-2#1)(1992-1#3)(1992-2#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#3)(1996-3#3)(1997-1#3)(1997-2#3)(1997-3#1)(2007-10#3)(2007-3#1)(2007-5#2)(2008-1#7)(2008-10#2)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#7)
issues are considered##2##3##(1993-12#1)(1994-11#1)
issues are discussed and##2##4##(1991-3#1)(1997-1#1)
issues are discussed##9##3##(1991-3#2)(1996-1#1)(1997-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
issues are more##2##3##(1995-1#1)(2008-11#1)
issues are the##2##3##(2007-12#1)(2008-3#1)
issues are##33##2##(1991-3#2)(1993-12#3)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-1#2)(2007-12#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2013-1#1)
issues arising from the##3##4##(2008-11#1)(2010-5#1)(2011-1#1)
issues arising from##4##3##(2008-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
issues arising##6##2##(1991-12#1)(1995-2#1)(2008-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
issues around##3##2##(2008-11#1)(2009-8#1)(2012-12#1)
issues as they##2##3##(1996-1#1)(1997-2#1)
issues as well as##2##4##(2008-6#1)(2012-2#1)
issues as##11##2##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-6#1)(2010-12#1)(2012-2#1)
issues associated with studies##2##4##(2008-12#1)(2008-8#1)
issues associated with the##6##4##(1996-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-12#1)
issues associated with##18##3##(1991-1#1)(1994-3#1)(1995-6#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
issues at##4##2##(1994-12#1)(1995-2#1)(2008-6#1)(2011-2#1)
issues by##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
issues can##2##2##(1992-3#1)(1995-1#1)
issues concerned with##2##3##(1995-2#1)(2008-11#1)
issues concerned##3##2##(1995-2#1)(2008-11#2)
issues concerning the##4##3##(1992-2#1)(1993-11#1)(1996-12#1)(2009-4#1)
issues concerning##11##2##(1992-2#1)(1993-11#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#1)
issues connected##2##2##(1990-6#1)(1994-6#1)
issues contribute to##2##3##(1995-12#1)(2008-11#1)
issues could be##2##3##(2008-3#1)(2010-11#1)
issues discussed##2##2##(2008-11#1)(2013-8#1)
issues during##3##2##(2007-10#1)(2008-4#1)(2010-3#1)
issues faced by##3##3##(1993-12#1)(1995-3#1)(1997-3#1)
issues facing##8##2##(1991-3#1)(1994-1#1)(1995-1#1)(2007-12#1)(2008-11#2)(2010-11#1)(2012-12#1)
issues for the 21st century##2##5##(2007-12#1)(2008-12#1)
issues for the##7##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2013-8#1)
issues for##36##2##(1991-1#1)(1991-12#1)(1993-1#3)(1993-3#2)(1995-1#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
issues frequently##2##2##(1992-3#1)(1993-12#1)
issues from##2##2##(1994-2#1)(2008-11#1)
issues have##3##2##(1991-2#1)(1996-12#1)(2008-10#1)
issues identified##2##2##(1991-1#1)(2009-4#1)
issues in a##2##3##(1995-12#1)(2012-2#1)
issues in health care##8##4##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#1)(2008-11#2)
issues in health##9##3##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#1)(1995-12#1)(2008-11#2)
issues in long-term care##2##4##(1991-1#1)(2009-4#1)
issues in nursing##3##3##(2008-11#3)
issues in protein requirements and consumption for resistance trained athletes##2##10##(2008-5#2)
issues in the design of##2##5##(1992-9#1)(2012-3#1)
issues in the evaluation##2##4##(1994-3#1)(1995-5#1)
issues in the field##2##4##(2009-8#1)(2012-2#1)
issues in the##23##3##(1991-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-5#1)(2008-11#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
issues in##111##2##(1991-1#3)(1991-12#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-9#1)(1993-1#3)(1993-2#4)(1993-3#2)(1994-1#1)(1994-2#2)(1994-3#2)(1995-12#4)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)
issues include##4##2##(1992-3#1)(2008-6#1)(2010-11#1)(2010-7#1)
issues including##5##2##(2008-11#1)(2008-5#2)(2008-6#1)(2010-5#1)
issues involved in##12##3##(1991-12#2)(1993-2#1)(1994-3#1)(1995-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-9#1)(2010-7#1)
issues involved##16##2##(1991-12#2)(1993-2#1)(1994-3#1)(1995-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-9#1)(2010-7#2)
issues is##4##2##(1991-1#1)(2007-12#1)(2009-8#1)(2011-1#1)
issues limit the##2##3##(1992-9#1)(2008-10#1)
issues may##5##2##(1991-3#1)(1997-2#1)(2008-1#1)(2009-5#1)(2010-11#1)
issues need to be addressed##2##5##(1994-1#1)(1997-5#1)
issues need to be##4##4##(1994-1#1)(1997-5#1)(2008-10#1)(2008-11#1)
issues of the##7##3##(1992-2#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
issues of##64##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-2#2)(1992-9#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-12#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2010-1#2)(2010-3#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
issues on the##2##3##(1996-8#1)(2010-4#1)
issues on##3##2##(1996-8#1)(2008-7#1)(2010-4#1)
issues pertaining to##6##3##(2008-2#1)(2008-4#1)(2009-3#1)(2009-8#2)(2010-4#1)
issues raised by##4##3##(1994-1#1)(1996-1#1)(2008-10#2)
issues raised##5##2##(1991-2#1)(1994-1#1)(1996-1#1)(2008-10#2)
issues regarding the use of##2##5##(1992-9#1)(2009-11#1)
issues regarding the##8##3##(1992-9#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-2#1)(2009-11#1)(2009-3#1)(2010-5#1)
issues regarding##14##2##(1992-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
issues related to its implementation##2##5##(1992-1#1)(2008-3#1)
issues related to multiple##2##4##(2008-11#2)
issues related to the##10##4##(1991-5#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2010-3#1)(2012-3#1)(2013-1#1)
issues related to##36##3##(1991-2#1)(1991-5#1)(1992-1#1)(1993-3#1)(1994-2#1)(1996-12#2)(1996-3#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
issues relating to the##2##4##(2008-11#1)(2012-12#1)
issues relating to##10##3##(1993-3#1)(1995-12#1)(1995-5#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
issues relevant to the##3##4##(1992-3#1)(2008-7#1)(2010-8#1)
issues relevant to##5##3##(1992-12#1)(1992-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
issues specific to the##2##4##(1997-1#1)(2008-8#1)
issues specific to##3##3##(1997-1#1)(2008-8#1)(2012-12#1)
issues such as the##4##4##(2008-12#1)(2008-7#2)(2012-3#1)
issues such as##19##3##(1995-1#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
issues surrounding the##2##3##(2008-11#1)(2012-2#1)
issues surrounding##11##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
issues that are relevant##2##4##(1992-12#1)(2012-1#1)
issues that are##4##3##(1992-12#1)(2008-6#1)(2011-2#1)(2012-1#1)
issues that arise##2##3##(1994-2#1)(2008-11#1)
issues that arose##2##3##(1997-1#1)(2008-12#1)
issues that can##3##3##(1991-3#1)(2010-7#1)(2010-8#1)
issues that have##2##3##(2008-11#1)(2008-7#1)
issues that must be addressed##2##5##(1995-2#1)(2007-12#1)
issues that must be considered in##2##6##(1997-2#1)(2008-4#1)
issues that must be considered when##2##6##(2008-4#2)
issues that must be considered##4##5##(1997-2#1)(2008-4#3)
issues that must be##6##4##(1995-2#1)(1997-2#1)(2007-12#1)(2008-4#3)
issues that need to be addressed##15##6##(1993-11#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#9)
issues that need to be##16##5##(1993-11#1)(1994-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#9)
issues that should be##2##4##(1997-4#1)(2012-2#1)
issues that##60##2##(1991-1#1)(1991-12#1)(1991-3#2)(1992-12#1)(1993-11#1)(1994-2#2)(1995-12#1)(1995-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#8)(2008-6#2)(2008-7#1)(2008-9#3)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#10)
issues to be addressed before##2##5##(2010-10#1)(2011-2#1)
issues to be addressed in##3##5##(1994-12#1)(1997-2#1)(2013-1#1)
issues to be addressed##5##4##(1994-12#1)(1997-2#1)(2010-10#1)(2011-2#1)(2013-1#1)
issues to be considered when##2##5##(1993-2#2)
issues to be considered##3##4##(1993-2#2)(1997-3#1)
issues to be resolved##2##4##(1992-1#1)(2008-3#1)
issues to be##12##3##(1992-1#1)(1993-2#2)(1994-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
issues to consider##2##3##(2010-6#1)(2013-7#1)
issues to##17##2##(1992-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-3#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
issues was##2##2##(2008-10#1)(2008-12#1)
issues were identified##3##3##(2013-1#1)(2013-8#2)
issues were##11##2##(1991-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
issues when##3##2##(1997-2#1)(2010-8#1)(2012-12#1)
issues which##5##2##(1994-12#1)(1995-1#1)(2008-1#1)(2008-11#2)
issues will need to##2##4##(2007-7#1)(2008-1#1)
issues will##4##2##(2007-7#1)(2008-1#1)(2008-2#1)(2012-12#1)
issues with respect to##3##4##(1997-1#1)(2008-12#1)(2010-4#1)
issues with##11##2##(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-4#1)(2010-5#1)(2012-2#1)
issues within the##3##3##(1991-12#1)(1995-1#1)(1996-2#1)
issues within##5##2##(1991-12#1)(1995-1#1)(1996-2#1)(2008-3#1)(2009-5#1)
issues##1005##1##(1990-2#1)(1990-6#2)(1990-8#1)(1991-1#12)(1991-12#11)(1991-2#8)(1991-3#14)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#8)(1992-11#2)(1992-12#4)(1992-2#9)(1992-3#16)(1992-9#7)(1993-1#9)(1993-11#2)(1993-12#8)(1993-2#14)(1993-3#8)(1993-9#1)(1994-1#7)(1994-11#1)(1994-12#9)(1994-2#16)(1994-3#8)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#16)(1995-12#11)(1995-2#9)(1995-3#9)(1995-5#10)(1995-6#2)(1995-9#1)(1996-1#17)(1996-11#2)(1996-12#9)(1996-2#15)(1996-3#13)(1996-6#2)(1996-8#3)(1997-1#18)(1997-2#17)(1997-3#11)(1997-4#3)(1997-5#3)(2007-10#9)(2007-11#5)(2007-12#17)(2007-2#3)(2007-3#1)(2007-5#4)(2007-7#2)(2008-1#22)(2008-10#39)(2008-11#96)(2008-12#31)(2008-2#12)(2008-3#16)(2008-4#29)(2008-5#12)(2008-6#18)(2008-7#33)(2008-8#9)(2008-9#19)(2009-10#6)(2009-11#4)(2009-12#5)(2009-3#4)(2009-4#6)(2009-5#13)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#5)(2010-1#7)(2010-10#6)(2010-11#7)(2010-12#3)(2010-2#1)(2010-3#8)(2010-4#5)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#10)(2011-1#14)(2011-2#24)(2012-1#2)(2012-12#23)(2012-2#19)(2012-3#19)(2013-1#20)(2013-7#1)(2013-8#33)
issues)##2##1##(1993-12#1)(2008-9#1)
issuing##3##1##(2008-10#1)(2008-3#1)(2010-3#1)
isthmic##6##1##(1993-12#2)(1996-5#3)(2013-8#1)
isthmus and##3##2##(1997-6#1)(2007-8#1)(2008-12#1)
isthmus in##2##2##(2010-8#1)(2013-1#1)
isthmus##12##1##(1997-6#1)(2007-11#1)(2007-8#3)(2008-12#1)(2010-8#1)(2013-1#5)
it &quot##3##2##(1994-1#1)(2009-5#1)(2012-2#1)
it a true##2##3##(2008-10#1)(2008-5#1)
it a useful##2##3##(2008-10#2)
it a very##3##3##(2008-10#2)(2010-5#1)
it a##40##2##(1990-3#1)(1991-3#1)(1993-11#1)(1994-1#1)(1994-11#1)(1994-9#1)(1996-9#1)(1997-5#1)(2007-12#1)(2007-5#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
it abolished the##2##3##(1990-3#1)(1991-6#1)
it accounts for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
it achieved##2##2##(1991-12#1)(2008-10#1)
it achieves##2##2##(2008-10#1)(2008-2#1)
it activates##3##2##(1994-12#1)(1996-5#1)(2008-4#1)
it acts as a##2##4##(2008-3#1)(2010-3#1)
it acts##7##2##(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-3#1)(2012-12#1)
it affect##7##2##(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(2008-10#1)
it affects the##2##3##(2007-11#1)(2013-7#1)
it affects##10##2##(1991-8#1)(1993-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-7#1)
it against##4##2##(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
it aims to##4##3##(2008-7#1)(2010-4#1)(2012-2#1)(2012-3#1)
it all together##2##3##(1991-3#1)(2013-1#1)
it all##5##2##(1991-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2013-1#1)
it allowed##4##2##(1992-12#1)(2008-10#1)(2008-12#1)(2011-1#1)
it allows for##2##3##(1994-12#1)(2011-2#1)
it allows the##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
it allows##17##2##(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
it also has##2##3##(1992-9#1)(2009-6#1)
it also highlights the##2##4##(2007-12#1)(2011-2#1)
it also performs##2##3##(1995-6#1)(2008-3#1)
it also showed a##3##4##(2008-10#1)(2008-9#1)(2011-3#1)
it also shows##2##3##(2008-11#1)(2008-5#1)
it also underscores the##2##4##(1990-8#1)(2008-7#1)
it also##55##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#5)(2009-10#3)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
it an attractive##3##3##(2012-3#1)(2012-8#1)(2013-1#1)
it an ideal##6##3##(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#2)
it an important##5##3##(1994-12#1)(1995-12#1)(2008-1#1)(2012-2#2)
it an##22##2##(1990-12#1)(1991-12#1)(1994-12#1)(1995-12#1)(1997-2#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
it analyzes##2##2##(2009-7#1)(2010-5#1)
it and how to##2##4##(1995-1#1)(1997-3#1)
it and the##5##3##(2008-3#2)(2008-8#1)(2011-2#1)(2013-8#1)
it and##20##2##(1992-12#1)(1994-1#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
it appeared that the##4##4##(1993-8#1)(2008-10#2)(2011-2#1)
it appeared that##8##3##(1990-7#1)(1993-8#1)(1995-9#1)(1996-5#1)(1997-6#1)(2008-10#2)(2011-2#1)
it appeared to##3##3##(1997-2#1)(2008-5#1)(2010-5#1)
it appeared##12##2##(1990-7#1)(1993-8#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)
it appears possible##2##3##(1990-9#1)(2007-11#1)
it appears that a##4##4##(1992-11#1)(1994-11#1)(2010-4#1)(2011-1#1)
it appears that an##2##4##(1992-12#1)(2010-4#1)
it appears that the##16##4##(1990-11#1)(1991-8#1)(1992-6#2)(1993-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#1)(2013-1#1)
it appears that this##2##4##(2008-6#1)(2008-7#1)
it appears that##55##3##(1990-11#2)(1991-12#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-5#1)(1994-11#2)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
it appears to be##2##4##(1991-12#1)(1993-2#1)
it appears to##5##3##(1991-12#1)(1993-2#1)(2008-5#1)(2009-12#1)(2009-7#1)
it appears##69##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#1)
it applies to##3##3##(2008-1#1)(2008-8#1)(2010-11#1)
it applies##4##2##(2008-1#1)(2008-8#1)(2010-11#1)(2012-7#1)
it approaches##2##2##(2012-2#1)(2013-8#1)
it are##8##2##(1991-12#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-2#1)(2008-4#1)(2008-7#1)(2010-11#1)
it as &quot##2##3##(1991-2#1)(2011-2#1)
it as a##18##3##(1991-12#1)(1992-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
it as an##4##3##(2008-11#1)(2008-12#1)(2009-3#1)(2013-1#1)
it as##35##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-3#1)(1994-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
it associated with##2##3##(1994-8#1)(2011-2#1)
it at all##2##3##(1995-12#1)(2010-1#1)
it at higher##2##3##(1992-8#1)(2008-2#1)
it at the##4##3##(1995-2#1)(1996-11#1)(2009-2#1)(2011-2#1)
it at##11##2##(1992-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-1#1)(2011-1#1)(2011-2#1)
it attenuates##2##2##(2008-5#1)(2013-8#1)
it be of##2##3##(2008-9#1)(2009-6#1)
it be##11##2##(1991-11#1)(1991-8#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-6#1)
it became apparent that##3##4##(1994-2#1)(1996-3#1)(2008-2#1)
it became apparent##4##3##(1993-1#1)(1994-2#1)(1996-3#1)(2008-2#1)
it became clear that##6##4##(1990-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
it became evident that##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
it became##22##2##(1990-11#1)(1992-11#1)(1993-1#1)(1994-2#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)
it because of the##2##4##(1995-6#1)(2010-8#1)
it becomes a##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
it becomes clear that##2##4##(2009-5#1)(2010-11#1)
it becomes more##3##3##(1991-6#1)(2010-8#1)(2011-2#1)
it becomes possible to##2##4##(2008-5#1)(2008-7#1)
it becomes##19##2##(1990-3#1)(1991-6#1)(1993-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
it before##2##2##(2008-10#1)(2013-8#1)
it being##4##2##(1996-3#1)(2008-10#3)
it belongs to##2##3##(1991-12#1)(2013-8#1)
it better##2##2##(1997-6#1)(2011-2#1)
it binds to##2##3##(1994-3#1)(2008-10#1)
it binds##5##2##(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-10#1)
it bound##2##2##(1994-8#1)(1996-5#1)
it but##2##2##(1993-6#1)(2008-10#1)
it by the##2##3##(1994-12#1)(2008-5#1)
it by##18##2##(1993-1#1)(1994-12#2)(1994-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
it came to##2##3##(1992-6#1)(2013-1#1)
it can also be used##2##5##(2008-4#1)(2008-8#1)
it can also be##10##4##(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-10#1)
it can also##18##3##(1991-12#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2012-12#1)(2013-1#1)
it can attain##2##3##(1990-8#1)(2007-12#1)
it can be accurate##2##4##(1993-3#1)(2008-3#1)
it can be an##2##4##(1996-1#1)(2007-11#1)
it can be applied to##2##5##(2007-11#1)(2008-7#1)
it can be applied##4##4##(1997-2#1)(2007-11#1)(2008-7#2)
it can be argued that##2##5##(1994-12#1)(2008-11#1)
it can be concluded that the##3##6##(2008-10#2)(2010-5#1)
it can be concluded that##21##5##(1990-12#1)(1994-7#1)(1997-6#1)(2007-7#1)(2008-10#5)(2008-12#3)(2008-6#1)(2010-5#1)(2012-2#4)(2012-9#1)(2013-1#1)(2013-8#1)
it can be concluded##22##4##(1990-12#1)(1994-12#1)(1994-7#1)(1997-6#1)(2007-7#1)(2008-10#5)(2008-12#3)(2008-6#1)(2010-5#1)(2012-2#4)(2012-9#1)(2013-1#1)(2013-8#1)
it can be considered##2##4##(1993-3#1)(1994-3#1)
it can be deduced##2##4##(2008-10#1)(2008-3#1)
it can be difficult to##2##5##(2012-12#1)(2012-2#1)
it can be difficult##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
it can be easily##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
it can be employed as a stability indicating one##2##9##(2008-10#2)
it can be expected that##2##5##(1990-2#1)(2010-8#1)
it can be found that##2##5##(2007-11#2)
it can be found##3##4##(2007-11#2)(2007-5#1)
it can be interpreted as a##2##6##(1993-8#1)(2008-1#1)
it can be interpreted as##3##5##(1993-8#1)(2008-1#1)(2008-3#1)
it can be released##2##4##(1990-11#1)(2008-4#1)
it can be seen that##3##5##(2008-2#1)(2008-8#1)(2013-8#1)
it can be stated that##2##5##(1992-11#1)(2009-8#1)
it can be suggested that##2##5##(1994-11#1)(2010-4#1)
it can be used as a##4##6##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
it can be used as##7##5##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
it can be used for##3##5##(2008-10#2)(2008-3#1)
it can be used in##3##5##(2008-10#1)(2008-9#1)(2013-7#1)
it can be used to##6##5##(1994-5#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
it can be used##23##4##(1994-5#1)(1996-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2012-2#1)(2013-1#1)(2013-7#1)
it can be useful##4##4##(1995-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
it can be##159##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#2)(2012-9#1)(2013-1#7)(2013-7#1)(2013-8#6)
it can cause##6##3##(1992-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
it can easily accommodate additional chips as well as two-dimensional##2##10##(2008-3#2)
it can easily be##2##4##(2007-12#1)(2008-3#1)
it can easily##4##3##(2007-12#1)(2008-3#3)
it can fail to##2##4##(2008-10#1)(2008-3#1)
it can have##2##3##(1996-2#1)(2011-2#1)
it can lead to##3##4##(1997-5#1)(2008-7#1)(2012-12#1)
it can provide##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
it can sometimes##2##3##(2009-5#1)(2012-1#1)
it can##257##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#8)(2008-12#7)(2008-2#8)(2008-3#24)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#3)(2012-9#1)(2013-1#11)(2013-7#1)(2013-8#12)
it can't##2##2##(1993-2#1)(2010-10#1)
it cannot be considered##2##4##(1992-2#1)(2007-12#1)
it cannot be##11##3##(1992-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)
it cannot##18##2##(1990-2#1)(1992-11#1)(1992-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-5#1)(2011-2#1)
it carried##2##2##(1993-2#1)(2008-11#1)
it cause##2##2##(2008-10#1)(2008-9#1)
it caused##6##2##(1992-12#1)(2008-10#4)(2008-7#1)
it causes a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
it causes##14##2##(1994-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
it challenging to##2##3##(2012-2#1)(2013-1#1)
it challenging##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
it clear that##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
it clear##6##2##(2007-12#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
it clearly##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
it combines##2##2##(1996-12#1)(2007-12#1)
it comes to##10##3##(1991-3#1)(1994-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-7#1)(2009-11#2)(2010-12#1)(2011-2#1)
it comes##13##2##(1990-2#1)(1991-3#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-7#1)(2008-10#1)(2009-11#2)(2010-12#1)(2011-2#1)
it compared##2##2##(2008-10#1)(2009-8#1)
it completely##2##2##(1994-8#1)(2008-9#1)
it conducive to##2##3##(2011-1#2)
it consisted of##2##3##(1993-9#1)(2012-12#1)
it constitutes a##2##3##(1991-5#1)(2008-1#1)
it contained##5##2##(1990-11#1)(1991-9#1)(1995-12#1)(2008-10#1)(2008-11#1)
it contains a##2##3##(1993-12#1)(1997-3#1)
it contains##10##2##(1990-3#1)(1993-12#1)(1994-9#1)(1996-10#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#2)
it continues to##2##3##(2008-1#1)(2008-6#1)
it controls##2##2##(2008-7#1)(2010-11#1)
it costs##2##2##(1995-1#1)(2008-7#1)
it could be a##5##4##(2008-2#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
it could be concluded that the##3##6##(1990-11#1)(2008-10#1)(2008-5#1)
it could be shown that##4##5##(1990-8#1)(1995-12#1)(1996-12#1)(2008-10#1)
it could be that the##2##5##(2008-2#1)(2013-8#1)
it could be the##2##4##(1992-12#1)(2010-8#1)
it could be used##3##4##(2008-10#2)(2008-9#1)
it could be useful##2##4##(2008-10#1)(2008-11#1)
it could be##45##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
it could help##2##3##(2009-12#1)(2010-1#1)
it could not be##2##4##(2008-7#1)(2009-5#1)
it could not##5##3##(2008-10#1)(2008-7#2)(2009-5#1)(2013-1#1)
it could result in##2##4##(1991-6#1)(2010-9#1)
it could##77##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
it creates##4##2##(1990-9#1)(1994-8#1)(1996-3#1)(2012-3#1)
it declined##2##2##(2009-9#1)(2011-2#1)
it decreased from 2##2##4##(2008-7#2)
it decreased gradually##2##3##(1997-6#1)(2008-10#1)
it decreased with increasing##2##4##(2008-10#1)(2008-11#1)
it decreased##8##2##(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-7#2)
it demands##2##2##(2008-1#1)(2010-12#1)
it demonstrated##3##2##(2008-2#1)(2010-3#1)(2010-8#1)
it demonstrates##2##2##(2008-1#1)(2013-1#1)
it depends on you!)##2##4##(2009-3#2)
it depends on##4##3##(1994-5#1)(2007-4#1)(2009-3#2)
it depends##5##2##(1994-5#1)(2007-4#1)(2008-3#1)(2009-3#2)
it describes the##5##3##(2008-4#1)(2008-6#1)(2008-8#3)
it describes##8##2##(1994-2#1)(2008-4#2)(2008-6#1)(2008-8#3)(2010-1#1)
it deserves##2##2##(1996-11#1)(2011-2#1)
it detects##2##2##(2008-10#1)(2008-4#1)
it determines##5##2##(2008-10#1)(2008-2#3)(2013-1#1)
it develops##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
it did in##2##3##(2008-12#1)(2008-8#1)
it did not affect##2##4##(1997-6#1)(2008-5#1)
it did not impair##2##4##(1995-2#1)(2008-7#1)
it did not improve##2##4##(1996-12#1)(2008-10#1)
it did not induce##3##4##(1992-8#1)(1993-8#1)(2008-8#1)
it did not inhibit##2##4##(1990-11#1)(1990-5#1)
it did not promote##2##4##(2008-11#2)
it did not show any##2##5##(2008-5#1)(2011-2#1)
it did not show##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
it did not##36##3##(1990-11#1)(1990-5#1)(1991-12#1)(1992-8#2)(1993-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-5#3)(2008-7#2)(2008-8#2)(2009-6#1)(2010-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
it did##45##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-8#2)(1993-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#3)(2009-6#1)(2010-1#2)(2011-2#3)(2013-1#3)(2013-8#1)
it differs from##4##3##(2008-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
it differs##6##2##(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
it difficult for##4##3##(2008-8#1)(2009-8#1)(2010-12#1)(2013-8#1)
it difficult to determine##2##4##(2008-8#1)(2010-3#1)
it difficult to identify the##2##5##(2008-4#1)(2012-3#1)
it difficult to perform##2##4##(2008-11#1)(2013-7#1)
it difficult to##25##3##(1992-12#1)(1992-6#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2009-9#1)(2010-10#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
it difficult##30##2##(1992-12#1)(1992-6#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
it diminished##2##2##(1994-9#1)(2012-2#1)
it directly##3##2##(1994-11#1)(2008-10#1)(2008-3#1)
it disappeared##2##2##(1991-11#1)(1996-2#1)
it displays##2##2##(2008-10#1)(2011-2#1)
it do##2##2##(2012-12#2)
it does for##2##3##(2008-3#1)(2008-8#1)
it does in##3##3##(1991-12#1)(1991-2#1)(2010-10#1)
it does not have##2##4##(2008-2#1)(2011-1#1)
it does not necessarily##2##4##(1992-1#1)(2009-5#1)
it does not need##2##4##(2008-2#1)(2008-5#1)
it does not require##5##4##(2007-11#1)(2008-10#1)(2008-3#2)(2009-7#1)
it does not use##2##4##(2008-10#1)(2008-6#1)
it does not##55##3##(1990-5#2)(1992-1#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
it does##74##2##(1990-5#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-6#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
it doesn't##2##2##(1993-2#1)(2010-9#1)
it during##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
it easier for##2##3##(1995-1#1)(1997-7#1)
it easier to##11##3##(1992-12#1)(1992-8#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
it easier##13##2##(1992-12#1)(1992-8#1)(1995-1#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
it effectively##2##2##(2008-11#2)
it either##2##2##(1993-1#1)(1996-3#1)
it elicits##2##2##(1996-5#1)(1997-2#1)
it emerges##2##2##(1990-9#1)(2008-12#1)
it enables##7##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-5#1)
it encodes a##4##3##(1990-11#1)(1990-12#1)(2008-9#1)(2009-10#1)
it encodes##7##2##(1990-11#1)(1990-12#1)(1994-8#1)(1995-2#1)(2008-9#1)(2009-10#1)(2009-12#1)
it encourages##2##2##(2008-11#1)(2008-7#1)
it enters##2##2##(1990-5#1)(2009-7#1)
it especially##2##2##(2007-12#1)(2011-2#1)
it essential##2##2##(2012-2#2)
it establishes a##2##3##(1996-11#1)(2012-3#1)
it even##2##2##(2008-5#1)(2010-6#1)
it examines##3##2##(1994-2#1)(1996-3#1)(2009-7#1)
it exhibited##3##2##(1991-8#1)(2008-4#1)(2009-11#1)
it exhibits a##2##3##(1991-12#1)(2007-11#1)
it exhibits##7##2##(1990-5#1)(1991-12#1)(1996-2#1)(2007-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
it exist?##2##2##(1994-8#1)(1996-2#1)
it existed##2##2##(1994-1#1)(2013-1#1)
it exists##5##2##(1991-12#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-3#1)
it explains##2##2##(2008-2#1)(2009-8#1)
it extends the LR parsing algorithm by using a##2##9##(2011-3#2)
it extends##5##2##(1993-6#1)(2008-4#1)(2008-7#1)(2011-3#2)
it facilitated##2##2##(1993-6#1)(2010-8#1)
it facilitates##2##2##(1994-2#1)(2009-2#1)
it failed to##2##3##(1992-2#1)(1993-6#1)
it feasible to##2##3##(1994-6#1)(2008-8#1)
it feasible?##2##2##(2007-10#1)(2011-2#1)
it focuses on##2##3##(2008-12#1)(2010-1#1)
it focuses##4##2##(1994-1#1)(2007-12#1)(2008-12#1)(2010-1#1)
it follows that the##2##4##(1990-11#1)(1994-8#1)
it follows that##4##3##(1990-11#1)(1994-8#1)(2008-10#1)(2010-1#1)
it follows##5##2##(1990-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-1#1)
it for the##3##3##(1990-7#1)(1997-3#1)(2008-11#1)
it for##20##2##(1990-7#1)(1991-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#2)
it formed##2##2##(1996-12#1)(2008-5#1)
it forms a##3##3##(1992-3#1)(1993-11#1)(1997-2#1)
it forms##6##2##(1992-3#1)(1993-11#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-7#1)
it found that##2##3##(2007-9#1)(2008-10#1)
it from being##2##3##(1994-2#1)(2008-5#1)
it from other##3##3##(1994-6#1)(2007-12#1)(2012-3#1)
it from the other##2##4##(1992-5#1)(2008-10#1)
it from the##4##3##(1992-5#1)(1996-4#1)(2008-10#1)(2008-8#1)
it from##17##2##(1992-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
it functions in the##2##4##(1993-12#1)(1996-3#1)
it functions in##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
it gave a##3##3##(1997-2#1)(2008-10#2)
it gave##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
it generally##2##2##(1992-9#1)(2008-10#1)
it generated##2##2##(2008-2#1)(2012-2#1)
it generates##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
it gets##2##2##(2008-2#1)(2012-2#1)
it gives##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#2)
it greatly##2##2##(1994-9#1)(2008-2#1)
it grows##2##2##(2008-10#1)(2011-2#1)
it had a sensitivity of##2##5##(1993-2#1)(1997-8#1)
it had a##11##3##(1992-8#1)(1993-2#1)(1994-9#1)(1995-12#1)(1997-8#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-4#1)
it had an##2##3##(1991-4#1)(1995-6#1)
it had been##3##3##(2008-8#1)(2009-7#1)(2010-3#1)
it had no effect at##2##5##(1993-12#1)(2008-2#1)
it had no effect on##5##5##(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-4#1)
it had no effect##7##4##(1993-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
it had only##2##3##(2008-10#1)(2008-6#1)
it had to##2##3##(2007-9#1)(2011-2#1)
it had##39##2##(1991-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-7#2)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
it hard##2##2##(1995-5#1)(2012-2#1)
it harder to##2##3##(1996-5#1)(2009-8#1)
it harder##3##2##(1996-5#2)(2009-8#1)
it has 92%##2##3##(1997-4#1)(2008-8#1)
it has a high##2##4##(1992-8#1)(2010-3#1)
it has a##18##3##(1991-5#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-6#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
it has also been##6##4##(1994-2#2)(2006-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
it has also##9##3##(1994-2#2)(2006-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2011-2#1)(2011-3#1)
it has an##5##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
it has become apparent that##3##5##(1995-3#1)(1997-8#1)(2008-11#1)
it has become clear that##4##5##(2008-10#1)(2009-3#2)(2010-12#1)
it has become evident that##2##5##(2011-2#1)(2012-2#1)
it has become increasingly##4##4##(1995-2#1)(2008-4#1)(2008-9#1)(2010-12#1)
it has become possible to##3##5##(2006-10#1)(2008-7#1)(2010-12#1)
it has become##20##3##(1995-2#1)(1995-3#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#2)(2010-12#3)(2011-2#1)(2012-2#1)
it has been applied##3##4##(1990-9#1)(2008-10#2)
it has been argued that##2##5##(2008-9#1)(2009-11#1)
it has been associated with##3##5##(2008-10#1)(2009-3#1)(2012-12#1)
it has been concluded that##2##5##(2008-10#2)
it has been demonstrated that##10##5##(1991-1#1)(1991-5#1)(1994-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
it has been demonstrated##11##4##(1990-9#1)(1991-1#1)(1991-5#1)(1994-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
it has been determined that##2##5##(1992-11#1)(2008-10#1)
it has been difficult to##3##5##(2008-4#1)(2008-8#1)(2013-8#1)
it has been difficult##4##4##(1993-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
it has been established that the##2##6##(1990-8#1)(1993-6#1)
it has been established that##7##5##(1990-8#1)(1993-6#1)(2006-4#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
it has been found that the##3##6##(1990-8#1)(2008-10#2)
it has been found that##8##5##(1990-8#1)(2008-10#5)(2008-9#1)(2009-11#1)
it has been hypothesized that##3##5##(2008-8#1)(2009-12#1)(2011-2#1)
it has been known for##2##5##(2008-1#1)(2012-2#1)
it has been known##4##4##(2008-1#1)(2012-2#1)(2013-1#2)
it has been necessary to##2##5##(2008-10#1)(2008-4#1)
it has been necessary##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
it has been observed that##5##5##(1991-2#1)(2008-10#3)(2010-1#1)
it has been observed##6##4##(1991-2#1)(2008-10#4)(2010-1#1)
it has been possible to##10##5##(1993-8#1)(1994-6#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-9#1)(2011-1#1)
it has been possible##11##4##(1993-8#1)(1994-6#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-6#1)(2010-9#1)(2011-1#1)
it has been postulated that##2##5##(2008-7#1)(2013-1#1)
it has been proposed that the##3##6##(1994-3#1)(1995-2#1)(2008-1#1)
it has been proposed that##7##5##(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
it has been proved that##2##5##(1992-5#1)(2012-12#1)
it has been proved##3##4##(1992-5#1)(2008-10#1)(2012-12#1)
it has been proven that##2##5##(2008-1#1)(2010-5#1)
it has been reported that##3##5##(1997-6#1)(2008-7#1)(2013-8#1)
it has been reported to##2##5##(2011-1#1)(2012-3#1)
it has been reported##6##4##(1997-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
it has been revealed that##3##5##(1991-9#1)(2008-1#1)(2008-9#1)
it has been shown that the##7##6##(1990-11#1)(1995-3#1)(1996-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
it has been shown that##13##5##(1990-11#1)(1994-11#1)(1995-3#1)(1995-9#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-1#3)(2013-8#1)
it has been shown to##5##5##(2007-10#1)(2007-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
it has been shown##20##4##(1990-11#1)(1994-11#1)(1995-3#1)(1995-9#1)(1996-5#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
it has been suggested that these##2##6##(1994-2#1)(2008-10#1)
it has been suggested that##19##5##(1990-8#1)(1992-12#1)(1992-8#2)(1994-2#1)(1995-6#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
it has been used to##3##5##(1993-2#1)(2008-10#1)(2008-4#1)
it has been used##4##4##(1993-2#1)(2008-10#2)(2008-4#1)
it has been well##2##4##(1992-9#1)(2008-7#1)
it has been##169##3##(1990-11#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#7)(2008-10#32)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#5)
it has direct##2##3##(2009-3#1)(2011-1#1)
it has evolved##2##3##(1991-1#1)(2009-6#1)
it has grown##2##3##(2011-2#2)
it has long been recognized that##2##6##(2008-5#1)(2010-1#1)
it has long been##3##4##(2008-5#1)(2008-7#1)(2010-1#1)
it has long##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)
it has many##2##3##(2008-2#1)(2012-2#1)
it has no##4##3##(1997-7#1)(2008-10#1)(2008-7#1)(2010-6#1)
it has not been possible to##2##6##(2008-8#1)(2010-8#1)
it has not been##6##4##(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
it has not##10##3##(1992-2#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
it has now become##2##4##(2008-10#1)(2008-7#1)
it has now##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
it has potential##3##3##(2006-12#1)(2008-10#2)
it has proved to##2##4##(2008-6#1)(2008-8#1)
it has reached##3##3##(1991-6#1)(2009-8#1)(2013-8#1)
it has recently been##3##4##(1994-11#1)(1996-2#1)(2010-12#1)
it has recently##4##3##(1994-11#1)(1996-2#1)(2008-4#1)(2010-12#1)
it has some##2##3##(2012-2#1)(2013-1#1)
it has the advantage of##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
it has the potential to##3##5##(1996-11#1)(2008-10#1)(2008-11#1)
it has the potential##4##4##(1996-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
it has the##14##3##(1996-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2013-8#1)
it has to be##5##4##(1993-11#1)(2007-7#1)(2008-12#1)(2008-6#1)(2010-10#1)
it has##362##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#3)(1993-8#2)(1994-11#3)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#4)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-7#1)(2007-8#2)(2008-1#11)(2008-10#59)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#10)(2008-6#3)(2008-7#17)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#5)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#18)(2013-8#8)
it have a##3##3##(1997-7#1)(2007-11#1)(2008-2#1)
it have been##2##3##(2007-7#1)(2013-1#1)
it have##7##2##(1995-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
it helped##2##2##(2007-7#1)(2010-3#1)
it helps to##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
it helps##8##2##(1990-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-3#1)(2012-2#1)
it highly##4##2##(1996-12#1)(2008-11#1)(2008-3#1)(2010-4#1)
it holds the##2##3##(1994-1#1)(1995-5#1)
it if they##2##3##(1994-2#1)(2008-7#1)
it ignores the##2##3##(2007-12#1)(2013-1#1)
it ignores##3##2##(2007-12#2)(2013-1#1)
it important##2##2##(1996-11#1)(2011-7#1)
it impossible to##7##3##(2007-12#1)(2008-1#1)(2008-3#1)(2009-8#1)(2012-12#1)(2012-3#2)
it improved##2##2##(2007-2#1)(2013-7#1)
it improves##5##2##(2008-4#2)(2008-7#1)(2010-7#1)(2011-2#1)
it in a##10##3##(1993-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
it in the##11##3##(1993-6#1)(1995-11#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#2)
it in##52##2##(1990-8#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-9#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
it inaccessible##2##2##(1993-3#1)(2008-11#1)
it included##2##2##(1991-6#1)(2008-10#1)
it includes##4##2##(1997-5#1)(2008-9#1)(2010-7#1)(2011-2#1)
it increased##14##2##(1990-5#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
it increases the##5##3##(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
it increases with##2##3##(2008-3#1)(2009-6#1)
it increases##11##2##(1996-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-8#1)(2009-12#1)(2009-6#1)
it indicates that##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
it indicates##5##2##(1995-6#1)(2007-8#1)(2008-10#2)(2011-2#1)
it induced##4##2##(1992-11#1)(1996-5#1)(2008-10#1)(2012-3#1)
it induces##4##2##(1997-2#1)(2007-7#1)(2009-2#1)(2012-2#1)
it inhibited the##2##3##(2008-11#2)
it inhibited##4##2##(1994-11#1)(1997-4#1)(2008-11#2)
it inhibits the##2##3##(1994-8#1)(2008-5#1)
it inhibits##4##2##(1994-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
it interacts##2##2##(1991-9#1)(2013-8#1)
it into a##4##3##(2007-8#1)(2008-10#1)(2008-12#1)(2010-8#1)
it into the##4##3##(1994-9#1)(1995-12#1)(1997-4#1)(2008-2#1)
it into##13##2##(1994-9#1)(1995-12#2)(1997-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)
it involves##6##2##(1994-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-1#1)
it is a common##2##4##(2008-10#1)(2008-2#1)
it is a critical##2##4##(1997-3#1)(2008-12#1)
it is a major##2##4##(1992-6#1)(2013-1#1)
it is a matter of##2##5##(2007-2#1)(2009-5#1)
it is a novel##2##4##(2008-10#1)(2010-10#1)
it is a rare##2##4##(2011-2#1)(2013-7#1)
it is a serious##2##4##(2008-3#1)(2009-3#1)
it is a significant cause of morbidity##2##7##(2008-7#1)(2013-8#1)
it is a useful tool for##2##6##(2008-5#1)(2008-8#1)
it is a valuable##2##4##(2007-11#1)(2008-11#1)
it is a very##4##4##(1992-12#1)(1995-3#1)(2008-10#2)
it is a##76##3##(1990-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
it is able to##10##4##(1990-2#1)(1997-6#1)(2008-1#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#2)(2013-8#1)
it is about##3##3##(1990-2#1)(1996-5#1)(2008-11#1)
it is accompanied by##2##4##(1995-3#1)(2008-12#1)
it is achieved##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
it is activated by##2##4##(1991-9#1)(2008-4#1)
it is advisable to##6##4##(1992-12#1)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
it is advisable##7##3##(1992-12#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
it is advised to##2##4##(2007-11#1)(2008-1#1)
it is affected by##2##4##(2008-5#1)(2013-8#1)
it is already##2##3##(2007-7#1)(2013-8#1)
it is also a##3##4##(2009-5#1)(2010-7#1)(2012-12#1)
it is also important##2##4##(2008-10#2)
it is also likely to##2##5##(2008-5#1)(2010-2#1)
it is also likely##3##4##(2008-5#1)(2009-8#1)(2010-2#1)
it is also possible that##2##5##(1994-9#1)(2013-1#1)
it is also possible to##3##5##(1997-6#1)(2008-10#1)(2008-4#1)
it is also possible##5##4##(1994-9#1)(1997-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
it is also the##2##4##(2009-1#1)(2012-2#1)
it is also well##2##4##(1990-3#1)(2008-9#1)
it is also##38##3##(1990-3#1)(1992-8#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#5)(2009-1#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
it is always##3##3##(1991-11#1)(1994-2#1)(2008-5#1)
it is amenable to##2##4##(1996-2#1)(2008-4#1)
it is an important##2##4##(2007-2#1)(2008-11#1)
it is an##17##3##(1991-2#1)(1994-1#1)(1994-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
it is apparent that##3##4##(2007-12#1)(2008-10#1)(2009-6#1)
it is applied to the##2##5##(1991-12#1)(2008-2#1)
it is applied to##5##4##(1991-12#1)(1995-5#1)(2008-10#1)(2008-2#1)(2012-2#1)
it is applied##8##3##(1991-12#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-2#1)(2012-2#1)
it is appropriate to##4##4##(1993-1#1)(1993-2#1)(2008-10#2)
it is appropriate##5##3##(1993-1#1)(1993-2#1)(2008-10#3)
it is approximately##2##3##(1997-5#1)(2008-3#1)
it is argued that##8##4##(1994-5#1)(1995-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#1)(2013-8#2)
it is argued##9##3##(1994-5#1)(1995-11#1)(1997-1#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#1)(2013-8#2)
it is assessed##2##3##(2008-11#1)(2012-2#1)
it is associated with a##2##5##(2011-2#1)(2013-7#1)
it is associated with##14##4##(1990-5#1)(1993-6#1)(1996-2#1)(2007-2#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
it is assumed that the##3##5##(1990-3#1)(1993-3#1)(2008-3#1)
it is assumed that##8##4##(1990-3#1)(1993-3#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-3#1)
it is at least##3##4##(1991-12#1)(2008-1#1)(2008-10#1)
it is at##5##3##(1991-12#1)(2008-1#1)(2008-10#1)(2009-8#1)(2013-1#1)
it is attributed to##2##4##(1990-5#1)(2008-5#1)
it is based on the##2##5##(2008-3#1)(2008-9#1)
it is based##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
it is becoming increasingly important##2##5##(2007-8#1)(2011-2#1)
it is becoming##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
it is being used as##2##5##(2008-11#2)
it is being used##3##4##(2007-7#1)(2008-11#2)
it is being##7##3##(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
it is believed that##5##4##(1994-8#1)(1995-1#1)(2007-2#1)(2008-11#1)(2008-7#1)
it is believed to be##2##5##(1997-8#1)(2008-10#1)
it is believed##8##3##(1994-8#1)(1995-1#1)(1997-1#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
it is beneficial to##4##4##(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
it is best##2##3##(2008-10#1)(2008-4#1)
it is both##2##3##(1996-8#1)(2008-7#1)
it is called##2##3##(1991-1#1)(2009-10#1)
it is capable of##2##4##(2007-12#1)(2008-3#1)
it is caused by##3##4##(2007-11#1)(2008-10#1)(2009-6#1)
it is characterized by##3##4##(2007-11#1)(2009-3#1)(2013-8#1)
it is clear that the##3##5##(1997-6#1)(2008-10#1)(2008-12#1)
it is clear that##20##4##(1994-11#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
it is clear##21##3##(1994-11#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
it is clearly##2##3##(2008-11#1)(2008-4#1)
it is combined with##2##4##(2007-11#1)(2011-2#1)
it is compared##2##3##(2008-3#1)(2012-2#1)
it is conceivable that##2##4##(1995-12#1)(2008-10#1)
it is concluded that the##9##5##(1990-7#1)(1991-11#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)
it is concluded that##21##4##(1990-2#1)(1990-7#1)(1991-11#1)(1992-11#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2009-7#1)
it is concluded##22##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1992-11#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2009-7#1)
it is confirmed that the##2##5##(2007-12#1)(2008-2#1)
it is confirmed that##3##4##(2007-12#1)(2008-2#1)(2008-8#1)
it is considered a##4##4##(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
it is considered that##3##4##(2008-10#1)(2008-9#2)
it is considered##10##3##(1994-8#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-9#2)(2011-2#2)(2012-2#1)
it is contended##2##3##(2013-8#2)
it is converted##2##3##(1994-2#1)(2008-10#1)
it is critical that the##3##5##(1996-4#1)(2008-3#1)(2013-1#1)
it is critical that##5##4##(1996-4#1)(2008-3#1)(2010-11#1)(2010-6#1)(2013-1#1)
it is critical to##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
it is critical##8##3##(1996-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-11#1)(2010-6#1)(2013-1#1)
it is crucial for##2##4##(2008-6#1)(2008-7#1)
it is crucial that##2##4##(2008-10#1)(2011-2#1)
it is crucial to##4##4##(1991-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
it is crucial##8##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
it is currently##5##3##(1991-2#1)(1992-12#1)(2008-10#1)(2008-3#2)
it is demonstrated that the##5##5##(1992-12#1)(1992-9#1)(2008-10#1)(2008-3#1)(2013-1#1)
it is demonstrated that##11##4##(1990-12#2)(1992-12#1)(1992-9#1)(2007-12#2)(2008-10#2)(2008-3#2)(2013-1#1)
it is demonstrated##12##3##(1990-12#2)(1992-12#1)(1992-9#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2013-1#1)
it is described##2##3##(1995-12#1)(2008-1#1)
it is desirable to minimize##2##5##(2008-6#1)(2012-3#1)
it is desirable to##7##4##(1991-5#1)(1997-4#1)(2007-11#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-3#1)
it is desirable##10##3##(1991-5#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-5#1)(2010-2#1)(2012-3#1)
it is determined##2##3##(2008-10#1)(2008-7#1)
it is difficult to achieve##2##5##(1994-11#1)(2010-12#1)
it is difficult to diagnose##3##5##(2009-12#1)(2009-5#1)(2013-8#1)
it is difficult to differentiate##2##5##(2007-8#1)(2008-1#1)
it is difficult to distinguish##2##5##(2012-9#1)(2013-8#1)
it is difficult to predict##2##5##(1996-2#1)(2011-2#1)
it is difficult to##34##4##(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-9#1)(2013-8#2)
it is difficult##39##3##(1991-3#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-9#1)(2013-8#2)
it is discussed how##2##4##(1995-5#1)(2008-11#1)
it is easier and##2##4##(1991-3#1)(2008-12#1)
it is easier to##2##4##(2008-10#1)(2013-1#1)
it is easier##4##3##(1991-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
it is easily##2##3##(2008-10#1)(2008-4#1)
it is easy to carry and store the##2##8##(2008-10#2)
it is easy to see##2##5##(1994-12#1)(2011-2#1)
it is easy to##7##4##(1994-12#1)(2008-10#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)
it is easy##8##3##(1994-12#1)(2008-10#3)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)
it is effective##3##3##(1997-2#1)(2008-11#1)(2008-2#1)
it is enhanced##2##3##(2008-7#1)(2008-9#1)
it is envisioned that##2##4##(2008-10#1)(2012-2#1)
it is especially important##2##4##(1994-3#1)(2008-5#1)
it is especially##5##3##(1991-8#1)(1994-3#1)(2008-5#1)(2013-1#1)(2013-7#1)
it is essential for##3##4##(1990-5#1)(1996-3#1)(2008-1#1)
it is essential that##4##4##(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
it is essential to have##2##5##(1995-5#1)(2008-2#1)
it is essential to##16##4##(1991-6#1)(1994-9#1)(1995-5#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
it is essential##23##3##(1990-5#1)(1991-6#1)(1994-9#1)(1995-5#2)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
it is estimated that the##2##5##(1993-8#1)(2008-5#1)
it is estimated that##7##4##(1993-8#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
it is estimated##9##3##(1993-8#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
it is evident that the##4##5##(1993-1#1)(1997-8#1)(2008-11#1)(2008-9#1)
it is evident that##8##4##(1993-1#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#1)
it is expected that##2##4##(2008-10#1)(2010-12#1)
it is expected##5##3##(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
it is expressed##2##3##(1992-12#1)(2008-1#1)
it is extremely##2##3##(2008-3#1)(2012-2#1)
it is feasible that##2##4##(2008-11#1)(2009-7#1)
it is feasible to##7##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
it is feasible##10##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
it is for##3##3##(1994-1#1)(2008-3#2)
it is found in##2##4##(1990-3#1)(2012-2#1)
it is found that the##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-7#1)
it is found that##14##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#3)(2009-7#1)
it is found##19##3##(1990-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#3)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
it is frequently misdiagnosed##2##4##(2008-11#1)(2013-8#1)
it is frequently##5##3##(1990-5#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
it is generally accepted that##4##5##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
it is generally assumed that##2##5##(1994-11#1)(2008-3#1)
it is generally##14##3##(1994-11#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2012-7#1)
it is hard to##2##4##(2008-9#1)(2011-2#1)
it is highly desirable to##2##5##(2008-11#1)(2011-2#1)
it is highly##7##3##(1992-3#1)(2007-7#1)(2008-11#2)(2011-2#1)(2013-1#1)(2013-8#1)
it is hoped that##3##4##(1994-2#1)(2008-10#1)(2008-4#1)
it is hoped##7##3##(1992-12#1)(1993-3#1)(1994-2#1)(2008-1#1)(2008-10#2)(2008-4#1)
it is hypothesized that this##2##5##(1995-11#1)(2009-1#1)
it is hypothesized that##7##4##(1992-8#1)(1995-11#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-5#1)
it is hypothesized##8##3##(1992-8#1)(1995-11#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-5#1)(2010-11#1)
it is imperative that##9##4##(1995-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-3#1)(2011-1#1)
it is imperative to##5##4##(2008-3#1)(2009-7#1)(2012-12#1)(2013-1#2)
it is imperative##15##3##(1995-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
it is implemented##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
it is important for physicians##2##5##(1991-1#1)(2011-1#1)
it is important for##8##4##(1991-1#1)(1993-1#1)(2008-10#1)(2008-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
it is important that the##2##5##(2010-8#1)(2013-8#1)
it is important that##8##4##(1992-6#1)(1994-5#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2013-8#1)
it is important to assess##3##5##(2008-10#1)(2009-11#1)(2011-2#1)
it is important to be able to##2##7##(1991-1#1)(2009-11#1)
it is important to characterize##2##5##(2008-3#1)(2012-2#1)
it is important to consider##4##5##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
it is important to determine whether##2##6##(2008-4#1)(2010-6#1)
it is important to determine##3##5##(2008-4#1)(2010-6#1)(2012-2#1)
it is important to develop##2##5##(1992-9#1)(2008-6#1)
it is important to establish##5##5##(1993-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
it is important to evaluate##2##5##(2008-1#1)(2008-9#1)
it is important to exclude##2##5##(2009-8#1)(2010-10#1)
it is important to have##2##5##(2008-10#1)(2008-9#1)
it is important to identify##2##5##(2010-11#1)(2012-2#1)
it is important to immediately##2##5##(2010-6#1)(2011-2#1)
it is important to keep in mind##2##7##(2009-12#1)(2009-6#1)
it is important to keep##3##5##(2008-1#1)(2009-12#1)(2009-6#1)
it is important to know the##2##6##(2008-10#1)(2010-5#1)
it is important to know##4##5##(1997-5#1)(2008-10#1)(2008-4#1)(2010-5#1)
it is important to make##2##5##(2008-7#1)(2011-2#1)
it is important to perform##2##5##(2008-7#1)(2012-3#1)
it is important to recognize the##2##6##(2011-2#1)(2013-1#1)
it is important to understand the statistical sample of groups from which these norms are drawn##2##16##(1994-3#2)
it is important to understand the##4##6##(1994-3#2)(2010-8#1)(2012-2#1)
it is important to understand##7##5##(1994-3#2)(2008-10#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
it is important to##76##4##(1991-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#2)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-1#3)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#7)(2012-2#5)(2012-3#1)(2013-1#6)
it is important##96##3##(1991-1#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-2#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#8)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#1)
it is impossible to predict a priori##2##7##(1990-8#2)
it is impossible to predict##3##5##(1990-8#2)(2008-8#1)
it is impossible to##10##4##(1990-8#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
it is impossible##12##3##(1990-8#2)(1994-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
it is in##12##3##(1990-2#1)(1990-5#1)(1991-1#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)
it is increasingly##3##3##(1994-2#1)(1994-3#1)(2008-11#1)
it is indispensable to##2##4##(2008-5#1)(2012-8#1)
it is inhibited##2##3##(2008-10#1)(2008-7#1)
it is insensitive to##2##4##(1995-11#1)(2008-2#1)
it is involved in##2##4##(1995-2#1)(1996-12#1)
it is involved##4##3##(1995-2#1)(1996-12#1)(2011-1#1)(2013-7#1)
it is known in##2##4##(1992-2#1)(2009-3#1)
it is known that the##3##5##(1990-6#1)(2008-2#1)(2012-1#1)
it is known that##6##4##(1990-6#1)(1993-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)
it is known to be##2##5##(2010-3#1)(2011-2#1)
it is known to##3##4##(2008-5#1)(2010-3#1)(2011-2#1)
it is known##12##3##(1990-6#1)(1992-2#1)(1993-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)
it is lacking##2##3##(1995-11#1)(2009-7#1)
it is large##2##3##(1994-2#1)(2011-2#1)
it is legal##2##3##(2008-11#1)(2010-12#1)
it is less invasive##2##4##(2008-7#1)(2011-2#1)
it is less##4##3##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
it is likely that the##9##5##(1992-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
it is likely that this##7##5##(1990-11#1)(1992-12#1)(1993-11#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
it is likely that##38##4##(1990-11#1)(1992-12#3)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#3)(1995-6#1)(1997-1#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
it is likely to be##2##5##(2008-4#1)(2012-2#1)
it is likely to##4##4##(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
it is likely##42##3##(1990-11#1)(1992-12#3)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#3)(1995-6#1)(1997-1#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
it is located##3##3##(1990-12#1)(1995-2#1)(1995-6#1)
it is made##4##3##(1996-5#1)(2008-10#1)(2008-3#1)(2009-7#1)
it is mainly##2##3##(2008-5#1)(2010-8#1)
it is measured##2##3##(2008-9#2)
it is mixed##2##3##(2008-10#2)
it is more commonly##2##4##(2008-7#1)(2008-8#1)
it is more difficult to##2##5##(2008-11#1)(2010-6#1)
it is more effective to##2##5##(2008-3#1)(2008-7#1)
it is more likely##2##4##(2008-5#1)(2010-3#1)
it is more sensitive##3##4##(2008-2#1)(2008-4#1)(2008-6#1)
it is more##21##3##(1993-1#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)
it is much faster##3##4##(2008-10#1)(2008-3#2)
it is much##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
it is natural to##2##4##(1995-5#1)(1997-4#1)
it is nearly##2##3##(1994-12#1)(2008-8#1)
it is necessary for##2##4##(2008-11#1)(2010-7#1)
it is necessary that##2##4##(2008-2#1)(2013-1#1)
it is necessary to carry##2##5##(1991-9#1)(2008-11#1)
it is necessary to consider##3##5##(1996-11#1)(2008-3#1)(2008-5#1)
it is necessary to develop##3##5##(2008-10#1)(2008-9#2)
it is necessary to evaluate##2##5##(1990-8#1)(2008-12#1)
it is necessary to examine##2##5##(1996-12#1)(2008-11#1)
it is necessary to have a##2##6##(1991-1#1)(2008-2#1)
it is necessary to have##3##5##(1991-1#1)(2008-11#1)(2008-2#1)
it is necessary to identify##4##5##(1990-6#1)(1995-5#1)(2008-10#1)(2010-5#1)
it is necessary to improve##2##5##(2008-11#1)(2013-1#1)
it is necessary to understand##5##5##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
it is necessary to##66##4##(1990-6#1)(1990-8#2)(1991-1#2)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
it is necessary##72##3##(1990-6#1)(1990-8#2)(1991-1#2)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
it is needed##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
it is no longer##2##4##(1995-3#1)(2008-10#1)
it is no wonder that##2##5##(1991-5#1)(2012-2#1)
it is no##4##3##(1991-5#1)(1995-3#1)(2008-10#1)(2012-2#1)
it is not a##4##4##(1994-12#1)(1995-6#1)(2008-3#1)(2010-9#1)
it is not always##4##4##(1997-3#1)(2007-11#1)(2008-10#1)(2009-3#1)
it is not as##2##4##(1990-6#1)(1996-11#1)
it is not clear whether##6##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)
it is not clear##9##4##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-1#1)(2013-1#1)
it is not completely understood##2##5##(2008-1#1)(2008-4#1)
it is not completely##3##4##(2008-1#2)(2008-4#1)
it is not fully##2##4##(2007-11#1)(2008-4#1)
it is not known if##2##5##(1996-2#1)(2008-10#1)
it is not known##5##4##(1996-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)
it is not necessary to##4##5##(1997-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
it is not possible to obtain##2##6##(2007-12#1)(2008-3#1)
it is not possible to##10##5##(1990-5#1)(1993-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
it is not readily##2##4##(1990-5#1)(2008-2#1)
it is not surprising that##3##5##(1997-6#1)(2008-7#1)(2011-2#1)
it is not very likely##2##5##(1994-3#1)(2013-1#1)
it is not widely used##2##5##(2010-6#1)(2013-1#1)
it is not yet generally##2##5##(1990-2#1)(1992-12#1)
it is not yet possible to##2##6##(2008-5#1)(2010-8#1)
it is not yet##5##4##(1990-2#1)(1992-12#1)(1993-2#1)(2008-5#1)(2010-8#1)
it is not##98##3##(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
it is noteworthy that##4##4##(1993-2#1)(2008-7#1)(2010-10#1)(2012-2#1)
it is now clear that##2##5##(2010-12#1)(2011-2#1)
it is now possible to##5##5##(1990-12#1)(1991-1#1)(1993-8#1)(2008-10#1)(2012-12#1)
it is now widely accepted that##2##6##(2011-2#1)(2012-3#1)
it is now widely##3##4##(2008-4#1)(2011-2#1)(2012-3#1)
it is now##19##3##(1990-12#1)(1991-1#1)(1993-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
it is nowadays accepted that##2##5##(1992-3#1)(2008-10#1)
it is obvious that##2##4##(1994-12#1)(2007-12#1)
it is of interest to##2##5##(1993-12#1)(2008-7#1)
it is of paramount importance to##2##6##(1991-5#1)(2008-10#1)
it is of##16##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
it is often desirable to##2##5##(2008-1#1)(2008-9#1)
it is often found that##2##5##(2008-7#1)(2010-4#1)
it is often necessary to##2##5##(2008-2#1)(2008-9#1)
it is often necessary##3##4##(2007-7#1)(2008-2#1)(2008-9#1)
it is often##15##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#2)
it is one of the most##4##6##(1994-12#1)(2008-11#1)(2008-4#1)(2010-10#1)
it is one of the##7##5##(1994-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-10#1)(2012-2#1)
it is only a##2##4##(1994-12#1)(2013-8#1)
it is only present##2##4##(1996-12#1)(2008-10#1)
it is only##12##3##(1993-9#1)(1994-12#2)(1994-7#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
it is our##2##3##(1995-8#1)(2010-12#1)
it is particularly##2##3##(2010-5#1)(2012-12#1)
it is perceived##2##3##(2008-12#1)(2010-12#1)
it is performed by##2##4##(1991-3#1)(2007-8#1)
it is planned##2##3##(1994-12#1)(2007-11#1)
it is plausible that##3##4##(2008-11#1)(2009-6#1)(2009-8#1)
it is plausible to##2##4##(2008-10#1)(2008-2#1)
it is plausible##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2009-8#1)
it is possible for##3##4##(2007-12#2)(2008-11#1)
it is possible that the##5##5##(1997-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
it is possible that they##2##5##(1994-5#1)(2008-11#1)
it is possible that this##2##5##(1995-5#1)(1997-1#1)
it is possible that##25##4##(1991-6#1)(1992-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
it is possible to achieve##2##5##(2007-11#1)(2008-2#1)
it is possible to assess the##2##6##(1993-6#1)(2008-10#1)
it is possible to avoid##3##5##(1990-8#1)(2007-11#1)(2008-2#1)
it is possible to combine##2##5##(2007-12#1)(2013-1#1)
it is possible to construct a##2##6##(2008-2#1)(2008-9#1)
it is possible to construct##3##5##(2008-2#1)(2008-3#1)(2008-9#1)
it is possible to control##3##5##(2008-10#1)(2008-3#2)
it is possible to design and##2##6##(2008-2#1)(2012-3#1)
it is possible to design##4##5##(1992-8#1)(2008-2#1)(2008-3#1)(2012-3#1)
it is possible to detect##4##5##(1990-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
it is possible to determine the approximate degree of coupling by amino acid analysis##3##14##(2008-2#1)(2008-4#2)
it is possible to determine the##6##6##(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#1)
it is possible to determine##10##5##(1997-2#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-9#1)
it is possible to distinguish##2##5##(2007-12#1)(2010-4#1)
it is possible to establish##2##5##(2008-5#1)(2013-1#1)
it is possible to estimate the##2##6##(1996-12#1)(2008-3#1)
it is possible to estimate##4##5##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)
it is possible to extract the##2##6##(2008-3#2)
it is possible to extract##3##5##(2008-3#2)(2008-9#1)
it is possible to identify##2##5##(2006-4#1)(2008-11#1)
it is possible to introduce##2##5##(2006-12#1)(2008-10#1)
it is possible to investigate##2##5##(1997-8#1)(2008-7#1)
it is possible to measure##3##5##(1990-12#1)(2008-3#1)(2009-12#1)
it is possible to obtain a model adjusted to the concentration values of the mixtures used in the calibration##2##19##(2008-10#2)
it is possible to obtain##7##5##(1990-12#1)(2007-12#1)(2008-10#4)(2008-4#1)
it is possible to perform quantitative##2##6##(2008-10#2)
it is possible to perform##5##5##(2007-12#1)(2008-10#3)(2008-7#1)
it is possible to produce##3##5##(2008-10#1)(2008-11#1)(2008-2#1)
it is possible to reduce the##2##6##(2007-12#1)(2008-3#1)
it is possible to##143##4##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#9)(2008-12#3)(2008-2#12)(2008-3#19)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
it is possible##176##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#11)(2007-8#2)(2008-1#3)(2008-10#33)(2008-11#12)(2008-12#3)(2008-2#12)(2008-3#19)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
it is predicted that the##2##5##(2008-7#2)
it is predicted that##3##4##(2008-3#1)(2008-7#2)
it is predicted##4##3##(1994-2#1)(2008-3#1)(2008-7#2)
it is preferable to##3##4##(1990-6#1)(2008-10#1)(2011-3#1)
it is preferable##4##3##(1990-6#1)(2007-12#1)(2008-10#1)(2011-3#1)
it is premature to##2##4##(2008-6#1)(2013-1#1)
it is premature##3##3##(2008-6#1)(2009-9#1)(2013-1#1)
it is present##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
it is primarily##3##3##(1992-12#1)(2008-3#1)(2009-9#1)
it is probable##2##3##(2007-11#1)(2007-12#1)
it is produced##2##3##(1992-7#1)(2008-11#1)
it is proposed that the##4##5##(1993-11#1)(2008-10#2)(2013-8#1)
it is proposed that##14##4##(1990-7#1)(1992-5#1)(1993-11#1)(1993-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
it is proposed to##2##4##(2008-2#1)(2013-8#1)
it is proposed##19##3##(1990-5#1)(1990-7#1)(1991-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#3)
it is proven##2##3##(2008-10#1)(2008-11#1)
it is prudent##2##3##(2008-5#1)(2013-1#1)
it is questionable##2##3##(1995-2#1)(1996-9#1)
it is quite likely that##3##5##(1991-2#1)(1997-1#1)(2008-4#1)
it is quite##7##3##(1991-2#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
it is rare##4##3##(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)
it is rarely seen##2##4##(2008-11#1)(2013-8#1)
it is rarely##6##3##(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2013-8#1)
it is rather##2##3##(2008-10#1)(2008-11#1)
it is reasonable to##8##4##(1991-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
it is recognized##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
it is recommended that the##3##5##(2008-7#1)(2012-12#2)
it is recommended that##16##4##(1991-3#1)(1994-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
it is recommended to##3##4##(1995-4#1)(2008-10#1)(2008-11#1)
it is recommended##19##3##(1991-3#1)(1994-11#1)(1995-4#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
it is related to the##2##5##(2008-2#1)(2013-1#1)
it is related to##5##4##(2008-1#1)(2008-2#1)(2008-5#1)(2009-10#1)(2013-1#1)
it is relatively##6##3##(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#1)
it is released##2##3##(1991-8#1)(1995-11#1)
it is removed##2##3##(2010-6#1)(2011-2#1)
it is reported##4##3##(2008-12#1)(2011-2#1)(2012-12#2)
it is required##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
it is responsible for the##4##5##(1994-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
it is robust##2##3##(2008-10#1)(2008-9#1)
it is safe to##2##4##(1993-9#1)(2008-12#1)
it is safe##3##3##(1993-9#1)(2008-12#1)(2011-1#1)
it is seen that the##2##5##(2008-10#1)(2008-3#1)
it is seen##6##3##(1991-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
it is shown how the##3##5##(2008-3#1)(2008-6#2)
it is shown how##4##4##(2008-3#1)(2008-4#1)(2008-6#2)
it is shown that a##5##5##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
it is shown that it is##2##6##(2008-2#1)(2008-3#1)
it is shown that the##22##5##(1991-9#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2008-7#1)(2009-9#1)(2010-3#1)
it is shown that these##2##5##(1990-7#1)(2008-2#1)
it is shown that this##2##5##(2007-12#1)(2008-3#1)
it is shown that##60##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#18)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)
it is shown to##2##4##(2008-10#1)(2010-4#1)
it is shown##68##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#20)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)
it is significantly##3##3##(1992-12#1)(1992-6#1)(2008-6#1)
it is simple##5##3##(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
it is sometimes##2##3##(1996-12#1)(2008-3#1)
it is speculated that##2##4##(1992-3#1)(1996-2#1)
it is stated that##2##4##(1993-6#1)(1995-6#1)
it is still a##3##4##(1994-6#1)(2010-11#2)
it is still not##2##4##(2009-5#1)(2011-2#1)
it is still unclear whether##2##5##(2013-8#2)
it is still unclear##5##4##(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#2)
it is still##21##3##(1994-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#3)
it is strictly##2##3##(2008-10#1)(2011-2#1)
it is striking to##2##4##(2008-1#1)(2012-1#1)
it is striking##3##3##(2008-1#1)(2009-8#1)(2012-1#1)
it is strongly##2##3##(2008-11#1)(2012-12#1)
it is subjected##2##3##(2008-3#1)(2009-12#1)
it is suggested that both##2##5##(2008-8#1)(2012-2#1)
it is suggested that the##14##5##(1991-2#1)(1991-9#1)(1994-8#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
it is suggested that this##3##5##(2008-10#1)(2008-12#1)(2008-8#1)
it is suggested that##40##4##(1991-12#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-7#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#5)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
it is suggested##42##3##(1991-12#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-7#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#5)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
it is suitable for##5##4##(1994-3#1)(2008-10#3)(2008-4#1)
it is suitable##6##3##(1994-3#1)(2008-10#3)(2008-4#1)(2010-12#1)
it is suspected that##2##4##(1990-9#1)(1997-4#1)
it is the case##3##4##(2008-10#2)(2008-5#1)
it is the first time##2##5##(2008-10#2)
it is the first##4##4##(2008-10#4)
it is the most##3##4##(2008-1#1)(2008-7#1)(2011-2#1)
it is the same##2##4##(1996-6#1)(2008-8#1)
it is the##54##3##(1990-2#1)(1990-8#1)(1991-10#1)(1991-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#3)(2012-12#2)(2013-8#2)
it is therefore##2##3##(2007-11#1)(2008-3#1)
it is thought that##3##4##(1990-6#1)(1996-11#1)(2008-2#1)
it is thought##4##3##(1990-6#1)(1992-12#1)(1996-11#1)(2008-2#1)
it is time for##4##4##(1991-3#1)(2007-11#1)(2008-1#1)(2008-7#1)
it is to##9##3##(1990-12#1)(1992-3#1)(1993-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)
it is too early to##2##5##(2008-1#1)(2008-5#1)
it is too##5##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
it is unclear how##6##4##(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
it is unclear if##5##4##(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
it is unclear whether the##2##5##(2008-8#2)
it is unclear whether##8##4##(1996-1#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2013-1#2)
it is unclear##23##3##(1994-12#1)(1996-1#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
it is unknown whether##4##4##(2006-10#1)(2008-11#2)(2008-7#1)
it is unknown##7##3##(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2013-1#1)
it is unlikely that this##2##5##(1995-5#1)(2008-10#1)
it is unlikely that##16##4##(1990-2#1)(1990-7#1)(1990-8#1)(1993-9#1)(1995-12#1)(1995-5#2)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)
it is urgent##2##3##(1994-12#1)(2013-1#1)
it is used in##2##4##(2008-6#1)(2013-8#1)
it is used##6##3##(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#2)(2013-8#1)
it is useful in##2##4##(2010-12#1)(2012-2#1)
it is useful to##3##4##(1991-1#1)(2008-10#1)(2013-1#1)
it is useful##6##3##(1991-1#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-1#1)
it is usually possible##2##4##(1997-3#1)(2008-9#1)
it is usually##9##3##(1991-2#1)(1995-5#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-7#2)(2008-9#1)
it is very difficult to establish##2##6##(2008-11#1)(2008-7#1)
it is very difficult to##4##5##(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)
it is very important to investigate the##2##7##(2008-10#1)(2008-11#1)
it is very important to##4##5##(2008-10#2)(2008-11#1)(2008-8#1)
it is very important##6##4##(1993-12#1)(2008-10#2)(2008-11#2)(2008-8#1)
it is very##14##3##(1993-12#1)(1993-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
it is vital for##3##4##(2008-9#1)(2009-9#1)(2010-10#1)
it is vital that researchers explore the intersection of spirituality##2##10##(2013-1#2)
it is vital that##4##4##(1997-1#1)(2007-11#1)(2013-1#2)
it is vital to##3##4##(1995-3#1)(2012-12#1)(2013-8#1)
it is vital##10##3##(1995-3#1)(1997-1#1)(2007-11#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
it is well known that##5##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
it is well suited##2##4##(2008-11#1)(2008-6#1)
it is well##11##3##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
it is well-known that##2##4##(2008-10#1)(2008-11#1)
it is widely##2##3##(1994-8#1)(2007-11#1)
it is wished##2##3##(1993-9#1)(2008-8#1)
it is worthwhile to##2##4##(1996-4#1)(2008-4#1)
it is##2099##2##(1990-11#4)(1990-12#13)(1990-2#9)(1990-3#5)(1990-5#12)(1990-6#6)(1990-7#4)(1990-8#8)(1990-9#3)(1991-1#10)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#9)(1991-5#5)(1991-6#5)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#16)(1992-2#2)(1992-3#12)(1992-4#1)(1992-5#4)(1992-6#7)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#5)(1993-11#4)(1993-12#9)(1993-2#6)(1993-3#5)(1993-6#4)(1993-8#6)(1993-9#7)(1994-1#6)(1994-11#7)(1994-12#17)(1994-2#11)(1994-3#12)(1994-5#8)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#7)(1995-1#4)(1995-11#7)(1995-12#9)(1995-2#12)(1995-3#7)(1995-4#1)(1995-5#15)(1995-6#11)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#6)(1996-12#16)(1996-2#9)(1996-3#9)(1996-4#3)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#13)(1997-2#7)(1997-3#8)(1997-4#6)(1997-5#5)(1997-6#6)(1997-7#5)(1997-8#6)(1997-9#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#38)(2007-12#46)(2007-2#5)(2007-5#2)(2007-6#1)(2007-7#13)(2007-8#11)(2008-1#39)(2008-10#275)(2008-11#108)(2008-12#31)(2008-2#77)(2008-3#131)(2008-4#47)(2008-5#49)(2008-6#19)(2008-7#81)(2008-8#47)(2008-9#55)(2009-1#3)(2009-10#9)(2009-11#7)(2009-12#8)(2009-2#5)(2009-3#5)(2009-4#4)(2009-5#14)(2009-6#7)(2009-7#12)(2009-8#11)(2009-9#8)(2010-1#3)(2010-10#6)(2010-11#13)(2010-12#13)(2010-2#6)(2010-3#13)(2010-4#8)(2010-5#8)(2010-6#11)(2010-7#5)(2010-8#15)(2010-9#2)(2011-1#19)(2011-2#91)(2011-3#3)(2012-1#7)(2012-12#25)(2012-2#43)(2012-3#26)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#59)(2013-7#9)(2013-8#46)
it just a##3##3##(2008-10#1)(2008-11#2)
it lacks adequate##2##3##(2012-2#1)(2013-1#1)
it lacks##7##2##(1990-7#1)(1997-5#1)(2008-4#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
it lasted##2##2##(2008-5#1)(2012-3#1)
it leads to a##3##4##(1994-6#1)(2008-10#1)(2008-7#1)
it leads to##6##3##(1994-6#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
it led to##2##3##(1995-2#1)(2011-2#1)
it led##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
it made##2##2##(1991-3#1)(2011-1#1)
it makes the##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
it makes##9##2##(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-8#1)
it matter##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
it may act as a##4##5##(1994-10#1)(2008-1#1)(2008-7#1)(2008-8#1)
it may act as##5##4##(1990-2#1)(1994-10#1)(2008-1#1)(2008-7#1)(2008-8#1)
it may also be##5##4##(2008-10#1)(2008-8#2)(2010-3#1)(2010-8#1)
it may also lead to##2##5##(2013-7#1)(2013-8#1)
it may also occur##2##4##(1997-8#1)(2008-8#1)
it may also##12##3##(1997-8#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
it may be a##9##4##(1990-2#1)(1993-2#1)(1994-11#1)(1996-4#1)(2008-10#3)(2008-3#1)(2010-7#1)
it may be an##3##4##(2007-11#1)(2008-11#1)(2008-9#1)
it may be applied to##2##5##(2008-2#2)
it may be associated with the##2##6##(2008-7#1)(2009-9#1)
it may be associated with##5##5##(1995-3#1)(2008-7#1)(2009-9#1)(2010-4#1)(2013-1#1)
it may be associated##6##4##(1995-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-4#1)(2013-1#1)
it may be concluded that##4##5##(1992-12#1)(1992-5#1)(1997-6#1)(2008-11#1)
it may be desirable to##2##5##(2008-11#1)(2008-4#1)
it may be difficult to##2##5##(1992-2#1)(2013-1#1)
it may be inferred that##2##5##(1995-6#1)(2008-3#1)
it may be more accurate##2##5##(2008-3#1)(2008-6#1)
it may be more##4##4##(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
it may be necessary to##4##5##(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#1)
it may be possible to use##2##6##(2008-3#1)(2008-5#1)
it may be possible to##11##5##(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-4#1)(2011-1#1)
it may be possible##12##4##(1993-12#1)(1994-6#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-4#1)(2011-1#1)
it may be that##2##4##(2008-10#1)(2008-7#1)
it may be useful to##3##5##(1992-2#1)(1997-3#1)(2008-10#1)
it may be useful##4##4##(1992-2#1)(1997-3#1)(1997-4#1)(2008-10#1)
it may be##86##3##(1990-11#1)(1990-2#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#3)
it may become##2##3##(2008-10#1)(2011-2#1)
it may cause##2##3##(2008-7#2)
it may contribute##2##3##(2008-7#1)(2012-12#1)
it may have##6##3##(1995-9#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)
it may mimic##2##3##(2007-5#1)(2011-2#1)
it may not##4##3##(1990-2#2)(1992-10#1)(1997-3#1)
it may play a role in##3##6##(1991-5#1)(1996-4#1)(2007-12#1)
it may play a##6##4##(1991-5#1)(1993-3#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#1)
it may play an important role in##2##7##(2008-10#1)(2010-5#1)
it may play##8##3##(1991-5#1)(1993-3#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#2)(2010-5#1)
it may prevent##2##3##(1994-9#1)(2008-8#1)
it may provide##3##3##(2008-7#1)(2009-2#1)(2010-1#1)
it may reduce##2##3##(1995-5#1)(2013-1#1)
it may represent a##2##4##(2008-10#1)(2011-2#1)
it may represent##3##3##(2008-10#1)(2011-2#2)
it may require##2##3##(1997-4#1)(2006-10#1)
it may result in##2##4##(2007-8#1)(2008-11#1)
it may##183##2##(1990-11#1)(1990-2#4)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-4#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#10)(2008-9#3)(2009-10#4)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
it means that##2##3##(2008-7#1)(2010-7#1)
it means##9##2##(1991-1#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#2)
it mediates##4##2##(1993-12#1)(1997-2#1)(2008-5#1)(2012-2#1)
it meets the##2##3##(1994-3#1)(1997-3#1)
it might be##16##3##(1993-5#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-6#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
it might have been##2##4##(1990-3#1)(2008-7#1)
it might##24##2##(1990-3#1)(1991-12#1)(1993-5#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
it minimizes##3##2##(2008-4#2)(2011-2#1)
it more difficult##2##3##(1997-2#1)(2008-9#1)
it more##8##2##(1990-8#1)(1992-1#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
it moves##2##2##(1991-3#1)(2010-12#1)
it must be##12##3##(1992-1#1)(1992-5#1)(1995-5#1)(1996-1#1)(2007-10#1)(2008-10#1)(2008-3#3)(2008-7#1)(2011-1#1)(2012-2#1)
it must not be##2##4##(1991-1#1)(2012-12#1)
it must##20##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#2)(1995-5#1)(1996-1#1)(1996-4#1)(2007-10#1)(2008-10#1)(2008-3#4)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
it necessary to##9##3##(1991-3#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#2)(2010-5#1)(2011-2#1)
it necessary##11##2##(1991-1#1)(1991-3#1)(1992-2#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#2)(2010-5#1)(2011-2#1)
it needs to be##4##4##(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
it no##2##2##(2008-1#1)(2008-10#1)
it not##2##2##(1996-12#1)(2011-2#1)
it now##4##2##(1990-11#1)(1993-12#1)(2009-5#1)(2012-2#1)
it occurred##4##2##(1993-3#1)(1995-5#1)(2007-10#1)(2008-10#1)
it occurs in##4##3##(2009-10#1)(2010-11#1)(2012-12#1)(2013-7#1)
it occurs##11##2##(1992-12#1)(1997-7#1)(2008-4#1)(2008-7#2)(2009-10#2)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
it offers a##2##3##(2008-10#1)(2013-8#1)
it offers many advantages over##2##5##(2012-2#1)(2012-3#1)
it offers##8##2##(1996-1#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
it often happens##2##3##(2008-1#1)(2013-1#1)
it often is##2##3##(1990-9#1)(2009-3#1)
it often leads to##2##4##(2009-3#1)(2012-3#1)
it often##10##2##(1990-9#1)(2007-5#1)(2008-1#1)(2008-11#1)(2009-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
it on the##3##3##(1995-5#1)(1997-6#1)(2008-9#1)
it on##8##2##(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#1)
it one of the most common##2##6##(1991-2#1)(1997-7#1)
it only requires##2##3##(2007-12#1)(2008-5#1)
it only##5##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
it opens a##2##3##(2008-10#1)(2012-2#1)
it or##2##2##(2007-12#1)(2011-2#1)
it out##3##2##(1997-1#1)(2008-10#1)(2012-12#1)
it particularly##3##2##(1993-12#1)(2008-3#1)(2008-5#1)
it passes through##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
it passes##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
it pays##2##2##(1992-12#1)(2008-10#1)
it performs##2##2##(2008-1#1)(2008-7#1)
it permissible##2##2##(1990-6#1)(1993-9#1)
it permits a##2##3##(2007-12#1)(2008-2#1)
it permits the##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
it permits##8##2##(1993-12#1)(1995-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)
it permitted##2##2##(1992-3#1)(2008-3#1)
it plays an important role in##2##6##(2008-8#2)
it plays##6##2##(1993-8#1)(1997-1#1)(2008-8#2)(2013-1#2)
it possesses a##2##3##(1993-12#1)(2009-8#1)
it possesses##5##2##(1993-12#1)(1995-2#1)(1995-9#1)(2008-4#1)(2009-8#1)
it possible for the##2##4##(1990-5#1)(1994-3#1)
it possible for##9##3##(1990-5#1)(1992-3#1)(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
it possible to avoid##2##4##(1992-5#1)(2007-8#1)
it possible to carry out##2##5##(1993-11#1)(1997-6#1)
it possible to characterize the##3##5##(1992-3#1)(2008-10#1)(2008-6#1)
it possible to compare the##2##5##(1994-6#1)(2008-10#1)
it possible to compare##3##4##(1994-6#1)(2008-10#1)(2008-2#1)
it possible to control the##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
it possible to detect##3##4##(1991-6#1)(1994-6#1)(2008-1#1)
it possible to determine##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
it possible to distinguish##3##4##(1996-5#1)(2008-10#1)(2013-7#1)
it possible to establish##2##4##(1990-3#1)(2013-1#1)
it possible to extend the##2##5##(2007-11#1)(2008-10#1)
it possible to identify##5##4##(2008-10#1)(2008-11#2)(2008-4#2)
it possible to monitor##2##4##(2008-10#1)(2008-2#1)
it possible to obtain##6##4##(2008-10#3)(2008-3#2)(2010-7#1)
it possible to select##2##4##(1997-2#1)(2008-10#1)
it possible to study the##2##5##(2008-2#1)(2008-9#1)
it possible to##109##3##(1990-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-6#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-2#6)(2008-3#12)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
it possible##121##2##(1990-3#1)(1990-5#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-6#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#7)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#4)(2008-2#6)(2008-3#12)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
it potentially##2##2##(2008-10#1)(2008-5#1)
it potentiated##3##2##(1990-5#1)(2008-8#1)(2009-4#1)
it presents in##2##3##(2009-1#1)(2013-1#1)
it presents with##2##3##(2006-10#1)(2011-2#1)
it presents##8##2##(1995-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
it preserves##3##2##(1994-6#1)(2008-2#2)
it prevents##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
it produced a##3##3##(1991-5#1)(1992-12#1)(2008-9#1)
it produced##6##2##(1990-8#1)(1991-5#1)(1992-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
it produces##5##2##(2008-2#2)(2008-3#1)(2008-6#1)(2013-8#1)
it promotes##5##2##(1991-6#1)(2008-11#1)(2013-1#3)
it proved##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
it provided##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
it provides a##6##3##(1996-3#1)(2008-10#1)(2008-9#2)(2009-3#1)(2009-8#1)
it provides an overview of##2##5##(1994-2#1)(2010-6#1)
it provides an##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2010-6#1)
it provides the same##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
it provides the##7##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-10#1)
it provides##30##2##(1993-1#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-6#1)(2013-1#2)
it raised##2##2##(1991-12#1)(2007-5#1)
it raises##3##2##(1993-2#1)(1995-2#1)(2008-11#1)
it rapidly##2##2##(2008-10#1)(2008-3#1)
it reached##4##2##(1995-2#1)(2008-11#1)(2010-1#1)(2011-2#1)
it reaches##4##2##(1992-3#1)(1997-2#1)(2008-11#1)(2009-10#1)
it reacts with##2##3##(2008-10#2)
it reacts##3##2##(1997-7#1)(2008-10#2)
it ready for the next##2##5##(2008-10#2)
it ready for##3##3##(2008-10#2)(2010-5#1)
it really##5##2##(1997-4#1)(2008-1#1)(2008-7#2)(2012-12#1)
it receives##2##2##(2009-12#1)(2010-5#1)
it reduced##6##2##(1994-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-1#1)
it reduces the##3##3##(2008-6#1)(2010-8#1)(2011-2#1)
it reduces##4##2##(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
it relates to their##2##4##(2008-4#1)(2012-3#1)
it relates to##14##3##(1994-2#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
it relates##15##2##(1994-2#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
it reliable##2##2##(2007-7#1)(2008-10#1)
it remained##2##2##(1990-5#1)(2008-10#1)
it remains a##4##3##(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)
it remains an##2##3##(2008-4#1)(2011-1#1)
it remains controversial##2##3##(1994-12#1)(1997-7#1)
it remains difficult to##3##4##(1997-3#1)(2007-8#1)(2008-4#1)
it remains important to##2##4##(2008-2#1)(2011-2#1)
it remains largely unknown how##2##5##(2011-2#1)(2012-3#1)
it remains the##2##3##(2008-10#1)(2013-1#1)
it remains to be determined##2##5##(2011-2#1)(2012-12#1)
it remains to be seen whether##2##6##(2008-9#1)(2012-2#1)
it remains to be shown##2##5##(2008-10#1)(2013-8#1)
it remains to be##8##4##(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
it remains to##9##3##(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
it remains unclear how##2##4##(2008-8#1)(2009-5#1)
it remains unclear whether##3##4##(2010-5#1)(2012-2#1)(2013-1#1)
it remains unclear##8##3##(2008-8#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
it remains unknown whether##2##4##(2012-2#1)(2012-3#1)
it remains##46##2##(1990-12#1)(1991-12#1)(1994-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
it removes##2##2##(1990-3#1)(2012-3#1)
it represented##4##2##(1990-11#1)(1991-2#1)(2008-10#2)
it represents a##4##3##(2007-12#1)(2008-10#2)(2012-3#1)
it represents an##3##3##(1994-12#1)(2011-2#1)(2013-7#1)
it represents the##3##3##(1993-5#1)(2008-7#1)(2009-6#1)
it represents##12##2##(1993-5#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
it requires a##3##3##(1995-12#1)(1996-4#1)(2010-10#1)
it requires fewer##3##3##(2008-1#1)(2008-2#2)
it requires only##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
it requires the##6##3##(1993-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
it requires##34##2##(1991-3#1)(1993-1#1)(1995-12#1)(1996-3#1)(1996-4#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
it resembles##2##2##(1993-9#1)(1994-12#1)
it results from##3##3##(2008-6#1)(2010-4#1)(2013-1#1)
it results in##2##3##(2008-9#1)(2012-3#1)
it results##6##2##(2008-10#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
it revealed a##2##3##(1991-11#1)(2011-2#1)
it revealed##3##2##(1991-11#1)(2008-5#1)(2011-2#1)
it reviews##3##2##(2008-11#1)(2008-4#2)
it right##5##2##(1991-2#1)(1993-1#1)(1994-12#1)(1997-1#1)(2013-8#1)
it safe in##2##3##(1997-2#1)(2008-11#1)
it safe to##2##3##(2008-11#1)(2011-2#1)
it safe##6##2##(1997-2#1)(2008-11#3)(2011-2#2)
it says##2##2##(2008-11#1)(2008-9#1)
it seemed##4##2##(1990-2#1)(1993-8#1)(2008-10#1)(2008-8#1)
it seems a##2##3##(2008-1#1)(2008-10#1)
it seems likely that##2##4##(1995-2#1)(2008-3#1)
it seems not to##2##4##(2008-5#2)
it seems possible to##2##4##(2008-10#1)(2008-5#1)
it seems prudent##2##3##(1991-12#1)(2010-5#1)
it seems reasonable to recommend##2##5##(1990-9#1)(1993-11#1)
it seems reasonable to##5##4##(1990-9#1)(1993-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
it seems that it##2##4##(2009-5#1)(2013-7#1)
it seems that the##7##4##(1990-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
it seems that there is##2##5##(2008-7#1)(2010-8#1)
it seems that there##3##4##(2008-2#1)(2008-7#1)(2010-8#1)
it seems that##25##3##(1990-12#3)(1993-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
it seems to be##3##4##(1996-5#1)(2008-11#1)(2013-1#1)
it seems to##9##3##(1996-2#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#2)
it seems##57##2##(1990-12#3)(1990-9#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#1)
it serves as a##4##4##(1994-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
it serves as an##2##4##(1996-1#1)(2008-11#1)
it serves as##7##3##(1994-8#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#2)(2011-2#1)
it serves to##2##3##(1990-5#1)(2008-9#1)
it serves##11##2##(1990-5#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
it shares##6##2##(1994-12#1)(1994-2#1)(1995-6#1)(1996-6#1)(1997-4#1)(2008-9#1)
it should be combined with##2##5##(2008-10#1)(2011-2#1)
it should be noted that these##2##6##(1991-9#1)(2012-3#1)
it should be noted that##5##5##(1991-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
it should be possible to develop##2##6##(2008-11#1)(2008-9#1)
it should be possible to##9##5##(1994-12#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)
it should be taken##2##4##(2008-10#1)(2013-1#1)
it should be very useful for##2##6##(1997-8#1)(2008-10#1)
it should be##59##3##(1991-1#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-12#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
it should consider##2##3##(1995-3#1)(2008-10#1)
it should not be##3##4##(1994-2#1)(1996-6#1)(2008-8#1)
it should##72##2##(1991-1#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#2)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
it showed a##3##3##(2008-11#1)(2008-5#1)(2010-5#1)
it showed an##3##3##(1995-12#1)(2007-11#1)(2009-4#1)
it showed no##3##3##(1997-7#1)(2008-10#2)
it showed significant##2##3##(2008-10#1)(2013-1#1)
it showed that##2##3##(2008-10#1)(2013-8#1)
it showed##20##2##(1994-12#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-5#2)(2011-2#2)(2013-1#1)(2013-8#1)
it shows that##2##3##(2008-3#1)(2011-1#1)
it shows the##2##3##(2008-10#1)(2008-2#1)
it shows##14##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2011-1#1)(2011-2#1)
it significantly potentiated##2##3##(1996-2#2)
it significantly##10##2##(1992-8#1)(1994-2#1)(1995-12#1)(1996-2#2)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
it simply##2##2##(1996-1#1)(2007-12#1)
it slows##2##2##(2008-10#1)(2013-8#1)
it specifically##2##2##(1992-3#1)(2008-4#1)
it stands##2##2##(1994-3#1)(2011-2#1)
it still remains##2##3##(2010-6#1)(2012-2#1)
it still##5##2##(1996-10#1)(2006-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
it stimulates the##2##3##(1994-5#1)(2008-5#1)
it stimulates##4##2##(1994-5#1)(2008-12#1)(2008-5#2)
it strongly##4##2##(1990-5#1)(1993-8#1)(2008-8#2)
it suggests that the##2##4##(2007-7#1)(2008-10#1)
it suggests that##6##3##(1990-2#1)(2007-7#1)(2008-10#2)(2008-8#2)
it suggests##9##2##(1990-2#1)(1992-12#1)(2007-7#1)(2008-10#2)(2008-8#2)(2008-9#1)(2013-1#1)
it suitable for##6##3##(1996-12#1)(2008-10#1)(2008-3#2)(2009-8#1)(2013-1#1)
it suitable##7##2##(1996-12#1)(2008-10#1)(2008-3#3)(2009-8#1)(2013-1#1)
it supports##2##2##(1996-12#1)(2008-8#1)
it suppresses##3##2##(2008-10#2)(2013-8#1)
it take##3##2##(1997-3#1)(2007-9#1)(2008-8#1)
it takes a##2##3##(2008-10#1)(2010-3#1)
it takes for##2##3##(2008-3#1)(2012-3#1)
it takes to##5##3##(1993-12#1)(1993-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
it takes##13##2##(1991-3#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-3#1)(2010-5#1)(2012-3#2)(2012-8#1)
it tended to##2##3##(1991-3#1)(2008-5#1)
it tends to##2##3##(2008-2#1)(2008-8#1)
it the##11##2##(1992-1#1)(1992-6#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
it there##2##2##(2010-5#1)(2011-2#1)
it through##7##2##(1994-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)
it thus##3##2##(1990-9#1)(2008-5#1)(2008-7#1)
it time##3##2##(1995-8#1)(2008-3#1)(2012-12#1)
it to a control##2##4##(1992-12#1)(2008-9#1)
it to a##12##3##(1992-12#1)(1995-5#1)(1996-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)
it to an##2##3##(1992-11#1)(2008-6#1)
it to be a##2##4##(2008-10#1)(2012-2#1)
it to be##24##3##(1990-2#1)(1991-2#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
it to create##2##3##(2008-7#1)(2009-7#1)
it to differ from##2##4##(2008-10#2)
it to participate in##2##4##(2008-1#1)(2008-3#1)
it to the##22##3##(1990-8#1)(1993-6#1)(1995-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#2)
it to##138##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-4#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#3)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
it tries to##2##3##(2009-10#1)(2013-1#1)
it truly##2##2##(1991-3#1)(2008-3#1)
it turns##2##2##(2011-1#1)(2013-8#1)
it under##2##2##(2008-4#1)(2008-6#1)
it up##3##2##(1996-4#1)(2008-10#1)(2008-6#1)
it useful##2##2##(2007-12#1)(2008-11#1)
it uses##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
it usually##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
it utilizes##2##2##(1996-12#1)(2007-12#1)
it values##2##2##(1997-3#1)(2010-3#1)
it very##2##2##(1992-4#1)(2009-7#1)
it was 0##5##3##(2008-10#5)
it was a##10##3##(1990-5#1)(1995-12#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
it was abolished by##2##4##(1995-2#1)(2008-6#1)
it was about##2##3##(1992-3#1)(2008-6#1)
it was absent##2##3##(2008-4#1)(2008-5#1)
it was also found that##3##5##(2008-11#1)(2008-5#1)(2008-7#1)
it was also observed that##2##5##(2008-10#1)(2012-6#1)
it was also present##2##4##(1994-6#1)(2012-2#1)
it was also##16##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-6#1)
it was an##3##3##(1992-9#1)(2008-10#1)(2012-12#1)
it was applied to the determination of these##2##8##(2008-10#2)
it was applied to the determination of##3##7##(2008-10#3)
it was applied to the##8##5##(2008-10#7)(2010-4#1)
it was applied to##10##4##(2008-10#8)(2010-4#1)(2011-2#1)
it was applied##14##3##(2008-10#10)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)
it was ascertained that##2##4##(1994-8#1)(2008-6#1)
it was associated with##3##4##(1994-12#1)(2008-5#1)(2010-7#1)
it was associated##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
it was assumed that##4##4##(2008-10#2)(2008-6#2)
it was believed##2##3##(1990-3#1)(2012-3#1)
it was capable of##2##4##(1995-2#1)(2013-1#1)
it was caused by##2##4##(2008-10#1)(2010-1#1)
it was characterized by##2##4##(1990-7#1)(2006-10#1)
it was clarified that##2##4##(2007-12#1)(2009-6#1)
it was combined##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
it was compared##2##3##(2008-10#1)(2012-2#1)
it was composed##2##3##(1990-6#1)(2007-12#1)
it was concluded that the##12##5##(1990-11#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-11#1)(1994-2#1)(2008-10#2)(2008-5#1)(2010-4#1)(2013-1#1)
it was concluded that##23##4##(1990-11#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-12#1)(1993-11#1)(1994-2#1)(1994-7#1)(2008-10#8)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
it was confirmed that##2##4##(1995-12#1)(2008-8#1)
it was confirmed##3##3##(1992-8#1)(1995-12#1)(2008-8#1)
it was considered the##2##4##(2008-10#1)(2008-7#1)
it was considered##6##3##(1991-6#1)(1995-4#1)(2008-10#1)(2008-7#2)(2013-8#1)
it was decided that##2##4##(2008-11#1)(2011-4#1)
it was decided##3##3##(1994-2#1)(2008-11#1)(2011-4#1)
it was demonstrated that a##2##5##(2008-10#1)(2013-8#1)
it was demonstrated that the##4##5##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)
it was demonstrated that##15##4##(1990-12#1)(1994-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-11#1)(2013-8#1)
it was demonstrated##20##3##(1990-12#1)(1991-5#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-11#1)(2013-8#1)
it was dependent on##2##4##(1992-2#1)(2012-2#1)
it was detected in##2##4##(2008-10#1)(2008-8#1)
it was detected##4##3##(2007-10#2)(2008-10#1)(2008-8#1)
it was determined that##4##4##(1992-6#1)(2008-5#1)(2012-12#1)(2013-1#1)
it was developed##2##3##(1990-8#1)(2008-10#1)
it was diagnosed##2##3##(1990-9#1)(2012-3#1)
it was difficult to##5##4##(1990-10#1)(1990-2#1)(1990-8#1)(2008-10#1)(2008-3#1)
it was discovered that##2##4##(1997-1#1)(2008-10#1)
it was easy##2##3##(1991-3#1)(1992-11#1)
it was effective##2##3##(1990-6#1)(2007-8#1)
it was established that##3##4##(1990-10#1)(1996-3#1)(2013-8#1)
it was established##4##3##(1990-10#1)(1994-1#1)(1996-3#1)(2013-8#1)
it was evident##2##3##(1993-12#1)(2010-8#1)
it was expected that##2##4##(1990-12#1)(2008-8#1)
it was expressed##2##3##(1995-3#1)(2008-9#1)
it was felt##2##3##(2008-1#1)(2008-9#1)
it was first described##2##4##(1992-2#1)(2008-3#1)
it was first introduced##2##4##(1991-3#1)(2008-10#1)
it was first##7##3##(1991-3#1)(1992-2#1)(1992-9#1)(1997-6#1)(2008-10#2)(2008-3#1)
it was found in##4##4##(1994-11#1)(2008-10#1)(2008-6#1)(2009-11#1)
it was found that As(2)O(3)##2##5##(2008-8#2)
it was found that a##2##5##(1992-1#1)(2007-11#1)
it was found that at##2##5##(1993-11#1)(2008-10#1)
it was found that it is##2##6##(2008-11#1)(2008-8#1)
it was found that systemically administered##2##6##(1993-12#2)
it was found that the##38##5##(1990-10#1)(1990-8#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#1)(2013-1#1)(2013-8#1)
it was found that they##2##5##(2008-10#1)(2010-1#1)
it was found that this##2##5##(1995-3#1)(2008-3#1)
it was found that##99##4##(1990-10#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#3)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#7)(2009-11#1)(2010-1#1)(2010-2#1)(2010-5#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
it was found to be##6##5##(1990-5#1)(2007-7#1)(2008-10#3)(2008-11#1)
it was found to##8##4##(1990-5#1)(1991-2#1)(1992-6#1)(2007-7#1)(2008-10#3)(2008-11#1)
it was found##116##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#3)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#7)(2009-11#2)(2010-1#1)(2010-2#1)(2010-5#3)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
it was given in##2##4##(1993-6#1)(1995-3#1)
it was given##3##3##(1993-6#2)(1995-3#1)
it was helpful##2##3##(1994-3#1)(2008-12#1)
it was higher in the##2##5##(2007-11#1)(2013-7#1)
it was higher##3##3##(2007-11#1)(2011-2#1)(2013-7#1)
it was highest in##2##4##(1990-8#1)(2008-12#1)
it was highly##2##3##(1993-11#1)(1993-12#1)
it was hypothesized that##5##4##(1992-2#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
it was impossible to##3##4##(1994-2#1)(2008-10#1)(2008-3#1)
it was in##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
it was incubated##3##3##(2008-7#2)(2013-1#1)
it was indicated##2##3##(2008-10#1)(2008-8#1)
it was inhibited##2##3##(2008-11#1)(2012-3#1)
it was introduced into##3##4##(1992-6#1)(2008-10#2)
it was introduced##5##3##(1992-6#1)(2008-10#2)(2010-12#1)(2011-1#1)
it was located in the##3##5##(2006-12#1)(2008-8#1)(2013-8#1)
it was made##2##3##(2013-1#2)
it was mainly##2##3##(1991-2#1)(1992-11#1)
it was measured##2##3##(1997-3#1)(2012-3#1)
it was more##7##3##(1991-8#1)(1993-8#1)(1993-9#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)
it was most##4##3##(2008-10#2)(2008-9#1)(2009-7#1)
it was necessary to remove##2##5##(2008-10#2)
it was necessary to##10##4##(1990-2#2)(1990-5#1)(1992-6#1)(2008-10#3)(2008-5#1)(2010-2#1)(2011-2#1)
it was not affected by##2##5##(1990-6#1)(1993-2#1)
it was not as##3##4##(1991-3#1)(2008-10#2)
it was not associated with##2##5##(2008-10#1)(2012-12#1)
it was not in##2##4##(2008-10#1)(2011-2#1)
it was not inhibited##2##4##(1993-6#1)(2008-10#1)
it was not possible to##6##5##(1992-9#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-2#1)
it was not powered##2##4##(2008-5#1)(2013-1#1)
it was not present in##2##5##(1995-8#1)(2008-11#1)
it was not present##3##4##(1995-8#1)(2008-10#1)(2008-11#1)
it was not##43##3##(1990-6#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-4#1)(1995-8#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
it was noted that there was##2##6##(1995-12#1)(2008-11#1)
it was noted that##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
it was observed a##2##4##(1991-6#1)(2008-11#1)
it was observed that the##7##5##(1993-9#1)(2008-10#3)(2009-6#1)(2011-1#1)(2012-12#1)
it was observed that##19##4##(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#2)(2013-1#1)
it was observed##24##3##(1991-6#1)(1991-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#2)
it was of interest to##2##5##(1991-12#1)(1992-3#1)
it was one##2##3##(1992-9#1)(1997-6#1)
it was only a##2##4##(2007-12#1)(2008-10#1)
it was only##5##3##(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2011-1#1)
it was possible to achieve##2##5##(2008-10#1)(2008-7#1)
it was possible to completely##2##5##(2007-8#1)(2008-10#1)
it was possible to estimate the##2##6##(2008-10#2)
it was possible to estimate##3##5##(1991-3#1)(2008-10#2)
it was possible to obtain a##2##6##(2008-10#2)
it was possible to obtain an##2##6##(2008-10#2)
it was possible to obtain##5##5##(2008-10#5)
it was possible to perform##2##5##(2008-10#1)(2008-2#1)
it was possible to##54##4##(1990-3#1)(1990-6#1)(1991-3#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#26)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#5)(2008-9#1)(2010-3#1)(2013-1#1)
it was possible##56##3##(1990-3#1)(1990-6#1)(1991-3#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#27)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#5)(2008-9#2)(2010-3#1)(2013-1#1)
it was present##2##3##(2008-10#2)
it was previously##2##3##(2008-10#1)(2012-3#1)
it was proposed that##2##4##(2008-9#1)(2009-4#1)
it was proved that##4##4##(1995-3#1)(2007-10#1)(2008-10#2)
it was reasonable to##2##4##(1997-7#1)(2008-7#1)
it was recently##2##3##(2008-10#1)(2010-7#1)
it was revealed that##3##4##(1993-12#1)(2008-10#2)
it was reversed##3##3##(1994-2#1)(1997-7#1)(2008-10#1)
it was seen that##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
it was seen##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
it was selected##2##3##(1997-6#1)(2009-6#1)
it was shown for##2##4##(1990-5#1)(1996-2#1)
it was shown that some##2##5##(2011-2#1)(2013-1#1)
it was shown that the##10##5##(1990-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
it was shown that treatment##2##5##(1990-6#1)(1996-5#1)
it was shown that##35##4##(1990-5#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#3)(2008-3#4)(2008-5#2)(2008-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
it was shown##41##3##(1990-5#2)(1990-6#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
it was significantly different##2##4##(2008-10#1)(2011-1#1)
it was significantly##7##3##(1991-9#1)(1995-12#1)(2008-10#2)(2010-11#1)(2010-4#1)(2011-1#1)
it was still##2##3##(2008-10#1)(2011-1#1)
it was successfully applied to the##2##6##(2008-10#2)
it was successfully applied to##3##5##(2008-10#3)
it was successfully applied##4##4##(2008-10#4)
it was suggested that the##5##5##(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#1)(2011-1#1)
it was suggested that##12##4##(1993-3#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
it was suggested##13##3##(1993-3#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-8#1)
it was the##10##3##(1990-6#1)(1991-8#1)(1994-11#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-6#1)(2011-1#1)(2012-12#1)
it was thought that##3##4##(1996-3#1)(2008-3#1)(2008-4#1)
it was thought##4##3##(1996-3#1)(2008-11#1)(2008-3#1)(2008-4#1)
it was too##2##3##(1991-3#1)(1995-12#1)
it was unclear whether##2##4##(2010-3#1)(2012-2#1)
it was undetectable##2##3##(1990-5#1)(2008-10#1)
it was used to##4##4##(1992-12#1)(2008-10#2)(2008-3#1)
it was used##12##3##(1990-6#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#1)(2013-1#1)
it was##860##2##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#5)(1990-5#8)(1990-6#7)(1990-7#2)(1990-8#6)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#10)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#4)(1992-12#4)(1992-2#6)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#1)(1992-9#6)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#2)(1993-6#5)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#3)(1994-6#2)(1994-7#2)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#8)(1995-4#2)(1995-5#2)(1995-6#5)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#6)(2007-11#11)(2007-12#12)(2007-2#1)(2007-7#2)(2007-8#8)(2008-1#6)(2008-10#224)(2008-11#39)(2008-12#21)(2008-2#7)(2008-3#20)(2008-4#8)(2008-5#25)(2008-6#10)(2008-7#27)(2008-8#27)(2008-9#12)(2009-10#2)(2009-11#3)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#10)(2011-2#23)(2011-3#1)(2011-4#1)(2012-1#1)(2012-12#8)(2012-2#12)(2012-3#7)(2012-6#1)(2013-1#23)(2013-7#4)(2013-8#18)
it wasn't##2##2##(1997-3#1)(2012-2#1)
it were##9##2##(1993-2#1)(1995-12#1)(1995-3#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
it which##2##2##(1995-2#1)(1997-4#1)
it will be a##5##4##(1996-3#1)(1996-4#1)(2008-10#1)(2008-5#1)(2009-5#1)
it will be an##2##4##(1996-1#1)(2008-11#1)
it will be important to##2##5##(1997-6#1)(1997-7#1)
it will be important##3##4##(1996-2#1)(1997-6#1)(1997-7#1)
it will be more##2##4##(2008-12#1)(2008-8#1)
it will be necessary to##3##5##(2008-7#2)(2013-1#1)
it will be possible for##2##5##(1992-9#1)(2007-4#1)
it will be possible to##2##5##(2008-8#1)(2010-12#1)
it will be possible##5##4##(1992-9#1)(2007-4#1)(2008-8#1)(2009-8#1)(2010-12#1)
it will be useful for##2##5##(1996-12#1)(2008-10#1)
it will be##39##3##(1991-7#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
it will not be##2##4##(1995-2#1)(2008-10#1)
it will not##3##3##(1993-3#1)(1995-2#1)(2008-10#1)
it will provide##3##3##(2008-11#1)(2008-9#1)(2009-12#1)
it will##64##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#3)
it with a##9##3##(1996-1#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2013-8#1)
it with other##3##3##(2008-11#1)(2008-5#1)(2012-1#1)
it with that##2##3##(1990-6#1)(2008-3#1)
it with the##15##3##(1990-2#1)(1990-7#1)(1992-8#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-3#2)
it with##55##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1992-12#1)(1992-8#1)(1994-5#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-3#3)(2013-1#1)(2013-8#1)
it within##2##2##(2008-10#1)(2013-8#1)
it work##2##2##(1993-11#1)(2011-3#1)
it worked##2##2##(1993-3#1)(2008-7#1)
it works##4##2##(2008-10#1)(2008-4#2)(2008-9#1)
it worth##2##2##(2008-11#1)(2008-3#1)
it worth?##2##2##(2008-11#1)(2013-8#1)
it would appear that the##3##5##(1991-11#1)(1994-8#1)(1996-5#1)
it would appear that##5##4##(1991-11#1)(1994-8#1)(1996-5#1)(2008-2#1)(2011-2#1)
it would appear##7##3##(1991-11#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-2#1)(2011-2#1)
it would be beneficial##2##4##(2011-1#1)(2012-12#1)
it would be expected that##2##5##(1994-3#1)(2008-10#1)
it would be necessary to##2##5##(2008-12#1)(2008-8#1)
it would be possible to##3##5##(1996-3#1)(2008-10#1)(2011-3#1)
it would be##28##3##(1990-11#1)(1991-12#1)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-5#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
it would have been easier##2##5##(2008-7#1)(2010-2#1)
it would have been##3##4##(2008-7#2)(2010-2#1)
it would have##4##3##(2008-2#1)(2008-7#2)(2010-2#1)
it would seem##4##3##(2008-11#2)(2008-7#1)(2009-1#1)
it would##55##2##(1990-11#2)(1990-5#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#2)(2008-7#4)(2008-8#1)(2009-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#3)
it yields##3##2##(2008-3#2)(2008-7#1)
it##6972##1##(1990-10#3)(1990-11#27)(1990-12#30)(1990-2#30)(1990-3#18)(1990-5#39)(1990-6#18)(1990-7#13)(1990-8#25)(1990-9#14)(1991-1#21)(1991-10#1)(1991-11#8)(1991-12#36)(1991-2#16)(1991-3#37)(1991-4#5)(1991-5#20)(1991-6#20)(1991-7#1)(1991-8#12)(1991-9#21)(1992-1#14)(1992-10#1)(1992-11#18)(1992-12#41)(1992-2#24)(1992-3#34)(1992-4#5)(1992-5#13)(1992-6#24)(1992-7#4)(1992-8#24)(1992-9#17)(1993-1#13)(1993-11#26)(1993-12#33)(1993-2#25)(1993-3#27)(1993-5#4)(1993-6#27)(1993-8#24)(1993-9#15)(1994-1#21)(1994-10#2)(1994-11#23)(1994-12#52)(1994-2#40)(1994-3#36)(1994-5#17)(1994-6#17)(1994-7#7)(1994-8#35)(1994-9#21)(1995-1#12)(1995-11#16)(1995-12#46)(1995-2#43)(1995-3#29)(1995-4#3)(1995-5#41)(1995-6#40)(1995-8#8)(1995-9#7)(1996-1#16)(1996-10#2)(1996-11#14)(1996-12#48)(1996-2#34)(1996-3#34)(1996-4#14)(1996-5#31)(1996-6#14)(1996-7#1)(1996-8#11)(1996-9#7)(1997-1#29)(1997-2#37)(1997-3#39)(1997-4#29)(1997-5#18)(1997-6#29)(1997-7#28)(1997-8#20)(1997-9#1)(2006-10#8)(2006-12#7)(2006-4#2)(2006-6#2)(2007-1#1)(2007-10#24)(2007-11#103)(2007-12#131)(2007-2#17)(2007-3#2)(2007-4#2)(2007-5#8)(2007-6#3)(2007-7#34)(2007-8#34)(2007-9#3)(2008-1#111)(2008-10#992)(2008-11#309)(2008-12#105)(2008-2#175)(2008-3#334)(2008-4#132)(2008-5#184)(2008-6#69)(2008-7#269)(2008-8#195)(2008-9#177)(2009-1#10)(2009-10#39)(2009-11#21)(2009-12#25)(2009-2#14)(2009-3#21)(2009-4#13)(2009-5#40)(2009-6#29)(2009-7#39)(2009-8#37)(2009-9#15)(2010-1#19)(2010-10#23)(2010-11#28)(2010-12#36)(2010-2#15)(2010-3#35)(2010-4#24)(2010-5#38)(2010-6#28)(2010-7#24)(2010-8#50)(2010-9#9)(2011-1#72)(2011-2#267)(2011-3#12)(2011-4#1)(2011-7#2)(2012-1#19)(2012-12#90)(2012-2#155)(2012-3#93)(2012-6#1)(2012-7#2)(2012-8#3)(2012-9#3)(2013-1#213)(2013-7#33)(2013-8#141)
it&quot##4##1##(2008-11#1)(2008-5#2)(2008-7#1)
it's a##2##2##(1997-2#1)(2010-4#1)
it's time to##2##3##(1993-2#1)(2007-9#1)
it's time##3##2##(1993-2#1)(2007-9#1)(2013-8#1)
it's##30##1##(1990-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-8#2)
it)##5##1##(1992-3#1)(1992-9#1)(1993-6#1)(2008-7#1)(2011-1#1)
it?##16##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-9#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-4#2)(2009-11#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
it?]##4##1##(1990-6#1)(1991-3#1)(1991-6#1)(1996-2#1)
it]##3##1##(1992-5#1)(1995-6#1)(1997-5#1)
italiae##3##1##(2008-10#3)
italian##5##1##(2008-10#1)(2013-1#4)
italicum was##2##2##(2008-10#2)
italicum##4##1##(2008-10#4)
itch and##3##2##(2008-5#3)
itch in dry skin##2##4##(2008-5#2)
itch scores##2##2##(2011-1#2)
itch##11##1##(2008-5#8)(2010-8#1)(2011-1#2)
itching and##2##2##(2008-3#1)(2008-5#1)
itching eyes##2##2##(2008-11#2)
itching or##3##2##(2008-5#1)(2008-8#1)(2013-8#1)
itching##23##1##(1996-11#4)(2007-2#2)(2007-7#2)(2008-11#2)(2008-3#2)(2008-5#5)(2008-8#1)(2011-1#2)(2012-12#2)(2013-8#1)
itchy##5##1##(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
item &quot##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
item and##4##2##(2008-11#1)(2012-2#2)(2013-1#1)
item by##3##2##(1993-9#1)(1996-1#1)(2012-2#1)
item familiarity##2##2##(2008-4#2)
item hierarchy##2##2##(2012-2#2)
item in the set##2##4##(1990-11#2)
item is##2##2##(2012-2#2)
item length##2##2##(2012-2#2)
item of##2##2##(2007-10#1)(2011-1#1)
item quality##2##2##(2012-2#2)
item scores##2##2##(1990-10#1)(2010-4#1)
item was##2##2##(2008-5#1)(2008-9#1)
item##66##1##(1990-10#1)(1990-11#2)(1993-2#1)(1993-6#1)(1993-9#1)(1996-1#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#21)(2012-3#2)(2013-1#3)
item-writing flaws##5##2##(2008-12#5)
item-writing guidelines##2##2##(2008-12#2)
item-writing##8##1##(2008-12#8)
items and##5##2##(1990-3#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
items are##7##2##(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-12#2)
items as##2##2##(2011-1#2)
items encoded in##2##3##(2008-9#2)
items for##3##2##(1993-12#1)(2008-12#1)(2010-3#1)
items from##2##2##(1993-12#1)(2008-9#1)
items had##2##2##(1990-10#1)(2012-2#1)
items in the##3##3##(2007-10#1)(2010-1#1)(2012-2#1)
items in##15##2##(1991-8#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-8#2)(2011-1#2)(2012-2#3)(2013-1#1)
items long##2##2##(2012-2#2)
items of the##4##3##(2008-10#2)(2008-6#1)(2010-10#1)
items of##6##2##(1991-2#1)(2008-10#2)(2008-6#2)(2010-10#1)
items on##2##2##(2009-2#1)(2013-1#1)
items relating to##2##3##(1993-1#1)(1993-12#1)
items showed##3##2##(2008-6#1)(2010-10#1)(2012-1#1)
items that##2##2##(2008-7#1)(2009-4#1)
items to##2##2##(2008-10#1)(2012-2#1)
items was##4##2##(2008-11#1)(2009-5#1)(2012-2#1)(2013-1#1)
items were##11##2##(1991-2#2)(2008-12#2)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
items with##5##2##(2008-11#1)(2010-11#1)(2010-2#2)(2012-2#1)
items##167##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-1#2)(1992-12#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#9)(2008-12#5)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#5)(2008-9#5)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#8)(2010-1#3)(2010-10#2)(2010-11#3)(2010-2#3)(2010-3#4)(2010-8#4)(2011-1#14)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#22)(2012-3#2)(2013-1#5)(2013-8#1)
items)##5##1##(1990-12#1)(1990-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
iterated prisoner's dilemma##2##3##(2008-8#2)
iterated##4##1##(2008-10#2)(2008-8#2)
iteration is##2##2##(2008-3#2)
iteration of##3##2##(2008-3#2)(2011-8#1)
iteration procedure##2##2##(2007-12#1)(2008-3#1)
iteration##22##1##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#10)(2009-2#1)(2009-9#1)(2011-1#1)(2011-8#1)
iterations of##3##2##(1992-12#1)(2008-11#1)(2008-12#1)
iterations##9##1##(1992-12#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-1#1)
iterations/s##2##1##(2007-11#1)(2008-3#1)
iterative Fourier transform algorithm##3##4##(2008-2#1)(2008-3#2)
iterative Fourier transform##4##3##(2008-2#1)(2008-3#3)
iterative algorithm for##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
iterative algorithm##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
iterative algorithms##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
iterative approach##2##2##(2008-11#1)(2008-3#1)
iterative computer##2##2##(2008-10#2)
iterative constrained Tikhonov##2##3##(2008-2#2)
iterative inversion##2##2##(2008-3#2)
iterative method for##4##3##(2008-10#1)(2008-3#2)(2010-3#1)
iterative method of##2##3##(2008-10#1)(2008-3#1)
iterative method##8##2##(2008-10#2)(2008-3#5)(2010-3#1)
iterative methods##2##2##(2008-3#1)(2008-7#1)
iterative optimization##3##2##(2008-3#1)(2009-2#1)(2012-2#1)
iterative procedure##5##2##(2007-11#1)(2008-3#3)(2008-6#1)
iterative retrieval of the##2##4##(2007-11#1)(2008-2#1)
iterative search##3##2##(2008-10#2)(2010-2#1)
iterative target transformation factor analysis##2##5##(2008-10#2)
iterative technique##3##2##(2008-10#1)(2008-3#2)
iterative##104##1##(1992-9#1)(2007-11#5)(2008-10#13)(2008-11#5)(2008-2#18)(2008-3#36)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-8#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
iteratively##14##1##(2008-10#3)(2008-2#3)(2008-3#3)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
iteroparous##2##1##(2008-8#1)(2013-7#1)
itinerary##3##1##(2009-10#1)(2010-1#1)(2012-12#1)
itraconazole and##2##2##(2008-5#2)
itraconazole##20##1##(1990-9#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-3#1)(2008-5#11)(2013-8#1)
its &quot##3##2##(1990-9#1)(1994-1#1)(2008-11#1)
its 1##12##2##(2008-10#5)(2011-2#7)
its 1990##2##2##(1990-2#1)(1994-2#1)
its 3##14##2##(1996-2#1)(2008-10#1)(2008-9#1)(2011-2#11)
its 3'##2##2##(1997-7#1)(2007-12#1)
its 5' flanking##3##3##(1990-8#1)(1993-6#1)(2011-10#1)
its 5'##5##2##(1990-8#1)(1993-6#1)(1997-8#1)(2008-8#1)(2011-10#1)
its 50th##3##2##(1991-3#1)(2008-10#2)
its A##3##2##(1993-11#2)(2008-3#1)
its ATPase##2##2##(1994-8#1)(2008-11#1)
its C terminus##3##3##(1995-3#1)(1995-6#1)(1997-4#1)
its C-terminal##4##2##(1991-5#1)(1992-5#1)(1993-12#1)(1993-6#1)
its CNS##2##2##(1993-6#1)(1997-4#1)
its DNA##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
its DNA-binding##5##2##(1990-11#1)(1993-11#1)(1994-12#1)(1996-2#1)(2008-8#1)
its Fourier transform##2##3##(2008-3#2)
its Fourier##3##2##(2008-3#3)
its N terminus##2##3##(1995-2#1)(1995-6#1)
its N-terminal##6##2##(1994-9#1)(1995-8#1)(2008-7#2)(2008-8#1)(2011-1#1)
its N-terminus##3##2##(1991-5#1)(1994-2#1)(2012-2#1)
its S##2##2##(2008-3#1)(2012-12#1)
its UV absorbance##2##3##(1995-2#1)(2008-5#1)
its UV##3##2##(1995-2#1)(2007-12#1)(2008-5#1)
its ability to activate##2##4##(1990-5#1)(2012-2#1)
its ability to bind##2##4##(2008-10#1)(2008-3#1)
its ability to cause##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
its ability to detect##2##4##(1991-3#1)(1997-7#1)
its ability to extract##2##4##(2008-10#2)
its ability to generate##2##4##(1994-3#1)(2010-7#1)
its ability to grow##2##4##(2008-10#1)(2011-2#1)
its ability to hydrolyze##2##4##(1992-9#1)(1993-8#1)
its ability to induce##6##4##(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
its ability to inhibit##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
its ability to interact with##2##5##(1993-3#1)(1995-5#1)
its ability to stimulate##2##4##(2008-10#1)(2012-12#1)
its ability to suppress##2##4##(1993-2#1)(2008-10#1)
its ability to##90##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
its ability##91##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#5)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
its absence##9##2##(1991-12#1)(1993-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-9#2)(2013-8#1)
its absorbance##3##2##(2008-10#2)(2008-2#1)
its absorption and##3##3##(1997-7#1)(2008-2#1)(2011-1#1)
its absorption##4##2##(1997-7#1)(2008-10#1)(2008-2#1)(2011-1#1)
its accelerated##2##2##(1995-1#1)(1997-8#1)
its accumulation was##2##3##(2008-10#2)
its accumulation##7##2##(1995-6#1)(2008-10#4)(2008-5#1)(2008-9#1)
its accuracy and##4##3##(2008-10#2)(2008-3#1)(2011-1#1)
its accuracy was##3##3##(2008-10#3)
its accuracy##14##2##(1993-2#1)(1994-2#1)(2008-10#6)(2008-2#1)(2008-3#3)(2011-1#1)(2012-1#1)
its acetylated##2##2##(2008-10#2)
its action on the##2##4##(1996-5#1)(2008-7#1)
its action on##3##3##(1996-5#1)(2008-10#1)(2008-7#1)
its action##10##2##(1990-2#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#1)
its actions are##2##3##(2008-4#1)(2013-7#1)
its activation##6##2##(1990-2#1)(1997-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
its active metabolite##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
its active site##5##3##(1990-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)
its active##15##2##(1990-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
its activities##5##2##(1993-3#1)(2008-6#1)(2009-6#1)(2010-9#1)(2011-2#1)
its activity after##2##3##(1991-11#1)(1995-6#1)
its activity by##2##3##(2010-11#1)(2013-1#1)
its activity for##2##3##(2008-10#1)(2008-6#1)
its activity in##4##3##(1990-12#1)(1991-12#1)(1994-2#1)(2008-9#1)
its activity is not##2##4##(1994-11#1)(2008-5#1)
its activity is##6##3##(1992-8#1)(1994-11#1)(1997-4#1)(2008-11#1)(2008-5#2)
its activity was##2##3##(1993-12#1)(1997-8#1)
its activity##40##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#2)(2010-6#1)(2011-2#2)(2013-1#2)
its actual##2##2##(2007-8#1)(2008-10#1)
its acute##4##2##(1994-5#1)(2008-9#2)(2010-12#1)
its adaptation##2##2##(2008-12#1)(2008-3#1)
its adequate##2##2##(1991-2#2)
its administration##5##2##(1993-6#1)(2007-8#1)(2008-10#3)
its adoption##4##2##(1994-12#1)(2008-3#2)(2008-4#1)
its adsorption##3##2##(2008-10#2)(2013-1#1)
its advantage##3##2##(2007-10#1)(2008-2#1)(2012-2#1)
its advantages and disadvantages##2##4##(2008-10#1)(2012-2#1)
its advantages and##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
its advantages in##2##3##(2008-10#1)(2009-8#1)
its advantages##10##2##(1997-4#1)(2008-10#4)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
its affinity for the##2##4##(1995-11#1)(1995-2#1)
its affinity for##4##3##(1992-6#1)(1995-11#1)(1995-2#1)(1997-2#1)
its affinity##8##2##(1992-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2013-8#1)
its aggregation in##2##3##(1991-2#1)(2012-2#1)
its aggregation##4##2##(1990-12#1)(1991-2#1)(2009-11#1)(2012-2#1)
its aims and##2##3##(1993-11#1)(2010-1#1)
its aims##4##2##(1993-11#1)(1993-6#1)(2008-5#1)(2010-1#1)
its alignment##2##2##(2008-4#1)(2008-9#1)
its alpha##3##2##(1990-12#1)(1990-8#1)(1991-7#1)
its amino acid composition and##2##5##(1990-7#1)(2008-7#1)
its amino acid sequence##2##4##(2008-10#2)
its amino acid##5##3##(1990-7#1)(2008-10#3)(2008-7#1)
its amino terminus##2##3##(1991-8#1)(1997-6#1)
its amino##9##2##(1990-7#2)(1991-8#1)(1997-6#1)(2008-10#4)(2008-7#1)
its analgesic effect##2##3##(2009-12#1)(2013-7#1)
its analgesic##4##2##(1990-6#1)(2009-12#2)(2013-7#1)
its analog##2##2##(1990-2#1)(1997-2#1)
its analogs##5##2##(1990-5#1)(1995-12#1)(1995-3#1)(2008-11#1)(2009-7#1)
its analogue##4##2##(2008-11#2)(2010-3#2)
its analogues##8##2##(1994-2#1)(1994-8#1)(1996-7#3)(2008-10#2)(2010-5#1)
its analytical##11##2##(2008-10#10)(2010-7#1)
its anatomic position##2##3##(2008-9#1)(2009-4#1)
its anatomical location##2##3##(1994-5#1)(2011-2#1)
its anatomical##6##2##(1994-5#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
its angular##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
its annual##2##2##(2007-9#1)(2012-12#1)
its antagonists##3##2##(2008-4#1)(2008-8#2)
its anti-inflammatory effects##2##3##(2008-3#1)(2011-2#1)
its anti-inflammatory##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
its anti-proliferative##2##2##(2008-8#2)
its anti-tumor##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
its antibody##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
its antigen##2##2##(2008-11#1)(2009-3#1)
its antioxidant##4##2##(2008-10#2)(2010-5#1)(2012-3#1)
its antiproliferative##2##2##(1990-11#1)(1994-11#1)
its antipsychotic-like effect##2##3##(2008-6#2)
its antitumor##2##2##(2008-10#1)(2008-8#1)
its antiviral activity##2##3##(2008-10#1)(2011-3#1)
its apparent##5##2##(1990-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(2011-2#1)
its appearance in##2##3##(2007-8#1)(2008-10#1)
its appearance##3##2##(2007-8#1)(2008-10#2)
its applicability and##2##3##(2007-12#1)(2008-10#1)
its applicability for the##3##4##(2008-10#3)
its applicability for##6##3##(1992-12#1)(2008-10#3)(2008-3#2)
its applicability in the##3##4##(1991-1#1)(1994-3#1)(2012-3#1)
its applicability in##5##3##(1991-1#1)(1994-3#1)(2008-10#1)(2010-12#1)(2012-3#1)
its applicability to##3##3##(2008-10#1)(2008-3#2)
its applicability##18##2##(1991-1#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2010-12#1)(2012-3#1)
its application are##2##3##(1997-7#1)(2008-2#1)
its application as a##3##4##(2008-10#2)(2008-3#1)
its application as an##2##4##(1997-6#1)(2008-10#1)
its application as##6##3##(1997-6#1)(2008-10#4)(2008-3#1)
its application for the##5##4##(2008-10#4)(2008-11#1)
its application for##14##3##(1992-6#1)(2008-10#11)(2008-11#1)(2008-7#1)
its application in a##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
its application in the##9##4##(1993-2#2)(2008-10#3)(2008-2#1)(2008-7#1)(2009-11#1)(2010-8#1)
its application in##36##3##(1993-2#2)(1995-3#1)(2008-10#18)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
its application is##2##3##(2008-10#1)(2011-1#1)
its application to the##16##4##(1995-1#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
its application to##54##3##(1990-5#1)(1990-8#1)(1995-1#1)(2007-11#5)(2007-12#2)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-8#1)(2011-2#1)(2012-2#2)
its application##133##2##(1990-5#1)(1990-8#1)(1992-2#1)(1992-6#1)(1993-2#2)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#5)(2007-12#3)(2008-10#71)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#4)(2013-8#2)
its applications in##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)
its applications##15##2##(1990-12#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#3)(2008-7#1)(2010-9#1)(2013-1#1)
its approach to##4##3##(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)
its approach##5##2##(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
its appropriate##6##2##(1990-12#1)(1991-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
its aqueous##2##2##(2008-10#2)
its assessment##3##2##(2010-7#1)(2012-1#1)(2013-7#1)
its associated problems##2##3##(2008-7#1)(2009-5#1)
its associated risk factors##2##4##(2008-8#1)(2012-1#1)
its associated risk##3##3##(2008-11#1)(2008-8#1)(2012-1#1)
its associated##39##2##(1994-3#1)(1994-8#1)(1994-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
its associates and impact on work load in institutional long-term care##2##11##(2008-7#2)
its association with the##5##4##(1992-3#1)(1994-12#1)(1995-2#1)(1997-5#1)(2009-8#1)
its association with##36##3##(1990-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
its association##37##2##(1990-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)
its assumptions##2##2##(2008-3#1)(2008-9#1)
its attachment to##4##3##(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)
its attachment##5##2##(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2013-1#1)
its attention on the##2##4##(1993-6#1)(2008-7#1)
its autophosphorylation##2##2##(1995-2#1)(1995-8#1)
its availability##4##2##(1991-3#1)(1994-2#1)(1997-1#1)(2012-3#1)
its axis##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
its basal##2##2##(2008-7#1)(2012-3#1)
its base##3##2##(1993-12#1)(2008-12#1)(2013-1#1)
its basic##4##2##(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
its basis##3##2##(1994-2#1)(1995-3#1)(2008-4#1)
its beginning##2##2##(2008-10#1)(2009-8#1)
its behavior##5##2##(1993-8#1)(2008-5#2)(2008-8#1)(2009-5#1)
its behaviour##2##2##(2008-5#1)(2013-1#1)
its being##2##2##(1991-7#1)(2013-8#1)
its beneficial##3##2##(1997-6#1)(2008-5#1)(2011-2#1)
its beneficiaries##2##2##(1995-2#1)(1997-3#1)
its benefit##2##2##(2010-8#1)(2011-10#1)
its benefits##3##2##(1996-2#1)(2007-8#1)(2008-3#1)
its better##2##2##(2008-10#1)(2011-2#1)
its binding characteristics##2##3##(1991-12#1)(1995-11#1)
its binding site##4##3##(1992-3#1)(1996-3#1)(2008-10#1)(2008-8#1)
its binding to DNA##2##4##(1992-12#1)(2008-8#1)
its binding to##10##3##(1991-9#1)(1992-12#1)(1992-9#1)(1993-8#1)(1997-4#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-12#1)
its binding##27##2##(1990-12#1)(1990-2#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#4)(2009-9#1)(2012-12#1)
its bioavailability##3##2##(2008-10#1)(2009-12#1)(2011-2#1)
its biocompatibility##2##2##(2008-10#1)(2008-12#1)
its biological activity##8##3##(1990-12#1)(1990-2#1)(1991-8#2)(1992-8#1)(1995-12#1)(2008-8#2)
its biological effects##2##3##(2008-5#1)(2009-10#1)
its biological function##3##3##(1994-6#1)(2007-12#1)(2008-9#1)
its biological properties##2##3##(1991-9#1)(2008-11#1)
its biological##18##2##(1990-12#2)(1990-2#1)(1991-8#2)(1991-9#1)(1992-8#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)
its biology##4##2##(2008-5#1)(2009-5#1)(2010-3#1)(2013-7#1)
its biosynthetic##2##2##(1992-3#1)(1994-12#1)
its boards##2##2##(2012-2#2)
its brain##2##2##(1993-8#1)(2009-5#1)
its branches and##2##3##(1997-8#2)
its branches##5##2##(1997-8#5)
its breakdown##3##2##(2008-10#3)
its broad##6##2##(1992-8#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-1#1)
its cDNA was##2##3##(1990-8#1)(2008-9#1)
its cDNA##8##2##(1990-8#1)(1992-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
its canonical##3##2##(1990-7#1)(2007-12#1)(2013-1#1)
its capability to##5##3##(1993-12#1)(2009-11#1)(2009-12#1)(2010-3#1)(2012-2#1)
its capability##6##2##(1993-12#1)(2007-11#1)(2009-11#1)(2009-12#1)(2010-3#1)(2012-2#1)
its capacity for##2##3##(2008-2#1)(2011-2#1)
its capacity of##2##3##(1997-4#1)(2008-11#1)
its capacity to##7##3##(1994-8#1)(1995-2#1)(2008-10#4)(2013-1#1)
its capacity##11##2##(1994-8#1)(1995-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
its carrier##2##2##(2008-10#1)(2009-5#1)
its catalytic action on the oxidation of##2##7##(2008-10#2)
its catalytic action on##3##4##(2008-10#3)
its catalytic activity to##2##4##(1996-2#1)(2008-10#1)
its catalytic activity##6##3##(1993-8#1)(1996-2#1)(2008-10#3)(2012-2#1)
its catalytic effect on the##10##5##(2008-10#10)
its catalytic effect on##11##4##(2008-10#11)
its catalytic function##2##3##(1990-5#1)(1996-2#1)
its catalytic##25##2##(1990-5#1)(1991-5#2)(1993-8#1)(1996-2#2)(2008-10#18)(2012-2#1)
its causes##3##2##(1991-12#1)(1996-12#1)(2009-4#1)
its cell##5##2##(1990-5#1)(1990-8#1)(2007-12#1)(2008-11#1)(2011-2#1)
its cells##4##2##(2007-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
its cellular##7##2##(1995-11#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)
its center##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
its central cardioregulatory##2##3##(1991-5#2)
its central nervous system##2##4##(2008-10#1)(2010-1#1)
its central##8##2##(1990-7#1)(1991-5#2)(1992-11#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#1)
its challenges and##2##3##(2008-6#1)(2013-1#1)
its changes##5##2##(1993-9#1)(1996-5#1)(2008-10#1)(2008-6#1)(2012-12#1)
its characteristic##3##2##(2010-6#1)(2012-12#1)(2013-1#1)
its characteristics##9##2##(1992-9#1)(1993-3#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
its chemical##9##2##(1990-2#1)(1993-6#1)(2008-10#4)(2008-7#2)(2011-2#1)
its chemistry##2##2##(2008-9#1)(2013-1#1)
its chronic##4##2##(1992-12#1)(1996-12#1)(2008-12#1)(2010-12#1)
its clinical features and##3##4##(2008-7#1)(2010-1#1)(2013-8#1)
its clinical importance##2##3##(2008-11#1)(2012-2#1)
its clinical presentation and##2##4##(2010-3#1)(2010-8#1)
its clinical presentation##5##3##(2007-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-8#1)
its clinical significance##2##3##(2008-10#1)(2012-3#1)
its clinical use##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
its clinical##35##2##(1991-11#1)(1995-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-2#2)(2012-3#2)(2013-8#3)
its close##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
its coat protein##2##3##(2008-10#1)(2008-7#1)
its coding sequence##2##3##(2007-7#1)(2008-4#1)
its cognate##3##2##(1995-8#1)(2008-10#1)(2011-1#1)
its color##2##2##(2008-10#1)(2011-1#1)
its combination with##3##3##(1997-6#1)(2012-2#1)(2012-7#1)
its commercial##2##2##(2008-10#1)(2013-7#1)
its common##2##2##(2008-10#1)(2012-12#1)
its comparison##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
its competitive##3##2##(1990-5#1)(2008-10#1)(2008-12#1)
its complementary##4##2##(1991-5#1)(1996-2#1)(2007-11#1)(2008-8#1)
its complete##5##2##(1991-12#1)(1995-2#1)(1995-6#1)(2008-9#1)(2011-2#1)
its complex with##3##3##(2008-10#3)
its complex##11##2##(1994-6#1)(2008-10#7)(2009-5#1)(2012-3#1)(2013-1#1)
its complexation with##2##3##(2008-10#2)
its complexes##4##2##(1992-9#1)(2008-10#3)
its complexity and##2##3##(2007-12#1)(2013-1#1)
its complexity##5##2##(1992-12#1)(2007-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
its complicated##3##2##(2011-2#2)(2012-2#1)
its complications##14##2##(1990-11#1)(2007-10#2)(2007-5#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
its component##5##2##(1993-8#2)(1995-3#1)(1997-1#1)(2008-3#1)
its components##18##2##(1990-11#1)(1991-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
its composition##3##2##(1990-7#1)(1994-9#1)(2008-10#1)
its comprehensive##2##2##(1997-2#1)(2013-1#1)
its concentration has##2##3##(2008-10#1)(2010-4#1)
its concentration in##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
its concentration was##4##3##(1991-5#1)(2008-10#3)
its concentration##22##2##(1991-5#1)(1993-11#1)(2008-10#15)(2008-11#2)(2008-8#1)(2009-9#1)(2010-4#1)
its conception##2##2##(1990-12#1)(2008-7#1)
its conclusion##4##2##(1992-2#2)(1994-9#1)(2008-5#1)
its configuration##2##2##(1995-3#1)(2008-10#1)
its conformation##3##2##(1992-5#1)(1997-3#1)(2008-8#1)
its conformational##4##2##(1992-6#1)(2008-7#1)(2008-8#1)(2009-5#1)
its congeners##2##2##(1993-1#1)(2008-7#1)
its connections with the##2##4##(1993-6#1)(2013-8#1)
its connections with##3##3##(1993-6#1)(2011-2#1)(2013-8#1)
its connections##6##2##(1993-6#2)(2011-2#3)(2013-8#1)
its consequences for the##2##4##(1990-2#1)(2008-2#1)
its consequences for##4##3##(1990-2#1)(2008-2#1)(2008-8#1)(2011-2#1)
its consequences in##2##3##(2008-7#1)(2011-2#1)
its consequences on##2##3##(1996-5#1)(2013-8#1)
its consequences##17##2##(1990-2#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#2)
its considerable##3##2##(1994-1#1)(1995-12#1)(2011-2#1)
its constituent##5##2##(1990-7#1)(1992-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
its constituents##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
its construction##2##2##(1992-12#1)(1993-3#1)
its content in##2##3##(2008-5#1)(2009-7#1)
its content of##2##3##(1992-3#1)(2008-5#1)
its content was determined by##3##5##(2008-10#3)
its content##10##2##(1990-3#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-7#1)(2012-2#1)
its contents##3##2##(2008-11#1)(2009-7#1)(2011-2#1)
its context##3##2##(2008-2#1)(2008-9#1)(2013-1#1)
its continuous##5##2##(1996-12#1)(2008-10#2)(2009-12#1)(2013-1#1)
its contribution to the##2##4##(2008-3#1)(2008-7#1)
its contribution to##4##3##(1993-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
its control in##2##3##(1993-6#1)(2008-11#1)
its control##9##2##(1990-11#1)(1991-2#1)(1993-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-8#1)
its controlled object##2##3##(2009-5#2)
its conversion into##3##3##(1991-7#1)(2008-10#1)(2008-11#1)
its conversion to##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
its conversion##6##2##(1991-7#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
its core##2##2##(1993-1#1)(1994-2#1)
its correct diagnosis##2##3##(2012-12#1)(2012-3#1)
its correct##4##2##(2008-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
its correlates##2##2##(2007-12#1)(2009-5#1)
its correlation with serum##2##4##(2009-5#1)(2011-2#1)
its correlation with the##3##4##(2008-10#1)(2009-11#1)(2013-8#1)
its correlation with##9##3##(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-7#1)(2013-8#2)
its correlation##10##2##(2008-10#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-7#1)(2013-8#2)
its corresponding##14##2##(1994-8#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)
its cost and##2##3##(2008-10#1)(2013-1#1)
its costs##2##2##(2008-1#1)(2009-1#1)
its counterpart##3##2##(1992-8#2)(2008-10#1)
its coupling to##2##3##(1997-7#1)(2007-11#1)
its course in##2##3##(2007-11#1)(2013-1#1)
its course##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)
its critical##10##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-11#1)(2013-1#1)
its crucial role##2##3##(1993-6#1)(1994-2#1)
its current state##2##3##(2008-1#1)(2013-1#1)
its current##12##2##(1992-2#1)(1995-3#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2012-2#1)(2013-1#1)
its cyclic##2##2##(1991-12#1)(2013-7#1)
its cytoplasm##2##2##(2008-8#1)(2011-2#1)
its cytosolic##2##2##(1990-5#1)(1993-11#1)
its daily##2##2##(1991-2#1)(2013-1#1)
its damage##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2013-8#1)
its decline##2##2##(1995-2#1)(2011-2#1)
its decrease##2##2##(2008-10#1)(2011-2#1)
its deduced##4##2##(1991-12#1)(1995-6#1)(1996-10#1)(1996-6#1)
its degradation product were##2##4##(2008-10#2)
its degradation product##5##3##(2008-10#4)(2008-5#1)
its degradation products##6##3##(1997-2#1)(2008-10#4)(2011-1#1)
its degradation##13##2##(1995-8#1)(1997-2#1)(2008-10#8)(2008-5#1)(2011-1#1)(2012-12#1)
its degree of##3##3##(1990-6#1)(1991-5#1)(1992-6#1)
its degree##5##2##(1990-6#1)(1991-5#1)(1992-6#1)(2008-1#1)(2008-11#1)
its deletion##3##2##(1994-11#1)(1995-8#1)(2008-12#1)
its density##2##2##(1990-7#1)(2008-10#1)
its dependence on the##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
its dependence on##13##3##(1990-8#1)(1997-2#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#2)
its derivative##4##2##(2008-10#3)(2008-5#1)
its derivatives##39##2##(1990-5#1)(1990-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-5#4)(2008-8#2)(2008-9#3)(2011-2#1)(2013-1#1)
its design and##2##3##(1996-6#1)(2008-6#1)
its design##3##2##(1996-6#1)(2008-6#1)(2010-8#1)
its detection in male patients with non gonococcal urethritis in New Delhi##2##12##(2007-7#2)
its detection in##4##3##(2006-10#1)(2007-7#2)(2008-10#1)
its detection##18##2##(1995-5#1)(2006-10#1)(2007-7#4)(2008-10#9)(2011-2#1)(2013-1#2)
its determination at##3##3##(2008-10#3)
its determination by flame atomic##3##5##(2008-10#3)
its determination by the##2##4##(2008-10#1)(2008-11#1)
its determination by##13##3##(2008-10#12)(2008-11#1)
its determination in##9##3##(2008-10#9)
its determination##31##2##(1997-2#2)(2008-10#28)(2008-11#1)
its development and##5##3##(1992-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
its development are##2##3##(2008-11#1)(2010-6#1)
its development##22##2##(1992-1#1)(2006-6#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
its diagnosis and##3##3##(2007-7#1)(2011-1#1)(2012-3#1)
its diagnosis##8##2##(2007-5#1)(2007-7#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
its diagnostic accuracy##2##3##(2011-2#2)
its diagnostic##4##2##(2008-7#1)(2011-2#3)
its dielectric##2##2##(2007-11#1)(2008-3#1)
its diet##2##2##(2008-5#1)(2010-8#1)
its different##6##2##(1990-2#1)(2008-5#1)(2009-10#1)(2013-1#1)(2013-8#2)
its differential##2##2##(2008-10#1)(2008-8#1)
its diffusion##2##2##(2008-10#1)(2008-11#1)
its digestive##2##2##(1997-7#1)(2008-5#1)
its direct##9##2##(1991-12#1)(1992-8#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
its direction##5##2##(1991-2#2)(2007-11#1)(2008-11#1)(2008-9#1)
its discovery##2##2##(2009-3#1)(2011-1#1)
its disorders##2##2##(1995-5#1)(2008-6#1)
its dissociation##3##2##(1995-11#1)(2008-10#2)
its distal##3##2##(1997-5#1)(2008-7#1)(2011-2#1)
its distribution and##3##3##(2008-10#2)(2008-7#1)
its distribution##8##2##(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
its doctors##2##2##(1995-12#1)(1996-2#1)
its dosage##2##2##(1993-5#1)(2008-10#1)
its downstream effector##2##3##(2012-2#1)(2013-1#1)
its downstream##6##2##(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-1#1)
its duration##2##2##(1991-12#1)(2012-2#1)
its dynamic##2##2##(2008-5#1)(2009-10#1)
its dynamics##2##2##(2008-9#1)(2009-4#1)
its earlier##3##2##(1993-3#1)(2010-8#1)(2010-9#1)
its earliest stages##2##3##(2010-10#1)(2011-2#1)
its earliest##4##2##(1996-3#1)(2010-10#1)(2010-9#1)(2011-2#1)
its early diagnosis and##2##4##(1993-11#1)(2008-12#1)
its early diagnosis##3##3##(1993-11#1)(2008-12#1)(2010-8#1)
its early##10##2##(1993-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#2)(2012-12#1)
its ease of##2##3##(2008-10#1)(2008-11#1)
its easy##2##2##(2007-7#1)(2013-1#1)
its ecological##2##2##(2009-8#1)(2011-2#1)
its economic##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
its effect in##2##3##(2008-5#1)(2012-3#1)
its effect is not##2##4##(2008-2#1)(2012-12#1)
its effect is##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2012-12#1)
its effect of##2##3##(2011-3#2)
its effect on the binding of##2##6##(1995-11#2)
its effect on the##17##4##(1990-11#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
its effect on##64##3##(1990-11#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
its effect##84##2##(1990-11#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
its effectiveness in the##2##4##(2007-11#1)(2012-3#1)
its effectiveness in##6##3##(1993-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
its effectiveness##15##2##(1991-3#1)(1993-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-4#1)(2012-3#1)
its effects are not##2##4##(1992-8#1)(1994-3#1)
its effects are##4##3##(1992-8#1)(1994-3#1)(2008-9#1)(2011-1#1)
its effects at the##2##4##(2008-5#1)(2009-6#1)
its effects in the##2##4##(1996-5#1)(2008-1#1)
its effects in##3##3##(1991-9#1)(1996-5#1)(2008-1#1)
its effects on the##5##4##(1990-5#1)(2010-2#1)(2012-12#1)(2013-1#2)
its effects on##32##3##(1990-2#1)(1990-3#1)(1990-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)
its effects through##2##3##(1993-6#1)(2009-11#1)
its effects##53##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#2)(1996-5#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)
its efficacy and safety profile##2##5##(2008-5#1)(2008-6#1)
its efficacy and safety##6##4##(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2012-3#1)
its efficacy and##7##3##(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2012-3#1)
its efficacy for##3##3##(2007-10#1)(2008-11#1)(2009-10#1)
its efficacy in##7##3##(1990-12#1)(2007-7#1)(2008-10#2)(2010-12#1)(2010-3#1)(2010-5#1)
its efficacy is##3##3##(1995-12#1)(2008-2#1)(2008-3#1)
its efficacy was##2##3##(2011-2#2)
its efficacy##28##2##(1990-12#1)(1995-12#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-3#2)
its efficiency in##2##3##(1991-12#1)(2008-2#1)
its efficiency##4##2##(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
its efforts##3##2##(1994-3#1)(1995-5#1)(1996-12#1)
its electrochemical behavior and##2##4##(2008-10#2)
its electrochemical##6##2##(2008-10#6)
its electron##2##2##(2007-12#1)(2008-7#1)
its electrostatic interaction with##2##4##(2008-10#2)
its elemental##2##2##(2008-5#1)(2013-8#1)
its elimination##7##2##(1994-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-2#1)
its elongation##2##2##(1992-3#1)(2013-8#1)
its emergence##2##2##(2008-1#1)(2008-8#1)
its emphasis on##2##3##(1997-1#1)(2008-8#1)
its empirical##2##2##(1992-12#2)
its employees and##2##3##(1995-12#1)(1996-12#1)
its employees##4##2##(1992-3#1)(1995-12#1)(1996-12#1)(2008-11#1)
its enantiomer##2##2##(1992-12#1)(2008-8#1)
its end##2##2##(1996-2#1)(2008-9#1)
its endogenic##2##2##(2009-8#1)(2013-1#1)
its enhanced##2##2##(2008-8#1)(2009-3#1)
its enhancement by##2##3##(1992-8#1)(1997-7#1)
its enhancement##5##2##(1992-8#1)(1997-7#1)(2008-10#3)
its enhancing effect on the##5##5##(2008-10#5)
its entire##5##2##(1996-6#1)(2008-10#1)(2008-2#2)(2008-3#1)
its environment##9##2##(1990-8#1)(1992-6#1)(1994-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)
its environmental##7##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
its enzymatic##2##2##(1994-6#1)(2008-10#1)
its epidemiology##2##2##(2008-7#2)
its equilibrium##3##2##(2008-10#2)(2009-11#1)
its equivalent##2##2##(1991-8#1)(1997-6#1)
its eradication##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
its essential##2##2##(2011-2#1)(2012-3#1)
its established##2##2##(1991-9#1)(2012-12#1)
its ethyl##3##2##(1991-6#1)(2008-10#2)
its etiology and##2##3##(1992-3#1)(2008-4#1)
its etiology##8##2##(1992-3#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-3#1)(2010-6#1)(2011-1#1)
its evaluation##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
its evolution and##2##3##(1996-12#1)(2008-10#1)
its evolution##15##2##(1991-3#1)(1991-8#1)(1992-2#1)(1992-9#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
its evolutionary##4##2##(1997-4#1)(2008-9#2)(2009-6#1)
its exact##8##2##(1991-12#1)(1994-8#1)(1996-3#1)(2007-12#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
its excitation and emission##2##4##(2008-10#1)(2008-4#1)
its existence##3##2##(1992-2#1)(2008-10#1)(2011-2#1)
its experience##3##2##(1995-5#1)(1996-12#1)(2008-5#1)
its experimental##5##2##(2008-11#1)(2008-3#4)
its export##2##2##(2008-10#1)(2008-12#1)
its exposure to##2##3##(2008-10#1)(2008-11#1)
its exposure##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
its expression and##2##3##(2008-8#1)(2009-10#1)
its expression in the##6##4##(1995-12#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)
its expression in##13##3##(1995-12#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-7#1)(2008-8#2)(2009-9#1)
its expression is##7##3##(1992-12#1)(1995-6#1)(1996-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
its expression level##2##3##(1996-6#1)(2010-12#1)
its expression pattern##2##3##(1997-2#1)(2008-8#1)
its expression##46##2##(1990-11#1)(1991-11#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#2)(1995-6#2)(1996-10#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#5)(1997-4#2)(1997-7#1)(1997-9#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
its extension to##2##3##(2008-2#1)(2009-7#1)
its extension##3##2##(2008-2#1)(2008-8#1)(2009-7#1)
its extensive##2##2##(2009-6#1)(2013-1#1)
its external##3##2##(1994-3#1)(2008-3#1)(2008-5#1)
its extracellular##8##2##(1991-6#1)(1992-12#3)(1993-6#2)(1997-7#1)(2010-11#1)
its extraction##3##2##(2008-10#2)(2008-12#1)
its extreme##4##2##(1996-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
its extrinsic##2##2##(2008-6#1)(2012-1#1)
its facile##2##2##(1995-3#1)(2008-4#1)
its failure##5##2##(1990-11#1)(1990-6#1)(2007-7#1)(2009-7#1)(2013-8#1)
its family##2##2##(1995-5#1)(1996-12#1)
its fast##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
its fate in##2##3##(2008-11#1)(2012-1#1)
its favorable##2##2##(2008-10#1)(2010-11#1)
its feasibility for##2##3##(2008-10#1)(2008-5#1)
its feasibility##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
its features##3##2##(1991-1#1)(2011-2#1)(2012-1#1)
its final##6##2##(1996-12#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)
its findings##2##2##(1995-5#1)(2008-11#1)
its first appearance##2##3##(1990-9#1)(1992-2#1)
its first description##4##3##(2007-7#1)(2011-2#3)
its first year##2##3##(1991-1#1)(1995-1#1)
its first##27##2##(1990-11#2)(1990-9#1)(1991-1#1)(1991-12#1)(1992-2#1)(1994-3#1)(1995-1#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#3)
its fish##2##2##(2009-2#1)(2013-7#1)
its flexibility##2##2##(2008-3#1)(2011-1#1)
its flower##2##2##(2011-2#1)(2013-1#1)
its fluorescence intensity##2##3##(2008-10#2)
its fluorescence##5##2##(1990-12#1)(2008-10#4)
its focus on##3##3##(1993-1#1)(2007-4#1)(2010-10#1)
its focus##5##2##(1993-1#1)(2007-12#1)(2007-4#1)(2008-7#1)(2010-10#1)
its formation##6##2##(1990-7#1)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
its former glory##2##3##(2008-5#1)(2010-8#1)
its four##5##2##(1990-3#1)(1995-3#1)(2008-10#2)(2013-1#1)
its free##3##2##(1997-7#1)(2008-5#1)(2011-1#1)
its frequency##6##2##(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
its full complement of##2##4##(1992-8#1)(2011-2#1)
its full potential##3##3##(1996-2#1)(1996-3#1)(2008-11#1)
its full##8##2##(1992-8#1)(1994-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
its function and##2##3##(1993-6#1)(2013-1#1)
its function in##7##3##(1993-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)
its function is##2##3##(2011-2#1)(2012-2#1)
its function##24##2##(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#2)(1996-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
its functional and##2##3##(1990-2#1)(2011-2#1)
its functional role in##2##4##(2008-7#1)(2013-1#1)
its functional##13##2##(1990-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
its functioning##2##2##(2013-1#1)(2013-7#1)
its functions are##2##3##(1995-12#1)(2011-2#1)
its functions##6##2##(1995-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#2)
its fundamental##3##2##(1993-2#1)(2008-3#2)
its future##6##2##(1994-1#1)(1996-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
its gating##2##2##(1993-12#1)(2008-8#1)
its gene expression##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
its gene product##2##3##(1995-6#1)(1995-8#1)
its gene##11##2##(1991-7#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
its genetic##9##2##(1995-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
its genetically##2##2##(2009-5#1)(2011-1#1)
its genome##10##2##(2008-10#2)(2008-7#2)(2011-1#1)(2011-2#4)(2012-3#1)
its genomic##5##2##(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#2)
its geographic range##2##3##(2007-1#1)(2008-10#1)
its geographic##3##2##(2007-1#1)(2008-10#2)
its goal##3##2##(1991-3#1)(2007-4#1)(2008-11#1)
its goals##6##2##(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-4#1)(2008-3#1)
its good##5##2##(1992-12#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-4#1)
its great##4##2##(1995-6#1)(1996-1#1)(2008-11#1)(2008-12#1)
its greater##2##2##(1997-4#1)(2008-7#1)
its growing##2##2##(1994-6#1)(2013-8#1)
its growth##7##2##(1993-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)
its haemodynamic##2##2##(1991-2#1)(2013-1#1)
its health##10##2##(1992-11#1)(1992-12#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
its height##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
its high content of##2##4##(1990-2#1)(2008-12#1)
its high incidence and##2##4##(2008-10#1)(2008-7#1)
its high incidence##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
its high production volume and use##2##6##(2008-9#2)
its high sensitivity##4##3##(2008-10#2)(2008-3#1)(2012-1#1)
its high spatial resolution##2##4##(2012-12#1)(2012-2#1)
its high##47##2##(1990-2#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-3#2)(1994-12#1)(1997-4#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#1)(2010-11#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
its higher##6##2##(2007-8#1)(2008-10#2)(2008-5#2)(2011-2#1)
its highest##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
its highly##5##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
its history and##3##3##(1990-3#1)(1992-3#1)(1995-1#1)
its history##8##2##(1990-3#1)(1992-3#1)(1995-1#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)
its host plant##3##3##(2009-8#3)
its host##21##2##(1997-1#1)(2008-10#10)(2008-9#3)(2009-8#3)(2011-1#1)(2011-2#2)(2013-8#1)
its hosts##2##2##(2008-10#1)(2008-8#1)
its human counterpart##4##3##(1997-7#2)(2009-5#1)(2011-1#1)
its human##8##2##(1994-9#1)(1997-7#2)(2008-10#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
its humectancy##2##2##(2008-5#2)
its hydrolysis products##3##3##(2008-10#3)
its hydrolysis##8##2##(1990-12#1)(1993-8#1)(1997-7#1)(2008-10#5)
its hydrophobic##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
its identification by##2##3##(1990-2#1)(2007-8#1)
its identification##6##2##(1990-2#1)(1992-12#1)(1996-4#1)(2007-8#1)(2012-1#1)(2013-1#1)
its image##4##2##(1994-12#1)(1994-3#2)(2008-3#1)
its immune system##2##3##(1995-12#1)(2012-2#1)
its immunogenicity##2##2##(2008-11#1)(2013-8#1)
its impact on developing countries##2##5##(2009-4#2)
its impact on the outcome of##2##6##(2006-10#1)(2009-12#1)
its impact on the##12##4##(1996-1#1)(2006-10#2)(2008-11#2)(2009-12#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
its impact on##43##3##(1991-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)
its impact##50##2##(1991-1#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#4)(2008-7#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)
its implementation are##2##3##(2008-3#1)(2011-1#1)
its implementation in##3##3##(1995-3#1)(1995-5#1)(2008-3#1)
its implementation will##2##3##(2011-1#2)
its implementation##22##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-3#3)(2009-4#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
its implication##6##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)
its implications on##3##3##(1992-12#1)(2011-1#1)(2011-2#1)
its implications##23##2##(1990-10#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-4#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
its importance for##2##3##(2007-10#1)(2008-5#1)
its importance in##8##3##(1994-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-1#1)(2013-1#2)
its importance##16##2##(1993-6#1)(1994-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-6#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#2)
its important derivatives##2##3##(2008-10#2)
its important##3##2##(1997-4#1)(2008-10#2)
its improvement##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
its in vitro##2##3##(1995-2#1)(2008-11#1)
its in vivo##2##3##(1992-6#1)(2008-10#1)
its in##5##2##(1992-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
its inability to##3##3##(1994-12#1)(1995-3#1)(1996-2#1)
its inactivation##4##2##(1991-9#1)(1992-11#1)(1995-6#1)(2007-12#1)
its inactive##2##2##(2008-4#1)(2012-3#1)
its inception in##5##3##(1995-12#1)(1996-3#1)(2008-1#1)(2010-8#1)(2011-1#1)
its inception##12##2##(1995-12#1)(1996-3#2)(2008-1#2)(2008-12#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
its incidence##5##2##(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
its inclusion in##2##3##(2008-5#1)(2009-10#1)
its inclusion##4##2##(1995-12#2)(2008-5#1)(2009-10#1)
its incorporation into the##3##4##(1992-6#1)(2008-3#1)(2009-2#1)
its incorporation into##6##3##(1990-7#1)(1992-6#1)(1994-12#1)(2008-3#1)(2008-7#1)(2009-2#1)
its incorporation##7##2##(1990-7#1)(1992-6#1)(1994-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-8#1)
its increased##2##2##(1995-2#1)(2008-10#1)
its increasing##4##2##(1991-6#1)(1994-12#1)(2007-12#1)(2008-5#1)
its induction##5##2##(1993-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-12#1)
its infancy##10##2##(1995-5#1)(1996-2#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
its influence on the##6##4##(1991-6#1)(1994-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)
its influence on##13##3##(1991-6#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
its influence##15##2##(1991-6#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2013-1#1)(2013-8#1)
its information##2##2##(1991-2#1)(1993-3#1)
its inherent##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)
its inhibition effect on the##2##5##(2008-10#2)
its inhibition of##4##3##(1992-3#1)(1992-9#1)(1993-8#1)(2008-10#1)
its inhibition##15##2##(1992-3#1)(1992-9#1)(1993-8#1)(1995-6#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
its inhibitory effect on the##3##5##(1993-6#1)(2008-10#2)
its inhibitory effect on##5##4##(1993-6#1)(2008-10#3)(2008-5#1)
its inhibitory effect##6##3##(1992-8#1)(1993-6#1)(2008-10#3)(2008-5#1)
its inhibitory effects##2##3##(1994-11#1)(2013-1#1)
its inhibitory##10##2##(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#1)
its initial value##4##3##(1990-12#1)(1993-6#1)(2008-3#1)(2008-4#1)
its initial##22##2##(1990-12#1)(1991-12#1)(1992-2#1)(1993-6#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
its inner##2##2##(2008-10#1)(2008-3#1)
its insect##2##2##(2008-8#1)(2008-9#1)
its insensitivity to##2##3##(2007-12#1)(2010-7#1)
its insertion into##2##3##(1990-8#1)(2008-3#1)
its instability##2##2##(1994-6#1)(1996-2#1)
its integral##2##2##(1994-12#1)(2008-8#1)
its intensity and##2##3##(1994-8#1)(2011-2#1)
its intensity##7##2##(1994-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-1#1)
its intent##2##2##(1992-1#2)
its interaction with a##2##4##(1994-11#1)(1994-8#1)
its interaction with the##3##4##(2007-12#1)(2008-8#1)(2011-1#1)
its interaction with##25##3##(1990-5#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-8#1)
its interaction##27##2##(1990-5#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-4#1)(2011-1#1)(2012-8#1)
its interactions with##4##3##(1995-5#1)(1997-2#1)(2008-9#1)(2009-9#1)
its interactions##6##2##(1995-5#1)(1997-2#2)(2008-9#1)(2009-4#1)(2009-9#1)
its interest##2##2##(1992-3#1)(1996-9#1)
its interference##4##2##(1997-1#1)(2008-10#2)(2008-3#1)
its interferogram##2##2##(2008-2#1)(2008-3#1)
its internal##3##2##(2008-12#1)(2009-10#1)(2011-1#1)
its internalization##2##2##(2009-2#1)(2011-2#1)
its international##2##2##(2011-2#2)
its intracellular##5##2##(1992-3#1)(1996-2#1)(2008-11#1)(2009-8#1)(2011-1#1)
its intrinsic##3##2##(1992-11#1)(2008-10#1)(2013-1#1)
its introduction into the##2##4##(2008-10#1)(2013-1#1)
its introduction##7##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
its inversion performance##2##3##(2008-3#2)
its inversion##3##2##(2008-3#3)
its investigation##2##2##(1992-6#1)(2011-2#1)
its involvement in the##3##4##(2008-5#2)(2010-12#1)
its involvement in##5##3##(1996-12#1)(1996-2#1)(2008-5#2)(2010-12#1)
its involvement##7##2##(1996-12#1)(1996-2#2)(2008-5#2)(2010-12#1)(2011-2#1)
its ion pair##3##3##(1995-6#1)(2008-10#2)
its ionic##2##2##(2008-10#1)(2010-7#1)
its ionization##2##2##(2008-10#2)
its isoelectric point##2##3##(1991-2#1)(2008-7#1)
its isoelectric##3##2##(1991-2#1)(2008-7#2)
its isolated##8##2##(1993-8#1)(1994-11#1)(1995-2#1)(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
its isolation from##2##3##(2008-1#1)(2008-3#1)
its isolation##4##2##(2008-1#1)(2008-3#1)(2009-12#1)(2009-7#1)
its isotope##2##2##(2008-10#2)
its joint##2##2##(1995-12#1)(2008-9#1)
its keto acid##3##3##(2008-11#3)
its key role in##2##4##(2008-9#1)(2013-1#1)
its key##6##2##(1993-3#1)(2008-6#1)(2008-9#1)(2012-8#1)(2013-1#2)
its kinase##2##2##(1995-6#1)(2013-8#1)
its known##7##2##(1991-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-2#1)
its lack of##8##3##(1992-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
its large size##3##3##(2008-6#1)(2009-11#1)(2013-7#1)
its large##5##2##(2008-6#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
its largest##2##2##(2008-2#1)(2011-2#1)
its late##2##2##(2008-7#1)(2012-12#1)
its later##3##2##(1992-2#1)(2008-4#1)(2010-5#1)
its lateral##2##2##(2007-11#1)(2008-3#1)
its leadership role##2##3##(2008-11#1)(2008-12#1)
its length##9##2##(1990-5#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#2)
its level was##2##3##(1992-6#1)(1993-6#1)
its level##5##2##(1992-6#1)(1993-12#1)(1993-6#1)(2008-10#2)
its life and##2##3##(1994-5#1)(2009-7#1)
its life cycle##4##3##(2008-10#1)(2009-3#1)(2009-8#1)(2012-2#1)
its life##7##2##(1994-5#2)(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-2#1)
its ligand##6##2##(1994-12#1)(1995-2#1)(2008-7#1)(2008-8#2)(2011-2#1)
its likely##2##2##(2008-10#1)(2008-5#1)
its limitations and##2##3##(2008-3#1)(2012-12#1)
its limitations in##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
its limitations##14##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
its limited##2##2##(2008-8#1)(2013-1#1)
its link to speciation##2##4##(2008-8#2)
its link to##3##3##(2008-11#1)(2008-8#2)
its lipid##4##2##(2008-12#1)(2008-5#1)(2013-1#2)
its local##6##2##(1992-12#1)(1993-12#1)(1995-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
its localization##3##2##(1991-12#1)(2008-9#1)(2012-2#1)
its location##9##2##(1990-8#1)(1990-9#1)(1994-9#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
its locus##2##2##(1991-6#1)(2008-9#1)
its long history##2##3##(1993-11#1)(1997-3#1)
its long##8##2##(1993-11#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)
its long-lasting##2##2##(2008-5#1)(2013-1#1)
its long-term##5##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)
its longitudinal##2##2##(2007-12#1)(2008-3#1)
its loss##2##2##(2008-10#1)(2013-1#1)
its low concentration##2##3##(2008-10#1)(2009-10#1)
its low cost##2##3##(1993-3#1)(2009-1#1)
its low##19##2##(1991-5#1)(1993-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#1)
its lower##2##2##(2008-10#2)
its mRNA expression##2##3##(1994-11#1)(1994-12#1)
its mRNA level##3##3##(1994-11#1)(2008-9#1)(2013-1#1)
its mRNA##14##2##(1990-7#1)(1991-5#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(2008-8#1)(2008-9#2)(2013-1#1)
its magnitude##2##2##(1996-3#1)(2007-11#1)
its main branches##2##3##(1997-8#2)
its main metabolites##2##3##(1995-11#1)(2008-10#1)
its main##28##2##(1995-11#1)(1997-8#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2009-1#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
its major metabolite##4##3##(1992-11#1)(2008-10#2)(2013-1#1)
its major metabolites##4##3##(1990-8#1)(1996-5#1)(2008-10#1)(2011-3#1)
its major##19##2##(1990-2#1)(1990-8#1)(1992-11#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
its malignant nature##2##3##(2008-5#1)(2010-11#1)
its malignant##3##2##(2008-5#1)(2010-11#1)(2013-1#1)
its mammalian##2##2##(1990-5#1)(2011-2#1)
its managed care##3##3##(1993-2#1)(1994-12#1)(1996-12#1)
its management and##2##3##(1991-2#1)(2013-1#1)
its management##16##2##(1991-2#1)(1995-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#3)
its manufacture to the##2##4##(2008-3#2)
its manufacture##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
its many##5##2##(1990-2#1)(1992-3#1)(2008-5#2)(2008-7#1)
its mark##2##2##(1996-2#1)(2008-7#1)
its market##2##2##(1996-1#1)(2008-12#1)
its mass##2##2##(2007-12#1)(2008-8#1)
its material##2##2##(2008-3#1)(2013-8#1)
its maximal##3##2##(1992-12#1)(1993-8#1)(1994-6#1)
its maximum value##3##3##(1992-11#1)(2008-10#2)
its maximum##15##2##(1992-11#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2013-8#1)
its meaning##2##2##(2008-11#1)(2010-10#1)
its measured##2##2##(2008-3#1)(2008-5#1)
its measurement##5##2##(1996-3#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-2#1)
its mechanical properties##2##3##(2008-6#1)(2010-9#1)
its mechanical##3##2##(2008-6#1)(2010-9#1)(2012-2#1)
its mechanism is##2##3##(2008-8#1)(2013-8#1)
its mechanism of action##9##4##(1992-3#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-3#1)
its mechanism of##12##3##(1990-11#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#2)(2011-3#1)
its mechanism##19##2##(1990-11#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-8#2)
its mechanisms##4##2##(1994-2#1)(2010-12#1)(2011-2#1)(2011-3#1)
its medical##2##2##(1993-2#1)(1995-2#1)
its medication##4##2##(1994-8#1)(2011-1#3)
its members##14##2##(1992-2#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2011-2#2)(2012-12#1)
its membership##2##2##(1996-1#1)(1996-3#1)
its membrane##2##2##(1994-6#1)(2011-1#1)
its messenger RNA##3##3##(1990-5#1)(1993-11#1)(1994-11#1)
its metabolic##5##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
its metabolism to active compounds which could play a role in a cell signalling system##2##15##(1994-11#1)(1994-6#1)
its metabolism##5##2##(1994-11#1)(1994-6#1)(1995-11#1)(2008-3#2)
its metabolite##16##2##(1993-12#1)(1995-11#1)(1995-3#2)(1996-5#1)(2008-1#1)(2008-10#9)(2009-6#1)
its metabolites##28##2##(1992-10#1)(1993-3#1)(1993-6#1)(1995-8#1)(1996-5#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-7#2)(2008-8#2)(2011-3#1)
its metal##3##2##(2008-10#3)
its methyl ester##2##3##(1995-11#1)(1996-7#1)
its methyl##3##2##(1995-11#1)(1996-7#1)(2007-11#1)
its mission##3##2##(1994-12#1)(1995-2#1)(2011-2#1)
its mobility##3##2##(1994-7#1)(2008-10#2)
its mode of##2##3##(1992-10#1)(2008-8#1)
its model##3##2##(1993-6#1)(2008-10#1)(2012-3#1)
its modular##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
its modulation##7##2##(1990-3#3)(1993-2#1)(1994-2#1)(2008-2#1)(2013-8#1)
its modulatory##2##2##(2008-7#1)(2009-12#1)
its molecular mass##3##3##(1994-9#1)(1997-4#1)(2008-10#1)
its molecular mechanism##2##3##(2008-10#1)(2008-8#1)
its molecular structure##3##3##(1991-2#1)(2008-10#2)
its molecular weight##2##3##(1992-6#1)(2008-8#1)
its molecular##18##2##(1991-2#1)(1992-6#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-3#1)(2012-2#2)
its more##8##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-8#1)
its morphological and##2##3##(1997-2#1)(2008-5#1)
its morphological##3##2##(1997-2#1)(2008-5#1)(2012-12#1)
its morphology##2##2##(2008-5#1)(2009-2#1)
its mortality##3##2##(2007-12#1)(2011-2#1)(2012-12#1)
its most##7##2##(1990-5#1)(1993-12#1)(1994-12#1)(2008-1#1)(2010-5#1)(2012-12#1)(2012-3#1)
its mouth##3##2##(2007-12#1)(2008-5#2)
its movement##4##2##(1990-2#1)(2008-10#2)(2013-8#1)
its multifactorial##2##2##(1992-5#1)(2008-1#1)
its multiple##2##2##(1994-6#1)(2008-3#1)
its mutant##4##2##(1995-11#1)(2008-8#2)(2008-9#1)
its name##3##2##(1991-3#1)(2006-10#1)(2009-7#1)
its narrow##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-2#1)
its native state##3##3##(2008-10#3)
its native##16##2##(1990-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)
its natural##14##2##(1990-7#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)
its near-isogenic##2##2##(2008-10#1)(2011-2#1)
its negative##4##2##(1994-9#1)(2007-12#1)(2012-2#1)(2013-7#1)
its neurotoxic##2##2##(1990-5#1)(2012-12#1)
its new##3##2##(1992-12#1)(2008-5#1)(2008-8#1)
its next##2##2##(1990-7#1)(2012-12#1)
its normal##3##2##(1990-5#1)(1995-12#1)(2008-10#1)
its novel##4##2##(1992-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
its nuclear export##2##3##(2011-2#1)(2012-2#1)
its nuclear##6##2##(1990-5#1)(1994-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
its numerical##2##2##(2008-2#1)(2008-3#1)
its nursing##2##2##(2008-12#1)(2012-12#1)
its objectives##3##2##(1990-10#1)(1992-1#1)(1992-3#1)
its obligation to##2##3##(1995-12#1)(1995-6#1)
its occurrence and##2##3##(2008-10#1)(2008-7#1)
its occurrence##10##2##(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#3)
its on-line##2##2##(2008-10#2)
its onset##3##2##(1991-6#1)(1997-7#1)(2007-7#1)
its opening##2##2##(1990-3#1)(2009-4#1)
its operation##8##2##(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-2#1)
its operator##2##2##(1992-6#1)(2008-11#1)
its optical##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
its optimal##2##2##(2008-10#1)(2011-2#1)
its optimization##2##2##(2008-10#1)(2008-7#1)
its optimum##5##2##(2008-3#1)(2008-6#2)(2011-1#1)(2013-1#1)
its organization##2##2##(1993-3#1)(1994-11#1)
its organizational structure##3##3##(1994-2#1)(1996-1#1)(1997-2#1)
its organizational##4##2##(1992-12#1)(1994-2#1)(1996-1#1)(1997-2#1)
its orientation##2##2##(1996-3#1)(2008-3#1)
its origin and##3##3##(1991-12#1)(2008-5#1)(2008-7#1)
its origin in the##2##4##(1990-2#1)(1992-12#1)
its origin in##4##3##(1990-2#1)(1992-12#1)(2007-11#1)(2008-8#1)
its origin##13##2##(1990-2#1)(1991-12#2)(1992-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#1)(2013-1#2)(2013-8#1)
its original value##2##3##(2008-5#1)(2008-8#1)
its original##7##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2013-8#1)
its origins and##2##3##(1995-11#1)(1997-7#1)
its origins##3##2##(1991-12#1)(1995-11#1)(1997-7#1)
its outcome##3##2##(2008-3#1)(2008-9#1)(2012-3#1)
its output##2##2##(2007-11#1)(2007-12#1)
its outstanding##2##2##(2008-9#1)(2009-8#1)
its own challenges##2##3##(2008-11#1)(2008-8#1)
its own experience##2##3##(1995-1#1)(2010-6#1)
its own expression##2##3##(1990-5#1)(2010-10#1)
its own processes##2##3##(1995-12#1)(1995-3#1)
its own promoter##3##3##(1995-2#2)(2008-10#1)
its own##88##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#4)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
its oxidation products##3##3##(2008-10#2)(2008-11#1)
its oxidation##10##2##(2008-10#7)(2008-11#1)(2008-5#1)(2011-1#1)
its parallel##2##2##(2008-2#1)(2011-1#1)
its parameters##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
its parent##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
its participation in##3##3##(1994-9#1)(2011-2#1)(2013-8#1)
its pathogenesis and##2##3##(2010-10#1)(2013-8#1)
its pathogenesis##11##2##(1991-3#1)(1992-5#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)(2013-8#2)
its pathogenicity##2##2##(2008-10#1)(2011-2#1)
its pathophysiology and##2##3##(2010-6#1)(2012-3#1)
its pathophysiology##3##2##(1996-11#1)(2010-6#1)(2012-3#1)
its patients##3##2##(1992-3#1)(1996-1#1)(2009-7#1)
its patrons##2##2##(2009-7#1)(2012-2#1)
its pattern of##3##3##(1991-5#1)(2010-12#1)(2013-8#1)
its pattern##4##2##(1991-5#1)(2008-1#1)(2010-12#1)(2013-8#1)
its peak current##2##3##(2008-10#2)
its peak##6##2##(1991-5#1)(1995-6#1)(2007-10#2)(2008-10#2)
its peptide##2##2##(1990-5#1)(1990-7#1)
its perception##2##2##(1991-12#1)(1995-5#1)
its performance with##4##3##(1994-9#1)(2008-3#1)(2008-5#1)(2008-7#1)
its performance##21##2##(1994-9#1)(1996-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
its performances##2##2##(2008-3#2)
its peripheral##2##2##(1997-7#1)(2008-8#1)
its permeation##2##2##(2008-10#1)(2008-5#1)
its persistent##2##2##(1992-9#1)(2008-8#1)
its pharmaceutical formulation##5##3##(2008-10#5)
its pharmaceutical formulations (tablets and injections)##2##6##(2008-10#2)
its pharmaceutical formulations##3##3##(2008-10#3)
its pharmaceutical##10##2##(2008-10#10)
its pharmacokinetics##2##2##(1990-11#1)(1991-2#1)
its pharmacological##2##2##(1991-2#1)(2009-7#1)
its phase##2##2##(2007-12#1)(2008-2#1)
its phosphate##2##2##(1990-10#1)(1991-8#1)
its phosphorylated##3##2##(2008-4#1)(2008-7#2)
its phosphorylation##4##2##(1990-11#1)(1995-2#2)(2008-11#1)
its phylogenetic##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
its physical and##2##3##(2008-5#1)(2013-1#1)
its physical##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
its physiological role##2##3##(1995-11#1)(2012-2#1)
its physiological##9##2##(1994-3#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
its place##2##2##(1995-1#1)(2010-11#1)
its plasma##2##2##(2008-4#1)(2012-12#1)
its polarization##2##2##(2008-2#1)(2008-3#1)
its policies##2##2##(1993-2#1)(1995-1#1)
its policy##2##2##(1991-1#1)(1992-12#1)
its population of##2##3##(1997-5#1)(2012-2#1)
its population##3##2##(1990-6#1)(1997-5#1)(2012-2#1)
its portability and##2##3##(2008-10#2)
its position in the##4##4##(1994-12#1)(2007-12#1)(2008-12#1)(2009-5#1)
its position in##5##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-5#1)
its position with respect to the##2##6##(2008-2#1)(2008-3#1)
its position##9##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
its positive##2##2##(2010-8#1)(2012-3#1)
its possibility##2##2##(2008-12#1)(2010-5#1)
its possible role in##2##4##(2008-12#1)(2008-5#1)
its possible role##4##3##(2008-12#1)(2008-5#2)(2010-10#1)
its possible use in##3##4##(2007-5#1)(2008-5#1)(2013-1#1)
its possible use##4##3##(2007-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
its possible##26##2##(1991-3#1)(1994-6#1)(2006-10#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#2)
its posterior##2##2##(1994-8#1)(2007-12#1)
its potency in##2##3##(1992-2#1)(2008-7#1)
its potency##7##2##(1991-8#1)(1992-2#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
its potential advantages##2##3##(2008-3#1)(2010-8#1)
its potential application as constructed wetland media##2##7##(2013-1#2)
its potential application as##3##4##(2008-10#1)(2013-1#2)
its potential application to##2##4##(2007-12#1)(2007-6#1)
its potential application##6##3##(2007-12#1)(2007-6#1)(2008-10#1)(2011-2#1)(2013-1#2)
its potential as a##7##4##(1994-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
its potential for##11##3##(1992-6#1)(1994-3#1)(1996-1#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-9#2)(2010-12#1)(2010-5#1)
its potential impact in##2##4##(2008-11#1)(2008-3#1)
its potential impact##3##3##(1993-2#1)(2008-11#1)(2008-3#1)
its potential importance##2##3##(1997-8#1)(2010-7#1)
its potential role in##3##4##(1991-12#1)(2008-11#1)(2008-5#1)
its potential therapeutic##2##3##(1993-8#1)(2013-1#1)
its potential to##12##3##(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2012-2#3)(2012-6#1)
its potential use as##2##4##(1990-8#1)(2012-2#1)
its potential use in##2##4##(1997-4#1)(2007-12#1)
its potential use##6##3##(1990-8#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2012-2#1)
its potential usefulness##2##3##(1990-2#1)(2008-10#1)
its potential##80##2##(1990-2#1)(1990-8#1)(1991-12#2)(1992-12#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#5)(2012-6#1)(2013-1#6)
its potentially##2##2##(2008-11#1)(2008-9#1)
its power and##2##3##(2009-11#1)(2011-1#1)
its power spectrum##2##3##(1997-6#1)(2007-11#1)
its power##4##2##(1997-6#1)(2007-11#1)(2009-11#1)(2011-1#1)
its practical implications##2##3##(1996-7#1)(2008-3#1)
its practical use and##2##4##(2008-4#1)(2010-3#1)
its practical##10##2##(1996-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-3#1)(2010-9#1)
its practice##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
its precise mechanism##2##3##(2008-1#1)(2008-9#1)
its precise##4##2##(2008-1#1)(2008-9#1)(2009-10#1)(2012-2#1)
its precision##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
its preconcentration##4##2##(2008-10#4)
its precursor##4##2##(1992-9#1)(1994-6#1)(1995-5#1)(1996-12#1)
its predatory##2##2##(2008-5#2)
its predecessor##2##2##(2008-11#1)(2008-5#1)
its predictions##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
its predictive ability##2##3##(2007-11#1)(2011-1#1)
its predictive value##2##3##(2008-9#1)(2011-2#1)
its predictive##5##2##(1991-5#1)(2007-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
its preferences##2##2##(2008-5#1)(2010-8#1)
its preliminary##3##2##(1991-6#1)(2008-8#1)(2012-3#1)
its presence in the##3##4##(1994-12#1)(1995-11#1)(2008-10#1)
its presence in##8##3##(1994-12#1)(1994-6#1)(1995-11#1)(2008-10#4)(2013-7#1)
its presence##17##2##(1990-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-10#6)(2008-3#1)(2009-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
its presentation in##2##3##(1991-11#1)(2009-8#1)
its presentation##4##2##(1991-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
its prevalence and##4##3##(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
its prevalence##8##2##(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
its prevention##10##2##(1991-9#1)(1993-10#1)(1997-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
its previously##3##2##(1995-2#1)(1997-7#1)(2008-10#1)
its primary##8##2##(1990-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1997-1#1)(1997-4#1)(2008-7#1)(2013-8#1)
its principal##5##2##(1994-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
its problems##3##2##(1993-11#1)(1994-2#1)(1994-9#1)
its processing##4##2##(1992-8#1)(2008-3#1)(2008-9#1)(2013-1#1)
its product##6##2##(1990-11#2)(1991-7#1)(1995-2#1)(2008-4#1)(2011-2#1)
its production in##2##3##(1991-12#1)(2013-8#1)
its production##5##2##(1991-12#1)(1991-3#1)(2007-5#1)(2008-6#1)(2013-8#1)
its products##2##2##(2008-10#1)(2008-8#1)
its professional##2##2##(2008-1#1)(2008-10#1)
its prognosis and##2##3##(1990-3#1)(2013-1#1)
its prognosis##3##2##(1990-3#1)(2010-5#1)(2013-1#1)
its prognostic##3##2##(1994-8#1)(2007-8#1)(2009-11#1)
its progression##3##2##(2010-6#1)(2011-2#1)(2012-12#1)
its promoter##2##2##(2012-3#1)(2013-1#1)
its proper##3##2##(1991-4#1)(2008-10#1)(2008-11#1)
its properties were##2##3##(1993-3#1)(2008-5#1)
its properties##10##2##(1991-12#1)(1993-3#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-1#1)
its property##2##2##(1997-7#1)(2012-1#1)
its proposed##2##2##(1993-2#1)(2008-12#1)
its protective effect##2##3##(1993-9#1)(2013-1#1)
its protective##6##2##(1992-6#1)(1993-9#1)(2008-5#2)(2011-2#1)(2013-1#1)
its protein product##2##3##(1993-12#1)(1994-11#1)
its protein##6##2##(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-8#1)(2008-10#1)
its proteolytic activity##2##3##(2013-1#1)(2013-8#1)
its proteolytic##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
its protonated##2##2##(2008-10#2)
its psychological##2##2##(1991-9#1)(2008-11#1)
its public health##2##3##(1997-3#1)(2007-2#1)
its purification##2##2##(1995-2#1)(2008-10#1)
its purified##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
its purity##2##2##(2008-8#1)(2012-2#1)
its putative role##2##3##(1990-5#1)(2008-10#1)
its putative##9##2##(1990-5#1)(1991-5#1)(1994-12#1)(1997-2#1)(2008-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
its quality##2##2##(2008-10#2)
its quantitative##2##2##(2008-10#2)
its quantity##2##2##(1991-11#1)(2011-2#1)
its radiology##2##2##(1993-12#1)(1996-3#1)
its rapid##5##2##(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)
its rarity and##2##3##(2006-12#1)(2011-2#1)
its rarity##7##2##(2006-12#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
its reaction with##15##3##(1995-5#1)(1996-5#1)(2008-10#13)
its reactivity##3##2##(1990-12#1)(1996-2#1)(2010-7#1)
its real##4##2##(1996-1#1)(2007-11#2)(2011-1#1)
its recent##6##2##(1992-1#1)(1996-2#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)
its receptor in##8##3##(1991-7#1)(1993-3#1)(1995-11#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)(2013-7#1)
its receptor##40##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-6#2)(1997-4#1)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#1)(2012-2#1)(2013-7#1)
its receptors##8##2##(1992-4#1)(2008-8#3)(2011-1#1)(2011-2#3)
its recognition by##3##3##(1994-3#1)(1995-2#1)(2008-10#1)
its recognition##6##2##(1990-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#1)
its recombinant##4##2##(1994-8#1)(2008-8#1)(2008-9#1)(2012-2#1)
its recurrence##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
its redox##2##2##(2008-10#2)
its reduced##4##2##(1993-11#1)(1997-7#1)(2008-10#2)
its reducing##2##2##(2008-10#2)
its reduction##4##2##(1994-11#1)(2008-10#2)(2011-2#1)
its regular##2##2##(2007-8#1)(2011-2#1)
its regulation by##4##3##(1990-5#1)(1990-8#1)(2008-4#2)
its regulation##11##2##(1990-2#1)(1990-5#1)(1990-8#1)(1994-11#1)(1996-2#1)(2006-6#1)(2008-4#2)(2010-11#1)(2010-3#1)(2011-1#1)
its regulatory##6##2##(1996-8#1)(2008-4#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
its related##16##2##(1992-6#1)(2008-10#2)(2008-11#3)(2008-8#3)(2009-10#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
its relation to##20##3##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-12#2)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
its relation##21##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-12#2)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
its relationship to the##6##4##(1993-2#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
its relationship to##25##3##(1992-12#2)(1993-12#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
its relationship with other##2##4##(2008-4#1)(2013-1#1)
its relationship with the##7##4##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
its relationship with##19##3##(1990-9#1)(1991-12#1)(1995-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-12#2)(2013-1#4)
its relationship##44##2##(1990-9#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-12#2)(1996-5#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#3)(2009-1#1)(2009-11#2)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
its relationships with##3##3##(1990-12#1)(2012-12#1)(2013-8#1)
its relative simplicity##2##3##(2008-1#1)(2008-4#1)
its relative##5##2##(2008-1#1)(2008-10#2)(2008-4#1)(2012-3#1)
its relatively high##2##3##(1997-2#1)(2009-5#1)
its relatively low##3##3##(2008-10#1)(2009-1#1)(2012-2#1)
its relatively##6##2##(1997-2#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#1)(2012-2#1)
its release from the##2##4##(1994-6#1)(2007-12#1)
its release##4##2##(1994-6#1)(2007-12#1)(2008-10#1)(2009-3#1)
its relevance to the##5##4##(1991-5#1)(2007-12#1)(2007-9#1)(2008-9#1)(2012-3#1)
its relevance to##10##3##(1991-5#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#1)
its relevance##13##2##(1991-5#1)(1993-9#1)(1994-12#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-2#1)(2012-2#1)(2012-3#1)
its reliability and##2##3##(1990-5#1)(2007-7#1)
its reliability##8##2##(1990-5#1)(2007-7#1)(2008-10#4)(2008-11#2)
its removal##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
its replication##2##2##(2008-12#1)(2008-9#1)
its reproducibility##2##2##(2008-12#1)(2008-5#1)
its reproductive##2##2##(2010-1#1)(2012-12#1)
its requirement##2##2##(2009-10#1)(2010-2#1)
its requirements and##2##3##(2008-10#1)(2012-2#1)
its requirements for##2##3##(1991-1#1)(1995-3#1)
its requirements##6##2##(1991-1#1)(1994-3#1)(1995-3#1)(2008-10#1)(2012-2#1)(2013-7#1)
its research##6##2##(2007-7#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-3#1)
its resistance to##5##3##(1994-8#1)(1997-4#1)(2007-8#1)(2008-3#1)(2013-8#1)
its resistance##10##2##(1994-8#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2013-8#1)
its resolution##2##2##(2008-10#1)(2012-2#1)
its resonance##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
its respective##6##2##(1991-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
its response element##2##3##(1992-8#1)(1993-6#1)
its response time##2##3##(2008-2#2)
its response to the##2##4##(1997-2#1)(2009-8#1)
its response to##7##3##(1990-8#1)(1997-2#1)(2007-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#1)
its response##16##2##(1990-8#1)(1992-8#1)(1993-6#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-12#1)
its responses to##2##3##(2008-9#1)(2012-2#1)
its resultant##2##2##(2007-8#1)(2010-3#1)
its results##10##2##(1990-3#1)(1992-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-6#1)(2012-1#1)
its reversal potential##2##3##(1992-11#1)(1995-5#1)
its risk factors in##2##4##(2007-7#1)(2012-2#1)
its risk factors##4##3##(2007-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
its risks##2##2##(1995-12#1)(2013-1#1)
its robustness##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
its role as a##8##4##(1997-5#1)(2007-11#1)(2008-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2011-2#1)
its role in calcium homeostasis##2##5##(2012-12#1)(2012-2#1)
its role in chronic##2##4##(2008-1#1)(2008-7#1)
its role in disease##2##4##(1991-12#1)(1994-8#1)
its role in the##17##4##(1995-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-10#1)(2011-7#1)(2012-2#1)(2013-1#2)
its role in##67##3##(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
its role##85##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2007-11#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
its roots##6##2##(1993-2#1)(1997-2#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-8#1)
its rotational##2##2##(1990-7#1)(2013-1#1)
its routine##2##2##(1997-5#1)(2007-12#1)
its safety and efficacy##2##4##(2008-8#1)(2013-1#1)
its safety and##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
its safety profile##2##3##(2012-3#1)(2013-1#1)
its safety##11##2##(1990-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
its scientific##2##2##(2008-3#1)(2008-9#1)
its scores##2##2##(2007-12#2)
its second harmonic##2##3##(2007-12#2)
its second site##2##3##(2008-8#2)
its second##6##2##(1995-8#1)(2007-12#2)(2008-4#1)(2008-8#2)
its secondary structure similar to its native state in##2##9##(2008-10#2)
its secondary structure##3##3##(1990-5#1)(2008-10#2)
its secondary##4##2##(1990-5#1)(1995-12#1)(2008-10#2)
its selective##2##2##(2008-10#1)(2013-7#1)
its selectivity and##2##3##(2008-10#1)(2009-2#1)
its selectivity##3##2##(2008-10#2)(2009-2#1)
its sensitivity is##2##3##(1990-9#1)(2009-5#1)
its sensitivity to##6##3##(1990-11#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
its sensitivity was##4##3##(1992-6#1)(1996-2#1)(2007-8#1)(2008-11#1)
its sensitivity##17##2##(1990-11#1)(1990-9#1)(1992-6#1)(1995-11#1)(1996-2#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)
its separation from##2##3##(1990-3#1)(2008-10#1)
its separation##4##2##(1990-3#1)(2008-10#3)
its sequelae##2##2##(1997-2#1)(2010-6#1)
its sequence##7##2##(1993-9#1)(1997-7#1)(2008-10#3)(2008-4#2)
its services##4##2##(1993-1#1)(1995-12#1)(2011-2#2)
its severity##3##2##(2011-1#1)(2011-2#1)(2012-3#1)
its shape##5##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
its short##2##2##(2008-10#2)
its side##5##2##(1993-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
its side-effects##3##2##(2008-11#3)
its signal##5##2##(2008-10#1)(2008-3#3)(2010-6#1)
its significance##6##2##(2007-10#1)(2007-7#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-6#1)
its significant##3##2##(2008-4#1)(2010-7#1)(2011-2#1)
its similarity to##2##3##(2008-10#1)(2008-5#1)
its similarity##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
its simple##2##2##(1991-4#1)(2007-12#1)
its simplicity and##4##3##(1990-7#1)(2008-11#1)(2008-3#1)(2008-5#1)
its simplicity##11##2##(1990-7#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2010-7#1)(2013-1#1)
its single##3##2##(1994-5#1)(1995-5#1)(2008-10#1)
its sister##2##2##(2008-10#1)(2008-8#1)
its size and##2##3##(2007-8#1)(2008-5#1)
its size##11##2##(1996-2#1)(1996-6#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-8#1)(2013-8#1)
its slope##2##2##(2007-11#2)
its small##2##2##(1994-2#1)(2008-5#1)
its social##4##2##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
its solubility in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
its soluble##2##2##(2008-10#2)
its solution##4##2##(2008-10#2)(2009-3#1)(2009-7#1)
its sorption onto##2##3##(2008-10#2)
its sorption##3##2##(2008-10#3)
its spatial distribution##3##3##(2008-3#1)(2008-8#1)(2009-10#1)
its spatial##5##2##(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)
its speciation##2##2##(2008-10#2)
its specific activity##2##3##(1992-12#1)(1993-8#1)
its specific receptor##3##3##(1990-5#1)(1993-12#1)(1994-11#1)
its specific receptors##2##3##(1990-7#1)(2013-7#1)
its specific##29##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
its specificity for##3##3##(1992-9#1)(1995-6#1)(2008-10#1)
its specificity##8##2##(1990-12#1)(1991-12#1)(1992-9#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2011-2#1)
its spectral##4##2##(2008-10#1)(2008-9#1)(2009-4#1)(2013-8#1)
its spectrophotometric determination##2##3##(2008-10#2)
its spectrum##3##2##(2007-11#1)(2008-6#1)(2011-2#1)
its speed##5##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
its spread##2##2##(2008-10#1)(2010-8#1)
its stability and##2##3##(1994-8#1)(2008-10#1)
its stability in##2##3##(2008-10#1)(2008-8#1)
its stability##12##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#2)(2009-7#1)(2011-2#1)
its staff##4##2##(1991-12#1)(1993-1#1)(1994-12#1)(1997-2#1)
its statistical##2##2##(1995-12#1)(2008-11#1)
its status##2##2##(1995-2#1)(2008-1#1)
its stimulating##2##2##(1995-11#1)(2012-3#1)
its stimulation##3##2##(1990-8#1)(1992-8#1)(2008-7#1)
its strategic##4##2##(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)
its strength is##2##3##(2008-10#1)(2008-9#1)
its strength##4##2##(1990-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
its strengths##2##2##(2008-7#1)(2011-2#1)
its strong##5##2##(1992-6#1)(1996-12#1)(1996-3#1)(2008-9#1)(2010-11#1)
its structural and##2##3##(2008-7#1)(2009-10#1)
its structural##10##2##(1992-5#1)(1993-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#2)(2011-2#1)(2012-2#1)
its structure and##4##3##(1991-6#1)(1993-8#1)(1994-11#1)(1997-7#1)
its structure##19##2##(1990-7#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1997-7#2)(2008-10#3)(2008-5#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
its study##3##2##(1995-12#1)(2008-10#1)(2010-8#1)
its subsequent##19##2##(1992-5#1)(1993-6#2)(1994-11#2)(1994-6#2)(1996-5#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
its substrate specificity##2##3##(1995-2#1)(1995-6#1)
its substrate##10##2##(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-2#2)(2008-7#1)(2009-7#2)
its subtypes##3##2##(1995-12#1)(2007-10#1)(2008-3#1)
its subunits##3##2##(1990-5#1)(1992-11#1)(2008-10#1)
its success is##3##3##(1994-2#1)(1994-3#1)(1994-9#1)
its success##11##2##(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-1#1)(2008-11#2)(2008-2#1)(2008-8#1)
its successful##2##2##(2008-2#1)(2009-5#1)
its suitability for##5##3##(1995-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
its suitability##7##2##(1995-11#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-7#1)
its superior##4##2##(2008-1#1)(2009-4#1)(2011-2#1)(2012-3#1)
its supportive##2##2##(1996-1#1)(2008-11#1)
its suppression by##6##3##(1992-12#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-9#1)
its suppression##7##2##(1992-12#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-9#1)
its surface##23##2##(1993-6#1)(1995-2#1)(1995-5#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2009-7#1)(2010-4#1)(2011-1#1)(2013-1#1)
its surrounding##5##2##(2007-11#1)(2007-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
its surroundings##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
its survival in##2##3##(2008-10#1)(2008-8#1)
its survival##4##2##(2008-1#1)(2008-10#2)(2008-8#1)
its susceptibility to##2##3##(1991-12#1)(2008-2#1)
its susceptibility##3##2##(1991-12#1)(2008-2#1)(2010-8#1)
its sustainability##2##2##(2008-12#1)(2012-2#1)
its synaptic##3##2##(2008-11#1)(2008-4#2)
its synthesis##6##2##(1990-5#1)(1992-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(2008-5#1)
its synthetic##4##2##(1990-2#1)(1997-3#1)(1997-7#1)(2009-3#1)
its system##2##2##(1990-3#1)(1995-12#1)
its systemic##2##2##(2008-10#1)(2008-8#1)
its tandem repeat##2##3##(1997-7#2)
its target genes##2##3##(1997-7#1)(2013-1#1)
its target##8##2##(1993-3#1)(1994-3#1)(1995-6#1)(1997-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
its taxonomic##2##2##(2007-12#1)(2013-1#1)
its technical##3##2##(1990-9#1)(1996-1#1)(2009-5#1)
its temperature##2##2##(2008-10#1)(2008-2#1)
its temporal##3##2##(2008-11#1)(2010-11#1)(2013-7#1)
its termination##2##2##(1991-3#1)(2009-2#1)
its tertiary structure##3##3##(1990-5#1)(1991-5#1)(2008-4#1)
its theoretical##3##2##(1997-3#1)(2008-10#2)
its therapeutic effect##2##3##(2008-7#1)(2010-3#1)
its therapeutic##8##2##(1994-8#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)
its thickness##2##2##(2007-11#1)(2008-5#1)
its third##3##2##(2007-12#1)(2008-3#2)
its three##4##2##(1990-8#1)(1996-6#2)(2007-12#1)
its threshold##3##2##(1996-5#1)(2009-5#1)(2010-7#1)
its tissue##3##2##(1991-2#1)(1991-5#1)(1993-11#1)
its tolerance##2##2##(1996-3#1)(2008-10#1)
its total##6##2##(1997-4#1)(2008-10#3)(2008-5#1)(2013-1#1)
its toxic##5##2##(1994-8#1)(2008-10#3)(2008-3#1)
its toxicity##4##2##(1995-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
its trace##2##2##(2008-10#2)
its transcription is##3##3##(1994-10#1)(1994-5#1)(2011-1#1)
its transcription##6##2##(1994-10#1)(1994-5#1)(2007-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
its transcriptional activity##2##3##(1997-4#1)(2008-8#1)
its transcriptional##4##2##(1994-11#1)(1997-4#1)(2008-8#1)(2008-9#1)
its transformation##2##2##(2008-8#1)(2013-1#1)
its transmission##8##2##(1992-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-1#1)(2012-3#1)
its transport##2##2##(1994-11#1)(2008-3#1)
its treatment and##2##3##(2009-10#1)(2012-2#1)
its treatment with##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
its treatment##26##2##(1990-6#1)(1991-2#1)(1992-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
its two##9##2##(1991-2#1)(1992-11#1)(1992-3#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
its type species##2##3##(2011-2#2)
its type##3##2##(2008-10#1)(2011-2#2)
its typical##3##2##(1991-6#1)(2007-11#1)(2011-3#1)
its ultimate##2##2##(2009-10#1)(2009-5#1)
its underlying##7##2##(1990-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-11#1)
its unique##8##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)
its unusual##4##2##(1992-5#1)(2008-10#1)(2009-8#1)(2013-1#1)
its upper##2##2##(2008-11#1)(2008-5#1)
its uptake##2##2##(1990-7#1)(1993-5#1)
its urinary##2##2##(1990-8#1)(1991-8#1)
its usage##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
its use and##2##3##(2010-5#1)(2013-8#1)
its use are##2##3##(1992-6#1)(2008-10#1)
its use as a##9##4##(1991-9#1)(1994-7#1)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
its use as##13##3##(1990-6#1)(1991-9#1)(1994-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
its use for the##2##4##(2008-10#1)(2010-8#1)
its use for##12##3##(1990-3#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)
its use has##2##3##(2009-9#1)(2010-7#1)
its use in a##2##4##(1993-9#1)(1996-3#1)
its use in the##12##4##(1994-12#1)(1994-6#1)(1995-12#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-8#1)
its use in##34##3##(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-3#1)(1997-5#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-7#1)(2013-8#1)
its use is##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
its use of##2##3##(2008-2#1)(2012-3#1)
its use on##2##3##(1991-5#1)(2008-3#1)
its use to##2##3##(1993-3#1)(2008-9#1)
its use under##2##3##(1992-3#1)(2008-6#1)
its use with##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
its use##109##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#21)(2008-11#9)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-3#3)(2013-7#2)(2013-8#4)
its usefulness for##2##3##(1995-3#1)(2008-10#1)
its usefulness##11##2##(1992-12#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
its usual##2##2##(1995-3#1)(1997-1#1)
its utility in##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2013-8#1)
its utility##10##2##(1995-3#2)(2008-10#2)(2008-11#2)(2008-2#1)(2009-6#1)(2012-3#1)(2013-8#1)
its utilization##5##2##(2008-10#2)(2008-7#2)(2013-1#1)
its validity##2##2##(1994-3#1)(1997-4#1)
its value as##3##3##(1991-12#1)(1997-3#1)(2009-8#1)
its value for##2##3##(1994-12#1)(2008-3#1)
its value in##4##3##(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#1)
its value##12##2##(1991-12#1)(1994-12#1)(1997-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)
its variability##3##2##(2008-10#1)(2008-5#1)(2009-4#1)
its variant##5##2##(1990-8#1)(2008-8#3)(2013-1#1)
its variants##3##2##(1991-8#1)(2008-9#1)(2013-1#1)
its various forms##2##3##(2010-12#1)(2012-12#1)
its various##9##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
its vascular##5##2##(1991-6#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-6#1)
its vector##7##2##(2008-10#5)(2008-5#1)(2008-8#1)
its velocity##2##2##(2008-7#2)
its versatility##5##2##(2007-12#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
its very low##2##3##(2007-8#1)(2011-2#1)
its very nature##2##3##(2007-12#1)(2010-12#1)
its very##9##2##(1993-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#2)
its vicinity##2##2##(1995-5#1)(2007-11#1)
its virulence##5##2##(1993-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
its volatile##3##2##(2007-12#1)(2008-10#1)(2011-10#1)
its voltammetric determination##2##3##(2008-10#2)
its way into##2##3##(1994-3#1)(1995-6#1)
its way to##2##3##(2008-11#1)(2009-10#1)
its way##7##2##(1994-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-10#1)
its weight##3##2##(1993-3#2)(2008-9#1)
its well known##2##3##(1993-6#1)(2011-1#1)
its well##3##2##(1993-6#1)(2008-7#1)(2011-1#1)
its whitefly vector##2##3##(2008-10#2)
its wide##5##2##(2008-10#1)(2009-1#2)(2009-12#1)(2011-2#1)
its widespread use##3##3##(1997-5#1)(2008-9#1)(2009-3#1)
its widespread##6##2##(1997-5#1)(2008-10#2)(2008-9#2)(2009-3#1)
its wild-type##4##2##(1996-5#1)(2008-10#1)(2008-6#1)(2011-1#1)
its withdrawal##3##2##(1996-12#2)(2011-2#1)
its work##2##2##(1995-6#1)(1997-3#1)
its yeast##2##2##(1995-2#1)(2008-5#1)
its zinc-finger domain##2##3##(1995-2#2)
its##7014##1##(1990-10#6)(1990-11#25)(1990-12#26)(1990-2#32)(1990-3#16)(1990-4#2)(1990-5#48)(1990-6#11)(1990-7#21)(1990-8#29)(1990-9#11)(1991-1#11)(1991-11#8)(1991-12#47)(1991-2#37)(1991-3#17)(1991-4#2)(1991-5#31)(1991-6#19)(1991-7#8)(1991-8#12)(1991-9#19)(1992-1#14)(1992-10#5)(1992-11#16)(1992-12#46)(1992-2#22)(1992-3#26)(1992-4#1)(1992-5#18)(1992-6#30)(1992-8#25)(1992-9#22)(1993-1#15)(1993-10#2)(1993-11#29)(1993-12#27)(1993-2#23)(1993-3#37)(1993-5#6)(1993-6#44)(1993-8#35)(1993-9#10)(1994-1#11)(1994-10#2)(1994-11#37)(1994-12#49)(1994-2#25)(1994-3#45)(1994-5#29)(1994-6#31)(1994-7#2)(1994-8#34)(1994-9#21)(1995-1#15)(1995-10#1)(1995-11#44)(1995-12#49)(1995-2#70)(1995-3#31)(1995-5#27)(1995-6#47)(1995-8#24)(1995-9#3)(1996-1#20)(1996-10#3)(1996-11#3)(1996-12#33)(1996-2#42)(1996-3#27)(1996-4#7)(1996-5#27)(1996-6#11)(1996-7#8)(1996-8#7)(1996-9#5)(1997-1#21)(1997-2#53)(1997-3#20)(1997-4#35)(1997-5#12)(1997-6#14)(1997-7#49)(1997-8#17)(1997-9#1)(2006-10#7)(2006-12#2)(2006-6#2)(2007-1#2)(2007-10#21)(2007-11#85)(2007-12#119)(2007-2#5)(2007-4#5)(2007-5#11)(2007-6#6)(2007-7#29)(2007-8#31)(2007-9#5)(2008-1#74)(2008-10#1232)(2008-11#279)(2008-12#91)(2008-2#123)(2008-3#276)(2008-4#98)(2008-5#233)(2008-6#62)(2008-7#197)(2008-8#201)(2008-9#149)(2009-1#13)(2009-10#53)(2009-11#28)(2009-12#24)(2009-2#15)(2009-3#19)(2009-4#20)(2009-5#37)(2009-6#19)(2009-7#41)(2009-8#52)(2009-9#20)(2010-1#8)(2010-10#17)(2010-11#25)(2010-12#39)(2010-2#15)(2010-3#33)(2010-4#16)(2010-5#29)(2010-6#21)(2010-7#20)(2010-8#43)(2010-9#13)(2011-1#109)(2011-10#4)(2011-2#330)(2011-3#17)(2011-4#1)(2011-7#6)(2012-1#25)(2012-12#79)(2012-2#148)(2012-3#85)(2012-6#3)(2012-7#1)(2012-8#2)(2013-1#199)(2013-7#35)(2013-8#102)
its'##4##1##(2008-1#1)(2008-11#2)(2011-2#1)
itself a##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
itself affects##2##2##(1990-12#1)(1994-8#1)
itself against##2##2##(2008-5#1)(2012-2#1)
itself and its##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
itself and the##10##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-12#1)(2012-3#1)
itself and to##2##3##(2009-10#1)(2010-4#1)
itself and##25##2##(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
itself as a##6##3##(1994-2#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)(2013-7#1)
itself as the##3##3##(1995-3#1)(1996-12#1)(2011-4#1)
itself as##12##2##(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-4#1)(2012-2#1)(2013-7#1)
itself be##2##2##(1997-6#1)(2012-3#1)
itself but##4##2##(1992-11#1)(1992-6#1)(1994-11#1)(1995-6#1)
itself can also##2##3##(2009-12#1)(2013-8#1)
itself can##5##2##(2007-12#1)(2008-5#1)(2008-6#1)(2009-12#1)(2013-8#1)
itself did not affect##2##4##(1990-11#1)(1995-12#1)
itself does not##3##3##(1990-11#1)(2008-8#1)(2011-2#1)
itself from##2##2##(2008-10#2)
itself had no##4##3##(1991-8#1)(1996-2#2)(2008-10#1)
itself has##3##2##(1996-3#1)(2008-4#1)(2013-7#1)
itself in a##2##3##(1996-12#1)(2008-3#1)
itself in the##4##3##(1996-8#1)(2007-11#1)(2008-3#1)(2011-1#1)
itself in##17##2##(1990-8#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2011-1#1)(2013-1#1)
itself is of##2##3##(2008-3#1)(2009-12#1)
itself is the##2##3##(2008-4#1)(2013-7#1)
itself is##23##2##(1991-6#1)(1993-1#1)(1994-12#3)(1995-5#1)(1996-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-1#1)(2010-10#1)(2013-1#1)(2013-7#1)
itself may##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
itself of##3##2##(1997-4#1)(1997-7#1)(1997-8#1)
itself on##2##2##(1995-6#1)(1996-11#1)
itself or##7##2##(1991-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-9#1)(2011-2#1)
itself plays##2##2##(2008-5#2)
itself to be##2##3##(2008-4#1)(2008-5#1)
itself to##17##2##(1994-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2012-3#1)
itself was##5##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
itself with##2##2##(1994-3#1)(2009-9#1)
itself##306##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#28)(2008-11#10)(2008-12#8)(2008-2#2)(2008-3#21)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#6)(2011-4#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#7)(2013-7#3)(2013-8#2)
itself)##2##1##(1994-3#1)(2011-2#1)
ituC##2##1##(2008-10#2)
iturin##5##1##(1994-2#4)(2008-10#1)
iv##6##1##(1990-2#1)(1990-8#1)(1991-3#1)(1991-4#1)(2008-10#1)(2013-8#1)
iv)##4##1##(2006-12#1)(2007-11#1)(2008-11#1)(2009-9#1)
ivermectin in##2##2##(2010-2#1)(2010-8#1)
ivermectin##4##1##(1996-11#1)(1997-3#1)(2010-2#1)(2010-8#1)
ixodid tick species##2##3##(2011-1#2)
ixodid ticks##2##2##(1997-4#1)(2011-1#1)
ixodid##4##1##(1997-4#1)(2011-1#3)
j##11##1##(1997-4#6)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#1)
j)(pot) value##2##2##(2008-10#2)
j)(pot) values##2##2##(2008-10#2)
j)(pot)##4##1##(2008-10#4)
jaapii##7##1##(2008-10#7)
jaceae##6##1##(2008-10#6)
jack bean##2##2##(1993-6#2)
jack##4##1##(1993-6#2)(2008-10#1)(2008-7#1)
jade##2##1##(2013-8#2)
jadeite##2##1##(2013-8#2)
jaggedness##3##1##(2008-3#3)
jaguars##6##1##(1996-12#1)(2009-4#5)
jail##3##1##(1992-2#1)(1996-5#1)(2009-11#1)
jaipur##2##1##(2013-1#2)
jam##3##1##(2008-10#1)(2012-2#2)
jambos over##2##2##(2008-5#2)
jambos##12##1##(2008-5#12)
jannaschii##2##1##(2008-7#2)
janvier##2##1##(2013-1#2)
japonica in##3##2##(2010-8#1)(2012-3#2)
japonica rice##3##2##(1996-8#1)(2008-10#2)
japonica were##3##2##(2008-5#1)(2010-8#1)(2012-3#1)
japonica##33##1##(1994-11#1)(1996-8#1)(2008-10#9)(2008-5#7)(2008-8#3)(2008-9#1)(2009-10#2)(2010-8#4)(2012-3#4)(2013-8#1)
japonica)##6##1##(1997-3#2)(2008-6#2)(2008-8#1)(2009-10#1)
japonicum infection##3##2##(2008-8#2)(2012-3#1)
japonicum to##2##2##(2008-8#1)(2012-3#1)
japonicum##20##1##(1994-6#2)(1994-8#2)(2008-10#3)(2008-8#8)(2011-2#1)(2012-3#4)
japonicus and##2##2##(2008-12#1)(2011-2#1)
japonicus##14##1##(2008-12#3)(2008-5#3)(2008-6#2)(2009-8#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-8#1)
jar##2##1##(2008-10#1)(2013-1#1)
jargon##4##1##(1992-3#2)(1997-3#1)(2008-8#1)
jasminoside##3##1##(2013-1#3)
jasmonate (MeJA) treatment##2##3##(2008-10#1)(2011-10#1)
jasmonate (MeJA)##3##2##(2008-10#1)(2011-10#2)
jasmonate and##2##2##(2008-10#1)(2011-10#1)
jasmonate##14##1##(2008-10#10)(2008-9#1)(2011-10#3)
jasmonic acid (JA)##3##3##(2009-8#2)(2011-10#1)
jasmonic acid production##3##3##(2008-5#3)
jasmonic acid##13##2##(2008-10#5)(2008-5#3)(2009-8#3)(2011-10#1)(2012-2#1)
jasmonic##16##1##(2008-10#7)(2008-5#3)(2009-6#1)(2009-8#3)(2011-10#1)(2012-2#1)
jatamansi##2##1##(2013-8#2)
jatropha oil##2##2##(2009-3#2)
jatropha##4##1##(2009-3#4)
jaundice and##3##2##(2008-11#1)(2013-1#2)
jaundice caused by##2##3##(1991-3#1)(2007-10#1)
jaundice in##2##2##(2011-1#1)(2013-1#1)
jaundice secondary to##2##3##(1991-3#1)(1992-9#1)
jaundice##37##1##(1990-5#1)(1990-8#3)(1990-9#1)(1991-3#2)(1991-5#1)(1992-9#4)(1994-12#1)(1994-6#1)(1995-3#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)
jaundiced##3##1##(1991-8#1)(2012-2#1)(2013-1#1)
javanica##15##1##(2008-10#15)
jaw and##4##2##(2008-5#1)(2008-7#1)(2013-1#2)
jaw relationship##2##2##(2007-12#1)(2013-1#1)
jaw that##2##2##(2010-3#1)(2011-2#1)
jaw##39##1##(1990-9#3)(1993-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-3#3)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#11)(2013-7#1)
jaw-closer##2##1##(1997-2#2)
jaws##18##1##(1991-3#1)(2007-12#4)(2008-1#3)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-12#3)(2013-1#3)
jealousy##4##1##(2008-12#3)(2010-11#1)
jeddah##2##1##(2007-7#1)(2008-1#1)
jejunal enterocytes##2##2##(1994-6#2)
jejunal epithelial cells##2##3##(1994-6#1)(2013-1#1)
jejunal fluid##2##2##(1991-12#2)
jejunal mucosa##3##2##(1991-11#1)(1991-12#1)(1995-12#1)
jejunal mucosal##3##2##(1991-11#2)(1994-6#1)
jejunal##18##1##(1990-5#1)(1990-9#1)(1991-11#3)(1991-12#3)(1991-9#1)(1994-6#4)(1995-12#1)(2007-12#1)(2008-5#1)(2013-1#2)
jejuni chromosomal DNA##2##3##(1993-9#2)
jejuni infection##2##2##(1990-3#1)(1995-5#1)
jejuni##16##1##(1990-3#3)(1993-9#5)(1995-5#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#3)
jejunum and ileum##2##3##(2008-5#1)(2012-2#1)
jejunum and##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
jejunum was##3##2##(1991-5#1)(1995-3#1)(2008-10#1)
jejunum##27##1##(1990-5#2)(1990-9#1)(1991-12#1)(1991-5#4)(1992-5#1)(1995-3#2)(2008-10#7)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#3)
jelly (RJ)##2##2##(2008-10#2)
jelly coat##3##2##(1994-11#1)(2008-8#2)
jelly coats in##2##3##(2008-8#2)
jelly coats##5##2##(2008-8#5)
jelly components##2##2##(1992-8#2)
jelly##24##1##(1992-8#8)(1994-11#1)(2008-10#6)(2008-8#8)(2011-2#1)
jellyfish##6##1##(1996-6#1)(2008-10#2)(2012-3#3)
jeopardise the##2##2##(2010-3#1)(2011-2#1)
jeopardise##3##1##(2010-3#1)(2010-4#1)(2011-2#1)
jeopardised##2##1##(1997-6#1)(2008-7#1)
jeopardize the##2##2##(2007-8#1)(2013-1#1)
jeopardize##9##1##(1992-3#1)(1994-1#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-9#1)(2013-1#1)
jeopardizes##3##1##(1996-11#1)(2008-5#1)(2011-1#1)
jeopardizing##4##1##(1992-4#1)(1994-12#1)(2010-3#1)(2010-8#1)
jeopardy##3##1##(1992-1#1)(1995-6#1)(2008-11#1)
jerks##6##1##(1993-9#1)(1995-12#4)(2007-7#1)
jet and a##2##3##(2007-12#1)(2008-3#1)
jet and##3##2##(1991-1#1)(2007-12#1)(2008-3#1)
jet by##2##2##(2008-2#1)(2008-3#1)
jet nebulizer##8##2##(1991-1#3)(1993-2#1)(1994-12#2)(1996-3#2)
jet nebulizers##7##2##(1992-3#1)(1993-2#1)(1994-12#1)(1995-3#4)
jet with##2##2##(2008-2#1)(2013-8#1)
jet##71##1##(1991-1#4)(1992-11#1)(1992-3#1)(1993-2#2)(1994-12#3)(1995-3#5)(1995-8#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-6#2)(2007-11#1)(2007-12#3)(2007-2#3)(2008-10#8)(2008-11#6)(2008-2#7)(2008-3#11)(2008-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
jets##9##1##(1992-7#1)(1996-12#1)(2007-12#3)(2008-2#1)(2008-3#3)
jewellery industry##2##2##(2008-10#2)
jewellery##3##1##(2008-10#3)
jig##2##1##(2009-3#1)(2012-3#1)
jigsaw##2##1##(1995-8#1)(2008-12#1)
jiroveci infection##2##2##(2010-12#2)
jiroveci##3##1##(2010-12#3)
jitter and boresight##2##3##(2008-3#2)
jitter and##7##2##(2007-11#3)(2007-12#1)(2008-3#2)(2012-3#1)
jitter between##3##2##(2007-11#3)
jitter has been##2##3##(2007-11#1)(2008-3#1)
jitter in a##2##3##(2007-11#1)(2007-12#1)
jitter in##9##2##(2007-11#5)(2007-12#2)(2008-3#1)(2009-8#1)
jitter is##7##2##(2007-11#3)(2007-12#1)(2008-3#3)
jitter of the##2##3##(2007-11#2)
jitter of##9##2##(2007-11#5)(2008-3#4)
jitter##64##1##(2007-11#27)(2007-12#10)(2008-2#3)(2008-3#22)(2009-8#1)(2012-3#1)
jitteriness##2##1##(2011-1#2)
jitters##3##1##(2007-12#2)(2008-3#1)
job at##3##2##(1990-2#1)(1991-2#1)(2008-8#1)
job burnout##4##2##(1996-2#2)(2008-9#1)(2010-12#1)
job content and salary##3##4##(1991-12#1)(1991-3#1)(1995-3#1)
job content and##5##3##(1991-12#1)(1991-3#1)(1995-2#1)(1995-3#2)
job content##7##2##(1991-12#1)(1991-3#2)(1995-2#1)(1995-3#3)
job density measures##2##3##(2009-9#2)
job density##4##2##(2009-9#4)
job description##2##2##(1992-12#1)(1994-12#1)
job descriptions##2##2##(1994-1#1)(1997-2#1)
job functions of top level nurse executives in acute##2##9##(1993-12#2)
job functions##3##2##(1993-12#3)
job has##2##2##(1991-2#1)(2008-1#1)
job in##7##2##(1993-1#1)(1993-2#2)(1995-6#1)(2008-1#1)(2013-1#2)
job insecurity in##2##3##(2009-10#2)
job insecurity##5##2##(2009-10#4)(2011-2#1)
job is##2##2##(2010-9#1)(2011-2#1)
job loss##2##2##(1994-3#1)(2008-2#1)
job market##2##2##(1993-2#1)(1996-3#1)
job of##6##2##(1994-3#1)(1995-2#1)(1996-1#1)(1996-4#1)(2011-2#1)(2012-12#1)
job opportunities##2##2##(1994-3#1)(1997-5#1)
job outlook in brief##4##4##(1991-1#1)(1993-1#1)(1995-1#1)(1997-1#1)
job performance##2##2##(1991-3#1)(2009-7#1)
job placement##2##2##(1993-3#1)(2012-3#1)
job resourcefulness##2##2##(2008-12#2)
job responsibilities##2##2##(1990-12#1)(1993-12#1)
job satisfaction among nurses##2##4##(2008-11#1)(2008-7#1)
job satisfaction among##4##3##(1992-1#1)(1994-1#1)(2008-11#1)(2008-7#1)
job satisfaction and##8##3##(1991-2#1)(1993-2#1)(1994-1#1)(1996-9#1)(2008-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
job satisfaction of##5##3##(1991-2#1)(1992-3#1)(1994-5#1)(2010-11#1)(2013-1#1)
job satisfaction were##2##3##(1994-1#1)(2008-11#1)
job satisfaction##47##2##(1991-12#1)(1991-2#5)(1992-1#1)(1992-3#1)(1993-2#2)(1993-3#3)(1994-1#3)(1994-5#1)(1995-1#1)(1995-2#1)(1996-9#2)(2007-10#1)(2008-11#6)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-11#3)(2011-1#1)(2013-1#7)
job security##3##2##(1994-1#1)(2008-9#1)(2009-10#1)
job strain in##3##3##(2008-10#3)
job strain##5##2##(2008-10#5)
job stress##5##2##(1994-1#1)(1996-2#1)(2010-10#3)
job turnover and regional attrition##3##5##(1994-3#3)
job##190##1##(1990-12#2)(1990-2#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#11)(1991-3#4)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#5)(1993-2#6)(1993-3#9)(1993-5#1)(1994-1#7)(1994-12#2)(1994-2#1)(1994-3#7)(1994-5#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#2)(1996-1#2)(1996-2#6)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-5#2)(2007-10#1)(2007-6#1)(2008-1#3)(2008-10#5)(2008-11#7)(2008-12#7)(2008-2#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#8)(2009-5#1)(2009-7#1)(2009-9#4)(2010-10#5)(2010-11#5)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#3)
job-related stress##2##2##(2010-10#2)
job-related##3##1##(2008-12#1)(2010-10#2)
job-sharing##5##1##(1992-12#5)
jobs and##2##2##(1994-3#1)(1997-3#1)
jobs at##2##2##(1992-8#1)(2008-11#1)
jobs can##2##2##(1995-3#1)(1997-3#1)
jobs in##3##2##(1996-2#2)(2009-9#1)
jobs##42##1##(1990-2#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-4#1)(1992-8#1)(1993-1#3)(1994-3#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#2)(1997-3#4)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-9#3)(2010-3#1)(2010-6#1)(2011-1#2)
jock##2##1##(2010-7#2)
jogging##10##1##(1991-8#10)
join##19##1##(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-3#1)(2012-12#1)(2012-2#1)
joined by a##2##3##(2008-4#1)(2008-7#1)
joined by##7##2##(1992-6#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)
joined forces to##2##3##(1997-1#1)(2008-6#1)
joined forces##3##2##(1994-12#1)(1997-1#1)(2008-6#1)
joined the##9##2##(1990-7#1)(1991-11#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
joined to the##2##3##(1994-8#1)(1997-1#1)
joined to##8##2##(1990-7#1)(1994-3#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-5#1)
joined together##4##2##(1997-4#1)(2008-3#1)(2012-2#1)(2013-1#1)
joined with##5##2##(1991-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-1#1)
joined##45##1##(1990-7#2)(1991-1#1)(1991-11#2)(1991-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-2#1)(1997-1#2)(1997-4#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
joining a##2##2##(1996-3#1)(2008-9#1)
joining activity##2##2##(1993-2#1)(1997-3#1)
joining of the##2##3##(1997-7#1)(2007-12#1)
joining of##6##2##(1997-7#3)(2007-12#1)(2008-2#1)(2008-3#1)
joining or##2##2##(2008-2#1)(2008-5#1)
joining the##3##2##(1992-6#1)(2008-10#1)(2008-7#1)
joining##37##1##(1991-6#2)(1992-6#1)(1993-2#2)(1993-5#1)(1993-6#1)(1995-9#1)(1996-3#1)(1997-3#4)(1997-7#5)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-10#1)(2011-1#1)(2012-12#1)
joins##6##1##(1996-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
joint (TMJ)##2##2##(2011-2#1)(2012-3#1)
joint -##2##2##(2007-11#1)(2011-2#1)
joint action of##2##3##(1994-11#1)(2013-8#1)
joint action##4##2##(1994-11#1)(1996-2#1)(2008-5#1)(2013-8#1)
joint after##4##2##(1995-10#1)(2008-5#1)(2009-4#1)(2010-5#1)
joint and the##4##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
joint and##13##2##(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)
joint angle##3##2##(1995-2#1)(2012-12#2)
joint angles##3##2##(2007-12#1)(2008-12#1)(2011-2#1)
joint application##3##2##(1995-12#1)(2008-5#2)
joint arthritis##3##2##(2008-9#1)(2009-10#1)(2010-11#1)
joint attention##3##2##(2008-11#1)(2010-10#1)(2013-1#1)
joint can be##2##3##(2007-11#1)(2013-1#1)
joint cultivation##2##2##(2013-1#2)
joint damage and##2##3##(2010-5#1)(2013-8#1)
joint damage##3##2##(1992-5#1)(2010-5#1)(2013-8#1)
joint destruction##5##2##(2008-8#1)(2009-1#1)(2011-2#2)(2012-3#1)
joint discs##2##2##(2009-4#2)
joint disease##9##2##(1992-4#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
joint diseases##8##2##(1993-2#1)(2007-11#1)(2010-11#1)(2010-5#5)
joint distribution##4##2##(1997-4#2)(2008-8#1)(2012-3#1)
joint during##2##2##(2007-8#1)(2009-10#1)
joint dysfunction##10##2##(2010-1#2)(2012-2#6)(2013-1#2)
joint effect of##2##3##(2008-10#1)(2008-9#1)
joint effect##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
joint endoprostheses##2##2##(2007-11#1)(2011-2#1)
joint fractional transform correlator##2##4##(2008-3#2)
joint fractional transform##3##3##(2008-3#3)
joint fractional##7##2##(2008-2#2)(2008-3#5)
joint function##4##2##(1990-6#1)(1996-6#1)(2010-11#1)(2010-3#1)
joint had an increased##2##4##(2011-2#2)
joint has been found##2##4##(2007-11#1)(2008-3#1)
joint in both##2##3##(2007-8#1)(2011-2#1)
joint in the##4##3##(2007-11#2)(2007-8#1)(2013-1#1)
joint in##16##2##(1996-9#1)(2007-11#8)(2007-8#4)(2011-2#2)(2013-1#1)
joint infection##3##2##(2007-12#2)(2012-12#1)
joint initiative between##2##3##(2008-11#2)
joint instabilities##2##2##(2012-1#2)
joint instability##3##2##(2012-1#3)
joint involvement##2##2##(1996-6#1)(2006-10#1)
joint is a##3##3##(1991-4#1)(2007-11#1)(2008-9#1)
joint is the##2##3##(2008-9#1)(2011-1#1)
joint is##10##2##(1991-4#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)
joint manipulation##7##2##(2007-11#2)(2008-12#5)
joint meeting##2##2##(2008-5#1)(2009-11#1)
joint moment##2##2##(2011-2#2)
joint moments##3##2##(2011-2#3)
joint motion##5##2##(2011-2#1)(2012-1#4)
joint of the little finger##3##5##(2008-9#3)
joint of the##7##3##(2008-7#1)(2008-9#6)
joint of##9##2##(2007-11#1)(2008-7#1)(2008-9#6)(2012-3#1)
joint or##2##2##(2007-7#1)(2010-3#1)
joint osteoarthritis##3##2##(2008-9#3)
joint pain and##3##3##(2008-8#1)(2012-2#1)(2012-3#1)
joint pain##8##2##(1997-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
joint pains##2##2##(2007-8#1)(2012-2#1)
joint pathology##2##2##(2007-11#1)(2008-5#1)
joint polymorphism##2##2##(2008-9#2)
joint position##3##2##(1993-1#1)(1994-2#1)(2012-3#1)
joint power spectrum##2##3##(2008-2#2)
joint project##2##2##(2008-6#1)(2010-4#1)
joint prostheses##3##2##(2009-7#3)
joint provider##2##2##(1992-12#2)
joint quality##2##2##(1992-2#1)(2009-7#1)
joint reconstruction##3##2##(2007-8#1)(2010-3#1)(2012-3#1)
joint replacement##12##2##(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2012-3#1)
joint spatial encodings for the##2##5##(2008-2#2)
joint spatial encodings##5##3##(2008-2#5)
joint spatial##6##2##(2008-2#5)(2008-8#1)
joint stability##3##2##(2007-8#1)(2012-2#2)
joint strength##2##2##(2009-7#2)
joint surface##2##2##(2007-8#1)(2009-3#1)
joint surgery##2##2##(2007-12#1)(2007-8#1)
joint swelling##4##2##(1997-3#3)(2008-5#1)
joint symptoms##2##2##(1997-8#1)(2006-10#1)
joint syndrome##6##2##(1990-6#3)(1991-2#2)(1996-2#1)
joint synovial fluid##2##3##(1994-8#1)(2011-1#1)
joint transform correlation##12##3##(2008-3#12)
joint transform correlator by##2##4##(2008-2#1)(2008-3#1)
joint transform correlator for##4##4##(2008-2#1)(2008-3#3)
joint transform correlator is proposed##2##5##(2008-2#1)(2008-3#1)
joint transform correlator is##6##4##(2008-2#4)(2008-3#2)
joint transform correlator system##2##4##(2008-2#2)
joint transform correlator##34##3##(2008-2#19)(2008-3#15)
joint transform##51##2##(2008-2#20)(2008-3#31)
joint use of##2##3##(2008-10#2)
joint venture##5##2##(1992-8#1)(1994-1#1)(1994-3#2)(2008-5#1)
joint ventures have a##2##4##(2008-11#2)
joint ventures##12##2##(1991-1#1)(1992-3#1)(1993-1#2)(2008-11#8)
joint was##9##2##(2007-11#1)(2007-8#2)(2008-2#1)(2010-3#2)(2010-4#1)(2012-2#1)(2013-8#1)
joint wavelet transform##2##3##(2008-2#2)
joint were##2##2##(2007-12#1)(2007-8#1)
joint with##2##2##(2007-11#1)(2010-3#1)
joint##609##1##(1990-10#1)(1990-6#7)(1990-7#1)(1991-1#1)(1991-2#3)(1991-3#3)(1991-4#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#4)(1993-2#3)(1993-5#1)(1994-1#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-6#1)(1995-9#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#2)(1997-2#1)(1997-3#7)(1997-4#3)(1997-6#3)(1997-8#3)(2006-10#6)(2007-11#50)(2007-12#13)(2007-7#1)(2007-8#62)(2008-1#2)(2008-10#11)(2008-11#16)(2008-12#13)(2008-2#38)(2008-3#40)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#12)(2008-9#34)(2009-1#1)(2009-10#5)(2009-11#2)(2009-3#9)(2009-4#10)(2009-6#1)(2009-7#11)(2010-1#5)(2010-10#2)(2010-11#5)(2010-3#11)(2010-4#4)(2010-5#13)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#32)(2012-1#10)(2012-12#7)(2012-2#20)(2012-3#15)(2013-1#17)(2013-8#9)
joint-space narrowing in##2##3##(2011-2#2)
joint-space narrowing##3##2##(2011-2#3)
joint-space widening in##2##3##(2011-2#2)
joint-space widening##3##2##(2011-2#3)
joint-space##6##1##(2011-2#6)
joint]##2##1##(1990-11#1)(2011-2#1)
jointed##2##1##(2007-12#1)(2008-8#1)
jointly by the##3##3##(1991-3#1)(1994-7#1)(2008-5#1)
jointly by##6##2##(1991-3#1)(1994-7#1)(1996-1#1)(2008-10#2)(2008-5#1)
jointly##28##1##(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1994-5#1)(1994-7#1)(1996-1#1)(1996-4#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
joints and the##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
joints and##13##2##(1990-6#2)(1992-5#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
joints as seen in##2##4##(2006-10#2)
joints as##3##2##(2006-10#2)(2007-11#1)
joints in##8##2##(1995-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2011-2#3)
joints is##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
joints of the##3##3##(2007-12#1)(2009-3#1)(2011-1#1)
joints of##10##2##(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#2)(2009-3#1)(2011-1#1)(2012-3#1)
joints were##7##2##(2007-8#2)(2008-11#1)(2009-7#2)(2011-2#1)(2013-8#1)
joints##116##1##(1990-11#1)(1990-6#3)(1991-11#2)(1991-6#1)(1992-5#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#2)(1997-3#3)(1997-5#2)(1997-7#1)(2006-10#2)(2007-11#18)(2007-12#9)(2007-8#8)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#4)(2009-3#2)(2009-4#1)(2009-7#3)(2009-8#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#4)(2013-8#3)
joints)##4##1##(1992-5#1)(2009-3#2)(2012-3#1)
joke##2##1##(1992-12#1)(1995-9#1)
jordan##6##1##(2007-7#2)(2008-1#2)(2008-4#1)(2012-3#1)
jordani##4##1##(2010-8#4)
joules##3##1##(1992-12#1)(1993-1#1)(2008-3#1)
journal and##2##2##(1991-12#1)(1996-12#1)
journal articles on strategic management in nonprofit organizations##2##8##(1993-12#2)
journal articles##4##2##(1993-12#2)(1994-3#1)(1996-2#1)
journal club##4##2##(2008-12#3)(2012-3#1)
journal clubs##2##2##(2008-12#2)
journal for##2##2##(2008-3#1)(2009-4#1)
journal is##4##2##(1991-2#1)(1992-2#1)(1994-6#1)(2013-1#1)
journal of##4##2##(2008-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
journal questions##2##2##(2007-10#2)
journal writing##2##2##(2007-10#1)(2012-12#1)
journal##90##1##(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#3)(1993-11#1)(1993-12#2)(1993-6#4)(1993-8#1)(1994-12#2)(1994-3#2)(1994-6#3)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(2007-10#5)(2007-12#1)(2007-8#12)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#9)
journal's##3##1##(1993-12#1)(1993-6#1)(2009-4#1)
journalists##7##1##(1992-6#1)(1994-3#1)(1995-12#1)(2008-12#1)(2008-9#2)(2009-10#1)
journals and##10##2##(1995-12#1)(1997-1#1)(1997-3#2)(2008-10#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
journals for##2##2##(1991-12#1)(1994-6#1)
journals in the##2##3##(2011-2#1)(2013-1#1)
journals in##6##2##(1991-12#1)(1994-6#1)(2007-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
journals of psychology and##2##4##(2011-1#2)
journals of##3##2##(2009-6#1)(2011-1#2)
journals published##2##2##(1993-6#1)(2012-12#1)
journals were##2##2##(2010-11#1)(2013-1#1)
journals##78##1##(1991-12#5)(1991-2#1)(1991-3#1)(1991-6#1)(1993-12#2)(1993-6#3)(1994-12#2)(1994-6#2)(1995-12#1)(1995-2#2)(1995-9#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#4)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#6)(2011-2#2)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#11)(2013-8#1)
journals]##2##1##(1991-6#1)(1996-3#1)
journey from a##2##3##(2008-11#1)(2011-2#1)
journey from##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
journey into##2##2##(1994-2#1)(2008-10#1)
journey is##3##2##(1994-1#1)(2008-1#1)(2008-9#1)
journey of##7##2##(1997-3#1)(2008-12#1)(2010-12#1)(2010-3#3)(2013-8#1)
journey to##3##2##(1995-12#1)(2008-11#1)(2008-9#1)
journey##42##1##(1992-12#1)(1992-2#1)(1994-1#3)(1994-2#1)(1995-12#2)(1997-3#1)(2007-12#1)(2007-2#2)(2008-1#4)(2008-10#3)(2008-11#5)(2008-12#4)(2008-9#2)(2010-12#1)(2010-3#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
joy##3##1##(2009-10#1)(2010-3#1)(2013-1#1)
joys##2##1##(2008-4#1)(2013-8#1)
jp/arabi/##2##1##(1997-6#1)(1997-8#1)
jpg&quot##2##1##(2013-8#2)
judge ruled that##2##3##(1997-5#2)
judge the##2##2##(1997-6#1)(2008-10#1)
judge##39##1##(1991-9#1)(1994-12#1)(1994-8#1)(1995-12#5)(1995-6#2)(1996-2#1)(1996-5#4)(1997-5#8)(1997-6#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#3)(2010-8#1)
judged by an##2##3##(1992-3#1)(2008-5#1)
judged by the##10##3##(1991-3#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(2008-11#2)(2010-6#1)(2013-1#1)
judged by##31##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#4)(1997-7#1)(2007-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2010-6#1)(2013-1#1)
judged how##2##2##(1992-3#1)(2012-3#1)
judged their##2##2##(1990-6#1)(2008-10#1)
judged to be equivocal##4##4##(2008-8#1)(2008-9#3)
judged to be##12##3##(1992-12#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#3)
judged to##14##2##(1992-12#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#3)
judged##70##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-8#1)(1997-2#4)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#4)(2010-3#1)(2010-6#1)(2010-7#1)(2011-10#1)(2012-2#2)(2012-3#2)(2013-1#1)
judgement and##3##2##(1997-3#1)(2008-5#1)(2008-9#1)
judgement in##3##2##(1994-12#1)(2008-4#1)(2013-8#1)
judgement of the##3##3##(1996-6#1)(1997-2#1)(2008-2#1)
judgement of##5##2##(1995-5#1)(1996-6#1)(1997-2#1)(2008-2#2)
judgement##23##1##(1990-12#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#4)
judgements and##2##2##(2008-12#1)(2008-5#1)
judgements of##2##2##(2008-9#1)(2013-8#1)
judgements##10##1##(1990-12#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
judges##5##1##(1997-8#1)(2008-9#2)(2009-8#1)(2013-1#1)
judging by##2##2##(1990-11#1)(1995-5#1)
judging from its##2##3##(1993-3#1)(1996-6#1)
judging from the##2##3##(2008-5#1)(2012-2#1)
judging from##4##2##(1993-3#1)(1996-6#1)(2008-5#1)(2012-2#1)
judging the##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
judging##15##1##(1990-11#1)(1992-12#1)(1993-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
judgment and##7##2##(1993-12#1)(1993-2#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#2)
judgment are##2##2##(2009-9#1)(2010-8#1)
judgment for##2##2##(2008-11#1)(2008-6#1)
judgment strategies##2##2##(2009-9#2)
judgment##32##1##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-12#1)(2006-5#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#3)(2009-9#5)(2010-3#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
judgmental accuracy##2##2##(2009-8#2)
judgmental##5##1##(1993-1#1)(2007-2#1)(2008-11#1)(2009-8#2)
judgments about the self relative to##2##6##(2008-11#2)
judgments about the##3##3##(2008-11#2)(2012-3#1)
judgments about##7##2##(1994-3#1)(2008-11#5)(2012-3#1)
judgments are##3##2##(1992-11#1)(2008-11#1)(2009-8#1)
judgments as well as##2##4##(2008-11#1)(2009-8#1)
judgments in##3##2##(2008-11#1)(2008-6#1)(2009-8#1)
judgments of##6##2##(1992-11#1)(1992-3#1)(1993-12#1)(2008-1#1)(2008-12#1)(2009-11#1)
judgments##36##1##(1992-11#2)(1992-3#1)(1993-12#3)(1994-3#1)(2008-1#1)(2008-11#9)(2008-12#1)(2008-6#7)(2009-11#2)(2009-5#2)(2009-8#3)(2011-2#2)(2012-3#2)
judicial##13##1##(1992-9#1)(1993-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-12#1)(2011-2#3)(2013-8#1)
judiciary##4##1##(1995-1#1)(2011-2#3)
judicious choice of##3##3##(2007-12#1)(2008-2#1)(2009-8#1)
judicious use of##5##3##(2008-1#1)(2009-3#1)(2011-2#1)(2013-1#2)
judicious##19##1##(1990-3#1)(1996-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-8#2)(2010-1#1)(2011-2#2)(2013-1#2)
judiciously##2##1##(2009-7#1)(2013-1#1)
jugular and subclavian##3##3##(2008-12#3)
jugular and##4##2##(2008-12#3)(2012-3#1)
jugular catheter##2##2##(2007-7#1)(2011-2#1)
jugular catheters##2##2##(2007-7#1)(2008-4#1)
jugular foramen##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
jugular vein and##2##3##(1997-7#1)(2012-3#1)
jugular vein in##2##3##(2012-3#2)
jugular vein##14##2##(1992-12#2)(1996-6#1)(1997-7#1)(2008-1#1)(2009-6#2)(2011-1#2)(2011-2#1)(2012-3#4)
jugular veins##3##2##(2011-1#1)(2011-2#1)(2012-3#1)
jugular venous oximetry##2##3##(2008-7#2)
jugular venous##5##2##(2008-1#1)(2008-7#4)
jugular##43##1##(1992-12#3)(1994-7#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-12#3)(2008-4#1)(2008-7#6)(2009-6#2)(2011-1#4)(2011-2#6)(2012-3#9)
juice agar##3##2##(2008-10#1)(2008-8#2)
juice and##8##2##(1993-2#4)(2008-10#3)(2009-7#1)
juice as##2##2##(2008-10#2)
juice by##3##2##(2008-10#3)
juice from##3##2##(2008-10#1)(2008-5#2)
juice is##2##2##(1997-4#1)(2008-10#1)
juice of##5##2##(2008-10#3)(2009-7#1)(2012-12#1)
juice sac##7##2##(2008-10#7)
juice samples were##3##3##(2008-10#3)
juice samples##7##2##(2008-10#7)
juice were##2##2##(2008-10#2)
juice##110##1##(1990-12#5)(1993-2#4)(1993-6#2)(1997-4#6)(2007-7#2)(2008-10#61)(2008-5#3)(2008-7#3)(2008-8#5)(2009-7#3)(2010-4#2)(2010-5#5)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
juice)##3##1##(2008-10#3)
juices and soft drinks##2##4##(2008-10#2)
juices and tea infusions##2##4##(2008-10#2)
juices and##11##2##(2008-10#10)(2009-8#1)
juices by##3##2##(2008-10#3)
juices##32##1##(1992-8#1)(2008-10#28)(2009-8#1)(2012-12#2)
juiciness##5##1##(2010-2#1)(2010-4#4)
jujube fruit##4##2##(2008-10#4)
jujube##5##1##(2008-10#5)
juliana##2##1##(1997-6#2)
juliflora##2##1##(2013-1#2)
jump anastomoses (P&lt##2##3##(2007-8#2)
jump attempts##2##2##(2009-1#2)
jump between##2##2##(1997-3#1)(2008-11#1)
jump height##7##2##(1995-2#3)(2009-1#4)
jump is##3##2##(2007-12#1)(2008-3#2)
jump muscle##2##2##(2008-9#2)
jump output##2##2##(2008-9#2)
jump process##2##2##(2011-2#1)(2013-8#1)
jump protocol##2##2##(2009-1#2)
jump was##2##2##(2008-3#1)(2008-8#1)
jump##47##1##(1990-11#1)(1993-3#2)(1995-2#5)(1997-3#1)(2007-12#5)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#11)(2011-2#1)(2012-2#1)(2013-8#1)
jump)##3##1##(1990-11#2)(2008-3#1)
jumping behaviour in morphine-dependent mice##3##5##(1996-2#3)
jumping behaviour##4##2##(1996-2#4)
jumping is##2##2##(1996-2#1)(2007-12#1)
jumping mechanism##2##2##(2007-12#2)
jumping spiders##2##2##(2007-12#1)(2009-9#1)
jumping##21##1##(1990-6#1)(1995-2#2)(1996-2#5)(2007-12#7)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#2)(2012-1#1)
jumps are##3##2##(1993-11#1)(1995-2#1)(2009-6#1)
jumps in##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
jumps##23##1##(1993-11#1)(1995-2#5)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-7#1)(2009-1#3)(2009-6#1)(2011-2#1)(2012-2#2)
jun##6##1##(1991-12#3)(1991-2#1)(1992-12#1)(1994-6#1)
jun-B and c-jun expression##2##4##(1991-12#1)(1991-2#1)
jun-B and c-jun##4##3##(1991-12#3)(1991-2#1)
jun-B##7##1##(1991-12#4)(1991-2#2)(1993-6#1)
junB##9##1##(1992-12#1)(1994-8#8)
junD mRNA was##2##3##(1996-12#2)
junD mRNA##3##2##(1996-12#3)
junD##8##1##(1996-12#8)
juncea and B##3##3##(2008-10#3)
juncea and##4##2##(2008-10#3)(2011-1#1)
juncea cv##2##2##(2008-10#2)
juncea recombinant line##2##3##(2008-10#2)
juncea recombinant##3##2##(2008-10#3)
juncea seed meal##3##3##(2008-10#3)
juncea##29##1##(1991-12#2)(2008-10#23)(2008-8#3)(2011-1#1)
juncea)##4##1##(2008-10#2)(2011-1#2)
juncos##3##1##(2008-8#3)
junction (DEJ)##2##2##(2008-5#1)(2010-10#1)
junction and a##2##3##(2009-8#1)(2013-1#1)
junction and##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
junction arteriovenous fistulas##2##3##(2008-7#2)
junction at the##2##3##(2009-5#1)(2012-2#1)
junction between the##4##3##(2007-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
junction between##6##2##(1993-8#1)(2007-10#1)(2007-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
junction in##3##2##(2009-3#2)(2009-8#1)
junction obstruction in##5##3##(2007-8#1)(2008-10#3)(2008-7#1)
junction obstruction unmasked after correction of vesicoureteral reflux using endoscopic treatment with Deflux##2##13##(2008-10#2)
junction obstruction##17##2##(1990-8#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-7#2)(2009-9#1)
junction of the##9##3##(1996-12#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)
junction of##16##2##(1990-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1996-12#3)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)
junction potential##7##2##(1996-5#2)(1997-4#2)(2008-10#3)
junction regulation##2##2##(2009-10#2)
junction restructuring##3##2##(2009-10#3)
junction sequences##3##2##(1992-6#1)(1993-6#1)(1994-12#1)
junction to##3##2##(2008-12#1)(2009-10#1)(2012-2#1)
junction was used##2##3##(2008-10#2)
junction was##3##2##(1992-5#1)(2008-10#2)
junction##196##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-12#1)(1994-3#4)(1994-9#2)(1996-12#4)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#2)(1997-4#2)(1997-8#1)(2007-10#4)(2007-11#3)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#5)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#17)(2008-8#1)(2008-9#3)(2009-10#14)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#10)(2012-12#2)(2012-2#14)(2012-3#7)(2013-1#5)(2013-8#1)
junction)##2##1##(2008-11#1)(2012-2#1)
junction-field-effect transistors##2##2##(2009-6#2)
junctional diversity##2##2##(1997-9#2)
junctional protein##2##2##(1994-6#1)(2008-11#1)
junctional##21##1##(1990-2#1)(1994-11#2)(1994-6#1)(1995-6#2)(1996-12#2)(1997-9#2)(2007-8#1)(2008-11#2)(2008-7#3)(2008-8#2)(2009-10#1)(2010-5#1)(2013-1#1)
junctions and##9##2##(1991-12#1)(1992-3#1)(1994-3#1)(1995-8#1)(2007-11#1)(2008-11#2)(2009-10#2)
junctions are##4##2##(1996-12#1)(2008-7#1)(2009-10#2)
junctions between##4##2##(2008-7#1)(2009-10#1)(2012-2#2)
junctions can be##3##3##(1991-5#1)(2008-7#2)
junctions can##4##2##(1991-5#1)(2008-7#2)(2010-4#1)
junctions have##2##2##(2008-7#2)
junctions in the##4##3##(1991-12#1)(1991-6#1)(1997-9#1)(2009-10#1)
junctions in##10##2##(1991-12#2)(1991-6#1)(1996-12#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-10#1)
junctions inManduca sextamidgut epithelium##2##4##(2008-7#2)
junctions is##2##2##(1997-7#1)(2008-7#1)
junctions of##2##2##(1991-5#1)(2008-10#1)
junctions or##2##2##(1995-11#1)(2010-9#1)
junctions that##3##2##(1996-4#1)(2009-3#1)(2011-2#1)
junctions with##4##2##(2007-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
junctions##117##1##(1990-7#2)(1991-12#3)(1991-5#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-6#5)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-4#4)(1997-7#2)(1997-9#4)(2007-11#2)(2007-12#6)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#26)(2009-10#16)(2009-3#1)(2010-4#3)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#8)
juncture##4##1##(2007-7#1)(2008-7#1)(2010-8#1)(2011-2#1)
june##5##1##(1996-3#1)(2008-11#1)(2008-2#1)(2010-11#1)(2012-2#1)
junior doctors##4##2##(1990-3#1)(2010-12#3)
junior faculty##7##2##(2009-4#6)(2012-3#1)
junior high school##2##3##(1993-1#1)(2009-5#1)
junior##23##1##(1990-3#1)(1991-2#1)(1993-1#1)(2007-11#2)(2008-1#1)(2009-4#7)(2009-5#1)(2009-7#1)(2010-12#4)(2011-2#2)(2012-3#1)(2013-1#1)
juniper pollen##2##2##(2008-2#2)
juniper##4##1##(2008-2#3)(2012-3#1)
junk bond##3##2##(1992-11#3)
junk##6##1##(1992-11#5)(2013-1#1)
juries##3##1##(1992-2#1)(1992-3#1)(2011-1#1)
jurisdiction over##3##2##(1997-5#2)(2008-4#1)
jurisdiction##7##1##(1996-12#1)(1997-5#2)(2008-10#1)(2008-12#2)(2008-4#1)
jurisdictional##2##1##(2008-12#1)(2011-9#1)
jurisdictions and##2##2##(2008-12#1)(2013-8#1)
jurisdictions##14##1##(1994-1#1)(1995-1#1)(1995-12#2)(1996-12#2)(1996-3#1)(2008-12#3)(2011-1#1)(2011-9#1)(2013-8#2)
jury award##2##2##(1995-6#1)(1997-5#1)
jury##11##1##(1995-12#2)(1995-6#3)(1996-2#1)(1996-5#2)(1997-5#3)
jury's##3##1##(1991-12#1)(1995-12#1)(1995-6#1)
just 10%##2##2##(2008-6#1)(2010-12#1)
just 3##2##2##(1991-9#1)(2008-10#1)
just a few years##2##4##(1992-9#1)(2008-10#1)
just a few##7##3##(1992-9#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
just a##21##2##(1992-9#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
just about##2##2##(2008-11#2)
just above the##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
just above threshold##2##3##(2007-11#1)(2008-3#1)
just above##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)
just after the##2##3##(1990-12#1)(2008-10#1)
just after##7##2##(1990-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
just an##5##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)
just another##3##2##(1995-2#1)(1996-12#1)(2008-11#1)
just as important##3##3##(1995-5#1)(2008-6#1)(2010-6#1)
just as likely to##3##4##(1990-2#1)(1994-12#1)(2013-1#1)
just as the##2##3##(1997-3#1)(2013-8#1)
just as##15##2##(1990-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
just at##3##2##(1990-3#1)(2008-10#1)(2009-8#1)
just be##2##2##(1996-3#1)(2008-10#1)
just before and##2##3##(2008-10#1)(2012-1#1)
just before birth##2##3##(1993-3#1)(2008-7#1)
just before the##6##3##(1991-9#1)(1992-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)
just before their##2##3##(2007-12#1)(2008-11#1)
just before they##2##3##(1992-12#1)(2008-10#1)
just before##19##2##(1990-10#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1996-4#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-1#1)
just beginning to be understood##2##5##(1997-7#1)(2009-8#1)
just beginning to##4##3##(1994-2#1)(1997-7#1)(2009-8#2)
just beginning##6##2##(1994-2#2)(1996-2#1)(1997-7#1)(2009-8#2)
just behind the##2##3##(2008-3#2)
just below the##2##3##(2008-10#2)
just below##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)
just beneath the##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
just by##2##2##(2007-11#1)(2008-10#1)
just can't##2##2##(1995-2#1)(1997-6#1)
just detectable in##2##3##(1994-11#2)
just downstream##2##2##(1994-12#1)(2008-11#1)
just five##2##2##(2008-10#1)(2010-9#1)
just for##2##2##(1994-3#1)(2008-9#1)
just how##2##2##(1997-4#1)(2008-11#1)
just in##2##2##(2008-9#1)(2011-2#1)
just inside the##2##3##(1995-2#1)(2008-9#1)
just like the##2##3##(2008-11#1)(2009-4#1)
just one enzyme##2##3##(2008-10#1)(2008-7#1)
just one single##2##3##(2010-8#1)(2013-8#1)
just one##15##2##(1992-10#1)(1993-11#1)(1995-2#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
just over##3##2##(1992-6#1)(1992-9#1)(2013-8#1)
just prior to##7##3##(1994-8#1)(1996-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
just right&quot##2##2##(1995-3#1)(2007-2#1)
just the same##2##3##(1993-12#1)(2011-1#1)
just the tip of the iceberg?##2##6##(1992-12#1)(2012-12#1)
just the tip of the##3##5##(1992-12#1)(1994-2#1)(2012-12#1)
just the##23##2##(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#2)(1994-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
just three##2##2##(2007-12#1)(2009-5#1)
just two##2##2##(1994-12#1)(2008-7#1)
just under##3##2##(1992-6#2)(2010-11#1)
just upstream from the##3##4##(1997-2#1)(1997-4#1)(1997-7#1)
just upstream##4##2##(1997-2#1)(1997-4#1)(1997-7#1)(2012-2#1)
just##269##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#4)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#2)(1994-8#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2008-1#2)(2008-10#37)(2008-11#18)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#6)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#8)(2013-8#6)
just?##2##1##(1992-2#1)(1996-12#1)
justice (fairness of##2##3##(2011-2#2)
justice and##4##2##(2010-11#1)(2011-2#3)
justice are##2##2##(2007-2#1)(2010-10#1)
justice in##3##2##(1994-2#1)(2009-11#1)(2009-6#1)
justice is##3##2##(1990-12#1)(2011-2#2)
justice system##10##2##(1996-1#2)(2008-11#4)(2009-11#1)(2009-8#1)(2009-9#1)(2012-2#1)
justice##50##1##(1990-12#1)(1991-12#1)(1992-2#1)(1994-1#1)(1994-2#2)(1996-1#4)(1996-5#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-11#7)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#10)(2012-2#1)(2013-1#1)
justifiable##7##1##(1991-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
justification and##2##2##(1992-3#1)(1995-1#1)
justification for the##3##3##(2008-11#1)(2008-2#1)(2009-6#1)
justification for##11##2##(1991-5#1)(1995-6#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-6#1)(2010-11#1)(2013-1#2)
justification is##2##2##(2008-11#1)(2008-7#1)
justification##20##1##(1991-5#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-11#1)(2012-2#2)(2013-1#3)
justified and##4##2##(1992-6#1)(2008-10#1)(2008-6#1)(2011-2#1)
justified as##2##2##(1990-8#1)(2008-5#1)
justified by the##2##3##(1992-2#1)(1993-12#1)
justified by##3##2##(1992-2#1)(1993-12#1)(2007-11#1)
justified from##2##2##(2008-8#1)(2012-2#1)
justified in the##2##3##(1992-11#1)(1994-3#1)
justified in##7##2##(1991-8#2)(1992-11#1)(1994-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
justified on##2##2##(1997-4#1)(2008-7#1)
justified to##2##2##(1992-4#1)(2008-3#1)
justified##37##1##(1990-6#2)(1990-8#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-4#2)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
justifies the##3##2##(1994-3#1)(2007-7#1)(2009-8#1)
justifies##9##1##(1991-4#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)
justify a##4##2##(1990-12#1)(1990-9#1)(1997-8#1)(2008-7#1)
justify the##15##2##(1991-11#1)(1995-1#1)(1997-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
justify their##3##2##(1997-1#1)(2008-5#1)(2012-1#1)
justify##35##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1995-1#1)(1995-5#2)(1995-6#1)(1997-1#2)(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
justifying the##7##2##(1996-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)
justifying##13##1##(1996-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
juvenile age##3##2##(1994-8#3)
juvenile and adult##2##3##(2012-2#2)
juvenile and layer##3##3##(2013-1#3)
juvenile and##8##2##(2007-8#2)(2008-5#1)(2012-2#2)(2013-1#3)
juvenile animal studies##3##3##(2008-10#3)
juvenile court##3##2##(1997-6#1)(2009-8#1)(2011-2#1)
juvenile dermatomyositis##2##2##(2007-7#1)(2012-2#1)
juvenile development##2##2##(2007-12#1)(2008-10#1)
juvenile growth##5##2##(2007-5#1)(2008-11#3)(2008-9#1)
juvenile hormone (JH)##4##3##(1992-6#1)(1995-11#1)(2008-7#1)(2012-2#1)
juvenile hormone##8##2##(1992-6#1)(1995-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)
juvenile idiopathic arthritis##2##3##(2012-3#2)
juvenile justice##4##2##(2008-11#1)(2009-7#1)(2009-8#1)(2010-10#1)
juvenile peptide hormone in lepidopteran insects##2##6##(1992-6#2)
juvenile plants##2##2##(2008-10#2)
juvenile polyps##4##2##(2009-12#1)(2011-2#2)(2013-1#1)
juvenile rheumatoid arthritis in##2##4##(2007-12#1)(2012-3#1)
juvenile rheumatoid arthritis##3##3##(2007-12#1)(2012-3#2)
juvenile stage and##2##3##(2007-12#1)(2008-6#1)
juvenile stage##4##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-6#1)
juvenile survival##7##2##(2008-11#2)(2008-8#4)(2012-2#1)
juvenile tick##2##2##(2008-8#2)
juvenile viability##3##2##(2008-8#3)
juvenile##149##1##(1990-12#2)(1990-6#1)(1992-6#4)(1993-11#2)(1993-5#1)(1994-11#1)(1994-8#5)(1995-11#2)(1997-3#3)(1997-6#1)(2007-11#1)(2007-12#3)(2007-5#4)(2007-7#3)(2007-8#2)(2008-10#11)(2008-11#8)(2008-12#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#18)(2008-9#3)(2009-12#3)(2009-7#3)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-8#13)(2011-2#7)(2012-2#6)(2012-3#5)(2013-1#11)(2013-7#4)(2013-8#1)
juvenile-onset##3##1##(1997-8#1)(2006-10#1)(2013-1#1)
juveniles and young adults##2##4##(2007-12#2)
juveniles and young##3##3##(2007-12#2)(2008-10#1)
juveniles and##6##2##(2007-12#2)(2008-10#2)(2008-9#1)(2012-3#1)
juveniles from##2##2##(2008-10#2)
juveniles in##3##2##(2008-10#2)(2008-9#1)
juveniles of the##3##3##(2008-10#3)
juveniles of##5##2##(2008-10#4)(2008-8#1)
juveniles were##2##2##(2008-10#1)(2010-8#1)
juveniles##58##1##(1994-8#1)(2007-12#6)(2008-10#26)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#6)(2010-8#5)(2011-2#1)(2012-3#1)(2013-7#3)
juxtamembrane##4##1##(1994-6#3)(2013-1#1)
juxtaposed##5##1##(1990-11#1)(1995-3#1)(2008-12#1)(2008-7#1)(2009-4#1)
juxtaposition##3##1##(1990-7#1)(2007-12#1)(2008-7#1)
k =##3##2##(1995-2#1)(2007-11#1)(2008-2#1)
k and##2##2##(2008-3#1)(2008-8#1)
k in##2##2##(1990-12#1)(2008-3#1)
k is##6##2##(1992-9#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
k of the##2##3##(2007-11#1)(2008-10#1)
k of##3##2##(2007-11#1)(2008-10#2)
k populations##2##2##(1996-3#2)
k was##4##2##(1990-12#1)(2008-10#2)(2011-2#1)
k##73##1##(1990-12#9)(1992-9#5)(1995-2#2)(1995-3#4)(1996-3#2)(1997-4#1)(2007-10#1)(2007-11#3)(2008-10#10)(2008-2#7)(2008-3#18)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
k(2) values##2##2##(2007-11#2)
k(2)##3##1##(2007-11#3)
k(L)a##2##1##(2008-11#1)(2008-6#1)
k(ROH)##2##1##(2009-8#2)
k(ROH)/k(s)##3##1##(2009-8#3)
k(a)##2##1##(2008-10#1)(2008-12#1)
k(d) was 0##2##3##(2008-10#2)
k(d) was##3##2##(2008-10#3)
k(exp)##3##1##(2008-10#3)
k(inact)/Ki##2##1##(1993-8#2)
k(lambda)##2##1##(2007-12#1)(2008-3#1)
k(perpendicular)##2##1##(2008-3#2)
k) of the##2##3##(1996-2#1)(2008-2#1)
k)##8##1##(1996-2#1)(2007-11#1)(2008-10#5)(2008-2#1)
k)fluoranthene##2##1##(2008-10#2)
kB##2##1##(1993-11#1)(2013-8#1)
kD and##3##2##(1991-2#1)(1991-8#1)(2009-9#1)
kD domain##2##2##(2010-5#2)
kD hsp##2##2##(2008-5#2)
kD protein was##3##3##(1990-11#2)(2008-11#1)
kD protein##10##2##(1990-11#2)(1990-7#3)(1992-8#1)(1993-3#1)(2008-11#1)(2008-7#1)(2009-9#1)
kD substrate##2##2##(1993-3#2)
kD##49##1##(1990-11#4)(1990-7#6)(1991-12#1)(1991-2#3)(1991-8#2)(1992-11#2)(1992-12#3)(1992-8#1)(1993-3#3)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-7#4)(2008-11#4)(2008-5#2)(2008-7#1)(2009-9#2)(2010-5#2)
kD) and##2##2##(1992-8#1)(2008-7#1)
kD)##7##1##(1992-8#2)(1993-11#1)(2008-7#3)(2011-2#1)
kDNA##3##1##(2010-2#3)
kDa (SR##2##2##(1995-6#2)
kDa TNF##3##2##(1990-12#2)(1994-2#1)
kDa and a##2##3##(1993-11#1)(2008-10#1)
kDa and an##4##3##(1990-5#1)(1992-8#1)(2008-10#2)
kDa and consists of##2##4##(1993-11#1)(2009-2#1)
kDa and was##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
kDa and##40##2##(1990-12#1)(1990-5#3)(1990-7#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-6#2)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-10#7)(2008-4#2)(2008-5#2)(2008-6#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
kDa as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##2##9##(2008-10#2)
kDa as determined by##3##4##(1990-7#1)(2008-10#2)
kDa band##7##2##(1990-11#1)(1990-8#1)(1991-12#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-7#1)
kDa by intensity light scattering and sedimentation equilibrium##2##8##(1995-11#2)
kDa consisting of##2##3##(1995-6#1)(1997-4#1)
kDa for the##2##3##(1993-2#1)(1993-6#1)
kDa for##7##2##(1990-7#3)(1993-2#1)(1993-6#1)(1995-11#1)(1995-8#1)
kDa form##7##2##(1992-6#3)(1993-8#2)(1995-5#2)
kDa forms##2##2##(1992-6#1)(1993-3#1)
kDa from##2##2##(1995-6#1)(2008-10#1)
kDa glycoprotein##2##2##(1993-3#1)(1996-3#1)
kDa guanine nucleotide-binding protein##2##4##(1992-8#2)
kDa has##2##2##(1993-11#1)(1993-2#1)
kDa heat shock protein##3##4##(1996-12#2)(1997-4#1)
kDa human##2##2##(1994-2#1)(1994-6#1)
kDa in apo##2##3##(1990-8#2)
kDa in size##3##3##(2008-11#3)
kDa in the case of##2##5##(2008-10#2)
kDa in##19##2##(1990-12#1)(1990-8#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#6)(2008-11#3)
kDa is##2##2##(1993-2#1)(1996-5#1)
kDa isoform of##2##3##(1996-12#2)
kDa isoform##3##2##(1996-12#2)(2008-11#1)
kDa membrane protein##3##3##(1991-12#1)(1994-2#2)
kDa membrane##5##2##(1990-12#1)(1991-12#1)(1994-2#2)(1995-12#1)
kDa neurofilament##2##2##(1991-5#1)(1996-5#1)
kDa on SDS-polyacrylamide gels##2##4##(1994-5#1)(1997-4#1)
kDa on SDS-polyacrylamide##3##3##(1994-5#1)(1997-4#1)(2008-11#1)
kDa on##5##2##(1991-12#1)(1992-9#1)(1994-5#1)(1997-4#1)(2008-11#1)
kDa or##3##2##(1990-11#1)(1990-8#1)(1995-5#1)
kDa pea##3##2##(1993-6#3)
kDa peptide##6##2##(1990-11#4)(1990-7#1)(1994-11#1)
kDa polypeptide##10##2##(1990-11#2)(1991-9#2)(1992-3#1)(1993-8#1)(1994-11#1)(1995-5#3)
kDa protein and##3##3##(1990-8#1)(1992-9#1)(2008-7#1)
kDa protein in##5##3##(1991-12#1)(1991-9#2)(1995-11#1)(2008-6#1)
kDa protein of##4##3##(1993-11#1)(1993-6#2)(1996-11#1)
kDa protein was##6##3##(1990-11#1)(1990-2#1)(1991-9#1)(1993-3#1)(1995-8#1)(2011-2#1)
kDa protein which##4##3##(1990-7#1)(1997-1#1)(1997-4#1)(1997-8#1)
kDa protein with##3##3##(1993-3#1)(1996-12#1)(1996-2#1)
kDa protein##55##2##(1990-11#5)(1990-2#5)(1990-7#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#4)(1994-11#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-6#1)(2008-7#4)(2009-8#1)(2011-2#1)
kDa proteins##2##2##(1993-8#1)(1996-12#1)
kDa respectively##2##2##(1991-12#1)(2008-5#1)
kDa smaller than the##2##4##(1990-7#1)(1992-10#1)
kDa species that was##2##4##(1992-10#2)
kDa species##3##2##(1992-10#2)(1994-6#1)
kDa subunit of##3##3##(1991-12#1)(2008-6#1)(2009-7#1)
kDa subunit##6##2##(1990-5#1)(1991-12#1)(1994-11#1)(2008-6#1)(2009-7#1)(2011-2#1)
kDa that##4##2##(1992-10#1)(1993-9#1)(2008-10#1)(2011-2#1)
kDa was observed##2##3##(2008-10#2)
kDa was shown to##2##4##(1996-2#1)(2008-10#1)
kDa was##12##2##(1990-7#2)(1993-8#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2013-1#1)
kDa were##6##2##(1992-9#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
kDa which contains all##2##4##(1990-5#1)(1995-2#1)
kDa which were##2##3##(1990-5#1)(2008-4#1)
kDa which##7##2##(1990-5#3)(1993-8#1)(1995-12#1)(1995-2#1)(2008-4#1)
kDa with an##2##3##(2008-10#2)
kDa##531##1##(1990-11#17)(1990-12#13)(1990-2#6)(1990-5#18)(1990-7#16)(1990-8#12)(1991-12#12)(1991-2#6)(1991-5#4)(1991-8#3)(1991-9#12)(1992-10#6)(1992-12#4)(1992-3#7)(1992-6#9)(1992-8#16)(1992-9#7)(1993-1#3)(1993-11#6)(1993-12#4)(1993-2#5)(1993-3#9)(1993-6#16)(1993-8#12)(1993-9#1)(1994-11#13)(1994-12#1)(1994-2#6)(1994-5#2)(1994-6#10)(1994-8#6)(1995-11#12)(1995-12#13)(1995-2#6)(1995-3#2)(1995-5#11)(1995-6#13)(1995-8#5)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#16)(1996-2#4)(1996-3#2)(1996-5#6)(1996-6#3)(1997-1#2)(1997-2#15)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#5)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#53)(2008-11#15)(2008-12#5)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#8)(2009-2#1)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#9)(2012-1#3)(2012-2#7)(2012-3#1)(2013-1#2)
kDa) and beta##2##3##(1993-6#1)(1994-12#1)
kDa) and the##2##3##(1994-11#1)(1994-5#1)
kDa) and##17##2##(1990-7#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-11#4)(2008-10#2)(2008-11#1)(2009-9#1)
kDa) have##2##2##(1994-5#1)(2008-10#1)
kDa) in##3##2##(1994-11#1)(1995-11#1)(2012-2#1)
kDa) is##3##2##(1995-11#2)(2012-2#1)
kDa) was identified##2##3##(1991-8#1)(1997-4#1)
kDa) was##7##2##(1991-10#1)(1991-8#1)(1995-11#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)
kDa) were##4##2##(1991-9#1)(1994-11#1)(1995-11#1)(2010-11#1)
kDa)##82##1##(1990-5#3)(1990-7#3)(1991-10#1)(1991-12#3)(1991-2#1)(1991-8#1)(1991-9#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#4)(1994-12#5)(1994-5#2)(1995-11#18)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-4#1)(1997-6#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#1)(2009-9#1)(2010-11#1)(2011-2#3)(2012-2#3)
kDa)]##2##1##(1995-11#2)
kGy at##2##2##(1997-4#2)
kGy##12##1##(1997-4#4)(2008-10#2)(2008-5#3)(2009-7#3)
kHz and##3##2##(2007-12#1)(2008-3#1)(2010-9#1)
kHz are##2##2##(2008-3#2)
kHz for the##2##3##(2008-2#2)
kHz for##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
kHz have been demonstrated##2##4##(2007-11#1)(2008-3#1)
kHz in##2##2##(1990-12#1)(2007-12#1)
kHz is##4##2##(2007-12#2)(2008-3#2)
kHz over##2##2##(2007-11#1)(2008-2#1)
kHz to the##2##3##(2007-12#2)
kHz to##3##2##(2007-11#1)(2007-12#2)
kHz were##2##2##(2007-12#1)(2008-3#1)
kHz with##2##2##(2007-11#1)(2008-2#1)
kHz##89##1##(1990-12#1)(1994-8#3)(1997-8#1)(2006-12#1)(2007-11#15)(2007-12#23)(2007-5#2)(2008-10#2)(2008-2#8)(2008-3#28)(2009-5#2)(2010-9#1)(2011-1#1)(2012-3#1)
kHz)##11##1##(1993-8#1)(1995-12#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#1)
kII =##2##2##(1990-5#2)
kII##3##1##(1990-5#3)
kJ m(-2)##2##2##(2008-5#2)
kJ mol(-1) at 298 K##2##5##(2008-10#2)
kJ mol(-1) by##2##3##(2008-10#2)
kJ mol(-1) n(-1) and##2##4##(2008-10#2)
kJ mol(-1) n(-1)##4##3##(2008-10#4)
kJ mol(-1)##20##2##(1996-2#3)(2008-10#16)(2008-5#1)
kJ mol(-1)n(-1)##2##2##(2008-10#2)
kJ mol-1##6##2##(1992-10#4)(1993-11#1)(1994-11#1)
kJ##45##1##(1990-2#2)(1992-10#4)(1993-11#2)(1994-11#1)(1996-2#4)(2008-10#19)(2008-3#2)(2008-5#4)(2008-8#2)(2008-9#2)(2013-8#3)
kJ/m2 exposure##2##2##(1994-6#2)
kJ/mol at##2##2##(1992-3#2)
kJ/mol for the##2##3##(1993-8#2)
kJ/mol##8##1##(1992-3#3)(1993-8#3)(1994-12#1)(1996-2#1)
kJmol(-1)##3##1##(2008-10#3)
kOe at##2##2##(2008-10#2)
kOmega##2##1##(2008-10#1)(2009-11#1)
kPa during##2##2##(2007-12#2)
kPa for##2##2##(2008-10#2)
kPa to##3##2##(2007-12#1)(2008-10#1)(2009-7#1)
kPa##21##1##(1990-2#1)(2007-12#3)(2008-10#13)(2008-7#1)(2009-5#1)(2009-7#2)
kV in a##3##3##(1996-5#1)(2008-10#2)
kV##19##1##(1990-7#1)(1996-5#2)(1997-8#2)(2008-10#10)(2008-2#1)(2008-3#1)(2012-1#2)
kV(-1)##2##1##(2008-2#2)
kV) &gt##5##2##(1997-8#5)
kV)##8##1##(1997-8#7)(2012-1#1)
kW and##2##2##(2008-3#2)
kW at a##2##3##(2007-11#1)(2007-12#1)
kW at##3##2##(2007-11#1)(2007-12#2)
kW##13##1##(2007-11#4)(2007-12#5)(2008-3#4)
kW/cm(2)##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
kaempferol##2##1##(2008-10#1)(2008-5#1)
kainate and quisqualate##2##3##(1990-8#2)
kainate and##3##2##(1990-8#2)(2012-2#1)
kainate binding protein##2##3##(1995-5#2)
kainate receptors##5##2##(1993-12#1)(1995-11#2)(2012-2#2)
kainate##16##1##(1990-8#2)(1993-12#1)(1994-2#2)(1995-11#4)(1995-2#1)(1995-5#2)(2008-7#1)(2012-2#3)
kainate-induced seizures##3##2##(1994-2#3)
kainic acid##8##2##(1993-12#2)(1993-6#1)(1995-12#4)(2008-4#1)
kairomones##3##1##(2008-9#3)
kallikrein##5##1##(1990-5#2)(2008-4#2)(2010-12#1)
kallikreins 10##2##2##(2009-4#2)
kallikreins##5##1##(2009-4#5)
kan gene##3##2##(1990-5#3)
kan##5##1##(1990-5#4)(2012-12#1)
kanamycin resistance##6##2##(2008-10#5)(2008-7#1)
kanamycin##13##1##(1994-12#1)(1997-8#1)(2008-10#7)(2008-5#1)(2008-7#2)(2008-9#1)
kangaroo mothers' programme##2##3##(2013-1#2)
kangaroo##3##1##(2008-10#1)(2013-1#2)
kaolin##3##1##(2008-10#1)(2013-1#2)
kapa##2##1##(1994-12#2)
kapalabhati (KB)##2##2##(1991-10#1)(1991-12#1)
kappa = 0##3##3##(1997-8#2)(2008-3#1)
kappa =##5##2##(1990-5#2)(1997-8#2)(2008-3#1)
kappa B activity##3##3##(1994-6#3)
kappa B##23##2##(1991-9#1)(1992-12#1)(1993-3#1)(1993-9#2)(1994-6#5)(1994-8#1)(1995-2#6)(2007-8#2)(2010-10#1)(2011-1#2)(2013-1#1)
kappa coefficient##3##2##(2011-2#3)
kappa concordance##2##2##(2009-8#2)
kappa light chain constant region##2##5##(1997-8#2)
kappa light chain restriction##2##4##(2009-8#2)
kappa light chain##4##3##(1997-8#2)(2009-8#2)
kappa opiate##2##2##(1991-1#1)(1993-12#1)
kappa opioid receptors##3##3##(1993-12#2)(2009-12#1)
kappa opioid##4##2##(1993-12#3)(2009-12#1)
kappa s##2##2##(1990-5#2)
kappa was##2##2##(2008-3#1)(2012-1#1)
kappa##96##1##(1990-5#9)(1991-1#4)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#3)(1993-12#9)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-6#5)(1994-8#1)(1995-2#9)(1995-6#2)(1996-12#1)(1997-8#5)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#8)(2009-12#2)(2009-8#4)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#2)
kappa(t)##2##1##(2008-10#2)
kappa-##3##1##(1991-1#1)(1995-12#1)(2008-10#1)
kappa-caseins##3##1##(2008-10#1)(2008-12#2)
kappa-opioid agonist##2##2##(1997-2#1)(2009-12#1)
kappa-opioid and NMDA receptors##2##4##(1997-2#2)
kappa-opioid and NMDA##3##3##(1997-2#3)
kappa-opioid##12##1##(1995-11#5)(1997-2#6)(2009-12#1)
kappa-selective opioid##2##2##(1995-12#2)
kappa-selective##3##1##(1991-1#1)(1995-12#2)
kappaB##2##1##(2008-9#1)(2010-8#1)
karyological##3##1##(2008-5#1)(2010-3#2)
karyopherin beta##2##2##(1995-2#2)
karyopherin##3##1##(1995-2#3)
karyosome capsule##5##2##(2007-12#2)(2008-7#3)
karyosome##17##1##(2007-12#8)(2008-7#9)
karyotype analysis##2##2##(1994-12#1)(2008-9#1)
karyotype and the##2##3##(2010-3#2)
karyotype and##4##2##(1996-2#1)(2008-11#1)(2010-3#2)
karyotype in##5##2##(1993-9#1)(2008-10#1)(2008-11#2)(2008-12#1)
karyotype of##8##2##(1993-9#1)(2007-11#1)(2008-10#1)(2008-12#3)(2009-2#2)
karyotype variation##2##2##(2008-12#2)
karyotype##37##1##(1991-4#1)(1992-10#2)(1993-9#2)(1994-12#1)(1995-2#1)(1996-2#2)(1997-3#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#8)(2008-5#1)(2008-9#1)(2009-2#2)(2010-3#5)(2013-8#1)
karyotyped##2##1##(2008-11#1)(2010-3#1)
karyotypes and##4##2##(2008-12#3)(2012-12#1)
karyotypes in##3##2##(2008-10#1)(2010-1#2)
karyotypes of the##2##3##(1990-5#1)(2008-12#1)
karyotypes of##10##2##(1990-5#1)(1994-11#1)(2008-12#5)(2008-5#1)(2010-3#2)
karyotypes with##3##2##(2008-10#1)(2010-11#1)(2010-3#1)
karyotypes##32##1##(1990-5#2)(1993-9#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-12#12)(2008-5#2)(2010-1#2)(2010-11#1)(2010-3#6)(2012-12#1)(2012-3#1)
karyotypic abnormalities##3##2##(1990-5#1)(2008-8#2)
karyotypic analysis of##2##3##(1994-11#1)(1996-12#1)
karyotypic complexity##2##2##(2012-3#2)
karyotypic##14##1##(1990-5#1)(1992-2#1)(1993-9#1)(1994-11#2)(1996-12#1)(2008-5#1)(2008-8#2)(2012-3#5)
karyotyping##9##1##(1996-6#1)(2008-1#2)(2008-10#2)(2008-5#2)(2010-8#1)(2012-12#1)
kashmir##2##1##(2008-5#1)(2013-8#1)
kava on a##2##3##(2008-1#2)
kava on##3##2##(2008-1#3)
kava##9##1##(2008-1#9)
kava-drinking##2##1##(2008-1#2)
kazusa##2##1##(1997-6#1)(1997-8#1)
kb DNA fragment from the##2##5##(1996-3#1)(1997-3#1)
kb DNA fragment was determined and##2##6##(1997-8#1)(2008-8#1)
kb DNA fragment was##3##4##(1997-8#1)(2008-8#2)
kb DNA fragment##8##3##(1992-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-8#3)(2008-9#1)
kb DNA##12##2##(1992-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-8#2)(2008-8#5)(2008-9#1)
kb M-CSF mRNA##2##3##(1994-6#2)
kb RNA was##3##3##(1991-12#2)(2008-11#1)
kb and 1##3##3##(1994-6#1)(1997-6#1)(1997-8#1)
kb and 5##2##3##(1997-8#1)(2008-8#1)
kb and a##2##3##(1992-3#1)(1992-8#1)
kb and consists of##2##4##(1991-6#1)(2008-12#1)
kb and##21##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-8#2)(2008-11#1)(2008-12#1)(2008-8#4)(2011-2#1)(2012-3#1)
kb band##5##2##(1990-12#1)(1992-3#3)(1994-9#1)
kb by##3##2##(1995-2#1)(1996-6#2)
kb cDNA##3##2##(1990-2#1)(1992-12#1)(1996-2#1)
kb clone##2##2##(1990-12#1)(1990-2#1)
kb downstream from##4##3##(1990-5#1)(1993-2#2)(1997-8#1)
kb fragment##4##2##(1995-9#2)(1997-3#1)(2008-5#1)
kb from the##3##3##(1993-6#1)(1996-6#1)(1997-3#1)
kb from##4##2##(1993-6#1)(1995-9#1)(1996-6#1)(1997-3#1)
kb in length and##2##4##(1993-2#1)(2008-8#1)
kb in length##8##3##(1991-6#1)(1993-2#2)(1993-3#1)(1997-2#1)(2008-10#1)(2008-8#2)
kb in size and##2##4##(1994-11#1)(2011-2#1)
kb in size##6##3##(1994-11#1)(1995-8#1)(2008-10#3)(2011-2#1)
kb in the##5##3##(1990-2#1)(1997-7#1)(2008-11#2)(2012-3#1)
kb in##24##2##(1990-2#2)(1991-6#1)(1993-2#2)(1993-3#1)(1994-11#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#4)(2011-2#1)(2012-3#1)
kb insert##3##2##(1992-9#1)(1997-6#2)
kb long and expressed##2##4##(1993-2#1)(2008-8#1)
kb long and##3##3##(1993-2#1)(1993-6#1)(2008-8#1)
kb long##5##2##(1993-2#1)(1993-6#1)(1995-8#1)(1997-7#1)(2008-8#1)
kb mRNA##7##2##(1993-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#2)
kb of DNA##4##3##(1991-6#1)(1993-12#1)(1995-2#1)(2012-3#1)
kb of genomic DNA##3##4##(1993-2#1)(1997-6#1)(1997-7#1)
kb of genomic##4##3##(1993-2#2)(1997-6#1)(1997-7#1)
kb of the 5'-flanking##2##4##(1990-8#1)(1993-2#1)
kb of the genome##2##4##(2008-10#2)
kb of the##10##3##(1990-8#1)(1993-2#2)(1993-3#1)(1993-6#1)(1997-8#1)(2008-10#3)(2008-8#1)
kb of##25##2##(1990-8#1)(1991-6#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1995-2#1)(1996-12#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#2)(2012-3#1)
kb on the##5##3##(1993-12#2)(1993-6#2)(1996-6#1)
kb on##7##2##(1993-12#2)(1993-6#2)(1996-3#1)(1996-6#1)(1997-7#1)
kb or##2##2##(1995-2#1)(1995-5#1)
kb region at Xq28##2##4##(2008-12#2)
kb region##9##2##(1993-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#3)
kb segment from##2##3##(1995-9#1)(1996-6#1)
kb segment of##2##3##(1995-9#1)(2008-11#1)
kb segment##6##2##(1995-9#2)(1996-6#2)(1997-3#1)(2008-11#1)
kb sequence##2##2##(1997-4#1)(2008-8#1)
kb to##4##2##(1992-12#1)(1992-8#1)(1997-2#1)(2012-3#1)
kb transcript##8##2##(1990-12#1)(1991-9#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-2#2)(2008-8#1)
kb were##4##2##(1996-10#1)(1997-3#1)(2008-10#1)(2008-8#1)
kb##271##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#1)(1990-8#1)(1991-12#3)(1991-6#6)(1991-9#2)(1992-12#3)(1992-3#6)(1992-8#4)(1992-9#3)(1993-12#6)(1993-2#12)(1993-3#8)(1993-6#8)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#4)(1995-8#6)(1995-9#5)(1996-10#6)(1996-12#4)(1996-2#2)(1996-3#5)(1996-6#9)(1996-8#1)(1997-2#16)(1997-3#8)(1997-4#2)(1997-6#8)(1997-7#7)(1997-8#7)(1997-9#1)(2007-12#1)(2008-10#23)(2008-11#10)(2008-12#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#26)(2008-9#5)(2011-2#3)(2012-3#7)
kb) and##5##2##(1995-6#1)(1997-2#1)(2008-10#1)(2008-6#1)(2010-3#1)
kb) for##2##2##(1995-12#1)(1995-6#1)
kb) from##2##2##(2008-10#1)(2008-11#1)
kb) was detected in##2##4##(1993-3#1)(2008-5#1)
kb) was detected##3##3##(1991-12#1)(1993-3#1)(2008-5#1)
kb) was##8##2##(1991-12#2)(1993-12#1)(1993-3#2)(1993-8#1)(2008-11#1)(2008-5#1)
kb)##33##1##(1991-12#2)(1992-12#1)(1993-12#1)(1993-3#4)(1993-8#1)(1994-11#3)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#2)(1997-2#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2010-3#1)(2013-1#1)
kbar##3##1##(1995-2#1)(1996-5#1)(2008-3#1)
kbp of##2##2##(1990-12#1)(1993-6#1)
kbp##12##1##(1990-12#2)(1992-8#1)(1993-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-5#1)
kbp)##4##1##(1995-2#1)(2008-10#2)(2008-2#1)
kcal mol-1 for##2##3##(1990-8#2)
kcal mol-1##7##2##(1990-8#2)(1995-5#1)(1997-2#4)
kcal##10##1##(1990-8#2)(1992-3#1)(1992-6#1)(1994-12#1)(1995-5#1)(1997-2#4)
kcal)##4##1##(1990-2#2)(2008-5#2)
kcal/d energy##2##2##(2013-1#2)
kcal/day##4##1##(2008-3#3)(2013-1#1)
kcal/mL##2##1##(1995-2#2)
kcal/mol barrier##2##2##(1990-3#2)
kcal/mol for the##2##3##(1996-2#2)
kcal/mol for##5##2##(1996-2#4)(2008-11#1)
kcal/mol is##3##2##(1992-3#1)(1996-2#1)(2008-11#1)
kcal/mol of##4##2##(1990-7#1)(1992-6#1)(2012-12#2)
kcal/mol##50##1##(1990-3#3)(1990-7#2)(1990-8#2)(1991-8#3)(1992-3#2)(1992-6#2)(1993-8#5)(1994-3#2)(1994-5#2)(1996-2#11)(2007-11#1)(2008-11#5)(2008-6#1)(2010-2#1)(2012-12#8)
kcal/mol) in the##2##3##(1993-8#2)
kcal/mol)##10##1##(1990-8#2)(1992-6#2)(1993-8#5)(1996-5#1)
kcal/mole##2##1##(1991-5#2)
kcat and##2##2##(1992-3#1)(1995-2#1)
kcat for the##2##3##(1990-7#1)(1992-8#1)
kcat values##4##2##(1990-7#1)(1991-5#1)(1994-5#1)(1995-6#1)
kcat was##3##2##(1990-7#1)(1990-8#1)(1993-9#1)
kcat##27##1##(1990-7#3)(1990-8#1)(1991-5#1)(1992-3#3)(1992-8#2)(1993-9#1)(1994-5#5)(1995-2#6)(1995-5#2)(1995-6#2)(1995-8#1)
kcat/Km of##4##2##(1993-8#1)(1995-2#3)
kcat/Km##8##1##(1993-8#2)(1994-5#2)(1995-2#4)
kd##8##1##(1990-2#1)(1991-5#2)(1992-3#1)(1993-12#2)(1994-9#1)(1996-12#1)
kda bFGFs##3##2##(1990-12#3)
kda##5##1##(1990-12#4)(1991-9#1)
kdiff' is##2##2##(2008-3#2)
kdiff'##7##1##(2008-3#7)
keV and##2##2##(2007-11#2)
keV photons##3##2##(2009-8#1)(2012-12#2)
keV with##3##2##(2007-11#1)(2008-3#2)
keV##26##1##(1992-11#1)(2006-4#2)(2007-11#5)(2008-2#5)(2008-3#6)(2008-8#1)(2009-2#1)(2009-8#1)(2012-12#4)
keV)##7##1##(2007-11#1)(2008-2#2)(2008-3#3)(2010-3#1)
keen interest in##3##3##(1991-1#1)(1995-1#1)(1996-12#1)
keen interest##4##2##(1991-1#1)(1995-1#1)(1996-12#1)(1997-4#1)
keen##6##1##(1991-1#1)(1995-1#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#1)
keep a##5##2##(1992-11#1)(1992-3#1)(1993-1#1)(2007-12#1)(2011-1#1)
keep an eye##2##3##(1994-2#1)(2012-12#1)
keep his##2##2##(1993-11#1)(2008-10#1)
keep in mind that the##2##5##(1992-3#1)(2010-8#1)
keep in mind that##5##4##(1992-3#1)(2009-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
keep in mind the##4##4##(1995-3#1)(2009-1#1)(2009-6#1)(2012-1#1)
keep in mind##10##3##(1992-3#1)(1995-3#1)(2007-7#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
keep in touch##2##3##(2008-11#1)(2008-9#1)
keep in##16##2##(1990-9#1)(1991-1#1)(1992-3#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
keep pace with##3##3##(1996-2#2)(2008-3#1)
keep pace##5##2##(1995-1#1)(1996-2#2)(2008-3#1)(2009-6#1)
keep the medical group##3##4##(1991-1#1)(1994-3#2)
keep the patient##2##3##(1992-1#1)(1994-5#1)
keep the##28##2##(1991-1#1)(1992-1#1)(1992-3#1)(1994-3#3)(1994-5#1)(1994-8#1)(1997-2#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#3)(2012-1#1)
keep them##3##2##(1993-6#1)(1994-3#1)(2010-4#1)
keep themselves##2##2##(1993-3#1)(1995-3#1)
keep this##2##2##(2007-8#1)(2013-8#1)
keep up with the##2##4##(1996-3#1)(2008-3#1)
keep up with##3##3##(1996-3#1)(2008-1#1)(2008-3#1)
keep your##5##2##(1991-1#1)(1993-2#1)(1994-1#1)(2007-10#1)(2008-10#1)
keep##111##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#1)(1995-1#2)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#3)(1997-2#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
keeping a##3##2##(1994-7#1)(2007-11#1)(2011-1#1)
keeping in mind##2##3##(2008-4#1)(2013-1#1)
keeping in view the##2##4##(2008-10#2)
keeping in##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2013-1#1)
keeping pace##2##2##(1991-2#1)(2008-11#1)
keeping paediatric patients motivated during the cochlear implant rehabilitative process##2##10##(2008-9#2)
keeping records##2##2##(1992-2#1)(1995-3#1)
keeping tabs on an endangered species##2##6##(1991-5#2)
keeping the##19##2##(1992-9#1)(1996-2#1)(2008-10#6)(2008-3#2)(2008-5#4)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#2)
keeping them##4##2##(1995-12#1)(2008-9#1)(2010-9#1)(2013-7#1)
keeping up with##2##3##(2008-1#1)(2008-11#1)
keeping up##4##2##(1997-2#1)(2008-1#1)(2008-11#1)(2009-5#1)
keeping with expectations##2##3##(2008-10#1)(2008-8#1)
keeping with other##3##3##(1990-6#1)(2007-1#1)(2008-12#1)
keeping with the##10##3##(1994-1#1)(1994-12#1)(1995-1#1)(1997-8#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-2#1)
keeping with##20##2##(1990-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)
keeping##95##1##(1990-6#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-2#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-11#2)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
keeps its##3##2##(2008-10#2)(2012-1#1)
keeps the temperature##2##3##(2008-3#1)(2010-11#1)
keeps the##6##2##(2007-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)
keeps##16##1##(1994-2#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-11#1)(2012-1#1)(2013-1#1)
kefyr 2Y305##2##2##(2013-1#2)
kefyr##3##1##(2008-6#1)(2013-1#2)
keloid##3##1##(2007-7#2)(2010-8#1)
keloids##3##1##(2008-9#1)(2010-8#2)
kelp and##2##2##(2008-10#2)
kelp##3##1##(2008-10#3)
kelulau##2##1##(2008-1#2)
kelvin##2##1##(1994-9#1)(1995-6#1)
kenkey milieu of pH 4 were##2##6##(1997-4#2)
kenkey milieu of pH 4##3##5##(1997-4#3)
kenkey##17##1##(1997-4#17)
kenkey's##3##1##(1997-4#3)
keoxifene##7##1##(1992-5#7)
kept as##5##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2013-1#1)
kept at 4 degrees C##2##5##(2008-10#1)(2008-11#1)
kept at a##2##3##(1992-1#1)(2008-3#1)
kept at##16##2##(1990-8#1)(1992-1#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
kept constant at##3##3##(1993-11#1)(2008-10#2)
kept constant##7##2##(1993-11#1)(1997-6#1)(2008-10#2)(2008-2#2)(2008-3#1)
kept fixed##3##2##(2008-3#3)
kept for##6##2##(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-8#1)
kept in a##5##3##(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
kept in captivity##2##3##(1996-12#1)(2008-5#1)
kept in mind##12##3##(2008-7#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
kept in solution##2##3##(2008-10#1)(2008-6#1)
kept in the##5##3##(1992-4#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
kept in two##2##3##(1994-7#1)(2008-10#1)
kept in##45##2##(1991-2#1)(1992-4#1)(1994-7#1)(1995-3#2)(1996-12#2)(1997-6#1)(2007-6#1)(2008-10#11)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
kept on##6##2##(1992-9#1)(1994-3#1)(2008-6#2)(2011-2#1)(2013-8#1)
kept stable##2##2##(2008-10#1)(2011-1#1)
kept the##3##2##(2008-8#1)(2010-1#1)(2010-4#1)
kept to a minimum##3##4##(2007-5#2)(2008-5#1)
kept unchanged##2##2##(2008-3#1)(2008-8#1)
kept under##9##2##(1994-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
kept wet##2##2##(2008-10#2)
kept##152##1##(1990-2#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-12#2)(1995-3#3)(1995-8#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#33)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#8)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#8)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
keratan sulphate peptides in biological fluids##3##6##(1990-12#3)
keratan sulphate peptides##4##3##(1990-12#4)
keratan sulphate##7##2##(1990-12#6)(1993-2#1)
keratan##9##1##(1990-12#7)(1993-2#2)
keratectomy##3##1##(2008-3#2)(2013-1#1)
keratin 1##3##2##(1996-2#1)(2011-2#2)
keratin 14##4##2##(1991-12#2)(1996-2#1)(2008-8#1)
keratin 8##3##2##(2012-3#3)
keratin gene##2##2##(1991-12#1)(2008-9#1)
keratin genes##2##2##(1996-2#1)(2011-2#1)
keratin intermediate filament##3##3##(1991-12#1)(2008-5#2)
keratin intermediate filaments##4##3##(2008-5#1)(2008-8#3)
keratin intermediate##8##2##(1991-12#1)(2008-5#3)(2008-8#4)
keratin##51##1##(1991-12#5)(1996-2#5)(2008-11#2)(2008-5#17)(2008-6#2)(2008-8#6)(2008-9#1)(2009-10#1)(2011-2#7)(2012-1#2)(2012-3#3)
keratin-like proteins##2##2##(2008-8#2)
keratinase##2##1##(2008-6#2)
keratinization##3##1##(2008-5#2)(2010-6#1)
keratinized tissue##2##2##(2008-5#1)(2013-1#1)
keratinized##5##1##(1990-3#2)(2008-3#1)(2008-5#1)(2013-1#1)
keratinocyte cells##3##2##(2008-11#1)(2012-3#2)
keratinocyte cultures##3##2##(1992-2#1)(2008-1#1)(2008-4#1)
keratinocyte differentiation##8##2##(1994-3#2)(2008-11#2)(2008-4#1)(2008-5#3)
keratinocyte growth factor##3##3##(1994-11#1)(2008-7#1)(2013-8#1)
keratinocyte growth##4##2##(1994-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
keratinocyte##33##1##(1991-12#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-3#3)(1996-2#1)(2008-1#1)(2008-11#7)(2008-4#3)(2008-5#7)(2008-7#1)(2008-9#2)(2012-3#2)(2013-8#1)
keratinocyte-fibroblast##2##1##(2008-9#2)
keratinocytes and melanocytes##2##3##(2008-5#2)
keratinocytes and##7##2##(2008-4#2)(2008-5#3)(2008-7#1)(2009-3#1)
keratinocytes are##3##2##(2008-1#1)(2008-12#1)(2008-5#1)
keratinocytes have been##2##3##(2008-1#1)(2012-2#1)
keratinocytes in vitro##4##3##(1992-2#1)(2008-8#3)
keratinocytes in##9##2##(1990-11#1)(1992-2#1)(1997-1#1)(2008-1#1)(2008-5#1)(2008-8#3)(2012-2#1)
keratinocytes only##2##2##(2008-11#1)(2008-5#1)
keratinocytes to##2##2##(2008-5#1)(2012-3#1)
keratinocytes was##2##2##(1990-11#1)(1996-2#1)
keratinocytes were##3##2##(1995-11#1)(2008-5#2)
keratinocytes with##2##2##(1991-9#1)(2008-7#1)
keratinocytes##100##1##(1990-11#2)(1990-3#1)(1991-9#3)(1992-2#3)(1992-9#1)(1993-11#1)(1993-5#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-2#3)(1997-1#3)(1997-4#2)(2006-12#1)(2008-1#3)(2008-11#7)(2008-12#4)(2008-4#8)(2008-5#27)(2008-7#3)(2008-8#7)(2009-3#1)(2009-6#3)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#1)(2012-8#4)(2013-1#1)
keratinolytic activity of##2##3##(2008-6#2)
keratinolytic activity##6##2##(2008-6#6)
keratinolytic##9##1##(2008-6#9)
keratins and##3##2##(2008-5#2)(2008-8#1)
keratins##13##1##(2008-11#1)(2008-5#7)(2008-8#2)(2011-2#3)
keratitis after##2##2##(2013-1#2)
keratitis in##4##2##(2007-7#2)(2010-10#1)(2011-2#1)
keratitis##17##1##(2007-7#2)(2009-10#1)(2009-3#1)(2010-10#2)(2011-2#7)(2012-2#2)(2013-1#2)
keratoacanthoma##5##1##(2010-8#5)
keratoconic cornea##2##2##(2009-7#2)
keratoconic##4##1##(2009-7#4)
keratoconjunctivitis in yaks##2##3##(2011-2#2)
keratoconjunctivitis in##4##2##(2008-9#1)(2011-2#2)(2012-3#1)
keratoconjunctivitis##10##1##(2008-9#1)(2011-2#6)(2012-3#2)(2013-8#1)
keratoconus##6##1##(2009-7#1)(2011-1#2)(2011-2#2)(2012-3#1)
keratocysts##7##1##(1997-3#1)(2007-12#4)(2007-4#1)(2013-1#1)
keratocyte##3##1##(2007-11#1)(2008-3#2)
keratoderma##2##1##(2007-7#2)
keratolytic##3##1##(2008-5#1)(2012-12#2)
keratomycosis##2##1##(2007-7#2)
keratopathy##3##1##(2011-2#1)(2012-12#1)(2012-3#1)
keratoplasty (PK)##2##2##(2011-2#2)
keratoplasty##9##1##(2010-10#2)(2011-1#2)(2011-2#4)(2013-1#1)
keratoses##4##1##(2010-8#3)(2011-2#1)
keratosis actinica##3##2##(2011-2#3)
keratosis in##2##2##(2007-8#1)(2010-8#1)
keratosis##17##1##(1990-6#2)(2007-8#3)(2010-8#5)(2011-2#6)(2012-12#1)
kerf##2##1##(2008-2#1)(2008-7#1)
kernel blight##2##2##(2008-10#2)
kernel density clustering method##2##4##(2008-7#2)
kernel density clustering##4##3##(2008-7#4)
kernel density##6##2##(2008-10#1)(2008-7#4)(2010-3#1)
kernel development##3##2##(2008-10#3)
kernel functions##2##2##(2008-3#2)
kernel infection by##2##3##(2008-10#2)
kernel infection##6##2##(2008-10#6)
kernel partial least-squares##2##3##(2008-10#2)
kernel proteins##3##2##(2008-10#3)
kernel weight loss##2##3##(2011-2#2)
kernel weight##3##2##(2011-2#3)
kernel were##2##2##(2008-10#2)
kernel##68##1##(2008-1#1)(2008-10#35)(2008-2#6)(2008-3#7)(2008-5#5)(2008-7#4)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#6)(2011-3#1)
kernels and a##2##3##(2008-10#1)(2012-3#1)
kernels and##4##2##(2008-10#3)(2012-3#1)
kernels are used##2##3##(2008-3#1)(2009-12#1)
kernels may##2##2##(2008-3#1)(2012-3#1)
kernels of##6##2##(2008-10#4)(2008-5#1)(2010-4#1)
kernels than in##2##3##(2008-10#2)
kernels that##2##2##(2008-10#1)(2008-3#1)
kernels used in##2##3##(2008-3#2)
kernels was affected by##2##4##(2011-2#2)
kernels was##3##2##(2011-2#3)
kernels with wounded##2##3##(2008-10#2)
kernels with##4##2##(2008-10#3)(2008-8#1)
kernels##70##1##(1991-9#1)(2008-10#40)(2008-12#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#5)(2013-8#1)
kerosene##13##1##(2008-10#10)(2008-11#3)
ketal##2##1##(1996-5#1)(2007-11#1)
ketals##4##1##(1993-8#1)(1996-5#1)(2008-5#2)
ketamine and##4##2##(2008-10#1)(2012-2#2)(2012-3#1)
ketamine hydrochloride and##2##3##(2013-1#2)
ketamine hydrochloride##3##2##(2013-1#3)
ketamine in##4##2##(1991-1#1)(2011-2#2)(2012-2#1)
ketamine injectors##3##2##(2007-4#3)
ketamine is##2##2##(2007-4#1)(2011-2#1)
ketamine##42##1##(1991-1#1)(1992-12#1)(1994-8#1)(2007-4#5)(2008-10#1)(2009-5#1)(2011-2#10)(2012-12#4)(2012-2#10)(2012-3#2)(2013-1#6)
ketanserin##3##1##(1995-3#3)
ketimine##6##1##(1990-8#4)(1994-11#2)
keto acid##5##2##(2008-10#2)(2008-11#3)
keto##12##1##(1990-9#1)(1993-11#3)(1996-5#2)(2008-10#2)(2008-11#4)
ketoacidosis##11##1##(1993-6#1)(1994-6#2)(2009-8#1)(2011-1#4)(2011-2#3)
ketoconazole and##2##2##(1991-5#1)(2008-5#1)
ketoconazole or##2##2##(2008-5#2)
ketoconazole was##4##2##(2008-11#1)(2008-5#3)
ketoconazole##24##1##(1991-5#1)(2007-7#3)(2008-11#4)(2008-3#1)(2008-5#11)(2010-8#1)(2011-2#2)(2012-3#1)
ketogenic##2##1##(2008-3#2)
ketone (MIBK)##4##2##(2008-10#4)
ketone and##9##2##(1992-8#1)(2007-11#1)(2008-10#7)
ketone bodies##5##2##(1996-12#1)(2008-10#2)(2008-5#2)
ketone body ratio##3##3##(2007-8#2)(2008-10#1)
ketone body##4##2##(2007-8#2)(2008-10#1)(2008-5#1)
ketone group##2##2##(1997-1#2)
ketone reduction##2##2##(2007-11#2)
ketone##65##1##(1992-8#2)(1993-11#3)(1994-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#3)(1997-1#5)(2007-11#5)(2007-8#2)(2008-10#37)(2008-11#1)(2008-5#3)
ketone)##3##1##(2010-4#2)(2010-7#1)
ketones and##5##2##(1992-5#1)(1996-5#2)(2008-12#1)(2011-2#1)
ketones are##2##2##(2008-10#1)(2012-3#1)
ketones from##2##2##(2010-7#1)(2012-3#1)
ketones##28##1##(1992-5#1)(1996-5#5)(1997-1#1)(2007-11#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#1)
ketoprofen was##2##2##(1997-7#1)(2008-10#1)
ketoprofen##11##1##(1997-7#1)(2008-10#6)(2012-3#4)
ketorolac##11##1##(1992-9#1)(2008-10#5)(2008-9#1)(2009-5#1)(2011-2#3)
ketosis##4##1##(2008-10#1)(2008-3#1)(2008-5#2)
ketotifen##3##1##(2010-6#3)
key activities##2##2##(2008-11#1)(2013-1#1)
key amino acids##2##3##(2009-8#1)(2011-2#1)
key amino##3##2##(2008-8#1)(2009-8#1)(2011-2#1)
key areas of##2##3##(2008-10#1)(2012-3#1)
key areas##7##2##(1991-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
key aspect of##2##3##(2008-6#1)(2008-7#1)
key aspect##3##2##(2008-6#1)(2008-7#1)(2010-5#1)
key aspects of##4##3##(2009-3#1)(2010-10#1)(2012-2#1)(2012-3#1)
key aspects##6##2##(1995-2#1)(2008-6#1)(2009-3#1)(2010-10#1)(2012-2#1)(2012-3#1)
key assumptions##2##2##(2008-8#1)(2012-3#1)
key business##3##2##(1993-1#1)(1993-12#1)(1993-3#1)
key challenges to##2##3##(2009-11#1)(2011-1#1)
key challenges##3##2##(2009-11#1)(2010-12#1)(2011-1#1)
key characteristics of the##2##4##(2010-12#1)(2013-1#1)
key characteristics of##4##3##(1994-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
key charged##2##2##(1995-6#2)
key clinical##4##2##(1995-3#1)(1997-2#2)(2008-11#1)
key code is##2##3##(2008-3#2)
key code##6##2##(2008-3#6)
key communication##2##2##(1995-12#1)(2008-12#1)
key component of##6##3##(1995-2#1)(2007-12#1)(2008-10#2)(2009-11#1)(2010-3#1)
key component##10##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2009-11#1)(2010-3#1)(2013-8#1)
key components in##2##3##(2008-10#2)
key components of the##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
key components of##9##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)
key components##13##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)
key concepts of##2##3##(1992-2#1)(2012-2#1)
key concepts##4##2##(1992-2#2)(2007-11#1)(2012-2#1)
key concerns##2##2##(2009-5#1)(2011-2#1)
key criteria##2##2##(2007-12#1)(2013-1#1)
key data##2##2##(2011-2#1)(2012-3#1)
key debates##2##2##(1994-3#1)(2013-1#1)
key determinant of the##2##4##(2008-7#1)(2009-8#1)
key determinant of##5##3##(1996-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-12#1)
key determinant##6##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-12#1)
key determinants##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
key developmental##2##2##(2009-8#2)
key developments##3##2##(2009-9#1)(2010-2#1)(2011-2#1)
key dimensions##2##2##(1993-1#1)(2009-11#1)
key distillation##2##2##(2008-2#2)
key domains##2##2##(2008-11#1)(2009-11#1)
key element for##2##3##(2008-10#1)(2008-2#1)
key element in##2##3##(2008-7#1)(2009-10#1)
key element of##2##3##(1996-8#1)(2007-11#1)
key element##6##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)
key elements in the##4##4##(1996-12#1)(2008-10#1)(2009-3#1)(2010-4#1)
key elements in##6##3##(1996-12#1)(2008-10#2)(2009-3#1)(2010-4#1)(2011-1#1)
key elements of the##4##4##(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
key elements of##5##3##(1994-1#1)(2008-11#1)(2008-9#2)(2012-12#1)
key elements to##3##3##(1991-12#1)(1993-12#1)(2010-8#1)
key elements##18##2##(1991-12#1)(1993-12#2)(1994-1#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-9#2)(2009-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
key enabling##2##2##(2008-3#1)(2008-4#1)
key environmental##2##2##(2007-5#1)(2008-5#1)
key enzyme for##3##3##(1997-1#1)(2008-11#1)(2008-8#1)
key enzyme in##6##3##(1990-2#1)(1992-3#1)(1992-8#1)(1995-8#1)(2008-9#1)(2013-1#1)
key enzyme of##4##3##(1992-8#1)(1993-6#1)(2008-10#1)(2009-8#1)
key enzyme##17##2##(1990-2#1)(1992-3#2)(1992-8#2)(1993-6#1)(1995-11#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#1)
key enzymes in the##2##4##(2008-10#1)(2011-2#1)
key enzymes in##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
key enzymes involved in the##2##5##(2008-9#1)(2012-5#1)
key enzymes involved in##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2012-5#1)
key enzymes of the##2##4##(1994-12#1)(1994-6#1)
key enzymes of##3##3##(1994-12#1)(1994-6#1)(2008-8#1)
key enzymes##13##2##(1994-12#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-5#1)
key event in##2##3##(2008-4#1)(2011-2#1)
key event##3##2##(2008-4#1)(2009-9#1)(2011-2#1)
key events##4##2##(1995-3#1)(2009-10#2)(2011-2#1)
key factor for##4##3##(2008-10#2)(2008-9#1)(2009-7#1)
key factor in##17##3##(1994-5#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
key factor that##4##3##(2008-3#2)(2012-2#2)
key factor##29##2##(1994-5#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
key factors in##4##3##(1995-3#1)(2008-1#1)(2008-10#1)(2012-3#1)
key factors influencing##2##3##(2007-8#1)(2012-2#1)
key factors that influence##2##4##(2008-11#1)(2009-6#1)
key factors that##5##3##(2007-11#1)(2008-11#2)(2008-7#1)(2009-6#1)
key factors##23##2##(1990-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
key feature of the##4##4##(1996-12#1)(2008-10#2)(2008-9#1)
key feature of##8##3##(1991-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
key feature##9##2##(1991-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
key features for##2##3##(1994-9#1)(2009-12#1)
key features of##4##3##(1997-6#1)(2008-8#1)(2011-2#2)
key features##11##2##(1994-9#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-8#2)(2009-12#1)(2011-2#3)(2012-3#1)
key findings of##2##3##(2008-12#1)(2008-5#1)
key findings##4##2##(1991-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
key focus of##2##3##(2008-11#1)(2012-3#1)
key for understanding##2##3##(2008-11#1)(2008-8#1)
key for##7##2##(1993-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-7#1)(2013-8#1)
key functional##3##2##(1992-12#1)(1993-6#1)(2012-3#1)
key functions of##2##3##(1997-1#1)(2013-1#1)
key functions##4##2##(1997-1#1)(2008-3#1)(2009-5#1)(2013-1#1)
key genes##2##2##(2008-3#1)(2010-3#1)
key goal##3##2##(1991-2#1)(2007-8#1)(2008-7#1)
key goals##2##2##(1996-1#1)(2012-12#1)
key health##2##2##(1996-12#1)(2008-3#1)
key hormones##2##2##(2008-3#1)(2008-6#1)
key hospital##2##2##(1993-3#1)(1994-3#1)
key immune##2##2##(2009-12#1)(2011-2#1)
key in the##5##3##(2008-10#1)(2008-3#2)(2008-6#1)(2011-1#1)
key in##11##2##(1996-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
key informant interviews##6##3##(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
key informant##7##2##(1994-2#1)(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
key informants##4##2##(1996-3#1)(2008-1#1)(2013-1#2)
key intermediate##5##2##(1990-8#1)(1992-12#1)(1996-5#1)(2009-12#1)(2011-1#1)
key intermediates##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
key is provided for##2##4##(2008-5#1)(2010-3#1)
key is provided##3##3##(2008-5#1)(2010-3#1)(2013-7#1)
key is##9##2##(1993-2#1)(1994-12#1)(2007-11#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-2#1)(2013-7#1)
key issue##8##2##(1991-3#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-5#1)
key issues and##2##3##(1997-2#1)(2010-8#1)
key issues in##5##3##(1992-3#2)(1995-12#1)(2008-2#1)(2008-7#1)
key issues that##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
key issues##19##2##(1992-1#1)(1992-3#3)(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
key lessons learned##2##3##(1995-12#1)(1995-3#1)
key lessons##4##2##(1995-12#1)(1995-3#1)(2008-12#2)
key mechanism##4##2##(2008-10#2)(2012-2#2)
key mediators##3##2##(2008-11#1)(2009-10#1)(2012-3#1)
key messages##5##2##(2010-4#2)(2010-8#2)(2012-12#1)
key molecule of the##2##4##(2008-1#1)(2008-4#1)
key molecule##4##2##(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
key molecules for##2##3##(2008-1#1)(2009-8#1)
key molecules involved in##3##4##(2008-5#1)(2009-4#1)(2013-8#1)
key molecules##5##2##(2008-1#1)(2008-5#1)(2009-4#1)(2009-8#1)(2013-8#1)
key nutrient components##2##3##(2008-7#2)
key objectives##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
key odour-active compounds##2##3##(2008-10#2)
key parameters that##2##3##(2008-10#1)(2013-8#1)
key parameters##10##2##(1992-3#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
key part of##2##3##(2008-2#1)(2009-5#1)
key player in##4##3##(1994-12#1)(1996-2#1)(2008-4#1)(2011-2#1)
key players in the##5##4##(1997-2#1)(2008-4#1)(2009-10#1)(2009-5#1)(2011-1#1)
key players in##8##3##(1997-2#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2013-7#2)
key players##9##2##(1997-2#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#2)
key point in##2##3##(1995-11#1)(2008-10#1)
key point##4##2##(1995-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
key points of##2##3##(2008-3#1)(2008-8#1)
key points##6##2##(2007-5#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
key principles##3##2##(1996-3#1)(2008-3#1)(2012-2#1)
key problems##3##2##(1995-12#1)(2010-5#1)(2013-8#1)
key process in the##2##4##(2008-10#1)(2012-12#1)
key process in##3##3##(2008-10#1)(2010-8#1)(2012-12#1)
key process##6##2##(1993-12#1)(2008-10#2)(2010-11#1)(2010-8#1)(2012-12#1)
key processes##2##2##(2009-4#1)(2010-8#1)
key proteins in##2##3##(2008-8#1)(2012-2#1)
key question##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
key questions that##2##3##(1995-1#1)(2010-12#1)
key questions##4##2##(1995-1#1)(1995-6#1)(2008-11#1)(2010-12#1)
key raw material##2##3##(2008-10#2)
key reaction##4##2##(1990-7#1)(2009-5#1)(2013-1#2)
key regulator of##8##3##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
key regulator##9##2##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-8#1)(2013-8#1)
key regulators of the##2##4##(2009-8#1)(2012-12#1)
key regulators of##7##3##(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#2)
key regulatory##15##2##(1990-4#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2012-1#1)(2013-1#1)
key research##3##2##(2010-10#1)(2011-2#1)(2013-1#1)
key result##4##2##(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
key results##4##2##(2007-12#1)(2008-8#1)(2009-8#1)(2012-1#1)
key risk##3##2##(2006-10#1)(2012-3#1)(2013-1#1)
key role for##3##3##(1990-2#1)(2009-9#1)(2010-8#1)
key role in##82##3##(1990-2#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-1#5)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)
key role of the##2##4##(1991-7#1)(1996-12#1)
key role of##8##3##(1991-7#1)(1996-12#1)(2008-9#1)(2009-8#1)(2013-1#4)
key role##101##2##(1990-2#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#1)
key roles in the##3##4##(2007-10#1)(2008-1#1)(2010-12#1)
key roles in##14##3##(1996-10#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
key roles##20##2##(1991-5#1)(1996-10#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
key signal##3##2##(2008-11#1)(2009-8#1)(2010-11#1)
key signaling##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
key signalling##2##2##(2009-5#1)(2012-2#1)
key species##2##2##(2008-11#1)(2008-3#1)
key stakeholder##2##2##(1991-3#1)(2012-3#1)
key stakeholders##5##2##(1991-1#1)(1991-3#1)(1992-1#1)(1996-1#1)(2011-1#1)
key step for##2##3##(2008-11#1)(2012-3#1)
key step in the##4##4##(1990-5#1)(1992-3#1)(2008-10#2)
key step in this##3##4##(1992-8#1)(1996-2#1)(2008-11#1)
key step in##11##3##(1990-5#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-11#2)(2009-2#1)(2011-2#1)
key step##18##2##(1990-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
key steps##2##2##(1992-1#1)(1994-3#1)
key strategies in##2##3##(2008-10#2)
key strategies##4##2##(1995-2#1)(2008-10#2)(2012-3#1)
key string##5##2##(2008-7#5)
key strings##3##2##(2008-7#3)
key structural##4##2##(1995-3#1)(2009-12#1)(2010-10#1)(2012-2#1)
key studies##2##2##(2008-10#1)(2008-7#1)
key success factors##3##3##(1994-2#1)(1996-12#1)(2010-8#1)
key success##4##2##(1994-2#1)(1996-1#1)(1996-12#1)(2010-8#1)
key technical##2##2##(1991-3#1)(1994-2#1)
key terms##5##2##(1993-2#2)(2008-12#1)(2008-4#1)(2009-8#1)
key that##2##2##(2008-2#1)(2011-2#1)
key themes that##2##3##(2011-1#1)(2013-8#1)
key themes##6##2##(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#2)(2013-8#1)
key theoretical##2##2##(2008-7#1)(2011-2#1)
key to a##2##3##(1991-1#1)(2011-2#1)
key to any##2##3##(1994-2#1)(2008-9#1)
key to effective##3##3##(1993-1#1)(1997-3#1)(2008-7#1)
key to minimizing##2##3##(1995-12#1)(2008-10#1)
key to success in##3##4##(1997-1#1)(2008-11#1)(2011-1#1)
key to success##9##3##(1994-1#2)(1995-12#2)(1996-12#1)(1997-1#1)(2008-11#1)(2011-1#1)(2011-2#1)
key to successful##2##3##(2007-12#2)
key to the##20##3##(1990-3#1)(1990-8#1)(1991-1#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-5#1)(2011-9#1)(2012-2#1)
key to this##2##3##(2008-10#2)
key to understanding the##4##4##(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)
key to understanding##7##3##(2008-1#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)
key to##102##2##(1990-3#1)(1990-8#1)(1991-1#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#2)(1995-1#2)(1995-12#5)(1996-1#1)(1996-12#1)(1997-1#3)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#4)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-9#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
key topics##3##2##(1992-5#1)(2007-12#1)(2012-12#1)
key trends##3##2##(1993-2#1)(1997-1#1)(2008-6#1)
key wavelength##2##2##(2008-2#2)
key words including##2##3##(2008-7#1)(2012-2#1)
key words##10##2##(2008-1#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
key##1090##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#3)(1991-12#5)(1991-2#2)(1991-3#5)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#5)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#9)(1992-4#1)(1992-5#1)(1992-8#6)(1992-9#2)(1993-1#4)(1993-12#10)(1993-2#6)(1993-3#2)(1993-5#1)(1993-6#6)(1993-8#1)(1993-9#1)(1994-1#6)(1994-10#1)(1994-11#1)(1994-12#11)(1994-2#12)(1994-3#9)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#4)(1995-11#3)(1995-12#10)(1995-2#11)(1995-3#8)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#8)(1996-10#1)(1996-12#7)(1996-2#9)(1996-3#5)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#9)(1997-2#8)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#13)(2007-12#18)(2007-2#1)(2007-5#2)(2007-8#7)(2008-1#19)(2008-10#77)(2008-11#55)(2008-12#20)(2008-2#15)(2008-3#39)(2008-4#22)(2008-5#29)(2008-6#11)(2008-7#47)(2008-8#33)(2008-9#23)(2009-1#1)(2009-10#10)(2009-11#9)(2009-12#10)(2009-2#2)(2009-3#6)(2009-4#4)(2009-5#10)(2009-6#4)(2009-7#3)(2009-8#22)(2009-9#6)(2010-1#1)(2010-10#10)(2010-11#7)(2010-12#9)(2010-2#3)(2010-3#7)(2010-4#14)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#14)(2010-9#1)(2011-1#21)(2011-10#1)(2011-2#41)(2011-3#3)(2011-9#1)(2012-1#4)(2012-12#31)(2012-2#41)(2012-3#22)(2012-5#1)(2012-8#1)(2013-1#45)(2013-7#8)(2013-8#19)
keyboard##2##1##(1991-12#1)(2010-12#1)
keyhole limpet hemocyanin (KLH)##5##4##(2008-10#4)(2008-9#1)
keyhole limpet##6##2##(2008-10#4)(2008-9#1)(2012-2#1)
keyhole##7##1##(2008-10#4)(2008-2#1)(2008-9#1)(2012-2#1)
keying##6##1##(2007-11#6)
keynote##3##1##(2008-7#3)
keypeck)##2##1##(2008-5#2)
keys for##2##2##(2007-12#1)(2012-2#1)
keys to success##2##3##(1996-1#1)(2010-3#1)
keys to the genera of##2##5##(2008-10#2)
keys to the##4##3##(2008-1#1)(2008-10#3)
keys to##13##2##(1991-1#1)(1991-12#1)(1995-1#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-3#1)(2011-2#1)
keys##21##1##(1991-1#1)(1991-12#1)(1995-1#1)(1996-1#1)(2007-12#4)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
keyword and##2##2##(2010-12#2)
keyword search##2##2##(2010-12#1)(2011-2#1)
keyword##8##1##(1991-12#1)(2008-7#2)(2010-12#4)(2011-2#1)
keywords##9##1##(2008-10#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2013-1#1)
kg (dry wt##2##3##(2007-5#2)
kg N ha(-1) from##2##4##(2008-12#2)
kg N ha(-1)##6##3##(2008-12#6)
kg N##8##2##(1996-12#1)(2008-12#7)
kg and##3##2##(2008-3#2)(2008-7#1)
kg body weight##3##3##(1997-4#1)(2008-9#1)(2013-7#1)
kg body##4##2##(1997-4#1)(2008-9#1)(2011-2#1)(2013-7#1)
kg fresh##2##2##(2008-10#2)
kg ha(-1)##8##2##(2008-12#8)
kg ha(-1)) and##2##3##(2008-12#2)
kg ha(-1))##3##2##(2008-12#3)
kg in##5##2##(1990-11#1)(1994-3#1)(2012-2#1)(2012-3#2)
kg live weight##2##3##(2010-2#2)
kg of soil##2##3##(2008-10#2)
kg of##8##2##(1990-8#1)(1995-2#1)(2008-10#3)(2008-11#2)(2013-1#1)
kg over##2##2##(2008-3#2)
kg per##2##2##(1994-5#1)(2007-7#1)
kg##106##1##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-5#2)(1995-2#1)(1996-12#3)(1997-4#2)(2007-12#2)(2007-5#3)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#24)(2008-3#8)(2008-4#2)(2008-5#9)(2008-7#3)(2008-9#6)(2009-6#1)(2010-2#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
kg(-1) and##11##2##(2008-10#2)(2010-7#2)(2011-3#1)(2012-2#2)(2013-8#4)
kg(-1) body weight##3##3##(2008-12#1)(2010-11#1)(2012-3#1)
kg(-1) body##8##2##(2008-10#3)(2008-12#2)(2010-11#1)(2011-1#1)(2012-3#1)
kg(-1) bw##4##2##(2008-10#3)(2010-5#1)
kg(-1) day(-1))##2##2##(2008-10#1)(2010-7#1)
kg(-1) for##15##2##(2008-10#5)(2008-12#6)(2008-7#1)(2013-8#3)
kg(-1) i##4##2##(2008-12#4)
kg(-1) in##2##2##(2008-10#1)(2008-3#1)
kg(-1) of##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2012-2#1)
kg(-1) was##2##2##(2008-11#1)(2008-5#1)
kg(-1) were##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
kg(-1)##120##1##(2008-10#44)(2008-11#7)(2008-12#28)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#7)(2010-8#2)(2011-1#1)(2011-3#2)(2012-2#5)(2012-3#2)(2013-8#10)
kg(-1)) and##7##2##(2008-10#3)(2008-12#3)(2010-7#1)
kg(-1)) in##2##2##(2008-10#1)(2008-12#1)
kg(-1)) were##3##2##(2008-10#3)
kg(-1))##39##1##(1997-4#1)(2008-10#26)(2008-12#9)(2008-7#1)(2010-7#1)(2011-3#1)
kg) were##2##2##(2007-8#1)(2013-1#1)
kg)##16##1##(1996-12#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2010-2#1)(2012-1#1)(2013-1#1)
kg- 1##3##2##(2008-11#3)
kg-##4##1##(2008-11#4)
kg-1 and##2##2##(1995-5#1)(2008-11#1)
kg-1 animal##2##2##(1994-8#2)
kg-1 h-1)##4##2##(1995-12#4)
kg-1##41##1##(1991-8#1)(1992-3#1)(1993-12#5)(1994-8#2)(1995-12#5)(1995-5#7)(1997-2#2)(2008-11#14)(2008-5#3)(2008-9#1)
kg/day)##2##1##(2010-2#2)
kg/ha##9##1##(2008-10#5)(2011-1#4)
kg/ha)##2##1##(2008-10#2)
kg/kg dry raw material##2##4##(2008-6#2)
kg/m(2)##8##1##(2006-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-4#1)(2013-1#1)
kg/m(2)) were##2##2##(2008-3#2)
kg/m(2))##6##1##(2008-3#3)(2010-8#1)(2012-12#2)
kg/m2##8##1##(2008-5#1)(2010-4#1)(2011-2#6)
kg/m2) and##2##2##(2011-2#1)(2012-2#1)
kg/m2)##5##1##(1994-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
kg/week)##2##1##(2008-3#2)
ki =##2##2##(1991-5#2)
kick in##2##2##(1994-2#1)(2009-3#1)
kick##3##1##(1994-2#1)(2008-7#1)(2009-3#1)
kicked rotor##2##2##(2007-11#2)
kicked##5##1##(2007-11#3)(2008-5#1)(2010-3#1)
kickoff conference##2##2##(2012-2#2)
kid was born##2##3##(2008-9#2)
kidnapping##2##1##(1992-2#1)(1993-12#1)
kidney (HEK) 293##4##3##(2008-11#1)(2009-12#1)(2013-1#2)
kidney 293##2##2##(2008-11#2)
kidney and a##2##3##(2008-1#1)(2011-2#1)
kidney and brain##3##3##(1992-11#1)(1993-11#1)(1994-5#1)
kidney and heart##2##3##(1990-11#1)(2013-1#1)
kidney and in##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
kidney and intestine##3##3##(2007-7#1)(2008-11#2)
kidney and liver in##2##4##(1990-7#1)(2008-12#1)
kidney and liver of##3##4##(1990-7#1)(2008-7#1)(2013-1#1)
kidney and liver##17##3##(1990-7#2)(1991-5#2)(1992-6#1)(1992-9#1)(1994-5#1)(1995-3#1)(1996-12#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2013-1#1)
kidney and lung##4##3##(1993-3#1)(1993-8#1)(1997-4#1)(2008-9#1)
kidney and pancreas of##2##4##(1995-3#2)
kidney and pancreas transplantation##2##4##(2008-1#1)(2012-2#1)
kidney and pancreas##6##3##(1995-3#3)(2008-1#1)(2008-8#1)(2012-2#1)
kidney and serum##3##3##(1992-11#1)(1992-3#2)
kidney and the##2##3##(1994-9#1)(2007-12#1)
kidney and##79##2##(1990-11#4)(1990-7#2)(1991-12#1)(1991-5#3)(1992-11#3)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#3)(1994-9#1)(1995-3#4)(1996-12#2)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#6)(2013-7#1)
kidney as##2##2##(1990-11#1)(2008-10#1)
kidney biopsies performed##2##3##(2007-7#1)(2008-1#1)
kidney biopsies##4##2##(2007-7#1)(2008-1#3)
kidney biopsy##3##2##(1996-6#1)(2008-1#1)(2012-2#1)
kidney but##3##2##(1990-3#1)(2008-11#1)(2011-2#1)
kidney by##2##2##(1991-5#1)(2007-7#1)
kidney cDNA library##4##3##(1993-6#1)(1994-12#1)(1997-7#1)(2010-5#1)
kidney cDNA##5##2##(1993-6#1)(1994-12#2)(1997-7#1)(2010-5#1)
kidney cancer##5##2##(1991-8#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
kidney cell##3##2##(1990-8#2)(1994-6#1)
kidney cells and##5##3##(1990-8#1)(1991-3#1)(2007-6#1)(2008-7#1)(2013-8#1)
kidney cells##11##2##(1990-8#1)(1991-12#1)(1991-3#3)(1993-8#1)(1994-9#1)(2007-6#2)(2008-7#1)(2013-8#1)
kidney cortex##5##2##(1993-3#1)(1994-8#3)(2010-4#1)
kidney cytosols##2##2##(1990-11#2)
kidney damage##4##2##(1990-2#1)(1992-3#2)(2011-2#1)
kidney dialysis##2##2##(2008-5#2)
kidney disease (CKD) is##2##4##(2009-1#1)(2012-2#1)
kidney disease (CKD)##8##3##(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
kidney disease and##3##3##(2008-11#1)(2011-2#2)
kidney disease are##2##3##(2009-12#1)(2013-1#1)
kidney disease can be##2##4##(2007-8#1)(2008-1#1)
kidney disease in##4##3##(2009-6#2)(2012-2#1)(2012-3#1)
kidney disease##73##2##(1997-1#2)(2007-7#6)(2007-8#1)(2008-1#10)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-1#2)(2009-12#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-4#3)(2010-6#1)(2010-8#2)(2011-2#12)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#8)(2013-8#1)
kidney disease]##2##2##(2012-2#1)(2013-1#1)
kidney diseases##6##2##(1990-8#1)(2008-1#4)(2008-4#1)
kidney donation##4##2##(2007-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
kidney donor transplant##2##3##(2011-2#2)
kidney donor##4##2##(1991-11#1)(2008-1#1)(2011-2#2)
kidney enzyme##2##2##(1990-7#1)(1992-11#1)
kidney failure##8##2##(1990-9#1)(1996-6#1)(2008-11#1)(2011-2#3)(2012-12#1)(2013-1#1)
kidney fibroblast##2##2##(1991-2#1)(1991-9#1)
kidney fibroblasts##2##2##(2008-11#1)(2008-5#1)
kidney from##3##2##(1990-3#1)(2008-11#1)(2011-2#1)
kidney function##10##2##(1991-3#1)(1992-12#1)(1993-2#1)(1994-5#1)(1994-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
kidney glucagon##2##2##(1995-11#2)
kidney graft recipients##2##3##(2008-1#1)(2013-1#1)
kidney graft##5##2##(1995-9#2)(2008-1#1)(2011-2#1)(2013-1#1)
kidney haemodynamics##3##2##(2013-1#3)
kidney in a##2##3##(2008-10#1)(2012-2#1)
kidney in the##3##3##(2008-10#1)(2011-2#2)
kidney in##14##2##(1997-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
kidney injury##10##2##(2008-8#3)(2009-6#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#3)
kidney involvement##2##2##(2009-5#1)(2012-2#1)
kidney is##11##2##(1990-2#1)(1994-5#1)(2007-7#1)(2008-10#3)(2008-7#1)(2010-10#1)(2011-2#3)
kidney living##2##2##(2011-2#2)
kidney of##8##2##(1995-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#1)(2012-3#1)
kidney on##2##2##(2008-10#1)(2011-2#1)
kidney or##2##2##(2008-10#2)
kidney soluble extract##2##3##(1990-2#2)
kidney soluble##3##2##(1990-2#3)
kidney stones##4##2##(2008-11#1)(2008-12#1)(2009-7#1)(2013-8#1)
kidney tissue##3##2##(2008-7#1)(2010-4#2)
kidney to##3##2##(1995-11#1)(2010-1#1)(2011-2#1)
kidney transplant patients##3##3##(1994-5#3)
kidney transplant recipients##4##3##(2007-7#1)(2008-1#2)(2010-8#1)
kidney transplant##20##2##(1991-3#1)(1994-5#3)(1997-4#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-5#2)(2009-3#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
kidney transplantation and##2##3##(2010-8#1)(2011-2#1)
kidney transplantation in##5##3##(2008-1#1)(2008-7#3)(2011-2#1)
kidney transplantation##38##2##(1990-11#1)(1991-9#1)(1995-12#3)(2007-10#1)(2007-7#2)(2008-1#3)(2008-5#1)(2008-7#5)(2010-8#3)(2011-2#13)(2012-12#2)(2013-1#3)
kidney transplantation]##6##2##(1994-5#1)(2011-2#5)
kidney transplanted patients##2##3##(2007-9#1)(2008-10#1)
kidney transplants##2##2##(2011-2#2)
kidney tumor##2##2##(1992-5#1)(2013-1#1)
kidney tumors were##2##3##(1994-5#2)
kidney tumors##6##2##(1992-12#1)(1992-5#2)(1994-5#2)(2011-2#1)
kidney was##8##2##(1990-2#1)(1991-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
kidney weights in##2##3##(2008-9#2)
kidney weights were significantly##2##4##(2008-9#2)
kidney weights were##3##3##(2008-9#3)
kidney weights##8##2##(2008-9#8)
kidney were##7##2##(1992-9#1)(1995-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
kidney which##2##2##(1990-9#1)(2011-2#1)
kidney while##2##2##(1990-3#1)(1994-5#1)
kidney with##4##2##(1992-6#1)(1993-9#1)(2008-1#1)(2013-1#1)
kidney##708##1##(1990-11#17)(1990-12#7)(1990-2#10)(1990-3#6)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#6)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#6)(1991-5#4)(1991-8#5)(1991-9#3)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#8)(1992-5#4)(1992-6#3)(1992-9#3)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#5)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#6)(1994-12#4)(1994-3#1)(1994-5#16)(1994-6#3)(1994-8#5)(1994-9#6)(1995-11#8)(1995-12#10)(1995-2#2)(1995-3#6)(1995-9#2)(1996-11#1)(1996-12#3)(1996-5#3)(1996-6#2)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#5)(1997-8#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#21)(2007-8#2)(2007-9#2)(2008-1#35)(2008-10#45)(2008-11#23)(2008-12#7)(2008-3#1)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#28)(2008-8#16)(2008-9#17)(2009-1#2)(2009-11#1)(2009-12#3)(2009-3#4)(2009-5#4)(2009-6#7)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#6)(2010-4#8)(2010-5#4)(2010-6#2)(2010-8#6)(2011-1#6)(2011-2#78)(2011-3#1)(2012-1#2)(2012-12#16)(2012-2#21)(2012-3#12)(2013-1#46)(2013-7#1)(2013-8#14)
kidney&quot##4##1##(2008-1#4)
kidney) and##2##2##(1990-5#1)(2008-10#1)
kidney)##3##1##(1990-5#1)(2007-8#1)(2008-10#1)
kidney-derived##3##1##(1991-3#1)(2008-7#2)
kidneys and liver##2##3##(1994-12#1)(2008-7#1)
kidneys and##12##2##(1990-11#1)(1992-12#2)(1993-8#1)(1994-12#1)(1995-3#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-7#2)
kidneys from##3##2##(1996-3#1)(2011-2#1)(2013-7#1)
kidneys in##4##2##(1997-4#1)(2008-12#1)(2008-4#2)
kidneys of rats##2##3##(1994-5#1)(2009-6#1)
kidneys of streptozotocin-induced diabetic rats##2##5##(2011-3#2)
kidneys of streptozotocin-induced diabetic##3##4##(2011-3#3)
kidneys of##16##2##(1990-7#1)(1994-5#3)(1997-1#1)(1997-6#2)(2008-1#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-3#3)(2013-1#1)
kidneys to##2##2##(2007-7#1)(2008-3#1)
kidneys were##6##2##(1995-11#1)(1995-12#1)(2008-12#1)(2008-5#1)(2009-6#1)(2012-3#1)
kidneys with##5##2##(1996-6#2)(2008-10#1)(2008-4#2)
kidneys##100##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-12#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#6)(1994-6#1)(1995-11#2)(1995-12#2)(1995-3#2)(1996-3#2)(1996-6#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#6)(2007-8#1)(2008-1#8)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#10)(2008-5#6)(2008-7#2)(2009-6#2)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
kids##5##1##(1994-3#1)(1996-1#1)(1996-12#1)(2008-4#1)(2008-9#1)
kikuchii was##2##2##(2008-10#2)
kikuchii##5##1##(2008-10#5)
kill over##2##2##(2008-10#1)(2008-7#1)
kill the##7##2##(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-6#1)(2011-2#1)
kill tumour cells##2##3##(2008-11#1)(2008-7#1)
kill##50##1##(1992-6#1)(1994-2#1)(1994-6#1)(1995-2#3)(1996-3#1)(1996-9#1)(1997-5#3)(2006-10#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
killed after##2##2##(2008-10#1)(2008-11#1)
killed all##2##2##(1994-2#1)(1996-12#1)
killed and##3##2##(1995-3#1)(1997-3#1)(2009-12#1)
killed at##5##2##(1992-6#1)(2006-9#1)(2008-7#1)(2008-8#1)(2008-9#1)
killed by tobacco##2##3##(1992-6#2)
killed by##9##2##(1992-6#2)(2008-10#3)(2008-5#2)(2012-2#1)(2012-3#1)
killed cells##2##2##(1990-12#1)(2013-1#1)
killed for##2##2##(1991-12#1)(2011-1#1)
killed in##2##2##(1992-3#1)(1992-9#1)
killed root##2##2##(2008-10#2)
killed##57##1##(1990-12#2)(1990-3#2)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-12#3)(1997-3#1)(2006-9#1)(2007-10#2)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
killer (LAK) cells##5##3##(1992-2#1)(2008-11#1)(2008-4#3)
killer (NK) cells##8##3##(1992-2#1)(1995-2#1)(2006-10#1)(2008-4#2)(2010-1#1)(2012-3#1)(2013-1#1)
killer (NK)##15##2##(1992-2#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-4#4)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#3)
killer T cells##2##3##(2010-5#2)
killer cell activity##7##3##(1991-8#1)(1993-3#1)(1994-5#1)(2007-11#1)(2008-10#3)
killer cell##21##2##(1991-8#1)(1993-3#1)(1994-5#1)(1995-3#2)(2006-10#1)(2007-11#1)(2008-10#6)(2008-4#2)(2008-7#3)(2008-9#1)(2012-2#1)(2012-3#1)
killer cells##24##2##(1990-12#3)(1991-8#1)(1993-3#2)(1993-6#2)(1995-2#1)(1995-3#1)(1996-12#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#3)
killer in##2##2##(2009-5#1)(2012-12#1)
killer toxins##4##2##(1993-12#3)(2008-10#1)
killer whale (Orcinus orca)##2##4##(2012-3#2)
killer whale##3##2##(2012-3#3)
killer##98##1##(1990-12#3)(1991-8#2)(1992-2#3)(1993-12#5)(1993-3#3)(1993-6#2)(1994-10#1)(1994-2#5)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#4)(1996-12#2)(2006-10#4)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#11)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-5#1)(2010-1#1)(2010-5#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#2)
killer?##2##1##(2007-9#1)(2012-3#1)
killifish Rivulus##2##2##(2008-5#1)(2008-8#1)
killifish##4##1##(2008-1#1)(2008-5#1)(2008-8#1)(2012-3#1)
killing activity##2##2##(2008-11#1)(2012-12#1)
killing and##3##2##(2008-7#2)(2008-9#1)
killing by H2O2##2##3##(1991-9#1)(1995-8#1)
killing by##8##2##(1991-9#2)(1992-11#1)(1994-5#1)(1995-8#1)(1997-4#1)(2008-8#1)(2012-2#1)
killing effect of##2##3##(2008-5#1)(2008-9#1)
killing of tumor##2##3##(1992-9#1)(2008-4#1)
killing of##7##2##(1991-9#1)(1992-9#1)(1993-8#3)(2008-4#1)(2008-8#1)
killing requires##2##2##(1991-5#1)(1995-5#1)
killing spectra##2##2##(1993-12#2)
killing the##3##2##(1994-3#1)(1996-12#1)(2009-5#1)
killing to##2##2##(2008-4#1)(2008-8#1)
killing which##2##2##(1996-12#1)(2012-1#1)
killing##73##1##(1990-7#1)(1991-5#2)(1991-8#1)(1991-9#5)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-8#4)(1994-1#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#4)(1996-12#3)(1997-4#2)(2007-4#1)(2008-10#4)(2008-11#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-5#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
kills##12##1##(1991-12#1)(1992-8#4)(1994-11#1)(1996-9#2)(1997-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
kilobase pairs##2##2##(1990-8#1)(1992-11#1)
kilobase##6##1##(1990-8#1)(1992-11#1)(1997-9#1)(2008-12#1)(2008-8#1)(2010-11#1)
kilobases (kb)##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
kilobases##12##1##(1990-11#1)(1991-12#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-9#2)(2008-10#2)(2011-2#1)
kilobases)##4##1##(1990-11#2)(1995-11#1)(2008-4#1)
kilodalton##2##1##(1993-3#1)(1994-11#1)
kilogram of body weight##2##4##(2011-3#2)
kilogram of##5##2##(2008-10#2)(2008-12#1)(2011-3#2)
kilogram##8##1##(1996-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2010-8#1)(2011-3#2)
kilohertz repetition rates##2##3##(2008-3#2)
kilohertz repetition##5##2##(2007-12#2)(2008-3#3)
kilohertz repetition-rate##3##2##(2007-11#1)(2007-12#2)
kilohertz##14##1##(2007-11#1)(2007-12#7)(2008-3#6)
kilometers driven##2##2##(1992-6#2)
kilometers##14##1##(1991-8#2)(1992-6#2)(1992-7#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)
kin discrimination##2##2##(2008-8#1)(2009-5#1)
kin groups##2##2##(2010-8#2)
kin recognition##5##2##(2008-8#4)(2013-1#1)
kin selection and##2##3##(2008-8#1)(2010-4#1)
kin selection##5##2##(2008-8#3)(2010-4#2)
kin##22##1##(1993-6#1)(1997-5#1)(2008-10#2)(2008-5#1)(2008-8#9)(2009-10#2)(2009-5#1)(2010-4#2)(2010-8#2)(2013-1#1)
kin-discrimination mechanisms##2##2##(2008-8#2)
kinaesthetic##2##1##(2013-8#2)
kinase (ERK)##4##2##(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
kinase (JNK) and p38##2##4##(2010-12#1)(2013-7#1)
kinase (JNK)##4##2##(2008-4#1)(2010-12#1)(2011-2#1)(2013-7#1)
kinase (PK)##6##2##(1993-2#2)(1993-9#1)(1997-6#1)(2008-7#1)(2013-1#1)
kinase (TK)##2##2##(1996-5#1)(1997-7#1)
kinase (protein kinase##4##3##(1993-8#2)(1994-9#1)(2009-2#1)
kinase 1##3##2##(2008-4#1)(2011-2#2)
kinase 2 (Cdk2)##2##3##(2012-3#1)(2013-1#1)
kinase 2##4##2##(2012-3#2)(2013-1#2)
kinase A pathway##2##3##(1995-12#1)(1997-1#1)
kinase A##41##2##(1990-12#2)(1991-2#4)(1992-12#3)(1993-8#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
kinase B (Akt)##2##3##(2008-10#1)(2012-3#1)
kinase B##5##2##(2008-10#1)(2008-3#2)(2010-12#1)(2012-3#1)
kinase C (PKC) is##3##4##(1992-9#1)(1995-11#1)(1995-2#1)
kinase C (PKC)##51##3##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-8#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#2)
kinase C activation##15##3##(1990-12#1)(1992-6#3)(1992-8#1)(1993-3#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-3#1)(2013-1#2)
kinase C activity##15##3##(1990-2#2)(1990-5#1)(1990-8#2)(1992-11#1)(1993-12#3)(1993-8#2)(1994-11#1)(1997-6#1)(2008-11#1)(2008-3#1)
kinase C and##20##3##(1991-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#2)(2008-11#3)(2008-3#1)(2008-4#3)
kinase C appears##2##3##(1992-8#1)(1992-9#1)
kinase C in the##5##4##(1994-11#1)(1996-5#1)(1996-9#1)(1997-1#2)
kinase C in##21##3##(1990-11#2)(1990-2#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-5#2)(1996-9#2)(1997-1#2)(2008-11#3)
kinase C##279##2##(1990-11#9)(1990-12#4)(1990-2#7)(1990-5#12)(1990-7#2)(1990-8#8)(1991-12#2)(1991-2#5)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#5)(1992-12#5)(1992-3#2)(1992-6#7)(1992-8#9)(1992-9#16)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#10)(1993-6#6)(1993-8#10)(1994-11#14)(1994-2#1)(1994-3#4)(1994-5#10)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#4)(1996-12#1)(1996-5#4)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(2008-1#3)(2008-10#1)(2008-11#20)(2008-12#2)(2008-3#5)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
kinase C-beta-like immunoreactivity##2##3##(1991-12#2)
kinase C-mediated##3##2##(1993-12#2)(1993-6#1)
kinase I##8##2##(1993-6#2)(1993-8#1)(1994-11#2)(1994-6#3)
kinase II (CaM kinase II)##2##5##(1990-5#1)(1993-6#1)
kinase II (CaMK##2##3##(1995-8#1)(1996-12#1)
kinase II (CaMKII)##3##3##(2008-8#1)(2009-7#1)(2012-2#1)
kinase II immunoreactivity in##2##4##(1990-5#2)
kinase II in##2##3##(1993-8#1)(1997-2#1)
kinase II of##2##3##(1990-5#1)(2008-8#1)
kinase II with calmodulin##2##4##(1993-6#2)
kinase II##55##2##(1990-11#2)(1990-12#3)(1990-5#6)(1991-2#1)(1993-11#1)(1993-6#12)(1993-8#3)(1994-11#1)(1995-2#4)(1995-8#2)(1996-12#2)(1996-2#3)(1997-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#5)(2008-8#3)(2008-9#1)(2009-7#1)(2012-2#1)
kinase II)##3##2##(1990-5#1)(1993-6#1)(2008-4#1)
kinase V and##2##3##(1994-6#2)
kinase V##5##2##(1994-6#5)
kinase activation and##3##3##(1994-8#1)(1997-1#1)(2009-6#1)
kinase activation##16##2##(1992-8#1)(1994-11#2)(1994-8#1)(1995-6#1)(1995-8#7)(1997-1#1)(2008-8#1)(2009-6#1)(2009-8#1)
kinase activities of##2##3##(1992-6#1)(1993-8#1)
kinase activities##7##2##(1991-2#1)(1992-6#1)(1993-11#1)(1993-8#2)(1994-8#1)(1997-2#1)
kinase activity and##3##3##(1992-3#1)(1994-8#1)(2012-12#1)
kinase activity by##3##3##(1993-8#1)(1997-7#1)(2011-2#1)
kinase activity in a##3##4##(1992-7#1)(1992-8#1)(1993-12#1)
kinase activity in the##3##4##(1992-12#1)(1992-8#1)(2008-3#1)
kinase activity in vitro##2##4##(1991-12#1)(1997-7#1)
kinase activity in##14##3##(1991-12#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-8#1)(1995-12#2)(1996-5#1)(1997-7#1)(2008-3#1)(2008-6#1)
kinase activity is##2##3##(1990-5#1)(2011-1#1)
kinase activity of the##5##4##(1991-11#1)(1991-12#1)(1992-8#2)(1993-8#1)
kinase activity of##7##3##(1991-11#1)(1991-12#1)(1992-8#2)(1993-8#1)(2009-7#1)(2011-2#1)
kinase activity was not affected##2##5##(1997-1#1)(1997-7#1)
kinase activity was##6##3##(1992-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-6#1)
kinase activity##78##2##(1990-12#3)(1990-5#1)(1990-7#2)(1991-11#2)(1991-12#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#3)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#4)(1994-6#1)(1994-8#3)(1995-12#4)(1995-6#2)(1995-8#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#4)(2008-3#2)(2008-4#3)(2008-6#2)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2013-8#1)
kinase and its##2##3##(1990-8#1)(1991-5#1)
kinase and the##2##3##(1993-3#1)(1996-2#1)
kinase and##32##2##(1990-8#2)(1991-5#1)(1992-7#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#4)(2008-10#3)(2008-7#2)(2009-6#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
kinase are##2##2##(1993-6#1)(1995-11#1)
kinase as a##2##3##(1992-9#1)(2010-11#1)
kinase as##4##2##(1991-12#1)(1992-9#2)(2010-11#1)
kinase assay##4##2##(1993-6#1)(2008-4#2)(2010-4#1)
kinase at##2##2##(1991-2#1)(1993-8#1)
kinase by##6##2##(1990-8#1)(1993-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-6#1)
kinase cascade##3##2##(1995-2#1)(1997-1#1)(2009-8#1)
kinase catalytic subunit##2##3##(2010-11#1)(2013-1#1)
kinase catalytic##3##2##(1994-11#1)(2010-11#1)(2013-1#1)
kinase catalyzed phosphorylation##2##3##(1990-11#1)(1994-5#1)
kinase domain auto-dephosphorylation##2##3##(1992-12#2)
kinase domain in complex with imatinib##2##6##(2009-7#2)
kinase domain##20##2##(1991-12#1)(1992-12#4)(1993-3#2)(1995-2#1)(1997-4#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#2)(2012-1#1)(2012-2#1)
kinase encoded by##2##3##(2008-10#1)(2011-2#1)
kinase family of##2##3##(2008-4#1)(2012-2#1)
kinase family##10##2##(1990-7#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-4#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
kinase for##4##2##(1992-6#1)(1992-9#1)(1996-12#1)(2008-8#1)
kinase from##12##2##(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#2)(1993-6#1)(1994-8#1)(1997-4#1)
kinase gene in##2##3##(2007-11#1)(2012-2#1)
kinase gene##9##2##(1992-9#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-8#1)
kinase genes##3##2##(1993-8#1)(2008-7#1)(2012-12#1)
kinase has##2##2##(1990-12#1)(1990-5#1)
kinase in a##2##3##(1993-8#1)(1995-2#1)
kinase in the##5##3##(1992-9#1)(1993-3#1)(1993-8#1)(1995-8#1)(2010-10#1)
kinase in##19##2##(1990-11#1)(1990-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#4)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(2008-4#1)(2010-10#1)(2012-3#1)(2013-1#1)
kinase inhibit##2##2##(1992-9#1)(1996-2#1)
kinase inhibition##3##2##(1994-8#1)(2008-10#1)(2010-4#1)
kinase inhibitor for##2##3##(1991-11#1)(2010-11#1)
kinase inhibitor genistein##3##3##(1993-8#1)(1997-4#1)(2008-3#1)
kinase inhibitor p21##2##3##(2010-6#1)(2012-3#1)
kinase inhibitor##47##2##(1990-11#2)(1990-12#3)(1991-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-11#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)
kinase inhibitor)##2##2##(2008-4#1)(2008-9#1)
kinase inhibitors H7##2##3##(1994-11#1)(1994-9#1)
kinase inhibitors have been##2##4##(2009-7#1)(2010-4#1)
kinase inhibitors##32##2##(1990-8#2)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-9#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2009-7#3)(2010-4#2)(2010-5#3)(2010-8#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#3)(2013-1#1)
kinase is a##3##3##(1992-8#1)(1994-8#1)(1996-2#1)
kinase is##13##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-8#3)(1993-11#1)(1994-8#1)(1995-8#1)(1996-2#1)
kinase may be##4##3##(1993-3#1)(1994-11#1)(1996-2#1)(2008-7#1)
kinase may##5##2##(1992-8#1)(1993-3#1)(1994-11#1)(1996-2#1)(2008-7#1)
kinase or casein kinase II##4##5##(1990-11#1)(2008-4#3)
kinase or##6##2##(1990-11#1)(1995-2#1)(1996-2#1)(2008-4#3)
kinase pathway in##3##3##(1991-12#1)(2008-3#1)(2009-4#1)
kinase pathway##5##2##(1991-12#2)(1996-2#1)(2008-3#1)(2009-4#1)
kinase pathways##4##2##(1995-8#1)(2008-4#1)(2012-12#1)(2013-7#1)
kinase phosphorylation##4##2##(2008-12#2)(2008-4#1)(2008-9#1)
kinase reaction##4##2##(1992-12#1)(1992-6#1)(1993-8#1)(1994-8#1)
kinase receptor##5##2##(1993-3#1)(1994-12#2)(2009-2#1)(2013-1#1)
kinase receptors##5##2##(1995-2#2)(2008-8#1)(2009-8#1)(2012-3#1)
kinase showed##2##2##(1990-10#1)(1995-12#1)
kinase signal##2##2##(1996-2#1)(2008-11#1)
kinase signaling pathways##2##3##(1994-8#1)(2008-7#1)
kinase signaling##6##2##(1994-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
kinase signalling##2##2##(1994-12#1)(1995-8#1)
kinase that##10##2##(1991-2#1)(1992-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#2)
kinase to##2##2##(1994-5#1)(2012-2#1)
kinase was##7##2##(1990-5#1)(1992-7#1)(1992-9#1)(1994-8#1)(2008-6#1)(2011-2#1)(2013-7#1)
kinase were##3##2##(1993-11#1)(1994-3#1)(1997-6#1)
kinase which is##2##3##(1992-8#1)(1994-12#1)
kinase which##4##2##(1990-2#1)(1992-8#2)(1994-12#1)
kinase whose##2##2##(1996-2#1)(2012-12#1)
kinase with##5##2##(1990-8#2)(1991-2#1)(1993-6#1)(1995-6#1)
kinase##1211##1##(1990-10#2)(1990-11#19)(1990-12#18)(1990-2#11)(1990-5#34)(1990-7#7)(1990-8#27)(1991-11#5)(1991-12#14)(1991-2#21)(1991-3#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-9#6)(1992-11#6)(1992-12#24)(1992-2#1)(1992-3#20)(1992-6#17)(1992-7#9)(1992-8#29)(1992-9#31)(1993-11#13)(1993-12#9)(1993-2#4)(1993-3#27)(1993-6#29)(1993-8#53)(1993-9#2)(1994-11#31)(1994-12#12)(1994-2#2)(1994-3#6)(1994-5#14)(1994-6#22)(1994-8#37)(1994-9#7)(1995-11#13)(1995-12#17)(1995-2#44)(1995-3#3)(1995-5#4)(1995-6#19)(1995-8#28)(1996-12#9)(1996-2#27)(1996-5#10)(1996-6#2)(1996-9#2)(1997-1#11)(1997-2#15)(1997-3#5)(1997-4#7)(1997-6#6)(1997-7#14)(1997-8#4)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#23)(2008-11#27)(2008-12#5)(2008-3#12)(2008-4#43)(2008-5#8)(2008-6#6)(2008-7#21)(2008-8#25)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#11)(2009-8#18)(2009-9#2)(2010-10#3)(2010-11#12)(2010-12#9)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#31)(2011-3#1)(2012-1#4)(2012-12#20)(2012-2#9)(2012-3#16)(2013-1#20)(2013-7#6)(2013-8#9)
kinase(s)##5##1##(1992-12#1)(1993-6#1)(1994-5#3)
kinase) family##2##2##(1996-2#2)
kinase)##12##1##(1992-12#1)(1992-3#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-10#1)(2012-3#1)
kinase-##2##1##(1997-6#1)(2008-10#1)
kinase-1##2##1##(1992-6#1)(1992-8#1)
kinase-2##6##1##(1992-6#2)(1993-11#2)(1994-6#1)(2008-10#1)
kinase-dependent##3##1##(1993-3#1)(1995-2#1)(2009-7#1)
kinase-encoding gene##4##2##(1990-5#2)(1991-9#1)(1997-4#1)
kinase-inactive##2##1##(1992-8#1)(1995-11#1)
kinase-mediated phosphoryltransfer##2##2##(2008-7#2)
kinase-mediated##3##1##(1996-12#1)(2008-7#2)
kinase-negative##5##1##(1992-8#1)(1996-2#1)(1997-7#3)
kinases (ERK1/2)##2##2##(2008-4#2)
kinases and they##2##3##(1997-2#1)(2008-4#1)
kinases and##14##2##(1990-8#1)(1994-8#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#3)(2013-1#1)
kinases are##8##2##(1995-11#1)(1995-6#1)(1996-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
kinases as##3##2##(1991-12#2)(2013-1#1)
kinases for##3##2##(2008-4#1)(2012-12#2)
kinases from##2##2##(1995-11#1)(1997-6#1)
kinases in the##4##3##(1994-9#1)(2008-11#1)(2012-12#1)(2012-3#1)
kinases in##11##2##(1992-8#1)(1994-8#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-11#1)(2012-12#3)(2012-3#1)
kinases on##2##2##(1994-8#1)(2013-1#1)
kinases such as##2##3##(1993-8#1)(1994-8#1)
kinases that are##2##3##(1995-2#1)(2010-8#1)
kinases that may regulate##2##4##(1993-3#1)(2012-2#1)
kinases that phosphorylate##2##3##(1993-2#1)(2010-9#1)
kinases that regulate##2##3##(2012-12#1)(2013-1#1)
kinases that##10##2##(1992-3#1)(1993-2#1)(1993-3#1)(1995-2#2)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
kinases to##3##2##(1993-3#1)(1996-2#1)(2009-8#1)
kinases##182##1##(1990-5#2)(1990-8#4)(1991-11#1)(1991-12#2)(1992-12#4)(1992-3#4)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#5)(1994-11#6)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#9)(1994-9#2)(1995-11#5)(1995-2#10)(1995-6#9)(1995-8#1)(1996-2#11)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(2008-11#4)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-5#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#16)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
kind in##6##2##(1996-3#1)(2007-8#2)(2008-3#1)(2008-8#1)(2012-2#1)
kind of activity##2##3##(1990-9#1)(1995-11#1)
kind of an##2##3##(2007-11#1)(2008-3#1)
kind of bond##2##3##(2007-11#2)
kind of effect##2##3##(1993-3#1)(2008-11#1)
kind of interference##2##3##(2008-10#2)
kind of memory##2##3##(2009-10#2)
kind of problems##2##3##(1994-6#1)(2013-7#1)
kind of rare##2##3##(2007-11#1)(2011-1#1)
kind of samples##3##3##(2008-10#3)
kind of structure##2##3##(2008-3#1)(2008-7#1)
kind of treatment##7##3##(1993-3#1)(1995-6#1)(2007-8#2)(2008-12#1)(2008-4#1)(2013-8#1)
kind of##170##2##(1990-10#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#4)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#3)(1995-11#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(2007-10#2)(2007-11#9)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#35)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#6)(2009-10#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-7#2)(2013-8#3)
kind was##3##2##(2008-10#2)(2008-2#1)
kind##207##1##(1990-10#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#4)(1994-1#2)(1994-12#2)(1994-3#1)(1994-6#3)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(2007-10#2)(2007-11#9)(2007-12#6)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#41)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-7#2)(2013-8#3)
kindergarten teachers in##2##3##(2008-12#1)(2012-12#1)
kindergarten##10##1##(1997-3#1)(2008-11#1)(2008-12#4)(2011-2#1)(2012-12#2)(2013-1#1)
kindergartens and##2##2##(2011-2#1)(2013-1#1)
kindergartens taking##2##2##(2013-1#2)
kindergartens##8##1##(1995-8#1)(2011-2#3)(2013-1#4)
kindled animals##2##2##(1996-12#2)
kindled rats##3##2##(1990-5#2)(1992-12#1)
kindled seizures##3##2##(1990-5#1)(1992-12#1)(1994-2#1)
kindled##13##1##(1990-5#4)(1992-12#3)(1994-2#1)(1996-12#5)
kindling epileptogenesis##2##2##(1996-12#1)(2013-8#1)
kindling##12##1##(1990-5#1)(1992-12#2)(1994-2#4)(1996-12#2)(1997-2#1)(2012-12#1)(2013-8#1)
kindling-like state##3##2##(1997-2#3)
kindred##4##1##(1993-6#1)(1994-8#2)(2008-7#1)
kindreds##7##1##(1993-3#1)(1994-8#1)(1995-8#1)(1997-7#3)(2008-7#1)
kinds and concentrations of##2##4##(2008-12#1)(2008-8#1)
kinds and##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
kinds of cell lines##2##4##(1997-4#1)(2008-9#1)
kinds of cells##2##3##(2008-4#1)(2008-9#1)
kinds of commercially available##2##4##(1993-3#1)(2008-10#1)
kinds of common##2##3##(2013-8#2)
kinds of evidence##2##3##(2008-7#1)(2010-4#1)
kinds of milk##3##3##(2008-10#2)(2010-2#1)
kinds of oncogenes##2##3##(2008-11#2)
kinds of##181##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-6#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#45)(2008-11#12)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#6)
kinds##190##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-6#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#45)(2008-11#12)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#6)
kinematic characteristics##2##2##(2009-2#1)(2011-2#1)
kinematic focusing##4##2##(2008-10#4)
kinematic model##2##2##(2007-12#1)(2011-1#1)
kinematic parameters##3##2##(2009-4#2)(2013-1#1)
kinematic plan##2##2##(2008-11#2)
kinematic##27##1##(1993-3#1)(1994-3#1)(1996-2#1)(1996-4#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-7#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
kinematically aligned##2##2##(2008-3#2)
kinematically##3##1##(2008-3#2)(2009-7#1)
kinematics and##3##2##(2007-12#1)(2008-11#1)(2008-6#1)
kinematics as well##2##3##(2008-12#1)(2011-2#1)
kinematics during##2##2##(2008-12#1)(2013-1#1)
kinematics in##2##2##(2007-12#1)(2009-4#1)
kinematics of the##3##3##(2011-2#3)
kinematics of##6##2##(2009-4#1)(2011-2#5)
kinematics were##2##2##(2009-2#1)(2011-2#1)
kinematics##31##1##(1996-4#1)(2007-12#2)(2008-11#2)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#2)(2010-8#2)(2011-2#10)(2013-1#2)
kinesin##7##1##(1995-3#4)(2009-10#1)(2010-11#1)(2012-2#1)
kinesin-1/Kif5B##2##1##(2010-11#2)
kinesins##2##1##(1995-3#1)(2009-10#1)
kinesio##2##1##(2013-1#2)
kinetic analyses##2##2##(1992-8#1)(2011-2#1)
kinetic analysis of##12##3##(1990-2#1)(1991-8#1)(1993-8#2)(1995-6#1)(2008-10#5)(2008-2#1)(2008-5#1)
kinetic analysis##22##2##(1990-2#1)(1991-8#1)(1993-3#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)
kinetic and equilibrium measurements##2##4##(1990-8#1)(2008-10#1)
kinetic and equilibrium methods##2##4##(1990-8#1)(2008-10#1)
kinetic and equilibrium##6##3##(1990-8#2)(2008-10#3)(2010-5#1)
kinetic and thermodynamic##5##3##(1990-9#1)(1991-6#1)(1992-3#1)(2008-10#2)
kinetic and##26##2##(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)
kinetic approach##2##2##(2008-10#1)(2008-5#1)
kinetic behavior##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-7#1)
kinetic characteristics##2##2##(1995-11#1)(2008-10#1)
kinetic constants for the##2##4##(1993-8#1)(1995-5#1)
kinetic constants for##4##3##(1993-8#1)(1994-8#1)(1995-5#1)(2008-10#1)
kinetic constants of##3##3##(1996-2#1)(2008-10#1)(2008-4#1)
kinetic constants##13##2##(1991-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2011-1#1)
kinetic curve of##2##3##(2008-10#2)
kinetic data##18##2##(1990-8#1)(1995-5#1)(1997-2#1)(2008-10#8)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#2)(2010-5#1)(2013-1#1)
kinetic determination of##11##3##(2008-10#11)
kinetic effect of##2##3##(2008-10#1)(2008-8#1)
kinetic effect##5##2##(1992-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
kinetic effects##5##2##(1992-6#1)(1995-12#1)(2007-12#1)(2008-11#1)(2009-12#1)
kinetic energy##8##2##(2008-10#7)(2008-11#1)
kinetic equations and##2##3##(2008-10#2)
kinetic experiments##3##2##(1991-5#1)(1996-5#1)(2008-4#1)
kinetic fluorimetric method##2##3##(2008-10#2)
kinetic information##3##2##(2008-10#2)(2008-4#1)
kinetic isotope effect measurements##2##4##(1992-3#2)
kinetic isotope effect##8##3##(1991-3#1)(1992-3#3)(1993-8#1)(1995-6#1)(1996-5#1)(2009-6#1)
kinetic isotope effects on##4##4##(1992-3#4)
kinetic isotope effects##11##3##(1991-9#2)(1992-3#7)(1995-2#1)(2009-9#1)
kinetic isotope##19##2##(1991-3#1)(1991-9#2)(1992-3#10)(1993-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2009-6#1)(2009-9#1)
kinetic measurements##5##2##(1993-11#1)(1994-3#1)(2008-10#3)
kinetic mechanism for the##2##4##(1995-6#1)(2008-10#1)
kinetic mechanism of##2##3##(1990-11#1)(1991-9#1)
kinetic mechanism##8##2##(1990-11#1)(1991-9#1)(1992-3#1)(1995-2#1)(1995-6#2)(2008-10#1)(2008-3#1)
kinetic method for the determination of##2##6##(2008-10#2)
kinetic method for the##3##4##(2008-10#3)
kinetic method for##4##3##(2008-10#4)
kinetic method is##2##3##(2008-10#2)
kinetic method was##2##3##(2008-10#2)
kinetic method##15##2##(2008-10#15)
kinetic methods##3##2##(2008-10#3)
kinetic model and##2##3##(2010-5#1)(2013-8#1)
kinetic model for##4##3##(1994-5#1)(1996-2#1)(2012-12#1)(2013-1#1)
kinetic model that##2##3##(1997-2#1)(2008-11#1)
kinetic model##13##2##(1994-5#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-7#1)(2009-11#3)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
kinetic models##9##2##(1991-5#2)(1991-8#1)(2008-1#1)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#1)
kinetic of##6##2##(2008-10#5)(2008-12#1)
kinetic parameter##2##2##(1992-3#1)(2013-8#1)
kinetic parameters are##2##3##(1991-9#1)(2008-6#1)
kinetic parameters for the##5##4##(1990-9#1)(1994-5#1)(1995-2#1)(2008-7#1)(2011-2#1)
kinetic parameters for##9##3##(1990-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
kinetic parameters in the##2##4##(1994-8#1)(2008-10#1)
kinetic parameters in##4##3##(1994-8#1)(1995-12#2)(2008-10#1)
kinetic parameters involved in##2##4##(1995-12#1)(2008-10#1)
kinetic parameters of the##3##4##(1995-5#2)(2009-11#1)
kinetic parameters of##8##3##(1990-3#1)(1990-5#1)(1995-5#2)(2008-10#1)(2008-4#1)(2009-11#1)(2011-2#1)
kinetic parameters##51##2##(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-12#4)(1995-2#2)(1995-5#3)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#3)(2011-3#1)(2013-1#1)
kinetic processes##2##2##(2008-10#1)(2008-4#1)
kinetic profiles##3##2##(2008-10#3)
kinetic properties of##7##3##(1993-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-5#1)
kinetic properties##11##2##(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#2)(2008-1#1)(2008-4#1)(2008-5#1)
kinetic rate##4##2##(1997-2#1)(2008-4#1)(2012-2#2)
kinetic rates##3##2##(2008-6#1)(2010-10#2)
kinetic reaction##2##2##(2008-10#2)
kinetic resistance##2##2##(2008-11#2)
kinetic resolution##2##2##(1992-11#1)(2011-1#1)
kinetic results##7##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-11#1)(1995-6#1)(2007-11#1)(2009-12#1)
kinetic spectrophotometric determination of##6##4##(2008-10#6)
kinetic spectrophotometric method for##2##4##(2008-10#2)
kinetic spectrophotometric method##5##3##(2008-10#5)
kinetic spectrophotometric##13##2##(2008-10#13)
kinetic studies of##7##3##(1990-11#1)(1990-7#1)(1991-5#1)(1993-8#1)(1994-5#1)(2008-11#2)
kinetic studies show that##2##4##(1995-6#1)(2008-10#1)
kinetic studies##17##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#3)
kinetic study of the reduction##2##5##(2008-10#1)(2008-8#1)
kinetic study of##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
kinetic study using##2##3##(2008-10#2)
kinetic study##9##2##(2008-10#5)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
kinetic surface##2##2##(2008-10#2)
kinetic theory##3##2##(1990-5#2)(2008-3#1)
kinetic##427##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-3#3)(1991-5#8)(1991-6#2)(1991-8#3)(1991-9#6)(1992-11#2)(1992-12#1)(1992-3#17)(1992-6#3)(1992-8#6)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#11)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#3)(1995-11#2)(1995-12#6)(1995-2#8)(1995-3#2)(1995-5#5)(1995-6#9)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#3)(1996-7#2)(1997-2#9)(1997-4#2)(1997-6#1)(1997-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#155)(2008-11#13)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#12)(2008-5#5)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#4)(2009-12#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
kinetic-catalytic##2##1##(2008-10#2)
kinetic-fluorimetric methods##2##2##(2008-10#2)
kinetic-fluorimetric##3##1##(2008-10#3)
kinetic-spectrophotometric determination of levodopa##2##4##(2008-10#2)
kinetic-spectrophotometric determination of##5##3##(2008-10#5)
kinetic-spectrophotometric method is##2##3##(2008-10#2)
kinetic-spectrophotometric method##3##2##(2008-10#3)
kinetic-spectrophotometric##10##1##(2008-10#10)
kinetically as##2##2##(1992-3#1)(1995-5#1)
kinetically controlled##2##2##(1992-11#1)(2008-7#1)
kinetically derived binding constants##2##4##(1990-8#2)
kinetically derived##5##2##(1990-8#5)
kinetically##34##1##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#5)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-7#3)(2009-10#1)(2010-4#1)(2011-1#1)
kinetically-hindered surface##2##2##(2008-10#2)
kinetically-hindered##3##1##(2008-10#3)
kinetics and mass transfer##2##4##(2008-10#1)(2010-4#1)
kinetics and the##6##3##(1990-11#1)(1991-5#1)(2006-10#1)(2008-10#3)
kinetics and thermodynamics of biomachining pure copper##2##7##(2008-8#2)
kinetics and thermodynamics of##4##4##(1993-3#1)(2008-10#1)(2008-8#2)
kinetics and##40##2##(1990-11#1)(1990-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
kinetics are##5##2##(1990-7#1)(1992-3#1)(1993-11#1)(1995-5#1)(2008-10#1)
kinetics associated with##2##3##(1994-11#2)
kinetics at##2##2##(2008-10#1)(2013-8#1)
kinetics based##2##2##(2008-1#1)(2008-9#1)
kinetics between##2##2##(2007-11#1)(2009-10#1)
kinetics by##4##2##(1997-2#1)(2008-11#1)(2009-11#1)(2011-2#1)
kinetics can be##2##3##(2008-10#1)(2008-8#1)
kinetics can##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
kinetics during##2##2##(1995-2#1)(2008-7#1)
kinetics for the##2##3##(2008-10#1)(2008-6#1)
kinetics for##5##2##(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
kinetics in both##2##3##(2008-10#1)(2012-2#1)
kinetics in the##7##3##(1990-2#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-6#1)(2013-8#1)
kinetics in##22##2##(1990-2#1)(1990-5#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2012-1#1)(2012-2#1)(2013-8#2)
kinetics indicate##3##2##(1990-11#1)(1992-4#1)(1992-6#1)
kinetics is##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
kinetics of double-stranded DNA probes for rapid molecular analysis##2##9##(2010-5#2)
kinetics of double-stranded DNA probes##3##5##(2010-5#3)
kinetics of impurity removal##2##4##(2008-7#2)
kinetics of induction##2##3##(1995-2#1)(2008-10#1)
kinetics of recovery##3##3##(1994-8#1)(2008-8#2)
kinetics of the antibody response##2##5##(2008-10#2)
kinetics of the reaction##4##4##(2008-10#4)
kinetics of the two##2##4##(2008-10#1)(2010-4#1)
kinetics of the##48##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-6#2)(1992-9#1)(1995-2#1)(1995-9#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2010-4#1)(2010-5#3)(2010-6#1)(2011-2#2)(2011-3#1)
kinetics of this reaction##2##4##(2008-10#2)
kinetics of this##3##3##(2008-10#3)
kinetics of##170##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#5)(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#4)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-5#3)(1995-8#2)(1995-9#1)(1996-2#1)(1997-2#2)(1997-4#2)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#45)(2008-11#11)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#10)(2008-9#5)(2009-11#1)(2009-12#2)(2009-5#1)(2010-4#1)(2010-5#8)(2010-6#1)(2011-2#6)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#3)
kinetics or##2##2##(2009-12#1)(2011-1#1)
kinetics revealed##2##2##(1990-5#1)(2013-8#1)
kinetics studies performed##2##3##(2008-10#2)
kinetics study##2##2##(2008-10#1)(2013-1#1)
kinetics through##2##2##(1997-4#1)(2008-11#1)
kinetics to wild-type##2##3##(2013-1#2)
kinetics to##6##2##(1990-5#1)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#2)
kinetics using##3##2##(1992-4#1)(1996-2#1)(2008-6#1)
kinetics was##5##2##(1995-11#1)(2008-10#3)(2008-7#1)
kinetics were##9##2##(1994-6#1)(1995-12#1)(2008-10#4)(2008-11#2)(2010-5#1)
kinetics with a##2##3##(1994-5#1)(2008-10#1)
kinetics with respect to##2##4##(1991-8#1)(2008-10#1)
kinetics with##6##2##(1991-5#2)(1991-8#1)(1994-5#1)(2008-10#2)
kinetics##402##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#7)(1990-7#1)(1990-8#7)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#6)(1993-3#3)(1993-6#4)(1993-8#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#4)(1995-11#4)(1995-12#6)(1995-2#8)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#5)(1996-5#2)(1997-2#4)(1997-4#3)(1997-6#2)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#4)(2008-10#99)(2008-11#29)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#7)(2008-7#15)(2008-8#16)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#1)(2009-5#1)(2010-4#2)(2010-5#15)(2010-6#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-2#9)(2012-3#1)(2013-1#7)(2013-8#9)
kinetin at 0##2##3##(2008-10#2)
kinetin##3##1##(2008-10#2)(2013-1#1)
kinetochores##3##1##(1994-8#3)
kinetoplast##2##1##(2010-2#1)(2012-2#1)
king##5##1##(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-2#1)
kingdom##16##1##(1996-12#1)(1997-3#1)(2007-12#2)(2008-1#3)(2008-10#2)(2009-12#1)(2009-8#4)(2011-2#1)(2013-8#1)
kingdoms##7##1##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#2)(2011-1#1)
kingfishers (Megaceryle torquata torquata)##2##4##(2007-6#2)
kink of##2##2##(2008-7#1)(2008-9#1)
kink##7##1##(1993-5#1)(1994-5#2)(1996-4#1)(2008-7#1)(2008-9#2)
kinking of the##2##3##(2008-9#1)(2011-2#1)
kinking##4##1##(2008-9#1)(2011-2#2)(2013-1#1)
kinoform lenses##3##2##(2008-2#3)
kinoform reconstruction##3##2##(2008-3#3)
kinoform##16##1##(2008-2#13)(2008-3#3)
kinoforms##7##1##(2008-2#6)(2008-3#1)
kinship analysis##2##2##(1995-6#2)
kinship##18##1##(1995-6#2)(1997-6#1)(2008-12#4)(2008-5#2)(2010-8#2)(2011-2#4)(2012-12#2)(2013-8#1)
kiss##2##1##(2008-9#1)(2010-5#1)
kissing##3##1##(2008-11#1)(2011-2#2)
kissing&quot##2##1##(1994-8#2)
kisspeptins##2##1##(2009-6#2)
kit and##3##2##(2008-12#1)(2012-2#1)(2013-8#1)
kit for##4##2##(1996-5#1)(2007-7#1)(2008-10#1)(2010-8#1)
kit methods##2##2##(1993-12#2)
kit##59##1##(1990-7#1)(1993-12#2)(1994-2#2)(1995-2#1)(1996-2#1)(1996-5#7)(1997-4#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#8)(2008-5#5)(2008-7#1)(2008-8#2)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#3)
kitchen##10##1##(1995-1#1)(1995-12#1)(1996-3#2)(2007-10#1)(2007-12#1)(2008-12#1)(2011-2#1)(2013-1#2)
kits and##2##2##(1997-7#1)(2008-10#1)
kits are##2##2##(2008-10#1)(2008-5#1)
kits available in##2##3##(2007-7#2)
kits can##2##2##(2008-10#1)(2010-11#1)
kits for##3##2##(2008-2#1)(2008-4#2)
kits were##2##2##(1994-1#1)(2008-5#1)
kits which##2##2##(2011-2#1)(2012-2#1)
kits##32##1##(1991-3#1)(1994-1#1)(1994-2#1)(1995-11#1)(1996-5#2)(1997-7#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2009-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)
kiwifruit##4##1##(2008-10#4)
klaroid##4##1##(2008-9#4)
klarsicht##2##1##(2008-9#2)
km altitude##3##2##(2008-3#1)(2012-2#2)
km and##3##2##(2008-3#3)
km are##2##2##(2008-2#2)
km at##2##2##(2008-10#1)(2008-2#1)
km but do discriminate against foreign songs##2##7##(2008-8#2)
km for##2##2##(2007-12#1)(2008-3#1)
km from the##5##3##(1997-5#1)(2007-8#1)(2008-3#2)(2011-1#1)
km from##9##2##(1994-9#1)(1996-11#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2011-1#1)
km in diameter (&gt##2##4##(1997-5#2)
km in diameter##6##3##(1997-5#6)
km in the##3##3##(2008-2#1)(2008-3#2)
km in##13##2##(1997-5#6)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
km north##2##2##(2008-3#1)(2010-8#1)
km of the##2##3##(2008-3#1)(2010-8#1)
km of##7##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-8#2)
km or##2##2##(1996-4#1)(2008-2#1)
km the##2##2##(2008-3#1)(2012-2#1)
km to##3##2##(2008-3#3)
km were##2##2##(2008-3#2)
km with##3##2##(2008-2#2)(2008-3#1)
km##114##1##(1990-11#1)(1992-6#1)(1994-9#1)(1996-11#1)(1996-4#2)(1997-4#1)(1997-5#9)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#15)(2008-3#41)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#1)(2012-2#4)(2013-1#1)
km(-1)##2##1##(2008-3#2)
km(2) and is##2##3##(2007-5#2)
km(2)##5##1##(2007-5#3)(2008-10#2)
km)##12##1##(1997-5#1)(2007-12#1)(2008-10#3)(2008-3#5)(2010-6#1)(2013-1#1)
km/s##2##1##(2008-2#1)(2008-3#1)
km2##3##1##(2008-8#1)(2011-2#2)
knee OA##4##2##(1992-3#2)(2013-1#2)
knee and ankle##3##3##(2009-4#1)(2011-2#1)(2012-2#1)
knee and hip##4##3##(2007-8#3)(2013-1#1)
knee and##14##2##(1995-3#1)(1996-9#1)(2007-8#4)(2009-11#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
knee arthroplasty (TKA)##12##3##(1994-3#1)(2007-8#1)(2008-8#2)(2009-3#2)(2011-2#2)(2013-1#4)
knee arthroplasty on##2##3##(2008-8#1)(2011-2#1)
knee arthroplasty##56##2##(1994-3#2)(1997-2#1)(2007-11#2)(2007-8#3)(2008-8#13)(2009-3#4)(2011-1#1)(2011-2#14)(2012-12#3)(2012-2#1)(2013-1#12)
knee during##2##2##(2007-11#1)(2013-1#1)
knee evaluation scoring systems##2##4##(2013-1#2)
knee evaluation##6##2##(2013-1#6)
knee extension AROM##3##3##(2008-12#3)
knee extension##8##2##(2007-11#2)(2008-12#5)(2011-2#1)
knee flexion angle##2##3##(2013-1#2)
knee flexion##7##2##(2009-3#2)(2011-2#2)(2013-1#3)
knee function##2##2##(2007-11#1)(2013-1#1)
knee injury##6##2##(2007-11#1)(2007-8#1)(2012-12#3)(2012-2#1)
knee joint arthroscopy##4##3##(2007-11#4)
knee joint in the course of##2##6##(2007-11#1)(2013-1#1)
knee joint replacement##2##3##(2007-8#1)(2008-7#1)
knee joint##40##2##(1992-6#2)(1994-8#1)(1997-8#1)(2007-11#10)(2007-8#12)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#3)(2009-4#2)(2009-7#1)(2011-2#1)(2013-1#3)
knee joints##8##2##(1991-6#1)(1994-8#1)(2007-11#2)(2011-2#3)(2012-12#1)
knee ligaments##3##2##(2009-7#1)(2012-12#1)(2013-1#1)
knee of##2##2##(2009-3#2)
knee or hip##4##3##(2006-10#1)(2007-10#1)(2007-8#1)(2013-1#1)
knee osteoarthritis##7##2##(1992-3#1)(2006-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
knee pain and##2##3##(2006-10#1)(2012-3#1)
knee pain##11##2##(2006-10#2)(2007-8#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
knee prostheses##4##2##(2007-8#2)(2012-2#1)(2013-1#1)
knee range of##3##3##(1995-3#1)(1996-3#1)(2013-1#1)
knee rating##2##2##(2007-8#1)(2011-2#1)
knee replacement##20##2##(1990-6#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-3#1)(2007-10#1)(2007-8#4)(2008-7#1)(2008-8#2)(2009-3#1)(2011-2#2)(2012-12#2)(2013-1#2)
knee score##2##2##(2009-3#2)
knee surgery in Poland##2##4##(2007-8#2)
knee surgery##6##2##(2007-8#6)
knee was##9##2##(1997-8#6)(2007-8#1)(2008-8#1)(2013-1#1)
knee with##2##2##(2006-10#1)(2008-12#1)
knee##357##1##(1990-11#1)(1990-6#2)(1991-6#2)(1992-3#3)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-3#5)(1996-9#1)(1997-2#1)(1997-8#11)(2006-10#7)(2007-10#2)(2007-11#29)(2007-12#1)(2007-8#55)(2008-11#2)(2008-12#12)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#26)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#15)(2009-4#5)(2009-7#2)(2010-12#5)(2010-3#4)(2011-1#1)(2011-2#38)(2012-12#11)(2012-2#17)(2012-3#2)(2013-1#69)(2013-7#1)
knees and ankles##2##3##(2006-10#1)(2009-4#1)
knees and##5##2##(2006-10#1)(2008-8#2)(2009-3#1)(2009-4#1)
knees in##4##2##(2013-1#4)
knees were##3##2##(2009-3#2)(2011-2#1)
knees with##2##2##(2013-1#2)
knees##29##1##(1992-3#1)(1996-9#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#4)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#13)
knew about##2##2##(1990-2#1)(2013-1#1)
knew that##2##2##(1996-6#1)(2009-10#1)
knew the##3##2##(2008-11#1)(2011-1#1)(2013-8#1)
knew##15##1##(1990-2#1)(1990-6#1)(1993-2#1)(1995-3#1)(1996-6#2)(2007-9#1)(2008-11#2)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
knife##14##1##(1991-3#1)(1993-3#1)(1994-12#3)(1996-3#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-7#2)(2009-7#1)(2011-2#1)(2013-1#1)
knife-edge technique##3##2##(2008-3#3)
knife-edge##8##1##(2007-12#1)(2008-3#7)
knitted Dacron##2##2##(2008-7#1)(2010-8#1)
knitted##5##1##(2008-10#1)(2008-7#1)(2010-8#1)(2012-1#2)
knitting##3##1##(2008-11#1)(2010-12#1)(2012-1#1)
knives##3##1##(1991-3#1)(2008-10#2)
knobs##3##1##(1991-5#1)(2008-10#1)(2009-10#1)
knock down##2##2##(2010-12#1)(2011-1#1)
knock out mice##2##3##(1995-12#1)(2008-9#1)
knock out##3##2##(1995-12#1)(2008-2#1)(2008-9#1)
knock##7##1##(1995-12#1)(2007-5#2)(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)
knock-down of##2##2##(2008-9#1)(2012-2#1)
knock-down##8##1##(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
knock-in##2##1##(1996-2#1)(2013-8#1)
knock-out##5##1##(1993-9#1)(1995-12#2)(1995-8#1)(2008-4#1)
knockdown of##6##2##(2010-11#1)(2011-1#1)(2012-12#3)(2013-1#1)
knockdown##15##1##(2008-8#1)(2009-10#4)(2009-11#1)(2010-11#1)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
knockdowns##2##1##(2008-4#1)(2012-2#1)
knocked out##2##2##(1996-5#1)(2011-1#1)
knocked##3##1##(1996-5#1)(2011-1#1)(2012-12#1)
knockin' on heaven's door##2##4##(2007-5#2)
knocking down##2##2##(2008-9#1)(2013-8#1)
knocking##6##1##(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2013-8#1)
knockout mice show##3##3##(2008-12#1)(2008-4#2)
knockout mice##26##2##(1994-12#1)(1994-6#1)(1995-2#1)(1996-6#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2012-12#6)
knockout mouse and##2##3##(2011-1#1)(2012-2#1)
knockout mouse##5##2##(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
knockout plants##2##2##(2008-7#1)(2009-10#1)
knockout##56##1##(1994-12#1)(1994-6#1)(1995-2#2)(1996-6#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#8)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#8)(2012-2#1)(2012-3#1)(2013-8#1)
knockout&quot##2##1##(1995-2#1)(2008-4#1)
knockouts##4##1##(2008-4#2)(2008-7#1)(2008-8#1)
knot tying##4##2##(1995-1#2)(2007-7#1)(2010-3#1)
knot##11##1##(1995-1#4)(2007-7#1)(2008-10#3)(2010-3#1)(2012-2#1)(2012-3#1)
knots in##2##2##(1995-1#1)(2009-5#1)
knots##6##1##(1993-5#1)(1995-1#2)(2008-10#2)(2009-5#1)
knotted and serpentine reactors##2##4##(2008-10#2)
knotted and##4##2##(2008-10#4)
knotted reactor preconcentration systems##2##4##(2008-10#2)
knotted reactor##6##2##(2008-10#6)
knotted##15##1##(1995-6#1)(2008-10#14)
know about the##9##3##(1992-3#1)(1995-1#2)(1995-5#1)(1996-2#1)(2007-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
know about##24##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-1#1)(1994-2#2)(1995-1#4)(1995-5#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
know and##6##2##(1995-3#1)(2007-7#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)
know enough about##2##3##(1990-6#1)(1991-2#1)
know how to##6##3##(1992-12#1)(1993-1#1)(1994-3#1)(1996-12#1)(2011-1#1)(2013-8#1)
know how##13##2##(1991-3#1)(1992-12#1)(1993-1#1)(1994-3#1)(1996-12#1)(2008-2#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
know if the##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
know if##8##2##(1991-3#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
know it##3##2##(1994-3#1)(2013-7#1)(2013-8#1)
know little about##4##3##(1997-2#1)(2008-10#2)(2009-9#1)
know more##4##2##(1991-12#1)(1996-3#1)(2008-5#1)(2010-8#1)
know of##2##2##(1996-11#1)(2008-9#1)
know that the##4##3##(1991-12#1)(1994-1#1)(1997-1#1)(2011-2#1)
know that they##2##3##(1993-3#1)(1995-9#1)
know that##15##2##(1991-12#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-9#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-1#1)(2011-2#1)
know the##45##2##(1991-9#1)(1994-2#1)(1995-5#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#3)
know their##3##2##(1992-12#1)(1996-11#1)(2013-1#1)
know this##2##2##(2008-2#1)(2012-12#1)
know to##3##2##(1991-12#1)(2009-5#1)(2009-6#1)
know what a healthy human looks##2##6##(1991-2#2)
know what##11##2##(1991-2#2)(1994-12#1)(1996-11#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2012-1#1)(2013-8#1)
know when to##2##3##(1996-11#1)(2008-7#1)
know where we are##2##4##(2013-1#2)
know where##3##2##(1996-12#1)(2013-1#2)
know whether they##2##3##(1995-1#1)(2012-3#1)
know whether##11##2##(1993-12#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
know##218##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-9#1)(1992-12#2)(1992-3#4)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#2)(1995-1#5)(1995-3#2)(1995-5#2)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#4)(2007-9#2)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#7)(2009-11#2)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#6)
know-how##3##1##(2008-11#2)(2009-10#1)
know?##3##1##(2007-12#1)(2008-1#1)(2008-11#1)
knowing in practice##3##3##(2008-12#3)
knowing in##4##2##(2008-11#1)(2008-12#3)
knowing that the##2##3##(1996-12#1)(2008-11#1)
knowing the##9##2##(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
knowing##23##1##(1993-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
knowledge about HIV transmission and prevention and##2##7##(2011-2#1)(2012-12#1)
knowledge about HIV##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
knowledge about diabetes and its medication##2##6##(2011-1#2)
knowledge about diabetes##4##3##(1993-12#1)(2008-7#1)(2011-1#2)
knowledge about its##3##3##(1996-5#1)(2011-2#1)(2013-7#1)
knowledge about medical##2##3##(1997-3#1)(2012-3#1)
knowledge about patients' rights##4##4##(2013-8#4)
knowledge about the biology##2##4##(2009-8#1)(2011-2#1)
knowledge about the effects of##3##5##(2008-11#1)(2009-10#1)(2012-2#1)
knowledge about the factors##2##4##(1996-11#1)(2008-9#1)
knowledge about the physical##2##4##(2007-12#1)(2008-2#1)
knowledge about the##40##3##(1991-6#2)(1993-11#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-2#2)
knowledge about their##3##3##(2007-11#1)(2010-1#1)(2011-1#1)
knowledge about this##3##3##(2007-7#1)(2008-11#1)(2011-3#1)
knowledge about##109##2##(1991-3#1)(1991-6#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-3#3)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
knowledge acquisition and##2##3##(2008-12#1)(2008-9#1)
knowledge acquisition##4##2##(2008-11#2)(2008-12#1)(2008-9#1)
knowledge among##4##2##(1993-2#1)(1997-5#1)(2009-12#1)(2012-12#1)
knowledge amongst##3##2##(2008-11#1)(2008-7#1)(2009-4#1)
knowledge and attitudes toward testicular cancer##2##6##(2009-5#2)
knowledge and attitudes##8##3##(1991-2#1)(1996-8#1)(2009-5#2)(2010-3#2)(2011-2#1)(2013-1#1)
knowledge and behaviors##2##3##(2008-12#1)(2009-6#1)
knowledge and cultural beliefs about the etiology and management of orofacial clefts##2##12##(2009-10#2)
knowledge and experience##4##3##(2008-1#1)(2008-11#3)
knowledge and expertise##3##3##(1991-12#1)(2010-4#1)(2012-2#1)
knowledge and its##2##3##(1991-9#1)(2008-11#1)
knowledge and perception of##2##4##(1996-7#1)(2012-12#1)
knowledge and practices##4##3##(2010-1#1)(2010-9#1)(2012-12#1)(2012-2#1)
knowledge and recent##2##3##(2011-1#1)(2012-3#1)
knowledge and skill##2##3##(1993-2#1)(1995-12#1)
knowledge and skills in##4##4##(2008-11#1)(2008-7#1)(2009-6#1)(2012-12#1)
knowledge and skills##8##3##(1991-1#1)(1995-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#2)
knowledge and the##2##3##(2007-11#1)(2009-10#1)
knowledge and to##3##3##(2009-4#1)(2011-2#1)(2012-3#1)
knowledge and training##2##3##(1991-3#1)(2007-12#1)
knowledge and understanding of the##4##5##(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)
knowledge and understanding of##8##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)(2012-3#1)
knowledge and understanding##10##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
knowledge and##127##2##(1990-2#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-6#2)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#12)(2008-12#6)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#5)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#5)
knowledge are##4##2##(1996-2#1)(2008-10#1)(2008-12#1)(2009-5#1)
knowledge areas##2##2##(1992-3#1)(1996-1#1)
knowledge as well as##2##4##(1994-12#1)(2009-6#1)
knowledge as##4##2##(1992-1#1)(1994-12#1)(2007-8#1)(2009-6#1)
knowledge base and##2##3##(2008-11#1)(2013-1#1)
knowledge base to##2##3##(1992-9#1)(2008-5#1)
knowledge base##10##2##(1992-9#1)(1995-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-1#1)
knowledge can be used to##3##5##(2008-2#1)(2008-5#1)(2009-12#1)
knowledge can be used##4##4##(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
knowledge can##5##2##(1995-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
knowledge concerning the##2##3##(2008-5#1)(2011-3#1)
knowledge concerning##3##2##(2008-5#1)(2011-3#1)(2012-1#1)
knowledge database##3##2##(2008-8#2)(2008-9#1)
knowledge development in##2##3##(2008-11#1)(2010-10#1)
knowledge development##6##2##(2008-11#4)(2010-10#1)(2010-9#1)
knowledge diffusion##2##2##(2010-12#2)
knowledge does##2##2##(1993-8#1)(2008-12#1)
knowledge for the first time##5##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
knowledge for##13##2##(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-8#1)
knowledge from the##3##3##(1994-6#1)(1996-3#1)(2008-11#1)
knowledge from##11##2##(1994-6#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-11#2)(2008-7#3)(2008-8#1)(2010-10#1)
knowledge gained from##2##3##(2009-9#1)(2011-8#1)
knowledge gained##6##2##(2008-11#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-8#1)
knowledge gaps in##2##3##(2009-11#1)(2013-1#1)
knowledge gaps##4##2##(2009-11#1)(2013-1#3)
knowledge has been##5##3##(1994-5#1)(2009-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
knowledge has not##2##3##(2010-6#1)(2012-2#1)
knowledge has##7##2##(1994-5#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
knowledge held##2##2##(2008-7#1)(2011-1#1)
knowledge in a##3##3##(1990-6#1)(2007-11#1)(2007-12#1)
knowledge in the area##2##4##(2007-8#1)(2008-7#1)
knowledge in the##7##3##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
knowledge in this area##3##4##(1995-3#1)(2008-11#1)(2009-7#1)
knowledge in##36##2##(1990-6#1)(1995-3#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
knowledge indicates that##2##3##(1994-1#1)(2008-11#1)
knowledge into##2##2##(1992-5#1)(2008-11#1)
knowledge is a##9##3##(2007-8#1)(2008-2#1)(2008-3#7)
knowledge is important##2##3##(1993-1#1)(2008-3#1)
knowledge is##22##2##(1990-8#1)(1991-9#1)(1993-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
knowledge it is##2##3##(1991-3#1)(2008-10#1)
knowledge management##3##2##(2008-11#1)(2008-8#1)(2011-1#1)
knowledge may be##2##3##(1996-7#1)(2013-1#1)
knowledge may##3##2##(1996-7#1)(2013-1#2)
knowledge of HIV transmission##2##4##(1993-1#1)(2011-2#1)
knowledge of HIV##3##3##(1993-1#1)(2011-2#2)
knowledge of a##4##3##(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
knowledge of all##2##3##(1995-1#1)(2011-2#1)
knowledge of biological##3##3##(2008-10#2)(2012-12#1)
knowledge of cellular##3##3##(1992-2#1)(2008-11#1)(2008-4#1)
knowledge of child development##2##4##(1995-1#1)(2011-1#1)
knowledge of child##3##3##(1995-1#1)(2011-1#1)(2012-12#1)
knowledge of drugs##2##3##(1990-2#1)(2010-8#1)
knowledge of health##2##3##(1993-2#1)(2008-1#1)
knowledge of how##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
knowledge of its##6##3##(1994-10#1)(1996-9#1)(2008-5#1)(2008-8#2)(2010-12#1)
knowledge of medical##2##3##(2012-3#2)
knowledge of mental health##2##4##(2011-2#2)
knowledge of osteoporosis in the##2##5##(1996-6#1)(2008-8#1)
knowledge of osteoporosis##4##3##(1996-6#3)(2008-8#1)
knowledge of postcoital##2##3##(1993-2#2)
knowledge of sex chromosomal disorders##2##5##(2013-1#2)
knowledge of sex##3##3##(2010-3#1)(2013-1#2)
knowledge of stroke##2##3##(2007-10#2)
knowledge of such##4##3##(1997-4#1)(2008-7#1)(2013-1#2)
knowledge of the biology##2##4##(1994-11#1)(2008-7#1)
knowledge of the disease##2##4##(2008-2#1)(2010-8#1)
knowledge of the female##2##4##(1991-6#1)(2007-7#1)
knowledge of the functional##2##4##(2008-7#1)(2012-2#1)
knowledge of the genetics##2##4##(2008-10#1)(2008-8#1)
knowledge of the guidelines##2##4##(1990-6#1)(2012-12#1)
knowledge of the insanity defense##4##5##(2011-1#4)
knowledge of the mechanism##2##4##(2008-10#1)(2012-3#1)
knowledge of the mechanisms##4##4##(1992-9#1)(2008-7#1)(2010-3#1)(2012-12#1)
knowledge of the molecular##2##4##(2011-2#1)(2013-1#1)
knowledge of the natural##3##4##(1990-12#1)(1997-3#1)(2006-12#1)
knowledge of the number##2##4##(2008-3#1)(2010-12#1)
knowledge of the original##3##4##(2008-10#1)(2008-3#2)
knowledge of the structure##2##4##(1992-12#1)(2013-1#1)
knowledge of the type of##2##5##(1994-3#1)(2008-3#1)
knowledge of the various##3##4##(1993-11#1)(1997-4#1)(2012-2#1)
knowledge of the##151##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-11#2)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-3#3)(1997-4#2)(1997-7#1)(2006-12#1)(2007-12#2)(2007-7#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#10)(2008-3#19)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
knowledge of their##7##3##(1990-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-7#1)
knowledge of these##5##3##(1994-11#1)(1996-12#1)(2012-2#1)(2013-1#2)
knowledge of this##2##3##(1994-1#1)(2008-7#1)
knowledge of ways in which##2##5##(2008-10#2)
knowledge of what##2##3##(2009-10#1)(2010-10#1)
knowledge of##350##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-6#1)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#3)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-7#3)(2008-1#5)(2008-10#39)(2008-11#18)(2008-12#2)(2008-2#14)(2008-3#22)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#9)(2008-9#10)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#10)(2011-2#18)(2012-12#5)(2012-2#12)(2012-3#10)(2013-1#25)(2013-7#2)(2013-8#2)
knowledge ofthe##2##2##(2008-2#1)(2013-8#1)
knowledge on how to##2##4##(2012-12#1)(2012-3#1)
knowledge on how##5##3##(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
knowledge on the##27##3##(1990-8#1)(1991-3#1)(1993-1#1)(1993-2#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
knowledge on this##2##3##(2007-5#1)(2008-10#1)
knowledge on##56##2##(1990-8#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1995-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2010-12#1)(2011-1#3)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#6)
knowledge or##3##2##(2008-5#1)(2012-12#1)(2012-2#1)
knowledge produced##3##2##(1993-6#1)(2011-2#1)(2012-3#1)
knowledge questionnaire##2##2##(1991-2#1)(2012-3#1)
knowledge questions##2##2##(2012-1#1)(2013-1#1)
knowledge regarding the role of##2##5##(2008-11#1)(2010-9#1)
knowledge regarding the##9##3##(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
knowledge regarding##18##2##(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
knowledge related to the##2##4##(1997-1#1)(2009-5#1)
knowledge related to##6##3##(1997-1#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
knowledge repositories##2##2##(2008-7#2)
knowledge representation##2##2##(2008-7#1)(2010-9#1)
knowledge scores were##2##3##(1996-9#2)
knowledge scores##3##2##(1996-9#2)(2013-1#1)
knowledge should##2##2##(1993-12#1)(2009-10#1)
knowledge such as##2##3##(2010-8#1)(2011-2#1)
knowledge such##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
knowledge systems##2##2##(2009-12#1)(2009-6#1)
knowledge that could be##2##4##(2007-10#1)(2012-2#1)
knowledge that##20##2##(1990-11#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
knowledge the first demonstration of##3##5##(2007-11#1)(2007-12#2)
knowledge the first experimental evidence##2##5##(2007-11#1)(2007-12#1)
knowledge the first experimental##6##4##(2007-11#2)(2007-12#3)(2008-3#1)
knowledge the first time##8##4##(2007-12#6)(2008-2#1)(2008-3#1)
knowledge the first##42##3##(2007-11#14)(2007-12#19)(2008-10#1)(2008-2#5)(2008-3#3)
knowledge the##50##2##(2007-11#18)(2007-12#22)(2008-10#1)(2008-2#6)(2008-3#3)
knowledge this is the first##12##5##(1990-12#1)(1991-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-3#1)
knowledge this is the##15##4##(1990-12#1)(1991-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
knowledge this##20##2##(1990-12#1)(1991-9#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
knowledge to##11##2##(1992-2#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#3)
knowledge transfer##2##2##(2008-11#1)(2008-7#1)
knowledge translation##4##2##(2008-12#1)(2010-10#2)(2011-2#1)
knowledge was measured##2##3##(1991-2#1)(2013-8#1)
knowledge was##7##2##(1991-2#1)(1993-12#1)(1994-6#1)(2008-11#1)(2008-5#1)(2009-3#1)(2013-8#1)
knowledge which##4##2##(2007-5#1)(2008-12#1)(2008-6#1)(2012-12#1)
knowledge will##2##2##(2008-4#1)(2011-2#1)
knowledge with##6##2##(2007-12#1)(2008-2#1)(2010-10#1)(2011-1#2)(2012-12#1)
knowledge##1513##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#7)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#9)(1991-3#6)(1991-5#1)(1991-6#4)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#3)(1993-11#4)(1993-12#9)(1993-2#9)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#7)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#1)(1995-1#8)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#5)(1995-6#5)(1995-8#2)(1996-1#6)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#7)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#11)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#5)(2006-10#3)(2006-12#1)(2006-9#1)(2007-10#8)(2007-11#51)(2007-12#68)(2007-2#4)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#11)(2008-1#20)(2008-10#95)(2008-11#97)(2008-12#34)(2008-2#70)(2008-3#129)(2008-4#22)(2008-5#17)(2008-6#5)(2008-7#52)(2008-8#26)(2008-9#25)(2009-1#2)(2009-10#15)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#14)(2009-5#13)(2009-6#9)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#8)(2010-10#14)(2010-11#5)(2010-12#12)(2010-2#4)(2010-3#13)(2010-4#5)(2010-5#11)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#8)(2011-1#46)(2011-2#64)(2011-3#3)(2011-7#2)(2011-8#1)(2012-1#7)(2012-12#29)(2012-2#42)(2012-3#42)(2013-1#86)(2013-7#7)(2013-8#23)
knowledge-based##4##1##(1992-3#1)(1997-8#1)(2010-10#1)(2010-5#1)
knowledge]##3##1##(1990-12#1)(2009-5#1)(2013-8#1)
knowledgeable about the##3##3##(1991-1#1)(2008-12#1)(2013-1#1)
knowledgeable about##5##2##(1991-1#1)(1995-3#1)(2007-10#1)(2008-12#1)(2013-1#1)
knowledgeable in the##2##3##(1992-3#1)(1993-1#1)
knowledgeable##11##1##(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#1)(2007-10#1)(2008-12#1)(2013-1#2)
knowledgebase##2##1##(2008-8#1)(2009-9#1)
knowlesi infections##4##2##(2011-1#4)
knowlesi malaria##2##2##(2012-12#2)
knowlesi parasitized erythrocytes##2##3##(1990-2#2)
knowlesi##15##1##(1990-2#5)(2011-1#5)(2012-12#5)
known DNA##2##2##(1993-11#1)(1997-7#1)
known DNA-binding##2##2##(1996-2#1)(2008-8#1)
known Gaussian##2##2##(2008-2#2)
known SLe(x)##2##2##(1992-12#2)
known a priori##3##3##(2008-2#1)(2010-1#1)(2012-3#1)
known a##5##2##(2008-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2012-3#1)
known about effects##2##3##(2010-8#2)
known about how##10##3##(1997-1#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
known about the##87##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
known about their effects on##2##5##(1992-10#1)(2008-4#1)
known about their##8##3##(1992-1#1)(1992-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
known about these##2##3##(2007-11#1)(2008-11#1)
known about##145##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#9)(2008-8#3)(2008-9#4)(2009-4#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#6)
known agents##2##2##(2008-10#2)
known amino acid##2##3##(1993-6#1)(2012-2#1)
known amount of##5##3##(2008-10#4)(2008-12#1)
known amounts of##9##3##(1993-6#1)(2008-10#7)(2008-5#1)
known and the##2##3##(1991-4#1)(2008-3#1)
known and unknown##2##3##(1995-9#1)(2008-10#1)
known and##24##2##(1990-2#1)(1991-1#1)(1991-4#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-5#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
known antioxidants##2##2##(2008-5#2)
known as &quot##13##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
known as a##14##3##(1991-12#1)(1992-3#2)(1995-12#1)(1996-3#1)(2007-8#2)(2008-10#1)(2008-5#2)(2009-12#2)(2010-6#1)(2010-7#1)
known as an##6##3##(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)
known as polymorphic##2##3##(2008-10#1)(2008-5#1)
known as the &quot##2##4##(2008-4#1)(2012-3#1)
known as the##36##3##(1993-3#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
known as##235##2##(1990-11#1)(1990-12#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-2#5)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#34)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#10)(2009-12#4)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#14)(2012-12#5)(2012-2#12)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#1)
known bacterial##5##2##(1996-12#1)(2008-10#2)(2008-7#2)
known baseline##2##2##(2008-10#1)(2011-2#1)
known because of##2##3##(2008-5#1)(2010-6#1)
known binding##2##2##(2008-11#1)(2008-9#1)
known both##2##2##(1991-9#1)(1992-12#1)
known but##5##2##(1995-11#1)(2007-8#1)(2008-7#1)(2009-7#1)(2012-2#1)
known case of##2##3##(2007-12#1)(2008-6#1)
known case##3##2##(2007-12#1)(2008-6#1)(2013-1#1)
known cause of##4##3##(2008-4#2)(2010-12#1)(2012-12#1)
known cause##7##2##(2007-7#1)(2008-4#2)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
known causes of##4##3##(1990-3#1)(2007-7#1)(2008-10#1)(2009-5#1)
known causes##6##2##(1990-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)
known cellular##3##2##(1995-2#1)(1997-1#1)(2012-3#1)
known chemical##2##2##(1990-9#1)(2010-7#1)
known chronic venous disorders##2##4##(2010-7#2)
known complication of##4##3##(2008-12#1)(2012-2#2)(2013-1#1)
known complication##6##2##(1991-11#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-1#1)
known complications##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
known compounds##5##2##(2007-1#1)(2008-11#1)(2010-2#2)(2010-3#1)
known concentration of##2##3##(2008-10#1)(2010-2#1)
known concentration##5##2##(2008-10#4)(2010-2#1)
known concentrations##5##2##(2008-10#4)(2008-3#1)
known disease##2##2##(2008-10#1)(2013-1#1)
known distribution##2##2##(1990-11#1)(2008-8#1)
known drug##2##2##(2008-11#1)(2010-12#1)
known effects of##2##3##(1990-2#1)(1997-7#1)
known effects##3##2##(1990-2#1)(1997-7#1)(2006-6#1)
known example##2##2##(2008-12#1)(2011-2#1)
known excess of##2##3##(2008-10#2)
known factors##2##2##(2009-12#1)(2013-1#1)
known for a##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
known for its##5##3##(2008-10#2)(2009-9#1)(2011-2#2)
known for many##2##3##(2010-12#1)(2012-1#1)
known for the##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
known for their##6##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-5#1)
known for##43##2##(1991-12#2)(1995-12#1)(1997-4#3)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-5#1)
known from previous##2##3##(1992-10#1)(2008-3#1)
known from the##5##3##(1991-2#1)(1997-5#1)(2008-10#1)(2008-5#2)
known from##18##2##(1991-2#1)(1992-10#1)(1997-4#2)(1997-5#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2010-3#2)(2011-2#1)
known function##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
known gene##2##2##(1995-8#1)(1997-3#1)
known genes and##3##3##(1995-12#1)(1995-6#1)(1996-6#1)
known genes for##2##3##(1994-12#1)(2008-10#1)
known genes to##2##3##(1996-10#1)(2010-3#1)
known genes##30##2##(1994-12#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#3)(1997-2#1)(1997-3#3)(1997-6#2)(1997-8#3)(2008-10#2)(2008-4#1)(2008-9#1)(2010-3#1)
known genetic##3##2##(1997-3#1)(2008-10#2)
known history of hypertension and taking##2##6##(2008-7#2)
known history##4##2##(2008-10#1)(2008-7#3)
known how##3##2##(1997-7#1)(2010-11#1)(2012-2#1)
known human##3##2##(1990-8#1)(2008-4#1)(2008-8#1)
known immunosuppressive##2##2##(2008-10#2)
known in the literature##2##4##(2007-11#1)(2008-2#1)
known in the##14##3##(1992-3#1)(1996-11#2)(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#1)(2013-1#1)
known in##29##2##(1991-12#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-2#1)(1996-11#2)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-5#2)(2008-6#1)(2009-10#2)(2009-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#2)
known inhibitors of##2##3##(1992-8#1)(1996-12#1)
known is##2##2##(2008-3#1)(2011-2#1)
known mammalian##3##2##(1994-8#1)(2008-4#1)(2008-8#1)
known markers##2##2##(2008-9#1)(2011-2#1)
known mechanisms of##2##3##(1994-8#1)(2008-2#1)
known mechanisms##6##2##(1990-2#1)(1994-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)
known medical##2##2##(1997-8#1)(2010-6#1)
known meiotic##2##2##(2008-9#1)(2012-3#1)
known members of the##4##4##(1991-5#1)(1993-9#1)(1994-8#1)(1995-6#1)
known membrane##2##2##(2008-4#1)(2013-1#1)
known molecular##2##2##(1997-3#1)(2008-5#1)
known of the##7##3##(1996-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)
known of##13##2##(1992-10#1)(1993-1#1)(1993-6#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)
known ones##2##2##(1995-5#1)(2008-1#1)
known only##4##2##(2007-11#1)(2008-1#1)(2008-10#2)
known optical properties##2##3##(2007-12#1)(2008-2#1)
known optical##3##2##(2007-12#1)(2008-2#2)
known or if##2##3##(2008-2#2)
known or predicted##3##3##(1994-9#1)(1997-6#1)(1997-8#1)
known or unknown##5##3##(2007-12#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-5#1)
known or##17##2##(1994-9#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#1)
known phase##2##2##(2008-10#1)(2008-3#1)
known primary##2##2##(2008-10#1)(2012-2#1)
known properties##2##2##(2009-7#1)(2012-3#1)
known protein##7##2##(1990-5#1)(1992-4#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
known proteins in##2##3##(1995-12#1)(1997-2#1)
known proteins##12##2##(1993-6#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2010-10#1)(2013-8#1)
known races##2##2##(2008-10#2)
known refractive index##2##3##(2008-2#1)(2008-3#1)
known refractive##3##2##(2008-2#2)(2008-3#1)
known risk factors and##2##4##(1993-11#1)(2011-1#1)
known risk factors for##2##4##(1997-5#1)(2009-2#1)
known risk factors##7##3##(1990-8#1)(1993-11#1)(1997-5#1)(2008-8#1)(2009-2#1)(2011-1#1)(2013-1#1)
known risk##8##2##(1990-8#1)(1993-11#1)(1997-5#2)(2008-8#1)(2009-2#1)(2011-1#1)(2013-1#1)
known sequence##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
known sequences of##2##3##(1992-6#1)(1993-11#1)
known sequences##4##2##(1992-6#1)(1993-11#1)(1993-8#1)(1997-3#1)
known shape##2##2##(2008-3#2)
known side-effects##2##2##(1992-4#1)(2008-10#1)
known since##3##2##(2008-10#2)(2008-5#1)
known site##2##2##(1991-2#1)(1993-11#1)
known size##3##2##(2008-2#1)(2008-3#2)
known small##2##2##(2008-9#1)(2010-2#1)
known source##2##2##(2008-10#1)(2010-4#1)
known sources##2##2##(1991-5#1)(2008-11#1)
known species##4##2##(1995-12#1)(2008-5#1)(2010-3#1)(2013-7#1)
known strains##2##2##(2008-10#1)(2008-12#1)
known structures##2##2##(2008-7#1)(2010-10#1)
known that an##4##3##(2008-12#1)(2008-2#2)(2009-12#1)
known that both##2##3##(2008-11#1)(2011-2#1)
known that the##11##3##(1990-6#1)(1993-3#1)(1997-2#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
known that##62##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-3#2)(1993-6#1)(1996-3#1)(1997-2#2)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#7)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
known three-dimensional structure##2##3##(1992-1#1)(1993-6#1)
known three-dimensional##4##2##(1990-11#1)(1992-1#1)(1993-6#1)(2008-7#1)
known to act as##2##4##(1990-2#1)(2008-8#1)
known to act##3##3##(1990-2#1)(1990-5#1)(2008-8#1)
known to activate##2##3##(1992-11#1)(1996-6#1)
known to affect the##5##4##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-3#1)
known to affect##13##3##(1991-5#1)(1992-2#1)(1993-11#2)(1994-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
known to alter##4##3##(1992-12#1)(1994-9#1)(1996-5#1)(2008-7#1)
known to be a good##2##5##(1994-11#1)(2008-7#1)
known to be a key regulator of##2##7##(2008-5#1)(2010-8#1)
known to be a key##3##5##(2008-11#1)(2008-5#1)(2010-8#1)
known to be a##20##4##(1994-11#1)(1994-5#1)(1996-2#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#1)
known to be an##3##4##(2008-1#1)(2008-6#1)(2013-8#1)
known to be associated with##8##5##(2007-8#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
known to be endemic##2##4##(2007-12#1)(2008-1#1)
known to be expressed##3##4##(1992-11#1)(2011-1#1)(2012-3#1)
known to be exquisitely sensitive to##2##6##(2008-7#1)(2012-2#1)
known to be important##3##4##(1995-6#1)(2008-3#1)(2008-8#1)
known to be induced##2##4##(1994-11#1)(1994-2#1)
known to be infected with##2##5##(1993-6#1)(2008-10#1)
known to be involved in DNA##2##6##(1993-12#1)(1993-2#1)
known to be involved in early##2##6##(2010-11#1)(2012-1#1)
known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis##2##13##(2008-4#2)
known to be involved in the##3##6##(2008-4#1)(2009-5#1)(2009-8#1)
known to be involved in tumor##2##6##(1991-8#1)(1992-8#1)
known to be involved in##17##5##(1990-12#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-4#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-1#1)
known to be related to##3##5##(1993-11#1)(2008-10#1)(2008-4#1)
known to be responsible for##4##5##(1997-8#1)(2008-3#2)(2011-1#1)
known to be sensitive to##2##5##(1990-12#1)(2008-8#1)
known to be specific for##2##5##(1990-7#1)(2008-11#1)
known to be specific##3##4##(1990-7#1)(2007-12#1)(2008-11#1)
known to be##139##3##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#3)(1997-8#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#12)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#1)
known to carry the##2##4##(1991-8#1)(1994-6#1)
known to cause such##2##4##(1996-3#1)(2007-7#1)
known to cause##12##3##(1991-12#1)(1993-8#1)(1994-10#1)(1996-3#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#1)(2009-6#1)(2012-12#1)(2012-2#1)
known to complicate##2##3##(2010-3#1)(2013-1#1)
known to confer##2##3##(2008-10#2)
known to contain a##2##4##(2008-10#1)(2008-11#1)
known to contain##10##3##(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
known to control##2##3##(2008-10#1)(2009-8#1)
known to differ in##2##4##(1991-12#1)(2013-1#1)
known to enhance the##2##4##(2008-11#1)(2008-4#1)
known to enhance##7##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-2#1)
known to exert##3##3##(1992-2#1)(2012-2#2)
known to exhibit a##2##4##(2008-3#1)(2012-2#1)
known to exhibit##5##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
known to exist##3##3##(1990-11#1)(2008-10#1)(2008-5#1)
known to extend##2##3##(2008-10#1)(2008-11#1)
known to form complexes with##2##5##(2008-10#1)(2010-11#1)
known to form##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
known to have a##4##4##(1993-12#1)(1994-11#1)(2008-1#1)(2010-5#1)
known to have an##2##4##(2010-12#1)(2012-3#1)
known to have##23##3##(1990-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
known to improve##2##3##(1996-2#1)(2008-11#1)
known to increase##4##3##(2008-1#1)(2012-12#1)(2012-2#2)
known to induce the##2##4##(1993-8#1)(1996-12#1)
known to induce##20##3##(1990-2#1)(1991-2#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2012-12#1)
known to infect##3##3##(2008-10#2)(2012-2#1)
known to influence##9##3##(1995-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-7#1)
known to inhibit the##2##4##(1991-9#1)(2008-5#1)
known to inhibit##5##3##(1991-9#1)(1993-1#1)(1997-3#1)(1997-6#1)(2008-5#1)
known to interfere with##4##4##(1993-12#1)(2008-10#3)
known to interfere##5##3##(1993-12#1)(2008-10#4)
known to mediate##4##3##(2009-8#1)(2010-11#1)(2010-7#1)(2013-1#1)
known to modulate##5##3##(1992-8#1)(1995-9#1)(2008-11#1)(2008-4#1)(2008-5#1)
known to occur in the##2##5##(2008-7#1)(2010-3#1)
known to occur in##7##4##(1990-11#1)(1994-8#1)(1997-7#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)
known to occur##13##3##(1990-11#1)(1994-8#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
known to play a critical role in##2##7##(1994-9#1)(1997-4#1)
known to play a critical role##3##6##(1994-9#1)(1997-4#1)(2008-11#1)
known to play a role in##3##6##(1996-2#1)(2012-2#1)(2012-7#1)
known to play a##9##4##(1993-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-7#1)
known to play an important role in the##2##8##(1994-2#1)(1996-12#1)
known to play an important role in##4##7##(1994-2#1)(1996-12#1)(2011-2#2)
known to play##13##3##(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-7#1)
known to possess##4##3##(2006-12#1)(2008-11#1)(2009-2#1)(2012-12#1)
known to produce##8##3##(1991-12#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-2#1)
known to promote##4##3##(1992-6#1)(1995-8#1)(2008-1#1)(2008-10#1)
known to protect##2##3##(2010-7#1)(2013-1#1)
known to reduce##5##3##(2008-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
known to regulate##8##3##(1995-11#1)(1995-2#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-2#2)
known to require##2##3##(1993-6#1)(1995-2#1)
known to respond to##2##4##(1996-5#1)(2007-12#1)
known to result in##2##4##(1995-2#1)(2008-10#1)
known to stimulate##3##3##(1990-5#1)(1991-12#1)(1995-8#1)
known to the##6##3##(1996-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
known to undergo##2##3##(1997-2#1)(2011-2#1)
known to##451##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#4)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#7)(1993-2#1)(1993-6#4)(1993-8#3)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#4)(1995-6#2)(1995-8#4)(1995-9#2)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#50)(2008-11#25)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#11)(2008-5#20)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#5)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#3)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#13)(2012-1#6)(2012-12#9)(2012-2#20)(2012-3#3)(2012-6#1)(2012-7#1)(2013-1#14)(2013-7#1)(2013-8#2)
known today##3##2##(1991-6#1)(2008-10#1)(2011-1#1)
known transcription factor##2##3##(1992-9#1)(2009-10#1)
known vertebrate##2##2##(1997-9#1)(2010-5#1)
known whether##7##2##(1990-5#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
known yeast genes##2##3##(1995-9#1)(1997-3#1)
known##1973##1##(1990-11#13)(1990-12#7)(1990-2#10)(1990-3#2)(1990-5#8)(1990-6#2)(1990-7#7)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#18)(1991-2#9)(1991-3#2)(1991-4#1)(1991-5#13)(1991-6#4)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#4)(1992-11#4)(1992-12#15)(1992-2#4)(1992-3#12)(1992-4#3)(1992-5#4)(1992-6#8)(1992-8#10)(1992-9#4)(1993-1#2)(1993-11#13)(1993-12#14)(1993-2#2)(1993-3#7)(1993-6#17)(1993-8#8)(1993-9#6)(1994-1#2)(1994-10#2)(1994-11#9)(1994-12#9)(1994-2#5)(1994-3#6)(1994-5#8)(1994-6#7)(1994-8#10)(1994-9#6)(1995-1#1)(1995-11#5)(1995-12#17)(1995-2#24)(1995-3#10)(1995-5#8)(1995-6#12)(1995-8#12)(1995-9#6)(1996-1#3)(1996-10#4)(1996-11#4)(1996-12#18)(1996-2#14)(1996-3#10)(1996-5#8)(1996-6#7)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#12)(1997-3#14)(1997-4#9)(1997-5#11)(1997-6#4)(1997-7#11)(1997-8#12)(1997-9#2)(2006-10#3)(2006-12#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#22)(2007-12#37)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#14)(2007-9#1)(2008-1#26)(2008-10#258)(2008-11#73)(2008-12#28)(2008-2#60)(2008-3#60)(2008-4#46)(2008-5#77)(2008-6#13)(2008-7#83)(2008-8#37)(2008-9#43)(2009-10#5)(2009-11#4)(2009-12#9)(2009-2#6)(2009-3#6)(2009-4#5)(2009-5#16)(2009-6#5)(2009-7#6)(2009-8#18)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#11)(2010-12#17)(2010-2#8)(2010-3#16)(2010-4#9)(2010-5#4)(2010-6#8)(2010-7#10)(2010-8#9)(2010-9#2)(2011-1#20)(2011-2#70)(2011-3#4)(2012-1#14)(2012-12#26)(2012-2#66)(2012-3#26)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#62)(2013-7#10)(2013-8#22)
known&quot##2##1##(2008-10#2)
known)##4##1##(1990-7#1)(2008-3#3)
known-groups validity##2##2##(2007-10#2)
knows about##2##2##(1990-11#1)(1991-3#1)
knows that##3##2##(1995-1#1)(2008-10#1)(2012-3#1)
knows##6##1##(1990-11#1)(1991-3#1)(1995-1#1)(2008-10#2)(2012-3#1)
knuckles##3##1##(2008-5#2)(2009-4#1)
koepferae##3##1##(1995-8#3)
kojic acid##6##2##(2008-5#6)
kolleri##3##1##(2008-10#3)
koningii were##2##2##(2008-10#1)(2008-5#1)
koningii##8##1##(2008-10#7)(2008-5#1)
korean##7##1##(2008-10#1)(2010-1#3)(2010-6#1)(2012-3#1)(2013-1#1)
kow##3##1##(1991-5#3)
kraft pulp##2##2##(2008-11#1)(2008-6#1)
kriging##6##1##(2008-10#4)(2008-11#1)(2008-8#1)
krill and##2##2##(2008-10#1)(2009-4#1)
kringle 1 + 2 + 3 and kringle 1##2##9##(1990-5#2)
kringle 1 + 2 + 3##4##6##(1990-5#4)
kringle 1##12##2##(1990-5#10)(1995-6#1)(2008-8#1)
kringle 4##2##2##(1993-8#2)
kringle domain##2##2##(1991-6#1)(1993-8#1)
kringle##23##1##(1990-5#11)(1991-6#2)(1993-8#6)(1995-6#1)(1997-2#1)(2008-8#2)
kringles##4##1##(1990-5#1)(1993-8#1)(1995-6#1)(2008-8#1)
krusei and##2##2##(2008-5#2)
krusei##8##1##(2008-5#7)(2010-5#1)
krypton fluoride (KrF)##2##3##(2008-3#2)
krypton##4##1##(1992-8#1)(2008-2#1)(2008-3#2)
ku (1##2##2##(2008-8#2)
ku protein##3##2##(2008-8#2)(2008-9#1)
ku##31##1##(2008-4#1)(2008-8#15)(2008-9#15)
kudzu (Pueraria lobata) vine retting##2##5##(2008-6#2)
kudzu##3##1##(2008-10#1)(2008-6#2)
kuehniella and##3##2##(2008-6#3)
kuehniella##5##1##(2008-6#5)
kundalini yoga##2##2##(2008-3#2)
kurodai##8##1##(1990-7#1)(1997-6#7)
kurstaki HBK-51##2##2##(2013-1#2)
kurstaki##4##1##(2011-2#1)(2013-1#3)
kuwanon##2##1##(2011-3#2)
kwo##3##1##(1991-5#3)
ky##2##1##(2007-5#2)
kynurenate##4##1##(1991-5#4)
kynurenic acid##9##2##(1992-3#6)(1996-5#1)(2009-12#1)(2011-1#1)
kyphoplasty in the##2##3##(2008-12#1)(2008-7#1)
kyphoplasty in##5##2##(2007-8#2)(2008-12#1)(2008-7#2)
kyphoplasty##10##1##(2007-8#3)(2008-12#1)(2008-7#6)
kyphoscoliosis##3##1##(1991-3#1)(2008-7#1)(2008-8#1)
kyphosis from##2##2##(2008-8#2)
kyphosis in##3##2##(2009-3#1)(2012-12#2)
kyphosis that##2##2##(2009-3#1)(2012-12#1)
kyphosis##17##1##(2007-11#4)(2008-7#1)(2008-8#3)(2009-3#3)(2012-12#6)
kyste##3##1##(2011-2#2)(2013-1#1)
l and##3##2##(2008-10#2)(2008-3#1)
l is the##2##3##(2008-3#1)(2008-4#1)
l is##3##2##(2008-3#2)(2008-4#1)
l min(-1)##9##2##(2008-10#9)
l mol(-1) cm(-1) and 0##3##5##(2008-10#3)
l mol(-1) cm(-1) and 2##2##5##(2008-10#2)
l mol(-1) cm(-1) and detection limit 0##2##7##(2008-10#2)
l mol(-1) cm(-1) and the##2##5##(2008-10#2)
l mol(-1) cm(-1) and##12##4##(2008-10#12)
l mol(-1) cm(-1) at 612 nm##2##6##(2008-10#2)
l mol(-1) cm(-1) at 660 nm##2##6##(2008-10#2)
l mol(-1) cm(-1) at##10##4##(2008-10#10)
l mol(-1) cm(-1) for##2##4##(2008-10#2)
l mol(-1) cm(-1)##44##3##(2008-10#44)
l mol(-1) cm(-1))##2##3##(2008-10#2)
l mol(-1)##54##2##(2008-10#54)
l mol(-1)cm(-1)##2##2##(2008-10#2)
l sample at##2##3##(2008-10#2)
l scale##5##2##(1992-11#2)(2008-11#3)
l stirred##3##2##(2008-11#3)
l##134##1##(1991-12#1)(1991-5#6)(1992-11#2)(1993-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#81)(2008-11#20)(2008-2#2)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#3)(2010-3#1)(2010-6#1)(2011-2#1)(2012-6#1)(2013-7#1)
l'absorption##2##1##(2008-5#2)
l'hydatidose##2##1##(2011-2#2)
l'utilisation##2##1##(2008-5#1)(2011-2#1)
l'âge##4##1##(2008-11#1)(2011-2#3)
l(+)##2##1##(2008-10#1)(2008-5#1)
l(-1) (3sigma)##3##2##(2008-10#3)
l(-1) (S/N=3)##4##2##(2008-10#4)
l(-1) (as##3##2##(2008-10#3)
l(-1) Co(II)##2##2##(2008-10#2)
l(-1) Cr(VI)##6##2##(2008-10#6)
l(-1) Fe##2##2##(2008-10#2)
l(-1) Fe(II)##2##2##(2008-10#2)
l(-1) NaCl##7##2##(2008-10#6)(2008-5#1)
l(-1) Ni##2##2##(2008-10#2)
l(-1) Pb(II)##2##2##(2008-10#2)
l(-1) S(2-)##3##2##(2008-10#3)
l(-1) Se##2##2##(2008-10#2)
l(-1) V##2##2##(2008-10#2)
l(-1) acetic acid##2##3##(2008-10#2)
l(-1) and 1##2##3##(2008-10#2)
l(-1) and 2##3##3##(2008-10#3)
l(-1) and 3##2##3##(2008-10#2)
l(-1) and a##8##3##(2008-10#8)
l(-1) and detection##2##3##(2008-10#2)
l(-1) and the detection limit##4##5##(2008-10#4)
l(-1) and the detection##5##4##(2008-10#5)
l(-1) and the relative standard deviation##4##6##(2008-10#4)
l(-1) and the relative standard##5##5##(2008-10#5)
l(-1) and the##19##3##(2008-10#19)
l(-1) and##56##2##(2008-10#56)
l(-1) ascorbic acid was 2##2##5##(2008-10#2)
l(-1) ascorbic acid##4##3##(2008-10#4)
l(-1) at a##2##3##(2008-10#2)
l(-1) at pH##3##3##(2008-10#3)
l(-1) at##7##2##(2008-10#7)
l(-1) bromide##2##2##(2008-10#2)
l(-1) can be##2##3##(2008-10#2)
l(-1) chromium(VI)##2##2##(2008-10#2)
l(-1) concentration range##4##3##(2008-10#4)
l(-1) concentration##8##2##(2008-10#8)
l(-1) concentrations##2##2##(2008-10#2)
l(-1) detection limit##3##3##(2008-10#3)
l(-1) detection##4##2##(2008-10#4)
l(-1) for 5##2##3##(2008-10#2)
l(-1) for Cd##4##3##(2008-10#4)
l(-1) for Cd(II)##2##3##(2008-10#2)
l(-1) for a##3##3##(2008-10#3)
l(-1) for cadmium##3##3##(2008-10#3)
l(-1) for copper and 0##2##5##(2008-10#2)
l(-1) for copper and##3##4##(2008-10#3)
l(-1) for copper##4##3##(2008-10#4)
l(-1) for iron##2##3##(2008-10#2)
l(-1) for the##9##3##(2008-10#9)
l(-1) for##109##2##(2008-10#106)(2009-6#3)
l(-1) fructose solution##2##3##(2008-10#2)
l(-1) glucose##2##2##(2008-10#1)(2008-11#1)
l(-1) hydrogen peroxide##3##3##(2008-10#3)
l(-1) in the##4##3##(2008-10#4)
l(-1) in##14##2##(2008-10#14)
l(-1) lead##2##2##(2008-10#2)
l(-1) level of##3##3##(2008-10#3)
l(-1) level##16##2##(2008-10#16)
l(-1) level)##7##2##(2008-10#7)
l(-1) levels in##2##3##(2008-10#2)
l(-1) levels of##3##3##(2008-10#3)
l(-1) levels##10##2##(2008-10#10)
l(-1) of BPA##2##3##(2008-10#2)
l(-1) of Mo##2##3##(2008-10#2)
l(-1) of Trolox##2##3##(2008-10#2)
l(-1) of##58##2##(2008-10#56)(2008-11#2)
l(-1) or##3##2##(2008-10#3)
l(-1) range##5##2##(2008-10#5)
l(-1) sample is##2##3##(2008-10#2)
l(-1) sodium##7##2##(2008-10#7)
l(-1) tetrabutylammonium##3##2##(2008-10#3)
l(-1) to nmol l(-1)##2##4##(2008-10#2)
l(-1) to##6##2##(2008-10#5)(2008-11#1)
l(-1) using##4##2##(2008-10#4)
l(-1) was achieved##3##3##(2008-10#3)
l(-1) was obtained##7##3##(2008-10#7)
l(-1) was##15##2##(2008-10#15)
l(-1) were##5##2##(2008-10#5)
l(-1) with a detection limit of 0##4##7##(2008-10#4)
l(-1) with a detection limit of##14##6##(2008-10#14)
l(-1) with a relative standard deviation##2##6##(2008-10#2)
l(-1) with a##24##3##(2008-10#24)
l(-1) with an##4##3##(2008-10#4)
l(-1) with the detection limit of##3##6##(2008-10#3)
l(-1) with the detection limit##4##5##(2008-10#4)
l(-1) with the detection##5##4##(2008-10#5)
l(-1) with the##9##3##(2008-10#9)
l(-1) with##39##2##(2008-10#39)
l(-1) zinc##2##2##(2008-10#2)
l(-1)##980##1##(2008-10#963)(2008-11#12)(2008-5#2)(2009-6#3)
l(-1)) and good##2##3##(2008-10#2)
l(-1)) and##11##2##(2008-10#11)
l(-1)) of iron##2##3##(2008-10#2)
l(-1)) of##5##2##(2008-10#2)(2008-11#3)
l(-1)) or##2##2##(2008-10#1)(2008-5#1)
l(-1)) was##7##2##(2008-10#7)
l(-1)) were##3##2##(2008-10#3)
l(-1))##78##1##(2008-10#71)(2008-11#4)(2008-5#3)
l(-3)##3##1##(2008-10#3)
l)##8##1##(1995-12#3)(2008-10#1)(2008-11#3)(2008-3#1)
l- and##3##2##(2008-10#3)
l-1##6##1##(1993-8#2)(2008-11#4)
l-1)##3##1##(1993-8#2)(2008-11#1)
l-2-haloacid dehalogenases##2##2##(2011-1#2)
l-3##2##1##(2008-10#1)(2008-7#1)
l-Arginine phosphate monohydrate##2##3##(2008-2#2)
l-ascorbate##3##1##(2008-10#3)
l-ascorbic acid and##2##3##(2008-10#2)
l-ascorbic acid concentration##2##3##(2008-10#2)
l-ascorbic acid in pharmaceutical formulations##2##5##(2008-10#2)
l-ascorbic acid in##4##3##(2008-10#4)
l-ascorbic acid##27##2##(2008-10#26)(2008-5#1)
l-carnosine##5##1##(2011-1#5)
l-cysteine (0##2##2##(2008-10#2)
l-cysteine and glutathione##8##3##(2008-10#8)
l-cysteine and##16##2##(2008-10#15)(2011-1#1)
l-cysteine self-assembled monolayers modified gold electrode##2##6##(2008-10#2)
l-cysteine##39##1##(2008-10#38)(2011-1#1)
l-cystine and##2##2##(2008-10#2)
l-cystine##7##1##(2008-10#7)
l-dT##3##1##(2008-4#3)
l-dansyl amino acids##2##3##(2008-10#2)
l-dopa and/or##2##2##(2008-7#2)
l-dopa##11##1##(2008-10#8)(2008-7#3)
l-glutamate##7##1##(2008-10#7)
l-his##2##1##(2008-10#2)
l-lactate and pyruvate##3##3##(2008-10#3)
l-lactate production##2##2##(2013-1#2)
l-lactate##11##1##(2008-10#7)(2013-1#4)
l-lysine##5##1##(2008-10#3)(2008-5#1)(2012-5#1)
l-malate##6##1##(2008-10#6)
l-malic acid with##3##3##(2008-10#3)
l-malic acid##4##2##(2008-10#4)
l-phenylalanine##5##1##(2008-10#5)
l-serine##2##1##(2008-10#2)
l-thyroxine (l-T(4))##2##2##(2008-10#2)
l-tyrosine and its##2##3##(2008-10#2)
l-tyrosine##7##1##(2008-10#7)
l/day##2##1##(1990-11#2)
l/min (P&lt##2##2##(2007-8#2)
l/min versus##3##2##(2007-8#3)
l/min##17##1##(1993-2#1)(1995-3#1)(2007-8#8)(2010-6#1)(2011-2#6)
l/s##2##1##(2007-8#1)(2008-5#1)
lCl-##2##1##(1995-11#2)
lEA##2##1##(2007-2#2)
la CAPB##4##2##(2008-5#4)
la Caféine##3##2##(2013-1#3)
la Recherche##3##2##(2008-3#2)(2008-7#1)
la chirurgie##2##2##(2011-2#2)
la compatibilite environnementale##2##3##(2008-5#2)
la consommation##2##2##(2013-1#2)
la femme##3##2##(2013-1#3)
la grande citerne##2##3##(2013-1#2)
la grossesse##6##2##(2011-2#1)(2013-1#5)
la guérison##2##2##(2013-1#2)
la littérature##3##2##(2011-2#1)(2013-1#2)
la mesure##2##2##(2008-5#2)
la mise en place d'un##3##5##(2011-2#1)(2013-1#2)
la prise en charge##2##4##(2011-2#1)(2013-1#1)
la survenue##2##2##(2013-1#2)
la##117##1##(1990-6#2)(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#23)(2008-7#1)(2009-4#4)(2010-8#5)(2011-2#13)(2011-3#3)(2013-1#48)(2013-7#1)
lab and##2##2##(2008-10#1)(2009-5#1)
lab at##2##2##(2008-2#1)(2009-5#1)
lab on a##2##3##(2008-10#1)(2011-1#1)
lab on##3##2##(2008-10#2)(2011-1#1)
lab results##2##2##(2009-4#1)(2012-3#1)
lab to##2##2##(2008-7#1)(2008-9#1)
lab##50##1##(1990-12#1)(1992-1#1)(1994-8#1)(1994-9#1)(1996-3#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#3)
lab-on-a-chip##2##1##(2008-10#1)(2009-11#1)
lab-on-chip##2##1##(2010-8#2)
lab-on-valve##9##1##(2008-10#9)
lab-scale##2##1##(2008-7#1)(2013-1#1)
label and##4##2##(2008-10#2)(2009-5#1)(2012-12#1)
label distribution in##2##3##(2008-7#2)
label free##2##2##(2010-5#1)(2010-7#1)
label in the##4##3##(1990-7#1)(1991-3#1)(2008-10#1)(2009-12#1)
label in##5##2##(1990-12#1)(1990-7#1)(1991-3#1)(2008-10#1)(2009-12#1)
label redistribution##2##2##(2012-1#2)
label specific##2##2##(1993-11#1)(2008-9#1)
label the##6##2##(2008-1#2)(2008-11#1)(2008-7#1)(2008-9#2)
label to identify##2##3##(1992-5#1)(1996-11#1)
label to##5##2##(1992-5#1)(1996-11#1)(2008-11#1)(2008-12#1)(2009-8#1)
label was##5##2##(1992-9#3)(1993-11#1)(2008-10#1)
label were present in the##2##5##(1992-12#2)
label with##3##2##(2008-7#2)(2010-12#1)
label##93##1##(1990-12#4)(1990-7#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-8#1)(1995-12#2)(1995-2#1)(1996-11#1)(1997-4#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#8)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#5)
label-free capacitive immunosensor##2##3##(2008-10#2)
label-free detection of##4##3##(2008-10#1)(2009-6#1)(2013-1#2)
label-free detection##5##2##(2008-10#2)(2009-6#1)(2013-1#2)
label-free##22##1##(2008-10#6)(2008-7#2)(2009-3#1)(2009-6#1)(2010-11#2)(2010-2#1)(2011-1#1)(2012-2#4)(2013-1#4)
label-retaining cells##3##2##(2009-12#3)
labeled BCX-4208##2##2##(2010-4#2)
labeled DNA##6##2##(1990-5#1)(1991-9#1)(2008-10#1)(2008-4#2)(2012-3#1)
labeled RGD-BBN##2##2##(2010-6#2)
labeled SUVs##2##2##(2008-10#2)
labeled and##3##2##(1990-12#1)(2008-10#1)(2010-3#1)
labeled antibody##2##2##(2008-10#2)
labeled antigen##4##2##(1990-12#4)
labeled as##5##2##(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
labeled at the##2##3##(2008-4#1)(2009-6#1)
labeled at##3##2##(1994-12#1)(2008-4#1)(2009-6#1)
labeled axons##3##2##(1997-3#2)(2008-11#1)
labeled by a##2##3##(2008-10#2)
labeled by##20##2##(1990-12#1)(1990-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-12#2)(2010-2#1)
labeled cells were##3##3##(1990-9#1)(1994-6#1)(2012-1#1)
labeled cells##5##2##(1990-9#1)(1993-11#1)(1994-6#1)(2009-6#1)(2012-1#1)
labeled from##2##2##(1997-3#1)(2010-2#1)
labeled goat##2##2##(2008-10#2)
labeled in a##2##3##(1995-6#1)(2008-2#1)
labeled in##5##2##(1994-8#1)(1995-6#2)(1997-3#1)(2008-2#1)
labeled internal standards##2##3##(1991-5#1)(2008-10#1)
labeled membranes##2##2##(1994-8#1)(1995-11#1)
labeled neurons##3##2##(1994-2#1)(1996-5#1)(2008-4#1)
labeled peptide##4##2##(1994-5#1)(1996-5#3)
labeled polypeptides##4##2##(1994-11#2)(1994-5#1)(1995-2#1)
labeled probe##2##2##(2008-10#1)(2008-5#1)
labeled proteins##2##2##(1993-11#1)(2008-4#1)
labeled rate (7##2##3##(2008-10#2)
labeled rate##5##2##(2008-10#5)
labeled substrate##2##2##(2008-10#1)(2009-5#1)
labeled target cells##2##3##(1990-12#1)(2008-4#1)
labeled the surface of##2##4##(2008-10#2)
labeled the##3##2##(1993-1#1)(2008-10#2)
labeled variant cells##2##3##(1992-9#2)
labeled with 3H-glucosamine##2##3##(1992-8#2)
labeled with a##5##3##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
labeled with acrylodan at its##2##5##(1994-5#2)
labeled with both##2##3##(1991-3#1)(2008-12#1)
labeled with different fluorescent dyes##2##5##(2008-10#2)
labeled with digoxigenin##2##3##(2008-12#1)(2008-4#1)
labeled with exogenous##2##3##(1994-11#1)(1995-12#1)
labeled with horseradish peroxidase (HRP)##2##5##(2008-10#1)(2012-2#1)
labeled with horseradish peroxidase##4##4##(2008-10#2)(2010-5#1)(2012-2#1)
labeled with radioactive##2##3##(1992-8#1)(2008-1#1)
labeled with the fluorescent##2##4##(1992-3#1)(1993-9#1)
labeled with the##5##3##(1992-3#2)(1993-9#1)(2008-10#1)(2008-4#1)
labeled with##81##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#5)(1992-8#4)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-2#3)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#9)(2008-8#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-5#1)(2012-2#1)
labeled##327##1##(1990-11#4)(1990-12#7)(1990-2#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-12#4)(1992-3#6)(1992-5#1)(1992-8#6)(1992-9#2)(1993-1#3)(1993-11#8)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#8)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#8)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-5#1)(1995-6#6)(1996-12#2)(1996-2#1)(1996-5#8)(1997-1#8)(1997-2#6)(1997-3#5)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-1#7)(2008-10#71)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#24)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
labeling and##22##2##(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-1#2)(2008-10#3)(2008-4#3)(2008-8#2)(2008-9#3)(2009-2#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
labeling as##2##2##(1997-2#1)(2008-10#1)
labeling at##2##2##(1997-3#1)(2008-7#1)
labeling by##2##2##(2008-4#1)(2008-8#1)
labeling demonstrated that##2##3##(1994-11#1)(2008-10#1)
labeling experiments##4##2##(1992-8#1)(1995-5#1)(2008-10#1)(2008-9#1)
labeling for##5##2##(1997-2#1)(2008-11#1)(2008-9#1)(2009-9#1)(2011-2#1)
labeling in a##2##3##(1991-5#1)(2008-10#1)
labeling in the##2##3##(1997-3#1)(2008-7#1)
labeling in##12##2##(1991-5#2)(1994-8#1)(1995-11#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#1)
labeling index of##4##3##(2008-4#3)(2009-1#1)
labeling index##6##2##(1991-12#1)(2008-11#1)(2008-4#3)(2009-1#1)
labeling intensity##2##2##(1990-12#1)(1990-7#1)
labeling is##3##2##(1991-9#1)(2007-11#2)
labeling medical images##2##3##(2013-1#2)
labeling methods##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
labeling of DNA##2##3##(2008-4#1)(2012-2#1)
labeling of a##2##3##(1992-3#1)(1993-8#1)
labeling of cells##3##3##(2008-1#1)(2008-4#2)
labeling of chitin##2##3##(2008-10#2)
labeling of histidine##3##3##(2008-10#3)
labeling of nuclear##2##3##(2008-9#1)(2012-3#1)
labeling of proteins or##2##4##(2008-4#1)(2008-9#1)
labeling of proteins##5##3##(2008-4#4)(2008-9#1)
labeling of the##14##3##(1990-11#1)(1990-12#2)(1990-2#1)(1992-3#1)(1992-9#1)(1995-6#3)(2007-7#1)(2008-10#4)
labeling of two##2##3##(1992-9#1)(1995-6#1)
labeling of##74##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#5)(1996-12#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#16)(2008-4#17)(2008-7#2)(2008-9#4)(2009-10#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
labeling pattern##7##2##(1990-8#1)(2008-10#3)(2008-7#3)
labeling patterns##2##2##(2008-10#1)(2008-7#1)
labeling procedure##2##2##(2008-10#1)(2008-4#1)
labeling schemes##2##2##(2009-5#1)(2009-6#1)
labeling studies##2##2##(1990-8#1)(1995-6#1)
labeling techniques that##2##3##(2008-4#1)(2009-11#1)
labeling techniques##4##2##(2008-4#2)(2009-11#1)(2013-1#1)
labeling the##2##2##(1995-12#1)(1997-2#1)
labeling using##2##2##(2008-4#1)(2011-2#1)
labeling was##9##2##(1990-12#1)(1990-9#1)(1991-12#3)(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#1)
labeling with a##3##3##(1993-11#1)(1994-8#1)(2008-9#1)
labeling with antibodies##2##3##(2008-9#1)(2011-1#1)
labeling with the##2##3##(2008-10#1)(2008-7#1)
labeling with##16##2##(1990-5#1)(1991-12#2)(1993-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#4)(2011-1#1)
labeling##303##1##(1990-11#5)(1990-12#6)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-12#10)(1991-5#2)(1991-9#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-11#4)(1993-2#2)(1993-3#1)(1993-8#3)(1994-11#2)(1994-3#1)(1994-5#3)(1994-8#3)(1995-11#4)(1995-12#2)(1995-5#1)(1995-6#8)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-1#9)(2008-10#51)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#40)(2008-5#2)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#2)(2009-2#1)(2009-5#4)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
labelled HRP##2##2##(2008-10#2)
labelled PNA##3##2##(2008-2#3)
labelled and were##2##3##(1992-8#2)
labelled and##3##2##(1992-8#2)(2007-12#1)
labelled antibodies##3##2##(2008-10#3)
labelled antigen##2##2##(1994-2#2)
labelled as##3##2##(1993-5#1)(1997-4#1)(2011-2#1)
labelled by##7##2##(1990-8#1)(1993-11#1)(1994-2#2)(1995-12#2)(1996-5#1)
labelled cDNA from##3##3##(2008-7#3)
labelled cells were##3##3##(1992-12#1)(1996-5#1)(2008-11#1)
labelled cells##9##2##(1990-12#1)(1992-10#1)(1992-12#1)(1994-10#1)(1994-12#1)(1996-5#3)(2008-11#1)
labelled for##3##2##(1995-12#1)(1996-5#2)
labelled in##2##2##(1995-12#1)(1996-5#1)
labelled metabolites##2##2##(2008-5#2)
labelled to##2##2##(1990-11#1)(1991-5#1)
labelled with alkaline phosphatase##2##4##(1991-5#1)(2008-10#1)
labelled with horseradish peroxidase##2##4##(1997-3#1)(2008-10#1)
labelled with the##2##3##(1995-12#1)(1997-3#1)
labelled with##17##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-12#2)(1997-3#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)
labelled##125##1##(1990-11#2)(1990-12#9)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#4)(1992-8#4)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-6#1)(1995-11#1)(1995-12#8)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#9)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#8)(2008-2#3)(2008-5#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2011-2#3)(2012-1#2)(2013-8#1)
labelling and##2##2##(2008-1#1)(2010-4#1)
labelling can##2##2##(2008-7#2)
labelling in##3##2##(1992-10#1)(1993-9#1)(2009-8#1)
labelling methods##2##2##(1995-12#1)(2008-11#1)
labelling of the##4##3##(1993-9#1)(1994-2#1)(2009-8#2)
labelling of##10##2##(1990-11#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-5#1)(2008-2#1)(2009-8#2)(2011-1#1)
labelling technique##2##2##(1994-10#1)(1997-3#1)
labelling with##2##2##(1996-5#1)(2008-10#1)
labelling##47##1##(1990-11#2)(1990-8#1)(1992-10#2)(1992-12#2)(1992-9#1)(1993-12#1)(1993-9#2)(1994-10#3)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#2)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#3)(2009-8#4)(2010-4#1)(2011-1#1)
labels and##4##2##(1992-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
labels in##3##2##(1995-1#1)(2008-10#1)(2008-12#1)
labels into proteins##2##3##(2008-4#2)
labels of infant health##2##4##(1994-3#2)
labels of##3##2##(1994-3#2)(2012-2#1)
labels used##3##2##(1997-4#1)(2008-10#2)
labels##51##1##(1990-2#1)(1990-7#1)(1992-10#1)(1992-12#1)(1992-3#3)(1993-6#1)(1993-8#4)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-12#2)(2008-4#6)(2008-9#1)(2009-11#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
labetalol##2##1##(1992-5#1)(1995-12#1)
labial gland of##2##3##(2007-12#2)
labial gland##3##2##(2007-12#3)
labial##12##1##(1991-2#1)(1995-3#1)(2007-12#8)(2012-3#1)(2013-1#1)
labile C and##2##3##(2013-7#2)
labile protein##2##2##(1993-8#1)(2008-4#1)
labile species##2##2##(2008-10#2)
labile##38##1##(1990-12#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-5#2)(1996-2#2)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2012-2#1)(2013-7#2)
lability of the##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
lability of##9##2##(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(2007-11#1)(2008-10#2)(2012-12#1)
lability##15##1##(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-6#3)(2008-8#1)(2011-1#1)(2012-12#1)
labium##3##1##(2007-12#3)
labor and delivery##2##3##(2007-2#1)(2008-9#1)
labor and employment issues##2##4##(1993-12#2)
labor and##10##2##(1992-2#1)(1993-12#2)(2007-2#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#2)
labor as##3##2##(1990-2#1)(1991-6#1)(1994-3#1)
labor force##6##2##(1991-1#2)(1997-2#1)(1997-6#1)(2008-9#1)(2009-10#1)
labor in##8##2##(2008-12#1)(2008-8#3)(2008-9#1)(2012-3#3)
labor intensive and##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
labor intensive##8##2##(1990-5#1)(1997-1#1)(2008-10#2)(2008-11#2)(2012-3#1)(2013-1#1)
labor market areas##5##3##(1992-12#5)
labor market in##2##3##(1991-1#1)(2013-1#1)
labor market##16##2##(1991-1#1)(1992-12#5)(1992-2#1)(1994-12#1)(1994-3#2)(2008-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
labor of##2##2##(2007-2#1)(2013-8#1)
labor seniority##2##2##(2011-2#2)
labor to##2##2##(1994-3#2)
labor##125##1##(1990-2#1)(1990-5#1)(1991-1#3)(1991-6#3)(1992-1#1)(1992-12#5)(1992-2#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#9)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-2#4)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-6#2)(2008-8#7)(2008-9#4)(2009-10#3)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#20)(2012-12#2)(2012-3#8)(2013-1#9)(2013-8#1)
labor-intensive##3##1##(2008-11#1)(2008-4#1)(2011-7#1)
labor]##2##1##(1991-6#1)(1993-3#1)
laboratorial##2##1##(2008-10#1)(2008-5#1)
laboratories and##9##2##(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#1)(2013-1#1)
laboratories are##7##2##(1994-12#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#2)
laboratories as##2##2##(1994-1#1)(2008-10#1)
laboratories by##3##2##(1992-11#1)(1994-6#1)(2008-10#1)
laboratories for##2##2##(1994-12#1)(2008-10#1)
laboratories from##4##2##(2008-10#3)(2008-5#1)
laboratories have shown that##2##4##(1991-12#1)(2008-8#1)
laboratories have##5##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
laboratories in Australia##2##3##(1997-8#1)(2008-12#1)
laboratories in the United States##2##5##(2008-4#1)(2008-9#1)
laboratories in##16##2##(1993-6#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#3)
laboratories involved in##3##3##(2008-10#1)(2008-12#1)(2010-11#1)
laboratories is##3##2##(1994-12#1)(2008-10#2)
laboratories of##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
laboratories on##2##2##(2008-11#1)(2010-5#1)
laboratories or##4##2##(1991-6#1)(2010-10#1)(2011-2#1)(2012-3#1)
laboratories revealed that##3##3##(2008-10#2)(2008-6#1)
laboratories that##2##2##(1995-3#1)(2008-11#1)
laboratories to##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)(2013-8#1)
laboratories took part in##2##4##(2008-10#2)
laboratories using##2##2##(2008-10#1)(2009-8#1)
laboratories were##3##2##(1990-8#1)(2008-12#1)(2008-6#1)
laboratories where##2##2##(1994-5#1)(2008-11#1)
laboratories with##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
laboratories##213##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#58)(2008-11#12)(2008-12#11)(2008-2#2)(2008-3#4)(2008-4#9)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#9)(2009-11#2)(2009-4#1)(2009-8#3)(2010-10#2)(2010-11#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#11)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#2)
laboratory analyses are##2##3##(1993-3#1)(1994-11#1)
laboratory analysis of##2##3##(2010-4#1)(2012-2#1)
laboratory analysis##7##2##(2008-10#4)(2010-4#1)(2012-2#1)(2013-1#1)
laboratory and clinical##7##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)
laboratory and field##3##3##(2008-10#2)(2010-8#1)
laboratory and the##5##3##(1993-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
laboratory and##54##2##(1991-3#1)(1993-1#1)(1994-12#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
laboratory animal model##2##3##(1992-3#1)(1996-12#1)
laboratory animal##3##2##(1992-3#1)(1996-12#1)(2008-10#1)
laboratory animals and##5##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-4#2)
laboratory animals##17##2##(1992-10#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-10#4)(2008-4#4)(2008-8#1)(2009-7#1)(2011-3#1)(2012-2#1)(2013-7#1)
laboratory are##2##2##(2008-10#1)(2011-2#1)
laboratory as##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
laboratory assay##2##2##(2008-10#2)
laboratory assays##2##2##(1997-6#1)(2008-10#1)
laboratory assessments##2##2##(2008-5#1)(2013-7#1)
laboratory at the##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
laboratory automation and##4##3##(2008-10#4)
laboratory automation##17##2##(2008-10#17)
laboratory based##2##2##(2008-10#1)(2008-7#1)
laboratory calibration of a nonimaging spectroradiometer##2##6##(2008-3#2)
laboratory calibration##3##2##(2008-3#3)
laboratory can##2##2##(1993-2#1)(2008-10#1)
laboratory colony##4##2##(1996-6#1)(2008-9#1)(2010-4#1)(2011-2#1)
laboratory conditions and##2##3##(1992-3#1)(2008-10#1)
laboratory conditions with##3##3##(2008-10#1)(2008-9#1)(2011-10#1)
laboratory conditions##31##2##(1992-3#1)(1992-8#1)(1993-6#1)(1996-12#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#3)
laboratory constructed##2##2##(2008-10#2)
laboratory criteria##2##2##(2008-11#1)(2008-7#1)
laboratory culture and##2##3##(1996-2#1)(2008-9#1)
laboratory culture##7##2##(1996-2#2)(2008-11#1)(2008-12#1)(2008-9#2)(2011-1#1)
laboratory cultures##4##2##(1994-8#2)(2011-1#2)
laboratory data was##2##3##(2012-2#1)(2013-1#1)
laboratory data##16##2##(1991-3#1)(1994-5#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-5#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#3)
laboratory detection##2##2##(2008-10#1)(2013-8#1)
laboratory diagnosis of##6##3##(2008-10#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
laboratory diagnosis##10##2##(1994-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
laboratory diagnostic##3##2##(1994-12#1)(2011-1#1)(2013-8#1)
laboratory diagnostics##3##2##(1994-12#2)(2013-8#1)
laboratory equipment##3##2##(2007-12#1)(2008-8#1)(2012-12#1)
laboratory examination##2##2##(1997-8#2)
laboratory experiences##2##2##(1992-11#1)(1997-2#1)
laboratory experiment##2##2##(2008-7#1)(2010-3#1)
laboratory experiments on##2##3##(1996-4#1)(2008-2#1)
laboratory experiments with##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
laboratory experiments##19##2##(1991-9#1)(1996-4#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#2)(2010-5#1)
laboratory findings and##2##3##(1993-5#1)(1997-3#1)
laboratory findings##10##2##(1990-6#1)(1990-9#1)(1993-5#2)(1994-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-6#1)(2011-2#1)
laboratory flight tunnel##2##3##(2011-2#2)
laboratory for studying##3##3##(2009-11#2)(2011-2#1)
laboratory for the##2##3##(2008-10#1)(2008-4#1)
laboratory for##12##2##(1991-8#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-11#2)(2011-2#1)(2013-8#1)
laboratory glassware##2##2##(2008-10#2)
laboratory has shown that##2##4##(1994-8#1)(2008-10#1)
laboratory has##9##2##(1992-6#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)
laboratory have shown that##2##4##(2008-10#1)(2008-3#1)
laboratory have shown##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
laboratory have##5##2##(1991-2#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
laboratory in the##2##3##(2008-11#1)(2010-4#1)
laboratory in##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-4#1)
laboratory information##2##2##(2008-10#1)(2013-1#1)
laboratory investigation##3##2##(1997-7#1)(2011-2#1)(2012-2#1)
laboratory investigations and##2##3##(2008-12#1)(2012-3#1)
laboratory investigations of##2##3##(1990-2#1)(2008-7#1)
laboratory investigations##14##2##(1990-2#1)(1990-3#1)(1992-11#1)(1994-6#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#2)
laboratory is##5##2##(1996-4#1)(2008-2#1)(2008-7#1)(2009-11#2)
laboratory maintenance of##2##3##(2008-9#2)
laboratory measurements of##2##3##(2008-3#1)(2011-1#1)
laboratory measurements##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
laboratory measures of##2##3##(2009-8#1)(2010-6#1)
laboratory measures##3##2##(1992-9#1)(2009-8#1)(2010-6#1)
laboratory medicine##8##2##(1994-12#6)(2008-10#1)(2012-1#1)
laboratory method##2##2##(2008-10#1)(2008-7#1)
laboratory methods##3##2##(1997-4#1)(2008-11#1)(2009-5#1)
laboratory mice##4##2##(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
laboratory microwave scattering measurements##2##4##(2008-2#2)
laboratory mixer##3##2##(2008-5#3)
laboratory mouse##2##2##(2008-6#1)(2009-5#1)
laboratory must##2##2##(2007-7#2)
laboratory of the##4##3##(2008-10#3)(2011-2#1)
laboratory of##10##2##(2007-12#1)(2008-10#4)(2008-12#1)(2010-12#2)(2010-6#1)(2011-2#1)
laboratory or clinical##3##3##(2007-11#1)(2009-11#1)(2011-2#1)
laboratory or##12##2##(1994-12#1)(1995-9#1)(2007-11#1)(2008-10#4)(2008-9#1)(2009-11#1)(2011-2#2)(2012-3#1)
laboratory parameters##9##2##(1990-5#1)(1996-1#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
laboratory physicians##3##2##(1994-12#2)(1997-2#1)
laboratory population was##3##3##(2008-10#2)(2011-2#1)
laboratory population##8##2##(2008-10#7)(2011-2#1)
laboratory populations of##2##3##(2008-8#1)(2008-9#1)
laboratory practice##3##2##(2007-8#1)(2008-10#1)(2008-12#1)
laboratory prepared##3##2##(2008-10#3)
laboratory procedures##4##2##(2008-5#1)(2008-7#1)(2009-8#1)(2013-7#1)
laboratory rats##2##2##(1992-1#1)(1992-12#1)
laboratory reference##2##2##(2008-10#1)(2008-3#1)
laboratory reports##2##2##(2007-7#1)(2008-2#1)
laboratory research##2##2##(2008-10#1)(2011-7#1)
laboratory results##10##2##(2008-10#3)(2008-2#2)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
laboratory revealed that##2##3##(2010-11#1)(2012-2#1)
laboratory rodents##4##2##(2008-4#4)
laboratory samples##2##2##(2008-10#1)(2011-2#1)
laboratory scale##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
laboratory sciences##3##2##(1994-12#3)
laboratory scientists##3##2##(1994-12#1)(2008-12#1)(2008-6#1)
laboratory service##4##2##(1993-2#2)(1997-3#1)(2008-6#1)
laboratory services##4##2##(1993-2#1)(1994-3#2)(2008-12#1)
laboratory setting##6##2##(1994-1#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
laboratory settings##2##2##(1994-3#1)(2008-5#1)
laboratory setup are##2##3##(2008-3#1)(2008-9#1)
laboratory should##2##2##(2007-7#1)(2011-2#1)
laboratory showed that##3##3##(1991-3#1)(1993-1#1)(2009-8#1)
laboratory staff##2##2##(1997-3#1)(2008-6#1)
laboratory stocks##2##2##(2008-9#1)(2009-5#1)
laboratory strain of##2##3##(1996-12#1)(2007-6#1)
laboratory strain##7##2##(1996-12#1)(2007-6#1)(2011-2#3)(2012-3#2)
laboratory strains of##3##3##(1996-6#1)(2012-3#2)
laboratory strains##6##2##(1996-6#1)(2011-2#1)(2012-3#4)
laboratory studies of##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
laboratory studies##19##2##(1994-8#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-2#1)
laboratory system##2##2##(2008-10#1)(2011-2#1)
laboratory techniques##5##2##(2007-11#1)(2007-7#2)(2008-7#1)(2012-2#1)
laboratory technologists and##2##3##(1994-12#1)(2008-12#1)
laboratory test##3##2##(1992-9#1)(1994-6#1)(1997-4#1)
laboratory testing for##2##3##(2008-10#1)(2013-1#1)
laboratory testing##12##2##(1994-12#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
laboratory tests and##2##3##(1996-2#1)(2009-4#1)
laboratory tests in##2##3##(1995-6#1)(2011-2#1)
laboratory tests##30##2##(1990-3#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-4#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)
laboratory to##12##2##(2008-10#5)(2008-11#1)(2008-5#2)(2010-5#1)(2011-1#1)(2011-2#2)
laboratory tool##2##2##(2008-10#1)(2012-2#1)
laboratory use##2##2##(1993-8#1)(2008-10#1)
laboratory using##7##2##(1990-11#1)(1990-2#1)(2008-10#4)(2012-2#1)
laboratory values##4##2##(1996-4#1)(2008-1#1)(2010-10#1)(2011-2#1)
laboratory variables##5##2##(2008-1#1)(2011-1#2)(2011-2#2)
laboratory was##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
laboratory were##4##2##(1993-1#1)(2008-10#3)
laboratory with the different##2##4##(2008-10#2)
laboratory with##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
laboratory yeast strains##2##3##(1996-6#2)
laboratory##955##1##(1990-11#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#5)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#38)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#5)(1996-6#6)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#12)(1997-4#8)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#3)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#3)(2008-1#12)(2008-10#216)(2008-11#21)(2008-12#22)(2008-2#33)(2008-3#39)(2008-4#25)(2008-5#25)(2008-6#14)(2008-7#35)(2008-8#16)(2008-9#35)(2009-11#5)(2009-3#4)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#11)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#10)(2010-5#5)(2010-6#10)(2010-8#6)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#57)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#10)(2012-2#18)(2012-3#13)(2013-1#23)(2013-7#5)(2013-8#6)
laboratory&quot##2##1##(2008-1#1)(2008-10#1)
laboratory's##2##1##(1997-2#1)(2012-12#1)
laboratory)##2##1##(1995-5#1)(2008-12#1)
laboratory- and##2##2##(2008-10#1)(2008-6#1)
laboratory-adapted##2##1##(1997-3#1)(2009-5#1)
laboratory-based studies##2##2##(2008-11#1)(2008-7#1)
laboratory-based survey of Campylobacter infections in##2##6##(2008-10#2)
laboratory-based##9##1##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)
laboratory-confirmed##2##1##(2009-5#1)(2013-1#1)
laboratory-made##10##1##(1990-8#1)(2008-10#8)(2008-5#1)
laboratory-prepared test##2##2##(2008-10#2)
laboratory-prepared##3##1##(2008-10#3)
laboratory-processed composite##2##2##(2008-7#2)
laboratory-reared##2##1##(2007-12#1)(2008-10#1)
laboratory-selected##2##1##(2008-10#1)(2011-2#1)
laboratory]##2##1##(2007-10#1)(2012-3#1)
labored##2##1##(2007-2#1)(2013-1#1)
laborers##9##1##(1990-12#1)(1997-6#2)(2009-10#1)(2009-12#5)
laboring##2##1##(2007-2#2)
laborious and time-consuming##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
laborious and##7##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#1)
laborious##22##1##(1995-11#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)
labour and puerperium##2##3##(2008-11#1)(2012-12#1)
labour and##8##2##(1994-3#1)(2007-12#1)(2007-8#1)(2008-11#2)(2010-3#1)(2012-12#1)(2013-1#1)
labour can##2##2##(1992-5#1)(1996-11#1)
labour could be##2##3##(1992-4#1)(2013-1#1)
labour in##5##2##(2007-7#1)(2008-10#1)(2009-7#2)(2013-1#1)
labour intensive##2##2##(1992-3#1)(2008-10#1)
labour##66##1##(1990-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-10#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#7)(1994-5#5)(1995-5#2)(1996-11#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-7#1)(2009-7#2)(2010-3#4)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2013-1#9)(2013-8#2)
labour-intensive and##2##2##(1993-9#1)(2008-7#1)
labour-intensive##3##1##(1993-9#1)(2008-10#1)(2008-7#1)
labral##7##1##(2007-11#1)(2007-12#4)(2008-8#2)
labrum##14##1##(2007-11#3)(2007-12#11)
labrusca##3##1##(2008-10#3)
labruscana 'Concord'##3##2##(2008-10#3)
labruscana##5##1##(2008-10#5)
labs##8##1##(2008-10#5)(2008-11#1)(2008-2#1)(2012-2#1)
labyrinth##10##1##(1991-2#2)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#3)
labyrinthectomy##2##1##(1993-9#2)
labyrinthine##3##1##(1991-2#1)(2008-12#1)(2008-9#1)
labyrinthitis##2##1##(2008-9#2)
lac operator##2##2##(1990-5#1)(1997-6#1)
lac operon##2##2##(1995-3#2)
lac promoter##4##2##(1992-3#1)(1992-9#1)(1995-2#1)(2008-10#1)
lac##19##1##(1990-5#5)(1992-3#1)(1992-9#1)(1994-12#1)(1995-2#1)(1995-3#4)(1997-6#3)(2008-10#2)(2009-8#1)
lacI(-) mutants were##2##3##(2008-4#2)
lacZ (encoding beta-galactosidase)##2##3##(1994-12#1)(1997-4#1)
lacZ alpha fragment##3##3##(1997-4#3)
lacZ alpha##5##2##(1990-7#1)(1991-9#1)(1997-4#3)
lacZ and##3##2##(1990-5#1)(1994-12#1)(1997-7#1)
lacZ as a reporter gene##2##5##(1991-9#1)(1997-6#1)
lacZ as##3##2##(1990-5#1)(1991-9#1)(1997-6#1)
lacZ beta-galactosidase##2##2##(1994-6#1)(1997-7#1)
lacZ expression##3##2##(1993-12#1)(1995-6#1)(1997-8#1)
lacZ fusion gene##2##3##(1993-9#1)(1995-3#1)
lacZ fusion##6##2##(1990-5#1)(1993-9#2)(1995-3#1)(2008-10#1)(2013-1#1)
lacZ fusions##3##2##(1990-5#1)(1993-12#1)(1997-7#1)
lacZ gene in##4##3##(1991-7#1)(1997-4#1)(2008-11#2)
lacZ gene##11##2##(1991-7#1)(1993-12#2)(1997-4#3)(1997-8#1)(2008-11#4)
lacZ in##2##2##(1997-4#1)(2009-12#1)
lacZ reporter gene##7##3##(1993-12#1)(1993-9#1)(1994-12#1)(1997-4#2)(2008-8#1)(2009-12#1)
lacZ reporter##10##2##(1991-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1997-4#2)(1997-6#2)(2008-8#1)(2009-12#1)
lacZ##70##1##(1990-5#4)(1990-7#1)(1991-12#1)(1991-7#2)(1991-9#2)(1992-5#1)(1993-12#12)(1993-9#3)(1994-12#3)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-3#2)(1997-4#15)(1997-6#3)(1997-7#3)(1997-8#3)(2008-10#1)(2008-11#4)(2008-8#1)(2009-12#2)(2013-1#1)
lacZ-based vectors##2##2##(1993-12#2)
lacZ-based##3##1##(1993-12#3)
laccase activity##5##2##(2008-10#5)
laccase and##4##2##(2008-10#2)(2008-5#2)
laccase from##3##2##(2008-10#2)(2008-6#1)
laccase##31##1##(2008-10#22)(2008-5#2)(2008-6#2)(2009-2#2)(2011-1#2)(2013-1#1)
laccase-catalysed polymerization of natural phenols##2##5##(2011-1#2)
laceration in##2##2##(2007-8#2)
laceration##7##1##(1991-3#1)(2007-8#3)(2010-1#1)(2011-1#1)(2012-2#1)
lacerations##6##1##(1990-2#1)(1995-9#1)(2007-11#1)(2007-7#1)(2010-1#1)(2012-2#1)
lacidipine##4##1##(1994-9#3)(2008-10#1)
lack a glycine at this position##2##6##(2008-8#2)
lack a##14##2##(1990-2#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#3)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-2#1)
lack any##5##2##(1993-3#1)(1994-2#1)(2008-5#1)(2008-7#2)
lack emotional##2##2##(2008-1#1)(2013-1#1)
lack functional##2##2##(1996-2#1)(1997-7#1)
lack knowledge and##2##3##(1990-6#1)(1995-1#1)
lack of a##38##3##(1990-11#1)(1990-2#1)(1991-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-6#1)(1995-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
lack of access to##3##4##(1996-8#1)(2008-10#1)(2010-10#1)
lack of access##4##3##(1996-8#1)(2008-10#1)(2008-4#1)(2010-10#1)
lack of accuracy##2##3##(2008-11#1)(2008-2#1)
lack of activity##3##3##(1995-11#1)(1995-12#1)(2008-7#1)
lack of additional##2##3##(2008-12#1)(2011-2#1)
lack of adequate testing##3##4##(2008-9#2)(2010-5#1)
lack of adequate##8##3##(2008-10#1)(2008-11#1)(2008-9#3)(2010-5#1)(2010-6#1)(2011-3#1)
lack of an##9##3##(1993-12#1)(1994-12#1)(1995-2#1)(2008-7#1)(2010-12#1)(2011-10#1)(2011-2#1)(2013-1#2)
lack of animal##3##3##(1995-2#1)(2008-12#1)(2008-9#1)
lack of any##4##3##(2008-10#1)(2008-5#1)(2010-10#1)(2013-8#1)
lack of appropriate##2##3##(2008-10#1)(2008-9#1)
lack of association of##2##4##(2007-2#1)(2008-10#1)
lack of association##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
lack of attention##3##3##(1994-2#1)(2008-12#1)(2012-2#1)
lack of available##4##3##(1990-9#1)(1992-1#1)(2007-10#1)(2011-2#1)
lack of awareness and##2##4##(2007-2#1)(2009-4#1)
lack of awareness of##2##4##(2008-10#1)(2011-2#1)
lack of awareness##7##3##(1996-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
lack of clarity##2##3##(2008-12#2)
lack of common##2##3##(2010-8#1)(2013-8#1)
lack of competition##2##3##(1992-3#1)(2008-11#1)
lack of confidence##2##3##(2008-10#1)(2008-12#1)
lack of consensus on##2##4##(2008-5#1)(2012-12#1)
lack of consensus##6##3##(1995-5#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
lack of control##3##3##(1992-3#1)(2009-7#1)(2013-1#1)
lack of correlation between##4##4##(1991-12#1)(2008-10#2)(2010-6#1)
lack of correlation##8##3##(1991-12#1)(1996-7#1)(2008-10#4)(2008-3#1)(2010-6#1)
lack of data##6##3##(2007-11#1)(2008-11#2)(2008-8#1)(2010-10#1)(2011-2#1)
lack of desquamation##2##3##(2008-5#2)
lack of discussion##2##3##(2008-11#1)(2008-8#1)
lack of education##4##3##(2007-10#1)(2008-1#1)(2010-8#1)(2013-8#1)
lack of effect of##2##4##(1990-12#1)(1991-6#1)
lack of effect##5##3##(1990-12#1)(1991-6#1)(1995-12#1)(2012-2#1)(2013-1#1)
lack of effective##3##3##(1990-7#1)(2008-11#1)(2008-9#1)
lack of efficacy##2##3##(2008-7#1)(2011-2#1)
lack of efficient##2##3##(2008-10#1)(2008-12#1)
lack of evidence##7##3##(1995-2#1)(2008-11#2)(2008-12#1)(2011-10#1)(2011-2#1)(2013-8#1)
lack of exchange##2##3##(2007-11#1)(2008-10#1)
lack of expression of##4##4##(1991-2#1)(1992-3#1)(2008-9#1)(2009-8#1)
lack of familiarity with##2##4##(2007-12#1)(2011-2#1)
lack of family##2##3##(1994-1#1)(2008-7#1)
lack of genetic##2##3##(2008-10#1)(2008-5#1)
lack of improvement##2##3##(2007-12#1)(2008-10#1)
lack of influence##2##3##(2008-6#1)(2012-3#1)
lack of information concerning##2##4##(2008-6#1)(2010-3#1)
lack of information in##2##4##(1992-2#2)
lack of information on##3##4##(1997-3#1)(2012-2#2)
lack of information##9##3##(1992-2#2)(1993-3#1)(1997-3#1)(2008-6#1)(2010-3#1)(2012-12#1)(2012-2#2)
lack of informed consent##2##4##(1993-2#2)
lack of inhibition of##2##4##(1992-5#1)(1996-12#1)
lack of inhibition##3##3##(1992-5#1)(1995-6#1)(1996-12#1)
lack of insulin##2##3##(2008-10#1)(2008-3#1)
lack of interest##3##3##(2008-5#1)(2010-3#1)(2013-1#1)
lack of judgment and insight##2##5##(2008-6#2)
lack of knowledge about the##3##5##(1996-11#1)(2008-3#1)(2009-11#1)
lack of knowledge about##5##4##(1996-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#1)
lack of knowledge and##6##4##(1990-6#1)(2008-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)
lack of knowledge of##3##4##(2008-1#1)(2008-11#1)(2012-3#1)
lack of knowledge to help patients to quit (OR = 0##2##9##(2011-2#2)
lack of knowledge##22##3##(1990-6#1)(1996-11#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)
lack of natural##2##3##(2008-10#2)
lack of physical activity##9##4##(2008-11#1)(2013-8#8)
lack of physical##11##3##(2008-11#1)(2008-3#1)(2009-4#1)(2013-8#8)
lack of policy##2##3##(2012-2#1)(2013-8#1)
lack of power##2##3##(2008-8#1)(2009-3#1)
lack of proper##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
lack of research in this area##2##6##(2012-12#1)(2013-8#1)
lack of research in##3##4##(2007-11#1)(2012-12#1)(2013-8#1)
lack of resistance##2##3##(2008-12#1)(2009-8#1)
lack of resources and##4##4##(1997-3#1)(2008-1#1)(2010-12#1)(2012-2#1)
lack of resources##5##3##(1996-1#1)(1997-3#1)(2008-1#1)(2010-12#1)(2012-2#1)
lack of response##4##3##(2008-8#1)(2011-2#1)(2013-1#2)
lack of scientific##2##3##(1995-12#1)(1997-7#1)
lack of selectivity##2##3##(1997-1#1)(2008-5#1)
lack of sensitivity and##2##4##(2008-4#1)(2011-2#1)
lack of sensitivity##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
lack of significant differences##2##4##(2010-8#1)(2013-1#1)
lack of significant##4##3##(2008-10#2)(2010-8#1)(2013-1#1)
lack of social##4##3##(1992-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
lack of spatial##3##3##(1995-11#1)(2008-10#2)
lack of specific##6##3##(1990-3#1)(2008-4#2)(2008-9#1)(2012-1#1)(2013-8#1)
lack of standard##2##3##(1997-6#1)(2012-2#1)
lack of standardization of##2##4##(2008-10#1)(2012-2#1)
lack of standardization##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
lack of structural##3##3##(1994-2#1)(2008-7#1)(2009-12#1)
lack of studies##3##3##(2008-11#1)(2008-7#1)(2009-7#1)
lack of sufficient##2##3##(2008-11#1)(2012-2#1)
lack of suitable##2##3##(2007-6#1)(2013-1#1)
lack of support##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
lack of systematic##2##3##(1994-6#1)(2011-2#1)
lack of the##7##3##(1994-7#1)(1994-8#1)(1997-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
lack of toxicity##3##3##(1991-12#1)(2008-10#1)(2009-4#1)
lack of training##2##3##(2008-9#1)(2012-3#1)
lack of transparency##3##3##(2008-11#1)(2011-2#2)
lack of typical##4##3##(2007-12#1)(2008-5#1)(2009-8#1)(2013-8#1)
lack of understanding of the##2##5##(2008-11#1)(2008-7#1)
lack of understanding##3##3##(2008-11#1)(2008-7#1)(2010-3#1)
lack of##633##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-2#3)(1992-3#3)(1992-5#2)(1992-9#1)(1993-12#2)(1993-2#5)(1993-3#6)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#4)(1995-11#4)(1995-12#7)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#1)(1996-3#7)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#2)(2007-10#5)(2007-11#10)(2007-12#6)(2007-2#5)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#11)(2008-10#78)(2008-11#39)(2008-12#22)(2008-2#3)(2008-3#14)(2008-4#10)(2008-5#17)(2008-6#9)(2008-7#24)(2008-8#11)(2008-9#18)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#4)(2010-8#7)(2011-1#5)(2011-10#2)(2011-2#40)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#22)(2012-3#10)(2013-1#27)(2013-8#22)
lack specific##2##2##(1990-2#1)(2008-7#1)
lack sufficient##3##2##(1992-6#1)(2013-1#1)(2013-8#1)
lack the required##2##3##(2008-10#1)(2009-9#1)
lack the##16##2##(1994-1#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lack##740##1##(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#5)(1993-3#8)(1993-5#1)(1993-6#4)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#10)(1995-2#8)(1995-3#3)(1995-5#2)(1995-6#7)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#8)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#2)(2006-10#2)(2006-6#2)(2007-10#6)(2007-11#11)(2007-12#8)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#13)(2008-10#84)(2008-11#39)(2008-12#23)(2008-2#4)(2008-3#15)(2008-4#12)(2008-5#18)(2008-6#9)(2008-7#28)(2008-8#17)(2008-9#18)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#4)(2010-6#4)(2010-8#7)(2011-1#5)(2011-10#2)(2011-2#42)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#25)(2012-3#13)(2013-1#31)(2013-8#28)
lacked a##8##2##(1990-7#1)(1993-3#1)(1995-6#1)(1997-7#1)(2008-10#2)(2009-8#1)(2010-3#1)
lacked both##3##2##(1992-3#1)(1995-2#1)(2008-5#1)
lacked knowledge##2##2##(2008-1#1)(2011-1#1)
lacked the ability to##2##4##(1992-12#1)(2009-12#1)
lacked the##9##2##(1990-5#1)(1991-8#1)(1992-12#1)(2008-10#4)(2008-8#1)(2009-12#1)
lacked##63##1##(1990-5#3)(1990-7#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-1#2)(2008-10#14)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#2)
lacking Gla##2##2##(1991-12#2)
lacking a C3 ketone##2##4##(1997-1#2)
lacking a functional##2##3##(1992-8#1)(1996-6#1)
lacking a##12##2##(1992-8#1)(1993-6#1)(1996-6#1)(1997-1#2)(1997-2#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
lacking an##2##2##(1993-3#1)(2010-5#1)
lacking any##2##2##(1992-6#1)(1995-2#1)
lacking both##4##2##(1992-10#1)(1993-12#1)(1997-3#1)(2013-1#1)
lacking for most##2##3##(2010-12#1)(2010-5#1)
lacking for##3##2##(2010-12#1)(2010-5#1)(2011-2#1)
lacking in##14##2##(1995-11#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-8#2)(2012-2#1)
lacking knowledge##2##2##(1996-12#1)(2007-11#1)
lacking or overproducing##2##3##(1995-8#1)(2012-3#1)
lacking or##4##2##(1995-8#1)(1996-12#1)(2008-5#1)(2012-3#1)
lacking phytoene synthase##2##3##(2009-10#2)
lacking the transmembrane##2##3##(1994-11#1)(1997-4#1)
lacking the##18##2##(1990-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#3)(2009-8#1)(2011-2#1)
lacking these##2##2##(1994-3#1)(1995-2#1)
lacking this##2##2##(1992-6#1)(2008-10#1)
lacking with##2##2##(1992-3#1)(2013-1#1)
lacking##217##1##(1990-5#2)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#2)(1995-6#4)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#4)(2007-7#1)(2008-1#4)(2008-10#26)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#14)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#1)
lacks a##4##2##(1992-11#1)(2008-12#1)(2009-8#1)(2011-1#1)
lacks an##3##2##(1992-12#1)(1992-6#1)(1993-3#1)
lacks catalytic activity##2##3##(2012-12#2)
lacks sensitivity for##2##3##(2008-10#1)(2008-6#1)
lacks sensitivity##3##2##(1997-4#1)(2008-10#1)(2008-6#1)
lacks some##2##2##(2008-10#1)(2010-10#1)
lacks the C-terminal##3##3##(1994-5#1)(2008-8#1)(2010-5#1)
lacks the typical##2##3##(1995-2#1)(1997-6#1)
lacks the##28##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-6#2)(2008-10#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#2)(2010-5#1)(2011-2#1)(2012-3#1)
lacks##75##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lacquer film were##2##3##(2008-10#2)
lacquer film##9##2##(2008-10#9)
lacquer films were##2##3##(2008-10#2)
lacquer films##7##2##(2008-10#7)
lacquer##22##1##(2008-10#21)(2008-5#1)
lacrimal gland##4##2##(2011-1#1)(2013-8#3)
lacrimal glands##4##2##(2011-1#2)(2011-2#2)
lacrimal##15##1##(1993-5#1)(1995-9#1)(2007-11#1)(2011-1#6)(2011-2#2)(2013-8#4)
lactalbumin hydrolysate and yeast##2##4##(2008-11#2)
lactalbumin hydrolysate##3##2##(2008-11#3)
lactalbumin##4##1##(1990-12#1)(2008-11#3)
lactam##4##1##(1993-8#1)(2007-7#2)(2009-7#1)
lactamase##2##1##(2007-7#1)(2010-2#1)
lactase activity of##2##3##(1991-12#2)
lactase activity##3##2##(1991-12#3)
lactase##9##1##(1991-12#6)(1992-9#1)(2013-1#2)
lactate accumulation##5##2##(2008-10#2)(2008-11#3)
lactate and ammonia##2##3##(2008-11#1)(2008-7#1)
lactate and pyruvate##3##3##(1994-9#1)(1995-8#1)(2008-10#1)
lactate and##12##2##(1994-5#1)(1994-9#1)(1995-8#1)(2008-10#3)(2008-11#3)(2008-7#2)(2012-3#1)
lactate as##2##2##(1994-8#1)(2008-5#1)
lactate concentration##7##2##(2008-10#2)(2008-6#2)(2012-12#1)(2013-8#2)
lactate dehydrogenase (LDH)##12##3##(1992-11#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-3#1)(2008-10#1)(2008-11#3)(2013-1#1)
lactate dehydrogenase activity##6##3##(1992-11#1)(2008-11#2)(2008-7#1)(2012-2#2)
lactate dehydrogenase and##2##3##(1995-3#1)(2012-3#1)
lactate dehydrogenase from##2##3##(1994-11#1)(2008-4#1)
lactate dehydrogenase##50##2##(1990-3#1)(1990-5#1)(1992-11#5)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#3)(1995-3#3)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#8)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
lactate dehydrogenase-B processed pseudogene##2##4##(1990-8#2)
lactate dehydrogenase-B##4##2##(1990-8#4)
lactate flux was##2##3##(1991-5#2)
lactate from glucose##2##3##(2008-11#2)
lactate from##3##2##(1992-6#1)(2008-11#2)
lactate in##3##2##(2008-10#2)(2008-4#1)
lactate levels##2##2##(2008-5#1)(2009-3#1)
lactate oxidase##2##2##(2008-10#2)
lactate production from glucose##2##4##(1990-11#2)
lactate production from##3##3##(1990-11#2)(1991-5#1)
lactate production##13##2##(1990-11#2)(1991-5#3)(1992-9#1)(2008-11#5)(2008-6#1)(2008-7#1)
lactate transport##2##2##(1991-5#2)
lactate was##3##2##(1994-8#1)(2008-11#2)
lactate yield##2##2##(1994-5#1)(2008-7#1)
lactate##171##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#4)(1991-3#1)(1991-5#9)(1991-9#1)(1992-11#5)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#3)(1995-11#3)(1995-12#6)(1995-3#3)(1995-5#1)(1995-8#1)(1997-1#1)(2007-12#1)(2007-7#2)(2008-10#24)(2008-11#28)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#12)(2008-9#1)(2009-1#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
lactate/pyruvate##5##1##(1995-8#4)(1997-3#1)
lactatedehydrogenase activity##2##2##(2008-11#2)
lactating camels##2##2##(2011-2#2)
lactating cows##2##2##(1990-6#1)(2012-2#1)
lactating mammary##3##2##(1990-11#1)(1991-12#1)(1992-12#1)
lactating mothers##4##2##(2008-10#1)(2008-8#1)(2011-2#2)
lactating rats##6##2##(1990-11#4)(1994-6#2)
lactating##23##1##(1990-11#5)(1990-6#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-6#2)(2008-10#1)(2008-8#2)(2010-2#1)(2011-2#4)(2012-2#1)(2013-1#2)
lactation and##2##2##(1997-6#1)(2008-7#1)
lactation by##2##2##(2008-12#1)(2008-9#1)
lactation diet##2##2##(2010-2#1)(2012-2#1)
lactation in##5##2##(1992-5#1)(2007-9#1)(2008-9#2)(2012-12#1)
lactation on##2##2##(2007-2#1)(2013-8#1)
lactation performance##2##2##(2012-2#2)
lactation period##2##2##(1991-11#1)(2012-2#1)
lactation stage##2##2##(2012-2#2)
lactation##50##1##(1991-11#1)(1991-12#1)(1992-5#3)(1996-8#3)(1997-6#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#10)(2010-2#4)(2012-12#4)(2012-2#9)(2012-3#1)(2013-8#1)
lactational##2##1##(1992-2#1)(2008-10#1)
lactic acid (pH##2##3##(2010-3#2)
lactic acid and##3##3##(2008-10#2)(2008-5#1)
lactic acid as a##2##4##(2008-6#2)
lactic acid as##4##3##(2008-6#4)
lactic acid at##2##3##(2008-5#1)(2008-6#1)
lactic acid bacteria (LAB) and##2##5##(2009-5#1)(2013-1#1)
lactic acid bacteria (LAB) strains##2##5##(2008-6#1)(2012-2#1)
lactic acid bacteria (LAB)##5##4##(2008-6#1)(2009-5#1)(2012-2#2)(2013-1#1)
lactic acid bacteria and##3##4##(2008-11#1)(2012-2#1)(2013-1#1)
lactic acid bacteria##21##3##(1995-8#1)(1997-4#3)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2012-2#4)(2013-1#2)
lactic acid by the##2##4##(1990-12#1)(2008-6#1)
lactic acid by##3##3##(1990-12#1)(2008-6#2)
lactic acid dehydrogenase##2##3##(2013-7#2)
lactic acid from##3##3##(2008-6#3)
lactic acid in##6##3##(2008-10#5)(2013-8#1)
lactic acid produced by##2##4##(2008-6#2)
lactic acid produced##3##3##(2008-6#3)
lactic acid production##5##3##(2008-6#3)(2008-7#2)
lactic acid productivity##2##3##(2008-6#2)
lactic acid to##4##3##(2008-5#1)(2008-6#1)(2012-2#2)
lactic acid was produced##2##4##(2008-6#2)
lactic acid##83##2##(1990-12#1)(1990-3#1)(1995-8#1)(1997-4#3)(2008-10#11)(2008-11#6)(2008-5#6)(2008-6#29)(2008-7#4)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#2)(2011-1#1)(2012-2#7)(2013-1#5)(2013-7#2)(2013-8#1)
lactic acidosis and##4##3##(1990-12#2)(1990-3#2)
lactic acidosis##6##2##(1990-12#2)(1990-3#2)(1991-11#1)(2008-8#1)
lactic acids##2##2##(1997-4#1)(2008-10#1)
lactic and##3##2##(2008-10#1)(2008-5#2)
lactic dehydrogenase##3##2##(1990-5#2)(2008-5#1)
lactic##109##1##(1990-12#3)(1990-3#3)(1990-5#2)(1991-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-4#4)(2008-10#17)(2008-11#6)(2008-5#11)(2008-6#30)(2008-7#5)(2008-8#2)(2009-5#2)(2010-10#2)(2010-3#2)(2011-1#1)(2012-2#7)(2013-1#5)(2013-7#2)(2013-8#1)
lacticin 3147##4##2##(2011-1#4)
lactis and Saccharomyces cerevisiae##2##4##(2008-6#2)
lactis and##3##2##(1993-2#1)(2008-6#2)
lactis bv##2##2##(2008-6#2)
lactis##30##1##(1991-5#2)(1991-9#2)(1992-3#1)(1993-2#1)(1994-12#1)(1995-8#3)(1997-4#2)(2008-10#1)(2008-5#2)(2008-6#9)(2008-7#4)(2012-2#2)
lactobacilli exhibit##2##2##(2008-11#1)(2012-2#1)
lactobacilli##12##1##(1991-3#2)(1994-6#1)(1997-4#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-2#2)
lactobacillus##3##1##(2008-12#1)(2012-2#2)
lactofen##7##1##(2008-10#7)
lactofermentum##2##1##(2008-6#2)
lactoferrin gene expression levels##2##4##(2008-10#2)
lactoferrin gene##6##2##(1992-12#3)(2008-10#3)
lactoferrin##20##1##(1992-12#4)(1996-12#8)(2008-10#6)(2013-8#2)
lactogenic hormones##2##2##(1991-12#1)(1995-11#1)
lactone form##2##2##(2008-10#2)
lactone quorum-sensing signals##2##3##(2008-9#2)
lactone##18##1##(1991-6#2)(1994-3#2)(1995-2#3)(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#2)(2008-9#2)(2009-6#2)
lactones (AHLs)##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
lactones##10##1##(1996-5#3)(2007-11#1)(2008-10#2)(2008-9#3)(2013-1#1)
lactonization##4##1##(1994-3#2)(2010-7#2)
lactonized##2##1##(1994-3#2)
lactose and##5##2##(1990-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2010-5#1)
lactose content##2##2##(2012-2#1)(2013-1#1)
lactose medium##2##2##(2008-6#2)
lactose monohydrate##4##2##(2013-8#4)
lactose permease##2##2##(1993-11#2)
lactose repressor from Escherichia coli##2##5##(1993-11#2)
lactose##49##1##(1990-2#3)(1993-11#7)(1994-3#1)(1994-6#2)(1994-9#4)(1996-12#1)(1996-5#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-6#7)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
lactotropes##3##1##(1993-11#2)(1994-9#1)
lactucae on Lettuce##2##3##(2008-10#2)
lactucae on##3##2##(2008-10#3)
lactucae sporangia##3##2##(2008-10#3)
lactucae##18##1##(2008-10#18)
lactulose administration##2##2##(1996-6#2)
lactulose##7##1##(1990-2#3)(1992-12#1)(1996-6#3)
lacunae##7##1##(2007-10#1)(2011-1#5)(2011-2#1)
lacunar infarct in patients without hypertension##3##6##(2007-10#3)
lacunar infarct in##4##3##(2007-10#4)
lacunar infarct##6##2##(2007-10#6)
lacunar infarction##4##2##(2007-10#2)(2008-7#1)(2009-10#1)
lacunar infarctions##2##2##(2007-10#2)
lacunar infarcts in##2##3##(2007-10#2)
lacunar infarcts##5##2##(2007-10#5)
lacunar syndrome##8##2##(2007-10#3)(2009-10#5)
lacunar##29##1##(2007-10#20)(2008-7#2)(2009-10#6)(2009-11#1)
lacustrine##4##1##(2008-5#3)(2013-8#1)
ladder and##2##2##(2008-1#1)(2008-9#1)
ladder##25##1##(1994-10#2)(1994-12#2)(1995-2#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#1)
ladder&quot##2##1##(1990-12#2)
laddering##3##1##(2008-10#2)(2008-11#1)
ladders##4##1##(1994-3#1)(1995-6#1)(2008-2#1)(2013-7#1)
laden##2##1##(2008-8#2)
lady who presented with a history of##2##7##(2008-12#1)(2012-2#1)
lady who presented with##4##4##(2008-1#1)(2008-12#1)(2012-2#1)(2013-1#1)
lady who##7##2##(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
lady with##9##2##(2007-7#3)(2007-8#1)(2008-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)
lady##28##1##(1992-12#2)(2007-7#7)(2007-8#2)(2008-1#2)(2008-12#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
ladybirds##2##1##(2008-12#1)(2008-9#1)
laevis PARP##3##2##(1993-12#3)
laevis development##2##2##(1993-6#1)(2008-6#1)
laevis egg extracts##3##3##(1993-2#1)(2008-8#1)(2008-9#1)
laevis egg##6##2##(1993-2#2)(1993-6#1)(2008-8#1)(2008-9#2)
laevis eggs##2##2##(1993-2#1)(1993-6#1)
laevis gamma-cry##3##2##(1993-6#3)
laevis genomic##2##2##(1993-6#1)(1994-12#1)
laevis were##2##2##(1990-12#1)(2010-3#1)
laevis##74##1##(1990-12#2)(1991-12#4)(1991-6#2)(1992-3#3)(1993-12#5)(1993-2#3)(1993-5#6)(1993-6#14)(1994-12#2)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#4)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2010-2#1)(2010-3#2)(2011-2#3)(2013-8#1)
laevis)##5##1##(1996-6#2)(2008-10#1)(2009-4#2)
laeviuscula##3##1##(2008-6#3)
lag and##3##2##(1992-11#1)(1997-6#1)(2008-11#1)
lag behind their##2##3##(2008-9#1)(2011-2#1)
lag behind##8##2##(1995-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
lag between##2##2##(2008-7#1)(2008-8#1)
lag distances##3##2##(2008-10#3)
lag in##2##2##(2008-7#1)(2010-1#1)
lag or##2##2##(2007-2#1)(2008-9#1)
lag period##6##2##(2008-10#4)(2008-6#1)(2008-7#1)
lag phase and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
lag phase of##2##3##(1995-12#1)(2011-1#1)
lag phase##19##2##(1990-7#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#6)(2012-2#1)
lag phases##3##2##(2008-11#1)(2008-5#2)
lag phenomenon##2##2##(2008-7#2)
lag time before the##2##4##(1990-8#1)(2008-6#1)
lag time##15##2##(1990-8#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
lag times from##2##3##(2008-5#1)(2011-2#1)
lag times of##2##3##(2008-5#2)
lag times##5##2##(2008-5#4)(2011-2#1)
lag##96##1##(1990-7#1)(1990-8#1)(1991-8#1)(1992-11#1)(1993-6#3)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1997-3#1)(1997-6#3)(1997-7#1)(2007-11#2)(2007-2#3)(2008-10#13)(2008-11#6)(2008-12#1)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#2)(2010-1#1)(2010-8#1)(2011-1#4)(2011-2#14)(2012-12#1)(2012-2#3)(2013-1#1)
lag-2##4##1##(1994-12#4)
lag-phase duration##2##2##(2008-11#2)
lagenophorae##3##1##(2008-10#3)
lager beers##2##2##(2008-10#2)
lagged##4##1##(1997-3#1)(2008-10#1)(2013-1#2)
lagging##4##1##(1992-5#1)(1993-11#1)(2008-10#1)(2010-2#1)
lagging-strand##5##1##(1992-3#5)
lagoon and##2##2##(2008-12#1)(2011-2#1)
lagoon##16##1##(2007-5#4)(2008-10#1)(2008-12#1)(2008-5#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-7#3)
lags behind##3##2##(2008-11#1)(2010-12#1)(2012-2#1)
lags##5##1##(2008-11#1)(2008-8#2)(2010-12#1)(2012-2#1)
lagunculariae##2##1##(2010-3#2)
lahorensis Bij##2##2##(2008-12#2)
lahorensis Mesh##2##2##(2008-12#2)
lahorensis##8##1##(2008-12#8)
laid a##2##2##(2008-9#1)(2011-2#1)
laid by##2##2##(2008-3#1)(2008-9#1)
laid down in the##2##4##(1997-5#1)(2008-11#1)
laid down in##3##3##(1991-11#1)(1997-5#1)(2008-11#1)
laid down to##2##3##(2008-1#1)(2008-10#1)
laid down##12##2##(1991-11#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2012-2#2)
laid in##3##2##(2008-12#2)(2008-8#1)
laid on##11##2##(1990-3#4)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#1)
laid out by##2##3##(2008-10#1)(2011-1#1)
laid out##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
laid the foundation for##2##4##(2008-10#1)(2009-3#1)
laid the##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
laid##45##1##(1990-3#4)(1991-11#1)(1991-6#1)(1995-2#1)(1996-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)
lake and##8##2##(2008-10#4)(2008-8#1)(2011-2#1)(2012-3#2)
lake area##2##2##(2010-6#2)
lake fish assemblage##2##3##(2010-8#2)
lake in##2##2##(2008-10#1)(2013-8#1)
lake level fluctuations##2##3##(1996-6#2)
lake sediment samples##3##3##(2008-10#3)
lake sediment##5##2##(1992-3#1)(2008-10#4)
lake sediments##3##2##(1991-8#1)(2008-10#2)
lake water and##3##3##(2008-10#2)(2013-8#1)
lake water sample##2##3##(2008-10#2)
lake water samples by##2##4##(2008-10#2)
lake water samples##6##3##(2008-10#6)
lake water##19##2##(2008-10#18)(2013-8#1)
lake##65##1##(1990-11#1)(1991-8#2)(1992-3#2)(1996-6#5)(1996-8#1)(2008-10#35)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-6#2)(2010-8#2)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#4)
lakes and##3##2##(1996-9#1)(2008-5#1)(2010-6#1)
lakes##26##1##(1991-8#1)(1996-9#2)(2008-2#1)(2008-5#3)(2008-8#4)(2008-9#2)(2010-6#5)(2013-1#6)(2013-8#2)
lakoocha extract##2##2##(2008-5#2)
lakoocha##7##1##(2008-5#7)
lamb meat##2##2##(2010-4#2)
lamb##15##1##(1991-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#6)
lambda &gt##2##2##(2008-3#2)
lambda &lt##4##2##(2008-2#2)(2008-3#2)
lambda -##2##2##(2007-12#2)
lambda = 0##6##3##(2008-2#2)(2008-3#4)
lambda = 1##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
lambda = 3##2##3##(2007-12#1)(2008-3#1)
lambda = 632##3##3##(2008-3#3)
lambda = 633 nm##3##4##(2008-3#3)
lambda = 633##4##3##(2008-3#4)
lambda =##31##2##(2007-11#1)(2007-12#4)(2008-2#8)(2008-3#18)
lambda DNA##7##2##(1991-9#1)(1994-11#2)(1995-2#1)(1995-3#1)(2008-11#1)(2008-2#1)
lambda EMBL3##2##2##(1993-8#1)(1994-11#1)
lambda EMBL4##2##2##(1991-6#1)(1993-2#1)
lambda MCP9##2##2##(1994-11#2)
lambda N antitermination protein##2##4##(1995-3#2)
lambda and##4##2##(1992-6#1)(1994-11#1)(1996-5#1)(2008-8#1)
lambda cI repressor##2##3##(1992-4#1)(1995-8#1)
lambda clones##2##2##(1992-3#1)(1996-6#1)
lambda from##2##2##(1992-6#1)(2008-3#1)
lambda gt 11 cDNA library##3##5##(1990-7#1)(2008-11#1)(2008-8#1)
lambda gt##4##2##(1990-7#1)(1991-6#1)(2008-11#1)(2008-8#1)
lambda gt11 cDNA library##3##4##(1990-8#1)(1991-12#1)(1993-6#1)
lambda gt11##7##2##(1990-8#1)(1991-12#2)(1992-8#1)(1993-6#1)(1994-6#1)(1994-8#1)
lambda has##2##2##(1992-6#1)(1994-11#1)
lambda in##2##2##(1994-11#2)
lambda is a##2##3##(1992-6#1)(2008-8#1)
lambda is reduced to 0##2##5##(2008-3#2)
lambda is the wavelength##2##4##(2008-3#2)
lambda is the##4##3##(2008-2#1)(2008-3#2)(2008-8#1)
lambda is##10##2##(1992-6#1)(2008-2#1)(2008-3#4)(2008-8#4)
lambda libraries##2##2##(1991-9#1)(1995-6#1)
lambda light chain disease##2##4##(1992-2#2)
lambda light chain##4##3##(1992-2#2)(2008-11#1)(2009-3#1)
lambda light##5##2##(1992-2#2)(2008-11#2)(2009-3#1)
lambda phage DNA##2##3##(1990-12#1)(1995-8#1)
lambda phage##5##2##(1990-12#1)(1990-5#1)(1994-12#2)(1995-8#1)
lambda plasmid DNA replication##3##4##(1994-11#3)
lambda plasmid replication##2##3##(1994-11#2)
lambda plasmid##5##2##(1994-11#5)
lambda to##2##2##(1992-6#1)(2008-8#1)
lambda##171##1##(1990-12#3)(1990-5#6)(1990-7#1)(1990-8#1)(1991-12#2)(1991-6#2)(1991-9#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#8)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#5)(1994-11#17)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#3)(1995-2#4)(1995-3#5)(1995-6#3)(1995-8#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#8)(2008-10#7)(2008-11#4)(2008-2#13)(2008-3#35)(2008-4#1)(2008-8#10)(2008-9#2)(2009-3#1)
lambda(-4##2##1##(2008-2#2)
lambda(1) and##2##2##(2008-10#1)(2008-3#1)
lambda(1)##4##1##(2008-10#2)(2008-3#2)
lambda(2)##3##1##(2008-10#1)(2008-3#2)
lambda(2))##2##1##(2008-10#1)(2008-3#1)
lambda(SFS)(max)##2##1##(2008-10#2)
lambda(e) is##2##2##(2008-3#2)
lambda(em)##5##1##(1996-5#1)(2008-10#4)
lambda(ex) =##2##2##(2008-10#1)(2008-2#1)
lambda(i) = 3##2##3##(1997-5#2)
lambda(i) =##4##2##(1997-5#4)
lambda(i)##6##1##(1997-5#5)(2008-3#1)
lambda(max) and##2##2##(2008-10#1)(2008-5#1)
lambda(max) at##2##2##(2008-10#2)
lambda(max) of##3##2##(2008-10#2)(2008-9#1)
lambda(max)##18##1##(2008-10#16)(2008-5#1)(2008-9#1)
lambda)##2##1##(2008-3#2)
lambda-DNA##4##1##(2008-8#4)
lambda-DNA/HindIII##2##1##(2008-10#2)
lambda-cyhalothrin##11##1##(2007-10#2)(2008-10#1)(2011-1#6)(2011-2#2)
lambda/2##2##1##(2008-2#1)(2008-3#1)
lambda/4##2##1##(2008-3#2)
lambda/50##2##1##(2008-2#1)(2008-3#1)
lambda=0##2##1##(2007-11#1)(2009-7#1)
lambdaN gene expression##3##3##(2008-8#1)(2008-9#2)
lambdaN gene##13##2##(2008-8#10)(2008-9#3)
lambdaN##15##1##(2008-8#11)(2008-9#4)
lambda~1##2##1##(2007-11#2)
lambing and fecundity rates##2##4##(2008-12#2)
lambs at the end of##2##5##(1996-12#1)(2008-12#1)
lambs at##3##2##(1996-12#1)(2008-12#1)(2010-2#1)
lambs fed a diet based on dried##2##7##(2008-12#2)
lambs from##4##2##(1991-8#1)(1994-7#1)(2008-12#1)(2010-4#1)
lambs had##2##2##(1996-12#1)(2010-4#1)
lambs in##3##2##(1994-7#1)(2008-12#1)(2010-4#1)
lambs of##2##2##(2008-10#1)(2008-12#1)
lambs that had been infested with##2##6##(1996-12#2)
lambs that had##3##3##(1996-12#3)
lambs that were##2##3##(1994-7#1)(2010-2#1)
lambs that##5##2##(1994-7#1)(1996-12#3)(2010-2#1)
lambs were infested with##2##4##(1996-12#2)
lambs were##8##2##(1991-8#1)(1996-12#4)(2010-2#1)(2010-4#2)
lambs with##2##2##(1990-3#1)(2010-4#1)
lambs##59##1##(1990-3#1)(1990-6#1)(1991-8#3)(1994-7#6)(1996-12#15)(2008-10#1)(2008-12#10)(2008-7#3)(2008-9#2)(2009-4#1)(2010-2#5)(2010-4#11)
lamella##6##1##(2008-10#1)(2008-7#3)(2010-6#1)(2012-2#1)
lamellae and##2##2##(1990-11#1)(2008-5#1)
lamellae in the##3##3##(2008-5#1)(2008-7#2)
lamellae in##4##2##(2008-5#1)(2008-7#3)
lamellae of##2##2##(2008-7#2)
lamellae to##2##2##(2008-10#1)(2008-7#1)
lamellae##29##1##(1990-11#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-5#5)(2008-7#15)
lamellar grating##2##2##(2008-2#2)
lamellar keratoplasty assisted by##2##4##(2011-1#2)
lamellar keratoplasty##3##2##(2011-1#2)(2013-1#1)
lamellar lipid##2##2##(2008-5#2)
lamellar liquid##2##2##(1994-3#1)(2008-5#1)
lamellar phase##4##2##(1994-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
lamellar silk scaffolds##3##3##(2012-2#3)
lamellar structure##4##2##(2007-12#2)(2008-5#2)
lamellar##46##1##(1990-12#1)(1990-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-8#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#10)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#2)(2012-2#8)(2013-1#1)
lamellarin H##2##2##(2008-5#2)
lamellipodia##3##1##(2008-6#1)(2012-2#2)
lamellipodium##2##1##(2012-2#2)
lamellulae##4##1##(2010-10#4)
lameness and##3##2##(1994-9#1)(1997-3#2)
lameness##10##1##(1990-9#1)(1994-9#1)(1997-3#5)(2012-3#1)(2013-8#2)
lamin A and##2##3##(1990-11#1)(1992-12#1)
lamin A in##2##3##(1990-11#2)
lamin A tail##5##3##(2011-2#5)
lamin A##18##2##(1990-11#6)(1992-12#1)(1993-8#2)(2011-2#9)
lamin B##3##2##(1992-12#1)(2008-8#1)(2011-2#1)
lamin B1##2##2##(2011-2#2)
lamin C##2##2##(1990-11#1)(2011-2#1)
lamin C2##5##2##(2011-2#5)
lamin##34##1##(1990-11#7)(1992-12#2)(1993-8#2)(2008-8#3)(2011-2#20)
lamina II##3##2##(1997-2#1)(1997-3#2)
lamina and##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
lamina in##3##2##(1995-5#1)(2008-8#2)
lamina is##2##2##(2008-7#1)(2008-8#1)
lamina of##4##2##(1992-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
lamina propria mononuclear cells from##2##5##(2008-4#2)
lamina propria of##2##3##(2008-11#1)(2009-1#1)
lamina propria##11##2##(1997-1#1)(2008-11#4)(2008-4#3)(2008-5#1)(2009-1#1)(2011-2#1)
lamina##64##1##(1990-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-5#5)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#5)(2007-12#4)(2007-8#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#11)(2009-1#1)(2009-10#1)(2011-2#4)(2013-7#1)
laminae I and II of the dorsal horn##2##8##(1995-12#2)
laminae I and II of the##3##6##(1995-12#2)(1997-2#1)
laminae I and II##5##4##(1995-12#3)(1997-2#2)
laminae of##2##2##(1993-12#1)(1997-3#1)
laminae##18##1##(1993-12#5)(1995-12#3)(1997-2#2)(1997-3#6)(2007-12#2)
laminar counterflow##3##2##(2008-2#1)(2008-3#2)
laminar diffusion flames##2##3##(2008-3#2)
laminar diffusion##3##2##(2008-3#3)
laminar distribution of##2##3##(1993-12#1)(1997-2#1)
laminar distribution##4##2##(1993-12#2)(1997-2#2)
laminar flow##8##2##(1991-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
laminar flows##6##2##(2008-10#3)(2008-9#3)
laminar grating with##2##3##(2008-2#2)
laminar##59##1##(1991-11#2)(1992-6#1)(1992-9#1)(1993-12#6)(1993-9#1)(1997-2#3)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#11)(2008-3#15)(2008-7#2)(2008-9#3)(2010-10#1)(2010-9#1)(2011-1#1)
laminarin##2##1##(2008-10#2)
laminarinase was##2##2##(2008-10#2)
laminarinase##7##1##(2008-10#7)
laminate##2##1##(2008-10#1)(2013-1#1)
laminated##6##1##(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)(2012-1#1)
laminectomy and##2##2##(2009-3#1)(2012-12#1)
laminectomy from T12 to##2##4##(1991-11#1)(2009-3#1)
laminectomy##20##1##(1991-11#1)(1991-9#1)(1992-12#1)(1996-9#4)(2007-11#1)(2007-8#4)(2008-6#1)(2008-7#1)(2009-3#2)(2011-2#1)(2012-12#2)(2013-1#1)
laminin 332 γ2 chain##2##4##(2013-8#2)
laminin 332##12##2##(2013-8#12)
laminin 5 and##2##3##(2010-11#2)
laminin 5##4##2##(2010-11#3)(2013-8#1)
laminin and fibronectin##3##3##(1990-12#1)(1993-5#1)(1995-12#1)
laminin and##6##2##(1990-12#1)(1992-9#1)(1993-5#1)(1995-12#1)(2008-10#1)(2008-11#1)
laminin chain variants##2##3##(2008-11#2)
laminin fragments##3##2##(1997-1#3)
laminin receptor genes##2##3##(1991-2#2)
laminin receptor is##2##3##(1991-2#2)
laminin receptor##6##2##(1991-2#6)
laminin##56##1##(1990-12#1)(1991-2#6)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#1)(1997-1#4)(1997-4#2)(2008-10#2)(2008-11#5)(2008-7#2)(2008-9#1)(2010-11#3)(2012-1#1)(2012-5#3)(2013-8#13)
laminin-5##3##1##(2008-11#1)(2008-5#2)
laminin-enriched extract##2##2##(1997-3#2)
laminins##3##1##(2008-11#3)
laminitis##3##1##(1997-5#3)
laminotomy##3##1##(2008-7#2)(2011-2#1)
lamins (gene)##2##2##(2008-8#2)
lamins A and C##6##4##(1992-12#6)
lamins are##2##2##(2008-8#1)(2011-2#1)
lamins in##2##2##(2011-2#2)
lamins##24##1##(1992-12#6)(2008-8#4)(2011-2#14)
lamivudine##11##1##(1996-11#1)(2006-10#1)(2007-12#1)(2008-5#3)(2009-8#5)
lamotrigine##4##1##(2008-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
lamp and##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2010-8#1)
lamp chamber##2##2##(2008-2#2)
lamp examination##2##2##(2012-2#1)(2013-1#1)
lamp is used##2##3##(2007-12#1)(2008-10#1)
lamp is##3##2##(2007-12#1)(2008-10#2)
lamp of##2##2##(2008-10#1)(2008-11#1)
lamp results##2##2##(2008-2#2)
lamp to##2##2##(2008-2#1)(2008-3#1)
lamp with##2##2##(2008-12#1)(2008-3#1)
lamp##54##1##(1994-6#1)(1995-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#11)(2008-9#2)(2010-4#1)(2010-8#2)(2012-2#1)(2013-1#1)
lamprey##9##1##(1993-3#3)(1994-11#1)(1997-3#5)
lamps from##2##2##(2008-3#2)
lamps##16##1##(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)
land and groove recording##3##4##(2008-3#3)
land and##8##2##(2008-2#1)(2008-3#6)(2008-9#1)
land application of sewage sludge##3##5##(1997-4#2)(2007-12#1)
land application##4##2##(1997-4#2)(2007-12#1)(2008-6#1)
land birds##2##2##(2008-8#2)
land mine detection##2##3##(2008-10#2)
land mine##3##2##(2008-10#3)
land mines##5##2##(2008-10#5)
land of##2##2##(2008-11#1)(2008-12#1)
land plants and algae##3##4##(2012-2#3)
land plants and##5##3##(2010-6#1)(2012-2#4)
land plants##12##2##(2009-6#4)(2010-6#1)(2012-2#6)(2013-1#1)
land surface emissivity##3##3##(2013-8#3)
land surface temperature##2##3##(2008-3#1)(2008-8#1)
land surface##5##2##(2008-3#1)(2008-8#1)(2013-8#3)
land use##7##2##(1990-9#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-7#1)
land##82##1##(1990-6#1)(1990-9#1)(1992-1#2)(1992-8#1)(1994-1#1)(1997-4#3)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-10#1)(2009-6#4)(2009-7#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#7)(2013-1#1)(2013-8#5)
land-race##2##1##(2008-10#2)
land-use##2##1##(1996-4#1)(2012-2#1)
landfill leachate##2##2##(2012-1#2)
landfill leachates##3##2##(2008-10#3)
landfill##8##1##(2008-10#6)(2012-1#2)
landing in##2##2##(2011-2#1)(2013-1#1)
landing on##2##2##(2008-10#1)(2012-12#1)
landing##11##1##(1996-10#1)(1997-2#1)(2007-2#1)(2008-10#1)(2011-2#5)(2012-12#1)(2013-1#1)
landings is##2##2##(2011-2#1)(2013-7#1)
landlords##2##1##(1996-5#2)
landmark points##2##2##(2010-8#2)
landmark##23##1##(1990-11#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-5#1)(1996-7#2)(2008-11#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#2)(2012-12#1)(2013-1#2)
landmark-based##2##1##(1996-5#2)
landmarks and##7##2##(1995-6#1)(2008-8#1)(2009-5#1)(2010-6#1)(2012-12#3)
landmarks for##2##2##(1993-2#1)(2012-12#1)
landmarks in##4##2##(1996-5#1)(1997-2#1)(2008-9#2)
landmarks to##2##2##(1996-7#1)(2008-1#1)
landmarks when learning a new##2##5##(2012-12#2)
landmarks##32##1##(1993-2#1)(1995-6#1)(1996-5#2)(1996-7#3)(1997-2#1)(2006-12#1)(2008-1#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-5#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#11)
landrace##2##1##(2008-10#2)
landraces##8##1##(2008-10#8)
lands##5##1##(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
landscape and##3##2##(2008-1#1)(2008-12#1)(2012-9#1)
landscape genetic##2##2##(2013-1#2)
landscape genetics##2##2##(2013-1#2)
landscape is##2##2##(2008-10#1)(2008-6#1)
landscape of the##2##3##(2008-10#2)
landscape of##12##2##(1993-2#1)(1994-1#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-9#2)
landscape structure##3##2##(2008-8#1)(2013-1#2)
landscape##55##1##(1993-2#2)(1994-1#2)(1995-3#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#3)(2008-8#9)(2008-9#2)(2009-11#4)(2009-5#1)(2012-12#1)(2012-2#1)(2012-9#1)(2013-1#11)(2013-7#1)
landscapes to##2##2##(1995-3#1)(2008-8#1)
landscapes##26##1##(1995-3#4)(1997-2#1)(2008-3#2)(2008-8#12)(2008-9#4)(2009-3#1)(2010-3#1)(2013-1#1)
lane##4##1##(1996-12#1)(1996-2#1)(2009-12#1)(2012-12#1)
langerhans cell histiocytosis##2##3##(2009-5#1)(2012-3#1)
language abilities is##2##3##(2011-1#1)(2012-3#1)
language abilities##5##2##(2010-4#1)(2011-1#1)(2012-3#3)
language ability and##2##3##(2009-4#1)(2012-3#1)
language ability##5##2##(2008-9#1)(2009-4#1)(2012-3#3)
language and cognitive##2##3##(2008-9#1)(2012-3#1)
language and literacy skills##2##4##(2010-4#1)(2012-3#1)
language and literacy##4##3##(2008-11#1)(2010-4#2)(2012-3#1)
language and speech##2##3##(1993-9#1)(2011-2#1)
language and vocal skills of a set of monozygous twin girls##2##11##(2008-9#2)
language and##28##2##(1993-9#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#5)(2009-8#1)(2009-9#1)(2010-4#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
language as##2##2##(2012-2#1)(2012-3#1)
language background##2##2##(2013-8#2)
language comprehension processes in##2##4##(2012-3#2)
language comprehension##4##2##(2008-1#1)(2012-3#2)(2013-1#1)
language deficits##2##2##(1995-5#1)(1996-7#1)
language delay##3##2##(2008-11#1)(2008-9#2)
language development in##3##3##(2008-9#3)
language development##13##2##(2008-11#2)(2008-2#2)(2008-9#5)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
language difficulties##2##2##(2011-1#1)(2013-1#1)
language disorders##2##2##(2008-11#1)(2008-7#1)
language disturbances##6##2##(2007-8#5)(2011-1#1)
language evolution##2##2##(2012-12#2)
language for##5##2##(1992-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
language impairment (SLI)##4##3##(2008-11#1)(2009-8#1)(2012-3#2)
language impairment##6##2##(2008-11#2)(2009-8#2)(2012-3#2)
language in##6##2##(1991-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2012-3#1)(2013-1#1)
language is##3##2##(2010-4#1)(2011-2#1)(2013-8#1)
language models##2##2##(2008-6#2)
language of##12##2##(1995-1#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
language or##2##2##(2008-7#1)(2013-1#1)
language processing##4##2##(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
language production of children##2##4##(2011-1#2)
language production##3##2##(1996-2#1)(2011-1#2)
language proficiency##2##2##(2008-12#1)(2012-12#1)
language skills and##2##3##(2012-3#1)(2013-1#1)
language skills of##4##3##(2008-9#4)
language skills##9##2##(1995-5#1)(2008-9#5)(2012-3#2)(2013-1#1)
language spoken##2##2##(1995-12#1)(2013-1#1)
language that##2##2##(2008-9#1)(2012-12#1)
language to the##2##3##(2008-10#2)
language to##3##2##(2008-10#2)(2011-2#1)
language used##3##2##(2008-11#1)(2013-1#2)
language was##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
language##274##1##(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#3)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#4)(1996-5#1)(1996-7#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#2)(2007-2#1)(2007-8#6)(2008-1#4)(2008-10#14)(2008-11#19)(2008-12#7)(2008-2#11)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#23)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-4#10)(2010-5#6)(2010-9#1)(2011-1#12)(2011-2#17)(2012-1#1)(2012-12#10)(2012-2#4)(2012-3#25)(2013-1#22)(2013-8#13)
language)##3##1##(2008-1#1)(2009-9#1)(2012-12#1)
language-processing##2##1##(2008-4#2)
language-specific##2##1##(2010-8#1)(2013-8#1)
language?##3##1##(1992-2#1)(1997-7#1)(2012-2#1)
languages and##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
languages with a##2##3##(2013-8#2)
languages##21##1##(1993-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2010-5#2)(2010-8#1)(2011-3#1)(2012-12#2)(2012-3#2)(2013-8#4)
lanosterol 14 alpha-demethylase (P-450(14)DM)##2##4##(1992-3#2)
lanosterol 14 alpha-demethylase##5##3##(1992-3#2)(1994-6#1)(2008-5#2)
lanosterol 14##7##2##(1991-5#2)(1992-3#2)(1994-6#1)(2008-5#2)
lanosterol and##2##2##(1992-3#2)
lanosterol##13##1##(1990-2#1)(1991-5#2)(1992-11#1)(1992-3#4)(1992-8#1)(1994-6#2)(2008-5#2)
lansoprazole##13##1##(2008-11#8)(2012-2#5)
lanthanide complexes##2##2##(2008-10#2)
lanthanide ion##5##2##(1990-11#1)(2012-12#4)
lanthanide ions were##2##3##(2008-10#1)(2012-12#1)
lanthanide ions##7##2##(2008-10#4)(2012-12#3)
lanthanide metal ions was in the order##2##7##(2008-10#2)
lanthanide metal ions##5##3##(2008-10#5)
lanthanide metal##7##2##(2008-10#5)(2008-4#1)(2010-5#1)
lanthanide##38##1##(1990-11#1)(1997-2#1)(1997-7#1)(2008-10#25)(2008-4#1)(2010-5#1)(2012-12#8)
lanthanide(III) ions##3##2##(2008-10#3)
lanthanide(III)##4##1##(2008-10#4)
lanthanides and##2##2##(2008-10#2)
lanthanides are##2##2##(2008-10#2)
lanthanides from##3##2##(2008-10#3)
lanthanides in##3##2##(2008-10#3)
lanthanides with##2##2##(2008-10#2)
lanthanides##35##1##(2008-10#35)
lanthanoid series##2##2##(2008-10#2)
lanthanoids(III)##4##1##(2008-10#4)
lanthanum and##2##2##(2008-10#2)
lanthanum chloride##4##2##(1992-11#2)(2008-10#2)
lanthanum from##2##2##(2008-10#1)(2008-7#1)
lanthanum metal##2##2##(2008-10#2)
lanthanum##35##1##(1990-2#2)(1992-11#2)(1997-2#2)(2007-11#2)(2007-12#1)(2008-10#21)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
lanthanum(III)##3##1##(2008-10#3)
lanthanum-modified lead zirconate titanate##5##4##(2008-2#5)
lap belt was##2##3##(2013-1#2)
lap shear##2##2##(2009-7#2)
lap##5##1##(2009-7#2)(2011-2#1)(2013-1#2)
laparoceles]##4##1##(1992-3#4)
laparoscope is##2##2##(1991-12#2)
laparoscope##6##1##(1991-12#2)(1992-1#1)(1992-12#2)(1996-3#1)
laparoscopic Roux-en-Y gastric bypass##3##4##(2010-8#1)(2013-1#2)
laparoscopic adhesiolysis##3##2##(1991-3#3)
laparoscopic adjustable gastric banding##3##4##(2012-12#3)
laparoscopic adrenalectomy##3##2##(2008-5#1)(2012-12#2)
laparoscopic and open##2##3##(2007-10#1)(2010-12#1)
laparoscopic and##4##2##(2007-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
laparoscopic appendectomy was performed##2##4##(2011-2#2)
laparoscopic appendectomy##3##2##(1992-2#1)(2011-2#2)
laparoscopic approach##4##2##(1994-2#1)(1996-1#1)(2011-2#1)(2012-2#1)
laparoscopic cholecystectomy##18##2##(1991-6#1)(2008-10#1)(2008-12#4)(2008-8#1)(2009-3#3)(2009-8#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
laparoscopic fundoplication##2##2##(2008-12#2)
laparoscopic gastric bypass##2##3##(2013-1#2)
laparoscopic gastric##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
laparoscopic hepatectomy##5##2##(2013-8#5)
laparoscopic hysterectomy (TLH)##2##3##(2010-3#1)(2013-1#1)
laparoscopic hysterectomy##14##2##(1993-3#2)(1996-1#3)(1996-2#1)(2010-3#5)(2011-2#1)(2013-1#2)
laparoscopic inguinal hernia##2##3##(2011-2#2)
laparoscopic management of##2##3##(2008-10#1)(2010-8#1)
laparoscopic management##3##2##(2008-10#2)(2010-8#1)
laparoscopic myomectomy##4##2##(1993-12#1)(1993-3#1)(1994-2#1)(2011-1#1)
laparoscopic nephrectomy##2##2##(2008-10#1)(2011-2#1)
laparoscopic orchidopexy##3##2##(2008-10#2)(2011-2#1)
laparoscopic partial##2##2##(2013-1#1)(2013-8#1)
laparoscopic placement of PDC##2##4##(2007-7#2)
laparoscopic placement of##4##3##(2007-7#4)
laparoscopic presacral neurectomy##3##3##(1994-3#3)
laparoscopic procedure##2##2##(1994-9#1)(2011-1#1)
laparoscopic procedures has##2##3##(2008-10#2)
laparoscopic procedures##6##2##(1993-3#1)(2008-10#2)(2009-12#1)(2011-2#2)
laparoscopic radical##3##2##(1994-2#1)(2009-2#1)(2012-2#1)
laparoscopic repair##3##2##(2010-8#1)(2011-2#2)
laparoscopic resection of##2##3##(2008-5#1)(2012-12#1)
laparoscopic skills##5##2##(1995-1#1)(2010-3#3)(2012-3#1)
laparoscopic sterilization##3##2##(1995-1#2)(1996-3#1)
laparoscopic surgery for##4##3##(1996-8#1)(2013-1#3)
laparoscopic surgery##24##2##(1991-3#1)(1993-12#2)(1993-9#1)(1995-1#1)(1996-8#1)(2008-10#2)(2008-12#2)(2009-8#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#6)
laparoscopic surgical##3##2##(1996-2#1)(2009-5#1)(2011-2#1)
laparoscopic suturing##2##2##(1995-1#1)(2008-10#1)
laparoscopic technique##2##2##(1996-2#1)(2007-7#1)
laparoscopic techniques##4##2##(1994-3#1)(1995-1#1)(2008-10#1)(2011-2#1)
laparoscopic tubal##2##2##(1993-12#1)(1993-3#1)
laparoscopic##216##1##(1990-6#1)(1991-3#4)(1991-6#2)(1992-2#2)(1992-3#2)(1993-12#7)(1993-2#1)(1993-3#6)(1993-9#2)(1994-2#4)(1994-3#4)(1994-9#2)(1995-1#9)(1995-3#1)(1996-1#4)(1996-2#8)(1996-3#1)(1996-8#1)(1996-9#1)(2007-10#1)(2007-7#5)(2008-10#15)(2008-12#10)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#9)(2010-5#2)(2010-7#1)(2010-8#7)(2011-1#5)(2011-2#30)(2012-12#19)(2012-2#2)(2012-3#7)(2013-1#20)(2013-8#6)
laparoscopically assisted vaginal hysterectomies##2##4##(1993-12#1)(1995-1#1)
laparoscopically assisted vaginal hysterectomy (LAVH) with total##2##7##(1994-2#1)(2010-3#1)
laparoscopically assisted vaginal hysterectomy (LAVH)##3##5##(1994-2#1)(1996-2#1)(2010-3#1)
laparoscopically assisted vaginal hysterectomy is##2##5##(1993-12#1)(2011-2#1)
laparoscopically assisted vaginal hysterectomy##14##4##(1993-12#4)(1994-2#3)(1996-2#2)(2010-3#1)(2011-2#4)
laparoscopically assisted vaginal radical hysterectomy##2##5##(1994-2#2)
laparoscopically assisted vaginal##18##3##(1993-12#5)(1994-2#5)(1995-1#1)(1996-2#2)(2010-3#1)(2011-2#4)
laparoscopically##29##1##(1992-3#1)(1993-12#5)(1994-2#5)(1994-3#2)(1994-9#1)(1995-1#1)(1996-2#2)(2008-10#1)(2009-7#1)(2010-3#1)(2011-2#7)(2013-1#2)
laparoscopies##2##1##(1991-12#1)(1992-2#1)
laparoscopy and the##2##3##(1993-12#1)(1993-6#1)
laparoscopy and##9##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1996-3#1)(2008-7#1)(2009-8#1)(2012-12#1)
laparoscopy for adnexal##2##3##(1996-3#2)
laparoscopy for the treatment of##2##5##(1995-2#1)(2010-8#1)
laparoscopy for treatment of pelvic##3##5##(1992-1#1)(1992-3#1)(1995-2#1)
laparoscopy for##12##2##(1992-1#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-3#2)(2008-10#1)(2010-8#2)(2011-2#1)
laparoscopy has##5##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)
laparoscopy in a##2##3##(1993-12#1)(2008-7#1)
laparoscopy in the##3##3##(1991-12#1)(1996-1#1)(2011-2#1)
laparoscopy in##12##2##(1991-12#2)(1991-3#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-1#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
laparoscopy is##4##2##(1994-3#1)(1995-2#1)(1996-3#1)(2011-2#1)
laparoscopy to##3##2##(1993-12#1)(1995-2#1)(2011-2#1)
laparoscopy was used##2##3##(1991-3#1)(1992-1#1)
laparoscopy was##4##2##(1991-3#1)(1992-1#1)(1994-9#1)(2008-10#1)
laparoscopy were##2##2##(1991-2#1)(2011-1#1)
laparoscopy with##2##2##(1991-11#1)(1996-1#1)
laparoscopy##102##1##(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#7)(1992-1#2)(1992-12#1)(1992-3#4)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#5)(1993-6#1)(1993-9#3)(1994-12#1)(1994-3#4)(1994-9#5)(1995-1#1)(1995-2#10)(1995-3#6)(1996-1#5)(1996-2#2)(1996-3#6)(1996-8#1)(2007-7#2)(2008-10#2)(2008-7#2)(2009-8#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#3)
laparoscopy-assisted##3##1##(1993-2#1)(2013-1#2)
laparotomy (group##2##2##(1991-3#1)(1996-3#1)
laparotomy and laparoscopy##2##3##(1996-1#1)(2011-1#1)
laparotomy and##8##2##(1994-3#2)(1994-9#1)(1996-1#2)(2009-7#1)(2011-1#1)(2013-1#1)
laparotomy for##7##2##(1991-2#1)(1996-3#3)(2008-12#1)(2011-2#1)(2013-7#1)
laparotomy in the management of ovarian masses##2##7##(1996-1#2)
laparotomy in the##4##3##(1991-3#1)(1996-1#2)(2009-7#1)
laparotomy in##5##2##(1991-3#1)(1993-6#1)(1996-1#2)(2009-7#1)
laparotomy is##3##2##(1990-2#1)(1992-5#1)(2011-2#1)
laparotomy or##2##2##(1990-2#1)(2011-2#1)
laparotomy revealed a##2##3##(2008-12#1)(2009-5#1)
laparotomy revealed##3##2##(2007-8#1)(2008-12#1)(2009-5#1)
laparotomy should be performed##2##4##(1990-10#1)(2008-12#1)
laparotomy should be##3##3##(1990-10#1)(1990-2#1)(2008-12#1)
laparotomy was performed##3##3##(1990-2#1)(1992-3#1)(1992-4#1)
laparotomy was##5##2##(1990-2#2)(1992-3#1)(1992-4#1)(2013-8#1)
laparotomy with##3##2##(2008-1#1)(2008-6#1)(2011-2#1)
laparotomy##81##1##(1990-10#1)(1990-2#6)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-4#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-2#2)(1994-3#4)(1994-9#2)(1995-3#1)(1996-1#7)(1996-3#6)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-6#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
laponite##2##1##(2008-10#2)
laponite-clay-nanoparticles##2##1##(2008-10#2)
lapping##5##1##(2008-3#4)(2011-1#1)
laps##3##1##(2008-2#2)(2008-3#1)
lapse of##2##2##(2008-10#1)(2012-2#1)
lapse rates##3##2##(1993-3#1)(2008-3#1)(2012-6#1)
lapse##11##1##(1993-3#1)(1994-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)(2012-2#1)(2012-6#1)(2013-8#1)
lapsed##2##1##(1996-5#1)(2012-3#1)
larch##3##1##(2008-10#3)
lard##3##1##(1990-7#3)
large (&gt##3##2##(1996-12#1)(2007-12#1)(2008-8#1)
large (n =##4##3##(1990-5#1)(1992-8#1)(2009-2#1)(2009-9#1)
large AVMs##2##2##(2008-7#2)
large B cell##2##3##(2013-1#2)
large B-cell lymphoma (DLBCL)##4##4##(2009-8#2)(2012-2#1)(2013-1#1)
large B-cell lymphoma##8##3##(2008-5#1)(2009-8#3)(2012-2#1)(2013-1#2)(2013-8#1)
large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia##2##8##(2013-8#2)
large B-cell##13##2##(2008-5#1)(2009-8#6)(2012-2#1)(2013-1#2)(2013-8#3)
large Brazilian##4##2##(1994-8#2)(2012-1#1)(2013-8#1)
large DNA##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
large He-Ne ring##2##3##(2008-2#2)
large Kerr##2##2##(2007-11#1)(2007-12#1)
large N(e)##2##2##(2013-1#2)
large RNAs##3##2##(2008-2#1)(2008-4#2)
large T-antigen##2##2##(1997-7#1)(2008-11#1)
large a sample##2##3##(1995-3#1)(2007-7#1)
large a##3##2##(1995-3#1)(2007-7#1)(2008-8#1)
large aberrations##2##2##(2007-11#1)(2008-3#1)
large absorption##3##2##(2007-12#2)(2011-1#1)
large academic##4##2##(1995-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
large aggregates##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
large alternating magnetic##2##3##(2012-2#2)
large amount of data##7##4##(1995-5#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-8#1)
large amount of material##2##4##(2007-11#1)(2012-12#1)
large amount of the##4##4##(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
large amount of##40##3##(1991-12#1)(1994-12#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
large amount##43##2##(1991-12#1)(1994-12#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
large amounts of SSAT##2##4##(1995-2#2)
large amounts of data##3##4##(1995-12#1)(2008-7#1)(2008-8#1)
large amounts of hIL-6##2##4##(2008-11#2)
large amounts of polysaccharides##2##4##(2008-2#1)(2011-2#1)
large amounts of sample##2##4##(2008-10#2)
large amounts of the##3##4##(1994-5#1)(2010-10#2)
large amounts of##67##3##(1990-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-6#1)(2007-12#1)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-10#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
large amounts##74##2##(1990-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-6#1)(2007-12#1)(2008-10#24)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-10#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
large amplitude##8##2##(1993-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
large and complex##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
large and diverse##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
large and giant middle cerebral artery aneurysms##2##7##(2011-2#2)
large and giant##3##3##(2011-2#2)(2013-7#1)
large and high-flow cerebral arteriovenous##2##5##(2008-7#2)
large and high-flow##3##3##(2008-7#3)
large and small vessel vasculitis in Japan##2##7##(1997-8#2)
large and small##9##3##(1995-12#1)(1997-6#1)(1997-8#2)(2008-3#1)(2008-7#2)(2009-9#1)(2010-11#1)
large and stable##2##3##(2007-11#1)(2008-2#1)
large and variable##2##3##(1992-6#1)(2008-11#1)
large and##52##2##(1992-6#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-7#1)
large angular##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
large animal model of##2##4##(2012-2#2)
large animal model##3##3##(2012-12#1)(2012-2#2)
large animal models##2##3##(2008-4#1)(2011-2#1)
large animal##7##2##(2008-11#1)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#2)
large animals##2##2##(2008-10#1)(2008-4#1)
large anisotropy##3##2##(2007-12#2)(2008-2#1)
large aperture of##2##3##(2007-11#1)(2007-12#1)
large aperture##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
large aqueous pore##2##3##(1990-2#2)
large aqueous##3##2##(1990-2#3)
large area##8##2##(1992-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
large areas and##2##3##(2008-7#2)
large areas of the##2##4##(1991-12#1)(2008-10#1)
large areas of##5##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#2)
large areas with##2##3##(2008-7#1)(2009-10#1)
large areas##14##2##(1990-8#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-10#1)(2010-8#1)
large arteries##3##2##(2008-3#1)(2008-7#1)(2010-4#1)
large artery##6##2##(2007-10#5)(2013-8#1)
large as that##2##3##(2007-12#1)(2008-10#1)
large as##26##2##(1990-7#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#4)(2009-11#1)
large bandwidth##4##2##(2008-3#4)
large biobanks##2##2##(2008-7#2)
large birefringence##3##2##(2007-12#1)(2008-3#2)
large bladder##3##2##(2007-10#1)(2008-10#2)
large blood##5##2##(1994-9#1)(2011-2#3)(2013-1#1)
large body mass##2##3##(2008-9#1)(2011-2#1)
large body of data##2##4##(1993-12#1)(2010-5#1)
large body of evidence##3##4##(1992-3#1)(2008-10#1)(2009-3#1)
large body of##12##3##(1992-3#1)(1992-5#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-2#2)
large body##15##2##(1992-3#1)(1992-5#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
large bowel##18##2##(1991-6#4)(1992-8#1)(1993-8#1)(1993-9#7)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
large bubble##3##2##(2008-11#3)
large cell lymphoma##6##3##(1997-3#2)(2011-2#3)(2012-3#1)
large cell neuroendocrine carcinoma of##2##5##(2008-8#1)(2013-1#1)
large cell neuroendocrine##3##3##(2008-8#1)(2013-1#2)
large cell##17##2##(1991-9#1)(1997-3#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
large cells##3##2##(1991-6#2)(2008-7#1)
large changes in the##2##4##(2008-10#1)(2008-7#1)
large changes in##4##3##(2008-10#1)(2008-3#2)(2008-7#1)
large changes##5##2##(1996-4#1)(2008-10#1)(2008-3#2)(2008-7#1)
large chi((3))##2##2##(2007-11#1)(2007-12#1)
large chromosomal##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
large circumferential##4##2##(2011-2#4)
large cities are##2##3##(1991-1#1)(1992-11#1)
large cities##3##2##(1991-1#1)(1992-11#1)(2007-7#1)
large class##3##2##(2007-11#1)(2008-11#1)(2013-8#1)
large clinical trial##2##3##(1995-9#1)(2013-1#1)
large clinical##6##2##(1995-12#1)(1995-9#1)(2008-10#1)(2010-2#1)(2013-1#2)
large cluster##2##2##(1996-12#1)(2008-10#1)
large clusters##2##2##(2008-10#1)(2013-1#1)
large coalesced LCA consisting almost##2##5##(1997-6#2)
large coalesced LCA consisting##3##4##(1997-6#3)
large coalesced##4##2##(1997-6#3)(2008-10#1)
large cohort of##6##3##(2007-4#1)(2008-3#1)(2009-8#1)(2011-2#2)(2012-3#1)
large cohort##8##2##(2007-4#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-3#1)
large cohorts##2##2##(2008-7#2)
large combinatorial##2##2##(2008-10#1)(2013-1#1)
large community##2##2##(2011-2#2)
large community-based##2##2##(2009-8#1)(2009-9#1)
large complex refractive##4##3##(2008-3#4)
large complex##8##2##(1994-2#2)(2008-10#1)(2008-3#4)(2012-2#1)
large complexes##2##2##(1991-5#1)(2012-2#1)
large concentrations of##5##3##(1990-8#1)(2008-10#4)
large conductance Ca(2+)-activated K+ channels in##2##6##(1994-11#2)
large conformational##2##2##(1995-3#1)(2007-11#1)
large contribution to the##2##4##(2008-10#1)(2008-2#1)
large contribution##4##2##(2008-10#1)(2008-2#1)(2009-4#1)(2013-8#1)
large controlled##2##2##(1994-9#1)(2008-7#1)
large core##2##2##(2007-11#2)
large cystic##5##2##(1990-6#1)(2008-1#1)(2008-7#2)(2011-2#1)
large cysts##4##2##(1991-2#1)(1995-12#1)(2011-1#2)
large data sets##4##3##(2008-3#1)(2008-4#1)(2009-9#1)(2012-12#1)
large data##8##2##(1994-3#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#2)(2010-12#1)(2012-12#1)
large datasets##2##2##(2008-7#1)(2013-1#1)
large decrease in the##2##4##(1995-2#1)(2008-10#1)
large deflection angles##2##3##(2008-3#2)
large defocus##2##2##(2008-3#2)
large degraded image##2##3##(2008-3#2)
large deletion##2##2##(1990-5#1)(1993-8#1)
large delta##2##2##(1994-11#2)
large dependence on##2##3##(2011-2#1)(2012-2#1)
large diameter##3##2##(2007-7#1)(2008-3#1)(2008-7#1)
large diameters##2##2##(2008-3#1)(2009-6#1)
large difference between##2##3##(1993-9#1)(1994-6#1)
large difference##4##2##(1993-9#1)(1994-6#1)(2008-11#1)(2008-8#1)
large differences between##3##3##(1994-5#1)(1995-12#1)(2008-7#1)
large differences in the##3##4##(1990-2#1)(2008-11#1)(2013-8#1)
large differences in##9##3##(1990-2#1)(1992-3#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
large differences##17##2##(1990-2#1)(1992-12#1)(1992-3#1)(1994-5#2)(1995-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
large dispersion##6##2##(1990-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
large distance to##2##3##(2007-12#1)(2008-12#1)
large distance##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)
large distances##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
large dose##3##2##(1994-6#2)(2008-7#1)
large doses of##3##3##(1990-9#1)(1992-3#1)(2011-1#1)
large doses##5##2##(1990-9#1)(1991-8#1)(1992-3#1)(2010-5#1)(2011-1#1)
large droplets##2##2##(1994-12#1)(2008-3#1)
large dsRNA (L-dsRNA)##2##3##(2008-10#2)
large ducts##2##2##(2009-12#2)
large dynamic range##5##3##(2008-3#5)
large dynamic##6##2##(2008-10#1)(2008-3#5)
large earthquakes in##2##3##(1996-4#2)
large earthquakes##8##2##(1996-4#8)
large effect size##2##3##(2007-11#1)(2009-9#1)
large effect##6##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
large effective population##2##3##(2008-10#1)(2013-1#1)
large effective##4##2##(1992-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
large effects on##3##3##(2008-10#1)(2008-8#2)
large effects##5##2##(1994-9#1)(2008-10#1)(2008-8#2)(2012-3#1)
large employers##2##2##(1996-2#1)(1997-2#1)
large enhancement of the##2##4##(2007-11#2)
large enhancement of##5##3##(1995-5#1)(2007-11#2)(2008-6#2)
large enhancement##6##2##(1990-2#1)(1995-5#1)(2007-11#2)(2008-6#2)
large enough to##10##3##(1990-11#1)(1991-8#1)(1992-6#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-7#1)
large enough##12##2##(1990-11#1)(1991-8#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)(2013-7#1)
large errors for##2##3##(2008-11#1)(2008-3#1)
large errors##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)
large events##4##2##(1996-4#4)
large excess of##9##3##(1991-11#1)(1992-6#1)(1995-2#1)(2008-10#5)(2008-2#1)
large excess##11##2##(1991-11#1)(1992-6#1)(1995-2#1)(2008-10#7)(2008-2#1)
large excesses of##2##3##(2008-10#2)
large extent##15##2##(1991-8#1)(1992-6#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
large extracellular domain##3##3##(1993-6#1)(1996-5#1)(2008-4#1)
large extracellular##6##2##(1993-6#1)(1996-5#1)(2007-12#1)(2008-4#2)(2009-8#1)
large field of view##4##4##(2008-3#2)(2008-7#1)(2010-12#1)
large field##10##2##(2007-4#1)(2008-10#2)(2008-3#3)(2008-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
large flow range##2##3##(2008-10#2)
large fluctuations in##2##3##(1991-1#1)(2007-11#1)
large fluctuations##3##2##(1991-1#1)(2007-11#1)(2012-2#1)
large for##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
large format##2##2##(2008-10#1)(2008-6#1)
large fraction of##5##3##(1990-9#1)(2008-10#2)(2008-7#1)(2013-8#1)
large fragments of##2##3##(1991-9#1)(2008-2#1)
large fragments##3##2##(1991-9#1)(1994-11#1)(2008-2#1)
large free##2##2##(2008-2#1)(2008-7#1)
large gene##2##2##(2008-10#1)(2009-10#1)
large genetic##2##2##(2008-8#1)(2008-9#1)
large geographic##3##2##(1994-12#1)(2008-10#1)(2013-7#1)
large granular lymphocytes (LGL)##3##4##(1990-12#2)(1992-5#1)
large granular##7##2##(1990-12#2)(1992-5#1)(2008-7#1)(2009-8#2)(2010-1#1)
large granules##2##2##(2008-5#2)
large grating##2##2##(2008-10#1)(2008-3#1)
large group of##13##3##(1991-11#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
large group##18##2##(1991-11#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
large groups##8##2##(1993-12#1)(1994-9#1)(2008-10#4)(2008-7#1)(2010-8#1)
large health##2##2##(1991-7#1)(2010-8#1)
large hospital##4##2##(1993-2#2)(2010-8#1)(2012-2#1)
large hospitals##3##2##(1991-12#1)(2008-4#2)
large host##2##2##(2008-10#1)(2008-8#1)
large human##3##2##(2007-11#3)
large hydrated##2##2##(1990-11#1)(2008-10#1)
large image##3##2##(2008-3#2)(2008-6#1)
large impact on##6##3##(1991-3#1)(1994-12#1)(1995-6#1)(2008-3#1)(2009-7#1)(2012-12#1)
large impact##10##2##(1991-3#1)(1994-12#1)(1995-6#1)(1997-5#2)(2008-10#1)(2008-3#1)(2009-7#1)(2012-12#1)(2013-1#1)
large in size##2##3##(2008-7#1)(2010-8#1)
large in##4##2##(1990-11#1)(2008-7#1)(2010-8#1)(2012-2#1)
large in-plane##2##2##(2008-3#2)
large increases in##5##3##(1990-12#1)(1990-6#1)(1990-7#1)(1995-3#1)(2008-10#1)
large index##2##2##(1993-9#1)(2007-12#1)
large insert DNA into##2##4##(2008-4#2)
large insert##3##2##(2008-4#3)
large integrated##2##2##(1997-3#1)(2009-12#1)
large intensity##2##2##(2007-12#1)(2012-3#1)
large interannual variations in soil GHG fluxes##2##7##(2012-2#2)
large interest##3##2##(2011-2#3)
large intergenic region##2##3##(2008-9#2)
large intestinal##3##2##(2009-8#1)(2011-2#2)
large intestine##13##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-9#2)(1995-10#1)(2007-8#1)(2008-12#1)(2009-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
large intra- and inter-individual variations in serum T##2##8##(2013-8#2)
large intracranial##2##2##(1995-11#1)(2011-2#1)
large libraries of##2##3##(2010-12#2)
large linear##4##2##(2007-12#1)(2008-10#3)
large lipid droplets##2##3##(2007-12#2)
large literature##2##2##(2008-11#1)(2009-11#1)
large loop excision of the transformation zone##2##7##(1994-2#1)(2011-2#1)
large loop excision of the##3##5##(1994-2#1)(2011-2#1)(2012-3#1)
large loop##4##2##(1994-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
large majority of the##2##4##(2008-3#1)(2013-8#1)
large majority of##9##3##(1990-3#1)(1991-9#1)(2008-10#3)(2008-3#2)(2010-8#1)(2013-8#1)
large majority##11##2##(1990-3#1)(1991-9#1)(1997-2#1)(2008-10#3)(2008-3#2)(2010-8#1)(2011-2#1)(2013-8#1)
large mammals##2##2##(1996-6#1)(2008-9#1)
large map strength##2##3##(2007-11#1)(2007-12#1)
large mass##6##2##(1991-2#1)(2008-11#2)(2008-6#2)(2011-2#1)
large meals in##2##3##(2008-3#2)
large meals##3##2##(2008-3#3)
large metropolitan areas##2##3##(1991-2#1)(1994-1#1)
large metropolitan##3##2##(1991-2#1)(1994-1#1)(2008-11#1)
large modulation##2##2##(2007-12#2)
large molecular##3##2##(1990-5#1)(1994-8#2)
large molecule##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
large molecules##5##2##(2008-10#1)(2008-5#2)(2008-6#1)(2010-12#1)
large monophyletic##2##2##(2008-10#1)(2013-8#1)
large mothers produce large##2##4##(2008-8#2)
large mothers##3##2##(2008-8#3)
large motor##2##2##(1993-12#1)(2013-1#1)
large multipolar##2##2##(1991-7#1)(2007-12#1)
large national##2##2##(1993-1#1)(1997-1#1)
large necrotic areas##2##3##(2008-10#1)(2010-12#1)
large negative##2##2##(2007-12#1)(2010-4#1)
large neurons##5##2##(1991-12#1)(1996-12#3)(2008-7#1)
large noise##3##2##(2008-2#1)(2008-3#2)
large nonlinear##2##2##(2007-11#1)(2007-12#1)
large nonspherical##4##2##(2008-3#4)
large nuclei##2##2##(2008-10#1)(2008-5#1)
large number of cases##2##4##(2008-6#1)(2011-2#1)
large number of cations##4##4##(2008-10#4)
large number of different##6##4##(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
large number of genes##6##4##(1996-12#1)(1996-6#1)(2008-7#2)(2011-1#1)(2011-2#1)
large number of new##3##4##(1990-6#1)(1994-3#1)(1997-3#1)
large number of optically##2##4##(2007-12#1)(2008-3#1)
large number of patients##7##4##(1993-11#2)(1996-3#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-12#1)
large number of samples##10##4##(1997-4#1)(2008-10#5)(2008-11#2)(2008-9#1)(2010-11#1)
large number of studies##3##4##(2008-1#1)(2008-5#1)(2012-12#1)
large number of##197##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-9#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#47)(2008-11#9)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
large number##200##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-9#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#49)(2008-11#9)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
large numbers of T cells##3##5##(2008-4#2)(2011-2#1)
large numbers of cells##5##4##(2008-11#2)(2008-4#2)(2008-9#1)
large numbers of children##3##4##(1996-12#1)(2008-12#1)(2009-6#1)
large numbers of individuals##2##4##(1996-12#1)(2008-10#1)
large numbers of patients##2##4##(1991-11#1)(2008-10#1)
large numbers of proteins in##2##5##(2008-4#2)
large numbers of samples##4##4##(2008-10#2)(2008-9#2)
large numbers of##62##3##(1991-11#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-8#1)(2007-6#1)(2007-7#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-7#4)(2008-9#9)(2009-10#1)(2009-6#1)(2011-2#2)
large numbers##67##2##(1991-11#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#3)(2008-7#4)(2008-9#9)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#1)
large off-axis angles##2##3##(2008-3#2)
large oil##2##2##(2009-10#2)
large open reading frame##3##4##(1997-3#1)(2008-10#2)
large open reading##4##3##(1997-3#1)(2008-10#3)
large open##5##2##(1993-3#1)(1997-3#1)(2008-10#3)
large optical loss##2##3##(2007-11#2)
large optical path##2##3##(2008-3#1)(2013-8#1)
large optical##10##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2013-8#1)
large or small##3##3##(2007-10#1)(2008-9#1)(2010-11#1)
large or##7##2##(1993-2#1)(1994-2#1)(2007-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)
large outbreak##2##2##(2011-1#1)(2013-1#1)
large outbreaks##2##2##(2012-2#2)
large part of##11##3##(1990-7#1)(1990-8#1)(1992-3#1)(1993-2#1)(1996-6#1)(2008-10#1)(2008-5#2)(2008-8#3)
large part##25##2##(1990-7#1)(1990-8#1)(1992-3#1)(1993-2#2)(1995-12#1)(1995-6#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
large particles##10##2##(2008-10#5)(2008-2#2)(2008-3#3)
large patches##2##2##(2008-9#2)
large peak##2##2##(2007-12#1)(2008-10#1)
large pedigrees##2##2##(2012-3#2)
large pharmaceutical companies##2##3##(2008-10#1)(2008-11#1)
large phase III trial##2##4##(2008-8#1)(2012-12#1)
large phase##3##2##(2007-12#1)(2008-8#1)(2012-12#1)
large pinnipeds##2##2##(2008-9#2)
large plasmid##3##2##(1995-8#1)(2008-10#1)(2012-3#1)
large plasmids##2##2##(2012-3#2)
large population size##2##3##(2008-10#1)(2008-9#1)
large population##17##2##(1994-8#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#2)
large populations in##2##3##(1992-2#1)(2008-10#1)
large populations of##4##3##(1997-6#1)(2008-10#2)(2011-1#1)
large populations##15##2##(1992-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-6#2)(2007-11#1)(2008-10#4)(2009-12#1)(2009-7#1)(2011-1#1)(2013-1#1)
large portion of##4##3##(1993-2#1)(2007-5#1)(2008-7#1)(2012-3#1)
large portion##5##2##(1993-2#1)(2007-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
large positive##4##2##(1992-3#1)(2008-3#1)(2009-6#1)(2012-2#1)
large potential##2##2##(2008-6#1)(2008-8#1)
large primary##3##2##(1992-6#1)(2008-3#1)(2008-6#1)
large propagation##2##2##(2007-12#1)(2008-2#1)
large proportion of the total##2##5##(2008-11#1)(2008-8#1)
large proportion of the##12##4##(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2013-8#1)
large proportion of##30##3##(1990-3#1)(1991-4#1)(1992-12#2)(1994-2#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
large prospective##2##2##(1992-6#1)(2008-3#1)
large protein##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
large proteins are##2##3##(1994-2#1)(1997-2#1)
large proteins##9##2##(1994-2#1)(1994-8#1)(1997-2#5)(2008-1#1)(2008-4#1)
large public##3##2##(1993-1#1)(2008-10#1)(2009-9#1)
large quantities in##3##3##(1994-8#1)(2008-10#2)
large quantities of data##2##4##(2007-10#1)(2008-3#1)
large quantities of##28##3##(1990-8#1)(1991-9#1)(1993-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2013-1#2)
large quantities##37##2##(1990-8#1)(1991-9#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#9)(2008-11#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2013-1#2)
large quantity##4##2##(1990-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
large randomized controlled trials##3##4##(2008-8#1)(2010-8#1)(2012-2#1)
large randomized trial##2##3##(2008-7#1)(2008-8#1)
large randomized##10##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
large range of##18##3##(1991-5#1)(1993-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)
large receptive fields##2##3##(2007-12#1)(2008-11#1)
large relative to the strength of##2##6##(2008-8#2)
large relative to the##3##4##(2008-8#2)(2011-2#1)
large release of##2##3##(1994-2#1)(2008-9#1)
large response##2##2##(2008-10#2)
large restriction fragments##2##3##(1992-6#2)
large restriction##3##2##(1992-6#2)(2008-1#1)
large retrospective##2##2##(1994-11#1)(2008-8#1)
large ring laser gyroscope##2##4##(2008-2#1)(2008-3#1)
large ring##4##2##(2008-2#1)(2008-3#3)
large sample of##6##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#1)
large sample size##2##3##(2012-2#1)(2013-1#1)
large sample theory##3##3##(1995-9#1)(1996-3#1)(2008-7#1)
large sample##22##2##(1992-11#1)(1995-9#1)(1996-3#1)(1997-3#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#3)(2013-1#1)
large samples##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
large scale application##2##3##(2008-11#1)(2008-7#1)
large scale cell##2##3##(2008-11#2)
large scale of##2##3##(2008-11#1)(2011-3#1)
large scale production##3##3##(2008-11#2)(2011-2#1)
large scale sampling studies##2##4##(2008-10#2)
large scale##59##2##(1990-12#1)(1991-2#1)(1994-5#1)(1994-6#1)(1996-4#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#16)(2008-12#1)(2008-6#1)(2008-7#5)(2009-12#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
large scales##3##2##(2008-5#1)(2008-8#1)(2009-8#1)
large sequence sets##2##3##(2008-4#2)
large sequences##2##2##(2009-5#2)
large series of samples##2##4##(2008-10#2)
large series of##10##3##(1992-8#1)(1993-9#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
large series##13##2##(1992-8#1)(1993-9#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)
large set of##10##3##(2008-11#1)(2008-2#2)(2008-3#3)(2009-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
large sets of##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)
large shears##2##2##(2008-3#2)
large shifts##2##2##(1993-12#1)(2009-6#1)
large shocks##2##2##(1996-4#2)
large single##2##2##(1997-7#1)(2012-2#1)
large size of the##5##4##(1991-3#1)(1995-5#1)(1996-4#1)(2009-2#1)(2010-3#1)
large size##20##2##(1991-3#1)(1993-8#1)(1995-5#1)(1996-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-11#2)(2009-2#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-7#1)
large sizes##3##2##(2008-7#1)(2008-8#1)(2013-8#1)
large skeletal defects##2##3##(2010-6#2)
large skin##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
large social##3##2##(2008-8#1)(2009-4#2)
large soft tissue##2##3##(2009-3#1)(2010-6#1)
large spatial##4##2##(2008-9#1)(2009-9#2)(2013-1#1)
large spectral##4##2##(2007-11#2)(2008-3#2)
large studies have##2##3##(2007-8#1)(2010-12#1)
large studies##6##2##(1994-2#1)(2007-8#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-1#1)
large study##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
large subunit ribosomal protein 29 (L29)##2##6##(1994-12#2)
large subunit ribosomal##4##3##(1991-6#1)(1994-12#2)(2010-4#1)
large subunit##15##2##(1991-6#1)(1992-3#2)(1992-8#3)(1993-8#1)(1994-12#2)(1995-12#1)(1995-8#1)(2008-10#2)(2010-4#1)(2013-8#1)
large surface area and##2##4##(2010-7#1)(2012-2#1)
large surface area##5##3##(2008-10#1)(2008-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
large surface##8##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-10#1)(2010-7#1)(2012-2#1)
large surface-to-volume ratio##2##3##(2009-11#1)(2010-7#1)
large teaching##4##2##(1991-3#1)(1993-3#1)(1996-2#1)(2007-2#1)
large telescope##3##2##(2008-3#3)
large text##2##2##(1991-8#2)
large three-dimensional##2##2##(2007-11#1)(2008-3#1)
large tissue##2##2##(2007-8#1)(2008-3#1)
large to pass through##2##4##(2007-5#1)(2008-9#1)
large to##8##2##(1992-5#1)(1993-12#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
large trials##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
large tumor (T) antigen##2##4##(1995-2#1)(2008-2#1)
large tumor (T)##3##3##(1995-2#2)(2008-2#1)
large tumor antigen##3##3##(1995-2#2)(2013-1#1)
large tumor##9##2##(1994-8#1)(1995-2#4)(2008-2#1)(2013-1#2)(2013-8#1)
large tumours##2##2##(2008-2#1)(2008-6#1)
large uncertainties in the##2##4##(2008-3#2)
large uncertainties##3##2##(1996-4#1)(2008-3#2)
large unilamellar vesicles##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
large units##2##2##(2008-7#1)(2011-2#1)
large urban centers##2##3##(2012-12#2)
large urban##10##2##(1992-1#1)(1992-12#2)(1995-5#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-12#2)
large vacuoles##2##2##(2008-11#1)(2008-12#1)
large value of##2##3##(2008-3#2)
large values of##3##3##(2007-12#1)(2008-3#2)
large values##4##2##(2007-12#2)(2008-3#2)
large variability in##2##3##(2010-10#1)(2011-2#1)
large variability##7##2##(1997-3#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-2#1)
large variation in the##2##4##(2007-11#1)(2008-11#1)
large variation in##4##3##(2007-11#1)(2008-11#1)(2010-8#1)(2013-1#1)
large variation##5##2##(2007-11#1)(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
large variations in the##3##4##(1996-4#1)(2008-10#1)(2008-3#1)
large variations in##4##3##(1996-4#1)(2008-10#1)(2008-3#1)(2012-1#1)
large variations##6##2##(1996-2#1)(1996-4#1)(2008-10#1)(2008-3#2)(2012-1#1)
large variety of applications##3##4##(2008-3#1)(2008-7#1)(2008-9#1)
large variety of##18##3##(1992-9#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2010-8#2)(2011-2#2)
large versus small##2##3##(2007-10#1)(2008-9#1)
large vessel##2##2##(2007-10#1)(2012-3#1)
large vessels or##2##3##(1990-2#1)(2011-2#1)
large vessels##8##2##(1990-2#2)(1991-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-2#1)
large vibrational##2##2##(2007-11#1)(2007-12#1)
large volume of HuES media##3##5##(2008-8#3)
large volume of aqueous##4##4##(2008-10#4)
large volume of literature##3##4##(2006-10#1)(2008-10#1)(2013-8#1)
large volume of##15##3##(1995-3#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-8#3)(2010-8#1)(2013-8#1)
large volume water##2##3##(2008-10#2)
large volume##25##2##(1995-3#1)(2006-10#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-8#1)(2013-8#1)
large volumes of water##2##4##(2008-10#1)(2013-1#1)
large volumes of##9##3##(2008-10#6)(2009-7#1)(2012-2#1)(2013-1#1)
large volumes##12##2##(2007-12#1)(2008-10#6)(2008-3#1)(2009-7#2)(2012-2#1)(2013-1#1)
large white##3##2##(2008-12#2)(2010-1#1)
large working distance##2##3##(2011-1#1)(2012-2#1)
large##2699##1##(1990-11#9)(1990-12#9)(1990-2#7)(1990-3#5)(1990-5#6)(1990-6#3)(1990-7#8)(1990-8#7)(1990-9#4)(1991-1#2)(1991-11#4)(1991-12#7)(1991-2#8)(1991-3#7)(1991-4#1)(1991-5#5)(1991-6#11)(1991-7#2)(1991-8#9)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#10)(1992-2#5)(1992-3#20)(1992-5#7)(1992-6#16)(1992-8#11)(1992-9#4)(1993-1#3)(1993-11#8)(1993-12#19)(1993-2#6)(1993-3#7)(1993-6#5)(1993-8#7)(1993-9#16)(1994-1#3)(1994-11#10)(1994-12#16)(1994-2#21)(1994-3#9)(1994-5#8)(1994-6#6)(1994-8#12)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#15)(1995-2#19)(1995-3#7)(1995-5#11)(1995-6#8)(1995-8#10)(1995-9#2)(1996-11#1)(1996-12#12)(1996-2#14)(1996-3#5)(1996-4#25)(1996-5#9)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#5)(1997-1#8)(1997-2#14)(1997-3#21)(1997-4#7)(1997-5#7)(1997-6#11)(1997-7#6)(1997-8#5)(1997-9#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#12)(2007-11#66)(2007-12#103)(2007-2#1)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#10)(2007-8#21)(2007-9#1)(2008-1#17)(2008-10#375)(2008-11#117)(2008-12#26)(2008-2#83)(2008-3#217)(2008-4#56)(2008-5#54)(2008-6#41)(2008-7#129)(2008-8#77)(2008-9#70)(2009-1#2)(2009-10#10)(2009-11#9)(2009-12#14)(2009-2#4)(2009-3#4)(2009-4#11)(2009-5#10)(2009-6#7)(2009-7#14)(2009-8#28)(2009-9#12)(2010-1#4)(2010-10#13)(2010-11#9)(2010-12#14)(2010-2#3)(2010-3#9)(2010-4#8)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#26)(2010-9#1)(2011-1#36)(2011-2#93)(2011-3#1)(2012-1#7)(2012-12#26)(2012-2#63)(2012-3#38)(2012-7#1)(2012-9#1)(2013-1#73)(2013-7#6)(2013-8#32)
large-angle##3##1##(2008-2#1)(2008-3#1)(2008-7#1)
large-aperture antenna##2##2##(2007-12#1)(2008-3#1)
large-aperture periodically poled##2##3##(2007-12#2)
large-aperture photoconductors##2##2##(2007-12#2)
large-aperture##13##1##(2007-12#7)(2008-2#1)(2008-3#5)
large-area semiconductor##2##2##(2007-11#2)
large-area##14##1##(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-11#2)(2011-2#1)
large-artery##4##1##(2007-10#3)(2012-12#1)
large-caliber##2##1##(2011-3#1)(2013-1#1)
large-cell lymphoma##2##2##(1996-8#1)(2013-1#1)
large-cell non-Hodgkin's##2##2##(1990-3#2)
large-cell##5##1##(1990-3#2)(1993-9#1)(1996-8#1)(2013-1#1)
large-conductance##2##1##(2008-4#1)(2009-2#1)
large-core##9##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)
large-diameter##2##1##(2008-2#1)(2008-3#1)
large-mode holey fibers##2##3##(2007-12#2)
large-mode holey##4##2##(2007-12#4)
large-mode-area##2##1##(2007-12#2)
large-numerical-aperture##2##1##(2007-11#1)(2008-3#1)
large-object##3##1##(2008-2#2)(2008-3#1)
large-ring cyclodextrins##2##2##(2008-10#2)
large-sample##3##1##(1992-6#2)(2012-3#1)
large-scale analysis of##2##3##(2010-1#1)(2010-4#1)
large-scale analysis##3##2##(2008-7#1)(2010-1#1)(2010-4#1)
large-scale clinical##2##2##(2008-11#1)(2010-5#1)
large-scale data##2##2##(2010-11#1)(2012-3#1)
large-scale empirical##2##2##(2008-12#1)(2008-7#1)
large-scale environmental##2##2##(1997-5#1)(2008-11#1)
large-scale epidemiological studies##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
large-scale epidemiological##4##2##(1991-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
large-scale expression data##3##3##(2008-4#2)(2008-7#1)
large-scale expression##4##2##(1995-12#1)(2008-4#2)(2008-7#1)
large-scale fermentation##3##2##(1990-5#1)(2008-11#2)
large-scale field##2##2##(2008-9#1)(2009-2#1)
large-scale gene expression##3##3##(2008-4#2)(2008-8#1)
large-scale genomic analyses##2##3##(2008-4#2)
large-scale genomic##3##2##(2008-4#2)(2013-8#1)
large-scale gold nanoplate##2##3##(2013-1#2)
large-scale mammalian cell##2##3##(2008-11#2)
large-scale microarray expression##2##3##(2008-7#2)
large-scale phylogenetic##2##2##(2008-10#1)(2011-2#1)
large-scale population##2##2##(2008-1#1)(2008-10#1)
large-scale preparation##2##2##(1995-12#1)(2008-9#1)
large-scale production of recombinant proteins##2##5##(1997-4#1)(2008-11#1)
large-scale production of##7##3##(1992-11#1)(1997-4#1)(2008-11#2)(2008-2#1)(2008-4#2)
large-scale production##11##2##(1992-11#1)(1997-4#1)(2008-11#4)(2008-2#1)(2008-4#3)(2011-2#1)
large-scale proteomic##2##2##(2008-4#1)(2008-7#1)
large-scale randomized##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
large-scale screening##2##2##(2008-9#2)
large-scale sequencing##2##2##(2008-4#1)(2012-3#1)
large-scale studies have##2##3##(2008-5#1)(2011-2#1)
large-scale studies##7##2##(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-8#1)
large-scale trials##2##2##(2008-10#1)(2008-3#1)
large-scale##176##1##(1990-3#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#13)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#17)(2008-5#1)(2008-6#2)(2008-7#19)(2008-8#5)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#1)(2011-2#5)(2011-8#1)(2012-2#10)(2012-3#4)(2013-1#7)(2013-8#2)
large-signal##3##1##(2007-12#1)(2008-3#2)
large-sized##3##1##(2007-10#1)(2012-1#1)(2013-7#1)
large-vessel lesions##2##2##(2007-10#2)
large-vessel##3##1##(2007-10#2)(2012-3#1)
large-volume##9##1##(1996-2#1)(2008-10#6)(2008-7#1)(2009-8#1)
largely a##4##2##(1997-3#1)(2007-7#1)(2009-5#1)(2011-2#1)
largely absent##3##2##(2008-7#1)(2009-4#1)(2009-7#1)
largely attributable to##2##3##(1991-9#1)(2010-12#1)
largely based on##2##3##(2008-5#1)(2008-7#1)
largely based##4##2##(2008-12#2)(2008-5#1)(2008-7#1)
largely be##3##2##(1996-3#1)(2012-2#1)(2013-8#1)
largely because of the##2##4##(1995-5#1)(2008-8#1)
largely because of##6##3##(1995-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#2)
largely because##10##2##(1994-3#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-8#2)
largely been ignored##2##3##(1996-12#1)(2012-2#1)
largely been##9##2##(1996-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-4#1)
largely by the##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
largely by##10##2##(1994-3#1)(1995-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-6#1)
largely considered##2##2##(2008-4#1)(2008-9#1)
largely consistent with the##2##4##(1994-3#1)(2010-3#1)
largely consistent with##3##3##(1994-3#1)(2008-7#1)(2010-3#1)
largely dependent on the##4##4##(1990-8#1)(1996-12#1)(2008-10#1)(2011-2#1)
largely dependent on##6##3##(1990-8#1)(1996-12#1)(2007-8#1)(2008-10#2)(2011-2#1)
largely dependent##7##2##(1990-8#1)(1996-12#1)(2007-8#1)(2008-10#3)(2011-2#1)
largely depends on##2##3##(2008-10#1)(2008-5#1)
largely determined by##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
largely directed##2##2##(1997-7#1)(2010-12#1)
largely disappeared##2##2##(1991-12#1)(1995-12#1)
largely due to the##6##4##(1994-12#2)(2008-11#1)(2012-2#2)(2013-7#1)
largely due to##11##3##(1994-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-2#2)(2013-7#1)
largely due##12##2##(1994-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-4#1)(2012-2#2)(2013-7#1)
largely eliminated##2##2##(2007-12#1)(2008-2#1)
largely excluded##2##2##(2008-10#1)(2011-2#1)
largely focused on##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
largely from##4##2##(1993-2#1)(1995-2#1)(1997-1#1)(2007-12#1)
largely ignored##6##2##(1997-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)
largely in##4##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
largely incomplete##2##2##(2008-11#1)(2009-7#1)
largely independent of the##2##4##(2008-2#1)(2008-3#1)
largely independent of##4##3##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
largely ineffective##2##2##(2008-10#1)(2010-3#1)
largely informal##2##2##(1992-1#1)(2008-11#1)
largely inhibited##2##2##(1994-9#1)(2008-10#1)
largely insensitive to##2##3##(1997-9#1)(2008-3#1)
largely mediated by##3##3##(1997-4#1)(2008-5#1)(2010-2#1)
largely not##3##2##(1997-3#1)(1997-4#1)(2012-3#1)
largely on its##2##3##(1990-5#1)(1994-3#1)
largely on the##3##3##(2008-3#1)(2008-5#1)(2013-8#1)
largely on##12##2##(1990-5#1)(1993-2#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-2#1)(2013-8#1)
largely overlapped##2##2##(2008-10#1)(2012-2#1)
largely overlapping##2##2##(1994-8#1)(1995-6#1)
largely overlooked##4##2##(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)
largely prevented##2##2##(1996-2#1)(1997-4#1)
largely reduced##2##2##(2008-10#1)(2008-5#1)
largely resolved##2##2##(1994-5#1)(2008-1#1)
largely responsible for the##3##4##(1995-8#1)(1996-3#1)(2008-10#1)
largely responsible for these##2##4##(1997-7#1)(2009-11#1)
largely responsible for##7##3##(1993-2#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-10#1)(2009-11#1)(2012-2#1)
largely restricted to##4##3##(1990-3#1)(1994-3#1)(1997-3#1)(2012-2#1)
largely result##2##2##(1996-5#1)(2012-2#1)
largely similar##2##2##(2008-12#1)(2010-10#1)
largely superseded##2##2##(1990-11#1)(2011-2#1)
largely the##2##2##(1995-12#1)(2008-1#1)
largely thought to##2##3##(2008-10#1)(2008-8#1)
largely through##3##2##(1992-1#1)(2008-10#1)(2009-10#1)
largely to the##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
largely to##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)
largely unaffected##2##2##(1991-12#1)(2008-3#1)
largely unchanged##3##2##(1991-8#1)(1996-5#1)(2008-3#1)
largely uncharacterized##2##2##(2008-9#1)(2012-2#1)
largely unexplored##4##2##(1992-12#1)(2008-8#1)(2008-9#1)(2013-7#1)
largely unknown##30##2##(1994-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
largely unrecognized##2##2##(2008-5#1)(2010-6#1)
largely used in the##2##4##(1990-3#1)(2010-3#1)
largely used in##3##3##(1990-3#1)(2010-3#1)(2013-1#1)
largely used##5##2##(1990-3#1)(1990-5#1)(2009-10#1)(2010-3#1)(2013-1#1)
largely##385##1##(1990-11#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-8#1)(1994-12#5)(1994-2#2)(1994-3#6)(1994-5#2)(1994-8#1)(1994-9#3)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#5)(1997-6#1)(1997-7#4)(1997-8#3)(1997-9#1)(2007-10#2)(2007-11#3)(2007-12#9)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#35)(2008-11#11)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#14)(2008-8#15)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#4)(2010-8#3)(2011-1#3)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#15)(2012-3#4)(2012-4#1)(2013-1#6)(2013-7#4)(2013-8#8)
larger (p = 0##2##4##(1993-11#1)(1996-2#1)
larger ICH##2##2##(2007-10#2)
larger amount of##5##3##(1992-3#1)(2008-10#4)
larger amounts of##7##3##(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-3#1)
larger and more##7##3##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-3#1)
larger and##13##2##(1992-3#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#2)
larger area##3##2##(1991-6#1)(2008-11#1)(2008-3#1)
larger areas##2##2##(2008-3#1)(2013-7#1)
larger as##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
larger body##2##2##(2007-11#1)(2008-9#1)
larger by##5##2##(1996-1#1)(2008-2#1)(2008-3#3)
larger cell##2##2##(1995-2#1)(2012-5#1)
larger clinical##2##2##(2008-1#1)(2011-2#1)
larger cohorts##2##2##(2008-1#1)(2012-3#1)
larger colonies##2##2##(2008-9#2)
larger context of##2##3##(1997-1#1)(2010-7#1)
larger defects##2##2##(2012-2#2)
larger diameter##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
larger differences##2##2##(1994-2#1)(2009-9#1)
larger doses##2##2##(1992-3#1)(2012-2#1)
larger effective##3##2##(2008-2#1)(2010-8#1)(2012-5#1)
larger extent than##3##3##(1995-2#1)(2009-8#1)(2011-2#1)
larger extent##4##2##(1995-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
larger females##2##2##(2008-8#2)
larger field##2##2##(2008-3#1)(2010-11#1)
larger for the##2##3##(2007-11#1)(2007-12#1)
larger for##10##2##(1991-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2010-9#1)(2012-12#1)
larger group of patients##4##4##(1995-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
larger group##7##2##(1994-2#1)(1995-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
larger groups##6##2##(1995-11#1)(1996-7#1)(2008-8#4)
larger health##2##2##(1994-12#1)(2011-1#1)
larger in size##2##3##(1996-2#1)(2008-10#1)
larger in the##4##3##(1991-6#1)(2008-7#2)(2011-1#1)
larger in##23##2##(1990-12#1)(1991-6#1)(1996-2#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2010-8#1)(2011-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
larger individuals##3##2##(2008-9#1)(2010-8#1)(2013-7#1)
larger international##2##2##(2008-10#1)(2012-12#1)
larger lesions##4##2##(2008-10#4)
larger livers##2##2##(2010-8#2)
larger mRNA species##2##3##(1990-11#1)(1992-12#1)
larger number of patients is##2##5##(2008-1#1)(2008-10#1)
larger number of patients##4##4##(1992-2#1)(2008-1#2)(2008-10#1)
larger number of##14##3##(1992-2#1)(1992-9#1)(1997-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)
larger numbers of patients##2##4##(1995-12#1)(2010-3#1)
larger numbers of##6##3##(1995-12#1)(2007-11#1)(2008-3#1)(2010-3#1)(2010-5#1)(2012-2#1)
larger numbers##7##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-5#1)(2012-2#1)
larger off-axis##2##2##(2008-2#1)(2008-3#1)
larger oligosaccharides##3##2##(1994-5#2)(1995-2#1)
larger one##2##2##(2008-10#1)(2013-8#1)
larger or smaller than##2##4##(1995-5#1)(2008-2#1)
larger or smaller##3##3##(1995-5#1)(2008-2#2)
larger or##4##2##(1995-5#1)(2008-2#2)(2010-7#1)
larger over the##2##3##(1995-12#1)(2008-10#1)
larger particle##2##2##(2008-10#1)(2008-3#1)
larger patient##2##2##(1993-12#1)(2008-6#1)
larger population##3##2##(1995-12#1)(2007-9#1)(2008-10#1)
larger populations##2##2##(1996-3#1)(2012-12#1)
larger proportion of##4##3##(1990-6#1)(1995-5#1)(2008-1#1)(2008-2#1)
larger prospective##2##2##(1992-12#1)(2008-7#1)
larger regions##2##2##(2008-3#1)(2009-5#1)
larger research##2##2##(1992-1#1)(1997-1#1)
larger sample of##2##3##(2008-11#1)(2010-7#1)
larger sample size##3##3##(2007-10#1)(2008-10#1)(2012-3#1)
larger sample##9##2##(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2010-7#1)(2012-3#1)
larger samples##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
larger scale are##2##3##(2008-1#1)(2009-8#1)
larger scale##6##2##(1992-5#1)(1994-3#1)(2008-1#1)(2008-11#1)(2009-8#1)(2013-8#1)
larger seeds##2##2##(2008-8#1)(2008-9#1)
larger series##3##2##(2008-10#1)(2008-4#1)(2010-12#1)
larger size and##2##3##(2011-2#2)
larger size##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-3#1)
larger sizes##2##2##(2008-10#1)(2010-8#1)
larger structures##2##2##(1997-5#2)
larger studies are##2##3##(2012-3#1)(2013-8#1)
larger studies##6##2##(2008-11#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
larger study##10##2##(1994-10#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-7#1)
larger surface##4##2##(1994-9#1)(1996-12#1)(2008-7#1)(2012-12#1)
larger than 0##6##3##(2008-10#1)(2008-2#2)(2009-12#1)(2009-7#1)(2013-8#1)
larger than 1##3##3##(1997-1#1)(2008-10#2)
larger than 10##2##3##(2008-2#1)(2010-12#1)
larger than 100##3##3##(1996-3#1)(2008-10#1)(2009-7#1)
larger than 15##2##3##(2008-10#1)(2008-5#1)
larger than 4##2##3##(2008-2#2)
larger than 5##2##3##(1993-11#1)(2012-2#1)
larger than 50 kDa##2##4##(1997-2#1)(2008-10#1)
larger than 50##4##3##(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
larger than 50%##2##3##(2008-3#2)
larger than a wavelength##2##4##(2007-11#1)(2008-3#1)
larger than a##6##3##(1995-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
larger than expected##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
larger than in##3##3##(1990-6#1)(2007-11#1)(2012-3#1)
larger than its##2##3##(2007-12#1)(2008-8#1)
larger than previously##2##3##(1992-3#1)(2008-10#1)
larger than that in##3##4##(1997-7#1)(2008-10#1)(2010-8#1)
larger than that measured##2##4##(2007-12#1)(2008-10#1)
larger than that obtained##2##4##(2008-2#1)(2008-3#1)
larger than that of the##8##5##(1995-11#1)(1997-1#1)(2008-11#1)(2008-3#2)(2008-9#2)(2013-8#1)
larger than that of##14##4##(1995-11#1)(1995-6#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-2#1)(2013-8#1)
larger than that##30##3##(1990-7#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#1)(2010-8#1)(2013-8#1)
larger than the wavelength##2##4##(2007-11#1)(2008-3#1)
larger than the##33##3##(1995-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#9)(2010-9#1)(2011-1#1)(2012-2#1)
larger than those in the##2##5##(2008-2#1)(2009-7#1)
larger than those of##5##4##(1990-5#1)(1992-6#1)(2007-12#2)(2011-2#1)
larger than those##16##3##(1990-5#1)(1991-5#1)(1992-6#1)(1994-8#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)
larger than when##2##3##(1993-12#1)(2007-11#1)
larger than##165##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#2)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#11)(2007-12#14)(2008-10#28)(2008-11#2)(2008-2#13)(2008-3#27)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
larger the##11##2##(1995-11#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)
larger units##4##2##(2011-2#4)
larger value of##4##3##(2008-10#3)(2008-7#1)
larger vesicles##3##2##(1990-2#1)(1995-6#2)
larger volume##2##2##(2008-10#1)(2008-5#1)
larger volumes of sample##2##4##(2008-10#2)
larger volumes of##3##3##(2008-10#2)(2008-9#1)
larger volumes##4##2##(2008-10#2)(2008-2#1)(2008-9#1)
larger when##2##2##(2008-10#1)(2008-2#1)
larger with##2##2##(2007-12#1)(2008-10#1)
larger##741##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#6)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#4)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#8)(1995-3#5)(1995-5#4)(1995-6#6)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#5)(1996-7#1)(1997-1#5)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(2007-10#7)(2007-11#22)(2007-12#31)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#113)(2008-11#25)(2008-12#8)(2008-2#43)(2008-3#63)(2008-4#5)(2008-5#14)(2008-6#5)(2008-7#28)(2008-8#34)(2008-9#22)(2009-10#4)(2009-12#2)(2009-2#3)(2009-4#2)(2009-5#4)(2009-7#5)(2009-8#3)(2009-9#5)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#7)(2010-8#9)(2010-9#3)(2011-1#6)(2011-2#18)(2012-1#2)(2012-12#8)(2012-2#13)(2012-3#13)(2012-5#2)(2013-1#7)(2013-7#5)(2013-8#10)
larger)##2##1##(1994-9#1)(2007-8#1)
largescale##2##1##(2008-10#1)(2008-7#1)
largest amount of##4##3##(1995-11#1)(2008-5#1)(2009-5#1)(2011-2#1)
largest and most##4##3##(1994-12#1)(2008-1#1)(2008-10#2)
largest and##7##2##(1994-12#1)(2008-1#1)(2008-10#3)(2013-1#1)(2013-8#1)
largest difference##2##2##(1993-8#1)(1996-6#1)
largest distances##2##2##(2013-1#2)
largest endemic##2##2##(1996-11#1)(1996-4#1)
largest for##2##2##(2008-11#1)(2008-2#1)
largest group of##4##3##(1995-12#1)(1995-6#1)(2011-2#1)(2013-1#1)
largest group##6##2##(1995-12#1)(1995-6#1)(1997-6#1)(2011-2#2)(2013-1#1)
largest increase in the##2##4##(1992-12#1)(1992-3#1)
largest number of##7##3##(1991-5#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
largest of##2##2##(2008-10#1)(2009-5#1)
largest portion of the##2##4##(2008-5#1)(2011-2#1)
largest professional##2##2##(2008-5#1)(2011-2#1)
largest share of##2##3##(2008-10#1)(2010-12#1)
largest single##4##2##(1992-1#1)(1992-6#1)(2008-11#1)(2009-5#1)
largest subunit of the##2##4##(1995-6#1)(2010-6#1)
largest subunit of##4##3##(1995-6#2)(1997-7#1)(2010-6#1)
largest subunit##5##2##(1995-6#2)(1997-7#2)(2010-6#1)
largest##205##1##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#6)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#3)(1997-5#2)(1997-6#3)(1997-7#3)(2007-11#3)(2007-12#4)(2007-5#2)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#12)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#9)(2013-7#3)(2013-8#2)
larici-populina strain 93CV1##2##3##(2008-10#2)
larici-populina strain 93ID6##2##3##(2008-10#2)
larici-populina strain##5##2##(2008-10#5)
larici-populina##20##1##(2008-10#20)
laromustine##3##1##(2010-11#3)
larva and##3##2##(2008-6#2)(2011-2#1)
larva before##2##2##(1992-6#1)(2007-12#1)
larva in##2##2##(2008-12#1)(2008-8#1)
larva migrans in##2##3##(2007-2#1)(2012-2#1)
larva migrans##5##2##(2007-2#2)(2007-7#1)(2012-2#2)
larva was##2##2##(2008-5#1)(2011-2#1)
larva##28##1##(1992-6#1)(1996-12#1)(1996-6#1)(2007-12#5)(2007-2#2)(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#3)(2012-2#2)
larvae acquired the virus##2##4##(2008-10#2)
larvae and adult mites##3##4##(2007-12#3)
larvae and adults##4##3##(1997-7#1)(1997-8#1)(2008-12#1)(2011-2#1)
larvae and at##3##3##(1993-12#2)(1995-2#1)
larvae and pupae##2##3##(2008-5#1)(2008-6#1)
larvae and##24##2##(1993-12#2)(1995-2#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#1)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2010-8#1)(2011-2#2)
larvae are the most##2##4##(2008-5#2)
larvae are##7##2##(2007-12#1)(2008-12#1)(2008-5#3)(2008-8#1)(2013-1#1)
larvae as##3##2##(2008-7#1)(2009-6#1)(2012-2#1)
larvae being##2##2##(2007-5#1)(2008-8#1)
larvae by##2##2##(2007-10#1)(2008-12#1)
larvae collected##2##2##(2008-10#1)(2010-8#1)
larvae during##2##2##(2010-8#1)(2011-2#1)
larvae entered the roots of##2##5##(2011-2#2)
larvae from##3##2##(2008-12#1)(2008-9#2)
larvae have##2##2##(1995-12#1)(2008-8#1)
larvae in the##2##3##(2008-5#1)(2010-8#1)
larvae in##8##2##(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)
larvae increased##2##2##(2008-6#1)(2008-7#1)
larvae infected with##2##3##(2008-11#1)(2010-6#1)
larvae is##2##2##(2008-8#2)
larvae of C##2##3##(2008-10#1)(2011-2#1)
larvae of M##3##3##(2008-11#2)(2013-1#1)
larvae of the##11##3##(1992-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
larvae of##39##2##(1992-8#1)(1997-8#1)(2007-12#3)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-4#1)(2010-8#3)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
larvae or##2##2##(2010-10#1)(2010-8#1)
larvae showed##3##2##(2007-5#1)(2008-5#1)(2008-7#1)
larvae sired by males of the##2##6##(2010-8#2)
larvae than##2##2##(2008-9#1)(2011-2#1)
larvae that were##2##3##(2008-5#1)(2010-2#1)
larvae that##3##2##(2008-5#1)(2010-2#1)(2010-8#1)
larvae to##3##2##(2008-8#1)(2010-8#1)(2013-1#1)
larvae treated with##3##3##(2008-12#2)(2008-6#1)
larvae was##4##2##(2008-7#3)(2011-2#1)
larvae were exposed to##3##4##(2008-5#1)(2010-8#1)(2013-1#1)
larvae were fed##2##3##(1995-2#1)(2008-11#1)
larvae were##23##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-8#2)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#1)
larvae whose parents survived##2##4##(2011-2#2)
larvae with##2##2##(2008-12#1)(2008-7#1)
larvae##296##1##(1992-6#4)(1992-8#1)(1993-12#3)(1993-9#1)(1995-11#1)(1995-12#2)(1995-2#5)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#4)(1997-9#1)(2007-10#1)(2007-12#15)(2007-2#1)(2007-5#4)(2008-10#15)(2008-11#8)(2008-12#23)(2008-2#5)(2008-5#24)(2008-6#14)(2008-7#25)(2008-8#17)(2008-9#10)(2009-10#1)(2009-5#2)(2009-6#5)(2010-10#4)(2010-11#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#25)(2011-2#36)(2012-12#6)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#6)
larvae)##3##1##(2008-11#1)(2008-5#1)(2008-7#1)
larval CNS##2##2##(2008-8#2)
larval abundances##2##2##(2011-2#2)
larval age##2##2##(2007-5#1)(2008-12#1)
larval aggregation##3##2##(2008-9#3)
larval and adult##2##3##(2011-2#1)(2012-12#1)
larval and##6##2##(2007-5#1)(2010-8#3)(2011-2#1)(2012-12#1)
larval brain##2##2##(2007-12#2)
larval density##4##2##(2008-9#1)(2009-10#2)(2010-8#1)
larval development##7##2##(2008-5#2)(2008-6#1)(2008-7#3)(2011-2#1)
larval dispersal##2##2##(2007-5#1)(2008-6#1)
larval feeding##3##2##(2008-9#1)(2011-2#2)
larval fishes##2##2##(2010-8#2)
larval food resources##2##3##(2008-8#1)(2008-9#1)
larval form from##2##3##(2011-2#2)
larval growth##6##2##(2007-5#3)(2008-7#1)(2010-8#2)
larval instar##4##2##(1992-6#1)(2008-12#2)(2008-5#1)
larval instars of##2##3##(2008-10#1)(2008-5#1)
larval instars##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
larval molt##2##2##(1992-6#1)(2007-12#1)
larval period and##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
larval period##4##2##(2007-12#2)(2008-7#1)(2012-3#1)
larval stage##9##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#3)(2013-1#1)
larval stages##5##2##(1990-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
larval supply##2##2##(2008-9#2)
larval survival##2##2##(2008-9#1)(2011-2#1)
larval thrips##2##2##(2008-10#2)
larval weight##3##2##(2010-10#2)(2011-2#1)
larval##155##1##(1990-3#1)(1992-6#3)(1995-2#3)(1996-12#4)(1996-2#1)(1997-4#1)(2007-12#15)(2007-2#1)(2007-5#9)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#6)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#16)(2008-9#15)(2009-10#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-8#17)(2011-2#16)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#3)
larvicides##2##1##(1991-12#1)(2013-8#1)
laryngeal afferent system##2##3##(1996-5#2)
laryngeal and##2##2##(1991-12#1)(2008-2#1)
laryngeal cancer##6##2##(1992-9#2)(2007-10#1)(2011-2#2)(2012-2#1)
laryngeal cancers##3##2##(1991-4#2)(1997-8#1)
laryngeal carcinoma cells##2##3##(2011-2#2)
laryngeal carcinoma##9##2##(1993-8#1)(1997-8#2)(2011-2#5)(2012-2#1)
laryngeal edema##2##2##(2007-2#1)(2013-1#1)
laryngeal involvement##2##2##(1990-6#2)
laryngeal lesions##3##2##(2008-5#3)
laryngeal mask airway##2##3##(2008-8#1)(2012-12#1)
laryngeal mask##9##2##(1993-2#4)(2007-8#1)(2008-2#2)(2008-8#1)(2012-12#1)
laryngeal mucosa##3##2##(2008-11#1)(2012-3#2)
laryngeal nerve##5##2##(1993-12#1)(1996-5#1)(2008-2#2)(2011-2#1)
laryngeal tumors##2##2##(1990-9#1)(1997-8#1)
laryngeal##69##1##(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-4#2)(1992-9#2)(1993-12#1)(1993-2#4)(1993-8#1)(1995-9#1)(1996-5#3)(1996-8#1)(1997-8#5)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-5#3)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#2)
laryngectomy based on##2##3##(2011-1#1)(2012-2#1)
laryngectomy##8##1##(2007-8#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-7#1)
laryngomalacia##3##1##(2013-8#3)
laryngopharyngitis and tonsillitis caused by Streptococcus##2##6##(2011-2#2)
laryngopharyngitis##4##1##(2011-2#4)
laryngoscopy##3##1##(2011-2#1)(2012-12#1)(2013-8#1)
laryngotomy approach##3##2##(2012-12#3)
laryngotomy##5##1##(2012-12#5)
larynx and##3##2##(1996-12#1)(2010-7#1)(2011-2#1)
larynx in##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
larynx##39##1##(1990-8#1)(1991-4#1)(1992-2#3)(1992-8#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-2#1)(1996-12#3)(1996-5#2)(2008-11#2)(2008-5#1)(2009-11#1)(2010-7#6)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
las##2##1##(2012-12#1)(2013-1#1)
lasB##3##1##(1995-2#3)
lasB-lacZ##3##1##(1995-2#3)
lasR##8##1##(1995-2#8)
lasalocid##8##1##(2007-6#5)(2008-10#3)
lascivious##2##1##(1995-12#1)(2009-10#1)
laser (COIL)##3##2##(2008-2#1)(2008-3#2)
laser (CVL)##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser (pulse##2##2##(2007-12#2)
laser Doppler flowmetry##2##3##(2007-7#1)(2008-5#1)
laser Doppler velocimeter##2##3##(2008-3#2)
laser Doppler velocimetry##2##3##(1994-11#1)(2008-3#1)
laser Doppler wind sensor##3##4##(2008-3#3)
laser Doppler##17##2##(1990-7#2)(1994-11#1)(2007-11#3)(2007-7#1)(2008-3#8)(2008-5#2)
laser Raman spectroscopy##2##3##(1992-8#1)(2008-3#1)
laser Raman##4##2##(1992-8#2)(2008-2#1)(2008-3#1)
laser ablation ICP-MS##2##3##(2008-10#2)
laser ablation and##2##3##(2008-1#1)(2008-3#1)
laser ablation for##2##3##(2008-10#1)(2008-3#1)
laser ablation inductively coupled plasma mass spectrometry##2##7##(2008-10#1)(2010-11#1)
laser ablation inductively coupled plasma time of flight mass spectrometry (LA-ICP-TOF-MS)##2##11##(2008-10#2)
laser ablation inductively coupled plasma##4##5##(2008-10#3)(2010-11#1)
laser ablation##32##2##(1991-2#1)(1994-12#1)(1996-1#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#11)(2008-3#5)(2010-11#1)(2011-2#2)(2013-8#2)
laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS)##2##6##(2008-10#2)
laser absorption spectrometer that##2##4##(2008-3#2)
laser absorption spectrometer##4##3##(2008-3#4)
laser absorption spectroscopy##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
laser absorption##13##2##(2007-12#2)(2008-2#1)(2008-3#10)
laser absorption-scattering technique##2##3##(2008-3#2)
laser achieved##2##2##(2007-11#1)(2008-2#1)
laser action in##2##3##(2007-11#1)(2008-2#1)
laser action on scar modes##2##5##(2007-11#2)
laser action on##3##3##(2007-11#3)
laser action##11##2##(2007-11#5)(2008-2#5)(2008-7#1)
laser amplifier system##3##3##(2007-11#2)(2008-3#1)
laser amplifier##10##2##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#2)
laser amplifiers##3##2##(2007-11#1)(2008-2#2)
laser and a##13##3##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#3)
laser and allows##2##3##(2008-2#1)(2008-3#1)
laser and amplifier##2##3##(2007-11#1)(2008-3#1)
laser and detector##3##3##(2008-3#3)
laser and its##3##3##(2008-2#1)(2008-3#2)
laser and show that##2##4##(2007-11#2)
laser and the power##2##4##(2008-3#2)
laser and the##10##3##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#5)
laser and##64##2##(1991-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(2007-11#11)(2007-12#15)(2008-10#2)(2008-2#11)(2008-3#21)
laser angioplasty##2##2##(1991-3#2)
laser application in##2##3##(2010-8#1)(2013-7#1)
laser application##3##2##(2007-8#1)(2010-8#1)(2013-7#1)
laser applications##2##2##(2008-2#1)(2008-3#1)
laser are presented##3##3##(2008-2#2)(2008-3#1)
laser are used##2##3##(2007-11#1)(2008-1#1)
laser are##17##2##(1991-6#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#3)
laser array##11##2##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#2)
laser arrays is##2##3##(2007-11#1)(2008-3#1)
laser arrays##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
laser as a function of laser##2##6##(2007-11#1)(2008-2#1)
laser as a function of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
laser as a light source##3##5##(2008-10#1)(2008-2#2)
laser as a##12##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)
laser as an##3##3##(1991-1#1)(2008-10#2)
laser as the excitation##2##4##(2007-11#1)(2008-5#1)
laser as the light source##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
laser as the##8##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
laser as##24##2##(1991-1#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#10)(2008-5#1)
laser at 1##7##3##(2007-12#2)(2008-2#2)(2008-3#3)
laser at 1064 nm##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
laser at 1064##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
laser at 157 nm##2##4##(2008-3#2)
laser at 532 nm##3##4##(2007-12#2)(2008-3#1)
laser at 8##2##3##(2007-12#2)
laser at the##2##3##(2007-11#1)(2008-3#1)
laser at##51##2##(1991-3#1)(2007-11#4)(2007-12#17)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#16)
laser attenuation##2##2##(2008-3#2)
laser based on a##2##4##(2007-11#1)(2008-2#1)
laser based on##8##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)
laser based##10##2##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
laser beam and##9##3##(2007-12#2)(2008-2#2)(2008-3#5)
laser beam are##2##3##(2008-2#1)(2008-3#1)
laser beam as##3##3##(2008-2#1)(2008-3#2)
laser beam at##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
laser beam by use of a##2##6##(2007-11#1)(2008-3#1)
laser beam by use of##3##5##(2007-11#1)(2008-3#2)
laser beam by##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
laser beam energy##2##3##(2007-11#1)(2008-10#1)
laser beam focused##2##3##(2008-2#1)(2008-3#1)
laser beam from a ground station to##2##7##(2008-3#2)
laser beam from a##3##4##(2008-3#2)(2012-2#1)
laser beam in a##2##4##(2007-11#1)(2007-12#1)
laser beam in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser beam is##13##3##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#6)
laser beam of##3##3##(2007-11#2)(2008-2#1)
laser beam on the##2##4##(2008-10#1)(2008-3#1)
laser beam on##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
laser beam passes through##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
laser beam propagation##2##3##(2007-12#1)(2008-3#1)
laser beam spot sizes##2##4##(2008-3#2)
laser beam spot##3##3##(2008-3#3)
laser beam that##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
laser beam through##2##3##(2007-12#1)(2008-3#1)
laser beam to a##2##4##(2008-3#2)
laser beam to##5##3##(2007-11#1)(2008-3#3)(2011-1#1)
laser beam was##3##3##(2008-3#3)
laser beam with a##4##4##(2007-11#1)(2008-3#3)
laser beam with the##2##4##(2007-11#1)(2008-3#1)
laser beam with##8##3##(2007-11#3)(2008-3#4)(2009-5#1)
laser beam##181##2##(1993-3#1)(2007-11#22)(2007-12#24)(2008-10#4)(2008-2#33)(2008-3#86)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2011-1#3)(2012-2#1)
laser beam)##2##2##(2008-2#1)(2008-3#1)
laser beams are##6##3##(2008-2#1)(2008-3#5)
laser beams is##3##3##(2008-2#2)(2008-3#1)
laser beams of##2##3##(2007-11#1)(2008-3#1)
laser beams with##3##3##(2007-12#1)(2008-3#2)
laser beams##43##2##(2007-11#4)(2007-12#4)(2008-2#12)(2008-3#22)(2011-1#1)
laser by a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser by an##2##3##(2007-11#1)(2007-12#1)
laser by means of##2##4##(2007-12#1)(2008-3#1)
laser by use of a##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
laser by use of an intracavity##2##6##(2007-12#2)
laser by use of##7##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
laser by using a##2##4##(2007-11#1)(2007-12#1)
laser by##24##2##(2007-11#6)(2007-12#12)(2008-2#1)(2008-3#5)
laser calorimetry##4##2##(2008-2#3)(2008-3#1)
laser can be used to##3##5##(1992-1#2)(2008-2#1)
laser can be##8##3##(1992-1#2)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
laser can produce##2##3##(2007-11#1)(2007-12#1)
laser can##12##2##(1992-1#2)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)(2012-3#1)
laser capture microdissection##2##3##(2008-4#1)(2010-12#1)
laser capture##4##2##(2008-4#1)(2010-12#1)(2010-6#2)
laser cavities##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
laser cavity and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser cavity can##2##3##(2008-3#2)
laser cavity length##2##3##(2007-11#1)(2008-3#1)
laser cavity with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser cavity##32##2##(2007-11#7)(2007-12#4)(2008-2#5)(2008-3#16)
laser coagulation##2##2##(1991-9#2)
laser communication##4##2##(2008-2#4)
laser components##2##2##(2008-2#1)(2008-3#1)
laser conditioning of##2##3##(2007-12#1)(2008-3#1)
laser configuration##3##2##(2008-3#3)
laser confocal scanning microscopy##2##4##(2008-10#1)(2008-7#1)
laser confocal##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
laser cooling in##2##3##(2007-11#2)
laser coupled to an##2##4##(2008-10#1)(2008-3#1)
laser crystal##14##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#6)
laser current##3##2##(2007-12#1)(2008-3#2)
laser cutting##3##2##(1995-2#1)(2010-6#2)
laser cytometers##2##2##(2008-9#2)
laser cytometry##2##2##(2008-9#2)
laser damage threshold##5##3##(2008-2#3)(2008-3#2)
laser damage thresholds##2##3##(2008-2#1)(2008-3#1)
laser damage##7##2##(2008-2#4)(2008-3#3)
laser delivery##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser densitometry##2##2##(1990-5#1)(1994-9#1)
laser desorption mass spectrometry##2##4##(1992-3#1)(2008-10#1)
laser desorption##5##2##(1992-3#1)(2008-10#2)(2012-3#2)
laser desorption/ionization (MALDI)##4##3##(2008-11#1)(2008-4#1)(2010-5#1)(2010-7#1)
laser desorption/ionization mass spectrometry##2##4##(2008-10#1)(2010-5#1)
laser desorption/ionization time of flight mass spectrometry##3##7##(2008-10#1)(2008-11#2)
laser desorption/ionization time-of-flight mass spectrometry##3##5##(2008-10#2)(2011-2#1)
laser desorption/ionization time-of-flight##5##3##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
laser desorption/ionization##14##2##(2008-10#4)(2008-11#4)(2008-4#1)(2008-9#1)(2010-5#2)(2010-7#1)(2011-2#1)
laser devices##5##2##(2007-12#1)(2008-2#4)
laser diffraction and##2##3##(1995-3#1)(2010-5#1)
laser diffraction##6##2##(1995-3#1)(2008-3#4)(2010-5#1)
laser diode (LD)##2##3##(2007-11#1)(2008-3#1)
laser diode and##5##3##(2007-12#1)(2008-3#4)
laser diode array##2##3##(2008-2#1)(2008-3#1)
laser diode as the##2##4##(2008-2#2)
laser diode as##4##3##(2007-12#1)(2008-2#3)
laser diode for##4##3##(2008-2#1)(2008-3#3)
laser diode in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser diode interferometer##2##3##(2007-12#1)(2008-3#1)
laser diode is presented##2##4##(2008-3#2)
laser diode is##10##3##(2007-12#1)(2008-2#4)(2008-3#5)
laser diode pulses##2##3##(2008-2#2)
laser diode pumped##2##3##(2007-11#1)(2008-3#1)
laser diode pumping##2##3##(2007-11#1)(2007-12#1)
laser diode that is##2##4##(2007-12#1)(2008-2#1)
laser diode to a single-mode##2##5##(2008-2#2)
laser diode to single-mode fiber##2##5##(2008-2#1)(2008-3#1)
laser diode to single-mode##3##4##(2008-2#1)(2008-3#2)
laser diode to##7##3##(2008-2#5)(2008-3#2)
laser diode with a##3##4##(2007-11#1)(2008-3#2)
laser diode with an##2##4##(2007-12#1)(2008-3#1)
laser diode with##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
laser diode##120##2##(2007-11#13)(2007-12#28)(2008-10#3)(2008-2#32)(2008-3#43)(2010-11#1)
laser diode's##2##2##(2008-2#1)(2008-3#1)
laser diodes for##2##3##(2008-3#2)
laser diodes in##3##3##(2008-2#1)(2008-3#2)
laser diodes is##2##3##(2008-2#1)(2008-3#1)
laser diodes that##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
laser diodes to##2##3##(2008-2#1)(2008-3#1)
laser diodes with##2##3##(2007-11#2)
laser diodes##33##2##(2007-11#7)(2007-12#5)(2008-2#8)(2008-3#13)
laser direct-casting process##2##3##(2008-2#2)
laser directly##2##2##(2007-12#2)
laser dye##5##2##(2007-12#3)(2008-2#2)
laser dyes in##2##3##(2007-11#1)(2013-7#1)
laser emission at##2##3##(2007-11#1)(2008-2#1)
laser emission from##2##3##(2008-2#2)
laser emission of##2##3##(2007-12#1)(2008-2#1)
laser emission##13##2##(2007-11#3)(2007-12#3)(2008-2#5)(2008-3#2)
laser emits a##2##3##(2008-3#1)(2008-9#1)
laser emitting at##5##3##(2007-12#4)(2008-10#1)
laser emitting##8##2##(2007-12#5)(2008-10#1)(2008-3#1)(2008-9#1)
laser energy and##2##3##(2007-12#1)(2008-3#1)
laser energy at##2##3##(2008-10#1)(2008-3#1)
laser energy delivery##2##3##(2007-12#1)(2008-3#1)
laser energy##14##2##(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
laser excision of##2##3##(1991-2#2)
laser excision##3##2##(1991-2#2)(1996-1#1)
laser excisional conization##2##3##(1991-1#2)
laser excisional##3##2##(1991-1#3)
laser excitation is##2##3##(2007-11#1)(2008-3#1)
laser excitation##12##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2011-1#1)
laser excited##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser feedback##2##2##(2007-11#1)(2008-3#1)
laser fiber##4##2##(1992-1#1)(1994-2#1)(1995-2#1)(2012-1#1)
laser field##9##2##(2007-11#1)(2007-12#7)(2008-3#1)
laser fields##3##2##(2008-3#3)
laser flash photolysis##3##3##(1991-12#1)(1995-2#1)(2008-8#1)
laser fluence and##3##3##(2008-2#1)(2008-3#2)
laser fluence##11##2##(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#4)
laser fluorescence##2##2##(1994-9#1)(2008-3#1)
laser for##21##2##(1992-1#1)(1992-3#1)(1996-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#8)(2010-8#1)
laser frequency shift##2##3##(2008-3#2)
laser frequency to##2##3##(2008-2#2)
laser frequency##21##2##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#11)
laser from##7##2##(1991-12#1)(2007-11#2)(2007-12#3)(2008-2#1)
laser gain media##3##3##(2008-3#3)
laser gain##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
laser generated##2##2##(2007-11#2)
laser generates##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
laser generating##3##2##(2007-11#2)(2007-12#1)
laser guide star##4##3##(2008-2#2)(2008-3#2)
laser guide##5##2##(2008-2#3)(2008-3#2)
laser had a##3##3##(2008-2#3)
laser harmonics##2##2##(2008-2#1)(2008-3#1)
laser has a##2##3##(2007-11#1)(2012-3#1)
laser has been demonstrated by use of##2##7##(2007-11#2)
laser has been demonstrated for the first time to the##2##10##(2008-2#2)
laser has been demonstrated##6##4##(2007-11#2)(2007-12#2)(2008-2#2)
laser has been developed##3##4##(2007-12#2)(2008-3#1)
laser has been stabilized##2##4##(2007-11#1)(2007-12#1)
laser has been used to##2##5##(2008-10#1)(2008-3#1)
laser has been##22##3##(1992-3#1)(2007-11#3)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#5)
laser has##24##2##(1992-3#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#5)(2012-3#1)
laser have been studied##2##4##(2008-2#1)(2008-3#1)
laser heating##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
laser heterodyne##3##2##(1995-5#2)(2008-3#1)
laser illumination and##2##3##(2008-2#1)(2008-3#1)
laser illumination at##2##3##(2008-2#2)
laser illumination##12##2##(1992-9#3)(2007-11#1)(2008-2#6)(2008-3#2)
laser imaging##3##2##(2008-3#1)(2011-1#2)
laser in a##11##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)(2011-1#1)
laser in an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser in the##13##3##(1996-1#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)(2013-1#1)
laser in this##2##3##(2007-12#1)(2008-2#1)
laser in##54##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-6#2)(1994-12#1)(1996-1#1)(2007-11#9)(2007-12#11)(2008-2#9)(2008-3#11)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
laser induced breakdown##2##3##(2008-10#2)
laser induced fluorescence detection##2##4##(1997-2#1)(2008-10#1)
laser induced fluorescence##6##3##(1997-2#1)(2008-10#5)
laser induced##11##2##(1997-2#1)(2007-8#1)(2008-10#9)
laser induced-breakdown spectroscopy##2##3##(2008-10#2)
laser initiation##2##2##(2008-2#2)
laser intensities##4##2##(2008-3#4)
laser intensity##15##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#10)
laser interference##4##2##(2008-3#2)(2010-4#2)
laser interferometer##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
laser interferometers##2##2##(2008-2#1)(2008-3#1)
laser interferometric gravitational-wave detectors##2##4##(2008-2#2)
laser interferometry##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
laser into a##2##3##(2007-12#1)(2008-3#1)
laser into the##4##3##(2008-2#1)(2008-3#3)
laser into##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
laser irradiance##4##2##(1993-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
laser irradiation at##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
laser irradiation is##2##3##(2007-12#2)
laser irradiation time##2##3##(2013-8#2)
laser irradiation##27##2##(1992-9#1)(1996-5#1)(2007-11#2)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#6)(2012-2#3)(2012-3#1)(2013-8#2)
laser is also##2##3##(2008-2#1)(2008-3#1)
laser is an##2##3##(2007-12#1)(2008-3#1)
laser is demonstrated by use of##2##6##(2007-11#1)(2008-3#1)
laser is demonstrated##7##3##(2007-11#5)(2007-12#1)(2008-3#1)
laser is mode locked by use of##2##7##(2007-11#2)
laser is mode locked##3##4##(2007-11#2)(2007-12#1)
laser is presented##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
laser is proposed##2##3##(2008-3#2)
laser is pumped##3##3##(2007-11#2)(2007-12#1)
laser is reported##4##3##(2007-12#1)(2008-2#3)
laser is shown##2##3##(2007-11#1)(2008-3#1)
laser is used as the light source##2##7##(2008-2#1)(2008-3#1)
laser is used##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
laser is##77##2##(2007-11#20)(2007-12#18)(2008-10#1)(2008-2#19)(2008-3#17)(2008-5#1)(2012-3#1)
laser laparoscopic adhesiolysis##2##3##(1991-3#2)
laser laparoscopy for treatment of pelvic endometriosis##2##7##(1992-1#1)(1995-2#1)
laser laparoscopy##9##2##(1991-3#1)(1992-1#2)(1992-3#1)(1995-2#5)
laser level##2##2##(2007-12#1)(2008-3#1)
laser light by an average-sized##2##5##(2008-3#2)
laser light by##3##3##(2007-12#1)(2008-3#2)
laser light on##2##3##(2008-2#1)(2012-2#1)
laser light scattered##3##3##(2008-2#2)(2008-3#1)
laser light scattering##3##3##(2008-10#1)(2008-3#2)
laser light source##3##3##(2008-2#2)(2008-3#1)
laser light through the##2##4##(2008-3#1)(2010-8#1)
laser light through##4##3##(2007-11#1)(2008-3#2)(2010-8#1)
laser light to##4##3##(2007-12#1)(2007-8#1)(2008-3#2)
laser light with a##3##4##(2007-12#1)(2008-3#2)
laser light with##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
laser light##78##2##(1994-3#1)(2007-11#5)(2007-12#10)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#15)(2008-3#33)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#4)
laser light-scattering##2##2##(1993-2#1)(2008-3#1)
laser line##10##2##(2007-12#2)(2008-2#3)(2008-3#5)
laser lines##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
laser linewidth is##2##3##(2007-12#2)
laser linewidth##9##2##(2007-12#3)(2008-2#3)(2008-3#3)
laser linewidths##2##2##(2008-2#1)(2008-3#1)
laser machine##2##2##(2008-10#2)
laser machining##2##2##(2007-11#1)(2008-3#1)
laser material##4##2##(2007-11#1)(2008-3#3)
laser medium##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
laser method##2##2##(2007-12#1)(2013-8#1)
laser microdissection##2##2##(2008-12#2)
laser micropatterning##2##2##(2008-5#2)
laser microscopy##4##2##(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
laser mode locked##3##3##(2007-12#2)(2008-2#1)
laser mode##8##2##(2007-12#5)(2008-2#1)(2008-3#2)
laser model##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
laser modes##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
laser neural network (LNN)##2##4##(2008-2#1)(2008-3#1)
laser neural network##3##3##(2008-2#1)(2008-3#2)
laser of##6##2##(1993-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
laser on##6##2##(2007-12#1)(2008-3#4)(2008-9#1)
laser operated##2##2##(2007-12#1)(2008-2#1)
laser operates##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
laser operating at a##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
laser operating at##16##3##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#5)(2011-1#1)
laser operating in the##4##4##(2008-10#1)(2008-3#3)
laser operating in##6##3##(2007-12#2)(2008-10#1)(2008-3#3)
laser operating near 2##2##4##(2007-12#1)(2008-3#1)
laser operating near##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
laser operating on##2##3##(2007-11#1)(2008-2#1)
laser operating##29##2##(2007-11#3)(2007-12#7)(2008-10#3)(2008-2#5)(2008-3#10)(2011-1#1)
laser operation in##2##3##(2008-2#1)(2008-3#1)
laser operation of##2##3##(2007-12#2)
laser operation##12##2##(2007-12#3)(2008-2#3)(2008-3#5)(2010-11#1)
laser ophthalmoscopy##4##2##(2007-11#1)(2011-1#2)(2011-7#1)
laser optical feedback imaging##2##4##(2008-3#2)
laser or##2##2##(1992-1#1)(2008-2#1)
laser oscillation##8##2##(2007-11#3)(2007-12#3)(2008-3#2)
laser oscillator is##2##3##(2007-11#1)(2008-3#1)
laser oscillator##10##2##(2007-11#5)(2007-12#1)(2008-3#4)
laser oscillator-amplifier##3##2##(2007-12#1)(2008-3#2)
laser oscillators##4##2##(2007-11#2)(2008-3#2)
laser output of##2##3##(2007-12#2)
laser output power of##4##4##(2008-2#2)(2008-3#2)
laser output power##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
laser output##20##2##(2007-11#2)(2007-12#7)(2008-2#6)(2008-3#5)
laser outputs##2##2##(2007-11#1)(2007-12#1)
laser over##2##2##(2007-11#1)(2008-10#1)
laser parameters##5##2##(2007-12#1)(2008-3#2)(2011-1#2)
laser particle##3##2##(2008-3#3)
laser pattern generator for##2##4##(2008-2#2)
laser performance of##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
laser performance##9##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
laser performs##2##2##(2008-2#2)
laser phase noise##2##3##(2007-11#1)(2007-12#1)
laser photocoagulation##4##2##(1993-6#3)(2011-1#1)
laser photolysis and laser-induced fluorescence##2##5##(2008-3#2)
laser plasma##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
laser power and##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
laser power is##4##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
laser power##29##2##(1992-12#2)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#11)(2011-1#2)
laser powers##2##2##(2007-12#2)
laser produced##3##2##(2007-11#2)(2007-12#1)
laser produces##8##2##(2007-11#4)(2007-12#3)(2008-3#1)
laser producing##4##2##(2007-11#4)
laser propagation in the atmosphere##2##5##(2008-3#2)
laser propagation##6##2##(2007-11#2)(2008-1#1)(2008-3#3)
laser provides##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
laser pulse and the##2##4##(2007-12#1)(2008-3#1)
laser pulse and##3##3##(2007-12#2)(2008-3#1)
laser pulse at##2##3##(2008-3#2)
laser pulse by##3##3##(2007-11#2)(2007-12#1)
laser pulse energy##2##3##(2007-12#2)
laser pulse in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser pulse into a##2##4##(2007-11#1)(2007-12#1)
laser pulse is used to##2##5##(2008-10#1)(2008-2#1)
laser pulse is##4##3##(2007-11#2)(2008-10#1)(2008-2#1)
laser pulse that##2##3##(2007-11#1)(2008-3#1)
laser pulse to##2##3##(2007-11#1)(2008-2#1)
laser pulse##49##2##(1995-6#1)(2007-11#11)(2007-12#11)(2008-10#3)(2008-2#11)(2008-3#11)(2011-1#1)
laser pulses and##4##3##(2007-11#4)
laser pulses at a##2##4##(2007-12#1)(2011-1#1)
laser pulses at##7##3##(2007-12#3)(2008-2#1)(2008-3#2)(2011-1#1)
laser pulses by##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
laser pulses in a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
laser pulses in air##2##4##(2007-11#1)(2007-12#1)
laser pulses in the##3##4##(2007-11#2)(2007-12#1)
laser pulses in##11##3##(2007-11#4)(2007-12#4)(2008-2#1)(2008-3#2)
laser pulses is demonstrated##2##4##(2007-11#1)(2008-3#1)
laser pulses is##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
laser pulses of##3##3##(2007-11#2)(2008-3#1)
laser pulses propagating in##3##4##(2007-11#1)(2007-12#2)
laser pulses to##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser pulses was##2##3##(2008-3#2)
laser pulses were##3##3##(2007-11#2)(2008-3#1)
laser pulses with a total##2##5##(2007-11#1)(2007-12#1)
laser pulses with a##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
laser pulses with##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
laser pulses##126##2##(1992-8#1)(2007-11#41)(2007-12#32)(2008-10#1)(2008-2#18)(2008-3#30)(2011-1#1)(2012-2#2)
laser pumped by a Nd##2##5##(2008-2#2)
laser pumped by a##6##4##(2007-12#2)(2008-2#4)
laser pumped by an##2##4##(2007-12#1)(2008-2#1)
laser pumped by the second harmonic of##2##7##(2008-2#1)(2008-3#1)
laser pumped by the##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
laser pumped by##13##3##(2007-12#5)(2008-2#7)(2008-3#1)
laser pumped##14##2##(1993-5#1)(2007-12#5)(2008-2#7)(2008-3#1)
laser pumping##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
laser radar applications##2##3##(2007-12#1)(2008-3#1)
laser radar cross##2##3##(2008-3#2)
laser radar has been##2##4##(2008-3#2)
laser radar system##2##3##(2008-3#2)
laser radar##14##2##(2007-12#2)(2008-3#12)
laser radars with##2##3##(2008-2#2)
laser radiation at a wavelength of##2##6##(2007-11#1)(2008-2#1)
laser radiation at##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
laser radiation in##4##3##(2008-2#4)
laser radiation is##3##3##(2007-12#1)(2008-2#2)
laser radiation that##2##3##(2008-2#1)(2008-3#1)
laser radiation##37##2##(1996-5#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-2#19)(2008-3#7)(2013-1#1)
laser ranging##3##2##(2008-3#3)
laser rate equation##2##3##(2008-3#2)
laser ray-tracing method##2##3##(2007-12#1)(2008-3#1)
laser remote sensing##2##3##(2008-2#2)
laser resonator##10##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#2)
laser resonators##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
laser revascularization (TMLR)##2##3##(2007-8#2)
laser revascularization##3##2##(2007-8#3)
laser rod##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
laser rotary encoder##2##3##(2006-4#1)(2008-2#1)
laser safety##4##2##(1993-3#4)
laser satellite##2##2##(2008-3#2)
laser scanned##2##2##(2008-10#2)
laser scanner##3##2##(2008-3#3)
laser scanning confocal microscopy##3##4##(2008-11#2)(2008-7#1)
laser scanning confocal##4##3##(2008-1#1)(2008-11#2)(2008-7#1)
laser scanning cytometry##3##3##(2008-9#3)
laser scanning microscope##7##3##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
laser scanning microscopy (CLSM)##2##4##(2008-9#1)(2010-8#1)
laser scanning microscopy##13##3##(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#3)(2008-9#3)(2010-8#1)
laser scanning##33##2##(1992-9#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#9)(2010-8#1)(2011-2#1)(2012-2#1)
laser sensor for##4##3##(2008-2#3)(2008-3#1)
laser sensor##8##2##(2007-11#3)(2008-2#4)(2008-3#1)
laser shots##4##2##(2008-2#1)(2008-3#3)
laser shows##2##2##(2008-2#1)(2008-3#1)
laser side pumped by##2##4##(2008-2#1)(2008-3#1)
laser side##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
laser source based on a##2##5##(2007-12#2)
laser source based on##3##4##(2007-12#3)
laser source for##2##3##(2007-12#1)(2008-10#1)
laser source is##2##3##(2007-11#2)
laser source##40##2##(1992-6#1)(2007-11#4)(2007-12#10)(2008-10#1)(2008-2#3)(2008-3#18)(2008-9#3)
laser sources##14##2##(1992-1#1)(2007-11#1)(2008-2#2)(2008-3#9)(2008-9#1)
laser speckle##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
laser spectrometer##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
laser spectroscopic imaging##2##3##(2007-12#2)
laser spectroscopy##4##2##(2008-2#4)
laser spot##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
laser subject to##3##3##(2007-11#1)(2007-12#2)
laser surgery is##2##3##(1991-4#1)(2008-3#1)
laser surgery##10##2##(1991-4#3)(1992-1#2)(1992-2#2)(2008-3#2)(2012-12#1)
laser system and##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
laser system are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser system at##2##3##(2007-12#1)(2008-2#1)
laser system based on optical parametric chirped pulse amplification##2##9##(2007-11#2)
laser system based on##3##4##(2007-11#2)(2008-3#1)
laser system by##2##3##(2008-3#2)
laser system for the##4##4##(2008-3#4)
laser system for##5##3##(2007-12#1)(2008-3#4)
laser system has been developed##2##5##(2007-12#1)(2008-2#1)
laser system has been##3##4##(2007-12#2)(2008-2#1)
laser system has##4##3##(2007-12#2)(2008-2#2)
laser system is##3##3##(2007-11#1)(2008-2#2)
laser system that produces##2##4##(2007-11#1)(2007-12#1)
laser system was used##2##4##(2007-11#1)(2008-3#1)
laser system with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
laser system with##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-1#1)
laser system##67##2##(1992-11#1)(2007-11#13)(2007-12#11)(2008-10#1)(2008-2#13)(2008-3#21)(2008-7#3)(2010-1#4)
laser systems##10##2##(1991-1#1)(1991-3#1)(2007-11#3)(2007-12#1)(2008-3#4)
laser technique##2##2##(2007-12#1)(2008-3#1)
laser technology##7##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#2)(2008-9#1)
laser telemeter head##2##3##(2008-2#1)(2008-3#1)
laser that generates##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser that is passively##2##4##(2007-12#2)
laser that is##7##3##(2007-11#3)(2007-12#2)(2008-3#2)
laser that operates##3##3##(2008-2#1)(2008-3#2)
laser that produces##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
laser that uses##2##3##(2007-11#1)(2007-12#1)
laser that was##2##3##(2007-12#1)(2008-2#1)
laser that##28##2##(2007-11#10)(2007-12#8)(2008-2#3)(2008-3#6)(2011-1#1)
laser therapy in##2##3##(2007-12#1)(2007-8#1)
laser therapy is##4##3##(1991-6#1)(1991-9#1)(2010-8#2)
laser therapy##15##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2010-8#5)(2011-1#1)(2013-1#1)
laser threshold##2##2##(2007-12#1)(2008-2#1)
laser to a##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)
laser to fabricate##2##3##(2007-12#1)(2008-2#1)
laser to##22##2##(2007-11#2)(2007-12#6)(2008-2#6)(2008-3#7)(2008-4#1)
laser trabeculoplasty in##2##3##(1990-11#1)(2011-2#1)
laser trabeculoplasty##6##2##(1990-11#3)(2011-2#3)
laser transition##2##2##(2007-12#2)
laser transmission##2##2##(2008-2#1)(2008-3#1)
laser transmitter##2##2##(2008-2#2)
laser trap##2##2##(2007-11#1)(2008-3#1)
laser trapping and##2##3##(2008-3#1)(2008-8#1)
laser trapping##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
laser treatment of##2##3##(1996-3#1)(2008-2#1)
laser treatment##9##2##(1990-11#1)(1993-6#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)
laser tuning##3##2##(2008-3#3)
laser used##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
laser users##2##2##(1993-3#2)
laser using##3##2##(2007-12#2)(2008-2#1)
laser vaporization has been##2##4##(1991-2#1)(2008-10#1)
laser vaporization of##3##3##(1992-3#1)(2007-12#1)(2008-10#1)
laser vaporization##7##2##(1991-2#2)(1992-3#1)(2007-12#1)(2008-10#3)
laser velocimetry##2##2##(2007-11#1)(2008-3#1)
laser was constructed##2##3##(2008-2#2)
laser was pumped##2##3##(2007-12#1)(2008-3#1)
laser was used as the##2##5##(2008-2#1)(2008-3#1)
laser was used as##3##4##(1990-11#1)(2008-2#1)(2008-3#1)
laser was used for##2##4##(2007-11#1)(2008-3#1)
laser was used to perform##2##5##(2008-2#2)
laser was used to##5##4##(2007-11#1)(2008-2#4)
laser was used##11##3##(1990-11#1)(2007-11#2)(2008-10#1)(2008-2#5)(2008-3#2)
laser was##42##2##(1990-11#1)(1992-12#2)(2007-11#3)(2007-12#7)(2008-10#1)(2008-2#15)(2008-3#8)(2008-5#1)(2012-2#1)(2012-3#3)
laser wave##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
laser wavelength can be##2##4##(2007-11#1)(2008-7#1)
laser wavelength##17##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#6)(2008-7#1)
laser wavelengths of 442##3##4##(2008-2#2)(2008-3#1)
laser wavelengths##12##2##(2007-12#1)(2008-2#4)(2008-3#7)
laser welding##2##2##(2008-3#2)
laser were##7##2##(1991-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)
laser windows##3##2##(2008-2#3)
laser with 1##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
laser with a Co(2+)##2##4##(2007-11#1)(2008-3#1)
laser with a Cr##2##4##(2008-3#2)
laser with a flat##2##4##(2008-10#1)(2008-3#1)
laser with a novel##2##4##(2008-2#2)
laser with a pulse##2##4##(2007-11#1)(2008-3#1)
laser with a wavelength of 1##2##6##(2007-12#1)(2008-3#1)
laser with a wavelength##3##4##(2007-12#1)(2008-3#2)
laser with a##52##3##(1996-11#1)(2007-11#9)(2007-12#10)(2008-10#1)(2008-2#12)(2008-3#19)
laser with an intracavity##3##4##(2007-11#1)(2007-12#2)
laser with an output power of##3##6##(2007-11#1)(2007-12#1)(2008-3#1)
laser with an##14##3##(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#3)
laser with external##2##3##(2008-2#1)(2008-3#1)
laser with high##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
laser with output##2##3##(2007-12#2)
laser with the##9##3##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)
laser with two##2##3##(2007-12#1)(2008-3#1)
laser with wavelength##2##3##(2007-11#1)(2008-3#1)
laser with##109##2##(1991-2#1)(1996-11#1)(2007-11#21)(2007-12#25)(2008-10#2)(2008-2#23)(2008-3#33)(2008-5#1)(2012-2#2)
laser without##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
laser working##2##2##(2008-3#2)
laser writing##2##2##(2008-3#2)
laser yielded a maximum output power of##2##7##(2007-12#1)(2008-3#1)
laser##3256##1##(1990-11#5)(1990-12#3)(1990-5#4)(1990-6#1)(1990-7#2)(1991-1#5)(1991-12#3)(1991-2#13)(1991-3#12)(1991-4#3)(1991-6#3)(1991-9#4)(1992-1#16)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#14)(1992-6#1)(1992-8#4)(1992-9#9)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#8)(1993-5#2)(1993-6#7)(1993-8#1)(1994-11#1)(1994-12#8)(1994-2#2)(1994-3#2)(1994-9#2)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#6)(1996-11#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-6#1)(1997-8#1)(2006-4#1)(2007-11#486)(2007-12#611)(2007-7#1)(2007-8#18)(2008-1#7)(2008-10#114)(2008-11#12)(2008-12#2)(2008-2#629)(2008-3#980)(2008-4#8)(2008-5#13)(2008-7#13)(2008-8#7)(2008-9#25)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#9)(2010-1#4)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#37)(2011-2#8)(2011-7#2)(2012-1#3)(2012-12#2)(2012-2#19)(2012-3#13)(2013-1#4)(2013-7#2)(2013-8#7)
laser's##12##1##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)
laser)##3##1##(1990-5#1)(2007-11#1)(2008-3#1)
laser-active##2##1##(2008-3#2)
laser-assisted##10##1##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2009-2#1)(2012-3#2)
laser-backlit##4##1##(2008-3#4)
laser-based intracellular nanosurgery##2##3##(2011-1#2)
laser-based##13##1##(1992-3#1)(2008-10#3)(2008-2#4)(2008-3#2)(2010-1#1)(2011-1#2)
laser-beam transfer through a##2##4##(2008-2#2)
laser-beam##4##1##(2008-2#3)(2008-3#1)
laser-capture microdissection##3##2##(2009-8#1)(2010-1#1)(2011-2#1)
laser-cooled atoms##2##2##(2007-11#2)
laser-cooled##5##1##(2007-11#2)(2007-12#2)(2008-2#1)
laser-created##2##1##(2007-12#1)(2008-1#1)
laser-desorption mass-spectrometer microprobe##2##3##(2008-2#2)
laser-desorption##3##1##(2008-2#3)
laser-diode pump##2##2##(2008-2#1)(2008-3#1)
laser-diode side-pumped solid-state##2##3##(2008-3#2)
laser-diode system with optical feedback##2##5##(2008-3#2)
laser-diode to single-mode fiber##2##4##(2008-2#2)
laser-diode##16##1##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#9)
laser-diode-pumped Nd##2##2##(2007-12#1)(2008-3#1)
laser-diode-pumped##18##1##(2007-11#3)(2007-12#11)(2008-2#1)(2008-3#3)
laser-enhanced ionization spectrometry##2##3##(2008-1#1)(2008-10#1)
laser-enhanced ionization##4##2##(2008-1#2)(2008-10#2)
laser-excited time-resolved Shpol'skii spectrometry##3##4##(2008-10#3)
laser-excited##6##1##(1994-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
laser-heated pulling##2##2##(2008-2#2)
laser-heated##9##1##(2008-10#2)(2008-2#5)(2008-3#2)
laser-illuminated##2##1##(2007-12#1)(2008-6#1)
laser-induced air optical breakdown##2##4##(2008-2#2)
laser-induced breakdown spectroscopy in liquid jets##2##6##(2007-12#2)
laser-induced breakdown spectroscopy##6##3##(2007-12#2)(2008-2#2)(2013-8#2)
laser-induced breakdown##13##2##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2013-1#1)(2013-8#2)
laser-induced damage threshold (LIDT)##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
laser-induced damage threshold##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
laser-induced damage thresholds##2##3##(2007-11#1)(2008-3#1)
laser-induced damage##10##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)
laser-induced electrostrictive gratings##2##3##(2007-12#2)
laser-induced fluorescence (LIF) method##2##4##(2008-2#1)(2008-3#1)
laser-induced fluorescence (LIF)##11##3##(2008-10#3)(2008-2#5)(2008-3#3)
laser-induced fluorescence detection##6##3##(1997-2#3)(2008-10#2)(2008-2#1)
laser-induced fluorescence detector##2##3##(2008-10#2)
laser-induced fluorescence excitation##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
laser-induced fluorescence of atomic##2##4##(2008-2#2)
laser-induced fluorescence of organic dyes hosted##2##6##(2007-12#1)(2008-3#1)
laser-induced fluorescence of##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
laser-induced fluorescence spectra##2##3##(2008-2#1)(2008-3#1)
laser-induced fluorescence spectroscopy##2##3##(2008-10#2)
laser-induced fluorescence with##2##3##(2008-2#1)(2008-3#1)
laser-induced fluorescence##55##2##(1997-2#3)(2007-12#1)(2008-10#12)(2008-2#19)(2008-3#19)(2011-1#1)
laser-induced fluorimetry##2##2##(2008-10#2)
laser-induced grating##2##2##(2007-12#2)
laser-induced incandescence (LII)##3##3##(2008-2#2)(2008-3#1)
laser-induced incandescence##8##2##(2007-12#1)(2008-2#3)(2008-3#4)
laser-induced phycoerythrin fluorescence##2##3##(2008-2#2)
laser-induced plasma spectrometry##2##3##(2007-12#2)
laser-induced plasma##8##2##(2007-12#4)(2008-10#2)(2008-3#2)
laser-induced pump saturation##2##3##(2007-11#2)
laser-induced thermal acoustics##7##3##(2007-11#1)(2008-3#6)
laser-induced thermal##8##2##(2007-11#2)(2008-3#6)
laser-induced thermotherapy##2##2##(2008-2#2)
laser-induced##140##1##(1991-2#1)(1997-2#3)(2007-11#8)(2007-12#14)(2008-10#19)(2008-11#1)(2008-2#40)(2008-3#44)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)(2013-8#2)
laser-induced-damage##2##1##(2008-3#2)
laser-induced-fluorescence measurements of NO##2##4##(2008-2#2)
laser-induced-fluorescence measurements##3##2##(2008-2#3)
laser-induced-fluorescence##6##1##(2007-12#1)(2008-2#5)
laser-irradiated##2##1##(2007-12#1)(2008-2#1)
laser-produced##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
laser-pulse##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
laser-pumped magnetic-field-modulation##2##2##(2008-2#2)
laser-pumped##6##1##(2007-11#1)(2008-2#4)(2008-3#1)
laser-saturated##2##1##(2008-2#2)
laser-scanning confocal microscope##2##3##(2007-11#2)
laser-scanning confocal microscopy##2##3##(1996-5#1)(2007-11#1)
laser-scanning confocal##4##2##(1996-5#1)(2007-11#3)
laser-scanning microscopy##2##2##(2007-12#1)(2008-1#1)
laser-scanning##8##1##(1996-5#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#1)
laser-tissue interaction##2##2##(1993-1#1)(2008-7#1)
laser-tissue##3##1##(1992-12#1)(1993-1#1)(2008-7#1)
laserlike emission from##2##3##(2007-12#1)(2008-3#1)
laserlike emission##4##2##(2007-12#2)(2008-3#2)
laserlike##5##1##(2007-12#2)(2008-3#3)
lasers and##10##2##(1992-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)(2010-8#1)
lasers are operated##2##3##(2007-11#1)(2007-12#1)
lasers are presented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
lasers are used##3##3##(2008-2#1)(2008-3#2)
lasers are##21##2##(2007-11#4)(2007-12#6)(2008-2#2)(2008-3#8)(2008-9#1)
lasers as a##2##3##(2008-3#1)(2012-3#1)
lasers as well as##2##4##(2008-2#1)(2008-3#1)
lasers as##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
lasers at low##2##3##(2007-11#1)(2007-12#1)
lasers at##10##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#3)
lasers based on##5##3##(2007-12#2)(2008-3#3)
lasers because of##2##3##(2007-11#1)(2008-2#1)
lasers by use of##6##4##(2007-11#4)(2008-3#2)
lasers by##12##2##(2007-11#5)(2007-12#1)(2008-3#6)
lasers can be used##2##4##(2007-12#1)(2008-3#1)
lasers can be##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
lasers emitting##3##2##(2007-11#1)(2008-3#2)
lasers for##16##2##(1991-3#2)(1993-3#1)(2007-11#1)(2008-2#3)(2008-3#8)(2011-1#1)
lasers has been##3##3##(2007-12#1)(2008-3#2)
lasers have been##2##3##(2008-4#1)(2008-7#1)
lasers have##4##2##(1992-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
lasers in a##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
lasers in the##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
lasers in##22##2##(1993-3#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#11)
lasers is presented##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
lasers is proposed and demonstrated##2##5##(2007-11#1)(2008-3#1)
lasers is reported##2##3##(2007-12#2)
lasers is##17##2##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#7)(2008-9#1)
lasers operating at##2##3##(2007-11#2)
lasers operating in##2##3##(2007-11#1)(2008-2#1)
lasers operating near 1##2##4##(2008-3#2)
lasers operating near##4##3##(2008-2#1)(2008-3#3)
lasers operating##9##2##(2007-11#4)(2008-2#2)(2008-3#3)
lasers or##2##2##(2008-2#1)(2008-3#1)
lasers over##2##2##(2008-3#2)
lasers pumped##2##2##(2007-12#1)(2008-3#1)
lasers subject to##2##3##(2007-11#2)
lasers that are##2##3##(2008-3#2)
lasers that##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
lasers to##11##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#6)
lasers used as##2##3##(2008-2#1)(2008-3#1)
lasers used##3##2##(2008-2#1)(2008-3#2)
lasers was##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
lasers were##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
lasers will##2##2##(2007-11#1)(2008-3#1)
lasers with a##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
lasers with deformed##2##3##(2007-11#2)
lasers with##42##2##(2007-11#12)(2007-12#8)(2008-2#4)(2008-3#17)(2012-3#1)
lasers##464##1##(1991-3#5)(1992-12#2)(1992-9#2)(1993-12#1)(1993-3#4)(2007-11#98)(2007-12#95)(2008-1#1)(2008-10#2)(2008-2#59)(2008-3#175)(2008-4#1)(2008-7#5)(2008-9#4)(2009-7#1)(2010-8#2)(2011-1#3)(2012-3#3)(2013-8#1)
lasers)##2##1##(2007-12#2)
lasing and##2##2##(2007-11#1)(2007-12#1)
lasing at##4##2##(2007-11#3)(2007-12#1)
lasing efficiency of##2##3##(2008-2#2)
lasing efficiency##4##2##(2008-2#3)(2008-3#1)
lasing field##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
lasing in##8##2##(2007-11#3)(2008-2#1)(2008-3#2)(2008-7#2)
lasing intensity distribution##2##3##(2007-12#2)
lasing line##2##2##(2007-11#1)(2008-3#1)
lasing materials##2##2##(2008-2#1)(2008-3#1)
lasing modes##2##2##(2007-11#2)
lasing of##7##2##(2007-11#4)(2007-12#2)(2008-3#1)
lasing threshold##3##2##(2007-11#3)
lasing was##2##2##(2008-3#2)
lasing wavelength separations##2##3##(2007-12#2)
lasing wavelength##8##2##(2007-12#4)(2008-2#2)(2008-3#2)
lasing wavelengths##2##2##(2007-12#2)
lasing##74##1##(2007-11#23)(2007-12#21)(2008-2#11)(2008-3#17)(2008-7#2)
last 15 years##13##3##(1991-11#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#2)(2010-3#1)(2012-2#1)
last 15##14##2##(1991-11#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#2)(2010-3#1)(2012-2#2)
last 17##2##2##(2011-2#1)(2013-1#1)
last 2##10##2##(1990-6#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
last 20 years##11##3##(1991-4#1)(1992-4#1)(1994-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-11#1)(2011-3#1)
last 20##17##2##(1991-4#1)(1992-4#1)(1992-6#1)(1994-12#2)(1994-3#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-8#1)(2009-10#1)(2010-11#1)(2011-3#1)
last 30 days##2##3##(2007-12#1)(2011-2#1)
last 30 years##13##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
last 30##17##2##(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-1#1)
last 50 years##7##3##(1990-6#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)
last 50##8##2##(1990-6#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
last 6 years##4##3##(1996-9#1)(1997-4#1)(2007-8#1)(2008-8#1)
last 6##7##2##(1996-9#1)(1997-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
last but not least##3##4##(1991-3#1)(2007-11#1)(2011-1#1)
last case of##2##3##(1991-8#1)(1994-9#1)
last case##6##2##(1991-8#2)(1994-9#2)(2008-3#1)(2008-7#1)
last century##8##2##(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2011-3#1)(2013-1#1)(2013-7#1)
last check-up##2##2##(2007-8#1)(2010-9#1)
last decade##94##2##(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#3)(1992-1#2)(1992-11#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-7#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#7)
last dose of##3##3##(1995-3#1)(2008-7#1)(2013-1#1)
last dose##7##2##(1992-8#1)(1995-3#1)(1996-5#2)(1997-7#1)(2008-7#1)(2013-1#1)
last evaluation##2##2##(2008-7#1)(2011-2#1)
last exposure##3##2##(1991-9#1)(2008-10#2)
last few years##28##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#2)(1992-12#1)(1994-6#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2009-3#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
last few##40##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#2)(1992-12#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-1#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#5)(2009-3#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
last fights##2##2##(2008-9#2)
last follow-up##8##2##(1997-3#1)(2008-1#2)(2008-10#1)(2008-6#3)(2012-12#1)
last for##3##2##(2008-3#2)(2008-7#1)
last group##2##2##(2008-5#1)(2012-3#1)
last in a##3##3##(1995-2#1)(1996-2#1)(2008-4#1)
last in##4##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-4#1)
last injection##3##2##(1994-5#1)(1995-5#1)(2008-8#1)
last instar larvae##2##3##(1992-6#2)
last instar##4##2##(1992-6#2)(2008-6#2)
last month of##4##3##(1996-12#2)(2008-9#1)(2013-8#1)
last month##6##2##(1996-12#2)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
last name##2##2##(1997-5#1)(2007-11#1)
last one##9##2##(1993-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
last resort##4##2##(1997-2#1)(2008-8#1)(2009-8#1)(2010-10#1)
last section##2##2##(1992-6#1)(2011-2#1)
last several years##11##3##(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)
last several##13##2##(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)
last step##4##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-4#1)
last time##4##2##(1991-3#2)(2011-1#1)(2012-12#1)
last twelve##2##2##(2011-1#1)(2013-1#1)
last two decades have##3##4##(2007-12#1)(2009-8#1)(2010-11#1)
last two decades##29##3##(1994-3#2)(1995-12#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
last two steps of##3##4##(1993-2#1)(2010-2#1)(2011-1#1)
last two##52##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-7#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
last week##2##2##(1991-3#1)(1994-6#1)
last word##2##2##(1993-12#1)(2008-11#1)
last year##11##2##(1993-8#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2013-7#1)
last years##17##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#6)(2011-3#1)
last##732##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#4)(1990-5#1)(1990-6#7)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#5)(1991-12#5)(1991-2#3)(1991-3#8)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#6)(1994-3#7)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#7)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#7)(1996-5#4)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#7)(1997-6#2)(1997-7#5)(1997-8#2)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#1)(2008-1#13)(2008-10#64)(2008-11#19)(2008-12#9)(2008-2#6)(2008-3#9)(2008-4#14)(2008-5#19)(2008-6#9)(2008-7#22)(2008-8#18)(2008-9#15)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#6)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#3)(2010-6#4)(2010-8#7)(2010-9#2)(2011-1#14)(2011-2#48)(2011-3#7)(2012-1#6)(2012-12#8)(2012-2#19)(2012-3#10)(2012-7#1)(2013-1#25)(2013-7#4)(2013-8#5)
last-minute travellers##2##2##(2007-2#2)
last-minute##3##1##(2007-2#3)
last-names in##2##2##(2012-12#2)
last-names##3##1##(2012-12#3)
last?##2##1##(2007-1#1)(2008-8#1)
lasted at least##3##3##(1991-8#1)(2008-10#1)(2008-8#1)
lasted for 3##4##3##(2008-8#2)(2011-1#1)(2011-2#1)
lasted for a##2##3##(1991-2#1)(2008-3#1)
lasted for about##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
lasted for one year##2##4##(1993-2#1)(2008-10#1)
lasted for##25##2##(1990-5#1)(1991-2#1)(1991-6#2)(1993-2#1)(1993-3#1)(1994-6#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#3)(2011-2#1)(2013-1#1)
lasted less than##2##3##(1990-5#1)(1995-5#1)
lasted longer##2##2##(1997-6#1)(2008-10#1)
lasted more than##3##3##(1990-12#1)(2008-9#2)
lasted on##2##2##(2008-6#1)(2012-3#1)
lasted only##2##2##(2008-10#1)(2008-8#1)
lasted until##2##2##(1992-6#1)(2009-7#1)
lasted##61##1##(1990-12#1)(1990-5#2)(1991-2#1)(1991-6#3)(1991-8#3)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-7#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
lasting 4##2##2##(2007-7#1)(2008-5#1)
lasting and##2##2##(1992-1#1)(2008-10#1)
lasting change##2##2##(1991-6#1)(2009-9#1)
lasting effect on##2##3##(1991-6#1)(2008-12#1)
lasting effect##3##2##(1991-6#1)(1993-2#1)(2008-12#1)
lasting effects##2##2##(2008-11#1)(2013-8#1)
lasting for more than##2##4##(1990-9#1)(1996-3#1)
lasting for##13##2##(1990-9#1)(1991-5#2)(1992-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(2007-7#3)(2008-10#1)(2011-2#1)(2013-1#1)
lasting impact##2##2##(2007-12#1)(2008-10#1)
lasting until##2##2##(2008-6#1)(2008-7#1)
lasting##85##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-2#2)(1994-8#2)(1995-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
lastly##8##1##(1990-3#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-6#1)(1994-12#1)(2008-10#1)(2011-10#1)
lasts &gt##2##2##(2008-10#1)(2008-7#1)
lasts##6##1##(1991-11#1)(1991-12#1)(2008-10#1)(2008-7#2)(2009-5#1)
lata##16##1##(2008-10#14)(2009-3#1)(2011-2#1)
late 1990s##7##2##(1990-11#1)(2008-10#3)(2008-7#1)(2010-5#1)(2013-1#1)
late 20th century##2##3##(2008-7#1)(2012-12#1)
late G1##4##2##(1993-6#2)(1994-6#1)(1997-1#1)
late March##3##2##(2008-10#3)
late S##2##2##(1996-3#1)(2008-11#1)
late adolescence##6##2##(2008-11#2)(2009-7#3)(2010-8#1)
late appearance##2##2##(2008-10#1)(2008-9#1)
late as##3##2##(1992-12#1)(2008-5#1)(2008-7#1)
late blight developed in##2##4##(2008-10#2)
late blight epidemics##5##3##(2008-10#5)
late blight in the##2##4##(2008-10#2)
late blight in##7##3##(2008-10#7)
late blight of potato and tomato##2##6##(2008-10#2)
late blight of potato##4##4##(2008-10#4)
late blight of##7##3##(2008-10#7)
late blight pathogen##5##3##(2008-10#5)
late blight resistance##2##3##(2008-10#2)
late blight severity##4##3##(2008-10#4)
late blight##63##2##(2008-10#61)(2008-8#1)(2009-6#1)
late colonizers##3##2##(2008-5#3)
late complication of##9##3##(1991-9#1)(2007-8#3)(2008-12#1)(2009-5#2)(2012-2#1)(2013-7#1)
late complication##11##2##(1991-9#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-6#1)(2009-5#2)(2012-2#1)(2013-7#1)
late complications##11##2##(1992-10#1)(1993-9#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2011-2#4)(2011-3#1)
late conversion##2##2##(2007-8#2)
late damage##4##2##(1992-10#2)(2008-6#1)(2012-2#1)
late development##2##2##(2009-8#1)(2012-1#1)
late diagnosis of##3##3##(2007-11#2)(2011-2#1)
late effects##5##2##(2007-10#1)(2010-11#3)(2011-2#1)
late embryogenesis abundant##2##3##(2008-10#2)
late embryonic##2##2##(1996-12#1)(2008-11#1)
late enhancement or viable tissue##2##5##(2013-7#2)
late enhancement##3##2##(2013-7#3)
late events##3##2##(1994-5#1)(2007-12#1)(2008-7#1)
late exponential growth##2##3##(2008-11#1)(2011-2#1)
late failure of##2##3##(2008-2#1)(2012-3#1)
late fall##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
late family formation##2##3##(2011-2#2)
late fetal##2##2##(1994-6#1)(1997-1#1)
late flowering##3##2##(2008-10#3)
late follow-up##2##2##(1992-9#1)(2007-8#1)
late for##4##2##(1994-3#1)(2008-1#1)(2013-1#2)
late gene expression##4##3##(1997-3#4)
late gene transcription##2##3##(1997-3#2)
late gene##6##2##(1997-3#6)
late gestation##3##2##(2010-2#1)(2012-2#1)(2013-8#1)
late in life##3##3##(2007-8#1)(2008-10#1)(2010-2#1)
late in the growing season##3##5##(2008-10#2)(2009-2#1)
late in the season##2##4##(2008-10#2)
late in the##11##3##(1992-3#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-2#1)(2013-8#1)
late in##24##2##(1991-5#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-9#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
late mortality##2##2##(2007-8#1)(2013-1#1)
late nineteenth century##5##3##(2010-1#3)(2011-2#1)(2013-7#1)
late nineteenth##7##2##(2010-1#5)(2011-2#1)(2013-7#1)
late nineteenth- and early twentieth-century##2##5##(2008-7#1)(2010-1#1)
late onset of##2##3##(1991-6#1)(2008-1#1)
late onset##10##2##(1990-11#1)(1991-6#1)(1995-4#1)(1996-6#1)(1997-5#1)(2008-1#2)(2008-4#1)(2008-7#1)(2010-11#1)
late onsetters##2##2##(2007-9#2)
late phase of##5##3##(1990-6#2)(1992-3#1)(1995-12#1)(1995-6#1)
late phase##12##2##(1990-6#2)(1991-5#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(2008-11#1)(2010-8#1)
late phases##5##2##(2008-6#1)(2008-9#1)(2010-12#2)(2013-8#1)
late presentation##8##2##(2008-1#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#4)
late preterm infant##3##3##(2008-11#1)(2010-11#2)
late preterm##7##2##(2008-11#3)(2010-11#2)(2012-2#2)
late promoter##5##2##(1994-8#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-11#1)
late promoters##2##2##(1995-6#1)(1997-4#1)
late radiation-induced##2##2##(1990-10#1)(2007-4#1)
late rather##2##2##(2009-7#2)
late recanalization##2##2##(1993-9#1)(2008-7#1)
late recurrence##2##2##(2008-7#1)(2011-2#1)
late restenosis##3##2##(1994-11#1)(2006-6#2)
late season##4##2##(2008-10#4)
late sequelae of##2##3##(1996-8#1)(2013-8#1)
late sequelae##3##2##(1992-10#1)(1996-8#1)(2013-8#1)
late spring##5##2##(2008-10#4)(2011-2#1)
late stage of MS##2##4##(2008-7#2)
late stage of##10##3##(1991-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)
late stage##13##2##(1991-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#1)
late stages of the HIV-1 replication cycle##3##7##(2011-3#3)
late stages of the clinical curriculum##2##6##(1992-6#2)
late stages of the##5##4##(1992-6#2)(2011-3#3)
late stages of##13##3##(1992-6#2)(1994-12#1)(2008-10#3)(2008-5#1)(2009-5#1)(2011-3#3)(2012-2#1)(2012-3#1)
late stages##18##2##(1992-6#2)(1994-12#1)(2008-10#5)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-3#4)(2012-2#1)(2012-3#1)
late successional##2##2##(2008-9#2)
late summer##5##2##(2007-12#1)(2008-10#4)
late teens##2##2##(2009-8#2)
late times##2##2##(1993-9#1)(1997-3#1)
late vitellogenic##2##2##(2008-6#1)(2010-5#1)
late yolk sacs##2##3##(2007-12#2)
late##557##1##(1990-10#1)(1990-11#2)(1990-3#1)(1990-6#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#4)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#8)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#11)(1997-4#4)(1997-5#3)(1997-8#5)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#13)(2007-9#2)(2008-1#9)(2008-10#135)(2008-11#20)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#12)(2008-6#8)(2008-7#23)(2008-8#8)(2008-9#15)(2009-10#2)(2009-12#2)(2009-2#2)(2009-5#4)(2009-6#1)(2009-7#6)(2009-8#5)(2009-9#1)(2010-1#6)(2010-10#1)(2010-11#7)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#28)(2011-3#5)(2012-1#4)(2012-12#3)(2012-2#10)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#17)(2013-7#5)(2013-8#7)
late-LTP##2##1##(2008-7#1)(2009-6#1)
late-arising mutation##2##2##(2008-9#2)
late-arising##5##1##(2008-9#5)
late-life##4##1##(1996-7#1)(2007-12#2)(2008-7#1)
late-maturing##2##1##(2008-10#2)
late-onset Alzheimer's disease##2##3##(2008-10#1)(2008-7#1)
late-onset schizophrenia##3##2##(1996-7#1)(2008-9#1)(2009-9#1)
late-onset##18##1##(1990-11#1)(1990-5#2)(1991-3#1)(1994-5#1)(1996-7#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#3)(2009-9#1)
late-season##7##1##(2008-10#6)(2011-2#1)
late-stage##5##1##(1997-1#1)(2008-11#1)(2010-12#3)
late-term##3##1##(1991-12#2)(2012-3#1)
lately as##2##2##(2008-11#1)(2012-2#1)
lately##6##1##(1997-6#1)(2008-11#1)(2008-8#2)(2011-1#1)(2012-2#1)
latencies and##2##2##(1996-2#1)(2009-9#1)
latencies compared to##2##3##(1993-12#2)
latencies in the##2##3##(1994-3#1)(1995-12#1)
latencies in##4##2##(1994-3#1)(1995-12#1)(1996-2#1)(2008-7#1)
latencies of##5##2##(1993-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)
latencies were##2##2##(1993-12#1)(1996-6#1)
latencies##24##1##(1992-11#1)(1993-12#5)(1993-3#1)(1994-3#1)(1995-12#1)(1996-2#6)(1996-5#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-8#1)
latency and##10##2##(1996-5#1)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)
latency between the##2##3##(2007-6#1)(2011-2#1)
latency between##3##2##(2007-6#1)(2008-7#1)(2011-2#1)
latency by##2##2##(1995-2#1)(2012-2#1)
latency for##3##2##(1996-2#1)(2008-11#2)
latency in the##2##3##(2008-7#1)(2012-12#1)
latency in##7##2##(1995-12#1)(2008-10#2)(2008-7#3)(2012-12#1)
latency is##2##2##(2008-7#1)(2012-12#1)
latency of the##5##3##(1995-12#2)(2008-3#2)(2008-8#1)
latency of##13##2##(1990-7#1)(1993-3#1)(1995-12#2)(1996-5#2)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
latency period between##2##3##(2008-4#1)(2011-2#1)
latency period##5##2##(1992-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
latency responses##4##2##(1996-5#3)(2008-9#1)
latency than##3##2##(1993-3#1)(1996-5#1)(2010-7#1)
latency time##3##2##(1995-2#1)(2008-5#2)
latency to immobility##2##3##(2008-11#2)
latency to##8##2##(1993-12#2)(1996-5#1)(1997-6#1)(2007-11#1)(2008-11#2)(2010-3#1)
latency was##2##2##(1996-2#1)(2007-6#1)
latency##107##1##(1990-7#2)(1990-8#1)(1992-9#2)(1993-12#3)(1993-3#2)(1994-5#1)(1995-12#7)(1995-2#2)(1995-5#1)(1996-2#4)(1996-5#9)(1997-1#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-6#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#1)(2009-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
latent B##2##2##(2008-10#2)
latent EBV infection##2##3##(2010-6#2)
latent S##3##2##(2008-10#3)
latent and##4##2##(1992-2#1)(2008-10#2)(2008-5#1)
latent androgen##2##2##(1990-6#2)
latent factors explaining##2##3##(2008-10#2)
latent factors##4##2##(2008-10#4)
latent finger##2##2##(2012-2#2)
latent form##3##2##(1990-2#1)(1994-5#1)(2008-12#1)
latent growth##2##2##(2009-7#1)(2009-8#1)
latent infection at##2##3##(2008-10#2)
latent infection in##2##3##(2008-10#2)
latent infection on##2##3##(2008-10#2)
latent infection was##3##3##(2008-10#3)
latent infection##29##2##(2008-10#29)
latent infections in the##2##4##(1993-11#1)(2008-10#1)
latent infections##8##2##(1993-11#1)(2008-10#7)
latent inhibition##2##2##(2008-5#2)
latent period (LP)##3##3##(2008-10#3)
latent period for##2##3##(2008-10#2)
latent period of P##2##4##(2008-10#2)
latent period of##4##3##(2008-10#4)
latent period was recorded##2##4##(2008-10#2)
latent period was##6##3##(2008-10#6)
latent period##46##2##(1990-11#1)(1991-3#1)(2008-10#44)
latent periods in##2##3##(2008-10#2)
latent periods##6##2##(2008-10#4)(2008-8#2)
latent precursor##3##2##(1994-5#1)(2011-2#2)
latent promoter BC-R2##2##3##(1992-12#2)
latent state##2##2##(1991-11#1)(2008-10#1)
latent variable##8##2##(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)
latent variables##4##2##(1997-4#1)(2008-1#1)(2008-7#1)(2009-4#1)
latent virus##6##2##(2008-10#2)(2008-9#3)(2010-12#1)
latent##194##1##(1990-11#1)(1990-2#3)(1990-6#3)(1990-9#1)(1991-11#2)(1991-3#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-6#1)(1995-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#113)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#3)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
latent-class##2##1##(2010-1#2)
latent-period duration##3##2##(2008-10#3)
latent-period##5##1##(2008-10#5)
latently infected plants##3##3##(2008-10#3)
latently infected##12##2##(1991-3#1)(2008-10#10)(2012-12#1)
later a##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
later and##10##2##(1994-2#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#2)
later as##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
later became##2##2##(1995-1#1)(2008-12#1)
later by a##2##3##(1994-3#1)(2008-8#1)
later by##6##2##(1993-3#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
later confirmed by##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
later confirmed##4##2##(2007-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
later determined to be##2##4##(2009-8#2)
later developed##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
later development of##2##3##(1996-11#1)(2007-12#1)
later development##3##2##(1996-11#1)(2007-12#1)(2013-1#1)
later developmental stages##2##3##(1997-7#1)(2008-10#1)
later during##2##2##(2008-8#1)(2011-2#1)
later examination##2##2##(1996-12#1)(2013-1#1)
later for##4##2##(1990-3#1)(2008-5#1)(2009-6#1)(2013-1#1)
later health##2##2##(2008-11#1)(2009-5#1)
later in life##12##3##(1991-6#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
later in pregnancy##2##3##(1990-2#1)(1994-3#1)
later in the course of##2##5##(2008-7#1)(2008-9#1)
later in the course##3##4##(1996-11#1)(2008-7#1)(2008-9#1)
later in the##12##3##(1995-3#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-6#1)
later in##36##2##(1990-2#1)(1991-6#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#3)
later known as##2##3##(1996-3#2)
later life##9##2##(1995-12#1)(2007-8#1)(2008-11#1)(2009-8#1)(2012-2#3)(2013-1#2)
later of##2##2##(1994-6#1)(2008-10#1)
later on in##2##3##(2010-5#1)(2013-1#1)
later on##8##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-5#1)(2013-1#1)
later phases of##2##3##(2008-8#1)(2011-2#1)
later presented with##2##3##(2009-5#1)(2012-12#1)
later revealed##3##2##(1994-9#1)(2008-12#1)(2013-8#1)
later school##2##2##(2008-12#1)(2009-9#1)
later showed##5##2##(1993-12#1)(1994-12#1)(1994-5#1)(1997-5#1)(2007-8#1)
later stage of##5##3##(1992-6#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-10#1)
later stage##13##2##(1992-6#1)(2007-11#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-8#1)(2012-1#1)(2013-8#1)
later stages of infection##2##4##(2008-10#1)(2008-2#1)
later stages of##14##3##(1990-5#1)(1991-12#1)(1992-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-2#1)(2009-5#1)(2012-3#1)(2013-8#1)
later stages##22##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
later steps##3##2##(1997-7#2)(2011-2#1)
later than the##2##3##(1990-8#1)(2008-10#1)
later than##9##2##(1990-8#1)(1995-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
later the patient##3##3##(1990-2#1)(2007-4#1)(2009-3#1)
later the##10##2##(1990-2#1)(1992-5#1)(1993-11#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
later there##2##2##(1990-11#1)(2010-10#1)
later they##2##2##(2008-11#1)(2011-2#1)
later this year##2##3##(2008-4#1)(2008-5#1)
later time points##3##3##(1993-11#1)(2008-8#1)(2009-11#1)
later time##8##2##(1991-12#1)(1993-11#2)(1997-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2012-2#1)
later to determine##2##3##(1994-3#1)(2010-12#1)
later to##6##2##(1990-9#1)(1992-12#1)(1994-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
later transferred to##2##3##(1992-4#1)(1995-6#1)
later underwent##3##2##(1994-2#1)(2008-6#1)(2009-5#1)
later used##2##2##(2008-10#1)(2008-8#1)
later using##2##2##(1991-3#1)(1996-5#1)
later was##2##2##(2007-8#1)(2008-1#1)
later were##2##2##(1991-6#1)(1995-3#1)
later with a##2##3##(1997-8#1)(2008-10#1)
later with##8##2##(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
later##604##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#5)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#3)(1995-8#3)(1995-9#2)(1996-11#2)(1996-12#4)(1996-3#7)(1996-5#6)(1996-6#1)(1996-9#4)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#4)(1997-8#1)(2006-10#2)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#17)(2008-1#13)(2008-10#63)(2008-11#23)(2008-12#12)(2008-2#9)(2008-3#7)(2008-4#11)(2008-5#15)(2008-6#9)(2008-7#32)(2008-8#15)(2008-9#8)(2009-1#2)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#9)(2011-2#19)(2011-3#2)(2012-1#5)(2012-12#5)(2012-2#20)(2012-3#11)(2012-6#1)(2012-8#2)(2013-1#33)(2013-7#2)(2013-8#13)
later-inoculated##2##1##(2008-10#2)
later-life appraisals##6##2##(2013-1#6)
later]##2##1##(1997-2#1)(1997-3#1)
lateral alignment##2##2##(2008-2#1)(2009-4#1)
lateral and axial resolutions##2##4##(2007-11#1)(2008-3#1)
lateral and axial##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
lateral and posterior##5##3##(2007-12#1)(2007-8#2)(2011-2#1)(2013-1#1)
lateral and vertical##3##3##(2008-2#1)(2008-5#1)(2009-11#1)
lateral and##24##2##(1993-9#2)(1995-5#1)(1996-5#2)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#1)
lateral ankle sprain##2##3##(2012-3#1)(2013-1#1)
lateral bending##6##2##(2012-12#1)(2012-2#1)(2013-1#4)
lateral branches##2##2##(2008-10#1)(2012-3#1)
lateral cells##2##2##(2007-12#1)(2008-10#1)
lateral chest##3##2##(1997-8#3)
lateral condensation technique##2##3##(2013-1#2)
lateral condensation##3##2##(1991-3#1)(2013-1#2)
lateral cortex##2##2##(1992-10#1)(2010-3#1)
lateral curvature##3##2##(2007-11#1)(2008-11#1)(2013-1#1)
lateral diffusion of##3##3##(1990-2#1)(1994-5#1)(2008-3#1)
lateral diffusion##6##2##(1990-2#1)(1994-5#1)(2007-12#1)(2008-3#1)(2008-7#2)
lateral dimension##2##2##(2009-11#1)(2010-12#1)
lateral direction##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
lateral discoid meniscus##2##3##(2013-1#2)
lateral discoid##3##2##(2013-1#3)
lateral dispersal##2##2##(2008-10#2)
lateral displacement##4##2##(2007-10#1)(2007-8#1)(2008-2#1)(2008-3#1)
lateral displacements of##3##3##(2008-2#2)(2013-1#1)
lateral displacements##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
lateral epicondylalgia##3##2##(2008-12#3)
lateral eyes##3##2##(1993-3#3)
lateral film##3##2##(1997-8#3)
lateral flow##2##2##(2008-10#2)
lateral gene transfer##3##3##(2008-7#1)(2010-5#1)(2012-3#1)
lateral geniculate nucleus##4##3##(1992-10#1)(1993-12#1)(1997-7#1)(2008-1#1)
lateral hypothalamic ICSS##2##3##(1991-2#2)
lateral hypothalamic##8##2##(1991-2#3)(1992-11#1)(1993-6#2)(1994-2#1)(1995-5#1)
lateral hypothalamus##12##2##(1990-7#2)(1991-12#1)(1992-10#1)(1993-6#4)(1996-2#2)(2009-10#2)
lateral incisor##5##2##(2008-7#1)(2010-3#1)(2012-12#2)(2013-1#1)
lateral incisors##3##2##(2012-12#3)
lateral light##2##2##(2007-12#1)(2008-3#1)
lateral lobes##2##2##(2007-12#2)
lateral margin compromise##3##3##(2013-8#3)
lateral mass screw fixation##2##4##(2012-12#2)
lateral mass##3##2##(2012-12#2)(2012-3#1)
lateral mobility##2##2##(2008-7#2)
lateral mode locking##2##3##(2007-11#2)
lateral modes##4##2##(2008-3#4)
lateral offset##3##2##(2008-2#1)(2008-3#2)
lateral offsets##2##2##(2008-2#1)(2008-3#1)
lateral or medial##2##3##(1993-11#1)(1997-2#1)
lateral or##5##2##(1993-10#1)(1993-11#1)(1993-12#1)(1995-6#1)(1997-2#1)
lateral orbital rim osteotomy##2##4##(2006-12#2)
lateral orbital rim##3##3##(2006-12#3)
lateral orbital wall##3##3##(2008-10#1)(2009-2#1)(2010-10#1)
lateral orbital##7##2##(1994-3#1)(2006-12#3)(2008-10#1)(2009-2#1)(2010-10#1)
lateral orbitotomy##2##2##(2006-12#1)(2008-7#1)
lateral perforant##4##2##(1993-12#3)(2009-8#1)
lateral periodontal cyst##2##3##(2013-1#2)
lateral position##5##2##(1992-4#1)(1993-10#2)(2008-3#2)
lateral positioning##2##2##(2008-2#1)(2008-3#1)
lateral recess##9##2##(2006-12#1)(2008-7#1)(2011-2#5)(2013-1#2)
lateral region##2##2##(2008-7#1)(2008-9#1)
lateral regions of the##2##4##(1991-10#1)(1996-12#1)
lateral regions of##3##3##(1990-9#1)(1991-10#1)(1996-12#1)
lateral regions##4##2##(1990-9#1)(1991-10#1)(1996-12#1)(2008-11#1)
lateral resolution in##2##3##(2008-3#1)(2010-3#1)
lateral resolution of the##4##4##(2007-12#1)(2008-3#3)
lateral resolution of##9##3##(2007-11#1)(2007-12#2)(2008-3#5)(2010-4#1)
lateral resolution##30##2##(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#15)(2010-3#1)(2010-4#1)(2012-2#2)
lateral root development##2##3##(2011-1#2)
lateral root##5##2##(2008-8#2)(2011-1#2)(2013-1#1)
lateral roots##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
lateral sclerosis (ALS)##4##3##(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)
lateral sclerosis##17##2##(1993-9#1)(1995-2#1)(1996-5#1)(2008-4#2)(2008-7#2)(2009-12#2)(2009-7#1)(2009-9#2)(2010-7#1)(2012-3#2)(2013-1#2)
lateral sensillum styloconicum##3##3##(2008-8#3)
lateral shearing interferograms##4##3##(2008-3#4)
lateral shearing interferometer##4##3##(2007-11#2)(2008-2#2)
lateral shearing interferometry##2##3##(2007-11#1)(2007-12#1)
lateral shearing##12##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#6)
lateral shift of##2##3##(2007-11#1)(2008-3#1)
lateral shift##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
lateral sinus##2##2##(2008-7#1)(2010-5#1)
lateral sizes##5##2##(2008-10#5)
lateral skull base##4##3##(2011-2#4)
lateral temporal##3##2##(1996-5#1)(2008-11#1)(2011-2#1)
lateral than##2##2##(1993-10#1)(2013-1#1)
lateral to the##3##3##(1991-12#1)(2008-7#1)(2012-3#1)
lateral to##4##2##(1991-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
lateral tunnel Fontan##2##3##(2007-8#1)(2010-5#1)
lateral tunnel##4##2##(2007-8#1)(2010-5#3)
lateral ventricle##9##2##(1991-12#1)(1992-8#1)(1995-12#1)(1996-7#1)(2008-7#4)(2010-2#1)
lateral ventricles and##2##3##(1991-12#1)(1996-5#1)
lateral ventricles##7##2##(1991-12#1)(1991-8#1)(1993-12#1)(1995-5#1)(1996-5#2)(2012-12#1)
lateral wall of the##6##4##(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
lateral wall of##8##3##(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
lateral wall##10##2##(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
lateral walls##4##2##(1991-6#1)(2008-10#1)(2008-7#2)
lateral##518##1##(1990-12#2)(1990-2#2)(1990-3#3)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#3)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#6)(1993-11#1)(1993-12#13)(1993-2#1)(1993-3#5)(1993-6#9)(1993-9#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#2)(1996-5#9)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#8)(1997-6#1)(1997-7#1)(1997-8#8)(2006-12#5)(2007-10#2)(2007-11#22)(2007-12#33)(2007-8#11)(2008-1#1)(2008-10#20)(2008-11#10)(2008-12#7)(2008-2#23)(2008-3#56)(2008-4#3)(2008-5#11)(2008-6#3)(2008-7#28)(2008-8#10)(2008-9#5)(2009-1#3)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#3)(2009-4#2)(2009-7#3)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#18)(2012-12#12)(2012-2#9)(2012-3#13)(2013-1#34)(2013-7#3)(2013-8#4)
lateral)##3##1##(1990-12#1)(2012-8#1)(2013-1#1)
lateralis muscle##3##2##(2008-5#2)(2011-2#1)
lateralis##16##1##(1996-5#1)(2008-10#5)(2008-5#2)(2008-6#2)(2010-4#4)(2011-2#2)
laterality in##2##2##(2007-12#1)(2011-2#1)
laterality of the##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
laterality of##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
laterality##13##1##(1994-8#3)(1996-5#1)(2007-12#2)(2008-10#2)(2010-5#1)(2011-2#3)(2013-1#1)
lateralization in the##2##3##(1994-3#2)
lateralization in##3##2##(1994-3#2)(1995-11#1)
lateralization of##4##2##(2012-2#3)(2013-8#1)
lateralization on the##2##3##(1994-8#1)(1997-2#1)
lateralization on##3##2##(1994-8#1)(1995-5#1)(1997-2#1)
lateralization##19##1##(1992-11#3)(1994-3#2)(1994-8#2)(1995-11#1)(1995-5#1)(1997-2#3)(2007-8#2)(2009-9#1)(2012-2#3)(2013-8#1)
lateralized##4##1##(1992-11#1)(1994-8#1)(2009-10#1)(2010-2#1)
laterally across the##2##3##(2009-9#1)(2012-1#1)
laterally across##3##2##(2008-2#1)(2009-9#1)(2012-1#1)
laterally based thenar flap##2##4##(2008-9#2)
laterally in##2##2##(2008-3#1)(2012-2#1)
laterally to##3##2##(1995-5#1)(1997-7#1)(2011-1#1)
laterally when##2##2##(1992-7#2)
laterally##36##1##(1992-7#2)(1993-12#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-9#2)(2011-1#1)(2012-1#1)(2012-2#1)
latero-lateral##2##1##(2008-10#2)
latest IAHSS survey##4##3##(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)
latest IAHSS##7##2##(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-12#1)
latest data##3##2##(1997-2#1)(2011-1#1)(2012-2#1)
latest findings##3##2##(1990-3#1)(2009-10#1)(2012-12#1)
latest follow-up##2##2##(2011-2#1)(2013-1#1)
latest research on##2##3##(2007-5#1)(2008-5#1)
latest research##6##2##(2007-5#1)(2008-11#1)(2008-5#2)(2010-6#1)(2013-8#1)
latest version##2##2##(2008-4#1)(2012-1#1)
latest##92##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#3)
latex 1##2##2##(2008-10#2)
latex agglutination test##3##3##(1990-12#1)(1992-6#1)(2011-2#1)
latex agglutination##6##2##(1990-12#1)(1992-6#1)(2007-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
latex and##3##2##(1990-9#1)(2008-3#1)(2011-2#1)
latex films##4##2##(2008-10#3)(2010-4#1)
latex inclusions##2##2##(2008-2#2)
latex microspheres##2##2##(1992-10#1)(2008-2#1)
latex or##2##2##(1991-12#1)(2008-11#1)
latex particle##2##2##(1990-12#1)(2008-10#1)
latex particles were##2##3##(1990-12#1)(2008-10#1)
latex particles##12##2##(1990-12#4)(2007-10#1)(2008-10#3)(2008-3#1)(2010-6#3)
latex sphere suspensions##2##3##(2008-3#2)
latex spheres##9##2##(2007-11#1)(2008-3#8)
latex strips##2##2##(1990-7#2)
latex##71##1##(1990-12#11)(1990-7#3)(1990-9#1)(1991-12#1)(1992-10#1)(1992-6#1)(1995-3#1)(1996-12#1)(2007-10#5)(2007-11#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#12)(2008-5#2)(2008-9#1)(2010-4#4)(2010-5#1)(2010-6#3)(2011-2#3)
latexes##2##1##(2008-10#2)
lather creaminess##2##2##(2008-5#2)
lather##4##1##(2008-10#1)(2008-5#3)
lathyroides and##3##2##(2008-10#3)
lathyroides##5##1##(2008-10#5)
lathyroides)##2##1##(2008-10#2)
latifolia)##2##1##(2008-10#1)(2013-1#1)
latin##2##1##(2010-8#1)(2011-2#1)
latipes##9##1##(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#2)(2009-7#2)
latissimus dorsi flap##2##3##(1992-9#1)(2008-7#1)
latissimus dorsi free##2##3##(2008-10#1)(2008-9#1)
latissimus dorsi myocutaneous##2##3##(1990-9#1)(1994-12#1)
latissimus dorsi##18##2##(1990-9#2)(1992-9#1)(1994-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#2)
latitude and##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
latitude in##3##2##(2007-2#2)(2008-9#1)
latitude##14##1##(2007-2#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-7#1)
latitudes##7##1##(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#2)(2013-1#2)
latitudinal positions##2##2##(2008-10#2)
latitudinal variation in##2##3##(2008-9#2)
latitudinal##7##1##(2008-10#3)(2008-9#3)(2010-8#1)
latter approach##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
latter are##13##2##(1996-5#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#2)(2010-2#1)(2011-2#2)
latter being the##4##3##(1995-11#1)(2008-12#1)(2008-6#1)(2012-2#1)
latter being##10##2##(1990-7#1)(1992-2#1)(1995-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
latter can##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
latter case##23##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-6#2)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-8#1)
latter category##2##2##(1996-2#1)(2008-12#1)
latter compound##2##2##(1990-8#1)(1996-2#1)
latter conditions##2##2##(1996-2#1)(2008-10#1)
latter effect was##3##3##(1991-9#1)(1995-12#1)(1995-2#1)
latter effect##8##2##(1990-2#1)(1991-12#1)(1991-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-3#1)(2008-5#1)
latter enzymes##2##2##(1991-8#1)(1994-8#1)
latter expressed##2##2##(1991-8#1)(1995-5#1)
latter group a##2##3##(1993-8#1)(1996-9#1)
latter group is##2##3##(2008-7#1)(2011-1#1)
latter group of##2##3##(1991-12#1)(2008-10#1)
latter group##15##2##(1991-12#2)(1992-5#2)(1993-8#1)(1996-9#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#2)(2011-1#2)
latter had##2##2##(2008-10#1)(2013-1#1)
latter has been##2##3##(2006-10#1)(2008-10#1)
latter has##4##2##(1995-5#1)(2006-10#1)(2008-10#1)(2008-8#1)
latter have##2##2##(1991-12#1)(1992-3#1)
latter includes##4##2##(1993-11#1)(1996-9#1)(2008-2#1)(2008-7#1)
latter is a##2##3##(1997-7#1)(2008-10#1)
latter is not##5##3##(1991-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
latter is of##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
latter is the##4##3##(1990-7#1)(1991-3#1)(2008-10#1)(2012-1#1)
latter is##42##2##(1990-11#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#10)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
latter may be##4##3##(1996-6#1)(1997-8#1)(2008-1#1)(2008-7#1)
latter may##7##2##(1993-11#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
latter mechanism##2##2##(1997-4#1)(2008-10#1)
latter method##6##2##(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
latter of which##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
latter part##6##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
latter process##3##2##(1995-12#1)(1995-8#2)
latter represents##2##2##(1993-6#1)(2008-11#1)
latter samples##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
latter structure##2##2##(1991-12#1)(1994-3#1)
latter systems##2##2##(2008-10#1)(2013-1#1)
latter technique##4##2##(2006-6#1)(2008-10#2)(2008-3#1)
latter three##4##2##(2008-10#2)(2008-8#1)(2009-3#1)
latter two##14##2##(1990-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-7#1)(2008-10#5)(2008-8#1)(2009-7#1)(2010-5#1)(2013-1#1)
latter was##16##2##(1991-2#2)(1992-12#1)(1992-5#1)(1994-11#1)(1995-2#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2012-2#2)(2013-1#1)
latter were##6##2##(1990-8#1)(1991-4#1)(1994-9#1)(2008-1#1)(2008-7#1)(2013-1#1)
latter##500##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#7)(1995-8#3)(1996-1#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#5)(1997-7#6)(1997-8#4)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#13)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#87)(2008-11#12)(2008-12#8)(2008-2#8)(2008-3#20)(2008-4#4)(2008-5#14)(2008-6#5)(2008-7#21)(2008-8#14)(2008-9#5)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#19)(2012-1#3)(2012-12#4)(2012-2#13)(2012-3#2)(2012-6#1)(2013-1#11)(2013-7#3)(2013-8#3)
lattice and##2##2##(1992-4#1)(1996-12#1)
lattice constants a =##3##4##(1996-2#2)(2013-8#1)
lattice model##2##2##(2008-10#1)(2008-5#1)
lattice of the##2##3##(2008-10#2)
lattice of##6##2##(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#2)
lattice parameter##2##2##(2008-10#1)(2008-5#1)
lattice parameters for##2##3##(1996-2#1)(2008-10#1)
lattice parameters##6##2##(1996-2#1)(1997-7#2)(2008-10#2)(2013-8#1)
lattice##69##1##(1991-9#1)(1992-4#1)(1993-11#3)(1993-2#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#3)(1997-7#3)(2006-4#1)(2007-11#10)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#6)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#2)(2011-2#2)(2012-2#5)(2013-8#2)
lattice-like##2##1##(1996-12#1)(2011-2#1)
lattices of##2##2##(2008-3#2)
lattices##10##1##(1992-9#1)(1993-5#1)(2007-11#3)(2008-2#1)(2008-3#4)
launch in##2##2##(2008-2#1)(2008-3#1)
launch of##5##2##(2008-12#1)(2010-5#1)(2010-8#2)(2011-2#1)
launch##20##1##(1996-1#1)(1996-2#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#2)(2011-2#1)
launched a##5##2##(1991-6#1)(1993-3#1)(1994-11#1)(2007-7#1)(2012-12#1)
launched by the##4##3##(1993-6#1)(2007-11#1)(2008-3#1)(2013-8#1)
launched by##5##2##(1993-6#1)(2007-11#2)(2008-3#1)(2013-8#1)
launched in the##5##3##(2007-11#1)(2008-6#1)(2010-12#1)(2010-5#1)(2013-1#1)
launched in##16##2##(1996-9#1)(2007-11#2)(2008-3#1)(2008-5#4)(2008-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#2)
launched into an optical fiber and the##2##7##(2008-3#2)
launched into##3##2##(2008-3#3)
launched on##4##2##(2008-2#1)(2008-3#3)
launched pump power of##2##4##(2007-12#1)(2008-2#1)
launched pump power##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
launched pump##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
launched the##2##2##(2008-5#1)(2012-2#1)
launched##66##1##(1990-6#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-9#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#1)(2008-2#5)(2008-3#18)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
launches##9##1##(1993-5#1)(1994-12#1)(1995-1#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-3#1)(2008-5#1)(2012-2#1)
launching a new##2##3##(1990-11#1)(1995-12#1)
launching a##4##2##(1990-11#1)(1994-12#1)(1995-12#1)(2007-11#1)
launching coupler for small-bore##2##4##(2008-2#2)
launching of##3##2##(1991-12#1)(2007-12#1)(2008-3#1)
launching the##2##2##(2008-10#1)(2008-5#1)
launching##22##1##(1990-11#1)(1991-12#1)(1994-12#1)(1995-12#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#6)
laundering##3##1##(2008-11#1)(2013-8#2)
laurentii##8##1##(2008-10#6)(2008-5#2)
laureth##2##1##(2008-5#2)
lauric acid##9##2##(1991-5#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-3#1)(2008-10#4)
lauric##10##1##(1991-5#2)(1991-9#1)(1992-11#1)(1994-3#1)(1995-3#1)(2008-10#4)
lauryl ether##8##2##(2008-10#3)(2008-5#5)
lauryl##14##1##(1992-12#1)(2008-10#4)(2008-5#8)(2010-3#1)
laurylether sulphate##2##2##(2008-5#2)
lavage and##3##2##(1991-12#1)(1996-12#2)
lavage fluid##18##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#4)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-5#2)(2008-7#1)(2012-2#1)
lavage in##5##2##(1990-2#2)(2008-5#1)(2008-8#1)(2012-2#1)
lavage was performed##3##3##(1990-2#1)(1995-11#1)(2007-8#1)
lavage was##6##2##(1990-2#2)(1995-11#1)(2007-8#1)(2010-7#1)(2011-2#1)
lavage##62##1##(1990-2#8)(1991-12#2)(1991-9#1)(1992-11#1)(1992-3#5)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#6)(1996-9#1)(2007-12#1)(2007-8#5)(2008-1#5)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#3)(2010-7#4)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
lavender and rose oil##2##4##(2008-10#2)
lavender and rose##3##3##(2008-10#3)
lavender and##4##2##(2008-10#3)(2010-3#1)
lavender##7##1##(2008-10#5)(2010-3#2)
law also##2##2##(2008-11#1)(2010-4#1)
law and its##3##3##(1992-1#1)(1993-2#1)(2013-8#1)
law and the##7##3##(1996-4#1)(1997-8#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
law and##24##2##(1992-1#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-4#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#4)
law by##2##2##(1991-12#1)(2011-2#1)
law did not##2##3##(1992-12#1)(1995-6#1)
law enforcement agencies##2##3##(1992-3#1)(2010-5#1)
law enforcement##7##2##(1992-3#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-5#1)(2013-8#2)
law firm##2##2##(1995-12#2)
law for##12##2##(1995-12#1)(1996-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#4)
law has##2##2##(1993-11#1)(1997-8#1)
law in the##10##3##(1997-8#1)(2008-10#8)(2008-6#1)
law in##16##2##(1993-1#1)(1993-12#1)(1996-5#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-6#1)(2010-4#1)(2013-1#1)
law is##41##2##(1993-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-3#1)
law model##5##2##(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
law of similars##3##3##(1997-6#3)
law of thermodynamics##2##3##(1993-12#1)(2008-5#1)
law of##18##2##(1990-7#1)(1991-1#1)(1993-12#1)(1993-6#1)(1997-6#4)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
law on##3##2##(1993-6#1)(1995-5#1)(1997-8#1)
law regarding##4##2##(1991-1#1)(1992-1#1)(1992-12#1)(1996-2#1)
law since##2##2##(1991-4#1)(1994-1#1)
law that##3##2##(1996-4#1)(2008-3#1)(2008-8#1)
law the##2##2##(1994-3#1)(1995-12#1)
law to##4##2##(1996-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
law was developed##2##3##(2008-10#2)
law was##23##2##(1992-1#1)(1997-8#1)(2008-10#18)(2008-8#2)(2011-2#1)
law will##2##2##(1992-1#1)(1994-1#1)
law with##5##2##(2008-10#2)(2008-8#2)(2009-10#1)
law##351##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#6)(1992-12#7)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#5)(1993-7#1)(1994-1#6)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#1)(1995-1#5)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#4)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#7)(1996-5#8)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#8)(2007-11#7)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#102)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#8)
law)##4##1##(1994-5#1)(1996-4#1)(2008-10#1)(2010-2#1)
law-enforcement##2##1##(2010-1#2)
law]##3##1##(1996-9#1)(1997-3#1)(2008-9#1)
lawn##3##1##(2008-10#1)(2008-12#1)(2012-12#1)
lawns##2##1##(2008-11#1)(2008-9#1)
laws and regulations##2##3##(2007-9#1)(2012-3#1)
laws and##12##2##(1992-12#1)(1992-3#1)(1993-3#2)(1994-2#1)(1996-2#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-3#1)
laws for##3##2##(1992-8#1)(2008-3#1)(2008-7#1)
laws in##3##2##(1991-6#1)(1997-3#1)(2007-2#1)
laws or##2##2##(2008-11#1)(2008-8#1)
laws that##5##2##(1991-5#1)(2008-12#1)(2008-2#2)(2011-2#1)
laws were##2##2##(1997-1#1)(2008-10#1)
laws which##2##2##(2008-12#1)(2008-7#1)
laws##83##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-8#1)(1993-1#2)(1993-3#2)(1994-12#2)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-4#4)(1997-1#1)(1997-3#4)(1997-5#2)(2007-2#3)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
lawsuit filed by##3##3##(1995-12#2)(1996-5#1)
lawsuit filed##4##2##(1995-12#2)(1996-5#1)(1997-5#1)
lawsuit was##2##2##(1993-12#1)(1996-5#1)
lawsuit##16##1##(1992-2#1)(1992-3#1)(1993-12#1)(1995-12#4)(1996-5#4)(1997-5#4)(2008-11#1)
lawsuits##14##1##(1992-1#2)(1992-2#1)(1993-12#1)(1995-6#1)(1997-5#1)(2007-5#1)(2008-11#4)(2008-4#1)(2012-12#1)(2013-1#1)
lawyer##2##1##(1995-12#1)(2008-6#1)
lawyers##3##1##(1993-1#1)(1996-6#1)(2008-4#1)
lax##3##1##(1995-6#1)(1996-5#1)(2008-11#1)
laxa is##2##2##(2008-7#2)
laxa##9##1##(2008-10#5)(2008-5#1)(2008-7#3)
laxative medication##2##2##(1991-8#2)
laxative##4##1##(1991-6#1)(1991-8#2)(2011-2#1)
laxatives##5##1##(1991-8#2)(2008-10#1)(2008-7#2)
laxity##3##1##(2008-8#1)(2013-1#2)
lay a##2##2##(2008-8#1)(2010-10#1)
lay eggs in##2##3##(2011-2#1)(2013-1#1)
lay eggs##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
lay in the##3##3##(1997-7#1)(2008-10#2)
lay people##2##2##(2008-10#1)(2012-12#1)
lay press##3##2##(1997-6#1)(2008-12#1)(2009-10#1)
lay the foundation for a##2##5##(1992-12#1)(2012-12#1)
lay the foundation for##5##4##(1992-12#1)(2007-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
lay the##6##2##(1992-12#1)(2007-11#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-8#1)
lay their eggs##2##3##(2007-12#1)(2008-9#1)
lay to rest the##2##4##(1993-12#1)(2008-9#1)
lay##42##1##(1992-12#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-12#4)(2013-1#1)(2013-8#1)
layer 4##2##2##(2008-11#2)
layer IV and##2##3##(1997-2#1)(1997-3#1)
layer IV##12##2##(1993-12#3)(1995-2#4)(1997-2#1)(1997-3#2)(2008-1#2)
layer V##2##2##(2008-11#1)(2012-2#1)
layer above the surface##2##4##(2008-10#1)(2008-2#1)
layer after##3##2##(2008-3#2)(2013-8#1)
layer and a##4##3##(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
layer and the output layer##4##5##(2010-8#4)
layer and the substrate##2##4##(2008-2#1)(2008-3#1)
layer and the##14##3##(1991-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#5)
layer and##36##2##(1991-6#2)(1992-6#1)(1992-9#1)(1993-8#1)(1997-3#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-8#6)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
layer are##6##2##(1992-9#1)(2008-3#3)(2008-8#1)(2010-4#1)
layer around the##2##3##(2008-10#1)(2009-4#1)
layer around##3##2##(2008-10#2)(2009-4#1)
layer as##3##2##(2008-3#2)(2010-5#1)
layer at the##4##3##(2008-10#3)(2008-3#1)
layer at##6##2##(2008-10#4)(2008-3#2)
layer between the##5##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
layer between##7##2##(1993-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)
layer but##2##2##(2008-3#1)(2009-7#1)
layer by layer##2##3##(2007-12#1)(2013-1#1)
layer by##13##2##(1991-5#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#3)(2008-2#1)(2013-1#1)(2013-8#1)
layer can be##3##3##(2008-3#3)
layer cells##2##2##(2008-11#2)
layer damage##2##2##(1996-1#1)(2007-11#1)
layer during##2##2##(2008-2#1)(2008-3#1)
layer for ArF excimer laser lithography##2##6##(2008-3#2)
layer for##5##2##(1995-3#1)(2008-2#1)(2008-3#3)
layer formed##3##2##(2008-2#1)(2008-3#2)
layer from##2##2##(2008-2#1)(2008-5#1)
layer has been##2##3##(2007-12#1)(2009-11#1)
layer have been##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
layer have##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
layer in a##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
layer in the##11##3##(1991-5#5)(2007-11#1)(2007-12#1)(2008-2#2)(2009-5#1)(2011-2#1)
layer in##18##2##(1991-5#5)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
layer inside##2##2##(2008-3#2)
layer is close to##2##4##(2008-3#1)(2013-8#1)
layer is formed##2##3##(2007-12#1)(2009-7#1)
layer is investigated in##2##4##(2008-2#1)(2008-5#1)
layer is##27##2##(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#1)(2009-7#1)(2013-8#2)
layer may be##2##3##(1996-5#1)(2007-11#1)
layer may##3##2##(1996-5#1)(2007-11#1)(2008-10#1)
layer near##2##2##(1992-6#1)(2011-1#1)
layer of FF##2##3##(2008-12#2)
layer of Nafion##2##3##(2008-10#2)
layer of Nafion(R)##2##3##(2008-10#2)
layer of a##2##3##(2008-2#1)(2008-3#1)
layer of an##2##3##(2008-12#1)(2008-2#1)
layer of compact osmiophilic material##2##5##(2008-10#2)
layer of medium electron density##2##5##(2008-12#2)
layer of sclerites##2##3##(2008-7#2)
layer of the skin##3##4##(2008-5#3)
layer of the##41##3##(1991-5#1)(1992-6#1)(1994-5#1)(1995-12#2)(1996-2#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-8#1)
layer of##129##2##(1990-11#1)(1990-4#1)(1991-5#3)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-12#3)(1996-12#1)(1996-2#1)(1997-6#2)(2007-11#3)(2007-12#6)(2008-10#30)(2008-11#1)(2008-12#11)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#9)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
layer on a##2##3##(1991-5#1)(2008-10#1)
layer on the surface of##3##5##(1990-12#1)(2008-10#2)
layer on the##13##3##(1990-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)
layer on##24##2##(1990-12#1)(1991-5#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2009-5#1)(2013-1#1)
layer or##4##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
layer over the##2##3##(1996-1#1)(2012-12#1)
layer over##3##2##(1996-1#1)(2008-2#1)(2012-12#1)
layer parameters##2##2##(2008-3#2)
layer showed##2##2##(1995-8#1)(2008-3#1)
layer structure##3##2##(1994-9#1)(2008-3#2)
layer that##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
layer the##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
layer thickness is##2##3##(2008-10#1)(2009-5#1)
layer thickness##17##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-5#1)(2010-4#3)
layer thicknesses##2##2##(2008-2#1)(2008-3#1)
layer titration##3##2##(2008-10#3)
layer to the##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
layer to##16##2##(1994-6#1)(2008-10#8)(2008-3#3)(2008-7#2)(2010-4#1)(2013-8#1)
layer turkeys##4##2##(2013-1#4)
layer was deposited on##2##4##(2009-11#1)(2009-5#1)
layer was##21##2##(1990-12#1)(2008-10#10)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-8#1)(2013-8#1)
layer were##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
layer with a##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
layer with an##2##3##(2008-2#1)(2009-5#1)
layer with##19##2##(1994-8#1)(2007-12#2)(2008-10#7)(2008-2#3)(2008-3#2)(2009-5#2)(2009-7#1)(2012-12#1)
layer##795##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1991-10#5)(1991-2#1)(1991-5#11)(1991-6#3)(1991-9#1)(1992-3#2)(1992-6#4)(1992-9#4)(1993-12#6)(1993-3#4)(1993-8#1)(1993-9#3)(1994-11#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(2006-12#1)(2006-6#1)(2007-11#18)(2007-12#40)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#192)(2008-11#18)(2008-12#29)(2008-2#64)(2008-3#127)(2008-4#6)(2008-5#30)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#5)(2009-11#5)(2009-12#3)(2009-4#3)(2009-5#13)(2009-6#2)(2009-7#8)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#3)(2010-4#12)(2010-5#5)(2010-6#1)(2010-8#17)(2011-1#1)(2011-2#15)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#12)
layer's##2##1##(2008-3#1)(2009-5#1)
layer)##2##1##(1994-2#1)(2008-3#1)
layer-by-layer (LBL)##4##2##(2008-10#3)(2009-11#1)
layer-by-layer assembled##2##2##(2010-4#2)
layer-by-layer assembly##4##2##(2008-10#3)(2009-11#1)
layer-by-layer electrostatic##2##2##(2008-10#1)(2008-7#1)
layer-by-layer self-assembly##4##2##(2008-10#3)(2008-7#1)
layer-by-layer##23##1##(2008-10#13)(2008-2#1)(2008-7#2)(2009-11#2)(2010-4#4)(2010-9#1)
layered double##2##2##(2010-4#2)
layered manufacturing##2##2##(2009-7#2)
layered media##5##2##(2007-12#2)(2008-3#3)
layered medium##2##2##(2008-2#2)
layered on the##2##3##(1997-1#1)(2008-9#1)
layered onto the##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
layered onto##4##2##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
layered structure##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
layered##53##1##(1993-2#1)(1994-9#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#3)(2010-4#2)(2010-8#1)(2012-2#2)
layering##2##1##(2008-10#1)(2010-12#1)
layers (n =##2##3##(1990-2#2)
layers II to VI##2##4##(1994-2#2)
layers II##7##2##(1993-12#1)(1994-2#5)(1997-2#1)
layers and a##2##3##(1993-12#1)(2010-8#1)
layers and the##6##3##(2007-11#1)(2008-2#3)(2008-3#2)
layers and##32##2##(1993-12#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#6)(2008-9#1)(2009-9#1)(2010-8#2)(2011-2#2)
layers are considered##2##3##(2008-3#2)
layers are##10##2##(2008-3#9)(2013-1#1)
layers as well as##2##4##(2008-3#2)
layers as well##3##3##(2008-2#1)(2008-3#2)
layers as##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
layers below##2##2##(2008-2#1)(2008-3#1)
layers by##6##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-3#3)
layers can be##2##3##(2008-12#1)(2008-3#1)
layers can##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
layers containing##2##2##(2007-11#1)(2008-3#1)
layers for##2##2##(2007-11#1)(2008-3#1)
layers formed##2##2##(2008-10#1)(2008-2#1)
layers from##6##2##(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#1)
layers has been##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
layers in a##2##3##(2008-3#2)
layers in the##8##3##(1991-5#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-3#3)(2010-8#1)
layers in##14##2##(1991-5#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-7#1)(2010-8#1)
layers is presented##2##3##(2008-10#1)(2008-3#1)
layers is##5##2##(2008-10#1)(2008-3#3)(2008-8#1)
layers of a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
layers of iron(III) tetra-(N-methyl-4-pyridyl)-porphyrin##2##4##(2008-10#2)
layers of the epidermis##2##4##(1994-5#1)(2008-5#1)
layers of the skin##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
layers of the stratum corneum##4##5##(2008-5#4)
layers of the##39##3##(1990-5#2)(1990-9#1)(1992-3#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#6)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2010-8#4)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#3)
layers of two##2##3##(2008-12#1)(2008-2#1)
layers of##99##2##(1990-5#2)(1990-9#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#4)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#2)(1997-4#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#10)(2008-5#6)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#4)(2011-2#4)(2012-12#2)(2013-1#2)(2013-8#4)
layers on the##3##3##(2008-10#2)(2008-3#1)
layers on##8##2##(2008-10#5)(2008-3#1)(2009-11#1)(2010-2#1)
layers only##2##2##(2008-5#1)(2012-2#1)
layers than##2##2##(1993-12#1)(2008-10#1)
layers that##4##2##(2007-12#1)(2007-9#1)(2008-10#2)
layers the##2##2##(1992-9#1)(2008-10#1)
layers to##5##2##(2008-10#4)(2008-7#1)
layers was##3##2##(1995-2#1)(2007-11#1)(2011-1#1)
layers were##16##2##(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2010-8#1)(2013-1#1)
layers with a##3##3##(1990-2#1)(2008-12#1)(2008-3#1)
layers with one another##2##4##(2007-11#1)(2008-3#1)
layers with##13##2##(1990-2#1)(1997-5#1)(2007-11#2)(2008-12#1)(2008-3#7)(2009-7#1)
layers##430##1##(1990-11#1)(1990-2#5)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#14)(1994-11#1)(1994-2#9)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-5#2)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#3)(2006-4#1)(2007-11#16)(2007-12#15)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#76)(2008-11#12)(2008-12#15)(2008-2#22)(2008-3#94)(2008-5#18)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#10)(2011-1#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#4)
layers)##3##1##(1996-12#1)(2008-10#1)(2008-3#1)
laying performance and##2##3##(2012-2#2)
laying performance##5##2##(2010-2#1)(2012-2#4)
laying##21##1##(2007-12#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#4)(2009-5#4)(2010-2#1)(2011-1#1)(2012-2#6)
layman##2##1##(1991-8#1)(2007-2#1)
laymen##2##1##(2008-5#2)
layout is##2##2##(2008-3#2)
layout of the##3##3##(2007-12#2)(2008-9#1)
layout of##5##2##(2007-12#2)(2008-9#1)(2009-6#1)(2012-2#1)
layout results##2##2##(2008-2#1)(2008-6#1)
layout with##2##2##(2008-12#1)(2008-3#1)
layout##29##1##(1993-12#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#7)(2008-6#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-2#1)
layouts of##2##2##(2008-10#1)(2009-10#1)
layouts##5##1##(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)
laypersons'##2##1##(2011-1#1)(2013-8#1)
lays out##2##2##(1997-3#1)(2012-3#1)
lays the foundation for##2##4##(2008-11#1)(2008-4#1)
lays##7##1##(1995-12#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
lazarets##2##1##(2009-4#2)
lazaroid##4##1##(1995-12#4)
lazaroids##3##1##(1992-5#3)
laziness were the##2##3##(1991-6#1)(1992-2#1)
lb##2##1##(2007-8#1)(2008-6#1)
lbs##3##1##(2007-7#1)(2008-6#1)(2010-1#1)
le 3ème trimestre##2##3##(2013-1#2)
le arning##2##2##(2008-11#2)
le cas##5##2##(2011-2#1)(2013-1#4)
le plus souvent##3##3##(2011-2#2)(2013-1#1)
le plus##4##2##(2008-5#1)(2011-2#2)(2013-1#1)
le pronostic##2##2##(2011-2#1)(2013-1#1)
le risque##2##2##(2013-1#2)
le syndrome de sevrage##2##4##(2013-1#2)
le type##2##2##(2008-5#1)(2013-1#1)
le##53##1##(2007-5#1)(2008-11#4)(2008-5#9)(2009-4#1)(2011-2#8)(2011-3#1)(2013-1#29)
leach from##4##2##(2008-10#4)
leachability##2##1##(2008-10#2)
leachable and total metals in##3##5##(2008-10#3)
leachable and total##4##3##(2008-10#4)
leachant##2##1##(2008-10#2)
leachate##5##1##(2008-10#1)(2012-1#2)(2013-1#2)
leachates and##3##2##(2008-10#3)
leachates by##2##2##(2008-10#2)
leachates were##2##2##(2008-10#1)(2013-1#1)
leachates##19##1##(1997-4#3)(2008-10#15)(2013-1#1)
leached with##3##2##(2008-10#3)
leached##9##1##(2008-10#8)(2011-1#1)
leaching and##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
leaching behaviour##2##2##(2008-10#2)
leaching factor##3##2##(2008-12#3)
leaching from##2##2##(2008-10#1)(2008-5#1)
leaching method is##2##3##(2008-10#2)
leaching method was##3##3##(2008-10#3)
leaching method##6##2##(2008-10#6)
leaching of the##3##3##(2008-10#3)
leaching of##12##2##(2008-10#11)(2008-6#1)
leaching procedures##2##2##(2008-10#2)
leaching process##2##2##(2008-10#2)
leaching solutions##2##2##(2008-10#2)
leaching with##4##2##(2008-10#4)
leaching##68##1##(1997-4#1)(2008-10#56)(2008-11#3)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
lead (II) ions##2##3##(2008-10#2)
lead (II)##10##2##(2008-10#10)
lead (Pb)##7##2##(1995-3#1)(1997-4#1)(2008-10#4)(2008-7#1)
lead a##6##2##(1994-12#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
lead acetate exposed cells##2##4##(1997-4#2)
lead acetate##7##2##(1997-4#6)(2008-11#1)
lead an##2##2##(1997-1#1)(2009-6#1)
lead and cadmium were##2##4##(2008-10#2)
lead and cadmium##8##3##(2008-10#8)
lead and chromium(VI)##2##3##(2008-10#2)
lead and copper##6##3##(2008-10#6)
lead and mercury##5##3##(2008-10#3)(2009-12#1)(2013-1#1)
lead and nickel in##2##4##(2008-10#2)
lead and nickel##7##3##(2008-10#7)
lead and thallium##3##3##(2008-10#3)
lead and the##2##3##(1996-5#1)(2011-1#1)
lead and zinc in##2##4##(2008-10#2)
lead and zinc##7##3##(1997-4#1)(2008-10#6)
lead and##56##2##(1996-3#1)(1996-5#1)(1997-4#2)(2008-1#1)(2008-10#47)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
lead are##3##2##(1997-4#1)(2008-10#2)
lead as##3##2##(1992-3#1)(2008-10#2)
lead at##4##2##(1995-3#2)(2008-1#1)(2008-10#1)
lead beads##2##2##(2008-5#2)
lead by##8##2##(1992-3#1)(2008-10#6)(2013-8#1)
lead can be##2##3##(2008-10#2)
lead candidates##2##2##(1997-4#1)(2008-10#1)
lead carboxymethyl cellulose (Pb(CMC)(2))##2##4##(2008-10#2)
lead cation##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
lead coffin##2##2##(2008-10#2)
lead complex##3##2##(2008-10#3)
lead compound##4##2##(1992-12#1)(2008-11#1)(2008-5#1)(2011-3#1)
lead compounds##4##2##(1997-4#2)(2008-10#1)(2013-7#1)
lead concentration in##3##3##(2008-10#2)(2012-12#1)
lead concentration of##3##3##(2008-10#3)
lead concentration##13##2##(1992-12#3)(1992-3#1)(2008-10#8)(2012-12#1)
lead concentrations in##2##3##(1995-11#1)(2008-10#1)
lead concentrations##4##2##(1995-11#2)(1997-4#1)(2008-10#1)
lead content##4##2##(2008-10#4)
lead determination in##4##3##(2008-10#4)
lead determination was##2##3##(2008-10#2)
lead determination##12##2##(2008-10#12)
lead determined##2##2##(2008-10#2)
lead electrode##2##2##(2008-10#2)
lead exposure to##2##3##(1995-11#2)
lead exposure##9##2##(1995-11#3)(1995-3#2)(1997-4#3)(2009-12#1)
lead for##2##2##(1996-3#1)(2008-8#1)
lead free##3##2##(2009-5#3)
lead from water##3##3##(2011-2#3)
lead from##10##2##(1992-12#1)(1992-3#1)(2008-10#4)(2009-10#1)(2011-2#3)
lead in biological samples##2##4##(2008-10#2)
lead in biological##3##3##(2008-10#3)
lead in blood is##2##4##(2008-10#2)
lead in blood##3##3##(2008-10#3)
lead in drinking water##3##4##(2008-10#3)
lead in human##4##3##(2008-10#3)(2012-9#1)
lead in several samples##2##4##(2008-10#2)
lead in several##3##3##(2008-10#3)
lead in soil##4##3##(1992-3#1)(2008-10#3)
lead in the##7##3##(1997-4#1)(2007-5#1)(2008-10#4)(2012-12#1)
lead in water samples##4##4##(2008-10#4)
lead in water##10##3##(2008-10#9)(2013-8#1)
lead in##104##2##(1992-1#1)(1992-12#2)(1992-3#4)(1995-2#1)(1995-3#1)(1997-4#2)(1997-7#1)(2007-5#1)(2007-7#1)(2008-10#87)(2012-12#1)(2012-9#1)(2013-8#1)
lead into##2##2##(2007-12#1)(2010-2#1)
lead ion##6##2##(2008-10#6)
lead ions##4##2##(2008-10#4)
lead is##6##2##(2007-5#1)(2008-10#5)
lead isotopic##2##2##(2013-8#2)
lead level##3##2##(1992-12#1)(2008-10#2)
lead nephropathy##2##2##(2007-7#1)(2010-12#1)
lead nitrate##4##2##(1995-6#2)(2008-11#2)
lead nurses##2##2##(2008-11#2)
lead of##2##2##(1992-3#1)(2008-10#1)
lead on##5##2##(1995-11#1)(1995-3#3)(2012-2#1)
lead only to##2##3##(1991-3#1)(2008-1#1)
lead optimization##2##2##(2008-10#1)(2010-11#1)
lead reacts with##3##3##(2008-10#3)
lead results##2##2##(1997-4#1)(2008-10#1)
lead salts##5##2##(2008-10#5)
lead smelter##3##2##(1992-3#1)(1995-11#2)
lead smelters##2##2##(1992-3#1)(2008-10#1)
lead the way in##2##4##(1995-12#1)(2011-2#1)
lead the##7##2##(1991-2#1)(1995-12#1)(2008-1#1)(2009-6#1)(2009-7#2)(2011-2#1)
lead time bias##2##3##(1990-8#1)(1992-2#1)
lead to a better understanding of the##2##7##(2009-12#1)(2010-3#1)
lead to a better understanding of##3##6##(2008-11#1)(2009-12#1)(2010-3#1)
lead to a better understanding##4##5##(2008-11#1)(2008-3#1)(2009-12#1)(2010-3#1)
lead to a better##7##4##(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-3#1)(2011-2#2)
lead to a decrease in##2##5##(2008-10#2)
lead to a decrease##3##4##(2008-10#2)(2010-1#1)
lead to a greater##2##4##(2008-6#1)(2008-7#1)
lead to a loss##2##4##(2007-7#1)(2008-3#1)
lead to a more##2##4##(1990-3#1)(2008-10#1)
lead to a new##4##4##(2007-11#2)(2008-11#1)(2010-4#1)
lead to a reduction in##2##5##(2008-3#1)(2013-8#1)
lead to a reduction##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
lead to a significant##2##4##(2008-10#1)(2009-11#1)
lead to a##72##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-1#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
lead to acute##3##3##(1996-3#1)(2007-8#1)(2012-3#1)
lead to additional##3##3##(1997-1#1)(2006-10#1)(2008-3#1)
lead to advances in##2##4##(2008-11#1)(2013-8#1)
lead to adverse##5##3##(2007-7#1)(2008-11#2)(2011-1#2)
lead to altered##2##3##(2008-7#1)(2011-10#1)
lead to an improved##2##4##(2008-10#1)(2008-7#1)
lead to an improvement in##2##5##(2008-2#2)
lead to an improvement##3##4##(1990-2#1)(2008-2#2)
lead to an increase in##3##5##(1995-6#1)(2007-2#1)(2008-11#1)
lead to an increase of##2##5##(2008-11#1)(2009-11#1)
lead to an increase##5##4##(1995-6#1)(2007-2#1)(2008-11#2)(2009-11#1)
lead to an overestimate of the##2##6##(1996-12#1)(1996-4#1)
lead to an##30##3##(1990-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
lead to better results##2##4##(2007-11#1)(2008-11#1)
lead to better##9##3##(1993-2#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-10#1)(2012-12#1)
lead to cell death##2##4##(1991-9#1)(1994-5#1)
lead to cell##4##3##(1991-9#1)(1994-5#1)(2008-2#1)(2011-3#1)
lead to changes in the##2##5##(1992-6#1)(2011-2#1)
lead to changes in##4##4##(1992-6#1)(1997-1#1)(2008-11#1)(2011-2#1)
lead to changes##5##3##(1992-6#1)(1997-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
lead to chronic##5##3##(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
lead to complete##2##3##(2009-7#1)(2013-7#1)
lead to congenital##2##3##(2010-11#1)(2012-2#1)
lead to correct##2##3##(2008-1#1)(2008-10#1)
lead to death##3##3##(1997-8#1)(2006-10#1)(2011-2#1)
lead to different##4##3##(2008-4#2)(2008-5#1)(2013-7#1)
lead to disease##2##3##(2008-10#1)(2008-7#1)
lead to early##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
lead to either##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
lead to enhanced AChE activity##2##5##(2008-11#2)
lead to enhanced##3##3##(2008-11#2)(2008-5#1)
lead to evolution##2##3##(2012-3#2)
lead to formation of##2##4##(1994-8#1)(2009-5#1)
lead to further##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
lead to future##2##3##(1995-11#1)(2011-2#1)
lead to greater##6##3##(2008-10#3)(2009-7#1)(2011-2#2)
lead to higher##8##3##(1992-11#1)(1993-3#1)(2007-5#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)
lead to impaired##2##3##(2008-3#1)(2012-3#1)
lead to important##3##3##(1994-11#1)(2008-3#1)(2011-2#1)
lead to improved##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-10#1)(2011-2#1)
lead to improvement of##2##4##(1997-8#1)(2011-2#1)
lead to improvement##3##3##(1997-8#1)(2007-2#1)(2011-2#1)
lead to improvements in##2##4##(2009-8#1)(2011-2#1)
lead to increased##14##3##(1991-12#1)(1992-4#1)(1994-11#2)(1994-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
lead to increases##2##3##(1992-6#1)(2008-12#1)
lead to large##3##3##(2007-12#1)(2008-10#1)(2010-6#1)
lead to lethal##3##3##(1994-11#1)(2013-1#1)(2013-7#1)
lead to local##2##3##(1990-8#1)(2008-8#1)
lead to loss of##4##4##(1993-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
lead to loss##5##3##(1993-12#1)(2008-4#1)(2008-9#1)(2010-10#1)(2012-3#1)
lead to more effective##2##4##(1997-2#1)(2008-10#1)
lead to more##12##3##(1995-5#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2013-1#2)
lead to new strategies##2##4##(2008-11#1)(2008-4#1)
lead to new##13##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-8#1)
lead to novel##4##3##(2007-12#1)(2008-7#2)(2010-5#1)
lead to optimal##2##3##(2008-8#1)(2013-8#1)
lead to patient##2##3##(2008-3#1)(2011-2#1)
lead to progressive##3##3##(2008-11#1)(2008-7#2)
lead to reduced##3##3##(1995-2#1)(2009-6#1)(2012-2#1)
lead to regional##2##3##(2008-3#1)(2008-8#1)
lead to serious##7##3##(1990-3#1)(1997-1#1)(2008-10#2)(2009-9#1)(2010-8#1)(2011-2#1)
lead to severe##5##3##(1994-5#1)(1996-3#1)(2007-11#1)(2008-5#1)(2011-1#1)
lead to significant improvement##2##4##(2008-2#1)(2013-8#1)
lead to significant##11##3##(1995-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
lead to symptoms##4##3##(1992-1#1)(1997-3#1)(2013-1#1)(2013-8#1)
lead to the accumulation of##2##5##(2008-10#2)
lead to the conclusion that##2##5##(2008-10#1)(2008-3#1)
lead to the creation of##2##5##(2008-10#1)(2010-1#1)
lead to the death of##2##5##(2008-7#1)(2009-10#1)
lead to the development of a##2##6##(2008-10#1)(2008-3#1)
lead to the development of novel##3##6##(2008-5#2)(2009-8#1)
lead to the development of##15##5##(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#3)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
lead to the development##17##4##(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
lead to the expression of##3##5##(1996-12#1)(2008-5#1)(2009-8#1)
lead to the formation of##5##5##(1996-5#1)(2008-10#1)(2008-12#1)(2011-2#2)
lead to the formation##6##4##(1996-5#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-2#1)
lead to the further##2##4##(2010-10#1)(2010-12#1)
lead to the highest##2##4##(1990-6#1)(2008-9#1)
lead to the identification of##5##5##(2008-10#1)(2008-11#1)(2009-4#1)(2012-1#1)(2012-12#1)
lead to the inhibition of##2##5##(2008-10#1)(2012-2#1)
lead to the isolation of##2##5##(2008-10#1)(2011-1#1)
lead to the loss of##2##5##(1997-4#1)(2011-2#1)
lead to the most##3##4##(2007-6#1)(2008-10#1)(2010-2#1)
lead to the preferential##2##4##(2008-11#2)
lead to the##105##3##(1990-3#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
lead to their##3##3##(1992-1#1)(2012-12#1)(2013-1#1)
lead to this##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
lead to treatment failure##2##4##(2009-7#1)(2013-8#1)
lead to very##3##3##(1997-6#1)(2012-12#1)(2012-2#1)
lead to##700##2##(1990-11#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#3)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#3)(2006-10#5)(2006-5#1)(2007-10#3)(2007-11#14)(2007-12#11)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#2)(2007-9#2)(2008-1#10)(2008-10#77)(2008-11#40)(2008-12#6)(2008-2#9)(2008-3#31)(2008-4#10)(2008-5#27)(2008-6#5)(2008-7#39)(2008-8#19)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#9)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#9)(2011-10#2)(2011-2#44)(2011-3#1)(2012-1#3)(2012-12#19)(2012-2#18)(2012-3#16)(2013-1#21)(2013-7#6)(2013-8#21)
lead us to conclude that##3##5##(1991-2#1)(2008-10#2)
lead us to conclude##5##4##(1991-2#1)(1993-12#1)(2008-10#3)
lead us to##12##3##(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(2008-10#5)(2008-4#1)(2008-7#1)
lead us##13##2##(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(2008-10#5)(2008-4#1)(2008-7#1)(2012-3#1)
lead using##5##2##(2008-10#5)
lead was determined##2##3##(1992-3#1)(2008-10#1)
lead was removed##2##3##(2011-2#1)(2012-2#1)
lead was##12##2##(1992-3#1)(2008-1#1)(2008-10#7)(2011-2#1)(2012-2#2)
lead were##8##2##(2008-10#6)(2008-8#1)(2011-1#1)
lead white##2##2##(2008-10#2)
lead with##10##2##(2008-10#9)(2013-8#1)
lead zirconate##6##2##(2008-2#6)
lead##1342##1##(1990-11#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#4)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#10)(1992-2#2)(1992-3#17)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#7)(1994-12#4)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#14)(1995-12#5)(1995-2#2)(1995-3#20)(1995-5#1)(1995-6#5)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#33)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#5)(2006-5#1)(2007-10#3)(2007-11#14)(2007-12#19)(2007-2#4)(2007-3#1)(2007-5#6)(2007-6#2)(2007-7#11)(2007-8#2)(2007-9#2)(2008-1#16)(2008-10#461)(2008-11#47)(2008-12#8)(2008-2#19)(2008-3#36)(2008-4#11)(2008-5#36)(2008-6#5)(2008-7#47)(2008-8#22)(2008-9#18)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#5)(2009-2#2)(2009-3#9)(2009-4#1)(2009-5#12)(2009-6#3)(2009-7#7)(2009-8#5)(2009-9#4)(2010-1#6)(2010-10#5)(2010-11#4)(2010-12#6)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#13)(2011-10#2)(2011-2#52)(2011-3#2)(2012-1#3)(2012-12#21)(2012-2#26)(2012-3#19)(2012-9#1)(2013-1#27)(2013-7#7)(2013-8#28)
lead(II) and cadmium(II)##5##3##(2008-10#5)
lead(II) and##7##2##(2008-10#7)
lead(II) by##2##2##(2008-10#2)
lead(II) in natural water samples##2##5##(2008-10#2)
lead(II) in##7##2##(2008-10#7)
lead(II) ions##2##2##(2008-10#2)
lead(II)##56##1##(2008-10#56)
lead)##3##1##(2008-10#3)
lead-acid##4##1##(1992-2#2)(2008-10#2)
lead-induced liver proliferation##2##3##(1994-11#2)
lead-induced##3##1##(1994-11#2)(1997-4#1)
lead-salt diode##2##2##(2008-2#1)(2008-3#1)
lead-salt##3##1##(2008-2#1)(2008-3#2)
lead-treated rats##3##2##(2008-7#3)
leader RNA##2##2##(2008-8#2)
leader and the##2##3##(2008-1#1)(2008-8#1)
leader and trailer##2##3##(2008-8#2)
leader and##6##2##(2008-1#1)(2008-10#1)(2008-8#3)(2012-2#1)
leader exon and##2##3##(1990-11#1)(1991-9#1)
leader exon##3##2##(1990-11#2)(1991-9#1)
leader exons##2##2##(1992-9#2)
leader in##5##2##(1992-9#1)(1994-1#1)(1995-1#1)(2008-11#1)(2012-3#1)
leader of the##5##3##(1991-10#1)(1992-5#1)(1993-12#1)(1996-1#1)(2008-9#1)
leader of##6##2##(1991-10#1)(1992-5#1)(1993-12#1)(1996-1#1)(2008-9#2)
leader peptide##3##2##(1990-2#1)(1992-8#1)(1995-6#1)
leader region of##4##3##(1991-9#1)(1994-8#1)(2008-9#2)
leader region##5##2##(1991-9#1)(1994-8#1)(2008-8#1)(2008-9#2)
leader sequence and a##2##4##(1991-10#1)(1993-6#1)
leader sequence and##3##3##(1991-10#1)(1993-6#2)
leader sequence of the##2##4##(1991-10#1)(2008-9#1)
leader sequence of##3##3##(1991-10#2)(2008-9#1)
leader sequence##12##2##(1991-10#4)(1991-11#1)(1993-6#3)(1995-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
leader sequences##3##2##(1997-3#1)(1997-6#1)(2008-8#1)
leader##74##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-10#5)(1991-11#1)(1991-9#5)(1992-5#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-6#3)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-1#6)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#6)(2012-2#1)(2012-3#2)
leader's role in##2##3##(1994-1#1)(2008-1#1)
leader's role##3##2##(1994-1#1)(2008-1#2)
leaders and##5##2##(1993-12#2)(1996-3#1)(2009-9#1)(2010-11#1)
leaders are##3##2##(1992-1#1)(1997-1#1)(2012-3#1)
leaders as##2##2##(1996-1#1)(2010-10#1)
leaders can##3##2##(1994-12#1)(1996-3#1)(1997-1#1)
leaders from the##2##3##(1992-3#1)(2010-8#1)
leaders have##2##2##(1992-5#1)(2012-3#1)
leaders in a##2##3##(1993-12#1)(1995-3#1)
leaders in the field##2##4##(1992-12#1)(2009-3#1)
leaders in the##6##3##(1992-12#1)(1992-2#1)(1996-2#1)(2008-1#1)(2008-7#1)(2009-3#1)
leaders in##13##2##(1992-12#1)(1992-2#1)(1993-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-9#1)(2008-1#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
leaders must##6##2##(1993-1#1)(1993-2#1)(1994-12#1)(1995-3#1)(1997-3#1)(2008-1#1)
leaders of the##2##3##(1994-1#1)(2012-2#1)
leaders of##5##2##(1992-2#1)(1994-1#1)(1994-2#1)(2012-2#1)(2013-1#1)
leaders should take##2##3##(1994-1#2)
leaders to##6##2##(1996-3#1)(1997-2#1)(2008-1#2)(2008-6#1)(2009-3#1)
leaders were##3##2##(2009-5#1)(2012-3#2)
leaders who##4##2##(1994-1#1)(1994-2#2)(2012-2#1)
leaders will be##2##3##(1993-12#2)
leaders will##3##2##(1993-12#2)(2008-1#1)
leaders##121##1##(1991-2#1)(1992-1#4)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#2)(1993-1#2)(1993-12#7)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#6)(1994-12#4)(1994-2#5)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#5)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(2007-12#1)(2008-1#9)(2008-11#2)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#9)(2013-1#2)(2013-7#1)(2013-8#3)
leaders'##8##1##(2009-5#3)(2012-3#5)
leaders?##2##1##(1993-1#1)(1997-5#1)
leadership and management##4##3##(1996-3#1)(2008-11#1)(2008-12#1)(2012-12#1)
leadership and shared##2##3##(1996-12#1)(2012-3#1)
leadership and##18##2##(1991-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#3)
leadership can##2##2##(1994-1#1)(1994-2#1)
leadership challenges##2##2##(1993-2#1)(1997-1#1)
leadership development##7##2##(1993-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-12#1)(2010-3#1)(2012-3#1)
leadership in an##2##3##(1993-12#1)(1994-2#1)
leadership in order to##2##4##(1995-1#1)(2012-3#1)
leadership in the##10##3##(1991-12#1)(1993-1#1)(1994-2#2)(1995-1#1)(1996-3#1)(2008-12#1)(2008-6#2)(2008-7#1)
leadership in##23##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#2)(1993-12#1)(1994-2#3)(1995-1#2)(1996-2#1)(1996-3#3)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#1)(2012-2#2)(2012-3#1)
leadership is to be able to##2##6##(2008-1#2)
leadership is##5##2##(1991-2#1)(2008-1#2)(2009-5#1)(2012-3#1)
leadership of##4##2##(1995-1#1)(1996-1#1)(2009-5#1)(2012-1#1)
leadership qualities##2##2##(1990-12#1)(1993-12#1)
leadership role##4##2##(1993-3#1)(2008-11#1)(2008-12#1)(2008-6#1)
leadership roles in##2##3##(2007-4#1)(2012-2#1)
leadership roles##4##2##(1991-3#1)(1996-12#1)(2007-4#1)(2012-2#1)
leadership skills##5##2##(1994-3#1)(2009-5#4)
leadership style##4##2##(1992-2#4)
leadership styles and theories##2##4##(2013-8#2)
leadership styles and##3##3##(2012-3#1)(2013-8#2)
leadership styles##5##2##(1992-2#1)(2010-10#1)(2012-3#1)(2013-8#2)
leadership successes##2##2##(2012-3#2)
leadership was##2##2##(1996-3#1)(2012-3#1)
leadership##176##1##(1990-12#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#3)(1992-1#1)(1992-2#6)(1992-5#2)(1993-1#5)(1993-12#7)(1993-2#2)(1993-3#2)(1994-1#8)(1994-12#2)(1994-2#5)(1994-3#3)(1995-1#6)(1995-12#2)(1995-2#2)(1996-1#8)(1996-12#3)(1996-2#1)(1996-3#7)(1997-1#3)(1997-2#4)(1997-3#3)(2007-10#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#10)(2008-10#1)(2008-11#6)(2008-12#6)(2008-4#1)(2008-6#10)(2008-7#2)(2009-5#8)(2009-7#1)(2010-1#1)(2010-10#3)(2010-3#2)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#12)(2013-1#3)(2013-8#2)
leadership]##2##1##(1992-9#2)
leading cause of acquired blindness##2##5##(2008-1#2)
leading cause of blindness##5##4##(2007-11#2)(2008-1#1)(2010-10#1)(2011-1#1)
leading cause of cancer##2##4##(2013-1#2)
leading cause of cancer-related death in##2##6##(2008-1#1)(2012-1#1)
leading cause of cancer-related##4##4##(2008-1#1)(2011-1#1)(2011-2#1)(2012-1#1)
leading cause of death and##4##5##(1995-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
leading cause of death in##5##5##(1995-2#1)(1995-9#1)(2008-8#1)(2010-10#1)(2012-2#1)
leading cause of death worldwide##3##5##(2011-2#1)(2012-1#1)(2013-8#1)
leading cause of death##18##4##(1990-6#1)(1995-11#1)(1995-2#1)(1995-9#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
leading cause of morbidity and mortality in the##2##8##(2008-7#1)(2008-8#1)
leading cause of morbidity and mortality in##3##7##(1993-3#1)(2008-7#1)(2008-8#1)
leading cause of morbidity and mortality##4##6##(1993-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
leading cause of mortality in##3##5##(2008-3#1)(2009-4#1)(2010-7#1)
leading cause of##62##3##(1990-6#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-7#2)(2008-1#6)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#4)(2009-4#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
leading causes of death were##2##5##(2008-10#1)(2013-8#1)
leading causes of death##11##4##(2007-7#1)(2008-10#1)(2012-3#1)(2013-8#8)
leading causes of##22##3##(1995-12#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#10)
leading edge##7##2##(2007-12#2)(2008-1#1)(2008-10#1)(2011-2#2)(2012-12#1)
leading edges stimulated an ETR under##3##6##(2011-2#3)
leading edges stimulated an ETR##4##5##(2011-2#4)
leading electrolyte##2##2##(2008-10#2)
leading experts##2##2##(2008-8#1)(2012-2#1)
leading from##2##2##(1996-2#1)(2008-9#1)
leading in##2##2##(2008-1#1)(2010-11#1)
leading method of##2##3##(1996-8#1)(2008-12#1)
leading not only to##2##4##(2008-9#1)(2011-2#1)
leading risk factor##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
leading role##3##2##(1994-9#1)(2009-7#1)(2011-1#1)
leading symptoms##2##2##(1992-9#1)(1995-6#1)
leading the##5##2##(1996-5#1)(1997-1#1)(2008-11#1)(2008-9#1)(2009-4#1)
leading to a better##2##4##(2008-10#1)(2008-11#1)
leading to a decrease in the##2##6##(2008-10#1)(2013-1#1)
leading to a decrease in##3##5##(2008-10#1)(2008-6#1)(2013-1#1)
leading to a decrease##4##4##(2008-10#2)(2008-6#1)(2013-1#1)
leading to a high##2##4##(2011-2#2)
leading to a reduction of##2##5##(1991-2#1)(2008-10#1)
leading to a##62##3##(1991-12#1)(1991-2#1)(1993-8#1)(1993-9#1)(1995-11#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#4)(2008-7#3)(2008-8#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
leading to an increase##2##4##(1991-12#1)(2008-10#1)
leading to an increased##3##4##(1995-6#1)(1995-8#1)(2008-3#1)
leading to an##19##3##(1990-11#1)(1991-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
leading to better##4##3##(1992-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
leading to cell death##4##4##(1992-6#1)(2008-10#1)(2012-12#1)(2013-7#1)
leading to cell##5##3##(1992-6#1)(2008-10#1)(2010-2#1)(2012-12#1)(2013-7#1)
leading to cellular##2##3##(2008-5#1)(2013-8#1)
leading to chronic##3##3##(1991-4#1)(2008-11#1)(2008-7#1)
leading to death##3##3##(1990-11#1)(2008-9#1)(2012-3#1)
leading to dementia##2##3##(1996-11#1)(2008-4#1)
leading to design##2##3##(2008-10#1)(2008-2#1)
leading to different levels of##2##5##(2008-10#1)(2008-11#1)
leading to different##4##3##(2008-10#2)(2008-11#2)
leading to disease##2##3##(2008-4#1)(2012-2#1)
leading to effects on##2##4##(2008-8#1)(2012-12#1)
leading to enhanced##2##3##(2007-11#1)(2008-5#1)
leading to excessive##2##3##(1995-5#1)(2008-11#1)
leading to extensive##2##3##(1990-11#1)(2008-10#1)
leading to extradural abscess##2##4##(2007-7#2)
leading to full##2##3##(2009-7#1)(2012-2#1)
leading to functional selectivity in##2##5##(2009-12#2)
leading to further##2##3##(1991-2#1)(1992-4#1)
leading to greater##4##3##(1994-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
leading to higher##3##3##(2008-8#1)(2011-7#1)(2013-1#1)
leading to incomplete##2##3##(2007-2#1)(2008-10#1)
leading to increased##11##3##(1995-12#1)(2008-8#1)(2010-2#1)(2010-8#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
leading to inhibition of##3##4##(1994-12#1)(2009-8#1)(2013-1#1)
leading to loss of##3##4##(2008-8#1)(2012-3#1)(2013-8#1)
leading to low##3##3##(1996-6#1)(2008-10#1)(2009-9#1)
leading to more##5##3##(2008-10#2)(2011-2#1)(2012-3#1)(2013-1#1)
leading to no##2##3##(1991-6#1)(2012-3#1)
leading to physiological##2##3##(1990-5#1)(2012-2#1)
leading to production of##2##4##(1997-4#1)(2008-11#1)
leading to progressive##3##3##(2008-7#1)(2011-1#1)(2012-3#1)
leading to pulmonary##2##3##(2008-12#1)(2011-2#1)
leading to recognition of##2##4##(2008-3#1)(2012-2#1)
leading to reduced##3##3##(1995-5#1)(2007-11#1)(2008-2#1)
leading to results##2##3##(2008-3#2)
leading to significant##5##3##(2007-12#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-3#1)
leading to successful##2##3##(1994-2#1)(2008-11#1)
leading to sustained##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
leading to the accumulation of##2##5##(1994-11#1)(2008-10#1)
leading to the characterization of##2##5##(1994-8#1)(2008-10#1)
leading to the conclusion that##2##5##(2008-10#1)(2008-5#1)
leading to the development of##4##5##(1992-3#1)(1994-8#1)(2008-1#1)(2008-9#1)
leading to the establishment of##4##5##(1996-9#1)(2008-11#1)(2009-10#1)(2012-12#1)
leading to the eventual##2##4##(2008-12#1)(2008-5#1)
leading to the evolution of the##2##6##(1993-8#1)(2012-3#1)
leading to the formation of##5##5##(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)
leading to the identification##2##4##(1991-8#1)(2008-10#1)
leading to the##83##3##(1990-12#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-6#3)(1996-5#2)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#2)
leading to their##4##3##(1995-2#1)(2007-2#1)(2008-10#1)(2011-2#1)
leading to these##2##3##(2008-8#1)(2011-2#1)
leading to this##3##3##(2008-11#1)(2009-12#1)(2010-2#1)
leading to transformation##2##3##(2006-10#1)(2010-3#1)
leading to two##2##3##(2008-10#2)
leading to##535##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#6)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#5)(1995-5#4)(1995-6#5)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#5)(1997-7#2)(1997-8#1)(2006-10#2)(2007-11#12)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#8)(2008-10#59)(2008-11#28)(2008-12#8)(2008-2#13)(2008-3#12)(2008-4#6)(2008-5#17)(2008-6#13)(2008-7#17)(2008-8#16)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#8)(2011-2#23)(2011-7#1)(2012-1#2)(2012-12#11)(2012-2#21)(2012-3#18)(2012-5#1)(2013-1#23)(2013-7#4)(2013-8#8)
leading toward##2##2##(1992-12#1)(2011-2#1)
leading up to the##3##4##(1990-9#1)(1996-12#1)(1997-2#1)
leading up to##6##3##(1990-9#1)(1996-12#1)(1997-2#1)(2010-3#1)(2012-12#2)
leading us to##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
leading##742##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#6)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#6)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#4)(1997-6#5)(1997-7#3)(1997-8#2)(2006-10#2)(2007-11#17)(2007-12#12)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#5)(2008-1#21)(2008-10#73)(2008-11#35)(2008-12#11)(2008-2#14)(2008-3#16)(2008-4#8)(2008-5#21)(2008-6#13)(2008-7#22)(2008-8#24)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#2)(2010-2#7)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#13)(2011-2#49)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#14)(2012-2#26)(2012-3#23)(2012-5#1)(2013-1#31)(2013-7#4)(2013-8#21)
leading-trailing time##3##2##(2008-3#3)
leading-trailing##4##1##(2008-3#4)
leads V1-V3##2##2##(2008-12#1)(2012-12#1)
leads and##3##2##(1993-1#1)(2008-12#1)(2009-10#1)
leads are##2##2##(2008-6#1)(2012-3#1)
leads for##6##2##(2007-11#1)(2008-10#1)(2008-4#2)(2013-1#1)(2013-7#1)
leads in##2##2##(2008-3#1)(2011-2#1)
leads speakers to##2##3##(2008-2#2)
leads the##2##2##(2010-9#1)(2011-2#1)
leads to a complex##2##4##(1990-12#1)(2006-10#1)
leads to a decrease in the##2##6##(1992-8#1)(2008-3#1)
leads to a decrease in##3##5##(1992-8#1)(2008-3#1)(2013-1#1)
leads to a decrease of##2##5##(1993-12#1)(2008-7#1)
leads to a decrease##5##4##(1992-8#1)(1993-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
leads to a high##4##4##(2008-10#2)(2008-6#1)(2010-12#1)
leads to a higher##3##4##(2010-7#1)(2012-3#1)(2013-1#1)
leads to a large##2##4##(2008-10#1)(2008-3#1)
leads to a marked##2##4##(1994-8#1)(1995-2#1)
leads to a phase##2##4##(2007-12#1)(2008-10#1)
leads to a reduction in the##2##6##(1995-5#1)(2008-3#1)
leads to a reduction in##3##5##(1995-5#1)(2008-3#2)
leads to a reduction##4##4##(1995-5#1)(2008-3#2)(2008-7#1)
leads to a shift##3##4##(1990-7#1)(1994-5#1)(2007-11#1)
leads to a significant##5##4##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
leads to a significantly##2##4##(2007-8#1)(2008-5#1)
leads to a stable##2##4##(1995-5#1)(2008-8#1)
leads to a variety of##2##5##(2007-12#1)(2008-7#1)
leads to a##90##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
leads to activation of the##2##5##(1992-6#1)(2008-8#1)
leads to activation of##4##4##(1992-6#1)(1994-6#1)(2008-12#1)(2008-8#1)
leads to aggregation##2##3##(1992-3#1)(2010-4#1)
leads to an exact##2##4##(2007-12#1)(2008-10#1)
leads to an improved anti-fouling ability against##2##7##(2008-10#2)
leads to an improved##3##4##(2008-10#2)(2008-5#1)
leads to an increase in the##2##6##(1990-5#1)(2009-8#1)
leads to an increase in##3##5##(1990-5#1)(2008-10#1)(2009-8#1)
leads to an increase##4##4##(1990-5#1)(2008-10#1)(2008-3#1)(2009-8#1)
leads to an increased##3##4##(1995-6#1)(1997-6#1)(2010-5#1)
leads to an##35##3##(1990-11#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-8#1)(1994-11#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#6)(2008-3#6)(2008-5#2)(2008-6#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-3#1)(2012-12#1)
leads to better results##2##4##(2007-11#1)(2008-10#1)
leads to better##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2009-5#1)
leads to cell death##2##4##(2008-11#1)(2012-2#1)
leads to cell##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
leads to collapse of the##2##5##(2008-11#1)(2009-3#1)
leads to confusion##2##3##(1991-2#1)(2013-1#1)
leads to death##2##3##(1997-3#1)(2011-2#1)
leads to different##2##3##(2008-10#1)(2008-3#1)
leads to enhanced##2##3##(1993-9#1)(1994-12#1)
leads to failure of##2##4##(2009-8#1)(2012-3#1)
leads to high##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
leads to higher##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-5#1)(2010-8#1)
leads to improved##3##3##(2007-11#1)(2010-12#1)(2010-4#1)
leads to increased##15##3##(1995-12#1)(1995-2#2)(1996-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
leads to increasing##2##3##(1992-6#1)(2007-12#1)
leads to inhibition of##2##4##(1992-12#1)(2011-1#1)
leads to inhibition##3##3##(1990-5#1)(1992-12#1)(2011-1#1)
leads to much##2##3##(2008-7#1)(2010-12#1)
leads to neuronal##2##3##(1995-12#1)(2007-12#1)
leads to platelet##2##3##(2008-11#2)
leads to poor##2##3##(2008-7#1)(2008-9#1)
leads to rapid##2##3##(2008-8#1)(2012-2#1)
leads to reduced##4##3##(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)
leads to reductions in##2##4##(1995-2#1)(2008-4#1)
leads to results##2##3##(2008-3#1)(2009-5#1)
leads to several##2##3##(2008-7#1)(2009-5#1)
leads to signal##2##3##(2007-12#1)(2008-10#1)
leads to significant##9##3##(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-3#1)(2012-2#1)(2013-1#1)
leads to some##2##3##(2008-3#1)(2012-3#1)
leads to stimulation of##2##4##(1994-8#1)(2008-8#1)
leads to the accumulation of##3##5##(1995-2#1)(2009-7#1)(2012-3#1)
leads to the activation of##4##5##(1993-12#1)(1994-6#1)(1995-6#1)(2010-11#1)
leads to the conclusion that##6##5##(1992-3#1)(1995-2#1)(2008-7#1)(2008-9#2)(2011-2#1)
leads to the development of##3##5##(1995-3#1)(2012-2#1)(2013-8#1)
leads to the formation of a##3##6##(1997-2#1)(2007-12#1)(2008-3#1)
leads to the formation of an##2##6##(1995-5#1)(2008-10#1)
leads to the formation of##15##5##(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
leads to the production of##4##5##(1997-4#1)(2007-11#1)(2009-2#1)(2009-6#1)
leads to the##79##3##(1990-11#1)(1990-5#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-5#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
leads to their##2##3##(2008-5#1)(2011-9#1)
leads to transient##2##3##(2008-7#1)(2011-1#1)
leads to tumor regression##2##4##(2009-9#1)(2011-2#1)
leads to tumor##3##3##(2009-9#1)(2011-2#1)(2013-1#1)
leads to very##3##3##(2008-10#1)(2008-4#2)
leads to##504##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#5)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#14)(1995-3#2)(1995-5#3)(1995-6#6)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#7)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#3)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#19)(2007-12#22)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#35)(2008-11#16)(2008-12#5)(2008-2#10)(2008-3#39)(2008-4#9)(2008-5#11)(2008-6#2)(2008-7#28)(2008-8#15)(2008-9#8)(2009-1#1)(2009-10#4)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#7)(2009-6#5)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#10)(2011-2#12)(2011-3#3)(2011-9#1)(2012-1#3)(2012-12#5)(2012-2#16)(2012-3#12)(2013-1#20)(2013-8#6)
leads us to##8##3##(1994-8#1)(1997-6#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-6#1)
leads##572##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#14)(1995-3#2)(1995-5#3)(1995-6#6)(1995-8#4)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#7)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#3)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#21)(2007-12#22)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#17)(2008-12#8)(2008-2#16)(2008-3#50)(2008-4#12)(2008-5#13)(2008-6#3)(2008-7#31)(2008-8#16)(2008-9#8)(2009-1#1)(2009-10#5)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#8)(2009-6#5)(2009-7#3)(2009-8#6)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#18)(2011-3#4)(2011-9#1)(2012-1#3)(2012-12#6)(2012-2#17)(2012-3#13)(2013-1#21)(2013-7#1)(2013-8#6)
leaf (or##2##2##(2008-10#2)
leaf N and NSC##3##4##(2012-5#3)
leaf N/P quotient##2##3##(2008-5#2)
leaf age##8##2##(2008-10#8)
leaf and flower blight##3##4##(2008-10#3)
leaf and flower##5##3##(1993-2#1)(2008-10#4)
leaf and fruit##2##3##(2008-10#2)
leaf and plant##2##3##(2008-10#2)
leaf and pod##2##3##(2008-10#1)(2013-8#1)
leaf and root##3##3##(2008-10#1)(2010-11#2)
leaf and shoot##2##3##(2008-10#2)
leaf and stem##4##3##(2008-10#4)
leaf and stripe rust##2##4##(2008-10#2)
leaf and##38##2##(1993-2#1)(2008-10#27)(2008-12#3)(2008-8#1)(2008-9#2)(2010-11#2)(2011-2#1)(2013-8#1)
leaf area covered by##2##4##(2008-10#2)
leaf area was##2##3##(2008-10#2)
leaf area##37##2##(2008-10#27)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-5#1)(2013-7#4)
leaf at##2##2##(2008-10#2)
leaf bases##2##2##(2008-10#2)
leaf biomass##3##2##(2008-5#2)(2013-7#1)
leaf blade##4##2##(2008-10#2)(2008-5#2)
leaf blades##3##2##(2008-10#3)
leaf blast lesions##2##3##(2008-10#2)
leaf blast##9##2##(2008-10#9)
leaf blight (caused by##2##4##(2008-10#2)
leaf blight and leaf spot##2##5##(2008-10#2)
leaf blight and##3##3##(2008-10#3)
leaf blight in##5##3##(2008-10#5)
leaf blight of carrot##2##4##(2008-10#2)
leaf blight of##5##3##(2008-10#5)
leaf blight on##2##3##(2008-10#2)
leaf blight symptoms##2##3##(2008-10#2)
leaf blight##36##2##(2008-10#36)
leaf blotch in##3##3##(2008-10#3)
leaf blotch resistance##2##3##(2008-10#2)
leaf blotch##14##2##(2008-10#14)
leaf cell turgor##2##3##(2013-1#2)
leaf cell##4##2##(2008-10#2)(2013-1#2)
leaf chlorophyll##3##2##(2008-12#2)(2012-9#1)
leaf colonization in##3##3##(2008-10#3)
leaf colonization##7##2##(2008-10#7)
leaf crumple disease##2##3##(2008-10#2)
leaf crumple virus##4##3##(2008-10#4)
leaf crumple##7##2##(2008-10#7)
leaf curl Bangladesh virus##2##4##(2008-10#2)
leaf curl disease##3##3##(2008-10#3)
leaf curl symptoms in tomato plants##3##6##(2008-10#3)
leaf curl symptoms in tomato##4##5##(2008-10#4)
leaf curl symptoms in##5##4##(2008-10#5)
leaf curl symptoms##7##3##(2008-10#7)
leaf curl virus (CaLCV)##2##4##(2008-10#2)
leaf curl virus in##2##4##(2008-10#1)(2008-9#1)
leaf curl virus##33##3##(2008-10#30)(2008-8#1)(2008-9#2)
leaf curl##71##2##(2008-10#68)(2008-8#1)(2008-9#2)
leaf curling##3##2##(2008-10#3)
leaf development##3##2##(2008-10#1)(2009-6#1)(2009-8#1)
leaf dip bioassays##2##3##(2011-2#2)
leaf dip##4##2##(2008-10#1)(2011-2#3)
leaf discs of##3##3##(2008-10#2)(2008-7#1)
leaf discs##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
leaf disease##2##2##(2008-10#2)
leaf disk##2##2##(2008-10#2)
leaf disks colonized)##2##3##(2008-10#2)
leaf disks in##2##3##(2008-10#2)
leaf disks incubated under##2##4##(2008-10#2)
leaf disks of##2##3##(2008-10#2)
leaf disks were##3##3##(2008-10#3)
leaf disks##21##2##(2008-10#21)
leaf distortion##4##2##(2008-10#4)
leaf drop##2##2##(2008-10#2)
leaf extract as##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
leaf extract of##3##3##(2010-9#1)(2013-7#2)
leaf extract##15##2##(2008-10#6)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-9#1)(2013-1#1)(2013-7#2)
leaf extracts of##3##3##(1996-12#1)(2010-3#2)
leaf extracts##13##2##(1996-12#1)(2008-10#9)(2010-3#3)
leaf gas exchange##3##3##(2008-12#1)(2008-5#1)(2012-5#1)
leaf growth##3##2##(2013-1#3)
leaf hairs##3##2##(2008-10#3)
leaf has##2##2##(2008-9#1)(2009-6#1)
leaf in##4##2##(1991-11#1)(2008-10#3)
leaf incidence##2##2##(2008-10#2)
leaf infection by##2##3##(2008-10#2)
leaf infection##7##2##(2008-10#7)
leaf inoculation##2##2##(2008-10#2)
leaf lesions in##2##3##(2008-10#2)
leaf lesions##8##2##(2008-10#8)
leaf level##2##2##(2008-10#2)
leaf litter##9##2##(2008-10#5)(2008-8#2)(2010-3#2)
leaf luteovirus##2##2##(2008-10#2)
leaf mass##2##2##(2008-12#1)(2008-8#1)
leaf material##3##2##(2007-5#1)(2008-10#2)
leaf mesophyll##2##2##(2008-10#2)
leaf mold##6##2##(2008-12#6)
leaf nitrogen (N)##2##3##(2012-5#1)(2012-9#1)
leaf nitrogen content##2##3##(2008-10#2)
leaf nitrogen##6##2##(2008-10#3)(2012-5#2)(2012-9#1)
leaf of the##3##3##(1994-8#1)(2008-9#1)(2010-9#1)
leaf of##8##2##(1994-8#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-9#1)
leaf or##2##2##(2008-10#1)(2008-9#1)
leaf pathogen##2##2##(2008-10#2)
leaf pathogens##3##2##(2008-10#2)(2010-3#1)
leaf petioles##2##2##(2008-10#2)
leaf phenolics##2##2##(2008-11#2)
leaf position##3##2##(2008-10#3)
leaf production##2##2##(2008-5#1)(2008-8#1)
leaf removal##2##2##(2008-12#2)
leaf rot##2##2##(2008-10#2)
leaf rust (Puccinia##2##3##(2008-10#2)
leaf rust and stripe rust##5##5##(2008-10#5)
leaf rust and##8##3##(2008-10#8)
leaf rust caused by Melampsora medusae##2##6##(2008-10#2)
leaf rust caused by##4##4##(2008-10#4)
leaf rust in##5##3##(2008-10#5)
leaf rust isolates##4##3##(2008-10#4)
leaf rust resistance and##3##4##(2008-10#3)
leaf rust resistance gene Lr34##2##5##(2008-10#2)
leaf rust resistance gene##7##4##(2008-10#7)
leaf rust resistance genes##10##4##(2008-10#10)
leaf rust resistance in##4##4##(2008-10#4)
leaf rust resistance##31##3##(2008-10#31)
leaf rust severity and##2##4##(2008-10#2)
leaf rust severity as##2##4##(2008-10#2)
leaf rust severity##5##3##(2008-10#5)
leaf rust than tan spot##2##5##(2008-10#2)
leaf rust uredospore production##2##4##(2008-10#2)
leaf rust##90##2##(2008-10#90)
leaf rust-susceptible##2##2##(2008-10#2)
leaf samples##13##2##(2008-10#11)(2008-12#2)
leaf scab and##2##3##(2008-10#2)
leaf scald##4##2##(2008-10#4)
leaf scale##3##2##(2008-10#3)
leaf scorch disease##2##3##(2008-10#2)
leaf scorch strains##2##3##(2008-10#2)
leaf scorch##7##2##(2008-10#7)
leaf segments incubated in##2##4##(2008-10#2)
leaf segments##6##2##(2008-10#6)
leaf shape##2##2##(2009-5#2)
leaf sheath##5##2##(2008-10#5)
leaf sheaths##2##2##(2008-10#1)(2013-8#1)
leaf size##4##2##(2008-9#2)(2012-9#2)
leaf soil##2##2##(2008-11#2)
leaf spot (CLS)##2##3##(2008-10#1)(2012-3#1)
leaf spot (GLS)##3##3##(2008-10#3)
leaf spot development##5##3##(2008-10#5)
leaf spot disease##8##3##(2008-10#7)(2010-3#1)
leaf spot epidemics##5##3##(2008-10#5)
leaf spot in##4##3##(2008-10#4)
leaf spot incidence##2##3##(2008-10#2)
leaf spot is##4##3##(2008-10#4)
leaf spot isolates were##4##4##(2008-10#4)
leaf spot isolates##5##3##(2008-10#5)
leaf spot of perennial ryegrass##3##5##(2008-10#3)
leaf spot of##19##3##(2008-10#19)
leaf spot on##7##3##(2008-10#7)
leaf spot pathogen##2##3##(2008-10#2)
leaf spot severity in##2##4##(2008-10#2)
leaf spot severity##5##3##(2008-10#5)
leaf spot suppression##2##3##(2008-10#2)
leaf spot symptoms##2##3##(2008-10#2)
leaf spot virus##8##3##(2008-10#8)
leaf spot was##2##3##(2008-10#2)
leaf spot##122##2##(2008-10#120)(2010-3#1)(2012-3#1)
leaf spot)##2##2##(2008-10#2)
leaf spots##10##2##(2008-10#9)(2010-3#1)
leaf spotting##2##2##(2008-10#2)
leaf stages of##2##3##(2008-12#2)
leaf stages##3##2##(2008-10#1)(2008-12#2)
leaf streak##2##2##(2008-10#2)
leaf surface##12##2##(1994-11#1)(2008-10#11)
leaf surfaces and##3##3##(2008-10#3)
leaf surfaces of##2##3##(2008-10#2)
leaf surfaces##7##2##(2008-10#7)
leaf temperature##3##2##(2008-10#3)
leaf thickness##2##2##(2008-8#1)(2013-7#1)
leaf through##2##2##(2008-10#2)
leaf tip necrosis##3##3##(2008-10#3)
leaf tissue at##2##3##(2008-10#1)(2013-8#1)
leaf tissue by##2##3##(2008-10#2)
leaf tissue of##3##3##(2008-10#3)
leaf tissue##28##2##(2008-10#25)(2008-8#1)(2013-8#2)
leaf tissues and##3##3##(2008-10#3)
leaf tissues was##2##3##(2008-10#2)
leaf tissues##20##2##(2008-10#18)(2008-8#2)
leaf to##2##2##(2008-10#2)
leaf turnover rate##2##3##(2008-5#2)
leaf type##2##2##(2008-12#1)(2013-7#1)
leaf veins##2##2##(2008-10#2)
leaf was##7##2##(2008-10#7)
leaf water##2##2##(2012-7#1)(2012-9#1)
leaf wetness duration and##2##4##(2008-10#2)
leaf wetness duration##15##3##(2008-10#15)
leaf wetness durations##3##3##(2008-10#3)
leaf wetness period##4##3##(2008-10#4)
leaf wetness required##2##3##(2008-10#2)
leaf wetness was##5##3##(2008-10#5)
leaf wetness##49##2##(2008-10#49)
leaf without##2##2##(2008-10#1)(2009-8#1)
leaf##1030##1##(1991-11#1)(1993-2#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-5#1)(2008-10#840)(2008-11#8)(2008-12#30)(2008-5#19)(2008-7#1)(2008-8#21)(2008-9#15)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#2)(2010-3#11)(2010-9#2)(2011-10#2)(2011-2#8)(2012-3#1)(2012-5#7)(2012-6#1)(2012-7#2)(2012-9#8)(2013-1#11)(2013-7#9)(2013-8#6)
leaf-associated##4##1##(2008-10#4)
leaf-cutting ant##3##2##(2008-6#1)(2008-8#2)
leaf-cutting##4##1##(2008-6#2)(2008-8#2)
leaf-to-fruit ratios had##2##3##(2008-10#2)
leafhopper proteins##2##2##(2008-10#2)
leafhopper vector##3##2##(2008-10#3)
leafhopper##21##1##(2006-12#1)(2007-12#1)(2008-10#17)(2011-2#2)
leafhoppers and##2##2##(2008-10#2)
leafhoppers##16##1##(2008-10#16)
leaflet of the mitral valve##2##5##(2007-8#2)
leaflet of the##5##3##(1992-3#1)(1995-2#1)(2007-8#2)(2009-2#1)
leaflet of##6##2##(1992-3#1)(1995-2#1)(2007-8#2)(2008-11#1)(2009-2#1)
leaflet or##2##2##(2008-10#2)
leaflet##42##1##(1992-3#1)(1993-12#1)(1995-2#1)(2007-12#1)(2007-8#8)(2008-10#22)(2008-11#3)(2008-7#1)(2009-2#1)(2010-8#1)(2013-1#2)
leaflets (7##2##2##(2008-10#2)
leaflets and##7##2##(2008-10#6)(2008-11#1)
leaflets in##3##2##(2008-10#2)(2010-5#1)
leaflets##35##1##(1996-1#1)(2007-8#1)(2008-10#27)(2008-11#1)(2009-4#1)(2010-5#3)(2013-1#1)
leafminer##5##1##(2008-10#3)(2011-2#2)
leafminers##2##1##(2011-2#2)
leafroll virus (PLRV)##2##3##(2008-10#2)
leafroll virus##4##2##(2008-10#4)
leafroll##5##1##(2008-10#5)
leafroll-associated##6##1##(2008-10#6)
leafworm##7##1##(2008-12#2)(2008-6#1)(2010-10#2)(2013-8#2)
leafy##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
league table##2##2##(1993-2#1)(2010-12#1)
league tables##3##2##(1993-2#3)
league##5##1##(1993-2#4)(2010-12#1)
leak and##5##2##(2008-7#2)(2008-9#1)(2011-2#2)
leak at##2##2##(1995-11#1)(2008-10#1)
leak following##2##2##(2007-8#1)(2010-5#1)
leak in##5##2##(1993-10#1)(1993-3#1)(2008-1#2)(2008-9#1)
leak into the##2##3##(1996-4#1)(2012-12#1)
leak is##2##2##(2012-12#1)(2013-1#1)
leak or##2##2##(2009-6#1)(2011-2#1)
leak out##2##2##(2007-12#1)(2008-9#1)
leak##54##1##(1991-8#1)(1993-10#1)(1993-3#2)(1995-11#2)(1996-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-8#5)(2008-1#3)(2008-10#5)(2008-12#1)(2008-7#7)(2008-9#3)(2009-6#1)(2010-5#5)(2010-8#1)(2011-2#8)(2012-12#2)(2012-3#2)(2013-1#1)
leak-type##2##1##(1995-11#2)
leakage after##3##2##(2007-8#2)(2012-3#1)
leakage and##6##2##(2008-10#3)(2008-3#2)(2013-1#1)
leakage at##3##2##(1994-3#1)(1995-11#1)(1997-7#1)
leakage current measurement##3##3##(2012-3#3)
leakage current##6##2##(2012-2#1)(2012-3#5)
leakage from##3##2##(1994-5#1)(1997-3#1)(2008-10#1)
leakage in##6##2##(1990-5#1)(1992-3#2)(2007-11#1)(2008-12#1)(2011-2#1)
leakage increased##2##2##(1994-5#1)(2008-12#1)
leakage is##3##2##(1990-11#1)(1992-6#1)(2008-12#1)
leakage of lactate dehydrogenase##3##4##(1994-11#1)(1995-11#1)(2008-10#1)
leakage of the##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
leakage of urine##2##3##(1996-12#1)(2008-10#1)
leakage of##21##2##(1990-2#1)(1990-3#1)(1992-3#2)(1994-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)
leakage than##2##2##(2008-10#2)
leakage to##2##2##(2008-3#1)(2012-3#1)
leakage was##2##2##(1994-5#1)(2008-10#1)
leakage were##2##2##(2007-8#1)(2008-12#1)
leakage##96##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#2)(1992-3#6)(1992-6#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1995-11#2)(1996-12#1)(1996-2#1)(1996-4#3)(1997-3#1)(1997-7#2)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#22)(2008-12#6)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#8)(2013-1#1)
leaked##2##1##(2008-10#1)(2008-6#1)
leakiness##3##1##(1992-11#1)(1994-8#1)(2011-2#1)
leaking##7##1##(1991-5#1)(1993-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#2)
leaks and##4##2##(1994-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
leaks as##2##2##(2008-2#2)
leaks in##2##2##(2007-8#1)(2008-3#1)
leaks##23##1##(1994-6#2)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-3#2)
leaky waveguide##2##2##(2008-10#2)
leaky##8##1##(1990-5#2)(1993-9#1)(1997-4#1)(2007-12#1)(2008-10#3)
lean Zucker rats##3##3##(1994-11#1)(1995-5#2)
lean and##5##2##(1997-7#1)(2007-12#1)(2008-3#3)
lean body mass and water content##2##6##(2008-7#2)
lean body mass##8##3##(1995-3#1)(1997-8#1)(2008-3#1)(2008-5#2)(2008-7#2)(2012-2#1)
lean body mass)##2##3##(2008-3#1)(2012-2#1)
lean body##11##2##(1995-3#1)(1997-8#1)(2008-3#2)(2008-5#2)(2008-7#3)(2012-2#2)
lean direct-injection spray flame##2##4##(2008-2#2)
lean mass##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
lean muscle##3##2##(2010-4#1)(2013-1#2)
lean rats##6##2##(1995-5#3)(1996-12#3)
lean subjects##2##2##(2008-3#2)
lean##59##1##(1994-11#1)(1995-3#1)(1995-5#6)(1996-12#7)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#3)(2008-7#6)(2008-9#1)(2010-4#2)(2011-2#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#3)
leaner##2##1##(1997-1#1)(2007-12#1)
leap##4##1##(1996-1#1)(2010-4#3)
leaping detector##2##2##(2008-10#2)
learn about the##2##3##(2008-10#1)(2008-11#1)
learn about##16##2##(1994-1#1)(1994-2#2)(1996-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#4)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
learn and##9##2##(1994-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)
learn anything from##2##3##(1992-5#1)(1993-12#1)
learn better##2##2##(1992-3#1)(2013-8#1)
learn from each other##2##4##(1997-3#1)(2008-11#1)
learn from experience##2##3##(1991-1#1)(2008-4#1)
learn from industry##2##3##(1991-3#1)(1991-6#1)
learn from the##3##3##(1993-6#1)(1995-3#1)(2008-7#1)
learn from##21##2##(1991-1#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
learn how to##7##3##(1991-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-9#2)(2009-6#1)
learn how##9##2##(1991-1#1)(1991-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-9#2)(2009-6#1)(2012-2#1)
learn in##2##2##(2008-11#1)(2009-3#1)
learn lessons from##2##3##(1993-8#1)(2011-2#1)
learn more about the pathophysiology of##2##6##(2008-7#1)(2010-11#1)
learn more about the##5##4##(1993-11#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)
learn more about##8##3##(1993-11#1)(1993-2#1)(1995-2#1)(1997-3#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)
learn more##12##2##(1993-11#1)(1993-2#1)(1995-2#1)(1997-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-1#2)(2013-8#1)
learn new skills##2##3##(1993-12#1)(2007-8#1)
learn new##5##2##(1993-12#1)(1995-1#1)(1996-3#1)(2007-8#1)(2010-4#1)
learn that##5##2##(1992-12#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-3#1)
learn the##13##2##(1993-3#1)(1993-5#1)(1994-12#1)(1996-5#1)(1997-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-6#1)(2013-1#3)
learn to discriminate##3##3##(2008-8#1)(2010-2#2)
learn to share##2##3##(1992-1#1)(1994-1#1)
learn to##21##2##(1990-11#1)(1991-2#1)(1992-1#1)(1993-12#1)(1994-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-2#2)(2012-2#1)(2013-8#1)
learn##151##1##(1990-11#1)(1990-6#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#4)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#15)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#5)
learned a##4##2##(1991-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
learned about the##3##3##(1993-12#1)(2008-4#1)(2012-2#1)
learned about##17##2##(1993-12#1)(1993-3#1)(1995-1#1)(1995-6#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
learned and##4##2##(1994-2#1)(1995-12#1)(2009-10#1)(2013-8#1)
learned by##6##2##(1993-12#1)(1994-1#1)(1995-2#1)(2008-12#2)(2012-3#1)
learned during the##2##3##(1993-12#1)(2008-12#1)
learned during##5##2##(1993-12#1)(1995-3#1)(2008-1#1)(2008-12#1)(2010-7#1)
learned from a##4##3##(2008-8#1)(2010-8#1)(2012-3#2)
learned from the##8##3##(1991-11#1)(1992-2#1)(1997-2#1)(2006-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
learned from this process##2##4##(1993-12#1)(2012-2#1)
learned from this##7##3##(1993-12#1)(1994-3#2)(2008-11#1)(2009-8#1)(2012-2#2)
learned from##34##2##(1991-11#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-3#2)(1997-2#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
learned helplessness##2##2##(1996-7#2)
learned in the##2##3##(2008-2#1)(2010-12#1)
learned in##8##2##(1991-2#1)(1993-11#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)
learned so##2##2##(1993-1#1)(2007-2#1)
learned that##3##2##(1991-12#1)(1997-3#1)(2009-8#1)
learned the task at an older juvenile age##2##8##(1994-8#2)
learned the task at##3##4##(1994-8#3)
learned the##5##2##(1992-8#1)(1994-8#3)(2008-3#1)
learned to##11##2##(1991-12#1)(1993-5#1)(1993-6#1)(1995-3#1)(1996-1#2)(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#2)
learned##159##1##(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-5#2)(1993-6#2)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#5)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#1)(2013-8#2)
learned&quot##2##1##(2011-2#2)
learned?##2##1##(2008-10#2)
learner to##2##2##(2008-11#1)(2008-12#1)
learner##4##1##(1994-2#1)(2007-5#1)(2008-11#1)(2008-12#1)
learner-centered##3##1##(1992-12#2)(2008-5#1)
learners and##4##2##(1994-12#1)(2008-12#1)(2010-2#1)(2013-1#1)
learners in##5##2##(2008-11#3)(2011-2#1)(2012-1#1)
learners to##3##2##(2008-12#2)(2013-8#1)
learners##24##1##(1994-12#1)(2008-11#6)(2008-12#6)(2008-6#1)(2009-2#1)(2010-2#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
learning (EBL)##2##2##(2008-12#2)
learning (PBL)##7##2##(2008-10#1)(2008-11#1)(2008-12#3)(2011-1#1)(2013-8#1)
learning a##3##2##(1992-11#1)(2012-12#2)
learning abilities##3##2##(1994-8#2)(2009-2#1)
learning ability of##2##3##(1990-5#1)(1994-3#1)
learning ability##6##2##(1990-5#1)(1991-2#1)(1994-3#1)(1995-8#3)
learning about the##3##3##(1994-2#1)(2007-11#1)(2010-10#1)
learning about##8##2##(1994-2#1)(2007-11#1)(2008-11#2)(2009-9#1)(2010-10#1)(2012-1#1)(2012-12#1)
learning activities##7##2##(1992-1#1)(1994-12#1)(2008-11#2)(2008-12#2)(2010-8#1)
learning algorithm##6##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
learning algorithms##3##2##(2008-7#3)
learning among##2##2##(1995-1#1)(2008-11#1)
learning and assessment##2##3##(2008-11#1)(2008-7#1)
learning and competence##2##3##(2008-11#2)
learning and developing##2##3##(1995-12#1)(2008-11#1)
learning and development at work##2##5##(2011-1#2)
learning and development goals##3##4##(2011-1#3)
learning and development##6##3##(2011-1#6)
learning and memory ability##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
learning and memory and##2##4##(1993-12#1)(2011-2#1)
learning and memory are##2##4##(2008-5#1)(2012-2#1)
learning and memory deficits##2##4##(2008-10#1)(2012-2#1)
learning and memory has##2##4##(1996-5#1)(2009-8#1)
learning and memory have##2##4##(2007-8#1)(2009-8#1)
learning and memory in the##2##5##(1993-3#1)(1997-6#1)
learning and memory in##9##4##(1993-3#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-8#4)(2011-2#1)
learning and memory processes##2##4##(1992-11#2)
learning and memory##52##3##(1992-11#2)(1993-12#2)(1993-3#2)(1994-8#1)(1996-5#3)(1997-6#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#6)(2011-2#3)(2012-2#9)(2013-8#1)
learning and recognition##2##3##(2008-2#1)(2008-3#1)
learning and teaching strategy##2##4##(2008-11#2)
learning and teaching##3##3##(2008-11#3)
learning and the##2##3##(2008-11#2)
learning and to##2##3##(2011-1#1)(2013-8#1)
learning and##119##2##(1991-7#1)(1992-1#1)(1992-11#2)(1993-12#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1996-5#3)(1997-2#1)(1997-6#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#20)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#7)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#7)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#12)(2012-3#4)(2013-8#2)
learning approach to##4##3##(2008-11#2)(2008-12#1)(2013-1#1)
learning approach##8##2##(2008-11#3)(2008-12#2)(2010-12#1)(2011-1#1)(2013-1#1)
learning approaches are##2##3##(2008-12#1)(2012-3#1)
learning approaches##8##2##(2008-11#4)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
learning are##4##2##(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)
learning as##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
learning at##4##2##(1993-12#1)(2007-8#1)(2008-11#1)(2008-12#1)
learning by##8##2##(1993-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-12#1)(2012-2#1)
learning can be##4##3##(1997-2#1)(2008-11#2)(2012-2#1)
learning can##5##2##(1997-2#1)(2008-11#2)(2012-1#1)(2012-2#1)
learning classifier##2##2##(2010-7#2)
learning community##3##2##(2008-11#1)(2008-12#2)
learning contract##4##2##(1992-1#1)(2008-11#3)
learning contracts as##2##3##(2008-11#2)
learning contracts##7##2##(2008-11#7)
learning curve and##2##3##(2007-8#1)(2008-9#1)
learning curve for##3##3##(1995-11#1)(2008-11#1)(2011-2#1)
learning curve of##2##3##(2009-4#1)(2011-2#1)
learning curve##12##2##(1995-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2011-2#3)(2012-2#1)
learning deficit##6##2##(1991-7#2)(1993-12#4)
learning deficits on this task##2##5##(1993-3#2)
learning deficits##7##2##(1993-12#1)(1993-3#4)(2012-2#1)(2013-1#1)
learning difficulties##8##2##(1997-3#1)(2008-11#6)(2011-1#1)
learning disabilities##12##2##(1995-1#1)(2008-11#2)(2008-12#2)(2011-1#6)(2012-3#1)
learning disability##5##2##(2008-11#5)
learning disturbance at 7 months##2##5##(1995-8#2)
learning during a##2##3##(2008-11#2)
learning during the##2##3##(1993-3#1)(2008-11#1)
learning during##7##2##(1993-3#1)(2008-11#5)(2011-1#1)
learning environment for##2##3##(2008-11#1)(2013-8#1)
learning environment to##2##3##(2008-12#2)
learning environment##19##2##(2007-10#1)(2008-11#4)(2008-12#9)(2009-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
learning environments##6##2##(2008-11#4)(2010-2#1)(2012-3#1)
learning experience in##2##3##(2008-11#1)(2013-1#1)
learning experience##9##2##(1992-8#1)(2008-11#3)(2008-12#3)(2013-1#2)
learning experiences##10##2##(1994-2#1)(2008-1#1)(2008-11#6)(2008-12#1)(2013-1#1)
learning following##2##2##(1996-5#1)(2008-12#1)
learning for students##2##3##(2008-11#2)
learning for##9##2##(1995-2#1)(2008-11#5)(2008-12#1)(2012-2#1)(2013-1#1)
learning framework##2##2##(2008-12#1)(2012-12#1)
learning from the##3##3##(2008-12#1)(2011-1#1)(2012-3#1)
learning from##11##2##(1992-12#1)(1992-2#1)(2006-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
learning groups##3##2##(2008-11#3)
learning has##3##2##(2008-11#2)(2008-4#1)
learning how to##2##3##(1992-1#1)(2009-12#1)
learning in a##10##3##(1993-3#1)(1996-5#1)(2008-11#4)(2008-12#2)(2009-10#1)(2011-1#1)
learning in health##3##3##(1994-1#1)(1996-1#1)(2008-11#1)
learning in nurse education##3##4##(2008-11#2)(2008-12#1)
learning in practice settings##2##4##(2008-11#2)
learning in practice##9##3##(2008-11#8)(2008-12#1)
learning in rats##2##3##(1992-10#1)(2008-9#1)
learning in the clinical##3##4##(2008-11#1)(2009-12#1)(2013-1#1)
learning in the water maze##2##5##(2008-9#2)
learning in the workplace##2##4##(2008-11#2)
learning in the##15##3##(1993-12#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-12#1)(2012-2#1)(2013-1#2)
learning in this##2##3##(2008-11#1)(2008-12#1)
learning in##68##2##(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-5#2)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1996-1#1)(1996-5#2)(2007-7#1)(2008-11#25)(2008-12#7)(2008-3#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#4)
learning into##2##2##(2008-11#1)(2008-12#1)
learning is a##2##3##(2010-10#1)(2011-2#1)
learning is##17##2##(1994-1#1)(1995-2#2)(2008-11#8)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
learning items##2##2##(2008-11#2)
learning materials##5##2##(1993-12#1)(2008-11#2)(2008-12#2)
learning may##2##2##(1993-12#1)(1994-12#1)
learning mechanisms##2##2##(2012-3#2)
learning method in the self-organizing neural network##2##7##(2008-3#2)
learning method##8##2##(2008-11#3)(2008-12#1)(2008-3#3)(2012-1#1)
learning methods##7##2##(2008-10#2)(2008-12#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
learning model##6##2##(1994-2#1)(1997-2#1)(2008-11#3)(2013-8#1)
learning more##2##2##(2008-11#1)(2008-5#1)
learning needs##6##2##(1992-12#1)(2008-11#1)(2008-12#1)(2010-2#1)(2012-3#2)
learning new##3##2##(1994-2#2)(2008-9#1)
learning objectives##2##2##(1994-9#1)(2007-12#1)
learning occurred##3##2##(2009-8#1)(2010-5#2)
learning of a##2##3##(2008-11#2)
learning of large networks##2##4##(2010-10#2)
learning of the##2##3##(1994-3#1)(2010-6#1)
learning of##26##2##(1992-11#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-3#1)(2007-12#1)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#2)(2010-6#1)(2011-1#1)(2012-12#1)
learning on##3##2##(2008-11#2)(2009-5#1)
learning operation is##2##3##(2008-3#2)
learning operation##4##2##(2008-3#4)
learning opportunities and##2##3##(2008-11#1)(2010-3#1)
learning opportunities##8##2##(1997-3#1)(2008-11#4)(2008-12#1)(2010-3#1)(2013-8#1)
learning or##6##2##(1992-12#1)(1993-12#3)(1996-2#1)(2013-8#1)
learning organization##2##2##(1992-3#1)(1995-1#1)
learning outcome##5##2##(2011-2#5)
learning outcomes from##2##3##(2007-10#1)(2011-2#1)
learning outcomes that##2##3##(2008-11#2)
learning outcomes##18##2##(2007-10#1)(2008-11#7)(2008-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
learning paradigm##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
learning paradigms##3##2##(2008-7#2)(2012-12#1)
learning performance##3##2##(2008-7#1)(2008-8#2)
learning principles##3##2##(1992-1#1)(1995-3#1)(2008-12#1)
learning problem##2##2##(2010-7#2)
learning problems##2##2##(1997-3#1)(2008-2#1)
learning process##8##2##(1997-6#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2013-1#1)
learning rate eta##2##3##(2008-10#2)
learning rate##5##2##(2008-10#5)
learning resource##2##2##(2008-11#2)
learning resources use by nursing students##2##6##(2008-11#2)
learning resources##12##2##(1996-2#1)(2008-11#9)(2008-12#1)(2010-2#1)
learning rule##6##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
learning session##2##2##(1994-8#2)
learning skills##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
learning strategies that##2##3##(2008-11#1)(2008-12#1)
learning strategies##7##2##(2008-11#3)(2008-12#2)(2010-5#1)(2012-3#1)
learning strategy##6##2##(2008-11#5)(2008-12#1)
learning style##3##2##(1995-3#1)(2012-2#1)(2013-8#1)
learning styles of##2##3##(2013-8#2)
learning styles##6##2##(2008-11#1)(2013-8#5)
learning system##3##2##(2008-7#1)(2009-5#1)(2010-12#1)
learning task in the##2##4##(1993-3#1)(2008-7#1)
learning task in##3##3##(1993-3#1)(1993-5#1)(2008-7#1)
learning task##6##2##(1992-8#1)(1993-3#1)(1993-5#2)(2008-7#1)(2009-5#1)
learning tasks##2##2##(2008-5#1)(2013-8#1)
learning teams##2##2##(2008-11#2)
learning technology##4##2##(2008-11#1)(2008-12#2)(2012-12#1)
learning that##6##2##(1995-12#1)(1996-1#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#1)
learning the##5##2##(1994-8#1)(1995-8#1)(2008-11#2)(2008-9#1)
learning theories##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
learning theory##3##2##(2008-12#1)(2008-4#1)(2013-8#1)
learning through##3##2##(1995-2#1)(2008-11#1)(2012-1#1)
learning to##13##2##(1991-9#1)(1993-2#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
learning together##2##2##(2008-11#1)(2013-1#1)
learning tool##4##2##(2008-11#2)(2008-12#2)
learning using##4##2##(1994-3#1)(2008-11#3)
learning was associated##2##3##(2013-1#2)
learning was##5##2##(1992-11#1)(2010-5#1)(2011-1#1)(2013-1#2)
learning were##3##2##(1995-2#1)(2008-11#1)(2012-1#1)
learning with##3##2##(2008-11#2)(2012-3#1)
learning within##2##2##(1993-1#1)(2008-12#1)
learning##1011##1##(1990-5#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#5)(1991-8#1)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#6)(1992-12#6)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#3)(1993-1#1)(1993-12#29)(1993-2#1)(1993-3#11)(1993-5#4)(1993-6#4)(1994-1#5)(1994-12#5)(1994-2#8)(1994-3#7)(1994-6#1)(1994-8#8)(1994-9#1)(1995-1#7)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#2)(1995-8#7)(1996-1#3)(1996-12#1)(1996-2#8)(1996-3#2)(1996-5#11)(1997-2#3)(1997-3#3)(1997-6#4)(1997-7#2)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#12)(2008-1#3)(2008-10#28)(2008-11#287)(2008-12#99)(2008-2#8)(2008-3#14)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#25)(2008-8#12)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#1)(2009-8#16)(2009-9#8)(2010-1#1)(2010-10#8)(2010-12#4)(2010-2#5)(2010-3#5)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#6)(2010-8#2)(2011-1#31)(2011-2#24)(2012-1#13)(2012-12#17)(2012-2#30)(2012-3#23)(2013-1#25)(2013-7#2)(2013-8#30)
learning&quot##2##1##(1992-12#1)(2008-5#1)
learning)##4##1##(1993-3#1)(2008-12#1)(2008-7#1)(2009-9#1)
learning-based##4##1##(2008-8#3)(2010-12#1)
learning/memory##2##1##(1993-3#1)(2008-8#1)
learning?##2##1##(1991-12#1)(2008-8#1)
learns##5##1##(2007-2#1)(2008-12#1)(2008-4#1)(2010-10#1)(2012-12#1)
learnt from the##4##3##(2007-7#1)(2009-2#1)(2010-5#1)(2012-12#1)
learnt##12##1##(1992-11#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
leasing##4##1##(1992-12#1)(1993-2#2)(1995-3#1)
least 1##21##2##(1990-6#1)(1991-8#1)(1994-12#1)(1995-2#2)(2007-10#2)(2007-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
least 12##5##2##(1995-2#1)(2008-1#1)(2008-10#3)
least 120##2##2##(2008-10#2)
least 13 distinct##2##3##(1997-4#1)(2008-10#1)
least 15##7##2##(1990-12#1)(1994-3#1)(1994-7#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-5#1)
least 2##20##2##(1992-8#1)(1996-12#1)(2006-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#1)
least 20##8##2##(1991-12#1)(1992-3#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-2#1)
least 3##27##2##(1995-11#1)(2007-10#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
least 30##6##2##(1991-6#1)(1995-2#1)(2008-2#1)(2008-3#1)(2011-2#2)
least 5##15##2##(1990-5#1)(1991-12#1)(1991-7#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
least 6 months after##2##4##(1995-2#1)(2008-4#1)
least 6 months##12##3##(1990-12#1)(1991-2#1)(1991-8#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-5#2)
least 6##18##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#2)
least 90%##3##2##(1991-6#1)(2008-10#1)(2008-9#1)
least absolute shrinkage and selection operator (LASSO)##2##7##(2012-3#2)
least affected by##2##3##(2008-10#2)
least affected##3##2##(2008-10#3)
least amount of##9##3##(2007-11#1)(2008-10#7)(2008-7#1)
least amount##10##2##(2007-11#1)(2008-10#7)(2008-7#2)
least and the##2##3##(2008-12#2)
least as##23##2##(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
least at##8##2##(1991-3#2)(1994-3#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
least common##2##2##(2007-8#1)(2009-5#1)
least cost##2##2##(1994-12#1)(1995-12#1)
least eight##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
least favorable##2##2##(2008-10#1)(2008-5#1)
least five##11##2##(1993-6#1)(2008-10#5)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
least for##19##2##(1995-4#1)(1996-3#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
least four##19##2##(1990-11#1)(1992-4#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#2)(1997-7#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
least frequent##2##2##(2008-10#1)(2011-2#1)
least in the##11##3##(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#3)
least in##92##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-2#3)(1994-6#3)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#4)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#1)(2010-4#1)(2011-2#6)(2012-2#5)(2013-1#2)
least likely to##2##3##(1992-2#1)(2008-10#1)
least median squares (LMS)##2##4##(2008-10#2)
least not##2##2##(1993-6#1)(2010-9#1)
least of##4##2##(1991-3#1)(2008-5#1)(2009-12#1)(2011-1#1)
least on##2##2##(2008-10#1)(2010-4#1)
least once per##2##3##(2008-10#1)(2008-7#1)
least once##10##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
least one in##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
least one of##15##3##(1993-2#1)(1994-11#1)(1994-6#1)(2007-10#1)(2008-10#1)(2008-3#2)(2009-2#1)(2010-11#2)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
least one test##2##3##(2008-11#1)(2011-1#1)
least one##145##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#7)(2012-2#1)(2012-3#7)(2013-1#11)(2013-8#3)
least partially##15##2##(1991-4#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2012-2#1)
least prevalent##2##2##(2008-10#1)(2011-2#1)
least satisfied##4##2##(1993-3#1)(1993-6#1)(2008-10#1)(2009-11#1)
least sensitive##2##2##(2008-10#1)(2008-3#1)
least seven##7##2##(1990-12#1)(1992-5#1)(1996-10#1)(2008-10#1)(2008-12#1)(2010-2#1)(2013-1#1)
least six##9##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2013-8#1)
least some of the##7##4##(1990-12#1)(1990-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
least some of##14##3##(1990-11#1)(1990-12#1)(1990-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
least some##34##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1996-9#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
least square (PLS)##4##3##(2008-10#4)
least square analysis##2##3##(2008-10#1)(2008-8#1)
least square##18##2##(2008-10#13)(2008-8#2)(2013-1#1)(2013-8#2)
least squares (PLS)##32##3##(2008-10#30)(2009-10#1)(2013-8#1)
least squares analysis##2##3##(1997-2#1)(2008-7#1)
least squares estimate method##2##4##(2008-6#2)
least squares method##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
least squares modeling##4##3##(2008-10#4)
least squares regression analysis##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
least squares regression and##3##4##(2008-10#3)
least squares regression to##2##4##(2008-10#2)
least squares regression was used##2##5##(2008-10#2)
least squares regression##25##3##(1993-12#1)(2008-10#21)(2008-11#2)(2011-2#1)
least squares##137##2##(1992-6#3)(1993-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#108)(2008-11#3)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
least stable##2##2##(1991-8#1)(2008-2#1)
least susceptible##2##2##(2008-10#1)(2010-5#1)
least the##13##2##(1990-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)
least three distinct##5##3##(1992-8#1)(1994-5#1)(2008-10#1)(2008-5#1)(2009-8#1)
least three of these##2##4##(1993-6#1)(2011-2#1)
least three##56##2##(1990-7#1)(1990-8#2)(1991-2#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#3)(1996-3#1)(1997-3#1)(1997-4#3)(2007-12#3)(2007-5#1)(2008-10#13)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-3#1)
least two classes##2##3##(1995-11#1)(1995-8#1)
least two distinct##4##3##(1990-8#1)(2008-10#1)(2010-10#1)(2012-2#1)
least two of the##2##4##(2008-10#1)(2012-3#1)
least two of##4##3##(1997-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
least two other##3##3##(1996-5#1)(2008-10#1)(2009-9#1)
least two##97##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-8#1)(1992-10#2)(1992-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)
least up to##3##3##(2008-10#2)(2011-1#1)
least##1342##1##(1990-11#7)(1990-12#10)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#4)(1990-8#10)(1990-9#3)(1991-11#2)(1991-12#5)(1991-2#6)(1991-3#5)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#8)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#6)(1992-8#5)(1993-1#3)(1993-11#4)(1993-12#10)(1993-2#6)(1993-3#7)(1993-5#1)(1993-6#8)(1993-8#12)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#6)(1994-2#10)(1994-3#4)(1994-5#1)(1994-6#10)(1994-7#1)(1994-8#5)(1994-9#4)(1995-11#6)(1995-12#10)(1995-2#17)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#8)(1995-8#6)(1995-9#1)(1996-1#4)(1996-10#3)(1996-12#9)(1996-2#2)(1996-3#5)(1996-5#4)(1996-6#4)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#11)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#5)(2006-10#2)(2006-6#1)(2007-10#8)(2007-11#12)(2007-12#13)(2007-2#4)(2007-5#1)(2007-6#5)(2007-7#6)(2007-8#4)(2008-1#15)(2008-10#368)(2008-11#48)(2008-12#15)(2008-2#12)(2008-3#33)(2008-4#14)(2008-5#35)(2008-6#22)(2008-7#39)(2008-8#30)(2008-9#28)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#3)(2010-11#6)(2010-12#3)(2010-2#6)(2010-3#7)(2010-4#5)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#12)(2011-2#43)(2012-1#2)(2012-12#19)(2012-2#19)(2012-3#17)(2012-4#1)(2012-5#1)(2013-1#35)(2013-7#3)(2013-8#12)
least)##2##1##(2008-10#2)
least-square##2##1##(2008-10#2)
least-squares (PLS) regression##2##3##(2007-12#1)(2008-10#1)
least-squares (PLS)##10##2##(2007-11#1)(2007-12#1)(2008-10#8)
least-squares algorithm##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
least-squares analysis of##2##3##(1990-8#1)(2008-3#1)
least-squares analysis##3##2##(1990-8#2)(2008-3#1)
least-squares and principal component regression##2##5##(2008-10#2)
least-squares and##3##2##(2008-10#3)
least-squares fit of##2##3##(2008-2#1)(2008-3#1)
least-squares fit##10##2##(2007-12#1)(2008-2#2)(2008-3#7)
least-squares fits##3##2##(2008-2#1)(2008-3#2)
least-squares fitting of the##2##4##(2008-2#2)
least-squares fitting of##4##3##(2008-2#3)(2008-3#1)
least-squares fitting##7##2##(2007-11#1)(2008-2#3)(2008-3#3)
least-squares method are##2##3##(2008-3#1)(2012-1#1)
least-squares method is##2##3##(2008-2#1)(2012-1#1)
least-squares method##16##2##(2008-10#4)(2008-2#3)(2008-3#6)(2012-1#3)
least-squares minimization##2##2##(1992-4#1)(2008-2#1)
least-squares regression (PLS)##2##3##(2008-10#2)
least-squares regression##12##2##(2008-10#12)
least-squares solution##3##2##(2008-2#1)(2008-3#2)
least-squares technique##3##2##(2008-3#3)
least-squares##109##1##(1990-8#3)(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-10#49)(2008-2#13)(2008-3#29)(2008-6#1)(2012-1#3)(2013-1#1)
leather and##2##2##(2008-10#1)(2012-2#1)
leather tanneries##3##2##(2009-12#3)
leather##13##1##(2008-10#9)(2009-12#3)(2012-2#1)
leatherback nests were##2##3##(2007-5#2)
leatherback##4##1##(2007-5#4)
leave a##6##2##(1990-3#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)
leave it in##2##3##(1993-6#2)
leave more##2##2##(1990-3#1)(2013-8#1)
leave the hospital##2##3##(1992-3#1)(2011-2#1)
leave the##16##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(2008-8#2)(2008-9#2)(2010-3#2)(2011-2#2)(2012-3#1)
leave their##4##2##(1996-3#1)(2008-9#3)
leave##58##1##(1990-3#2)(1991-2#1)(1991-3#1)(1991-8#4)(1992-12#1)(1992-3#2)(1992-4#1)(1993-5#1)(1993-6#2)(1994-5#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-10#1)(2009-9#1)(2010-3#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
leave-on##7##1##(2008-5#7)
leave-one-out method##2##2##(2011-3#1)(2012-3#1)
leave-one-out##5##1##(2007-11#1)(2008-10#1)(2010-8#1)(2011-3#1)(2012-3#1)
leaves (NIST##2##2##(2008-10#2)
leaves (cv##2##2##(2008-10#2)
leaves (leaf##2##2##(2008-10#2)
leaves GBW##2##2##(2008-10#2)
leaves NIST##2##2##(2008-10#2)
leaves after##6##2##(2008-10#3)(2008-12#1)(2008-9#1)(2013-8#1)
leaves against##4##2##(2008-10#3)(2013-1#1)
leaves also##2##2##(2008-10#2)
leaves and berries##3##3##(2008-10#3)
leaves and coverslips were sprayed with##2##6##(2008-10#2)
leaves and coverslips##4##3##(2008-10#4)
leaves and flowers##2##3##(2008-10#1)(2008-5#1)
leaves and fruit##6##3##(2008-10#6)
leaves and fruits##4##3##(2008-12#4)
leaves and reduced##2##3##(2008-10#1)(2013-1#1)
leaves and roots of##2##4##(2008-10#1)(2008-12#1)
leaves and roots##9##3##(2008-10#5)(2008-12#2)(2009-10#1)(2009-8#1)
leaves and seed##2##3##(2008-10#2)
leaves and stems of##2##4##(2008-10#1)(2008-11#1)
leaves and stems##11##3##(2008-10#9)(2008-11#2)
leaves and subsequent##2##3##(2008-10#2)
leaves and the##5##3##(2008-10#3)(2008-12#1)(2008-9#1)
leaves and was##2##3##(2008-10#2)
leaves and##99##2##(2008-10#65)(2008-11#4)(2008-12#11)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-3#1)(2011-10#1)(2013-1#1)(2013-7#1)(2013-8#1)
leaves appeared to##2##3##(2008-10#2)
leaves appeared##3##2##(2008-10#3)
leaves aqueous extract##2##3##(2008-12#2)
leaves are not##2##3##(2008-10#2)
leaves are##4##2##(2008-10#2)(2011-1#1)(2013-7#1)
leaves as##3##2##(2008-10#2)(2008-8#1)
leaves at##16##2##(2008-10#10)(2008-12#3)(2008-5#1)(2008-8#1)(2013-8#1)
leaves but also##2##3##(2008-10#2)
leaves but not##2##3##(2008-10#2)
leaves but##4##2##(2008-10#4)
leaves by means of##2##4##(2008-10#2)
leaves by##12##2##(1994-11#1)(2008-10#11)
leaves caused##2##2##(2008-10#2)
leaves collected##2##2##(2008-10#2)
leaves colonized by##2##3##(2008-10#2)
leaves compared with##4##3##(2008-10#4)
leaves contain##3##2##(2007-1#1)(2008-10#1)(2008-9#1)
leaves demonstrated##2##2##(2008-10#1)(2010-3#1)
leaves extract##2##2##(2008-12#1)(2013-7#1)
leaves extracts were##2##3##(2008-12#2)
leaves extracts##6##2##(2008-12#6)
leaves following##2##2##(2008-10#2)
leaves for the##2##3##(2008-10#2)
leaves for##6##2##(2008-10#6)
leaves from healthy##2##3##(2008-10#2)
leaves from##11##2##(2008-10#10)(2008-8#1)
leaves in the presence of##2##5##(2008-10#2)
leaves in the##5##3##(2008-10#4)(2013-7#1)
leaves in##17##2##(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#2)(2013-7#1)
leaves increased##3##2##(2008-10#3)
leaves incubated##2##2##(2008-10#2)
leaves induced necrosis##2##3##(2008-10#2)
leaves infected with##4##3##(2008-10#4)
leaves infected##5##2##(2008-10#5)
leaves inoculated with##3##3##(2008-10#3)
leaves is##2##2##(2008-10#1)(2010-3#1)
leaves little##2##2##(2008-4#1)(2009-8#1)
leaves may be##2##3##(2008-10#2)
leaves may##3##2##(2008-10#3)
leaves of Chimonanthus##2##3##(2012-3#2)
leaves of Morus alba##4##4##(2011-3#4)
leaves of a##2##3##(2008-10#2)
leaves of the##8##3##(1992-2#1)(1995-2#1)(2008-10#4)(2008-6#1)(2013-8#1)
leaves of##91##2##(1990-11#2)(1991-12#1)(1992-2#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#46)(2008-11#2)(2008-12#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#2)(2010-3#2)(2011-1#2)(2011-2#1)(2011-3#4)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#1)
leaves on the##2##3##(2008-10#2)
leaves on##8##2##(2008-10#6)(2008-12#1)(2008-5#1)
leaves or young##2##3##(2008-10#2)
leaves or##13##2##(2008-10#11)(2009-8#1)(2011-10#1)
leaves per##3##2##(2008-10#2)(2008-12#1)
leaves pretreated with ASM##2##4##(2008-10#2)
leaves showed##5##2##(2008-10#3)(2010-3#1)(2013-7#1)
leaves showing##6##2##(2008-10#6)
leaves than##4##2##(2008-10#3)(2012-9#1)
leaves that were##2##3##(2008-10#2)
leaves that##7##2##(1991-1#1)(1992-3#1)(2008-10#4)(2008-12#1)
leaves the##6##2##(1996-2#1)(1997-3#1)(2007-12#1)(2008-3#1)(2010-3#2)
leaves to##7##2##(1997-4#1)(2008-10#4)(2013-7#1)(2013-8#1)
leaves treated with##5##3##(2008-10#4)(2008-12#1)
leaves under##5##2##(2008-10#3)(2008-8#1)(2013-8#1)
leaves using##3##2##(2008-10#3)
leaves was significantly##5##3##(2008-10#5)
leaves was studied##2##3##(2008-10#2)
leaves was##22##2##(2007-1#1)(2008-10#18)(2008-9#1)(2009-6#1)(2013-8#1)
leaves were added to##2##4##(2008-10#2)
leaves were first##2##3##(2008-10#2)
leaves were ground and##2##4##(2008-10#1)(2013-7#1)
leaves were significantly##2##3##(2008-10#1)(2012-9#1)
leaves were used##2##3##(2011-2#1)(2013-8#1)
leaves were##31##2##(2008-10#23)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-7#1)(2013-8#1)
leaves when##3##2##(2008-10#3)
leaves which##2##2##(2008-10#2)
leaves with a##2##3##(2008-10#2)
leaves with##13##2##(2008-10#12)(2011-1#1)
leaves within##2##2##(2008-10#2)
leaves##802##1##(1990-11#3)(1990-5#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#2)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#578)(2008-11#9)(2008-12#40)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#18)(2008-6#5)(2008-7#3)(2008-8#14)(2008-9#14)(2009-10#1)(2009-6#2)(2009-8#3)(2010-2#2)(2010-3#9)(2011-1#4)(2011-10#6)(2011-2#5)(2011-3#4)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#4)(2012-7#1)(2012-9#3)(2013-1#6)(2013-7#16)(2013-8#9)
leaves) and##2##2##(2008-10#2)
leaves)##10##1##(2008-10#9)(2008-5#1)
leaving a##6##2##(1992-11#1)(1995-12#1)(2008-5#1)(2010-8#1)(2011-2#2)
leaving behind##4##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
leaving group at C-4 of the##2##6##(1993-8#2)
leaving group at##4##3##(1992-6#1)(1993-8#2)(1995-5#1)
leaving group##13##2##(1992-6#2)(1993-8#8)(1995-5#1)(2008-11#1)(2009-9#1)
leaving open the##2##3##(2008-4#1)(2012-3#1)
leaving the##25##2##(1990-11#1)(1991-5#1)(1993-1#1)(1994-12#1)(1995-9#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
leaving them##2##2##(1997-2#1)(2008-2#1)
leaving##82##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-6#2)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#8)(1994-12#2)(1994-5#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-2#3)(2012-3#2)(2013-1#1)
lecanii and##3##2##(2008-10#3)
lecanii strains##2##2##(2008-5#2)
lecanii##12##1##(2008-10#9)(2008-5#3)
lecithin cholesterol##2##2##(1993-6#1)(2013-1#1)
lecithin##16##1##(1990-3#1)(1991-12#1)(1992-3#1)(1993-6#1)(1993-8#2)(1995-5#1)(2008-10#4)(2008-11#2)(2008-5#2)(2013-1#1)
lectin (BRA-3)##2##2##(1993-6#2)
lectin (MBL)##2##2##(2008-4#1)(2012-3#1)
lectin 2##3##2##(2013-1#3)
lectin and##7##2##(1993-8#4)(2008-10#2)(2008-4#1)
lectin column##2##2##(1990-11#1)(1993-11#1)
lectin concentration##2##2##(1993-8#1)(2010-10#1)
lectin for##2##2##(1990-7#1)(2010-10#1)
lectin from##3##2##(2008-10#2)(2010-10#1)
lectin is##2##2##(1994-8#1)(2013-1#1)
lectin jacalin##2##2##(1994-12#2)
lectin of##4##2##(1990-5#2)(1991-7#1)(2008-10#1)
lectin pathway##2##2##(2008-4#1)(2012-3#1)
lectin promoter polymorphisms and gene variants##2##6##(2013-1#2)
lectin was##2##2##(1990-5#2)
lectin were##2##2##(2010-4#1)(2011-2#1)
lectin##86##1##(1990-11#1)(1990-12#2)(1990-5#9)(1990-7#2)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#2)(1993-11#1)(1993-3#2)(1993-6#3)(1993-8#14)(1994-12#3)(1994-6#1)(1994-8#1)(1995-11#1)(2006-12#1)(2008-10#10)(2008-11#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#4)(2010-4#2)(2011-2#4)(2012-3#3)(2013-1#6)
lectin-based##4##1##(1992-6#1)(2008-1#1)(2008-7#1)(2010-11#1)
lectin-blotting##2##1##(2008-5#2)
lectins and##3##2##(1990-5#1)(1991-9#1)(2013-1#1)
lectins##37##1##(1990-12#3)(1990-5#10)(1990-7#6)(1991-9#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-11#3)(1995-11#6)(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
lecture##15##1##(1991-5#1)(1994-9#2)(1996-1#1)(1996-2#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
lecturer and##2##2##(2008-11#2)
lecturer practitioner and joint##2##4##(2008-11#2)
lecturer practitioner##11##2##(2008-11#6)(2008-12#5)
lecturer practitioners##3##2##(2008-11#1)(2008-12#2)
lecturer preceptor##2##2##(2008-11#2)
lecturer##30##1##(2007-2#1)(2008-11#21)(2008-12#8)
lecturer's##4##1##(2008-11#4)
lecturers and##3##2##(2008-11#2)(2008-12#1)
lecturers are##2##2##(2008-11#2)
lecturers in the##2##3##(2008-10#2)
lecturers in##6##2##(2008-10#2)(2008-11#4)
lecturers were##2##2##(2008-10#2)
lecturers within##2##2##(2008-11#2)
lecturers##33##1##(2008-10#6)(2008-11#22)(2008-12#3)(2010-3#1)(2013-1#1)
lecturers'##3##1##(2008-11#3)
lectures and##2##2##(1994-12#1)(2007-8#1)
lectures on##2##2##(2007-5#1)(2012-2#1)
lectures##15##1##(1993-11#1)(1994-12#3)(1994-6#1)(1994-9#3)(2007-5#1)(2007-8#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
led a##2##2##(1996-11#1)(2010-11#1)
led by the##2##3##(1994-12#1)(2008-10#1)
led by##8##2##(1994-12#1)(1995-12#1)(1996-1#1)(1996-11#1)(2008-10#2)(2009-8#1)(2011-2#1)
led in##2##2##(1995-5#1)(2011-3#1)
led into##3##2##(2006-12#1)(2008-10#2)
led researchers##4##2##(2007-2#1)(2008-11#2)(2011-2#1)
led several##2##2##(2008-2#1)(2011-2#1)
led the way##2##3##(2009-3#1)(2011-1#1)
led the##10##2##(1994-1#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#1)
led them to##3##3##(2012-1#2)(2012-12#1)
led to a decrease in the##2##6##(1991-5#1)(2008-5#1)
led to a decrease in##5##5##(1991-5#1)(1995-3#1)(2008-3#1)(2008-5#1)(2013-7#1)
led to a diagnosis of##2##5##(2011-2#1)(2012-2#1)
led to a dramatic##2##4##(1996-6#1)(1997-1#1)
led to a greater##2##4##(2009-11#1)(2012-2#1)
led to a loss of##2##5##(1992-12#1)(2008-11#1)
led to a model##2##4##(1993-8#1)(2007-12#1)
led to a new concept##2##5##(2008-2#1)(2012-2#1)
led to a new##4##4##(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
led to a number of##2##5##(1994-2#1)(2008-7#1)
led to a partial##2##4##(1994-6#1)(2008-9#1)
led to a pronounced##2##4##(1995-12#1)(1997-7#1)
led to a rapid and transient##2##6##(1990-12#1)(1997-1#1)
led to a rapid##3##4##(1990-12#2)(1997-1#1)
led to a reduction in the##2##6##(2008-10#1)(2008-3#1)
led to a reduction in##4##5##(1992-2#1)(2008-10#1)(2008-3#2)
led to a series of##2##5##(1996-3#1)(2013-1#1)
led to a sharp##2##4##(2009-6#1)(2012-2#1)
led to a shift##2##4##(1993-12#1)(2012-3#1)
led to a significant decrease in##2##6##(1994-6#1)(2008-11#1)
led to a significant increase##2##5##(1993-12#1)(2008-11#1)
led to a significant reduction in##2##6##(2009-4#1)(2011-10#1)
led to a significant reduction##3##5##(2008-10#1)(2009-4#1)(2011-10#1)
led to a significant##9##4##(1993-12#1)(1994-6#1)(2008-10#1)(2008-11#2)(2009-4#1)(2011-10#1)(2013-1#2)
led to a substantial##2##4##(1993-6#1)(2008-10#1)
led to a time- and##2##5##(1990-5#1)(1993-3#1)
led to a variety of##2##5##(2008-11#1)(2012-3#1)
led to a##125##3##(1990-12#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-12#2)(1992-2#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-2#3)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-3#1)(2010-6#3)(2011-10#1)(2011-2#7)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
led to an increase in the##6##6##(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#2)
led to an increase in##12##5##(1995-2#1)(1995-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#2)(2011-3#1)(2013-1#1)
led to an increase of##3##5##(1991-12#1)(1991-6#1)(2008-11#1)
led to an increase##15##4##(1991-12#1)(1991-6#1)(1995-2#1)(1995-3#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2011-2#2)(2011-3#1)(2013-1#1)
led to an increased##2##4##(1992-8#1)(2008-7#1)
led to an##34##3##(1990-12#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1995-2#2)(1995-3#2)(1995-6#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#3)(2010-12#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#2)
led to better##3##3##(1990-6#1)(2008-9#1)(2012-12#1)
led to changes in the##3##5##(2008-10#1)(2008-2#1)(2009-12#1)
led to complete##2##3##(1994-3#1)(2006-10#1)
led to death##3##3##(1992-10#1)(2007-8#1)(2009-4#1)
led to decreased##2##3##(2008-8#1)(2009-5#1)
led to full##2##3##(2007-8#1)(2008-10#1)
led to functional##2##3##(1990-5#1)(2008-10#1)
led to further##3##3##(1996-1#1)(1997-7#1)(2008-10#1)
led to hypotheses##2##3##(2009-5#1)(2010-3#1)
led to improved##5##3##(1990-9#1)(1995-1#1)(2008-10#1)(2008-8#1)(2009-6#1)
led to increase in the##2##5##(2008-5#2)
led to increased##11##3##(1992-9#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
led to interest in##2##4##(1994-12#1)(2008-10#1)
led to its##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
led to less##2##3##(1993-11#1)(2011-2#1)
led to marked##4##3##(2007-12#1)(2008-10#1)(2009-3#1)(2012-2#1)
led to more##4##3##(1994-12#1)(2008-10#3)
led to production of##2##4##(2007-7#1)(2008-10#1)
led to reduced##2##3##(2008-5#1)(2008-9#1)
led to remarkable##2##3##(2007-7#1)(2013-1#1)
led to satisfactory##2##3##(2008-10#2)
led to significant increase##2##4##(2008-10#1)(2011-1#1)
led to significant##9##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
led to significantly higher##2##4##(1992-2#1)(2012-5#1)
led to significantly##3##3##(1992-2#1)(1994-3#1)(2012-5#1)
led to similar##2##3##(1995-2#1)(2008-2#1)
led to specific##3##3##(1992-3#1)(1995-2#1)(2010-6#1)
led to the accumulation of##4##5##(1995-3#1)(2008-10#1)(2010-2#1)(2011-1#1)
led to the appearance of##2##5##(1992-6#1)(1992-8#1)
led to the assumption that##2##5##(1990-5#1)(2009-2#1)
led to the conclusion that the##3##6##(1992-9#1)(2008-10#1)(2008-3#1)
led to the conclusion that##5##5##(1992-9#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-3#1)
led to the development of a##6##6##(1991-9#1)(1994-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
led to the development of an##2##6##(1995-12#1)(2008-3#1)
led to the development of the##2##6##(2008-3#2)
led to the development of##25##5##(1991-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
led to the diagnosis of##3##5##(1992-5#1)(1996-3#1)(2007-7#1)
led to the diagnosis##4##4##(1992-5#1)(1996-3#1)(2007-7#1)(2008-10#1)
led to the discovery of the##3##6##(2008-11#1)(2011-3#1)(2013-8#1)
led to the discovery of##9##5##(1995-8#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-5#1)(2011-3#1)(2012-3#2)(2013-8#1)
led to the discovery##11##4##(1995-8#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#1)
led to the establishment of##2##5##(2008-10#1)(2008-5#1)
led to the finding that##2##5##(1994-8#1)(2010-7#1)
led to the finding##3##4##(1994-8#1)(1996-5#1)(2010-7#1)
led to the following##3##4##(2008-11#1)(2008-6#1)(2012-12#1)
led to the formation of##3##5##(1996-5#1)(2008-10#1)(2009-11#1)
led to the identification of a##2##6##(2009-5#1)(2012-3#1)
led to the identification of two##4##6##(1991-9#1)(1994-9#1)(2008-11#1)(2011-2#1)
led to the identification of##11##5##(1991-9#1)(1994-9#1)(2008-11#2)(2008-7#3)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
led to the identification##12##4##(1991-9#1)(1994-9#1)(2008-11#2)(2008-7#4)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
led to the introduction of##2##5##(2008-12#1)(2010-4#1)
led to the investigation of##2##5##(1991-12#1)(2010-3#1)
led to the isolation of##3##5##(1992-8#1)(2009-10#1)(2010-2#1)
led to the rapid##4##4##(1996-2#1)(2007-6#1)(2008-8#2)
led to the recognition of##4##5##(1997-8#1)(2008-4#1)(2008-7#1)(2010-4#1)
led to the release of##2##5##(2008-10#2)
led to the same results##2##5##(2008-10#1)(2012-2#1)
led to the suggestion that##3##5##(1991-10#1)(1992-6#1)(1997-4#1)
led to the total##2##4##(2008-10#1)(2008-11#1)
led to the use of##2##5##(2008-11#1)(2010-6#1)
led to the##177##3##(1990-5#3)(1990-6#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#3)(2008-10#22)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#5)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#4)(2011-3#2)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#2)
led to this##2##3##(1990-11#1)(2009-4#1)
led to weight loss##2##4##(1995-12#1)(2008-3#1)
led to widespread##2##3##(1997-6#1)(2008-10#1)
led to##592##2##(1990-11#1)(1990-12#3)(1990-5#6)(1990-6#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#3)(1992-6#3)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#9)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-5#6)(1996-6#5)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#4)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#5)(2008-1#7)(2008-10#67)(2008-11#26)(2008-12#6)(2008-2#10)(2008-3#18)(2008-4#6)(2008-5#15)(2008-6#6)(2008-7#27)(2008-8#16)(2008-9#7)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#7)(2010-7#1)(2010-8#6)(2011-1#5)(2011-10#1)(2011-2#27)(2011-3#3)(2012-1#2)(2012-12#13)(2012-2#16)(2012-3#11)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#8)
led us to conclude that##2##5##(1994-8#1)(2008-6#1)
led us to investigate the##2##5##(1992-12#1)(1994-8#1)
led us to perform a##2##5##(2011-2#1)(2012-1#1)
led us to perform##3##4##(2008-10#1)(2011-2#1)(2012-1#1)
led us to propose##2##4##(1994-2#1)(2009-8#1)
led us to study##2##4##(2008-5#1)(2010-4#1)
led us to##21##3##(1990-2#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-3#1)
led##679##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#6)(1990-6#4)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#1)(1992-5#3)(1992-6#3)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#2)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#7)(1995-2#9)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#1)(1996-2#6)(1996-3#5)(1996-5#6)(1996-6#6)(1997-1#6)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#7)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#2)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#74)(2008-11#33)(2008-12#8)(2008-2#11)(2008-3#18)(2008-4#6)(2008-5#20)(2008-6#9)(2008-7#27)(2008-8#17)(2008-9#9)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#6)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#6)(2010-4#5)(2010-5#2)(2010-6#7)(2010-7#1)(2010-8#6)(2011-1#6)(2011-10#1)(2011-2#34)(2011-3#4)(2012-1#5)(2012-12#15)(2012-2#17)(2012-3#12)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#8)
ledger##2##1##(1993-1#1)(1993-12#1)
leech##8##1##(1991-5#2)(1994-6#1)(1996-12#2)(1997-3#1)(2008-10#1)(2009-8#1)
leek and##2##2##(2008-10#2)
leek blight##2##2##(2008-10#2)
leek leaves##3##2##(2008-10#3)
leek plants were##2##3##(2008-10#2)
leek plants##3##2##(2008-10#3)
leek##20##1##(2008-10#20)
leeway for##2##2##(2008-2#1)(2009-8#1)
lef##4##1##(1997-3#4)
lef-7##3##1##(1997-3#3)
leflunomide##4##1##(2006-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
lefs##4##1##(1997-3#4)
left BA##2##2##(2008-11#1)(2012-12#1)
left HM and##2##3##(2008-9#2)
left HM##4##2##(2008-9#4)
left ITA##2##2##(2007-8#2)
left L5##2##2##(2012-2#2)
left MeA##2##2##(1997-3#2)
left a##2##2##(1991-2#1)(2007-5#1)
left adrenal adenoma##2##3##(2011-2#2)
left adrenal gland##2##3##(2008-8#1)(2011-2#1)
left adrenal##6##2##(1990-6#1)(1992-2#1)(2008-8#1)(2011-2#3)
left alone##2##2##(1995-3#1)(2008-6#1)
left and right increases in the number of letters again produced near-identical effects on reaction time##2##16##(2009-2#2)
left and right internal##2##4##(2007-7#1)(2007-8#1)
left and right temporal##2##4##(1992-12#1)(2010-7#1)
left and right##22##3##(1991-2#1)(1992-12#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#4)(2010-12#2)(2010-7#1)(2011-2#3)(2013-7#1)
left and##26##2##(1991-2#1)(1992-12#1)(1995-2#1)(1997-8#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#4)(2010-12#2)(2010-7#1)(2011-2#3)(2013-7#1)
left anterior descending artery##7##4##(1994-11#1)(2007-8#3)(2008-11#3)
left anterior descending coronary artery occlusion##2##6##(1995-12#1)(2013-1#1)
left anterior descending coronary artery##6##5##(1995-12#1)(2007-8#1)(2008-7#1)(2013-1#2)(2013-7#1)
left anterior descending##13##3##(1994-11#1)(1995-12#1)(2007-8#4)(2008-11#3)(2008-7#1)(2013-1#2)(2013-7#1)
left anterior fascicle block##6##4##(2008-7#6)
left anterior fascicle##7##3##(2008-7#7)
left anterior##26##2##(1993-12#1)(1994-11#1)(1995-12#1)(1996-2#1)(2007-8#5)(2008-11#3)(2008-6#1)(2008-7#9)(2009-2#1)(2013-1#2)(2013-7#1)
left anterolateral thoracotomy##2##3##(2007-8#2)
left arm##23##2##(1991-3#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-6#3)(1995-9#4)(1996-3#4)(1996-6#4)(2007-12#2)(2009-3#1)(2010-8#1)
left aryepiglottic##2##2##(2011-2#2)
left atria##3##2##(1995-12#1)(2013-1#2)
left atrial appendage is##2##4##(2007-8#2)
left atrial appendage perforation##2##4##(2008-11#2)
left atrial appendage##6##3##(2007-8#3)(2008-11#2)(2010-12#1)
left atrial myxoma##3##3##(2008-7#2)(2009-6#1)
left atrial thrombosis##2##3##(2007-8#2)
left atrial thrombus##2##3##(2008-12#1)(2008-7#1)
left atrial##17##2##(1997-8#1)(2007-8#6)(2008-11#3)(2008-12#1)(2008-7#3)(2009-6#1)(2010-12#1)(2013-1#1)
left atrium and##2##3##(2007-12#1)(2007-8#1)
left atrium##8##2##(2007-12#1)(2007-8#3)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
left basal##4##2##(1993-9#3)(2007-8#1)
left behind by the project##2##5##(2008-1#2)
left behind##4##2##(2008-1#2)(2008-10#2)
left border##2##2##(2008-10#2)
left breast cancer##2##3##(1994-7#1)(2013-1#1)
left breast##10##2##(1994-7#2)(2007-7#1)(2008-10#3)(2011-2#1)(2012-3#2)(2013-1#1)
left bundle branch block##2##4##(1997-3#1)(2008-10#1)
left buttock##3##2##(2012-12#2)(2013-8#1)
left by##2##2##(1995-8#1)(2008-8#1)
left cardiac sympathetic nerve##4##4##(2008-9#4)
left cardiac##6##2##(1993-3#1)(2007-8#1)(2008-9#4)
left cerebellar##2##2##(2013-8#2)
left cerebellum##2##2##(2008-11#2)
left cervical##4##2##(1991-3#1)(1996-5#1)(2012-3#1)(2013-8#1)
left chest##3##2##(1996-3#1)(2007-8#1)(2011-2#1)
left circumflex##2##2##(2007-8#1)(2008-12#1)
left coronary artery##9##3##(1991-9#1)(1994-11#1)(2007-8#2)(2010-5#1)(2013-2#2)(2013-8#2)
left coronary##13##2##(1991-9#1)(1994-11#2)(2007-8#4)(2010-5#2)(2013-2#2)(2013-8#2)
left end##4##2##(1994-12#1)(1996-6#1)(1997-7#1)(2010-7#1)
left eye##14##2##(1993-12#1)(2007-7#1)(2008-11#1)(2010-10#1)(2010-9#1)(2011-2#6)(2013-1#2)(2013-8#1)
left flank pain##3##3##(2009-5#1)(2011-2#1)(2013-1#1)
left flank##5##2##(2008-12#2)(2009-5#1)(2011-2#1)(2013-1#1)
left foot##5##2##(1996-11#1)(2010-3#2)(2010-5#1)(2013-1#1)
left for##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
left forearm##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
left from##2##2##(2008-10#1)(2008-7#1)
left frontal lobe##2##3##(1996-2#1)(2008-12#1)
left frontal##5##2##(1990-8#1)(1996-2#1)(2008-1#1)(2008-12#1)(2013-1#1)
left hand##3##2##(1994-3#1)(2010-4#1)(2012-12#1)
left heart bypass to prevent##2##5##(2007-8#2)
left heart bypass##4##3##(2007-8#4)
left heart##9##2##(1997-1#1)(2007-8#5)(2010-6#1)(2011-2#2)
left hemiparesis##7##2##(1991-6#1)(2007-10#3)(2008-12#1)(2008-7#1)(2013-8#1)
left hemisphere##12##2##(1990-3#1)(1991-11#1)(1996-2#1)(1996-5#2)(1997-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2013-1#2)
left hemispheric##2##2##(1996-2#1)(1996-5#1)
left hip##2##2##(2012-12#1)(2013-1#1)
left hock joint##2##3##(1997-3#2)
left iliac##3##2##(1997-3#1)(2008-12#1)(2010-6#1)
left in place for##2##4##(2008-5#1)(2008-9#1)
left in place##4##3##(1990-8#1)(1994-9#1)(2008-5#1)(2008-9#1)
left in situ##2##3##(1990-10#1)(2008-9#1)
left in the##4##3##(2008-5#2)(2012-12#1)(2013-1#1)
left in##14##2##(1990-10#1)(1990-8#1)(1992-9#1)(1994-9#1)(1996-2#1)(2008-5#3)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#2)
left inferior frontal##4##3##(2008-11#1)(2009-9#2)(2012-1#1)
left inferior##6##2##(2008-11#2)(2009-8#1)(2009-9#2)(2012-1#1)
left internal mammary artery##2##4##(2007-8#1)(2011-2#1)
left internal thoracic artery (LITA)##2##5##(2007-8#1)(2011-2#1)
left internal thoracic artery##3##4##(2007-8#2)(2011-2#1)
left internal##10##2##(1997-6#1)(2007-8#3)(2008-7#2)(2010-3#1)(2011-2#2)(2012-3#1)
left kidney and##5##3##(2008-1#1)(2011-2#1)(2013-1#3)
left kidney##15##2##(1990-6#1)(2007-7#1)(2008-1#3)(2011-2#4)(2013-1#6)
left knees##2##2##(2009-4#1)(2011-2#1)
left lateral incisor##2##3##(2008-7#1)(2013-1#1)
left lateral position##2##3##(1993-10#2)
left lateral##20##2##(1990-3#1)(1992-9#1)(1993-10#6)(1993-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-2#2)(2012-3#1)(2013-1#2)
left lateralization of the pTC##2##5##(2012-2#2)
left lateralization of##3##3##(2012-2#3)
left lobe##4##2##(1993-5#1)(2008-1#1)(2010-11#1)(2012-12#1)
left lobectomy##3##2##(2008-10#3)
left lower extremity##3##3##(1993-8#1)(2009-1#1)(2012-2#1)
left lower lobe##10##3##(1991-3#1)(2007-8#4)(2008-1#3)(2008-6#2)
left lower lobectomy was performed##2##5##(2008-1#1)(2008-7#1)
left lower##22##2##(1991-3#1)(1993-8#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-6#2)(2008-7#2)(2009-1#1)(2009-5#1)(2010-11#3)(2012-2#1)
left lung cancer##3##3##(2007-8#3)
left lung##14##2##(1991-9#1)(2007-8#3)(2008-1#2)(2008-4#2)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
left lungs##2##2##(1996-3#1)(2008-10#1)
left main coronary artery##9##4##(2007-8#3)(2007-9#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-8#2)
left main coronary##10##3##(2007-8#3)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-8#2)
left main disease##4##3##(2007-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
left main stenting##2##3##(2011-2#2)
left main##25##2##(1990-9#2)(2007-8#5)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#2)(2010-2#1)(2011-2#4)(2013-1#1)(2013-8#2)
left mammary##2##2##(1992-6#1)(2011-2#1)
left many##2##2##(1992-1#1)(2010-12#1)
left maxilla##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
left maxillary sinus##2##3##(2008-2#1)(2008-7#1)
left maxillary##3##2##(2007-10#1)(2008-2#1)(2008-7#1)
left median##2##2##(2010-8#2)
left middle cerebral artery##3##4##(2008-7#2)(2013-8#1)
left middle##4##2##(2008-11#1)(2008-7#2)(2013-8#1)
left neck##2##2##(2007-5#1)(2013-1#1)
left neglect##2##2##(2007-10#1)(2009-10#1)
left nephrectomy was##2##3##(2008-10#1)(2013-1#1)
left nephrectomy##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
left occipital##3##2##(1996-5#1)(2007-7#1)(2008-7#1)
left of##2##2##(2009-10#1)(2009-2#1)
left on the##2##3##(2008-8#1)(2009-5#1)
left open##3##2##(1992-3#1)(2008-11#2)
left or right##5##3##(1997-8#1)(2007-4#1)(2007-8#1)(2008-8#1)(2009-10#1)
left or##8##2##(1997-8#1)(2007-4#2)(2007-8#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
left orbitofrontal##2##2##(2012-12#2)
left ovarian##2##2##(1997-8#1)(2013-1#1)
left parietal##2##2##(1996-5#1)(2012-12#1)
left parietotemporal##3##2##(1995-2#2)(1997-3#1)
left parotid##2##2##(2007-5#2)
left pleural effusion##4##3##(1991-12#1)(1997-4#1)(2007-8#1)(2013-1#1)
left pleural space##2##3##(2008-11#1)(2012-3#1)
left pleural##8##2##(1990-5#2)(1991-12#1)(1997-4#1)(2007-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
left pneumonectomy##3##2##(2007-8#1)(2008-6#1)(2009-3#1)
left posterior temporal##2##3##(2009-8#1)(2012-2#1)
left posterior##4##2##(1997-6#1)(2007-10#1)(2009-8#1)(2012-2#1)
left posterolateral##2##2##(2007-8#1)(2011-2#1)
left pulmonary artery##4##3##(2008-1#1)(2012-12#2)(2013-1#1)
left pulmonary##5##2##(2008-1#2)(2012-12#2)(2013-1#1)
left renal artery##3##3##(1990-2#1)(2008-1#1)(2008-11#1)
left renal vein##5##3##(2008-7#1)(2010-11#4)
left renal##11##2##(1990-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#4)(2012-2#1)
left side of##12##3##(1991-3#1)(1993-6#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)
left side##28##2##(1990-3#1)(1991-3#1)(1993-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
left sided##11##2##(1997-6#1)(2007-8#3)(2008-7#1)(2010-11#1)(2011-2#4)(2013-1#1)
left subclavian artery and##2##4##(2007-7#1)(2010-7#1)
left subclavian artery##3##3##(2007-7#1)(2008-11#1)(2010-7#1)
left subclavian##4##2##(2007-7#1)(2008-11#1)(2010-7#1)(2011-2#1)
left superior temporal gyrus##2##4##(1996-2#2)
left superior temporal##4##3##(1996-2#2)(1996-7#1)(2012-12#1)
left superior vena cava (PLSVC)##2##5##(2010-11#1)(2012-2#1)
left superior vena cava##5##4##(2010-11#2)(2011-2#1)(2012-2#2)
left superior##11##2##(1990-9#1)(1996-2#2)(1996-7#1)(2010-11#2)(2011-2#2)(2012-12#1)(2012-2#2)
left teeth##2##2##(1996-5#1)(2008-12#1)
left temporal lobe##3##3##(1993-9#1)(2008-1#1)(2008-7#1)
left temporal##4##2##(1993-9#1)(2008-1#1)(2008-7#1)(2010-7#1)
left testicular##2##2##(2008-10#1)(2008-6#1)
left testis##5##2##(1997-3#1)(2008-10#1)(2008-6#2)(2011-2#1)
left thalamus##2##2##(2008-7#2)
left the hospital in##2##4##(1993-6#1)(2008-12#1)
left the hospital##3##3##(1993-6#1)(2008-12#1)(2012-12#1)
left the##13##2##(1993-3#1)(1993-6#2)(1995-5#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
left thigh##5##2##(2007-7#1)(2008-6#2)(2013-1#1)(2013-8#1)
left thoracic##2##2##(2010-4#1)(2011-2#1)
left thumb##4##2##(2010-6#4)
left to the##2##3##(1996-9#1)(2008-3#1)
left to##10##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
left transverse sinus##2##3##(1996-6#2)
left undisturbed##2##2##(2008-10#1)(2008-8#1)
left unilateral neglect##4##3##(1995-12#1)(1996-5#1)(2009-10#1)(2009-2#1)
left unprotected##2##2##(1991-7#1)(2011-2#1)
left untreated##12##2##(1992-2#1)(1994-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
left upper lobe##4##3##(2007-7#1)(2007-8#1)(2008-1#2)
left upper##12##2##(1991-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-6#2)(2011-1#1)(2012-3#1)(2013-1#2)
left ventricle and##4##3##(2008-10#1)(2011-1#2)(2013-8#1)
left ventricle in##4##3##(2007-7#1)(2007-8#1)(2013-1#2)
left ventricle##42##2##(1991-3#1)(1992-9#2)(1997-8#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#5)(2009-12#4)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#2)(2013-1#11)(2013-8#1)
left ventricular (LV)##4##3##(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
left ventricular aneurysm##2##3##(2007-8#2)
left ventricular apical ballooning##2##4##(2009-6#1)(2010-5#1)
left ventricular assist##3##3##(2007-8#2)(2012-3#1)
left ventricular cavity and##2##4##(2008-11#1)(2012-2#1)
left ventricular contractile state##2##4##(2012-2#2)
left ventricular dilatation##3##3##(1995-3#1)(1997-3#1)(2008-12#1)
left ventricular dilation##2##3##(2013-1#1)(2013-7#1)
left ventricular dimensions##3##3##(2008-12#3)
left ventricular dysfunction##14##3##(1990-12#1)(1992-12#1)(1994-7#1)(1996-9#1)(2007-8#3)(2008-12#1)(2008-3#2)(2009-1#1)(2010-5#1)(2010-6#1)(2011-2#1)
left ventricular ejection fraction was##2##5##(1997-5#1)(2008-12#1)
left ventricular ejection fraction##8##4##(1995-3#1)(1997-5#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)
left ventricular end-diastolic dimension##3##4##(2008-12#2)(2008-7#1)
left ventricular end-diastolic##4##3##(1997-8#1)(2008-12#2)(2008-7#1)
left ventricular failure##3##3##(1990-9#1)(1996-3#1)(2010-5#1)
left ventricular free wall rupture and ventricular septal##2##8##(2007-8#2)
left ventricular free wall rupture##4##5##(2007-8#3)(2011-2#1)
left ventricular function##13##3##(1990-9#1)(1995-3#1)(1997-3#1)(2007-8#2)(2007-9#2)(2008-3#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#1)
left ventricular global##2##3##(2008-12#2)
left ventricular hypertrophy and##4##4##(2007-7#1)(2008-1#1)(2013-1#1)(2013-8#1)
left ventricular hypertrophy##14##3##(1992-8#1)(1995-11#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-12#2)(2009-1#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
left ventricular mass was##2##4##(2012-3#2)
left ventricular mass##8##3##(1995-3#2)(1997-8#1)(2011-2#1)(2012-12#1)(2012-3#3)
left ventricular myocardial performance index##3##5##(2008-12#3)
left ventricular outflow tract obstruction##2##5##(2011-1#1)(2012-2#1)
left ventricular outflow tract##7##4##(2007-9#1)(2011-1#3)(2012-2#1)(2013-8#2)
left ventricular remodeling in##2##4##(2012-12#1)(2013-8#1)
left ventricular remodeling##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
left ventricular structure and function##2##5##(2009-1#1)(2012-2#1)
left ventricular systolic dysfunction##4##4##(2007-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
left ventricular systolic function following##2##5##(2008-11#1)(2010-6#1)
left ventricular systolic function with##2##5##(2008-4#1)(2013-1#1)
left ventricular systolic function##7##4##(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
left ventricular systolic##12##3##(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
left ventricular volume##2##3##(2011-2#2)
left ventricular wall motion abnormality##2##5##(1997-3#2)
left ventricular wall##4##3##(1993-12#1)(1997-3#2)(2012-2#1)
left ventricular##154##2##(1990-12#1)(1990-9#2)(1992-12#2)(1992-8#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-11#2)(1995-3#7)(1996-3#1)(1996-9#2)(1997-3#4)(1997-5#2)(1997-6#1)(1997-8#3)(2007-10#1)(2007-7#1)(2007-8#15)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#16)(2008-3#3)(2008-4#1)(2008-7#2)(2009-1#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#4)(2011-1#3)(2011-2#13)(2012-12#5)(2012-2#12)(2012-3#5)(2013-1#5)(2013-7#4)(2013-8#5)
left versus right##2##3##(2009-10#1)(2010-7#1)
left visual field##3##3##(1996-2#2)(2007-10#1)
left##1075##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#7)(1990-5#3)(1990-6#5)(1990-8#3)(1990-9#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#6)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-10#6)(1993-12#10)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#9)(1994-11#3)(1994-12#3)(1994-3#2)(1994-6#1)(1994-7#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#10)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#4)(1996-11#2)(1996-2#11)(1996-3#9)(1996-5#10)(1996-6#9)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-3#14)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#14)(2006-10#1)(2006-8#1)(2007-10#10)(2007-11#1)(2007-12#6)(2007-4#2)(2007-5#4)(2007-7#18)(2007-8#83)(2007-9#5)(2008-1#35)(2008-10#44)(2008-11#36)(2008-12#33)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#8)(2008-6#21)(2008-7#67)(2008-8#12)(2008-9#15)(2009-1#6)(2009-10#9)(2009-12#7)(2009-2#8)(2009-3#5)(2009-4#7)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#6)(2010-10#1)(2010-11#15)(2010-12#7)(2010-2#3)(2010-3#7)(2010-4#3)(2010-5#10)(2010-6#13)(2010-7#8)(2010-8#8)(2010-9#2)(2011-1#12)(2011-2#78)(2011-3#1)(2012-1#3)(2012-12#29)(2012-2#28)(2012-3#26)(2012-7#1)(2013-1#72)(2013-2#2)(2013-7#7)(2013-8#28)
left- and right-handed helical##2##4##(2008-7#2)
left- and right-handed##3##3##(2008-7#2)(2010-12#1)
left- and##5##2##(1995-11#2)(2008-7#2)(2010-12#1)
left-handed##6##1##(1992-6#1)(1992-8#1)(1995-6#1)(2006-4#1)(2007-11#1)(2008-7#1)
left-handedness in##2##2##(1995-11#1)(1995-8#1)
left-handedness##3##1##(1995-11#2)(1995-8#1)
left-pawed##3##1##(1997-2#3)
left-right asymmetry##2##2##(2011-2#2)
left-right randomized clinical study assessing two topical products##2##8##(2008-5#2)
left-right##9##1##(2008-10#1)(2008-5#2)(2010-3#2)(2010-9#1)(2011-2#3)
left-side dominance in controlling##3##4##(2008-9#3)
left-side dominance in##4##3##(2008-9#4)
left-side dominance##5##2##(2008-1#1)(2008-9#4)
left-side##8##1##(2008-1#1)(2008-10#1)(2008-9#5)(2010-3#1)
left-sided##22##1##(1997-7#1)(2007-7#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-8#1)
left-to-right shunt##2##2##(1996-3#1)(2007-8#1)
left-to-right##5##1##(1996-3#1)(2007-8#1)(2008-11#1)(2010-10#1)(2011-2#1)
left-ventricular##3##1##(1992-9#1)(2008-5#1)(2012-1#1)
left/right asymmetry in##2##3##(2010-4#2)
left/right asymmetry##4##2##(2010-4#4)
left/right##8##1##(1996-11#2)(2008-12#1)(2009-10#1)(2010-4#4)
leftward##7##1##(1990-5#1)(1994-8#1)(2008-5#1)(2008-7#2)(2009-10#2)
leg and##7##2##(1990-11#1)(1991-3#1)(1997-8#1)(2008-12#2)(2008-5#1)(2011-2#1)
leg coordination##2##2##(2007-12#2)
leg exercises##2##2##(2013-8#2)
leg extension##2##2##(2007-12#1)(2013-1#1)
leg joints##3##2##(2007-12#3)
leg length discrepancy##2##3##(2008-6#1)(2008-8#1)
leg length##6##2##(1995-2#1)(1997-4#2)(2008-6#1)(2008-8#1)(2011-2#1)
leg mass##2##2##(1995-2#2)
leg movements##5##2##(2007-12#5)
leg muscle##3##2##(1995-2#1)(1996-12#1)(2008-9#1)
leg muscles in##3##3##(1995-12#1)(1996-5#1)(2007-12#1)
leg muscles is##2##3##(1995-12#1)(2007-12#1)
leg muscles##11##2##(1995-12#3)(1995-2#1)(1996-5#1)(2007-12#3)(2013-8#3)
leg musculature##2##2##(2007-12#2)
leg pain and##2##3##(2010-9#1)(2011-2#1)
leg pain##12##2##(1991-11#1)(1997-2#1)(2007-11#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
leg press##3##2##(2008-5#3)
leg segments##2##2##(1995-2#1)(2007-12#1)
leg skin##2##2##(2008-5#2)
leg strength##2##2##(2008-6#1)(2013-1#1)
leg ulcers##9##2##(1990-6#1)(1993-8#1)(1996-7#1)(1997-3#2)(2008-1#1)(2013-1#3)
leg wash##2##2##(2008-5#2)
leg with##3##2##(2010-9#1)(2012-12#2)
leg##154##1##(1990-11#3)(1990-6#1)(1991-11#1)(1991-3#2)(1992-5#1)(1993-12#3)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#3)(1995-2#8)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#3)(1997-3#5)(1997-4#3)(1997-8#2)(2007-10#2)(2007-11#4)(2007-12#36)(2007-8#8)(2008-1#1)(2008-12#5)(2008-5#12)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#3)(2011-2#3)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#5)
leg]##2##1##(1990-3#1)(1990-6#1)
legacies##3##1##(2007-3#1)(2008-2#1)(2008-7#1)
legacy of the##2##3##(1997-3#1)(2013-1#1)
legacy of##8##2##(1993-1#2)(1995-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
legacy##21##1##(1992-12#2)(1992-3#2)(1993-1#2)(1995-1#1)(1995-3#1)(1996-3#2)(1997-3#1)(2007-2#2)(2008-10#2)(2008-11#2)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)
legal abortion##2##2##(1996-8#1)(2008-11#1)
legal abortions in##2##3##(1996-11#2)
legal abortions##3##2##(1996-11#3)
legal action##4##2##(1992-2#1)(2008-11#2)(2009-11#1)
legal and ethical##2##3##(1996-4#1)(2012-12#1)
legal and illegal##2##3##(2008-11#2)
legal and social issues##2##4##(2008-12#1)(2008-4#1)
legal and##13##2##(1991-6#1)(1992-3#1)(1993-3#1)(1996-1#1)(1996-4#1)(1997-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2012-12#1)
legal aspects of##2##3##(2007-11#1)(2011-2#1)
legal aspects##5##2##(2007-11#1)(2011-2#4)
legal assistant##2##2##(1992-4#2)
legal basis##2##2##(1995-12#1)(2013-8#1)
legal cases##6##2##(2008-11#5)(2008-7#1)
legal challenges to##2##3##(1992-2#1)(2008-12#1)
legal framework##4##2##(1994-1#1)(1996-3#1)(2008-10#1)(2008-7#1)
legal implications##3##2##(1993-3#1)(1997-2#1)(1997-5#1)
legal in##3##2##(2008-11#1)(2013-1#2)
legal issues in##4##3##(1994-3#1)(1996-1#1)(2008-11#2)
legal issues##12##2##(1991-1#1)(1994-3#2)(1995-12#1)(1996-1#1)(1997-3#1)(2008-11#4)(2008-12#1)(2013-7#1)
legal penalties##2##2##(1992-2#2)
legal regulations##2##2##(1997-7#1)(2012-1#1)
legal requirements##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
legal right to##2##3##(1992-3#1)(2008-11#1)
legal rights##2##2##(1995-1#1)(1995-6#1)
legal standards##6##2##(1991-12#1)(1996-9#1)(2008-1#1)(2008-12#1)(2013-1#2)
legal structure##2##2##(1996-12#1)(1996-2#1)
legal system##9##2##(1991-12#1)(1994-2#1)(1995-1#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
legal##180##1##(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#6)(1992-3#3)(1992-4#2)(1993-1#1)(1993-12#1)(1993-3#4)(1993-6#1)(1994-1#3)(1994-2#2)(1994-3#4)(1994-6#1)(1994-7#1)(1995-1#6)(1995-12#3)(1995-6#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#2)(2007-11#2)(2007-3#1)(2008-1#3)(2008-10#9)(2008-11#29)(2008-12#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
legality##2##1##(1992-12#1)(2013-1#1)
legalization of##2##2##(2010-12#1)(2010-5#1)
legalization##3##1##(2010-12#2)(2010-5#1)
legally##7##1##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
legend##3##1##(1992-11#1)(2011-2#2)
legged locomotion##6##2##(2007-12#6)
legged robots##3##2##(2007-12#3)
legged##10##1##(2007-12#10)
leghorn##3##1##(1997-6#3)
legislated##2##1##(1992-1#1)(1992-12#1)
legislation and##10##2##(1991-12#1)(1994-1#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
legislation did##2##2##(2008-11#1)(2013-8#1)
legislation enacted##3##2##(1993-2#1)(1997-1#1)(2012-12#1)
legislation has been##2##3##(1996-1#1)(2008-10#1)
legislation has##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
legislation in the##3##3##(1994-1#1)(2008-10#1)(2008-4#1)
legislation of##2##2##(1997-3#1)(2012-3#1)
legislation on##2##2##(1993-6#1)(2012-12#1)
legislation regarding##2##2##(2008-6#1)(2010-9#1)
legislation related to##2##3##(1997-1#1)(2008-11#1)
legislation that##5##2##(1991-2#1)(1994-1#1)(2007-2#1)(2008-7#1)(2009-7#1)
legislation to##2##2##(1992-1#1)(2007-2#1)
legislation would##2##2##(1993-1#1)(2008-11#1)
legislation##103##1##(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-1#8)(1994-3#1)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-8#1)(2007-11#3)(2007-2#2)(2007-9#1)(2008-10#7)(2008-11#11)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-7#1)(2010-9#2)(2011-2#2)(2012-12#3)(2012-3#3)(2013-8#2)
legislation]##3##1##(1990-2#1)(1993-6#1)(1996-1#1)
legislative and##2##2##(1992-1#1)(2008-12#1)
legislative issues##2##2##(1992-2#2)
legislative##25##1##(1990-11#1)(1992-1#2)(1992-2#3)(1994-1#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-3#2)(2007-5#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
legislatively mandated##2##2##(1997-3#2)
legislator##2##1##(1995-1#1)(2008-11#1)
legislators##10##1##(1992-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#5)(2010-5#1)
legislatures##4##1##(2008-12#1)(2008-4#1)(2008-6#1)(2012-2#1)
legitimacy of##2##2##(1996-12#1)(2012-2#1)
legitimacy##5##1##(1993-2#1)(1996-12#1)(1997-3#1)(2012-2#1)(2013-1#1)
legitimate##14##1##(1991-1#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-2#1)(2007-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
legitimated##2##1##(2008-11#1)(2009-7#1)
legs and##4##2##(1993-8#1)(2007-12#2)(2013-8#1)
legs in##4##2##(2007-12#3)(2011-2#1)
legs is a##2##3##(2007-12#1)(2008-5#1)
legs is##3##2##(2007-12#2)(2008-5#1)
legs of##8##2##(2007-12#6)(2008-3#1)(2008-7#1)
legs syndrome (RLS)##2##3##(2012-12#1)(2012-3#1)
legs syndrome##4##2##(2012-12#2)(2012-3#1)(2013-7#1)
legs walk##2##2##(2007-12#2)
legs##73##1##(1993-8#1)(1995-2#3)(1995-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#28)(2007-2#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
legs]##3##1##(1997-3#1)(2008-4#2)
legume Stylosanthes at##2##3##(2008-10#2)
legume seeds##2##2##(1992-8#1)(2008-10#1)
legume##18##1##(1992-8#1)(1993-8#1)(1994-8#1)(2008-10#11)(2009-8#1)(2010-10#2)(2013-8#1)
legumes and##2##2##(2008-7#1)(2012-1#1)
legumes##13##1##(2008-10#8)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
leguminous##6##1##(2008-10#3)(2008-6#2)(2010-7#1)
leiden##2##1##(1997-6#1)(2013-8#1)
leiocephala##2##1##(2010-3#2)
leiomyocytes were##2##2##(2012-1#2)
leiomyoma is##2##2##(1990-10#1)(1992-9#1)
leiomyoma of the ureter##3##4##(2013-7#3)
leiomyoma of the##7##3##(1992-5#1)(1992-6#1)(2012-2#2)(2013-7#3)
leiomyoma##25##1##(1990-10#2)(1992-12#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-9#1)(2008-6#1)(2009-5#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-7#4)
leiomyomas and##2##2##(1991-2#1)(1994-6#1)
leiomyomas are##2##2##(1991-2#2)
leiomyomas##9##1##(1991-2#6)(1994-6#1)(2008-6#1)(2012-12#1)
leiomyomatosis##2##1##(1992-12#1)(2013-1#1)
leiomyosarcoma and##4##2##(1992-8#1)(1993-9#1)(2008-5#1)(2008-6#1)
leiomyosarcoma cell##2##2##(2008-6#2)
leiomyosarcoma of the##7##3##(1991-4#1)(2007-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2013-1#1)
leiomyosarcoma of##9##2##(1991-4#1)(2007-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2013-1#1)
leiomyosarcoma##32##1##(1990-11#1)(1990-9#1)(1991-4#2)(1992-10#1)(1992-8#1)(1993-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#3)(2008-6#14)(2008-7#1)(2012-2#2)(2013-1#1)
leiomyosarcomas##2##1##(1994-6#1)(2008-6#1)
leishmania##5##1##(2007-7#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
leishmaniasis in a##2##3##(2007-7#1)(2013-1#1)
leishmaniasis in##10##2##(2007-12#2)(2007-7#2)(2008-7#1)(2008-8#2)(2009-5#1)(2012-2#1)(2013-1#1)
leishmaniasis is##3##2##(1991-11#1)(2007-12#1)(2012-12#1)
leishmaniasis was##2##2##(2007-7#2)
leishmaniasis##54##1##(1990-6#1)(1990-7#2)(1990-9#2)(1991-11#1)(1995-12#1)(1996-12#1)(2007-12#6)(2007-7#8)(2008-10#2)(2008-12#6)(2008-7#7)(2008-8#3)(2009-10#1)(2009-5#1)(2010-5#2)(2012-12#5)(2012-2#2)(2013-1#3)
leishmanin skin test and positive splenic culture for Leishmania##2##9##(2008-7#2)
leishmanin skin test##4##3##(2008-7#4)
leishmaniosis##4##1##(2011-2#4)
leisure activities##8##2##(1992-5#1)(1996-3#1)(2007-1#2)(2008-1#1)(2012-12#2)(2013-8#1)
leisure and##3##2##(2010-10#1)(2013-1#2)
leisure time##5##2##(1996-11#1)(1997-2#1)(2009-3#1)(2010-11#1)(2012-1#1)
leisure##18##1##(1992-5#1)(1994-11#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-1#2)(2008-1#1)(2008-5#1)(2009-3#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
leisure-time physical activity##2##3##(2011-2#1)(2013-1#1)
leisure-time##3##1##(1992-8#1)(2011-2#1)(2013-1#1)
lemildipine##2##1##(2008-5#2)
lemma and palea##4##3##(2008-10#4)
lemma##12##1##(2008-10#8)(2008-8#2)(2008-9#2)
lemmas##4##1##(2008-5#3)(2008-9#1)
lemmings##2##1##(1996-6#1)(2008-7#1)
lemon and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
lemon juice##3##2##(2008-10#3)
lemon pectin##2##2##(2011-2#2)
lemon##21##1##(2008-10#11)(2010-8#2)(2011-2#6)(2013-1#2)
lemur##2##1##(2009-8#1)(2011-2#1)
lemurs##7##1##(2009-8#2)(2011-2#5)
lenalidomide##3##1##(2010-4#3)
lend further support to the##2##5##(2008-5#1)(2012-2#1)
lend strong support##2##3##(1990-11#1)(1991-1#1)
lend support to the##4##4##(1993-12#1)(2008-2#1)(2009-7#1)(2010-1#1)
lend support to##8##3##(1990-3#1)(1993-12#1)(1994-2#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-1#1)
lend support##9##2##(1990-3#1)(1993-12#1)(1994-2#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-4#1)
lend##21##1##(1990-11#1)(1990-3#1)(1991-1#1)(1993-12#1)(1994-2#1)(1996-3#1)(2007-2#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
lending##3##1##(1992-2#1)(1992-3#1)(1994-1#1)
lends further support to the##2##5##(1993-9#1)(2010-10#1)
lends itself to##7##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)
lends support to the hypothesis that##2##6##(2008-8#1)(2008-9#1)
lends support to the##3##4##(1995-11#1)(2008-8#1)(2008-9#1)
lends support to##4##3##(1995-11#1)(1995-8#1)(2008-8#1)(2008-9#1)
lends##17##1##(1991-9#1)(1993-9#1)(1995-11#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2012-3#1)
length (1##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
length (SL)##2##2##(2008-5#1)(2013-7#1)
length (e##2##2##(1997-6#1)(2008-6#1)
length L##3##2##(2007-12#1)(2008-3#2)
length after compression##2##3##(2010-4#2)
length after##4##2##(2008-5#1)(2010-4#2)(2010-5#1)
length and a##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
length and abdominal girth##2##4##(1996-8#2)
length and diameter##2##3##(2008-10#1)(2012-2#1)
length and fan angle of##2##5##(2008-2#2)
length and gluteal muscle strength in##2##6##(2012-2#2)
length and gluteal muscle strength##3##5##(2012-2#3)
length and head##2##3##(2008-12#2)
length and intensity##2##3##(2008-10#1)(2009-11#1)
length and secondary##2##3##(2008-10#2)
length and sequence##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
length and the##12##3##(1992-7#1)(1993-12#2)(2007-11#1)(2007-12#3)(2008-3#2)(2008-9#2)(2012-2#1)
length and weight##2##3##(2008-5#1)(2008-9#1)
length and width gradient##3##4##(2008-10#3)
length and width of##3##4##(2008-10#2)(2008-5#1)
length and width##10##3##(1993-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2013-7#2)
length and##121##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#3)(1993-2#2)(1994-12#2)(1995-12#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#20)(2008-12#8)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#7)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#5)(2013-1#2)(2013-7#3)(2013-8#1)
length as the##2##3##(1992-8#1)(2007-11#1)
length as##6##2##(1991-3#1)(1992-8#1)(2007-11#2)(2008-10#1)(2009-5#1)
length at first##2##3##(2008-12#1)(2013-7#1)
length at##7##2##(1992-6#1)(1997-4#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-8#1)(2013-7#1)
length between##5##2##(2008-2#1)(2008-5#1)(2012-2#2)(2013-7#1)
length both##3##2##(1995-6#1)(2007-11#1)(2007-5#1)
length but##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
length by##2##2##(2007-10#1)(2007-12#1)
length can be##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
length complementary##2##2##(1990-12#1)(2008-8#1)
length data##2##2##(1996-2#1)(2008-10#1)
length density##3##2##(2008-10#3)
length did not##3##3##(1997-4#1)(2008-10#1)(2010-8#1)
length discrepancy##4##2##(2008-6#1)(2008-8#1)(2010-5#1)(2012-2#1)
length during##3##2##(2008-10#1)(2009-1#1)(2010-2#1)
length for the##6##3##(1995-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-2#1)(2013-7#1)
length for##13##2##(1992-6#1)(1995-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-3#1)(2010-2#1)(2013-7#1)
length from##6##2##(1993-11#1)(2008-10#1)(2008-2#1)(2013-1#2)(2013-7#1)
length in a##5##3##(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)
length in human##2##3##(2008-11#1)(2008-2#1)
length in long##2##3##(2007-11#1)(2007-12#1)
length in the##6##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
length in##23##2##(1992-8#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#3)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
length increased##3##2##(2008-10#2)(2008-5#1)
length inside the##2##3##(2007-11#1)(2008-2#1)
length is less than##2##4##(1997-8#1)(2008-11#1)
length is not##2##3##(2007-11#1)(2008-10#1)
length is##23##2##(1992-11#1)(1996-6#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
length measurement##2##2##(2008-3#1)(2008-9#1)
length measurements##2##2##(2008-3#2)
length mouse glycophorin##2##3##(1991-5#2)
length of 0##2##3##(2008-2#1)(2008-9#1)
length of 1 mm##2##4##(1994-2#1)(2008-3#1)
length of 1##7##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
length of 100##3##3##(1996-3#1)(2008-2#1)(2008-3#1)
length of 17##2##3##(1997-2#1)(2013-1#1)
length of 2##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
length of 21##2##3##(1997-2#1)(2008-7#1)
length of 24##2##3##(2007-11#1)(2008-3#1)
length of 25##2##3##(1997-8#1)(2008-10#1)
length of 3##2##3##(2007-12#1)(2009-1#1)
length of 5##3##3##(2007-11#1)(2007-8#1)(2010-8#1)
length of UV irradiation##2##4##(2008-10#2)
length of a##10##3##(2008-2#3)(2008-3#5)(2008-5#1)(2010-5#1)
length of about##2##3##(1990-2#1)(1995-2#1)
length of all##2##3##(2012-1#1)(2012-2#1)
length of an optical##2##4##(2007-12#1)(2008-3#1)
length of an##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
length of each##2##3##(1990-5#1)(1991-6#1)
length of fiber##2##3##(2007-11#1)(2007-12#1)
length of follow-up##4##3##(1994-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
length of gestation##2##3##(2007-11#1)(2008-12#1)
length of highly nonlinear##2##4##(2007-11#2)
length of hospital stay##20##4##(1991-12#3)(1992-2#1)(1994-5#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#2)(2011-2#3)(2013-1#3)(2013-8#1)
length of hospitalization##5##3##(1991-2#1)(1993-12#1)(1993-2#1)(1996-2#1)(2008-10#1)
length of more than##2##4##(1997-4#1)(2008-5#1)
length of stay (LOS)##6##4##(1991-12#1)(1993-12#3)(1994-12#1)(1994-3#1)
length of stay and##9##4##(1993-3#1)(1995-12#2)(1995-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
length of stay for##3##4##(1992-2#1)(1993-12#1)(1993-2#1)
length of stay in hospital##3##5##(1990-6#1)(1992-5#1)(2013-1#1)
length of stay in the##3##5##(1996-2#1)(2006-10#1)(2007-5#1)
length of stay in##8##4##(1990-6#1)(1992-5#1)(1996-2#1)(2006-10#2)(2007-5#1)(2008-3#1)(2013-1#1)
length of stay of##2##4##(1991-1#1)(1992-12#1)
length of stay was##2##4##(2008-3#1)(2012-2#1)
length of stay##73##3##(1990-6#1)(1991-1#1)(1991-12#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#2)(1994-12#2)(1994-3#5)(1995-1#1)(1995-12#3)(1995-3#3)(1996-2#1)(1997-1#2)(2006-10#3)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#11)(2012-3#3)(2013-1#2)(2013-8#1)
length of stays##5##3##(2010-8#5)
length of surgery##2##3##(1995-1#1)(2010-3#1)
length of survival##2##3##(2012-2#2)
length of the CLMMG##2##4##(2009-3#2)
length of the device##2##4##(2007-11#1)(2007-12#1)
length of the fiber##2##4##(2007-11#1)(2008-3#1)
length of the humerus##2##4##(2013-8#2)
length of the inhibition period##2##5##(1991-12#2)
length of the nauplii##3##4##(2008-5#3)
length of the two-input coupler##2##5##(2008-3#2)
length of the##128##3##(1991-12#3)(1991-2#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#3)(2007-10#1)(2007-11#7)(2007-12#9)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#18)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
length of therapy##3##3##(2008-11#1)(2008-6#2)
length of time since##2##4##(1996-2#1)(2008-7#1)
length of time##8##3##(1992-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-3#1)
length of##432##2##(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#9)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#4)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#6)(1995-2#1)(1995-3#5)(1995-5#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#2)(1997-8#4)(2006-10#3)(2007-10#3)(2007-11#17)(2007-12#20)(2007-2#3)(2007-5#1)(2007-8#7)(2008-1#3)(2008-10#37)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#43)(2008-4#2)(2008-5#14)(2008-6#9)(2008-7#9)(2008-8#11)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-7#3)(2009-9#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#10)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#17)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#8)
length on the##4##3##(2008-3#2)(2008-9#1)(2009-9#1)
length on##7##2##(2007-12#1)(2008-3#2)(2008-6#1)(2008-9#2)(2009-9#1)
length or##3##2##(2008-10#1)(2008-6#1)(2013-8#1)
length patients##2##2##(2013-1#2)
length polymorphism (RFLP)##43##3##(1993-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#31)(2008-4#1)(2008-5#1)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
length polymorphism for##2##3##(1997-3#1)(2008-10#1)
length polymorphism##200##2##(1990-3#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-8#1)(2008-10#169)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#3)(2009-6#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
length ranging from##2##3##(2008-5#1)(2013-1#1)
length relative to##2##3##(2008-5#1)(2008-8#1)
length scale of the##4##4##(2008-10#1)(2008-3#1)(2010-9#2)
length scale of##5##3##(2008-10#2)(2008-3#1)(2010-9#2)
length scale##14##2##(1996-4#2)(2008-10#5)(2008-3#1)(2008-7#1)(2010-9#2)(2012-2#1)(2013-1#2)
length scales##12##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-7#6)(2012-1#1)
length that##7##2##(1996-12#1)(1996-4#1)(2008-2#2)(2008-3#2)(2012-2#1)
length to##10##2##(1994-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#5)(2008-5#1)
length under##2##2##(2007-11#1)(2011-1#1)
length variation##6##2##(1994-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
length variations##2##2##(2008-5#1)(2013-8#1)
length was determined##2##3##(2008-11#1)(2008-3#1)
length was measured in##2##4##(2008-10#1)(2008-7#1)
length was measured##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)
length was##20##2##(1992-5#1)(1993-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#2)
length were##12##2##(1992-6#1)(1993-12#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2012-3#1)(2013-1#1)
length which##2##2##(1995-12#1)(2010-2#1)
length with the##3##3##(1993-8#1)(1996-6#1)(2008-7#1)
length with##11##2##(1993-8#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2011-1#1)
length##1452##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#8)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#13)(1993-2#10)(1993-3#7)(1993-6#2)(1993-8#5)(1994-1#1)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#7)(1994-5#4)(1994-6#5)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#10)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#7)(1996-11#1)(1996-12#8)(1996-2#8)(1996-3#4)(1996-4#8)(1996-5#3)(1996-6#4)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#9)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#8)(1997-9#1)(2006-10#5)(2006-8#1)(2007-10#4)(2007-11#50)(2007-12#53)(2007-2#3)(2007-5#2)(2007-8#9)(2008-1#5)(2008-10#355)(2008-11#27)(2008-12#27)(2008-2#54)(2008-3#115)(2008-4#9)(2008-5#43)(2008-6#17)(2008-7#42)(2008-8#38)(2008-9#34)(2009-1#5)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#8)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#7)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#8)(2010-6#2)(2010-7#2)(2010-8#25)(2010-9#3)(2011-1#18)(2011-2#25)(2011-3#3)(2012-1#3)(2012-12#3)(2012-2#41)(2012-3#14)(2012-5#1)(2013-1#42)(2013-7#20)(2013-8#19)
length) were##5##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
length)##18##1##(1990-2#1)(1990-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-7#1)
length-modulated radiometer##2##2##(2008-3#2)
length-weight##2##1##(2013-7#2)
length/width##2##1##(2008-3#1)(2008-8#1)
lengthen##5##1##(1990-12#1)(1991-8#1)(2007-11#1)(2008-2#1)(2012-3#1)
lengthened segments])##2##2##(2009-3#2)
lengthened the##2##2##(2008-11#1)(2008-5#1)
lengthened##7##1##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#2)
lengthening index values were found in##2##6##(2007-8#2)
lengthening index values were##3##4##(2007-8#3)
lengthening index##7##2##(2007-8#6)(2009-3#1)
lengthening of the##3##3##(1994-3#1)(1995-3#1)(2009-11#1)
lengthening of##6##2##(1990-6#1)(1994-3#1)(1995-3#1)(2007-11#1)(2009-11#1)(2009-2#1)
lengthening procedures##3##2##(2007-11#1)(2010-3#1)(2012-2#1)
lengthening the##2##2##(2008-10#1)(2008-8#1)
lengthening##43##1##(1990-6#1)(1994-3#1)(1995-3#1)(1997-4#1)(2007-11#5)(2007-8#7)(2008-10#2)(2008-4#1)(2008-8#2)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#2)
lengthenings in##2##2##(2007-8#1)(2009-3#1)
lengthenings##4##1##(2007-8#3)(2009-3#1)
lengths and##11##2##(1992-4#2)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-1#1)
lengths are##2##2##(1994-11#1)(2008-3#1)
lengths as##2##2##(2007-11#1)(2007-12#1)
lengths at birth and##2##4##(2008-1#1)(2009-4#1)
lengths at##4##2##(2008-1#1)(2009-4#1)(2012-2#1)(2013-7#1)
lengths for each##2##3##(2008-10#1)(2008-2#1)
lengths for##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
lengths from##5##2##(1997-6#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-8#1)
lengths in##4##2##(2008-3#3)(2008-9#1)
lengths is##2##2##(1996-4#1)(2008-3#1)
lengths of pediatric patient stay##2##5##(1994-1#2)
lengths of stay##14##3##(1991-3#1)(1992-3#2)(1993-1#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(2010-8#1)
lengths of the rows of##2##5##(2007-12#2)
lengths of the##10##3##(1992-12#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-3#2)
lengths of these##2##3##(2008-2#1)(2008-6#1)
lengths of##55##2##(1990-5#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-3#2)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#7)(2008-6#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
lengths on##2##2##(2008-10#2)
lengths that are##2##3##(2007-11#1)(2008-3#1)
lengths that##4##2##(2007-11#1)(2008-3#2)(2013-8#1)
lengths were measured##2##3##(1992-5#1)(2009-3#1)
lengths were##9##2##(1992-5#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#2)
lengths when##2##2##(2008-10#1)(2008-3#1)
lengths##168##1##(1990-3#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-4#3)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#3)(2007-11#8)(2007-12#11)(2008-1#3)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#31)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#2)(2013-8#3)
lengths)##3##1##(2008-2#1)(2008-3#1)(2009-10#1)
lengthy process##3##2##(1990-12#1)(1992-2#1)(2008-7#1)
lengthy##15##1##(1990-12#1)(1992-12#2)(1992-2#1)(1994-8#2)(1995-1#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)
lens MIP##2##2##(1993-2#2)
lens aberrations##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
lens and a##3##3##(2008-2#2)(2008-3#1)
lens and beam##3##3##(2008-3#3)
lens and scanner##2##3##(2008-2#2)
lens and the##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
lens and##31##2##(1991-9#1)(1993-9#1)(2007-12#4)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#12)(2010-8#1)(2011-1#1)
lens aperture##6##2##(2008-2#5)(2008-3#1)
lens are##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
lens array and##2##3##(2008-3#2)
lens array##6##2##(2007-11#1)(2008-3#5)
lens arrays##3##2##(2007-12#2)(2008-3#1)
lens at the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
lens by##2##2##(1992-12#1)(2008-3#1)
lens can be##2##3##(2008-3#2)
lens can##4##2##(2008-10#1)(2008-3#2)(2011-1#1)
lens design##2##2##(2007-12#1)(2008-3#1)
lens designs##2##2##(2012-12#2)
lens dose##2##2##(1993-9#2)
lens duct##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
lens ducts##2##2##(2008-2#2)
lens elements##3##2##(2008-2#1)(2008-3#2)
lens end##3##2##(2008-2#2)(2008-3#1)
lens epithelial cells##2##3##(2012-2#2)
lens exchange with multifocal intraocular lens implantation##2##7##(2011-2#2)
lens exchange##3##2##(2011-2#3)
lens fibers##2##2##(2012-2#2)
lens for##11##2##(2008-2#5)(2008-3#4)(2011-1#2)
lens has##2##2##(2008-11#1)(2008-3#1)
lens in a##2##3##(2007-12#1)(2008-3#1)
lens in the##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
lens in##10##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2011-1#1)(2011-2#1)
lens is##8##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
lens made##3##2##(2008-3#2)(2011-1#1)
lens manufacturing conditions##2##3##(2008-3#2)
lens manufacturing##3##2##(2008-3#3)
lens null correctors##2##3##(2008-3#2)
lens of the##3##3##(2008-10#1)(2008-3#2)
lens of##7##2##(1991-9#1)(1993-3#1)(2008-10#1)(2008-3#3)(2012-12#1)
lens on the##2##3##(2008-2#1)(2008-3#1)
lens on##3##2##(2008-2#1)(2008-3#2)
lens signal##2##2##(2008-10#1)(2008-2#1)
lens spectrometry (TLS)##3##3##(2008-10#3)
lens spectrometry##10##2##(2008-10#10)
lens system##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
lens systems##5##2##(1993-11#1)(2008-3#4)
lens that is##2##3##(2007-12#1)(2008-3#1)
lens that##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
lens tilt on##2##3##(2008-2#2)
lens tilt##4##2##(2008-2#4)
lens to the##2##3##(2007-12#1)(2008-3#1)
lens to##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
lens under##2##2##(2007-11#1)(2008-3#1)
lens was measured to be##2##5##(2008-2#1)(2008-3#1)
lens was measured##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
lens was##11##2##(1991-9#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#4)
lens with a##8##3##(2007-11#1)(2007-12#1)(2008-3#6)
lens with##12##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#7)
lens would##2##2##(2008-3#1)(2011-1#1)
lens##401##1##(1990-12#2)(1990-3#1)(1991-2#1)(1991-6#2)(1991-9#7)(1992-11#2)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#7)(1993-3#1)(1993-6#1)(1993-9#4)(1994-9#1)(2007-11#24)(2007-12#39)(2008-10#24)(2008-11#3)(2008-2#78)(2008-3#152)(2009-6#1)(2009-7#1)(2010-8#2)(2010-9#2)(2011-1#16)(2011-2#13)(2011-7#1)(2012-12#3)(2012-2#8)(2013-1#2)
lens's##2##1##(2008-3#2)
lens-axicon doublets##2##2##(2008-2#2)
lens-axicon##3##1##(2008-2#3)
lens-based##2##1##(2008-2#1)(2008-3#1)
lens-free relay##5##2##(2008-2#5)
lens-free##6##1##(2008-2#6)
lenses and##9##2##(1991-6#1)(2007-11#1)(2008-3#5)(2011-2#1)(2012-12#1)
lenses are discussed##2##3##(2008-2#1)(2008-3#1)
lenses are used##2##3##(2008-3#2)
lenses are##9##2##(1993-11#1)(2008-2#3)(2008-3#5)
lenses as##2##2##(2008-3#2)
lenses fabricated from##2##3##(2007-11#1)(2008-3#1)
lenses for##7##2##(2008-2#2)(2008-3#5)
lenses from##2##2##(1991-9#2)
lenses in a##2##3##(2008-3#2)
lenses in the##3##3##(2008-3#3)
lenses in##7##2##(2008-3#6)(2011-2#1)
lenses is##5##2##(2008-3#5)
lenses made from##2##3##(2007-11#1)(2008-2#1)
lenses made##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
lenses of##2##2##(1991-6#1)(2008-2#1)
lenses on##3##2##(2008-3#2)(2012-12#1)
lenses that have##2##3##(2008-3#2)
lenses that##5##2##(2007-11#1)(2008-3#3)(2008-7#1)
lenses with a##2##3##(2008-3#2)
lenses with##7##2##(2008-2#2)(2008-3#5)
lenses##144##1##(1990-12#1)(1991-2#1)(1991-6#2)(1991-9#3)(1993-11#3)(2007-11#13)(2007-12#4)(2008-10#2)(2008-2#19)(2008-3#81)(2008-6#1)(2008-7#1)(2011-2#4)(2012-12#6)(2013-1#3)
lenses)##2##1##(2007-11#1)(2008-2#1)
lensing and##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
lensing in the##2##3##(2007-12#1)(2008-3#1)
lensing in##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
lensing is##3##2##(2008-10#2)(2008-3#1)
lensing signal is##3##3##(2008-2#3)
lensing signal##5##2##(2008-2#5)
lensing##52##1##(2007-11#2)(2007-12#5)(2008-10#8)(2008-2#15)(2008-3#22)
lensless Fourier-transform holography##2##3##(2008-3#2)
lensless##5##1##(2008-3#4)(2011-1#1)
lenslet array##2##2##(2008-2#1)(2008-3#1)
lenslet##8##1##(2008-2#2)(2008-3#6)
lenslets##2##1##(2007-12#1)(2008-2#1)
lenticels##3##1##(2008-10#3)
lenticularis##2##1##(2008-5#1)(2008-7#1)
lentigines##2##1##(2008-5#1)(2013-8#1)
lentiginous##2##1##(2010-6#1)(2012-3#1)
lentigo maligna melanoma##2##3##(2011-2#2)
lentigo maligna##3##2##(2011-2#3)
lentigo##8##1##(2011-2#8)
lentil and##2##2##(2008-10#2)
lentil lectin monomers##3##3##(1993-8#3)
lentil lectin##6##2##(1993-8#6)
lentil##17##1##(1993-8#6)(2008-10#11)
lentis##3##1##(2008-10#3)
lentiviral vector##3##2##(2008-2#3)
lentiviral vectors##4##2##(2008-2#2)(2008-4#1)(2008-7#1)
lentiviral##8##1##(2008-2#5)(2008-4#1)(2008-7#1)(2013-1#1)
lentivirus infection##2##2##(1995-2#2)
lentivirus##4##1##(1995-2#2)(2008-11#1)(2008-4#1)
lentiviruses##2##1##(1994-6#1)(2008-2#1)
leonurine##5##1##(2012-2#5)
lepidopteran insect cells##3##3##(1995-2#2)(1997-4#1)
lepidopteran insect##4##2##(1995-2#2)(1997-4#1)(2008-11#1)
lepidopteran pests##2##2##(2008-10#1)(2008-5#1)
lepidopteran##11##1##(1992-6#2)(1995-2#2)(1997-4#1)(2008-10#2)(2008-11#2)(2008-5#2)
lepidopterophagy##2##1##(2012-3#2)
lepidopterous and coleopteran pests##2##4##(2008-10#2)
leprae##3##1##(2008-8#1)(2011-2#2)
lepromatous leprosy and##2##3##(2012-12#2)
lepromatous leprosy##5##2##(2009-5#1)(2012-12#4)
leprosis##6##1##(2008-10#6)
leprosy and##5##2##(2007-7#1)(2008-8#1)(2012-12#2)(2012-2#1)
leprosy cases##6##2##(1995-9#2)(2007-7#2)(2009-5#2)
leprosy in##7##2##(2007-7#1)(2008-8#1)(2009-7#1)(2010-9#1)(2012-12#3)
leprosy patients##11##2##(1995-9#1)(2007-7#4)(2009-5#3)(2012-12#3)
leprosy prevalence##3##2##(2008-8#3)
leprosy with##3##2##(2007-7#2)(2009-5#1)
leprosy##77##1##(1990-12#1)(1990-5#1)(1991-11#1)(1991-6#1)(1995-6#1)(1995-9#6)(2007-7#24)(2008-7#1)(2008-8#6)(2009-5#13)(2009-7#2)(2010-9#1)(2011-2#1)(2012-12#17)(2012-2#1)
leprosy]##2##1##(1995-3#1)(1997-6#1)
leptin and adiponectin##6##3##(2011-1#6)
leptin and decreased adiponectin levels##2##5##(2011-1#1)(2012-1#1)
leptin and insulin resistance##2##4##(2013-1#1)(2013-8#1)
leptin and insulin##3##3##(2010-6#1)(2013-1#1)(2013-8#1)
leptin and##13##2##(2010-6#1)(2011-1#7)(2012-1#1)(2013-1#2)(2013-8#2)
leptin gene##3##2##(2008-10#3)
leptin has##2##2##(1997-3#1)(2008-4#1)
leptin in##6##2##(1997-4#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-3#2)
leptin is##2##2##(2008-4#1)(2011-2#1)
leptin level in men##2##4##(2011-1#2)
leptin level##3##2##(2011-1#2)(2011-2#1)
leptin levels in##2##3##(2006-10#1)(2013-1#1)
leptin levels##8##2##(2006-10#1)(2007-7#1)(2011-1#1)(2013-1#4)(2013-8#1)
leptin receptor##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
leptin to##2##2##(2008-4#1)(2011-2#1)
leptin##73##1##(1997-3#1)(1997-4#4)(2006-10#1)(2007-7#1)(2008-10#6)(2008-3#4)(2008-4#9)(2008-8#1)(2008-9#3)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#12)(2011-2#8)(2012-1#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#7)
leptokurtic movement distributions##2##3##(2008-8#2)
leptokurtosis##3##1##(2008-8#3)
leptomeningeal spread##3##2##(2008-7#1)(2012-12#2)
leptomeningeal venous disconnection##2##3##(2008-7#2)
leptomeningeal venous##4##2##(2008-7#4)
leptomeningeal##13##1##(2008-7#7)(2012-12#2)(2012-3#2)(2013-8#2)
leptospirosis in##4##2##(1991-8#1)(2007-7#2)(2008-9#1)
leptospirosis##10##1##(1991-8#1)(1996-3#1)(2007-7#2)(2008-9#3)(2009-12#1)(2011-1#1)(2011-2#1)
leptuphylla##2##1##(2008-5#2)
les caractéristiques##2##2##(2013-1#2)
les cheveux##2##2##(2008-5#2)
les complications##2##2##(2011-2#2)
les données##3##2##(2011-2#1)(2013-1#2)
les produits##5##2##(2008-5#5)
les proprietes##2##2##(2008-5#2)
les##62##1##(1990-6#1)(1996-3#1)(2008-11#4)(2008-3#1)(2008-5#22)(2009-10#1)(2009-4#6)(2011-2#12)(2013-1#14)
lesbian and bisexual college women##4##5##(2008-12#4)
lesbian and bisexual women##2##4##(2008-12#2)
lesbian and bisexual##7##3##(2008-12#7)
lesbian and gay adolescents##2##4##(1992-1#2)
lesbian and gay parents##4##4##(2012-2#4)
lesbian and gay##6##3##(1992-1#2)(2012-2#4)
lesbian and##15##2##(1992-1#2)(2008-12#9)(2012-2#4)
lesbian identity##2##2##(2008-12#2)
lesbian women##2##2##(2008-12#2)
lesbian##34##1##(1992-1#2)(1995-6#1)(2008-12#23)(2009-7#1)(2010-8#3)(2012-2#4)
lesbian/bisexual mothers##3##2##(2009-7#3)
lesbian/bisexual##4##1##(2009-7#4)
lesbians are##2##2##(2008-12#2)
lesbians##9##1##(1996-5#1)(1997-7#2)(2008-12#6)
lesbians'##2##1##(2008-12#2)
lesion (1##2##2##(1997-6#1)(2008-12#1)
lesion after##2##2##(1997-8#1)(2011-2#1)
lesion and for the##2##4##(1990-10#1)(2008-5#1)
lesion and of the##2##4##(1997-6#1)(2008-3#1)
lesion and was##2##3##(1995-8#1)(2006-6#1)
lesion and##23##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#2)(1993-9#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
lesion appearance##2##2##(2008-10#1)(2010-6#1)
lesion appeared##2##2##(1993-3#1)(2006-12#1)
lesion are discussed##2##3##(2008-2#1)(2013-1#1)
lesion are##6##2##(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2013-1#1)
lesion area##10##2##(2008-10#7)(2012-3#3)
lesion as##3##2##(1993-12#1)(2010-6#1)(2013-8#1)
lesion at##2##2##(2009-2#1)(2013-8#1)
lesion caused by##2##3##(1991-6#1)(2008-1#1)
lesion caused##3##2##(1991-6#1)(2008-1#1)(2008-10#1)
lesion conspicuity##5##2##(1997-8#5)
lesion density##11##2##(2008-10#11)
lesion detection and##2##3##(2008-1#1)(2010-12#1)
lesion detection##7##2##(1997-8#2)(2007-11#1)(2008-1#1)(2008-7#2)(2010-12#1)
lesion development##15##2##(1997-8#2)(2008-10#12)(2009-7#1)
lesion diameter##3##2##(1990-9#1)(2008-10#2)
lesion did not##3##3##(1992-10#1)(1995-12#1)(2006-10#1)
lesion disappeared##2##2##(2008-1#1)(2013-1#1)
lesion echogenicity##2##2##(2007-10#2)
lesion expansion and growth in planta##2##6##(2008-10#2)
lesion expansion##12##2##(2008-10#12)
lesion extension##6##2##(2008-10#5)(2012-3#1)
lesion for##4##2##(1991-5#1)(1994-12#1)(2010-8#1)(2011-2#1)
lesion formation##7##2##(1997-8#1)(2008-10#1)(2008-5#1)(2009-7#3)(2012-3#1)
lesion from##3##2##(1995-5#1)(2010-3#1)(2013-1#1)
lesion groups were##2##3##(1993-3#1)(1993-5#1)
lesion groups##3##2##(1993-3#2)(1993-5#1)
lesion growth rate of##2##4##(2008-8#2)
lesion growth rate##3##3##(2008-10#1)(2008-8#2)
lesion growth##4##2##(2008-10#1)(2008-8#3)
lesion had##5##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)
lesion has been##2##3##(1996-2#1)(2008-9#1)
lesion has##3##2##(1996-2#1)(2008-9#1)(2013-1#1)
lesion impaired the acquisition of##2##5##(1992-10#1)(1993-3#1)
lesion impaired##3##2##(1992-10#2)(1993-3#1)
lesion in her##2##3##(2007-7#1)(2008-5#1)
lesion in the nervous system##2##5##(1992-12#1)(1996-3#1)
lesion in the right##4##4##(2006-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
lesion in the##32##3##(1990-7#1)(1990-9#1)(1991-2#2)(1992-12#1)(1993-12#2)(1993-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-12#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
lesion in##49##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-12#1)(1993-12#2)(1993-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-5#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-6#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
lesion involving the##3##3##(1996-5#1)(2009-5#1)(2011-2#1)
lesion involving##4##2##(1996-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
lesion is the##2##3##(1991-6#1)(2007-8#1)
lesion is##15##2##(1990-12#1)(1990-3#1)(1991-6#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-2#3)(2013-1#1)
lesion length was##2##3##(2008-10#2)
lesion length##9##2##(2008-10#9)
lesion lengths##2##2##(2008-10#2)
lesion location and##3##3##(2008-2#2)(2012-2#1)
lesion location##4##2##(2007-12#1)(2008-2#2)(2012-2#1)
lesion may##4##2##(1990-12#1)(1990-5#1)(2008-10#1)(2013-1#1)
lesion measured##2##2##(2010-6#1)(2012-3#1)
lesion not##2##2##(1993-9#1)(1997-8#1)
lesion number score##2##3##(2010-8#2)
lesion number##5##2##(2008-10#3)(2010-8#2)
lesion numbers##3##2##(2008-10#3)
lesion of nucleus robustus archistriatalis##2##5##(2008-8#2)
lesion of the nigrostriatal##2##4##(1994-8#1)(1996-12#1)
lesion of the##24##3##(1991-3#1)(1992-5#1)(1993-12#2)(1994-8#2)(1996-12#1)(1996-2#3)(1997-6#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
lesion of##44##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-12#2)(1993-5#1)(1994-8#2)(1996-12#1)(1996-2#3)(1996-5#2)(1997-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#6)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
lesion on the##7##3##(1996-3#1)(2007-10#2)(2007-7#1)(2008-10#1)(2010-6#1)(2012-12#1)
lesion on##16##2##(1994-8#1)(1996-3#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#2)
lesion or##7##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
lesion per##4##2##(2008-10#4)
lesion placement##2##2##(2008-7#1)(2010-6#1)
lesion produced##2##2##(1995-12#1)(2013-1#1)
lesion resulted in##2##3##(1996-12#1)(2012-3#1)
lesion scores##6##2##(2008-5#6)
lesion should##2##2##(1996-3#1)(1997-8#1)
lesion showed##2##2##(2010-6#1)(2012-1#1)
lesion site##3##2##(1992-9#1)(1996-5#1)(2008-7#1)
lesion size determined##2##3##(2007-10#2)
lesion size was##2##3##(2008-10#2)
lesion size##25##2##(1995-12#1)(2007-10#3)(2008-10#19)(2010-6#1)(2012-3#1)
lesion status##2##2##(2012-2#2)
lesion suggested to be caused by##2##6##(1994-9#2)
lesion that##5##2##(1990-12#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-3#1)
lesion the##3##2##(1991-3#1)(1993-8#1)(1997-6#1)
lesion was a##2##3##(2010-6#1)(2013-1#1)
lesion was associated with##3##4##(1990-8#1)(2007-10#1)(2007-7#1)
lesion was classified##2##3##(2007-10#1)(2013-1#1)
lesion was considered##2##3##(2006-10#1)(2008-6#1)
lesion was detected##2##3##(2007-7#1)(2010-12#1)
lesion was found in##3##4##(2006-10#1)(2007-5#1)(2008-1#1)
lesion was found##5##3##(2006-10#1)(2007-5#1)(2008-1#1)(2009-11#1)(2011-2#1)
lesion was positive for##2##4##(1995-4#1)(2011-1#1)
lesion was##51##2##(1990-8#1)(1993-11#2)(1995-11#1)(1995-4#1)(1997-8#1)(2006-10#3)(2007-10#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
lesion were##9##2##(1991-6#1)(1993-12#1)(1993-8#1)(1996-3#1)(2008-10#2)(2008-6#1)(2008-9#1)(2012-3#1)
lesion which##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
lesion with a##3##3##(1993-9#1)(2008-11#1)(2010-5#1)
lesion with##21##2##(1990-6#2)(1993-12#1)(1993-9#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
lesion##733##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-3#2)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#5)(1991-7#1)(1991-9#1)(1992-10#4)(1992-12#3)(1992-2#3)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#11)(1993-3#8)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#3)(1995-11#5)(1995-12#9)(1995-4#1)(1995-5#3)(1995-8#2)(1996-12#4)(1996-2#8)(1996-3#7)(1996-5#10)(1996-9#4)(1997-2#3)(1997-3#1)(1997-6#8)(1997-7#2)(1997-8#28)(2006-10#8)(2006-12#2)(2006-6#1)(2007-10#16)(2007-11#10)(2007-12#4)(2007-5#6)(2007-6#1)(2007-7#11)(2007-8#10)(2008-1#17)(2008-10#139)(2008-11#8)(2008-12#7)(2008-2#8)(2008-3#1)(2008-4#7)(2008-5#16)(2008-6#9)(2008-7#34)(2008-8#10)(2008-9#7)(2009-1#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-3#3)(2010-5#3)(2010-6#11)(2010-7#1)(2010-8#8)(2011-1#3)(2011-2#39)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#19)(2012-3#23)(2013-1#34)(2013-8#14)
lesion)##3##1##(1992-8#1)(2008-12#1)(2008-4#1)
lesion-induced EEG changes##2##3##(1991-9#2)
lesion-induced deficits in##2##3##(1993-12#2)
lesion-induced deficits##4##2##(1991-2#1)(1993-12#2)(1997-2#1)
lesion-induced##13##1##(1991-12#1)(1991-2#1)(1991-9#2)(1993-12#3)(1993-3#2)(1993-5#1)(1994-3#1)(1996-12#1)(1997-2#1)
lesion-to-liver contrast##2##2##(1997-8#2)
lesion]##6##1##(1997-8#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lesioned and##2##2##(1992-11#1)(1994-2#1)
lesioned animals##4##2##(1990-5#1)(1993-3#1)(1994-3#1)(2008-7#1)
lesioned monkeys##3##2##(1993-12#1)(1994-3#2)
lesioned pigeons##2##2##(1990-11#2)
lesioned rats##10##2##(1992-10#1)(1993-12#2)(1994-8#4)(1997-2#2)(2012-2#1)
lesioned with##2##2##(2008-5#1)(2008-7#1)
lesioned##46##1##(1990-11#3)(1990-5#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#3)(1994-8#4)(1995-12#1)(1996-5#3)(1997-2#3)(1997-6#5)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#7)(2012-2#1)
lesioning of##2##2##(2008-10#1)(2008-7#1)
lesioning procedures##2##2##(2008-1#1)(2009-9#1)
lesioning the##3##2##(1993-6#1)(1995-12#1)(2008-7#1)
lesioning##15##1##(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-1#3)(2008-10#1)(2008-7#4)(2009-9#2)
lesions after##5##2##(1991-3#1)(1995-3#1)(2010-7#1)(2012-3#1)(2013-8#1)
lesions also##2##2##(1992-10#1)(1993-6#1)
lesions and benign##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
lesions and in##2##3##(2008-11#1)(2010-12#1)
lesions and multiple##2##3##(2007-7#1)(2011-2#1)
lesions and the##3##3##(1994-3#1)(1996-12#1)(2011-1#1)
lesions and to##2##3##(1994-9#1)(2008-10#1)
lesions and##76##2##(1990-3#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#1)(1996-12#1)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#4)
lesions and/or##2##2##(2008-4#1)(2008-5#1)
lesions appearing in##2##3##(1992-2#1)(2012-1#1)
lesions are common##2##3##(2008-1#1)(2012-2#1)
lesions are found##2##3##(1997-8#1)(2007-2#1)
lesions are##45##2##(1990-3#1)(1991-5#1)(1991-9#1)(1994-9#1)(1995-11#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#2)(2010-12#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
lesions as compared to##2##4##(1997-6#1)(2011-2#1)
lesions as##7##2##(1990-9#1)(1997-6#1)(2007-10#1)(2008-11#1)(2011-2#2)(2011-3#1)
lesions associated with##4##3##(1994-11#1)(1997-3#1)(2008-1#1)(2008-5#1)
lesions at the##7##3##(1992-6#1)(2008-12#1)(2008-9#4)(2013-1#1)
lesions at##12##2##(1992-6#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-9#4)(2010-8#1)(2012-3#1)(2013-1#1)
lesions became##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
lesions but##3##2##(1995-2#1)(1996-6#1)(1996-8#1)
lesions by##8##2##(1990-7#1)(1995-3#1)(1995-5#1)(2007-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
lesions can be##4##3##(1990-9#1)(1992-9#1)(1993-9#1)(2012-2#1)
lesions can##7##2##(1990-9#1)(1992-9#1)(1993-9#1)(2006-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
lesions cannot be##2##3##(1990-9#1)(2012-3#1)
lesions cause##2##2##(2007-10#1)(2008-11#1)
lesions caused by human##2##4##(2013-1#2)
lesions caused by##10##3##(1991-8#1)(1995-11#1)(2008-10#5)(2012-3#1)(2013-1#2)
lesions caused##11##2##(1991-8#1)(1993-12#1)(1995-11#1)(2008-10#5)(2012-3#1)(2013-1#2)
lesions consisted of##2##3##(1997-8#1)(2008-5#1)
lesions consisting of##2##3##(1990-5#1)(2008-10#1)
lesions consisting##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
lesions constitute##2##2##(2008-10#1)(2012-2#1)
lesions contained##2##2##(1994-1#1)(1997-3#1)
lesions containing##2##2##(2011-1#1)(2012-2#1)
lesions could##2##2##(2008-10#1)(2008-12#1)
lesions detected by##2##3##(1997-3#1)(2012-2#1)
lesions detected##4##2##(1997-3#2)(2008-5#1)(2012-2#1)
lesions develop in##2##3##(2008-10#1)(2008-4#1)
lesions developed at##2##3##(2008-10#2)
lesions developed on##2##3##(2008-10#2)
lesions developed##5##2##(1997-8#1)(2008-10#4)
lesions diagnosed##2##2##(1991-2#1)(2013-1#1)
lesions did not##3##3##(1993-5#1)(1997-3#1)(2008-1#1)
lesions do not##2##3##(1993-12#1)(1994-3#1)
lesions due to##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
lesions during the acute phase of##2##6##(2013-1#2)
lesions during##4##2##(2010-8#1)(2012-2#1)(2013-1#2)
lesions even##2##2##(1990-5#1)(2008-7#1)
lesions extending##2##2##(1990-6#1)(2011-2#1)
lesions facilitated##2##2##(1993-6#1)(2009-10#1)
lesions following##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
lesions for##3##2##(1992-8#1)(2006-12#1)(2010-8#1)
lesions from##6##2##(1991-8#1)(1992-2#1)(2008-10#1)(2008-6#1)(2008-7#2)
lesions gradually##2##2##(2012-3#1)(2013-8#1)
lesions had no effect on##3##5##(1990-5#1)(1993-6#1)(1994-2#1)
lesions had##11##2##(1990-5#1)(1992-10#2)(1993-6#1)(1994-2#1)(1997-8#1)(2012-3#1)(2013-8#4)
lesions has##6##2##(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
lesions have##5##2##(2007-12#1)(2008-12#1)(2008-7#2)(2012-12#1)
lesions in a##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
lesions in adult##2##3##(1993-12#1)(2008-7#1)
lesions in children##3##3##(2007-12#1)(2013-1#1)(2013-8#1)
lesions in different##2##3##(1990-3#1)(1990-6#1)
lesions in female##2##3##(2008-9#1)(2013-8#1)
lesions in order to##2##4##(1991-5#1)(2010-8#1)
lesions in patients with##6##4##(1992-6#1)(1993-6#1)(1996-11#1)(2007-10#1)(2008-11#1)(2008-7#1)
lesions in patients##9##3##(1992-6#1)(1993-6#1)(1996-11#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
lesions in the colon and##2##5##(2008-12#2)
lesions in the liver##3##4##(1991-6#1)(2008-5#1)(2011-2#1)
lesions in the lower##2##4##(1996-12#1)(2011-2#1)
lesions in the lung##2##4##(1992-9#1)(2008-8#1)
lesions in the##60##3##(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-9#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#4)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
lesions in these##2##3##(2008-6#1)(2009-9#1)
lesions in this##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
lesions in##160##2##(1990-3#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#3)(1992-12#2)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-3#2)(1997-6#3)(1997-8#5)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#7)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#3)(2009-11#2)(2009-5#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#3)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
lesions include##2##2##(2006-12#1)(2007-12#1)
lesions included##2##2##(1994-12#1)(1997-6#1)
lesions including##2##2##(1997-3#1)(2012-3#1)
lesions increased##5##2##(1991-9#1)(2008-10#2)(2011-1#1)(2011-2#1)
lesions induced by##3##3##(1990-2#1)(1990-5#1)(2008-4#1)
lesions induced in##2##3##(1990-2#1)(2008-10#1)
lesions induced##5##2##(1990-2#2)(1990-5#1)(2008-10#1)(2008-4#1)
lesions involving the##2##3##(2008-7#1)(2012-3#1)
lesions involving##3##2##(1997-8#1)(2008-7#1)(2012-3#1)
lesions is not##2##3##(1993-12#1)(2013-8#1)
lesions is the##2##3##(2012-3#2)
lesions is##20##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(2008-11#1)(2008-7#3)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
lesions located##2##2##(2007-8#1)(2008-9#1)
lesions may##8##2##(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-6#1)(2010-8#1)(2013-8#1)
lesions more##2##2##(1997-6#1)(2008-10#1)
lesions observed in##2##3##(2008-4#1)(2008-9#1)
lesions observed##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
lesions occur##2##2##(1991-2#1)(2012-1#1)
lesions occurred##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
lesions of the LH##2##4##(2009-10#2)
lesions of the TM nucleus##2##5##(1994-3#2)
lesions of the central##2##4##(1993-12#1)(2008-9#1)
lesions of the cervix##2##4##(1994-1#1)(1994-5#1)
lesions of the entorhinal cortex##2##5##(1994-3#1)(1997-3#1)
lesions of the hippocampus##6##4##(1990-11#1)(1993-12#2)(1993-6#2)(1994-3#1)
lesions of the lateral##2##4##(1993-12#1)(1993-6#1)
lesions of the neostriatum##2##4##(1993-3#2)
lesions of the nucleus accumbens##3##5##(1993-6#1)(1994-3#1)(1996-5#1)
lesions of the nucleus basalis magnocellularis##2##6##(1993-3#1)(1995-12#1)
lesions of the nucleus##5##4##(1993-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-5#1)
lesions of the right##2##4##(2007-10#1)(2009-10#1)
lesions of the ventral##2##4##(1993-6#1)(1997-2#1)
lesions of the white matter##2##5##(1996-11#2)
lesions of the##85##3##(1990-11#1)(1990-3#2)(1990-5#1)(1992-10#1)(1992-11#2)(1992-6#1)(1993-12#6)(1993-3#4)(1993-5#3)(1993-6#9)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-5#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2011-2#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
lesions of their##2##3##(1991-2#1)(1996-5#1)
lesions of##133##2##(1990-11#2)(1990-3#2)(1990-5#1)(1991-2#1)(1992-10#2)(1992-11#3)(1992-6#1)(1993-12#7)(1993-3#4)(1993-5#3)(1993-6#10)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#8)(1994-5#3)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-5#6)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#4)(2006-12#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
lesions often##2##2##(2008-10#2)
lesions on a##4##3##(1993-3#1)(1994-3#1)(2008-10#2)
lesions on the leaves##2##4##(2008-10#2)
lesions on the##15##3##(1991-9#1)(2008-10#9)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lesions on wounded##2##3##(2008-10#2)
lesions on##48##2##(1990-5#1)(1991-9#1)(1993-3#2)(1993-5#1)(1994-3#1)(1997-6#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#31)(2008-12#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lesions only##2##2##(2008-10#1)(2008-11#1)
lesions or##7##2##(1991-8#1)(1993-3#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2012-3#1)
lesions over##2##2##(1993-6#1)(2008-6#1)
lesions per cm(2))##2##3##(2008-10#2)
lesions per leaf and##2##4##(2008-10#2)
lesions per leaf for the##2##5##(2008-10#2)
lesions per leaf##4##3##(2008-10#4)
lesions per plant##2##3##(2008-10#2)
lesions per##11##2##(2008-10#10)(2011-2#1)
lesions produce##3##2##(1993-3#1)(2008-12#2)
lesions produced by##2##3##(1995-5#1)(2008-10#1)
lesions produced##6##2##(1992-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-5#1)(2008-10#1)
lesions resulting##2##2##(2007-11#1)(2008-9#1)
lesions revealed##2##2##(1990-3#1)(2008-5#1)
lesions should be##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
lesions showed##4##2##(1996-5#1)(1997-8#1)(2007-7#1)(2012-3#1)
lesions shown##2##2##(2007-11#1)(2008-5#1)
lesions similar to those##2##4##(2006-10#1)(2008-10#1)
lesions such as##6##3##(1992-5#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
lesions tend to##2##3##(1997-8#1)(2008-7#1)
lesions than##5##2##(1991-2#1)(2007-11#1)(2008-10#2)(2008-7#1)
lesions that are difficult to##2##5##(2010-8#1)(2011-2#1)
lesions that are##5##3##(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
lesions that can be##2##4##(2008-9#1)(2012-2#1)
lesions that were##4##3##(2008-5#1)(2008-8#1)(2008-9#2)
lesions that##23##2##(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#1)
lesions to the fruit##2##4##(2008-10#2)
lesions to the##8##3##(1993-12#1)(1993-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-10#1)(2011-1#1)
lesions to##18##2##(1990-6#1)(1993-12#2)(1993-8#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
lesions treated with##2##3##(2008-10#1)(2008-5#1)
lesions using##7##2##(1991-3#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-1#1)
lesions was noted##2##3##(2008-6#1)(2009-7#1)
lesions was observed##2##3##(1993-3#1)(2013-8#1)
lesions was##20##2##(1990-6#1)(1991-4#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-4#1)(1997-3#1)(1997-6#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
lesions were also##2##3##(1993-5#1)(2008-10#1)
lesions were classified into##2##4##(1990-12#1)(1997-6#1)
lesions were classified##3##3##(1990-12#1)(1993-8#1)(1997-6#1)
lesions were excised and##2##4##(2008-10#1)(2011-2#1)
lesions were located in the##3##5##(1991-8#1)(2013-8#2)
lesions were located in##4##4##(1991-8#1)(2012-3#1)(2013-8#2)
lesions were located##5##3##(1991-8#1)(2007-2#1)(2012-3#1)(2013-8#2)
lesions were more##2##3##(1993-8#1)(1997-6#1)
lesions were observed##5##3##(1997-3#2)(2008-10#1)(2008-5#1)(2013-1#1)
lesions were only##2##3##(2008-10#1)(2013-1#1)
lesions were repaired by##2##4##(2008-11#2)
lesions were seen in##2##4##(2007-7#1)(2011-1#1)
lesions were seen##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
lesions were treated by##2##4##(2007-8#1)(2008-3#1)
lesions were visible##2##3##(1995-4#1)(2013-8#1)
lesions were##83##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-4#2)(1997-3#2)(1997-6#4)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-6#3)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#9)
lesions when##4##2##(1991-2#1)(1991-8#2)(2011-2#1)
lesions which may##2##3##(1993-2#1)(2010-12#1)
lesions which##5##2##(1993-2#1)(2008-7#2)(2010-12#1)(2011-2#1)
lesions who underwent##2##3##(2008-7#1)(2011-2#1)
lesions with##19##2##(1993-12#1)(1995-11#1)(1996-6#2)(1997-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)
lesions within the##2##3##(2008-10#1)(2012-2#1)
lesions without evidence of##2##4##(2007-12#1)(2012-12#1)
lesions without##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
lesions##1467##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#8)(1990-5#10)(1990-6#7)(1990-7#1)(1990-9#6)(1991-11#3)(1991-12#4)(1991-2#15)(1991-3#5)(1991-4#1)(1991-5#5)(1991-6#8)(1991-7#2)(1991-8#12)(1991-9#5)(1992-1#1)(1992-10#11)(1992-11#14)(1992-12#3)(1992-2#5)(1992-3#1)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#21)(1993-2#3)(1993-3#19)(1993-5#7)(1993-6#25)(1993-8#8)(1993-9#4)(1994-1#9)(1994-11#9)(1994-12#11)(1994-2#3)(1994-3#15)(1994-5#6)(1994-6#3)(1994-8#3)(1994-9#5)(1995-11#4)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#5)(1996-1#1)(1996-11#6)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#8)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#24)(1997-4#4)(1997-6#20)(1997-7#3)(1997-8#34)(2006-10#5)(2006-12#6)(2007-10#26)(2007-11#23)(2007-12#17)(2007-2#4)(2007-5#1)(2007-7#15)(2007-8#21)(2007-9#1)(2008-1#17)(2008-10#174)(2008-11#25)(2008-12#26)(2008-2#5)(2008-3#6)(2008-4#14)(2008-5#61)(2008-6#27)(2008-7#72)(2008-8#9)(2008-9#35)(2009-1#1)(2009-10#11)(2009-11#5)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#24)(2010-2#1)(2010-3#5)(2010-4#2)(2010-6#15)(2010-7#2)(2010-8#21)(2010-9#5)(2011-1#18)(2011-2#76)(2011-3#7)(2011-7#1)(2012-1#6)(2012-12#7)(2012-2#48)(2012-3#52)(2013-1#55)(2013-7#3)(2013-8#40)
lesions)##14##1##(1990-8#1)(1991-2#1)(1992-6#1)(1994-12#2)(1994-6#1)(1997-2#1)(1997-4#1)(2008-10#3)(2011-2#2)(2012-1#1)
lesions]##4##1##(1990-9#1)(2008-11#1)(2012-2#1)(2012-3#1)
less about##2##2##(1995-11#1)(1996-6#1)
less abundant in##3##3##(1994-2#1)(1996-12#1)(2008-10#1)
less abundant##6##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
less accessible##2##2##(1996-12#1)(2008-4#1)
less accurate in##2##3##(2009-12#1)(2009-7#1)
less accurate##6##2##(2007-12#1)(2008-1#1)(2009-12#2)(2009-2#1)(2009-7#1)
less acidic##2##2##(2008-10#1)(2012-2#1)
less active in##3##3##(1995-11#1)(1996-2#1)(2011-2#1)
less active than the##3##4##(1992-6#1)(2008-5#1)(2010-5#1)
less active than##5##3##(1992-6#1)(1994-8#1)(1995-8#1)(2008-5#1)(2010-5#1)
less active##17##2##(1992-12#1)(1992-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#1)(1997-7#1)(2007-11#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)
less activity##2##2##(1994-9#1)(2013-1#1)
less affected by##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-10#1)(2012-3#1)
less affected##11##2##(1991-5#1)(1993-12#1)(1993-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-10#1)(2012-3#1)(2013-1#1)
less affinity for##2##3##(1994-11#1)(2008-10#1)
less affinity##3##2##(1994-11#1)(1994-2#1)(2008-10#1)
less aggregated##2##2##(2008-10#2)
less aggressive than##2##3##(2008-10#2)
less aggressive##10##2##(2008-10#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
less agreement with##4##3##(2013-1#4)
less agreement##5##2##(1995-1#1)(2013-1#4)
less amount of##2##3##(2008-10#1)(2008-12#1)
less amounts of##2##3##(1997-4#1)(2008-10#1)
less and less##2##3##(1990-5#1)(1994-2#1)
less and##5##2##(1990-5#1)(1994-2#1)(1996-1#1)(2008-1#1)(2013-8#1)
less anxiety than##2##3##(2007-6#2)
less anxiety##3##2##(2007-6#2)(2008-1#1)
less anxious##3##2##(1991-1#1)(1993-12#1)(2009-12#1)
less apparent##2##2##(2008-10#2)
less area##2##2##(1996-1#1)(2008-10#1)
less at the##2##3##(2008-10#1)(2008-9#1)
less at##8##2##(1991-6#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-9#1)(2012-12#1)
less attention has been##3##4##(1993-12#1)(2007-2#1)(2009-4#1)
less attention##6##2##(1993-12#1)(2007-2#1)(2008-2#1)(2008-9#1)(2009-4#1)(2009-5#1)
less attractive than ORE##2##4##(2008-10#2)
less attractive than##3##3##(2008-10#3)
less attractive to##2##3##(2008-10#2)
less attractive##7##2##(2008-10#5)(2013-8#2)
less background absorbance in##2##4##(1994-9#1)(2008-10#1)
less black rot##2##3##(2008-10#2)
less blood loss##2##3##(2006-12#1)(2012-3#1)
less blood##3##2##(2006-12#1)(2011-2#1)(2012-3#1)
less body##2##2##(2008-8#1)(2010-4#1)
less by##3##2##(1997-1#1)(2009-8#1)(2011-2#1)
less certain##2##2##(2007-8#1)(2008-8#1)
less clear##15##2##(1991-12#1)(1991-9#1)(1992-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
less close##2##2##(2008-12#2)
less common allele##2##3##(1993-6#1)(1995-12#1)
less common in##5##3##(1990-2#1)(2008-1#1)(2008-9#1)(2009-1#1)(2010-6#1)
less common than##3##3##(2011-2#2)(2013-1#1)
less common with##2##3##(2008-5#1)(2013-1#1)
less common##28##2##(1990-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1995-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
less commonly used##2##3##(2008-4#1)(2011-2#1)
less commonly##8##2##(2007-12#1)(2008-11#1)(2008-4#1)(2011-2#3)(2012-3#2)
less complex and##2##3##(1993-6#1)(2010-5#1)
less complex than##2##3##(1994-3#1)(2008-3#1)
less complex##7##2##(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#2)(2008-3#1)(2010-5#1)
less concerned##2##2##(1997-8#1)(2009-12#1)
less confusion and##3##3##(1997-3#1)(2013-1#2)
less conserved##2##2##(2008-10#1)(2008-7#1)
less consistent in##2##3##(2008-10#1)(2010-12#1)
less consistent##7##2##(1990-3#2)(1991-6#1)(1996-7#1)(2008-10#1)(2008-6#1)(2010-12#1)
less consistently##2##2##(2008-3#1)(2008-7#1)
less contaminated##2##2##(2008-11#2)
less control over##2##3##(1995-1#1)(1995-12#1)
less controlled##3##2##(2008-10#2)(2012-1#1)
less cost##3##2##(1994-1#2)(2010-8#1)
less costly##2##2##(2007-11#1)(2007-7#1)
less damage##2##2##(2007-11#1)(2012-2#1)
less dependent on##4##3##(1992-8#1)(1996-2#1)(2008-3#1)(2011-2#1)
less dependent##5##2##(1992-8#1)(1996-2#1)(2007-11#1)(2008-3#1)(2011-2#1)
less differentiated##2##2##(2008-11#1)(2008-8#1)
less discriminating##2##2##(1995-6#2)
less disease (P = 0##2##5##(2008-10#2)
less disease##11##2##(2008-10#11)
less diseased##2##2##(2008-10#2)
less distressed##2##2##(2008-3#1)(2013-8#1)
less diverse and##2##3##(2007-5#1)(2013-1#1)
less diverse##3##2##(2007-5#1)(2012-3#1)(2013-1#1)
less dramatic##4##2##(1995-12#1)(1996-11#1)(1996-2#1)(2008-9#1)
less educated##2##2##(1995-12#1)(2009-5#1)
less effect##3##2##(1994-9#1)(1995-12#1)(2008-8#1)
less effective and##3##3##(1992-12#1)(1994-2#1)(1995-6#1)
less effective at##2##3##(2008-10#1)(2008-8#1)
less effective in##6##3##(1992-2#1)(1993-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
less effective than##8##3##(1990-8#1)(1995-11#1)(1995-2#1)(2008-10#3)(2009-7#1)(2012-12#1)
less effective##39##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
less effectively##4##2##(1990-2#1)(1996-2#1)(2008-11#1)(2013-1#1)
less efficacious##2##2##(1994-8#1)(2008-3#1)
less efficient than the##2##4##(2008-11#1)(2008-9#1)
less efficient than##7##3##(1990-12#1)(1995-2#2)(2008-11#1)(2008-9#1)(2012-12#2)
less efficient##20##2##(1990-11#1)(1990-12#1)(1990-5#1)(1995-1#1)(1995-2#2)(1995-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-5#1)
less efficiently than##2##3##(1990-12#1)(1992-6#1)
less efficiently##4##2##(1990-12#1)(1991-7#1)(1992-6#1)(2008-10#1)
less emotional##2##2##(1994-1#1)(1995-1#1)
less energy##2##2##(2008-7#1)(2013-1#1)
less evident##6##2##(1990-2#1)(1992-2#1)(1994-3#1)(1995-5#1)(2007-12#1)(2009-1#1)
less expensive than##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
less expensive##15##2##(1992-1#1)(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#1)
less extensive surgery##2##3##(1992-5#1)(2008-6#1)
less extensive##10##2##(1992-5#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-6#1)(2012-12#1)(2012-3#1)
less favorable##7##2##(1997-2#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#2)
less favorably##2##2##(2008-10#1)(2008-7#1)
less flexion##2##2##(2008-9#2)
less for##7##2##(2008-10#3)(2008-9#1)(2011-2#1)(2012-2#2)
less frequency##3##2##(1995-8#1)(2010-8#1)(2011-2#1)
less frequent in##6##3##(1994-6#1)(2011-2#3)(2013-1#2)
less frequent than##4##3##(1996-11#1)(2007-8#1)(2008-10#1)(2008-6#1)
less frequent variants##2##3##(2012-3#2)
less frequent##24##2##(1990-5#1)(1990-6#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
less frequently in##2##3##(2008-4#1)(2011-2#1)
less frequently than##2##3##(2008-10#1)(2013-1#1)
less frequently##29##2##(1990-12#1)(1992-10#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)
less gastrointestinal##2##2##(2008-5#1)(2008-8#1)
less good##4##2##(1996-6#1)(2008-3#1)(2010-3#1)(2011-2#1)
less harmful##4##2##(1990-11#1)(2008-10#1)(2008-6#1)(2012-3#1)
less highly aligned##2##3##(2013-1#2)
less hypothermia##2##2##(1993-12#2)
less immunogenic##3##2##(1992-2#1)(2008-1#1)(2012-2#1)
less impaired##2##2##(1994-8#1)(2008-9#1)
less importance##3##2##(2007-10#1)(2008-7#1)(2009-6#1)
less important than##4##3##(2008-11#1)(2008-9#1)(2009-2#1)(2010-6#1)
less important##20##2##(1990-5#1)(1991-2#2)(1992-6#1)(1993-2#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
less in the##8##3##(1994-11#1)(1995-3#1)(1997-6#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
less in##29##2##(1990-8#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-10#8)(2008-7#1)(2008-9#2)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)
less influenced by##3##3##(1997-2#1)(2008-3#1)(2012-3#1)
less influenced##4##2##(1997-2#1)(2007-11#1)(2008-3#1)(2012-3#1)
less information##2##2##(2008-6#1)(2011-2#1)
less inhibitory than##2##3##(2008-10#2)
less inoculum##2##2##(2008-10#1)(2008-11#1)
less input##2##2##(2008-2#1)(2012-2#1)
less intense##7##2##(1996-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)
less intensive##2##2##(2008-10#2)
less intrusive##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
less invasive and##4##3##(2008-10#1)(2008-7#2)(2010-12#1)
less invasive surgical##3##3##(2007-11#1)(2008-8#1)(2011-2#1)
less invasive than##2##3##(2008-4#1)(2009-3#1)
less invasive##18##2##(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#2)
less involved in##2##3##(2011-1#1)(2011-2#1)
less is known about the##7##5##(1990-5#1)(1991-2#1)(1994-3#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
less is known about##13##4##(1990-5#1)(1991-2#1)(1994-3#1)(1995-6#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
less is##17##2##(1990-5#1)(1991-2#1)(1993-12#2)(1994-3#1)(1995-6#1)(1996-9#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
less labor##2##2##(2008-11#2)
less laborious##3##2##(2008-10#3)
less leaf##2##2##(2008-10#2)
less likely than white##2##4##(1995-12#1)(1995-2#1)
less likely than##6##3##(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(2009-5#1)(2011-2#1)
less likely to be##11##4##(1994-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)
less likely to have##7##4##(1992-2#1)(1995-11#1)(1995-12#1)(2007-2#1)(2008-7#1)(2009-5#1)(2013-1#1)
less likely to provide##3##4##(1995-12#1)(2008-9#1)(2011-2#1)
less likely to receive##5##4##(1995-12#1)(2008-3#1)(2011-2#2)(2012-3#1)
less likely to smoke##2##4##(1991-11#1)(2011-2#1)
less likely to##50##3##(1991-11#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-12#4)(1996-11#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#2)(2009-7#2)(2010-11#1)(2011-2#10)(2012-12#2)(2012-3#1)(2013-1#1)
less likely##57##2##(1991-11#1)(1992-2#1)(1993-1#1)(1994-2#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#3)(2009-7#2)(2010-11#1)(2011-2#11)(2012-12#2)(2012-3#1)(2013-1#1)
less long-term##2##2##(2008-11#1)(2013-1#1)
less malignant##2##2##(1993-8#1)(1994-5#1)
less marked##4##2##(1990-12#1)(1997-8#1)(2008-11#1)(2008-3#1)
less morbidity than##2##3##(2008-7#1)(2011-2#1)
less morbidity##5##2##(1997-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
less negative##3##2##(1995-8#1)(1996-1#1)(2010-7#1)
less noisy##2##2##(2008-3#2)
less obvious##4##2##(1991-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
less of an##2##3##(1991-12#1)(1992-8#1)
less of the##2##3##(2008-10#2)
less of##4##2##(1991-12#1)(1992-8#1)(2008-10#2)
less often##8##2##(1990-8#1)(2007-1#1)(2007-5#1)(2008-11#1)(2008-4#1)(2011-2#3)
less on the##2##3##(2007-12#1)(2008-7#1)
less or more##2##3##(2010-3#1)(2012-3#1)
less or##4##2##(2010-3#1)(2012-3#3)
less pain##5##2##(1992-2#1)(1993-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
less pathogenic##2##2##(2008-10#2)
less polar environment##2##3##(1994-5#1)(2012-2#1)
less polar##4##2##(1990-2#1)(1994-5#1)(1997-7#1)(2012-2#1)
less positive potentials##2##3##(2008-10#2)
less positive values##3##3##(2008-10#3)
less positive##10##2##(2008-10#6)(2008-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
less postoperative##3##2##(1993-2#1)(2009-2#1)(2010-8#1)
less potent in##2##3##(1992-5#1)(1995-12#1)
less potent than the##2##4##(1994-6#1)(1995-12#1)
less potent than##7##3##(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)
less potent##17##2##(1991-12#1)(1991-5#1)(1992-1#1)(1992-5#1)(1992-6#1)(1994-11#2)(1994-6#2)(1994-8#1)(1995-12#4)(1995-5#1)(2008-3#1)(2008-8#1)
less power##2##2##(2007-11#1)(2010-8#1)
less precise##2##2##(2008-10#1)(2012-2#1)
less predictable##2##2##(2007-8#1)(2008-7#1)
less prevalent##3##2##(1993-1#1)(2011-2#1)(2012-3#1)
less prominent##6##2##(1995-2#1)(2007-12#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)
less prone to##4##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
less pronounced in the##2##4##(1994-2#1)(2011-1#1)
less pronounced in##5##3##(1994-2#1)(1996-5#1)(2008-3#1)(2011-1#1)(2012-6#1)
less pronounced than in the##3##5##(1990-2#1)(1992-11#1)(2006-6#1)
less pronounced than in##4##4##(1990-2#1)(1992-11#1)(2006-6#1)(2012-1#1)
less pronounced than##6##3##(1990-2#1)(1992-11#1)(2006-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
less pronounced when the##2##4##(2008-10#1)(2008-4#1)
less pronounced##23##2##(1990-2#3)(1992-11#1)(1994-2#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#2)(2011-1#1)(2012-1#1)(2012-6#1)
less protection against##2##3##(1991-6#1)(2008-10#1)
less protective##2##2##(1992-2#1)(2008-10#1)
less reactive with##2##3##(1993-8#1)(2008-6#1)
less reactive##3##2##(1993-8#1)(2008-6#1)(2010-4#1)
less reliable##5##2##(2007-10#1)(2008-10#2)(2012-2#1)(2013-1#1)
less resistant to##3##3##(1995-3#1)(1996-2#1)(1996-5#1)
less responsive to##2##3##(2008-1#1)(2008-9#1)
less responsive##4##2##(2008-1#1)(2008-9#1)(2010-2#1)(2010-3#1)
less rigid##2##2##(1993-12#1)(2011-1#1)
less risk of##2##3##(2008-10#1)(2013-8#1)
less risk##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
less risky##3##2##(1990-2#1)(2009-7#1)(2013-1#1)
less robust##4##2##(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)
less satisfactory##3##2##(2008-10#2)(2008-9#1)
less satisfied than##2##3##(1996-2#2)
less satisfied with##2##3##(1995-12#1)(2010-10#1)
less satisfied##5##2##(1992-3#1)(1995-12#1)(1996-2#2)(2010-10#1)
less sedating##2##2##(1992-12#1)(2007-11#1)
less sedentary behavior##2##3##(2013-1#2)
less segregated from##3##3##(2011-2#3)
less selective##3##2##(1995-5#1)(1996-2#1)(2008-10#1)
less sensitive than##3##3##(2008-10#1)(2010-6#1)(2010-7#1)
less sensitive to noise than##2##5##(2008-2#2)
less sensitive to temperature##2##4##(2007-11#1)(2008-9#1)
less sensitive to the##5##4##(2008-10#3)(2008-2#1)(2008-8#1)
less sensitive to##26##3##(1990-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-11#2)(2008-10#4)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-1#1)
less sensitive##40##2##(1990-5#1)(1991-1#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)
less severe and##2##3##(2008-10#1)(2012-1#1)
less severe form##2##3##(1997-3#1)(2011-1#1)
less severe in##4##3##(1994-5#1)(1997-2#1)(2007-11#1)(2008-10#1)
less severe than the##2##4##(2008-5#1)(2008-8#1)
less severe than##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
less severe##23##2##(1994-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
less sharply##2##2##(2006-12#1)(2012-12#1)
less significant##6##2##(2007-10#1)(2008-10#2)(2008-3#1)(2013-1#2)
less similar##2##2##(2008-10#2)
less similarity to##2##3##(1995-8#1)(2008-10#1)
less so##2##2##(1994-2#1)(2008-10#1)
less social support##2##3##(1996-2#1)(2008-12#1)
less social##4##2##(1996-2#1)(2008-12#1)(2009-8#1)(2011-1#1)
less sophisticated##3##2##(1997-6#1)(2009-10#1)(2011-2#1)
less specific##7##2##(1991-2#1)(2008-10#4)(2008-7#1)(2012-2#1)
less stable than##3##3##(1994-6#2)(2008-9#1)
less stable##12##2##(1990-2#1)(1992-6#1)(1994-6#2)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)
less stress and##2##3##(2013-1#2)
less stringent##5##2##(1995-6#1)(2007-11#1)(2008-12#1)(2008-3#1)(2010-11#1)
less strong##3##2##(1992-11#1)(2008-10#1)(2013-8#1)
less strongly##3##2##(2007-12#1)(2008-10#1)(2010-2#1)
less successful##4##2##(1991-2#1)(1993-2#1)(1994-2#1)(2008-10#1)
less suitable##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
less suited for##2##3##(2008-10#1)(2012-12#1)
less susceptible to the##2##4##(1996-12#1)(2011-2#1)
less susceptible to##10##3##(1991-2#2)(1993-12#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)
less susceptible##12##2##(1991-2#2)(1993-12#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-2#1)(2009-9#1)(2011-2#1)
less tense and elastic##2##4##(2008-5#2)
less than 0##206##3##(1990-11#2)(1990-12#11)(1990-2#10)(1990-3#7)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#4)(1991-11#5)(1991-12#7)(1991-2#8)(1991-3#2)(1991-4#4)(1991-5#9)(1991-6#4)(1991-8#3)(1991-9#21)(1992-12#4)(1992-2#9)(1992-3#7)(1992-5#4)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#2)(1994-1#4)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#1)(1996-2#1)(1996-6#1)(2007-11#6)(2008-10#20)(2008-2#7)(2008-3#15)(2008-6#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
less than 1 and##2##4##(2008-10#1)(2008-3#1)
less than 1 min##2##4##(2008-3#2)
less than 1 mm##2##4##(2008-3#1)(2008-9#1)
less than 1 month##2##4##(1990-2#1)(2008-11#1)
less than 1 ms##2##4##(2007-12#2)
less than 1 nm##3##4##(2008-3#3)
less than 1 percent##2##4##(1992-1#1)(2008-1#1)
less than 1 year##3##4##(1991-2#1)(1995-8#1)(2012-3#1)
less than 1##72##3##(1990-2#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-9#1)(1994-1#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#4)(2008-3#14)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#3)
less than 1% and##2##4##(2008-10#2)
less than 1% for##2##4##(1996-5#1)(2008-2#1)
less than 1% of all##4##5##(1997-1#1)(2010-3#1)(2013-7#2)
less than 1% of the##3##5##(1996-5#1)(2008-10#1)(2008-3#1)
less than 1% of##12##4##(1996-11#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-3#1)(2013-7#2)
less than 1%##34##3##(1990-8#1)(1992-12#1)(1992-2#1)(1996-11#1)(1996-5#3)(1997-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2010-3#1)(2013-7#2)
less than 10 cm##2##4##(1997-8#1)(2007-8#1)
less than 10 nm##2##4##(2007-12#1)(2008-2#1)
less than 10##23##3##(1990-12#1)(1992-8#1)(1996-5#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
less than 10% of the##3##5##(2007-2#1)(2008-10#2)
less than 10% of##10##4##(1990-5#1)(2007-2#1)(2007-7#1)(2008-10#3)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#1)
less than 10%##25##3##(1990-5#1)(1995-12#1)(1996-12#1)(2007-2#1)(2007-7#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
less than 10(-5)##2##3##(2008-2#2)
less than 100 mg/dL##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
less than 100##15##3##(1990-5#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-3#7)(2008-5#1)(2011-2#1)(2012-3#1)
less than 10min##3##3##(2008-10#3)
less than 11##2##3##(2008-10#2)
less than 12##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
less than 12%##2##3##(2008-10#1)(2008-3#1)
less than 14##2##3##(2008-10#1)(2013-8#1)
less than 15##3##3##(1991-5#1)(2007-7#1)(2008-10#1)
less than 15%##3##3##(2008-10#1)(2008-3#1)(2011-3#1)
less than 150##3##3##(1996-12#1)(2008-1#1)(2011-2#1)
less than 1500 g##3##4##(1992-2#1)(2008-11#2)
less than 16##2##3##(2008-2#2)
less than 18##2##3##(2007-11#1)(2009-11#1)
less than 180##2##3##(2007-8#1)(2008-3#1)
less than 2 cm##3##4##(1990-9#1)(1991-4#1)(1997-4#1)
less than 2 nm##2##4##(2008-3#2)
less than 2 x 10(-4)##2##5##(1996-12#1)(2008-2#1)
less than 2##34##3##(1990-9#1)(1991-4#2)(1991-8#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#5)(2009-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
less than 2% of all##3##5##(2007-5#1)(2010-6#1)(2013-1#1)
less than 2% of the##2##5##(2009-11#1)(2011-2#1)
less than 2% of##6##4##(1990-11#1)(2007-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
less than 2%##18##3##(1990-11#1)(1996-8#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-3#3)(2009-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
less than 20 min##2##4##(1994-3#1)(2008-10#1)
less than 20##13##3##(1990-12#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)
less than 20% of##3##4##(1996-5#1)(1997-4#1)(2008-8#1)
less than 20%##7##3##(1996-5#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
less than 200##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
less than 24##2##3##(1995-5#1)(2007-8#1)
less than 24 hours post operatively from a tonsillectomy##2##8##(2013-1#2)
less than 25##6##3##(1993-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
less than 25%##2##3##(1993-11#1)(2008-11#1)
less than 27##2##3##(2007-11#1)(2008-7#1)
less than 2s##2##3##(2008-10#1)(2013-1#1)
less than 3 MHz##2##4##(2007-11#1)(2007-12#1)
less than 3##22##3##(1990-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)
less than 3% for all##2##5##(2008-10#1)(2008-3#1)
less than 3%##6##3##(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#1)
less than 3-kDa##2##3##(1990-5#2)
less than 30 minutes##2##4##(1993-1#1)(1997-2#1)
less than 30 s##4##4##(1990-5#1)(2008-10#3)
less than 30##10##3##(1990-5#1)(1993-1#1)(1994-12#1)(1997-2#1)(2008-10#3)(2008-6#1)(2011-1#1)(2011-3#1)
less than 32##2##3##(1992-2#1)(2008-10#1)
less than 37##2##3##(2007-12#1)(2011-2#1)
less than 4 min##3##4##(2008-10#2)(2008-2#1)
less than 4##16##3##(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#2)(2010-9#1)(2012-12#1)(2013-8#2)
less than 4% in##2##4##(2008-1#1)(2008-10#1)
less than 4%##14##3##(1990-6#1)(1991-11#1)(2008-1#1)(2008-10#7)(2008-3#3)(2011-1#1)
less than 40 years##3##4##(1997-8#1)(2013-1#2)
less than 40##6##3##(1996-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2013-1#2)
less than 4min##2##3##(2008-10#2)
less than 5 and##2##4##(2008-10#1)(2011-2#1)
less than 5 min##5##4##(1993-3#1)(2008-10#2)(2008-7#1)(2011-1#1)
less than 5 s##2##4##(2008-10#1)(2008-3#1)
less than 5##20##3##(1990-7#1)(1991-2#1)(1992-3#1)(1993-3#1)(1995-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)
less than 5% and##2##4##(2008-10#1)(2008-3#1)
less than 5% error##2##4##(2008-2#1)(2012-2#1)
less than 5% for both##3##5##(2008-10#3)
less than 5% for##4##4##(2008-10#4)
less than 5% in##3##4##(1994-9#1)(2008-10#2)
less than 5% of the##3##5##(1995-2#1)(2008-10#1)(2008-5#1)
less than 5% of##9##4##(1991-12#1)(1995-2#1)(1995-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
less than 5%##37##3##(1991-12#1)(1992-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-10#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#2)
less than 5%)##2##3##(2008-10#2)
less than 50 percent##2##4##(1994-3#1)(1995-2#1)
less than 50##14##3##(1990-7#1)(1991-2#1)(1991-6#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#4)(2011-1#1)(2013-1#1)
less than 50% in##2##4##(1997-3#1)(2008-5#1)
less than 50% of##3##4##(1993-12#1)(1994-3#1)(2013-1#1)
less than 50%##13##3##(1993-12#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
less than 500##3##3##(2008-3#1)(2012-2#1)(2012-3#1)
less than 5min##2##3##(2008-10#2)
less than 6 months##2##4##(2008-11#1)(2013-1#1)
less than 6##12##3##(1992-6#1)(1994-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#2)
less than 60##6##3##(2007-12#2)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
less than 7##9##3##(1990-2#1)(1990-5#1)(1996-11#1)(2007-11#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-3#1)
less than 7%##3##3##(2008-10#1)(2008-2#2)
less than 70##4##3##(2008-1#3)(2012-3#1)
less than 75 years old##3##5##(1993-9#2)(2008-5#1)
less than 75 years##4##4##(1991-2#1)(1993-9#2)(2008-5#1)
less than 75##6##3##(1991-2#1)(1993-9#2)(2008-10#1)(2008-2#1)(2008-5#1)
less than 8 min##2##4##(2008-10#2)
less than 8##7##3##(1995-3#1)(2008-10#5)(2008-2#1)
less than 8% for##2##4##(2008-10#1)(2008-5#1)
less than 8%##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
less than 90##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
less than a minute##2##4##(2007-12#1)(2008-11#1)
less than a##10##3##(1995-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
less than about 10##2##4##(2008-1#2)
less than approximately##9##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)
less than at##2##3##(2008-10#1)(2008-3#1)
less than did##2##3##(2008-10#2)
less than earlier##2##3##(1993-12#1)(2008-10#1)
less than expected##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
less than four##5##3##(1993-6#1)(1997-4#1)(2008-10#3)
less than half of the##3##5##(1995-6#1)(2008-1#1)(2008-7#1)
less than half of##4##4##(1994-2#1)(1995-6#1)(2008-1#1)(2008-7#1)
less than half the##2##4##(1995-5#1)(2008-3#1)
less than half##8##3##(1994-2#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
less than ideal##2##3##(2008-5#1)(2012-2#1)
less than in the##4##4##(1996-12#1)(2008-10#2)(2008-7#1)
less than in##11##3##(1992-9#1)(1995-12#2)(1996-12#1)(2007-12#1)(2008-10#4)(2008-7#1)(2012-2#1)
less than one half##2##4##(1991-6#1)(2008-2#1)
less than one##17##3##(1990-12#1)(1991-6#1)(1992-9#1)(1994-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2009-2#1)(2012-3#1)(2013-8#1)
less than optimal##4##3##(1991-2#1)(1996-11#1)(1997-2#1)(2013-1#1)
less than or comparable with the##2##6##(2007-12#1)(2008-3#1)
less than or equal to 0##5##6##(1990-3#3)(1990-6#2)
less than or equal to 60##2##6##(1991-2#1)(1991-6#1)
less than or equal to##15##5##(1990-12#1)(1990-3#4)(1990-6#2)(1991-2#1)(1991-5#1)(1991-6#1)(1993-2#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
less than or##18##3##(1990-12#1)(1990-3#4)(1990-6#2)(1991-2#1)(1991-5#1)(1991-6#1)(1993-2#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
less than other##2##3##(1993-11#1)(2008-11#1)
less than predicted##2##3##(2008-10#1)(2008-3#1)
less than seven##2##3##(1990-3#1)(1997-2#1)
less than that by##4##4##(2008-9#3)(2010-2#1)
less than that in the##2##5##(1994-12#1)(1994-6#1)
less than that of the##6##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
less than that of##11##4##(1990-12#1)(1992-6#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)
less than that with the##2##5##(2008-10#2)
less than that with##3##4##(1993-6#1)(2008-10#2)
less than that##24##3##(1990-11#1)(1990-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#5)(2010-2#1)
less than the mean of the components in##2##8##(2008-10#2)
less than the mean of the components##3##7##(2008-10#3)
less than the##33##3##(1992-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#6)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
less than those of the control groups##4##7##(2008-9#4)
less than those of the control##8##6##(2008-9#8)
less than those of the vehicle controls##12##7##(2008-9#12)
less than those of the vehicle##13##6##(2008-9#13)
less than those of the##30##5##(1990-5#1)(1991-11#1)(2008-11#1)(2008-8#1)(2008-9#26)
less than those of##34##4##(1990-5#1)(1991-11#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#26)(2010-4#1)(2013-7#1)
less than those##37##3##(1990-5#1)(1991-11#1)(1991-3#1)(1993-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#26)(2010-4#1)(2013-7#1)
less than three##3##3##(1996-11#1)(2007-2#1)(2011-2#1)
less than two years##2##4##(1996-3#1)(2012-12#1)
less than two##3##3##(1995-11#1)(1996-3#1)(2012-12#1)
less than unity##4##3##(1990-8#1)(2008-3#3)
less than##1092##2##(1990-11#5)(1990-12#20)(1990-2#16)(1990-3#12)(1990-4#1)(1990-5#13)(1990-6#5)(1990-7#8)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#7)(1991-12#8)(1991-2#14)(1991-3#3)(1991-4#7)(1991-5#11)(1991-6#9)(1991-8#5)(1991-9#21)(1992-1#1)(1992-12#5)(1992-2#13)(1992-3#9)(1992-5#4)(1992-6#4)(1992-8#5)(1992-9#6)(1993-1#4)(1993-11#2)(1993-12#5)(1993-2#7)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#5)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#8)(1995-6#2)(1995-8#1)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-10#4)(2007-11#20)(2007-12#27)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#8)(2008-1#16)(2008-10#248)(2008-11#23)(2008-12#2)(2008-2#54)(2008-3#116)(2008-4#2)(2008-5#20)(2008-6#6)(2008-7#14)(2008-8#8)(2008-9#39)(2009-11#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#23)(2011-3#3)(2012-1#2)(2012-12#2)(2012-2#18)(2012-3#17)(2013-1#22)(2013-7#4)(2013-8#9)
less that##2##2##(2008-10#1)(2013-8#1)
less the##4##2##(2008-10#2)(2008-2#1)(2009-4#1)
less then##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
less they##2##2##(2008-5#1)(2009-7#1)
less time consuming##4##3##(2008-10#2)(2008-5#1)(2013-8#1)
less time in##2##3##(1992-3#1)(2008-11#1)
less time##15##2##(1992-3#1)(1996-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-8#1)
less time-consuming than##3##3##(1992-6#1)(1993-9#1)(2009-10#1)
less time-consuming##5##2##(1992-6#1)(1993-9#1)(2008-10#1)(2008-5#1)(2009-10#1)
less to##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
less toxic than##6##3##(1994-5#2)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
less toxic to##2##3##(2008-10#1)(2013-1#1)
less toxic##17##2##(1991-8#1)(1994-5#2)(1995-3#1)(1997-4#1)(2007-11#2)(2008-10#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
less toxicity than##2##3##(2008-3#2)
less traumatic##2##2##(2010-7#1)(2012-3#1)
less tumorigenic##2##2##(1992-9#1)(1994-5#1)
less variable##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
less virulent than##5##3##(2008-10#5)
less virulent##10##2##(2006-6#1)(2008-10#9)
less vulnerable to##2##3##(1996-11#1)(2009-8#1)
less well defined##2##3##(1993-11#1)(2013-1#1)
less well established##2##3##(2008-1#1)(2011-2#1)
less well known##2##3##(2008-11#1)(2008-7#1)
less well than##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
less well understood##4##3##(1995-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
less well##21##2##(1992-3#1)(1993-11#1)(1994-6#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
less when##3##2##(2007-7#1)(2008-10#1)(2008-11#1)
less with a##2##3##(2008-10#2)
less with##3##2##(1992-9#1)(2008-10#2)
less##2618##1##(1990-11#8)(1990-12#27)(1990-2#26)(1990-3#17)(1990-4#1)(1990-5#21)(1990-6#7)(1990-7#9)(1990-8#8)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#9)(1991-12#16)(1991-2#22)(1991-3#4)(1991-4#8)(1991-5#13)(1991-6#14)(1991-7#1)(1991-8#7)(1991-9#24)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#10)(1992-2#22)(1992-3#13)(1992-5#9)(1992-6#13)(1992-8#9)(1992-9#11)(1993-1#9)(1993-11#7)(1993-12#20)(1993-2#16)(1993-3#3)(1993-5#2)(1993-6#8)(1993-8#4)(1993-9#6)(1994-1#8)(1994-11#10)(1994-12#7)(1994-2#17)(1994-3#8)(1994-5#10)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#4)(1995-1#8)(1995-11#11)(1995-12#26)(1995-2#13)(1995-3#10)(1995-4#1)(1995-5#17)(1995-6#9)(1995-8#9)(1995-9#1)(1996-1#5)(1996-11#9)(1996-12#9)(1996-2#17)(1996-3#8)(1996-4#1)(1996-5#13)(1996-6#7)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#14)(1997-3#12)(1997-4#15)(1997-5#4)(1997-6#8)(1997-7#6)(1997-8#6)(2006-10#1)(2006-12#2)(2006-6#2)(2007-1#1)(2007-10#12)(2007-11#42)(2007-12#46)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#18)(2007-9#3)(2008-1#36)(2008-10#509)(2008-11#67)(2008-12#23)(2008-2#83)(2008-3#160)(2008-4#18)(2008-5#53)(2008-6#23)(2008-7#52)(2008-8#47)(2008-9#87)(2009-1#2)(2009-10#9)(2009-11#11)(2009-12#10)(2009-2#6)(2009-3#5)(2009-4#6)(2009-5#10)(2009-6#4)(2009-7#14)(2009-8#9)(2009-9#7)(2010-1#2)(2010-10#5)(2010-11#8)(2010-12#8)(2010-2#5)(2010-3#8)(2010-4#9)(2010-5#8)(2010-6#9)(2010-7#7)(2010-8#13)(2010-9#4)(2011-1#23)(2011-10#1)(2011-2#111)(2011-3#4)(2011-7#1)(2012-1#8)(2012-12#21)(2012-2#49)(2012-3#45)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#83)(2013-7#4)(2013-8#30)
less-healthy##2##1##(2011-2#2)
less-thans##3##1##(2008-10#3)
lessen the##4##2##(1991-3#1)(1997-2#1)(1997-8#1)(2008-9#1)
lessen##8##1##(1990-4#1)(1991-3#1)(1994-2#1)(1997-2#1)(1997-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
lessened##2##1##(1997-7#1)(2009-1#1)
lessening##6##1##(1991-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
lessens the##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
lessens##4##1##(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)
lesser amounts of the##2##4##(1995-6#1)(2008-11#1)
lesser amounts##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
lesser degree##15##2##(1991-12#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)
lesser extent in##5##3##(1995-12#1)(1997-2#1)(1997-9#1)(2007-11#1)(2008-11#1)
lesser extent to##2##3##(1990-11#1)(2011-2#1)
lesser extent##68##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#1)(1997-9#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#15)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)
lesser rheas##3##2##(2013-1#3)
lesser than##5##2##(2007-7#1)(2008-10#1)(2009-6#1)(2013-1#2)
lesser##132##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-2#3)(1997-5#2)(1997-7#1)(1997-9#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#5)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#12)(2012-12#2)(2012-2#3)(2013-1#8)
lesson from##2##2##(1996-3#1)(1997-4#1)
lesson in##3##2##(1991-3#1)(1992-2#1)(1995-12#1)
lesson learned##2##2##(2008-7#1)(2008-8#1)
lesson of a five-part WMU/AHRA magazine course on ethics##3##9##(1991-12#1)(1992-1#1)(1992-2#1)
lesson of##6##2##(1991-12#1)(1992-1#1)(1992-2#1)(2008-2#1)(2012-2#2)
lesson##21##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1993-2#1)(1995-12#1)(1996-3#1)(1997-4#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#2)(2013-1#1)
lessons about strategy and implementation##3##5##(1996-1#2)(1996-2#1)
lessons about##4##2##(1996-1#2)(1996-2#1)(2010-8#1)
lessons associated with##2##3##(1996-2#1)(2008-12#1)
lessons for##7##2##(1991-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-11#1)
lessons from a##3##3##(2008-1#1)(2008-8#1)(2012-3#1)
lessons from the field##3##4##(1996-2#1)(2008-1#1)(2013-8#1)
lessons from the##13##3##(1993-2#1)(1994-12#1)(1996-2#2)(1997-8#1)(2008-1#2)(2008-10#2)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
lessons from##34##2##(1992-2#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-1#2)(1996-2#2)(1997-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
lessons have been##2##3##(2008-10#1)(2008-12#1)
lessons have##3##2##(2008-10#2)(2008-12#1)
lessons in##3##2##(1991-8#1)(1992-2#1)(2008-10#1)
lessons learned and##3##3##(1994-2#1)(1995-12#1)(2009-10#1)
lessons learned during##3##3##(1995-3#1)(2008-1#1)(2010-7#1)
lessons learned for greater success##2##5##(1994-1#2)
lessons learned for##3##3##(1994-1#2)(2011-2#1)
lessons learned from a##3##4##(2008-8#1)(2010-8#1)(2012-3#1)
lessons learned from conducting an online randomized controlled trial##2##9##(2010-10#2)
lessons learned from this##4##4##(1993-12#1)(1994-3#2)(2012-2#1)
lessons learned from##11##3##(1993-12#1)(1994-3#2)(1997-2#1)(2008-8#1)(2010-10#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
lessons learned in##2##3##(1995-12#1)(2008-8#1)
lessons learned##43##2##(1993-12#1)(1993-3#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#2)(2009-10#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#1)
lessons learnt from the##3##4##(2007-7#1)(2009-2#1)(2010-5#1)
lessons learnt##5##2##(2007-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
lessons may be##2##3##(1993-12#1)(2012-2#1)
lessons of##2##2##(1991-2#1)(1993-2#1)
lessons that##6##2##(1993-12#1)(1995-12#1)(1996-12#1)(2008-12#1)(2008-7#1)(2009-6#1)
lessons to be learned##2##4##(1993-1#1)(2008-12#1)
lessons to be##3##3##(1993-1#1)(2008-12#2)
lessons to learn##2##3##(2008-10#1)(2013-1#1)
lessons to##5##2##(1993-1#1)(2008-10#1)(2008-12#2)(2013-1#1)
lessons we have learned##2##4##(2008-3#1)(2009-8#1)
lessons we##3##2##(2008-3#1)(2009-8#1)(2012-2#1)
lessons were learned##3##3##(1991-2#1)(1996-2#1)(2011-2#1)
lessons were##4##2##(1991-2#1)(1996-2#1)(2007-5#1)(2011-2#1)
lessons##139##1##(1991-12#1)(1991-2#3)(1991-8#1)(1992-2#2)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#2)(1996-1#5)(1996-12#2)(1996-2#5)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#3)(2007-7#1)(2008-1#5)(2008-10#6)(2008-11#6)(2008-12#7)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#2)
let the##7##2##(1994-1#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-3#1)(2008-6#1)(2009-5#1)
let us##4##2##(1992-12#1)(2007-11#1)(2007-8#1)(2008-8#1)
let##24##1##(1991-9#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#2)(2013-8#2)
let-60 ras##4##2##(1990-11#4)
let-60##8##1##(1990-11#8)
let-7 expression##3##2##(2008-7#2)(2012-12#1)
let-7 in normal fimbrial epithelial cells of##2##7##(2012-12#2)
let-7##15##1##(2008-1#2)(2008-7#7)(2012-12#6)
lethal Escherichia coli septic shock##2##5##(1995-2#2)
lethal arrhythmias##4##2##(1995-12#2)(2012-12#1)(2013-1#1)
lethal candidiasis##2##2##(2008-5#2)
lethal challenge##2##2##(1995-2#1)(2012-2#1)
lethal complication##3##2##(2012-1#1)(2012-12#2)
lethal concentration (LC(50))##2##3##(2008-10#1)(2013-1#1)
lethal concentration##3##2##(2008-10#2)(2013-1#1)
lethal condition##2##2##(2008-10#2)
lethal disease##4##2##(1995-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
lethal dose##3##2##(1995-11#1)(2007-10#1)(2008-11#1)
lethal doses##2##2##(2008-10#1)(2013-1#1)
lethal event##2##2##(1994-3#1)(2010-7#1)
lethal for##4##2##(1996-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
lethal in##2##2##(1997-3#1)(2012-3#1)
lethal milk mouse##3##3##(2008-10#3)
lethal outcome##2##2##(2011-2#1)(2013-1#1)
lethal phenotype##3##2##(1995-2#1)(1997-3#1)(2008-12#1)
lethal photosensitization##2##2##(2012-2#2)
lethal seizures##2##2##(1995-12#2)
lethal systemic##2##2##(1990-9#1)(2010-3#1)
lethal to##5##2##(1992-3#1)(1992-8#1)(1993-12#1)(2008-10#2)
lethal##128##1##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-3#2)(1992-8#3)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1997-3#3)(1997-4#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#3)(2009-6#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#1)
lethality and##5##2##(1993-12#1)(1996-12#1)(1997-3#1)(2009-10#1)(2011-2#1)
lethality data##2##2##(1996-12#1)(2008-7#1)
lethality from##2##2##(1996-12#2)
lethality in a dose-dependent manner##2##5##(1996-12#2)
lethality in##5##2##(1990-9#1)(1995-2#1)(1996-12#2)(2008-5#1)
lethality of##8##2##(1994-5#1)(1994-8#1)(1996-12#1)(1997-6#1)(1997-8#3)(2008-4#1)
lethality was##2##2##(1992-3#1)(1993-12#1)
lethality##41##1##(1990-9#1)(1992-3#1)(1993-12#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#10)(1997-3#1)(1997-6#1)(1997-8#6)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
lethally irradiated mice##2##3##(2008-10#1)(2008-9#1)
lethally irradiated##5##2##(1997-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
lethargy and##2##2##(1997-6#1)(2013-7#1)
lethargy##7##1##(1997-6#1)(2008-11#1)(2008-7#2)(2012-3#1)(2013-7#1)(2013-8#1)
lets us##2##2##(2008-3#1)(2008-6#1)
lets##3##1##(2008-3#1)(2008-6#1)(2013-1#1)
letter and##2##2##(2008-11#1)(2008-12#1)
letter fluency##2##2##(1996-2#2)
letter identity##2##2##(2012-1#2)
letter of##4##2##(1992-2#1)(2008-5#2)(2008-7#1)
letter or##2##2##(2007-2#1)(2011-1#1)
letter regarding##2##2##(1996-3#1)(2013-8#1)
letter to the##4##3##(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)
letter to##5##2##(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)
letter##47##1##(1992-2#1)(1996-2#2)(1996-3#1)(1997-2#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#8)(2013-8#1)
letters and##6##2##(1990-9#1)(2008-10#1)(2010-5#1)(2013-1#2)(2013-8#1)
letters of##2##2##(1991-9#1)(2013-8#1)
letters or##2##2##(1990-8#1)(1997-3#1)
letters requesting##2##2##(1992-8#1)(2010-8#1)
letters to the left and right of##2##7##(2009-2#2)
letters to the left##3##4##(2009-2#3)
letters to the##4##3##(1993-10#1)(2009-2#3)
letters to##6##2##(1993-10#1)(2008-3#1)(2009-2#3)(2010-8#1)
letters were##2##2##(2007-12#1)(2013-8#1)
letters##53##1##(1990-8#1)(1990-9#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-2#4)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2009-12#1)(2009-2#5)(2010-5#1)(2010-8#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#5)
letting the##2##2##(1995-1#1)(2009-5#1)
letting##8##1##(1991-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-5#1)
lettuce (Lactuca sativa)##2##3##(2008-10#2)
lettuce and##15##2##(1997-4#1)(2008-10#10)(2008-11#1)(2008-5#2)(2010-10#1)
lettuce by##2##2##(2008-10#2)
lettuce crops##2##2##(2008-10#2)
lettuce cultivars##2##2##(2008-10#2)
lettuce downy mildew##4##3##(2008-10#4)
lettuce drop incidence##3##3##(2008-10#3)
lettuce drop##8##2##(2008-10#8)
lettuce in Ohio##2##3##(2008-10#2)
lettuce infected with##2##3##(2008-10#2)
lettuce infectious yellows virus##3##4##(2008-10#3)
lettuce is##3##2##(2008-10#2)(2008-11#1)
lettuce leaves##2##2##(2008-10#2)
lettuce plants and##2##3##(2008-10#1)(2010-10#1)
lettuce plants##8##2##(2008-10#7)(2010-10#1)
lettuce production##2##2##(2008-10#2)
lettuce seedlings##4##2##(2008-10#4)
lettuce to##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
lettuce##111##1##(1997-4#1)(2008-10#97)(2008-11#4)(2008-12#1)(2008-5#4)(2010-10#3)(2013-8#1)
lettuce)##3##1##(2008-10#3)
leu-enkephalin##2##1##(2012-1#2)
leucine aminopeptidase##5##2##(1992-3#1)(1992-5#2)(1993-6#1)(2012-6#1)
leucine and##7##2##(1994-8#1)(2008-10#1)(2008-11#3)(2009-5#2)
leucine at##2##2##(1992-3#1)(2013-8#1)
leucine for##2##2##(1992-8#1)(1993-8#1)
leucine residue##2##2##(1992-3#1)(1994-9#1)
leucine rich repeat##2##3##(2008-9#2)
leucine zipper structure##3##3##(1992-8#3)
leucine zipper##9##2##(1992-3#3)(1992-8#3)(1993-12#2)(1996-6#1)
leucine##59##1##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#6)(1992-5#2)(1992-6#4)(1992-8#4)(1993-11#2)(1993-12#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-5#1)(1995-6#3)(1996-6#1)(1997-7#1)(1997-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#3)(2010-6#1)(2012-6#1)(2013-8#1)
leucine-rich repeat##3##2##(2009-6#2)(2009-8#1)
leucine-rich##5##1##(1992-10#1)(2007-8#1)(2009-6#2)(2009-8#1)
leucine-zipper##2##1##(1994-12#1)(2008-9#1)
leucinostatin A##2##2##(1994-3#2)
leucisculus##5##1##(2012-2#5)
leucite and apatite glass-ceramics##2##4##(2009-7#2)
leucite##3##1##(2009-7#3)
leuco Xylene cyanol FF##2##4##(2008-10#2)
leuco Xylene##3##2##(2008-10#3)
leuco crystal violet##2##3##(2008-10#2)
leuco##5##1##(2008-10#5)
leucocrystal violet##2##2##(2008-10#2)
leucocyte counts##2##2##(1990-10#1)(2008-10#1)
leucocyte##12##1##(1990-10#1)(1991-12#2)(1993-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
leucocytes in##2##2##(2008-10#1)(2011-2#1)
leucocytes##16##1##(1990-2#1)(1990-7#2)(1991-11#4)(1991-5#2)(1994-11#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
leucocytosis and##2##2##(1993-6#1)(2009-11#1)
leucocytosis##5##1##(1993-6#1)(1995-3#1)(1997-8#1)(2008-12#1)(2009-11#1)
leucogenys##4##1##(2008-5#4)
leucomelas##3##1##(2011-2#3)
leucopenia##3##1##(2007-11#1)(2007-2#1)(2008-7#1)
leucovorin##6##1##(1990-2#1)(1991-4#3)(2008-10#1)(2010-3#1)
leucrose##2##1##(1992-12#2)
leucyl##2##1##(1990-2#1)(1993-6#1)
leucémie aiguë##6##2##(2013-1#6)
leucémies aiguës myéloblastiques##2##3##(2013-1#2)
leucémies aiguës##3##2##(2013-1#3)
leukaemia after##2##2##(1991-11#1)(2010-11#1)
leukaemia and##6##2##(1991-11#1)(1991-8#1)(1992-5#1)(1997-8#1)(2008-7#1)(2009-3#1)
leukaemia in##3##2##(1991-11#1)(2011-2#1)(2013-8#1)
leukaemia is##3##2##(2008-5#1)(2011-3#1)(2013-8#1)
leukaemia with##2##2##(1993-2#1)(2011-3#1)
leukaemia##55##1##(1990-9#1)(1991-11#3)(1991-8#1)(1992-5#1)(1993-2#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-8#4)(2006-6#2)(2008-11#3)(2008-12#6)(2008-5#6)(2008-7#2)(2009-12#1)(2009-3#4)(2009-4#1)(2010-11#2)(2011-2#5)(2011-3#2)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
leukaemias##4##1##(1991-8#1)(1995-11#1)(2008-11#1)(2011-2#1)
leukaemic##2##1##(2010-11#1)(2013-7#1)
leukemia (ALL)##7##2##(1991-2#1)(1991-8#1)(2010-6#1)(2011-1#1)(2011-2#3)
leukemia (AML)##13##2##(1992-10#1)(2007-10#1)(2008-4#1)(2010-1#1)(2010-4#2)(2011-2#4)(2012-12#2)(2013-1#1)
leukemia (ATL)##4##2##(1991-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
leukemia (CML) is a clonal##2##5##(2010-4#1)(2012-12#1)
leukemia (CML) is##4##3##(2007-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
leukemia (CML)##11##2##(1990-2#1)(1991-4#1)(2006-10#1)(2007-11#1)(2009-7#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-12#2)
leukemia HL-60 cells##4##3##(1992-11#2)(2008-11#1)(2008-8#1)
leukemia and its##2##3##(1994-12#1)(2012-2#1)
leukemia and lymphoma##5##3##(1991-3#1)(1992-3#3)(2013-1#1)
leukemia and##23##2##(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#3)(1994-12#1)(1997-7#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
leukemia associated##2##2##(2011-2#2)
leukemia cell line HL-60##2##4##(1991-12#1)(1994-12#1)
leukemia cell line##11##3##(1991-12#2)(1991-4#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
leukemia cell lines A20##2##4##(2008-9#2)
leukemia cell lines##8##3##(1993-3#2)(2008-11#2)(2008-9#2)(2011-2#1)(2012-3#1)
leukemia cell##24##2##(1991-12#2)(1991-4#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(1997-4#1)(2007-4#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-3#1)
leukemia cells and##4##3##(1992-3#1)(1994-5#1)(2010-6#1)(2011-2#1)
leukemia cells by##4##3##(1991-4#1)(1994-11#1)(2011-2#1)(2012-12#1)
leukemia cells to##2##3##(1990-2#1)(2011-2#1)
leukemia cells with##2##3##(1990-6#1)(1991-9#1)
leukemia cells##32##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-4#3)(1991-9#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(2008-11#3)(2008-9#1)(2009-12#2)(2010-6#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)
leukemia have##2##2##(2008-7#1)(2009-8#1)
leukemia in a##3##3##(1990-8#2)(2009-8#1)
leukemia in##12##2##(1990-8#2)(1991-9#1)(1993-8#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#2)(2011-2#1)
leukemia inhibitory factor (LIF) and##2##5##(1994-9#1)(2009-3#1)
leukemia inhibitory factor (LIF)##6##4##(1991-12#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(2009-3#1)
leukemia inhibitory factor##8##3##(1991-12#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(2009-3#1)(2009-5#1)(2010-6#1)
leukemia is##5##2##(2007-12#1)(2009-8#2)(2010-1#1)(2011-2#1)
leukemia mortality##2##2##(1991-3#2)
leukemia or myelodysplastic syndrome##2##4##(1992-10#1)(2011-2#1)
leukemia or##5##2##(1991-3#1)(1992-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
leukemia patients with##2##3##(2012-12#1)(2012-2#1)
leukemia patients##8##2##(1991-2#1)(2007-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
leukemia presenting##2##2##(2008-11#1)(2011-2#1)
leukemia stem cells##3##3##(2010-4#1)(2011-2#2)
leukemia virus type##3##3##(1991-12#2)(2011-2#1)
leukemia virus##20##2##(1990-12#1)(1990-8#1)(1991-12#2)(1991-5#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-11#5)(2011-2#1)(2012-12#5)(2012-3#1)
leukemia virus-transformed lamb##2##3##(1995-8#1)(2008-11#1)
leukemia virus-transformed##3##2##(1995-8#2)(2008-11#1)
leukemia was##5##2##(1991-2#1)(1991-3#1)(2008-11#1)(2008-4#1)(2012-3#1)
leukemia with##5##2##(1991-4#1)(1992-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
leukemia##350##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#8)(1991-2#7)(1991-3#5)(1991-4#9)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#5)(1992-10#5)(1992-11#2)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-5#3)(1994-8#5)(1994-9#1)(1995-11#1)(1995-2#3)(1995-8#2)(1996-2#4)(1996-3#1)(1996-5#1)(1997-4#2)(1997-5#4)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#4)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#11)(2008-11#30)(2008-12#1)(2008-4#8)(2008-5#3)(2008-7#8)(2008-8#3)(2008-9#14)(2009-12#6)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#8)(2010-1#3)(2010-11#4)(2010-3#2)(2010-4#9)(2010-6#7)(2010-8#1)(2011-1#4)(2011-2#47)(2012-12#20)(2012-2#3)(2012-3#8)(2013-1#6)(2013-8#2)
leukemia-derived##2##1##(1992-3#1)(1997-1#1)
leukemia-inhibitory factor (LIF)##3##3##(2008-4#2)(2009-3#1)
leukemia-inhibitory factor##4##2##(2008-4#2)(2009-3#2)
leukemia]##12##1##(1990-6#1)(1992-6#1)(1997-3#1)(2008-7#1)(2011-2#5)(2012-2#2)(2012-3#1)
leukemias and lymphomas##2##3##(1991-3#1)(1991-4#1)
leukemias and##3##2##(1990-8#1)(1991-3#1)(1991-4#1)
leukemias##10##1##(1990-8#2)(1991-3#1)(1991-4#1)(1992-2#1)(1994-8#1)(2007-11#1)(2010-6#1)(2011-2#2)
leukemic cell line##4##3##(1990-5#1)(1994-6#2)(2008-11#1)
leukemic cell lines##4##3##(1990-2#1)(2008-11#1)(2008-4#1)(2008-9#1)
leukemic cell##9##2##(1990-2#1)(1990-5#1)(1993-12#1)(1994-6#2)(2008-11#2)(2008-4#1)(2008-9#1)
leukemic cells in##2##3##(1991-2#1)(2010-6#1)
leukemic cells##17##2##(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#2)(1995-2#1)(2008-11#2)(2008-9#3)(2010-6#1)(2011-2#1)
leukemic##37##1##(1990-2#1)(1990-5#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#3)(1994-6#2)(1995-2#1)(2007-2#1)(2008-11#4)(2008-4#2)(2008-9#5)(2009-12#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-1#3)
leukemogenesis##3##1##(1994-8#1)(2010-4#2)
leukoaraiosis##12##1##(2007-10#9)(2008-8#2)(2010-12#1)
leukocyte (PMN)##2##2##(1991-8#1)(1993-6#1)
leukocyte 12-lipoxygenase##3##2##(1994-11#3)
leukocyte activation##3##2##(1991-9#1)(2006-6#2)
leukocyte adherence##4##2##(1991-12#1)(1991-5#1)(2008-4#2)
leukocyte adhesion molecule##2##3##(1996-2#1)(2008-11#1)
leukocyte adhesion##7##2##(1995-2#2)(1996-2#2)(2008-1#1)(2008-11#1)(2012-12#1)
leukocyte alkaline phosphatase##2##3##(1991-4#2)
leukocyte cell##2##2##(1993-11#1)(2008-7#1)
leukocyte chemotaxis##2##2##(1996-2#1)(2010-5#1)
leukocyte count##4##2##(2007-12#1)(2009-7#1)(2010-5#2)
leukocyte counts##2##2##(1994-12#1)(2008-9#1)
leukocyte differentials##2##2##(2008-10#2)
leukocyte elastase (HLE)##4##3##(1992-12#1)(1993-8#1)(2008-5#2)
leukocyte elastase##7##2##(1991-9#2)(1992-12#1)(1993-8#1)(2008-5#3)
leukocyte endothelial adhesion##2##3##(1996-2#2)
leukocyte levels##2##2##(1992-12#1)(1996-12#1)
leukocyte recruitment and##2##3##(2008-1#1)(2009-11#1)
leukocyte recruitment##3##2##(2008-1#1)(2008-3#1)(2009-11#1)
leukocyte subpopulations##2##2##(1995-12#2)
leukocyte subsets##2##2##(2008-9#1)(2009-6#1)
leukocyte surface##2##2##(2008-4#1)(2010-12#1)
leukocyte transendothelial migration##2##3##(1995-2#2)
leukocyte##88##1##(1990-12#2)(1990-5#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#3)(1992-12#3)(1992-3#2)(1992-6#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#4)(1996-12#1)(1996-2#5)(1997-1#1)(1997-4#1)(2006-6#3)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#8)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-5#3)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
leukocyte-endothelium interaction##2##2##(1995-2#2)
leukocyte-mediated##2##1##(1996-2#1)(2009-6#1)
leukocytes (PMN)##4##2##(1991-2#1)(1993-11#1)(2008-4#2)
leukocytes and##11##2##(1991-5#2)(1995-12#1)(1996-2#2)(2006-6#2)(2008-10#1)(2008-4#1)(2008-5#2)
leukocytes are##2##2##(1992-5#1)(2008-1#1)
leukocytes at##2##2##(1992-3#1)(1992-6#1)
leukocytes in##5##2##(1992-12#1)(1995-12#1)(1996-3#1)(2007-10#1)(2008-10#1)
leukocytes is##2##2##(1990-11#1)(1990-12#1)
leukocytes of##2##2##(1997-4#1)(2009-6#1)
leukocytes or##3##2##(1990-8#2)(1991-5#1)
leukocytes through endothelial##2##3##(2008-10#2)
leukocytes to the##2##3##(2008-3#1)(2008-5#1)
leukocytes to##4##2##(1992-12#1)(1995-2#1)(2008-3#1)(2008-5#1)
leukocytes were##4##2##(1990-3#1)(1992-12#2)(2012-2#1)
leukocytes with##3##2##(1994-11#1)(2008-1#1)(2008-12#1)
leukocytes##103##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#2)(1991-2#1)(1991-5#3)(1991-8#4)(1991-9#2)(1992-12#7)(1992-3#1)(1992-5#1)(1992-6#3)(1993-11#2)(1993-6#3)(1994-11#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-8#1)(2006-6#2)(2007-10#2)(2007-12#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#6)(2008-3#1)(2008-4#4)(2008-5#7)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#2)(2012-2#2)(2013-1#5)
leukocytes)##2##1##(2008-10#1)(2013-8#1)
leukocytic chemotaxis##3##2##(2008-10#3)
leukocytic##5##1##(2008-10#4)(2008-5#1)
leukocytoclastic vasculitis##2##2##(1997-8#1)(2006-10#1)
leukocytoclastic##3##1##(1997-4#1)(1997-8#1)(2006-10#1)
leukocytosis and##2##2##(2011-2#2)
leukocytosis##15##1##(1990-9#1)(2006-10#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#8)(2013-1#1)(2013-8#1)
leukodystrophy##6##1##(1997-3#2)(2008-11#2)(2012-12#2)
leukoencephalopathy##8##1##(1991-8#2)(1996-11#1)(2007-10#1)(2007-9#1)(2008-8#1)(2010-12#2)
leukopenia and##2##2##(2008-5#1)(2008-8#1)
leukopenia in##2##2##(1991-8#1)(1993-2#1)
leukopenia##13##1##(1990-10#1)(1990-12#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1993-2#1)(1994-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
leukoplakia##2##1##(2007-1#1)(2008-7#1)
leukotriene A4##3##2##(1990-11#3)
leukotriene B4 (LTB4)##3##3##(1991-5#1)(1991-8#2)
leukotriene B4##6##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-8#2)(1994-8#1)
leukotriene C4##2##2##(1992-3#1)(1993-6#1)
leukotriene D4 receptor##5##3##(1993-6#5)
leukotriene D4##7##2##(1991-8#1)(1993-6#6)
leukotriene E4##2##2##(1993-6#1)(1993-9#1)
leukotriene antagonist##2##2##(2007-11#1)(2008-1#1)
leukotriene antagonists##2##2##(2007-11#2)
leukotriene receptor antagonists##4##3##(2008-1#1)(2008-3#2)(2012-12#1)
leukotriene receptor##6##2##(2008-1#2)(2008-3#2)(2012-12#2)
leukotriene##38##1##(1990-11#4)(1990-12#1)(1991-5#1)(1991-8#3)(1992-3#1)(1993-6#9)(1993-9#2)(1994-8#1)(1995-12#1)(2007-11#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-1#2)(2012-12#2)
leukotrienes and##3##2##(1994-12#1)(2008-3#1)(2010-1#1)
leukotrienes##15##1##(1990-3#1)(1992-2#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#2)
leupeptin and E-64##2##3##(1990-7#1)(1992-9#1)
leupeptin and##4##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-9#1)
leupeptin##8##1##(1990-7#1)(1991-12#1)(1992-12#2)(1992-9#1)(1994-10#1)(1995-6#1)(2008-10#1)
leur##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
leurs##5##1##(2008-11#1)(2008-5#4)
levamisole and##2##2##(2008-1#2)
levamisole##16##1##(1991-8#1)(1992-8#1)(1996-6#1)(2007-11#1)(2007-7#3)(2008-1#7)(2008-4#1)(2013-1#1)
levator scapulae##2##2##(2010-9#2)
level &gt##3##2##(2006-10#1)(2008-7#1)(2008-9#1)
level &lt##4##2##(2008-7#2)(2013-1#1)(2013-8#1)
level (2##4##2##(1993-1#2)(1993-12#1)(2008-10#1)
level (4##2##2##(2013-1#1)(2013-8#1)
level (ICPC##2##2##(1994-6#2)
level (MCL)##2##2##(2008-10#1)(2008-9#1)
level (P##2##2##(2009-7#1)(2013-1#1)
level (about##2##2##(1994-3#1)(1994-6#1)
level (i##2##2##(2008-10#2)
level (p &lt##4##3##(1994-11#2)(2006-10#1)(2008-3#1)
level (p##5##2##(1994-11#2)(2006-10#1)(2008-3#1)(2011-2#1)
level 1##7##2##(1993-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
level 2##2##2##(2008-7#1)(2011-2#1)
level 3##3##2##(1997-7#1)(2008-7#1)(2011-2#1)
level 5##3##2##(2009-6#3)
level 6##2##2##(2008-11#1)(2009-6#1)
level C##2##2##(2008-10#2)
level I##2##2##(2008-5#1)(2013-1#1)
level II##2##2##(1992-2#1)(2011-2#1)
level III##5##2##(1994-12#2)(2008-10#2)(2008-11#1)
level about##2##2##(1997-3#1)(2008-10#1)
level above##4##2##(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
level after AuTM injection##2##4##(1994-5#1)(1995-3#1)
level after AuTM##3##3##(1994-5#1)(1995-3#2)
level after##13##2##(1994-5#1)(1995-3#2)(2008-10#1)(2008-6#2)(2008-7#5)(2009-8#1)(2010-6#1)
level alone (greater than##2##4##(1992-3#2)
level among the##2##3##(2008-11#1)(2010-8#1)
level among##3##2##(2008-11#1)(2010-12#1)(2010-8#1)
level and a##3##3##(2008-3#2)(2008-6#1)
level and at the##2##4##(2008-4#1)(2011-2#1)
level and at##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
level and duration of##2##4##(2008-11#1)(2013-1#1)
level and frequency of##2##4##(2008-10#1)(2008-12#1)
level and increased##4##3##(2008-10#2)(2011-1#1)(2013-1#1)
level and is##2##3##(2008-10#1)(2012-12#1)
level and net severity##3##4##(1992-6#3)
level and on##3##3##(2008-10#1)(2010-11#1)(2010-12#1)
level and that##2##3##(1992-8#1)(2008-8#1)
level and the calibration curve was linear over the concentration range##2##11##(2008-10#2)
level and the##13##3##(1992-6#1)(1993-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)
level and type of##3##4##(1996-2#1)(2008-11#1)(2010-5#1)
level and with##2##3##(2008-10#1)(2008-12#1)
level and within##3##3##(2008-10#2)(2009-7#1)
level and##144##2##(1990-11#1)(1990-12#3)(1990-3#2)(1991-1#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#4)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#3)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#7)
level are not##2##3##(1992-9#1)(2008-9#1)
level are obtained##2##3##(2007-12#1)(2008-10#1)
level are##11##2##(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)
level as high as##2##4##(1992-6#1)(2007-11#1)
level as in##2##3##(2008-9#1)(2013-1#1)
level as low as 0##2##5##(2008-10#2)
level as the##4##3##(1991-11#1)(1991-12#1)(2008-10#1)(2008-5#1)
level as well as##5##4##(2008-11#3)(2008-4#1)(2013-1#1)
level as##23##2##(1991-11#1)(1991-12#1)(1992-6#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
level at a##2##3##(2008-10#2)
level at around##2##3##(1997-1#1)(1997-2#1)
level at the end of##3##5##(2008-10#1)(2008-9#2)
level at the##6##3##(2008-10#2)(2008-3#1)(2008-9#2)(2013-1#1)
level at which the##4##4##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
level at which##5##3##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
level at##25##2##(1990-5#1)(1991-12#1)(1991-6#1)(1993-6#1)(1994-11#1)(1997-1#1)(1997-2#2)(2007-11#2)(2007-8#1)(2008-10#7)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
level attained with##2##3##(1994-11#1)(2008-11#1)
level attained##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
level based on the##2##4##(2008-10#2)
level based on##3##3##(2008-10#3)
level below##7##2##(1991-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)
level between the##2##3##(2008-10#2)
level between##8##2##(2007-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2013-1#1)
level but##3##2##(1992-8#1)(2008-8#1)(2008-9#1)
level by the##2##3##(1997-2#1)(1997-7#1)
level by thermal lensing##2##4##(2008-10#2)
level by using##2##3##(1991-9#1)(2011-2#1)
level by##29##2##(1991-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
level can be reduced##2##4##(2008-10#1)(2008-3#1)
level can be##8##3##(1991-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
level can##9##2##(1991-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-1#1)
level caused##2##2##(2008-10#1)(2008-12#1)
level comparable##2##2##(2008-10#1)(2012-3#1)
level compared with##2##3##(2007-11#1)(2013-8#1)
level compared##3##2##(1996-12#1)(2007-11#1)(2013-8#1)
level could##2##2##(2009-8#1)(2010-3#1)
level data##2##2##(2011-9#2)
level decreased in##2##3##(2008-11#1)(2008-7#1)
level decreased##5##2##(2008-11#1)(2008-12#1)(2008-7#2)(2011-1#1)
level decreases##2##2##(2008-10#1)(2008-9#1)
level detection##2##2##(2008-10#1)(2012-2#1)
level determination##5##2##(2008-10#4)(2009-8#1)
level did not##2##3##(2008-7#1)(2009-6#1)
level due to##4##3##(1996-12#1)(2008-10#1)(2011-10#1)(2012-12#1)
level during the##5##3##(1993-6#1)(1994-12#2)(2008-8#1)(2013-1#1)
level during##12##2##(1990-9#1)(1993-6#1)(1993-9#1)(1994-12#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-2#1)(2013-1#1)
level elimination##2##2##(2008-10#2)
level equal##2##2##(1994-6#1)(2008-10#1)
level expression and##2##3##(1994-6#1)(2008-8#1)
level expression of##5##3##(1994-3#1)(1994-8#1)(2008-11#1)(2008-5#1)(2011-1#1)
level expression##8##2##(1994-3#1)(1994-6#1)(1994-8#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)
level following##2##2##(2008-3#1)(2012-2#1)
level for the##5##3##(1990-2#1)(1996-7#1)(2008-10#1)(2008-3#1)(2010-10#1)
level for##32##2##(1990-2#1)(1992-6#1)(1993-9#1)(1996-12#1)(1996-7#1)(1996-8#1)(2008-10#13)(2008-3#3)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)(2012-2#3)(2013-1#3)
level from##8##2##(1990-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#2)(2012-2#1)
level had a##3##3##(2008-10#1)(2009-3#1)(2010-4#1)
level had##7##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-3#1)(2010-4#1)
level has been##4##3##(1994-6#1)(2007-12#1)(2008-11#1)(2011-1#1)
level has##6##2##(1994-6#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-1#1)
level have##3##2##(1997-7#1)(2008-1#1)(2008-10#1)
level higher than##2##3##(2008-10#1)(2011-2#1)
level in a##5##3##(2008-10#2)(2008-9#1)(2010-3#2)
level in all##2##3##(1993-11#1)(2012-1#1)
level in both groups##3##4##(1994-6#3)
level in both##7##3##(1994-6#3)(2007-7#1)(2008-5#1)(2008-7#1)(2009-12#1)
level in different##2##3##(1992-3#1)(2010-1#1)
level in human##3##3##(1992-3#1)(1993-3#1)(2008-11#1)
level in men##3##3##(1992-3#1)(2011-1#2)
level in milk##2##3##(2008-10#1)(2012-2#1)
level in our##2##3##(2007-7#1)(2008-1#1)
level in patients##2##3##(2008-12#1)(2008-7#1)
level in rat##2##3##(1993-6#1)(1994-11#1)
level in the liver##2##4##(1992-11#1)(1993-3#1)
level in the thymus##2##4##(1993-3#1)(2008-10#1)
level in the##43##3##(1990-3#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-3#3)(1994-11#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-12#1)(1996-2#4)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)
level in vitro##2##3##(2008-3#1)(2008-9#1)
level in##162##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-3#5)(1993-6#2)(1993-8#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#5)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#4)(1997-2#2)(1997-4#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#18)(2008-11#6)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#8)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#2)
level including##2##2##(2008-11#1)(2008-7#1)
level increase##2##2##(1990-12#1)(2008-7#1)
level increased##6##2##(1991-9#1)(1997-1#1)(2008-10#1)(2008-7#1)(2011-1#2)
level indicating##2##2##(1993-2#1)(2008-8#1)
level information was##2##3##(1996-5#1)(2011-9#1)
level is less than##2##4##(2007-11#1)(2008-10#1)
level is presented##2##3##(2008-10#1)(2008-2#1)
level is##39##2##(1991-8#1)(1993-11#2)(1993-8#1)(1995-8#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#3)
level lasted for 3 hours##2##5##(2008-8#2)
level may be##3##3##(1993-12#1)(1995-5#1)(2008-9#1)
level may##10##2##(1993-12#1)(1995-5#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#2)
level observed##5##2##(1993-8#1)(1997-9#2)(2008-5#1)(2011-2#1)
level of &gt##2##3##(2007-7#1)(2008-1#1)
level of &quot##2##3##(2008-7#1)(2013-1#1)
level of 0##10##3##(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
level of 1##7##3##(1996-5#1)(2008-10#4)(2008-11#1)(2012-1#1)
level of 10##2##3##(1995-3#1)(2008-10#1)
level of 15% of##2##4##(2011-1#1)(2012-2#1)
level of 2##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
level of 3##2##3##(2008-10#1)(2008-11#1)
level of 300##2##3##(2007-12#1)(2008-6#1)
level of 4##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
level of 8##2##3##(1990-11#1)(2008-10#1)
level of 90%##3##3##(1997-5#1)(2008-2#1)(2008-8#1)
level of ATP##3##3##(1991-9#1)(2008-11#1)(2008-8#1)
level of BOLD##2##3##(2009-6#2)
level of CAT mRNA was##2##5##(1990-8#1)(2008-11#1)
level of CAT##4##3##(1990-8#1)(1997-8#1)(2008-11#2)
level of D##2##3##(1990-8#1)(1994-7#1)
level of DNA damage was##2##5##(1994-8#2)
level of DNA damage##4##4##(1992-3#1)(1994-8#2)(1996-2#1)
level of DNA##5##3##(1992-3#1)(1994-8#2)(1996-2#1)(2008-7#1)
level of G##2##3##(2008-7#1)(2012-2#1)
level of HSP72 expression##2##4##(1995-5#2)
level of IgG##2##3##(2010-3#1)(2011-1#1)
level of NGF##2##3##(1997-6#1)(2008-11#1)
level of PHS##2##3##(2012-3#2)
level of PRL##2##3##(2008-7#2)
level of PVA addition##2##4##(2008-10#2)
level of PVA##3##3##(2008-10#3)
level of TGF-alpha mRNA##2##4##(1992-9#2)
level of TGF-alpha##3##3##(1992-9#3)
level of TSP##2##3##(1993-9#2)
level of VEGF expression##2##4##(2009-8#1)(2012-1#1)
level of a##8##3##(1990-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(2008-4#1)(2008-6#1)(2008-9#1)
level of about 0##2##4##(2008-10#1)(2009-5#1)
level of about##3##3##(1991-12#1)(2008-10#1)(2009-5#1)
level of accuracy of the##2##5##(1993-5#1)(1995-6#1)
level of accuracy of##3##4##(1993-5#1)(1995-6#2)
level of accuracy##10##3##(1993-5#1)(1995-6#2)(2008-10#4)(2008-3#2)(2008-9#1)
level of activation##2##3##(2009-6#2)
level of activity of the##3##5##(1994-2#2)(2008-7#1)
level of activity##9##3##(1994-2#2)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
level of aggressiveness##2##3##(2008-10#2)
level of agreement between##4##4##(2008-10#1)(2011-2#3)
level of agreement##7##3##(2007-5#1)(2008-10#2)(2009-5#1)(2011-2#3)
level of all##2##3##(2008-10#1)(2008-12#1)
level of alpha-FP##2##3##(1992-3#2)
level of antibody production##2##4##(2008-11#2)
level of antibody##4##3##(1996-12#1)(2008-11#2)(2008-12#1)
level of antioxidant##2##3##(2008-10#1)(2011-2#1)
level of apoptosis##2##3##(2008-11#1)(2008-12#1)
level of approximately 0##2##4##(1995-6#1)(2008-11#1)
level of approximately##4##3##(1995-3#1)(1995-6#1)(2008-11#1)(2008-3#1)
level of ascorbic acid##2##4##(1997-4#1)(2008-7#1)
level of athleticism##2##3##(2009-7#2)
level of automation##2##3##(2008-10#1)(2008-4#1)
level of beta-galactosidase from cells transfected with##2##7##(1992-12#2)
level of beta2-M in the##2##5##(2007-7#2)
level of blood##2##3##(2008-1#2)
level of both##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
level of calcium##3##3##(1992-9#1)(1994-3#1)(2008-8#1)
level of care##9##3##(1990-10#1)(1991-1#1)(2008-10#1)(2010-10#1)(2012-12#4)(2013-8#1)
level of cell death##2##4##(2008-11#2)
level of cell##3##3##(2008-11#3)
level of chemotaxis##2##3##(1993-6#2)
level of cholesterol##3##3##(1990-8#1)(1992-6#1)(1996-2#1)
level of clinical##2##3##(2008-11#1)(2012-3#1)
level of cognitive##4##3##(2010-12#1)(2010-3#1)(2012-12#2)
level of colonization##2##3##(2008-10#1)(2008-11#1)
level of competence##5##3##(1991-6#1)(1993-2#1)(2007-11#2)(2007-12#1)
level of complexity##2##3##(2008-2#1)(2008-3#1)
level of compliance with##2##4##(2007-12#1)(2012-12#1)
level of compliance##4##3##(2007-12#2)(2008-10#1)(2012-12#1)
level of concentration##2##3##(2008-10#1)(2008-6#1)
level of concern##2##3##(1993-3#1)(2008-10#1)
level of confidence in##2##4##(2008-10#2)
level of confidence##9##3##(2008-10#7)(2008-9#1)(2009-7#1)
level of consciousness##4##3##(1997-3#1)(2007-8#1)(2008-7#1)(2012-12#1)
level of conservation##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
level of contamination##4##3##(1997-4#1)(2008-1#1)(2008-10#2)
level of control##7##3##(2008-10#2)(2008-11#1)(2009-11#1)(2010-12#1)(2010-5#1)(2012-2#1)
level of cooperation##2##3##(2012-2#1)(2012-3#1)
level of corticosterone##4##3##(2008-7#2)(2012-1#1)(2013-1#1)
level of data##2##3##(2008-3#1)(2011-3#1)
level of depression##3##3##(1990-3#1)(1996-7#1)(2013-1#1)
level of depressive symptoms##2##4##(2010-10#1)(2011-1#1)
level of detail##2##3##(2008-6#1)(2011-2#1)
level of detection (LOD)##2##4##(2008-10#2)
level of detection of##2##4##(2008-10#1)(2008-5#1)
level of detection##7##3##(1993-8#1)(2008-10#4)(2008-5#2)
level of discrimination and##2##4##(1992-10#1)(2009-3#1)
level of discrimination##4##3##(1992-10#2)(2008-10#1)(2009-3#1)
level of disease incidence##2##4##(2008-10#2)
level of disease severity##2##4##(2008-7#1)(2009-2#1)
level of disease##12##3##(2008-10#10)(2008-7#1)(2009-2#1)
level of diversity##4##3##(2008-10#3)(2013-1#1)
level of drugs##2##3##(1990-2#1)(2007-7#1)
level of each##2##3##(2008-5#1)(2011-1#1)
level of education and the##2##5##(1991-2#1)(2013-1#1)
level of education##9##3##(1991-2#1)(1994-3#1)(1995-5#1)(2007-8#1)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
level of energy##4##3##(1995-12#1)(2008-12#2)(2012-2#1)
level of environmental##2##3##(2008-10#1)(2008-8#1)
level of evidence##4##3##(1996-6#1)(2008-8#1)(2011-2#2)
level of exposure##2##3##(1996-3#1)(2013-1#1)
level of expression of the alpha 5/beta 1##2##8##(1993-9#2)
level of expression of the##7##5##(1993-9#2)(2008-10#2)(2008-11#2)(2011-1#1)
level of expression of##9##4##(1993-9#2)(1995-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2011-1#1)
level of expression##19##3##(1992-10#1)(1992-9#1)(1993-9#2)(1995-11#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
level of familiarity##2##3##(2007-10#1)(2008-8#1)
level of function##2##3##(2010-3#1)(2013-8#1)
level of functional##2##3##(2007-8#1)(2009-6#1)
level of functioning##3##3##(1993-2#1)(1997-8#2)
level of gene##8##3##(1994-12#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
level of genetic differentiation among##2##5##(2008-10#2)
level of genetic differentiation##4##4##(2008-10#4)
level of genetic variability##2##4##(2008-5#1)(2008-9#1)
level of genetic variation##2##4##(2008-10#2)
level of genetic##14##3##(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)
level of genotype resistance##2##4##(2008-10#2)
level of glucose##2##3##(2007-8#1)(2008-1#1)
level of glutathione (GSH)##2##4##(1991-9#1)(2008-7#1)
level of health care##3##4##(1990-2#1)(1993-3#1)(1996-3#1)
level of health##4##3##(1990-2#1)(1993-3#1)(1996-3#1)(2008-10#1)
level of homogeneity##4##3##(1997-4#1)(1997-5#1)(2008-10#1)(2012-3#1)
level of importance##2##3##(2007-12#1)(2011-2#1)
level of improvement##2##3##(1995-2#1)(2008-5#1)
level of induction##3##3##(2008-10#2)(2008-11#1)
level of information##3##3##(1995-3#1)(2008-8#1)(2010-11#1)
level of inhibition##4##3##(1990-11#1)(1995-2#1)(1995-3#1)(2010-1#1)
level of iron##3##3##(2008-10#2)(2008-4#1)
level of its##2##3##(2008-8#1)(2012-2#1)
level of knowledge about##3##4##(1992-6#1)(2012-12#1)(2013-8#1)
level of knowledge##12##3##(1991-9#1)(1992-6#1)(1995-3#1)(2008-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
level of latent infection##2##4##(2008-10#2)
level of less than##5##4##(2007-12#1)(2007-7#1)(2008-1#2)(2011-2#1)
level of light##2##3##(2008-10#2)
level of lipid peroxidation##2##4##(1991-5#1)(2009-8#1)
level of lipid##5##3##(1991-5#1)(2008-5#2)(2009-8#2)
level of mRNA for##2##4##(1995-12#1)(2007-8#1)
level of mRNA##9##3##(1990-12#2)(1992-3#1)(1993-9#1)(1995-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
level of methylation##2##3##(1992-9#1)(2008-4#1)
level of motivation##2##3##(1996-7#2)
level of neck##2##3##(2009-4#1)(2013-1#1)
level of noise##3##3##(2008-10#1)(2008-9#2)
level of nursing##3##3##(1991-2#2)(2008-1#1)
level of oral##2##3##(2012-12#1)(2012-2#1)
level of oxidative stress##2##4##(2008-7#1)(2009-12#1)
level of oxidative##3##3##(1990-5#1)(2008-7#1)(2009-12#1)
level of pain##5##3##(2007-11#1)(2007-8#2)(2008-7#1)(2012-3#1)
level of parallelism##2##3##(2008-3#1)(2010-8#1)
level of parasite virulence##2##4##(2008-8#2)
level of participation##2##3##(1992-1#1)(2007-10#1)
level of patient care##2##4##(1997-1#1)(2007-12#1)
level of performance##6##3##(1990-11#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(2010-5#1)
level of phosphorylation##3##3##(1993-9#1)(1994-11#1)(2008-8#1)
level of physical activity##5##4##(2008-12#1)(2012-12#2)(2013-1#2)
level of physical##7##3##(2008-12#1)(2011-1#2)(2012-12#2)(2013-1#2)
level of plasma vWF##3##4##(2007-10#3)
level of plasma##6##3##(2007-10#4)(2008-12#1)(2011-2#1)
level of polymorphism##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
level of population##2##3##(2008-10#1)(2008-12#1)
level of practice##2##3##(2008-1#1)(2008-12#1)
level of precision##2##3##(2008-10#1)(2009-5#1)
level of processing##3##3##(2008-11#1)(2009-10#1)(2009-12#1)
level of prostacyclin##2##3##(1994-9#1)(1995-11#1)
level of protection##5##3##(1994-2#1)(1996-12#1)(2008-10#3)
level of protein##6##3##(1990-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-3#2)
level of quality##3##3##(1994-2#1)(2013-1#2)
level of recombinant human##2##4##(1993-6#1)(2008-7#1)
level of recombinant##3##3##(1993-6#1)(2008-7#2)
level of reduced glutathione (GSH)##2##5##(2008-12#1)(2013-1#1)
level of regulatory##2##3##(2008-10#1)(2011-2#1)
level of reporter gene expression##2##5##(1995-2#1)(2008-8#1)
level of reproductive effort##2##4##(2008-8#2)
level of resistance of##2##4##(2008-10#2)
level of resistance to Tomato##2##5##(2008-10#2)
level of resistance to WB on##2##6##(2008-10#2)
level of resistance to##12##4##(2008-10#9)(2008-12#1)(2008-8#1)(2011-2#1)
level of resistance was##3##4##(2008-10#3)
level of resistance##25##3##(2008-10#21)(2008-12#1)(2008-8#2)(2011-2#1)
level of resolution##3##3##(1996-7#1)(2008-10#1)(2008-7#1)
level of satisfaction with the##2##5##(2008-11#1)(2013-8#1)
level of satisfaction with##3##4##(1996-3#1)(2008-11#1)(2013-8#1)
level of selfishness##3##3##(2008-9#3)
level of sensitivity##2##3##(2008-4#1)(2008-9#1)
level of serum##6##3##(1990-6#1)(1991-6#1)(1994-7#2)(2013-1#1)(2013-7#1)
level of service##4##3##(1995-3#1)(1996-1#1)(2012-3#2)
level of significance##6##3##(1992-2#1)(1996-2#1)(2009-7#1)(2010-6#1)(2010-9#1)(2013-8#1)
level of stress##3##3##(2008-11#3)
level of superoxide##2##3##(1993-6#1)(2008-10#1)
level of suppression##2##3##(2008-10#2)
level of survival##2##3##(1996-12#1)(2008-6#1)
level of susceptibility##2##3##(2007-10#1)(2008-10#1)
level of testosterone##2##3##(1990-12#1)(2008-7#1)
level of the mRNA##3##4##(1990-11#1)(1992-1#1)(1992-9#1)
level of the second##2##4##(2007-12#1)(2013-1#1)
level of the skin##2##4##(2008-5#2)
level of the stratum corneum##2##5##(2008-5#2)
level of the##105##3##(1990-11#1)(1990-3#2)(1990-7#1)(1991-12#3)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-12#3)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
level of their##3##3##(2007-6#1)(2008-10#1)(2008-11#1)
level of theory##2##3##(2008-10#2)
level of thiobarbituric acid-reactive substances##3##5##(1995-12#3)
level of this##4##3##(1991-6#1)(2008-10#2)(2010-8#1)
level of total##2##3##(2007-2#1)(2008-4#1)
level of training##2##3##(1996-12#1)(2007-8#1)
level of treatment##2##3##(2008-2#1)(2008-7#1)
level of uncertainty##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
level of understanding was##3##4##(2008-7#3)
level of understanding##4##3##(2008-1#1)(2008-7#3)
level of use of certificated##2##5##(2008-12#2)
level of use of##4##4##(1992-1#1)(1994-2#1)(2008-12#2)
level of use##5##3##(1991-3#1)(1992-1#1)(1994-2#1)(2008-12#2)
level of variation##2##3##(2008-12#1)(2013-1#1)
level of virulence##3##3##(2008-10#3)
level of virus accumulation##2##4##(2008-10#2)
level of virus##4##3##(2008-10#3)(2008-12#1)
level of vitamin##2##3##(1990-8#1)(1993-12#1)
level of##1419##2##(1990-10#2)(1990-11#5)(1990-12#8)(1990-2#7)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#7)(1991-1#3)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#2)(1991-5#3)(1991-6#5)(1991-8#1)(1991-9#7)(1992-1#5)(1992-10#6)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#8)(1992-6#8)(1992-7#1)(1992-8#2)(1992-9#12)(1993-1#2)(1993-11#6)(1993-12#7)(1993-2#3)(1993-3#7)(1993-5#1)(1993-6#10)(1993-8#4)(1993-9#10)(1994-11#4)(1994-12#3)(1994-2#17)(1994-3#4)(1994-5#3)(1994-6#5)(1994-7#4)(1994-8#8)(1994-9#3)(1995-1#2)(1995-11#6)(1995-12#9)(1995-2#8)(1995-3#12)(1995-5#3)(1995-6#6)(1995-8#10)(1995-9#1)(1996-1#5)(1996-10#1)(1996-12#15)(1996-2#7)(1996-3#7)(1996-5#4)(1996-6#2)(1996-7#6)(1996-9#3)(1997-1#8)(1997-2#3)(1997-3#9)(1997-4#14)(1997-5#4)(1997-6#5)(1997-7#7)(1997-8#8)(2006-6#1)(2007-10#10)(2007-11#12)(2007-12#18)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#16)(2008-1#22)(2008-10#246)(2008-11#67)(2008-12#24)(2008-2#12)(2008-3#24)(2008-4#19)(2008-5#31)(2008-6#15)(2008-7#55)(2008-8#61)(2008-9#28)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#9)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#10)(2009-7#10)(2009-8#15)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#6)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#5)(2011-1#29)(2011-10#1)(2011-2#46)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#6)(2012-12#25)(2012-2#24)(2012-3#25)(2013-1#48)(2013-7#1)(2013-8#22)
level on day##2##3##(2008-7#1)(2008-9#1)
level on the##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)
level on##20##2##(1991-9#1)(1996-3#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-6#1)(2011-2#1)(2012-3#2)
level or##12##2##(1993-6#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)
level profiles##3##2##(2010-5#3)
level ranged from##2##3##(2007-7#1)(2013-1#1)
level reached##3##2##(2007-6#1)(2008-10#1)(2008-11#1)
level remained##3##2##(1993-12#1)(2011-1#1)(2012-5#1)
level required for##3##3##(1990-8#1)(2007-12#1)(2008-8#1)
level required##4##2##(1990-8#1)(2007-12#1)(2008-8#1)(2010-7#1)
level resistance to##2##3##(2008-5#1)(2011-2#1)
level returned to##2##3##(1991-6#1)(1995-5#1)
level revealed##2##2##(2008-10#1)(2008-11#1)
level set by##2##3##(2008-10#1)(2008-9#1)
level set##7##2##(2008-10#1)(2008-12#1)(2008-6#3)(2008-9#1)(2009-10#1)
level sets##2##2##(2008-6#2)
level should be##2##3##(2008-1#1)(2011-2#1)
level should##3##2##(1993-11#1)(2008-1#1)(2011-2#1)
level showed##3##2##(2008-12#1)(2011-1#2)
level significantly increased in##2##4##(2008-11#1)(2008-12#1)
level similar to##3##3##(2008-10#3)
level than the##2##3##(1995-12#1)(1996-9#1)
level than##6##2##(1990-8#1)(1995-12#1)(1996-9#1)(2008-10#2)(2010-8#1)
level that is##2##3##(2008-2#1)(2008-3#1)
level that##10##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-2#1)
level the##11##2##(1991-6#1)(1992-5#1)(1996-5#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
level through##2##2##(1991-8#1)(2011-2#1)
level to a##2##3##(2007-12#1)(2008-10#1)
level to that##2##3##(1995-8#1)(2008-5#1)
level to the##11##3##(1993-2#1)(1993-8#1)(1997-4#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)
level to##27##2##(1990-2#1)(1990-6#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
level under##5##2##(1991-9#1)(1997-5#1)(1997-7#1)(2011-1#1)(2012-1#1)
level using a##3##3##(1990-12#1)(1997-2#1)(2008-10#1)
level using##7##2##(1990-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
level was 1##2##3##(1993-8#1)(2008-10#1)
level was 3##4##3##(2008-10#3)(2010-3#1)
level was 4##3##3##(1995-11#1)(2008-10#2)
level was also##3##3##(1995-2#1)(2008-11#2)
level was assessed##2##3##(2012-2#1)(2012-3#1)
level was associated with increased##2##5##(2011-1#1)(2012-1#1)
level was associated with##4##4##(2009-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
level was below the##2##4##(1992-6#1)(2011-2#1)
level was determined by##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
level was determined##6##3##(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-12#1)
level was elevated##2##3##(1992-6#1)(1993-6#1)
level was evaluated##2##3##(1993-8#1)(2007-8#1)
level was found in##2##4##(1996-2#1)(2008-10#1)
level was found to be##3##5##(1993-12#1)(2008-11#1)(2008-3#1)
level was found##7##3##(1993-12#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)
level was higher in##2##4##(1990-8#1)(2013-8#1)
level was higher##3##3##(1990-8#1)(2013-1#1)(2013-8#1)
level was low##2##3##(2008-10#1)(2013-1#1)
level was lower in##2##4##(2008-7#1)(2008-9#1)
level was lower##3##3##(2007-7#1)(2008-7#1)(2008-9#1)
level was normal##2##3##(1991-6#1)(2008-7#1)
level was not significantly##2##4##(1996-12#1)(2011-1#1)
level was not##3##3##(1996-12#1)(1997-1#1)(2011-1#1)
level was observed at##2##4##(1991-9#1)(1994-11#1)
level was observed in##2##4##(2008-10#1)(2008-7#1)
level was observed##11##3##(1991-9#1)(1994-11#1)(2008-10#7)(2008-7#1)(2011-2#1)
level was raised##2##3##(1990-9#1)(2007-8#1)
level was recorded##2##3##(2008-1#1)(2013-8#1)
level was reduced##2##3##(2008-1#1)(2010-2#1)
level was significantly higher in the##2##6##(1993-1#1)(2011-2#1)
level was significantly higher in##3##5##(1993-1#1)(1995-5#1)(2011-2#1)
level was significantly higher##4##4##(1993-1#1)(1995-5#1)(2008-1#1)(2011-2#1)
level was significantly lower in##2##5##(1992-3#1)(2011-1#1)
level was significantly lower##3##4##(1991-11#1)(1992-3#1)(2011-1#1)
level was significantly##13##3##(1991-11#1)(1992-3#1)(1993-1#1)(1995-5#1)(1996-12#5)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
level was slightly##2##3##(2008-11#1)(2008-3#1)
level was very##2##3##(1992-9#1)(2008-10#1)
level was##141##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-6#3)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-12#6)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#28)(2008-11#5)(2008-3#3)(2008-4#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
level were all below##2##4##(2008-10#2)
level were below 10%##2##4##(2008-10#2)
level were estimated##3##3##(2008-10#2)(2012-12#1)
level were obtained##2##3##(2008-10#2)
level were significantly##2##3##(1997-2#1)(2008-12#1)
level were##22##2##(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#13)(2008-12#2)(2008-4#1)(2012-12#2)(2013-1#1)
level where##3##2##(2008-10#2)(2010-8#1)
level which##2##2##(1996-2#1)(2008-5#1)
level while##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
level will##3##2##(1997-2#1)(2008-11#1)(2009-10#1)
level with a##2##3##(1992-2#1)(2008-10#1)
level with the##6##3##(1992-12#1)(1997-6#1)(2008-10#2)(2008-6#1)(2013-8#1)
level with those##2##3##(1994-2#1)(2008-10#1)
level with##24##2##(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1997-2#1)(1997-6#1)(2008-10#9)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-1#1)(2013-8#2)
level within the##3##3##(2011-1#1)(2011-2#2)
level within##7##2##(1993-11#1)(1995-1#1)(1997-7#1)(2008-10#1)(2011-1#1)(2011-2#2)
level without##6##2##(1993-8#1)(2007-10#1)(2007-8#1)(2008-7#2)(2008-8#1)
level##3519##1##(1990-10#2)(1990-11#11)(1990-12#15)(1990-2#18)(1990-3#9)(1990-5#8)(1990-6#5)(1990-7#1)(1990-8#13)(1990-9#3)(1991-1#4)(1991-11#6)(1991-12#18)(1991-2#11)(1991-3#6)(1991-4#2)(1991-5#6)(1991-6#19)(1991-7#1)(1991-8#3)(1991-9#19)(1992-1#8)(1992-10#6)(1992-11#8)(1992-12#10)(1992-2#8)(1992-3#19)(1992-5#2)(1992-6#21)(1992-7#1)(1992-8#5)(1992-9#18)(1993-1#7)(1993-11#15)(1993-12#30)(1993-2#8)(1993-3#17)(1993-5#2)(1993-6#22)(1993-8#16)(1993-9#14)(1994-11#19)(1994-12#22)(1994-2#29)(1994-3#8)(1994-5#8)(1994-6#26)(1994-7#4)(1994-8#14)(1994-9#5)(1995-1#4)(1995-11#14)(1995-12#18)(1995-2#17)(1995-3#21)(1995-5#11)(1995-6#9)(1995-8#14)(1995-9#2)(1996-1#8)(1996-10#1)(1996-12#33)(1996-2#21)(1996-3#14)(1996-5#13)(1996-6#8)(1996-7#7)(1996-8#2)(1996-9#4)(1997-1#13)(1997-2#19)(1997-3#18)(1997-4#25)(1997-5#7)(1997-6#14)(1997-7#19)(1997-8#11)(1997-9#2)(2006-10#2)(2006-6#1)(2007-10#18)(2007-11#42)(2007-12#44)(2007-2#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#15)(2007-8#27)(2008-1#49)(2008-10#666)(2008-11#163)(2008-12#75)(2008-2#32)(2008-3#90)(2008-4#37)(2008-5#76)(2008-6#40)(2008-7#156)(2008-8#136)(2008-9#74)(2009-1#1)(2009-10#15)(2009-11#4)(2009-12#13)(2009-2#3)(2009-3#11)(2009-4#13)(2009-5#14)(2009-6#23)(2009-7#17)(2009-8#27)(2009-9#5)(2010-1#6)(2010-10#11)(2010-11#9)(2010-12#15)(2010-2#7)(2010-3#14)(2010-4#18)(2010-5#15)(2010-6#9)(2010-7#7)(2010-8#19)(2010-9#10)(2011-1#69)(2011-10#4)(2011-2#128)(2011-3#3)(2011-7#1)(2011-8#1)(2011-9#4)(2012-1#20)(2012-12#52)(2012-2#56)(2012-3#53)(2012-5#4)(2012-6#1)(2013-1#130)(2013-7#8)(2013-8#46)
level) and the##3##3##(2007-7#1)(2008-10#2)
level) and##11##2##(1990-8#1)(2007-10#1)(2007-7#1)(2008-10#7)(2011-1#1)
level) for##2##2##(2008-10#2)
level) in##2##2##(2007-10#1)(2008-3#1)
level) is##2##2##(1991-12#1)(2008-10#1)
level)##53##1##(1990-8#2)(1991-12#2)(1991-6#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-7#1)(2008-10#32)(2008-3#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
level-set##6##1##(2008-6#5)(2010-2#1)
level=18##2##1##(2012-12#2)
level?##2##1##(2008-11#1)(2009-3#1)
leveled off##3##2##(1996-12#1)(1997-7#1)(2008-10#1)
leveled##5##1##(1996-12#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
leveling##4##1##(1994-2#1)(1995-12#1)(2012-3#2)
levels &gt##8##2##(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#1)
levels &lt##6##2##(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#2)
levels (&gt##2##2##(1993-12#1)(1995-3#1)
levels (0##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
levels (as##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
levels (mean +/-##2##3##(1992-3#1)(2011-2#1)
levels (p &lt##5##3##(2006-10#3)(2008-5#2)
levels (p less than 0##2##5##(1990-3#1)(1994-3#1)
levels (p##8##2##(1990-3#1)(1994-3#1)(2006-10#3)(2008-5#2)(2010-10#1)
levels (p&lt##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
levels above 250 mg/dl (6##2##5##(1990-2#2)
levels above the##3##3##(2008-6#1)(2009-6#1)(2012-2#1)
levels above##11##2##(1990-2#2)(1994-8#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-6#1)(2012-2#1)
levels achieved##2##2##(1995-2#1)(2010-11#1)
levels after 15##2##3##(1990-12#1)(2008-5#1)
levels after 24##3##3##(1991-12#1)(1995-5#1)(2009-8#1)
levels after the##2##3##(1991-2#1)(2008-10#1)
levels after##23##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1992-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-7#1)
levels against 10 serotypes of##2##5##(2012-12#2)
levels against##3##2##(2009-5#1)(2012-12#2)
levels alone##4##2##(2008-3#4)
levels along with##2##3##(2007-5#1)(2010-7#1)
levels along##3##2##(2007-5#1)(2008-10#1)(2010-7#1)
levels also were##3##3##(1993-2#1)(2008-10#1)(2012-3#1)
levels also##5##2##(1993-2#1)(1996-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
levels among patients with##3##4##(2006-10#1)(2012-12#1)(2013-7#1)
levels among the##2##3##(1995-12#1)(1996-7#1)
levels among##14##2##(1995-12#1)(1996-12#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
levels and a##4##3##(2008-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
levels and activities of##2##4##(2008-10#1)(2008-5#1)
levels and after##2##3##(1997-4#1)(2009-7#1)
levels and are##2##3##(2007-12#1)(2008-9#1)
levels and bone##2##3##(2008-8#1)(2012-2#1)
levels and by##2##3##(1994-6#1)(2013-1#1)
levels and changes in##2##4##(1991-2#2)
levels and decreased##3##3##(1995-3#1)(1997-6#1)(2008-5#1)
levels and for##2##3##(2008-2#1)(2012-12#1)
levels and higher##2##3##(1992-9#1)(2008-8#1)
levels and increased##2##3##(2008-5#1)(2013-1#1)
levels and its association with##2##5##(2011-1#1)(2011-2#1)
levels and levels of##2##4##(2008-10#1)(2009-2#1)
levels and metabolic##2##3##(2012-2#1)(2012-4#1)
levels and reduce the##2##4##(2008-7#1)(2010-9#1)
levels and that##2##3##(1996-12#1)(1997-7#1)
levels and the OSC amplitude##3##5##(2008-6#3)
levels and the presence of##2##5##(2008-5#1)(2010-8#1)
levels and the##23##3##(1991-1#1)(1991-2#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-6#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#2)
levels and their##3##3##(2008-10#1)(2010-9#2)
levels and to##2##3##(1994-2#1)(2012-12#1)
levels and weight##2##3##(2007-7#1)(2008-12#1)
levels and##205##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#5)(1992-9#3)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#4)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#3)(2011-1#11)(2011-2#9)(2012-12#5)(2012-2#7)(2012-3#3)(2012-4#2)(2013-1#9)(2013-7#2)(2013-8#4)
levels are affected by##2##4##(2008-2#1)(2010-8#1)
levels are also##3##3##(1991-12#1)(2008-9#1)(2013-1#1)
levels are associated with##5##4##(1992-6#1)(2008-2#1)(2008-7#1)(2009-5#1)(2012-1#1)
levels are decreased in##2##4##(1991-9#1)(2013-8#1)
levels are decreased##3##3##(1991-9#1)(2008-8#1)(2013-8#1)
levels are depressed##2##3##(1990-11#1)(1993-8#1)
levels are elevated in##2##4##(1993-12#1)(2007-10#1)
levels are elevated##3##3##(1993-12#1)(1997-1#1)(2007-10#1)
levels are high##4##3##(1994-5#1)(2007-8#1)(2008-1#2)
levels are higher##2##3##(2007-10#1)(2008-11#1)
levels are increased in##2##4##(1994-11#1)(2011-1#1)
levels are increased##3##3##(1994-11#1)(1996-12#1)(2011-1#1)
levels are mainly##2##3##(1996-5#1)(2009-5#1)
levels are not##4##3##(1995-8#1)(2008-9#2)(2011-1#1)
levels are usually##2##3##(2007-7#1)(2008-3#1)
levels are##75##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#3)(1996-5#1)(1997-1#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#2)(2013-8#3)
levels as a predictor##2##4##(2012-3#1)(2013-1#1)
levels as a response to##2##5##(2009-5#2)
levels as a##7##3##(2008-8#1)(2009-3#1)(2009-5#2)(2012-3#1)(2013-1#2)
levels as compared to##3##4##(2008-10#1)(2013-1#2)
levels as low as 2##2##5##(1990-8#1)(2008-10#1)
levels as low as##6##4##(1990-8#1)(2008-10#4)(2008-3#1)
levels as the##2##3##(1993-3#1)(2011-2#1)
levels as well as the##3##5##(2008-1#1)(2008-7#1)(2009-6#1)
levels as well as##7##4##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)
levels as well##8##3##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)
levels as##36##2##(1990-8#1)(1993-11#1)(1993-3#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#4)
levels associated with##2##3##(1997-7#1)(2011-1#1)
levels at least##2##3##(1995-3#1)(2008-3#1)
levels at stage##3##3##(2011-2#3)
levels at the end of the##2##6##(2007-5#2)
levels at the time of##2##5##(1990-11#1)(2010-9#1)
levels at the##8##3##(1990-11#1)(1997-6#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
levels at which##2##3##(2009-5#1)(2009-9#1)
levels at##32##2##(1990-11#1)(1991-9#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-5#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-2#3)(2012-3#1)
levels became undetectable##2##3##(2008-1#1)(2010-12#1)
levels became##3##2##(2008-1#1)(2010-12#1)(2013-7#1)
levels being##2##2##(1995-12#1)(2008-5#1)
levels below##14##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-9#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2012-1#1)(2012-12#1)
levels between 4##3##3##(2008-10#1)(2012-3#2)
levels between the##4##3##(1994-2#1)(1995-12#1)(2009-5#1)(2011-2#1)
levels between##23##2##(1990-3#1)(1994-2#2)(1995-12#1)(1996-5#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
levels but##8##2##(1990-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
levels by a##2##3##(2008-10#1)(2013-1#1)
levels by hydride##2##3##(2008-10#2)
levels by testosterone##2##3##(1995-12#2)
levels by the##3##3##(1992-8#1)(2008-10#1)(2013-1#1)
levels by##43##2##(1991-11#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-12#5)(1995-2#1)(1996-12#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-10#1)(2013-1#4)(2013-7#1)(2013-8#1)
levels can be restored##2##4##(1992-8#1)(1994-8#1)
levels can be##10##3##(1992-8#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
levels can##18##2##(1991-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
levels clearly##2##2##(1994-6#1)(2008-10#1)
levels comparable to those##4##4##(1990-2#1)(1991-12#1)(1993-6#1)(2008-10#1)
levels comparable to##7##3##(1990-2#1)(1991-12#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-5#1)
levels comparable with those of##2##5##(2008-2#1)(2013-1#1)
levels comparable with##3##3##(2008-2#1)(2012-2#1)(2013-1#1)
levels comparable##10##2##(1990-2#1)(1991-12#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
levels compared to##4##3##(1993-12#1)(1993-2#1)(2010-4#1)(2013-1#1)
levels compared with##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
levels compared##7##2##(1993-12#1)(1993-2#1)(2008-10#1)(2010-4#2)(2013-1#2)
levels correlate with##2##3##(2012-3#1)(2013-1#1)
levels correlated positively with##2##4##(1995-8#1)(2013-1#1)
levels correlated significantly with##2##4##(1995-11#1)(2008-1#1)
levels correlated with the##2##4##(1991-4#1)(2012-5#1)
levels correlated with##4##3##(1991-4#1)(2006-10#2)(2012-5#1)
levels correlated##9##2##(1991-4#1)(1995-11#1)(1995-8#2)(2006-10#2)(2008-1#1)(2012-5#1)(2013-1#1)
levels could be##2##3##(1996-12#1)(2012-2#1)
levels could##5##2##(1994-1#1)(1996-12#1)(2008-10#1)(2012-2#2)
levels declined##3##2##(1990-5#1)(1995-5#1)(2008-10#1)
levels decrease##2##2##(2008-10#1)(2008-4#1)
levels decreased##15##2##(1990-3#2)(1991-9#1)(1994-5#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
levels detected by##2##3##(1992-8#1)(1997-6#1)
levels detected##5##2##(1992-8#1)(1995-11#1)(1997-6#1)(2008-11#1)(2008-8#1)
levels did not change significantly##2##5##(1994-2#1)(2011-1#1)
levels did not change##4##4##(1994-2#1)(2008-10#1)(2011-1#2)
levels did not differ between the##2##6##(2008-10#1)(2013-8#1)
levels did not differ between##4##5##(1993-12#1)(2008-10#1)(2009-12#1)(2013-8#1)
levels did not differ##6##4##(1993-12#1)(1996-7#2)(2008-10#1)(2009-12#1)(2013-8#1)
levels did not##15##3##(1993-12#1)(1994-2#1)(1996-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#3)(2013-8#1)
levels do not##3##3##(1991-9#1)(1992-1#1)(1994-2#1)
levels do##4##2##(1991-12#1)(1991-9#1)(1992-1#1)(1994-2#1)
levels dropped##2##2##(1990-7#1)(1995-12#1)
levels during pregnancy and##2##4##(1994-3#1)(2011-2#1)
levels during pregnancy##3##3##(1994-3#1)(2008-11#1)(2011-2#1)
levels during the first##3##4##(1995-8#1)(2007-10#1)(2008-5#1)
levels during the subjective##2##4##(1995-12#2)
levels during the##10##3##(1995-12#2)(1995-5#1)(1995-8#1)(2007-10#1)(2008-5#3)(2012-12#1)(2012-2#1)
levels during##30##2##(1991-5#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-7#2)(1997-6#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-5#3)(2011-2#2)(2012-12#1)(2012-2#4)
levels estimated##2##2##(2008-10#1)(2008-9#1)
levels even##2##2##(2008-8#1)(2011-2#1)
levels exceeded##2##2##(2008-5#1)(2008-7#1)
levels exhibited##2##2##(2012-2#1)(2013-8#1)
levels fell##5##2##(1990-12#1)(1990-2#1)(1994-12#1)(1997-4#1)(2011-2#1)
levels following##3##2##(2008-3#1)(2008-5#1)(2013-1#1)
levels for a##2##3##(2008-4#2)
levels for all##3##3##(1994-3#1)(2008-10#2)
levels for each##2##3##(2008-11#1)(2011-2#1)
levels for the##4##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
levels for young##2##3##(1992-2#1)(2012-2#1)
levels for##40##2##(1991-1#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
levels found in patients##2##4##(1994-2#2)
levels found in##9##3##(1993-12#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
levels found##10##2##(1993-12#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#2)(2013-1#1)(2013-8#1)
levels from 3##3##3##(2008-10#3)
levels from the##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
levels from##17##2##(1990-2#1)(1992-12#1)(1996-12#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)
levels greater than##4##3##(1991-4#1)(1997-4#1)(2008-10#1)(2008-11#1)
levels had returned to##2##4##(1990-11#1)(1996-12#1)
levels had##9##2##(1990-11#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
levels has been##4##3##(1993-2#1)(2008-10#2)(2009-5#1)
levels have been reported##5##4##(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
levels have been##14##3##(1990-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
levels have##19##2##(1990-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
levels higher than##2##3##(2008-10#1)(2008-7#1)
levels in AD##2##3##(1993-12#1)(2009-12#1)
levels in F##2##3##(1995-8#1)(2008-10#1)
levels in OAA-##2##3##(2008-10#2)
levels in a dose-dependent manner##2##5##(2008-11#1)(2008-5#1)
levels in a##13##3##(1993-12#1)(1993-3#1)(1996-2#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#2)
levels in acute stroke##2##4##(2007-10#2)
levels in acute##5##3##(1991-9#1)(2007-10#2)(2008-7#1)(2010-3#1)
levels in all##3##3##(2007-5#1)(2010-5#1)(2013-8#1)
levels in an##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
levels in anxiety disorders##2##4##(2013-8#2)
levels in any##2##3##(1996-12#1)(2013-8#1)
levels in blood and##2##4##(2007-10#1)(2008-10#1)
levels in blood##3##3##(1996-12#1)(2007-10#1)(2008-10#1)
levels in both sexes##4##4##(1991-6#1)(1995-2#1)(2010-8#1)(2013-1#1)
levels in both the##2##4##(2008-10#1)(2008-11#1)
levels in both##8##3##(1991-6#1)(1993-12#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
levels in bovine##2##3##(1991-9#2)
levels in brain##2##3##(1994-11#1)(1997-2#1)
levels in children with##3##4##(2011-1#3)
levels in children##5##3##(1997-4#2)(2011-1#3)
levels in control##2##3##(2007-11#1)(2013-1#1)
levels in culture##2##3##(2008-10#2)
levels in diabetes##3##3##(1993-3#1)(2011-2#2)
levels in different##3##3##(2008-10#1)(2011-1#2)
levels in eggs and##2##4##(2008-10#1)(2010-2#1)
levels in endothelial cells##2##4##(1992-10#1)(1993-3#1)
levels in eutopic##2##3##(1995-12#1)(2013-8#1)
levels in excess of##2##4##(2008-10#1)(2008-7#1)
levels in food##2##3##(2008-10#2)
levels in healthy##2##3##(2008-7#1)(2013-1#1)
levels in human serum##2##4##(2008-3#1)(2011-2#1)
levels in human vascular##2##4##(1993-11#1)(1993-3#1)
levels in human##15##3##(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
levels in large##2##3##(1996-12#1)(2007-11#1)
levels in male rats##3##4##(1995-12#1)(1995-3#2)
levels in maternal serum##2##4##(1995-8#2)
levels in mice##3##3##(1992-8#2)(2010-11#1)
levels in most##2##3##(1993-2#1)(1995-2#1)
levels in mouse##2##3##(2008-10#1)(2008-4#1)
levels in natural waters##2##4##(2008-10#2)
levels in normal##4##3##(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
levels in obese##2##3##(2013-1#1)(2013-8#1)
levels in patients with dysthymic##2##5##(2011-2#2)
levels in patients with high-risk##2##5##(2011-2#2)
levels in patients with rheumatoid arthritis##2##6##(2006-10#1)(2008-7#1)
levels in patients with##15##4##(1991-7#1)(1992-11#1)(1993-2#2)(1996-12#1)(2006-10#1)(2007-10#1)(2008-7#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)
levels in peripheral##2##3##(1995-3#1)(2008-8#1)
levels in plants##2##3##(2008-10#2)
levels in plasma##4##3##(1993-12#1)(1995-12#1)(2008-5#1)(2012-3#1)
levels in rat##4##3##(1992-6#1)(1993-5#1)(1993-9#1)(1994-6#1)
levels in rats##3##3##(1990-2#1)(1991-12#1)(2008-11#1)
levels in relation to##2##4##(2008-6#1)(2008-7#1)
levels in serum and##2##4##(2007-8#1)(2008-10#1)
levels in serum##7##3##(1992-12#1)(1994-3#1)(1996-10#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
levels in smokers##3##3##(1992-9#2)(1994-6#1)
levels in subjects with##3##4##(1993-8#1)(2013-1#2)
levels in the blood##4##4##(2008-10#2)(2008-5#1)(2013-8#1)
levels in the brain##2##4##(1993-3#1)(2011-1#1)
levels in the control group##3##5##(2009-12#1)(2011-1#2)
levels in the heart and gastrocnemius tissues##2##7##(2013-1#2)
levels in the heart##3##4##(2013-1#3)
levels in the most##2##4##(1993-5#1)(2008-9#1)
levels in the normal##3##4##(1992-9#1)(2008-1#1)(2008-9#1)
levels in the patients with##2##5##(1991-4#1)(2009-8#1)
levels in the plasma##2##4##(1990-7#1)(1992-9#1)
levels in the serum##2##4##(1997-4#1)(2012-1#1)
levels in the spleen##2##4##(1994-2#1)(2008-10#1)
levels in the striatum##2##4##(1996-12#1)(2009-8#1)
levels in the##120##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-9#2)(1993-3#1)(1993-5#2)(1994-11#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-8#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#8)(2013-8#2)
levels in these##5##3##(1990-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
levels in this##4##3##(1990-2#1)(1996-12#1)(2007-12#1)(2013-1#1)
levels in those##2##3##(2008-10#1)(2013-8#1)
levels in two##2##3##(2008-10#1)(2009-3#1)
levels in urine##2##3##(1990-2#1)(2008-10#1)
levels in urines##2##3##(1990-8#2)
levels in various##2##3##(1996-7#1)(2008-10#1)
levels in vitro##3##3##(1993-6#1)(1997-7#1)(2008-5#1)
levels in vivo##5##3##(1990-2#1)(1992-11#1)(1995-5#3)
levels in##491##2##(1990-12#4)(1990-2#5)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#3)(1992-9#8)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#5)(1993-3#5)(1993-5#4)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#10)(1995-2#6)(1995-3#5)(1995-5#4)(1995-6#2)(1995-8#7)(1996-10#2)(1996-12#12)(1996-2#4)(1996-5#2)(1996-6#1)(1996-7#3)(1997-2#7)(1997-3#1)(1997-4#9)(1997-6#4)(1997-7#3)(2006-10#1)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#2)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#73)(2008-11#13)(2008-12#8)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#14)(2008-6#6)(2008-7#15)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#4)(2010-7#2)(2010-8#4)(2011-1#13)(2011-2#25)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#26)(2013-8#13)
levels increase##8##2##(1990-12#1)(1990-4#1)(1992-11#1)(1994-1#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-11#1)
levels increased during##2##3##(1993-6#1)(2008-10#1)
levels increased in the##2##4##(2008-10#1)(2008-7#1)
levels increased in##4##3##(1990-5#1)(2008-10#1)(2008-7#2)
levels increased with age##2##4##(1991-12#1)(2009-5#1)
levels increased with##3##3##(1991-12#1)(2008-10#1)(2009-5#1)
levels increased##20##2##(1990-5#1)(1991-12#1)(1993-12#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#2)(2008-7#4)(2009-5#1)(2013-8#1)
levels indicate##2##2##(2008-7#1)(2012-3#1)
levels induced by##3##3##(1994-8#1)(2008-3#1)(2011-2#1)
levels inside##2##2##(2008-10#2)
levels into##2##2##(2008-8#1)(2012-5#1)
levels is presented##2##3##(2008-10#1)(2008-3#1)
levels is the##2##3##(1994-7#1)(1997-2#1)
levels is##18##2##(1990-8#1)(1991-12#1)(1994-7#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
levels lower than##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
levels markedly##2##2##(1991-6#1)(2008-10#1)
levels may be##3##3##(1991-3#1)(1992-9#1)(2009-11#1)
levels may serve as a##2##5##(1990-2#1)(2013-1#1)
levels may##13##2##(1990-2#1)(1991-3#1)(1992-9#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-8#1)(2013-1#2)
levels measured over##2##3##(2012-5#1)(2013-1#1)
levels measured##5##2##(1991-4#1)(1992-9#1)(1995-12#1)(2012-5#1)(2013-1#1)
levels might be##2##3##(2011-2#1)(2013-1#1)
levels might##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
levels must be##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
levels near##7##2##(2007-11#1)(2008-10#6)
levels normally seen##2##3##(2008-10#2)
levels observed for the##2##4##(2008-10#1)(2011-1#1)
levels observed for##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
levels observed in##3##3##(1993-3#1)(2008-10#2)
levels observed##9##2##(1991-3#1)(1993-3#1)(2008-10#3)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
levels obtained from##2##3##(1996-12#1)(2011-1#1)
levels obtained using##2##3##(2008-10#1)(2008-7#1)
levels obtained with##2##3##(2008-7#1)(2010-12#1)
levels obtained##8##2##(1994-3#1)(1996-12#2)(2008-10#1)(2008-7#2)(2010-12#1)(2011-1#1)
levels occurred when##2##3##(1992-10#1)(2008-10#1)
levels occurred##5##2##(1991-12#1)(1992-10#1)(2008-10#1)(2008-7#1)(2009-7#1)
levels of 0##8##3##(1994-5#1)(2008-10#4)(2011-1#2)(2012-2#1)
levels of 1##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
levels of 10##3##3##(1994-12#1)(2008-10#1)(2008-6#1)
levels of 200##2##3##(2008-5#1)(2010-1#1)
levels of 5-FU incorporation##2##4##(1993-8#2)
levels of 5-HIAA##2##3##(1995-11#1)(2008-3#1)
levels of AA##2##3##(1992-12#1)(1993-3#1)
levels of ACTH and##2##4##(1996-12#1)(2011-2#1)
levels of ADMA##2##3##(2009-4#2)
levels of APN mRNA##2##4##(1995-8#2)
levels of ATP##3##3##(1991-12#1)(1994-3#2)
levels of As(III) and As(V) in##2##6##(2008-10#2)
levels of BDNF##2##3##(2009-3#1)(2011-2#1)
levels of CAT##2##3##(1990-8#1)(1995-2#1)
levels of CRP##2##3##(2007-10#2)
levels of Cd##2##3##(1997-4#1)(2008-10#1)
levels of CoQ10##3##3##(1991-5#1)(1993-3#2)
levels of D-dimer##2##3##(2010-3#1)(2011-2#1)
levels of DA##2##3##(1996-12#1)(1997-2#1)
levels of DNA damage##2##4##(1994-5#1)(2011-2#1)
levels of DNA##4##3##(1993-11#1)(1994-5#1)(2008-10#1)(2011-2#1)
levels of Emotional Stability##2##4##(2010-12#2)
levels of F##4##3##(2008-10#4)
levels of GH and IGF-I##2##5##(2012-3#2)
levels of GH were##2##4##(2010-5#1)(2012-3#1)
levels of GH##4##3##(2010-5#1)(2012-3#3)
levels of GTH-II##2##3##(2008-5#2)
levels of IFNgamma##2##3##(2008-10#2)
levels of IGF-I##2##3##(2012-3#1)(2013-1#1)
levels of IL-2##4##3##(1990-2#2)(1991-12#1)(1993-6#1)
levels of IL-4##2##3##(2009-12#1)(2010-12#1)
levels of ILI##2##3##(2008-10#2)
levels of IgG##2##3##(1990-12#1)(2008-7#1)
levels of LH beta mRNA##3##5##(1997-2#3)
levels of LH##4##3##(1997-2#3)(2013-8#1)
levels of MMP-2##2##3##(1992-9#2)
levels of NOx##2##3##(2007-10#2)
levels of Notch##2##3##(2010-3#2)
levels of P4##2##3##(2008-5#2)
levels of PR##2##3##(1993-9#1)(2008-10#1)
levels of RA synthesizing enzyme##2##5##(1996-5#2)
levels of ROS##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
levels of T##2##3##(1993-12#1)(2013-8#1)
levels of TAT##2##3##(1991-3#1)(2010-3#1)
levels of TNF-alpha##2##3##(1995-12#2)
levels of TYLCV resistance##2##4##(2008-10#2)
levels of a number of##2##5##(2008-10#1)(2008-4#1)
levels of a##11##3##(1992-12#1)(1997-4#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#1)(2012-2#1)
levels of access##2##3##(1995-12#1)(1996-1#1)
levels of active##3##3##(1993-8#1)(1997-7#1)(2012-1#1)
levels of activity##3##3##(1997-3#1)(2008-10#1)(2010-12#1)
levels of adenosine##3##3##(1997-7#1)(2008-4#2)
levels of adiponectin##2##3##(2011-1#2)
levels of alanine##2##3##(2011-2#1)(2012-3#1)
levels of alcohol involvement##2##4##(1994-2#2)
levels of alcohol##5##3##(1994-2#2)(1997-2#1)(2009-7#1)(2013-1#1)
levels of alkaline phosphatase (ALP)##2##5##(2008-11#1)(2013-1#1)
levels of alkaline phosphatase##3##4##(1994-12#1)(2008-11#1)(2013-1#1)
levels of all##2##3##(2008-1#1)(2008-9#1)
levels of alpha-bungarotoxin binding##2##4##(1996-12#2)
levels of amino acids##2##4##(2008-10#1)(2010-1#1)
levels of ammonia##3##3##(2008-3#2)(2008-9#1)
levels of angiogenic inhibitors##2##4##(2008-1#2)
levels of anti-(NANP)n IgG##2##4##(1990-12#2)
levels of antibodies against##2##4##(1996-6#1)(2007-2#1)
levels of antinuclear##2##3##(2006-10#1)(2008-10#1)
levels of antioxidant##2##3##(1991-12#1)(2011-1#1)
levels of antisocial##2##3##(2009-5#1)(2010-4#1)
levels of anxiety##4##3##(2008-1#1)(2008-11#3)
levels of arachidonic acid##2##4##(1992-12#1)(2008-3#1)
levels of arsenic##4##3##(1995-11#2)(2008-10#1)(2013-1#1)
levels of ascorbic acid##2##4##(2011-2#2)
levels of bFGF mRNA##2##4##(1995-12#2)
levels of binding##2##3##(1993-8#2)
levels of blood##2##3##(1995-12#1)(2011-2#1)
levels of both enzymes##2##4##(1993-9#1)(2008-10#1)
levels of both the##2##4##(1997-7#1)(2012-3#1)
levels of both##15##3##(1992-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#3)(2012-3#2)
levels of brain alpha-bungarotoxin binding##2##5##(1996-12#2)
levels of brain function##2##4##(2008-11#1)(2008-7#1)
levels of brain##5##3##(1996-12#2)(2008-11#1)(2008-7#1)(2013-1#1)
levels of burnout##3##3##(1992-1#1)(2010-9#2)
levels of c-myc##2##3##(1992-2#1)(1992-9#1)
levels of cAMP##2##3##(1994-8#1)(1997-2#1)
levels of cadmium##2##3##(1997-4#1)(2008-10#1)
levels of calcium##4##3##(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
levels of carbon dioxide##2##4##(1996-12#1)(2008-11#1)
levels of care##5##3##(1991-11#2)(1994-12#1)(1996-3#1)(2010-3#1)
levels of cellular##2##3##(1992-11#1)(2008-7#1)
levels of charity##2##3##(1996-2#2)
levels of children##2##3##(1996-12#1)(1997-4#1)
levels of cholesterol##2##3##(1991-4#1)(2012-2#1)
levels of chromosome pairing at pachytene##2##6##(2008-5#2)
levels of circulating##6##3##(1996-12#1)(2007-5#1)(2008-7#3)(2011-2#1)
levels of clinical##3##3##(1991-2#1)(2008-11#1)(2012-3#1)
levels of cobalt##2##3##(2008-10#2)
levels of cognitive complexity##2##4##(2007-8#2)
levels of complexity##2##3##(2007-12#1)(2008-10#1)
levels of confidence##3##3##(2008-10#3)
levels of contact##2##3##(2009-4#1)(2010-5#1)
levels of control##3##3##(2008-10#2)(2008-7#1)
levels of cooperation##2##3##(1995-1#1)(2008-8#1)
levels of copper##4##3##(2008-10#3)(2010-5#1)
levels of corticosterone##5##3##(1997-2#2)(2008-7#2)(2008-8#1)
levels of cortisol##3##3##(1991-6#1)(2008-6#1)(2010-4#1)
levels of covalent##2##3##(1995-6#2)
levels of creatinine##2##3##(2008-1#1)(2013-1#1)
levels of cross-protection##2##3##(2008-8#2)
levels of cyclic AMP##2##4##(1994-2#1)(1997-2#1)
levels of cyclin##2##3##(1993-6#1)(1997-7#1)
levels of cytokine##2##3##(2008-4#1)(2009-3#1)
levels of depression and anxiety##2##5##(2008-11#1)(2009-5#1)
levels of depression##5##3##(1991-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-5#1)
levels of depressive symptoms and higher levels of self-esteem##2##9##(2009-5#2)
levels of depressive symptoms##4##4##(1994-2#1)(2009-5#3)
levels of diabetic patients##2##4##(2007-10#2)
levels of diabetic##3##3##(2007-10#2)(2008-7#1)
levels of diacylglycerol##2##3##(1991-3#1)(1992-8#1)
levels of dietary fiber##3##4##(1993-11#3)
levels of dietary##6##3##(1990-3#1)(1993-11#3)(2008-10#2)
levels of different##2##3##(2007-7#1)(2013-8#1)
levels of differentiation among##2##4##(2008-10#2)
levels of dioxins##2##3##(2008-10#1)(2008-7#1)
levels of disease severity##4##4##(2008-10#3)(2009-4#1)
levels of disease##16##3##(2008-10#14)(2008-5#1)(2009-4#1)
levels of dissolved##4##3##(2008-10#3)(2008-7#1)
levels of diversity##4##3##(2008-10#2)(2009-2#2)
levels of dopamine##3##3##(1991-1#1)(1997-7#1)(2008-7#1)
levels of each##5##3##(1997-7#1)(2008-10#3)(2011-2#1)
levels of early##3##3##(1996-12#1)(2008-10#1)(2009-7#1)
levels of education and##2##4##(1993-3#1)(2008-1#1)
levels of education##9##3##(1993-3#1)(1994-3#1)(2008-1#1)(2009-11#1)(2009-7#2)(2011-2#2)(2012-12#1)
levels of efficiency##2##3##(1996-1#1)(2008-6#1)
levels of either##2##3##(1992-10#1)(1997-7#1)
levels of endogenous adenosine in##2##5##(1997-7#2)
levels of endogenous adenosine##5##4##(1997-7#5)
levels of endogenous##10##3##(1995-2#1)(1997-7#5)(2008-11#1)(2008-8#1)(2009-8#1)(2010-2#1)
levels of engaged lifestyle were more likely to show relatively##2##10##(2010-12#2)
levels of epidermal##2##3##(2008-5#1)(2010-8#1)
levels of estrogen receptor##4##4##(2008-11#4)
levels of estrogen##6##3##(2008-11#6)
levels of ethnic##2##3##(2009-7#2)
levels of evidence##2##3##(2007-12#1)(2008-7#1)
levels of excitatory##2##3##(1990-11#1)(1994-11#1)
levels of exposure to##3##4##(1993-1#1)(2009-9#1)(2013-1#1)
levels of exposure##5##3##(1993-1#1)(2008-10#1)(2008-12#1)(2009-9#1)(2013-1#1)
levels of expression in##2##4##(1997-1#1)(1997-6#1)
levels of expression of the##2##5##(1995-8#1)(2008-11#1)
levels of expression of##4##4##(1995-8#1)(1997-4#1)(2008-11#1)(2010-1#1)
levels of expression##13##3##(1994-8#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-6#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)
levels of extracellular##6##3##(1993-6#1)(1994-2#1)(2008-10#2)(2008-4#2)
levels of family##2##3##(2010-10#1)(2013-1#1)
levels of fatty acids##2##4##(1996-7#1)(2008-5#1)
levels of fatty##3##3##(1996-7#1)(2008-5#1)(2008-6#1)
levels of field resistance##3##4##(2008-10#3)
levels of floral integration##3##4##(2009-8#3)
levels of free##4##3##(1990-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
levels of function##2##3##(1996-1#1)(2008-7#1)
levels of functioning##2##3##(2008-9#1)(2012-12#1)
levels of funding##2##3##(1995-3#1)(2008-8#1)
levels of gamma-aminobutyric acid##2##4##(1996-7#2)
levels of gene diversity##2##4##(2008-10#1)(2012-5#1)
levels of gene expression##2##4##(2008-9#1)(2011-2#1)
levels of gene flow##2##4##(2008-10#2)
levels of gene##9##3##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-5#1)(2013-8#1)
levels of genetic differentiation were##2##5##(2008-10#2)
levels of genetic differentiation##6##4##(2008-10#4)(2012-3#1)(2012-5#1)
levels of genetic diversity##4##4##(2008-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
levels of genetic##12##3##(2008-10#6)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)(2012-5#1)(2013-1#1)
levels of genotypic##4##3##(2008-10#4)
levels of glucose##5##3##(1990-5#1)(2008-12#2)(2008-6#1)(2011-2#1)
levels of government##2##3##(1996-3#2)
levels of health##3##3##(1991-2#1)(1995-12#1)(2011-1#1)
levels of heavy##2##3##(1994-2#1)(2008-10#1)
levels of homocysteine##4##3##(2008-3#2)(2010-5#1)(2011-2#1)
levels of immunostaining##2##3##(1995-12#2)
levels of inbreeding##2##3##(2008-9#1)(2012-3#1)
levels of infection and##2##4##(1991-8#1)(2008-10#1)
levels of infection##6##3##(1991-8#1)(2008-10#3)(2008-12#1)(2008-8#1)
levels of inflammatory##2##3##(2008-10#1)(2008-3#1)
levels of inorganic mercury##2##4##(2008-10#2)
levels of inorganic##3##3##(2008-10#2)(2010-8#1)
levels of inositol phosphates##2##4##(1992-11#1)(2008-4#1)
levels of inositol##3##3##(1991-12#1)(1992-11#1)(2008-4#1)
levels of insensitivity##2##3##(2008-10#2)
levels of insulin##2##3##(1994-11#1)(2007-7#1)
levels of interleukin##2##3##(2008-6#1)(2013-1#1)
levels of interleukin-1##2##3##(1995-6#1)(2012-2#1)
levels of iron##2##3##(1993-2#1)(2012-2#1)
levels of irrationality##2##3##(2010-5#2)
levels of lactate##2##3##(1994-9#1)(2009-8#1)
levels of latent infection##3##4##(2008-10#3)
levels of leaf##2##3##(2008-10#2)
levels of less than##2##4##(2008-3#1)(2011-2#1)
levels of lipid hydroperoxides and antioxidants in##2##7##(1992-11#2)
levels of lipid##5##3##(1990-5#2)(1992-11#2)(1992-12#1)
levels of liver##2##3##(1990-7#1)(2008-1#1)
levels of long-chain fatty acids##2##5##(2008-4#1)(2008-5#1)
levels of mRNA in##2##4##(1991-5#1)(2008-7#1)
levels of mRNA##6##3##(1991-5#1)(1993-5#1)(1995-12#1)(2008-7#2)(2009-12#1)
levels of mRNAs encoding the##2##5##(1995-2#1)(2008-7#1)
levels of mRNAs##3##3##(1995-2#1)(1997-2#1)(2008-7#1)
levels of maternal monitoring##2##4##(2009-7#2)
levels of maternal##3##3##(1990-9#1)(2009-7#2)
levels of mercury in##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
levels of mercury##4##3##(1995-6#1)(2008-10#2)(2013-1#1)
levels of methamphetamine##2##3##(1990-8#1)(1991-1#1)
levels of moniliformin##2##3##(2008-10#1)(2008-5#1)
levels of net revenue##2##4##(2008-11#2)
levels of nitrite and##2##4##(2006-10#1)(2008-10#1)
levels of nitrite##3##3##(2006-10#1)(2008-10#2)
levels of noise##3##3##(2008-3#2)(2013-8#1)
levels of non-esterified##2##3##(1991-12#1)(1992-5#1)
levels of norepinephrine##2##3##(1996-7#1)(2013-1#1)
levels of one##2##3##(2008-7#1)(2011-3#1)
levels of organization##2##3##(2008-9#1)(2012-1#1)
levels of other##2##3##(1990-12#1)(1995-8#1)
levels of oxidative##2##3##(2011-1#1)(2012-3#1)
levels of oxygen##2##3##(1992-9#1)(1994-11#1)
levels of p53##3##3##(1992-12#2)(2012-1#1)
levels of palladium##2##3##(2008-10#2)
levels of partial resistance##4##4##(2008-10#4)
levels of participation##4##3##(1995-2#2)(2007-11#1)(2009-5#1)
levels of particulate##2##3##(1997-1#1)(2008-6#1)
levels of patients with##2##4##(2008-7#2)
levels of perceived##2##3##(1995-3#1)(1996-3#1)
levels of persistent##3##3##(1994-5#1)(2008-11#2)
levels of pesticide##2##3##(2008-10#2)
levels of pesticides##2##3##(2008-10#2)
levels of phenolic##2##3##(2008-10#2)
levels of phosphate and##2##4##(2008-10#1)(2012-12#1)
levels of phosphate##3##3##(2008-10#2)(2012-12#1)
levels of phosphorylated##2##3##(2008-7#1)(2008-9#1)
levels of phosphorylation##2##3##(2008-8#1)(2013-1#1)
levels of plasma##6##3##(1995-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#2)
levels of play##2##3##(2007-11#2)
levels of polymorphism##2##3##(2008-5#1)(2010-3#1)
levels of practice##2##3##(2008-11#2)
levels of precision##2##3##(1994-11#1)(2008-10#1)
levels of productivity##2##3##(2008-8#1)(2008-9#1)
levels of protection##2##3##(1994-2#1)(2013-1#1)
levels of protein##3##3##(2008-1#1)(2008-11#2)
levels of pseudouridine and 1-methyladenosine##2##5##(1992-3#2)
levels of purines##2##3##(1995-12#1)(2013-8#1)
levels of radioactivity##2##3##(1996-2#1)(2008-7#1)
levels of reactive oxygen species##4##5##(1994-11#1)(2008-10#2)(2013-1#1)
levels of reactive##7##3##(1994-11#1)(1996-11#1)(1997-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
levels of resistance to##8##4##(2008-10#6)(2011-2#1)(2013-1#1)
levels of resistance were##2##4##(2008-10#2)
levels of resistance##18##3##(2008-10#14)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
levels of resource##3##3##(2008-8#3)
levels of risk##5##3##(1993-12#1)(1995-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
levels of risky sexual##2##4##(2011-2#1)(2013-1#1)
levels of satisfaction and##2##4##(1995-12#1)(2008-10#1)
levels of satisfaction##3##3##(1995-12#1)(2008-10#2)
levels of school##2##3##(2009-7#2)
levels of selection##3##3##(2008-8#3)
levels of selenite##2##3##(1993-12#2)
levels of self-esteem##3##3##(2009-5#3)
levels of sensitivity##2##3##(1993-3#1)(2008-10#1)
levels of serum##11##3##(1991-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-1#2)(2008-9#1)(2009-12#1)(2010-1#1)(2012-3#1)(2013-8#1)
levels of several##3##3##(1992-11#1)(2008-10#1)(2010-1#1)
levels of sexual##3##3##(2009-8#1)(2012-12#1)(2012-3#1)
levels of signal##2##3##(1990-11#1)(2011-1#1)
levels of social##4##3##(1996-1#1)(1997-1#1)(2010-8#1)(2013-1#1)
levels of specific##5##3##(1995-11#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-7#1)
levels of spontaneous##3##3##(1993-6#1)(1997-7#1)(2013-1#1)
levels of staff##3##3##(1994-1#2)(1995-1#1)
levels of stress##4##3##(2008-4#1)(2008-9#1)(2011-2#2)
levels of subsequent##2##3##(2009-7#2)
levels of supervised time##2##4##(2009-7#2)
levels of support##2##3##(1993-1#1)(2008-12#1)
levels of suppressiveness##4##3##(2008-10#4)
levels of testosterone##4##3##(1990-2#2)(2008-3#1)(2008-7#1)
levels of the hormone##2##4##(1990-12#1)(1993-9#1)
levels of the pro-inflammatory##2##4##(2008-10#2)
levels of the two##2##4##(1991-12#1)(1991-6#1)
levels of the##100##3##(1990-11#1)(1990-12#3)(1990-5#3)(1991-12#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#4)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-3#1)(2013-8#3)
levels of these proteins##2##4##(1994-12#1)(2011-2#1)
levels of these two##3##4##(1990-11#1)(2009-10#1)(2010-2#1)
levels of these##17##3##(1990-11#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
levels of this enzyme##3##4##(1994-8#1)(2008-10#1)(2008-6#1)
levels of this##10##3##(1991-5#1)(1992-5#1)(1992-8#1)(1994-8#1)(2008-10#4)(2008-6#1)(2011-2#1)
levels of those##2##3##(2007-10#1)(2008-11#1)
levels of three##5##3##(1993-3#1)(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
levels of thyroid hormone led to##2##6##(1995-2#2)
levels of thyroid hormones##2##4##(1995-8#1)(2012-2#1)
levels of thyroid##4##3##(1995-2#2)(1995-8#1)(2012-2#1)
levels of tissue##4##3##(1990-8#1)(1994-3#1)(2008-7#2)
levels of total cholesterol##2##4##(2011-2#1)(2013-1#1)
levels of total##12##3##(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-1#2)
levels of transcripts of##2##4##(2008-10#1)(2008-8#1)
levels of transcripts##5##3##(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
levels of tumor necrosis factor##2##5##(2006-10#1)(2011-2#1)
levels of tumor##4##3##(1990-2#1)(1994-7#1)(2006-10#1)(2011-2#1)
levels of two##3##3##(1993-3#1)(1995-3#1)(2008-10#1)
levels of unstimulated##2##3##(1992-12#1)(1996-2#1)
levels of urinary factor H##3##5##(2009-6#3)
levels of urinary##7##3##(1996-12#2)(2008-10#2)(2009-6#3)
levels of various##2##3##(2008-7#1)(2010-12#1)
levels of violence victimization##2##4##(2013-1#2)
levels of violence##3##3##(2013-1#3)
levels of viral##3##3##(1991-2#1)(1997-3#1)(2008-10#1)
levels of virulence##4##3##(2008-10#2)(2008-8#2)
levels of virus##2##3##(2008-10#1)(2008-5#1)
levels of vitamin##2##3##(1992-9#1)(2012-3#1)
levels of worksite tenure##2##4##(2010-6#2)
levels of##1795##2##(1990-11#6)(1990-12#14)(1990-2#10)(1990-3#5)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#9)(1990-9#3)(1991-1#7)(1991-11#2)(1991-12#20)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#7)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#10)(1992-12#15)(1992-2#4)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#15)(1992-9#14)(1993-1#5)(1993-11#7)(1993-12#13)(1993-2#2)(1993-3#14)(1993-5#1)(1993-6#10)(1993-8#10)(1993-9#5)(1994-1#3)(1994-11#11)(1994-12#9)(1994-2#19)(1994-3#9)(1994-5#7)(1994-6#11)(1994-7#4)(1994-8#7)(1994-9#6)(1995-1#2)(1995-11#9)(1995-12#21)(1995-2#25)(1995-3#7)(1995-5#3)(1995-6#9)(1995-8#7)(1996-1#7)(1996-11#2)(1996-12#29)(1996-2#10)(1996-3#5)(1996-5#5)(1996-6#1)(1996-7#6)(1996-9#1)(1997-1#7)(1997-2#15)(1997-3#8)(1997-4#17)(1997-6#7)(1997-7#21)(1997-8#2)(1997-9#1)(2006-10#5)(2007-10#11)(2007-11#8)(2007-12#12)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#26)(2008-10#354)(2008-11#84)(2008-12#24)(2008-2#9)(2008-3#30)(2008-4#18)(2008-5#41)(2008-6#20)(2008-7#60)(2008-8#47)(2008-9#28)(2009-10#7)(2009-11#4)(2009-12#7)(2009-2#2)(2009-3#2)(2009-4#8)(2009-5#15)(2009-6#6)(2009-7#25)(2009-8#13)(2009-9#2)(2010-1#10)(2010-10#5)(2010-11#4)(2010-12#11)(2010-2#6)(2010-3#7)(2010-4#4)(2010-5#12)(2010-6#8)(2010-7#4)(2010-8#11)(2010-9#2)(2011-1#23)(2011-10#1)(2011-2#69)(2011-3#2)(2012-1#10)(2012-12#18)(2012-2#25)(2012-3#33)(2012-5#4)(2012-6#2)(2012-7#2)(2013-1#52)(2013-3#1)(2013-7#8)(2013-8#17)
levels on day##2##3##(1995-11#1)(2007-9#1)
levels on the##2##3##(1993-8#1)(2012-2#1)
levels on##17##2##(1993-8#1)(1994-9#1)(1995-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
levels only##2##2##(1991-9#1)(2013-8#1)
levels or##13##2##(1993-6#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2012-1#1)
levels over the##2##3##(1990-11#1)(2010-7#1)
levels over##4##2##(1990-11#1)(1991-9#1)(2008-2#1)(2010-7#1)
levels present in##2##3##(1996-12#1)(2008-10#1)
levels progressively##2##2##(1990-3#1)(2011-2#1)
levels ranged from##5##3##(2008-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
levels ranged##7##2##(1993-2#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-2#1)
levels ranging from 0 to##2##5##(1993-12#1)(2008-10#1)
levels ranging from##6##3##(1993-12#2)(1996-12#1)(2008-10#3)
levels remained stable##2##3##(2008-1#1)(2008-5#1)
levels remained unchanged##3##3##(1991-2#1)(1991-6#1)(1993-12#1)
levels remained##10##2##(1991-2#1)(1991-6#1)(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-1#2)(2012-5#1)
levels required for##2##3##(1995-2#1)(2008-8#1)
levels resulted in##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
levels resulting in##2##3##(2008-10#1)(2012-12#1)
levels rose##3##2##(1992-3#1)(1995-2#1)(1995-3#1)
levels seem to##2##3##(2008-10#1)(2011-2#1)
levels seen in##4##3##(1992-3#1)(1994-5#1)(1996-5#1)(2008-7#1)
levels seen##5##2##(1992-3#1)(1994-5#1)(1996-5#1)(2008-7#1)(2013-8#1)
levels should be##3##3##(1990-12#1)(1994-9#2)
levels showed a##4##3##(1990-8#1)(1996-12#1)(2008-1#1)(2008-10#1)
levels significantly##5##2##(1990-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
levels similar to those of##3##5##(2007-8#1)(2008-10#2)
levels similar to##4##3##(1993-3#1)(2007-8#1)(2008-10#2)
levels than in the male##2##5##(2013-1#2)
levels than in##3##3##(2008-6#1)(2013-1#2)
levels than subjects##2##3##(2008-9#1)(2012-3#1)
levels than the user##2##4##(1996-7#2)
levels than the##5##3##(1990-8#1)(1996-7#2)(2008-10#1)(2013-1#1)
levels than those##3##3##(1991-11#1)(2008-11#1)(2011-1#1)
levels than women##2##3##(1992-9#1)(2013-1#1)
levels than##26##2##(1990-8#1)(1991-11#1)(1992-9#1)(1996-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
levels that are##4##3##(2008-11#2)(2008-7#1)(2010-6#1)
levels that were##2##3##(1997-6#1)(2012-3#1)
levels that##19##2##(1992-2#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
levels through##3##2##(1992-10#1)(2008-11#1)(2009-9#1)
levels to a##2##3##(1994-8#1)(2013-1#1)
levels to reduce##2##3##(2008-11#1)(2012-3#1)
levels to the##5##3##(1991-8#1)(1995-5#1)(2007-12#1)(2011-2#1)(2013-8#1)
levels to which##2##3##(1992-9#1)(2008-10#1)
levels to##37##2##(1991-12#1)(1991-6#1)(1991-8#3)(1992-9#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#2)(2013-8#2)
levels under the##2##3##(2008-11#1)(2008-7#1)
levels under##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
levels up to##7##3##(1990-12#1)(1994-8#1)(1997-2#1)(2008-10#2)(2010-4#1)(2011-2#1)
levels using a##3##3##(2008-10#2)(2012-5#1)
levels using the##2##3##(2008-10#2)
levels using##11##2##(1997-2#1)(2008-10#9)(2012-5#1)
levels varied among##2##3##(1993-3#1)(2009-5#1)
levels varied##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2009-5#1)
levels via##2##2##(2008-10#1)(2008-6#1)
levels was associated with##2##4##(2008-7#1)(2010-8#1)
levels was established##2##3##(1995-5#1)(2008-10#1)
levels was observed in##2##4##(1994-8#1)(1996-12#1)
levels was observed##7##3##(1992-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
levels was##24##2##(1990-3#1)(1992-3#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#3)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
levels were 0##2##3##(1993-3#1)(2011-1#1)
levels were 4##3##3##(1994-9#1)(2007-2#1)(2008-12#1)
levels were achieved##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
levels were also##11##3##(1990-3#1)(1991-12#1)(1994-2#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
levels were approximately##2##3##(2008-10#1)(2008-8#1)
levels were assessed##2##3##(2008-10#1)(2008-12#1)
levels were associated with##3##4##(2008-7#1)(2011-1#1)(2012-3#1)
levels were comparable##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
levels were compared##3##3##(1996-12#1)(2008-7#1)(2012-2#1)
levels were correlated##2##3##(2008-10#1)(2008-4#1)
levels were decreased in##2##4##(1996-5#1)(2009-6#1)
levels were decreased##4##3##(1993-6#1)(1996-5#1)(2009-6#1)(2013-1#1)
levels were defined##2##3##(2009-3#1)(2013-1#1)
levels were detected in##2##4##(2009-5#1)(2009-8#1)
levels were detected##4##3##(2008-10#1)(2009-5#2)(2009-8#1)
levels were determined in##5##4##(1990-12#1)(1993-2#1)(1994-5#1)(2007-10#1)(2008-10#1)
levels were determined with##2##4##(2008-3#1)(2009-9#1)
levels were determined##14##3##(1990-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
levels were either##2##3##(2008-7#2)
levels were elevated in##5##4##(1993-9#1)(1994-3#1)(1995-2#1)(2007-10#1)(2009-6#1)
levels were elevated##8##3##(1990-11#1)(1991-5#1)(1993-9#1)(1994-3#1)(1995-2#1)(2007-10#1)(2008-1#1)(2009-6#1)
levels were found in the##2##5##(1994-2#1)(2008-12#1)
levels were found in##6##4##(1993-12#1)(1993-9#1)(1994-2#1)(1997-4#1)(2008-12#1)(2008-7#1)
levels were found to##2##4##(1995-2#1)(1995-8#1)
levels were found##15##3##(1993-12#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-1#1)(2011-2#3)
levels were generally##2##3##(1992-6#1)(1997-4#1)
levels were high##2##3##(1991-5#1)(1995-8#1)
levels were higher and##2##4##(2010-8#1)(2011-1#1)
levels were higher in##9##4##(1992-1#1)(1995-12#1)(1996-9#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#2)
levels were higher than##3##4##(1995-12#1)(2008-5#1)(2011-1#1)
levels were higher##16##3##(1992-1#1)(1994-2#1)(1995-12#2)(1996-9#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#3)(2011-2#2)
levels were highly##2##3##(1992-3#1)(2008-12#1)
levels were in##2##3##(2008-7#1)(2011-1#1)
levels were increased in##5##4##(1992-12#1)(1996-5#1)(2008-6#1)(2008-7#1)(2009-8#1)
levels were increased##11##3##(1992-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)
levels were less##2##3##(1996-5#1)(2011-2#1)
levels were low##3##3##(1995-12#1)(2008-7#1)(2011-1#1)
levels were lower in##2##4##(2011-1#1)(2013-8#1)
levels were lower##3##3##(1990-9#1)(2011-1#1)(2013-8#1)
levels were maintained##3##3##(2008-10#2)(2008-6#1)
levels were measured at##2##4##(2008-3#1)(2012-4#1)
levels were measured before and##2##5##(2008-3#1)(2011-1#1)
levels were measured in##7##4##(1990-3#1)(1991-4#1)(1992-9#1)(1994-5#1)(2007-10#1)(2011-1#1)(2013-7#1)
levels were measured using the##2##5##(2008-7#1)(2013-1#1)
levels were measured using##4##4##(2008-10#1)(2008-7#1)(2013-1#2)
levels were measured##21##3##(1990-3#1)(1991-4#1)(1992-9#1)(1994-3#1)(1994-5#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#2)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
levels were monitored##2##3##(1991-4#1)(2009-4#1)
levels were more##2##3##(1992-3#1)(2008-10#1)
levels were negatively correlated##2##4##(2008-10#1)(2010-12#1)
levels were not significantly altered##2##5##(1995-3#1)(2012-12#1)
levels were not significantly different##3##5##(1991-12#1)(1992-3#1)(2008-7#1)
levels were not significantly##8##4##(1990-8#1)(1991-12#1)(1992-3#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-7#1)(2012-12#1)
levels were not##12##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-10#2)(2008-7#1)(2010-8#1)(2012-12#1)
levels were observed in##3##4##(1996-12#1)(2011-1#1)(2013-1#1)
levels were observed##7##3##(1994-3#1)(1996-12#2)(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
levels were positively correlated with##2##5##(2010-12#1)(2011-2#1)
levels were positively correlated##3##4##(2008-7#1)(2010-12#1)(2011-2#1)
levels were positively##4##3##(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
levels were reduced in the##2##5##(1996-12#1)(1996-5#1)
levels were reduced in##5##4##(1992-2#1)(1996-12#2)(1996-5#1)(2008-10#1)
levels were reduced significantly by##2##5##(2008-10#1)(2010-2#1)
levels were reduced##10##3##(1992-2#1)(1993-3#1)(1996-12#2)(1996-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-2#1)
levels were repeatedly##2##3##(2007-12#1)(2012-2#1)
levels were seen##2##3##(2008-11#1)(2008-5#1)
levels were significantly decreased##2##4##(2008-10#1)(2011-2#1)
levels were significantly higher in patients with##2##7##(2008-7#1)(2013-1#1)
levels were significantly higher in the##2##6##(1997-7#1)(2013-8#1)
levels were significantly higher in##8##5##(1992-5#1)(1997-7#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
levels were significantly higher##11##4##(1992-5#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
levels were significantly increased in the##2##6##(2008-10#1)(2013-8#1)
levels were significantly increased##3##4##(1995-3#1)(2008-10#1)(2013-8#1)
levels were significantly lower in##2##5##(1991-12#1)(2009-12#1)
levels were significantly lower##5##4##(1991-12#1)(1996-7#1)(2007-10#1)(2007-8#1)(2009-12#1)
levels were significantly reduced in##3##5##(1991-12#1)(1996-12#1)(2013-1#1)
levels were significantly reduced##6##4##(1991-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2010-4#1)(2013-1#1)
levels were significantly##31##3##(1991-12#2)(1992-5#1)(1993-8#1)(1995-3#1)(1996-12#1)(1996-7#2)(1997-3#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#2)(2009-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
levels were similar between##3##4##(1994-11#1)(2012-12#1)(2012-5#1)
levels were similar in##2##4##(1990-11#1)(1995-12#1)
levels were similar##8##3##(1990-11#1)(1991-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-5#1)(2012-12#1)(2012-5#1)
levels were used##2##3##(1990-5#1)(2008-2#1)
levels were within normal range in 17 patients##2##8##(2008-7#2)
levels were within normal range in##3##6##(2008-7#3)
levels were within##4##3##(2008-7#3)(2011-1#1)
levels were##308##2##(1990-11#2)(1990-12#3)(1990-3#3)(1990-5#3)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#5)(1991-4#2)(1991-5#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-8#3)(1996-12#8)(1996-2#1)(1996-5#5)(1996-7#4)(1996-9#2)(1997-3#2)(1997-4#7)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#7)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#19)(2008-8#4)(2008-9#4)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#17)(2011-2#15)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#5)
levels when the##3##3##(1995-12#1)(2008-8#1)(2013-8#1)
levels when##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
levels whereas##3##2##(1990-5#1)(1995-11#1)(2012-2#1)
levels which##4##2##(1991-3#1)(1993-9#1)(2008-10#1)(2011-2#1)
levels while##2##2##(1996-2#1)(1997-7#1)
levels will##2##2##(1993-12#1)(2008-7#1)
levels with##15##2##(1994-8#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
levels within 24##2##3##(1990-10#1)(2008-7#1)
levels within the##4##3##(1992-8#1)(1997-1#1)(2008-12#1)(2009-4#1)
levels within##13##2##(1990-10#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)
levels without any##2##3##(1990-5#1)(2009-5#1)
levels without##3##2##(1990-5#1)(1994-5#1)(2009-5#1)
levels worldwide##2##2##(1994-9#1)(2008-11#1)
levels##4755##1##(1990-10#2)(1990-11#16)(1990-12#39)(1990-2#29)(1990-3#15)(1990-4#1)(1990-5#31)(1990-6#5)(1990-7#6)(1990-8#19)(1990-9#8)(1991-1#10)(1991-11#10)(1991-12#51)(1991-2#14)(1991-3#11)(1991-4#10)(1991-5#19)(1991-6#14)(1991-7#4)(1991-8#8)(1991-9#17)(1992-1#6)(1992-10#8)(1992-11#19)(1992-12#25)(1992-2#14)(1992-3#27)(1992-4#1)(1992-5#8)(1992-6#9)(1992-8#33)(1992-9#37)(1993-1#8)(1993-11#14)(1993-12#43)(1993-2#14)(1993-3#39)(1993-5#6)(1993-6#28)(1993-8#19)(1993-9#15)(1994-1#9)(1994-10#1)(1994-11#23)(1994-12#18)(1994-2#48)(1994-3#32)(1994-5#20)(1994-6#23)(1994-7#6)(1994-8#20)(1994-9#18)(1995-1#2)(1995-11#24)(1995-12#68)(1995-2#48)(1995-3#30)(1995-5#16)(1995-6#14)(1995-8#27)(1995-9#1)(1996-1#12)(1996-10#2)(1996-11#3)(1996-12#93)(1996-2#21)(1996-3#6)(1996-5#19)(1996-6#7)(1996-7#23)(1996-8#2)(1996-9#3)(1997-1#17)(1997-2#38)(1997-3#17)(1997-4#42)(1997-6#25)(1997-7#42)(1997-8#5)(1997-9#1)(2006-10#16)(2006-12#1)(2006-6#3)(2007-1#1)(2007-10#32)(2007-11#26)(2007-12#32)(2007-2#4)(2007-5#8)(2007-6#3)(2007-7#11)(2007-8#13)(2007-9#2)(2008-1#62)(2008-10#799)(2008-11#181)(2008-12#58)(2008-2#40)(2008-3#115)(2008-4#56)(2008-5#138)(2008-6#53)(2008-7#193)(2008-8#90)(2008-9#83)(2009-10#14)(2009-11#8)(2009-12#20)(2009-2#7)(2009-3#12)(2009-4#15)(2009-5#37)(2009-6#13)(2009-7#34)(2009-8#26)(2009-9#10)(2010-1#15)(2010-10#12)(2010-11#18)(2010-12#21)(2010-2#9)(2010-3#11)(2010-4#18)(2010-5#23)(2010-6#10)(2010-7#10)(2010-8#29)(2010-9#8)(2011-1#100)(2011-10#1)(2011-2#180)(2011-3#3)(2012-1#27)(2012-12#55)(2012-2#76)(2012-3#74)(2012-4#6)(2012-5#17)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#177)(2013-3#2)(2013-7#21)(2013-8#73)
levels) and##3##2##(2008-12#1)(2008-9#1)(2009-8#1)
levels) in##2##2##(1995-1#1)(2008-12#1)
levels)##14##1##(1995-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-9#2)(2009-8#2)(2010-3#1)(2010-7#1)(2013-1#1)
levels?##2##1##(2008-4#1)(2013-8#1)
levels]##6##1##(1997-3#1)(1997-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
lever##13##1##(1992-11#3)(1993-6#5)(1995-5#1)(1997-1#1)(2009-11#1)(2011-2#1)(2013-8#1)
leverage on##2##2##(1991-1#1)(2013-1#1)
leverage points##2##2##(1997-3#1)(2013-1#1)
leverage the##3##2##(2009-6#1)(2010-2#1)(2012-3#1)
leverage##16##1##(1991-1#1)(1994-1#2)(1994-2#2)(1997-3#2)(2008-2#1)(2009-6#1)(2010-2#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
leveraged##3##1##(2009-11#1)(2012-2#2)
leveraging the##2##2##(2011-9#1)(2013-1#1)
leveraging##4##1##(2008-9#1)(2011-9#1)(2013-1#2)
levers##5##1##(1992-11#2)(1993-6#1)(1995-2#2)
levis##2##1##(2008-5#2)
levitated##6##1##(2007-11#1)(2008-2#5)
levitation and trapping##2##3##(2008-3#2)
levitation of absorbing##2##3##(2007-11#2)
levitation##7##1##(2007-11#3)(2008-2#1)(2008-3#3)
levobupivacaine##2##1##(2009-3#1)(2012-12#1)
levocetirizine##3##1##(2008-3#3)
levodopa and##5##2##(2008-10#4)(2008-7#1)
levodopa treatment##3##2##(2008-7#3)
levodopa##39##1##(1996-3#1)(2008-10#7)(2008-6#1)(2008-7#25)(2010-12#5)
levodopa-induced motor complications##2##3##(2010-12#2)
levodropropizine##3##1##(1991-2#3)
levofloxacin and##3##2##(2007-12#1)(2008-7#1)(2008-8#1)
levofloxacin##22##1##(2007-12#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-7#5)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)
levofloxacin-based##2##1##(2010-12#2)
levonorgestrel in##2##2##(2008-10#2)
levonorgestrel##8##1##(1996-6#1)(2008-10#5)(2011-2#2)
levorphanol-induced##2##1##(1996-2#2)
levosimendan##2##1##(2007-8#2)
levothyroxin replacement therapy##2##3##(2008-7#2)
levulinylation of##2##2##(2008-4#2)
levéis of##3##2##(2013-8#3)
levéis##4##1##(2013-8#4)
lexical and structural priming##2##4##(2008-2#2)
lexical and##3##2##(2008-2#3)
lexical decision##2##2##(2008-11#1)(2009-2#1)
lexical effects##2##2##(2012-1#2)
lexical overlap##2##2##(2008-2#2)
lexical processing##2##2##(1991-2#1)(2009-9#1)
lexical##31##1##(1991-2#6)(2008-11#1)(2008-2#10)(2008-4#1)(2008-9#3)(2009-11#1)(2009-2#3)(2009-9#1)(2010-1#1)(2012-1#2)(2013-8#2)
lexical-semantic##2##1##(2008-7#1)(2013-1#1)
lexicon##3##1##(2008-10#1)(2008-6#1)(2012-12#1)
li ved##2##2##(2012-12#2)
li##3##1##(2012-12#2)(2012-2#1)
liabilities##6##1##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-7#1)
liability and##3##2##(1991-1#1)(1991-3#1)(1993-12#1)
liability exposure##3##2##(1992-12#1)(1995-1#1)(1995-2#1)
liability for the##4##3##(1993-12#1)(1995-1#1)(1995-6#1)(1996-2#1)
liability for##10##2##(1991-12#1)(1992-3#2)(1993-12#2)(1993-3#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-2#1)
liability in##2##2##(1992-1#1)(1992-3#1)
liability insurance##9##2##(1992-2#3)(1993-1#2)(1993-3#2)(1994-1#2)
liability issues and##2##3##(1991-1#1)(1994-1#1)
liability issues##3##2##(1991-1#1)(1994-1#1)(2008-6#1)
liability of physicians and##2##4##(1992-1#1)(1993-12#1)
liability of##8##2##(1991-12#3)(1992-1#2)(1993-12#1)(1995-3#1)(2008-4#1)
liability on##2##2##(1993-1#1)(2007-12#1)
liability reform##2##2##(2008-4#2)
liability risk##2##2##(1993-12#1)(1994-12#1)
liability to the##2##3##(1993-1#1)(1993-2#1)
liability to##6##2##(1993-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1997-3#1)(1997-5#1)
liability##108##1##(1991-1#4)(1991-12#7)(1991-3#7)(1992-1#3)(1992-12#3)(1992-2#6)(1992-3#5)(1993-1#9)(1993-12#8)(1993-2#4)(1993-3#4)(1994-1#9)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#1)(1997-3#3)(1997-5#1)(2007-12#1)(2007-3#3)(2008-1#1)(2008-4#5)(2008-6#3)
liable for##5##2##(1994-3#1)(1995-12#1)(1997-1#1)(2007-3#2)
liable to##6##2##(1990-2#1)(1990-3#1)(1997-8#1)(2008-12#1)(2008-7#1)(2011-2#1)
liable##12##1##(1990-2#1)(1990-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-3#2)(2008-12#1)(2008-7#1)(2011-2#1)
liaison##11##1##(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
liberal use of##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
liberal##8##1##(1995-5#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
liberalism##2##1##(1993-1#1)(1993-11#1)
liberate##5##1##(1993-8#1)(2008-10#3)(2008-6#1)
liberated by##4##2##(2008-10#2)(2008-3#1)(2009-8#1)
liberated from the##5##3##(1995-2#1)(2008-10#3)(2008-7#1)
liberated from##8##2##(1993-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-7#1)
liberated in##2##2##(1994-9#1)(2007-12#1)
liberated into##2##2##(2008-10#2)
liberated iodine##2##2##(2008-10#2)
liberated##30##1##(1990-8#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-3#1)(2013-1#1)
liberates##3##1##(1996-2#1)(2008-11#1)(2010-12#1)
liberating##5##1##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
liberation in##2##2##(1995-11#1)(2008-10#1)
liberation of free##2##3##(2007-8#1)(2008-10#1)
liberation of the##3##3##(1990-2#1)(1992-8#1)(1996-2#1)
liberation of##13##2##(1990-2#1)(1992-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-7#1)
liberation##23##1##(1990-2#1)(1992-8#1)(1994-3#4)(1995-11#4)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-7#1)
liberty interest##2##2##(1995-12#1)(1996-9#1)
liberty##5##1##(1995-12#1)(1996-9#1)(2011-2#3)
libido##3##1##(2008-1#2)(2012-12#1)
libitum##15##1##(1991-12#1)(1992-3#1)(1994-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#3)(2013-1#1)(2013-8#3)
librarian##17##1##(1991-1#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-4#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1996-1#1)
librarians and##2##2##(1992-2#2)
librarians are##2##2##(1994-12#1)(1995-1#1)
librarians in##2##2##(1992-12#1)(1995-1#1)
librarians to##5##2##(1991-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-3#1)
librarians##30##1##(1991-2#2)(1991-3#3)(1992-12#3)(1992-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#4)(1996-1#7)(1996-12#2)(1997-3#1)
librarianship##7##1##(1994-3#1)(1995-1#4)(1995-3#2)
libraries and##8##2##(1992-2#1)(1994-12#2)(1995-2#1)(1996-1#1)(1997-4#1)(2008-2#1)(2010-10#1)
libraries are described##2##3##(1991-12#1)(2008-4#1)
libraries are##7##2##(1991-12#1)(1991-3#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
libraries as##2##2##(1994-12#1)(1997-4#1)
libraries constructed from##2##3##(1997-6#1)(2008-9#1)
libraries constructed##3##2##(1997-2#1)(1997-6#1)(2008-9#1)
libraries containing##2##2##(1997-4#1)(2011-2#1)
libraries for##4##2##(1994-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
libraries from##3##2##(1990-5#1)(1995-2#1)(1997-6#1)
libraries have##2##2##(2008-7#2)
libraries in##4##2##(1994-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
libraries incorporating##2##2##(1997-4#1)(2013-1#1)
libraries is##2##2##(1993-2#1)(2008-7#1)
libraries of expressed sequence tags##2##5##(2010-4#2)
libraries of##14##2##(1992-1#1)(1994-12#2)(1995-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-12#2)(2010-4#2)
libraries showed##2##2##(1994-12#1)(2010-4#1)
libraries that can##2##3##(1997-6#1)(2008-4#1)
libraries that##7##2##(1995-2#1)(1997-2#1)(1997-6#2)(2008-4#2)(2011-2#1)
libraries using##2##2##(1991-9#1)(1997-3#1)
libraries were##4##2##(1991-6#1)(1996-8#1)(1997-6#1)(2008-9#1)
libraries with##8##2##(1990-11#1)(1990-5#1)(1997-2#2)(1997-4#1)(2008-2#1)(2008-4#1)(2012-3#1)
libraries##152##1##(1990-11#1)(1990-4#2)(1990-5#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-1#4)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#10)(1995-2#5)(1995-6#3)(1996-1#3)(1996-12#2)(1996-3#2)(1996-8#2)(1997-1#1)(1997-2#7)(1997-3#9)(1997-4#10)(1997-6#6)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#3)(2008-4#18)(2008-5#2)(2008-7#5)(2008-9#3)(2010-10#1)(2010-12#4)(2010-4#4)(2011-2#3)(2012-2#7)(2012-3#3)(2013-1#1)
library and obtained one cDNA clone##2##6##(2008-8#2)
library and sequenced##4##3##(1992-10#1)(1994-11#1)(1996-10#1)(1997-7#1)
library and##20##2##(1990-5#1)(1992-10#1)(1993-3#1)(1993-6#1)(1994-11#2)(1996-10#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-7#2)(2008-8#6)(2011-2#1)
library as##3##2##(1997-3#1)(1997-4#1)(1997-6#1)
library by screening with##2##4##(1993-2#2)
library by using##2##3##(1993-2#1)(2008-9#1)
library by##11##2##(1993-2#3)(1994-8#2)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)
library consisting of##3##3##(1990-11#1)(2011-1#1)(2013-1#1)
library constructed for##2##3##(1993-12#1)(2010-3#1)
library constructed from the##3##4##(1995-2#1)(1997-2#1)(2012-2#1)
library constructed from##6##3##(1990-7#1)(1991-6#1)(1994-8#1)(1995-2#1)(1997-2#1)(2012-2#1)
library constructed##11##2##(1990-5#1)(1990-7#1)(1991-6#1)(1993-12#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2010-3#1)(2012-2#1)
library construction##3##2##(1996-2#1)(1997-7#1)(2008-4#1)
library containing##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
library for the##3##3##(1994-6#1)(1996-12#2)
library for##6##2##(1994-6#1)(1996-12#2)(2008-5#1)(2008-9#2)
library from barley (Hordeum vulgare L##2##6##(2008-5#2)
library from##8##2##(1990-7#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(2008-5#2)(2008-8#1)
library has##2##2##(1994-11#1)(2008-8#1)
library in lambda gt11 was##2##5##(1994-6#1)(1994-8#1)
library in lambda##3##3##(1994-11#1)(1994-6#1)(1994-8#1)
library in##4##2##(1993-1#1)(1994-11#1)(1994-6#1)(1994-8#1)
library is##2##2##(1990-4#1)(2008-8#1)
library of a##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
library of human##2##3##(1993-11#1)(1995-8#1)
library of the##4##3##(1994-11#1)(1995-12#1)(1997-6#1)(1997-8#1)
library of##54##2##(1990-11#3)(1990-5#4)(1991-2#1)(1991-9#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
library on##2##2##(1995-2#1)(2008-10#1)
library research##4##2##(1992-12#2)(1995-12#1)(1995-3#1)
library screening and##3##3##(1991-9#1)(1993-12#1)(1996-2#1)
library screening##5##2##(1991-9#1)(1993-12#1)(1996-2#1)(2008-9#1)(2011-2#1)
library search##2##2##(2008-5#1)(2011-2#1)
library services##5##2##(1995-2#2)(1996-2#3)
library staff##3##2##(1995-3#2)(1996-12#1)
library that##7##2##(1991-9#1)(1994-12#1)(1996-2#1)(2008-10#2)(2009-12#2)
library to##6##2##(1990-4#1)(1996-3#2)(1997-8#1)(2012-3#1)(2013-8#1)
library users##2##2##(1993-1#1)(1996-2#1)
library using a##2##3##(1992-8#1)(1994-12#1)
library using the##2##3##(1992-11#1)(2008-10#1)
library using##10##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-12#1)(1997-4#2)(2008-10#1)
library was constructed using##3##4##(2008-6#1)(2008-9#2)
library was constructed##9##3##(1990-11#1)(2008-6#1)(2008-8#2)(2008-9#4)(2010-5#1)
library was generated by##2##4##(2008-5#1)(2008-8#1)
library was generated##3##3##(1992-8#1)(2008-5#1)(2008-8#1)
library was screened for##3##4##(1992-11#1)(1994-12#1)(1995-2#1)
library was screened using the##2##5##(2008-8#2)
library was screened using##5##4##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#2)
library was screened with##5##4##(1990-12#1)(1990-8#1)(1992-3#2)(2008-8#1)
library was screened##15##3##(1990-12#1)(1990-8#1)(1992-11#1)(1992-3#3)(1992-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-8#3)(2008-9#1)
library was##37##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-12#2)(1995-2#1)(1996-12#1)(1997-3#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#5)(2010-5#1)
library with a##7##3##(1991-2#1)(1991-9#1)(1992-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
library with the##3##3##(1992-9#1)(1993-8#1)(2008-9#1)
library with##17##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)
library work##2##2##(1991-3#1)(1996-3#1)
library##397##1##(1990-11#7)(1990-12#4)(1990-4#2)(1990-5#7)(1990-7#2)(1990-8#2)(1991-1#3)(1991-12#6)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#4)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#6)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#3)(1993-2#5)(1993-3#8)(1993-6#7)(1993-8#5)(1993-9#1)(1994-11#11)(1994-12#14)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#9)(1995-6#3)(1995-8#2)(1996-1#4)(1996-10#5)(1996-12#8)(1996-2#11)(1996-3#5)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#9)(1997-4#6)(1997-6#7)(1997-7#6)(1997-8#7)(2007-12#2)(2008-10#24)(2008-11#3)(2008-2#6)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#32)(2008-9#19)(2009-10#1)(2009-12#3)(2009-8#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
library's##6##1##(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2010-8#1)
lice and##2##2##(1996-12#1)(2008-12#1)
lice##12##1##(1996-12#4)(2007-12#1)(2007-2#1)(2008-12#1)(2011-2#5)
licence activities on render##2##4##(2011-2#2)
licence##3##1##(1996-8#1)(2011-2#2)
licencing agreements for these medicines##2##5##(2013-8#2)
license to##2##2##(1997-1#1)(2008-8#1)
license##9##1##(1992-1#2)(1992-6#1)(1996-5#1)(1997-1#1)(2008-12#1)(2008-5#2)(2008-8#1)
licensed for##3##2##(1995-5#1)(2010-5#1)(2012-12#1)
licensed in##3##2##(1994-6#1)(2007-12#1)(2010-11#1)
licensed##31##1##(1991-3#2)(1992-1#2)(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-3#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#3)(2008-5#3)(2010-11#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
licenses##5##1##(1992-1#3)(1994-12#1)(2012-12#1)
licensing board##2##2##(1992-1#1)(2012-3#1)
licensing##11##1##(1992-1#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-8#2)(2012-12#1)(2012-3#1)(2013-8#3)
licensure and##2##2##(1991-1#1)(1992-1#1)
licensure examination##2##2##(1994-2#1)(2012-2#1)
licensure##9##1##(1991-1#1)(1992-1#2)(1994-2#2)(1995-2#1)(1995-5#1)(2011-2#1)(2012-2#1)
lichen planus (OLP) is a##2##5##(2009-6#1)(2013-1#1)
lichen planus and##5##3##(1991-2#1)(2008-4#1)(2009-6#2)(2013-1#1)
lichen planus##23##2##(1990-5#1)(1991-2#2)(1991-3#1)(2007-7#3)(2008-4#6)(2009-6#5)(2013-1#5)
lichen ruber planus##3##3##(2011-2#3)
lichen samples##4##2##(2008-10#4)
lichen sclerosus##2##2##(2012-1#2)
lichen species##2##2##(2008-10#2)
lichen##53##1##(1990-5#1)(1991-2#2)(1991-3#1)(1992-3#2)(2007-7#3)(2008-10#12)(2008-11#2)(2008-4#7)(2008-5#2)(2008-9#1)(2009-6#5)(2010-6#4)(2011-2#4)(2012-1#2)(2013-1#5)
licheniformis##11##1##(1990-11#1)(1997-4#4)(2008-10#2)(2008-8#2)(2011-2#2)
lichenoid##2##1##(2008-8#1)(2011-2#1)
lichens and##3##2##(2008-10#3)
lichens##13##1##(2008-10#9)(2010-6#4)
lick and the##2##3##(1990-7#1)(2008-11#1)
lick suppression##2##2##(2008-4#1)(2008-5#1)
lick##11##1##(1990-7#2)(1992-2#1)(1997-6#2)(2008-11#4)(2008-4#1)(2008-5#1)
licking frequency in rats injected with 2##2##7##(2013-7#2)
licking##7##1##(1990-7#2)(2008-11#1)(2012-2#1)(2013-7#3)
licks##6##1##(1990-7#2)(1997-6#1)(2008-11#3)
licorice water extract##2##3##(2008-10#2)
licorice##9##1##(2008-10#5)(2008-5#2)(2009-12#1)(2012-3#1)
lid##10##1##(1992-8#1)(1994-3#1)(2007-7#2)(2009-6#1)(2010-10#1)(2010-11#2)(2011-1#2)
lidamycin##4##1##(2008-9#4)
lidar LEANDRE II##2##3##(2008-3#2)
lidar and##8##2##(2008-2#5)(2008-3#3)
lidar application##3##2##(2007-11#1)(2008-2#2)
lidar applications##6##2##(2008-2#4)(2008-3#2)
lidar at 9##3##3##(2008-2#2)(2008-3#1)
lidar at##4##2##(2008-2#2)(2008-3#2)
lidar backscatter measurements##3##3##(2008-3#3)
lidar backscatter##5##2##(2008-3#5)
lidar beam##5##2##(2008-3#5)
lidar data##16##2##(2008-10#1)(2008-2#2)(2008-3#13)
lidar depolarization##2##2##(2008-2#1)(2008-3#1)
lidar equation##5##2##(2008-2#2)(2008-3#3)
lidar equations##2##2##(2008-3#2)
lidar for atmospheric##4##3##(2008-3#4)
lidar for the##2##3##(2008-2#2)
lidar for##13##2##(2008-2#7)(2008-3#6)
lidar from a##2##3##(2008-2#1)(2008-3#1)
lidar from##4##2##(2008-2#2)(2008-3#2)
lidar in the##6##3##(2008-2#1)(2008-3#5)
lidar in##7##2##(2008-2#2)(2008-3#5)
lidar instrument##2##2##(2008-2#1)(2008-3#1)
lidar instruments##2##2##(2008-2#1)(2008-3#1)
lidar inversion##8##2##(2008-2#2)(2008-3#6)
lidar is##3##2##(2008-3#3)
lidar measurement of##4##3##(2008-3#4)
lidar measurement##6##2##(2008-3#6)
lidar measurements are##2##3##(2008-2#1)(2008-3#1)
lidar measurements at##2##3##(2008-3#2)
lidar measurements for##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
lidar measurements from##2##3##(2008-3#2)
lidar measurements in##2##3##(2008-2#1)(2008-3#1)
lidar measurements is##4##3##(2008-3#4)
lidar measurements of##8##3##(2008-2#5)(2008-3#3)
lidar measurements with##2##3##(2007-11#1)(2008-3#1)
lidar measurements##40##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#16)(2008-3#21)
lidar observations of##2##3##(2008-2#1)(2008-3#1)
lidar observations##4##2##(2008-2#1)(2008-3#3)
lidar ozone measurements##2##3##(2008-3#2)
lidar ozone profiles##2##3##(2008-2#2)
lidar ozone##4##2##(2008-2#2)(2008-3#2)
lidar parameters##2##2##(2008-3#2)
lidar performance##5##2##(2008-3#5)
lidar profiles with##2##3##(2008-3#2)
lidar profiles##5##2##(2007-12#1)(2008-3#4)
lidar pulse##4##2##(2008-2#2)(2008-3#2)
lidar ratio##4##2##(2008-2#4)
lidar receivers##4##2##(2008-2#3)(2008-3#1)
lidar return power can exceed##2##5##(2008-3#2)
lidar return signals for##3##4##(2008-2#2)(2008-3#1)
lidar return signals##8##3##(2008-2#6)(2008-3#2)
lidar return##21##2##(2008-2#9)(2008-3#12)
lidar returns##8##2##(2008-2#4)(2008-3#4)
lidar sensing of##2##3##(2008-2#1)(2008-3#1)
lidar signal is##2##3##(2008-2#1)(2008-3#1)
lidar signal##9##2##(2008-2#3)(2008-3#6)
lidar signals are##2##3##(2008-2#1)(2008-3#1)
lidar signals detected##2##3##(2008-2#1)(2008-3#1)
lidar signals is##2##3##(2008-2#1)(2008-3#1)
lidar signals##19##2##(2008-2#6)(2008-3#13)
lidar system at NASA Langley Research Center in Hampton##2##9##(2008-2#1)(2008-3#1)
lidar system at##3##3##(2008-2#1)(2008-3#2)
lidar system for##3##3##(2008-2#1)(2008-3#2)
lidar system in the##2##4##(2008-3#2)
lidar system is##3##3##(2008-2#1)(2008-3#2)
lidar system that##2##3##(2008-2#1)(2008-3#1)
lidar system##25##2##(2008-2#7)(2008-3#18)
lidar systems are##2##3##(2008-3#2)
lidar systems##13##2##(2008-2#1)(2008-3#12)
lidar teams involved in##2##4##(2008-3#2)
lidar technique##6##2##(2008-3#6)
lidar to##2##2##(2008-2#2)
lidar transmitter##2##2##(2007-12#1)(2008-3#1)
lidar was##2##2##(2008-2#1)(2008-3#1)
lidar wavelength##2##2##(2008-2#2)
lidar with a##3##3##(2008-2#2)(2008-3#1)
lidar with##9##2##(2008-2#4)(2008-3#5)
lidar##427##1##(2007-11#6)(2007-12#5)(2008-10#2)(2008-2#143)(2008-3#271)
lidar-observed##2##1##(2008-3#2)
lidars are##2##2##(2008-3#2)
lidars##24##1##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#18)
lidocaine and ofloxacin##3##3##(2008-10#3)
lidocaine and##5##2##(2007-10#1)(2008-10#4)
lidocaine gel applied##2##3##(1993-1#2)
lidocaine gel##3##2##(1993-1#3)
lidocaine hydrochloride##2##2##(2008-10#2)
lidocaine injection##2##2##(2008-9#2)
lidocaine with##2##2##(1993-1#1)(2008-9#1)
lidocaine##47##1##(1990-9#6)(1991-1#2)(1993-1#4)(1993-12#4)(1994-8#1)(1996-12#3)(1996-9#2)(2007-10#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#7)(2009-5#1)(2012-12#1)
lidoflazine##3##1##(1994-8#3)
lie at the##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
lie at##6##2##(1990-2#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
lie between##3##2##(1994-8#2)(2008-10#1)
lie in a##2##3##(2011-2#1)(2012-2#1)
lie in the##10##3##(1992-12#1)(1993-9#1)(1996-2#2)(2008-10#2)(2008-8#2)(2010-5#1)(2010-7#1)
lie in##18##2##(1992-12#1)(1993-12#1)(1993-9#1)(1996-2#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-8#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
lie on chromosome XV##2##4##(1995-6#2)
lie on##5##2##(1993-11#1)(1995-6#2)(2007-12#1)(2010-8#1)
lie upstream of##2##3##(1996-2#1)(2008-10#1)
lie within the##4##3##(1996-2#1)(2008-10#2)(2010-11#1)
lie within##6##2##(1994-5#1)(1996-2#1)(2008-10#2)(2008-2#1)(2010-11#1)
lie##50##1##(1990-2#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-6#2)(1996-2#4)(1997-2#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#1)
lies at the##3##3##(1993-3#1)(2008-5#1)(2013-1#1)
lies between the##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2012-12#1)
lies between##7##2##(1992-12#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-12#1)
lies close to the##2##4##(1997-7#1)(2007-8#1)
lies in a##2##3##(2012-12#1)(2013-1#1)
lies in its ability to##3##5##(2008-10#1)(2010-8#1)(2012-3#1)
lies in its##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2010-8#1)(2012-3#1)
lies in the fact that##3##5##(2008-3#1)(2008-9#1)(2009-4#1)
lies in the##28##3##(1990-11#1)(1991-5#1)(1994-5#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
lies in##46##2##(1990-11#1)(1991-5#1)(1994-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
lies on the##2##3##(1995-6#1)(1997-3#1)
lies with the##2##3##(1993-1#1)(2007-6#1)
lies within a##4##3##(1992-4#1)(2008-10#2)(2013-8#1)
lies within the##3##3##(1990-5#1)(2007-11#1)(2007-12#1)
lies within##11##2##(1990-5#1)(1992-4#1)(1992-6#1)(1992-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2013-8#1)
lies##95##1##(1990-11#2)(1990-5#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#4)(2006-6#1)(2007-11#2)(2007-12#6)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#2)
lieu##7##1##(1996-12#1)(1997-3#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-8#1)
life activity##2##2##(2007-11#1)(2013-8#1)
life after##9##2##(1992-4#1)(1995-8#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-7#1)(2011-2#2)
life among##6##2##(2008-7#1)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
life and death##9##3##(1992-1#3)(1993-11#2)(2007-2#1)(2008-4#1)(2009-10#1)(2011-9#1)
life and disease##2##3##(1993-11#1)(2012-1#1)
life and health##4##3##(1991-12#1)(2009-5#2)(2012-2#1)
life and improving##2##3##(2007-11#1)(2009-11#1)
life and the##8##3##(1990-3#1)(1992-12#1)(1996-9#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
life and##107##2##(1990-3#1)(1991-11#1)(1991-12#1)(1992-1#4)(1992-11#1)(1992-12#1)(1993-11#3)(1993-12#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#8)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#14)(2011-9#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
life are##4##2##(1997-5#1)(2008-1#1)(2008-9#1)(2011-2#1)
life as an##2##3##(2008-10#1)(2008-6#1)
life as##8##2##(1996-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#3)(2010-12#1)
life but##3##2##(1991-2#1)(2008-8#1)(2011-2#1)
life by##4##2##(1993-3#1)(2007-11#1)(2007-7#1)(2008-5#1)
life can##2##2##(2008-1#2)
life changes##3##2##(2010-10#1)(2011-2#1)(2012-1#1)
life comfort of##2##3##(2007-11#2)
life compared##2##2##(2009-11#1)(2010-12#1)
life conditions##6##2##(1991-6#1)(2008-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
life contexts##3##2##(1993-12#1)(2009-5#2)
life course approach##4##3##(2008-12#2)(2009-10#2)
life course epidemiology approach##2##4##(2008-12#2)
life course epidemiology##3##3##(2008-12#3)
life course transitions##3##3##(2011-2#3)
life course##22##2##(2008-12#5)(2009-10#3)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2013-1#4)
life courses##2##2##(2011-2#2)
life cycle and##5##3##(2008-10#1)(2008-12#1)(2010-1#2)(2012-3#1)
life cycle components##2##3##(2008-10#2)
life cycle in##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
life cycle of the##4##4##(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#1)
life cycle of this##2##4##(2007-6#1)(2008-9#1)
life cycle of##16##3##(1994-11#1)(1997-7#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
life cycle stages##3##3##(2008-10#2)(2008-11#1)
life cycle that##2##3##(2008-8#1)(2009-2#1)
life cycle##67##2##(1992-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#3)(1997-6#1)(1997-7#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#2)(2008-6#1)(2008-8#4)(2008-9#4)(2009-2#1)(2009-3#3)(2009-8#1)(2010-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
life cycles of##5##3##(2008-10#2)(2008-9#1)(2012-2#2)
life cycles##14##2##(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#3)(2013-1#1)(2013-7#2)
life during##6##2##(1990-2#2)(2008-9#2)(2009-9#1)(2012-2#1)
life event##2##2##(2008-4#1)(2009-11#1)
life events and##3##3##(2008-12#1)(2011-2#2)
life events were##2##3##(2008-4#1)(2009-9#1)
life events##19##2##(1991-12#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-8#1)(2009-12#1)(2009-9#2)(2011-2#5)(2013-8#1)
life expectancies##2##2##(2008-8#1)(2011-2#1)
life expectancy and##3##3##(2008-4#1)(2009-12#1)(2012-12#1)
life expectancy as well as##2##5##(1996-6#1)(2008-7#1)
life expectancy at birth##2##4##(1992-3#1)(2008-10#1)
life expectancy for##2##3##(1996-3#1)(2011-2#1)
life expectancy in##7##3##(1993-1#1)(1996-3#2)(1997-6#1)(2008-9#1)(2010-4#1)(2011-1#1)
life expectancy of##5##3##(1993-9#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-12#1)
life expectancy##45##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-3#5)(1996-6#1)(1996-8#1)(1997-6#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
life expectation##3##2##(1991-8#2)(1992-9#1)
life extension##4##2##(1994-5#1)(2008-7#3)
life for##26##2##(1991-6#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
life from##2##2##(2007-11#1)(2010-1#1)
life habits##2##2##(1992-9#1)(2010-1#1)
life has been##2##3##(2008-7#1)(2010-11#1)
life has##4##2##(2008-7#2)(2010-11#1)(2012-2#1)
life histories of##3##3##(2008-8#1)(2009-6#1)(2013-8#1)
life histories##16##2##(2008-10#1)(2008-8#8)(2008-9#4)(2009-6#1)(2010-8#1)(2013-8#1)
life history and behavior##2##4##(2008-8#2)
life history and##5##3##(2008-10#1)(2008-12#1)(2008-8#3)
life history of the##5##4##(1995-6#1)(2008-11#2)(2008-8#1)(2011-2#1)
life history of##8##3##(1995-6#1)(2008-11#2)(2008-8#2)(2009-10#1)(2011-2#1)(2013-7#1)
life history strategies##2##3##(2012-2#2)
life history traits##6##3##(2009-9#1)(2010-3#2)(2012-2#2)(2012-3#1)
life history##47##2##(1995-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#18)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#3)(2010-8#4)(2011-2#1)(2012-2#5)(2012-3#1)(2013-7#1)
life improves##2##2##(2008-4#1)(2011-3#1)
life in a##4##3##(2008-11#1)(2009-8#1)(2013-1#2)
life in general##3##3##(1993-6#1)(2007-1#1)(2007-10#1)
life in particular##2##3##(2007-11#1)(2010-9#1)
life in the##14##3##(1993-6#1)(1994-11#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
life in which##2##3##(1990-3#1)(2009-5#1)
life in##87##2##(1990-2#2)(1990-3#1)(1991-6#2)(1992-11#1)(1993-3#1)(1993-6#2)(1994-11#1)(1996-7#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#9)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#3)
life insurance##10##2##(1991-12#1)(1994-12#1)(1995-1#5)(1995-12#1)(1996-2#1)(2008-7#1)
life is##17##2##(1995-1#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
life maintenance##2##2##(2008-9#2)
life may be##2##3##(1994-6#1)(2008-4#1)
life may##4##2##(1994-6#1)(2008-11#1)(2008-4#1)(2010-1#1)
life more##2##2##(2008-4#1)(2013-1#1)
life of patients with##4##4##(2007-8#1)(2008-7#1)(2009-1#1)(2011-2#1)
life of patients##7##3##(1996-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-1#1)(2011-2#1)
life of persons##2##3##(1995-6#1)(2007-8#1)
life of the affected##2##4##(1996-12#1)(2010-11#1)
life of the patient##3##4##(1993-11#1)(2008-6#1)(2011-3#1)
life of the patients##4##4##(2007-11#2)(2012-3#1)(2013-1#1)
life of the##24##3##(1993-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
life of##90##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#5)(2007-3#2)(2007-8#4)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#4)(2008-4#4)(2008-6#1)(2008-7#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
life on Earth##2##3##(2008-12#1)(2012-3#1)
life on the##2##3##(2008-5#1)(2011-2#1)
life on##6##2##(1996-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
life or##3##2##(2008-4#1)(2008-7#1)(2008-8#1)
life phenomena##2##2##(2010-10#2)
life quality##7##2##(1997-4#1)(2007-11#3)(2008-1#1)(2008-4#1)(2010-7#1)
life roles##2##2##(2007-10#2)
life satisfaction one year after a##2##6##(2007-10#2)
life satisfaction##14##2##(1997-1#1)(2007-10#3)(2008-12#1)(2008-7#1)(2009-5#3)(2012-1#4)(2013-1#1)
life saving causal therapy##2##4##(2007-10#2)
life saving##6##2##(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
life science research##2##3##(2012-3#1)(2013-1#1)
life science##5##2##(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
life sciences##11##2##(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
life situation##3##2##(1991-6#1)(2009-5#1)(2012-3#1)
life situations##2##2##(1995-1#1)(2010-4#1)
life span and##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
life span by##2##3##(1990-3#2)
life span in##5##3##(1994-5#1)(1996-6#1)(2008-3#1)(2008-7#1)(2010-8#1)
life span is##2##3##(1992-2#1)(2008-10#1)
life span of the##6##4##(1991-12#1)(1991-5#1)(1993-8#1)(2008-10#2)(2008-7#1)
life span of##18##3##(1990-3#1)(1991-12#1)(1991-5#1)(1992-5#1)(1993-8#3)(1995-6#1)(2008-10#3)(2008-7#4)(2008-9#1)(2010-4#1)(2012-2#1)
life span was##4##3##(1990-3#1)(1995-6#1)(2008-9#1)(2013-7#1)
life span##72##2##(1990-3#6)(1991-12#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-8#3)(1994-5#5)(1994-6#5)(1995-6#3)(1996-6#1)(2008-10#8)(2008-11#4)(2008-3#6)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#4)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
life spans##3##2##(2008-3#2)(2008-9#1)
life stages##7##2##(2008-8#1)(2010-8#3)(2011-2#1)(2012-12#2)
life stressors##2##2##(2008-2#1)(2008-4#1)
life style and##2##3##(2009-8#1)(2010-8#1)
life style##11##2##(1990-6#2)(1992-11#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-8#1)(2010-1#1)(2010-8#1)
life styles##4##2##(1990-9#1)(1994-5#1)(1997-6#1)(2010-9#1)
life support##14##2##(1992-5#2)(1995-1#1)(1995-12#1)(1995-5#1)(2008-11#3)(2009-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
life sustaining treatment##2##3##(1990-11#1)(1991-2#1)
life table analysis##3##3##(1991-3#1)(1993-2#1)(2008-9#1)
life table##11##2##(1991-3#1)(1993-1#1)(1993-2#1)(1995-3#2)(2008-12#1)(2008-9#1)(2011-2#4)
life tables##3##2##(1994-11#1)(2008-12#1)(2011-2#1)
life than##3##2##(1991-2#1)(2007-1#1)(2013-1#1)
life that##5##2##(2008-7#4)(2011-2#1)
life threatening complication##5##3##(1992-11#1)(2007-8#1)(2008-12#1)(2011-2#2)
life threatening complications##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
life threatening condition##2##3##(2007-10#1)(2007-7#1)
life threatening event##2##3##(2011-2#2)
life threatening##24##2##(1992-11#1)(2006-10#1)(2007-10#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
life time of##2##3##(1994-5#1)(2008-10#1)
life time##5##2##(1994-5#1)(1995-12#1)(2008-10#3)
life to##9##2##(1993-12#1)(1996-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
life using the##2##3##(1990-5#1)(2013-1#1)
life using##5##2##(1990-5#1)(2008-11#1)(2009-5#1)(2010-3#1)(2013-1#1)
life was##15##2##(1990-12#1)(1992-10#1)(1995-12#1)(1995-6#1)(1997-2#1)(2007-1#1)(2007-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-2#1)
life were##4##2##(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
life while##2##2##(1993-6#1)(1995-12#1)
life with##10##2##(1995-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2009-6#1)(2011-1#1)(2013-1#2)
life without##2##2##(1992-3#1)(2012-2#1)
life year##3##2##(2007-8#1)(2012-12#2)
life years##6##2##(2009-8#1)(2011-1#1)(2012-12#4)
life##1523##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#8)(1990-5#1)(1990-6#4)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#3)(1991-5#2)(1991-6#11)(1991-8#5)(1991-9#1)(1992-1#5)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#7)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#8)(1993-12#13)(1993-2#2)(1993-3#7)(1993-6#4)(1993-8#4)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#10)(1994-6#8)(1994-7#3)(1994-8#2)(1994-9#1)(1995-1#15)(1995-11#1)(1995-12#11)(1995-2#6)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#11)(1995-8#3)(1995-9#1)(1996-11#4)(1996-12#4)(1996-2#7)(1996-3#12)(1996-5#4)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#3)(2006-10#2)(2007-1#5)(2007-10#11)(2007-11#40)(2007-12#4)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#12)(2007-8#20)(2007-9#2)(2008-1#24)(2008-10#104)(2008-11#42)(2008-12#43)(2008-2#14)(2008-3#11)(2008-4#30)(2008-5#24)(2008-6#15)(2008-7#108)(2008-8#51)(2008-9#39)(2009-1#1)(2009-10#14)(2009-11#10)(2009-12#11)(2009-2#1)(2009-3#6)(2009-5#17)(2009-6#9)(2009-7#5)(2009-8#8)(2009-9#10)(2010-1#11)(2010-10#18)(2010-11#13)(2010-12#11)(2010-2#4)(2010-3#11)(2010-4#11)(2010-5#10)(2010-6#5)(2010-7#7)(2010-8#20)(2010-9#5)(2011-1#23)(2011-2#112)(2011-3#7)(2011-7#2)(2011-9#1)(2012-1#13)(2012-12#36)(2012-2#57)(2012-3#28)(2012-9#1)(2013-1#68)(2013-7#14)(2013-8#24)
life&quot##6##1##(2008-10#2)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#1)
life's##2##1##(1993-12#1)(2009-8#1)
life)##7##1##(1993-2#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-5#1)
life-and-death##2##1##(1995-1#1)(1995-5#1)
life-course##3##1##(2008-12#1)(2012-3#2)
life-cycle##4##1##(2007-6#1)(2008-10#1)(2011-2#1)(2011-3#1)
life-extending and##2##2##(2008-11#1)(2008-7#1)
life-history data##2##2##(2008-8#2)
life-history evolution##3##2##(2008-8#2)(2008-9#1)
life-history patterns##3##2##(2008-8#3)
life-history strategies##5##2##(2008-8#5)
life-history theory and##2##3##(2008-8#2)
life-history theory##6##2##(2008-8#6)
life-history traits of##4##3##(2008-11#1)(2008-8#1)(2010-3#1)(2013-7#1)
life-history traits on the##2##4##(2008-8#2)
life-history traits##24##2##(2008-11#1)(2008-8#16)(2008-9#5)(2010-3#1)(2013-7#1)
life-history transitions##3##2##(2008-8#3)
life-history##71##1##(2007-12#1)(2008-11#1)(2008-8#49)(2008-9#13)(2010-3#1)(2010-8#3)(2011-2#1)(2012-3#1)(2013-7#1)
life-like##2##1##(2008-11#1)(2009-5#1)
life-long learning##5##2##(2008-11#3)(2008-12#2)
life-long##19##1##(1990-11#1)(1991-1#1)(1993-11#1)(1996-3#1)(1996-6#1)(2007-12#2)(2007-7#1)(2008-11#4)(2008-12#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#2)
life-prolonging treatment preferences##2##3##(2009-11#2)
life-prolonging##6##1##(1994-6#1)(2008-7#1)(2009-11#4)
life-saving therapy##2##2##(2010-6#1)(2011-2#1)
life-saving##7##1##(1994-3#1)(1995-12#1)(2006-7#1)(2008-1#1)(2010-6#1)(2011-2#1)(2013-7#1)
life-sciences##3##1##(1992-12#1)(2008-9#2)
life-span##9##1##(1994-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-12#1)(2009-5#1)(2013-1#1)
life-style##5##1##(1991-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
life-styles##2##1##(1991-1#1)(2012-12#1)
life-support##3##1##(1991-2#2)(2008-3#1)
life-sustaining treatment##3##2##(1991-2#2)(2010-4#1)
life-sustaining##7##1##(1991-2#2)(1993-12#1)(1995-12#1)(2008-7#1)(2010-4#2)
life-table parameters##3##2##(2011-2#3)
life-table##6##1##(2008-8#1)(2011-2#5)
life-threatening complication in patients##2##4##(2011-2#1)(2012-12#1)
life-threatening complication in##3##3##(2011-2#1)(2011-3#1)(2012-12#1)
life-threatening complication of##6##3##(2007-8#1)(2008-12#2)(2009-7#1)(2010-10#1)(2011-2#1)
life-threatening complication##12##2##(1993-8#1)(2006-10#1)(2007-8#1)(2008-12#2)(2009-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
life-threatening complications##3##2##(2011-2#1)(2013-1#2)
life-threatening condition##6##2##(2009-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
life-threatening conditions##3##2##(1995-8#1)(1996-9#2)
life-threatening disease##5##2##(1991-8#1)(2007-12#1)(2008-11#1)(2010-5#1)(2011-2#1)
life-threatening diseases##2##2##(2007-4#1)(2012-2#1)
life-threatening illness##2##2##(1995-12#1)(2008-11#1)
life-threatening illnesses##4##2##(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
life-threatening infection##2##2##(2008-12#1)(2011-2#1)
life-threatening sequelae##2##2##(2007-8#1)(2010-8#1)
life-threatening##100##1##(1990-3#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#3)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#15)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#8)(2013-8#4)
life-time is##2##2##(1993-11#1)(2008-10#1)
life-time##4##1##(1993-11#1)(2008-10#3)
life?##5##1##(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)(2013-7#1)
life]##5##1##(1994-5#1)(1994-8#1)(1997-2#1)(2008-4#1)(2009-10#1)
lifecycle funds##2##2##(2011-2#2)
lifecycle##7##1##(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#3)
lifelong non-smokers##2##2##(1996-3#2)
lifelong##15##1##(1990-11#2)(1992-12#2)(1994-12#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-12#2)(2012-2#2)
lifesaving##6##1##(1994-6#1)(2008-10#1)(2010-5#2)(2011-2#1)(2013-8#1)
lifespan and##3##2##(2009-12#2)(2013-7#1)
lifespan in##2##2##(1997-7#1)(2012-2#1)
lifespan of##4##2##(2008-7#1)(2009-12#1)(2009-5#1)(2012-2#1)
lifespan##32##1##(1996-2#1)(1997-7#1)(2008-11#3)(2008-7#3)(2008-9#2)(2009-12#9)(2009-5#2)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#1)
lifestyle activities##2##2##(2010-12#2)
lifestyle and mental##2##3##(2008-6#1)(2010-12#1)
lifestyle and risk##3##3##(2010-7#2)(2010-9#1)
lifestyle and socioeconomic##2##3##(2008-1#1)(2013-8#1)
lifestyle and##17##2##(1996-8#1)(2008-1#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
lifestyle are##2##2##(1994-3#1)(2009-5#1)
lifestyle as##2##2##(2011-2#2)
lifestyle behaviors are associated with overweight and obesity and subsequent NCD that##2##12##(2013-8#2)
lifestyle behaviors are associated with overweight and obesity and subsequent##3##10##(2013-8#3)
lifestyle behaviors are associated with overweight and obesity##4##8##(2013-8#4)
lifestyle behaviors lead to overweight and obesity and subsequent NCD##5##10##(2013-8#5)
lifestyle behaviors##11##2##(2009-5#1)(2013-8#10)
lifestyle change##4##2##(2007-12#1)(2008-1#2)(2009-9#1)
lifestyle changes in##3##3##(2009-11#1)(2010-8#2)
lifestyle changes##17##2##(1994-12#1)(2007-10#1)(2008-12#1)(2008-3#5)(2008-8#1)(2009-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#2)
lifestyle disease risk##2##3##(2008-1#2)
lifestyle diseases##3##2##(2008-1#2)(2009-8#1)
lifestyle factors with myocardial infarction and stroke##2##7##(2009-9#2)
lifestyle factors##9##2##(1993-11#1)(2008-7#1)(2009-8#1)(2009-9#3)(2010-5#1)(2011-2#1)(2012-3#1)
lifestyle intervention##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
lifestyle interventions##3##2##(2009-4#1)(2010-10#1)(2012-2#1)
lifestyle modification##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
lifestyle of##4##2##(1990-9#1)(2007-4#1)(2008-5#1)(2010-1#1)
lifestyle practices##2##2##(2011-2#1)(2013-1#1)
lifestyle risk factors##4##3##(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
lifestyle risk##5##2##(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
lifestyle that##2##2##(2009-5#1)(2010-12#1)
lifestyle##146##1##(1990-11#1)(1990-9#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#2)(1996-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#11)(2008-10#2)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#1)(2010-12#7)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#11)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#6)(2013-8#12)
lifestyle)##2##1##(1994-6#1)(2013-1#1)
lifestyle-related diseases in the Asia-Pacific region##2##6##(2008-10#2)
lifestyles and##5##2##(2007-12#2)(2009-9#1)(2011-2#1)(2012-12#1)
lifestyles in##2##2##(2008-10#1)(2008-12#1)
lifestyles##31##1##(1991-1#1)(1994-12#1)(2007-12#2)(2008-10#2)(2008-12#3)(2008-3#3)(2008-4#5)(2008-6#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
lifething ST segment##2##3##(2008-10#2)
lifetime accumulated cadmium intake from food##3##6##(1992-12#3)
lifetime accumulated cadmium intake##4##4##(1992-12#4)
lifetime and the##2##3##(2008-3#2)
lifetime and##13##2##(1991-5#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
lifetime by##2##2##(2008-10#1)(2009-3#1)
lifetime determination##2##2##(2007-11#1)(2007-12#1)
lifetime difference##2##2##(2008-10#2)
lifetime imaging microscopy##3##3##(2008-1#2)(2009-4#1)
lifetime imaging##11##2##(2007-11#1)(2007-12#5)(2008-1#2)(2009-4#1)(2011-1#2)
lifetime in##3##2##(2008-3#3)
lifetime incidence of##2##3##(2008-4#1)(2012-12#1)
lifetime is about##2##3##(2008-10#2)
lifetime is##8##2##(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-6#1)
lifetime measurements##2##2##(1990-2#1)(2008-8#1)
lifetime of 2##2##3##(2008-10#2)
lifetime of the biosensor##2##4##(2008-10#2)
lifetime of the electrode##3##4##(2008-10#3)
lifetime of the sensor was##2##5##(2008-10#2)
lifetime of the sensor##5##4##(2008-10#5)
lifetime of the##27##3##(2007-12#2)(2008-10#20)(2008-7#1)(2009-6#1)(2010-2#2)(2013-8#1)
lifetime of tumor-bearing mice##2##4##(2008-9#2)
lifetime of##61##2##(1992-5#1)(1992-6#1)(1994-5#2)(1995-5#1)(2007-11#3)(2007-12#4)(2008-10#34)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-2#2)(2012-12#1)(2013-8#1)
lifetime or##2##2##(2010-9#1)(2012-2#1)
lifetime prevalence and##2##3##(2012-12#1)(2013-1#1)
lifetime prevalence of##2##3##(2013-1#2)
lifetime prevalence##5##2##(2011-1#1)(2012-12#1)(2013-1#3)
lifetime reproduction##3##2##(2008-3#3)
lifetime reproductive success##9##3##(2008-8#2)(2008-9#7)
lifetime use of##2##3##(2009-5#1)(2012-1#1)
lifetime was##4##2##(2008-10#4)
lifetime were##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
lifetime##239##1##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-3#2)(1995-5#3)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#8)(2007-12#16)(2007-2#1)(2007-3#1)(2008-1#3)(2008-10#68)(2008-12#2)(2008-2#6)(2008-3#20)(2008-4#1)(2008-7#5)(2008-8#10)(2008-9#12)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-9#6)(2010-10#1)(2010-2#2)(2010-4#1)(2010-9#2)(2011-1#8)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#4)(2013-8#1)
lifetimes are##2##2##(1993-11#1)(2008-3#1)
lifetimes as##2##2##(1991-12#1)(2008-9#1)
lifetimes of the##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
lifetimes of##7##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-12#1)
lifetimes##36##1##(1991-12#1)(1991-5#1)(1993-11#1)(1994-11#1)(1995-5#1)(1996-2#2)(1997-2#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#5)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#2)(2010-2#2)(2012-8#1)
lift and##3##2##(2009-9#1)(2010-1#1)(2010-5#1)
lift##15##1##(1994-2#1)(1997-3#1)(2007-10#2)(2007-12#1)(2008-11#3)(2008-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#2)(2012-12#1)
lift-off##2##1##(2008-10#1)(2008-3#1)
lifted##12##1##(1990-4#1)(2007-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#4)
lifting an expected##2##3##(2012-12#2)
lifting an##4##2##(2012-12#4)
lifting of##2##2##(1994-8#1)(2012-12#1)
lifting##19##1##(1990-12#1)(1994-8#1)(1997-8#1)(2008-6#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#9)(2013-1#1)
lifts##6##1##(1993-8#1)(1996-5#1)(2010-3#3)(2010-9#1)
ligament and##2##2##(2009-7#2)
ligament of the##3##3##(2008-12#1)(2008-8#1)(2013-1#1)
ligament of##4##2##(2008-12#1)(2008-8#1)(2013-1#2)
ligament reconstruction##12##2##(2008-11#3)(2008-12#1)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#4)
ligament tears and##2##3##(2009-3#1)(2012-3#1)
ligament with##2##2##(1996-2#2)
ligament##84##1##(1990-6#2)(1991-6#1)(1995-8#2)(1996-2#2)(1997-8#2)(2007-11#4)(2007-8#7)(2008-11#4)(2008-12#3)(2008-6#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#2)(2009-7#8)(2009-9#1)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#24)(2013-8#1)
ligamentous injury##2##2##(2012-12#1)(2013-1#1)
ligamentous##6##1##(2009-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
ligaments are##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
ligaments between the midgut and salivary glands##2##7##(2008-10#2)
ligaments or tendons##2##3##(2013-1#2)
ligaments##27##1##(2007-11#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#5)(2008-9#3)(2009-4#1)(2009-7#3)(2012-12#1)(2013-1#4)
ligamentum teres##2##2##(2008-10#1)(2008-8#1)
ligamentum##4##1##(1990-7#1)(1996-3#1)(2008-10#1)(2008-8#1)
ligand (RANKL)##3##2##(2008-7#1)(2011-1#2)
ligand 1##2##2##(2008-10#1)(2012-3#1)
ligand LAG-2##2##2##(1994-12#1)(2007-12#1)
ligand and its##4##3##(1990-2#1)(1996-2#2)(2008-10#1)
ligand and the##3##3##(1996-2#1)(1997-2#1)(2008-10#1)
ligand and##22##2##(1990-2#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-2#3)(1997-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2013-1#1)(2013-8#1)
ligand are the##2##3##(2008-4#1)(2008-8#1)
ligand are##5##2##(1996-2#2)(2008-10#1)(2008-4#1)(2008-8#1)
ligand as##3##2##(2008-10#2)(2008-4#1)
ligand binding and##3##3##(1994-8#1)(2008-4#1)(2012-2#1)
ligand binding by##2##3##(1990-8#1)(1992-9#1)
ligand binding can##2##3##(2007-12#1)(2008-4#1)
ligand binding domain##3##3##(1991-5#1)(1996-5#1)(2006-6#1)
ligand binding in##2##3##(1995-11#1)(1996-12#1)
ligand binding or##2##3##(1992-9#1)(1995-2#1)
ligand binding properties##3##3##(1990-8#1)(1993-8#1)(2008-4#1)
ligand binding site is##2##4##(1990-8#1)(1991-12#1)
ligand binding studies##2##3##(1994-8#1)(1995-2#1)
ligand binding to either the##2##5##(1994-5#2)
ligand binding to the##3##4##(1993-8#1)(1995-2#1)(1997-7#1)
ligand binding to##13##3##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-8#2)(1994-5#2)(1995-2#2)(1997-2#1)(1997-7#1)(2008-4#1)
ligand binding##59##2##(1990-5#2)(1990-8#5)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#4)(1993-6#1)(1993-8#4)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#4)(1995-2#6)(1995-6#2)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#8)(2008-8#1)(2012-2#1)
ligand binds##2##2##(1995-2#1)(1995-3#1)
ligand bound##3##2##(1994-5#1)(1996-2#1)(2007-11#1)
ligand by##3##2##(1992-9#1)(1995-5#1)(1997-7#1)
ligand complex##2##2##(2008-10#2)
ligand complexes##3##2##(2008-10#3)
ligand concentration##7##2##(1995-3#1)(1997-2#1)(2008-10#5)
ligand concentrations##3##2##(1993-11#2)(2008-10#1)
ligand coupled##2##2##(2008-10#1)(2008-5#1)
ligand densities##2##2##(1997-2#1)(2008-7#1)
ligand dictionary is##2##3##(2008-4#2)
ligand dictionary##3##2##(2008-4#3)
ligand dissociation##2##2##(1990-8#1)(1992-6#1)
ligand exchange##4##2##(1990-12#1)(2008-10#3)
ligand expression##2##2##(2008-11#1)(2013-1#1)
ligand field##5##2##(1997-7#4)(2012-12#1)
ligand for the##7##3##(1991-12#1)(1991-5#1)(1996-2#1)(1996-5#1)(2008-7#1)(2008-9#1)(2010-1#1)
ligand for##19##2##(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#1)(1993-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)
ligand from##2##2##(1996-12#1)(1996-2#1)
ligand have##2##2##(2008-10#2)
ligand in the##2##3##(2006-6#1)(2008-10#1)
ligand in##10##2##(1990-11#1)(1992-12#1)(1996-2#1)(2006-6#1)(2008-10#5)(2008-11#1)
ligand increases##2##2##(1997-7#1)(2008-10#1)
ligand is##15##2##(1994-5#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-4#6)(2008-7#1)(2010-10#1)
ligand models of humic substances##2##5##(2008-10#2)
ligand of pph(3)##2##3##(2013-1#2)
ligand of the##6##3##(1991-6#2)(1995-8#1)(2007-7#1)(2011-2#1)(2012-2#1)
ligand of##14##2##(1991-6#2)(1994-5#2)(1995-8#1)(1997-7#2)(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
ligand or##4##2##(1997-2#2)(2010-11#1)(2010-4#1)
ligand recognition##2##2##(1995-6#1)(2008-1#1)
ligand signatures##2##2##(2010-11#2)
ligand sink##2##2##(1997-4#2)
ligand specificity of##2##3##(1990-5#2)
ligand specificity##5##2##(1990-5#2)(1991-9#1)(1992-12#1)(1997-7#1)
ligand structure##4##2##(1993-11#1)(2008-10#3)
ligand substitution kinetic##2##3##(2008-10#2)
ligand substitution##3##2##(2008-10#2)(2008-12#1)
ligand system##2##2##(2008-12#1)(2008-8#1)
ligand to metal ratio##2##4##(1996-2#1)(2008-10#1)
ligand to the heme iron##2##5##(1991-9#1)(2008-10#1)
ligand to the##3##3##(1991-9#1)(1992-3#1)(2008-10#1)
ligand to##10##2##(1990-12#1)(1991-2#1)(1991-9#2)(1992-3#1)(1994-6#1)(1996-2#1)(2008-10#3)
ligand was found to be##2##5##(2008-10#2)
ligand was##11##2##(1991-8#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-5#1)(2008-10#4)(2008-8#1)(2012-12#1)
ligand with the##2##3##(1995-2#1)(2008-10#1)
ligand with##6##2##(1995-2#1)(1996-2#1)(2008-10#3)(2008-8#1)
ligand##488##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#7)(1990-7#1)(1990-8#14)(1991-12#4)(1991-2#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#8)(1992-11#2)(1992-12#5)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#6)(1993-11#6)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#7)(1993-9#1)(1994-11#2)(1994-12#4)(1994-5#8)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#6)(1995-12#2)(1995-2#17)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#1)(1996-12#6)(1996-2#22)(1996-5#2)(1997-1#2)(1997-2#10)(1997-4#5)(1997-7#29)(2006-6#2)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#135)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#28)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#7)(2009-10#2)(2009-3#2)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#6)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
ligand(s)##5##1##(1994-6#2)(1994-8#1)(2008-3#2)
ligand) complexes##2##2##(1995-11#1)(2008-10#1)
ligand)##8##1##(1993-5#1)(1995-11#1)(2008-10#6)
ligand-activated transcription factors##3##3##(2008-1#1)(2008-4#1)(2013-7#1)
ligand-binding assay##2##2##(2008-4#1)(2010-11#1)
ligand-binding assays##2##2##(2010-11#1)(2013-1#1)
ligand-binding domain of the aspartate receptor##2##6##(1992-8#1)(1992-9#1)
ligand-binding domain of the##4##4##(1991-12#2)(1992-8#1)(1992-9#1)
ligand-binding domain of##6##3##(1991-12#2)(1992-8#1)(1992-9#1)(2008-8#2)
ligand-binding domain##11##2##(1991-12#2)(1992-8#1)(1992-9#1)(1994-12#1)(1997-4#1)(2008-4#1)(2008-8#4)
ligand-binding properties##2##2##(1993-11#1)(1995-2#1)
ligand-binding subunit##3##2##(1993-11#3)
ligand-binding##25##1##(1991-12#2)(1992-8#1)(1992-9#1)(1993-11#4)(1994-12#1)(1995-11#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-4#3)(2008-8#4)(2010-11#2)(2010-7#1)(2012-2#1)(2013-1#1)
ligand-dependent transcription##2##2##(1995-2#2)
ligand-dependent##7##1##(1995-2#2)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
ligand-directed##3##1##(1992-3#1)(2012-1#1)(2012-2#1)
ligand-gated##3##1##(1996-2#1)(2008-4#1)(2008-8#1)
ligand-induced conformational changes##2##3##(1992-6#1)(1992-8#1)
ligand-induced##7##1##(1990-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-11#1)(2008-10#1)(2012-12#1)
ligand-macromolecule interactions##3##2##(1997-2#3)
ligand-macromolecule##4##1##(1997-2#4)
ligand-receptor binding##2##2##(1993-3#1)(2008-9#1)
ligand-receptor interaction##3##2##(1991-3#1)(2008-1#1)(2012-2#1)
ligand-receptor interactions##2##2##(2008-4#1)(2008-9#1)
ligand-receptor##7##1##(1991-3#1)(1993-3#1)(2008-1#1)(2008-4#1)(2008-9#2)(2012-2#1)
liganded##14##1##(1990-8#3)(1992-6#7)(1992-8#2)(1994-11#1)(1995-2#1)
ligands and the##7##3##(1996-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-8#1)
ligands and##22##2##(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#6)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2012-12#1)(2012-3#1)
ligands are##11##2##(1995-11#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#1)
ligands bound to##2##3##(2008-5#1)(2012-2#1)
ligands by##3##2##(2008-4#1)(2008-9#2)
ligands containing##3##2##(1994-6#1)(2010-12#1)(2013-1#1)
ligands do##2##2##(1995-5#1)(1996-2#1)
ligands for the##7##3##(1991-1#2)(2008-10#3)(2008-5#2)
ligands for##27##2##(1991-1#2)(1991-9#1)(1992-4#1)(1993-12#1)(1994-2#2)(1994-6#3)(1995-11#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-8#3)(2009-10#1)(2009-9#2)(2013-1#1)(2013-8#1)
ligands have been##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
ligands have##9##2##(1991-12#1)(1996-2#1)(2008-10#3)(2009-8#1)(2010-11#1)(2012-2#2)
ligands in a##5##3##(2008-10#4)(2009-3#1)
ligands in chickens##2##3##(2013-1#2)
ligands in the##4##3##(1990-8#1)(1996-2#1)(2008-10#1)(2010-11#1)
ligands in##25##2##(1990-8#1)(1991-11#1)(1995-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2013-1#3)(2013-7#1)
ligands including##3##2##(1995-11#1)(1995-6#1)(2009-8#1)
ligands is##4##2##(1997-7#1)(2008-4#1)(2008-5#1)(2010-5#1)
ligands may be##3##3##(1993-11#1)(1995-12#1)(2008-10#1)
ligands may##5##2##(1993-11#1)(1995-12#1)(1997-4#1)(2008-10#1)(2009-6#1)
ligands of the aryl hydrocarbon receptor##2##6##(2008-7#2)
ligands of the##3##3##(1993-8#1)(2008-7#2)
ligands of##18##2##(1991-5#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-7#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)
ligands on the##4##3##(1994-11#1)(1995-5#1)(2008-10#1)(2009-7#1)
ligands on##6##2##(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#1)(2008-10#1)(2009-7#1)
ligands or##3##2##(1992-5#1)(2008-10#1)(2008-4#1)
ligands such as##2##3##(1991-7#1)(2008-4#1)
ligands that bind to##2##4##(2008-1#1)(2008-4#1)
ligands that##7##2##(1993-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-3#1)
ligands to be##2##3##(1990-8#1)(2008-1#1)
ligands to opioid receptors##2##4##(2009-7#2)
ligands to the diiron site##2##5##(1991-12#2)
ligands to the##5##3##(1991-12#2)(1993-11#2)(2008-10#1)
ligands to##18##2##(1990-8#1)(1991-12#2)(1993-11#2)(1995-12#1)(1995-5#1)(1997-2#2)(2008-1#2)(2008-10#3)(2008-7#1)(2009-7#2)(2013-1#1)
ligands was##5##2##(1992-9#1)(1994-6#1)(2008-10#2)(2008-9#1)
ligands were found to be##3##5##(1993-3#1)(1995-11#1)(2012-2#1)
ligands were##12##2##(1993-3#1)(1995-11#2)(2008-10#6)(2008-7#1)(2010-11#1)(2012-2#1)
ligands which##6##2##(1990-2#2)(1994-6#1)(1995-5#1)(1995-6#1)(1997-7#1)
ligands will##2##2##(2008-11#1)(2009-7#1)
ligands with different##2##3##(1992-3#1)(2008-8#1)
ligands with potential##2##3##(2012-2#1)(2013-1#1)
ligands with the##2##3##(1994-6#1)(2012-2#1)
ligands with##12##2##(1990-8#1)(1992-3#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-2#4)(2013-1#1)
ligands##392##1##(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#10)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-11#11)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#5)(1994-5#1)(1994-6#8)(1994-8#2)(1995-11#9)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#7)(1995-6#3)(1996-2#14)(1996-5#2)(1997-1#1)(1997-2#4)(1997-4#1)(1997-7#16)(2007-11#4)(2007-12#2)(2008-1#5)(2008-10#103)(2008-11#2)(2008-3#3)(2008-4#25)(2008-5#11)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#6)(2009-8#8)(2009-9#3)(2010-11#5)(2010-12#2)(2010-5#1)(2012-12#3)(2012-2#13)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#1)
ligands)##2##1##(2008-10#1)(2008-4#1)
ligase IV##8##2##(1997-7#8)
ligase and##2##2##(1994-12#1)(2011-1#1)
ligase in the##3##3##(1993-11#1)(2009-10#1)(2013-1#1)
ligase was##2##2##(1990-7#1)(2011-3#1)
ligase##45##1##(1990-7#2)(1993-11#1)(1993-2#1)(1993-3#5)(1994-12#2)(1995-6#1)(1996-8#1)(1997-3#1)(1997-7#11)(2008-4#1)(2008-8#4)(2009-10#3)(2009-8#1)(2011-1#1)(2011-3#3)(2012-12#4)(2012-2#1)(2013-1#2)
ligase-based##2##1##(2008-2#1)(2010-7#1)
ligases and##2##2##(1994-12#1)(1995-6#1)
ligases##16##1##(1994-12#2)(1995-6#2)(1997-7#2)(2008-2#1)(2008-4#2)(2009-10#2)(2010-7#1)(2012-12#1)(2013-1#3)
ligate the##2##2##(1993-8#1)(2011-3#1)
ligate##4##1##(1993-8#1)(2008-4#1)(2008-8#1)(2011-3#1)
ligated His85 are##2##3##(2008-9#2)
ligated His85##3##2##(2008-9#3)
ligated into the##2##3##(1990-7#1)(2008-4#1)
ligated into##3##2##(1990-7#1)(1993-9#1)(2008-4#1)
ligated species was##2##3##(1990-8#2)
ligated species##7##2##(1990-8#7)
ligated to a##2##3##(1992-3#1)(2008-10#1)
ligated to##4##2##(1992-3#1)(1993-11#1)(2008-10#1)(2008-2#1)
ligated with##4##2##(1990-5#1)(1995-8#1)(2008-8#2)
ligated##42##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#8)(1991-11#3)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-8#1)(1997-2#5)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-8#3)(2008-9#4)(2013-1#1)(2013-8#1)
ligating##3##1##(1997-2#1)(2008-10#1)(2008-8#1)
ligation and sclerotherapy##3##3##(2011-2#1)(2013-1#2)
ligation and##11##2##(1993-2#1)(1996-12#1)(1996-5#1)(2007-8#1)(2008-11#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
ligation in##2##2##(1994-1#1)(2008-8#1)
ligation is##3##2##(1994-5#1)(1996-8#1)(2013-1#1)
ligation mixture##2##2##(1993-11#1)(1994-12#1)
ligation model##2##2##(2008-4#2)
ligation of a##2##3##(1990-7#1)(2007-9#1)
ligation of left##2##3##(2008-11#1)(2013-8#1)
ligation of the external##2##4##(1997-6#1)(2007-8#1)
ligation of the##6##3##(1993-12#1)(1994-12#1)(1997-6#1)(2007-10#1)(2007-8#2)
ligation of two##2##3##(1993-6#1)(2011-3#1)
ligation of##18##2##(1990-5#1)(1990-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1997-6#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-3#2)(2013-1#1)(2013-8#1)
ligation or##3##2##(1993-12#1)(2008-4#1)(2010-11#1)
ligation reactions##3##2##(2010-7#3)
ligation states##2##2##(1990-8#2)
ligation was##2##2##(2013-1#2)
ligation with##3##2##(1993-2#1)(2012-2#1)(2013-1#1)
ligation##103##1##(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#5)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-8#5)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-11#2)(2008-2#2)(2008-4#8)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#3)(2009-7#1)(2010-11#1)(2010-7#5)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
ligation)##2##1##(1996-5#1)(2008-4#1)
ligation-based##2##1##(2008-2#2)
ligature material##3##2##(2012-12#3)
ligature##9##1##(1990-9#1)(1995-1#3)(2008-10#1)(2012-12#4)
ligatures##3##1##(2007-8#2)(2009-7#1)
light (109##2##2##(2012-2#2)
light (approximately##2##2##(1990-11#1)(1992-1#1)
light (lambda =##3##3##(2008-3#3)
light (lambda##4##2##(2008-11#1)(2008-3#3)
light absorption##12##2##(1994-5#1)(2008-10#2)(2008-2#4)(2008-3#5)
light activation##3##2##(2009-4#1)(2011-1#1)(2013-1#1)
light after##2##2##(1997-6#1)(2007-12#1)
light also##2##2##(1995-5#1)(2008-3#1)
light amplification##2##2##(2007-11#2)
light and by##2##3##(2008-3#2)
light and color in##2##4##(2008-2#2)
light and dark##3##3##(2008-10#2)(2013-7#1)
light and electron microscopic##3##4##(1993-9#1)(1996-5#1)(2008-7#1)
light and electron microscopy##13##4##(1992-2#1)(1992-9#1)(1995-2#1)(1997-3#1)(2006-6#1)(2008-10#5)(2008-4#1)(2008-7#1)(2012-1#1)
light and electron##20##3##(1992-2#1)(1992-9#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#3)(2012-1#1)
light and fluorescence##3##3##(2008-10#3)
light and for##2##3##(2007-11#1)(2008-2#1)
light and heavy chains were##2##5##(1993-8#1)(2008-11#1)
light and heavy##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
light and high##2##3##(1995-12#1)(2008-8#1)
light and is##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
light and scanning##2##3##(2008-10#1)(2008-9#1)
light and temperature##2##3##(2008-10#2)
light and the##11##3##(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#2)(2008-3#4)
light and transmission electron microscopy##2##5##(2008-10#1)(2008-7#1)
light and transmission electron##5##4##(2006-10#1)(2008-10#1)(2008-7#3)
light and##109##2##(1990-5#2)(1992-2#1)(1992-8#2)(1992-9#1)(1993-8#1)(1993-9#1)(1995-12#3)(1995-2#1)(1996-10#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#16)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-8#4)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
light are investigated##2##3##(2007-11#1)(2008-3#1)
light are##11##2##(2007-11#3)(2008-2#3)(2008-3#3)(2008-8#1)(2010-6#1)
light as a##3##3##(2008-2#1)(2008-3#2)
light as##6##2##(1991-6#1)(2008-2#1)(2008-3#4)
light at 3##2##3##(2007-12#1)(2008-10#1)
light at 470 nm##2##4##(2008-10#1)(2008-11#1)
light at a##4##3##(1991-2#1)(2007-12#2)(2008-3#1)
light at the end of the##2##6##(1991-12#1)(2007-7#1)
light at the##4##3##(1991-12#1)(2007-7#1)(2008-2#2)
light at wavelengths##2##3##(2007-11#2)
light at##29##2##(1991-12#1)(1991-2#2)(1995-5#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#4)(2008-9#1)(2011-2#1)
light attenuation by##2##3##(2008-7#2)
light availability##2##2##(2008-5#1)(2009-8#1)
light beam from##2##3##(2007-12#1)(2008-3#1)
light beam in the##2##4##(2007-11#1)(2008-3#1)
light beam is##4##3##(2008-2#1)(2008-3#3)
light beam##26##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#5)(2008-3#17)
light beams in##2##3##(2007-11#1)(2007-12#1)
light beams with##2##3##(2007-11#1)(2008-3#1)
light beams##20##2##(2007-11#5)(2007-12#4)(2008-2#5)(2008-3#6)
light becomes##2##2##(2008-10#1)(2008-3#1)
light before##2##2##(1997-6#1)(2008-10#1)
light brown to brown type##2##5##(2008-10#2)
light brown to brown##3##4##(2008-10#3)
light brown##5##2##(2008-10#5)
light but##3##2##(1991-2#2)(2008-2#1)
light by a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light by an##4##3##(2008-2#1)(2008-3#3)
light by intracavity frequency doubling##2##5##(2007-12#2)
light by means of##2##4##(2007-11#1)(2007-12#1)
light by use of##4##4##(2007-11#1)(2007-12#3)
light by##35##2##(2007-11#6)(2007-12#10)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#1)
light cables##2##2##(2011-2#2)
light can be##11##3##(1990-5#1)(1991-9#1)(1993-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-12#1)
light can##15##2##(1990-5#1)(1991-9#1)(1993-3#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
light caused an##2##3##(1992-6#1)(2009-6#1)
light caused by##2##3##(2008-3#2)
light caused##5##2##(1992-6#1)(2008-10#1)(2008-3#2)(2009-6#1)
light chain amyloidosis##3##3##(2010-4#2)(2011-2#1)
light chain deposition##2##3##(1993-2#1)(2013-8#1)
light chain disease##3##3##(1992-2#2)(2013-8#1)
light chain of human##2##4##(1993-11#1)(2008-11#1)
light chain of##6##3##(1993-11#2)(1994-11#1)(1994-5#1)(2007-7#1)(2008-11#1)
light chain phosphorylation##3##3##(1990-11#2)(1994-11#1)
light chain restriction##3##3##(2008-9#1)(2009-8#2)
light chain##72##2##(1990-11#8)(1990-5#2)(1991-2#4)(1991-8#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-8#4)(1993-9#3)(1994-11#7)(1994-5#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-4#2)(2011-2#3)(2012-2#1)(2013-8#4)
light chains are##3##3##(1993-9#3)
light chains in##2##3##(1993-9#2)
light chains of##3##3##(1990-12#1)(1994-5#2)
light chains##17##2##(1990-12#2)(1993-9#7)(1994-11#1)(1994-5#2)(1995-2#1)(1996-9#1)(2008-5#1)(2011-2#2)
light collected by##2##3##(2008-2#1)(2008-3#1)
light collection##3##2##(2008-2#3)
light compressor##2##2##(2008-3#2)
light conditions##5##2##(2008-10#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)
light could##2##2##(2008-3#1)(2008-9#1)
light coupled##2##2##(2007-11#1)(2007-12#1)
light coupling##2##2##(2007-12#1)(2010-5#1)
light curves##2##2##(1995-6#1)(2011-2#1)
light cycle##3##2##(1991-9#1)(1997-6#2)
light delivered##2##2##(2008-3#1)(2008-7#1)
light delivery to##2##3##(2008-2#1)(2008-3#1)
light delivery##7##2##(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)
light detection cell is##2##4##(2008-10#2)
light detection cell##6##3##(2008-10#6)
light detection##7##2##(2008-10#6)(2012-2#1)
light detector##3##2##(2008-10#3)
light diesel fuels##2##3##(2008-11#2)
light diffracted##2##2##(2007-11#1)(2008-3#1)
light diffusion##2##2##(1992-8#1)(2008-3#1)
light distribution in the tissue##2##5##(2008-3#2)
light distribution in##6##3##(2008-3#6)
light distribution##16##2##(2007-12#1)(2008-2#2)(2008-3#12)(2008-7#1)
light distributions is##2##3##(2007-11#1)(2007-12#1)
light distributions##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
light dose of 4##2##4##(2012-3#2)
light dose##6##2##(2007-8#1)(2012-2#2)(2012-3#3)
light doses##3##2##(1992-6#1)(2008-7#1)(2012-3#1)
light during the##5##3##(1992-8#1)(2008-2#2)(2008-3#2)
light during##7##2##(1991-2#1)(1992-8#1)(2007-11#1)(2008-2#2)(2008-3#2)
light efficiency and##2##3##(2008-2#1)(2008-3#1)
light efficiency##6##2##(2008-2#3)(2008-3#3)
light emission at##3##3##(2007-11#1)(2008-10#2)
light emission from##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
light emission##21##2##(1990-8#1)(2007-11#2)(2008-10#13)(2008-2#3)(2010-7#1)(2011-1#1)
light emitted from a##2##4##(2007-12#1)(2008-2#1)
light emitted from##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light emitted##5##2##(1992-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
light emitting diode (LED)##5##4##(2008-10#4)(2008-11#1)
light emitting diode (LED)-induced fluorescence##2##5##(2008-10#2)
light emitting diode as##2##4##(2008-10#1)(2008-7#1)
light emitting diode##15##3##(1991-2#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)
light emitting diodes (LEDs)##2##4##(2008-10#2)
light emitting diodes##3##3##(2008-10#2)(2011-1#1)
light emitting##20##2##(1991-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)
light energy##2##2##(2008-9#1)(2013-1#1)
light exposure##8##2##(1990-10#1)(1990-11#1)(1992-6#1)(1995-12#1)(1996-9#1)(1997-6#1)(2008-5#2)
light extinction##3##2##(2008-2#3)
light field##11##2##(2008-2#1)(2008-3#10)
light fields##2##2##(2008-3#2)
light fluctuations##5##2##(2007-12#1)(2008-3#2)(2008-8#2)
light fluence##4##2##(1992-6#1)(2008-7#1)(2011-1#2)
light for sensitization and a red##2##6##(2007-12#2)
light for##20##2##(1991-6#1)(1994-6#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)
light from a##17##3##(2007-11#6)(2007-12#1)(2008-2#2)(2008-3#8)
light from an##2##3##(2007-12#1)(2008-10#1)
light from the##13##3##(1991-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#3)
light from##50##2##(1991-6#1)(2007-11#8)(2007-12#8)(2008-10#5)(2008-2#9)(2008-3#18)(2008-9#1)
light generated by##2##3##(2007-11#1)(2008-3#1)
light growth of##2##3##(2007-12#2)
light guides##2##2##(2007-11#1)(2008-2#1)
light harvesting##2##2##(1997-6#1)(2009-7#1)
light has been##3##3##(2008-2#1)(2008-3#2)
light has##7##2##(1990-11#1)(2008-2#1)(2008-3#5)
light illumination##2##2##(2008-9#1)(2011-2#1)
light imaging##3##2##(2007-12#2)(2008-3#1)
light impairs sleep##2##3##(1994-8#2)
light in a medium##2##4##(2007-12#2)
light in a##15##3##(2007-11#2)(2007-12#7)(2008-2#2)(2008-3#2)(2008-9#1)(2009-4#1)
light in an##4##3##(2007-12#1)(2008-3#3)
light in scattering media##2##4##(2008-2#1)(2008-3#1)
light in the fiber##2##4##(2008-3#2)
light in the presence of##2##5##(1990-8#1)(1992-5#1)
light in the##23##3##(1990-5#1)(1990-8#1)(1992-5#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#12)(2008-9#1)(2013-1#1)
light in turbid##2##3##(2007-11#1)(2008-3#1)
light in##69##2##(1990-5#1)(1990-8#1)(1992-5#1)(1992-8#1)(1997-6#1)(2007-11#3)(2007-12#13)(2008-10#4)(2008-2#15)(2008-3#20)(2008-9#3)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
light incident from##2##3##(2008-3#2)
light incident on##2##3##(2008-3#2)
light incident upon the##2##4##(2007-12#1)(2008-2#1)
light incident##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
light initiation and##2##3##(2008-10#2)
light initiation##9##2##(2008-10#9)
light intensities##11##2##(1992-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-8#1)(2012-3#1)
light intensity and##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
light intensity distribution##2##3##(2008-3#2)
light intensity from##2##3##(2007-12#1)(2008-10#1)
light intensity in##2##3##(2007-12#1)(2008-3#1)
light intensity of##3##3##(2007-11#1)(2008-12#1)(2008-6#1)
light intensity##36##2##(1996-4#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
light interaction with##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
light interacts##2##2##(2007-11#1)(2008-4#1)
light interception##2##2##(2008-10#2)
light interference##2##2##(2008-2#1)(2008-3#1)
light into a##2##3##(2008-3#1)(2010-5#1)
light into the##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
light into##15##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)
light irradiation##8##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-3#2)(2009-8#1)(2013-8#1)
light is found to be##2##5##(2008-2#1)(2008-3#1)
light is frequency##2##3##(2008-2#1)(2008-3#1)
light is possible##2##3##(2007-12#1)(2008-5#1)
light is presented##2##3##(2008-3#2)
light is proposed and##2##4##(2007-12#2)
light is the##2##3##(2008-12#1)(2008-3#1)
light is used##4##3##(2008-2#1)(2008-3#3)
light is##56##2##(1997-6#2)(2007-11#6)(2007-12#11)(2008-10#1)(2008-12#1)(2008-2#8)(2008-3#23)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
light it##2##2##(2008-3#1)(2008-5#1)
light itself##2##2##(1994-8#1)(2007-12#1)
light leaf spot##4##3##(2008-10#4)
light level##3##2##(1992-6#1)(2007-12#1)(2008-2#1)
light levels and##2##3##(2008-2#1)(2008-8#1)
light levels in##2##3##(2007-12#1)(2008-8#1)
light levels##11##2##(2007-12#2)(2007-5#1)(2008-2#4)(2008-3#2)(2008-8#2)
light limitation##2##2##(2008-7#1)(2012-1#1)
light loss##2##2##(2007-12#1)(2008-3#1)
light make##2##2##(2007-12#2)
light masks##2##2##(2013-1#2)
light may##2##2##(1997-6#1)(2012-2#1)
light microscope##17##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-9#3)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
light microscopic##6##2##(1996-5#1)(2007-12#1)(2008-10#3)(2012-2#1)
light microscopy and scanning electron microscopy##2##6##(2007-12#1)(2008-10#1)
light microscopy and##8##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
light microscopy of##2##3##(2009-4#1)(2011-2#1)
light microscopy showed##2##3##(2007-12#1)(2008-10#1)
light microscopy using##2##3##(2008-5#1)(2013-7#1)
light microscopy##51##2##(1992-5#1)(1993-8#1)(1995-12#1)(1996-3#1)(2007-12#6)(2007-7#2)(2008-1#4)(2008-10#8)(2008-11#2)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#6)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
light modulation with##2##3##(2007-12#1)(2008-2#1)
light modulation##4##2##(2007-12#3)(2008-2#1)
light modulator##54##2##(2007-11#6)(2007-12#6)(2008-2#14)(2008-3#28)
light modulators have##2##3##(2007-12#1)(2008-2#1)
light modulators##29##2##(2007-12#4)(2008-2#13)(2008-3#12)
light near the##2##3##(2008-3#2)
light of a##5##3##(1993-11#1)(1993-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
light of current##6##3##(1991-12#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
light of new##3##3##(2007-12#1)(2008-9#1)(2010-12#1)
light of other##3##3##(1994-12#1)(1994-2#1)(2008-11#1)
light of past##2##3##(2012-2#1)(2012-9#1)
light of previous##5##3##(1994-5#1)(2008-10#2)(2008-3#1)(2009-2#1)
light of recent##8##3##(1990-9#1)(1991-4#1)(1991-6#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)
light of research##2##3##(2009-5#1)(2010-7#1)
light of the present results##2##5##(1995-12#1)(2008-5#1)
light of the present##4##4##(1995-12#1)(1996-2#1)(2008-5#1)(2009-10#1)
light of the recent##2##4##(1994-2#1)(2008-11#1)
light of the results##2##4##(2008-11#1)(2010-7#1)
light of the##60##3##(1990-3#2)(1990-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#5)(2009-10#1)(2009-5#1)(2010-7#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
light of these findings##4##4##(2008-7#1)(2010-2#1)(2010-8#1)(2013-8#1)
light of these##9##3##(1990-12#1)(1993-1#1)(2007-5#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
light of this##3##3##(2007-12#1)(2008-8#1)(2011-1#1)
light of##161##2##(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-12#1)(1993-1#1)(1993-11#2)(1993-3#3)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#5)(2009-10#1)(2009-2#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#7)(2012-3#5)(2012-9#1)(2013-1#3)(2013-8#3)
light on a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light on both the##2##4##(2008-1#1)(2012-3#1)
light on the importance of##2##5##(2012-12#1)(2013-1#1)
light on the molecular##3##4##(2009-5#1)(2010-12#1)(2012-1#1)
light on the##34##3##(1992-9#1)(1994-1#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#1)
light on this problem##2##4##(1992-8#1)(2008-8#1)
light on this##5##3##(1992-8#1)(1997-2#1)(2008-8#1)(2012-2#1)(2013-1#1)
light on##73##2##(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-11#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-9#1)(2007-12#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#2)
light only##2##2##(1990-5#1)(2007-12#1)
light onto the##2##3##(2008-2#1)(2011-2#1)
light or malate##2##3##(2008-10#2)
light or##14##2##(1992-11#1)(1992-8#1)(1997-3#2)(2006-11#1)(2008-10#3)(2008-3#2)(2010-4#3)(2010-8#1)
light output##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
light over##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
light passing through the##3##4##(2007-12#1)(2008-3#2)
light path##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
light paths##2##2##(2007-12#1)(2008-3#1)
light patterns##4##2##(2007-11#3)(2007-12#1)
light penetration##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
light perception##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
light period##5##2##(1994-8#1)(1995-11#1)(1997-2#2)(1997-6#1)
light periods##4##2##(1997-6#1)(2008-10#2)(2008-6#1)
light phase group##2##3##(2010-8#2)
light phase photoperiod##2##3##(2010-8#2)
light phase##6##2##(1993-12#1)(2007-11#1)(2010-8#4)
light pillars from##2##3##(2008-2#2)
light pillars##4##2##(2008-2#4)
light polarization##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
light power##2##2##(2008-3#2)
light produced by##2##3##(2008-3#2)
light produced##3##2##(2008-3#2)(2008-9#1)
light production##2##2##(2007-12#1)(2008-10#1)
light projection##2##2##(2008-3#2)
light propagating in the##2##4##(2007-11#1)(2008-2#1)
light propagating in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
light propagating##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
light propagation in the##2##4##(2008-3#2)
light propagation in turbid media##2##5##(2008-2#1)(2008-3#1)
light propagation in##7##3##(2008-10#1)(2008-2#1)(2008-3#5)
light propagation is##2##3##(2007-11#1)(2008-3#1)
light propagation through##3##3##(2007-12#2)(2008-3#1)
light propagation within the##2##4##(2008-10#2)
light propagation##20##2##(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#11)
light provides##2##2##(2007-11#1)(2008-3#1)
light pulse##8##2##(1994-2#2)(2007-11#2)(2008-3#2)(2008-5#2)
light pulses and##2##3##(2007-12#1)(2008-2#1)
light pulses in##2##3##(2007-12#2)
light pulses##20##2##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#4)(2008-5#6)
light quality##2##2##(2008-10#1)(2008-5#1)
light quantity##4##2##(2008-10#4)
light rays##2##2##(2008-2#1)(2008-3#1)
light reflected from a##3##4##(2007-12#1)(2008-3#2)
light reflected##6##2##(2007-12#1)(2008-3#5)
light reflection##2##2##(2008-3#1)(2008-5#1)
light regime##3##2##(2008-11#3)
light response##2##2##(1991-2#1)(1992-8#1)
light scanning##2##2##(2007-12#1)(2008-10#1)
light scatter as##2##3##(2006-6#1)(2008-3#1)
light scatter is##2##3##(2008-3#1)(2008-9#1)
light scatter##8##2##(2006-6#1)(2008-3#2)(2008-9#4)(2009-4#1)
light scattered by a##3##4##(2007-11#1)(2008-2#2)
light scattered by##11##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
light scattered from a##4##4##(2008-3#4)
light scattered from an##3##4##(2007-12#1)(2008-2#2)
light scattered from the##2##4##(2008-3#2)
light scattered from##12##3##(2007-12#1)(2008-2#3)(2008-3#8)
light scattered##27##2##(1990-8#1)(2007-11#3)(2007-12#2)(2008-2#8)(2008-3#13)
light scattering (RLS) technique##3##4##(2008-10#3)
light scattering (RLS)##9##3##(2008-10#9)
light scattering and fluorescence##3##4##(1992-3#1)(2008-10#1)(2008-9#1)
light scattering and##10##3##(1992-3#1)(1995-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
light scattering by a##4##4##(2008-2#1)(2008-3#3)
light scattering by dielectric particles##3##5##(2008-3#3)
light scattering by##19##3##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#11)
light scattering for##3##3##(2008-3#3)
light scattering from##13##3##(2007-11#1)(2008-2#4)(2008-3#6)(2008-6#2)
light scattering in laser particle sizing##2##6##(2008-3#2)
light scattering in the##2##4##(1994-3#1)(2008-2#1)
light scattering in##11##3##(1994-3#2)(2007-11#1)(2008-2#2)(2008-3#6)
light scattering intensity##4##3##(2008-10#3)(2008-3#1)
light scattering is##8##3##(2008-2#1)(2008-3#5)(2008-4#1)(2008-9#1)
light scattering of##5##3##(2008-10#5)
light scattering on##2##3##(2008-3#2)
light scattering signals##3##3##(2008-10#3)
light scattering technique and its##2##5##(2008-10#2)
light scattering technique was##2##4##(2008-10#2)
light scattering technique##10##3##(2008-10#9)(2011-2#1)
light scattering techniques##3##3##(1992-3#1)(2011-2#1)(2012-1#1)
light scattering to##2##3##(2007-11#1)(2009-9#1)
light scattering were used##2##4##(2008-2#1)(2008-8#1)
light scattering were##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
light scattering##171##2##(1990-12#1)(1992-3#2)(1994-3#2)(1995-11#2)(2007-11#5)(2007-12#2)(2008-10#55)(2008-2#22)(2008-3#63)(2008-4#3)(2008-6#2)(2008-8#3)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-7#1)
light sensitivity in##2##3##(2007-12#1)(2008-8#1)
light shorter than##2##3##(1995-3#1)(2008-7#1)
light show the##2##3##(2007-11#1)(2008-3#1)
light source (LED) and##2##4##(2008-10#2)
light source and a##5##4##(2007-11#1)(2008-10#3)(2008-2#1)
light source and##12##3##(2007-11#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)
light source based##2##3##(2007-11#1)(2008-10#1)
light source for the##2##4##(2007-11#1)(2010-12#1)
light source for##6##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)
light source in a##2##4##(2007-12#1)(2008-3#1)
light source in##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
light source is##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
light source such##2##3##(2008-2#2)
light source to##4##3##(2008-2#1)(2008-3#2)(2012-3#1)
light source with a##3##4##(2008-3#3)
light source with##5##3##(2007-12#1)(2008-12#1)(2008-3#3)
light source##117##2##(1990-12#1)(1990-8#1)(1993-3#1)(1995-3#1)(2007-11#8)(2007-12#12)(2008-1#1)(2008-10#18)(2008-12#3)(2008-2#17)(2008-3#40)(2008-4#1)(2008-5#4)(2009-4#1)(2010-12#1)(2010-5#2)(2011-2#1)(2011-7#1)(2012-3#2)(2013-8#1)
light sources and##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
light sources are##3##3##(2007-11#1)(2008-3#2)
light sources can##2##3##(2008-3#1)(2010-9#1)
light sources for##2##3##(2008-3#1)(2008-9#1)
light sources in the##2##4##(2008-3#1)(2011-7#1)
light sources in##4##3##(2007-11#1)(2008-3#2)(2011-7#1)
light sources is presented##2##4##(2007-12#1)(2008-3#1)
light sources is##3##3##(2007-12#1)(2008-3#2)
light sources##39##2##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#14)(2008-4#2)(2008-5#1)(2008-9#3)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#2)(2012-12#1)
light stress##3##2##(2008-10#1)(2008-7#2)
light than##2##2##(2008-3#1)(2008-9#1)
light that is##4##3##(2007-11#1)(2008-3#3)
light that##12##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)(2008-8#1)
light the##2##2##(2007-11#1)(2008-9#1)
light therapy##4##2##(1995-5#1)(2007-11#1)(2008-12#1)(2013-1#1)
light through a single-mode##2##4##(2008-3#2)
light through a##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-7#1)
light through the##6##3##(2007-12#1)(2008-3#4)(2010-8#1)
light through##22##2##(1994-11#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#11)(2008-6#1)(2008-7#1)(2010-8#1)
light to a##2##3##(2008-2#1)(2008-3#1)
light to and from##2##4##(2008-10#1)(2008-3#1)
light to be##3##3##(2007-11#1)(2008-2#2)
light to the##5##3##(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#1)
light to##25##2##(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-9#1)(2009-8#1)
light transfer##2##2##(2008-10#1)(2008-2#1)
light transmission through a##2##4##(2007-12#2)
light transmission through##3##3##(2007-11#1)(2007-12#2)
light transmission##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
light transmitted by##3##3##(2008-2#2)(2008-3#1)
light transmitted through the##2##4##(2008-2#1)(2008-3#1)
light transmitted through##4##3##(2008-2#1)(2008-3#3)
light transmitted##7##2##(2008-2#3)(2008-3#4)
light transport in##3##3##(2008-3#1)(2011-1#2)
light transport##4##2##(2008-3#1)(2011-1#3)
light treatment##3##2##(1997-6#1)(2008-5#1)(2009-3#1)
light used for##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
light used to##2##3##(2008-3#1)(2009-12#1)
light used##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)
light utilization efficiency of##3##4##(2013-8#3)
light utilization efficiency##4##3##(2013-8#4)
light utilization##5##2##(2008-3#1)(2013-8#4)
light valve##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
light valves##3##2##(2008-2#2)(2008-3#1)
light was emitted##2##3##(2008-10#1)(2008-7#1)
light was generated##2##3##(2007-12#2)
light was measured##2##3##(2008-3#2)
light was observed##2##3##(2007-12#1)(2008-10#1)
light was used to detect and##2##6##(2007-12#1)(2008-2#1)
light was used to##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
light was used##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
light was##30##2##(1992-8#1)(2007-11#1)(2007-12#6)(2008-10#7)(2008-2#4)(2008-3#7)(2008-7#3)(2011-1#1)
light wave##5##2##(2008-2#1)(2008-3#4)
light wavelengths##2##2##(2008-10#1)(2008-11#1)
light waves##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
light weight##3##2##(2007-7#1)(2008-3#1)(2009-11#1)
light were used##2##3##(2007-12#1)(2008-11#1)
light were##6##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-1#1)
light when the##2##3##(2008-2#1)(2008-3#1)
light when##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
light with a wavelength##2##4##(2007-12#1)(2010-8#1)
light with a##11##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#4)(2010-8#1)
light with an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light with different##2##3##(2007-11#1)(2007-12#1)
light with##31##2##(2007-11#6)(2007-12#7)(2008-10#2)(2008-2#3)(2008-3#11)(2008-7#1)(2010-8#1)
light within##3##2##(2008-1#1)(2008-3#2)
light##2635##1##(1990-10#1)(1990-11#11)(1990-12#5)(1990-3#3)(1990-5#8)(1990-6#1)(1990-8#5)(1990-9#2)(1991-1#1)(1991-12#5)(1991-2#12)(1991-4#1)(1991-6#5)(1991-8#3)(1991-9#6)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#7)(1992-8#12)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#10)(1993-5#1)(1993-6#2)(1993-8#7)(1993-9#12)(1994-1#3)(1994-11#11)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#6)(1994-6#3)(1994-8#5)(1995-11#7)(1995-12#10)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#4)(1997-6#17)(1997-7#1)(1997-8#4)(1997-9#1)(2006-10#1)(2006-11#4)(2006-6#2)(2007-10#2)(2007-11#165)(2007-12#242)(2007-2#1)(2007-5#2)(2007-7#7)(2007-8#6)(2008-1#20)(2008-10#319)(2008-11#51)(2008-12#17)(2008-2#315)(2008-3#642)(2008-4#38)(2008-5#57)(2008-6#8)(2008-7#45)(2008-8#39)(2008-9#60)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#8)(2009-5#9)(2009-6#6)(2009-7#3)(2009-8#14)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#11)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#17)(2010-9#2)(2011-1#26)(2011-2#38)(2011-7#4)(2012-1#8)(2012-12#7)(2012-2#33)(2012-3#21)(2012-9#1)(2013-1#23)(2013-7#5)(2013-8#21)
light's pulse width##2##3##(2007-12#2)
light)##10##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-1#5)
light- and##2##2##(1997-2#1)(2008-11#1)
light-##3##1##(1997-2#1)(2008-10#1)(2008-11#1)
light-absorbing##3##1##(2008-10#2)(2008-3#1)
light-absorption##2##1##(2008-10#1)(2008-2#1)
light-activated disinfection (LAD) in the treatment of peri-implantitis##2##8##(2013-1#2)
light-activation##2##1##(2008-12#2)
light-beam##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
light-chain##6##1##(1991-5#2)(1993-8#1)(1994-8#1)(1997-2#1)(2008-9#1)
light-colored##3##1##(1995-2#1)(2008-10#2)
light-controlled##3##1##(2008-4#2)(2009-7#1)
light-cured##5##1##(2008-12#1)(2013-1#4)
light-curing technique##2##2##(2013-1#2)
light-curing units##4##2##(2008-12#4)
light-curing##10##1##(2008-12#5)(2009-2#1)(2013-1#4)
light-dark adaptation##2##2##(1991-12#1)(1993-11#1)
light-dark cycle##2##2##(2008-5#2)
light-dark cycles##3##2##(1990-5#1)(1995-12#1)(2008-5#1)
light-dark regimes##2##2##(2008-11#2)
light-dark##12##1##(1990-5#1)(1991-12#1)(1991-9#1)(1993-11#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-5#3)
light-dependent##5##1##(1991-12#1)(1991-2#1)(1995-6#1)(2008-11#1)(2009-8#1)
light-driven molecular##2##2##(2008-7#2)
light-driven##3##1##(2008-7#2)(2009-5#1)
light-emitting diode (LED)##2##3##(2008-10#2)
light-emitting diode##10##2##(2007-11#3)(2008-10#5)(2008-7#1)(2013-1#1)
light-emitting diodes##8##2##(1995-3#1)(2007-11#1)(2007-12#3)(2008-3#3)
light-emitting##21##1##(1995-3#1)(2007-11#4)(2007-12#4)(2008-10#6)(2008-3#3)(2008-7#2)(2013-1#1)
light-emitting-diode##2##1##(2008-10#1)(2008-3#1)
light-evoked##2##1##(1997-7#1)(2008-5#1)
light-exposed##2##1##(2009-9#2)
light-grown cocultures##2##2##(2008-10#2)
light-harvesting chlorophyll a/b-binding##2##3##(1995-2#1)(2008-7#1)
light-harvesting chlorophyll##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
light-harvesting##12##1##(1995-2#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-2#4)(2012-6#1)
light-induced reflectivity##4##2##(2007-11#4)
light-induced scattering##2##2##(2007-12#1)(2008-3#1)
light-induced##25##1##(1992-8#1)(1994-2#3)(1995-2#1)(1997-6#1)(2007-11#6)(2007-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2010-1#1)
light-intensity##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
light-scattering and##2##2##(2007-11#1)(2008-2#1)
light-scattering data##9##2##(2007-11#1)(2008-3#8)
light-scattering experiments##3##2##(2008-2#2)(2008-3#1)
light-scattering instrument that##2##3##(2007-11#1)(2008-3#1)
light-scattering instrument##3##2##(2007-11#2)(2008-3#1)
light-scattering measurement##2##2##(2008-10#1)(2008-3#1)
light-scattering measurements of##2##3##(2007-11#1)(2008-3#1)
light-scattering measurements with##2##3##(2008-3#2)
light-scattering measurements##9##2##(2007-11#1)(2008-3#8)
light-scattering medium##2##2##(2008-3#2)
light-scattering spectroscopy##2##2##(2007-11#1)(2008-3#1)
light-scattering technique with##2##3##(2008-10#2)
light-scattering technique##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
light-scattering techniques##2##2##(2008-3#2)
light-scattering##80##1##(1993-2#1)(1995-3#2)(2007-11#10)(2007-12#2)(2008-10#11)(2008-2#6)(2008-3#47)(2008-5#1)
light-source##3##1##(2008-3#3)
light-stripe##3##1##(2008-2#2)(2008-3#1)
light-wave propagation##2##2##(2008-2#1)(2008-3#1)
light-wave##3##1##(2008-2#1)(2008-3#2)
light/dark##5##1##(1995-11#1)(1995-6#1)(2008-6#1)(2008-8#2)
lighten the##3##2##(2008-3#1)(2013-1#2)
lightening##6##1##(2008-5#6)
lighter shade##2##2##(1991-5#1)(2008-12#1)
lighter##9##1##(1990-5#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2010-6#2)(2012-12#1)
lighting and##2##2##(2008-10#1)(2008-7#1)
lighting conditions##2##2##(1991-2#2)
lighting the##2##2##(2010-8#1)(2011-2#1)
lighting to##2##2##(1996-3#1)(2010-8#1)
lighting##18##1##(1991-2#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#3)(2011-2#2)
lightly anesthetized rats##2##3##(2008-4#2)
lightly anesthetized##3##2##(1991-12#1)(2008-4#2)
lightly fixed##2##2##(2008-7#1)(2008-9#1)
lightly infested##2##2##(1996-12#2)
lightly labelled##2##2##(1992-8#1)(1995-12#1)
lightly##25##1##(1990-7#1)(1991-12#1)(1992-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
lightness##3##1##(2008-5#2)(2009-10#1)
lightning detector##2##2##(2008-3#2)
lightning##4##1##(2008-3#4)
lights are##2##2##(2011-2#1)(2013-8#1)
lights##15##1##(1995-3#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#5)(2013-8#1)
lightweight##11##1##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2011-2#1)(2012-2#1)
lignans##5##1##(2008-10#1)(2008-11#1)(2011-3#2)(2012-2#1)
lignification##2##1##(2008-10#2)
lignin and##3##2##(2008-10#1)(2008-6#1)(2013-8#1)
lignin biosynthesis##4##2##(2008-10#2)(2009-8#2)
lignin content##3##2##(2008-10#1)(2008-6#2)
lignin degradation##2##2##(2008-6#1)(2009-9#1)
lignin depolymerization##3##2##(2008-6#2)(2011-1#1)
lignin genes##2##2##(2008-10#2)
lignin in##3##2##(2008-6#2)(2013-8#1)
lignin peroxidase (LIP)##2##3##(1990-12#1)(2008-6#1)
lignin peroxidase H2##2##3##(1993-3#2)
lignin peroxidase##9##2##(1990-12#2)(1991-11#1)(1993-3#2)(2008-6#4)
lignin peroxidases##2##2##(1993-3#1)(2008-6#1)
lignin was##2##2##(2012-2#1)(2013-1#1)
lignin##60##1##(1990-12#2)(1991-11#1)(1993-3#3)(2008-10#11)(2008-11#3)(2008-6#21)(2009-8#7)(2009-9#1)(2011-1#2)(2012-2#4)(2013-1#2)(2013-8#3)
lignin-degrading##2##1##(1994-11#1)(2008-10#1)
lignin-like compounds##2##2##(2008-10#2)
ligninolytic##5##1##(2008-10#1)(2008-5#2)(2009-9#1)(2011-1#1)
lignocellulose##5##1##(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
lignocellulosic biomass to##2##3##(2008-6#2)
lignocellulosic biomass##9##2##(2008-6#5)(2013-1#4)
lignocellulosic hydrolysate##2##2##(2011-1#2)
lignocellulosic hydrolysates##3##2##(2011-1#2)(2013-1#1)
lignocellulosic##16##1##(2008-6#6)(2011-1#4)(2013-1#5)(2013-8#1)
lignosulfonate##2##1##(2008-6#2)
ligule##2##1##(2008-5#2)
like &quot##3##2##(1992-3#1)(1994-1#1)(2009-4#1)
like DNA##2##2##(1996-12#1)(2008-11#1)
like HIV infection##2##3##(2006-10#1)(2008-5#1)
like a##27##2##(1990-2#1)(1991-11#1)(1992-1#1)(1992-4#1)(1996-5#2)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#2)
like an##9##2##(1991-2#1)(1992-6#1)(1995-4#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)
like bone##2##2##(2009-7#1)(2011-2#1)
like cancer##2##2##(1993-5#1)(2011-3#1)
like cell##2##2##(2008-11#1)(2009-3#1)
like changes##2##2##(2012-3#2)
like diabetes mellitus##2##3##(2008-11#1)(2013-1#1)
like flow##2##2##(1994-1#1)(2008-10#1)
like growth##4##2##(1993-5#1)(1997-7#1)(2008-8#1)(2008-9#1)
like in the##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
like in##9##2##(1993-12#1)(1995-5#1)(2007-12#2)(2008-7#2)(2009-6#1)(2011-2#2)
like it##2##2##(1997-7#1)(2013-7#1)
like its##2##2##(1993-6#1)(2011-1#1)
like linear discriminant analysis##2##4##(2008-10#2)
like manner##2##2##(1995-2#1)(2011-2#1)
like many other##2##3##(1997-2#1)(2008-12#1)
like many##8##2##(1991-6#1)(1994-11#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
like most##2##2##(2008-10#1)(2009-10#1)
like other##11##2##(1991-9#1)(1994-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
like power##2##2##(2008-10#1)(2008-11#1)
like rheumatoid arthritis##2##3##(1990-6#1)(2007-11#1)
like several other##2##3##(1995-6#1)(2008-9#1)
like structures##3##2##(1997-2#1)(2008-11#1)(2009-9#1)
like superoxide dismutase##2##3##(2012-2#1)(2013-1#1)
like that of the##4##4##(1994-2#1)(1996-2#1)(2008-10#1)(2011-2#1)
like that of##9##3##(1992-12#1)(1992-9#1)(1993-1#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)
like that##13##2##(1990-5#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-6#1)(2011-2#1)
like the##49##2##(1990-10#1)(1990-11#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-3#2)(1996-4#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
like this##3##2##(1994-12#1)(2008-6#1)(2008-7#1)
like those of##3##3##(1994-12#1)(1997-6#1)(2007-12#1)
like those##7##2##(1992-12#1)(1994-12#1)(1995-12#1)(1996-4#1)(1997-6#1)(2007-12#1)(2008-6#1)
like time##2##2##(2008-10#2)
like tissue##2##2##(2011-2#2)
like to be a##2##4##(1997-1#1)(2008-8#1)
like to be##3##3##(1992-2#1)(1997-1#1)(2008-8#1)
like to present##3##3##(1996-6#1)(2007-8#1)(2012-12#1)
like to see an##2##4##(1997-4#1)(2008-3#1)
like to see##6##3##(1992-3#3)(1997-4#1)(2008-3#1)(2008-5#1)
like to##24##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#3)(1996-6#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
like you##2##2##(2008-1#1)(2011-1#1)
like##620##1##(1990-10#1)(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#3)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#8)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#5)(1996-6#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#8)(1997-7#5)(2006-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#10)(2008-10#100)(2008-11#37)(2008-12#12)(2008-2#2)(2008-3#15)(2008-4#7)(2008-5#11)(2008-6#11)(2008-7#21)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#5)(2010-2#1)(2010-3#3)(2010-4#8)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#20)(2011-2#32)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#23)(2012-3#4)(2013-1#15)(2013-7#6)(2013-8#11)
liked##5##1##(1990-2#1)(1992-3#1)(2012-2#3)
likelihood and##5##2##(1994-9#1)(2008-10#2)(2008-3#1)(2012-1#1)
likelihood approach##2##2##(1996-3#1)(2011-2#1)
likelihood based confidence##2##3##(1996-3#1)(2009-12#1)
likelihood based##7##2##(1996-3#3)(1997-5#1)(2008-8#1)(2009-12#1)(2010-2#1)
likelihood for##6##2##(1992-1#1)(2007-12#2)(2008-3#2)(2008-8#1)
likelihood functions##2##2##(2011-2#2)
likelihood is##3##2##(1994-11#1)(2008-3#1)(2008-8#1)
likelihood methods##8##2##(1992-6#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
likelihood models##2##2##(1994-9#1)(2008-8#1)
likelihood of a##5##3##(2009-5#1)(2009-6#2)(2011-2#1)(2013-1#1)
likelihood of adverse##2##3##(2009-1#1)(2010-12#1)
likelihood of detecting##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
likelihood of having##6##3##(1992-2#1)(1995-12#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
likelihood of occurrence##2##3##(2008-11#1)(2012-2#1)
likelihood of smoking##2##3##(2010-11#2)
likelihood of success##2##3##(2008-8#2)
likelihood of##103##2##(1991-12#2)(1992-12#4)(1992-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-9#1)(1997-2#1)(1997-3#3)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#4)(2009-1#1)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#3)(2010-8#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
likelihood paradigm##2##2##(2011-2#2)
likelihood ratio =##2##3##(2008-12#2)
likelihood ratio test is##2##4##(2008-11#1)(2008-3#1)
likelihood ratio test##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
likelihood ratio##18##2##(1996-12#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-3#3)(2008-9#1)(2012-2#1)(2013-1#1)
likelihood ratios##2##2##(2008-3#1)(2011-2#1)
likelihood that##10##2##(1994-2#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)
likelihood##221##1##(1991-1#1)(1991-12#2)(1992-1#1)(1992-12#4)(1992-2#3)(1992-6#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#6)(1996-12#1)(1996-3#4)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#2)(2007-12#4)(2007-4#1)(2008-10#20)(2008-11#5)(2008-12#8)(2008-3#10)(2008-4#7)(2008-5#2)(2008-6#6)(2008-7#5)(2008-8#19)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#4)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#13)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#8)(2013-1#9)(2013-8#2)
likelihood-based##4##1##(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
likelihoods##2##1##(1996-3#1)(2008-9#1)
likely a consequence of##2##4##(2008-10#1)(2009-2#1)
likely a##17##2##(1995-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
likely achieved##2##2##(1995-6#1)(2011-1#1)
likely acquired##2##2##(2008-10#1)(2010-10#1)
likely acting##2##2##(1990-5#1)(1995-2#1)
likely among the##2##3##(2008-1#1)(2009-8#1)
likely an##3##2##(1992-6#1)(2008-7#1)(2009-8#1)
likely and##2##2##(2008-7#1)(2012-3#1)
likely as##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
likely associated with##2##3##(1997-2#1)(2008-7#1)
likely be##7##2##(1997-5#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)
likely because of the##2##4##(2007-10#1)(2008-11#1)
likely because##3##2##(2007-10#1)(2008-11#1)(2008-8#1)
likely by##6##2##(1994-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
likely candidates for##3##3##(1992-12#1)(2008-6#1)(2008-7#1)
likely candidates##4##2##(1992-12#1)(2008-6#1)(2008-7#2)
likely cause of her##2##4##(1991-12#1)(2008-7#1)
likely cause of##5##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
likely causes of##2##3##(2008-8#1)(2012-2#1)
likely causes##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
likely change##2##2##(2008-10#1)(2008-11#1)
likely coding##3##2##(1995-12#3)
likely contribute to the##2##4##(2008-10#1)(2012-2#1)
likely contribute to##4##3##(1995-2#1)(2008-1#1)(2008-10#1)(2012-2#1)
likely contributes to##3##3##(2008-3#1)(2009-2#1)(2011-1#1)
likely correlated with the##2##4##(2008-8#1)(2009-8#1)
likely due to a##3##4##(2008-3#2)(2008-5#1)
likely due to the##8##4##(1994-8#1)(1995-12#1)(1995-5#1)(2008-10#3)(2011-1#1)(2013-8#1)
likely due to##29##3##(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(2007-10#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#1)
likely explanation for the##3##4##(1990-5#1)(1991-8#1)(1992-5#1)
likely explanation for##6##3##(1990-5#1)(1991-8#1)(1992-5#1)(2008-10#1)(2012-3#2)
likely explanation##8##2##(1990-5#1)(1991-8#1)(1992-5#1)(1997-1#1)(2008-10#2)(2012-3#2)
likely form##2##2##(2006-10#1)(2009-10#1)
likely genes##3##2##(1995-12#2)(1997-6#1)
likely has a##4##3##(1992-12#1)(1992-3#1)(2012-2#2)
likely have##2##2##(2008-11#1)(2009-9#1)
likely in##6##2##(1997-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
likely include##3##2##(1992-12#1)(2008-3#1)(2012-3#1)
likely influence##2##2##(1997-7#1)(2013-1#1)
likely involved in##4##3##(1992-8#1)(1993-5#1)(2009-10#1)(2009-8#1)
likely involved##7##2##(1992-8#1)(1993-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2009-10#1)(2009-8#1)
likely involves##2##2##(1994-11#1)(2008-10#1)
likely is##2##2##(1993-12#1)(2008-10#1)
likely lead to##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
likely linked to##2##3##(1992-6#1)(2008-4#1)
likely mechanism##2##2##(2008-10#2)
likely mediated by##2##3##(1992-3#1)(2008-5#1)
likely more##2##2##(2008-10#1)(2011-2#1)
likely not##5##2##(2008-10#3)(2008-9#1)(2013-8#1)
likely originated##2##2##(2008-10#2)
likely outcome##2##2##(1995-6#1)(2008-11#1)
likely part of the##2##4##(2008-10#1)(2013-8#1)
likely play a role in##2##5##(2008-10#1)(2011-10#1)
likely play##3##2##(2008-10#1)(2008-8#1)(2011-10#1)
likely plays a##3##3##(1994-5#1)(2012-2#1)(2013-1#1)
likely possess##2##2##(2008-10#2)
likely reflect a##2##3##(1992-12#1)(1996-7#1)
likely reflect##3##2##(1992-12#1)(1996-7#1)(2010-6#1)
likely reflected##2##2##(1995-6#1)(2012-3#1)
likely reflects##2##2##(1994-5#1)(2009-6#1)
likely reform##2##2##(1993-12#1)(1993-5#1)
likely related to##5##3##(1997-2#1)(2008-7#2)(2009-2#1)(2011-2#1)
likely represent##2##2##(1995-3#1)(2012-2#1)
likely represented##2##2##(2006-10#1)(2012-12#1)
likely represents##4##2##(1992-11#1)(1996-5#1)(2006-10#1)(2008-5#1)
likely require##2##2##(2010-3#1)(2012-1#1)
likely responsible for the##3##4##(1993-3#1)(2009-8#1)(2011-2#1)
likely result in##4##3##(1996-2#1)(1997-1#1)(2009-3#1)(2012-2#1)
likely result##6##2##(1996-2#1)(1997-1#1)(1997-2#1)(2009-3#1)(2012-2#2)
likely site##2##2##(1993-3#1)(2008-10#1)
likely than their##2##3##(1995-6#1)(2012-3#1)
likely than##22##2##(1990-3#1)(1991-8#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-10#1)(2008-12#5)(2008-4#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
likely that at least##2##4##(2008-10#1)(2008-11#1)
likely that effective##2##3##(1993-11#1)(2008-8#1)
likely that many##3##3##(1995-6#1)(1997-1#1)(2007-12#1)
likely that the##21##3##(1990-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#1)(2013-1#1)
likely that this##12##3##(1990-11#1)(1990-3#1)(1992-12#1)(1992-5#1)(1993-11#1)(1995-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
likely that##84##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-2#2)(1992-12#3)(1992-5#1)(1992-6#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#3)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
likely the result of##4##4##(1993-3#1)(1995-12#1)(2008-10#2)
likely the##16##2##(1992-3#1)(1993-3#1)(1993-8#1)(1995-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)
likely through##4##2##(1992-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
likely time##3##2##(1996-11#1)(2011-2#1)(2013-7#1)
likely to account for the##2##5##(1992-12#1)(1995-12#1)
likely to achieve##6##3##(1992-2#1)(1992-6#1)(2007-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
likely to affect##4##3##(1997-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
likely to be a##6##4##(1994-8#1)(1995-5#1)(1997-6#1)(2008-12#1)(2008-8#1)(2010-10#1)
likely to be affected by##3##5##(2009-8#1)(2010-10#1)(2013-8#1)
likely to be an underestimate##2##5##(2008-10#1)(2011-2#1)
likely to be an##4##4##(1990-2#1)(1995-6#1)(2008-10#1)(2011-2#1)
likely to be associated with##6##5##(1992-12#1)(2008-2#2)(2008-7#1)(2013-1#1)(2013-7#1)
likely to be based on##2##5##(1994-12#1)(2008-10#1)
likely to be classified##2##4##(2008-4#1)(2013-1#1)
likely to be due to##7##5##(1991-11#1)(1994-9#1)(2008-11#2)(2008-3#1)(2009-7#1)(2011-2#1)
likely to be encountered in##2##5##(2008-3#1)(2011-1#1)
likely to be encountered##3##4##(2008-3#1)(2011-1#1)(2012-2#1)
likely to be found##2##4##(2007-12#1)(2009-9#1)
likely to be important for##2##5##(1996-2#1)(2008-4#1)
likely to be important in##4##5##(1996-2#1)(2009-6#1)(2010-3#1)(2011-3#1)
likely to be important##7##4##(1992-6#1)(1996-2#2)(2008-4#1)(2009-6#1)(2010-3#1)(2011-3#1)
likely to be in##2##4##(1995-3#1)(2008-4#1)
likely to be involved in##6##5##(1990-6#1)(1991-7#1)(2008-4#1)(2008-7#1)(2010-10#2)
likely to be involved##8##4##(1990-6#1)(1991-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#2)
likely to be married##3##4##(1995-2#1)(2010-11#1)(2011-2#1)
likely to be mediated##2##4##(1992-3#1)(2012-12#1)
likely to be missed##2##4##(2007-2#1)(2012-2#1)
likely to be more vulnerable to##2##6##(2007-12#1)(2008-10#1)
likely to be more##5##4##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
likely to be present in##2##5##(1991-6#2)
likely to be related to##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
likely to be sexually##2##4##(2009-7#1)(2013-1#1)
likely to be successful in##2##5##(2008-8#1)(2010-3#1)
likely to be the##5##4##(1993-2#1)(1994-3#1)(1996-12#1)(2007-7#1)(2011-2#1)
likely to be useful in##2##5##(1995-8#1)(2008-8#1)
likely to be useful##6##4##(1993-12#1)(1995-8#1)(2008-8#1)(2012-2#2)(2013-1#1)
likely to be vaccinated than those who were not##2##9##(2007-2#2)
likely to be vaccinated than##3##5##(2007-2#2)(2009-5#1)
likely to be##201##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#17)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#13)(2008-9#6)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#7)(2013-1#9)(2013-7#1)(2013-8#2)
likely to become##8##3##(1991-3#1)(1993-11#1)(1993-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-7#1)
likely to benefit from this##3##5##(2008-12#1)(2011-2#1)(2013-8#1)
likely to benefit from##8##4##(1997-6#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-3#1)(2011-2#2)(2013-8#1)
likely to benefit##10##3##(1997-3#1)(1997-6#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#2)(2013-8#1)
likely to bring##2##3##(2008-10#1)(2011-2#1)
likely to cause##5##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
likely to change##5##3##(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)
likely to contain##3##3##(2008-12#1)(2008-4#1)(2008-7#1)
likely to continue##8##3##(1993-2#2)(1996-1#1)(2007-7#1)(2008-11#1)(2009-5#1)(2010-5#1)(2012-12#1)
likely to contribute to##2##4##(1997-2#1)(2008-10#1)
likely to correctly##2##3##(2007-10#1)(2013-1#1)
likely to develop an##2##4##(1997-1#1)(2013-8#1)
likely to develop##9##3##(1997-1#1)(1997-8#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-8#2)
likely to die in##3##4##(1994-7#1)(2011-2#2)
likely to die##9##3##(1994-7#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)
likely to encounter##2##3##(1991-12#1)(2008-9#1)
likely to engage in##5##4##(2008-1#1)(2009-7#2)(2011-2#1)(2013-1#1)
likely to evolve##4##3##(2008-8#1)(2010-10#2)(2010-3#1)
likely to experience the##2##4##(1996-9#1)(2012-3#1)
likely to experience##10##3##(1994-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
likely to fall##2##3##(1990-2#1)(2008-8#1)
likely to find##2##3##(2008-1#1)(2008-8#1)
likely to give##2##3##(1995-5#1)(2007-10#1)
likely to have a family history of##2##7##(1995-11#1)(2008-3#1)
likely to have a##12##4##(1995-11#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#1)
likely to have an impact on##2##6##(1994-2#1)(2007-7#1)
likely to have an##5##4##(1991-12#1)(1994-2#1)(1995-5#1)(2007-7#1)(2013-1#1)
likely to have been##2##4##(1992-2#1)(2008-10#1)
likely to have had##2##4##(2008-11#1)(2012-3#1)
likely to have the##3##4##(1994-2#1)(1996-2#1)(2009-4#1)
likely to have visited##2##4##(2007-2#2)
likely to have##58##3##(1991-12#3)(1992-2#3)(1993-11#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#2)(2010-11#1)(2010-9#1)(2011-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
likely to increase##4##3##(1990-7#1)(1992-12#1)(2009-5#1)(2012-2#1)
likely to influence the##3##4##(1996-12#1)(1997-1#1)(2008-10#1)
likely to influence##6##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
likely to intervene if they##2##5##(2008-12#2)
likely to lead to##2##4##(1996-11#1)(2013-1#1)
likely to occur in##5##4##(1990-6#1)(2008-10#1)(2008-8#3)
likely to occur##14##3##(1990-6#1)(1996-11#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#4)
likely to perform the##2##4##(2008-5#1)(2010-4#1)
likely to play a##6##4##(1992-12#1)(1992-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
likely to play##7##3##(1992-12#1)(1992-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
likely to produce##6##3##(1993-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
likely to provide the home modalities##2##6##(1995-12#2)
likely to provide##11##3##(1990-3#1)(1995-12#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)
likely to reach the##3##4##(1997-1#1)(2008-11#1)(2011-2#1)
likely to receive Pap smear screening##2##6##(2011-2#2)
likely to receive a##2##4##(1995-12#1)(2012-3#1)
likely to receive##14##3##(1995-12#1)(2007-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#5)(2012-3#2)(2013-1#2)
likely to regulate##2##3##(1990-11#1)(2007-12#1)
likely to remain##2##3##(2008-9#1)(2013-1#1)
likely to report##12##3##(1995-12#1)(1997-2#1)(2008-12#1)(2009-5#3)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
likely to represent##4##3##(2008-4#1)(2008-7#1)(2009-8#1)(2010-3#1)
likely to respond to##2##4##(1996-11#1)(2008-12#1)
likely to respond##3##3##(1996-11#1)(2008-12#1)(2012-3#1)
likely to result in##3##4##(1997-4#1)(2008-10#1)(2009-2#1)
likely to result##6##3##(1994-3#1)(1996-6#1)(1997-4#1)(2008-10#1)(2009-2#1)(2010-10#1)
likely to see##2##3##(2008-1#1)(2011-2#1)
likely to seek medical attention##2##5##(2012-12#2)
likely to shape the##2##4##(1991-1#1)(2009-8#1)
likely to succeed##3##3##(1997-2#1)(2008-8#2)
likely to take place##2##4##(1993-2#1)(2008-10#1)
likely to take##3##3##(1993-2#1)(1996-1#1)(2008-10#1)
likely to trigger##2##3##(2012-12#2)
likely to work##2##3##(1995-3#1)(1997-6#1)
likely to##606##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#5)(1992-2#5)(1992-3#3)(1992-5#1)(1992-6#4)(1993-1#1)(1993-11#2)(1993-12#9)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#4)(1994-2#3)(1994-3#5)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#9)(1995-2#7)(1995-3#3)(1995-5#6)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#6)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#7)(2007-11#4)(2007-12#8)(2007-2#8)(2007-4#2)(2007-7#4)(2008-1#14)(2008-10#35)(2008-11#21)(2008-12#19)(2008-2#8)(2008-3#7)(2008-4#13)(2008-5#6)(2008-6#4)(2008-7#19)(2008-8#42)(2008-9#21)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#14)(2009-6#3)(2009-7#10)(2009-8#4)(2009-9#2)(2010-10#8)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#5)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#40)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#11)(2012-3#5)(2013-1#28)(2013-7#1)(2013-8#11)
likely was##3##2##(2008-10#2)(2008-7#1)
likely will##2##2##(2008-10#2)
likely with##2##2##(2008-9#2)
likely##1167##1##(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#5)(1991-12#12)(1991-2#5)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#13)(1992-2#7)(1992-3#6)(1992-5#3)(1992-6#8)(1992-8#4)(1993-1#2)(1993-11#4)(1993-12#11)(1993-2#6)(1993-3#5)(1993-5#3)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#8)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#24)(1995-2#13)(1995-3#5)(1995-5#11)(1995-6#12)(1995-8#3)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#5)(1996-12#6)(1996-2#10)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#12)(1997-2#10)(1997-3#9)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#3)(2006-10#5)(2007-10#12)(2007-11#6)(2007-12#15)(2007-2#8)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#22)(2008-10#120)(2008-11#37)(2008-12#28)(2008-2#10)(2008-3#18)(2008-4#22)(2008-5#21)(2008-6#6)(2008-7#45)(2008-8#67)(2008-9#35)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#7)(2009-3#5)(2009-4#5)(2009-5#16)(2009-6#6)(2009-7#10)(2009-8#15)(2009-9#4)(2010-1#1)(2010-10#11)(2010-11#5)(2010-12#8)(2010-2#1)(2010-3#11)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#57)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#33)(2012-3#18)(2012-6#1)(2012-7#1)(2013-1#43)(2013-7#3)(2013-8#16)
likened##2##1##(1994-9#1)(1996-3#1)
likeness##3##1##(2008-11#2)(2012-3#1)
likewise##13##1##(1990-3#1)(1992-11#1)(1995-2#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
liking##2##1##(1992-3#1)(2013-1#1)
lilii##3##1##(2008-10#3)
lily##6##1##(2008-10#6)
lima bean##3##2##(2008-10#3)
lima##8##1##(2008-10#4)(2008-5#1)(2008-7#3)
limb allometry##3##2##(2011-2#3)
limb and##9##2##(1995-8#1)(2007-11#2)(2008-1#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#1)
limb anomalies##2##2##(2008-10#2)
limb bud and##2##3##(1995-8#1)(2010-3#1)
limb bud##10##2##(1991-11#1)(1992-8#1)(1993-12#4)(1995-8#3)(2010-3#1)
limb buds##2##2##(1992-8#1)(1993-12#1)
limb by##4##2##(1996-5#1)(2007-11#1)(2009-3#1)(2012-1#1)
limb cartilages##2##2##(2008-11#2)
limb cellulitis##4##2##(1991-8#4)
limb circulation##2##2##(2008-1#2)
limb deformity##4##2##(2009-3#4)
limb development##6##2##(1997-3#1)(2008-11#1)(2009-3#3)(2010-3#1)
limb discrepancy##2##2##(2007-11#2)
limb during##4##2##(2011-2#1)(2013-1#1)(2013-8#2)
limb dysfunction##2##2##(2007-11#2)
limb dystonia##2##2##(2008-7#2)
limb elements##4##2##(2011-2#4)
limb emission##2##2##(2008-2#1)(2008-3#1)
limb fractures##2##2##(2007-11#1)(2008-12#1)
limb function##3##2##(2007-11#3)
limb girdle##2##2##(2008-6#1)(2008-7#1)
limb in##2##2##(1996-5#1)(2010-3#1)
limb inequality treatment##2##3##(2013-1#2)
limb inequality##4##2##(2013-1#4)
limb is##3##2##(2007-8#2)(2008-11#1)
limb ischemia##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
limb length discrepancy##2##3##(2010-5#1)(2012-2#1)
limb length##3##2##(2010-5#2)(2012-2#1)
limb lengthening##3##2##(2012-2#2)(2013-1#1)
limb mesenchymal cells##3##3##(1994-11#3)
limb mesenchyme##5##2##(1995-8#1)(2008-11#4)
limb movement##3##2##(1994-8#1)(2012-3#2)
limb movements##3##2##(1995-5#1)(2008-11#1)(2012-3#1)
limb muscle dysfunction##2##3##(2013-8#2)
limb of##2##2##(1995-6#1)(2007-7#1)
limb perfusion##2##2##(2008-6#1)(2012-3#1)
limb reconstruction##4##2##(1996-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
limb salvage by##2##3##(2008-6#1)(2011-3#1)
limb salvage patients##3##3##(2008-6#1)(2010-3#2)
limb salvage was##2##3##(2010-3#1)(2011-2#1)
limb salvage##14##2##(2008-6#7)(2010-3#4)(2011-2#1)(2011-3#2)
limb sparing surgery##2##3##(1990-12#1)(2011-1#1)
limb sparing##5##2##(1990-12#1)(2008-6#1)(2011-1#3)
limb use##2##2##(1992-11#2)
limb was##7##2##(1994-3#1)(2007-11#1)(2007-8#1)(2009-3#1)(2011-3#1)(2012-3#2)
limb weakness##3##2##(2007-10#1)(2011-2#1)(2012-3#1)
limb##268##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#3)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#4)(1992-11#5)(1992-8#2)(1992-9#1)(1993-12#8)(1994-11#3)(1994-3#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#7)(1996-3#1)(1996-5#3)(1997-3#4)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#21)(2007-12#2)(2007-7#5)(2007-8#12)(2008-1#5)(2008-10#5)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#7)(2008-6#17)(2008-7#13)(2008-8#2)(2008-9#2)(2009-1#2)(2009-3#12)(2010-11#1)(2010-3#11)(2010-5#2)(2010-8#1)(2011-1#6)(2011-2#22)(2011-3#5)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#10)(2013-1#13)(2013-8#9)
limb-length discrepancy##3##2##(2009-3#3)
limb-salvage surgery##5##2##(2008-6#4)(2010-3#1)
limb-salvage##7##1##(2008-6#5)(2010-3#2)
limb-sounding measurements##3##2##(2008-3#3)
limb-sounding##4##1##(2008-3#4)
limb-sparing surgery##3##2##(2008-6#2)(2013-8#1)
limb-sparing##6##1##(2008-6#2)(2010-3#3)(2013-8#1)
limbal##8##1##(2008-11#1)(2008-7#1)(2010-10#4)(2011-1#1)(2012-3#1)
limber##3##1##(1997-5#2)(2008-10#1)
limbic and cortical##3##3##(1991-10#3)
limbic and##5##2##(1991-10#4)(1995-11#1)
limbic regions##2##2##(1991-10#2)
limbic structures##2##2##(1996-5#1)(2013-8#1)
limbic system is##2##3##(1992-12#2)
limbic system##15##2##(1992-12#10)(1997-2#1)(2008-1#1)(2008-6#3)
limbic##43##1##(1990-7#1)(1991-1#1)(1991-10#6)(1991-5#1)(1992-12#10)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-1#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2009-9#1)(2013-8#1)
limbs and##5##2##(1991-11#1)(2008-7#1)(2010-12#1)(2012-2#2)
limbs are##4##2##(1991-3#1)(2007-11#1)(2010-3#1)(2012-12#1)
limbs in##7##2##(1993-12#1)(1996-6#1)(1997-8#2)(2010-12#1)(2012-1#1)(2013-1#1)
limbs of the##2##3##(1994-8#1)(2008-2#1)
limbs of##7##2##(1993-12#1)(1994-8#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-2#1)(2010-6#1)
limbs were##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
limbs with##2##2##(2010-8#1)(2012-2#1)
limbs##78##1##(1990-3#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#2)(1991-8#1)(1993-12#2)(1993-5#1)(1994-8#1)(1996-6#1)(1997-3#2)(1997-8#4)(2006-10#4)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
limbs)##2##1##(1997-8#2)
limbus##4##1##(2008-11#2)(2010-10#1)(2011-1#1)
lime leaf##2##2##(2008-10#1)(2011-2#1)
lime##11##1##(2008-10#10)(2011-2#1)
limetta fruit peel##2##3##(2012-3#2)
limetta##3##1##(2012-3#3)
limit (0##7##2##(2008-10#7)
limit (3s) of##4##3##(2008-10#4)
limit (3s)##5##2##(2008-10#5)
limit (3sigma) was 0##4##4##(2008-10#4)
limit (3sigma) was##5##3##(2008-10#5)
limit (3sigma)##27##2##(2008-10#27)
limit (3sigma/S) of 0##2##4##(2008-10#2)
limit 0##11##2##(1992-11#1)(2008-10#10)
limit 2##3##2##(1993-8#1)(2008-10#2)
limit = 0##2##3##(2008-10#2)
limit accepted##2##2##(2008-10#1)(2008-12#1)
limit and##31##2##(2007-11#1)(2008-1#1)(2008-10#25)(2008-3#2)(2008-7#1)(2012-3#1)
limit are obtained##2##3##(1996-7#1)(2007-11#1)
limit are##5##2##(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)
limit as##2##2##(2008-10#1)(2012-2#1)
limit at##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
limit between##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
limit by##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
limit can be##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
limit cycles##2##2##(1993-5#1)(1995-5#1)
limit for the##9##3##(2008-10#8)(2008-3#1)
limit for##57##2##(1990-8#2)(1991-8#1)(2008-10#46)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#1)(2012-3#1)
limit imposed##2##2##(2007-11#1)(2008-3#1)
limit in the##6##3##(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2012-12#1)
limit in##14##2##(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#3)(2008-7#1)(2009-5#1)(2012-12#1)
limit is 0##27##3##(2008-10#27)
limit is 2##7##3##(2008-10#7)
limit is down to##3##4##(2008-10#2)(2013-1#1)
limit is found to##4##4##(2007-12#2)(2008-10#2)
limit is##87##2##(1996-5#1)(2007-12#3)(2008-10#79)(2008-2#1)(2008-3#2)(2013-1#1)
limit its##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2008-7#1)
limit levels##2##2##(2008-10#2)
limit of 0##112##3##(1992-11#1)(1997-4#1)(2007-12#1)(2008-10#103)(2008-11#3)(2008-2#1)(2010-4#1)(2013-1#1)
limit of 1##57##3##(1991-5#1)(1996-5#1)(2008-10#50)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2013-1#1)
limit of 2##22##3##(2007-12#1)(2008-10#21)
limit of 3##14##3##(2007-12#1)(2008-10#13)
limit of 4##16##3##(1991-5#1)(2008-10#15)
limit of 5##11##3##(2008-10#10)(2008-7#1)
limit of 96##2##3##(2008-10#2)
limit of approximately##2##3##(2008-1#1)(2008-10#1)
limit of ascorbic acid was##2##5##(2008-10#2)
limit of detection (3sigma) of##3##5##(2008-10#3)
limit of detection (3sigma) was 0##2##6##(2008-10#2)
limit of detection (3sigma) was##3##5##(2008-10#3)
limit of detection (3sigma)##9##4##(2008-10#9)
limit of detection (LOD) and##3##5##(2008-10#3)
limit of detection (LOD) for##5##5##(2008-10#5)
limit of detection (LOD) of 0##2##6##(2008-10#2)
limit of detection (LOD) of##9##5##(2008-10#9)
limit of detection (LOD) was##3##5##(2008-10#3)
limit of detection (LOD)##35##4##(2008-10#34)(2012-1#1)
limit of detection (S/N =##2##5##(2008-10#1)(2011-1#1)
limit of detection (S/N=3) was 0##3##6##(2008-10#3)
limit of detection 0##3##4##(2008-10#3)
limit of detection achieved##3##4##(2008-10#3)
limit of detection and limit of quantification##3##7##(2008-10#2)(2012-2#1)
limit of detection and limit of##4##6##(2008-10#2)(2010-3#1)(2012-2#1)
limit of detection and relative standard deviations were found to be##3##11##(2008-10#3)
limit of detection and##15##4##(1997-2#1)(2008-10#11)(2010-3#2)(2012-2#1)
limit of detection for the##3##5##(2008-10#3)
limit of detection for##22##4##(1990-8#1)(1995-2#1)(2008-10#19)(2008-2#1)
limit of detection in##3##4##(1993-8#1)(2008-10#1)(2012-8#1)
limit of detection is 0##7##5##(2008-10#7)
limit of detection is 1##3##5##(2008-10#2)(2013-1#1)
limit of detection is 2##4##5##(2008-10#4)
limit of detection is 4##2##5##(2008-10#1)(2011-1#1)
limit of detection is##19##4##(2008-10#17)(2011-1#1)(2013-1#1)
limit of detection of 0##8##5##(2008-10#8)
limit of detection of 1##4##5##(2008-10#4)
limit of detection of 3##2##5##(2008-10#2)
limit of detection of the method was##4##7##(2008-10#4)
limit of detection of the method##5##6##(2008-10#5)
limit of detection of the proposed##6##6##(2008-10#6)
limit of detection of the##15##5##(2008-10#15)
limit of detection of##55##4##(2008-1#1)(2008-10#50)(2009-6#1)(2011-1#1)(2011-2#2)
limit of detection was 0##11##5##(2008-10#11)
limit of detection was 3##2##5##(2008-10#2)
limit of detection was as low as##2##7##(2008-10#2)
limit of detection was found to be##3##7##(2008-10#3)
limit of detection was##40##4##(1991-5#1)(1997-2#1)(2008-10#36)(2010-5#2)
limit of detection##275##3##(1990-8#1)(1991-5#1)(1993-8#1)(1995-2#1)(1997-2#2)(2008-1#1)(2008-10#247)(2008-2#1)(2009-6#1)(2009-8#2)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#1)
limit of determination##5##3##(2008-10#5)
limit of normal##3##3##(2008-1#1)(2008-3#1)(2012-3#1)
limit of quantification (LOQ)##5##4##(2008-10#5)
limit of quantification for##2##4##(2008-10#1)(2012-2#1)
limit of quantification of##3##4##(2008-10#2)(2008-5#1)
limit of quantification was 0##2##5##(2008-10#1)(2011-2#1)
limit of quantification was##4##4##(2008-10#1)(2008-5#1)(2011-2#2)
limit of quantification were##2##4##(2008-10#2)
limit of quantification##30##3##(2008-10#23)(2008-5#3)(2011-2#2)(2012-12#1)(2012-2#1)
limit of quantitation (LOQ)##6##4##(1992-8#1)(2008-10#5)
limit of quantitation for##2##4##(2008-10#1)(2010-3#1)
limit of quantitation of##4##4##(1996-5#1)(2008-10#2)(2012-12#1)
limit of quantitation was 0##3##5##(1996-5#1)(2008-10#2)
limit of quantitation was##4##4##(1996-5#1)(2008-10#3)
limit of quantitation##18##3##(1992-8#1)(1996-5#2)(2008-10#12)(2010-3#2)(2012-12#1)
limit of resolution##6##3##(1992-5#1)(2008-3#4)(2008-4#1)
limit of the proposed technique##2##5##(2008-10#2)
limit of the proposed##6##4##(2008-10#6)
limit of the##46##3##(1993-2#1)(1995-6#1)(1997-2#1)(2007-11#2)(2008-10#26)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#2)
limit of this##11##3##(1990-2#1)(1991-2#1)(1995-11#1)(2008-10#6)(2008-11#1)(2010-7#1)
limit of##811##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#4)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#3)(1997-2#3)(1997-4#1)(2007-11#6)(2007-12#12)(2008-1#4)(2008-10#674)(2008-11#7)(2008-12#1)(2008-2#13)(2008-3#14)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#4)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#4)
limit on the##3##3##(1993-12#1)(2007-11#1)(2008-2#1)
limit on##7##2##(1993-12#2)(2007-11#1)(2007-12#2)(2008-2#1)(2012-2#1)
limit or##3##2##(1993-2#1)(1995-1#1)(2008-1#1)
limit that##4##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
limit the applicable##2##3##(2008-2#1)(2008-3#1)
limit the application of##2##4##(2008-3#1)(2008-7#1)
limit the damage##2##3##(2008-10#1)(2009-8#1)
limit the effectiveness of##2##4##(2008-10#1)(2008-9#1)
limit the potential##2##3##(1994-2#1)(1997-5#1)
limit the spread of##3##4##(1990-6#2)(2011-2#1)
limit the use of##2##4##(2007-10#1)(2008-10#1)
limit the##81##2##(1990-6#3)(1990-9#1)(1991-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#11)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
limit their use##2##3##(2009-12#1)(2011-2#1)
limit their##9##2##(1991-12#1)(1996-11#1)(1996-5#1)(2007-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
limit this##2##2##(1996-8#1)(2008-2#1)
limit to##11##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)(2010-7#1)(2010-8#1)
limit using##3##2##(2008-10#3)
limit value##2##2##(2008-10#1)(2008-11#1)
limit values##4##2##(1991-12#1)(1991-4#1)(2008-11#1)(2011-2#1)
limit was 0##33##3##(1992-11#1)(1994-9#1)(2008-10#31)
limit was 2##10##3##(2008-10#10)
limit was 3##5##3##(2008-10#5)
limit was 4##4##3##(1990-12#1)(2008-10#3)
limit was 5##4##3##(2008-10#4)
limit was achieved##2##3##(1991-5#1)(2007-12#1)
limit was lower than##3##4##(2008-10#3)
limit was lower##4##3##(2008-10#4)
limit was##131##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-11#1)(1994-9#1)(2007-11#1)(2007-12#2)(2008-10#121)(2008-3#1)(2013-8#1)
limit were##7##2##(2008-10#7)
limit with##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
limit##1675##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#8)(1991-8#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#6)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#31)(2007-12#37)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#1239)(2008-11#15)(2008-12#6)(2008-2#35)(2008-3#59)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#16)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-11#1)(2010-3#4)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#18)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#11)(2012-3#5)(2012-8#1)(2013-1#8)(2013-7#2)(2013-8#7)
limit) and##3##2##(2008-10#2)(2008-2#1)
limit)##5##1##(2008-10#3)(2008-2#2)
limitation and##11##2##(1992-2#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
limitation as##2##2##(2007-7#1)(2008-2#1)
limitation by##4##2##(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)
limitation due to##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
limitation for##7##2##(1993-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-7#2)(2012-2#1)
limitation imposed by##2##3##(2007-11#1)(2007-12#1)
limitation in the##3##3##(2007-12#1)(2008-7#1)(2010-4#1)
limitation in##8##2##(1994-8#1)(1997-1#1)(2007-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2012-2#1)
limitation is that##2##3##(2007-7#1)(2013-1#1)
limitation is the##2##3##(2008-3#1)(2012-2#1)
limitation is##9##2##(1993-12#1)(2007-7#1)(2008-3#3)(2009-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
limitation may be##2##3##(2008-3#1)(2008-8#1)
limitation of the##11##3##(1991-3#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2010-10#1)(2010-5#1)
limitation of this##2##3##(2009-10#1)(2010-6#1)
limitation of using##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
limitation of##37##2##(1991-3#1)(1991-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#1)(2013-8#1)
limitation on##4##2##(2008-3#1)(2008-9#2)(2012-2#1)
limitation to##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-8#1)
limitation##141##1##(1991-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-12#3)(1994-2#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#10)(2008-6#2)(2008-7#8)(2008-8#11)(2008-9#6)(2009-1#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#5)
limitations and future##3##3##(1990-3#1)(2008-11#1)(2008-7#1)
limitations and implications##3##3##(2007-12#1)(2008-10#1)(2009-11#1)
limitations and##34##2##(1990-3#1)(1992-12#1)(1993-11#1)(1995-2#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#5)(2012-12#1)(2012-8#1)(2013-1#2)
limitations are discussed##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
limitations are##9##2##(1996-11#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
limitations associated with the##3##4##(1996-12#1)(2008-3#1)(2013-8#1)
limitations associated with##7##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2013-8#1)
limitations due to##6##3##(2007-11#4)(2008-11#1)(2012-12#1)
limitations for##6##2##(1995-2#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-2#1)
limitations imposed by the##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
limitations imposed by##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)
limitations imposed##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
limitations in activities##3##3##(1993-3#1)(2008-12#2)
limitations in the##12##3##(1993-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-5#1)
limitations in##34##2##(1993-3#2)(1993-6#1)(1994-12#1)(1995-10#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
limitations may##2##2##(2009-8#1)(2012-7#1)
limitations of a##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
limitations of conventional##3##3##(1996-3#1)(2008-11#1)(2008-7#1)
limitations of current##2##3##(2008-7#1)(2011-2#1)
limitations of the studies##2##4##(2008-12#1)(2011-2#1)
limitations of the##35##3##(1992-3#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
limitations of these##6##3##(1994-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
limitations of this approach##2##4##(2008-9#1)(2012-12#1)
limitations of this study##5##4##(1993-1#1)(2008-8#1)(2012-1#1)(2013-1#2)
limitations of this##14##3##(1990-6#1)(1993-1#1)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
limitations of using##2##3##(1996-2#1)(2008-10#1)
limitations of##139##2##(1990-10#1)(1990-12#1)(1990-6#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#4)(2008-1#4)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#5)(2009-1#1)(2010-2#1)(2010-3#2)(2010-8#3)(2011-1#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)
limitations on the##3##3##(1993-3#1)(2008-2#1)(2008-3#1)
limitations on##15##2##(1993-3#1)(1996-5#1)(2007-12#1)(2008-2#2)(2008-3#6)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)
limitations that##7##2##(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
limitations to the study##2##4##(2007-12#1)(2008-11#1)
limitations to the##3##3##(2007-12#1)(2008-11#2)
limitations to this##2##3##(1994-12#1)(2008-3#1)
limitations to##13##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
limitations with##5##2##(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
limitations##411##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#2)(1991-1#2)(1991-11#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#3)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#14)(2007-12#9)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#7)(2008-1#9)(2008-10#42)(2008-11#22)(2008-12#8)(2008-2#10)(2008-3#31)(2008-4#15)(2008-5#5)(2008-6#4)(2008-7#21)(2008-8#8)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#10)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#4)(2011-1#2)(2011-2#21)(2011-3#1)(2011-7#3)(2012-1#1)(2012-12#9)(2012-2#17)(2012-3#10)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#14)(2013-7#1)(2013-8#3)
limite##2##1##(2008-5#1)(2013-1#1)
limited English##4##2##(2008-12#2)(2010-8#2)
limited ability to##3##3##(1992-10#1)(2011-2#1)(2012-3#1)
limited ability##4##2##(1992-10#1)(1995-12#1)(2011-2#1)(2012-3#1)
limited access to##7##3##(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-6#1)(2013-1#1)
limited access##8##2##(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-6#1)(2013-1#1)
limited accuracy##2##2##(1996-4#1)(2008-4#1)
limited amount of##13##3##(1993-12#1)(1995-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
limited amounts of##6##3##(1993-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)
limited and the##6##3##(1992-9#1)(1996-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
limited and##28##2##(1992-8#1)(1992-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#2)
limited anterior##2##2##(2008-8#2)
limited application##2##2##(2012-12#1)(2012-2#1)
limited as##3##2##(1996-3#1)(2011-2#1)(2013-1#1)
limited availability of##3##3##(2010-11#1)(2011-2#1)(2013-8#1)
limited availability##4##2##(1994-12#1)(2010-11#1)(2011-2#1)(2013-8#1)
limited because of its##2##4##(2008-2#1)(2010-6#1)
limited because of##4##3##(2008-2#1)(2008-9#1)(2009-5#1)(2010-6#1)
limited because##5##2##(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)
limited but##4##2##(2007-8#1)(2008-6#1)(2009-5#1)(2010-8#1)
limited by a lack of##3##5##(2007-11#1)(2008-12#1)(2009-7#1)
limited by a##9##3##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-7#1)
limited by diffusion##2##3##(1990-12#1)(2008-10#1)
limited by donor##3##3##(2007-8#1)(2008-9#1)(2009-9#1)
limited by its##7##3##(1994-9#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
limited by our##2##3##(2008-11#1)(2008-3#1)
limited by residual##2##3##(2007-12#1)(2008-2#1)
limited by the availability of##3##5##(2008-10#2)(2008-8#1)
limited by the fact that the##2##6##(2007-11#1)(2008-10#1)
limited by the lack of##2##5##(2011-1#1)(2013-8#1)
limited by the low##2##4##(2008-3#1)(2011-2#1)
limited by the number of##3##5##(2008-3#1)(2012-3#1)(2013-8#1)
limited by the small##2##4##(1994-6#1)(2009-5#1)
limited by the##68##3##(1991-3#1)(1992-6#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#6)(2007-12#6)(2007-6#1)(2008-1#1)(2008-10#8)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#3)
limited by time##2##3##(2007-5#1)(2008-8#1)
limited by##145##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-6#2)(1993-1#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-11#10)(2007-12#10)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#4)(2008-2#12)(2008-3#21)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
limited capacity for##2##3##(2008-10#1)(2011-2#1)
limited capacity##4##2##(1993-12#1)(1994-2#1)(2008-10#1)(2011-2#1)
limited clinical##2##2##(2008-7#1)(2013-1#1)
limited confirmation of##2##3##(1992-3#2)
limited control##3##2##(2008-10#2)(2012-12#1)
limited cutaneous SSc##2##3##(2008-8#2)
limited cutaneous##3##2##(2008-8#2)(2009-8#1)
limited data available##2##3##(2008-8#1)(2012-12#1)
limited data sets##5##3##(2008-3#3)(2008-5#2)
limited data##11##2##(1995-6#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
limited diagnostic##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
limited discovery##4##2##(1991-7#4)
limited dispersal##4##2##(2008-9#1)(2013-1#3)
limited distribution is##2##3##(2008-10#1)(2013-8#1)
limited due to the##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)
limited due to##8##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-8#1)(2012-12#1)
limited effect##4##2##(1990-6#1)(1994-12#1)(2008-1#1)(2008-6#1)
limited effectiveness##2##2##(2012-2#2)
limited effects of##2##3##(2008-10#1)(2008-5#1)
limited effects##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
limited efficacy##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
limited evidence##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
limited experience##4##2##(1990-2#1)(1996-2#1)(1997-6#1)(2007-8#1)
limited exposure##2##2##(1996-1#1)(2008-8#1)
limited expression##2##2##(1993-11#1)(1997-7#1)
limited extent##2##2##(1995-3#1)(2008-10#1)
limited field of view##2##4##(2007-11#1)(2009-8#1)
limited field##4##2##(2007-11#1)(2008-10#1)(2009-12#1)(2009-8#1)
limited financial resources##2##3##(2008-1#1)(2013-8#1)
limited financial##4##2##(2008-1#1)(2008-8#1)(2012-12#1)(2013-8#1)
limited for##4##2##(1996-12#1)(2008-10#2)(2009-7#1)
limited form of granulomatosis with polyangiitis with bronchiolitis obliterans organizing pneumonia-like variant##2##12##(2012-12#2)
limited form##3##2##(1995-11#1)(2012-12#2)
limited frequency##2##2##(2007-7#1)(2013-1#1)
limited funds##2##2##(1991-3#1)(1993-1#1)
limited gene flow##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
limited genetic diversity##2##3##(2008-10#2)
limited geographic##5##2##(1993-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
limited geographical##2##2##(2008-10#1)(2010-5#1)
limited health##2##2##(1995-2#1)(2010-9#1)
limited in scope to##2##4##(1994-3#1)(2008-3#1)
limited in scope##4##3##(1994-3#1)(2008-1#1)(2008-3#1)(2008-7#1)
limited in the##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
limited in their##2##3##(2008-9#1)(2011-2#1)
limited in##28##2##(1994-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-7#1)(2013-8#2)
limited indications##2##2##(2007-11#1)(2011-2#1)
limited information on the##2##4##(2011-2#2)
limited information on##5##3##(1992-11#1)(2009-3#1)(2011-2#2)(2012-1#1)
limited information##11##2##(1992-11#1)(1994-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#3)(2012-1#1)(2013-7#1)
limited interest##2##2##(1996-3#1)(2008-5#1)
limited investigation##2##2##(2008-10#1)(2008-7#1)
limited involvement##3##2##(2007-12#1)(2008-12#1)(2008-9#1)
limited knowledge##4##2##(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
limited life span##2##3##(2008-9#1)(2010-3#1)
limited linear##2##2##(2008-10#1)(2008-4#1)
limited memory##2##2##(2008-11#1)(2011-2#1)
limited number of patients##2##4##(2008-12#1)(2008-7#1)
limited number of studies have##2##5##(1995-5#1)(2007-11#1)
limited number of studies##6##4##(1995-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
limited number of##46##3##(1990-12#1)(1991-2#1)(1992-10#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#1)
limited number##47##2##(1990-12#1)(1991-2#1)(1992-10#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
limited on the##2##3##(1997-2#1)(2011-2#1)
limited on##4##2##(1997-2#1)(2008-12#1)(2011-2#1)(2012-2#1)
limited only by the##7##4##(1993-12#1)(2007-11#1)(2007-12#2)(2008-3#3)
limited only by##12##3##(1993-12#1)(1994-2#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-3#3)(2009-5#1)
limited only##13##2##(1993-12#1)(1994-2#1)(1994-9#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-3#3)(2009-5#1)
limited or no##2##3##(2008-11#1)(2008-5#1)
limited or##5##2##(1995-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
limited oxygen availability##2##3##(1995-12#1)(2008-7#1)
limited oxygen##3##2##(1995-12#1)(2008-7#2)
limited period##3##2##(1993-3#1)(2008-6#1)(2008-8#1)
limited pool of##2##3##(1997-7#1)(2011-2#1)
limited potential##2##2##(1997-3#1)(2013-1#1)
limited primarily to##2##3##(2008-3#1)(2009-7#1)
limited primarily##3##2##(2008-3#1)(2008-9#1)(2009-7#1)
limited proteolysis##7##2##(1990-12#1)(1993-8#1)(1995-11#1)(1997-2#2)(2008-9#1)(2012-12#1)
limited published data##2##3##(2008-11#1)(2011-2#1)
limited range of motion##3##4##(2007-12#1)(2008-2#1)(2008-6#1)
limited range of##11##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
limited range##13##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
limited replication of##2##3##(2008-10#1)(2013-1#1)
limited resection##7##2##(1990-2#3)(1992-3#1)(1994-12#2)(2010-12#1)
limited resolution##4##2##(1992-3#1)(2008-2#1)(2008-3#1)(2010-6#1)
limited resource countries##3##3##(2009-6#3)
limited resource##8##2##(2009-6#6)(2010-8#1)(2011-2#1)
limited resources for##2##3##(1991-6#1)(2008-7#1)
limited resources##16##2##(1990-2#1)(1991-6#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2012-12#1)
limited sensitivity##4##2##(2008-7#2)(2010-5#1)(2012-3#1)
limited sequence##3##2##(1990-5#1)(2008-10#2)
limited set of##5##3##(2008-11#2)(2009-11#1)(2009-5#1)(2011-2#1)
limited spatial##2##2##(2008-3#1)(2012-2#1)
limited spread of##2##3##(1996-11#1)(2013-1#1)
limited stability##2##2##(2008-10#1)(2012-8#1)
limited study##2##2##(1997-3#1)(2010-11#1)
limited success##3##2##(1994-2#1)(1995-2#1)(2012-3#1)
limited supply of##3##3##(1994-1#1)(1996-11#1)(2008-10#1)
limited supply##4##2##(1994-1#1)(1996-11#1)(2008-10#1)(2009-12#1)
limited surgery##4##2##(1990-12#1)(1991-4#1)(1992-8#2)
limited surgical management of malignant##2##5##(2007-8#2)
limited surgical management##3##3##(2007-8#3)
limited survey##2##2##(2008-10#1)(2011-1#1)
limited the number of##2##4##(1995-2#1)(2008-7#1)
limited the##12##2##(1995-2#1)(1997-8#1)(2007-5#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
limited their##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
limited time in general##2##4##(2007-2#1)(2010-12#1)
limited time##5##2##(2007-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
limited to a distinct##2##4##(1994-9#1)(2008-7#1)
limited to a few##2##4##(1996-12#1)(2010-8#1)
limited to a small area##2##5##(1991-8#1)(2008-10#1)
limited to a##9##3##(1991-8#1)(1994-9#1)(1996-1#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-8#1)
limited to low##2##3##(1991-9#1)(2011-1#1)
limited to one##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
limited to only##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
limited to patients with nodal involvement##2##6##(2008-10#2)
limited to single##2##3##(1991-6#1)(2013-1#1)
limited to the##27##3##(1990-5#1)(1991-4#2)(1991-5#1)(1991-9#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-10#7)(2008-3#2)(2008-5#2)(2008-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
limited to##128##2##(1990-2#1)(1990-5#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-3#2)(2007-10#4)(2007-12#3)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#6)(2011-7#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
limited understanding of##2##3##(1992-3#1)(2012-2#1)
limited use in##3##3##(1992-2#1)(2008-7#1)(2011-2#1)
limited use of##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
limited use##10##2##(1992-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#2)
limited usefulness##2##2##(1991-3#1)(2008-10#1)
limited users##2##2##(2008-9#2)
limited utility##2##2##(2008-9#1)(2012-3#1)
limited validity##2##2##(2007-10#1)(2008-2#1)
limited value in the##2##4##(1995-12#1)(2010-4#1)
limited value in##3##3##(1995-12#1)(2008-7#1)(2010-4#1)
limited value##7##2##(1995-12#1)(1995-3#2)(1995-6#1)(2008-5#1)(2008-7#1)(2010-4#1)
limited variation##2##2##(2008-10#1)(2012-3#1)
limited water##2##2##(2008-5#1)(2013-7#1)
limited with##3##2##(2008-2#2)(2008-3#1)
limited##1151##1##(1990-11#1)(1990-12#6)(1990-2#6)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#7)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#7)(1995-3#8)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#6)(1996-2#9)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#4)(1997-2#11)(1997-3#8)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#2)(1997-9#1)(2007-10#6)(2007-11#25)(2007-12#28)(2007-2#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#11)(2008-1#12)(2008-10#151)(2008-11#31)(2008-12#18)(2008-2#34)(2008-3#64)(2008-4#21)(2008-5#23)(2008-6#16)(2008-7#45)(2008-8#44)(2008-9#42)(2009-1#1)(2009-10#7)(2009-11#7)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#11)(2009-6#8)(2009-7#4)(2009-8#7)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#5)(2010-3#8)(2010-4#2)(2010-5#4)(2010-6#4)(2010-8#14)(2010-9#2)(2011-1#13)(2011-2#59)(2011-3#3)(2011-7#3)(2012-1#4)(2012-12#22)(2012-2#37)(2012-3#21)(2012-7#1)(2012-8#1)(2013-1#42)(2013-7#6)(2013-8#14)
limited-access##2##1##(2008-4#2)
limited-angle tomography##2##2##(2008-2#1)(2012-1#1)
limited-fan-out space-variant##2##2##(2008-2#2)
limited-fan-out##3##1##(2008-2#3)
limited-view##2##1##(2008-2#2)
limiter##6##1##(2007-12#4)(2008-3#2)
limiting amino acid##2##3##(2011-2#1)(2012-2#1)
limiting behavior of##3##3##(2007-11#2)(2007-12#1)
limiting behavior##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
limiting case of##2##3##(2008-3#1)(2008-9#1)
limiting case##6##2##(2008-3#2)(2008-9#4)
limiting concentration##2##2##(1996-5#1)(2008-11#1)
limiting conditions##3##2##(2008-12#2)(2008-6#1)
limiting dilution##4##2##(1990-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
limiting effect in##2##3##(2007-11#1)(2008-3#1)
limiting effect##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
limiting exposure to##2##3##(1994-5#2)
limiting factor for the##2##4##(2008-10#1)(2012-3#1)
limiting factor for##8##3##(2008-10#5)(2008-11#1)(2012-2#1)(2012-3#1)
limiting factor in the##2##4##(1991-12#1)(2008-10#1)
limiting factor in##4##3##(1991-12#1)(1996-3#1)(2008-10#2)
limiting factor##20##2##(1991-12#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
limiting factors##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
limiting for##3##2##(1991-9#1)(1993-8#1)(2009-10#1)
limiting in##2##2##(2007-12#1)(2008-10#1)
limiting its##3##2##(1994-6#1)(1997-1#1)(2008-2#1)
limiting mechanism##2##2##(2008-3#2)
limiting of##2##2##(2008-3#2)
limiting performance##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
limiting resource##3##2##(2008-8#3)
limiting resources##2##2##(2008-8#1)(2008-9#1)
limiting step for the##2##4##(1993-6#1)(1994-11#1)
limiting step in##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
limiting step of##2##3##(1991-9#1)(2008-10#1)
limiting step##9##2##(1991-9#1)(1993-6#1)(1994-11#3)(2008-10#2)(2008-11#1)(2008-5#1)
limiting the number of##2##4##(2008-8#2)
limiting the##28##2##(1991-6#1)(1992-11#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
limiting their##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
limiting threshold##2##2##(2008-3#2)
limiting##212##1##(1990-11#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#9)(2007-12#7)(2008-1#3)(2008-10#31)(2008-11#11)(2008-12#3)(2008-2#11)(2008-3#27)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-10#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#3)
limits (1##2##2##(2008-10#1)(2008-5#1)
limits (3sigma##3##2##(2008-10#3)
limits (3sigma) were 0##2##4##(2008-10#2)
limits (3sigma) were##4##3##(2008-10#4)
limits (3sigma)##11##2##(2008-10#11)
limits (DLs)##3##2##(2008-10#3)
limits (MDL)##2##2##(2008-10#2)
limits (ppb)##2##2##(2008-10#2)
limits 0##5##2##(2008-10#3)(2013-1#2)
limits 1##2##2##(1997-3#1)(2008-10#1)
limits achieved were##3##3##(2008-10#3)
limits achieved##8##2##(2008-10#7)(2008-3#1)
limits and applicability##2##3##(2008-10#1)(2008-2#1)
limits and relative standard deviation##2##5##(2008-10#2)
limits and the##3##3##(2006-12#1)(2008-10#2)
limits and##27##2##(1991-3#1)(1994-1#1)(2006-12#1)(2007-12#1)(2008-10#15)(2008-2#1)(2008-3#4)(2008-9#1)(2009-7#1)(2013-8#1)
limits are 0##9##3##(2008-10#9)
limits are 1##4##3##(2008-10#4)
limits are compared##2##3##(1995-9#1)(2008-3#1)
limits are##30##2##(1995-9#3)(2007-12#1)(2008-10#23)(2008-3#2)(2009-7#1)
limits around##2##2##(1990-7#1)(2008-10#1)
limits as##4##2##(2008-10#3)(2008-8#1)
limits based on##2##3##(1997-3#1)(2008-10#1)
limits between##2##2##(2008-10#1)(2009-9#1)
limits by##2##2##(2008-10#1)(2009-4#1)
limits determined##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
limits for Cd(II)##2##3##(2008-10#2)
limits for the##9##3##(2008-10#7)(2008-3#1)(2008-7#1)
limits for##71##2##(1990-8#1)(1995-9#3)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#53)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2011-1#1)(2013-8#1)
limits have been##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
limits in the##7##3##(1994-2#1)(2008-10#5)(2008-3#1)
limits in##16##2##(1992-11#1)(1994-2#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-6#1)(2012-3#1)
limits its##4##2##(1993-8#1)(2008-10#1)(2008-5#1)(2010-11#1)
limits obtained were in the range##2##6##(2008-10#2)
limits obtained were##4##3##(2008-10#4)
limits obtained##9##2##(2008-10#9)
limits of 0##22##3##(1997-4#1)(2008-10#21)
limits of 1##5##3##(1997-4#1)(2008-10#4)
limits of 27 and##2##4##(2008-10#2)
limits of 27##3##3##(2008-10#3)
limits of 6##2##3##(2008-10#2)
limits of agreement##3##3##(2008-12#2)(2009-1#1)
limits of detection (3##2##4##(2008-10#2)
limits of detection (3sigma)##2##4##(2008-10#2)
limits of detection (LOD) and##3##5##(2008-10#3)
limits of detection (LOD) ranged##2##5##(2008-10#2)
limits of detection (LOD)##10##4##(2008-10#9)(2010-5#1)
limits of detection (LODs)##5##4##(2008-10#5)
limits of detection (signal-to-noise##2##4##(2008-10#1)(2008-3#1)
limits of detection and quantification of##2##6##(2008-10#2)
limits of detection and quantification##5##5##(2008-10#4)(2009-7#1)
limits of detection and quantitation were##2##6##(2008-10#2)
limits of detection and quantitation##3##5##(2008-10#3)
limits of detection and##13##4##(2008-10#12)(2009-7#1)
limits of detection are##5##4##(2008-10#5)
limits of detection for##14##4##(1990-8#1)(2008-10#12)(2010-11#1)
limits of detection from 0##2##5##(2008-10#2)
limits of detection from##3##4##(2008-10#3)
limits of detection in the##4##5##(2008-10#4)
limits of detection in##6##4##(2008-10#6)
limits of detection obtained##2##4##(2008-10#1)(2008-2#1)
limits of detection of the##2##5##(2008-10#1)(2011-1#1)
limits of detection of##10##4##(2008-10#8)(2008-3#1)(2011-1#1)
limits of detection than##2##4##(2008-10#1)(2008-2#1)
limits of detection was##2##4##(2008-10#2)
limits of detection were 0##3##5##(2008-10#3)
limits of detection were##18##4##(2008-10#16)(2008-2#1)(2011-1#1)
limits of detection##124##3##(1990-8#1)(1996-5#1)(2008-10#110)(2008-2#3)(2008-3#2)(2009-7#1)(2010-11#1)(2010-5#2)(2011-1#2)(2012-1#1)
limits of determination##2##3##(2008-10#2)
limits of each##2##3##(2008-10#1)(2008-2#1)
limits of normal##2##3##(1991-6#1)(1993-2#1)
limits of optics##2##3##(2007-12#2)
limits of quantification (LOQ)##3##4##(2008-10#2)(2011-1#1)
limits of quantification were##3##4##(2008-10#2)(2011-3#1)
limits of quantification##13##3##(2008-10#10)(2011-1#2)(2011-3#1)
limits of quantitation were##2##4##(2008-10#2)
limits of quantitation##5##3##(2008-10#4)(2013-1#1)
limits of such##2##3##(2008-10#1)(2009-2#1)
limits of the developed method##2##5##(2008-10#2)
limits of the method for##2##5##(2008-10#2)
limits of the method##6##4##(2008-10#4)(2008-5#1)(2012-1#1)
limits of the proposed##3##4##(2008-10#3)
limits of the##36##3##(1993-2#1)(1994-5#1)(2007-11#1)(2008-10#21)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
limits of this##4##3##(2007-12#1)(2008-10#3)
limits of##320##2##(1990-8#1)(1991-6#1)(1993-2#2)(1993-3#2)(1994-5#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#243)(2008-11#1)(2008-12#3)(2008-2#11)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
limits on the##4##3##(1992-11#1)(1995-9#1)(2008-10#1)(2008-3#1)
limits on##19##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-9#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#3)(2009-5#1)(2010-3#1)
limits ranged from 0##3##4##(2008-10#3)
limits ranged from##4##3##(2008-10#4)
limits ranging from 0##4##4##(2008-10#4)
limits ranging from##8##3##(2008-10#8)
limits reached##2##2##(2008-10#2)
limits that are##2##3##(2008-3#2)
limits that##4##2##(2008-10#1)(2008-3#3)
limits the ability of##2##4##(2008-8#1)(2010-1#1)
limits the application of##3##4##(1993-10#1)(2008-10#1)(2009-10#1)
limits the integration##2##3##(2009-11#1)(2010-10#1)
limits the##38##2##(1991-12#1)(1993-10#1)(1994-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-8#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#3)(2012-2#2)
limits their##2##2##(1997-4#1)(2008-5#1)
limits to the##5##3##(1990-7#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
limits to##8##2##(1990-7#1)(1993-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
limits under##3##2##(1995-9#1)(2008-10#2)
limits using##4##2##(2008-10#4)
limits were 0##14##3##(2008-10#13)(2011-1#1)
limits were calculated##3##3##(2008-10#3)
limits were determined##3##3##(2008-10#3)
limits were found to be##7##5##(2008-10#7)
limits were##68##2##(1994-9#1)(2008-10#65)(2011-1#1)(2011-2#1)
limits when##2##2##(2008-10#1)(2008-9#1)
limits which##2##2##(2008-10#1)(2012-1#1)
limits with##2##2##(2008-10#2)
limits within the##2##3##(1992-6#1)(2008-10#1)
limits within##3##2##(1992-6#1)(2008-10#2)
limits##909##1##(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-6#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#9)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#4)(1997-3#6)(1997-4#7)(1997-5#1)(2006-12#1)(2007-10#2)(2007-11#5)(2007-12#14)(2007-8#1)(2008-1#4)(2008-10#619)(2008-11#4)(2008-12#8)(2008-2#26)(2008-3#38)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#8)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
limits) of##2##2##(2008-10#1)(2008-8#1)
limits)##4##1##(1996-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
limnophilus##3##1##(2011-2#3)
limonene and##3##2##(2008-11#2)(2008-5#1)
limonene##14##1##(1994-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#8)
limosum exoenzyme##2##2##(1992-3#2)
limpet hemocyanin (KLH)##8##3##(2008-10#7)(2008-9#1)
limpet##10##1##(2008-10#8)(2008-9#1)(2012-2#1)
limpets##2##1##(2011-2#2)
limping child##2##2##(2013-8#2)
lin-12 and##3##2##(1994-12#3)
lin-12##6##1##(1994-12#6)
linalool##8##1##(1992-8#1)(2008-10#7)
lincomycin##5##1##(1991-8#1)(2007-7#3)(2008-10#1)
lincospectine##2##1##(2008-12#2)
lindane##4##1##(2008-10#2)(2010-6#2)
lindemuthianum from##2##2##(2008-10#2)
lindemuthianum had##2##2##(2008-10#2)
lindemuthianum##19##1##(2008-10#19)
line (P29)##2##2##(2008-10#2)
line 10##2##2##(1991-9#2)
line 183-2##2##2##(2008-10#2)
line 19##2##2##(2008-10#2)
line 24-18-7 was##2##3##(2008-10#2)
line COLO##2##2##(1992-8#1)(2013-1#1)
line H960642 is a##2##4##(2008-8#2)
line OT364##2##2##(2008-10#2)
line SS767##2##2##(2008-10#2)
line TAI-27##2##2##(2008-8#1)(2008-9#1)
line and a##2##3##(2008-10#1)(2008-4#1)
line and its##2##3##(2008-10#1)(2008-11#1)
line and the##7##3##(2008-10#2)(2008-3#1)(2013-7#3)(2013-8#1)
line and##46##2##(1992-2#1)(1996-3#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#3)(2013-8#1)
line are##6##2##(1995-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
line as a##3##3##(2008-11#1)(2008-3#2)
line as##5##2##(1995-2#1)(2008-11#1)(2008-3#2)(2010-3#1)
line at the##3##3##(2007-12#2)(2008-10#1)
line at##16##2##(1993-11#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)
line between both##2##3##(2007-8#1)(2008-10#1)
line between the##2##3##(1995-8#1)(2008-10#1)
line between##8##2##(1995-8#1)(1996-11#1)(1997-5#1)(2007-8#1)(2008-10#3)(2008-3#1)
line broadening##5##2##(1995-2#2)(2008-10#1)(2008-2#2)
line by##15##2##(1990-11#1)(1994-6#2)(1997-6#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
line can be##2##3##(1993-8#1)(2008-3#1)
line charges##3##2##(2010-12#3)
line containing##4##2##(2008-10#3)(2011-2#1)
line contains##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
line cross-contamination##4##2##(2008-11#4)
line drawings##4##2##(1996-2#1)(2007-12#1)(2008-6#2)
line drawn##2##2##(2007-11#1)(2008-7#1)
line established from##2##3##(2008-10#1)(2008-11#1)
line established##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
line exhibited##2##2##(2008-10#1)(2008-11#1)
line expressing a##2##3##(2008-10#1)(2013-7#1)
line expressing##5##2##(2008-10#1)(2008-11#2)(2012-12#1)(2013-7#1)
line flow system##2##3##(2008-10#2)
line for a##2##3##(2007-12#1)(2008-10#1)
line for the##2##3##(1990-11#1)(2009-5#1)
line for##19##2##(1990-11#1)(1990-8#1)(1991-5#1)(1992-2#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)
line from##6##2##(1991-3#1)(1995-11#2)(2008-10#1)(2008-11#1)(2013-1#1)
line generator##2##2##(2008-2#2)
line has##5##2##(1992-9#1)(2008-11#2)(2008-5#1)(2009-4#1)
line health##2##2##(1997-4#1)(2008-11#1)
line illuminator##2##2##(2008-3#2)
line imaging##2##2##(2008-2#2)
line in a##2##3##(2008-11#1)(2013-8#1)
line in pilot scale##2##4##(2008-11#2)
line in the##5##3##(1991-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
line in vitro##3##3##(1993-12#1)(2008-11#1)(2008-9#1)
line in which##3##3##(1994-3#1)(2008-10#2)
line in##29##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-8#1)
line increased##2##2##(2008-10#1)(2011-2#1)
line index##4##2##(2013-8#4)
line intensity ratio##3##3##(2008-10#3)
line intensity##5##2##(2008-10#3)(2013-8#2)
line is a##3##3##(1990-11#1)(1990-5#1)(1994-12#1)
line is##24##2##(1990-11#1)(1990-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#3)(2008-6#1)(2009-3#1)
line jitter of CCD images##2##5##(2008-3#2)
line jitter of##3##3##(2008-3#3)
line jitter##5##2##(2008-3#5)
line object##2##2##(2008-2#2)
line of defense against##3##4##(1993-12#1)(2007-12#1)(2008-11#1)
line of defense##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
line of descent##2##3##(1997-7#1)(2011-2#1)
line of sight between##2##4##(2007-12#1)(2008-2#1)
line of sight##9##3##(2007-12#1)(2008-2#3)(2008-3#4)(2008-6#1)
line of the##9##3##(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
line of##63##2##(1990-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#5)(2008-11#8)(2008-2#6)(2008-3#9)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
line on##4##2##(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
line optical tweezers##2##3##(2007-11#2)
line or##3##2##(1997-7#1)(2008-2#1)(2009-10#1)
line orientations##2##2##(2013-1#2)
line p53 mutations##4##3##(1990-12#3)(1994-12#1)
line pairs##3##2##(2008-2#2)(2008-3#1)
line pairs/mm##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
line parameters##3##2##(2008-2#1)(2008-3#2)
line population##5##2##(2008-10#5)
line positions##3##2##(2008-2#1)(2008-3#2)
line producing##6##2##(1992-9#1)(1994-5#1)(1997-2#1)(2008-11#3)
line profile##2##2##(2008-10#1)(2008-3#1)
line profiles##2##2##(2008-10#1)(2008-3#1)
line scan camera for##2##4##(2011-1#2)
line scan camera##3##3##(2011-1#3)
line scan##6##2##(2007-11#1)(2008-3#1)(2011-1#3)(2012-12#1)
line secretes##2##2##(1990-11#1)(1990-5#1)
line shape and##2##3##(2008-2#1)(2008-3#1)
line shape in conjunction with in situ##3##7##(2008-3#3)
line shape of the##2##4##(2008-2#1)(2008-3#1)
line shape of##5##3##(2008-2#2)(2008-3#3)
line shape##17##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#10)
line shapes and signal intensities are measured##2##7##(2008-3#2)
line shapes and##4##3##(2008-3#4)
line shapes to the experimental counterparts##2##6##(2008-2#1)(2008-3#1)
line shapes to##3##3##(2008-2#2)(2008-3#1)
line shapes##13##2##(2008-2#5)(2008-3#8)
line showed no##2##3##(1993-6#1)(2008-10#1)
line showed##4##2##(1993-6#1)(2008-10#2)(2011-2#1)
line source##4##2##(2008-3#4)
line strength is##2##3##(2008-3#2)
line strength##9##2##(2008-2#1)(2008-3#8)
line tension##3##2##(1990-11#1)(1997-2#2)
line that##13##2##(1990-7#1)(1992-9#1)(1993-3#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
line the##3##2##(1990-6#1)(1994-8#1)(2008-4#1)
line therapy in##2##3##(1990-2#1)(1992-6#1)
line therapy##10##2##(1990-2#1)(1992-6#3)(1993-12#1)(1996-7#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-5#1)
line through##3##2##(1994-3#2)(2008-11#1)
line to##12##2##(1990-6#1)(1992-3#2)(1994-8#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-12#1)(2011-2#1)
line used in##2##3##(2008-11#1)(2008-5#1)
line used##3##2##(2008-11#2)(2008-5#1)
line was found to##2##4##(2008-2#1)(2008-3#1)
line was##33##2##(1992-9#1)(1994-5#3)(1995-12#1)(1995-8#1)(1997-6#1)(2007-10#2)(2008-10#6)(2008-11#11)(2008-2#1)(2008-3#3)(2011-2#1)(2012-12#1)(2013-8#1)
line were identified##2##3##(1996-10#1)(2008-8#1)
line were inoculated##2##3##(2008-10#2)
line were##14##2##(1992-9#1)(1996-10#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)
line which##7##2##(1990-12#1)(1990-8#1)(2007-8#1)(2008-11#3)(2012-2#1)
line width##2##2##(2008-2#1)(2008-7#1)
line with BYDV resistance##2##4##(2008-10#1)(2008-8#1)
line with a##8##3##(1991-6#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)
line with an##2##3##(1997-4#1)(2008-11#1)
line with our##2##3##(1995-12#1)(1995-3#1)
line with that##2##3##(1992-1#1)(2008-3#1)
line with the##21##3##(1990-12#1)(1991-1#1)(1992-3#1)(1996-5#1)(1996-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-11#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
line with##68##2##(1990-12#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#3)(2008-3#4)(2008-5#2)(2008-8#3)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
line within the##2##3##(2007-11#1)(2008-2#1)
line##1433##1##(1990-11#12)(1990-12#18)(1990-2#4)(1990-4#1)(1990-5#12)(1990-6#2)(1990-7#2)(1990-8#5)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#10)(1991-8#1)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#9)(1992-5#3)(1992-6#4)(1992-8#6)(1992-9#15)(1993-1#7)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#15)(1993-6#11)(1993-8#6)(1993-9#9)(1994-1#3)(1994-11#11)(1994-12#11)(1994-2#5)(1994-3#5)(1994-5#6)(1994-6#8)(1994-8#7)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#8)(1995-3#5)(1995-5#1)(1995-6#7)(1995-8#8)(1996-10#4)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#3)(1996-5#3)(1996-7#2)(1997-1#9)(1997-2#11)(1997-3#1)(1997-4#6)(1997-5#3)(1997-6#12)(1997-7#7)(1997-8#1)(1997-9#1)(2007-10#3)(2007-11#30)(2007-12#27)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#211)(2008-11#251)(2008-12#5)(2008-2#70)(2008-3#125)(2008-4#17)(2008-5#18)(2008-6#12)(2008-7#19)(2008-8#49)(2008-9#33)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#7)(2009-4#4)(2009-5#4)(2009-7#1)(2010-1#1)(2010-11#5)(2010-12#6)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#8)(2011-2#27)(2012-1#4)(2012-12#8)(2012-2#15)(2012-3#13)(2013-1#20)(2013-7#4)(2013-8#19)
line' by##2##2##(2008-10#2)
line'##3##1##(2008-10#3)
line) to##2##2##(1994-11#1)(2011-1#1)
line)##17##1##(1994-11#3)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
line-broadening##3##1##(1996-2#1)(2008-3#2)
line-by-line##8##1##(2008-3#8)
line-dependent##2##1##(1994-2#1)(2008-11#1)
line-of-sight data##2##2##(2008-3#2)
line-of-sight velocity##2##2##(2007-11#1)(2008-3#1)
line-of-sight##10##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
line-shape analysis was##2##3##(1994-5#1)(2008-2#1)
line-shape distortions in##2##3##(2008-2#1)(2008-3#1)
line-shape distortions##4##2##(2008-2#2)(2008-3#2)
line-shape##10##1##(1994-5#1)(2007-11#1)(2008-2#4)(2008-3#4)
line-space##3##1##(2008-3#3)
lineage 6##3##2##(2008-10#3)
lineage 7##2##2##(2008-10#2)
lineage C##2##2##(2008-10#2)
lineage I was##2##3##(2008-10#2)
lineage I##4##2##(2008-10#4)
lineage II##2##2##(2008-10#2)
lineage III##2##2##(2008-10#2)
lineage and##5##2##(1990-11#1)(2006-10#1)(2007-12#2)(2013-1#1)
lineage determination##2##2##(1992-3#1)(1992-5#1)
lineage from##6##2##(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
lineage had##2##2##(2008-10#2)
lineage in##2##2##(1994-12#1)(2008-10#1)
lineage included isolates of C##2##5##(2008-10#2)
lineage is a##2##3##(2008-4#1)(2012-12#1)
lineage is##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
lineage leading to the##2##4##(1995-11#1)(2012-3#1)
lineage leading to##3##3##(1995-11#1)(2010-4#1)(2012-3#1)
lineage of a##2##3##(2007-6#1)(2008-9#1)
lineage of##8##2##(1995-2#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#1)
lineage sorting and meiotic and sexual recombination##2##7##(2008-8#2)
lineage sorting and##3##3##(2008-8#2)(2012-3#1)
lineage sorting##6##2##(2008-8#2)(2010-6#1)(2012-3#3)
lineage was##3##2##(2008-10#3)
lineage with##2##2##(2010-3#1)(2012-12#1)
lineage##158##1##(1990-11#2)(1991-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#5)(2007-6#2)(2008-1#2)(2008-10#60)(2008-11#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#1)(2009-2#1)(2009-8#2)(2010-11#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#5)(2012-7#1)(2012-8#1)(2013-1#6)
lineage-restricted##4##1##(1992-3#1)(1994-10#1)(2008-4#1)(2008-9#1)
lineage-specific##5##1##(1992-5#1)(2008-9#2)(2009-10#1)(2011-2#1)
lineages (US-1##2##2##(2008-10#2)
lineages (e##2##2##(2008-8#2)
lineages A##2##2##(2008-10#2)
lineages and human evolution##2##4##(1996-5#2)
lineages and##9##2##(1995-6#1)(1996-5#2)(1997-4#1)(2008-10#2)(2008-9#1)(2010-8#1)(2013-1#1)
lineages are##2##2##(2008-10#1)(2008-4#1)
lineages as a##2##3##(2007-12#1)(2010-6#1)
lineages as##3##2##(2007-12#1)(2008-11#1)(2010-6#1)
lineages differ##2##2##(2008-10#2)
lineages each contained##2##3##(2008-10#2)
lineages for##3##2##(1990-11#1)(2008-10#2)
lineages frequently##2##2##(2010-6#2)
lineages had##2##2##(2008-10#2)
lineages have been##3##3##(2008-7#1)(2009-2#1)(2010-6#1)
lineages have##4##2##(2008-10#1)(2008-7#1)(2009-2#1)(2010-6#1)
lineages in##7##2##(1995-12#1)(1995-2#1)(2008-10#2)(2010-8#1)(2013-1#1)(2013-8#1)
lineages may##2##2##(2008-10#1)(2008-6#1)
lineages of F##3##3##(2008-10#3)
lineages of the##4##3##(2008-10#2)(2009-2#1)(2013-1#1)
lineages of##23##2##(1995-2#1)(2008-10#9)(2008-8#2)(2009-2#2)(2010-3#1)(2010-6#3)(2012-12#1)(2012-7#1)(2013-1#3)
lineages or groups of##2##4##(2008-9#1)(2010-3#1)
lineages or##5##2##(1995-6#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
lineages that##8##2##(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
lineages was##3##2##(1990-5#1)(2008-8#1)(2010-8#1)
lineages were found##2##3##(2008-10#2)
lineages were identified##6##3##(1996-4#1)(2008-10#5)
lineages were isolated from##2##4##(2008-10#2)
lineages were##14##2##(1996-4#1)(2008-10#11)(2008-5#1)(2009-2#1)
lineages within the##2##3##(2008-10#1)(2011-2#1)
lineages within##5##2##(2008-10#4)(2011-2#1)
lineages##206##1##(1990-11#2)(1990-5#3)(1991-9#1)(1992-3#1)(1993-3#2)(1993-6#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2007-12#6)(2007-6#1)(2008-1#1)(2008-10#80)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#14)(2008-9#5)(2009-12#1)(2009-2#10)(2009-3#2)(2009-8#2)(2010-11#2)(2010-3#7)(2010-6#9)(2010-8#7)(2011-2#3)(2012-12#2)(2012-3#4)(2012-7#1)(2013-1#7)(2013-8#3)
lineal##5##1##(1991-2#1)(2008-10#3)(2013-1#1)
linear (P &lt##2##3##(2008-10#1)(2010-2#1)
linear DNA##3##2##(1990-5#1)(1995-8#1)(2008-10#1)
linear Raman##4##2##(2008-2#4)
linear absorption##7##2##(2007-11#1)(2007-12#1)(2008-3#4)(2008-8#1)
linear accelerator##9##2##(1990-12#1)(1992-12#1)(1993-9#1)(2008-2#1)(2008-3#4)(2009-11#1)
linear alkylbenzene sulfonates (LAS)##3##4##(2008-10#3)
linear alkylbenzene sulfonates##5##3##(2008-10#5)
linear alpha(1--&gt##2##2##(2009-12#2)
linear analysis##5##2##(2008-10#4)(2011-2#1)
linear analytical##2##2##(2008-10#2)
linear and circular##4##3##(1994-8#1)(2007-12#2)(2008-3#1)
linear and non-linear##2##3##(2008-10#1)(2008-11#1)
linear and nonlinear absorption##3##4##(2007-11#2)(2008-3#1)
linear and nonlinear##8##3##(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#2)
linear and quadratic discriminant##2##4##(1991-12#2)
linear and quadratic##5##3##(1991-12#3)(2007-11#1)(2008-8#1)
linear and##28##2##(1991-12#3)(1994-8#1)(2007-11#6)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2010-10#1)
linear area##2##2##(1991-11#1)(1996-1#1)
linear array##4##2##(2008-2#2)(2008-3#1)(2008-5#1)
linear at##2##2##(2008-10#1)(2008-11#1)
linear between 0##2##3##(2008-10#2)
linear between##10##2##(1995-2#1)(2008-10#8)(2012-2#1)
linear birefringence##6##2##(2008-2#2)(2008-3#4)
linear calibration curve in the range##3##6##(2008-10#3)
linear calibration curve was##3##4##(2008-10#3)
linear calibration curve##15##3##(2008-10#14)(2011-2#1)
linear calibration curves##4##3##(2008-10#4)
linear calibration for##2##3##(1992-11#1)(1996-5#1)
linear calibration graph was obtained from##2##6##(2008-10#2)
linear calibration graph was obtained in the range##2##8##(2008-10#2)
linear calibration graph was obtained in the##3##7##(2008-10#3)
linear calibration graph was obtained over the##3##7##(2008-10#3)
linear calibration graph was obtained within 0##2##7##(2008-10#2)
linear calibration graph was obtained##13##5##(2008-10#13)
linear calibration graph##16##3##(2008-10#16)
linear calibration graphs were obtained over the##2##7##(2008-10#2)
linear calibration graphs were obtained##4##5##(2008-10#4)
linear calibration graphs were##7##4##(2008-10#7)
linear calibration graphs##9##3##(2008-10#9)
linear calibration range of##3##4##(2008-10#3)
linear calibration range was##5##4##(2008-10#5)
linear calibration range##13##3##(2008-10#13)
linear calibration ranges##3##3##(2008-10#3)
linear calibration##79##2##(1992-11#3)(1996-5#1)(2008-10#74)(2011-2#1)
linear carrier##2##2##(2008-2#1)(2008-3#1)
linear chirp of##2##3##(2007-12#1)(2008-3#1)
linear chirp time delays##2##4##(2008-3#2)
linear chirp##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
linear combination of the##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2012-12#1)
linear combination of##11##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
linear combination##13##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
linear combinations of##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
linear concentration range of##10##4##(2008-10#9)(2013-1#1)
linear concentration range was from##2##5##(2008-10#2)
linear concentration range was##3##4##(2008-10#3)
linear concentration range##16##3##(2008-10#15)(2013-1#1)
linear concentration ranges were##2##4##(2008-10#2)
linear concentration ranges##8##3##(2008-10#8)
linear concentration##24##2##(2008-10#23)(2013-1#1)
linear contrasts##2##2##(2008-10#2)
linear correlation between the##5##4##(1996-2#1)(2008-10#4)
linear correlation between total cholesterolemia and##2##6##(1991-12#2)
linear correlation between##11##3##(1991-12#2)(1995-8#1)(1996-2#1)(2008-10#6)(2008-3#1)
linear correlation coefficient##4##3##(1992-11#1)(2008-10#2)(2011-1#1)
linear correlation filter##2##3##(2008-2#1)(2008-3#1)
linear correlation was found between##2##5##(1993-1#1)(1995-8#1)
linear correlation was found##3##4##(1993-1#1)(1995-8#1)(2008-10#1)
linear correlation was##4##3##(1993-1#1)(1995-8#1)(2008-10#2)
linear correlation with the##2##4##(2008-10#1)(2008-11#1)
linear correlation##34##2##(1991-12#2)(1991-6#1)(1992-11#1)(1993-1#1)(1995-8#2)(1996-2#1)(1997-3#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#6)(2011-1#1)
linear correlations##2##2##(2007-11#1)(2008-10#1)
linear dependence between the##2##4##(2008-10#2)
linear dependence of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
linear dependence of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
linear dependence on##2##3##(2008-10#1)(2008-3#1)
linear dependence##8##2##(2008-10#5)(2008-2#1)(2008-3#2)
linear depolarization##4##2##(2008-3#4)
linear detection##2##2##(2008-10#1)(2008-3#1)
linear determination range##4##3##(2008-10#4)
linear determination##6##2##(2008-10#6)
linear dichroism##8##2##(1994-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-5#2)
linear dimension##3##2##(1996-4#1)(2008-6#1)(2009-8#1)
linear diode laser##2##3##(2007-12#1)(2011-1#1)
linear discriminant analysis (LDA) and soft independent##2##7##(2008-10#2)
linear discriminant analysis (LDA) and##3##5##(2008-10#3)
linear discriminant analysis (LDA)##9##4##(2008-10#7)(2008-6#1)(2008-7#1)
linear discriminant analysis and artificial neural networks##2##7##(2008-10#2)
linear discriminant analysis and##4##4##(2007-11#1)(2008-10#3)
linear discriminant analysis##20##3##(2007-11#1)(2008-10#17)(2008-6#1)(2008-7#1)
linear discriminant##23##2##(2007-11#3)(2008-10#18)(2008-6#1)(2008-7#1)
linear dynamic range for##2##4##(2008-10#2)
linear dynamic range from##9##4##(2008-10#9)
linear dynamic range is##2##4##(2008-10#2)
linear dynamic range of##8##4##(2008-10#8)
linear dynamic range was##3##4##(2008-10#3)
linear dynamic range##38##3##(2008-10#38)
linear dynamic ranges of##5##4##(2008-10#5)
linear dynamic ranges##10##3##(2008-10#10)
linear dynamic##52##2##(2008-10#52)
linear effect##2##2##(2008-3#1)(2009-5#1)
linear energy transfer radiation)##2##4##(2008-7#2)
linear energy transfer##5##3##(1994-3#1)(2008-7#4)
linear epitope##2##2##(1995-12#1)(1995-2#1)
linear epitopes##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
linear equation##3##2##(1990-5#1)(2008-10#2)
linear equations for##2##3##(2008-10#1)(2008-3#1)
linear equations##5##2##(2008-10#2)(2008-3#2)(2008-7#1)
linear filter##2##2##(2008-3#2)
linear filtering##3##2##(2008-2#1)(2008-3#2)
linear filters##2##2##(2008-7#2)
linear food##2##2##(2008-8#1)(2008-9#1)
linear for the##3##3##(2008-10#3)
linear for##8##2##(1996-12#1)(2008-10#7)
linear frequency chirp##2##3##(2007-12#2)
linear frequency##3##2##(2007-12#2)(2008-3#1)
linear from 0##9##3##(1997-2#1)(2008-10#8)
linear from 1##3##3##(2008-10#3)
linear from 5##2##3##(2008-10#2)
linear from##25##2##(1997-2#1)(2008-10#24)
linear function of the##6##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2013-8#1)
linear function of##13##3##(1990-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
linear function##15##2##(1990-11#1)(1990-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
linear functions of##3##3##(1990-11#1)(1992-5#1)(2008-10#1)
linear gradient elution##4##3##(1990-8#1)(2008-10#3)
linear gradient##7##2##(1990-8#1)(2008-10#5)(2013-1#1)
linear group delay##2##3##(2008-3#2)
linear growth##6##2##(1996-11#1)(2008-10#1)(2008-12#2)(2009-2#1)(2009-8#1)
linear homoscedastic assays##3##3##(1995-9#3)
linear in the concentration range 0##2##6##(2008-10#2)
linear in the concentration range from##3##6##(2008-10#3)
linear in the concentration range of 0##2##7##(2008-10#2)
linear in the concentration range of##5##6##(2008-10#5)
linear in the concentration range##13##5##(2008-10#13)
linear in the concentration##15##4##(2008-10#15)
linear in the range 0##9##5##(2008-10#9)
linear in the range from##4##5##(1990-8#2)(2008-10#2)
linear in the range of 0##8##6##(2008-10#8)
linear in the range of 1##3##6##(2008-10#3)
linear in the range of##28##5##(2008-10#28)
linear in the range##53##4##(1990-8#2)(2008-10#51)
linear in the##78##3##(1990-8#2)(2007-11#1)(2008-10#73)(2008-2#1)(2008-3#1)
linear in##84##2##(1990-8#2)(1992-3#1)(2007-11#2)(2008-10#76)(2008-2#2)(2008-3#1)
linear increase in##10##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#3)(2011-2#1)(2012-2#1)
linear increase##13##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2010-2#1)(2011-2#1)(2012-2#1)
linear indices##4##2##(2007-11#4)
linear interpolation##2##2##(2008-3#1)(2012-2#1)
linear isotherm##3##2##(2008-10#3)
linear kinetics in##2##3##(1990-5#1)(2013-8#1)
linear laser oscillator-amplifier system##2##4##(2008-3#2)
linear laser##3##2##(2008-2#1)(2008-3#2)
linear least-squares##2##2##(2007-12#1)(2013-1#1)
linear locomotion##2##2##(1995-12#2)
linear manner##2##2##(1990-8#1)(2008-10#1)
linear matrix##3##2##(2007-12#1)(2008-2#2)
linear measure of##3##3##(1994-12#2)(2012-2#1)
linear measurement of the applanation diameter or##2##7##(2008-3#2)
linear measurement##3##2##(2008-3#3)
linear method##3##2##(2008-10#3)
linear minimum mean-squared-error##2##3##(2008-3#2)
linear mixed models with##2##4##(2012-1#1)(2013-1#1)
linear mixed models##5##3##(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)
linear mixed##8##2##(1990-11#1)(1992-6#1)(1997-7#1)(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)
linear model for repeated measures##2##5##(2008-10#1)(2013-8#1)
linear model with##2##3##(2008-7#1)(2010-5#1)
linear model##24##2##(1992-6#2)(1995-12#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#2)(2010-2#1)(2010-5#2)(2011-1#1)(2013-8#1)
linear modeling##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-8#1)
linear models and##4##3##(2008-10#1)(2008-3#1)(2009-9#1)(2010-12#1)
linear models were##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
linear models##23##2##(1992-6#2)(2008-10#6)(2008-2#1)(2008-3#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
linear molecular motors##4##3##(2009-12#3)(2010-12#1)
linear motor##3##2##(2008-3#2)(2013-1#1)
linear multiple regression analysis##2##4##(2007-11#1)(2008-11#1)
linear nevus sebaceous syndrome##2##4##(2011-1#2)
linear no threshold (LNT)##2##4##(2008-7#1)(2013-1#1)
linear no-threshold (LNT)##3##3##(2008-7#2)(2013-1#1)
linear no-threshold##4##2##(2008-7#2)(2013-1#2)
linear optical##5##2##(2007-11#3)(2008-3#1)(2012-2#1)
linear or non-linear##2##3##(1994-11#1)(2013-8#1)
linear or##7##2##(1994-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-5#1)(2013-8#1)
linear oscillator##3##2##(2009-10#2)(2009-8#1)
linear over a range of##4##5##(2008-10#4)
linear over a range##5##4##(1993-9#1)(2008-10#4)
linear over a wide##3##4##(1996-5#1)(2008-10#2)
linear over a##12##3##(1993-9#1)(1996-5#1)(2008-10#9)(2011-2#1)
linear over the concentration range 0##4##6##(2008-10#4)
linear over the concentration range from##4##6##(2008-10#4)
linear over the concentration range of##5##6##(2008-10#5)
linear over the concentration range##18##5##(2008-10#18)
linear over the range 0##8##5##(2008-10#8)
linear over the range of 0##4##6##(2008-10#4)
linear over the range of 2##3##6##(2008-10#3)
linear over the range of##11##5##(2008-10#11)
linear over the range##30##4##(1996-5#1)(2008-10#29)
linear over the##55##3##(1996-5#1)(2008-10#54)
linear over three orders of magnitude with##2##7##(2008-10#2)
linear over##80##2##(1993-9#1)(1996-5#2)(2007-12#1)(2008-10#75)(2011-2#1)
linear peptide##2##2##(2008-11#1)(2013-1#1)
linear phase##3##2##(2008-2#2)(2008-8#1)
linear polarization in##2##3##(2008-3#2)
linear polarization##13##2##(2007-12#1)(2008-2#6)(2008-3#6)
linear polarized##2##2##(2008-2#1)(2008-3#1)
linear polyene were carried out to examine this process##2##9##(2010-2#2)
linear potential response in the concentration range of##2##8##(2008-10#2)
linear potential response##3##3##(2008-10#3)
linear potential##4##2##(2008-10#4)
linear programming##5##2##(2008-11#1)(2008-2#1)(2008-7#2)(2009-3#1)
linear quadrupole##2##2##(2007-11#1)(2008-10#1)
linear range and detection limit##2##5##(2008-10#2)
linear range and slope##3##4##(2008-10#3)
linear range and##12##3##(2008-10#12)
linear range between 1##4##4##(2008-10#4)
linear range between##10##3##(2008-10#10)
linear range extended##2##3##(2008-10#2)
linear range for the determination of##3##6##(2008-10#3)
linear range for##8##3##(2008-10#8)
linear range from 0##6##4##(2008-10#5)(2013-1#1)
linear range from 1##3##4##(2008-10#3)
linear range from##14##3##(2008-10#13)(2013-1#1)
linear range is 0##3##4##(2008-10#3)
linear range is##7##3##(2008-10#7)
linear range of 0##5##4##(2008-10#5)
linear range of the calibration curve##3##6##(2008-10#3)
linear range of the determination##3##5##(2008-10#3)
linear range of the##19##4##(2008-10#18)(2008-11#1)
linear range of this##4##4##(2008-10#4)
linear range of##58##3##(1991-2#1)(1992-8#1)(2008-10#55)(2008-11#1)
linear range up to 100##2##5##(2008-10#2)
linear range up to##4##4##(2008-10#4)
linear range was 0##4##4##(2008-10#2)(2010-5#1)(2011-1#1)
linear range was from##3##4##(2008-10#3)
linear range was##13##3##(2008-10#11)(2010-5#1)(2011-1#1)
linear range##161##2##(1991-2#1)(1992-8#1)(1997-3#1)(2008-10#151)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
linear ranges are##2##3##(2008-10#2)
linear ranges of##9##3##(2008-10#7)(2008-4#1)(2011-1#1)
linear ranges were##5##3##(2008-10#5)
linear ranges##20##2##(2008-10#18)(2008-4#1)(2011-1#1)
linear regression (MLR)##5##3##(2008-10#5)
linear regression analyses##5##3##(2008-10#1)(2009-5#1)(2009-9#1)(2010-8#1)(2013-1#1)
linear regression analysis##14##3##(1993-12#1)(1993-2#2)(1995-2#1)(2008-10#8)(2008-3#1)(2011-1#1)
linear regression and##3##3##(2008-10#2)(2012-3#1)
linear regression between##3##3##(2007-11#1)(2008-3#1)(2010-12#1)
linear regression equation##7##3##(2008-10#6)(2008-7#1)
linear regression equations##2##3##(2010-5#1)(2012-3#1)
linear regression method##4##3##(2008-10#3)(2013-8#1)
linear regression methods##5##3##(2008-10#5)
linear regression model##5##3##(1995-9#2)(2007-11#1)(2008-10#1)(2013-7#1)
linear regression models##7##3##(2007-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-3#1)(2013-7#1)
linear regression of##3##3##(2008-10#3)
linear regression on##2##3##(1991-5#1)(2013-8#1)
linear regression was used to##2##5##(2013-1#1)(2013-8#1)
linear regression was##5##3##(2008-10#3)(2013-1#1)(2013-8#1)
linear regression##100##2##(1991-5#1)(1993-12#1)(1993-2#2)(1995-2#2)(1995-9#4)(2007-11#4)(2007-12#1)(2008-10#53)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#3)
linear regressions##2##2##(2010-4#1)(2013-7#1)
linear relation between the##4##4##(2008-3#4)
linear relation between##6##3##(1997-6#1)(2008-3#4)(2009-5#1)
linear relation in the range##2##5##(2008-10#2)
linear relation##14##2##(1997-6#3)(2008-10#4)(2008-3#6)(2009-5#1)
linear relationship between peak##3##4##(2008-10#3)
linear relationship between the average##2##5##(2008-10#1)(2009-11#1)
linear relationship between the##28##4##(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
linear relationship between##50##3##(2007-12#1)(2007-2#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#2)(2013-8#1)
linear relationship can be##2##4##(1990-7#1)(2008-2#1)
linear relationship exists between the##2##5##(1995-8#1)(2008-10#1)
linear relationship in the##2##4##(2008-10#2)
linear relationship was found between##4##5##(1995-8#1)(2008-10#2)(2009-7#1)
linear relationship was found##5##4##(1995-8#1)(2008-10#3)(2009-7#1)
linear relationship was observed between the##2##6##(1990-7#1)(2008-2#1)
linear relationship was observed between##4##5##(1990-7#1)(2008-10#2)(2008-2#1)
linear relationship was obtained between the##6##6##(1990-2#1)(2008-10#5)
linear relationship was obtained##7##4##(1990-2#1)(2008-10#6)
linear relationship was##20##3##(1990-2#1)(1990-7#1)(1995-8#1)(2008-10#15)(2008-2#1)(2009-7#1)
linear relationship with the concentration of##2##6##(2008-10#2)
linear relationship with the##7##4##(2007-12#1)(2008-10#6)
linear relationship with##10##3##(2007-12#1)(2008-10#9)
linear relationship##93##2##(1990-2#1)(1990-7#3)(1995-8#2)(2007-12#2)(2007-2#1)(2008-10#62)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#1)(2009-11#2)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#2)(2013-8#1)
linear relationships between the##3##4##(2008-10#2)(2011-1#1)
linear relationships between##5##3##(2008-10#4)(2011-1#1)
linear relationships##11##2##(2008-10#10)(2011-1#1)
linear renin-inhibiting peptide EMD 51921##2##5##(1994-12#2)
linear response and##2##3##(2008-10#1)(2008-2#1)
linear response between##2##3##(1992-2#1)(2008-10#1)
linear response for##11##3##(2008-10#10)(2008-3#1)
linear response in##5##3##(1996-12#1)(2008-10#4)
linear response is observed##3##4##(2008-10#3)
linear response is##8##3##(2008-10#8)
linear response of##4##3##(2008-10#4)
linear response over##8##3##(2008-10#7)(2010-3#1)
linear response range between 50 and##2##6##(2008-10#2)
linear response range from##2##4##(2008-10#2)
linear response range of##5##4##(2008-10#5)
linear response range##16##3##(2008-10#16)
linear response ranging from##2##4##(2008-10#1)(2013-1#1)
linear response to Cu(II)##2##4##(2008-10#2)
linear response to pH##2##4##(2008-10#2)
linear response to##14##3##(2008-10#14)
linear response towards Hg(II)##2##4##(2008-10#2)
linear response was obtained in the##2##6##(2008-10#2)
linear response was obtained##4##4##(2008-10#4)
linear response was##5##3##(2008-10#5)
linear response with##9##3##(2008-10#7)(2008-3#1)(2008-7#1)
linear response##99##2##(1992-2#1)(1996-12#1)(2008-10#91)(2008-2#1)(2008-3#2)(2008-7#1)(2010-3#1)(2013-1#1)
linear responses in the range##3##5##(2008-10#3)
linear responses##7##2##(2008-10#7)
linear retarder##3##2##(2008-2#2)(2008-3#1)
linear scale up##3##3##(2008-7#3)
linear scan##4##2##(2008-10#4)
linear selection gradients##2##3##(2008-8#2)
linear selective to hydrogen ion in the##2##7##(2008-10#2)
linear shift-invariant processing##2##3##(2008-3#2)
linear shift-invariant##3##2##(2008-3#3)
linear source##2##2##(1996-4#1)(2008-2#1)
linear spectral##2##2##(2007-11#1)(2008-3#1)
linear stability analysis and##2##4##(2007-11#1)(2007-12#1)
linear stability analysis##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
linear static##2##2##(2008-11#1)(2013-1#1)
linear stepwise regression##2##3##(2011-1#1)(2012-12#1)
linear strain##3##2##(2008-10#3)
linear sweep stripping voltammetry##2##4##(2008-10#2)
linear sweep stripping##4##3##(2008-10#4)
linear sweep voltammetric##2##3##(2008-10#2)
linear sweep voltammetry and##3##4##(2008-10#3)
linear sweep voltammetry at a##2##5##(2008-10#2)
linear sweep voltammetry##11##3##(2008-10#11)
linear sweep##26##2##(2008-10#26)
linear system analysis##2##3##(2011-1#2)
linear system metrics##2##3##(2011-1#2)
linear system##5##2##(2008-3#1)(2011-1#4)
linear systems##4##2##(2008-2#1)(2008-3#1)(2008-7#2)
linear technique##2##2##(2007-11#2)
linear time-invariant control##2##3##(2008-3#2)
linear to its##2##3##(2008-10#2)
linear to the concentration of##2##5##(2008-10#2)
linear to the##4##3##(2008-10#4)
linear to##9##2##(2008-10#9)
linear transducer##2##2##(2007-11#1)(2008-3#1)
linear transform##2##2##(2007-12#2)
linear transformation##5##2##(2008-3#2)(2008-6#1)(2011-2#1)(2012-2#1)
linear transformations##3##2##(2008-6#1)(2010-1#2)
linear trend##2##2##(2008-10#1)(2008-8#1)
linear up to 0##3##4##(2008-10#3)
linear up to 20##2##4##(2008-10#2)
linear up to 50##3##4##(2008-10#3)
linear up to a concentration of##2##6##(2008-10#2)
linear up to##26##3##(1992-3#1)(2008-10#25)
linear variation##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
linear waveguides##2##2##(2008-3#2)
linear wear##3##2##(2008-8#3)
linear with a##8##3##(2008-10#8)
linear with the concentration of##4##5##(2008-10#4)
linear with the concentration##5##4##(2008-10#5)
linear with the##11##3##(2008-10#11)
linear with##26##2##(2008-10#25)(2008-3#1)
linear within the##2##3##(2008-10#1)(2010-5#1)
linear working range##4##3##(2008-10#4)
linear working##6##2##(2008-10#6)
linear##1767##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#4)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#5)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#5)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#6)(1995-9#8)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#4)(1996-6#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#1)(2007-11#50)(2007-12#39)(2007-2#1)(2008-1#4)(2008-10#1034)(2008-11#19)(2008-12#5)(2008-2#63)(2008-3#145)(2008-4#6)(2008-5#4)(2008-6#13)(2008-7#43)(2008-8#23)(2008-9#7)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#8)(2010-3#1)(2010-4#3)(2010-5#13)(2010-6#4)(2010-8#6)(2011-1#21)(2011-2#16)(2011-3#1)(2012-1#6)(2012-12#3)(2012-2#10)(2012-3#7)(2013-1#18)(2013-7#4)(2013-8#13)
linear)##2##1##(2008-10#1)(2012-12#1)
linear-quadratic##2##1##(1996-6#2)
linear-structure light with isosceles triangle teeth##2##6##(2008-3#2)
linearisation methods##2##2##(2008-10#2)
linearities##2##1##(2008-10#1)(2011-1#1)
linearity (r(2)##2##2##(2008-10#1)(2009-8#1)
linearity and reproducibility##3##3##(2007-12#1)(2008-10#2)
linearity and sensitivity##2##3##(2008-10#1)(2008-2#1)
linearity and##18##2##(1990-8#1)(1993-8#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#4)(2008-5#1)
linearity are##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
linearity between the##2##3##(2008-10#1)(2008-12#1)
linearity between##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
linearity for##2##2##(2008-10#1)(2012-12#1)
linearity in the range of##4##5##(2008-10#3)(2012-1#1)
linearity in the range##7##4##(2008-10#6)(2012-1#1)
linearity in the##12##3##(2008-10#10)(2011-1#1)(2012-1#1)
linearity in##16##2##(2008-10#13)(2011-1#1)(2011-3#1)(2012-1#1)
linearity is maintained in the##5##5##(2008-10#5)
linearity is##7##2##(2008-10#7)
linearity of determination for both##2##5##(2008-10#2)
linearity of response##2##3##(2008-10#1)(2010-3#1)
linearity of the calibration##3##4##(2008-10#3)
linearity of the##11##3##(1996-2#1)(2007-12#1)(2008-10#7)(2008-3#2)
linearity of this method##2##4##(2008-10#2)
linearity of##25##2##(1996-2#1)(2007-12#1)(2008-10#18)(2008-3#4)(2010-3#1)
linearity on##2##2##(2008-5#2)
linearity over the concentration##2##4##(2008-10#2)
linearity over the##4##3##(2008-10#3)(2009-9#1)
linearity range of##4##3##(2008-10#3)(2011-1#1)
linearity range##12##2##(2008-10#11)(2011-1#1)
linearity ranging from##2##3##(2008-10#1)(2012-1#1)
linearity was in the##2##4##(2008-10#2)
linearity was observed##2##3##(1991-5#1)(2010-5#1)
linearity was##12##2##(1990-2#1)(1991-5#1)(1994-9#1)(2008-10#7)(2010-5#2)
linearity were##4##2##(2008-10#3)(2011-1#1)
linearity with a##2##3##(2008-10#2)
linearity with##3##2##(2008-10#2)(2009-9#1)
linearity##195##1##(1990-2#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-9#3)(1996-2#2)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#128)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#15)(2008-5#4)(2008-9#2)(2009-8#3)(2009-9#2)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#3)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
linearization of##2##2##(1996-2#1)(2008-3#1)
linearization procedure##2##2##(2008-3#1)(2008-7#1)
linearization##7##1##(1996-2#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)
linearized plasmid##2##2##(1991-6#1)(1993-11#1)
linearized##11##1##(1991-6#1)(1993-11#1)(1996-2#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
linearizing##2##1##(1990-11#1)(2008-7#1)
linearly and circularly polarized light##2##5##(2008-3#2)
linearly and circularly polarized##3##4##(2008-3#3)
linearly as##4##2##(1990-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
linearly by##4##2##(2008-10#3)(2008-2#1)
linearly chirped fiber##2##3##(2007-12#1)(2008-3#1)
linearly chirped##7##2##(2007-12#6)(2008-3#1)
linearly correlated with the##2##4##(2008-7#2)
linearly correlated with##5##3##(1991-9#1)(2008-10#2)(2008-7#2)
linearly correlated##7##2##(1991-9#1)(2008-10#3)(2008-5#1)(2008-7#2)
linearly decreased##3##2##(2008-10#2)(2010-2#1)
linearly dependent on the##5##4##(1990-11#1)(2008-10#3)(2008-9#1)
linearly dependent on##6##3##(1990-11#1)(2008-10#4)(2008-9#1)
linearly from##2##2##(2008-11#1)(2010-2#1)
linearly in the##3##3##(2008-10#3)
linearly in##5##2##(2008-10#4)(2008-3#1)
linearly increased##2##2##(2008-10#2)
linearly increases##3##2##(1994-11#1)(2008-5#1)(2009-5#1)
linearly on##7##2##(2008-10#6)(2008-8#1)
linearly polarized light through a##2##5##(2008-3#2)
linearly polarized light##10##3##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#3)
linearly polarized modes##2##3##(2007-12#1)(2008-3#1)
linearly polarized output##2##3##(2007-12#1)(2008-3#1)
linearly polarized##37##2##(2007-11#9)(2007-12#11)(2008-2#7)(2008-3#10)
linearly proportional to the concentration of##5##6##(2008-10#5)
linearly proportional to the##14##4##(1994-3#1)(2008-10#8)(2008-2#1)(2008-3#3)(2009-11#1)
linearly proportional to##15##3##(1994-3#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#3)(2009-11#1)
linearly proportional##16##2##(1994-3#1)(1995-3#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#3)(2009-11#1)
linearly related to the concentration of##3##6##(2008-10#3)
linearly related to the##12##4##(1994-11#1)(1995-3#1)(2008-10#8)(2008-2#1)(2010-8#1)
linearly related to##15##3##(1993-12#1)(1994-11#1)(1995-3#1)(2008-10#10)(2008-2#1)(2010-8#1)
linearly related##16##2##(1993-12#1)(1994-11#1)(1995-3#1)(2008-10#10)(2008-2#1)(2008-6#1)(2010-8#1)
linearly tapered##4##2##(2008-2#1)(2008-3#3)
linearly to the##2##3##(1995-3#1)(2008-10#1)
linearly to##6##2##(1995-3#1)(2008-10#4)(2008-7#1)
linearly tunable##2##2##(2008-3#2)
linearly with age##4##3##(1995-3#1)(2008-3#1)(2008-5#1)(2008-7#1)
linearly with both##2##3##(1993-8#1)(2008-10#1)
linearly with concentration##2##3##(2008-10#1)(2008-3#1)
linearly with dose##2##3##(1993-8#1)(2013-1#1)
linearly with increasing##7##3##(1991-11#2)(2007-9#1)(2008-10#1)(2008-6#2)(2009-7#1)
linearly with the concentration of##6##5##(2008-10#6)
linearly with the increase##2##4##(2007-11#1)(2010-8#1)
linearly with the##20##3##(2007-11#2)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-8#1)
linearly with time##2##3##(2008-10#2)
linearly with##55##2##(1990-5#1)(1991-11#2)(1992-6#1)(1993-8#2)(1995-3#1)(1996-4#1)(1996-5#1)(2007-11#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2013-1#2)
linearly##219##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-6#1)(1995-3#4)(1996-4#1)(1996-5#1)(1997-2#1)(2007-11#14)(2007-12#18)(2007-9#1)(2008-1#1)(2008-10#75)(2008-11#5)(2008-2#14)(2008-3#35)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#3)(2009-12#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-4#1)(2010-8#2)(2012-2#2)(2013-1#2)
lined by flattened##2##3##(1990-6#1)(2008-12#1)
lined by##11##2##(1990-6#2)(2007-12#1)(2008-11#1)(2008-12#2)(2010-6#2)(2011-2#1)(2013-1#1)(2013-8#1)
lined with a##2##3##(2007-12#1)(2008-10#1)
lined with##6##2##(2007-12#1)(2008-10#3)(2010-12#1)(2013-1#1)
lined##21##1##(1990-6#2)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
linens##3##1##(1991-2#1)(2013-8#2)
liner##9##1##(1990-2#2)(2008-10#1)(2008-5#1)(2008-8#3)(2013-1#2)
liners and##2##2##(1990-2#1)(2008-10#1)
liners##5##1##(1990-2#2)(2008-10#1)(2010-9#1)(2013-1#1)
lines (NILs)##4##2##(2008-10#4)
lines (RILs) derived from##2##4##(2008-10#2)
lines (RILs) derived##3##3##(2008-10#3)
lines (RILs) from a##2##4##(2008-10#2)
lines (RILs) from##3##3##(2008-10#2)(2008-8#1)
lines (RILs)##11##2##(2008-10#9)(2008-8#1)(2012-3#1)
lines across the##2##3##(2008-10#1)(2008-2#1)
lines after##2##2##(2008-9#1)(2012-2#1)
lines along##3##2##(2008-2#3)
lines and cultivars##2##3##(2008-10#2)
lines and the##2##3##(1994-12#1)(2008-10#1)
lines and##71##2##(1990-11#1)(1990-12#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-5#1)(2008-10#14)(2008-11#13)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
lines are##23##2##(1992-4#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-12#1)(1995-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2009-11#2)(2012-2#1)
lines as well as the##2##5##(2008-11#1)(2008-2#1)
lines as well as##5##4##(1996-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
lines as well##6##3##(1996-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-9#1)
lines as##10##2##(1993-12#1)(1996-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)
lines at the##2##3##(2008-10#1)(2008-3#1)
lines at##8##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
lines because##2##2##(2008-10#1)(2008-5#1)
lines between##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
lines but not in##2##4##(1992-8#1)(2008-10#1)
lines but##5##2##(1992-8#1)(2008-10#3)(2009-9#1)
lines by##21##2##(1991-12#1)(1992-9#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-2#1)(2012-3#1)
lines can be##2##3##(1990-5#1)(2008-3#1)
lines can##5##2##(1990-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
lines carrying the##4##3##(1995-2#1)(2008-10#3)
lines carrying##5##2##(1995-2#1)(2008-10#4)
lines compared with susceptible ones##2##5##(2008-10#2)
lines compared with##6##3##(2008-10#5)(2008-11#1)
lines compared##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
lines contained##2##2##(1990-2#1)(2008-11#1)
lines containing##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
lines could be##2##3##(2008-10#1)(2011-2#1)
lines could##5##2##(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)
lines cultured##2##2##(2008-11#1)(2008-9#1)
lines derived from a cross between##3##6##(2008-10#1)(2008-5#2)
lines derived from the cross##6##5##(2008-10#5)(2012-3#1)
lines derived from the##7##4##(2008-10#5)(2008-11#1)(2012-3#1)
lines derived from##23##3##(1991-2#1)(1992-2#1)(1993-8#1)(1995-12#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-3#1)
lines derived##24##2##(1991-2#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-12#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-3#1)
lines developed##2##2##(2008-10#2)
lines differing in##3##3##(1995-12#1)(1997-6#1)(2008-10#1)
lines emitted##2##2##(2007-11#1)(2008-3#1)
lines expressing CP under the control of##2##7##(2008-10#2)
lines expressing##9##2##(1992-12#1)(1993-3#1)(1994-2#1)(2008-10#4)(2008-2#1)(2012-2#1)
lines for sequential sampling##2##4##(2008-10#2)
lines for the##2##3##(2008-11#1)(2008-3#1)
lines for##18##2##(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2012-2#2)
lines from different##2##3##(1994-12#1)(1995-2#1)
lines from the##10##3##(2008-10#6)(2008-2#1)(2008-5#2)(2008-9#1)
lines from##27##2##(1990-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-7#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-5#2)(2008-9#1)(2010-3#1)(2012-12#1)(2013-8#1)
lines grown##2##2##(2008-10#1)(2008-11#1)
lines had##3##2##(2008-11#1)(2008-8#1)(2009-10#1)
lines harboring##3##2##(2008-10#2)(2012-2#1)
lines has been##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
lines has##7##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2013-1#1)
lines have been established##2##4##(1996-6#1)(2008-11#1)
lines have been##7##3##(1996-6#1)(2008-11#4)(2008-2#1)(2008-3#1)
lines have##13##2##(1996-6#1)(2008-10#2)(2008-11#8)(2008-2#1)(2008-3#1)
lines having##2##2##(1995-12#1)(2008-10#1)
lines if##2##2##(1992-3#2)
lines in a potato background##2##5##(2008-5#2)
lines in a##3##3##(1993-9#1)(2008-5#2)
lines in the##11##3##(1992-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)
lines in##43##2##(1990-11#1)(1991-6#1)(1992-3#1)(1993-9#4)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2011-3#1)(2012-12#1)(2013-8#1)
lines including a##2##3##(2008-10#1)(2008-11#1)
lines including##3##2##(2008-10#2)(2008-11#1)
lines indicated that##2##3##(1992-2#1)(2008-10#1)
lines infected with##4##3##(1991-12#2)(1997-8#1)(2008-10#1)
lines intensity of##2##3##(2008-9#1)(2013-8#1)
lines intensity##3##2##(2008-9#2)(2013-8#1)
lines is##9##2##(1994-8#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#2)(2012-12#2)
lines may be##3##3##(1993-12#1)(2008-11#1)(2008-12#1)
lines may##5##2##(1992-5#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
lines of a##5##3##(2008-10#4)(2008-9#1)
lines of carbon##2##3##(2008-2#1)(2008-3#1)
lines of evidence indicate that##7##5##(1990-11#1)(2008-7#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
lines of evidence suggest that##4##5##(1991-9#1)(2008-2#1)(2008-4#1)(2011-2#1)
lines of evidence##15##3##(1990-11#1)(1991-9#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#3)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
lines of maize##2##3##(2008-5#2)
lines of nitrogen##2##3##(2008-3#2)
lines of normal##2##3##(2008-10#1)(2008-11#1)
lines of the##16##3##(1995-6#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2012-3#1)
lines of##101##2##(1990-11#1)(1991-9#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#24)(2008-11#3)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
lines on##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
lines or##7##2##(1993-8#1)(1997-3#1)(2008-10#2)(2008-11#3)
lines originating from##2##3##(1993-9#1)(2008-11#1)
lines possessing##2##2##(2008-10#2)
lines represent##2##2##(2008-11#2)
lines representing##2##2##(1992-3#1)(2008-8#1)
lines required##2##2##(1993-9#1)(2008-3#1)
lines requires##2##2##(1990-7#1)(2008-11#1)
lines selected##2##2##(2008-10#1)(2008-8#1)
lines should be##3##3##(1995-12#1)(2008-10#2)
lines showed##8##2##(1992-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
lines showing a##2##3##(2008-10#2)
lines such as##4##3##(1994-6#1)(2008-11#3)
lines tested##7##2##(1992-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
lines that are##8##3##(1992-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)
lines that can##2##3##(2008-4#1)(2008-8#1)
lines that expressed##2##3##(1994-5#1)(2010-3#1)
lines that had##2##3##(2008-10#1)(2012-3#1)
lines that have been##2##4##(2008-10#1)(2008-5#1)
lines that##34##2##(1991-12#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
lines the##2##2##(2009-12#1)(2013-1#1)
lines to identify##2##3##(1992-6#1)(2008-10#1)
lines to##14##2##(1990-5#1)(1992-1#1)(1992-6#2)(1993-8#1)(2008-10#4)(2008-11#3)(2008-9#1)(2011-1#1)
lines used##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
lines using##6##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-2#1)
lines was##16##2##(1990-12#1)(1992-2#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
lines were analyzed for##2##4##(1992-2#1)(2008-10#1)
lines were analyzed##3##3##(1992-2#1)(2008-10#1)(2008-9#1)
lines were derived##2##3##(1993-9#1)(2008-10#1)
lines were evaluated##2##3##(2008-10#2)
lines were grown##2##3##(2008-10#1)(2010-3#1)
lines were identified##3##3##(2008-10#3)
lines were inoculated##2##3##(2008-10#2)
lines were not##2##3##(1994-12#1)(2008-8#1)
lines were selected##3##3##(2008-10#2)(2008-8#1)
lines were tested##5##3##(1994-8#1)(2008-10#4)
lines were used to##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
lines were##72##2##(1990-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#35)(2008-11#6)(2008-8#4)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
lines which##6##2##(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(2008-11#2)
lines while##2##2##(2008-2#1)(2011-2#1)
lines with high##2##3##(2008-10#1)(2012-3#1)
lines with resistance genes##2##4##(2008-10#2)
lines with single##2##3##(2008-10#2)
lines with the highest##2##4##(1992-9#1)(2008-10#1)
lines with the lowest##2##4##(2008-10#2)
lines with the##5##3##(1992-9#1)(2008-10#3)(2010-3#1)
lines with##42##2##(1992-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-6#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
lines##1356##1##(1990-11#7)(1990-12#4)(1990-2#6)(1990-5#4)(1990-6#4)(1990-7#3)(1990-8#3)(1991-12#10)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#6)(1991-9#3)(1992-1#1)(1992-12#6)(1992-2#19)(1992-3#14)(1992-4#4)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#15)(1992-9#17)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#10)(1993-5#2)(1993-6#9)(1993-8#6)(1993-9#20)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#9)(1994-2#10)(1994-3#1)(1994-5#4)(1994-6#11)(1994-8#8)(1995-12#16)(1995-2#10)(1995-3#2)(1995-6#7)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#5)(1996-6#3)(1996-7#2)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#5)(1997-6#3)(1997-7#12)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#13)(2007-12#10)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#316)(2008-11#217)(2008-12#9)(2008-2#52)(2008-3#58)(2008-4#24)(2008-5#28)(2008-6#10)(2008-7#24)(2008-8#53)(2008-9#44)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#8)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#22)(2011-3#3)(2012-1#1)(2012-12#14)(2012-2#22)(2012-3#21)(2013-1#15)(2013-8#7)
lines/mm##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
lineshape##2##1##(1994-11#1)(2008-10#1)
lineswhich##2##1##(2008-11#2)
linewidth and a##3##3##(2008-2#1)(2008-3#2)
linewidth and##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
linewidth equation##2##2##(2008-3#2)
linewidth estimate##2##2##(2008-3#2)
linewidth in a##2##3##(2007-11#1)(2007-12#1)
linewidth is##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
linewidth of a##5##3##(2007-11#1)(2008-2#4)
linewidth of the##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
linewidth of##27##2##(2007-11#5)(2007-12#3)(2008-2#9)(2008-3#9)(2009-11#1)
linewidth reduction##2##2##(2007-12#2)
linewidth to##2##2##(2007-12#1)(2008-2#1)
linewidth was##2##2##(2007-11#1)(2008-3#1)
linewidth##78##1##(2007-11#12)(2007-12#16)(2008-2#21)(2008-3#28)(2009-11#1)
linewidths and##2##2##(2008-3#2)
linewidths of the##2##3##(2007-11#1)(2007-12#1)
linewidths of##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
linewidths##14##1##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#5)
linezolid and rifampin##3##3##(2007-12#3)
linezolid and##4##2##(2007-12#3)(2010-6#1)
linezolid##14##1##(2006-10#2)(2007-12#3)(2007-7#1)(2008-10#4)(2008-8#1)(2010-6#1)(2011-2#2)
linger##2##1##(1992-12#1)(1995-1#1)
lingering##2##1##(1994-2#1)(2007-9#1)
lingual##9##1##(1994-12#1)(2008-11#2)(2010-3#3)(2012-2#1)(2013-1#2)
linguale##3##1##(2011-2#3)
linguistic access##2##2##(2010-8#2)
linguistic and cultural equivalency of two Chinese-version##2##7##(2010-5#2)
linguistic and cultural equivalency##3##4##(2010-5#3)
linguistic and cultural##5##3##(2010-5#3)(2010-8#2)
linguistic and##9##2##(2009-2#1)(2010-5#4)(2010-8#2)(2013-8#2)
linguistic features such as ambiguity##2##5##(2013-1#2)
linguistic performance##2##2##(1993-9#1)(2013-1#1)
linguistic representations##3##2##(2008-2#3)
linguistic##40##1##(1993-9#1)(1997-2#1)(2007-8#2)(2008-11#1)(2008-2#3)(2008-7#1)(2009-2#1)(2010-5#9)(2010-8#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#3)
lingular##2##1##(1991-3#1)(2008-1#1)
lini##7##1##(2008-10#7)
lining and##3##2##(1996-12#1)(2008-11#1)(2013-1#1)
lining of blood vessels##2##4##(1993-9#1)(2008-1#1)
lining of the##5##3##(1991-12#1)(1992-1#1)(2007-12#1)(2008-10#2)
lining of##10##2##(1991-12#1)(1992-1#1)(1993-9#2)(2007-12#1)(2008-1#1)(2008-10#2)(2010-9#1)(2013-1#1)
lining the##10##2##(1991-12#1)(1993-1#1)(2007-12#3)(2007-5#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
lining##32##1##(1991-12#2)(1992-1#1)(1993-1#1)(1993-9#2)(1996-12#1)(1996-9#1)(2007-12#6)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#3)
linings##2##1##(1995-12#1)(2010-3#1)
link analysis##2##2##(1990-3#1)(2008-2#1)
link and##2##2##(2008-10#1)(2008-9#1)
link between external##2##3##(1996-3#1)(2012-12#1)
link between inflammation and##2##4##(1997-2#1)(2008-3#1)
link between obesity##2##3##(2008-3#1)(2013-8#1)
link between the##20##3##(1990-11#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-11#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
link between these two##3##4##(2008-10#2)(2012-12#1)
link between these##5##3##(2008-10#2)(2009-10#1)(2012-12#1)(2012-2#1)
link between two##2##3##(1990-3#1)(1995-2#1)
link between##107##2##(1990-11#1)(1990-3#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#6)(2008-11#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#3)(2009-12#2)(2009-4#2)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#3)
link could be##2##3##(2007-7#1)(2013-7#1)
link exists between##2##3##(2008-3#1)(2008-8#1)
link in the##5##3##(1991-3#1)(2008-4#1)(2009-11#2)(2012-12#1)
link in##11##2##(1990-7#1)(1991-3#1)(1993-2#1)(1994-3#1)(2007-12#2)(2008-4#1)(2009-11#2)(2009-8#1)(2012-12#1)
link is##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-10#1)
link lecturers##2##2##(2008-11#2)
link nurses##3##2##(2008-11#3)
link of the##2##3##(1993-6#1)(2012-2#1)
link of##6##2##(1993-6#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-2#2)
link protein##2##2##(1991-5#1)(1992-12#1)
link the##12##2##(1993-12#1)(1994-12#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-9#1)
link them##3##2##(1993-2#1)(1996-3#1)(2008-6#1)
link these##2##2##(1994-2#1)(2012-12#1)
link to##9##2##(1993-12#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#1)
link was##4##2##(1993-9#1)(2008-4#1)(2012-3#1)(2013-1#1)
link with the##2##3##(2008-5#1)(2012-1#1)
link with##8##2##(1990-3#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-1#1)
link##265##1##(1990-11#1)(1990-3#4)(1990-7#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#4)(2007-12#13)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#19)(2008-11#23)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#8)(2008-9#4)(2009-10#3)(2009-11#3)(2009-12#3)(2009-4#3)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#4)
link?##6##1##(1991-3#1)(1992-1#1)(1994-3#1)(2008-3#1)(2008-7#1)(2009-5#1)
linkage analyses##3##2##(1997-5#1)(2008-10#2)
linkage analysis and##4##3##(1994-3#1)(2008-1#1)(2008-4#1)(2011-2#1)
linkage analysis is##3##3##(2008-4#2)(2012-3#1)
linkage analysis##31##2##(1990-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#11)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#2)
linkage and association##4##3##(2008-4#1)(2012-2#1)(2012-3#2)
linkage and##6##2##(1997-5#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#2)
linkage between the##9##3##(1990-8#1)(1993-12#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)
linkage between##27##2##(1990-8#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-6#1)(1997-5#2)(1997-9#1)(2008-10#5)(2008-12#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)
linkage disequilibria between##2##3##(2008-10#1)(2008-8#1)
linkage disequilibrium (LD)##3##3##(2008-12#1)(2010-5#1)(2012-5#1)
linkage disequilibrium among##2##3##(2008-10#2)
linkage disequilibrium between##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
linkage disequilibrium in##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
linkage disequilibrium with##4##3##(1997-5#1)(2012-3#3)
linkage disequilibrium##25##2##(1995-6#1)(1997-5#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#2)(2012-3#8)(2012-5#1)
linkage effects involving##2##3##(1990-8#2)
linkage effects##6##2##(1990-8#6)
linkage for##3##2##(1990-8#1)(2012-3#1)(2013-8#1)
linkage group##18##2##(2008-10#15)(2008-5#1)(2008-9#1)(2013-8#1)
linkage groups##17##2##(2008-10#10)(2008-12#1)(2008-5#2)(2009-12#1)(2013-8#3)
linkage in the##2##3##(1997-4#1)(2010-2#1)
linkage in##6##2##(1990-8#2)(1997-4#1)(2007-11#1)(2010-2#1)(2012-3#1)
linkage is##2##2##(2007-11#1)(2008-4#1)
linkage map is##2##3##(1994-9#1)(2013-8#1)
linkage map of##9##3##(1996-8#1)(2008-10#2)(2008-5#3)(2008-8#1)(2010-8#1)(2013-8#1)
linkage map was constructed##2##4##(2008-10#1)(2008-4#1)
linkage map with##2##3##(1994-9#1)(2008-8#1)
linkage map##48##2##(1994-9#2)(1995-6#1)(1996-10#1)(1996-12#5)(1996-6#2)(1996-8#2)(1997-2#1)(2008-10#10)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-8#6)
linkage mapping##5##2##(1995-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
linkage maps##5##2##(1995-6#1)(2008-10#2)(2008-7#1)(2008-8#1)
linkage of male##2##3##(2008-8#1)(2012-3#1)
linkage of the##5##3##(1993-11#1)(1994-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
linkage of##25##2##(1990-5#1)(1990-7#1)(1990-9#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(2007-6#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#3)(2010-11#1)(2011-2#1)(2012-3#3)
linkage region##2##2##(2012-3#2)
linkage relationships##4##2##(1990-8#1)(1995-8#1)(2008-10#2)
linkage search##2##2##(1994-9#1)(2008-1#1)
linkage studies##3##2##(2008-4#1)(2009-6#1)(2011-2#1)
linkage system##3##2##(1990-8#2)(2008-10#1)
linkage to a##2##3##(2008-10#1)(2008-7#1)
linkage to bipolar disorder##2##4##(1997-5#2)
linkage to the##3##3##(1992-10#1)(1992-3#1)(1997-7#1)
linkage to##20##2##(1990-8#1)(1992-10#1)(1992-3#2)(1997-3#1)(1997-5#4)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)
linkage was obtained##2##3##(1997-5#2)
linkage was##7##2##(1990-5#1)(1993-11#1)(1997-5#2)(2008-10#3)
linkage were##2##2##(1993-11#1)(1997-5#1)
linkage with##5##2##(1991-2#1)(1995-3#1)(2008-10#1)(2008-7#2)
linkage##340##1##(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#18)(1990-9#3)(1991-2#2)(1991-5#1)(1992-10#1)(1992-3#3)(1992-6#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#5)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#6)(1995-8#1)(1996-10#2)(1996-12#5)(1996-2#2)(1996-6#2)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#21)(1997-7#1)(1997-8#2)(1997-9#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#75)(2008-11#6)(2008-12#4)(2008-3#3)(2008-4#22)(2008-5#16)(2008-7#9)(2008-8#13)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#1)(2010-11#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#24)(2012-5#1)(2013-8#11)
linkages among##2##2##(1996-4#1)(2008-8#1)
linkages and##2##2##(2009-10#1)(2011-1#1)
linkages between##12##2##(1991-1#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2009-7#1)(2009-8#1)
linkages in##3##2##(1997-4#1)(1997-5#1)(2008-4#1)
linkages of##3##2##(1994-11#1)(1997-4#1)(2008-4#1)
linkages were##2##2##(1990-8#1)(2008-10#1)
linkages with##2##2##(1991-12#1)(1997-2#1)
linkages##53##1##(1990-8#2)(1991-1#2)(1991-12#1)(1991-7#1)(1992-12#1)(1994-1#1)(1994-11#3)(1994-3#1)(1995-1#1)(1995-11#1)(1996-4#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(2007-12#1)(2008-10#9)(2008-12#1)(2008-4#9)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2011-1#2)(2012-12#1)
linked administrative##3##2##(2008-6#1)(2011-1#1)(2011-2#1)
linked at##6##2##(1990-7#1)(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2009-12#1)
linked by a##2##3##(1990-2#1)(2008-7#1)
linked by##11##2##(1990-2#1)(1992-12#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-2#1)
linked for##2##2##(2012-1#1)(2012-2#1)
linked genes##4##2##(2008-10#4)
linked in coupling phase to##2##5##(2008-10#2)
linked in coupling phase##3##4##(2008-10#3)
linked in repulsion with the resistance##2##6##(2008-10#2)
linked in repulsion##3##3##(2008-10#3)
linked in##9##2##(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)
linked loci##3##2##(1995-2#1)(2008-10#2)
linked markers##3##2##(2008-10#3)
linked on the##3##3##(1990-9#1)(1993-6#1)(2008-4#1)
linked on##4##2##(1990-9#1)(1993-6#1)(2008-10#1)(2008-4#1)
linked pairs##2##2##(1993-8#1)(2008-12#1)
linked resistance genes##2##3##(2008-10#2)
linked sialic##3##2##(1991-9#1)(1994-9#1)(2008-7#1)
linked through##3##2##(1996-2#1)(2008-7#1)(2008-9#1)
linked to Co-4##2##3##(2008-10#2)
linked to Rcm##2##3##(2008-10#2)
linked to Rsp genes##3##4##(2008-10#3)
linked to Rsp2##2##3##(2008-10#2)
linked to a major##3##4##(2008-10#1)(2008-8#1)(2010-5#1)
linked to a##24##3##(1990-8#1)(1991-11#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2013-8#1)
linked to an##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
linked to both##4##3##(2008-12#1)(2012-12#2)(2012-3#1)
linked to cell##2##3##(2008-7#1)(2011-2#1)
linked to chromosome##2##3##(2008-7#1)(2011-1#1)
linked to clinical##2##3##(1992-12#1)(2011-2#1)
linked to each other##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
linked to each##5##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
linked to genetic##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
linked to human##2##3##(2008-4#1)(2012-9#1)
linked to increased##5##3##(1997-3#1)(2008-10#2)(2008-3#1)(2011-1#1)
linked to its##6##3##(1991-6#1)(1996-8#1)(2008-4#2)(2009-12#1)(2012-1#1)
linked to normal##2##3##(1990-4#1)(2009-7#1)
linked to several##2##3##(2008-7#1)(2013-1#1)
linked to some##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
linked to the avirulence gene##2##5##(2008-10#2)
linked to the chloramphenicol acetyltransferase##3##5##(1990-8#1)(1991-2#1)(1995-2#1)
linked to the coding domain of##2##6##(1994-5#2)
linked to the development of##3##5##(2008-11#1)(2009-5#1)(2012-5#1)
linked to the gene##2##4##(1991-12#1)(2011-2#1)
linked to the pathogenesis of##2##5##(2011-2#1)(2012-2#1)
linked to the##97##3##(1990-3#1)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-10#1)(1996-12#1)(1996-3#3)(1997-2#3)(1997-5#2)(2008-1#1)(2008-10#24)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
linked to therapeutic##2##3##(1993-1#1)(2011-1#1)
linked to this##2##3##(2008-10#1)(2008-12#1)
linked to##368##2##(1990-3#1)(1990-4#1)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#9)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#7)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#5)(1997-5#3)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#84)(2008-11#14)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#15)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-2#14)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#5)(2012-5#1)(2012-9#1)(2013-1#12)(2013-7#3)(2013-8#4)
linked together##3##2##(2007-11#1)(2008-4#1)(2008-7#1)
linked with a##3##3##(1992-2#1)(1994-12#1)(2008-10#1)
linked with the##7##3##(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)(2013-7#1)
linked with##44##2##(1990-8#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-6#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
linked##563##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#4)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#2)(1991-6#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#10)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#7)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#7)(1997-5#3)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-8#1)(2008-1#6)(2008-10#128)(2008-11#19)(2008-12#6)(2008-2#6)(2008-3#5)(2008-4#16)(2008-5#21)(2008-6#5)(2008-7#17)(2008-8#16)(2008-9#10)(2009-10#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#8)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#5)(2011-1#8)(2011-2#19)(2011-3#3)(2012-1#4)(2012-12#8)(2012-2#10)(2012-3#5)(2012-5#1)(2012-9#1)(2013-1#14)(2013-7#5)(2013-8#5)
linker DNA##2##2##(1994-9#2)
linker and the resulting##2##4##(2008-10#2)
linker and the##3##3##(2008-10#2)(2013-8#1)
linker between the two##2##4##(2008-10#1)(2010-5#1)
linker can##2##2##(1997-4#1)(2013-7#1)
linker group##2##2##(1991-12#2)
linker of##4##2##(1990-7#1)(1992-6#1)(2009-6#1)(2011-2#1)
linker protein##2##2##(1992-3#1)(2010-3#1)
linker repeat##3##2##(2008-6#3)
linker to the##3##3##(1992-6#1)(2008-4#2)
linker##52##1##(1990-2#1)(1990-7#1)(1991-12#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#4)(1994-5#1)(1994-9#3)(1997-4#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#1)
linker)##2##1##(2008-2#2)
linkers and resins##3##3##(1997-4#1)(2008-4#2)
linkers and##4##2##(1997-3#1)(1997-4#1)(2008-4#2)
linkers for solid-phase synthesis##2##4##(1997-4#2)
linkers for##3##2##(1997-3#1)(1997-4#2)
linkers into##2##2##(2008-4#2)
linkers to ligands##2##3##(2008-4#2)
linkers##25##1##(1991-8#2)(1994-12#2)(1997-3#2)(1997-4#4)(2008-10#1)(2008-2#4)(2008-4#9)(2010-7#1)
linking a##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
linking all##2##2##(1992-2#1)(2008-3#1)
linking clone##2##2##(1995-6#1)(1995-8#1)
linking equation##4##2##(2008-3#4)
linking impacts of##2##3##(1997-5#1)(2009-9#1)
linking it##2##2##(1996-3#1)(2011-2#1)
linking libraries and##2##3##(1994-12#2)
linking libraries##4##2##(1994-12#4)
linking number##2##2##(1994-6#1)(1995-8#1)
linking of##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
linking the##13##2##(1993-2#1)(1994-8#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-7#2)(2013-1#1)
linking theory##2##2##(2008-11#2)
linking to##2##2##(1993-8#1)(2012-3#1)
linking with the##2##3##(2008-10#1)(2008-2#1)
linking with##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
linking##108##1##(1990-5#1)(1990-8#1)(1990-9#4)(1992-2#1)(1993-2#1)(1993-8#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
links and##5##2##(2008-11#2)(2008-2#1)(2011-1#1)(2011-3#1)
links between the##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
links between these##3##3##(2009-10#1)(2012-12#1)(2013-8#1)
links between##37##2##(1992-12#2)(1992-4#1)(1992-5#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
links in##3##2##(1996-12#1)(2008-3#1)(2010-1#1)
links of##4##2##(2008-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
links that##2##2##(2008-3#1)(2009-5#1)
links the##5##2##(1992-5#1)(1996-1#1)(2008-6#1)(2008-8#1)(2010-4#1)
links to other##2##3##(2008-4#1)(2011-2#1)
links to the##2##3##(2008-8#1)(2008-9#1)
links to##9##2##(1996-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)
links were##3##2##(2008-10#1)(2009-7#1)(2011-1#1)
links with##6##2##(1991-6#1)(1994-1#1)(2007-12#1)(2008-11#1)(2009-10#1)(2011-2#1)
links##123##1##(1990-7#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-4#1)(1992-5#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#9)(2008-12#2)(2008-2#10)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#3)(2009-7#5)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
linoleate##12##1##(1990-2#1)(1995-2#6)(2008-10#3)(2008-5#2)
linoleic acid (CLA)##2##3##(2008-5#2)
linoleic acid and##3##3##(1990-2#1)(2008-11#1)(2009-6#1)
linoleic acid##23##2##(1990-12#1)(1990-2#1)(1992-8#3)(1994-12#1)(2008-11#8)(2008-12#2)(2008-5#4)(2008-7#1)(2009-6#1)(2012-2#1)
linoleic acids##2##2##(1994-8#1)(2009-6#1)
linoleic and arachidonic acids in A23187-stimulated##2##6##(1990-2#2)
linoleic and arachidonic##3##3##(1990-2#2)(1994-2#1)
linoleic##34##1##(1990-12#1)(1990-2#3)(1992-8#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-11#9)(2008-12#2)(2008-5#5)(2008-7#2)(2009-6#2)(2012-2#1)
linolenic and##2##2##(2008-11#1)(2008-5#1)
linolenic##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
linuron and neburon##2##3##(2008-10#2)
linuron##4##1##(2008-10#4)
lion##5##1##(2009-2#4)(2013-1#1)
lions##4##1##(1996-12#1)(2009-2#2)(2013-1#1)
lip and cleft##2##3##(2009-6#1)(2012-12#1)
lip and dental trauma##2##4##(2010-7#2)
lip and palate##14##3##(2007-12#3)(2008-10#1)(2009-8#1)(2010-3#1)(2011-2#3)(2013-1#5)
lip and##21##2##(1993-12#1)(2007-12#3)(2007-5#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
lip in##2##2##(2007-12#1)(2013-1#1)
lip or##2##2##(1997-3#1)(2012-3#1)
lip reconstruction##2##2##(2007-12#2)
lip repair##2##2##(2012-12#1)(2013-1#1)
lip with or without cleft palate##2##6##(2009-6#1)(2012-12#1)
lip##65##1##(1991-6#1)(1991-8#2)(1992-8#1)(1993-12#1)(1994-8#1)(1995-12#1)(1997-3#1)(2007-12#9)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#6)(2008-9#3)(2009-6#2)(2009-8#1)(2010-3#2)(2010-4#1)(2010-7#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-3#3)(2013-1#12)
lip/palate##4##1##(2011-1#1)(2011-2#3)
lipase (LPL)##10##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)
lipase GDSL##2##2##(2009-8#2)
lipase activity by##2##3##(1992-12#1)(2012-2#1)
lipase activity in##3##3##(2008-10#1)(2010-10#2)
lipase activity inhibitor##4##3##(2010-10#4)
lipase activity was##2##3##(2012-2#2)
lipase activity##20##2##(1991-5#1)(1992-12#1)(2008-10#5)(2008-7#1)(2010-10#8)(2012-2#4)
lipase and a##2##3##(2012-2#1)(2013-1#1)
lipase and amylase##2##3##(2008-10#2)
lipase and##5##2##(1992-3#1)(2008-10#2)(2012-2#1)(2013-1#1)
lipase cofactor##2##2##(1995-5#2)
lipase concentration as an##2##4##(1994-7#2)
lipase concentration##3##2##(1994-7#3)
lipase enzyme##2##2##(2008-6#1)(2008-7#1)
lipase from Pseudomonas cepacia##2##4##(2008-7#2)
lipase from##6##2##(1992-11#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-2#1)
lipase in##2##2##(1994-8#1)(2008-7#1)
lipase production##2##2##(2008-8#1)(2012-2#1)
lipase substrate##2##2##(1995-5#2)
lipase was##3##2##(2008-7#2)(2011-2#1)
lipase with##2##2##(1992-12#1)(1995-5#1)
lipase##109##1##(1991-12#3)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#5)(1992-9#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-3#2)(1994-7#4)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#9)(1995-6#2)(1996-11#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#12)(2008-8#2)(2009-8#2)(2010-10#8)(2011-1#1)(2011-2#3)(2012-2#11)(2012-3#1)(2013-1#4)
lipase-acyltransferase from Candida parapsilosis##2##4##(1997-2#2)
lipase-catalyzed##2##1##(2008-10#1)(2008-7#1)
lipase-producing##2##1##(2012-2#2)
lipases##13##1##(1995-2#2)(1995-3#2)(1995-5#1)(2008-7#1)(2008-8#3)(2011-1#1)(2012-2#1)(2013-1#2)
lipid (MEL)##2##2##(2008-11#2)
lipid A (MLA)##2##3##(1996-9#2)
lipid A in##2##3##(1990-5#1)(1991-5#1)
lipid A##15##2##(1990-11#1)(1990-5#4)(1991-5#2)(1993-11#2)(1995-12#1)(1996-9#2)(2011-2#3)
lipid abnormalities##2##2##(1991-12#1)(1993-2#1)
lipid absorption##2##2##(2008-2#1)(2012-2#1)
lipid accumulation in the##2##4##(1992-3#1)(2008-10#1)
lipid accumulation in##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
lipid accumulation##11##2##(1992-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#5)
lipid activators##3##2##(1991-9#2)(1994-12#1)
lipid analysis##2##2##(2008-10#1)(2008-4#1)
lipid and glucose levels in##2##5##(2008-10#2)
lipid and glucose levels##3##4##(2008-10#3)
lipid and glucose metabolism##4##4##(2008-1#1)(2008-3#2)(2012-3#1)
lipid and glucose##7##3##(2008-1#1)(2008-10#3)(2008-3#2)(2012-3#1)
lipid and lipoprotein metabolism and##2##5##(2008-11#1)(2008-6#1)
lipid and lipoprotein profile##2##4##(1992-2#1)(2008-2#1)
lipid and lipoprotein##8##3##(1992-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2012-2#1)(2013-1#2)
lipid and protein##4##3##(1993-11#1)(2009-8#1)(2010-4#2)
lipid and##32##2##(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1995-12#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
lipid as##2##2##(1992-6#1)(2009-8#1)
lipid barrier##5##2##(2008-5#4)(2013-1#1)
lipid barriers##2##2##(2008-5#2)
lipid bilayer induced by##2##4##(1990-11#1)(1992-6#1)
lipid bilayer membranes##2##3##(1993-11#2)
lipid bilayer of##2##3##(1990-11#1)(2011-1#1)
lipid bilayer##27##2##(1990-11#3)(1990-2#1)(1990-7#1)(1991-5#1)(1992-6#2)(1992-9#2)(1993-11#3)(1993-3#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2011-1#1)
lipid bilayers and its##2##4##(1993-3#1)(1994-12#1)
lipid bilayers##19##2##(1990-2#2)(1990-5#1)(1992-6#4)(1993-11#1)(1993-3#2)(1994-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#2)
lipid binding##4##2##(1992-12#1)(1992-3#1)(1992-9#1)(2008-10#1)
lipid changes##4##2##(2008-12#1)(2008-4#2)(2013-1#1)
lipid class##3##2##(2012-12#1)(2013-1#2)
lipid classes in##2##3##(2008-11#1)(2008-5#1)
lipid classes of BHK cells##2##5##(1992-9#2)
lipid classes of##3##3##(1992-9#2)(2008-11#1)
lipid classes##11##2##(1992-9#3)(1994-5#1)(2008-11#4)(2008-5#2)(2013-1#1)
lipid components of##2##3##(1994-11#1)(2008-11#1)
lipid components##6##2##(1992-12#1)(1993-11#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-11#1)
lipid composition and phase##2##4##(1994-5#1)(2008-5#1)
lipid composition of##7##3##(1990-7#2)(1994-2#1)(1994-3#1)(1994-6#1)(2008-7#1)(2013-7#1)
lipid composition##19##2##(1990-2#2)(1990-7#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-5#5)(2008-7#1)(2010-5#1)(2013-1#1)(2013-7#1)
lipid compositions##3##2##(1991-4#1)(1994-3#1)(2008-11#1)
lipid concentrations##4##2##(2008-3#1)(2008-4#1)(2012-2#2)
lipid content and##2##3##(2008-11#1)(2013-1#1)
lipid content of##4##3##(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
lipid content##11##2##(1994-11#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#2)
lipid core##4##2##(1990-2#1)(1994-3#2)(2010-9#1)
lipid coverage of##2##3##(2008-5#2)
lipid coverage##3##2##(2008-5#3)
lipid deposition##3##2##(2008-3#1)(2012-2#2)
lipid domains in##2##3##(1993-11#1)(1994-12#1)
lipid domains##5##2##(1993-11#2)(1994-12#2)(2008-5#1)
lipid droplet##2##2##(2007-12#1)(2013-1#1)
lipid droplets and##4##3##(2007-12#2)(2008-10#1)(2008-12#1)
lipid droplets##22##2##(1992-9#1)(1995-2#1)(1995-3#1)(2007-12#12)(2008-10#2)(2008-11#1)(2008-12#1)(2009-3#1)(2012-2#1)(2013-1#1)
lipid environment##3##2##(1994-12#1)(1997-7#1)(2008-4#1)
lipid extract of##3##3##(1990-2#1)(2008-10#2)
lipid extract##6##2##(1990-2#1)(1991-5#3)(2008-10#2)
lipid extracts##3##2##(1992-8#1)(2008-10#2)
lipid film##3##2##(2008-11#1)(2008-5#2)
lipid fluidity##4##2##(1991-5#1)(1994-2#1)(1995-8#2)
lipid formulations of amphotericin##2##4##(2011-2#2)
lipid fraction##2##2##(1990-2#1)(2008-11#1)
lipid fractions##6##2##(1992-10#1)(1994-3#1)(1996-8#1)(2007-7#1)(2008-11#1)(2008-5#1)
lipid globules##2##2##(2008-10#2)
lipid head##2##2##(2008-10#1)(2009-2#1)
lipid homeostasis##6##2##(2008-2#2)(2008-3#1)(2008-5#1)(2010-10#2)
lipid hydrolysis##3##2##(1994-3#2)(1995-5#1)
lipid hydroperoxides##13##2##(1992-11#2)(1995-2#2)(2008-10#1)(2008-5#2)(2009-8#4)(2010-6#1)(2013-1#1)
lipid in##3##2##(1994-3#1)(2008-9#1)(2013-1#1)
lipid kinases##2##2##(2008-4#1)(2010-9#1)
lipid lamellae are##2##3##(2008-5#2)
lipid lamellae##6##2##(2008-10#1)(2008-5#5)
lipid layer##4##2##(1992-6#1)(1994-11#1)(2008-5#1)(2008-8#1)
lipid levels and##3##3##(1993-9#1)(2008-12#1)(2013-1#1)
lipid levels##15##2##(1991-4#1)(1991-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1997-8#1)(2008-12#2)(2008-5#2)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
lipid lowering drugs##5##3##(1990-2#1)(2008-11#2)(2008-5#1)(2013-1#1)
lipid lowering##14##2##(1990-2#2)(1992-7#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#3)(2009-12#1)(2009-6#1)(2013-1#1)
lipid matrix##2##2##(2008-5#2)
lipid mediator##3##2##(1991-12#1)(1994-12#1)(1995-2#1)
lipid mediators##5##2##(1993-9#1)(1994-10#2)(1994-9#2)
lipid membrane and##2##3##(1994-11#1)(2008-10#1)
lipid membrane##11##2##(1990-2#1)(1990-7#1)(1994-11#3)(1994-5#3)(2008-10#2)(2009-12#1)
lipid membranes##17##2##(1990-11#1)(1992-6#2)(1993-5#1)(1994-12#3)(1997-7#2)(2008-10#4)(2009-12#2)(2010-5#2)
lipid messenger##2##2##(2012-2#1)(2013-1#1)
lipid metabolism and##4##3##(1994-12#1)(2008-11#1)(2008-3#1)(2013-7#1)
lipid metabolism are##2##3##(1990-2#1)(2010-5#1)
lipid metabolism as##2##3##(1992-3#1)(2013-1#1)
lipid metabolism in##6##3##(2008-11#1)(2008-9#1)(2011-2#2)(2013-1#2)
lipid metabolism was##2##3##(2008-10#1)(2008-9#1)
lipid metabolism##45##2##(1990-2#1)(1992-10#1)(1992-11#1)(1992-3#1)(1994-12#2)(1994-3#1)(1995-6#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#2)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#7)(2013-7#1)
lipid metabolites##2##2##(2008-1#1)(2013-8#1)
lipid microenvironment##2##2##(1991-9#1)(2008-10#1)
lipid mixture##4##2##(1990-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
lipid mixtures##2##2##(1995-5#1)(2008-5#1)
lipid mobilization in##2##3##(2008-6#1)(2009-10#1)
lipid mobilization##4##2##(2008-3#1)(2008-6#2)(2009-10#1)
lipid molecule##3##2##(1990-7#1)(1992-9#1)(1996-2#1)
lipid molecules##3##2##(1990-11#1)(1990-2#1)(2008-7#1)
lipid monolayer##7##2##(1990-5#1)(1991-5#2)(1994-3#2)(2009-12#2)
lipid monolayers##4##2##(1990-5#2)(1995-5#1)(2008-10#1)
lipid nanoparticles##3##2##(2008-5#3)
lipid of the##2##3##(1993-6#1)(2008-9#1)
lipid of##4##2##(1991-12#1)(1993-6#1)(2008-12#1)(2008-9#1)
lipid or##3##2##(1992-3#1)(1992-9#1)(2008-3#1)
lipid organization##4##2##(1993-8#1)(1994-5#1)(2008-5#2)
lipid oxidation##4##2##(2008-5#1)(2010-4#3)
lipid oxidative modification##2##3##(1990-12#1)(2009-8#1)
lipid oxidative##3##2##(1990-12#1)(2009-8#2)
lipid packing##5##2##(1992-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
lipid parameters##2##2##(1993-9#1)(2010-10#1)
lipid pattern of##2##3##(1990-7#1)(1991-12#1)
lipid peroxidation (LPO)##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
lipid peroxidation and antioxidant defense##2##5##(1996-9#1)(2013-1#1)
lipid peroxidation and antioxidant##3##4##(1996-9#1)(2008-7#1)(2013-1#1)
lipid peroxidation and muscle damage##2##5##(2008-5#2)
lipid peroxidation and the##2##4##(2008-4#1)(2008-7#1)
lipid peroxidation and##14##3##(1990-12#1)(1996-2#2)(1996-9#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
lipid peroxidation at##2##3##(1994-11#1)(2008-5#1)
lipid peroxidation by free radicals##2##5##(1990-3#1)(1993-2#1)
lipid peroxidation by##5##3##(1990-3#1)(1993-2#1)(1994-8#1)(1995-6#2)
lipid peroxidation in##5##3##(1992-3#1)(1994-6#2)(2008-11#1)(2008-12#1)
lipid peroxidation induced by FeCl2 in rat liver##2##8##(2008-4#2)
lipid peroxidation induced by##3##4##(1995-6#1)(2008-4#2)
lipid peroxidation induced##4##3##(1995-6#1)(1996-2#1)(2008-4#2)
lipid peroxidation of##4##3##(1991-5#1)(1991-9#1)(1994-6#1)(2008-5#1)
lipid peroxidation product##2##3##(1990-5#1)(2008-10#1)
lipid peroxidation products##6##3##(1990-5#1)(1994-11#1)(1995-12#1)(2009-8#3)
lipid peroxidation was##4##3##(1991-5#1)(1995-6#1)(2008-4#1)(2008-7#1)
lipid peroxidation were##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
lipid peroxidation##105##2##(1990-12#1)(1990-3#2)(1990-5#2)(1991-12#2)(1991-5#3)(1991-9#1)(1992-3#2)(1992-8#1)(1993-2#3)(1993-8#2)(1994-11#5)(1994-12#1)(1994-5#2)(1994-6#7)(1994-8#2)(1995-12#4)(1995-3#1)(1995-6#5)(1996-2#7)(1996-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#7)(2008-7#7)(2008-8#1)(2009-12#2)(2009-5#1)(2009-8#5)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
lipid peroxides at the##3##4##(2008-5#3)
lipid peroxides in##4##3##(1990-5#3)(2013-1#1)
lipid peroxides##10##2##(1990-5#4)(1991-9#1)(2008-5#3)(2008-7#1)(2013-1#1)
lipid phase##8##2##(1990-2#1)(1991-5#3)(1994-3#1)(1994-5#1)(2008-10#1)(2012-1#1)
lipid phases##5##2##(1992-9#2)(1994-5#1)(2008-5#2)
lipid probe##2##2##(2010-5#2)
lipid profile and##5##3##(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
lipid profile in##2##3##(2008-12#1)(2012-2#1)
lipid profile of##4##3##(2008-10#1)(2008-3#2)(2011-2#1)
lipid profile##27##2##(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-4#2)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
lipid profiles and##2##3##(2008-3#2)
lipid profiles in##3##3##(2008-12#1)(2008-3#1)(2010-4#1)
lipid profiles##18##2##(1991-12#2)(1991-4#1)(2008-10#2)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#2)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
lipid rafts##7##2##(2008-11#4)(2008-7#2)(2011-2#1)
lipid ratios##2##2##(1991-12#1)(2011-2#1)
lipid regulators##2##2##(2008-10#2)
lipid response to##2##3##(2012-2#2)
lipid rigidity##2##2##(1995-8#1)(2008-5#1)
lipid second##2##2##(1991-9#1)(2008-11#1)
lipid sialic acid##2##3##(1995-12#2)
lipid species##3##2##(1990-2#1)(2012-12#2)
lipid spectrum##2##2##(1992-3#2)
lipid status##2##2##(2011-1#2)
lipid storage diseases##2##3##(1993-9#2)
lipid storage##4##2##(1993-12#1)(1993-9#2)(2010-8#1)
lipid system##2##2##(2008-1#1)(2008-5#1)
lipid transfer##3##2##(1995-5#1)(2008-6#1)(2009-9#1)
lipid transfer/lipopolysaccharide##2##2##(1995-5#2)
lipid transport##4##2##(1992-9#2)(1995-6#1)(2011-2#1)
lipid values##2##2##(2008-10#2)
lipid vesicles of##2##3##(1990-2#1)(2013-7#1)
lipid vesicles##11##2##(1990-2#2)(1992-6#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-4#1)(2013-7#1)
lipid was##3##2##(1992-6#1)(1994-3#1)(2008-9#1)
lipid##869##1##(1990-11#7)(1990-12#4)(1990-2#24)(1990-3#3)(1990-5#18)(1990-7#8)(1991-12#10)(1991-4#3)(1991-5#16)(1991-6#1)(1991-9#7)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#8)(1992-6#17)(1992-7#1)(1992-8#2)(1992-9#16)(1993-11#10)(1993-12#1)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#5)(1994-10#2)(1994-11#13)(1994-12#13)(1994-2#4)(1994-3#17)(1994-5#13)(1994-6#8)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#3)(1995-5#9)(1995-6#7)(1995-8#5)(1996-2#10)(1996-3#2)(1996-8#1)(1996-9#3)(1997-6#2)(1997-7#3)(1997-8#4)(2007-11#1)(2007-12#16)(2007-7#2)(2008-1#9)(2008-10#66)(2008-11#48)(2008-12#12)(2008-2#6)(2008-3#23)(2008-4#18)(2008-5#80)(2008-6#7)(2008-7#32)(2008-8#10)(2008-9#15)(2009-10#1)(2009-12#11)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#19)(2009-9#3)(2010-10#4)(2010-11#1)(2010-12#3)(2010-4#7)(2010-5#9)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#10)(2011-2#20)(2012-1#3)(2012-12#6)(2012-2#20)(2012-3#6)(2013-1#44)(2013-7#6)(2013-8#1)
lipid-A##2##1##(2008-11#2)
lipid-associated##3##1##(1992-6#1)(1993-1#1)(2009-6#1)
lipid-laden##2##1##(1996-2#1)(2013-1#1)
lipid-like##2##1##(1994-12#1)(2007-12#1)
lipid-lowering therapy with##2##3##(2011-2#2)
lipid-lowering therapy##5##2##(2008-3#2)(2010-4#1)(2011-2#2)
lipid-lowering##10##1##(2008-3#4)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
lipid-mediated NGF cDNA transfection##2##4##(1996-12#2)
lipid-mediated NGF gene transfection##3##4##(1996-12#3)
lipid-mediated NGF##5##2##(1996-12#5)
lipid-mediated##6##1##(1996-12#6)
lipid-protein##2##1##(1992-6#1)(1994-3#1)
lipid-rich##3##1##(1991-8#1)(2008-5#1)(2010-12#1)
lipid-soluble##3##1##(1993-8#1)(2008-10#2)
lipid-stimulated kinase##5##2##(1992-9#5)
lipid-stimulated##6##1##(1992-9#6)
lipidic components##2##2##(2008-5#1)(2012-2#1)
lipidic model##2##2##(1994-2#1)(2008-10#1)
lipidic##13##1##(1990-2#1)(1991-5#1)(1994-2#1)(1994-3#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2012-2#1)
lipidosis of CF##3##3##(2012-3#3)
lipids and carbohydrates##2##3##(1990-8#1)(2008-5#1)
lipids and fatty##2##3##(1992-12#1)(2008-12#1)
lipids and lipoprotein##2##3##(2008-7#1)(2013-1#1)
lipids and proteins in the##2##5##(2008-10#1)(2008-7#1)
lipids and proteins##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
lipids and##54##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-10#4)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
lipids are##8##2##(1990-2#1)(1990-7#1)(2008-11#1)(2008-3#1)(2008-5#3)(2012-2#1)
lipids as well##2##3##(2008-5#1)(2008-8#1)
lipids at the##2##3##(2008-1#1)(2008-10#1)
lipids at##3##2##(1994-3#1)(2008-1#1)(2008-10#1)
lipids between##2##2##(1995-5#1)(2008-5#1)
lipids by##6##2##(1990-2#1)(1992-10#1)(1992-9#1)(1994-3#1)(2008-11#1)(2011-1#1)
lipids can be##2##3##(1992-9#1)(2008-4#1)
lipids extracted from##2##3##(2008-10#1)(2008-5#1)
lipids from S##2##3##(1990-2#1)(1994-11#1)
lipids from##3##2##(1990-2#1)(1994-11#1)(2008-5#1)
lipids in a##2##3##(1990-7#1)(2009-2#1)
lipids in the membrane##2##4##(1990-7#1)(1996-8#1)
lipids in the##9##3##(1990-7#1)(1992-8#1)(1993-11#1)(1994-5#2)(1996-8#1)(1997-2#1)(2008-9#1)(2010-11#1)
lipids in##28##2##(1990-12#1)(1990-7#2)(1991-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-5#2)(1996-8#3)(1997-2#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-2#2)(2013-8#1)
lipids is##2##2##(2008-1#1)(2008-5#1)
lipids of##6##2##(1992-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
lipids on##3##2##(2008-5#2)(2012-2#1)
lipids or##3##2##(1993-11#1)(2008-10#1)(2009-12#1)
lipids was##4##2##(1992-9#1)(1993-2#1)(1994-12#1)(2008-5#1)
lipids were measured##2##3##(2008-12#1)(2013-1#1)
lipids were##12##2##(1990-2#1)(1990-7#1)(1994-11#2)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-8#1)(2013-1#1)
lipids with a##2##3##(1995-2#1)(2008-10#1)
lipids with##9##2##(1995-2#2)(2008-10#1)(2009-12#1)(2009-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
lipids##289##1##(1990-12#3)(1990-2#12)(1990-7#6)(1990-8#3)(1991-11#1)(1991-4#1)(1991-5#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#6)(1997-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#21)(2008-11#14)(2008-12#13)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#47)(2008-7#8)(2008-8#5)(2008-9#4)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#6)(2010-11#1)(2010-5#4)(2010-8#1)(2011-1#5)(2011-2#8)(2012-12#3)(2012-2#4)(2013-1#12)(2013-8#3)
lipids)##5##1##(2007-12#1)(2008-11#2)(2008-5#1)(2008-9#1)
lipo-protein##2##1##(2008-3#1)(2011-2#1)
lipoamide dehydrogenase##11##2##(1992-1#5)(1992-3#1)(1996-12#5)
lipoamide dehydrogenase/citrate synthase##2##3##(1996-12#2)
lipoamide##15##1##(1992-1#5)(1992-3#3)(1996-12#7)
lipoatrophy##4##1##(2007-7#1)(2013-1#3)
lipoblastoma##2##1##(2010-11#1)(2012-2#1)
lipoblasts##2##1##(2008-6#1)(2013-1#1)
lipocalin##4##1##(2007-12#1)(2010-5#2)(2012-2#1)
lipodystrophy syndrome##2##2##(2008-3#2)
lipodystrophy##20##1##(1996-3#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#3)(2010-6#4)(2011-1#3)(2011-2#2)
lipofectin##4##1##(1991-5#3)(2008-11#1)
lipofection##6##1##(1997-4#2)(2008-1#1)(2008-11#1)(2008-4#2)
lipofuscin accumulation##2##2##(1994-6#2)
lipofuscin granules##2##2##(1995-3#1)(2008-7#1)
lipofuscin in##5##2##(1995-3#4)(2011-2#1)
lipofuscin was##2##2##(1994-6#1)(1995-3#1)
lipofuscin##17##1##(1992-12#1)(1994-6#3)(1995-3#10)(1996-12#1)(2008-7#1)(2011-2#1)
lipogenesis##9##1##(1992-10#1)(1994-6#2)(1994-8#1)(2010-4#1)(2012-2#3)(2013-1#1)
lipoic acid##7##2##(1990-8#1)(1992-3#2)(1995-3#2)(2008-5#2)
lipoid##4##1##(2008-5#2)(2011-2#2)
lipolysis and##3##2##(1994-6#1)(2008-3#1)(2008-5#1)
lipolysis in 3T3-L1 adipocytes following prolonged exposure to tolbutamide##2##9##(1991-12#2)
lipolysis in##3##2##(1991-12#3)
lipolysis of very low density lipoproteins##2##6##(1992-12#2)
lipolysis of##3##2##(1992-12#2)(1995-3#1)
lipolysis was##3##2##(1991-12#2)(2008-6#1)
lipolysis##20##1##(1991-12#5)(1992-12#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(2008-1#2)(2008-3#3)(2008-5#1)(2008-6#1)
lipolytic activity##5##2##(1991-5#1)(2010-10#3)(2012-2#1)
lipolytic enzymes##2##2##(1993-9#1)(2008-6#1)
lipolytic response of adipocytes to catecholamines##2##6##(1994-6#2)
lipolytic response##3##2##(1994-6#3)
lipolytic responses##2##2##(1991-12#2)
lipolytic##18##1##(1991-12#2)(1991-5#1)(1992-12#1)(1993-9#1)(1994-6#3)(1995-6#1)(2008-5#2)(2008-6#1)(2010-10#3)(2010-4#1)(2012-1#1)(2012-2#1)
lipolytica and##2##2##(2008-6#2)
lipolytica##5##1##(2008-6#2)(2011-1#3)
lipoma in##2##2##(1990-12#1)(2013-1#1)
lipoma is a##2##3##(1990-12#1)(2013-7#1)
lipoma is##5##2##(1990-12#1)(1993-9#1)(2010-3#1)(2013-1#1)(2013-7#1)
lipoma of the##3##3##(1990-3#1)(1993-9#1)(2011-2#1)
lipoma or##2##2##(1993-9#1)(2007-8#1)
lipoma was##3##2##(2010-3#1)(2013-1#1)(2013-7#1)
lipoma##35##1##(1990-12#4)(1990-3#1)(1993-9#8)(2007-8#2)(2008-10#3)(2008-6#2)(2010-3#4)(2011-2#1)(2012-1#1)(2013-1#5)(2013-7#4)
lipomas are##5##2##(1990-12#1)(1993-9#2)(2008-10#1)(2011-2#1)
lipomas##21##1##(1990-12#1)(1993-9#5)(2006-12#1)(2008-10#1)(2010-3#3)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
lipomata are##2##2##(1993-9#2)
lipomata##3##1##(1993-9#3)
lipomatosis and##2##2##(2007-2#1)(2012-2#1)
lipomatosis of the##2##3##(2009-3#1)(2011-2#1)
lipomatosis of##4##2##(2008-6#1)(2009-3#1)(2011-2#2)
lipomatosis##11##1##(1993-12#2)(2007-2#1)(2008-6#2)(2009-3#3)(2011-2#2)(2012-2#1)
lipomatous##8##1##(2008-6#2)(2009-1#3)(2012-2#3)
lipomeningomyelocele##2##1##(2008-7#2)
lipomyelomeningocele##2##1##(2008-7#2)
liponucleotide was##2##2##(1992-6#2)
liponucleotide##4##1##(1992-6#4)
lipooligosaccharide##3##1##(1993-11#2)(1994-8#1)
lipooligosaccharides##4##1##(1993-11#3)(1994-8#1)
lipopeptide##8##1##(1990-12#1)(1991-12#1)(1997-2#3)(2008-10#3)
lipopeptides##4##1##(1994-2#4)
lipoperoxidation##5##1##(1995-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
lipoperoxidative##2##1##(1995-3#2)
lipophilic TTF-TCNQ##2##2##(2008-10#2)
lipophilic acrylate resin##3##3##(2008-10#3)
lipophilic agents##3##2##(1997-1#2)(2008-5#1)
lipophilic anions##4##2##(2008-10#4)
lipophilic cation##2##2##(1993-11#1)(2008-9#1)
lipophilic cationic##4##2##(1993-11#1)(2008-10#3)
lipophilic chromoionophore##2##2##(2008-10#2)
lipophilic compounds##3##2##(2008-10#1)(2008-5#2)
lipophilic derivative##2##2##(1993-6#2)
lipophilic domains of membrane##2##4##(1994-11#2)
lipophilic drugs##3##2##(1997-1#2)(2008-11#1)
lipophilic fluorescent probe trimethylamino-diphenylhexatriene##2##4##(1990-11#2)
lipophilic fluorescent##3##2##(1990-11#2)(2008-9#1)
lipophilic salt##2##2##(2008-10#2)
lipophilic salts and various foreign common ions are tested##2##9##(2008-10#2)
lipophilic yeast##2##2##(1992-9#1)(2007-7#1)
lipophilic##111##1##(1990-11#2)(1990-2#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-6#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#4)(1996-2#1)(1997-1#4)(1997-6#1)(2007-7#1)(2008-10#57)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#14)(2008-9#2)(2009-2#1)
lipophilicity of##3##2##(2008-10#3)
lipophilicity##12##1##(1991-2#1)(1995-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2010-11#2)
lipoplexes##2##1##(2008-11#2)
lipopolyamine-condensed##2##1##(1995-2#2)
lipopolylysine##6##1##(1991-5#6)
lipopolysaccharide (LPS) and##3##3##(1993-3#2)(2008-11#1)
lipopolysaccharide (LPS) in##3##3##(1993-8#1)(1994-8#1)(1997-1#1)
lipopolysaccharide (LPS)##16##2##(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#2)(2009-12#1)(2010-8#1)
lipopolysaccharide and 8-bromo cAMP##2##4##(1991-2#2)
lipopolysaccharide and##3##2##(1991-2#3)
lipopolysaccharide could##2##2##(1996-12#2)
lipopolysaccharide of##5##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
lipopolysaccharide##64##1##(1990-2#1)(1990-5#4)(1991-2#4)(1992-12#2)(1992-3#3)(1992-8#1)(1993-3#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#5)(1996-12#7)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
lipopolysaccharide-induced##5##1##(1993-3#2)(1995-12#2)(2013-8#1)
lipopolysaccharide-stimulated##3##1##(1991-8#1)(1992-12#1)(1994-12#1)
lipopolysaccharide-treated host cells##2##3##(1996-12#2)
lipopolysaccharide-treated##3##1##(1996-12#3)
lipopolysaccharides##6##1##(1994-8#1)(1995-12#1)(2008-11#2)(2008-7#1)(2012-2#1)
lipoprotein (HDL) cholesterol##5##3##(2008-1#1)(2008-3#2)(2008-6#1)(2012-2#1)
lipoprotein (HDL) of##2##3##(1991-12#1)(2012-2#1)
lipoprotein (HDL)##14##2##(1991-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-4#1)(2012-2#3)
lipoprotein (HDL)-cholesterol##4##2##(1991-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
lipoprotein (LDL##3##2##(1993-11#1)(1994-6#1)(2013-8#1)
lipoprotein (LDL) cholesterol##4##3##(1991-8#1)(2008-3#1)(2010-12#1)(2012-2#1)
lipoprotein (LDL) is##2##3##(1994-3#1)(1996-2#1)
lipoprotein (LDL) receptor plays a##2##5##(1993-3#1)(1995-6#1)
lipoprotein (LDL) receptor##7##3##(1990-7#1)(1993-3#1)(1995-6#1)(1995-8#2)(2008-6#2)
lipoprotein (LDL)##32##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-3#1)(2008-10#3)(2008-3#3)(2008-6#4)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
lipoprotein (VLDL)##5##2##(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)
lipoprotein (a) concentrations##3##3##(1990-12#2)(2008-4#1)
lipoprotein (a) serum levels##2##4##(1990-12#2)
lipoprotein (a)##10##2##(1990-12#5)(1991-12#1)(1992-11#1)(2008-4#1)(2011-2#1)(2013-7#1)
lipoprotein and##3##2##(2008-10#1)(2008-12#2)
lipoprotein apheresis##3##2##(1994-12#1)(2011-2#2)
lipoprotein binding##3##2##(1995-5#3)
lipoprotein cholesterol (HDL-C)##5##3##(2008-1#1)(2010-8#1)(2012-6#1)(2013-1#2)
lipoprotein cholesterol (LDL-C) and##2##4##(2012-6#1)(2013-1#1)
lipoprotein cholesterol (LDL-C)##4##3##(2008-1#1)(2011-2#1)(2012-6#1)(2013-1#1)
lipoprotein cholesterol and##2##3##(2008-7#1)(2011-1#1)
lipoprotein cholesterol in##2##3##(1991-3#1)(2011-1#1)
lipoprotein cholesterol ratio##2##3##(2008-3#2)
lipoprotein cholesterol##30##2##(1991-3#1)(1993-12#2)(2008-1#2)(2008-3#4)(2008-7#3)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-3#1)(2012-6#2)(2013-1#5)
lipoprotein cholesterol)##3##2##(1990-8#2)(2008-3#1)
lipoprotein fraction##3##2##(1990-8#2)(2008-6#1)
lipoprotein fractions##5##2##(1990-8#1)(2008-6#1)(2008-7#1)(2012-2#2)
lipoprotein from##4##2##(1991-12#1)(1993-8#1)(1995-6#1)(2010-10#1)
lipoprotein levels##3##2##(1991-12#1)(2011-1#1)(2013-1#1)
lipoprotein lipase (LPL) in##3##4##(1993-8#1)(1995-6#1)(2008-11#1)
lipoprotein lipase (LPL)##7##3##(1991-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-7#1)
lipoprotein lipase##21##2##(1991-12#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-8#2)(1994-11#2)(1995-5#1)(1995-6#2)(1996-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
lipoprotein lipases##2##2##(1995-2#2)
lipoprotein metabolism and##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
lipoprotein metabolism in the metabolic syndrome##2##6##(2008-6#2)
lipoprotein metabolism in##5##3##(1993-6#1)(1994-8#1)(2008-6#3)
lipoprotein metabolism is##2##3##(2008-6#2)
lipoprotein metabolism##14##2##(1990-2#1)(1993-12#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-6#7)(2008-7#1)
lipoprotein oxidation and##2##3##(1994-9#1)(2008-5#1)
lipoprotein oxidation##3##2##(1994-9#1)(2008-5#1)(2008-8#1)
lipoprotein profile##4##2##(1992-2#1)(1993-12#2)(2008-2#1)
lipoprotein receptor by##2##3##(1990-7#1)(1995-6#1)
lipoprotein receptor##18##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-2#2)(1993-3#2)(1994-9#1)(1995-2#2)(1995-6#1)(2007-8#1)(2008-8#2)(2009-8#1)(2013-1#2)
lipoprotein subclass##3##2##(2008-3#3)
lipoprotein that##3##2##(1995-6#1)(2008-10#1)(2008-6#1)
lipoprotein were##2##2##(1993-9#1)(2008-12#1)
lipoprotein##263##1##(1990-11#2)(1990-12#6)(1990-2#8)(1990-7#2)(1990-8#5)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#9)(1993-3#5)(1993-6#5)(1993-8#4)(1993-9#3)(1994-11#6)(1994-12#2)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#3)(1995-12#2)(1995-2#5)(1995-5#4)(1995-6#7)(1995-8#3)(1996-11#1)(1996-2#2)(1996-3#1)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#18)(2008-4#2)(2008-5#4)(2008-6#23)(2008-7#11)(2008-8#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#6)(2012-2#9)(2012-3#1)(2012-6#2)(2013-1#12)(2013-7#1)(2013-8#2)
lipoprotein(a)##8##1##(1993-12#3)(1993-2#1)(1995-2#2)(1995-6#1)(2013-8#1)
lipoprotein-cholesterol and##3##2##(2010-5#3)
lipoprotein-cholesterol levels##2##2##(2008-7#1)(2010-5#1)
lipoprotein-cholesterol##11##1##(1997-8#1)(2008-7#2)(2010-5#8)
lipoproteins (HDL)##3##2##(1993-8#1)(1995-5#1)(2008-10#1)
lipoproteins (LDL)##9##2##(1991-5#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-3#1)(1995-12#1)(1995-5#1)(2008-10#1)
lipoproteins (VLDL)##5##2##(1990-8#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-3#1)
lipoproteins and##13##2##(1991-12#1)(1993-12#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#1)(2012-2#3)
lipoproteins are##7##2##(1990-2#1)(1993-12#1)(1994-12#1)(2008-5#3)(2013-1#1)
lipoproteins by##4##2##(1990-8#1)(1991-11#1)(1991-5#1)(1995-5#1)
lipoproteins contain##2##2##(1991-9#1)(2012-2#1)
lipoproteins containing apo##2##3##(1993-12#2)
lipoproteins containing##3##2##(1993-12#2)(1993-9#1)
lipoproteins in##5##2##(1990-2#1)(1990-8#1)(1993-12#1)(1995-6#1)(2010-12#1)
lipoproteins of##2##2##(1993-12#1)(2013-1#1)
lipoproteins on##2##2##(1995-8#1)(2008-6#1)
lipoproteins tested##2##2##(1992-3#1)(1993-6#1)
lipoproteins to##5##2##(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-7#1)
lipoproteins were##2##2##(1992-3#1)(2012-2#1)
lipoproteins##123##1##(1990-2#3)(1990-8#7)(1991-11#2)(1991-12#2)(1991-5#2)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#6)(1992-9#1)(1993-11#1)(1993-12#12)(1993-6#5)(1993-8#5)(1993-9#1)(1994-12#2)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#4)(1995-12#2)(1995-2#3)(1995-5#10)(1995-6#6)(1995-8#4)(1996-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2009-8#1)(2010-12#1)(2012-2#7)(2013-1#2)(2013-8#1)
lipoproteins]##2##1##(1991-11#1)(1992-11#1)
liposarcoma##17##1##(1990-5#1)(1990-9#2)(1992-10#1)(2007-8#1)(2008-6#9)(2009-9#1)(2013-1#2)
liposarcomas##2##1##(2012-2#2)
liposoluble##3##1##(1990-8#1)(2008-11#1)(2008-5#1)
liposomal amphotericin B##4##3##(2008-10#1)(2008-5#3)
liposomal antigen##2##2##(1995-5#2)
liposomal doxorubicin##2##2##(2007-7#1)(2008-7#1)
liposomal media##2##2##(2008-8#2)
liposomal nanovesicles for##3##3##(2008-10#3)
liposomal nanovesicles##6##2##(2008-10#6)
liposomal##39##1##(1990-12#1)(1990-2#2)(1992-6#1)(1994-12#2)(1995-2#2)(1995-5#4)(2007-11#5)(2007-7#1)(2008-10#11)(2008-5#4)(2008-7#1)(2008-8#3)(2010-3#1)(2013-1#1)
liposome and##3##2##(1994-9#1)(2008-8#1)(2011-2#1)
liposome chromatography##2##2##(2008-10#2)
liposome coated zirconia-magnesia##2##3##(2008-10#2)
liposome coated##4##2##(2008-10#4)
liposome systems##3##2##(2008-5#3)
liposome uptake##3##2##(1993-8#3)
liposome was##3##2##(1994-9#3)
liposome##39##1##(1993-8#3)(1994-12#1)(1994-5#2)(1994-9#7)(1997-7#1)(2008-10#11)(2008-5#4)(2008-8#3)(2008-9#4)(2010-3#1)(2010-5#1)(2011-2#1)
liposome-based##3##1##(2008-10#2)(2008-11#1)
liposome-encapsulated##2##1##(1994-11#1)(1994-12#1)
liposome-loaded##3##1##(1993-8#3)
liposome/DNA complexes##2##2##(1997-1#2)
liposomes and##10##2##(1992-6#1)(1994-11#1)(1994-5#1)(1997-1#2)(2008-10#3)(2008-8#1)(2012-2#1)
liposomes are##5##2##(2008-10#2)(2008-5#2)(2010-5#1)
liposomes as##4##2##(1994-12#1)(2008-10#3)
liposomes at##2##2##(1994-12#1)(2008-8#1)
liposomes by##2##2##(1997-1#1)(2008-10#1)
liposomes containing##4##2##(1993-9#1)(1994-3#1)(1995-2#1)(2008-8#1)
liposomes does not##2##3##(2008-10#1)(2008-5#1)
liposomes for##3##2##(1994-5#2)(2008-5#1)
liposomes has been##2##3##(2008-10#2)
liposomes have been##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
liposomes have##4##2##(2008-10#2)(2008-8#1)(2010-5#1)
liposomes in the##2##3##(1990-11#1)(1994-2#1)
liposomes in##7##2##(1990-11#1)(1990-2#2)(1993-11#1)(1993-8#1)(1994-2#1)(2008-10#1)
liposomes is##2##2##(2008-10#1)(2009-5#1)
liposomes made from##2##3##(1994-2#1)(2008-5#1)
liposomes may##2##2##(1995-5#1)(2008-1#1)
liposomes of dipalmitoylphosphatidylcholine##2##3##(1991-5#1)(1994-12#1)
liposomes of##4##2##(1991-5#1)(1994-12#2)(1995-2#1)
liposomes on the##2##3##(1994-12#1)(2008-5#1)
liposomes sensitized by hypocrellin and its derivatives##2##7##(2008-8#2)
liposomes sensitized by##3##3##(2008-8#3)
liposomes to the##2##3##(2008-10#1)(2008-8#1)
liposomes to##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
liposomes using##3##2##(1994-12#1)(2008-10#1)(2013-8#1)
liposomes was determined by##2##4##(1990-2#1)(1995-2#1)
liposomes was##8##2##(1990-11#1)(1990-2#2)(1994-3#3)(1995-2#1)(2008-5#1)
liposomes were##3##2##(1990-12#1)(1991-5#1)(1994-3#1)
liposomes with##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
liposomes##161##1##(1990-11#2)(1990-12#3)(1990-2#8)(1990-8#1)(1991-5#7)(1992-6#4)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#16)(1994-2#3)(1994-3#12)(1994-5#7)(1994-9#1)(1995-11#1)(1995-2#9)(1995-5#1)(1996-2#1)(1997-1#5)(1997-7#1)(2008-1#1)(2008-10#37)(2008-11#2)(2008-5#10)(2008-8#13)(2009-5#2)(2010-5#3)(2012-2#1)(2013-1#1)(2013-8#1)
lipospheres plain##2##2##(1993-1#2)
lipospheres##3##1##(1993-1#3)
liposuction##5##1##(2008-10#1)(2010-8#3)(2011-1#1)
lipoteichoic acid##3##2##(1995-6#2)(1996-12#1)
lipoxygenase activity##3##2##(2008-10#2)(2008-3#1)
lipoxygenase isolated from hairy root cultures of Solanum tuberosum##2##9##(1992-12#2)
lipoxygenase##19##1##(1992-12#3)(1992-3#1)(1992-8#1)(1994-9#1)(1995-5#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-10#1)
lipoxygenases##4##1##(2009-6#4)
lipozyme##2##1##(2008-6#2)
lips and##4##2##(1995-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
lips are##3##2##(2011-2#3)
lips##12##1##(1995-6#1)(2008-10#1)(2009-7#1)(2011-2#7)(2012-2#1)(2013-1#1)
lipstick was##2##2##(2008-5#2)
lipstick##13##1##(2008-5#13)
lipsticks##5##1##(2007-7#1)(2008-5#4)
liquefaction##2##1##(2008-10#1)(2008-6#1)
liquefied cassava starch##2##3##(2008-6#2)
liquefied##6##1##(1996-1#1)(2008-6#3)(2009-10#1)(2013-1#1)
liquid N(2)##2##2##(2007-12#1)(2008-3#1)
liquid aerosols##2##2##(2008-2#2)
liquid and glass##2##3##(2010-8#1)(2012-2#1)
liquid and solid media##2##4##(2008-9#2)
liquid and solid##9##3##(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#3)(2010-5#1)
liquid and##17##2##(1994-6#1)(1995-3#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#4)(2010-5#1)(2010-8#1)(2012-2#1)
liquid as it##2##3##(2012-2#2)
liquid as##4##2##(2008-10#1)(2012-2#2)(2013-1#1)
liquid chromatograph (HPLC)##2##3##(2008-10#2)
liquid chromatograph##3##2##(2008-10#3)
liquid chromatographic (HPLC)##9##3##(1990-8#3)(1996-5#1)(2008-10#4)(2008-5#1)
liquid chromatographic (LC) method##3##4##(2008-10#3)
liquid chromatographic (LC)##4##3##(2008-10#4)
liquid chromatographic analysis of##2##4##(2008-10#2)
liquid chromatographic analysis##4##3##(1994-8#1)(2008-10#3)
liquid chromatographic assay for the##2##5##(1996-5#2)
liquid chromatographic assay for##4##4##(1991-5#1)(1996-5#2)(2008-10#1)
liquid chromatographic assay of##3##4##(1991-5#2)(2008-10#1)
liquid chromatographic assay##8##3##(1991-5#3)(1996-5#2)(1997-2#1)(2008-10#2)
liquid chromatographic assays##2##3##(1991-5#2)
liquid chromatographic determination of##15##4##(1991-5#2)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#10)
liquid chromatographic method for the analysis of##2##7##(1992-3#1)(2008-10#1)
liquid chromatographic method for the determination of##5##7##(1990-8#1)(1993-9#1)(1996-5#1)(2008-10#2)
liquid chromatographic method for the##10##5##(1990-8#1)(1991-5#1)(1992-3#1)(1993-9#1)(1996-5#1)(2008-10#5)
liquid chromatographic method for##15##4##(1990-8#1)(1991-5#1)(1992-3#1)(1993-9#1)(1996-5#1)(1997-2#1)(2008-10#7)(2011-1#1)(2012-12#1)
liquid chromatographic method has been developed for the simultaneous##2##9##(2008-10#1)(2010-3#1)
liquid chromatographic method has been developed for the##3##8##(2008-10#1)(2010-3#1)(2012-12#1)
liquid chromatographic method has been developed##4##6##(2008-10#1)(2010-3#2)(2012-12#1)
liquid chromatographic method with##3##4##(1990-8#1)(1991-5#1)(2008-10#1)
liquid chromatographic method##31##3##(1990-8#2)(1991-5#5)(1992-3#1)(1993-9#1)(1996-5#2)(1997-2#3)(2008-10#11)(2010-3#2)(2011-1#1)(2012-12#2)(2012-2#1)
liquid chromatographic methods##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
liquid chromatographic separation of##5##4##(1997-2#1)(2008-10#4)
liquid chromatographic separation##8##3##(1991-5#1)(1997-2#1)(2008-10#5)(2012-1#1)
liquid chromatographic system for##2##4##(2013-1#2)
liquid chromatographic system##3##3##(2008-5#1)(2013-1#2)
liquid chromatographic##112##2##(1990-7#1)(1990-8#8)(1991-2#1)(1991-5#16)(1992-3#1)(1992-6#2)(1993-2#1)(1993-9#3)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#8)(1997-2#7)(2007-12#1)(2008-10#48)(2008-5#2)(2010-3#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
liquid chromatography (HPLC) and##12##4##(1992-2#1)(1992-8#1)(2008-10#6)(2009-8#1)(2010-2#2)(2011-1#1)
liquid chromatography (HPLC) as##2##4##(2008-10#2)
liquid chromatography (HPLC) coupled with##2##5##(2008-10#2)
liquid chromatography (HPLC) coupled##3##4##(2008-10#3)
liquid chromatography (HPLC) for the determination of##2##7##(2008-10#2)
liquid chromatography (HPLC) for the##3##5##(2008-10#3)
liquid chromatography (HPLC) has##2##4##(1991-5#1)(2008-5#1)
liquid chromatography (HPLC) is a##2##5##(1991-5#1)(2008-4#1)
liquid chromatography (HPLC) is##3##4##(1991-5#1)(2008-10#1)(2008-4#1)
liquid chromatography (HPLC) method with##3##5##(2008-10#3)
liquid chromatography (HPLC) method##8##4##(2008-10#6)(2008-5#1)(2011-2#1)
liquid chromatography (HPLC) using##4##4##(1992-11#1)(2008-10#3)
liquid chromatography (HPLC) was developed##2##5##(2008-10#2)
liquid chromatography (HPLC) was##3##4##(2008-10#3)
liquid chromatography (HPLC) with a##6##5##(2008-10#5)(2010-2#1)
liquid chromatography (HPLC) with detection at##2##6##(2008-10#2)
liquid chromatography (HPLC) with electrochemical##2##5##(2008-10#2)
liquid chromatography (HPLC) with fluorescence##2##5##(2008-10#2)
liquid chromatography (HPLC) with##20##4##(1995-3#1)(1997-2#2)(2008-10#14)(2008-5#1)(2010-2#1)(2010-5#1)
liquid chromatography (HPLC)##113##3##(1990-8#3)(1991-5#2)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#2)(2008-10#73)(2008-11#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#1)(2009-8#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#1)
liquid chromatography (LC) and##2##4##(2008-10#2)
liquid chromatography (LC) has##2##4##(2008-10#2)
liquid chromatography (LC) system##2##4##(2008-10#2)
liquid chromatography (LC)##15##3##(2008-10#15)
liquid chromatography (RP-HPLC) was##2##4##(2008-10#2)
liquid chromatography (RP-HPLC)##9##3##(1990-2#1)(1990-8#1)(2008-10#6)(2011-1#1)
liquid chromatography (RP-LC)##3##3##(2008-10#3)
liquid chromatography after##2##3##(1991-12#1)(2008-11#1)
liquid chromatography analysis##6##3##(2008-10#6)
liquid chromatography and capillary##3##4##(1996-5#3)
liquid chromatography and its application to##2##6##(1990-8#1)(2008-10#1)
liquid chromatography and mass spectrometry##3##5##(2008-1#1)(2008-10#1)(2010-11#1)
liquid chromatography and solid-phase##2##4##(1992-11#1)(2008-10#1)
liquid chromatography and ultraviolet detection##2##5##(2008-10#2)
liquid chromatography and##33##3##(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-6#1)(1993-9#1)(1995-2#1)(1996-5#3)(2008-1#1)(2008-10#15)(2008-7#1)(2010-11#1)(2011-1#1)
liquid chromatography coupled to##3##4##(2008-10#1)(2010-5#1)(2012-1#1)
liquid chromatography coupled with##9##4##(1995-11#1)(2008-10#7)(2012-3#1)
liquid chromatography coupled##12##3##(1995-11#1)(2008-10#8)(2010-5#1)(2012-1#1)(2012-3#1)
liquid chromatography demonstrated##2##3##(1990-11#1)(1990-7#1)
liquid chromatography determination##2##3##(2008-10#2)
liquid chromatography electrospray##2##3##(2008-10#2)
liquid chromatography for the determination of##2##6##(2008-10#2)
liquid chromatography for the##7##4##(1991-5#1)(2008-10#6)
liquid chromatography in##9##3##(1990-8#4)(1991-5#1)(2008-10#3)(2010-11#1)
liquid chromatography is##2##3##(1991-5#1)(2008-10#1)
liquid chromatography method##7##3##(1990-8#1)(1997-2#1)(2008-10#4)(2008-5#1)
liquid chromatography of##11##3##(1990-8#2)(1994-6#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-4#1)
liquid chromatography on a##2##4##(2008-10#2)
liquid chromatography on##7##3##(1990-8#2)(1991-12#1)(1997-2#1)(2008-10#3)
liquid chromatography separation##3##3##(2008-10#2)(2008-9#1)
liquid chromatography separations##2##3##(2008-10#1)(2008-7#1)
liquid chromatography using##7##3##(1991-5#1)(2008-10#5)(2011-1#1)
liquid chromatography was##2##3##(1990-8#1)(1992-6#1)
liquid chromatography with UV absorbance and##2##6##(2008-10#2)
liquid chromatography with UV##4##4##(1996-5#1)(2008-10#3)
liquid chromatography with a##5##4##(2008-10#2)(2008-5#2)(2009-8#1)
liquid chromatography with electrochemical detection##2##5##(1991-5#1)(2008-10#1)
liquid chromatography with fluorescence detection##11##5##(1991-5#1)(2008-10#10)
liquid chromatography with fluorescence##13##4##(1991-5#1)(1993-2#1)(2008-10#11)
liquid chromatography with##59##3##(1990-8#5)(1991-5#3)(1991-7#1)(1992-1#1)(1993-2#1)(1995-3#1)(1995-6#1)(1996-5#3)(1997-2#2)(2008-10#36)(2008-5#3)(2009-8#1)(2010-4#1)
liquid chromatography##473##2##(1990-11#1)(1990-12#2)(1990-2#5)(1990-5#1)(1990-7#5)(1990-8#31)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#18)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#3)(1992-2#2)(1992-3#1)(1992-6#4)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#3)(1996-2#2)(1996-5#11)(1997-2#9)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#271)(2008-11#2)(2008-4#3)(2008-5#17)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-8#4)(2010-11#3)(2010-2#3)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#11)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
liquid chromatography-UV irradiation-hydride##2##3##(2008-10#2)
liquid chromatography-UV##3##2##(2008-10#3)
liquid chromatography-electrospray ionization mass spectrometry##2##5##(2008-10#2)
liquid chromatography-electrospray ionization tandem mass spectrometry##4##6##(2008-10#1)(2011-1#1)(2011-2#2)
liquid chromatography-electrospray ionization tandem mass##5##5##(2008-10#1)(2011-1#2)(2011-2#2)
liquid chromatography-electrospray ionization##7##3##(2008-10#3)(2011-1#2)(2011-2#2)
liquid chromatography-electrospray ionization-mass##2##3##(2008-10#1)(2012-3#1)
liquid chromatography-electrospray mass spectrometry##3##4##(2008-10#3)
liquid chromatography-electrospray##16##2##(2008-10#7)(2008-8#2)(2010-4#1)(2011-1#3)(2011-2#2)(2012-3#1)
liquid chromatography-electrospray-ion trap mass spectrometry##2##5##(2008-10#2)
liquid chromatography-electrospray-mass spectrometry##3##3##(2008-10#3)
liquid chromatography-electrospray-tandem mass spectrometry##3##4##(2008-10#3)
liquid chromatography-inductively coupled plasma mass spectrometry##4##6##(2008-10#4)
liquid chromatography-inductively coupled plasma##5##4##(2008-10#5)
liquid chromatography-inductively coupled##6##3##(2008-10#6)
liquid chromatography-mass spectrometry (LC-MS)##3##4##(2008-10#1)(2011-1#1)(2012-1#1)
liquid chromatography-mass spectrometry##8##3##(1990-5#1)(1997-2#1)(2008-10#4)(2011-1#1)(2012-1#1)
liquid chromatography-mass##9##2##(1990-5#1)(1997-2#1)(2008-10#4)(2011-1#2)(2012-1#1)
liquid chromatography-tandem mass spectrometry##8##4##(2008-10#5)(2011-1#2)(2013-1#1)
liquid chromatography-tandem mass spectrometry]##4##4##(2011-1#4)
liquid chromatography-tandem mass##12##3##(2008-10#5)(2011-1#6)(2013-1#1)
liquid chromatography/electrospray ionization##2##3##(2008-10#1)(2011-1#1)
liquid chromatography/electrospray/mass spectrometry##4##3##(2008-10#4)
liquid chromatography/tandem mass spectrometry##3##4##(2010-7#2)(2013-1#1)
liquid chromatography/tandem##5##2##(2008-10#2)(2010-7#2)(2013-1#1)
liquid core microcapsules##4##3##(2008-11#4)
liquid core waveguide (LCW)##2##4##(2008-10#2)
liquid core waveguide##7##3##(2008-10#7)
liquid core##13##2##(2008-10#8)(2008-11#4)(2010-8#1)
liquid crystal cell##2##3##(2008-2#2)
liquid crystal materials##3##3##(2008-10#2)(2008-2#1)
liquid crystal##34##2##(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#8)(2008-2#6)(2008-3#3)(2008-5#1)(2008-7#1)(2011-1#1)
liquid crystalline##9##2##(1992-9#2)(1994-3#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
liquid crystalline)##2##2##(2008-10#2)
liquid crystallinity of##2##3##(2008-10#1)(2008-7#1)
liquid crystallinity##4##2##(2008-10#3)(2008-7#1)
liquid crystals (LCs)##2##3##(1995-6#1)(2008-10#1)
liquid crystals is##3##3##(2007-11#1)(2008-3#2)
liquid crystals##41##2##(1995-6#3)(2007-11#8)(2007-12#10)(2008-10#2)(2008-2#4)(2008-3#9)(2008-5#1)(2008-7#4)
liquid culture##10##2##(2008-10#6)(2008-11#1)(2008-9#1)(2013-1#2)
liquid donor##2##2##(2008-10#2)
liquid droplets##4##2##(2008-3#4)
liquid embolic material##2##3##(2008-7#2)
liquid embolization##2##2##(2008-7#2)
liquid extraction##7##2##(2008-10#7)
liquid film of##2##3##(2008-10#1)(2008-3#1)
liquid film##5##2##(2008-10#3)(2008-3#1)(2009-6#1)
liquid films##6##2##(1992-5#1)(2008-10#1)(2008-2#2)(2008-3#2)
liquid filtration membrane##3##3##(2012-3#3)
liquid flow##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
liquid flows##3##2##(2008-10#2)(2008-7#1)
liquid formulation##2##2##(2008-10#1)(2008-3#1)
liquid formulations##2##2##(2008-10#1)(2010-5#1)
liquid fraction##4##2##(2008-3#3)(2008-6#1)
liquid from the##3##3##(2008-10#1)(2008-12#1)(2009-6#1)
liquid from##4##2##(2008-10#2)(2008-12#1)(2009-6#1)
liquid handling##4##2##(2008-10#3)(2009-6#1)
liquid helium##3##2##(1993-11#1)(2008-10#1)(2008-7#1)
liquid hot water flow-through##2##4##(2013-1#2)
liquid hydrocarbon##3##2##(1992-5#3)
liquid in##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
liquid interface##2##2##(2007-12#2)
liquid ion##2##2##(2008-10#2)
liquid ionization##2##2##(2008-10#2)
liquid is##3##2##(1997-6#1)(2008-2#1)(2011-2#1)
liquid jets##3##2##(2007-12#3)
liquid junction potential##3##3##(2008-10#3)
liquid junction potentials##2##3##(2008-10#2)
liquid junction##7##2##(2008-10#7)
liquid lubricants##2##2##(2010-4#2)
liquid meal##3##2##(2008-7#3)
liquid media##19##2##(1990-8#1)(1991-11#1)(2008-10#7)(2008-2#3)(2008-7#1)(2008-8#3)(2008-9#2)(2010-4#1)
liquid medium and##2##3##(1990-6#1)(2008-5#1)
liquid medium with##2##3##(2008-10#2)
liquid medium##9##2##(1990-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2011-2#1)
liquid membrane (SLM) and##2##4##(2008-10#2)
liquid membrane (SLM) method for##2##5##(2008-10#2)
liquid membrane (SLM)##6##3##(2008-10#5)(2012-1#1)
liquid membrane and##4##3##(2008-10#4)
liquid membrane containing##6##3##(2008-10#6)
liquid membrane transport##2##3##(2008-10#2)
liquid membrane used##2##3##(2008-10#2)
liquid membrane using##3##3##(2008-10#3)
liquid membrane##42##2##(2008-10#41)(2012-1#1)
liquid membranes##7##2##(2008-10#7)
liquid mirror##3##2##(2008-3#3)
liquid mixing##3##2##(2008-2#2)(2008-6#1)
liquid mixtures##2##2##(2008-3#1)(2012-3#1)
liquid nitrogen for##2##3##(1990-11#1)(2008-8#1)
liquid nitrogen in##2##3##(1995-11#2)
liquid nitrogen was##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
liquid nitrogen##23##2##(1990-11#1)(1990-12#1)(1992-2#1)(1995-11#4)(2007-12#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-8#1)
liquid of##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
liquid or##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
liquid paraffin##2##2##(2008-3#2)
liquid particles##3##2##(1992-3#2)(2008-3#1)
liquid petroleum gas##2##3##(2008-10#2)
liquid pharmaceutical preparations##2##3##(2008-10#1)(2010-4#1)
liquid phase##16##2##(1992-5#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-4#1)(2013-1#1)
liquid propanol was##2##3##(2008-3#2)
liquid propanol##3##2##(2008-3#3)
liquid sample##15##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#3)(2011-1#1)
liquid samples and##2##3##(2008-10#1)(2008-3#1)
liquid samples##7##2##(2007-12#1)(2008-10#4)(2008-3#1)(2008-9#1)
liquid sampling##3##2##(2008-10#3)
liquid scintillation counting##3##3##(2008-10#2)(2008-11#1)
liquid scintillation##6##2##(1992-3#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-11#1)
liquid soap##6##2##(2008-10#5)(2008-5#1)
liquid source for##2##3##(2008-10#1)(2009-5#1)
liquid stationary phase##2##3##(2008-10#2)
liquid stationary##3##2##(2008-10#2)(2011-1#1)
liquid surface##5##2##(2008-2#3)(2008-3#2)
liquid termiticides##2##2##(2011-2#2)
liquid through the##2##3##(2008-10#1)(2011-2#1)
liquid to air##2##3##(1995-3#2)
liquid to##4##2##(1995-3#2)(2008-10#1)(2008-3#1)
liquid volume##2##2##(1997-1#1)(2008-10#1)
liquid water is##2##3##(2008-3#2)
liquid water##11##2##(1990-12#1)(2008-2#2)(2008-3#8)
liquid waveguide capillary cell##2##4##(2008-10#2)
liquid waveguide##3##2##(2008-10#3)
liquid##1304##1##(1990-11#2)(1990-12#7)(1990-2#5)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#41)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#34)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-2#3)(1992-3#5)(1992-5#6)(1992-6#8)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#6)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#6)(1995-12#2)(1995-2#2)(1995-3#10)(1995-6#7)(1996-1#2)(1996-2#4)(1996-3#1)(1996-5#20)(1996-9#1)(1997-1#1)(1997-2#18)(1997-3#1)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#18)(2007-12#38)(2008-1#2)(2008-10#621)(2008-11#12)(2008-12#3)(2008-2#47)(2008-3#71)(2008-4#13)(2008-5#28)(2008-6#11)(2008-7#34)(2008-8#10)(2008-9#12)(2009-10#1)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#4)(2010-11#3)(2010-2#3)(2010-3#2)(2010-4#8)(2010-5#5)(2010-7#3)(2010-8#3)(2011-1#31)(2011-2#22)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#10)(2012-3#7)(2013-1#16)(2013-8#4)
liquid-based##2##1##(2008-10#1)(2013-8#1)
liquid-core waveguide (LCW)##3##3##(2008-10#2)(2008-2#1)
liquid-core waveguide##6##2##(2008-10#5)(2008-2#1)
liquid-core##9##1##(2008-10#8)(2008-2#1)
liquid-crystal (LC)##2##2##(2008-3#2)
liquid-crystal Fabry-Perot##2##2##(2008-3#2)
liquid-crystal cell##7##2##(2007-11#4)(2007-12#3)
liquid-crystal cells##2##2##(2007-11#1)(2007-12#1)
liquid-crystal device##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
liquid-crystal devices##2##2##(2008-2#2)
liquid-crystal display (LCD)##2##3##(2008-2#1)(2010-9#1)
liquid-crystal display monitor##3##3##(2008-3#2)(2010-9#1)
liquid-crystal display to##2##3##(2008-3#2)
liquid-crystal display##18##2##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#9)(2010-9#2)
liquid-crystal displays##4##2##(2008-2#1)(2008-3#3)
liquid-crystal droplet##2##2##(2008-3#2)
liquid-crystal film##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
liquid-crystal films##3##2##(1995-6#1)(2007-11#1)(2007-12#1)
liquid-crystal grating##2##2##(2008-3#2)
liquid-crystal layer##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
liquid-crystal light valve##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
liquid-crystal light##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
liquid-crystal molecules##4##2##(2007-11#2)(2008-3#2)
liquid-crystal panel##2##2##(2008-2#2)
liquid-crystal panels##3##2##(2008-2#1)(2008-3#2)
liquid-crystal phase modulator##3##3##(2008-3#3)
liquid-crystal phase##5##2##(2007-11#1)(2008-3#4)
liquid-crystal projection##2##2##(2008-3#2)
liquid-crystal spatial light modulator (SLM)##3##5##(2007-11#1)(2008-3#2)
liquid-crystal spatial light modulator##23##4##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#13)
liquid-crystal spatial light modulators##5##4##(2008-3#5)
liquid-crystal spatial light##28##3##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#18)
liquid-crystal##147##1##(1995-6#1)(2007-11#28)(2007-12#20)(2008-10#1)(2008-2#23)(2008-3#71)(2010-9#2)(2012-2#1)
liquid-crystalline phase##3##2##(1990-2#1)(1990-7#1)(2008-8#1)
liquid-film thickness##2##2##(2008-2#2)
liquid-flat##2##1##(2008-2#2)
liquid-hydrogen droplet##2##2##(2007-11#2)
liquid-hydrogen##3##1##(2007-11#3)
liquid-like##3##1##(2012-2#3)
liquid-liquid extraction (LLE)##5##3##(2008-10#5)
liquid-liquid extraction and##6##3##(2008-10#6)
liquid-liquid extraction for##2##3##(2008-10#2)
liquid-liquid extraction method for the selective separation and preconcentration of##2##10##(2008-10#2)
liquid-liquid extraction method##6##3##(2008-10#6)
liquid-liquid extraction of##9##3##(2008-10#8)(2008-6#1)
liquid-liquid extraction procedure##4##3##(2008-10#4)
liquid-liquid extraction system##5##3##(2008-10#5)
liquid-liquid extraction technique for##2##4##(2008-10#2)
liquid-liquid extraction using##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
liquid-liquid extraction with##4##3##(2008-10#3)(2011-3#1)
liquid-liquid extraction##77##2##(1996-5#1)(1997-2#1)(2008-10#71)(2008-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
liquid-liquid extraction-gas##2##2##(2008-10#2)
liquid-liquid interfaces##2##2##(2008-10#1)(2008-3#1)
liquid-liquid microextraction##2##2##(2008-10#2)
liquid-liquid mixer##2##2##(2008-7#2)
liquid-liquid##96##1##(1996-5#1)(1997-2#1)(2008-10#83)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
liquid-nitrogen##4##1##(2007-12#1)(2008-2#2)(2009-11#1)
liquid-nitrogen-cooled high-emissivity blackbody##2##3##(2008-2#2)
liquid-nitrogen-cooled##4##1##(2008-10#1)(2008-2#3)
liquid-phase CRDS##2##2##(2010-7#2)
liquid-phase microextraction coupled with##3##4##(2008-10#3)
liquid-phase microextraction##8##2##(2008-10#8)
liquid-phase##17##1##(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2010-7#3)
liquid-polymeric##2##1##(2008-10#2)
liquid-solid interface##6##2##(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)
liquid-solid##11##1##(2008-10#4)(2008-3#2)(2008-7#2)(2009-8#1)(2011-1#2)
liquid-vapor##2##1##(2008-10#1)(2008-3#1)
liquid-water clouds##2##2##(2008-2#2)
liquid-water##3##1##(2008-2#3)
liquid/liquid##3##1##(2008-10#3)
liquids and##4##2##(1995-3#2)(2008-10#1)(2008-11#1)
liquids are##3##2##(1995-3#1)(2008-11#1)(2008-3#1)
liquids as##4##2##(2008-10#4)
liquids at##2##2##(2007-12#1)(2008-3#1)
liquids based simultaneous ultrasonic and microwave assisted extraction##2##8##(2012-1#2)
liquids by##2##2##(2008-3#2)
liquids can##2##2##(2008-2#1)(2011-2#1)
liquids in##3##2##(2008-11#1)(2008-2#1)(2010-7#1)
liquids obtained by thermal##2##4##(2008-10#2)
liquids on##2##2##(1995-3#1)(2008-3#1)
liquids or##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
liquids with##4##2##(2007-12#1)(2008-2#2)(2012-2#1)
liquids##72##1##(1994-2#1)(1995-3#9)(1996-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#6)(2008-2#7)(2008-3#11)(2008-5#4)(2008-7#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#4)(2012-2#1)
liquor by near-infrared##2##3##(2008-10#2)
liquor volume##6##2##(2012-12#6)
liquor##27##1##(1993-8#1)(1996-2#1)(2008-10#6)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2012-12#7)(2013-1#4)(2013-8#1)
liquors##4##1##(2008-10#4)
lisinopril##10##1##(1990-2#2)(1990-3#1)(1994-11#4)(2008-10#3)
lissamine rhodamine##3##2##(1993-9#3)
lissencephaly##2##1##(1997-3#1)(2012-2#1)
list and##3##2##(1992-11#1)(1996-3#1)(2007-8#1)
list as##3##2##(1991-11#1)(1993-2#1)(2008-10#1)
list for##2##2##(1997-1#1)(2011-2#1)
list is##2##2##(2008-10#1)(2008-5#1)
list length##4##2##(1993-3#1)(2008-6#3)
list of differential diagnosis##2##4##(2008-2#1)(2012-12#1)
list of potential##2##3##(1997-6#1)(2008-10#1)
list of references##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
list of the##6##3##(1993-8#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
list of##83##2##(1990-9#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-3#4)(1997-4#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
list parameters##2##2##(1991-11#2)
list the##2##2##(1994-6#1)(2011-1#1)
list##157##1##(1990-9#1)(1991-11#10)(1991-12#3)(1991-3#3)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#4)(1993-3#4)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-1#7)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#7)(2011-3#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
list)##3##1##(2008-10#1)(2011-3#1)(2013-1#1)
list-length##3##1##(2008-6#3)
listed above##5##2##(1993-2#1)(1994-3#1)(1996-5#1)(2009-8#1)(2013-1#1)
listed and##2##2##(1993-8#1)(2011-3#1)
listed as relaxing (n = 30)##2##6##(2007-6#2)
listed as##6##2##(2007-11#1)(2007-6#2)(2011-2#2)(2013-7#1)
listed by##2##2##(2007-11#1)(2008-10#1)
listed for##2##2##(1997-6#1)(2011-2#1)
listed here##3##2##(2008-2#1)(2008-4#2)
listed in the##3##3##(1995-8#1)(2010-3#1)(2013-7#1)
listed in##6##2##(1991-3#1)(1995-8#1)(1996-1#1)(1997-3#1)(2010-3#1)(2013-7#1)
listed##48##1##(1991-3#1)(1991-8#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-2#1)(2007-6#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
listen to##4##2##(1995-2#1)(2007-6#1)(2008-5#1)(2009-8#1)
listen##8##1##(1990-12#1)(1995-2#1)(1995-5#1)(2007-6#1)(2008-1#1)(2008-5#1)(2009-8#1)(2013-8#1)
listened to##5##2##(1997-4#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)
listened##6##1##(1993-12#1)(1997-4#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)
listener perceptions##5##2##(2011-1#5)
listener##6##1##(2009-10#1)(2011-1#5)
listeners to##3##2##(2009-10#1)(2009-5#1)(2013-8#1)
listeners##10##1##(1992-3#1)(2007-7#2)(2009-10#1)(2009-5#1)(2011-1#2)(2013-8#3)
listening and##3##2##(1993-1#2)(2008-9#1)
listening skills##2##2##(2008-9#1)(2012-2#1)
listening to music promotes falling asleep##2##6##(2007-6#2)
listening to music##5##3##(2007-6#5)
listening to student##2##3##(2013-1#2)
listening to the##2##3##(1996-2#1)(2008-9#1)
listening to##19##2##(1991-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-6#7)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#4)
listening##37##1##(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#3)(1996-2#1)(1996-5#1)(1997-1#1)(2007-6#8)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#6)(2009-10#1)(2011-2#1)(2012-2#3)(2013-1#5)
listerial##2##1##(2006-10#1)(2011-2#1)
listeriolysin O##6##2##(1996-12#6)
listeriosis##7##1##(1992-2#1)(1992-4#3)(2006-10#1)(2011-1#1)(2012-2#1)
listing and##2##2##(2008-7#1)(2011-3#1)
listing of##4##2##(1991-12#1)(1996-1#1)(2008-7#1)(2008-9#1)
listing the##3##2##(1993-1#1)(1997-4#1)(2008-2#1)
listing##16##1##(1991-12#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-12#2)(1996-1#1)(1997-1#1)(1997-4#1)(2008-2#1)(2008-7#3)(2008-9#1)(2011-3#1)(2013-1#1)
listmode data files##2##3##(2008-9#2)
listmode data##3##2##(2008-9#3)
listmode format##2##2##(2008-9#2)
listmode##5##1##(2008-9#5)
lists and##5##2##(1991-11#1)(1993-2#1)(1997-4#1)(2008-12#1)(2012-12#1)
lists are##2##2##(1993-2#1)(1996-8#1)
lists for##2##2##(1993-12#1)(2013-8#1)
lists in##6##2##(1991-11#2)(1993-2#4)
lists of words##2##3##(2007-12#1)(2008-7#1)
lists of##14##2##(1993-3#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-6#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#3)(2013-8#2)
lists were##2##2##(1991-6#1)(2012-2#1)
lists##62##1##(1991-11#8)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#11)(1993-3#1)(1994-12#2)(1996-1#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#4)
lists]##2##1##(1991-11#2)
listservs##3##1##(1996-2#1)(1997-3#1)(2008-11#1)
lit##3##1##(2007-7#1)(2008-5#2)
liter of##3##2##(1990-12#1)(1997-4#1)(2008-5#1)
liter per bucket##2##3##(2008-10#2)
liter##22##1##(1990-12#1)(1992-8#1)(1995-2#1)(1997-4#2)(2008-10#14)(2008-5#2)(2008-6#1)
liter(-1) DO##2##2##(2008-10#2)
liter(-1)##6##1##(2008-10#6)
liter) had##2##2##(2008-10#1)(2011-2#1)
liter)##6##1##(2008-10#3)(2011-2#3)
literacy and##5##2##(2008-11#1)(2009-4#1)(2009-5#1)(2010-9#1)(2013-8#1)
literacy in##4##2##(1996-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
literacy skills are##2##3##(1996-1#1)(2010-4#1)
literacy skills##10##2##(1992-12#1)(1996-1#1)(2008-12#1)(2010-4#2)(2010-9#1)(2011-2#2)(2012-3#2)
literacy##58##1##(1992-12#1)(1994-12#1)(1994-7#1)(1996-1#6)(2007-12#1)(2008-11#6)(2008-12#3)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#8)(2009-9#2)(2010-2#1)(2010-4#4)(2010-9#4)(2011-1#2)(2011-2#7)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#2)
literal three-dimensional imaging##2##3##(2008-2#2)
literal##5##1##(2008-11#1)(2008-2#3)(2008-7#1)
literally##5##1##(1991-3#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-2#1)
literary##3##1##(1993-3#1)(2008-7#1)(2012-3#1)
literate##2##1##(2009-9#2)
literature about the##4##3##(1990-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
literature about##12##2##(1990-6#1)(1990-8#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
literature addressing##2##2##(1993-2#1)(2008-11#1)
literature allowed##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
literature an##2##2##(1990-6#1)(2013-1#1)
literature and a##3##3##(1991-3#1)(2006-5#1)(2008-10#1)
literature and an##2##3##(1991-3#1)(2008-10#1)
literature and clinical##2##3##(2007-11#1)(2008-7#1)
literature and has been##2##4##(2008-10#1)(2008-3#1)
literature and in##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
literature and is##2##3##(1993-12#1)(2008-12#1)
literature and our##3##3##(2008-2#1)(2009-4#1)(2009-5#1)
literature and own experience##4##4##(2007-11#4)
literature and personal experience##2##4##(2007-8#1)(2008-8#1)
literature and personal##3##3##(1993-3#1)(2007-8#1)(2008-8#1)
literature and research##3##3##(1997-2#1)(2013-1#2)
literature and the press##2##4##(1996-9#1)(2006-10#1)
literature and the##9##3##(1990-10#1)(1996-2#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)
literature and##93##2##(1990-10#1)(1990-3#1)(1991-1#2)(1991-3#3)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-8#3)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)
literature are briefly reviewed##2##4##(1996-7#1)(2008-11#1)
literature are provided##2##3##(1994-3#1)(2008-10#1)
literature are reviewed##3##3##(1992-12#1)(2008-10#1)(2012-12#1)
literature are##16##2##(1992-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#2)(2012-12#1)
literature as a##6##3##(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#2)
literature as far as##2##4##(2008-2#1)(2011-2#1)
literature as well as the##3##5##(1992-1#1)(2007-2#1)(2011-3#1)
literature as well as##6##4##(1992-1#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2011-3#1)
literature as##18##2##(1992-1#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
literature available on##2##3##(2008-11#1)(2010-11#1)
literature available##5##2##(2008-10#1)(2008-11#2)(2010-11#1)(2012-2#1)
literature base on##2##3##(1997-2#1)(2012-2#1)
literature base##3##2##(1997-2#1)(2011-2#1)(2012-2#1)
literature between##3##2##(1995-11#1)(2010-7#1)(2012-3#1)
literature by##3##2##(2008-12#1)(2008-2#1)(2008-8#1)
literature concerning the##5##3##(1990-12#1)(1996-9#1)(2008-11#1)(2010-9#1)(2011-2#1)
literature concerning this##2##3##(1997-7#1)(2008-7#1)
literature concerning##15##2##(1990-12#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-9#2)(2011-2#1)(2013-8#1)
literature could##4##2##(2007-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
literature covering##2##2##(2008-10#1)(2009-5#1)
literature data from##2##3##(2008-7#1)(2013-7#1)
literature data on##3##3##(2008-10#2)(2011-2#1)
literature data##17##2##(1990-5#1)(1991-6#1)(1993-5#1)(2008-10#7)(2008-7#2)(2008-8#2)(2009-5#1)(2011-2#1)(2013-7#1)
literature databases##3##2##(1997-1#2)(2010-2#1)
literature describes##2##2##(2008-11#1)(2008-7#1)
literature describing##4##2##(1997-6#1)(2008-3#1)(2009-10#1)(2012-12#1)
literature does not##4##3##(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
literature exists##2##2##(2008-10#1)(2008-2#1)
literature for the treatment of##2##5##(2007-8#1)(2008-8#1)
literature for the##6##3##(1992-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
literature for##19##2##(1991-3#2)(1992-12#1)(1992-9#1)(1993-3#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
literature from the##3##3##(2007-7#1)(2008-4#1)(2012-3#1)
literature from##15##2##(1996-2#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-9#1)(2012-3#1)
literature has been##2##3##(1991-3#1)(1996-3#1)
literature has shown that##2##4##(1990-10#1)(2008-7#1)
literature has##11##2##(1990-10#1)(1991-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-9#1)(2010-8#1)(2013-1#2)
literature have been##3##3##(2007-5#2)(2008-8#1)
literature have##7##2##(1992-1#1)(2007-5#4)(2008-8#2)
literature in order to##3##4##(2008-11#1)(2008-12#1)(2008-5#1)
literature in the##4##3##(1991-3#1)(1995-12#1)(2008-7#1)(2010-2#1)
literature in this area##2##4##(2009-3#1)(2013-1#1)
literature in##22##2##(1991-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#4)
literature includes##2##2##(1993-3#1)(2012-2#1)
literature indicates that##4##3##(1993-1#1)(1993-11#1)(2009-7#1)(2012-12#1)
literature indicating##2##2##(1991-12#1)(2008-6#1)
literature is available on##2##4##(1994-12#1)(2007-12#1)
literature is limited##3##3##(1996-12#1)(2008-11#1)(2008-12#1)
literature is presented##4##3##(1990-3#1)(2010-11#1)(2010-12#1)(2010-8#1)
literature is reviewed and##5##4##(1993-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
literature is reviewed for##2##4##(1996-3#1)(2007-7#1)
literature is reviewed with##2##4##(1991-3#1)(2010-8#1)
literature is reviewed##18##3##(1990-9#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
literature is that of##2##4##(1993-1#1)(1994-12#1)
literature is##55##2##(1990-3#1)(1990-9#1)(1991-3#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#3)(1995-9#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
literature lacks##2##2##(1995-1#1)(2011-1#1)
literature of the##7##3##(1991-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2012-3#1)
literature of this##2##3##(2008-11#1)(2008-7#1)
literature of##23##2##(1991-3#1)(1993-12#1)(1996-12#1)(2007-8#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#3)
literature on how##3##3##(2009-5#1)(2010-9#1)(2012-2#1)
literature on its##2##3##(2008-3#1)(2010-8#1)
literature on nursing work##2##4##(2012-3#2)
literature on nursing##3##3##(2012-3#3)
literature on the effectiveness of##2##5##(1997-2#1)(2013-1#1)
literature on the effects of##4##5##(1992-12#1)(1993-11#1)(2008-5#1)(2008-7#1)
literature on the effects##5##4##(1992-12#1)(1993-11#1)(1996-3#1)(2008-5#1)(2008-7#1)
literature on the subject##6##4##(1994-1#1)(1994-11#1)(1996-11#1)(2009-1#1)(2012-12#1)(2012-2#1)
literature on the topic of##2##5##(2008-11#1)(2012-2#1)
literature on the topic##7##4##(2008-1#1)(2008-11#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
literature on the treatment of##3##5##(1992-1#1)(1996-11#1)(2011-2#1)
literature on the use of##3##5##(2011-2#1)(2013-1#2)
literature on the##60##3##(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-1#2)(1994-11#1)(1995-12#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-6#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#1)
literature on these##2##3##(2011-2#1)(2012-2#1)
literature on this topic##5##4##(1993-6#1)(2007-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
literature on this##11##3##(1990-2#1)(1993-6#1)(1994-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-2#1)
literature on##146##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-1#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#4)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#5)(2013-1#10)(2013-8#1)
literature over the##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
literature over##4##2##(2006-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
literature pertaining to##5##3##(1993-1#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-10#1)
literature pertaining##6##2##(1993-1#1)(2007-11#1)(2008-2#1)(2008-8#2)(2010-10#1)
literature provides some##2##3##(1992-12#1)(2013-1#1)
literature provides##5##2##(1992-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
literature published from##3##3##(2008-12#1)(2009-8#1)(2011-2#1)
literature published##6##2##(2007-11#1)(2008-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
literature references##2##2##(2008-10#1)(2008-4#1)
literature regarding its##2##3##(2008-6#1)(2012-2#1)
literature regarding the##5##3##(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#2)
literature regarding##19##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#7)(2013-1#2)(2013-8#1)
literature related to##5##3##(2008-11#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-2#1)
literature relating to##4##3##(1997-7#1)(2007-8#1)(2010-12#1)(2011-2#1)
literature reports##2##2##(1991-6#1)(2010-5#1)
literature research##2##2##(2011-2#1)(2012-3#1)
literature revealed##6##2##(1992-12#1)(1995-1#1)(2006-10#2)(2008-12#1)(2013-1#1)
literature reveals##3##2##(2007-2#1)(2008-1#1)(2008-11#1)
literature review and##7##3##(1992-12#1)(2008-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
literature review confirms##2##3##(2007-11#1)(2008-8#1)
literature review from##2##3##(2008-1#1)(2008-10#1)
literature review is##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
literature review of the##5##4##(2008-11#1)(2008-8#2)(2010-6#1)(2013-1#1)
literature review of##13##3##(2008-11#1)(2008-12#1)(2008-8#2)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#1)
literature review on##3##3##(2008-2#2)(2012-3#1)
literature review revealed##2##3##(2007-2#1)(2008-6#1)
literature review was performed to##2##5##(2008-10#1)(2011-2#1)
literature review was performed##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
literature review was##5##3##(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
literature review##143##2##(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-10#6)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#11)(2008-12#10)(2008-2#5)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#5)
literature review]##8##2##(1991-3#1)(1993-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
literature reviewed##5##2##(1993-2#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-12#1)
literature search was##4##3##(1996-12#1)(2011-2#2)(2013-1#1)
literature search##20##2##(1992-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
literature shows that##12##3##(1990-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
literature shows##15##2##(1990-6#1)(1990-8#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
literature since##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
literature so far##2##3##(2012-12#1)(2013-1#1)
literature sources##3##2##(2009-2#1)(2013-1#2)
literature suggest the##2##3##(2009-2#1)(2009-8#1)
literature suggest##4##2##(1990-6#1)(1992-2#1)(2009-2#1)(2009-8#1)
literature suggesting##2##2##(2008-12#1)(2009-9#1)
literature suggests a##3##3##(1992-12#1)(2007-4#1)(2011-2#1)
literature suggests that##9##3##(1995-3#1)(2008-11#3)(2009-3#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
literature suggests##17##2##(1992-12#1)(1992-2#1)(1995-3#1)(1997-1#1)(2007-4#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
literature surrounding the##2##3##(2010-12#1)(2011-2#1)
literature surrounding##3##2##(2008-6#1)(2010-12#1)(2011-2#1)
literature survey##5##2##(2008-10#1)(2008-8#2)(2012-1#1)(2013-1#1)
literature tends to##2##3##(2012-2#2)
literature that has##2##3##(2008-11#1)(2012-2#1)
literature that##18##2##(1991-6#1)(1994-1#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#2)
literature the##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
literature through##4##2##(1994-2#1)(2008-12#1)(2010-9#1)(2012-3#1)
literature to date##2##3##(2008-11#1)(2008-4#1)
literature to##21##2##(1992-10#1)(1994-12#1)(1996-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2013-8#1)
literature using##2##2##(1992-12#1)(2008-12#1)
literature values##12##2##(2007-11#1)(2008-10#8)(2008-7#2)(2012-12#1)
literature was performed##3##3##(1993-9#1)(2011-2#1)(2012-12#1)
literature was reviewed##5##3##(1992-3#1)(2007-12#2)(2007-2#1)(2011-2#1)
literature was searched##2##3##(2011-1#1)(2011-2#1)
literature was undertaken for articles published##2##6##(2012-12#2)
literature was undertaken to##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
literature was undertaken##5##3##(2008-7#1)(2012-12#3)(2012-2#1)
literature was##22##2##(1992-3#1)(1993-9#1)(1995-5#1)(2007-12#2)(2007-2#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#1)
literature we##2##2##(1993-6#1)(2007-5#1)
literature were##2##2##(2008-10#1)(2011-1#1)
literature with##11##2##(1992-12#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-8#1)(2013-1#1)
literature would suggest that##2##4##(2008-11#2)
literature would##3##2##(2008-11#2)(2013-1#1)
literature##1624##1##(1990-10#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-5#2)(1990-6#8)(1990-8#3)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#11)(1991-2#4)(1991-3#11)(1991-5#1)(1991-6#8)(1992-1#8)(1992-10#1)(1992-12#16)(1992-2#6)(1992-3#2)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#4)(1993-11#4)(1993-12#11)(1993-2#4)(1993-3#7)(1993-5#5)(1993-6#5)(1993-8#3)(1993-9#2)(1994-1#6)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#5)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#1)(1995-8#4)(1995-9#2)(1996-1#2)(1996-11#5)(1996-12#12)(1996-2#4)(1996-3#11)(1996-6#7)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#8)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#9)(2006-10#11)(2006-12#3)(2006-5#1)(2007-10#13)(2007-11#34)(2007-12#15)(2007-2#11)(2007-4#6)(2007-5#11)(2007-6#1)(2007-7#8)(2007-8#24)(2008-1#21)(2008-10#125)(2008-11#94)(2008-12#45)(2008-2#26)(2008-3#35)(2008-4#17)(2008-5#36)(2008-6#39)(2008-7#70)(2008-8#41)(2008-9#33)(2009-1#3)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#4)(2009-3#13)(2009-4#8)(2009-5#23)(2009-6#5)(2009-7#12)(2009-8#7)(2009-9#5)(2010-1#5)(2010-10#11)(2010-11#9)(2010-12#14)(2010-2#4)(2010-3#20)(2010-4#1)(2010-5#4)(2010-6#9)(2010-7#4)(2010-8#19)(2010-9#9)(2011-1#20)(2011-10#1)(2011-2#93)(2011-3#4)(2011-7#2)(2012-1#9)(2012-12#43)(2012-2#60)(2012-3#41)(2013-1#103)(2013-2#1)(2013-7#4)(2013-8#22)
literature)##3##1##(2008-2#1)(2008-3#1)(2008-5#1)
literature-based##4##1##(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
literature]##27##1##(1990-5#1)(1990-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2009-5#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-1#2)
literatures##10##1##(1990-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
literatuur##2##1##(2012-12#2)
literatuuronderzoek##2##1##(2012-12#2)
liters##3##1##(2007-7#1)(2008-10#1)(2008-11#1)
lithiasic##5##1##(1990-9#1)(1992-9#2)(2008-4#2)
lithiasis and##2##2##(1991-3#1)(1993-5#1)
lithiasis in the##2##3##(1992-3#1)(1993-5#1)
lithiasis in##4##2##(1991-5#1)(1992-3#1)(1993-5#1)(1997-8#1)
lithiasis of the##2##3##(1990-5#1)(1991-5#1)
lithiasis##16##1##(1990-3#3)(1990-5#1)(1991-11#2)(1991-3#1)(1991-5#3)(1992-3#2)(1993-5#2)(1997-8#1)(2008-10#1)
lithium aluminum hydride##2##3##(1996-5#1)(2009-11#1)
lithium aluminum##3##2##(1996-5#1)(2007-11#1)(2009-11#1)
lithium amide##3##2##(1996-5#1)(1997-7#2)
lithium and valproate##3##3##(2008-7#1)(2009-8#2)
lithium and##10##2##(1992-9#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-7#2)(2009-8#2)(2010-11#1)
lithium battery cell##2##3##(2012-2#2)
lithium beam##2##2##(2008-3#2)
lithium bis(oxalato)borate##2##2##(2008-10#2)
lithium borate##3##2##(2007-12#2)(2008-10#1)
lithium determination in##3##3##(2008-10#3)
lithium determination##5##2##(2008-10#5)
lithium during the first trimester of pregnancy##2##7##(1992-2#2)
lithium in##4##2##(1994-8#2)(2008-10#1)(2009-8#1)
lithium ion in##3##3##(2008-10#3)
lithium ion##4##2##(2008-10#4)
lithium ions content in##2##4##(2008-10#2)
lithium ions##6##2##(1997-7#1)(2008-10#5)
lithium niobate (LiNbO(3))##2##3##(2007-12#1)(2008-2#1)
lithium niobate and##2##3##(2007-12#1)(2008-3#1)
lithium niobate are##2##3##(2007-12#2)
lithium niobate crystal##7##3##(2007-11#3)(2007-12#3)(2008-3#1)
lithium niobate crystals##2##3##(2007-12#2)
lithium niobate resonator##2##3##(2008-2#2)
lithium niobate slab waveguides##2##4##(2007-12#2)
lithium niobate with##2##3##(2007-12#1)(2008-3#1)
lithium niobate##74##2##(2007-11#21)(2007-12#36)(2008-2#8)(2008-3#9)
lithium plasma##2##2##(2008-2#2)
lithium porphyrin##2##2##(2008-10#2)
lithium tantalate##7##2##(2007-11#1)(2007-12#4)(2008-3#2)
lithium tetracyanoethylenide (LiTCNE)##2##3##(2008-10#2)
lithium traces determination##2##3##(2008-10#2)
lithium traces##3##2##(2008-10#3)
lithium treatment##2##2##(1995-11#2)
lithium triborate##7##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
lithium was##2##2##(1992-2#1)(2008-10#1)
lithium##203##1##(1990-7#2)(1992-2#9)(1992-9#1)(1994-3#1)(1994-8#4)(1995-11#5)(1996-12#3)(1996-2#2)(1996-5#5)(1997-7#5)(2006-4#1)(2007-11#27)(2007-12#43)(2008-10#42)(2008-11#1)(2008-2#18)(2008-3#16)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#2)
lithium-stimulated Ins(1##2##2##(1994-8#2)
lithographic optical systems##2##3##(2008-3#2)
lithographic##14##1##(2007-12#2)(2008-2#3)(2008-3#8)(2008-7#1)
lithographically defined##2##2##(1994-9#1)(2008-2#1)
lithographically patterned##2##2##(2008-7#2)
lithographically##4##1##(1994-9#1)(2008-2#1)(2008-7#2)
lithography and reactive ion etching##2##5##(2008-3#2)
lithography and##8##2##(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#5)
lithography system##2##2##(2008-2#2)
lithography systems##2##2##(2008-3#2)
lithography to##2##2##(2007-12#1)(2008-7#1)
lithography with##4##2##(2008-3#3)(2012-2#1)
lithography##68##1##(2007-11#4)(2007-12#10)(2007-5#1)(2008-10#2)(2008-2#10)(2008-3#34)(2008-5#1)(2008-7#3)(2009-11#1)(2010-4#1)(2012-2#1)
lithosphere##2##1##(1995-6#1)(1996-4#1)
lithotomy##3##1##(2008-5#2)(2009-3#1)
lithotripsy (ESWL)##4##2##(1990-11#1)(2007-7#2)(2009-5#1)
lithotripsy in##2##2##(2008-10#2)
lithotripsy is##4##2##(1991-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
lithotripsy of##2##2##(1992-3#1)(2008-10#1)
lithotripsy##24##1##(1990-11#1)(1990-8#3)(1991-3#1)(1991-9#1)(1992-3#1)(2007-10#1)(2007-7#2)(2008-10#4)(2009-5#2)(2011-2#1)(2012-12#2)(2013-1#5)
lithotripter##3##1##(2008-11#2)(2008-3#1)
litigation may##2##2##(1991-3#1)(1996-12#1)
litigation##27##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#8)(1992-3#3)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-5#1)(2007-3#1)(2007-4#1)(2008-4#1)(2012-12#1)
litorale##4##1##(2007-12#4)
litre##5##1##(2008-10#4)(2008-11#1)
litter and##2##2##(1990-3#1)(1994-8#1)
litter in##2##2##(2008-10#1)(2010-3#1)
litter mass##2##2##(2012-12#2)
litter sex-ratio effects on##2##4##(1994-8#2)
litter sex-ratio##4##2##(1994-8#4)
litter size##4##2##(2008-8#3)(2012-12#1)
litter was##2##2##(1993-12#1)(2010-3#1)
litter were##2##2##(1996-12#1)(2008-10#1)
litter##46##1##(1990-3#1)(1993-12#1)(1994-6#2)(1994-8#7)(1996-12#1)(2008-10#8)(2008-11#4)(2008-6#1)(2008-8#7)(2010-2#2)(2010-3#5)(2011-2#1)(2012-12#4)(2013-7#2)
litterbag##3##1##(2008-11#3)
litterfall and##2##2##(2007-5#2)
litterfall rates##2##2##(2007-5#2)
litterfall##5##1##(2007-5#5)
littermate##2##1##(2010-11#1)(2012-12#1)
littermates were##2##2##(1993-12#1)(2008-3#1)
littermates##13##1##(1992-11#1)(1992-8#3)(1993-12#1)(1994-8#1)(1995-2#2)(1996-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-2#1)
litters of##3##2##(1994-8#1)(2008-10#1)(2012-12#1)
litters were##4##2##(1997-4#3)(2008-10#1)
litters with##2##2##(1993-12#1)(2012-12#1)
litters##22##1##(1993-12#1)(1994-8#2)(1997-4#10)(2008-10#3)(2008-8#1)(2010-3#1)(2012-12#4)
little about how##3##3##(1997-2#1)(2009-11#1)(2012-3#1)
little about##7##2##(1993-3#1)(1997-2#1)(2008-10#2)(2009-11#1)(2009-9#1)(2012-3#1)
little activity##3##2##(1991-5#1)(1992-3#1)(1994-8#1)
little additional##2##2##(1996-12#1)(2007-12#1)
little affected by##7##3##(1993-6#1)(2008-10#5)(2011-1#1)
little affected##8##2##(1993-6#1)(2008-10#6)(2011-1#1)
little agreement##2##2##(1994-3#1)(2008-7#1)
little as 0##9##3##(1991-2#1)(1993-1#1)(2008-10#5)(2008-6#1)(2010-4#1)
little as 50##2##3##(1994-2#1)(2008-10#1)
little as##38##2##(1990-8#1)(1991-2#2)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#2)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
little attention being##2##3##(2008-7#1)(2011-2#1)
little attention has been paid to the##4##7##(2008-7#1)(2009-8#1)(2012-2#1)(2013-2#1)
little attention has been paid to##7##6##(2008-5#1)(2008-7#2)(2009-8#1)(2010-1#1)(2012-2#1)(2013-2#1)
little attention in the literature##2##5##(2008-11#1)(2008-3#1)
little attention in##5##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
little attention##31##2##(1994-2#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-2#1)
little benefit##3##2##(1996-9#1)(2007-7#1)(2008-9#1)
little by##2##2##(2008-10#1)(2012-2#1)
little chance of##2##3##(1994-5#1)(2007-7#1)
little change in the##3##4##(1991-1#1)(2008-8#1)(2011-2#1)
little change in##4##3##(1991-1#1)(1991-4#1)(2008-8#1)(2011-2#1)
little change##8##2##(1991-1#1)(1991-4#1)(1995-9#1)(2008-10#1)(2008-8#2)(2011-2#1)(2011-3#1)
little changes in##2##3##(1995-2#1)(2012-3#1)
little clinical##2##2##(2008-4#1)(2008-9#1)
little communication##2##2##(2013-8#2)
little consistency##2##2##(2007-12#1)(2013-1#1)
little contribution##2##2##(2008-10#1)(2008-8#1)
little control over##3##3##(1995-1#1)(2008-1#2)
little control##4##2##(1995-1#1)(2008-1#2)(2011-2#1)
little correlation##2##2##(1992-12#1)(2012-12#1)
little damage to##3##3##(2008-10#2)(2008-6#1)
little data##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
little dependence on##2##3##(2008-10#1)(2010-10#1)
little difference in##7##3##(1992-3#1)(1995-2#1)(2008-11#1)(2008-5#2)(2010-8#1)(2013-8#1)
little difference##10##2##(1991-4#1)(1992-3#2)(1995-2#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-8#1)(2013-8#1)
little differences in the##4##4##(1997-7#1)(2008-10#2)(2008-5#1)
little different##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
little differentiation##2##2##(2008-10#1)(2013-1#1)
little direct evidence##2##3##(1993-11#1)(2011-2#1)
little direct##4##2##(1993-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
little discussion in##2##3##(2008-3#1)(2008-5#1)
little discussion##3##2##(2008-3#1)(2008-5#1)(2012-1#1)
little doubt about the##2##4##(2008-1#1)(2011-1#1)
little doubt that##2##3##(2008-4#1)(2012-2#1)
little doubt##4##2##(2008-1#1)(2008-4#1)(2011-1#1)(2012-2#1)
little effect and##2##3##(1993-6#1)(2008-10#1)
little effect of##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
little effect on the##16##4##(1990-2#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
little effect on##29##3##(1990-2#2)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-5#1)
little effect upon##3##3##(1992-12#1)(1992-6#1)(2008-10#1)
little effect##41##2##(1990-2#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-5#1)
little effort has been##2##4##(2008-10#1)(2008-9#1)
little empirical attention##2##3##(2010-1#1)(2012-12#1)
little empirical evidence##4##3##(2008-11#2)(2008-8#1)(2009-8#1)
little empirical##9##2##(1993-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-12#1)
little evidence for the##2##4##(2008-5#1)(2011-2#1)
little evidence for##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)
little evidence of the##2##4##(2008-5#1)(2012-3#1)
little evidence of##6##3##(1993-11#1)(1995-12#1)(2008-5#1)(2008-8#2)(2012-3#1)
little evidence that##4##3##(1993-3#1)(2008-7#1)(2009-7#1)(2012-1#1)
little evidence to suggest that##2##5##(2007-12#1)(2011-2#1)
little evidence to support##2##4##(2007-8#2)
little evidence to##6##3##(2007-11#1)(2007-12#1)(2007-8#2)(2008-5#1)(2011-2#1)
little evidence##23##2##(1993-11#1)(1993-3#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
little explored##2##2##(2008-8#1)(2012-2#1)
little finger##5##2##(2008-9#5)
little from##3##2##(1990-6#1)(1996-4#1)(2008-2#1)
little fundamental##2##2##(1994-2#1)(2009-7#1)
little genetic##2##2##(2008-10#1)(2013-1#1)
little guidance##2##2##(1996-3#1)(2010-4#1)
little has been published on##2##5##(1991-2#1)(2008-2#1)
little has been written##2##4##(1994-2#1)(1995-3#1)
little has been##6##3##(1991-2#1)(1994-2#1)(1995-3#1)(2008-2#1)(2010-3#1)(2013-1#1)
little has##7##2##(1991-2#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-2#1)(2010-3#1)(2013-1#1)
little help##2##2##(1990-6#1)(1997-2#1)
little homology##3##2##(1991-9#1)(1992-9#1)(1994-8#1)
little if any##6##3##(1991-7#1)(1993-5#1)(1995-2#1)(2008-3#1)(2009-9#1)(2012-2#1)
little impact on the##4##4##(1991-6#1)(1993-11#1)(1996-5#1)(2008-3#1)
little impact on##6##3##(1991-6#1)(1993-11#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-3#1)
little improvement##3##2##(1995-9#1)(2008-10#1)(2012-2#1)
little in the way of##2##5##(2008-11#1)(2008-12#1)
little in the##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
little in##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
little increase in##3##3##(1995-11#1)(2008-5#1)(2008-7#1)
little increase##4##2##(1995-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
little influence on the##6##4##(1997-8#1)(2008-10#1)(2008-11#2)(2010-4#2)
little influence on##9##3##(1997-8#1)(2008-10#2)(2008-11#2)(2009-5#1)(2009-7#1)(2010-4#2)
little influence##10##2##(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)(2010-4#2)
little information exists on##2##4##(1992-3#1)(2009-2#1)
little information exists##4##3##(1992-3#1)(2008-11#1)(2008-2#1)(2009-2#1)
little information is available for##2##5##(2008-8#1)(2013-1#1)
little information is available on the##2##6##(2008-10#1)(2008-5#1)
little information is available##8##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
little information##20##2##(1992-3#1)(1994-3#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2013-1#1)
little inhibitory##2##2##(1992-12#1)(1994-12#1)
little interference##2##2##(2008-10#2)
little investigated##2##2##(2008-8#1)(2009-6#1)
little is currently known##2##4##(2008-7#1)(2009-8#1)
little is known about how##5##5##(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
little is known about its##4##5##(1994-6#1)(2008-5#1)(2008-7#1)(2013-8#1)
little is known about mechanisms##2##5##(2008-10#1)(2011-2#1)
little is known about the effects of##2##7##(2008-10#1)(2008-8#1)
little is known about the genetic basis of##2##8##(2008-1#1)(2008-5#1)
little is known about the mechanism##2##6##(1991-12#1)(2008-7#1)
little is known about the potential##2##6##(2008-10#2)
little is known about the##44##5##(1991-12#1)(1991-2#1)(1992-5#1)(1994-5#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
little is known about their##5##5##(2007-12#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
little is known about##75##4##(1991-12#1)(1991-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
little is known of its##2##5##(1993-1#1)(1993-6#1)
little is known of the##4##5##(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
little is known of##7##4##(1993-1#1)(1993-6#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
little is known on the##2##5##(2007-8#1)(2008-8#1)
little is known regarding the##3##5##(1993-6#1)(2011-1#1)(2012-12#1)
little is known regarding##5##4##(1993-6#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
little is known##93##3##(1990-7#1)(1991-12#2)(1991-2#1)(1992-5#1)(1993-1#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-2#2)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
little is##98##2##(1990-7#1)(1991-12#2)(1991-2#1)(1992-5#1)(1993-1#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-2#2)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
little known##3##2##(1992-2#1)(2008-6#1)(2012-3#1)
little loss of##2##3##(2007-6#1)(2013-1#1)
little loss##3##2##(1990-7#1)(2007-6#1)(2013-1#1)
little measurable##2##2##(1997-1#1)(2008-10#1)
little migration##2##2##(1991-12#1)(2009-5#1)
little more than##2##3##(1992-7#1)(2010-8#1)
little more##4##2##(1992-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
little of the##2##3##(2010-8#1)(2012-2#1)
little of##4##2##(1994-3#1)(1996-11#1)(2010-8#1)(2012-2#1)
little or no ability to##2##5##(2008-5#1)(2010-11#1)
little or no change##2##4##(1990-3#1)(2008-10#1)
little or no dependence##2##4##(1993-8#2)
little or no effect on the determination of##2##8##(2008-10#2)
little or no effect on##4##5##(1994-6#1)(2008-10#3)
little or no effect##5##4##(1994-12#1)(1994-6#1)(2008-10#3)
little or no impact on##3##5##(1991-6#1)(1995-5#1)(2007-11#1)
little or no##64##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#3)(1997-3#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
little or not##2##3##(2008-10#1)(2008-12#1)
little or##69##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#3)(1997-3#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
little over the##2##3##(2012-12#1)(2012-2#1)
little overall##2##2##(2009-9#1)(2010-3#1)
little overlap##3##2##(1996-12#1)(2008-9#1)(2011-1#1)
little prior information##2##3##(1992-3#1)(2008-10#1)
little prior##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
little progress##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
little research has been conducted on##2##6##(2007-6#1)(2012-2#1)
little research has been conducted to examine the##2##8##(2008-10#1)(2008-11#1)
little research has been conducted to##3##6##(2008-10#1)(2008-11#1)(2008-12#1)
little research has been conducted##5##5##(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
little research has been##7##4##(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2012-2#1)
little research has##10##3##(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
little research##16##2##(1996-1#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
little risk of##2##3##(2008-2#1)(2013-8#1)
little role in the##3##4##(1992-6#1)(2008-7#1)(2011-2#1)
little role in##4##3##(1992-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
little signal##2##2##(2008-3#1)(2010-5#1)
little skate##2##2##(2008-11#1)(2010-8#1)
little studied##3##2##(1997-1#1)(2008-7#1)(2009-7#1)
little success##4##2##(1996-3#1)(2010-1#1)(2010-11#1)(2010-3#1)
little support##2##2##(2010-12#1)(2011-2#1)
little systematic research##2##3##(1992-1#1)(1993-1#1)
little systematic##3##2##(1992-1#1)(1993-1#1)(2008-8#1)
little time##2##2##(1995-6#1)(2012-8#1)
little to the##2##3##(1996-1#1)(2013-1#1)
little to##8##2##(1992-8#1)(1995-8#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
little value in##3##3##(1991-2#1)(1992-3#1)(2013-1#1)
little value##4##2##(1991-2#1)(1992-3#1)(2008-5#1)(2013-1#1)
little variability between##2##3##(2008-10#2)
little variability##3##2##(2008-10#2)(2008-5#1)
little variation in their##2##4##(1990-9#1)(1997-2#1)
little variation in##4##3##(1990-9#1)(1997-2#1)(2008-9#2)
little variation##6##2##(1990-9#1)(1997-2#1)(2008-10#2)(2008-9#2)
little work has been##2##4##(2008-10#1)(2008-5#1)
little work has##4##3##(1995-11#1)(2008-10#1)(2008-5#1)(2009-7#1)
little work##7##2##(1995-11#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)
little written about##2##3##(2008-11#1)(2008-12#1)
little##830##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#10)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#4)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#6)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#8)(1994-2#8)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#5)(1995-1#4)(1995-11#7)(1995-12#4)(1995-2#10)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#4)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#6)(1996-4#3)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#129)(2008-11#37)(2008-12#9)(2008-2#12)(2008-3#14)(2008-4#13)(2008-5#29)(2008-6#7)(2008-7#22)(2008-8#29)(2008-9#28)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#7)(2009-8#7)(2009-9#4)(2010-1#5)(2010-10#2)(2010-11#6)(2010-12#7)(2010-3#7)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#12)(2011-2#21)(2011-3#1)(2012-1#5)(2012-12#13)(2012-2#21)(2012-3#14)(2012-5#1)(2012-8#1)(2013-1#22)(2013-2#1)(2013-7#2)(2013-8#14)
little-known##3##1##(1992-5#1)(2008-8#1)(2010-2#1)
littoral##6##1##(2008-5#3)(2011-2#1)(2013-7#2)
littoralis##10##1##(2008-10#3)(2008-12#2)(2010-10#2)(2013-8#3)
live a##2##2##(2008-12#1)(2013-1#1)
live and fixed cells##3##4##(2008-9#3)
live and fixed##4##3##(2008-10#1)(2008-9#3)
live and##9##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-12#1)
live animal##2##2##(1997-8#1)(2007-12#1)
live animals##3##2##(1990-7#1)(2008-7#1)(2009-2#1)
live as##3##2##(2008-8#1)(2010-10#1)(2011-2#1)
live attenuated and inactivated##3##4##(1995-5#1)(2011-2#2)
live attenuated varicella##2##3##(2007-12#1)(2008-11#1)
live attenuated##11##2##(1995-5#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#4)
live birth rates##2##3##(1994-2#1)(2012-3#1)
live birth##4##2##(1994-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
live births##14##2##(1990-9#1)(1991-11#2)(1991-3#2)(1992-4#1)(1994-3#2)(2008-7#1)(2013-1#5)
live body##2##2##(2008-12#2)
live born infants)##2##3##(1995-5#2)
live born respectively##2##3##(2013-1#2)
live born##4##2##(1995-5#2)(2013-1#2)
live cell imaging##3##3##(2008-1#1)(2009-10#1)(2009-3#1)
live cell##6##2##(2008-1#1)(2008-11#3)(2009-10#1)(2009-3#1)
live cells and fixed##2##4##(2008-10#1)(2008-9#1)
live cells and##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)
live cells##23##2##(1995-3#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-4#3)(2008-9#5)(2009-6#2)(2011-1#1)
live coral cover##2##3##(2008-5#1)(2011-2#1)
live coral##3##2##(2008-5#1)(2011-2#2)
live donations##2##2##(2011-2#2)
live donor##2##2##(2007-9#1)(2010-6#1)
live in a##2##3##(2011-1#1)(2011-2#1)
live in areas##2##3##(1997-2#1)(2009-8#1)
live in the##2##3##(1992-5#1)(2007-2#1)
live in##24##2##(1992-5#1)(1996-1#1)(1996-12#2)(1997-2#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-1#1)
live infectious bronchitis virus##2##4##(2008-5#2)
live longer##4##2##(1991-2#1)(1995-12#1)(2010-4#1)(2010-5#1)
live mediums##2##2##(2008-5#2)
live microorganisms##2##2##(2009-5#2)
live mouse##2##2##(1995-2#1)(2009-2#1)
live on##2##2##(2013-1#1)(2013-7#1)
live or##2##2##(2008-10#1)(2009-8#1)
live oral##2##2##(2008-11#1)(2008-4#1)
live organ donors##2##3##(2008-12#1)(2010-12#1)
live up to##2##3##(1996-2#1)(2008-5#1)
live vaccine##4##2##(1995-5#1)(1997-6#1)(2008-11#1)(2013-8#1)
live vaccines in##2##3##(2008-11#1)(2013-1#1)
live virus vaccine##2##3##(1995-9#2)
live virus vaccines##2##3##(2008-11#1)(2011-2#1)
live virus##4##2##(1995-9#2)(2008-11#1)(2011-2#1)
live weight##5##2##(2010-2#3)(2010-4#2)
live with their##2##3##(1992-1#1)(1995-9#1)
live with##6##2##(1991-2#1)(1992-1#1)(1994-2#1)(1995-9#1)(2008-6#1)(2008-8#1)
live within##2##2##(2008-8#1)(2010-6#1)
live##265##1##(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#3)(1991-8#2)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#2)(1993-12#1)(1994-2#3)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#10)(1995-6#1)(1995-9#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-9#3)(2008-1#9)(2008-10#18)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#13)(2009-10#2)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#13)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#20)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#3)
live&quot##2##1##(1997-2#1)(2008-5#1)
live-action##2##1##(2008-11#1)(2008-7#1)
live-cell##2##1##(2008-3#1)(2008-7#1)
live-in##2##1##(1993-3#1)(2008-4#1)
live/dead##3##1##(2008-4#2)(2009-6#1)
live?##2##1##(1995-3#1)(2008-7#1)
lived alone##2##2##(1993-3#1)(2008-7#1)
lived and worked in##2##4##(2008-12#1)(2013-1#1)
lived experience of myocardial##2##4##(2009-5#2)
lived experience of##9##3##(2008-1#1)(2008-11#2)(2009-5#4)(2009-9#1)(2013-1#1)
lived experience##12##2##(2008-1#1)(2008-11#3)(2008-12#1)(2009-5#4)(2009-9#2)(2013-1#1)
lived experiences of##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
lived experiences##5##2##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)
lived in a##2##3##(1997-4#1)(2008-9#1)
lived in the##2##3##(1991-12#1)(2012-12#1)
lived in##11##2##(1991-12#1)(1992-1#2)(1997-4#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
lived longer##2##2##(2007-11#1)(2008-8#1)
lived on##2##2##(1992-6#1)(2008-8#1)
lived with##2##2##(2009-11#1)(2013-1#1)
lived##51##1##(1991-12#1)(1992-1#2)(1992-3#2)(1992-6#1)(1993-3#2)(1994-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#4)(2009-9#3)(2010-10#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
livedo##3##1##(2007-9#2)(2012-3#1)
livelihood##2##1##(2008-1#1)(2012-1#1)
liver (BAL)##2##2##(2010-12#1)(2012-2#1)
liver AGT activity##2##3##(1993-11#1)(2008-5#1)
liver DNA of##2##3##(1992-11#2)
liver DNA##7##2##(1991-8#1)(1992-11#3)(1993-12#1)(1993-6#1)(1997-4#1)
liver ID1 activity and ID1 mRNA levels##2##7##(1995-12#2)
liver ID1 activity##4##3##(1995-12#4)
liver ID1##6##2##(1995-12#6)
liver MT##4##2##(1996-12#1)(2008-10#3)
liver PC##2##2##(1995-8#2)
liver S9 activation enzymes##2##4##(2008-9#2)
liver S9##6##2##(2008-8#3)(2008-9#3)
liver UDP-glucuronosyltransferase##6##2##(2008-11#6)
liver abscess and##2##3##(2006-10#1)(2012-2#1)
liver abscess is##2##3##(2006-10#2)
liver abscess##11##2##(1995-10#1)(2006-10#7)(2012-2#3)
liver after##4##2##(1993-12#1)(1995-3#1)(2008-11#1)(2008-8#1)
liver alpha-N-acetylgalactosaminidase##2##2##(1993-12#2)
liver also##2##2##(1994-12#1)(2013-7#1)
liver and brain##7##3##(1990-11#1)(1990-7#1)(1992-10#1)(1994-5#1)(2008-4#2)(2010-3#1)
liver and heart tissues##4##4##(2008-10#4)
liver and hepatomas##2##3##(1990-5#2)
liver and in the##3##4##(1990-11#1)(2009-8#1)(2013-1#1)
liver and in##7##3##(1990-11#1)(1994-2#1)(1994-6#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
liver and its##2##3##(1994-8#1)(1996-2#1)
liver and kidney##19##3##(1990-11#2)(1990-12#2)(1990-8#1)(1991-5#1)(1993-12#2)(1994-11#2)(1997-8#1)(2008-10#2)(2008-7#2)(2008-9#2)(2011-2#1)(2013-8#1)
liver and lung metastases##2##4##(1991-6#2)
liver and lung##4##3##(1991-6#2)(2008-5#1)(2011-2#1)
liver and lungs##2##3##(2010-11#1)(2013-1#1)
liver and muscle##4##3##(1996-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
liver and serum##3##3##(1991-12#1)(1992-11#1)(2008-8#1)
liver and small intestine##4##4##(1990-7#1)(1992-11#3)
liver and spleen##6##3##(1991-8#1)(1997-6#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#1)
liver and the##7##3##(1990-12#1)(1993-9#1)(1994-7#2)(1995-3#1)(1995-9#1)(2008-11#1)
liver and##133##2##(1990-11#5)(1990-12#6)(1990-2#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#4)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#5)(1997-6#1)(1997-8#2)(2006-10#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-6#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#2)
liver and/or##2##2##(1994-5#1)(2011-2#1)
liver are##5##2##(1990-11#1)(1991-12#1)(1994-9#1)(1997-1#1)(2010-12#1)
liver aryl sulfotransferase##2##3##(1993-12#1)(1993-8#1)
liver as##4##2##(1995-3#1)(2008-8#1)(2010-5#1)(2010-8#1)
liver associated##2##2##(2010-12#1)(2011-2#1)
liver at##6##2##(1995-3#3)(1996-12#2)(2008-8#1)
liver biopsies##5##2##(1990-2#1)(1993-2#4)
liver biopsy##8##2##(1991-8#2)(2008-1#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
liver blood flow and##2##4##(2007-11#2)
liver but##2##2##(2012-2#1)(2013-1#1)
liver by the##2##3##(1993-12#1)(1994-8#1)
liver by##20##2##(1990-2#1)(1990-7#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-6#2)(1994-8#2)(1995-2#2)(1997-7#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
liver cDNA library and##2##4##(1994-11#1)(2008-8#1)
liver cDNA library##8##3##(1992-3#2)(1992-8#1)(1993-11#1)(1994-11#2)(1994-6#1)(2008-8#1)
liver cDNA##13##2##(1990-12#1)(1992-3#3)(1992-8#1)(1993-11#2)(1994-11#2)(1994-6#1)(2008-11#1)(2008-8#2)
liver cancer##10##2##(1990-8#1)(1991-11#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#3)
liver cancer]##2##2##(1990-2#1)(2008-7#1)
liver cell line##6##3##(1990-12#1)(1992-6#1)(1994-6#1)(2008-11#1)(2010-11#1)(2010-5#1)
liver cell lines##3##3##(1992-3#2)(2012-12#1)
liver cell##22##2##(1990-12#1)(1990-9#1)(1992-3#2)(1992-5#1)(1992-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(2006-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-5#1)(2012-12#1)
liver cells by##3##3##(1995-6#2)(2008-8#1)
liver cells was##2##3##(1994-6#1)(2009-8#1)
liver cells were##4##3##(1990-12#2)(1993-12#1)(1996-2#1)
liver cells##38##2##(1990-12#4)(1990-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#5)(1995-6#3)(1996-2#2)(1997-1#2)(1997-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#3)(2010-5#1)(2011-2#1)
liver cirrhosis and portal hypertension##2##5##(1991-5#1)(2010-10#1)
liver cirrhosis and##6##3##(1991-5#1)(1992-2#1)(1997-7#1)(2007-7#1)(2009-8#1)(2010-10#1)
liver cirrhosis is##2##3##(1997-7#1)(2013-8#1)
liver cirrhosis with##2##3##(1995-3#1)(2011-2#1)
liver cirrhosis##30##2##(1991-5#2)(1992-2#1)(1993-9#1)(1995-3#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#6)
liver cirrhosis]##2##2##(1991-11#1)(1991-5#1)
liver contained##2##2##(1990-11#1)(1993-3#1)
liver contains##3##2##(1990-11#1)(1990-2#1)(1991-12#1)
liver cytosol and##2##3##(1990-2#1)(1993-8#1)
liver cytosol by##2##3##(1996-5#1)(2008-10#1)
liver cytosol##7##2##(1990-2#1)(1993-6#1)(1993-8#1)(1996-5#1)(2008-10#3)
liver cytosolic##5##2##(1990-11#1)(1991-2#1)(1993-8#2)(1995-2#1)
liver cytosols##2##2##(1990-11#1)(2008-10#1)
liver damage by##2##3##(1992-9#1)(2011-2#1)
liver damage##11##2##(1992-9#2)(1995-3#2)(2008-3#1)(2008-8#1)(2009-8#3)(2011-2#1)(2012-2#1)
liver deposition and sparing##2##4##(2012-2#2)
liver deposition is##2##3##(2012-2#2)
liver deposition##4##2##(2012-2#4)
liver development and##2##3##(2011-2#1)(2013-1#1)
liver disease (CLD)##2##3##(2008-10#2)
liver disease and##4##3##(2007-7#1)(2009-8#1)(2013-8#2)
liver disease as##2##3##(2009-8#1)(2010-6#1)
liver disease associated with##2##4##(2008-1#1)(2013-8#1)
liver disease in##7##3##(1991-8#1)(2007-7#2)(2008-1#1)(2009-3#1)(2009-5#1)(2010-10#1)
liver disease patients##2##3##(2008-10#1)(2009-8#1)
liver disease was##2##3##(1991-8#1)(1994-7#1)
liver disease who##3##3##(2008-1#2)(2011-2#1)
liver disease will##2##3##(2006-10#2)
liver disease##98##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-8#6)(1992-12#2)(1992-6#2)(1993-12#2)(1994-7#2)(1996-1#4)(1996-3#1)(2006-10#12)(2007-7#4)(2008-1#10)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#8)(2010-10#1)(2010-12#3)(2010-6#4)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#9)(2013-8#6)
liver diseases##12##2##(1991-12#1)(1995-10#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
liver diseases]##2##2##(1994-7#1)(1997-8#1)
liver disorders##3##2##(1990-2#1)(2008-8#1)(2013-1#1)
liver doses##2##2##(2013-1#2)
liver drug##2##2##(2008-10#2)
liver during the##2##3##(1990-2#1)(2008-10#1)
liver during##4##2##(1990-2#1)(1990-3#1)(1990-7#1)(2008-10#1)
liver enzyme##9##2##(1990-7#1)(1991-12#1)(1992-3#4)(1993-12#1)(1995-6#1)(2008-8#1)
liver enzymes and##3##3##(2008-11#1)(2012-3#2)
liver enzymes were##2##3##(2008-1#1)(2008-8#1)
liver enzymes##10##2##(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2012-3#2)(2013-1#1)
liver extracts##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
liver failure or##2##3##(2007-10#1)(2010-12#1)
liver failure##10##2##(2007-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
liver fatty##2##2##(1994-8#1)(2009-8#1)
liver fibrosis in##2##3##(2013-1#1)(2013-8#1)
liver fibrosis##10##2##(2011-2#2)(2013-1#5)(2013-8#3)
liver fluke##4##2##(1992-6#1)(2008-12#3)
liver following burn injury##2##4##(2008-8#2)
liver following##3##2##(2008-10#1)(2008-8#2)
liver for##6##2##(1993-6#1)(1997-4#4)(2012-2#1)
liver from the##2##3##(2008-11#2)
liver from##8##2##(1993-11#1)(1994-2#1)(1995-6#2)(1996-2#1)(1997-8#1)(2008-11#2)
liver fructose-2##2##2##(1990-5#2)
liver function and##2##3##(1992-12#1)(2010-10#1)
liver function impairment##3##3##(2013-8#3)
liver function in##2##3##(2012-3#1)(2013-8#1)
liver function tests were##2##4##(1992-2#1)(2007-12#1)
liver function tests##7##3##(1991-8#1)(1992-2#1)(1992-6#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-4#1)
liver function##32##2##(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1994-7#1)(1995-11#2)(1996-12#1)(1996-3#1)(2006-6#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-3#2)(2013-8#6)
liver glutamate dehydrogenase##3##3##(1990-7#3)
liver glycogen##3##2##(1993-8#2)(2008-10#1)
liver growth##2##2##(1995-6#1)(2008-11#1)
liver had##3##2##(1993-12#1)(1997-3#1)(2011-2#1)
liver haemangioma##2##2##(2013-1#2)
liver has##2##2##(2008-11#1)(2012-2#1)
liver homogenates##3##2##(1990-11#1)(1992-11#1)(1995-3#1)
liver hyperplasia##4##2##(1994-11#3)(1995-6#1)
liver imaging##4##2##(2008-7#2)(2010-12#2)
liver in a##4##3##(1992-2#1)(2008-10#1)(2010-11#1)(2012-3#1)
liver in the##3##3##(1990-7#1)(1993-3#2)
liver in##21##2##(1990-11#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-12#1)(1992-2#1)(1993-3#2)(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-5#1)(2012-3#1)(2013-8#1)
liver indicated that##2##3##(1992-6#1)(1995-3#1)
liver injury and##4##3##(1994-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
liver injury by##3##3##(1995-3#1)(2008-11#1)(2013-1#1)
liver injury in##3##3##(2009-4#1)(2009-8#1)(2011-2#1)
liver injury was##2##3##(1994-7#1)(1996-11#1)
liver injury##30##2##(1992-2#2)(1994-6#2)(1994-7#2)(1995-3#1)(1996-11#2)(2006-10#1)(2008-11#1)(2008-8#6)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
liver investment##4##2##(2010-8#4)
liver is described##4##3##(1990-12#1)(1993-9#1)(1996-5#1)(2008-10#1)
liver is##17##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1993-9#1)(1996-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-8#1)
liver lesion detection##2##3##(2008-1#1)(2008-7#1)
liver lesion##5##2##(2007-5#1)(2008-1#1)(2008-7#1)(2012-3#2)
liver lesions##23##2##(1990-2#1)(1990-9#1)(2008-1#1)(2008-7#6)(2010-12#12)(2011-2#1)(2012-2#1)
liver library##2##2##(1993-3#2)
liver mass##2##2##(2010-8#1)(2012-2#1)
liver may##2##2##(1990-2#1)(2010-5#1)
liver membrane##2##2##(1990-2#1)(1994-2#1)
liver membranes##4##2##(1994-3#4)
liver metastases and##3##3##(1991-4#1)(2008-7#1)(2011-2#1)
liver metastases from breast cancer##2##5##(1995-4#2)
liver metastases from##4##3##(1994-6#1)(1995-4#2)(2009-9#1)
liver metastases of##3##3##(1991-6#1)(1995-4#1)(2010-12#1)
liver metastases##30##2##(1990-9#2)(1991-4#1)(1991-6#2)(1992-12#1)(1994-12#3)(1994-6#1)(1995-4#3)(2008-1#1)(2008-10#2)(2008-7#5)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#2)(2013-1#3)
liver metastasis is##2##3##(2011-2#2)
liver metastasis##10##2##(2007-5#2)(2011-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
liver microsomal##5##2##(1993-11#2)(1994-8#1)(1997-7#1)(2011-3#1)
liver microsomes by##3##3##(1990-12#1)(1991-5#1)(1994-8#1)
liver microsomes from##3##3##(1991-12#1)(1994-8#1)(2011-3#1)
liver microsomes of the three species##2##6##(2011-3#2)
liver microsomes of##4##3##(1991-12#1)(2011-3#3)
liver microsomes were##3##3##(1991-2#1)(2011-3#2)
liver microsomes##48##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#6)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-8#9)(1995-6#3)(1997-7#2)(2011-1#1)(2011-3#9)
liver mitochondria and##3##3##(1990-2#1)(1994-11#1)(2008-5#1)
liver mitochondria##14##2##(1990-2#1)(1991-5#1)(1994-11#2)(1994-12#2)(1994-8#3)(1995-11#1)(1995-12#1)(2008-5#2)(2013-1#1)
liver mitochondrial##5##2##(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#2)
liver model##2##2##(2009-11#1)(2009-12#1)
liver monoamine##2##2##(1994-8#2)
liver necrosis##2##2##(1992-6#1)(1994-5#1)
liver of rats##3##3##(1994-6#1)(2012-2#1)(2013-1#1)
liver of the female##3##4##(1995-9#1)(2010-5#2)
liver of the##8##3##(1990-7#1)(1992-12#1)(1992-9#1)(1995-9#1)(2008-12#1)(2010-5#3)
liver of##32##2##(1990-12#1)(1990-3#2)(1990-7#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-11#1)(1994-6#1)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#2)(2010-5#3)(2012-2#1)(2013-1#2)
liver or##11##2##(1990-11#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
liver parenchyma##4##2##(1995-6#1)(1996-2#1)(2011-2#1)(2012-2#1)
liver parenchymal cells##2##3##(1994-3#2)
liver parenchymal##3##2##(1994-3#2)(2012-3#1)
liver perfusion##3##2##(1991-8#1)(1992-5#1)(2008-7#1)
liver plasma##4##2##(1994-2#1)(1995-8#3)
liver proteins##2##2##(1990-2#1)(1993-6#1)
liver regeneration##8##2##(1993-8#1)(1995-6#1)(2008-10#1)(2008-8#4)(2012-2#1)
liver resection##12##2##(2008-10#3)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)
liver resections##2##2##(1991-8#1)(2008-10#1)
liver sample##2##2##(2008-10#2)
liver samples##7##2##(1991-5#2)(2008-10#3)(2008-2#1)(2008-8#1)
liver segment III##2##3##(2013-8#2)
liver showed##4##2##(1992-8#1)(1997-6#1)(2008-7#1)(2012-12#1)
liver size##3##2##(2008-10#1)(2010-8#2)
liver slice##2##2##(1995-11#1)(2008-6#1)
liver slices incubated in##2##4##(1995-11#1)(2008-6#1)
liver slices##4##2##(1994-5#1)(1995-11#2)(2008-6#1)
liver specific##4##2##(1992-8#1)(1994-11#1)(2008-11#2)
liver specimens##2##2##(2008-8#1)(2011-2#1)
liver steatosis##3##2##(2011-1#1)(2012-2#2)
liver stiffness##2##2##(2011-2#2)
liver support systems##6##3##(2008-11#5)(2010-12#1)
liver support##10##2##(2008-11#8)(2010-12#2)
liver syndrome##2##2##(1997-3#2)
liver tests was##2##3##(1991-6#1)(2009-11#1)
liver tests##5##2##(1991-6#2)(2009-11#2)(2012-2#1)
liver that##4##2##(1992-12#1)(1993-12#1)(1995-2#1)(2009-8#1)
liver the##2##2##(1995-12#1)(2009-8#1)
liver tissue were##3##3##(1990-2#1)(2008-10#1)(2011-2#1)
liver tissue##20##2##(1990-11#1)(1990-2#2)(1992-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
liver tissues##8##2##(1992-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-3#1)
liver to##8##2##(1995-8#1)(2008-11#1)(2008-5#2)(2010-11#1)(2012-2#2)(2013-8#1)
liver total lipids##4##3##(2008-12#4)
liver toxicity in rats##2##4##(1993-12#1)(2008-10#1)
liver toxicity##6##2##(1993-12#1)(1996-12#1)(2008-10#2)(2013-1#2)
liver transplant donor candidates##2##4##(2012-2#2)
liver transplant##9##2##(1990-8#1)(1993-9#1)(2008-6#1)(2009-2#2)(2010-6#1)(2012-2#2)(2012-3#1)
liver transplantation for##4##3##(1991-11#2)(2010-6#1)(2013-8#1)
liver transplantation has##2##3##(2006-10#2)
liver transplantation in##2##3##(1992-6#1)(2013-8#1)
liver transplantation is##4##3##(1994-6#1)(2006-10#1)(2013-1#2)
liver transplantation or##2##3##(2008-11#1)(2012-1#1)
liver transplantation##45##2##(1990-3#1)(1991-11#3)(1991-8#2)(1992-12#3)(1992-3#1)(1992-6#2)(1992-9#1)(1993-2#2)(1994-6#3)(1995-10#1)(2006-10#6)(2008-11#1)(2008-5#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#5)
liver transplantation]##4##2##(1990-3#1)(2011-2#2)(2012-3#1)
liver transplants##6##2##(1996-1#2)(1996-11#1)(2010-6#2)(2013-8#1)
liver trauma##2##2##(1991-6#1)(2013-8#1)
liver tumors in##2##3##(2008-9#1)(2011-1#1)
liver tumors were##2##3##(2008-10#2)
liver tumors##9##2##(1990-2#1)(1990-6#1)(1992-5#1)(2008-10#3)(2008-9#1)(2011-1#1)(2013-1#1)
liver tumour##2##2##(2011-2#1)(2012-2#1)
liver tumours##3##2##(1993-5#1)(2008-11#1)(2013-1#1)
liver type 1 iodothyronine deiodinase##2##5##(1995-12#2)
liver using the##2##3##(2008-1#1)(2012-1#1)
liver using##7##2##(1997-7#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-1#1)
liver was also##2##3##(1993-12#1)(2009-8#1)
liver was used##2##3##(1996-12#1)(2008-10#1)
liver was##21##2##(1990-11#1)(1990-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-6#1)(2009-8#1)(2010-5#1)(2011-1#2)
liver weight##8##2##(1992-5#1)(1994-5#1)(1995-6#1)(2008-12#1)(2008-9#2)(2013-1#2)
liver weights were##2##3##(1995-11#1)(2008-9#1)
liver weights##5##2##(1995-11#1)(2008-10#1)(2008-9#3)
liver were##9##2##(1994-8#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
liver which##4##2##(1992-12#1)(1993-8#1)(2008-12#2)
liver with##8##2##(1991-6#1)(1991-7#1)(1995-2#1)(1996-12#1)(1997-4#1)(2009-1#1)(2010-12#1)(2013-1#1)
liver##1757##1##(1990-10#4)(1990-11#42)(1990-12#25)(1990-2#21)(1990-3#6)(1990-5#32)(1990-6#2)(1990-7#21)(1990-8#12)(1990-9#6)(1991-11#6)(1991-12#24)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#24)(1991-6#13)(1991-7#4)(1991-8#20)(1991-9#2)(1992-10#3)(1992-11#20)(1992-12#16)(1992-2#8)(1992-3#14)(1992-5#8)(1992-6#21)(1992-8#22)(1992-9#11)(1993-11#10)(1993-12#24)(1993-2#8)(1993-3#18)(1993-5#4)(1993-6#15)(1993-8#19)(1993-9#8)(1994-11#18)(1994-12#10)(1994-2#6)(1994-3#9)(1994-5#11)(1994-6#30)(1994-7#10)(1994-8#29)(1994-9#1)(1995-10#4)(1995-11#12)(1995-12#14)(1995-2#13)(1995-3#22)(1995-4#3)(1995-5#3)(1995-6#24)(1995-8#9)(1995-9#4)(1996-1#6)(1996-11#5)(1996-12#19)(1996-2#7)(1996-3#3)(1996-5#6)(1996-6#1)(1997-1#6)(1997-3#7)(1997-4#17)(1997-5#1)(1997-6#2)(1997-7#14)(1997-8#10)(1997-9#1)(2006-10#33)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#3)(2007-7#8)(2007-8#2)(2008-1#31)(2008-10#107)(2008-11#58)(2008-12#22)(2008-2#3)(2008-3#8)(2008-4#16)(2008-5#24)(2008-6#7)(2008-7#45)(2008-8#44)(2008-9#27)(2009-1#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#36)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#13)(2010-12#44)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#15)(2010-6#11)(2010-7#7)(2010-8#11)(2011-1#12)(2011-2#51)(2011-3#10)(2012-1#3)(2012-12#9)(2012-2#48)(2012-3#22)(2013-1#98)(2013-7#4)(2013-8#40)
liver) and##2##2##(2008-10#2)
liver)##11##1##(1995-3#1)(1996-2#2)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)
liver-derived##3##1##(1992-9#1)(1994-6#1)(2011-2#1)
liver-kidney transplantation##2##2##(2013-8#2)
liver-only CRLM##2##2##(2013-1#2)
liver-specific expression##2##2##(1990-11#1)(1994-8#1)
liver-specific functions##3##2##(2008-11#2)(2008-7#1)
liver-specific##8##1##(1990-11#1)(1994-8#1)(1995-2#1)(2008-11#2)(2008-7#1)(2011-2#2)
liver]##5##1##(1991-3#1)(1992-5#1)(1993-5#1)(1997-7#1)(2008-7#1)
livers and##4##2##(1990-5#1)(1991-3#1)(2008-10#1)(2008-11#1)
livers by##2##2##(2008-10#2)
livers during##3##2##(1990-5#1)(2008-8#1)(2010-8#1)
livers of##13##2##(1991-12#1)(1992-11#2)(1992-8#1)(1993-6#1)(1994-6#1)(1994-7#1)(2008-10#2)(2008-5#2)(2008-8#1)(2012-2#1)
livers were##2##2##(1990-5#1)(1996-12#1)
livers##52##1##(1990-5#3)(1991-12#2)(1991-3#5)(1991-5#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-3#1)(1996-12#2)(1996-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2008-10#6)(2008-11#2)(2008-5#2)(2008-8#4)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#3)
livers)##2##1##(1994-6#1)(2008-10#1)
lives and##8##2##(2008-1#1)(2008-11#2)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
lives are##4##2##(1990-2#1)(1992-4#1)(2007-11#1)(2013-1#1)
lives as##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
lives in road##2##3##(2010-11#2)
lives in the##2##3##(1996-12#1)(2008-11#1)
lives in##10##2##(1995-1#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-11#2)(2010-12#1)
lives of the##2##3##(1991-2#1)(2012-2#1)
lives of##22##2##(1991-2#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(2007-2#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
lives than##2##2##(1996-8#1)(2012-12#1)
lives##101##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-4#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-9#2)(1995-1#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#12)(2008-12#3)(2008-2#3)(2008-3#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#6)(2013-8#2)
livestock and##8##2##(1994-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
livestock farm workers##2##3##(2008-12#2)
livestock farming##2##2##(2011-1#1)(2011-2#1)
livestock for##2##2##(2008-11#1)(2011-1#1)
livestock industries##3##2##(1997-7#2)(2011-2#1)
livestock keeping##3##2##(2011-1#2)(2011-2#1)
livestock production##5##2##(1997-7#1)(2011-2#4)
livestock##66##1##(1990-3#1)(1991-3#1)(1994-3#1)(1994-7#2)(1995-2#1)(1996-3#1)(1997-7#9)(2008-10#4)(2008-11#3)(2008-12#4)(2008-8#2)(2008-9#1)(2010-1#2)(2010-4#2)(2011-1#9)(2011-2#13)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
liveweight##2##1##(1991-3#1)(1996-12#1)
livia##2##1##(2008-5#1)(2008-8#1)
lividans##9##1##(1990-5#1)(1994-12#1)(1994-3#2)(2011-1#5)
lividus##5##1##(1997-4#1)(1997-6#2)(2011-2#2)
living activities##2##2##(2007-11#1)(2008-1#1)
living alone##4##2##(1993-12#1)(2008-7#1)(2011-1#2)
living and##17##2##(1991-12#1)(1995-2#1)(1995-3#1)(2007-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
living animals##7##2##(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)
living area##2##2##(2011-2#2)
living arrangements##2##2##(1997-3#1)(2011-2#1)
living at home##7##3##(1992-4#1)(1995-2#1)(2007-12#1)(2008-7#1)(2013-1#3)
living bacterial cells##2##3##(2008-10#2)
living biological##2##2##(2007-12#1)(2008-3#1)
living cancer patients##2##3##(1993-11#2)
living cell adhesion##2##3##(2008-11#2)
living cell##8##2##(1990-11#1)(1990-2#1)(2008-11#3)(2008-2#1)(2008-5#1)(2010-12#1)
living cells and##10##3##(1991-12#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2013-8#1)
living cells##59##2##(1991-12#1)(1992-5#2)(1993-6#1)(1995-11#1)(2007-11#2)(2007-12#3)(2008-1#10)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#6)(2008-7#2)(2008-8#3)(2008-9#5)(2009-2#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-12#3)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
living children##2##2##(1994-12#1)(2011-1#1)
living circumstances##3##2##(2011-2#3)
living conditions and##2##3##(2008-11#1)(2012-2#1)
living conditions strata##2##3##(2008-9#2)
living conditions##14##2##(1992-8#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#5)(2009-6#1)(2009-8#1)(2012-1#1)(2012-2#1)
living cultured cells##2##3##(2008-11#2)
living donation##5##2##(2011-2#5)
living donor kidney transplantation is##2##5##(2011-2#2)
living donor kidney transplantation##5##4##(2011-2#5)
living donor kidney##8##3##(2011-2#8)
living donor nephrectomies##2##3##(2007-7#2)
living donor nephrectomy is##2##4##(2007-7#1)(2011-2#1)
living donor nephrectomy##5##3##(2007-7#1)(2011-2#4)
living donor renal##2##3##(2007-7#1)(2011-2#1)
living donor transplant##2##3##(2011-2#2)
living donor##29##2##(2007-7#4)(2010-10#1)(2011-2#22)(2013-8#2)
living donors for##2##3##(2008-12#1)(2011-2#1)
living donors##6##2##(2008-1#1)(2008-12#2)(2011-2#3)
living donors]##3##2##(2011-2#3)
living embryo sacs of Torenia fournieri##2##6##(2008-11#1)(2008-9#1)
living embryo##3##2##(2008-11#2)(2008-9#1)
living human retina##3##3##(2007-11#2)(2011-1#1)
living human##4##2##(2007-11#2)(2008-8#1)(2011-1#1)
living in Brazil##3##3##(2008-2#3)
living in a##15##3##(1991-8#1)(1992-1#1)(1992-3#1)(1994-5#1)(1995-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-9#3)
living in an##2##3##(2011-2#1)(2012-12#1)
living in coastal##3##3##(2007-12#1)(2013-7#1)(2013-8#1)
living in four##2##3##(1992-6#1)(2007-12#1)
living in low##2##3##(2008-7#1)(2011-2#1)
living in nursing homes##3##4##(1993-11#1)(2007-10#1)(2010-10#1)
living in nursing##4##3##(1993-11#1)(2007-10#1)(2008-5#1)(2010-10#1)
living in rural areas##3##4##(1991-3#1)(1993-12#1)(2013-1#1)
living in rural##4##3##(1991-3#1)(1993-12#1)(2008-10#1)(2013-1#1)
living in the United States##2##5##(2008-12#1)(2008-3#1)
living in the city of##2##5##(1992-8#1)(2013-1#1)
living in the community##5##4##(2008-12#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-3#1)
living in the same##2##4##(2008-5#1)(2011-1#1)
living in the##27##3##(1990-3#1)(1991-12#1)(1992-8#1)(1993-6#1)(1996-6#1)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#1)(2009-6#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
living in urban areas##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
living in##113##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-6#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#5)(2008-2#6)(2008-3#3)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#2)(2009-5#3)(2009-6#1)(2010-10#1)(2010-9#3)(2011-1#4)(2011-2#10)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#3)
living kidney##2##2##(2008-9#1)(2011-2#1)
living life##2##2##(2007-11#1)(2010-10#1)
living longer##3##2##(2009-10#1)(2013-1#2)
living near##5##2##(1991-3#3)(1995-11#1)(2008-8#1)
living on the##2##3##(2008-5#2)
living on##3##2##(1996-6#1)(2008-5#2)
living organism##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
living organisms respond to##2##4##(2008-10#1)(2013-1#1)
living organisms##13##2##(1992-11#1)(1994-11#1)(2008-10#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
living related and##2##3##(2008-1#1)(2010-7#1)
living related##5##2##(2008-1#4)(2010-7#1)
living snails##2##2##(2012-3#2)
living standards##2##2##(1992-4#1)(2008-12#1)
living systems##7##2##(1991-9#1)(2008-1#1)(2008-7#1)(2012-2#4)
living things##3##2##(1991-2#1)(2012-2#2)
living tissue##7##2##(1993-3#1)(2008-2#2)(2009-8#1)(2011-1#2)(2012-2#1)
living tissues##2##2##(2012-2#2)
living under##4##2##(1990-12#1)(1995-11#1)(1996-6#1)(1997-6#1)
living with AIDS##2##3##(1997-6#1)(2012-3#1)
living with COPD##3##3##(2010-10#3)
living with HIV and##4##4##(2009-10#1)(2010-3#1)(2010-8#1)(2012-12#1)
living with HIV infection##2##4##(1992-9#1)(2011-1#1)
living with HIV##14##3##(1992-9#1)(1995-6#1)(2009-10#3)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
living with HIV/AIDS in##2##4##(2009-7#1)(2011-1#1)
living with HIV/AIDS##13##3##(2008-1#1)(2008-12#2)(2009-7#2)(2011-1#7)(2013-1#1)
living with a spouse##2##4##(1990-2#1)(1994-2#1)
living with a##8##3##(1990-2#1)(1992-12#1)(1994-2#1)(2008-2#1)(2008-6#2)(2008-7#1)(2012-12#1)
living with chronic##2##3##(2010-10#1)(2012-12#1)
living with type-2 diabetes##2##4##(2008-7#2)
living with##57##2##(1990-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-6#3)(2008-7#4)(2009-10#3)(2009-7#3)(2010-10#5)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#8)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#8)
living within##2##2##(1997-1#1)(2011-2#1)
living yeast##3##2##(1996-6#2)(2008-4#1)
living##544##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#4)(1996-11#1)(1996-3#1)(1996-6#5)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#3)(2007-10#3)(2007-11#12)(2007-12#9)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2008-1#23)(2008-10#35)(2008-11#23)(2008-12#27)(2008-2#11)(2008-3#7)(2008-4#8)(2008-5#15)(2008-6#4)(2008-7#20)(2008-8#10)(2008-9#18)(2009-10#5)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#7)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#1)(2010-10#9)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#5)(2011-1#22)(2011-2#64)(2012-1#1)(2012-12#8)(2012-2#13)(2012-3#5)(2013-1#28)(2013-7#4)(2013-8#12)
living-donor##7##1##(2006-10#1)(2007-8#1)(2011-2#5)
lizard genus Gekko##2##3##(2010-3#2)
lizard genus##3##2##(2010-3#3)
lizard##22##1##(1996-5#3)(2008-10#2)(2008-7#3)(2008-8#3)(2010-3#5)(2011-1#2)(2011-2#3)(2013-7#1)
lizards and##2##2##(2010-3#1)(2013-7#1)
lizards have##2##2##(2010-3#2)
lizards is##2##2##(1996-5#1)(2011-2#1)
lizards of##4##2##(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#1)
lizards that##2##2##(2010-3#2)
lizards##43##1##(1991-5#3)(1996-5#1)(2008-10#3)(2008-7#7)(2008-8#5)(2008-9#2)(2010-3#17)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
lm mice##4##2##(2008-10#4)
lm##6##1##(2008-10#5)(2008-3#1)
lmol(-1)cm(-1) at##2##2##(2008-10#2)
lmol(-1)cm(-1)##4##1##(2008-10#4)
ln [X + 1] -##2##5##(2008-10#2)
ln##8##1##(1995-5#1)(1997-2#1)(2008-10#5)(2011-1#1)
load (GL)##2##2##(2008-1#1)(2008-3#1)
load and the##2##3##(2007-7#1)(2012-12#1)
load and##18##2##(1994-6#2)(1997-4#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-9#2)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
load application##3##2##(2013-1#3)
load applied##3##2##(2007-12#1)(2008-5#2)
load at##2##2##(2008-3#1)(2008-5#1)
load cell##2##2##(2008-12#1)(2008-6#1)
load during##2##2##(2008-5#1)(2013-1#1)
load for##2##2##(2008-3#1)(2009-7#1)
load in##7##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2013-8#1)
load is##3##2##(1993-3#1)(2007-12#1)(2008-10#1)
load levels and##3##3##(2009-7#1)(2011-1#2)
load levels##4##2##(2009-7#1)(2011-1#3)
load of##11##2##(1992-11#1)(1993-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-2#1)(2010-8#1)(2012-3#1)
load on the##2##3##(2007-8#2)
load on##7##2##(1991-12#1)(1991-6#1)(1997-5#1)(2007-10#1)(2007-8#2)(2009-11#1)
load or##2##2##(1994-6#1)(2010-5#1)
load to##3##2##(2008-9#1)(2009-3#1)(2012-2#1)
load transfer##5##2##(2008-5#1)(2009-4#3)(2010-3#1)
load was##12##2##(1994-2#1)(1996-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2012-12#1)(2013-8#1)
load with##2##2##(2013-7#1)(2013-8#1)
load##202##1##(1991-12#1)(1991-6#2)(1992-10#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-2#3)(1994-6#3)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#7)(2008-5#11)(2008-6#6)(2008-7#9)(2008-9#6)(2009-10#1)(2009-11#2)(2009-2#5)(2009-3#1)(2009-4#7)(2009-5#1)(2009-7#6)(2009-8#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#9)(2012-3#8)(2013-1#20)(2013-7#2)(2013-8#6)
load)##2##1##(2009-7#1)(2010-10#1)
load-balanced##2##1##(2007-9#2)
load-bearing##5##1##(2009-7#3)(2010-4#1)(2012-2#1)
load-induced plastic strain##2##3##(2009-7#2)
load-induced##3##1##(1996-5#1)(2009-7#2)
loaded at##3##2##(2008-10#1)(2013-1#2)
loaded by##4##2##(1992-5#1)(2011-2#1)(2013-1#2)
loaded foam##2##2##(2008-10#2)
loaded in the##3##3##(2008-10#1)(2008-2#2)
loaded in##8##2##(2008-10#2)(2008-12#1)(2008-2#2)(2008-9#1)(2009-12#1)(2009-7#1)
loaded into a##2##3##(2007-12#1)(2008-10#1)
loaded into##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
loaded on the##3##3##(1994-2#1)(2008-10#2)
loaded on##8##2##(1994-2#1)(2008-10#7)
loaded onto##2##2##(2008-10#1)(2008-7#1)
loaded resin##4##2##(2008-10#4)
loaded side##2##2##(2007-8#2)
loaded silica gel was##2##4##(2008-10#2)
loaded silica gel##3##3##(2008-10#3)
loaded single implants##2##3##(2013-1#2)
loaded with 1##3##3##(2008-10#3)
loaded with 1-(2-pyridylazo)-2-naphthol (PAN)##2##4##(2008-10#2)
loaded with PAN##3##3##(2008-10#3)
loaded with a##3##3##(1994-2#2)(2008-10#1)
loaded with cadmium##2##3##(1995-5#1)(2008-10#1)
loaded with calmagite##3##3##(2008-10#3)
loaded with fura-2##2##3##(1992-5#1)(1992-6#1)
loaded with the##7##3##(1991-9#1)(1992-5#1)(1997-1#1)(2008-10#4)
loaded with##53##2##(1990-11#2)(1991-9#1)(1992-5#2)(1992-6#1)(1994-2#2)(1995-5#1)(1997-1#1)(2008-10#35)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
loaded##142##1##(1990-11#2)(1990-5#1)(1991-5#1)(1991-9#1)(1992-5#3)(1992-6#1)(1992-9#1)(1994-2#3)(1995-5#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#70)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-12#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-9#4)(2011-2#2)(2011-7#1)(2012-3#3)(2013-1#18)
loading and elution##4##3##(2008-10#3)(2008-7#1)
loading and the##2##3##(2007-12#1)(2008-10#1)
loading and unloading of##2##4##(2008-10#2)
loading and unloading##4##3##(2007-7#1)(2008-10#3)
loading and##25##2##(1990-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-3#1)(2008-7#1)(2009-4#2)(2009-7#1)(2010-11#1)(2013-1#4)
loading at##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-7#1)
loading can##2##2##(2008-3#1)(2010-9#1)
loading capacities of##2##3##(2008-10#2)
loading capacity for##2##3##(2008-10#1)(2013-1#1)
loading capacity of the##3##4##(2008-10#2)(2008-4#1)
loading capacity of##4##3##(2008-10#3)(2008-4#1)
loading capacity##9##2##(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2013-1#1)
loading conditions##3##2##(2006-10#1)(2009-12#1)(2009-7#1)
loading dose of##3##3##(1991-9#1)(2011-2#1)(2012-12#1)
loading dose##4##2##(1991-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
loading efficiency of##2##3##(2013-1#2)
loading efficiency##3##2##(2010-5#1)(2013-1#2)
loading flow rate##6##3##(2008-10#6)
loading flow rates##2##3##(2008-10#2)
loading flow##8##2##(2008-10#8)
loading for##2##2##(2008-7#1)(2010-12#1)
loading force on the##2##4##(2007-12#1)(2009-4#1)
loading force##3##2##(2007-12#1)(2009-4#2)
loading group and##3##3##(2013-1#3)
loading group##5##2##(2013-1#5)
loading half time (t(1/2))##2##4##(2008-10#2)
loading half time##3##3##(2008-10#3)
loading in the##5##3##(2008-10#1)(2008-2#1)(2013-1#3)
loading in##11##2##(2008-10#1)(2008-2#4)(2008-3#1)(2010-11#1)(2012-7#1)(2013-1#3)
loading is##5##2##(1994-2#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-7#1)
loading of implants in##2##4##(2010-5#1)(2013-1#1)
loading of single##2##3##(2013-1#2)
loading of the##5##3##(1990-12#1)(2008-10#3)(2010-5#1)
loading of##24##2##(1990-12#1)(1995-11#1)(1997-7#1)(2008-10#9)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2013-1#3)
loading on the##4##3##(1994-6#1)(2007-8#1)(2009-8#1)(2011-2#1)
loading on##7##2##(1994-6#1)(2007-8#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#2)
loading plots##2##2##(2008-10#2)
loading rate##5##2##(2008-7#3)(2009-7#1)(2013-1#1)
loading rates##4##2##(2008-6#2)(2009-7#1)(2013-1#1)
loading sample volume##2##3##(2008-10#2)
loading significantly##2##2##(2008-10#1)(2013-8#1)
loading the##7##2##(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)
loading time of##4##3##(2008-10#4)
loading time##6##2##(2008-10#6)
loading was##4##2##(1990-12#1)(1990-2#1)(2011-2#1)(2013-1#1)
loading with##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
loading##276##1##(1990-12#2)(1990-2#2)(1990-8#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-5#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#3)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#68)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#1)(2009-12#1)(2009-3#6)(2009-4#8)(2009-5#1)(2009-7#17)(2009-8#1)(2010-11#5)(2010-12#2)(2010-4#3)(2010-5#4)(2010-7#3)(2010-9#3)(2011-1#1)(2011-2#13)(2011-7#1)(2012-12#2)(2012-2#5)(2012-7#6)(2013-1#31)(2013-8#1)
loadings and##2##2##(1996-5#1)(1997-2#1)
loadings of##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
loadings versus##2##2##(2008-10#2)
loadings were##2##2##(1997-2#1)(2008-10#1)
loadings##17##1##(1996-5#1)(1997-2#2)(2008-10#6)(2008-7#1)(2008-8#2)(2009-7#1)(2010-8#1)(2011-2#3)
loads and##4##2##(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
loads are##2##2##(2007-8#1)(2008-3#1)
loads before##2##2##(1997-4#1)(2009-1#1)
loads in##2##2##(2008-7#1)(2011-2#1)
loads of##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
loads on a##2##3##(2008-3#2)
loads on##3##2##(2008-3#2)(2010-12#1)
loads were##2##2##(2010-1#1)(2012-3#1)
loads with##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
loads##43##1##(1992-11#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
loam amended with##2##3##(2008-10#2)
loam and##3##2##(2008-10#3)
loam field##3##2##(2008-10#3)
loam soil##6##2##(2008-10#5)(2011-1#1)
loam soils##2##2##(2008-10#2)
loam##24##1##(2008-10#23)(2011-1#1)
loamy sand##4##2##(2008-10#4)
loamy##6##1##(2008-10#5)(2008-11#1)
loan activity##2##2##(1995-2#1)(2011-2#1)
loan policies##2##2##(1994-1#2)
loan##11##1##(1991-3#1)(1992-2#2)(1992-5#2)(1994-1#2)(1995-2#2)(2011-2#2)
loans##5##1##(1992-2#1)(1996-9#1)(2008-1#1)(2008-12#1)(2011-2#1)
lobar ablation##3##2##(1997-8#3)
lobar and##2##2##(1991-11#1)(2012-2#1)
lobar lung transplantation##3##3##(2007-8#3)
lobar##15##1##(1990-2#1)(1991-11#1)(1997-8#3)(2007-8#4)(2008-2#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
lobata)##4##1##(2008-10#2)(2008-6#2)
lobby##4##1##(1992-5#1)(1996-3#1)(2008-10#1)(2008-12#1)
lobbying##4##1##(1991-8#1)(1996-3#2)(1997-3#1)
lobbyists##3##1##(1994-1#1)(1995-1#1)(2011-2#1)
lobe and the##2##3##(1996-7#1)(2009-8#1)
lobe and##10##2##(1992-9#1)(1993-5#1)(1996-7#1)(2007-8#2)(2008-1#2)(2008-7#1)(2008-9#1)(2009-8#1)
lobe epilepsy##3##2##(2008-4#3)
lobe extending##2##2##(2009-8#1)(2012-1#1)
lobe fixation##3##2##(2007-8#3)
lobe from##2##2##(2008-10#1)(2011-2#1)
lobe is##2##2##(2007-12#1)(2010-7#1)
lobe of the thyroid##2##4##(1992-2#1)(2012-12#1)
lobe of the##15##3##(1992-2#1)(1993-5#2)(1993-6#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
lobe of##21##2##(1992-2#1)(1993-5#3)(1993-6#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
lobe on##2##2##(2008-1#1)(2008-5#1)
lobe or##4##2##(1996-7#1)(2007-10#1)(2008-5#1)(2012-2#1)
lobe shape variation##2##3##(2012-3#2)
lobe shape##4##2##(2012-3#4)
lobe that##4##2##(1992-11#1)(1993-12#1)(2007-10#1)(2007-11#1)
lobe was##5##2##(1991-9#1)(2007-8#2)(2008-5#1)(2012-2#1)
lobe##193##1##(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-9#5)(1993-12#2)(1993-5#5)(1993-6#1)(1993-9#1)(1996-2#2)(1996-5#4)(1996-6#1)(1996-7#5)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#2)(2007-10#5)(2007-11#1)(2007-12#17)(2007-7#2)(2007-8#17)(2008-1#12)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#6)(2008-7#6)(2008-9#4)(2009-1#1)(2009-2#1)(2009-8#5)(2009-9#1)(2010-11#5)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#2)
lobe)##2##1##(1993-9#1)(2008-7#1)
lobectomies##4##1##(1990-2#1)(1991-8#1)(2007-8#1)(2008-10#1)
lobectomy and##4##2##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
lobectomy for##2##2##(2007-8#2)
lobectomy in##2##2##(2008-10#1)(2011-2#1)
lobectomy patients##2##2##(1992-12#1)(2007-8#1)
lobectomy##36##1##(1990-5#1)(1990-6#1)(1992-12#3)(1994-12#1)(2006-10#1)(2007-8#9)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2011-2#4)(2012-1#2)(2012-12#2)(2013-1#1)
lobed##2##1##(1997-6#1)(2007-11#1)
lobes and##4##2##(1996-5#1)(2008-7#1)(2009-8#1)(2010-7#1)
lobes in##2##2##(1991-12#1)(2010-11#1)
lobes of the pituitary##2##4##(1993-5#1)(2012-1#1)
lobes of the##8##3##(1990-8#1)(1993-5#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
lobes of##12##2##(1990-8#1)(1992-12#1)(1993-5#2)(1993-6#2)(2008-11#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
lobes were found##3##3##(2007-10#1)(2007-12#1)(2011-1#1)
lobes were##9##2##(1991-12#2)(2007-10#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
lobes##56##1##(1990-8#1)(1991-12#4)(1992-12#1)(1993-5#2)(1993-6#2)(1994-3#1)(1996-5#2)(1996-7#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#4)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)
loblolly pine##7##2##(2008-10#4)(2008-7#3)
loblolly##9##1##(2008-10#6)(2008-7#3)
lobotomized##2##1##(1993-6#2)
lobotomy was##2##2##(1993-6#2)
lobotomy##4##1##(1993-6#4)
lobster tissue##2##2##(2008-10#2)
lobster##10##1##(1990-2#3)(1991-5#1)(2007-12#3)(2008-10#3)
lobsters##2##1##(2007-12#2)
lobular carcinoma in situ##3##4##(1992-8#2)(1994-12#1)
lobular carcinoma in##4##3##(1992-8#2)(1994-12#1)(1997-3#1)
lobular carcinoma of the##2##4##(1992-5#1)(2007-5#1)
lobular carcinoma##8##2##(1992-5#1)(1992-8#2)(1994-12#2)(1997-3#1)(2007-5#1)(2013-1#1)
lobular panniculitis##2##2##(2008-7#1)(2012-12#1)
lobular##16##1##(1992-5#1)(1992-8#3)(1993-8#1)(1994-12#2)(1997-3#3)(2007-11#1)(2007-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
lobule VII##4##2##(1994-2#4)
lobule##11##1##(1990-11#1)(1994-2#4)(1996-2#1)(1996-5#1)(2008-11#3)(2012-2#1)
lobules of##3##2##(2008-1#1)(2012-2#1)(2013-7#1)
lobules##8##1##(1991-12#1)(1995-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2012-2#1)(2013-7#1)
local DIC##5##2##(2011-1#5)
local DPCM##2##2##(2013-8#2)
local PA facilities##2##3##(2011-2#2)
local ablation##2##2##(1994-2#1)(2013-8#1)
local access##2##2##(2008-3#1)(2008-9#1)
local accumulation of##3##3##(2008-10#2)(2008-8#1)
local accumulation##4##2##(2008-10#3)(2008-8#1)
local activation of##2##3##(1991-5#1)(2008-5#1)
local adaptation##7##2##(2008-8#3)(2008-9#1)(2012-7#3)
local adaptations##2##2##(2010-8#1)(2013-1#1)
local administration of##5##3##(1994-2#1)(1996-11#1)(2008-12#1)(2011-2#2)
local anaesthesia##10##2##(1991-9#1)(1994-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-1#3)(2013-1#2)
local anaesthetic##2##2##(1996-5#1)(2008-10#1)
local analysis##2##2##(2008-4#1)(2008-7#1)
local and distant##2##3##(1991-6#1)(1995-4#1)
local and general##2##3##(1990-5#1)(2007-10#1)
local and global##6##3##(1996-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)(2013-8#1)
local and imported##3##3##(1994-9#1)(2008-10#2)
local and international##3##3##(1996-12#1)(2008-1#1)(2008-12#1)
local and national##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
local and regional scales##4##4##(2008-10#1)(2008-8#3)
local and regional##10##3##(1997-3#1)(2008-10#1)(2008-8#5)(2008-9#1)(2009-2#2)
local and state##3##3##(1996-1#1)(1997-2#1)(2012-12#1)
local and systemic side effects##2##5##(1992-3#1)(1995-5#1)
local and systemic##18##3##(1990-8#1)(1991-8#1)(1992-3#1)(1995-5#1)(2008-10#5)(2008-12#1)(2008-6#3)(2010-6#1)(2011-2#3)(2013-1#1)
local and##65##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#7)(2008-9#2)(2009-2#2)(2009-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-9#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
local and/or##3##2##(1992-9#1)(1994-2#1)(2012-3#1)
local anesthesia was##3##3##(1993-1#1)(2007-11#1)(2007-7#1)
local anesthesia##22##2##(1990-5#1)(1992-12#5)(1992-6#1)(1993-1#5)(1995-3#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
local anesthetic agent##3##3##(1993-1#1)(2012-12#1)(2012-3#1)
local anesthetic efficacy##2##3##(1993-1#2)
local anesthetic preparation##2##3##(1993-1#2)
local anesthetic##20##2##(1993-1#11)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2009-3#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
local anesthetics##7##2##(1993-1#4)(1996-12#1)(2009-3#2)
local application of##6##3##(1990-5#1)(1991-2#1)(1995-12#1)(1997-2#1)(1997-3#2)
local application##7##2##(1990-5#1)(1991-2#1)(1993-11#1)(1995-12#1)(1997-2#1)(1997-3#2)
local area network##2##3##(2008-3#2)
local area##12##2##(1991-2#1)(1996-12#1)(2008-10#4)(2008-3#4)(2008-7#1)(2012-3#1)
local areas##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
local authorities##5##2##(1992-11#1)(1992-5#1)(2008-10#1)(2008-9#1)(2012-12#1)
local autonomy and citizens'##2##4##(1993-6#2)
local autonomy##3##2##(1993-6#3)
local bacterial##3##2##(2008-10#2)(2008-12#1)
local bodies##3##2##(1994-7#1)(2012-3#2)
local cancer##3##2##(1991-2#1)(1992-10#1)(1996-2#1)
local capture##4##2##(2008-4#4)
local circuit connections##2##3##(2008-11#2)
local circuit##6##2##(1996-12#1)(1997-7#1)(2008-11#3)(2013-8#1)
local clinical##2##2##(2008-7#2)
local clustering indices##2##3##(2008-10#2)
local coexistence of##2##3##(2008-8#2)
local coexistence##5##2##(2008-8#5)
local color##3##2##(2008-6#3)
local communities##7##2##(1991-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2009-2#1)(2011-2#1)
local community##11##2##(1992-12#1)(1992-6#1)(1994-1#2)(1994-12#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#3)
local competitive##2##2##(2008-8#2)
local complications##6##2##(2007-7#1)(2007-8#1)(2008-6#1)(2011-3#1)(2013-1#2)
local conditions and##2##3##(2007-12#1)(2008-10#1)
local conditions##7##2##(1993-11#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
local contrast is##2##3##(2008-3#2)
local contrast transform##3##3##(2008-3#3)
local contrast##6##2##(2008-3#6)
local control and##4##3##(1992-10#1)(1996-10#1)(2008-6#2)
local control of##3##3##(1994-2#1)(2008-6#1)(2008-7#1)
local control rate##5##3##(2007-11#1)(2008-6#3)(2010-3#1)
local control was##3##3##(2008-6#2)(2010-3#1)
local control##32##2##(1991-4#1)(1992-10#2)(1993-9#1)(1994-2#1)(1995-9#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#10)(2008-7#2)(2008-9#1)(2010-3#9)
local cortical##2##2##(2008-11#2)
local corticosteroid##3##2##(2008-9#3)
local councils##3##2##(1997-8#3)
local cultivars##2##2##(2008-10#2)
local defects##2##2##(2007-11#2)
local demes##2##2##(2008-10#1)(2008-9#1)
local density functionals have MUEs in the range 0##2##9##(2012-12#2)
local density regulation##5##3##(2008-8#5)
local density##10##2##(1996-2#1)(2008-8#6)(2012-12#2)(2013-1#1)
local destructive##2##2##(1991-2#2)
local discomfort##2##2##(1990-3#1)(1996-9#1)
local disease##2##2##(2008-1#2)
local diversity##4##2##(2008-8#4)
local doctor##3##2##(1993-3#1)(1993-6#1)(2008-10#1)
local drug##2##2##(2008-6#1)(2012-3#1)
local dynamics of##2##3##(2008-10#1)(2008-8#1)
local dynamics##5##2##(2008-10#2)(2008-8#1)(2008-9#2)
local economic structures##2##3##(2011-2#2)
local effect##2##2##(2008-10#2)
local effective diffusivity##2##3##(2008-3#2)
local elements##5##2##(2008-4#5)
local emergency##2##2##(2007-5#1)(2008-11#1)
local environment and##2##3##(2008-12#1)(2008-8#1)
local environment##5##2##(2008-1#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-7#1)
local environmental conditions##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
local environmental factors##2##3##(2010-6#2)
local environmental##12##2##(1996-9#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-6#4)
local environments##2##2##(1992-6#1)(2008-4#1)
local events##2##2##(1997-2#1)(2013-1#1)
local excision followed by##2##4##(1990-2#1)(2008-6#1)
local excision of the tumor##2##5##(2008-10#1)(2009-3#1)
local excision of##5##3##(1992-6#1)(1994-12#1)(2007-11#1)(2008-10#1)(2009-3#1)
local excision##21##2##(1990-2#1)(1992-6#3)(1994-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-6#4)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-2#1)
local excisions##2##2##(2007-11#1)(2008-6#1)
local exposure##2##2##(2008-9#1)(2011-2#1)
local external beam radiation therapy for symptomatic bone metastases##2##9##(2008-7#2)
local extinction probabilities and##2##4##(2008-8#2)
local extinction probabilities##3##3##(2008-8#3)
local extinction probability##3##3##(2008-8#3)
local extinction##11##2##(2008-3#1)(2008-8#9)(2008-9#1)
local failure##4##2##(1991-2#1)(2008-6#1)(2009-12#1)(2012-2#1)
local fibrinolysis and##2##3##(1991-3#1)(1996-6#1)
local fibrinolysis##4##2##(1991-3#3)(1996-6#1)
local field potential##2##3##(1990-5#1)(1994-8#1)
local field potentials (LFP)##2##4##(2008-11#2)
local field##5##2##(1990-5#1)(1994-8#1)(2008-10#1)(2008-11#2)
local fishermen##2##2##(2007-5#1)(2008-5#1)
local flap##4##2##(2008-7#1)(2008-9#2)(2011-2#1)
local flow##3##2##(1992-9#1)(2008-3#1)(2008-7#1)
local foods##2##2##(1994-9#1)(2008-1#1)
local gas##2##2##(2008-2#2)
local genetic map##2##3##(2008-10#2)
local government HIV/AIDS projects in South Africa##2##7##(2007-7#2)
local government HIV/AIDS##3##3##(2007-7#3)
local government##5##2##(1990-2#1)(2007-7#3)(2013-1#1)
local governments##6##2##(1993-2#1)(1995-1#1)(1997-1#1)(2010-12#1)(2013-1#2)
local health department##3##3##(1995-12#1)(1997-2#1)(2011-9#1)
local health departments (LHDs)##2##4##(1996-2#2)
local health departments##11##3##(1995-12#1)(1996-1#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2011-9#1)
local health policy##2##3##(1994-3#1)(1996-1#1)
local health service##2##3##(1995-6#1)(2012-2#1)
local health##33##2##(1991-6#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#3)(1995-12#2)(1995-6#1)(1996-1#3)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#3)(2011-9#2)(2012-2#1)
local hospital##8##2##(1990-11#1)(1992-2#1)(1993-2#1)(1993-6#1)(1996-3#1)(2007-12#1)(2011-2#1)(2013-8#1)
local hospitals##3##2##(1993-6#1)(1995-3#1)(1995-8#1)
local hyperthermia##2##2##(1994-11#1)(2013-8#1)
local immune##2##2##(1992-12#1)(2010-1#1)
local independence##2##2##(2011-2#1)(2012-2#1)
local infection##5##2##(1997-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-4#1)
local infiltration##2##2##(2009-3#2)
local inflammation##7##2##(2009-10#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
local information##2##2##(2008-6#1)(2008-8#1)
local infusion##2##2##(1993-3#1)(2008-9#1)
local injection of##3##3##(1992-10#1)(2008-9#1)(2011-2#1)
local injection##6##2##(1992-10#1)(1996-8#1)(2008-11#1)(2008-9#1)(2011-2#2)
local intensity##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
local interaction##2##2##(2008-10#1)(2008-8#1)
local interactions##2##2##(2008-7#1)(2008-8#1)
local intraarterial thrombolysis##2##3##(1996-6#2)
local invasion##3##2##(1990-9#1)(1993-9#1)(2013-1#1)
local items##2##2##(2008-4#2)
local knowledge of##2##3##(1994-11#1)(2009-4#1)
local knowledge##3##2##(1994-11#1)(2009-4#2)
local laser##2##2##(2008-3#2)
local lesion##3##2##(1997-6#1)(2008-10#1)(2008-9#1)
local level##15##2##(1992-2#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-7#1)(2008-10#2)(2008-12#1)(2011-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
local levels##4##2##(2008-2#1)(2008-9#1)(2010-8#1)(2012-12#1)
local linear##2##2##(2008-3#1)(2009-5#1)
local linkage effects##2##3##(1990-8#2)
local lymph node assay (LLNA)##2##5##(2008-10#1)(2008-5#1)
local lymph node assay##6##4##(2008-10#1)(2008-5#3)(2008-9#2)
local lymph node##8##3##(2008-10#1)(2008-3#1)(2008-5#3)(2008-9#3)
local management##2##2##(2007-11#1)(2009-12#1)
local markets##5##2##(1993-2#1)(1997-1#2)(2008-10#2)
local mass transfer##2##3##(2008-7#2)
local mass##3##2##(2008-3#1)(2008-7#2)
local maxima##3##2##(2008-2#1)(2008-8#2)
local measures of##4##3##(2008-5#1)(2008-9#1)(2013-1#2)
local medical##2##2##(1996-9#1)(1997-5#1)
local medicine##2##2##(2008-5#1)(2009-7#1)
local morphometric indices##2##3##(2008-7#2)
local motions##2##2##(1995-3#1)(2010-4#1)
local needs and##2##3##(1992-11#1)(2008-11#1)
local needs##3##2##(1992-11#1)(2008-11#1)(2012-12#1)
local newspapers##2##2##(1997-3#1)(2009-4#1)
local normal##3##2##(2008-3#3)
local optical##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
local optimum##2##2##(2008-10#1)(2008-8#1)
local or distant##2##3##(1990-6#1)(1997-8#1)
local or general##3##3##(1997-1#1)(2007-5#1)(2013-1#1)
local or regional##5##3##(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
local or systemic##3##3##(2008-1#1)(2008-9#2)
local or##18##2##(1990-6#2)(1992-2#1)(1995-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2013-1#3)
local orientation##2##2##(2007-11#1)(2012-2#1)
local origin##3##2##(2008-10#2)(2008-8#1)
local oscillator##8##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
local oxidative stress##2##3##(2010-5#1)(2011-2#1)
local pH##3##2##(2008-10#1)(2009-12#2)
local particle##2##2##(2007-12#1)(2008-3#1)
local partners##2##2##(2013-1#2)
local people##3##2##(2008-7#2)(2013-7#1)
local phase##2##2##(2007-12#1)(2008-2#1)
local plane-interface approximation##2##3##(2008-3#2)
local plasmon resonance##2##3##(2007-12#2)
local policies and guidelines for##2##5##(1996-11#1)(2010-5#1)
local polynomial##3##2##(2010-12#1)(2010-3#2)
local population growth##2##3##(2008-8#1)(2008-9#1)
local population of##3##3##(2008-7#1)(2008-9#2)
local population##16##2##(1995-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#4)(2011-2#1)(2012-2#1)
local populations of##2##3##(2008-10#2)
local populations##12##2##(2007-2#1)(2008-10#7)(2008-8#2)(2008-9#1)(2010-1#1)
local potential##2##2##(1994-3#1)(2011-2#1)
local practices##2##2##(2009-8#1)(2009-9#1)
local prey##3##2##(2008-8#2)(2008-9#1)
local processes##3##2##(2008-9#3)
local processing##2##2##(1996-5#1)(2008-11#1)
local production and##2##3##(2008-4#2)
local production of##2##3##(1993-11#1)(2008-5#1)
local production##4##2##(1993-11#1)(2008-4#2)(2008-5#1)
local progression##2##2##(2007-11#1)(2010-3#1)
local public health department##2##4##(1996-12#1)(1997-3#1)
local public health departments##2##4##(1996-12#1)(1996-2#1)
local public health jurisdictions##2##4##(1995-12#1)(1996-12#1)
local public health performance##5##4##(1995-12#2)(1996-3#3)
local public health##17##3##(1995-12#5)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)
local public##18##2##(1995-12#5)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)(2011-2#1)
local radiotherapy and chemotherapy##2##4##(2008-6#2)
local reactions##3##2##(1990-9#1)(1996-8#1)(2011-2#1)
local recidive##2##2##(1994-2#2)
local recurrence and metastasis##2##4##(2008-11#1)(2008-6#1)
local recurrence and##7##3##(2008-11#1)(2008-6#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
local recurrence in##2##3##(1990-12#1)(2010-3#1)
local recurrence of the tumour##2##5##(2008-6#2)
local recurrence of the##3##4##(2008-11#1)(2008-6#2)
local recurrence of##5##3##(2008-11#1)(2008-6#2)(2009-3#1)(2010-3#1)
local recurrence rate##3##3##(1990-12#1)(1997-7#1)(2010-3#1)
local recurrence rates##4##3##(2008-6#2)(2009-12#1)(2012-1#1)
local recurrence was##2##3##(1992-10#1)(2011-1#1)
local recurrence##56##2##(1990-12#2)(1990-3#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-12#2)(1994-8#1)(1997-7#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#14)(2008-7#1)(2009-12#1)(2009-3#2)(2010-12#1)(2010-3#9)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
local recurrences is##2##3##(1991-9#1)(2007-11#1)
local recurrences##17##2##(1990-12#1)(1990-6#4)(1991-4#2)(1991-9#2)(2007-11#1)(2008-6#4)(2011-1#2)(2013-8#1)
local reflectance of the##2##4##(2008-3#2)
local reflectance##3##2##(2008-3#3)
local region##2##2##(1995-6#1)(2008-7#1)
local regrowth##2##2##(1997-4#1)(2008-7#1)
local regulation##2##2##(2008-12#1)(2008-4#1)
local relapse##5##2##(1991-2#1)(1994-6#1)(1994-8#1)(2008-6#2)
local relapses##4##2##(1990-3#2)(1991-6#1)(1994-6#1)
local residents##2##2##(2008-5#1)(2012-3#1)
local resolution##2##2##(2008-2#1)(2008-6#1)
local resources##3##2##(1996-2#1)(2012-2#1)(2013-1#1)
local scale##5##2##(2008-10#1)(2008-6#1)(2008-8#3)
local search algorithm##2##3##(2008-3#2)
local search techniques##2##3##(2008-3#2)
local search##4##2##(2008-3#4)
local service##2##2##(1995-3#2)
local setting##2##2##(1992-2#1)(2007-7#1)
local shear##2##2##(1990-8#1)(2006-6#1)
local slopes##3##2##(2007-12#1)(2008-3#2)
local songs##2##2##(2008-8#2)
local source##2##2##(2008-3#2)
local sources##2##2##(2008-8#1)(2009-3#1)
local stability##2##2##(2008-8#2)
local strain##2##2##(2008-10#1)(2009-11#1)
local students##3##2##(2008-11#3)
local study##3##2##(1990-6#1)(2008-10#1)(2008-3#1)
local surface##2##2##(2008-2#2)
local symmetries in##2##3##(2010-8#2)
local symmetries##3##2##(2010-8#3)
local system##4##2##(1992-12#1)(2008-1#1)(2008-10#2)
local systems##2##2##(2011-9#2)
local therapy##8##2##(1995-5#1)(2008-6#5)(2011-2#2)
local tissue##4##2##(1993-1#1)(2007-12#1)(2008-5#1)(2008-6#1)
local tissues##2##2##(2008-9#1)(2012-12#1)
local toxicity##2##2##(1997-3#1)(2008-5#1)
local trauma##3##2##(2007-2#1)(2007-5#1)(2008-12#1)
local treatment of##5##3##(1990-11#1)(2007-11#1)(2010-3#3)
local treatment##13##2##(1990-11#1)(1994-2#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-3#3)(2011-2#3)
local tumor control##2##3##(2007-5#1)(2007-8#1)
local tumor##5##2##(2007-5#1)(2007-8#1)(2008-11#2)(2013-8#1)
local variation##2##2##(2008-3#1)(2008-8#1)
local variations in the##2##4##(1992-9#1)(2008-2#1)
local variations in##3##3##(1992-9#1)(2008-2#1)(2010-3#1)
local variations##4##2##(1992-9#1)(2008-2#1)(2008-3#1)(2010-3#1)
local vascular##2##2##(2009-8#1)(2010-10#1)
local##1454##1##(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#4)(1990-5#5)(1990-6#9)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#8)(1991-3#6)(1991-4#3)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#5)(1992-11#2)(1992-12#14)(1992-2#4)(1992-3#1)(1992-5#4)(1992-6#10)(1992-8#2)(1992-9#6)(1993-1#21)(1993-11#9)(1993-12#4)(1993-2#5)(1993-3#4)(1993-6#9)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#8)(1994-2#14)(1994-3#9)(1994-6#7)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#11)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#13)(1995-6#5)(1995-8#1)(1995-9#3)(1996-1#11)(1996-10#1)(1996-11#3)(1996-12#10)(1996-2#11)(1996-3#12)(1996-4#1)(1996-5#7)(1996-6#6)(1996-8#2)(1996-9#7)(1997-1#7)(1997-2#10)(1997-3#14)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#7)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#35)(2007-12#25)(2007-2#6)(2007-4#2)(2007-5#6)(2007-6#2)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#16)(2008-10#118)(2008-11#40)(2008-12#24)(2008-2#28)(2008-3#90)(2008-4#26)(2008-5#23)(2008-6#63)(2008-7#42)(2008-8#84)(2008-9#52)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#8)(2009-2#4)(2009-3#12)(2009-4#7)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#5)(2010-3#30)(2010-4#1)(2010-5#4)(2010-6#6)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#17)(2011-2#46)(2011-3#2)(2011-9#8)(2012-1#3)(2012-12#14)(2012-2#22)(2012-3#18)(2012-7#5)(2013-1#50)(2013-7#6)(2013-8#22)
local&quot##2##1##(2008-6#1)(2013-1#1)
local-field##6##1##(2007-11#5)(2008-3#1)
local-regional##4##1##(1991-4#2)(1992-12#2)
locale##2##1##(1995-6#1)(2008-7#1)
localisation and##4##2##(2007-11#3)(2011-2#1)
localisation is##3##2##(2008-2#1)(2010-12#1)(2011-2#1)
localisation of the tumor##2##4##(2007-11#2)
localisation of the##3##3##(2007-11#2)(2011-1#1)
localisation of##9##2##(1991-3#1)(1993-12#1)(1993-2#1)(2007-11#3)(2008-11#1)(2009-8#1)(2011-1#1)
localisation signal##2##2##(1991-2#1)(2008-11#1)
localisation##27##1##(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#1)(1996-9#1)(2007-11#9)(2008-11#4)(2008-2#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)
localise##3##1##(2008-11#1)(2009-7#1)(2012-2#1)
localised in##2##2##(1997-8#1)(2007-11#1)
localised on the##2##3##(1995-11#1)(1996-6#1)
localised on##3##2##(1995-11#1)(1996-6#1)(2007-11#1)
localised pain##3##2##(1997-4#3)
localised to##4##2##(1994-11#1)(1996-5#1)(2007-8#1)(2008-7#1)
localised##26##1##(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#2)(1996-5#1)(1996-6#1)(1997-4#3)(1997-8#1)(2007-11#3)(2007-7#4)(2007-8#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-10#1)(2012-2#2)
localities and##2##2##(1995-5#1)(2011-1#1)
localities in##5##2##(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
localities of##2##2##(2008-10#1)(2008-6#1)
localities were##2##2##(2008-5#1)(2011-1#1)
localities##25##1##(1995-5#1)(2008-10#1)(2008-5#3)(2008-6#2)(2008-8#4)(2009-10#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#2)(2013-8#1)
locality and##2##2##(2011-1#1)(2013-7#1)
locality of##2##2##(1990-8#1)(2008-9#1)
locality##13##1##(1990-8#1)(2008-11#2)(2008-5#2)(2008-9#1)(2010-4#1)(2011-1#3)(2012-3#2)(2013-7#1)
localization abilities##2##2##(2008-9#2)
localization accuracy##3##2##(2008-3#3)
localization and a##2##3##(1993-12#1)(1994-8#1)
localization and expression##2##3##(1996-6#1)(2012-3#1)
localization and function of##2##4##(2008-1#1)(2010-5#1)
localization and function##4##3##(2008-1#2)(2008-9#1)(2010-5#1)
localization and##38##2##(1991-3#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-8#1)(1996-12#2)(1996-6#2)(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-9#3)(2011-1#4)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
localization by##3##2##(1992-11#1)(1995-12#1)(2008-9#1)
localization in the##6##3##(1990-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
localization in##17##2##(1990-3#1)(1993-6#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#3)(2011-1#1)
localization is##5##2##(1994-5#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
localization of AID##2##3##(2011-2#2)
localization of a##9##3##(1990-12#1)(1991-10#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-12#2)(2008-4#1)
localization of basic fibroblast growth factor in##2##7##(1992-3#1)(1995-12#1)
localization of cell##2##3##(2008-9#1)(2010-8#1)
localization of cyclin A and cdk2##2##6##(1994-6#2)
localization of hair keratin homologs##2##5##(2011-2#2)
localization of hsp56##3##3##(1992-11#3)
localization of human##2##3##(1990-3#1)(2008-8#1)
localization of its##2##3##(1994-8#1)(2013-8#1)
localization of metastatic##2##3##(1992-6#1)(2007-10#1)
localization of parathyroid##2##3##(2008-10#1)(2009-7#1)
localization of protein kinase C##2##5##(1990-7#1)(1992-11#1)
localization of proteins##3##3##(2008-4#1)(2008-7#1)(2009-5#1)
localization of spatial##2##3##(1994-8#2)
localization of the bcl-2##2##4##(1994-10#2)
localization of the##26##3##(1992-11#1)(1994-10#2)(1994-12#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
localization of their##2##3##(2009-5#1)(2009-8#1)
localization of these enzymes##2##4##(1990-7#1)(2008-10#1)
localization of these##5##3##(1990-7#1)(1993-3#1)(1996-6#1)(2008-10#1)(2008-4#1)
localization of tumors##3##3##(1990-5#1)(2007-11#1)(2008-9#1)
localization of##198##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-10#1)(1991-12#1)(1991-6#3)(1991-9#1)(1992-11#5)(1992-3#3)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#4)(1996-12#4)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-3#7)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#11)(2009-10#4)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#6)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
localization on##2##2##(1996-2#1)(2007-8#1)
localization or##2##2##(1997-8#1)(2008-10#1)
localization pattern of##2##3##(1990-3#1)(2008-11#1)
localization pattern##3##2##(1990-3#2)(2008-11#1)
localization patterns##2##2##(2008-11#1)(2009-8#1)
localization plane##2##2##(2008-3#2)
localization planes##2##2##(2008-3#2)
localization principle##2##2##(2007-12#2)
localization signal##10##2##(1991-12#1)(1994-11#4)(1994-9#1)(1995-2#1)(1997-7#1)(2011-2#1)(2012-2#1)
localization studies##2##2##(1996-6#1)(2008-7#1)
localization technique##2##2##(1993-11#1)(2008-10#1)
localization to the plasma membrane##2##5##(1990-12#1)(2010-11#1)
localization to the##7##3##(1990-12#1)(1991-9#1)(1996-12#1)(2008-9#2)(2009-10#1)(2010-11#1)
localization to##9##2##(1990-12#1)(1991-9#1)(1992-10#1)(1996-12#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-11#1)
localization was##7##2##(1990-9#1)(1993-6#1)(1996-2#1)(1996-6#1)(2009-10#1)(2012-2#1)(2013-1#1)
localization with##2##2##(2007-8#1)(2008-12#1)
localization##394##1##(1990-11#1)(1990-12#2)(1990-3#4)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#4)(1991-9#2)(1992-10#1)(1992-11#6)(1992-3#3)(1992-6#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#2)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#5)(1995-8#1)(1996-12#9)(1996-2#4)(1996-5#2)(1996-6#6)(1997-1#3)(1997-2#7)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#14)(2007-12#12)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#20)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#17)(2008-4#13)(2008-5#9)(2008-6#3)(2008-7#15)(2008-8#6)(2008-9#29)(2009-10#7)(2009-2#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#7)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#16)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
localization]##2##1##(1992-5#1)(1993-3#1)
localizations are##3##2##(1991-9#1)(2008-4#2)
localizations in##3##2##(1996-5#1)(1997-3#1)(2012-2#1)
localizations of##5##2##(1991-12#1)(1991-8#1)(1992-8#1)(1995-5#1)(2011-1#1)
localizations##18##1##(1991-12#2)(1991-8#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-4#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
localize BYDV resistance##2##3##(2008-5#2)
localize in cholesterol and sphingolipid enriched##2##6##(2008-8#2)
localize in##3##2##(1994-12#1)(2008-8#2)
localize the##16##2##(1990-11#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2013-1#1)(2013-8#1)
localize to##4##2##(2007-8#1)(2011-2#1)(2012-12#2)
localize##59##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#3)(2009-8#2)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
localized and metastatic##2##3##(2008-7#1)(2010-3#1)
localized and##11##2##(2007-12#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#1)(2013-1#1)
localized approximation to speed up##2##5##(2008-3#2)
localized approximation to##3##3##(2008-3#3)
localized at the##8##3##(1991-5#1)(1993-12#2)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
localized at##13##2##(1990-11#1)(1991-5#1)(1993-12#2)(1994-10#1)(1994-8#1)(1995-6#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
localized between##2##2##(1993-3#1)(2007-11#1)
localized both##2##2##(1996-12#1)(2008-11#1)
localized brain##2##2##(1991-2#1)(1996-2#1)
localized breast cancer##2##3##(1992-2#1)(1997-3#1)
localized by##2##2##(2008-7#1)(2008-8#1)
localized cell##2##2##(2008-10#2)
localized changes##2##2##(2008-10#1)(2008-9#1)
localized correctly##2##2##(2007-11#1)(2008-7#1)
localized cutaneous##2##2##(1995-1#1)(2007-7#1)
localized delivery##2##2##(2009-12#1)(2010-10#1)
localized disease##4##2##(1991-12#1)(2010-3#3)
localized forms##2##2##(1992-5#2)
localized heating##3##2##(2008-3#3)
localized holograms in##2##3##(2007-12#2)
localized in a##3##3##(1993-3#1)(2009-10#1)(2013-1#1)
localized in all##2##3##(1990-11#1)(2010-11#1)
localized in different##2##3##(1995-6#1)(2008-10#1)
localized in several##2##3##(1992-9#1)(2008-4#1)
localized in the cytoplasm##2##4##(1992-3#1)(1997-8#1)
localized in the cytosol##2##4##(1992-6#1)(1993-6#1)
localized in the##30##3##(1990-5#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-6#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
localized in this##2##3##(1994-12#1)(1996-12#1)
localized in##65##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#5)(1994-6#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#3)
localized increase in##2##3##(1990-6#1)(2007-11#1)
localized inoculation##2##2##(2008-10#2)
localized inside##2##2##(2008-10#1)(2008-5#1)
localized lesions##2##2##(1992-9#1)(2012-12#1)
localized mainly in##2##3##(2008-9#1)(2009-10#1)
localized necrosis##2##2##(2008-10#2)
localized on human chromosome##2##4##(1994-12#1)(1997-4#1)
localized on##9##2##(1991-5#1)(1994-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-5#2)(2011-2#1)(2012-2#1)
localized only in the##3##4##(1991-9#1)(2008-10#1)(2008-5#1)
localized only in##4##3##(1991-9#1)(2008-10#2)(2008-5#1)
localized optical##3##2##(2007-11#2)(2009-5#1)
localized or##2##2##(2008-6#1)(2012-2#1)
localized prostate cancer##3##3##(2008-7#2)(2013-1#1)
localized prostate##4##2##(2008-7#2)(2011-2#1)(2013-1#1)
localized recording##2##2##(2008-3#2)
localized resistance##3##2##(2008-10#3)
localized scleroderma##6##2##(2011-2#6)
localized spins##2##2##(2008-7#2)
localized surface plasmon resonance (LSPR)##2##5##(2008-10#1)(2013-1#1)
localized surface##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
localized the##6##2##(1990-5#1)(1991-9#1)(1994-8#1)(1995-6#1)(2008-3#1)(2008-9#1)
localized tissue##2##2##(1996-6#1)(2009-7#1)
localized to chromosome##5##3##(1992-3#1)(1996-3#1)(1997-7#1)(2007-7#2)
localized to the Golgi##3##4##(1990-7#1)(1995-2#1)(2009-8#1)
localized to the nucleus##4##4##(1990-11#1)(1995-8#1)(2009-10#1)(2012-2#1)
localized to the##30##3##(1990-11#2)(1990-7#1)(1991-11#1)(1992-10#1)(1992-7#1)(1993-6#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-7#2)(2007-5#1)(2008-10#1)(2008-11#1)(2009-10#2)(2009-8#1)(2012-12#1)(2012-2#1)
localized to##55##2##(1990-11#2)(1990-7#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-6#5)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-3#1)(2009-8#2)(2012-12#1)(2012-2#1)
localized with different##2##3##(1996-5#1)(2008-10#1)
localized with##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
localized within##5##2##(1994-11#1)(1997-4#1)(2008-10#2)(2009-10#1)
localized##378##1##(1990-11#5)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#4)(1991-9#6)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#7)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#9)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#7)(1995-5#1)(1995-6#9)(1995-8#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#5)(1997-7#3)(1997-8#1)(2006-10#2)(2007-11#15)(2007-12#13)(2007-5#2)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#50)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#22)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#7)(2008-9#8)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#7)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#9)(2013-8#2)
localizes at the##2##3##(1991-5#1)(2008-8#1)
localizes in##2##2##(1992-11#1)(2008-8#1)
localizes to##4##2##(1995-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
localizes##11##1##(1991-5#1)(1992-11#1)(1993-11#1)(1994-9#1)(1995-5#1)(2007-12#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
localizing a##2##2##(2008-2#1)(2009-8#1)
localizing the##4##2##(1995-11#1)(2007-12#1)(2008-9#1)(2009-9#1)
localizing##19##1##(1995-11#1)(1995-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-8#1)(2009-9#1)(2012-12#1)
locally adapted##3##2##(2008-9#2)(2013-1#1)
locally adaptive##3##2##(2008-3#1)(2008-9#1)(2012-3#1)
locally advanced breast cancer with an inflammatory component##2##8##(1991-8#2)
locally advanced breast cancer with##3##5##(1991-8#2)(1994-2#1)
locally advanced breast cancer##12##4##(1991-4#2)(1991-8#6)(1993-11#1)(1994-2#1)(2007-5#2)
locally advanced breast##13##3##(1991-4#2)(1991-8#6)(1993-11#1)(1994-2#1)(2007-5#2)(2013-8#1)
locally advanced disease##2##3##(1992-3#1)(1997-7#1)
locally advanced head and neck##4##5##(1990-6#2)(1993-9#1)(1995-9#1)
locally advanced non-small cell lung cancer##2##6##(2007-4#1)(2008-10#1)
locally advanced of bladder##2##4##(2011-2#2)
locally advanced or metastatic breast cancer##2##6##(2009-9#2)
locally advanced or metastatic soft-tissue sarcoma##2##6##(2008-6#2)
locally advanced or metastatic##4##4##(2008-6#2)(2009-9#2)
locally advanced prostate cancer##3##4##(1995-8#1)(1997-7#1)(2008-7#1)
locally advanced stage III##2##4##(2008-10#2)
locally advanced vulvar##2##3##(1992-3#2)
locally advanced##53##2##(1990-12#1)(1990-6#4)(1991-4#2)(1991-8#6)(1992-3#4)(1993-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-8#1)(1995-9#1)(1997-7#2)(2007-10#1)(2007-4#1)(2007-5#2)(2008-10#5)(2008-6#4)(2008-7#1)(2009-5#2)(2009-9#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
locally aggressive and##2##3##(2007-12#1)(2010-3#1)
locally aggressive##5##2##(1993-6#1)(2007-12#1)(2008-7#1)(2010-3#2)
locally and systemically##2##3##(2008-10#1)(2010-12#1)
locally and##6##2##(1991-6#1)(1996-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#1)
locally applied##2##2##(1996-3#1)(2008-7#1)
locally as a##2##3##(2008-3#2)
locally as##3##2##(1992-12#1)(2008-3#2)
locally by##3##2##(1992-3#1)(2008-10#2)
locally delivered##2##2##(2008-4#1)(2012-3#1)
locally derived##2##2##(2007-8#2)
locally generated##2##2##(1995-2#1)(2008-2#1)
locally in the##6##3##(1991-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
locally in##8##2##(1991-1#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
locally independent##2##2##(2011-2#2)
locally invasive papillary thyroid carcinoma##2##5##(2013-1#2)
locally invasive##4##2##(1997-7#1)(1997-8#1)(2013-1#2)
locally on##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
locally or##4##2##(1997-3#1)(2007-10#1)(2008-7#1)(2012-2#1)
locally produced##2##2##(2012-2#1)(2013-8#1)
locally recurrent##2##2##(1993-1#1)(2010-3#1)
locally to##2##2##(2008-2#1)(2008-3#1)
locally with##2##2##(2007-12#1)(2012-7#1)
locally##174##1##(1990-12#1)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#6)(1992-12#1)(1992-3#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#24)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#7)(2008-7#8)(2008-8#5)(2008-9#6)(2009-4#1)(2009-5#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#3)(2010-9#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#4)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#2)
locate in the##2##3##(2008-7#1)(2008-8#1)
locate in##4##2##(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
locate##36##1##(1990-11#2)(1992-3#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#2)(2013-7#1)
located 2##2##2##(1995-6#1)(2007-12#1)
located 81##2##2##(1995-8#1)(1996-6#1)
located a##2##2##(2008-2#1)(2008-3#1)
located about the##2##3##(2008-2#1)(2008-3#1)
located about##4##2##(1993-2#1)(1994-12#1)(2008-2#1)(2008-3#1)
located accurately##2##2##(1996-5#1)(2008-10#1)
located adjacent to##2##3##(1996-10#1)(2013-1#1)
located almost##2##2##(1997-6#1)(2008-10#1)
located along the##2##3##(2008-10#1)(2010-8#1)
located along##3##2##(1993-5#1)(2008-10#1)(2010-8#1)
located and##4##2##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
located around the##3##3##(1995-8#1)(2008-3#1)(2011-2#1)
located around##4##2##(1991-6#1)(1995-8#1)(2008-3#1)(2011-2#1)
located as##3##2##(2008-10#2)(2009-8#1)
located at a distance##2##4##(1994-9#1)(2007-11#1)
located at a##5##3##(1990-11#1)(1992-6#1)(1994-9#1)(2007-11#1)(2008-6#1)
located at both ends##2##4##(1995-6#1)(2008-8#1)
located at different##2##3##(2008-10#1)(2012-7#1)
located at nucleotide##2##3##(1990-7#1)(2008-10#1)
located at or near the##3##5##(1995-5#1)(2008-10#2)
located at position##2##3##(1990-12#1)(1990-8#1)
located at the input##2##4##(2008-3#2)
located at the level of##2##5##(2008-7#1)(2012-2#1)
located at the upper side of the flow cell##2##9##(2008-10#2)
located at the##44##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-7#2)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
located at##101##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#2)(2007-11#1)(2007-2#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-8#3)
located below the##2##3##(2008-11#1)(2012-12#1)
located between nucleotides##2##3##(1991-2#1)(2012-2#1)
located between the##10##3##(1991-7#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#2)(2012-12#2)
located between two##2##3##(2008-2#1)(2011-1#1)
located between##27##2##(1991-2#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-8#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
located both upstream and downstream of##2##6##(1992-11#2)
located both##4##2##(1992-11#2)(2008-2#1)(2008-9#1)
located by##2##2##(1993-8#1)(2006-4#1)
located close to the##3##4##(1994-12#1)(1996-6#1)(2011-2#1)
located far##2##2##(1995-10#1)(2008-6#1)
located from the##2##3##(1997-6#1)(2008-10#1)
located from##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
located immediately downstream##3##3##(1992-9#1)(1997-2#1)(1997-6#1)
located immediately upstream of##2##4##(1994-6#1)(2011-1#1)
located immediately##7##2##(1991-9#1)(1992-9#1)(1994-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2011-1#1)
located in a##13##3##(1994-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
located in an area##2##4##(1991-12#1)(1997-6#1)
located in an##3##3##(1991-12#1)(1994-5#1)(1997-6#1)
located in different##2##3##(2008-9#1)(2013-8#1)
located in front of the##2##5##(2008-10#1)(2009-7#1)
located in its##2##3##(1995-6#1)(2008-7#1)
located in major cities##2##4##(2012-12#1)(2013-1#1)
located in microbodies##2##3##(2011-1#2)
located in or##3##3##(1992-12#1)(1997-3#1)(2008-4#1)
located in the C-terminal##2##4##(1994-12#1)(1995-2#1)
located in the Fresnel##3##4##(2007-12#2)(2008-3#1)
located in the anterior##4##4##(1991-8#1)(2006-12#1)(2007-11#1)(2007-8#1)
located in the center of##2##5##(2008-3#1)(2008-5#1)
located in the central##3##4##(2008-3#1)(2008-8#1)(2008-9#1)
located in the cytoplasm##2##4##(1995-2#1)(2008-11#1)
located in the distal##2##4##(2008-10#1)(2013-8#1)
located in the first##2##4##(1992-6#1)(2007-12#1)
located in the fourth##2##4##(2012-12#1)(2013-1#1)
located in the frontal##2##4##(2008-7#2)
located in the inner##2##4##(1990-11#1)(2008-11#1)
located in the middle of the##3##6##(1993-2#1)(2008-10#1)(2009-10#1)
located in the middle##5##4##(1993-2#1)(2008-10#1)(2009-10#1)(2010-3#1)(2013-8#1)
located in the near##3##4##(1990-8#1)(2008-2#1)(2008-3#1)
located in the plasma membrane##2##5##(1994-12#1)(2008-4#1)
located in the same##6##4##(1995-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
located in the spheno-clival region##2##5##(2011-2#2)
located in the third##2##4##(1990-12#1)(2008-4#1)
located in the vicinity of##2##5##(1990-2#1)(2008-2#1)
located in the##181##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-6#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#10)
located in this##2##3##(1992-1#1)(2008-12#1)
located in three##2##3##(2012-3#1)(2013-7#1)
located in two##3##3##(1994-6#1)(2008-10#1)(2009-10#1)
located in water##3##3##(2007-10#1)(2008-2#2)
located in##298##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-12#2)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#11)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#11)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#15)(2008-8#8)(2008-9#10)(2009-10#3)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#13)
located inside a##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
located inside##9##2##(1995-9#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
located mainly at the##2##4##(2008-10#1)(2008-5#1)
located mainly##4##2##(1993-12#1)(1996-5#1)(2008-10#1)(2008-5#1)
located more##2##2##(1991-12#1)(1992-11#1)
located mostly##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
located near the 3'##2##4##(2008-10#2)
located near the center##2##4##(1993-11#1)(2008-7#1)
located near the##12##3##(1992-8#1)(1992-9#1)(1993-11#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)
located near##20##2##(1992-8#1)(1992-9#1)(1993-11#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-8#1)
located nearby##2##2##(2008-10#2)
located on a##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
located on an##2##3##(2008-10#1)(2008-8#1)
located on chromosome 1##2##4##(1996-10#1)(2008-10#1)
located on chromosome 3##2##4##(1997-7#1)(2008-8#1)
located on chromosome IV##2##4##(1997-8#1)(2008-5#1)
located on chromosome##20##3##(1991-6#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)
located on chromosomes##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
located on rice chromosome##2##4##(2008-10#1)(2008-8#1)
located on the chromosome##2##4##(2008-10#1)(2008-9#1)
located on the distal##2##4##(2008-8#1)(2012-1#1)
located on the dorsal side##2##5##(2008-5#2)
located on the left arm of chromosome##5##7##(1993-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#1)
located on the left arm of##6##6##(1993-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#2)
located on the left side of the##2##7##(2010-12#1)(2011-1#1)
located on the left##8##4##(1993-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#2)(2010-12#1)(2011-1#1)
located on the long arm of chromosome##3##7##(2008-10#1)(2008-9#1)(2010-3#1)
located on the long arm of##4##6##(2008-10#2)(2008-9#1)(2010-3#1)
located on the plasma membrane of the##2##7##(2008-8#2)
located on the right arm of chromosome##2##7##(1995-6#1)(1996-6#1)
located on the right arm of##3##6##(1995-6#1)(1996-6#1)(1997-3#1)
located on the same##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
located on the short arm of chromosome 1A##2##8##(2008-10#2)
located on the short arm of chromosome##3##7##(2008-10#2)(2012-3#1)
located on the surface##2##4##(1992-12#1)(2008-9#1)
located on the##63##3##(1990-5#2)(1991-2#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#3)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
located on this chromosome##2##4##(2008-10#1)(2008-7#1)
located on##127##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-10#2)(1996-12#3)(1996-3#2)(1996-5#2)(1996-6#3)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#6)(2009-10#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
located outside the radiotherapeutic target volume for four treatment situations##2##10##(1993-9#2)
located outside the##5##3##(1992-9#1)(1993-9#2)(2008-10#1)(2008-7#1)
located outside##6##2##(1992-9#1)(1993-9#2)(1995-2#1)(2008-10#1)(2008-7#1)
located predominantly in##2##3##(1992-3#1)(2008-7#1)
located side by side##2##4##(2007-12#2)
located throughout the##2##3##(2008-12#1)(2013-1#1)
located to the##2##3##(2006-12#1)(2008-5#1)
located to##3##2##(1993-12#1)(2006-12#1)(2008-5#1)
located upstream from##2##3##(1993-6#1)(2008-10#1)
located upstream of the##3##4##(1991-7#1)(1995-6#1)(1995-8#1)
located upstream of##7##3##(1991-7#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#1)(2011-2#1)
located upstream##10##2##(1991-7#1)(1992-6#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
located with##5##2##(2008-10#2)(2008-3#2)(2008-9#1)
located within a distance of##2##5##(1992-6#1)(2008-5#1)
located within a##12##3##(1990-11#1)(1990-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)
located within the##14##3##(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(2007-8#2)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
located within##36##2##(1990-11#1)(1990-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-8#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#1)
located##831##1##(1990-11#5)(1990-12#5)(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#5)(1991-3#1)(1991-6#5)(1991-7#3)(1991-8#2)(1991-9#5)(1992-1#2)(1992-11#7)(1992-12#7)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#7)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#11)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#11)(1994-2#3)(1994-3#2)(1994-5#6)(1994-6#4)(1994-8#8)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#15)(1995-3#1)(1995-5#5)(1995-6#11)(1995-8#9)(1995-9#2)(1996-10#5)(1996-12#6)(1996-2#5)(1996-3#6)(1996-5#9)(1996-6#6)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#4)(1997-6#11)(1997-7#9)(1997-8#6)(1997-9#2)(2006-12#3)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#25)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#107)(2008-11#17)(2008-12#10)(2008-2#15)(2008-3#45)(2008-4#9)(2008-5#28)(2008-6#6)(2008-7#31)(2008-8#27)(2008-9#29)(2009-10#8)(2009-12#2)(2009-2#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#8)(2012-3#14)(2012-7#1)(2013-1#13)(2013-7#4)(2013-8#20)
locates##5##1##(1993-11#1)(1993-6#1)(1996-8#1)(2008-10#1)(2008-7#1)
locating and critically appraising##2##4##(2007-5#2)
locating and##4##2##(1993-12#1)(2007-5#2)(2008-11#1)
locating the##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
locating##26##1##(1990-5#1)(1993-12#1)(1993-9#1)(1995-1#3)(1996-7#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
location along the##2##3##(2011-2#1)(2012-3#1)
location and extent of##5##4##(1996-6#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#1)
location and its##2##3##(1992-5#1)(1994-5#1)
location and size of the##2##5##(1993-6#1)(1995-11#1)
location and size##3##3##(1993-6#1)(1995-11#1)(1996-5#1)
location and structure##2##3##(1995-2#1)(1995-5#1)
location and the##8##3##(1995-12#1)(2008-4#1)(2008-9#2)(2010-6#1)(2011-2#3)
location and time##2##3##(2008-3#1)(2008-7#1)
location and##64##2##(1992-5#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#3)(1996-5#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#2)(2011-2#8)(2012-12#1)(2012-2#4)(2013-1#3)
location and/or##2##2##(2008-7#1)(2011-2#1)
location as the##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
location as well as the##2##5##(1991-12#1)(2008-3#1)
location as##8##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2009-9#1)
location at the##2##3##(2008-5#1)(2011-2#1)
location at##4##2##(1993-12#1)(1994-2#1)(2008-5#1)(2011-2#1)
location between##2##2##(1994-6#1)(2008-10#1)
location by##2##2##(2008-2#1)(2008-3#1)
location distribution of the##2##4##(1991-6#2)
location factor##2##2##(1993-1#2)
location for a##2##3##(2010-7#1)(2012-12#1)
location for the##3##3##(1995-2#1)(1995-6#1)(2009-9#1)
location for this##2##3##(2008-10#2)
location for##11##2##(1993-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-10#3)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
location from##4##2##(1994-9#1)(2008-10#2)(2010-2#1)
location has been##2##3##(1996-5#1)(2008-10#1)
location in the##14##3##(1994-6#1)(1996-2#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)
location in which the arm##2##5##(1993-6#2)
location in##26##2##(1993-3#1)(1993-6#2)(1994-6#1)(1995-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)
location is##9##2##(1990-12#1)(1991-2#1)(1991-4#1)(1994-12#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
location of FLO5##2##3##(1995-6#2)
location of a##8##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)
location of decision thresholds##2##4##(1997-3#2)
location of hybridization domains##2##4##(2008-9#2)
location of newly##2##3##(2008-1#1)(2008-10#1)
location of specific##2##3##(1994-12#1)(2008-2#1)
location of the AFC##2##4##(2011-2#2)
location of the COP in##2##5##(1994-1#2)
location of the fragrance##2##4##(2008-5#2)
location of the nutrient foramen##3##5##(2013-8#3)
location of the resistance##2##4##(2008-10#2)
location of the##80##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-8#1)(1994-1#2)(1994-11#1)(1994-6#1)(1995-2#4)(1995-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(1997-9#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#9)(2008-11#4)(2008-2#3)(2008-3#8)(2008-5#4)(2008-7#3)(2008-8#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
location of these tumors##2##4##(2010-9#1)(2013-1#1)
location of these##4##3##(1992-12#1)(2008-10#1)(2010-9#1)(2013-1#1)
location of this##5##3##(1991-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
location of tumor##2##3##(1993-11#1)(2008-6#1)
location of##180##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-12#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#4)(1995-5#2)(1995-6#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#2)(2006-4#1)(2006-6#1)(2007-11#5)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#9)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#6)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#4)(2010-9#1)(2011-2#7)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#4)
location on the##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
location on##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2010-8#1)
location or##2##2##(1994-1#1)(2012-12#1)
location shift##3##2##(1992-6#1)(1996-3#2)
location that##2##2##(2008-3#1)(2013-1#1)
location theory##3##2##(1996-1#2)(2008-3#1)
location to the##2##3##(2008-10#1)(2008-2#1)
location to##4##2##(1996-12#2)(2008-10#1)(2008-2#1)
location was##5##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
location were##2##2##(2008-12#1)(2011-2#1)
location when##2##2##(2008-3#2)
location where the##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
location where##7##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)(2013-1#1)
location within the##3##3##(1995-2#1)(2008-12#1)(2012-2#1)
location within##6##2##(1995-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)
location##559##1##(1990-12#3)(1990-5#2)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#6)(1991-9#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1994-1#5)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#10)(1995-5#4)(1995-6#3)(1996-1#8)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#8)(2007-12#12)(2007-4#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#84)(2008-11#24)(2008-12#10)(2008-2#21)(2008-3#32)(2008-4#4)(2008-5#9)(2008-6#9)(2008-7#20)(2008-8#9)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#1)(2011-2#32)(2012-12#10)(2012-2#16)(2012-3#4)(2013-1#21)(2013-8#7)
location)##3##1##(2007-5#2)(2008-8#1)
location-scale test##3##2##(2012-1#3)
location-specific##2##1##(2008-10#1)(2013-1#1)
location-years##5##1##(2008-10#5)
locations across##3##2##(1995-2#1)(2008-10#2)
locations along the##3##3##(2006-12#1)(2008-3#1)(2008-7#1)
locations and years##2##3##(2008-10#2)
locations and##26##2##(1990-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
locations are##6##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-3#1)
locations around##2##2##(2008-10#1)(2008-5#1)
locations as logic##2##3##(2008-3#2)
locations as##5##2##(1997-6#1)(2007-8#1)(2008-3#2)(2012-3#1)
locations at which##2##3##(1992-5#2)
locations by##3##2##(2007-12#1)(2008-10#1)(2009-5#1)
locations during##2##2##(2008-10#1)(2008-7#1)
locations for##4##2##(2008-1#1)(2008-10#1)(2009-9#1)(2010-3#1)
locations had a##2##3##(2008-10#2)
locations had##3##2##(2008-10#3)
locations in Germany##2##3##(2008-10#2)
locations in Michigan##2##3##(2008-10#2)
locations in eastern North##2##4##(2008-10#2)
locations in eastern##3##3##(2008-10#3)
locations in the United States and##2##6##(2008-10#2)
locations in the United States##3##5##(2008-10#3)
locations in the##20##3##(1990-5#1)(1991-4#1)(1992-3#1)(1995-11#1)(1997-6#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#1)
locations in##57##2##(1990-5#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1995-11#1)(1997-6#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#34)(2008-3#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#1)
locations is##3##2##(1995-1#1)(2007-12#1)(2008-8#1)
locations near##2##2##(2007-5#1)(2008-10#1)
locations of the##9##3##(2008-10#4)(2008-2#2)(2008-3#1)(2012-12#1)(2013-1#1)
locations of these##2##3##(2007-11#1)(2007-12#1)
locations of##41##2##(1990-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
locations on the##6##3##(2008-10#1)(2008-3#2)(2009-7#1)(2010-4#1)(2011-2#1)
locations on##9##2##(1993-6#2)(2008-10#2)(2008-3#2)(2009-7#1)(2010-4#1)(2011-2#1)
locations over##2##2##(2008-10#2)
locations ranged from 0##2##4##(2008-10#2)
locations sampled in##2##3##(2008-10#2)
locations sampled##4##2##(2008-10#4)
locations that##6##2##(1997-2#1)(2008-2#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)
locations throughout the world##2##4##(2008-10#1)(2011-1#1)
locations throughout the##3##3##(2008-10#2)(2011-1#1)
locations throughout##5##2##(2008-10#3)(2008-8#1)(2011-1#1)
locations using a##2##3##(2008-10#1)(2008-7#1)
locations was##6##2##(2008-10#5)(2013-8#1)
locations were##14##2##(1990-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2013-7#1)(2013-8#2)
locations where##3##2##(2008-10#2)(2009-5#1)
locations with##5##2##(1993-6#1)(2008-10#2)(2011-2#1)(2012-2#1)
locations within the##2##3##(2008-10#2)
locations within##5##2##(2008-10#3)(2009-2#1)(2011-1#1)
locations worldwide##4##2##(2008-10#4)
locations##389##1##(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-12#2)(1993-6#3)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#3)(1997-8#1)(2006-12#1)(2007-11#6)(2007-12#6)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#163)(2008-11#5)(2008-12#3)(2008-2#9)(2008-3#21)(2008-4#2)(2008-5#10)(2008-7#7)(2008-8#12)(2008-9#6)(2009-1#2)(2009-10#1)(2009-2#2)(2009-5#4)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#4)(2011-1#4)(2011-2#12)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#6)
locations)##2##1##(2008-10#1)(2012-5#1)
locator##2##1##(1995-2#1)(2008-3#1)
loci (QTL)##34##2##(2008-10#26)(2008-7#1)(2008-8#3)(2009-5#1)(2011-1#1)(2012-3#2)
loci A##2##2##(2008-10#2)
loci across the##2##3##(2008-10#1)(2012-3#1)
loci and the##2##3##(2008-10#2)
loci and##19##2##(1993-6#1)(1996-6#1)(2008-10#10)(2008-9#1)(2009-3#1)(2012-3#3)(2013-1#1)(2013-8#1)
loci are required for##2##4##(1991-5#1)(1994-9#1)
loci are required##3##3##(1991-5#1)(1994-9#1)(2008-12#1)
loci are##13##2##(1991-5#1)(1994-9#2)(1997-7#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-3#1)
loci as##3##2##(1993-3#1)(2008-10#1)(2012-3#1)
loci associated with##2##3##(2008-10#1)(2008-3#1)
loci between##2##2##(2008-10#1)(2008-12#1)
loci by##3##2##(1994-7#1)(1997-4#1)(2008-10#1)
loci can##2##2##(1996-8#1)(2013-1#1)
loci conditioning##2##2##(2008-10#2)
loci conferring##2##2##(2008-10#1)(2008-8#1)
loci detected by the same##2##5##(2008-9#2)
loci detected by##3##3##(2008-9#3)
loci detected##4##2##(2008-10#1)(2008-9#3)
loci determine##2##2##(2008-10#1)(2008-8#1)
loci displayed##2##2##(2008-12#1)(2011-2#1)
loci for three##2##3##(1993-11#1)(2008-10#1)
loci for##13##2##(1993-11#1)(1994-3#1)(1995-2#1)(1997-5#1)(2008-10#7)(2008-4#1)(2009-10#1)
loci from##3##2##(2008-10#1)(2008-12#1)(2009-2#1)
loci have been##2##3##(1991-6#1)(2008-12#1)
loci in the##5##3##(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)
loci in this##2##3##(2009-2#1)(2011-2#1)
loci in##22##2##(1996-6#1)(2008-10#5)(2008-12#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-2#2)(2011-2#1)(2012-3#2)
loci is##2##2##(1994-3#1)(2008-10#1)
loci makes##2##2##(2008-8#2)
loci of the##5##3##(1995-5#1)(1996-8#1)(2008-12#2)(2008-2#1)
loci of##12##2##(1993-12#1)(1995-2#1)(1995-5#2)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)
loci on##5##2##(1994-12#1)(2008-10#2)(2008-5#2)
loci or##2##2##(1995-2#1)(2008-1#1)
loci that have##2##3##(2011-2#1)(2012-3#1)
loci that were##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
loci that##13##2##(1991-12#1)(1991-6#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#3)
loci to##6##2##(1995-6#1)(2008-10#3)(2008-5#1)(2008-9#1)
loci under##2##2##(1997-5#1)(2008-8#1)
loci using##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
loci was examined##2##3##(2010-8#1)(2011-2#1)
loci was##10##2##(2008-10#6)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
loci were at##2##3##(2008-10#1)(2008-12#1)
loci were detected##2##3##(2008-10#1)(2008-12#1)
loci were##26##2##(1990-11#1)(1997-9#1)(2008-10#13)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2013-8#3)
loci with a##2##3##(2008-10#1)(2008-11#1)
loci with##8##2##(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)
loci within the##3##3##(1990-9#1)(2008-12#1)(2009-6#1)
loci##427##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#4)(1991-6#4)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#5)(1995-11#3)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#2)(1996-2#1)(1996-6#2)(1996-8#2)(1997-4#1)(1997-5#5)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#1)(2008-1#2)(2008-10#151)(2008-11#7)(2008-12#41)(2008-2#1)(2008-3#2)(2008-4#12)(2008-5#15)(2008-7#10)(2008-8#20)(2008-9#20)(2009-10#3)(2009-2#4)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#33)(2012-5#1)(2013-1#6)(2013-8#8)
loci&quot##3##1##(2008-10#2)(2008-7#1)
lock##18##1##(2007-11#3)(2007-12#3)(2008-11#1)(2008-2#5)(2008-3#1)(2010-3#3)(2012-12#2)
lock-in amplifier##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
lock-in detection##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
lock-in technique##3##2##(2007-12#1)(2008-3#2)
lock-in##24##1##(1997-2#1)(2007-11#6)(2007-12#5)(2008-10#2)(2008-2#4)(2008-3#6)
locked and##3##2##(2007-12#2)(2008-3#1)
locked by##8##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
locked in the##2##3##(1995-8#1)(2007-11#1)
locked in##4##2##(1995-8#1)(2007-11#1)(2007-12#1)(2012-2#1)
locked nucleic##2##2##(2008-4#2)
locked to the##4##3##(2007-12#3)(2008-2#1)
locked to##8##2##(1993-12#1)(2007-12#4)(2008-2#3)
locked up##2##2##(1996-4#1)(2009-9#1)
locked##43##1##(1993-12#1)(1995-8#1)(1996-4#2)(2007-11#5)(2007-12#15)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#1)(2009-9#1)(2012-2#1)
locking a##3##2##(2007-11#1)(2007-12#2)
locking and##5##2##(1992-4#1)(2007-11#2)(2008-3#2)
locking in a##3##3##(2007-11#2)(2007-12#1)
locking in the##2##3##(2007-11#1)(2007-12#1)
locking in##5##2##(2007-11#3)(2007-12#2)
locking is##2##2##(2007-12#1)(2008-3#1)
locking mechanism and##2##3##(2008-8#2)
locking mechanism##4##2##(2008-8#4)
locking of a##8##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)
locking of the knee##2##4##(2008-11#2)
locking of the##4##3##(2007-11#1)(2007-12#1)(2008-11#2)
locking of##22##2##(2007-11#11)(2007-12#5)(2008-11#2)(2008-2#2)(2008-3#2)
locking plate##5##2##(2008-9#2)(2010-3#3)
locking plates##2##2##(2008-9#2)
locking the##2##2##(2007-12#2)
locking to##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
locking##98##1##(1992-4#1)(1996-4#1)(2007-11#32)(2007-12#25)(2008-10#2)(2008-11#4)(2008-2#5)(2008-3#13)(2008-8#6)(2008-9#4)(2010-3#4)(2012-3#1)
locks##3##1##(1996-5#1)(2008-11#1)(2011-2#1)
loco-regional anesthesia##2##2##(1992-6#2)
loco-regional##8##1##(1990-12#2)(1990-3#1)(1992-6#2)(1993-9#1)(2008-6#1)(2012-2#1)
locomotion activity##2##2##(2008-10#1)(2008-9#1)
locomotion and##4##2##(1997-2#1)(2008-8#1)(2009-10#1)(2009-5#1)
locomotion consumed##2##2##(2008-9#2)
locomotion data##3##2##(2013-1#3)
locomotion in##3##2##(1993-3#1)(1993-6#1)(2007-12#1)
locomotion of rats with a##2##5##(1993-3#2)
locomotion visual analogue scales (VASs)##2##5##(2008-10#2)
locomotion##63##1##(1990-8#1)(1991-2#1)(1993-12#2)(1993-3#7)(1993-6#2)(1994-2#2)(1995-12#2)(1997-2#1)(2007-12#13)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#2)(2011-2#3)(2012-2#4)(2013-1#5)(2013-7#1)
locomotive system in##2##3##(2007-11#1)(2007-8#1)
locomotive##5##1##(1995-11#1)(2007-11#2)(2007-8#1)(2013-1#1)
locomotor activity and the expression of##2##6##(2008-10#2)
locomotor activity and the##3##4##(2008-10#2)(2008-5#1)
locomotor activity and##9##3##(1993-6#1)(1995-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
locomotor activity in##2##3##(2008-4#1)(2013-1#1)
locomotor activity or##2##3##(1993-5#1)(2008-12#1)
locomotor activity##28##2##(1990-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2012-2#1)(2013-1#2)
locomotor and##2##2##(2007-8#1)(2013-1#1)
locomotor behavior##2##2##(2007-12#1)(2008-5#1)
locomotor behaviour##2##2##(1993-12#1)(1994-3#1)
locomotor effects##2##2##(1993-12#1)(2011-2#1)
locomotor pattern##2##2##(1993-12#2)
locomotor response to novelty##3##4##(1993-6#3)
locomotor response to##6##3##(1993-12#1)(1993-6#5)
locomotor response##7##2##(1993-12#1)(1993-6#6)
locomotor system##7##2##(1990-6#1)(2007-11#4)(2007-8#2)
locomotor##82##1##(1990-6#1)(1990-9#1)(1992-12#1)(1993-12#7)(1993-3#5)(1993-5#1)(1993-6#9)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#4)(2007-11#8)(2007-12#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#6)
locomotory##6##1##(1991-2#1)(1993-12#1)(1993-3#1)(1997-2#1)(2007-12#1)(2008-8#1)
locoregional control##3##2##(1994-12#1)(1996-10#1)(2012-2#1)
locoregional recurrence##2##2##(1993-11#1)(2009-2#1)
locoregional##15##1##(1991-8#1)(1993-11#3)(1994-12#1)(1996-10#1)(2007-10#1)(2009-2#1)(2011-2#1)(2011-3#2)(2012-2#2)(2013-1#2)
loculated##3##1##(2007-12#1)(2010-5#2)
locum tenens##2##2##(1991-3#1)(1992-8#1)
locum##3##1##(1991-3#1)(1992-8#1)(2012-12#1)
locus and##6##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
locus at##2##2##(1997-5#1)(2008-4#1)
locus by##3##2##(1996-2#1)(1996-8#1)(2008-8#1)
locus can##2##2##(2008-11#1)(2008-8#1)
locus coeruleus and##2##3##(1993-12#1)(2008-7#1)
locus coeruleus##13##2##(1993-12#2)(1994-2#1)(1995-12#3)(1996-12#1)(1996-5#2)(2008-7#4)
locus conditioning##2##2##(2008-10#2)
locus controlling##2##2##(2008-10#2)
locus for##14##2##(1994-12#1)(1994-2#1)(1996-2#1)(1997-5#3)(2007-7#1)(2008-10#4)(2008-11#1)(2009-10#1)(2011-1#1)
locus from H 7998##2##4##(2008-10#2)
locus from##4##2##(1997-3#1)(2008-10#3)
locus had the##3##3##(2008-12#3)
locus had##4##2##(2008-10#1)(2008-12#3)
locus haplotypes##2##2##(2008-10#2)
locus has been##3##3##(1991-6#1)(1997-7#1)(2009-5#1)
locus has##4##2##(1991-6#1)(1997-7#1)(1997-9#1)(2009-5#1)
locus identified##2##2##(2008-10#2)
locus in each##2##3##(2008-10#1)(2008-5#1)
locus in the##5##3##(1992-8#1)(1995-8#1)(2008-10#2)(2008-11#1)
locus in these##2##3##(1992-9#1)(2008-10#1)
locus in##15##2##(1992-3#1)(1992-8#1)(1992-9#1)(1995-8#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)
locus is##10##2##(1993-11#1)(1993-6#1)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)
locus linked to the markers in##2##6##(1997-5#2)
locus maps to##2##3##(2008-9#1)(2012-2#1)
locus of control##6##3##(1996-2#4)(2008-12#2)
locus of responsibility for##2##4##(1995-12#1)(1996-2#1)
locus of the##6##3##(1990-3#1)(1991-6#1)(1995-2#1)(1996-8#1)(2007-8#1)(2010-8#1)
locus of##26##2##(1990-3#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-2#3)(1996-2#5)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
locus on chromosome 14##2##4##(1996-2#1)(2011-2#1)
locus on chromosome##17##3##(1991-10#1)(1993-11#2)(1994-9#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#2)
locus on human chromosome##4##4##(1990-5#1)(1995-8#1)(2008-9#1)(2012-3#1)
locus on the##3##3##(1996-12#2)(2008-10#1)
locus on##28##2##(1990-5#1)(1991-10#1)(1993-11#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#2)(1997-2#1)(1997-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#1)
locus or##4##2##(2008-8#2)(2008-9#1)(2012-3#1)
locus showed##2##2##(1996-2#1)(2008-10#1)
locus that##5##2##(2008-10#4)(2010-5#1)
locus to##4##2##(2008-10#3)(2008-12#1)
locus was designated as##2##4##(2008-10#2)
locus was mapped to##3##4##(1993-2#1)(2008-10#1)(2008-8#1)
locus was##15##2##(1993-2#1)(1997-3#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)
locus were##6##2##(1997-3#1)(2008-10#2)(2009-10#2)(2009-8#1)
locus with##10##2##(1994-11#1)(1995-5#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-12#1)
locus##395##1##(1990-11#2)(1990-3#1)(1990-5#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-3#2)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#2)(1994-9#3)(1995-12#5)(1995-2#11)(1995-5#2)(1995-6#5)(1995-8#7)(1995-9#1)(1996-10#2)(1996-12#8)(1996-2#12)(1996-5#3)(1996-6#4)(1996-8#4)(1997-2#5)(1997-3#8)(1997-5#16)(1997-7#8)(1997-8#3)(1997-9#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#114)(2008-11#4)(2008-12#17)(2008-2#4)(2008-4#4)(2008-5#8)(2008-7#6)(2008-8#21)(2008-9#14)(2009-10#8)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#8)(2012-2#4)(2012-3#7)(2013-1#3)(2013-8#3)
locus)##3##1##(1996-3#1)(2008-11#1)(2008-8#1)
locus-specific##3##1##(2008-1#1)(2008-4#2)
locust ventral##2##2##(1994-2#2)
locust##14##1##(1991-5#1)(1994-2#3)(2007-12#9)(2012-12#1)
locusts and##3##2##(1995-2#1)(2007-12#1)(2008-8#1)
locusts##5##1##(1991-5#1)(1995-2#2)(2007-12#1)(2008-8#1)
lod score##4##2##(1997-5#4)
lod scores of##2##3##(1997-5#2)
lod scores##4##2##(1997-5#3)(2008-4#1)
lod##8##1##(1997-5#7)(2008-4#1)
lodge##2##1##(1993-3#1)(2008-11#1)
lodgepole pine (Pinus##2##3##(2008-10#1)(2013-1#1)
lodgepole pine##6##2##(2008-10#2)(2013-1#4)
lodging##5##1##(1993-1#1)(1995-2#1)(2008-10#2)(2011-2#1)
lofexidine##3##1##(2008-11#3)
loft##3##1##(1990-11#3)
log 1##2##2##(2008-10#2)
log 4##3##2##(2008-10#2)(2008-5#1)
log 5##6##2##(2008-10#5)(2008-5#1)
log 6##2##2##(2008-10#2)
log CFU + 1 per g of soil##2##8##(2008-10#2)
log CFU/ml##2##2##(2008-5#2)
log K##4##2##(1992-9#1)(2008-10#3)
log K(ex) was##2##3##(2008-10#2)
log K(ex)##6##2##(2008-10#6)
log P##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
log S and J'##2##4##(2008-8#2)
log S and##3##3##(2008-8#3)
log S##4##2##(2008-8#4)
log beta (CaF##2##3##(2008-10#2)
log c##2##2##(2008-10#2)
log degrees##2##2##(2008-10#2)
log k vs##2##3##(1995-3#2)
log k##3##2##(1995-3#2)(2007-11#1)
log of the likelihood ratio##2##5##(2008-10#2)
log of the##4##3##(2008-10#3)(2008-2#1)
log of##10##2##(1995-8#1)(2008-10#7)(2008-2#1)(2008-8#1)
log phase##2##2##(1993-6#1)(2008-7#1)
log ratios##2##2##(2008-10#2)
log reduction of##2##3##(2007-7#1)(2008-5#1)
log reduction##3##2##(2007-7#2)(2008-5#1)
log units##6##2##(2007-11#2)(2008-10#4)
log##116##1##(1990-5#2)(1991-9#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-7#3)(2008-1#2)(2008-10#59)(2008-2#2)(2008-3#1)(2008-5#7)(2008-7#2)(2008-8#6)(2009-11#1)(2009-6#1)(2009-7#2)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
log(10) CFU/g##3##2##(2007-3#3)
log(10) TCID(50)/ml##2##2##(2008-11#2)
log(10) copies/mL##2##2##(2013-1#2)
log(10)##12##1##(2007-3#3)(2008-10#3)(2008-11#2)(2008-5#1)(2012-3#1)(2013-1#2)
log-likelihood ratio##2##2##(2008-10#2)
log-likelihood##6##1##(2008-10#2)(2008-3#2)(2010-5#2)
log-linear model##2##2##(1994-2#1)(1994-9#1)
log-linear##8##1##(1994-2#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)
log-linearity##2##1##(2008-11#2)
log-log plots##3##2##(2008-10#3)
log-log transformation of incidence##2##4##(2008-10#2)
log-log##9##1##(1992-2#1)(2008-10#6)(2008-2#1)(2008-9#1)
log-normal assumptions##2##2##(2008-7#2)
log-normal distribution##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
log-normal##14##1##(1992-2#2)(1995-2#1)(1997-7#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#3)
log-normally distributed##2##2##(2008-7#2)
log-rank test##6##2##(2008-6#2)(2011-2#1)(2012-3#2)(2013-8#1)
log-rank test)##2##2##(1995-2#1)(2007-5#1)
log-rank##10##1##(1991-11#1)(1993-2#1)(1995-2#1)(2007-5#1)(2008-6#2)(2011-2#1)(2012-3#2)(2013-8#1)
log-scale##3##1##(2012-2#3)
log-transformed##3##1##(2008-10#1)(2009-1#1)(2013-1#1)
log10##5##1##(2007-6#2)(2008-10#2)(2013-1#1)
logD(M) versus##2##2##(2008-10#2)
logK values##2##2##(2008-10#2)
logK##4##1##(2008-10#4)
logK(D##2##1##(2008-10#2)
logK(H*)##2##1##(2008-10#2)
logK(ex(10))##2##1##(2008-10#2)
logK(ex)##2##1##(2008-10#2)
logK(s)(ZrO(2)-MgO)##2##1##(2008-10#2)
logK=2##2##1##(2008-10#2)
logMAR lines##2##2##(2011-2#2)
logMAR##3##1##(2011-2#3)
logarithm of the initial concentration of##2##6##(2008-10#2)
logarithm of the##19##3##(1994-12#2)(1996-4#2)(2008-10#11)(2008-3#2)(2008-5#2)
logarithm of##37##2##(1994-12#2)(1996-4#2)(2008-10#24)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-7#2)(2010-5#1)
logarithm##41##1##(1994-12#2)(1996-4#2)(2007-12#1)(2008-10#25)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-7#2)(2010-5#1)
logarithmic distribution##2##2##(2008-10#2)
logarithmic extraction constant##2##3##(2008-10#2)
logarithmic harmonic filter can##2##4##(2008-3#2)
logarithmic harmonic##3##2##(2008-3#3)
logarithmic phase##2##2##(2008-2#1)(2012-2#1)
logarithmic radial harmonic##2##3##(2008-3#2)
logarithmic scale##4##2##(1997-8#1)(2008-10#2)(2008-3#1)
logarithmic##32##1##(1996-4#1)(1997-8#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#1)
logarithmically##2##1##(1994-11#1)(2008-11#1)
logarithms of##3##2##(1990-2#1)(2008-10#1)(2008-7#1)
logbeta##3##1##(2008-10#3)
logbeta(1##6##1##(2008-10#6)
loggerhead sea turtle and##2##4##(1995-3#2)
loggerhead sea turtle##4##3##(1995-3#4)
logging##3##1##(2008-3#1)(2008-5#1)(2011-1#1)
logic and##3##2##(1994-3#1)(2008-12#1)(2008-8#1)
logic devices with##3##3##(2008-3#3)
logic for##2##2##(2008-12#1)(2008-9#1)
logic gate##4##2##(2007-12#1)(2008-3#2)(2013-7#1)
logic gates##10##2##(2008-3#7)(2008-7#1)(2013-7#2)
logic models from##2##3##(2009-11#2)
logic of the##3##3##(2008-7#1)(2008-8#1)(2010-11#1)
logic of##10##2##(1996-8#1)(2008-10#1)(2008-7#2)(2008-8#4)(2009-5#1)(2010-11#1)
logic operations##8##2##(2008-3#8)
logic##78##1##(1994-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#32)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#3)
logical to##5##2##(1994-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
logical treatment##3##2##(2007-11#1)(2010-8#1)(2013-8#1)
logical##41##1##(1991-5#1)(1991-9#1)(1992-2#1)(1993-2#1)(1994-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
logically##6##1##(1994-8#1)(1995-12#1)(2008-10#2)(2008-7#1)(2010-12#1)
logics##2##1##(2008-7#1)(2013-8#1)
logistic EuroSCORE##6##2##(2007-8#5)(2013-8#1)
logistic analysis##2##2##(2008-10#1)(2013-1#1)
logistic and exponential models best described the##2##7##(2008-10#2)
logistic and##4##2##(1994-2#1)(2008-10#2)(2010-8#1)
logistic equation##2##2##(2008-10#2)
logistic equations##3##2##(2008-11#3)
logistic function##4##2##(1992-9#1)(1997-8#1)(2008-10#2)
logistic growth##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
logistic model provided the best##2##5##(2008-10#2)
logistic model was##2##3##(2008-10#1)(2008-11#1)
logistic model##12##2##(1994-11#1)(2008-10#9)(2008-11#1)(2012-2#1)
logistic models##3##2##(2007-8#1)(2008-10#1)(2010-10#1)
logistic regression analyses were##2##4##(2007-10#1)(2010-11#1)
logistic regression analyses##6##3##(2007-10#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-7#1)
logistic regression analysis of##6##4##(2008-10#3)(2008-11#1)(2012-3#2)
logistic regression analysis showed that##4##5##(2008-11#2)(2011-1#2)
logistic regression analysis showed##5##4##(2008-11#2)(2008-3#1)(2011-1#2)
logistic regression analysis was##2##4##(2008-3#1)(2013-8#1)
logistic regression analysis##30##3##(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-3#2)(2008-7#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#2)
logistic regression and##2##3##(1995-2#1)(2008-10#1)
logistic regression indicated that##2##4##(1993-12#1)(2008-11#1)
logistic regression model for##2##4##(2008-8#1)(2011-2#1)
logistic regression model showed##2##4##(2012-12#1)(2013-1#1)
logistic regression model was##2##4##(2008-11#1)(2011-2#1)
logistic regression model##14##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#1)
logistic regression modeling##2##3##(2012-1#2)
logistic regression models for##2##4##(2008-8#1)(2013-1#1)
logistic regression models were##3##4##(2008-8#1)(2013-1#2)
logistic regression models##16##3##(1995-2#2)(2008-10#3)(2008-8#2)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#5)
logistic regression was used to estimate##2##6##(2008-8#1)(2011-2#1)
logistic regression was used to##4##5##(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
logistic regression was used##5##4##(1994-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
logistic regression was##7##3##(1994-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)
logistic regression were##4##3##(2009-4#1)(2013-1#2)(2013-8#1)
logistic regression with##3##3##(1996-7#1)(2011-2#1)(2013-8#1)
logistic regression##119##2##(1991-3#1)(1992-9#1)(1993-12#1)(1993-9#3)(1994-12#1)(1994-2#1)(1995-2#4)(1996-7#1)(2007-10#2)(2007-8#3)(2008-10#15)(2008-11#8)(2008-3#3)(2008-7#3)(2008-8#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#10)(2012-1#3)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#5)
logistic##173##1##(1991-12#2)(1991-3#1)(1992-9#3)(1993-12#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1995-2#4)(1996-7#1)(1997-8#1)(2007-10#2)(2007-2#1)(2007-8#11)(2008-10#36)(2008-11#12)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#10)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#8)
logistic)##2##1##(2007-8#1)(2008-10#1)
logistical advantages##2##2##(1996-12#2)
logistical##8##1##(1993-2#1)(1995-3#1)(1996-12#2)(2007-10#1)(2008-11#1)(2008-12#1)(2010-11#1)
logistics of##2##2##(1995-2#1)(2008-11#1)
logistics##4##1##(1993-2#1)(1995-2#1)(1995-5#1)(2008-11#1)
logit##3##1##(1997-7#1)(2010-12#1)(2012-2#1)
lognormal species abundance##2##3##(2008-8#2)
lognormal##5##1##(2008-3#1)(2008-8#4)
logrank test for##2##3##(1997-3#2)
logrank test##3##2##(1997-3#3)
logrank##4##1##(1997-3#4)
logs as##2##2##(2008-10#1)(2013-1#1)
logs higher##2##2##(1997-6#1)(2008-10#1)
logs##16##1##(1992-12#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#1)(2008-10#4)(2012-2#3)(2013-1#3)
logs)##2##1##(2013-1#2)
loin##2##1##(2007-7#1)(2008-1#1)
lomefloxacin##4##1##(2008-10#4)
lone pair##5##2##(1996-2#1)(1997-2#1)(2010-2#1)(2011-2#2)
loneliness##7##1##(1993-3#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#1)(2011-2#1)
lonely##3##1##(2008-7#2)(2010-10#1)
long (age-1) and##2##3##(2008-3#2)
long 3' untranslated region##2##4##(1994-8#1)(1996-12#1)
long 3' untranslated##3##3##(1993-8#1)(1994-8#1)(1996-12#1)
long 5'-untranslated region##2##3##(1993-12#1)(1997-7#1)
long Barrett's esophagus##4##3##(2013-8#4)
long DNA##5##2##(1994-12#1)(2008-11#3)(2008-7#1)
long Homer##2##2##(2008-11#2)
long PCR products##2##3##(1996-6#2)
long QT syndrome and##2##4##(2008-7#1)(2013-1#1)
long QT syndrome##6##3##(2008-7#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#2)
long QT##9##2##(2006-10#1)(2008-7#1)(2009-5#1)(2010-8#3)(2012-3#1)(2013-1#2)
long acting analogs##2##3##(2008-1#2)
long acting##7##2##(1993-2#1)(1993-6#1)(1996-11#1)(2007-7#1)(2008-1#3)
long after##2##2##(1992-6#1)(2008-10#1)
long ago##4##2##(1994-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
long alkyl chains##2##3##(2008-5#1)(2011-2#1)
long alkyl##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
long and contains##2##3##(1997-2#1)(2008-10#1)
long and filiform##2##3##(2007-12#1)(2008-7#1)
long and had##2##3##(1996-10#1)(2008-10#1)
long and has##2##3##(1996-12#1)(2008-7#1)
long and includes##2##3##(1993-2#1)(1994-12#1)
long and its##2##3##(1996-10#1)(2007-12#1)
long and short##5##3##(1991-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
long and##49##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
long arm of chromosome 5##2##5##(1997-5#1)(2012-12#1)
long arm of chromosome##12##4##(1997-3#1)(1997-5#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-3#1)(2012-12#3)
long arm of##23##3##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#8)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#2)(2010-7#1)(2012-1#1)(2012-12#3)
long arm##30##2##(1992-11#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2008-10#9)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#2)(2010-3#2)(2010-7#1)(2012-1#1)(2012-12#3)
long as a##4##3##(1996-6#1)(2008-1#1)(2009-3#1)(2012-3#1)
long as they##2##3##(1992-4#1)(2008-4#1)
long as we##2##3##(2008-10#1)(2012-3#1)
long as##68##2##(1990-2#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#8)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-10#2)(2010-7#1)(2012-12#1)(2012-3#2)
long at##2##2##(1990-2#1)(2008-11#1)
long axes##2##2##(1993-8#1)(2008-6#1)
long axis view) (p &lt##2##5##(2008-10#2)
long axis##6##2##(2008-10#3)(2008-2#1)(2009-10#1)(2009-11#1)
long been implicated in the##2##5##(2008-11#1)(2008-7#1)
long been implicated in##3##4##(2008-11#1)(2008-7#1)(2009-6#1)
long been known to##3##4##(2008-3#1)(2008-9#1)(2010-7#1)
long been known##6##3##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
long been recognized##8##3##(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
long been thought to##2##4##(1996-12#1)(2010-12#1)
long been used as##2##4##(2008-11#1)(2012-12#1)
long been used##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
long been##58##2##(1992-2#1)(1993-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)
long before the##5##3##(2008-10#2)(2008-4#1)(2009-12#1)(2012-12#1)
long before##6##2##(2008-10#2)(2008-4#1)(2009-12#1)(2012-12#1)(2013-8#1)
long bone fractures##4##3##(2007-11#2)(2009-3#1)(2013-1#1)
long bone metastases##3##3##(2007-11#3)
long bone##12##2##(2007-11#6)(2009-3#1)(2010-3#1)(2010-6#2)(2013-1#2)
long bones and##4##3##(2007-11#3)(2011-2#1)
long bones with##2##3##(2007-11#1)(2007-2#1)
long bones##28##2##(1995-6#1)(2007-11#15)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-3#2)(2010-6#1)(2011-2#1)(2013-8#1)
long cDNA##2##2##(1997-4#1)(2008-5#1)
long calls##4##2##(2008-8#4)
long cell##2##2##(2008-7#1)(2012-12#1)
long chain fatty acid##3##4##(1992-3#1)(1993-8#1)(2008-10#1)
long chain fatty acids##2##4##(2008-10#2)
long chain fatty##5##3##(1992-3#1)(1993-8#1)(2008-10#3)
long chain##16##2##(1990-5#1)(1992-3#1)(1992-8#1)(1993-8#2)(1995-6#3)(1996-7#1)(2008-10#3)(2008-7#1)(2009-6#1)(2012-2#2)
long clinical##2##2##(1993-2#1)(2008-1#1)
long daylengths##3##2##(2012-3#3)
long delay##3##2##(1991-1#1)(2007-12#1)(2009-11#1)
long distance##5##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
long distances in##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
long distances##16##2##(1995-12#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-3#1)(2011-2#1)
long duration of action##2##4##(1996-2#1)(2008-11#1)
long duration of the##2##4##(2008-12#1)(2012-2#1)
long duration of##4##3##(1996-2#1)(2008-11#1)(2008-12#1)(2012-2#1)
long duration##10##2##(1991-2#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
long enough for##4##3##(2012-12#3)(2013-1#1)
long enough to##5##3##(1993-8#1)(2008-10#1)(2008-3#2)(2013-7#1)
long enough##12##2##(1993-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2012-12#3)(2013-1#1)(2013-7#1)
long exposure to##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
long exposures##2##2##(2008-2#1)(2008-6#1)
long fatty acid chain##2##4##(1993-8#2)
long fiber##3##2##(2007-12#1)(2008-3#2)
long filament##3##2##(2007-11#3)
long finger##2##2##(2008-9#2)
long for##3##2##(2008-11#1)(2008-9#1)(2009-11#1)
long genomic sequences##2##3##(2008-4#2)
long glume awn##2##3##(2008-10#2)
long half life##2##3##(2008-10#1)(2008-9#1)
long half-life##2##2##(2008-1#1)(2008-11#1)
long haul##2##2##(2007-2#2)
long held##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
long history of##13##3##(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
long history##18##2##(1993-11#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
long homology##2##2##(1994-8#2)
long hours##2##2##(2009-10#1)(2010-7#1)
long is##2##2##(2012-2#1)(2013-7#1)
long journey##3##2##(2007-2#1)(2012-2#2)
long lasting effect##2##3##(1991-6#1)(1993-2#1)
long lasting##17##2##(1990-9#1)(1991-6#2)(1992-3#2)(1993-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-3#2)(2010-9#1)(2012-2#1)
long latency responses##2##3##(1996-5#2)
long latency##3##2##(1995-2#1)(1996-5#2)
long latent period##4##3##(2008-10#4)
long life##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)
long lifetime of the##2##4##(2007-12#1)(2008-10#1)
long lifetime##4##2##(2007-12#1)(2008-10#3)
long light##2##2##(2007-12#1)(2010-8#1)
long lived##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
long nucleotide##2##2##(1992-12#1)(2009-11#1)
long open reading frame##3##4##(1990-5#1)(2008-10#1)(2008-9#1)
long operation##2##2##(2008-7#2)
long optical paths##2##3##(2007-11#1)(2008-3#1)
long optical##3##2##(2007-11#1)(2008-3#2)
long or##3##2##(1992-12#1)(2007-11#1)(2009-4#1)
long overdue##2##2##(2008-11#1)(2013-1#1)
long path length spectroelectrochemical##2##4##(2008-10#2)
long pathlength##5##2##(2008-10#5)
long period of time##8##4##(1990-6#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#1)
long period of##10##3##(1990-6#1)(1990-8#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#1)(2012-7#1)
long period##19##2##(1990-6#1)(1990-8#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-7#1)
long periodicity##2##2##(1993-3#1)(2008-5#1)
long periods of time##6##4##(1991-5#1)(1995-1#1)(2008-10#1)(2008-11#2)(2011-1#1)
long periods of##9##3##(1991-5#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2011-1#1)
long periods##15##2##(1991-5#1)(1995-1#1)(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
long pulse##3##2##(1991-2#2)(2007-12#1)
long pulses##3##2##(2008-2#1)(2008-3#2)
long range and##2##3##(2008-3#1)(2008-9#1)
long range##8##2##(1991-8#1)(1996-4#1)(2007-10#1)(2008-3#3)(2008-9#1)(2009-8#1)
long ranges##2##2##(2008-2#2)
long reaction times##2##3##(2008-10#1)(2008-9#1)
long recognized##2##2##(2008-8#1)(2009-8#1)
long remained##3##2##(2008-3#1)(2008-7#1)(2010-1#1)
long residence##2##2##(1991-12#1)(2008-7#1)
long run##10##2##(1994-5#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
long separation##3##2##(1996-2#1)(2008-10#2)
long sequence##2##2##(1991-9#1)(2008-10#1)
long series of##2##3##(1992-11#1)(2010-4#1)
long shelf-life ultra-high temperature##2##4##(2013-1#2)
long single##6##2##(2009-11#1)(2011-2#5)
long single-mode fibers##2##3##(2007-12#2)
long single-mode##4##2##(2007-11#1)(2007-12#3)
long span partially edentulous maxilla with##2##6##(2013-1#2)
long span partially edentulous##3##4##(2013-1#3)
long standing diabetes##2##3##(2012-2#2)
long standing##6##2##(1997-1#1)(2007-7#2)(2008-4#1)(2012-2#2)
long strictures##2##2##(2008-10#1)(2013-1#1)
long survival##5##2##(1991-8#1)(1995-11#1)(1996-5#1)(2008-7#2)
long survivors##3##2##(1991-12#2)(2010-8#1)
long term and##2##3##(2008-4#1)(2008-8#1)
long term care insurance##3##4##(1992-12#1)(1993-3#2)
long term care##14##3##(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(2008-12#2)(2012-12#1)
long term clinical##2##3##(1997-4#1)(2008-8#1)
long term effects of##6##4##(1990-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-2#1)
long term follow up is##2##5##(2011-2#1)(2013-8#1)
long term follow up##3##4##(1993-2#1)(2011-2#1)(2013-8#1)
long term in##5##3##(2007-5#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-7#1)
long term memory##4##3##(2008-11#1)(2013-1#3)
long term outcome##2##3##(2008-1#1)(2011-2#1)
long term prognosis is##2##4##(1996-9#1)(2010-7#1)
long term prognosis##3##3##(1996-9#1)(2010-7#1)(2013-8#1)
long term results##5##3##(2007-11#2)(2007-8#1)(2011-2#1)(2013-1#1)
long term stability and##2##4##(2008-10#1)(2008-5#1)
long term stability##7##3##(2008-10#5)(2008-5#2)
long term survival##5##3##(1990-2#1)(2010-7#2)(2013-1#2)
long term treatment with##3##4##(1996-3#1)(2008-7#1)(2008-8#1)
long term treatment##5##3##(1996-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
long term##154##2##(1990-2#2)(1990-5#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#1)(2009-11#2)(2009-12#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#13)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#9)(2013-7#3)(2013-8#4)
long terminal repeat (LTR)##3##4##(1992-12#1)(1993-8#1)(1997-8#1)
long terminal repeat and##2##4##(1990-12#1)(1992-12#1)
long terminal repeat##15##3##(1990-12#2)(1992-12#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#2)(1997-8#1)(2008-5#1)(2008-9#1)(2012-3#1)
long terminal repeats##2##3##(1995-8#1)(2008-10#1)
long terminal##19##2##(1990-12#2)(1992-12#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
long time after##5##3##(1990-6#1)(1993-8#1)(1997-2#1)(1997-4#1)(2011-2#1)
long time series##2##3##(2008-8#1)(2008-9#1)
long time##46##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-9#1)(1993-2#1)(1993-8#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
long to##4##2##(2007-7#1)(2007-9#1)(2008-10#1)(2011-2#1)
long trace profiler##2##3##(2008-3#2)
long treatment##3##2##(2008-12#1)(2010-11#1)(2011-1#1)
long tubular##3##2##(2007-12#1)(2008-11#1)(2010-5#1)
long wave##2##2##(2008-7#2)
long wavelength##7##2##(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-7#1)
long were##2##2##(1994-9#1)(2008-10#1)
long with a diameter of##2##5##(2007-12#1)(2008-7#1)
long with a##3##3##(1993-3#1)(2007-12#1)(2008-7#1)
long work hours##2##3##(2008-6#1)(2013-1#1)
long working##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
long##1255##1##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#8)(1991-2#7)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#11)(1992-2#1)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#2)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#10)(1993-3#7)(1993-6#3)(1993-8#11)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#10)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#6)(1995-12#8)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#11)(1995-8#2)(1996-1#8)(1996-10#4)(1996-11#2)(1996-12#7)(1996-2#8)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#7)(1997-4#6)(1997-5#3)(1997-6#2)(1997-7#8)(1997-8#5)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#5)(2007-11#52)(2007-12#53)(2007-2#6)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#5)(2007-9#2)(2008-1#16)(2008-10#150)(2008-11#54)(2008-12#16)(2008-2#22)(2008-3#53)(2008-4#20)(2008-5#38)(2008-6#10)(2008-7#50)(2008-8#42)(2008-9#34)(2009-1#1)(2009-10#5)(2009-11#8)(2009-12#8)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#5)(2010-3#7)(2010-4#3)(2010-5#4)(2010-6#6)(2010-7#11)(2010-8#10)(2010-9#1)(2011-1#8)(2011-2#71)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#19)(2012-2#24)(2012-3#14)(2012-7#1)(2013-1#40)(2013-7#6)(2013-8#20)
long)##8##1##(1990-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2009-6#1)(2013-1#1)
long- and short-term##4##3##(2007-8#1)(2008-10#2)(2010-5#1)
long- and##6##2##(1996-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-5#1)
long-##7##1##(1996-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-5#1)
long-QT##2##1##(2009-8#2)
long-acting injections##2##2##(2009-9#2)
long-acting##18##1##(1996-11#1)(1997-1#2)(1997-4#1)(2008-11#1)(2008-3#1)(2009-6#1)(2009-9#7)(2010-5#1)(2013-1#1)(2013-8#2)
long-awaited##2##1##(1995-2#1)(1996-3#1)
long-baseline##3##1##(2007-11#1)(2008-3#2)
long-chain acyl-CoA esters##3##3##(1994-8#3)
long-chain acyl-CoA##9##2##(1990-5#1)(1994-8#8)
long-chain fatty acids and##2##4##(2008-5#1)(2013-1#1)
long-chain fatty acids##7##3##(1990-5#1)(1996-5#1)(2008-4#1)(2008-5#3)(2013-1#1)
long-chain##31##1##(1990-5#2)(1991-5#2)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#10)(1995-2#1)(1996-5#1)(2008-10#5)(2008-4#1)(2008-5#4)(2010-3#1)(2013-1#1)
long-chained marine##2##2##(2013-1#2)
long-chained##3##1##(2008-10#1)(2013-1#2)
long-day flowering##2##2##(2009-8#2)
long-day##3##1##(2009-8#3)
long-distance dispersal##6##2##(2008-10#4)(2008-9#1)(2011-2#1)
long-distance fiber-optic##2##2##(2007-11#1)(2007-12#1)
long-distance movement of##3##3##(2008-10#3)
long-distance movement##6##2##(2008-10#6)
long-distance transport of G##2##4##(2008-10#2)
long-distance transport of##3##3##(2008-10#3)
long-distance transport##4##2##(2008-10#3)(2012-8#1)
long-distance##31##1##(1993-2#1)(1995-11#1)(2007-11#1)(2007-12#3)(2008-10#16)(2008-3#2)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-8#1)
long-duration or##2##2##(2010-1#2)
long-duration space##2##2##(2008-3#1)(2011-1#1)
long-duration##8##1##(1991-2#2)(2008-1#1)(2008-3#1)(2010-1#2)(2011-1#1)(2011-2#1)
long-exposure##2##1##(2008-2#1)(2008-3#1)
long-haul##4##1##(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)
long-lasting and##3##2##(1997-6#1)(2007-11#1)(2011-2#1)
long-lasting changes##3##2##(1991-5#1)(2008-4#1)(2008-6#1)
long-lasting effects of##2##3##(1995-12#1)(2012-2#1)
long-lasting effects##4##2##(1991-12#1)(1993-12#1)(1995-12#1)(2012-2#1)
long-lasting in vitro hematopoiesis##4##4##(2009-12#4)
long-lasting phosphorescence##4##2##(2008-3#4)
long-lasting protection##2##2##(1997-4#1)(2008-10#1)
long-lasting##48##1##(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-3#2)(1992-8#3)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#5)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-12#4)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
long-latency##2##1##(2009-5#2)
long-lived elderly person##2##3##(2012-3#2)
long-lived elderly##3##2##(2012-3#3)
long-lived##27##1##(1991-12#2)(1991-5#2)(1991-8#1)(1992-12#1)(1994-5#1)(1995-12#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#3)(2012-5#1)
long-living##3##1##(2009-5#2)(2012-1#1)
long-pass filter##2##2##(2008-5#2)
long-pass##3##1##(2008-3#1)(2008-5#2)
long-path##3##1##(2008-2#1)(2008-3#2)
long-period fiber grating##8##3##(2007-11#2)(2007-12#1)(2008-3#5)
long-period fiber gratings by##2##4##(2007-12#2)
long-period fiber gratings##14##3##(2007-11#4)(2007-12#7)(2008-3#3)
long-period fiber##22##2##(2007-11#6)(2007-12#8)(2008-3#8)
long-period grating and##2##3##(2007-11#1)(2008-3#1)
long-period grating##8##2##(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#2)
long-period gratings in##3##3##(2007-11#3)
long-period gratings written in##3##4##(2007-11#3)
long-period gratings##11##2##(2007-11#9)(2007-12#1)(2008-3#1)
long-period##46##1##(1996-4#1)(1997-5#1)(2007-11#21)(2007-12#10)(2008-10#1)(2008-3#12)
long-pulse##2##1##(2008-2#1)(2008-3#1)
long-range correlations##2##2##(1996-4#1)(2007-12#1)
long-range electrostatic##2##2##(1990-8#1)(2008-10#1)
long-range interactions##2##2##(2012-2#2)
long-range order##2##2##(1990-4#1)(2008-7#1)
long-range restriction##2##2##(2008-4#2)
long-range##36##1##(1990-4#1)(1990-8#1)(1991-11#1)(1993-1#1)(1993-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-7#2)(2008-9#1)(2011-1#1)(2012-2#3)
long-range-ordered##2##1##(2009-11#2)
long-slit##2##1##(2008-3#2)
long-standing Parkinson's disease##2##3##(2008-7#2)
long-standing enigma##2##2##(2012-2#1)(2013-8#1)
long-standing##33##1##(1990-12#1)(1992-9#1)(1993-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
long-stay patients##2##2##(2008-7#2)
long-stay##4##1##(1993-12#1)(2008-7#2)(2011-2#1)
long-tailed tits Aegithalos caudatus##2##4##(2008-8#2)
long-tailed##3##1##(1996-6#1)(2008-8#2)
long-term (3##2##2##(2008-4#1)(2008-5#1)
long-term abstinent alcoholics##3##3##(1996-7#3)
long-term abstinent##4##2##(1996-7#4)
long-term adherence##2##2##(2008-10#1)(2011-1#1)
long-term administration of desipramine##2##4##(1995-12#2)
long-term administration of propranolol in##2##5##(2009-8#2)
long-term administration of##8##3##(1991-12#1)(1995-12#2)(1995-3#1)(1997-3#1)(2008-10#1)(2009-8#2)
long-term adverse##2##2##(2008-10#1)(2008-3#1)
long-term and residential care##2##4##(1997-1#2)
long-term and##4##2##(1993-3#1)(1997-1#2)(2011-2#1)
long-term antibiotic prophylaxis##3##3##(2009-5#3)
long-term benefits in##2##3##(2008-7#2)
long-term benefits of##3##3##(1993-1#1)(2008-12#1)(2012-2#1)
long-term benefits##9##2##(1993-1#1)(2008-12#3)(2008-7#2)(2010-12#1)(2012-2#2)
long-term care (LTC) programs##2##4##(1994-2#1)(1995-2#1)
long-term care (LTC)##9##3##(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1997-3#1)(2008-7#1)(2010-10#1)
long-term care administration##2##3##(1992-3#1)(1993-3#1)
long-term care administrators##3##3##(1992-12#1)(1992-3#1)(2009-4#1)
long-term care and##4##3##(1994-12#1)(1995-3#1)(2008-12#1)(2013-1#1)
long-term care facilities in##2##4##(1994-12#1)(1997-1#1)
long-term care facilities##14##3##(1991-1#1)(1991-3#1)(1993-3#2)(1994-12#1)(1995-3#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(2013-8#2)
long-term care facility##2##3##(1997-3#1)(2009-3#1)
long-term care for the##3##4##(1991-2#1)(1993-3#1)(2008-1#1)
long-term care for##4##3##(1991-2#1)(1993-3#1)(1996-2#1)(2008-1#1)
long-term care institutions##2##3##(1992-3#1)(1995-3#1)
long-term care insurance##2##3##(1993-3#1)(1996-1#1)
long-term care patients##3##3##(1995-3#2)(2008-7#1)
long-term care policy##3##3##(1997-2#1)(2009-3#1)(2011-2#1)
long-term care research##2##3##(2009-4#2)
long-term care residents##2##3##(2010-10#1)(2012-12#1)
long-term care services##3##3##(1991-3#1)(1995-3#1)(2011-2#1)
long-term care settings##4##3##(1997-1#2)(2009-4#2)
long-term care were##2##3##(1991-3#1)(1992-3#1)
long-term care##121##2##(1991-1#2)(1991-2#1)(1991-3#4)(1992-1#2)(1992-12#1)(1992-3#7)(1993-12#3)(1993-2#3)(1993-3#7)(1994-12#4)(1994-2#4)(1994-3#6)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#12)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#2)(1997-1#11)(1997-2#5)(1997-3#5)(2008-1#3)(2008-12#1)(2008-2#1)(2008-7#4)(2009-3#4)(2009-4#5)(2010-10#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
long-term changes in##2##3##(1994-8#1)(2008-8#1)
long-term chronic##2##2##(2011-2#1)(2013-7#1)
long-term clinical##8##2##(2007-8#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-3#2)(2013-1#1)(2013-8#1)
long-term complication##2##2##(2008-9#1)(2012-12#1)
long-term complications of##3##3##(2008-1#1)(2008-7#1)(2008-8#1)
long-term complications##5##2##(1993-9#1)(2008-1#2)(2008-7#1)(2008-8#1)
long-term consequences of##2##3##(2010-10#1)(2011-2#1)
long-term continuous##2##2##(1995-11#1)(2013-8#1)
long-term cultivation##5##2##(2008-11#3)(2008-5#1)(2008-7#1)
long-term cultured astrocytes##3##3##(1995-5#3)
long-term cultured##4##2##(1995-5#4)
long-term cultures##7##2##(2008-11#6)(2013-7#1)
long-term data##2##2##(1993-11#1)(2011-2#1)
long-term depression (LTD)##3##3##(1995-2#1)(2009-8#1)(2012-2#1)
long-term depression and##2##3##(1993-12#1)(1995-2#1)
long-term depression at##2##3##(1997-7#2)
long-term depression in##2##3##(2009-8#1)(2012-2#1)
long-term depression of##2##3##(1991-12#2)
long-term depression##13##2##(1991-12#2)(1993-12#1)(1995-2#2)(1997-7#3)(2009-8#3)(2012-2#2)
long-term dialysis patients##2##3##(1994-5#1)(2008-1#1)
long-term dialysis##4##2##(1994-5#1)(2006-10#1)(2007-12#1)(2008-1#1)
long-term disability##5##2##(1997-8#1)(2008-12#1)(2010-12#1)(2013-1#2)
long-term disease##2##2##(2008-10#1)(2008-6#1)
long-term durability and##2##3##(2010-3#1)(2010-8#1)
long-term durability##3##2##(2008-11#1)(2010-3#1)(2010-8#1)
long-term effect of##5##3##(1990-6#1)(1991-8#1)(2008-7#1)(2009-6#1)(2011-2#1)
long-term effect##7##2##(1990-6#1)(1991-8#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-1#1)
long-term effectiveness##4##2##(1993-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
long-term effects of##18##3##(1990-12#1)(1992-10#1)(1995-11#1)(1996-12#1)(1996-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#2)(2009-7#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
long-term effects on##2##3##(1993-11#1)(1993-3#1)
long-term effects##25##2##(1990-12#1)(1992-10#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-1#2)(2009-7#2)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
long-term efficacy##4##2##(1995-11#1)(2009-8#1)(2012-3#1)(2013-1#1)
long-term emotional##2##2##(2010-2#1)(2012-1#1)
long-term establishment of##2##3##(2008-11#2)
long-term evaluation of##2##3##(2008-9#1)(2009-2#1)
long-term experience##2##2##(2008-8#1)(2008-9#1)
long-term exposure to##5##3##(1993-6#1)(1994-5#1)(2008-5#1)(2011-2#1)(2012-3#1)
long-term follow up##4##3##(2008-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
long-term follow-up and##2##3##(1996-8#1)(2011-2#1)
long-term follow-up is##2##3##(2009-5#1)(2012-3#1)
long-term follow-up of##6##3##(2006-10#1)(2008-4#1)(2009-5#1)(2011-1#2)(2011-2#1)
long-term follow-up studies##2##3##(1992-9#1)(2009-8#1)
long-term follow-up##43##2##(1991-12#2)(1991-2#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-5#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#2)(2009-5#2)(2009-8#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-3#2)(2013-1#2)
long-term function##2##2##(2008-9#1)(2013-1#1)
long-term functional results##2##3##(1990-6#1)(2008-9#1)
long-term functional##3##2##(1990-6#1)(2008-9#1)(2012-3#1)
long-term geriatric care##2##3##(1993-3#2)
long-term glycemic##3##2##(2008-3#1)(2012-5#2)
long-term goal of##2##3##(2012-12#1)(2012-2#1)
long-term goal##3##2##(2008-6#1)(2012-12#1)(2012-2#1)
long-term growth##2##2##(2008-4#1)(2012-3#1)
long-term health care administrators##2##4##(1992-2#2)
long-term health care##5##3##(1992-2#2)(1996-1#1)(1996-2#1)(2013-1#1)
long-term health##7##2##(1992-2#2)(1996-1#1)(1996-2#1)(2008-7#1)(2013-1#2)
long-term hemodialysis##4##2##(1994-6#1)(2008-10#1)(2011-2#2)
long-term home health care##4##4##(1993-12#1)(1995-12#1)(1996-12#1)(1997-3#1)
long-term hospital##2##2##(2008-11#2)
long-term impact of##3##3##(1997-3#1)(2006-10#1)(2008-6#1)
long-term impairment##2##2##(2012-1#1)(2013-1#1)
long-term incubation##2##2##(1995-11#1)(2008-10#1)
long-term influence of##2##3##(2008-7#1)(2010-7#1)
long-term influences##2##2##(2010-7#2)
long-term knowledge##2##2##(2008-11#1)(2008-2#1)
long-term maintenance of##7##3##(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#1)
long-term management of##5##3##(1990-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
long-term management##11##2##(1990-6#1)(1996-7#2)(2007-5#1)(2008-10#3)(2008-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
long-term memory formation##3##3##(2009-6#1)(2009-8#1)(2013-1#1)
long-term memory##16##2##(1992-11#6)(2007-8#2)(2008-11#1)(2009-6#2)(2009-8#1)(2010-1#1)(2013-1#1)(2013-8#2)
long-term monitoring of##4##3##(1997-3#1)(2008-9#1)(2009-4#2)
long-term monitoring##8##2##(1997-3#1)(2008-11#1)(2008-3#2)(2008-9#2)(2009-4#2)
long-term morbidity and##2##3##(2008-2#1)(2008-7#1)
long-term morbidity##4##2##(2007-10#1)(2008-2#1)(2008-7#1)(2013-7#1)
long-term mortality##2##2##(2007-10#1)(2011-2#1)
long-term needs##2##2##(1993-12#2)
long-term neonatal##2##2##(2010-5#1)(2012-3#1)
long-term neurological##2##2##(2008-11#1)(2010-10#1)
long-term neurotoxicity of##2##3##(2008-6#2)
long-term operation of a##2##4##(2008-7#1)(2013-1#1)
long-term operation##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
long-term or##2##2##(1993-3#1)(2012-12#1)
long-term oral##2##2##(1990-6#1)(2009-5#1)
long-term outcome and##2##3##(2007-8#1)(2008-11#1)
long-term outcome##14##2##(1992-12#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-3#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
long-term outcomes after##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
long-term outcomes##21##2##(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#5)(2010-12#1)(2011-1#2)(2011-2#3)(2013-1#3)
long-term ozone##2##2##(1991-9#1)(2008-3#1)
long-term patency##5##2##(1997-3#1)(2007-8#3)(2009-11#1)
long-term peritoneal dialysis##3##3##(2007-12#1)(2011-2#2)
long-term peritoneal##4##2##(2007-12#1)(2011-2#3)
long-term persistence of##2##3##(2008-5#1)(2008-8#1)
long-term physical##2##2##(2009-6#1)(2013-8#1)
long-term postoperative##3##2##(1991-3#1)(2008-10#1)(2013-8#1)
long-term potentiation (LTP) and##3##4##(1993-12#1)(1995-2#1)(2009-8#1)
long-term potentiation (LTP) in the##3##5##(1990-5#1)(1992-12#1)(2008-7#1)
long-term potentiation (LTP) in##5##4##(1990-5#1)(1992-12#1)(1996-5#1)(2008-7#1)(2008-9#1)
long-term potentiation (LTP)##16##3##(1990-5#1)(1992-12#1)(1993-12#1)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#2)(2012-3#1)
long-term potentiation and##3##3##(1995-12#1)(2008-7#1)(2009-8#1)
long-term potentiation in area CA1##2##5##(1996-5#1)(2008-9#1)
long-term potentiation in the##5##4##(1990-5#1)(1995-12#3)(2008-7#1)
long-term potentiation in##9##3##(1990-5#1)(1993-12#1)(1995-12#3)(1996-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
long-term potentiation of the population spike##2##6##(1991-12#2)
long-term potentiation of##5##3##(1991-12#3)(1995-2#1)(2012-2#1)
long-term potentiation##47##2##(1990-5#3)(1991-12#6)(1992-12#2)(1993-12#3)(1995-12#10)(1995-2#2)(1996-2#1)(1996-5#3)(1997-2#1)(2008-11#1)(2008-7#6)(2008-9#2)(2009-8#4)(2012-2#1)(2012-3#1)(2013-8#1)
long-term preservation and##2##3##(2007-8#1)(2008-10#1)
long-term preservation##3##2##(2007-8#1)(2008-10#2)
long-term prognosis of the##2##4##(2007-8#1)(2011-3#1)
long-term prognosis of##4##3##(2007-8#1)(2008-3#1)(2011-3#1)(2011-7#1)
long-term prognosis##11##2##(1991-6#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2011-3#1)(2011-7#1)(2013-8#1)
long-term recurrence##2##2##(2011-2#1)(2013-8#1)
long-term regulation of##2##3##(2008-8#1)(2012-2#1)
long-term reliability of##2##3##(2007-12#1)(2008-6#1)
long-term reliability##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
long-term remission##4##2##(2007-7#2)(2010-12#1)(2010-5#1)
long-term remissions##2##2##(2006-10#1)(2010-5#1)
long-term renal##2##2##(2008-4#1)(2012-2#1)
long-term response of##2##3##(2008-10#1)(2008-8#1)
long-term response##3##2##(1990-2#1)(2008-10#1)(2008-8#1)
long-term results are comparable##2##4##(1991-3#1)(2007-8#1)
long-term results in patients with##2##5##(2008-10#1)(2010-10#1)
long-term results in##4##3##(1990-6#1)(1994-2#1)(2008-10#1)(2010-10#1)
long-term results of##6##3##(1991-6#1)(2007-8#1)(2007-9#1)(2009-8#1)(2012-3#2)
long-term results with the##2##4##(2008-10#1)(2011-2#1)
long-term results with##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
long-term results##26##2##(1990-6#1)(1991-3#1)(1991-6#2)(1992-9#1)(1993-11#1)(1994-2#1)(1995-8#1)(1995-9#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
long-term retrieval##2##2##(1995-12#2)
long-term risk of##4##3##(2007-7#1)(2008-3#1)(2009-8#1)(2011-2#1)
long-term risk##7##2##(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
long-term safety and##2##3##(2012-12#1)(2012-3#1)
long-term safety of##2##3##(2008-4#1)(2011-1#1)
long-term safety##8##2##(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#4)(2012-3#1)
long-term sequelae##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
long-term services##2##2##(2008-1#2)
long-term sexual##2##2##(2009-5#1)(2013-1#1)
long-term side##2##2##(2006-10#1)(2009-10#1)
long-term stability and reproducibility with##3##5##(2008-10#3)
long-term stability and##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
long-term stability of the##3##4##(2008-10#2)(2010-1#1)
long-term stability of##11##3##(2008-10#5)(2008-11#3)(2008-4#1)(2010-1#1)(2010-3#1)
long-term stability were##2##3##(2008-10#2)
long-term stability##35##2##(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-3#1)
long-term stable##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
long-term storage of the##2##4##(2008-10#2)
long-term storage of##3##3##(2008-10#2)(2008-9#1)
long-term storage##7##2##(1992-6#1)(2007-5#1)(2008-10#3)(2008-9#2)
long-term strategy##2##2##(1993-1#1)(2008-6#1)
long-term studies are needed##2##4##(1991-12#1)(2008-3#1)
long-term studies of##3##3##(2008-4#1)(2011-1#1)(2013-1#1)
long-term studies##8##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
long-term study of##3##3##(1991-2#1)(1992-9#1)(2008-5#1)
long-term study##5##2##(1991-2#1)(1992-9#1)(2008-1#2)(2008-5#1)
long-term success##2##2##(1991-3#1)(1995-12#1)
long-term surgical##2##2##(2007-8#1)(2010-3#1)
long-term survival is##2##3##(2011-3#2)
long-term survival of##4##3##(1997-3#1)(2008-10#1)(2008-9#1)(2010-11#1)
long-term survival rates##3##3##(2007-7#1)(2011-2#1)(2012-1#1)
long-term survival##23##2##(1990-8#1)(1991-12#2)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-3#1)(2013-1#1)
long-term survivors of##4##3##(1991-6#1)(1996-1#1)(2008-7#1)(2010-3#1)
long-term survivors##8##2##(1990-9#1)(1991-6#1)(1996-1#1)(1997-3#1)(2008-7#1)(2010-11#1)(2010-3#2)
long-term synaptic plasticity##2##3##(2008-7#1)(2011-2#1)
long-term synaptic##3##2##(1995-5#1)(2008-7#1)(2011-2#1)
long-term temporal##2##2##(2008-11#1)(2008-2#1)
long-term therapy##6##2##(2007-8#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#2)
long-term treatment of##8##3##(1994-2#1)(1995-12#1)(1997-4#1)(2007-7#1)(2007-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
long-term treatment rates##2##3##(2008-3#2)
long-term treatment with##9##3##(1990-2#1)(1991-12#1)(1992-11#1)(1994-6#1)(1995-8#1)(1996-3#1)(2008-1#2)(2010-5#1)
long-term treatment##30##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-11#2)(1993-10#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
long-term usage##2##2##(2008-10#1)(2009-5#1)
long-term use of these drugs##2##5##(2008-10#1)(2008-11#1)
long-term use of##9##3##(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
long-term use##16##2##(1993-2#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
long-term weight loss##2##3##(2013-1#2)
long-term##1145##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#15)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#6)(1992-10#3)(1992-11#8)(1992-12#5)(1992-2#3)(1992-3#9)(1992-6#1)(1992-9#5)(1993-1#5)(1993-10#1)(1993-11#4)(1993-12#16)(1993-2#9)(1993-3#13)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#3)(1994-12#7)(1994-2#11)(1994-3#10)(1994-5#4)(1994-6#6)(1994-8#3)(1995-1#1)(1995-11#6)(1995-12#22)(1995-2#10)(1995-3#13)(1995-5#7)(1995-8#3)(1995-9#1)(1996-1#6)(1996-12#5)(1996-2#10)(1996-3#7)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#7)(1996-8#1)(1996-9#1)(1997-1#14)(1997-2#10)(1997-3#16)(1997-4#2)(1997-5#1)(1997-7#4)(1997-8#1)(2006-10#6)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#4)(2007-7#15)(2007-8#24)(2007-9#1)(2008-1#25)(2008-10#81)(2008-11#70)(2008-12#11)(2008-2#11)(2008-3#20)(2008-4#17)(2008-5#17)(2008-6#17)(2008-7#47)(2008-8#20)(2008-9#25)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#7)(2009-4#7)(2009-5#13)(2009-6#5)(2009-7#4)(2009-8#20)(2009-9#3)(2010-1#3)(2010-10#5)(2010-11#9)(2010-12#6)(2010-2#3)(2010-3#12)(2010-4#2)(2010-5#10)(2010-6#3)(2010-7#6)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#56)(2011-3#5)(2011-7#1)(2012-1#7)(2012-12#19)(2012-2#23)(2012-3#27)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#45)(2013-7#4)(2013-8#23)
long-term-care services##2##2##(2008-5#2)
long-term-care##6##1##(1992-8#1)(1996-12#1)(1997-2#1)(2008-5#2)(2010-10#1)
long-time effects##2##2##(2007-12#1)(2011-2#1)
long-time##11##1##(1993-12#1)(1994-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
long-wave infrared##2##2##(2008-3#2)
long-wave##5##1##(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
long-wavelength cutoff##2##2##(2008-2#1)(2008-3#1)
long-wavelength infrared imaging spectroradiometer##2##4##(2008-3#2)
long-wavelength infrared##3##2##(2008-3#3)
long-wavelength limit##2##2##(2007-11#2)
long-wavelength##15##1##(1993-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#7)(2011-7#1)
longer FLT than the##2##4##(2009-12#2)
longer and more##2##3##(1991-1#1)(2008-10#1)
longer and##13##2##(1990-10#1)(1991-1#1)(1991-2#1)(1994-12#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
longer at##4##2##(1992-3#1)(2008-10#1)(2008-12#1)(2009-12#1)
longer cDNA##2##2##(1996-2#2)
longer development##2##2##(2008-9#1)(2010-2#1)
longer distances##2##2##(2007-11#1)(2008-7#1)
longer duration and##2##3##(1996-5#1)(2008-11#1)
longer duration in##3##3##(2008-5#1)(2009-11#1)(2012-3#1)
longer duration of action##2##4##(1991-5#1)(2008-11#1)
longer duration of diabetes##2##4##(2008-8#1)(2012-5#1)
longer duration of##8##3##(1991-12#1)(1991-5#1)(2008-11#1)(2008-5#2)(2008-8#1)(2012-2#1)(2012-5#1)
longer duration##18##2##(1991-12#1)(1991-5#1)(1996-5#1)(2008-11#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
longer exposition##2##2##(2011-2#1)(2013-1#1)
longer exposure of##2##3##(2008-12#1)(2013-1#1)
longer exposure##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
longer focal##2##2##(2008-3#2)
longer follow-up##9##2##(1990-12#1)(1992-6#1)(1993-11#1)(2011-2#3)(2012-12#2)(2013-1#1)
longer for##3##2##(1993-12#1)(1996-2#1)(2008-9#1)
longer have##2##2##(1996-11#1)(2009-10#1)
longer hospital stays##2##3##(2008-7#1)(2012-3#1)
longer hospital##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
longer if##2##2##(1991-12#1)(2007-6#1)
longer in patients##2##3##(2009-4#1)(2013-8#1)
longer in the##8##3##(1996-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
longer in##20##2##(1991-5#1)(1996-1#1)(1996-5#2)(1997-4#1)(1997-9#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2009-4#2)(2011-2#1)(2013-8#2)
longer incubation time##2##3##(1994-12#1)(1996-2#1)
longer incubation##3##2##(1994-12#1)(1996-2#1)(2008-9#1)
longer lasting##4##2##(1992-3#1)(1994-8#1)(1995-12#1)(2013-8#1)
longer latencies##2##2##(1994-3#1)(1996-2#1)
longer latency##2##2##(1993-12#1)(2008-4#1)
longer latent period##3##3##(2008-10#3)
longer life##2##2##(1996-8#1)(2008-5#1)
longer maintenance##2##2##(1990-7#1)(2008-11#1)
longer period of##9##3##(1993-3#1)(1995-6#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
longer period##14##2##(1991-9#1)(1993-3#1)(1994-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
longer periods of time##4##4##(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
longer periods of##7##3##(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
longer periods##14##2##(1990-11#1)(1991-9#1)(1993-11#1)(1996-6#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
longer storage##2##2##(2011-3#1)(2013-1#1)
longer surgery time##2##3##(1996-2#2)
longer survival##5##2##(1991-6#1)(1997-2#1)(1997-5#2)(2007-11#1)
longer term##11##2##(1992-3#1)(1993-12#3)(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2012-3#1)
longer than 10##2##3##(2007-12#1)(2009-2#1)
longer than 13##2##3##(1995-2#1)(2007-6#1)
longer than 300##2##3##(1996-3#1)(2009-4#1)
longer than 4##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
longer than a##2##3##(1997-4#1)(2008-3#1)
longer than in the##2##4##(1997-4#1)(2011-1#1)
longer than in##3##3##(1997-4#1)(2008-10#1)(2011-1#1)
longer than one##2##3##(2008-1#1)(2008-8#1)
longer than other##2##3##(1995-3#1)(2010-4#1)
longer than previously reported##2##4##(1993-11#1)(1994-11#1)
longer than that of##2##4##(1994-12#1)(2008-10#1)
longer than that##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
longer than the other##2##4##(1997-4#1)(2008-10#1)
longer than the##11##3##(1990-7#1)(1996-4#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)(2013-8#1)
longer than their##2##3##(2008-3#1)(2008-7#1)
longer than those##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
longer than two weeks##2##4##(2007-12#1)(2008-5#1)
longer than##72##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#3)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
longer the##6##2##(1992-1#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#2)
longer time than##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
longer time##12##2##(1991-3#1)(1994-12#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-8#1)
longer to##6##2##(1992-11#1)(1994-9#1)(2008-10#1)(2008-2#1)(2012-1#1)(2012-2#1)
longer wavelengths the##2##3##(2008-3#2)
longer wavelengths##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#6)(2008-7#1)
longer when##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
longer with##2##2##(1993-1#1)(1995-12#1)
longer##542##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#5)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#3)(1993-11#4)(1993-12#6)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#10)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#9)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#4)(1997-6#3)(1997-8#1)(1997-9#1)(2006-10#2)(2006-6#1)(2007-10#5)(2007-11#11)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#7)(2008-1#3)(2008-10#62)(2008-11#23)(2008-12#8)(2008-2#6)(2008-3#32)(2008-4#5)(2008-5#24)(2008-6#2)(2008-7#18)(2008-8#12)(2008-9#12)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#21)(2011-3#3)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#10)(2012-5#2)(2012-8#1)(2013-1#11)(2013-8#7)
longer)##2##1##(2008-3#1)(2010-1#1)
longer-term##9##1##(1992-5#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-12#1)(2011-2#1)
longer-than-average calls over##3##3##(2009-9#3)
longer-wavelength##2##1##(2008-3#1)(2010-8#1)
longest and##2##2##(2007-6#1)(2008-8#1)
longest quinoidal oligothiophene##2##3##(2011-2#2)
longest survival##2##2##(1990-8#1)(2007-11#1)
longest##36##1##(1990-8#1)(1991-1#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#2)(1996-10#1)(1996-9#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2010-11#1)(2011-2#6)(2012-3#1)
longevity and##11##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#5)(2012-2#1)
longevity in##6##2##(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
longevity indices in##2##3##(2008-10#2)
longevity of the Holstein population in Japan##2##7##(2012-2#2)
longevity of the##7##3##(1992-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#3)
longevity of##16##2##(1992-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2009-5#1)(2012-2#3)(2013-1#2)
longevity##69##1##(1991-6#1)(1992-10#1)(1992-11#3)(1992-5#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#3)(2009-6#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#4)
longibrachiatum##5##1##(2008-10#5)
longicaudata##3##1##(2007-12#2)(2013-8#1)
longicolla isolates##2##2##(2008-10#2)
longicolla was##2##2##(2008-10#2)
longicolla##19##1##(2008-10#19)
longicomin##6##1##(2008-8#6)
longicornis##5##1##(2008-5#2)(2008-6#1)(2008-8#2)
longifolia Jack##4##2##(2008-11#4)
longipalpis##2##1##(2007-12#2)
longisporum##2##1##(2008-10#2)
longissimus dorsi (LD) muscle and##2##5##(2008-9#1)(2010-4#1)
longissimus dorsi muscle##3##3##(2010-2#1)(2010-4#1)(2013-1#1)
longissimus dorsi##5##2##(2008-9#1)(2010-2#1)(2010-4#2)(2013-1#1)
longissimus lumborum##3##2##(2010-4#1)(2012-1#2)
longissimus##12##1##(2008-9#1)(2010-2#1)(2010-4#7)(2012-1#2)(2013-1#1)
longitude and##2##2##(1995-6#1)(2008-5#1)
longitude##5##1##(1995-6#1)(2008-10#3)(2008-5#1)
longitudinal Zeeman-effect background correction##2##4##(2008-10#2)
longitudinal analysis##2##2##(1995-2#1)(2008-12#1)
longitudinal and##8##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2010-1#1)(2013-1#1)
longitudinal assessment##2##2##(1993-12#1)(2013-1#1)
longitudinal axis##6##2##(1993-5#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
longitudinal case##2##2##(2008-3#1)(2011-1#1)
longitudinal cavity modes##2##3##(2008-2#1)(2008-3#1)
longitudinal cohort study of##2##4##(2013-1#2)
longitudinal cohort study##3##3##(2011-1#1)(2013-1#2)
longitudinal data analysis##2##3##(2009-6#1)(2012-12#1)
longitudinal data on##2##3##(2008-10#1)(2008-8#1)
longitudinal data with##2##3##(1997-8#1)(2011-1#1)
longitudinal data##18##2##(1992-6#1)(1993-2#1)(1995-12#1)(1997-8#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
longitudinal direction##8##2##(2007-12#1)(2008-3#2)(2008-9#1)(2009-7#1)(2011-2#3)
longitudinal directions##3##2##(2008-3#3)
longitudinal examination of##2##3##(2010-7#1)(2011-1#1)
longitudinal expansion##2##2##(2008-10#1)(2009-1#1)
longitudinal glia (LG)##2##3##(2008-7#2)
longitudinal glia##3##2##(2008-7#3)
longitudinal ligament##2##2##(2008-12#2)
longitudinal localization##2##2##(2008-3#2)
longitudinal mode operation##2##3##(2008-3#2)
longitudinal mode##8##2##(2007-12#4)(2008-2#1)(2008-3#3)
longitudinal models##3##2##(2013-1#3)
longitudinal modes of a##2##4##(2007-12#1)(2008-3#1)
longitudinal modes of##3##3##(2007-12#1)(2008-3#2)
longitudinal modes##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
longitudinal outcome study of##2##4##(2008-9#1)(2010-12#1)
longitudinal randomized##2##2##(2008-10#1)(2011-2#1)
longitudinal research##4##2##(1991-6#1)(1994-2#1)(2009-8#1)(2010-7#1)
longitudinal resolution of##2##3##(2007-11#1)(2008-2#1)
longitudinal shift##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
longitudinal studies are needed to##2##5##(2013-1#2)
longitudinal studies are##4##3##(2011-2#1)(2012-2#1)(2013-1#2)
longitudinal studies of the##2##4##(1992-12#1)(2009-8#1)
longitudinal studies##15##2##(1992-12#1)(1992-3#1)(1994-9#1)(1997-7#1)(2009-8#1)(2009-9#4)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
longitudinal study examines##2##3##(2009-7#1)(2013-1#1)
longitudinal study of##13##3##(1990-2#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
longitudinal study on##2##3##(1996-9#1)(2007-2#1)
longitudinal study to##2##3##(2008-3#1)(2012-12#1)
longitudinal study was conducted##2##4##(2008-9#1)(2012-12#1)
longitudinal study was##3##3##(2008-9#1)(2009-7#1)(2012-12#1)
longitudinal study##45##2##(1990-2#1)(1993-11#1)(1996-9#1)(2007-2#2)(2008-11#5)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#5)(2009-8#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
longitudinal vaginal septum##2##3##(2011-1#2)
longitudinal##278##1##(1990-2#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#3)(1995-2#3)(1996-5#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#9)(2007-12#19)(2007-2#3)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#4)(2008-2#9)(2008-3#27)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#8)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#8)(2011-2#11)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#21)(2013-7#4)(2013-8#2)
longitudinal-mode linewidth##3##2##(2007-11#3)
longitudinal-mode##6##1##(2007-11#3)(2008-2#2)(2008-3#1)
longitudinally pumped##3##2##(2007-12#1)(2008-3#2)
longitudinally##16##1##(1992-3#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
longrun##2##1##(1992-12#1)(1993-3#1)
longstanding AS##4##2##(2012-3#4)
longstanding##13##1##(1990-11#1)(1995-1#1)(2008-12#1)(2008-3#1)(2012-2#1)(2012-3#5)(2012-4#2)(2013-1#1)
longterm##9##1##(1990-6#1)(1994-6#1)(1995-12#2)(1997-2#1)(1997-3#1)(2007-7#1)(2008-7#1)(2013-1#1)
longus colli muscle##2##3##(2010-12#2)
longus muscle##2##2##(2008-7#1)(2008-9#1)
longus tendon##9##2##(2008-12#1)(2008-9#5)(2010-3#1)(2010-7#2)
longus##25##1##(1997-8#1)(2007-11#2)(2008-12#1)(2008-7#2)(2008-9#10)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-3#2)(2010-7#2)
lonicerae##2##1##(2013-8#2)
lonidamine##4##1##(1990-6#1)(1991-2#2)(1993-11#1)
look at the##26##3##(1991-3#2)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-6#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-8#1)
look at this##2##3##(1991-1#1)(2008-7#1)
look at##63##2##(1990-4#1)(1991-1#2)(1991-3#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#4)(1997-4#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#2)
look for in a##2##4##(1992-12#1)(2008-12#1)
look for in##3##3##(1992-12#1)(1996-3#1)(2008-12#1)
look for ways##2##3##(1996-3#1)(2008-8#1)
look for##27##2##(1991-11#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#3)(1996-4#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
look into the future##2##4##(1991-12#1)(1995-1#1)
look into the##4##3##(1991-12#1)(1995-1#1)(2008-1#1)(2008-8#1)
look into##7##2##(1991-12#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-8#1)
look like##4##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
look of the skin##2##4##(2008-5#2)
look of##3##2##(2008-5#2)(2011-2#1)
look promising##3##2##(2007-1#1)(2008-1#1)(2012-2#1)
look to the future##2##4##(1991-1#1)(1996-2#1)
look to the##4##3##(1991-1#1)(1996-2#1)(2008-11#1)(2012-2#1)
look to##5##2##(1991-1#1)(1996-2#1)(2008-11#1)(2010-10#1)(2012-2#1)
look towards##2##2##(2009-10#1)(2009-5#1)
look up##4##2##(1992-3#1)(2008-6#1)(2009-7#1)(2011-2#1)
look##153##1##(1990-4#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-1#2)(1993-2#3)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-2#2)(1996-3#4)(1996-4#1)(1997-3#6)(1997-4#1)(1997-6#3)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#9)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#7)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#4)
look-up##2##1##(2008-2#1)(2008-3#1)
looked after##3##2##(2007-7#1)(2008-1#1)(2008-7#1)
looked at the##4##3##(1995-6#1)(2008-7#1)(2008-8#1)(2009-6#1)
looked at##10##2##(1991-3#1)(1995-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#1)
looked for a##2##3##(1995-1#1)(1996-1#1)
looked for##11##2##(1990-3#1)(1990-5#1)(1991-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
looked upon##2##2##(1991-1#1)(1996-2#1)
looked##36##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-8#1)(1995-1#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-6#1)(2010-10#2)(2011-2#2)
looking at the##3##3##(2006-10#1)(2007-1#1)(2008-2#1)
looking at##13##2##(1992-3#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-6#1)(2009-7#1)(2013-1#1)(2013-8#1)
looking back##2##2##(2008-10#1)(2011-2#1)
looking beyond##3##2##(1994-3#1)(2008-7#1)(2012-2#1)
looking for the##2##3##(2007-8#1)(2008-11#1)
looking for ways to##3##4##(1990-4#1)(1996-12#1)(1997-3#1)
looking for##9##2##(1990-4#1)(1993-9#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-11#1)(2010-10#2)(2012-2#1)
looking to##5##2##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
looking toward##2##2##(2008-1#1)(2008-4#1)
looking##47##1##(1990-4#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#2)
looks at a##2##3##(1991-11#1)(2010-5#1)
looks at some of the##2##5##(1994-2#1)(2008-7#1)
looks at some##3##3##(1991-1#1)(1994-2#1)(2008-7#1)
looks at the##9##3##(1992-12#1)(1993-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
looks at##19##2##(1991-1#1)(1991-11#1)(1992-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
looks like##5##2##(1991-2#1)(2008-8#1)(2009-11#2)(2009-9#1)
looks##38##1##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(1997-3#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
lookup tables##3##2##(2008-2#1)(2012-2#2)
lookup##5##1##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#2)
looming##2##1##(1995-3#1)(2008-8#1)
looms##2##1##(1990-3#1)(2008-8#1)
loop (500mul)##2##2##(2008-10#2)
loop 39-52##3##2##(1992-4#3)
loop and the##3##3##(1991-9#1)(2007-12#1)(2013-1#1)
loop and##9##2##(1991-9#1)(1993-3#1)(1995-6#1)(1997-3#1)(2007-12#1)(2009-7#1)(2011-2#1)(2013-1#2)
loop are##3##2##(1995-5#1)(2007-11#1)(2008-3#1)
loop between alpha-helix##2##3##(1995-2#1)(1995-5#1)
loop between helices##2##3##(1995-2#2)
loop between the##2##3##(1992-4#1)(1995-8#1)
loop between##10##2##(1992-4#2)(1993-11#1)(1995-2#3)(1995-5#1)(1995-8#1)(2007-12#1)(2009-11#1)
loop configuration is##2##3##(2007-12#2)
loop configuration##5##2##(2007-12#5)
loop conization##4##2##(1992-2#1)(1994-12#3)
loop connections##4##2##(2008-11#4)
loop containing##2##2##(1996-12#1)(2009-11#1)
loop domain##3##2##(1992-11#1)(2007-11#1)(2008-11#1)
loop excision of the transformation zone##3##6##(1994-2#2)(2011-2#1)
loop excision of the##4##4##(1994-2#2)(2011-2#1)(2012-3#1)
loop fingerprint##2##2##(2011-2#2)
loop for##2##2##(1991-5#1)(2008-6#1)
loop formation##3##2##(1991-8#1)(1992-3#2)
loop has been##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
loop in the##3##3##(1995-2#1)(2009-6#1)(2010-8#1)
loop in##4##2##(1995-2#1)(2008-3#1)(2009-6#1)(2010-8#1)
loop involving the##2##3##(2008-11#1)(2011-1#1)
loop is##8##2##(1991-8#1)(1994-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
loop ligation##3##2##(1995-1#3)
loop ligature (Endoloop)##2##3##(1995-1#2)
loop ligature##3##2##(1995-1#3)
loop mirror with##2##3##(2007-12#1)(2008-2#1)
loop mirror##16##2##(2007-11#6)(2007-12#5)(2008-2#2)(2008-3#3)
loop mirrors##4##2##(2007-12#3)(2008-2#1)
loop of Duck HBV epsilon##2##5##(2009-7#2)
loop of an##2##3##(1993-11#1)(2008-10#1)
loop of the##5##3##(2008-10#2)(2009-7#3)
loop of##32##2##(1990-2#1)(1992-3#1)(1993-11#3)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#2)(2009-7#6)(2012-12#2)(2012-3#1)
loop region of##2##3##(1992-3#1)(1993-8#1)
loop region##4##2##(1991-12#1)(1992-3#1)(1993-8#1)(2008-4#1)
loop sequence##6##2##(1992-3#2)(1994-8#3)(2008-8#1)
loop size##3##2##(1992-3#1)(1993-12#1)(2008-10#1)
loop structure##2##2##(1990-5#1)(1995-2#1)
loop that contains##2##3##(1995-2#1)(2007-11#1)
loop that##6##2##(1995-2#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)
loop to##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
loop was##4##2##(1997-9#1)(2008-10#1)(2008-3#1)(2012-3#1)
loop which##2##2##(1992-3#1)(1992-8#1)
loop with##8##2##(1991-9#1)(2007-11#3)(2008-11#1)(2008-8#1)(2009-9#1)(2010-5#1)
loop##311##1##(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#2)(1991-5#3)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#14)(1992-4#5)(1992-8#1)(1993-11#6)(1993-12#2)(1993-3#2)(1993-8#3)(1994-11#2)(1994-12#4)(1994-2#3)(1994-8#8)(1995-1#7)(1995-2#12)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-9#1)(2007-11#22)(2007-12#20)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#17)(2008-12#2)(2008-2#8)(2008-3#22)(2008-4#3)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#1)(2009-11#2)(2009-5#1)(2009-6#2)(2009-7#8)(2009-8#4)(2009-9#1)(2010-11#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#8)(2013-8#1)
loop)##7##1##(1993-3#3)(1995-2#1)(2008-10#3)
loop-closing base pair##2##3##(1992-3#2)
looped suture employing a knot-free running##2##6##(1992-2#2)
looped suture##3##2##(1992-2#3)
looped##4##1##(1992-2#3)(2007-12#1)
looping##5##1##(2011-2#3)(2012-2#1)(2013-8#1)
loops and##6##2##(1991-6#1)(1994-9#1)(1995-3#1)(2008-4#1)(2009-7#1)(2012-2#1)
loops had##2##2##(2008-7#1)(2011-3#1)
loops in##4##2##(1995-3#1)(2008-3#1)(2008-7#1)(2012-2#1)
loops is##2##2##(2008-3#1)(2010-10#1)
loops of the##5##3##(1991-12#3)(1992-12#1)(1995-3#1)
loops of##9##2##(1991-12#3)(1992-12#1)(1992-3#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-12#1)
loops that##2##2##(1991-8#2)
loops with##5##2##(1991-8#1)(1992-3#1)(1993-12#1)(2007-11#1)(2008-11#1)
loops##71##1##(1991-11#1)(1991-12#3)(1991-6#1)(1991-8#5)(1992-12#2)(1992-3#2)(1993-11#1)(1993-12#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#4)(1995-8#1)(1997-4#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#5)
loose abrasives for##3##3##(2008-3#3)
loose bodies##4##2##(1992-4#2)(2008-8#1)(2013-1#1)
loose body formation##2##3##(2008-8#1)(2013-1#1)
loose body##5##2##(2008-8#1)(2013-1#4)
loose islets##4##2##(2008-5#4)
loose ligation##2##2##(1993-12#2)
loose##38##1##(1992-4#2)(1993-12#2)(1993-3#1)(1997-3#1)(2007-11#1)(2007-8#3)(2008-3#3)(2008-5#9)(2008-8#3)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
loosely adherent##2##2##(2008-11#1)(2012-3#1)
loosely associated##3##2##(1993-8#1)(2011-2#1)(2012-3#1)
loosely spaced##2##2##(2008-4#1)(2008-5#1)
loosely##22##1##(1993-11#1)(1993-8#1)(1994-8#1)(1995-1#1)(1996-9#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#2)
loosen the##2##2##(1995-2#1)(2008-2#1)
loosen##3##1##(1995-2#1)(2008-2#1)(2010-1#1)
loosened##2##1##(2007-11#1)(2008-10#1)
loosening and##5##2##(2008-11#2)(2008-8#1)(2009-4#1)(2013-1#1)
loosening of the##3##3##(2007-8#1)(2008-6#1)(2008-8#1)
loosening of##6##2##(2007-11#2)(2007-8#1)(2008-6#1)(2008-8#1)(2012-12#1)
loosening##18##1##(2007-11#2)(2007-8#1)(2008-11#4)(2008-6#1)(2008-8#3)(2009-4#2)(2012-12#1)(2013-1#4)
loosening)##2##1##(2008-11#2)
looser##3##1##(2008-11#1)(2008-8#1)(2008-9#1)
loosing##2##1##(1996-8#1)(2008-6#1)
lophophores are##3##2##(2008-9#3)
lophophores##6##1##(2008-9#6)
lopinavir and ritonavir##3##3##(2011-3#3)
lopinavir##5##1##(2011-3#5)
loratadine 10mg for##2##3##(2008-3#2)
loratadine and##2##2##(2007-11#2)
loratadine##9##1##(2007-11#2)(2008-10#1)(2008-3#4)(2010-9#1)(2013-8#1)
lorazepam in##2##2##(1991-1#1)(2008-10#1)
lorazepam##13##1##(1990-6#1)(1991-1#1)(1991-12#1)(2008-10#9)(2012-2#1)
lordosis##7##1##(2007-11#1)(2008-11#2)(2009-3#1)(2012-1#2)(2012-12#1)
lors de##2##2##(2011-2#2)
lors##3##1##(2008-5#1)(2011-2#2)
losartan in##2##2##(2011-2#1)(2012-3#1)
losartan##12##1##(1995-11#1)(2011-2#10)(2012-3#1)
lose all##2##2##(2008-10#1)(2008-8#1)
lose an##2##2##(1992-6#1)(2008-10#1)
lose the ability to##4##4##(1990-5#1)(2008-1#1)(2008-10#2)
lose the##8##2##(1990-3#1)(1990-5#1)(2008-1#2)(2008-10#3)(2008-9#1)
lose their ability to##3##4##(1991-12#1)(1992-1#1)(2012-2#1)
lose their##11##2##(1990-5#1)(1991-12#1)(1992-1#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2012-2#2)
lose viability##2##2##(2008-10#1)(2008-7#1)
lose##51##1##(1990-3#1)(1990-5#2)(1991-12#1)(1992-1#1)(1992-6#1)(1993-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
loses its##4##2##(1991-9#1)(2008-10#2)(2009-4#1)
loses##11##1##(1990-6#1)(1991-9#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-2#1)
losing one##2##2##(2009-4#2)
losing the##3##2##(1992-5#1)(1994-1#1)(2008-5#1)
losing their job##3##3##(1991-11#1)(1997-2#2)
losing their##4##2##(1991-11#1)(1996-11#1)(1997-2#2)
losing##24##1##(1990-4#1)(1991-11#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2013-1#1)
loss (0##2##2##(2008-2#1)(2008-3#1)
loss after##3##2##(2008-5#1)(2010-8#1)(2013-1#1)
loss and a##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
loss and increased##2##3##(2012-12#1)(2012-3#1)
loss and the##8##3##(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)
loss and##88##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#8)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#8)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#2)(2010-2#1)(2010-4#3)(2011-1#6)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#1)
loss are the key##2##4##(1995-5#1)(2012-2#1)
loss are##5##2##(1995-5#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
loss as well as##2##4##(1995-12#1)(2008-6#1)
loss as##8##2##(1994-3#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
loss associated with##7##3##(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
loss associated##8##2##(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
loss at the##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
loss at##10##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-9#1)(2011-2#1)
loss between##4##2##(1992-8#1)(2008-3#1)(2010-8#1)(2013-1#1)
loss but##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
loss by##9##2##(1990-7#1)(1993-2#1)(1994-11#1)(2007-12#2)(2008-2#1)(2010-11#1)(2010-4#1)(2013-7#1)
loss can be##2##3##(2008-3#2)
loss can##3##2##(1993-12#1)(2008-3#2)
loss caused by##3##3##(2008-10#2)(2008-3#1)
loss control##3##2##(1992-2#2)(1993-3#1)
loss d(-1)##3##2##(2007-5#3)
loss decreased##2##2##(2008-10#1)(2008-6#1)
loss did not##3##3##(2008-2#2)(2011-2#1)
loss distribution##2##2##(2008-3#2)
loss due to autophagy##2##4##(2008-7#2)
loss due to##14##3##(1991-6#1)(1993-2#2)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#2)
loss during the##2##3##(1993-11#1)(2008-2#1)
loss during##12##2##(1991-1#1)(1993-1#1)(1993-11#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-1#1)(2011-2#2)
loss following##2##2##(1991-5#1)(2012-2#1)
loss for the##3##3##(2007-9#1)(2008-2#1)(2010-9#1)
loss for##9##2##(1992-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-9#1)
loss from the##11##3##(1992-10#1)(1992-2#2)(1993-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-10#1)(2012-2#1)(2013-1#1)
loss from##28##2##(1992-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#2)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#3)(2009-10#1)(2009-5#1)(2010-11#3)(2010-4#1)(2012-2#1)(2013-1#1)
loss function##2##2##(1995-2#1)(2013-1#1)
loss has been##4##3##(2007-12#1)(2008-5#2)(2008-8#1)
loss has##5##2##(2007-12#2)(2008-5#2)(2008-8#1)
loss in a##5##3##(1992-8#1)(2008-3#3)(2008-7#1)
loss in diabetic##3##3##(2008-1#1)(2012-12#2)
loss in patients with##2##4##(2008-7#1)(2011-2#1)
loss in patients##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
loss in the##12##3##(1991-6#1)(1994-6#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
loss in##97##2##(1990-3#1)(1991-12#2)(1991-6#1)(1992-8#3)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#3)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#3)(2010-10#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#2)
loss increases##2##2##(2008-3#1)(2008-5#1)
loss induced by##3##3##(1996-12#1)(2011-1#1)(2011-2#1)
loss into##2##2##(1990-2#1)(2010-5#1)
loss is a common##2##4##(2011-2#2)
loss is a##5##3##(2008-7#1)(2011-1#1)(2011-2#3)
loss is caused by##2##4##(2007-12#1)(2008-3#1)
loss is correlated with##2##4##(2007-12#1)(2013-8#1)
loss is discussed##2##3##(2007-12#1)(2008-3#1)
loss is frequently##2##3##(1994-11#1)(2008-5#1)
loss is measured##2##3##(2007-11#1)(2008-2#1)
loss is not##2##3##(2008-8#1)(2011-1#1)
loss is the##2##3##(2008-5#1)(2012-2#1)
loss is##43##2##(1990-10#1)(1991-9#1)(1994-11#2)(1994-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
loss may be##4##3##(1997-3#1)(2007-11#1)(2013-1#2)
loss may##6##2##(1993-11#1)(1997-3#1)(2007-11#1)(2013-1#2)(2013-8#1)
loss measurements##7##2##(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)
loss model##3##2##(2008-12#2)(2010-3#1)
loss occurred in##2##3##(2008-10#1)(2008-3#1)
loss occurred##3##2##(2008-10#2)(2008-3#1)
loss occurs in##2##3##(2008-6#1)(2008-8#1)
loss occurs##3##2##(1995-5#1)(2008-6#1)(2008-8#1)
loss of 0##6##3##(2007-12#2)(2007-9#1)(2008-2#3)
loss of 1##2##3##(2007-12#1)(2008-2#1)
loss of 2##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
loss of 5##2##3##(2008-3#1)(2013-8#1)
loss of ATP##2##3##(2006-10#1)(2009-4#1)
loss of CD intensity at##2##5##(1995-5#2)
loss of DNA##2##3##(1990-5#1)(2008-9#1)
loss of Gpp(NH)p-sensitive high affinity##2##5##(2008-3#2)
loss of Medicaid eligibility##2##4##(1992-2#2)
loss of NOL7##2##3##(2013-1#2)
loss of SERS##2##3##(2007-12#2)
loss of WM integrity in the##2##6##(2010-7#2)
loss of a##16##3##(1990-8#1)(1991-1#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2012-3#1)
loss of activity is##2##4##(1995-5#1)(1995-6#1)
loss of activity##7##3##(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(2008-10#1)(2008-5#1)
loss of all##2##3##(1991-9#1)(1997-3#1)
loss of alleles##2##3##(1994-12#1)(2008-10#1)
loss of an##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
loss of approximately##4##3##(1993-11#1)(2008-2#2)(2010-4#1)
loss of autonomy and##2##4##(1992-1#1)(2008-9#1)
loss of avirulence##2##3##(2008-10#2)
loss of axon-Schwann cell##3##4##(2008-7#3)
loss of balance and##2##4##(1997-8#1)(2010-11#1)
loss of blood##3##3##(1996-9#1)(2009-3#1)(2010-7#1)
loss of body weight##2##4##(1990-9#1)(1992-8#1)
loss of body##6##3##(1990-9#1)(1992-8#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
loss of bone density##2##4##(2012-2#2)
loss of cell viability##3##4##(1997-4#3)
loss of cell##6##3##(1997-4#3)(2008-11#1)(2009-5#1)(2013-1#1)
loss of cells##2##3##(1992-11#1)(2008-9#1)
loss of colony##2##3##(1992-11#1)(2008-11#1)
loss of concentration##3##3##(1991-8#1)(1992-11#1)(2013-8#1)
loss of consciousness and##2##4##(2008-11#1)(2012-12#1)
loss of consciousness##10##3##(1992-6#1)(2008-1#1)(2008-11#4)(2012-12#2)(2012-3#2)
loss of contact##2##3##(1995-2#1)(2013-1#1)
loss of corneocytes##2##3##(2008-5#2)
loss of cortical MAP-2##2##4##(2008-7#2)
loss of cortical##3##3##(2008-7#2)(2012-2#1)
loss of dignity##3##3##(1990-6#1)(1991-8#1)(2012-3#1)
loss of dopaminergic##3##3##(1995-5#1)(2008-7#1)(2013-7#1)
loss of efficacy##2##3##(2008-10#1)(2008-7#1)
loss of endogenous##3##3##(2008-11#1)(2008-5#1)(2010-11#1)
loss of external##3##3##(2007-11#2)(2008-4#1)
loss of fat tissue##2##4##(2011-1#2)
loss of fluorescence##3##3##(1995-5#1)(2008-1#1)(2008-10#1)
loss of function alleles of Uba1##2##6##(2008-9#2)
loss of function and##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
loss of function of the##2##5##(2011-2#1)(2011-3#1)
loss of function of##3##4##(2008-9#1)(2011-2#1)(2011-3#1)
loss of function##18##3##(1990-12#1)(1994-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#4)(2010-11#1)(2011-2#2)(2011-3#1)(2012-2#1)
loss of functional##3##3##(1996-5#1)(2008-8#1)(2012-2#1)
loss of genetic##2##3##(1996-6#1)(2008-8#1)
loss of healthy growing points##2##5##(2008-10#2)
loss of hearing##2##3##(1994-9#2)
loss of heterozygosity (LOH) and##2##5##(2008-4#1)(2012-3#1)
loss of heterozygosity (LOH)##4##4##(2008-4#1)(2011-1#1)(2012-3#2)
loss of heterozygosity in##2##4##(1993-11#1)(1994-12#1)
loss of heterozygosity##8##3##(1993-11#1)(1994-12#1)(1994-6#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#2)
loss of independence##2##3##(2008-7#1)(2009-12#1)
loss of information##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-2#1)
loss of inhibition##2##3##(1995-6#1)(2008-1#1)
loss of integrity of##2##4##(2008-10#1)(2008-4#1)
loss of joint function##2##4##(1996-6#1)(2010-3#1)
loss of less than##2##4##(2008-2#2)
loss of libido##2##3##(2008-1#1)(2012-12#1)
loss of light##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
loss of membrane##2##3##(2008-10#1)(2008-9#1)
loss of mitochondrial##2##3##(2008-10#1)(2008-12#1)
loss of muscle##2##3##(1991-5#1)(2009-3#1)
loss of neurones in##2##4##(1995-12#2)
loss of neurons##3##3##(1997-2#1)(2008-5#2)
loss of normal##2##3##(2008-2#1)(2013-8#1)
loss of nuclear##2##3##(1992-9#1)(2008-1#1)
loss of one p53 allele##2##5##(2009-2#2)
loss of one##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#2)
loss of plasma##2##3##(1995-2#1)(1997-7#1)
loss of productivity##2##3##(2008-11#1)(2010-5#1)
loss of residual hearing##2##4##(2012-2#2)
loss of residual renal function##3##5##(2007-12#1)(2011-2#2)
loss of residual##6##3##(2007-12#1)(2011-2#2)(2012-2#3)
loss of retinal##2##3##(2007-11#1)(2011-2#1)
loss of sensitivity##6##3##(2008-10#5)(2008-3#1)
loss of some##2##3##(1991-12#1)(1995-3#1)
loss of specific##4##3##(1990-5#1)(1994-8#1)(2008-9#1)(2012-2#1)
loss of striatal dopamine##2##4##(1994-5#1)(1995-2#1)
loss of subcutaneous fat##2##4##(1996-3#1)(2011-1#1)
loss of substance##2##3##(2008-7#1)(2012-12#1)
loss of telomere repeats##2##4##(2011-1#2)
loss of telomeric DNA and eventual##2##6##(1990-5#2)
loss of telomeric DNA##3##4##(1990-5#3)
loss of the tyrosyl radical##2##5##(1993-11#2)
loss of the##54##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-12#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#1)(1997-3#2)(1997-4#1)(2007-11#5)(2007-12#4)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-12#1)(2009-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
loss of their##2##3##(1990-11#1)(2008-8#1)
loss of this##3##3##(1990-5#1)(1997-7#1)(2007-7#1)
loss of tissue##3##3##(1992-12#1)(2009-5#1)(2013-1#1)
loss of viability##3##3##(1995-2#1)(2008-7#1)(2012-3#1)
loss of virulence##3##3##(2008-11#2)(2013-1#1)
loss of vision in##2##4##(1994-8#1)(2011-2#1)
loss of vision##7##3##(1994-8#1)(1994-9#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
loss of water##3##3##(1996-2#1)(1996-5#1)(2008-6#1)
loss of weight and##2##4##(1990-9#1)(1993-3#1)
loss of weight##6##3##(1990-9#1)(1991-11#1)(1992-11#1)(1993-3#2)(2008-7#1)
loss of##635##2##(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-11#7)(1992-12#4)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#4)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#7)(1995-6#5)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#4)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#5)(1997-7#5)(1997-8#3)(2006-10#1)(2006-12#1)(2007-11#16)(2007-12#17)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#73)(2008-11#21)(2008-12#6)(2008-2#16)(2008-3#22)(2008-4#9)(2008-5#16)(2008-6#4)(2008-7#24)(2008-8#14)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#4)(2009-8#3)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#4)(2011-1#10)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#20)(2012-3#17)(2013-1#27)(2013-7#3)(2013-8#10)
loss on##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
loss or gain of##2##4##(2007-11#1)(2008-10#1)
loss or##15##2##(1992-5#1)(1994-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-10#1)(2013-1#1)
loss over##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
loss peaks##2##2##(2007-11#1)(2007-12#1)
loss per##6##2##(1996-12#1)(1996-5#1)(2008-10#2)(2008-3#2)
loss prevention##5##2##(1993-3#1)(1994-1#2)(1994-2#1)(2009-5#1)
loss rate of##3##3##(2008-10#1)(2012-3#2)
loss rate##11##2##(2008-10#2)(2008-3#6)(2012-3#3)
loss resulting from##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
loss resulting##4##2##(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)
loss results in##2##3##(2008-5#1)(2009-8#1)
loss results##3##2##(2008-5#1)(2009-8#1)(2013-1#1)
loss secondary to##2##3##(2008-7#1)(2013-8#1)
loss spectra##2##2##(2008-10#1)(2008-3#1)
loss than##2##2##(2009-8#1)(2011-2#1)
loss that is due to##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
loss that##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
loss the##3##2##(1995-6#1)(2011-2#2)
loss through##4##2##(1992-3#1)(2008-11#1)(2008-5#1)(2009-5#1)
loss to follow-up##2##3##(2012-12#2)
loss to##8##2##(1990-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2010-4#1)(2012-12#2)(2012-3#1)
loss varies##2##2##(2008-10#1)(2013-8#1)
loss was detected##2##3##(2008-10#1)(2008-6#1)
loss was measured##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
loss was not##2##3##(2008-10#2)
loss was observed##2##3##(1997-4#1)(2007-11#1)
loss was significantly greater in the##2##6##(2008-4#1)(2011-2#1)
loss was significantly##4##3##(1996-3#1)(2008-4#1)(2011-2#2)
loss was##45##2##(1991-2#1)(1992-2#1)(1992-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-2#7)(2012-12#2)(2013-1#2)
loss were##5##2##(2008-3#1)(2008-5#1)(2011-2#2)(2012-3#1)
loss when##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
loss which##2##2##(1996-3#1)(2008-10#1)
loss while the##2##3##(2008-1#1)(2008-10#1)
loss with the##2##3##(2007-11#1)(2012-2#1)
loss with##6##2##(2006-12#1)(2007-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
loss within the##2##3##(2007-12#1)(2008-5#1)
loss##1620##1##(1990-10#1)(1990-11#9)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#4)(1991-1#3)(1991-11#3)(1991-12#9)(1991-2#2)(1991-5#3)(1991-6#2)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#7)(1992-2#13)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#8)(1992-9#2)(1993-1#2)(1993-11#15)(1993-12#12)(1993-2#4)(1993-3#7)(1993-5#1)(1993-6#6)(1993-8#3)(1993-9#7)(1994-1#3)(1994-11#9)(1994-12#12)(1994-2#4)(1994-3#12)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#11)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#9)(1995-3#3)(1995-5#12)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#8)(1996-3#5)(1996-5#11)(1996-6#5)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#5)(1997-3#9)(1997-4#9)(1997-5#2)(1997-7#5)(1997-8#5)(2006-10#4)(2006-12#5)(2007-10#2)(2007-11#45)(2007-12#58)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#2)(2008-1#20)(2008-10#146)(2008-11#35)(2008-12#34)(2008-2#48)(2008-3#132)(2008-4#25)(2008-5#68)(2008-6#15)(2008-7#55)(2008-8#33)(2008-9#36)(2009-10#5)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#15)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#3)(2010-10#7)(2010-11#11)(2010-12#3)(2010-2#2)(2010-3#8)(2010-4#15)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#45)(2011-2#77)(2011-3#1)(2012-1#1)(2012-12#22)(2012-2#55)(2012-3#36)(2013-1#76)(2013-7#9)(2013-8#28)
loss) and##2##2##(1991-12#1)(2008-9#1)
loss)##9##1##(1991-12#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)
loss-of-function mutations in the##2##4##(2008-8#1)(2012-3#1)
loss-of-function mutations##4##2##(1990-11#1)(2007-11#1)(2008-8#1)(2012-3#1)
loss-of-function##14##1##(1990-11#1)(1993-9#1)(2007-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
losses and in##2##3##(1992-12#1)(2009-10#1)
losses and##17##2##(1992-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-10#2)(2010-4#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
losses are##5##2##(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)
losses at the##2##3##(2008-3#2)
losses at##3##2##(2008-3#3)
losses can be##2##3##(2008-10#1)(2008-2#1)
losses can##3##2##(1991-5#1)(2008-10#1)(2008-2#1)
losses caused by##5##3##(2008-10#2)(2008-2#2)(2011-1#1)
losses depend##2##2##(2007-11#1)(2008-3#1)
losses due to##5##3##(1997-5#1)(2008-10#3)(2008-8#1)
losses during##2##2##(2008-5#1)(2009-6#1)
losses for##7##2##(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
losses from the##3##3##(1993-3#1)(2008-7#2)
losses from##9##2##(1993-3#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-2#1)(2013-1#1)
losses in PPS 7##2##4##(1993-3#2)
losses in Spain##2##3##(2011-2#2)
losses in the##6##3##(1991-3#1)(1991-5#1)(2008-10#1)(2008-2#2)(2011-2#1)
losses in##36##2##(1991-3#1)(1991-5#1)(1993-12#1)(1993-3#2)(1994-2#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#4)(2008-3#4)(2008-7#2)(2009-10#1)(2011-2#4)(2012-3#1)
losses is##3##2##(2007-11#2)(2008-3#1)
losses of the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
losses of##28##2##(1990-6#1)(1991-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#7)(2009-6#1)(2010-3#1)(2012-2#1)
losses remain##2##2##(2008-10#1)(2008-3#1)
losses that are##2##3##(2007-12#1)(2008-3#1)
losses that##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
losses to##7##2##(2008-10#2)(2008-3#1)(2008-8#2)(2009-2#1)(2011-2#1)
losses were observed##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
losses were##7##2##(1993-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
losses worldwide##2##2##(2007-12#1)(2008-10#1)
losses##228##1##(1990-6#1)(1991-3#2)(1991-5#4)(1992-1#1)(1992-12#1)(1993-12#3)(1993-3#3)(1993-8#2)(1993-9#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-11#15)(2007-12#11)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#65)(2008-11#2)(2008-12#4)(2008-2#18)(2008-3#35)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#4)(2009-10#3)(2009-2#1)(2009-5#1)(2009-6#2)(2010-3#1)(2010-4#5)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
losses)##2##1##(2007-11#1)(2008-3#1)
lossless biaxial##2##2##(2008-3#2)
lossless compression##2##2##(2008-3#1)(2008-6#1)
lossless dielectric##3##2##(2007-12#3)
lossless receiver##2##2##(2008-2#2)
lossless##14##1##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#4)(2008-6#1)
lossy##7##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
lost a##6##2##(1990-5#1)(1994-2#1)(2008-3#2)(2009-5#1)(2012-3#1)
lost about##3##2##(1991-5#1)(2009-6#1)(2009-9#1)
lost activity##3##2##(1990-11#1)(1994-8#1)(1995-6#1)
lost after##7##2##(1991-8#1)(1994-8#1)(2008-10#2)(2010-11#1)(2012-3#1)(2013-1#1)
lost an average of##3##4##(2008-3#1)(2008-5#1)(2012-12#1)
lost are##2##2##(1992-6#1)(2010-4#1)
lost as##2##2##(2008-5#1)(2008-7#1)
lost chance of recovery##2##4##(1995-6#2)
lost during##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2009-10#1)
lost from##7##2##(1991-2#2)(1992-3#1)(1994-5#1)(1996-3#1)(2010-3#1)(2013-1#1)
lost in the##4##3##(2008-10#1)(2008-11#2)(2008-2#1)
lost in##17##2##(1991-9#1)(1992-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-7#2)(2008-9#1)(2010-5#1)(2013-1#1)(2013-7#1)
lost its activity##2##3##(1991-11#1)(1994-2#1)
lost its##9##2##(1990-2#1)(1991-11#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
lost motility##2##2##(2008-10#2)
lost on##2##2##(1995-12#1)(2007-12#1)
lost one##2##2##(2008-10#1)(2009-4#1)
lost or##3##2##(1993-10#1)(2008-10#1)(2008-9#1)
lost productivity##2##2##(1997-6#1)(2008-1#1)
lost some##2##2##(2007-12#1)(2010-8#1)
lost teeth##2##2##(2007-12#1)(2012-12#1)
lost the ability to bind##2##5##(1994-12#1)(2010-10#1)
lost the ability to induce##2##5##(2008-10#2)
lost the ability to##7##4##(1994-12#1)(2008-10#2)(2008-8#1)(2008-9#2)(2010-10#1)
lost the capacity to##2##4##(1993-2#1)(1993-5#1)
lost the capacity##3##3##(1993-2#1)(1993-5#1)(2009-6#1)
lost the##14##2##(1993-2#1)(1993-5#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-10#1)(2011-2#1)
lost their job##3##3##(1991-11#1)(2013-1#2)
lost their##13##2##(1991-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(2008-10#2)(2008-7#1)(2009-6#1)(2012-12#1)(2013-1#3)
lost this ability##2##3##(1990-2#1)(2008-9#1)
lost through##2##2##(1997-3#1)(2008-5#1)
lost to follow-up##6##3##(1996-3#1)(2008-11#1)(2008-6#1)(2013-1#3)
lost to the##5##3##(1991-2#1)(1992-12#1)(1993-12#1)(1996-1#1)(2008-5#1)
lost to##17##2##(1991-2#1)(1992-12#1)(1993-12#3)(1995-8#1)(1996-1#1)(1996-3#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2013-1#3)
lost upon##2##2##(1990-5#1)(1992-3#1)
lost vision##3##2##(2008-7#2)(2010-10#1)
lost weight during the study##2##5##(2008-9#2)
lost weight##6##2##(1993-12#1)(1993-2#1)(2008-9#2)(2009-5#1)(2010-8#1)
lost when##4##2##(1992-6#1)(1993-11#1)(2008-2#1)(2008-6#1)
lost##234##1##(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#3)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-3#3)(1997-1#1)(1997-3#2)(1997-6#3)(2006-10#1)(2007-12#5)(2007-8#1)(2008-1#10)(2008-10#22)(2008-11#10)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#12)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#4)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#2)
lost?##2##1##(1991-8#1)(2012-3#1)
lot of##42##2##(1990-2#1)(1990-6#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-4#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#3)(2008-9#3)(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
lot##61##1##(1990-2#1)(1990-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-4#2)(1997-4#1)(1997-6#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#4)(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
lota##2##1##(2008-10#1)(2008-7#1)
lotion and##3##2##(2008-5#3)
lotion was##3##2##(2008-10#2)(2008-5#1)
lotion##31##1##(2008-10#6)(2008-5#23)(2012-3#1)(2013-8#1)
lotion)##2##1##(2008-5#2)
lotions are##2##2##(2008-5#2)
lotions##17##1##(2008-10#3)(2008-5#13)(2010-8#1)
lots from##2##2##(1995-5#1)(2008-10#1)
lots of##5##2##(2006-11#1)(2008-10#1)(2008-11#2)(2010-7#1)
lots##27##1##(1995-5#4)(2006-11#4)(2008-10#14)(2008-11#3)(2010-7#1)(2012-2#1)
lottery##9##1##(2008-8#3)(2013-1#6)
loud##5##1##(1996-5#1)(2007-12#1)(2008-2#1)(2008-8#1)(2013-1#1)
loud-sound##2##1##(2008-8#2)
louder##2##1##(2009-8#1)(2009-9#1)
loudness##7##1##(1995-12#1)(2008-9#5)(2013-8#1)
louse##12##1##(1996-12#8)(2007-12#3)(2008-12#1)
lovastatin##10##1##(1991-6#1)(1992-11#4)(2008-5#2)(2008-7#3)
love##16##1##(1991-12#1)(1993-3#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#1)(2010-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
loved ones##4##2##(2009-5#2)(2011-2#1)(2013-8#1)
loved##6##1##(1993-3#1)(2009-5#2)(2009-7#1)(2011-2#1)(2013-8#1)
low (&lt##6##2##(1996-8#1)(2008-10#1)(2008-3#3)(2010-8#1)
low (0##6##2##(1991-11#1)(1992-11#1)(1996-9#1)(2008-10#1)(2008-7#1)(2012-12#1)
low (2##2##2##(1996-12#1)(2013-8#1)
low (3##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
low (5 degrees C) and high##2##6##(2008-12#2)
low (5##3##2##(2008-12#2)(2011-2#1)
low (alpha-)##3##2##(2008-10#3)
low (i##2##2##(2008-9#1)(2010-11#1)
low (n =##2##3##(1990-5#1)(1995-12#1)
low BMD##2##2##(2008-4#1)(2012-2#1)
low CD4##3##2##(2010-12#1)(2010-8#1)(2013-1#1)
low FRS##2##2##(2013-8#2)
low GC##2##2##(2012-2#2)
low H(2)O(2)##2##2##(2008-10#1)(2010-4#1)
low HDL cholesterol##7##3##(2008-10#1)(2008-3#4)(2008-6#1)(2009-4#1)
low HDL##9##2##(2008-10#1)(2008-3#5)(2008-6#1)(2009-4#1)(2011-1#1)
low HDL-cholesterol##4##2##(2008-5#1)(2009-11#1)(2013-1#1)(2013-8#1)
low HIV prevalence##2##3##(2007-7#1)(2012-3#1)
low HIV##3##2##(2007-7#1)(2009-12#1)(2012-3#1)
low K(m)##2##2##(1996-7#1)(2008-7#1)
low Km##5##2##(1990-11#2)(1993-6#1)(1994-8#1)(1994-9#1)
low LDL-C and##2##3##(2012-6#2)
low LDL-C##5##2##(2012-6#5)
low LET radiation exposure##2##4##(2008-7#2)
low LET radiation##10##3##(2008-7#10)
low LET##11##2##(2008-7#11)
low Lp(a)##2##2##(1996-8#2)
low Mr##4##2##(1990-5#3)(1991-2#1)
low N##2##2##(2007-12#1)(2012-1#1)
low Na+##2##2##(1996-9#2)
low RH##3##2##(2008-10#3)
low Reynolds number##2##3##(2008-10#1)(2013-1#1)
low Reynolds##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
low SES##5##2##(2011-1#5)
low TSPO expression levels##2##4##(2012-2#2)
low TSPO##3##2##(2012-2#3)
low UV detection##3##3##(1991-7#1)(2008-10#2)
low UV##5##2##(1991-7#1)(1994-9#1)(2008-10#2)(2008-5#1)
low absolute##2##2##(1994-11#1)(2012-2#1)
low abundance in##2##3##(2008-4#1)(2013-1#1)
low abundance mRNAs##2##3##(1996-12#2)
low abundance##9##2##(1995-8#1)(1996-12#3)(1997-2#1)(2008-4#2)(2013-1#1)(2013-8#1)
low accuracy##2##2##(2011-1#1)(2013-8#1)
low acid##2##2##(1997-1#1)(2008-10#1)
low activity in##2##3##(1991-12#1)(2008-10#1)
low activity of the##2##4##(1993-12#1)(1997-7#1)
low activity of##4##3##(1993-12#1)(1997-7#1)(1997-8#1)(2013-1#1)
low activity on##2##3##(1994-5#1)(2008-7#1)
low activity##13##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-6#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-7#2)(2013-1#1)
low acute toxicity##2##3##(1996-1#1)(2008-5#1)
low adverse##2##2##(1996-6#1)(2012-2#1)
low aerosol##2##2##(2008-2#1)(2008-3#1)
low affinity and##2##3##(1991-2#1)(1993-1#1)
low affinity binding sites##6##4##(1990-12#1)(1990-5#4)(1993-1#1)
low affinity binding##9##3##(1990-12#1)(1990-5#5)(1991-2#1)(1993-1#1)(2009-12#1)
low affinity for##6##3##(1990-8#1)(1991-1#1)(1991-11#1)(1995-2#1)(1995-6#1)(2008-10#1)
low affinity neurotensin##2##3##(1997-2#2)
low affinity of##2##3##(1991-5#1)(2008-10#1)
low affinity receptors##2##3##(1993-6#2)
low affinity##36##2##(1990-11#1)(1990-12#1)(1990-5#6)(1990-8#2)(1991-1#2)(1991-11#1)(1991-2#3)(1991-5#1)(1993-1#2)(1993-12#1)(1993-6#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-2#2)(2008-10#2)(2008-7#2)(2009-12#1)
low agitation##2##2##(2008-11#1)(2011-2#1)
low alloy steel##2##3##(2008-10#2)
low alloy##3##2##(2008-10#3)
low amino acid identities of##2##5##(2008-10#2)
low amino acid identities##3##4##(2008-10#3)
low among##2##2##(2008-10#1)(2008-11#1)
low amount of##4##3##(2008-10#3)(2008-11#1)
low amounts of##8##3##(1992-3#1)(1993-3#1)(2008-10#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
low amounts##9##2##(1992-3#1)(1993-3#1)(1994-2#1)(2008-10#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
low and high pH##2##4##(1991-9#1)(2009-12#1)
low and high sulfur containing##2##5##(2008-10#2)
low and high##21##3##(1991-9#1)(1992-3#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
low and middle-income countries##3##4##(2008-10#3)
low and moderate##2##3##(1994-11#1)(2008-8#1)
low and the##5##3##(1996-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
low and##65##2##(1991-9#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
low anterior resection##2##3##(1997-8#1)(2008-12#1)
low anterior##3##2##(1990-9#1)(1997-8#1)(2008-12#1)
low anxiety##3##2##(1995-1#1)(2009-7#2)
low as 10##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
low as##121##2##(1990-4#1)(1990-5#1)(1990-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#2)(1997-2#1)(1997-6#1)(2007-11#7)(2007-12#7)(2008-10#57)(2008-11#2)(2008-2#9)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-8#1)
low at the##2##3##(1994-5#1)(2008-10#1)
low at##8##2##(1994-5#1)(1995-9#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
low availability##2##2##(2008-8#1)(2009-1#1)
low average similarity##2##3##(2008-10#2)
low average##8##2##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
low back and pelvis kinematics##3##5##(2008-12#3)
low back and pelvis##5##4##(2008-12#5)
low back and##6##3##(2008-12#5)(2012-3#1)
low back pain (LBP)##5##4##(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
low back pain and##8##4##(2007-11#1)(2007-8#1)(2008-12#1)(2010-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
low back pain for##2##4##(1996-6#1)(2007-11#1)
low back pain in patients with infantile cerebral palsy##2##9##(2009-4#2)
low back pain in##5##4##(2009-4#3)(2010-10#1)(2012-3#1)
low back pain##57##3##(1990-6#1)(1993-6#2)(1994-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-11#3)(2007-8#4)(2008-10#2)(2008-12#7)(2009-11#1)(2009-4#4)(2010-1#5)(2010-10#1)(2010-12#2)(2010-9#3)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#1)
low back##70##2##(1990-6#1)(1993-6#2)(1994-2#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-8#4)(2008-10#2)(2008-12#16)(2009-11#1)(2009-4#4)(2010-1#5)(2010-10#1)(2010-12#2)(2010-9#3)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#2)
low background##3##2##(1994-2#1)(1995-11#1)(2008-7#1)
low basal levels##2##3##(1991-9#1)(2008-1#1)
low basal##4##2##(1991-9#2)(1996-5#1)(2008-1#1)
low beam##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
low because of##2##3##(2007-11#1)(2011-2#1)
low because##3##2##(2007-11#1)(2007-12#1)(2011-2#1)
low binding affinity##2##3##(1993-8#1)(1995-2#1)
low bioavailability##2##2##(2008-10#1)(2012-2#1)
low birth weight and##4##4##(1995-12#1)(2012-2#2)(2013-1#1)
low birth weight babies##3##4##(1991-12#1)(1994-3#1)(1995-12#1)
low birth weight infants##8##4##(1991-6#1)(1993-3#1)(1995-8#2)(2008-10#1)(2008-11#1)(2012-2#2)
low birth weight##35##3##(1991-11#1)(1991-12#3)(1991-6#1)(1992-2#1)(1993-3#2)(1994-3#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-11#1)(2008-10#1)(2008-11#5)(2008-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
low birth weights##2##3##(1994-6#2)
low birth##39##2##(1991-11#1)(1991-12#3)(1991-6#1)(1992-2#1)(1993-3#2)(1994-3#1)(1994-6#2)(1995-12#2)(1995-6#1)(1995-8#2)(1996-11#1)(2008-10#1)(2008-11#5)(2008-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)
low birthweight##6##2##(1992-11#1)(1997-2#1)(2007-2#1)(2010-10#2)(2010-5#1)
low blood levels of##2##4##(1993-1#1)(2013-1#1)
low blood pressure##5##3##(1992-11#1)(2007-12#2)(2007-7#1)(2010-4#1)
low blood##8##2##(1992-11#1)(1993-1#1)(2007-12#2)(2007-7#1)(2010-4#1)(2012-1#1)(2013-1#1)
low body fat##2##3##(2007-12#1)(2008-7#1)
low body mass index##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
low body weight##2##3##(2007-7#1)(2012-1#1)
low body##8##2##(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-1#1)
low bone mineral density##4##4##(2008-8#1)(2011-1#1)(2012-2#2)
low bone##6##2##(2008-8#1)(2011-1#3)(2012-2#2)
low but significant##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
low but statistically significant##4##4##(1996-8#2)(2008-10#1)(2009-3#1)
low but was##2##3##(2007-7#1)(2008-3#1)
low but##15##2##(1996-8#2)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)
low calcium##5##2##(1990-7#1)(1993-11#2)(1994-3#2)
low caloric##2##2##(1991-12#1)(2008-6#1)
low calorie##2##2##(1990-9#1)(2008-4#1)
low capacity##4##2##(1993-1#2)(1993-5#1)(1995-12#1)
low capillary##2##2##(2008-10#2)
low capital##2##2##(1995-3#1)(2013-1#1)
low carbohydrate##4##2##(2008-3#3)(2008-5#1)
low cardiac output##3##3##(2007-8#2)(2013-1#1)
low cell density##2##3##(1993-8#1)(1993-9#1)
low cell##7##2##(1991-8#1)(1993-8#1)(1993-9#1)(1995-6#1)(2008-11#2)(2010-11#1)
low channel##2##2##(2008-10#1)(2008-2#1)
low cholesterol##5##2##(1992-6#3)(2012-2#1)(2013-1#1)
low coefficient of##2##3##(2007-12#1)(2008-2#1)
low coefficients of##2##3##(2007-12#1)(2010-4#1)
low cognitive##2##2##(2008-12#1)(2010-7#1)
low compared to##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
low compared with that of##2##5##(2008-10#1)(2010-4#1)
low compared with that##3##4##(1993-8#1)(2008-10#1)(2010-4#1)
low compared with the##2##4##(2012-3#1)(2013-7#1)
low compared with##10##3##(1993-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
low compared##17##2##(1993-8#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
low complication rate and##2##4##(2008-1#1)(2011-2#1)
low complication rate##9##3##(1993-12#1)(1993-6#1)(1997-6#1)(2007-7#1)(2008-1#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
low complication rates##3##3##(2011-2#2)(2013-1#1)
low complication##12##2##(1993-12#1)(1993-6#1)(1997-6#1)(2007-7#1)(2008-1#1)(2009-5#1)(2010-3#1)(2011-2#3)(2013-1#2)
low complications##3##2##(2007-11#1)(2007-8#1)(2012-3#1)
low computational complexity##2##3##(2008-2#1)(2008-3#1)
low computational##3##2##(2008-2#1)(2008-3#1)(2009-11#1)
low concentration and##4##3##(1996-3#1)(2008-10#1)(2008-6#1)(2009-10#1)
low concentration in##3##3##(2008-10#3)
low concentration levels##5##3##(2008-10#5)
low concentration of the##2##4##(2008-10#1)(2011-1#1)
low concentration of##16##3##(1993-1#1)(1994-6#1)(1996-2#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-8#1)
low concentration##52##2##(1992-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-3#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
low concentrations (&lt##2##3##(1995-3#1)(2008-10#1)
low concentrations (0##5##3##(1990-5#1)(1995-3#1)(2006-6#1)(2008-10#1)(2008-5#1)
low concentrations by##3##3##(2008-10#3)
low concentrations in##8##3##(1990-11#1)(1993-11#1)(2008-10#3)(2008-12#2)(2013-8#1)
low concentrations of acridones##2##4##(1996-4#2)
low concentrations of the##8##4##(1991-5#1)(1992-5#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-11#1)
low concentrations of##47##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-8#2)(1996-12#1)(1996-4#2)(1997-2#1)(1997-4#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2010-11#1)(2011-2#1)
low concentrations with##2##3##(2008-10#1)(2013-1#1)
low concentrations##109##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#3)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-8#3)(1995-3#2)(1996-12#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-4#2)(2006-6#1)(2007-12#2)(2008-10#36)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#2)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
low consumption##3##2##(2008-10#2)(2008-5#1)
low contamination##2##2##(2008-10#2)
low content##2##2##(2008-10#2)
low contents of##2##3##(2008-10#2)
low contents##4##2##(2008-10#4)
low contrast and##2##3##(2008-2#1)(2010-8#1)
low contrast detectability##5##3##(2012-1#5)
low contrast module##2##3##(2012-1#2)
low contrast objects##3##3##(2012-1#3)
low contrast##16##2##(1996-5#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#12)
low copy number##5##3##(1990-5#1)(1991-7#1)(1995-8#1)(2008-10#1)(2008-12#1)
low copy##6##2##(1990-5#1)(1991-7#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
low correlation##4##2##(2008-10#1)(2013-1#1)(2013-7#2)
low cortisol and androgen levels##2##5##(2011-1#2)
low cost analysis##2##3##(2008-10#1)(2010-5#1)
low cost and##6##3##(2008-10#5)(2008-2#1)
low cost medium##2##3##(2008-11#1)(2008-6#1)
low cost of the##2##4##(2008-10#1)(2008-7#1)
low cost of##7##3##(1992-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)
low cost##64##2##(1992-3#1)(1992-5#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-2#3)(2008-3#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#3)(2009-5#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
low costs##3##2##(1991-3#1)(1997-3#1)(2008-10#1)
low cross talk in photonic crystal##2##6##(2007-11#2)
low cross talk##6##3##(2007-11#5)(2008-3#1)
low culture temperature##2##3##(1995-11#1)(2008-11#1)
low cytotoxicity##3##2##(2008-11#2)(2011-2#1)
low degree of differentiation##2##4##(2011-2#2)
low degree of##11##3##(1990-12#1)(1991-6#1)(1994-10#1)(1994-8#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)
low density lipoprotein (LDL) receptor##3##5##(1993-3#1)(1995-8#2)
low density lipoprotein (LDL)##12##4##(1990-11#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-8#3)(2008-10#1)(2010-12#1)
low density lipoprotein (LDL)-cholesterol##2##4##(2008-5#1)(2008-7#1)
low density lipoprotein cholesterol (LDL-C)##2##5##(2008-1#1)(2013-1#1)
low density lipoprotein cholesterol##4##4##(1991-3#1)(1993-12#1)(2008-1#1)(2013-1#1)
low density lipoprotein ligated cholesterol##2##5##(1991-11#2)
low density lipoprotein receptor gene##2##5##(1993-3#1)(2008-8#1)
low density lipoprotein receptor##10##4##(1990-11#1)(1991-2#1)(1993-3#2)(1994-9#1)(1995-2#2)(1995-6#1)(2008-8#1)(2013-1#1)
low density lipoprotein##47##3##(1990-11#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-5#1)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-8#2)(1994-9#2)(1995-2#3)(1995-6#2)(1995-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2013-1#2)
low density lipoprotein-cholesterol##5##3##(1997-8#1)(2010-5#4)
low density lipoproteins (LDL) and##2##5##(1993-8#1)(1994-3#1)
low density lipoproteins (LDL)##6##4##(1991-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(2008-10#1)
low density lipoproteins##21##3##(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#2)(1992-11#1)(1992-12#2)(1992-3#1)(1993-6#1)(1993-8#2)(1994-3#3)(1995-2#1)(1995-5#2)(2008-10#1)
low density##85##2##(1990-11#2)(1990-8#1)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#4)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#1)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-12#2)(1994-3#3)(1994-8#2)(1994-9#2)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#3)(1997-2#1)(1997-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#4)(2012-2#1)(2013-1#3)(2013-8#1)
low depressed##3##2##(2010-4#3)
low detection limit of 0##5##5##(2008-10#4)(2013-1#1)
low detection limit of##9##4##(2008-10#7)(2013-1#2)
low detection limit##25##3##(2008-10#22)(2010-5#1)(2013-1#2)
low detection limits##13##3##(2008-10#12)(2008-5#1)
low detection##40##2##(2008-10#36)(2008-5#1)(2010-5#1)(2013-1#2)
low dielectric constant##2##3##(2007-12#1)(2008-10#1)
low dielectric constants (K(D##2##4##(2008-10#2)
low dielectric constants##4##3##(2008-10#4)
low dielectric##6##2##(2007-12#1)(2008-10#5)
low differential absorption coefficient##2##4##(2008-2#2)
low diffusion##2##2##(2008-5#1)(2013-8#1)
low disease##6##2##(2008-10#6)
low dispersion##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
low diversity##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
low dosage##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
low dose ADR therapy##4##4##(1994-7#4)
low dose ADR##5##3##(1994-7#5)
low dose exposures##4##3##(2008-7#4)
low dose of##12##3##(1994-7#1)(1995-11#1)(1995-8#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
low dose oral##3##3##(1994-5#1)(2007-11#1)(2011-1#1)
low dose radiation##8##3##(2007-10#1)(2008-7#5)(2010-4#1)(2013-1#1)
low dose rate##3##3##(1994-8#1)(2008-6#1)(2008-7#1)
low dose rates##3##3##(2008-7#3)
low dose##83##2##(1991-11#1)(1992-8#1)(1994-5#2)(1994-7#6)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-6#3)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#30)(2008-8#2)(2009-5#1)(2010-1#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
low dose-rate##2##2##(1994-8#1)(2013-1#1)
low dose-rates##3##2##(2013-1#3)
low doses and##2##3##(2008-7#2)
low doses of DNA damaging agents##2##6##(2008-7#2)
low doses of ionizing radiation##4##5##(2008-7#2)(2011-1#1)(2013-1#1)
low doses of ionizing##6##4##(2008-7#3)(2011-1#2)(2013-1#1)
low doses of low LET radiation##4##6##(2008-7#4)
low doses of low-LET radiation##3##5##(2008-7#3)
low doses of radiation##7##4##(2008-7#6)(2010-4#1)
low doses of##44##3##(1990-10#2)(1990-5#1)(1990-6#1)(1992-5#1)(1993-1#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#22)(2008-8#1)(2010-1#1)(2010-4#1)(2011-1#2)(2013-1#3)
low doses##62##2##(1990-10#2)(1990-5#1)(1990-6#1)(1992-5#1)(1993-1#1)(1994-8#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#33)(2008-8#2)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#2)(2013-1#3)
low due to##3##3##(2008-10#1)(2012-12#2)
low during the##3##3##(1995-12#1)(2008-9#1)(2013-7#1)
low during##5##2##(1995-12#1)(1996-2#1)(2008-10#1)(2008-9#1)(2013-7#1)
low duty cycle##2##3##(2008-3#2)
low early##2##2##(1992-9#1)(2011-2#1)
low education##3##2##(2013-1#3)
low educational##2##2##(2013-1#1)(2013-8#1)
low efficiency##3##2##(1990-5#1)(2008-11#1)(2008-8#1)
low electrical resistance##2##3##(2008-10#1)(2008-9#1)
low electrical##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
low energy electronic##3##3##(2008-10#3)
low energy##10##2##(1993-5#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
low enough to##3##3##(1995-11#1)(1995-8#1)(2008-9#1)
low enough##5##2##(1995-11#1)(1995-3#1)(1995-8#1)(2008-2#1)(2008-9#1)
low enrollment##2##2##(1994-3#2)
low enzyme activity##2##3##(1990-5#1)(1993-3#1)
low enzyme##6##2##(1990-5#1)(1992-6#1)(1993-3#1)(2011-2#2)(2012-2#1)
low exposure##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
low exposures##2##2##(1991-12#1)(2013-8#1)
low expression in##2##3##(1992-8#1)(1997-7#1)
low expression##5##2##(1992-8#1)(1997-7#1)(2008-10#1)(2010-3#1)(2012-12#1)
low extinction coefficient##2##3##(2008-10#1)(2008-2#1)
low extracellular##2##2##(1992-3#1)(1993-8#1)
low f##2##2##(2007-12#1)(2008-3#1)
low fat##5##2##(1993-11#1)(2007-8#1)(2008-4#1)(2010-4#1)(2012-2#1)
low female##2##2##(1994-7#1)(2008-8#1)
low fertility##7##2##(1996-8#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-5#2)
low flow##2##2##(1991-6#1)(2007-8#1)
low fluences of alpha-particles##2##4##(2008-7#2)
low fluences##3##2##(2007-11#1)(2008-7#2)
low fluorescence##4##2##(2008-10#4)
low flux##3##2##(2007-7#2)(2012-2#1)
low folate##4##2##(2008-3#1)(2008-7#3)
low food##4##2##(2010-8#2)(2012-3#1)(2013-1#1)
low for##8##2##(1991-3#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
low frequencies##9##2##(2007-12#1)(2008-10#5)(2008-3#1)(2008-9#1)(2011-2#1)
low frequency and##2##3##(2008-9#1)(2009-2#1)
low frequency electromagnetic##5##3##(1992-11#1)(2008-12#3)(2011-2#1)
low frequency of##9##3##(1991-2#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#2)
low frequency##40##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-5#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
low friction##2##2##(2009-9#2)
low gene flow##2##3##(2008-10#2)
low gene##3##2##(2008-10#2)(2008-4#1)
low genetic diversity##4##3##(2008-10#3)(2011-2#1)
low genetic structure##2##3##(2013-1#2)
low genetic##10##2##(2008-10#4)(2011-2#2)(2011-3#1)(2013-1#3)
low glucose##6##2##(1994-8#1)(1996-2#1)(2010-11#2)(2011-2#2)
low grade inflammation##2##3##(2012-2#2)
low grade malignancy##2##3##(2007-8#1)(2008-4#1)
low grade##16##2##(1991-9#1)(1992-10#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
low growth##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
low health literacy##3##3##(2009-8#3)
low health##4##2##(2009-8#3)(2010-10#1)
low high density lipoprotein##2##4##(1994-11#1)(2008-1#1)
low humidity sensing##2##3##(2008-10#2)
low humidity sensor##2##3##(2008-10#2)
low humidity##4##2##(2008-10#4)
low if##3##2##(1990-8#1)(2008-10#1)(2008-11#1)
low immunization levels##2##3##(1996-12#2)
low immunization##3##2##(1996-12#3)
low immunogenicity##2##2##(2008-5#1)(2009-2#1)
low in all##4##3##(1992-9#1)(2008-10#2)(2013-1#1)
low in both##3##3##(1992-10#1)(1992-6#1)(2010-1#1)
low in cells##2##3##(1994-8#1)(1997-1#1)
low in comparison with##2##4##(1993-2#1)(2008-8#1)
low in patients with##2##4##(1991-5#1)(2008-9#1)
low in some##2##3##(2007-1#1)(2008-10#1)
low in the##11##3##(1990-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2009-7#1)
low in##61##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-1#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#3)(2010-1#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
low incidence of oropharyngeal adverse events##2##6##(2008-8#2)
low incidence of the##2##4##(2011-1#1)(2011-2#1)
low incidence of##23##3##(1990-2#1)(1990-6#2)(1991-4#1)(1993-11#1)(1993-9#1)(1995-5#1)(1996-11#1)(2007-8#2)(2008-5#1)(2008-7#2)(2008-8#3)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
low incidence##28##2##(1990-2#1)(1990-6#2)(1991-4#1)(1991-5#1)(1993-11#1)(1993-9#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-1#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
low income##13##2##(1991-3#1)(1991-6#2)(1992-5#1)(1994-12#2)(1995-12#1)(1997-4#1)(2008-12#1)(2008-9#2)(2011-1#1)(2012-2#1)
low initial##6##2##(1994-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)
low inoculum density##2##3##(2008-10#2)
low inoculum##4##2##(2008-10#4)
low intensities##2##2##(2007-11#1)(2007-12#1)
low intensity microwaves##2##3##(2011-2#2)
low intensity##8##2##(1992-3#1)(1996-5#1)(2008-10#2)(2008-2#1)(2011-2#2)(2013-1#1)
low ionic strength##13##3##(1990-11#1)(1990-2#1)(1990-5#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
low ionic strengths##2##3##(1995-2#1)(2008-7#1)
low ionic##15##2##(1990-11#1)(1990-2#1)(1990-5#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#1)
low is##2##2##(1994-1#1)(2008-10#1)
low laser power##2##3##(2008-2#1)(2011-1#1)
low laser##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
low level mercurialism##2##3##(1995-3#2)
low level of activity##2##4##(2008-7#1)(2011-2#1)
low level of education##2##4##(1995-5#1)(2011-2#1)
low level of##48##3##(1992-10#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-10#1)(2011-2#4)(2011-7#1)(2013-1#1)
low level##83##2##(1990-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-9#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2011-1#1)(2011-10#1)(2011-2#5)(2011-7#1)(2012-3#1)(2013-1#1)
low levels in these##2##4##(1990-12#1)(2008-4#1)
low levels in##12##3##(1990-12#1)(1992-11#1)(1992-12#1)(1993-2#1)(1994-9#1)(2008-10#4)(2008-4#1)(2008-6#1)(2012-12#1)
low levels of antibody##3##4##(1991-3#2)(2008-11#1)
low levels of genetic differentiation##2##5##(2012-3#1)(2012-5#1)
low levels of genetic##4##4##(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)
low levels of linkage disequilibrium##2##5##(2008-10#1)(2010-5#1)
low levels of the##3##4##(1990-5#1)(1991-9#1)(2008-10#1)
low levels of this##3##4##(1994-8#1)(2008-10#2)
low levels of##91##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-8#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#7)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#3)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#1)
low levels##123##2##(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#9)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#3)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#1)
low light levels##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
low light##12##2##(1992-6#1)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
low limit of detection##3##4##(2008-10#3)
low limit of determination##2##4##(2008-10#2)
low limit of##6##3##(2008-10#6)
low limits of detection##6##4##(2008-10#6)
low limits##7##2##(2008-10#7)
low linear##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
low load##2##2##(2009-7#1)(2013-1#1)
low loss##8##2##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
low lumbar spine##2##3##(2008-8#1)(2010-1#1)
low lumbar##3##2##(1991-11#1)(2008-8#1)(2010-1#1)
low luminance contrast stimuli##2##4##(1996-5#2)
low luminance##3##2##(1996-5#2)(2008-3#1)
low magnesium##3##2##(1992-6#1)(1993-8#1)(2008-6#1)
low maternal##3##2##(2009-10#2)(2009-11#1)
low mean##3##2##(2007-11#1)(2008-9#2)
low mechanical index##2##3##(2008-7#1)(2012-2#1)
low mechanical##4##2##(2007-8#1)(2008-7#1)(2009-7#1)(2012-2#1)
low melting point##2##3##(2008-10#1)(2009-11#1)
low mental##2##2##(2010-12#1)(2011-2#1)
low micromolar##5##2##(1992-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(2008-10#1)
low milk##2##2##(2010-12#2)
low mitochondrial##2##2##(1994-11#1)(2008-10#1)
low molecular mass GTP-binding##2##4##(1993-6#2)
low molecular mass##5##3##(1993-6#2)(1995-6#1)(2008-10#1)(2009-12#1)
low molecular weight (LMW)##3##4##(1990-12#1)(2008-10#2)
low molecular weight anions##2##4##(2008-10#2)
low molecular weight compound##2##4##(2009-4#2)
low molecular weight compounds##4##4##(2008-10#4)
low molecular weight heparin (LMWH)##3##5##(2007-7#1)(2007-8#1)(2008-8#1)
low molecular weight heparin and##2##5##(1995-5#1)(2007-7#1)
low molecular weight heparin for##3##5##(1996-6#1)(2007-7#1)(2008-8#1)
low molecular weight heparin in##2##5##(2008-7#1)(2013-1#1)
low molecular weight heparin##15##4##(1995-5#1)(1996-6#1)(1997-2#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#2)(2013-1#3)
low molecular weight heparins##3##4##(1997-2#1)(2007-10#1)(2008-3#1)
low molecular weight selenium compounds##2##5##(2010-11#2)
low molecular weight selenium species##2##5##(2010-11#2)
low molecular weight selenium##4##4##(2010-11#4)
low molecular weight##66##3##(1990-12#2)(1990-2#1)(1990-7#2)(1991-2#1)(1991-9#2)(1992-9#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-5#2)(1996-6#1)(1997-2#4)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#14)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#2)(2009-4#2)(2009-9#1)(2010-11#4)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
low molecular weights##2##3##(2008-10#1)(2008-2#1)
low molecular##76##2##(1990-12#2)(1990-2#1)(1990-7#2)(1991-2#1)(1991-9#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-6#1)(1997-2#4)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#2)(2009-9#1)(2010-11#4)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
low monitors##2##2##(2008-4#2)
low morbidity and##2##3##(1990-3#1)(2008-6#1)
low morbidity rate##3##3##(1994-2#1)(2011-2#2)
low morbidity##7##2##(1990-3#1)(1994-2#1)(1995-1#1)(2008-6#1)(2009-5#1)(2011-2#2)
low mortality and##2##3##(2007-8#1)(2008-3#1)
low mortality rate##3##3##(1994-3#1)(1995-12#1)(2008-4#1)
low mortality##6##2##(1994-3#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
low mug l(-1)##3##3##(2008-10#3)
low mug##4##2##(2008-10#4)
low mutation rates##2##3##(2008-8#2)
low noise##10##2##(2007-11#1)(2008-3#2)(2010-8#3)(2011-1#3)(2011-2#1)
low nucleotide##2##2##(2008-10#2)
low number of cells##2##4##(1993-6#1)(1995-9#1)
low number of##10##3##(1990-12#1)(1990-2#1)(1993-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)(2012-12#1)
low numbers in##2##3##(2008-10#1)(2008-6#1)
low numbers of ascospores##2##4##(2008-10#2)
low numbers of##7##3##(1992-12#1)(2008-10#3)(2008-4#1)(2009-11#1)(2013-1#1)
low numbers##10##2##(1992-12#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-11#1)(2013-1#1)
low on##9##2##(1993-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#2)
low operating voltage##2##3##(2007-12#2)
low operating##3##2##(2007-12#2)(2008-10#1)
low optical##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
low or absent##2##3##(1995-3#1)(2008-12#1)
low or even##2##3##(1994-3#2)
low or high##10##3##(1990-7#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)(2012-9#2)(2013-1#1)
low or undetectable levels##2##4##(2007-11#1)(2008-10#1)
low or undetectable##5##3##(1997-1#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
low or##29##2##(1990-7#1)(1992-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-2#1)(2012-3#1)(2012-9#2)(2013-1#1)(2013-8#2)
low oral##3##2##(2008-3#1)(2008-8#2)
low osmolarity##2##2##(1991-11#1)(1994-12#1)
low output##8##2##(1995-3#1)(1996-9#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2010-8#1)
low overall##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
low oxygen partial pressure##3##4##(2008-11#2)(2013-8#1)
low oxygen##8##2##(1996-12#2)(2008-10#1)(2008-11#2)(2009-4#1)(2011-2#1)(2013-8#1)
low pH (6##2##3##(1990-8#1)(2008-8#1)
low pH and##5##3##(1994-8#3)(2008-10#1)(2008-7#1)
low pH range##2##3##(2008-10#1)(2008-6#1)
low pH##35##2##(1990-5#2)(1990-8#2)(1991-9#2)(1992-6#1)(1993-8#2)(1994-6#1)(1994-8#4)(1995-2#2)(1995-5#2)(2008-10#9)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
low parasitemia##2##2##(1991-2#1)(2012-12#1)
low participation##2##2##(1996-12#1)(2013-1#1)
low particle concentrations##3##3##(2008-3#3)
low pathogenic##3##2##(1996-12#1)(2008-10#1)(2010-4#1)
low percentage of##5##3##(1994-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
low percentage##9##2##(1994-6#1)(2007-10#1)(2008-10#3)(2008-5#2)(2008-7#2)
low performance##4##2##(1993-12#1)(1994-8#1)(2008-10#1)(2011-2#1)
low photon##2##2##(2008-3#1)(2012-12#1)
low plasma##4##2##(1996-7#1)(1997-3#1)(1997-7#1)(2008-8#1)
low platelet##2##2##(2007-10#1)(2008-3#1)
low polarity##2##2##(2008-10#1)(2008-7#1)
low polydispersity (PDI##2##3##(2008-12#2)
low population density##3##3##(1990-11#1)(2008-8#1)(2008-9#1)
low population##9##2##(1990-11#1)(2008-10#2)(2008-8#3)(2008-9#3)
low potential##5##2##(1990-8#1)(2008-10#2)(2008-5#1)(2010-5#1)
low power lasers##2##3##(2009-7#1)(2012-3#1)
low power##10##2##(1995-2#1)(2007-11#1)(2008-10#4)(2009-7#1)(2011-2#1)(2012-3#2)
low precision##2##2##(2008-10#2)
low prediction##2##2##(2008-10#1)(2010-4#1)
low pressure##11##2##(1996-3#2)(1996-9#1)(2008-10#6)(2008-6#1)(2008-7#1)
low prevalence of##2##3##(2008-1#1)(2008-10#1)
low prevalence##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
low priority##3##2##(1996-2#1)(2007-7#1)(2013-1#1)
low production of##2##3##(1997-4#1)(2012-12#1)
low productivity##4##2##(2008-11#2)(2008-9#2)
low progression##2##2##(2008-12#1)(2010-8#1)
low protein concentrations##2##3##(1990-8#1)(1997-2#1)
low protein##9##2##(1990-8#1)(1993-8#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
low pump##4##2##(2008-3#4)
low pyrolysis##2##2##(2008-10#2)
low quality##5##2##(1991-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
low radiation doses##4##3##(1996-6#1)(2008-7#1)(2013-1#2)
low rainfall##3##2##(2008-10#2)(2008-8#1)
low rainfall)##2##2##(2008-10#2)
low rank##2##2##(2008-10#2)
low rate of complications in##2##5##(1991-9#1)(2008-1#1)
low rate of##18##3##(1990-11#1)(1991-9#1)(1993-6#1)(1994-1#1)(1996-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
low rate##19##2##(1990-11#1)(1991-9#1)(1993-6#1)(1994-1#1)(1996-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
low rates of##6##3##(1995-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-12#1)
low rates##8##2##(1992-10#1)(1995-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)
low ratios##2##2##(2009-12#1)(2010-12#1)
low reaction strains##2##3##(2013-8#2)
low reagent consumption##3##3##(2008-10#3)
low reagent##5##2##(2008-10#5)
low receptor##2##2##(1991-2#1)(1995-2#1)
low recovery##2##2##(2008-10#2)
low recurrence rate##2##3##(1994-9#1)(2013-7#1)
low recurrence##3##2##(1994-9#1)(2012-2#1)(2013-7#1)
low refractive index##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
low refractive##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
low relative humidity (RH)##2##4##(2008-10#2)
low relative humidity##3##3##(2008-10#3)
low relative##5##2##(2008-10#4)(2012-9#1)
low repetition rate##2##3##(2007-12#2)
low repetition rates and high peak##2##6##(2007-12#2)
low repetition##4##2##(2007-12#4)
low reproductive success in##2##4##(2008-9#1)(2012-3#1)
low reproductive success##4##3##(2008-9#1)(2009-12#1)(2012-3#2)
low reproductive##5##2##(2008-5#1)(2008-9#1)(2009-12#1)(2012-3#2)
low residual##2##2##(2008-11#1)(2008-3#1)
low resistance##6##2##(2008-10#5)(2009-8#1)
low resolution##5##2##(2008-10#3)(2008-8#1)(2010-8#1)
low resource settings##2##3##(2011-2#2)
low resource##4##2##(2008-9#1)(2011-2#2)(2013-1#1)
low response##2##2##(2007-11#1)(2013-7#1)
low risk for##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2009-3#1)
low risk of latent infection##2##5##(2008-10#2)
low risk of##11##3##(1992-5#1)(2006-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
low risk##31##2##(1991-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(2006-12#1)(2007-5#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
low salt##5##2##(1990-2#1)(1995-6#2)(2008-8#1)(2011-2#1)
low sample and reagent consumption##2##5##(2008-10#1)(2011-1#1)
low sample volume##3##3##(2008-10#3)
low sample##9##2##(2008-10#7)(2008-9#1)(2011-1#1)
low satisfaction with life##2##4##(1993-6#1)(1997-4#1)
low scattered light##2##3##(2008-2#1)(2008-3#1)
low scattering##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
low seed##2##2##(2008-2#1)(2008-7#1)
low selectivity##4##2##(1995-11#1)(2008-10#2)(2008-7#1)
low selenium mushroom##2##3##(2008-10#2)
low self-esteem##5##2##(1994-12#1)(2007-12#1)(2008-9#1)(2009-11#1)(2009-7#1)
low sensitivity and##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
low sensitivity of##5##3##(1990-2#1)(1990-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
low sensitivity to the##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
low sensitivity to##5##3##(1992-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
low sensitivity##23##2##(1990-2#1)(1990-3#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1997-3#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#4)
low sequence similarity##3##3##(1993-9#1)(2008-7#1)(2010-12#1)
low sequence##5##2##(1993-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
low serum levels of##2##4##(1993-3#1)(2013-7#1)
low serum##18##2##(1991-12#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-1#2)(2013-7#1)
low severity##3##2##(1992-3#1)(2008-10#2)
low shear##2##2##(1992-12#1)(2007-12#1)
low sideband##2##2##(2008-3#2)
low signal intensity in the##2##5##(1991-11#2)
low signal intensity##5##3##(1991-11#4)(2011-2#1)
low signal##6##2##(1991-11#4)(2008-10#1)(2011-2#1)
low signal-to-noise##2##2##(2008-2#1)(2008-3#1)
low similarity##3##2##(2008-12#1)(2008-9#2)
low socio-economic status##2##3##(2008-1#1)(2012-3#1)
low socio-economic##3##2##(2008-1#1)(2009-10#1)(2012-3#1)
low socioeconomic status##2##3##(1993-3#1)(2013-1#1)
low socioeconomic strata##2##3##(2008-1#1)(2013-1#1)
low socioeconomic##6##2##(1993-3#1)(2008-1#2)(2012-2#1)(2013-1#2)
low sodium diet##2##3##(2007-7#2)
low soil moisture##2##3##(2008-10#1)(2012-7#1)
low soil##3##2##(2008-10#2)(2012-7#1)
low solubility in##2##3##(2008-10#1)(2008-7#1)
low solubility##8##2##(1997-1#2)(2008-10#5)(2008-7#1)
low solvent consumption##2##3##(2008-10#2)
low spatial frequencies##2##3##(2008-2#2)
low spatial frequency##2##3##(2008-2#1)(2008-3#1)
low spatial##8##2##(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
low specificity##2##2##(2011-2#1)(2013-8#1)
low spin ferric##2##3##(1990-5#1)(1994-6#1)
low spin##5##2##(1990-5#4)(1994-6#1)
low spore numbers##2##3##(1997-4#1)(2008-10#1)
low spore##3##2##(1997-4#1)(2008-10#2)
low stability of##2##3##(1993-8#1)(1995-2#1)
low stability##4##2##(1993-8#1)(1995-2#1)(2008-10#2)
low standard##2##2##(2008-10#1)(2011-3#1)
low stress##2##2##(2008-7#1)(2008-8#1)
low stringency##3##2##(1991-5#1)(2013-1#2)
low substrate concentrations##3##3##(1992-8#1)(1993-8#1)(1994-9#1)
low substrate##6##2##(1992-8#1)(1993-8#1)(1994-9#1)(2008-3#2)(2011-2#1)
low surface energy##2##3##(1997-2#1)(2010-4#1)
low surface##7##2##(1992-6#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
low survival##4##2##(2006-10#1)(2008-9#2)(2010-6#1)
low susceptibility to the##2##4##(2008-3#1)(2008-5#1)
low susceptibility to##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
low susceptibility##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
low symmetry##2##2##(1997-7#1)(2013-8#1)
low symptom##2##2##(2008-10#1)(2011-1#1)
low systemic##2##2##(1991-3#1)(2010-10#1)
low tar and nicotine cigarettes##2##5##(2009-7#2)
low targeting##2##2##(2008-11#2)
low tech##2##2##(2008-12#1)(2010-4#1)
low temperature and##2##3##(2008-11#1)(2008-7#1)
low temperature culture##3##3##(2008-11#3)
low temperature electrothermal vaporization##2##4##(2008-10#2)
low temperature microwave-assisted extraction method##2##5##(2008-10#2)
low temperature of##2##3##(2008-10#2)
low temperature plasma##2##3##(2008-10#1)(2009-11#1)
low temperature##51##2##(1990-5#1)(1993-6#1)(1997-2#3)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-7#1)(2008-8#3)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-4#1)(2013-1#1)
low temperatures and##2##3##(1993-8#1)(2008-10#1)
low temperatures##30##2##(1990-3#1)(1993-8#2)(2007-12#2)(2008-10#11)(2008-2#2)(2008-3#4)(2008-7#2)(2008-8#3)(2009-7#1)(2011-2#1)(2013-1#1)
low temporal##2##2##(1996-2#1)(2007-11#1)
low thermal##4##2##(2008-2#1)(2008-3#3)
low threshold##6##2##(1993-9#1)(1997-2#1)(2007-11#3)(2008-7#1)
low throughput##2##2##(2008-10#1)(2011-1#1)
low to allow##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
low to medium##3##3##(2008-10#2)(2008-5#1)
low to moderate##6##3##(1997-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-6#1)
low to##27##2##(1992-6#1)(1995-2#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
low tolerance##2##2##(2007-8#1)(2008-10#1)
low toxicity##7##2##(1993-3#1)(2008-10#2)(2008-11#2)(2012-3#1)(2013-1#1)
low triglyceride##3##2##(2012-6#3)
low users##2##2##(1995-1#1)(1995-3#1)
low value of the##2##4##(2007-11#1)(2008-10#1)
low value of##4##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
low value##5##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)
low values for##2##3##(1992-12#1)(2008-10#1)
low values of##7##3##(1990-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
low values##15##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#3)
low variability##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
low virulence on##4##3##(2008-10#4)
low virulence##8##2##(2007-11#1)(2008-10#7)
low viscosity##4##2##(2008-10#1)(2008-8#2)(2009-7#1)
low vision was##2##3##(2010-8#2)
low vision##14##2##(2010-8#13)(2011-2#1)
low vitamin B12 level##2##4##(1990-3#1)(2010-1#1)
low vitamin B12##3##3##(1990-3#2)(2010-1#1)
low vitamin##5##2##(1990-3#2)(2010-1#1)(2012-2#1)(2013-7#1)
low volume##4##2##(1992-11#1)(2007-8#1)(2008-10#2)
low water contents##2##3##(2008-10#2)
low water##6##2##(2008-10#4)(2009-5#1)(2011-2#1)
low well-being##3##2##(2009-7#3)
low when##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
low wind##3##2##(2007-12#1)(2008-5#2)
low with an average##2##4##(2008-10#2)
low with##5##2##(1993-1#1)(2008-10#4)
low yield##4##2##(1994-11#1)(1995-8#1)(2008-10#1)(2008-5#1)
low yields##2##2##(1990-2#1)(1996-5#1)
low##3659##1##(1990-10#3)(1990-11#14)(1990-12#10)(1990-2#13)(1990-3#9)(1990-4#1)(1990-5#33)(1990-6#7)(1990-7#6)(1990-8#15)(1990-9#4)(1991-1#2)(1991-11#21)(1991-12#16)(1991-2#11)(1991-3#7)(1991-4#3)(1991-5#13)(1991-6#7)(1991-7#2)(1991-8#1)(1991-9#16)(1992-10#7)(1992-11#10)(1992-12#14)(1992-2#4)(1992-3#26)(1992-5#8)(1992-6#20)(1992-7#3)(1992-8#10)(1992-9#15)(1993-1#11)(1993-11#11)(1993-12#14)(1993-2#4)(1993-3#20)(1993-5#3)(1993-6#17)(1993-8#33)(1993-9#9)(1994-1#4)(1994-10#1)(1994-11#7)(1994-12#16)(1994-2#13)(1994-3#17)(1994-5#9)(1994-6#11)(1994-7#7)(1994-8#25)(1994-9#11)(1995-1#4)(1995-11#19)(1995-12#15)(1995-2#22)(1995-3#19)(1995-5#10)(1995-6#14)(1995-8#12)(1995-9#3)(1996-1#3)(1996-11#6)(1996-12#28)(1996-2#15)(1996-3#8)(1996-4#3)(1996-5#15)(1996-6#12)(1996-7#3)(1996-8#7)(1996-9#8)(1997-1#10)(1997-2#27)(1997-3#12)(1997-4#14)(1997-5#4)(1997-6#7)(1997-7#10)(1997-8#7)(1997-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#13)(2007-11#57)(2007-12#79)(2007-2#6)(2007-5#5)(2007-7#20)(2007-8#33)(2008-1#28)(2008-10#811)(2008-11#114)(2008-12#59)(2008-2#75)(2008-3#147)(2008-4#34)(2008-5#86)(2008-6#30)(2008-7#165)(2008-8#94)(2008-9#67)(2009-1#5)(2009-10#9)(2009-11#11)(2009-12#8)(2009-2#4)(2009-3#5)(2009-4#11)(2009-5#12)(2009-6#3)(2009-7#27)(2009-8#11)(2009-9#8)(2010-1#18)(2010-10#13)(2010-11#14)(2010-12#18)(2010-2#4)(2010-3#4)(2010-4#25)(2010-5#18)(2010-6#9)(2010-7#6)(2010-8#33)(2010-9#6)(2011-1#54)(2011-10#1)(2011-2#120)(2011-3#5)(2011-7#1)(2012-1#23)(2012-12#31)(2012-2#77)(2012-3#47)(2012-4#1)(2012-5#1)(2012-6#10)(2012-7#5)(2012-8#1)(2012-9#3)(2013-1#124)(2013-7#14)(2013-8#40)
low&quot##2##1##(1994-2#1)(2009-8#1)
low)##3##1##(1993-5#1)(2008-2#1)(2008-8#1)
low- and middle-income countries##3##4##(2010-11#1)(2012-12#2)
low- and middle-income##5##3##(1993-3#1)(2010-11#1)(2011-2#1)(2012-12#2)
low- and##15##2##(1992-10#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
low- or##5##2##(1992-12#1)(1993-1#1)(2008-10#1)(2010-2#1)(2013-8#1)
low- to##2##2##(2008-10#1)(2008-9#1)
low-##24##1##(1992-10#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
low-CHO diet was associated with##2##5##(2013-8#2)
low-CHO diet was##3##3##(2013-8#3)
low-CHO diet##6##2##(2013-8#6)
low-GDP##2##1##(2011-2#2)
low-GL##2##1##(2008-3#2)
low-LET radiation##7##2##(2008-7#7)
low-LET##9##1##(2008-7#9)
low-SI areas##2##2##(1997-8#2)
low-a(w)-tolerant cells##2##2##(2008-10#2)
low-abundance##3##1##(2008-4#1)(2008-9#1)(2012-1#1)
low-affinity sites for##2##3##(1990-11#1)(1995-12#1)
low-affinity##16##1##(1990-11#2)(1990-8#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-4#2)
low-amplitude##3##1##(2007-11#1)(2008-2#1)(2013-1#1)
low-anterior resection of the rectum##2##5##(2012-12#2)
low-anterior resection##3##2##(2012-12#3)
low-barrier hydrogen##3##2##(1995-5#3)
low-bias##2##1##(2008-12#1)(2008-3#1)
low-birefringence fiber##2##2##(2008-3#2)
low-birefringence##5##1##(2008-3#5)
low-birth-weight##4##1##(1995-2#1)(2013-1#3)
low-calorie##2##1##(1995-3#1)(2008-5#1)
low-carbohydrate##8##1##(2008-3#6)(2008-5#1)(2013-8#1)
low-coherence interferometric##4##2##(2007-12#1)(2008-3#3)
low-coherence interferometry for##2##3##(2007-11#2)
low-coherence interferometry##12##2##(2007-11#2)(2008-2#1)(2008-3#9)
low-coherence light##3##2##(2007-12#1)(2008-3#2)
low-coherence optical##3##2##(2008-2#1)(2008-3#2)
low-coherence reflectometer for##2##3##(2007-12#2)
low-coherence reflectometer##4##2##(2007-11#1)(2007-12#3)
low-coherence reflectometry##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
low-coherence sources##2##2##(2007-11#1)(2008-3#1)
low-coherence spectral interferometry of noiselike pulses##2##6##(2007-11#2)
low-coherence##47##1##(2007-11#9)(2007-12#11)(2008-2#3)(2008-3#24)
low-coherent##2##1##(2008-2#1)(2008-3#1)
low-contrast objects##2##2##(1997-8#2)
low-contrast##4##1##(1997-8#2)(2008-3#1)(2012-1#1)
low-copy probes##2##2##(2008-10#2)
low-copy##4##1##(1995-2#1)(2008-10#2)(2013-1#1)
low-copy-number##5##1##(1992-9#1)(1993-12#3)(1994-12#1)
low-cost alternative##2##2##(2008-10#1)(2008-9#1)
low-cost and##6##2##(2008-10#3)(2008-3#2)(2012-1#1)
low-cost health care##2##3##(1997-3#1)(2008-11#1)
low-cost optical##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
low-cost option for##2##3##(2008-10#2)
low-cost##86##1##(1995-1#1)(1996-12#1)(1996-3#2)(1997-3#2)(2007-11#5)(2007-12#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#23)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
low-density lipoprotein (LDL##2##3##(1994-6#1)(2013-8#1)
low-density lipoprotein (LDL) and##2##4##(2008-10#1)(2008-6#1)
low-density lipoprotein (LDL) cholesterol##3##4##(1991-8#1)(2008-3#1)(2012-2#1)
low-density lipoprotein (LDL) receptor##4##4##(1990-7#1)(1995-6#1)(2008-6#2)
low-density lipoprotein (LDL)##18##3##(1990-7#1)(1991-8#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-6#4)(2011-1#1)(2012-2#1)(2013-1#1)
low-density lipoprotein cholesterol (LDL-C)##2##4##(2011-2#1)(2012-6#1)
low-density lipoprotein cholesterol less than 100 mg/dL##2##7##(2008-3#1)(2012-3#1)
low-density lipoprotein cholesterol##9##3##(2008-3#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#1)
low-density lipoprotein oxidative modification by##2##5##(1994-11#2)
low-density lipoprotein receptor##3##3##(1990-7#1)(2009-8#1)(2013-1#1)
low-density lipoprotein##49##2##(1990-7#2)(1991-8#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-6#1)(1995-12#2)(1995-6#1)(1996-2#2)(1996-3#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#6)(2008-6#4)(2008-7#2)(2009-12#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
low-density lipoprotein-cholesterol##2##2##(2010-5#2)
low-density lipoproteins (LDL)##3##3##(1992-9#1)(1993-8#1)(1995-12#1)
low-density lipoproteins##7##2##(1991-9#2)(1992-9#1)(1993-8#1)(1995-12#2)(2009-8#1)
low-density plasma regime##2##3##(2011-1#2)
low-density##68##1##(1990-7#2)(1991-8#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-6#1)(1995-12#4)(1995-6#1)(1996-2#2)(1996-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-6#4)(2008-7#3)(2009-12#1)(2009-8#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#1)
low-depositing ZnPTO shampoo##2##3##(2008-5#2)
low-dimensional spaces##2##2##(2008-10#1)(2009-5#1)
low-dimensional##6##1##(1995-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)
low-diversity##2##1##(2008-9#2)
low-dosage tablets##2##2##(2008-10#2)
low-dosage##3##1##(2008-10#3)
low-dose X-rays##2##2##(2012-2#1)(2013-1#1)
low-dose aspirin##3##2##(1992-6#1)(2006-10#1)(2006-7#1)
low-dose formulations are##2##3##(1994-9#1)(2008-11#1)
low-dose interleukin-2 and##2##3##(1992-12#2)
low-dose interleukin-2 plus##2##3##(1993-12#1)(1993-6#1)
low-dose interleukin-2##5##2##(1992-12#2)(1993-12#2)(1993-6#1)
low-dose ion implantation##2##3##(2008-3#2)
low-dose ionizing radiation##2##3##(2008-7#2)
low-dose irradiation##2##2##(2008-7#2)
low-dose oral##6##2##(1994-5#1)(2007-7#3)(2013-1#2)
low-dose radiation##4##2##(2008-7#2)(2010-4#2)
low-dose region##2##2##(2008-7#2)
low-dose##71##1##(1990-6#2)(1992-12#3)(1992-6#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-5#2)(1994-9#1)(1997-7#1)(2006-10#2)(2006-7#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#20)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-6#1)(2011-2#6)(2012-2#3)(2013-1#4)(2013-8#3)
low-dose-rate irradiation##2##2##(2008-7#2)
low-dose-rate##5##1##(2008-7#5)
low-earth-orbit##2##1##(2008-2#2)
low-educated##2##1##(2009-9#2)
low-energy conformers of##2##3##(1993-8#1)(1995-11#1)
low-energy##15##1##(1993-8#2)(1994-5#2)(1995-11#1)(1996-2#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#3)(2012-2#1)
low-fat diet##2##2##(1995-9#1)(2008-3#1)
low-fat##7##1##(1992-9#1)(1995-9#1)(1997-1#1)(2008-3#1)(2012-2#1)(2013-1#2)
low-fat/low-calorie diet + medication##2##4##(2008-3#2)
low-fat/low-calorie diet +##3##3##(2008-3#3)
low-fat/low-calorie diet##4##2##(2008-3#4)
low-field##4##1##(1995-5#1)(2009-12#1)(2011-1#2)
low-finesse Fabry-Perot (FP)##2##3##(2008-3#2)
low-finesse Fabry-Perot##4##2##(2008-3#4)
low-finesse##6##1##(2007-11#1)(2008-3#5)
low-flow##3##1##(2007-11#1)(2008-10#1)(2012-2#1)
low-frequency blood pressure oscillations##2##4##(1991-10#2)
low-frequency fluctuation##3##2##(2007-12#3)
low-frequency fluctuations##5##2##(2007-11#2)(2007-12#3)
low-frequency hearing##2##2##(2012-2#2)
low-frequency pulsations##2##2##(2007-11#2)
low-frequency vibration blur##2##3##(2008-3#2)
low-frequency vibration##4##2##(2008-2#1)(2008-3#3)
low-frequency vibrations##4##2##(1990-12#1)(2008-2#1)(2008-3#2)
low-frequency##44##1##(1990-12#1)(1991-10#3)(1992-9#1)(2007-11#5)(2007-12#9)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-9#1)(2012-2#3)(2012-3#1)(2013-8#1)
low-gain##5##1##(2007-12#1)(2008-3#4)
low-glycemic##3##1##(2008-3#3)
low-grade astrocytomas##4##2##(1994-8#1)(2008-7#3)
low-grade inflammation##2##2##(2010-12#1)(2012-2#1)
low-grade intermittent##2##2##(2008-4#1)(2012-3#1)
low-grade non-Hodgkin's lymphomas##3##3##(1990-12#2)(1993-6#1)
low-grade tumors##2##2##(2008-6#2)
low-grade##42##1##(1990-10#1)(1990-12#4)(1993-6#1)(1994-1#2)(1994-8#1)(1996-6#1)(1997-1#4)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
low-income adults##4##2##(2013-1#4)
low-income countries##4##2##(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
low-income families##7##2##(1992-2#1)(1997-4#1)(2007-9#1)(2008-11#3)(2009-9#1)
low-income mothers##4##2##(2009-11#1)(2010-5#1)(2010-6#2)
low-income urban##2##2##(2009-7#1)(2013-1#1)
low-income women##2##2##(1994-2#1)(1997-2#1)
low-income##43##1##(1992-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-4#1)(2007-9#1)(2008-11#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#10)
low-index particles in##2##3##(2007-11#2)
low-index particles##3##2##(2007-11#3)
low-index##8##1##(2007-11#7)(2008-3#1)
low-intensity exercise##3##2##(2010-4#2)(2013-8#1)
low-intensity##12##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#1)
low-level determination of##2##3##(1996-5#1)(2008-10#1)
low-level exposures to##3##3##(2008-7#2)(2013-1#1)
low-level human exposure##2##3##(2008-9#2)
low-level lead##2##2##(1995-3#1)(2011-1#1)
low-level##29##1##(1993-8#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-7#3)(2008-9#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)
low-linear energy transfer (LET)##2##4##(2008-7#2)
low-loss fluorinated##2##2##(2007-11#2)
low-loss propagation##2##2##(2007-11#1)(2007-12#1)
low-loss##23##1##(2007-11#7)(2007-12#3)(2008-2#6)(2008-3#7)
low-lying##2##1##(1996-2#1)(1997-7#1)
low-modulation areas##2##2##(2008-2#2)
low-modulation##3##1##(2008-2#3)
low-molecular weight heparin##2##3##(2007-2#1)(2013-1#1)
low-molecular weight##8##2##(1990-5#1)(1991-12#1)(1992-11#1)(1994-9#1)(2007-2#1)(2008-10#2)(2013-1#1)
low-molecular##11##1##(1990-5#2)(1991-12#1)(1992-11#1)(1994-9#1)(2007-2#1)(2007-8#1)(2008-10#3)(2013-1#1)
low-molecular-mass##2##1##(1990-7#1)(2008-10#1)
low-molecular-weight fraction##2##2##(2008-10#1)(2010-4#1)
low-molecular-weight heparin and##2##3##(1995-6#1)(2008-7#1)
low-molecular-weight heparin##4##2##(1995-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
low-molecular-weight metabolites##3##2##(2008-10#3)
low-molecular-weight proteins##2##2##(2010-3#2)
low-molecular-weight##27##1##(1990-11#1)(1990-5#2)(1992-11#2)(1993-8#1)(1994-5#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-3#2)(2010-4#1)(2011-2#1)(2013-1#1)
low-nitrogen##2##1##(2008-10#2)
low-noise##10##1##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)(2009-7#1)
low-nutrition diet##3##2##(2011-2#3)
low-order Fabry-Perot##2##2##(2008-2#2)
low-order##13##1##(2008-2#7)(2008-3#6)
low-pass filter##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
low-pass filtering##4##2##(2008-2#1)(2008-3#3)
low-pass##11##1##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)
low-peak-power##2##1##(2007-12#2)
low-power diode##2##2##(2007-11#1)(2008-3#1)
low-power laser##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
low-power operation##2##2##(2008-3#1)(2012-2#1)
low-power seed##2##2##(2008-2#1)(2008-3#1)
low-power##30##1##(2007-11#6)(2007-12#5)(2007-4#1)(2008-10#2)(2008-2#5)(2008-3#7)(2009-5#2)(2012-2#2)
low-power-consumption##2##1##(2007-12#1)(2008-2#1)
low-predation environments##3##2##(2008-8#2)(2012-3#1)
low-predation##6##1##(2008-8#4)(2012-3#2)
low-pressure method##2##2##(2008-10#1)(2010-8#1)
low-pressure##11##1##(1995-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)(2013-1#1)
low-quality##7##1##(2008-10#1)(2008-3#1)(2008-8#4)(2008-9#1)
low-rainfall##2##1##(2008-10#2)
low-refractive-index##2##1##(2008-3#2)
low-repetition-rate##5##1##(2007-11#3)(2007-12#2)
low-resistance##2##1##(1996-2#1)(2008-2#1)
low-resolution##9##1##(1990-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-9#1)
low-risk PCa##2##2##(2013-1#2)
low-risk group##2##2##(1990-5#1)(1993-1#1)
low-risk of##2##2##(2010-12#1)(2013-8#1)
low-risk prostate cancer##2##3##(2013-1#2)
low-risk##25##1##(1990-5#1)(1993-1#1)(1993-12#1)(1995-1#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#1)
low-salt diet##2##2##(2012-12#2)
low-salt##4##1##(1993-12#1)(2012-12#3)
low-scatter##2##1##(2008-3#2)
low-serum##3##1##(1992-11#1)(2008-11#2)
low-shear##2##1##(2008-11#2)
low-spin cyanide-ligated bacterial hemoglobin from Vitreoscilla##2##6##(2008-9#2)
low-spin##11##1##(1993-8#3)(1994-5#1)(1994-8#1)(1997-7#3)(2008-10#1)(2008-9#2)
low-temperature plasma##2##2##(2008-6#2)
low-temperature##23##1##(1990-8#1)(1993-11#1)(1996-2#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)
low-temperature-grown GaAs##4##2##(2007-12#3)(2008-2#1)
low-temperature-grown##5##1##(2007-12#3)(2008-2#2)
low-threshold Ca2+##2##2##(1992-8#2)
low-threshold MUs##2##2##(1993-9#2)
low-threshold operation##2##2##(2008-2#2)
low-threshold##16##1##(1992-8#2)(1993-9#5)(1997-2#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-4#1)
low-utilizing##2##1##(2010-8#2)
low-value##3##1##(2008-6#1)(2012-2#2)
low-voltage##3##1##(1992-12#1)(2008-7#1)(2008-8#1)
low-volume##5##1##(1997-8#1)(2008-10#3)(2008-3#1)
low-wavelength UV##2##2##(1991-7#1)(1994-9#1)
low/lower-middle income countries##2##3##(2013-8#2)
lower (0##4##2##(1995-3#1)(2008-10#1)(2008-6#1)(2013-8#1)
lower (P &lt##4##3##(1993-12#1)(2010-2#3)
lower (P = 0##2##4##(2008-10#1)(2008-5#1)
lower (P =##3##3##(2008-10#1)(2008-5#1)(2009-1#1)
lower (P##7##2##(1993-12#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-2#3)
lower (from##2##2##(1996-2#1)(2008-6#1)
lower (p &lt##3##3##(2008-10#1)(2013-1#2)
lower (p##6##2##(1991-8#1)(1992-3#1)(2008-1#1)(2008-10#1)(2013-1#2)
lower A1c##2##2##(2008-1#2)
lower HDL-cholesterol##2##2##(2008-3#1)(2008-7#1)
lower PR in##2##3##(1994-9#2)
lower abdomen##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
lower abdominal pain##5##3##(1991-3#1)(1993-9#1)(2007-7#1)(2008-10#1)(2011-2#1)
lower abdominal##8##2##(1991-3#1)(1993-9#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
lower absolute##2##2##(1994-6#1)(2008-9#1)
lower academic achievement##2##3##(2008-11#1)(2010-1#1)
lower activities##2##2##(1995-2#1)(2008-10#1)
lower activity##5##2##(1995-2#1)(1995-5#1)(1995-8#1)(2008-5#1)(2008-8#1)
lower adiponectin##3##2##(2011-1#2)(2013-1#1)
lower affinity for##4##3##(1995-3#1)(1996-2#1)(1997-2#1)(2008-4#1)
lower affinity than##2##3##(1995-11#1)(1995-6#1)
lower affinity##10##2##(1990-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-4#1)(2008-7#1)
lower after##3##2##(1991-6#1)(1996-5#1)(2008-4#1)
lower age##2##2##(2008-7#1)(2013-1#1)
lower among##7##2##(1992-8#1)(2008-10#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
lower amount of##2##3##(2007-12#1)(2008-10#1)
lower amounts of##2##3##(1997-2#1)(2008-10#1)
lower amounts##3##2##(1990-11#1)(1997-2#1)(2008-10#1)
lower and higher##8##3##(1994-11#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-8#1)
lower and more variable##2##4##(1996-2#1)(2007-8#1)
lower and more##4##3##(1992-3#1)(1996-2#1)(2007-8#1)(2012-1#1)
lower and upper##7##3##(1997-8#1)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
lower and##30##2##(1990-8#1)(1992-3#1)(1994-11#1)(1994-7#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
lower antibody##2##2##(1991-11#1)(1997-6#1)
lower at the##2##3##(2008-11#1)(2008-5#1)
lower at##17##2##(1994-2#1)(1995-6#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
lower back pain##3##3##(2008-4#1)(2009-9#1)(2012-12#1)
lower back##7##2##(2008-4#1)(2008-5#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
lower binding##2##2##(1992-10#1)(2008-7#1)
lower blood pressure##4##3##(1990-3#1)(1993-2#1)(2008-7#1)(2012-12#1)
lower blood##6##2##(1990-3#1)(1993-2#1)(2008-7#2)(2012-12#1)(2013-8#1)
lower body mass index##2##4##(2011-2#1)(2013-1#1)
lower body##5##2##(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
lower bound for the##2##4##(1997-6#1)(2007-11#1)
lower bound##3##2##(1997-6#1)(2007-11#1)(2008-2#1)
lower bounds on the##2##4##(2008-3#1)(2009-5#1)
lower brachial##2##2##(2008-11#1)(2009-3#1)
lower brain##2##2##(1991-12#2)
lower but##3##2##(1993-11#1)(2008-7#2)
lower cell##6##2##(1993-9#1)(2008-11#3)(2008-5#1)(2008-9#1)
lower circulating##2##2##(1992-9#2)
lower compared to##2##3##(2008-5#1)(2010-3#1)
lower compared with the##2##4##(2007-10#1)(2011-1#1)
lower compared with##6##3##(2007-10#1)(2008-10#1)(2011-1#1)(2011-2#2)(2011-3#1)
lower compared##8##2##(2007-10#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)
lower complication rate##2##3##(1991-3#1)(2007-7#1)
lower complication rates##2##3##(2007-7#1)(2011-2#1)
lower complication##4##2##(1991-3#1)(2007-7#2)(2011-2#1)
lower concentration of##8##3##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#2)(2013-1#1)
lower concentration than##2##3##(2008-10#1)(2008-11#1)
lower concentration##15##2##(1993-6#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#2)(2013-1#1)
lower concentrations (0##2##3##(1992-8#1)(2008-10#1)
lower concentrations and##3##3##(2008-10#2)(2013-8#1)
lower concentrations in##2##3##(2008-10#2)
lower concentrations of the##2##4##(1992-11#1)(1992-9#1)
lower concentrations of##8##3##(1992-11#1)(1992-9#1)(1993-12#1)(1994-2#1)(2008-10#4)
lower concentrations than##2##3##(1990-12#1)(2013-8#1)
lower concentrations##27##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-9#1)(1997-2#1)(2008-10#13)(2008-8#1)(2013-1#1)(2013-8#2)
lower copy##3##2##(1990-5#1)(1993-9#1)(2008-10#1)
lower cost per##2##3##(1996-12#2)
lower cost##10##2##(1993-8#1)(1994-12#1)(1996-12#2)(1997-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
lower costs and higher##2##4##(2008-11#1)(2011-2#1)
lower costs##9##2##(1994-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-11#3)(2011-2#2)
lower coverage and##2##3##(2007-11#1)(2012-2#1)
lower cranial nerve palsies##2##4##(2008-7#1)(2011-2#1)
lower cranial##4##2##(2008-7#2)(2011-2#2)
lower critical##2##2##(2008-10#1)(2008-4#1)
lower crustal zone##3##3##(1996-4#3)
lower cutoff##2##2##(2008-2#1)(2012-2#1)
lower degree of##3##3##(1996-12#1)(2007-10#1)(2010-3#1)
lower density in the##2##4##(2008-7#1)(2008-9#1)
lower density in##3##3##(1993-12#1)(2008-7#1)(2008-9#1)
lower depression scores##2##3##(2010-7#1)(2012-12#1)
lower detection limit and##2##4##(2008-10#2)
lower detection limit of##11##4##(2008-10#10)(2008-11#1)
lower detection limit was##3##4##(1990-12#1)(1991-5#1)(2008-10#1)
lower detection limit##24##3##(1990-12#1)(1991-5#1)(2008-10#21)(2008-11#1)
lower detection limits##9##3##(2008-10#9)
lower detection##33##2##(1990-12#1)(1991-5#1)(2008-10#30)(2008-11#1)
lower developmental threshold##2##3##(2008-8#2)
lower dimensional##2##2##(2009-9#1)(2013-8#1)
lower disease incidence##2##3##(2008-10#2)
lower disease severity##2##3##(2008-10#2)
lower disease##4##2##(2008-10#4)
lower dosages of##2##3##(1992-12#1)(2008-10#1)
lower dose of##3##3##(1994-6#1)(1995-5#1)(2008-10#1)
lower dose##10##2##(1994-5#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2012-3#2)
lower doses of EPO##2##4##(2007-7#1)(2008-1#1)
lower doses of##6##3##(1991-11#1)(1993-12#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)
lower doses##16##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#3)(2011-1#1)
lower during##2##2##(2008-5#1)(2011-2#1)
lower educational level##2##3##(2009-5#1)(2013-1#1)
lower educational##5##2##(2009-5#1)(2009-7#1)(2013-1#2)(2013-8#1)
lower efficacy##2##2##(2008-10#1)(2008-5#1)
lower efficiency##2##2##(1992-11#1)(1992-12#1)
lower elevations##2##2##(1996-12#1)(2009-2#1)
lower energy##5##2##(2007-11#1)(2008-7#2)(2008-8#1)(2010-5#1)
lower enhancement##2##2##(1997-8#1)(2008-4#1)
lower esophageal sphincter (LES)##3##4##(2011-2#1)(2013-8#2)
lower esophageal sphincter##8##3##(1992-6#1)(1992-9#1)(2011-2#1)(2012-3#1)(2013-8#4)
lower eukaryotes##6##2##(1995-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2012-2#1)
lower expression of##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
lower expression##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
lower extremities and##2##3##(1993-6#1)(2009-5#1)
lower extremities##28##2##(1990-5#1)(1993-6#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#4)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)
lower extremity function##2##3##(1996-3#1)(2013-1#1)
lower extremity injuries##2##3##(2013-1#2)
lower extremity of##2##3##(1993-8#1)(2008-6#1)
lower extremity pain##2##3##(2012-2#2)
lower extremity weakness##2##3##(2008-8#1)(2009-3#1)
lower extremity##43##2##(1991-12#1)(1993-8#1)(1996-3#4)(2007-11#2)(2008-12#4)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#6)
lower eye lid##2##3##(2007-7#2)
lower eyelid sagging##2##3##(2008-5#2)
lower eyelid##5##2##(2008-5#5)
lower female reproductive##3##3##(1996-12#2)(2008-5#1)
lower female##6##2##(1990-2#1)(1994-1#1)(1996-12#3)(2008-5#1)
lower flow##2##2##(2008-7#1)(2010-4#1)
lower flux##3##2##(2008-10#1)(2008-7#2)
lower following##2##2##(2010-8#1)(2012-12#1)
lower for patients##2##3##(1990-12#1)(2010-10#1)
lower for the##2##3##(2008-10#2)
lower for##32##2##(1990-12#2)(1993-11#1)(1993-2#1)(1995-1#2)(1995-2#1)(1997-2#1)(2008-10#15)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#1)
lower fraction of##4##3##(1991-11#2)(2008-7#2)
lower fraction##5##2##(1991-11#2)(1994-2#1)(2008-7#2)
lower frequency of##8##3##(1991-3#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-3#1)(2013-1#1)
lower frequency##11##2##(1991-3#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
lower gastrointestinal bleeding in##2##4##(2010-8#1)(2013-1#1)
lower gastrointestinal bleeding##5##3##(2010-8#1)(2011-2#1)(2013-1#3)
lower gastrointestinal##7##2##(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#4)
lower genital tract##9##3##(1991-2#2)(1992-3#2)(1994-1#1)(2011-2#4)
lower genotypic diversity##2##3##(2008-10#2)
lower global##2##2##(1992-3#1)(2011-2#1)
lower growth rate##2##3##(2008-5#1)(2008-9#1)
lower immune responses##2##3##(2008-9#1)(2013-1#1)
lower immune##4##2##(2008-9#1)(2011-2#1)(2013-1#2)
lower in both##2##3##(2008-10#1)(2008-7#1)
lower in comparison with the control group##2##7##(2007-11#2)
lower in comparison##3##3##(2007-11#3)
lower in energy than##2##4##(1996-5#1)(2011-2#1)
lower in males##2##3##(1991-6#2)
lower in men##2##3##(2011-1#1)(2013-8#1)
lower in old##2##3##(1991-12#1)(2008-7#1)
lower in older##2##3##(1995-5#1)(2008-7#1)
lower in patients with##4##4##(1990-2#1)(2008-7#1)(2009-4#1)(2012-3#1)
lower in patients##6##3##(1990-2#1)(1993-1#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
lower in subjects##2##3##(2008-5#1)(2013-1#1)
lower in the Alzheimer##2##4##(1990-3#2)
lower in the flexed left lateral##2##6##(1993-10#2)
lower in the obese patients##2##5##(2011-1#1)(2011-2#1)
lower in the##45##3##(1990-12#1)(1990-3#2)(1991-11#1)(1993-10#2)(1993-8#1)(1994-2#2)(1996-5#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
lower in##148##2##(1990-12#1)(1990-2#2)(1990-3#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-6#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-8#1)(1994-2#4)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
lower incidence of##10##3##(1990-8#1)(1992-3#1)(1996-3#1)(2008-10#4)(2011-1#1)(2011-2#2)
lower incidence##13##2##(1990-8#1)(1992-3#1)(1992-9#1)(1996-3#1)(2008-10#5)(2011-1#1)(2011-2#2)(2013-1#1)
lower income##2##2##(2009-5#1)(2011-2#1)
lower infection##2##2##(2008-10#2)
lower intensity of##2##3##(2008-7#1)(2012-12#1)
lower intensity##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
lower intestinal##2##2##(1992-5#2)
lower jaw##6##2##(1993-12#1)(2007-5#1)(2008-5#1)(2008-7#1)(2013-1#2)
lower leaf##2##2##(2008-10#1)(2012-9#1)
lower leaves##2##2##(2008-10#2)
lower left##3##2##(2011-2#1)(2013-1#2)
lower leg and##2##3##(1997-8#1)(2011-2#1)
lower leg muscles##2##3##(1995-12#2)
lower leg##20##2##(1990-11#2)(1991-3#1)(1994-6#1)(1995-12#2)(1997-8#2)(2007-11#1)(2007-8#6)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#2)
lower legs##3##2##(1993-8#1)(1997-8#1)(2007-2#1)
lower level of##17##3##(1992-11#1)(1992-8#1)(1993-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
lower level##22##2##(1990-3#1)(1992-11#1)(1992-8#1)(1993-8#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-12#1)(2010-11#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
lower levels in##2##3##(1992-10#1)(1995-2#1)
lower levels of safer##2##4##(2009-5#2)
lower levels of social##2##4##(1996-1#1)(1997-1#1)
lower levels of total##2##4##(2008-10#1)(2008-7#1)
lower levels of##50##3##(1990-3#1)(1991-1#1)(1993-1#1)(1993-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#3)(2009-7#6)(2010-6#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
lower levels than##3##3##(2008-6#1)(2012-1#1)(2012-2#1)
lower levels##65##2##(1990-12#2)(1990-3#1)(1991-1#1)(1992-10#1)(1993-1#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(2007-11#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#3)(2009-7#6)(2010-6#2)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#1)
lower life satisfaction##3##3##(2009-5#2)(2012-1#1)
lower limb amputations##2##3##(2008-1#1)(2008-7#1)
lower limb inequality##3##3##(2013-1#3)
lower limb ischemia##2##3##(2008-7#1)(2012-2#1)
lower limb##33##2##(1990-11#1)(1990-3#1)(1990-6#1)(1995-2#1)(2007-11#5)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#4)(2009-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
lower limbs##25##2##(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#2)(1993-5#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2012-1#2)(2012-2#2)(2013-1#1)
lower limit of detection (LOD)##5##5##(2008-10#5)
lower limit of detection of##3##5##(2008-10#3)
lower limit of detection was##3##5##(2008-10#1)(2010-5#2)
lower limit of detection##14##4##(2008-10#12)(2010-5#2)
lower limit of quantification##3##4##(2008-10#1)(2011-2#2)
lower limit of quantitation was 0##2##6##(2008-10#2)
lower limit of quantitation was##3##5##(2008-10#3)
lower limit of quantitation##5##4##(1996-5#1)(2008-10#4)
lower limit of##27##3##(1991-5#1)(1996-5#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#2)(2011-2#2)
lower limit##31##2##(1991-5#1)(1996-5#1)(2008-1#1)(2008-10#19)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#2)(2011-2#2)
lower limits of detection and##4##5##(2008-10#3)(2009-7#1)
lower limits of detection##9##4##(2008-10#7)(2008-2#1)(2009-7#1)
lower limits of##12##3##(2008-10#8)(2008-2#1)(2008-7#1)(2009-7#1)(2011-3#1)
lower limits##14##2##(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-3#1)
lower lip and##3##3##(1993-12#1)(2007-5#1)(2012-3#1)
lower lip##8##2##(1991-8#2)(1993-12#1)(2007-12#1)(2007-5#1)(2012-3#1)(2013-1#2)
lower lobe and##2##3##(2007-8#2)
lower lobe artery##2##3##(2007-8#2)
lower lobe of the##3##4##(1992-2#1)(2007-7#1)(2007-8#1)
lower lobe##20##2##(1991-3#1)(1992-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#10)(2008-1#3)(2008-6#2)
lower lobectomy was performed##3##4##(2008-1#2)(2008-7#1)
lower lung fields##2##3##(2008-1#1)(2012-12#1)
lower lung lobe##2##3##(2008-1#1)(2008-6#1)
lower lung##9##2##(1991-2#1)(1996-3#1)(2008-1#5)(2008-6#1)(2012-12#1)
lower maximal##2##2##(1995-12#1)(2008-11#1)
lower mean values##3##3##(1990-2#1)(1991-12#1)(2008-7#1)
lower mean##7##2##(1990-2#1)(1991-12#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-9#2)
lower molecular weight##2##3##(1993-11#1)(1995-8#1)
lower molecular##3##2##(1990-12#1)(1993-11#1)(1995-8#1)
lower morbidity##5##2##(1992-3#1)(2007-10#1)(2008-10#1)(2010-5#1)(2012-12#1)
lower mortality##5##2##(2008-7#1)(2012-12#1)(2013-1#3)
lower nitrates##2##2##(2009-5#2)
lower number of##7##3##(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
lower numbers of##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
lower numbers##4##2##(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
lower occurrence of##2##3##(2008-10#1)(2012-3#1)
lower odds of##2##3##(2010-7#1)(2011-2#1)
lower odds##3##2##(2010-7#1)(2011-2#1)(2012-3#1)
lower on the##3##3##(2008-5#1)(2010-8#2)
lower on##7##2##(2008-10#1)(2008-5#1)(2009-7#1)(2010-8#3)(2011-2#1)
lower or##3##2##(1995-5#1)(2008-10#2)
lower out-of-pocket medical expenditures and medical debt (including fewer bills sent to collection)##2##13##(2013-1#2)
lower pH##7##2##(1990-8#1)(1992-12#1)(2008-10#3)(2010-4#1)(2013-1#1)
lower pain##2##2##(2008-12#1)(2013-1#1)
lower part of the##3##4##(1996-12#1)(2008-10#2)
lower part of##5##3##(1995-3#1)(1996-12#1)(2008-10#2)(2008-12#1)
lower part##7##2##(1993-9#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-12#1)
lower parts##6##2##(2008-10#2)(2008-12#2)(2013-1#2)
lower patency rate##2##3##(1993-1#1)(2007-10#1)
lower patient##2##2##(2009-9#1)(2012-12#1)
lower performance in##3##3##(1991-2#1)(2009-10#1)(2013-8#1)
lower physical##2##2##(2008-6#1)(2012-2#1)
lower plasma##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
lower pole##3##2##(2007-10#1)(2008-10#1)(2008-9#1)
lower population densities##2##3##(2008-10#2)
lower population##5##2##(2008-10#3)(2008-8#2)
lower power##4##2##(1992-12#1)(2007-11#1)(2008-3#1)(2008-7#1)
lower precision##2##2##(2008-10#1)(2008-2#1)
lower prevalence of##3##3##(1992-9#1)(2007-12#2)
lower prevalence##6##2##(1992-9#1)(2007-12#2)(2008-7#1)(2012-3#2)
lower productivity##3##2##(1997-4#1)(2008-11#2)
lower proportions of##2##3##(1992-2#1)(2012-3#1)
lower protein##3##2##(2007-12#1)(2008-7#1)(2013-8#1)
lower quality and##2##3##(1993-12#1)(2008-9#1)
lower quality##4##2##(1993-12#1)(1994-2#1)(2008-9#1)(2010-9#1)
lower rate of##7##3##(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#3)
lower rate##9##2##(2007-4#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#3)
lower rates of##6##3##(1992-6#1)(2007-2#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
lower rates than predicted by##2##5##(2008-6#1)(2008-8#1)
lower rates##10##2##(1992-6#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2012-12#1)(2013-1#1)
lower ratio of##2##3##(1992-11#1)(2009-4#1)
lower ratio##3##2##(1992-11#1)(2008-6#1)(2009-4#1)
lower relative##2##2##(1991-12#1)(1996-5#1)
lower reproductive tract infections among women aged 25 - 54 years in Beijing##3##13##(2011-1#3)
lower reproductive tract infections##4##4##(2011-1#4)
lower reproductive tract##7##3##(1996-12#2)(2011-1#5)
lower reproductive##8##2##(1996-12#2)(2011-1#5)(2013-7#1)
lower resistance##3##2##(1990-5#1)(1992-6#1)(2013-8#1)
lower resolution##4##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)
lower respiratory tract infection##3##4##(1996-3#1)(2008-7#1)(2010-10#1)
lower respiratory tract infections in##2##5##(2008-11#1)(2009-2#1)
lower respiratory tract infections##5##4##(2008-11#1)(2009-2#2)(2009-3#1)(2010-5#1)
lower respiratory tract##14##3##(1991-6#1)(1992-11#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-7#1)(2009-2#2)(2009-3#2)(2010-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
lower respiratory##17##2##(1991-6#1)(1992-11#1)(1994-2#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-2#2)(2009-3#2)(2010-10#1)(2010-5#1)(2012-12#1)(2013-8#2)
lower risk for##2##3##(2009-8#1)(2013-8#1)
lower risk of developing##2##4##(2008-1#1)(2009-3#1)
lower risk of##12##3##(1990-3#1)(1990-5#1)(1991-11#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2012-12#1)(2013-1#3)
lower risk##15##2##(1990-3#1)(1990-5#1)(1991-11#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-8#1)(2012-12#1)(2013-1#3)(2013-8#1)
lower root##2##2##(2008-10#1)(2008-9#1)
lower scale##2##2##(2008-10#2)
lower scores for##2##3##(2008-7#1)(2013-7#1)
lower scores on all##2##4##(2007-12#1)(2013-1#1)
lower scores on##4##3##(2007-12#2)(2008-12#1)(2013-1#1)
lower scores##8##2##(2007-12#2)(2008-12#1)(2008-7#2)(2010-10#1)(2013-1#1)(2013-7#1)
lower sensitivity to##5##3##(1991-6#1)(2008-8#1)(2012-12#2)(2012-3#1)
lower sensitivity##7##2##(1991-6#1)(2008-10#1)(2008-8#1)(2012-12#2)(2012-3#2)
lower serum cholesterol##2##3##(1991-6#2)
lower serum magnesium##2##3##(2011-2#2)
lower serum##5##2##(1991-6#2)(2007-12#1)(2011-2#2)
lower small intestine##3##3##(2008-5#3)
lower socioeconomic status##3##3##(2006-10#1)(2011-2#2)
lower socioeconomic##4##2##(2006-10#1)(2010-6#1)(2011-2#2)
lower spatial##3##2##(2008-2#1)(2009-1#1)(2011-1#1)
lower stability of##2##3##(2008-10#2)
lower stability##3##2##(1992-10#1)(2008-10#2)
lower stem##2##2##(2008-10#2)
lower stems##3##2##(2008-10#3)
lower stratosphere##8##2##(2008-2#1)(2008-3#7)
lower stress##2##2##(2008-7#1)(2012-1#1)
lower survival rates##2##3##(2008-11#1)(2009-10#1)
lower survival than##2##3##(2008-10#1)(2012-3#1)
lower survival##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
lower susceptibility##2##2##(2008-10#1)(2008-5#1)
lower temperature##11##2##(1992-10#1)(1992-8#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#3)
lower temperatures and##2##3##(2008-10#2)
lower temperatures##10##2##(1994-3#1)(1995-5#1)(2008-10#6)(2008-9#2)
lower than 0##14##3##(2008-10#12)(2008-3#1)(2012-1#1)
lower than 1##5##3##(2008-10#4)(2008-2#1)
lower than 1%##5##3##(2007-11#1)(2008-10#4)
lower than 10##3##3##(1996-2#1)(2008-10#2)
lower than 10% for##2##4##(2008-10#2)
lower than 10%##6##3##(2008-10#6)
lower than 100##2##3##(1990-12#1)(2008-10#1)
lower than 2##3##3##(2008-10#2)(2008-6#1)
lower than 2%##3##3##(2008-10#3)
lower than 20%##2##3##(2008-10#2)
lower than 3##6##3##(1990-2#1)(2008-10#4)(2012-12#1)
lower than 4##4##3##(2008-10#4)
lower than 40%##2##3##(1991-12#1)(1997-3#1)
lower than 5##2##3##(2008-10#1)(2012-1#1)
lower than 5%##2##3##(2008-10#2)
lower than 7##2##3##(1990-9#1)(2008-10#1)
lower than 7%##2##3##(2008-10#2)
lower than 90%##2##3##(2008-10#2)
lower than 98 fl##2##4##(1990-3#2)
lower than controls##2##3##(1993-3#1)(1994-8#1)
lower than expected##8##3##(1991-2#1)(1995-1#1)(1996-3#1)(2007-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)
lower than for##5##3##(1995-3#1)(2008-10#3)(2012-1#1)
lower than had##2##3##(2008-10#1)(2008-2#1)
lower than in control##7##4##(1991-11#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)
lower than in controls##3##4##(1992-11#1)(2008-7#1)(2011-2#1)
lower than in patients without##2##5##(2007-8#1)(2008-7#1)
lower than in patients##3##4##(1993-2#1)(2007-8#1)(2008-7#1)
lower than in the##14##4##(1990-8#1)(1995-11#1)(1995-8#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
lower than in those##3##4##(1997-3#1)(2011-2#2)
lower than in##46##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#2)(1992-11#1)(1992-3#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#7)(2008-8#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#4)(2013-1#1)
lower than normal##6##3##(1993-3#1)(2007-2#1)(2007-7#3)(2008-10#1)
lower than other##4##3##(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
lower than predicted by##3##4##(1995-11#1)(2008-7#1)(2013-8#1)
lower than that for##5##4##(1992-3#1)(1993-8#1)(1994-7#1)(1995-2#1)(2008-11#1)
lower than that found in##2##5##(1990-6#1)(2008-10#1)
lower than that in the##5##5##(1995-4#1)(1995-8#1)(2008-11#1)(2010-8#1)(2012-2#1)
lower than that in##10##4##(1993-11#1)(1995-4#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
lower than that measured##2##4##(1996-2#1)(2008-10#1)
lower than that observed##3##4##(1994-2#1)(1995-8#1)(2008-11#1)
lower than that obtained##2##4##(2008-11#1)(2009-10#1)
lower than that of the bare##2##6##(2008-10#2)
lower than that of the##13##5##(1990-11#1)(1991-8#1)(1995-2#1)(1997-5#1)(2008-10#5)(2008-4#1)(2008-9#1)(2010-1#1)(2011-1#1)
lower than that of##40##4##(1990-11#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)
lower than that reported##4##4##(1997-8#1)(2008-10#1)(2008-5#1)(2009-5#1)
lower than that##79##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-8#2)(1996-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
lower than the Km for the androgenic steroid##2##8##(1990-11#2)
lower than the average##2##4##(1992-6#1)(2011-2#1)
lower than the corresponding##3##4##(1990-8#1)(2008-10#1)(2009-9#1)
lower than the mean##2##4##(2008-7#1)(2009-11#1)
lower than the other##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
lower than the##53##3##(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-8#2)(1996-12#1)(1996-4#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#4)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
lower than their##2##3##(2008-10#1)(2008-3#1)
lower than those detected in##2##5##(1995-12#1)(2008-10#1)
lower than those for the##2##5##(1995-5#1)(2008-11#1)
lower than those in other##2##5##(2008-10#2)
lower than those in the##4##5##(2010-8#1)(2011-2#2)(2012-3#1)
lower than those in##12##4##(1994-2#1)(1995-8#1)(2008-10#2)(2008-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
lower than those obtained with the##2##6##(2008-10#2)
lower than those obtained##4##4##(1990-8#1)(2008-10#2)(2008-11#1)
lower than those of the##9##5##(1990-2#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-3#1)(2013-1#1)
lower than those of##21##4##(1990-2#1)(1990-6#1)(1990-8#1)(1993-12#1)(1995-8#1)(1997-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
lower than those##54##3##(1990-2#1)(1990-6#1)(1990-8#3)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#2)(1997-6#1)(2006-10#1)(2008-10#15)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#3)
lower than what##2##3##(2008-6#1)(2009-7#1)
lower than with the##2##4##(2008-3#1)(2010-8#1)
lower than with##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
lower than##410##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#5)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#7)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#6)(2007-8#1)(2008-10#136)(2008-11#16)(2008-12#9)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#16)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#6)(2011-1#6)(2011-2#15)(2011-3#2)(2012-1#6)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#9)(2013-8#2)
lower the detection##2##3##(2008-10#1)(2008-2#1)
lower the risk of##3##4##(1996-3#1)(2010-8#1)(2011-1#1)
lower the##31##2##(1990-12#1)(1992-11#1)(1993-3#1)(1994-12#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
lower thoracic##5##2##(1993-12#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-3#1)
lower threshold##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)
lower to##4##2##(1990-12#1)(1997-2#2)(2008-10#1)
lower tooth##2##2##(2008-12#1)(2012-2#1)
lower total##8##2##(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2013-1#2)(2013-8#1)
lower toxicity##5##2##(1990-11#1)(1997-4#1)(2008-10#2)(2012-12#1)
lower trapezius##6##2##(2007-5#2)(2010-9#4)
lower under##2##2##(2008-7#1)(2012-12#1)
lower urinary tract symptoms (LUTS)##2##5##(2008-1#1)(2013-1#1)
lower urinary tract symptoms##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
lower urinary tract##10##3##(1991-11#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
lower urinary##13##2##(1991-11#3)(2007-7#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
lower value##3##2##(1991-9#1)(1994-6#1)(2013-1#1)
lower values for##2##3##(2008-10#1)(2008-7#1)
lower values of##7##3##(1995-12#1)(1996-3#1)(2007-11#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
lower values than##4##3##(1991-5#1)(1996-3#1)(2011-2#2)
lower values were##2##3##(2008-10#1)(2010-6#1)
lower values##19##2##(1991-5#1)(1995-12#1)(1996-3#2)(1996-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)
lower vertebrates##4##2##(1994-5#1)(2008-12#1)(2008-4#1)(2010-3#1)
lower vitamin D##2##3##(2012-2#1)(2012-3#1)
lower water##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
lower weight##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
lower when compared to##2##4##(2008-12#1)(2013-8#1)
lower when compared##3##3##(2008-12#1)(2012-3#1)(2013-8#1)
lower when##7##2##(1990-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
lower with the##2##3##(1995-2#1)(2011-2#1)
lower with##5##2##(1995-2#1)(1996-8#1)(2008-10#1)(2011-2#2)
lower yeast##2##2##(2008-10#1)(2008-7#1)
lower yield##2##2##(2008-10#1)(2008-5#1)
lower##2395##1##(1990-11#12)(1990-12#16)(1990-2#6)(1990-3#14)(1990-5#7)(1990-6#8)(1990-7#2)(1990-8#13)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#14)(1991-12#12)(1991-2#6)(1991-3#8)(1991-4#1)(1991-5#4)(1991-6#14)(1991-8#5)(1991-9#4)(1992-10#5)(1992-11#10)(1992-12#7)(1992-2#4)(1992-3#13)(1992-5#5)(1992-6#9)(1992-8#5)(1992-9#12)(1993-1#5)(1993-10#2)(1993-11#5)(1993-12#17)(1993-2#4)(1993-3#8)(1993-5#2)(1993-6#5)(1993-8#9)(1993-9#6)(1994-1#3)(1994-11#3)(1994-12#5)(1994-2#19)(1994-3#3)(1994-5#3)(1994-6#8)(1994-7#4)(1994-8#6)(1994-9#3)(1995-1#5)(1995-11#4)(1995-12#10)(1995-2#14)(1995-3#10)(1995-4#2)(1995-5#9)(1995-6#7)(1995-8#11)(1996-1#4)(1996-12#16)(1996-2#10)(1996-3#18)(1996-4#11)(1996-5#14)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#12)(1997-3#9)(1997-4#6)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#14)(2006-10#6)(2007-10#20)(2007-11#35)(2007-12#21)(2007-2#5)(2007-4#1)(2007-5#10)(2007-7#15)(2007-8#32)(2008-1#28)(2008-10#490)(2008-11#73)(2008-12#43)(2008-2#26)(2008-3#57)(2008-4#12)(2008-5#48)(2008-6#31)(2008-7#121)(2008-8#44)(2008-9#48)(2009-1#4)(2009-10#6)(2009-11#4)(2009-12#8)(2009-2#4)(2009-3#10)(2009-4#3)(2009-5#17)(2009-6#1)(2009-7#18)(2009-8#8)(2009-9#6)(2010-1#6)(2010-10#4)(2010-11#9)(2010-12#6)(2010-2#8)(2010-3#5)(2010-4#14)(2010-5#8)(2010-6#8)(2010-7#6)(2010-8#20)(2010-9#6)(2011-1#41)(2011-2#116)(2011-3#6)(2011-7#1)(2012-1#19)(2012-12#41)(2012-2#50)(2012-3#40)(2012-5#3)(2012-7#2)(2012-9#1)(2013-1#113)(2013-3#1)(2013-7#9)(2013-8#42)
lower-cost##2##1##(1992-11#1)(1994-2#1)
lower-extremity##4##1##(2007-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
lower-income##4##1##(2011-1#2)(2012-3#2)
lower-leg##2##1##(2010-5#1)(2011-1#1)
lower-level##2##1##(2008-6#1)(2013-1#1)
lower-limb##7##1##(2007-5#1)(2007-7#3)(2011-2#3)
lower-order##4##1##(1994-2#1)(2011-2#3)
lower-risk##2##1##(1990-5#1)(2010-12#1)
lower-scattering##2##1##(2008-3#2)
lowered and##2##2##(1994-3#1)(2011-2#1)
lowered at##2##2##(2008-5#1)(2012-1#1)
lowered blood##2##2##(2008-11#1)(2008-5#1)
lowered by##7##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(1996-12#1)(2007-11#1)(2008-10#1)
lowered cell##2##2##(2009-12#1)(2009-6#1)
lowered cellular##2##2##(1994-11#1)(2008-10#1)
lowered in##2##2##(2008-10#1)(2010-5#1)
lowered mean##2##2##(1991-5#1)(2007-10#1)
lowered the blood##2##3##(1994-11#1)(2008-10#1)
lowered the number of##2##4##(2008-10#1)(2008-7#1)
lowered the##19##2##(1992-12#3)(1992-3#1)(1994-11#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
lowered##86##1##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#15)(2008-11#7)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
lowering diets##2##2##(2008-4#2)
lowering drugs##6##2##(1990-2#1)(2008-11#2)(2008-5#1)(2009-4#1)(2013-1#1)
lowering may##2##2##(2008-4#1)(2009-11#1)
lowering of blood##2##3##(2010-2#1)(2011-2#1)
lowering of the##7##3##(1991-8#1)(1997-5#1)(2008-10#3)(2010-11#1)(2013-1#1)
lowering of##30##2##(1991-12#1)(1991-6#2)(1991-8#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-5#1)(2007-11#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
lowering the concentration of##2##4##(1995-5#1)(2008-10#1)
lowering the pH to 5##2##5##(1991-8#2)
lowering the pH##3##3##(1991-8#3)
lowering the##22##2##(1991-8#3)(1993-1#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-10#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
lowering with##4##2##(2008-5#3)(2013-8#1)
lowering##112##1##(1990-2#2)(1990-7#1)(1991-12#2)(1991-6#2)(1991-8#7)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-5#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-10#3)(2007-11#3)(2008-1#5)(2008-10#16)(2008-11#9)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
lowers blood##2##2##(2007-10#1)(2008-11#1)
lowers the##9##2##(1993-12#1)(1995-2#1)(1996-2#2)(2007-8#1)(2008-10#1)(2008-2#2)(2010-5#1)
lowers##19##1##(1990-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1995-2#1)(1995-8#1)(1996-2#2)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)
lowest at##4##2##(2007-5#1)(2008-10#1)(2008-12#2)
lowest average##2##2##(1990-2#1)(2012-12#1)
lowest capacity##2##2##(2008-10#1)(2013-1#1)
lowest concentration of##5##3##(2008-10#3)(2010-10#1)(2013-8#1)
lowest concentration##11##2##(1991-12#1)(1991-9#1)(1994-11#1)(2008-10#5)(2010-10#1)(2012-1#1)(2013-8#1)
lowest detected##3##2##(2008-10#2)(2009-5#1)
lowest detection limit##3##3##(2008-10#3)
lowest detection##5##2##(2008-10#5)
lowest energy##2##2##(1993-8#1)(2011-2#1)
lowest fitness##2##2##(2008-10#2)
lowest for##5##2##(1992-8#1)(1993-9#1)(2008-10#2)(2008-9#1)
lowest in the##7##3##(1993-8#1)(1996-12#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-2#1)
lowest in##28##2##(1991-6#1)(1993-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-7#2)(2010-2#1)(2013-8#1)
lowest level of##4##3##(1996-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
lowest level##12##2##(1993-2#1)(1996-12#1)(1996-8#1)(2008-10#4)(2008-8#1)(2012-3#1)(2013-1#3)
lowest levels of##4##3##(2008-10#1)(2009-8#1)(2010-5#1)(2013-1#1)
lowest limit of detection##3##4##(2008-10#3)
lowest limit##4##2##(2008-10#4)
lowest motility##2##2##(2008-12#2)
lowest on the##2##3##(2008-5#1)(2011-2#1)
lowest on##5##2##(2008-10#2)(2008-5#1)(2009-7#1)(2011-2#1)
lowest possible cost##2##3##(1997-1#1)(2008-11#1)
lowest possible##3##2##(1997-1#1)(2008-11#1)(2008-6#1)
lowest prevalence of##2##3##(2007-7#1)(2008-10#1)
lowest quartile of##2##3##(2007-10#1)(2013-1#1)
lowest resistance##2##2##(2007-7#1)(2008-10#1)
lowest scores##2##2##(2009-11#1)(2012-3#1)
lowest unoccupied##2##2##(1996-2#1)(2013-1#1)
lowest values##5##2##(2008-10#3)(2008-11#1)(2013-1#1)
lowest was##5##2##(2008-12#3)(2008-5#1)(2013-8#1)
lowest with##2##2##(2008-10#1)(2008-12#1)
lowest##289##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#4)(1991-9#1)(1992-8#1)(1993-12#2)(1993-2#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#94)(2008-11#7)(2008-12#15)(2008-2#5)(2008-3#10)(2008-5#10)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#3)
lowest-order Hermite-Gaussian laser##2##3##(2007-12#2)
lowest-order modes##3##2##(2008-3#3)
lowest-order##12##1##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#5)
lowland rice##2##2##(2008-10#2)
lowland##10##1##(2008-10#3)(2008-5#2)(2008-8#2)(2010-8#2)(2013-1#1)
lowlands##3##1##(2013-1#2)(2013-7#1)
lows##3##1##(1994-1#1)(1994-2#1)(2012-2#1)
loyal##2##1##(1995-12#1)(2009-7#1)
loyalty of##2##2##(1994-12#1)(1996-1#1)
loyalty to##2##2##(1993-3#1)(1994-12#1)
loyalty##7##1##(1993-3#1)(1994-12#2)(1995-2#1)(1996-1#1)(1997-3#1)(2008-1#1)
lp/mm##3##1##(2008-2#1)(2008-3#2)
lpr##2##1##(1997-8#2)
lr34/yr18##2##1##(2008-10#2)
lts1##2##1##(2009-10#2)
lubricant##7##1##(2007-12#1)(2008-10#4)(2009-12#1)(2010-10#1)
lubricants by##2##2##(2008-10#1)(2010-4#1)
lubricants##10##1##(2008-10#2)(2008-7#2)(2009-12#2)(2010-4#4)
lubricating oil samples##3##3##(2008-10#3)
lubricating oil##7##2##(2008-10#7)
lubricating oils by##4##3##(2008-10#4)
lubricating oils##15##2##(2008-10#15)
lubricating##25##1##(1995-3#1)(2008-10#23)(2010-10#1)
lubrication and##2##2##(1994-9#1)(2010-10#1)
lubrication##6##1##(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#2)
lubricin##6##1##(2010-10#6)
lucent vacuoles and##2##3##(2007-12#2)
lucent##11##1##(2007-10#1)(2007-12#5)(2008-5#2)(2008-7#3)
lucetia##2##1##(2008-5#2)
lucidum and its##2##3##(2013-8#2)
lucidum and##3##2##(2013-8#3)
lucidum##12##1##(1997-2#2)(2008-11#3)(2013-8#7)
luciferase activity was##2##3##(2008-11#2)
luciferase activity##5##2##(1996-5#2)(2008-11#3)
luciferase and##3##2##(1993-6#1)(2008-10#1)(2008-4#1)
luciferase assay##2##2##(2008-11#1)(2009-8#1)
luciferase gene##7##2##(1991-2#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#3)
luciferase in##2##2##(2008-10#2)
luciferase reporter assay##2##3##(2011-2#1)(2013-1#1)
luciferase reporter gene##4##3##(1992-9#1)(1995-6#1)(1996-5#1)(2008-9#1)
luciferase reporter system##2##3##(2008-9#2)
luciferase reporter##10##2##(1992-9#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-9#4)(2011-2#1)(2013-1#1)
luciferase with##2##2##(1990-7#1)(2008-10#1)
luciferase##62##1##(1990-5#1)(1990-7#3)(1991-2#1)(1991-9#2)(1992-9#1)(1993-6#1)(1995-2#5)(1995-6#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-4#1)(2008-10#11)(2008-11#14)(2008-4#2)(2008-8#3)(2008-9#5)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
luciferase-encoding##2##1##(1993-6#1)(1997-4#1)
luciferases##3##1##(1990-7#3)
luciferin##4##1##(1997-4#1)(2008-10#3)
lucigenin CL##4##2##(1991-9#3)(2008-10#1)
lucigenin by##2##2##(2008-10#2)
lucigenin##14##1##(1991-9#3)(2008-10#11)
lucky##3##1##(1996-11#1)(2012-2#1)(2012-3#1)
lucrative##4##1##(1996-1#1)(1997-3#1)(2009-7#1)(2010-8#1)
ludens##3##1##(2011-2#3)
lugubris##3##1##(2007-12#3)
lumbago##3##1##(1991-11#1)(1991-12#1)(2008-7#1)
lumbal##2##1##(1997-3#1)(2013-1#1)
lumbar BMC##2##2##(1991-11#2)
lumbar CSF##2##2##(1993-1#2)
lumbar bone##2##2##(1991-11#1)(2011-1#1)
lumbar disc degeneration##2##3##(2012-12#1)(2013-8#1)
lumbar disc disease or##2##4##(2008-12#1)(2013-1#1)
lumbar disc disease##4##3##(2007-11#1)(2007-8#1)(2008-12#1)(2013-1#1)
lumbar disc herniation##7##3##(1997-2#1)(1997-3#1)(2007-11#1)(2008-12#3)(2013-1#1)
lumbar disc replacement in##2##4##(2012-12#2)
lumbar disc##18##2##(1997-2#1)(1997-3#1)(2007-11#3)(2007-8#2)(2008-12#4)(2012-12#4)(2013-1#2)(2013-8#1)
lumbar discs##2##2##(2007-8#1)(2012-3#1)
lumbar disk prolapse##2##3##(1992-5#1)(1997-2#1)
lumbar disk##5##2##(1990-9#1)(1992-5#1)(1997-2#1)(2007-10#1)(2009-3#1)
lumbar dorsal##2##2##(2008-4#1)(2013-8#1)
lumbar epidural##2##2##(2009-5#1)(2011-2#1)
lumbar hernia##3##2##(1993-9#1)(2008-12#2)
lumbar hernias are##2##3##(2008-12#2)
lumbar hernias##3##2##(2008-12#2)(2010-8#1)
lumbar interbody fusion##6##3##(2008-11#3)(2011-2#3)
lumbar lateral##3##2##(2011-2#2)(2012-2#1)
lumbar pain##2##2##(2007-11#2)
lumbar paravertebral muscles##3##3##(1997-2#3)
lumbar puncture##11##2##(1990-12#1)(1994-12#1)(1995-11#3)(2008-1#1)(2008-7#2)(2010-11#1)(2012-2#1)(2012-3#1)
lumbar punctures and##2##3##(1996-2#1)(2008-7#1)
lumbar scoliosis in the##2##4##(1997-4#1)(2008-8#1)
lumbar scoliosis##3##2##(1997-4#1)(2008-8#2)
lumbar space and##2##3##(1993-9#2)
lumbar space##3##2##(1993-9#3)
lumbar spinal cord##4##3##(1990-5#2)(1993-12#1)(2008-7#1)
lumbar spinal stenosis##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
lumbar spinal##11##2##(1990-5#2)(1993-12#1)(2007-8#2)(2008-7#3)(2008-8#1)(2012-12#1)(2012-2#1)
lumbar spine and##2##3##(1991-11#1)(2011-2#1)
lumbar spine in##3##3##(1991-11#1)(2012-1#2)
lumbar spine surgery##10##3##(2008-7#3)(2012-12#7)
lumbar spine##48##2##(1991-11#3)(1993-11#1)(2007-11#5)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2010-1#1)(2010-3#4)(2011-2#5)(2012-1#4)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#1)
lumbar vein##5##2##(1991-8#1)(2011-2#4)
lumbar vertebrae##7##2##(1996-6#1)(1997-4#2)(2011-2#1)(2013-1#1)(2013-8#2)
lumbar vertebral##3##2##(1997-4#1)(2008-7#1)(2011-2#1)
lumbar##210##1##(1990-12#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-11#6)(1991-8#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-9#5)(1994-12#1)(1995-11#3)(1996-2#1)(1996-3#2)(1996-6#3)(1997-2#5)(1997-3#1)(1997-4#4)(2006-12#1)(2007-10#1)(2007-11#13)(2007-8#12)(2008-1#1)(2008-11#5)(2008-12#10)(2008-4#2)(2008-6#1)(2008-7#12)(2008-8#8)(2009-3#2)(2009-5#1)(2010-1#2)(2010-11#1)(2010-3#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#23)(2012-1#6)(2012-12#23)(2012-2#13)(2012-3#5)(2013-1#12)(2013-8#6)
lumber##2##1##(2008-10#2)
lumbo-pelvic##3##1##(2009-9#2)(2012-3#1)
lumbo-sacral junction##2##2##(2008-12#2)
lumbo-sacral spine after##2##3##(2007-11#2)
lumbo-sacral spine##5##2##(2007-11#5)
lumbo-sacral##9##1##(2007-11#5)(2008-12#4)
lumborum and##3##2##(2010-4#2)(2012-1#1)
lumborum##6##1##(2010-4#4)(2012-1#2)
lumbosacral PVM##3##2##(2013-8#3)
lumbosacral area##3##2##(2007-8#1)(2010-6#2)
lumbosacral schwannoma in##2##3##(2012-12#2)
lumbosacral##23##1##(1995-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#3)(2009-11#1)(2009-9#1)(2010-6#2)(2012-12#3)(2012-3#2)(2013-8#5)
lumen and##6##2##(1996-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#2)
lumen are##2##2##(2008-7#2)
lumen between##2##2##(2007-12#1)(2008-7#1)
lumen diameter##6##2##(1997-4#1)(2007-7#1)(2008-3#1)(2009-1#2)(2011-2#1)
lumen even##2##2##(2008-7#1)(2011-2#1)
lumen in the##2##3##(2007-8#1)(2008-10#1)
lumen in##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
lumen is##5##2##(1991-12#1)(2007-12#2)(2007-8#1)(2011-2#1)
lumen of the gland##2##4##(2007-12#2)
lumen of the##17##3##(1993-6#2)(1997-1#1)(1997-6#1)(2007-12#3)(2007-8#2)(2008-10#3)(2008-7#2)(2011-2#3)
lumen of##24##2##(1993-6#2)(1997-1#1)(1997-6#2)(2007-12#3)(2007-8#2)(2008-10#6)(2008-7#3)(2010-4#1)(2011-2#3)(2011-3#1)
lumen to##2##2##(1997-1#1)(2008-4#1)
lumen was##3##2##(2008-6#1)(2008-7#2)
lumen were observed##2##3##(1991-6#1)(2011-3#1)
lumen with##3##2##(1990-8#1)(2007-12#1)(2008-7#1)
lumen##119##1##(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-5#1)(1993-12#2)(1993-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-4#2)(1997-6#3)(1997-8#1)(2007-12#16)(2007-7#2)(2007-8#5)(2008-10#12)(2008-11#7)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#17)(2009-1#2)(2009-10#1)(2009-3#2)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#2)(2013-1#4)
lumens##2##1##(1994-9#1)(2010-3#1)
lumina##4##1##(1990-6#1)(1993-9#1)(2008-7#1)(2011-2#1)
luminaire##5##1##(2008-3#5)
luminal endothelial##2##2##(1995-2#2)
luminal fluid##3##2##(1991-12#1)(2008-5#2)
luminal narrowing##2##2##(2007-10#1)(2007-8#1)
luminal surface LDL concentration##3##4##(2008-9#3)
luminal surface##6##2##(1995-11#1)(2008-9#5)
luminal surfaces of##3##3##(1995-11#2)(2008-9#1)
luminal##35##1##(1991-12#1)(1992-9#1)(1993-6#1)(1995-11#3)(1995-2#3)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#6)(2009-12#3)(2010-12#2)(2010-3#1)(2011-2#1)(2013-1#1)
luminance and contrast##2##3##(2008-3#2)
luminance contrast##4##2##(1996-2#1)(1996-5#2)(2008-2#1)
luminance in a##2##3##(2008-3#2)
luminance in##3##2##(2008-3#3)
luminance levels##3##2##(2008-3#1)(2011-2#2)
luminance of##3##2##(2008-3#2)(2010-9#1)
luminance##32##1##(1992-8#1)(1996-2#4)(1996-5#3)(2007-12#1)(2008-2#3)(2008-3#11)(2008-8#1)(2010-9#5)(2011-2#3)
luminescence analysis was##2##3##(2008-10#2)
luminescence analysis##6##2##(2008-10#6)
luminescence and##4##2##(1995-3#1)(1996-12#1)(2008-10#2)
luminescence determination of oil products and phenols in natural water##2##10##(2008-10#2)
luminescence determination of##4##3##(2008-10#4)
luminescence for the##2##3##(2008-10#2)
luminescence from##3##2##(2007-12#2)(2009-6#1)
luminescence in##2##2##(1992-11#1)(2008-7#1)
luminescence intensity##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
luminescence is##4##2##(1995-3#1)(2007-11#1)(2011-1#1)(2012-12#1)
luminescence method##4##2##(2008-10#4)
luminescence of##7##2##(1995-3#1)(2008-10#1)(2008-2#2)(2008-3#3)
luminescence phenomenon##2##2##(2008-10#2)
luminescence quantum##3##2##(2008-2#3)
luminescence quenching##2##2##(2008-10#2)
luminescence signal##2##2##(1996-12#1)(2008-10#1)
luminescence spectrometer##2##2##(2008-10#2)
luminescence spectroscopy##4##2##(2008-10#3)(2009-7#1)
luminescence technique##2##2##(2008-10#2)
luminescence under##2##2##(2008-3#2)
luminescence was##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
luminescence with##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
luminescence##107##1##(1992-11#1)(1995-3#3)(1996-12#3)(1997-7#1)(2007-11#3)(2007-12#4)(2008-10#52)(2008-11#2)(2008-2#11)(2008-3#11)(2008-6#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-1#1)(2011-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
luminescens##5##1##(1990-7#3)(2008-10#1)(2008-11#1)
luminescent CdTe quantum dots prepared in aqueous phase##2##8##(2008-10#2)
luminescent CdTe quantum dots##3##4##(2008-10#3)
luminescent assay##2##2##(2008-10#2)
luminescent quantum efficiency of##2##4##(2008-2#2)
luminescent reagents##2##2##(2008-10#2)
luminescent##46##1##(1990-8#1)(1994-11#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#25)(2008-11#4)(2008-2#4)(2008-4#3)(2008-5#1)(2009-11#1)(2012-12#1)(2012-2#1)
luminol and ferricyanide##3##3##(2008-10#3)
luminol and periodate##3##3##(2008-10#3)
luminol and##11##2##(2008-10#11)
luminol in##2##2##(2008-10#2)
luminol oxidation by##2##3##(2008-10#2)
luminol oxidation##3##2##(2008-10#3)
luminol solution##6##2##(2008-10#6)
luminol##64##1##(1991-5#3)(1995-3#4)(2008-10#57)
luminol- and##2##2##(1991-9#1)(2008-10#1)
luminol-H(2)O(2)##4##1##(2008-10#4)
luminol-H(2)O(2)-Cr(3+) system##2##2##(2008-10#2)
luminol-KIO(4)-H(2)O(2) CL system##2##3##(2008-10#2)
luminol-KIO(4)-H(2)O(2) CL##3##2##(2008-10#3)
luminol-based chemiluminescence##2##2##(2008-10#2)
luminol-dimethylsulfoxide-OH(-) chemiluminescence##2##2##(2008-10#2)
luminol-hydrogen peroxide##2##2##(2008-10#2)
luminol-hydrogen##3##1##(2008-10#3)
luminometer##6##1##(2008-10#4)(2008-9#1)(2012-2#1)
luminosity-type horizontal cells##2##3##(2008-8#2)
luminous object##2##2##(2008-2#2)
luminous##5##1##(2008-2#3)(2008-3#2)
lumogallion##4##1##(2008-10#4)
lump in the left##2##4##(2007-7#1)(2008-6#1)
lump in the##3##3##(1994-7#1)(2007-7#1)(2008-6#1)
lump in##4##2##(1994-7#1)(2007-7#1)(2008-6#1)(2012-3#1)
lump##11##1##(1990-10#1)(1991-12#2)(1994-7#2)(1997-1#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#1)
lumpectomy##6##1##(1991-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(2011-1#1)(2013-8#1)
lumped amplification##2##2##(2007-11#1)(2007-12#1)
lumped into##2##2##(2008-10#1)(2008-7#1)
lumped##9##1##(2007-11#4)(2007-12#1)(2008-10#1)(2008-7#2)(2013-1#1)
lumps##9##1##(1990-10#3)(1991-12#1)(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#2)
lumpy nodules##2##2##(2009-9#2)
lumpy##4##1##(2008-5#1)(2009-9#2)(2011-1#1)
lunar albedo##2##2##(2008-2#2)
lunar and##2##2##(2008-3#2)
lunar cycle##4##2##(2011-1#4)
lunar measurements##3##2##(2008-3#3)
lunar##20##1##(2008-2#6)(2008-3#5)(2011-1#6)(2013-8#3)
lunata##2##1##(2008-10#2)
lunate##3##1##(2012-1#1)(2012-3#1)(2013-1#1)
lunch and##2##2##(2012-12#1)(2013-8#1)
lunch##6##1##(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
lunches##6##1##(2008-4#1)(2012-12#5)
lung -##2##2##(2007-11#1)(2012-3#1)
lung adenocarcinoma##12##2##(2008-1#1)(2008-11#3)(2008-9#4)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
lung and bone##2##3##(2007-7#1)(2010-3#1)
lung and heart##2##3##(1990-5#2)
lung and kidney##3##3##(1994-9#1)(1995-11#1)(1997-6#1)
lung and stomach##2##3##(2011-2#2)
lung and##36##2##(1990-12#1)(1990-5#2)(1991-2#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-6#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#2)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#1)
lung as##2##2##(1991-12#1)(1991-2#1)
lung at the##2##3##(1995-8#1)(1997-1#1)
lung biopsy in##3##3##(2008-5#1)(2010-8#1)(2013-1#1)
lung biopsy##12##2##(1996-9#1)(2008-1#4)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#3)
lung by##4##2##(1992-12#1)(1994-12#2)(1995-8#1)
lung cDNA library##5##3##(1991-5#2)(1993-3#1)(1994-11#1)(1997-2#1)
lung cancer (NSCLC) is##2##4##(2008-4#1)(2012-1#1)
lung cancer (NSCLC)##16##3##(1990-2#1)(1991-2#1)(1993-2#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#1)
lung cancer and mesothelioma##3##4##(1991-12#2)(2010-5#1)
lung cancer and other solid tumors##2##6##(2008-7#2)
lung cancer and other##3##4##(2008-7#2)(2009-7#1)
lung cancer and##10##3##(1991-12#3)(1992-6#1)(1996-9#1)(2008-7#3)(2009-7#1)(2010-5#1)
lung cancer are##2##3##(2007-6#1)(2012-1#1)
lung cancer by##2##3##(1995-9#1)(2010-12#1)
lung cancer cell line##6##4##(1993-3#1)(1997-2#1)(2008-8#1)(2010-12#1)(2013-1#2)
lung cancer cell lines##3##4##(1992-9#1)(2008-11#1)(2012-2#1)
lung cancer cell##9##3##(1992-9#1)(1993-3#1)(1997-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#2)
lung cancer cells##5##3##(2008-11#1)(2008-5#1)(2009-12#1)(2010-12#1)(2013-1#1)
lung cancer in Chinese##2##4##(2008-8#1)(2010-12#1)
lung cancer in order to##2##5##(1996-9#1)(2013-7#1)
lung cancer in the##2##4##(1996-7#1)(2010-8#1)
lung cancer in##19##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-3#1)(1994-12#1)(1996-7#1)(1996-9#1)(2008-12#1)(2008-7#3)(2008-8#2)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
lung cancer incidence in Connecticut##2##5##(1996-3#2)
lung cancer incidence##7##3##(1996-3#4)(2008-7#2)(2011-3#1)
lung cancer is##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2010-5#1)
lung cancer patients and##2##4##(2008-11#1)(2010-5#1)
lung cancer patients with##2##4##(2010-8#2)
lung cancer patients##9##3##(1996-9#2)(2007-8#1)(2008-11#2)(2010-2#1)(2010-5#1)(2010-8#2)
lung cancer rates##3##3##(1992-6#1)(2008-7#2)
lung cancer risk in##2##4##(1991-2#1)(1996-3#1)
lung cancer risk##6##3##(1991-2#2)(1996-3#2)(2008-7#2)
lung cancer screening##2##3##(2008-2#2)
lung cancer specific##2##3##(2008-11#2)
lung cancer specimens##3##3##(1993-8#3)
lung cancer tissues##3##3##(1991-12#2)(2008-4#1)
lung cancer was##2##3##(2008-7#1)(2012-1#1)
lung cancer were observed##2##4##(1990-12#1)(2011-1#1)
lung cancer were##6##3##(1990-12#1)(1990-2#1)(1992-12#1)(2007-8#1)(2008-11#1)(2011-1#1)
lung cancer with##2##3##(1995-8#1)(2009-11#1)
lung cancer##250##2##(1990-12#2)(1990-2#7)(1990-5#1)(1990-8#1)(1991-12#9)(1991-2#7)(1991-4#1)(1991-6#1)(1991-8#3)(1992-12#2)(1992-3#2)(1992-6#4)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-3#8)(1996-7#1)(1996-8#2)(1996-9#6)(1997-2#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#10)(2008-1#10)(2008-10#5)(2008-11#12)(2008-12#1)(2008-2#7)(2008-4#2)(2008-5#1)(2008-7#21)(2008-8#5)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#3)(2009-7#2)(2010-12#4)(2010-2#3)(2010-5#6)(2010-8#11)(2011-1#7)(2011-2#3)(2011-3#5)(2012-1#9)(2012-2#6)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#4)
lung cancer]##11##2##(1996-9#2)(1997-4#1)(2008-1#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#4)
lung cancers and##2##3##(2007-11#1)(2012-2#1)
lung cancers##13##2##(1992-3#1)(1993-8#1)(1995-9#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
lung capacity##5##2##(1991-12#1)(1996-2#2)(2008-7#1)(2012-3#1)
lung carcinoid##3##2##(2013-1#3)
lung carcinoma (NSCLC)##3##3##(1993-9#1)(2012-12#1)(2013-1#1)
lung carcinoma cell line##3##4##(1994-8#1)(1996-12#1)(1997-2#1)
lung carcinoma##27##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#2)(1996-12#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-1#2)(2008-11#2)(2008-8#2)(2008-9#2)(2009-7#1)(2012-12#1)(2013-1#1)
lung carcinomas##3##2##(2008-4#1)(2009-11#1)(2013-7#1)
lung cavities##3##2##(2010-8#3)
lung cell##4##2##(1990-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
lung cells##5##2##(1990-6#1)(1992-11#1)(1995-8#2)(2008-8#1)
lung cyst##2##2##(2007-12#1)(2012-2#1)
lung cysts##2##2##(2012-2#2)
lung damage##4##2##(1990-5#1)(1994-5#1)(1994-8#1)(1995-3#1)
lung defense responses##3##3##(2008-10#3)
lung deposition##3##2##(1997-1#2)(2008-11#1)
lung development and##3##3##(1994-3#1)(1995-8#1)(1996-2#1)
lung development in##2##3##(1994-3#1)(1995-8#1)
lung development##7##2##(1994-3#2)(1995-8#3)(1996-2#1)(2010-7#1)
lung disease among##2##3##(1992-2#1)(2012-12#1)
lung disease and##5##3##(1997-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-3#1)
lung disease in a##2##4##(1997-4#1)(2011-2#1)
lung disease in##11##3##(1990-3#1)(1991-12#1)(1997-3#1)(1997-4#2)(2006-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
lung disease is##2##3##(1996-2#1)(2006-10#1)
lung disease or##2##3##(1997-2#1)(2008-9#1)
lung disease##60##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1992-2#2)(1992-9#2)(1994-12#1)(1994-6#2)(1995-2#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-8#1)(2006-10#7)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-8#1)
lung diseases such as##2##4##(2008-5#1)(2013-1#1)
lung diseases##10##2##(1994-12#1)(1994-6#1)(1995-2#1)(2008-5#1)(2008-6#1)(2009-1#1)(2011-3#2)(2012-2#1)(2013-1#1)
lung disorders##2##2##(1991-2#1)(1994-12#1)
lung dose##3##2##(1993-9#1)(1995-12#1)(1997-1#1)
lung eosinophilia##2##2##(2008-10#2)
lung epithelial cells##2##3##(1992-3#1)(1995-2#1)
lung epithelial##5##2##(1992-3#1)(1995-2#1)(2008-9#3)
lung expansion##2##2##(2008-10#1)(2012-3#1)
lung fibroblast##3##2##(2008-10#2)(2008-4#1)
lung fibroblasts##7##2##(1990-5#2)(1993-3#1)(1995-12#1)(1995-8#2)(2008-11#1)
lung field##6##2##(2007-12#1)(2008-1#5)
lung fields##5##2##(1991-12#1)(2007-8#1)(2008-1#2)(2012-12#1)
lung function and##5##3##(1991-12#1)(1992-9#1)(1995-8#1)(2006-10#1)(2008-11#1)
lung function has##2##3##(1991-4#2)
lung function in##2##3##(2006-10#1)(2012-2#1)
lung function tests and##2##4##(1997-2#1)(2008-7#1)
lung function tests##3##3##(1991-12#1)(1997-2#1)(2008-7#1)
lung function##35##2##(1991-12#4)(1991-2#1)(1991-4#2)(1992-6#1)(1992-9#2)(1995-8#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(2006-10#5)(2007-8#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-5#2)(2011-2#1)(2012-2#2)
lung functions##4##2##(2012-2#3)(2012-3#1)
lung grafts##4##2##(2008-5#1)(2011-3#3)
lung hypoplasia##3##2##(1994-3#1)(2013-1#2)
lung in patients##2##3##(2007-8#1)(2008-2#1)
lung in##9##2##(1990-12#1)(1990-8#1)(1991-12#2)(2007-8#1)(2008-2#1)(2010-7#1)(2012-3#1)(2013-1#1)
lung infection##3##2##(2007-12#2)(2008-5#1)
lung infections##4##2##(1997-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
lung inflammation##3##2##(1990-2#1)(1996-12#1)(2008-10#1)
lung injuries##4##2##(1994-6#1)(2010-9#1)(2011-2#2)
lung injury such##2##3##(2008-8#2)
lung injury##19##2##(1991-9#3)(1993-10#2)(1994-12#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
lung involvement##5##2##(1991-2#1)(1997-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
lung is##8##2##(1990-6#1)(1991-2#1)(1992-9#1)(1994-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
lung lavage##5##2##(2010-7#4)(2012-2#1)
lung lesions##7##2##(1991-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#2)
lung lobe in##2##3##(2008-1#1)(2013-1#1)
lung lobe with##2##3##(2013-1#2)
lung lobe##6##2##(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#3)
lung metastases in a##2##4##(2008-6#2)
lung metastases in##3##3##(2008-6#2)(2010-3#1)
lung metastases##21##2##(1990-2#1)(1990-8#1)(1991-6#3)(1992-6#1)(1994-12#2)(2007-10#2)(2008-5#1)(2008-6#3)(2010-3#7)
lung metastasis##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
lung nodule##5##2##(2008-8#2)(2010-9#3)
lung or##4##2##(1991-12#1)(2006-10#1)(2010-3#1)(2012-2#1)
lung parenchyma##8##2##(1991-12#3)(1992-1#1)(1993-9#1)(2009-1#1)(2011-2#1)(2013-7#1)
lung phagocytes and epithelial##2##4##(1991-9#2)
lung primary##2##2##(1990-12#1)(2008-2#1)
lung prostaglandin F synthase##2##4##(1992-3#2)
lung prostaglandin##3##2##(1992-3#2)(1993-8#1)
lung pseudocyst##5##2##(2013-1#5)
lung resection##9##2##(2006-10#2)(2007-8#5)(2008-6#1)(2011-2#1)
lung resistance and leakage of##2##5##(1992-3#2)
lung resistance##5##2##(1992-3#4)(2008-11#1)
lung sounds in##2##3##(1993-12#2)
lung sounds##6##2##(1993-12#6)
lung surgery##3##2##(2008-6#1)(2011-2#1)(2012-12#1)
lung tissue##16##2##(1991-12#3)(1992-11#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#3)(2013-1#2)(2013-8#1)
lung tissues and##2##3##(1997-4#1)(2008-4#1)
lung tissues were##2##3##(2008-4#1)(2011-2#1)
lung tissues##9##2##(1990-7#1)(1993-3#1)(1993-8#2)(1997-4#1)(2008-12#1)(2008-4#2)(2011-2#1)
lung transplant##5##2##(1992-3#1)(2011-3#3)(2013-1#1)
lung transplantation for##3##3##(2007-8#2)(2012-1#1)
lung transplantation in##3##3##(1994-3#1)(1996-6#1)(2007-8#1)
lung transplantation is##2##3##(2011-3#1)(2012-2#1)
lung transplantation remains the##2##4##(1997-5#1)(2010-10#1)
lung transplantation##29##2##(1993-2#1)(1994-3#3)(1996-6#1)(1997-5#1)(2007-8#4)(2010-10#2)(2011-2#2)(2011-3#9)(2012-1#1)(2012-2#4)(2013-1#1)
lung transplantations are##2##3##(2011-3#2)
lung transplantations##4##2##(1996-6#1)(2011-2#1)(2011-3#2)
lung tumor multiplicity##2##3##(1994-5#2)
lung tumor##7##2##(1991-12#1)(1994-5#2)(1994-6#1)(2007-8#2)(2013-1#1)
lung tumors in the##2##4##(1990-6#1)(2007-8#1)
lung tumors##8##2##(1990-6#1)(1990-7#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2009-11#1)
lung tumours##2##2##(2012-2#2)
lung type prostaglandin F synthase##2##5##(1992-3#2)
lung type##3##2##(1992-12#1)(1992-3#2)
lung volumes##4##2##(1991-12#1)(1992-6#2)(2008-1#1)
lung was##4##2##(1995-8#1)(2008-4#1)(2008-8#1)(2009-9#1)
lung weight##2##2##(1994-5#1)(1995-3#1)
lung weights of##2##3##(2008-9#2)
lung##1135##1##(1990-12#8)(1990-2#9)(1990-3#2)(1990-5#10)(1990-6#5)(1990-7#3)(1990-8#7)(1991-11#1)(1991-12#42)(1991-2#16)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#7)(1991-8#8)(1991-9#11)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#11)(1992-2#8)(1992-3#19)(1992-5#5)(1992-6#8)(1992-8#2)(1992-9#18)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#6)(1993-8#11)(1993-9#10)(1994-1#1)(1994-11#5)(1994-12#15)(1994-2#5)(1994-3#11)(1994-5#5)(1994-6#7)(1994-7#2)(1994-8#9)(1994-9#3)(1995-11#3)(1995-12#4)(1995-2#6)(1995-3#4)(1995-8#18)(1995-9#3)(1996-11#1)(1996-12#6)(1996-2#11)(1996-3#13)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#11)(1997-1#11)(1997-2#12)(1997-3#4)(1997-4#5)(1997-5#3)(1997-6#2)(1997-8#3)(2006-10#16)(2007-10#4)(2007-11#6)(2007-12#8)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#38)(2008-1#38)(2008-10#38)(2008-11#34)(2008-12#7)(2008-2#11)(2008-3#2)(2008-4#13)(2008-5#14)(2008-6#19)(2008-7#33)(2008-8#24)(2008-9#17)(2009-1#6)(2009-11#5)(2009-12#1)(2009-3#3)(2009-4#4)(2009-7#4)(2009-8#2)(2009-9#5)(2010-10#7)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#13)(2010-4#1)(2010-5#15)(2010-6#1)(2010-7#13)(2010-8#28)(2010-9#4)(2011-1#10)(2011-2#42)(2011-3#31)(2012-1#15)(2012-12#10)(2012-2#38)(2012-3#15)(2013-1#58)(2013-7#7)(2013-8#13)
lung)##4##1##(1994-12#1)(1996-2#1)(2008-10#1)(2008-9#1)
lung-cancer##2##1##(1992-9#2)
lung-derived##2##1##(1992-9#2)
lung-transplant recipients and##2##3##(2012-2#2)
lung]##5##1##(1991-9#1)(1997-5#1)(2007-10#1)(2007-6#1)(2008-1#1)
lungs against##2##2##(1991-9#1)(1992-12#1)
lungs and brain##2##3##(2008-10#1)(2009-9#1)
lungs and kidneys##2##3##(1990-2#1)(2008-5#1)
lungs and other##2##3##(1994-5#1)(1996-3#1)
lungs and##23##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-5#1)(1995-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-5#3)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
lungs are##5##2##(2008-1#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-3#1)
lungs from the##2##3##(2007-6#1)(2007-8#1)
lungs in##5##2##(2007-8#1)(2008-5#2)(2010-8#1)(2011-1#1)
lungs may##2##2##(1994-6#1)(1995-3#1)
lungs of mice##2##3##(1993-3#1)(2013-1#1)
lungs of##16##2##(1991-12#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2013-1#3)
lungs were##8##2##(1996-3#2)(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#1)
lungs with##2##2##(1992-12#1)(1997-1#1)
lungs##161##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#4)(1994-11#2)(1994-12#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#10)(1996-8#1)(1997-1#8)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-6#1)(2007-8#14)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#4)(2012-2#4)(2012-3#3)(2013-1#12)
lupane##6##1##(2008-11#6)
lupin anthracnose##2##2##(2008-10#2)
lupin##10##1##(1990-5#1)(2008-10#8)(2009-2#1)
lupins##3##1##(2008-10#3)
lupus and##2##2##(1992-5#1)(2008-8#1)
lupus anticoagulant##2##2##(1994-9#1)(2006-10#1)
lupus erythematosus (SLE) in##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
lupus erythematosus (SLE) is##4##4##(2010-12#1)(2010-5#1)(2011-2#2)
lupus erythematosus (SLE)##22##3##(1990-12#1)(1994-6#1)(2006-10#4)(2008-1#5)(2008-10#2)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#1)
lupus erythematosus and##5##3##(1992-5#1)(2008-8#1)(2009-3#1)(2012-12#2)
lupus erythematosus associated##2##3##(2009-5#1)(2011-1#1)
lupus erythematosus in##5##3##(1990-9#1)(1992-5#2)(2006-10#1)(2007-7#1)
lupus erythematosus is an autoimmune disorder##2##6##(2012-2#2)
lupus erythematosus is##3##3##(2012-2#3)
lupus erythematosus with##4##3##(1997-8#1)(2007-7#1)(2008-1#1)(2012-2#1)
lupus erythematosus##88##2##(1990-12#1)(1990-9#2)(1991-5#2)(1992-2#1)(1992-5#4)(1993-2#1)(1994-6#2)(1994-9#2)(1995-5#1)(1997-8#2)(2006-10#12)(2007-12#2)(2007-7#5)(2008-1#7)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#5)
lupus nephritis (LN)##2##3##(2008-1#2)
lupus nephritis and##2##3##(2006-10#1)(2008-1#1)
lupus nephritis in##2##3##(2008-1#1)(2008-10#1)
lupus nephritis##22##2##(2006-10#5)(2007-7#5)(2008-1#10)(2008-10#1)(2013-1#1)
lupus profundus##3##2##(2013-1#3)
lupus##133##1##(1990-12#1)(1990-8#1)(1990-9#2)(1991-5#2)(1992-2#1)(1992-5#5)(1993-2#1)(1994-6#2)(1994-9#4)(1995-5#1)(1997-8#3)(2006-10#19)(2007-12#2)(2007-5#1)(2007-7#11)(2008-1#18)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#10)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#10)(2013-8#1)
lupus-prone##3##1##(1992-8#1)(1993-3#1)(2008-10#1)
lure##3##1##(1992-1#1)(2008-5#1)(2011-2#1)
lures##3##1##(2011-2#3)
lurk##2##1##(1993-6#1)(2012-2#1)
lustre##2##1##(2008-5#2)
luteal and menstrual##2##3##(2012-2#2)
luteal cells express##3##3##(1994-11#2)(2008-4#1)
luteal cells##5##2##(1994-11#3)(1997-1#1)(2008-4#1)
luteal phase##13##2##(1990-8#1)(1990-9#1)(1991-11#1)(1994-9#5)(1995-2#1)(2008-5#1)(2012-2#3)
luteal regression##2##2##(2008-9#2)
luteal##29##1##(1990-8#1)(1990-9#1)(1991-11#1)(1992-9#4)(1994-11#3)(1994-6#1)(1994-9#5)(1995-2#1)(1997-1#2)(2008-4#1)(2008-5#2)(2008-9#2)(2012-2#5)
luteinization of##2##2##(1990-8#1)(1992-11#1)
luteinized##4##1##(1992-3#1)(1997-1#1)(2008-5#2)
luteinizing hormone (LH) and##3##4##(2008-3#1)(2008-4#1)(2011-2#1)
luteinizing hormone (LH) levels##2##4##(1995-3#1)(2011-1#1)
luteinizing hormone (LH)##10##3##(1995-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
luteinizing hormone and##5##3##(1990-9#1)(1991-3#1)(1994-8#1)(2008-4#1)(2012-12#1)
luteinizing hormone receptor##4##3##(1995-11#1)(1996-5#1)(2008-5#1)(2008-8#1)
luteinizing hormone##25##2##(1990-2#1)(1990-9#1)(1991-3#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
luteinizing hormone-releasing hormone (LHRH) neurons##2##5##(1995-12#2)
luteinizing hormone-releasing hormone (LHRH)##3##4##(1992-12#1)(1995-12#2)
luteinizing hormone-releasing hormone##6##3##(1992-12#2)(1993-1#2)(1995-12#2)
luteinizing##33##1##(1990-2#1)(1990-9#1)(1991-3#2)(1992-11#1)(1992-12#2)(1993-1#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
luteolin &gt##2##2##(2008-11#1)(2008-4#1)
luteolin and genistein##3##3##(2008-4#3)
luteolin##20##1##(1994-11#3)(2008-10#3)(2008-11#4)(2008-4#8)(2010-6#2)
luteolysis##2##1##(1994-6#1)(2008-9#1)
luteovirus isolates##2##2##(2008-10#2)
luteovirus##11##1##(2008-10#11)
luteoviruses##5##1##(2008-10#5)
lutetium aluminum garnet##2##3##(2008-3#2)
lutetium##4##1##(2008-10#1)(2008-3#2)(2010-5#1)
luteum##11##1##(1992-11#1)(1992-9#1)(1994-11#1)(1994-6#2)(1995-12#1)(2008-4#1)(2008-9#2)(2010-3#2)
luteus##12##1##(1990-5#3)(1992-3#1)(1994-2#1)(1997-6#2)(2008-10#1)(2008-12#2)(2012-3#2)
lutheri bags and##2##3##(2012-1#2)
lutheri bags##4##2##(2012-1#4)
lutheri##7##1##(2012-1#7)
luting cement##4##2##(1990-3#1)(2013-1#3)
luting##6##1##(1990-3#1)(2009-8#1)(2012-2#1)(2013-1#3)
lutreola##2##1##(2008-6#2)
lutropin##6##1##(1991-3#2)(1992-10#1)(1993-6#1)(1996-2#2)
luxA and luxB genes of##3##5##(1990-7#3)
luxA and luxB##4##3##(1990-7#3)(2008-11#1)
luxA##5##1##(1990-7#3)(2008-11#2)
luxB##5##1##(1990-7#3)(2008-11#2)
luxCDABE##2##1##(2011-1#2)
luxation of the shoulder##2##4##(2007-11#2)
luxation of the##3##3##(2007-11#2)(2009-3#1)
luxation##6##1##(1994-9#1)(1996-6#1)(2007-11#2)(2007-8#1)(2009-3#1)
luxations##3##1##(1996-6#1)(2007-11#2)
luxury##4##1##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
lx##4##1##(2008-10#2)(2008-3#1)(2011-2#1)
lyase activity and##2##3##(1995-2#1)(2008-10#1)
lyase activity##4##2##(1990-8#1)(1995-2#1)(2008-10#2)
lyase and##3##2##(2008-10#2)(2008-6#1)
lyase deficiency##3##2##(1990-8#3)
lyase in##2##2##(1990-8#1)(2008-10#1)
lyase to##2##2##(1990-8#1)(2008-4#1)
lyase was##2##2##(2008-10#2)
lyase##34##1##(1990-8#8)(1993-9#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-10#16)(2008-4#2)(2008-6#1)(2008-7#1)(2013-1#1)
lyases##3##1##(1991-9#1)(2011-2#2)
lycopene content##2##2##(2010-4#2)
lycopene##6##1##(1990-7#1)(1992-9#1)(2010-4#4)
lycopersici race##2##2##(2008-10#2)
lycopersici was##2##2##(2008-10#2)
lycopersici were##2##2##(2008-10#2)
lycopersici##26##1##(2008-10#26)
lying between##3##2##(1994-8#1)(2008-10#1)(2008-7#1)
lying down##2##2##(2008-7#1)(2011-2#1)
lying in the##2##3##(1990-7#1)(2012-2#1)
lying in##4##2##(1990-7#1)(1993-8#1)(2012-2#1)(2013-1#1)
lying to##2##2##(2010-10#2)
lying within##2##2##(1993-6#1)(2008-10#1)
lying##25##1##(1990-7#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-7#5)(2009-3#1)(2010-10#4)(2011-2#1)(2012-2#2)(2013-1#2)
lymph edema##2##2##(2010-8#2)
lymph flow##2##2##(1991-9#1)(2013-8#1)
lymph node (SLN) biopsy##2##4##(2008-10#1)(2013-1#1)
lymph node and##2##3##(1995-1#1)(2009-3#1)
lymph node assay (LLNA)##3##4##(2008-10#2)(2008-5#1)
lymph node assay##10##3##(2008-10#5)(2008-5#3)(2008-9#2)
lymph node biopsies##3##3##(2008-5#1)(2012-12#1)(2013-7#1)
lymph node biopsy in##2##4##(2008-1#1)(2008-10#1)
lymph node biopsy revealed##2##4##(1991-3#1)(2010-12#1)
lymph node biopsy was##2##4##(2010-12#1)(2011-2#1)
lymph node biopsy##9##3##(1991-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#2)(2011-2#2)(2013-1#1)
lymph node detection##2##3##(2010-11#1)(2010-12#1)
lymph node dissection##8##3##(1990-8#3)(1994-7#1)(1995-5#1)(2007-5#1)(2010-8#1)(2013-1#1)
lymph node enlargement and##2##4##(2009-5#1)(2013-8#1)
lymph node enlargement##3##3##(2007-10#1)(2009-5#1)(2013-8#1)
lymph node involvement##6##3##(1990-6#1)(1994-12#1)(2011-2#4)
lymph node lymphocytes from##2##4##(2008-11#2)
lymph node mapping in##3##4##(2008-10#2)(2010-8#1)
lymph node metastases was##2##4##(1990-6#1)(1990-8#1)
lymph node metastases were##4##4##(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
lymph node metastases##16##3##(1990-6#1)(1990-8#1)(1994-12#1)(1997-3#2)(2008-10#1)(2008-4#1)(2008-9#2)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
lymph node metastasis and##2##4##(2010-8#1)(2013-1#1)
lymph node metastasis in##5##4##(2009-2#1)(2011-2#3)(2013-1#1)
lymph node metastasis##24##3##(1990-2#1)(1991-12#1)(1994-12#1)(1994-7#1)(1996-6#1)(2007-10#1)(2008-12#1)(2009-12#1)(2009-2#1)(2010-6#2)(2010-8#1)(2011-2#6)(2013-1#4)(2013-8#2)
lymph node of##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
lymph node or##2##3##(1990-6#1)(1990-9#1)
lymph node responses##2##3##(2008-10#2)
lymph node samples##5##3##(1993-2#1)(2012-2#2)(2012-3#2)
lymph node##133##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#4)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#2)(1993-2#2)(1994-12#3)(1994-7#2)(1995-1#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(2007-10#2)(2007-5#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-9#7)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#15)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#7)
lymph nodes and##10##3##(1990-12#1)(1990-8#1)(1992-2#1)(2007-10#1)(2008-1#2)(2008-10#2)(2010-8#1)(2012-12#1)
lymph nodes in##4##3##(1990-12#2)(1990-8#1)(2008-1#1)
lymph nodes on##3##3##(2011-2#3)
lymph nodes or##2##3##(2007-10#1)(2013-1#1)
lymph nodes was##6##3##(1994-12#2)(2008-7#1)(2011-2#2)(2013-1#1)
lymph nodes were positive##2##4##(1994-7#1)(2007-5#1)
lymph nodes were##12##3##(1990-8#1)(1993-2#1)(1994-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-7#1)
lymph nodes##108##2##(1990-12#3)(1990-3#1)(1990-8#4)(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-12#4)(1994-7#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#3)(2007-10#3)(2007-5#2)(2007-8#1)(2008-1#8)(2008-10#10)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2009-1#1)(2009-12#1)(2009-5#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#12)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#3)
lymph nodes)##2##2##(1997-8#1)(2008-10#1)
lymph##257##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#8)(1990-9#3)(1991-12#1)(1991-3#2)(1991-6#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-8#1)(1993-2#5)(1993-3#1)(1993-9#1)(1994-12#7)(1994-7#3)(1995-1#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2007-10#5)(2007-12#1)(2007-5#4)(2007-8#1)(2008-1#10)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#8)(2008-7#2)(2008-9#7)(2009-1#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-6#3)(2010-7#1)(2010-8#9)(2011-1#2)(2011-2#27)(2012-12#8)(2012-2#3)(2012-3#9)(2013-1#20)(2013-7#3)(2013-8#11)
lymph-node lymphocytes##2##2##(1990-12#2)
lymph-node##6##1##(1990-12#2)(1990-9#1)(2007-8#1)(2008-1#1)(2013-7#1)
lymphadenectomy and intraoperative mediastinoscopy##3##4##(2007-8#3)
lymphadenectomy and##4##2##(1992-9#1)(2007-8#3)
lymphadenectomy##15##1##(1990-3#1)(1990-8#1)(1992-9#1)(1993-3#1)(2007-8#5)(2008-10#2)(2011-2#2)(2013-1#2)
lymphadenitis and##2##2##(2008-1#1)(2009-7#1)
lymphadenitis in##3##2##(2008-5#2)(2013-8#1)
lymphadenitis is##2##2##(1991-9#1)(2011-2#1)
lymphadenitis##19##1##(1991-3#2)(1991-4#3)(1991-9#3)(1993-2#1)(1997-5#1)(2007-12#1)(2008-1#3)(2008-5#2)(2009-7#1)(2011-2#1)(2013-8#1)
lymphadenopathy in##3##2##(2008-1#1)(2011-1#2)
lymphadenopathy or##2##2##(2010-1#1)(2010-6#1)
lymphadenopathy were##3##2##(2011-1#3)
lymphadenopathy with##2##2##(2011-2#1)(2012-12#1)
lymphadenopathy##34##1##(1990-9#1)(1992-8#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#10)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
lymphangiogenesis in##2##2##(2010-8#1)(2011-2#1)
lymphangiogenesis##3##1##(2010-8#1)(2011-2#1)(2013-1#1)
lymphangioleiomyomatosis##2##1##(2007-8#2)
lymphangioma of the##2##3##(2008-5#1)(2013-1#1)
lymphangioma##12##1##(1990-6#1)(2007-8#5)(2008-10#1)(2008-5#3)(2013-1#2)
lymphatic and##3##2##(2008-6#1)(2011-1#1)(2012-3#1)
lymphatic endothelial cells##3##3##(1997-7#1)(2008-9#1)(2013-7#1)
lymphatic filariasis elimination##3##3##(2008-1#3)
lymphatic filariasis##4##2##(1993-12#1)(2008-1#3)
lymphatic flow##2##2##(2011-1#1)(2013-8#1)
lymphatic leukaemia##2##2##(1997-8#1)(2008-11#1)
lymphatic metastases##2##2##(2008-11#1)(2009-5#1)
lymphatic metastasis##2##2##(2008-11#1)(2012-3#1)
lymphatic vascular##2##2##(2008-9#1)(2011-1#1)
lymphatic vessels##4##2##(1995-4#1)(2010-1#1)(2011-2#1)(2013-1#1)
lymphatic##54##1##(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1993-12#1)(1995-4#1)(1996-11#1)(1996-3#1)(1997-7#2)(1997-8#1)(2008-1#4)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
lymphatics in##3##2##(2007-12#1)(2011-2#2)
lymphatics##7##1##(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)(2011-2#2)
lymphectomy##2##1##(1992-9#2)
lymphedema##7##1##(1992-12#1)(2009-3#5)(2011-1#1)
lymphedematous arm##2##2##(1992-12#2)
lymphnode metastasis##2##2##(2010-11#2)
lymphnode##4##1##(1990-10#1)(2010-11#2)(2010-8#1)
lympho-macrophage hybrids##2##2##(1992-9#2)
lymphoblastic leukemia (ALL)##6##3##(1991-2#1)(2010-6#1)(2011-1#1)(2011-2#3)
lymphoblastic leukemia##24##2##(1991-2#2)(2008-10#2)(2008-11#5)(2008-5#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-12#3)
lymphoblastic##40##1##(1990-12#1)(1991-2#2)(1996-6#1)(2008-10#2)(2008-11#5)(2008-12#5)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-11#2)(2010-6#1)(2011-1#2)(2011-2#9)(2012-12#3)(2013-7#1)
lymphoblastoid cell lines##3##3##(1993-9#1)(1994-8#1)(1996-12#1)
lymphoblastoid cell##4##2##(1993-9#1)(1994-8#1)(1996-12#1)(2008-11#1)
lymphoblastoid cells##4##2##(1990-12#1)(2008-4#1)(2008-5#2)
lymphoblastoid##10##1##(1990-12#1)(1993-9#1)(1994-3#2)(1994-8#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-5#2)
lymphoblasts and very rare mitotic figures##2##6##(1997-6#2)
lymphoblasts and##3##2##(1997-6#2)(2008-5#1)
lymphoblasts with##4##2##(1994-8#1)(1997-6#3)
lymphoblasts##16##1##(1994-8#3)(1995-12#1)(1996-2#3)(1997-6#5)(2008-5#4)
lymphocele##4##1##(2008-1#4)
lymphocyte activation##6##2##(2007-12#1)(2008-4#4)(2008-9#1)
lymphocyte activity##3##2##(1995-3#1)(2008-1#1)(2008-3#1)
lymphocyte and##5##2##(1996-12#1)(1997-4#2)(2008-12#1)(2013-1#1)
lymphocyte antigen##2##2##(2008-1#1)(2008-7#1)
lymphocyte count##6##2##(1990-2#1)(1990-9#2)(1993-12#1)(2008-7#1)(2010-5#1)
lymphocyte counts##2##2##(1997-6#1)(2009-12#1)
lymphocyte cultures##5##2##(1991-9#1)(1995-12#1)(1996-2#2)(2008-11#1)
lymphocyte depletion##2##2##(2008-5#1)(2011-2#1)
lymphocyte differentiation##3##2##(1991-9#2)(2008-4#1)
lymphocyte function##5##2##(1991-12#1)(2007-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
lymphocyte functions##2##2##(1991-9#2)
lymphocyte kynureninase activity##4##3##(1991-5#4)
lymphocyte migration##4##2##(1990-12#1)(2008-4#3)
lymphocyte number##2##2##(1992-12#1)(2006-10#1)
lymphocyte populations##5##2##(1994-9#1)(1995-12#1)(1995-8#1)(2008-4#1)(2013-7#1)
lymphocyte proliferation and##2##3##(1993-12#1)(1995-12#1)
lymphocyte proliferation assay##4##3##(1995-12#1)(2008-12#1)(2011-2#2)
lymphocyte proliferation assays##2##3##(1991-9#1)(2008-10#1)
lymphocyte proliferation was##2##3##(2007-2#1)(2008-11#1)
lymphocyte proliferation##13##2##(1991-9#1)(1993-12#1)(1995-12#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#2)
lymphocyte ratio##2##2##(2010-8#1)(2013-8#1)
lymphocyte subpopulation##3##2##(2008-4#2)(2013-1#1)
lymphocyte subpopulations##4##2##(1991-5#1)(1995-12#1)(2008-10#1)(2008-4#1)
lymphocyte subsets and##2##3##(1991-6#1)(2008-10#1)
lymphocyte subsets in##2##3##(1990-2#1)(1991-6#1)
lymphocyte subsets##9##2##(1990-2#1)(1991-6#3)(2008-10#3)(2008-11#1)(2008-9#1)
lymphocyte type##2##2##(2008-5#1)(2008-7#1)
lymphocyte##147##1##(1990-12#3)(1990-2#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-5#5)(1991-6#4)(1991-9#8)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#8)(1995-2#1)(1995-3#5)(1995-8#2)(1996-12#1)(1996-2#2)(1996-9#1)(1997-4#3)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#9)(2008-12#3)(2008-3#1)(2008-4#13)(2008-5#4)(2008-7#6)(2008-9#3)(2009-12#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
lymphocytes after##2##2##(1996-2#1)(2012-2#1)
lymphocytes and M/E ratio##2##4##(2008-10#2)
lymphocytes and eosinophils##3##3##(1992-12#1)(2008-10#2)
lymphocytes and in##3##3##(1991-12#1)(1993-3#1)(2007-8#1)
lymphocytes and macrophages##3##3##(1992-9#1)(1997-8#2)
lymphocytes and monocytes##3##3##(1990-5#2)(1992-12#1)
lymphocytes and other cells##2##4##(1990-9#1)(2008-4#1)
lymphocytes and##43##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-5#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-6#2)(1997-8#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-11#1)(2011-2#3)
lymphocytes are##7##2##(1991-5#1)(1992-9#1)(1996-12#1)(2008-10#1)(2008-4#2)(2011-2#1)
lymphocytes but##3##2##(1992-5#1)(1993-6#1)(1994-3#1)
lymphocytes by flow cytometry##2##4##(2007-10#1)(2008-4#1)
lymphocytes by the##2##3##(1992-6#1)(1997-4#1)
lymphocytes by##10##2##(1991-3#1)(1992-6#1)(1994-3#2)(1997-4#1)(2007-10#1)(2008-10#1)(2008-4#3)
lymphocytes can##2##2##(1995-12#1)(2008-1#1)
lymphocytes could be##2##3##(1995-2#1)(2011-2#1)
lymphocytes exposed to##2##3##(1993-8#1)(2008-11#1)
lymphocytes for##5##2##(1994-5#1)(1995-12#1)(1996-12#1)(2008-11#1)(2012-2#1)
lymphocytes from patients##2##3##(2008-11#2)
lymphocytes from##20##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-6#1)(1996-10#1)(1997-3#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-7#1)(2011-2#1)
lymphocytes have##2##2##(1994-3#1)(2012-2#1)
lymphocytes in the##10##3##(1990-12#1)(1991-5#1)(1992-2#1)(1993-11#1)(1995-8#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
lymphocytes in vitro##3##3##(1995-3#1)(2008-11#1)(2008-9#1)
lymphocytes in##24##2##(1990-12#1)(1991-5#2)(1992-2#2)(1993-11#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-9#1)(2008-11#2)(2008-4#1)(2008-9#2)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
lymphocytes incubated##2##2##(1993-8#1)(1996-12#1)
lymphocytes is a##4##3##(1992-2#1)(2008-4#3)
lymphocytes is##6##2##(1990-12#1)(1992-2#1)(1993-8#1)(2008-4#3)
lymphocytes of##12##2##(1990-12#1)(1991-4#1)(1992-8#1)(1993-1#2)(1995-8#2)(1996-12#1)(2007-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
lymphocytes or##4##2##(1990-3#1)(1991-9#1)(1997-4#1)(2008-4#1)
lymphocytes play##3##2##(1995-2#1)(1995-5#1)(2010-5#1)
lymphocytes stimulated with##2##3##(2008-11#2)
lymphocytes to detect##2##3##(2008-10#1)(2008-4#1)
lymphocytes to##10##2##(1992-5#1)(1992-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#2)
lymphocytes using##3##2##(1992-6#1)(1997-4#1)(2008-9#1)
lymphocytes was##5##2##(1995-5#1)(2008-10#3)(2008-12#1)
lymphocytes were T cells##2##4##(2008-11#1)(2008-9#1)
lymphocytes were##10##2##(1990-12#2)(1992-12#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#1)
lymphocytes which##2##2##(1997-8#1)(2011-2#1)
lymphocytes with the##2##3##(1993-9#1)(1997-4#1)
lymphocytes with##9##2##(1990-2#1)(1992-8#1)(1993-9#1)(1997-4#1)(1997-6#2)(2008-2#1)(2008-4#2)
lymphocytes##379##1##(1990-12#14)(1990-2#2)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#6)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#7)(1992-11#4)(1992-12#7)(1992-2#4)(1992-3#2)(1992-5#4)(1992-6#4)(1992-8#8)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#7)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#12)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#8)(1995-2#2)(1995-3#2)(1995-5#4)(1995-8#7)(1996-10#1)(1996-12#7)(1996-2#3)(1996-9#1)(1997-3#2)(1997-4#9)(1997-5#2)(1997-6#5)(1997-8#4)(1997-9#1)(2007-10#4)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#18)(2008-11#33)(2008-12#2)(2008-2#4)(2008-4#38)(2008-5#1)(2008-7#11)(2008-8#2)(2008-9#19)(2009-11#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#3)(2013-8#4)
lymphocytes)##5##1##(1990-2#1)(1991-2#1)(1992-6#1)(1996-7#1)(2013-8#1)
lymphocytic cellular##2##2##(2008-9#2)
lymphocytic infiltrates##4##2##(2011-2#2)(2013-1#2)
lymphocytic infiltration of##2##3##(1995-12#1)(2008-7#1)
lymphocytic infiltration##5##2##(1995-12#1)(2007-11#1)(2008-7#1)(2013-1#2)
lymphocytic leukemia (CLL)##6##3##(1991-4#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)
lymphocytic leukemia##16##2##(1991-4#2)(1991-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#2)(2009-2#2)(2009-6#1)(2011-2#1)
lymphocytic##44##1##(1991-12#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-11#1)(1993-9#2)(1994-11#2)(1994-8#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#4)(2009-12#2)(2009-2#2)(2009-6#1)(2010-1#1)(2011-2#3)(2012-2#3)(2013-1#4)
lymphocytoses##2##1##(2010-1#2)
lymphocytosis##6##1##(1995-3#1)(2007-2#1)(2008-1#1)(2008-7#2)(2010-1#1)
lymphoedema##2##1##(2007-7#1)(2008-6#1)
lymphoepithelial lesions##2##2##(2009-8#2)
lymphohistiocytosis (HLH)##3##2##(2011-2#2)(2012-3#1)
lymphohistiocytosis##7##1##(2011-2#4)(2012-12#1)(2012-3#2)
lymphoid cell lines##2##3##(1994-2#2)
lymphoid cell##7##2##(1994-2#2)(1997-6#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-8#1)
lymphoid cells and##4##3##(1993-3#1)(2007-8#1)(2008-5#1)(2009-8#1)
lymphoid cells##14##2##(1991-6#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(2007-8#1)(2008-4#3)(2008-5#3)(2009-8#1)
lymphoid follicles##5##2##(1997-1#1)(1997-3#1)(2008-7#1)(2009-4#1)(2009-8#1)
lymphoid infiltrate##2##2##(2009-8#2)
lymphoid infiltrates##3##2##(2009-8#3)
lymphoid leukemia##2##2##(1997-5#1)(2012-3#1)
lymphoid organs and##2##3##(2008-4#1)(2008-8#1)
lymphoid organs##9##2##(1990-12#1)(1996-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
lymphoid patches##4##2##(1992-12#4)
lymphoid progenitors##2##2##(2008-4#2)
lymphoid proliferation in##3##3##(2008-11#3)
lymphoid proliferation##5##2##(1991-9#1)(2008-11#4)
lymphoid tissue (MALT)##6##3##(1991-6#1)(1997-1#1)(2008-1#1)(2009-8#2)(2013-1#1)
lymphoid tissue in##2##3##(2008-7#2)
lymphoid tissue##19##2##(1991-6#1)(1992-12#1)(1997-1#1)(2008-1#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#3)(2012-3#1)(2013-1#3)
lymphoid tissues##11##2##(1996-12#2)(1997-9#1)(2008-10#5)(2008-9#1)(2010-12#1)(2011-2#1)
lymphoid##104##1##(1990-12#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#5)(1992-3#1)(1993-3#1)(1994-2#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-8#1)(1996-12#3)(1997-1#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#14)(2008-5#5)(2008-7#5)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#10)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#4)
lymphokine activated killer##2##3##(1991-8#1)(2008-11#1)
lymphokine##7##1##(1990-12#1)(1991-12#1)(1991-8#1)(1992-2#1)(2008-11#1)(2008-4#2)
lymphokine-activated killer (LAK) cells##4##4##(1992-2#1)(2008-4#3)
lymphokine-activated killer cells##3##3##(1993-3#2)(1993-6#1)
lymphokine-activated killer##8##2##(1992-2#1)(1993-3#3)(1993-6#1)(2008-4#3)
lymphokines##4##1##(1991-12#1)(1991-3#1)(2008-4#1)(2008-5#1)
lymphoma (ALCL)##4##2##(1997-3#1)(2011-2#2)(2013-1#1)
lymphoma (FL)##2##2##(2010-11#2)
lymphoma (NHL) is##2##3##(2007-10#1)(2013-1#1)
lymphoma (NHL)##8##2##(1996-8#1)(2007-10#2)(2009-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
lymphoma (PBL) is a rare##2##5##(2007-5#1)(2012-2#1)
lymphoma - a##2##3##(2007-10#1)(2012-2#1)
lymphoma -##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
lymphoma and##20##2##(1991-8#1)(1994-3#1)(1995-11#1)(1996-8#1)(1997-1#2)(2008-10#1)(2008-7#2)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
lymphoma associated with##2##3##(2011-2#1)(2013-1#1)
lymphoma by##2##2##(1992-3#1)(2012-2#1)
lymphoma can##2##2##(1997-1#2)
lymphoma cell##4##2##(1993-2#1)(1995-11#1)(2008-4#1)(2009-11#1)
lymphoma cells##6##2##(1993-9#2)(1997-4#1)(2008-10#1)(2008-4#1)(2009-11#1)
lymphoma entities##2##2##(2009-8#2)
lymphoma have##2##2##(1997-1#1)(2007-5#1)
lymphoma in a##3##3##(1991-6#1)(1993-6#1)(2009-1#1)
lymphoma in the##4##3##(2008-5#1)(2008-7#1)(2009-1#1)(2009-7#1)
lymphoma in##12##2##(1991-6#1)(1993-6#1)(1994-2#1)(1996-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-7#1)
lymphoma involving the##3##3##(2008-1#1)(2009-7#2)
lymphoma involving##4##2##(2008-1#1)(2009-7#2)(2009-8#1)
lymphoma is an##2##3##(2009-8#1)(2012-1#1)
lymphoma is usually##2##3##(2009-8#1)(2013-8#1)
lymphoma is##9##2##(1991-6#1)(2008-1#1)(2008-10#1)(2009-8#3)(2012-1#1)(2013-8#2)
lymphoma kinase (ALK)##2##3##(2011-2#1)(2013-1#1)
lymphoma lesions##3##2##(2008-5#3)
lymphoma line##4##2##(1992-9#3)(1993-9#1)
lymphoma of mucosa-associated lymphoid tissue (MALT)##2##6##(2009-8#2)
lymphoma of mucosa-associated lymphoid tissue##3##5##(2009-8#3)
lymphoma of the##13##3##(1991-2#3)(1993-6#1)(1997-3#1)(2007-10#1)(2008-1#2)(2009-1#1)(2009-8#1)(2013-1#2)(2013-8#1)
lymphoma of##19##2##(1991-12#1)(1991-2#3)(1993-6#1)(1997-3#1)(2007-10#1)(2008-1#2)(2009-1#1)(2009-5#1)(2009-8#4)(2013-1#3)(2013-8#1)
lymphoma or##2##2##(2007-7#1)(2008-5#1)
lymphoma presenting as phlegmonous gastritis##2##5##(2008-12#2)
lymphoma presenting as##5##3##(2008-12#2)(2008-3#1)(2012-1#1)(2012-3#1)
lymphoma presenting##6##2##(2008-12#3)(2008-3#1)(2012-1#1)(2012-3#1)
lymphoma survivors##2##2##(2008-7#1)(2013-1#1)
lymphoma to##2##2##(2007-11#1)(2008-1#1)
lymphoma with##6##2##(1990-3#1)(1993-2#1)(2007-7#1)(2013-1#3)
lymphoma##274##1##(1990-11#2)(1990-3#2)(1990-6#2)(1990-9#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#1)(1992-9#6)(1993-2#3)(1993-6#2)(1993-9#5)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#2)(1996-11#2)(1996-3#1)(1996-8#3)(1997-1#5)(1997-3#3)(1997-4#1)(1997-8#3)(2007-1#1)(2007-10#5)(2007-11#1)(2007-2#2)(2007-5#5)(2007-7#3)(2007-8#1)(2008-1#8)(2008-10#8)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#11)(2008-7#13)(2008-9#1)(2009-1#9)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#5)(2009-8#28)(2010-11#4)(2010-3#1)(2011-1#1)(2011-2#12)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#24)(2013-7#3)(2013-8#6)
lymphoma-like##2##1##(1990-6#2)
lymphoma]##3##1##(1993-9#1)(2012-2#2)
lymphomagenesis##6##1##(1991-5#4)(1992-2#2)
lymphomas and angioimmunoblastic##2##3##(1992-8#1)(2009-4#1)
lymphomas and##7##2##(1992-8#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
lymphomas are##3##2##(1997-1#2)(2009-8#1)
lymphomas of the gastrointestinal tract##2##5##(1990-8#1)(2008-10#1)
lymphomas of the##4##3##(1990-8#2)(1991-6#1)(2008-10#1)
lymphomas##67##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-8#3)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#2)(1997-1#3)(1997-3#2)(1997-8#1)(2007-10#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-4#5)(2009-8#10)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#3)
lymphomatous##3##1##(1990-12#1)(1990-3#1)(2008-3#1)
lymphomononuclear cells from healthy donors##2##5##(1994-12#1)(1994-3#1)
lymphomononuclear##3##1##(1994-12#1)(1994-3#2)
lymphopenia##3##1##(1996-3#2)(2007-10#1)
lymphoplasmacytic infiltration##2##2##(1997-6#1)(2009-8#1)
lymphoplasmacytic##3##1##(1997-6#1)(2008-5#1)(2009-8#1)
lymphopoiesis##4##1##(1994-3#2)(1997-9#1)(2008-4#1)
lymphoproliferation and##2##2##(2008-10#1)(2008-5#1)
lymphoproliferation##5##1##(1992-2#1)(2008-10#1)(2008-5#2)(2011-2#1)
lymphoproliferative disease##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
lymphoproliferative disorder##2##2##(2008-5#1)(2009-8#1)
lymphoproliferative disorders##11##2##(1992-2#1)(1992-8#2)(2007-2#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2011-3#1)
lymphoproliferative responses##2##2##(1995-5#1)(2011-2#1)
lymphoproliferative##24##1##(1992-2#1)(1992-8#2)(1995-5#1)(1997-4#1)(2007-12#1)(2007-2#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
lymphoreticular##2##1##(1990-8#1)(1993-3#1)
lymphosarcoma##8##1##(1992-8#4)(1995-11#2)(2010-9#1)(2012-3#1)
lymphotoxin (LT)##2##2##(1994-2#1)(2008-11#1)
lymphotoxin##4##1##(1994-2#1)(1997-2#2)(2008-11#1)
lymphotropic virus##3##2##(1991-11#1)(1991-6#1)(2012-12#1)
lymphovascular emboli##2##2##(2011-2#2)
lymphovascular invasion##5##2##(2009-12#1)(2011-2#4)
lymphovascular##9##1##(2009-12#1)(2011-2#8)
lyophilised samples##2##2##(2008-10#2)
lyophilised##6##1##(2008-10#6)
lyophilization process##2##2##(2008-6#1)(2009-7#1)
lyophilization##7##1##(2008-10#2)(2008-5#2)(2008-6#1)(2009-7#1)(2013-1#1)
lyophilized bone graft##3##3##(2007-11#3)
lyophilized cells##4##2##(1994-6#1)(2008-10#3)
lyophilized##20##1##(1992-8#1)(1994-6#1)(1995-2#1)(2007-11#4)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#2)(2013-7#1)
lyophylization##2##1##(1992-8#2)
lyophylized##5##1##(1992-8#5)
lyotropic##2##1##(1993-11#1)(1995-5#1)
lys##2##1##(1997-4#2)
lys7 delta mutant##2##3##(1995-8#2)
lys7##3##1##(1995-8#3)
lysate of##2##2##(1997-1#1)(2008-11#1)
lysate was investigated##2##3##(1992-11#1)(2008-11#1)
lysate was##9##2##(1992-11#1)(1992-8#1)(1994-11#2)(1994-5#1)(2008-11#3)(2010-11#1)
lysate with a##2##3##(2008-10#1)(2008-4#1)
lysate##42##1##(1990-11#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-5#5)(1995-12#2)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-11#13)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2013-1#2)
lysates and##6##2##(1990-2#1)(1992-11#2)(1992-9#1)(2008-1#1)(2008-4#1)
lysates containing##2##2##(2008-10#1)(2008-7#1)
lysates from##3##2##(1994-8#3)
lysates is##2##2##(1994-8#1)(2008-7#1)
lysates of##9##2##(1992-8#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-3#2)(2010-12#1)
lysates##55##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#2)(1994-8#8)(1995-6#2)(1995-8#1)(1996-12#3)(1997-3#4)(2008-1#2)(2008-10#2)(2008-4#5)(2008-7#6)(2008-9#1)(2010-12#1)(2011-2#1)(2012-6#2)
lyse##11##1##(1993-9#1)(1994-3#2)(1994-5#1)(1995-2#1)(1997-3#1)(2008-4#1)(2009-6#2)(2010-3#1)(2011-2#1)
lysed by##2##2##(1993-9#1)(2008-10#1)
lysed cells##2##2##(1990-2#1)(2008-4#1)
lysed in##2##2##(1992-11#1)(1993-9#1)
lysed##15##1##(1990-2#1)(1992-11#1)(1993-9#2)(2008-10#4)(2008-11#2)(2008-4#3)(2008-7#1)(2011-2#1)
lysergic acid##3##2##(1997-7#2)(2008-10#1)
lyses##6##1##(1994-2#1)(1994-3#3)(2011-1#1)(2011-2#1)
lysimeter##4##1##(2008-10#4)
lysine (0##2##2##(1995-6#1)(2008-10#1)
lysine (AAG)##2##2##(1990-8#1)(1991-8#1)
lysine 4##2##2##(2013-1#2)
lysine 79 in##2##3##(2008-4#2)
lysine 79##3##2##(2008-4#3)
lysine 9##3##2##(2013-1#3)
lysine analogs##2##2##(1995-6#2)
lysine and arginine residues##2##4##(1995-2#2)
lysine and guanine##2##3##(2008-10#2)
lysine and tryptophan##2##3##(2012-2#2)
lysine and##9##2##(1995-2#3)(1995-8#1)(2008-10#2)(2008-11#1)(2012-2#2)
lysine at##2##2##(1994-3#1)(2008-4#1)
lysine biosynthesis##3##2##(1995-8#2)(2008-7#1)
lysine diet##3##2##(2012-2#3)
lysine for##3##2##(1991-8#2)(1993-3#1)
lysine is##2##2##(2008-11#1)(2008-4#1)
lysine methylation##2##2##(1994-8#1)(2008-9#1)
lysine oxidase on##2##3##(2008-10#2)
lysine residue at##2##3##(1997-2#1)(2008-10#1)
lysine residue##5##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-4#2)
lysine residues are##2##3##(1995-6#2)
lysine residues in##4##3##(1995-6#1)(1997-2#1)(1997-7#1)(2013-1#1)
lysine residues of HPRG##2##4##(1995-2#2)
lysine residues of##4##3##(1995-2#2)(2008-4#1)(2008-8#1)
lysine residues##20##2##(1990-5#1)(1992-6#1)(1994-5#2)(1995-2#2)(1995-6#8)(1997-2#1)(1997-7#1)(2008-4#1)(2008-8#1)(2009-12#1)(2013-1#1)
lysine##105##1##(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-8#3)(1992-6#2)(1993-11#2)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#6)(1995-5#1)(1995-6#11)(1995-8#3)(1996-2#1)(1997-2#5)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-4#9)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-2#10)(2013-1#6)(2013-8#1)
lysine(469 and 707)##2##3##(1996-2#2)
lysine)##3##1##(2012-2#3)
lysine-binding site##3##2##(1990-5#3)
lysine-binding##4##1##(1990-5#4)
lysine-rich##2##1##(1994-9#1)(2011-2#1)
lysines in##2##2##(2008-11#2)
lysines##4##1##(1995-2#1)(1997-2#1)(2008-11#2)
lysing##3##1##(2008-4#1)(2008-9#2)
lysis and##6##2##(1994-3#1)(1997-8#1)(2008-10#2)(2008-4#1)(2011-1#1)
lysis buffer##2##2##(2008-12#1)(2008-2#1)
lysis by the##2##3##(1993-9#1)(2008-10#1)
lysis by##7##2##(1992-2#2)(1993-9#2)(2008-10#1)(2008-4#1)(2008-9#1)
lysis is##2##2##(2008-8#1)(2013-1#1)
lysis method##3##2##(2008-12#1)(2008-4#1)(2009-5#1)
lysis of the##4##3##(1992-12#1)(1992-5#1)(1997-6#1)(2008-4#1)
lysis of##12##2##(1990-12#1)(1992-12#2)(1992-5#1)(1996-1#1)(1997-6#1)(1997-8#1)(2008-4#2)(2009-6#1)(2010-3#1)(2013-1#1)
lysis or##2##2##(1994-2#1)(2009-6#1)
lysis procedure##2##2##(2008-12#1)(2008-4#1)
lysis syndrome in##3##3##(2008-7#3)
lysis syndrome##10##2##(2008-7#9)(2012-12#1)
lysis was##2##2##(2008-10#2)
lysis##79##1##(1990-12#1)(1991-3#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-6#1)(1993-9#4)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2006-10#1)(2007-11#1)(2008-10#7)(2008-12#3)(2008-2#2)(2008-4#7)(2008-7#12)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#3)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#3)
lyso-PC##6##1##(2008-8#6)
lysoPC##3##1##(1990-11#2)(1995-8#1)
lysogenic phage##2##2##(1996-12#1)(1996-6#1)
lysogenic##3##1##(1995-5#1)(1996-12#1)(1996-6#1)
lysophosphatidic acid##10##2##(1990-8#1)(1991-2#7)(1994-12#1)(1997-6#1)
lysophosphatidic##12##1##(1990-8#1)(1991-2#8)(1994-12#1)(1997-6#1)(2008-7#1)
lysophosphatidylcholine (LPC)##2##2##(1992-10#1)(1995-3#1)
lysophosphatidylcholine##8##1##(1990-2#3)(1990-5#1)(1992-10#1)(1994-12#1)(1995-3#1)(2008-8#1)
lysophospholipase##4##1##(1990-2#4)
lysophospholipid##2##1##(1990-2#1)(1995-3#1)
lysophospholipids##2##1##(1995-3#1)(2008-4#1)
lysosomal aspartyl protease##3##3##(1994-5#1)(1995-8#2)
lysosomal beta-galactosidase##2##2##(1990-11#1)(1995-2#1)
lysosomal carboxypeptidase B and prolyl-carboxypeptidase##2##5##(2006-6#2)
lysosomal degradation##3##2##(1991-5#1)(1992-12#1)(1994-5#1)
lysosomal enzyme assay##2##3##(2010-8#2)
lysosomal enzyme##8##2##(1990-5#2)(1991-2#1)(1993-8#1)(1996-8#1)(1997-7#1)(2010-8#2)
lysosomal enzymes##5##2##(1990-5#1)(1991-12#1)(1995-6#2)(2012-3#1)
lysosomal exocytosis in hypertrophic chondrocytes##2##5##(2012-12#2)
lysosomal exocytosis in##3##3##(2012-12#3)
lysosomal exocytosis##7##2##(2012-12#7)
lysosomal function##2##2##(1992-12#2)
lysosomal glycosidase##2##2##(1992-10#2)
lysosomal hydrolases##3##2##(1992-9#1)(2012-12#2)
lysosomal import and degradation##2##4##(1994-11#2)
lysosomal protease##2##2##(1990-5#1)(1997-1#1)
lysosomal proteases##2##2##(1992-12#1)(1997-1#1)
lysosomal protective protein##2##3##(1994-11#2)
lysosomal proteins##2##2##(1995-6#2)
lysosomal storage disease##4##3##(1992-10#1)(2007-7#1)(2010-8#2)
lysosomal storage disorder##3##3##(1996-8#1)(2006-10#1)(2008-10#1)
lysosomal storage disorders##2##3##(2008-11#2)
lysosomal storage of sulfated glycosaminoglycans##2##5##(1993-12#2)
lysosomal storage of##3##3##(1993-12#3)
lysosomal storage##12##2##(1992-10#1)(1993-12#3)(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-8#2)
lysosomal system##5##2##(1992-12#3)(2008-7#2)
lysosomal##92##1##(1990-11#1)(1990-5#5)(1991-12#4)(1991-2#1)(1991-5#1)(1991-7#2)(1992-10#4)(1992-12#12)(1992-9#1)(1993-12#5)(1993-8#4)(1993-9#1)(1994-11#6)(1994-5#4)(1995-2#2)(1995-6#4)(1995-8#2)(1996-8#2)(1997-1#2)(1997-7#1)(2006-10#1)(2006-6#2)(2007-7#2)(2008-10#1)(2008-11#2)(2008-7#3)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#4)(2012-12#9)(2012-3#1)
lysosome and##2##2##(1994-11#1)(2013-1#1)
lysosome##7##1##(1992-12#2)(1994-11#1)(1995-2#1)(2008-11#1)(2008-4#1)(2013-1#1)
lysosome-associated membrane##4##2##(1994-11#2)(1994-6#1)(2012-12#1)
lysosome-like##2##1##(1992-9#1)(2007-12#1)
lysosomes and##4##2##(1992-11#1)(1992-12#2)(2008-1#1)
lysosomes##20##1##(1990-11#1)(1990-5#2)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#7)(2007-7#1)(2008-1#1)(2008-7#1)(2010-11#4)
lysosomotropic##3##1##(1990-7#1)(1992-9#1)(1995-2#1)
lysostaphin##2##1##(2008-4#1)(2009-6#1)
lysozyme (HEL)##4##2##(1990-12#2)(1994-8#1)(2008-11#1)
lysozyme activity##4##2##(2008-10#4)
lysozyme and ovalbumin##3##3##(2008-11#1)(2008-7#2)
lysozyme and##7##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#2)
lysozyme at##2##2##(1992-8#1)(2008-7#1)
lysozyme crystals grown in gravity and microgravity##2##7##(2008-4#2)
lysozyme crystals##3##2##(2008-4#3)
lysozyme from##4##2##(2008-10#4)
lysozyme is##2##2##(2008-11#1)(2011-2#1)
lysozyme was##3##2##(2008-10#3)
lysozyme##65##1##(1990-12#3)(1992-12#1)(1992-8#3)(1992-9#1)(1994-8#1)(1995-3#1)(1997-2#5)(1997-4#2)(1997-8#1)(2008-10#19)(2008-11#4)(2008-12#3)(2008-4#3)(2008-7#8)(2011-2#6)(2012-1#1)(2013-8#3)
lysozyme-like##2##1##(1990-5#1)(2008-12#1)
lystate##3##1##(1990-11#2)(1992-8#1)
lysyl endopeptidase##3##2##(2008-11#3)
lysyl##5##1##(2006-6#1)(2008-11#3)(2008-5#1)
lytic activity##4##2##(1997-6#2)(2008-10#1)(2009-6#1)
lytic enzymes##3##2##(1997-3#1)(2008-10#2)
lytic##30##1##(1990-2#1)(1991-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-3#2)(1997-6#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
lésions##2##1##(2013-1#2)
m &lt##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
m = 0##2##3##(2008-2#1)(2008-3#1)
m = 1##2##3##(2008-3#2)
m = 3##5##3##(1991-12#1)(1991-8#4)
m =##17##2##(1991-12#1)(1991-8#7)(2008-10#1)(2008-2#1)(2008-3#7)
m a##3##2##(2008-10#1)(2008-11#1)(2010-6#1)
m above sea level##2##4##(2008-8#2)
m above sea##3##3##(2008-3#1)(2008-8#2)
m above the ground##2##4##(2008-10#2)
m above##5##2##(2008-10#2)(2008-3#1)(2008-8#2)
m and a##2##3##(2008-3#2)
m and##13##2##(1990-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#7)
m at##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
m depth##3##2##(2007-5#1)(2008-5#2)
m downwind##2##2##(2008-10#2)
m during the##2##3##(2007-5#1)(2008-10#1)
m during##4##2##(2007-5#1)(2008-10#1)(2008-12#2)
m for a##2##3##(2008-3#2)
m for colony##2##3##(2011-2#2)
m for##6##2##(2008-3#4)(2011-2#2)
m from the source##3##4##(2008-10#2)(2008-3#1)
m from the##9##3##(2008-10#5)(2008-3#4)
m from##11##2##(2008-10#6)(2008-3#4)(2008-5#1)
m gamma-IFN and h gamma-IFN##2##5##(1994-5#2)
m gamma-IFN--transduced tumor cells##2##4##(1994-5#2)
m in length##2##3##(2008-10#1)(2008-5#1)
m in##9##2##(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)
m is##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
m long##4##2##(1994-9#1)(2008-10#2)(2013-1#1)
m of the##3##3##(2008-10#2)(2008-3#1)
m of##11##2##(2007-11#1)(2008-10#4)(2008-3#5)(2011-2#1)
m on a##2##3##(2008-2#2)
m on##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
m s(-1)##8##2##(2008-10#1)(2008-11#3)(2008-3#2)(2010-8#2)
m s(-1))##3##2##(2008-10#3)
m s(-2)) was##2##3##(2010-8#2)
m to##2##2##(2007-5#1)(2008-5#1)
m value##2##2##(1997-2#1)(2007-12#1)
m values##8##2##(1997-2#7)(2008-10#1)
m was##3##2##(2008-3#3)
m wide##5##2##(2008-10#5)
m x 0##2##3##(2008-10#1)(2011-1#1)
m x##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
m##364##1##(1990-12#3)(1990-2#1)(1990-8#1)(1990-9#5)(1991-12#2)(1991-6#2)(1991-8#8)(1992-12#1)(1992-6#1)(1992-9#1)(1994-5#4)(1994-9#1)(1995-12#1)(1996-12#4)(1996-4#3)(1997-2#8)(1997-5#1)(1997-7#1)(2006-4#1)(2007-10#2)(2007-11#10)(2007-12#11)(2007-5#8)(2007-8#1)(2008-10#93)(2008-11#9)(2008-12#7)(2008-2#11)(2008-3#79)(2008-5#16)(2008-7#3)(2008-8#10)(2008-9#3)(2009-7#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#9)(2011-1#1)(2011-2#11)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#7)
m(-1) sr(-1)##4##2##(2008-2#2)(2008-3#2)
m(-1)##21##1##(2008-10#2)(2008-2#8)(2008-3#6)(2008-5#1)(2008-7#4)
m(-1)) was##2##2##(2008-10#1)(2010-8#1)
m(-1))##11##1##(2008-10#4)(2008-12#2)(2008-3#2)(2008-7#1)(2010-8#2)
m(-2) d(-1)##4##2##(2007-5#2)(2008-5#2)
m(-2) d(-1))##2##2##(2007-5#2)
m(-2) h(-1)##2##2##(2008-10#1)(2008-7#1)
m(-2) in##4##2##(2008-5#4)
m(-2) of##2##2##(2008-10#1)(2008-5#1)
m(-2) was##4##2##(2008-12#2)(2008-6#1)(2012-12#1)
m(-2)##49##1##(2006-11#1)(2007-5#9)(2008-10#12)(2008-11#1)(2008-12#7)(2008-3#2)(2008-5#9)(2008-6#3)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
m(-2))##8##1##(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2013-8#1)
m(-3)##20##1##(2008-10#10)(2008-2#1)(2008-3#4)(2008-5#3)(2010-5#2)
m(-3))##6##1##(2008-10#1)(2008-2#1)(2009-7#2)(2010-5#2)
m(2) g(-1)##6##2##(2008-10#4)(2008-11#1)(2009-11#1)
m(2) in##3##2##(2008-10#3)
m(2)##20##1##(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
m(2)) per##2##2##(2008-10#2)
m(2))##5##1##(2008-10#5)
m(2)/g##2##1##(2008-3#1)(2010-4#1)
m(3) Pa(-1) mol(-1) at the##2##5##(2008-10#2)
m(3) Pa(-1)##3##2##(2008-10#3)
m(3)##7##1##(2008-10#4)(2008-2#1)(2008-7#1)(2010-8#1)
m(3))##3##1##(2008-3#3)
m(o) of##6##2##(2008-10#6)
m(o) were##3##2##(2008-10#3)
m(o)##10##1##(2008-10#10)
m(o)=2##3##1##(2008-10#3)
m) and##5##2##(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
m) for##2##2##(2008-3#1)(2012-4#1)
m) in the##2##3##(2008-3#1)(2008-7#1)
m) in##3##2##(2008-3#1)(2008-7#1)(2013-7#1)
m) on##2##2##(2008-10#1)(2008-3#1)
m) the signal##2##3##(2008-3#2)
m) to##2##2##(2008-10#2)
m)##42##1##(2006-4#1)(2008-10#10)(2008-11#1)(2008-3#13)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#5)(2012-4#1)(2013-7#1)
m- and##2##2##(1995-11#1)(2008-10#1)
m-##3##1##(1995-11#1)(2008-10#2)
m-2 yr-1##2##2##(2008-9#2)
m-CPBA##2##1##(2007-11#1)(2008-11#1)
m-FISH##2##1##(2013-8#2)
m-Nis##4##1##(2011-3#4)
m-THF##2##1##(1997-1#2)
m-axis##3##1##(2008-3#3)
m-chloroperoxybenzoic##2##1##(1990-11#1)(2007-11#1)
m-cresol##5##1##(1990-8#1)(2008-10#2)(2011-1#2)
m-dinitrobenzene##2##1##(2008-10#2)
m-nitroaniline##3##1##(2008-10#3)
m-xylene##2##1##(2008-10#2)
m/s + 0##4##3##(2008-1#4)
m/s + 1##2##3##(2008-1#2)
m/s +##6##2##(2008-1#6)
m/s and##4##2##(1993-3#1)(2007-12#1)(2008-3#1)(2010-9#1)
m/s for##3##2##(2008-2#2)(2010-9#1)
m/s the##2##2##(2008-3#2)
m/s with##2##2##(2008-3#2)
m/s##29##1##(1993-3#3)(2007-11#1)(2007-12#2)(2008-1#6)(2008-2#4)(2008-3#7)(2009-7#4)(2010-9#2)
m/s) and##2##2##(2008-3#2)
m/s)##4##1##(2008-3#3)(2011-2#1)
m/v NaBH(4)##2##2##(2008-10#2)
m/v for##2##2##(2008-10#2)
m/v##11##1##(2008-10#11)
m/z##16##1##(2008-10#10)(2008-11#1)(2009-12#1)(2011-2#1)(2011-3#3)
m0##2##1##(2008-9#2)
m1 and##2##2##(1993-12#1)(2009-10#1)
m1 muscarinic receptor##2##3##(1993-11#1)(2008-10#1)
m1##8##1##(1993-11#1)(1993-12#2)(2008-10#1)(2008-11#1)(2009-10#3)
m2 muscarinic receptor##2##3##(1995-6#2)
m2 muscarinic##3##2##(1995-6#3)
m2 was##2##2##(2008-12#1)(2011-2#1)
m2##20##1##(1995-6#3)(2007-5#1)(2008-11#1)(2008-12#3)(2008-5#1)(2009-10#3)(2011-2#8)
m2)##4##1##(2007-8#1)(2011-2#3)
m3##3##1##(2009-10#1)(2012-3#2)
m6418##5##1##(2008-10#5)
m6A##2##1##(1994-12#2)
mA M(-1))##2##2##(2008-10#2)
mA##17##1##(2007-11#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
mA)##2##1##(2008-3#2)
mAMSA##5##1##(1994-8#5)
mATP##3##1##(2008-2#3)
mAb HUC2-13##2##2##(2008-11#2)
mAb M2##2##2##(1997-3#2)
mAb and##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
mAb binding##3##2##(1997-6#2)(2008-11#1)
mAb enhanced##2##2##(1996-12#1)(2008-8#1)
mAb for##2##2##(1994-2#1)(2008-10#1)
mAb production##3##2##(2008-11#1)(2011-2#2)
mAb to the##2##3##(1994-5#2)
mAb##57##1##(1990-5#1)(1993-2#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-5#3)(1996-11#1)(1996-12#6)(1996-5#4)(1997-3#3)(1997-6#3)(2008-10#7)(2008-11#9)(2008-4#2)(2008-7#2)(2008-8#3)(2009-8#1)(2011-2#5)
mAb)##2##1##(1993-2#1)(1997-6#1)
mAbs M1##3##2##(1997-3#3)
mAbs and##4##2##(1990-12#1)(1997-3#1)(1997-6#1)(2008-4#1)
mAbs are##2##2##(2008-8#2)
mAbs have##2##2##(1993-8#1)(2008-11#1)
mAbs to##2##2##(1994-2#1)(2008-4#1)
mAbs were##4##2##(1996-12#3)(2008-8#1)
mAbs##44##1##(1990-12#1)(1993-8#3)(1994-2#3)(1994-5#3)(1996-12#7)(1997-3#5)(1997-6#4)(2008-10#1)(2008-11#9)(2008-4#3)(2008-8#4)(2009-2#1)
mAs##4##1##(2012-1#4)
mCMV##4##1##(2008-4#4)
mCherry as an##2##3##(2009-4#2)
mCherry##6##1##(2009-4#5)(2012-2#1)
mCi##2##1##(1996-2#1)(2008-7#1)
mEH##4##1##(1997-7#4)
mES cells##4##2##(2008-11#4)
mEq/L##2##1##(2011-2#2)
mGlu and cannabinoid receptors##3##4##(2008-7#3)
mGlu and##4##2##(2008-7#4)
mGlu group II receptors##2##4##(1995-12#2)
mGlu group II##3##3##(1995-12#3)
mGlu group##5##2##(1995-12#5)
mGlu receptor##2##2##(1995-12#2)
mGlu receptors##3##2##(1995-12#1)(2012-2#2)
mGlu##14##1##(1995-12#8)(2008-7#4)(2012-2#2)
mGlu(1)##2##1##(2012-2#2)
mGlu(5) receptors##2##2##(2012-2#2)
mGluR##3##1##(1995-12#2)(2008-4#1)
mGluR1 antagonist##2##2##(2008-4#2)
mGluR1 mRNA##2##2##(1996-12#2)
mGluR1##5##1##(1996-12#3)(2008-4#2)
mGluR5 antagonist##2##2##(2008-4#2)
mGluR5 mRNA##2##2##(1996-12#2)
mGluR5##8##1##(1992-11#1)(1996-12#4)(2008-4#3)
mGluR7##6##1##(1995-12#4)(1997-2#2)
mGluR7-LI##3##1##(1997-2#3)
mGluR7-like immunoreactivity##3##2##(1995-12#2)(1997-2#1)
mGnRH (analog##3##2##(1994-8#3)
mGnRH##4##1##(1994-8#4)
mGuHCl##6##1##(1992-6#6)
mGy##8##1##(1991-5#1)(2008-7#3)(2012-1#2)(2013-1#2)
mGy)##2##1##(2008-7#1)(2012-1#1)
mGy/hr##3##1##(2008-7#3)
mGy/min)##2##1##(2008-7#2)
mHz##3##1##(1990-9#1)(2008-3#2)
mIFN-gamma##2##1##(2008-11#2)
mIGFBP-2##2##1##(1993-2#2)
mIU/mL##3##1##(2009-12#1)(2011-1#2)
mJ and##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mJ at the 2##2##4##(2007-11#2)
mJ at##7##2##(2007-11#3)(2008-2#2)(2008-3#1)(2010-1#1)
mJ cm(-2) min(-1)##4##3##(2008-10#4)
mJ cm(-2)##5##2##(2008-10#5)
mJ in##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
mJ of##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
mJ##46##1##(2007-11#9)(2007-12#12)(2008-10#8)(2008-2#6)(2008-3#7)(2008-5#1)(2010-1#3)
mJ)##4##1##(2007-12#2)(2008-10#1)(2008-2#1)
mJ/cm(2)##5##1##(2007-12#3)(2008-2#1)(2008-3#1)
mJ/cm(2))##3##1##(2008-3#3)
mJ/cm2##3##1##(2008-10#1)(2008-3#2)
mJ/pulse##2##1##(2008-2#2)
mK##2##1##(2008-3#1)(2008-7#1)
mL and##2##2##(2011-2#1)(2012-3#1)
mL extraction reservoir##2##3##(2008-10#2)
mL in##2##2##(2007-9#2)
mL min(-1) and##3##3##(2008-5#3)
mL min(-1)##6##2##(2008-5#4)(2010-5#1)(2012-12#1)
mL of##16##2##(1993-1#3)(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#1)(2013-1#2)
mL x min(-1) x kg(-1)##2##5##(2011-3#2)
mL x min(-1)##3##3##(2011-3#2)(2012-3#1)
mL##56##1##(1993-1#3)(1994-12#1)(1994-6#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
mL(-1) for lopinavir##2##3##(2011-3#2)
mL(-1) for the##2##3##(2008-10#2)
mL(-1) for##22##2##(2008-10#5)(2008-5#10)(2011-3#7)
mL(-1) in##3##2##(2010-5#2)(2012-1#1)
mL(-1)##46##1##(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#17)(2009-6#2)(2010-5#2)(2011-2#1)(2011-3#9)(2012-1#1)(2013-8#1)
mL(-1))##4##1##(2008-11#1)(2008-12#1)(2011-3#1)(2012-2#1)
mL)##10##1##(1996-3#2)(2008-11#1)(2010-1#1)(2010-3#2)(2011-2#4)
mL-1##5##1##(2008-11#3)(2009-6#2)
mL/kg/min during##2##2##(2013-1#2)
mL/min##15##1##(2007-12#1)(2008-10#2)(2008-6#2)(2009-8#1)(2011-1#4)(2011-2#5)
mL/min/nmol CYP450)##4##2##(2011-2#4)
mLTC-1 cells##3##2##(1996-5#3)
mLTC-1##4##1##(1996-5#4)
mL·mm Hg(-1) × 10##2##4##(2013-8#2)
mL·mm Hg(-1) × 100##2##4##(2013-8#2)
mL·mm Hg(-1) ×##4##3##(2013-8#4)
mM (0##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
mM (R(2)=0##2##2##(2008-10#2)
mM (n =##2##3##(1990-12#1)(1994-3#1)
mM CHAPS##3##2##(1990-11#3)
mM Ca2+##11##2##(1990-5#1)(1990-7#2)(1990-8#2)(1992-6#1)(1993-8#1)(1995-6#2)(1996-2#1)(1997-2#1)
mM CaCl2##2##2##(1992-9#1)(1993-6#1)
mM DPPH was##2##3##(2008-10#2)
mM DTT##2##2##(2011-2#2)
mM EDTA##2##2##(1992-3#1)(1997-4#1)
mM EGTA##2##2##(1992-9#1)(1994-6#1)
mM GTP gamma S##2##4##(1992-11#2)
mM HCO3-)##2##2##(1995-8#2)
mM K+##6##2##(1994-2#2)(1995-12#1)(1996-5#1)(1997-1#1)(2008-11#1)
mM KCl##5##2##(1990-2#1)(1992-6#1)(1993-9#1)(1996-5#1)(2008-12#1)
mM LiCl for 1 h##2##5##(1992-6#2)
mM Mg2+##2##2##(1993-6#1)(1995-6#1)
mM MgCl2##2##2##(1993-8#1)(1995-11#1)
mM NaCl and##2##3##(1992-6#1)(2008-10#1)
mM NaCl##10##2##(1990-8#1)(1992-6#3)(1994-5#1)(2008-10#2)(2008-11#1)(2009-12#2)
mM NaCl)##2##2##(2008-12#1)(2010-5#1)
mM NaF##2##2##(1990-8#1)(1993-3#1)
mM NaH(2)PO(4)##2##2##(2008-10#2)
mM NaOH##2##2##(1994-9#1)(2008-10#1)
mM Ni2+##2##2##(1994-2#2)
mM SDS##2##2##(2008-10#2)
mM Tris##3##2##(1993-9#1)(2008-10#2)
mM Tris-HCl buffer##2##3##(2008-10#2)
mM ammonium##2##2##(1996-5#1)(2008-10#1)
mM and 0##2##3##(1995-5#1)(2008-10#1)
mM and 1##2##3##(1990-12#1)(2008-6#1)
mM and a Vmax of##3##5##(1994-6#1)(1995-2#2)
mM and a##6##3##(1994-6#1)(1995-2#2)(2008-10#3)
mM and##24##2##(1990-12#2)(1991-5#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-2#2)(1995-5#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2011-2#1)
mM at##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
mM borate buffer (pH 9##2##5##(2008-10#2)
mM borate buffer (pH##3##4##(2008-10#3)
mM borate buffer##5##3##(1996-5#1)(2008-10#4)
mM borate##7##2##(1996-5#1)(2008-10#6)
mM borax##3##2##(1994-9#1)(2008-10#2)
mM calcium concentration##2##3##(1994-3#2)
mM calcium##6##2##(1994-3#4)(1995-8#1)(1997-4#1)
mM cholesterol##2##2##(2008-10#2)
mM did not##2##3##(1994-11#1)(1997-1#1)
mM erythritol##2##2##(1991-5#2)
mM ethanol##4##2##(1990-12#1)(1992-7#3)
mM ethephon##2##2##(2006-11#1)(2008-10#1)
mM extracellular##2##2##(1992-6#1)(1993-8#1)
mM for the##2##3##(1992-11#1)(2008-11#1)
mM for##15##2##(1991-12#2)(1991-5#1)(1992-11#2)(1994-8#1)(1995-3#3)(1996-5#1)(2008-10#1)(2008-11#3)(2008-7#1)
mM glucose##18##2##(1990-11#1)(1990-12#2)(1992-8#5)(1993-8#1)(1994-11#1)(1994-8#1)(1995-8#3)(1997-1#1)(2008-10#2)(2008-11#1)
mM glutamate##4##2##(1997-1#1)(2008-11#2)(2008-7#1)
mM glycine##3##2##(1997-1#2)(1997-2#1)
mM hex2-PhosChol##3##2##(1990-11#3)
mM hydroxyurea##2##2##(1993-6#1)(2008-5#1)
mM in 100 mul saline)##2##5##(2008-4#2)
mM in the##3##3##(1995-12#1)(2008-10#1)(2008-8#1)
mM in##9##2##(1992-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)
mM malonic##2##2##(2008-10#2)
mM n-hexanoyl cystamine and 1##2##5##(2011-2#2)
mM of##10##2##(1990-8#1)(1991-9#1)(1992-12#1)(1994-11#1)(1996-5#2)(2008-10#2)(2010-4#1)(2010-5#1)
mM or##6##2##(1990-11#1)(1992-8#2)(1995-11#1)(1997-2#1)(2008-6#1)
mM pNP/mg##2##2##(2008-11#2)
mM phosphate buffer (pH 6##2##5##(2008-10#1)(2008-4#1)
mM phosphate buffer (pH 7##2##5##(2008-10#2)
mM phosphate buffer (pH 7)##2##5##(2008-10#2)
mM phosphate buffer (pH##8##4##(1996-5#2)(2008-10#5)(2008-4#1)
mM phosphate buffer##13##3##(1996-5#4)(2008-10#8)(2008-4#1)
mM phosphate##15##2##(1990-11#1)(1996-5#4)(2008-10#9)(2008-4#1)
mM potassium##4##2##(1994-9#1)(2008-10#3)
mM respectively##2##2##(1995-5#1)(2008-6#1)
mM sodium butyrate##2##3##(2008-11#2)
mM sodium dodecyl sulfate (pH 9##2##6##(1996-5#1)(2008-10#1)
mM sodium dodecyl sulfate##3##4##(1996-5#1)(2008-10#2)
mM sodium dodecyl##4##3##(1996-5#1)(2008-10#3)
mM sodium dodecylsulfate (SDS)##2##4##(2008-10#2)
mM sodium dodecylsulfate##4##3##(2008-10#3)(2008-5#1)
mM sodium phosphate##3##3##(2008-10#2)(2009-8#1)
mM sodium sulphide##2##3##(2008-10#2)
mM sodium##23##2##(1990-8#1)(1994-9#2)(1996-5#1)(2008-10#14)(2008-11#2)(2008-5#1)(2009-8#1)(2011-1#1)
mM was##5##2##(1992-12#2)(1992-9#1)(1994-9#1)(2008-10#1)
mM with a detection limit of##2##6##(2008-10#2)
mM with a##5##3##(1992-11#1)(2008-10#4)
mM with##6##2##(1992-11#1)(2008-10#5)
mM##544##1##(1990-11#16)(1990-12#9)(1990-2#2)(1990-5#4)(1990-7#7)(1990-8#9)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#6)(1991-7#1)(1991-8#3)(1991-9#3)(1992-11#10)(1992-12#4)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#14)(1992-7#5)(1992-8#10)(1992-9#6)(1993-11#5)(1993-12#4)(1993-3#2)(1993-6#4)(1993-8#6)(1993-9#5)(1994-11#11)(1994-12#1)(1994-2#4)(1994-3#8)(1994-5#6)(1994-6#6)(1994-8#6)(1994-9#11)(1995-11#6)(1995-12#4)(1995-2#7)(1995-3#9)(1995-5#4)(1995-6#4)(1995-8#12)(1996-2#1)(1996-5#19)(1997-1#10)(1997-2#10)(1997-4#3)(1997-6#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#152)(2008-11#33)(2008-12#5)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#8)(2008-8#8)(2009-12#4)(2009-6#2)(2009-8#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#16)(2012-12#1)
mM(-1)##5##1##(2008-10#5)
mM) and glutamine##2##3##(2008-11#2)
mM) and##16##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-9#1)(2008-10#4)(2008-11#2)
mM) as##2##2##(1991-7#1)(1995-2#1)
mM) but##2##2##(1994-9#1)(1995-2#1)
mM) concentrations of##2##3##(1991-5#1)(1995-11#1)
mM) did not significantly##2##4##(1990-12#1)(1994-6#1)
mM) has been##2##3##(1992-11#1)(2008-5#1)
mM) has##3##2##(1992-11#1)(1995-8#1)(2008-5#1)
mM) in the##2##3##(1992-6#1)(2008-11#1)
mM) in##8##2##(1992-6#1)(1993-11#1)(1996-5#1)(1996-9#1)(2008-11#3)(2010-11#1)
mM) induced the##2##3##(1997-2#1)(2011-2#1)
mM) induced##3##2##(1996-2#1)(1997-2#1)(2011-2#1)
mM) of the##2##3##(1994-11#1)(1994-9#1)
mM) of##5##2##(1990-2#1)(1994-11#1)(1994-9#1)(2008-10#1)(2008-7#1)
mM) or##4##2##(1990-2#1)(1990-7#1)(1996-2#1)(1997-7#1)
mM) significantly##2##2##(1990-7#1)(1994-2#1)
mM) the##2##2##(1990-11#1)(1990-12#1)
mM) was##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
mM)##120##1##(1990-11#2)(1990-12#3)(1990-2#4)(1990-5#1)(1990-7#7)(1991-5#2)(1991-7#1)(1992-11#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#5)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#6)(1996-2#6)(1996-5#1)(1996-9#4)(1997-1#2)(1997-2#4)(1997-4#1)(1997-7#1)(2008-10#14)(2008-11#11)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#2)(2010-11#1)(2011-2#3)
mM-1 min-1 for##2##3##(1997-2#2)
mM-1 min-1##4##2##(1997-2#4)
mM-1 s-1)##3##2##(1995-6#3)
mM-1##9##1##(1990-12#1)(1991-9#1)(1995-6#3)(1997-2#4)
mM/5 microl)##2##2##(1995-12#2)
mM/5##3##1##(1995-12#3)
mN##2##1##(2008-7#1)(2009-9#1)
mN/m##5##1##(1994-3#1)(1997-2#2)(2008-6#2)
mN/m)##4##1##(1994-3#4)
mOsm kg(-1)##5##2##(2008-11#5)
mOsm kg- 1##2##3##(2008-11#2)
mOsm kg-##3##2##(2008-11#3)
mOsm kg-1##3##2##(2008-11#3)
mOsm##14##1##(2008-11#14)
mOsm/kg##4##1##(1994-12#1)(1997-7#1)(2008-11#2)
mOsmol kg-1##11##2##(2008-11#11)
mOsmol##13##1##(2008-11#13)
mOsmol·kg(-1)##2##1##(2013-8#2)
mPFC##13##1##(2008-11#6)(2008-6#2)(2008-7#5)
mPGES-1##8##1##(2012-2#8)
mPKC##2##1##(1994-3#2)
mPa##2##1##(2008-10#2)
mRCC##2##1##(2011-1#2)
mRNA (4##2##2##(1991-12#1)(2008-6#1)
mRNA (about##2##2##(1990-5#1)(1995-6#1)
mRNA abundance in##2##3##(2010-4#1)(2012-2#1)
mRNA abundance of##2##3##(2010-4#1)(2012-2#1)
mRNA abundance##12##2##(1991-12#1)(1995-2#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#4)(2012-2#2)
mRNA accumulation##4##2##(1990-12#1)(1991-12#1)(1994-11#1)(2009-8#1)
mRNA also##2##2##(1997-6#1)(2012-2#1)
mRNA analysis##2##2##(2008-11#1)(2008-7#1)
mRNA and IL-1Ra mRNA##2##4##(1996-12#2)
mRNA and concomitant##2##3##(1996-2#1)(1997-4#1)
mRNA and enzyme activity##2##4##(1995-2#1)(1996-12#1)
mRNA and immunoreactivity##2##3##(1992-8#2)
mRNA and infiltration of##3##4##(2010-1#3)
mRNA and protein are##2##4##(1997-7#1)(2008-1#1)
mRNA and protein by##2##4##(1993-8#1)(1995-12#1)
mRNA and protein expression of##3##5##(2009-12#1)(2010-4#1)(2012-2#1)
mRNA and protein expression##7##4##(2008-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#2)
mRNA and protein in##3##4##(1995-12#1)(2008-7#1)(2012-3#1)
mRNA and protein levels of##3##5##(2011-3#2)(2012-2#1)
mRNA and protein levels##7##4##(1993-6#1)(2008-5#1)(2008-9#1)(2011-3#2)(2012-2#1)(2013-8#1)
mRNA and protein was##2##4##(1991-5#1)(1995-6#1)
mRNA and protein were##4##4##(1993-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
mRNA and protein##40##3##(1990-5#1)(1991-12#1)(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
mRNA and serum##2##3##(2008-9#1)(2011-2#1)
mRNA and the protein##2##4##(1993-6#1)(2008-11#1)
mRNA and the##5##3##(1993-6#1)(2008-10#1)(2008-11#3)
mRNA and##99##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#2)(1996-12#3)(1996-2#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#2)(2010-1#3)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#2)
mRNA are not##2##3##(1992-11#1)(2012-2#1)
mRNA are##6##2##(1992-11#1)(1993-5#1)(1993-8#1)(1995-12#1)(1996-12#1)(2012-2#1)
mRNA as a##2##3##(2008-10#1)(2008-4#1)
mRNA as##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2012-1#1)
mRNA at the anterior##2##4##(1994-12#2)
mRNA at the##3##3##(1994-12#2)(1995-5#1)
mRNA at##7##2##(1991-9#1)(1992-11#1)(1994-12#2)(1995-5#1)(1996-12#1)(1997-2#1)
mRNA became##2##2##(1990-7#1)(2008-8#1)
mRNA but##3##2##(1993-3#1)(1995-12#1)(1995-2#1)
mRNA by PCR##2##3##(1992-12#1)(2008-2#1)
mRNA by RT-PCR##2##3##(1993-8#1)(2008-9#1)
mRNA by the##2##3##(1991-2#1)(1992-10#1)
mRNA by##20##2##(1990-12#1)(1991-2#3)(1992-10#1)(1992-12#1)(1993-8#2)(1995-6#3)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)
mRNA can be##2##3##(1993-6#1)(1997-6#1)
mRNA can##3##2##(1993-6#1)(1997-6#1)(2011-2#1)
mRNA coding for##5##3##(1992-1#1)(1992-12#1)(1996-5#1)(2006-6#1)(2008-11#1)
mRNA compared with##3##3##(2008-11#2)(2012-2#1)
mRNA compared##4##2##(2008-11#3)(2012-2#1)
mRNA concentrations##2##2##(1990-5#1)(2008-11#1)
mRNA consists of##2##3##(1992-11#1)(2008-9#1)
mRNA contains##3##2##(1996-12#1)(2007-12#1)(2008-9#1)
mRNA content of##2##3##(1993-8#1)(2011-2#1)
mRNA content##6##2##(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-9#1)(2011-2#1)
mRNA could be detected in##2##5##(2008-10#1)(2008-8#1)
mRNA could be detected##4##4##(1994-2#1)(2008-10#2)(2008-8#1)
mRNA decreased##3##2##(1990-5#1)(2008-8#1)(2012-3#1)
mRNA degradation##2##2##(2008-11#1)(2011-2#1)
mRNA detection##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
mRNA did not##2##3##(1994-8#1)(1997-2#1)
mRNA differential display##5##3##(2008-8#2)(2008-9#3)
mRNA down-regulation##3##2##(1995-12#3)
mRNA during##3##2##(1990-5#1)(1994-12#1)(1994-9#1)
mRNA editing protein##5##3##(1994-8#5)
mRNA editing##14##2##(1990-11#1)(1990-7#3)(1992-11#2)(1994-8#7)(1995-5#1)
mRNA encoding the##2##3##(1995-2#1)(2008-9#1)
mRNA encoding##11##2##(1991-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-2#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-9#1)
mRNA expressed##3##2##(1990-12#1)(1994-6#1)(2012-3#1)
mRNA expression and##8##3##(1994-11#1)(1995-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-1#2)
mRNA expression as##2##3##(1995-12#1)(2008-8#1)
mRNA expression by##3##3##(1995-12#1)(1996-2#1)(2010-1#1)
mRNA expression in serum-deprived L6J1 rat##2##6##(1990-12#2)
mRNA expression in the kidney##2##5##(2008-11#1)(2008-7#1)
mRNA expression in the rat brain##2##6##(1996-12#2)
mRNA expression in the rat##3##5##(1996-12#2)(1997-6#1)
mRNA expression in the##13##4##(1994-12#1)(1995-2#1)(1996-12#3)(1997-2#1)(1997-6#1)(2008-11#3)(2008-6#1)(2008-7#1)(2010-12#1)
mRNA expression in##37##3##(1990-12#2)(1991-11#1)(1991-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#5)(1996-12#4)(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#2)(2013-1#2)
mRNA expression is regulated##2##4##(1996-2#1)(1997-6#1)
mRNA expression is##7##3##(1991-11#1)(1993-3#3)(1996-2#1)(1997-6#1)(2008-4#1)
mRNA expression levels##6##3##(1993-3#1)(1995-12#1)(2008-11#3)(2009-8#1)
mRNA expression of genes##2##4##(2013-1#2)
mRNA expression of##17##3##(1990-12#1)(1996-12#2)(1996-2#1)(2007-8#1)(2008-4#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
mRNA expression was detected##2##4##(1995-12#1)(2008-9#1)
mRNA expression was increased in##2##5##(1994-11#1)(2008-8#1)
mRNA expression was##16##3##(1992-9#1)(1994-11#1)(1995-12#3)(1995-2#1)(1996-12#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2013-1#1)
mRNA expression which##2##3##(1996-12#1)(2008-5#1)
mRNA expression##137##2##(1990-12#4)(1991-11#2)(1991-12#2)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#6)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#7)(1995-2#8)(1996-12#14)(1996-2#6)(1997-2#1)(1997-6#3)(2007-8#2)(2008-10#4)(2008-11#6)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#7)(2008-9#4)(2009-8#2)(2010-1#3)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)(2011-3#2)(2012-1#4)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#1)
mRNA expressions##3##2##(2012-3#2)(2013-1#1)
mRNA for the P2Y2 receptor##2##5##(2008-4#2)
mRNA for the##12##3##(1992-8#1)(1994-8#1)(1995-8#1)(1996-12#6)(1997-4#1)(2008-4#2)
mRNA for##32##2##(1990-12#1)(1990-7#2)(1991-12#2)(1991-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-12#6)(1997-2#1)(1997-4#1)(2007-8#2)(2008-11#1)(2008-4#3)(2008-7#1)
mRNA forms##2##2##(1990-2#1)(1992-8#1)
mRNA from the##2##3##(2008-7#2)
mRNA from##11##2##(1990-7#1)(1991-2#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(2008-7#2)(2009-12#1)
mRNA gave##2##2##(1991-12#2)
mRNA has##3##2##(1993-2#1)(1993-8#1)(2008-1#1)
mRNA in a human##2##4##(1992-8#1)(1993-6#1)
mRNA in a rat focal cerebral ischemia-reperfusion model##2##8##(1996-12#2)
mRNA in a##6##3##(1992-8#1)(1993-6#1)(1996-12#2)(2008-11#1)(2012-2#1)
mRNA in both##4##3##(1991-12#1)(1992-11#1)(1994-5#1)(1996-12#1)
mRNA in human##3##3##(1995-12#1)(1996-2#1)(2013-1#1)
mRNA in liver##2##3##(1993-12#1)(2008-9#1)
mRNA in normal and##2##4##(1995-12#1)(1995-8#1)
mRNA in normal##4##3##(1992-12#1)(1993-8#1)(1995-12#1)(1995-8#1)
mRNA in rat brain##2##4##(1994-12#1)(1996-12#1)
mRNA in rat##8##3##(1991-12#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(2012-1#1)(2012-2#1)
mRNA in response to##2##4##(1994-11#1)(2008-10#1)
mRNA in situ hybridization##2##4##(1997-4#1)(2008-8#1)
mRNA in the cells##3##4##(1991-12#1)(1995-2#2)
mRNA in the cortex##2##4##(1994-2#2)
mRNA in the dorsal##2##4##(1994-2#1)(1997-2#1)
mRNA in the granulosa##2##4##(2008-12#1)(2008-5#1)
mRNA in the peripheral blood of##2##6##(2007-10#1)(2008-10#1)
mRNA in the##49##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-8#2)(1996-12#4)(1996-5#1)(1997-2#3)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
mRNA in these cells##2##4##(1994-6#1)(1995-6#1)
mRNA in total##2##3##(1996-12#1)(2008-8#1)
mRNA in##136##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#6)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-8#5)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#6)(1994-11#3)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#8)(1995-2#3)(1995-6#1)(1995-8#4)(1996-12#13)(1996-2#1)(1996-5#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#4)
mRNA increased by##2##3##(1996-2#1)(2012-1#1)
mRNA increased in the##2##4##(1996-12#1)(2008-11#1)
mRNA increased##5##2##(1995-8#1)(1996-12#1)(1996-2#1)(2008-11#1)(2012-1#1)
mRNA induction by##2##3##(1990-5#1)(1994-12#1)
mRNA induction in##2##3##(1993-8#1)(2008-11#1)
mRNA induction##6##2##(1990-12#1)(1990-5#1)(1993-8#1)(1994-12#1)(2008-11#2)
mRNA into##3##2##(1995-2#1)(2008-4#1)(2012-2#1)
mRNA is expressed in##3##4##(1994-9#1)(1996-12#1)(2008-1#1)
mRNA is expressed##7##3##(1991-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-1#1)
mRNA is highly##2##3##(1990-12#1)(1997-9#1)
mRNA is present in the##2##5##(1993-12#1)(1993-6#1)
mRNA is present in##6##4##(1991-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(2008-12#1)(2008-9#1)
mRNA is present##7##3##(1991-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(2008-12#1)(2008-9#1)(2012-2#1)
mRNA is##40##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#2)(1997-6#1)(1997-7#1)(1997-9#1)(2008-1#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#3)(2012-3#1)
mRNA isolated from##2##3##(1991-6#1)(1997-8#1)
mRNA level (p &lt##2##4##(1994-11#2)
mRNA level and##3##3##(1993-8#1)(1995-6#1)(2010-8#1)
mRNA level in##6##3##(1992-3#1)(1994-11#1)(2008-11#3)(2010-5#1)
mRNA level of the##3##4##(1996-12#1)(2008-11#2)
mRNA level of##11##3##(1994-9#1)(1995-11#1)(1996-12#1)(2008-11#3)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#1)
mRNA level was significantly reduced in##3##6##(1996-12#3)
mRNA level was significantly reduced##4##5##(1996-12#4)
mRNA level was significantly##5##4##(1996-12#5)
mRNA level was##14##3##(1992-6#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-12#6)(1996-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
mRNA level##65##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-11#5)(1994-6#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-6#1)(1996-12#10)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-11#8)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
mRNA levels after##2##3##(1995-2#1)(1995-5#1)
mRNA levels and##10##3##(1991-12#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-6#2)(1994-10#1)(1994-11#1)(2008-4#1)(2013-7#1)
mRNA levels are##3##3##(1993-8#1)(1994-11#1)(1997-1#1)
mRNA levels by##3##3##(1995-12#1)(1997-2#2)
mRNA levels decreased##2##3##(1990-3#1)(1991-9#1)
mRNA levels during##2##3##(1993-11#1)(1995-5#1)
mRNA levels for##4##3##(1991-12#1)(1994-5#1)(2008-9#1)(2013-1#1)
mRNA levels in cultured##2##4##(1993-11#1)(1995-12#1)
mRNA levels in human##3##4##(1993-11#1)(1994-8#1)(1995-6#1)
mRNA levels in rats##2##4##(1990-2#1)(1991-12#1)
mRNA levels in the pituitary##2##5##(1992-3#1)(1993-5#1)
mRNA levels in the##13##4##(1992-3#1)(1993-5#2)(1994-11#1)(1995-12#1)(1996-12#4)(1997-2#1)(1997-3#1)(2008-6#2)
mRNA levels in##27##3##(1990-2#1)(1991-12#2)(1991-5#1)(1992-3#1)(1993-11#3)(1993-5#2)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#5)(1995-6#1)(1996-12#4)(1997-2#1)(1997-3#1)(2008-6#2)
mRNA levels increased##2##3##(1997-3#1)(2008-7#1)
mRNA levels of ALDH3c##2##4##(1992-8#2)
mRNA levels of##12##3##(1992-8#2)(1992-9#1)(1993-3#2)(1994-11#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#2)
mRNA levels was##4##3##(1992-3#1)(1996-12#2)(1997-2#1)
mRNA levels were decreased##3##4##(1993-6#1)(1996-5#1)(2013-1#1)
mRNA levels were increased in the##2##6##(1992-12#1)(1996-5#1)
mRNA levels were increased##3##4##(1992-12#1)(1996-12#1)(1996-5#1)
mRNA levels were reduced in##2##5##(1996-12#1)(1996-5#1)
mRNA levels were reduced##3##4##(1996-12#1)(1996-5#1)(2008-8#1)
mRNA levels were similar##2##4##(1994-11#1)(1995-12#1)
mRNA levels were##23##3##(1991-5#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#1)(1995-12#1)(1996-12#5)(1996-5#4)(2008-6#1)(2008-8#2)(2013-1#1)
mRNA levels##133##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#7)(1991-5#4)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#5)(1992-9#2)(1993-11#4)(1993-3#4)(1993-5#3)(1993-6#7)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#12)(1995-2#1)(1995-5#4)(1995-6#3)(1996-12#18)(1996-5#4)(1997-1#1)(1997-2#5)(1997-3#2)(1997-7#1)(2008-11#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2011-2#1)(2013-1#5)(2013-7#1)
mRNA may##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
mRNA of genes##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
mRNA of the##3##3##(1995-12#1)(1997-8#1)(2010-1#1)
mRNA of##26##2##(1990-8#2)(1991-12#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-8#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)
mRNA only##2##2##(1995-6#1)(2008-11#1)
mRNA or in##2##3##(1994-6#1)(2008-7#1)
mRNA or##5##2##(1994-6#1)(1996-12#1)(1997-2#1)(2008-7#1)(2008-9#1)
mRNA population##2##2##(1996-10#1)(1996-2#1)
mRNA positive##2##2##(2008-10#1)(2008-8#1)
mRNA present in##2##3##(1996-12#1)(1996-2#1)
mRNA processing##3##2##(1995-2#1)(2008-2#1)(2012-2#1)
mRNA remained unchanged##2##3##(1996-12#2)
mRNA sequence##4##2##(1992-8#2)(1993-6#1)(1994-8#1)
mRNA sequences##3##2##(1992-11#1)(1995-9#1)(2008-4#1)
mRNA showed that##2##3##(1992-9#1)(1993-6#1)
mRNA showed##6##2##(1992-9#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#1)(2013-1#1)
mRNA significantly decreased##3##3##(1997-2#1)(2008-7#1)(2013-1#1)
mRNA significantly##5##2##(1997-2#2)(2008-7#1)(2013-1#2)
mRNA species in##2##3##(1996-9#1)(2008-4#1)
mRNA species is directed by##2##5##(1990-11#2)
mRNA species of##6##3##(1990-11#1)(1990-2#1)(1991-6#1)(1992-12#2)(1994-6#1)
mRNA species##19##2##(1990-11#4)(1990-2#3)(1990-7#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-11#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(2008-4#1)(2009-12#1)
mRNA splicing##5##2##(1996-2#1)(2008-4#2)(2009-2#2)
mRNA stability##7##2##(1995-2#1)(2008-1#3)(2008-11#2)(2008-5#1)
mRNA synthesis##2##2##(2009-9#1)(2012-1#1)
mRNA target##3##2##(2008-5#1)(2011-2#2)
mRNA than males##2##3##(1990-12#1)(1995-8#1)
mRNA than##3##2##(1990-12#1)(1994-12#1)(1995-8#1)
mRNA to produce the##3##4##(1993-8#1)(2012-2#2)
mRNA to the endoplasmic reticulum##2##5##(2008-11#2)
mRNA to##12##2##(1990-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-2#2)(2008-11#2)(2010-11#1)(2012-2#2)
mRNA transcribed##2##2##(1991-12#1)(1997-8#1)
mRNA transcript##4##2##(1990-12#1)(1997-2#1)(2008-8#1)(2008-9#1)
mRNA transcription cycle##2##3##(2013-1#2)
mRNA transcription##7##2##(1995-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#3)
mRNA transcripts were##2##3##(1992-3#1)(1994-2#1)
mRNA transcripts##11##2##(1990-7#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-2#2)(1997-1#1)(1997-2#1)(2008-8#2)(2009-10#1)
mRNA translation##3##2##(1991-9#1)(1992-11#1)(2007-12#1)
mRNA transport##2##2##(1995-2#1)(2012-2#1)
mRNA turnover##2##2##(1997-2#2)
mRNA under##2##2##(1996-12#1)(2008-10#1)
mRNA using a##2##3##(1991-9#1)(1996-12#1)
mRNA using##5##2##(1991-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
mRNA was about##2##3##(1990-8#1)(1993-2#1)
mRNA was abundantly expressed in##2##5##(1994-11#2)
mRNA was also detected##2##4##(1990-11#1)(1991-9#1)
mRNA was also##4##3##(1990-11#1)(1991-9#1)(1992-9#1)(1993-11#1)
mRNA was detected by##2##4##(1990-7#1)(1993-12#1)
mRNA was detected in##4##4##(1993-11#1)(1994-11#1)(1997-4#1)(2008-6#1)
mRNA was detected##8##3##(1990-7#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-11#1)(1996-12#1)(1997-4#1)(2008-6#1)
mRNA was determined by##2##4##(1997-4#1)(2008-11#1)
mRNA was determined##3##3##(1995-12#1)(1997-4#1)(2008-11#1)
mRNA was examined in##2##4##(1991-11#1)(1995-12#1)
mRNA was examined##3##3##(1991-11#1)(1995-12#1)(2011-2#1)
mRNA was expressed in the##4##5##(1997-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
mRNA was expressed in##5##4##(1997-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
mRNA was expressed##7##3##(1991-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
mRNA was found in##2##4##(1993-12#1)(1997-4#1)
mRNA was found to##3##4##(1990-11#2)(1992-9#1)
mRNA was found##5##3##(1990-11#2)(1992-9#1)(1993-12#1)(1997-4#1)
mRNA was further##2##3##(1993-11#1)(1994-12#1)
mRNA was induced in the##2##5##(1996-12#1)(2010-5#1)
mRNA was localized in##2##4##(1997-4#1)(2008-9#1)
mRNA was localized##3##3##(1995-12#1)(1997-4#1)(2008-9#1)
mRNA was not detected##2##4##(1991-2#1)(1996-2#1)
mRNA was not observed in##2##5##(1995-11#1)(1996-12#1)
mRNA was not##6##3##(1991-2#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-8#1)
mRNA was observed in the##2##5##(1990-7#1)(1992-9#1)
mRNA was observed in##4##4##(1990-7#1)(1992-9#1)(2008-7#1)(2008-8#1)
mRNA was observed##7##3##(1990-3#1)(1990-7#1)(1992-9#1)(1996-12#1)(2008-7#2)(2008-8#1)
mRNA was seen in##2##4##(1996-12#2)
mRNA was##91##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-8#1)(1996-12#14)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#5)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)
mRNA were also##2##3##(1990-5#1)(2008-11#1)
mRNA were higher##2##3##(1992-9#1)(1993-3#1)
mRNA were measured in##2##4##(1990-3#1)(1994-11#1)
mRNA were observed at involution day 3 compared to involution day 1##2##12##(1997-6#2)
mRNA were observed##3##3##(1996-12#1)(1997-6#2)
mRNA were significantly increased##2##4##(1991-12#1)(1996-2#1)
mRNA were##26##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-12#5)(1996-2#1)(1997-6#2)(2008-11#1)(2008-12#3)(2008-6#1)
mRNA which##2##2##(1990-11#1)(1997-2#1)
mRNA with##6##2##(1990-7#1)(1992-8#1)(1993-6#1)(2008-4#1)(2008-9#1)(2012-2#1)
mRNA within##2##2##(1992-3#1)(1994-9#1)
mRNA##1417##1##(1990-11#16)(1990-12#18)(1990-2#8)(1990-3#3)(1990-5#14)(1990-7#21)(1990-8#7)(1991-1#3)(1991-11#3)(1991-12#29)(1991-2#13)(1991-5#13)(1991-6#5)(1991-9#12)(1992-1#2)(1992-10#3)(1992-11#20)(1992-12#17)(1992-3#13)(1992-4#2)(1992-6#11)(1992-8#25)(1992-9#16)(1993-1#1)(1993-11#9)(1993-12#10)(1993-2#8)(1993-3#33)(1993-5#7)(1993-6#30)(1993-8#36)(1993-9#4)(1994-10#1)(1994-11#32)(1994-12#20)(1994-2#9)(1994-3#2)(1994-5#5)(1994-6#18)(1994-8#25)(1994-9#10)(1995-11#12)(1995-12#50)(1995-2#32)(1995-3#1)(1995-5#7)(1995-6#18)(1995-8#11)(1995-9#1)(1996-10#1)(1996-12#128)(1996-2#20)(1996-5#10)(1996-6#2)(1996-9#3)(1997-1#7)(1997-2#35)(1997-3#3)(1997-4#12)(1997-6#15)(1997-7#8)(1997-8#7)(1997-9#1)(2006-6#2)(2007-10#2)(2007-12#3)(2007-8#4)(2008-1#10)(2008-10#35)(2008-11#58)(2008-12#7)(2008-2#4)(2008-4#32)(2008-5#20)(2008-6#21)(2008-7#25)(2008-8#47)(2008-9#42)(2009-10#1)(2009-12#5)(2009-2#2)(2009-8#4)(2009-9#1)(2010-1#10)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#7)(2010-5#6)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#16)(2011-3#4)(2012-1#10)(2012-12#1)(2012-2#45)(2012-3#17)(2013-1#36)(2013-7#1)(2013-8#6)
mRNA)##8##1##(1990-5#1)(1993-3#1)(1996-12#3)(2008-1#1)(2008-10#1)(2008-9#1)
mRNA-injected oocytes was##2##3##(1994-8#2)
mRNA-injected oocytes##3##2##(1994-8#3)
mRNA/protein##2##1##(2010-10#2)
mRNAs (for##2##2##(1990-5#2)
mRNAs and##5##2##(1996-12#1)(1996-2#1)(1997-6#1)(2008-11#1)(2010-11#1)
mRNAs are##10##2##(1990-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-12#2)(1996-2#1)(2007-12#1)
mRNAs at##2##2##(2008-10#1)(2008-2#1)
mRNAs encoding##8##2##(1993-5#1)(1994-2#1)(1995-2#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)
mRNAs expressed in the##2##4##(1990-11#1)(1994-6#1)
mRNAs for##8##2##(1993-11#1)(1993-6#1)(1995-2#1)(1996-12#2)(2008-8#3)
mRNAs from individual genes##2##4##(2012-2#2)
mRNAs from##7##2##(1990-2#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#2)
mRNAs in the rat##2##4##(1992-6#1)(1993-12#1)
mRNAs in the##4##3##(1990-8#1)(1992-6#1)(1993-12#1)(2008-4#1)
mRNAs in##12##2##(1990-8#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-4#1)
mRNAs increased##2##2##(2008-10#1)(2008-7#1)
mRNAs of##8##2##(1992-3#1)(1992-6#1)(1992-9#1)(1996-12#2)(1997-2#1)(1997-6#1)(2008-4#1)
mRNAs that are##2##3##(1990-7#1)(1991-7#1)
mRNAs that##6##2##(1990-5#1)(1990-7#1)(1991-7#1)(1995-2#1)(2007-12#1)(2010-10#1)
mRNAs to##5##2##(1994-12#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
mRNAs was##2##2##(1996-12#1)(2013-1#1)
mRNAs were expressed##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
mRNAs were##14##2##(1990-12#1)(1991-5#1)(1993-12#1)(1993-9#2)(1996-12#3)(1996-2#2)(2008-11#2)(2008-5#1)(2013-1#1)
mRNAs within the##2##3##(1993-12#1)(2008-10#1)
mRNAs##163##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#6)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#5)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-12#22)(1996-2#6)(1996-5#1)(1997-2#3)(1997-6#3)(2007-12#7)(2008-10#8)(2008-11#11)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-6#1)(2010-10#1)(2010-11#2)(2011-2#2)(2012-12#3)(2012-2#5)(2013-1#5)(2013-8#1)
mRS##2##1##(2013-1#2)
mRT-PCR##3##1##(2008-10#3)
mSERT cDNA##2##2##(1996-12#2)
mSERT##5##1##(1996-12#5)
mSTI1##3##1##(1997-7#3)
mSv##8##1##(1996-6#5)(1997-8#1)(2011-2#1)(2012-2#1)
mT##3##1##(1996-2#1)(2008-10#1)(2008-3#1)
mT)##3##1##(2008-12#1)(2011-2#2)
mTBI##2##1##(2009-8#2)
mTERT##5##1##(2008-11#5)
mTOR and##3##2##(2009-7#1)(2010-3#1)(2011-2#1)
mTOR inhibitor##2##2##(2013-1#2)
mTOR inhibitors##2##2##(2013-1#2)
mTOR kinase inhibitors##3##3##(2009-7#3)
mTOR signaling is##2##3##(2009-7#1)(2011-2#1)
mTOR signaling##6##2##(2009-7#1)(2010-3#3)(2011-2#1)(2013-8#1)
mTOR##29##1##(2009-7#7)(2010-3#4)(2011-1#2)(2011-2#10)(2013-1#5)(2013-8#1)
mTORC1##2##1##(2011-2#2)
mTORC2##2##1##(2011-2#2)
mU l(-1)##2##2##(2008-10#2)
mU##4##1##(1991-8#1)(1995-5#1)(2008-10#2)
mU/l##3##1##(1990-11#1)(2008-10#2)
mU/ml##2##1##(1990-7#2)
mV (versus SCE)##2##3##(2008-10#2)
mV (versus##3##2##(2008-10#3)
mV (vs##3##2##(2008-10#3)
mV M(-1) for##5##3##(2008-10#5)
mV M(-1)##6##2##(2008-10#6)
mV and pulse##2##3##(2008-10#2)
mV and##7##2##(1995-12#2)(2008-10#4)(2009-12#1)
mV at pH 6##2##4##(2008-10#2)
mV at##3##2##(2008-10#3)
mV decade(-1)##7##2##(2008-10#7)
mV decade(-1))##2##2##(2008-10#2)
mV for##3##2##(1997-7#3)
mV in##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
mV on##2##2##(2008-10#1)(2008-8#1)
mV pH(-1) at 20+/-0##2##4##(2008-10#2)
mV per concentration decade##6##4##(2008-10#6)
mV per concentration##7##3##(2008-10#7)
mV per decade and a##2##5##(2008-10#2)
mV per decade and##4##4##(2008-10#4)
mV per decade of activity##2##5##(2008-10#2)
mV per decade of##3##4##(2008-10#3)
mV per decade over the concentration range of##2##8##(2008-10#2)
mV per decade over the##3##5##(2008-10#3)
mV per decade##27##3##(2008-10#27)
mV per decade)##2##3##(2008-10#2)
mV per pH##2##3##(2008-10#2)
mV per##38##2##(2008-10#38)
mV s(-1) and##2##3##(2008-10#2)
mV s(-1)##10##2##(2008-10#10)
mV to the##2##3##(1997-7#2)
mV to##3##2##(1993-12#1)(1997-7#2)
mV versus Ag/AgCl##5##3##(2008-10#5)
mV versus SCE##2##3##(2008-10#2)
mV versus##12##2##(1991-8#1)(2008-10#11)
mV vs##6##2##(1991-5#1)(2008-10#4)(2008-6#1)
mV##184##1##(1990-5#2)(1990-7#1)(1991-5#1)(1991-8#4)(1991-9#7)(1992-11#2)(1992-5#1)(1993-12#2)(1993-8#6)(1995-12#4)(1995-5#1)(1996-5#5)(1996-6#1)(1997-2#2)(1997-7#5)(2008-10#127)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#4)(2009-9#2)(2012-2#1)
mV) while##2##2##(1992-5#1)(2008-10#1)
mV)##14##1##(1990-5#2)(1992-5#1)(1996-5#1)(2008-10#9)(2008-8#1)
mV/10-fold change in selenite concentration##2##5##(2008-10#2)
mV/decade and a##3##3##(2008-10#3)
mV/decade of##2##2##(2008-10#2)
mV/decade##7##1##(2008-10#7)
mV/pH##3##1##(1991-8#1)(2008-10#2)
mVdecade)##2##1##(2009-6#2)
mVs(-1)##2##1##(2008-10#2)
mW and a slope efficiency of##5##6##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
mW and a##9##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
mW and photon-conversion efficiencies of##2##5##(2007-11#2)
mW and the##2##3##(2007-11#1)(2008-2#1)
mW and##19##2##(2007-11#6)(2007-12#6)(2008-2#2)(2008-3#5)
mW are##2##2##(2007-11#1)(2007-12#1)
mW at 1##2##3##(2008-3#2)
mW at 7##2##3##(2007-11#2)
mW at a##2##3##(2007-11#1)(2007-12#1)
mW at##22##2##(2007-11#7)(2007-12#5)(2008-2#5)(2008-3#5)
mW by##2##2##(2007-12#1)(2008-2#1)
mW for##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mW has been##2##3##(2007-11#1)(2007-12#1)
mW have been##2##3##(2007-11#1)(2008-2#1)
mW in the##3##3##(2008-3#3)
mW in##6##2##(2007-12#1)(2008-3#5)
mW is obtained##2##3##(2007-11#1)(2007-12#1)
mW is##3##2##(2007-11#1)(2007-12#2)
mW of 1064-nm##2##3##(2008-2#1)(2008-3#1)
mW of average power at##3##5##(2007-11#1)(2007-12#2)
mW of average power##6##4##(2007-11#2)(2007-12#3)(2008-3#1)
mW of average##7##3##(2007-11#2)(2007-12#4)(2008-3#1)
mW of cw##3##3##(2007-12#2)(2008-2#1)
mW of green##2##3##(2007-11#2)
mW of output power##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
mW of output##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
mW of power and##2##4##(2007-11#1)(2007-12#1)
mW of power at##5##4##(2007-12#3)(2008-2#1)(2008-3#1)
mW of power in##2##4##(2007-11#1)(2007-12#1)
mW of power##14##3##(2007-11#3)(2007-12#6)(2008-2#3)(2008-3#2)
mW of pump power##2##4##(2007-11#1)(2008-2#1)
mW of single-frequency output##2##4##(2007-12#1)(2008-3#1)
mW of single-frequency##4##3##(2007-12#2)(2008-3#2)
mW of the##2##3##(2008-2#1)(2008-3#1)
mW of##54##2##(2007-11#10)(2007-12#22)(2008-2#11)(2008-3#10)(2008-9#1)
mW to##3##2##(2008-2#3)
mW was obtained##2##3##(2008-2#1)(2008-3#1)
mW were achieved##2##3##(2007-12#1)(2008-2#1)
mW were##4##2##(2007-12#2)(2008-2#2)
mW##174##1##(1995-2#1)(2007-11#37)(2007-12#59)(2007-8#1)(2008-12#2)(2008-2#36)(2008-3#35)(2008-5#1)(2008-9#1)(2010-8#1)
mW/cm(2)##8##1##(2007-12#1)(2008-11#1)(2008-12#3)(2008-7#3)
mW/cm2##5##1##(1992-9#1)(1993-8#2)(2008-3#1)(2013-1#1)
mW/sr at##2##2##(2008-3#2)
mWard##2##1##(2010-8#2)
ma'edamines A and B##2##4##(2013-1#2)
ma'edamines A##3##2##(2013-1#3)
ma'edamines##5##1##(2013-1#5)
mab 164 reacted##2##3##(1992-3#2)
mab 164##3##2##(1992-3#3)
mabs##2##1##(2006-6#2)
macaque##7##1##(1993-6#2)(1994-2#1)(1997-2#1)(1997-3#1)(2009-10#1)(2013-8#1)
macaques and##3##2##(1991-9#1)(1995-2#2)
macaques with SIV-PBj14##2##3##(1997-3#2)
macaques with##4##2##(1991-2#2)(1997-3#2)
macaques##19##1##(1990-11#1)(1991-2#2)(1991-9#1)(1992-11#1)(1994-2#1)(1995-2#4)(1997-3#4)(2008-10#1)(2008-4#3)(2012-3#1)
macaw##5##1##(1997-3#2)(2008-5#3)
macaws##4##1##(1997-3#1)(2008-5#3)
macclellandi##3##1##(2008-5#3)
macedonica and Ph##2##3##(2008-12#2)
macerated##4##1##(1995-9#1)(2008-10#2)(2008-11#1)
maceration and##2##2##(2008-10#2)
maceration##9##1##(2008-10#6)(2008-5#1)(2013-1#2)
mach-zehnder interferometer##2##2##(2008-3#2)
machine for##2##2##(2008-7#1)(2013-1#1)
machine is##2##2##(1997-6#1)(2011-3#1)
machine learning approaches##2##3##(2011-2#1)(2012-2#1)
machine learning##9##2##(2008-7#3)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#2)
machine readable##2##2##(2010-8#2)
machine vision##8##2##(2007-11#3)(2008-2#2)(2008-3#2)(2008-6#1)
machine##74##1##(1990-2#1)(1990-6#1)(1991-3#1)(1991-8#1)(1993-2#2)(1997-6#6)(1997-8#1)(2007-10#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
machine-processible##2##1##(2008-7#2)
machined##2##1##(2008-10#2)
machineries##4##1##(1994-8#1)(2009-10#1)(2009-2#1)(2012-12#1)
machinery and##4##2##(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
machinery for##3##2##(2008-7#1)(2008-9#1)(2010-5#1)
machinery in##4##2##(1990-5#1)(2008-8#1)(2009-6#1)(2012-12#1)
machinery is##7##2##(1994-8#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
machinery of##6##2##(1991-5#1)(1992-6#1)(2007-12#1)(2008-4#2)(2009-5#1)
machinery proteins##2##2##(2008-7#1)(2013-1#1)
machinery that##6##2##(1993-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
machinery to##7##2##(1994-8#1)(1995-6#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
machinery##88##1##(1990-5#1)(1991-5#2)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-6#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#9)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#4)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-11#3)(2010-2#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#1)
machines and##3##2##(2008-1#1)(2008-7#1)(2009-7#1)
machines are##2##2##(2009-12#1)(2009-7#1)
machines for##2##2##(1991-12#1)(2008-3#1)
machines of##2##2##(2010-7#1)(2011-3#1)
machines per##2##2##(2008-1#2)
machines was##3##2##(2008-12#1)(2009-12#1)(2013-8#1)
machines work##2##2##(2008-10#1)(2008-7#1)
machines##54##1##(1990-11#1)(1991-12#1)(1995-1#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#5)(2008-7#7)(2008-8#2)(2009-10#1)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
machining of##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
machining processes##2##2##(2008-10#1)(2008-3#1)
machining##21##1##(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#8)(2008-8#4)(2012-2#2)
machinists##3##1##(1991-12#3)
macro CK-MM3##3##2##(1991-2#3)
macro and micro##4##3##(1990-6#1)(1996-12#1)(2008-11#1)(2008-9#1)
macro and##6##2##(1990-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
macro##20##1##(1990-5#1)(1990-6#1)(1991-2#3)(1994-12#1)(1996-12#1)(2008-10#6)(2008-11#2)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#2)
macro- and micronutrients##2##3##(2008-10#1)(2012-2#1)
macro- and microvascular##2##3##(1997-1#1)(2008-5#1)
macro- and##7##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)
macro-##8##1##(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)
macro-gravimetric##2##1##(2008-10#2)
macroadenoma##7##1##(1991-6#1)(2008-7#1)(2008-8#3)(2011-2#2)
macroalbuminuric##3##1##(1992-9#3)
macroalgae##4##1##(2008-5#4)
macroangiopathy##3##1##(1993-2#1)(2008-1#1)(2012-2#1)
macroarrays##2##1##(2008-10#1)(2008-7#1)
macrocarpum##3##1##(2008-11#1)(2008-12#2)
macrocephaly##5##1##(1997-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
macrochaete##2##1##(2009-5#2)
macrochaetes##2##1##(2009-5#2)
macrochirus##3##1##(2010-8#3)
macrochromosomes and##3##2##(2010-3#3)
macrochromosomes##4##1##(2010-3#4)
macroclada was##2##2##(2008-10#2)
macroclada##5##1##(2008-10#5)
macroconidia##5##1##(2008-10#3)(2008-5#1)(2008-8#1)
macroconidial##2##1##(2008-10#2)
macrocrania##2##1##(1996-9#1)(2008-7#1)
macrocycle with##2##2##(2009-10#2)
macrocycle##21##1##(1991-5#1)(2007-11#1)(2008-10#15)(2008-6#1)(2009-10#2)(2010-6#1)
macrocycles##3##1##(2008-10#3)
macrocyclic compounds##2##2##(2008-10#2)
macrocyclic diamides##2##2##(2008-10#2)
macrocyclic dithioxamide receptor##2##3##(2008-10#2)
macrocyclic ethers##3##2##(2008-10#3)
macrocyclic glycopeptide antibiotics-vancomycin and teicoplanin##2##5##(2008-10#2)
macrocyclic polyether##2##2##(2008-10#2)
macrocyclic##33##1##(1996-2#1)(2008-10#30)(2008-6#2)
macrocyclization and##2##2##(2012-12#2)
macrocytosis##2##1##(1990-3#1)(2013-1#1)
macrodactyly##4##1##(2007-7#1)(2009-5#3)
macrodilution##2##1##(2008-5#1)(2011-2#1)
macroecology##2##1##(2008-8#1)(2008-9#1)
macroeconomic##2##1##(1993-2#1)(2008-7#1)
macrofauna##4##1##(2008-11#1)(2012-1#3)
macrofilled##2##1##(2011-2#2)
macrofungi##2##1##(2008-12#2)
macroglobulinemia##2##1##(2009-10#1)(2010-11#1)
macrokinetic models##3##2##(2008-7#3)
macrokinetic##6##1##(2008-7#6)
macrolide##7##1##(1990-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)
macrolides and##3##2##(2007-11#1)(2007-2#1)(2008-10#1)
macrolides##6##1##(1996-3#1)(1997-3#1)(2007-11#2)(2007-2#1)(2008-10#1)
macromolecular chelator##2##2##(2008-10#2)
macromolecular complexes##3##2##(2008-4#3)
macromolecular pseudograph's alpha-carbon atom adjacency##2##5##(2007-11#2)
macromolecular synthesis (MMS) operon##2##4##(1994-12#2)
macromolecular##45##1##(1990-8#2)(1991-11#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-12#2)(1995-3#1)(2006-4#1)(2007-11#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#6)(2008-7#4)(2009-5#1)(2009-8#2)(2010-7#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
macromolecule and##2##2##(1997-2#1)(2008-4#1)
macromolecule degradation##2##2##(2010-10#1)(2012-1#1)
macromolecule##16##1##(1990-12#1)(1990-8#2)(1991-11#1)(1993-3#1)(1997-2#4)(2008-1#1)(2008-10#1)(2008-4#3)(2010-10#1)(2012-1#1)
macromolecules and cytokines##2##3##(2012-3#2)
macromolecules and particles##2##3##(2008-10#2)
macromolecules and##9##2##(1997-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2012-3#2)
macromolecules as##2##2##(2007-12#1)(2008-4#1)
macromolecules such as##2##3##(1996-9#1)(2009-11#1)
macromolecules##53##1##(1990-8#2)(1991-9#1)(1995-12#1)(1995-2#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-6#4)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#5)(2008-7#8)(2008-9#1)(2009-11#3)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#2)
macronuclear DNA carrying RPL29##2##4##(1994-12#2)
macronuclear DNA##3##2##(1994-12#3)
macronucleus##2##1##(2008-9#1)(2012-3#1)
macronutrient composition##4##2##(2008-3#4)
macronutrient intake##2##2##(2008-5#1)(2011-1#1)
macronutrient##11##1##(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#1)(2011-1#1)(2011-2#1)
macronutrients and micronutrients##2##3##(2008-12#1)(2008-5#1)
macronutrients##9##1##(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-5#1)(2013-1#1)
macroorganisms##2##1##(2008-10#1)(2008-8#1)
macrophage accumulation in adipose tissue##2##5##(2012-2#2)
macrophage activity was##2##3##(1992-12#2)
macrophage activity##3##2##(1992-12#2)(2008-11#1)
macrophage cell line##4##3##(1990-12#1)(1993-3#1)(1995-3#1)(2008-10#1)
macrophage cell##6##2##(1990-12#1)(1993-3#1)(1993-8#1)(1995-3#2)(2008-10#1)
macrophage colony stimulating factor gene##3##5##(1990-5#1)(2012-2#2)
macrophage colony stimulating factor##7##4##(1990-5#1)(1992-3#2)(2008-11#1)(2012-2#3)
macrophage colony-stimulating factor (M-CSF)##2##4##(1990-5#1)(1994-6#1)
macrophage colony-stimulating factor##3##3##(1990-5#1)(1994-6#2)
macrophage depletion##2##2##(2008-12#2)
macrophage differentiation##2##2##(1991-12#1)(1995-6#1)
macrophage foam cell formation##3##4##(2013-1#3)
macrophage function##2##2##(1997-4#1)(2008-10#1)
macrophage fusion##2##2##(2008-4#2)
macrophage infiltration##2##2##(2008-10#1)(2008-7#1)
macrophage inflammatory##2##2##(2008-10#1)(2008-7#1)
macrophage recognition of##2##3##(1990-12#1)(1995-2#1)
macrophage stimulating protein##2##3##(2008-10#1)(2008-8#1)
macrophage was##2##2##(2008-11#1)(2013-1#1)
macrophage##87##1##(1990-12#2)(1990-5#3)(1990-7#2)(1991-12#2)(1991-5#5)(1991-6#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-4#3)(2008-7#3)(2008-8#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#8)(2013-1#6)
macrophage-derived##3##1##(1991-12#1)(1992-2#1)(2010-6#1)
macrophage-like cell line##2##3##(1991-2#2)
macrophage-like cells##3##2##(1994-11#1)(1996-12#2)
macrophage-like##5##1##(1991-2#2)(1994-11#1)(1996-12#2)
macrophages activated by##2##3##(1994-11#1)(2008-11#1)
macrophages after##2##2##(2006-7#1)(2008-8#1)
macrophages and T##2##3##(2008-10#1)(2012-2#1)
macrophages and T-cells##2##3##(2008-10#2)
macrophages and dendritic cells##4##4##(2008-4#1)(2008-6#1)(2009-12#1)(2012-1#1)
macrophages and lymphocytes##2##3##(1991-9#1)(2008-10#1)
macrophages and osteoclasts##3##3##(1990-5#1)(1991-5#1)(2011-2#1)
macrophages and##29##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(2008-10#5)(2008-4#2)(2008-6#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
macrophages appeared to##2##3##(1990-7#1)(2008-10#1)
macrophages are##4##2##(2008-10#2)(2008-9#2)
macrophages as##2##2##(1992-11#1)(2007-2#1)
macrophages by##3##2##(1993-6#1)(2008-12#1)(2011-1#1)
macrophages can##2##2##(1993-6#1)(2008-10#1)
macrophages during the##2##3##(1991-5#1)(1996-11#1)
macrophages from##2##2##(1991-12#1)(1996-12#1)
macrophages in all##2##3##(1990-12#1)(1997-8#1)
macrophages in the##2##3##(1997-2#1)(2008-11#1)
macrophages in vivo##2##3##(1992-12#1)(2008-11#1)
macrophages in##15##2##(1990-12#1)(1992-12#1)(1992-9#1)(1995-12#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-1#2)(2013-1#1)
macrophages incubated with##2##3##(1994-8#1)(2013-1#1)
macrophages is##3##2##(1993-3#1)(1995-12#1)(2008-11#1)
macrophages may be##2##3##(1990-5#1)(2008-8#1)
macrophages may##4##2##(1990-5#1)(1994-5#1)(2008-11#1)(2008-8#1)
macrophages obtained from##3##3##(1997-4#1)(2008-12#1)(2013-1#1)
macrophages obtained##4##2##(1996-2#1)(1997-4#1)(2008-12#1)(2013-1#1)
macrophages or##4##2##(1990-6#1)(2008-10#2)(2009-6#1)
macrophages play##2##2##(2008-9#1)(2012-12#1)
macrophages stimulated##2##2##(1993-3#1)(2013-8#1)
macrophages taking up nanorose##2##4##(2011-1#2)
macrophages that##2##2##(1992-10#1)(2008-5#1)
macrophages to##7##2##(1990-2#1)(1990-5#2)(1995-2#1)(2007-11#1)(2008-8#2)
macrophages was inhibited##2##3##(1991-5#1)(1993-3#1)
macrophages was##6##2##(1991-5#1)(1993-3#2)(1993-6#1)(2007-2#1)(2013-1#1)
macrophages were cultured##2##3##(1992-8#1)(1994-8#1)
macrophages were investigated##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
macrophages were##12##2##(1990-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-8#2)(2010-10#1)(2013-1#1)
macrophages with##5##2##(1994-9#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-4#1)
macrophages##272##1##(1990-11#1)(1990-12#5)(1990-2#4)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#3)(1991-12#1)(1991-5#9)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#9)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#15)(1993-6#4)(1993-8#4)(1994-11#3)(1994-12#1)(1994-5#3)(1994-6#6)(1994-8#8)(1994-9#2)(1995-11#1)(1995-12#6)(1995-2#8)(1995-3#3)(1995-5#3)(1995-6#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-7#3)(2007-8#1)(2008-10#23)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-8#14)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#3)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#8)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
macrophages]##3##1##(1992-5#1)(2008-12#1)(2013-8#1)
macrophyllum##2##1##(2008-10#2)
macrophyte richness##2##2##(2013-7#2)
macrophyte##6##1##(2010-6#2)(2013-7#4)
macrophytes##3##1##(2008-12#1)(2011-1#1)(2013-7#1)
macropores##2##1##(2008-10#1)(2008-6#1)
macroporous resin##4##2##(2008-10#3)(2013-8#1)
macroporous support##2##2##(2008-10#2)
macroporous##25##1##(2007-12#1)(2008-10#13)(2008-11#4)(2008-6#1)(2008-7#1)(2010-7#1)(2012-1#3)(2013-8#1)
macrorelief##3##1##(2008-5#3)
macroscale##2##1##(2010-4#1)(2010-7#1)
macroscopic activity##2##2##(2008-11#2)
macroscopic and microscopic##6##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2013-7#1)
macroscopic and##11##2##(1991-12#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-7#1)(2013-7#1)
macroscopic appearance##2##2##(1995-12#1)(2011-1#1)
macroscopic haematuria##4##2##(1995-5#4)
macroscopic hematuria##3##2##(1990-11#1)(2007-10#1)(2008-1#1)
macroscopic objects##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
macroscopic scale##3##2##(1995-3#1)(2009-7#2)
macroscopic symptoms##2##2##(2008-10#2)
macroscopic##83##1##(1990-11#1)(1991-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#4)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#3)(2009-7#5)(2009-8#1)(2010-4#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#7)(2013-1#1)(2013-7#2)(2013-8#1)
macroscopically visible##2##2##(2008-10#1)(2013-1#1)
macroscopically##10##1##(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-12#1)(2013-1#2)
macrosomia and##2##2##(2008-1#2)
macrosomia##8##1##(1996-11#3)(2008-1#3)(2009-2#1)(2009-3#1)
macrospadiceus##3##1##(2013-1#3)
macrostate##2##1##(1997-2#1)(2012-3#1)
macrostimulation##2##1##(2008-7#2)
macrovascular complications of##2##3##(2008-1#1)(2013-1#1)
macrovascular complications##4##2##(2008-1#3)(2013-1#1)
macrovascular disease##2##2##(2008-3#1)(2013-1#1)
macrovascular##8##1##(2008-1#4)(2008-3#1)(2013-1#3)
macula##4##1##(2010-2#1)(2010-8#1)(2011-2#2)
maculans avirulence##2##2##(2008-10#2)
maculans isolate PHW1245##2##3##(2008-10#2)
maculans isolates##6##2##(2008-10#6)
maculans##42##1##(2008-10#40)(2011-10#2)
macular degeneration (AMD)##9##3##(2009-12#1)(2010-2#1)(2011-2#5)(2011-7#1)(2013-1#1)
macular degeneration with##2##3##(2008-4#1)(2011-2#1)
macular degeneration##32##2##(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#3)(2011-2#15)(2011-7#2)(2013-1#1)
macular degeneration?##2##2##(2011-2#2)
macular disease##3##2##(2013-1#2)(2013-8#1)
macular edema (DME)##2##3##(2008-1#1)(2011-7#1)
macular edema##5##2##(2008-1#1)(2011-7#2)(2013-1#2)
macular epiretinal membrane##2##3##(2011-2#2)
macular thickness##6##2##(2011-2#2)(2013-1#4)
macular##73##1##(2007-11#7)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#30)(2011-7#4)(2013-1#16)(2013-8#1)
maculata##2##1##(2008-10#2)
maculatus##3##1##(2009-10#1)(2010-8#2)
macules##10##1##(2010-6#6)(2011-2#1)(2012-3#2)(2013-1#1)
maculicola KD4326##2##2##(2008-10#2)
maculicola##5##1##(2008-10#5)
maculipennis##2##1##(2010-1#1)(2013-7#1)
maculopapular##2##1##(1996-3#1)(2012-2#1)
maculopathy##5##1##(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
mad cow##2##2##(1996-3#2)
mad##4##1##(1996-3#2)(2008-7#2)
made a comparison of##2##4##(1995-6#1)(2013-1#1)
made a complete recovery##2##4##(1992-3#1)(2008-7#1)
made a detailed comparison##2##4##(1990-11#1)(1991-6#1)
made a full recovery##4##4##(2007-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
made a good##5##3##(1997-6#1)(2006-12#1)(2008-7#1)(2010-5#1)(2011-1#1)
made a significant contribution to##4##5##(2008-11#2)(2013-1#2)
made a significant impact##4##4##(1992-1#1)(2008-8#1)(2009-6#1)(2010-12#1)
made a significant##11##3##(1992-1#1)(1993-3#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
made a##61##2##(1990-11#2)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#3)(1992-12#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#4)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#5)(2013-8#2)
made about the##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
made about##4##2##(1995-2#1)(2008-10#1)(2008-6#1)(2012-12#1)
made according to the##2##4##(2008-1#1)(2012-3#1)
made according to##5##3##(2007-11#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
made according##6##2##(2007-11#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
made after##5##2##(1990-11#1)(1992-12#1)(1994-2#1)(2008-10#1)(2013-1#1)
made against##2##2##(1990-12#1)(1993-9#1)
made among##4##2##(2008-10#2)(2010-12#1)(2013-1#1)
made an attempt to##3##4##(2007-12#1)(2008-10#1)(2009-7#1)
made an uneventful recovery##3##4##(1993-9#1)(1994-2#1)(1997-3#1)
made an##13##2##(1993-11#1)(1993-9#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
made and the##2##3##(2008-10#1)(2010-9#1)
made and##19##2##(1990-6#1)(1992-9#1)(1994-5#1)(1997-4#2)(2007-11#1)(2008-10#6)(2008-12#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
made approximately##2##2##(2008-10#1)(2008-3#1)
made as##7##2##(1997-4#1)(2008-1#1)(2008-2#2)(2010-8#1)(2012-3#1)(2013-8#1)
made at a##4##3##(1990-2#1)(2008-2#1)(2008-3#2)
made at an##2##3##(2008-2#1)(2013-1#1)
made at the##10##3##(1990-3#1)(1991-12#1)(1992-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-3#2)
made at##33##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-2#4)(2008-3#6)(2008-5#1)(2010-10#2)(2013-1#1)
made available for##3##3##(1993-1#1)(1995-5#1)(2007-6#1)
made available through the##2##4##(2008-2#1)(2009-6#1)
made available to##5##3##(2007-4#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-7#1)
made available##19##2##(1993-1#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#2)(2013-7#1)
made aware##2##2##(2008-10#1)(2012-12#1)
made based on the##3##4##(1991-6#1)(1994-2#1)(2011-2#1)
made based on##11##3##(1990-11#1)(1991-6#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
made before##4##2##(1994-6#1)(1997-5#1)(1997-8#1)(2009-1#1)
made between a##2##3##(1990-7#1)(2013-7#1)
made between the##9##3##(1990-5#1)(1990-6#1)(1992-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-3#1)
made between##39##2##(1990-5#1)(1990-6#1)(1990-7#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-11#1)(1996-4#1)(1997-2#1)(2007-10#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
made but##2##2##(1995-6#1)(2009-5#1)
made by a##5##3##(1995-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
made by clinical##2##3##(1992-5#1)(2008-10#1)
made by ion##2##3##(2007-12#1)(2008-10#1)
made by means of##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)
made by measuring##2##3##(1991-3#1)(2008-6#1)
made by pressing##2##3##(2007-12#1)(2008-10#1)
made by the##19##3##(1990-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)(2012-3#1)
made by use of the##3##5##(2007-11#2)(2007-12#1)
made by use of##5##4##(1995-12#1)(2007-11#2)(2007-12#1)(2008-3#1)
made by using the##3##4##(2008-10#2)(2012-7#1)
made by using##5##3##(2008-10#4)(2012-7#1)
made by##131##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-8#3)(2008-1#4)(2008-10#28)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#12)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#1)
made changes##2##2##(2008-11#1)(2008-9#1)
made clear##3##2##(1997-8#1)(2007-4#1)(2008-3#1)
made compatible with##2##3##(2007-12#1)(2010-8#1)
made concerning##2##2##(1992-11#1)(1994-3#1)
made contact##2##2##(1992-3#1)(2008-10#1)
made during the##6##3##(2006-10#1)(2008-10#2)(2008-8#1)(2010-3#1)(2012-12#1)
made during##11##2##(1994-11#1)(1996-1#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
made early##2##2##(1996-5#1)(2010-4#1)
made easier##2##2##(1996-1#1)(2008-9#1)
made evident##3##2##(2008-2#2)(2013-1#1)
made feasible in##2##3##(2008-3#1)(2009-11#1)
made fewer##2##2##(2012-12#1)(2012-2#1)
made following##2##2##(2007-8#1)(2010-3#1)
made for each##4##3##(1996-4#1)(2008-10#3)
made for the##6##3##(1991-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
made for three##2##3##(2008-3#1)(2008-5#1)
made for##50##2##(1991-1#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
made from a##8##3##(1993-12#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#1)
made from the same##2##4##(2008-10#1)(2008-7#1)
made from the##14##3##(1991-5#1)(1995-12#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)
made from two##2##3##(2007-6#1)(2008-7#1)
made from##78##2##(1991-5#1)(1991-6#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-11#6)(2007-12#6)(2007-6#1)(2008-10#19)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)
made great strides##3##3##(2008-10#1)(2009-5#1)(2012-3#1)
made great##4##2##(2008-10#1)(2009-5#1)(2011-3#1)(2012-3#1)
made if##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
made in 8 cases##2##4##(1991-2#1)(2007-11#1)
made in a single##2##4##(1996-2#1)(2008-9#1)
made in a##10##3##(1991-2#1)(1994-2#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-9#1)
made in an##2##3##(2008-10#1)(2008-3#1)
made in biological##2##3##(2010-3#1)(2010-7#1)
made in both##3##3##(2007-11#1)(2008-2#1)(2012-12#1)
made in different##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
made in high##2##3##(1995-12#1)(2008-4#1)
made in mammalian##2##3##(2008-11#1)(2009-8#1)
made in order to##5##4##(2008-10#2)(2008-11#1)(2012-1#1)(2012-7#1)
made in sequence##2##3##(1990-8#2)
made in terms of##2##4##(2008-10#1)(2008-2#1)
made in the assessment##2##4##(2008-11#1)(2008-8#1)
made in the development of##2##5##(2008-10#1)(2008-7#1)
made in the development##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
made in the field of##3##5##(2009-6#2)(2010-10#1)
made in the field##5##4##(2008-9#1)(2009-6#2)(2010-10#1)(2012-12#1)
made in the laboratory##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
made in the management of##3##5##(2006-10#1)(2008-3#1)(2010-6#1)
made in the past few years##2##6##(2010-7#1)(2011-2#1)
made in the past##3##4##(2007-12#1)(2010-7#1)(2011-2#1)
made in the study of##2##5##(1991-12#1)(2008-10#1)
made in the treatment of##2##5##(2007-6#1)(2008-5#1)
made in the treatment##3##4##(2007-6#1)(2008-5#1)(2013-1#1)
made in the##59##3##(1990-9#1)(1991-12#1)(1992-3#2)(1995-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
made in this study##2##4##(1996-12#1)(2008-10#1)
made in this##5##3##(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
made in understanding the##6##4##(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#2)(2011-2#1)
made in understanding##8##3##(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#2)(2011-2#2)(2012-2#1)
made in##190##2##(1990-10#2)(1990-3#1)(1990-6#1)(1990-8#6)(1990-9#1)(1991-12#2)(1991-2#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-9#1)(2006-10#2)(2007-11#7)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#15)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#1)
made into##6##2##(1992-10#1)(1996-5#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-3#1)
made it necessary to##2##4##(1995-6#1)(1997-2#1)
made it possible for##4##4##(1992-3#1)(2007-7#1)(2008-10#1)(2010-12#1)
made it possible to detect##2##5##(1991-6#1)(1994-6#1)
made it possible to identify##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
made it possible to obtain##4##5##(2008-10#3)(2008-3#1)
made it possible to##31##4##(1990-3#1)(1991-6#1)(1992-9#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#1)(2010-5#1)(2013-1#1)
made it possible##36##3##(1990-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#2)
made it##52##2##(1990-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-6#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
made its##3##2##(2007-8#1)(2008-11#1)(2010-12#1)
made late##2##2##(1990-3#1)(2012-1#1)
made little##2##2##(2008-10#1)(2008-9#1)
made more errors##2##3##(1992-11#1)(1996-5#1)
made more##11##2##(1992-11#2)(1994-1#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-2#2)
made no##2##2##(1997-8#1)(2012-3#1)
made of Teflon AF-2400##2##4##(2008-10#2)
made of a##9##3##(1992-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-7#1)
made of the clinical##2##4##(2012-12#1)(2012-3#1)
made of the same##2##4##(2008-11#2)
made of the##30##3##(1991-1#1)(1991-3#2)(1992-1#1)(1992-6#2)(1993-2#1)(1994-1#1)(1994-2#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
made of two different##2##4##(2007-12#1)(2008-3#1)
made of two##3##3##(2007-12#1)(2008-3#2)
made of##103##2##(1991-1#1)(1991-3#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#21)(2008-11#5)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)
made on a##6##3##(1994-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-3#1)
made on other##2##3##(2008-10#1)(2008-8#1)
made on the basis of the##3##6##(1992-12#1)(2008-10#1)(2008-3#1)
made on the basis of##9##5##(1992-12#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
made on the##22##3##(1990-11#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-1#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#2)(2009-10#1)(2013-1#1)
made on##51##2##(1990-11#1)(1990-8#1)(1991-3#2)(1991-6#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
made out of##2##3##(1993-3#1)(2008-10#1)
made over a##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
made over the##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
made over##8##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#1)
made possible by a##4##4##(1994-6#1)(2007-12#1)(2008-12#1)(2008-3#1)
made possible by the##6##4##(1994-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2011-2#1)
made possible by use of##2##5##(2008-2#1)(2008-3#1)
made possible by##20##3##(1994-12#1)(1994-3#1)(1994-6#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
made possible the determination of##2##5##(2008-10#2)
made possible the##4##3##(1991-5#1)(2008-10#2)(2008-5#1)
made possible##26##2##(1991-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
made publicly available##2##3##(1996-11#1)(2013-1#1)
made sense##2##2##(2008-1#1)(2008-10#1)
made significant##4##2##(2008-12#1)(2008-8#2)(2012-2#1)
made significantly fewer##2##3##(2008-11#1)(2011-2#1)
made significantly##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
made since##2##2##(1991-5#1)(2007-7#1)
made some##2##2##(2008-9#1)(2013-1#1)
made that##11##2##(1990-11#1)(1992-12#1)(1994-2#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)
made the diagnosis of##2##4##(2011-1#1)(2012-12#1)
made the largest##2##3##(2008-8#1)(2010-6#1)
made the##33##2##(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
made their##3##2##(1997-3#1)(2009-6#1)(2010-10#1)
made them##5##2##(1991-3#1)(2008-10#2)(2011-3#1)(2012-2#1)
made these##5##2##(1994-5#1)(2007-11#1)(2008-3#1)(2011-2#2)
made this##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
made through the##2##3##(1992-9#1)(2007-12#1)
made through##5##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-10#1)
made to a##2##3##(1993-12#1)(2008-5#1)
made to correlate##2##3##(1992-12#1)(2008-10#1)
made to detect##2##3##(1996-12#1)(2008-9#1)
made to determine the##4##4##(1990-6#1)(2007-2#1)(2008-10#1)(2013-1#1)
made to determine##5##3##(1990-6#1)(2007-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
made to develop a##3##4##(2008-10#2)(2008-9#1)
made to develop##6##3##(1991-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)
made to find##5##3##(1992-12#1)(2008-5#1)(2009-5#1)(2010-4#1)(2012-2#1)
made to improve##4##3##(1991-1#1)(1994-5#1)(2008-10#1)(2008-11#1)
made to react with##3##4##(2008-10#3)
made to study##2##3##(2008-10#1)(2008-11#1)
made to the##15##3##(1991-12#1)(1993-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-11#1)(2011-1#1)(2011-2#1)
made to understand the##4##4##(2008-4#2)(2011-2#1)(2012-12#1)
made to understand##5##3##(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)
made to##129##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#4)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#1)(2008-8#4)(2008-9#5)(2009-11#2)(2009-5#2)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#1)
made towards##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
made under##2##2##(2008-12#1)(2008-3#1)
made until##2##2##(2008-7#1)(2010-1#1)
made up by a##3##4##(2008-10#2)(2008-5#1)
made up by##5##3##(2008-10#2)(2008-5#2)(2009-7#1)
made up from##2##3##(1995-11#1)(2008-10#1)
made up of a##4##4##(1993-6#1)(1996-2#1)(2008-12#1)(2008-9#1)
made up of an##2##4##(1991-3#1)(2008-3#1)
made up of two##4##4##(2008-2#2)(2008-3#1)(2009-2#1)
made up of##35##3##(1991-12#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-2#1)(2006-12#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)
made up the##2##3##(2008-11#1)(2010-9#1)
made up to##3##3##(2008-10#2)(2009-7#1)
made up women##3##3##(2008-5#3)
made up##61##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-2#1)(2006-12#2)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#9)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#2)(2010-9#1)(2011-2#1)
made use of a##2##4##(2008-3#1)(2009-8#1)
made use of##3##3##(2008-3#1)(2009-8#1)(2011-2#1)
made using a##11##3##(1995-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-7#1)
made using##32##2##(1990-5#1)(1991-5#1)(1993-8#1)(1994-3#1)(1995-11#1)(2007-12#1)(2007-5#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-7#1)(2013-1#1)
made via##2##2##(2011-1#1)(2012-12#1)
made when##4##2##(1992-9#1)(2008-10#1)(2008-4#1)(2009-6#1)
made which##2##2##(2008-11#1)(2013-8#1)
made with a##9##3##(1995-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)
made with conventional##2##3##(2008-2#2)
made with the##14##3##(1993-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-6#1)(2010-7#1)(2013-1#1)
made with this##4##3##(2008-10#2)(2008-2#1)(2010-12#1)
made with##74##2##(1990-12#1)(1991-3#1)(1991-4#1)(1993-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#11)(2008-3#12)(2008-5#3)(2008-7#4)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#3)(2013-7#1)
made within##3##2##(1992-12#1)(1996-6#1)(2008-10#1)
made without##4##2##(1996-4#1)(1997-2#1)(2010-4#1)(2012-12#1)
made##1736##1##(1990-10#2)(1990-11#7)(1990-12#3)(1990-2#4)(1990-3#7)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#8)(1990-9#1)(1991-1#4)(1991-12#8)(1991-2#5)(1991-3#12)(1991-4#1)(1991-5#5)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#6)(1992-10#5)(1992-11#6)(1992-12#12)(1992-2#2)(1992-3#10)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#7)(1993-1#3)(1993-11#4)(1993-12#10)(1993-2#8)(1993-3#7)(1993-6#1)(1993-8#3)(1993-9#4)(1994-1#4)(1994-11#3)(1994-12#10)(1994-2#13)(1994-3#7)(1994-5#5)(1994-6#7)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#4)(1995-12#10)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#9)(1995-6#9)(1995-8#5)(1995-9#2)(1996-1#10)(1996-11#4)(1996-12#4)(1996-2#7)(1996-3#5)(1996-4#3)(1996-5#7)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#5)(1997-4#7)(1997-5#7)(1997-6#4)(1997-7#4)(1997-8#8)(1997-9#1)(2006-10#6)(2006-12#3)(2007-10#8)(2007-11#43)(2007-12#46)(2007-2#4)(2007-4#4)(2007-5#4)(2007-6#4)(2007-7#7)(2007-8#12)(2008-1#18)(2008-10#302)(2008-11#65)(2008-12#31)(2008-2#68)(2008-3#125)(2008-4#19)(2008-5#49)(2008-6#13)(2008-7#61)(2008-8#29)(2008-9#39)(2009-1#1)(2009-10#10)(2009-11#7)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#8)(2009-6#9)(2009-7#15)(2009-8#7)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#11)(2010-4#8)(2010-5#5)(2010-6#4)(2010-7#6)(2010-8#14)(2010-9#4)(2011-1#22)(2011-2#48)(2011-3#4)(2012-1#5)(2012-12#32)(2012-2#31)(2012-3#26)(2012-7#4)(2013-1#57)(2013-7#5)(2013-8#15)
madness##5##1##(1993-8#1)(2008-4#1)(2009-10#2)(2009-7#1)
maduramicin and##2##2##(2007-6#2)
maduramicin##3##1##(2007-6#3)
maenas##4##1##(1994-11#1)(1996-2#1)(2007-12#1)(2008-7#1)
mag-fura-2##2##1##(1990-7#1)(1991-5#1)
magainin##2##1##(1995-11#2)
magazine##5##1##(1991-12#1)(1992-1#1)(1992-2#2)(2009-10#1)
magazines##2##1##(2007-8#1)(2008-12#1)
magic T##2##2##(2008-3#2)
magic angle spinning (CPMAS) NMR and diffuse reflectance infrared##2##9##(2008-10#2)
magic angle spinning##4##3##(2008-10#3)(2013-8#1)
magic angle##6##2##(2008-1#1)(2008-10#4)(2013-8#1)
magic##14##1##(1994-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-7#2)(2013-8#1)
magma##2##1##(2008-10#1)(2013-8#1)
magna##3##1##(2008-10#1)(2008-9#1)(2013-1#1)
magnesia##2##1##(2008-10#1)(2011-2#1)
magnesium acetate##2##2##(1995-3#1)(2008-7#1)
magnesium and age##2##3##(2008-7#2)
magnesium and calcium binding##2##4##(2008-10#2)
magnesium and calcium##3##3##(2008-10#3)
magnesium and iron##2##3##(1994-5#1)(2010-2#1)
magnesium and zinc in honey##2##5##(2008-10#2)
magnesium and zinc##3##3##(2008-10#3)
magnesium and##17##2##(1994-5#1)(2007-11#1)(2008-10#9)(2008-6#1)(2008-7#2)(2010-2#1)(2011-2#2)
magnesium ascorbyl phosphate##2##3##(2008-5#2)
magnesium chloride##2##2##(1995-12#1)(1996-6#1)
magnesium concentration##8##2##(1993-11#3)(2008-7#4)(2011-2#1)
magnesium concentrations were##2##3##(2008-7#2)
magnesium concentrations##6##2##(1991-9#1)(1992-6#1)(2008-7#4)
magnesium homeostasis##2##2##(1996-9#1)(2008-7#1)
magnesium hydroxide coprecipitation##2##3##(2008-10#2)
magnesium in the##2##3##(2008-10#2)
magnesium in##16##2##(1991-1#1)(2008-10#14)(2010-12#1)
magnesium indicators##3##2##(1991-5#3)
magnesium ions##9##2##(1994-5#1)(2008-10#6)(2008-4#1)(2013-1#1)
magnesium is described##2##3##(2008-10#2)
magnesium is##4##2##(1997-7#1)(2008-10#2)(2011-2#1)
magnesium nitrate##3##2##(1991-12#1)(2008-10#2)
magnesium over##2##2##(2008-10#2)
magnesium reabsorption##2##2##(1997-8#1)(2008-6#1)
magnesium salts##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
magnesium selectivity##2##2##(2008-10#2)
magnesium status##2##2##(2008-5#1)(2008-6#1)
magnesium stearate and##2##3##(2008-10#1)(2013-8#1)
magnesium stearate##4##2##(2008-10#2)(2010-5#1)(2013-8#1)
magnesium sulphate##3##2##(2008-7#1)(2013-1#2)
magnesium were##6##2##(2008-10#5)(2008-5#1)
magnesium with##3##2##(2008-10#2)(2011-2#1)
magnesium##191##1##(1990-7#3)(1990-9#4)(1991-1#1)(1991-12#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-6#2)(1993-11#5)(1993-8#2)(1994-5#5)(1994-6#1)(1995-12#1)(1995-3#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#3)(2007-11#2)(2008-10#85)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#7)(2008-7#20)(2008-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#10)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
magnesium(II)##4##1##(2008-10#4)
magnesium-dependent##2##1##(1992-9#1)(1993-8#1)
magnet and##2##2##(2008-10#2)
magnet to##2##2##(2007-9#1)(2008-3#1)
magnet##32##1##(1990-12#2)(1994-9#1)(1996-12#1)(2007-9#1)(2008-10#11)(2008-3#3)(2008-8#2)(2008-9#3)(2009-5#3)(2010-4#2)(2010-5#1)(2012-2#1)(2012-3#1)
magnetic and##5##2##(1992-3#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-11#1)
magnetic bead##3##2##(1990-12#1)(2008-4#1)(2010-5#1)
magnetic beads and##2##3##(1995-6#1)(2008-10#1)
magnetic beads in##3##3##(2008-10#3)
magnetic beads were introduced##2##4##(2008-10#2)
magnetic beads##26##2##(1990-12#1)(1995-6#3)(1995-8#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-4#2)(2008-8#1)(2010-11#1)
magnetic behavior##3##2##(1996-2#1)(2008-10#1)(2010-4#1)
magnetic behaviour##2##2##(2009-11#2)
magnetic domains##3##2##(2008-2#1)(2008-3#2)
magnetic field can##2##3##(2008-9#2)
magnetic field direction##2##3##(2008-3#2)
magnetic field enhancement##2##3##(2007-11#2)
magnetic field homogeneity##2##3##(2008-1#1)(2010-2#1)
magnetic field in the##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
magnetic field in##4##3##(2007-12#1)(2008-10#1)(2008-8#2)
magnetic field is##7##3##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#1)
magnetic field on##6##3##(2008-10#1)(2008-3#1)(2008-8#2)(2012-1#2)
magnetic field strength##3##3##(1995-11#1)(2008-2#1)(2008-3#1)
magnetic field strengths##2##3##(2008-3#1)(2008-7#1)
magnetic field to##3##3##(2008-3#2)(2012-1#1)
magnetic field##82##2##(1992-12#1)(1992-3#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#13)(2008-7#4)(2008-8#13)(2008-9#6)(2009-11#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#2)
magnetic fields##23##2##(1992-3#8)(1994-5#1)(1996-5#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#1)(2012-2#1)
magnetic fluid##2##2##(2008-2#1)(2010-5#1)
magnetic flux##2##2##(2006-4#1)(2008-7#1)
magnetic imaging##2##2##(2008-11#1)(2012-12#1)
magnetic interaction##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
magnetic interactions##2##2##(2007-11#2)
magnetic isolation##2##2##(2008-10#2)
magnetic moment##3##2##(2007-11#1)(2008-5#1)(2009-11#1)
magnetic motor evoked potentials##2##4##(1996-6#2)
magnetic nanoparticles (MNPs)##2##3##(2009-11#1)(2013-1#1)
magnetic nanoparticles is##2##3##(2009-11#1)(2012-2#1)
magnetic nanoparticles##13##2##(2008-10#4)(2009-11#4)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
magnetic properties of the##2##4##(1997-7#1)(2007-11#1)
magnetic properties of##5##3##(1997-7#4)(2007-11#1)
magnetic properties##11##2##(1997-7#4)(2007-11#3)(2008-11#1)(2009-8#1)(2010-5#1)(2010-6#1)
magnetic resonance (CMR) imaging has##2##5##(2010-11#1)(2010-8#1)
magnetic resonance (MR) angiography##2##4##(1995-11#1)(2007-10#1)
magnetic resonance (MR) images is##2##5##(1995-5#1)(2010-8#1)
magnetic resonance (MR) imaging##7##4##(1990-10#1)(1994-8#1)(1996-2#1)(2008-7#1)(2008-8#1)(2011-2#2)
magnetic resonance (MR)##18##3##(1990-10#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#2)
magnetic resonance (NMR) studies##2##4##(1991-5#1)(2008-4#1)
magnetic resonance (NMR)##19##3##(1991-5#1)(1992-3#1)(1992-4#1)(1993-3#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
magnetic resonance and computed##2##4##(2007-11#1)(2009-10#1)
magnetic resonance and##9##3##(1996-11#1)(1997-8#1)(2007-11#1)(2008-10#3)(2009-10#1)(2010-5#1)(2012-2#1)
magnetic resonance angiography (MRA)##4##4##(2008-12#1)(2008-7#2)(2012-2#1)
magnetic resonance angiography##16##3##(1997-8#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#4)(2008-9#1)(2009-4#1)(2009-8#1)(2012-2#1)
magnetic resonance for##3##3##(1994-8#1)(2009-10#2)
magnetic resonance image##4##3##(2007-10#1)(2008-7#2)(2010-8#1)
magnetic resonance images##12##3##(1995-8#1)(1996-5#2)(1996-7#1)(2006-12#1)(2008-3#2)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
magnetic resonance imaging (MRI) contrast agents##2##6##(2010-2#1)(2012-3#1)
magnetic resonance imaging (MRI) findings##4##5##(1996-11#1)(2012-12#2)(2012-3#1)
magnetic resonance imaging (MRI) has##3##5##(2010-8#1)(2011-1#1)(2013-1#1)
magnetic resonance imaging (MRI) in##2##5##(1996-8#1)(2007-10#1)
magnetic resonance imaging (MRI) of the##3##6##(2008-7#1)(2010-12#1)(2012-2#1)
magnetic resonance imaging (MRI) scan##2##5##(2008-7#1)(2013-1#1)
magnetic resonance imaging (MRI) showed##2##5##(2013-1#1)(2013-8#1)
magnetic resonance imaging (MRI) study##2##5##(1996-7#2)
magnetic resonance imaging (MRI)##50##4##(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#2)(1996-8#1)(2006-12#1)(2007-10#3)(2007-11#1)(2008-1#3)(2008-3#1)(2008-7#4)(2008-9#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
magnetic resonance imaging and pathological##2##5##(2007-4#1)(2008-7#1)
magnetic resonance imaging and##20##4##(2007-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-8#2)
magnetic resonance imaging characteristics##2##4##(2007-8#1)(2011-2#1)
magnetic resonance imaging have##3##4##(2007-10#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging in the##3##5##(1990-12#1)(2008-8#1)(2010-12#1)
magnetic resonance imaging in##6##4##(1990-12#1)(1996-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-3#1)
magnetic resonance imaging is the##2##5##(2010-3#1)(2011-2#1)
magnetic resonance imaging is##6##4##(1990-12#1)(1994-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
magnetic resonance imaging of a##2##5##(2011-2#1)(2013-1#1)
magnetic resonance imaging of the##5##5##(1996-3#3)(2007-10#1)(2011-2#1)
magnetic resonance imaging of##11##4##(1994-8#1)(1996-3#3)(2007-10#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
magnetic resonance imaging or computed tomography##2##6##(2008-7#1)(2008-8#1)
magnetic resonance imaging or##3##4##(2007-11#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging procedures##2##4##(1995-12#2)
magnetic resonance imaging revealed##2##4##(2008-11#1)(2008-12#1)
magnetic resonance imaging scans##4##4##(1996-5#1)(2007-9#1)(2008-9#1)(2011-2#1)
magnetic resonance imaging showed##3##4##(2007-8#1)(2008-7#1)(2010-10#1)
magnetic resonance imaging studies##2##4##(2008-2#1)(2013-1#1)
magnetic resonance imaging study##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
magnetic resonance imaging to##4##4##(1990-12#1)(2007-9#1)(2008-9#1)(2012-3#1)
magnetic resonance imaging was performed##2##5##(2011-2#1)(2012-12#1)
magnetic resonance imaging was used to##2##6##(1996-2#1)(2008-11#1)
magnetic resonance imaging was##6##4##(1996-2#1)(2008-11#1)(2009-5#1)(2011-2#2)(2012-12#1)
magnetic resonance imaging##223##3##(1990-12#3)(1991-12#1)(1992-12#1)(1992-3#4)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-5#3)(1996-11#1)(1996-2#2)(1996-3#3)(1996-5#3)(1996-7#3)(1996-8#1)(1997-6#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#10)(2007-11#3)(2007-4#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#1)(2008-11#13)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#21)(2008-8#6)(2008-9#7)(2009-1#1)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#4)(2011-2#16)(2012-1#1)(2012-12#6)(2012-2#16)(2012-3#7)(2013-1#6)(2013-3#2)(2013-7#3)(2013-8#4)
magnetic resonance measurements##2##3##(2008-11#1)(2010-8#1)
magnetic resonance microscopy##2##3##(2008-10#1)(2008-7#1)
magnetic resonance spectra##3##3##(2008-6#2)(2009-6#1)
magnetic resonance spectroscopy (MRS)##2##4##(2008-7#1)(2011-1#1)
magnetic resonance spectroscopy and##4##4##(2008-11#1)(2008-7#1)(2010-5#2)
magnetic resonance spectroscopy combined with##3##5##(1994-5#1)(1995-5#1)(2008-6#1)
magnetic resonance spectroscopy to##2##4##(1993-11#1)(1994-2#1)
magnetic resonance spectroscopy##34##3##(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-11#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(2007-10#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#4)(2010-12#1)(2010-5#2)(2011-1#1)(2013-8#1)
magnetic resonance studies of##2##4##(1991-5#1)(1991-6#1)
magnetic resonance studies##4##3##(1991-5#1)(1991-6#1)(2008-10#1)(2011-1#1)
magnetic resonance study##3##3##(1991-5#1)(2008-7#1)(2012-3#1)
magnetic resonance techniques##3##3##(1990-2#1)(2008-10#1)(2008-4#1)
magnetic resonance venography##2##3##(2012-3#2)
magnetic resonance##418##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-5#4)(1991-6#1)(1992-12#2)(1992-3#11)(1992-4#1)(1993-11#6)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-4#1)(1995-5#8)(1995-8#1)(1995-9#1)(1996-11#3)(1996-2#4)(1996-3#3)(1996-5#5)(1996-7#4)(1996-8#1)(1997-6#1)(1997-8#5)(2006-10#2)(2006-12#2)(2007-10#16)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#23)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#6)(2008-7#38)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#5)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#3)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#9)(2010-9#4)(2011-1#8)(2011-2#24)(2012-1#1)(2012-12#6)(2012-2#21)(2012-3#10)(2013-1#8)(2013-3#2)(2013-7#3)(2013-8#5)
magnetic rotation spectroscopy of##2##4##(2008-2#2)
magnetic rotation##3##2##(2008-2#3)
magnetic sector##2##2##(2008-10#2)
magnetic separation##4##2##(2008-10#1)(2008-12#2)(2010-5#1)
magnetic stimulation (TMS)##3##3##(2010-7#2)(2011-2#1)
magnetic stimulation (rTMS)##7##3##(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
magnetic stimulation in##3##3##(2008-7#1)(2012-2#2)
magnetic stimulation##32##2##(2008-10#2)(2008-2#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-5#2)(2010-7#7)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#3)
magnetic structure of the##2##4##(2007-11#2)
magnetic susceptibilities##2##2##(1996-2#1)(1997-7#1)
magnetic susceptibility measurement##2##3##(2008-10#2)
magnetic susceptibility##6##2##(1997-7#1)(2007-11#1)(2008-10#2)(2009-7#1)(2012-2#1)
magnetic tips##2##2##(2008-7#2)
magnetic##737##1##(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#21)(1992-4#1)(1993-11#6)(1993-12#1)(1993-3#2)(1993-5#5)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#8)(1995-6#4)(1995-8#3)(1995-9#1)(1996-11#3)(1996-12#2)(1996-2#8)(1996-3#3)(1996-5#7)(1996-6#2)(1996-7#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#9)(1997-8#5)(2006-10#2)(2006-12#2)(2006-4#3)(2007-10#16)(2007-11#18)(2007-12#10)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#8)(2008-10#79)(2008-11#24)(2008-12#8)(2008-2#17)(2008-3#32)(2008-4#9)(2008-5#7)(2008-6#6)(2008-7#56)(2008-8#24)(2008-9#19)(2009-1#2)(2009-10#6)(2009-11#14)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#16)(2010-6#5)(2010-7#10)(2010-8#9)(2010-9#5)(2011-1#15)(2011-2#30)(2012-1#7)(2012-12#7)(2012-2#38)(2012-3#10)(2013-1#15)(2013-3#2)(2013-7#3)(2013-8#6)
magnetic-field##4##1##(2007-12#1)(2008-10#1)(2008-3#2)
magnetic-field-modulation##3##1##(2008-2#3)
magnetically induced superresolution disks##2##4##(2008-2#2)
magnetically induced##3##2##(2008-2#2)(2008-3#1)
magnetically##10##1##(1997-7#2)(2008-2#2)(2008-3#1)(2009-11#2)(2009-6#1)(2012-2#1)(2013-8#1)
magnetism of##2##2##(1992-11#1)(2007-11#1)
magnetism##4##1##(1992-11#1)(2007-11#1)(2008-7#2)
magnetite nanoparticles##2##2##(2008-7#2)
magnetite particles were##2##3##(1992-12#2)
magnetite particles##3##2##(1992-12#3)
magnetite##11##1##(1990-12#1)(1992-12#3)(2008-10#3)(2008-7#3)(2013-1#1)
magnetization reversal##2##2##(2008-7#1)(2009-6#1)
magnetization transfer##2##2##(2010-9#1)(2012-12#1)
magnetization##18##1##(1992-12#3)(1996-2#3)(1997-7#2)(2006-4#1)(2008-10#2)(2008-7#1)(2009-6#3)(2010-9#1)(2012-12#1)(2013-1#1)
magneto-optic (MO)##2##2##(2008-3#2)
magneto-optic trap for##2##3##(2007-12#2)
magneto-optic trap##4##2##(2007-11#2)(2007-12#2)
magneto-optic##17##1##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#8)
magneto-optical disk##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
magneto-optical disks##5##2##(2008-2#3)(2008-3#2)
magneto-optical materials##2##2##(2008-2#2)
magneto-optical media##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
magneto-optical relaxation measurements##2##3##(2009-11#2)
magneto-optical##24##1##(2007-12#5)(2008-2#8)(2008-3#9)(2009-11#2)
magnetoencephalographic##2##1##(2012-12#2)
magnetoencephalography##3##1##(1994-3#1)(1996-5#1)(2012-12#1)
magnetometer based on the##2##4##(2007-12#1)(2008-2#1)
magnetometer based on##3##3##(1992-8#1)(2007-12#1)(2008-2#1)
magnetometer##7##1##(1992-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-2#2)(2012-12#1)
magnetometry##4##1##(2007-11#1)(2008-11#1)(2008-2#1)(2010-4#1)
magnetoresistance in##2##2##(1992-11#1)(2008-7#1)
magnetoresistance##4##1##(1990-4#1)(1992-11#1)(2008-7#2)
magnetron sputtering##2##2##(2007-11#1)(2008-3#1)
magnetron##4##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
magnets adherent across##2##3##(2007-5#2)
magnets were##2##2##(2007-5#1)(2010-4#1)
magnets##7##1##(2007-5#4)(2008-10#2)(2010-4#1)
magnifica##4##1##(2011-2#4)
magnification and##3##2##(2008-2#1)(2008-5#1)(2011-2#1)
magnification are##2##2##(2008-3#2)
magnification of the##2##3##(2008-2#1)(2008-3#1)
magnification of##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-9#1)
magnification##30##1##(1991-2#1)(1993-3#1)(2007-11#4)(2007-12#3)(2008-2#6)(2008-3#7)(2008-5#2)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
magnifications##7##1##(2008-2#4)(2008-3#2)(2011-1#1)
magnified images##3##2##(2008-2#1)(2008-3#2)
magnified##8##1##(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)
magnifying##6##1##(1995-5#1)(2007-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
magnitude and direction of##4##4##(2010-5#1)(2010-8#2)(2013-1#1)
magnitude and direction##6##3##(1990-8#1)(2008-10#1)(2010-5#1)(2010-8#2)(2013-1#1)
magnitude and duration of##2##4##(1996-2#1)(2008-11#1)
magnitude and the##6##3##(2008-10#3)(2008-3#1)(2009-5#1)(2013-8#1)
magnitude and##39##2##(1990-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#4)(2008-7#2)(2008-8#2)(2009-5#1)(2010-5#1)(2010-8#3)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
magnitude are##2##2##(2007-12#1)(2008-2#1)
magnitude but##3##2##(1990-10#1)(1995-5#1)(2008-2#1)
magnitude by##4##2##(1992-12#1)(2008-3#1)(2009-11#1)(2010-5#1)
magnitude depends on##3##3##(2007-12#1)(2008-3#2)
magnitude during##2##2##(2008-10#1)(2012-6#1)
magnitude estimation of intensity##3##4##(2012-12#3)
magnitude estimation of pleasantness##4##4##(2012-12#4)
magnitude estimation of##7##3##(2012-12#7)
magnitude estimation##8##2##(2012-12#8)
magnitude for the##2##3##(1995-5#1)(2008-3#1)
magnitude for##7##2##(1991-5#1)(1995-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)
magnitude higher than##12##3##(1990-7#1)(1991-5#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2012-2#1)
magnitude higher##15##2##(1990-7#1)(1991-5#1)(1992-8#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
magnitude in the##4##3##(1993-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
magnitude in##8##2##(1990-5#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)
magnitude is##3##2##(1996-5#1)(2008-3#2)
magnitude may##2##2##(1993-12#1)(2007-11#1)
magnitude model##3##2##(2008-3#3)
magnitude of 5HT-amplified DGS##2##4##(1996-7#2)
magnitude of K(ex)##3##3##(2008-10#3)
magnitude of a##2##3##(2008-3#1)(2012-2#1)
magnitude of change##3##3##(1994-8#1)(1996-2#1)(2008-10#1)
magnitude of n(2)##3##3##(2007-11#2)(2008-2#1)
magnitude of suppression##2##3##(2008-10#1)(2008-7#1)
magnitude of the RCE was##2##5##(2008-7#2)
magnitude of the birefringence##2##4##(2008-3#2)
magnitude of the change##2##4##(2007-12#1)(2008-10#1)
magnitude of the##94##3##(1990-12#1)(1990-5#3)(1990-8#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#2)(1996-6#1)(1997-7#2)(2007-11#6)(2007-12#4)(2008-10#20)(2008-2#2)(2008-3#14)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#3)(2013-8#2)
magnitude of these##5##3##(1995-12#1)(1995-3#1)(1997-2#1)(2007-10#1)(2008-8#1)
magnitude of this##8##3##(1990-2#2)(2007-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
magnitude of underreporting##2##3##(1997-3#2)
magnitude of##214##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#3)(1990-8#3)(1991-12#2)(1991-8#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#2)(2007-10#2)(2007-11#10)(2007-12#6)(2007-8#2)(2008-10#41)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#22)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#15)(2008-9#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
magnitude on the##2##3##(2007-11#1)(2008-3#1)
magnitude order##3##2##(2008-10#3)
magnitude relative to the##2##4##(1995-2#1)(1996-3#1)
magnitude relative to##5##3##(1994-5#1)(1994-8#1)(1995-2#1)(1996-3#1)(2008-10#1)
magnitude than those##2##3##(2008-10#2)
magnitude than##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
magnitude to that caused by##2##5##(1992-8#1)(2010-4#1)
magnitude to that##3##3##(1992-8#1)(1995-12#1)(2010-4#1)
magnitude to##5##2##(1992-8#1)(1995-12#1)(2008-7#1)(2010-4#1)(2011-2#1)
magnitude was##3##2##(2007-11#1)(2008-10#2)
magnitude were##2##2##(2008-2#1)(2009-2#1)
magnitude with##7##2##(1997-2#1)(2008-10#4)(2008-5#1)(2009-11#1)
magnitude##537##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#4)(1990-7#1)(1990-8#5)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#6)(1995-5#5)(1995-6#3)(1995-8#2)(1996-11#1)(1996-2#3)(1996-3#2)(1996-4#10)(1996-5#2)(1996-6#1)(1996-7#3)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#2)(1997-7#3)(2007-10#2)(2007-11#27)(2007-12#23)(2007-8#2)(2008-10#124)(2008-11#12)(2008-12#2)(2008-2#24)(2008-3#65)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#21)(2008-9#6)(2009-10#1)(2009-11#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-8#7)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#11)(2012-2#9)(2012-3#3)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#8)
magnitude)##4##1##(1995-2#1)(1996-4#1)(2008-10#2)
magnitudes and##4##2##(1991-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
magnitudes as##2##2##(2008-3#2)
magnitudes of the##5##3##(2008-10#1)(2008-2#2)(2008-8#1)(2009-2#1)
magnitudes of##14##2##(1997-2#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2012-12#1)
magnitudes##30##1##(1991-12#1)(1996-4#2)(1997-2#1)(2008-10#5)(2008-2#6)(2008-3#6)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
magnocellular neurons##3##2##(2008-4#2)(2008-7#1)
magnocellular nuclei of##2##3##(1995-5#1)(2008-7#1)
magnocellular nuclei##3##2##(1995-5#1)(2008-7#2)
magnocellular pathway##2##2##(1996-2#1)(1996-5#1)
magnocellular##11##1##(1993-12#1)(1995-12#2)(1995-5#1)(1996-2#1)(1996-5#1)(2008-4#2)(2008-7#3)
magnocellularis##9##1##(1991-12#1)(1991-5#1)(1993-12#3)(1993-3#2)(1995-12#1)(2008-8#1)
magnoliae##6##1##(2008-6#6)
magnolol to##2##2##(2011-2#2)
magnolol##15##1##(2008-10#7)(2011-2#8)
magnum##7##1##(1996-9#2)(2008-12#2)(2008-7#2)(2011-2#1)
maiden thoroughbred mares##2##3##(1994-7#2)
maidis##7##1##(2008-10#7)
mail and##3##2##(1992-3#1)(1994-12#1)(1996-1#1)
mail questionnaire##3##2##(1994-3#1)(1996-2#1)(2008-1#1)
mail survey of##2##3##(1993-12#1)(1996-2#1)
mail survey##6##2##(1991-2#1)(1993-12#1)(1994-2#1)(1996-2#1)(2011-1#1)(2012-3#1)
mail to##3##2##(1996-1#1)(2007-12#1)(2008-8#1)
mail##26##1##(1991-2#1)(1992-2#1)(1992-3#2)(1993-12#2)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-2#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-3#2)(2013-1#1)
mailed to a##4##3##(1991-3#1)(1995-12#1)(2007-7#1)(2009-4#1)
mailed to##11##2##(1991-3#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(2007-10#1)(2007-7#1)(2008-4#2)(2009-4#1)
mailed##24##1##(1991-3#1)(1991-8#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#2)(2009-4#1)(2010-10#1)(2010-11#2)
mailing##3##1##(1997-2#1)(2011-2#1)(2012-2#1)
main acidic##3##2##(2006-6#2)(2008-10#1)
main active##2##2##(2008-5#2)
main activity##2##2##(2013-1#2)
main actors##3##2##(2009-5#1)(2010-1#1)(2011-1#1)
main advantage of the##5##4##(2008-10#3)(2008-3#2)
main advantage of##16##3##(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
main advantage##17##2##(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
main advantages and##2##3##(2008-10#2)
main advantages of the##4##4##(2008-10#2)(2008-3#2)
main advantages of this##4##4##(2007-11#2)(2008-11#1)(2011-2#1)
main advantages of##13##3##(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-2#1)
main advantages##18##2##(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
main adverse##2##2##(2008-8#1)(2013-8#1)
main aim is to##2##4##(2008-10#2)
main aim is##3##3##(2007-8#1)(2008-10#2)
main aim of##9##3##(1993-2#1)(1997-7#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
main aim##12##2##(1993-2#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
main allergens##2##2##(1990-3#1)(1996-5#1)
main analytical characteristics##2##3##(2008-10#2)
main analytical##3##2##(2008-10#3)
main and foreign##2##3##(2008-10#2)
main and secondary##2##3##(2008-10#1)(2011-1#1)
main and##6##2##(2008-10#4)(2008-5#1)(2011-1#1)
main applications##2##2##(2008-10#1)(2012-2#1)
main areas##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
main arteries##3##2##(1997-8#3)
main artery##2##2##(1996-6#1)(2007-8#1)
main aspects of##3##3##(2008-10#1)(2008-9#1)(2009-7#1)
main attributes##2##2##(2008-10#1)(2008-2#1)
main axes##2##2##(2008-2#1)(2008-9#1)
main axis##2##2##(2008-2#1)(2008-8#1)
main biological##2##2##(1991-6#1)(2008-5#1)
main bottleneck##2##2##(2010-5#1)(2011-2#1)
main branches##3##2##(1994-9#1)(1997-8#2)
main bronchus##4##2##(1990-12#1)(2007-8#1)(2008-6#1)(2010-2#1)
main categories##6##2##(1993-11#1)(2007-4#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
main cause for##2##3##(2008-3#1)(2008-5#1)
main cause of##21##3##(1991-12#1)(1991-6#1)(1993-5#1)(1994-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)
main cause##27##2##(1991-12#1)(1991-6#1)(1993-5#1)(1994-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)
main causes of the##2##4##(1996-8#1)(2008-8#1)
main causes of##10##3##(1990-9#1)(1996-8#1)(1997-3#1)(2008-1#2)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
main causes##15##2##(1990-9#1)(1996-8#1)(1997-3#1)(2008-1#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
main cell##2##2##(2007-12#1)(2009-10#1)
main chain##8##2##(1992-4#1)(1995-5#2)(2007-12#1)(2008-9#2)(2009-7#1)(2013-1#1)
main chains##2##2##(1997-2#1)(2008-4#1)
main characteristics of##5##3##(1991-12#1)(1993-11#1)(2008-10#2)(2013-1#1)
main characteristics##7##2##(1991-12#1)(1993-11#1)(2008-10#3)(2011-2#1)(2013-1#1)
main clades##3##2##(2008-10#2)(2013-8#1)
main clinical##9##2##(1991-2#1)(1993-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
main component of the##3##4##(2007-12#1)(2011-1#1)(2011-2#1)
main component of##5##3##(1992-12#1)(2007-12#1)(2008-1#1)(2011-1#1)(2011-2#1)
main component##9##2##(1992-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-1#1)(2011-2#1)
main components of the##2##4##(2008-1#1)(2008-5#1)
main components of##8##3##(1992-12#1)(1993-8#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)
main components were##2##3##(2008-11#1)(2013-1#1)
main components##15##2##(1990-11#1)(1992-12#1)(1993-8#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-5#2)(2011-2#1)(2013-1#1)
main compound##3##2##(2008-10#2)(2013-1#1)
main concern##3##2##(2008-1#1)(2008-10#1)(2009-10#1)
main conclusion is that##2##4##(2008-10#1)(2008-3#1)
main conclusion##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
main contributions##3##2##(1992-10#1)(2008-10#1)(2011-3#1)
main coronary##11##2##(2007-8#3)(2007-9#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-12#1)(2013-8#2)
main data##2##2##(2009-4#2)
main degradation product##2##3##(2008-10#2)
main degradation products##3##3##(2008-10#3)
main degradation##5##2##(2008-10#5)
main determinants##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
main difference##7##2##(2008-10#4)(2008-3#1)(2011-2#1)(2012-3#1)
main difficulties##2##2##(1993-2#1)(2008-10#1)
main directions##2##2##(2008-1#1)(2011-1#1)
main disease##5##2##(2007-8#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
main drawback##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
main driving force##2##3##(2008-10#1)(2008-11#1)
main effect##7##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#1)
main effects and##2##3##(1996-2#1)(2008-10#1)
main effects of##4##3##(2008-10#3)(2008-5#1)
main effects on the##2##4##(2008-10#1)(2008-6#1)
main effects##10##2##(1996-2#1)(2008-10#6)(2008-5#1)(2008-6#1)(2013-1#1)
main emphasis on##3##3##(1991-9#1)(2008-8#2)
main emphasis##4##2##(1991-9#1)(2008-12#1)(2008-8#2)
main etiologic##2##2##(2008-1#1)(2008-4#1)
main factor limiting##2##3##(1997-3#1)(2007-11#1)
main factor##11##2##(1993-12#1)(1994-5#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#2)
main factors affecting the##3##4##(2008-10#2)(2008-6#1)
main factors affecting##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
main factors that influence##2##4##(2008-10#2)
main factors that##4##3##(2008-10#3)(2012-2#1)
main factors##24##2##(1991-6#1)(1994-12#1)(1994-6#1)(1996-1#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
main families##2##2##(2012-2#1)(2012-3#1)
main feature of##2##3##(2011-2#1)(2013-1#1)
main features are##2##3##(2008-2#1)(2008-5#1)
main features of the##7##4##(1990-3#1)(1991-12#1)(1992-1#1)(2007-12#2)(2008-10#1)(2008-3#1)
main features of##14##3##(1990-3#1)(1991-12#1)(1992-1#1)(1992-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
main features##18##2##(1990-3#1)(1991-12#1)(1992-1#1)(1992-5#1)(1996-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)
main feeding##2##2##(2008-7#2)
main finding was##2##3##(1993-12#1)(1995-6#1)
main finding##5##2##(1993-12#1)(1995-6#1)(1996-7#1)(2008-8#1)(2012-12#1)
main findings are##3##3##(2008-6#1)(2008-8#1)(2009-7#1)
main findings##13##2##(1992-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#3)(2012-12#1)
main focus in##2##3##(1997-4#1)(2008-1#1)
main focus is##2##3##(1997-2#1)(2008-11#1)
main focus of##6##3##(1992-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2011-1#2)
main focus on##2##3##(2009-5#1)(2012-6#1)
main focus was##2##3##(2008-11#1)(2009-4#1)
main focus##15##2##(1992-12#1)(1995-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#2)(2012-6#1)
main food##2##2##(2008-10#1)(2008-12#1)
main function##3##2##(2007-12#1)(2008-7#2)
main functional##2##2##(2008-10#2)
main functions##4##2##(1996-5#1)(2007-12#1)(2008-11#1)(2008-4#1)
main generator of##2##3##(2007-8#1)(2008-7#1)
main goal of the##2##4##(1991-3#1)(2008-10#1)
main goal of##7##3##(1991-3#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
main goal was to##3##4##(1992-1#1)(2008-11#1)(2008-12#1)
main goal##14##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
main goals of##3##3##(1994-7#1)(2009-10#1)(2009-6#1)
main goals##4##2##(1994-7#1)(2009-10#1)(2009-6#1)(2012-2#1)
main group elements were tolerated in##2##6##(2008-10#2)
main group elements##3##3##(2008-10#3)
main group##8##2##(1991-9#1)(2008-10#4)(2009-8#1)(2011-1#2)
main groups of##2##3##(1991-6#1)(2013-8#1)
main groups##11##2##(1991-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
main hypothesis##2##2##(1994-2#1)(1997-3#1)
main implications##2##2##(2009-2#1)(2013-1#1)
main indication for##2##3##(2008-1#1)(2008-11#1)
main indication##5##2##(1992-6#1)(2008-1#2)(2008-11#1)(2010-6#1)
main indications for surgery##2##4##(1990-3#1)(1992-9#1)
main indications for##3##3##(1990-3#1)(1992-9#1)(2008-1#1)
main indications##5##2##(1990-3#1)(1991-5#1)(1992-9#1)(1993-3#1)(2008-1#1)
main issue##2##2##(2012-2#2)
main limitation of##4##3##(2008-11#2)(2009-10#1)(2010-5#1)
main limitation##5##2##(2008-11#2)(2009-1#1)(2009-10#1)(2010-5#1)
main manifestations##2##2##(2008-5#1)(2012-2#1)
main mechanism of##4##3##(2007-11#1)(2008-12#1)(2012-3#1)(2013-7#1)
main mechanism##9##2##(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-7#1)
main metabolite##12##2##(1990-11#1)(1993-3#1)(2008-10#10)
main metabolites##7##2##(1990-11#1)(1993-12#1)(1995-11#1)(2008-10#4)
main methods used##2##3##(2007-12#1)(2012-2#1)
main molecular forms##2##3##(1990-12#2)
main objective of the##4##4##(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)
main objective of this work was to##2##7##(2008-5#1)(2013-7#1)
main objective of this work##4##5##(2008-10#1)(2008-5#1)(2009-6#1)(2013-7#1)
main objective of this##8##4##(1992-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2013-7#1)
main objective of##13##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-7#1)
main objectives of##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
main objectives##8##2##(2006-10#1)(2008-10#1)(2008-11#2)(2010-3#1)(2011-2#2)(2013-1#1)
main optical##3##2##(2008-2#1)(2008-3#2)
main outcome measure##4##3##(2007-7#1)(2008-7#1)(2011-2#2)
main outcome##10##2##(1993-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#3)(2013-1#1)
main oxidation##3##2##(2008-10#3)
main parameters##2##2##(2008-10#1)(2008-5#1)
main pathways of##2##3##(1995-12#1)(2009-8#1)
main patterns##2##2##(2008-10#1)(2011-1#1)
main peak##6##2##(1992-3#1)(2008-10#3)(2012-12#1)(2012-2#1)
main peaks##2##2##(2008-10#2)
main periods##2##2##(2008-10#1)(2013-1#1)
main phase transition##7##3##(1990-2#2)(1990-7#2)(2008-10#3)
main phases##2##2##(2012-2#1)(2012-9#1)
main plots##7##2##(2008-10#4)(2008-12#3)
main points##4##2##(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
main principles of##2##3##(2008-11#1)(2008-3#1)
main principles##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
main problem##8##2##(1994-6#1)(1995-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2012-3#1)
main problems##6##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
main product##3##2##(1990-7#1)(2008-10#1)(2008-7#1)
main prognostic##3##2##(1994-6#1)(2011-2#2)
main properties of##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
main protein##4##2##(1995-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
main proximity##2##2##(2008-10#2)
main pulmonary artery##4##3##(1991-5#1)(2007-8#2)(2008-11#1)
main purpose is to##5##4##(1992-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)
main purpose of##11##3##(1997-3#1)(2007-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2012-12#1)(2013-1#1)
main purpose##17##2##(1992-1#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
main purposes##2##2##(1991-2#1)(2013-8#1)
main questions##3##2##(1991-6#1)(2009-4#1)(2011-2#1)
main rationale for the##2##4##(2008-1#1)(2010-6#1)
main reason for the##3##4##(1991-9#1)(1994-6#1)(2009-12#1)
main reason for this##2##4##(2007-11#1)(2008-2#1)
main reason for##9##3##(1991-9#1)(1994-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#1)
main reason##13##2##(1990-6#1)(1991-9#1)(1994-6#1)(2007-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
main reasons for##5##3##(1990-12#1)(1996-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
main reasons##11##2##(1990-12#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
main regions##2##2##(1997-2#1)(2008-10#1)
main research##2##2##(2008-12#1)(2011-2#1)
main result is a##2##4##(2008-2#1)(2008-3#1)
main result is that##2##4##(2008-9#1)(2010-1#1)
main result is##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)
main result of##2##3##(1993-3#1)(2011-1#1)
main result##9##2##(1993-3#1)(2008-2#2)(2008-3#1)(2008-9#2)(2010-1#1)(2011-1#1)(2013-8#1)
main results##10##2##(1991-6#1)(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-2#1)
main risk factors##3##3##(1992-4#1)(1994-2#1)(2013-1#1)
main risk##5##2##(1992-4#1)(1994-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
main role is##2##3##(1997-2#1)(2010-3#1)
main role##5##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-3#1)
main site-specific cancer mortalities##2##4##(2010-1#2)
main source of##12##3##(1992-3#1)(1993-1#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
main source##13##2##(1992-3#1)(1993-1#1)(1994-12#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
main sources of##9##3##(1991-3#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
main stem##4##2##(1990-9#2)(2008-10#1)(2008-3#1)
main steps##2##2##(2008-10#1)(2011-2#1)
main strategies##3##2##(1993-6#1)(2008-11#1)(2009-12#1)
main strategy##2##2##(1993-11#1)(2008-2#1)
main structural##4##2##(1995-2#1)(1997-4#2)(2008-8#1)
main symptom##4##2##(1996-6#1)(2007-8#1)(2008-7#1)(2012-1#1)
main symptoms##4##2##(1996-6#1)(1997-3#1)(2007-4#1)(2013-8#1)
main target##4##2##(1990-5#1)(1992-9#1)(2008-11#2)
main targets##2##2##(1994-6#1)(2008-9#1)
main techniques used to##2##4##(2008-11#1)(2008-7#1)
main techniques##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
main theme of##2##3##(2008-11#1)(2012-3#1)
main theme##6##2##(2007-8#1)(2008-11#1)(2010-10#3)(2012-3#1)
main themes emerged##2##3##(2008-11#1)(2010-10#1)
main themes##5##2##(2008-11#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
main theoretical##2##2##(2008-12#1)(2008-3#1)
main theories of##2##3##(1997-6#1)(2008-11#1)
main thoracic##2##2##(2007-8#1)(2009-3#1)
main topic of##2##3##(2013-1#1)(2013-7#1)
main topic##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
main topics##4##2##(2008-10#2)(2008-5#1)(2012-3#1)
main transcription start##3##3##(1990-5#1)(1991-6#1)(1991-9#1)
main transition##2##2##(2008-10#1)(2008-8#1)
main trunk##3##2##(1994-1#1)(1996-3#1)(2006-12#1)
main types of##6##3##(1996-12#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-12#1)
main vector species##5##3##(2008-10#5)
main vector##7##2##(2008-10#5)(2008-11#1)(2008-5#1)
main ways##2##2##(2008-4#1)(2011-1#1)
main##1220##1##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#3)(1990-3#3)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#5)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#10)(1991-9#6)(1992-1#3)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#6)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#6)(1995-6#3)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#6)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#8)(1997-4#6)(1997-6#3)(1997-7#2)(1997-8#6)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#4)(2007-11#18)(2007-12#14)(2007-4#2)(2007-7#8)(2007-8#20)(2007-9#2)(2008-1#27)(2008-10#227)(2008-11#59)(2008-12#34)(2008-2#25)(2008-3#52)(2008-4#12)(2008-5#55)(2008-6#10)(2008-7#38)(2008-8#35)(2008-9#18)(2009-1#3)(2009-10#10)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#7)(2009-9#2)(2010-1#6)(2010-10#6)(2010-11#5)(2010-12#7)(2010-2#4)(2010-3#9)(2010-4#1)(2010-5#8)(2010-6#4)(2010-7#2)(2010-8#8)(2011-1#25)(2011-2#58)(2011-3#2)(2012-1#5)(2012-12#12)(2012-2#28)(2012-3#13)(2012-6#1)(2012-9#1)(2013-1#41)(2013-7#8)(2013-8#27)
main-chain##2##1##(1994-5#1)(2008-8#1)
mainland China##3##2##(2011-2#1)(2013-8#2)
mainland Mexico##2##2##(2008-8#1)(2008-9#1)
mainland Portugal##2##2##(1997-5#2)
mainland##19##1##(1995-6#1)(1996-6#2)(1997-5#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
mainly a##6##2##(1997-6#1)(2007-11#1)(2008-2#1)(2008-5#2)(2013-1#1)
mainly affects females##2##3##(2008-5#1)(2013-1#1)
mainly affects##5##2##(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
mainly as a result of##3##5##(2008-3#2)(2008-6#1)
mainly as a##6##3##(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-3#1)
mainly as##12##2##(1991-5#1)(1993-11#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)
mainly associated with the##2##4##(2008-10#2)
mainly associated with##5##3##(2008-10#2)(2008-5#1)(2011-3#1)(2012-12#1)
mainly at the level of##2##5##(1993-6#1)(2008-10#1)
mainly at the##8##3##(1993-3#1)(1993-6#1)(1997-3#1)(2008-10#2)(2008-5#2)(2013-7#1)
mainly at##12##2##(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1997-3#1)(2008-10#3)(2008-5#3)(2013-7#1)
mainly attributed to##3##3##(2008-10#2)(2008-6#1)
mainly based on the##3##4##(1996-11#1)(2008-9#1)(2009-5#1)
mainly based on##11##3##(1995-5#1)(1996-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#1)(2009-5#1)
mainly be##3##2##(1990-6#1)(2008-6#1)(2012-12#1)
mainly because it is more sensitive than Coomassie staining##2##9##(2008-2#1)(2008-4#1)
mainly because it##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
mainly because of the##4##4##(1996-6#2)(2008-3#1)(2008-8#1)
mainly because of##10##3##(1995-5#1)(1996-6#2)(1996-9#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-7#1)
mainly because the##2##3##(1992-9#1)(2011-2#1)
mainly because##18##2##(1992-9#1)(1995-5#1)(1996-6#2)(1996-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2011-7#1)
mainly been##3##2##(1995-8#1)(2008-3#1)(2012-12#1)
mainly by initial conditions##3##4##(2008-10#3)
mainly by mu##2##3##(2008-10#2)
mainly by the##5##3##(1992-1#1)(1992-5#1)(1994-8#1)(2008-7#1)(2011-1#1)
mainly by their##3##3##(1995-8#1)(2008-10#1)(2008-4#1)
mainly by##48##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-8#3)(1995-11#1)(1995-6#1)(1995-8#1)(1997-8#2)(2007-11#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
mainly caused by##5##3##(1994-9#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)
mainly centered on the##2##4##(2009-10#1)(2010-7#1)
mainly characterized by##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
mainly children##2##2##(2007-8#1)(2013-1#1)
mainly composed of##5##3##(1992-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
mainly confined to the##2##4##(1993-9#1)(2010-12#1)
mainly confined to##3##3##(1993-9#1)(1994-11#1)(2010-12#1)
mainly consisted of##4##3##(2008-10#2)(2008-11#1)(2012-1#1)
mainly consisting of##3##3##(1991-8#1)(1996-2#1)(2013-8#1)
mainly contains##2##2##(2008-10#1)(2010-6#1)
mainly dependent on conglutinin##2##4##(1992-9#2)
mainly depends on the##2##4##(2008-7#1)(2011-1#1)
mainly detected##2##2##(2008-10#1)(2012-12#1)
mainly determined by the##2##4##(1994-12#1)(2008-8#1)
mainly due to a##7##4##(1994-5#1)(1997-2#1)(2008-10#5)
mainly due to the development of##2##6##(2009-7#1)(2010-8#1)
mainly due to the##14##4##(1990-12#1)(1992-1#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-8#1)(2012-12#1)
mainly due to their##2##4##(2008-5#1)(2010-5#1)
mainly due to##45##3##(1990-12#1)(1991-2#1)(1992-1#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
mainly expressed in##2##3##(1995-5#1)(2008-8#1)
mainly expressed##3##2##(1995-12#1)(1995-5#1)(2008-8#1)
mainly focus on the##2##4##(2009-5#1)(2013-8#1)
mainly focused on the##3##4##(2008-5#1)(2009-5#1)(2010-11#1)
mainly focused on##4##3##(2008-5#1)(2009-5#1)(2010-11#1)(2011-2#1)
mainly for##9##2##(1990-10#1)(1995-11#1)(1995-2#1)(2008-3#1)(2008-8#1)(2011-1#2)(2011-2#2)
mainly found##4##2##(1991-2#1)(1995-3#1)(2008-5#1)(2013-7#1)
mainly from the##6##3##(1992-3#1)(1997-6#1)(2008-10#2)(2008-3#1)(2012-12#1)
mainly from##19##2##(1992-3#1)(1992-9#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
mainly has##2##2##(2008-1#1)(2008-10#1)
mainly in patients with##3##4##(1997-6#1)(2007-11#1)(2008-7#1)
mainly in regions##2##3##(1995-5#1)(2008-3#1)
mainly in the central##2##4##(1992-9#1)(2008-10#1)
mainly in the form of##4##5##(2008-10#2)(2008-5#2)
mainly in the##33##3##(1990-3#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
mainly in their##2##3##(2008-5#1)(2010-2#1)
mainly in young##2##3##(1993-1#1)(2011-2#1)
mainly in##88##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#2)(1995-5#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
mainly interested##2##2##(2011-2#1)(2013-1#1)
mainly involve##2##2##(1994-5#1)(2011-2#1)
mainly involved##3##2##(1995-6#1)(2008-7#1)(2013-8#1)
mainly involving the##4##3##(1997-3#1)(1997-8#1)(2010-2#1)(2013-1#1)
mainly involving##5##2##(1997-3#1)(1997-8#2)(2010-2#1)(2013-1#1)
mainly localized in the##2##4##(1994-12#1)(1994-6#1)
mainly localized in##3##3##(1994-12#1)(1994-6#2)
mainly localized##5##2##(1994-11#1)(1994-12#1)(1994-6#2)(1997-7#1)
mainly located on the##2##4##(2008-9#2)
mainly located##3##2##(1996-5#1)(2008-9#2)
mainly mediated by the##2##4##(2008-11#1)(2008-4#1)
mainly mediated by##5##3##(1995-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)
mainly neutropenia##2##2##(2008-10#2)
mainly observed in##3##3##(2008-10#2)(2013-1#1)
mainly observed##5##2##(2008-10#3)(2008-3#1)(2013-1#1)
mainly of the##2##3##(2008-12#1)(2008-4#1)
mainly of three##2##3##(1992-12#1)(1994-5#1)
mainly of types##2##3##(1997-6#2)
mainly of##25##2##(1990-6#1)(1992-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-6#4)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-8#1)
mainly on the##17##3##(1992-12#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2013-1#1)
mainly on##48##2##(1990-6#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1996-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
mainly owing to good##2##4##(1992-5#1)(2013-8#1)
mainly owing to##3##3##(1992-5#1)(1996-11#1)(2013-8#1)
mainly present in##3##3##(1993-8#1)(1994-2#1)(2008-5#1)
mainly present##4##2##(1993-8#1)(1994-2#1)(2008-5#1)(2011-2#1)
mainly reduced##2##2##(1991-5#1)(2008-10#1)
mainly reflected##3##2##(2008-12#1)(2012-5#1)(2013-1#1)
mainly regulated by##2##3##(2008-4#1)(2009-5#1)
mainly regulated##3##2##(2008-4#1)(2009-5#1)(2013-1#1)
mainly related to the##4##4##(2008-11#2)(2008-3#1)(2008-5#1)
mainly related to##8##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#1)(2010-7#1)(2012-2#1)
mainly responsible for the##2##4##(2008-10#1)(2008-3#1)
mainly responsible for##10##3##(1992-11#1)(1992-6#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#1)
mainly the retina##2##3##(2009-12#2)
mainly the##17##2##(1990-2#1)(1991-9#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-12#2)(2013-1#2)
mainly through the##3##3##(2008-12#1)(2008-5#1)(2010-2#1)
mainly through##10##2##(1993-6#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
mainly to the##11##3##(1992-8#2)(1992-9#1)(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
mainly to##37##2##(1991-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1994-12#1)(1994-8#1)(1996-11#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
mainly trihalomethanes##2##2##(2008-10#2)
mainly under##2##2##(2010-10#1)(2011-1#1)
mainly used to##3##3##(2008-2#1)(2012-2#1)(2013-1#1)
mainly used##6##2##(1991-5#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
mainly via##2##2##(2008-7#1)(2008-8#1)
mainly when##2##2##(1992-5#1)(2008-10#1)
mainly with##6##2##(1992-12#1)(1994-6#1)(2008-10#1)(2008-7#2)(2011-1#1)
mainly##771##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#5)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#7)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#5)(1992-3#2)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#7)(1993-1#2)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#5)(1994-8#5)(1994-9#5)(1995-11#3)(1995-12#7)(1995-2#2)(1995-3#1)(1995-5#6)(1995-6#5)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#9)(1997-7#6)(1997-8#9)(2007-11#10)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#9)(2008-10#136)(2008-11#22)(2008-12#9)(2008-2#8)(2008-3#27)(2008-4#11)(2008-5#47)(2008-6#6)(2008-7#46)(2008-8#23)(2008-9#15)(2009-10#5)(2009-12#6)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#8)(2010-6#4)(2010-7#3)(2010-8#6)(2011-1#15)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#10)(2012-2#13)(2012-3#8)(2012-5#1)(2013-1#30)(2013-7#4)(2013-8#16)
mainshock##2##1##(1996-4#2)
mainstay of the##2##3##(2008-12#1)(2010-1#1)
mainstay of therapy for##3##4##(2008-8#1)(2010-12#2)
mainstay of treatment in##3##4##(2008-11#1)(2010-6#1)(2013-1#1)
mainstay of treatment##12##3##(2008-11#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#2)
mainstay of##29##2##(1995-5#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
mainstay##34##1##(1995-5#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
mainstream society##2##2##(2008-11#1)(2010-8#1)
mainstream##28##1##(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
maintain a high index of suspicion##2##6##(2006-10#1)(2011-2#1)
maintain a high level of##2##5##(1991-6#1)(2012-2#1)
maintain a high##4##3##(1991-6#1)(2006-10#1)(2011-2#1)(2012-2#1)
maintain a large##2##3##(2008-4#1)(2008-8#1)
maintain a projection to the lumbar spinal cord##2##8##(1990-5#2)
maintain a##35##2##(1990-4#1)(1990-5#2)(1991-1#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
maintain abstinence##2##2##(2010-2#2)
maintain accurate##3##2##(1992-11#1)(2007-12#1)(2008-7#1)
maintain an##8##2##(1993-1#1)(1995-2#2)(2006-10#1)(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
maintain and##3##2##(2007-12#1)(2010-10#2)
maintain appropriate##2##2##(1997-7#1)(2008-9#1)
maintain blood glucose##2##3##(2008-3#1)(2008-7#1)
maintain clinical credibility##2##3##(2008-11#2)
maintain clinical##3##2##(1997-1#1)(2008-11#2)
maintain excessive##2##2##(1994-8#1)(2008-10#1)
maintain good##2##2##(2013-1#2)
maintain high quality patient care##2##5##(1994-1#1)(1997-2#1)
maintain high##3##2##(1994-1#1)(1997-2#1)(2008-10#1)
maintain higher##2##2##(1991-12#1)(2013-1#1)
maintain homeostasis##4##2##(2009-12#1)(2010-1#1)(2013-1#1)(2013-8#1)
maintain long-term##4##2##(2007-7#1)(2008-11#1)(2013-1#1)(2013-8#1)
maintain or increase##2##3##(1993-2#1)(1996-1#1)
maintain or##4##2##(1993-2#1)(1995-3#1)(1996-1#1)(2010-10#1)
maintain quality of life for##2##5##(2008-11#1)(2010-12#1)
maintain quality of##3##3##(2008-11#2)(2010-12#1)
maintain self-administration behavior in monkeys##2##5##(2008-4#1)(2012-3#1)
maintain the##68##2##(1990-10#1)(1990-11#1)(1990-3#1)(1992-10#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
maintain their identity##2##3##(2009-6#1)(2012-2#1)
maintain their##9##2##(1990-5#1)(1991-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-1#1)
maintain this##2##2##(1995-2#1)(2013-1#1)
maintain##299##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1991-1#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#2)(2007-10#3)(2007-11#4)(2007-12#6)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#19)(2008-11#21)(2008-12#2)(2008-2#4)(2008-3#12)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#12)(2013-7#4)(2013-8#5)
maintained a normal range##2##4##(1997-6#2)
maintained a normal##3##3##(1997-6#2)(2010-11#1)
maintained a##14##2##(1994-8#2)(1995-2#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#2)
maintained after##4##2##(1991-2#1)(1994-1#1)(2008-10#1)(2009-6#1)
maintained almost constant##3##3##(1997-6#1)(2007-3#1)(2008-11#1)
maintained and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
maintained as##15##2##(1995-2#2)(1997-4#3)(2008-4#2)(2008-6#2)(2008-9#3)(2009-7#1)(2011-2#1)(2012-2#1)
maintained at +0##2##3##(2008-10#2)
maintained at 30 degrees C##2##5##(2008-10#2)
maintained at 37 degrees C##3##5##(1995-11#1)(1996-5#1)(2008-11#1)
maintained at 37 degrees##4##4##(1995-11#1)(1996-5#1)(2008-11#1)(2010-3#1)
maintained at a##3##3##(1993-12#1)(1994-5#1)(2008-11#1)
maintained at different temperatures##2##4##(2008-10#1)(2008-6#1)
maintained at follow-up##2##3##(2007-12#2)
maintained at the Metropolitan Zoo of Santiago##2##7##(1997-6#1)(2008-5#1)
maintained at the same level##2##5##(2008-7#1)(2012-12#1)
maintained at the##7##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
maintained at##50##2##(1993-12#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-6#2)(2007-11#1)(2007-12#4)(2008-10#15)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
maintained between the##2##3##(1996-2#1)(2008-10#1)
maintained between##6##2##(1996-2#1)(2008-1#1)(2008-10#3)(2012-2#1)
maintained by the##3##3##(1994-9#1)(1997-6#1)(2013-1#1)
maintained by##29##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-7#1)(1993-6#1)(1994-9#1)(1996-12#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#3)(2013-7#1)
maintained constant##3##2##(2008-10#2)(2008-7#1)
maintained continuously##2##2##(2008-10#2)
maintained during the##2##3##(2008-6#1)(2011-2#1)
maintained during##8##2##(1994-9#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#3)
maintained even after##3##3##(2008-11#1)(2008-3#1)(2009-12#1)
maintained even##4##2##(1990-8#1)(2008-11#1)(2008-3#1)(2009-12#1)
maintained for 12##2##3##(2008-11#1)(2008-3#1)
maintained for 3##2##3##(1990-6#1)(2008-5#1)
maintained for at least##2##4##(1995-12#1)(2007-11#1)
maintained for over##2##3##(1995-12#1)(2008-11#1)
maintained for up to##3##4##(1995-2#1)(2009-12#1)(2010-9#1)
maintained for##34##2##(1990-6#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#4)(2011-3#1)
maintained high##2##2##(2008-10#1)(2008-11#1)
maintained in UF##2##3##(1994-2#2)
maintained in a##7##3##(1991-12#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-9#1)(2011-2#2)
maintained in the laboratory##4##4##(2008-10#1)(2008-4#2)(2008-9#1)
maintained in the##26##3##(1990-5#1)(1994-3#1)(1997-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-7#1)(2012-12#1)(2013-1#1)
maintained in##66##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#3)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
maintained its##3##2##(2008-10#1)(2008-6#1)(2010-8#1)
maintained normal##2##2##(2011-1#1)(2012-3#1)
maintained on collagen##3##3##(1994-8#3)
maintained on the##2##3##(1991-12#1)(2008-3#1)
maintained on##20##2##(1991-12#1)(1994-8#5)(1997-4#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#2)(2010-8#1)
maintained or##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
maintained over the##4##3##(1991-2#1)(1993-6#1)(2008-5#1)(2010-11#1)
maintained over##8##2##(1991-2#1)(1993-6#1)(2007-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
maintained that##2##2##(1991-6#1)(1997-5#1)
maintained the ability to##2##4##(1993-8#1)(2012-2#1)
maintained the features of simplicity##2##5##(2008-10#2)
maintained the##14##2##(1992-12#1)(1993-8#1)(1996-1#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
maintained their##13##2##(1990-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
maintained through##4##2##(2006-12#1)(2008-11#1)(2008-8#1)(2009-9#1)
maintained throughout the##3##3##(2007-12#1)(2008-11#1)(2009-2#1)
maintained throughout##6##2##(1994-12#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-11#1)(2013-8#1)
maintained to##4##2##(1997-4#3)(2008-10#1)
maintained under##10##2##(1991-2#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-7#1)
maintained until##2##2##(2008-6#1)(2010-4#1)
maintained up to##2##3##(2008-10#1)(2008-8#1)
maintained viability##2##2##(2007-8#2)
maintained when##2##2##(2008-11#1)(2008-8#1)
maintained with##9##2##(1996-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-7#3)(2011-2#1)
maintained within a##2##3##(1996-12#1)(2011-2#1)
maintained within##4##2##(1992-10#1)(1996-12#1)(2008-2#1)(2011-2#1)
maintained without##5##2##(2006-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
maintained##475##1##(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#3)(1995-11#3)(1995-12#6)(1995-2#7)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#7)(1997-5#1)(1997-6#6)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#8)(2008-10#71)(2008-11#44)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#9)(2008-5#13)(2008-6#13)(2008-7#15)(2008-8#15)(2008-9#17)(2009-10#3)(2009-12#5)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#13)(2013-7#2)(2013-8#7)
maintaining a constant##2##3##(2008-10#1)(2008-2#1)
maintaining a healthy##2##3##(2008-8#1)(2011-2#1)
maintaining a high##3##3##(2012-2#1)(2012-3#1)(2012-6#1)
maintaining a##32##2##(1992-3#1)(1993-3#1)(1995-12#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-6#1)
maintaining confidentiality##2##2##(1993-3#1)(2012-3#1)
maintaining constant##3##2##(2007-11#1)(2008-7#1)(2008-9#1)
maintaining diversity##2##2##(2008-8#1)(2013-1#1)
maintaining dosage##2##2##(2011-1#2)
maintaining dose##2##2##(1994-12#1)(2011-1#1)
maintaining efficacy##2##2##(1991-9#1)(2008-7#1)
maintaining factor##2##2##(2008-8#2)
maintaining fluid##2##2##(1997-3#1)(2008-7#1)
maintaining genetic##2##2##(2008-8#1)(2009-2#1)
maintaining good##4##2##(2007-12#1)(2008-10#2)(2011-2#1)
maintaining health##3##2##(2008-10#2)(2011-2#1)
maintaining high##3##2##(2008-10#3)
maintaining or##2##2##(2008-11#1)(2010-11#1)
maintaining stability##2##2##(2008-11#1)(2011-2#1)
maintaining the cold chain##2##4##(1994-9#2)
maintaining the high##2##3##(2008-10#1)(2008-8#1)
maintaining the homeostasis of the##2##5##(2009-10#1)(2013-8#1)
maintaining the integrity of the##2##5##(1990-2#1)(2008-10#1)
maintaining the integrity of##3##4##(1990-2#1)(2008-10#1)(2008-9#1)
maintaining the quality of##3##4##(1996-2#1)(2008-3#1)(2013-8#1)
maintaining the##44##2##(1990-2#1)(1990-5#1)(1990-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-12#2)(1994-9#2)(1995-6#2)(1995-9#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#4)(2009-10#2)(2009-8#1)(2010-9#1)(2012-2#2)(2013-8#2)
maintaining their##6##2##(1991-11#1)(1991-12#1)(1996-7#1)(2008-10#1)(2010-10#1)(2012-8#1)
maintaining these##2##2##(2008-4#1)(2012-1#1)
maintaining##264##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#20)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#14)(2008-9#11)(2009-10#3)(2009-11#2)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#14)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#12)(2012-3#5)(2012-6#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
maintains its##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
maintains that##3##2##(1992-1#1)(1997-2#1)(2011-2#1)
maintains the##11##2##(1991-6#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
maintains##44##1##(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
maintenance HD##6##2##(2007-7#6)
maintenance and differentiation##2##3##(2008-11#2)
maintenance and repair##3##3##(2008-7#2)(2012-12#1)
maintenance and restoration of##2##4##(1995-3#2)
maintenance and that they##2##4##(2008-10#1)(2009-8#1)
maintenance and##25##2##(1995-3#2)(1996-2#1)(1996-9#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-5#1)(2008-7#5)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
maintenance by##2##2##(2008-11#1)(2008-6#1)
maintenance can##2##2##(1992-2#1)(2011-1#1)
maintenance care of dental implants##2##5##(2013-1#2)
maintenance consumption##2##2##(1990-9#2)
maintenance dose##2##2##(1991-8#1)(2012-12#1)
maintenance energy##2##2##(2008-6#1)(2008-7#1)
maintenance hemodialysis##11##2##(1991-11#1)(2007-7#4)(2008-1#6)
maintenance in##4##2##(1997-3#1)(1997-7#1)(2008-8#1)(2009-9#1)
maintenance is##4##2##(1996-2#1)(2007-7#1)(2008-4#2)
maintenance metabolism##2##2##(2008-7#2)
maintenance might##2##2##(2008-12#1)(2012-12#1)
maintenance of LTP##3##3##(1997-2#2)(2008-7#1)
maintenance of Mycobacterium tuberculosis##2##4##(2008-9#2)
maintenance of Mycobacterium##3##3##(2008-9#3)
maintenance of a##15##3##(1990-3#1)(1992-1#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
maintenance of bone##2##3##(1997-1#1)(2008-4#1)
maintenance of cell##4##3##(2008-11#2)(2008-9#1)(2011-2#1)
maintenance of continuous##2##3##(2008-7#1)(2011-2#1)
maintenance of function and quality of##2##6##(2009-12#2)
maintenance of genetic##3##3##(1996-6#1)(1996-8#1)(2013-1#1)
maintenance of glucose homeostasis##3##4##(1991-7#1)(2008-4#2)
maintenance of glucose##4##3##(1991-7#1)(2008-1#1)(2008-4#2)
maintenance of high##4##3##(1995-11#1)(2008-11#1)(2008-8#1)(2013-1#1)
maintenance of life##2##3##(2010-9#1)(2012-2#1)
maintenance of liver-specific functions in##2##5##(2008-11#1)(2008-7#1)
maintenance of oral##2##3##(2008-11#1)(2008-5#1)
maintenance of persistent pain##3##4##(2008-7#3)
maintenance of pregnancy##2##3##(1995-12#1)(2012-3#1)
maintenance of sinus rhythm##2##4##(2008-7#1)(2010-12#1)
maintenance of sodium channel##2##4##(2008-7#2)
maintenance of such##2##3##(2008-10#1)(2012-1#1)
maintenance of telomere##2##3##(2008-11#1)(2013-1#1)
maintenance of telomeres and##2##4##(2008-11#1)(2011-2#1)
maintenance of the##26##3##(1990-7#1)(1990-8#1)(1991-2#2)(1992-9#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-2#2)
maintenance of thermal hyperalgesia##3##4##(1995-12#2)(1996-5#1)
maintenance of this##2##3##(1990-11#1)(1996-5#1)
maintenance of vascular##2##3##(2008-1#1)(2009-8#1)
maintenance of##212##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#2)(2007-10#1)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#20)(2008-12#1)(2008-2#1)(2008-4#11)(2008-5#7)(2008-6#4)(2008-7#22)(2008-8#6)(2008-9#20)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#2)(2009-6#3)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#10)(2013-7#4)(2013-8#2)
maintenance organization (S/HMO)##3##3##(1992-1#1)(1995-2#1)(1997-1#1)
maintenance organization and##2##3##(1992-2#1)(1993-12#1)
maintenance organization##36##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-12#6)(1994-3#4)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#1)(2008-11#1)
maintenance organizations##30##2##(1991-1#2)(1991-3#7)(1993-1#1)(1993-12#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-4#1)(2011-1#1)(2011-2#1)
maintenance patients##2##2##(1991-1#1)(2012-2#1)
maintenance period##2##2##(2008-11#1)(2008-3#1)
maintenance phase##4##2##(1996-11#1)(1997-2#1)(2008-1#1)(2013-8#1)
maintenance program##5##2##(2008-10#2)(2010-10#3)
maintenance therapy with##3##3##(1991-2#1)(2011-2#1)(2011-3#1)
maintenance therapy##5##2##(1991-2#1)(2008-4#1)(2011-2#2)(2011-3#1)
maintenance to##2##2##(2008-7#1)(2011-2#1)
maintenance treatment##8##2##(1993-8#1)(1996-3#3)(1997-3#1)(2008-11#1)(2008-6#1)(2010-12#1)
maintenance work##2##2##(1991-12#1)(2009-10#1)
maintenance workers##4##2##(1991-12#4)
maintenance##505##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#8)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#9)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#3)(1992-2#3)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#7)(1994-2#1)(1994-3#6)(1994-5#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#12)(1996-3#6)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#7)(1997-3#4)(1997-4#1)(1997-7#4)(2007-10#1)(2007-7#13)(2007-8#4)(2008-1#13)(2008-10#13)(2008-11#39)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#17)(2008-5#9)(2008-6#10)(2008-7#38)(2008-8#8)(2008-9#28)(2009-10#4)(2009-11#4)(2009-12#4)(2009-3#4)(2009-4#1)(2009-6#5)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#12)(2012-3#6)(2013-1#13)(2013-7#5)(2013-8#9)
mais##4##1##(2011-2#1)(2013-1#3)
maitake##2##1##(1995-9#1)(2008-10#1)
maize (Zea mays L##6##4##(2008-10#1)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#1)
maize (Zea mays##8##3##(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
maize (Zea mays)##3##3##(2008-10#2)(2012-2#1)
maize (Zea##11##2##(2008-10#3)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#2)(2012-3#1)
maize AChE##3##2##(2009-8#3)
maize alcohol dehydrogenase##2##3##(1991-10#2)
maize also##2##2##(2008-10#2)
maize and##8##2##(1990-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2011-2#1)(2012-3#1)
maize cultivars##3##2##(2008-10#1)(2008-12#2)
maize dwarf mosaic##3##3##(2008-10#1)(2008-9#2)
maize ears##5##2##(2008-10#5)
maize embryo sacs##2##3##(2008-11#2)
maize field##2##2##(2008-10#2)
maize genome##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
maize genotype##3##2##(2008-10#2)(2011-2#1)
maize genotypes have been identified##2##5##(2008-10#2)
maize genotypes##16##2##(2008-10#10)(2008-5#1)(2011-2#5)
maize grain##2##2##(2008-10#1)(2012-2#1)
maize grown in##2##3##(2008-10#1)(2008-12#1)
maize hybrid##2##2##(2008-10#2)
maize in##6##2##(2008-10#3)(2008-12#1)(2008-9#1)(2012-2#1)
maize inbred##5##2##(2008-10#4)(2012-3#1)
maize inbreds##2##2##(2008-10#2)
maize kernel##2##2##(2008-10#2)
maize kernels##6##2##(2008-10#5)(2008-5#1)
maize leaves showing chlorotic streaks##2##5##(2008-10#2)
maize leaves showing##3##3##(2008-10#3)
maize leaves##11##2##(1994-8#1)(2008-10#10)
maize lines##5##2##(2008-10#5)
maize maltose##2##2##(2008-6#2)
maize or##2##2##(2008-10#2)
maize plants##7##2##(2008-10#4)(2008-8#3)
maize recombinant inbred##2##3##(2008-10#2)
maize residue on the##2##4##(2008-10#2)
maize residue##4##2##(2008-10#4)
maize seedlings##4##2##(2008-10#2)(2009-8#2)
maize stalks##2##2##(2008-10#2)
maize storage##2##2##(1991-12#1)(1995-8#1)
maize that##2##2##(2008-12#2)
maize tissues##2##2##(1995-8#1)(2008-10#1)
maize to##3##2##(2008-10#1)(2012-2#2)
maize was##4##2##(1995-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
maize were##2##2##(2008-10#1)(2008-12#1)
maize with other countries##2##4##(2008-12#2)
maize with##5##2##(2008-10#2)(2008-12#2)(2008-5#1)
maize yield and LAI losses##2##5##(2008-12#2)
maize yield in##3##3##(2008-12#3)
maize yield##8##2##(2008-12#8)
maize##308##1##(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#1)(1994-6#2)(1994-8#3)(1995-2#3)(1995-6#1)(1995-8#3)(1997-4#2)(2008-10#160)(2008-11#3)(2008-12#32)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#15)(2008-9#10)(2009-10#9)(2009-8#10)(2011-2#12)(2012-2#17)(2012-3#7)(2013-8#3)
maize-infecting isolates##2##2##(2008-10#2)
maize-specific##2##1##(2008-8#2)
maize-type##3##1##(2008-10#3)
major AT loci##2##3##(1995-6#2)
major AT##3##2##(1995-6#3)
major NORs##6##2##(1993-12#6)
major QTL on##2##3##(2008-10#1)(2012-3#1)
major QTL##6##2##(2008-10#4)(2008-8#1)(2012-3#1)
major R##2##2##(2008-10#2)
major T cell##2##3##(1991-9#1)(1997-8#1)
major U##3##2##(1995-3#1)(2008-10#1)(2009-7#1)
major abdominal##5##2##(1993-12#2)(2009-12#2)(2009-5#1)
major achievements and future potential##2##5##(1993-12#2)
major achievements##3##2##(1993-12#2)(2012-12#1)
major active ingredient##2##3##(2008-5#1)(2012-3#1)
major active##4##2##(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)
major activity##3##2##(1996-12#1)(2008-4#1)(2012-12#1)
major advances have been made in##2##6##(2011-1#1)(2013-1#1)
major advances have been##3##4##(2006-10#1)(2011-1#1)(2013-1#1)
major advances##5##2##(2006-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
major advantage of this##2##4##(2007-12#1)(2008-10#1)
major advantage of##8##3##(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2012-12#1)
major advantage##11##2##(1992-9#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2012-12#1)
major advantages##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
major adverse cardiac events##3##4##(2008-11#2)(2010-12#1)
major adverse events##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
major adverse##8##2##(2008-11#2)(2008-8#2)(2009-12#1)(2010-12#2)(2011-2#1)
major affective disorders##2##3##(1992-2#2)
major aim of##2##3##(2008-12#1)(2010-8#1)
major alkaloids##3##2##(2008-10#2)(2012-3#1)
major alleles##2##2##(1996-6#1)(2008-5#1)
major and minor complications##2##4##(1990-9#1)(2009-3#1)
major and minor##9##3##(1990-12#1)(1990-9#1)(2008-10#4)(2008-4#1)(2009-3#1)(2013-1#1)
major and##16##2##(1990-12#1)(1990-9#1)(1993-11#1)(1997-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
major antigen-presenting##2##2##(2008-10#1)(2010-5#1)
major antigenic##2##2##(1995-2#1)(2008-5#1)
major application of##2##3##(2008-1#1)(2008-4#1)
major application##3##2##(1995-8#1)(2008-1#1)(2008-4#1)
major approach##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
major approaches##4##2##(1994-9#1)(2008-10#1)(2008-4#1)(2011-1#1)
major areas of##4##3##(1993-3#1)(2008-10#1)(2009-10#1)(2013-8#1)
major areas##7##2##(1990-12#1)(1993-3#1)(1994-2#1)(2008-10#1)(2009-10#1)(2011-1#1)(2013-8#1)
major aromatic##2##2##(2008-10#2)
major arsenic##3##2##(2008-10#3)
major ascospore showers##2##3##(2008-10#2)
major aspects of##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
major axis##4##2##(2008-2#2)(2008-3#1)(2008-5#1)
major bands##2##2##(1993-11#1)(2009-11#1)
major barrier to the##2##4##(1994-1#1)(2010-8#1)
major barrier to##4##3##(1994-1#1)(1997-1#1)(2008-1#1)(2010-8#1)
major barrier##5##2##(1994-1#1)(1997-1#1)(2008-1#1)(2010-11#1)(2010-8#1)
major barriers for##2##3##(1991-9#1)(2010-5#1)
major barriers to##2##3##(2008-11#2)
major barriers##4##2##(1991-9#1)(2008-11#2)(2010-5#1)
major beta##2##2##(1991-11#1)(2011-2#1)
major bleeding##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
major bottleneck##2##2##(2008-4#1)(2011-1#1)
major bottlenecks for##2##3##(2008-7#1)(2012-3#1)
major brain##2##2##(2012-3#2)
major branches##2##2##(1997-8#1)(2008-10#1)
major capsid protein gene##2##4##(2009-5#2)
major capsid protein##4##3##(1994-8#1)(2008-1#1)(2009-5#2)
major capsid##6##2##(1994-12#1)(1994-8#1)(2008-1#1)(2008-5#1)(2009-5#2)
major carbon##2##2##(2008-10#1)(2011-2#1)
major cardiovascular events##4##3##(2008-3#2)(2010-1#1)(2013-8#1)
major cardiovascular surgery##2##3##(2008-8#2)
major cardiovascular##9##2##(1990-12#1)(1994-7#1)(2008-3#2)(2008-8#2)(2010-1#1)(2011-2#1)(2013-8#1)
major categories##3##2##(1996-9#1)(2008-11#1)(2008-12#1)
major category of##2##3##(2008-11#2)
major cause for##3##3##(2008-11#1)(2008-3#1)(2010-3#1)
major cause of blindness in##2##5##(2011-1#1)(2011-2#1)
major cause of death in##4##5##(2008-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
major cause of death##7##4##(2008-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
major cause of##60##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
major cause##64##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
major causes for##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
major causes of morbidity and mortality##2##6##(2008-10#1)(2010-11#1)
major causes of morbidity and##3##5##(1995-9#1)(2008-10#1)(2010-11#1)
major causes of##13##3##(1990-8#1)(1995-9#1)(1997-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#1)
major causes##18##2##(1990-6#1)(1990-8#1)(1992-9#1)(1995-9#1)(1997-4#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#1)
major cell##5##2##(1994-11#1)(1995-6#1)(1997-3#1)(2008-5#1)(2008-7#1)
major cellular events##2##3##(2008-12#1)(2011-2#1)
major cellular##7##2##(1992-11#1)(1995-8#1)(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
major centres##2##2##(1997-5#1)(2011-1#1)
major challenge facing##2##3##(1996-6#1)(2012-3#1)
major challenge for the##3##4##(1991-1#1)(2008-7#1)(2010-5#1)
major challenge for##5##3##(1991-1#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-5#1)
major challenge##17##2##(1991-1#1)(1996-11#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#2)
major challenges in##4##3##(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
major challenges##8##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
major change in##3##3##(1995-3#1)(2008-10#2)
major change##7##2##(1991-12#1)(1991-2#1)(1995-3#1)(1997-3#1)(2008-10#2)(2010-6#1)
major changes in the##2##4##(1991-3#1)(1994-10#1)
major changes in##5##3##(1991-3#2)(1994-10#1)(1996-3#1)(2009-10#1)
major changes##9##2##(1991-3#2)(1994-10#1)(1995-1#1)(1996-3#1)(1996-6#1)(2007-8#1)(2009-10#1)(2012-1#1)
major characteristics##4##2##(1994-8#1)(2008-10#2)(2008-4#1)
major cities##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
major clades##2##2##(2008-10#1)(2013-8#1)
major classes of##10##3##(1995-11#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2012-3#1)
major classes##12##2##(1994-2#1)(1995-11#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2009-10#1)(2012-3#1)
major clinical##8##2##(1994-1#1)(1994-7#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)
major cluster##3##2##(2008-10#2)(2008-5#1)
major clusters##5##2##(2007-12#1)(2008-10#4)
major complex##2##2##(1992-6#1)(1995-2#1)
major complexes##2##2##(1995-2#1)(2008-10#1)
major complication of##2##3##(2009-10#1)(2012-12#1)
major complication rate##2##3##(2010-3#1)(2012-2#1)
major complication##6##2##(2007-12#1)(2008-1#1)(2009-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
major complications associated with##2##4##(2007-12#1)(2011-2#1)
major complications occurred##2##3##(1991-2#1)(2007-7#1)
major complications##21##2##(1990-3#1)(1991-2#1)(1992-5#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
major component of the##11##4##(1990-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
major component of##26##3##(1990-9#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-4#1)(2013-1#1)
major component##37##2##(1990-7#1)(1990-9#1)(1992-3#2)(1992-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-5#1)(2013-1#1)
major components in illicit heroin##2##5##(2012-2#2)
major components of the##5##4##(1990-7#1)(1996-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
major components of##12##3##(1990-7#1)(1996-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#1)(2011-3#2)(2012-3#1)
major components##20##2##(1990-7#1)(1996-1#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-6#1)(2009-5#1)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#1)(2013-8#1)
major compound of the##2##4##(2008-10#1)(2013-1#1)
major compound##5##2##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
major compounds##2##2##(2008-12#1)(2008-5#1)
major concepts##2##2##(1992-12#1)(1996-2#1)
major concern for##2##3##(2008-5#1)(2008-7#1)
major concern in the##2##4##(2011-1#1)(2012-3#1)
major concern in##8##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-1#1)(2012-3#1)
major concern is that##2##4##(2008-10#1)(2008-8#1)
major concern##19##2##(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
major concerns##2##2##(2008-1#1)(2008-10#1)
major constituent of##5##3##(1990-8#1)(1992-12#1)(1995-6#1)(2009-11#1)(2012-2#1)
major constituent##6##2##(1990-8#1)(1992-12#1)(1995-3#1)(1995-6#1)(2009-11#1)(2012-2#1)
major constituents in##2##3##(1990-8#1)(2008-10#1)
major constituents of##5##3##(2008-10#2)(2008-12#2)(2009-8#1)
major constituents##10##2##(1990-8#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2009-8#1)
major contaminant of##2##3##(1997-3#1)(2008-7#1)
major contribution to the##4##4##(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
major contribution to##5##3##(2007-5#1)(2008-10#2)(2008-2#1)(2008-7#1)
major contributions##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
major contributor to the##5##4##(1994-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-12#1)
major contributor to##8##3##(1994-8#1)(2008-1#2)(2008-2#1)(2008-8#1)(2010-12#1)(2011-9#1)(2012-12#1)
major contributor##9##2##(1994-8#1)(2008-1#3)(2008-2#1)(2008-8#1)(2010-12#1)(2011-9#1)(2012-12#1)
major criteria##3##2##(1997-8#2)(2011-2#1)
major crops##2##2##(2008-10#1)(2011-10#1)
major cytoskeletal##2##2##(2009-10#1)(2009-8#1)
major damage to the anterior cruciate ligament##2##7##(2007-8#2)
major defects##2##2##(1996-12#1)(2011-3#1)
major degradation product of##2##4##(2008-10#2)
major degradation product##3##3##(2008-10#3)
major degradation##5##2##(2008-10#5)
major depression and bipolar disorder##2##5##(2008-7#2)
major depression and##3##3##(1995-11#1)(2008-7#2)
major depression##31##2##(1995-11#2)(1995-5#1)(1996-7#7)(2007-10#1)(2008-11#1)(2008-6#4)(2008-7#3)(2009-8#3)(2009-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-8#1)
major depressive disorder (MDD)##4##4##(2008-4#1)(2009-9#1)(2011-2#1)(2012-3#1)
major depressive disorder and##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
major depressive disorder were##2##4##(2011-2#2)
major depressive disorder##17##3##(1996-7#2)(2008-4#2)(2009-9#2)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-7#2)
major depressive episode##2##3##(2010-2#1)(2013-1#1)
major depressive symptoms##2##3##(2013-8#2)
major depressive##24##2##(1996-7#2)(1997-5#1)(2008-4#2)(2009-9#2)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
major determinant of##12##3##(1993-11#1)(1994-6#1)(1994-8#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2013-1#1)
major determinant##13##2##(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2013-1#1)
major determinants of##4##3##(1997-9#1)(2008-10#1)(2008-5#1)(2010-6#1)
major detrimental##2##2##(1997-3#1)(2007-12#1)
major developmental##2##2##(2007-2#1)(2011-2#1)
major developments in##2##3##(2012-2#1)(2013-8#1)
major developments##6##2##(1992-12#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-8#1)
major difference##2##2##(2008-10#2)
major differences between##2##3##(1990-11#1)(2011-2#1)
major differences in the##3##4##(1996-9#1)(1997-2#1)(2008-10#1)
major differences in##6##3##(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2010-6#1)
major differences##11##2##(1990-11#1)(1992-6#1)(1995-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
major difficulty##2##2##(1996-2#1)(2007-12#1)
major disability##2##2##(1991-11#1)(2007-10#1)
major disabling conditions##2##3##(1994-1#1)(2010-12#1)
major disadvantage for##2##3##(2008-11#1)(2008-7#1)
major disease##9##2##(1994-5#1)(2008-10#7)(2008-7#1)
major diseases##2##2##(2008-10#1)(2008-7#1)
major drawbacks##2##2##(2008-11#1)(2011-2#1)
major economic impact##2##3##(1992-6#1)(2008-7#1)
major economic##5##2##(1992-6#1)(1997-3#1)(2008-10#2)(2008-7#1)
major effect on##3##3##(2008-9#2)(2013-1#1)
major effect##6##2##(1990-5#1)(2008-10#2)(2008-9#2)(2013-1#1)
major effects on##3##3##(1994-12#1)(1995-12#1)(2008-4#1)
major effects##5##2##(1994-12#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-4#1)
major efforts##2##2##(1994-5#1)(2009-10#1)
major elements##6##2##(1995-6#1)(2008-10#3)(2008-6#1)(2008-8#1)
major emphasis##3##2##(1990-11#1)(1991-6#1)(2013-8#1)
major endogenous##3##2##(1994-12#1)(1994-5#1)(2008-7#1)
major energy##2##2##(2008-11#1)(2008-7#1)
major environmental factor##2##3##(2008-12#1)(2011-2#1)
major environmental##4##2##(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
major ethnic##2##2##(2009-10#2)
major evolutionary##2##2##(2008-10#1)(2013-1#1)
major extracellular proteins of##2##4##(1995-2#2)
major extracellular##3##2##(1995-2#2)(2008-4#1)
major factor contributing to##2##4##(2008-7#1)(2008-9#1)
major factor in causing##2##4##(2007-11#1)(2008-10#1)
major factor in##11##3##(1992-1#1)(1993-9#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)
major factor##26##2##(1991-9#1)(1992-1#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-2#1)(2010-5#1)(2011-2#2)
major factors##11##2##(1994-5#1)(1995-12#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-3#1)(2012-2#1)(2012-3#1)
major fatty##3##2##(2008-10#2)(2013-1#1)
major feature of##2##3##(1990-2#1)(2008-7#1)
major feature##3##2##(1990-2#1)(2008-3#1)(2008-7#1)
major features of##3##3##(1991-9#1)(2008-3#1)(2010-5#1)
major features##5##2##(1991-9#1)(1994-12#1)(2008-3#1)(2008-9#1)(2010-5#1)
major field of##3##3##(1995-6#1)(1997-2#1)(2008-7#1)
major finding of##2##3##(2009-7#1)(2011-1#1)
major finding##3##2##(2008-1#1)(2009-7#1)(2011-1#1)
major findings of##2##3##(1995-9#1)(2008-5#1)
major findings##5##2##(1995-9#1)(1996-4#1)(1997-3#1)(2008-5#1)(2011-1#1)
major fishing##2##2##(2011-2#1)(2013-7#1)
major focus has been##2##4##(1996-2#1)(2012-2#1)
major focus is on##4##4##(2008-3#1)(2008-5#3)
major focus is##5##3##(1997-3#1)(2008-3#1)(2008-5#3)
major focus of research##2##4##(1997-1#1)(2008-9#1)
major focus of##8##3##(1995-1#1)(1997-1#1)(2007-2#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
major focus##17##2##(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
major food##3##2##(1994-3#1)(2011-2#2)
major force##2##2##(1991-1#1)(2008-10#1)
major form of##6##3##(1990-7#1)(1993-5#1)(2008-10#2)(2008-11#1)(2008-4#1)
major form##8##2##(1990-2#1)(1990-7#1)(1992-6#1)(1993-5#1)(2008-10#2)(2008-11#1)(2008-4#1)
major fraction##4##2##(1990-4#1)(1994-2#1)(2007-11#1)(2008-10#1)
major function of##2##3##(1990-5#1)(1997-2#1)
major functions of##2##3##(2009-7#1)(2012-2#1)
major fungal##4##2##(2008-10#3)(2009-6#1)
major gaps##4##2##(1993-3#1)(1997-5#1)(2008-12#1)(2009-3#1)
major gastrointestinal##2##2##(2012-2#2)
major gene controls##2##3##(2008-10#2)
major gene for resistance to##3##5##(2008-10#3)
major gene for resistance##4##4##(2008-10#4)
major gene for##5##3##(2008-10#5)
major gene of##2##3##(2013-1#2)
major gene##30##2##(1997-5#1)(2007-6#1)(2008-10#18)(2008-8#5)(2008-9#1)(2009-6#1)(2013-1#2)(2013-8#1)
major genes##7##2##(2008-10#7)
major genetic changes##2##3##(2008-10#2)
major genetic determinant##2##3##(2009-5#2)
major genetic##8##2##(2008-10#4)(2008-7#1)(2009-5#2)(2010-5#1)
major global health##2##3##(2011-1#1)(2013-8#1)
major global##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
major goal in the##2##4##(1991-6#1)(2008-11#1)
major goal of##2##3##(1996-1#1)(2007-12#1)
major goal##6##2##(1991-6#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
major groove of DNA##3##4##(1994-6#1)(2008-4#2)
major groove of##5##3##(1991-2#1)(1994-6#1)(1995-5#1)(2008-4#2)
major groove##11##2##(1991-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(2008-4#2)
major groups of##5##3##(1990-5#1)(1992-12#1)(2008-10#2)(2009-8#1)
major groups##12##2##(1990-5#1)(1991-5#1)(1992-12#1)(2008-10#6)(2009-8#2)(2010-3#1)
major health##19##2##(1991-12#1)(1993-11#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
major hematologic response##2##3##(2008-7#2)
major hindrance to##2##3##(2008-9#1)(2013-1#1)
major histocompatibility (MHC) class##2##4##(1997-9#1)(2008-4#1)
major histocompatibility (MHC)##3##3##(1997-9#1)(2008-4#1)(2009-2#1)
major histocompatibility complex (MHC) class I##3##6##(1995-12#1)(1995-2#1)(2008-1#1)
major histocompatibility complex (MHC)##7##4##(1990-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)(2008-4#1)
major histocompatibility complex class I##2##5##(1997-9#1)(2008-4#1)
major histocompatibility complex class II##4##5##(1993-6#1)(1994-8#1)(2008-10#1)(2008-5#1)
major histocompatibility complex class##7##4##(1993-6#1)(1994-8#1)(1997-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
major histocompatibility complex molecules##2##4##(1997-4#1)(2012-2#1)
major histocompatibility complex##22##3##(1990-5#2)(1993-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1997-4#1)(1997-9#2)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
major histocompatibility complexes##2##3##(2008-4#2)
major histocompatibility##33##2##(1990-11#1)(1990-5#2)(1991-5#1)(1993-6#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1997-4#1)(1997-9#3)(2008-1#2)(2008-10#1)(2008-4#6)(2008-5#1)(2008-8#1)(2009-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
major human##2##2##(2008-5#1)(2008-9#1)
major hurdle##2##2##(2010-10#1)(2012-12#1)
major identified##2##2##(1993-9#1)(2009-6#1)
major impact on the##5##4##(1992-6#1)(1993-12#1)(1994-12#1)(2008-11#1)(2013-7#1)
major impact on##14##3##(1992-6#1)(1993-12#1)(1994-12#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#2)(2013-7#1)
major impact##18##2##(1992-6#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-12#2)(2013-7#1)
major implications##4##2##(1991-1#1)(1991-12#1)(1992-2#1)(1996-12#1)
major impurity was##2##3##(2008-10#2)
major in##2##2##(1991-3#1)(1994-12#1)
major incidents##2##2##(2007-2#1)(2008-11#1)
major inhibitory##2##2##(2008-10#1)(2008-11#1)
major interest##4##2##(1996-12#1)(2008-7#1)(2009-10#1)(2010-7#1)
major intracellular##2##2##(2008-8#1)(2012-3#1)
major intrinsic protein##2##3##(1993-2#2)
major ions##5##2##(1994-12#1)(2008-10#4)
major isoforms of##2##3##(1992-12#1)(1996-12#1)
major issue##6##2##(1991-2#1)(1992-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
major issues##6##2##(1993-12#1)(1995-1#1)(1996-12#1)(2008-10#1)(2012-3#1)(2013-8#1)
major late promoter##4##3##(1994-8#1)(1997-2#1)(1997-3#1)(2008-11#1)
major life events##2##3##(2008-2#1)(2008-8#1)
major life##4##2##(2008-2#2)(2008-4#1)(2008-8#1)
major limb##2##2##(2007-11#1)(2011-2#1)
major limitation of##5##3##(2008-11#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-8#1)
major limitation##9##2##(1997-1#1)(2008-11#2)(2008-6#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
major limitations to##2##3##(2008-7#1)(2011-2#1)
major limitations##4##2##(2008-7#2)(2008-8#1)(2011-2#1)
major limiting factor##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
major lineages of##2##3##(2010-6#2)
major lineages##3##2##(2008-6#1)(2010-6#2)
major loci##6##2##(2008-10#2)(2008-4#1)(2009-4#2)(2010-4#1)
major locus##3##2##(2008-10#2)(2009-5#1)
major losses##3##2##(2008-10#2)(2012-3#1)
major lung resection##2##3##(2007-8#2)
major mRNA##2##2##(1991-6#1)(1995-6#1)
major mass extinctions##3##3##(1997-5#3)
major mechanism of##3##3##(1993-3#1)(2008-4#1)(2008-8#1)
major mechanism##6##2##(1993-3#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)
major mechanisms of##2##3##(1997-4#1)(2012-2#1)
major mechanisms##3##2##(1997-4#1)(2011-2#1)(2012-2#1)
major medical##7##2##(1992-2#1)(1995-2#1)(2007-7#1)(2008-1#2)(2008-7#1)(2010-12#1)
major medication##2##2##(2008-12#2)
major membrane##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
major mental disorder##2##3##(2009-9#2)
major mental##3##2##(2009-9#2)(2011-2#1)
major metabolic##5##2##(1990-6#1)(1991-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
major metabolite##9##2##(1990-12#1)(1991-12#2)(1992-11#1)(1993-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
major metabolites in##3##3##(1990-8#1)(1996-5#1)(2008-10#1)
major metabolites##12##2##(1990-8#2)(1993-12#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2011-3#1)
major metals##2##2##(2008-10#2)
major methodological##2##2##(2008-2#1)(2008-7#1)
major methods of##2##3##(2008-1#1)(2008-9#1)
major molecular##5##2##(1990-7#1)(1992-9#1)(2007-12#1)(2007-4#1)(2008-7#1)
major morbidity##4##2##(1994-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
major mouse##2##2##(1991-5#1)(1997-7#1)
major muscle##4##2##(2011-2#3)(2012-3#1)
major muscles##2##2##(1992-6#1)(2013-1#1)
major myelin##2##2##(2009-6#2)
major myocutaneous flap##2##3##(2007-12#2)
major nodes##2##2##(2010-5#2)
major nutritional##2##2##(2011-1#1)(2012-2#1)
major objective of##2##3##(2008-7#1)(2011-2#1)
major objective##3##2##(2008-7#2)(2011-2#1)
major obstacle to##5##3##(1994-12#1)(2008-11#1)(2009-11#1)(2012-12#1)(2012-2#1)
major obstacle##7##2##(1994-12#1)(2008-11#1)(2008-5#2)(2009-11#1)(2012-12#1)(2012-2#1)
major obstacles to##3##3##(1996-5#1)(2007-12#1)(2008-12#1)
major obstacles##4##2##(1996-5#1)(2007-12#1)(2008-12#1)(2008-4#1)
major one##3##2##(1992-3#1)(2008-6#1)(2011-2#1)
major open reading frame##2##4##(1990-11#1)(1997-7#1)
major open reading##3##3##(1990-11#1)(1997-7#1)(2008-10#1)
major organic##2##2##(2008-10#2)
major organizational changes##2##3##(2009-10#2)
major organizational##4##2##(1992-12#1)(1994-2#1)(2009-10#2)
major organs##2##2##(2008-12#1)(2013-1#1)
major paradigm##2##2##(1994-3#1)(2010-5#1)
major parameters##2##2##(2008-10#1)(2008-12#1)
major part of the##14##4##(1990-12#1)(1992-11#1)(1994-1#2)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#1)
major part##17##2##(1990-12#1)(1992-11#1)(1993-9#1)(1994-1#2)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
major pathogen of##3##3##(2008-10#3)
major pathogens##2##2##(1990-6#1)(1994-11#1)
major pathological##2##2##(1991-9#1)(2008-1#1)
major pathways##5##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#2)
major peaks##4##2##(1990-7#1)(1993-6#1)(1995-3#1)(2008-10#1)
major pelvic##2##2##(1992-12#1)(1992-8#1)
major phase##2##2##(2008-8#1)(2011-3#1)
major phenolic##3##2##(2008-10#1)(2011-1#2)
major phylogenetic groups##2##3##(2008-10#2)
major phylogenetic##3##2##(2008-10#2)(2008-8#1)
major physiological##7##2##(1990-12#1)(1994-8#1)(1995-2#1)(2008-10#1)(2009-12#1)(2012-3#1)(2013-8#1)
major players in##3##3##(1997-3#1)(2008-7#1)(2009-5#1)
major polypeptide##2##2##(1993-1#2)
major portion of the##3##4##(2008-10#2)(2008-3#1)
major portion of##5##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
major practical##2##2##(2008-8#1)(2011-2#1)
major problem in the##4##4##(1991-9#1)(2007-2#1)(2007-7#1)(2011-2#1)
major problem in##9##3##(1991-9#1)(1994-3#1)(1997-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
major problem was##2##3##(1992-3#1)(2008-10#1)
major problem##28##2##(1990-10#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-8#1)
major problems encountered##2##3##(2008-12#1)(2010-10#1)
major problems in##4##3##(1993-1#1)(2007-11#1)(2010-8#1)(2012-12#1)
major problems##16##2##(1990-2#2)(1993-1#1)(1994-11#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#2)(2009-12#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#2)
major product##9##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-8#1)(1995-3#1)(1996-5#1)(2007-11#1)(2009-2#1)
major production areas##3##3##(2008-10#3)
major production##4##2##(1992-3#1)(2008-10#3)
major progress##2##2##(1994-8#1)(2013-8#1)
major protein component of the##2##5##(1997-8#1)(2008-5#1)
major protein component of##3##4##(1993-6#1)(1997-8#1)(2008-5#1)
major protein component##5##3##(1993-6#1)(1997-8#1)(2008-10#2)(2008-5#1)
major protein depletion##2##3##(2008-4#2)
major protein##17##2##(1990-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-5#1)(1997-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)
major proteins in##2##3##(1990-2#1)(2008-10#1)
major proteins##7##2##(1990-2#1)(1990-8#1)(1992-3#1)(1997-4#1)(2008-10#2)(2008-6#1)
major psychoses##4##2##(1997-5#4)
major public health threat in##3##5##(2007-12#1)(2011-1#1)(2011-2#1)
major public health##28##3##(1992-9#2)(1993-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
major pulmonary##2##2##(1996-11#1)(2007-8#1)
major quantitative trait locus for##4##5##(2008-10#4)
major quantitative trait locus##8##4##(2008-10#8)
major quantitative trait##9##3##(2008-10#9)
major question##2##2##(2009-5#1)(2009-8#1)
major reason for the##2##4##(2008-8#1)(2009-5#1)
major reason for##7##3##(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-5#1)(2012-1#1)
major reason##9##2##(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2012-1#1)(2013-1#1)
major reasons for##2##3##(2008-1#1)(2013-1#1)
major reduction in##3##3##(1990-11#1)(1994-11#1)(2008-10#1)
major reduction##5##2##(1990-11#1)(1990-5#1)(1994-11#1)(1995-3#1)(2008-10#1)
major research##2##2##(2008-5#1)(2012-2#1)
major resistance gene##3##3##(2008-10#3)
major resistance genes##13##3##(2008-10#13)
major resistance##19##2##(2008-10#18)(2012-2#1)
major response##2##2##(2008-10#1)(2008-7#1)
major risk factor for##8##4##(1990-2#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
major risk factor##9##3##(1990-2#1)(1990-6#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
major risk factors for##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
major risk factors of##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
major risk factors##8##3##(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)
major risk##19##2##(1990-2#1)(1990-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
major role in regulating##5##4##(1997-9#1)(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
major role in the##25##4##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-7#1)(2010-4#1)(2011-2#1)
major role in##65##3##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
major role of##5##3##(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
major role##81##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
major roles in the##2##4##(2008-7#2)
major roles in##5##3##(1994-11#1)(2007-12#1)(2008-7#3)
major roles##6##2##(1994-11#1)(2007-12#1)(2008-7#4)
major route##3##2##(1997-1#2)(2010-1#1)
major salivary glands##2##3##(1990-11#1)(2013-1#1)
major salivary##3##2##(1990-11#1)(2011-1#1)(2013-1#1)
major scab resistance##2##3##(2008-10#2)
major second messenger##2##3##(1993-6#1)(1994-8#1)
major second##3##2##(1993-6#1)(1994-8#1)(2008-11#1)
major secretory##2##2##(1994-5#1)(1995-2#1)
major security##2##2##(2007-12#1)(2008-10#1)
major side effect##2##3##(1990-6#1)(2008-5#1)
major side effects##2##3##(1990-6#1)(2013-1#1)
major side##4##2##(1990-6#2)(2008-5#1)(2013-1#1)
major signalling##2##2##(1992-9#1)(1994-11#1)
major site of##8##3##(1990-12#1)(1994-11#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-7#1)(2010-8#1)(2012-1#1)
major site##9##2##(1990-12#1)(1994-11#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-1#1)
major sites of##2##3##(1993-3#1)(1993-5#1)
major social##3##2##(2008-1#1)(2008-11#1)(2008-6#1)
major source of##16##3##(1991-2#1)(1991-9#1)(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-11#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
major source##19##2##(1991-2#1)(1991-9#1)(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
major sources of##5##3##(1994-3#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
major sources##7##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)
major species##9##2##(1994-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2010-11#1)
major states##2##2##(2008-3#1)(2013-1#1)
major steps##6##2##(1996-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
major structural##5##2##(1995-2#2)(1995-6#1)(2008-7#1)(2009-7#1)
major studies##4##2##(1991-2#1)(1991-8#1)(2008-2#2)
major study##2##2##(1990-6#1)(2008-10#1)
major sublineages##2##2##(1995-3#2)
major substrate##3##2##(1994-8#1)(2008-11#1)(2012-2#1)
major subtypes##2##2##(1997-2#1)(2008-8#1)
major surgery##3##2##(2009-5#1)(2009-6#2)
major surgical procedures##2##3##(1990-2#1)(1992-6#1)
major surgical##5##2##(1990-2#1)(1992-6#1)(2007-8#1)(2008-7#2)
major symptoms##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
major target of##3##3##(1992-10#1)(1996-5#1)(2009-11#1)
major target##6##2##(1992-10#1)(1996-5#1)(2008-11#1)(2008-5#2)(2009-11#1)
major targets of##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
major targets##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
major thalassemia##3##2##(2011-2#1)(2013-1#2)
major themes##7##2##(1991-2#1)(1994-12#1)(2008-12#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
major therapeutic##5##2##(1990-6#1)(1997-2#1)(2008-1#1)(2008-12#1)(2010-11#1)
major topic##2##2##(2008-11#1)(2008-3#1)
major toxin##2##2##(1997-6#1)(2008-10#1)
major tranquilliser##2##2##(2008-7#2)
major tranquillisers##2##2##(2008-7#2)
major transcription start##2##3##(1990-11#1)(1997-6#1)
major transcription##3##2##(1990-11#1)(1997-6#1)(2011-2#1)
major transformation##3##2##(1992-1#1)(2008-10#2)
major trauma##3##2##(1990-6#1)(1990-9#1)(2009-3#1)
major trends##3##2##(1991-1#1)(2008-10#1)(2008-2#1)
major vascular##5##2##(1994-3#1)(1996-11#1)(2007-10#1)(2008-1#1)(2009-5#1)
major vault protein##3##3##(1994-12#2)(2008-11#1)
major vessels##3##2##(2010-8#1)(2013-1#2)
major virulence factor##2##3##(2007-8#1)(2008-10#1)
major was##2##2##(1992-9#1)(2008-10#1)
major wheat##2##2##(2008-10#2)
major##2409##1##(1990-10#2)(1990-11#12)(1990-12#11)(1990-2#10)(1990-3#2)(1990-4#2)(1990-5#12)(1990-6#13)(1990-7#6)(1990-8#10)(1990-9#4)(1991-1#6)(1991-11#4)(1991-12#10)(1991-2#14)(1991-3#7)(1991-4#1)(1991-5#7)(1991-6#9)(1991-8#3)(1991-9#17)(1992-1#6)(1992-10#2)(1992-11#9)(1992-12#14)(1992-2#9)(1992-3#12)(1992-4#2)(1992-5#2)(1992-6#15)(1992-8#7)(1992-9#12)(1993-1#4)(1993-11#12)(1993-12#19)(1993-2#7)(1993-3#13)(1993-5#3)(1993-6#11)(1993-8#4)(1993-9#4)(1994-1#8)(1994-10#1)(1994-11#17)(1994-12#25)(1994-2#15)(1994-3#8)(1994-5#8)(1994-6#4)(1994-7#2)(1994-8#19)(1994-9#8)(1995-1#9)(1995-11#8)(1995-12#14)(1995-2#27)(1995-3#19)(1995-5#9)(1995-6#16)(1995-8#8)(1995-9#2)(1996-1#8)(1996-11#5)(1996-12#19)(1996-2#9)(1996-3#7)(1996-4#4)(1996-5#12)(1996-6#6)(1996-7#9)(1996-8#2)(1996-9#4)(1997-1#13)(1997-2#11)(1997-3#15)(1997-4#9)(1997-5#12)(1997-6#7)(1997-7#8)(1997-8#15)(1997-9#6)(2006-10#3)(2006-6#2)(2007-10#9)(2007-11#14)(2007-12#34)(2007-2#10)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#21)(2007-8#16)(2008-1#49)(2008-10#379)(2008-11#91)(2008-12#39)(2008-2#29)(2008-3#44)(2008-4#50)(2008-5#73)(2008-6#27)(2008-7#93)(2008-8#54)(2008-9#37)(2009-1#2)(2009-10#18)(2009-11#8)(2009-12#11)(2009-2#7)(2009-3#9)(2009-4#7)(2009-5#18)(2009-6#13)(2009-7#7)(2009-8#13)(2009-9#6)(2010-1#4)(2010-10#4)(2010-11#10)(2010-12#17)(2010-2#4)(2010-3#14)(2010-4#7)(2010-5#16)(2010-6#10)(2010-7#2)(2010-8#18)(2010-9#4)(2011-1#35)(2011-10#1)(2011-2#92)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#7)(2012-12#28)(2012-2#62)(2012-3#37)(2013-1#53)(2013-7#7)(2013-8#32)
major)##7##1##(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#2)
majorities of##2##2##(1997-5#1)(2008-9#1)
majority (77%)##2##2##(2008-10#1)(2012-12#1)
majority (85%) of##2##3##(2008-1#1)(2008-7#1)
majority (96%)##2##2##(1995-1#1)(2010-8#1)
majority and minority##2##3##(2008-10#1)(2008-2#1)
majority had##2##2##(2007-7#1)(2012-12#1)
majority of Americans##2##3##(1997-5#1)(2007-6#1)
majority of adverse##2##3##(2008-5#1)(2010-5#1)
majority of affected##2##3##(2007-8#1)(2012-3#1)
majority of all##2##3##(2008-7#1)(2010-12#1)
majority of cancers##2##3##(1994-2#1)(2008-7#1)
majority of cases are##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
majority of cases of##5##4##(2007-7#2)(2008-7#1)(2009-8#1)(2012-3#1)
majority of cases the##3##4##(1997-4#1)(2008-9#1)(2010-11#1)
majority of cases##41##3##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1995-11#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
majority of cells##5##3##(1993-8#1)(1994-2#1)(2008-11#1)(2008-9#2)
majority of cellular##2##3##(1990-2#1)(2008-4#1)
majority of children##4##3##(1996-12#1)(2008-11#1)(2009-9#1)(2011-2#1)
majority of conidia##2##3##(2008-10#2)
majority of individuals##5##3##(1990-3#1)(1995-3#1)(1997-5#1)(2013-7#2)
majority of investigations##2##3##(2008-10#1)(2008-7#1)
majority of isolates##5##3##(2008-10#4)(2008-5#1)
majority of new##2##3##(1991-9#1)(2013-8#1)
majority of nursing##2##3##(2012-12#1)(2012-3#1)
majority of parents##2##3##(1992-2#1)(2008-9#1)
majority of participants##4##3##(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
majority of patients who##4##4##(2007-7#1)(2008-1#1)(2008-3#1)(2013-1#1)
majority of patients with##9##4##(1992-3#1)(1992-8#1)(1993-2#1)(1996-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
majority of patients##35##3##(1992-1#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
majority of peptide##2##3##(2008-4#2)
majority of published studies##2##4##(2008-9#1)(2011-2#1)
majority of reported##2##3##(2007-7#1)(2013-1#1)
majority of research in##2##4##(2008-11#1)(2013-1#1)
majority of respondents reported that##2##5##(2008-12#1)(2010-8#1)
majority of respondents##6##3##(1997-3#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
majority of students##3##3##(1991-9#1)(2008-12#1)(2012-1#1)
majority of studies##5##3##(1997-6#1)(2008-2#1)(2012-2#3)
majority of the general practitioners##2##5##(1993-2#2)
majority of the isolates were resistant##2##6##(2008-10#1)(2011-2#1)
majority of the participants##2##4##(2009-6#1)(2011-2#1)
majority of the patients##6##4##(2007-11#1)(2007-7#1)(2008-4#1)(2010-6#1)(2011-1#1)(2013-8#1)
majority of the respondents##2##4##(1996-3#1)(2008-12#1)
majority of the subjects##2##4##(1995-11#1)(2013-8#1)
majority of the target##2##4##(2008-10#1)(2008-8#1)
majority of the##102##3##(1990-11#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#6)(2013-1#1)(2013-8#4)
majority of them could##2##4##(1995-8#1)(2011-1#1)
majority of them##10##3##(1995-2#1)(1995-8#1)(2007-5#1)(2007-6#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
majority of these studies##2##4##(2008-12#1)(2012-2#1)
majority of these##18##3##(1993-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
majority of those##5##3##(1993-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
majority of women##4##3##(1996-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
majority of##487##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#5)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#5)(2007-5#4)(2007-6#2)(2007-7#9)(2007-8#2)(2008-1#10)(2008-10#53)(2008-11#21)(2008-12#9)(2008-2#1)(2008-3#5)(2008-4#14)(2008-5#15)(2008-6#8)(2008-7#24)(2008-8#8)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-3#8)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#24)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#19)(2012-3#10)(2013-1#13)(2013-7#3)(2013-8#10)
majority reported##2##2##(1993-1#1)(2008-12#1)
majority were##5##2##(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
majority##564##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#5)(1994-5#1)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#8)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#3)(2007-11#6)(2007-12#3)(2007-2#5)(2007-5#4)(2007-6#2)(2007-7#11)(2007-8#2)(2008-1#12)(2008-10#65)(2008-11#23)(2008-12#13)(2008-2#4)(2008-3#5)(2008-4#14)(2008-5#15)(2008-6#8)(2008-7#25)(2008-8#11)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#9)(2010-5#7)(2010-6#5)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#27)(2011-3#1)(2012-1#5)(2012-12#10)(2012-2#21)(2012-3#13)(2013-1#15)(2013-7#4)(2013-8#12)
majors##2##1##(2008-11#1)(2012-12#1)
majus##3##1##(2008-10#2)(2008-8#1)
make a comprehensive assessment##2##4##(2009-10#1)(2013-8#1)
make a decision##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
make a detailed##2##3##(1997-8#1)(2008-3#1)
make a diagnosis##6##3##(1997-8#1)(2007-11#2)(2009-11#1)(2012-2#1)(2013-8#1)
make a difference##9##3##(1993-3#1)(1994-2#1)(2008-1#1)(2008-11#2)(2010-7#1)(2011-2#2)(2013-7#1)
make a difference?##2##3##(1991-12#1)(2013-1#1)
make a distinction between##4##4##(2008-7#1)(2010-12#2)(2012-2#1)
make a distinction##5##3##(2008-11#1)(2008-7#1)(2010-12#2)(2012-2#1)
make a greater##2##3##(1994-1#1)(2008-5#1)
make a large##2##3##(1993-2#1)(2008-2#1)
make a modest##2##3##(2008-7#1)(2011-1#1)
make a number of##2##4##(2008-11#1)(2008-12#1)
make a positive##2##3##(1997-2#1)(1997-4#1)
make a review##2##3##(2008-10#1)(2012-3#1)
make a significant contribution to##4##5##(1992-12#1)(1994-12#1)(2007-11#1)(2011-1#1)
make a significant contribution##5##4##(1992-12#1)(1994-12#1)(2007-11#1)(2011-1#1)(2013-8#1)
make a significant##6##3##(1992-12#1)(1994-12#1)(2007-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
make a strong##2##3##(1994-9#1)(2008-6#1)
make a##100##2##(1991-12#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#2)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#3)(2008-1#3)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-8#1)(2010-12#3)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
make accurate##5##2##(1992-6#1)(2008-11#1)(2008-3#2)(2012-2#1)
make among##2##2##(1991-2#1)(1994-3#1)
make an analysis of the##2##5##(2009-7#1)(2012-1#1)
make an##15##2##(1992-12#1)(1992-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-1#1)
make any##2##2##(1993-12#1)(2010-7#1)
make appropriate##4##2##(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
make better##3##2##(2008-3#1)(2008-9#1)(2010-9#1)
make certain##4##2##(1994-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
make choices##2##2##(2009-5#1)(2012-1#1)
make clear##3##2##(1996-3#1)(2012-12#1)(2012-3#1)
make comparisons##4##2##(1991-12#1)(1995-12#1)(2008-10#1)(2011-1#1)
make decisions about##2##3##(1994-9#1)(1997-3#1)
make decisions on##2##3##(2008-10#1)(2010-8#1)
make decisions regarding##3##3##(1992-12#1)(2011-1#1)(2011-8#1)
make decisions##15##2##(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-9#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-8#1)
make different##2##2##(2007-12#1)(2011-2#1)
make explicit##2##2##(1991-12#1)(2011-2#1)
make extensive##2##2##(2008-10#1)(2013-1#1)
make for##2##2##(1991-12#1)(1996-1#1)
make good##2##2##(1993-2#1)(2008-1#1)
make health##3##2##(1994-3#1)(1997-4#1)(2008-1#1)
make in##3##2##(1992-2#1)(2008-10#1)(2008-3#1)
make increasingly##2##2##(2009-5#1)(2011-1#1)
make informed##4##2##(1991-2#1)(2008-1#1)(2008-12#2)
make it a good##2##4##(2008-10#2)
make it a##10##3##(1990-3#1)(1994-9#1)(1996-9#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)
make it an##2##3##(2010-6#1)(2012-8#1)
make it clear that##2##4##(2011-2#1)(2012-3#1)
make it difficult to##8##4##(1995-3#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-7#1)
make it easier to##5##4##(1992-12#1)(2007-12#1)(2008-9#1)(2009-5#1)(2013-8#1)
make it easier##6##3##(1992-12#1)(1995-1#1)(2007-12#1)(2008-9#1)(2009-5#1)(2013-8#1)
make it easy##2##3##(2007-12#1)(2007-2#1)
make it highly##2##3##(2008-11#1)(2008-3#1)
make it possible for##2##4##(1990-5#1)(2011-2#1)
make it possible to understand the##2##6##(1996-4#1)(2008-8#1)
make it possible to##24##4##(1992-3#1)(1992-5#1)(1996-4#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#3)(2009-11#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)
make it possible##26##3##(1990-5#1)(1992-3#1)(1992-5#1)(1996-4#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#3)(2009-11#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#1)
make it the##2##3##(2008-9#1)(2011-2#1)
make it unlikely that##2##4##(2008-10#1)(2011-2#1)
make it well suited##2##4##(2007-12#1)(2008-7#1)
make it##97##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#8)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
make its##4##2##(1995-3#1)(2008-12#1)(2008-4#1)(2012-12#1)
make more##8##2##(1995-1#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
make no##6##2##(1995-2#1)(1996-3#1)(1997-4#1)(2008-2#1)(2008-8#1)(2013-8#1)
make or##2##2##(1994-1#1)(1994-3#1)
make possible##4##2##(1994-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
make predictions##4##2##(1991-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
make progress##4##2##(1996-2#1)(2008-5#1)(2008-7#1)(2010-3#1)
make recommendations about##2##3##(1995-2#1)(2008-10#1)
make recommendations for the use of##2##6##(2008-6#2)
make recommendations for the##4##4##(1994-3#1)(1995-2#1)(2008-6#2)
make recommendations for##8##3##(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-6#2)(2009-11#1)
make recommendations##13##2##(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-2#1)(2008-10#1)(2008-6#2)(2009-11#1)(2009-3#1)(2009-6#1)(2011-1#1)
make responsible##2##2##(1996-2#1)(2010-8#1)
make sense in##2##3##(1997-7#1)(2011-1#1)
make sense of##2##3##(2009-5#1)(2010-11#1)
make sense##6##2##(1997-2#1)(1997-7#2)(2009-5#1)(2010-11#1)(2011-1#1)
make specific##2##2##(1992-3#1)(2008-9#1)
make steady##2##2##(1997-2#1)(2008-4#1)
make such##5##2##(1991-1#1)(2007-6#1)(2008-10#2)(2008-2#1)
make sure that##6##3##(1993-1#2)(1993-3#1)(1995-9#1)(2008-10#1)(2008-11#1)
make sure##8##2##(1993-1#2)(1993-3#1)(1995-6#1)(1995-9#1)(2008-10#2)(2008-11#1)
make that##3##2##(2008-5#1)(2010-4#2)
make the following##2##3##(1997-1#1)(2008-10#1)
make the most of##2##4##(1994-12#2)
make the most##5##3##(1993-12#1)(1994-12#2)(2010-8#1)(2012-2#1)
make the##77##2##(1991-3#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-5#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
make their mark on##2##4##(1991-5#1)(1995-3#1)
make their way##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
make their##8##2##(1991-5#1)(1994-3#1)(1995-3#1)(1996-12#1)(2008-10#2)(2012-12#1)(2013-8#1)
make them attractive##2##3##(2008-10#1)(2011-2#1)
make them more##2##3##(1996-3#1)(2008-4#1)
make them useful##2##3##(2008-10#1)(2010-7#1)
make them##26##2##(1991-1#1)(1992-3#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#1)
make these##8##2##(1993-9#1)(1994-1#1)(2008-11#1)(2009-12#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
make things##2##2##(1996-6#1)(2011-2#1)
make this case##2##3##(2011-2#1)(2013-7#1)
make this##24##2##(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-1#1)(2009-5#1)(2011-2#1)(2013-7#1)
make those##3##2##(1995-12#1)(2012-3#1)(2013-7#1)
make to the##3##3##(1992-2#1)(1993-12#1)(1996-11#1)
make to##4##2##(1992-2#1)(1993-12#1)(1996-11#1)(2007-10#1)
make up a##4##3##(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)
make up for##2##3##(2008-12#1)(2009-7#1)
make up the##10##3##(2008-10#2)(2008-4#2)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
make up##21##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
make use of the vast##2##5##(1993-12#1)(2008-5#1)
make use of the##3##4##(1993-12#1)(2008-10#1)(2008-5#1)
make use of##11##3##(1992-9#1)(1993-12#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#1)
make use##12##2##(1992-9#1)(1993-12#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-9#1)(2011-2#1)
make##784##1##(1990-2#1)(1990-3#5)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#4)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#5)(1992-5#3)(1992-6#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#6)(1993-8#1)(1993-9#2)(1994-1#8)(1994-11#1)(1994-12#7)(1994-2#5)(1994-3#8)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#4)(1995-12#9)(1995-2#12)(1995-3#5)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#5)(1996-12#5)(1996-2#6)(1996-3#9)(1996-4#2)(1996-5#5)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#11)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#2)(2007-10#5)(2007-11#12)(2007-12#15)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#12)(2008-10#62)(2008-11#26)(2008-12#12)(2008-2#21)(2008-3#37)(2008-4#12)(2008-5#19)(2008-6#8)(2008-7#29)(2008-8#25)(2008-9#25)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#4)(2010-8#10)(2010-9#4)(2011-1#14)(2011-2#36)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#4)(2012-12#13)(2012-2#17)(2012-3#9)(2012-8#1)(2013-1#20)(2013-7#8)(2013-8#15)
make-up of##3##2##(1997-8#1)(2008-7#1)(2013-8#1)
make-up only##2##2##(2008-5#2)
make-up##15##1##(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#8)(2008-7#1)(2009-7#1)(2011-1#1)(2013-8#1)
maker##5##1##(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#2)
makers and program planners seeking to promote##2##7##(2013-1#2)
makers and##14##2##(1992-12#1)(1993-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-1#2)
makers are##2##2##(1996-12#1)(2009-7#1)
makers of##6##2##(1993-2#1)(1994-1#1)(1996-3#1)(1996-5#1)(2012-12#1)(2012-2#1)
makers##66##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#3)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
makes a difference in##2##4##(1997-3#1)(2008-9#1)
makes a##24##2##(1990-6#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-8#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-12#2)(2013-8#1)
makes an##2##2##(2010-7#1)(2011-2#1)
makes clear##2##2##(2008-2#1)(2010-3#1)
makes good##3##2##(1993-3#1)(2008-4#2)
makes it a##7##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)
makes it an ideal##2##4##(2008-10#1)(2012-2#1)
makes it an important##2##4##(1995-12#1)(2012-2#1)
makes it an##7##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#2)(2012-3#1)
makes it challenging##2##3##(2008-12#1)(2012-2#1)
makes it clear that##2##4##(2007-12#1)(2008-7#1)
makes it difficult for##2##4##(2010-12#1)(2013-8#1)
makes it difficult to##6##4##(1992-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-3#1)
makes it difficult##8##3##(1992-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
makes it easier to##2##4##(2008-3#2)
makes it harder##2##3##(1996-5#2)
makes it impossible to##3##4##(2008-3#1)(2009-8#1)(2012-3#1)
makes it necessary to##5##4##(2008-10#2)(2008-3#2)(2010-5#1)
makes it possible for##3##4##(1994-3#1)(2007-12#1)(2008-9#1)
makes it possible to control the##2##6##(2008-2#1)(2008-3#1)
makes it possible to determine##2##5##(2008-10#1)(2013-1#1)
makes it possible to distinguish##2##5##(1996-5#1)(2008-10#1)
makes it possible to increase##2##5##(1997-3#1)(2008-10#1)
makes it possible to##35##4##(1992-8#1)(1994-6#1)(1996-5#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
makes it possible##39##3##(1992-8#1)(1994-3#1)(1994-6#1)(1996-5#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-6#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
makes it suitable for use##2##5##(2008-3#1)(2013-1#1)
makes it suitable for##4##4##(1996-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
makes it suitable##5##3##(1996-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
makes it##100##2##(1991-2#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#4)(1997-2#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#13)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
makes its##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
makes monitoring##2##2##(1991-5#1)(2008-4#1)
makes only##2##2##(1995-2#1)(2008-8#1)
makes our##2##2##(2008-6#1)(2012-1#1)
makes possible a##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
makes possible the##6##3##(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-3#1)
makes possible##13##2##(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
makes risk adjustment##2##3##(1997-1#1)(2008-11#1)
makes sense to##2##3##(2008-11#1)(2008-9#1)
makes sense##3##2##(2008-11#1)(2008-9#1)(2012-2#1)
makes some##2##2##(1991-12#1)(2007-12#1)
makes such##3##2##(1996-1#1)(2008-3#1)(2008-8#1)
makes the dominant contribution to the##2##6##(1992-5#1)(1995-12#1)
makes the method##2##3##(2008-3#1)(2008-7#1)
makes the peak##2##3##(2008-10#2)
makes the study of##2##4##(2008-7#1)(2010-11#1)
makes the system##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
makes the##61##2##(1992-5#1)(1993-2#2)(1993-6#1)(1994-3#2)(1995-12#1)(1996-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-8#3)
makes them a##2##3##(2008-10#1)(2008-7#1)
makes them an important##2##4##(2008-5#1)(2008-9#1)
makes them an##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
makes them attractive as##2##4##(2011-2#1)(2012-12#1)
makes them less##2##3##(2008-1#1)(2008-3#1)
makes them promising##2##3##(2008-10#1)(2008-9#1)
makes them suitable for##2##4##(2008-10#1)(2008-11#1)
makes them##27##2##(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2011-2#4)(2012-12#2)(2013-1#1)
makes this approach##2##3##(2008-9#1)(2010-5#1)
makes this species##3##3##(1996-2#1)(2008-10#2)
makes this technique##2##3##(1991-5#1)(2008-10#1)
makes this##14##2##(1990-6#1)(1991-5#1)(1993-12#1)(1996-2#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)
makes up a##3##3##(2008-9#1)(2009-4#1)(2010-8#1)
makes up the##3##3##(2007-12#1)(2008-5#1)(2010-8#1)
makes up##7##2##(2007-12#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-8#2)
makes us##3##2##(1991-4#1)(2008-12#1)(2011-2#1)
makes use of a##5##4##(2008-2#1)(2008-3#2)(2008-9#1)(2009-5#1)
makes use of an##4##4##(2007-12#2)(2008-3#1)(2008-8#1)
makes use of only##2##4##(2008-2#1)(2008-3#1)
makes use of readily available##2##5##(2008-10#1)(2008-8#1)
makes use of the##8##4##(1992-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-8#1)
makes use of##35##3##(1991-5#1)(1992-6#2)(1994-12#1)(2007-12#3)(2008-10#5)(2008-2#5)(2008-3#11)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#2)
makes use##36##2##(1991-5#1)(1992-6#2)(1994-12#1)(2007-12#3)(2008-10#6)(2008-2#5)(2008-3#11)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#2)
makes##422##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#5)(2007-12#17)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#64)(2008-11#15)(2008-12#5)(2008-2#13)(2008-3#46)(2008-4#13)(2008-5#7)(2008-6#4)(2008-7#17)(2008-8#19)(2008-9#16)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#9)
makeup of##5##2##(1995-5#1)(1997-2#1)(2008-2#1)(2008-9#1)(2012-2#1)
makeup##13##1##(1994-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-2#1)(2008-5#5)(2008-9#1)(2012-2#1)
making a direct##2##3##(2008-10#1)(2012-12#1)
making a transition from##2##4##(1993-12#1)(1997-1#1)
making a##30##2##(1990-5#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-12#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#2)(2011-3#1)(2012-12#2)(2013-1#1)
making absolute##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
making accurate##3##2##(2008-10#1)(2008-3#2)
making an##4##2##(1992-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
making and##21##2##(1992-1#1)(1992-3#1)(1993-3#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-4#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)
making any##2##2##(2011-2#1)(2012-2#1)
making clinical##2##2##(2008-12#1)(2012-12#1)
making comparisons between the##2##4##(1990-6#1)(2013-1#1)
making comparisons##5##2##(1990-6#1)(1994-3#2)(2009-8#1)(2013-1#1)
making decisions about##2##3##(1993-12#1)(1996-2#1)
making decisions##6##2##(1993-12#1)(1996-2#1)(1996-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
making for##7##2##(1992-3#1)(1993-12#1)(2007-10#1)(2008-7#1)(2010-2#2)(2011-2#1)
making full use of##3##4##(2008-9#1)(2010-6#1)(2012-3#1)
making health##2##2##(1994-2#1)(1997-3#1)
making identification##2##2##(1997-3#1)(2008-12#1)
making in##13##2##(1990-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-10#2)(2010-11#1)(2012-1#1)(2013-7#1)
making inferences about##2##3##(1993-1#1)(2008-12#1)
making informed##2##2##(2007-4#1)(2013-1#1)
making it a##5##3##(1994-11#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-10#1)
making it an ideal##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
making it an important##2##4##(2008-1#1)(2012-2#1)
making it an##7##3##(1990-12#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
making it difficult for##2##4##(2008-8#1)(2009-8#1)
making it difficult to##6##4##(2007-12#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-8#1)
making it difficult##9##3##(2007-12#1)(2008-10#2)(2008-8#2)(2009-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
making it impossible to##3##4##(2007-12#1)(2008-1#1)(2012-12#1)
making it more##3##3##(1995-3#1)(2008-2#1)(2008-9#1)
making it possible to##9##4##(1997-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2013-7#1)
making it##56##2##(1990-12#1)(1992-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
making its##5##2##(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
making methods##2##2##(2008-10#1)(2009-11#1)
making new##2##2##(2008-9#1)(2012-2#1)
making of##10##2##(1991-1#1)(2007-11#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-4#1)(2012-12#1)(2013-1#2)
making or##2##2##(1991-1#1)(2009-10#1)
making possible the##4##3##(2007-11#1)(2008-10#2)(2008-9#1)
making processes##4##2##(2007-5#1)(2013-7#3)
making risky decisions##2##3##(2008-11#1)(2013-1#1)
making sense of##2##3##(2008-11#1)(2008-7#1)
making significant progress in##2##4##(2009-5#1)(2010-10#1)
making such##5##2##(1994-1#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-4#1)
making sure that the process does not impede patient care##2##10##(2011-1#1)(2011-2#1)
making the case for##2##4##(2007-9#1)(2011-2#1)
making the diagnosis of##3##4##(2008-12#1)(2011-2#2)
making the diagnosis##5##3##(2007-11#1)(2008-12#1)(2011-2#3)
making the technique##3##3##(2007-11#1)(2007-12#1)(2008-4#1)
making the transition to##2##4##(1997-6#1)(2007-2#1)
making the transition##3##3##(1996-12#1)(1997-6#1)(2007-2#1)
making the##57##2##(1992-1#1)(1994-1#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-1#2)(2010-5#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
making their##5##2##(1995-12#1)(1996-2#2)(2007-7#1)(2011-2#1)
making them a##2##3##(2008-10#1)(2012-12#1)
making them##15##2##(1993-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#2)(2012-12#1)(2013-8#1)
making these cells##2##3##(2008-11#1)(2012-12#1)
making these##8##2##(1990-8#1)(1994-3#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
making this##8##2##(1990-8#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
making trait##2##2##(2008-11#1)(2012-12#1)
making up##2##2##(2008-10#1)(2008-5#1)
making use of a##4##4##(1994-12#1)(2008-10#2)(2008-9#1)
making use of the##6##4##(2008-10#3)(2008-2#1)(2008-4#1)(2009-9#1)
making use of##20##3##(1990-2#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)
making your##2##2##(1993-3#1)(1996-3#1)
making##532##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1993-1#1)(1993-12#6)(1993-3#3)(1993-6#1)(1994-1#8)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#11)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#4)(1996-1#2)(1996-12#8)(1996-2#8)(1996-3#5)(1996-5#1)(1996-6#4)(1997-1#2)(1997-2#2)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#4)(2007-11#17)(2007-12#9)(2007-2#3)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#12)(2008-10#53)(2008-11#21)(2008-12#10)(2008-2#14)(2008-3#22)(2008-4#12)(2008-5#5)(2008-6#6)(2008-7#21)(2008-8#9)(2008-9#19)(2009-10#5)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#12)(2012-3#11)(2012-6#1)(2013-1#11)(2013-7#11)(2013-8#5)
mal##3##1##(1992-2#1)(1997-3#1)(2013-8#1)
malabathricum##5##1##(2009-8#5)
malabsorption and maldigestion##3##3##(2011-2#3)
malabsorption and##5##2##(1993-12#1)(2010-12#1)(2011-2#3)
malabsorption of protein-bound vitamin##2##4##(1990-3#2)
malabsorption syndrome##2##2##(2008-9#1)(2013-8#1)
malabsorption##12##1##(1990-3#2)(1993-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
malachite green and##2##3##(2008-10#2)
malachite green##8##2##(2008-10#4)(2008-3#1)(2010-5#3)
malachite##9##1##(2008-10#5)(2008-3#1)(2010-5#3)
malacostracan##3##1##(2007-12#3)
maladapted##2##1##(2008-8#2)
maladaptive##8##1##(2008-8#1)(2009-11#1)(2009-9#1)(2012-1#1)(2012-12#3)(2013-1#1)
maladie épileptique##2##2##(2013-1#2)
maladie##6##1##(2009-4#2)(2013-1#4)
maladies##2##1##(2007-2#1)(2010-1#1)
maladjusted and##2##2##(2009-11#2)
maladjusted##3##1##(2008-12#1)(2009-11#2)
maladjustment##2##1##(1991-6#1)(2008-11#1)
malady##3##1##(1992-8#1)(2008-6#1)(2009-7#1)
malaise##7##1##(1991-4#1)(1992-12#1)(1995-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
malakoplakia##3##1##(2007-10#1)(2009-5#2)
malalignment##4##1##(2009-4#2)(2012-2#1)(2013-1#1)
malar eminence##3##2##(2012-12#3)
malar##6##1##(2006-10#1)(2008-5#1)(2012-12#3)(2013-1#1)
malaria and the##2##3##(2009-6#1)(2012-12#1)
malaria and##11##2##(1997-4#2)(2007-2#1)(2007-7#1)(2008-1#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
malaria by##3##2##(1991-2#1)(1993-8#1)(2007-2#1)
malaria cases in the##2##4##(2008-8#1)(2012-3#1)
malaria cases##13##2##(2008-8#5)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)
malaria control##9##2##(1997-4#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
malaria diagnosis and treatment in##2##5##(2012-12#2)
malaria diagnosis and treatment##3##4##(2012-12#3)
malaria diagnosis network##3##3##(2012-12#3)
malaria diagnosis##13##2##(2007-2#4)(2012-12#9)
malaria diagnostic##2##2##(2007-2#1)(2012-12#1)
malaria elimination##2##2##(2012-12#1)(2012-2#1)
malaria endemic regions##2##3##(2007-2#1)(2012-2#1)
malaria endemic##3##2##(2007-2#1)(2008-8#1)(2012-2#1)
malaria endemicity##2##2##(2008-8#1)(2010-1#1)
malaria epidemic##4##2##(2012-3#4)
malaria from##3##2##(1991-5#1)(2007-2#1)(2012-12#1)
malaria importation##3##2##(2012-2#3)
malaria in Colombia##4##3##(2012-12#4)
malaria in patients##2##3##(2007-2#1)(2012-12#1)
malaria in the##6##3##(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)
malaria in##35##2##(1990-3#1)(1991-5#1)(1994-11#1)(1995-12#1)(2007-2#6)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#14)(2012-2#1)(2012-3#3)
malaria incidence in Colombian##2##4##(2012-12#2)
malaria incidence##3##2##(2012-12#3)
malaria is not##2##3##(2012-12#2)
malaria is##11##2##(1997-4#1)(2007-2#3)(2008-10#1)(2008-11#2)(2011-2#1)(2012-12#3)
malaria may##2##2##(2007-2#2)
malaria mortality##2##2##(2007-2#1)(2012-12#1)
malaria parasite##8##2##(1993-2#2)(2008-3#1)(2010-2#1)(2012-2#3)(2013-8#1)
malaria parasites##9##2##(1994-11#1)(2007-7#1)(2010-12#1)(2010-3#1)(2012-2#3)(2012-3#2)
malaria patient##2##2##(2007-2#1)(2010-12#1)
malaria patients##3##2##(1994-8#1)(2012-12#2)
malaria prophylaxis##3##2##(2007-2#1)(2011-2#2)
malaria research##2##2##(1997-7#1)(2009-6#1)
malaria risk data##2##3##(2008-8#2)
malaria risk maps##2##3##(2008-8#2)
malaria risk##6##2##(2008-8#5)(2012-12#1)
malaria should##2##2##(2007-2#1)(2012-3#1)
malaria that##2##2##(1994-11#1)(2012-12#1)
malaria transmission in##2##3##(2008-8#1)(2012-2#1)
malaria transmission##10##2##(2008-8#5)(2010-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
malaria transmissions##2##2##(2008-8#2)
malaria vaccines##2##2##(1991-5#1)(2012-2#1)
malaria vectors##2##2##(2007-2#1)(2008-8#1)
malaria was##3##2##(2011-2#1)(2012-12#2)
malaria were##4##2##(1997-3#1)(2007-2#1)(2012-12#2)
malaria with##4##2##(1993-8#1)(2007-2#1)(2011-2#1)(2012-12#1)
malaria##326##1##(1990-12#1)(1990-3#2)(1991-12#1)(1991-2#2)(1991-5#5)(1992-2#1)(1992-6#3)(1993-2#2)(1993-8#4)(1994-11#5)(1994-7#1)(1994-8#1)(1995-12#3)(1995-5#2)(1996-11#1)(1996-8#1)(1997-3#1)(1997-4#6)(1997-7#1)(2007-12#2)(2007-2#46)(2007-7#7)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#37)(2008-9#1)(2009-10#1)(2009-6#5)(2009-9#1)(2010-1#15)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#22)(2012-1#1)(2012-12#69)(2012-2#20)(2012-3#27)(2013-1#1)(2013-8#5)
malaria&quot##2##1##(2007-2#1)(2010-1#1)
malaria-endemic##2##1##(2007-2#2)
malaria-tolerant##2##1##(1996-11#2)
malaria]##4##1##(1997-2#1)(2012-12#2)(2013-1#1)
malariae##3##1##(2008-4#1)(2012-12#1)(2012-2#1)
malarial tolerance##2##2##(1996-11#2)
malarial##9##1##(1993-2#1)(1996-11#3)(2007-2#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
malarious areas##2##2##(2007-2#2)
malarious##3##1##(2007-2#2)(2008-8#1)
malate dehydrogenase##8##2##(1990-5#1)(1993-11#4)(2008-10#3)
malate##18##1##(1990-5#1)(1991-3#1)(1993-11#4)(1993-6#1)(2008-10#10)(2012-1#1)
malathion##10##1##(1994-5#2)(2008-10#7)(2013-1#1)
maldistributed##2##1##(1994-12#1)(1996-3#1)
male (133/207##2##2##(2007-2#2)
male (n =##2##3##(2009-1#1)(2013-1#1)
male CD-1 mice##2##3##(1990-6#2)
male DNA##5##2##(1992-11#2)(2008-12#3)
male EODs##2##2##(2009-8#2)
male F344 rats##3##3##(1992-3#2)(1992-9#1)
male F344/N rats##2##3##(2008-8#1)(2008-9#1)
male F344/N##3##2##(2008-8#1)(2008-9#2)
male Filipino seafarers##5##3##(2011-2#5)
male Fischer (F344/NCr)##2##3##(1993-12#2)
male Fischer 344 rats##8##4##(1990-3#1)(1990-6#2)(1992-12#1)(1994-3#2)(1994-5#1)(2008-7#1)
male Fischer 344##9##3##(1990-3#1)(1990-6#2)(1992-12#1)(1994-3#3)(1994-5#1)(2008-7#1)
male Fischer F344 rats##2##4##(1990-3#2)
male Fischer##13##2##(1990-3#3)(1990-6#2)(1992-12#1)(1993-12#2)(1994-3#3)(1994-5#1)(2008-7#1)
male Sprague-Dawley rats weighing##2##4##(2008-12#1)(2008-4#1)
male Sprague-Dawley rats were##3##4##(1993-3#1)(2008-10#1)(2013-1#1)
male Sprague-Dawley rats##12##3##(1991-12#1)(1993-3#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2011-2#1)(2013-1#1)
male Sprague-Dawley##14##2##(1991-12#1)(1993-3#1)(1995-3#2)(1996-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
male Wistar Albino rats##2##4##(1996-12#1)(2008-11#1)
male Wistar rats were##4##4##(1996-12#1)(1997-7#1)(2008-7#1)(2011-3#1)
male Wistar rats##12##3##(1992-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
male Wistar##15##2##(1992-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
male activity of female-search##2##4##(2008-6#2)
male adolescents##3##2##(1992-11#2)(2008-9#1)
male adults of##2##3##(1991-5#1)(2013-8#1)
male adults##4##2##(1991-12#1)(1991-5#1)(1996-11#1)(2013-8#1)
male albino rats were##3##4##(2008-10#2)(2012-2#1)
male albino rats##6##3##(1993-5#1)(2008-10#3)(2012-2#2)
male albino##11##2##(1993-5#1)(1994-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#2)
male and 30##2##3##(2008-1#1)(2008-5#1)
male and female Tg##7##4##(2008-8#1)(2008-9#6)
male and female components##3##4##(2008-9#3)
male and female gametes##2##4##(1997-7#1)(2008-11#1)
male and female mice##7##4##(1995-11#1)(2008-9#6)
male and female patients##4##4##(2008-7#4)
male and female plant##2##4##(2008-8#2)
male and female rats is##3##5##(1993-5#1)(2008-10#1)(2010-1#1)
male and female rats##13##4##(1993-5#1)(1994-2#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#3)(2008-12#4)(2010-1#1)
male and female subjects##4##4##(2008-10#1)(2008-5#2)(2013-1#1)
male and female##110##3##(1990-12#1)(1990-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#2)(1994-2#1)(1995-11#1)(1995-3#1)(1995-8#2)(1997-7#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-11#4)(2008-12#9)(2008-4#1)(2008-5#9)(2008-7#6)(2008-8#9)(2008-9#21)(2010-1#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#5)
male and healthy female##2##4##(2008-10#2)
male and infected female##2##4##(2008-10#2)
male and##191##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-12#1)(1997-7#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#9)(2008-8#12)(2008-9#59)(2009-11#1)(2010-1#1)(2010-12#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#6)
male batterers##3##2##(2009-5#3)
male blood##2##2##(1994-12#1)(2013-7#1)
male body odor##2##3##(2008-5#2)
male body size##2##3##(1995-2#1)(2008-8#1)
male body##6##2##(1995-2#1)(2007-12#1)(2008-5#3)(2008-8#1)
male breast cancer##7##3##(1990-12#1)(1990-2#2)(1997-7#2)(2011-2#2)
male breast##10##2##(1990-12#2)(1990-2#2)(1992-2#2)(1997-7#2)(2011-2#2)
male buffalo meat##3##3##(2010-4#3)
male cadaver##3##2##(2008-7#2)(2013-1#1)
male cells##5##2##(1990-3#2)(2008-12#3)
male characters##3##2##(2008-8#2)(2008-9#1)
male child presented with##2##4##(2008-10#1)(2010-11#1)
male child who presented with##4##5##(2007-8#1)(2010-4#1)(2012-12#2)
male child with##4##3##(2007-8#1)(2008-1#1)(2012-12#1)(2012-3#1)
male child##11##2##(2007-8#2)(2008-1#1)(2008-10#1)(2010-11#1)(2010-4#1)(2012-12#3)(2012-3#1)(2013-1#1)
male children##2##2##(2010-5#1)(2011-1#1)
male circumcision##3##2##(2011-1#3)
male contraceptive##3##2##(1994-8#1)(1997-6#2)
male controls##3##2##(2008-3#2)(2008-7#1)
male diabetic##2##2##(1990-6#1)(2007-7#1)
male dominance##2##2##(1991-6#1)(1995-6#1)
male embryos##3##2##(1994-11#2)(2008-11#1)
male endophalli##2##2##(2008-5#2)
male excess##2##2##(1991-6#1)(2008-11#1)
male factor infertility##3##3##(1996-9#1)(2007-10#1)(2008-1#1)
male female-search##3##2##(2008-6#3)
male fertility are##2##3##(2008-9#1)(2012-2#1)
male fertility in##2##3##(2008-9#1)(2012-2#1)
male fertility##13##2##(1991-11#1)(2008-8#2)(2008-9#3)(2009-10#3)(2012-2#4)
male fetuses##2##2##(1993-12#1)(2013-1#1)
male fish##2##2##(2009-9#1)(2010-5#1)
male fitness##7##2##(2008-8#3)(2008-9#4)
male folklore##2##2##(2009-10#2)
male from##3##2##(1990-9#1)(2007-12#1)(2012-2#1)
male function##2##2##(2008-9#2)
male gender and##2##3##(2008-10#1)(2013-8#1)
male gender##14##2##(2007-10#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#3)(2013-1#2)(2013-8#2)
male genital tract##4##3##(1990-11#1)(2008-4#1)(2012-1#1)(2012-2#1)
male genital##9##2##(1990-11#1)(1993-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
male genitalia##4##2##(2008-2#1)(2008-5#2)(2012-3#1)
male germ cells##5##3##(1994-11#2)(1997-3#1)(2012-2#2)
male germ##8##2##(1994-11#2)(1997-3#1)(2009-3#3)(2012-2#2)
male germ-line##2##2##(2009-3#2)
male gonad##2##2##(2007-12#1)(2012-1#1)
male gonadal##2##2##(2008-7#1)(2012-2#1)
male groups of F and##2##5##(2008-12#2)
male groups##3##2##(2008-12#2)(2008-9#1)
male heterogametic##2##2##(2008-8#2)
male hosts##2##2##(2008-5#2)
male human##3##2##(2008-7#1)(2012-2#2)
male in##2##2##(2007-8#1)(2008-6#1)
male indicator trait##2##3##(2008-9#2)
male infant with##2##3##(1997-3#1)(2010-6#1)
male infant##8##2##(1994-12#1)(1997-3#1)(2007-8#2)(2008-12#1)(2010-6#1)(2011-1#2)
male infertility##7##2##(1997-4#1)(2008-12#2)(2009-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
male investment##2##2##(2008-8#2)
male is described##2##3##(2008-11#1)(2010-6#1)
male is##3##2##(2007-10#1)(2008-11#1)(2010-6#1)
male killing##5##2##(2008-8#3)(2008-9#1)(2012-3#1)
male lambs##7##2##(2008-12#2)(2010-2#5)
male lures##2##2##(2011-2#2)
male mating structures##2##3##(2007-12#2)
male mating##3##2##(2007-12#2)(2012-3#1)
male meadow voles##2##3##(1994-3#1)(2008-9#1)
male meiosis##4##2##(2008-12#1)(2008-5#3)
male mice were##2##3##(2008-9#1)(2012-2#1)
male mice##19##2##(1990-7#2)(1995-11#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#8)(2011-2#1)(2012-2#1)(2013-1#1)
male morphology##2##2##(2008-5#1)(2008-8#1)
male morphotypes##2##2##(2013-7#2)
male offspring##4##2##(2008-10#1)(2012-3#3)
male or female Tg##6##4##(2008-9#6)
male or female##17##3##(1994-7#1)(2008-7#2)(2008-8#1)(2008-9#12)(2009-9#1)
male parental care and female multiple mating##3##7##(2008-8#3)
male parental care##4##3##(2008-8#4)
male partners##2##2##(1993-9#1)(2010-11#1)
male patient in##2##3##(2007-10#1)(2012-12#1)
male patient presented with a##2##5##(2006-12#1)(2010-6#1)
male patient presented with##4##4##(2006-12#1)(2008-7#1)(2010-6#1)(2012-2#1)
male patient suffered##2##3##(1997-6#1)(2007-8#1)
male patient was##2##3##(2007-7#1)(2010-12#1)
male patient who##3##3##(2009-11#1)(2009-4#1)(2012-2#1)
male patient with##9##3##(1997-2#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
male patient##30##2##(1997-2#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
male patients who##2##3##(1990-5#1)(2012-3#1)
male patients with schizophrenia##2##4##(1996-7#2)
male patients with##13##3##(1990-2#1)(1991-2#1)(1993-12#1)(1996-7#2)(2007-10#1)(2007-7#3)(2007-8#1)(2008-3#1)(2011-2#1)(2012-3#1)
male patients##35##2##(1990-2#1)(1990-5#1)(1991-2#4)(1993-12#1)(1996-7#3)(1997-3#1)(1997-8#1)(2007-10#2)(2007-7#4)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
male physicians who##3##3##(2011-2#3)
male physicians##5##2##(1994-3#1)(2011-2#4)
male population##5##2##(1993-11#1)(1995-11#1)(2008-1#1)(2011-2#1)(2013-8#1)
male predominance in##3##3##(1994-12#1)(2012-3#1)(2013-8#1)
male predominance##6##2##(1994-12#1)(2008-1#2)(2008-7#1)(2012-3#1)(2013-8#1)
male presented to##3##3##(1992-6#1)(2010-5#1)(2013-1#1)
male presented with a##6##4##(2008-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-6#1)
male presented with severe##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
male presented with##16##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
male presented##19##2##(1992-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
male presenting with a##2##4##(2013-1#1)(2013-7#1)
male presenting with##5##3##(2008-6#2)(2013-1#2)(2013-7#1)
male presenting##6##2##(2008-6#2)(2013-1#2)(2013-7#1)(2013-8#1)
male pseudohermaphrodites##2##2##(2008-10#1)(2008-4#1)
male pseudohermaphroditism##4##2##(2008-2#2)(2008-4#2)
male rat liver cytosolic estrogen receptor##2##6##(1993-8#2)
male rat sexual behavior##6##4##(1991-2#6)
male rat##15##2##(1990-11#1)(1991-2#7)(1992-8#1)(1993-12#1)(1993-8#2)(1994-2#2)(2008-9#1)
male rats after##2##3##(1993-12#1)(2013-1#1)
male rats at##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
male rats in##2##3##(1992-1#1)(2013-1#1)
male rats received##2##3##(1992-12#1)(2013-1#1)
male rats were treated##2##4##(1997-4#1)(2008-11#1)
male rats were##6##3##(1990-11#1)(1992-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-1#1)
male rats##75##2##(1990-11#3)(1990-3#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-2#4)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#4)(2007-11#2)(2008-10#1)(2008-11#7)(2008-3#1)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)(2013-1#11)
male remating time##2##3##(2008-5#2)
male remating##3##2##(2008-5#3)
male reproductive##7##2##(1993-3#1)(2007-12#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
male secondary sexual##2##3##(2007-12#1)(2008-9#1)
male sex##8##2##(1997-7#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2013-1#1)
male sexual and reproductive health in Colombia##2##7##(2012-12#2)
male sexual behavior##2##3##(1994-2#1)(1995-12#1)
male sexual characters##2##3##(2012-3#2)
male sexual partners of##2##4##(1991-2#2)
male sexual##15##2##(1991-2#2)(1994-2#1)(1995-12#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-12#3)(2012-3#3)
male sexuality##2##2##(2008-10#1)(2009-10#1)
male skin##4##2##(2008-5#4)
male smoker##2##2##(2006-10#1)(2008-6#1)
male smokers##3##2##(1993-6#1)(1996-3#1)(2006-10#1)
male specific##2##2##(1992-11#1)(1995-2#1)
male sperm##2##2##(2008-9#1)(2011-2#1)
male sterile##3##2##(1996-10#1)(2008-10#1)(2008-8#1)
male sterility##5##2##(1993-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
male students##3##2##(1992-6#1)(2008-1#1)(2013-8#1)
male subjects##10##2##(1992-3#2)(1994-9#1)(2008-5#3)(2009-1#1)(2009-12#1)(2011-2#1)(2012-3#1)
male than##3##2##(1994-11#1)(1994-2#1)(2008-9#1)
male to female##8##3##(1993-9#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-5#2)(2008-7#1)(2011-2#1)
male to##11##2##(1993-9#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-5#2)(2008-7#2)(2008-8#2)(2011-2#1)
male trait##2##2##(2008-8#2)
male traits##3##2##(2008-8#3)
male versus female##2##3##(2008-8#2)
male volunteers##5##2##(1996-5#1)(1996-7#1)(2008-5#1)(2009-11#1)(2012-12#1)
male was admitted##3##3##(1992-5#1)(1993-3#1)(2013-1#1)
male was##6##2##(1992-5#1)(1993-3#1)(1997-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
male water buffalo calf##2##4##(2008-12#2)
male who developed##2##3##(1990-3#1)(2010-6#1)
male who had##4##3##(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
male who presented with a painless##2##6##(2008-7#1)(2011-2#1)
male who presented with a##4##5##(2008-7#2)(2011-2#1)(2013-8#1)
male who presented with##5##4##(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
male who presented##6##3##(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
male who##15##2##(1990-3#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
male with a history of##2##5##(2010-10#1)(2012-2#1)
male with a##9##3##(2007-8#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
male with chronic##3##3##(2008-7#1)(2010-7#1)(2013-1#1)
male with left##2##3##(2007-5#1)(2013-1#1)
male with no##2##3##(2010-3#1)(2013-8#1)
male with##43##2##(1990-3#1)(1996-3#1)(1996-7#1)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#7)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
male workers##3##2##(2008-8#1)(2009-12#1)(2009-9#1)
male x##2##2##(2008-12#2)
male young##2##2##(2007-8#1)(2008-5#1)
male##1328##1##(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#9)(1990-5#3)(1990-6#7)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#13)(1991-3#1)(1991-5#4)(1991-6#8)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#11)(1992-12#4)(1992-2#3)(1992-3#12)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#8)(1993-3#4)(1993-5#4)(1993-6#3)(1993-8#4)(1993-9#2)(1994-11#9)(1994-12#4)(1994-2#17)(1994-3#5)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#5)(1994-9#2)(1995-11#5)(1995-12#10)(1995-2#4)(1995-3#9)(1995-6#3)(1995-8#5)(1996-10#1)(1996-11#5)(1996-12#8)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#6)(1996-8#1)(1996-9#3)(1997-2#4)(1997-3#8)(1997-4#2)(1997-5#1)(1997-6#12)(1997-7#6)(1997-8#3)(2006-10#2)(2006-12#1)(2007-10#11)(2007-11#3)(2007-12#31)(2007-2#9)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#16)(2008-1#13)(2008-10#38)(2008-11#25)(2008-12#47)(2008-2#7)(2008-3#8)(2008-4#20)(2008-5#62)(2008-6#22)(2008-7#62)(2008-8#80)(2008-9#122)(2009-1#4)(2009-10#14)(2009-11#5)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#18)(2009-6#3)(2009-7#6)(2009-8#8)(2009-9#16)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#5)(2010-3#3)(2010-4#16)(2010-5#12)(2010-6#5)(2010-7#4)(2010-8#3)(2011-1#15)(2011-2#65)(2011-3#1)(2012-1#9)(2012-12#26)(2012-2#34)(2012-3#37)(2012-7#1)(2013-1#65)(2013-7#11)(2013-8#28)
male's##4##1##(2008-8#3)(2009-8#1)
male) between##2##2##(2008-5#1)(2013-1#1)
male) were##2##2##(2011-2#1)(2013-8#1)
male)##17##1##(1993-12#1)(2007-12#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
male-biased##5##1##(1994-8#1)(1996-6#1)(2008-8#3)
male-female ratio##2##2##(1992-5#1)(2008-1#1)
male-female##5##1##(1992-5#1)(2008-1#1)(2008-12#1)(2008-8#2)
male-killing##3##1##(2012-3#3)
male-male competition##3##2##(2008-8#2)(2013-1#1)
male-male##5##1##(2008-5#1)(2008-8#2)(2013-1#2)
male-specific##11##1##(1995-2#3)(2007-12#4)(2012-3#3)(2013-1#1)
male-sterile##3##1##(2008-10#1)(2008-8#2)
male-to-female ratio of##2##3##(2008-9#2)
male-to-female ratio##4##2##(2008-9#4)
male-to-female##8##1##(2007-10#1)(2008-5#1)(2008-9#5)(2011-2#1)
male/female ratio##2##2##(2007-2#1)(2011-3#1)
male/female##5##1##(2007-2#1)(2008-1#1)(2008-5#1)(2011-2#1)(2011-3#1)
maleate##15##1##(1993-12#1)(1996-12#4)(1996-5#1)(2008-10#4)(2010-3#2)(2010-5#2)(2012-12#1)
maleic and phthalic acids##2##4##(2008-10#2)
maleic anhydride##5##2##(1993-11#1)(1994-8#1)(1995-11#1)(1996-5#1)(2007-11#1)
maleic##14##1##(1993-11#1)(1994-8#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-10#7)(2013-1#2)
maleimide and##2##2##(2008-10#1)(2008-6#1)
maleimide##10##1##(1990-12#1)(1990-2#1)(2008-10#1)(2008-4#2)(2008-6#4)(2009-9#1)
males (mean##4##2##(2007-12#1)(2008-1#1)(2008-4#1)(2013-8#1)
males (the##3##2##(2008-7#1)(2008-8#2)
males 13-24 years old##2##4##(1995-9#2)
males after##2##2##(2008-8#1)(2011-2#1)
males aged##4##2##(1990-3#1)(1992-5#1)(1993-11#1)(2011-1#1)
males and 1##7##3##(1991-6#1)(1992-9#1)(1993-9#1)(1994-6#1)(2007-7#1)(2008-9#2)
males and 10 females##4##4##(2007-8#1)(2008-9#3)
males and 10##5##3##(1994-6#1)(2007-8#1)(2008-9#3)
males and 100##2##3##(1995-6#1)(2008-9#1)
males and 11##2##3##(1997-4#1)(2008-9#1)
males and 12 females##2##4##(1991-2#1)(2008-5#1)
males and 13##2##3##(1993-11#1)(2008-9#1)
males and 15 females##2##4##(1991-12#2)
males and 15##3##3##(1991-12#2)(2008-6#1)
males and 2##2##3##(2007-7#1)(2013-7#1)
males and 20 females##2##4##(1991-2#1)(2007-7#1)
males and 20##3##3##(1991-2#1)(2007-7#1)(2010-4#1)
males and 22##2##3##(1991-6#1)(2008-9#1)
males and 27##2##3##(2007-7#1)(2011-2#1)
males and 28##3##3##(1994-6#1)(2008-1#1)(2008-9#1)
males and 31##2##3##(2007-7#1)(2008-9#1)
males and 4##3##3##(1993-9#1)(2008-10#1)(2013-7#1)
males and 5##4##3##(1991-6#1)(1994-6#1)(2007-7#1)(2008-5#1)
males and 8##2##3##(1994-12#1)(2008-12#1)
males and 800##2##3##(2008-9#2)
males and absolute##2##3##(2008-9#2)
males and females and##3##4##(2008-4#1)(2008-9#1)(2013-7#1)
males and females at##6##4##(2008-9#6)
males and females exposed to##4##5##(2008-9#4)
males and females in both studies##3##6##(2008-9#3)
males and females in the##3##5##(2008-9#3)
males and females in##7##4##(2008-9#6)(2012-3#1)
males and females may##2##4##(1995-6#1)(2012-12#1)
males and females of##3##4##(2007-12#1)(2008-7#1)(2013-7#1)
males and females reported##2##4##(2008-5#1)(2012-12#1)
males and females was similar to that of the control groups##4##11##(2008-9#4)
males and females was similar to that of the##8##9##(2008-9#8)
males and females was similar to that##9##7##(2008-9#9)
males and females was##11##4##(1994-6#1)(2008-9#10)
males and females were##8##4##(2008-4#1)(2008-9#7)
males and females##92##3##(1990-3#1)(1990-8#1)(1991-2#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#50)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#5)(2013-8#1)
males and five females)##2##4##(2007-7#1)(2013-7#1)
males and in##3##3##(1993-12#1)(2008-9#2)
males and on the##2##4##(2008-10#1)(2012-12#1)
males and oviparae##3##3##(2008-9#3)
males and the##2##3##(1991-6#1)(2012-3#1)
males and three females##2##4##(2007-7#1)(2008-1#1)
males and##230##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#3)(1991-6#5)(1992-9#3)(1993-11#1)(1993-12#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#5)(1995-10#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-7#12)(2007-8#2)(2008-1#9)(2008-10#7)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#82)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#9)(2013-8#3)
males are##9##2##(1997-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#1)
males as##2##2##(1995-12#1)(2009-10#1)
males at 39 weeks##2##4##(2008-9#2)
males at 43 weeks##4##4##(2008-9#4)
males at##9##2##(2008-9#8)(2013-7#1)
males but not##3##3##(1995-2#1)(2008-9#1)(2013-8#1)
males but##6##2##(1994-6#1)(1995-2#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
males compared to females##2##4##(2008-5#1)(2008-8#1)
males developing in##2##3##(2013-1#2)
males did not##2##3##(2008-11#1)(2013-8#1)
males exposed to##4##3##(2008-8#1)(2008-9#3)
males following##2##2##(2010-7#1)(2013-1#1)
males for##2##2##(1990-3#1)(2008-5#1)
males from a##2##3##(2008-12#1)(2008-8#1)
males from##6##2##(2008-1#1)(2008-12#2)(2008-6#1)(2008-8#1)(2012-3#1)
males had significantly##2##3##(2008-1#1)(2008-10#1)
males had##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2010-4#1)(2013-1#1)
males have##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
males in a##2##3##(2009-1#1)(2013-1#1)
males in four age groups (4##2##6##(2008-7#2)
males in the##4##3##(2008-5#1)(2008-8#1)(2008-9#2)
males in##15##2##(1990-2#1)(1997-7#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
males increased##2##2##(2008-6#1)(2008-9#1)
males invest in##2##3##(2008-8#1)(2008-9#1)
males irradiated with##3##3##(2011-2#2)(2012-12#1)
males living##2##2##(2008-10#1)(2013-1#1)
males may be##2##3##(2008-8#1)(2009-9#1)
males may##3##2##(1991-2#1)(2008-8#1)(2009-9#1)
males of the common shrew (Sorex##2##6##(2008-12#2)
males of the##7##3##(2007-12#1)(2008-1#1)(2008-12#2)(2008-6#1)(2010-8#2)
males of##22##2##(1995-8#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2010-8#2)(2011-2#3)(2013-7#1)(2013-8#1)
males older than##2##3##(1990-12#1)(2011-2#1)
males or##3##2##(2008-4#1)(2008-9#1)(2012-12#1)
males over the age of 50##2##6##(1994-12#2)
males spent more time##4##4##(2008-5#1)(2009-9#2)(2012-3#1)
males than in##10##3##(1990-12#1)(1992-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-3#1)
males than##12##2##(1990-12#1)(1992-12#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-3#1)
males that##3##2##(2008-5#1)(2008-6#1)(2009-5#1)
males to##8##2##(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
males typically##2##2##(1996-12#1)(2009-8#1)
males use##3##2##(2008-8#1)(2009-9#2)
males used computers##2##3##(2013-8#2)
males used##4##2##(2012-12#1)(2013-8#3)
males vs##2##2##(1990-6#1)(2010-3#1)
males was also##2##3##(2008-9#1)(2012-3#1)
males was less than that##2##5##(2008-9#2)
males was##13##2##(1993-8#2)(1995-9#1)(2008-10#1)(2008-5#1)(2008-9#4)(2011-2#2)(2012-3#2)
males were also##3##3##(1995-3#1)(2008-5#1)(2008-9#1)
males were less than those of the controls##3##8##(2008-8#1)(2008-9#2)
males were less than those of the##5##7##(2008-8#1)(2008-9#4)
males were less##7##3##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#4)
males were more##2##3##(1995-2#1)(2008-12#1)
males were significantly greater than##5##5##(2008-9#5)
males were significantly increased##2##4##(2008-9#2)
males were significantly less than those of the control group##4##10##(2008-9#4)
males were significantly less than those of the##7##8##(2008-9#7)
males were significantly##14##3##(2008-9#14)
males were##45##2##(1991-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#5)(2008-8#4)(2008-9#20)(2009-9#1)(2012-12#1)(2013-7#2)
males who##5##2##(1994-12#1)(2010-7#2)(2012-12#1)(2012-2#1)
males with a##3##3##(1992-5#1)(2008-10#1)(2008-9#1)
males with ankylosing spondylitis##2##4##(2011-2#2)
males with the##2##3##(2008-7#1)(2008-9#1)
males with##22##2##(1991-1#1)(1992-5#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
males##841##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#5)(1990-6#4)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#9)(1991-6#11)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-9#4)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#11)(1994-3#1)(1994-6#12)(1994-7#2)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#4)(1995-6#9)(1995-8#3)(1995-9#3)(1996-12#4)(1996-2#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-7#4)(2007-10#2)(2007-12#13)(2007-7#20)(2007-8#2)(2008-1#21)(2008-10#23)(2008-11#13)(2008-12#16)(2008-3#4)(2008-4#14)(2008-5#46)(2008-6#13)(2008-7#18)(2008-8#75)(2008-9#166)(2009-1#2)(2009-10#4)(2009-3#1)(2009-5#8)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#16)(2010-12#4)(2010-3#6)(2010-4#9)(2010-5#1)(2010-7#3)(2010-8#10)(2011-1#8)(2011-2#32)(2012-1#1)(2012-12#22)(2012-2#11)(2012-3#19)(2013-1#22)(2013-7#25)(2013-8#16)
males'##4##1##(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
males) aging from##2##3##(2011-2#2)
males) with##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
males)##16##1##(1996-9#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#3)(2013-1#3)(2013-8#1)
male &gt##3##1##(2012-12#3)
malformation and##4##2##(1990-8#1)(2007-10#1)(2008-7#1)(2010-11#1)
malformation characterized by##2##3##(1992-6#1)(2008-11#1)
malformation disease##4##2##(2008-10#4)
malformation has##2##2##(2008-10#2)
malformation in##5##2##(1992-5#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)
malformation is##3##2##(2007-10#1)(2008-7#1)(2009-5#1)
malformation of the##7##3##(2008-10#1)(2008-4#1)(2008-8#2)(2009-4#1)(2009-5#1)(2012-3#1)
malformation of##8##2##(2008-10#1)(2008-4#1)(2008-8#2)(2009-4#1)(2009-5#1)(2012-3#2)
malformation presenting##2##2##(2012-12#1)(2013-1#1)
malformation syndrome##3##2##(2007-7#1)(2008-10#2)
malformation was##4##2##(1990-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
malformation with##3##2##(1996-6#1)(1997-3#1)(2012-2#1)
malformation##109##1##(1990-8#2)(1990-9#3)(1991-3#1)(1992-2#2)(1992-5#2)(1992-6#1)(1996-12#1)(1996-6#5)(1996-9#1)(1997-3#1)(1997-4#1)(2007-10#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#28)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#3)(2010-10#2)(2010-11#2)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#1)
malformations and##10##2##(1991-2#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-1#3)(2011-2#1)(2013-8#1)
malformations are##3##2##(1990-8#1)(2008-1#1)(2008-10#1)
malformations associated with##2##3##(2008-1#1)(2008-9#1)
malformations but##3##2##(1995-8#1)(1996-12#1)(2012-3#1)
malformations in a##2##3##(2011-2#1)(2012-3#1)
malformations in cerebral##2##3##(2008-1#1)(2008-7#1)
malformations in the##4##3##(2007-12#1)(2008-10#1)(2008-7#2)
malformations in##11##2##(1991-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#3)(2011-2#1)(2012-3#2)
malformations is##5##2##(1990-9#1)(1995-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
malformations may##2##2##(2008-8#1)(2008-9#1)
malformations of the brain##3##4##(1997-6#1)(2008-7#2)
malformations of the##7##3##(1997-6#1)(2007-7#1)(2008-10#1)(2008-7#4)
malformations should be##2##3##(1996-11#1)(2008-7#1)
malformations was##5##2##(1993-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
malformations were##2##2##(1990-8#1)(1993-12#1)
malformations with##6##2##(2008-7#4)(2011-2#2)
malformations##165##1##(1990-5#2)(1990-8#6)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-12#3)(1993-9#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#3)(2006-12#2)(2007-10#5)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#37)(2008-8#4)(2008-9#10)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#11)(2012-1#3)(2012-2#5)(2012-3#11)(2013-1#3)(2013-8#2)
malformations]##3##1##(1991-2#1)(1992-3#1)(1993-5#1)
malformed##3##1##(1996-12#1)(2008-10#1)(2008-3#1)
malfunction of the##2##3##(2009-3#1)(2011-2#1)
malfunction of##4##2##(1997-4#1)(2008-11#1)(2009-3#1)(2011-2#1)
malfunction##7##1##(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)
malfunctioning hemodialysis##2##2##(2008-1#2)
malfunctioning##4##1##(2007-8#1)(2008-1#2)(2008-7#1)
malfunctions of##2##2##(1991-2#1)(2010-8#1)
malfunctions##4##1##(1991-2#1)(2007-8#1)(2010-8#1)(2012-12#1)
mali'##3##1##(2008-10#3)
mali)##2##1##(2008-10#2)
malic acid##7##2##(1992-3#1)(2008-10#5)(2008-5#1)
malic and##3##2##(2008-10#2)(2008-5#1)
malic enzyme and##2##3##(2008-10#1)(2013-1#1)
malic enzyme##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
malic##20##1##(1992-3#1)(2008-10#13)(2008-5#3)(2012-2#1)(2013-1#2)
maligna melanoma##3##2##(2011-2#3)
maligna##5##1##(2011-2#5)
malignancies and##15##2##(1990-12#1)(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
malignancies are##7##2##(1990-8#1)(1992-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)
malignancies during pregnancy##2##3##(2013-1#2)
malignancies have##3##2##(2008-1#1)(2008-4#1)(2011-2#1)
malignancies in##8##2##(1991-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
malignancies is##3##2##(1991-3#1)(2010-11#1)(2012-2#1)
malignancies of the##4##3##(1993-6#1)(1994-1#1)(2011-2#2)
malignancies of##8##2##(1990-2#1)(1990-6#1)(1993-6#1)(1993-9#1)(1994-1#1)(2011-2#3)
malignancies such as##2##3##(1991-11#1)(2011-2#1)
malignancies that##2##2##(2013-1#1)(2013-7#1)
malignancies was##2##2##(1990-12#1)(1995-12#1)
malignancies were found##2##3##(1990-12#1)(1994-2#1)
malignancies with##4##2##(1991-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
malignancies##177##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#2)(1991-8#3)(1992-2#1)(1992-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#4)(1995-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#24)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#5)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#24)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#2)
malignancies]##2##1##(1996-8#1)(2010-8#1)
malignancy and the most##2##4##(2008-7#1)(2010-4#1)
malignancy and the##5##3##(1991-3#1)(1997-6#1)(2008-7#1)(2010-4#1)(2012-3#1)
malignancy and##17##2##(1991-3#2)(1993-8#2)(1994-12#1)(1997-6#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
malignancy by##3##2##(1990-3#1)(1994-12#1)(2013-8#1)
malignancy has##2##2##(1995-6#1)(2012-12#1)
malignancy in children##3##3##(2009-1#1)(2010-11#1)(2011-2#1)
malignancy in the##2##3##(1997-2#1)(2012-12#1)
malignancy in##15##2##(1990-10#1)(1990-2#1)(1997-2#1)(2007-7#1)(2008-11#2)(2009-1#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
malignancy is##7##2##(1990-10#1)(1996-1#1)(2008-1#1)(2008-4#1)(2010-5#1)(2013-8#2)
malignancy of the##3##3##(1990-6#1)(1992-9#1)(2008-3#1)
malignancy of##7##2##(1990-6#1)(1992-9#1)(2008-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
malignancy or##3##2##(1991-2#1)(1993-8#1)(2007-7#1)
malignancy patients with##2##3##(2012-2#1)(2013-8#1)
malignancy to##2##2##(2008-1#1)(2010-4#1)
malignancy was##7##2##(1990-2#2)(1990-3#1)(1991-8#1)(1997-2#1)(2008-5#2)
malignancy were##2##2##(2011-1#1)(2011-2#1)
malignancy with##2##2##(1997-5#1)(2013-8#1)
malignancy##205##1##(1990-10#2)(1990-12#1)(1990-2#8)(1990-3#2)(1990-6#4)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-8#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-8#4)(1994-11#3)(1994-12#3)(1994-5#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#2)(2007-7#7)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#2)(2009-1#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#13)(2012-1#1)(2012-12#9)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#16)
malignancy-associated##3##1##(1994-11#1)(2008-5#1)(2011-2#1)
malignant HMEC##2##2##(1990-12#2)
malignant and benign##4##3##(1993-9#1)(1994-2#1)(2013-1#1)(2013-8#1)
malignant and non-malignant##3##3##(2010-11#1)(2012-2#1)(2012-3#1)
malignant and##18##2##(1990-10#1)(1991-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(2008-2#1)(2008-3#2)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
malignant behavior##4##2##(1990-2#2)(1990-6#1)(2008-6#1)
malignant bone tumors and##2##4##(2008-6#2)
malignant bone tumors##5##3##(2008-6#4)(2011-2#1)
malignant bone tumours##2##3##(2008-6#1)(2010-3#1)
malignant bone##11##2##(1994-5#1)(2008-6#6)(2008-7#1)(2010-3#1)(2011-2#2)
malignant brain##5##2##(1995-12#1)(1997-8#1)(2008-7#1)(2011-3#1)(2013-8#1)
malignant catarrhal fever##2##3##(1990-6#1)(2011-1#1)
malignant cell lines##2##3##(1994-3#1)(2008-6#1)
malignant cell##4##2##(1994-3#1)(2007-10#1)(2008-6#1)(2011-2#1)
malignant cells are##2##3##(1993-11#1)(1997-4#1)
malignant cells of##2##3##(2011-2#1)(2013-1#1)
malignant cells##28##2##(1990-11#1)(1993-1#1)(1993-11#1)(1994-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-1#2)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
malignant change in##3##3##(1990-10#1)(2008-7#1)(2010-12#1)
malignant change##7##2##(1990-10#3)(1991-2#1)(2008-7#2)(2010-12#1)
malignant cutaneous##3##2##(1996-6#1)(2007-12#1)(2013-7#1)
malignant cystosarcoma phyllodes##2##3##(2011-3#2)
malignant degeneration##4##2##(1990-11#1)(2006-10#1)(2008-5#1)(2011-2#1)
malignant disease##18##2##(1990-9#1)(1991-4#1)(1992-2#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)
malignant diseases##8##2##(1990-11#1)(1990-2#1)(1992-2#1)(1992-8#1)(1997-5#1)(2008-11#1)(2008-4#1)(2008-5#1)
malignant disorders##5##2##(1990-10#2)(1992-8#1)(2008-9#1)(2011-2#1)
malignant effusions##2##2##(1992-2#1)(2008-4#1)
malignant epithelial##5##2##(1993-9#3)(2012-1#1)(2012-3#1)
malignant fibrous histiocytoma of bone in the##2##7##(1990-12#2)
malignant fibrous histiocytoma of bone##4##5##(1990-12#2)(2008-6#2)
malignant fibrous histiocytoma##12##3##(1990-12#3)(1990-8#1)(2008-11#1)(2008-6#6)(2012-1#1)
malignant form##2##2##(2008-5#1)(2010-3#1)
malignant gastric outlet obstruction##4##4##(2012-2#3)(2013-1#1)
malignant glioma##15##2##(1993-9#1)(1994-3#1)(1995-2#1)(1997-7#1)(2008-5#4)(2008-8#4)(2011-2#2)(2013-1#1)
malignant gliomas##10##2##(1993-9#1)(1995-9#1)(2008-12#4)(2008-5#1)(2008-7#3)
malignant hemangiopericytoma##2##2##(2008-6#2)
malignant histiocytosis##2##2##(2012-1#2)
malignant human##5##2##(1990-12#1)(1994-2#2)(1994-8#1)(2008-6#1)
malignant hyperthermia##6##2##(1990-9#1)(1997-3#5)
malignant in##4##2##(1992-5#1)(2011-1#1)(2013-1#2)
malignant lesion##3##2##(1990-12#1)(1995-4#1)(1997-2#1)
malignant lesions##10##2##(1992-2#1)(2007-5#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#3)
malignant lymphoma##11##2##(1991-6#1)(1991-9#1)(2008-10#4)(2008-5#1)(2009-1#1)(2009-8#1)(2012-1#1)(2012-3#1)
malignant lymphomas##6##2##(1993-2#1)(1997-3#2)(1997-8#1)(2008-4#1)(2011-2#1)
malignant melanoma and##2##3##(2008-7#1)(2011-2#1)
malignant melanoma cells##3##3##(1991-5#1)(1997-4#1)(2011-2#1)
malignant melanoma of the##2##4##(2007-12#1)(2007-5#1)
malignant melanoma of##3##3##(2007-12#1)(2007-5#1)(2008-6#1)
malignant melanoma##43##2##(1990-6#1)(1991-5#1)(1991-6#3)(1993-5#1)(1993-6#1)(1993-8#4)(1996-6#2)(1997-4#1)(2007-10#3)(2007-12#1)(2007-5#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-6#2)(2011-2#10)(2012-3#2)(2013-1#1)
malignant mesenchymal tumor##3##3##(2009-3#2)(2013-1#1)
malignant mesenchymal##5##2##(2009-3#2)(2011-2#2)(2013-1#1)
malignant mesothelioma had##2##3##(1992-11#2)
malignant mesothelioma in##3##3##(1991-12#2)(2008-8#1)
malignant mesothelioma is##4##3##(1991-12#1)(1992-11#1)(2007-8#1)(2010-12#1)
malignant mesothelioma of the pleura##2##5##(1991-12#1)(2007-8#1)
malignant mesothelioma##26##2##(1991-12#10)(1991-2#3)(1992-11#4)(1993-9#2)(1995-2#1)(2007-8#2)(2008-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
malignant mixed Müllerian##2##3##(2011-2#2)
malignant mixed##3##2##(2011-2#3)
malignant nature##4##2##(1990-6#1)(2008-5#1)(2010-11#1)(2012-3#1)
malignant neoplasm##2##2##(1991-8#1)(2008-3#1)
malignant neoplasms of the##3##4##(1990-3#1)(2008-10#1)(2013-8#1)
malignant neoplasms##12##2##(1990-3#1)(1991-8#1)(1993-9#2)(1994-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-3#2)(2013-8#1)
malignant neoplastic##3##2##(2008-6#1)(2010-12#1)(2012-2#1)
malignant nodes##2##2##(1991-12#1)(2008-1#1)
malignant ones##2##2##(2008-6#1)(2012-2#1)
malignant or##2##2##(1994-5#1)(2012-12#1)
malignant pain##2##2##(2008-4#2)
malignant patients##2##2##(1990-2#1)(2010-11#1)
malignant peripheral nerve sheath##2##4##(2008-7#1)(2009-1#1)
malignant phenotype##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
malignant phyllodes tumor##4##3##(1992-10#1)(1995-4#3)
malignant phyllodes##5##2##(1992-10#1)(1995-4#3)(2011-2#1)
malignant pleural effusions##2##3##(1991-6#2)
malignant pleural mesothelioma##14##3##(1990-12#2)(1992-12#3)(1995-2#1)(1997-5#2)(2007-8#4)(2008-10#1)(2011-2#1)
malignant pleural##18##2##(1990-12#2)(1991-6#2)(1992-11#2)(1992-12#3)(1995-2#1)(1997-5#2)(2007-8#4)(2008-10#1)(2011-2#1)
malignant potential##5##2##(1994-2#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-1#1)
malignant schwannoma##3##2##(1994-6#3)
malignant skin##2##2##(2011-2#2)
malignant solid tumors##2##3##(1990-2#2)
malignant solid##3##2##(1990-2#2)(2008-1#1)
malignant spinal cord compression##4##4##(1996-9#2)(2008-6#2)
malignant spinal cord##5##3##(1996-9#2)(2008-6#2)(2012-2#1)
malignant supratentorial infarction##3##3##(2012-3#3)
malignant syndrome and##3##3##(1990-9#1)(2009-11#1)(2012-2#1)
malignant syndrome##9##2##(1990-9#1)(2008-3#1)(2009-11#4)(2012-2#2)(2012-3#1)
malignant tissues##6##2##(1994-5#1)(2008-12#4)(2010-3#1)
malignant transformation by##2##3##(1990-8#1)(1991-9#1)
malignant transformation has been##2##4##(2008-7#1)(2012-12#1)
malignant transformation in the##2##4##(1990-5#1)(2006-10#1)
malignant transformation in##8##3##(1990-5#2)(2006-10#1)(2007-7#1)(2008-6#1)(2008-7#2)(2011-2#1)
malignant transformation of oral lichen planus to##2##7##(2008-4#2)
malignant transformation of##5##3##(1991-12#1)(2008-4#2)(2008-5#1)(2012-12#1)
malignant transformation##38##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-9#2)(1992-9#2)(1993-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2009-8#2)(2010-12#2)(2011-2#3)(2012-12#6)(2013-1#3)
malignant transformations##2##2##(1991-9#1)(2013-8#1)
malignant tumor of the##4##4##(2007-8#1)(2008-10#1)(2008-6#1)(2010-3#1)
malignant tumor##13##2##(1990-5#1)(1993-9#2)(1994-12#2)(2007-5#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2010-3#1)(2013-1#1)
malignant tumors in##2##3##(2007-11#1)(2008-4#1)
malignant tumors##22##2##(1990-11#1)(1991-5#1)(1994-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#3)(2008-4#3)(2008-5#1)(2010-1#2)(2010-3#1)(2011-2#4)
malignant tumors]##3##2##(1993-2#1)(2011-1#1)(2013-1#1)
malignant tumour cells##2##3##(2008-6#1)(2008-9#1)
malignant tumour##8##2##(1994-3#1)(2008-6#3)(2008-9#3)(2010-3#1)
malignant tumours and##2##3##(1997-2#1)(2012-2#1)
malignant tumours##11##2##(1990-12#1)(1997-2#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-3#2)(2012-2#4)
malignant ventricular##2##2##(1996-3#1)(2012-3#1)
malignant##639##1##(1990-10#7)(1990-11#5)(1990-12#10)(1990-2#9)(1990-3#2)(1990-5#4)(1990-6#4)(1990-8#5)(1990-9#4)(1991-11#1)(1991-12#12)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#7)(1991-8#2)(1991-9#5)(1992-10#1)(1992-11#7)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#4)(1993-2#3)(1993-5#2)(1993-6#4)(1993-8#7)(1993-9#13)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#4)(1995-9#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-6#3)(1996-9#3)(1997-2#3)(1997-3#8)(1997-4#4)(1997-5#5)(1997-7#2)(1997-8#3)(2006-10#3)(2007-10#5)(2007-11#4)(2007-12#7)(2007-4#1)(2007-5#8)(2007-7#3)(2007-8#14)(2008-1#6)(2008-10#9)(2008-11#11)(2008-12#12)(2008-2#1)(2008-3#9)(2008-4#15)(2008-5#17)(2008-6#38)(2008-7#26)(2008-8#7)(2008-9#4)(2009-1#4)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-1#5)(2010-11#4)(2010-12#8)(2010-3#11)(2010-6#4)(2010-8#3)(2011-1#7)(2011-2#45)(2011-3#7)(2012-1#5)(2012-12#15)(2012-2#31)(2012-3#15)(2013-1#22)(2013-7#2)(2013-8#13)
malignant&quot##2##1##(1997-2#2)
malleable##5##1##(2008-12#1)(2008-7#3)(2009-9#1)
malleole)##2##1##(2013-1#2)
malleolus##5##1##(2009-3#1)(2010-3#1)(2010-6#2)(2012-2#1)
malmoense##3##1##(1991-11#3)
malnourished and well-nourished##2##3##(2008-11#2)
malnourished males##2##2##(2008-11#2)
malnourished patients##3##2##(1990-3#1)(1992-9#1)(2013-1#1)
malnourished##12##1##(1990-3#1)(1992-9#2)(2007-12#1)(2008-11#6)(2010-6#1)(2013-1#1)
malnutrition and feeding##2##3##(2010-9#2)
malnutrition and##12##2##(1993-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)
malnutrition in Yemen##4##3##(2010-6#4)
malnutrition in children##3##3##(1996-3#1)(2012-2#1)(2013-1#1)
malnutrition in the community##2##4##(2012-12#2)
malnutrition in##14##2##(1990-9#1)(1991-3#1)(1993-9#1)(1996-3#1)(1997-4#1)(2010-6#5)(2012-12#2)(2012-2#1)(2013-1#1)
malnutrition may##2##2##(2008-12#1)(2012-2#1)
malnutrition##62##1##(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-12#3)(1993-9#1)(1996-3#1)(1997-4#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-7#2)(2009-10#1)(2010-2#1)(2010-6#7)(2010-9#3)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#8)(2013-1#1)(2013-8#1)
malocclusion with##4##2##(2011-2#1)(2013-1#3)
malocclusion##15##1##(1995-9#1)(2006-12#1)(2007-12#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
malocclusions##2##1##(2009-7#1)(2013-7#1)
malodor##6##1##(2008-5#6)
malodour and##2##2##(2008-5#1)(2013-7#1)
malodour is##2##2##(2008-5#2)
malodour##12##1##(2008-10#2)(2008-5#9)(2013-7#1)
malonamide##3##1##(2008-10#3)
malonate##6##1##(2008-10#6)
malondialdehyde (MDA) levels in##2##4##(2009-5#1)(2013-1#1)
malondialdehyde (MDA) levels##3##3##(2008-7#1)(2009-5#1)(2013-1#1)
malondialdehyde (MDA)##10##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#2)(2013-1#1)
malondialdehyde concentration##2##2##(2008-11#1)(2010-12#1)
malondialdehyde formation##6##2##(1990-12#1)(1994-11#2)(1996-2#1)(1996-9#1)(2008-10#1)
malondialdehyde in##3##2##(1993-2#1)(2013-1#1)(2013-8#1)
malondialdehyde##35##1##(1990-12#1)(1993-2#2)(1994-11#2)(1995-12#1)(1996-2#1)(1996-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#5)(2010-12#1)(2011-1#2)(2012-2#4)(2013-1#2)(2013-8#1)
malonic acid##8##2##(2008-10#7)(2008-5#1)
malonic##17##1##(1994-9#1)(2008-10#15)(2008-5#1)
malononitrile and##2##2##(2007-11#1)(2008-11#1)
malonyl-CoA##6##1##(1995-6#6)
malonyl-di-aldehyde##3##1##(1990-8#3)
malperfusion##2##1##(2007-8#2)
malposition##3##1##(2008-7#2)(2013-8#1)
malpractice and##5##2##(1991-1#1)(1991-12#2)(1992-2#1)(1994-1#1)
malpractice claims in##2##3##(1995-2#1)(2008-3#1)
malpractice claims##11##2##(1991-12#1)(1992-2#1)(1993-1#1)(1993-2#2)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-3#1)(2012-3#1)
malpractice liability##3##2##(1992-2#2)(1993-12#1)
malpractice litigation##2##2##(1991-12#1)(1996-2#1)
malpractice of##2##2##(2007-3#1)(2010-8#1)
malpractice suit##2##2##(1995-12#2)
malpractice suits##2##2##(1991-12#1)(1995-12#1)
malpractice##68##1##(1990-9#1)(1991-1#2)(1991-12#17)(1992-1#1)(1992-2#7)(1993-1#3)(1993-12#4)(1993-2#4)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-2#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-3#1)(2007-4#1)(2008-3#3)(2008-7#1)(2010-8#1)(2012-3#1)(2013-7#1)
malprogramming##2##1##(2012-2#2)
malrotation##5##1##(2007-8#1)(2011-2#1)(2012-3#3)
malt wastes##2##2##(2008-6#2)
malt##4##1##(1990-3#1)(2008-6#2)(2009-5#1)
maltase##3##1##(2012-2#2)(2013-1#1)
malting##3##1##(2008-10#3)
maltodextrin##11##1##(2007-11#4)(2008-10#3)(2008-5#3)(2008-6#1)
maltodextrins##4##1##(2008-10#4)
maltol in beverages##4##3##(2008-10#4)
maltol was##2##2##(2008-10#2)
maltol##9##1##(2008-10#9)
maltopentaitol##2##1##(1990-7#2)
maltophilia##8##1##(1993-6#1)(2008-10#7)
maltosa was##3##2##(1993-12#1)(1996-3#2)
maltosa##8##1##(1991-9#3)(1993-12#2)(1996-3#3)
maltose binding protein##3##3##(1995-12#1)(1997-4#1)(1997-6#1)
maltose were##2##2##(1994-12#1)(2008-6#1)
maltose##17##1##(1992-12#1)(1992-9#1)(1993-12#1)(1994-12#3)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-6#3)
maltose) and##2##2##(2010-11#2)
maltose-binding protein (MBP)##3##3##(1992-9#1)(1994-8#1)(1995-12#1)
maltose-binding protein##4##2##(1992-9#1)(1994-8#2)(1995-12#1)
maltotriitol##2##1##(1990-9#2)
maltotriose##7##1##(1990-12#3)(1992-12#3)(1995-5#1)
maltreatment and##3##2##(2009-8#3)
maltreatment##15##1##(1994-2#1)(2009-5#1)(2009-8#12)(2012-3#1)
malunions##2##1##(2007-8#1)(2008-9#1)
malvacearum##6##1##(2008-10#6)
malvarum represent##2##2##(2008-10#2)
malvarum##3##1##(2008-10#3)
mammal species##4##2##(2008-5#2)(2009-5#1)(2013-1#1)
mammal##13##1##(1996-6#1)(1997-2#1)(2008-10#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-5#1)(2011-3#1)(2013-1#1)
mammalia##3##1##(2008-8#3)
mammalian ARF##2##2##(1993-6#2)
mammalian CES5##3##2##(2009-9#3)
mammalian DNA##3##2##(1990-7#1)(1992-11#1)(1997-7#1)
mammalian FMRFamide##4##2##(1990-7#2)(1991-1#2)
mammalian PKC##3##2##(1993-11#2)(1996-6#1)
mammalian RNA##2##2##(1995-6#1)(2012-2#1)
mammalian S-type lectins##2##3##(1990-12#2)
mammalian S-type##3##2##(1990-12#3)
mammalian TRs##2##2##(1991-6#2)
mammalian and Drosophila##2##3##(2008-2#1)(2009-3#1)
mammalian and avian##3##3##(1991-6#1)(1993-2#1)(1997-1#1)
mammalian and yeast##2##3##(2008-11#1)(2009-6#1)
mammalian and##11##2##(1991-6#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-6#1)
mammalian brain##12##2##(1992-3#1)(1993-11#1)(1994-6#1)(1995-6#1)(2007-12#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)
mammalian cell culture processes##2##4##(2008-11#2)
mammalian cell culture##9##3##(2008-11#8)(2008-7#1)
mammalian cell cultures##10##3##(2008-11#10)
mammalian cell lines growing in##2##5##(2008-11#2)
mammalian cell lines##15##3##(1994-6#1)(2008-11#9)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
mammalian cell system##2##3##(2008-4#1)(2009-8#1)
mammalian cell##53##2##(1992-6#1)(1994-6#1)(2008-1#1)(2008-11#34)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#2)(2013-8#1)
mammalian cells and embryos##2##4##(2008-4#2)
mammalian cells and##13##3##(1996-2#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-8#2)(2009-12#1)(2012-3#1)(2013-7#1)
mammalian cells are##3##3##(1994-12#1)(1997-7#1)(2008-9#1)
mammalian cells by##5##3##(1994-8#1)(2008-11#2)(2010-10#1)(2011-2#1)
mammalian cells can##2##3##(2008-11#2)
mammalian cells for##4##3##(2008-11#2)(2008-7#1)(2008-9#1)
mammalian cells grown in serum-free suspension culture##2##7##(2008-11#2)
mammalian cells grown in##3##4##(1993-12#1)(2008-11#2)
mammalian cells grown##4##3##(1993-12#1)(2008-11#3)
mammalian cells have##2##3##(2008-11#1)(2008-9#1)
mammalian cells in a##3##4##(2008-11#2)(2008-7#1)
mammalian cells in vitro##2##4##(1994-3#1)(1994-5#1)
mammalian cells in##8##3##(1994-3#1)(1994-5#1)(2008-11#4)(2008-7#1)(2008-8#1)
mammalian cells infected with##2##4##(1991-5#1)(2008-8#1)
mammalian cells is##3##3##(1990-5#1)(1994-2#1)(2008-11#1)
mammalian cells to##6##3##(1994-11#1)(1994-8#1)(2008-11#1)(2008-2#1)(2009-2#1)(2013-8#1)
mammalian cells using a##2##4##(2009-3#1)(2011-1#1)
mammalian cells using##5##3##(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-1#1)
mammalian cells##173##2##(1990-2#1)(1990-5#2)(1991-12#1)(1991-5#4)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#5)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#4)(1995-11#1)(1995-2#3)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#5)(2006-12#1)(2008-1#4)(2008-11#40)(2008-2#13)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#12)(2008-9#10)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
mammalian central nervous system##6##4##(1990-5#1)(1993-12#1)(2008-11#1)(2008-8#2)(2012-2#1)
mammalian central##7##2##(1990-5#1)(1990-7#1)(1993-12#1)(2008-11#1)(2008-8#2)(2012-2#1)
mammalian counterparts##2##2##(1993-6#1)(1994-12#1)
mammalian development##5##2##(1990-11#2)(1995-2#1)(1996-12#1)(1996-5#1)
mammalian enzyme##2##2##(1990-7#1)(1991-6#1)
mammalian evolution##2##2##(1992-12#1)(1992-8#1)
mammalian expression vector##2##3##(2007-7#1)(2008-8#1)
mammalian expression vectors##3##3##(2008-11#3)
mammalian expression##6##2##(1994-11#1)(2007-7#1)(2008-11#3)(2008-8#1)
mammalian gene##3##2##(1994-8#1)(1995-5#1)(2008-11#1)
mammalian genomes##6##2##(1991-6#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-11#1)(2008-7#1)
mammalian glial##2##2##(2008-7#2)
mammalian herpesviruses##2##2##(1995-3#2)
mammalian homologous##2##2##(1994-8#1)(1995-2#1)
mammalian homologue of##4##3##(1991-9#1)(1992-12#1)(1992-8#1)(1993-9#1)
mammalian host##5##2##(2008-11#1)(2008-9#3)(2011-2#1)
mammalian hosts##2##2##(2008-8#1)(2011-2#1)
mammalian kidney##2##2##(1990-11#1)(1990-2#1)
mammalian male##2##2##(2009-9#2)
mammalian mitochondrial##2##2##(1995-11#1)(2013-8#1)
mammalian models##2##2##(2008-10#1)(2008-11#1)
mammalian neocortex##2##2##(1994-3#1)(2008-11#1)
mammalian nuclear extracts##2##3##(1995-2#2)
mammalian or##2##2##(1991-6#1)(2008-10#1)
mammalian origin##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
mammalian pineal organ##4##3##(1994-5#4)
mammalian protein##3##2##(1995-8#1)(1996-5#1)(2008-11#1)
mammalian serine/threonine kinase##2##3##(1994-12#1)(1995-2#1)
mammalian species##16##2##(1991-12#1)(1991-2#1)(1992-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
mammalian sperm cells##2##3##(1993-6#2)
mammalian sperm##4##2##(1993-6#2)(2008-4#1)(2008-9#1)
mammalian system##2##2##(1993-12#1)(2009-8#1)
mammalian systems are##2##3##(2008-11#1)(2009-10#1)
mammalian systems##8##2##(1994-5#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-10#1)
mammalian target of rapamycin (mTOR) inhibitor##2##6##(2008-3#1)(2013-1#1)
mammalian target of rapamycin (mTOR)##6##5##(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
mammalian telomere##2##2##(2008-11#2)
mammalian tissues##6##2##(1991-8#1)(1994-11#1)(1994-5#1)(2008-1#2)(2012-12#1)
mammalian##561##1##(1990-11#3)(1990-12#7)(1990-2#2)(1990-5#10)(1990-7#7)(1990-8#1)(1991-1#5)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#8)(1991-8#2)(1991-9#4)(1992-11#4)(1992-12#6)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#6)(1993-12#6)(1993-2#2)(1993-6#13)(1993-8#1)(1993-9#3)(1994-11#12)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#9)(1994-6#2)(1994-8#11)(1994-9#2)(1995-11#3)(1995-2#13)(1995-3#8)(1995-5#5)(1995-6#9)(1995-8#4)(1996-12#4)(1996-2#3)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#3)(1997-6#3)(1997-7#10)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#9)(2008-10#8)(2008-11#110)(2008-12#1)(2008-2#17)(2008-3#2)(2008-4#15)(2008-5#9)(2008-7#21)(2008-8#27)(2008-9#27)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#7)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#11)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
mammalian-cell culture##2##2##(2008-11#2)
mammals and other##2##3##(1997-4#1)(2008-10#1)
mammals and##15##2##(1995-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
mammals are##4##2##(1992-12#1)(2008-8#2)(2012-2#1)
mammals have##2##2##(2008-11#1)(2008-7#1)
mammals in##2##2##(1993-6#1)(1996-6#1)
mammals is##9##2##(1992-2#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
mammals that##2##2##(2008-8#1)(2010-3#1)
mammals##136##1##(1990-5#2)(1991-1#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-11#2)(1994-2#1)(1994-5#6)(1994-9#1)(1995-11#4)(1995-2#2)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-7#4)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#7)(2008-8#12)(2008-9#10)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#10)(2013-1#6)
mammals)##2##1##(2008-8#1)(2013-1#1)
mammary adenocarcinoma##5##2##(1990-7#1)(1990-8#1)(1992-2#1)(1992-9#1)(2012-1#1)
mammary arteries##2##2##(2007-8#2)
mammary artery##11##2##(1993-8#2)(2007-8#6)(2008-8#1)(2011-2#2)
mammary cancer##7##2##(1991-9#1)(1993-1#4)(1995-2#1)(2008-10#1)
mammary carcinoma##5##2##(1992-9#2)(1995-3#1)(2012-1#2)
mammary cells##6##2##(1993-11#1)(1995-11#3)(2008-4#1)(2012-12#1)
mammary epithelial cell##2##3##(1993-11#1)(1994-11#1)
mammary epithelial cells and##2##4##(1991-2#1)(2008-9#1)
mammary epithelial cells##14##3##(1990-12#2)(1991-2#2)(1993-11#4)(1995-2#1)(1995-9#2)(2008-11#1)(2008-8#1)(2008-9#1)
mammary epithelial##19##2##(1990-12#2)(1991-12#1)(1991-2#2)(1993-11#6)(1994-11#2)(1995-2#1)(1995-9#2)(2008-11#1)(2008-8#1)(2008-9#1)
mammary gland and##2##3##(1995-12#1)(2008-8#1)
mammary gland cells##3##3##(2008-9#2)(2013-8#1)
mammary gland##43##2##(1990-11#1)(1990-12#1)(1991-12#2)(1992-4#1)(1992-9#3)(1994-12#1)(1995-11#2)(1995-12#1)(1995-9#1)(1997-6#3)(2008-10#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#5)(2012-1#2)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
mammary glands of pregnant and lactating rats##2##7##(1990-11#2)
mammary glands of##6##3##(1990-11#2)(1991-12#2)(1992-12#1)(2008-8#1)
mammary glands##16##2##(1990-11#2)(1991-12#3)(1992-12#1)(1992-9#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#1)
mammary lymph node##2##3##(1994-12#1)(2012-2#1)
mammary progenitor##2##2##(2009-12#2)
mammary secretions##5##2##(1991-11#5)
mammary tissue##4##2##(1991-12#1)(1994-5#2)(1995-9#1)
mammary tumor##10##2##(1990-11#1)(1993-1#2)(1993-11#1)(1994-11#2)(1994-12#1)(1994-7#1)(2013-7#1)(2013-8#1)
mammary tumorigenesis##4##2##(1992-9#2)(1995-9#2)
mammary tumors and##2##3##(1993-11#1)(1994-7#1)
mammary tumors##14##2##(1992-9#5)(1993-1#1)(1993-11#1)(1994-7#3)(1995-9#2)(2012-3#1)(2013-7#1)
mammary tumour cell line##3##4##(2008-11#3)
mammary##197##1##(1990-11#4)(1990-12#4)(1990-2#2)(1990-7#1)(1990-8#1)(1991-11#5)(1991-12#8)(1991-2#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#16)(1993-1#8)(1993-11#10)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#3)(1994-5#3)(1994-7#4)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#1)(1995-9#15)(1997-6#4)(1997-7#1)(2007-10#1)(2007-7#2)(2007-8#9)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#7)(2008-9#4)(2009-12#8)(2011-2#3)(2012-1#6)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#5)
mammogram##4##1##(1997-1#1)(1997-8#1)(2010-8#1)(2013-1#1)
mammograms##10##1##(1995-2#1)(1997-1#1)(1997-2#1)(2008-3#2)(2008-7#1)(2009-12#2)(2010-8#2)
mammograph##2##1##(2008-3#2)
mammographic and##4##2##(1990-10#1)(1990-2#1)(1997-7#1)(2010-8#1)
mammographic patterns##2##2##(1993-5#2)
mammographic screening##2##2##(1992-2#1)(1993-2#1)
mammographic##12##1##(1990-10#1)(1990-2#1)(1992-2#2)(1992-8#1)(1993-2#1)(1993-5#2)(1997-7#1)(2008-10#1)(2009-11#1)(2010-8#1)
mammography alone##2##2##(1995-4#2)
mammography and ultrasound##2##3##(2010-8#2)
mammography and##9##2##(1990-10#1)(1995-4#1)(1997-8#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
mammography facilities##2##2##(1995-2#2)
mammography for screening purposes##2##4##(1990-6#2)
mammography for##3##2##(1990-6#2)(2012-2#1)
mammography in##8##2##(1990-11#1)(1992-2#1)(1994-3#1)(1995-4#1)(1996-3#1)(1997-8#2)(2007-4#1)
mammography services##2##2##(1993-3#1)(2007-4#1)
mammography##66##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-6#5)(1991-2#1)(1991-3#3)(1991-8#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-2#3)(1995-4#6)(1995-8#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-5#2)(1997-8#9)(2007-4#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-11#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
man admitted to hospital with##2##5##(1992-6#1)(2007-12#1)
man and a##2##3##(1991-6#1)(2008-8#1)
man and the environment##3##4##(1992-3#2)(1995-11#1)
man and##19##2##(1990-5#2)(1991-6#3)(1992-3#2)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1997-8#1)(2008-8#2)(2009-1#1)(2009-10#2)(2011-2#2)
man developed##3##2##(1990-9#1)(1993-8#1)(1994-3#1)
man diagnosed with##2##3##(2008-7#1)(2010-12#1)
man had##3##2##(1990-11#1)(1994-11#1)(2011-1#1)
man in a##2##3##(2010-1#1)(2013-1#1)
man in##4##2##(1997-7#1)(2010-1#1)(2013-1#2)
man is presented##3##3##(1997-8#1)(2008-11#1)(2008-7#1)
man is##5##2##(1992-2#1)(1997-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
man made mounds the##2##4##(2008-12#2)
man made mounds##8##3##(2008-12#8)
man presented as an emergency with##2##6##(1993-9#2)
man presented to##2##3##(2007-12#1)(2011-1#1)
man presented with a##9##4##(2008-6#2)(2008-7#1)(2008-8#1)(2010-6#3)(2011-2#1)(2013-1#1)
man presented with an##2##4##(2008-12#1)(2010-1#1)
man presented with##23##3##(1997-3#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-11#1)(2010-1#1)(2010-6#3)(2011-2#2)(2012-12#1)(2013-1#2)
man presented##28##2##(1993-9#2)(1997-3#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-11#1)(2010-1#1)(2010-6#3)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
man presenting with a##2##4##(2008-6#1)(2008-7#1)
man presenting with##7##3##(2007-7#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#1)
man presenting##9##2##(2007-7#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
man suffering from##4##3##(2007-10#1)(2007-8#1)(2010-7#1)(2012-1#1)
man sustained a##2##3##(2008-12#1)(2012-12#1)
man than##2##2##(1993-6#1)(2010-5#1)
man underwent##3##2##(2007-8#2)(2009-1#1)
man was admitted to our hospital for##2##7##(2008-1#1)(2013-8#1)
man was admitted to our hospital##4##6##(2008-1#3)(2013-8#1)
man was admitted to our##6##5##(2008-1#3)(2008-12#2)(2013-8#1)
man was admitted to##7##4##(1992-2#1)(2008-1#3)(2008-12#2)(2013-8#1)
man was admitted with fever##2##5##(2009-3#1)(2010-12#1)
man was admitted with##3##4##(2008-6#1)(2009-3#1)(2010-12#1)
man was admitted##12##3##(1992-2#1)(2007-7#1)(2008-1#3)(2008-12#2)(2008-6#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
man was diagnosed with##2##4##(2007-4#1)(2007-8#1)
man was diagnosed##3##3##(2007-4#1)(2007-8#1)(2008-12#1)
man was involved in a##2##5##(2008-7#1)(2013-1#1)
man was##25##2##(1992-2#1)(1997-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#2)(2010-12#1)(2013-1#2)(2013-8#2)
man who developed##4##3##(2007-10#1)(2008-7#2)(2009-8#1)
man who had a##2##4##(1990-11#1)(2006-10#1)
man who had##10##3##(1990-11#1)(1990-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#3)(2010-6#1)
man who presented with a##2##5##(2008-5#1)(2008-7#1)
man who presented with##9##4##(2008-5#1)(2008-7#2)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
man who presented##13##3##(1991-11#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
man who underwent##4##3##(2007-8#1)(2012-12#2)(2012-2#1)
man who was##3##3##(1997-5#1)(2008-10#1)(2011-2#1)
man who##42##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-4#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
man with a history of##2##5##(2012-12#1)(2013-1#1)
man with a##13##3##(1992-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
man with complaints of##2##4##(2008-1#1)(2010-12#1)
man with diabetes mellitus##2##4##(2013-1#1)(2013-8#1)
man with history of##2##4##(2008-1#1)(2013-1#1)
man with metastatic##2##3##(2007-6#1)(2011-2#1)
man with multiple##2##3##(1997-8#1)(2012-3#1)
man with no##4##3##(2009-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
man with primary##2##3##(2009-8#1)(2010-5#1)
man with##73##2##(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-3#1)(1996-6#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#3)(2008-7#2)(2008-9#2)(2009-1#1)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#3)
man without##3##2##(1990-5#1)(2008-7#1)(2013-8#1)
man##358##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#5)(1990-6#3)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#1)(1992-12#3)(1992-2#5)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#4)(1997-3#5)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#6)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#9)(2007-8#10)(2008-1#8)(2008-10#2)(2008-11#9)(2008-12#20)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#20)(2008-8#9)(2008-9#4)(2009-1#5)(2009-10#3)(2009-11#1)(2009-3#5)(2009-5#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-5#2)(2010-6#6)(2010-7#3)(2010-9#1)(2011-1#3)(2011-2#22)(2012-1#1)(2012-12#10)(2012-2#4)(2012-3#15)(2013-1#22)(2013-7#1)(2013-8#9)
man&quot##3##1##(1993-2#1)(2008-11#1)(2008-4#1)
man's##2##1##(1990-9#1)(1992-1#1)
man-made sources##2##2##(1996-6#2)
man-made##13##1##(1991-6#1)(1996-6#2)(1997-8#1)(2007-12#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
manage a##3##2##(2007-2#1)(2013-1#2)
manage an##2##2##(1994-12#1)(2008-1#1)
manage data##2##2##(2008-9#1)(2013-1#1)
manage for##3##2##(1994-1#2)(2008-10#1)
manage health care##3##3##(1994-3#1)(1996-3#1)(1997-2#1)
manage it##2##2##(2008-7#1)(2010-11#1)
manage patient##2##2##(2007-4#1)(2008-8#1)
manage patients##2##2##(2008-3#1)(2008-8#1)
manage problems##2##2##(2008-7#1)(2012-3#1)
manage psychiatric##2##2##(2013-1#2)
manage side effects##2##3##(2008-6#1)(2010-7#1)
manage such##2##2##(1994-9#1)(2011-2#1)
manage the care of##2##4##(1996-12#1)(1997-1#1)
manage the disease##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
manage the risks##2##3##(1993-2#1)(1996-2#1)
manage the##33##2##(1993-12#1)(1993-2#1)(1994-2#3)(1994-3#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
manage their##13##2##(1991-12#2)(1992-2#1)(1994-1#2)(1997-2#1)(2007-12#1)(2010-9#2)(2013-1#2)(2013-7#1)(2013-8#1)
manage these##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2012-12#1)
manage this problem##3##3##(1994-3#2)(2007-11#1)
manage this##8##2##(1994-3#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
manage to##2##2##(2007-3#1)(2008-8#1)
manage##178##1##(1990-3#1)(1991-1#1)(1991-12#2)(1992-2#1)(1993-12#3)(1993-2#1)(1994-1#5)(1994-12#1)(1994-2#5)(1994-3#5)(1994-9#1)(1995-12#5)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#4)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#14)(2008-11#10)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#3)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#12)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#2)
manageable and##2##2##(1996-3#1)(2008-6#1)
manageable with##2##2##(1993-3#1)(2007-10#1)
manageable##11##1##(1993-3#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-6#2)(2008-7#1)(2010-4#1)(2012-12#1)
managed Medicare##2##2##(1997-2#1)(2008-6#1)
managed according to##2##3##(1994-2#1)(2008-10#1)
managed and##5##2##(1994-3#1)(2008-1#1)(2009-10#1)(2010-6#1)(2011-2#1)
managed at the##2##3##(2007-11#1)(2011-2#1)
managed at##5##2##(2007-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
managed behavioral health care companies##2##5##(1995-1#2)
managed by a##2##3##(1991-2#1)(2007-12#1)
managed by non-surgical therapy##2##4##(2008-10#2)
managed by the##3##3##(1994-7#1)(2008-10#1)(2012-3#1)
managed by##29##2##(1991-12#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-7#1)(1995-10#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
managed care and health##2##4##(1995-2#1)(1997-3#1)
managed care and its##2##4##(1995-1#1)(1997-1#1)
managed care and##16##3##(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-11#1)
managed care approach##2##3##(1996-12#1)(1997-2#1)
managed care are##4##3##(1994-3#1)(1995-1#1)(1997-3#1)(2008-11#1)
managed care arrangements##4##3##(1991-3#1)(1994-1#1)(1995-1#2)
managed care as##2##3##(1996-12#1)(2008-7#1)
managed care can##3##3##(1994-2#1)(1996-1#1)(1997-1#1)
managed care changes##2##3##(1991-3#1)(1997-3#1)
managed care companies and##2##4##(1993-2#1)(1995-1#1)
managed care companies##9##3##(1991-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-1#2)(1996-3#1)
managed care company##3##3##(1995-1#1)(1996-12#1)(1996-3#1)
managed care concepts##2##3##(1997-2#1)(2008-12#1)
managed care contract##2##3##(1991-3#1)(1994-3#1)
managed care contracting##6##3##(1992-2#2)(1992-3#2)(1994-12#1)(1995-12#1)
managed care contracts##3##3##(1991-3#1)(1992-2#1)(2008-11#1)
managed care delivery##2##3##(1995-12#1)(1996-3#1)
managed care environment##7##3##(1993-3#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-2#1)(1997-3#1)
managed care firms##3##3##(1991-3#1)(1994-1#2)
managed care for##3##3##(1996-3#1)(1997-2#1)(2008-12#1)
managed care in rural areas##2##5##(1994-3#1)(1996-3#1)
managed care in the##2##4##(1997-3#1)(2008-6#1)
managed care in##10##3##(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-6#1)
managed care industry##3##3##(1994-12#1)(1994-3#1)(1996-1#1)
managed care is##5##3##(1993-12#1)(1994-12#1)(1996-1#1)(1997-3#2)
managed care model##2##3##(1994-2#1)(1995-3#1)
managed care on the##2##4##(1992-3#1)(1995-12#1)
managed care on##6##3##(1991-3#1)(1992-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(2006-10#1)
managed care organization##4##3##(1993-12#1)(1996-1#1)(1997-3#2)
managed care organizations and##2##4##(1996-2#1)(1997-3#1)
managed care organizations##21##3##(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(2008-11#1)(2008-6#2)(2008-7#3)(2009-6#1)
managed care participation##2##3##(1994-3#2)
managed care partners##2##3##(1994-2#1)(1996-12#1)
managed care performance##3##3##(1993-12#2)(1996-3#1)
managed care plan##3##3##(1996-12#1)(1997-2#2)
managed care plans for##3##4##(1995-12#2)(1997-2#1)
managed care plans in##3##4##(1995-12#2)(2008-11#1)
managed care plans to##2##4##(1996-12#1)(1997-3#1)
managed care plans##31##3##(1991-3#1)(1992-2#1)(1994-1#4)(1994-2#2)(1994-3#3)(1995-12#7)(1996-12#3)(1997-1#2)(1997-2#4)(1997-3#3)(2008-11#1)
managed care program##3##3##(1995-12#1)(1996-1#1)(1997-2#1)
managed care programs##7##3##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)
managed care setting##5##3##(1992-2#2)(1997-2#2)(2009-11#1)
managed care should##2##3##(1993-12#1)(1995-1#1)
managed care system can##2##4##(1993-2#1)(1996-12#1)
managed care system##15##3##(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(2006-10#8)
managed care to##4##3##(1994-3#1)(1995-1#1)(1995-3#1)(1997-1#1)
managed care##353##2##(1991-12#2)(1991-2#1)(1991-3#11)(1992-2#7)(1992-3#4)(1993-12#11)(1993-2#2)(1993-3#3)(1994-1#10)(1994-12#15)(1994-2#11)(1994-3#23)(1995-1#18)(1995-12#24)(1995-2#8)(1995-3#11)(1996-1#13)(1996-12#27)(1996-2#14)(1996-3#23)(1997-1#16)(1997-2#34)(1997-3#28)(1997-6#1)(2006-10#10)(2008-1#1)(2008-11#6)(2008-12#4)(2008-6#6)(2008-7#6)(2009-11#1)(2009-6#2)
managed care's##3##2##(1994-2#1)(1996-1#1)(1997-7#1)
managed care?##5##2##(1991-3#1)(1994-3#1)(1995-1#2)(1996-1#1)
managed competition##20##2##(1994-1#1)(1994-3#11)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1997-2#3)
managed conservatively##8##2##(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#2)
managed cross protection##2##3##(2008-10#2)
managed differently##2##2##(1995-2#1)(1996-3#1)
managed forests##2##2##(2008-10#1)(2012-9#1)
managed groves##3##2##(2011-2#3)
managed health care##4##3##(1994-12#1)(1994-2#1)(1997-3#2)
managed in the##2##3##(1995-2#1)(2008-8#1)
managed in##6##2##(1995-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
managed laparoscopically##2##2##(1994-9#1)(2009-7#1)
managed mental health care##4##4##(1991-3#1)(1995-1#2)(1995-3#1)
managed mental health treatment##3##4##(1995-1#3)
managed mental health##12##3##(1991-3#3)(1995-1#8)(1995-3#1)
managed mental##13##2##(1991-3#4)(1995-1#8)(1995-3#1)
managed on##4##2##(1993-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
managed plots was##2##3##(2008-10#1)(2011-2#1)
managed successfully with##2##3##(2008-11#1)(2010-10#1)
managed successfully##6##2##(1994-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-11#1)(2012-2#1)
managed surgically##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
managed through##3##2##(2008-10#2)(2008-11#1)
managed to##9##2##(1994-3#1)(1995-1#1)(1995-5#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-1#1)(2013-8#1)
managed treatment##2##2##(1995-1#2)
managed using a##2##3##(2008-12#1)(2011-2#1)
managed using##5##2##(2007-9#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-1#1)
managed with a##4##3##(2008-8#1)(2011-3#1)(2012-12#1)(2013-8#1)
managed with endovascular##2##3##(2008-12#2)
managed with the##2##3##(2008-11#1)(2011-1#1)
managed with##28##2##(2006-10#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
managed##593##1##(1991-12#4)(1991-2#2)(1991-3#17)(1992-12#1)(1992-2#8)(1992-3#5)(1992-8#1)(1993-1#1)(1993-12#14)(1993-2#2)(1993-3#3)(1994-1#13)(1994-12#17)(1994-2#17)(1994-3#38)(1994-7#1)(1994-9#1)(1995-1#35)(1995-10#1)(1995-12#26)(1995-2#12)(1995-3#13)(1995-5#1)(1996-1#17)(1996-11#1)(1996-12#29)(1996-2#14)(1996-3#27)(1997-1#18)(1997-2#39)(1997-3#31)(1997-6#1)(1997-7#1)(2006-10#13)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#12)(2008-12#7)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#7)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#5)(2012-9#1)(2013-1#12)(2013-7#1)(2013-8#6)
managed-care initiatives##2##2##(1992-2#2)
managed-care plans##4##2##(1996-2#4)
managed-care quality##2##2##(1996-2#2)
managed-care##16##1##(1992-2#3)(1995-2#1)(1996-2#12)
management (UM)##3##2##(1992-1#1)(1996-1#1)(1997-2#1)
management a##2##2##(2009-10#1)(2010-12#1)
management action##2##2##(2008-10#2)
management advisory report##2##3##(1993-1#1)(1994-2#1)
management advisory##3##2##(1993-1#1)(1994-1#1)(1994-2#1)
management after##2##2##(2008-11#1)(2011-2#1)
management algorithms##2##2##(2009-9#1)(2013-8#1)
management among##4##2##(2009-12#1)(2010-11#1)(2011-2#2)
management and conservation##2##3##(2007-5#1)(2013-7#1)
management and early##2##3##(2008-5#1)(2009-6#1)
management and health care##3##4##(1991-12#1)(1993-12#1)(1994-12#1)
management and how##2##3##(1992-3#1)(2008-1#1)
management and immunosuppressive##2##3##(2010-7#1)(2011-3#1)
management and leadership##2##3##(1992-2#1)(1994-2#1)
management and monitoring##2##3##(1992-12#1)(2013-1#1)
management and organizational##2##3##(1991-1#1)(1994-2#1)
management and outcome##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2013-1#1)
management and outcomes of##3##4##(2008-3#1)(2010-5#1)(2011-2#1)
management and outcomes##6##3##(2007-12#1)(2008-3#3)(2010-5#1)(2011-2#1)
management and planning tools##4##4##(1994-1#2)(1994-2#2)
management and policy##2##3##(1991-2#1)(1993-1#1)
management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary##2##19##(2008-11#2)
management and prevention of##3##4##(2008-10#1)(2008-11#2)
management and prognosis##2##3##(2008-10#1)(2012-2#1)
management and quality##2##3##(1995-1#1)(1995-2#1)
management and reconstruction##3##3##(2011-2#2)(2012-2#1)
management and research##2##3##(2008-10#1)(2010-8#1)
management and surveillance##3##3##(2007-12#1)(2009-12#1)(2011-2#1)
management and the##7##3##(1991-3#1)(1992-12#1)(1995-3#1)(1996-2#1)(2007-11#1)(2011-1#1)(2012-2#1)
management and their##2##3##(2007-8#1)(2008-10#1)
management and treatment of##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
management and treatment##4##3##(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
management and##149##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#2)(1994-1#4)(1994-12#2)(1994-2#5)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1996-1#1)(1996-2#3)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#1)
management application##2##2##(1992-3#1)(1997-3#1)
management approach for##2##3##(2008-3#1)(2013-1#1)
management approach to##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
management approach##12##2##(1994-1#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-8#1)(2013-1#1)
management approaches##4##2##(1992-12#1)(2007-5#1)(2008-10#1)(2009-3#1)
management are discussed##4##3##(1996-2#1)(2008-10#1)(2011-3#1)(2013-1#1)
management are##19##2##(1993-12#2)(1996-2#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
management as a##6##3##(1992-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-1#1)
management as##7##2##(1992-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-1#1)(2010-5#1)
management at##11##2##(1995-12#3)(1996-2#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
management based on##2##3##(1994-3#1)(1997-3#1)
management because##2##2##(2008-10#1)(2011-2#1)
management by##10##2##(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-3#1)(2007-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
management can be##5##3##(2007-9#1)(2008-10#1)(2008-12#1)(2010-10#1)(2013-7#1)
management can facilitate##2##3##(1994-12#1)(1996-3#1)
management can##13##2##(1991-12#2)(1991-8#1)(1994-12#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-5#1)(2013-7#1)
management capability##2##2##(2008-11#2)
management capacity in##2##3##(1993-3#1)(2012-12#1)
management capacity##6##2##(1993-3#2)(1995-3#1)(2012-12#2)(2013-1#1)
management challenges##6##2##(1992-2#1)(1993-2#1)(1996-3#1)(2008-12#1)(2008-5#1)(2013-8#1)
management competencies##3##2##(1992-1#1)(1996-3#1)(2008-1#1)
management computer##2##2##(1992-12#1)(1994-2#1)
management concepts##2##2##(2008-11#1)(2008-8#1)
management considerations##3##2##(2007-12#1)(2008-7#2)
management consists of##2##3##(2006-10#1)(2008-10#1)
management costs##2##2##(1991-3#1)(1992-3#1)
management cycle##2##2##(1996-2#1)(1997-1#1)
management decision making##2##3##(1994-3#2)
management decision-making##2##2##(1992-1#1)(2008-10#1)
management decisions in##2##3##(1997-1#1)(2010-5#1)
management decisions##11##2##(1995-3#1)(1997-1#1)(2008-10#5)(2008-5#1)(2009-4#1)(2010-10#1)(2010-5#1)
management development in##6##3##(1991-2#1)(1994-1#2)(1994-2#1)(1995-3#1)(1996-3#1)
management development needs##2##3##(1994-1#1)(1995-12#1)
management development programs##3##3##(1994-1#2)(1996-3#1)
management development##25##2##(1991-2#1)(1992-1#2)(1994-1#11)(1994-2#3)(1994-3#2)(1995-12#1)(1995-3#2)(1996-3#3)
management direction and##2##3##(2008-1#2)
management during##8##2##(1995-3#1)(2007-9#1)(2008-11#2)(2009-5#1)(2011-2#1)(2012-12#2)
management education in##5##3##(1992-12#1)(1994-12#3)(1995-3#1)
management education##17##2##(1991-12#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-12#1)(1994-12#4)(1995-12#2)(1995-3#1)(1996-1#2)(2009-8#1)
management efforts##4##2##(1996-1#1)(1997-3#1)(2008-10#1)(2011-2#1)
management focus##2##2##(1994-12#1)(1994-3#1)
management for the##3##3##(2010-9#1)(2011-2#2)
management for##29##2##(1991-6#1)(1992-3#1)(1994-1#1)(1994-3#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)
management from the##4##3##(1993-3#1)(2008-1#2)(2010-3#1)
management from##5##2##(1993-3#1)(1996-2#1)(2008-1#2)(2010-3#1)
management function##2##2##(1996-2#1)(2011-2#1)
management functions##4##2##(1993-12#1)(1994-3#2)(1995-12#1)
management guidelines for##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
management guidelines##9##2##(1990-6#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
management has become##2##3##(1997-2#1)(2006-10#1)
management has been##3##3##(1994-3#1)(1995-2#1)(2013-7#1)
management has##14##2##(1994-3#2)(1995-2#1)(1996-1#2)(1997-2#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
management have##4##2##(1997-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
management implementation##2##2##(1991-12#1)(1995-3#1)
management implications of##2##3##(1992-12#1)(1994-12#1)
management implications##4##2##(1992-12#1)(1993-12#1)(1994-12#1)(2008-8#1)
management in a##5##3##(1994-2#1)(1996-1#1)(2007-12#1)(2008-11#1)(2009-7#1)
management in acute##2##3##(2006-12#1)(2013-1#1)
management in cardiac surgery##2##4##(2010-8#1)(2013-1#1)
management in children##2##3##(2010-3#1)(2012-1#1)
management in health care##6##4##(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-3#1)
management in health##8##3##(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(2007-10#1)(2010-7#1)
management in long-term care##3##4##(1992-3#2)(1993-3#1)
management in long-term##4##3##(1992-3#2)(1993-3#1)(1996-1#1)
management in older adults##3##4##(2010-11#1)(2010-7#2)
management in patients with##4##4##(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
management in patients##7##3##(2006-10#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
management in the 1990s##3##4##(1991-12#1)(1991-3#2)
management in the##24##3##(1991-12#1)(1991-3#2)(1992-1#1)(1992-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-7#1)(2013-1#1)
management in their##2##3##(1993-1#1)(1994-3#1)
management in this##2##3##(2008-10#2)
management in today's##2##3##(1991-12#1)(1994-1#1)
management in##122##2##(1991-1#1)(1991-12#4)(1991-3#2)(1992-1#3)(1992-2#2)(1992-3#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1996-1#6)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#4)(2010-8#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
management included##3##2##(2008-9#1)(2009-3#1)(2010-7#1)
management includes##2##2##(1991-12#1)(2006-10#1)
management including##2##2##(2011-2#1)(2011-3#1)
management indicators##5##2##(2012-12#5)
management information systems##2##3##(1991-6#1)(1993-3#1)
management information##9##2##(1991-6#1)(1992-3#2)(1993-3#1)(1994-3#1)(1996-12#1)(2008-4#1)(2012-12#1)(2013-7#1)
management initiatives##5##2##(1996-2#1)(2011-2#1)(2012-2#1)(2012-3#2)
management into##2##2##(1994-1#1)(1997-3#1)
management is a##2##3##(1993-1#1)(2007-2#1)
management is based on##2##4##(2009-8#1)(2010-5#1)
management is essential##2##3##(1992-9#1)(2010-8#1)
management is likely to be##2##5##(1994-3#1)(2008-10#1)
management is still##2##3##(2008-9#1)(2011-2#1)
management is that##2##3##(2008-10#1)(2012-3#1)
management is the##4##3##(1991-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
management is to##2##3##(1992-2#1)(2008-10#1)
management is##54##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
management issues and##4##3##(1996-2#1)(1996-3#1)(2008-1#1)(2010-6#1)
management issues##14##2##(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#2)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#2)(2012-3#1)
management literature##3##2##(1994-1#1)(2008-11#1)(2008-12#1)
management may##3##2##(2008-9#1)(2011-1#1)(2013-8#1)
management methodology##2##2##(1996-2#1)(2009-12#1)
management methods in##3##3##(1993-3#1)(1996-1#1)(1997-2#1)
management methods used##2##3##(2008-10#1)(2012-1#1)
management methods##7##2##(1993-3#1)(1996-1#1)(1997-2#1)(2008-10#3)(2012-1#1)
management model for##2##3##(2007-10#1)(2008-1#1)
management model##7##2##(1994-3#2)(1996-12#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-1#1)
management models##2##2##(1994-12#1)(2008-12#1)
management must##3##2##(1994-2#1)(1994-8#1)(2008-11#1)
management need##3##2##(1990-9#1)(1994-12#1)(2008-10#1)
management needs of##2##3##(2008-11#1)(2012-3#1)
management needs##4##2##(1997-3#1)(2007-7#1)(2008-11#1)(2012-3#1)
management nursing##2##2##(2008-1#1)(2012-1#1)
management of ACS##3##3##(2008-3#3)
management of AF##2##3##(2008-6#1)(2010-12#1)
management of AIDS##2##3##(1994-3#1)(2009-4#1)
management of CRF##2##3##(2007-7#1)(2008-1#1)
management of Crohn's disease##2##4##(2010-12#2)
management of Fusarium wilt##2##4##(2008-10#2)
management of Fusarium##3##3##(2008-10#3)
management of HIV-infected patients##2##4##(2008-3#1)(2011-2#1)
management of HIV-infected##3##3##(2008-3#1)(2010-5#1)(2011-2#1)
management of HIV/AIDS##2##3##(2008-1#2)
management of OP poisoning##4##4##(2013-1#4)
management of PCS##2##3##(2013-1#2)
management of Rh##2##3##(1996-3#2)
management of a maxillary first molar with two palatal canals##2##10##(2013-1#2)
management of a patient with##5##5##(2008-10#1)(2008-12#2)(2011-2#1)(2012-2#1)
management of a patient##8##4##(2007-8#1)(2008-10#1)(2008-12#3)(2008-8#1)(2011-2#1)(2012-2#1)
management of a##32##3##(1991-12#1)(1993-11#1)(1994-12#1)(1997-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)
management of acute coronary syndrome##2##5##(2008-3#2)
management of acute coronary syndromes##3##5##(2008-3#3)
management of acute coronary##5##4##(2008-3#5)
management of acute renal failure##2##5##(2008-4#2)
management of acute##18##3##(1995-8#1)(1997-8#1)(2007-12#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
management of adrenal incidentalomas##2##4##(2008-4#2)
management of advanced##2##3##(2012-3#1)(2013-1#1)
management of alcohol##2##3##(1997-2#1)(2008-2#1)
management of an##6##3##(1991-6#1)(1996-11#1)(1997-6#1)(2008-12#1)(2010-7#1)(2012-2#1)
management of aortic stenosis##2##4##(2012-2#2)
management of apple replant disease##2##5##(2008-10#2)
management of asthma in##3##4##(1990-9#1)(2008-11#2)
management of asthma##6##3##(1990-9#1)(2008-11#2)(2010-2#1)(2010-5#2)
management of asymptomatic##2##3##(2007-12#1)(2012-3#1)
management of bacterial##2##3##(2008-10#2)
management of behavioral##2##3##(1995-1#1)(2010-9#1)
management of bladder cancer##2##4##(2009-4#1)(2011-2#1)
management of blood##3##3##(1991-1#1)(1994-9#1)(2008-1#1)
management of bone##4##3##(2008-6#1)(2008-7#3)
management of both##3##3##(1992-2#1)(2007-12#1)(2008-7#1)
management of breast cancer##5##4##(1990-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2010-8#1)
management of breast##9##3##(1990-11#1)(1994-12#2)(2007-10#1)(2007-11#1)(2008-1#1)(2010-8#1)(2012-2#1)(2013-8#1)
management of cardiac amyloidosis##2##4##(2010-8#2)
management of cardiac##5##3##(2008-10#1)(2008-11#1)(2010-8#2)(2012-12#1)
management of cardiovascular##2##3##(1993-12#1)(2009-4#1)
management of carinal resection and##2##5##(2010-7#2)
management of certain##4##3##(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)
management of cervical##4##3##(1994-5#1)(2007-8#2)(2008-7#1)
management of chemicals##2##3##(2008-11#2)
management of childhood##2##3##(1995-3#1)(2009-6#1)
management of children with##3##4##(2008-10#2)(2008-11#1)
management of children##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
management of chronic disease##2##4##(2011-2#1)(2012-2#1)
management of chronic hepatitis B##2##5##(2007-12#1)(2009-8#1)
management of chronic hepatitis##3##4##(2007-12#1)(2009-8#2)
management of chronic viral##2##4##(2007-12#1)(2008-8#1)
management of chronic##13##3##(1990-2#1)(1997-1#1)(2007-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
management of complex##3##3##(2008-12#1)(2010-8#1)(2013-1#1)
management of congenital##2##3##(1992-5#1)(2012-2#1)
management of coronary##2##3##(2008-11#1)(2008-12#1)
management of craniofacial##2##3##(2007-12#2)
management of critical##4##3##(1994-12#1)(1996-2#2)(2007-12#1)
management of cutaneous##3##3##(2007-12#3)
management of daily and rapidly changing situations##2##7##(2008-11#2)
management of daily##4##3##(2008-11#3)(2008-9#1)
management of diabetes##4##3##(2007-10#1)(2008-10#1)(2009-11#1)(2013-8#1)
management of diabetic##2##3##(2008-9#1)(2011-7#1)
management of diverticular disease##2##4##(2010-8#2)
management of diverticular##3##3##(2010-8#3)
management of early breast cancer##2##5##(1993-9#1)(2013-1#1)
management of ectopic##2##3##(2009-8#1)(2013-8#1)
management of fever in##4##4##(1994-3#3)(2008-11#1)
management of fever##5##3##(1994-3#3)(2008-11#1)(2012-12#1)
management of fire blight##2##4##(2008-10#2)
management of foot melanoma##3##4##(2012-3#3)
management of foot##5##3##(2010-10#2)(2012-3#3)
management of gallbladder cancer##3##4##(2010-12#2)(2013-1#1)
management of genital##2##3##(2013-8#2)
management of heart failure##3##4##(2008-3#2)(2009-10#1)
management of heart##5##3##(1994-7#1)(2008-3#3)(2009-10#1)
management of high-grade dysplasia##2##4##(2009-4#2)
management of high-risk##2##3##(2006-10#1)(2012-2#1)
management of hypertension##2##3##(1990-11#1)(1992-8#1)
management of hypothyroidism and hyperthyroidism##2##5##(1996-8#1)(2008-4#1)
management of implantable medical device##2##5##(2012-3#2)
management of inflammatory##2##3##(2010-5#1)(2013-8#1)
management of interfering peaks##2##4##(1997-2#2)
management of intersex disorders##2##4##(2008-10#2)
management of intra-laboratory flows##2##4##(2013-1#2)
management of invasive aspergillosis##2##4##(2009-3#2)
management of invasive##3##3##(2008-7#1)(2009-3#2)
management of ischemic##2##3##(1997-8#1)(2007-10#1)
management of large##2##3##(1992-3#1)(2011-2#1)
management of locally advanced##3##4##(1990-6#1)(1993-9#1)(2008-10#1)
management of lung cancer##3##4##(1996-9#1)(2008-1#1)(2010-5#1)
management of lung##4##3##(1996-9#1)(2008-1#1)(2009-9#1)(2010-5#1)
management of malignant##3##3##(2007-8#2)(2012-2#1)
management of metastatic##3##3##(1993-9#1)(2008-10#1)(2012-2#1)
management of migraine##3##3##(1996-9#1)(2008-9#1)(2009-9#1)
management of musculoskeletal##2##3##(2008-3#2)
management of non-ST-segment elevation##2##4##(2008-3#2)
management of osteoporosis##6##3##(1993-11#2)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
management of osteosarcoma##3##3##(2008-6#1)(2010-3#2)
management of our##2##3##(2011-1#1)(2013-1#1)
management of painful##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
management of patient##2##3##(2008-1#2)
management of patients undergoing##2##4##(2011-2#1)(2012-3#1)
management of patients with Marfan##2##5##(2008-8#1)(2009-7#1)
management of patients with acute##2##5##(2007-8#1)(2008-3#1)
management of patients with bipolar disorder##2##6##(2012-3#2)
management of patients with chronic##3##5##(2008-4#1)(2011-2#1)(2012-1#1)
management of patients with diabetes##3##5##(2007-10#1)(2013-1#1)(2013-8#1)
management of patients with severe##2##5##(2012-12#1)(2013-1#1)
management of patients with suspected##2##5##(1995-6#1)(2012-2#1)
management of patients with##53##4##(1990-8#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#1)
management of patients##60##3##(1990-8#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#1)
management of pediatric craniofacial injuries##2##5##(2007-12#2)
management of pediatric craniofacial##3##4##(2007-12#3)
management of pediatric##8##3##(2006-10#1)(2007-12#3)(2011-1#2)(2012-3#1)(2013-8#1)
management of pharmaceuticals##2##3##(2010-3#2)
management of postmenopausal##3##3##(1991-4#1)(2011-1#2)
management of potato##2##3##(2008-10#2)
management of potential##3##3##(2007-12#1)(2009-4#1)(2010-12#1)
management of primary##3##3##(2008-10#1)(2010-3#1)(2012-2#1)
management of pulmonary metastases##2##4##(2010-3#2)
management of pulmonary##4##3##(1997-1#1)(2008-3#1)(2010-3#2)
management of ramus-condyle unit fractures##2##5##(2007-12#2)
management of recurrent##3##3##(2007-12#1)(2007-7#1)(2009-4#1)
management of refractory##4##3##(2007-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
management of renal##2##3##(2008-1#1)(2008-12#1)
management of rheumatic diseases##2##4##(1990-6#1)(1991-8#1)
management of risk##2##3##(2011-2#1)(2012-12#1)
management of severe##6##3##(1991-3#1)(2007-12#1)(2008-11#1)(2008-9#2)(2011-2#1)
management of sleep##4##3##(2007-12#2)(2008-11#1)(2008-7#1)
management of soilborne pests##2##4##(2008-10#2)
management of soilborne##4##3##(2008-10#4)
management of some##2##3##(1993-6#1)(2008-12#1)
management of spinal##4##3##(1995-9#1)(2006-12#1)(2011-2#1)(2012-2#1)
management of stage##2##3##(1990-2#1)(1990-6#1)
management of sternal wound infection##2##5##(2012-2#2)
management of such complex##2##4##(2011-2#1)(2013-1#1)
management of such patients##3##4##(1995-11#1)(2009-10#1)(2012-2#1)
management of such##12##3##(1995-11#1)(2007-12#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
management of symptomatic##5##3##(2008-8#2)(2012-2#2)(2012-3#1)
management of the breast##2##4##(1994-12#1)(2010-7#1)
management of the child with##2##5##(2008-11#1)(2013-8#1)
management of the disease##5##4##(1997-8#1)(2008-10#3)(2011-2#1)
management of the health care##2##5##(1993-12#1)(1995-2#1)
management of the metabolic syndrome##3##5##(2008-1#1)(2008-3#2)
management of the odontogenic keratocyst##2##5##(2007-12#2)
management of the patient##4##4##(1996-3#1)(2008-3#1)(2008-8#1)(2012-12#1)
management of the primary##2##4##(2010-3#1)(2011-3#1)
management of the##70##3##(1991-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-12#6)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
management of therapy-related PN##2##4##(2008-7#2)
management of these cases##5##4##(2007-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2013-1#1)
management of these infections##2##4##(2008-7#1)(2010-6#1)
management of these patients##9##4##(1991-2#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
management of these##26##3##(1991-2#1)(1993-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)
management of this condition##5##4##(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)
management of this disease##4##4##(1991-2#1)(2008-10#1)(2010-8#1)(2011-2#1)
management of this rare##2##4##(2010-3#1)(2013-1#1)
management of this##24##3##(1991-2#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-7#4)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#1)
management of thyroid##2##3##(2008-5#1)(2013-7#1)
management of traumatic##2##3##(2010-12#1)(2010-8#1)
management of tubal##3##3##(1991-12#1)(1994-3#1)(2011-1#1)
management of tuberculous##2##3##(2008-7#1)(2011-2#1)
management of two##3##3##(1997-3#1)(2010-7#1)(2011-1#1)
management of type 2 diabetes##2##5##(2008-1#1)(2008-3#1)
management of unacceptable##2##3##(2011-2#2)
management of uncontrolled hypertensives##2##4##(2008-10#2)
management of urological complications##2##4##(2008-1#2)
management of workplace violence##2##4##(1997-2#1)(2008-7#1)
management of##1030##2##(1990-10#1)(1990-11#2)(1990-2#3)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#5)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#6)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#8)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#3)(2006-12#3)(2006-5#1)(2006-7#1)(2007-10#9)(2007-11#12)(2007-12#54)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#20)(2007-9#3)(2008-1#25)(2008-10#77)(2008-11#29)(2008-12#23)(2008-2#7)(2008-3#48)(2008-4#11)(2008-5#8)(2008-6#13)(2008-7#56)(2008-8#27)(2008-9#20)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#10)(2009-2#3)(2009-3#2)(2009-4#9)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#22)(2010-2#3)(2010-3#11)(2010-4#5)(2010-5#9)(2010-6#6)(2010-7#12)(2010-8#15)(2010-9#5)(2011-1#13)(2011-10#1)(2011-2#64)(2011-3#5)(2011-7#5)(2012-1#2)(2012-12#20)(2012-2#39)(2012-3#30)(2013-1#61)(2013-7#3)(2013-8#16)
management on##7##2##(1993-12#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2013-1#1)
management opportunities##2##2##(1994-12#1)(2012-3#1)
management options##6##2##(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-12#1)
management or##4##2##(1993-12#1)(1995-3#1)(2011-2#1)(2013-7#1)
management perspective##5##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-3#2)
management plan is##4##3##(1996-1#1)(2008-5#1)(2011-1#1)(2011-2#1)
management plan##9##2##(1996-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
management plans##4##2##(2007-5#1)(2008-4#1)(2009-12#1)(2010-7#1)
management policies are##2##3##(2008-7#1)(2012-3#1)
management policies##4##2##(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
management policy##2##2##(2007-5#1)(2008-10#1)
management positions##7##2##(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#3)(2008-1#1)
management possible##3##2##(1994-6#2)(2010-4#1)
management practice##3##2##(1996-3#1)(2008-10#2)
management practices such as##3##4##(2008-10#3)
management practices that##2##3##(1993-1#1)(2008-10#1)
management practices used##2##3##(2008-10#1)(2010-11#1)
management practices##23##2##(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#2)
management principles##5##2##(1996-1#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
management problem##2##2##(1990-6#1)(1995-3#1)
management process##8##2##(1991-2#1)(1992-2#1)(1994-1#1)(1994-2#2)(1995-12#2)(2008-3#1)
management processes##2##2##(1995-12#1)(1996-12#1)
management professionals##2##2##(1993-1#1)(1997-2#1)
management program designed to##2##4##(1997-2#1)(2013-1#1)
management program for##3##3##(2008-4#1)(2013-1#1)(2013-8#1)
management program##27##2##(1991-12#2)(1991-2#1)(1992-1#1)(1993-2#1)(1993-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)(2013-8#1)
management programme##2##2##(1991-8#1)(2010-11#1)
management programs and##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
management programs##26##2##(1991-12#2)(1992-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
management protocol##2##2##(2007-7#1)(2011-2#1)
management purposes##2##2##(1993-1#1)(2007-10#1)
management recommendations##2##2##(2007-12#1)(2008-3#1)
management regime##2##2##(2008-7#1)(2011-2#1)
management remains##2##2##(1997-5#1)(2008-8#1)
management requires##5##2##(1994-3#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)
management response##2##2##(2008-11#1)(2011-2#1)
management roles##2##2##(1992-1#1)(1994-1#1)
management scheme##2##2##(2007-2#1)(2012-3#1)
management service##2##2##(1992-12#1)(2013-1#1)
management services##4##2##(1991-12#1)(1994-2#1)(1996-2#1)(2010-6#1)
management should be##5##3##(1993-1#1)(1995-8#1)(2009-3#1)(2009-7#1)(2013-1#1)
management should##8##2##(1993-1#1)(1995-8#1)(2008-10#1)(2008-11#2)(2009-3#1)(2009-7#1)(2013-1#1)
management skills for##2##3##(1992-1#1)(1994-1#1)
management skills##11##2##(1991-12#1)(1992-1#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-3#3)(1996-3#1)(2007-12#1)
management software##5##2##(1991-3#1)(1992-3#2)(1993-2#1)(2010-6#1)
management staff##3##2##(1992-2#2)(1993-12#1)
management stocks##2##2##(2009-2#2)
management strategies and##4##3##(1996-1#1)(2006-5#1)(2008-12#1)(2008-3#1)
management strategies could##2##3##(2008-10#1)(2008-6#1)
management strategies for##9##3##(2008-1#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
management strategies in##2##3##(2008-3#1)(2010-12#1)
management strategies of##2##3##(2012-2#1)(2013-8#1)
management strategies that##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
management strategies which##2##3##(2008-10#1)(2013-8#1)
management strategies##46##2##(1990-11#1)(1994-1#1)(1995-1#1)(1996-1#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#6)(2008-6#2)(2008-9#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
management strategy for##7##3##(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
management strategy in##2##3##(1992-1#1)(2013-8#1)
management strategy##17##2##(1992-1#1)(2008-10#8)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
management structure##3##2##(1994-1#1)(1995-1#1)(1996-3#1)
management structures##4##2##(1990-4#2)(1996-2#1)(2012-1#1)
management support##2##2##(1997-2#1)(2008-6#1)
management system for##3##3##(1992-2#1)(1993-1#1)(1993-3#1)
management system in##3##3##(2007-10#1)(2008-12#2)
management system##22##2##(1992-2#1)(1993-1#1)(1993-3#1)(1995-12#1)(1997-1#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-9#1)(2010-5#1)(2010-9#1)(2013-1#1)
management systems and##2##3##(1997-2#1)(2008-10#1)
management systems in##2##3##(1996-12#1)(2008-1#1)
management systems that##3##3##(2008-1#1)(2008-12#2)
management systems to##2##3##(1997-1#1)(2008-10#1)
management systems##20##2##(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-2#2)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-9#1)(2012-12#1)
management tactics##3##2##(2007-8#1)(2008-10#2)
management tasks##2##2##(1994-1#1)(2008-7#1)
management team to##2##3##(1994-3#1)(2008-7#1)
management team##8##2##(1993-1#2)(1994-3#3)(2008-1#1)(2008-11#1)(2008-7#1)
management teams##4##2##(1990-4#1)(1994-1#1)(1994-2#1)(1997-2#1)
management techniques##6##2##(1991-12#1)(1991-3#1)(1995-1#1)(1996-3#1)(2009-12#1)(2010-7#1)
management that##3##2##(1992-12#1)(1993-3#1)(2008-10#1)
management through##4##2##(1994-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
management to improve their##2##4##(1994-1#1)(2010-8#1)
management to improve##4##3##(1993-3#1)(1994-1#1)(2009-9#1)(2010-8#1)
management to##19##2##(1991-3#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2009-9#1)(2010-8#1)
management tool that##2##3##(1993-3#1)(1996-2#1)
management tool##10##2##(1992-12#2)(1993-3#1)(1994-12#2)(1994-3#1)(1996-2#2)(2008-10#1)(2008-11#1)
management tools##11##2##(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-10#5)(2011-2#1)
management training##10##2##(1991-2#1)(1993-1#3)(1994-2#3)(1997-2#2)(2009-11#1)
management under##4##2##(1992-12#2)(1997-1#1)(2012-2#1)
management units##4##2##(2008-10#1)(2009-2#1)(2010-8#2)
management using##4##2##(1992-1#1)(1992-6#1)(2007-10#1)(2008-8#1)
management was done##2##3##(2011-1#1)(2013-1#1)
management was##9##2##(1993-2#1)(2008-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
management were##7##2##(1990-8#1)(1992-1#1)(1995-3#1)(2007-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
management which##2##2##(1994-3#1)(2011-2#1)
management will##4##2##(1994-2#1)(1995-2#1)(2007-11#1)(2008-8#1)
management with##15##2##(1993-3#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#4)(2011-2#1)(2012-12#1)(2013-1#1)
management within##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
management without##2##2##(2007-12#1)(2013-1#1)
management##3029##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#4)(1990-6#6)(1990-8#2)(1990-9#4)(1991-1#7)(1991-11#1)(1991-12#36)(1991-2#15)(1991-3#21)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#5)(1991-9#2)(1992-1#27)(1992-11#1)(1992-12#40)(1992-2#25)(1992-3#29)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#27)(1993-10#2)(1993-11#5)(1993-12#32)(1993-2#24)(1993-3#28)(1993-6#2)(1993-9#5)(1994-1#48)(1994-11#2)(1994-12#43)(1994-2#53)(1994-3#57)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#29)(1995-10#1)(1995-11#7)(1995-12#34)(1995-2#24)(1995-3#35)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#43)(1996-11#6)(1996-12#16)(1996-2#32)(1996-3#33)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#21)(1997-2#30)(1997-3#39)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#7)(2006-10#16)(2006-12#7)(2006-5#3)(2006-7#1)(2007-10#22)(2007-11#36)(2007-12#88)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#12)(2007-6#3)(2007-7#19)(2007-8#30)(2007-9#9)(2008-1#66)(2008-10#249)(2008-11#93)(2008-12#61)(2008-2#18)(2008-3#74)(2008-4#25)(2008-5#32)(2008-6#29)(2008-7#108)(2008-8#57)(2008-9#41)(2009-1#4)(2009-10#10)(2009-11#15)(2009-12#22)(2009-2#7)(2009-3#9)(2009-4#17)(2009-5#8)(2009-6#5)(2009-7#9)(2009-8#12)(2009-9#7)(2010-1#4)(2010-10#9)(2010-11#17)(2010-12#30)(2010-2#3)(2010-3#22)(2010-4#6)(2010-5#20)(2010-6#16)(2010-7#27)(2010-8#44)(2010-9#14)(2011-1#35)(2011-10#1)(2011-2#169)(2011-3#11)(2011-7#7)(2012-1#8)(2012-12#51)(2012-2#74)(2012-3#68)(2012-8#1)(2013-1#125)(2013-7#17)(2013-8#37)
management'##2##1##(1997-5#1)(2010-10#1)
management's##6##1##(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-11#1)
management--a##2##1##(1991-9#1)(1994-2#1)
management?##2##1##(1993-2#1)(2008-11#1)
management]##8##1##(1990-12#1)(1991-6#1)(1992-2#1)(1997-3#1)(2008-5#1)(2009-1#1)(2009-5#1)(2010-6#1)
managements##5##1##(1994-3#1)(2012-12#1)(2013-1#3)
manager and the##2##3##(1992-12#1)(2008-12#1)
manager and##4##2##(1990-12#1)(1992-12#1)(1994-1#1)(2008-12#1)
manager for##2##2##(1997-5#1)(2007-12#1)
manager in##5##2##(1991-12#1)(1992-1#1)(1993-12#1)(1995-1#1)(1995-3#1)
manager of##2##2##(1993-12#1)(1993-2#1)
manager should##3##2##(1992-2#1)(1994-1#1)(1994-3#1)
manager to##2##2##(1993-1#1)(2007-10#1)
manager with##4##2##(1990-12#1)(1992-2#1)(1994-2#1)(1996-12#1)
manager##51##1##(1990-12#2)(1991-1#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#3)(1993-2#4)(1993-3#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-12#2)(2008-8#1)(2012-12#1)(2012-3#5)
manager's perspective##3##2##(1993-12#1)(1997-1#1)(2008-10#1)
manager's role in##3##3##(1994-2#1)(1995-12#1)(1997-1#1)
manager's role##7##2##(1992-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)
manager's view##2##2##(1993-2#1)(2007-3#1)
manager's##13##1##(1992-12#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#2)(1997-2#1)(2007-3#1)(2008-10#1)
managerial and##2##2##(1993-2#1)(2008-11#1)
managerial competencies##2##2##(2008-1#2)
managerial implications##3##2##(1994-3#1)(1996-2#1)(2008-11#1)
managerial roles##2##2##(1994-1#1)(1994-3#1)
managerial stereotypes##4##2##(2012-3#4)
managerial support##2##2##(2008-10#1)(2008-12#1)
managerial##39##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#4)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2009-8#1)(2010-10#1)(2012-3#5)
managers and##22##2##(1991-12#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
managers are##8##2##(1990-12#2)(1991-2#1)(1992-3#1)(1993-2#2)(2010-4#1)(2012-12#1)
managers as##2##2##(1997-1#2)
managers at##3##2##(1994-1#1)(1994-3#1)(2008-1#1)
managers can use these##2##4##(1996-12#1)(2008-12#1)
managers can use##4##3##(1991-12#1)(1996-12#1)(2006-5#1)(2008-12#1)
managers can##12##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#2)(1995-3#2)(1996-12#1)(1996-3#1)(2006-5#1)(2008-12#1)
managers could##3##2##(1992-3#1)(1993-2#1)(1994-2#1)
managers for##3##2##(1992-1#1)(1997-1#1)(2011-1#1)
managers have##3##2##(1996-1#1)(1997-2#1)(2012-3#1)
managers in British Columbia##3##4##(1994-1#1)(1994-2#1)(1997-2#1)
managers in the##4##3##(1991-2#1)(1994-1#1)(1994-2#1)(2012-12#1)
managers in##21##2##(1991-2#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#3)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2010-8#1)(2012-12#1)(2012-3#2)
managers is##3##2##(1996-3#1)(2009-4#1)(2012-3#1)
managers may##2##2##(1993-2#1)(1997-1#1)
managers must##7##2##(1992-12#1)(1993-2#1)(1995-1#2)(2006-5#1)(2007-11#1)(2008-1#1)
managers need to##3##3##(1992-3#1)(1994-1#1)(1996-2#1)
managers need##4##2##(1992-3#1)(1994-1#1)(1996-2#1)(1996-3#1)
managers of health systems##2##4##(1994-3#1)(2013-8#1)
managers of these##2##3##(1994-12#1)(2008-12#1)
managers of##11##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#3)(1997-2#1)(2008-12#1)(2013-8#1)
managers should##6##2##(1991-12#1)(1992-2#2)(1993-1#1)(1997-3#1)(2012-12#1)
managers to##15##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-3#1)(1997-2#1)(2006-5#1)(2007-3#1)(2010-8#1)
managers who are##2##3##(1997-2#1)(2012-3#1)
managers who##4##2##(1992-1#1)(1997-2#1)(2008-10#1)(2012-3#1)
managers will##2##2##(1995-3#1)(1997-1#1)
managers with the##2##3##(1993-12#1)(1994-2#1)
managers with##5##2##(1993-12#1)(1994-2#1)(1995-2#1)(2008-7#1)(2009-3#1)
managers##250##1##(1990-12#6)(1991-1#4)(1991-12#6)(1991-2#5)(1991-3#5)(1992-1#9)(1992-12#3)(1992-2#9)(1992-3#7)(1993-1#3)(1993-12#3)(1993-2#13)(1993-3#7)(1993-5#1)(1993-8#1)(1994-1#12)(1994-12#9)(1994-2#14)(1994-3#8)(1995-1#7)(1995-12#4)(1995-2#5)(1995-3#8)(1996-1#6)(1996-12#6)(1996-2#9)(1996-3#7)(1997-1#7)(1997-2#8)(1997-3#5)(1997-4#2)(2006-5#4)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#5)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#5)(2012-3#12)(2013-8#1)
managers'##6##1##(1991-2#2)(1991-3#1)(1992-1#2)(2008-1#1)
manages its##2##2##(1992-12#1)(2010-9#1)
manages##5##1##(1992-12#2)(1994-1#1)(1996-12#1)(2010-9#1)
managing &quot##2##2##(1994-1#2)
managing aggressive##3##2##(1995-2#1)(2008-7#1)(2009-6#1)
managing and##4##2##(1994-2#1)(1997-3#1)(2008-11#1)(2012-3#1)
managing care##3##2##(1995-12#1)(1997-1#1)(2013-1#1)
managing change##2##2##(1991-1#1)(1994-3#1)
managing children's##2##2##(2008-11#1)(2010-11#1)
managing health##2##2##(1995-3#1)(1997-2#1)
managing of##2##2##(1995-12#1)(1996-3#1)
managing patients with##3##3##(1995-6#1)(2006-10#1)(2011-2#1)
managing patients##4##2##(1995-6#1)(2006-10#1)(2008-8#1)(2011-2#1)
managing relationships##2##2##(1992-1#1)(2008-12#1)
managing stress##2##2##(1994-2#1)(2008-5#1)
managing the##19##2##(1992-1#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2009-10#1)(2009-5#1)(2011-1#1)(2013-1#3)(2013-8#1)
managing their##2##2##(1994-3#1)(2013-1#1)
managing this##4##2##(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
managing value##2##2##(1995-12#2)
managing##157##1##(1991-1#2)(1991-12#2)(1991-9#1)(1992-1#3)(1992-2#1)(1992-3#2)(1993-2#3)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#6)(1994-7#1)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#6)(2006-10#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#13)(2008-11#9)(2008-12#6)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#8)(2013-8#3)
mancozeb##8##1##(2008-10#7)(2011-2#1)
mandarin##3##1##(2008-10#2)(2012-12#1)
mandarins##2##1##(2008-10#1)(2008-5#1)
mandate and##3##2##(1991-12#1)(1997-2#1)(2008-3#1)
mandate for##4##2##(1996-3#1)(2008-12#1)(2008-6#1)(2010-5#1)
mandate includes##2##2##(1991-3#1)(2011-2#1)
mandate is##3##2##(1992-9#1)(1993-3#1)(1996-3#1)
mandate of##2##2##(1994-12#1)(2008-2#1)
mandate the##2##2##(1997-3#1)(2010-8#1)
mandate to##3##2##(1996-2#1)(2007-5#1)(2011-2#1)
mandate##40##1##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-12#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-5#1)(2010-8#3)(2011-2#6)(2012-1#1)(2012-12#2)(2013-7#1)
mandated by the##4##3##(1996-6#1)(1997-2#1)(2008-2#1)(2009-3#1)
mandated by##8##2##(1990-4#1)(1992-1#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-2#1)(2009-3#1)
mandated the##2##2##(1997-3#1)(2008-12#1)
mandated to##2##2##(2008-12#1)(2010-11#1)
mandated##23##1##(1990-4#1)(1991-1#1)(1991-3#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#3)(2008-12#2)(2008-2#1)(2009-3#1)(2010-11#1)(2013-1#1)
mandates to##2##2##(2011-9#1)(2013-1#1)
mandates##15##1##(1990-4#1)(1991-2#2)(1993-2#1)(1993-3#1)(1996-1#1)(1997-1#1)(2010-8#4)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
mandating##3##1##(1996-5#1)(2006-12#1)(2008-10#1)
mandatory HIV testing of##2##4##(1990-3#1)(1995-1#1)
mandatory for##4##2##(2007-8#1)(2008-7#1)(2010-8#1)(2012-12#1)
mandatory in##6##2##(1990-2#1)(1992-9#2)(2008-3#1)(2010-12#1)(2012-12#1)
mandatory minimum##2##2##(2008-10#1)(2013-8#1)
mandatory physician loss prevention seminar##2##5##(1994-1#2)
mandatory testing##2##2##(1994-2#1)(1996-5#1)
mandatory to perform##2##3##(2011-2#1)(2012-2#1)
mandatory to##11##2##(1994-5#1)(1997-6#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#4)(2012-2#1)
mandatory##74##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1992-9#2)(1993-3#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-8#2)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
mandelic acid dioxolanone##3##3##(2007-11#3)
mandelic##4##1##(2007-11#3)(2008-5#1)
mandible and##2##2##(2008-6#1)(2013-1#1)
mandible##33##1##(1991-4#1)(1993-12#2)(1996-3#1)(1997-3#1)(2007-12#2)(2007-5#2)(2008-12#2)(2008-6#1)(2008-7#6)(2009-4#1)(2010-3#1)(2010-6#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#7)
mandibles##5##1##(1995-9#1)(2007-12#1)(2009-3#1)(2010-5#1)(2011-2#1)
mandibular and maxillary##2##3##(2013-1#2)
mandibular and##3##2##(2007-12#1)(2013-1#2)
mandibular bone##2##2##(2008-5#1)(2013-1#1)
mandibular canines and##2##3##(2012-3#2)
mandibular canines##3##2##(2012-3#3)
mandibular condylar chondrocytes##2##3##(1994-6#2)
mandibular distraction##2##2##(2007-12#2)
mandibular left central##2##3##(2012-2#2)
mandibular molars##3##2##(2013-1#3)
mandibular overdentures##3##2##(2013-1#3)
mandibular##62##1##(1993-1#1)(1994-6#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#8)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#5)(2011-7#1)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#21)
maneb##2##1##(2008-10#2)
maneuver and##2##2##(2007-8#1)(2012-3#1)
maneuver for##2##2##(2008-7#1)(2013-1#1)
maneuver in##3##2##(2008-7#1)(2009-4#1)(2012-3#1)
maneuver##18##1##(2007-8#1)(2008-1#1)(2008-7#6)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
maneuvers for##3##2##(1990-9#1)(2008-7#1)(2013-8#1)
maneuvers##13##1##(1990-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-3#1)(2011-7#1)(2013-8#2)
mangabey##2##1##(1995-2#1)(2010-4#1)
manganese (II)##7##2##(2008-10#5)(2008-7#2)
manganese and iron##3##3##(2007-12#1)(2008-10#2)
manganese and zinc in##4##4##(2008-10#4)
manganese and zinc##6##3##(2008-10#6)
manganese and##17##2##(1990-2#1)(2007-12#1)(2008-10#14)(2013-1#1)
manganese by##3##2##(2008-10#3)
manganese can be##2##3##(2008-10#2)
manganese content##2##2##(2008-10#2)
manganese determination by##2##3##(2008-10#2)
manganese determination##3##2##(2008-10#3)
manganese dioxide##4##2##(2008-10#4)
manganese hexacyanoferrate##2##2##(2008-10#2)
manganese in grain##2##3##(2008-10#2)
manganese in##25##2##(2008-10#24)(2010-8#1)
manganese ion##2##2##(1993-8#1)(2008-10#1)
manganese oxide##5##2##(2008-10#5)
manganese peroxidase##6##2##(2008-5#2)(2008-6#2)(2008-7#2)
manganese phthalocyanine##2##2##(2008-10#2)
manganese superoxide dismutase##6##3##(1994-6#1)(1995-6#1)(1996-6#2)(2008-10#1)(2008-5#1)
manganese using##2##2##(2008-10#2)
manganese was##4##2##(2008-10#4)
manganese with##3##2##(2008-10#3)
manganese##164##1##(1990-2#2)(1990-8#1)(1991-12#2)(1993-8#2)(1994-6#1)(1995-3#3)(1995-6#1)(1996-2#1)(1996-6#2)(1997-7#1)(2007-12#1)(2008-10#127)(2008-5#3)(2008-6#2)(2008-7#5)(2009-12#1)(2010-11#2)(2010-8#1)(2011-2#2)(2013-1#4)
manganese(II) in##4##2##(2008-10#4)
manganese(II)##27##1##(2008-10#24)(2008-5#1)(2011-1#2)
manganese(IV) oxide##3##2##(2008-10#3)
manganese(IV)##8##1##(2008-10#8)
mangiferae##4##1##(2008-10#4)
mangiferin##8##1##(2010-5#8)
mangle##3##1##(2007-5#1)(2011-2#2)
mango floral and vegetative##2##4##(2008-10#2)
mango isolates as C##2##4##(2008-10#2)
mango isolates##4##2##(2008-10#4)
mango malformation disease##2##3##(2008-10#2)
mango trees##3##2##(2008-10#3)
mango##22##1##(2008-10#22)
mangrove prop##2##2##(2007-5#1)(2008-5#1)
mangrove species in##2##3##(2008-5#2)
mangrove swamp##2##2##(2007-5#2)
mangrove systems##2##2##(2008-5#2)
mangrove##25##1##(2007-5#6)(2008-10#1)(2008-11#1)(2008-5#8)(2008-7#2)(2011-2#5)(2013-7#2)
mangroves##4##1##(2008-5#1)(2011-2#2)(2013-7#1)
mania and after##2##3##(2013-8#2)
mania and##4##2##(1995-5#1)(2009-8#1)(2013-8#2)
mania or hypomania##2##3##(1996-7#2)
mania##13##1##(1995-5#2)(1996-7#2)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#3)
manic depressive disorder##2##3##(1995-6#1)(2009-8#1)
manic states##2##2##(2012-3#2)
manic##12##1##(1994-8#1)(1995-5#1)(1995-6#1)(1996-7#2)(2009-8#1)(2012-3#3)(2013-8#3)
manic-depressive illness##3##2##(1997-5#3)
manic-depressive##6##1##(1997-5#5)(2008-9#1)
maniculatus)##2##1##(2008-10#1)(2010-6#1)
manifest as##7##2##(1997-3#1)(2008-1#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-8#1)
manifest disease##2##2##(1990-2#1)(1993-11#1)
manifest in the##2##3##(2007-7#1)(2008-4#1)
manifest in##10##2##(2007-12#1)(2007-7#1)(2008-11#2)(2008-4#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
manifest themselves##4##2##(1997-3#1)(2007-12#1)(2008-3#1)(2008-7#1)
manifest with##2##2##(2012-3#1)(2013-1#1)
manifest##61##1##(1990-2#4)(1990-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-3#2)(1997-4#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
manifestation and##2##2##(2008-7#1)(2011-1#1)
manifestation in##3##2##(1993-2#1)(1997-8#1)(2013-8#1)
manifestation is##2##2##(2007-7#1)(2008-4#1)
manifestation of T1D##2##3##(2007-5#2)
manifestation of a##7##3##(1990-12#1)(1991-6#1)(1994-2#1)(1996-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
manifestation of central##2##3##(2007-10#1)(2008-10#1)
manifestation of disease and##2##4##(2008-10#1)(2013-1#1)
manifestation of infection##2##3##(1991-3#1)(2011-3#1)
manifestation of sarcoidosis##2##3##(2008-4#1)(2012-3#1)
manifestation of the##9##3##(1992-12#1)(1992-5#1)(1994-2#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
manifestation of this disease##2##4##(1996-12#1)(2008-7#1)
manifestation of this##4##3##(1992-1#1)(1996-12#1)(2008-7#1)(2008-9#1)
manifestation of##93##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-5#1)(1994-2#3)(1995-11#1)(1996-11#2)(1996-12#1)(1996-4#1)(1997-5#1)(1997-8#1)(2006-10#4)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#3)(2007-7#4)(2007-8#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#2)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
manifestation##121##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-5#1)(1993-2#1)(1994-2#3)(1995-11#1)(1996-11#2)(1996-12#1)(1996-4#1)(1997-5#1)(1997-8#3)(2006-10#4)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#3)(2007-7#6)(2007-8#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-5#2)(2010-10#1)(2010-12#3)(2010-5#2)(2010-6#4)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#4)
manifestations and management##2##3##(2010-3#2)
manifestations and##9##2##(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#3)(2013-1#1)
manifestations are common##2##3##(2009-12#1)(2012-2#1)
manifestations are##16##2##(1990-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
manifestations can be found##2##4##(1991-11#1)(2008-9#1)
manifestations can##5##2##(1991-11#1)(2008-9#2)(2010-6#1)(2012-2#1)
manifestations for##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
manifestations in the##2##3##(1996-12#1)(2007-10#1)
manifestations in##17##2##(1993-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-2#2)(2013-8#1)
manifestations include##4##2##(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
manifestations included##2##2##(2006-10#1)(2012-1#1)
manifestations of SLE##3##3##(2011-2#3)
manifestations of a##3##3##(2012-12#1)(2013-1#2)
manifestations of aging##2##3##(1992-12#1)(1994-6#1)
manifestations of chronic##2##3##(1990-9#1)(2013-1#1)
manifestations of primary Sjogren's syndrome]##2##5##(1990-2#2)
manifestations of primary##4##3##(1990-2#3)(2007-2#1)
manifestations of systemic##2##3##(2012-3#2)
manifestations of the disease##5##4##(2007-7#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
manifestations of the##10##3##(1991-12#1)(1995-3#1)(2007-7#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
manifestations of this disease##2##4##(1997-8#1)(2008-7#1)
manifestations of this##4##3##(1991-11#1)(1997-8#1)(2008-7#2)
manifestations of##84##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-6#3)(1995-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#7)
manifestations similar to##2##3##(2006-10#1)(2008-5#1)
manifestations such as##2##3##(2009-4#1)(2012-2#1)
manifestations to##2##2##(2009-7#1)(2011-2#1)
manifestations were##10##2##(1996-11#1)(2007-10#2)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#3)
manifestations##241##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#12)(2007-10#8)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#7)(2008-7#15)(2008-8#2)(2008-9#4)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#5)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#6)(2010-3#7)(2010-4#1)(2010-6#1)(2010-9#2)(2011-2#18)(2011-8#1)(2012-1#1)(2012-12#7)(2012-2#17)(2012-3#8)(2013-1#22)(2013-8#3)
manifestations]##4##1##(1990-3#2)(1991-2#1)(1992-11#1)
manifested as##5##2##(2007-12#1)(2008-1#1)(2008-10#2)(2012-1#1)
manifested at##3##2##(2007-7#1)(2008-1#1)(2008-7#1)
manifested by a##11##3##(1992-5#1)(1993-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#3)(2012-2#2)
manifested by the##3##3##(1997-4#1)(2008-3#1)(2008-4#1)
manifested by##25##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-2#1)(2009-8#3)(2012-1#1)(2012-2#2)(2013-1#1)
manifested clinically##2##2##(1995-5#1)(2008-1#1)
manifested in the##4##3##(1994-9#1)(2007-11#1)(2008-3#1)(2010-4#1)
manifested in##7##2##(1992-5#1)(1994-9#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-3#1)(2010-4#1)
manifested through##2##2##(2008-10#1)(2012-1#1)
manifested##64##1##(1990-5#2)(1992-1#1)(1992-12#1)(1992-5#3)(1993-1#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#4)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#3)(2010-4#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#1)
manifesting as severe##2##3##(2011-2#1)(2012-2#1)
manifesting as##7##2##(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
manifesting##13##1##(1994-2#1)(1995-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
manifests a##3##2##(1997-2#1)(2008-2#2)
manifests as a##3##3##(2007-12#1)(2007-7#1)(2010-6#1)
manifests as##5##2##(2007-12#1)(2007-7#1)(2008-3#1)(2009-12#1)(2010-6#1)
manifests in##3##2##(2007-7#1)(2008-11#1)(2008-2#1)
manifests itself in the##2##4##(2007-11#1)(2008-3#1)
manifests itself in##5##3##(1990-8#1)(1996-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
manifests itself##6##2##(1990-8#1)(1996-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-8#1)
manifests with##2##2##(2007-7#1)(2013-1#1)
manifests##24##1##(1990-8#1)(1995-8#1)(1996-12#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
manifold and##6##2##(2008-10#6)
manifold coupled##2##2##(2008-10#2)
manifold for the##4##3##(2008-10#4)
manifold for##8##2##(2008-10#8)
manifold in##4##2##(2008-10#4)
manifold of##3##2##(2008-10#2)(2013-8#1)
manifold reconfiguration##2##2##(2008-10#2)
manifold was designed with##2##4##(2008-10#2)
manifold was designed##3##3##(2008-10#3)
manifold was used to##4##4##(2008-10#4)
manifold was##11##2##(2008-10#11)
manifold with##3##2##(2008-10#3)
manifold##90##1##(1991-4#1)(1997-7#1)(2007-12#1)(2008-10#79)(2008-11#3)(2008-4#1)(2008-5#1)(2009-10#1)(2013-8#2)
manifolds with##2##2##(2008-10#2)
manifolds##6##1##(2008-10#6)
manihotis from##3##2##(2008-10#3)
manihotis strains##2##2##(2008-10#2)
manihotis##15##1##(2008-10#15)
manipulate a##2##2##(1995-2#1)(2008-8#1)
manipulate the##12##2##(1990-2#1)(1993-12#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-7#1)(2013-1#1)(2013-8#1)
manipulate their##2##2##(2009-8#1)(2012-3#1)
manipulate##45##1##(1990-2#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-5#2)(2009-8#3)(2010-2#1)(2010-7#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
manipulated and##2##2##(2008-11#1)(2012-3#1)
manipulated by a##2##3##(1993-3#1)(2008-3#1)
manipulated by##10##2##(1993-3#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-8#1)
manipulated in a##2##3##(2009-12#1)(2012-3#1)
manipulated in##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-3#1)
manipulated to##7##2##(1991-12#1)(2008-10#3)(2009-11#1)(2009-12#1)(2009-8#1)
manipulated using##3##2##(2007-6#1)(2008-4#1)(2012-2#1)
manipulated##54##1##(1991-12#1)(1992-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-8#2)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
manipulates##4##1##(1990-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
manipulating and##2##2##(1995-2#1)(2009-12#1)
manipulating the##14##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
manipulating##39##1##(1994-3#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-5#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
manipulation and##13##2##(1995-5#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2009-9#1)
manipulation are##2##2##(2008-11#1)(2008-3#1)
manipulation could##2##2##(2008-7#1)(2011-1#1)
manipulation during##2##2##(2007-10#1)(2008-10#1)
manipulation for##3##2##(2008-2#1)(2008-9#1)(2010-4#1)
manipulation in the management of lateral epicondylalgia##2##7##(2008-12#2)
manipulation in the##3##3##(2008-12#2)(2008-2#1)
manipulation in##4##2##(2008-12#2)(2008-2#1)(2009-5#1)
manipulation is##2##2##(1995-5#1)(2008-10#1)
manipulation of microscopic objects##2##4##(2008-3#2)
manipulation of the##17##3##(1993-1#1)(1994-9#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)
manipulation of these##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
manipulation of##68##2##(1991-8#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(2007-11#4)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
manipulation on##3##2##(2007-11#2)(2013-8#1)
manipulation techniques##3##2##(2008-12#1)(2009-12#2)
manipulation through##2##2##(2007-11#1)(2008-11#1)
manipulation treatment##2##2##(2008-12#2)
manipulation with the##2##3##(1995-5#1)(2008-10#1)
manipulation with##3##2##(1995-5#1)(2008-10#1)(2009-5#1)
manipulation##171##1##(1990-2#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-9#1)(1995-12#2)(1995-5#3)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#12)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#22)(2008-2#4)(2008-3#8)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#3)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
manipulation)##2##1##(2009-12#2)
manipulations and##2##2##(2008-2#1)(2008-4#1)
manipulations of the##5##3##(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)
manipulations of##13##2##(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
manipulations on##2##2##(2008-4#1)(2013-1#1)
manipulations that##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
manipulations to##2##2##(1997-2#1)(2008-2#1)
manipulations with##2##2##(2007-12#1)(2008-11#1)
manipulations##54##1##(1990-11#1)(1991-12#1)(1991-7#1)(1992-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-2#3)(2008-4#11)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-7#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#2)(2013-1#1)
manipulative therapy##6##2##(2008-12#4)(2013-1#2)
manipulative##8##1##(2008-12#5)(2013-1#3)
manipulator##3##1##(2007-12#1)(2008-10#2)
mankind##4##1##(1994-5#1)(2007-8#1)(2008-10#1)(2011-1#1)
manmade##2##1##(2008-10#1)(2008-3#1)
mannan (Candida##2##2##(2008-10#2)
mannan##4##1##(1991-5#1)(2008-10#2)(2008-4#1)
mannan-binding lectin##2##2##(2008-4#2)
mannan-binding protein##2##2##(1993-3#2)
mannan-binding##5##1##(1991-5#1)(1993-3#2)(2008-4#2)
mannan-degrading##2##1##(2008-6#2)
mannanase activity##3##2##(2008-6#3)
mannanase##6##1##(2008-6#6)
manned hydrogen-gas##2##2##(2008-11#2)
manned##3##1##(2008-11#2)(2009-12#1)
mannequin##2##1##(2008-11#1)(2013-8#1)
mannequins##2##1##(2008-11#1)(2013-8#1)
manner (IC50##2##2##(1992-3#1)(1992-6#1)
manner across##2##2##(1996-1#1)(1996-12#1)
manner and can##2##3##(1990-12#1)(2013-1#1)
manner and may##2##3##(1994-8#1)(2008-4#1)
manner and that these##2##4##(2008-11#1)(2008-7#1)
manner and that##4##3##(1990-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
manner and was##2##3##(1990-8#1)(1993-6#1)
manner and##26##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#3)(1995-3#1)(1996-3#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
manner as compared##2##3##(1994-11#1)(2007-10#1)
manner as for##2##3##(2008-1#1)(2008-10#1)
manner as##12##2##(1990-11#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-9#1)
manner at concentrations##2##3##(1995-12#1)(2008-11#1)
manner at##4##2##(1991-6#1)(1992-6#1)(1995-12#1)(2008-11#1)
manner but##3##2##(1992-12#1)(1993-9#1)(2008-10#1)
manner by a##2##3##(2008-2#1)(2008-9#1)
manner by##17##2##(1990-12#1)(1990-5#1)(1993-9#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)
manner during the##2##3##(2008-2#1)(2008-6#1)
manner during##4##2##(1994-9#1)(1995-11#1)(2008-2#1)(2008-6#1)
manner either##2##2##(2008-5#1)(2009-12#1)
manner for##6##2##(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
manner has##2##2##(1990-11#1)(2008-8#1)
manner in a##2##3##(1992-6#1)(1995-11#1)
manner in primary##2##3##(1993-8#1)(1995-8#1)
manner in the##3##3##(1992-2#1)(2007-11#2)
manner in which the##7##4##(1992-1#1)(1994-2#1)(1997-8#1)(2008-1#1)(2008-2#1)(2009-5#1)(2011-1#1)
manner in which##15##3##(1992-1#1)(1993-2#2)(1994-2#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-5#2)(2010-5#1)(2011-1#1)(2011-2#1)
manner in##40##2##(1990-5#1)(1990-7#1)(1991-10#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-5#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
manner is##4##2##(1997-1#1)(2008-11#1)(2008-3#1)(2009-9#1)
manner of##15##2##(1990-12#1)(1995-1#1)(1995-11#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2013-8#1)
manner on##3##2##(1995-6#1)(1997-7#1)(2012-3#1)
manner or as a##2##4##(1994-9#1)(2008-4#1)
manner over the##2##3##(2008-2#1)(2008-8#1)
manner provide##2##2##(1992-9#1)(2008-10#1)
manner so##2##2##(2009-10#1)(2010-5#1)
manner than##2##2##(2008-11#1)(2010-4#1)
manner that depends on the##2##5##(2008-11#1)(2012-12#1)
manner that##18##2##(1991-8#1)(1993-6#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-12#1)
manner the##2##2##(2008-10#1)(2009-3#1)
manner to the##4##3##(1997-2#1)(2008-11#2)(2012-3#1)
manner to##17##2##(1990-5#1)(1992-10#1)(1994-2#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#2)(2012-3#1)
manner using##2##2##(2008-3#1)(2009-10#1)
manner via##2##2##(1991-9#1)(2011-1#1)
manner when##3##2##(1993-8#1)(2008-1#1)(2008-5#1)
manner which##4##2##(1993-8#1)(1994-6#1)(1997-1#1)(2010-9#1)
manner with IC50 values of##2##5##(1992-5#1)(1995-12#1)
manner with a##2##3##(1995-11#1)(1997-6#1)
manner with##10##2##(1990-7#1)(1991-2#1)(1992-5#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-5#1)(1997-6#1)(2008-8#1)
manner##640##1##(1990-11#6)(1990-12#6)(1990-2#4)(1990-5#3)(1990-6#1)(1990-7#7)(1990-8#6)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#6)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#7)(1992-5#1)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#5)(1993-8#10)(1993-9#3)(1994-11#12)(1994-12#6)(1994-2#5)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#8)(1994-9#5)(1995-1#1)(1995-11#12)(1995-12#13)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#8)(1996-1#2)(1996-12#11)(1996-2#6)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#10)(1997-8#2)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#7)(2008-10#68)(2008-11#48)(2008-12#5)(2008-2#13)(2008-3#14)(2008-4#14)(2008-5#15)(2008-6#9)(2008-7#12)(2008-8#11)(2008-9#15)(2009-10#4)(2009-11#2)(2009-12#7)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#4)(2009-8#3)(2009-9#5)(2010-1#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#9)(2012-7#1)(2013-1#9)(2013-8#5)
manners##12##1##(1993-6#1)(1994-3#2)(1997-3#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
mannitol into the##2##3##(1991-10#1)(1995-12#1)
mannitol oxidase##3##2##(2008-7#3)
mannitol was##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
mannitol##42##1##(1991-10#9)(1992-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-1#5)(2008-10#11)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#1)(2011-2#1)(2012-7#2)
mannitolilytica##3##1##(2007-7#3)
mannose 6-phosphate##2##2##(1995-6#2)
mannose and##2##2##(1990-7#1)(1992-9#1)
mannose moiety##2##2##(2008-10#2)
mannose##28##1##(1990-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-6#4)(1996-6#3)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-3#1)
mannose-binding lectin 2##2##3##(2013-1#2)
mannose-binding lectin##3##2##(2013-1#3)
mannose-binding##4##1##(1994-8#1)(2013-1#3)
mannose-rich sugar##2##2##(2008-11#2)
mannose-rich##3##1##(2008-11#3)
mannosidase activity##2##2##(1995-2#2)
mannosidase##3##1##(1995-2#3)
mannosidases in##2##2##(1995-2#2)
mannosylerythritol##3##1##(2008-11#3)
manoeuvre##4##1##(1994-3#1)(2008-9#2)(2009-4#1)
manoeuvres##6##1##(2008-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
manometric##2##1##(2012-2#1)(2013-8#1)
manpower and##7##2##(1990-2#2)(1991-2#1)(1994-2#1)(1995-9#3)
manpower planning##3##2##(1991-2#2)(2012-2#1)
manpower##23##1##(1990-2#2)(1990-6#3)(1991-2#6)(1993-1#1)(1994-2#1)(1995-9#3)(2008-1#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
mansoni##19##1##(1993-2#3)(1993-6#1)(1996-8#1)(1997-6#4)(2008-12#4)(2010-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
mantelzorger##3##1##(2012-12#3)
mantle cell lymphoma involving the appendix##2##6##(2009-7#2)
mantle cell lymphoma##9##3##(2008-7#2)(2009-1#1)(2009-7#5)(2009-8#1)
mantle cell##10##2##(2008-7#2)(2009-1#1)(2009-7#5)(2009-8#1)(2012-2#1)
mantle##20##1##(1991-8#1)(1995-6#2)(1996-2#1)(1996-4#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-7#5)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
manual analysis of##2##3##(2008-10#1)(2011-1#1)
manual and automated##4##3##(2008-10#3)(2008-4#1)
manual and mechanical rotary instrumentation##2##5##(2008-11#2)
manual and##11##2##(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)
manual curation##2##2##(2008-7#1)(2011-2#1)
manual estimation##2##2##(2008-3#2)
manual flame atomic absorption##2##4##(2008-10#2)
manual for the##3##3##(1991-12#1)(2010-10#1)(2013-8#1)
manual for##4##2##(1991-12#1)(2010-10#1)(2011-2#1)(2013-8#1)
manual interpretation of##2##3##(2008-4#1)(2008-8#1)
manual interpretation##4##2##(1994-6#1)(2008-4#2)(2008-8#1)
manual labels##2##2##(2010-9#2)
manual labor##2##2##(2008-9#1)(2009-7#1)
manual method##2##2##(1991-12#1)(2008-10#1)
manual methods based on##2##4##(2008-10#2)
manual methods##6##2##(1991-3#2)(1993-1#1)(2008-10#3)
manual muscle testing##2##3##(2008-12#1)(2008-9#1)
manual muscle##4##2##(2008-12#3)(2008-9#1)
manual operations##2##2##(2008-11#1)(2010-8#1)
manual palpation and##2##3##(2008-8#2)
manual palpation##7##2##(2007-5#1)(2007-8#1)(2008-8#4)(2010-9#1)
manual polybrene technique##2##3##(1994-12#2)
manual procedure##2##2##(2008-10#2)
manual process##3##2##(1996-3#3)
manual searches##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
manual shimming##2##2##(2012-3#2)
manual system##2##2##(1995-12#1)(2008-10#1)
manual systems##2##2##(1995-12#1)(1995-2#1)
manual test##2##2##(2008-10#2)
manual testing##2##2##(1994-6#2)
manual therapists##2##2##(2012-2#2)
manual therapy practitioners##2##3##(2008-12#2)
manual therapy trials##3##3##(2012-2#3)
manual therapy##19##2##(2007-11#2)(2008-12#6)(2010-3#1)(2012-2#9)(2013-1#1)
manual titration##2##2##(2008-10#2)
manual treatment##2##2##(2009-3#1)(2010-9#1)
manual vacuum aspiration##3##3##(1996-8#1)(2011-1#2)
manual##192##1##(1990-5#1)(1991-12#2)(1991-3#3)(1992-8#1)(1993-1#1)(1993-12#2)(1994-12#4)(1994-6#7)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#3)(1996-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#46)(2008-11#9)(2008-12#11)(2008-2#2)(2008-3#2)(2008-4#14)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#9)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#5)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#13)(2012-3#2)(2013-1#4)(2013-8#2)
manually and##4##2##(1996-12#1)(2009-3#1)(2011-1#1)(2012-3#1)
manually infested##2##2##(2008-10#2)
manually operated##2##2##(2008-10#2)
manually##27##1##(1994-6#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-3#1)
manuals##5##1##(2008-9#1)(2010-8#1)(2012-12#1)(2013-8#2)
manufactory##4##1##(2008-10#3)(2012-3#1)
manufacturability##2##1##(2008-3#1)(2010-7#1)
manufacture and use of a##2##5##(2008-3#1)(2008-7#1)
manufacture and##7##2##(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
manufacture of the##3##3##(2008-3#2)(2008-5#1)
manufacture of##19##2##(1994-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
manufacture to##3##2##(2008-3#3)
manufacture##55##1##(1994-12#1)(1995-3#1)(1996-9#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#5)(2008-2#4)(2008-3#13)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
manufactured by##12##2##(1994-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
manufactured in a##2##3##(1995-5#1)(2007-11#1)
manufactured in##4##2##(1995-5#1)(1997-6#1)(2007-11#1)(2008-10#1)
manufactured on##2##2##(2008-3#1)(2008-5#1)
manufactured with##3##2##(2008-3#2)(2010-4#1)
manufactured##37##1##(1994-3#1)(1995-5#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-8#1)(2009-11#1)(2010-4#2)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
manufacturer of##2##2##(2008-10#1)(2011-2#1)
manufacturer##23##1##(1994-3#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-8#2)(2010-5#1)(2010-6#1)(2011-2#4)(2013-1#1)
manufacturer's##14##1##(1994-1#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-7#1)(2011-2#1)
manufacturer)##2##1##(1996-2#1)(2009-8#1)
manufacturers and##4##2##(1993-12#1)(1997-1#1)(2008-10#1)(2010-4#1)
manufacturers are##2##2##(1991-12#1)(2010-4#1)
manufacturers have##2##2##(2008-7#1)(2011-2#1)
manufacturers is##3##2##(1997-3#1)(1997-4#1)(2010-5#1)
manufacturers of##5##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
manufacturers to##2##2##(1994-2#1)(2008-10#1)
manufacturers##51##1##(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#1)
manufacturers'##2##1##(1993-3#1)(2012-12#1)
manufacturing and##9##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2012-2#4)
manufacturing conditions##4##2##(2008-11#1)(2008-3#2)(2008-5#1)
manufacturing industries##3##2##(1995-1#1)(1995-2#1)(2008-10#1)
manufacturing practice##2##2##(2008-7#1)(2012-12#1)
manufacturing procedures##2##2##(2008-10#1)(2008-7#1)
manufacturing process controls##2##3##(2008-11#2)
manufacturing process of##3##3##(2008-10#2)(2008-2#1)
manufacturing process##18##2##(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2010-4#1)(2012-2#2)
manufacturing processes and##2##3##(2008-11#1)(2008-3#1)
manufacturing processes##6##2##(1995-5#1)(2008-11#2)(2008-3#3)
manufacturing techniques##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
manufacturing technologies##2##2##(1992-3#1)(2008-11#1)
manufacturing technology##2##2##(2008-3#1)(2010-3#1)
manufacturing to##2##2##(2008-10#1)(2011-2#1)
manufacturing using##2##2##(2008-10#1)(2009-7#1)
manufacturing##111##1##(1992-2#1)(1992-3#2)(1993-3#1)(1994-3#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-10#18)(2008-11#13)(2008-2#4)(2008-3#19)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2009-7#4)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#8)(2013-8#1)
manure P excretion##2##3##(2010-2#2)
manure compost##2##2##(2008-10#2)
manure composted for##2##3##(2008-10#2)
manure or##3##2##(2008-10#3)
manure##34##1##(2007-12#1)(2008-10#31)(2010-2#2)
manures and crop sequences##2##4##(2008-10#2)
manures##4##1##(2008-10#4)
manuscript is##3##2##(2010-3#1)(2011-2#1)(2012-2#1)
manuscript##39##1##(2007-11#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
manuscripts for##2##2##(1992-12#1)(2011-2#1)
manuscripts in##2##2##(2008-10#1)(2008-3#1)
manuscripts##10##1##(1991-6#1)(1992-12#1)(2008-10#3)(2008-3#2)(2008-8#1)(2011-2#2)
many &quot##2##2##(2008-3#1)(2008-4#1)
many Canadian hospitals are##2##4##(1991-12#1)(1994-12#1)
many Canadian##3##2##(1991-12#1)(1994-12#1)(2008-10#1)
many European countries##2##3##(1996-2#1)(2007-2#1)
many Gram-negative##2##2##(2008-9#1)(2011-2#1)
many States##2##2##(1994-3#1)(1995-1#1)
many US##2##2##(2008-3#1)(2011-2#1)
many actions##2##2##(1993-6#1)(2013-1#1)
many advances in the##2##4##(2010-3#1)(2013-8#1)
many advances in##5##3##(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2013-8#1)
many advances##6##2##(1990-9#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2013-8#1)
many advantages for##4##3##(1993-1#1)(2008-2#2)(2012-2#1)
many advantages over conventional##2##4##(2008-4#1)(2008-7#1)
many advantages over other##4##4##(1994-5#1)(2007-11#1)(2007-12#1)(2012-2#1)
many advantages over##10##3##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
many advantages##23##2##(1993-1#1)(1994-3#1)(1994-5#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
many adverse##4##2##(2007-2#1)(2009-6#1)(2010-11#1)(2010-5#1)
many amino acids and metal ions##2##6##(2008-10#2)
many analytical techniques##2##3##(2010-5#1)(2010-7#1)
many analytical##3##2##(2008-10#1)(2010-5#1)(2010-7#1)
many anatomical##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
many and##2##2##(1994-3#1)(2008-3#1)
many animals##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
many applications in##5##3##(1995-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-2#1)
many applications##19##2##(1991-5#1)(1993-3#1)(1995-11#1)(1996-3#1)(2006-4#1)(2007-12#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-8#1)(2012-2#1)
many approaches##2##2##(2010-12#1)(2010-8#1)
many are##4##2##(1991-2#1)(1995-5#1)(2011-2#1)(2012-12#1)
many areas of the##4##4##(1992-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
many areas of##7##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
many areas to##2##3##(1994-3#1)(2008-11#1)
many areas##13##2##(1992-12#1)(1994-3#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)
many as##27##2##(1995-1#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
many aspects of cellular##2##4##(2009-8#1)(2011-2#1)
many aspects of the##2##4##(2008-5#1)(2012-2#1)
many aspects of this##2##4##(2008-3#1)(2012-2#1)
many aspects of##29##3##(1991-12#1)(1992-2#1)(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
many aspects##34##2##(1991-12#1)(1992-11#1)(1992-2#1)(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
many attempts to##2##3##(2007-11#1)(2008-5#1)
many attempts##4##2##(1994-3#1)(2007-11#1)(2008-5#1)(2010-12#1)
many authors##7##2##(1993-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
many available##2##2##(1996-9#1)(2008-7#1)
many avian species##2##3##(2008-3#1)(2008-8#1)
many bacteria##2##2##(1994-12#1)(1996-12#1)
many basic##3##2##(1997-8#1)(2007-5#1)(2010-8#1)
many behavioral##2##2##(2008-8#2)
many benefits##2##2##(1993-12#1)(2008-10#1)
many benign##2##2##(2010-11#1)(2013-1#1)
many biological processes##4##3##(2008-2#1)(2009-11#1)(2009-12#1)(2010-12#1)
many biological##12##2##(2008-2#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-1#1)
many brain regions##2##3##(1996-5#1)(2008-11#1)
many cancer patients##2##3##(2008-10#1)(2008-11#1)
many cancers##5##2##(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
many cases it##3##3##(1991-6#1)(2008-3#1)(2008-4#1)
many cases of##5##3##(1990-9#1)(1994-12#1)(1997-6#1)(2007-12#1)(2010-3#1)
many cases the##3##3##(1994-11#1)(2010-3#1)(2011-2#1)
many cases##52##2##(1990-9#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
many cations and anions##2##4##(2008-10#2)
many cations and##3##3##(2008-10#3)
many cell functions##2##3##(1995-8#1)(2011-2#1)
many cell types including##2##4##(2008-1#2)
many cell types##11##3##(1991-9#1)(1992-8#1)(1993-6#1)(1994-5#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)
many cell##16##2##(1991-9#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-8#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
many cells in##2##3##(1997-7#1)(2008-9#1)
many cells##4##2##(1997-7#1)(2008-1#1)(2008-9#1)(2013-8#1)
many cellular functions##5##3##(1993-8#1)(2008-1#1)(2009-4#1)(2011-2#1)(2012-3#1)
many cellular processes##6##3##(1994-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#2)
many cellular proteins##2##3##(2008-5#1)(2008-8#1)
many cellular##14##2##(1993-6#1)(1993-8#1)(1994-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
many centers##7##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
many challenges in##2##3##(2008-7#1)(2011-2#1)
many challenges remain##2##3##(2012-12#2)
many challenges still##2##3##(2009-3#1)(2012-12#1)
many challenges to##4##3##(2008-12#1)(2010-10#1)(2011-1#2)
many challenges##18##2##(1992-1#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#3)
many changes in the##3##4##(1994-8#1)(2007-8#1)(2012-2#1)
many changes##7##2##(1994-1#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
many channels##2##2##(1994-12#1)(2008-3#1)
many characteristics of##4##3##(1993-3#1)(1997-4#1)(2008-7#1)(2008-9#1)
many characteristics##6##2##(1993-3#1)(1997-4#1)(2007-4#1)(2008-7#1)(2008-9#2)
many chemical##3##2##(2008-10#2)(2008-7#1)
many children are being treated with##2##6##(1997-1#1)(2011-1#1)
many children are##4##3##(1994-2#1)(1997-1#1)(2009-10#1)(2011-1#1)
many children in##2##3##(1997-4#1)(2008-11#1)
many children##9##2##(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-4#1)(2008-11#2)(2009-10#1)(2011-1#1)
many chronic diseases##2##3##(2008-10#1)(2010-1#1)
many chronic##3##2##(1994-3#1)(2008-10#1)(2010-1#1)
many clinical trials##4##3##(1995-9#1)(1997-3#1)(2008-5#1)(2008-9#1)
many clinical##14##2##(1995-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)
many commercially available##2##3##(2008-2#1)(2008-5#1)
many common anions##3##3##(2008-10#3)
many common##11##2##(1990-8#1)(1991-9#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)
many complex##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
many components of##2##3##(1991-3#1)(2008-11#1)
many components##3##2##(1991-3#1)(2008-11#1)(2009-10#1)
many compounds##2##2##(2008-10#1)(2008-8#1)
many conditions##6##2##(1995-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)
many contributing factors##2##3##(2008-10#1)(2008-12#1)
many contributing##3##2##(2008-10#1)(2008-12#1)(2009-4#1)
many controversies##2##2##(2008-7#1)(2012-3#1)
many conventional##2##2##(2008-10#1)(2008-9#1)
many cosmetic##3##2##(2008-5#3)
many countries and##2##3##(1993-12#1)(2011-2#1)
many countries because##2##3##(2008-10#1)(2010-7#1)
many countries##34##2##(1990-12#1)(1991-4#1)(1991-6#2)(1992-3#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#4)(2012-12#4)(2013-8#1)
many cultivars##2##2##(2008-10#2)
many current##3##2##(2008-11#1)(2008-6#1)(2008-8#1)
many cytokines##2##2##(2006-10#2)
many data##5##2##(1990-6#1)(1995-2#1)(2008-12#1)(2008-3#1)(2009-10#1)
many decades##4##2##(2008-1#1)(2008-2#1)(2008-7#1)(2012-1#1)
many decisions##2##2##(2008-10#1)(2010-12#1)
many definitions##2##2##(2007-11#1)(2008-10#1)
many desirable##3##2##(2007-12#1)(2008-4#1)(2008-6#1)
many details##2##2##(2008-9#1)(2010-10#1)
many developing countries##2##3##(2008-1#1)(2010-12#1)
many developmental##2##2##(1994-2#1)(2010-3#1)
many differences##3##2##(1996-1#1)(2011-2#1)(2012-2#1)
many different causes of##2##4##(2007-12#1)(2008-10#1)
many different cell types##7##4##(1994-5#1)(2008-2#1)(2008-4#3)(2008-9#2)
many different factors##2##3##(2007-11#1)(2008-10#1)
many different types of##4##4##(2007-12#1)(2008-3#2)(2008-4#1)
many different##48##2##(1990-5#1)(1992-12#1)(1994-5#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-6#1)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
many difficulties##5##2##(1993-3#1)(2008-10#2)(2008-11#1)(2013-7#1)
many dimensions##2##2##(1992-3#1)(1996-2#1)
many disciplines##3##2##(2008-4#1)(2010-10#1)(2013-1#1)
many diseases and##2##3##(2008-5#1)(2013-1#1)
many diseases##21##2##(1991-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2011-10#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
many dissimilar##2##2##(1990-11#1)(2008-3#1)
many distinct##2##2##(2010-5#1)(2012-2#1)
many diverse cellular##2##3##(2008-4#1)(2013-8#1)
many diverse##5##2##(2008-12#1)(2008-4#1)(2011-1#2)(2013-8#1)
many drugs##7##2##(1992-8#1)(1994-8#1)(2006-10#2)(2008-10#1)(2008-8#1)(2011-1#1)
many economically important##3##3##(2008-10#3)
many economically##4##2##(2007-2#1)(2008-10#3)
many effects on##2##3##(2007-7#1)(2008-8#1)
many effects##3##2##(2007-7#1)(2008-8#1)(2011-2#1)
many efforts have been##2##4##(2008-10#1)(2008-4#1)
many efforts##3##2##(1993-11#1)(2008-10#1)(2008-4#1)
many elements in##2##3##(2008-10#1)(2008-2#1)
many elements##3##2##(1993-3#1)(2008-10#1)(2008-2#1)
many epidemiological studies##2##3##(2008-10#1)(2008-7#1)
many essential##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
many ethnic##2##2##(2008-1#1)(2010-8#1)
many eukaryotic species##2##3##(2008-7#1)(2009-10#1)
many eukaryotic##5##2##(1992-3#1)(1995-2#1)(1996-2#1)(2008-7#1)(2009-10#1)
many examples of##2##3##(2009-12#1)(2011-2#1)
many examples##5##2##(1992-1#1)(2008-10#1)(2009-12#1)(2011-2#2)
many exciting##3##2##(2008-10#2)(2009-5#1)
many existing methods##2##3##(2007-6#1)(2009-9#1)
many existing##4##2##(2007-6#1)(2008-10#1)(2009-9#1)(2011-2#1)
many experimental##8##2##(1993-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)
many facets of##5##3##(1994-12#1)(2007-12#1)(2008-2#1)(2010-4#1)(2012-3#1)
many facets##6##2##(1994-12#1)(2007-12#1)(2008-2#1)(2009-11#1)(2010-4#1)(2012-3#1)
many factors associated with##2##4##(2008-3#1)(2010-12#1)
many factors including##2##3##(2008-5#1)(2009-11#1)
many factors that##3##3##(2007-8#1)(2008-7#1)(2009-1#1)
many factors##24##2##(1991-12#1)(1993-2#1)(1994-1#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
many features of##2##3##(1995-12#1)(2008-4#1)
many features that##4##3##(1994-8#1)(1997-2#1)(2008-9#1)(2011-1#1)
many features with##2##3##(1997-3#1)(2009-11#1)
many features##10##2##(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)
many female##2##2##(2008-8#1)(2009-10#1)
many females##2##2##(2008-12#1)(2008-8#1)
many fewer##2##2##(1992-3#1)(2008-7#1)
many fields##7##2##(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
many forms of##4##3##(1990-9#1)(2008-8#2)(2010-11#1)
many forms##11##2##(1990-9#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-11#1)(2012-12#1)
many fragments##2##2##(1995-2#1)(2008-10#1)
many functional##2##2##(2008-7#1)(2009-2#1)
many genes and##2##3##(2012-3#1)(2013-8#1)
many genes##13##2##(1995-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#3)(2013-8#2)
many genetic and##2##3##(2011-2#1)(2012-2#1)
many genetic##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
many have##8##2##(1991-1#1)(1993-3#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2010-9#1)
many health care organizations##4##4##(1993-1#1)(1994-12#1)(1996-1#1)(2008-11#1)
many health care##11##3##(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-1#2)(2008-11#2)(2010-10#1)(2010-12#1)
many health##14##2##(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#2)(2008-11#3)(2009-5#1)(2010-10#1)(2010-12#1)
many horticultural##2##2##(2008-10#2)
many hospital##3##2##(1994-12#1)(1994-2#1)(2008-11#1)
many hospitals##4##2##(1991-9#1)(1994-3#1)(1996-1#1)(2008-11#1)
many hours##2##2##(2007-9#1)(2008-10#1)
many human cancers##4##3##(2011-2#2)(2012-12#2)
many human diseases##5##3##(2006-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
many human##14##2##(1993-11#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
many imaging##2##2##(2008-3#1)(2009-11#1)
many important physiological##2##3##(2008-8#2)
many important##14##2##(1995-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
many improvements have been##2##4##(1997-8#1)(2010-5#1)
many in the##2##3##(2007-2#1)(2008-6#1)
many in##3##2##(2007-2#1)(2008-11#1)(2008-6#1)
many incidents of##2##3##(1991-6#1)(2011-1#1)
many independent##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
many individuals with##2##3##(1994-12#1)(2013-1#1)
many individuals##3##2##(1994-12#1)(1995-1#1)(2013-1#1)
many industries##2##2##(1992-1#1)(2011-2#1)
many infectious##2##2##(2008-10#1)(2008-8#1)
many inflammatory conditions##2##3##(1993-3#1)(2013-1#1)
many inflammatory##3##2##(1993-3#1)(2010-11#1)(2013-1#1)
many instances##10##2##(1990-8#1)(1992-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
many institutions##2##2##(1995-12#1)(2008-7#1)
many instruments had not been validated##2##6##(2013-1#2)
many investigators##2##2##(2008-11#1)(2008-4#1)
many isolates##3##2##(2008-10#3)
many issues##3##2##(1991-2#1)(2009-12#1)(2010-8#1)
many known##2##2##(2010-12#1)(2012-2#1)
many laboratories##5##2##(1990-5#1)(1997-4#1)(2007-11#1)(2008-3#1)(2012-2#1)
many laboratory##2##2##(1996-2#1)(2013-1#1)
many large##4##2##(1997-2#1)(2008-11#1)(2008-5#1)(2010-12#1)
many long and##2##3##(2008-4#1)(2008-7#1)
many long##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
many mammalian##2##2##(1992-12#1)(1994-8#1)
many managers##2##2##(1993-1#1)(1997-1#1)
many marine species##2##3##(2013-1#2)
many marine##4##2##(1990-7#1)(2008-8#1)(2013-1#2)
many measures##3##2##(1996-1#1)(2010-8#1)(2012-1#1)
many mechanisms##2##2##(2011-2#1)(2013-1#1)
many medical schools##2##3##(2011-2#1)(2013-1#1)
many medical##9##2##(1991-3#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
many mental##2##2##(2008-12#1)(2013-7#1)
many metabolic##3##2##(2008-11#1)(2011-1#1)(2013-7#1)
many methodological##2##2##(1990-3#1)(2010-10#1)
many methods##4##2##(2008-2#1)(2008-3#1)(2009-10#1)(2011-3#1)
many miRNAs##3##2##(2010-11#1)(2010-7#2)
many mitochondria##2##2##(2007-12#1)(2008-5#1)
many models##3##2##(2008-1#1)(2008-2#1)(2008-8#1)
many molecular##4##2##(2007-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
many months##5##2##(1996-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
many more have##2##3##(2008-7#1)(2012-3#1)
many more##24##2##(1990-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
many national##3##2##(1996-9#1)(2010-5#1)(2011-1#1)
many neural##2##2##(2007-12#1)(2008-7#1)
many neurological##2##2##(2008-11#1)(2008-8#1)
many neurons##3##2##(1996-12#1)(1997-2#1)(2008-4#1)
many new##11##2##(1991-12#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-2#1)
many novel##3##2##(1997-4#1)(2008-5#1)(2012-12#1)
many nurses##2##2##(2007-2#1)(2008-7#1)
many nursing faculty##2##3##(2008-11#2)
many nursing##3##2##(2007-10#1)(2008-11#2)
many observers##2##2##(1993-12#1)(2008-2#1)
many of its##5##3##(2008-5#1)(2008-6#1)(2009-8#2)(2011-2#1)
many of our##3##3##(1992-2#1)(1995-2#1)(2008-7#1)
many of the current##2##4##(2008-10#1)(2008-6#1)
many of the features##4##4##(2007-12#1)(2008-3#1)(2010-12#1)(2013-8#1)
many of the issues involved##2##5##(1993-2#1)(2008-9#1)
many of the issues##5##4##(1993-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)
many of the requirements##2##4##(1996-1#1)(2009-12#1)
many of the same##8##4##(1992-10#1)(1994-11#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-3#1)(2012-3#1)
many of the techniques##2##4##(2008-2#1)(2008-4#1)
many of the##119##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
many of their biological##2##4##(2008-7#1)(2009-3#1)
many of their##6##3##(1995-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)
many of them might##2##4##(2008-10#1)(2010-8#1)
many of them##15##3##(1990-6#1)(1992-11#1)(1994-3#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
many of these agents##2##4##(2006-12#1)(2008-8#1)
many of these clinical##2##4##(2013-7#2)
many of these##38##3##(1994-12#1)(1994-2#1)(1994-6#1)(1996-12#1)(2006-12#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#2)
many of those##6##3##(1991-3#1)(1994-12#1)(2007-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
many of us##2##3##(1994-2#2)
many of which are##5##4##(1992-5#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-4#1)
many of which can be##2##5##(2009-7#1)(2013-1#1)
many of which may##2##4##(2008-7#1)(2008-9#1)
many of which##16##3##(1992-5#1)(1995-12#1)(1996-2#1)(1996-3#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2013-1#1)
many of whom##4##3##(1994-11#1)(1994-2#1)(1997-2#1)(2012-3#1)
many of##219##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#3)(1992-5#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#7)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#11)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#8)(2008-8#8)(2008-9#12)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#5)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#2)
many older##2##2##(1995-1#1)(2012-1#1)
many opportunities to##2##3##(1996-2#1)(2008-11#1)
many optical##2##2##(2007-11#1)(2008-2#1)
many options##3##2##(1996-1#1)(1996-2#1)(1997-3#1)
many or##2##2##(1990-5#1)(1993-2#1)
many orders of magnitude##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
many organ systems##2##3##(2008-4#1)(2010-11#1)
many organic vapors investigated##2##4##(2008-10#2)
many organic##4##2##(2008-10#3)(2008-3#1)
many organisms##7##2##(1994-11#1)(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#2)
many organizations##3##2##(1994-2#1)(1996-1#1)(2008-12#1)
many organs##3##2##(1992-5#1)(1995-12#1)(2009-4#1)
many other proteins##2##3##(2008-11#1)(2010-4#1)
many other##60##2##(1991-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-7#1)(2007-7#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#3)(2010-1#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
many others##12##2##(1991-3#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(2008-10#2)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
many parameters##3##2##(2008-10#1)(2008-3#2)
many participants##2##2##(2008-12#1)(2013-8#1)
many parts of the world##6##5##(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
many parts of the##9##4##(1990-2#1)(1990-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
many parts of##11##3##(1990-2#1)(1990-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
many pathological##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
many patients and##3##3##(1994-3#1)(2008-11#1)(2012-12#1)
many patients are##2##3##(2008-7#1)(2010-3#1)
many patients have##2##3##(1997-6#1)(2012-12#1)
many patients still##2##3##(2008-1#1)(2009-10#1)
many patients with cancer##2##4##(2008-7#2)
many patients with##8##3##(1997-7#1)(2007-11#1)(2008-12#1)(2008-7#3)(2012-2#1)(2013-1#1)
many patients##45##2##(1992-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#6)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
many people to##2##3##(2008-2#1)(2013-1#1)
many people##11##2##(1995-1#1)(1997-4#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
many persons##3##2##(1994-9#1)(2007-6#1)(2008-11#1)
many pharmaceutical##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
many phenotypic##2##2##(2008-11#1)(2009-5#1)
many physicians##4##2##(1994-2#1)(1996-8#1)(2008-7#1)(2009-11#1)
many physiological functions##2##3##(1992-9#1)(2008-10#1)
many physiological processes##3##3##(2008-9#2)(2010-10#1)
many physiological##7##2##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-10#1)(2013-8#1)
many places##2##2##(2007-10#1)(2007-8#1)
many plant pathogens##3##3##(2008-10#3)
many plant##6##2##(2008-10#5)(2009-8#1)
many points##4##2##(2007-2#1)(2008-10#1)(2008-2#2)
many positive##2##2##(2007-6#1)(2008-7#1)
many possible##5##2##(1990-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
many potential applications in##3##4##(2008-10#1)(2008-4#2)
many potential applications##4##3##(2008-10#1)(2008-4#2)(2008-7#1)
many potential##14##2##(1992-12#1)(1995-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)
many practical##3##2##(1996-1#1)(2007-12#1)(2008-3#1)
many previous studies##2##3##(2008-2#1)(2008-8#1)
many previous##3##2##(2008-2#2)(2008-8#1)
many primary care physicians##2##4##(1994-12#1)(2007-12#1)
many principles##2##2##(2008-12#2)
many problems##5##2##(2008-1#1)(2008-10#2)(2008-11#1)(2012-2#1)
many protein##4##2##(2006-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
many proteins##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
many publications##4##2##(1992-3#1)(1997-8#1)(2007-6#1)(2008-11#1)
many quality##2##2##(1993-12#1)(2012-2#1)
many questions remain unanswered##2##4##(2007-4#1)(2009-4#1)
many questions##5##2##(1990-2#1)(1990-9#1)(1997-5#1)(2007-4#1)(2009-4#1)
many real##3##2##(2008-10#2)(2008-7#1)
many recent##5##2##(1990-8#1)(2008-11#1)(2009-11#1)(2009-5#1)(2009-8#1)
many regions of the world##2##5##(2008-10#1)(2008-5#1)
many regions of the##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
many regions##8##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)
many reported##3##2##(1997-3#1)(2008-10#1)(2008-9#1)
many reports##4##2##(1991-5#1)(2008-10#1)(2010-8#1)(2013-1#1)
many researchers in##2##3##(2008-10#1)(2008-7#1)
many researchers##7##2##(1996-8#1)(2008-10#1)(2008-7#2)(2010-10#1)(2012-2#1)(2013-1#1)
many researches##2##2##(2010-10#1)(2013-1#1)
many respondents##2##2##(2008-11#1)(2012-3#1)
many responses##2##2##(1992-1#1)(2008-4#1)
many risks##2##2##(2011-1#1)(2013-1#1)
many roles##3##2##(2008-11#1)(2009-8#1)(2010-10#1)
many samples to##2##3##(2008-10#1)(2008-4#1)
many samples##4##2##(1996-12#1)(2008-10#2)(2008-4#1)
many scattering##2##2##(2008-10#1)(2008-3#1)
many scientists##2##2##(2008-9#1)(2012-12#1)
many sectors##2##2##(1991-6#1)(2013-1#1)
many settings##3##2##(1992-12#1)(1996-12#1)(2012-2#1)
many similarities##5##2##(1993-3#1)(2008-7#1)(2008-9#1)(2013-8#2)
many situations##2##2##(2007-12#1)(2008-9#1)
many species are##3##3##(2008-1#1)(2008-8#1)(2013-1#1)
many species of birds##2##4##(1997-3#1)(2008-3#1)
many species of##6##3##(1990-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
many species##19##2##(1990-2#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
many steps##2##2##(1996-2#1)(2008-9#1)
many still##2##2##(1991-2#1)(2011-2#1)
many striatal##2##2##(1995-5#1)(2008-5#1)
many students##4##2##(1992-6#1)(2008-11#2)(2008-12#1)
many studies have##9##3##(1992-9#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#2)(2013-1#1)
many studies reveal that##2##4##(1992-6#1)(2012-3#1)
many studies##24##2##(1992-3#1)(1992-6#1)(1992-9#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
many such##5##2##(1991-12#1)(1995-11#1)(1997-6#1)(2008-7#1)(2008-9#1)
many survivors##3##2##(2007-10#1)(2008-7#1)(2009-10#1)
many tasks##2##2##(2008-7#1)(2008-9#1)
many taxa##2##2##(2008-5#1)(2012-2#1)
many theoretical##3##2##(2008-8#2)(2011-2#1)
many times in##2##3##(2007-8#1)(2008-12#1)
many times that##2##3##(2007-11#1)(2008-3#1)
many times##17##2##(1990-12#1)(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-8#1)
many tissues##11##2##(1992-3#1)(1994-11#2)(1995-12#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2012-3#1)
many transcription##2##2##(2009-10#1)(2009-8#1)
many transcriptional##2##2##(1996-2#1)(2008-7#1)
many treatment##3##2##(2007-11#1)(2009-8#1)(2012-1#1)
many tumor##2##2##(2009-3#1)(2012-1#1)
many tumors##3##2##(2008-11#1)(2008-5#1)(2008-6#1)
many types of organizations##2##4##(1993-1#1)(1994-3#1)
many types of##14##3##(1992-2#1)(1993-1#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-1#1)(2011-1#1)
many unanswered questions##5##3##(1993-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)
many unique##3##2##(1991-5#1)(2010-2#1)(2010-8#1)
many variables##2##2##(2008-7#1)(2009-8#1)
many variations##2##2##(2008-4#1)(2009-11#1)
many very##2##2##(2008-12#2)
many vital##2##2##(2008-10#2)
many volatile##2##2##(2008-10#2)
many wavelengths##2##2##(2008-10#1)(2008-2#1)
many ways##16##2##(1991-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
many were##7##2##(1991-2#1)(1992-8#1)(1995-6#1)(2008-11#1)(2010-1#1)(2010-8#1)(2011-2#1)
many who##3##2##(1993-2#1)(1995-12#1)(2008-10#1)
many will##2##2##(2008-1#1)(2013-8#1)
many with##2##2##(2010-10#1)(2010-3#1)
many women in##2##3##(2008-5#1)(2011-2#1)
many women##5##2##(2008-5#2)(2011-2#2)(2013-8#1)
many years in##3##3##(1991-4#1)(2008-5#1)(2010-4#1)
many years of##2##3##(1994-5#1)(2008-9#1)
many years to##2##3##(1997-1#1)(2008-10#1)
many years##60##2##(1990-9#1)(1991-12#1)(1991-4#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-5#2)(1994-7#1)(1997-1#2)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
many##2485##1##(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#6)(1991-1#3)(1991-11#1)(1991-12#16)(1991-2#5)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#11)(1992-10#1)(1992-11#6)(1992-12#11)(1992-2#11)(1992-3#13)(1992-5#8)(1992-6#2)(1992-8#6)(1992-9#5)(1993-1#12)(1993-11#5)(1993-12#12)(1993-2#9)(1993-3#11)(1993-6#11)(1993-8#3)(1994-1#3)(1994-11#13)(1994-12#27)(1994-2#21)(1994-3#18)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#15)(1995-11#6)(1995-12#17)(1995-2#21)(1995-3#8)(1995-5#7)(1995-6#10)(1995-8#3)(1995-9#3)(1996-1#14)(1996-10#2)(1996-11#2)(1996-12#9)(1996-2#15)(1996-3#12)(1996-5#3)(1996-6#3)(1996-8#6)(1996-9#5)(1997-1#7)(1997-2#13)(1997-3#10)(1997-4#16)(1997-5#3)(1997-6#8)(1997-7#8)(1997-8#9)(2006-10#9)(2006-12#5)(2006-4#1)(2006-6#1)(2007-10#5)(2007-11#33)(2007-12#59)(2007-2#14)(2007-4#6)(2007-5#4)(2007-6#6)(2007-7#11)(2007-8#12)(2007-9#3)(2008-1#37)(2008-10#285)(2008-11#116)(2008-12#37)(2008-2#49)(2008-3#80)(2008-4#70)(2008-5#70)(2008-6#28)(2008-7#117)(2008-8#82)(2008-9#95)(2009-1#3)(2009-10#21)(2009-11#14)(2009-12#10)(2009-2#3)(2009-3#6)(2009-4#10)(2009-5#17)(2009-6#5)(2009-7#7)(2009-8#21)(2009-9#6)(2010-1#9)(2010-10#14)(2010-11#13)(2010-12#28)(2010-2#4)(2010-3#26)(2010-4#10)(2010-5#16)(2010-6#4)(2010-7#13)(2010-8#24)(2010-9#1)(2011-1#28)(2011-10#1)(2011-2#93)(2011-3#7)(2011-7#2)(2012-1#12)(2012-12#43)(2012-2#51)(2012-3#36)(2012-4#1)(2013-1#66)(2013-7#15)(2013-8#36)
many-body##4##1##(1990-4#1)(2008-11#1)(2009-9#1)(2012-2#1)
map and a##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
map and the##3##3##(1997-6#1)(2008-11#1)(2008-5#1)
map and##15##2##(1992-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
map based on##2##3##(2008-10#2)
map based##3##2##(2008-10#2)(2011-2#1)
map blood flow##2##3##(2007-12#1)(2008-2#1)
map by##2##2##(1996-8#1)(2008-2#1)
map comprises##2##2##(1997-8#1)(2008-5#1)
map construction and##2##3##(2008-5#1)(2008-8#1)
map construction##5##2##(1997-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
map contained##2##2##(2013-8#2)
map containing##3##2##(2008-10#2)(2010-3#1)
map for##6##2##(1992-1#1)(1992-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
map formation##3##2##(1993-9#3)
map has been##2##3##(1996-10#1)(1996-3#1)
map has##4##2##(1994-9#1)(1996-10#1)(1996-3#1)(2008-10#1)
map in##3##2##(2006-6#1)(2008-10#1)(2008-11#1)
map is##10##2##(1991-5#1)(1994-9#1)(1995-3#1)(1996-6#1)(2008-3#2)(2008-7#2)(2008-8#1)(2013-8#1)
map location of##2##3##(2008-10#2)
map location##4##2##(1994-12#1)(2008-10#2)(2008-4#1)
map of chromosome 7A##2##4##(2008-10#2)
map of chromosome##4##3##(1997-6#1)(1997-8#1)(2008-10#2)
map of rice##3##3##(1996-10#2)(2008-8#1)
map of the##31##3##(1991-5#1)(1992-3#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-8#4)(1997-2#1)(1997-8#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#2)
map of this##2##3##(1993-6#1)(1995-2#1)
map of##72##2##(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#2)(1995-2#2)(1995-6#2)(1996-10#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#4)(1997-2#2)(1997-6#2)(1997-8#4)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-8#1)
map on##2##2##(1993-11#1)(2008-7#1)
map position and##2##3##(1995-6#1)(1995-8#1)
map position##7##2##(1995-6#1)(1995-8#2)(1995-9#1)(1996-6#1)(2008-10#1)(2008-11#1)
map positions 64% to 92% of the genome##2##8##(1995-8#2)
map positions##3##2##(1995-8#2)(2008-9#1)
map previously##2##2##(1996-2#1)(2008-10#1)
map showed##2##2##(1990-11#1)(1991-3#1)
map strength##5##2##(2007-11#2)(2007-12#3)
map that##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2012-1#1)
map the gene##4##3##(1995-2#1)(2008-10#3)
map the##35##2##(1990-11#1)(1990-2#1)(1990-7#1)(1993-11#2)(1993-12#1)(1994-8#1)(1995-2#1)(1997-8#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)
map to the same##2##4##(2008-3#1)(2012-3#1)
map to the##5##3##(1996-8#1)(1997-9#2)(2008-3#1)(2012-3#1)
map to##8##2##(1990-5#1)(1995-6#1)(1996-8#1)(1997-9#2)(2008-10#1)(2008-3#1)(2012-3#1)
map was constructed##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
map was##5##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
map were##4##2##(1997-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
map will##3##2##(1997-2#1)(1997-8#1)(2010-3#1)
map with##5##2##(1994-9#1)(1996-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
map##375##1##(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#6)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#6)(1995-2#3)(1995-3#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-10#7)(1996-12#9)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#4)(1996-8#6)(1997-2#5)(1997-4#1)(1997-6#3)(1997-8#12)(1997-9#3)(2006-4#1)(2006-6#2)(2007-11#5)(2007-12#14)(2008-10#63)(2008-11#13)(2008-12#2)(2008-2#9)(2008-3#25)(2008-4#10)(2008-5#16)(2008-6#1)(2008-7#17)(2008-8#14)(2008-9#7)(2009-10#2)(2009-12#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#1)(2013-8#10)
map-based cloning of the##3##4##(2008-5#1)(2008-8#1)(2008-9#1)
map-based cloning of this##2##4##(2008-10#1)(2012-3#1)
map-based cloning of##6##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
map-based cloning##8##2##(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#2)
map-based##10##1##(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2012-3#2)
mapped 1##3##2##(1993-9#1)(2008-5#2)
mapped DNA markers##4##3##(1996-10#2)(1996-12#1)(2012-3#1)
mapped DNA##5##2##(1996-10#2)(1996-12#2)(2012-3#1)
mapped a##2##2##(1994-12#1)(1996-6#1)
mapped and characterized quantitative trait loci (QTL)##2##7##(2008-10#2)
mapped and##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
mapped at the##2##3##(2008-10#1)(2008-8#1)
mapped at##5##2##(1995-8#1)(2008-10#2)(2008-8#2)
mapped by##6##2##(1993-6#1)(1995-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-9#1)
mapped in the##6##3##(1990-5#1)(1995-6#1)(2008-5#1)(2008-8#2)(2008-9#1)
mapped in this##2##3##(2008-8#1)(2012-3#1)
mapped in##11##2##(1990-5#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#1)(2012-3#2)
mapped into##2##2##(2008-10#1)(2008-3#1)
mapped on chromosome 1##2##4##(1996-10#1)(2008-10#1)
mapped on chromosome##9##3##(1996-10#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)
mapped on the long##2##4##(1997-8#1)(2008-7#1)
mapped on the right arm of chromosome##2##7##(1990-12#1)(1995-6#1)
mapped on the##9##3##(1990-12#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-7#1)(2008-8#2)(2013-8#1)
mapped on##23##2##(1990-12#1)(1995-6#2)(1996-10#3)(1996-8#2)(1997-2#1)(1997-6#1)(1997-8#2)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2013-8#1)
mapped onto##4##2##(1996-8#1)(2008-8#1)(2008-9#1)(2012-1#1)
mapped the distribution of##2##4##(2008-7#2)
mapped the gene to##2##4##(1994-12#1)(1997-6#1)
mapped the gene##3##3##(1994-12#1)(1997-6#1)(2008-10#1)
mapped the##17##2##(1990-12#1)(1991-11#1)(1993-12#1)(1994-12#2)(1996-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#3)(2011-1#2)(2012-2#1)(2012-3#1)
mapped through##2##2##(2008-10#1)(2010-8#1)
mapped to a##6##3##(1993-12#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-10#2)
mapped to chromosome##5##3##(1996-6#1)(1997-7#1)(2008-8#2)(2012-3#1)
mapped to human chromosome##3##4##(1994-12#1)(1997-8#1)(2008-9#1)
mapped to the X chromosome##2##5##(1994-9#2)
mapped to the distal##2##4##(2008-10#1)(2008-8#1)
mapped to the right arm of chromosome##2##7##(1995-6#2)
mapped to the same linkage group##2##6##(2008-10#2)
mapped to the same##4##4##(2008-10#4)
mapped to the short arm of chromosome##3##7##(2008-10#3)
mapped to the##24##3##(1990-8#1)(1991-10#1)(1991-6#1)(1993-2#1)(1994-11#1)(1994-9#2)(1995-6#2)(1997-2#2)(2008-10#10)(2008-3#1)(2008-8#1)(2012-3#1)
mapped to##54##2##(1990-8#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#2)(1995-6#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#16)(2008-3#1)(2008-8#4)(2008-9#2)(2011-2#1)(2012-3#6)(2013-1#1)
mapped using##3##2##(2008-4#1)(2008-5#1)(2008-8#1)
mapped with a##2##3##(2007-11#1)(2007-12#1)
mapped with##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
mapped within a##2##3##(2008-10#1)(2012-3#1)
mapped within##5##2##(1990-5#1)(1993-12#1)(1997-4#1)(2008-10#1)(2012-3#1)
mapped##184##1##(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-6#1)(1994-9#2)(1995-2#1)(1995-6#7)(1995-8#2)(1996-10#5)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#4)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#5)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#2)(2008-10#40)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#17)(2008-9#6)(2009-10#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#15)(2013-1#2)(2013-8#1)
mapper##2##1##(2007-12#1)(2008-2#1)
mapping algorithm##2##2##(2008-3#1)(2013-1#1)
mapping analysis##4##2##(1991-9#2)(1997-9#1)(2008-10#1)
mapping and DNA##2##3##(1991-2#1)(1997-4#1)
mapping and biopsy##2##3##(2008-10#1)(2010-8#1)
mapping and expression##2##3##(2008-8#1)(2012-3#1)
mapping and sentinel##2##3##(2008-10#1)(2012-12#1)
mapping and sequencing of##2##4##(1994-11#1)(1997-7#1)
mapping and sequencing##3##3##(1994-11#1)(1997-7#1)(2008-7#1)
mapping and##38##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
mapping by##5##2##(1990-7#1)(2007-7#1)(2008-10#2)(2008-2#1)
mapping can be##2##3##(2008-12#1)(2010-8#1)
mapping data##3##2##(1995-6#1)(2008-10#1)(2010-3#1)
mapping experiments##4##2##(1991-2#1)(1993-11#1)(1993-3#1)(1993-9#1)
mapping for##3##2##(2008-10#2)(2010-1#1)
mapping function##2##2##(2008-6#1)(2010-5#1)
mapping has been##2##3##(2008-10#1)(2011-1#1)
mapping in a##2##3##(2008-3#1)(2008-8#1)
mapping in hybrid zones##2##4##(2008-8#2)
mapping in##19##2##(1995-8#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#3)(2010-3#1)(2010-7#1)(2010-8#3)(2012-3#2)
mapping indicated that##2##3##(2008-10#1)(2011-1#1)
mapping is##3##2##(2008-12#1)(2010-7#1)(2010-8#1)
mapping method##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
mapping of a##9##3##(1991-6#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-9#2)
mapping of gene##2##3##(1994-12#1)(2008-9#1)
mapping of phosphate##3##3##(2008-10#3)
mapping of rice chromosomes 8 and 9##2##7##(1996-12#2)
mapping of rice chromosomes##3##4##(1996-12#2)(1997-2#1)
mapping of rice##4##3##(1996-10#1)(1996-12#2)(1997-2#1)
mapping of the##28##3##(1990-5#1)(1990-7#1)(1990-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-9#1)(2006-4#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#2)(2009-10#1)(2010-7#2)(2010-8#1)(2013-1#1)
mapping of various##2##3##(1994-12#1)(2009-5#1)
mapping of##104##2##(1990-5#2)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-3#1)(1996-10#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(1997-9#3)(2006-4#1)(2007-11#1)(2007-12#5)(2008-10#23)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#2)(2009-5#3)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
mapping on##2##2##(1993-11#1)(2008-10#1)
mapping population and##3##3##(2008-10#2)(2012-3#1)
mapping population of##6##3##(2008-10#5)(2008-5#1)
mapping population was##2##3##(2008-10#1)(2008-5#1)
mapping population##23##2##(2008-10#18)(2008-5#3)(2008-8#1)(2012-3#1)
mapping populations##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
mapping procedure##4##2##(2008-10#1)(2008-5#2)(2012-2#1)
mapping region##2##2##(2008-9#2)
mapping results##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
mapping should##2##2##(2008-7#1)(2008-8#1)
mapping software##2##2##(2011-1#1)(2012-3#1)
mapping studies##5##2##(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
mapping technique##4##2##(1996-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
mapping the##4##2##(2007-11#1)(2008-3#2)(2010-3#1)
mapping their##2##2##(1995-3#1)(2008-8#1)
mapping these##2##2##(2008-2#1)(2008-5#1)
mapping to be##2##3##(1993-9#1)(1994-11#1)
mapping to##12##2##(1991-1#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
mapping using##5##2##(1990-8#1)(2008-10#1)(2008-11#2)(2010-8#1)
mapping was##4##2##(1990-11#1)(2008-10#2)(2013-1#1)
mapping with##4##2##(1990-2#1)(2008-11#1)(2008-3#1)(2008-4#1)
mapping##419##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#5)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#2)(1991-9#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#4)(1994-8#1)(1994-9#2)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#7)(1995-8#3)(1996-10#3)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#2)(1997-9#5)(2006-4#1)(2007-11#3)(2007-12#10)(2007-5#2)(2007-7#1)(2008-10#89)(2008-11#10)(2008-12#6)(2008-2#8)(2008-3#17)(2008-4#12)(2008-5#11)(2008-6#2)(2008-7#14)(2008-8#29)(2008-9#15)(2009-10#7)(2009-5#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#9)(2011-1#6)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#15)(2013-1#20)(2013-7#2)(2013-8#3)
mappings to##2##2##(2010-10#1)(2013-1#1)
mappings##8##1##(1991-9#1)(2008-2#1)(2008-3#1)(2010-10#2)(2013-1#3)
maprotiline and imipramine##2##3##(2008-10#2)
maprotiline and##3##2##(2008-10#3)
maps and##9##2##(1992-11#1)(1994-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
maps are##6##2##(1995-6#1)(2007-12#1)(2008-12#2)(2008-3#1)(2008-4#1)
maps can be##2##3##(2008-2#2)
maps can##3##2##(2008-10#1)(2008-2#2)
maps developed##2##2##(2008-8#1)(2010-10#1)
maps for##8##2##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#2)
maps in##6##2##(2007-5#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#2)
maps is##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)
maps obtained with##2##3##(1993-11#1)(2008-3#1)
maps obtained##3##2##(1993-11#1)(1996-5#1)(2008-3#1)
maps of R2 that had been##2##6##(1993-11#2)
maps of a##2##3##(1990-11#1)(2008-3#1)
maps of pea##3##3##(2008-5#3)
maps of the##10##3##(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#5)(2011-3#1)
maps of their##2##3##(2008-8#2)
maps of##38##2##(1990-11#1)(1993-11#2)(1993-12#1)(1993-9#1)(1995-6#2)(1996-5#1)(1997-2#2)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-12#1)(2011-3#1)
maps showed##3##2##(2007-5#1)(2008-10#1)(2008-4#1)
maps the##4##2##(2007-11#1)(2008-3#2)(2012-12#1)
maps to a region of##2##5##(1993-12#1)(2012-2#1)
maps to a##5##3##(1993-12#1)(1995-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
maps to chromosome##3##3##(1990-5#1)(1990-8#1)(2008-6#1)
maps to##18##2##(1990-5#1)(1990-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-2#1)
maps were developed and##2##4##(2008-12#1)(2010-8#1)
maps were then##2##3##(2007-5#1)(2011-2#1)
maps were##10##2##(2007-5#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
maps with##4##2##(2007-5#1)(2008-10#1)(2008-3#1)(2011-3#1)
maps within the##2##3##(1997-3#1)(1997-9#1)
maps within##4##2##(1994-12#1)(1997-3#1)(1997-9#1)(2008-10#1)
maps##209##1##(1990-11#1)(1990-5#1)(1990-8#2)(1991-6#1)(1992-11#1)(1992-6#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#3)(1995-2#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-9#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#13)(2008-10#22)(2008-11#5)(2008-12#5)(2008-2#13)(2008-3#32)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#10)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-2#2)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
maquila##2##1##(2011-2#2)
marae##2##1##(2008-1#2)
marajoara sensu stricto##2##3##(2012-12#2)
marajoara##5##1##(2007-12#2)(2012-12#3)
marathon##2##1##(2008-3#1)(2010-7#1)
marble industry effluent##3##3##(2008-12#3)
marble samples##2##2##(2008-10#1)(2008-2#1)
marble##11##1##(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)
marbles by##2##2##(2008-10#1)(2008-2#1)
marbles##4##1##(2008-10#3)(2008-2#1)
marbling images##3##2##(2010-4#3)
marbling##13##1##(2010-2#2)(2010-4#11)
marcescens GPS 5##3##3##(2008-10#3)
marcescens strains from##2##3##(2008-10#2)
marcescens strains##3##2##(2008-10#3)
marcescens##31##1##(1996-12#3)(2008-10#18)(2009-5#5)(2009-6#2)(2010-6#2)(2011-2#1)
march##5##1##(1990-10#1)(1991-3#1)(2007-8#1)(2008-11#1)(2008-8#1)
mare##3##1##(2008-5#1)(2008-8#1)(2012-2#1)
mares and##2##2##(1994-7#1)(2012-3#1)
mares##11##1##(1994-7#5)(2008-10#1)(2012-2#2)(2012-3#2)(2013-1#1)
margarine##2##1##(1990-8#1)(2008-6#1)
margin and##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
margin around##2##2##(2008-2#1)(2010-12#1)
margin in the##2##3##(2007-11#1)(2008-1#1)
margin in##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
margin is##4##2##(2008-3#3)(2008-6#1)
margin of 2 cm##2##4##(1990-9#1)(1991-12#1)
margin of a##3##3##(2008-10#1)(2008-3#2)
margin of the##5##3##(1993-12#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-2#1)
margin of##15##2##(1990-9#1)(1991-12#1)(1993-12#1)(1994-3#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
margin was##4##2##(1994-7#1)(1995-4#2)(2008-3#1)
margin##73##1##(1990-9#1)(1991-12#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-7#2)(1995-1#1)(1995-4#3)(1996-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#7)(2008-5#2)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
margin)##2##1##(1996-2#1)(2008-6#1)
marginal adaptation##2##2##(1990-9#1)(2008-7#1)
marginal and##2##2##(2008-7#1)(2011-3#1)
marginal bone##7##2##(2009-8#1)(2013-1#6)
marginal chlorosis##2##2##(2008-10#2)
marginal distributions of##2##3##(2008-7#1)(2010-3#1)
marginal distributions##4##2##(1994-9#1)(2008-7#1)(2010-3#1)(2013-1#1)
marginal dose##2##2##(2008-7#2)
marginal effect##3##2##(1990-12#1)(1990-2#1)(2008-4#1)
marginal effects##2##2##(2008-10#1)(2008-4#1)
marginal excision##3##2##(2008-6#2)(2009-4#1)
marginal gains##2##2##(1996-12#1)(2008-8#1)
marginal increases in##2##3##(2008-6#1)(2013-1#1)
marginal influence##2##2##(1990-6#1)(2010-4#1)
marginal or##2##2##(1993-6#1)(2007-11#1)
marginal probabilities##2##2##(2010-1#1)(2011-2#1)
marginal resection of##2##3##(2008-6#2)
marginal resection##3##2##(2008-6#3)
marginal sinus##11##2##(1996-9#11)
marginal survival distribution##3##3##(1995-9#3)
marginal survival##4##2##(1995-9#4)
marginal zone B cell lymphoma of mucosa-associated lymphoid tissue##2##9##(2009-8#2)
marginal zone B cell lymphoma##3##5##(2009-8#3)
marginal zone lymphoma of##2##4##(2009-8#2)
marginal zone lymphoma##3##3##(2009-8#3)
marginal zone##11##2##(1997-1#1)(2008-7#1)(2009-5#1)(2009-8#7)(2012-1#1)
marginal##113##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-9#4)(1996-12#1)(1996-9#12)(1997-1#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#8)(2008-7#10)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#9)(2010-1#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#11)
marginality##2##1##(2012-12#2)
marginalization##3##1##(2008-12#1)(2010-8#1)(2011-1#1)
marginalized##9##1##(1993-3#1)(1993-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-11#1)(2010-9#1)(2012-12#1)(2013-1#1)
marginally affected by##3##3##(1996-11#1)(2008-10#1)(2008-3#1)
marginally affected##5##2##(1995-6#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-3#1)
marginally higher##2##2##(2008-10#1)(2008-8#1)
marginally increased##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
marginally more##3##2##(2008-10#3)
marginally reduced##2##2##(2008-10#1)(2011-1#1)
marginally significant##5##2##(1991-8#1)(1994-2#1)(1996-9#1)(2011-2#1)(2012-3#1)
marginally toxic##2##2##(1990-2#1)(1990-5#1)
marginally##43##1##(1990-2#2)(1990-5#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#2)
marginata and##2##2##(2010-3#2)
marginata##3##1##(2010-3#3)
marginatus##5##1##(1995-12#2)(2007-12#2)(2008-8#1)
margins after##3##2##(1995-4#1)(2008-6#2)
margins and##3##2##(1997-7#1)(2008-10#1)(2009-10#1)
margins are##3##2##(1997-7#1)(2010-8#1)(2011-2#1)
margins for##3##2##(2008-3#2)(2012-2#1)
margins in##5##2##(1995-4#1)(2008-10#1)(2008-6#2)(2010-8#1)
margins of resection##2##3##(2008-9#2)
margins of the##4##3##(1996-9#1)(2007-8#1)(2008-9#1)(2011-2#1)
margins of##10##2##(1995-2#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#3)(2011-2#1)
margins to##2##2##(1992-12#1)(2008-9#1)
margins was##2##2##(2011-1#1)(2011-2#1)
margins were positive##2##3##(1995-4#2)
margins were##10##2##(1990-12#1)(1991-6#1)(1992-2#1)(1995-4#3)(1997-7#1)(2007-8#1)(2008-3#1)(2008-6#1)
margins##75##1##(1990-12#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-4#8)(1996-2#2)(1996-9#1)(1997-7#8)(1997-8#2)(2007-12#2)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#10)(2008-9#5)(2009-10#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#6)(2013-1#1)
mariana##2##1##(2008-5#1)(2013-8#1)
marigold##3##1##(2008-10#3)
marijuana abusers##3##2##(1996-5#3)
marijuana and##5##2##(1991-1#1)(2008-11#1)(2009-11#1)(2009-5#1)(2012-1#1)
marijuana smoking##2##2##(1991-1#1)(2013-8#1)
marijuana use##10##2##(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#2)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
marijuana users##2##2##(1996-5#1)(2012-12#1)
marijuana##38##1##(1991-1#3)(1991-12#1)(1991-4#2)(1996-1#1)(1996-5#6)(1997-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#4)(2011-1#1)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#7)
marina##2##1##(2008-10#2)
marinades and marinated##2##3##(2010-4#2)
marinades##4##1##(2010-4#4)
marinas in Hong Kong##2##4##(2008-10#2)
marinas in##3##2##(2007-5#1)(2008-10#2)
marinas##5##1##(2007-5#3)(2008-10#2)
marinated pork##4##2##(2010-4#4)
marinated products##2##2##(2010-4#2)
marinated##6##1##(2010-4#6)
marine algae samples##2##3##(2008-10#1)(2008-11#1)
marine algae##10##2##(2008-10#4)(2008-11#5)(2012-1#1)
marine bacteria##4##2##(1990-7#1)(2008-10#1)(2011-1#2)
marine bacterium##2##2##(2007-7#1)(2009-10#1)
marine benthic##2##2##(2007-5#1)(2008-10#1)
marine brown alga Sargassum##3##4##(2008-11#1)(2008-12#2)
marine brown algae##2##3##(1990-7#1)(2008-11#1)
marine brown##5##2##(1990-7#1)(2008-11#2)(2008-12#2)
marine bulk liquid transport##2##4##(2008-11#2)
marine constituents##6##2##(2008-2#5)(2008-3#1)
marine cyanobacteria##2##2##(2008-2#1)(2013-1#1)
marine ecosystems##3##2##(2008-10#1)(2012-2#2)
marine environment##16##2##(1994-9#1)(1997-4#1)(2007-5#2)(2008-10#2)(2008-11#9)(2011-2#1)
marine environments##4##2##(2008-10#3)(2011-2#1)
marine fish##5##2##(2008-10#1)(2009-5#1)(2010-5#2)(2012-3#1)
marine habitat in##2##3##(2008-9#2)
marine habitat##4##2##(2008-9#3)(2009-2#1)
marine invertebrate##4##2##(2008-11#1)(2008-8#2)(2010-7#1)
marine invertebrates and vertebrates##2##4##(2008-9#2)
marine invertebrates##6##2##(1996-2#1)(2007-5#1)(2008-9#3)(2009-2#1)
marine mammals##3##2##(2008-10#2)(2009-2#1)
marine microbes##2##2##(2011-1#2)
marine mollusc Aplysia californica##2##4##(1994-8#1)(1997-6#1)
marine mollusc Aplysia##3##3##(1994-8#1)(1997-6#2)
marine n-3 PUFA and rectal cancer risk##2##7##(2010-6#2)
marine n-3##3##2##(2010-6#3)
marine natural products##4##3##(2009-2#1)(2010-7#1)(2013-1#2)
marine natural##5##2##(2009-2#1)(2010-7#2)(2013-1#2)
marine oils##2##2##(1991-6#1)(2012-1#1)
marine organisms##7##2##(2007-5#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-12#2)
marine ornamental fish##3##3##(2007-5#3)
marine ornamental##5##2##(2007-5#5)
marine phytoplankton##4##2##(1994-8#1)(2008-10#1)(2008-3#2)
marine pollution##2##2##(2007-5#1)(2008-11#1)
marine reflectance##6##2##(2008-3#6)
marine sediment samples##3##3##(2008-10#3)
marine sediment##10##2##(2008-10#10)
marine sediments##9##2##(2008-10#7)(2011-2#2)
marine species##7##2##(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
marine to freshwater##3##3##(2010-8#3)
marine toxins##2##2##(2008-11#1)(2011-2#1)
marine water##6##2##(2008-10#5)(2008-9#1)
marine waters##7##2##(2008-10#6)(2008-2#1)
marine worm##2##2##(1994-2#1)(1996-2#1)
marine##253##1##(1990-7#2)(1991-12#1)(1991-6#1)(1993-3#1)(1994-2#2)(1994-8#3)(1994-9#2)(1996-2#4)(1997-4#2)(1997-6#3)(2007-5#12)(2007-7#1)(2008-10#63)(2008-11#24)(2008-12#2)(2008-2#9)(2008-3#14)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#15)(2009-10#2)(2009-2#4)(2009-5#2)(2009-8#3)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#5)(2011-1#7)(2011-2#17)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#14)(2013-7#1)
marine-derived##3##1##(2008-9#1)(2011-1#2)
marinum and##2##2##(2008-9#2)
marinum infection##3##2##(2008-9#3)
marinum##11##1##(2008-9#11)
marinus##3##1##(1993-5#2)(2008-10#1)
marital and##2##2##(1996-12#1)(2009-7#1)
marital or##3##2##(2007-8#1)(2009-11#1)(2009-4#1)
marital quality##5##2##(2007-10#3)(2011-2#2)
marital status and##2##3##(1990-6#1)(1991-6#1)
marital status##15##2##(1990-12#1)(1990-6#1)(1991-6#3)(1992-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
marital##35##1##(1990-12#1)(1990-6#1)(1991-6#3)(1992-2#1)(1996-12#1)(2007-10#4)(2007-12#1)(2007-2#5)(2007-7#1)(2007-8#1)(2008-2#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-2#2)
maritima##9##1##(1995-5#3)(2008-7#2)(2010-10#2)(2011-1#2)
maritime##8##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#4)
maritimus)##2##1##(1996-12#2)
mark Trace Elements in##4##4##(2008-10#4)
mark Trace Elements##5##3##(2008-10#5)
mark and##4##2##(2008-10#1)(2008-7#3)
mark cells##6##2##(2008-11#3)(2008-7#3)
mark for##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
mark in##2##2##(1995-12#1)(2008-7#1)
mark intensity##2##2##(2008-10#1)(2013-7#1)
mark length##2##2##(2007-12#1)(2008-2#1)
mark on##3##2##(1991-5#1)(1995-3#1)(2008-3#1)
mark success##2##2##(2010-8#2)
mark the development of##2##4##(1996-1#1)(2012-5#1)
mark the##5##2##(1996-1#1)(1997-5#1)(2008-4#1)(2010-2#1)(2012-5#1)
mark##116##1##(1991-5#1)(1991-6#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#19)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#13)(2009-2#1)(2009-3#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-8#4)(2011-2#2)(2012-12#1)(2012-2#6)(2012-5#1)(2013-1#1)(2013-7#2)
mark)##8##1##(1994-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)
mark-recapture study##2##2##(2008-8#2)
mark-recapture##3##1##(2008-8#2)(2011-2#1)
mark-release-recapture##3##1##(2011-2#3)
marked after##2##2##(1991-12#1)(2008-11#1)
marked amelioration of##2##3##(1990-3#1)(2008-6#1)
marked and##6##2##(1993-11#1)(1994-12#1)(1994-5#1)(1997-6#1)(2008-5#1)(2008-8#1)
marked at##2##2##(2008-4#1)(2008-5#1)
marked by a##5##3##(1996-12#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
marked by an##2##3##(2007-12#1)(2008-10#1)
marked by##25##2##(1991-4#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
marked cellular##2##2##(1994-8#1)(2008-10#1)
marked change##2##2##(2008-11#1)(2011-2#1)
marked changes in the##3##4##(1990-2#1)(1990-5#1)(2012-2#1)
marked changes in##7##3##(1990-12#1)(1990-2#1)(1990-5#1)(1993-12#1)(1993-9#1)(1996-2#1)(2012-2#1)
marked changes##8##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-12#1)(1993-9#1)(1996-2#1)(2008-7#1)(2012-2#1)
marked clinical##2##2##(2008-7#1)(2008-9#1)
marked decrease of the##2##4##(1991-12#1)(1994-5#1)
marked decrease of##6##3##(1991-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(2008-10#1)(2012-3#1)
marked decrease##22##2##(1991-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#3)(2012-3#1)(2013-8#1)
marked difference in the##5##4##(1990-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
marked difference##6##2##(1990-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
marked differences in##2##3##(1996-5#1)(2008-2#1)
marked differences##5##2##(1991-9#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-2#1)
marked diurnal##2##2##(1992-3#1)(2008-7#1)
marked effect on the##2##4##(1996-3#1)(2008-10#1)
marked effect on##4##3##(1995-3#1)(1996-3#1)(2008-10#1)(2008-5#1)
marked effects on the##2##4##(1995-12#1)(2008-8#1)
marked elevation of##2##3##(2007-10#1)(2012-3#1)
marked elevation##3##2##(1995-2#1)(2007-10#1)(2012-3#1)
marked enhancement of##3##3##(1992-3#1)(2008-10#2)
marked enhancement##5##2##(1992-3#1)(2008-10#3)(2012-2#1)
marked eosinophilia##2##2##(1991-12#2)
marked host cell##2##3##(2008-10#2)
marked host##3##2##(2008-10#3)
marked improvement in##8##3##(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
marked improvement##14##2##(1990-12#1)(1996-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
marked improvements##2##2##(2008-5#1)(2010-3#1)
marked in the##3##3##(1991-12#1)(2008-11#1)(2009-10#1)
marked in##6##2##(1990-11#1)(1991-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2009-10#1)
marked increase in the##6##4##(1990-5#1)(1991-11#1)(1994-12#1)(1995-5#1)(1997-7#1)(2008-3#1)
marked increase in##23##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-4#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-2#1)(2007-7#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
marked increase##25##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-4#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-3#1)(1997-7#2)(2007-2#1)(2007-7#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
marked increases in##4##3##(1992-3#1)(1992-8#1)(1996-12#1)(2008-6#1)
marked induction##2##2##(1996-12#1)(2008-10#1)
marked influence##2##2##(1993-6#1)(2008-10#1)
marked inhibitory##3##2##(1990-5#1)(1991-12#1)(1993-11#1)
marked loss of##2##3##(1997-8#1)(2008-10#1)
marked redness##2##2##(2008-5#1)(2011-2#1)
marked reduction in##13##3##(1990-12#1)(1992-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-10#1)(2012-2#1)
marked reduction of##3##3##(1990-12#1)(1994-8#1)(2013-1#1)
marked reduction##16##2##(1990-12#2)(1992-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
marked reductions in##3##3##(1995-2#1)(2008-10#1)(2009-3#1)
marked release of##2##3##(1992-6#1)(1995-8#1)
marked rise in##2##3##(1990-3#1)(1992-5#1)
marked secretory##2##2##(1994-5#1)(2008-7#1)
marked shift##2##2##(2007-12#1)(2008-10#1)
marked strains##3##2##(2008-10#3)
marked suppression of##3##3##(2008-5#1)(2008-6#1)(2010-4#1)
marked suppression##4##2##(2008-5#1)(2008-6#1)(2010-4#2)
marked variation##3##2##(1992-11#1)(1993-11#1)(1993-12#1)
marked with the##2##3##(1995-8#1)(2008-10#1)
marked with##7##2##(1995-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-8#1)
marked##390##1##(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#7)(1991-4#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#5)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#1)(2007-6#2)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#44)(2008-11#12)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#21)(2008-6#6)(2008-7#18)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#3)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#8)
markedly accelerate##2##2##(2008-11#1)(2011-2#1)
markedly activated##2##2##(2011-2#1)(2013-8#1)
markedly affect##2##2##(1991-5#1)(1994-9#1)
markedly affected by##3##3##(1992-3#1)(2007-10#1)(2008-10#1)
markedly altered##4##2##(2008-10#3)(2009-12#1)
markedly and##5##2##(1992-3#1)(1994-2#1)(1995-2#1)(2008-5#1)(2012-12#1)
markedly at##2##2##(1990-2#1)(2008-10#1)
markedly attenuated##2##2##(2008-11#1)(2013-7#1)
markedly augmented##2##2##(1993-8#1)(1993-9#1)
markedly decreased as##2##3##(2008-10#1)(2008-11#1)
markedly decreased in##3##3##(1994-9#1)(2008-10#1)(2008-12#1)
markedly decreased##12##2##(1990-2#1)(1991-2#1)(1991-6#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2013-8#1)
markedly depressed##2##2##(1993-5#1)(1997-2#1)
markedly different from##2##3##(1991-2#1)(2008-4#1)
markedly different##8##2##(1991-2#1)(1992-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
markedly elevated##5##2##(1992-12#1)(1992-8#1)(1993-8#1)(2008-1#1)(2008-12#1)
markedly enhanced##8##2##(1990-11#1)(1992-8#2)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-6#1)
markedly from##3##2##(1990-7#1)(2008-2#1)(2012-3#1)
markedly higher for##2##3##(1993-2#1)(1995-6#1)
markedly higher in##2##3##(1994-9#1)(1997-2#1)
markedly higher than##3##3##(1992-12#1)(2008-9#1)(2010-7#1)
markedly higher##9##2##(1992-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-9#1)(2010-7#1)
markedly improve##2##2##(2008-3#2)
markedly improved##12##2##(1991-3#1)(1992-6#1)(1993-11#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-7#2)(2010-6#1)(2011-2#2)
markedly in the##4##3##(1990-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
markedly in their##3##3##(1993-6#1)(2008-11#1)(2012-3#1)
markedly in##11##2##(1990-12#1)(1990-9#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-1#1)(2012-3#1)
markedly increase the##3##3##(1990-8#1)(1995-3#1)(2008-1#1)
markedly increase##4##2##(1990-8#1)(1995-3#1)(1995-6#1)(2008-1#1)
markedly increased in##4##3##(1994-2#1)(1995-3#1)(2012-2#1)(2012-3#1)
markedly increased the##3##3##(1992-8#1)(2008-10#1)(2013-7#1)
markedly increased##21##2##(1990-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-7#2)
markedly increases##3##2##(1992-12#1)(1993-6#1)(1995-8#1)
markedly inhibited by##4##3##(1990-2#1)(1991-2#1)(1993-8#1)(1994-2#1)
markedly inhibited the##6##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
markedly inhibited##19##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-2#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2011-2#1)
markedly less##3##2##(1990-5#1)(1995-11#1)(2008-10#1)
markedly lower than those##2##4##(2008-10#1)(2008-11#1)
markedly lower than##4##3##(1993-3#1)(2008-10#1)(2008-11#2)
markedly lower##5##2##(1993-3#1)(1997-6#1)(2008-10#1)(2008-11#2)
markedly more##4##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-5#1)
markedly reduce the##2##3##(2008-12#1)(2008-8#1)
markedly reduce##4##2##(2008-12#1)(2008-8#2)(2012-12#1)
markedly reduced by##4##3##(1993-11#2)(1996-2#1)(1997-1#1)
markedly reduced pyrogenic##2##3##(1990-2#2)
markedly reduced the##2##3##(2008-10#1)(2008-7#1)
markedly reduced##23##2##(1990-2#2)(1991-5#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-7#1)(2013-1#1)(2013-7#1)
markedly slower##3##2##(1992-8#1)(1994-5#1)(2008-10#1)
markedly stimulated##2##2##(1990-12#1)(2008-11#1)
markedly suppressed##5##2##(1993-3#1)(1994-11#1)(1994-6#2)(2011-2#1)
markedly upregulated in##2##3##(2008-6#1)(2013-7#1)
markedly upregulated##3##2##(2008-6#1)(2013-1#1)(2013-7#1)
markedly when##2##2##(1991-5#1)(2008-9#1)
markedly with##2##2##(1994-8#1)(2008-8#1)
markedly##276##1##(1990-11#4)(1990-12#3)(1990-2#6)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#5)(1992-3#6)(1992-6#2)(1992-8#6)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#7)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#6)(1994-8#7)(1994-9#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#4)(1997-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#31)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#4)(2009-12#2)(2009-5#1)(2010-1#2)(2010-10#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#5)(2013-8#4)
marker D1S249 locus##2##3##(2008-9#2)
marker D21S246##2##2##(1995-8#2)
marker XGli1##2##2##(2008-10#2)
marker accounted for##2##3##(2008-10#2)
marker allele##2##2##(2008-4#1)(2008-5#1)
marker analysis##2##2##(2008-10#2)
marker and the##4##3##(2007-12#1)(2008-10#1)(2008-11#2)
marker and##15##2##(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)
marker as an##2##3##(1992-9#1)(2008-12#1)
marker assisted selection (MAS)##2##4##(2008-8#1)(2013-8#1)
marker blocks##2##2##(2007-11#2)
marker chromosome##2##2##(1991-4#1)(2007-11#1)
marker chromosomes##4##2##(1991-4#2)(1993-9#1)(2008-1#1)
marker cyclin##2##2##(2012-3#2)
marker data were##2##3##(1997-5#1)(2008-10#1)
marker data##9##2##(1997-5#1)(2008-1#2)(2008-10#5)(2008-5#1)
marker enzyme activities##2##3##(1990-5#1)(1995-3#1)
marker enzyme##5##2##(1990-5#2)(1995-3#1)(2008-10#1)(2008-7#1)
marker enzymes##3##2##(1990-12#1)(1991-12#1)(2008-10#1)
marker expression##5##2##(2008-10#2)(2010-8#1)(2012-5#1)(2013-1#1)
marker for a##2##3##(2008-4#1)(2011-2#1)
marker for the resistant##2##4##(2008-10#2)
marker for the##14##3##(1990-5#1)(1993-8#1)(1995-12#2)(1995-6#1)(1997-9#1)(2008-10#4)(2008-7#2)(2009-2#1)(2010-5#1)
marker for this##2##3##(1994-2#1)(2013-8#1)
marker for##83##2##(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-5#4)(1996-6#2)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#4)(2013-8#2)
marker gene in##2##3##(2008-10#1)(2008-11#1)
marker gene##11##2##(1994-5#1)(1994-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
marker genes##8##2##(1992-3#1)(1994-5#1)(2008-10#3)(2008-8#2)(2011-10#1)
marker in the##3##3##(1996-11#1)(1997-2#1)(2008-1#1)
marker in##14##2##(1990-3#1)(1990-8#1)(1993-6#1)(1995-11#1)(1996-11#1)(1996-7#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-2#1)(2012-3#1)
marker ion##2##2##(2008-10#2)
marker is##4##2##(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
marker linked to##2##3##(2008-2#1)(2008-9#1)
marker linked##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
marker loci##7##2##(1997-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
marker mapping##2##2##(2008-10#1)(2008-7#1)
marker of Down's syndrome##2##4##(1996-12#2)
marker of an##2##3##(1994-2#1)(2012-3#1)
marker of axonal##2##3##(2008-7#1)(2011-7#1)
marker of bone##2##3##(1990-2#1)(1995-2#1)
marker of cellular##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
marker of early##2##3##(2011-2#2)
marker of inflammation##4##3##(2009-10#1)(2011-2#1)(2012-2#2)
marker of renal##3##3##(2013-1#3)
marker of the##12##3##(1992-6#1)(1992-9#1)(1996-7#1)(1997-6#1)(2007-10#1)(2008-10#3)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
marker of##103##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-10#2)(1992-6#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-7#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#4)(2008-1#2)(2008-10#10)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-5#2)(2010-8#1)(2011-2#10)(2011-7#1)(2012-2#7)(2012-3#2)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#3)
marker patterns##5##2##(2008-10#4)(2010-12#1)
marker sequences##2##2##(1996-10#1)(2008-10#1)
marker showed##2##2##(1997-4#1)(2011-1#1)
marker stocks##2##2##(2008-10#2)
marker system was##3##3##(2008-10#3)
marker system##4##2##(2008-10#4)
marker that##5##2##(2008-10#2)(2008-4#1)(2009-9#1)(2013-8#1)
marker to detect##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
marker to select##2##3##(2008-10#1)(2008-11#1)
marker to##10##2##(1992-5#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#2)
marker was##8##2##(1994-2#1)(2008-10#6)(2008-11#1)
marker##543##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#7)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#6)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#4)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-3#1)(1996-5#5)(1996-6#4)(1996-7#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#2)(1997-9#1)(2006-10#2)(2007-10#8)(2007-11#7)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#135)(2008-11#25)(2008-12#8)(2008-2#6)(2008-3#3)(2008-4#15)(2008-5#22)(2008-6#3)(2008-7#13)(2008-8#19)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#3)(2011-1#4)(2011-10#1)(2011-2#20)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#16)(2012-3#8)(2012-4#1)(2012-5#2)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#11)
marker)##2##1##(2008-5#1)(2009-3#1)
marker-assisted breeding##4##2##(2008-10#3)(2008-12#1)
marker-assisted selection (MAS)##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
marker-assisted selection in##3##3##(2008-10#3)
marker-assisted selection of##3##3##(2008-10#3)
marker-assisted selection##20##2##(2008-10#15)(2008-5#2)(2008-7#1)(2012-3#2)
marker-assisted##25##1##(2008-10#18)(2008-12#2)(2008-5#2)(2008-7#1)(2012-3#2)
marker-trait##2##1##(2008-10#2)
markers (AIMs)##2##2##(2008-12#1)(2009-5#1)
markers after##2##2##(2011-2#1)(2012-3#1)
markers allowed##2##2##(1995-6#1)(2008-10#1)
markers also##3##2##(1997-5#1)(2008-10#2)
markers amplified##2##2##(2008-10#1)(2008-5#1)
markers and by##2##3##(1996-10#1)(2008-10#1)
markers and that##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
markers and the##8##3##(1994-7#1)(1994-9#1)(1997-9#1)(2008-10#4)(2009-3#1)
markers and vertebrae##2##3##(2013-1#2)
markers and##68##2##(1990-8#1)(1991-11#1)(1994-3#1)(1994-7#1)(1994-9#1)(1996-10#2)(1996-5#1)(1997-5#1)(1997-7#1)(1997-9#1)(2008-10#26)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
markers are also##2##3##(2008-7#2)
markers are available##2##3##(1990-3#1)(2008-4#1)
markers are##19##2##(1990-3#1)(1996-10#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
markers as##3##2##(2007-11#1)(2008-5#2)
markers associated with##7##3##(1992-2#1)(2008-10#4)(2008-7#1)(2011-2#1)
markers at##7##2##(1994-9#1)(1997-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)
markers being##2##2##(2008-11#1)(2008-7#1)
markers can be used to##2##5##(2012-2#1)(2013-1#1)
markers can be used##3##4##(2010-12#1)(2012-2#1)(2013-1#1)
markers can be##10##3##(1994-12#2)(1996-12#2)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
markers can##16##2##(1994-12#3)(1996-12#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
markers closely linked to##2##4##(2008-10#2)
markers correlated with##2##3##(2008-10#1)(2013-8#1)
markers could be##2##3##(1996-3#1)(2007-7#1)
markers decreased upon##3##3##(1993-9#1)(2008-11#2)
markers developed##2##2##(2008-10#2)
markers during##2##2##(2008-10#1)(2008-11#1)
markers flanking the##2##3##(2008-10#1)(2012-3#1)
markers for adult##2##3##(1996-5#1)(2008-10#1)
markers for diagnosis##2##3##(2008-6#1)(2010-12#1)
markers for marker-assisted##2##3##(2008-10#2)
markers for phylogenetic##2##3##(2008-8#2)
markers for the##10##3##(1994-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2013-1#1)
markers for this pathogen##2##4##(2008-10#2)
markers for this##4##3##(1991-11#1)(1994-2#1)(2008-10#2)
markers for use in##2##4##(2008-5#1)(2009-9#1)
markers for##81##2##(1991-11#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-9#2)(1995-6#1)(1996-12#3)(1996-5#1)(1997-8#3)(2007-6#1)(2007-7#2)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#4)
markers from chromosomes##2##3##(1996-12#1)(1997-5#1)
markers from##6##2##(1996-12#2)(1997-5#1)(2008-10#3)
markers generally were##2##3##(2008-10#2)
markers has been##2##3##(2008-7#1)(2008-9#1)
markers has##4##2##(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)
markers have been developed##2##4##(2008-9#1)(2010-10#1)
markers have been##5##3##(2008-5#3)(2008-9#1)(2010-10#1)
markers have##9##2##(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
markers identified in##3##3##(2008-10#3)
markers identified##8##2##(1996-10#1)(2008-10#7)
markers in a##7##3##(1991-11#1)(1995-6#1)(2008-5#3)(2009-8#1)(2012-5#1)
markers in order to##3##4##(2008-10#2)(2008-5#1)
markers in patients##2##3##(2011-2#1)(2013-1#1)
markers in the##11##3##(1996-3#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-1#1)
markers in this##2##3##(1997-5#1)(2008-10#1)
markers in##77##2##(1991-11#2)(1993-5#1)(1994-6#1)(1994-7#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-5#5)(2007-10#3)(2007-4#1)(2007-7#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#11)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-5#1)(2013-1#1)(2013-8#2)
markers include##2##2##(2008-1#1)(2011-2#1)
markers including##3##2##(2007-7#1)(2011-1#1)(2013-1#1)
markers is##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
markers like##2##2##(2007-7#1)(2013-1#1)
markers linked to a##3##4##(2008-10#2)(2008-5#1)
markers linked to the##6##4##(1995-6#1)(2008-10#4)(2008-5#1)
markers linked to##24##3##(1995-6#1)(2008-10#19)(2008-5#3)(2008-8#1)
markers localized in##2##3##(1996-12#1)(2008-10#1)
markers localized##3##2##(1996-12#1)(2008-10#2)
markers located at 21 linkage groups##2##6##(2013-8#2)
markers located at##3##3##(1995-6#1)(2013-8#2)
markers may be##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
markers may##7##2##(1997-7#1)(2007-2#1)(2008-10#2)(2008-12#1)(2012-3#1)(2013-8#1)
markers of bone resorption and formation##2##6##(1993-11#1)(2007-11#1)
markers of bone turnover in##2##5##(1997-6#1)(2008-7#1)
markers of bone turnover##4##4##(1993-11#2)(1997-6#1)(2008-7#1)
markers of bone##8##3##(1993-11#3)(1994-12#1)(1997-6#1)(2007-11#1)(2008-7#2)
markers of cardiovascular risk during##2##5##(2013-8#2)
markers of hepatitis B##2##4##(1993-2#1)(2008-12#1)
markers of inflammation and##2##4##(2012-2#1)(2013-1#1)
markers of inflammation##5##3##(1990-2#1)(2008-3#1)(2012-2#2)(2013-1#1)
markers of nutrition##2##3##(2011-2#2)
markers of oxidative stress##4##4##(2008-5#1)(2009-6#1)(2013-8#2)
markers of plaque##2##3##(2008-8#1)(2010-9#1)
markers of the##12##3##(1990-3#1)(1993-3#1)(1993-6#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)(2013-8#1)
markers of##114##2##(1990-2#1)(1990-3#3)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#6)(2008-7#7)(2008-8#5)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#6)(2013-8#9)
markers on chromosome##2##3##(1996-12#1)(1997-5#1)
markers on chromosomes##2##3##(1996-12#1)(1997-5#1)
markers on the##2##3##(2008-5#1)(2013-8#1)
markers on##12##2##(1996-12#2)(1997-5#3)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2013-8#1)
markers or##11##2##(1996-12#2)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-3#1)(2011-2#1)
markers over##2##2##(2008-10#1)(2008-11#1)
markers placed##2##2##(2007-10#1)(2012-2#1)
markers present in##2##3##(2008-10#1)(2008-5#1)
markers revealed a##2##3##(2008-10#1)(2012-3#1)
markers revealed##5##2##(1990-8#1)(2008-10#3)(2012-3#1)
markers segregated in##2##3##(2008-10#2)
markers segregated##3##2##(2008-10#2)(2008-5#1)
markers showed significant##3##3##(2008-10#2)(2008-5#1)
markers showed##7##2##(1997-5#1)(2008-10#4)(2008-5#1)(2012-3#1)
markers spanning the##3##3##(1997-5#1)(2008-10#2)
markers spanning##4##2##(1997-5#2)(2008-10#2)
markers specific for##2##3##(1993-9#1)(2008-10#1)
markers specific##3##2##(1993-9#1)(2008-10#1)(2008-5#1)
markers such as##6##3##(1990-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)
markers that can##2##3##(2008-5#1)(2012-3#1)
markers that could be used to##2##6##(2008-10#1)(2008-7#1)
markers that could be used##3##5##(2008-10#1)(2008-6#1)(2008-7#1)
markers that have been##2##4##(1997-5#1)(2008-3#1)
markers that were detected##2##4##(2008-10#2)
markers that were##6##3##(2008-10#6)
markers that##27##2##(1994-9#1)(1996-10#1)(1997-5#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
markers tightly linked to the##2##5##(1995-6#1)(2008-10#1)
markers tightly linked to##4##4##(1995-6#1)(2008-10#3)
markers to identify##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
markers to investigate##2##3##(2008-10#2)
markers to monitor##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
markers to study the##2##4##(2008-10#2)
markers to the##2##3##(1992-3#1)(2008-10#1)
markers to##27##2##(1992-3#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
markers used in this study##2##5##(2008-10#1)(2008-12#1)
markers used in##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
markers used##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
markers was##15##2##(1994-8#1)(2008-10#7)(2008-5#3)(2008-9#1)(2009-2#1)(2012-3#1)(2013-8#1)
markers were converted into##2##4##(1995-6#1)(2008-10#1)
markers were detected##2##3##(2008-10#2)
markers were determined##2##3##(1997-8#1)(2009-8#1)
markers were developed from##2##4##(1997-8#1)(2008-10#1)
markers were developed##5##3##(1997-8#1)(2008-10#3)(2008-8#1)
markers were identified##5##3##(2008-10#3)(2008-5#1)(2012-5#1)
markers were not##2##3##(2008-10#2)
markers were tested##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
markers were used to characterize##2##5##(2008-10#1)(2011-2#1)
markers were used to determine##2##5##(2008-10#2)
markers were used to identify##2##5##(2008-10#2)
markers were used to##11##4##(2008-10#10)(2011-2#1)
markers were used##12##3##(2008-10#11)(2011-2#1)
markers were##66##2##(1990-8#1)(1991-4#1)(1994-7#2)(1995-6#1)(1996-12#2)(1996-8#1)(1997-8#2)(1997-9#1)(2008-10#35)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
markers when##3##2##(1993-2#1)(2008-8#1)(2013-7#1)
markers will be useful##2##4##(1991-5#1)(2008-10#1)
markers will##6##2##(1991-5#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-6#1)
markers with the##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
markers with##10##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#1)
markers within##3##2##(1997-5#1)(2008-12#1)(2008-5#1)
markers##1046##1##(1990-2#1)(1990-3#4)(1990-8#4)(1991-11#5)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-8#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#6)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#5)(1994-8#1)(1994-9#5)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#8)(1995-9#1)(1996-10#11)(1996-12#25)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#21)(1997-6#2)(1997-7#6)(1997-8#12)(1997-9#2)(2006-10#2)(2007-10#7)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#11)(2008-1#4)(2008-10#313)(2008-11#22)(2008-12#22)(2008-2#6)(2008-3#15)(2008-4#17)(2008-5#75)(2008-6#9)(2008-7#32)(2008-8#30)(2008-9#32)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#8)(2009-6#7)(2009-8#5)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#7)(2010-3#2)(2010-4#2)(2010-5#7)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#37)(2011-3#5)(2012-1#5)(2012-12#11)(2012-2#10)(2012-3#29)(2012-5#6)(2012-7#1)(2012-8#1)(2013-1#39)(2013-7#2)(2013-8#38)
markers)##3##1##(2008-12#1)(2010-9#1)(2012-3#1)
markers]##2##1##(1992-11#1)(1994-2#1)
market a##2##2##(1991-12#1)(1997-2#1)
market and##12##2##(1991-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
market area##2##2##(1992-12#1)(1996-12#1)
market areas##6##2##(1992-12#5)(1994-12#1)
market basket##2##2##(1992-1#2)
market because##2##2##(1994-1#1)(2008-11#1)
market concentration##2##2##(1996-3#2)
market conditions##2##2##(1992-2#1)(1994-3#1)
market demands##2##2##(1990-12#1)(1992-12#1)
market economy##4##2##(1991-12#1)(1991-3#1)(1994-2#2)
market for health services##2##4##(1991-3#1)(1994-1#1)
market for health##4##3##(1991-3#1)(1994-1#1)(1994-2#2)
market for##15##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(2007-8#1)(2008-6#2)(2010-8#1)(2012-3#1)
market forces##2##2##(1995-1#1)(1995-3#1)
market has been##2##3##(1992-11#1)(2006-12#1)
market has##3##2##(1992-11#1)(2006-12#1)(2010-4#1)
market in##7##2##(1991-1#1)(1996-5#1)(1997-3#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
market integration##2##2##(2011-1#1)(2012-12#1)
market may##2##2##(2008-11#1)(2010-5#1)
market place##3##2##(1996-1#1)(1996-3#1)(2008-11#1)
market power##3##2##(1997-1#2)(2008-11#1)
market reform##6##2##(1993-12#1)(1997-3#4)(2011-2#1)
market research##6##2##(1994-12#2)(1994-2#2)(1996-1#1)(2008-12#1)
market share and##2##3##(1993-1#1)(1996-3#1)
market share##9##2##(1991-12#1)(1991-3#1)(1993-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-12#1)
market structure##2##2##(1992-3#1)(2013-1#1)
market to##3##2##(1994-2#1)(1996-2#1)(2008-6#1)
market trends##2##2##(1991-3#1)(1995-3#1)
market value##2##2##(1991-2#1)(2008-10#1)
market##265##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#4)(1991-12#4)(1991-2#3)(1991-3#8)(1992-1#3)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#3)(1992-8#1)(1993-1#3)(1993-12#5)(1993-2#7)(1993-3#3)(1993-6#1)(1994-1#6)(1994-12#7)(1994-2#9)(1994-3#9)(1994-5#2)(1995-1#4)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#2)(1996-1#4)(1996-12#5)(1996-2#2)(1996-3#5)(1996-5#1)(1997-1#9)(1997-2#7)(1997-3#10)(1997-5#2)(1997-6#3)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#19)(2008-12#4)(2008-3#2)(2008-5#14)(2008-6#4)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
market-driven##4##1##(1994-12#1)(1995-12#1)(1997-2#1)(2008-5#1)
market-oriented##6##1##(1994-1#1)(1995-2#5)
marketability##2##1##(2008-10#2)
marketable pods##2##2##(2008-12#2)
marketable##8##1##(1992-1#1)(2008-10#4)(2008-12#2)(2011-2#1)
marketed conventional (Norbid)##2##3##(2012-2#2)
marketed drugs##3##2##(2008-1#1)(2008-10#1)(2011-3#1)
marketed for##3##2##(1993-1#1)(2007-2#1)(2008-1#1)
marketed gel##2##2##(2010-5#2)
marketed in##4##2##(1991-2#1)(2007-12#1)(2010-4#1)(2012-12#1)
marketed product##2##2##(2010-5#2)
marketed##35##1##(1991-2#1)(1993-1#2)(1995-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#3)
marketers need##3##2##(1995-2#1)(1997-1#1)(2008-12#1)
marketers##22##1##(1993-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#2)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#2)(1997-3#1)(2008-12#4)
marketing and sales##2##3##(2008-11#2)
marketing and##9##2##(1991-3#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-11#2)(2008-12#2)
marketing applications##3##2##(2010-6#1)(2012-2#2)
marketing challenge##2##2##(2008-12#2)
marketing challenges##2##2##(2008-12#2)
marketing communication strategy##2##3##(1994-12#1)(2008-12#1)
marketing efforts##2##2##(1996-3#1)(2008-6#1)
marketing implications for the##2##4##(1991-2#1)(1993-12#1)
marketing implications##4##2##(1991-2#1)(1993-12#1)(1994-2#1)(2008-12#1)
marketing in##2##2##(1994-12#1)(2008-5#1)
marketing is a##2##3##(1994-8#1)(1997-3#1)
marketing is##3##2##(1992-3#1)(1994-8#1)(1997-3#1)
marketing literature##2##2##(2008-12#2)
marketing managers##2##2##(1994-2#1)(1996-3#1)
marketing of a##2##3##(1992-9#1)(1996-5#1)
marketing of food and beverages##2##5##(2012-2#2)
marketing of##11##2##(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-11#2)(2012-2#2)
marketing plan##7##2##(1991-3#1)(1993-3#1)(1994-3#2)(1995-1#2)(2010-7#1)
marketing program##2##2##(1991-1#1)(1994-12#1)
marketing strategies##8##2##(1992-3#2)(1993-12#1)(1994-3#1)(1995-1#1)(1997-4#1)(2008-11#1)(2012-3#1)
marketing to##3##2##(1996-5#1)(2008-12#2)
marketing tool##2##2##(1994-3#1)(1997-4#1)
marketing tools##3##2##(2008-12#3)
marketing warfare##2##2##(1991-3#1)(1993-12#1)
marketing##153##1##(1991-1#3)(1991-12#2)(1991-2#2)(1991-3#4)(1992-2#3)(1992-3#9)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#1)(1993-3#4)(1994-12#5)(1994-2#6)(1994-3#7)(1994-8#1)(1995-1#6)(1995-12#3)(1995-3#3)(1996-1#6)(1996-12#1)(1996-3#7)(1996-5#2)(1997-1#4)(1997-3#8)(1997-4#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#26)(2008-5#4)(2008-6#1)(2008-8#2)(2009-7#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)
marketing-oriented##2##1##(2008-12#2)
marketplace is##2##2##(1995-12#1)(1997-1#1)
marketplace##36##1##(1991-1#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#3)(2012-1#1)
markets and##8##2##(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2009-7#2)(2012-12#1)(2013-8#1)
markets by##2##2##(1996-1#1)(1996-3#1)
markets for##2##2##(2011-2#2)
markets in the##2##3##(1996-3#1)(2012-2#1)
markets in##4##2##(1995-3#1)(1996-3#1)(1997-1#1)(2012-2#1)
markets with##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
markets##62##1##(1991-3#1)(1992-2#2)(1993-12#2)(1993-2#1)(1994-3#2)(1995-2#4)(1995-3#1)(1996-1#1)(1996-3#6)(1997-1#7)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#5)(2009-7#2)(2010-7#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
marking of##4##2##(1996-6#1)(2007-8#2)(2010-8#1)
marking##23##1##(1990-2#1)(1994-5#2)(1996-3#1)(1996-6#1)(2007-8#3)(2008-11#5)(2008-2#1)(2008-3#1)(2010-8#5)(2013-1#1)(2013-7#2)
markings##13##1##(1996-2#1)(1997-3#1)(2008-5#1)(2008-8#1)(2008-9#7)(2013-1#2)
markov model##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
marks across##2##2##(2007-12#1)(2008-9#1)
marks and##3##2##(1996-5#1)(2008-3#1)(2012-2#1)
marks as##2##2##(2007-11#2)
marks from##2##2##(2008-11#1)(2012-2#1)
marks in the##2##3##(2009-12#1)(2013-1#1)
marks of##2##2##(2008-10#1)(2008-3#1)
marks on##5##2##(2007-12#1)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)
marks the##3##2##(2009-5#1)(2009-8#1)(2011-1#1)
marks##50##1##(1995-3#1)(1996-3#1)(1996-5#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-9#2)(2009-10#1)(2009-12#4)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#6)(2013-1#3)(2013-7#3)(2013-8#2)
markup##2##1##(2008-7#1)(2010-10#1)
marmoratus is##2##2##(2008-5#2)
marmoratus##4##1##(2008-10#1)(2008-5#3)
marneffei in the##2##3##(2011-2#2)
marneffei##6##1##(2008-5#1)(2011-2#5)
marriage and divorce##2##3##(2008-12#1)(2011-2#1)
marriage and##4##2##(1992-12#1)(2008-12#1)(2010-3#1)(2011-2#1)
marriage benefits##2##2##(2008-10#1)(2009-11#1)
marriage is##3##2##(2008-6#1)(2011-2#2)
marriage of##3##2##(1995-3#1)(2008-11#1)(2008-6#1)
marriage pattern##2##2##(1994-6#1)(2011-2#1)
marriage that##2##2##(2009-11#1)(2010-4#1)
marriage##37##1##(1992-12#1)(1993-2#1)(1994-6#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-6#2)(2009-11#6)(2010-3#1)(2010-4#1)(2011-2#5)(2012-12#3)
marriages##10##1##(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2011-2#2)(2012-2#1)
married and have children under##2##5##(1995-2#1)(1996-12#1)
married and##7##2##(1992-4#1)(1995-2#1)(1996-12#1)(2007-12#1)(2011-2#2)(2013-1#1)
married couples##3##2##(1996-9#1)(2009-9#1)(2011-2#1)
married or##5##2##(1994-6#2)(2007-12#1)(2008-6#2)
married to##4##2##(1991-11#1)(1994-6#2)(1996-3#1)
married women of##2##3##(1990-6#1)(2012-12#1)
married women##6##2##(1990-6#1)(1991-6#1)(2011-1#3)(2012-12#1)
married##47##1##(1990-6#2)(1991-11#1)(1991-6#3)(1992-4#2)(1994-3#1)(1994-6#4)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(2007-10#1)(2007-12#3)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-11#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
marrow and red##2##3##(1992-12#1)(2008-6#1)
marrow and##14##2##(1991-6#1)(1992-12#1)(1992-2#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
marrow cells from##3##3##(1990-3#1)(2008-10#1)(2012-2#1)
marrow cells##38##2##(1990-3#2)(1990-5#1)(1990-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-3#1)(1997-8#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-1#2)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)
marrow changes##2##2##(2008-6#2)
marrow culture##2##2##(2007-11#1)(2010-4#1)
marrow examination##4##2##(2007-7#1)(2008-11#1)(2012-2#1)(2013-1#1)
marrow failure##4##2##(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
marrow fibrosis##5##2##(2009-8#5)
marrow from##3##2##(1993-9#1)(2008-6#1)(2010-11#1)
marrow hematopoietic stem##3##3##(1993-8#1)(2010-11#2)
marrow in##5##2##(1995-11#1)(2008-10#1)(2010-6#1)(2011-2#2)
marrow microenvironment##4##2##(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
marrow mononuclear cell##2##3##(2010-6#2)
marrow mononuclear##8##2##(2008-10#1)(2010-6#6)(2012-1#1)
marrow necrosis preceding infantile acute lymphoblastic leukaemia##2##7##(2008-12#2)
marrow necrosis##4##2##(2008-12#4)
marrow progenitors##2##2##(1993-9#1)(2011-2#1)
marrow stem cells##2##3##(2010-6#1)(2012-2#1)
marrow stem##4##2##(2010-11#1)(2010-6#1)(2010-8#1)(2012-2#1)
marrow stromal cell##7##3##(2008-10#1)(2008-11#3)(2008-8#2)(2011-1#1)
marrow stromal##9##2##(2008-10#1)(2008-11#4)(2008-8#2)(2009-4#1)(2011-1#1)
marrow transplant##6##2##(1995-1#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-8#1)
marrow transplantation (BMT)##3##3##(2007-4#1)(2008-1#1)(2009-10#1)
marrow transplantation has been##2##4##(2008-11#1)(2010-11#1)
marrow transplantation was##3##3##(1991-5#1)(1997-3#1)(2010-6#1)
marrow transplantation##34##2##(1991-2#1)(1991-5#3)(1993-2#1)(1994-5#3)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(1997-3#2)(1997-5#1)(1997-7#3)(2007-4#2)(2008-1#1)(2008-11#4)(2009-10#1)(2010-11#3)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
marrow with##2##2##(1994-5#1)(2009-8#1)
marrow##354##1##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#2)(1991-2#4)(1991-4#1)(1991-5#7)(1991-6#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#6)(1993-9#2)(1994-10#1)(1994-12#2)(1994-5#10)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-4#4)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#21)(2008-11#36)(2008-12#7)(2008-4#15)(2008-5#7)(2008-6#8)(2008-7#11)(2008-8#8)(2008-9#16)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-8#10)(2010-1#5)(2010-11#11)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#13)(2010-7#1)(2010-8#11)(2011-1#3)(2011-2#25)(2012-1#9)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
marrow-derived mast cells##2##3##(2008-11#1)(2009-6#1)
marrow-derived mesenchymal stem cells (MSCs)##2##5##(2012-12#2)
marrow-derived stem cells in##2##4##(2008-9#1)(2010-6#1)
marrow-derived##14##1##(1992-10#1)(1997-8#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-6#1)(2012-12#2)(2012-3#1)
marsh tits##4##2##(1994-3#3)(2008-5#1)
marsh##5##1##(1994-3#4)(2008-5#1)
marshland##5##1##(2008-5#1)(2012-3#4)
marsupial and placental mammals##2##4##(2008-9#2)
marsupial##3##1##(1992-8#1)(2008-9#2)
marsupialization##3##1##(2007-12#1)(2010-3#1)(2012-12#1)
martensite phase##2##2##(2009-7#2)
martial##2##1##(1991-12#1)(2009-7#1)
martis##3##1##(2011-2#3)
marxianus##3##1##(1995-6#2)(2008-6#1)
marylandi##5##1##(2008-10#5)
mascaras were##3##2##(2008-5#3)
mascaras##7##1##(2008-5#7)
masculine and##2##2##(2012-3#2)
masculine norms##3##2##(2009-5#3)
masculine ones##2##2##(2013-1#2)
masculine roles and interest in casual sex##2##7##(2010-8#2)
masculine roles##3##2##(2010-8#3)
masculine##16##1##(2008-11#1)(2008-9#1)(2009-5#4)(2009-7#2)(2010-8#3)(2012-3#2)(2013-1#3)
masculineC (Tb) and##2##3##(2008-6#2)
masculineC and##2##2##(2008-6#2)
masculineC on##3##2##(2008-6#3)
masculineC##12##1##(2008-6#12)
masculinities##3##1##(2008-11#2)(2011-2#1)
masculinity in##3##2##(2008-10#1)(2009-5#2)
masculinity is##3##2##(2008-11#1)(2009-5#2)
masculinity##12##1##(2008-10#1)(2008-11#5)(2009-5#6)
maser##2##1##(1990-12#1)(2007-12#1)
mash##3##1##(1997-4#2)(2010-2#1)
mashed tomato##3##2##(2008-10#3)
mashing##4##1##(1991-5#1)(1997-4#2)(2013-1#1)
mask and the##2##3##(2008-3#1)(2013-8#1)
mask and##7##2##(2008-2#4)(2008-3#1)(2012-12#1)(2013-8#1)
mask for##2##2##(2008-3#1)(2009-7#1)
mask in the##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
mask in##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
mask is determined##2##3##(2008-3#2)
mask is##9##2##(2007-11#1)(2008-3#8)
mask layer##2##2##(2007-11#1)(2010-2#1)
mask on the##2##3##(2008-2#2)
mask on##3##2##(2008-2#2)(2009-7#1)
mask pattern##2##2##(2007-12#1)(2008-2#1)
mask structures##2##2##(2008-3#2)
mask that##5##2##(2007-11#1)(2008-3#2)(2013-1#2)
mask the##6##2##(1990-5#1)(1990-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-5#1)
mask to##3##2##(2007-12#1)(2008-3#1)(2009-11#1)
mask with##3##2##(2008-2#2)(2008-3#1)
mask##126##1##(1990-5#1)(1990-6#1)(1993-2#4)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#3)(2007-11#7)(2007-12#3)(2007-8#2)(2008-10#5)(2008-12#2)(2008-2#30)(2008-3#42)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#4)(2010-2#1)(2010-3#1)(2010-5#2)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#2)
masked by##10##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
masked##27##1##(1990-12#1)(1993-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#2)
masking action##2##2##(2008-10#2)
masking agent##12##2##(2008-10#12)
masking agents##10##2##(2008-10#10)
masking effect was##2##3##(2008-5#2)
masking effect##4##2##(2008-10#1)(2008-5#3)
masking effects##2##2##(2008-10#1)(2008-5#1)
masking is##2##2##(2009-10#1)(2010-5#1)
masking noise##2##2##(2009-5#2)
masking of##5##2##(1997-7#2)(2008-10#2)(2008-12#1)
masking reagent##2##2##(2008-10#2)
masking some##2##2##(2008-10#2)
masking the##4##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
masking##66##1##(1994-2#1)(1995-8#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2009-10#2)(2009-11#1)(2009-5#5)(2010-5#1)(2011-2#1)(2012-2#3)
masks and##4##2##(1992-3#1)(1997-1#1)(2008-3#2)
masks are used##2##3##(2008-3#2)
masks are##5##2##(2008-3#5)
masks for##2##2##(1995-9#1)(2008-3#1)
masks is##2##2##(2008-3#2)
masks the##4##2##(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)
masks to##2##2##(2008-3#2)
masks with##3##2##(2008-2#1)(2008-3#2)
masks##45##1##(1992-3#1)(1995-9#1)(1996-3#1)(1997-1#1)(2008-2#5)(2008-3#27)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
maspin is##3##2##(1995-6#3)
maspin##8##1##(1995-6#8)
masquerading as##3##2##(2007-8#1)(2008-1#1)(2009-5#1)
masquerading##4##1##(2007-8#1)(2008-1#1)(2009-5#1)(2012-2#1)
mass % higher##2##3##(1993-2#2)
mass %##4##2##(1993-2#4)
mass (-0##4##2##(2008-5#4)
mass (0##2##2##(2008-10#1)(2008-7#1)
mass 1##2##2##(2007-12#1)(2008-2#1)
mass according to##2##3##(2008-10#1)(2011-2#1)
mass accuracy##2##2##(2011-2#1)(2012-12#1)
mass action##4##2##(1990-7#1)(2008-10#1)(2008-11#2)
mass after##2##2##(1997-3#1)(2008-10#1)
mass analysis##5##2##(2008-10#4)(2008-3#1)
mass analyzer##2##2##(2010-7#2)
mass and a##2##3##(2008-5#1)(2013-1#1)
mass and heat transfer##2##4##(2008-3#1)(2013-1#1)
mass and heat##3##3##(2008-3#2)(2013-1#1)
mass and strength##2##3##(2007-11#1)(2007-8#1)
mass and the##6##3##(1994-12#1)(1996-5#1)(2007-8#1)(2008-3#1)(2008-7#1)(2013-8#1)
mass and##67##2##(1990-5#1)(1990-7#1)(1992-9#1)(1993-11#5)(1993-12#1)(1994-12#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#4)(2010-10#1)(2010-11#4)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#3)(2013-1#5)(2013-7#1)(2013-8#1)
mass are##2##2##(2007-8#1)(2011-2#1)
mass arising from the##2##4##(2007-7#1)(2008-11#1)
mass as##3##2##(1992-3#1)(2008-10#1)(2010-5#1)
mass at the##6##3##(1990-3#1)(2008-10#2)(2008-9#1)(2013-1#2)
mass at##10##2##(1990-3#1)(2008-10#3)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#3)
mass attached to##2##3##(2008-6#1)(2011-1#1)
mass balance equations##2##3##(2008-10#1)(2008-6#1)
mass balance##9##2##(1995-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
mass balances for##2##3##(2008-5#1)(2008-7#1)
mass balances##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
mass based##2##2##(2008-10#1)(2010-7#1)
mass bias##2##2##(2008-10#2)
mass bleaching##3##2##(2008-9#2)(2012-2#1)
mass by 11%##2##3##(1997-4#1)(2008-6#1)
mass by##6##2##(1996-3#1)(1997-4#1)(2007-8#1)(2008-6#1)(2009-4#1)(2011-1#1)
mass casualty##2##2##(2011-1#1)(2013-1#1)
mass change##2##2##(2008-10#2)
mass changes##2##2##(1990-8#1)(2008-10#1)
mass closure of##2##3##(1992-1#1)(1992-2#1)
mass closure##3##2##(1992-1#2)(1992-2#1)
mass concentration##5##2##(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#2)
mass conservation##3##2##(2008-3#1)(2009-5#1)(2011-2#1)
mass culture##2##2##(2008-5#1)(2008-7#1)
mass data##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
mass decreased##2##2##(1995-3#1)(2008-7#1)
mass density##2##2##(2008-3#2)
mass depopulation##2##2##(2007-6#2)
mass detection##4##2##(1990-8#1)(2008-10#3)
mass disaster##5##2##(1995-11#5)
mass distribution of##2##3##(1992-6#1)(1993-2#1)
mass distribution##5##2##(1992-6#1)(1993-2#2)(1996-3#1)(2011-2#1)
mass distributions##2##2##(1992-2#1)(2010-7#1)
mass during##4##2##(1993-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
mass effect and oedema was##2##5##(1996-6#2)
mass effect and oedema##3##4##(1996-6#3)
mass effect and##6##3##(1996-6#3)(2008-7#2)(2012-12#1)
mass effect##8##2##(1996-6#3)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
mass excision##2##2##(2011-1#1)(2012-3#1)
mass extinctions##7##2##(1997-5#7)
mass flow rate##2##3##(1996-3#2)
mass flow##5##2##(1996-3#3)(2008-10#1)(2008-3#1)
mass for##2##2##(1994-3#1)(2008-10#1)
mass fraction##5##2##(1995-3#1)(2008-10#2)(2008-3#1)(2012-5#1)
mass from##4##2##(1993-3#1)(1994-11#1)(2008-6#1)(2008-7#1)
mass gain##2##2##(1993-11#1)(2008-9#1)
mass had##2##2##(2012-1#1)(2013-1#1)
mass has been##2##3##(1990-8#1)(2008-8#1)
mass has##5##2##(1990-8#1)(1993-8#1)(1995-2#1)(2008-8#1)(2012-12#1)
mass immunization##2##2##(1994-9#2)
mass in a##2##3##(1990-2#1)(1991-8#1)
mass in the head of the pancreas##2##7##(1991-3#1)(2013-1#1)
mass in the left lower##3##5##(2008-6#1)(2010-11#2)
mass in the left##12##4##(1990-6#1)(1992-6#1)(2008-11#1)(2008-6#2)(2010-11#2)(2010-6#1)(2012-12#2)(2013-1#2)
mass in the right##8##4##(1994-8#1)(2007-8#2)(2008-1#1)(2008-6#1)(2009-5#1)(2012-1#1)(2013-1#1)
mass in the##45##3##(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#3)(2009-1#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#6)(2013-8#2)
mass in##61##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-9#2)(2009-1#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#4)
mass increased##2##2##(1992-12#1)(2010-8#1)
mass index (BMI) and##6##4##(2007-12#3)(2008-3#1)(2012-3#1)(2013-1#1)
mass index (BMI) of##4##4##(2008-12#1)(2008-3#1)(2012-12#1)(2012-3#1)
mass index (BMI) was##3##4##(2006-8#1)(2008-1#1)(2008-9#1)
mass index (BMI)##41##3##(1991-11#1)(1994-12#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-9#1)(2010-1#1)(2010-4#2)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)
mass index and##10##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2011-2#3)
mass index was##2##3##(2008-12#1)(2008-9#1)
mass index##128##2##(1990-3#1)(1991-11#2)(1991-12#2)(1993-12#1)(1994-12#4)(2006-8#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#5)(2009-2#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-4#4)(2010-6#2)(2010-7#1)(2011-1#11)(2011-2#15)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#3)
mass is a##2##3##(2008-2#1)(2011-2#1)
mass is an important##2##4##(2008-2#1)(2012-2#1)
mass is##17##2##(1990-9#1)(1993-11#2)(1994-12#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
mass lesion##7##2##(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
mass lesions##7##2##(1996-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
mass loading##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
mass loss##11##2##(1993-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-4#2)(2013-8#1)
mass markedly##2##2##(2008-12#1)(2008-5#1)
mass may##5##2##(1993-11#2)(2008-8#1)(2008-9#1)(2013-1#1)
mass measurement##6##2##(1990-8#1)(1993-11#2)(2008-10#1)(2008-7#1)(2010-7#1)
mass measurements##8##2##(1990-8#1)(1993-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
mass media##9##2##(1991-3#1)(1992-2#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-8#1)(2007-12#1)(2009-5#1)(2012-12#1)
mass median aerodynamic diameter (MMAD)##3##5##(1992-2#1)(1996-12#1)(1997-2#1)
mass median diameter##2##3##(1995-3#1)(1996-3#1)
mass median diameters (MMD)##2##4##(1993-2#1)(1995-3#1)
mass median##7##2##(1992-2#1)(1993-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)
mass mimicking##4##2##(2008-11#1)(2008-12#1)(2012-12#2)
mass of 1##2##3##(2008-10#2)
mass of 14##2##3##(1992-8#1)(2008-11#1)
mass of 34##2##3##(2008-10#1)(2009-2#1)
mass of 35 kDa##3##4##(2008-10#3)
mass of 35##4##3##(2008-10#4)
mass of aerosol##2##3##(1992-3#1)(1996-3#1)
mass of approximately##2##3##(1992-8#1)(2008-10#1)
mass of drug##2##3##(1995-3#1)(1996-2#1)
mass of eggs##2##3##(2010-8#2)
mass of food##2##3##(2008-4#1)(2010-8#1)
mass of the enzyme##2##4##(1990-7#1)(1991-8#1)
mass of the gel##3##4##(2008-10#3)
mass of the induced##2##4##(2008-12#2)
mass of the##28##3##(1990-7#2)(1990-8#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-6#2)(1996-10#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
mass of this##2##3##(1995-2#1)(2010-6#1)
mass of##153##2##(1990-5#5)(1990-7#6)(1990-8#1)(1991-12#3)(1991-2#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-6#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#42)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#5)(2009-2#3)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
mass on the##8##3##(1990-8#1)(1991-12#1)(2008-10#1)(2010-6#1)(2012-12#2)(2012-3#1)(2013-8#1)
mass on##11##2##(1990-8#1)(1991-12#1)(2007-7#1)(2008-10#2)(2010-6#1)(2012-12#3)(2012-3#1)(2013-8#1)
mass or##7##2##(1991-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)
mass output rates##3##3##(2008-10#3)
mass output##4##2##(2008-10#4)
mass per area-based##2##3##(2008-12#2)
mass per egg##2##3##(2010-8#2)
mass per##6##2##(2008-12#3)(2008-7#1)(2010-8#2)
mass production and##3##3##(1992-12#1)(2008-2#1)(2013-1#1)
mass production of the##2##4##(2008-7#1)(2013-8#1)
mass production of##6##3##(2008-11#3)(2008-7#2)(2013-8#1)
mass production##20##2##(1992-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2013-1#1)(2013-8#1)
mass profile##2##2##(1993-8#2)
mass range##4##2##(1992-3#1)(2008-10#1)(2010-5#1)(2013-1#1)
mass ratio##5##2##(2008-10#1)(2008-6#2)(2008-8#1)(2011-2#1)
mass rearing##2##2##(2008-6#1)(2013-7#1)
mass recovery##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
mass relation was##2##3##(2008-5#2)
mass remains##2##2##(2008-11#1)(2008-5#1)
mass resolution##2##2##(2008-7#1)(2012-12#1)
mass screening for breast cancer##2##5##(1995-4#2)
mass screening##6##2##(1994-11#1)(1995-4#3)(1996-12#1)(2008-4#1)
mass showed##2##2##(2011-1#1)(2013-1#1)
mass spectra and##2##3##(2011-2#2)
mass spectra obtained##2##3##(2010-5#2)
mass spectra of the##3##4##(1991-5#1)(2008-10#2)
mass spectra of##5##3##(1991-5#1)(2008-10#4)
mass spectra##25##2##(1991-5#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#2)(2011-2#6)
mass spectral analysis##2##3##(1991-8#1)(2008-11#1)
mass spectral fragmentation##2##3##(2008-10#1)(2011-2#1)
mass spectral##13##2##(1991-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#7)
mass spectrometer equipped with##3##4##(2008-10#1)(2009-2#1)(2011-3#1)
mass spectrometer for##4##3##(2008-10#2)(2008-4#1)(2010-6#1)
mass spectrometer in##2##3##(2008-10#1)(2011-1#1)
mass spectrometer##44##2##(1996-7#1)(1997-8#1)(2008-1#1)(2008-10#24)(2008-2#2)(2008-3#2)(2008-4#5)(2009-2#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-3#1)
mass spectrometers##8##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#2)(2011-2#1)
mass spectrometric analysis##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
mass spectrometric and##5##3##(1990-7#1)(1993-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
mass spectrometric data##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
mass spectrometric detection##15##3##(2008-10#11)(2008-4#1)(2008-5#2)(2012-1#1)
mass spectrometric detector##2##3##(2008-10#2)
mass spectrometric identification##3##3##(2008-10#2)(2008-4#1)
mass spectrometric measurements##2##3##(2008-10#1)(2010-11#1)
mass spectrometric methods##4##3##(1992-12#1)(2008-7#1)(2013-1#2)
mass spectrometric techniques##2##3##(2008-10#2)
mass spectrometric##49##2##(1990-7#2)(1992-12#1)(1993-8#1)(2008-10#26)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#2)
mass spectrometry (ESI-MS)##5##3##(2008-10#4)(2011-1#1)
mass spectrometry (GC-MS)##2##3##(2008-10#2)
mass spectrometry (GC-oaTOFMS)##2##3##(2008-10#2)
mass spectrometry (ICP-MS)##27##3##(2008-10#25)(2013-8#2)
mass spectrometry (LA-ICP-MS)##3##3##(2008-10#1)(2010-11#2)
mass spectrometry (LC-MS/MS)##5##3##(2008-10#2)(2011-1#2)(2013-1#1)
mass spectrometry (MALDI-TOF-MS)##2##3##(2008-10#2)
mass spectrometry (MS) and##2##4##(1997-2#1)(2008-10#1)
mass spectrometry (MS)##8##3##(1997-2#1)(2008-10#3)(2008-4#2)(2008-8#1)(2010-7#1)
mass spectrometry after##2##3##(1992-3#1)(2008-10#1)
mass spectrometry analysis is##2##4##(2008-10#1)(2010-6#1)
mass spectrometry analysis of##2##4##(2008-7#1)(2011-1#1)
mass spectrometry analysis##5##3##(2008-10#2)(2008-7#1)(2010-6#1)(2011-1#1)
mass spectrometry and multivariate##2##4##(2008-10#1)(2010-5#1)
mass spectrometry and##18##3##(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
mass spectrometry are##2##3##(2008-10#1)(2010-5#1)
mass spectrometry as a##4##4##(1997-2#1)(2008-10#2)(2011-2#1)
mass spectrometry as##6##3##(1995-2#1)(1997-2#1)(2008-10#2)(2011-2#1)(2012-1#1)
mass spectrometry can be##2##4##(2008-10#1)(2008-4#1)
mass spectrometry data##4##3##(2009-11#1)(2010-2#1)(2012-1#2)
mass spectrometry detection have been##2##5##(2008-10#1)(2010-5#1)
mass spectrometry detection##9##3##(2008-10#8)(2010-5#1)
mass spectrometry detector##2##3##(2008-10#2)
mass spectrometry for the##5##4##(2008-10#4)(2008-4#1)
mass spectrometry for##11##3##(1997-4#1)(2008-10#9)(2008-4#1)
mass spectrometry has been##2##4##(1990-12#1)(1997-2#1)
mass spectrometry in##6##3##(2008-10#3)(2010-5#1)(2010-7#2)
mass spectrometry is described##2##4##(2008-10#1)(2008-11#1)
mass spectrometry is##5##3##(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)
mass spectrometry of##5##3##(1992-6#1)(1994-3#1)(2008-10#1)(2008-9#1)(2010-7#1)
mass spectrometry system##2##3##(1997-2#1)(2008-10#1)
mass spectrometry technique##3##3##(1992-6#1)(2008-2#1)(2011-2#1)
mass spectrometry to##9##3##(1991-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
mass spectrometry using a##2##4##(2008-10#1)(2008-4#1)
mass spectrometry using##4##3##(2008-10#2)(2008-4#1)(2010-5#1)
mass spectrometry was applied to##2##5##(2008-10#1)(2011-3#1)
mass spectrometry was used to##2##5##(2008-10#2)
mass spectrometry was used##3##4##(2008-10#3)
mass spectrometry was##7##3##(1993-11#1)(2008-10#4)(2011-3#1)(2012-12#1)
mass spectrometry with##7##3##(2008-10#4)(2008-7#1)(2011-1#1)(2011-2#1)
mass spectrometry##413##2##(1990-12#2)(1990-7#2)(1990-8#5)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-5#3)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1997-2#7)(1997-4#3)(2006-12#1)(2008-1#1)(2008-10#219)(2008-11#9)(2008-2#5)(2008-4#15)(2008-5#3)(2008-6#1)(2008-7#14)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2010-11#6)(2010-2#2)(2010-4#2)(2010-5#10)(2010-6#3)(2010-7#12)(2010-8#2)(2011-1#10)(2011-2#8)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#6)
mass spectrometry)##3##2##(2008-12#1)(2008-7#2)
mass spectrometry-based electronic nose##2##4##(2008-10#2)
mass spectrometry-based##4##2##(2008-10#2)(2010-5#1)(2010-7#1)
mass spectrometry]##6##2##(2011-1#4)(2013-8#2)
mass spectroscopy##7##2##(2008-10#3)(2008-4#1)(2008-7#3)
mass spectrum##5##2##(1990-12#2)(2008-10#1)(2008-5#1)(2013-8#1)
mass tag##2##2##(2008-7#2)
mass tags'##2##2##(2008-7#2)
mass than##3##2##(1993-11#1)(2008-12#1)(2008-9#1)
mass that was##2##3##(2007-8#1)(2008-9#1)
mass that##3##2##(2007-8#1)(2008-9#1)(2011-2#1)
mass to the##2##3##(2008-10#1)(2013-1#1)
mass to##7##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
mass transfer and##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-11#1)
mass transfer area##2##3##(2011-2#2)
mass transfer coefficient and##2##4##(2008-7#2)
mass transfer coefficient was##3##4##(2008-6#1)(2008-7#2)
mass transfer coefficient##10##3##(2008-10#1)(2008-6#2)(2008-7#7)
mass transfer coefficients##2##3##(1997-2#1)(2008-7#1)
mass transfer in##4##3##(2008-10#2)(2008-7#1)(2009-11#1)
mass transfer of##5##3##(1990-12#1)(1994-12#1)(2008-10#2)(2013-1#1)
mass transfer resistance##2##3##(2012-2#2)
mass transfer##39##2##(1990-12#1)(1994-12#1)(1995-5#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-6#4)(2008-7#10)(2009-11#4)(2010-4#1)(2011-2#2)(2012-2#3)(2013-1#2)
mass transport in the adsorbent bed##2##6##(2008-10#2)
mass transport limited##2##3##(1997-2#2)
mass transport phenomenon##2##3##(2008-9#2)
mass transport to##2##3##(2008-10#1)(2008-3#1)
mass transport##12##2##(1997-2#4)(2008-10#3)(2008-3#1)(2008-9#2)(2010-7#1)(2011-2#1)
mass vaccination##4##2##(1993-6#1)(1994-9#1)(2010-8#1)(2011-2#1)
mass was found to##2##4##(1992-2#1)(2011-2#1)
mass was found##5##3##(1992-2#1)(1997-8#1)(2008-3#1)(2011-2#1)(2013-8#1)
mass was more##2##3##(2008-3#1)(2012-9#1)
mass was##42##2##(1990-2#1)(1992-12#1)(1992-2#1)(1994-6#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#2)(2012-9#1)(2013-1#2)(2013-8#4)
mass were##9##2##(1997-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-9#1)(2013-1#2)
mass which##2##2##(2008-7#1)(2011-2#1)
mass with a##2##3##(1994-7#1)(2011-2#1)
mass with fat##2##3##(2013-1#2)
mass with##15##2##(1990-6#1)(1994-7#1)(2007-10#1)(2008-1#1)(2008-6#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
mass without##2##2##(2008-7#1)(2012-3#1)
mass##1837##1##(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#2)(1990-5#9)(1990-6#3)(1990-7#13)(1990-8#12)(1990-9#1)(1991-11#5)(1991-12#9)(1991-2#5)(1991-3#2)(1991-5#4)(1991-6#1)(1991-8#5)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#10)(1992-2#7)(1992-3#9)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#7)(1992-9#3)(1993-11#26)(1993-12#2)(1993-2#7)(1993-3#3)(1993-6#7)(1993-8#7)(1993-9#6)(1994-11#6)(1994-12#11)(1994-3#5)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#4)(1995-11#9)(1995-12#1)(1995-2#10)(1995-3#12)(1995-4#4)(1995-5#3)(1995-6#4)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#7)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#17)(1997-3#2)(1997-4#9)(1997-5#8)(1997-6#1)(1997-7#3)(1997-8#8)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#15)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#21)(2008-1#12)(2008-10#505)(2008-11#45)(2008-12#26)(2008-2#18)(2008-3#27)(2008-4#43)(2008-5#35)(2008-6#29)(2008-7#102)(2008-8#26)(2008-9#43)(2009-1#3)(2009-10#2)(2009-11#5)(2009-12#1)(2009-2#8)(2009-3#6)(2009-4#2)(2009-5#8)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#21)(2010-12#2)(2010-2#5)(2010-3#4)(2010-4#12)(2010-5#19)(2010-6#12)(2010-7#26)(2010-8#19)(2010-9#1)(2011-1#52)(2011-2#86)(2011-3#3)(2012-1#12)(2012-12#42)(2012-2#25)(2012-3#24)(2012-5#1)(2012-9#2)(2013-1#66)(2013-7#4)(2013-8#38)
mass) and##2##2##(2008-10#1)(2011-1#1)
mass)##12##1##(1990-5#2)(2008-10#4)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
mass-balance data##2##2##(2008-10#2)
mass-balance##4##1##(2008-10#3)(2013-1#1)
mass-flow rate##2##2##(2008-3#2)
mass-flow##3##1##(2008-3#3)
mass-specific BMR##3##2##(2013-1#3)
mass-specific M(sum)##2##2##(2013-1#2)
mass-specific##7##1##(2007-12#2)(2013-1#5)
mass-spectrometric##2##1##(2008-10#1)(2010-7#1)
mass-transport##2##1##(2008-10#1)(2008-3#1)
massA mutant 10##2##3##(2008-10#2)
massage for medically fragile infants##2##5##(2008-10#2)
massage for##3##2##(2008-10#2)(2013-1#1)
massage in the##2##3##(2009-3#1)(2010-7#1)
massage in##6##2##(2008-10#2)(2008-12#1)(2009-3#1)(2010-7#2)
massage on##4##2##(2008-12#1)(2009-3#1)(2010-12#1)(2010-7#1)
massage sessions##2##2##(2008-10#2)
massage therapists##4##2##(2008-10#1)(2008-12#3)
massage therapy##6##2##(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2010-6#1)
massage twice##2##2##(2008-10#1)(2008-12#1)
massage##58##1##(1991-2#2)(2008-10#21)(2008-11#1)(2008-12#12)(2008-5#2)(2008-7#1)(2009-3#4)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#5)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
massaged##8##1##(2008-12#4)(2009-3#4)
masses and##9##2##(1990-3#1)(1994-2#1)(2007-10#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)
masses are##2##2##(1992-4#1)(2008-10#1)
masses associated with##2##3##(2011-2#1)(2013-1#1)
masses in the##4##3##(1990-10#1)(2008-1#1)(2011-2#1)(2012-3#1)
masses in##9##2##(1990-10#1)(1990-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)
masses may##3##2##(1992-4#1)(2011-2#2)
masses of approximately##3##3##(1992-3#1)(1993-11#1)(2008-10#1)
masses of the##5##3##(1993-8#1)(2008-10#3)(2010-8#1)
masses of##31##2##(1990-12#1)(1990-5#2)(1991-12#2)(1991-6#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-8#3)(1996-5#1)(2007-12#2)(2008-10#12)(2008-4#1)(2008-8#1)(2010-8#1)
masses present##2##2##(1992-8#1)(2011-2#1)
masses up to##2##3##(2008-10#2)
masses was##2##2##(1996-1#1)(2010-8#1)
masses were##4##2##(1990-3#1)(2008-5#1)(2010-8#2)
masses with##2##2##(2008-1#1)(2012-2#1)
masses##145##1##(1990-10#3)(1990-12#4)(1990-3#5)(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#4)(1994-2#1)(1996-1#5)(1996-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-12#6)(2007-5#2)(2007-8#3)(2008-1#2)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-6#1)(2010-7#3)(2010-8#6)(2011-1#1)(2011-2#10)(2012-1#2)(2012-2#9)(2012-3#1)(2013-1#6)
masseter muscle##12##2##(1993-12#1)(1996-2#1)(2008-10#1)(2008-4#5)(2010-6#1)(2010-9#1)(2013-1#2)
masseter muscles##2##2##(2008-4#1)(2010-6#1)
masseter were##2##2##(2010-6#1)(2013-1#1)
masseter##21##1##(1993-12#2)(1996-2#1)(2008-10#3)(2008-4#6)(2010-6#3)(2010-9#3)(2013-1#3)
massetolide A##3##2##(2008-10#3)
massive AC##2##2##(1994-9#2)
massive accumulation of##2##3##(1994-11#1)(1995-12#1)
massive amount of##3##3##(2008-6#1)(2008-7#1)(2009-6#1)
massive and##5##2##(1992-9#1)(2007-5#1)(2008-10#2)(2008-5#1)
massive bone##2##2##(1996-3#1)(2007-11#1)
massive campaigns##3##2##(2007-10#3)
massive haemorrhage##2##2##(2008-7#2)
massive loss of##2##3##(1996-5#1)(2011-2#1)
massive pneumoperitoneum##2##2##(2007-5#2)
massive pulmonary embolism##4##3##(2007-10#1)(2007-8#1)(2011-2#1)(2012-3#1)
massive pulmonary##7##2##(2007-10#2)(2007-8#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
massive wavelength-division multiplexing##2##3##(2007-12#2)
massive##128##1##(1990-3#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-2#1)(1992-5#2)(1992-9#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-10#6)(2007-11#2)(2007-12#8)(2007-5#4)(2007-7#2)(2007-8#6)(2008-10#7)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
massively in the##2##3##(2008-10#1)(2008-9#1)
massively parallel sequencing##2##3##(2011-2#1)(2012-2#1)
massively parallel##15##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
massively##28##1##(1990-6#1)(1991-9#1)(1994-5#1)(1994-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-9#2)(2009-10#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
mast cell activation##5##3##(1995-11#4)(2008-7#1)
mast cell tumors##3##3##(2012-3#3)
mast cell##23##2##(1993-3#2)(1993-8#1)(1995-11#4)(1995-12#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-6#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#3)
mast cell-mediated##2##2##(2008-10#1)(2010-8#1)
mast cell/IgE##2##2##(2008-8#2)
mast cells (for##2##3##(2008-4#2)
mast cells and eosinophils##2##4##(1992-2#2)
mast cells and##4##3##(1992-2#2)(1993-3#1)(2008-7#1)
mast cells are##3##3##(1995-12#2)(2008-7#1)
mast cells by##2##3##(2008-7#1)(2008-9#1)
mast cells in##2##3##(1995-12#1)(2008-7#1)
mast cells is##2##3##(1991-2#1)(2009-6#1)
mast cells##49##2##(1991-12#5)(1991-2#3)(1992-2#2)(1992-3#4)(1993-3#1)(1995-11#1)(1995-12#6)(2008-10#2)(2008-11#2)(2008-4#9)(2008-6#1)(2008-7#5)(2008-9#4)(2009-6#2)(2011-2#1)(2013-1#1)
mast seeding##4##2##(2008-8#4)
mast##83##1##(1991-12#5)(1991-2#3)(1992-2#2)(1992-3#4)(1993-3#3)(1993-8#1)(1995-11#5)(1995-12#8)(2008-10#3)(2008-11#2)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#5)(2009-6#4)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#1)
mast-cell activation##2##2##(2009-6#2)
mast-cell##4##1##(1996-8#1)(2008-7#1)(2009-6#2)
mastalgia and breast nodularity##3##4##(1994-5#3)
mastalgia##5##1##(1994-5#5)
mastectomies##8##1##(2011-2#7)(2013-1#1)
mastectomy and postoperative radiotherapy##2##4##(1991-4#1)(1994-2#1)
mastectomy and##8##2##(1990-12#1)(1991-4#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-7#1)(2011-1#1)(2012-3#1)
mastectomy for##4##2##(1994-12#1)(1994-7#1)(2011-2#1)(2013-1#1)
mastectomy in##2##2##(1991-4#1)(2007-11#1)
mastectomy was performed##3##3##(2008-10#2)(2012-3#1)
mastectomy with##3##2##(1994-7#1)(1995-11#1)(1997-7#1)
mastectomy##45##1##(1990-12#3)(1990-9#1)(1991-4#2)(1992-12#3)(1993-11#2)(1994-12#4)(1994-2#1)(1994-7#3)(1995-11#1)(1995-4#1)(1997-7#1)(2007-11#1)(2008-10#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#5)(2013-1#11)
master laser##2##2##(2008-2#1)(2008-3#1)
master modulatory loci&quot##2##3##(2008-10#2)
master of##2##2##(1996-12#1)(2007-4#1)
master oscillator##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
master oscillator-power##2##2##(2007-12#2)
master patient scheduling##2##3##(1996-2#2)
master##37##1##(1991-3#1)(1992-1#1)(1992-2#3)(1994-12#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-3#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
master's##4##1##(1990-12#1)(1993-12#1)(1994-12#2)
master-oscillator fiber##2##2##(2007-12#2)
master-oscillator power amplifier##3##3##(2008-2#3)
master-oscillator power-amplifier system##2##3##(2007-12#1)(2008-2#1)
master-oscillator power-amplifier##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
master-oscillator##10##1##(2007-12#4)(2008-2#4)(2008-3#2)
master-slave##2##1##(2007-12#1)(2008-2#1)
mastering##2##1##(2007-8#1)(2008-7#1)
mastery of the##2##3##(2008-9#1)(2013-8#1)
mastery##4##1##(2008-12#2)(2008-9#1)(2013-8#1)
mastication##4##1##(2007-12#1)(2008-10#1)(2011-2#2)
masticatory forces##3##2##(2011-2#1)(2013-1#2)
masticatory muscle reflexes##4##3##(1996-2#4)
masticatory muscle##5##2##(1996-2#4)(2008-7#1)
masticatory system##4##2##(2008-7#1)(2010-9#2)(2012-12#1)
masticatory##17##1##(1990-6#1)(1990-9#1)(1991-3#1)(1996-2#4)(2008-7#2)(2010-9#3)(2011-2#2)(2012-12#1)(2013-1#2)
masting and##2##2##(2008-8#1)(2008-9#1)
masting##4##1##(2008-8#2)(2008-9#2)
mastitis in which##2##3##(1993-2#2)
mastitis in##3##2##(1993-2#2)(1996-8#1)
mastitis##15##1##(1990-6#1)(1991-8#2)(1992-2#2)(1993-2#2)(1996-3#1)(1996-8#2)(1997-8#2)(2011-1#3)
mastocytes in##2##2##(1991-11#2)
mastocytes##7##1##(1991-11#7)
mastocytic nodules##2##2##(1991-11#2)
mastocytosis##12##1##(1991-11#5)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#3)
mastoid fascial flap##4##3##(2009-1#4)
mastoid process##6##2##(2008-7#5)(2008-9#1)
mastoid##24##1##(1990-12#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#6)(2009-1#4)(2011-2#1)(2013-7#1)
mastoidectomy and##2##2##(2008-9#2)
mastoidectomy to##2##2##(2008-7#2)
mastoidectomy##12##1##(2008-7#7)(2008-9#5)
mastoiditis##2##1##(2008-9#2)
mastoparan (Mast)##2##2##(2008-10#2)
mastoparan and##2##2##(1991-5#1)(2008-10#1)
mastoparan##13##1##(1991-5#2)(1992-11#1)(1994-11#5)(1997-1#2)(2008-10#3)
mastoparan-induced inhibition of##2##3##(1997-1#2)
masturbation and##2##2##(2008-7#1)(2011-1#1)
masturbation##4##1##(2008-7#1)(2011-1#3)
mat properties##3##2##(2011-2#3)
mat##15##1##(1990-11#1)(2009-1#1)(2009-11#5)(2009-12#1)(2011-2#7)
mat1-2##3##1##(2008-10#3)
match between the##3##3##(1995-3#1)(2008-8#1)(2011-2#1)
match between##9##2##(1995-12#1)(1995-3#1)(2007-12#1)(2008-3#3)(2008-8#1)(2010-10#1)(2011-2#1)
match of the##4##3##(2007-11#2)(2008-3#1)(2008-9#1)
match the##29##2##(1991-3#1)(1991-5#1)(1992-9#1)(1994-2#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-3#4)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
match their##2##2##(1996-2#1)(2007-11#1)
match those determined for the##2##5##(1992-9#2)
match those of the##2##4##(2007-12#1)(2009-7#1)
match those of##4##3##(2007-12#1)(2008-5#1)(2009-7#2)
match those##6##2##(1992-9#2)(2007-12#1)(2008-5#1)(2009-7#2)
match to sample##3##3##(2008-11#1)(2013-8#2)
match to the##3##3##(1994-9#1)(1996-6#1)(1996-8#1)
match to##8##2##(1990-5#1)(1994-9#1)(1996-6#1)(1996-8#1)(2008-11#1)(2008-3#1)(2013-8#2)
match well##3##2##(2008-11#1)(2008-3#1)(2010-2#1)
match with the##4##3##(1990-2#1)(2008-10#1)(2012-2#2)
match with##6##2##(1990-2#1)(1993-11#1)(2008-10#1)(2012-2#2)(2013-8#1)
match##105##1##(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-9#3)(1993-11#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-7#1)(2007-11#5)(2007-12#5)(2007-7#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#9)
match-to-sample##4##1##(2011-2#4)
matched a##2##2##(2008-7#1)(2010-4#1)
matched an##2##2##(1994-12#2)
matched and##3##2##(2008-2#1)(2009-10#1)(2011-2#1)
matched at##2##2##(2007-11#1)(2008-5#1)
matched by age##2##3##(1991-6#1)(2013-1#1)
matched by##8##2##(1991-6#1)(1995-2#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
matched case-control study##4##3##(1992-6#2)(2012-2#1)(2013-1#1)
matched case-control##6##2##(1992-6#3)(2009-9#1)(2012-2#1)(2013-1#1)
matched control group##3##3##(2008-12#1)(2008-5#1)(2012-2#1)
matched control groups##2##3##(2011-2#2)
matched control##8##2##(1991-12#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-2#1)
matched controls for##2##3##(1997-5#1)(2011-2#1)
matched controls##20##2##(1991-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-1#2)
matched filter for##4##3##(2007-12#2)(2008-2#2)
matched filter##6##2##(2007-12#2)(2008-2#3)(2012-1#1)
matched filtering##3##2##(2007-12#2)(2008-2#1)
matched for age and##3##4##(1993-10#1)(2008-7#2)
matched for age##8##3##(1993-10#1)(1995-1#1)(1996-3#2)(2008-7#2)(2008-8#1)(2013-1#1)
matched for available##2##3##(2010-8#2)
matched for sex##2##3##(2008-1#1)(2008-3#1)
matched for##20##2##(1991-12#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-10#1)(1995-1#1)(1995-2#1)(1996-3#2)(2008-1#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-8#2)(2013-1#1)(2013-8#1)
matched in##3##2##(2007-12#1)(2008-3#2)
matched its text field##2##4##(2010-8#2)
matched normal##3##2##(1995-5#1)(2008-7#1)(2010-12#1)
matched pairs##2##2##(1992-12#1)(1992-8#1)
matched patients##2##2##(2007-8#1)(2013-1#1)
matched potential method##3##3##(2008-10#3)
matched study##2##2##(1994-12#1)(2007-7#1)
matched the##16##2##(1993-11#1)(1994-6#1)(1995-12#2)(1995-2#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-8#1)(2013-1#2)
matched those##2##2##(1996-10#1)(1996-12#1)
matched to a##2##3##(2008-2#1)(2008-6#1)
matched to the##9##3##(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)
matched to##18##2##(2007-11#2)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#1)
matched well##2##2##(2008-10#1)(2011-2#1)
matched with the##5##3##(2008-10#2)(2008-6#1)(2012-1#1)(2012-2#1)
matched with##18##2##(1990-7#1)(1993-1#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
matched##236##1##(1990-7#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#2)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#5)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-8#2)(1994-12#4)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-8#1)(2007-11#4)(2007-12#11)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#4)(2008-2#11)(2008-3#20)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#8)(2008-9#4)(2009-10#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#4)
matched-pair##2##1##(1993-12#1)(2008-10#1)
matches a##3##2##(2007-12#2)(2013-1#1)
matches in##3##2##(1995-11#1)(2008-10#2)
matches reported##2##2##(2008-3#1)(2011-2#1)
matches that of the##2##4##(2007-12#1)(2008-9#1)
matches that of##3##3##(1995-5#1)(2007-12#1)(2008-9#1)
matches the##17##2##(1994-12#1)(1996-6#2)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
matches to##2##2##(2008-10#1)(2008-8#1)
matches well with the##2##4##(2007-4#1)(2008-7#1)
matches well##3##2##(1996-5#1)(2007-4#1)(2008-7#1)
matches##45##1##(1994-12#1)(1995-11#1)(1995-5#2)(1996-5#1)(1996-6#2)(2007-11#2)(2007-12#6)(2007-4#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#1)
matching algorithm##2##2##(2008-6#1)(2012-2#1)
matching and##5##2##(2007-10#1)(2007-12#2)(2008-3#1)(2011-3#1)
matching between##2##2##(2008-2#1)(2008-4#1)
matching for##6##2##(1991-8#1)(2007-11#2)(2008-3#1)(2012-2#1)(2012-3#1)
matching in a##4##3##(2007-11#1)(2007-12#3)
matching in##10##2##(2007-11#4)(2007-12#5)(2008-3#1)
matching is##5##2##(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
matching layer was##2##3##(2009-5#2)
matching of local##2##3##(2008-3#1)(2008-6#1)
matching of the##5##3##(1995-6#1)(2007-11#1)(2008-2#1)(2008-3#2)
matching of##14##2##(1992-11#1)(1994-2#1)(1995-6#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)
matching procedures##2##2##(1991-8#1)(2008-12#1)
matching resistance genes in the differential hosts is proposed##2##9##(2008-10#2)
matching resistance##4##2##(2008-10#2)(2010-8#2)
matching technique##2##2##(2007-10#1)(2008-3#1)
matching the##6##2##(1990-5#1)(2008-2#2)(2008-3#2)(2013-8#1)
matching to sample##3##3##(1995-5#2)(2011-2#1)
matching to##6##2##(1995-5#2)(2007-12#1)(2008-3#2)(2011-2#1)
matching with the##3##3##(2007-12#1)(2008-3#1)(2009-2#1)
matching with##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-2#1)
matching##152##1##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-1#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#2)(1997-7#1)(2007-10#2)(2007-11#23)(2007-12#25)(2008-1#1)(2008-10#12)(2008-12#3)(2008-2#9)(2008-3#18)(2008-4#3)(2008-5#1)(2008-6#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
matching-law##2##1##(2011-2#2)
matching-to-sample##2##1##(1993-12#1)(2011-2#1)
matchup##2##1##(2008-3#2)
mate and##3##2##(2008-8#1)(2008-9#1)(2009-9#1)
mate choice and##2##3##(2008-9#2)
mate choice in birds##2##4##(2008-8#2)
mate choice in##5##3##(2008-8#4)(2008-9#1)
mate choice is##2##3##(2009-6#1)(2013-1#1)
mate choice##27##2##(2008-8#5)(2008-9#11)(2009-5#1)(2009-6#7)(2012-3#1)(2013-1#2)
mate preference##2##2##(2008-9#2)
mate preferences for##2##3##(2008-9#2)
mate preferences of##2##3##(2008-8#1)(2008-9#1)
mate preferences##5##2##(2008-8#1)(2008-9#4)
mate recognition in##3##3##(2008-8#1)(2008-9#1)(2009-5#1)
mate recognition system##4##3##(2008-8#1)(2008-9#3)
mate recognition systems##3##3##(2008-8#2)(2008-9#1)
mate recognition##13##2##(2008-8#6)(2008-9#6)(2009-5#1)
mate search strategies##2##3##(2008-8#2)
mate search##6##2##(2008-8#6)
mate searching is##2##3##(2008-8#2)
mate searching##3##2##(2008-8#3)
mate to##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
mate with##2##2##(2008-8#1)(2011-2#1)
mate##83##1##(1995-6#1)(2007-12#2)(2008-10#1)(2008-8#30)(2008-9#27)(2009-5#4)(2009-6#9)(2009-9#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
mate-finding strategies##2##2##(1990-8#2)
mate-finding##3##1##(1990-8#3)
mate-locating##2##1##(2008-6#2)
mate-search efficiency##2##2##(2008-8#2)
mated and##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
mated females##3##2##(2007-12#2)(2008-7#1)
mated to##2##2##(2008-10#1)(2008-5#1)
mated with##4##2##(1997-2#1)(2008-10#1)(2008-6#1)(2012-12#1)
mated##17##1##(1992-3#2)(1997-2#1)(2007-12#2)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)
material (GBW##4##2##(2008-10#4)
material absorption##3##2##(2008-3#1)(2008-5#2)
material and a##5##3##(1990-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
material and an##2##3##(2008-10#1)(2008-5#1)
material and its##5##3##(2008-10#3)(2008-2#1)(2010-10#1)
material and of##2##3##(2008-10#1)(2008-5#1)
material and the##8##3##(1995-2#1)(2007-12#2)(2008-10#3)(2008-3#1)(2009-8#1)
material and##74##2##(1990-8#1)(1995-11#1)(1995-2#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#30)(2008-11#4)(2008-2#4)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-3#1)(2013-1#1)(2013-7#1)
material are##6##2##(1994-11#1)(2008-2#2)(2008-3#2)(2008-5#1)
material as a##3##3##(2008-3#1)(2009-11#1)(2009-7#1)
material as##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-7#1)(2013-1#1)
material at##5##2##(2008-10#2)(2008-3#2)(2012-12#1)
material based on##2##3##(2007-11#1)(2008-10#1)
material because##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
material by the##2##3##(1991-2#1)(2008-10#1)
material by##13##2##(1991-2#1)(1992-6#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)
material can be##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
material can##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
material characteristics##2##2##(2007-12#2)
material coated on a##2##4##(2008-3#2)
material coated##3##2##(2008-3#2)(2012-3#1)
material collected##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
material composition##4##2##(2008-2#2)(2008-3#1)(2012-2#1)
material consisted of##4##3##(2007-11#2)(2007-8#2)
material consisting of##4##3##(1990-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
material constants##3##2##(2008-2#1)(2008-3#1)(2009-4#1)
material containing##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2009-7#1)
material deposited##4##2##(1994-2#1)(1995-12#1)(1997-5#1)(2008-10#1)
material did not##2##3##(1990-2#1)(2008-12#1)
material did##3##2##(1990-2#1)(2008-12#1)(2012-12#1)
material dispersion in the##2##4##(2007-11#1)(2008-3#1)
material dispersion##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
material exhibits##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)
material flow##4##2##(1997-6#1)(2008-11#2)(2008-3#1)
material for a##2##3##(2008-9#1)(2009-12#1)
material for an##2##3##(2008-10#1)(2011-2#1)
material for fabrication of##2##4##(2008-10#1)(2008-11#1)
material for holographic##2##3##(2008-3#2)
material for the##17##3##(1995-6#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
material for use in##2##4##(2007-11#1)(2008-10#1)
material for##78##2##(1990-12#1)(1995-6#1)(1997-3#1)(2007-11#4)(2008-1#1)(2008-10#27)(2008-11#6)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#2)
material found in##2##3##(2008-10#1)(2013-1#1)
material frequently##2##2##(2008-10#2)
material from the##8##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)
material from##24##2##(1990-7#1)(1991-9#1)(1992-3#1)(1994-2#1)(1997-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-6#1)(2013-8#1)
material has been##7##3##(1990-9#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-4#1)(2013-1#1)
material has##9##2##(1990-9#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2013-1#1)
material have been##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
material have##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)(2011-1#1)
material identified##2##2##(2008-10#1)(2010-3#1)
material in a##5##3##(2008-10#3)(2008-3#1)(2009-12#1)
material in different##2##3##(1990-9#1)(2010-5#1)
material in the cytoplasm##2##4##(1992-2#1)(2008-10#1)
material in the tissues##2##4##(2008-10#1)(2008-7#1)
material in the##16##3##(1992-2#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-7#3)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)
material in##36##2##(1990-9#2)(1992-2#1)(1994-5#2)(1995-12#1)(1995-8#1)(2007-8#1)(2008-10#12)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2013-1#1)
material includes##2##2##(2010-5#1)(2013-1#1)
material into the##4##3##(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
material into##8##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
material is described##3##3##(2007-11#1)(2008-10#2)
material is essential##2##3##(2008-9#1)(2009-2#1)
material is obtained##2##3##(2008-10#1)(2008-2#1)
material is used for##2##4##(2007-12#1)(2008-3#1)
material is used##3##3##(2007-12#1)(2008-3#1)(2009-10#1)
material is##47##2##(1990-3#1)(1991-1#1)(1991-12#1)(1994-5#2)(1995-3#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#4)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-11#1)(2010-4#1)(2012-12#1)
material may##2##2##(1990-12#1)(2008-10#1)
material model##4##2##(2009-6#1)(2009-7#3)
material of a##2##3##(2008-10#2)
material of choice##3##3##(2006-12#1)(2010-10#1)(2011-3#1)
material of high##2##3##(2008-2#1)(2008-3#1)
material of the##4##3##(2007-11#2)(2010-8#2)
material of##33##2##(1991-11#1)(1994-3#1)(1995-6#1)(2006-12#1)(2007-11#3)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
material on the##2##3##(2008-10#1)(2008-5#1)
material on##7##2##(1996-4#1)(2008-10#2)(2008-5#1)(2008-9#2)(2011-2#1)
material onto##2##2##(2008-10#1)(2008-3#1)
material or##4##2##(1996-11#1)(1996-12#2)(2009-3#1)
material parameters##7##2##(2008-3#4)(2009-4#1)(2009-7#1)(2013-1#1)
material presented##3##2##(2007-12#1)(2008-8#1)(2011-1#1)
material processing is##2##3##(2008-3#2)
material processing##4##2##(2007-11#1)(2008-3#3)
material properties of##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
material properties##14##2##(2007-11#2)(2008-10#2)(2008-3#3)(2008-7#1)(2009-11#1)(2009-7#2)(2011-1#1)(2012-1#1)(2013-1#1)
material recovered##2##2##(2008-10#2)
material removal##5##2##(2007-11#1)(2008-3#4)
material removed##3##2##(2008-10#2)(2008-3#1)
material resembling##2##2##(1990-5#1)(2008-7#1)
material resources##4##2##(2008-11#1)(2008-9#1)(2010-11#1)(2011-1#1)
material science##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
material should##2##2##(2007-10#1)(2007-12#1)
material showed##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
material strongly##2##2##(2008-10#2)
material surfaces##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2010-10#1)
material system for broadband##2##4##(2007-12#2)
material system##7##2##(2007-11#1)(2007-12#4)(2008-2#1)(2010-7#1)
material systems##2##2##(2009-5#1)(2012-2#1)
material that is##4##3##(1993-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
material that##19##2##(1993-1#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)
material to be##3##3##(2007-12#1)(2010-11#1)(2011-1#1)
material to##18##2##(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#3)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#2)
material used##2##2##(2008-7#1)(2012-3#1)
material was also##2##3##(2008-10#2)
material was deposited##2##3##(2007-11#1)(2008-7#1)
material was expressed from##2##4##(2007-7#1)(2012-3#1)
material was found to##3##4##(2008-10#2)(2008-3#1)
material was not##2##3##(2008-10#1)(2010-3#1)
material was processed##2##3##(1996-12#1)(2013-1#1)
material was recovered##2##3##(2008-10#1)(2011-2#1)
material was##51##2##(1996-12#1)(1997-3#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#22)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#1)
material were analyzed##2##3##(2008-10#2)
material were investigated##2##3##(2008-2#1)(2008-3#1)
material were##12##2##(1990-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#3)
material which##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
material will##2##2##(2008-9#1)(2010-5#1)
material with a##5##3##(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-7#1)
material with##20##2##(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2009-7#3)(2010-6#1)(2011-2#1)(2012-2#1)
material within the##3##3##(1992-2#1)(2010-6#1)(2011-2#1)
material within##5##2##(1992-2#1)(2008-10#2)(2010-6#1)(2011-2#1)
material without##2##2##(1994-5#1)(2008-3#1)
material would##2##2##(1995-12#1)(2008-7#1)
material##1204##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#7)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#3)(2006-12#1)(2007-10#3)(2007-11#50)(2007-12#58)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#15)(2008-1#9)(2008-10#378)(2008-11#41)(2008-12#11)(2008-2#55)(2008-3#109)(2008-4#6)(2008-5#40)(2008-6#7)(2008-7#42)(2008-8#6)(2008-9#22)(2009-10#2)(2009-11#12)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#24)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#6)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#6)(2011-1#13)(2011-2#28)(2011-3#2)(2012-1#6)(2012-12#9)(2012-2#22)(2012-3#9)(2013-1#30)(2013-7#7)(2013-8#10)
material's##7##1##(2008-10#1)(2008-2#1)(2008-3#3)(2010-10#1)(2012-8#1)
material)##3##1##(2008-10#3)
material-dependent##4##1##(1996-12#1)(2007-12#1)(2008-2#1)(2013-1#1)
material]##7##1##(1994-2#1)(1995-2#1)(1996-9#1)(2010-10#4)
materially##5##1##(1992-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
materials after##2##2##(2008-10#1)(2009-7#1)
materials analysis##2##2##(2008-10#1)(2008-3#1)
materials and devices##2##3##(1995-3#1)(2007-11#1)
materials and procedures##2##3##(2008-4#1)(2008-9#1)
materials and structures##2##3##(2010-10#2)
materials and techniques in##2##4##(2007-12#1)(2009-3#1)
materials and techniques##4##3##(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#1)
materials and the##7##3##(2008-10#4)(2008-2#1)(2008-7#1)(2012-3#1)
materials and##85##2##(1990-2#1)(1991-12#1)(1992-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#6)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
materials are available for##2##4##(2008-10#1)(2012-8#1)
materials are available##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2012-8#1)
materials are discussed##3##3##(2008-10#3)
materials are presented##2##3##(2007-11#1)(2008-2#1)
materials are used##2##3##(2007-12#1)(2008-10#1)
materials are##34##2##(1995-3#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-8#1)(2013-8#1)
materials as well as##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
materials as##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
materials at##6##2##(2008-10#1)(2008-3#3)(2010-7#1)(2013-8#1)
materials based on##3##3##(1996-12#1)(2008-2#1)(2008-5#1)
materials by direct##2##3##(2008-10#1)(2008-3#1)
materials by electrothermal atomic absorption spectrometry (ETAAS)##2##7##(2008-10#2)
materials by electrothermal atomic absorption spectrometry##4##6##(2008-10#4)
materials by use of##3##4##(2007-12#2)(2008-3#1)
materials by using##3##3##(2008-10#3)
materials by##32##2##(1990-8#1)(1991-7#1)(1997-3#1)(2007-12#2)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#4)(2010-5#1)(2012-3#1)
materials can be##7##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-9#1)
materials can##8##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2010-9#1)
materials containing##3##2##(1990-8#1)(1991-12#1)(2008-10#1)
materials derived from##3##3##(2008-2#1)(2008-6#1)(2008-8#1)
materials design##3##2##(2008-10#1)(2009-8#1)(2010-10#1)
materials during##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
materials exhibited##2##2##(1995-3#1)(2009-5#1)
materials for the##9##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-3#1)
materials for##40##2##(1993-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#4)
materials from the##3##3##(1997-2#1)(2008-10#2)
materials from##7##2##(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)
materials has been##3##3##(2008-10#3)
materials has##6##2##(2008-10#4)(2008-3#1)(2012-3#1)
materials have also been##2##4##(2008-2#1)(2010-8#1)
materials have been##5##3##(2008-10#1)(2008-5#1)(2009-11#1)(2009-5#1)(2012-2#1)
materials have##11##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
materials in a##3##3##(2008-3#1)(2009-12#1)(2010-12#1)
materials in the##6##3##(1990-9#1)(1991-12#1)(1992-6#1)(2007-12#1)(2008-10#1)(2009-7#1)
materials in which##2##3##(2006-4#1)(2008-3#1)
materials in##34##2##(1990-9#1)(1991-12#2)(1992-6#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-10#7)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
materials include##2##2##(1997-3#1)(2009-7#1)
materials into##6##2##(2008-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-5#1)
materials is a##2##3##(2008-10#1)(2008-5#1)
materials is described##2##3##(2008-10#2)
materials is the##2##3##(2008-11#1)(2010-10#1)
materials is##17##2##(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)
materials like##2##2##(2008-3#1)(2008-6#1)
materials obtained##2##2##(1990-8#1)(2008-10#1)
materials of##27##2##(1992-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)
materials often##3##2##(2006-4#1)(2008-5#1)(2012-2#1)
materials on the##4##3##(2008-10#2)(2008-3#1)(2010-4#1)
materials on##8##2##(2008-10#5)(2008-3#1)(2008-5#1)(2010-4#1)
materials or##2##2##(2008-6#1)(2012-1#1)
materials over##2##2##(1996-4#1)(2012-12#1)
materials presented##2##2##(2013-1#2)
materials processing##2##2##(2007-11#1)(2008-3#1)
materials produced##2##2##(2008-3#1)(2013-1#1)
materials ranged from##2##3##(2008-10#2)
materials released##2##2##(2008-5#2)
materials requires##2##2##(2008-9#1)(2009-12#1)
materials science##9##2##(1997-4#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#1)(2012-2#1)
materials selection##2##2##(2008-10#1)(2010-7#1)
materials should be##2##3##(2008-3#1)(2011-2#1)
materials should##3##2##(1994-3#1)(2008-3#1)(2011-2#1)
materials showed##2##2##(2008-10#1)(2013-1#1)
materials studied##2##2##(2008-10#2)
materials such as##13##3##(2007-11#3)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2010-6#1)(2012-2#2)
materials tested##2##2##(2008-10#1)(2008-12#1)
materials testing machine##2##3##(2007-8#1)(2008-9#1)
materials that are##2##3##(2008-10#1)(2008-11#1)
materials that can##5##3##(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)
materials that have##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-10#1)
materials that##23##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#2)(2010-10#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
materials through##3##2##(1990-2#1)(2009-10#1)(2013-1#1)
materials to##11##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
materials under##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
materials upon##2##2##(2007-11#1)(2012-1#1)
materials used for##4##3##(1990-5#1)(2008-10#2)(2013-1#1)
materials used in the##4##4##(2008-10#3)(2011-2#1)
materials used in##9##3##(2008-10#5)(2008-2#1)(2010-3#1)(2011-2#2)
materials used##17##2##(1990-5#1)(2008-10#8)(2008-2#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#1)
materials using##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
materials was good in##2##4##(2013-1#1)(2013-8#1)
materials was##10##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
materials were analysed##2##3##(2008-10#1)(2013-1#1)
materials were analyzed##3##3##(2008-10#2)(2013-1#1)
materials were prepared by##2##4##(2009-7#1)(2010-4#1)
materials were synthesized by##2##4##(2008-10#2)
materials were used##2##3##(2007-8#1)(2008-7#1)
materials were##40##2##(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#2)(2010-5#1)(2013-1#2)(2013-8#1)
materials which##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
materials will##2##2##(2008-10#1)(2008-3#1)
materials with a##2##3##(2008-3#2)
materials with different##3##3##(2008-3#1)(2008-5#1)(2012-1#1)
materials with satisfactory results##2##4##(2008-10#2)
materials with##35##2##(1996-12#2)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#7)(2008-5#3)(2008-8#1)(2009-7#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-3#1)(2012-1#1)(2012-2#1)
materials##1070##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#4)(1990-9#1)(1991-1#4)(1991-12#8)(1991-3#2)(1991-7#2)(1991-9#1)(1992-1#2)(1992-2#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#6)(1994-9#1)(1995-12#1)(1995-3#8)(1995-6#2)(1996-1#1)(1996-12#13)(1996-2#3)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#1)(2006-4#5)(2007-10#1)(2007-11#31)(2007-12#39)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#380)(2008-11#22)(2008-12#11)(2008-2#36)(2008-3#94)(2008-4#6)(2008-5#35)(2008-6#11)(2008-7#39)(2008-8#8)(2008-9#15)(2009-10#3)(2009-11#5)(2009-12#7)(2009-3#2)(2009-5#8)(2009-7#16)(2009-8#4)(2009-9#3)(2010-10#14)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#5)(2010-4#23)(2010-5#8)(2010-6#1)(2010-7#8)(2010-8#6)(2010-9#3)(2011-1#3)(2011-2#19)(2011-3#2)(2012-1#4)(2012-12#3)(2012-2#19)(2012-3#9)(2012-6#1)(2012-7#1)(2012-8#2)(2013-1#28)(2013-7#2)(2013-8#11)
materials'##2##1##(2008-10#1)(2010-7#1)
materials) or##2##2##(2008-12#1)(2010-7#1)
materials)##8##1##(1997-2#1)(2008-10#4)(2008-12#1)(2010-3#1)(2010-7#1)
materials]##2##1##(1990-9#1)(2013-1#1)
materiel management can##2##3##(1991-12#2)
materiel management##4##2##(1991-12#2)(1992-1#2)
materiel managers##2##2##(1994-1#2)
materiel##6##1##(1991-12#2)(1992-1#2)(1994-1#2)
maternal acculturation##6##2##(2009-7#6)
maternal age and##4##3##(1995-6#1)(1996-12#2)(2009-12#1)
maternal age at##2##3##(2012-12#1)(2013-1#1)
maternal age##21##2##(1992-2#1)(1993-10#1)(1995-6#1)(1996-12#2)(1997-3#6)(2008-1#1)(2008-10#1)(2009-12#3)(2010-6#1)(2012-12#1)(2012-3#2)(2013-1#1)
maternal and child health services##2##5##(1996-12#1)(2009-7#1)
maternal and child health##7##4##(1991-3#1)(1994-3#1)(1995-12#1)(1996-12#2)(1997-2#1)(2009-7#1)
maternal and fetal##3##3##(1990-12#2)(2008-10#1)
maternal and foetal outcome##2##4##(2010-11#1)(2011-1#1)
maternal and foetal##4##3##(2007-2#1)(2008-7#1)(2010-11#1)(2011-1#1)
maternal and infant##2##3##(2009-11#1)(2010-5#1)
maternal and neonatal##4##3##(2010-12#1)(2010-5#1)(2012-3#2)
maternal and paternal warmth were##2##5##(2009-11#2)
maternal and paternal##4##3##(2008-12#1)(2008-9#1)(2009-11#2)
maternal and perinatal morbidity and mortality##2##6##(1991-6#1)(2013-1#1)
maternal and perinatal##3##3##(1991-6#1)(2013-1#1)(2013-8#1)
maternal and##34##2##(1990-12#3)(1991-3#1)(1991-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-11#3)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#3)(2011-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
maternal antibodies##2##2##(1992-2#1)(2011-2#1)
maternal behavior##6##2##(1990-12#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
maternal behaviors##3##2##(2008-8#1)(2009-11#2)
maternal blood##9##2##(1992-5#1)(1996-12#6)(1996-3#1)(2011-2#1)
maternal body##2##2##(2008-8#1)(2010-6#1)
maternal care##2##2##(2008-8#2)
maternal cocaine use##2##3##(1992-12#2)
maternal cocaine##3##2##(1992-12#2)(2010-11#1)
maternal complications##2##2##(1996-3#1)(2013-1#1)
maternal control at T1##2##4##(2009-10#2)
maternal control at##3##3##(2009-10#3)
maternal cradling##3##2##(2007-12#3)
maternal death##4##2##(1992-5#1)(2010-12#2)(2013-1#1)
maternal deaths##5##2##(1994-3#1)(1996-8#1)(2008-11#2)(2008-7#1)
maternal deprivation##2##2##(2008-4#1)(2010-6#1)
maternal diabetes##5##2##(1996-11#3)(2007-12#1)(2012-3#1)
maternal diet##2##2##(1991-12#1)(1996-8#1)
maternal drug##2##2##(2008-7#1)(2012-3#1)
maternal effect##4##2##(1991-5#1)(2008-10#2)(2008-5#1)
maternal effects on##2##3##(2008-8#2)
maternal effects##6##2##(1997-7#1)(2008-10#2)(2008-8#3)
maternal emotion socialization##2##3##(2012-12#2)
maternal emotion##3##2##(2012-12#3)
maternal experience with##2##3##(2011-2#2)
maternal factors##2##2##(1993-3#1)(2008-11#1)
maternal fitness##2##2##(2008-9#2)
maternal glucose##2##2##(2008-1#2)
maternal health care##2##3##(1994-3#1)(2013-8#1)
maternal health in Nepal##2##4##(2008-7#2)
maternal health in##4##3##(1994-3#1)(2008-7#2)(2010-5#1)
maternal health services##2##3##(1994-3#1)(2012-2#1)
maternal health##15##2##(1994-3#4)(2008-7#3)(2010-12#1)(2010-5#2)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
maternal illness##2##2##(2013-1#2)
maternal infection##2##2##(1990-9#2)
maternal involvement##3##2##(1996-2#3)
maternal labor supply##2##3##(2009-10#2)
maternal lines##4##2##(2008-10#4)
maternal mRNA##5##2##(1993-6#1)(2007-12#3)(2012-2#1)
maternal mRNAs##3##2##(1993-6#2)(2007-12#1)
maternal morbidity##4##2##(1992-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
maternal mortality##16##2##(1994-3#3)(1995-12#1)(1996-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#2)(2011-1#3)(2012-12#1)(2012-2#1)
maternal or paternal effects##2##4##(2008-9#1)(2011-2#1)
maternal or##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
maternal perception of##2##3##(1993-3#2)
maternal performance##3##2##(2008-8#3)
maternal phenotype##2##2##(2008-8#2)
maternal plasma PC##2##3##(1995-8#2)
maternal plasma##5##2##(1990-12#2)(1995-8#2)(2010-11#1)
maternal responsivity##2##2##(2009-10#2)
maternal seed size##5##3##(2008-9#5)
maternal selection##3##2##(2008-8#3)
maternal self-esteem##2##2##(1993-3#2)
maternal serum alpha-fetoprotein##2##3##(1990-9#1)(2011-2#1)
maternal serum##10##2##(1990-9#1)(1992-9#1)(1995-8#4)(1996-12#3)(2011-2#1)
maternal size##2##2##(2008-8#2)
maternal smoking##3##2##(1992-11#1)(2008-1#1)(2010-6#1)
maternal stress##3##2##(2008-2#3)
maternal thyroid##2##2##(2008-4#2)
maternal toxicity##6##2##(2011-2#6)
maternal vitamin##2##2##(1996-3#1)(2012-2#1)
maternal warmth##2##2##(2009-11#1)(2009-9#1)
maternal weight##2##2##(1996-12#1)(1997-7#1)
maternal##373##1##(1990-11#2)(1990-12#7)(1990-8#1)(1990-9#5)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-4#1)(1992-5#4)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#5)(1993-6#4)(1994-11#2)(1994-3#12)(1994-6#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#9)(1996-11#4)(1996-12#17)(1996-2#3)(1996-3#3)(1996-5#1)(1996-8#3)(1997-2#1)(1997-3#6)(1997-6#1)(1997-7#5)(2006-10#1)(2007-12#11)(2007-2#3)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#5)(2008-2#3)(2008-4#4)(2008-5#4)(2008-7#9)(2008-8#25)(2008-9#13)(2009-10#8)(2009-11#7)(2009-12#4)(2009-4#1)(2009-7#12)(2009-9#6)(2010-11#5)(2010-12#6)(2010-3#3)(2010-4#2)(2010-5#8)(2010-6#7)(2010-8#6)(2011-1#12)(2011-2#18)(2012-12#10)(2012-2#5)(2012-3#13)(2013-1#16)(2013-8#2)
maternal-child health program##2##3##(1993-3#2)
maternal-child##3##1##(1993-3#2)(1997-4#1)
maternal-fetal##4##1##(1995-12#1)(2007-2#1)(2008-1#1)(2013-1#1)
maternally and paternally silenced##2##4##(2008-7#2)
maternally derived deletions##3##3##(1997-3#3)
maternally derived##5##2##(1991-3#1)(1997-3#4)
maternally inherited##6##2##(1993-1#1)(1995-8#1)(2007-10#1)(2008-9#1)(2012-3#1)(2013-8#1)
maternally transmitted##4##2##(1993-1#2)(2008-9#1)(2012-3#1)
maternally##19##1##(1991-3#1)(1993-1#3)(1995-8#1)(1997-3#4)(2007-10#1)(2008-7#4)(2008-9#2)(2012-3#2)(2013-8#1)
maternally-derived##3##1##(1997-3#1)(2008-5#2)
maternel##3##1##(2011-2#1)(2013-1#2)
maternities##2##1##(2009-10#1)(2012-3#1)
maternity care##13##2##(1994-1#1)(1994-3#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
maternity hospital##2##2##(2011-2#1)(2013-1#1)
maternity in##2##2##(2008-9#1)(2011-1#1)
maternity patients##2##2##(2007-12#2)
maternity services##3##2##(1994-12#2)(2008-11#1)
maternity units##2##2##(1990-9#1)(1996-11#1)
maternity##35##1##(1990-9#1)(1992-4#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-12#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-1#2)(2011-2#3)(2012-3#6)(2013-1#5)(2013-8#1)
mates and##3##2##(2008-8#2)(2013-1#1)
mates##25##1##(1991-6#1)(1995-12#1)(2008-8#16)(2008-9#4)(2009-2#1)(2012-3#1)(2013-1#1)
math and##4##2##(2008-12#1)(2009-7#3)
math##8##1##(2008-12#1)(2009-7#3)(2009-9#1)(2010-3#2)(2012-2#1)
mathematic##2##1##(2008-12#2)
mathematical analysis is##3##3##(2008-3#3)
mathematical analysis##6##2##(2008-3#6)
mathematical and statistical##4##3##(2008-4#1)(2008-9#1)(2009-5#1)(2013-8#1)
mathematical and##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-8#1)
mathematical arguments##2##2##(2008-3#2)
mathematical background##2##2##(2008-10#1)(2008-7#1)
mathematical derivation##2##2##(2008-3#2)
mathematical description of##2##3##(2008-2#1)(2010-10#1)
mathematical description##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
mathematical formalism##2##2##(2008-1#1)(2011-2#1)
mathematical formulation##2##2##(2008-3#1)(2008-6#1)
mathematical framework##3##2##(1990-8#1)(1992-9#1)(2008-3#1)
mathematical method##2##2##(2008-2#1)(2009-5#1)
mathematical model for analyzing##2##4##(2007-12#1)(2009-11#1)
mathematical model for##6##3##(2007-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2013-7#1)(2013-8#1)
mathematical model incorporating##2##3##(2008-10#1)(2008-9#1)
mathematical model is##9##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)
mathematical model of the fringe patterns##2##6##(2008-3#2)
mathematical model of the##8##4##(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
mathematical model of##25##3##(1991-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
mathematical model to describe the##2##5##(1991-11#1)(1992-9#1)
mathematical model to##10##3##(1991-11#1)(1992-9#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-2#1)(2013-7#1)
mathematical model was developed##2##4##(2008-10#2)
mathematical model was##8##3##(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-8#2)
mathematical model which##4##3##(1991-2#1)(2008-10#3)
mathematical model##96##2##(1991-11#1)(1991-2#2)(1992-2#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#4)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#17)(2008-8#1)(2008-9#6)(2009-11#2)(2009-8#1)(2010-5#1)(2011-2#2)(2011-3#3)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#5)
mathematical modeling framework that##2##4##(2008-7#2)
mathematical modeling of##2##3##(2008-11#1)(2009-9#1)
mathematical modeling##9##2##(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
mathematical modelling##2##2##(2008-6#1)(2013-8#1)
mathematical models are##2##3##(2008-7#1)(2013-8#1)
mathematical models of##11##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-10#2)
mathematical models which##2##3##(2009-8#1)(2012-2#1)
mathematical models##24##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#2)(2010-5#1)(2012-2#1)(2013-8#3)
mathematical morphology##2##2##(2008-3#2)
mathematical processing##2##2##(2007-10#1)(2007-12#1)
mathematical results in##2##3##(2008-11#2)
mathematical results##3##2##(2008-11#3)
mathematical separation##2##2##(2008-2#1)(2008-3#1)
mathematical simulation of##2##3##(1996-12#1)(2008-10#1)
mathematical simulation##3##2##(1995-6#1)(1996-12#1)(2008-10#1)
mathematical techniques##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
mathematical test##2##2##(2008-11#2)
mathematical theory##2##2##(1990-8#1)(2008-10#1)
mathematical treatment##3##2##(2008-10#3)
mathematical treatments##2##2##(2008-10#2)
mathematical##247##1##(1990-8#2)(1991-11#1)(1991-2#2)(1992-2#1)(1992-9#2)(1994-5#2)(1994-8#1)(1995-3#1)(1995-6#2)(1996-12#3)(1997-1#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-5#1)(2008-1#3)(2008-10#47)(2008-11#15)(2008-12#5)(2008-2#10)(2008-3#37)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#24)(2008-8#2)(2008-9#12)(2009-11#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-5#3)(2011-2#5)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-7#2)(2013-8#12)
mathematically##23##1##(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-2#1)
mathematicians and##2##2##(2009-6#1)(2013-8#1)
mathematicians##4##1##(1990-8#1)(2009-5#1)(2009-6#1)(2013-8#1)
mathematics##10##1##(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-11#1)(2010-1#1)(2012-1#1)(2013-8#1)
matieres premieres##2##2##(2008-5#2)
mating advantage##2##2##(2008-8#2)
mating and##10##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#3)(2008-9#1)(2013-1#1)
mating behavior in##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
mating behavior of##3##3##(2008-12#2)(2008-5#1)
mating behavior##9##2##(1991-8#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#1)
mating behaviors##4##2##(2008-6#2)(2008-9#1)(2011-2#1)
mating but##2##2##(2008-10#1)(2008-9#1)
mating can##3##2##(2008-8#3)
mating decisions##3##2##(2008-8#2)(2008-9#1)
mating in##5##2##(2008-10#1)(2008-5#2)(2008-8#2)
mating inhibition##2##2##(2008-10#2)
mating is##3##2##(2008-8#2)(2008-9#1)
mating or teliospore germination##2##4##(2008-10#2)
mating or##4##2##(2008-10#4)
mating partners##4##2##(1990-11#2)(2008-8#2)
mating performance##3##2##(2011-2#2)(2012-12#1)
mating pheromone##5##2##(1991-5#3)(1994-12#2)
mating pheromones##2##2##(1990-11#1)(2008-10#1)
mating population##2##2##(2008-10#2)
mating preferences##3##2##(2008-8#1)(2009-6#2)
mating propensity##3##2##(2011-2#3)
mating response##2##2##(1996-2#2)
mating signal##2##2##(2009-9#2)
mating strategies##3##2##(2008-8#2)(2012-12#1)
mating structures##3##2##(2007-12#3)
mating success in##2##3##(2008-9#2)
mating success##12##2##(2008-8#3)(2008-9#7)(2012-3#2)
mating system in##4##3##(2008-10#1)(2008-9#3)
mating system of##3##3##(2008-9#3)
mating system##12##2##(2008-10#1)(2008-8#1)(2008-9#9)(2009-6#1)
mating systems##5##2##(1996-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
mating to##2##2##(2008-8#1)(2008-9#1)
mating type and##6##3##(2008-10#6)
mating type frequencies##2##3##(2008-10#2)
mating type isolate to produce oospores##2##6##(2008-10#2)
mating type isolates##2##3##(2008-10#2)
mating type locus##3##3##(2008-10#3)
mating type of the##2##4##(2008-10#2)
mating type of##3##3##(2008-10#3)
mating type that are highly fertile##2##6##(2008-10#2)
mating type was##2##3##(2008-10#2)
mating type were##4##3##(2008-10#4)
mating type##64##2##(2008-10#63)(2008-2#1)
mating types in##3##3##(2008-10#3)
mating types occurred##2##3##(2008-10#2)
mating types of##3##3##(2008-10#3)
mating types were found##2##4##(2008-10#2)
mating types were##5##3##(2008-10#5)
mating types##22##2##(2008-10#22)
mating with multiple##2##3##(2008-8#2)
mating with several males##2##4##(2008-8#2)
mating with##7##2##(2008-10#1)(2008-8#5)(2012-12#1)
mating##295##1##(1990-11#3)(1991-5#3)(1991-8#1)(1993-3#1)(1994-12#5)(1995-12#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-4#2)(2007-12#3)(2008-10#125)(2008-11#5)(2008-12#5)(2008-2#3)(2008-4#1)(2008-5#9)(2008-6#2)(2008-8#52)(2008-9#39)(2009-6#4)(2009-9#2)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#3)
mating-type##4##1##(2008-10#3)(2012-3#1)
matings between##4##2##(2008-10#2)(2008-9#1)(2009-9#1)
matings of##2##2##(1995-2#1)(2008-10#1)
matings##12##1##(1995-2#1)(2008-10#3)(2008-8#1)(2008-9#5)(2009-9#1)(2013-1#1)
matric potential##11##2##(2008-10#11)
matric potentials of -7 x 10(3)##2##6##(2008-10#2)
matric potentials##6##2##(2008-10#6)
matric##19##1##(2008-10#17)(2008-7#2)
matricellular protein that##2##3##(2008-1#2)
matrices (e##2##2##(2008-10#1)(2008-4#1)
matrices (i##2##2##(2008-10#1)(2012-12#1)
matrices and the##2##3##(2010-11#1)(2010-6#1)
matrices and##16##2##(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-2#1)
matrices are presented##2##3##(2007-12#1)(2008-3#1)
matrices are##10##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)
matrices as##3##2##(2008-10#2)(2009-4#1)
matrices at##2##2##(2008-10#1)(2008-3#1)
matrices by##10##2##(2008-10#9)(2008-5#1)
matrices compared##2##2##(2008-10#2)
matrices containing##5##2##(1995-5#1)(2008-10#4)
matrices could##2##2##(2008-10#2)
matrices for##11##2##(1996-5#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2010-11#1)
matrices in the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
matrices into##2##2##(2008-10#1)(2011-2#1)
matrices is presented##2##3##(2008-10#1)(2008-2#1)
matrices is##5##2##(1990-2#2)(2008-10#2)(2008-2#1)
matrices like##3##2##(2008-10#2)(2008-11#1)
matrices of biological tissue##2##4##(2008-3#2)
matrices of biological##3##3##(2008-3#2)(2011-1#1)
matrices of##14##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-8#1)(2011-1#1)(2012-2#1)
matrices on##3##2##(2008-10#2)(2008-2#1)
matrices such as##6##3##(2008-10#6)
matrices such##7##2##(2008-10#6)(2008-3#1)
matrices thus##2##2##(1995-12#1)(2008-10#1)
matrices to##3##2##(2008-2#1)(2008-7#1)(2009-11#1)
matrices using cyanex-923 extractant##2##4##(2008-10#2)
matrices using##6##2##(2008-10#5)(2010-11#1)
matrices was investigated##2##3##(2007-11#1)(2008-10#1)
matrices was##9##2##(1994-6#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-5#1)
matrices were##11##2##(2008-10#7)(2008-3#1)(2008-7#2)(2009-11#1)
matrices with##9##2##(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2012-2#1)
matrices without##2##2##(2008-10#2)
matrices##324##1##(1990-2#3)(1994-11#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#2)(2007-11#5)(2007-12#8)(2007-5#1)(2008-1#2)(2008-10#155)(2008-11#12)(2008-2#14)(2008-3#35)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#8)(2009-11#2)(2009-4#3)(2010-10#1)(2010-11#9)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#9)(2013-7#2)
matrices)##2##1##(2008-10#1)(2008-7#1)
matrigel##10##1##(1992-9#2)(1993-3#1)(2008-11#5)(2008-7#1)(2013-1#1)
matrigel-coated dishes##2##2##(2008-11#2)
matrine##9##1##(2008-10#8)(2012-3#1)
matrix (MA)##2##2##(2009-7#1)(2013-1#1)
matrix M##2##2##(2007-12#1)(2008-3#1)
matrix O##2##2##(2008-3#2)
matrix analysis##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#2)
matrix and a##2##3##(1996-12#1)(2008-10#1)
matrix and causes##2##3##(2007-12#1)(2009-6#1)
matrix and its##2##3##(2008-8#1)(2009-10#1)
matrix and the##12##3##(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-6#1)(2013-7#1)
matrix and##61##2##(1990-8#1)(1995-8#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#2)(2013-7#1)
matrix anions##2##2##(2008-10#2)
matrix approach##3##2##(1993-11#1)(1995-1#1)(2008-3#1)
matrix approximation method##3##3##(2008-3#3)
matrix are##8##2##(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)
matrix as a##3##3##(1997-3#1)(2008-10#2)
matrix assembly##6##2##(1993-9#1)(2008-1#4)(2008-8#1)
matrix at the##3##3##(1991-12#1)(2008-5#2)
matrix attached##2##2##(1990-5#1)(1994-5#1)
matrix attachment region##2##3##(2008-8#2)
matrix attachment##3##2##(2008-8#3)
matrix by##9##2##(1990-12#1)(2007-12#1)(2008-10#5)(2008-3#2)
matrix can be##6##3##(1993-11#1)(2008-10#2)(2008-2#1)(2012-12#1)(2013-8#1)
matrix can##11##2##(1993-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-8#2)(2008-9#1)(2012-12#1)(2013-8#1)
matrix component##2##2##(2008-1#2)
matrix components##10##2##(1993-11#1)(2008-10#3)(2008-5#2)(2008-7#2)(2010-9#1)(2011-1#1)
matrix composite##3##2##(1997-4#1)(2009-7#2)
matrix composition##2##2##(2008-10#2)
matrix considering##2##2##(2008-10#2)
matrix constituents##4##2##(2008-10#4)
matrix containing##2##2##(2008-10#2)
matrix culture##2##2##(2008-10#2)
matrix data##2##2##(2008-10#2)
matrix degradation##6##2##(1993-3#1)(2008-5#2)(2012-12#1)(2012-2#2)
matrix deposition##4##2##(2008-1#1)(2008-9#1)(2009-12#1)(2009-7#1)
matrix effect observed##2##3##(2008-10#2)
matrix effect##19##2##(2008-10#13)(2010-11#5)(2013-8#1)
matrix effects and##2##3##(2008-10#2)
matrix effects are##5##3##(2008-10#5)
matrix effects for##4##3##(2008-10#4)
matrix effects in the##2##4##(2008-10#2)
matrix effects were also##2##4##(2008-10#2)
matrix effects were##5##3##(1997-2#1)(2008-10#4)
matrix effects##32##2##(1997-2#2)(2008-10#30)
matrix element##2##2##(1995-2#1)(2008-3#1)
matrix elements are##3##3##(2008-3#2)(2010-7#1)
matrix elements for##3##3##(2008-2#1)(2008-3#1)(2010-7#1)
matrix elements of##6##3##(2008-3#4)(2010-7#2)
matrix elements were##2##3##(2008-10#2)
matrix elements##34##2##(2008-10#15)(2008-2#6)(2008-3#8)(2008-5#1)(2010-7#4)
matrix elimination##3##2##(2008-10#3)
matrix factorization##3##2##(2008-10#3)
matrix fluorescence##3##2##(2008-10#3)
matrix for a##4##3##(2008-3#3)(2008-5#1)
matrix for each##2##3##(2008-3#2)
matrix for highly scattering media##2##5##(2008-3#2)
matrix for the##7##3##(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)
matrix for##32##2##(1992-6#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-2#7)(2008-3#9)(2008-5#2)(2009-12#1)
matrix formalism##2##2##(2008-2#1)(2008-3#1)
matrix from##2##2##(2008-2#1)(2008-3#1)
matrix further##2##2##(2008-10#1)(2008-7#1)
matrix habitat##2##2##(2008-8#2)
matrix has been##2##3##(2008-10#2)
matrix has##4##2##(2008-10#4)
matrix hemorrhage##3##2##(2011-2#3)
matrix in a##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
matrix in its##2##3##(1997-1#1)(2008-8#1)
matrix in the form of##2##5##(1994-5#1)(2008-10#1)
matrix in the percentage ratio##2##5##(2008-10#2)
matrix in the##7##3##(1994-5#1)(2008-10#4)(2011-2#1)(2012-1#1)
matrix in which##2##3##(2008-5#2)
matrix in##30##2##(1991-5#1)(1993-6#1)(1994-5#1)(1997-1#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-5#6)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
matrix increased##2##2##(2008-5#1)(2009-7#1)
matrix influence##3##2##(2008-10#3)
matrix information##2##2##(2008-10#1)(2008-4#1)
matrix interference and##2##3##(2008-10#2)
matrix interference effect on the##2##5##(2008-10#2)
matrix interference##15##2##(2008-10#14)(2009-8#1)
matrix interferences can be eliminated because of the different retention times of the derivatives##2##14##(2008-11#2)
matrix interferences in##3##3##(2008-10#3)
matrix interferences##19##2##(2008-10#17)(2008-11#2)
matrix inversion of##2##3##(2008-2#2)
matrix inversion##8##2##(2008-2#5)(2008-3#3)
matrix ionized calcium##2##3##(1990-2#2)
matrix is a##2##3##(1993-9#1)(2008-3#1)
matrix is an##3##3##(2008-8#2)(2008-9#1)
matrix is described##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
matrix is discussed##2##3##(2007-12#1)(2008-12#1)
matrix is##35##2##(1993-9#1)(2007-11#1)(2007-12#3)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2012-12#1)
matrix isopotential synchronous##2##3##(2008-10#2)
matrix macromolecules and##2##3##(2007-8#1)(2012-3#1)
matrix made of##2##3##(2008-10#1)(2008-5#1)
matrix management##3##2##(1994-3#1)(1995-1#1)(2012-2#1)
matrix matched##4##2##(2008-10#4)
matrix matching##4##2##(2008-10#4)
matrix material##2##2##(2010-5#1)(2010-6#1)
matrix materials##2##2##(2008-10#2)
matrix may##4##2##(1997-3#1)(2008-10#1)(2008-8#2)
matrix membrane sensor##2##3##(2008-10#2)
matrix membrane sensors for##2##4##(2008-10#2)
matrix membrane sensors##3##3##(2008-10#3)
matrix membrane##7##2##(2008-10#7)
matrix metallopeptidases (MMPs)##2##3##(2008-4#2)
matrix metalloproteinase (MMP)##2##3##(2008-5#1)(2011-2#1)
matrix metalloproteinase activity##2##3##(2011-2#2)
matrix metalloproteinase##15##2##(1994-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#2)
matrix metalloproteinase-1##2##2##(1994-3#2)
matrix metalloproteinase-2 (MMP-2)##2##3##(2008-9#1)(2009-3#1)
matrix metalloproteinase-2##8##2##(1997-2#1)(2008-9#1)(2009-3#1)(2013-1#3)(2013-7#2)
matrix metalloproteinases (MMPs)##4##3##(2008-11#2)(2008-4#2)
matrix metalloproteinases and##4##3##(2008-1#1)(2008-9#1)(2009-3#1)(2013-1#1)
matrix metalloproteinases##20##2##(1993-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#4)(2009-3#1)(2009-5#3)(2013-1#1)
matrix method for##2##3##(2007-11#1)(2008-3#1)
matrix method is##2##3##(2007-12#1)(2008-3#1)
matrix method##6##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-6#1)
matrix model##2##2##(2008-2#1)(2008-9#1)
matrix modification##5##2##(1991-12#2)(2008-10#3)
matrix modifiers##4##2##(2008-10#4)
matrix molecules##2##2##(2008-11#1)(2008-9#1)
matrix of pairwise##2##3##(2008-4#1)(2008-5#1)
matrix of the##11##3##(1992-6#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)
matrix of##49##2##(1991-9#1)(1992-6#2)(1996-8#2)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#1)(2011-1#2)(2013-7#1)(2013-8#1)
matrix on the##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
matrix on##6##2##(1994-8#1)(2008-10#2)(2008-11#2)(2008-3#1)
matrix or##3##2##(2008-10#2)(2008-2#1)
matrix polarimetry##2##2##(2008-3#2)
matrix present##2##2##(2009-7#1)(2010-3#1)
matrix production##2##2##(2008-1#1)(2010-3#1)
matrix protein##5##2##(1990-2#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
matrix proteins are##2##3##(2010-11#1)(2012-1#1)
matrix proteins##18##2##(1994-12#2)(1995-9#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-12#1)(2010-11#4)(2012-1#2)(2012-12#2)
matrix quality can##2##3##(2008-8#2)
matrix quality##5##2##(2008-8#3)(2012-2#2)
matrix remodeling##2##2##(1994-11#1)(2013-8#1)
matrix resulted in a##2##4##(2008-10#2)
matrix samples##4##2##(2008-10#4)
matrix separation##6##2##(2008-10#6)
matrix showed##2##2##(2008-10#2)
matrix size##2##2##(1997-8#1)(2008-3#1)
matrix solid phase dispersion##3##4##(2008-10#3)
matrix solution##2##2##(2008-10#1)(2010-5#1)
matrix spectroscopy##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
matrix spiking and recovery analyses##4##5##(2008-10#4)
matrix structure##3##2##(1993-8#1)(1994-12#1)(2008-1#1)
matrix synthesis##2##2##(2009-11#1)(2010-12#1)
matrix systems##2##2##(2008-10#1)(2008-7#1)
matrix than##3##2##(1992-9#1)(2009-6#1)(2013-7#1)
matrix that##6##2##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)
matrix through##2##2##(2008-10#2)
matrix to the##3##3##(2008-10#2)(2008-3#1)
matrix to##11##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#1)
matrix used##2##2##(2007-12#1)(2008-10#1)
matrix using##4##2##(1992-11#1)(2008-10#2)(2008-5#1)
matrix was analyzed by##2##4##(2008-10#2)
matrix was developed##2##3##(2008-10#1)(2010-7#1)
matrix was nearly##2##3##(2008-10#2)
matrix was used for sensor##2##5##(2008-10#2)
matrix was used for##4##4##(2008-10#4)
matrix was used to##3##4##(2007-5#1)(2008-10#1)(2008-12#1)
matrix was used##8##3##(2007-5#1)(2008-10#6)(2008-12#1)
matrix was##43##2##(1990-7#1)(2007-5#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)
matrix were##10##2##(2007-12#1)(2008-10#7)(2011-2#1)(2012-1#1)
matrix whose elements##2##3##(2007-12#1)(2008-2#1)
matrix with a##2##3##(2008-10#2)
matrix with the##3##3##(2008-10#2)(2008-3#1)
matrix with##14##2##(1993-5#1)(2008-10#9)(2008-2#1)(2008-3#2)(2009-4#1)
matrix##1239##1##(1990-12#3)(1990-2#6)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#5)(1991-11#1)(1991-12#3)(1991-5#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#7)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#6)(1997-4#3)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#23)(2007-12#29)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#17)(2008-10#474)(2008-11#33)(2008-12#3)(2008-2#55)(2008-3#104)(2008-4#25)(2008-5#57)(2008-6#4)(2008-7#22)(2008-8#38)(2008-9#24)(2009-10#4)(2009-11#5)(2009-12#9)(2009-3#6)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#13)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#11)(2010-12#2)(2010-3#2)(2010-4#5)(2010-5#10)(2010-6#3)(2010-7#6)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#18)(2012-1#15)(2012-12#13)(2012-2#13)(2012-3#8)(2012-4#1)(2012-6#1)(2013-1#16)(2013-7#9)(2013-8#8)
matrix) as##2##2##(1992-9#1)(2008-5#1)
matrix)##9##1##(1992-9#2)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)
matrix-assisted laser desorption ionization time-of-flight mass spectrometry##3##7##(2008-10#1)(2012-3#2)
matrix-assisted laser desorption/ionization (MALDI)##3##4##(2008-11#1)(2010-5#1)(2010-7#1)
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)##2##5##(2008-11#1)(2008-9#1)
matrix-assisted laser desorption/ionization time-of-flight##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
matrix-assisted laser desorption/ionization##9##3##(2008-10#1)(2008-11#4)(2008-9#1)(2010-5#2)(2010-7#1)
matrix-assisted laser##13##2##(2008-10#3)(2008-11#4)(2008-9#1)(2010-5#2)(2010-7#1)(2012-3#2)
matrix-assisted##14##1##(2008-10#3)(2008-11#5)(2008-9#1)(2010-5#2)(2010-7#1)(2012-3#2)
matrix-based##2##1##(2008-7#1)(2012-2#1)
matrix-free standards##2##2##(1991-12#1)(2008-10#1)
matrix-matched##3##1##(2008-10#2)(2010-11#1)
matrix-matching procedure##2##2##(2008-10#2)
matrix-matching##3##1##(2008-1#1)(2008-10#2)
matrix-rich##4##1##(2010-12#2)(2010-4#2)
matrix-type##3##1##(1994-6#3)
matrixes of##2##2##(2008-10#2)
matrixes##13##1##(2008-10#12)(2008-5#1)
mats were##3##2##(2008-10#1)(2011-2#2)
mats##12##1##(1990-11#2)(2008-10#3)(2009-11#1)(2011-2#6)
matter and the##3##3##(2008-3#1)(2010-7#1)(2013-8#1)
matter and##24##2##(1991-12#1)(1993-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-10#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
matter are##6##2##(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#2)
matter by##8##2##(2006-4#1)(2008-10#4)(2008-11#2)(2008-3#1)
matter collected on##3##3##(2008-10#3)
matter collected##5##2##(2008-10#5)
matter content in##2##3##(2008-10#1)(2008-5#1)
matter content##8##2##(2008-10#7)(2008-5#1)
matter contents##2##2##(2008-10#2)
matter for##2##2##(1997-7#1)(2008-10#1)
matter from##3##2##(1990-7#1)(2008-10#1)(2013-8#1)
matter how##7##2##(1994-12#1)(2008-10#1)(2008-7#4)(2010-10#1)
matter if##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
matter in the##5##3##(1991-12#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-1#1)
matter in##10##2##(1991-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2011-1#1)(2012-1#1)
matter intake##2##2##(2008-12#1)(2012-2#1)
matter is##10##2##(1992-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-8#1)
matter of fact##4##3##(1996-7#1)(2007-8#1)(2008-7#1)(2013-1#1)
matter of the##7##3##(1995-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#2)
matter of##51##2##(1990-8#1)(1991-3#1)(1993-12#1)(1995-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-5#2)(1997-6#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#3)(2010-11#1)(2010-12#2)(2011-1#3)(2012-2#1)(2013-1#4)(2013-8#1)
matter on the##2##3##(2008-10#1)(2008-4#1)
matter on##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
matter or##3##2##(2007-12#2)(2008-3#1)
matter such as##2##3##(2008-10#1)(2010-12#1)
matter that##3##2##(2008-1#1)(2010-12#1)(2012-3#1)
matter to the##2##3##(2008-10#2)
matter to##8##2##(1995-12#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#1)
matter under##2##2##(2008-9#1)(2009-7#1)
matter was##9##2##(1996-5#1)(2008-10#7)(2008-5#1)
matter were##6##2##(1990-7#1)(1996-11#1)(2008-10#2)(2008-5#1)(2008-6#1)
matter whether##2##2##(1997-6#1)(2007-2#1)
matter which##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
matter with##7##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
matter##394##1##(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#2)(1993-12#4)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-5#4)(1995-6#1)(1995-8#7)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#1)(2006-4#1)(2007-10#3)(2007-12#4)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#118)(2008-11#24)(2008-12#13)(2008-2#7)(2008-3#17)(2008-4#2)(2008-5#16)(2008-6#7)(2008-7#12)(2008-8#2)(2008-9#8)(2009-10#2)(2009-12#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#9)
matter's##2##1##(1990-9#1)(2008-12#1)
matter)##4##1##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
matter?##7##1##(2008-11#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
matters for##2##2##(2011-2#1)(2012-12#1)
matters in the##2##3##(1992-8#1)(2008-10#1)
matters of##5##2##(1991-2#1)(1996-6#1)(2007-6#1)(2008-6#1)(2008-7#1)
matters to##3##2##(1996-12#1)(2008-7#1)(2013-8#1)
matters##43##1##(1990-6#1)(1991-2#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
maturase##2##1##(1995-6#2)
maturation and differentiation of the##2##5##(1991-7#1)(2010-11#1)
maturation and differentiation of##4##4##(1991-7#1)(2010-11#3)
maturation and the##2##3##(2008-10#1)(2008-9#1)
maturation and was##2##3##(2009-8#1)(2013-1#1)
maturation and##38##2##(1990-8#1)(1990-9#1)(1991-7#1)(1992-12#1)(1994-8#1)(1996-3#1)(1997-6#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#3)(2011-1#2)(2011-3#1)(2011-7#1)(2012-3#1)(2013-1#3)(2013-7#2)
maturation in the##3##3##(1993-12#1)(2008-5#1)(2008-8#1)
maturation in vitro##2##3##(2008-9#1)(2012-2#1)
maturation in##17##2##(1992-11#2)(1993-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#3)
maturation is##3##2##(2008-5#1)(2008-8#1)(2012-2#1)
maturation of CEs##4##3##(2008-5#4)
maturation of Xenopus oocytes##3##4##(1991-12#3)
maturation of adipose tissue with##2##5##(2008-11#2)
maturation of the spinal##2##4##(1992-12#2)
maturation of the##11##3##(1992-12#3)(1993-6#1)(1995-11#1)(2008-10#1)(2008-5#2)(2011-2#2)(2012-2#1)
maturation of##53##2##(1991-12#3)(1992-12#4)(1993-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#7)(2008-8#1)(2009-6#2)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
maturation process##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
maturation processes##2##2##(2008-5#1)(2010-12#1)
maturation rate##6##2##(2007-7#1)(2008-10#1)(2008-9#2)(2012-2#1)(2013-1#1)
maturation stage##2##2##(2008-10#1)(2008-12#1)
maturation time##2##2##(2008-8#1)(2013-1#1)
maturation##223##1##(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#5)(1991-7#1)(1992-11#3)(1992-12#6)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-3#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#4)(1997-6#2)(2006-10#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-1#3)(2008-10#26)(2008-11#9)(2008-12#5)(2008-3#3)(2008-4#7)(2008-5#24)(2008-7#5)(2008-8#11)(2008-9#7)(2009-11#2)(2009-12#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#18)(2013-7#3)(2013-8#1)
maturational##3##1##(2008-9#2)(2013-8#1)
mature 17 kDa TNF##2##4##(1990-12#2)
mature 17 kDa##3##3##(1990-12#3)
mature AFP##3##2##(1994-9#3)
mature CEs##2##2##(2008-5#2)
mature DC##2##2##(2008-11#2)
mature DCs##3##2##(2011-2#3)
mature ET-1(1-21)##2##2##(1990-12#2)
mature adipocytes##10##2##(2008-11#2)(2008-3#1)(2008-5#2)(2010-6#1)(2011-2#2)(2012-4#1)(2013-1#1)
mature aged workers##2##3##(2011-1#2)
mature and##7##2##(1991-11#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-5#1)
mature animals##2##2##(2008-4#1)(2012-3#1)
mature apothecia##2##2##(2008-10#2)
mature ascospores##2##2##(2008-10#2)
mature berries##2##2##(2008-10#2)
mature beta-lactamase##2##2##(1990-11#1)(1992-3#1)
mature blood##3##2##(2008-11#2)(2008-4#1)
mature cell##2##2##(1992-3#1)(2010-11#1)
mature cells##3##2##(2008-7#2)(2010-8#1)
mature cystic teratoma (dermoid##2##4##(2013-8#2)
mature cystic teratoma##5##3##(2009-7#1)(2013-8#4)
mature dendritic cells##2##3##(2011-2#2)
mature dendritic##3##2##(2011-1#1)(2011-2#2)
mature eggs##2##2##(2008-9#2)
mature enterocytes##2##2##(1991-12#2)
mature enzyme##4##2##(1991-2#1)(1991-9#1)(1992-12#1)(2009-11#1)
mature erythrocytes##2##2##(2008-9#2)
mature follicles##3##2##(2008-4#1)(2008-5#2)
mature form of##6##3##(1990-11#1)(1990-7#1)(1993-2#1)(1994-6#1)(2008-4#2)
mature form##14##2##(1990-11#1)(1990-7#2)(1991-2#2)(1992-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-8#2)(1997-1#1)(2008-4#2)
mature forms##4##2##(1991-12#1)(1992-12#2)(1997-4#1)
mature fruit##6##2##(2008-10#6)
mature fruits##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
mature hematopoietic cells##2##3##(2008-9#1)(2010-8#1)
mature human##2##2##(1992-8#1)(2008-4#1)
mature into##3##2##(2008-11#1)(2008-4#1)(2009-8#1)
mature lamin A##2##3##(2011-2#2)
mature larvae##2##2##(2011-2#2)
mature leaves##4##2##(2008-10#1)(2008-5#1)(2008-9#2)
mature macrophages##2##2##(1990-5#1)(1991-6#1)
mature male##2##2##(2008-5#1)(2012-3#1)
mature market##2##2##(1994-1#1)(1994-3#1)
mature oocytes##2##2##(2008-5#1)(2012-3#1)
mature osteoclasts through the##2##4##(2008-11#2)
mature osteoclasts through##3##3##(2008-11#3)
mature osteoclasts##7##2##(2008-11#7)
mature pear##2##2##(2008-10#2)
mature peptide##4##2##(1991-6#1)(1992-12#1)(1992-8#1)(2008-8#1)
mature pollen##4##2##(2008-10#1)(2009-10#1)(2009-12#2)
mature polypeptide##3##2##(1996-10#2)(2009-7#1)
mature protective protein was detected##2##5##(1994-11#2)
mature protective protein##3##3##(1994-11#3)
mature protein contains##2##3##(1991-11#1)(1995-2#1)
mature protein of##2##3##(1990-5#1)(2008-10#1)
mature protein##22##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#5)(1993-2#1)(1993-9#1)(1994-11#3)(1995-2#1)(1995-8#1)(1996-10#2)(2008-10#1)
mature proteins##2##2##(1992-12#1)(2013-1#1)
mature pseudothecia##4##2##(2008-10#4)
mature rat##2##2##(1991-2#1)(1991-7#1)
mature specimens##2##2##(2008-12#1)(2010-3#1)
mature sperm##2##2##(2007-12#2)
mature spermatozoa of the##2##4##(2008-7#2)
mature spermatozoa##3##2##(2008-7#2)(2011-1#1)
mature teratoma##4##2##(2007-8#1)(2008-10#1)(2008-7#2)
mature##384##1##(1990-11#5)(1990-12#15)(1990-2#1)(1990-5#4)(1990-7#5)(1990-8#2)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#9)(1992-3#9)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#8)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#5)(1996-10#4)(1996-2#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-6#1)(2007-11#1)(2007-12#6)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#58)(2008-11#25)(2008-12#4)(2008-3#1)(2008-4#12)(2008-5#19)(2008-7#10)(2008-8#9)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#3)(2009-5#2)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#15)(2011-3#3)(2012-12#3)(2012-2#4)(2012-3#7)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#5)
matured and##2##2##(2008-10#1)(2008-11#1)
matured in##2##2##(2008-5#1)(2008-9#1)
matured on##2##2##(2008-10#2)
matured oocytes##2##2##(2008-9#1)(2013-1#1)
matured rapidly##2##2##(2008-10#1)(2008-11#1)
matured##22##1##(1993-12#1)(1995-6#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-5#2)(2008-9#2)(2010-8#1)(2013-1#2)
matures##2##1##(2008-3#1)(2008-7#1)
maturing and##4##2##(1993-12#1)(1994-5#1)(2008-8#1)(2013-1#1)
maturing##17##1##(1993-12#1)(1994-5#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#2)(2013-1#1)
maturity and then##2##3##(1991-12#1)(2008-5#1)
maturity and##15##2##(1991-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#4)
maturity in##4##2##(2007-12#1)(2008-10#2)(2012-3#1)
maturity of the##5##3##(1995-5#1)(2007-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
maturity of##11##2##(1995-5#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-10#2)(2011-1#1)
maturity was##2##2##(2008-5#1)(2013-7#1)
maturity##89##1##(1991-12#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#23)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#10)(2009-10#2)(2009-7#1)(2009-9#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#5)
max (L##5##2##(2011-2#5)
max at##2##2##(1993-8#1)(1995-5#1)
max##20##1##(1990-5#1)(1991-5#1)(1993-8#1)(1994-8#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-7#4)(2011-2#5)(2013-1#3)
max)##14##1##(1990-7#1)(1991-12#1)(2008-10#9)(2008-11#1)(2013-1#2)
maxi-anion channel##2##2##(2008-4#2)
maxilla and##4##2##(2007-12#2)(2008-12#1)(2008-5#1)
maxilla##34##1##(1996-3#1)(2007-12#7)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-12#2)(2013-1#9)(2013-7#1)
maxillary advancement##2##2##(2011-2#2)
maxillary and mandibular##2##3##(2009-8#1)(2012-3#1)
maxillary and##3##2##(2009-8#1)(2012-3#1)(2013-1#1)
maxillary antrum##2##2##(2007-7#1)(2008-6#1)
maxillary branches of the##2##4##(1990-12#1)(1993-12#1)
maxillary canine##2##2##(2013-1#2)
maxillary canines##3##2##(2013-1#3)
maxillary central incisor##2##3##(2013-1#2)
maxillary central incisors##3##3##(2009-8#2)(2010-11#1)
maxillary central##5##2##(2009-8#2)(2010-11#1)(2013-1#2)
maxillary first##3##2##(2013-1#3)
maxillary incisors##4##2##(2008-12#1)(2009-7#1)(2013-1#2)
maxillary lateral incisor with##2##4##(2012-12#2)
maxillary lateral incisors##2##3##(2012-12#2)
maxillary lateral##4##2##(2012-12#4)
maxillary left##2##2##(2008-12#1)(2008-7#1)
maxillary palp##2##2##(2007-12#2)
maxillary premolars##2##2##(2013-1#2)
maxillary retrusion##2##2##(2009-7#2)
maxillary right##2##2##(2008-12#1)(2013-1#1)
maxillary second molar with two##2##5##(2013-1#2)
maxillary second molar##3##3##(2013-1#3)
maxillary sensilla styloconica of##2##4##(2008-8#2)
maxillary sensilla styloconica##3##3##(2008-8#3)
maxillary sinus floor##2##3##(2008-11#1)(2013-1#1)
maxillary sinus in##2##3##(2008-5#1)(2013-7#1)
maxillary sinus that##2##3##(2008-2#1)(2008-3#1)
maxillary sinus##21##2##(1993-1#1)(2007-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#5)(2013-7#1)
maxillary sinuses##2##2##(2011-1#1)(2011-7#1)
maxillary##105##1##(1990-12#1)(1990-3#1)(1991-2#1)(1993-1#1)(1993-12#1)(2007-10#4)(2007-12#8)(2007-7#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-7#5)(2009-8#3)(2010-1#1)(2010-11#2)(2011-1#3)(2011-2#10)(2011-7#2)(2012-1#1)(2012-12#6)(2012-3#2)(2013-1#32)(2013-7#1)
maxillofacial surgery##19##2##(1993-1#4)(2007-12#6)(2008-7#4)(2009-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
maxillofacial##39##1##(1993-1#4)(2007-12#19)(2008-7#6)(2009-7#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
maxillomandibular fixation##4##2##(2007-12#2)(2013-1#2)
maxillomandibular##7##1##(2007-12#2)(2008-12#1)(2009-3#1)(2009-5#1)(2013-1#2)
maxima and Achatina achatina##2##4##(2008-12#2)
maxima and minima##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
maxima and##9##2##(1991-8#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-9#1)
maxima are##2##2##(1994-5#1)(2008-8#1)
maxima as##2##2##(1995-5#1)(2008-3#1)
maxima at 367 and##2##4##(1994-6#2)
maxima at 410 and##2##4##(2008-10#1)(2008-11#1)
maxima at##12##2##(1992-8#1)(1993-11#1)(1994-6#2)(1996-2#1)(2008-10#6)(2008-11#1)
maxima in the lag##2##4##(2008-11#2)
maxima in the##7##3##(1990-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)
maxima in##10##2##(1990-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2012-7#1)
maxima of the##5##3##(1995-5#1)(2008-10#3)(2010-8#1)
maxima of##7##2##(1995-5#1)(2008-10#4)(2010-8#1)(2011-2#1)
maxima ranging from##2##3##(2008-10#2)
maxima was only##2##3##(2007-6#1)(2008-10#1)
maxima was##3##2##(2007-6#1)(2008-10#1)(2008-12#1)
maxima were##2##2##(2008-10#1)(2008-5#1)
maxima##77##1##(1990-8#1)(1991-8#1)(1992-8#1)(1993-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-5#3)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#3)(2007-6#2)(2008-10#22)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#4)(2009-9#1)(2010-8#3)(2011-2#1)(2012-7#1)
maximal activities of##2##3##(1994-3#1)(2013-1#1)
maximal activity##4##2##(1992-12#1)(1994-5#1)(1995-11#1)(2013-1#1)
maximal after##2##2##(1997-5#1)(2007-7#1)
maximal at 2##2##3##(2007-10#2)
maximal at##8##2##(1991-12#1)(1994-12#1)(1994-8#1)(2007-10#2)(2008-10#1)(2008-8#1)(2013-8#1)
maximal benefit##2##2##(2010-11#1)(2012-1#1)
maximal binding##2##2##(1991-5#1)(1994-12#1)
maximal cell concentration##2##3##(2008-11#2)
maximal cell densities##2##3##(2008-11#1)(2008-7#1)
maximal cell density##2##3##(2008-11#2)
maximal cell##8##2##(1990-2#1)(2008-11#6)(2008-7#1)
maximal concentration##2##2##(2008-12#1)(2010-12#1)
maximal contraction =##2##3##(1995-12#2)
maximal contraction##4##2##(1995-12#3)(2008-3#1)
maximal detector response##2##3##(2008-10#2)
maximal doses of##2##3##(2007-9#1)(2012-3#1)
maximal effect at##2##3##(1992-8#1)(1993-8#1)
maximal effect of##2##3##(1994-6#1)(1997-1#1)
maximal effect##8##2##(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#2)(1997-1#1)(2008-4#1)
maximal electroshock##2##2##(1995-12#1)(2010-3#1)
maximal enzyme##3##2##(1993-8#1)(2008-4#1)(2013-1#1)
maximal exercise##2##2##(2008-3#2)
maximal expiratory flow##3##3##(2008-1#1)(2008-7#1)(2009-1#1)
maximal expiratory##5##2##(1997-2#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-1#1)
maximal expression##2##2##(1997-7#1)(2008-2#1)
maximal growth rate##2##3##(2008-6#1)(2011-1#1)
maximal growth##4##2##(2008-6#2)(2011-1#1)(2011-2#1)
maximal in the presence of##2##5##(1990-10#1)(1993-6#1)
maximal in the##3##3##(1990-10#1)(1993-6#1)(2008-9#1)
maximal in##6##2##(1990-10#1)(1992-3#1)(1993-6#1)(1997-1#1)(2008-7#1)(2008-9#1)
maximal increase##2##2##(1994-6#1)(2008-5#1)
maximal inhibition of##2##3##(1994-12#1)(2008-11#1)
maximal inhibitory##2##2##(1990-5#1)(2011-2#1)
maximal level at##3##3##(1993-6#1)(1994-11#1)(2008-10#1)
maximal level##9##2##(1991-9#1)(1993-6#3)(1994-11#2)(1997-7#1)(2008-10#1)(2008-9#1)
maximal levels at##2##3##(1994-11#1)(1996-2#1)
maximal levels during##2##3##(1994-6#1)(1995-8#1)
maximal levels##7##2##(1990-12#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)
maximal occlusion##3##2##(2013-1#3)
maximal oxygen uptake##2##3##(2013-1#1)(2013-8#1)
maximal oxygen##3##2##(2013-1#1)(2013-8#2)
maximal peak##2##2##(1990-6#1)(1995-8#1)
maximal pressure##2##2##(2008-8#1)(2013-1#1)
maximal rate of##2##3##(1992-9#1)(1993-6#1)
maximal recovery##2##2##(1994-12#2)
maximal response##5##2##(1995-12#1)(1995-6#2)(2008-3#1)(2008-8#1)
maximal stimulation##2##2##(1991-12#1)(2008-11#1)
maximal surgical resection##2##3##(2011-3#1)(2013-1#1)
maximal total##2##2##(1994-8#1)(2008-10#1)
maximal velocity##3##2##(1990-3#1)(1991-11#1)(1993-8#1)
maximal voluntary contraction##4##3##(2010-6#1)(2010-9#1)(2013-8#2)
maximal voluntary##5##2##(1993-9#1)(2010-6#1)(2010-9#1)(2013-8#2)
maximal when##3##2##(1991-5#1)(1993-11#1)(1994-2#1)
maximal##266##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-5#6)(1991-9#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#7)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#8)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#1)(1997-7#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#16)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#6)(2009-1#2)(2009-2#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#6)
maximally in the##2##3##(2008-3#1)(2012-12#1)
maximally tolerated##2##2##(2008-6#1)(2012-2#1)
maximally##26##1##(1990-5#3)(1991-12#1)(1991-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-2#2)(2013-1#1)
maximise the##5##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
maximise##12##1##(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
maximises##2##1##(1997-4#1)(2008-11#1)
maximization and##2##2##(1991-1#1)(2008-3#1)
maximization of the##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
maximization of##6##2##(2008-10#2)(2008-7#2)(2008-9#1)(2012-2#1)
maximization##14##1##(1991-1#2)(1994-12#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
maximize detection##2##2##(2008-4#1)(2010-8#1)
maximize performance##2##2##(1992-12#1)(1997-3#1)
maximize the beneficial##2##3##(2008-10#1)(2008-9#1)
maximize the chances##2##3##(2008-5#1)(2012-12#1)
maximize the number of##3##4##(2008-4#1)(2012-2#1)(2013-7#1)
maximize the optical##2##3##(2008-3#2)
maximize the use of limited##2##5##(2008-10#1)(2008-7#1)
maximize the use of##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
maximize the##40##2##(1992-12#1)(1993-12#1)(1994-3#1)(1995-1#1)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2010-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
maximize their##6##2##(1995-12#1)(1996-12#1)(2008-11#1)(2008-9#2)(2013-1#1)
maximize##100##1##(1992-12#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#3)(2006-10#1)(2007-12#6)(2007-5#2)(2008-1#1)(2008-10#8)(2008-11#8)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#12)(2010-10#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
maximized by##2##2##(2008-11#1)(2008-3#1)
maximized##25##1##(1992-8#1)(1994-11#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#2)
maximizers##2##1##(1995-2#2)
maximizes the##8##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)
maximizes##18##1##(1996-1#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#3)(2012-2#1)
maximizing the##16##2##(1991-12#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#3)(2010-3#1)(2012-2#1)
maximizing treatment##2##2##(2008-11#1)(2010-12#1)
maximizing##36##1##(1991-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#4)(2010-3#2)(2011-2#1)(2012-1#1)(2012-2#1)
maximum (1-RM)##2##2##(2008-5#2)
maximum 3 months##2##3##(1996-2#1)(2008-12#1)
maximum PI##2##2##(2011-2#2)
maximum absolute##3##2##(2008-3#1)(2008-8#2)
maximum absorbance at##7##3##(2008-10#7)
maximum absorbance for##2##3##(2008-10#2)
maximum absorbance##13##2##(2008-10#13)
maximum absorption wavelength##6##3##(2008-10#5)(2008-3#1)
maximum absorption##14##2##(2008-10#11)(2008-3#1)(2008-5#1)(2013-1#1)
maximum acceptable##2##2##(2008-9#1)(2010-3#1)
maximum accuracy of##2##3##(2008-3#1)(2009-10#1)
maximum accuracy##3##2##(2008-3#2)(2009-10#1)
maximum achievable##2##2##(2007-12#1)(2008-3#1)
maximum activity at##3##3##(1992-9#1)(2008-8#1)(2010-3#1)
maximum activity was##2##3##(1991-6#1)(2012-2#1)
maximum activity##8##2##(1991-6#1)(1991-9#1)(1992-9#1)(1994-8#1)(1997-2#1)(2008-8#1)(2010-3#1)(2012-2#1)
maximum adsorption capacity##3##3##(2008-10#2)(2013-8#1)
maximum adsorption##4##2##(2008-10#3)(2013-8#1)
maximum after##3##2##(1990-7#1)(2008-10#2)
maximum amount of##10##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-5#1)
maximum amount##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-5#1)
maximum and minimum##8##3##(2008-10#4)(2008-3#2)(2008-8#1)(2011-2#1)
maximum and the##3##3##(2008-2#2)(2008-3#1)
maximum and##14##2##(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-8#1)(2011-2#1)
maximum antibody##2##2##(2008-11#1)(2008-2#1)
maximum around##2##2##(2008-10#2)
maximum at 10##2##3##(1993-11#1)(2008-3#1)
maximum at 285 nm##2##4##(2008-10#2)
maximum at 30##2##3##(1995-2#1)(2008-9#1)
maximum at 330nm##2##3##(1994-6#1)(2008-10#1)
maximum at 580 nm##2##4##(2008-10#1)(2008-8#1)
maximum at a##2##3##(2007-12#1)(2008-3#1)
maximum at around pH##2##4##(2008-10#2)
maximum at pH##2##3##(1997-6#1)(2008-10#1)
maximum at##50##2##(1990-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-6#1)(1995-2#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#23)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#4)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
maximum average of##4##3##(1996-12#4)
maximum average##11##2##(1996-12#5)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
maximum axial##2##2##(2008-2#1)(2008-3#1)
maximum benefit from##4##3##(2008-11#1)(2008-7#1)(2012-1#1)(2012-12#1)
maximum benefit##5##2##(1992-12#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-12#1)
maximum binding of##2##3##(1994-6#1)(2008-10#1)
maximum binding##8##2##(1994-6#1)(1995-8#2)(2008-10#4)(2008-6#1)
maximum breaking load##2##3##(2008-9#2)
maximum cell density and##2##4##(2008-11#1)(2008-7#1)
maximum cell density##8##3##(1993-8#1)(2008-11#5)(2008-7#2)
maximum cell##12##2##(1993-8#1)(1994-2#1)(2008-11#8)(2008-7#2)
maximum change##2##2##(2008-4#1)(2008-6#1)
maximum colour##2##2##(2008-10#2)
maximum comfort##2##2##(2008-9#1)(2012-12#1)
maximum concentration of##5##3##(1992-3#1)(1993-8#1)(2008-11#1)(2010-5#1)(2012-2#1)
maximum concentration##10##2##(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-5#1)(2012-2#1)(2012-3#2)
maximum concentrations##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
maximum conversion efficiencies##2##3##(2008-2#1)(2008-3#1)
maximum conversion efficiency of##3##4##(2007-12#3)
maximum conversion efficiency##4##3##(2007-12#3)(2008-2#1)
maximum conversion##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2009-11#1)
maximum correlation##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
maximum cumulative##2##2##(2012-12#1)(2012-2#1)
maximum current##3##2##(2008-10#2)(2009-10#1)
maximum dephasing##2##2##(2008-3#2)
maximum diameter##4##2##(1993-9#1)(2008-12#1)(2011-2#1)(2013-1#1)
maximum difference##3##2##(1996-2#1)(2008-11#2)
maximum diffraction efficiency of##2##4##(2008-3#2)
maximum diffraction efficiency##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
maximum disease severity##2##3##(2008-10#2)
maximum disease##3##2##(2008-10#3)
maximum dislocation##2##2##(2008-11#2)
maximum distance##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
maximum dose##3##2##(2007-10#1)(2008-10#1)(2012-2#1)
maximum drain flow##2##3##(2011-2#2)
maximum effect##3##2##(1992-3#1)(1995-5#1)(2008-10#1)
maximum effectiveness##2##2##(1994-3#1)(2013-1#1)
maximum efficiency##2##2##(2008-10#1)(2008-2#1)
maximum emission wavelength##2##3##(2008-10#2)
maximum emission##3##2##(2008-10#3)
maximum energy##2##2##(2007-12#2)
maximum enzyme production##2##3##(1994-3#1)(2012-2#1)
maximum error##2##2##(2008-10#1)(2008-3#1)
maximum excitation and emission wavelengths##5##5##(2008-10#5)
maximum excitation##6##2##(2008-10#6)
maximum expression of##2##3##(1990-5#1)(2008-11#1)
maximum flow##2##2##(2007-12#1)(2008-8#1)
maximum fluorescence intensity##2##3##(2008-10#1)(2008-3#1)
maximum fluorescence##5##2##(1995-5#1)(2008-10#2)(2008-3#1)(2013-8#1)
maximum for##4##2##(1992-10#1)(1992-12#1)(2008-10#1)(2008-7#1)
maximum force##3##2##(1995-12#1)(2007-8#1)(2008-11#1)
maximum fresh##2##2##(1996-12#1)(2009-6#1)
maximum gain was##2##3##(2007-11#2)
maximum gain##3##2##(2007-11#2)(2008-2#1)
maximum glucose##3##2##(1991-12#1)(2008-11#1)(2010-2#1)
maximum growth rate of##2##4##(2008-11#1)(2008-8#1)
maximum growth rate##4##3##(2008-11#1)(2008-8#2)(2011-2#1)
maximum growth##5##2##(2008-11#1)(2008-8#3)(2011-2#1)
maximum imaging depth##2##3##(2008-3#1)(2011-1#1)
maximum in the##8##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-6#1)
maximum in##23##2##(1994-9#1)(1995-5#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-5#1)(2009-6#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-7#1)
maximum increase in##3##3##(1997-3#1)(2010-2#1)(2013-1#1)
maximum increase##5##2##(1991-8#1)(1993-8#1)(1997-3#1)(2010-2#1)(2013-1#1)
maximum infection##3##2##(2007-7#1)(2008-10#2)
maximum information##3##2##(2008-10#1)(2008-3#2)
maximum intensity##5##2##(2008-2#3)(2008-3#1)(2008-7#1)
maximum is##5##2##(1994-5#1)(2008-10#2)(2008-8#1)(2013-8#1)
maximum length##3##2##(1995-6#1)(1997-8#1)(2008-11#1)
maximum level##7##2##(1994-6#1)(1995-3#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
maximum levels at##2##3##(1995-11#1)(2008-10#1)
maximum levels of##3##3##(1993-8#1)(1996-12#1)(2009-6#1)
maximum levels##7##2##(1993-8#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-6#1)
maximum likelihood and##2##3##(2008-10#1)(2012-1#1)
maximum likelihood estimators##3##3##(1997-4#1)(2008-7#1)(2012-3#1)
maximum likelihood method for##2##4##(2008-6#1)(2012-3#1)
maximum likelihood method##4##3##(2008-10#2)(2008-6#1)(2012-3#1)
maximum likelihood methods##4##3##(1992-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
maximum likelihood##33##2##(1992-6#1)(1994-9#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2012-1#3)(2012-3#6)(2013-8#1)
maximum likelihood-based##2##2##(2008-10#1)(2008-6#1)
maximum loading##3##2##(2008-10#2)(2010-11#1)
maximum loads##2##2##(2010-10#1)(2013-1#1)
maximum luminance of##2##3##(2008-3#1)(2010-9#1)
maximum luminance##6##2##(2008-3#1)(2010-9#5)
maximum mass##2##2##(2008-10#2)
maximum number of##12##3##(1990-8#1)(2007-12#1)(2008-10#8)(2008-3#1)(2013-8#1)
maximum number##14##2##(1990-8#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-7#1)(2013-8#1)
maximum of 10##3##3##(1990-6#1)(1992-9#1)(1996-5#1)
maximum of 12##2##3##(2008-10#2)
maximum of 2##5##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
maximum of about##2##3##(1993-12#1)(2009-9#1)
maximum of the##9##3##(1991-12#1)(1992-8#1)(1995-5#1)(2008-10#4)(2008-2#1)(2008-3#1)
maximum of##56##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#2)(1994-5#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1996-7#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-7#2)
maximum on##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
maximum optical##2##2##(2008-2#1)(2008-3#1)
maximum or##2##2##(1997-3#1)(2008-3#1)
maximum output energy##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
maximum output power of##8##4##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)
maximum output power##10##3##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#3)
maximum output powers##2##3##(2007-11#1)(2008-2#1)
maximum output##18##2##(2007-11#5)(2007-12#6)(2008-2#4)(2008-3#3)
maximum oxygen uptake##5##3##(2008-7#2)(2013-8#3)
maximum parsimony##7##2##(1995-3#1)(2007-12#1)(2008-10#4)(2008-9#1)
maximum peak##2##2##(2008-10#2)
maximum per-plant yield loss##2##4##(2008-10#2)
maximum performance##5##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-9#2)
maximum permissible levels##2##3##(2008-10#2)
maximum permissible load weight##2##4##(2013-1#2)
maximum permissible load##3##3##(2013-1#3)
maximum permissible##7##2##(1993-3#1)(2008-10#3)(2013-1#3)
maximum phase##2##2##(2008-2#1)(2008-3#1)
maximum population##2##2##(2008-10#1)(2011-2#1)
maximum possible sensitivity##2##3##(2008-12#1)(2008-3#1)
maximum possible##6##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)
maximum power##5##2##(1992-9#1)(2008-3#3)(2012-2#1)
maximum pressure##2##2##(1994-2#1)(2013-1#1)
maximum probability##2##2##(2008-3#1)(2013-8#1)
maximum product##2##2##(2008-11#1)(2008-2#1)
maximum production##3##2##(1994-3#1)(2008-11#2)
maximum protection##3##2##(1992-9#1)(1993-11#1)(2011-2#1)
maximum protein##2##2##(2008-11#1)(2008-6#1)
maximum radius of##2##3##(2008-2#1)(2008-3#1)
maximum radius##3##2##(2008-2#1)(2008-3#2)
maximum range##2##2##(2007-8#1)(2008-3#1)
maximum rate of##4##3##(1990-7#1)(1994-3#1)(2008-8#2)
maximum rate##8##2##(1990-11#1)(1990-7#1)(1992-11#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-8#2)
maximum recovery of##2##3##(1994-12#1)(2008-12#1)
maximum recovery##4##2##(1994-12#1)(2008-10#1)(2008-12#2)
maximum reduction of##2##3##(2008-11#1)(2008-3#1)
maximum reduction##3##2##(1994-5#1)(2008-11#1)(2008-3#1)
maximum relative##2##2##(2008-10#1)(2008-2#1)
maximum residue level##2##3##(2008-10#2)
maximum residue limits##2##3##(2008-7#1)(2010-4#1)
maximum residue##4##2##(2008-10#2)(2008-7#1)(2010-4#1)
maximum response at##2##3##(2007-12#1)(2008-10#1)
maximum response##10##2##(1990-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#1)
maximum retention##2##2##(2008-10#2)
maximum reuse##3##2##(2008-1#3)
maximum scattering##2##2##(2008-10#2)
maximum score##3##2##(1990-10#1)(1991-2#1)(2008-10#1)
maximum sensitivity and##2##3##(2008-10#2)
maximum sensitivity##7##2##(2007-7#1)(2008-10#6)
maximum signal##4##2##(2008-10#2)(2008-3#2)
maximum size##2##2##(1990-7#1)(2008-3#1)
maximum sorption##3##2##(2008-10#3)
maximum specific growth rate##5##4##(2008-10#1)(2008-7#3)(2010-11#1)
maximum specific growth##6##3##(2008-10#1)(2008-7#4)(2010-11#1)
maximum specific##9##2##(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#4)(2010-11#1)
maximum speed of##2##3##(2009-5#1)(2010-3#1)
maximum speed##4##2##(1994-8#1)(2007-12#1)(2009-5#1)(2010-3#1)
maximum stability##5##2##(1993-11#1)(2008-10#4)
maximum strength##2##2##(2007-8#1)(2008-11#1)
maximum striga##7##2##(2008-10#7)
maximum substrate consumption##2##3##(2008-7#2)
maximum susceptibility##4##2##(2008-10#4)
maximum sustainable loading##2##3##(2008-7#2)
maximum temperature and##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
maximum temperature of##3##3##(2008-2#1)(2011-1#2)
maximum temperature was##3##3##(1995-6#1)(2011-1#2)
maximum temperature##21##2##(1995-6#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#6)(2012-3#1)(2013-8#1)
maximum tension##3##2##(1991-12#1)(2008-11#2)
maximum tetanic##2##2##(2008-3#1)(2013-8#1)
maximum theoretical efficiency##2##3##(1990-7#1)(2008-3#1)
maximum theoretical##4##2##(1990-7#1)(2007-11#1)(2008-3#2)
maximum thermal gradient##2##3##(2008-3#2)
maximum to##2##2##(1994-5#1)(2008-10#1)
maximum tolerable##2##2##(2008-10#2)
maximum total##2##2##(2008-11#1)(2013-1#1)
maximum value at a##2##4##(1997-2#1)(2008-10#1)
maximum value at##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2010-1#1)
maximum value##16##2##(1992-11#1)(1992-7#1)(1993-11#1)(1994-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-1#1)
maximum values##4##2##(2008-10#2)(2010-3#1)(2010-5#1)
maximum velocity##3##2##(1995-11#1)(2008-7#1)(2010-8#1)
maximum voluntary contraction##3##3##(2010-6#2)(2012-12#1)
maximum voluntary##4##2##(1993-12#1)(2010-6#2)(2012-12#1)
maximum was##4##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-7#1)
maximum wavelength of##2##3##(2008-10#2)
maximum when##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
maximum with##3##2##(1995-5#1)(2008-10#1)(2013-8#1)
maximum yield of##3##3##(2008-11#1)(2008-12#1)(2008-6#1)
maximum##1073##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#4)(1993-3#4)(1993-8#7)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#7)(1994-5#7)(1994-6#3)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#5)(1995-6#6)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#4)(2007-11#22)(2007-12#35)(2007-7#5)(2007-8#3)(2008-1#5)(2008-10#309)(2008-11#49)(2008-12#18)(2008-2#51)(2008-3#90)(2008-4#6)(2008-5#21)(2008-6#25)(2008-7#35)(2008-8#27)(2008-9#15)(2009-10#2)(2009-11#4)(2009-2#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#10)(2010-6#3)(2010-8#5)(2010-9#6)(2011-1#10)(2011-2#19)(2012-1#5)(2012-12#7)(2012-2#20)(2012-3#12)(2013-1#27)(2013-7#8)(2013-8#17)
maximum) and##2##2##(1994-12#1)(2010-8#1)
maximum)##6##1##(1994-12#2)(2008-10#2)(2010-8#2)
maximum-likelihood (ML)##3##2##(2007-12#1)(2008-3#1)(2010-8#1)
maximum-likelihood approach##3##2##(2008-2#2)(2008-3#1)
maximum-likelihood detection##2##2##(2008-3#2)
maximum-likelihood ratio test##2##3##(2007-12#2)
maximum-likelihood##17##1##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#6)(2010-2#1)(2010-3#1)(2010-8#1)
maximums##2##1##(2008-10#2)
maximus##4##1##(1990-5#1)(2008-10#1)(2008-5#1)(2009-3#1)
may accelerate##3##2##(1990-12#1)(2008-12#1)(2008-7#1)
may account for the##11##4##(1990-12#1)(1991-3#1)(1992-9#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-1#1)(2010-3#1)(2012-3#1)
may account for##28##3##(1990-12#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-1#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
may account##29##2##(1990-12#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
may achieve##3##2##(1990-8#1)(1994-2#1)(2008-12#1)
may act as a##16##4##(1990-5#1)(1992-2#1)(1994-10#1)(1994-11#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-3#1)(2013-8#1)
may act as an##2##4##(1990-2#1)(2008-11#1)
may act as transient##2##4##(1996-4#2)
may act as##34##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-10#1)(1992-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
may act at##2##3##(1990-11#1)(1992-2#1)
may act by##2##3##(1992-11#1)(1995-8#1)
may act in##3##3##(1994-11#1)(1996-9#1)(2009-10#1)
may act on##3##3##(1990-5#1)(2008-3#1)(2008-8#1)
may act through##2##3##(1995-12#1)(2009-2#1)
may act to##4##3##(1991-9#1)(1996-9#1)(2007-12#1)(2008-7#1)
may act##55##2##(1990-11#2)(1990-2#1)(1990-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1993-6#1)(1994-10#1)(1994-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-9#2)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
may activate##9##2##(1991-12#1)(1991-4#1)(1991-5#1)(1992-8#1)(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#2)
may actually reduce##2##3##(2010-3#1)(2011-3#1)
may actually##8##2##(1991-9#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-3#1)
may add to the##2##4##(2007-7#1)(2008-12#1)
may adversely affect the##3##4##(1996-11#1)(2008-4#1)(2008-7#1)
may adversely##5##2##(1996-11#1)(1997-2#1)(2008-4#1)(2008-7#1)(2010-4#1)
may affect the quality of##3##5##(2008-1#1)(2008-12#1)(2008-8#1)
may affect the##25##3##(1992-10#1)(1993-11#1)(1995-2#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#2)
may affect their##3##3##(1997-3#1)(2012-2#1)(2012-3#1)
may affect##62##2##(1990-11#1)(1990-3#1)(1991-11#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
may aid in the##2##4##(2008-11#1)(2010-9#1)
may aid in##4##3##(2007-5#1)(2008-10#1)(2008-11#1)(2010-9#1)
may aid##5##2##(2007-5#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-7#1)
may all##3##2##(2008-10#2)(2009-10#1)
may alleviate##2##2##(2008-10#1)(2012-12#1)
may allow a##2##3##(2008-1#1)(2008-9#1)
may allow for a##2##4##(2008-8#1)(2008-9#1)
may allow for##3##3##(2007-11#1)(2008-8#1)(2008-9#1)
may allow one to##3##4##(1996-4#1)(1997-2#1)(2009-8#1)
may allow some##2##3##(1991-1#1)(2008-9#1)
may allow the use of##2##5##(2008-10#1)(2008-3#1)
may allow the##6##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-3#1)
may allow us to##2##4##(2008-10#2)
may allow##34##2##(1991-1#1)(1992-6#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#2)(2013-8#1)
may already be##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
may already##5##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
may also aid##2##3##(1993-11#1)(2008-11#1)
may also assist in##4##4##(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
may also be a##6##4##(1991-8#1)(1994-2#1)(2008-11#1)(2008-8#2)(2013-7#1)
may also be applied##2##4##(2008-10#1)(2008-9#1)
may also be considered##2##4##(2008-10#1)(2010-10#1)
may also be effective in##2##5##(1997-1#1)(2010-5#1)
may also be effective##3##4##(1997-1#1)(2008-7#1)(2010-5#1)
may also be found##2##4##(1996-3#1)(2008-9#1)
may also be important for##2##5##(1994-5#1)(2008-7#1)
may also be influenced##2##4##(2008-10#1)(2008-8#1)
may also be involved##3##4##(1995-5#1)(2008-8#2)
may also be present in##2##5##(2008-7#1)(2010-5#1)
may also be present##3##4##(2007-5#1)(2008-7#1)(2010-5#1)
may also be relevant##2##4##(2009-8#1)(2012-2#1)
may also be used for##2##5##(2008-10#1)(2008-2#1)
may also be used to##5##5##(1996-2#1)(1996-3#1)(2008-2#1)(2008-4#1)(2008-9#1)
may also be used##9##4##(1996-2#1)(1996-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
may also be useful for##2##5##(2008-8#1)(2012-12#1)
may also be useful##5##4##(1992-12#1)(1995-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
may also be##77##3##(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#8)(2008-9#3)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
may also become##2##3##(1997-4#1)(2007-2#1)
may also cause##6##3##(2006-6#1)(2008-7#2)(2011-2#3)
may also contribute to the##3##5##(1993-11#1)(1994-11#1)(2010-5#1)
may also contribute to##8##4##(1990-11#1)(1993-11#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-5#1)
may also have a role##2##5##(1991-9#1)(2008-5#1)
may also have a##4##4##(1991-9#1)(2008-5#1)(2011-2#1)(2012-12#1)
may also have an important##2##5##(1995-6#1)(2012-3#1)
may also have an##3##4##(1995-6#1)(2008-10#1)(2012-3#1)
may also have the##2##4##(1995-5#1)(2008-10#1)
may also have therapeutic##2##4##(1994-2#1)(1997-1#1)
may also have##17##3##(1991-9#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
may also help to##2##4##(2009-10#1)(2011-2#1)
may also help##3##3##(2008-7#1)(2009-10#1)(2011-2#1)
may also increase##2##3##(1991-8#1)(2008-2#1)
may also influence the clinicopathological tumor outcome##2##7##(2008-4#2)
may also influence##3##3##(2008-4#2)(2008-8#1)
may also involve##2##3##(1997-3#1)(2008-12#1)
may also lead to##5##4##(2008-10#1)(2008-7#2)(2013-7#1)(2013-8#1)
may also occur in##2##4##(2008-8#1)(2012-12#1)
may also occur through##2##4##(2008-10#2)
may also occur##8##3##(1991-9#1)(1997-8#1)(2008-10#2)(2008-8#2)(2009-12#1)(2012-12#1)
may also play a role in the##3##7##(2009-1#1)(2009-9#1)(2010-3#1)
may also play a role in##4##6##(1994-6#1)(2009-1#1)(2009-9#1)(2010-3#1)
may also play a##5##4##(1994-6#1)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#1)
may also play##7##3##(1993-1#1)(1994-11#1)(1994-6#1)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#1)
may also present##3##3##(1994-9#1)(2008-10#1)(2008-2#1)
may also prevent##5##3##(1993-2#1)(1994-1#1)(2008-8#2)(2009-8#1)
may also provide a##3##4##(2007-2#1)(2008-10#1)(2008-8#1)
may also provide##4##3##(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
may also reduce##2##3##(2008-9#1)(2013-1#1)
may also represent##2##3##(1996-4#1)(1996-9#1)
may also require##2##3##(2009-8#1)(2012-12#1)
may also result from##2##4##(1994-9#1)(2008-7#1)
may also serve as a transformative model for emerging EMR/EHR requirements##4##11##(2010-8#4)
may also serve##6##3##(1990-11#1)(2008-11#1)(2010-8#4)
may also suffer##2##3##(2009-8#1)(2011-2#1)
may also##228##2##(1990-11#2)(1990-2#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#4)(1995-5#3)(1995-6#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-6#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#22)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#15)(2008-8#15)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-5#4)(2010-8#6)(2011-2#10)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#2)
may alter the expression##2##4##(1992-3#1)(2009-2#1)
may alter the##14##3##(1992-3#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
may alter##21##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
may ameliorate##2##2##(1996-2#1)(2008-1#1)
may appear at##2##3##(1994-8#1)(2010-8#1)
may appear to be##3##4##(1994-3#1)(2008-1#1)(2008-3#1)
may appear##14##2##(1990-8#1)(1991-7#1)(1992-5#1)(1994-3#1)(1994-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2010-8#1)(2012-1#1)
may apply##2##2##(1995-2#1)(2011-2#1)
may arise as a##2##4##(2008-7#1)(2008-9#1)
may arise from a##3##4##(1992-8#1)(2008-8#1)(2012-12#1)
may arise from the##2##4##(1991-8#1)(2009-8#1)
may arise from##10##3##(1991-8#1)(1992-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)
may arise in##6##3##(1994-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)
may arise##29##2##(1991-8#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
may arrest##3##2##(2007-7#1)(2008-9#1)(2009-9#1)
may assist in the diagnosis##2##5##(1991-12#1)(2011-2#1)
may assist in the##7##4##(1991-12#1)(2007-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
may assist in##11##3##(1991-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
may assist##18##2##(1991-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#3)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
may assume##2##2##(1993-3#1)(2008-6#1)
may at first##2##3##(1990-6#1)(2011-2#1)
may at least in part##2##5##(2008-8#1)(2009-12#1)
may at##6##2##(1990-6#1)(2008-11#2)(2008-8#1)(2009-12#1)(2011-2#1)
may attach##3##2##(1991-3#1)(2008-11#2)
may avoid##8##2##(1990-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-6#1)(2012-3#1)
may be a better##3##4##(1995-3#1)(2007-7#1)(2008-10#1)
may be a candidate##3##4##(1990-3#1)(2008-9#1)(2009-9#1)
may be a common##5##4##(1990-5#1)(1994-11#2)(1997-3#1)(2008-8#1)
may be a consequence of##2##5##(2008-7#1)(2008-8#1)
may be a consequence##3##4##(1994-12#1)(2008-7#1)(2008-8#1)
may be a crucial##2##4##(1997-4#1)(2008-5#1)
may be a factor##2##4##(2007-2#1)(2011-2#1)
may be a function of##2##5##(1991-12#1)(1997-5#1)
may be a general##2##4##(2008-10#1)(2008-7#1)
may be a good alternative##2##5##(1995-6#1)(2009-8#1)
may be a good##5##4##(1995-6#1)(2008-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
may be a major##3##4##(1991-11#1)(1997-8#1)(2008-8#1)
may be a marker of##3##5##(2012-3#1)(2013-1#2)
may be a mechanism##2##4##(2009-2#1)(2010-1#1)
may be a more##5##4##(1993-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
may be a novel##4##4##(1990-7#1)(1997-1#1)(2011-2#1)(2013-1#1)
may be a part of the##2##6##(1995-2#1)(2008-7#1)
may be a physiological##2##4##(1990-11#1)(1991-12#1)
may be a possible##3##4##(1993-3#1)(2008-7#1)(2013-1#1)
may be a potential##4##4##(2008-4#2)(2012-3#1)(2013-1#1)
may be a practical##2##4##(1996-8#1)(2008-7#1)
may be a promising tool to##2##6##(2008-10#2)
may be a promising##5##4##(2008-10#3)(2011-2#1)(2013-8#1)
may be a reflection of the##2##6##(2008-10#1)(2012-12#1)
may be a reflection of##3##5##(2008-10#1)(2012-12#1)(2012-3#1)
may be a risk factor for##2##6##(1997-1#1)(2013-7#1)
may be a risk factor##3##5##(1997-1#1)(2007-11#1)(2013-7#1)
may be a significant##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
may be a simple##2##4##(1996-12#1)(2008-7#1)
may be a source of##2##5##(1990-7#1)(2008-11#1)
may be a suitable alternative##2##5##(1996-1#1)(2008-10#1)
may be a useful biomarker##2##5##(1992-9#1)(2009-6#1)
may be a useful tool##2##5##(1992-12#1)(2012-12#1)
may be a useful##20##4##(1991-3#1)(1992-12#3)(1992-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-10#4)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-12#1)
may be a valuable tool to##2##6##(1997-2#1)(2007-10#1)
may be a valuable tool##3##5##(1997-2#1)(2007-10#1)(2008-11#1)
may be a valuable##4##4##(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)
may be a##190##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#11)(2008-8#7)(2008-9#6)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#3)
may be able to##14##4##(1991-9#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-7#1)(2012-12#2)
may be absent##2##3##(1997-3#1)(2013-1#1)
may be accepted##3##3##(2008-11#1)(2011-2#2)
may be accessed##2##3##(1991-12#1)(2008-7#1)
may be achieved by##6##4##(1994-11#1)(1995-11#1)(2008-10#1)(2008-8#2)(2009-8#1)
may be achieved in##5##4##(1990-8#1)(1991-12#1)(1993-1#1)(2008-3#1)(2013-7#1)
may be achieved through##2##4##(2008-11#1)(2008-3#1)
may be achieved with the##2##5##(1995-3#1)(2008-3#1)
may be achieved with##3##4##(1995-3#1)(2008-3#1)(2008-7#1)
may be achieved##22##3##(1990-8#1)(1991-12#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-3#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2013-7#1)
may be acting as##3##4##(1990-11#1)(2012-2#2)
may be activated by##2##4##(2008-7#2)
may be activated##3##3##(2008-4#1)(2008-7#2)
may be adapted to##2##4##(2008-4#1)(2008-9#1)
may be adapted##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
may be administered##3##3##(1997-5#1)(2008-3#1)(2010-12#1)
may be adopted##2##3##(2008-6#1)(2013-8#1)
may be advantageous##3##3##(1997-7#1)(2008-1#1)(2008-10#1)
may be advisable##3##3##(2007-7#1)(2008-5#1)(2011-2#1)
may be affected by a variety of##2##7##(1997-8#1)(2013-1#1)
may be affected by##6##4##(1990-2#1)(1994-3#1)(1997-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
may be affected in##2##4##(2008-12#1)(2009-12#1)
may be affected##9##3##(1990-2#1)(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-12#1)(2013-1#1)(2013-8#1)
may be also##3##3##(1990-12#1)(2008-10#1)(2012-3#1)
may be altered by##2##4##(1990-7#1)(1994-9#1)
may be altered##3##3##(1990-7#1)(1994-9#1)(2009-11#1)
may be an additional mechanism##2##5##(1992-12#1)(2013-1#1)
may be an additional##5##4##(1992-12#1)(1993-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
may be an alternative in##2##5##(1994-11#1)(2007-8#1)
may be an alternative##7##4##(1994-11#1)(1997-7#1)(1997-8#1)(2007-8#2)(2008-10#1)(2013-1#1)
may be an attractive strategy##2##5##(2008-5#1)(2012-2#1)
may be an effective alternative##4##5##(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
may be an effective means##2##5##(2008-10#1)(2012-2#1)
may be an effective method##2##5##(1991-2#1)(1997-4#1)
may be an effective treatment##2##5##(2008-5#1)(2012-3#1)
may be an effective##19##4##(1991-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
may be an efficient##2##4##(2008-9#1)(2010-8#1)
may be an ideal##2##4##(1991-9#1)(1995-5#1)
may be an important component of##2##6##(2008-10#1)(2008-9#1)
may be an important determinant of##2##6##(2008-10#1)(2008-3#1)
may be an important factor for##2##6##(2008-5#1)(2013-7#1)
may be an important factor in##2##6##(1996-7#1)(2012-12#1)
may be an important factor##5##5##(1996-7#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-7#1)
may be an important mechanism of##2##6##(2008-10#1)(2011-2#1)
may be an important mechanism##4##5##(2008-10#2)(2008-8#1)(2011-2#1)
may be an important mediator of##2##6##(1994-11#2)
may be an important regulator of##2##6##(2008-4#1)(2008-8#1)
may be an important##28##4##(1993-9#1)(1994-11#2)(1995-2#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
may be an indirect##2##4##(1993-11#1)(1997-3#1)
may be an##102##3##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
may be analyzed in a##2##5##(1991-5#1)(2008-9#1)
may be analyzed in##3##4##(1991-5#1)(2008-4#1)(2008-9#1)
may be analyzed##4##3##(1991-5#1)(2008-4#1)(2008-9#1)(2013-8#1)
may be applicable to other##2##5##(2008-5#1)(2010-2#1)
may be applicable to##5##4##(1992-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-2#1)
may be applicable##6##3##(1992-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-2#1)(2012-2#1)
may be applied for##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
may be applied in##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
may be applied to other##3##5##(2008-2#1)(2008-4#2)
may be applied to##10##4##(2007-4#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
may be applied##21##3##(1993-6#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
may be appropriate for##3##4##(2008-10#1)(2009-6#1)(2013-1#1)
may be appropriate##6##3##(2007-8#1)(2008-10#1)(2009-11#1)(2009-6#1)(2013-1#2)
may be as##4##3##(1990-2#1)(1995-5#1)(2008-11#1)(2010-2#1)
may be ascribed to##2##4##(1994-3#1)(2008-10#1)
may be ascribed##3##3##(1994-3#1)(2008-10#2)
may be associated with a##5##5##(1992-3#1)(1994-2#1)(2008-10#1)(2009-8#1)(2010-10#1)
may be associated with an##3##5##(1990-5#1)(1995-3#1)(2010-12#1)
may be associated with both##2##5##(2008-5#1)(2009-12#1)
may be associated with the##11##5##(1990-7#1)(1992-12#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-7#2)(2009-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
may be associated with##56##4##(1990-5#1)(1990-7#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-2#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
may be associated##59##3##(1990-5#1)(1990-7#1)(1992-10#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-2#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
may be assumed to##2##4##(1994-5#1)(2010-10#1)
may be assumed##3##3##(1992-2#1)(1994-5#1)(2010-10#1)
may be asymptomatic and##2##4##(2008-7#1)(2009-3#1)
may be asymptomatic but##2##4##(1991-4#1)(2012-2#1)
may be asymptomatic##7##3##(1991-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
may be at greater##2##4##(1993-1#1)(2012-12#1)
may be at increased risk for##2##6##(2008-11#1)(2011-2#1)
may be at increased risk##3##5##(2007-2#1)(2008-11#1)(2011-2#1)
may be at least##3##4##(1997-7#1)(1997-8#2)
may be at risk##2##4##(1996-12#1)(2010-5#1)
may be at##16##3##(1992-12#1)(1993-1#1)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#2)(2007-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)
may be attenuated##2##3##(1991-9#1)(1995-5#1)
may be attractive##2##3##(2009-7#1)(2013-1#1)
may be attributable to##5##4##(1993-12#1)(1994-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
may be attributable##6##3##(1993-12#1)(1994-2#1)(1994-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
may be attributed to its##2##5##(2008-12#1)(2012-3#1)
may be attributed to the reduction of##2##7##(2008-10#2)
may be attributed to the##9##5##(1995-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#2)
may be attributed to their##2##5##(2008-10#1)(2008-11#1)
may be attributed to##20##4##(1995-3#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-8#2)(2008-9#1)(2009-11#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
may be attributed##22##3##(1995-3#1)(1996-8#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-11#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
may be available to##2##4##(2007-4#1)(2012-3#1)
may be avoided##2##3##(2008-6#1)(2012-2#1)
may be based##2##3##(1991-5#1)(2008-6#1)
may be because residents##2##4##(2011-1#2)
may be because##6##3##(1990-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2011-1#2)
may be beneficial for##7##4##(1994-11#1)(1995-12#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
may be beneficial in the##3##5##(2007-7#1)(2011-2#1)(2012-1#1)
may be beneficial in##8##4##(2007-7#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)
may be beneficial##21##3##(1994-11#1)(1995-12#1)(1995-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
may be best##2##3##(2006-10#1)(2007-8#1)
may be better##5##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
may be between##2##3##(2008-10#1)(2008-5#1)
may be calculated##4##3##(2007-11#1)(2008-3#2)(2008-8#1)
may be called##2##3##(1995-3#1)(2007-11#1)
may be candidates for##2##4##(2008-10#1)(2013-1#1)
may be carried out##3##4##(2007-10#1)(2008-10#1)(2013-7#1)
may be carried##4##3##(2007-10#1)(2008-10#2)(2013-7#1)
may be causally##2##3##(1992-9#1)(1994-6#1)
may be caused by a##3##5##(1994-12#1)(2008-10#1)(2009-6#1)
may be caused by##19##4##(1992-2#1)(1993-3#1)(1994-12#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
may be caused##20##3##(1992-2#1)(1993-3#1)(1994-12#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
may be challenging##2##3##(2010-10#1)(2012-3#1)
may be characterized##2##3##(1995-3#1)(2008-11#1)
may be classified as##4##4##(1990-3#1)(1991-1#1)(2011-2#1)(2013-1#1)
may be classified##5##3##(1990-3#1)(1991-1#1)(1992-9#1)(2011-2#1)(2013-1#1)
may be clinically##6##3##(1991-6#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-12#1)
may be closely associated with##2##5##(2008-10#1)(2008-7#1)
may be closely linked to##2##5##(2008-10#1)(2008-11#1)
may be closely related to##3##5##(2008-4#2)(2008-8#1)
may be closely##7##3##(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)
may be collected##2##3##(2008-10#1)(2008-12#1)
may be combined##2##3##(2008-12#1)(2008-3#1)
may be common##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
may be compared to##2##4##(2008-1#1)(2008-7#1)
may be compared##4##3##(1993-8#1)(2008-1#1)(2008-7#1)(2008-9#1)
may be complicated by##4##4##(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
may be complicated##5##3##(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
may be composed of##2##4##(1995-11#1)(1997-4#1)
may be compromised by##2##4##(2010-11#1)(2011-2#1)
may be compromised in##2##4##(1995-5#1)(1996-7#1)
may be compromised##6##3##(1995-5#1)(1996-7#1)(2008-10#1)(2010-11#2)(2011-2#1)
may be computed##2##3##(2008-2#1)(2008-4#1)
may be concluded that##5##4##(1992-12#1)(1992-5#1)(1997-6#1)(2008-11#1)(2008-12#1)
may be confused with##4##4##(1990-5#1)(2007-7#1)(2008-9#1)(2011-2#1)
may be connected##2##3##(2008-11#1)(2008-5#1)
may be consequences of##2##4##(1996-11#1)(2010-10#1)
may be conserved##2##3##(2008-10#1)(2012-3#1)
may be considered a##12##4##(1991-6#1)(1993-6#1)(1995-12#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2011-2#1)(2013-1#1)
may be considered an##2##4##(1990-6#1)(2008-10#1)
may be considered as a first##2##6##(2007-12#1)(2009-10#1)
may be considered as a##4##5##(1994-5#1)(1994-6#1)(2007-12#1)(2009-10#1)
may be considered as##11##4##(1994-3#1)(1994-5#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#1)
may be considered to be a##3##6##(2007-12#1)(2008-8#1)(2012-3#1)
may be considered to be##4##5##(2007-12#1)(2008-8#1)(2010-11#1)(2012-3#1)
may be considered to##5##4##(2007-12#1)(2008-11#1)(2008-8#1)(2010-11#1)(2012-3#1)
may be considered##44##3##(1990-6#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-5#1)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
may be consistent with##2##4##(2007-10#1)(2008-11#1)
may be constructed##2##3##(1990-11#1)(2008-2#1)
may be correct##2##3##(2008-11#1)(2008-6#1)
may be correlated with the##2##5##(1991-12#1)(2008-10#1)
may be correlated with##4##4##(1991-12#1)(2008-10#2)(2009-4#1)
may be correlated##6##3##(1991-12#1)(1993-3#1)(2008-10#3)(2009-4#1)
may be counteracted by##2##4##(1992-11#1)(1993-1#1)
may be critical for##3##4##(2008-10#1)(2008-8#1)(2012-7#1)
may be critically##2##3##(1995-5#1)(2008-7#1)
may be crucial to##4##4##(2008-12#1)(2010-11#1)(2010-5#1)(2012-12#1)
may be crucial##6##3##(1997-1#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-5#1)(2012-12#1)
may be dangerous##2##3##(1995-11#1)(2013-1#1)
may be defined as the##2##5##(2008-1#1)(2008-7#1)
may be defined as##3##4##(1993-6#1)(2008-1#1)(2008-7#1)
may be defined##5##3##(1993-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
may be delayed##5##3##(1990-12#1)(1992-2#1)(2008-1#1)(2009-10#1)(2012-3#1)
may be demonstrated##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
may be dependent on##3##4##(1995-11#1)(1995-12#1)(1996-12#1)
may be derived from##4##4##(1991-12#1)(1994-6#1)(2009-6#1)(2012-3#1)
may be derived##6##3##(1991-12#1)(1994-6#1)(2008-11#1)(2008-3#1)(2009-6#1)(2012-3#1)
may be described##2##3##(2008-10#1)(2008-3#1)
may be designed to##2##4##(2008-3#1)(2008-4#1)
may be designed##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
may be desirable##3##3##(1993-1#1)(2008-11#1)(2008-4#1)
may be detected in##2##4##(1997-5#1)(2007-8#1)
may be detected##4##3##(1990-12#1)(1997-5#1)(2007-8#1)(2008-4#1)
may be determined in a##2##5##(2008-10#2)
may be determined##9##3##(1992-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
may be developed##2##3##(2008-3#1)(2011-2#1)
may be different from that##2##5##(1993-6#1)(1996-5#1)
may be different from##3##4##(1993-6#1)(1996-2#1)(1996-5#1)
may be different##10##3##(1990-8#1)(1993-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-12#2)(2008-8#1)(2012-2#1)
may be difficult if##2##4##(2008-5#1)(2011-1#1)
may be difficult to obtain##3##5##(1991-2#1)(1992-9#1)(2006-12#1)
may be difficult to##8##4##(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(2006-12#1)(2008-11#1)(2009-10#1)(2013-1#1)
may be difficult##19##3##(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
may be directly##3##3##(1992-2#1)(1993-8#1)(2008-8#1)
may be discovered##3##3##(1991-5#1)(2008-10#1)(2009-8#1)
may be disrupted##2##3##(1993-6#1)(2008-10#1)
may be distinct##3##3##(1996-2#1)(2006-6#1)(2008-10#1)
may be distinguished by##2##4##(2007-11#1)(2008-11#1)
may be distinguished##5##3##(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-12#1)
may be divided into##2##4##(2008-10#2)
may be done##3##3##(1991-2#1)(2007-8#1)(2008-8#1)
may be drawn##2##3##(1992-3#1)(1994-11#1)
may be due in part to the##2##7##(1995-9#1)(2012-12#1)
may be due in part to##4##6##(1995-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
may be due to a##2##5##(2008-6#1)(2011-2#1)
may be due to its##4##5##(1991-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
may be due to the fact that##2##7##(1991-2#1)(2008-9#1)
may be due to the increased##2##6##(1991-2#1)(2012-3#1)
may be due to the##16##5##(1990-2#1)(1991-2#2)(1991-5#1)(1993-2#1)(1994-11#1)(1995-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
may be due to their##2##5##(2008-3#1)(2011-2#1)
may be due to##57##4##(1990-2#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
may be due##69##3##(1990-2#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
may be easily##6##3##(2008-1#1)(2008-10#2)(2008-4#1)(2012-3#1)(2013-8#1)
may be effective for##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
may be effective in##9##4##(1992-12#1)(2006-7#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2013-1#2)
may be effective##17##3##(1992-12#1)(1993-8#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
may be effectively##3##3##(1992-9#1)(2008-10#1)(2009-9#1)
may be either##7##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-6#1)
may be employed to##3##4##(2008-2#1)(2008-4#1)(2013-1#1)
may be employed##4##3##(1991-12#1)(2008-2#1)(2008-4#1)(2013-1#1)
may be encountered##9##3##(1990-8#1)(1993-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(2008-11#1)(2011-1#1)(2012-2#2)
may be enhanced by##5##4##(1993-2#1)(2008-10#1)(2008-5#1)(2008-9#2)
may be enhanced##6##3##(1993-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#2)
may be equivalent##2##3##(2008-10#1)(2012-3#1)
may be especially important##2##4##(2007-10#1)(2009-8#1)
may be especially useful##2##4##(1994-2#1)(2007-11#1)
may be especially##12##3##(1994-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)
may be essential for##2##4##(1994-8#1)(2008-10#1)
may be essential##4##3##(1994-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
may be etiologically##2##3##(1997-5#1)(2007-10#1)
may be evaluated##3##3##(2006-5#1)(2008-1#1)(2008-3#1)
may be expected in the##2##5##(1991-3#1)(1996-2#1)
may be expected to##6##4##(1992-12#1)(1995-2#1)(1995-5#1)(2008-7#1)(2010-5#1)(2012-3#1)
may be expected##12##3##(1991-3#2)(1992-12#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
may be explained by assuming##2##5##(2008-3#2)
may be explained by the##7##5##(1990-5#1)(1992-12#1)(1995-11#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
may be explained by##15##4##(1990-5#1)(1992-12#1)(1995-11#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
may be explained in terms of##2##6##(2008-6#1)(2013-7#1)
may be explained##18##3##(1990-5#1)(1992-12#1)(1995-11#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-7#1)
may be exploited##3##3##(2008-2#1)(2009-6#1)(2013-1#1)
may be exposed##2##3##(2008-10#1)(2010-9#1)
may be extended by##2##4##(2008-10#1)(2008-3#1)
may be extended##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
may be extremely##2##3##(1995-6#1)(2008-12#1)
may be followed by##2##4##(1996-12#1)(2008-4#1)
may be formed##2##3##(1995-6#1)(1997-4#1)
may be found at##2##4##(2008-10#1)(2008-7#1)
may be found in the##2##5##(1996-12#1)(2008-9#1)
may be found in##6##4##(1990-12#1)(1996-12#1)(1997-8#1)(2008-9#1)(2010-1#1)(2010-7#1)
may be found##13##3##(1990-12#1)(1990-5#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)
may be functionally related##2##4##(1992-11#1)(2008-8#1)
may be functionally##3##3##(1992-11#1)(2008-8#1)(2010-10#1)
may be generally##2##3##(2011-2#2)
may be generated##2##3##(1992-9#1)(2007-12#1)
may be genetically##6##3##(1994-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#1)
may be given##2##3##(1994-9#1)(2009-2#1)
may be greater##2##3##(1992-2#1)(2012-12#1)
may be harmful##2##3##(1994-11#1)(1997-5#1)
may be helpful for##5##4##(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2013-8#1)
may be helpful in the##3##5##(2008-9#1)(2009-3#1)(2011-2#1)
may be helpful in##6##4##(2008-4#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-7#1)
may be helpful##14##3##(1997-5#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
may be higher in##3##4##(1992-9#1)(2007-10#1)(2012-12#1)
may be higher##5##3##(1992-9#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-12#1)
may be highly##4##3##(1993-10#1)(1993-11#1)(2011-2#1)(2013-1#1)
may be identical to the##2##5##(1993-6#1)(1994-11#1)
may be identified##3##3##(1992-2#1)(2008-7#1)(2012-2#1)
may be impaired by##2##4##(2007-10#1)(2010-11#1)
may be implemented##2##3##(2008-8#1)(2012-1#1)
may be implicated in the##4##5##(1993-3#1)(1993-9#1)(2008-8#1)(2008-9#1)
may be implicated in##5##4##(1991-3#1)(1993-3#1)(1993-9#1)(2008-8#1)(2008-9#1)
may be implicated##6##3##(1991-3#1)(1992-12#1)(1993-3#1)(1993-9#1)(2008-8#1)(2008-9#1)
may be important for the##2##5##(2007-11#1)(2008-10#1)
may be important for##12##4##(1992-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-10#1)(2011-2#1)(2012-2#1)
may be important in the regulation of##2##7##(1993-8#1)(1995-12#1)
may be important in the##10##5##(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
may be important in understanding##2##5##(1991-12#1)(2008-10#1)
may be important in##27##4##(1990-5#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-12#2)(2008-10#6)(2008-5#1)(2008-7#1)(2012-2#2)
may be important to##4##4##(1994-8#1)(2008-8#1)(2009-6#1)(2013-7#1)
may be important##56##3##(1990-5#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#4)(2013-7#1)
may be improved by##2##4##(2008-4#1)(2010-8#1)
may be improved##4##3##(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)
may be in part##2##4##(2007-10#1)(2009-12#1)
may be in the##4##4##(1993-11#1)(2007-9#1)(2008-3#1)(2012-3#1)
may be in##13##3##(1993-11#1)(1995-6#1)(1996-2#1)(1996-6#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-3#1)(2012-3#1)
may be incorporated##2##3##(2006-4#1)(2008-8#1)
may be increased in##2##4##(1993-3#1)(2008-10#1)
may be increased##4##3##(1993-3#1)(1997-4#1)(2008-10#1)(2008-7#1)
may be independent of##3##4##(1995-12#1)(2006-10#1)(2010-10#1)
may be indicated in##2##4##(2010-12#1)(2013-1#1)
may be indicated##6##3##(1991-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
may be indicative of##2##4##(1991-2#1)(2011-2#1)
may be indistinguishable from##2##4##(1990-12#1)(2008-9#1)
may be induced by##3##4##(1996-3#1)(2008-10#1)(2008-8#1)
may be induced##5##3##(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
may be inefficient##2##3##(1997-4#1)(2008-8#1)
may be infected##2##3##(2008-10#1)(2012-3#1)
may be inferred##3##3##(1995-6#1)(2008-3#1)(2008-7#1)
may be influenced by##9##4##(1990-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
may be influenced##10##3##(1990-3#1)(1990-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
may be inherited##2##3##(2007-7#1)(2008-6#1)
may be inhibitory##2##3##(2008-11#2)
may be initiated##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
may be interesting##2##3##(1993-8#1)(2008-10#1)
may be interpreted##2##3##(1997-2#1)(2008-1#1)
may be involved as##2##4##(2008-10#1)(2008-3#1)
may be involved in controlling##2##5##(1997-2#1)(2008-8#1)
may be involved in determining the##3##6##(1990-12#1)(1990-8#1)(1997-7#1)
may be involved in insulin##2##5##(1994-6#1)(2010-4#1)
may be involved in its##2##5##(2008-11#1)(2008-8#1)
may be involved in regulating##2##5##(2008-8#2)
may be involved in the development of##2##7##(1992-3#1)(2010-12#1)
may be involved in the process of##3##7##(1995-5#1)(2008-1#1)(2011-1#1)
may be involved in the regulation of##2##7##(2008-8#1)(2010-12#1)
may be involved in the response##2##6##(1992-3#1)(1995-5#1)
may be involved in the##41##5##(1990-11#1)(1990-12#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#3)(1997-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-12#2)(2011-1#1)(2013-1#1)
may be involved in##94##4##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-6#2)(1997-7#2)(1997-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
may be involved##105##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-6#2)(1997-7#2)(1997-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2009-10#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
may be isolated##2##3##(2008-4#1)(2011-2#1)
may be justified##4##3##(1990-6#1)(1991-8#1)(1997-4#1)(2008-6#1)
may be lacking in##2##4##(2008-10#2)
may be larger than##2##4##(1997-1#1)(1997-3#1)
may be larger##3##3##(1997-1#1)(1997-3#1)(2012-12#1)
may be less##10##3##(1992-2#1)(1992-9#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
may be limited by##2##4##(2008-8#1)(2012-2#1)
may be limited in##2##4##(1996-11#1)(2011-1#1)
may be limited##10##3##(1995-3#1)(1996-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
may be linked to the##3##5##(2008-7#1)(2009-6#1)(2012-2#1)
may be linked to##8##4##(1992-8#1)(1993-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#1)
may be linked##9##3##(1992-8#1)(1993-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#1)
may be located on##3##4##(1996-5#2)(2008-10#1)
may be located##5##3##(1990-2#1)(1996-5#2)(2008-10#1)(2012-3#1)
may be long##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
may be lost##2##3##(1995-12#1)(2008-11#1)
may be lower##2##3##(1992-6#1)(2009-4#1)
may be made##6##3##(1993-2#1)(1994-1#1)(2008-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
may be measured##4##3##(1990-12#1)(2008-10#2)(2009-11#1)
may be mediated by a##2##5##(1992-8#1)(2012-3#1)
may be mediated by the##5##5##(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
may be mediated by##16##4##(1990-5#1)(1992-8#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
may be mediated in part##2##5##(1994-6#1)(1995-12#1)
may be mediated through##3##4##(1991-1#1)(1994-8#1)(1995-12#1)
may be mediated##23##3##(1990-5#1)(1991-1#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
may be minimized by##2##4##(2011-2#1)(2012-2#1)
may be misleading##4##3##(1997-8#1)(2008-11#1)(2008-7#2)
may be modified##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
may be modulated by##5##4##(1991-12#1)(1992-12#1)(1992-8#1)(2009-6#1)(2012-2#1)
may be monitored##2##3##(2008-10#2)
may be more accurate##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
may be more appropriate##2##4##(2008-12#1)(2010-2#1)
may be more clinically##2##4##(2009-11#1)(2013-1#1)
may be more common in##3##5##(2008-4#1)(2008-7#1)(2008-8#1)
may be more common##4##4##(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
may be more complex##2##4##(2008-10#1)(2008-8#1)
may be more complicated##2##4##(2008-3#1)(2008-8#1)
may be more effective if##2##5##(2008-10#1)(2010-2#1)
may be more frequently##2##4##(2008-6#1)(2008-7#1)
may be more important in##3##5##(2013-1#3)
may be more important##6##4##(1990-7#1)(2008-8#1)(2010-1#1)(2013-1#3)
may be more sensitive to##2##5##(2008-10#1)(2010-6#1)
may be more suitable for##2##5##(2008-10#1)(2011-2#1)
may be more than##2##4##(2012-2#1)(2013-1#1)
may be more widespread than previously##2##6##(1996-3#1)(2008-10#1)
may be more##64##3##(1990-7#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-12#2)(1994-11#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#6)
may be most##2##3##(1991-1#1)(2008-8#1)
may be much##2##3##(2008-10#1)(2010-3#1)
may be necessary for##5##4##(1993-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-8#1)
may be necessary in##2##4##(2008-10#1)(2008-3#1)
may be necessary to##13##4##(1990-3#1)(1991-12#1)(1992-8#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#1)(2009-5#1)(2012-2#1)
may be necessary##23##3##(1990-3#1)(1991-12#1)(1992-8#1)(1993-8#1)(1994-3#1)(1996-2#1)(1997-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
may be needed to##3##4##(2008-4#1)(2008-8#1)(2009-8#1)
may be needed##14##3##(1990-11#1)(1992-9#1)(1997-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-1#1)
may be negatively##2##3##(1993-6#1)(2008-5#1)
may be new##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
may be not##2##3##(2008-7#2)
may be observed in##2##4##(1991-2#1)(2009-11#1)
may be observed##7##3##(1991-2#1)(1997-8#1)(2007-11#1)(2008-11#1)(2009-11#1)(2009-5#1)(2012-12#1)
may be obtained by##2##4##(1991-8#1)(2008-10#1)
may be obtained##10##3##(1991-8#1)(1992-5#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)
may be occurring##2##3##(2008-10#1)(2008-11#1)
may be of benefit##2##4##(1992-3#1)(2008-3#1)
may be of biological##3##4##(1990-5#1)(1991-12#1)(2011-2#1)
may be of general##2##4##(2008-9#1)(2011-1#1)
may be of great##3##4##(1990-6#1)(2008-10#1)(2010-5#1)
may be of importance for the##2##6##(1992-12#1)(1994-11#1)
may be of importance for##3##5##(1992-12#1)(1994-11#1)(2008-5#1)
may be of importance##5##4##(1990-12#1)(1992-12#1)(1994-11#1)(1995-8#1)(2008-5#1)
may be of interest to##3##5##(1995-12#1)(2008-11#1)(2011-1#1)
may be of particular##4##4##(1993-12#2)(2007-2#1)(2013-8#1)
may be of potential use in##3##6##(2008-10#1)(2008-5#1)(2010-4#1)
may be of potential use##4##5##(1993-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
may be of relevance##2##4##(2007-2#1)(2012-2#1)
may be of special##2##4##(1995-12#1)(2007-11#1)
may be of therapeutic##2##4##(1991-9#1)(1995-3#1)
may be of use in##2##5##(2008-11#1)(2008-3#1)
may be of use##3##4##(2008-11#2)(2008-3#1)
may be of value in the##2##6##(1990-12#1)(2008-5#1)
may be of value in##4##5##(1990-12#1)(2008-11#1)(2008-5#1)(2008-9#1)
may be of value to##2##5##(1997-3#1)(2008-11#1)
may be of value##6##4##(1990-12#1)(1997-3#1)(2008-11#2)(2008-5#1)(2008-9#1)
may be of##56##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-9#1)(1997-3#1)(2007-11#1)(2007-2#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
may be one of the factors##5##6##(1994-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
may be one of the mechanisms##2##6##(2008-10#1)(2009-12#1)
may be one of the##15##5##(1991-12#1)(1994-2#1)(1994-6#2)(1995-5#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
may be one##20##3##(1991-12#1)(1993-6#1)(1994-2#1)(1994-6#2)(1995-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
may be only##2##3##(2008-7#1)(2009-9#1)
may be overestimated##2##3##(2008-10#1)(2013-1#1)
may be part of a##4##5##(1994-8#1)(1994-9#1)(1997-5#1)(2008-11#1)
may be part of an##3##5##(1992-2#1)(1992-4#1)(2008-10#1)
may be part of the##4##5##(1994-9#1)(1996-2#1)(2008-7#1)(2008-9#1)
may be part of##12##4##(1992-2#1)(1992-4#1)(1994-8#1)(1994-9#2)(1996-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
may be partially due to##2##5##(1994-11#1)(2008-10#1)
may be partially explained by##3##5##(1993-11#1)(2008-10#2)
may be partially##7##3##(1990-7#1)(1993-11#1)(1994-11#1)(1996-2#1)(2008-10#3)
may be particularly effective in##2##5##(2010-10#1)(2013-1#1)
may be particularly effective##3##4##(2008-10#1)(2010-10#1)(2013-1#1)
may be particularly helpful in patients with##2##7##(2008-6#1)(2013-1#1)
may be particularly useful as##2##5##(1997-4#1)(2008-10#1)
may be particularly useful##5##4##(1992-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
may be particularly##15##3##(1992-8#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
may be partly##2##3##(2011-1#1)(2013-8#1)
may be performed in##2##4##(2008-4#1)(2011-2#1)
may be performed using##2##4##(2008-10#1)(2011-2#1)
may be performed##10##3##(1990-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#3)
may be placed in##2##4##(1996-1#1)(2008-10#1)
may be placed##4##3##(1996-1#1)(1997-5#1)(2007-6#1)(2008-10#1)
may be playing##2##3##(1993-5#1)(1997-2#1)
may be possible by##3##4##(1996-12#1)(2008-3#1)(2009-7#1)
may be possible to##12##4##(1993-12#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2009-4#1)(2011-1#1)
may be possible##20##3##(1993-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#1)(2009-4#1)(2009-7#1)(2011-1#1)
may be potential##3##3##(1992-1#1)(2008-5#1)(2011-2#1)
may be potentially##3##3##(2008-3#1)(2009-11#1)(2013-7#1)
may be predicted##2##3##(2008-10#1)(2008-11#1)
may be preferable##3##3##(1994-2#1)(2008-7#1)(2010-11#1)
may be present at##2##4##(2011-2#1)(2012-3#1)
may be present in the##2##5##(2008-10#1)(2008-7#1)
may be present in##9##4##(1996-5#1)(2008-10#3)(2008-7#2)(2008-9#2)(2010-4#1)
may be present on##2##4##(1993-9#1)(1997-2#1)
may be present##20##3##(1991-12#1)(1993-9#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-4#1)(2011-2#1)(2012-3#1)
may be presented##2##3##(2011-1#1)(2011-2#1)
may be preserved##2##3##(2007-7#1)(2008-7#1)
may be prevented by##4##4##(2008-1#1)(2013-1#3)
may be prevented##6##3##(2008-1#1)(2008-11#1)(2010-10#1)(2013-1#3)
may be produced by##4##4##(2008-7#2)(2008-8#1)(2009-10#1)
may be produced##6##3##(1990-11#1)(1994-3#1)(2008-7#2)(2008-8#1)(2009-10#1)
may be propagated##2##3##(1995-6#1)(2008-8#1)
may be protective##2##3##(2009-7#1)(2013-1#1)
may be provided##2##3##(2008-11#1)(2009-8#1)
may be quite##4##3##(1990-5#1)(1993-3#1)(2008-10#1)(2008-4#1)
may be rare##2##3##(2008-4#1)(2010-8#1)
may be readily##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
may be realized##4##3##(1996-3#1)(2008-3#3)
may be recommended##5##3##(1994-3#1)(1996-6#1)(1997-7#1)(2008-10#1)(2011-2#1)
may be reduced by##3##4##(1997-1#1)(2009-5#1)(2011-2#1)
may be reduced significantly##2##4##(2008-10#1)(2008-3#1)
may be reduced##9##3##(1993-8#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
may be reflected in##2##4##(1995-11#1)(2013-8#1)
may be reflected##4##3##(1991-9#1)(1995-11#1)(2012-3#1)(2013-8#1)
may be regarded as a##4##5##(1991-3#1)(1997-6#1)(2008-10#1)(2012-2#1)
may be regarded as##6##4##(1991-3#1)(1997-6#1)(2008-10#2)(2008-3#1)(2012-2#1)
may be regulated at the##2##5##(1992-3#1)(1992-8#1)
may be regulated by##5##4##(1993-12#1)(1995-11#1)(1995-2#1)(2009-6#1)(2012-2#1)
may be regulated##9##3##(1992-3#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(2009-3#1)(2009-6#1)(2012-2#1)
may be related to a##2##5##(1990-5#1)(1997-7#1)
may be related to an##2##5##(1990-8#1)(2008-6#1)
may be related to better##2##5##(1994-9#1)(2010-2#1)
may be related to differences in##2##6##(2008-10#1)(2008-5#1)
may be related to its##2##5##(1995-12#1)(2007-12#1)
may be related to the presence of##2##7##(2008-10#1)(2011-2#1)
may be related to the##25##5##(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-8#1)
may be related to##59##4##(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-2#3)(1997-6#1)(1997-7#2)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#3)(2010-12#1)(2010-2#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#2)
may be related##63##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-2#3)(1997-6#1)(1997-7#2)(2006-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
may be relevant for##2##4##(1996-5#2)
may be relevant to the##3##5##(1994-2#1)(1996-2#1)(1996-5#1)
may be relevant to##7##4##(1990-5#1)(1994-2#1)(1996-2#1)(1996-5#1)(2008-11#1)(2010-10#1)(2012-2#1)
may be relevant##9##3##(1990-5#1)(1994-2#1)(1996-2#1)(1996-5#3)(2008-11#1)(2010-10#1)(2012-2#1)
may be removed##2##3##(1993-12#1)(2008-3#1)
may be replaced##2##3##(2007-11#1)(2008-4#1)
may be represented by##2##4##(1992-3#1)(2008-2#1)
may be required as##2##4##(2012-2#1)(2012-3#1)
may be required for##11##4##(1991-7#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2013-1#2)
may be required in##3##4##(1993-6#1)(2007-8#1)(2008-6#1)
may be required to##2##4##(2008-8#1)(2008-9#1)
may be required##26##3##(1991-7#1)(1992-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1995-11#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
may be resistant to##3##4##(2008-10#1)(2008-5#1)(2009-9#1)
may be responsible for certain##2##5##(1991-12#1)(1992-8#1)
may be responsible for pathogen suppression##2##6##(2008-10#2)
may be responsible for some##2##5##(1996-12#1)(2007-12#1)
may be responsible for specific##2##5##(1995-11#1)(2011-2#1)
may be responsible for the high##2##6##(1996-12#1)(2012-1#1)
may be responsible for the increased##2##6##(1990-5#1)(1990-8#1)
may be responsible for the##17##5##(1990-2#1)(1990-5#2)(1990-8#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-7#1)(2007-4#1)(2008-7#2)(2008-9#1)(2012-1#1)
may be responsible for their##2##5##(1995-5#1)(2008-10#1)
may be responsible for this##3##5##(1993-12#1)(1996-6#1)(2013-1#1)
may be responsible for##47##4##(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-10#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
may be responsible in##2##4##(1991-12#1)(2008-10#1)
may be responsible##50##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-10#7)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
may be retained##2##3##(1997-2#1)(2008-10#1)
may be safe and##2##4##(2008-9#1)(2011-1#1)
may be safely##2##3##(1993-12#1)(2008-10#1)
may be secondary to##3##4##(2008-8#1)(2009-4#1)(2012-12#1)
may be seen in##2##4##(1994-5#1)(2007-7#1)
may be seen##5##3##(1994-5#1)(1997-5#1)(2007-7#1)(2008-7#1)(2012-12#1)
may be selected##2##3##(2008-8#2)
may be severely##2##3##(2007-8#1)(2012-12#1)
may be significant##8##3##(1992-5#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
may be similar to##2##4##(2007-2#1)(2012-2#1)
may be similar##3##3##(2007-2#1)(2008-10#1)(2012-2#1)
may be simultaneously##3##3##(2008-10#1)(2009-10#1)(2010-2#1)
may be some##2##3##(2008-3#1)(2012-3#1)
may be specific##2##3##(2009-10#1)(2010-6#1)
may be specifically##2##3##(1993-2#1)(1996-7#1)
may be stored##3##3##(2008-10#2)(2008-3#1)
may be subjected to##2##4##(2008-6#1)(2009-3#1)
may be subjected##3##3##(1993-3#1)(2008-6#1)(2009-3#1)
may be successfully##2##3##(1994-5#1)(2008-11#1)
may be sufficient for##2##4##(1995-4#1)(1997-8#1)
may be sufficient to achieve##2##5##(1994-5#1)(2008-10#1)
may be sufficient to##4##4##(1994-5#1)(2006-12#1)(2008-10#1)(2012-2#1)
may be sufficient##7##3##(1991-2#1)(1994-5#1)(1995-4#1)(1997-8#1)(2006-12#1)(2008-10#1)(2012-2#1)
may be suitable for the##2##5##(2008-11#1)(2008-8#1)
may be suitable for##5##4##(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)
may be suitable##6##3##(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-3#1)
may be superresolved##2##3##(2008-2#1)(2008-3#1)
may be susceptible to failure in the healthcare setting##2##9##(2011-1#1)(2011-2#1)
may be synthesized##3##3##(1990-2#1)(1993-3#1)(2008-4#1)
may be taken##2##3##(1990-6#1)(2008-3#1)
may be targeted for##2##4##(1996-11#2)
may be targeted##5##3##(1996-11#2)(2009-8#1)(2012-2#1)(2012-3#1)
may be that it##2##4##(2008-7#2)
may be that##5##3##(1993-3#1)(2008-10#1)(2008-7#2)(2012-1#1)
may be the basis of##2##5##(1992-12#1)(2008-10#1)
may be the basis##3##4##(1992-12#1)(2008-10#1)(2012-3#1)
may be the best##5##4##(1993-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-7#1)
may be the causal agent of one form of YLS##2##10##(2008-10#2)
may be the causal agent of##3##6##(2008-10#3)
may be the cause of##3##5##(1990-6#1)(1992-9#1)(2009-3#1)
may be the cause##4##4##(1990-6#1)(1992-9#1)(2008-7#1)(2009-3#1)
may be the consequence of##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
may be the first##6##4##(1993-8#1)(1994-8#1)(1996-11#1)(2008-6#1)(2010-3#1)(2011-1#1)
may be the main##3##4##(2007-8#1)(2008-8#1)(2009-12#1)
may be the most important##2##5##(1991-3#1)(1992-6#1)
may be the most##4##4##(1991-3#1)(1992-6#1)(1994-5#1)(2007-9#1)
may be the only option##2##5##(1992-3#1)(2008-9#1)
may be the only##4##4##(1992-3#1)(1992-5#1)(2007-7#1)(2008-9#1)
may be the presenting##2##4##(1995-11#1)(2008-1#1)
may be the primary##2##4##(2007-12#1)(2008-1#1)
may be the prototype##2##4##(1994-9#1)(1997-3#1)
may be the reason for the##2##6##(2008-11#1)(2008-7#1)
may be the result of the##2##6##(1991-12#1)(1993-11#1)
may be the result of##10##5##(1991-12#1)(1993-11#1)(1993-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)
may be the result##11##4##(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)
may be the##88##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
may be time to##2##4##(1995-2#1)(2010-10#1)
may be time##3##3##(1995-2#1)(1997-7#1)(2010-10#1)
may be to##7##3##(1992-6#1)(1993-11#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
may be too##4##3##(1995-5#1)(2008-7#2)(2008-8#1)
may be toxic##2##3##(1991-9#1)(1997-4#1)
may be treated##2##3##(2008-2#1)(2008-7#1)
may be triggered by##2##4##(1997-6#1)(2012-3#1)
may be two##4##3##(1996-4#1)(1997-4#1)(2008-10#1)(2009-11#1)
may be unable to##2##4##(2008-10#1)(2011-2#1)
may be under##2##3##(1990-11#1)(2010-6#1)
may be unique to##2##4##(1992-12#1)(2012-2#1)
may be uniquely##2##3##(2008-3#1)(2008-9#1)
may be used as a reference##2##6##(2008-10#1)(2008-12#1)
may be used as a##11##5##(1993-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-6#1)(2012-3#1)(2013-1#1)
may be used as an##4##5##(2007-7#1)(2008-10#2)(2010-3#1)
may be used as part of##2##6##(2008-10#1)(2010-5#1)
may be used as##29##4##(1990-11#1)(1991-4#1)(1993-11#1)(1996-5#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
may be used for the##5##5##(1990-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)
may be used for##15##4##(1990-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#1)(2012-12#1)(2013-8#2)
may be used in a##2##5##(2008-7#1)(2011-2#1)
may be used in order to##2##6##(1991-6#1)(1995-1#1)
may be used in the##2##5##(1992-6#1)(2008-3#1)
may be used in##19##4##(1991-6#1)(1992-6#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-3#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2011-2#1)(2013-8#1)
may be used to##35##4##(1991-2#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-12#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
may be used##110##3##(1990-11#2)(1991-2#2)(1991-4#1)(1991-6#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-7#2)(2008-1#6)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
may be useful as a##7##5##(1994-2#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2010-3#1)
may be useful as##11##4##(1994-2#1)(1994-6#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#2)(2010-3#1)(2011-2#1)
may be useful for estimating##2##5##(1994-3#1)(2008-10#1)
may be useful for evaluating##2##5##(2008-5#1)(2010-4#1)
may be useful for the##2##5##(2008-3#1)(2013-1#1)
may be useful for##34##4##(1990-8#1)(1994-3#2)(1994-5#1)(1994-6#1)(1997-4#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
may be useful in defining##2##5##(2008-7#1)(2009-9#1)
may be useful in developing##2##5##(2008-10#1)(2013-8#1)
may be useful in predicting##2##5##(2009-5#1)(2013-1#1)
may be useful in preventing##2##5##(2008-11#1)(2013-7#1)
may be useful in screening##2##5##(2008-10#1)(2012-3#1)
may be useful in the##3##5##(1996-7#1)(2008-10#1)(2012-2#1)
may be useful in treating##2##5##(2008-4#1)(2013-1#1)
may be useful in##32##4##(1994-7#1)(1994-8#1)(1996-7#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
may be useful to monitor##2##5##(2007-12#1)(2007-9#1)
may be useful to##15##4##(1992-2#1)(1993-12#1)(1997-3#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#2)(2013-8#1)
may be useful##100##3##(1990-8#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
may be utilized for the##2##5##(2008-10#2)
may be utilized##6##3##(2008-10#3)(2008-11#1)(2011-1#1)(2013-8#1)
may be valuable to##2##4##(2008-6#1)(2013-1#1)
may be valuable##3##3##(2007-7#1)(2008-6#1)(2013-1#1)
may be variably##2##3##(2012-12#1)(2012-3#1)
may be varied##2##3##(2008-3#2)
may be very important for##2##5##(1990-12#1)(2010-7#1)
may be very important##4##4##(1990-12#1)(2006-10#1)(2008-7#1)(2010-7#1)
may be very##12##3##(1990-12#1)(1993-12#1)(1997-8#1)(2006-10#1)(2008-1#2)(2008-7#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
may be viewed as a##2##5##(2008-4#1)(2008-7#1)
may be viewed as##3##4##(2007-11#1)(2008-4#1)(2008-7#1)
may be vital to##2##4##(2008-11#1)(2008-8#1)
may be warranted in##2##4##(2008-10#1)(2008-7#1)
may be warranted##6##3##(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)
may be worth##2##3##(1994-3#1)(1997-1#1)
may be worthwhile##2##3##(2007-6#1)(2007-7#1)
may be##2887##2##(1990-10#1)(1990-11#14)(1990-12#20)(1990-2#11)(1990-3#5)(1990-5#14)(1990-6#10)(1990-7#8)(1990-8#13)(1991-1#6)(1991-11#3)(1991-12#23)(1991-2#18)(1991-3#11)(1991-4#3)(1991-5#6)(1991-6#9)(1991-7#1)(1991-8#4)(1991-9#8)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#20)(1992-2#13)(1992-3#20)(1992-4#3)(1992-5#6)(1992-6#11)(1992-7#1)(1992-8#12)(1992-9#19)(1993-1#7)(1993-10#2)(1993-11#10)(1993-12#25)(1993-2#12)(1993-3#16)(1993-5#2)(1993-6#15)(1993-8#14)(1993-9#9)(1994-1#2)(1994-11#19)(1994-12#8)(1994-2#17)(1994-3#18)(1994-5#12)(1994-6#16)(1994-7#1)(1994-8#12)(1994-9#13)(1995-1#4)(1995-11#16)(1995-12#19)(1995-2#19)(1995-3#19)(1995-4#2)(1995-5#19)(1995-6#8)(1995-8#9)(1995-9#3)(1996-1#2)(1996-11#6)(1996-12#20)(1996-2#15)(1996-3#12)(1996-4#3)(1996-5#13)(1996-6#4)(1996-7#7)(1996-8#5)(1996-9#3)(1997-1#14)(1997-2#17)(1997-3#20)(1997-4#17)(1997-5#17)(1997-6#12)(1997-7#18)(1997-8#15)(1997-9#1)(2006-10#11)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#15)(2007-11#30)(2007-12#30)(2007-2#12)(2007-4#6)(2007-5#2)(2007-6#2)(2007-7#21)(2007-8#19)(2007-9#3)(2008-1#54)(2008-10#337)(2008-11#106)(2008-12#54)(2008-2#28)(2008-3#94)(2008-4#61)(2008-5#68)(2008-6#32)(2008-7#134)(2008-8#97)(2008-9#81)(2009-1#1)(2009-10#15)(2009-11#21)(2009-12#11)(2009-2#7)(2009-3#12)(2009-4#10)(2009-5#13)(2009-6#12)(2009-7#8)(2009-8#17)(2009-9#12)(2010-1#8)(2010-10#15)(2010-11#13)(2010-12#21)(2010-2#11)(2010-3#10)(2010-4#11)(2010-5#11)(2010-6#9)(2010-7#9)(2010-8#16)(2010-9#1)(2011-1#37)(2011-10#1)(2011-2#99)(2011-3#3)(2011-7#2)(2012-1#8)(2012-12#33)(2012-2#70)(2012-3#50)(2012-7#1)(2013-1#81)(2013-7#12)(2013-8#39)
may become a new##2##4##(2008-1#1)(2012-12#1)
may become a##5##3##(1992-12#1)(2008-1#1)(2008-10#1)(2010-6#1)(2012-12#1)
may become an##2##3##(1992-8#1)(2008-7#1)
may become available##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
may become more##4##3##(2008-10#1)(2008-6#1)(2010-6#1)(2011-2#1)
may become part of##2##4##(2008-10#1)(2009-11#1)
may become##37##2##(1991-2#1)(1992-12#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)
may belong to a##3##4##(1992-9#1)(2008-10#2)
may belong to the##3##4##(1993-8#1)(1995-6#1)(2008-10#1)
may belong to##7##3##(1992-9#1)(1993-8#1)(1995-6#1)(2008-10#3)(2008-8#1)
may benefit from this##2##4##(2008-10#1)(2008-5#1)
may benefit from##20##3##(1990-3#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#4)(2012-2#1)(2012-3#1)(2012-7#1)
may benefit most##2##3##(2011-1#1)(2012-2#1)
may benefit##29##2##(1990-3#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
may better##4##2##(2008-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
may bind to##2##3##(1995-11#1)(2008-8#1)
may bind##5##2##(1994-5#1)(1995-11#1)(1995-3#1)(2008-8#1)(2010-10#1)
may block the##2##3##(1992-3#1)(2008-8#1)
may block##3##2##(1992-3#1)(2008-8#1)(2009-8#1)
may both be##2##3##(1995-5#1)(2012-2#1)
may both##5##2##(1990-11#1)(1995-5#1)(1997-6#1)(2008-10#1)(2012-2#1)
may bring about##3##3##(1991-8#1)(2008-10#1)(2011-2#1)
may bring##6##2##(1991-8#1)(1996-3#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-2#1)
may carry a##2##3##(2008-10#1)(2008-8#1)
may carry##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
may cause DNA##2##3##(1997-4#1)(2011-2#1)
may cause a##5##3##(1994-12#1)(2008-7#1)(2011-2#3)
may cause damage##2##3##(2006-10#1)(2008-10#1)
may cause harm##2##3##(1993-1#1)(1996-3#1)
may cause multiple##2##3##(2008-3#1)(2011-1#1)
may cause mutations##3##3##(1993-8#1)(1994-5#1)(2013-1#1)
may cause other##2##3##(2008-10#1)(2013-7#1)
may cause the##6##3##(1995-11#1)(1995-3#1)(1995-8#1)(2007-7#2)(2008-9#1)
may cause##71##2##(1991-2#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
may change##10##2##(1992-9#1)(1994-5#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)
may choose##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
may clarify##2##2##(1996-2#1)(2013-1#1)
may coexist##5##2##(2007-11#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)
may combine##2##2##(1990-8#1)(2008-7#1)
may come##3##2##(1997-2#1)(2008-8#1)(2009-9#1)
may comment##7##2##(1995-3#1)(2012-3#6)
may commonly##2##2##(1995-9#1)(2009-4#1)
may compensate for the##2##4##(1994-12#1)(1995-8#1)
may compensate for##3##3##(1994-12#1)(1995-8#1)(2008-10#1)
may compensate##4##2##(1991-12#1)(1994-12#1)(1995-8#1)(2008-10#1)
may compete with##3##3##(1997-6#1)(2008-10#1)(2009-3#1)
may compete##5##2##(1997-6#1)(2008-10#2)(2008-5#1)(2009-3#1)
may complicate the##2##3##(1997-4#1)(2009-7#1)
may complicate##4##2##(1997-4#1)(1997-8#1)(2009-7#1)(2013-1#1)
may compromise patient care##2##4##(2010-9#1)(2013-1#1)
may compromise the##3##3##(1996-2#1)(2008-3#1)(2011-1#1)
may compromise##14##2##(1991-6#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
may confer a##2##3##(1993-2#1)(1994-12#1)
may confer##4##2##(1993-2#1)(1994-12#1)(2008-10#1)(2013-7#1)
may conflict##2##2##(1993-2#1)(2008-12#1)
may confound the##2##3##(2010-4#1)(2012-12#1)
may confound##3##2##(2008-9#1)(2010-4#1)(2012-12#1)
may consequently##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
may consider##3##2##(1991-3#1)(1994-3#1)(2012-12#1)
may constitute a##11##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
may constitute an important##2##4##(1992-8#1)(2008-10#1)
may constitute an##3##3##(1992-8#1)(2008-10#1)(2013-8#1)
may constitute##18##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-6#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#2)(2013-1#1)(2013-8#1)
may constrain##2##2##(2008-10#1)(2008-8#1)
may contain a##4##3##(1990-3#1)(1995-12#1)(2008-2#1)(2008-5#1)
may contain high##2##3##(2008-5#1)(2010-11#1)
may contain##30##2##(1990-3#1)(1990-5#1)(1991-2#1)(1993-8#2)(1995-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2010-11#1)(2010-8#1)
may continue to##5##3##(1995-3#1)(2007-12#1)(2008-10#1)(2013-1#2)
may continue##8##2##(1992-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2011-2#1)(2011-7#1)(2013-1#2)
may contribute significantly to##2##4##(2008-10#1)(2012-12#1)
may contribute to a##7##4##(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)
may contribute to alterations##2##4##(1996-5#1)(1996-6#1)
may contribute to cardiovascular##2##4##(2008-9#1)(2012-2#1)
may contribute to some##2##4##(1996-12#1)(2008-9#1)
may contribute to the development of##4##6##(1992-10#1)(1995-11#1)(2008-12#1)(2012-12#1)
may contribute to the inhibition of##2##6##(1990-2#1)(1992-6#1)
may contribute to the reduction of##2##6##(1995-12#1)(2012-3#1)
may contribute to the regulation of##2##6##(1995-5#1)(2008-4#1)
may contribute to the##49##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
may contribute to these##2##4##(2007-12#1)(2012-1#1)
may contribute to##120##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#4)
may contribute##128##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#4)
may control the##2##3##(2008-1#1)(2010-11#1)
may control##6##2##(1994-11#1)(1994-8#1)(2008-1#1)(2008-11#1)(2009-11#1)(2010-11#1)
may cooperate##2##2##(1995-8#1)(1997-3#1)
may correlate with##4##3##(2008-10#2)(2009-8#1)(2013-1#1)
may correlate##6##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)(2013-1#1)
may correspond to the##2##4##(1995-9#1)(1997-6#1)
may correspond to##7##3##(1990-5#1)(1993-11#1)(1995-12#1)(1995-9#1)(1997-3#1)(1997-6#1)(2008-10#1)
may correspond##8##2##(1990-5#1)(1993-11#1)(1995-12#1)(1995-9#1)(1997-3#1)(1997-6#1)(2008-10#2)
may counteract the##2##3##(1995-2#1)(1995-3#1)
may counteract##4##2##(1994-12#1)(1995-2#1)(1995-3#1)(2008-5#1)
may create a##3##3##(1994-9#1)(2008-3#1)(2013-1#1)
may create##7##2##(1994-1#1)(1994-3#1)(1994-9#1)(2008-2#1)(2008-3#1)(2013-1#2)
may damage##2##2##(1990-11#1)(2008-7#1)
may decline when##2##3##(1992-2#1)(1995-5#1)
may decline##4##2##(1992-12#1)(1992-2#1)(1995-5#1)(2008-8#1)
may decrease the##5##3##(2007-11#1)(2009-9#1)(2011-2#2)(2013-8#1)
may decrease with increasing##2##4##(2008-8#1)(2012-3#1)
may decrease##17##2##(1990-12#1)(1994-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
may define the##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
may delay##4##2##(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
may demonstrate##3##2##(1995-12#1)(2008-10#1)(2009-9#1)
may depend on the##5##4##(1992-7#1)(1994-8#1)(2006-4#1)(2008-10#1)(2008-12#1)
may depend on whether##2##4##(2008-1#1)(2008-3#1)
may depend on##15##3##(1992-7#1)(1994-2#1)(1994-8#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-1#1)(2012-2#1)
may depend##18##2##(1991-12#1)(1992-7#1)(1994-2#1)(1994-8#1)(1996-3#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-1#1)(2012-2#1)
may derive##3##2##(1996-7#1)(2008-10#1)(2008-11#1)
may determine the##3##3##(1997-8#1)(2008-7#1)(2008-9#1)
may determine##6##2##(1997-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
may develop in##3##3##(1997-1#1)(2008-7#1)(2011-2#1)
may develop##18##2##(1994-2#1)(1994-5#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-8#1)
may differ between##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
may differ from the##2##4##(2008-4#1)(2011-2#1)
may differ from those##2##4##(1994-9#1)(2008-7#1)
may differ from##8##3##(1994-9#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#3)
may differ in##6##3##(2007-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
may differ significantly from##2##4##(1993-11#1)(2008-7#1)
may differ##27##2##(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
may directly contribute to##2##4##(2009-8#1)(2013-1#1)
may directly##11##2##(1995-9#1)(2006-6#1)(2008-10#3)(2008-8#1)(2009-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
may display##2##2##(1993-2#1)(2011-2#1)
may disrupt##2##2##(2009-4#1)(2009-9#1)
may disturb the##2##3##(2008-10#2)
may dominate##2##2##(2008-10#1)(2008-8#1)
may drive##2##2##(2008-6#1)(2013-8#1)
may effectively##4##2##(2007-11#1)(2008-10#2)(2010-10#1)
may either##5##2##(2008-10#1)(2008-8#2)(2012-12#1)(2013-1#1)
may elicit##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
may eliminate the##2##3##(2008-10#2)
may eliminate##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2012-12#1)
may emerge##4##2##(2008-2#1)(2008-8#1)(2010-11#1)(2012-3#1)
may enable us to##2##4##(2010-8#1)(2010-9#1)
may enable##11##2##(1993-1#1)(1997-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-8#1)(2010-9#1)(2011-2#1)
may encode##2##2##(2008-2#1)(2013-8#1)
may encounter##4##2##(1992-1#1)(2007-4#1)(2008-12#1)(2008-4#1)
may encourage##2##2##(1992-12#1)(2009-8#1)
may engage in##2##3##(1996-3#1)(2012-12#1)
may engage##3##2##(1996-3#1)(2012-12#1)(2013-8#1)
may enhance performance##2##3##(1992-12#1)(2008-8#1)
may enhance the effect of conventional antipsychotic drugs in schizophrenia##2##10##(2008-6#2)
may enhance the##12##3##(1990-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-7#1)(2012-12#1)(2013-1#2)
may enhance their##2##3##(2008-8#1)(2009-11#1)
may enhance##26##2##(1990-12#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-8#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2010-11#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
may ensure##2##2##(2008-10#1)(2008-5#1)
may even be##3##3##(1997-7#1)(2008-10#1)(2010-10#1)
may even##12##2##(1991-1#1)(1992-12#1)(1994-3#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-7#1)
may eventually be##2##3##(2007-10#1)(2008-5#1)
may eventually##7##2##(1992-12#1)(1992-3#1)(1993-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
may evoke##2##2##(1992-6#1)(2012-1#1)
may evolve into##2##3##(1996-3#1)(2011-2#1)
may evolve##8##2##(1990-6#1)(1996-3#1)(2007-5#1)(2008-8#2)(2008-9#2)(2011-2#1)
may exceed##2##2##(2008-9#1)(2009-3#1)
may exert an##3##3##(1994-7#1)(1996-9#1)(2011-2#1)
may exert its##3##3##(1990-7#1)(1993-9#1)(1994-11#1)
may exert##14##2##(1990-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-11#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#2)
may exhibit a##3##3##(1997-6#1)(2007-12#1)(2009-10#1)
may exhibit##15##2##(1997-6#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
may exist in the##5##4##(1995-5#1)(1997-6#1)(2008-11#2)(2008-9#1)
may exist in##6##3##(1995-5#1)(1996-3#1)(1997-6#1)(2008-11#2)(2008-9#1)
may exist##17##2##(1992-12#1)(1994-5#1)(1995-5#2)(1996-3#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)
may expect and##2##3##(1990-8#2)
may experience##12##2##(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
may explain how##2##3##(2008-8#2)
may explain its##2##3##(1993-8#1)(2008-11#1)
may explain some##3##3##(1992-9#1)(2008-10#1)(2008-3#1)
may explain the high##2##4##(2008-10#1)(2008-3#1)
may explain the reduced##2##4##(1990-12#1)(1990-3#1)
may explain the remarkable##2##4##(2008-8#1)(2012-2#1)
may explain the##34##3##(1990-12#2)(1990-3#1)(1991-1#1)(1991-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
may explain their##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
may explain this##2##3##(2008-10#1)(2009-8#1)
may explain why the##2##4##(1994-8#1)(2008-10#1)
may explain why##8##3##(1991-8#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)
may explain##69##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-1#1)(1991-8#1)(1991-9#2)(1992-9#1)(1993-3#1)(1993-8#4)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
may expose##3##2##(2007-2#1)(2011-2#1)(2012-2#1)
may extend the##3##3##(1991-2#1)(2007-11#1)(2008-3#1)
may extend##8##2##(1991-2#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
may face##4##2##(1994-1#1)(1996-1#1)(2008-11#1)(2012-2#1)
may facilitate a##4##3##(2008-9#1)(2010-1#1)(2010-4#1)(2012-12#1)
may facilitate the##12##3##(1993-12#2)(1994-12#2)(1997-4#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-6#1)(2013-1#1)(2013-7#1)
may facilitate##30##2##(1992-9#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-6#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
may fail to##8##3##(1995-2#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-6#1)
may fail##9##2##(1995-2#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-2#1)
may favor##4##2##(1994-8#1)(2008-10#1)(2008-9#1)(2012-12#1)
may favour##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
may find##8##2##(1995-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2010-9#1)(2012-3#1)(2013-8#1)
may follow##2##2##(1994-1#1)(2011-2#1)
may form a##4##3##(1994-6#2)(2007-12#1)(2008-10#1)
may form the basis for##2##5##(1995-2#1)(2008-3#1)
may form##11##2##(1990-7#1)(1994-6#2)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-7#1)
may function as a##6##4##(1991-12#1)(1995-11#1)(1995-2#2)(1997-7#1)(2009-8#1)
may function as##12##3##(1991-12#1)(1992-9#1)(1995-11#1)(1995-2#2)(1997-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
may function in##3##3##(1994-12#1)(1995-2#2)
may function to##3##3##(1991-10#1)(1994-8#1)(2008-8#1)
may function##23##2##(1991-10#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#4)(1997-2#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-2#1)
may further##11##2##(1991-12#1)(1993-11#1)(1996-9#1)(2008-11#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
may gain##3##2##(1994-10#1)(2012-2#1)(2012-3#1)
may generate##6##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)
may get##4##2##(1995-12#1)(2006-10#1)(2008-3#1)(2012-12#1)
may give a##2##3##(1992-4#1)(2008-11#1)
may give an##2##3##(2007-11#1)(2011-2#1)
may give rise to##4##4##(1991-3#1)(1994-3#1)(1996-12#1)(2009-5#1)
may give##11##2##(1991-3#1)(1992-4#1)(1994-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2011-2#1)
may go##4##2##(1991-2#1)(1997-4#1)(2008-5#1)(2010-12#1)
may greatly##3##2##(2007-10#1)(2008-8#1)(2012-3#1)
may guide##3##2##(2008-10#1)(2010-8#1)(2012-1#1)
may hamper the##2##3##(1995-3#1)(2008-5#1)
may harbor##4##2##(2008-4#2)(2008-9#1)(2012-3#1)
may have a beneficial##2##4##(2011-2#1)(2013-1#1)
may have a future role in##2##6##(2008-1#1)(2010-4#1)
may have a higher risk of developing breast cancer##2##9##(2008-12#2)
may have a higher risk of##3##6##(2008-12#2)(2013-1#1)
may have a higher##5##4##(2008-12#2)(2008-2#1)(2011-2#1)(2013-1#1)
may have a more##2##4##(2008-10#1)(2008-9#1)
may have a negative effect on##2##6##(1993-6#1)(2007-12#1)
may have a negative##3##4##(1993-6#1)(2007-12#1)(2010-8#1)
may have a potential##3##4##(2011-2#1)(2012-2#1)(2013-8#1)
may have a protective effect##2##5##(2008-10#1)(2008-12#1)
may have a role in the##4##6##(1992-2#1)(1993-9#1)(1996-2#1)(2008-10#1)
may have a role in##13##5##(1992-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1996-2#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#1)
may have a role to play##2##6##(2008-7#1)(2010-10#1)
may have a role##15##4##(1992-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1996-2#1)(2008-10#3)(2008-5#2)(2008-7#2)(2009-6#1)(2010-10#1)(2011-2#1)
may have a selective##2##4##(2008-8#2)
may have a significant impact on##2##6##(2008-5#1)(2011-2#1)
may have a specific##2##4##(1995-3#1)(2008-10#1)
may have a variety of##3##5##(2011-2#1)(2012-12#1)(2013-8#1)
may have a##82##3##(1990-3#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
may have advantages for##2##4##(2008-4#1)(2008-7#1)
may have advantages##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
may have affected the##2##4##(1992-11#1)(2010-12#1)
may have affected##4##3##(1991-3#1)(1992-11#1)(2008-6#1)(2010-12#1)
may have an effect on the##2##6##(1996-2#1)(2008-2#1)
may have an effect on##4##5##(1996-2#1)(1997-4#1)(2008-11#1)(2008-2#1)
may have an impact on##2##5##(1991-7#1)(2008-1#1)
may have an important role##2##5##(2008-3#1)(2008-6#1)
may have an increased risk of##2##6##(1997-7#1)(2008-11#1)
may have an##18##3##(1991-7#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-10#1)(2010-3#1)(2012-3#1)
may have application in##2##4##(2007-11#1)(2010-5#1)
may have application##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
may have applications in##2##4##(2008-3#1)(2013-7#1)
may have arisen##3##3##(2008-10#3)
may have been a##3##4##(1992-6#1)(2008-10#1)(2013-7#1)
may have been caused by##3##5##(1993-1#1)(1994-3#1)(2008-8#1)
may have been derived from##3##5##(1992-12#1)(1993-2#1)(2010-8#1)
may have been due to the##2##6##(2008-10#1)(2009-5#1)
may have been generated##2##4##(1993-6#1)(1995-9#1)
may have been involved in the##2##6##(1996-6#1)(2008-10#1)
may have been related to##2##5##(2008-9#2)
may have been used##2##4##(2008-10#2)
may have been##46##3##(1990-11#1)(1990-6#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
may have beneficial effects##2##4##(2007-12#1)(2009-10#1)
may have beneficial##3##3##(2007-12#1)(2009-10#1)(2009-3#1)
may have caused the##2##4##(1991-3#1)(2008-11#1)
may have caused##4##3##(1991-3#1)(1997-8#1)(2008-11#2)
may have certain##2##3##(2008-11#1)(2008-9#1)
may have clinical implications##2##4##(2008-4#1)(2010-1#1)
may have clinical##4##3##(2007-12#1)(2008-4#1)(2010-1#1)(2011-2#1)
may have consequences for the##2##5##(1994-11#1)(2008-11#1)
may have consequences for##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
may have consequences##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
may have contributed to the##5##5##(1991-2#1)(1997-5#1)(2008-10#1)(2010-4#1)(2012-7#1)
may have contributed to##12##4##(1991-2#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-10#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-7#1)
may have contributed##13##3##(1991-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-10#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-7#1)
may have developed##3##3##(1997-3#1)(2008-10#2)
may have different##2##3##(2008-10#1)(2008-3#1)
may have effects##2##3##(1990-2#1)(1996-2#1)
may have errors larger than##2##5##(2008-3#2)
may have evolved as a##2##5##(2008-7#1)(2013-7#1)
may have evolved##7##3##(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-7#1)
may have for the##2##4##(2008-12#1)(2013-1#1)
may have functional##2##3##(1996-2#1)(2007-8#1)
may have generated##2##3##(2008-6#1)(2008-8#1)
may have great significance in##2##5##(2007-11#1)(2010-7#1)
may have great##4##3##(2007-11#1)(2008-8#1)(2008-9#1)(2010-7#1)
may have had##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#1)
may have implications for the##5##5##(1995-6#1)(1996-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
may have implications for##10##4##(1992-9#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
may have implications##11##3##(1992-9#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
may have important implications for##4##5##(1993-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
may have important implications##7##4##(1993-11#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-11#1)
may have important##9##3##(1993-11#1)(1994-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-11#1)(2011-1#1)
may have in##3##3##(1990-8#1)(1993-2#1)(2010-1#1)
may have led to the##2##5##(2007-6#1)(2008-8#1)
may have led to##4##4##(1996-1#1)(2007-6#1)(2008-1#1)(2008-8#1)
may have less##2##3##(2008-1#1)(2012-12#1)
may have little##3##3##(1991-2#1)(1995-5#1)(2008-11#1)
may have lost##2##3##(1994-12#1)(2008-6#1)
may have more##2##3##(1993-2#1)(1996-2#1)
may have occurred##7##3##(2008-10#4)(2008-2#1)(2011-2#2)
may have on the##3##4##(1990-2#1)(1997-2#1)(2008-5#1)
may have on##11##3##(1990-2#1)(1992-1#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
may have only##3##3##(1991-3#1)(1997-3#1)(2013-8#1)
may have originated##3##3##(2007-12#2)(2008-10#1)
may have other##2##3##(2008-2#1)(2009-3#1)
may have particular##2##3##(2010-12#1)(2012-2#1)
may have played a##2##4##(2008-7#1)(2008-8#1)
may have played##3##3##(1995-4#1)(2008-7#1)(2008-8#1)
may have potential##6##3##(1994-6#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
may have predisposed##3##3##(1994-3#2)(2007-7#1)
may have profound effects on##2##5##(2008-5#1)(2008-8#1)
may have relevance to the##2##5##(1993-12#1)(1994-8#1)
may have resulted from the##2##5##(1992-9#1)(2008-6#1)
may have resulted from##6##4##(1992-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-3#1)
may have resulted##7##3##(1992-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-3#1)
may have several##2##3##(1993-1#1)(2008-8#1)
may have significant##6##3##(1992-8#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-8#1)(2011-1#1)
may have similar effects##2##4##(1992-3#1)(2012-2#1)
may have some effect on##2##5##(1996-2#1)(2011-1#1)
may have some##7##3##(1993-3#1)(1996-2#1)(2008-5#1)(2011-1#2)(2012-1#1)(2012-12#1)
may have the##3##3##(1992-2#1)(2009-10#1)(2010-4#1)
may have therapeutic implications##2##4##(2008-7#1)(2012-2#1)
may have therapeutic##7##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
may have to##4##3##(1993-12#1)(1995-2#1)(2007-10#1)(2009-6#1)
may have various##2##3##(1993-3#1)(2008-4#1)
may have##444##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-6#3)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#7)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#58)(2008-11#12)(2008-12#7)(2008-2#4)(2008-3#14)(2008-4#9)(2008-5#13)(2008-6#9)(2008-7#13)(2008-8#18)(2008-9#10)(2009-10#3)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#17)(2012-1#2)(2012-12#9)(2012-2#8)(2012-3#6)(2012-7#1)(2013-1#12)(2013-7#5)(2013-8#8)
may help clinicians##2##3##(1992-3#1)(2012-2#1)
may help explain the##2##4##(1993-12#1)(2012-3#1)
may help explain##4##3##(1993-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
may help identify##3##3##(2009-10#1)(2010-10#1)(2011-2#1)
may help in the##2##4##(2008-5#1)(2011-2#1)
may help in##11##3##(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-2#3)(2013-8#1)
may help prevent##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
may help reduce##3##3##(2008-10#1)(2010-10#1)(2010-4#1)
may help the##6##3##(1991-2#1)(1997-2#1)(2007-11#1)(2010-5#1)(2013-1#2)
may help these##2##3##(2008-11#1)(2008-9#1)
may help to decrease##2##4##(2008-1#1)(2012-3#1)
may help to develop##2##4##(2009-10#1)(2010-2#1)
may help to explain##4##4##(2008-1#1)(2009-12#1)(2009-7#1)(2012-2#1)
may help to overcome##2##4##(2008-10#1)(2008-5#1)
may help to prevent##3##4##(1992-9#1)(2011-2#1)(2012-3#1)
may help to reduce##2##4##(2008-6#1)(2012-3#1)
may help to understand##2##4##(2011-1#1)(2013-7#1)
may help to##37##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#1)(2013-7#1)
may help##103##2##(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-2#5)(2012-3#5)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#1)
may hold##4##2##(1992-12#1)(2008-8#2)(2012-3#1)
may however##3##2##(1991-4#1)(2008-12#1)(2013-1#1)
may identify##5##2##(1991-2#1)(1993-12#1)(2007-7#1)(2010-5#1)(2011-1#1)
may impact on##2##3##(2007-11#1)(2008-9#1)
may impact the##5##3##(2007-7#1)(2008-10#1)(2012-2#2)(2013-1#1)
may impact##12##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
may impair##9##2##(1991-9#1)(1992-10#1)(1992-8#1)(1995-11#1)(2008-3#1)(2009-9#1)(2011-1#1)(2011-2#2)
may implicitly##2##2##(2008-10#1)(2009-9#1)
may imply##4##2##(1996-11#1)(2008-9#3)
may impose##2##2##(2008-5#1)(2011-1#1)
may improve the outcome##2##4##(1992-4#1)(2012-2#1)
may improve the##12##3##(1992-4#1)(1994-5#1)(1994-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
may improve##42##2##(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-12#3)(2009-4#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#6)
may in fact be##2##4##(1991-2#1)(1994-5#1)
may in fact##3##3##(1991-2#1)(1994-5#1)(2008-7#1)
may in part be##2##4##(1994-11#1)(2007-8#1)
may in part##3##3##(1994-11#1)(2007-8#1)(2011-2#1)
may in the##2##3##(2008-10#1)(2008-8#1)
may in turn lead to##3##5##(2006-5#1)(2010-5#1)(2013-1#1)
may in##16##2##(1991-2#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2013-1#2)
may include a##4##3##(2008-11#1)(2008-6#1)(2009-11#1)(2013-8#1)
may include both##2##3##(1995-2#1)(2008-9#1)
may include the##4##3##(2007-8#1)(2008-8#2)(2010-4#1)
may include##26##2##(1995-2#1)(1995-3#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-8#1)
may incorporate##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
may increase morbidity##2##3##(2010-12#1)(2013-8#1)
may increase the risk of##8##5##(1991-9#1)(1994-2#1)(1996-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
may increase the##23##3##(1991-9#1)(1992-5#1)(1994-2#1)(1996-11#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#2)
may increase##49##2##(1991-9#1)(1992-12#1)(1992-5#1)(1994-2#2)(1996-11#2)(1996-6#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#7)(2013-7#2)(2013-8#1)
may indeed##3##2##(1991-9#1)(2008-9#1)(2009-8#1)
may indicate a need for##2##5##(1996-2#1)(1996-6#1)
may indicate a##4##3##(1996-2#1)(1996-6#1)(2008-10#2)
may indicate an##3##3##(1993-1#1)(2008-7#1)(2012-2#1)
may indicate that the##2##4##(1990-11#1)(2008-10#1)
may indicate that##12##3##(1990-11#1)(1991-5#1)(1992-8#1)(2008-10#6)(2008-4#1)(2008-8#1)(2010-5#1)
may indicate the##4##3##(2007-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
may indicate##31##2##(1990-11#1)(1991-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(2007-10#1)(2008-10#9)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-5#1)
may induce a##2##3##(1992-8#1)(1995-8#1)
may induce apoptosis##2##3##(2008-12#1)(2009-12#1)
may induce the##3##3##(1995-5#1)(1997-7#1)(2012-2#1)
may induce##27##2##(1990-9#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
may infect##2##2##(2006-5#1)(2008-10#1)
may influence the development of##3##5##(1994-8#1)(2007-10#1)(2009-9#1)
may influence the##21##3##(1990-2#1)(1992-8#1)(1993-2#2)(1994-2#1)(1994-8#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
may influence##51##2##(1990-2#1)(1990-6#1)(1992-3#1)(1992-8#1)(1993-2#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1997-2#1)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
may inform##2##2##(1994-1#1)(2008-12#1)
may inhibit##4##2##(1992-3#1)(1992-9#1)(1993-3#1)(1995-8#1)
may initially##2##2##(2008-9#1)(2009-3#1)
may initiate##4##2##(1993-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
may interact with##4##3##(1990-2#1)(1993-11#1)(1995-6#1)(2008-5#1)
may interact##8##2##(1990-2#1)(1992-9#1)(1993-11#1)(1995-6#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-3#1)
may interfere with the##4##4##(2008-10#1)(2008-5#1)(2010-3#1)(2012-3#1)
may interfere with##8##3##(1995-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
may introduce##4##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
may involve a##3##3##(1990-7#1)(1993-8#1)(2008-10#1)
may involve an##2##3##(1991-5#1)(1996-8#1)
may involve the action of##2##5##(1996-2#1)(2008-10#1)
may involve the##7##3##(1990-12#1)(1996-2#2)(2008-10#2)(2011-2#1)(2012-2#1)
may involve##31##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#2)(1992-11#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-8#2)(1994-6#1)(1995-5#1)(1996-2#2)(1996-5#2)(1996-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
may jeopardize##3##2##(2007-8#1)(2009-11#1)(2010-4#1)
may justify##4##2##(1990-12#1)(1995-6#1)(1997-8#1)(2008-5#1)
may lack##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
may largely##3##2##(1995-6#1)(2008-10#1)(2013-8#1)
may lead to a better##2##5##(2008-3#1)(2008-6#1)
may lead to a new##2##5##(2007-11#1)(2008-11#1)
may lead to a##10##4##(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#2)(2010-7#1)(2012-12#1)(2012-2#1)
may lead to an##5##4##(1990-2#1)(1994-8#1)(2008-11#1)(2008-8#1)(2013-1#1)
may lead to better##2##4##(2008-5#1)(2009-11#1)
may lead to erectile dysfunction##2##5##(2008-10#1)(2013-8#1)
may lead to important##2##4##(1994-11#1)(2011-2#1)
may lead to increased##4##4##(1992-4#1)(1994-11#1)(2008-10#1)(2012-12#1)
may lead to lethal##2##4##(1994-11#1)(2013-1#1)
may lead to misleading results##2##5##(1997-2#1)(2008-12#1)
may lead to new therapeutic##2##5##(2008-1#1)(2012-2#1)
may lead to new##4##4##(2008-1#1)(2008-4#1)(2008-5#1)(2012-2#1)
may lead to novel##2##4##(2007-12#1)(2010-5#1)
may lead to severe##2##4##(1994-5#1)(2011-1#1)
may lead to the emergence##2##5##(2010-4#1)(2013-1#1)
may lead to the##13##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#5)(2012-12#1)(2013-1#1)
may lead to##111##3##(1990-2#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
may lead##112##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
may lie in##2##3##(2007-12#1)(2010-7#1)
may lie##5##2##(1996-2#1)(2007-12#1)(2008-11#1)(2010-7#1)(2011-2#1)
may limit its##2##3##(1995-3#1)(2008-7#1)
may limit their##2##3##(2011-2#1)(2012-12#1)
may limit##6##2##(1994-3#1)(1995-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
may link##2##2##(2008-5#1)(2012-12#1)
may lose##2##2##(2008-10#1)(2008-7#1)
may maintain##2##2##(2009-7#1)(2013-7#1)
may make a##3##3##(2008-5#1)(2009-10#1)(2009-11#1)
may make it##2##3##(2011-2#2)
may make them##2##3##(2008-10#1)(2009-5#1)
may make##13##2##(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-2#2)(2013-8#1)
may manifest as##2##3##(2008-7#1)(2011-2#1)
may mask the##2##3##(1990-5#1)(1990-6#1)
may mask##3##2##(1990-5#1)(1990-6#1)(2008-12#1)
may mean##4##2##(1993-11#1)(1994-3#1)(2008-7#2)
may mediate the##3##3##(1994-8#2)(2007-8#1)
may mediate##14##2##(1991-12#2)(1991-5#1)(1993-11#1)(1994-8#4)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-8#1)(2012-12#1)
may mimic other##2##3##(2007-5#1)(2008-8#1)
may mimic the##4##3##(1994-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
may mimic##19##2##(1991-6#1)(1994-5#1)(1996-8#1)(2007-5#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
may minimize the##2##3##(1994-2#1)(2008-10#1)
may mitigate##3##2##(1994-2#1)(2008-12#1)(2013-1#1)
may modulate the##2##3##(1997-4#1)(2008-10#1)
may modulate##15##2##(1992-12#1)(1992-6#1)(1992-8#2)(1993-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
may necessitate##2##2##(1990-2#1)(2008-9#1)
may need to be##4##4##(1994-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
may need to##13##3##(1992-2#1)(1994-2#1)(1994-3#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#2)(2013-1#1)
may need##21##2##(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-5#1)(2011-2#2)(2013-1#2)
may negatively##4##2##(1995-1#1)(2007-2#1)(2008-8#1)(2011-2#1)
may nevertheless occur##2##3##(1990-8#1)(2008-11#1)
may not always be##2##4##(1996-12#1)(1997-3#1)
may not always##3##3##(1996-12#1)(1997-3#1)(2008-9#1)
may not be a##7##4##(1992-2#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
may not be able to##5##5##(1994-2#2)(1996-2#1)(2008-2#1)(2012-12#1)
may not be appropriate for##2##5##(2007-11#1)(2008-10#1)
may not be as##7##4##(1991-8#1)(1992-8#1)(2008-5#1)(2012-1#1)(2013-1#2)(2013-7#1)
may not be associated with##3##5##(1992-12#1)(2006-6#1)(2013-1#1)
may not be available##2##4##(2008-10#1)(2008-12#1)
may not be essential for##2##5##(2008-10#1)(2011-2#1)
may not be essential##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
may not be evident in##2##5##(2011-2#2)
may not be fully##2##4##(2008-11#1)(2009-7#1)
may not be involved in the##2##6##(1992-3#1)(2008-8#1)
may not be involved in##3##5##(1992-3#1)(1994-6#1)(2008-8#1)
may not be involved##4##4##(1992-3#1)(1994-6#1)(2008-8#2)
may not be related to##4##5##(1990-12#1)(1991-8#1)(2012-12#1)(2013-1#1)
may not be representative of##2##5##(2008-10#1)(2009-8#1)
may not be sufficient to##3##5##(2007-6#1)(2010-11#1)(2010-3#1)
may not be sufficient##4##4##(1992-8#1)(2007-6#1)(2010-11#1)(2010-3#1)
may not be the##7##4##(1996-1#1)(2008-1#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)
may not be valid for##2##5##(1997-8#1)(2008-3#1)
may not be valid##3##4##(1997-8#1)(2007-12#1)(2008-3#1)
may not be##121##3##(1990-12#1)(1991-2#1)(1991-8#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)
may not fully##3##3##(2009-3#1)(2012-12#1)(2013-8#1)
may not have a##2##4##(1996-12#1)(2008-6#1)
may not have been##2##4##(1993-12#1)(2008-3#1)
may not have##7##3##(1991-8#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
may not improve##2##3##(2008-10#1)(2008-3#1)
may not involve##2##3##(1996-3#1)(2012-3#1)
may not necessarily##3##3##(1996-9#1)(2007-11#1)(2008-6#1)
may not only##6##3##(1990-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
may not provide##4##3##(1995-5#1)(2008-5#1)(2008-8#1)(2010-9#1)
may not reflect##2##3##(2009-5#1)(2010-8#1)
may not represent##2##3##(1996-2#1)(2008-5#1)
may not require##2##3##(2008-9#1)(2012-3#1)
may not result in##2##4##(1995-1#1)(1997-1#1)
may not translate##2##3##(2011-2#1)(2012-12#1)
may not##210##2##(1990-12#2)(1990-2#2)(1991-2#2)(1991-8#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#2)
may now be##4##3##(1990-12#1)(1997-6#1)(2008-11#1)(2008-8#1)
may obscure##2##2##(2008-10#1)(2008-7#1)
may obtain##2##2##(1991-5#1)(2008-10#1)
may occasionally present##2##3##(1992-2#1)(2008-7#1)
may occasionally##5##2##(1992-2#1)(2008-7#2)(2011-2#2)
may occur after##5##3##(2007-12#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
may occur as a##2##4##(2011-2#1)(2012-3#1)
may occur as##5##3##(1991-9#1)(2007-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
may occur because of##2##4##(1995-11#1)(2011-2#1)
may occur by##4##3##(1992-8#1)(1995-6#1)(2007-8#1)(2008-7#1)
may occur due to##2##4##(2007-10#1)(2008-10#1)
may occur during the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
may occur during##8##3##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
may occur either##2##3##(2008-9#1)(2011-2#1)
may occur following##2##3##(2008-7#1)(2012-2#1)
may occur if##2##3##(2008-7#1)(2008-8#1)
may occur in as##2##4##(2008-11#1)(2009-5#1)
may occur in patients##2##4##(1991-11#1)(2007-10#1)
may occur in the absence of##2##6##(2006-10#1)(2010-4#1)
may occur in the##7##4##(1995-5#1)(1995-6#1)(2006-10#2)(2007-12#1)(2010-4#1)(2011-1#1)
may occur in##29##3##(1990-11#1)(1990-8#1)(1991-11#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-1#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#2)
may occur on##2##3##(2008-10#2)
may occur spontaneously or##2##4##(1990-2#1)(2011-2#1)
may occur spontaneously##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
may occur with##3##3##(1993-6#1)(2011-2#1)(2012-3#1)
may occur within##2##3##(1996-12#1)(2008-3#1)
may occur##96##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-8#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
may offer a##7##3##(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-7#1)
may offer additional##2##3##(2006-10#1)(2010-11#1)
may offer an##2##3##(2008-1#1)(2013-1#1)
may offer better##3##3##(2008-2#1)(2009-9#1)(2010-5#1)
may offer important##4##3##(1997-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
may offer new##2##3##(2008-7#1)(2013-1#1)
may offer the##2##3##(2008-7#1)(2011-1#1)
may offer##36##2##(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#3)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-7#1)
may often be##3##3##(2008-2#1)(2009-6#1)(2013-8#1)
may often##5##2##(1992-3#1)(2008-2#1)(2009-10#1)(2009-6#1)(2013-8#1)
may only be##6##3##(1997-3#1)(2007-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2013-8#1)
may only##9##2##(1997-3#1)(2007-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#2)(2013-1#1)(2013-8#1)
may open##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#1)
may operate##5##2##(1990-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
may or may not be associated with##2##7##(1992-12#1)(2013-1#1)
may or may not be##10##5##(1990-12#1)(1992-12#1)(1994-2#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#1)(2013-1#1)
may or may not##16##4##(1990-12#1)(1992-12#1)(1994-2#2)(1995-1#1)(1995-5#1)(2007-10#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
may originate from##5##3##(1990-8#1)(1992-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
may originate in##2##3##(1995-3#1)(2008-2#1)
may originate##7##2##(1990-8#1)(1992-3#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
may overcome##3##2##(2008-10#1)(2009-11#1)(2009-2#1)
may partially explain the##3##4##(1992-8#1)(2012-3#1)(2013-1#1)
may partially##6##2##(1990-11#1)(1992-8#1)(1997-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
may participate in##5##3##(1995-6#1)(1996-2#1)(1997-2#1)(2008-7#1)(2011-2#1)
may participate##6##2##(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-7#1)(2011-2#1)
may partly explain the##2##4##(2008-11#1)(2008-5#1)
may partly explain##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
may partly##6##2##(1992-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
may penetrate into##2##3##(1992-4#1)(2008-5#1)
may permit##4##2##(1991-12#1)(1993-12#1)(2007-12#2)
may persist for years##2##4##(1995-9#1)(2011-2#1)
may persist##3##2##(1995-9#1)(2011-2#2)
may play a causal role in##2##6##(1991-12#1)(1995-12#1)
may play a certain role in the##2##7##(2008-8#2)
may play a critical role in##7##6##(1991-6#1)(1992-9#1)(1993-6#1)(1995-2#1)(1996-5#1)(2010-12#1)(2012-2#1)
may play a crucial role in##3##6##(2008-4#1)(2008-7#1)(2008-9#1)
may play a major role in##3##6##(1997-6#1)(2008-4#1)(2008-6#1)
may play a pivotal role in the##2##7##(1995-12#1)(1995-2#1)
may play a pivotal role in##4##6##(1995-12#1)(1995-2#1)(1997-8#1)(2011-1#1)
may play a pivotal role##5##5##(1995-12#1)(1995-2#1)(1997-8#1)(2011-1#1)(2013-7#1)
may play a regulatory role in##2##6##(1991-12#1)(1994-12#1)
may play a regulatory role##3##5##(1991-12#1)(1993-3#1)(1994-12#1)
may play a role in defense##2##6##(2008-10#2)
may play a role in some##2##6##(1995-12#1)(2008-5#1)
may play a role in the development of##4##8##(2008-1#1)(2009-1#1)(2010-8#1)(2011-10#1)
may play a role in the development##5##7##(2008-1#1)(2009-1#1)(2010-8#1)(2011-10#1)(2012-3#1)
may play a role in the induction of##2##8##(1997-6#1)(2012-3#1)
may play a role in the pathogenesis of the##2##9##(1991-5#1)(1992-6#1)
may play a role in the pathogenesis of##5##8##(1991-5#1)(1992-6#1)(1993-12#1)(1994-2#1)(2008-3#1)
may play a role in the regulation of##3##8##(1990-5#1)(1992-12#1)(2008-1#1)
may play a role in the##39##6##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-10#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-10#1)(2012-2#2)(2012-3#2)(2013-8#2)
may play a role in their##2##6##(1992-6#1)(1995-12#1)
may play a role in##79##5##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-5#2)(1992-12#1)(1992-6#2)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#6)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-10#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#3)
may play a role##88##4##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-5#2)(1991-7#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#6)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#3)
may play a significant role in##2##6##(1995-6#1)(2008-10#1)
may play a##136##3##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#8)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#4)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-8#1)(2013-7#1)(2013-8#4)
may play an important role in the regulation of##2##9##(1993-11#1)(2008-8#1)
may play an important role in the##13##7##(1991-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2010-5#1)(2011-1#1)(2013-1#2)
may play an important role in##31##6##(1990-12#1)(1991-12#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#2)
may play an important role##35##5##(1990-12#1)(1991-12#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#3)(2013-1#2)
may play an##37##3##(1990-12#1)(1991-12#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#3)(2013-1#2)
may play important roles in##4##5##(1994-11#1)(1995-11#1)(2008-9#1)(2013-1#1)
may play important##5##3##(1994-11#1)(1995-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
may play in##3##3##(2008-7#2)(2008-9#1)
may play roles in##3##4##(1994-8#1)(2008-9#1)(2012-3#1)
may play roles##4##3##(1991-2#1)(1994-8#1)(2008-9#1)(2012-3#1)
may play some##2##3##(1993-8#1)(2008-7#1)
may play##197##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#9)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#2)(1997-3#2)(1997-6#2)(1997-8#1)(1997-9#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#9)(2008-9#10)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#5)
may pose a##2##3##(2011-1#1)(2013-8#1)
may pose##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
may possess in vivo##2##4##(1992-2#1)(1997-4#1)
may possess##9##2##(1990-12#1)(1992-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)
may possibly be##3##3##(1990-12#1)(1997-3#1)(1997-4#1)
may possibly##8##2##(1990-12#1)(1992-2#1)(1997-3#1)(1997-4#1)(2008-6#1)(2012-3#1)(2013-1#2)
may potentially be##3##3##(2007-10#1)(2008-10#1)(2009-5#1)
may potentially serve as##2##4##(1991-12#1)(2008-5#1)
may potentially##11##2##(1991-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-1#1)
may potentiate##4##2##(1992-12#1)(2007-7#1)(2010-3#1)(2012-6#1)
may precede##4##2##(1996-4#1)(2008-10#1)(2010-12#1)(2012-3#1)
may precipitate##4##2##(1991-11#1)(1996-2#1)(1996-3#1)(2008-6#1)
may predict##5##2##(1993-8#1)(1997-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
may predispose to##2##3##(1991-9#1)(1997-8#1)
may predispose##10##2##(1990-9#1)(1991-9#1)(1992-2#1)(1993-2#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-8#1)
may present a##2##3##(2006-10#1)(2008-8#1)
may present as##5##3##(2007-7#1)(2008-1#1)(2008-8#1)(2009-10#1)(2011-1#1)
may present in##4##3##(1992-9#1)(2007-12#2)(2011-1#1)
may present with clinical##2##4##(2006-10#1)(2008-3#1)
may present with symptoms##2##4##(2008-9#1)(2013-8#1)
may present with##12##3##(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
may present##30##2##(1992-2#1)(1992-9#1)(2006-10#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
may preserve the##2##3##(1996-9#1)(2013-8#1)
may prevent##20##2##(1990-12#1)(1991-3#1)(1992-9#1)(1993-11#2)(1994-9#1)(1997-5#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
may proceed##2##2##(2008-10#1)(2010-10#1)
may produce a##6##3##(1991-12#1)(1992-12#1)(1993-11#1)(2007-10#1)(2008-5#1)(2012-2#1)
may produce##28##2##(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#1)(2012-2#1)(2013-1#1)
may profoundly##2##2##(1994-9#1)(1995-5#1)
may progress##3##2##(1992-5#1)(2008-7#1)(2011-1#1)
may promote##10##2##(1991-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
may propagate##2##2##(2007-12#1)(2013-1#1)
may protect against##4##3##(1991-8#1)(2008-7#1)(2010-2#1)(2013-1#1)
may protect##11##2##(1991-2#1)(1991-8#1)(1995-12#1)(2007-2#2)(2008-7#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-7#2)
may prove helpful##2##3##(1993-9#1)(1997-3#1)
may prove of##2##3##(1994-11#1)(2012-2#1)
may prove to be a useful##2##6##(1994-3#1)(2008-1#1)
may prove to be an##2##5##(1994-11#1)(2008-10#1)
may prove to be more##3##5##(2008-8#1)(2008-9#1)(2009-3#1)
may prove to be the##2##5##(1996-3#1)(2008-8#1)
may prove to be##15##4##(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)
may prove to##16##3##(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)
may prove useful in determining##2##5##(1990-5#1)(1996-2#1)
may prove useful in future studies of##2##7##(2007-7#1)(2013-1#1)
may prove useful in##6##4##(1990-5#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-5#1)(2013-1#1)
may prove useful##9##3##(1990-5#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-1#1)
may prove##40##2##(1990-5#1)(1992-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
may provide a means##2##4##(1990-5#1)(1997-8#1)
may provide a mechanism##2##4##(1995-8#2)
may provide a more##4##4##(2008-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
may provide a new##3##4##(1996-5#1)(2008-4#1)(2012-2#1)
may provide a novel##4##4##(1991-5#1)(1994-11#1)(1994-3#1)(2008-10#1)
may provide a significant##2##4##(2008-10#1)(2012-2#1)
may provide a simple##2##4##(2008-10#1)(2012-3#1)
may provide a useful##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
may provide a valuable tool##2##5##(2007-11#1)(2008-10#1)
may provide a##53##3##(1990-5#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#2)(1996-5#1)(1997-8#1)(2007-11#2)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#3)(2013-8#2)
may provide additional##2##3##(1997-4#1)(2008-3#1)
may provide an additional##2##4##(1994-8#1)(2008-6#1)
may provide an alternative##3##4##(2008-10#1)(2008-8#1)(2009-9#1)
may provide an effective##2##4##(1993-12#1)(2008-10#1)
may provide an important##3##4##(2008-1#1)(2010-11#1)(2011-2#1)
may provide an improved##2##4##(2008-10#1)(2010-8#1)
may provide an opportunity to##2##5##(2011-2#1)(2013-1#1)
may provide an opportunity##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
may provide an##25##3##(1991-5#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-2#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
may provide better##2##3##(2008-8#1)(2010-1#1)
may provide clues##2##3##(2008-8#1)(2009-2#1)
may provide for##2##3##(1990-2#1)(1996-4#1)
may provide further##2##3##(1995-3#1)(2012-2#1)
may provide important insights into##2##5##(2008-7#1)(2012-12#1)
may provide important##3##3##(2008-6#1)(2008-7#1)(2012-12#1)
may provide incentives##2##3##(1994-2#1)(1997-2#1)
may provide insight into the mechanisms##2##6##(2008-4#1)(2008-9#1)
may provide insight into the##4##5##(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)
may provide insight into##6##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-2#1)
may provide insight##7##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-2#1)
may provide new insights##2##4##(2008-10#1)(2009-4#1)
may provide new##5##3##(1991-5#1)(2008-10#2)(2009-4#1)(2011-2#1)
may provide novel##3##3##(2008-4#1)(2009-6#1)(2013-8#1)
may provide some##4##3##(1993-5#1)(2007-11#1)(2008-10#1)(2009-8#1)
may provide the best##3##4##(2008-8#1)(2012-1#1)(2013-1#1)
may provide the most##2##4##(2008-11#1)(2011-2#1)
may provide the##16##3##(1992-12#1)(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
may provide us##2##3##(2007-11#1)(2013-1#1)
may provide valuable information##2##4##(1996-12#1)(1997-4#1)
may provide valuable##3##3##(1996-12#1)(1997-4#1)(2008-6#1)
may provide##165##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#2)(2007-11#4)(2008-1#7)(2008-10#18)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#10)(2013-8#3)
may provoke##2##2##(1992-2#1)(1995-6#1)
may raise##2##2##(1993-2#1)(2009-8#1)
may rarely##2##2##(2007-8#1)(2010-11#1)
may reach##9##2##(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
may readily##2##2##(2008-4#1)(2009-8#1)
may reduce the need##2##4##(2008-11#1)(2008-9#1)
may reduce the number of##2##5##(1997-7#1)(2012-1#1)
may reduce the risk of##2##5##(1991-9#1)(2008-7#1)
may reduce the risk##3##4##(1991-9#1)(2008-7#2)
may reduce the##16##3##(1990-7#1)(1991-9#1)(1992-8#1)(1993-2#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2012-1#1)
may reduce##42##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-5#1)(1996-12#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#2)(2011-7#1)(2012-1#1)(2013-1#3)
may reflect a##8##3##(1994-3#1)(1995-11#1)(1996-12#1)(2006-10#1)(2007-10#2)(2008-2#1)(2010-5#1)
may reflect functional differences##2##4##(1993-2#1)(2008-6#1)
may reflect the##17##3##(1992-11#1)(1993-6#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-10#2)(2009-3#1)(2012-3#1)
may reflect##46##2##(1990-12#1)(1990-3#1)(1992-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(2006-10#2)(2007-10#3)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#3)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
may regulate the##5##3##(1991-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-4#1)
may regulate##15##2##(1990-7#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#2)(1995-2#2)(1995-6#1)(2008-4#2)(2012-2#2)
may relate to the##2##4##(1992-6#1)(1997-6#1)
may relate to##12##3##(1990-5#1)(1992-6#1)(1993-5#1)(1994-11#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
may relate##15##2##(1990-5#1)(1992-6#1)(1993-5#1)(1994-11#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
may release##3##2##(1990-12#1)(2008-10#1)(2010-5#1)
may rely on##2##3##(2006-6#1)(2008-10#1)
may remain alive##2##3##(2008-10#1)(2011-2#1)
may remain in the##2##4##(2008-12#1)(2008-9#1)
may remain stable##2##3##(2013-1#1)(2013-8#1)
may remain##13##2##(1990-8#1)(1991-11#1)(1991-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
may render the##2##3##(1990-12#1)(2008-11#1)
may render##7##2##(1990-12#1)(1994-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#1)(2010-3#1)
may replace##3##2##(1990-11#1)(1994-9#1)(2012-3#1)
may represent a new##3##4##(1991-9#1)(2008-10#1)(2010-5#1)
may represent a novel target for##2##6##(2011-2#1)(2013-8#1)
may represent a novel##5##4##(1991-9#1)(1996-9#1)(2008-7#1)(2011-2#1)(2013-8#1)
may represent a potential##2##4##(2007-12#1)(2008-10#1)
may represent a##43##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-6#1)(1994-11#2)(1994-12#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#7)(2008-7#4)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-8#1)(2013-8#1)
may represent additional##2##3##(2008-1#1)(2008-5#1)
may represent an##10##3##(1992-3#1)(1995-5#1)(1995-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
may represent novel##2##3##(2009-6#1)(2010-3#1)
may represent the activity of##2##5##(1992-5#1)(1996-4#1)
may represent the first##2##4##(1990-2#1)(1990-5#1)
may represent the##9##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1996-4#1)(2007-12#1)(2008-10#1)
may represent##92##2##(1990-12#1)(1990-2#2)(1990-5#2)(1991-2#2)(1991-4#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#2)
may require a##5##3##(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)
may require new##2##3##(2008-3#1)(2010-9#1)
may require several##3##3##(1992-12#1)(2008-2#1)(2012-2#1)
may require surgical##2##3##(1991-2#1)(2013-1#1)
may require##43##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-4#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#5)
may resemble##2##2##(2007-11#1)(2007-8#1)
may reside in##3##3##(1990-5#1)(1995-8#1)(2008-10#1)
may resolve##3##2##(1995-5#1)(2008-8#1)(2012-2#1)
may respond to changes in##2##5##(2009-2#1)(2013-1#1)
may respond to##8##3##(1994-12#1)(1996-12#1)(2008-2#1)(2009-2#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
may respond##9##2##(1994-12#1)(1996-12#1)(2008-2#1)(2009-2#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
may result from direct##2##4##(1994-11#1)(2012-12#1)
may result from the##6##4##(1990-5#1)(1990-8#1)(1991-12#1)(1995-12#1)(2013-1#1)(2013-8#1)
may result from##27##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
may result in a##8##4##(1995-5#1)(1996-4#1)(2007-10#1)(2008-10#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
may result in an increase in the number of##2##9##(1997-6#1)(2008-10#1)
may result in delayed##2##4##(2008-10#1)(2012-2#1)
may result in increased##2##4##(1997-2#1)(2009-6#1)
may result in reduced##2##4##(2008-10#1)(2008-5#1)
may result in significant##2##4##(1997-3#1)(2011-2#1)
may result in the##3##4##(2008-11#1)(2009-5#1)(2011-2#1)
may result in##71##3##(1990-5#1)(1991-4#1)(1992-2#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
may result##102##2##(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-4#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
may retain##2##2##(2008-7#1)(2011-1#1)
may retard the##2##3##(2008-11#1)(2010-5#1)
may retard##3##2##(1995-3#1)(2008-11#1)(2010-5#1)
may reveal novel##4##3##(2008-4#2)(2011-2#1)(2012-2#1)
may reveal##11##2##(2008-10#2)(2008-4#2)(2009-10#1)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#2)
may rise##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
may run##2##2##(1991-12#1)(2008-9#1)
may safely and effectively be##2##5##(1991-1#1)(2012-1#1)
may seem##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
may selectively##2##2##(1996-2#1)(2009-3#1)
may sensitize##2##2##(2009-12#1)(2010-4#1)
may seriously##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
may serve as a potential##3##5##(1991-9#1)(2008-10#1)(2008-5#1)
may serve as a protective factor##2##6##(2009-11#1)(2013-8#1)
may serve as a useful##3##5##(1995-5#1)(2009-11#1)(2009-4#1)
may serve as a##29##4##(1990-12#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
may serve as an alternative to##2##6##(2008-10#1)(2012-3#1)
may serve as an##7##4##(2008-10#2)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
may serve as potential##2##4##(1993-2#1)(2012-3#1)
may serve as##50##3##(1990-12#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
may serve to##7##3##(1991-2#1)(1994-12#1)(1994-5#1)(1997-2#1)(2008-1#1)(2008-4#1)(2009-6#1)
may serve##61##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#2)(1992-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
may shape##3##2##(2010-9#1)(2011-2#1)(2012-3#1)
may share##7##2##(1992-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-4#1)(2010-7#1)
may shed##2##2##(1994-12#1)(2008-7#1)
may shorten##4##2##(1991-1#1)(1994-3#1)(2008-12#1)(2012-3#1)
may show up##2##3##(2008-1#1)(2008-3#1)
may show##10##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
may significantly influence##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
may significantly##8##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)
may simply reflect##2##3##(2008-10#1)(2012-1#1)
may simply##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
may simulate##2##2##(2007-7#2)
may simultaneously##2##2##(2008-10#1)(2008-8#1)
may sometimes be##2##3##(1993-11#1)(1993-9#1)
may sometimes##7##2##(1993-11#1)(1993-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
may soon##4##2##(1990-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
may specify##2##2##(2008-10#2)
may stabilize##3##2##(2008-8#2)(2009-12#1)
may stain##2##2##(2008-11#1)(2008-7#1)
may start##2##2##(2007-4#1)(2008-9#1)
may still be##4##3##(1996-11#1)(1996-2#1)(2008-10#1)(2008-8#1)
may still##13##2##(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)
may stimulate the proliferation##2##4##(1993-9#1)(2008-5#1)
may stimulate##5##2##(1993-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
may strongly##2##2##(2008-10#1)(2009-2#1)
may subsequently##3##2##(1990-6#1)(2008-7#1)(2013-8#1)
may substantially##2##2##(1993-12#1)(2008-8#1)
may suffer from##2##3##(1995-8#1)(2007-10#1)
may suffer##6##2##(1991-4#1)(1995-8#1)(2007-10#1)(2007-11#1)(2008-3#1)(2010-8#1)
may suggest a##7##3##(1997-5#1)(2007-2#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#2)
may suggest an##2##3##(1991-12#1)(2010-8#1)
may suggest that the##4##4##(1995-6#1)(2007-10#1)(2007-6#1)(2008-5#1)
may suggest that##8##3##(1990-3#1)(1995-6#1)(1996-5#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2013-8#1)
may suggest the##3##3##(1990-5#1)(1996-12#1)(2006-6#1)
may suggest##26##2##(1990-3#1)(1990-5#1)(1991-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(2006-6#1)(2007-10#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
may support the##4##3##(1993-3#1)(1997-4#1)(2008-7#1)(2012-3#1)
may support##7##2##(1993-12#1)(1993-2#1)(1993-3#1)(1997-4#1)(1997-6#1)(2008-7#1)(2012-3#1)
may suppress##3##2##(1990-12#1)(2009-8#1)(2012-12#1)
may take decades##2##3##(1996-4#1)(2010-12#1)
may take on##2##3##(1993-12#1)(1996-3#1)
may take place##2##3##(1996-8#1)(2007-12#1)
may take##11##2##(1991-12#1)(1993-12#1)(1993-2#1)(1996-3#1)(1996-4#1)(1996-8#2)(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
may target##3##2##(2007-11#1)(2009-6#1)(2011-2#1)
may tell##2##2##(2008-1#1)(2008-7#1)
may then be##8##3##(1994-6#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-9#1)
may then##13##2##(1994-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)
may therefore be considered##3##4##(1991-5#1)(1991-9#1)(2007-8#1)
may therefore be##17##3##(1990-10#1)(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-2#1)(1995-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#1)
may therefore have##2##3##(2008-11#1)(2011-2#1)
may therefore##25##2##(1990-10#1)(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-11#2)(1993-2#1)(1995-12#1)(1995-2#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
may thus be##7##3##(1990-6#1)(1993-12#1)(1994-11#1)(1995-3#1)(1997-3#1)(2008-10#1)(2011-2#1)
may thus provide##2##3##(2008-8#1)(2010-3#1)
may thus##20##2##(1990-11#1)(1990-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#1)(2011-2#1)
may transactivate##2##2##(1994-12#1)(2008-8#1)
may trigger##4##2##(2008-10#1)(2011-2#1)(2012-2#2)
may ultimately be##2##3##(1994-5#1)(2011-2#1)
may ultimately##8##2##(1994-5#1)(1997-1#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
may uncover##2##2##(2008-1#1)(2013-8#1)
may underlie the development of##2##5##(1993-8#1)(2012-12#1)
may underlie the##6##3##(1993-8#1)(1994-8#1)(1996-5#1)(2008-2#1)(2008-8#1)(2012-12#1)
may underlie##11##2##(1990-8#1)(1993-8#1)(1994-8#1)(1996-5#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)
may underpin##2##2##(2008-5#1)(2010-9#1)
may unravel##2##2##(2013-1#1)(2013-8#1)
may use the##2##3##(1994-3#1)(2008-1#1)
may use##9##2##(1993-6#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-1#1)
may utilize##3##2##(2008-11#2)(2011-2#1)
may vary according to the##2##5##(1993-9#1)(2008-5#1)
may vary considerably##2##3##(2008-5#1)(2008-9#1)
may vary from##5##3##(1997-2#1)(2007-4#1)(2009-12#1)(2010-12#1)(2013-1#1)
may vary with the type of##2##6##(1997-1#1)(2008-10#1)
may vary with the##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
may vary with##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
may vary##24##2##(1991-10#1)(1992-2#1)(1993-9#1)(1995-12#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#2)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
may very well##2##3##(2008-7#1)(2012-2#1)
may want to##4##3##(1992-12#1)(2007-12#1)(2008-4#1)(2011-1#1)
may well be##6##3##(1994-9#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
may well have##2##3##(1992-2#1)(1993-5#1)
may well##20##2##(1990-10#1)(1990-5#1)(1991-5#1)(1992-2#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-8#1)
may wish to##2##3##(2007-2#1)(2008-11#1)
may work##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
may yield##5##2##(1997-8#1)(2008-7#2)(2009-8#1)(2012-2#1)
may##7742##1##(1990-10#3)(1990-11#35)(1990-12#47)(1990-2#30)(1990-3#15)(1990-5#34)(1990-6#19)(1990-7#15)(1990-8#30)(1990-9#3)(1991-1#12)(1991-10#2)(1991-11#11)(1991-12#51)(1991-2#41)(1991-3#22)(1991-4#8)(1991-5#27)(1991-6#13)(1991-7#4)(1991-8#15)(1991-9#29)(1992-1#11)(1992-10#8)(1992-11#13)(1992-12#58)(1992-2#37)(1992-3#41)(1992-4#9)(1992-5#12)(1992-6#27)(1992-7#2)(1992-8#40)(1992-9#43)(1993-1#18)(1993-10#2)(1993-11#36)(1993-12#56)(1993-2#35)(1993-3#34)(1993-5#6)(1993-6#29)(1993-8#36)(1993-9#24)(1994-1#11)(1994-10#3)(1994-11#55)(1994-12#36)(1994-2#56)(1994-3#46)(1994-5#29)(1994-6#35)(1994-7#3)(1994-8#44)(1994-9#30)(1995-1#9)(1995-11#37)(1995-12#67)(1995-2#59)(1995-3#41)(1995-4#3)(1995-5#47)(1995-6#34)(1995-8#28)(1995-9#12)(1996-1#8)(1996-10#2)(1996-11#15)(1996-12#45)(1996-2#47)(1996-3#32)(1996-4#14)(1996-5#29)(1996-6#16)(1996-7#10)(1996-8#12)(1996-9#15)(1997-1#33)(1997-2#42)(1997-3#43)(1997-4#45)(1997-5#29)(1997-6#31)(1997-7#35)(1997-8#38)(1997-9#4)(2006-10#34)(2006-12#3)(2006-4#2)(2006-5#4)(2006-6#12)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#48)(2007-11#80)(2007-12#95)(2007-2#26)(2007-3#2)(2007-4#10)(2007-5#11)(2007-6#8)(2007-7#54)(2007-8#55)(2007-9#6)(2008-1#124)(2008-10#787)(2008-11#276)(2008-12#119)(2008-2#77)(2008-3#195)(2008-4#144)(2008-5#179)(2008-6#91)(2008-7#333)(2008-8#299)(2008-9#218)(2009-1#5)(2009-10#51)(2009-11#37)(2009-12#32)(2009-2#17)(2009-3#39)(2009-4#26)(2009-5#39)(2009-6#37)(2009-7#28)(2009-8#67)(2009-9#37)(2010-1#22)(2010-10#40)(2010-11#42)(2010-12#53)(2010-2#16)(2010-3#34)(2010-4#33)(2010-5#41)(2010-6#20)(2010-7#20)(2010-8#57)(2010-9#14)(2011-1#106)(2011-10#2)(2011-2#328)(2011-3#7)(2011-7#7)(2012-1#38)(2012-12#113)(2012-2#189)(2012-3#132)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2012-9#2)(2013-1#263)(2013-7#45)(2013-8#128)
maybe##19##1##(1991-9#1)(1994-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)
maydis sequence##2##2##(1996-6#2)
maydis##26##1##(1996-6#5)(2008-10#17)(2009-8#2)(2010-7#2)
mayor##3##1##(2007-11#1)(2008-7#1)(2011-2#1)
mays L##19##2##(2008-10#3)(2008-12#4)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#5)(2012-2#1)(2012-3#3)
mays and##2##2##(2008-11#1)(2008-7#1)
mays ssp##2##2##(2008-5#2)
mays##31##1##(2008-10#7)(2008-11#1)(2008-12#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#5)(2012-2#1)(2012-3#4)
mays)##8##1##(2008-10#6)(2008-5#1)(2012-2#1)
maze and##3##2##(2008-12#1)(2008-9#1)(2011-2#1)
maze at##2##2##(1997-2#2)
maze is##2##2##(1994-3#1)(2008-11#1)
maze learning##4##2##(1993-12#1)(1994-3#1)(1996-5#2)
maze of##2##2##(1995-1#1)(2007-9#1)
maze task and##2##3##(2008-10#1)(2008-4#1)
maze task##8##2##(1994-3#3)(1994-6#1)(1997-2#1)(2008-10#1)(2008-4#2)
maze test##5##2##(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
maze training##2##2##(1992-8#1)(1994-3#1)
maze was##3##2##(1991-2#1)(1992-12#1)(1994-6#1)
maze were##3##2##(1993-12#1)(1994-3#1)(1994-8#1)
maze which##2##2##(1993-12#1)(1993-6#1)
maze##81##1##(1991-2#1)(1992-10#1)(1992-12#3)(1992-7#1)(1992-8#2)(1993-12#12)(1993-3#3)(1993-5#1)(1993-6#3)(1994-2#1)(1994-3#9)(1994-6#7)(1994-8#3)(1995-1#1)(1996-5#3)(1997-2#4)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#2)(2008-7#1)(2008-9#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
mazes##2##1##(1992-12#1)(2012-2#1)
mbar##3##1##(2007-12#2)(2008-2#1)
mbila##5##1##(2008-10#5)
mblf##2##1##(2013-8#2)
mccEh252 and herbicolin O##2##4##(2008-10#2)
mcg ethinyl estradiol and##2##4##(1994-5#2)
mcg kg(-1)##2##2##(2008-12#2)
mcg of##2##2##(1995-8#1)(2008-5#1)
mcg##8##1##(1994-5#4)(1995-8#1)(2008-12#2)(2008-5#1)
mdr1##2##1##(2008-11#2)
mdr1a (-/-) mice##4##3##(2008-10#4)
mdx mice##2##2##(2008-7#2)
mdx muscles##2##2##(1995-12#1)(2008-7#1)
mdx##8##1##(1995-12#4)(2008-7#4)
me to##3##2##(2010-1#1)(2010-9#1)(2013-7#1)
me##19##1##(1991-12#1)(1992-3#1)(1996-12#1)(1996-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#2)
meV##2##1##(2007-12#1)(2012-2#1)
meadow voles mounted higher##2##4##(2008-9#2)
meadow voles##9##2##(1994-3#2)(1994-8#3)(2008-9#4)
meadow##11##1##(1994-3#3)(1994-8#3)(2008-8#1)(2008-9#4)
meadows##2##1##(2008-8#1)(2011-2#1)
meager##2##1##(2008-4#1)(2011-2#1)
meal amendments##5##2##(2008-10#5)
meal and##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
meal at##3##2##(1994-12#1)(2008-10#2)
meal in##5##2##(1995-5#1)(2008-7#2)(2012-2#1)(2012-3#1)
meal services in child day care centers]##2##7##(2007-3#2)
meal was##2##2##(2008-10#2)
meal##81##1##(1991-8#1)(1992-9#1)(1994-12#4)(1995-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-3#2)(2008-10#43)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#1)(2010-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
meal)##2##1##(2008-10#1)(2008-3#1)
meals and##6##2##(1995-6#1)(2007-10#1)(2012-1#1)(2013-1#2)(2013-7#1)
meals at##2##2##(2008-12#2)
meals per##2##2##(1993-2#1)(1994-6#1)
meals were##2##2##(1997-4#1)(2013-1#1)
meals##45##1##(1990-2#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-6#1)(1997-2#1)(1997-4#3)(2007-10#2)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#7)(2008-4#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#8)(2013-7#4)
mealybug wilt of pineapple##3##4##(2008-10#3)
mealybug wilt-associated##2##2##(2008-10#2)
mealybug##14##1##(2008-10#14)
mealybug-transmitted##4##1##(2008-10#4)
mealybugs##6##1##(2007-12#1)(2008-10#5)
mean (+/-##3##2##(1991-5#1)(1994-7#1)(2011-2#1)
mean (+/-SD) age##2##3##(2008-10#1)(2008-3#1)
mean (+/-SD)##5##2##(1993-10#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
mean (SD) increase##2##3##(2008-3#1)(2013-1#1)
mean (SD)##3##2##(2008-3#1)(2013-1#2)
mean (range)##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
mean +##3##2##(1992-3#1)(1996-7#2)
mean +/- S##4##3##(1991-8#1)(1994-3#1)(1997-1#1)(1997-3#1)
mean +/- SD##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
mean +/-##13##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-3#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
mean +/-s##3##2##(2010-8#3)
mean 1##3##2##(1993-2#1)(1996-2#1)(2008-7#1)
mean 39##2##2##(2007-11#1)(2013-1#1)
mean 41##2##2##(2008-12#2)
mean 43) and 40 periodontally##2##5##(2008-12#2)
mean 8##2##2##(1992-6#1)(1996-1#1)
mean =##2##2##(1993-1#2)
mean ADC in the##2##4##(2009-11#2)
mean BMI of##2##3##(2008-1#1)(2013-1#1)
mean Breslow's thickness of the##2##5##(2011-2#2)
mean CBF##4##2##(2008-7#4)
mean CNR##2##2##(2008-2#2)
mean DON##4##2##(2008-10#4)
mean ESR##2##2##(2007-7#2)
mean FEV1##2##2##(2007-8#2)
mean IND##3##2##(2008-10#3)
mean LOS##2##2##(1994-3#2)
mean QTc of##2##3##(2008-8#2)
mean QTc##6##2##(2008-8#6)
mean R##2##2##(2008-10#2)
mean SRIF level##2##3##(1997-2#2)
mean SRIF##3##2##(1997-2#3)
mean a##2##2##(2008-1#1)(2010-12#1)
mean absolute##5##2##(1991-10#1)(2008-10#2)(2008-11#1)(2008-3#1)
mean abundance##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
mean activity coefficients##2##3##(2008-10#2)
mean activity##4##2##(1991-5#1)(2008-10#2)(2008-8#1)
mean affinity##2##2##(1990-8#1)(2008-10#1)
mean age 34##2##3##(1990-3#1)(2007-7#1)
mean age 37##2##3##(1990-2#1)(1994-3#1)
mean age 45##2##3##(1994-3#1)(2008-1#1)
mean age 48##2##3##(1991-5#1)(1995-3#1)
mean age 57##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
mean age 62##3##3##(1990-11#1)(1994-3#1)(2011-2#1)
mean age 69##2##3##(2008-7#1)(2011-2#1)
mean age =##5##3##(1995-11#1)(1996-7#1)(2008-9#1)(2010-1#2)
mean age and the##2##4##(1997-8#1)(2007-10#1)
mean age and##5##3##(1991-12#1)(1997-8#1)(2007-10#1)(2007-7#1)(2013-8#1)
mean age at the##2##4##(2007-8#2)
mean age at##8##3##(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
mean age of 30 years##2##5##(1997-3#1)(2012-2#1)
mean age of 32##3##4##(2008-1#1)(2010-3#1)(2011-2#1)
mean age of 48##3##4##(1992-2#1)(2013-1#2)
mean age of 50##3##4##(2007-8#1)(2008-7#1)(2009-8#1)
mean age of 62##2##4##(2008-7#1)(2013-1#1)
mean age of onset##5##4##(1994-2#1)(1996-2#1)(2007-8#1)(2008-7#1)(2008-8#1)
mean age of the patients was##11##6##(1991-8#1)(1993-2#1)(1995-4#1)(2008-1#4)(2008-11#1)(2010-6#1)(2011-3#1)(2012-3#1)
mean age of the patients##12##5##(1991-8#1)(1993-2#1)(1995-4#1)(2008-1#4)(2008-11#1)(2010-6#1)(2011-3#1)(2012-2#1)(2012-3#1)
mean age of the##17##4##(1991-8#1)(1993-2#1)(1995-4#1)(2007-2#2)(2008-1#5)(2008-11#2)(2010-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
mean age of##84##3##(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-4#1)(1996-2#1)(1997-3#3)(2007-10#1)(2007-2#3)(2007-7#3)(2007-8#6)(2008-1#12)(2008-11#2)(2008-12#2)(2008-7#5)(2008-8#1)(2009-8#3)(2010-1#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
mean age was 17##2##4##(2007-8#1)(2011-2#1)
mean age was 39##2##4##(1990-9#1)(2010-3#1)
mean age was 9##2##4##(2007-7#1)(2008-12#1)
mean age was##24##3##(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1997-8#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
mean age##178##2##(1990-11#2)(1990-2#2)(1990-3#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-7#1)(1997-3#3)(1997-8#2)(2007-10#2)(2007-2#3)(2007-7#9)(2007-8#10)(2008-1#16)(2008-10#2)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#3)(2009-8#3)(2010-1#4)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#13)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#9)(2013-1#9)(2013-7#1)(2013-8#9)
mean amplitude of glycemic excursions (MAGE)##2##6##(2009-11#1)(2012-5#1)
mean amplitude##4##2##(2009-11#1)(2012-5#1)(2013-8#2)
mean analysis##3##2##(2008-10#3)
mean and maximum lifespan of##2##5##(2009-5#1)(2012-2#1)
mean and median##2##3##(1993-9#1)(2007-8#1)
mean and the distribution of values of##2##7##(2013-1#2)
mean and the##4##3##(2008-2#1)(2008-3#1)(2013-1#2)
mean and##21##2##(1990-12#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#4)(2009-5#1)(2012-2#1)(2013-1#2)
mean angle##3##2##(2008-9#1)(2009-12#2)
mean annual##3##2##(1992-7#1)(2008-8#1)(2008-9#1)
mean arterial blood pressure (MAP)##2##5##(2008-7#1)(2013-8#1)
mean arterial blood pressure##10##4##(1990-3#1)(1991-2#1)(1992-3#1)(1992-5#1)(1996-5#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
mean arterial pressure (MAP)##3##4##(1991-5#1)(2011-2#1)(2013-8#1)
mean arterial pressure##14##3##(1990-12#1)(1990-8#2)(1991-5#2)(1994-3#1)(1995-12#1)(2007-9#3)(2008-7#1)(2011-2#2)(2013-8#1)
mean arterial##25##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-2#1)(1991-5#2)(1992-3#1)(1992-5#1)(1994-3#1)(1995-12#1)(1996-5#1)(2007-9#3)(2008-5#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
mean as##3##2##(2008-6#1)(2011-2#2)
mean blood##6##2##(2007-7#1)(2008-10#1)(2008-4#2)(2010-3#1)(2013-8#1)
mean body weight and body weight gain of##2##8##(2008-9#2)
mean body weight and##3##4##(2008-9#2)(2011-1#1)
mean body weight gain of##2##5##(2008-9#2)
mean body weight gain##3##4##(2008-12#1)(2008-9#2)
mean body weight##7##3##(2008-12#1)(2008-9#5)(2011-1#1)
mean body weights of dosed groups were similar to those of the vehicle controls##4##14##(2008-9#4)
mean body weights of males administered 50##2##7##(2008-9#2)
mean body weights of##12##4##(2008-8#1)(2008-9#11)
mean body weights were similar to those of##2##8##(2008-9#2)
mean body weights##18##3##(2008-8#2)(2008-9#16)
mean body##30##2##(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-8#2)(2008-9#22)(2011-1#1)(2011-2#1)
mean bond##2##2##(2008-12#1)(2013-1#1)
mean by##3##2##(2009-12#1)(2011-2#1)(2013-1#1)
mean cell hemoglobin##4##3##(2008-9#4)
mean cell##7##2##(2008-11#1)(2008-7#1)(2008-9#4)(2012-1#1)
mean centering of ratio kinetic profiles##2##6##(2008-10#2)
mean centering of ratio##3##4##(2008-10#3)
mean centering##5##2##(2008-10#5)
mean change in##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
mean changes##4##2##(1990-9#1)(1992-9#1)(2008-5#1)(2008-7#1)
mean clinical##3##2##(2008-5#1)(2008-8#1)(2012-12#1)
mean complex refractive index##3##4##(2008-3#3)
mean concentration of##4##3##(1995-12#1)(2008-12#1)(2008-8#1)(2012-3#1)
mean concentration##9##2##(1991-5#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
mean concentrations of##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
mean concentrations##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)
mean content##3##2##(2008-10#2)(2008-8#1)
mean contents at##2##3##(1997-6#2)
mean corpuscular hemoglobin##2##3##(2008-10#2)
mean corpuscular volume##4##3##(1990-3#1)(1993-3#2)(2008-10#1)
mean corpuscular##6##2##(1990-3#1)(1993-3#2)(2008-10#3)
mean cycle duration##3##3##(1990-9#3)
mean daily##5##2##(1990-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
mean death time in##2##4##(1997-3#1)(2007-6#1)
mean degree##2##2##(2008-10#2)
mean densities were##2##3##(2008-5#2)
mean densities##3##2##(2008-5#2)(2012-3#1)
mean density##5##2##(2008-10#1)(2008-5#2)(2013-7#2)
mean diameter and##2##3##(2008-7#2)
mean diameter of the##3##4##(2007-8#1)(2008-11#1)(2008-7#1)
mean diameter of##8##3##(1994-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-11#1)
mean diameter##10##2##(1994-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#3)(2009-11#1)
mean difference between##2##3##(2008-10#1)(2008-7#1)
mean difference in##2##3##(1992-9#1)(2008-10#1)
mean difference of##3##3##(2007-10#2)(2012-3#1)
mean difference##10##2##(1992-9#1)(2007-10#2)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
mean differences##6##2##(2008-10#1)(2008-12#2)(2010-3#1)(2011-1#1)(2012-2#1)
mean disease incidence##2##3##(2008-10#2)
mean disease##9##2##(2008-10#8)(2010-12#1)
mean dispersal##3##2##(2013-1#3)
mean distance##4##2##(2008-10#3)(2013-8#1)
mean dose of##2##3##(2008-1#1)(2012-3#1)
mean dose##5##2##(1992-10#1)(2008-1#1)(2009-2#2)(2012-3#1)
mean duration of##26##3##(1991-2#1)(1994-8#1)(1995-5#1)(1996-3#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
mean duration##28##2##(1991-2#1)(1994-8#1)(1995-5#1)(1996-3#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
mean egg recovery rate##2##4##(1996-12#2)
mean egg##3##2##(1996-12#2)(2008-8#1)
mean errors##2##2##(2008-2#1)(2008-3#1)
mean excursion##2##2##(2012-2#2)
mean field##2##2##(2008-11#1)(2009-8#1)
mean filter##4##2##(2008-3#4)
mean fitness in##2##3##(1997-7#2)
mean fitness##11##2##(1997-7#2)(2008-8#3)(2008-9#6)
mean follow-up of##15##3##(1990-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-3#2)(2012-2#1)(2013-1#1)
mean follow-up period was##3##4##(1990-9#1)(1997-8#1)(2008-1#1)
mean follow-up period##5##3##(1990-9#1)(1997-8#1)(2008-1#2)(2008-6#1)
mean follow-up time##3##3##(2007-8#1)(2010-3#1)(2011-2#1)
mean follow-up##30##2##(1990-6#2)(1990-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-8#1)(2007-10#2)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-3#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
mean for the##2##3##(1991-11#1)(1994-3#1)
mean for##5##2##(1991-11#1)(1991-12#1)(1994-3#1)(2008-3#1)(2008-5#1)
mean force##3##2##(1997-8#1)(2007-8#1)(2008-10#1)
mean free energy##3##3##(2008-10#3)
mean free path of the##3##5##(2008-3#3)
mean free path##13##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#8)
mean free paths is##2##4##(2007-12#1)(2008-2#1)
mean free paths##7##3##(2007-12#3)(2008-2#1)(2008-3#3)
mean free##26##2##(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#12)
mean germination time##2##3##(2008-12#2)
mean glucose##2##2##(2008-5#1)(2009-11#1)
mean haemoglobin##3##2##(1996-9#1)(2009-10#2)
mean height##4##2##(2008-1#1)(2009-1#1)(2011-1#1)(2011-2#1)
mean hematocrit##3##2##(1990-2#1)(2008-1#1)(2008-4#1)
mean hemoglobin##5##2##(2007-7#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-5#1)
mean heritability for##2##3##(2008-10#2)
mean hospital stay##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
mean hospital##4##2##(1996-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
mean hot flash##2##3##(2008-7#2)
mean hyphal diameter of##2##4##(2008-10#2)
mean hyphal##3##2##(2008-10#2)(2008-7#1)
mean image##2##2##(2011-2#1)(2012-1#1)
mean in##3##2##(1995-8#1)(2008-3#1)(2010-12#1)
mean incidence as##2##3##(2008-10#2)
mean incidence##8##2##(1992-2#1)(2008-10#7)
mean increase in##2##3##(1991-2#1)(1992-12#1)
mean increase##3##2##(1991-2#1)(1992-12#1)(2011-2#1)
mean infarct volume was##2##4##(2008-7#2)
mean insulin##3##2##(1994-12#2)(2008-5#1)
mean intensity of##5##3##(2008-2#3)(2008-6#1)(2012-2#1)
mean intensity##8##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-9#1)(2012-2#1)
mean interommatidial##2##2##(2007-12#2)
mean interval##2##2##(2007-8#1)(2008-5#1)
mean is##3##2##(2009-9#1)(2010-5#1)(2011-2#1)
mean lateral##2##2##(2008-10#1)(2009-2#1)
mean length of the##3##4##(1991-12#1)(2007-8#1)(2013-8#1)
mean length of##9##3##(1991-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
mean level change##2##3##(2008-12#2)
mean level of##7##3##(1993-11#1)(1994-6#1)(2008-10#3)(2008-12#1)(2008-8#1)
mean level##11##2##(1992-11#1)(1993-11#1)(1994-6#1)(2008-10#3)(2008-12#3)(2008-8#1)(2012-2#1)
mean levels of##4##3##(1997-2#1)(2008-1#1)(2008-12#1)(2013-7#1)
mean levels##5##2##(1997-2#1)(2008-1#1)(2008-12#2)(2013-7#1)
mean life expectancy##2##3##(2008-2#1)(2008-9#1)
mean life##3##2##(1996-3#1)(2008-2#1)(2008-9#1)
mean local##3##2##(2008-10#1)(2008-8#2)
mean nuclear##3##2##(1996-9#2)(2008-10#1)
mean number of##27##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-6#1)(1992-3#2)(1992-6#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#1)
mean number##28##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-6#2)(1992-3#2)(1992-6#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#1)
mean of 0##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
mean of 1##3##3##(1990-6#1)(2008-10#1)(2010-6#1)
mean of 2##2##3##(1996-2#1)(2008-10#1)
mean of 4##4##3##(1995-8#1)(2008-1#1)(2009-4#1)(2010-6#1)
mean of all##2##3##(2008-10#1)(2011-2#1)
mean of differences##2##3##(2009-11#1)(2011-2#1)
mean of the##14##3##(1992-3#1)(1993-8#1)(1994-3#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-8#1)(2012-2#1)
mean of##78##2##(1990-11#1)(1990-2#3)(1990-6#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-8#2)(1994-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-7#2)(2008-1#4)(2008-10#19)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-6#2)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)
mean particle##2##2##(2008-5#1)(2013-1#1)
mean path length##2##3##(2008-10#1)(2008-3#1)
mean path##3##2##(1994-3#1)(2008-10#1)(2008-3#1)
mean peak plasma##2##3##(1990-6#1)(2011-2#1)
mean peak##3##2##(1990-6#1)(2008-10#1)(2011-2#1)
mean percent recovery##2##3##(2008-10#2)
mean percent##5##2##(1990-9#1)(1996-3#1)(2008-10#3)
mean percentage of##5##3##(1991-5#1)(1994-1#1)(2008-10#2)(2013-1#1)
mean percentage##8##2##(1991-5#1)(1994-1#1)(2008-10#5)(2013-1#1)
mean percentages##2##2##(1990-12#1)(2008-10#1)
mean phase##2##2##(2008-2#2)
mean plasma##4##2##(1992-6#1)(2008-1#1)(2008-4#1)(2011-2#1)
mean platelet volume##2##3##(2008-10#1)(2008-7#1)
mean power##3##2##(2007-11#2)(2008-2#1)
mean prediction error##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
mean preoperative##2##2##(2009-10#1)(2013-1#1)
mean pressure##2##2##(1997-8#1)(2007-8#1)
mean pressures##2##2##(1991-12#1)(2008-7#1)
mean proportion of diseased spikelets per spike)##2##7##(2008-10#2)
mean protection)##2##2##(1995-5#2)
mean r##2##2##(2008-10#1)(2008-9#1)
mean radiation dose##2##3##(2011-2#1)(2012-2#1)
mean radius##2##2##(2008-2#1)(2008-3#1)
mean rates##2##2##(2008-8#1)(2011-2#1)
mean ratio of##2##3##(2008-12#1)(2008-2#1)
mean ratio##3##2##(2008-12#2)(2008-2#1)
mean recoveries of##2##3##(2008-10#2)
mean recoveries##6##2##(2008-10#6)
mean recovery of##4##3##(1990-11#1)(1993-3#1)(2008-10#2)
mean recovery##11##2##(1990-11#1)(1993-3#1)(2008-10#9)
mean relative error##4##3##(2008-10#4)
mean relative standard deviation##2##4##(2008-10#2)
mean relative##11##2##(2008-10#9)(2008-2#1)(2008-3#1)
mean reproductive success##2##3##(2008-9#2)
mean residence time##2##3##(2008-12#1)(2011-2#1)
mean response##2##2##(2010-2#2)
mean risk score for##2##4##(1991-6#2)
mean sampling rate##2##3##(2008-10#2)
mean score for##4##3##(1990-2#2)(1991-2#2)
mean score of knowledge##2##4##(2011-1#2)
mean score of##4##3##(1995-4#1)(2011-1#3)
mean score##13##2##(1990-2#2)(1991-2#2)(1995-4#1)(1997-3#1)(2009-7#1)(2011-1#3)(2011-2#1)(2013-8#2)
mean scores of##7##3##(1992-1#1)(1995-4#1)(2008-10#1)(2008-7#2)(2009-10#2)
mean scores##10##2##(1992-1#1)(1995-4#1)(2008-1#1)(2008-10#2)(2008-7#3)(2009-10#2)
mean sellar volume##2##3##(2011-2#2)
mean sensitivity of the##2##4##(2008-10#1)(2011-2#1)
mean sensitivity of##3##3##(2008-10#2)(2011-2#1)
mean sensitivity##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
mean serum creatinine##2##3##(2008-1#2)
mean serum##8##2##(1991-12#1)(1992-8#1)(2008-1#3)(2008-3#1)(2009-10#1)(2011-2#1)
mean signal##2##2##(2008-10#1)(2009-11#1)
mean significantly##2##2##(1994-6#2)
mean size of the##3##4##(1995-4#1)(2013-7#1)(2013-8#1)
mean size of##7##3##(1995-3#1)(1995-4#1)(1997-2#1)(2008-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
mean slope of field gradients downwind of##2##7##(2008-10#2)
mean slope##3##2##(2008-10#3)
mean square and##2##3##(2008-3#1)(2012-2#1)
mean square error and##2##4##(2010-8#1)(2012-1#1)
mean square error##12##3##(2008-1#1)(2008-10#8)(2010-8#1)(2011-2#1)(2012-1#1)
mean square##30##2##(1992-4#1)(1992-9#1)(1994-5#2)(1997-4#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#4)(2008-9#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
mean square)##2##2##(2008-2#1)(2008-7#1)
mean squared error##4##3##(2008-10#3)(2008-7#1)
mean squared##5##2##(2008-10#3)(2008-7#2)
mean standard error##3##3##(2008-10#3)
mean standard##6##2##(2008-10#5)(2010-8#1)
mean surface area##2##3##(2011-2#2)
mean surface##4##2##(2007-10#1)(2009-11#1)(2011-2#2)
mean survival of##2##3##(1990-2#2)
mean survival##7##2##(1990-2#2)(1991-8#1)(2007-11#1)(2008-6#1)(2008-7#2)
mean systolic and diastolic blood##2##5##(2008-10#1)(2010-7#1)
mean systolic and##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
mean systolic##4##2##(1991-6#1)(2008-10#1)(2008-7#1)(2010-7#1)
mean temperature##9##2##(2008-10#8)(2008-8#1)
mean temperatures##2##2##(2008-10#1)(2012-6#1)
mean that the##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-3#1)
mean that we are##2##4##(2008-9#1)(2012-3#1)
mean that##16##2##(1990-9#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-3#1)(2012-3#1)
mean the##5##2##(1994-12#1)(1995-2#1)(1996-5#2)(2008-7#1)
mean time interval between implantation and##2##6##(2008-9#2)
mean time of##8##3##(1997-4#1)(2007-11#1)(2007-12#2)(2008-11#2)(2009-3#2)
mean time to##8##3##(2007-10#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
mean time##25##2##(1991-6#1)(1992-11#1)(1992-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#3)(2009-3#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
mean titers##2##2##(1992-8#2)
mean to##4##2##(1990-11#1)(1991-1#1)(2008-10#1)(2008-3#1)
mean total number of wireworms per bait##2##7##(2011-2#2)
mean total number of wireworms##3##5##(2011-2#3)
mean total number of##4##4##(2010-12#1)(2011-2#3)
mean total##12##2##(1991-11#1)(1993-11#1)(1994-2#1)(1995-12#1)(2007-7#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#3)(2012-1#1)
mean transit time##2##3##(2007-10#2)
mean treatment##2##2##(1993-11#1)(2009-9#1)
mean value and##3##3##(1993-1#1)(2008-3#2)
mean value for##3##3##(2008-11#1)(2008-3#2)
mean value of the##4##4##(2008-11#1)(2008-3#2)(2009-6#1)
mean value of##21##3##(1990-2#1)(1991-12#2)(1993-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
mean value was##2##3##(2008-1#1)(2008-4#1)
mean value##42##2##(1990-2#1)(1991-12#2)(1993-1#1)(1993-8#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
mean values and##2##3##(2008-10#2)
mean values for##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
mean values of the##2##4##(2008-7#1)(2010-1#1)
mean values of##12##3##(1990-2#1)(1991-12#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#3)(2010-1#1)
mean values were##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
mean values##29##2##(1990-2#1)(1991-12#2)(1993-1#1)(1994-12#1)(1995-12#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#4)(2009-11#1)(2010-1#1)(2010-12#1)(2012-3#1)
mean velocity##6##2##(1993-12#3)(2008-2#2)(2013-8#1)
mean volume##2##2##(1996-9#1)(2009-11#1)
mean was##3##2##(2007-11#1)(2011-2#2)
mean weekly dose of##2##4##(2007-7#1)(2008-1#1)
mean weekly##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
mean weight of##2##3##(2008-1#1)(2008-12#1)
mean weight##5##2##(1996-5#1)(2008-1#1)(2008-12#1)(2008-5#1)(2013-8#1)
mean white blood cell count##2##5##(2008-10#1)(2011-2#1)
mean width##2##2##(2009-1#2)
mean yield##2##2##(2008-10#1)(2008-9#1)
mean ± standard deviation)##2##4##(2011-2#1)(2012-3#1)
mean ±##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
mean##1680##1##(1990-11#9)(1990-12#4)(1990-2#19)(1990-3#6)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#7)(1990-9#9)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#14)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#11)(1991-6#9)(1991-8#8)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#8)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#10)(1994-2#7)(1994-3#11)(1994-5#3)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#10)(1995-2#3)(1995-3#5)(1995-4#4)(1995-5#6)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#6)(1996-5#6)(1996-6#3)(1996-7#8)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#6)(1997-3#7)(1997-4#10)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#8)(2006-4#1)(2007-10#17)(2007-11#16)(2007-12#17)(2007-2#3)(2007-6#1)(2007-7#28)(2007-8#37)(2007-9#4)(2008-1#56)(2008-10#290)(2008-11#32)(2008-12#35)(2008-2#37)(2008-3#91)(2008-4#20)(2008-5#41)(2008-6#13)(2008-7#75)(2008-8#40)(2008-9#65)(2009-1#4)(2009-10#8)(2009-11#12)(2009-12#3)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#3)(2010-1#5)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#11)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#9)(2010-9#3)(2011-1#17)(2011-2#83)(2011-3#1)(2012-1#8)(2012-12#16)(2012-2#30)(2012-3#32)(2012-5#2)(2012-6#1)(2013-1#60)(2013-7#9)(2013-8#31)
mean-centred##2##1##(2008-10#2)
mean-field approximation##2##2##(2008-2#1)(2008-8#1)
mean-field##8##1##(2007-12#1)(2008-2#3)(2008-3#3)(2008-8#1)
mean-free path##2##2##(2008-2#1)(2008-3#1)
mean-free##3##1##(2008-2#2)(2008-3#1)
mean-square error##2##2##(2007-12#1)(2008-3#1)
mean-square##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
mean-squared error##5##2##(2008-10#1)(2008-3#4)
mean?##3##1##(2007-12#1)(2011-2#1)(2013-8#1)
meaning and origins##2##3##(2008-11#2)
meaning and##11##2##(1992-2#1)(1995-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-6#1)
meaning at the##2##3##(2008-7#1)(2012-12#1)
meaning of a##4##3##(1995-2#1)(1996-9#1)(2008-11#1)(2011-3#1)
meaning of an##2##3##(2008-11#1)(2008-12#1)
meaning of the profession to##2##5##(2012-3#2)
meaning of the##7##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-3#2)
meaning of##37##2##(1990-12#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-10#2)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#2)
meaning that##8##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2013-1#1)(2013-8#1)
meaning to##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
meaning##88##1##(1990-12#1)(1992-2#2)(1993-1#1)(1993-2#2)(1994-1#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-9#1)(2008-1#5)(2008-10#6)(2008-11#12)(2008-12#5)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#6)(2013-1#7)(2013-8#1)
meaningful activities##3##2##(2007-10#2)(2012-2#1)
meaningful and##5##2##(1992-12#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
meaningful comparison of##2##3##(2008-7#1)(2012-12#1)
meaningful comparison##3##2##(1993-2#1)(2008-7#1)(2012-12#1)
meaningful comparisons of##2##3##(2010-12#1)(2013-1#1)
meaningful comparisons##4##2##(1993-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
meaningful daily##2##2##(2007-10#1)(2009-6#1)
meaningful health##2##2##(1994-2#1)(1996-1#1)
meaningful improvement##2##2##(2008-12#1)(2011-1#1)
meaningful improvements in##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
meaningful improvements##4##2##(2008-12#2)(2008-7#1)(2012-3#1)
meaningful in##2##2##(2008-12#1)(2010-7#1)
meaningful retrievals##2##2##(2008-2#1)(2008-3#1)
meaningful to##2##2##(2011-2#1)(2012-2#1)
meaningful use##2##2##(2012-2#1)(2012-3#1)
meaningful way##2##2##(1995-3#2)
meaningful##104##1##(1990-11#1)(1991-1#1)(1992-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#5)(1995-12#2)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#4)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#10)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#1)(2013-8#1)
meaningfully##7##1##(1991-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#1)
meaningless##3##1##(1994-8#1)(2007-11#1)(2008-10#1)
meanings of##7##2##(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2012-3#1)
meanings##13##1##(1995-1#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#3)(2010-8#1)(2012-3#1)(2013-1#1)
means &quot##3##2##(1990-2#1)(1996-4#1)(2010-8#1)
means +/-##2##2##(1990-5#1)(2008-10#1)
means an##3##2##(1991-1#1)(1993-3#1)(1995-1#1)
means analysis##2##2##(2008-10#2)
means and standard deviations were##2##5##(2011-2#2)
means and the##2##3##(1993-8#1)(2008-10#1)
means and##10##2##(1993-8#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#3)
means by which the##4##4##(2007-2#1)(2008-10#2)(2008-9#1)
means by which this##2##4##(1996-1#1)(2010-1#1)
means by which##16##3##(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-2#1)(2008-9#2)(2010-1#1)(2012-3#1)
means for determining##2##3##(2008-10#1)(2008-7#1)
means for overcoming##2##3##(2008-11#1)(2012-12#1)
means for signal##2##3##(1996-2#1)(2007-12#1)
means for studying##2##3##(1995-2#1)(2012-2#1)
means for the##10##3##(1991-12#1)(1991-6#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#2)
means for##49##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-2#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
means in a##2##3##(2007-11#1)(2013-8#1)
means in both##2##3##(2008-10#1)(2008-12#1)
means in##8##2##(1992-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2013-1#1)(2013-8#1)
means is##2##2##(1994-1#1)(2008-2#1)
means of 3D##2##3##(2007-11#1)(2007-12#1)
means of a dynamic##2##4##(2007-11#1)(2008-10#1)
means of a model##3##4##(1994-6#1)(2008-10#1)(2009-8#1)
means of a##125##3##(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#3)(1991-3#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-8#1)(2008-10#40)(2008-11#3)(2008-2#7)(2008-3#20)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
means of achieving##3##3##(1990-2#1)(1996-3#1)(2011-1#1)
means of adjusting the##2##4##(2008-11#1)(2008-2#1)
means of adjusting##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
means of administering##2##3##(1994-9#1)(1995-5#1)
means of assessing##5##3##(1995-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2010-11#1)
means of capturing##3##3##(2007-5#2)(2011-7#1)
means of changing the##2##4##(2008-3#2)
means of communication##2##3##(1992-2#1)(1992-3#1)
means of comparing the##2##4##(1994-12#1)(2008-3#1)
means of comparing##3##3##(1994-12#1)(2008-3#1)(2008-5#1)
means of confirming##2##3##(1990-8#1)(2008-10#1)
means of control of##2##4##(1994-11#1)(2008-5#1)
means of control##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
means of controlling the##2##4##(1991-12#1)(1994-11#1)
means of controlling##4##3##(1991-12#1)(1994-11#1)(2010-1#1)(2012-2#1)
means of creating##2##3##(1994-3#1)(2008-3#1)
means of designing##3##3##(2008-3#1)(2009-10#1)(2010-8#1)
means of determining the##2##4##(2008-3#2)
means of determining##3##3##(1996-3#1)(2008-3#2)
means of enhancing##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
means of evaluating##4##3##(1990-8#1)(1994-2#1)(2008-9#1)(2010-4#1)
means of maintaining##2##3##(2008-8#1)(2008-9#1)
means of modifying##2##3##(2008-4#1)(2012-12#1)
means of molecular##2##3##(1992-6#1)(1992-8#1)
means of monitoring for##2##4##(2008-10#2)
means of monitoring the##4##4##(2008-2#1)(2008-3#2)(2013-8#1)
means of monitoring##8##3##(2008-10#4)(2008-2#1)(2008-3#2)(2013-8#1)
means of observing##2##3##(2008-10#1)(2008-3#1)
means of obtaining##3##3##(1994-12#1)(2008-3#1)(2008-4#1)
means of performing##2##3##(1991-3#1)(2013-1#1)
means of preventing##5##3##(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-8#1)
means of providing##5##3##(1992-3#1)(1993-1#1)(2007-12#1)(2008-4#1)(2010-8#1)
means of quantifying the concentration of##2##6##(2008-10#2)
means of quantifying the##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
means of reducing the##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
means of reducing##6##3##(1993-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
means of release of##2##4##(2008-10#1)(2008-4#1)
means of removing##2##3##(2008-5#1)(2008-7#1)
means of simultaneously##2##3##(2008-3#1)(2011-2#1)
means of storing##2##3##(1996-12#1)(2008-3#1)
means of the##83##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#25)(2008-11#2)(2008-2#6)(2008-3#15)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
means of this##8##3##(1993-3#1)(1994-6#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
means of two##6##3##(2008-10#1)(2008-11#2)(2008-2#1)(2009-11#1)(2013-8#1)
means of understanding##5##3##(1990-5#1)(1993-11#1)(2008-10#1)(2008-11#1)(2009-12#1)
means of##836##2##(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#6)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#2)(1991-5#2)(1991-8#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#4)(1994-8#4)(1994-9#3)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#6)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#2)(2007-10#3)(2007-11#36)(2007-12#30)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#205)(2008-11#31)(2008-12#7)(2008-2#39)(2008-3#118)(2008-4#7)(2008-5#26)(2008-6#5)(2008-7#15)(2008-8#16)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#13)(2012-3#3)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#10)
means on the##2##3##(2008-8#1)(2008-9#1)
means on##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
means or##2##2##(1992-9#1)(2008-9#1)
means such as##2##3##(2008-7#2)
means that a##5##3##(1991-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-7#1)
means that the##19##3##(1993-6#1)(1993-8#1)(1995-3#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
means that this##2##3##(2008-3#1)(2008-5#1)
means that we##2##3##(2008-8#1)(2013-7#1)
means that##59##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-6#1)(2007-12#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
means the##5##2##(1990-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-3#1)
means to achieve the required##2##5##(1995-1#1)(2007-12#1)
means to achieve the##3##4##(1990-11#1)(1995-1#1)(2007-12#1)
means to assess the##2##4##(2008-12#1)(2008-4#1)
means to develop##2##3##(2008-11#1)(2012-1#1)
means to enhance##2##3##(1995-1#1)(2012-2#1)
means to improve##3##3##(2007-8#1)(2008-10#1)(2010-11#1)
means to resolve##2##3##(2008-10#1)(2009-10#1)
means to the##3##3##(1991-1#1)(1993-11#1)(2008-5#1)
means to##92##2##(1990-11#2)(1991-1#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#3)(2007-12#3)(2007-8#1)(2008-10#13)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#3)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
means total##2##2##(2008-10#1)(2008-12#1)
means was##3##2##(2008-10#2)(2008-6#1)
means were##3##2##(1992-12#1)(1997-4#1)(2008-5#1)
means with##3##2##(1994-3#1)(1995-12#1)(2012-1#1)
means##1222##1##(1990-11#4)(1990-12#7)(1990-2#4)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#6)(1991-1#2)(1991-11#4)(1991-12#9)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#3)(1991-8#3)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#5)(1992-6#8)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#5)(1993-12#4)(1993-2#3)(1993-3#6)(1993-6#4)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#7)(1994-6#4)(1994-8#6)(1994-9#3)(1995-1#5)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#8)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#4)(1996-3#9)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#7)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#3)(2006-6#1)(2007-10#4)(2007-11#40)(2007-12#41)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#266)(2008-11#64)(2008-12#19)(2008-2#46)(2008-3#139)(2008-4#13)(2008-5#36)(2008-6#11)(2008-7#26)(2008-8#29)(2008-9#24)(2009-1#1)(2009-10#6)(2009-11#6)(2009-12#7)(2009-3#3)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#5)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#10)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#10)(2012-2#19)(2012-3#8)(2012-7#1)(2013-1#21)(2013-7#5)(2013-8#15)
meant a##2##2##(1990-8#1)(2009-7#1)
meant that the##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#1)
meant that##9##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)
meant to be##3##3##(1996-2#1)(2007-12#1)(2007-2#1)
meant to##12##2##(1993-1#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-1#1)
meant##36##1##(1990-8#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-2#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
meanwhile the##2##2##(2008-10#1)(2013-8#1)
meanwhile##11##1##(1997-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2011-2#1)(2013-8#1)
measles (rubella)##2##2##(2012-12#2)
measles and German measles in Colombia##2##6##(2012-12#2)
measles and German measles##4##4##(2012-12#4)
measles and##7##2##(2008-8#1)(2012-12#6)
measles epidemics##4##2##(1995-5#2)(2008-9#2)
measles in##3##2##(1995-3#1)(2012-12#2)
measles##39##1##(1991-8#1)(1994-11#1)(1994-3#1)(1995-3#2)(1995-5#3)(1996-1#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-4#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#15)(2013-7#1)
measles)##2##1##(2008-11#1)(2012-12#1)
measles-specific##4##1##(2008-12#4)
measurability##2##1##(1993-5#1)(2012-2#1)
measurable and##2##2##(1991-2#1)(1994-1#1)
measurable disease##3##2##(1991-2#1)(2008-6#2)
measurable effect on spread##2##4##(2008-10#2)
measurable effect on##4##3##(1992-12#1)(1993-3#1)(2008-10#2)
measurable improvements in##3##3##(1995-12#1)(1996-12#1)(1996-2#1)
measurable in##2##2##(2008-10#1)(2008-5#1)
measurable parameters##3##2##(2007-8#2)(2010-10#1)
measurable quantities##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
measurable range##2##2##(1990-8#1)(2007-12#1)
measurable receptor##2##2##(2007-11#1)(2008-4#1)
measurable##99##1##(1990-12#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(2007-11#7)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
measurably insensitive to variations in internal or external calcium##2##9##(1990-2#2)
measurably##10##1##(1990-2#2)(1991-12#1)(1994-6#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-6#1)
measure a large##2##3##(2010-8#1)(2012-2#1)
measure a##8##2##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
measure analysis##2##2##(1991-2#1)(2012-12#1)
measure and##20##2##(1991-11#1)(1994-3#1)(1995-3#2)(1996-3#1)(1997-2#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#3)
measure based on##2##3##(1992-11#1)(2008-2#1)
measure blood pressure##2##3##(2008-1#1)(2012-3#1)
measure blood##7##2##(2007-8#1)(2008-1#1)(2008-10#3)(2010-11#1)(2012-3#1)
measure both the##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
measure both##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-1#1)
measure can be##2##3##(2008-3#1)(2008-6#1)
measure cerebral blood flow and##2##5##(1994-2#1)(2012-3#1)
measure construction##2##2##(2013-1#2)
measure could##2##2##(2008-9#1)(2011-2#1)
measure directly##3##2##(2008-2#2)(2012-2#1)
measure effects of##2##3##(2008-10#2)
measure for persistence in holographic recording##2##6##(2008-3#2)
measure for the##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
measure for##24##2##(1990-3#1)(1992-10#1)(1994-9#2)(1997-1#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#4)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
measure human##4##2##(1992-9#1)(1993-6#1)(2008-4#1)(2011-2#1)
measure in the management of##2##5##(1990-3#1)(2008-3#1)
measure in vivo##2##3##(2008-4#1)(2008-5#1)
measure in##15##2##(1990-3#1)(1996-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#2)
measure is used##2##3##(2008-10#1)(2008-3#1)
measure is##13##2##(1992-2#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
measure it?##2##2##(2009-11#1)(2010-10#1)
measure its##2##2##(2008-10#1)(2008-6#1)
measure multiple##2##2##(2008-9#1)(2012-12#1)
measure number six##2##3##(2007-8#2)
measure number##3##2##(2007-8#3)
measure of aggregation##2##3##(2008-10#2)
measure of gait##2##3##(2013-1#1)(2013-7#1)
measure of its##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
measure of multilocus correlation##4##4##(2008-10#4)
measure of multilocus##5##3##(2008-10#5)
measure of output##3##3##(1993-3#1)(1994-12#1)(2008-11#1)
measure of performance##2##3##(2008-11#1)(2008-2#1)
measure of quality##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
measure of the extent of##2##5##(1993-2#1)(2008-10#1)
measure of the##47##3##(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-7#1)(1994-8#1)(1997-1#1)(1997-2#2)(2006-6#1)(2007-12#2)(2007-7#1)(2008-10#11)(2008-2#3)(2008-3#6)(2008-4#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-3#1)
measure of##201##2##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-4#2)(1992-12#1)(1992-2#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#4)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-7#3)(2008-1#1)(2008-10#30)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#8)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#6)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#9)(2013-7#2)(2013-8#2)
measure only##3##2##(1992-12#1)(2008-3#1)(2008-4#1)
measure performance##2##2##(1995-12#1)(1996-3#1)
measure progress##4##2##(1996-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
measure selection/specification##2##2##(2013-1#2)
measure social##2##2##(1992-3#1)(2011-2#1)
measure that##7##2##(1995-2#1)(1996-5#1)(1997-1#1)(2008-7#1)(2008-9#2)(2011-2#1)
measure the Earth's##2##3##(2008-2#1)(2008-3#1)
measure the ability of##2##4##(2008-1#1)(2008-8#1)
measure the ability##3##3##(2008-1#1)(2008-8#1)(2012-3#1)
measure the absorption coefficient of pulsed##2##6##(2008-2#2)
measure the absorption##3##3##(2008-2#3)
measure the amount of##2##4##(2008-11#1)(2008-9#1)
measure the changes##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
measure the concentrations of##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
measure the effects of##3##4##(1995-12#1)(2008-2#1)(2008-9#1)
measure the expression##2##3##(2008-7#2)
measure the extent of##4##4##(1994-5#1)(1997-6#1)(2008-10#1)(2008-4#1)
measure the impact of##4##4##(1992-12#1)(1995-2#1)(2008-9#1)(2013-1#1)
measure the kinetics of##3##4##(2008-3#1)(2008-4#1)(2008-8#1)
measure the optical##4##3##(2008-3#4)
measure the relative##4##3##(1991-9#1)(2008-10#2)(2008-3#1)
measure the spatial##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
measure the surface##6##3##(1992-3#1)(2007-12#1)(2008-2#2)(2008-3#2)
measure the three-dimensional##2##3##(2008-2#1)(2008-3#1)
measure the total##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
measure the##247##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1993-11#1)(1993-8#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#9)(2007-12#10)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#4)(2008-2#30)(2008-3#56)(2008-4#10)(2008-5#8)(2008-7#3)(2008-8#5)(2008-9#8)(2009-11#2)(2009-12#3)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
measure their##7##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)
measure this##2##2##(2008-2#1)(2008-3#1)
measure tissue##2##2##(2008-4#1)(2012-2#1)
measure to##6##2##(1995-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-1#1)
measure used to##2##3##(1996-1#1)(2008-11#1)
measure used##3##2##(1996-1#1)(2008-11#1)(2008-9#1)
measure was the##6##3##(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
measure was##11##2##(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
measure with##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
measure without##2##2##(2008-10#1)(2011-2#1)
measure##1047##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#4)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#8)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#3)(1995-12#12)(1995-2#7)(1995-3#4)(1995-5#7)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#6)(1996-12#9)(1996-2#6)(1996-3#8)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#5)(1997-1#8)(1997-2#6)(1997-3#5)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#5)(2007-11#18)(2007-12#36)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#11)(2008-10#110)(2008-11#28)(2008-12#13)(2008-2#65)(2008-3#144)(2008-4#34)(2008-5#26)(2008-6#22)(2008-7#20)(2008-8#15)(2008-9#36)(2009-1#1)(2009-10#2)(2009-11#7)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#4)(2009-9#2)(2010-1#3)(2010-10#6)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#7)(2010-8#7)(2010-9#2)(2011-1#7)(2011-2#35)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#16)(2012-2#28)(2012-3#15)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#36)(2013-7#5)(2013-8#8)
measure) and##2##2##(2008-12#1)(2008-4#1)
measure)##4##1##(2008-12#3)(2008-4#1)
measure?##3##1##(1993-1#1)(2008-8#1)(2011-2#1)
measured (1)##2##2##(1995-5#1)(2012-1#1)
measured 4##2##2##(1997-2#1)(2013-1#1)
measured 5##2##2##(2008-12#1)(2009-8#1)
measured DHR##2##2##(2008-3#2)
measured UV##3##2##(2008-3#3)
measured a##6##2##(1994-9#1)(1996-3#1)(2007-11#1)(2008-3#1)(2009-11#1)(2010-4#1)
measured absorbance##2##2##(2008-10#2)
measured absorption##4##2##(2008-2#1)(2008-3#3)
measured across##3##2##(1990-12#1)(2008-12#1)(2009-11#1)
measured after a##2##3##(1992-12#1)(2007-11#1)
measured after the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
measured after##21##2##(1992-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
measured against##6##2##(1992-6#1)(1993-12#1)(2008-10#3)(2011-2#1)
measured along##3##2##(2007-10#1)(2008-2#1)(2013-7#1)
measured amount of##2##3##(1991-12#1)(2011-2#1)
measured an##6##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
measured and analyzed##3##3##(2007-8#1)(2008-12#1)(2009-10#1)
measured and calculated values##3##4##(2008-3#3)
measured and calculated##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2012-2#1)
measured and compared with theory##2##5##(2007-12#2)
measured and compared with##7##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-6#1)
measured and compared##11##3##(1995-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2009-6#1)(2010-8#1)(2011-2#1)
measured and correlated##2##3##(2007-11#1)(2008-10#1)
measured and found to be##3##5##(2007-11#1)(2007-12#1)(2012-3#1)
measured and found to##4##4##(2007-11#2)(2007-12#1)(2012-3#1)
measured and modeled##2##3##(2008-3#2)
measured and predicted##4##3##(2008-2#1)(2009-5#1)(2010-8#2)
measured and simulated##3##3##(2008-2#1)(2008-3#2)
measured and the influence of##2##5##(2008-10#1)(2008-2#1)
measured and the##11##3##(1990-11#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)
measured and their##2##3##(2008-10#1)(2008-3#1)
measured and theoretical values##2##4##(2008-10#1)(2008-2#1)
measured and theoretical##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
measured and used to calculate##2##5##(2008-10#1)(2008-11#1)
measured and used to##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
measured and used##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
measured and##84##2##(1990-11#1)(1991-3#2)(1993-12#1)(1994-3#2)(1995-12#1)(1996-2#1)(1997-8#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#22)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
measured as a function of temperature##3##6##(1996-7#1)(1997-7#1)(2008-10#1)
measured as a function of the##7##6##(1996-5#1)(2007-12#1)(2008-2#2)(2008-3#3)
measured as a function of##23##5##(1993-11#1)(1993-12#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#6)(2008-7#1)
measured as a##25##3##(1993-11#1)(1993-12#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#6)(2008-7#1)(2012-3#1)
measured as an##6##3##(1996-4#1)(2008-10#2)(2008-11#2)(2008-4#1)
measured as far as##2##4##(2007-12#1)(2008-10#1)
measured as number of##2##4##(2008-10#2)
measured as the##7##3##(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2009-6#1)
measured as##69##2##(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-10#17)(2008-11#4)(2008-2#5)(2008-3#8)(2008-4#1)(2008-7#2)(2009-6#1)(2012-3#2)(2013-1#1)(2013-8#1)
measured at 1##3##3##(2007-12#1)(2008-3#2)
measured at 205 nm##2##4##(2008-1#1)(2008-10#1)
measured at 420 nm##2##4##(2008-10#2)
measured at 980 nm##2##4##(2007-12#1)(2008-10#1)
measured at a fixed##2##4##(2008-10#1)(2008-3#1)
measured at a resolution of 1##2##6##(2008-10#1)(2008-3#1)
measured at a wavelength of##2##5##(2007-11#1)(2007-12#1)
measured at a##12##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#5)(2008-5#1)(2009-2#1)
measured at baseline and##2##4##(2007-10#1)(2008-3#1)
measured at different##5##3##(1996-12#1)(2008-10#1)(2008-7#2)(2008-8#1)
measured at each##3##3##(2008-2#1)(2009-2#1)(2011-2#1)
measured at four##5##3##(2008-11#1)(2008-3#2)(2010-5#1)(2013-3#1)
measured at low##3##3##(1993-9#1)(1995-5#1)(2008-7#1)
measured at pH##2##3##(1991-12#1)(1992-12#1)
measured at several##2##3##(2008-10#1)(2008-3#1)
measured at specific##3##3##(2008-10#2)(2008-7#1)
measured at the same time##3##5##(1991-6#1)(2008-2#1)(2008-3#1)
measured at the##20##3##(1991-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#6)(2010-12#1)(2010-7#1)(2012-4#1)(2013-7#1)
measured at two##4##3##(2007-5#1)(2008-2#2)(2008-9#1)
measured at##160##2##(1990-11#2)(1990-2#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-5#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#62)(2008-11#2)(2008-2#11)(2008-3#25)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-4#1)(2013-1#3)(2013-3#1)(2013-7#1)(2013-8#2)
measured bandwidth of##2##3##(2007-12#1)(2008-3#1)
measured bandwidth##3##2##(2007-12#2)(2008-3#1)
measured based on the##2##4##(2008-10#1)(2013-8#1)
measured based on##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
measured before and after##6##4##(1996-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2011-1#1)
measured before and at##2##4##(2008-3#1)(2008-5#1)
measured before and##9##3##(1992-6#1)(1996-2#1)(2007-12#1)(2008-3#2)(2008-5#2)(2009-12#1)(2011-1#1)
measured before##17##2##(1992-6#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-5#2)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
measured between##5##2##(1994-11#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-3#1)
measured blood pressure##2##3##(2008-1#1)(2008-11#1)
measured body##2##2##(2008-7#1)(2013-1#1)
measured by 13C##2##3##(1990-9#1)(1995-11#1)
measured by CAT##2##3##(1995-8#1)(2008-11#1)
measured by ELISA##5##3##(1990-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
measured by HPLC##2##3##(1992-11#1)(2008-6#1)
measured by Western blot analysis##2##5##(1990-8#1)(2011-2#1)
measured by Western##3##3##(1990-8#1)(2008-5#1)(2011-2#1)
measured by a Fourier transform##2##5##(2007-11#1)(2007-12#1)
measured by a##37##3##(1990-6#1)(1991-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#5)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#2)(2011-3#1)(2013-1#1)
measured by an ELISA##2##4##(1991-3#1)(1993-12#1)
measured by an##12##3##(1991-2#1)(1991-3#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)
measured by atomic force microscopy##2##5##(2008-2#1)(2008-3#1)
measured by atomic##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
measured by both##4##3##(1993-12#1)(2008-10#2)(2011-2#1)
measured by dual##2##3##(1991-11#1)(2008-4#1)
measured by echocardiography##3##3##(1995-3#1)(1996-6#1)(2011-2#1)
measured by ellipsometry##2##3##(2008-10#1)(2008-2#1)
measured by flame atomic absorption spectrometry##2##6##(2008-10#2)
measured by flow##2##3##(1993-2#1)(2008-11#1)
measured by fluorescence##2##3##(2008-10#1)(2009-12#1)
measured by gas liquid chromatography##2##5##(2008-7#2)
measured by gas##4##3##(2008-10#1)(2008-11#1)(2008-7#2)
measured by heterodyne##2##3##(2008-3#2)
measured by high##2##3##(1993-12#1)(1995-12#1)
measured by immunoblotting##2##3##(1992-6#1)(2009-11#1)
measured by immunofluorescence##2##3##(1996-2#1)(2012-2#1)
measured by in situ##2##4##(1995-12#1)(1996-12#1)
measured by in vitro##3##4##(1993-5#1)(2008-10#1)(2008-11#1)
measured by in##6##3##(1993-5#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
measured by lidar##2##3##(2008-3#2)
measured by liquid scintillation counting##2##5##(2008-10#1)(2008-11#1)
measured by means of the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
measured by means of##5##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
measured by microdialysis##3##3##(1995-12#1)(1997-2#1)(1997-7#1)
measured by monitoring##2##3##(1991-9#1)(2008-10#1)
measured by other##2##3##(2008-2#1)(2008-3#1)
measured by quantitative autoradiography##2##4##(1992-5#1)(1995-12#1)
measured by quantitative##4##3##(1992-5#1)(1995-12#1)(1995-5#1)(2013-1#1)
measured by radioimmunoassay##4##3##(1990-5#1)(1992-9#1)(1994-5#1)(2011-1#1)
measured by selective##2##3##(1995-11#1)(2008-11#1)
measured by spectrophotometry##2##3##(2008-10#1)(2008-7#1)
measured by standard##2##3##(2008-10#1)(2008-2#1)
measured by the area under the##2##6##(2008-3#1)(2013-1#1)
measured by the formation of##2##5##(1993-3#1)(2008-10#1)
measured by the inhibition##2##4##(1992-3#1)(1992-8#1)
measured by the number of##2##5##(1991-2#1)(2008-10#1)
measured by the##93##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-5#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-10#3)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#3)(2008-2#4)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
measured by their##2##3##(1994-8#1)(2008-10#1)
measured by this method are in good agreement with those##2##10##(2008-10#2)
measured by this method##3##4##(1995-12#1)(2008-10#2)
measured by this##5##3##(1993-1#1)(1995-12#1)(2008-10#3)
measured by ultrafiltration##2##3##(1993-12#1)(2008-10#1)
measured by ultrasound##3##3##(1992-11#1)(2013-1#1)(2013-8#1)
measured by use of a##3##5##(2008-2#1)(2008-3#1)(2009-1#1)
measured by use of an##2##5##(2007-12#1)(2008-2#1)
measured by use of##13##4##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)(2009-1#1)(2013-1#1)
measured by using an##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
measured by using the##2##4##(2008-10#1)(2013-8#1)
measured by using##10##3##(1995-8#1)(2008-10#3)(2008-2#2)(2008-5#1)(2013-1#1)(2013-8#2)
measured by##472##2##(1990-11#3)(1990-12#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#6)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#8)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#2)(1997-1#2)(1997-2#5)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#6)(2007-11#5)(2007-12#12)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#94)(2008-11#19)(2008-12#3)(2008-2#24)(2008-3#43)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-9#2)(2011-1#7)(2011-2#16)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#7)
measured concentration##2##2##(2008-10#2)
measured concentrations of##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
measured concentrations##8##2##(1996-12#1)(2008-10#5)(2008-2#1)(2013-1#1)
measured cw##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
measured data with##3##3##(2008-3#3)
measured data##23##2##(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#11)(2008-5#1)(2008-7#1)(2012-3#1)
measured directly by this##2##4##(2007-11#1)(2008-11#1)
measured directly by##5##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
measured directly in##3##3##(2008-10#2)(2008-2#1)
measured directly with a##2##4##(2007-12#1)(2008-10#1)
measured directly with##5##3##(1993-6#1)(2007-12#1)(2008-10#2)(2008-3#1)
measured directly##22##2##(1993-6#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)
measured distributions##2##2##(2008-3#2)
measured during the##4##3##(1992-2#1)(2007-7#1)(2008-11#1)(2008-7#1)
measured during##14##2##(1992-2#1)(1993-1#1)(1995-11#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-7#1)
measured dynamic##2##2##(2007-12#2)
measured effective##2##2##(2007-12#1)(2008-2#1)
measured every##5##2##(1995-11#1)(2007-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
measured experimentally##3##2##(2008-10#1)(2008-3#2)
measured exposure##3##2##(1993-1#2)(2011-2#1)
measured field##2##2##(2007-12#1)(2008-10#1)
measured flow##3##2##(2007-8#1)(2008-7#2)
measured fluorescence from##2##3##(2008-3#2)
measured fluorescence##4##2##(2008-3#4)
measured following application of##2##4##(2008-10#1)(2008-3#1)
measured following##4##2##(1992-3#1)(2008-10#2)(2008-3#1)
measured for a##3##3##(2007-11#2)(2008-2#1)
measured for both##2##3##(1995-2#1)(2008-3#1)
measured for each##8##3##(1992-3#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-9#1)(2013-7#1)
measured for the first time##3##5##(2007-12#1)(2008-5#1)(2009-4#1)
measured for the##11##3##(1996-5#1)(2007-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2009-4#1)
measured for##61##2##(1990-8#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#6)(2008-10#13)(2008-11#1)(2008-2#7)(2008-3#11)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
measured from a##2##3##(2008-2#2)
measured from the##19##3##(1990-8#1)(1991-5#1)(1991-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)
measured from##31##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-5#1)(1995-2#1)(1995-6#1)(1997-2#2)(2007-12#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)
measured image##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
measured immediately##2##2##(2008-10#1)(2008-6#1)
measured impedance##2##2##(1995-11#1)(2008-9#1)
measured in 10##2##3##(1990-2#1)(1995-5#1)
measured in 15##2##3##(1990-2#1)(2008-8#1)
measured in a##21##3##(1992-9#1)(1993-11#2)(1994-3#1)(1996-2#1)(1996-7#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#2)
measured in an##2##3##(1995-12#1)(2008-10#1)
measured in aqueous##3##3##(1995-11#1)(2008-10#2)
measured in both the##2##4##(2013-1#1)(2013-7#1)
measured in both##7##3##(1993-3#1)(1994-3#1)(2008-3#2)(2011-1#1)(2013-1#1)(2013-7#1)
measured in different##2##3##(1990-3#1)(2008-10#1)
measured in eight##3##3##(1990-3#1)(2008-10#1)(2008-6#1)
measured in healthy##2##3##(1992-9#1)(1993-9#1)
measured in hours##2##3##(1994-3#1)(2006-4#1)
measured in order to##2##4##(1994-2#1)(2007-12#1)
measured in plasma##3##3##(1990-2#1)(1993-2#1)(2010-11#1)
measured in real time##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
measured in samples##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
measured in sera##2##3##(1993-1#1)(1996-12#1)
measured in seven##2##3##(2007-5#1)(2008-5#1)
measured in situ##4##3##(2008-10#1)(2008-3#2)(2010-8#1)
measured in terms of the##3##5##(1992-3#1)(1996-3#1)(2008-10#1)
measured in terms of##11##4##(1991-6#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
measured in the field##2##4##(2008-10#2)
measured in the laboratory##2##4##(2008-3#2)
measured in the presence of##4##5##(1990-5#1)(1991-12#1)(2007-11#1)(2008-10#1)
measured in the presence##5##4##(1990-5#1)(1991-12#1)(1993-3#1)(2007-11#1)(2008-10#1)
measured in the range##4##4##(2007-11#1)(2008-10#3)
measured in the same##4##4##(2008-10#1)(2008-3#1)(2008-7#2)
measured in the##64##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-11#5)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
measured in these##2##3##(2008-10#1)(2008-3#1)
measured in this study##3##4##(2008-10#2)(2008-7#1)
measured in this##6##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
measured in transfected##2##3##(1992-9#1)(1995-11#1)
measured in vitro by##3##4##(1991-9#1)(2008-1#1)(2008-9#1)
measured in vitro##8##3##(1990-6#1)(1991-2#1)(1991-9#1)(1993-9#1)(2008-1#1)(2008-10#2)(2008-9#1)
measured in vivo##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
measured in whole##2##3##(2007-11#1)(2010-8#1)
measured in##289##2##(1990-2#6)(1990-3#6)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#4)(1994-3#4)(1994-5#1)(1994-7#1)(1994-8#2)(1995-11#3)(1995-12#5)(1995-3#1)(1995-5#4)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#2)(2007-10#2)(2007-11#10)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#54)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#27)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)
measured including##3##2##(2008-12#2)(2008-2#1)
measured independently##3##2##(2007-11#1)(2008-3#2)
measured is##2##2##(1997-8#1)(2008-3#1)
measured just before##2##3##(1991-4#1)(2012-1#1)
measured just##4##2##(1990-3#1)(1991-4#1)(2008-9#1)(2012-1#1)
measured lateral resolution of##2##4##(2008-3#2)
measured mass##3##2##(1993-2#1)(2008-10#2)
measured nonlinearity##2##2##(2008-2#2)
measured on a##7##3##(1991-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
measured on radiograms##2##3##(2007-11#2)
measured on the##6##3##(1994-7#1)(2007-11#1)(2008-2#2)(2009-2#1)(2010-11#1)
measured on##34##2##(1991-3#1)(1994-7#1)(1995-3#1)(1995-5#1)(1996-5#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
measured optical##4##2##(2008-3#4)
measured or##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
measured output##3##2##(2008-2#1)(2008-3#2)
measured over a##12##3##(1991-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2011-1#1)(2011-2#1)(2012-5#1)
measured over the##5##3##(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
measured over##25##2##(1991-9#1)(1995-11#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-8#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
measured parameters of##2##3##(2007-6#1)(2008-10#1)
measured parameters##7##2##(2007-6#1)(2008-10#1)(2008-3#2)(2009-8#1)(2010-8#1)(2011-2#1)
measured patient satisfaction##2##3##(1996-3#1)(2008-9#1)
measured performance##4##2##(2008-2#1)(2008-3#3)
measured polarization##2##2##(2008-2#1)(2008-3#1)
measured profiles of the beam attenuation coefficient##2##7##(2008-3#2)
measured quantitatively##5##2##(1996-6#1)(2008-10#2)(2008-12#1)(2008-3#1)
measured radiances##3##2##(2008-2#1)(2008-3#2)
measured rate##2##2##(2008-10#1)(2008-11#1)
measured reduction in##2##3##(2007-12#1)(2008-5#1)
measured relative to##2##3##(2007-10#1)(2008-3#1)
measured relative##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
measured repeatedly over time##2##4##(1994-2#1)(2010-1#1)
measured responses##4##2##(2008-10#3)(2008-11#1)
measured responsivity##2##2##(2008-3#2)
measured results##7##2##(2008-3#7)
measured rms##2##2##(2008-2#2)
measured scattering##3##2##(2007-11#1)(2008-3#2)
measured sensitivity##2##2##(2007-11#1)(2008-3#1)
measured separately##2##2##(2008-3#1)(2008-4#1)
measured serum concentrations of##2##4##(1992-2#1)(2011-1#1)
measured serum levels of##2##4##(1991-8#1)(2008-6#1)
measured serum##6##2##(1991-8#1)(1992-2#1)(1993-2#1)(2008-1#1)(2008-6#1)(2011-1#1)
measured simultaneously by##2##3##(2008-10#1)(2008-3#1)
measured simultaneously in the##2##4##(2008-5#1)(2011-1#1)
measured simultaneously in##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
measured simultaneously over a##2##4##(2008-2#1)(2008-3#1)
measured simultaneously##13##2##(1992-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#2)(2011-1#1)
measured skin##2##2##(2008-5#2)
measured spatial##2##2##(2008-3#2)
measured specific##2##2##(1996-7#1)(2008-11#1)
measured spectra##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
measured spectral extinction##3##3##(2008-3#3)
measured spectral responses##2##3##(2007-11#1)(2008-2#1)
measured spectral##11##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
measured spectrophotometrically##5##2##(1993-12#1)(1996-9#1)(2008-10#3)
measured speed of##3##3##(2008-3#3)
measured surface##3##2##(2008-10#1)(2008-3#2)
measured temperature##2##2##(2008-3#2)
measured temporal##2##2##(1994-12#1)(2008-2#1)
measured the absorption##3##3##(2007-12#1)(2008-2#2)
measured the distribution of##2##4##(1992-2#1)(2008-11#1)
measured the effect of##3##4##(1991-2#1)(1995-1#1)(2008-12#1)
measured the effects of##2##4##(1995-2#1)(2008-5#1)
measured the fluorescence##2##3##(1995-2#1)(2007-12#1)
measured the frequency of the##2##5##(2007-12#2)
measured the number and##2##4##(1995-8#1)(2008-5#1)
measured the sizes and##2##4##(2007-12#1)(2008-7#1)
measured the##95##2##(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-1#1)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(2007-10#1)(2007-11#7)(2007-12#6)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#16)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
measured thermal##2##2##(2008-2#1)(2008-3#1)
measured three times##2##3##(2008-10#1)(2009-9#1)
measured three##3##2##(1994-9#1)(2008-10#1)(2009-9#1)
measured through a##2##3##(2008-2#1)(2008-6#1)
measured through##9##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-8#1)
measured throughout##2##2##(2010-7#1)(2013-8#1)
measured to as high as##2##5##(2008-3#2)
measured to be 0##5##4##(2007-11#1)(2007-12#2)(2008-3#2)
measured to be less than##2##5##(2007-11#1)(2008-10#1)
measured to be##29##3##(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#11)(2008-8#1)(2009-11#1)(2009-7#1)
measured to determine the##3##4##(1992-12#1)(2008-10#2)
measured to determine##6##3##(1992-12#1)(2007-8#1)(2008-10#3)(2010-4#1)
measured to evaluate##2##3##(1996-6#1)(2011-2#1)
measured to obtain the##2##4##(2008-2#1)(2008-3#1)
measured to within##2##3##(2008-2#1)(2008-3#1)
measured to##58##2##(1992-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1996-6#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#8)(2008-3#17)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#2)(2009-7#1)(2010-4#1)(2011-2#1)
measured total##5##2##(1990-12#1)(1993-2#1)(1993-9#1)(2008-12#1)(2008-3#1)
measured transfer##2##2##(2007-12#1)(2008-3#1)
measured transmission spectra##2##3##(2007-11#1)(2008-3#1)
measured two##2##2##(1994-8#1)(2009-5#1)
measured under##5##2##(1990-8#1)(2007-12#1)(2008-10#2)(2008-8#1)
measured using a##16##3##(1990-12#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#1)(2011-1#1)(2012-2#1)
measured using optical##3##3##(2008-10#2)(2008-5#1)
measured using the##17##3##(1990-11#1)(1991-2#1)(1993-2#2)(1994-3#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2012-3#1)(2013-1#2)
measured using##78##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1993-2#3)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
measured value##3##2##(2008-3#2)(2010-2#1)
measured values##8##2##(2008-10#1)(2008-2#3)(2008-3#4)
measured variables##2##2##(2008-5#1)(2013-7#1)
measured via##6##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#2)
measured was##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
measured were##5##2##(1996-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
measured when the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
measured when##6##2##(1990-11#1)(1992-3#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
measured while##2##2##(2008-3#2)
measured with a detection##2##4##(2008-10#1)(2008-3#1)
measured with a precision of approximately##2##6##(2008-3#2)
measured with a precision of##4##5##(2007-11#1)(2008-3#3)
measured with a##57##3##(1991-3#1)(1993-12#1)(2007-11#5)(2007-12#5)(2008-10#10)(2008-12#2)(2008-2#7)(2008-3#21)(2008-4#1)(2008-5#3)(2009-11#1)
measured with an array##2##4##(2008-10#1)(2008-3#1)
measured with an##18##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)
measured with and without##2##4##(2008-2#1)(2008-3#1)
measured with error##2##3##(2010-2#1)(2012-1#1)
measured with high##3##3##(1993-8#1)(2008-3#1)(2008-8#1)
measured with respect to##2##4##(2008-10#1)(2008-3#1)
measured with synchrotron radiation##3##4##(2007-11#1)(2008-3#2)
measured with the fluorescent##2##4##(1994-6#1)(1995-5#1)
measured with the##17##3##(1991-8#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)
measured with this##4##3##(2008-10#1)(2008-3#3)
measured with##170##2##(1990-12#4)(1991-3#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-5#7)(1996-6#1)(2007-11#8)(2007-12#11)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-12#6)(2008-2#12)(2008-3#48)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-3#1)
measured within##6##2##(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
measured##2638##1##(1990-11#10)(1990-12#12)(1990-2#7)(1990-3#7)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#8)(1990-9#4)(1991-11#5)(1991-12#8)(1991-2#7)(1991-3#8)(1991-4#2)(1991-5#12)(1991-6#5)(1991-8#6)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#13)(1992-5#3)(1992-6#7)(1992-8#4)(1992-9#10)(1993-1#10)(1993-10#2)(1993-11#7)(1993-12#19)(1993-2#13)(1993-3#10)(1993-5#2)(1993-6#4)(1993-8#6)(1993-9#6)(1994-1#1)(1994-11#12)(1994-12#6)(1994-2#10)(1994-3#11)(1994-5#4)(1994-6#10)(1994-7#2)(1994-8#9)(1994-9#2)(1995-1#2)(1995-11#15)(1995-12#17)(1995-2#10)(1995-3#10)(1995-5#23)(1995-6#3)(1995-8#7)(1995-9#1)(1996-1#2)(1996-12#11)(1996-2#13)(1996-3#4)(1996-4#1)(1996-5#18)(1996-6#7)(1996-7#8)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#15)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#7)(1997-8#8)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#3)(2007-1#1)(2007-10#19)(2007-11#101)(2007-12#107)(2007-2#3)(2007-5#5)(2007-6#2)(2007-7#3)(2007-8#11)(2007-9#2)(2008-1#22)(2008-10#456)(2008-11#68)(2008-12#32)(2008-2#207)(2008-3#451)(2008-4#21)(2008-5#62)(2008-6#17)(2008-7#64)(2008-8#30)(2008-9#41)(2009-1#3)(2009-10#3)(2009-11#8)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#8)(2009-8#8)(2009-9#9)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#9)(2010-2#6)(2010-3#4)(2010-4#9)(2010-5#7)(2010-6#4)(2010-7#7)(2010-8#10)(2010-9#3)(2011-1#31)(2011-2#53)(2011-3#3)(2012-1#7)(2012-12#15)(2012-2#17)(2012-3#19)(2012-4#1)(2012-5#3)(2012-6#1)(2013-1#69)(2013-3#2)(2013-7#14)(2013-8#27)
measured)##2##1##(2008-2#1)(2008-7#1)
measurement accuracy in##2##3##(2008-3#2)
measurement accuracy is##2##3##(2008-3#2)
measurement accuracy of##4##3##(2008-2#1)(2008-3#3)
measurement accuracy##19##2##(2008-10#1)(2008-2#3)(2008-3#13)(2008-7#1)(2012-3#1)
measurement and analysis##2##3##(2008-1#1)(2008-11#1)
measurement and applied to##2##4##(2007-11#1)(2008-10#1)
measurement and speciation of##2##4##(2008-10#2)
measurement and the##6##3##(1990-8#1)(2008-10#2)(2008-3#2)(2013-8#1)
measurement and##62##2##(1990-8#1)(1992-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-6#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#2)
measurement are demonstrated##2##3##(1992-9#1)(2007-12#1)
measurement are##5##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-6#1)
measurement as##2##2##(2008-10#1)(2010-5#1)
measurement at##7##2##(2007-11#1)(2007-12#1)(2008-10#3)(2013-1#2)
measurement bandwidth##2##2##(2007-12#1)(2008-3#1)
measurement based on a##2##4##(2008-3#1)(2010-4#1)
measurement based on surface-plasmon resonance##2##5##(2008-3#2)
measurement based on the##3##4##(2008-2#2)(2008-3#1)
measurement based on##10##3##(2008-2#2)(2008-3#6)(2010-4#1)(2013-8#1)
measurement beam##3##2##(2008-3#3)
measurement bias##2##2##(2008-1#1)(2008-3#1)
measurement but##2##2##(2008-10#1)(2008-3#1)
measurement by ICP-MS##3##3##(2008-10#3)
measurement by a##2##3##(2008-10#2)
measurement by flame##2##3##(2008-10#2)
measurement by laser##2##3##(2008-2#1)(2008-3#1)
measurement by the##3##3##(2008-3#2)(2013-8#1)
measurement by use of a##3##5##(2007-11#1)(2008-3#2)
measurement by use of##5##4##(2007-11#2)(2008-3#3)
measurement by##36##2##(1996-3#1)(2007-11#3)(2008-10#14)(2008-2#5)(2008-3#10)(2008-7#1)(2009-10#1)(2013-8#1)
measurement campaign##3##2##(2008-3#2)(2008-5#1)
measurement can be##7##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
measurement can##9##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2012-2#1)
measurement capability##2##2##(2008-2#1)(2008-3#1)
measurement capacity##2##2##(2008-11#1)(2008-5#1)
measurement cell##2##2##(2008-10#2)
measurement conditions##7##2##(2008-10#4)(2008-3#3)
measurement could be##2##3##(2008-10#2)
measurement could##4##2##(1997-2#1)(2008-10#2)(2011-2#1)
measurement cycles##2##2##(2008-10#1)(2008-5#1)
measurement data are##2##3##(2008-11#1)(2010-8#1)
measurement data##9##2##(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2010-8#1)
measurement device with##2##3##(2007-11#1)(2008-3#1)
measurement device##4##2##(1994-1#1)(2007-11#1)(2008-11#1)(2008-3#1)
measurement equivalence##4##2##(2009-11#4)
measurement error and temporal variability of risk factors##2##8##(1992-9#2)
measurement error and temporal variability##3##5##(1992-9#3)
measurement error and##4##3##(1992-9#3)(2008-3#1)
measurement error in##5##3##(1997-4#1)(2007-11#1)(2008-3#2)(2012-1#1)
measurement error models##2##3##(1997-4#1)(2012-1#1)
measurement error of##2##3##(2008-12#1)(2008-3#1)
measurement error was##3##3##(2008-12#1)(2008-3#2)
measurement error##29##2##(1992-9#3)(1997-4#3)(2007-11#1)(2008-12#2)(2008-3#13)(2008-7#2)(2009-12#1)(2012-1#3)(2013-7#1)
measurement errors and##2##3##(2008-2#1)(2008-3#1)
measurement errors are##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
measurement errors in##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
measurement errors obtained##2##3##(2008-10#1)(2008-3#1)
measurement errors of the##2##4##(1997-8#1)(2008-3#1)
measurement errors of##4##3##(1997-8#1)(2008-10#2)(2008-3#1)
measurement errors##23##2##(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#9)(2008-7#1)(2008-8#1)(2012-1#1)
measurement even##2##2##(2007-11#1)(2012-2#1)
measurement for a##2##3##(1990-9#1)(2008-3#1)
measurement for the##2##3##(2008-10#1)(2008-3#1)
measurement for##13##2##(1990-9#1)(1992-1#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2013-1#3)
measurement frequency of##4##3##(2008-10#4)
measurement frequency##5##2##(2008-10#5)
measurement from##3##2##(2008-2#2)(2008-3#1)
measurement geometry##2##2##(2008-2#1)(2008-3#1)
measurement has also##2##3##(2007-11#1)(2008-5#1)
measurement has been##5##3##(2008-2#1)(2008-3#1)(2012-2#1)(2012-8#1)(2013-1#1)
measurement has##10##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)(2012-8#1)(2013-1#1)
measurement in patients with##2##4##(2011-2#1)(2013-8#1)
measurement in the##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
measurement in##39##2##(1991-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#4)(2008-7#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
measurement indicated##2##2##(2007-11#1)(2008-10#1)
measurement instruments##8##2##(1995-2#1)(2008-10#1)(2013-1#6)
measurement into##3##2##(1991-12#1)(1996-1#2)
measurement is a##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
measurement is described##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
measurement is often##2##3##(2008-2#1)(2008-3#1)
measurement is one of the##2##5##(2007-12#1)(2013-8#1)
measurement is proposed##3##3##(2008-10#1)(2008-3#2)
measurement is the##2##3##(1993-11#1)(2008-10#1)
measurement is##49##2##(1993-11#1)(1995-2#1)(2007-11#3)(2007-12#3)(2008-10#9)(2008-2#9)(2008-3#20)(2008-9#1)(2011-2#1)(2013-8#1)
measurement itself##2##2##(2008-11#1)(2008-3#1)
measurement location##2##2##(2008-3#1)(2009-4#1)
measurement may##2##2##(1992-3#1)(1993-8#1)
measurement method and##3##3##(2008-3#3)
measurement method for##3##3##(2008-3#3)
measurement method is##3##3##(2008-2#1)(2008-3#2)
measurement method##16##2##(2007-11#2)(2008-2#1)(2008-3#12)(2013-8#1)
measurement methods are##2##3##(2007-2#1)(2008-1#1)
measurement methods##8##2##(1992-9#1)(1996-1#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-7#1)
measurement must be##2##3##(1996-1#1)(2008-10#1)
measurement noise##4##2##(2008-2#2)(2008-3#2)
measurement occasions##2##2##(2009-10#1)(2010-10#1)
measurement of 3##2##3##(1997-4#1)(2008-10#1)
measurement of DNA##3##3##(1997-4#1)(2008-9#2)
measurement of NO production##2##4##(2008-7#2)
measurement of NO##3##3##(2008-10#1)(2008-7#2)
measurement of UV##2##3##(1994-9#1)(2008-3#1)
measurement of a series of##2##5##(2008-10#1)(2008-3#1)
measurement of a##16##3##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#9)(2010-2#1)
measurement of absolute##2##3##(2007-12#1)(2008-2#1)
measurement of acetate##2##3##(2008-10#2)
measurement of an##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
measurement of atmospheric##3##3##(2008-3#3)
measurement of birefringence##2##3##(2007-11#1)(2008-3#1)
measurement of blood pressure##3##4##(1991-6#1)(2008-1#1)(2008-7#1)
measurement of blood##4##3##(1990-8#1)(1991-6#1)(2008-1#1)(2008-7#1)
measurement of body##2##3##(1994-1#1)(2010-11#1)
measurement of bone mass##2##4##(1993-11#2)
measurement of bone##4##3##(1991-11#1)(1993-11#2)(2007-8#1)
measurement of both##7##3##(1994-2#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
measurement of chloroquine##2##3##(2008-10#2)
measurement of chromium(VI)##2##3##(2008-10#2)
measurement of clinical##3##3##(2008-8#1)(2012-3#1)(2013-8#1)
measurement of community benefit##2##4##(1995-2#2)
measurement of diffuse##3##3##(2008-3#3)
measurement of discontinuous objects##2##4##(2008-3#2)
measurement of dissolved##3##3##(2008-10#2)(2008-11#1)
measurement of drug##2##3##(1991-8#1)(2008-4#1)
measurement of flow##2##3##(2007-11#1)(2008-3#1)
measurement of fluorescence##5##3##(2008-10#2)(2008-3#2)(2008-9#1)
measurement of gas concentrations in a chemical vapor deposition##2##9##(2008-3#2)
measurement of gas##4##3##(2008-3#3)(2008-5#1)
measurement of human##3##3##(1992-11#1)(2008-4#2)
measurement of hydrogen peroxide in industrial applications##2##7##(2008-10#2)
measurement of hydrogen peroxide##3##4##(2008-10#2)(2008-4#1)
measurement of hydrogen##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
measurement of hydrostatic pressure##2##4##(2008-2#1)(2008-3#1)
measurement of in vivo##2##4##(2008-4#2)
measurement of in-plane##4##3##(2007-11#1)(2008-3#2)(2009-7#1)
measurement of index##2##3##(2007-11#1)(2008-3#1)
measurement of infrared##2##3##(2008-3#2)
measurement of its##2##3##(2007-11#1)(2008-5#1)
measurement of large##2##3##(2008-3#1)(2010-11#1)
measurement of mRNA##2##3##(2008-4#2)
measurement of metal##2##3##(2008-10#1)(2008-3#1)
measurement of moving##2##3##(1993-5#1)(2008-3#1)
measurement of natriuretic##2##3##(2009-5#2)
measurement of optical##5##3##(2008-10#1)(2008-3#4)
measurement of optically##2##3##(2007-11#1)(2008-3#1)
measurement of oropharyngeal clearance##3##4##(1996-2#3)
measurement of other##2##3##(2008-2#1)(2008-9#1)
measurement of oxygen##3##3##(1993-1#1)(2008-11#1)(2008-6#1)
measurement of pH in##2##4##(2008-10#1)(2010-8#1)
measurement of pH##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
measurement of phenol##2##3##(2008-10#2)
measurement of pressure##2##3##(2008-2#1)(2008-3#1)
measurement of quality##3##3##(1994-3#1)(2008-7#1)(2010-11#1)
measurement of reticulated platelets##2##4##(2006-6#2)
measurement of serum##4##3##(1996-6#1)(2010-1#1)(2012-12#1)(2013-1#1)
measurement of small##4##3##(2008-2#1)(2008-3#3)
measurement of soot volume fraction##3##5##(2008-2#3)
measurement of strain and temperature##6##5##(2008-3#6)
measurement of surface strains##2##4##(2008-2#2)
measurement of surface##4##3##(2008-2#3)(2008-3#1)
measurement of temperature##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
measurement of the absorbance of the##2##6##(2008-10#2)
measurement of the absorption and##2##5##(2007-11#1)(2008-3#1)
measurement of the absorption##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
measurement of the angle##3##4##(2008-2#1)(2008-3#2)
measurement of the decrease in the##2##6##(2008-10#2)
measurement of the dependence on##2##5##(2007-11#1)(2008-3#1)
measurement of the dependence##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
measurement of the electron-phonon coupling##2##5##(1990-4#1)(2008-3#1)
measurement of the fluorescence##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
measurement of the frequency##2##4##(2008-3#2)
measurement of the intensity##4##4##(2007-11#1)(2008-10#2)(2008-2#1)
measurement of the line##2##4##(2008-2#1)(2008-3#1)
measurement of the modulation transfer function##2##6##(2008-2#2)
measurement of the optical##2##4##(2008-3#2)
measurement of the output##2##4##(2007-11#1)(2008-2#1)
measurement of the phase##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
measurement of the refractive index and the geometrical thickness##3##9##(2008-3#3)
measurement of the refractive indices of##2##6##(2008-3#2)
measurement of the refractive##5##4##(2008-3#5)
measurement of the shift and##2##5##(2007-12#2)
measurement of the temperature##3##4##(2007-11#1)(2008-2#2)
measurement of the two-point field correlation function##2##7##(2007-11#2)
measurement of the value##2##4##(2008-10#1)(2008-3#1)
measurement of the variation##2##4##(2008-3#2)
measurement of the##219##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#2)(1992-11#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-4#1)(2006-6#2)(2007-11#24)(2007-12#26)(2008-10#40)(2008-11#1)(2008-2#19)(2008-3#68)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
measurement of thermal##2##3##(2008-3#2)
measurement of these##3##3##(2008-2#1)(2008-9#1)(2012-12#1)
measurement of three-dimensional refractive-index##2##4##(2007-11#2)
measurement of total##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
measurement of trace##2##3##(2008-10#2)
measurement of transparent thin-film layers##2##5##(2008-3#2)
measurement of tungsten##2##3##(2008-10#2)
measurement of two-photon##2##3##(2007-11#1)(2011-1#1)
measurement of urinary##2##3##(1994-12#1)(1996-12#1)
measurement of various##2##3##(2008-3#1)(2008-7#1)
measurement of##748##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#5)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#2)(1992-12#2)(1992-3#2)(1993-1#1)(1993-11#3)(1993-2#2)(1993-5#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#2)(2006-4#1)(2006-6#4)(2007-10#2)(2007-11#52)(2007-12#48)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#134)(2008-11#9)(2008-12#4)(2008-2#52)(2008-3#206)(2008-4#29)(2008-5#11)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#16)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#4)(2010-1#1)(2010-11#4)(2010-2#2)(2010-4#1)(2010-5#5)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#4)(2012-2#8)(2012-3#3)(2012-8#1)(2013-1#6)(2013-8#2)
measurement on##6##2##(1994-7#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
measurement parameters##2##2##(2008-10#1)(2008-3#1)
measurement plan##2##2##(2008-2#1)(2008-3#1)
measurement precision of##4##3##(2008-2#2)(2008-3#2)
measurement precision##10##2##(2008-10#3)(2008-2#5)(2008-3#2)
measurement principle##6##2##(2008-10#1)(2008-3#5)
measurement principles##2##2##(2008-11#1)(2010-7#1)
measurement procedure##3##2##(2008-10#2)(2008-5#1)
measurement process##4##2##(1996-3#1)(2008-10#3)
measurement profilometry##3##2##(2008-2#3)
measurement properties##3##2##(1995-2#1)(2012-2#2)
measurement range of##2##3##(2008-3#2)
measurement range##12##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#5)
measurement repeatability##3##2##(2008-10#3)
measurement reproducibility of##2##3##(2008-10#1)(2008-3#1)
measurement reproducibility##5##2##(2008-10#2)(2008-3#1)(2010-9#1)(2011-7#1)
measurement results are##2##3##(2008-3#1)(2012-2#1)
measurement results were##2##3##(2008-10#2)
measurement results##13##2##(2008-10#5)(2008-3#4)(2009-11#1)(2012-2#1)(2012-3#2)
measurement revealed that##2##3##(2008-10#1)(2008-5#1)
measurement scales##3##2##(1995-2#2)(2010-3#1)
measurement scheme##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
measurement sensitivity in the##2##4##(2008-3#2)
measurement sensitivity of##2##3##(2008-3#1)(2008-9#1)
measurement sensitivity##9##2##(2007-11#1)(2008-3#7)(2008-9#1)
measurement setup##4##2##(2008-2#2)(2008-3#2)
measurement showed##2##2##(1992-3#1)(2008-10#1)
measurement step##3##2##(2008-10#3)
measurement system and##2##3##(1996-2#1)(2010-8#1)
measurement system based on##2##4##(2008-3#2)
measurement system is##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
measurement system that##3##3##(1996-1#1)(2008-10#1)(2008-3#1)
measurement system to##2##3##(2008-2#2)
measurement system##26##2##(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-4#1)(2008-10#5)(2008-2#3)(2008-3#10)(2008-9#1)(2010-8#1)(2013-1#1)
measurement systems and##2##3##(1997-2#1)(2008-2#1)
measurement systems##15##2##(1994-3#4)(1997-1#2)(1997-2#2)(2008-2#2)(2008-3#2)(2009-11#1)(2011-2#1)(2013-1#1)
measurement technique for##3##3##(2008-3#3)
measurement technique is##2##3##(2007-12#1)(2008-2#1)
measurement technique were##2##3##(2008-3#1)(2011-2#1)
measurement technique##19##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#10)(2011-2#1)
measurement techniques##7##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)
measurement that uses##3##3##(2008-3#3)
measurement that##9##2##(1990-8#1)(1995-2#1)(2008-3#5)(2008-9#1)(2010-3#1)
measurement through##2##2##(2010-5#1)(2010-8#1)
measurement time##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
measurement to##4##2##(1993-12#1)(2008-3#3)
measurement tool##6##2##(1991-12#1)(1994-3#1)(1996-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
measurement tools to##3##3##(1996-3#1)(2007-8#1)(2010-7#1)
measurement tools##11##2##(1990-12#1)(1992-3#1)(1996-2#1)(1996-3#1)(2007-8#2)(2008-10#1)(2010-11#1)(2010-7#1)(2013-1#2)
measurement uncertainties##2##2##(2008-2#1)(2008-3#1)
measurement uncertainty of the##2##4##(2008-10#1)(2008-3#1)
measurement uncertainty of##5##3##(2008-10#3)(2008-3#2)
measurement uncertainty##17##2##(2008-10#7)(2008-2#4)(2008-3#6)
measurement using a##2##3##(2008-10#1)(2010-4#1)
measurement using##9##2##(1995-2#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
measurement variables##2##2##(1996-1#1)(2008-10#1)
measurement volume##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
measurement was 5##2##3##(2007-12#1)(2008-10#1)
measurement was based on##2##4##(2007-12#1)(2008-10#1)
measurement was carried out##2##4##(2008-5#1)(2009-11#1)
measurement was of##2##3##(2008-3#2)
measurement was performed##2##3##(1994-7#1)(2013-8#1)
measurement was then##2##3##(1991-9#1)(2013-8#1)
measurement was##26##2##(1991-9#1)(1993-12#1)(1994-7#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2013-1#1)(2013-8#2)
measurement were##3##2##(2008-3#1)(2008-5#2)
measurement with a single##2##4##(2008-3#2)
measurement with a##9##3##(2007-11#1)(2008-10#1)(2008-3#7)
measurement with high##2##3##(2008-10#1)(2008-3#1)
measurement with the##6##3##(1991-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
measurement with##29##2##(1991-3#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#17)
measurement within##2##2##(2008-10#1)(2008-3#1)
measurement##1816##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#8)(1990-9#1)(1991-11#2)(1991-12#6)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-9#5)(1993-1#2)(1993-11#5)(1993-12#3)(1993-2#4)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#6)(1994-2#7)(1994-3#10)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#14)(1995-3#4)(1995-8#1)(1996-1#8)(1996-12#6)(1996-2#15)(1996-3#10)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#4)(1997-2#8)(1997-3#2)(1997-4#7)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#4)(2007-10#4)(2007-11#97)(2007-12#80)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#6)(2008-1#9)(2008-10#363)(2008-11#28)(2008-12#9)(2008-2#156)(2008-3#504)(2008-4#34)(2008-5#34)(2008-6#2)(2008-7#28)(2008-8#6)(2008-9#27)(2009-1#1)(2009-10#5)(2009-11#8)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#11)(2010-6#2)(2010-7#9)(2010-8#8)(2010-9#2)(2011-1#10)(2011-2#20)(2011-7#1)(2012-1#4)(2012-12#7)(2012-2#24)(2012-3#10)(2012-8#2)(2013-1#30)(2013-7#1)(2013-8#15)
measurement)##3##1##(2008-10#1)(2008-2#1)(2010-7#1)
measurement-regeneration cycles##2##2##(2008-10#2)
measurements (n=5)##2##2##(2008-10#2)
measurements across##4##2##(1995-2#1)(1996-4#2)(2008-12#1)
measurements allow us to##2##4##(2007-12#1)(2008-7#1)
measurements allowed us to##2##4##(2008-10#1)(2008-2#1)
measurements allowed##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
measurements along##2##2##(2008-11#1)(2008-2#1)
measurements and a##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
measurements and applied##2##3##(2008-10#1)(2008-3#1)
measurements and are##2##3##(2008-3#1)(2011-1#1)
measurements and comparison with##2##4##(2008-11#1)(2008-3#1)
measurements and discuss##2##3##(2007-11#1)(2008-3#1)
measurements and for##2##3##(1997-6#1)(2008-2#1)
measurements and found##2##3##(2008-3#1)(2011-1#1)
measurements and have##2##3##(2008-3#2)
measurements and in##3##3##(2008-3#3)
measurements and model##2##3##(2008-2#1)(2008-3#1)
measurements and the effect of##2##5##(2008-3#2)
measurements and the##13##3##(2008-10#4)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2013-1#1)
measurements and##105##2##(1992-11#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#38)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-9#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
measurements are also##2##3##(2008-3#2)
measurements are carried out##2##4##(2008-10#1)(2008-2#1)
measurements are compared with##5##4##(2008-2#1)(2008-3#4)
measurements are compared##7##3##(2008-2#2)(2008-3#4)(2010-2#1)
measurements are discussed##2##3##(2007-12#1)(2008-3#1)
measurements are in good agreement with##3##6##(1992-12#1)(2007-12#2)
measurements are in##4##3##(1992-12#1)(2007-12#2)(2008-10#1)
measurements are less##2##3##(2008-2#1)(2008-3#1)
measurements are made for##2##4##(1991-8#1)(2008-10#1)
measurements are made##6##3##(1990-11#1)(1991-6#1)(1991-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
measurements are not##4##3##(1990-8#1)(2007-10#1)(2008-10#1)(2008-8#1)
measurements are now##2##3##(1993-11#1)(2011-7#1)
measurements are performed##2##3##(2008-10#1)(2008-3#1)
measurements are presented##6##3##(2007-12#1)(2008-3#5)
measurements are reported##2##3##(2008-3#1)(2008-5#1)
measurements are shown to##2##4##(2008-3#1)(2008-7#1)
measurements are shown##3##3##(2008-3#2)(2008-7#1)
measurements are used to##3##4##(2008-2#1)(2008-3#2)
measurements are used##5##3##(2008-2#1)(2008-3#4)
measurements are##80##2##(1990-11#1)(1990-8#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-11#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-10#13)(2008-11#1)(2008-2#11)(2008-3#30)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#1)(2011-7#1)
measurements as a function of the##2##6##(2008-3#1)(2011-1#1)
measurements as a function of##3##5##(2008-3#1)(2008-9#1)(2011-1#1)
measurements as a##5##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-1#1)
measurements as well as##4##4##(2008-10#3)(2012-3#1)
measurements as##11##2##(2008-10#4)(2008-3#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
measurements at a##3##3##(2008-2#1)(2008-3#2)
measurements at different##5##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
measurements at the level of##2##5##(2008-3#1)(2011-2#1)
measurements at the##10##3##(1993-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2011-2#1)
measurements at two different##2##4##(2008-10#1)(2008-3#1)
measurements at two##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
measurements at##47##2##(1993-11#2)(1996-12#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#5)(2008-3#19)(2011-2#1)(2012-2#1)(2013-1#1)
measurements based on the##3##4##(2008-2#1)(2008-3#2)
measurements based on##11##3##(2007-12#1)(2008-2#2)(2008-3#5)(2008-9#1)(2010-4#1)(2011-2#1)
measurements based##12##2##(2007-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
measurements become##2##2##(2008-3#1)(2008-9#1)
measurements between##4##2##(1995-6#2)(2006-12#1)(2008-10#1)
measurements but##3##2##(2008-5#1)(2010-4#1)(2011-2#1)
measurements by coherent##2##3##(2007-11#1)(2008-3#1)
measurements by linear Raman spectroscopy##2##5##(2008-2#2)
measurements by the##2##3##(2008-3#2)
measurements by use of a##4##5##(2008-2#1)(2008-3#3)
measurements by use of the##4##5##(2008-2#3)(2008-3#1)
measurements by use of##11##4##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)
measurements by using a##2##4##(2008-3#2)
measurements by using the##2##4##(2008-2#1)(2008-3#1)
measurements by using##4##3##(2008-2#1)(2008-3#3)
measurements by##43##2##(2007-11#2)(2007-12#6)(2008-10#3)(2008-2#11)(2008-3#20)(2011-1#1)
measurements can be incorporated into##2##5##(1995-2#1)(2010-11#1)
measurements can be performed##2##4##(2008-3#2)
measurements can be used to##3##5##(1996-4#1)(2008-2#2)
measurements can be used##4##4##(1996-4#1)(2008-10#1)(2008-2#2)
measurements can be##14##3##(1995-2#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-9#1)(2010-11#1)
measurements can##20##2##(1991-1#1)(1995-2#1)(1996-4#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-9#1)(2010-11#1)(2011-1#1)
measurements carried out##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
measurements collected##2##2##(2008-2#1)(2009-10#1)
measurements conducted##2##2##(2008-3#1)(2010-7#1)
measurements confirm##2##2##(2008-3#1)(2012-2#1)
measurements could be performed##2##4##(2008-11#1)(2008-3#1)
measurements could be##6##3##(1990-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
measurements could##8##2##(1990-2#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)
measurements demonstrated that##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
measurements during##6##2##(1990-9#1)(2008-3#2)(2008-5#1)(2011-1#1)(2013-1#1)
measurements even##2##2##(2008-3#1)(2013-1#1)
measurements for a##2##3##(2008-10#1)(2009-7#1)
measurements for the##6##3##(2008-10#1)(2008-2#2)(2008-3#2)(2011-1#1)
measurements for various##2##3##(2008-3#2)
measurements for which##2##3##(2008-3#2)
measurements for##41##2##(2007-11#2)(2007-12#3)(2008-10#10)(2008-2#10)(2008-3#9)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)
measurements from a##4##3##(2008-3#4)
measurements from different##2##3##(2008-3#1)(2009-7#1)
measurements from the Marine Optical Buoy##2##6##(2008-3#2)
measurements from the##4##3##(2008-3#3)(2011-2#1)
measurements from##31##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#18)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
measurements has been##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
measurements has##5##2##(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
measurements have been carried out on##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
measurements have been performed##2##4##(2008-2#1)(2008-5#1)
measurements have been used to##2##5##(2008-10#1)(2008-3#1)
measurements have been##10##3##(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)
measurements have##13##2##(2008-10#2)(2008-2#2)(2008-3#6)(2008-5#2)(2010-4#1)
measurements in 0##2##3##(2008-10#2)
measurements in a##13##3##(1993-3#1)(2008-10#1)(2008-2#7)(2008-3#4)
measurements in an##2##3##(2008-3#1)(2008-8#1)
measurements in randomized##2##3##(1992-9#1)(2012-1#1)
measurements in the NIR##2##4##(2008-10#2)
measurements in the far field##2##5##(2007-11#2)
measurements in the ultraviolet##2##4##(2008-2#1)(2008-3#1)
measurements in the visible##2##4##(2008-2#1)(2008-3#1)
measurements in the##41##3##(1991-11#1)(2007-11#3)(2007-12#2)(2008-10#7)(2008-2#7)(2008-3#17)(2008-6#1)(2009-11#1)(2013-1#1)(2013-8#1)
measurements in##137##2##(1990-2#1)(1990-6#2)(1990-8#2)(1991-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-11#4)(2007-12#5)(2008-10#26)(2008-11#2)(2008-2#21)(2008-3#41)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#3)(2010-12#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
measurements including##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
measurements indicate that the##4##4##(1995-3#1)(2008-10#1)(2012-2#2)
measurements indicate that##8##3##(1994-5#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-2#2)(2012-2#2)
measurements indicate the##2##3##(2008-3#2)
measurements indicate##14##2##(1994-5#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-2#1)(2012-1#1)(2012-2#2)
measurements indicated that##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
measurements indicated##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
measurements involving##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
measurements is 1##2##3##(2008-10#2)
measurements is discussed##3##3##(2008-10#1)(2008-3#2)
measurements is presented##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
measurements is##29##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#16)(2008-7#1)
measurements it##2##2##(1996-5#1)(2008-2#1)
measurements made by##2##3##(2008-10#1)(2008-9#1)
measurements made in##3##3##(2008-3#2)(2008-9#1)
measurements made on##4##3##(1990-8#1)(1996-1#1)(2008-2#1)(2008-5#1)
measurements made with this##2##4##(2008-10#1)(2008-2#1)
measurements made with##8##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)
measurements made##22##2##(1990-8#1)(1995-5#1)(1996-1#1)(2007-11#2)(2008-10#2)(2008-2#6)(2008-3#5)(2008-5#1)(2008-9#2)(2012-12#1)
measurements may be##2##3##(2008-8#1)(2010-7#1)
measurements may##4##2##(1993-11#1)(2008-8#1)(2010-7#1)(2012-3#1)
measurements more##2##2##(2007-11#1)(2010-5#1)
measurements near##2##2##(2008-10#1)(2008-3#1)
measurements not##2##2##(1990-11#1)(1992-10#1)
measurements obtained with##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
measurements obtained##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
measurements of 0##4##3##(2008-10#4)
measurements of 1##2##3##(2008-10#2)
measurements of CO##4##3##(2008-2#2)(2008-3#2)
measurements of CO(2)##4##3##(2008-2#3)(2008-3#1)
measurements of NH(3) and CO(2)##2##5##(2008-3#2)
measurements of NO in##2##4##(2008-2#2)
measurements of NO##4##3##(2008-10#1)(2008-2#3)
measurements of Raman scattering##2##4##(2008-2#1)(2008-3#1)
measurements of Raman##3##3##(2008-2#1)(2008-3#2)
measurements of T cell##2##4##(2008-4#2)
measurements of a##23##3##(2007-11#4)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#8)(2008-9#1)(2010-12#1)
measurements of absorption##2##3##(2008-2#2)
measurements of an##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
measurements of aromatic##2##3##(2008-10#1)(2008-11#1)
measurements of arsenic##2##3##(2008-10#2)
measurements of atmospheric##6##3##(2008-2#2)(2008-3#4)
measurements of beam##2##3##(2008-3#2)
measurements of blood pressure##2##4##(2008-1#1)(2008-11#1)
measurements of both##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
measurements of carbon##2##3##(2007-11#1)(2008-11#1)
measurements of cell##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
measurements of changes in##2##4##(2008-4#1)(2008-9#1)
measurements of chlorophyll fluorescence##2##4##(2008-3#1)(2008-8#1)
measurements of direct and##2##4##(2008-2#1)(2008-3#1)
measurements of direct solar radiation##2##5##(2008-2#2)
measurements of direct solar##3##4##(2008-2#3)
measurements of direct##5##3##(2008-2#4)(2008-3#1)
measurements of drug##2##3##(1990-2#1)(2010-11#1)
measurements of environmental##2##3##(2011-2#1)(2012-3#1)
measurements of femtosecond##2##3##(2007-12#2)
measurements of four##2##3##(2008-3#2)
measurements of hydrogen##2##3##(2008-10#1)(2008-3#1)
measurements of light scattering##2##4##(2008-10#1)(2008-9#1)
measurements of low##2##3##(2008-10#1)(2008-3#1)
measurements of methane##2##3##(2008-3#2)
measurements of multiple##3##3##(2008-3#3)
measurements of neutral atmospheric density##2##5##(2008-3#2)
measurements of neutral##3##3##(2008-3#3)
measurements of nitric oxide (NO)##2##5##(2008-10#1)(2008-2#1)
measurements of nitric oxide##5##4##(2008-10#2)(2008-2#3)
measurements of optical parameters##2##4##(2008-3#2)
measurements of optical##8##3##(2007-11#1)(2007-12#1)(2008-3#6)
measurements of oxygen##3##3##(1995-8#1)(2008-4#1)(2008-6#1)
measurements of reflectance##3##3##(2007-12#1)(2008-3#2)
measurements of seeded##2##3##(2008-2#1)(2008-3#1)
measurements of serum##2##3##(1990-6#1)(1991-5#1)
measurements of several##2##3##(2008-3#2)
measurements of skin##2##3##(2008-5#2)
measurements of solar##3##3##(2008-3#3)
measurements of temperature and##3##4##(2007-12#1)(2008-2#2)
measurements of temperature##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
measurements of the absorption##2##4##(2008-3#2)
measurements of the atmospheric##2##4##(2008-3#2)
measurements of the concentration of##2##5##(2007-12#1)(2008-3#1)
measurements of the degree of polarization##2##6##(2008-3#2)
measurements of the phase##3##4##(2007-11#1)(2008-2#2)
measurements of the spectral##2##4##(2008-2#1)(2008-3#1)
measurements of the two##2##4##(2008-10#1)(2008-3#1)
measurements of the##117##3##(1991-11#1)(1991-12#1)(1992-10#1)(1994-2#1)(1994-3#1)(1996-5#1)(1997-2#1)(2007-11#12)(2007-12#10)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#23)(2008-3#46)(2008-5#4)(2008-6#2)(2009-11#1)(2011-2#1)(2012-12#1)
measurements of these##4##3##(2008-10#3)(2008-3#1)
measurements of this##5##3##(1995-6#1)(2008-2#1)(2008-3#2)(2010-5#1)
measurements of three highly absorbing##2##5##(2008-3#2)
measurements of three##3##3##(2006-4#1)(2008-3#2)
measurements of tissue##2##3##(2008-2#1)(2008-3#1)
measurements of total##2##3##(2008-10#2)
measurements of trace gases in the##2##6##(2008-3#2)
measurements of trace gases in##3##5##(2008-3#3)
measurements of trace metals##2##4##(2008-10#2)
measurements of trace##8##3##(2008-10#4)(2008-11#1)(2008-3#3)
measurements of tropospheric##3##3##(2008-11#1)(2008-3#2)
measurements of##549##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#4)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#2)(2006-4#1)(2007-11#29)(2007-12#35)(2008-1#7)(2008-10#77)(2008-11#10)(2008-12#1)(2008-2#79)(2008-3#180)(2008-4#7)(2008-5#12)(2008-6#5)(2008-7#5)(2008-8#5)(2008-9#14)(2009-11#4)(2009-12#2)(2009-3#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
measurements often##3##2##(1991-12#1)(2006-10#1)(2008-2#1)
measurements on DSKNPH in DMSO##2##5##(2008-10#2)
measurements on a##3##3##(1996-3#1)(2007-11#1)(2008-3#1)
measurements on biological tissues##2##4##(2008-2#1)(2008-3#1)
measurements on different##2##3##(2008-2#1)(2008-4#1)
measurements on each##2##3##(1994-9#1)(2008-9#1)
measurements on fac-Re(CO)(3)(dpknph)Cl in polar##2##5##(2008-10#2)
measurements on fac-Re(CO)(3)(dpknph)Cl##3##3##(2008-10#3)
measurements on stratospheric##2##3##(2008-2#1)(2008-3#1)
measurements on the##9##3##(1996-3#1)(2008-10#1)(2008-2#4)(2008-3#3)
measurements on##51##2##(1991-8#1)(1994-9#1)(1996-3#2)(1997-7#1)(2007-11#1)(2008-10#12)(2008-2#11)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-2#1)
measurements or##4##2##(2007-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
measurements over a broad##2##4##(2007-11#1)(2008-3#1)
measurements over a range of##2##5##(2008-3#2)
measurements over a##6##3##(2007-11#2)(2008-3#4)
measurements over long##2##3##(2008-3#2)
measurements over the##2##3##(2008-2#1)(2008-3#1)
measurements over##12##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#8)
measurements per##2##2##(1992-6#1)(2008-10#1)
measurements performed on##3##3##(1997-4#1)(2008-3#2)
measurements performed over##2##3##(1991-12#1)(2008-5#1)
measurements performed with##2##3##(2008-2#1)(2008-3#1)
measurements performed##12##2##(1991-12#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#2)
measurements provide##5##2##(1990-8#1)(2008-3#3)(2008-7#1)
measurements provided##2##2##(1996-8#1)(2012-1#1)
measurements requires##2##2##(1996-12#1)(2008-3#1)
measurements reveal that##2##3##(2008-10#1)(2008-3#1)
measurements reveal##6##2##(2007-11#2)(2008-10#2)(2008-3#2)
measurements revealed that##4##3##(1994-5#1)(1995-6#1)(2007-12#1)(2011-1#1)
measurements revealed##7##2##(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
measurements should be performed##2##4##(2007-11#1)(2010-5#1)
measurements should be##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
measurements should##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2010-5#1)
measurements show a##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
measurements show that##7##3##(1994-5#1)(2007-12#1)(2008-3#3)(2008-7#1)(2010-4#1)
measurements show the##2##3##(2008-10#1)(2008-3#1)
measurements show##17##2##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#7)(2008-7#1)(2010-4#1)(2013-8#1)
measurements showed that##3##3##(2008-10#1)(2008-3#2)
measurements showed##6##2##(1996-6#1)(2008-10#3)(2008-3#2)
measurements such as##2##3##(2008-3#1)(2008-9#1)
measurements suggest##2##2##(1994-3#1)(2008-2#1)
measurements suggested that the##2##4##(1992-8#1)(1995-2#1)
measurements suggests##2##2##(2007-11#1)(2008-3#1)
measurements taken by##2##3##(2008-2#1)(2010-7#1)
measurements taken over the angular range 0 &lt##2##8##(2008-3#2)
measurements taken over##3##3##(1995-12#1)(2008-3#2)
measurements taken with a##2##4##(2008-2#2)
measurements taken with##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
measurements taken##13##2##(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#5)(2010-7#1)(2012-1#1)(2013-1#1)
measurements that were##2##3##(2008-2#1)(2008-3#1)
measurements that##11##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-9#1)
measurements the##3##2##(2008-3#3)
measurements through##2##2##(2007-11#1)(2008-3#1)
measurements to be made##2##4##(2007-12#2)
measurements to be##5##3##(1992-10#1)(2007-12#3)(2008-2#1)
measurements to characterize the##2##4##(2008-3#1)(2011-2#1)
measurements to determine##2##3##(2008-10#1)(2008-3#1)
measurements to quantify##3##3##(2008-10#2)(2008-5#1)
measurements to study the##2##4##(1995-8#1)(2007-11#1)
measurements to##34##2##(1990-11#1)(1992-10#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#4)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
measurements under##2##2##(2007-11#1)(2008-10#1)
measurements used##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
measurements using a##3##3##(2008-10#2)(2008-11#1)
measurements using the##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
measurements using##15##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2009-12#1)
measurements was developed##2##3##(2008-3#1)(2010-5#1)
measurements was evaluated##2##3##(2008-10#2)
measurements was found##2##3##(2008-10#1)(2011-2#1)
measurements was less than##2##4##(2008-10#1)(2008-2#1)
measurements was##17##2##(1994-1#1)(1995-6#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-12#1)
measurements were carried out at##2##5##(1997-2#1)(2008-10#1)
measurements were carried out in##2##5##(2008-10#2)
measurements were carried out using a conventional three-electrode cell##2##9##(2008-10#2)
measurements were carried out using##4##5##(2008-10#4)
measurements were carried out##11##4##(1997-2#1)(2007-12#1)(2008-10#9)
measurements were compared with##3##4##(2008-11#1)(2008-3#1)(2013-8#1)
measurements were compared##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
measurements were done##3##3##(2008-5#1)(2011-1#2)
measurements were found##2##3##(2010-4#1)(2011-2#1)
measurements were in##2##3##(2008-10#1)(2008-2#1)
measurements were made in##2##4##(2008-3#2)
measurements were made using##2##4##(2008-10#2)
measurements were made##13##3##(1992-11#1)(1993-12#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)
measurements were not##2##3##(1990-11#1)(2008-7#1)
measurements were obtained for##2##4##(2007-11#1)(2008-3#1)
measurements were obtained from##2##4##(2008-10#1)(2008-11#1)
measurements were obtained##5##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)
measurements were performed at##2##4##(1994-7#1)(2008-10#1)
measurements were performed by##2##4##(2008-10#2)
measurements were performed in solvents that absorb##2##7##(2008-3#2)
measurements were performed in##6##4##(1996-7#1)(2008-10#1)(2008-2#2)(2008-3#2)
measurements were performed on healthy##2##5##(2008-3#2)
measurements were performed on##3##4##(2008-10#1)(2008-3#2)
measurements were performed with a##2##5##(2008-2#1)(2008-3#1)
measurements were performed with##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
measurements were performed##25##3##(1992-3#1)(1994-7#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#5)(2008-3#8)(2008-5#1)(2012-2#1)
measurements were possible##3##3##(2008-10#2)(2008-3#1)
measurements were recorded##2##3##(2007-8#1)(2011-2#1)
measurements were sensitive##2##3##(1990-12#1)(2012-2#1)
measurements were taken at##2##4##(1994-2#1)(2007-8#1)
measurements were taken##6##3##(1994-2#1)(1995-12#1)(2007-8#1)(2008-3#1)(2010-7#1)(2013-7#1)
measurements were used to##2##4##(2007-12#1)(2008-10#1)
measurements were used##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
measurements were##109##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#19)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-5#1)(2013-7#1)(2013-8#2)
measurements when##3##2##(2008-2#2)(2008-3#1)
measurements which##4##2##(1995-2#1)(1996-8#1)(2008-10#1)(2008-5#1)
measurements while##2##2##(2008-10#1)(2008-3#1)
measurements will##2##2##(2007-11#1)(2011-2#1)
measurements with a##14##3##(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#5)
measurements with an error caused by laser properties of &lt##2##10##(2008-2#2)
measurements with an error##3##4##(2008-2#3)
measurements with an##5##3##(1992-6#1)(2008-2#3)(2008-3#1)
measurements with and without##2##4##(2008-2#1)(2008-3#1)
measurements with optical##2##3##(2008-2#1)(2008-3#1)
measurements with the##12##3##(1990-12#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#7)
measurements with##68##2##(1990-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1996-6#1)(1997-6#1)(2007-11#4)(2008-10#9)(2008-2#15)(2008-3#32)(2008-4#1)(2008-5#1)
measurements within a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
measurements without##2##2##(2008-3#1)(2008-7#1)
measurements##2314##1##(1990-11#6)(1990-12#3)(1990-2#5)(1990-6#3)(1990-8#10)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#6)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-10#4)(1992-11#2)(1992-12#4)(1992-3#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#9)(1993-12#7)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#4)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#10)(1995-3#4)(1995-5#11)(1995-6#12)(1995-8#5)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#5)(1996-5#3)(1996-6#6)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#4)(2006-10#1)(2006-12#2)(2006-4#2)(2007-10#2)(2007-11#82)(2007-12#105)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#434)(2008-11#38)(2008-12#14)(2008-2#310)(2008-3#726)(2008-4#15)(2008-5#48)(2008-6#8)(2008-7#32)(2008-8#18)(2008-9#38)(2009-10#4)(2009-11#15)(2009-12#5)(2009-2#2)(2009-3#2)(2009-5#4)(2009-7#7)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#5)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#26)(2011-2#34)(2011-7#1)(2012-1#14)(2012-12#7)(2012-2#17)(2012-3#5)(2012-5#1)(2013-1#17)(2013-7#2)(2013-8#7)
measurements) and##2##2##(2008-10#1)(2012-1#1)
measurements)##8##1##(2008-10#5)(2008-5#1)(2011-2#1)(2012-1#1)
measurements]##4##1##(1990-9#1)(1991-11#1)(1994-9#1)(2013-8#1)
measures (i##2##2##(1992-11#1)(2007-12#1)
measures 0##2##2##(2007-5#2)
measures against##6##2##(1995-5#1)(1996-3#1)(2007-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
measures aimed at##6##3##(1995-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-6#1)
measures although##2##2##(2008-5#1)(2012-2#1)
measures among##4##2##(2011-2#2)(2012-1#2)
measures analysis of##3##3##(1996-7#1)(2010-9#1)(2013-1#1)
measures analysis##4##2##(1996-7#1)(2008-10#1)(2010-9#1)(2013-1#1)
measures and a##2##3##(1994-5#1)(1997-3#1)
measures and the##2##3##(1991-6#1)(1996-12#1)
measures and##40##2##(1991-6#2)(1993-9#1)(1994-5#1)(1996-1#1)(1996-12#1)(1997-3#2)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#1)
measures are discussed##6##3##(1990-2#1)(1990-8#1)(1991-9#1)(1995-6#1)(2008-11#1)(2013-1#1)
measures are more##2##3##(2008-11#2)
measures are needed to##2##4##(2008-10#1)(2013-8#1)
measures are not##2##3##(1991-11#1)(2008-2#1)
measures are used##4##3##(1992-1#1)(1995-2#1)(1997-3#1)(2007-2#1)
measures are##42##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-9#2)(1994-3#2)(1995-2#1)(1995-6#1)(1995-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-2#2)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-6#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
measures as##4##2##(1997-2#1)(1997-3#1)(2007-2#1)(2013-7#1)
measures at##7##2##(1994-3#1)(1994-7#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)
measures based on##5##3##(1993-2#1)(1997-3#1)(2008-12#1)(2011-2#1)(2012-2#1)
measures based##6##2##(1991-3#1)(1993-2#1)(1997-3#1)(2008-12#1)(2011-2#1)(2012-2#1)
measures being##2##2##(2008-8#1)(2011-1#1)
measures both##2##2##(2007-8#1)(2008-3#1)
measures by##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
measures can##4##2##(1995-9#1)(1997-7#1)(2008-7#1)(2010-8#1)
measures changes##2##2##(2008-3#1)(2012-2#1)
measures data##4##2##(1994-9#1)(1997-7#2)(2010-2#1)
measures designed##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
measures during##2##2##(1991-12#1)(2013-8#1)
measures employed to##2##3##(1996-3#1)(2008-9#1)
measures for the prevention##2##4##(2008-9#1)(2009-10#1)
measures for the##6##3##(1993-12#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-9#1)(2009-10#1)
measures for##36##2##(1991-1#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
measures from the##3##3##(1997-1#1)(2008-8#1)(2010-8#1)
measures from##4##2##(1997-1#1)(2008-8#1)(2008-9#1)(2010-8#1)
measures have been##7##3##(1992-9#1)(1997-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
measures have##12##2##(1992-9#1)(1996-1#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
measures in clinical##2##3##(1992-9#1)(2008-3#1)
measures in medical##2##3##(1992-2#1)(1997-3#1)
measures in order to##2##4##(1992-9#1)(2008-7#1)
measures in the##5##3##(1990-6#1)(1991-11#1)(1996-8#1)(2007-11#1)(2008-10#1)
measures in##29##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#2)(1994-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#4)
measures include##5##2##(1995-12#1)(2007-7#2)(2008-12#1)(2010-3#1)
measures included the##3##3##(2007-10#1)(2008-12#1)(2012-2#1)
measures included##7##2##(2007-10#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-2#2)
measures including##2##2##(2011-2#1)(2012-3#1)
measures is##4##2##(2008-1#1)(2008-2#1)(2011-2#1)(2013-1#1)
measures may##3##2##(2007-7#1)(2008-9#1)(2010-8#1)
measures more##2##2##(1996-7#1)(2010-12#1)
measures need to be##2##4##(2007-12#1)(2013-1#1)
measures of absolute##2##3##(1994-8#1)(2010-8#1)
measures of aggregation##2##3##(2008-10#2)
measures of alcohol##2##3##(2008-6#1)(2013-8#1)
measures of attachment and##2##4##(2007-12#1)(2010-8#1)
measures of beta-cell function##2##4##(1994-12#2)
measures of body image##3##4##(2007-12#3)
measures of body##8##3##(2007-12#6)(2008-7#1)(2012-2#1)
measures of both##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
measures of cognitive functioning and##2##5##(1990-3#2)
measures of cognitive##4##3##(1990-3#2)(2009-8#1)(2013-1#1)
measures of depressive symptoms##3##4##(2009-11#1)(2009-5#1)(2010-10#1)
measures of durability are##2##4##(2008-10#2)
measures of durability##3##3##(2008-10#3)
measures of dynamic##2##3##(2008-12#1)(2008-3#1)
measures of efficacy##2##3##(2008-6#1)(2011-2#1)
measures of executive control##2##4##(2013-8#2)
measures of health care##2##4##(1995-2#1)(2013-7#1)
measures of health##5##3##(1993-6#1)(1995-2#1)(2008-12#1)(2011-2#1)(2013-7#1)
measures of illness##2##3##(1993-1#1)(2008-11#1)
measures of impulsivity##2##3##(2010-6#2)
measures of neuropathic pain##2##4##(2008-9#2)
measures of obesity##2##3##(2009-7#2)
measures of outcome##2##3##(2007-8#1)(2011-2#1)
measures of pain##2##3##(2007-11#1)(2010-12#1)
measures of perceptions##3##3##(2013-1#3)
measures of performance##3##3##(1994-3#2)(2008-3#1)
measures of quality##4##3##(1992-2#1)(1996-12#1)(1997-2#1)(1997-3#1)
measures of responding##2##3##(2008-5#2)
measures of skin##2##3##(2008-10#1)(2008-5#1)
measures of status##2##3##(2008-12#2)
measures of the##12##3##(1993-12#1)(1994-3#1)(1995-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)
measures of uncertainty##2##3##(2009-7#1)(2010-10#1)
measures of##246##2##(1990-3#2)(1990-6#1)(1991-1#1)(1991-11#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#5)(1994-8#3)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#11)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#8)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#4)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#2)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#10)(2012-1#6)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#21)(2013-7#1)(2013-8#6)
measures on##3##2##(1995-2#1)(2009-6#1)(2010-2#1)
measures or##2##2##(1995-2#1)(2008-10#1)
measures over##2##2##(1992-6#1)(2007-11#1)
measures performed in##2##3##(2008-1#1)(2010-8#1)
measures related to##4##3##(1996-2#1)(2007-2#1)(2011-2#2)
measures relative##2##2##(2008-10#1)(2008-3#1)
measures represent##2##2##(1995-2#1)(2008-7#1)
measures should be##6##3##(1991-11#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
measures showed##2##2##(2008-6#1)(2013-8#1)
measures simultaneously##2##2##(2008-10#1)(2008-7#1)
measures such as##5##3##(1992-12#1)(2008-7#2)(2009-7#1)(2011-1#1)
measures taken so far##2##4##(2008-11#2)
measures taken##9##2##(1991-3#2)(1996-6#1)(2008-11#3)(2010-6#1)(2011-2#2)
measures than##2##2##(2008-9#1)(2013-1#1)
measures that are used##2##4##(1992-9#1)(2008-10#1)
measures that are##4##3##(1992-9#1)(2008-10#1)(2009-9#1)(2011-2#1)
measures that may##2##3##(2007-11#1)(2009-9#1)
measures that##20##2##(1992-6#1)(1992-9#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)
measures the differential pressure as a function of time across the##2##11##(2008-10#2)
measures the effect of##2##4##(2007-11#1)(2008-11#1)
measures the relative##2##3##(2008-2#1)(2012-2#1)
measures the##30##2##(1990-8#1)(1991-11#1)(1992-9#1)(1995-3#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#2)(2012-12#1)(2012-2#1)(2013-1#1)
measures to assess##2##3##(1990-2#1)(1997-3#1)
measures to be taken##2##4##(2008-4#1)(2011-1#1)
measures to be##5##3##(1995-3#1)(2007-6#1)(2008-4#1)(2008-8#1)(2011-1#1)
measures to detect and##2##4##(1994-3#1)(2007-10#1)
measures to prevent##5##3##(1991-12#1)(1991-8#1)(1995-6#1)(2007-12#1)(2012-2#1)
measures to reduce##5##3##(1994-3#1)(1995-2#1)(2008-8#1)(2010-4#1)(2011-2#1)
measures to##55##2##(1990-2#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
measures total##2##2##(2008-10#1)(2008-9#1)
measures two##2##2##(2008-3#1)(2013-8#1)
measures used in##2##3##(1996-3#1)(2012-2#1)
measures used to##2##3##(2008-10#1)(2010-11#1)
measures used##7##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#2)(2010-11#1)(2012-2#1)
measures using##2##2##(1994-12#1)(2006-12#1)
measures was##11##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
measures were significantly##2##3##(1997-4#1)(2008-10#1)
measures were the##2##3##(1994-3#1)(2008-6#1)
measures were##40##2##(1990-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-11#1)(2011-2#5)(2012-1#1)(2013-1#6)
measures which are##2##3##(2008-10#1)(2010-8#1)
measures which##4##2##(2008-10#2)(2010-8#1)(2011-2#1)
measures will help in##2##4##(2009-12#2)
measures will##4##2##(2008-7#1)(2009-12#2)(2012-3#1)
measures with##8##2##(1990-2#1)(1995-9#1)(2007-12#1)(2008-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2013-1#1)
measures would##2##2##(1997-2#1)(2013-1#1)
measures##1091##1##(1990-12#2)(1990-2#6)(1990-3#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#6)(1991-12#5)(1991-2#1)(1991-3#5)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#5)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#14)(1993-1#2)(1993-10#1)(1993-12#8)(1993-2#4)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#16)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#4)(1995-12#9)(1995-2#9)(1995-3#4)(1995-5#6)(1995-6#3)(1995-9#3)(1996-1#10)(1996-12#7)(1996-2#9)(1996-3#15)(1996-6#2)(1996-7#7)(1996-8#2)(1997-1#2)(1997-2#11)(1997-3#19)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#1)(2006-10#4)(2006-12#3)(2007-10#4)(2007-11#16)(2007-12#27)(2007-2#8)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#2)(2008-1#10)(2008-10#79)(2008-11#30)(2008-12#31)(2008-2#13)(2008-3#41)(2008-4#18)(2008-5#12)(2008-6#13)(2008-7#24)(2008-8#27)(2008-9#33)(2009-1#3)(2009-10#13)(2009-11#11)(2009-12#4)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#6)(2009-7#8)(2009-8#1)(2009-9#10)(2010-1#8)(2010-10#7)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#7)(2010-5#6)(2010-6#7)(2010-7#6)(2010-8#11)(2010-9#3)(2011-1#21)(2011-2#74)(2011-3#3)(2011-9#1)(2012-1#14)(2012-12#17)(2012-2#21)(2012-3#17)(2012-7#1)(2013-1#69)(2013-7#4)(2013-8#19)
measuring 1##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#2)
measuring 2##3##2##(1994-6#1)(1994-7#1)(1996-1#1)
measuring a##5##2##(1992-5#1)(1993-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
measuring aberrations of optical components##2##5##(2008-3#2)
measuring aberrations##3##2##(2008-3#3)
measuring accuracy##2##2##(2008-3#2)
measuring and reporting##2##3##(1997-1#1)(2008-3#1)
measuring and##11##2##(1992-1#1)(1995-3#1)(1996-2#3)(1997-1#1)(2007-4#2)(2008-11#1)(2008-12#1)(2008-3#1)
measuring blood##2##2##(2008-1#1)(2008-3#1)
measuring body##2##2##(2008-3#1)(2010-12#1)
measuring cell and##3##3##(2008-10#3)
measuring cell##8##2##(2008-10#6)(2008-11#1)(2008-4#1)
measuring clinical##3##2##(1996-3#1)(1997-1#1)(2010-2#1)
measuring conditions##2##2##(2008-10#2)
measuring device for##2##3##(2008-3#2)
measuring device##4##2##(2008-10#2)(2008-3#2)
measuring different##2##2##(2008-10#1)(2008-5#1)
measuring displacement##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
measuring either the##2##3##(1991-5#1)(2008-3#1)
measuring error##2##2##(2007-12#1)(2008-2#1)
measuring fluorescence##3##2##(1990-7#1)(2008-10#1)(2008-9#1)
measuring glucose##2##2##(2008-8#1)(2009-3#1)
measuring how##2##2##(2008-7#1)(2012-2#1)
measuring in##2##2##(1995-3#1)(2008-10#1)
measuring intracellular##2##2##(1990-12#1)(2008-9#1)
measuring method##2##2##(2008-10#1)(2008-3#1)
measuring of##4##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-3#1)
measuring optical##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
measuring program##2##2##(2008-10#1)(2008-11#1)
measuring pulse##2##2##(2007-11#2)
measuring range and##2##3##(2008-10#2)
measuring range of the##4##4##(2008-10#3)(2008-11#1)
measuring range of##8##3##(2008-10#7)(2008-11#1)
measuring range was##3##3##(2008-10#3)
measuring range##20##2##(2008-10#17)(2008-11#1)(2008-3#2)
measuring relative##2##2##(2008-10#1)(2008-2#1)
measuring simultaneously##2##2##(2008-10#1)(2008-7#1)
measuring small##2##2##(2008-3#2)
measuring system##4##2##(2008-10#2)(2008-3#2)
measuring the Goos-Hänchen##2##3##(2007-11#2)
measuring the absorbance at##4##4##(2008-10#4)
measuring the absorbance##5##3##(2008-10#5)
measuring the activity of##2##4##(2008-8#1)(2011-2#1)
measuring the adhesion of##2##4##(1997-7#1)(2008-4#1)
measuring the amount of##3##4##(2008-10#2)(2008-5#1)
measuring the average##3##3##(2007-12#1)(2009-12#1)(2011-2#1)
measuring the capacity of##3##4##(1994-8#1)(2008-4#2)
measuring the change in##4##4##(2008-10#2)(2008-11#1)(2010-2#1)
measuring the change##5##3##(2008-10#3)(2008-11#1)(2010-2#1)
measuring the changes##2##3##(1994-3#1)(2008-3#1)
measuring the concentration of##5##4##(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)
measuring the decrease in absorbance at##2##6##(2008-10#2)
measuring the decrease in absorbance of##4##6##(2008-10#4)
measuring the decrease in absorbance##6##5##(2008-10#6)
measuring the decrease in##9##4##(2008-10#9)
measuring the decrease of##4##4##(2008-10#3)(2011-2#1)
measuring the decrease##13##3##(2008-10#12)(2011-2#1)
measuring the fraction of##2##4##(1995-3#1)(2008-2#1)
measuring the impact of##2##4##(2008-9#2)
measuring the incorporation of##2##4##(1990-11#1)(1995-5#1)
measuring the intensity##3##3##(2008-10#2)(2008-3#1)
measuring the latent##2##3##(2008-10#2)
measuring the levels of##2##4##(2008-1#1)(2008-11#1)
measuring the mean time of flight##2##6##(2007-12#2)
measuring the number of##2##4##(2008-4#2)
measuring the optical##2##3##(2008-3#1)(2008-6#1)
measuring the peak##3##3##(2008-10#3)
measuring the performance of##2##4##(1996-2#1)(1996-3#1)
measuring the phase##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
measuring the power spectrum of##2##5##(2008-3#2)
measuring the refractive index##2##4##(2008-2#1)(2008-3#1)
measuring the release of##7##4##(1990-12#1)(1990-5#1)(1993-6#1)(2008-11#1)(2008-4#2)(2008-5#1)
measuring the response of##2##4##(2008-3#1)(2008-7#1)
measuring the size of##2##4##(2008-10#1)(2008-7#1)
measuring the surface of a##2##5##(2008-2#2)
measuring the temporal##2##3##(2008-7#1)(2008-8#1)
measuring the transmission##2##3##(2007-12#1)(2008-5#1)
measuring the velocity of##2##4##(2008-10#1)(2008-3#1)
measuring the velocity##3##3##(2008-10#1)(2008-3#2)
measuring the##287##2##(1990-11#2)(1990-12#2)(1990-5#2)(1991-12#1)(1991-3#1)(1991-5#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#7)(2007-12#16)(2007-8#1)(2008-1#4)(2008-10#82)(2008-11#8)(2008-12#1)(2008-2#19)(2008-3#50)(2008-4#11)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#2)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
measuring their##5##2##(1996-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
measuring time##2##2##(2008-10#1)(2011-2#1)
measuring tissue##2##2##(1990-12#1)(2007-12#1)
measuring total##4##2##(1990-12#1)(1995-2#1)(2008-2#1)(2008-3#1)
measuring veiling glare##2##3##(2008-3#2)
measuring##717##1##(1990-11#3)(1990-12#6)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#3)(1991-12#5)(1991-3#2)(1991-5#5)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#4)(1995-3#6)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#6)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#17)(2007-12#25)(2007-4#2)(2007-8#2)(2008-1#7)(2008-10#171)(2008-11#20)(2008-12#4)(2008-2#41)(2008-3#128)(2008-4#29)(2008-5#26)(2008-6#2)(2008-7#11)(2008-8#13)(2008-9#14)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#14)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#2)
meat DNA##2##2##(2010-4#2)
meat and bone meal##4##4##(2008-10#4)
meat and carcass##2##3##(2010-4#1)(2013-1#1)
meat and fish##2##3##(1992-10#1)(2008-10#1)
meat and meat products##4##4##(2008-10#2)(2010-4#1)(2012-12#1)
meat and perirenal fat##2##4##(2010-4#2)
meat and##21##2##(1992-10#1)(2008-10#11)(2010-2#1)(2010-4#4)(2012-12#1)(2013-1#2)(2013-7#1)
meat color##2##2##(2010-2#2)
meat colour##3##2##(2010-4#1)(2013-1#2)
meat consumption##2##2##(1992-10#1)(2012-12#1)
meat extract##2##2##(1992-5#2)
meat for##2##2##(2010-4#2)
meat from the##2##3##(2010-4#2)
meat from yak and cattle using##2##6##(2010-4#2)
meat from##7##2##(2010-4#7)
meat has been##2##3##(2008-10#1)(2013-1#1)
meat has##3##2##(1997-2#1)(2008-10#1)(2013-1#1)
meat inspection##2##2##(1993-2#1)(2008-3#1)
meat is##3##2##(2010-4#3)
meat mixtures##2##2##(2010-4#2)
meat products and vegetables##2##4##(2008-10#2)
meat products and##3##3##(2008-10#3)
meat products##25##2##(2008-10#11)(2010-4#11)(2011-2#2)(2012-12#1)
meat quality in##3##3##(2010-2#2)(2010-4#1)
meat quality parameters##4##3##(2010-2#4)
meat quality traits in##2##4##(2010-4#2)
meat quality traits##3##3##(2010-4#2)(2012-2#1)
meat quality##18##2##(2008-8#1)(2010-2#7)(2010-4#4)(2012-2#3)(2013-1#3)
meat samples and##2##3##(2008-10#1)(2012-2#1)
meat samples##11##2##(2008-10#6)(2010-4#2)(2012-2#1)(2013-1#1)(2013-7#1)
meat species##2##2##(2010-4#2)
meat surface##2##2##(1997-2#1)(2010-4#1)
meat that##2##2##(2010-4#1)(2011-1#1)
meat was##2##2##(1992-5#1)(2010-4#1)
meat were##3##2##(2010-2#1)(2010-4#1)(2011-1#1)
meat with##3##2##(2008-10#2)(2010-4#1)
meat##197##1##(1990-8#1)(1992-10#2)(1992-5#3)(1993-2#2)(1997-2#2)(1997-4#2)(2007-12#1)(2008-10#58)(2008-3#1)(2008-8#1)(2009-4#1)(2010-2#13)(2010-4#74)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#5)(2013-1#16)(2013-7#4)
meatal stenosis##2##2##(2007-7#1)(2008-10#1)
meatal##3##1##(2007-7#1)(2008-10#2)
meats##9##1##(1997-2#1)(2008-10#4)(2010-4#3)(2013-7#1)
meatus and##2##2##(1992-1#1)(1994-2#1)
meatus##8##1##(1992-1#2)(1994-2#1)(2007-8#1)(2008-9#1)(2009-5#2)(2010-11#1)
mebendazole and##4##2##(2008-10#4)
mebendazole in##2##2##(2008-10#2)
mebendazole##15##1##(1990-8#1)(1991-8#2)(2008-10#12)
mecA gene##4##2##(2008-10#3)(2011-2#1)
mecA##5##1##(2008-10#4)(2011-2#1)
mecamylamine##2##1##(1993-9#1)(1996-2#1)
mechanical adjustment##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
mechanical allodynia##2##2##(2008-4#1)(2009-12#1)
mechanical and biological##5##3##(1990-9#1)(2008-6#1)(2010-8#2)(2012-2#1)
mechanical and chemical stability##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
mechanical and chemical##6##3##(2008-10#1)(2008-2#1)(2008-5#2)(2009-7#1)(2013-8#1)
mechanical and cold allodynia##2##4##(2009-12#1)(2011-2#1)
mechanical and degradation behaviors##2##4##(2012-2#2)
mechanical and degradation##4##3##(2012-2#4)
mechanical and##33##2##(1990-9#1)(1992-3#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-2#3)(2012-2#6)(2013-8#1)
mechanical asynchrony##4##2##(2008-10#4)
mechanical behavior of##6##3##(2008-11#1)(2009-7#3)(2012-2#2)
mechanical behaviour of Ti-15 Mo-5 Zr-3 Al alloy##2##8##(2009-7#2)
mechanical behaviour of##5##3##(2009-7#5)
mechanical behaviour##8##2##(2009-7#7)(2013-1#1)
mechanical cell##2##2##(2008-11#1)(2010-9#1)
mechanical challenge##2##2##(2008-5#2)
mechanical characterization of##2##3##(2009-7#1)(2013-1#1)
mechanical characterization##3##2##(2009-7#2)(2013-1#1)
mechanical circulatory support##6##3##(2010-6#2)(2010-8#1)(2011-2#2)(2012-3#1)
mechanical complications##3##2##(1993-5#1)(2007-11#1)(2013-8#1)
mechanical components##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mechanical deformation##3##2##(1992-6#1)(2007-12#1)(2008-3#1)
mechanical devices##4##2##(2008-3#2)(2008-7#1)(2012-12#1)
mechanical diagnosis and therapy##2##4##(2012-2#2)
mechanical effects##2##2##(2008-3#1)(2008-7#1)
mechanical efficiency##2##2##(2012-12#1)(2012-2#1)
mechanical endurance##3##2##(2007-8#3)
mechanical energy##2##2##(2009-10#1)(2010-8#1)
mechanical equilibrium##2##2##(2009-5#1)(2013-8#1)
mechanical factors##3##2##(2007-11#1)(2010-6#1)(2012-3#1)
mechanical fixation##2##2##(2007-11#2)
mechanical force##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
mechanical forces and##2##3##(2008-7#1)(2009-8#1)
mechanical forces##4##2##(2008-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
mechanical function of##2##3##(2008-3#1)(2009-7#1)
mechanical function##5##2##(2008-11#1)(2008-3#2)(2009-7#2)
mechanical heart valves##2##3##(1995-11#1)(2010-6#1)
mechanical heart##3##2##(1991-2#1)(1995-11#1)(2010-6#1)
mechanical ileus##2##2##(1997-8#1)(2008-10#1)
mechanical inhomogeneity##3##2##(2013-7#3)
mechanical injury##2##2##(1993-2#1)(2007-10#1)
mechanical inoculation of##4##3##(2008-10#4)
mechanical inoculation##12##2##(2008-10#12)
mechanical interaction between an electromagnetic field and a nanoscopic thin film near electronic resonance##2##14##(2007-11#2)
mechanical jaundice##4##2##(2011-1#3)(2012-12#1)
mechanical loads##3##2##(2008-7#2)(2008-8#1)
mechanical method##2##2##(2008-11#1)(2008-3#1)
mechanical mitral##2##2##(2009-5#1)(2013-1#1)
mechanical mixing##2##2##(2009-7#2)
mechanical movement##4##2##(1994-6#1)(2007-12#1)(2008-3#2)
mechanical obstruction##2##2##(2008-10#1)(2011-1#1)
mechanical or##2##2##(2008-3#1)(2008-9#1)
mechanical parameters of##2##3##(2008-11#1)(2008-5#1)
mechanical parameters##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2009-4#1)
mechanical performance##2##2##(2007-12#1)(2012-2#1)
mechanical polishing##4##2##(2008-10#2)(2008-3#2)
mechanical power##2##2##(2007-12#2)
mechanical pressure##2##2##(2008-10#1)(2008-8#1)
mechanical properties and##7##3##(2008-6#1)(2009-7#3)(2010-4#1)(2012-2#1)(2013-1#1)
mechanical properties as##2##3##(2008-5#1)(2012-2#1)
mechanical properties in the##3##4##(2007-12#1)(2008-3#2)
mechanical properties in##4##3##(2007-12#1)(2008-3#3)
mechanical properties of human##2##4##(2008-5#2)
mechanical properties of the scaffolds##2##5##(2009-7#2)
mechanical properties of the##20##4##(1996-4#1)(2007-11#1)(2007-8#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-7#6)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#2)
mechanical properties of##48##3##(1996-3#1)(1996-4#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#3)(2009-4#1)(2009-7#13)(2009-8#1)(2009-9#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
mechanical properties to##4##3##(2008-5#1)(2008-8#1)(2010-4#1)(2012-1#1)
mechanical properties were measured##2##4##(2009-7#1)(2010-10#1)
mechanical properties##106##2##(1995-3#1)(1996-3#1)(1996-4#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#12)(2008-6#5)(2008-7#8)(2008-8#1)(2009-11#3)(2009-4#3)(2009-6#1)(2009-7#25)(2009-8#2)(2009-9#1)(2010-10#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#5)(2013-8#1)
mechanical property##2##2##(2008-5#1)(2010-12#1)
mechanical prostheses##2##2##(2010-8#2)
mechanical reliability##2##2##(2008-2#1)(2008-3#1)
mechanical removal of the##2##4##(2007-8#1)(2012-2#1)
mechanical removal of##4##3##(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
mechanical reperfusion##2##2##(2008-3#2)
mechanical replacement valve##2##3##(2011-2#2)
mechanical resistance of##2##3##(2007-11#1)(2007-12#1)
mechanical resistance##3##2##(2007-11#1)(2007-12#1)(2008-5#1)
mechanical response of the##3##4##(1995-5#1)(2008-3#1)(2008-5#1)
mechanical response of##5##3##(1995-5#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)
mechanical responses in##2##3##(1994-6#2)
mechanical responses##3##2##(1994-6#2)(2008-11#1)
mechanical rigidity##2##2##(2008-10#1)(2008-7#1)
mechanical scanning##2##2##(2007-11#1)(2008-3#1)
mechanical shear##2##2##(2008-11#2)
mechanical stability of the##2##4##(2008-10#2)
mechanical stability of##6##3##(1991-12#1)(2008-10#2)(2008-7#2)(2009-9#1)
mechanical stability##17##2##(1991-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#5)(2009-9#2)
mechanical stimulation of##2##3##(1994-2#1)(2009-8#1)
mechanical stimulation##9##2##(1994-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#1)(2012-2#2)(2013-8#1)
mechanical stimuli##5##2##(1993-12#1)(1997-3#1)(2008-11#1)(2008-7#2)
mechanical stimulus##2##2##(2008-7#1)(2008-9#1)
mechanical strain##4##2##(1995-2#2)(2007-11#1)(2008-3#1)
mechanical strain-induced##3##2##(1995-2#3)
mechanical strength of the##2##4##(2008-3#1)(2010-2#1)
mechanical strength of##4##3##(2008-3#1)(2009-7#1)(2010-2#2)
mechanical strength##10##2##(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#3)(2009-9#1)(2010-2#2)(2010-4#1)
mechanical stress by##2##3##(2008-3#1)(2011-2#1)
mechanical stress to##2##3##(2008-12#1)(2008-7#1)
mechanical stress##9##2##(1992-6#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#2)(2011-2#1)
mechanical stretch##2##2##(1990-8#1)(2008-6#1)
mechanical testing##2##2##(2008-8#1)(2012-2#1)
mechanical thrombolysis##3##2##(2007-10#2)(2013-8#1)
mechanical valve##4##2##(1990-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
mechanical ventilation and the##2##4##(1995-2#1)(1996-9#1)
mechanical ventilation and##4##3##(1995-2#1)(1996-9#1)(2010-5#1)(2012-12#1)
mechanical ventilation at##2##3##(1994-1#1)(1995-5#1)
mechanical ventilation##29##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-2#1)(1994-1#1)(1994-6#1)(1995-2#2)(1995-5#2)(1996-9#1)(2006-10#1)(2007-11#1)(2007-6#3)(2007-7#1)(2008-11#1)(2009-7#1)(2010-5#4)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#1)
mechanical ventilator##2##2##(2010-8#2)
mechanical vibrations##3##2##(2008-2#2)(2008-3#1)
mechanical##608##1##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#5)(1994-8#1)(1995-11#1)(1995-2#7)(1995-3#1)(1995-5#3)(1995-8#1)(1996-3#2)(1996-4#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#6)(2007-11#21)(2007-12#19)(2007-6#3)(2007-7#2)(2007-8#14)(2007-9#1)(2008-1#1)(2008-10#49)(2008-11#21)(2008-12#7)(2008-2#15)(2008-3#51)(2008-4#8)(2008-5#29)(2008-6#9)(2008-7#35)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#5)(2009-12#6)(2009-3#2)(2009-4#6)(2009-5#5)(2009-6#3)(2009-7#51)(2009-8#11)(2009-9#5)(2010-10#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#5)(2010-6#6)(2010-7#1)(2010-8#9)(2010-9#4)(2011-1#6)(2011-2#25)(2012-1#3)(2012-12#9)(2012-2#25)(2012-3#9)(2013-1#17)(2013-7#5)(2013-8#8)
mechanically and##2##2##(2007-10#1)(2008-10#1)
mechanically by##2##2##(2008-10#1)(2008-2#1)
mechanically coupled joints##2##3##(2007-12#2)
mechanically coupled##3##2##(2007-12#3)
mechanically induced long-period fiber gratings##2##5##(2007-12#2)
mechanically induced##5##2##(1994-12#1)(1994-6#1)(2007-12#2)(2009-8#1)
mechanically inoculated##3##2##(2008-10#3)
mechanically robust and##2##3##(2007-12#1)(2012-2#1)
mechanically ruled##3##2##(2008-2#1)(2008-3#2)
mechanically stable##4##2##(2007-12#1)(2008-10#2)(2012-1#1)
mechanically stretched##2##2##(2008-3#1)(2008-7#1)
mechanically transmissible##2##2##(2008-10#2)
mechanically ventilated for##2##3##(1990-12#1)(2011-2#1)
mechanically ventilated##4##2##(1990-12#1)(1994-12#1)(2011-2#2)
mechanically##72##1##(1990-12#1)(1994-12#2)(1994-6#2)(1995-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#20)(2008-2#2)(2008-3#10)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)
mechanics and##6##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
mechanics have##3##2##(1996-5#1)(2007-12#1)(2008-7#1)
mechanics is##2##2##(1995-5#1)(2009-5#1)
mechanics of the##5##3##(1994-3#1)(2007-11#1)(2008-9#1)(2010-1#1)(2011-2#1)
mechanics of##15##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)
mechanics that##2##2##(2007-12#1)(2011-2#1)
mechanics##66##1##(1994-2#1)(1994-3#3)(1995-11#1)(1995-5#4)(1996-5#4)(2007-11#2)(2007-12#5)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2011-2#5)(2012-2#6)(2013-1#2)(2013-7#1)
mechanism (i##2##2##(2008-10#1)(2009-2#1)
mechanism [Ln(J) versus##2##3##(2009-11#2)
mechanism about##2##2##(2008-10#1)(2008-8#1)
mechanism and a##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
mechanism and show that##2##4##(1994-8#1)(2010-3#1)
mechanism and the##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
mechanism and##41##2##(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#3)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
mechanism are also discussed##2##4##(2008-10#2)
mechanism are##7##2##(1995-8#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#1)
mechanism as##6##2##(1990-11#1)(1990-2#1)(1993-12#1)(2007-12#1)(2008-10#1)(2011-1#1)
mechanism at the##2##3##(1990-7#1)(2008-10#1)
mechanism at##4##2##(1990-7#1)(2008-10#3)
mechanism based on##2##3##(2008-10#2)
mechanism based##3##2##(2008-10#2)(2008-7#1)
mechanism becomes##2##2##(2008-3#1)(2008-4#1)
mechanism behind##4##2##(2008-10#1)(2008-9#1)(2010-7#1)(2012-2#1)
mechanism between##3##2##(2008-8#1)(2009-8#1)(2013-1#1)
mechanism by which T##2##4##(1995-2#1)(2008-10#1)
mechanism by which it##2##4##(1995-9#1)(2011-1#1)
mechanism by which the##12##4##(1990-11#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
mechanism by which these##3##4##(1994-11#1)(1995-12#1)(2008-11#1)
mechanism by which this occurs##4##5##(1992-9#1)(2008-11#1)(2008-7#1)(2013-1#1)
mechanism by which this##9##4##(1990-7#1)(1992-3#1)(1992-9#1)(1994-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
mechanism by which##63##3##(1990-11#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#5)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#2)(2013-1#2)
mechanism by##68##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#5)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#2)(2013-1#2)
mechanism called##2##2##(2008-9#1)(2010-10#1)
mechanism can be##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
mechanism can promote diversity##2##4##(2008-8#2)
mechanism can##8##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2013-1#1)
mechanism contributing to##2##3##(1995-5#1)(2008-10#1)
mechanism dependent##3##2##(1990-12#1)(2013-1#2)
mechanism for a##3##3##(1995-8#1)(2007-11#1)(2008-10#1)
mechanism for financing##2##3##(1996-12#1)(2008-7#1)
mechanism for formation of the##3##5##(1990-5#1)(2008-10#1)(2008-2#1)
mechanism for increasing the##2##4##(2008-10#1)(2009-5#1)
mechanism for its##2##3##(2008-10#1)(2013-8#1)
mechanism for particles##2##3##(2008-11#2)
mechanism for rapid##2##3##(1993-6#1)(2008-11#1)
mechanism for the formation of##3##5##(1991-5#1)(2008-10#2)
mechanism for the interaction of##3##5##(1993-8#1)(2008-10#2)
mechanism for the male-specific expression##2##5##(1995-2#2)
mechanism for the reaction##2##4##(2008-10#2)
mechanism for the reduction was suggested##2##6##(2008-10#2)
mechanism for the reduction##4##4##(1995-5#1)(2008-10#3)
mechanism for the##57##3##(1991-12#1)(1991-5#2)(1992-12#2)(1993-6#1)(1993-8#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#3)(2008-10#19)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
mechanism for this effect##2##4##(1994-9#1)(2008-11#1)
mechanism for this##11##3##(1991-5#1)(1994-9#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-4#1)(2012-12#1)
mechanism for##187##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-9#2)(1992-1#1)(1992-12#4)(1993-12#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-12#4)(1996-3#1)(1996-4#1)(1997-4#2)(1997-7#3)(1997-8#1)(2006-12#1)(2007-11#5)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#33)(2008-11#11)(2008-2#2)(2008-3#9)(2008-4#4)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#3)
mechanism from##2##2##(1993-8#1)(2008-5#1)
mechanism has been##9##3##(1996-11#1)(1996-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
mechanism has##12##2##(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
mechanism how##2##2##(2008-8#1)(2011-2#1)
mechanism in the##12##3##(1990-5#1)(1990-7#1)(1993-3#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)
mechanism in this species##2##4##(2008-5#1)(2008-7#1)
mechanism in this##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
mechanism in which the##2##4##(1993-11#1)(2008-8#1)
mechanism in which##5##3##(1991-2#1)(1993-11#1)(1994-5#2)(2008-8#1)
mechanism in##50##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#2)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#2)(2012-2#3)(2013-1#1)(2013-8#1)
mechanism independent of##3##3##(1993-9#1)(2008-4#1)(2011-2#1)
mechanism involved in##4##3##(1994-12#1)(1994-2#1)(2008-7#1)(2012-12#1)
mechanism involved##6##2##(1994-12#1)(1994-2#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-12#1)
mechanism involves##6##2##(1992-3#1)(1995-5#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#1)
mechanism involving the##4##3##(1991-2#1)(1995-12#1)(2008-10#1)(2011-2#1)
mechanism involving##12##2##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1995-12#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
mechanism is affected##2##3##(2008-10#2)
mechanism is also discussed##3##4##(1992-8#1)(2008-10#2)
mechanism is also investigated##2##4##(2008-10#1)(2008-12#1)
mechanism is also##6##3##(1992-8#1)(2008-10#4)(2008-12#1)
mechanism is an##2##3##(1995-2#1)(2008-7#1)
mechanism is discussed##5##3##(1996-8#1)(2008-10#2)(2011-2#2)
mechanism is involved##2##3##(1994-12#1)(2008-7#1)
mechanism is proposed##4##3##(1996-5#1)(2008-10#3)
mechanism is responsible for the##2##5##(2007-11#1)(2012-2#1)
mechanism is still unknown##2##4##(2008-7#1)(2008-9#1)
mechanism is that##3##3##(1992-4#1)(1994-8#1)(2008-3#1)
mechanism is unclear##2##3##(2008-8#1)(2011-1#1)
mechanism is unknown##3##3##(1993-6#1)(2008-11#1)(2008-7#1)
mechanism is##83##2##(1990-11#2)(1990-8#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-3#1)(2010-10#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
mechanism may be##4##3##(1990-10#1)(2008-10#2)(2013-1#1)
mechanism may involve##2##3##(1996-5#1)(2008-10#1)
mechanism may##12##2##(1990-10#1)(1992-12#1)(1992-9#1)(1994-8#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
mechanism mediated by##2##3##(2009-3#1)(2012-12#1)
mechanism of 3##2##3##(2008-10#2)
mechanism of CL##3##3##(2008-10#3)
mechanism of Cr(VI)##2##3##(2008-10#1)(2011-2#1)
mechanism of Escherichia coli##2##4##(1992-6#1)(1995-6#1)
mechanism of JH delivery##2##4##(2012-2#2)
mechanism of RNA##2##3##(1992-11#1)(2013-1#1)
mechanism of action and##3##4##(1993-12#1)(1995-8#1)(2008-9#1)
mechanism of action for##4##4##(1993-3#1)(2008-10#1)(2008-5#1)(2010-9#1)
mechanism of action has##2##4##(1992-3#1)(2007-11#1)
mechanism of action is##2##4##(1994-6#1)(2009-12#1)
mechanism of action of the##7##5##(1992-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2013-8#1)
mechanism of action of##32##4##(1990-11#1)(1990-3#1)(1991-5#1)(1992-9#1)(1994-11#1)(1995-5#1)(1997-2#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
mechanism of action remains##2##4##(2008-10#1)(2009-7#1)
mechanism of action##88##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#2)(1991-5#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-5#2)(1995-8#1)(1997-2#2)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#7)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#2)(2009-9#1)(2010-11#2)(2010-4#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#3)(2013-7#1)(2013-8#1)
mechanism of activation of the##2##5##(1994-3#1)(2008-10#1)
mechanism of activation of##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
mechanism of activation##5##3##(1994-3#1)(1995-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
mechanism of an##5##3##(1995-5#1)(2008-10#2)(2008-7#1)(2009-3#1)
mechanism of biocontrol##3##3##(2008-10#3)
mechanism of biological control of##2##5##(2008-10#2)
mechanism of biological control##4##4##(2008-10#4)
mechanism of calcium##2##3##(1994-9#1)(2008-8#1)
mechanism of catalysis##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
mechanism of cell death##2##4##(2008-11#1)(2008-7#1)
mechanism of development##2##3##(1993-12#1)(2013-1#1)
mechanism of disease##2##3##(2008-10#1)(2008-12#1)
mechanism of drug##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
mechanism of each##2##3##(2010-7#1)(2010-8#1)
mechanism of enhanced##2##3##(2008-10#1)(2008-11#1)
mechanism of enhancement is##2##4##(1991-5#1)(2008-11#1)
mechanism of enhancement##3##3##(1991-5#2)(2008-11#1)
mechanism of environmental##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
mechanism of how##2##3##(2008-11#1)(2013-1#1)
mechanism of inhibition##3##3##(1990-11#1)(1992-3#1)(1992-8#1)
mechanism of injury##7##3##(2008-11#1)(2009-3#1)(2010-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
mechanism of interaction between##2##4##(1990-11#1)(1990-2#1)
mechanism of interaction##5##3##(1990-11#1)(1990-2#2)(2008-10#2)
mechanism of its##4##3##(1990-11#1)(1997-4#1)(2008-5#1)(2008-9#1)
mechanism of modulation##2##3##(1994-3#1)(1994-8#1)
mechanism of primary##3##3##(2008-10#2)(2008-8#1)
mechanism of protein##2##3##(1997-2#1)(2008-11#1)
mechanism of regulation##5##3##(1990-8#1)(1994-12#1)(1995-12#1)(2008-11#1)(2009-3#1)
mechanism of resistance in##2##4##(2008-10#2)
mechanism of resistance##6##3##(2008-10#6)
mechanism of steroid 5 alpha-reductase##2##5##(1990-11#2)
mechanism of steroid##4##3##(1990-11#2)(1996-2#1)(2008-4#1)
mechanism of such##2##3##(1991-9#1)(2008-9#1)
mechanism of the effect of##2##5##(1995-8#1)(2011-3#1)
mechanism of the enzyme##2##4##(1991-5#1)(1995-2#1)
mechanism of the formation of##2##5##(1992-5#1)(2011-2#1)
mechanism of the formation##3##4##(1992-5#1)(2008-10#1)(2011-2#1)
mechanism of the##67##3##(1990-2#1)(1990-5#1)(1991-5#2)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-8#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
mechanism of these##3##3##(2007-10#1)(2008-10#1)(2008-2#1)
mechanism of this effect##3##4##(1990-3#1)(1995-8#2)
mechanism of this reaction##3##4##(1994-8#1)(2008-10#1)(2009-10#1)
mechanism of this##30##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#2)(2007-10#1)(2008-10#5)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
mechanism of toxicity##2##3##(1992-9#1)(2008-10#1)
mechanism of transcriptional regulation##2##4##(1992-8#1)(2008-9#1)
mechanism of transcriptional##3##3##(1992-8#1)(2008-4#1)(2008-9#1)
mechanism of transport##2##3##(1994-6#1)(2008-10#1)
mechanism of tumor##2##3##(1993-9#1)(2013-8#1)
mechanism of##600##2##(1990-11#10)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#6)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#8)(1992-5#1)(1992-6#6)(1992-8#6)(1992-9#4)(1993-11#9)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#6)(1993-9#4)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#2)(1995-11#2)(1995-12#6)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#6)(1995-8#7)(1996-12#3)(1996-2#6)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#8)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-8#3)(2008-1#5)(2008-10#144)(2008-11#24)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#10)(2008-5#16)(2008-6#7)(2008-7#20)(2008-8#18)(2008-9#20)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#3)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#17)(2011-3#6)(2012-1#4)(2012-12#7)(2012-2#9)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#9)
mechanism on the##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
mechanism on##5##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
mechanism or##2##2##(2008-8#1)(2011-2#1)
mechanism other than##6##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)
mechanism proposed##2##2##(1996-5#1)(1997-6#1)
mechanism regulating##5##2##(1995-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)
mechanism remains unclear##2##3##(2008-11#1)(2008-8#1)
mechanism remains##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
mechanism responsible for the##3##4##(2008-10#2)(2008-4#1)
mechanism responsible for##6##3##(2008-10#3)(2008-4#1)(2010-3#1)(2012-2#1)
mechanism results in##2##3##(2008-7#1)(2013-1#1)
mechanism that allows##2##3##(2009-8#1)(2010-10#1)
mechanism that can be##2##4##(2007-11#1)(2012-2#1)
mechanism that can##5##3##(1991-9#1)(2007-11#1)(2008-9#1)(2010-4#1)(2012-2#1)
mechanism that is##6##3##(1995-2#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
mechanism that leads to the##2##5##(1994-9#1)(2008-3#1)
mechanism that leads to##4##4##(1994-9#1)(2008-3#1)(2011-2#1)(2013-1#1)
mechanism that reduces##2##3##(2008-10#1)(2008-6#1)
mechanism that regulates##2##3##(2008-11#1)(2010-11#1)
mechanism that##47##2##(1991-9#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-2#1)(2007-11#3)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
mechanism the##2##2##(2008-8#2)
mechanism through which##4##3##(1993-6#1)(2008-11#1)(2008-8#1)(2012-3#1)
mechanism to ensure##2##3##(1995-8#1)(2012-3#1)
mechanism to explain##2##3##(2009-10#1)(2011-1#1)
mechanism to prevent##3##3##(1993-2#1)(1994-9#1)(2008-10#1)
mechanism to the##3##3##(2008-7#2)(2011-1#1)
mechanism to##30##2##(1990-8#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#3)(2010-11#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
mechanism underlying its##2##3##(1990-3#1)(2010-2#1)
mechanism underlying the##10##3##(1991-9#1)(1992-9#1)(1996-12#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#1)
mechanism underlying their##2##3##(2008-3#1)(2010-8#1)
mechanism underlying this##4##3##(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
mechanism underlying##26##2##(1990-3#1)(1991-9#1)(1992-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
mechanism was also discussed##4##4##(2008-10#4)
mechanism was discussed##4##3##(2008-10#4)
mechanism was investigated##2##3##(2008-10#1)(2013-8#1)
mechanism was proposed##2##3##(2008-10#2)
mechanism was suggested to##2##4##(2008-10#2)
mechanism was##23##2##(2008-10#19)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
mechanism were##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
mechanism when##3##2##(1994-6#1)(2007-10#1)(2010-4#1)
mechanism where##2##2##(1991-12#1)(1995-5#1)
mechanism whereby##11##2##(1990-2#1)(1990-8#1)(1991-12#1)(1994-9#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
mechanism which##10##2##(1990-5#1)(1996-12#1)(1996-5#3)(1997-7#1)(2008-11#1)(2008-7#2)(2012-2#1)
mechanism with a##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
mechanism with the##2##3##(2008-10#2)
mechanism with##7##2##(1992-6#1)(1996-2#1)(2008-10#4)(2012-2#1)
mechanism within##4##2##(1995-12#1)(2007-12#1)(2008-7#1)(2009-7#1)
mechanism##1666##1##(1990-10#1)(1990-11#16)(1990-12#6)(1990-2#11)(1990-3#6)(1990-5#13)(1990-6#1)(1990-7#9)(1990-8#11)(1991-1#3)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#14)(1991-9#11)(1992-1#4)(1992-11#3)(1992-12#10)(1992-2#2)(1992-3#16)(1992-4#1)(1992-5#1)(1992-6#12)(1992-7#1)(1992-8#10)(1992-9#7)(1993-11#14)(1993-12#5)(1993-2#2)(1993-3#8)(1993-6#10)(1993-8#9)(1993-9#7)(1994-11#8)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#10)(1994-8#21)(1994-9#7)(1995-1#1)(1995-11#9)(1995-12#17)(1995-2#21)(1995-3#12)(1995-4#1)(1995-5#10)(1995-6#13)(1995-8#18)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#10)(1996-3#3)(1996-4#3)(1996-5#8)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#12)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#12)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#10)(2007-11#25)(2007-12#25)(2007-2#1)(2007-6#1)(2007-8#5)(2008-1#11)(2008-10#327)(2008-11#51)(2008-12#7)(2008-2#26)(2008-3#44)(2008-4#30)(2008-5#35)(2008-6#23)(2008-7#55)(2008-8#75)(2008-9#41)(2009-10#9)(2009-11#11)(2009-12#7)(2009-2#4)(2009-3#8)(2009-5#5)(2009-6#2)(2009-7#7)(2009-8#22)(2009-9#6)(2010-1#5)(2010-10#9)(2010-11#15)(2010-12#8)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#9)(2010-6#2)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#46)(2011-3#6)(2012-1#8)(2012-12#22)(2012-2#34)(2012-3#21)(2013-1#43)(2013-7#2)(2013-8#26)
mechanism(s) of##5##2##(1992-6#1)(1993-8#1)(1994-8#1)(2008-1#1)(2008-10#1)
mechanism(s) that##3##2##(1994-11#1)(2009-10#1)(2012-2#1)
mechanism(s)##16##1##(1991-6#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
mechanism)##2##1##(2008-10#1)(2008-8#1)
mechanism-based classification##3##2##(2008-12#2)(2008-7#1)
mechanism-based inactivation##2##2##(1992-11#1)(1995-2#1)
mechanism-based inactivator of##2##3##(1991-5#1)(1995-2#1)
mechanism-based inactivators##2##2##(1992-11#1)(2007-11#1)
mechanism-based inhibition of##2##3##(1993-11#1)(2008-3#1)
mechanism-based inhibitor##3##2##(1991-3#1)(1992-6#1)(2012-12#1)
mechanism-based##25##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#1)(1995-2#2)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-8#2)(2009-9#1)(2012-12#1)
mechanism]##3##1##(1990-11#1)(2010-12#1)(2012-2#1)
mechanisms (e##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
mechanisms affect##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
mechanisms against##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
mechanisms aiming##2##2##(2008-11#1)(2008-2#1)
mechanisms allowing##2##2##(2008-10#1)(2008-8#1)
mechanisms also##2##2##(1990-2#1)(2008-10#1)
mechanisms among##2##2##(2009-5#1)(2010-3#1)
mechanisms and clinical##4##3##(1994-2#1)(2008-4#1)(2010-6#1)(2012-2#1)
mechanisms and in##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
mechanisms and kinetics of##2##4##(1994-5#1)(2008-10#1)
mechanisms and management##3##3##(1990-9#1)(2008-3#1)(2011-2#1)
mechanisms and molecular##2##3##(2009-8#1)(2011-3#1)
mechanisms and pathways##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
mechanisms and that##4##3##(1993-6#1)(1994-9#1)(2008-4#1)(2010-5#1)
mechanisms and the##7##3##(1990-5#1)(1990-8#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-4#1)
mechanisms and to##3##3##(2008-11#1)(2010-5#1)(2012-3#1)
mechanisms and##73##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#5)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-2#5)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#1)
mechanisms appear to##3##3##(1995-8#1)(2008-10#2)
mechanisms appear##4##2##(1995-8#1)(2008-10#2)(2013-8#1)
mechanisms are also##2##3##(1996-11#1)(2008-10#1)
mechanisms are discussed##4##3##(1990-8#1)(2007-11#1)(2008-7#1)(2010-3#1)
mechanisms are impaired##2##3##(1997-1#1)(2013-7#1)
mechanisms are important##2##3##(2007-11#1)(2008-11#1)
mechanisms are involved##3##3##(1997-3#1)(2012-7#1)(2013-7#1)
mechanisms are largely##2##3##(2008-9#1)(2013-7#1)
mechanisms are not completely##2##4##(2008-10#1)(2008-7#1)
mechanisms are not fully##2##4##(2008-4#1)(2011-2#1)
mechanisms are not##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
mechanisms are poorly understood##2##4##(2008-3#1)(2013-8#1)
mechanisms are responsible for##2##4##(2008-10#2)
mechanisms are still##2##3##(2008-7#1)(2010-12#1)
mechanisms are the##2##3##(2007-11#1)(2008-11#1)
mechanisms are thought to##2##4##(2008-5#1)(2008-9#1)
mechanisms are##54##2##(1990-8#1)(1992-3#1)(1992-9#1)(1994-3#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#2)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-7#1)(2013-7#3)(2013-8#1)
mechanisms as##4##2##(1997-8#1)(2008-11#2)(2008-5#1)
mechanisms associated with##6##3##(2007-12#1)(2007-8#2)(2008-10#1)(2012-12#1)(2013-8#1)
mechanisms at different##2##3##(2008-7#1)(2011-2#1)
mechanisms at the##5##3##(1994-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
mechanisms at##8##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)
mechanisms based on two##2##4##(1990-8#1)(1995-12#1)
mechanisms become##2##2##(2008-10#1)(2012-1#1)
mechanisms behind these##3##3##(2008-11#1)(2008-5#1)(2012-2#1)
mechanisms behind##5##2##(2008-11#2)(2008-5#1)(2010-3#1)(2012-2#1)
mechanisms between##2##2##(2007-11#1)(2008-3#1)
mechanisms but##2##2##(2008-2#1)(2008-9#1)
mechanisms by which disgust##2##4##(2010-7#2)
mechanisms by which the##7##4##(1993-12#1)(2008-10#2)(2008-9#1)(2010-5#2)(2011-1#1)
mechanisms by which these##3##4##(1996-2#1)(2008-7#2)
mechanisms by which##71##3##(1992-2#1)(1993-12#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-8#4)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#3)
mechanisms by##75##2##(1992-11#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-8#4)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#4)(2011-3#2)(2012-1#1)(2012-2#4)(2013-1#3)
mechanisms can be##4##3##(2008-10#2)(2008-4#1)(2009-5#1)
mechanisms can contribute to the##2##5##(2007-12#1)(2011-3#1)
mechanisms can##10##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-5#1)(2011-3#1)(2013-1#1)
mechanisms causing##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
mechanisms contribute to##2##3##(2008-8#1)(2009-9#1)
mechanisms contributing to##2##3##(2008-11#2)
mechanisms controlling##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
mechanisms could be##2##3##(2010-6#1)(2011-2#1)
mechanisms could##6##2##(2008-8#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
mechanisms described##2##2##(1997-1#1)(2007-11#1)
mechanisms determining##2##2##(2010-5#1)(2012-12#1)
mechanisms employed by the##2##4##(2008-10#1)(2011-2#1)
mechanisms exist to##2##3##(2008-7#1)(2011-2#1)
mechanisms exist##4##2##(2008-10#1)(2008-7#1)(2011-2#2)
mechanisms explaining##2##2##(2008-11#1)(2008-8#1)
mechanisms for adhesion##2##3##(2006-6#1)(2012-1#1)
mechanisms for control##2##3##(1995-11#1)(2008-10#1)
mechanisms for its##2##3##(1995-6#1)(2008-10#1)
mechanisms for the##16##3##(1991-5#1)(1992-2#1)(1992-8#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)
mechanisms for these##3##3##(2008-3#1)(2008-7#2)
mechanisms for this##3##3##(1990-2#1)(2008-10#1)(2011-1#1)
mechanisms for##78##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
mechanisms generating##2##2##(2007-11#1)(2010-3#1)
mechanisms governing##7##2##(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
mechanisms has##2##2##(2007-8#1)(2011-2#1)
mechanisms have also##2##3##(2008-7#1)(2009-2#1)
mechanisms have been proposed##2##4##(1996-11#1)(2011-2#1)
mechanisms have been##13##3##(1992-9#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
mechanisms have to be##2##4##(2011-1#1)(2011-2#1)
mechanisms have##21##2##(1992-9#1)(1993-1#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#2)(2009-2#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
mechanisms in a##2##3##(2007-12#1)(2008-5#1)
mechanisms in the pathogenesis of##3##5##(1992-3#1)(1994-3#1)(1994-5#1)
mechanisms in the##12##3##(1992-3#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-8#1)(2007-8#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-8#1)
mechanisms in which##2##3##(2008-10#1)(2009-10#1)
mechanisms in##61##2##(1990-2#1)(1990-5#1)(1990-7#2)(1992-3#2)(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
mechanisms including##2##2##(1991-9#1)(1992-8#1)
mechanisms indicate that##2##3##(1990-6#1)(2008-10#1)
mechanisms interact##2##2##(1995-12#1)(2009-6#1)
mechanisms involve##2##2##(2009-7#1)(2013-1#1)
mechanisms involved in cell death##2##5##(2008-1#1)(2008-9#1)
mechanisms involved in response to low doses of##2##8##(2008-7#2)
mechanisms involved in the##7##4##(1990-8#1)(1993-5#1)(1995-11#1)(1997-3#1)(2008-11#1)(2008-4#1)(2009-12#1)
mechanisms involved in this##4##4##(1993-6#1)(1997-3#1)(2008-1#1)(2008-4#1)
mechanisms involved in##33##3##(1990-8#1)(1993-5#1)(1993-6#1)(1995-11#2)(1995-2#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#4)(2008-9#2)(2009-12#2)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
mechanisms involved##46##2##(1990-8#1)(1991-9#1)(1993-5#1)(1993-6#1)(1995-11#2)(1995-2#2)(1996-9#1)(1997-3#3)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#4)(2008-9#2)(2009-12#2)(2009-2#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
mechanisms involving the##2##3##(2009-6#1)(2011-2#1)
mechanisms involving##7##2##(2008-11#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#2)
mechanisms is##10##2##(1990-2#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)
mechanisms leading to the##2##4##(1994-8#1)(1996-5#1)
mechanisms leading to##8##3##(1992-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-1#1)
mechanisms like##2##2##(2008-5#1)(2011-1#1)
mechanisms may be##4##3##(1990-2#1)(1992-3#1)(2008-4#1)(2008-7#1)
mechanisms may##13##2##(1990-11#1)(1990-2#1)(1992-3#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
mechanisms mediating##2##2##(1997-7#1)(2008-7#1)
mechanisms might be##2##3##(2009-12#1)(2011-1#1)
mechanisms might##5##2##(2008-4#1)(2008-7#1)(2009-12#2)(2011-1#1)
mechanisms occur##2##2##(2008-9#1)(2010-1#1)
mechanisms of Abl##2##3##(2012-12#2)
mechanisms of Japanese cedar##2##4##(2012-12#2)
mechanisms of a##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
mechanisms of action and the##2##5##(1991-2#1)(2008-7#1)
mechanisms of action and therapeutic potential##2##6##(2008-7#2)
mechanisms of action and##9##4##(1991-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#1)(2012-3#1)
mechanisms of action are##3##4##(1990-12#1)(1995-12#1)(2008-7#1)
mechanisms of action of##14##4##(1990-2#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#3)(2010-8#1)(2011-1#1)
mechanisms of action##52##3##(1990-12#1)(1990-2#1)(1991-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2009-4#1)(2009-8#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
mechanisms of activation of##2##4##(1995-11#1)(1996-2#1)
mechanisms of biological control##2##4##(2008-10#2)
mechanisms of cell##2##3##(2008-10#1)(2011-2#1)
mechanisms of change##3##3##(2012-2#2)(2013-7#1)
mechanisms of collagen mineralization##2##4##(2009-8#2)
mechanisms of cytotoxicity##2##3##(1995-8#1)(2008-11#1)
mechanisms of differentiation##2##3##(2008-11#1)(2008-9#1)
mechanisms of disease##4##3##(2008-10#2)(2008-7#1)(2012-12#1)
mechanisms of dispersal were possible##2##5##(2008-10#2)
mechanisms of dispersal were##3##4##(2008-10#3)
mechanisms of drug resistance##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
mechanisms of early##3##3##(1997-7#1)(2008-11#1)(2012-2#1)
mechanisms of evolution##3##3##(2008-8#2)(2010-3#1)
mechanisms of gene expression##3##4##(2008-11#2)(2011-2#1)
mechanisms of gene##5##3##(2007-12#1)(2008-11#2)(2011-2#2)
mechanisms of how##2##3##(2009-8#1)(2012-3#1)
mechanisms of immune privilege##3##4##(2010-1#3)
mechanisms of immune##5##3##(2008-10#1)(2010-1#3)(2013-1#1)
mechanisms of increased##2##3##(1997-4#1)(2012-1#1)
mechanisms of injury##2##3##(2012-2#1)(2013-1#1)
mechanisms of interaction##2##3##(2008-12#1)(2008-7#1)
mechanisms of ischemic##2##3##(2008-8#1)(2013-7#1)
mechanisms of its##2##3##(1996-2#1)(2008-10#1)
mechanisms of joint manipulation##2##4##(2008-12#2)
mechanisms of neural##2##3##(2008-10#1)(2008-8#1)
mechanisms of normal##2##3##(1994-6#1)(2009-5#1)
mechanisms of receptor##3##3##(1995-6#1)(2008-4#1)(2008-5#1)
mechanisms of regulation of##2##4##(2008-7#2)
mechanisms of renal##2##3##(1996-6#1)(2013-1#1)
mechanisms of resistance to##3##4##(2008-11#2)(2010-7#1)
mechanisms of resistance##9##3##(1997-6#1)(2008-10#4)(2008-11#3)(2010-7#1)
mechanisms of the disease##3##4##(2008-8#1)(2010-12#1)(2010-6#1)
mechanisms of the##30##3##(1991-3#1)(1992-3#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)
mechanisms of their##2##3##(2008-10#1)(2013-1#1)
mechanisms of these##5##3##(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
mechanisms of this##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
mechanisms of tissue##2##3##(1996-2#1)(2008-11#1)
mechanisms of toxicity##2##3##(1991-1#1)(2008-11#1)
mechanisms of translational control##2##4##(2007-12#1)(2013-8#1)
mechanisms of##411##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#56)(2008-11#30)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#14)(2008-5#8)(2008-6#5)(2008-7#23)(2008-8#19)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#13)(2010-1#3)(2010-10#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#16)(2012-3#8)(2013-1#21)(2013-7#2)(2013-8#4)
mechanisms on##2##2##(2008-6#1)(2010-2#1)
mechanisms operate##2##2##(2008-8#1)(2009-12#1)
mechanisms operating##2##2##(1992-11#1)(2008-2#1)
mechanisms or##2##2##(2011-1#1)(2012-2#1)
mechanisms other than##8##3##(1991-5#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-8#1)
mechanisms play##3##2##(1990-2#1)(2009-4#1)(2011-2#1)
mechanisms potentially##2##2##(2009-2#1)(2009-6#1)
mechanisms promoting##2##2##(2008-8#1)(2008-9#1)
mechanisms regulating the##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
mechanisms regulating##14##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
mechanisms related to##3##3##(1996-12#1)(2013-1#2)
mechanisms relating to##2##3##(2008-11#1)(2008-7#1)
mechanisms remain unclear##2##3##(2008-11#1)(2008-9#1)
mechanisms remain unknown##2##3##(1991-4#1)(1993-8#1)
mechanisms remain##7##2##(1991-11#1)(1991-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-11#1)(2008-9#1)
mechanisms remains##2##2##(1994-5#1)(2013-8#1)
mechanisms responsible for its##2##4##(2012-12#1)(2013-8#1)
mechanisms responsible for the##8##4##(1994-11#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-5#1)(2011-2#1)
mechanisms responsible for these##2##4##(2011-2#1)(2012-3#1)
mechanisms responsible for##29##3##(1990-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mechanisms resulting in##3##3##(2008-3#1)(2009-11#1)(2010-12#1)
mechanisms seem##2##2##(1995-5#1)(2008-4#1)
mechanisms such as##13##3##(1992-9#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-12#1)(2013-1#1)
mechanisms that allow the##2##4##(2012-3#1)(2013-1#1)
mechanisms that allow##3##3##(2010-11#1)(2012-3#1)(2013-1#1)
mechanisms that are##7##3##(1994-9#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-3#1)(2012-12#1)
mechanisms that can##4##3##(1994-1#1)(1997-2#1)(2008-11#1)(2011-2#1)
mechanisms that cause##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
mechanisms that contribute to##2##4##(2011-7#1)(2012-3#1)
mechanisms that control##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
mechanisms that determine the##2##4##(2010-5#1)(2010-8#1)
mechanisms that include##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
mechanisms that increase##3##3##(1993-3#1)(2010-3#1)(2012-2#1)
mechanisms that involve##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
mechanisms that lead to the##2##5##(2008-10#1)(2012-3#1)
mechanisms that lead to##3##4##(1994-2#1)(2008-10#1)(2012-3#1)
mechanisms that lead##4##3##(1991-9#1)(1994-2#1)(2008-10#1)(2012-3#1)
mechanisms that may underlie##2##4##(2010-10#1)(2012-12#1)
mechanisms that may##7##3##(1994-8#1)(2008-8#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
mechanisms that mediate##4##3##(1993-8#1)(1996-2#1)(2011-2#1)(2013-8#1)
mechanisms that might##4##3##(2008-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
mechanisms that regulate the##2##4##(1995-8#1)(1997-6#1)
mechanisms that regulate##11##3##(1990-2#1)(1995-8#1)(1997-6#1)(2008-11#2)(2008-4#2)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
mechanisms that underlie##5##3##(2008-11#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)
mechanisms that##99##2##(1990-2#2)(1990-9#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#3)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#9)(2013-8#1)
mechanisms through which##6##3##(1992-8#1)(2006-12#1)(2008-4#1)(2010-1#1)(2012-12#1)(2012-2#1)
mechanisms to the##4##3##(1995-2#1)(2008-10#1)(2008-8#2)
mechanisms to##35##2##(1990-8#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-4#1)(2009-6#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-8#1)
mechanisms underlying glial##2##3##(2008-7#2)
mechanisms underlying human##2##3##(2012-12#1)(2012-2#1)
mechanisms underlying some##2##3##(1990-5#1)(2008-11#1)
mechanisms underlying the disease##2##4##(2010-2#1)(2011-1#1)
mechanisms underlying the generation of##2##5##(2008-4#1)(2008-7#1)
mechanisms underlying the induction##2##4##(2008-11#1)(2008-7#1)
mechanisms underlying the##31##3##(1992-3#1)(1992-4#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#3)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
mechanisms underlying these##6##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
mechanisms underlying##82##2##(1990-5#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#2)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
mechanisms used by##2##3##(2008-10#1)(2009-11#1)
mechanisms used##4##2##(1993-5#1)(2006-10#1)(2008-10#1)(2009-11#1)
mechanisms we##2##2##(2008-3#1)(2012-2#1)
mechanisms were##12##2##(1991-9#2)(1993-8#1)(2008-10#4)(2008-11#2)(2009-11#1)(2010-5#1)(2011-1#1)
mechanisms whereby##4##2##(1990-5#1)(1994-9#1)(1995-5#1)(2008-6#1)
mechanisms which##6##2##(1991-6#1)(1994-5#1)(1995-5#1)(2007-8#1)(2008-11#1)(2009-8#1)
mechanisms will be##2##3##(2008-10#1)(2009-2#1)
mechanisms will##4##2##(2008-10#1)(2008-3#1)(2009-2#1)(2009-6#1)
mechanisms with##2##2##(2008-10#1)(2010-10#1)
mechanisms within##4##2##(1991-5#1)(1994-6#1)(2008-5#1)(2008-7#1)
mechanisms would be##2##3##(2007-12#2)
mechanisms would##3##2##(2007-12#2)(2011-10#1)
mechanisms##1696##1##(1990-11#6)(1990-12#2)(1990-2#11)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-9#13)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#12)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#5)(1992-9#6)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#5)(1993-5#5)(1993-6#3)(1993-8#7)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#8)(1994-12#4)(1994-2#7)(1994-3#2)(1994-5#11)(1994-6#4)(1994-8#12)(1994-9#7)(1995-11#8)(1995-12#11)(1995-2#13)(1995-3#4)(1995-5#7)(1995-6#6)(1995-8#7)(1996-11#3)(1996-12#7)(1996-2#14)(1996-3#2)(1996-4#1)(1996-5#9)(1996-6#2)(1996-7#2)(1996-9#3)(1997-1#7)(1997-2#10)(1997-3#6)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#5)(2006-10#6)(2006-12#2)(2006-6#2)(2007-10#2)(2007-11#12)(2007-12#33)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#14)(2007-9#1)(2008-1#17)(2008-10#182)(2008-11#100)(2008-12#9)(2008-2#25)(2008-3#28)(2008-4#55)(2008-5#40)(2008-6#15)(2008-7#102)(2008-8#62)(2008-9#46)(2009-1#3)(2009-10#11)(2009-11#10)(2009-12#10)(2009-2#11)(2009-3#9)(2009-4#5)(2009-5#12)(2009-6#10)(2009-7#9)(2009-8#37)(2009-9#3)(2010-1#9)(2010-10#7)(2010-11#8)(2010-12#10)(2010-2#3)(2010-3#18)(2010-4#9)(2010-5#12)(2010-6#6)(2010-7#6)(2010-8#8)(2010-9#3)(2011-1#25)(2011-10#3)(2011-2#75)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#17)(2012-12#43)(2012-2#61)(2012-3#34)(2012-7#1)(2013-1#58)(2013-7#13)(2013-8#20)
mechanisms)##5##1##(1993-8#1)(1996-7#1)(2008-1#1)(2008-5#1)(2009-8#1)
mechanisms]##3##1##(2008-9#1)(2010-12#1)(2013-8#1)
mechanistic approach##3##2##(2008-2#1)(2010-7#1)(2013-1#1)
mechanistic basis of this##2##4##(1995-8#1)(2008-4#1)
mechanistic basis of##3##3##(1995-8#1)(2008-4#1)(2011-2#1)
mechanistic basis##5##2##(1995-8#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
mechanistic details##3##2##(2009-12#1)(2010-2#1)(2012-2#1)
mechanistic explanation for##4##3##(1997-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
mechanistic implications##4##2##(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#1)
mechanistic information##5##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2009-8#1)
mechanistic insight into##2##3##(2008-5#1)(2013-1#1)
mechanistic insight##6##2##(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
mechanistic insights into##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
mechanistic model##6##2##(2008-10#4)(2010-12#1)(2013-1#1)
mechanistic models##4##2##(2008-9#2)(2010-11#1)(2013-1#1)
mechanistic or##3##2##(2007-10#1)(2010-6#1)(2011-2#1)
mechanistic studies of##2##3##(2008-10#1)(2008-4#1)
mechanistic studies##7##2##(1994-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)
mechanistic understanding of##2##3##(2012-12#1)(2012-3#1)
mechanistic##94##1##(1990-8#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-2#3)(2007-10#1)(2008-10#14)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
mechanistically distinct##3##2##(2009-9#1)(2012-12#1)(2012-2#1)
mechanistically novel##2##2##(2008-5#1)(2010-10#1)
mechanistically related##2##2##(1994-5#1)(2010-6#1)
mechanistically##9##1##(1994-5#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
mechanized##3##1##(1993-8#1)(2008-10#2)
mechanobiology##2##1##(2008-5#2)
mechanoreceptor##4##1##(1993-12#2)(2009-5#2)
mechanoreceptors##3##1##(2007-12#1)(2008-12#1)(2009-5#1)
mechanosensitive##2##1##(1997-3#1)(2008-8#1)
mechanosensory##4##1##(1993-12#1)(2007-12#1)(2008-9#1)(2009-5#1)
mechanotherapy##4##1##(2008-12#4)
mechanotransduction##6##1##(1995-8#1)(2007-12#1)(2008-9#1)(2011-1#1)(2012-12#2)
meclofenamate##2##1##(1995-12#2)
meclofenamic##4##1##(2008-10#4)
meconium##2##1##(1997-3#1)(2008-10#1)
med##7##1##(1991-6#2)(1993-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#1)
medaka Oryzias latipes##2##3##(2008-1#1)(2008-11#1)
medaka Oryzias##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
medaka fish##6##2##(1997-9#1)(2008-11#2)(2008-5#2)(2008-6#1)
medaka testis##2##2##(2008-5#2)
medaka##26##1##(1992-6#1)(1997-9#1)(2008-1#1)(2008-11#9)(2008-5#7)(2008-6#1)(2008-8#2)(2009-7#4)
medfly populations##2##2##(2009-9#2)
medfly##7##1##(2007-12#3)(2008-11#1)(2008-3#1)(2009-9#2)
media after##2##2##(2008-10#1)(2013-1#1)
media alone##3##2##(1995-12#3)
media amended with##5##3##(1994-3#1)(2008-10#4)
media and for##2##3##(2008-11#1)(2008-9#1)
media and in##5##3##(2007-12#1)(2007-8#1)(2008-10#3)
media and is##2##3##(2008-10#1)(2008-3#1)
media and on##2##3##(2008-10#1)(2008-2#1)
media and the##3##3##(2008-2#2)(2008-8#1)
media and##52##2##(1991-4#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#15)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#4)(2008-9#3)(2010-8#1)(2011-1#1)(2013-8#2)
media are##15##2##(1990-3#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)
media as a##2##3##(1994-3#1)(2008-10#1)
media as well as##4##4##(1996-12#1)(2008-3#1)(2008-9#1)(2009-5#1)
media as well##5##3##(1990-8#1)(1996-12#1)(2008-3#1)(2008-9#1)(2009-5#1)
media as##7##2##(1990-8#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)
media at different##3##3##(2008-10#2)(2013-1#1)
media at the##2##3##(1994-2#1)(2008-11#1)
media at##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#2)
media attention in##2##3##(1996-11#1)(2008-11#1)
media attention##3##2##(1996-11#1)(2008-11#1)(2008-5#1)
media based on##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
media both##2##2##(1993-9#1)(2008-7#1)
media by means of a##2##5##(2008-10#2)
media by means of##3##4##(1994-8#1)(2008-10#2)
media by optical##2##3##(2007-11#1)(2008-3#1)
media by use of a##6##5##(2007-11#1)(2007-12#2)(2008-3#3)
media by use of##11##4##(2007-11#1)(2007-12#3)(2008-3#7)
media by##36##2##(1994-8#1)(2007-11#4)(2007-12#5)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#11)(2008-6#1)(2008-7#1)(2009-7#1)
media can be##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
media can##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)(2013-1#1)
media conditioned##2##2##(1991-5#1)(2013-1#1)
media containing different##3##3##(2008-10#2)(2008-12#1)
media containing either##2##3##(1992-8#1)(2008-10#1)
media containing the##2##3##(1997-7#1)(2013-8#1)
media containing##21##2##(1992-12#1)(1992-8#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2012-7#1)(2013-8#1)
media could##3##2##(1996-11#1)(2008-10#1)(2008-3#1)
media coverage##2##2##(1991-3#2)
media cultures##2##2##(2008-10#2)
media following##3##2##(2008-9#2)(2010-2#1)
media for a##2##3##(1994-11#1)(2008-3#1)
media for growing##2##3##(2008-10#1)(2008-12#1)
media for isolation of##3##4##(2008-10#2)(2008-12#1)
media for mammalian cells##2##4##(2008-11#2)
media for mammalian##3##3##(2008-11#3)
media for optical data storage##2##5##(2008-3#2)
media for the##5##3##(1991-8#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
media for##30##2##(1991-8#1)(1992-3#1)(1994-11#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#5)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
media formulations##2##2##(2008-11#1)(2008-9#1)
media from cultures##2##3##(1992-9#1)(2008-7#1)
media from##9##2##(1992-3#1)(1992-9#1)(1993-9#1)(1997-3#1)(2008-2#1)(2008-7#3)(2010-12#1)
media giving##3##2##(2008-10#2)(2008-7#1)
media had##2##2##(1996-8#1)(2008-10#1)
media has been##4##3##(2008-10#3)(2008-3#1)
media have been##5##3##(2007-11#1)(2008-10#3)(2008-7#1)
media have##6##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)
media images of##2##3##(2007-12#1)(2008-12#1)
media images##5##2##(2007-12#4)(2008-12#1)
media in a##3##3##(1990-3#1)(2007-12#1)(2008-3#1)
media in the##2##3##(2008-11#1)(2011-1#1)
media in which##2##3##(2008-10#1)(2008-2#1)
media in##18##2##(1990-3#1)(1991-3#1)(1993-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2011-1#1)
media influences##2##2##(2009-5#1)(2009-7#1)
media into a##2##3##(2008-10#1)(2008-3#1)
media into##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)
media is described##4##3##(1991-5#1)(1996-5#1)(2008-3#1)(2010-6#1)
media is##23##2##(1991-11#1)(1991-5#1)(1995-5#1)(1996-5#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#5)(2008-8#3)(2010-6#1)(2012-2#1)
media led to##2##3##(2008-11#1)(2012-5#1)
media levels of##2##3##(1994-9#2)
media may##2##2##(1991-5#1)(2010-5#1)
media must be##2##3##(1990-3#1)(2007-7#1)
media noise obtained##2##3##(2008-2#1)(2008-3#1)
media noise##9##2##(2008-2#4)(2008-3#5)
media of different refractive indices##2##5##(2008-2#2)
media of different##4##3##(2008-2#2)(2008-3#2)
media of the##4##3##(1993-8#1)(1995-1#1)(1996-7#1)(2008-11#1)
media of##22##2##(1991-5#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-7#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)
media on a##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
media on the##8##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)
media on##15##2##(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#4)(2008-8#1)(2010-8#1)
media or##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)
media over a wide##2##4##(2007-12#1)(2008-10#1)
media over a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
media over##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
media prior to##2##3##(2008-10#2)
media relations##3##2##(2008-12#3)
media reports##4##2##(2007-2#1)(2008-11#1)(2010-7#1)(2013-8#1)
media resulted in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
media showed##2##2##(1994-9#1)(2008-12#1)
media such as##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
media supplemented with##6##3##(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)
media supplemented##7##2##(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)
media that is##2##3##(2007-12#1)(2008-8#1)
media that##8##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#2)
media the##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
media thickness (IMT)##2##3##(2008-1#1)(2013-1#1)
media through the##2##3##(1993-12#1)(2012-12#1)
media to be##2##3##(2008-2#2)
media to##18##2##(1996-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
media types##2##2##(2008-2#1)(2012-4#1)
media under##2##2##(2008-11#1)(2008-3#1)
media used##4##2##(2008-1#1)(2008-10#2)(2008-12#1)
media using##14##2##(1994-2#1)(2008-10#8)(2008-3#1)(2009-7#1)(2010-4#1)(2011-1#2)
media was investigated##4##3##(2008-10#1)(2008-8#2)(2013-1#1)
media was used##3##3##(2008-10#2)(2010-3#1)
media was verified##2##3##(2008-5#1)(2008-6#1)
media was##27##2##(1991-3#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-3#1)(2011-1#2)(2012-12#1)(2013-1#2)
media were investigated##2##3##(1994-6#1)(2008-10#1)
media were tested##2##3##(2008-10#1)(2008-6#1)
media were used##3##3##(2008-6#1)(2013-1#2)
media were##23##2##(1991-8#2)(1994-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#2)(2013-1#3)
media when##4##2##(1991-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
media with a##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
media with different##2##3##(2008-12#1)(2008-2#1)
media with##41##2##(1997-4#1)(2007-11#2)(2007-12#5)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#7)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
media without##4##2##(2007-11#1)(2008-11#2)(2008-5#1)
media##1142##1##(1990-2#3)(1990-3#4)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#7)(1991-4#1)(1991-5#6)(1991-8#7)(1991-9#3)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#7)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#5)(1995-3#4)(1995-5#2)(1995-8#4)(1996-11#6)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#40)(2007-12#64)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#299)(2008-11#101)(2008-12#35)(2008-2#64)(2008-3#151)(2008-4#6)(2008-5#12)(2008-6#13)(2008-7#27)(2008-8#29)(2008-9#26)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#6)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#6)(2011-1#10)(2011-2#7)(2011-7#1)(2012-12#5)(2012-2#14)(2012-3#2)(2012-4#2)(2012-5#2)(2012-7#1)(2012-8#1)(2013-1#27)(2013-8#5)
media'##2##1##(2008-11#1)(2008-5#1)
media)##4##1##(1994-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
medial amygdala##2##2##(1997-3#2)
medial and lateral##6##3##(1993-12#1)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
medial and##9##2##(1993-12#1)(1994-8#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
medial antebrachial cutaneous nerve##3##4##(2008-9#3)
medial aspect of##2##3##(2007-8#1)(2008-7#1)
medial border of##4##3##(2007-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
medial collateral ligament##3##3##(2008-8#1)(2012-2#2)
medial collateral##6##2##(2008-5#1)(2008-8#1)(2012-2#4)
medial cortex##3##2##(2008-6#1)(2010-3#1)(2011-2#1)
medial epicondyle##3##2##(1995-6#2)(2008-8#1)
medial forebrain bundle (MFB)##2##4##(1991-2#1)(1993-12#1)
medial forebrain bundle##7##3##(1991-2#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)
medial frontal and posterior##2##4##(2008-11#1)(2008-6#1)
medial frontal##5##2##(1994-3#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-6#1)
medial gastrocnemius (MG)##2##3##(1993-12#1)(1996-2#1)
medial gastrocnemius##7##2##(1993-12#1)(1996-2#1)(1997-2#1)(2008-3#2)(2011-1#1)(2013-8#1)
medial habenula##2##2##(1996-12#2)
medial knee pain##2##3##(2006-10#2)
medial layer##2##2##(2006-6#1)(2010-4#1)
medial lobe##2##2##(2007-12#2)
medial longitudinal fasciculus##4##3##(1996-5#3)(2007-10#1)
medial malleolus##4##2##(2009-3#1)(2010-3#1)(2010-6#2)
medial neurosecretory cells of the##2##5##(1991-12#1)(2008-6#1)
medial parapatellar##2##2##(2012-12#1)(2013-1#1)
medial part##3##2##(2008-7#1)(2009-4#2)
medial pectoral nerve##2##3##(2013-1#2)
medial precuneus##2##2##(2008-11#2)
medial prefrontal cortex (PFC)##2##4##(1997-2#1)(2013-8#1)
medial prefrontal cortex (mPFC)##3##4##(2008-11#1)(2008-6#2)
medial prefrontal cortex is associated with##2##6##(2008-6#2)
medial prefrontal cortex##17##3##(1991-5#1)(1993-6#1)(1994-8#1)(1996-2#2)(1997-2#2)(2008-11#5)(2008-6#4)(2013-8#1)
medial prefrontal##24##2##(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-8#1)(1996-2#2)(1997-2#2)(1997-8#1)(2008-11#7)(2008-6#4)(2013-8#1)
medial preoptic area##3##3##(1992-12#1)(1992-5#1)(1994-2#1)
medial preoptic##4##2##(1992-12#1)(1992-5#2)(1994-2#1)
medial regions##2##2##(2008-11#2)
medial rostral prefrontal cortex##2##4##(2008-11#2)
medial sensillum styloconicum##2##3##(2008-8#2)
medial septal area##3##3##(1993-12#2)(2013-8#1)
medial septal stimulation improves##2##4##(1992-8#2)
medial septal stimulation##3##3##(1992-8#3)
medial septal##9##2##(1992-8#4)(1993-12#3)(1996-12#1)(2013-8#1)
medial septum (MS)##2##3##(1994-3#1)(2008-10#1)
medial septum##6##2##(1993-12#3)(1994-3#1)(1995-2#1)(2008-10#1)
medial temporal lobe lesions##3##4##(1992-11#2)(1993-12#1)
medial temporal lobe that##2##4##(1992-11#1)(1993-12#1)
medial temporal lobe##11##3##(1991-10#2)(1992-11#4)(1993-12#2)(2010-7#2)(2013-8#1)
medial temporal structures##4##3##(2008-11#3)(2008-6#1)
medial temporal##18##2##(1991-10#2)(1992-11#4)(1993-12#2)(1996-5#2)(2008-11#3)(2008-6#1)(2010-7#3)(2013-8#1)
medial thickness##2##2##(2008-3#1)(2012-3#1)
medial to##2##2##(2008-7#2)
medial unicompartmental knee##3##3##(2012-12#2)(2013-1#1)
medial wall of##2##3##(2008-7#1)(2008-9#1)
medial wall##5##2##(1997-8#1)(2008-7#2)(2008-8#1)(2008-9#1)
medial##256##1##(1990-3#1)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#3)(1991-10#2)(1991-12#3)(1991-2#3)(1991-5#3)(1992-10#2)(1992-11#4)(1992-12#2)(1992-3#2)(1992-5#2)(1992-8#4)(1993-11#1)(1993-12#16)(1993-3#2)(1993-6#1)(1994-2#3)(1994-3#5)(1994-8#2)(1995-12#5)(1995-2#1)(1995-6#2)(1996-12#3)(1996-2#5)(1996-5#7)(1996-9#1)(1997-2#3)(1997-3#7)(1997-4#1)(1997-8#2)(2006-10#3)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#10)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#19)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#10)(2008-7#11)(2008-8#6)(2008-9#6)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-8#2)(2010-11#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#2)(2011-2#9)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#14)(2013-8#5)
medial-frontal negativity##2##2##(2008-11#2)
medialis##3##1##(1994-8#2)(2008-6#1)
medialization##2##1##(2007-8#1)(2012-1#1)
medially and##3##2##(1993-12#1)(2007-8#1)(2008-9#1)
medially##8##1##(1993-12#1)(2007-12#1)(2007-8#1)(2008-9#2)(2009-1#1)(2009-9#1)(2011-2#1)
median (range)##2##2##(1993-12#1)(1994-9#1)
median 10##2##2##(1993-8#1)(1996-9#1)
median MoM##3##2##(1996-12#3)
median SVV error for the PD group##2##7##(2013-1#2)
median aerodynamic diameter##4##3##(1992-2#1)(1996-12#1)(1996-2#1)(1997-2#1)
median age 46##2##3##(2012-12#1)(2013-1#1)
median age at##2##3##(1990-9#1)(2013-1#1)
median age of the patients was##2##6##(1992-8#1)(1997-8#1)
median age of##11##3##(1992-5#1)(1992-8#1)(1992-9#1)(1997-8#1)(2007-11#1)(2008-6#1)(2009-12#1)(2011-1#2)(2013-1#2)
median age was 29 years##2##5##(1990-9#1)(2007-10#1)
median age was##10##3##(1990-9#1)(1991-2#1)(1991-4#1)(2007-10#1)(2007-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
median age##32##2##(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1997-5#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-12#1)(2010-3#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)
median and range##2##3##(2010-3#1)(2013-1#1)
median and##6##2##(2007-7#1)(2010-3#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
median concentration##2##2##(1993-9#2)
median cost##3##2##(1992-1#1)(1995-2#2)
median dose##3##2##(2008-7#1)(2010-3#1)(2013-1#1)
median duration of response was##3##5##(1990-2#1)(1992-8#1)(1994-8#1)
median duration of##11##3##(1990-12#1)(1990-2#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-8#1)(2007-2#1)(2008-6#1)(2008-7#1)(2013-8#1)
median duration##12##2##(1990-12#1)(1990-2#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-8#1)(2007-2#1)(2008-6#2)(2008-7#1)(2013-8#1)
median effective dose##2##3##(2008-10#2)
median eminence##2##2##(1995-12#1)(2008-9#1)
median follow-up of 8##2##4##(1990-2#1)(2012-12#1)
median follow-up of##12##3##(1990-12#2)(1990-2#1)(1990-6#1)(1992-12#1)(2008-6#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
median follow-up period##4##3##(1990-8#1)(1995-5#1)(2007-10#1)(2013-1#1)
median follow-up time was##2##4##(1990-2#1)(2008-6#1)
median follow-up was##2##3##(1993-11#1)(2010-3#1)
median follow-up##24##2##(1990-12#2)(1990-2#2)(1990-6#1)(1990-8#1)(1992-12#1)(1992-5#2)(1993-11#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-6#3)(2010-12#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#2)
median inhibitory concentration of##2##4##(2008-11#2)
median lethal##2##2##(2008-5#1)(2013-1#1)
median life##2##2##(1990-3#1)(2009-12#1)
median motor latency##2##3##(2010-8#2)
median nerve is##3##3##(2008-9#3)
median nerve##17##2##(1992-6#1)(1994-11#1)(2008-12#1)(2008-5#1)(2008-9#12)(2009-5#1)
median number of##5##3##(1994-8#1)(2008-12#1)(2010-12#1)(2011-2#2)
median of 0##2##3##(2008-8#1)(2013-1#1)
median of##24##2##(1990-2#2)(1991-2#1)(1991-3#1)(1992-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-10#1)(2008-10#3)(2008-6#2)(2008-7#2)(2008-8#2)(2010-12#1)(2012-2#1)(2013-1#4)
median raphe##5##2##(1991-2#3)(1993-12#2)
median sensory##2##2##(2010-8#2)
median serum##2##2##(2006-10#1)(2011-2#1)
median sternotomy and##2##3##(2007-8#2)
median sternotomy in paediatrics##2##4##(2007-8#2)
median sternotomy in##4##3##(2007-8#4)
median sternotomy is##2##3##(2007-8#1)(2008-10#1)
median sternotomy##20##2##(2007-8#15)(2008-1#1)(2008-10#2)(2012-2#1)(2013-1#1)
median survival and##2##3##(2008-10#1)(2008-6#1)
median survival index##3##3##(2008-10#3)
median survival of##6##3##(1991-4#1)(1992-9#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
median survival time of##2##4##(1990-9#1)(2007-11#1)
median survival time##6##3##(1990-9#2)(1994-8#1)(2007-11#2)(2012-1#1)
median survival was##9##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-12#1)(1993-6#1)(1997-5#1)(2008-10#1)(2008-6#1)
median survival##31##2##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-4#1)(1997-3#1)(1997-5#2)(2007-11#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)(2012-1#2)(2012-3#1)
median time to progression was##4##5##(1990-10#1)(1990-2#1)(1993-1#1)(2013-1#1)
median time to##7##3##(1990-10#1)(1990-2#1)(1993-1#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
median time##12##2##(1990-10#1)(1990-2#1)(1993-1#1)(1993-2#1)(2007-8#1)(2010-3#2)(2012-3#1)(2013-1#3)(2013-8#1)
median value##5##2##(1993-11#1)(1993-9#1)(1994-6#1)(2011-2#2)
median values##2##2##(1992-9#1)(1995-6#1)
median##370##1##(1990-10#3)(1990-12#6)(1990-2#6)(1990-3#1)(1990-6#1)(1990-8#4)(1990-9#6)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#4)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#5)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#8)(2007-11#3)(2007-12#9)(2007-2#2)(2007-7#2)(2007-8#22)(2008-1#4)(2008-10#29)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#16)(2008-7#7)(2008-8#3)(2008-9#13)(2009-12#2)(2009-4#1)(2009-5#3)(2010-12#4)(2010-3#7)(2010-4#1)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#4)(2012-3#10)(2013-1#30)(2013-8#5)
median)##2##1##(2007-8#1)(2009-11#1)
medians##6##1##(1990-8#1)(1992-9#1)(1994-12#1)(1995-3#1)(2012-1#2)
mediastinal adenopathies##3##2##(2008-7#1)(2013-7#2)
mediastinal and visceral abscesses##2##4##(2007-12#2)
mediastinal and##4##2##(1997-8#1)(2007-12#2)(2009-8#1)
mediastinal carcinoids##2##2##(2011-2#2)
mediastinal cyst##2##2##(2007-8#1)(2010-12#1)
mediastinal disease##2##2##(2007-7#1)(2007-8#1)
mediastinal imaging##2##2##(2007-8#2)
mediastinal localisation is##2##3##(2010-12#1)(2011-2#1)
mediastinal localisation##3##2##(2010-12#2)(2011-2#1)
mediastinal lymph node dissection##3##4##(1990-8#3)
mediastinal lymph node##4##3##(1990-8#4)
mediastinal lymph nodes##4##3##(1990-8#1)(1997-8#1)(2008-4#1)(2013-1#1)
mediastinal lymph##8##2##(1990-8#5)(1997-8#1)(2008-4#1)(2013-1#1)
mediastinal mass##6##2##(1991-8#1)(1997-3#1)(2007-8#2)(2008-6#1)(2012-3#1)
mediastinal node assessment by lymphadenectomy and intraoperative mediastinoscopy##2##8##(2007-8#2)
mediastinal node##3##2##(2007-8#3)
mediastinal paraganglioma with##2##3##(1997-8#2)
mediastinal paraganglioma##3##2##(1997-8#3)
mediastinal shift##3##2##(2007-12#2)(2007-8#1)
mediastinal structures##2##2##(2007-8#1)(2010-7#1)
mediastinal tumor##5##2##(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#2)
mediastinal##87##1##(1990-12#1)(1990-2#1)(1990-8#5)(1991-8#1)(1992-10#1)(1996-6#1)(1997-3#1)(1997-8#5)(2007-12#4)(2007-7#2)(2007-8#29)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#4)(2010-12#4)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#2)
mediastinitis##16##1##(1991-3#1)(1997-2#1)(2007-8#7)(2008-12#2)(2012-2#1)(2013-1#4)
mediastinoscopy##11##1##(2007-10#2)(2007-8#7)(2008-1#1)(2013-7#1)
mediastinum and##2##2##(2008-12#1)(2008-6#1)
mediastinum was##3##2##(1990-8#1)(1997-3#1)(2007-8#1)
mediastinum##31##1##(1990-8#3)(1991-8#2)(1997-3#1)(2007-5#1)(2007-8#8)(2008-11#1)(2008-12#1)(2008-6#5)(2008-7#1)(2010-12#2)(2011-2#5)(2012-2#1)
mediate ADCC##2##2##(1992-2#1)(2008-4#1)
mediate a##5##2##(2008-4#1)(2008-7#1)(2010-6#1)(2013-1#2)
mediate cell##4##2##(1990-11#1)(1993-8#1)(1994-11#1)(2011-1#1)
mediate efficient##2##2##(1991-5#1)(1994-5#1)
mediate induction by oleic acid##2##5##(1993-9#2)
mediate interactions between##2##3##(2008-7#1)(2013-1#1)
mediate many##4##2##(1996-2#1)(2008-4#2)(2009-8#1)
mediate specific##2##2##(1994-2#1)(1996-12#1)
mediate stimulatory actions of##2##4##(2010-11#2)
mediate the difference attributable to##2##5##(2008-12#2)
mediate the effect##2##3##(1996-2#1)(2008-4#1)
mediate the effects of##2##4##(2007-8#1)(2008-9#1)
mediate the modulation of##2##4##(1990-12#1)(1994-8#1)
mediate the relationship between##5##4##(2009-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)
mediate the superinduction##2##3##(1992-8#2)
mediate the##51##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-2#2)(1995-8#2)(1996-2#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-12#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)
mediate their##3##2##(1990-8#1)(1994-12#1)(1994-6#1)
mediate this##3##2##(1993-12#1)(1995-6#1)(2012-1#1)
mediate##172##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#5)(1994-11#4)(1994-12#2)(1994-2#2)(1994-5#4)(1994-6#2)(1994-8#7)(1994-9#2)(1995-12#4)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#4)(1996-12#2)(1996-2#3)(1997-4#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#11)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#2)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#2)
mediated at least in##2##4##(1992-6#1)(1994-6#1)
mediated at least##4##3##(1992-6#1)(1993-12#1)(1994-6#1)(2008-9#1)
mediated by Agrobacterium##2##3##(2008-8#1)(2011-2#1)
mediated by P-gp##2##3##(2011-3#2)
mediated by PKC##2##3##(2008-11#1)(2008-4#1)
mediated by Piwi and##2##4##(2009-3#2)
mediated by a family of##2##5##(1996-2#1)(2008-4#1)
mediated by a##27##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-1#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
mediated by activation of##5##4##(1992-3#1)(1995-12#1)(1996-2#1)(2006-10#1)(2008-4#1)
mediated by alterations in##2##4##(1991-5#1)(2009-5#1)
mediated by an##8##3##(1993-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
mediated by antibodies##2##3##(1995-11#1)(1997-5#1)
mediated by both##5##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
mediated by cyclic##2##3##(1991-9#1)(2008-4#1)
mediated by developmental changes in##2##5##(2008-11#1)(2012-1#1)
mediated by differences in##2##4##(2013-1#1)(2013-8#1)
mediated by different##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
mediated by family##2##3##(2010-7#1)(2012-1#1)
mediated by induction of##2##4##(1993-9#1)(2008-10#1)
mediated by ionotropic##2##3##(2008-4#1)(2008-7#1)
mediated by its##3##3##(1992-3#1)(1993-6#1)(1994-11#1)
mediated by muscarinic receptors##2##4##(1996-12#1)(2008-10#1)
mediated by non-NMDA receptors##2##4##(1997-2#1)(2008-7#1)
mediated by prostaglandins##2##3##(1994-3#1)(1996-2#1)
mediated by recombinant##2##3##(2008-9#2)
mediated by several##2##3##(2008-5#1)(2012-3#1)
mediated by specific##3##3##(2008-12#1)(2009-9#1)(2011-2#1)
mediated by the release of ATP##2##6##(2008-4#1)(2008-5#1)
mediated by the##52##3##(1991-10#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#1)(2008-5#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
mediated by these receptors##2##4##(1995-12#1)(2008-10#1)
mediated by these##3##3##(1991-5#1)(1995-12#1)(2008-10#1)
mediated by two##5##3##(1994-11#1)(1995-8#1)(2007-11#1)(2008-9#1)(2009-10#1)
mediated by type II AMPA receptors were##2##7##(1996-2#2)
mediated by type##5##3##(1994-2#1)(1996-2#4)
mediated by viral factors##2##4##(2008-11#2)
mediated by##315##2##(1990-11#1)(1990-12#3)(1990-5#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#3)(1991-9#3)(1992-2#2)(1992-3#8)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-3#5)(1993-6#3)(1993-9#5)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#8)(1994-9#1)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#2)(1996-12#4)(1996-2#12)(1996-3#1)(1996-5#3)(1996-7#2)(1997-1#1)(1997-2#6)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#27)(2008-11#18)(2008-12#1)(2008-2#1)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#2)(2011-2#6)(2011-3#2)(2012-1#5)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#4)
mediated cell-cell##2##2##(2008-7#1)(2008-8#1)
mediated contractions##2##2##(1994-6#2)
mediated disease##2##2##(2009-10#1)(2012-2#1)
mediated in part by##3##4##(1995-12#1)(2008-4#2)
mediated in part via##2##4##(1994-6#1)(1995-11#1)
mediated in part##5##3##(1994-6#1)(1995-11#1)(1995-12#1)(2008-4#2)
mediated in##6##2##(1994-6#1)(1995-11#1)(1995-12#1)(1996-9#1)(2008-4#2)
mediated increase of##2##3##(1993-11#1)(1993-12#1)
mediated inflammatory##3##2##(2007-2#1)(2011-1#1)(2012-3#1)
mediated not only##2##3##(2008-7#1)(2011-2#1)
mediated primarily##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
mediated searching##4##2##(1991-3#4)
mediated signaling##2##2##(2008-1#1)(2012-12#1)
mediated the association between attachment##2##5##(2010-8#2)
mediated the effects of objective##4##5##(2013-1#4)
mediated the effects of##8##4##(2009-6#1)(2010-2#1)(2013-1#6)
mediated the effects##9##3##(2008-9#1)(2009-6#1)(2010-2#1)(2013-1#6)
mediated the relation between RC##2##5##(2008-12#2)
mediated the relation between##4##4##(2007-12#1)(2008-12#2)(2010-1#1)
mediated the relationship between##4##4##(2008-12#1)(2009-11#1)(2009-7#1)(2011-1#1)
mediated the##24##2##(2007-12#1)(2008-12#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-8#2)(2011-1#1)(2013-1#8)
mediated through a##4##3##(1992-6#1)(1993-5#1)(2008-10#1)(2012-3#1)
mediated through the##12##3##(1990-11#1)(1994-6#1)(1995-12#2)(1996-2#2)(1996-7#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
mediated through##32##2##(1990-11#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-6#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1996-2#3)(1996-5#1)(1996-7#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
mediated transformation##2##2##(2008-8#2)
mediated via the##3##3##(1991-2#1)(1993-6#1)(2013-7#1)
mediated via##15##2##(1990-5#1)(1991-2#1)(1993-6#2)(1995-12#2)(1995-8#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2012-3#1)(2013-7#1)
mediated##530##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#4)(1991-3#5)(1991-5#5)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#3)(1992-3#13)(1992-5#1)(1992-6#5)(1992-8#4)(1992-9#3)(1993-11#6)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#5)(1993-9#7)(1994-11#10)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#7)(1994-8#12)(1994-9#2)(1995-11#6)(1995-12#14)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#5)(1995-8#3)(1996-12#4)(1996-2#15)(1996-3#1)(1996-5#4)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#7)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#4)(1997-9#1)(2006-10#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#36)(2008-11#26)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#21)(2008-5#11)(2008-6#2)(2008-7#14)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#5)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#5)(2011-1#4)(2011-2#17)(2011-3#2)(2012-1#5)(2012-12#11)(2012-2#11)(2012-3#11)(2013-1#18)(2013-7#4)(2013-8#6)
mediates a##6##2##(1991-2#1)(1993-12#1)(1995-2#1)(2008-7#2)(2013-1#1)
mediates active##2##2##(1997-7#1)(2008-10#1)
mediates increased##2##2##(2009-11#1)(2013-8#1)
mediates its##2##2##(1993-6#1)(1995-2#1)
mediates many##2##2##(1992-9#1)(1993-6#1)
mediates some##2##2##(2008-4#1)(2012-12#1)
mediates the influence of##2##4##(1994-2#1)(2009-7#1)
mediates the rate-limiting step of steroidogenesis##2##6##(2012-2#2)
mediates the relationship between executive function and social outcome##2##9##(2009-10#2)
mediates the##22##2##(1990-11#1)(1991-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-4#2)(2009-10#2)(2009-12#1)(2009-7#2)(2012-2#2)
mediates these##2##2##(2008-4#1)(2008-5#1)
mediates transcriptional activation##2##3##(1993-9#1)(1997-2#1)
mediates##90##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#4)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#6)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#8)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-7#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#2)
mediating between##2##2##(1990-7#1)(2010-8#1)
mediating contraction of the guinea-pig##2##5##(1997-7#2)
mediating influence##2##2##(1995-2#1)(2013-1#1)
mediating risk##2##2##(2009-7#2)
mediating role of##3##3##(2009-7#1)(2010-2#1)(2012-3#1)
mediating the effects of##4##4##(1993-6#1)(1994-8#1)(1996-12#1)(2008-10#1)
mediating the##35##2##(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
mediating this##5##2##(1993-12#1)(1995-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
mediating##112##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#4)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-7#3)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#2)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-9#1)(2012-3#2)(2013-1#6)(2013-8#3)
mediation by##3##2##(1992-8#1)(1994-9#1)(1995-5#1)
mediation of##15##2##(1990-12#1)(1990-2#1)(1991-2#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-4#3)(2009-3#1)(2011-2#1)(2012-12#1)
mediation##24##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-1#2)(1994-8#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-4#3)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
mediational##2##1##(2010-1#2)
mediator and##6##2##(1994-2#1)(2008-10#5)
mediator between##3##2##(1991-9#1)(2008-9#1)(2009-10#1)
mediator for##6##2##(2008-10#6)
mediator in the##2##3##(1994-9#1)(2010-9#1)
mediator in##8##2##(1991-2#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-6#1)(2010-9#1)(2013-1#1)(2013-7#1)
mediator of the##6##3##(1994-2#1)(1995-12#1)(2008-11#1)(2010-1#1)(2013-1#1)(2013-8#1)
mediator of##41##2##(1991-12#2)(1991-9#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-11#2)(1994-2#3)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
mediator to##2##2##(2008-10#2)
mediator##113##1##(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1996-2#2)(1997-6#1)(1997-7#1)(2008-10#51)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#3)(2010-5#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
mediator-free##4##1##(2008-10#4)
mediators and##13##2##(1996-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
mediators between##2##2##(2009-10#1)(2010-8#1)
mediators from##2##2##(2008-4#1)(2008-5#1)
mediators have##3##2##(2008-10#2)(2009-10#1)
mediators in##5##2##(1993-3#1)(1994-9#1)(1995-2#1)(2008-7#1)(2013-7#1)
mediators is increased##2##3##(1992-3#1)(2008-5#1)
mediators may##2##2##(2008-5#2)
mediators of biogenesis##2##3##(2012-3#2)
mediators of the effects of##2##5##(2008-4#1)(2012-2#1)
mediators of the##5##3##(1994-11#1)(2008-4#1)(2009-5#1)(2009-7#1)(2012-2#1)
mediators of##25##2##(1993-8#1)(1994-11#3)(1994-12#1)(1994-9#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
mediators such as cytokines##2##4##(2011-2#2)
mediators such as##6##3##(1991-3#1)(1992-2#1)(2008-10#2)(2011-2#2)
mediators that##8##2##(1997-1#1)(2007-2#1)(2008-4#2)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#1)
mediators were##4##2##(2008-10#4)
mediators##114##1##(1990-9#2)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-8#1)(1994-9#3)(1995-2#2)(1996-2#1)(1997-1#1)(2007-2#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#9)(2008-7#12)(2008-8#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#4)(2010-1#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
medica##3##1##(2008-10#1)(2011-2#2)
medicaginis##9##1##(2008-10#9)
medicaid##2##1##(2012-2#2)
medical abortion##6##2##(2009-1#1)(2011-1#1)(2011-2#4)
medical accelerator##2##2##(2009-11#2)
medical activities##3##2##(1995-2#1)(2008-7#1)(2013-1#1)
medical activity##2##2##(1991-3#1)(1997-6#1)
medical administrators##2##2##(1992-1#1)(1993-1#1)
medical admissions##5##2##(1990-11#1)(1996-3#1)(2010-12#3)
medical advances##2##2##(2007-11#1)(2008-11#1)
medical advice should##2##3##(1993-12#1)(2007-2#1)
medical advice##11##2##(1993-12#2)(1993-2#1)(1996-3#1)(2007-2#1)(2007-7#3)(2008-1#1)(2011-2#2)
medical and administrative##2##3##(1995-1#1)(1995-3#1)
medical and dental##2##3##(2008-11#1)(2013-1#1)
medical and economical##2##3##(1994-5#1)(2011-2#1)
medical and endoscopic treatment##2##4##(1991-11#1)(1993-2#1)
medical and epidemiological journals##2##4##(1995-2#2)
medical and ethical##3##3##(1994-9#1)(1995-6#1)(2013-1#1)
medical and financial##2##3##(2013-8#2)
medical and health care providers##3##5##(2013-8#3)
medical and health professionals should be aware and learn more on the toxicology##2##13##(2013-1#2)
medical and health##9##3##(2009-10#1)(2009-5#1)(2013-1#2)(2013-8#5)
medical and industrial##2##3##(2008-10#1)(2013-8#1)
medical and legal##2##3##(2008-1#1)(2010-5#1)
medical and mental health##6##4##(1991-12#3)(1992-3#2)(1997-5#1)
medical and non-medical graduates##3##4##(1994-12#3)
medical and non-medical##4##3##(1994-12#3)(2008-12#1)
medical and nonmedical services##2##4##(1997-1#2)
medical and nursing##5##3##(1991-12#1)(1993-3#1)(1995-9#1)(1996-6#1)(2007-11#1)
medical and pharmacy##2##3##(1994-12#1)(2009-6#1)
medical and psychological##2##3##(1996-6#1)(1997-3#1)
medical and psychosocial##2##3##(1995-5#1)(2009-7#1)
medical and public health##3##4##(1997-3#1)(2008-8#1)(2013-8#1)
medical and social services##2##4##(1994-12#1)(1996-3#1)
medical and social##9##3##(1992-5#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-3#2)(2010-11#1)(2012-12#1)(2012-3#1)
medical and surgical care##3##4##(1993-12#1)(2008-1#1)(2008-11#1)
medical and surgical management##2##4##(2007-12#1)(2008-7#1)
medical and surgical treatment##3##4##(2007-8#1)(2008-7#1)(2010-12#1)
medical and surgical##23##3##(1992-12#1)(1993-12#3)(1993-3#1)(1993-6#1)(1995-6#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
medical and##123##2##(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#8)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-3#2)(1996-6#2)(1997-1#2)(1997-3#2)(1997-5#1)(1997-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#10)
medical application##2##2##(2007-10#1)(2009-3#1)
medical applications##9##2##(1994-2#1)(2007-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-7#1)
medical arms race##2##3##(1993-2#2)
medical aspects of the##2##4##(1990-12#1)(1994-2#1)
medical assessment of##2##3##(1990-3#1)(2007-7#1)
medical attention##7##2##(1991-6#1)(1994-9#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#2)
medical audit##6##2##(1991-6#1)(1991-8#1)(1992-2#1)(1994-12#1)(2012-3#2)
medical benefits##2##2##(1997-5#1)(2008-11#1)
medical biochemists##2##2##(1994-12#2)
medical cannabis##2##2##(2013-8#2)
medical care and services##2##4##(1994-1#1)(1996-3#1)
medical care and##13##3##(1991-12#2)(1993-12#1)(1994-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2011-3#1)(2013-8#1)
medical care are##3##3##(1991-3#1)(2010-3#1)(2011-2#1)
medical care costs and##3##4##(2008-11#3)
medical care for##3##3##(1994-9#1)(1996-9#1)(2008-8#1)
medical care in the##3##4##(1994-11#1)(1997-1#1)(2010-8#1)
medical care in##6##3##(1993-11#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-1#1)(2010-8#1)
medical care is##6##3##(1992-2#1)(1997-4#1)(1997-5#1)(2008-4#1)(2008-7#1)(2012-2#1)
medical care of##2##3##(1992-3#1)(2010-3#1)
medical care organizations##2##3##(1991-2#1)(1996-3#1)
medical care services##3##3##(1993-12#1)(1994-3#1)(1995-2#1)
medical care system##6##3##(1995-12#3)(1997-3#1)(2007-11#1)(2013-8#1)
medical care they##2##3##(1991-2#1)(1996-12#1)
medical care to##2##3##(1995-6#1)(1996-9#1)
medical care use##2##3##(2012-3#1)(2013-1#1)
medical care##119##2##(1991-12#9)(1991-2#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#3)(1994-11#1)(1994-2#3)(1994-3#3)(1994-9#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#2)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#2)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
medical care]##2##2##(1994-8#1)(2011-2#1)
medical center in##2##3##(1990-10#1)(1995-3#1)
medical center were##2##3##(2008-1#1)(2012-3#1)
medical center##26##2##(1990-10#1)(1991-12#1)(1991-3#1)(1992-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)
medical center's##2##2##(1993-2#1)(1997-1#1)
medical centers and##3##3##(1994-3#1)(1997-2#1)(2013-1#1)
medical centers to##2##3##(1991-12#1)(1996-1#1)
medical centers##18##2##(1991-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#4)(1996-1#3)(1997-2#1)(2007-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
medical challenge##2##2##(1992-5#1)(1996-3#1)
medical charts##3##2##(1995-12#1)(2007-12#1)(2013-8#1)
medical clinics##3##2##(1995-10#1)(2007-7#1)(2013-8#1)
medical college##3##2##(2007-7#1)(2008-7#1)(2012-12#1)
medical colleges of##3##3##(2012-3#1)(2013-8#2)
medical colleges##5##2##(1992-1#1)(2010-11#1)(2012-3#1)(2013-8#2)
medical community##10##2##(1991-12#1)(1993-6#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-8#2)(2010-6#1)(2010-8#1)(2013-1#1)
medical comorbidities##5##2##(2008-8#1)(2008-9#1)(2009-5#2)(2013-1#1)
medical complications##7##2##(1992-5#1)(2007-7#1)(2008-9#3)(2012-3#1)(2013-8#1)
medical concepts##2##2##(2012-3#2)
medical condition##10##2##(1994-3#1)(1995-12#1)(1995-6#2)(1996-5#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
medical conditions and##4##3##(2008-10#1)(2008-8#1)(2009-1#1)(2011-2#1)
medical conditions##27##2##(1991-12#1)(1992-3#2)(1993-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-1#3)(2010-2#1)(2011-2#3)(2012-3#2)(2013-7#1)(2013-8#2)
medical consequences##3##2##(1992-5#1)(2008-1#1)(2008-5#1)
medical consultation##2##2##(1991-6#1)(2013-8#1)
medical consultations##3##2##(1990-12#1)(1993-6#1)(2007-11#1)
medical control subjects##2##3##(1996-7#2)
medical control##3##2##(1996-7#2)(2010-8#1)
medical costs and financial balance##2##5##(2010-8#2)
medical costs and##3##3##(2010-5#1)(2010-8#2)
medical costs##15##2##(1991-1#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-1#3)(1997-1#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#3)(2013-7#1)
medical coverage##4##2##(1994-1#1)(1995-12#2)(2011-1#1)
medical curriculum##2##2##(1994-12#1)(2010-2#1)
medical data##5##2##(1990-9#1)(1993-3#1)(2008-6#1)(2009-5#1)(2011-2#1)
medical database##2##2##(2010-8#2)
medical databases##4##2##(2008-10#1)(2010-8#3)
medical debt repayment##2##3##(2008-11#2)
medical debt##4##2##(2008-11#2)(2013-1#2)
medical decision##3##2##(1993-6#1)(1997-1#1)(2011-2#1)
medical decision-making##9##2##(1993-12#1)(1994-1#1)(1997-3#1)(2008-4#2)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
medical decisions for##2##3##(1995-12#2)
medical decisions##5##2##(1994-6#1)(1995-1#1)(1995-12#2)(2012-2#1)
medical departments at##2##3##(1993-6#1)(1997-2#1)
medical departments##4##2##(1992-6#1)(1993-6#1)(1997-2#1)(2012-2#1)
medical device##11##2##(1993-3#1)(1994-3#1)(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-3#4)
medical devices and##2##3##(2008-3#1)(2009-11#1)
medical devices is##2##3##(2010-6#2)
medical devices##22##2##(1992-3#1)(1994-1#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-6#2)(2010-6#3)(2011-2#3)(2012-3#2)
medical diagnoses##4##2##(1995-1#2)(2008-10#1)(2009-4#1)
medical diagnosis##4##2##(1990-12#1)(2009-11#1)(2010-3#1)(2013-8#1)
medical diagnostic##4##2##(1997-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
medical diagnostics##8##2##(2007-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-8#1)(2010-5#1)
medical director##3##2##(1993-1#1)(1993-12#2)
medical directors##5##2##(1991-3#1)(1995-1#2)(1995-3#1)(1996-2#1)
medical disorder##3##2##(2008-2#1)(2012-2#2)
medical disorders can lead to##2##5##(2006-10#1)(2012-12#1)
medical disorders##11##2##(1992-8#1)(1996-12#1)(1997-8#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
medical doctor##2##2##(1990-6#1)(1992-5#1)
medical doctors##9##2##(1996-6#2)(1997-8#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
medical education and##3##3##(2008-11#1)(2010-11#1)(2012-3#1)
medical education in Nigeria##2##4##(2009-10#2)
medical education in the United States##2##6##(1991-8#2)
medical education in the##5##4##(1990-5#1)(1991-8#2)(2008-12#2)
medical education in##10##3##(1990-5#1)(1991-8#2)(2008-11#1)(2008-12#2)(2008-8#1)(2009-10#2)(2009-7#1)
medical education is##2##3##(1997-4#1)(2007-4#1)
medical education on##2##3##(2008-11#1)(2008-3#1)
medical education program##2##3##(2008-12#1)(2008-4#1)
medical education##61##2##(1990-5#1)(1991-3#1)(1991-8#5)(1992-12#1)(1992-6#2)(1992-8#2)(1994-12#3)(1995-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-4#2)(2008-1#2)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-10#4)(2009-7#1)(2010-11#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
medical education]##3##2##(1992-4#1)(1992-9#1)(1997-4#1)
medical educators##3##2##(2009-10#1)(2009-12#1)(2010-2#1)
medical effectiveness##3##2##(1993-12#1)(1996-3#1)(2011-2#1)
medical emergencies##7##2##(1995-12#1)(2008-1#3)(2009-4#1)(2010-9#1)(2011-3#1)
medical emergency##7##2##(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
medical endoscopy##2##2##(2007-12#1)(2008-3#1)
medical entomology in France##2##4##(2010-1#2)
medical entomology in##4##3##(2010-1#4)
medical entomology##13##2##(2010-1#13)
medical environment##3##2##(1992-3#1)(1993-11#1)(2012-12#1)
medical equipment##6##2##(1997-8#1)(2008-11#1)(2010-8#2)(2011-2#1)(2012-3#1)
medical errors##2##2##(2008-11#1)(2008-7#1)
medical ethics##12##2##(1993-2#1)(2007-11#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
medical evaluation##4##2##(2008-5#1)(2011-2#3)
medical events##2##2##(1994-6#1)(2008-11#1)
medical evidence##4##2##(1990-2#1)(1995-12#1)(1996-1#1)(2008-11#1)
medical exam##5##2##(1991-6#4)(2011-2#1)
medical examination and##2##3##(2008-5#1)(2009-3#1)
medical examination##3##2##(1995-11#1)(2008-5#1)(2009-3#1)
medical examinations##5##2##(1997-8#2)(2009-12#1)(2010-6#2)
medical examiner##3##2##(1995-3#1)(2011-2#2)
medical expenditure of##2##3##(2010-8#2)
medical expenditure##6##2##(2010-8#6)
medical expenditures##4##2##(1994-2#1)(1997-1#1)(2013-1#2)
medical expert##3##2##(1995-11#1)(1996-2#1)(2011-2#1)
medical expertise##2##2##(1993-12#2)
medical experts##2##2##(1990-3#1)(2010-10#1)
medical facilities##2##2##(1996-2#1)(2007-2#1)
medical factors such as types of##2##6##(1994-12#2)
medical factors##6##2##(1994-12#3)(1995-5#1)(1997-5#1)(2008-11#1)
medical faculties##2##2##(2008-10#1)(2013-1#1)
medical fields##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
medical filters##3##2##(2011-2#3)
medical gas##3##2##(2011-2#3)
medical geographic##3##2##(2013-8#3)
medical graduates##9##2##(1991-8#1)(1992-1#1)(1994-12#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
medical group administrators##2##3##(1991-1#1)(1993-1#1)
medical group practice##2##3##(1991-3#2)
medical group##17##2##(1991-1#3)(1991-3#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-3#2)(1996-1#1)(1997-1#1)
medical groups and##3##3##(1992-3#2)(1997-2#1)
medical groups for managed care contracting##2##6##(1992-3#2)
medical groups##19##2##(1991-3#2)(1992-1#2)(1992-3#5)(1993-1#3)(1993-3#1)(1994-3#2)(1996-1#1)(1997-2#1)(2008-11#2)
medical histories##3##2##(1996-12#1)(1996-6#1)(2013-1#1)
medical history and##6##3##(2008-1#1)(2008-7#2)(2009-1#1)(2010-10#1)(2011-1#1)
medical history of##4##3##(2007-12#1)(2008-1#1)(2010-3#1)(2013-1#1)
medical history was##4##3##(2008-11#1)(2008-7#1)(2012-5#1)(2013-1#1)
medical history##34##2##(1991-2#1)(1992-9#2)(1993-2#1)(1995-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#2)(2013-8#2)
medical home##2##2##(2010-8#1)(2013-7#1)
medical humanities##5##2##(1997-3#1)(2011-2#4)
medical illness##5##2##(1993-12#2)(2008-3#1)(2009-4#1)(2012-3#1)
medical image##5##2##(1994-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)
medical images and##2##3##(2009-3#1)(2013-1#1)
medical images##9##2##(2008-8#1)(2009-12#1)(2009-3#1)(2010-8#3)(2013-1#3)
medical imaging and##4##3##(1996-1#1)(2007-12#1)(2007-8#1)(2012-12#1)
medical imaging##17##2##(1993-12#1)(1993-2#1)(1994-1#2)(1996-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-3#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
medical implants##2##2##(2008-5#1)(2009-7#1)
medical informatics##4##2##(1992-12#1)(1994-2#1)(2008-7#2)
medical information highway##2##3##(1996-3#2)
medical information system##2##3##(2010-8#2)
medical information##15##2##(1993-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#2)(2008-11#1)(2008-7#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-12#1)
medical inpatients##3##2##(2010-12#1)(2013-1#2)
medical intervention##2##2##(2008-8#1)(2010-10#1)
medical interventions in##2##3##(1991-6#1)(2010-10#1)
medical interventions##5##2##(1991-6#1)(1993-12#1)(1995-2#1)(2010-10#1)(2012-2#1)
medical issue##2##2##(1992-12#1)(2011-2#1)
medical journals##12##2##(1991-3#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
medical knowledge of##2##3##(2008-12#1)(2009-10#1)
medical knowledge was##2##3##(1993-12#1)(1994-6#1)
medical knowledge##9##2##(1991-11#1)(1993-12#1)(1994-6#1)(1996-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-3#1)
medical laboratory##2##2##(2008-10#1)(2008-12#1)
medical librarian##2##2##(1992-2#1)(1994-2#1)
medical librarians##4##2##(1991-2#2)(1996-1#2)
medical libraries##2##2##(1990-4#1)(1996-1#1)
medical library##4##2##(1990-4#1)(1991-1#2)(1996-1#1)
medical linear accelerator##3##3##(2008-3#2)(2009-11#1)
medical linear##4##2##(1995-8#1)(2008-3#2)(2009-11#1)
medical literature and##2##3##(1991-3#1)(1996-9#1)
medical literature is##2##3##(2007-7#1)(2009-7#1)
medical literature##32##2##(1990-8#1)(1991-3#1)(1992-12#1)(1996-6#2)(1996-9#1)(1997-1#1)(2007-5#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-6#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
medical malpractice claims##4##3##(1992-2#1)(1993-1#1)(1995-2#1)(2012-3#1)
medical malpractice insurance##3##3##(1993-1#2)(2013-7#1)
medical malpractice##21##2##(1991-1#1)(1991-12#4)(1992-1#1)(1992-2#3)(1993-1#3)(1993-12#1)(1994-1#2)(1994-2#1)(1995-2#1)(1997-1#1)(1997-8#1)(2012-3#1)(2013-7#1)
medical management and##3##3##(1996-3#1)(2009-6#1)(2010-8#1)
medical management is##3##3##(1992-9#1)(2008-9#1)(2011-2#1)
medical management of##5##3##(1991-2#1)(2007-12#1)(2012-2#1)(2013-8#2)
medical management##30##2##(1991-2#1)(1992-9#3)(1996-3#1)(1997-3#3)(2007-10#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-6#1)(2010-8#3)(2011-2#3)(2011-3#3)(2012-2#1)(2013-1#1)(2013-8#2)
medical manpower##6##2##(1990-6#3)(1991-2#3)
medical messages##2##2##(2010-8#2)
medical model##3##2##(1995-12#1)(1996-12#1)(2009-10#1)
medical need##3##2##(1992-3#1)(2008-5#2)
medical needs##2##2##(1992-3#1)(1997-3#1)
medical office group##2##3##(1994-3#2)
medical office##6##2##(1991-12#1)(1994-3#2)(1996-1#1)(1997-3#1)(2009-7#1)
medical officers in##2##3##(1996-9#1)(2008-1#1)
medical officers##8##2##(1995-5#2)(1996-9#1)(1997-8#2)(2007-5#1)(2008-1#1)(2012-12#1)
medical offices##2##2##(2008-10#1)(2009-6#1)
medical oncologists##2##2##(2013-1#2)
medical oncology##3##2##(2008-10#1)(2009-4#1)(2012-3#1)
medical or surgical treatment##2##4##(1996-6#1)(2010-6#1)
medical or surgical##8##3##(1990-5#1)(1996-6#1)(2007-12#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#2)
medical or##11##2##(1990-5#1)(1991-12#1)(1991-5#1)(1996-6#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#2)
medical organization##2##2##(1996-2#2)
medical organizations##2##2##(1993-12#1)(1996-3#1)
medical outcomes##4##2##(1992-4#2)(1995-2#1)(1996-3#1)
medical patients##5##2##(1993-2#1)(2010-12#4)
medical payments##2##2##(1991-12#2)
medical personnel and the##2##4##(2007-7#1)(2013-1#1)
medical personnel and##4##3##(1997-5#1)(2007-7#1)(2010-1#1)(2013-1#1)
medical personnel##13##2##(1992-3#1)(1994-6#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-3#1)(2010-1#2)(2011-1#1)(2012-3#1)(2013-1#1)
medical perspective##2##2##(1991-11#1)(2012-2#1)
medical physicists##3##2##(2007-4#3)
medical physics##2##2##(2007-4#2)
medical polypropylene##2##2##(2012-3#2)
medical practice (e##2##3##(2012-1#2)
medical practice and##3##3##(1993-12#1)(1995-12#1)(1996-2#1)
medical practice in##2##3##(1995-12#1)(1996-3#1)
medical practice organization##2##3##(1995-2#1)(1997-3#1)
medical practice parameters##2##3##(1993-3#2)
medical practice##44##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#3)(1997-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
medical practice]##2##2##(1990-11#1)(1996-3#1)
medical practices and##2##3##(1997-3#1)(2008-12#1)
medical practices in##2##3##(1995-3#1)(2008-7#1)
medical practices##17##2##(1991-3#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-7#1)(2012-2#1)
medical practitioners and##2##3##(1991-8#1)(2008-8#1)
medical practitioners to##2##3##(2008-10#1)(2013-8#1)
medical practitioners##11##2##(1991-8#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2013-8#1)
medical problem in##3##3##(2008-1#1)(2010-12#1)(2010-4#1)
medical problem of##2##3##(2007-7#1)(2011-2#1)
medical problem##10##2##(1997-3#1)(2007-7#1)(2008-1#2)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#2)
medical problems are##2##3##(1992-5#1)(2012-2#1)
medical problems##16##2##(1992-5#1)(1992-8#2)(1995-6#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-2#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
medical procedure##3##2##(1995-2#2)(1997-7#1)
medical procedures and##3##3##(1992-2#1)(1996-3#1)(2008-11#1)
medical procedures##15##2##(1992-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#1)
medical products##3##2##(1994-3#1)(2008-11#1)(2013-1#1)
medical profession must##2##3##(1991-11#1)(1992-9#1)
medical profession##15##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-9#1)(1995-11#1)(1996-11#1)(2008-12#3)(2008-7#2)(2009-10#1)(2009-5#1)(2012-2#1)(2013-1#1)
medical professionals##7##2##(1992-3#2)(1995-6#1)(1996-9#1)(2007-12#1)(2007-7#1)(2012-3#1)
medical professions##2##2##(2012-3#2)
medical program##2##2##(2008-12#2)
medical provider##4##2##(2013-1#4)
medical providers and##2##3##(2008-7#2)
medical providers##7##2##(2008-7#2)(2009-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
medical psychology##2##2##(2013-1#2)
medical purposes##4##2##(1996-9#1)(1997-6#2)(2013-8#1)
medical quality##2##2##(1993-8#1)(2010-8#1)
medical reasons##2##2##(2008-10#1)(2013-8#1)
medical record coder##2##3##(2007-12#2)
medical record keeping##2##3##(1992-12#1)(2008-12#1)
medical record##21##2##(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-6#2)(1996-2#1)(1996-3#1)(2007-12#4)(2007-9#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-3#1)
medical records and##10##3##(1993-2#1)(1994-3#2)(1997-2#1)(2006-10#1)(2007-8#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
medical records department##2##3##(1991-1#1)(1993-1#1)
medical records from##2##3##(1992-1#1)(2013-8#1)
medical records in hospitals]##2##4##(1993-11#2)
medical records in##4##3##(1993-11#2)(1994-6#2)
medical records of patients##5##4##(1992-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
medical records of##19##3##(1990-2#1)(1991-4#1)(1992-3#1)(1994-6#1)(1996-3#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
medical records to##2##3##(2007-10#1)(2013-1#1)
medical records were reviewed##2##4##(2007-10#1)(2008-9#1)
medical records##75##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1994-3#4)(1994-6#3)(1995-12#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#2)
medical reference librarians##3##3##(1996-1#3)
medical regimens##2##2##(1994-3#1)(2007-7#1)
medical rehabilitation##3##2##(1993-6#1)(1995-5#1)(2013-1#1)
medical reports##2##2##(1992-6#1)(1995-11#1)
medical representatives##3##2##(2008-7#3)
medical research and##2##3##(1997-3#1)(2012-12#1)
medical research##19##2##(1991-2#1)(1991-6#1)(1992-6#2)(1993-2#1)(1993-6#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-8#1)(2012-12#2)
medical research]##3##2##(1992-9#1)(1993-6#1)(1997-4#1)
medical resources and##3##3##(1994-3#1)(1996-2#1)(2008-1#1)
medical resources##8##2##(1990-6#1)(1991-12#1)(1992-2#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-1#1)(2010-8#1)
medical review##2##2##(1993-2#2)
medical school curriculum##2##3##(2008-3#1)(2012-3#1)
medical school in##3##3##(2008-7#1)(2013-8#2)
medical school libraries##2##3##(1991-3#2)
medical school##25##2##(1990-10#1)(1991-3#2)(1992-6#1)(1992-8#1)(1994-12#1)(1995-1#1)(2007-11#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
medical school-based##2##2##(1993-1#1)(2007-4#1)
medical schools and##2##3##(1991-8#1)(1997-3#1)
medical schools have##2##3##(2008-12#1)(2013-1#1)
medical schools in##4##3##(1991-6#1)(2009-10#1)(2013-1#2)
medical schools of##2##3##(2011-2#1)(2013-7#1)
medical schools##32##2##(1991-2#3)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#2)(1993-3#1)(1994-12#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-12#1)(2009-10#1)(2009-6#1)(2011-2#4)(2013-1#5)(2013-7#1)(2013-8#1)
medical science##4##2##(1993-11#1)(2009-7#1)(2010-12#1)(2013-8#1)
medical sciences##4##2##(2007-7#1)(2008-12#1)(2011-2#1)(2012-12#1)
medical search engines##2##3##(2010-8#2)
medical service in##2##3##(2008-3#1)(2010-4#1)
medical service use##2##3##(1991-1#2)
medical service##14##2##(1991-1#2)(1993-12#1)(1995-12#1)(1996-3#3)(2007-2#1)(2008-3#5)(2010-4#1)
medical services and##4##3##(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)
medical services to##3##3##(1994-3#2)(1996-12#1)
medical services##36##2##(1990-6#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-3#2)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
medical settings##6##2##(2008-4#1)(2009-5#1)(2009-6#3)(2011-2#1)
medical skills##2##2##(1990-11#1)(1995-6#1)
medical specialists in##4##3##(1991-12#1)(1995-12#1)(1996-1#1)(2008-7#1)
medical specialists##5##2##(1991-12#1)(1995-12#1)(1996-1#1)(2008-7#2)
medical specialties and diagnostic groups##2##5##(1991-11#2)
medical specialties and##5##3##(1991-11#2)(1991-6#1)(1992-4#2)
medical specialties##12##2##(1991-11#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-4#2)(1996-1#1)(1996-7#1)(2007-11#1)(2011-2#1)
medical specialty##4##2##(1994-12#1)(1994-3#1)(2010-10#1)(2010-12#1)
medical staff and##4##3##(1991-2#1)(1993-1#1)(1994-1#1)(2010-2#1)
medical staff are##2##3##(1993-2#1)(1997-5#1)
medical staff at##2##3##(1992-2#1)(1993-12#1)
medical staff bylaws##3##3##(1991-2#2)(1991-3#1)
medical staff committee minutes##2##4##(1993-12#2)
medical staff credentialing##6##3##(1993-1#1)(1993-12#3)(1994-3#1)(1997-2#1)
medical staff for##2##3##(2007-8#1)(2008-11#1)
medical staff in##2##3##(1994-2#1)(2010-12#1)
medical staff leaders for##2##4##(1992-1#2)
medical staff leaders##4##3##(1992-1#3)(1993-12#1)
medical staff members##3##3##(1991-12#1)(1993-1#2)
medical staff planning##3##3##(1994-1#3)
medical staff privileges##3##3##(1992-12#1)(1993-3#1)(1994-1#1)
medical staff##77##2##(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#2)(1992-2#5)(1993-1#9)(1993-12#8)(1993-2#2)(1993-3#3)(1994-1#9)(1994-12#2)(1994-2#3)(1994-3#3)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)(2010-2#2)(2012-2#2)(2012-3#1)
medical staffs and hospitals##2##4##(1991-2#1)(1992-1#1)
medical staffs and their members##2##5##(1991-2#1)(1993-1#1)
medical staffs and##5##3##(1991-2#3)(1992-1#1)(1993-1#1)
medical staffs##11##2##(1991-12#1)(1991-2#3)(1992-1#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)
medical strategy##2##2##(2007-8#1)(2009-5#1)
medical student##3##2##(1994-3#1)(2008-12#1)(2010-8#1)
medical students and##4##3##(1991-6#1)(2010-2#1)(2011-2#1)(2013-8#1)
medical students as##2##3##(2013-8#2)
medical students at the##4##4##(1992-6#1)(2008-10#1)(2008-11#1)(2010-9#1)
medical students at##6##3##(1991-6#1)(1992-6#1)(1993-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
medical students in a##2##4##(2009-4#1)(2011-2#1)
medical students in the##2##4##(2008-4#1)(2013-7#1)
medical students in##11##3##(1993-3#1)(2008-4#1)(2009-4#1)(2009-6#2)(2011-2#2)(2013-1#3)(2013-7#1)
medical students to the##2##4##(1992-6#1)(1997-1#1)
medical students to##7##3##(1992-2#1)(1992-6#2)(1997-1#1)(2008-11#1)(2008-3#1)(2012-3#1)
medical students##68##2##(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#5)(1993-3#2)(1994-12#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#8)
medical students'##3##2##(2009-12#1)(2010-2#1)(2012-3#1)
medical studies##4##2##(1994-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
medical subjects##2##2##(2009-4#2)
medical subspecialty##2##2##(1994-3#1)(2012-3#1)
medical symptoms##3##2##(2008-11#2)(2009-9#1)
medical system in##2##3##(2010-5#1)(2011-2#1)
medical system##5##2##(2007-9#1)(2008-1#1)(2010-5#1)(2010-8#1)(2011-2#1)
medical teaching##5##2##(1993-3#1)(1994-12#2)(1997-5#1)(2013-8#1)
medical technologies##4##2##(1997-1#1)(2009-6#1)(2010-8#1)(2012-2#1)
medical technologists at##2##3##(1994-12#1)(2010-6#1)
medical technologists##3##2##(1994-12#2)(2010-6#1)
medical technology##14##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#2)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-8#1)(2012-2#1)
medical tests##2##2##(2010-10#1)(2010-11#1)
medical textbooks##3##2##(1995-12#1)(2008-7#2)
medical therapies##3##2##(1995-3#1)(2008-3#1)(2009-9#1)
medical therapy and##2##3##(1996-11#1)(2010-6#1)
medical therapy as##2##3##(2011-3#1)(2013-1#1)
medical therapy in##3##3##(2009-10#1)(2011-3#1)(2012-12#1)
medical therapy is##2##3##(2006-10#1)(2010-12#1)
medical therapy##32##2##(1990-11#2)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-11#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-3#2)(2012-12#2)(2012-3#1)(2013-1#4)
medical think##2##2##(2008-6#2)
medical tourism##2##2##(2008-11#2)
medical trainees##2##2##(1994-12#1)(2010-2#1)
medical training##7##2##(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#1)(1997-8#1)(2008-11#1)(2012-2#1)
medical treatment and some##2##4##(1991-6#1)(2007-8#1)
medical treatment and surgical##2##4##(2010-3#1)(2011-2#1)
medical treatment and##9##3##(1991-6#1)(1994-7#1)(2007-8#2)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)
medical treatment for##4##3##(1991-11#1)(2007-8#1)(2008-12#1)(2012-3#1)
medical treatment in the##2##4##(1997-6#1)(2008-11#1)
medical treatment in##6##3##(1992-8#1)(1993-12#1)(1997-6#1)(2007-7#1)(2008-11#1)(2012-12#1)
medical treatment is##3##3##(1990-12#1)(1997-5#1)(2008-7#1)
medical treatment of patients with##2##5##(2007-11#1)(2011-2#1)
medical treatment of##10##3##(1994-2#1)(1994-9#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
medical treatment with##2##3##(1991-11#1)(2013-8#1)
medical treatment##79##2##(1990-12#1)(1991-11#3)(1991-6#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
medical treatments##4##2##(1994-9#1)(1996-6#1)(2009-11#1)(2009-9#1)
medical ultrasound transducers##3##3##(2010-8#3)
medical unit##4##2##(1992-6#1)(2010-10#1)(2010-12#2)
medical university staff##2##3##(2008-12#2)
medical university##3##2##(2008-12#2)(2011-1#1)
medical use of##2##3##(1991-6#1)(2013-1#1)
medical use##3##2##(1991-6#1)(2013-1#1)(2013-8#1)
medical views##3##2##(2009-7#1)(2013-1#2)
medical visit##2##2##(1991-8#1)(2009-10#1)
medical waste##2##2##(1992-1#1)(2007-7#1)
medical##2371##1##(1990-10#2)(1990-11#6)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#7)(1990-8#1)(1990-9#4)(1991-1#17)(1991-11#10)(1991-12#41)(1991-2#28)(1991-3#23)(1991-4#1)(1991-5#1)(1991-6#25)(1991-7#1)(1991-8#11)(1991-9#2)(1992-1#19)(1992-11#3)(1992-12#17)(1992-2#23)(1992-3#28)(1992-4#6)(1992-5#10)(1992-6#16)(1992-8#7)(1992-9#12)(1993-1#27)(1993-11#11)(1993-12#49)(1993-2#22)(1993-3#28)(1993-6#14)(1993-8#2)(1993-9#1)(1994-1#25)(1994-11#3)(1994-12#47)(1994-2#24)(1994-3#37)(1994-5#2)(1994-6#13)(1994-7#1)(1994-8#1)(1994-9#9)(1995-1#19)(1995-10#1)(1995-11#6)(1995-12#27)(1995-2#28)(1995-3#18)(1995-5#11)(1995-6#12)(1995-8#6)(1995-9#5)(1996-1#23)(1996-11#3)(1996-12#17)(1996-2#22)(1996-3#33)(1996-5#2)(1996-6#13)(1996-7#3)(1996-8#2)(1996-9#12)(1997-1#24)(1997-2#13)(1997-3#27)(1997-4#6)(1997-5#12)(1997-6#5)(1997-7#3)(1997-8#22)(2006-10#8)(2006-12#1)(2007-1#1)(2007-10#13)(2007-11#26)(2007-12#21)(2007-2#8)(2007-4#15)(2007-5#5)(2007-6#1)(2007-7#26)(2007-8#13)(2007-9#3)(2008-1#34)(2008-10#37)(2008-11#89)(2008-12#40)(2008-2#5)(2008-3#35)(2008-4#18)(2008-5#15)(2008-6#12)(2008-7#64)(2008-8#24)(2008-9#16)(2009-1#3)(2009-10#24)(2009-11#15)(2009-12#7)(2009-3#10)(2009-4#12)(2009-5#11)(2009-6#17)(2009-7#18)(2009-8#6)(2009-9#10)(2010-1#23)(2010-10#9)(2010-11#7)(2010-12#25)(2010-2#14)(2010-3#7)(2010-4#7)(2010-5#8)(2010-6#19)(2010-7#3)(2010-8#58)(2010-9#4)(2011-1#21)(2011-2#123)(2011-3#9)(2012-1#6)(2012-12#37)(2012-2#42)(2012-3#75)(2012-5#1)(2013-1#96)(2013-7#12)(2013-8#77)
medical-legal##4##1##(1994-1#1)(1996-2#1)(2009-7#2)
medical-scientific studies of humans##2##4##(1997-5#2)
medical-scientific##4##1##(1997-5#3)(2008-12#1)
medical-surgical##2##1##(2008-3#1)(2012-2#1)
medicalization of##4##2##(2008-10#1)(2009-10#2)(2009-7#1)
medicalization##5##1##(1995-6#1)(2008-10#1)(2009-10#2)(2009-7#1)
medically and##2##2##(2008-10#1)(2008-7#1)
medically compromised patients undergoing oral surgery##3##6##(1993-1#3)
medically compromised##5##2##(1993-1#3)(2008-1#1)(2010-3#1)
medically fragile infants##3##3##(1991-3#1)(2008-10#2)
medically fragile##4##2##(1991-3#1)(1992-3#1)(2008-10#2)
medically important##3##2##(1993-2#1)(2010-1#1)(2013-8#1)
medically indicated services##2##3##(1993-1#2)
medically indicated##5##2##(1993-1#3)(1993-11#1)(2012-2#1)
medically indigent##3##2##(1992-2#2)(2006-10#1)
medically treated##3##2##(1994-12#1)(1995-8#1)(2011-2#1)
medically underserved##5##2##(1997-1#2)(2008-1#2)(2008-10#1)
medically unexplained##4##2##(2009-6#1)(2010-1#1)(2010-12#1)(2012-2#1)
medically##59##1##(1990-12#1)(1991-2#1)(1991-3#2)(1992-2#4)(1992-3#2)(1993-1#6)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-1#1)(1997-1#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
medicament##4##1##(1997-2#2)(2008-10#1)(2013-1#1)
medicaments##8##1##(1991-8#1)(1997-2#3)(2008-11#2)(2011-1#1)(2011-3#1)
medicare##3##1##(1994-1#1)(2009-9#1)(2013-1#1)
medicated PD patients##2##3##(2008-7#2)
medicated##6##1##(1995-5#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-8#1)
medication abuse##2##2##(2008-3#2)
medication adherence##4##2##(1992-12#1)(2008-6#1)(2010-9#1)(2011-1#1)
medication administration##5##2##(2007-10#2)(2008-2#1)(2010-6#1)(2011-1#1)
medication after an AMI##2##4##(2009-6#2)
medication and medical##2##3##(2012-3#2)
medication and##13##2##(1991-8#1)(1992-9#1)(1995-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-3#3)
medication are##2##2##(1997-2#1)(2012-3#1)
medication because##2##2##(1990-3#1)(1992-12#1)
medication calculation##4##2##(2008-12#2)(2010-3#2)
medication can be##2##3##(1993-3#1)(2009-8#1)
medication chart written/updated##2##3##(2012-12#2)
medication chart##3##2##(2012-12#3)
medication compliance##3##2##(1997-1#1)(2013-8#2)
medication data##2##2##(2009-3#1)(2010-8#1)
medication delivery##2##2##(1997-2#1)(2008-3#1)
medication errors were##2##3##(2011-1#2)
medication errors##9##2##(2010-8#2)(2011-1#7)
medication for##10##2##(1994-7#1)(2007-2#2)(2008-10#1)(2008-11#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-8#1)
medication group##3##2##(2008-3#3)
medication in a##2##3##(1996-9#1)(2008-3#1)
medication in primary##2##3##(2008-11#1)(2011-1#1)
medication in the##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
medication in##18##2##(1996-9#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
medication is##8##2##(1994-9#1)(1995-5#1)(1996-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)
medication knowledge##2##2##(2008-3#2)
medication management##8##2##(2008-11#3)(2008-2#1)(2012-12#3)(2013-8#1)
medication of##4##2##(1993-12#3)(1994-8#1)
medication on their own##2##4##(1996-9#1)(2008-11#1)
medication on##3##2##(1996-7#1)(1996-9#1)(2008-11#1)
medication or##3##2##(1992-5#1)(2008-6#1)(2011-2#1)
medication overuse headache##2##3##(2012-3#2)
medication period##2##2##(2008-11#1)(2008-6#1)
medication safety##2##2##(2011-1#2)
medication score in favour of##2##5##(2011-2#2)
medication score##4##2##(2008-11#1)(2011-2#3)
medication should##2##2##(2008-1#1)(2008-8#1)
medication side effects##3##3##(1996-1#1)(2009-7#1)(2009-9#1)
medication than##2##2##(1992-3#1)(2008-2#1)
medication that##2##2##(1992-2#1)(2009-7#1)
medication to##7##2##(1992-12#1)(1995-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)
medication use##7##2##(2008-12#1)(2008-5#1)(2009-3#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
medication was##5##2##(1996-6#1)(2008-11#2)(2008-7#1)(2011-2#1)
medication were##2##2##(2007-7#1)(2011-1#1)
medication with##5##2##(1990-2#1)(1997-3#1)(2008-7#1)(2010-4#1)(2012-12#1)
medication##315##1##(1990-2#1)(1990-3#1)(1991-2#2)(1991-3#1)(1991-8#2)(1992-12#9)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#1)(2006-10#2)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#23)(2008-12#8)(2008-2#5)(2008-3#24)(2008-4#2)(2008-5#6)(2008-6#11)(2008-7#13)(2008-8#5)(2008-9#5)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#7)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#26)(2011-2#10)(2012-12#12)(2012-2#3)(2012-3#7)(2013-1#6)(2013-8#9)
medication-induced##2##1##(2010-5#1)(2012-12#1)
medication-related##2##1##(2008-3#1)(2013-8#1)
medications and##11##2##(1992-12#1)(1992-8#1)(1996-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-5#1)(2013-1#1)
medications are##6##2##(2008-1#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)
medications available for the##2##4##(2008-6#1)(2012-12#1)
medications can##2##2##(1997-1#1)(2010-1#1)
medications for##8##2##(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
medications have##2##2##(2006-12#1)(2009-3#1)
medications in##8##2##(2008-1#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-6#1)(2011-1#1)(2012-3#1)
medications is##7##2##(1990-5#1)(1991-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
medications may##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
medications or##4##2##(2009-8#1)(2011-2#3)
medications such as##2##3##(2008-8#1)(2010-1#1)
medications that##2##2##(2008-7#1)(2010-12#1)
medications they##2##2##(2007-2#1)(2008-8#1)
medications to##5##2##(1996-9#1)(2008-7#1)(2008-8#2)(2011-2#1)
medications used in the##2##4##(2008-3#1)(2008-8#1)
medications used in##4##3##(2008-11#2)(2008-3#1)(2008-8#1)
medications used##6##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)
medications were##6##2##(1997-3#1)(2008-11#2)(2010-6#1)(2012-1#1)(2012-12#1)
medications with##2##2##(2008-3#1)(2013-1#1)
medications##189##1##(1990-5#2)(1991-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2008-1#6)(2008-10#6)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#15)(2008-9#10)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#5)(2010-4#3)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#8)(2011-2#12)(2012-1#2)(2012-12#8)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#9)(2013-8#3)
medications)##2##1##(2008-1#1)(2008-6#1)
medications]##2##1##(1995-11#1)(1995-2#1)
medicinal and##2##2##(2007-11#1)(2008-10#1)
medicinal herb##3##2##(1994-11#1)(2008-11#1)(2009-3#1)
medicinal herbs##6##2##(1992-2#2)(2008-10#1)(2008-9#1)(2012-3#2)
medicinal plant##9##2##(1991-6#1)(2008-10#4)(2008-11#3)(2008-12#1)
medicinal plants and##2##3##(2008-10#1)(2009-11#1)
medicinal plants have##2##3##(2008-11#1)(2011-3#1)
medicinal plants in the##2##4##(2009-10#1)(2010-6#1)
medicinal plants were##4##3##(2008-10#2)(2010-3#1)(2012-2#1)
medicinal plants##24##2##(2008-10#8)(2008-11#3)(2008-5#3)(2009-10#2)(2009-11#1)(2010-3#1)(2010-6#1)(2011-3#1)(2012-2#3)(2013-1#1)
medicinal preparation##4##2##(2008-10#4)
medicinal preparations##3##2##(2008-10#3)
medicinal products##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
medicinal properties##2##2##(2007-1#1)(2012-2#1)
medicinal use##2##2##(2008-12#1)(2013-8#1)
medicinal##74##1##(1991-6#1)(1992-2#2)(1994-11#1)(1996-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#25)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
medicine -##4##2##(2008-11#1)(2010-3#3)
medicine across##2##2##(2007-7#1)(2008-6#1)
medicine and health##3##3##(1996-6#1)(2010-1#1)(2012-12#1)
medicine and management##2##3##(1991-3#1)(1992-3#1)
medicine and medical##2##3##(2008-11#1)(2011-3#1)
medicine and society##2##3##(1994-5#1)(2008-7#1)
medicine and the##5##3##(1997-6#1)(2008-11#2)(2008-5#1)(2010-1#1)
medicine and##63##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-6#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-6#2)(1997-6#1)(2007-2#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#3)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
medicine are##8##2##(1994-2#1)(1995-2#1)(1997-5#1)(2008-11#1)(2008-3#2)(2013-1#2)
medicine as a##3##3##(1996-9#1)(2008-10#1)(2012-2#1)
medicine as##7##2##(1996-9#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
medicine at the##3##3##(1992-3#1)(2010-1#1)(2010-6#1)
medicine at##4##2##(1992-3#1)(1993-11#1)(2010-1#1)(2010-6#1)
medicine can##2##2##(1994-3#1)(2013-7#1)
medicine clinics##3##2##(1994-3#2)(2011-2#1)
medicine department##3##2##(2007-11#1)(2008-7#1)(2009-10#1)
medicine does not##2##3##(1997-6#1)(2008-3#1)
medicine for many##2##3##(2008-5#1)(2009-8#1)
medicine for the treatment of##2##5##(2008-10#1)(2013-1#1)
medicine for the##3##3##(1995-9#1)(2008-10#1)(2013-1#1)
medicine for##9##2##(1992-2#1)(1995-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-8#1)(2013-1#2)
medicine from##2##2##(1991-2#1)(1996-11#1)
medicine has led to##2##4##(1992-5#1)(2013-8#1)
medicine has##10##2##(1990-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1996-3#2)(2008-6#1)(2010-10#1)(2013-8#2)
medicine have##3##2##(2008-5#1)(2008-8#1)(2013-8#1)
medicine imaging##2##2##(2010-6#1)(2011-2#1)
medicine in India##3##3##(2008-10#3)
medicine in the##10##3##(1990-6#1)(1991-11#1)(1995-6#1)(1997-6#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
medicine in##42##2##(1990-6#1)(1991-11#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-2#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-4#2)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#3)
medicine is increasingly##2##3##(2008-5#1)(2013-8#1)
medicine is practiced##2##3##(1995-1#1)(2011-2#1)
medicine is##22##2##(1993-11#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
medicine of the##3##3##(1993-11#1)(1996-2#1)(2010-3#1)
medicine of##7##2##(1993-11#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-3#1)(2012-3#1)
medicine or##2##2##(2011-2#1)(2013-8#1)
medicine practice##2##2##(2008-7#1)(2011-2#1)
medicine research##2##2##(2008-9#1)(2013-1#1)
medicine residents##2##2##(2007-5#1)(2007-7#1)
medicine that is##4##3##(2011-2#1)(2013-1#1)(2013-8#2)
medicine that##6##2##(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#3)
medicine to be applied##4##4##(2010-8#4)
medicine to##11##2##(1995-2#1)(1996-11#1)(1996-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-8#4)(2010-9#1)
medicine use##2##2##(2007-11#1)(2008-11#1)
medicine was##4##2##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
medicine were##2##2##(1994-3#1)(2012-3#1)
medicine will##3##2##(2012-3#1)(2013-8#2)
medicine with##5##2##(1992-11#1)(1996-11#1)(2012-3#3)
medicine##703##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#4)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#4)(1991-2#4)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#4)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#7)(1993-7#5)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#7)(1994-5#2)(1994-6#4)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#10)(1995-3#1)(1995-5#1)(1995-6#9)(1995-8#2)(1995-9#7)(1996-1#1)(1996-11#5)(1996-12#3)(1996-2#6)(1996-3#8)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#6)(1997-5#7)(1997-6#17)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#12)(2007-3#1)(2007-4#2)(2007-5#7)(2007-7#7)(2007-8#2)(2008-1#13)(2008-10#51)(2008-11#30)(2008-12#17)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#21)(2008-8#15)(2008-9#9)(2009-1#1)(2009-10#9)(2009-11#5)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#6)(2009-7#9)(2009-8#3)(2009-9#7)(2010-1#8)(2010-10#10)(2010-12#1)(2010-2#1)(2010-3#7)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#6)(2011-1#4)(2011-2#30)(2011-3#4)(2012-1#2)(2012-12#7)(2012-2#16)(2012-3#27)(2012-5#2)(2012-6#2)(2013-1#26)(2013-7#5)(2013-8#34)
medicine&quot##5##1##(1997-6#2)(2009-5#2)(2013-1#1)
medicine's##3##1##(2008-9#1)(2013-8#2)
medicine)##5##1##(1994-9#1)(1997-2#1)(2008-1#1)(2010-10#2)
medicine--a##3##1##(1993-3#1)(2008-11#2)
medicine?##4##1##(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#1)
medicine?]##4##1##(1990-2#1)(1993-11#1)(1993-3#1)(1994-2#1)
medicine]##37##1##(1990-2#1)(1990-3#2)(1991-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-11#3)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#3)(2009-1#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-2#2)(2013-1#2)
medicines and##10##2##(2008-10#2)(2008-7#1)(2008-9#3)(2009-5#1)(2010-2#1)(2011-1#1)(2011-3#1)
medicines are##5##2##(1997-6#1)(2008-11#1)(2011-1#3)
medicines classified in the cardiovascular therapeutic group##2##7##(2008-11#2)
medicines classified##3##2##(2008-11#3)
medicines for##2##2##(1990-3#1)(2009-3#1)
medicines have##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
medicines in##8##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
medicines is##3##2##(1995-9#1)(2008-11#1)(2011-2#1)
medicines to##6##2##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
medicines was significantly higher in##2##5##(2008-11#2)
medicines was significantly##3##3##(2008-11#3)
medicines were##3##2##(2008-10#2)(2011-1#1)
medicines##115##1##(1990-3#1)(1990-6#1)(1992-2#1)(1993-3#1)(1995-6#1)(1995-9#2)(1996-11#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#3)(2008-1#1)(2008-10#16)(2008-11#16)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#7)(2008-9#4)(2009-3#1)(2009-5#3)(2010-2#1)(2010-5#3)(2011-1#14)(2011-2#7)(2011-3#3)(2012-12#2)(2013-1#7)(2013-8#7)
medico-legal##4##1##(1997-8#1)(2008-7#1)(2012-12#2)
medicolegal##3##1##(1992-5#1)(1996-6#1)(2008-6#1)
medieval##8##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-6#1)(2013-8#2)
medigap insurance##2##2##(1991-2#1)(1992-2#1)
medigap##8##1##(1991-2#2)(1992-2#4)(1997-3#2)
medio##2##1##(2008-7#1)(2012-12#1)
mediolateral##3##1##(1995-4#1)(1997-3#1)(2010-9#1)
meditate##2##1##(2008-10#1)(2008-5#1)
meditation response versus##2##3##(2008-10#2)
meditation response##3##2##(2008-10#3)
meditation##13##1##(2008-10#10)(2008-3#3)
mediterranean##4##1##(1992-9#1)(2007-7#1)(2008-10#1)(2010-2#1)
medium (0 or##2##3##(2011-2#2)
medium (0##4##2##(2008-3#1)(2010-3#1)(2011-2#2)
medium (1##2##2##(2008-11#1)(2008-5#1)
medium (SFM)##3##2##(1991-8#1)(2008-11#1)(2008-7#1)
medium (maximal##2##2##(1997-3#1)(2008-11#1)
medium (pH##7##2##(2008-10#7)
medium (with##2##2##(2008-10#2)
medium C/N##2##2##(2008-10#1)(2008-6#1)
medium DRG neurons##2##3##(1996-12#2)
medium a##4##2##(1990-11#1)(1990-7#1)(1994-11#1)(2008-11#1)
medium abolished##2##2##(1995-12#1)(2008-10#1)
medium absorption##2##2##(2008-3#2)
medium adjusted##2##2##(1996-12#1)(2008-10#1)
medium after##4##2##(1993-8#1)(2008-10#3)
medium allowed##5##2##(1993-12#1)(2008-10#3)(2011-2#1)
medium also##2##2##(1993-12#1)(2008-11#1)
medium and an##3##3##(2007-11#2)(2008-7#1)
medium and by##2##3##(2008-10#1)(2012-2#1)
medium and can##2##3##(2008-11#2)
medium and in the##2##4##(2008-10#2)
medium and in##4##3##(2007-12#1)(2008-10#3)
medium and its##3##3##(2008-10#3)
medium and long##2##3##(2011-3#1)(2013-1#1)
medium and long-term##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
medium and of##2##3##(2007-12#1)(2008-11#1)
medium and on##2##3##(2008-10#1)(2008-11#1)
medium and the resulting##2##4##(2008-10#2)
medium and the##15##3##(1995-3#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-8#1)(2011-2#1)
medium and then##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
medium and was##2##3##(2007-12#1)(2008-10#1)
medium and##107##2##(1990-6#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#2)(1996-4#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#38)(2008-11#18)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-4#1)(2012-6#1)(2013-1#4)
medium are##7##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)
medium as a##2##3##(2008-10#1)(2008-11#1)
medium as an##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
medium as well as##2##4##(2008-11#1)(2008-3#1)
medium as##14##2##(1992-3#1)(1992-8#1)(2007-10#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)
medium at 37 degrees C##2##5##(2008-11#1)(2008-8#1)
medium at a##2##3##(1997-6#1)(2008-11#1)
medium at pH 7##2##4##(2008-10#2)
medium at pH##6##3##(2008-10#6)
medium at room temperature##4##4##(2008-10#3)(2008-3#1)
medium at the##2##3##(2008-11#1)(2008-3#1)
medium at##25##2##(1997-6#1)(2008-10#14)(2008-11#4)(2008-3#3)(2008-5#1)(2008-8#2)
medium based on the##2##4##(1996-5#1)(2008-10#1)
medium based on##3##3##(1996-5#1)(2008-10#2)
medium but also by the##2##5##(2008-11#1)(2008-3#1)
medium but##3##2##(2008-11#1)(2008-3#2)
medium by a##2##3##(1992-8#1)(2007-12#1)
medium by the##2##3##(2008-10#1)(2008-3#1)
medium by use of a##3##5##(2007-11#2)(2008-3#1)
medium by use of##4##4##(2007-11#2)(2008-3#2)
medium by using##2##3##(2008-2#1)(2008-3#1)
medium by##23##2##(1992-8#1)(1993-3#1)(1993-6#1)(1995-8#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#6)
medium can be##5##3##(1992-2#1)(2008-11#2)(2008-3#2)
medium can##8##2##(1992-2#1)(2007-12#1)(2008-11#2)(2008-3#3)(2012-1#1)
medium change##3##2##(1996-2#1)(2007-11#1)(2008-11#1)
medium collected##2##2##(1991-2#1)(1997-4#1)
medium compared with##2##3##(2007-11#1)(2008-10#1)
medium components##6##2##(2008-11#3)(2013-1#3)
medium composed of##3##3##(2008-10#3)
medium composition and##2##3##(2008-11#1)(2008-6#1)
medium composition##10##2##(2008-11#7)(2008-6#2)(2011-1#1)
medium conditioned by##3##3##(1992-9#1)(1994-5#1)(2008-11#1)
medium conditioned##4##2##(1992-9#1)(1994-5#1)(1996-5#1)(2008-11#1)
medium consisting of##4##3##(2007-11#1)(2008-11#2)(2008-12#1)
medium consists of##2##3##(2008-10#1)(2008-3#1)
medium consumption and##2##3##(2008-11#2)
medium containing 0 (control)##2##4##(2008-12#1)(2013-1#1)
medium containing 0##4##3##(1992-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
medium containing 1##2##3##(1991-12#1)(1992-11#1)
medium containing 1%##3##3##(1997-1#1)(2008-6#1)(2008-8#1)
medium containing 20%##2##3##(2008-10#2)
medium containing NAA##2##3##(2013-1#2)
medium containing a##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
medium containing glucose##2##3##(2008-10#1)(2008-6#1)
medium containing##90##2##(1991-12#1)(1991-7#1)(1992-11#1)(1992-6#2)(1992-8#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#21)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#1)(2008-8#5)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#8)
medium could##3##2##(1992-12#1)(2008-10#1)(2008-6#1)
medium decreased##2##2##(2008-11#1)(2011-2#1)
medium depth peel##2##3##(2008-5#2)
medium depth##3##2##(2008-5#2)(2011-2#1)
medium did not##2##3##(1994-2#1)(2008-7#1)
medium during##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
medium exchange##4##2##(2008-10#1)(2008-11#3)
medium feed##2##2##(2008-11#1)(2008-7#1)
medium flow##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
medium for Fusarium spp##2##4##(1997-6#2)
medium for human##2##3##(2008-9#2)
medium for the production of##2##5##(2008-11#1)(2008-6#1)
medium for the##9##3##(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)
medium for##40##2##(1996-1#1)(1997-6#3)(2007-11#1)(2008-10#12)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2011-1#2)(2013-1#1)
medium formed with##2##3##(2008-10#2)
medium formulation and##2##3##(2008-11#1)(2008-5#1)
medium formulation##8##2##(2008-11#7)(2008-5#1)
medium from the##2##3##(1994-5#1)(2008-3#1)
medium from##11##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
medium glucose concentration##2##3##(2008-11#2)
medium has been monitored##2##4##(2008-10#2)
medium has been##7##3##(2007-12#1)(2008-10#5)(2008-2#1)
medium has##11##2##(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-9#1)
medium hyposmolarity##3##2##(1990-7#1)(2008-8#2)
medium in a stirred tank bioreactor##2##6##(2008-11#2)
medium in a##5##3##(1990-12#1)(2007-12#1)(2008-11#3)
medium in the presence of##4##5##(1993-6#1)(1994-6#1)(1997-2#1)(2008-10#1)
medium in the range##3##4##(2008-10#3)
medium in the##19##3##(1992-11#1)(1992-8#1)(1993-6#1)(1994-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-2#1)(2011-2#1)
medium in which the##2##4##(2008-10#1)(2008-2#1)
medium in which##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
medium in##44##2##(1990-12#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#12)(2008-11#13)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)
medium increased##5##2##(1992-11#1)(2008-11#3)(2008-7#1)
medium inoculated with##2##3##(2008-10#1)(2008-7#1)
medium into##2##2##(2008-3#1)(2013-1#1)
medium is a##2##3##(1997-6#1)(2007-12#1)
medium is demonstrated##3##3##(2008-10#2)(2008-3#1)
medium is described##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
medium is presented##2##3##(2007-11#1)(2007-12#1)
medium is proposed##3##3##(2007-12#1)(2008-10#2)
medium is reported##2##3##(2008-10#1)(2008-3#1)
medium is used##2##3##(2008-11#1)(2008-2#1)
medium is##43##2##(1991-5#1)(1994-6#1)(1997-6#1)(2007-11#5)(2007-12#7)(2008-10#13)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#1)(2009-5#1)
medium lacking##2##2##(1992-9#1)(1995-2#1)
medium level of the range##2##5##(2008-10#2)
medium level of##3##3##(2008-10#3)
medium level##4##2##(2008-10#3)(2011-2#1)
medium of a##3##3##(1990-12#1)(2008-10#1)(2008-2#1)
medium of incidence##2##3##(2008-3#2)
medium of low##3##3##(1991-11#2)(2008-8#1)
medium of pH##3##3##(2008-10#3)
medium of the##6##3##(1994-6#1)(2008-10#1)(2008-3#3)(2008-5#1)
medium of##41##2##(1990-12#1)(1991-11#2)(1991-5#1)(1992-5#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-10#1)(2008-10#15)(2008-2#1)(2008-3#6)(2008-5#1)(2008-8#1)(2009-3#2)
medium on the##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
medium on##11##2##(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
medium only##2##2##(2008-11#1)(2009-4#1)
medium optimization##3##2##(2008-11#3)
medium or from##2##3##(2008-10#2)
medium or in the presence of##2##6##(1996-2#1)(2008-10#1)
medium or in the##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
medium or in##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
medium or##18##2##(1992-11#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2013-1#1)
medium osmotic potential##2##3##(2008-9#2)
medium performance##2##2##(2008-11#1)(2011-2#1)
medium perfusion rate##4##3##(2008-11#4)
medium perfusion##7##2##(2008-11#6)(2010-9#1)
medium power##4##2##(2008-10#1)(2008-3#3)
medium prevented##2##2##(1991-10#1)(2008-11#1)
medium rather than##2##3##(2007-6#1)(2010-2#1)
medium replacement##2##2##(2008-11#2)
medium risk##2##2##(2007-10#1)(2007-8#1)
medium should##2##2##(1990-3#1)(2008-10#1)
medium showed that##2##3##(2008-10#2)
medium showed##6##2##(2008-10#2)(2008-11#3)(2008-12#1)
medium significantly##3##2##(1990-7#1)(2008-3#1)(2008-7#1)
medium since##2##2##(2008-4#1)(2008-6#1)
medium size##3##2##(1997-4#1)(2008-4#1)(2012-12#1)
medium stimulated the##2##3##(2008-5#1)(2008-6#1)
medium stimulated##3##2##(1994-2#1)(2008-5#1)(2008-6#1)
medium such as##6##3##(1996-5#1)(2008-2#1)(2008-3#4)
medium supplement##2##2##(2008-11#2)
medium supplementation##2##2##(1994-5#1)(2008-11#1)
medium supplemented with 1##2##4##(2008-11#1)(2008-12#1)
medium supplemented with glucose##3##4##(2008-11#3)
medium supplemented with##21##3##(1992-2#1)(1994-5#1)(2007-11#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)
medium surface##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
medium term##5##2##(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
medium than in the##2##4##(1992-3#1)(2008-11#1)
medium than##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
medium that contained##2##3##(1993-12#1)(1997-4#1)
medium that contains##2##3##(2008-4#1)(2008-6#1)
medium that is##2##3##(2007-12#1)(2008-3#1)
medium that##12##2##(1993-12#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)
medium theories##2##2##(2008-2#2)
medium to form a##6##4##(2008-10#5)(2008-5#1)
medium to form##10##3##(2008-10#9)(2008-5#1)
medium to low##2##3##(2008-10#2)
medium to support##2##3##(2008-11#2)
medium to##33##2##(1994-3#2)(1994-6#1)(2008-10#15)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2013-1#1)
medium type and serum##2##4##(2008-11#2)
medium under##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
medium up to##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
medium used to##3##3##(1997-3#1)(2008-10#2)
medium used was##2##3##(2008-11#1)(2008-5#1)
medium used##6##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
medium using##8##2##(1992-12#1)(2008-10#6)(2008-7#1)
medium volume##2##2##(1993-12#1)(2008-7#1)
medium was developed##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
medium was evaluated##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
medium was formulated##2##3##(2008-11#1)(2008-7#1)
medium was investigated##4##3##(2008-10#3)(2008-6#1)
medium was replaced##2##3##(1993-11#1)(2008-11#1)
medium was replenished##2##3##(2008-10#1)(2008-11#1)
medium was studied##3##3##(2008-10#2)(2008-3#1)
medium was supplemented with##2##4##(1991-2#1)(2008-5#1)
medium was taken##2##3##(2008-10#1)(2008-11#1)
medium was used to##2##4##(2008-10#1)(2008-7#1)
medium was used##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
medium was##78##2##(1990-2#2)(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#2)(2008-10#23)(2008-11#20)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-2#1)(2010-3#3)(2011-1#1)(2011-2#1)
medium were determined##2##3##(1993-9#1)(2011-2#1)
medium were higher than in##2##5##(2008-10#1)(2008-11#1)
medium were studied##2##3##(1996-2#1)(2008-2#1)
medium were##16##2##(1993-9#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#1)
medium when##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
medium which##6##2##(1993-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#2)
medium with 10% FBS##2##4##(2007-11#1)(2008-11#1)
medium with a##7##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
medium with an##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
medium with or without##2##4##(1996-2#1)(2008-11#1)
medium with reduced serum content##2##5##(2008-7#2)
medium with the##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
medium with various concentrations of##2##5##(1994-12#1)(2008-12#1)
medium with various concentrations##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
medium with##65##2##(1991-2#1)(1993-12#1)(1993-6#2)(1994-12#1)(1996-2#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#4)
medium without Ca2+##3##3##(1992-6#1)(1995-12#2)
medium without##13##2##(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1995-12#2)(2008-10#3)(2008-11#4)
medium##1905##1##(1990-10#1)(1990-11#10)(1990-12#6)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#6)(1990-8#3)(1991-10#1)(1991-11#6)(1991-12#5)(1991-2#6)(1991-3#1)(1991-5#7)(1991-7#1)(1991-8#5)(1991-9#5)(1992-11#6)(1992-12#12)(1992-2#3)(1992-3#6)(1992-5#1)(1992-6#6)(1992-8#5)(1992-9#9)(1993-11#8)(1993-12#18)(1993-3#5)(1993-5#1)(1993-6#11)(1993-8#4)(1993-9#10)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#9)(1994-5#7)(1994-6#11)(1994-8#7)(1994-9#3)(1995-11#8)(1995-12#4)(1995-2#7)(1995-3#4)(1995-6#4)(1995-8#7)(1996-1#1)(1996-12#6)(1996-2#11)(1996-3#2)(1996-4#1)(1996-5#8)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#7)(1997-6#7)(1997-7#3)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#47)(2007-12#68)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#533)(2008-11#335)(2008-12#21)(2008-2#79)(2008-3#146)(2008-4#14)(2008-5#44)(2008-6#41)(2008-7#52)(2008-8#24)(2008-9#18)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#2)(2010-10#1)(2010-2#3)(2010-3#6)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#8)(2011-2#19)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#1)(2012-4#3)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#33)(2013-7#3)(2013-8#1)
medium's##2##1##(2007-11#1)(2008-2#1)
medium) and##2##2##(2008-10#1)(2008-9#1)
medium)##15##1##(1993-12#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-9#2)(2009-10#1)
medium- and##5##2##(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
medium-##7##1##(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#3)
medium-chain acyl-CoA dehydrogenase##3##3##(1990-8#1)(1991-8#1)(1995-5#1)
medium-chain fatty##2##2##(1995-5#1)(2011-1#1)
medium-chain##8##1##(1990-8#1)(1991-5#1)(1991-8#1)(1993-3#1)(1995-5#2)(2007-8#1)(2011-1#1)
medium-low SEL##2##2##(2012-2#2)
medium-range order##2##2##(2012-2#2)
medium-range##3##1##(2008-8#1)(2012-2#2)
medium-scale##4##1##(2007-12#1)(2007-9#1)(2008-10#2)
medium-severe form##2##2##(2013-1#2)
medium-size##2##1##(2008-10#1)(2008-4#1)
medium-sized and small##2##3##(1996-8#1)(2008-12#1)
medium-sized spiny neurons##2##3##(2013-8#2)
medium-sized##18##1##(1990-8#1)(1991-12#1)(1993-9#1)(1994-3#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#2)(2013-7#1)(2013-8#2)
medium-term##5##1##(1991-6#1)(2010-11#1)(2011-2#3)
mediumexchange##2##1##(2008-11#2)
mediums##8##1##(2008-10#5)(2008-3#1)(2008-5#2)
medius##2##1##(2009-3#1)(2013-1#1)
medline##2##1##(2007-8#1)(2009-6#1)
medoxomil##4##1##(2008-11#4)
medroxyprogesterone acetate (MPA)##6##3##(1993-1#2)(1993-8#1)(1994-9#2)(1995-4#1)
medroxyprogesterone acetate##12##2##(1993-1#4)(1993-2#1)(1993-8#1)(1994-9#2)(1995-4#1)(1997-7#1)(2008-10#1)(2011-2#1)
medroxyprogesterone##14##1##(1990-11#2)(1993-1#4)(1993-2#1)(1993-8#1)(1994-9#2)(1995-4#1)(1997-7#1)(2008-10#1)(2011-2#1)
medulla and##7##2##(1993-12#1)(1996-12#1)(1997-2#2)(2008-12#1)(2008-5#1)(2008-8#1)
medulla oblongata##5##2##(1990-12#1)(1997-2#1)(2008-6#2)(2011-2#1)
medulla##51##1##(1990-12#1)(1990-2#1)(1990-5#3)(1991-5#2)(1991-8#1)(1992-3#2)(1992-8#1)(1993-12#3)(1993-8#1)(1994-12#1)(1995-2#1)(1996-12#2)(1996-5#5)(1997-2#7)(1997-6#2)(2007-10#2)(2007-12#2)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2010-9#1)(2011-2#1)
medullar##2##1##(2009-3#1)(2009-5#1)
medullary cancer##2##2##(1994-12#1)(1996-11#1)
medullary cells##3##2##(1991-5#1)(1994-8#2)
medullary thyroid cancer##2##3##(1990-3#1)(2013-1#1)
medullary thyroid carcinoma##8##3##(1990-3#2)(1992-6#2)(2008-1#4)
medullary thyroid##12##2##(1990-3#3)(1992-6#3)(2008-1#4)(2008-7#1)(2013-1#1)
medullary type##2##2##(2008-8#2)
medullary##46##1##(1990-3#3)(1990-5#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-6#4)(1992-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-6#1)(1996-11#1)(1996-5#1)(1996-9#3)(2007-10#1)(2007-7#2)(2008-1#4)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#3)
medulloblastoma cell##2##2##(1991-6#2)
medulloblastoma in a##4##3##(1991-6#1)(2008-8#1)(2009-1#1)(2012-12#1)
medulloblastoma in the elderly##2##4##(2009-1#2)
medulloblastoma in the##4##3##(2008-7#1)(2009-1#3)
medulloblastoma in##10##2##(1991-6#1)(1997-3#1)(2008-7#2)(2008-8#1)(2009-1#4)(2012-12#1)
medulloblastoma##26##1##(1991-2#1)(1991-4#1)(1991-6#3)(1993-9#1)(1994-3#1)(1997-3#7)(2008-7#3)(2008-8#2)(2009-1#5)(2012-12#2)
medulloblastomas##10##1##(1991-2#5)(1991-4#3)(2008-7#1)(2009-1#1)
medulloepithelioma with divergent differentiation##2##4##(2012-12#2)
medusae f##4##2##(2008-10#4)
medusae##10##1##(2008-10#10)
meet a##3##2##(1991-1#1)(1995-12#1)(2009-11#1)
meet all##2##2##(2007-8#1)(2012-2#1)
meet and##4##2##(1991-6#1)(1994-2#1)(1995-3#1)(2010-6#1)
meet criteria for##2##3##(2011-2#1)(2012-12#1)
meet current##3##2##(1994-2#1)(2009-3#1)(2012-12#1)
meet or exceed##3##3##(1994-1#1)(1995-1#1)(2010-2#1)
meet our##2##2##(1997-7#1)(2008-3#1)
meet the challenges of##3##4##(1994-2#1)(2008-11#1)(2011-1#1)
meet the challenges##4##3##(1994-12#1)(1994-2#1)(2008-11#1)(2011-1#1)
meet the criteria for##3##4##(1995-5#1)(2008-3#1)(2012-1#1)
meet the criteria##4##3##(1995-5#1)(1997-2#1)(2008-3#1)(2012-1#1)
meet the demands##7##3##(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#2)
meet the health##2##3##(1993-6#1)(1996-3#1)
meet the information needs of##2##5##(1991-12#1)(1994-12#1)
meet the needs and##2##4##(2010-10#1)(2010-4#1)
meet the needs of both##2##5##(2008-6#1)(2010-7#1)
meet the needs of patients##3##5##(1992-2#1)(1996-12#1)(1996-2#1)
meet the needs of the##6##5##(1994-2#1)(1995-1#1)(1995-2#2)(1997-1#1)(2010-7#1)
meet the needs of##34##4##(1991-1#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#1)
meet the needs##36##3##(1991-1#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)
meet the requirement of##2##4##(2008-2#1)(2008-3#1)
meet the requirements of the##3##5##(1996-12#1)(2008-3#1)(2011-1#1)
meet the requirements of##6##4##(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
meet the requirements##7##3##(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#1)
meet the spiritual needs of##2##5##(2008-11#1)(2011-1#1)
meet the standards##3##3##(1991-8#1)(2008-9#1)(2011-2#1)
meet the##126##2##(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#2)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#3)(1997-1#3)(1997-2#3)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#8)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-12#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#3)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#7)
meet their##8##2##(1994-1#1)(1996-2#1)(1996-3#1)(2008-11#3)(2008-7#1)(2008-9#1)
meet these criteria##2##3##(1996-12#1)(2008-2#1)
meet these requirements##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
meet these##14##2##(1992-12#1)(1993-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
meet this challenge##2##3##(2007-4#1)(2008-8#1)
meet this##4##2##(1992-3#1)(1994-2#1)(2007-4#1)(2008-8#1)
meet with##2##2##(2008-11#1)(2010-8#1)
meet your##3##2##(1992-1#1)(1992-12#1)(1995-2#1)
meet##244##1##(1990-10#1)(1990-5#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#3)(1993-12#4)(1993-2#4)(1993-3#3)(1993-6#1)(1994-1#6)(1994-12#4)(1994-2#7)(1994-3#4)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#5)(1995-3#5)(1995-5#2)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#6)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#21)(2008-12#7)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#3)(2012-12#5)(2012-2#5)(2012-3#7)
meeting &quot##2##2##(2008-4#2)
meeting -##2##2##(2008-11#1)(2008-7#1)
meeting and##5##2##(1990-8#1)(2008-5#2)(2009-5#1)(2009-9#1)
meeting consisted of##2##3##(2008-5#1)(2008-7#1)
meeting convened##2##2##(2007-2#1)(2008-5#1)
meeting criteria##2##2##(2007-10#1)(2013-1#1)
meeting exercise recommendations##2##3##(2011-1#2)
meeting held##2##2##(1990-3#1)(2008-10#1)
meeting highlights##2##2##(2008-7#2)
meeting in##9##2##(1990-2#1)(2008-10#2)(2008-5#4)(2008-7#1)(2011-2#1)
meeting is##4##2##(2008-5#1)(2008-7#2)(2012-2#1)
meeting of the American Society##2##5##(1997-7#1)(2008-8#1)
meeting of the American##3##4##(1995-6#1)(1997-7#1)(2008-8#1)
meeting of the##12##3##(1995-6#1)(1997-7#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-5#1)(2011-2#2)
meeting of##17##2##(1992-3#1)(1992-5#1)(1995-6#1)(1996-3#1)(1997-7#1)(2006-10#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-4#1)(2009-5#1)(2011-2#2)
meeting on##5##2##(1992-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
meeting the challenge##4##3##(1993-3#1)(1997-2#1)(2010-11#1)(2012-12#1)
meeting the health needs of their##2##6##(1994-3#1)(1997-3#1)
meeting the inclusion##2##3##(2008-10#1)(2009-10#1)
meeting the need for##2##4##(1993-1#1)(2008-7#1)
meeting the needs of##4##4##(1995-1#1)(1995-3#1)(1997-1#1)(2008-11#1)
meeting the students' needs##2##4##(1995-1#1)(2008-12#1)
meeting the##30##2##(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
meeting their##2##2##(1994-1#1)(1994-2#1)
meeting these##3##2##(1994-2#1)(2008-7#1)(2012-12#1)
meeting was the##3##3##(2008-5#3)
meeting was to##3##3##(1994-9#1)(2008-5#2)
meeting was##17##2##(1994-9#1)(2008-10#1)(2008-5#12)(2008-7#1)(2008-8#1)(2010-5#1)
meeting with the##2##3##(1993-2#1)(2008-5#1)
meeting with##7##2##(1993-2#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-3#1)
meeting##261##1##(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#4)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#14)(2008-11#52)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#39)(2008-6#1)(2008-7#27)(2008-8#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-8#2)(2011-1#4)(2011-2#8)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#1)
meeting]##2##1##(1994-3#1)(2012-2#1)
meetings and##6##2##(1993-3#2)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
meetings held##3##2##(2008-7#1)(2008-9#1)(2012-12#1)
meetings in the##2##3##(1996-11#1)(2008-7#1)
meetings in##5##2##(1996-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
meetings of##2##2##(2007-2#1)(2008-8#1)
meetings to##2##2##(2012-12#1)(2013-1#1)
meetings with##2##2##(2009-6#1)(2013-1#1)
meetings##47##1##(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-1#1)(1994-2#3)(1995-6#1)(1996-11#2)(1996-3#1)(1997-1#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)
meets all##3##2##(2008-3#1)(2008-5#1)(2010-5#1)
meets its##2##2##(1991-5#1)(1994-9#1)
meets the needs of##2##4##(1994-3#1)(2008-10#1)
meets the needs##3##3##(1994-3#1)(2007-2#1)(2008-10#1)
meets the requirement of##2##4##(2008-3#1)(2013-1#1)
meets the requirements for##2##4##(2008-10#1)(2013-1#1)
meets the requirements##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
meets the##22##2##(1993-3#1)(1994-2#2)(1994-3#1)(1995-2#1)(1997-3#3)(2007-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
meets these requirements##2##3##(2008-2#1)(2008-3#1)
meets##47##1##(1991-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-3#4)(1997-5#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
mefenamic acid##5##2##(2008-10#1)(2012-2#4)
mefenamic##9##1##(2008-10#4)(2012-2#5)
mefenoxam insensitivity##2##2##(2008-10#2)
mefenoxam selection##2##2##(2008-10#2)
mefenoxam sensitivity##4##2##(2008-10#4)
mefenoxam##18##1##(2008-10#18)
mefloquine##7##1##(1993-8#2)(1996-3#1)(1996-8#1)(2011-2#3)
megabase##4##1##(1995-12#2)(2008-10#1)(2012-2#1)
megabases##2##1##(2008-1#1)(2008-10#1)
megacolon and##2##2##(1994-12#2)
megacolon associated with##2##3##(1994-12#2)
megacolon##6##1##(1993-6#1)(1994-12#4)(1996-3#1)
megacystis##2##1##(2008-10#1)(2008-7#1)
megahertz##6##1##(2007-12#2)(2008-2#3)(2008-3#1)
megakaryoblastic leukemia cell line##2##4##(1991-12#1)(2008-4#1)
megakaryoblastic leukemia##3##2##(1991-12#1)(2008-4#1)(2009-12#1)
megakaryoblastic##6##1##(1991-12#2)(2008-12#1)(2008-4#1)(2009-12#2)
megakaryocyte##4##1##(1991-12#1)(1995-11#2)(2008-7#1)
megakaryocytes##5##1##(1991-12#1)(1995-11#1)(2008-4#1)(2008-8#1)(2012-12#1)
megakaryocytic##5##1##(1991-12#3)(2008-4#1)(2008-8#1)
megakaryocytopoiesis##2##1##(1991-12#2)
megaloblastic anaemia##2##2##(2009-7#2)
megaloblastic##4##1##(1992-9#1)(2009-7#2)(2013-1#1)
megalocytiviruses##2##1##(2009-5#2)
megalourethra##5##1##(2008-10#5)
megasperma##3##1##(2008-10#3)
megaterium##6##1##(1994-9#1)(2008-10#2)(2011-1#3)
megaureter##2##1##(2008-10#2)
megaureters##4##1##(2008-10#4)
megavoltage##2##1##(1992-3#1)(2008-11#1)
megsin##6##1##(2008-7#6)
meibomiae##6##1##(2008-10#6)
meiofauna in##2##2##(2008-5#1)(2013-7#1)
meiofauna##6##1##(2008-5#3)(2013-7#3)
meiofaunal##2##1##(2013-7#2)
meioses##2##1##(2008-12#2)
meiosis and differentiation##2##3##(2009-10#1)(2012-2#1)
meiosis and the##2##3##(2011-1#1)(2012-2#1)
meiosis and##7##2##(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-2#3)
meiosis in##4##2##(2008-5#1)(2009-12#2)(2012-1#1)
meiosis is##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
meiosis occurs##2##2##(2008-9#2)
meiosis of##2##2##(2008-12#1)(2009-12#1)
meiosis stage##2##2##(2008-8#1)(2012-2#1)
meiosis##45##1##(1992-11#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-5#9)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#4)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#7)(2012-3#2)
meiosis-driven genome##2##2##(2008-7#2)
meiosis-specific RecA-like##2##2##(1995-6#1)(1995-8#1)
meiosis-specific lamin C2##2##3##(2011-2#2)
meiosis-specific proteins##2##2##(2008-7#1)(2012-3#1)
meiosis-specific recA-like genes##2##3##(1995-8#2)
meiosis-specific##9##1##(1995-6#2)(1995-8#3)(2008-7#1)(2011-2#2)(2012-3#1)
meiotic behavior##3##2##(2008-5#3)
meiotic cell##3##2##(2008-5#1)(2008-9#1)(2012-2#1)
meiotic division##2##2##(2008-7#1)(2013-1#1)
meiotic genes##6##2##(2008-7#5)(2008-9#1)
meiotic maturation and##4##3##(1994-8#1)(2012-3#1)(2013-1#2)
meiotic maturation in##3##3##(1992-11#2)(2013-1#1)
meiotic maturation##10##2##(1992-11#3)(1994-8#1)(2012-3#1)(2013-1#5)
meiotic mutants##6##2##(2008-5#2)(2008-9#4)
meiotic pentavalents##2##2##(2008-12#2)
meiotic prophase##7##2##(2007-12#2)(2008-11#1)(2008-5#1)(2011-2#3)
meiotic recombination##8##2##(1995-6#1)(1997-7#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-3#1)
meiotic silencing##2##2##(2012-3#2)
meiotic##82##1##(1992-11#3)(1994-8#2)(1995-6#1)(1997-7#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#13)(2008-7#16)(2008-8#2)(2008-9#10)(2009-10#1)(2010-3#1)(2011-2#5)(2012-2#1)(2012-3#5)(2013-1#6)
melamine based polymeric sequestering##2##4##(2008-10#2)
melamine##7##1##(1996-12#2)(2008-10#5)
melamine-treated##2##1##(1996-12#2)
melancholia and##3##2##(2008-12#3)
melancholia##9##1##(2008-12#4)(2008-6#2)(2010-6#3)
melancholic##2##1##(2008-11#1)(2010-7#1)
melanges a froid##2##3##(2008-5#2)
melanges a##3##2##(2008-5#3)
melanges##6##1##(2008-5#6)
melanin biosynthesis is##2##3##(2008-10#1)(2008-9#1)
melanin biosynthesis##4##2##(1994-12#1)(2008-10#2)(2008-9#1)
melanin content##5##2##(1991-5#1)(2008-5#2)(2013-1#2)
melanin pigment##3##2##(2008-1#1)(2010-6#2)
melanin pigmentation##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
melanin production##6##2##(1996-9#1)(2008-10#2)(2008-5#3)
melanin##39##1##(1991-5#2)(1994-12#1)(1996-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#13)(2008-8#1)(2008-9#2)(2010-6#2)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#3)
melanin-concentrating hormone in##2##3##(1993-5#2)
melanin-concentrating hormone##8##2##(1993-5#7)(2008-7#1)
melanization of the##2##3##(2008-10#2)
melanization of##3##2##(2008-10#3)
melanization##6##1##(2008-10#6)
melanized appressoria##4##2##(2008-10#4)
melanized##9##1##(2008-10#8)(2009-8#1)
melanocephalus##2##1##(2008-5#2)
melanocortin##4##1##(1993-5#2)(2008-4#1)(2008-9#1)
melanocortins##4##1##(1993-5#4)
melanocyte cultures##2##2##(2008-5#2)
melanocyte proliferation##2##2##(2008-5#1)(2008-9#1)
melanocyte##9##1##(1995-2#1)(2008-5#5)(2008-9#1)(2011-2#2)
melanocyte-stimulating hormone##3##2##(1993-5#2)(2008-6#1)
melanocytes and##6##2##(1994-12#1)(1996-9#1)(1997-7#1)(2008-5#2)(2008-8#1)
melanocytes in##2##2##(2008-5#2)
melanocytes into##2##2##(2008-5#1)(2009-3#1)
melanocytes is not##2##3##(2008-9#1)(2011-2#1)
melanocytes to##6##2##(1993-5#1)(2008-8#5)
melanocytes with##2##2##(1995-2#1)(2008-9#1)
melanocytes##45##1##(1993-5#3)(1994-12#3)(1995-2#6)(1996-9#1)(1997-7#1)(2008-10#1)(2008-5#14)(2008-8#8)(2008-9#2)(2009-3#1)(2010-6#2)(2011-2#2)(2013-1#1)
melanocytic nevi##4##2##(2011-2#2)(2012-3#2)
melanocytic##7##1##(2007-7#1)(2008-7#2)(2011-2#2)(2012-3#2)
melanocytoma##5##1##(2008-7#3)(2012-2#2)
melanogaster (hsp70-lacZ) Bg(9)##5##3##(2013-1#5)
melanogaster age at slow rates##2##5##(2008-8#2)
melanogaster and##12##2##(1991-5#2)(1993-2#1)(2008-10#2)(2008-7#2)(2012-2#2)(2012-3#3)
melanogaster is##2##2##(1994-9#1)(2009-5#1)
melanogaster protein##4##2##(1993-2#4)
melanogaster##109##1##(1990-12#2)(1991-12#2)(1991-5#2)(1991-6#1)(1993-12#2)(1993-2#14)(1993-6#3)(1993-9#1)(1994-12#3)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#3)(1996-2#3)(1996-5#1)(1997-6#2)(1997-7#6)(1997-8#4)(2007-12#6)(2008-10#3)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#6)(2008-9#9)(2009-5#2)(2009-7#2)(2010-1#1)(2010-9#1)(2012-2#2)(2012-3#6)(2013-1#5)
melanogenesis by##2##2##(2008-5#2)
melanogenesis in##2##2##(1991-5#1)(1993-5#1)
melanogenesis of##2##2##(1995-2#1)(2008-11#1)
melanogenesis##25##1##(1991-5#2)(1993-5#1)(1994-12#1)(1995-2#1)(1996-9#2)(2008-11#2)(2008-5#14)(2010-4#1)(2013-1#1)
melanogenic proteins##2##2##(1995-2#2)
melanogenic##9##1##(1995-2#5)(2008-11#1)(2008-5#3)
melanoma and##9##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#3)(2013-1#1)
melanoma are##2##2##(2010-9#1)(2011-2#1)
melanoma but##2##2##(1993-8#1)(2008-7#1)
melanoma by##3##2##(1991-6#1)(2008-7#1)(2010-6#1)
melanoma cell differentiation##2##3##(2008-11#2)
melanoma cell line##8##3##(1990-11#2)(1994-12#1)(1994-6#1)(1997-9#1)(2008-11#1)(2008-8#2)
melanoma cell lines and##2##4##(1992-3#1)(2008-7#1)
melanoma cell lines##7##3##(1992-2#1)(1992-3#2)(2008-10#1)(2008-7#3)
melanoma cell migration##2##3##(1990-5#2)
melanoma cell##25##2##(1990-11#2)(1990-5#2)(1992-2#2)(1992-3#2)(1992-9#1)(1994-12#1)(1994-6#1)(1997-9#1)(2008-10#1)(2008-11#3)(2008-7#3)(2008-8#4)(2009-10#2)
melanoma cell-line A2058##2##3##(1995-11#2)
melanoma cells and##4##3##(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
melanoma cells are##2##3##(1997-4#1)(2009-3#1)
melanoma cells by##2##3##(1990-5#1)(2008-10#1)
melanoma cells in##4##3##(1991-5#2)(2007-10#1)(2012-3#1)
melanoma cells to##5##3##(1990-5#1)(2009-3#1)(2009-4#2)(2012-3#1)
melanoma cells was##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
melanoma cells were##4##3##(1991-5#1)(1994-5#1)(2009-10#1)(2013-1#1)
melanoma cells with##2##3##(2008-11#1)(2013-1#1)
melanoma cells##62##2##(1990-5#5)(1991-5#3)(1992-3#3)(1992-9#1)(1993-5#3)(1994-5#1)(1996-9#1)(1997-4#3)(1997-7#3)(2007-10#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#5)(2009-10#2)(2009-3#7)(2009-4#2)(2011-2#2)(2012-12#5)(2012-3#3)(2013-1#6)
melanoma growth##2##2##(2013-1#2)
melanoma in a##2##3##(2011-2#1)(2013-8#1)
melanoma in##9##2##(1994-12#1)(1994-8#1)(2010-6#1)(2011-2#4)(2013-8#2)
melanoma is a rare##2##4##(2011-2#2)
melanoma is##9##2##(2008-9#1)(2009-3#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
melanoma metastasis##3##2##(2009-2#1)(2009-3#1)(2013-1#1)
melanoma of the head and neck##2##6##(2007-12#2)
melanoma of the##7##3##(1990-12#1)(2007-12#2)(2007-5#1)(2008-9#1)(2009-3#1)(2010-6#1)
melanoma of##9##2##(1990-12#1)(1990-2#1)(2007-12#2)(2007-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-6#1)
melanoma patients and##2##3##(2007-10#1)(2012-12#1)
melanoma patients in##2##3##(1994-5#1)(2011-2#1)
melanoma patients##6##2##(1993-5#1)(1994-5#1)(2007-10#2)(2011-2#1)(2012-12#1)
melanoma progression##3##2##(2008-7#1)(2009-4#1)(2013-1#1)
melanoma screening##2##2##(2013-1#2)
melanoma skin cancer cells##3##4##(2012-3#3)
melanoma skin cancer##4##3##(2012-3#4)
melanoma susceptibility##2##2##(1997-7#1)(2008-8#1)
melanoma tumor##3##2##(1994-5#1)(2012-12#1)(2012-3#1)
melanoma was##2##2##(2011-2#2)
melanoma##311##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#7)(1990-6#2)(1991-3#1)(1991-5#5)(1991-6#4)(1992-2#7)(1992-3#6)(1992-8#1)(1992-9#3)(1993-12#1)(1993-5#7)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#4)(1994-8#1)(1995-11#2)(1996-6#3)(1996-9#1)(1997-4#3)(1997-7#11)(1997-9#1)(2007-10#8)(2007-11#1)(2007-12#2)(2007-5#5)(2007-8#1)(2008-10#4)(2008-11#9)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#11)(2008-9#11)(2009-10#5)(2009-2#1)(2009-3#14)(2009-4#8)(2010-6#14)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#49)(2012-1#1)(2012-12#8)(2012-2#1)(2012-3#18)(2013-1#17)(2013-8#6)
melanoma)##2##1##(2007-5#1)(2008-11#1)
melanoma]##3##1##(1992-11#1)(1992-6#1)(2013-8#1)
melanomas and##2##2##(1992-8#1)(2009-4#1)
melanomas are##2##2##(2012-3#1)(2013-8#1)
melanomas from##2##2##(2008-9#1)(2009-4#1)
melanomas in##2##2##(1993-8#1)(2011-2#1)
melanomas were##2##2##(2009-4#1)(2011-2#1)
melanomas##29##1##(1992-8#1)(1993-8#2)(1994-6#1)(1996-6#1)(2008-7#1)(2008-9#3)(2009-4#7)(2011-2#8)(2012-12#2)(2012-3#2)(2013-8#1)
melanophore##5##1##(1995-3#3)(2008-5#2)
melanophores##9##1##(1992-3#3)(2008-5#5)(2008-6#1)
melanopterus at Palmyra##2##3##(2010-8#2)
melanopterus##4##1##(2010-8#4)
melanosome transfer efficacy from melanocytes to keratinocytes in vitro##2##9##(2008-8#2)
melanosome transfer efficacy from melanocytes to keratinocytes##3##7##(2008-8#3)
melanosome transfer##8##2##(2008-8#8)
melanosome##9##1##(2008-1#1)(2008-8#8)
melanosomes##11##1##(1996-9#1)(2008-1#3)(2008-5#1)(2008-8#5)(2009-4#1)
melanotic##3##1##(1991-5#1)(2007-12#1)(2012-2#1)
melanotrope cells of Xenopus laevis##4##5##(1993-5#4)
melanotrope cells##10##2##(1993-5#10)
melanotrope##12##1##(1993-5#12)
melanotropes##3##1##(1993-5#3)
melanotrophs##5##1##(1993-5#5)
melanotropic peptides in##2##3##(1993-5#2)
melanotropic peptides##5##2##(1993-5#4)(1995-2#1)
melanotropic##7##1##(1993-5#5)(1995-2#2)
melanotropin##2##1##(1993-5#1)(1995-2#1)
melanotropins##8##1##(1993-5#6)(1995-2#2)
melasma##4##1##(2007-7#3)(2008-5#1)
melatonin (MT)##3##2##(1996-7#1)(2008-11#2)
melatonin administration##2##2##(2008-12#2)
melatonin and its derivatives##3##4##(2008-10#3)
melatonin and its##4##3##(2008-10#4)
melatonin and##11##2##(1991-12#1)(1993-6#1)(1994-5#3)(1996-7#1)(2008-10#4)(2011-2#1)
melatonin as a##3##3##(1990-2#1)(1992-12#1)(1994-5#1)
melatonin binding##2##2##(1993-6#1)(1995-12#1)
melatonin biosynthesis##5##2##(1994-5#5)
melatonin concentrations##2##2##(2008-3#2)
melatonin in the##5##3##(1991-12#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)
melatonin in##12##2##(1991-12#1)(1993-12#1)(1995-11#2)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#3)(2009-12#1)
melatonin levels in##2##3##(1994-6#1)(1995-3#1)
melatonin levels were measured##2##4##(2008-3#2)
melatonin levels were##3##3##(1995-12#1)(2008-3#2)
melatonin levels##11##2##(1991-6#1)(1994-6#1)(1995-12#1)(1995-3#2)(2008-3#6)
melatonin may##2##2##(1990-5#1)(1994-5#1)
melatonin on##6##2##(1990-5#1)(1991-12#1)(1996-2#1)(2008-12#1)(2008-3#1)(2010-12#1)
melatonin production##3##2##(1994-5#2)(2008-5#1)
melatonin receptor in##2##3##(1990-7#1)(1995-3#1)
melatonin receptor##7##2##(1990-7#1)(1992-3#2)(1995-3#2)(1996-2#1)(2009-12#1)
melatonin receptors##4##2##(1995-12#1)(1996-2#2)(2013-7#1)
melatonin rhythms##2##2##(1995-12#2)
melatonin synthesis##2##2##(2008-5#2)
melatonin tablets##2##2##(2008-10#2)
melatonin to##3##2##(1990-5#1)(1994-5#1)(1995-12#1)
melatonin were##3##2##(1991-6#1)(1994-5#1)(2008-10#1)
melatonin##133##1##(1990-2#4)(1990-5#5)(1990-7#1)(1991-12#4)(1991-6#2)(1992-12#2)(1992-3#4)(1993-12#1)(1993-6#4)(1994-12#1)(1994-5#23)(1994-6#1)(1995-11#2)(1995-12#8)(1995-3#8)(1995-9#1)(1996-2#6)(1996-7#2)(2008-10#11)(2008-11#5)(2008-12#4)(2008-3#11)(2008-5#6)(2009-12#3)(2010-12#1)(2010-8#1)(2011-2#7)(2013-7#5)
melatonin-induced pigment##2##2##(1992-3#2)
melatonin-induced##4##1##(1992-3#3)(2011-2#1)
melatonin-loaded sugar spheres containing 10%##2##5##(2008-11#2)
melatonin-loaded sugar spheres##3##3##(2008-11#3)
meleagridis and M##3##3##(2008-5#3)
meleagridis##4##1##(2008-5#4)
melena##5##1##(1992-6#1)(2008-12#1)(2008-7#1)(2013-8#2)
melibiose##2##1##(1993-11#1)(1995-11#1)
meliloti##7##1##(1994-8#2)(2008-11#1)(2008-8#2)(2008-9#2)
melitensis##7##1##(1995-3#2)(1996-8#1)(1997-7#1)(2008-10#1)(2009-3#1)(2012-2#1)
melittin and mastoparan##3##3##(1994-11#3)
melittin on##3##2##(2008-10#3)
melittin or##2##2##(1994-5#1)(2009-12#1)
melittin##19##1##(1992-6#6)(1993-11#1)(1994-11#4)(1994-5#2)(2008-10#5)(2009-12#1)
melittin-DPPC##2##1##(2008-10#2)
melittin-induced arachidonic acid release##2##4##(2009-12#1)(2011-2#1)
mellifera L##4##2##(2008-6#3)(2011-2#1)
mellifera##8##1##(2008-6#3)(2008-7#2)(2008-8#1)(2011-2#2)
mellitin##2##1##(1996-5#2)
mellitus (DM) was##2##3##(2007-7#1)(2011-3#1)
mellitus (DM)##20##2##(2007-7#2)(2008-1#1)(2008-3#4)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
mellitus and hypertension##2##3##(1991-5#1)(2013-1#1)
mellitus and other##2##3##(2008-3#1)(2011-2#1)
mellitus and##39##2##(1990-11#1)(1991-5#1)(1992-12#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)
mellitus in children##2##3##(1994-6#1)(2013-1#1)
mellitus in##22##2##(1994-6#2)(1996-11#2)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-1#2)(2013-8#1)
mellitus is a##4##3##(2006-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
mellitus is##18##2##(1992-5#1)(1992-8#1)(1996-11#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-3#4)(2008-7#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
mellitus type 1 and##2##4##(2008-1#1)(2011-2#1)
mellitus type##6##2##(1993-11#1)(1993-2#1)(2008-1#1)(2011-2#2)(2012-2#1)
mellitus was##7##2##(1992-12#1)(1992-5#1)(1994-6#1)(2007-7#1)(2008-1#2)(2008-10#1)
mellitus##367##1##(1990-11#1)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#5)(1992-5#4)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#4)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-6#4)(1994-8#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#5)(1996-12#1)(1996-2#5)(1996-3#1)(1996-8#1)(1997-3#2)(1997-5#2)(1997-8#4)(2006-10#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#8)(2007-8#2)(2008-1#40)(2008-10#9)(2008-11#14)(2008-12#2)(2008-3#30)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#4)(2009-11#8)(2009-3#4)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#10)(2010-12#3)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#13)(2011-2#21)(2011-3#4)(2012-1#3)(2012-12#5)(2012-2#11)(2012-3#7)(2012-5#2)(2013-1#27)(2013-7#2)(2013-8#8)
melo##4##1##(2008-10#3)(2011-2#1)
melody recognition and##2##3##(2008-9#2)
melody recognition##6##2##(2008-9#6)
melon (Cucumis melo)##2##3##(2008-10#2)
melon (Cucumis##3##2##(2008-10#2)(2011-2#1)
melon and##2##2##(2008-10#2)
melon crops##2##2##(2008-10#2)
melon plants##3##2##(2008-10#3)
melon was##2##2##(2008-10#2)
melon##33##1##(2008-10#32)(2011-2#1)
melonis and F##2##3##(2008-10#2)
melonis race 1##3##3##(2008-10#3)
melonis##19##1##(2008-10#19)
meloxicam##10##1##(2008-11#8)(2011-2#2)
melphalan and##2##2##(1991-5#1)(2012-12#1)
melphalan##9##1##(1991-5#2)(1992-2#1)(1993-5#2)(2011-3#3)(2012-12#1)
melt inclusions in##3##3##(2008-10#3)
melt samples##2##2##(2008-10#2)
melt##25##1##(1996-2#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-3#3)(2010-5#3)
melted##3##1##(1995-6#1)(2007-12#1)(2012-3#1)
melting curves##2##2##(1994-8#1)(2008-10#1)
melting of the##3##3##(1992-1#1)(1994-11#1)(2007-11#1)
melting of##4##2##(1992-1#1)(1994-11#1)(2007-11#1)(2013-8#1)
melting or##2##2##(1991-2#1)(2010-9#1)
melting point##13##2##(1990-9#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-5#2)(2009-11#1)(2010-2#1)(2010-4#1)(2010-5#1)
melting temperature of##3##3##(2009-3#1)(2013-1#2)
melting temperature##6##2##(2007-11#1)(2008-11#1)(2009-3#1)(2011-1#1)(2013-1#2)
melting temperatures##2##2##(1992-3#1)(2008-4#1)
melting##50##1##(1990-4#1)(1990-9#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
melts after dissolution of the sample in dilute nitric acid##2##10##(2008-10#2)
melts by flame atomic absorption spectrometry##2##6##(2008-10#2)
melts by##3##2##(2008-10#3)
melts##7##1##(2008-10#7)
membenolytic activity##2##2##(1991-9#2)
member and##2##2##(1993-12#1)(1996-1#1)
member from##2##2##(1995-3#1)(2011-2#1)
member in##2##2##(2008-10#1)(2008-9#1)
member is##3##2##(1994-5#1)(2008-3#1)(2010-4#1)
member libraries##2##2##(1995-2#1)(1996-1#1)
member of a large family of##2##6##(1994-2#1)(2011-2#1)
member of a large##3##4##(1994-2#1)(2008-11#1)(2011-2#1)
member of a##16##3##(1991-2#1)(1992-3#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1995-8#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-2#1)
member of an##2##3##(1990-5#1)(2011-2#1)
member of the family Potyviridae##4##5##(2008-10#4)
member of the family##28##4##(1990-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#9)(2008-5#1)(2011-2#14)
member of the genus Begomovirus##2##5##(2008-10#2)
member of the genus Potyvirus##5##5##(2008-10#5)
member of the genus Tobamovirus##2##5##(2008-10#2)
member of the genus##35##4##(1997-4#1)(2008-10#22)(2011-2#12)
member of the growing##2##4##(1993-3#1)(2008-10#1)
member of the heat shock##2##5##(1992-12#1)(1995-11#1)
member of the nuclear hormone receptor superfamily##2##7##(1993-6#1)(1995-2#1)
member of the nuclear receptor##2##5##(1994-12#1)(2008-1#1)
member of the nuclear##4##4##(1993-6#1)(1994-12#1)(1995-2#1)(2008-1#1)
member of the superfamily of##2##5##(1995-12#1)(2008-11#1)
member of the##186##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1994-11#2)(1994-12#8)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#5)(1995-8#5)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#6)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#41)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-3#1)(2011-2#34)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
member of this family##4##4##(1990-12#1)(1991-2#1)(1996-2#1)(2010-10#1)
member of this##5##3##(1990-12#1)(1991-2#1)(1993-2#1)(1996-2#1)(2010-10#1)
member of##231##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#4)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#9)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#5)(1995-8#7)(1996-12#4)(1996-2#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#6)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#44)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#4)(2010-3#2)(2011-1#1)(2011-2#36)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
member organizations##2##2##(1993-11#1)(2008-5#1)
member satisfaction##5##2##(1996-3#4)(1997-3#1)
member states##2##2##(2008-10#1)(2010-4#1)
member that##2##2##(1996-2#1)(2012-12#1)
member who is##2##3##(1992-3#1)(1993-2#1)
member with##3##2##(1992-3#1)(2010-4#1)(2012-1#1)
member##297##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#9)(1993-3#4)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#10)(1994-2#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#4)(1995-6#5)(1995-8#8)(1996-1#2)(1996-12#5)(1996-2#4)(1996-3#7)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#46)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#10)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#5)(2010-3#2)(2010-4#3)(2011-1#1)(2011-2#38)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
membered rings##3##2##(1994-3#1)(2008-10#2)
membered##4##1##(1994-3#1)(2007-11#1)(2008-10#2)
members about their##3##3##(1994-1#1)(1995-1#1)(1995-2#1)
members and chairs##5##3##(2009-4#5)
members and the##4##3##(1993-12#1)(1996-3#2)(2012-1#1)
members and##24##2##(1993-12#1)(1995-6#1)(1996-2#1)(1996-3#5)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#6)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
members are##13##2##(1992-12#1)(1993-1#1)(1996-9#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
members as##2##2##(1995-3#1)(1996-3#1)
members belonging to##2##3##(1997-9#1)(2008-9#1)
members can be##2##3##(2007-5#1)(2008-9#1)
members can##7##2##(1992-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-5#1)(2008-9#1)
members expressed##2##2##(1993-12#1)(2009-12#1)
members for##2##2##(1993-1#2)
members from##2##2##(2008-10#1)(2011-2#1)
members have##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
members in a##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
members in an##2##3##(2008-4#1)(2012-12#1)
members in the##5##3##(1991-2#1)(1996-1#1)(2008-10#1)(2011-2#2)
members in##27##2##(1990-5#1)(1991-2#2)(1992-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
members may##3##2##(2007-4#1)(2008-11#1)(2009-4#1)
members of Jehovah's##2##3##(1996-9#1)(2008-11#1)
members of a family##3##4##(1995-8#1)(1997-6#1)(1997-8#1)
members of a large##2##4##(1991-7#1)(1993-6#1)
members of a tRNA(Gly)1 multigene family##2##6##(1997-7#2)
members of a##21##3##(1991-7#1)(1993-6#1)(1995-8#1)(1996-12#2)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
members of an##2##3##(2008-10#1)(2010-2#1)
members of both##3##3##(1995-3#1)(2008-8#1)(2012-12#1)
members of each##2##3##(2008-5#1)(2008-8#1)
members of herding##2##3##(2009-8#2)
members of hereditary melanoma##2##4##(1997-7#2)
members of the Association##4##4##(1994-3#2)(2007-12#1)(2008-10#1)
members of the B##2##4##(2008-10#1)(2011-2#1)
members of the Bcl-2 family##4##5##(2008-11#2)(2011-2#2)
members of the Brn-3 subfamily of POU transcription factors##2##9##(1996-12#2)
members of the E2F##2##4##(1995-2#2)
members of the Elip family are##2##6##(2008-7#2)
members of the IL-6 subfamily##2##5##(1996-2#2)
members of the Norwegian##2##4##(1996-9#1)(1997-6#1)
members of the Xanthomonas avr/pth gene family##2##7##(2008-10#2)
members of the Xanthomonas##3##4##(2008-10#3)
members of the class##3##4##(1991-2#1)(2008-10#2)
members of the family Bunyaviridae##2##5##(2008-10#2)
members of the family Enterobacteriaceae##2##5##(2008-10#2)
members of the family Potyviridae##3##5##(2008-10#3)
members of the family##20##4##(1991-12#1)(1995-3#1)(1997-8#2)(2008-10#9)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
members of the gene family##2##5##(2008-10#2)
members of the genera##2##4##(2008-10#1)(2013-8#1)
members of the genus Trichovirus##2##5##(2008-10#2)
members of the genus##14##4##(2008-10#9)(2008-5#1)(2008-9#1)(2011-2#3)
members of the group##2##4##(2008-10#1)(2008-11#1)
members of the health care team##2##6##(1995-3#1)(2008-11#1)
members of the heat shock protein family##2##7##(1994-11#1)(2008-7#1)
members of the hsp70 family##2##5##(1995-6#2)
members of the integrin family##2##5##(1994-9#1)(2008-1#1)
members of the nuclear receptor##3##5##(2008-3#1)(2008-4#1)(2008-7#1)
members of the public##2##4##(1997-8#1)(2011-2#1)
members of the rbcS gene family##2##6##(1993-12#1)(1994-8#1)
members of the same family##4##5##(1997-4#1)(2008-10#1)(2008-5#1)(2010-3#1)
members of the same species##2##5##(1995-2#1)(2012-2#1)
members of the same##7##4##(1995-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2010-3#1)(2012-2#1)
members of the team##2##4##(1996-1#1)(2007-5#1)
members of the yeast HSP70 multigene family##2##7##(1993-9#2)
members of the##214##3##(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-2#5)(1995-3#2)(1995-6#4)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#48)(2008-11#8)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#5)
members of their##5##3##(1991-1#1)(1995-1#1)(2008-7#1)(2010-10#1)(2011-2#1)
members of these families##2##4##(1997-9#1)(2006-6#1)
members of these##3##3##(1995-3#1)(1997-9#1)(2006-6#1)
members of this family##7##4##(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-11#1)(2010-3#1)
members of this##17##3##(1990-7#1)(1992-6#1)(1993-6#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-4#2)(2009-5#1)(2010-11#1)(2010-3#2)
members of two##4##3##(1994-8#1)(1995-3#1)(1997-7#1)(2006-6#1)
members of##324##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#3)(1992-6#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-2#5)(1995-3#5)(1995-6#7)(1995-8#2)(1996-1#2)(1996-12#8)(1996-2#6)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#6)(1997-9#1)(2006-6#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#61)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#4)(2009-6#2)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#17)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#5)
members on##3##2##(1995-3#2)(2010-1#1)
members or##3##2##(1996-12#1)(2009-6#1)(2011-1#1)
members share relatively low degrees of 16S rRNA gene sequence similarity##2##11##(2011-2#2)
members share##3##2##(1992-7#1)(2011-2#2)
members that##5##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
members through a##2##3##(1990-12#1)(2008-7#1)
members to contribute##2##3##(2008-10#1)(2012-1#1)
members to##12##2##(1996-2#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
members was##2##2##(2008-7#1)(2012-2#1)
members were##13##2##(1991-5#1)(1992-2#1)(1997-9#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
members while##2##2##(2008-4#1)(2010-8#1)
members who were##2##3##(1990-10#1)(1995-2#1)
members who##12##2##(1990-10#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-5#1)(2007-11#1)(2008-12#2)(2008-8#1)(2010-11#1)(2011-1#1)
members will##2##2##(1995-6#1)(1997-5#1)
members with##5##2##(1994-12#1)(1997-2#1)(1997-3#2)(2009-5#1)
members##665##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#4)(1992-6#3)(1992-7#1)(1993-1#11)(1993-11#1)(1993-12#11)(1993-3#2)(1993-6#5)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#10)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#5)(1995-12#3)(1995-2#10)(1995-3#12)(1995-6#15)(1995-8#2)(1996-1#4)(1996-12#11)(1996-2#16)(1996-3#18)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#7)(1997-8#6)(1997-9#3)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#73)(2008-11#30)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#18)(2008-5#7)(2008-6#8)(2008-7#18)(2008-8#9)(2008-9#28)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#1)(2009-4#9)(2009-5#12)(2009-6#5)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#10)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#10)(2011-2#35)(2012-1#3)(2012-12#12)(2012-2#13)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#9)
members' experiences of##2##3##(2010-10#1)(2011-1#1)
members'##18##1##(1990-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-8#1)(1997-3#2)(2008-11#1)(2008-6#1)(2009-5#1)(2009-9#1)(2010-10#5)(2011-1#1)(2011-2#1)
membership and##7##2##(1993-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2009-7#1)(2012-1#1)(2013-1#1)
membership criteria##2##2##(1991-1#1)(1992-2#1)
membership for##3##2##(2008-9#2)(2010-4#1)
membership grade of##2##3##(2008-10#2)
membership in the##2##3##(1993-1#1)(2008-4#1)
membership in##3##2##(1993-1#1)(2008-1#1)(2008-4#1)
membership is##2##2##(1995-2#1)(2008-1#1)
membership to##2##2##(1996-1#1)(2008-4#1)
membership was##2##2##(2008-10#1)(2010-8#1)
membership##53##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-12#3)(1994-1#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#4)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-4#2)(2008-9#2)(2009-5#1)(2009-7#3)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#4)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
memberships##6##1##(1997-1#1)(1997-3#1)(2008-6#1)(2010-8#1)(2012-2#2)
membranal PTKs##2##2##(1995-11#2)
membranal##3##1##(1994-6#1)(1995-11#2)
membrane (BBM)##2##2##(1991-9#1)(1992-6#1)
membrane (PM)##2##2##(2008-7#1)(2009-10#1)
membrane (or##2##2##(2009-7#2)
membrane H+##2##2##(1995-6#2)
membrane NTPDases##3##2##(2008-4#3)
membrane PKC##3##2##(1993-9#1)(1994-11#2)
membrane adhesion##2##2##(2009-6#1)(2012-2#1)
membrane adsorption##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
membrane anchor of##3##3##(1997-7#3)
membrane anchor##6##2##(1994-8#3)(1997-7#3)
membrane and cytoplasm##2##3##(2008-10#1)(2008-7#1)
membrane and cytoplasmic##2##3##(1991-5#1)(2008-8#1)
membrane and increase##2##3##(1992-9#1)(2008-10#1)
membrane and its##2##3##(1994-11#1)(1994-2#1)
membrane and the nucleus##2##4##(2008-11#2)
membrane and the underlying##2##4##(2009-10#1)(2009-5#1)
membrane and the##26##3##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
membrane and then##2##3##(2008-1#1)(2008-10#1)
membrane and to##2##3##(1994-11#1)(2008-10#1)
membrane and water solution##2##4##(2008-10#2)
membrane and##117##2##(1990-11#3)(1990-12#1)(1990-7#1)(1991-10#2)(1991-5#2)(1991-9#2)(1992-12#2)(1992-3#2)(1992-9#3)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#30)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-2#2)(2011-3#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
membrane and/or##2##2##(1994-12#1)(2008-7#1)
membrane anion and cation-selective electrodes##2##5##(2008-10#2)
membrane antigen##13##2##(1991-12#1)(1992-2#1)(1994-8#3)(1995-11#1)(1997-5#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
membrane antigens##2##2##(2007-7#1)(2008-4#1)
membrane are##6##2##(1990-5#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
membrane area##2##2##(2008-6#1)(2008-7#1)
membrane as an##2##3##(1994-8#1)(2008-1#1)
membrane as##6##2##(1991-5#1)(1994-8#1)(1997-4#1)(2007-7#1)(2008-1#2)
membrane assembly of##2##3##(1991-10#1)(1995-6#1)
membrane assembly##5##2##(1991-10#1)(1995-6#2)(1997-4#1)(2008-7#1)
membrane associated##5##2##(1991-2#1)(1992-9#1)(1993-8#1)(1995-12#1)(2012-12#1)
membrane association##2##2##(1991-10#1)(1992-6#1)
membrane at##5##2##(2008-10#2)(2008-8#1)(2009-10#2)
membrane based on the##2##4##(2008-10#2)
membrane based on##8##3##(2008-10#8)
membrane based##11##2##(2008-10#11)
membrane bilayer##2##2##(1991-9#2)
membrane binding domain##3##3##(1995-6#3)
membrane binding##6##2##(1995-12#1)(1995-6#4)(2008-11#1)
membrane bioreactor (MBR)##2##3##(2013-1#2)
membrane bioreactor##4##2##(2008-6#1)(2013-1#3)
membrane blebbing and##2##3##(2008-10#1)(2008-8#1)
membrane blebbing##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
membrane blebs##2##2##(1990-7#1)(1995-12#1)
membrane bound##10##2##(1990-11#1)(1990-5#1)(1992-12#1)(1993-11#1)(1994-6#2)(1994-8#1)(2007-12#1)(2009-4#1)(2009-8#1)
membrane but##2##2##(1994-11#1)(2009-10#1)
membrane by a##2##3##(1992-3#1)(2008-4#1)
membrane by the##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2011-2#1)
membrane by##20##2##(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-4#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-2#1)
membrane can be##6##3##(2008-1#1)(2008-10#4)(2008-2#1)
membrane can##9##2##(1995-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)
membrane carrier##5##2##(1992-3#1)(2008-10#4)
membrane causes##2##2##(2008-10#1)(2012-12#1)
membrane cell and##4##3##(2008-10#4)
membrane cell##7##2##(1994-2#1)(2008-10#6)
membrane changes##3##2##(1992-8#1)(2008-7#1)(2008-9#1)
membrane cholesterol efflux##2##3##(2011-1#2)
membrane cholesterol##6##2##(1991-5#1)(2008-8#3)(2011-1#2)
membrane chromatography##3##2##(1991-5#1)(1994-5#1)(2008-10#1)
membrane coated##2##2##(1995-2#1)(2008-10#1)
membrane complex##2##2##(1991-2#1)(2006-6#1)
membrane components in##2##3##(1992-11#2)
membrane components of##2##3##(2008-11#1)(2011-1#1)
membrane components##14##2##(1990-12#1)(1992-11#2)(1993-2#1)(1994-12#1)(1995-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#1)
membrane composition and##4##3##(1990-7#1)(1991-5#1)(2008-10#2)
membrane composition compared to##2##4##(2009-5#2)
membrane composition##20##2##(1990-7#1)(1991-5#1)(2008-10#12)(2008-4#1)(2009-5#4)(2010-5#1)
membrane compositions##2##2##(1996-7#1)(2008-10#1)
membrane conductance##2##2##(1991-5#1)(2011-2#1)
membrane containing##13##2##(2008-10#11)(2008-3#1)(2008-9#1)
membrane current##3##2##(1993-12#2)(2008-11#1)
membrane curvature##3##2##(1990-12#1)(2007-12#1)(2009-9#1)
membrane damage##6##2##(1994-5#1)(1995-8#2)(2009-6#3)
membrane defects##2##2##(1994-12#2)
membrane depolarization and##2##3##(2008-8#1)(2009-2#1)
membrane depolarization##5##2##(1992-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-11#1)
membrane desolvator##3##2##(2008-10#3)
membrane dialysis##2##2##(1994-5#1)(2008-10#1)
membrane disk modified by a recently synthesized##2##7##(2008-10#2)
membrane disks modified by##9##4##(2008-10#9)
membrane disks modified with##6##4##(2008-10#6)
membrane disks modified##15##3##(2008-10#15)
membrane disks##17##2##(1994-11#1)(2008-10#16)
membrane domain##4##2##(1993-6#2)(1997-2#1)(2008-8#1)
membrane domains##5##2##(1990-12#1)(1993-11#1)(1993-6#1)(2008-11#1)(2009-7#1)
membrane due to##2##3##(2008-10#2)
membrane dynamics##5##2##(1990-12#1)(2007-12#1)(2008-11#1)(2011-2#2)
membrane electrode and##2##3##(2008-10#2)
membrane electrode based on a##2##5##(2008-10#2)
membrane electrode based on##15##4##(2008-10#15)
membrane electrode for##6##3##(2008-10#6)
membrane electrode sensitive to##2##4##(2008-10#2)
membrane electrode was##2##3##(2008-10#2)
membrane electrode##52##2##(2008-10#51)(2010-12#1)
membrane electrodes based on some recently synthesized##2##7##(2008-10#2)
membrane electrodes based on##17##4##(2008-10#17)
membrane electrodes for the##3##4##(2008-10#3)
membrane electrodes for##4##3##(2008-10#4)
membrane electrodes were##4##3##(2008-10#4)
membrane electrodes##52##2##(2008-10#52)
membrane electron transport##6##3##(1992-11#1)(2009-9#5)
membrane electron##8##2##(1992-11#1)(2009-9#7)
membrane enzyme##3##2##(1990-12#1)(1991-12#1)(1995-3#1)
membrane enzymes##2##2##(2007-7#1)(2009-9#1)
membrane excitability##4##2##(1997-6#1)(2008-2#1)(2008-8#2)
membrane fatty acid composition##3##4##(2009-5#1)(2011-1#2)
membrane fatty acids##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
membrane fatty##6##2##(2008-9#1)(2009-5#1)(2011-1#3)(2011-2#1)
membrane filter##7##2##(2007-5#1)(2008-10#6)
membrane filters##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
membrane filtration##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
membrane fluidity and##4##3##(1990-12#1)(1995-11#2)(2008-9#1)
membrane fluidity##13##2##(1990-11#1)(1990-12#2)(1990-7#2)(1991-5#1)(1994-2#1)(1995-11#2)(1996-12#1)(1997-1#1)(2008-9#2)
membrane folding##2##2##(2008-7#1)(2009-5#1)
membrane for the##2##3##(2008-5#1)(2011-1#1)
membrane for##12##2##(2008-10#8)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
membrane forms##2##2##(1995-5#1)(2007-12#1)
membrane fouling##2##2##(2008-6#1)(2008-7#1)
membrane fraction of##2##3##(1992-9#1)(1994-12#1)
membrane fraction##20##2##(1990-11#1)(1990-2#2)(1991-12#1)(1991-5#2)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#1)(1995-11#2)(2008-11#2)
membrane fractionation using##2##3##(2008-8#2)
membrane fractions in##2##3##(1996-2#1)(1996-5#1)
membrane fractions of the##3##4##(1992-3#1)(1995-12#1)(2008-11#1)
membrane fractions of##5##3##(1990-2#1)(1992-3#1)(1995-11#1)(1995-12#1)(2008-11#1)
membrane fractions were prepared##2##4##(1995-8#1)(1997-6#1)
membrane fractions##27##2##(1990-2#1)(1990-5#2)(1991-11#1)(1991-2#2)(1992-3#3)(1992-6#1)(1993-6#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-8#2)(2009-10#1)
membrane from the##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
membrane from##6##2##(1991-5#1)(2008-10#3)(2008-11#1)(2008-5#1)
membrane functions##6##2##(1994-12#4)(1995-12#1)(2012-1#1)
membrane fusion##17##2##(1992-3#2)(1994-12#2)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-7#1)(2011-3#1)(2012-2#4)
membrane glycoprotein##5##2##(1990-11#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-4#1)
membrane glycoproteins##2##2##(2008-10#1)(2008-11#1)
membrane had##3##2##(1991-5#1)(1995-5#1)(2007-7#1)
membrane has been studied##3##4##(2008-10#3)
membrane has been##10##3##(1990-12#1)(2007-7#1)(2008-10#7)(2008-11#1)
membrane has##12##2##(1990-12#1)(2007-7#1)(2008-10#9)(2008-11#1)
membrane having##5##2##(2008-10#5)
membrane hyperpolarization and relaxation##2##4##(1997-4#2)
membrane hyperpolarization##6##2##(1994-11#1)(1997-4#2)(2008-2#1)(2008-4#2)
membrane impermeable##2##2##(1992-8#1)(2011-1#1)
membrane in a##9##3##(1992-12#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-4#3)(2010-10#1)(2012-2#1)
membrane in an##2##3##(1993-12#1)(2011-1#1)
membrane in the presence of##2##5##(1990-2#1)(1992-12#1)
membrane in the presence##3##4##(1990-2#1)(1992-12#1)(2008-8#1)
membrane in the##11##3##(1990-11#1)(1990-2#1)(1992-12#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
membrane in##39##2##(1990-11#3)(1990-2#1)(1992-12#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
membrane including##2##2##(2008-10#1)(2008-5#1)
membrane incorporated##2##2##(1994-3#1)(2008-10#1)
membrane incorporating##2##2##(2008-10#2)
membrane inlet mass spectrometric (MIMS)##2##5##(2008-10#2)
membrane inlet mass spectrometric##3##4##(2008-10#3)
membrane inlet mass##4##3##(2008-10#4)
membrane insertion##7##2##(1992-8#1)(1993-11#1)(1996-3#2)(2008-11#1)(2011-2#1)(2012-12#1)
membrane integrity of spermatozoa##2##4##(2012-3#1)(2013-1#1)
membrane integrity##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
membrane interface##3##2##(2008-10#2)(2012-2#1)
membrane into an acceptor stream containing##2##6##(2008-10#2)
membrane into an acceptor stream##3##5##(2008-10#3)
membrane into##7##2##(2008-10#4)(2008-7#3)
membrane ion selective electrode##3##4##(2008-10#3)
membrane ion##5##2##(1994-5#2)(2008-10#3)
membrane ion-selective electrodes##3##3##(2008-10#3)
membrane ion-selective##5##2##(2008-10#5)
membrane is a##2##3##(2008-10#1)(2010-4#1)
membrane is described##4##3##(1990-11#1)(2008-10#3)
membrane is enhanced##2##3##(2008-10#1)(2008-11#1)
membrane is formed##2##3##(1994-6#1)(2008-10#1)
membrane is not##2##3##(1990-8#1)(2008-10#1)
membrane is used##2##3##(2008-10#2)
membrane is##31##2##(1990-11#2)(1990-8#1)(1992-12#1)(1993-6#1)(1994-6#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-4#2)(2009-10#1)(2009-11#1)(2010-4#1)(2010-5#1)(2012-2#1)
membrane layers##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
membrane level##3##2##(1990-2#1)(1997-2#1)(2011-2#1)
membrane lipid bilayer##3##3##(1990-7#1)(1992-6#1)(2008-11#1)
membrane lipid peroxidation##2##3##(2008-10#1)(2008-8#1)
membrane lipid##15##2##(1990-2#1)(1990-7#1)(1992-6#1)(1994-11#1)(1995-8#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#4)
membrane lipids##9##2##(1990-2#2)(1991-5#1)(1994-2#1)(2008-8#3)(2009-6#1)(2013-1#1)
membrane localization of##3##3##(2008-8#1)(2009-10#1)(2010-12#1)
membrane localization##5##2##(1994-8#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-2#1)
membrane location##2##2##(1990-5#1)(1990-8#1)
membrane markers##3##2##(1995-11#1)(2013-1#2)
membrane material and##2##3##(2008-7#1)(2009-5#1)
membrane materials##2##2##(2008-10#2)
membrane matrix of##2##3##(1996-8#2)
membrane matrix##8##2##(1996-8#2)(2008-10#4)(2010-4#1)(2012-2#1)
membrane may##3##2##(1991-12#1)(2007-7#1)(2013-8#1)
membrane method##3##2##(2008-10#3)
membrane might be derived from pre-karyote##2##6##(2009-6#2)
membrane might##3##2##(1997-8#1)(2009-6#2)
membrane of Escherichia coli was##2##5##(1991-5#1)(2008-10#1)
membrane of Escherichia coli##5##4##(1990-11#2)(1991-10#1)(1991-5#1)(2008-10#1)
membrane of a##6##3##(2008-10#1)(2009-2#2)(2011-1#1)(2013-1#2)
membrane of rat##2##3##(1990-12#1)(2010-12#1)
membrane of rats##2##3##(1994-2#1)(2009-8#1)
membrane of the sperm##2##4##(1994-8#1)(2008-8#1)
membrane of the##25##3##(1990-11#1)(1990-12#2)(1990-2#1)(1992-5#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-11#1)(2012-2#1)
membrane of##95##2##(1990-11#4)(1990-12#5)(1990-2#2)(1990-5#2)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#1)(2009-11#1)(2009-2#2)(2009-8#2)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
membrane on the electrode##2##4##(2008-10#2)
membrane on the##4##3##(2008-10#3)(2011-1#1)
membrane or##5##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-7#1)
membrane orientation##3##2##(1991-10#1)(1996-3#1)(2009-12#1)
membrane patches##7##2##(1994-11#1)(1994-12#1)(1995-5#1)(1997-6#1)(2008-8#3)
membrane performance##2##2##(2008-10#2)
membrane permeability of the##2##4##(2008-10#1)(2013-7#1)
membrane permeability of##4##3##(1994-2#2)(2008-10#1)(2013-7#1)
membrane permeability##14##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-6#1)(1994-2#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-7#1)
membrane permeabilization##2##2##(2008-9#2)
membrane permeation##2##2##(1991-5#2)
membrane perturbation##3##2##(1995-11#1)(1997-1#2)
membrane phase and##2##3##(2008-10#2)
membrane phase##5##2##(2008-10#5)
membrane phosphatidylserine##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
membrane phospholipid fatty acid##2##4##(1992-8#1)(1996-7#1)
membrane phospholipid##5##2##(1990-7#1)(1992-8#1)(1995-2#2)(1996-7#1)
membrane phospholipids and##2##3##(1992-8#1)(2011-2#1)
membrane phospholipids in##2##3##(1992-8#1)(1994-3#1)
membrane phospholipids##12##2##(1990-11#1)(1991-5#1)(1992-8#2)(1994-3#3)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
membrane pore##3##2##(2008-11#1)(2008-7#2)
membrane potential and##5##3##(1992-3#1)(1994-11#1)(1997-1#2)(2008-8#1)
membrane potential by flow cytometry##2##5##(2008-9#2)
membrane potential in##3##3##(1992-3#1)(1993-11#1)(2008-9#1)
membrane potential of##3##3##(1990-5#1)(1996-5#1)(2008-9#1)
membrane potential##66##2##(1990-12#4)(1990-2#1)(1990-5#2)(1990-8#1)(1992-3#5)(1992-6#1)(1993-11#6)(1993-12#1)(1994-11#3)(1994-12#2)(1996-2#1)(1996-5#1)(1997-1#3)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#13)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
membrane potentials of##2##3##(2008-11#2)
membrane potentials were##2##3##(2008-11#2)
membrane potentials##7##2##(1991-9#1)(1994-11#1)(2008-11#5)
membrane potentiometric sensor for##3##4##(2008-10#3)
membrane potentiometric sensor##5##3##(2008-10#5)
membrane potentiometric##6##2##(2008-10#6)
membrane preconcentration##2##2##(2008-10#2)
membrane preparation##9##2##(1990-7#2)(1991-12#1)(1991-5#2)(1992-3#1)(1996-2#1)(2008-10#1)(2008-4#1)
membrane preparations##6##2##(1990-5#1)(1993-1#1)(1995-6#1)(1996-5#2)(2008-11#1)
membrane probe##3##2##(1991-5#2)(1993-11#1)
membrane properties##5##2##(1991-9#1)(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
membrane protein 1##2##3##(2011-2#1)(2012-12#1)
membrane protein and##2##3##(1990-2#1)(2013-7#1)
membrane protein from##3##3##(1991-12#1)(2009-7#2)
membrane protein in##2##3##(2008-11#1)(2011-2#1)
membrane protein of##11##3##(1991-9#2)(1993-9#2)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-5#1)
membrane protein overexpression in bacteria##2##5##(2011-1#2)
membrane protein overexpression##3##3##(2011-1#3)
membrane protein with##3##3##(1990-11#1)(1994-12#1)(2008-5#1)
membrane protein##75##2##(1990-11#5)(1990-12#1)(1990-2#2)(1990-5#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1993-11#4)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-12#4)(1994-2#3)(1995-12#2)(1995-2#2)(1996-6#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2009-7#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2013-7#1)
membrane proteins and lipids##2##4##(2008-7#1)(2008-8#1)
membrane proteins and##5##3##(1993-8#1)(1995-12#1)(2008-7#1)(2008-8#2)
membrane proteins are##3##3##(2008-4#1)(2009-9#1)(2011-2#1)
membrane proteins by##3##3##(1993-8#1)(1995-12#1)(2008-11#1)
membrane proteins in##4##3##(1990-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
membrane proteins of##5##3##(1995-12#2)(2008-12#1)(2008-5#1)(2008-7#1)
membrane proteins on##2##3##(1990-11#1)(2008-11#1)
membrane proteins under##2##3##(2008-7#2)
membrane proteins were##2##3##(1995-2#1)(2008-4#1)
membrane proteins with##4##3##(1990-5#1)(1994-11#1)(1995-8#1)(2008-7#1)
membrane proteins##81##2##(1990-11#2)(1990-12#2)(1990-5#4)(1991-2#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#11)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#5)(2011-2#5)(2012-1#1)(2013-1#1)(2013-7#1)
membrane reactor##2##2##(1994-5#1)(1995-3#1)
membrane receptor for##2##3##(1992-12#1)(2011-2#1)
membrane receptor##8##2##(1990-5#1)(1992-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
membrane receptors for##2##3##(1992-12#1)(2006-6#1)
membrane receptors that##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
membrane receptors##12##2##(1991-5#1)(1991-8#1)(1992-12#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2012-2#1)
membrane recruitment##2##2##(2008-7#1)(2013-8#1)
membrane recycling##4##2##(1997-1#3)(1997-7#1)
membrane redox##3##2##(1992-8#1)(2009-9#2)
membrane resistance##2##2##(1993-12#2)
membrane response##2##2##(1992-12#1)(2008-5#1)
membrane sampler##3##2##(2008-10#3)
membrane samples##3##2##(1994-5#2)(2008-11#1)
membrane sensor based on ethyl-2-benzoyl-2-phenylcarbamoyl acetate##2##6##(2008-10#2)
membrane sensor based on##6##4##(2008-10#6)
membrane sensor for##3##3##(2008-10#3)
membrane sensor##28##2##(2008-10#28)
membrane sensors based on##3##4##(2008-10#3)
membrane sensors for##5##3##(2008-10#5)
membrane sensors##14##2##(2008-10#14)
membrane separation##3##2##(1995-3#1)(2008-10#2)
membrane sheets##2##2##(1990-12#1)(2008-7#1)
membrane showed##3##2##(2008-10#3)
membrane sites##2##2##(1994-12#2)
membrane spanning##5##2##(1991-12#2)(1991-9#1)(1994-9#1)(2008-11#1)
membrane structure##7##2##(1990-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(2008-5#1)(2008-7#1)(2009-7#1)
membrane structures##6##2##(2008-10#1)(2008-11#3)(2011-1#1)(2013-1#1)
membrane support##4##2##(1991-5#2)(2008-4#2)
membrane surface area##2##3##(2008-11#1)(2008-7#1)
membrane surface##11##2##(1991-12#1)(1991-9#1)(1994-5#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
membrane surfaces##4##2##(1991-9#1)(2008-6#3)
membrane system can##2##3##(1992-3#1)(2008-10#1)
membrane system##6##2##(1991-9#1)(1992-3#1)(1996-3#1)(2008-10#3)
membrane systems##4##2##(1990-2#1)(2008-10#2)(2008-5#1)
membrane templating model##2##3##(2008-5#2)
membrane templating##3##2##(2008-5#3)
membrane than##3##2##(1990-5#1)(1990-7#1)(2008-10#1)
membrane that##8##2##(2007-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2009-10#1)
membrane thickness##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
membrane through a##3##3##(1990-2#1)(1996-3#2)
membrane through the##2##3##(2009-11#1)(2009-7#1)
membrane through##5##2##(1990-2#1)(1996-3#2)(2009-11#1)(2009-7#1)
membrane to the##3##3##(1990-11#1)(1990-12#1)(2009-2#1)
membrane to##11##2##(1990-11#1)(1990-12#1)(1990-7#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-5#2)(2009-2#1)(2011-1#1)
membrane topology##3##2##(1997-7#3)
membrane traffic in##2##3##(2008-1#1)(2008-11#1)
membrane traffic##4##2##(2008-1#1)(2008-11#3)
membrane translocation##3##2##(1992-6#1)(1993-6#1)(1994-8#1)
membrane transplantation in##2##3##(2011-1#1)(2011-2#1)
membrane transplantation##3##2##(2011-1#1)(2011-2#2)
membrane transport activity for the##2##5##(1991-9#2)
membrane transport in##2##3##(1996-2#1)(2008-4#1)
membrane transport of##4##3##(1996-2#2)(2008-10#1)(2008-5#1)
membrane transport##17##2##(1990-7#1)(1991-9#2)(1993-9#1)(1994-8#1)(1996-2#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
membrane transporter##3##2##(1996-12#3)
membrane type##4##2##(1993-12#1)(2008-7#2)(2009-3#1)
membrane up to##2##3##(2008-3#1)(2012-2#1)
membrane used for##2##3##(2008-10#1)(2008-5#1)
membrane used##3##2##(2008-10#2)(2008-5#1)
membrane using##5##2##(2008-1#1)(2008-10#3)(2008-5#1)
membrane vesicle##2##2##(1990-7#1)(1993-6#1)
membrane vesicles are##2##3##(1997-3#1)(2011-1#1)
membrane vesicles from##3##3##(1990-11#1)(2008-11#1)(2012-3#1)
membrane vesicles isolated##2##3##(1994-12#1)(2008-11#1)
membrane vesicles prepared from##2##4##(1997-8#1)(2008-11#1)
membrane vesicles prepared##3##3##(1990-7#1)(1997-8#1)(2008-11#1)
membrane vesicles were##2##3##(1990-2#1)(2008-7#1)
membrane vesicles with##4##3##(1990-11#2)(1990-2#1)(1997-8#1)
membrane vesicles##34##2##(1990-11#4)(1990-2#2)(1990-7#1)(1991-9#1)(1993-8#1)(1994-12#6)(1994-8#1)(1997-3#1)(1997-6#1)(1997-8#5)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-8#1)
membrane was found to##3##4##(1990-11#1)(2008-5#1)(2008-7#1)
membrane was##36##2##(1990-11#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-12#1)(1996-5#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#8)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
membrane water##2##2##(2010-2#1)(2013-7#1)
membrane were##16##2##(1990-11#1)(1991-3#1)(1993-3#1)(1994-5#1)(1995-12#1)(2008-10#9)(2008-11#1)(2012-3#1)
membrane which##2##2##(1997-6#1)(2008-10#1)
membrane while being##2##3##(1991-5#1)(2008-8#1)
membrane with 1##2##3##(2008-10#1)(2008-5#1)
membrane with a##7##3##(1992-6#1)(2008-10#4)(2008-5#1)(2010-2#1)
membrane with the##3##3##(1991-10#1)(2008-10#2)
membrane with##23##2##(1991-10#1)(1992-6#1)(1993-8#1)(2008-10#13)(2008-5#3)(2010-2#1)(2011-1#2)(2011-2#1)
membrane without##2##2##(1990-2#1)(1994-5#1)
membrane##2355##1##(1990-11#43)(1990-12#32)(1990-2#34)(1990-4#1)(1990-5#30)(1990-6#1)(1990-7#19)(1990-8#7)(1991-10#9)(1991-11#1)(1991-12#13)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#31)(1991-6#1)(1991-8#2)(1991-9#19)(1992-11#10)(1992-12#25)(1992-2#1)(1992-3#25)(1992-4#1)(1992-5#4)(1992-6#18)(1992-7#2)(1992-8#9)(1992-9#10)(1993-1#2)(1993-11#26)(1993-12#11)(1993-2#2)(1993-3#11)(1993-6#16)(1993-8#18)(1993-9#10)(1994-10#2)(1994-11#31)(1994-12#47)(1994-2#20)(1994-3#8)(1994-5#21)(1994-6#11)(1994-8#28)(1994-9#1)(1995-11#15)(1995-12#19)(1995-2#25)(1995-3#5)(1995-5#5)(1995-6#23)(1995-8#10)(1996-12#8)(1996-2#12)(1996-3#7)(1996-5#8)(1996-6#5)(1996-7#3)(1996-8#4)(1996-9#1)(1997-1#10)(1997-2#5)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#9)(1997-7#13)(1997-8#11)(2006-12#2)(2006-6#3)(2007-10#2)(2007-11#4)(2007-12#26)(2007-2#1)(2007-5#1)(2007-7#11)(2007-8#4)(2008-1#21)(2008-10#640)(2008-11#92)(2008-12#3)(2008-2#7)(2008-3#12)(2008-4#61)(2008-5#59)(2008-6#13)(2008-7#77)(2008-8#72)(2008-9#55)(2009-10#14)(2009-11#6)(2009-12#4)(2009-2#6)(2009-3#5)(2009-4#2)(2009-5#12)(2009-6#12)(2009-7#17)(2009-8#12)(2009-9#24)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#6)(2010-5#7)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#35)(2011-2#49)(2011-3#4)(2012-1#7)(2012-12#11)(2012-2#35)(2012-3#11)(2012-4#2)(2012-8#4)(2013-1#23)(2013-7#7)(2013-8#10)
membrane) is##2##2##(2008-7#1)(2011-1#1)
membrane)##11##1##(1992-3#1)(1997-8#2)(2008-10#5)(2008-7#1)(2008-9#1)(2011-1#1)
membrane-anchored##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
membrane-associated protein kinase C##2##4##(1994-3#2)
membrane-associated protein##3##2##(1994-12#1)(1994-3#2)
membrane-associated proteins##2##2##(1992-12#1)(1993-11#1)
membrane-associated##26##1##(1990-11#1)(1990-2#1)(1990-8#5)(1991-10#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#2)(1995-5#1)(1995-6#1)(1997-3#1)(2009-10#1)(2012-12#1)(2012-2#1)
membrane-based electrodes can also be used##2##6##(2008-10#2)
membrane-based optical flow-through sensor##2##4##(2008-10#2)
membrane-based##9##1##(2008-10#9)
membrane-bound and soluble##2##3##(1995-2#1)(2008-4#1)
membrane-bound and##4##2##(1994-11#1)(1995-2#1)(2008-4#1)(2008-6#1)
membrane-bound enzyme##4##2##(1990-11#1)(1995-6#1)(1996-2#1)(2007-11#1)
membrane-bound enzymes##2##2##(1991-5#1)(1996-8#1)
membrane-bound protein##2##2##(2008-4#1)(2008-7#1)
membrane-bound proteins##4##2##(1994-12#1)(2006-12#1)(2008-4#2)
membrane-bound##62##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#3)(1991-2#2)(1991-5#5)(1992-2#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#4)(1996-2#1)(1996-8#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#6)(2008-6#2)(2008-7#5)(2009-10#2)(2009-7#1)(2011-2#1)
membrane-compromised##2##1##(2008-9#2)
membrane-cytoskeletal##2##1##(1994-9#1)(2010-3#1)
membrane-cytoskeleton##2##1##(1992-12#1)(2012-2#1)
membrane-interacting##2##1##(1995-2#1)(2008-10#1)
membrane-like##2##1##(2008-10#1)(2008-7#1)
membrane-mediated##2##1##(1991-5#2)
membrane-spanning domains##4##2##(1991-2#1)(1995-2#1)(1995-8#1)(1997-7#1)
membrane-spanning##8##1##(1990-5#1)(1991-12#1)(1991-2#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-11#2)
membrane-targeted##2##1##(1994-8#2)
membrane-targeting sequence##2##2##(1994-8#2)
membrane-type matrix##2##2##(1997-2#2)
membranes also##2##2##(2008-10#2)
membranes and a##3##3##(1995-6#2)(2008-7#1)
membranes and human##2##3##(2008-5#2)
membranes and is##2##3##(2008-10#1)(2008-3#1)
membranes and the##4##3##(1990-11#1)(1994-12#1)(2008-10#1)(2008-11#1)
membranes and their##5##3##(1990-12#2)(1992-6#1)(1994-12#1)(2008-11#1)
membranes and##56##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-9#3)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1995-2#1)(1995-6#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2012-8#1)
membranes are##10##2##(1991-5#1)(1992-9#1)(1993-6#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-8#1)(2012-12#1)
membranes as a##2##3##(1993-1#1)(2008-10#1)
membranes as well as##2##4##(1990-11#1)(2008-5#1)
membranes as##10##2##(1990-11#1)(1990-5#1)(1992-3#1)(1992-6#1)(1993-1#1)(1995-2#1)(2008-10#1)(2008-5#1)(2012-3#1)(2012-8#1)
membranes at##4##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)
membranes based on##2##3##(2008-10#2)
membranes before##2##2##(2008-6#1)(2008-9#1)
membranes by##14##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
membranes can be##3##3##(1994-12#1)(2008-11#1)(2008-7#1)
membranes compared##2##2##(2007-12#1)(2012-3#1)
membranes composed of##3##3##(1993-11#1)(1994-12#1)(2008-10#1)
membranes contain##2##2##(1990-11#1)(1993-11#1)
membranes containing the##2##3##(2008-10#2)
membranes containing##14##2##(1996-8#1)(2008-10#13)
membranes coupled##2##2##(2008-10#1)(2010-4#1)
membranes during platelet stimulation with thrombin##2##6##(1992-6#2)
membranes during##3##2##(1992-6#2)(2012-2#1)
membranes for the##3##3##(2008-10#3)
membranes for##14##2##(1993-3#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-9#1)
membranes from MXT mammary cancer##2##5##(1993-1#2)
membranes from human##2##3##(1992-12#1)(1993-1#1)
membranes from rat##2##3##(1990-7#1)(1991-12#1)
membranes from##22##2##(1990-11#1)(1990-7#1)(1991-12#2)(1992-12#1)(1993-1#3)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2008-1#1)
membranes has been##4##3##(1990-12#1)(1990-5#1)(2008-10#1)(2008-6#1)
membranes have been##3##3##(1990-11#1)(2008-10#1)(2012-2#1)
membranes have##6##2##(1990-11#1)(1993-11#1)(2008-10#2)(2009-6#1)(2012-2#1)
membranes in a concentration-dependent manner##2##5##(1991-6#1)(1993-6#1)
membranes in a##6##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-6#1)(1993-6#1)(2008-10#1)
membranes in order to gain##2##5##(2008-9#2)
membranes in order to##3##4##(2008-3#1)(2008-9#2)
membranes in patients##2##3##(2008-6#1)(2012-2#1)
membranes in response to##3##4##(1994-6#1)(1996-8#1)(2008-7#1)
membranes in the##5##3##(1991-9#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-10#1)
membranes in##35##2##(1990-11#2)(1990-7#2)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#2)(2012-12#1)(2012-2#1)
membranes is##8##2##(1992-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-4#1)(2008-7#1)
membranes isolated from the##2##4##(1994-3#1)(1995-12#1)
membranes isolated from##5##3##(1992-7#1)(1994-3#1)(1995-12#2)(1997-1#1)
membranes isolated##6##2##(1992-7#1)(1994-3#1)(1995-12#2)(1997-1#1)(2008-4#1)
membranes leading to##2##3##(2008-10#1)(2008-11#1)
membranes may##2##2##(1992-12#1)(2008-4#1)
membranes obtained##2##2##(1990-8#1)(2008-10#1)
membranes of different##3##3##(2008-10#2)(2008-11#1)
membranes of human##2##3##(1990-2#1)(1993-1#1)
membranes of rat##3##3##(1990-5#1)(1992-3#1)(1995-2#1)
membranes of the##6##3##(1993-6#1)(1997-6#1)(2008-10#2)(2008-7#1)(2013-1#1)
membranes of##46##2##(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-6#3)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-9#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#2)
membranes on##2##2##(2008-11#1)(2009-12#1)
membranes or##4##2##(1992-9#1)(1994-5#2)(1995-11#1)
membranes plasticized with##2##3##(2008-10#2)
membranes prepared by##2##3##(2008-11#2)
membranes prepared from##3##3##(1991-5#1)(1995-11#1)(2008-11#1)
membranes prepared with iodoacetamide##2##4##(1994-6#2)
membranes prepared##8##2##(1991-5#1)(1994-6#2)(1995-11#1)(2008-11#4)
membranes showed##3##2##(1991-5#1)(2008-10#1)(2008-7#1)
membranes than##2##2##(2008-11#1)(2009-5#1)
membranes that are##2##3##(2008-11#1)(2009-8#1)
membranes that##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-7#1)
membranes the##2##2##(2008-10#2)
membranes to##7##2##(1990-11#1)(1991-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-8#1)(2013-7#1)
membranes using##7##2##(1990-12#1)(1993-6#1)(1995-11#1)(1996-2#1)(1997-7#1)(2008-10#2)
membranes was also##2##3##(1997-1#1)(1997-4#1)
membranes was enhanced##2##3##(1990-11#1)(1997-4#1)
membranes was observed##2##3##(1993-3#1)(1995-2#1)
membranes was##21##2##(1990-11#1)(1990-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)
membranes were examined##2##3##(1993-6#1)(2008-10#1)
membranes were investigated##2##3##(1991-5#1)(2008-7#1)
membranes were prepared by##2##4##(2008-10#2)
membranes were prepared##4##3##(1997-4#1)(2008-10#2)(2012-8#1)
membranes were tested##2##3##(2008-10#1)(2008-7#1)
membranes were##32##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-8#1)
membranes which##2##2##(1994-2#1)(1997-6#1)
membranes with EGF##2##3##(1993-3#2)
membranes with a##3##3##(1992-3#1)(1995-11#1)(2008-10#1)
membranes with different##2##3##(2010-5#1)(2013-1#1)
membranes with high##2##3##(1993-11#1)(2008-7#1)
membranes with the##5##3##(1992-7#1)(1993-6#1)(1994-12#1)(1994-8#1)(2008-7#1)
membranes with##32##2##(1990-11#1)(1992-12#1)(1992-3#3)(1992-7#2)(1993-11#2)(1993-3#3)(1993-6#2)(1994-12#2)(1994-3#2)(1994-8#2)(1995-11#2)(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#3)(2010-5#1)(2013-1#1)
membranes without##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
membranes##767##1##(1990-11#27)(1990-12#10)(1990-2#9)(1990-5#18)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#1)(1991-5#14)(1991-6#2)(1991-9#3)(1992-11#2)(1992-12#6)(1992-3#19)(1992-5#1)(1992-6#15)(1992-7#3)(1992-8#2)(1992-9#6)(1993-1#7)(1993-11#12)(1993-3#11)(1993-5#2)(1993-6#21)(1993-8#4)(1993-9#2)(1994-11#7)(1994-12#13)(1994-2#10)(1994-3#8)(1994-5#12)(1994-6#3)(1994-8#16)(1994-9#2)(1995-11#14)(1995-12#11)(1995-2#13)(1995-3#1)(1995-6#10)(1995-8#5)(1996-12#1)(1996-2#3)(1996-5#5)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#5)(1997-4#5)(1997-6#3)(1997-7#5)(1997-8#1)(2007-11#1)(2007-12#11)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#155)(2008-11#39)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#12)(2008-5#12)(2008-6#10)(2008-7#32)(2008-8#7)(2008-9#10)(2009-10#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#9)(2012-3#5)(2012-8#3)(2013-1#6)(2013-7#2)
membranes'##2##1##(1994-8#1)(2008-8#1)
membranes)##5##1##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
membranes]##3##1##(1991-11#1)(1996-9#1)(2011-1#1)
membrano-proliferative glomerulonephritis (MPGN)##2##3##(2008-1#2)
membrano-proliferative glomerulonephritis##3##2##(2007-8#1)(2008-1#2)
membrano-proliferative##5##1##(1997-8#1)(2007-8#1)(2008-1#3)
membranolytic activities##2##2##(1991-9#1)(1993-3#1)
membranolytic and nucleolytic activities##2##4##(1991-9#2)
membranolytic##5##1##(1991-9#4)(1993-3#1)
membranoproliferative GN##2##2##(2007-7#1)(2008-1#1)
membranoproliferative glomerulonephritis (MPGN)##3##3##(2007-7#1)(2008-1#1)(2013-1#1)
membranoproliferative glomerulonephritis##9##2##(2007-7#3)(2008-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
membranoproliferative##12##1##(2007-7#4)(2008-1#2)(2012-2#3)(2013-1#1)(2013-8#2)
membranous GN##3##2##(2007-7#1)(2008-1#2)
membranous fractions##3##2##(1993-12#2)(1993-6#1)
membranous glomerulonephritis##3##2##(2007-7#1)(2008-1#1)(2013-1#1)
membranous glomerulopathy##2##2##(2008-1#1)(2013-8#1)
membranous lipodystrophy##3##2##(2010-6#3)
membranous nephropathy##2##2##(2008-1#2)
membranous structures##2##2##(2008-5#1)(2013-8#1)
membranous##37##1##(1990-12#1)(1993-12#2)(1993-6#1)(1994-6#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#6)(2008-10#1)(2008-5#3)(2008-7#3)(2009-10#1)(2010-3#1)(2010-6#3)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
memo##4##1##(1995-6#1)(1996-5#1)(1997-5#1)(2008-8#1)
memoirs##4##1##(2007-8#1)(2008-7#1)(2009-10#2)
memorable##2##1##(1992-3#1)(2010-4#1)
memorial lecture##2##2##(2008-9#1)(2009-5#1)
memorial##5##1##(2007-2#1)(2007-8#1)(2008-9#1)(2009-5#1)(2010-1#1)
memories and##3##2##(2008-3#3)
memories are##4##2##(2007-8#1)(2008-2#2)(2009-2#1)
memories as##2##2##(2007-8#1)(2010-8#1)
memories in##2##2##(1995-8#1)(2009-11#1)
memories of##4##2##(1991-1#1)(2008-10#1)(2009-7#1)(2010-8#1)
memories##40##1##(1991-1#1)(1995-8#1)(1996-11#1)(1996-12#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-2#10)(2008-3#7)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#3)(2009-7#1)(2010-8#2)(2013-8#2)
memorize##5##1##(2008-6#4)(2010-8#1)
memorized color cues##2##3##(2008-6#2)
memorized##3##1##(2008-2#1)(2008-6#2)
memory (WM)##3##2##(1994-8#2)(2012-2#1)
memory (and hypnosis) lab##2##4##(2008-2#2)
memory (and hypnosis)##3##3##(2008-2#3)
memory CD4 cells##3##3##(2012-2#3)
memory CD4+ and CD8+##2##4##(1995-12#2)
memory T cells##4##3##(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
memory abilities##2##2##(1994-3#1)(2008-4#1)
memory and attention##4##3##(1991-5#1)(1991-6#1)(2008-7#1)(2012-1#1)
memory and swim speed##4##4##(2008-12#4)
memory and the##2##3##(2007-8#1)(2008-6#1)
memory and##36##2##(1991-10#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-12#4)(1997-4#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
memory architecture##2##2##(2008-2#1)(2008-3#1)
memory are##5##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2012-2#1)
memory as a##2##3##(2008-2#2)
memory as##5##2##(2007-8#1)(2008-2#2)(2010-8#1)(2013-7#1)
memory at the##2##3##(1997-6#1)(2012-3#1)
memory bias in##2##3##(2008-2#2)
memory bias##3##2##(2008-2#3)
memory by##2##2##(1996-5#1)(2010-1#1)
memory capacity##7##2##(2008-2#1)(2008-3#1)(2012-2#2)(2012-3#3)
memory coherence##2##2##(2010-8#2)
memory complaints##2##2##(2009-11#2)
memory deficits caused by bilateral cholinotoxin##2##6##(1995-5#2)
memory deficits in mice##2##4##(2008-5#2)
memory deficits in##4##3##(1991-6#1)(2008-5#2)(2013-1#1)
memory deficits##16##2##(1991-6#1)(1994-8#1)(1995-5#2)(1997-2#2)(2008-10#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
memory dysfunction##4##2##(1993-12#3)(1997-2#1)
memory effect##6##2##(2007-11#1)(2008-10#2)(2008-7#2)(2009-7#1)
memory effects##2##2##(2007-12#1)(2008-10#1)
memory enhancement##2##2##(1994-8#1)(2008-10#1)
memory evidence##2##2##(2009-8#2)
memory for the##6##3##(1992-11#2)(2008-10#1)(2008-11#2)(2012-1#1)
memory for##15##2##(1992-11#2)(1993-12#2)(2007-8#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-11#1)(2012-1#1)
memory formation in##2##3##(1994-3#1)(2013-1#1)
memory formation is##3##3##(1993-12#1)(2009-6#1)(2009-8#1)
memory formation##17##2##(1993-12#1)(1994-3#1)(1994-8#2)(1997-2#1)(2008-7#2)(2009-6#2)(2009-8#5)(2013-1#2)(2013-8#1)
memory function and##2##3##(1993-12#1)(1997-2#1)
memory function in##3##3##(1994-8#1)(2008-5#1)(2008-9#1)
memory function##10##2##(1993-12#3)(1994-8#1)(1997-2#1)(1997-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)
memory functioning in##3##3##(2008-7#2)(2010-7#1)
memory functioning##5##2##(1990-3#1)(1991-6#1)(2008-7#2)(2010-7#1)
memory functions##3##2##(1994-8#1)(2008-7#1)(2012-3#1)
memory group##3##2##(2008-12#3)
memory has##3##2##(1996-5#1)(2008-2#1)(2009-8#1)
memory have##3##2##(2007-8#2)(2009-8#1)
memory impairment in##3##3##(1997-2#1)(2009-10#1)(2009-6#1)
memory impairment observed in##2##4##(1994-6#2)
memory impairment##12##2##(1994-6#3)(1997-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-6#2)
memory impairments##3##2##(1993-12#1)(1994-8#1)(2008-7#1)
memory improvement##2##2##(2008-12#1)(2008-7#1)
memory in a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
memory in rats##3##3##(1992-10#1)(2008-7#1)(2011-2#1)
memory in the##11##3##(1991-2#1)(1993-12#1)(1993-3#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-2#2)(2009-8#1)(2012-2#2)
memory in##37##2##(1991-2#1)(1992-10#1)(1992-11#1)(1993-12#3)(1993-3#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-2#2)(2009-8#5)(2009-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
memory is##13##2##(1993-12#1)(1996-5#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-11#1)(2012-3#2)(2013-7#1)
memory load##2##2##(1993-3#1)(2008-3#1)
memory loss##5##2##(1991-11#1)(1993-12#1)(2007-8#1)(2008-7#1)(2013-1#1)
memory mechanisms##3##2##(1997-2#1)(2008-11#1)(2013-8#1)
memory of Dr##2##3##(2008-9#1)(2010-11#1)
memory of colors##2##3##(2008-6#2)
memory of the##2##3##(1991-12#1)(2008-7#1)
memory of##13##2##(1991-12#1)(1991-8#1)(1992-5#1)(2007-12#1)(2008-10#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)
memory on the##2##3##(2011-2#2)
memory or##2##2##(2008-2#1)(2008-4#1)
memory performance in##4##3##(1995-5#1)(2008-12#1)(2008-7#1)(2009-9#1)
memory performance was##2##3##(2010-7#2)
memory performance##15##2##(1993-12#1)(1994-8#1)(1995-5#1)(2008-12#4)(2008-5#1)(2008-7#1)(2009-9#2)(2010-7#3)(2012-3#1)
memory polymers##2##2##(2011-1#2)
memory problems##2##2##(2008-11#1)(2013-1#1)
memory process##2##2##(2007-12#1)(2008-8#1)
memory processes##16##2##(1992-11#2)(1992-8#2)(1993-12#2)(1994-8#2)(1995-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-10#2)(2009-11#1)(2012-12#1)
memory quotient##2##2##(2008-7#2)
memory requirements##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
memory research##3##2##(2008-1#1)(2009-6#1)(2013-8#1)
memory retention##4##2##(1993-3#1)(1994-5#1)(2008-9#1)(2011-2#1)
memory retrieval or##2##3##(1993-12#2)
memory retrieval##3##2##(1993-12#2)(1995-12#1)
memory self-efficacy and##2##3##(2008-12#1)(2008-9#1)
memory self-efficacy##7##2##(2008-12#6)(2008-9#1)
memory storage##2##2##(1994-8#1)(2008-11#1)
memory system that uses##2##4##(2008-3#2)
memory system that##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
memory system##18##2##(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#8)(2008-6#1)(2012-2#1)
memory systems##4##2##(2007-12#1)(2008-2#1)(2009-8#1)(2013-8#1)
memory task##10##2##(1993-12#1)(1993-5#1)(1994-8#4)(2007-8#1)(2008-7#1)(2009-2#1)(2012-3#1)
memory tasks and##2##3##(2008-7#1)(2013-8#1)
memory tasks##10##2##(1993-12#1)(1993-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#3)(2013-8#1)
memory testing##2##2##(1994-6#1)(2008-8#1)
memory tests##3##2##(2007-12#1)(2008-7#1)(2010-7#1)
memory that##6##2##(1993-3#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-6#1)(2013-7#1)
memory was##5##2##(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#1)
memory with##6##2##(2008-3#5)(2008-6#1)
memory##666##1##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#4)(1992-11#15)(1992-5#1)(1992-8#2)(1993-12#37)(1993-3#9)(1993-5#4)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#23)(1995-12#5)(1995-5#6)(1996-2#1)(1996-5#6)(1997-2#8)(1997-4#2)(1997-6#2)(2007-11#4)(2007-12#23)(2007-8#28)(2008-1#6)(2008-10#13)(2008-11#22)(2008-12#25)(2008-2#45)(2008-3#44)(2008-4#8)(2008-5#12)(2008-6#15)(2008-7#48)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#8)(2009-11#13)(2009-2#9)(2009-5#1)(2009-6#9)(2009-7#4)(2009-8#22)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#6)(2010-8#10)(2011-1#9)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#26)(2012-3#20)(2013-1#12)(2013-7#12)(2013-8#19)
memory&quot##3##1##(2009-8#1)(2012-2#2)
memory) and##2##2##(1993-3#1)(2012-12#1)
memory)##9##1##(1990-12#1)(1993-3#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-1#1)
memory-matrix-based identification##2##2##(2008-3#2)
men (45##2##2##(1992-5#1)(2011-2#1)
men (age##2##2##(2008-7#1)(2011-2#1)
men (effect-size r =##3##4##(2010-8#3)
men (mean age##2##3##(2007-11#1)(2008-9#1)
men (n =##4##3##(2008-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
men (p &lt##2##3##(2007-7#1)(2008-3#1)
men about##2##2##(1996-11#1)(2009-5#1)
men after a##2##3##(1996-1#1)(2012-3#1)
men after##4##2##(1996-1#1)(2011-2#2)(2012-3#1)
men aged 40-59##2##3##(2008-7#2)
men aged##19##2##(1990-6#1)(1991-6#2)(1993-9#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-7#5)(2009-10#1)(2009-5#3)(2011-1#1)
men also##2##2##(2008-12#1)(2008-4#1)
men and 11##2##3##(1992-6#1)(2008-5#1)
men and 16 women##2##4##(1990-8#1)(2007-12#1)
men and 2 women)##2##4##(1990-10#1)(2008-9#1)
men and 4 women)##2##4##(2008-9#1)(2013-1#1)
men and 4##4##3##(2007-8#2)(2008-9#1)(2013-1#1)
men and 79##2##3##(2008-9#1)(2009-4#1)
men and 8 women)##2##4##(2008-7#1)(2013-1#1)
men and 8##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
men and boys##2##3##(2009-10#1)(2013-8#1)
men and five##2##3##(1991-5#1)(2008-1#1)
men and in##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
men and women aged 40-42 in##2##6##(1994-11#2)
men and women aged##4##4##(1994-11#2)(1996-8#1)(2013-1#1)
men and women are##2##4##(1991-6#1)(1995-12#1)
men and women by##2##4##(1990-11#1)(2008-7#1)
men and women in the##2##5##(1991-6#1)(2010-12#1)
men and women in##3##4##(1991-6#1)(2007-7#1)(2010-12#1)
men and women of##2##4##(2008-1#1)(2011-1#1)
men and women were##4##4##(2008-9#1)(2010-5#1)(2011-1#2)
men and women with##5##4##(1992-2#1)(1995-3#1)(2008-3#1)(2008-5#1)(2010-10#1)
men and women##93##3##(1990-11#2)(1990-3#1)(1991-11#2)(1991-6#2)(1992-2#1)(1993-2#2)(1994-11#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#5)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#6)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#9)(2011-2#5)(2012-12#4)(2012-3#1)(2013-1#4)(2013-8#3)
men and##194##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-6#5)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#2)(1994-11#3)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-6#2)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#3)(2008-1#9)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-7#14)(2008-8#1)(2008-9#4)(2009-10#5)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#7)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#1)(2011-1#10)(2011-2#14)(2011-7#1)(2012-12#5)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#7)
men are##7##2##(1995-2#1)(2008-1#1)(2008-10#1)(2009-5#2)(2009-9#2)
men as##5##2##(1991-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
men at high##2##3##(1994-2#2)
men at##4##2##(1994-2#2)(2008-12#1)(2009-7#1)
men born in##3##3##(1990-2#1)(1994-6#2)
men by##4##2##(2008-12#2)(2011-2#2)
men caring for##2##3##(2009-5#2)
men did##2##2##(1992-2#1)(2013-8#1)
men drank##2##2##(2008-1#2)
men free of##2##3##(1991-7#1)(2008-3#1)
men from the##2##3##(2008-12#1)(2011-2#1)
men from##4##2##(2006-8#1)(2008-12#1)(2011-2#1)(2012-2#1)
men had significantly lower##2##4##(2008-7#1)(2013-1#1)
men had##6##2##(1996-11#1)(1996-6#1)(2008-7#3)(2013-1#1)
men has##2##2##(2008-10#1)(2009-5#1)
men have##6##2##(1991-11#1)(1996-11#1)(2008-4#1)(2009-5#2)(2010-6#1)
men having##2##2##(1994-11#1)(2013-8#1)
men in Norway##2##3##(1995-2#1)(1996-11#1)
men in Okinawa##3##3##(2008-10#3)
men in the United States##2##5##(2011-2#1)(2013-1#1)
men in the##11##3##(1991-3#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
men in this##3##3##(2008-10#1)(2009-10#1)(2009-5#1)
men in##37##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-11#2)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#6)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
men increased##2##2##(1996-3#1)(2008-10#1)
men need##2##2##(1995-9#1)(2010-10#1)
men of the##3##3##(1991-8#1)(2007-12#1)(2008-3#1)
men of##7##2##(1991-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)
men presenting with##2##3##(2008-5#1)(2011-2#1)
men providing care to##2##4##(2009-5#2)
men reported##2##2##(2009-5#1)(2013-7#1)
men than in##8##3##(1990-12#1)(1992-2#1)(1992-3#1)(1994-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
men than women##3##3##(1991-6#1)(1995-2#1)(2008-7#1)
men than##12##2##(1990-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-2#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
men to develop##2##3##(2007-12#1)(2008-4#1)
men to##9##2##(1990-9#1)(2007-12#1)(2008-12#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)
men treated##2##2##(2008-7#1)(2011-2#1)
men undergoing AS##3##3##(2010-10#3)
men undergoing active surveillance for prostate cancer##2##7##(2009-5#1)(2010-10#1)
men undergoing active surveillance##3##4##(2009-5#1)(2010-10#2)
men undergoing##6##2##(2009-5#1)(2010-10#5)
men was##7##2##(1991-5#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2013-1#1)
men were interviewed##2##3##(2008-1#1)(2009-5#1)
men were more##4##3##(2008-12#2)(2010-8#2)
men were recruited##3##3##(2008-1#1)(2008-4#1)(2009-5#1)
men were treated with##2##4##(1995-5#1)(2011-2#1)
men were##25##2##(1991-12#1)(1991-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(2008-1#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#4)(2010-8#2)(2011-2#2)(2012-12#1)
men who had##5##3##(1992-2#1)(1996-11#1)(1996-6#1)(2009-5#1)(2010-10#1)
men who have sex with men (MSM)##4##7##(2009-5#3)(2011-2#1)
men who have sex with men##15##6##(1996-5#1)(2008-10#1)(2008-11#1)(2009-5#7)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
men who have##17##3##(1996-5#1)(2008-10#1)(2008-11#1)(2009-5#8)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)
men who were##2##3##(1994-6#1)(2008-3#1)
men who##28##2##(1992-2#1)(1993-11#1)(1994-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#10)(2009-7#1)(2010-10#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)
men with 12 &lt##3##4##(2008-7#3)
men with AIDS##2##3##(1992-2#1)(1993-8#1)
men with a mean age of##2##6##(2008-1#1)(2012-12#1)
men with a normal##2##4##(1991-5#1)(2012-12#1)
men with a##4##3##(1991-5#1)(2008-1#1)(2012-12#2)
men with chronic##3##3##(1990-11#1)(2012-3#1)(2013-8#1)
men with coronary artery disease##2##5##(2008-4#2)
men with prostate cancer##8##4##(2008-7#3)(2009-5#5)
men with type 2##3##4##(2008-3#3)
men with##55##2##(1990-11#2)(1991-5#1)(1991-6#1)(1991-7#3)(1992-2#2)(1992-3#1)(1993-8#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#8)(2009-12#1)(2009-5#6)(2009-7#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
men without##4##2##(2008-4#1)(2009-5#2)(2013-1#1)
men worldwide##2##2##(2009-5#1)(2013-1#1)
men##831##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#7)(1990-3#4)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#4)(1991-11#10)(1991-12#5)(1991-3#1)(1991-5#3)(1991-6#11)(1991-7#4)(1991-8#8)(1991-9#2)(1992-1#1)(1992-2#8)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-2#3)(1993-3#1)(1993-8#6)(1993-9#5)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-9#2)(1996-1#1)(1996-11#12)(1996-2#1)(1996-3#6)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1997-2#4)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#6)(2006-8#2)(2007-10#4)(2007-11#7)(2007-12#16)(2007-7#7)(2007-8#8)(2007-9#1)(2008-1#24)(2008-10#20)(2008-11#15)(2008-12#28)(2008-2#3)(2008-3#24)(2008-4#21)(2008-5#17)(2008-6#2)(2008-7#52)(2008-8#3)(2008-9#8)(2009-10#11)(2009-11#7)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#96)(2009-7#9)(2009-8#3)(2009-9#7)(2010-1#1)(2010-10#14)(2010-12#6)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#21)(2011-2#57)(2011-3#1)(2011-7#2)(2012-1#4)(2012-12#15)(2012-2#4)(2012-3#7)(2013-1#32)(2013-7#8)(2013-8#28)
men's health##3##2##(2009-5#3)
men's perceptions and##3##3##(2008-1#2)(2008-11#1)
men's perceptions##5##2##(2008-1#2)(2008-11#2)(2009-5#1)
men's##20##1##(1995-3#1)(2007-12#2)(2008-1#2)(2008-11#2)(2009-5#12)(2010-10#1)
men) aged##2##2##(2007-11#1)(2008-7#1)
men) and##2##2##(2008-1#1)(2013-1#1)
men) in##2##2##(2007-11#2)
men) with##4##2##(1996-1#1)(1996-6#1)(2007-11#1)(2007-7#1)
men)##23##1##(1991-6#1)(1993-6#1)(1995-5#1)(1996-1#1)(1996-6#1)(2007-11#6)(2007-7#2)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
men]##5##1##(1990-3#1)(1990-9#1)(1991-8#1)(1993-3#1)(2009-10#1)
menace##2##1##(2013-1#1)(2013-8#1)
menadione removal##2##2##(2012-1#2)
menadione##7##1##(1995-8#2)(2008-10#1)(2008-12#1)(2012-1#3)
menadione-catalyzed H(2)O(2) production assay is##2##5##(2008-11#2)
menadione-catalyzed H(2)O(2) production assay##3##4##(2008-11#3)
menadione-catalyzed H(2)O(2) production##4##3##(2008-11#4)
menadione-catalyzed##7##1##(2008-11#7)
menarche and##2##2##(2013-1#2)
menarche##12##1##(1993-9#1)(2008-2#1)(2010-1#1)(2012-12#1)(2013-1#8)
menarche=48##2##1##(2012-12#2)
menin##4##1##(2008-11#4)
meningeal hemangiopericytoma##6##2##(2008-6#6)
meningeal melanocytoma##4##2##(2008-7#2)(2012-2#2)
meningeal##29##1##(1990-2#1)(1996-11#1)(1996-5#1)(1996-9#2)(2006-12#3)(2008-12#2)(2008-6#6)(2008-7#7)(2009-11#1)(2009-3#2)(2012-2#3)
meninges##7##1##(1993-12#3)(2008-1#1)(2008-7#1)(2008-8#1)(2012-3#1)
meningioma and##2##2##(2008-7#1)(2010-11#1)
meningioma in##2##2##(2008-10#1)(2008-7#1)
meningioma is##2##2##(2008-7#2)
meningioma of the sphenoid##2##4##(2008-10#1)(2008-7#1)
meningioma of the##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
meningioma without##2##2##(2010-11#2)
meningioma##38##1##(1995-12#1)(2006-12#5)(2008-10#4)(2008-6#2)(2008-7#14)(2008-8#1)(2010-11#5)(2011-2#4)(2012-12#1)(2013-1#1)
meningiomas##20##1##(1995-12#1)(1995-9#1)(1996-5#2)(2006-12#5)(2008-10#2)(2008-7#6)(2011-2#3)
meningitic E##2##2##(2009-12#2)
meningitides##2##1##(2008-7#1)(2009-7#1)
meningitidis isolates##3##2##(2007-12#2)(2008-12#1)
meningitidis was##2##2##(2008-12#2)
meningitidis##28##1##(1993-12#3)(2006-5#1)(2007-12#6)(2008-12#8)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2013-1#4)
meningitis and##10##2##(1993-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)
meningitis caused by##6##3##(1992-11#1)(2007-12#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-8#1)
meningitis due to##2##3##(1995-8#1)(2007-7#1)
meningitis from##3##2##(2007-5#1)(2008-9#1)(2013-7#1)
meningitis has##3##2##(1996-3#1)(2007-2#1)(2011-2#1)
meningitis in a##3##3##(2007-12#1)(2008-10#1)(2009-3#1)
meningitis in children##4##3##(2008-11#1)(2009-5#1)(2013-7#2)
meningitis in the##3##3##(1991-2#1)(2008-7#1)(2011-2#1)
meningitis in##19##2##(1991-2#1)(1992-11#1)(1993-12#1)(1995-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#2)(2013-7#3)
meningitis is a##2##3##(2010-12#1)(2011-2#1)
meningitis is##4##2##(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
meningitis or##2##2##(1995-11#1)(2006-10#1)
meningitis was##3##2##(2008-1#1)(2008-12#1)(2009-12#1)
meningitis who##2##2##(1996-3#1)(2008-10#1)
meningitis with##3##2##(2007-5#1)(2007-8#2)
meningitis##128##1##(1990-6#1)(1991-2#1)(1992-11#3)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#4)(1997-5#2)(2006-10#1)(2007-12#3)(2007-2#3)(2007-5#5)(2007-7#3)(2007-8#12)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#5)(2009-5#2)(2009-6#1)(2010-12#4)(2011-2#14)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#7)(2013-8#1)
meningocele##5##1##(2009-3#5)
meningococcal C conjugate vaccine##3##4##(2010-10#3)
meningococcal conjugate vaccine##3##3##(2010-10#2)(2013-1#1)
meningococcal disease cases in Canada##2##5##(2007-12#1)(2009-5#1)
meningococcal disease in Africa##3##4##(2007-2#3)
meningococcal disease in Canada##2##4##(2007-12#2)
meningococcal disease in##7##3##(1991-8#1)(2007-12#2)(2007-2#3)(2013-8#1)
meningococcal disease##22##2##(1991-8#4)(2007-12#6)(2007-2#5)(2008-11#2)(2008-5#1)(2009-5#1)(2013-1#2)(2013-8#1)
meningococcal infection##2##2##(1991-8#1)(2010-10#1)
meningococcal serogroup C##3##3##(2010-10#3)
meningococcal vaccination##2##2##(1995-2#1)(2008-7#1)
meningococcal##43##1##(1990-12#1)(1991-8#6)(1992-2#1)(1995-2#1)(2007-12#6)(2007-2#7)(2007-5#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#9)(2013-1#5)(2013-8#1)
meningococcemia##2##1##(2008-5#2)
meningococci##6##1##(2007-12#4)(2007-2#1)(2011-1#1)
meningococcus B##2##2##(2011-1#1)(2013-8#1)
meningococcus##3##1##(2011-1#1)(2013-8#2)
meningoencephalitis##2##1##(1996-11#1)(2012-12#1)
meningomyelocele##2##1##(2012-12#2)
meniscal##6##1##(1993-11#3)(2008-10#1)(2012-2#1)(2013-1#1)
meniscectomy##3##1##(2008-8#1)(2013-1#2)
menisci##2##1##(2013-1#2)
meniscus by##2##2##(1993-11#1)(2007-12#1)
meniscus repair and anterior cruciate ligament reconstruction##3##7##(2013-1#3)
meniscus##18##1##(1990-9#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-9#1)(2009-6#3)(2011-2#1)(2013-1#5)
menopausal hormone therapy##3##3##(2010-6#3)
menopausal status##9##2##(1991-12#2)(1993-1#1)(1993-11#1)(1993-2#1)(1997-7#1)(2009-3#1)(2010-10#1)(2011-1#1)
menopausal symptoms##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
menopausal transition##2##2##(2008-11#1)(2012-3#1)
menopausal women##2##2##(2008-11#1)(2009-5#1)
menopausal##23##1##(1990-9#1)(1991-12#2)(1993-1#1)(1993-11#1)(1993-2#1)(1997-7#1)(2007-7#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-6#3)(2011-1#2)(2012-3#1)
menopause duration##4##2##(2011-2#4)
menopause in women##2##3##(2008-12#1)(2010-12#1)
menopause in##3##2##(1993-11#1)(2008-12#1)(2010-12#1)
menopause##27##1##(1991-11#1)(1991-4#1)(1991-9#1)(1993-11#2)(1993-9#2)(1994-12#1)(1997-4#3)(1997-6#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#5)(2012-1#1)(2013-8#2)
menopause-related##4##1##(2008-10#1)(2012-2#3)
menopause]##2##1##(2008-11#1)(2013-8#1)
menorrhagia##3##1##(1991-11#1)(1994-9#1)(2008-8#1)
menses##3##1##(1994-9#1)(2007-7#1)(2010-12#1)
menstrual cycle##13##2##(1990-12#1)(1990-9#1)(1994-7#1)(1994-9#2)(1995-11#1)(2008-2#1)(2008-4#1)(2012-2#3)(2012-3#2)
menstrual cycles##3##2##(1995-11#1)(1995-12#1)(2011-1#1)
menstrual period##2##2##(2008-7#1)(2011-2#1)
menstrual##29##1##(1990-12#1)(1990-9#1)(1993-2#1)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#1)(1996-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#2)
menstruation##11##1##(1991-3#1)(1994-9#2)(1996-6#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2013-1#1)
menstruum##2##1##(2011-2#2)
mensuration##3##1##(1995-5#2)(2008-10#1)
ment of##2##2##(2008-11#1)(2012-1#1)
ment##3##1##(2008-11#2)(2012-1#1)
mentagrophytes##7##1##(2007-7#1)(2008-5#5)(2012-3#1)
mental ability##2##2##(1995-1#1)(2008-3#1)
mental and physical health##3##4##(1996-9#1)(2009-5#2)
mental and physical##8##3##(1994-11#1)(1996-9#1)(2009-5#2)(2010-1#2)(2013-8#2)
mental and social well-being##2##4##(2010-7#1)(2012-3#1)
mental and spiritual##2##3##(2008-12#2)
mental and##19##2##(1993-12#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-1#1)(2008-12#2)(2009-5#2)(2010-1#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#2)
mental component##4##2##(2007-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
mental confusion##2##2##(2008-7#1)(2008-9#1)
mental deterioration in the aged##2##5##(1990-3#2)
mental development##3##2##(1991-2#1)(1994-3#1)(2008-8#1)
mental disability##3##2##(1990-6#1)(1995-12#1)(1997-5#1)
mental disorder and##2##3##(2009-9#1)(2010-12#1)
mental disorder##11##2##(1991-1#1)(1992-5#1)(1996-8#1)(2008-7#2)(2009-9#2)(2010-12#1)(2012-2#1)(2013-8#2)
mental disorders and##3##3##(2010-4#3)
mental disorders in##3##3##(2009-2#1)(2012-12#1)(2013-8#1)
mental disorders##29##2##(1991-2#1)(1991-8#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-4#5)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#3)(2013-7#1)(2013-8#3)
mental disorders]##3##2##(1997-3#1)(2010-6#1)(2013-7#1)
mental fatigue##2##2##(2008-5#2)
mental functions##2##2##(1997-6#1)(2013-8#1)
mental health and substance abuse##3##5##(1996-12#1)(1997-2#1)(2012-2#1)
mental health and well-being##3##4##(2007-6#1)(2011-2#2)
mental health and##27##3##(1992-2#1)(1993-3#1)(1994-12#2)(1996-12#1)(1997-2#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
mental health as##2##3##(1995-2#1)(2010-2#1)
mental health care and##3##4##(1994-1#1)(1995-1#1)(2013-1#1)
mental health care have##2##4##(1995-1#1)(2013-1#1)
mental health care in##2##4##(2006-9#1)(2012-2#1)
mental health care is##2##4##(2008-11#1)(2013-1#1)
mental health care##28##3##(1991-1#1)(1991-3#1)(1994-1#1)(1994-3#1)(1995-1#6)(1995-3#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-9#1)(2008-11#1)(2008-2#2)(2012-2#1)(2012-3#1)(2013-1#6)
mental health clinic##2##3##(2009-9#1)(2010-2#1)
mental health companies##2##3##(1991-3#1)(1995-1#1)
mental health consultation##2##3##(1994-1#1)(2011-2#1)
mental health consumers who##2##4##(1995-1#2)
mental health consumers##4##3##(1995-1#3)(2008-12#1)
mental health correlates##2##3##(2008-11#1)(2009-2#1)
mental health delivery system##2##4##(1992-1#1)(1995-12#1)
mental health disorders among##2##4##(2008-11#2)
mental health disorders##8##3##(2008-11#3)(2012-12#1)(2013-8#4)
mental health has been##3##4##(1997-2#1)(2011-2#1)(2012-3#1)
mental health has##4##3##(1996-7#1)(1997-2#1)(2011-2#1)(2012-3#1)
mental health hospital##2##3##(1992-2#1)(1993-1#1)
mental health in##8##3##(1996-1#1)(2010-8#2)(2012-12#2)(2013-1#2)(2013-8#1)
mental health is##2##3##(1992-1#1)(2009-10#1)
mental health issues##9##3##(1996-8#1)(2008-11#2)(2008-12#2)(2010-1#1)(2012-12#2)(2012-2#1)
mental health legislation##2##3##(1994-1#2)
mental health management##2##3##(1992-12#1)(1997-2#1)
mental health needs of##2##4##(2008-11#1)(2010-10#1)
mental health needs##5##3##(1997-2#1)(2008-11#2)(2010-10#1)(2011-2#1)
mental health nurse##4##3##(2008-1#1)(2008-11#1)(2011-1#2)
mental health nurses##14##3##(2008-11#3)(2008-12#3)(2009-6#2)(2010-5#3)(2011-1#2)(2011-2#1)
mental health nursing practice##2##4##(2008-11#2)
mental health nursing students##2##4##(2008-11#1)(2008-12#1)
mental health nursing##10##3##(2008-11#6)(2008-12#3)(2009-6#1)
mental health of##5##3##(1990-6#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-12#1)
mental health outcomes##6##3##(2008-2#1)(2009-7#2)(2012-2#2)(2012-3#1)
mental health policy##4##3##(1991-1#1)(1992-1#2)(2008-2#1)
mental health practices##2##3##(2008-12#1)(2010-9#1)
mental health problem##2##3##(1994-1#1)(2011-2#1)
mental health problems among##3##4##(1996-1#1)(2012-12#1)(2013-1#1)
mental health problems in##5##4##(1992-2#1)(1993-1#1)(1997-5#1)(2009-7#1)(2011-1#1)
mental health problems is##2##4##(1997-3#1)(2011-2#1)
mental health problems were##2##4##(2008-11#1)(2013-1#1)
mental health problems##30##3##(1992-1#1)(1992-2#2)(1993-1#3)(1993-3#1)(1996-1#3)(1997-3#1)(1997-5#2)(2008-1#1)(2008-11#5)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
mental health professionals##13##3##(1991-1#1)(1992-6#1)(1994-1#4)(2008-11#3)(2008-2#1)(2008-3#1)(2009-9#2)
mental health profiles##2##3##(1992-1#1)(2008-11#1)
mental health promotion principles##2##4##(2011-2#2)
mental health promotion##8##3##(2008-11#1)(2010-12#2)(2011-2#4)(2013-1#1)
mental health providers##6##3##(1993-12#1)(1996-3#2)(2008-6#1)(2010-10#2)
mental health records##7##3##(1991-12#3)(1992-3#4)
mental health recovery##3##3##(2012-2#3)
mental health risk##2##3##(2009-9#1)(2012-3#1)
mental health service delivery##5##4##(1992-1#1)(1992-3#1)(2008-11#1)(2012-2#2)
mental health service in##2##4##(2008-12#1)(2008-2#1)
mental health service##13##3##(1991-3#1)(1992-1#1)(1992-3#1)(2008-11#3)(2008-12#2)(2008-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
mental health services for##2##4##(1992-12#1)(1994-1#1)
mental health services in##5##4##(1996-3#1)(2008-11#1)(2008-2#1)(2010-4#2)
mental health services research##2##4##(2012-2#2)
mental health services##33##3##(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#2)(1996-12#1)(1996-3#5)(1997-1#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-2#4)(2009-5#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)
mental health status##4##3##(1994-2#1)(2008-4#1)(2010-2#2)
mental health system##6##3##(1994-1#2)(1997-3#1)(2008-2#3)
mental health teams##3##3##(1993-10#1)(2008-12#2)
mental health treatment##8##3##(1993-1#1)(1995-1#4)(2011-1#3)
mental health utilization management##2##4##(1995-1#2)
mental health were##2##3##(2008-8#1)(2011-1#1)
mental health##436##2##(1990-6#1)(1991-1#3)(1991-12#3)(1991-3#4)(1992-1#10)(1992-12#3)(1992-2#5)(1992-3#8)(1992-6#1)(1993-1#6)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1994-1#16)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#23)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#7)(1996-12#4)(1996-3#8)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#10)(1997-3#8)(1997-4#1)(1997-5#4)(1997-8#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#41)(2008-12#26)(2008-2#16)(2008-3#1)(2008-4#3)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#6)(2009-11#1)(2009-2#1)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#1)(2009-9#7)(2010-1#2)(2010-10#3)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#10)(2010-5#4)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#15)(2011-2#27)(2012-12#14)(2012-2#21)(2012-3#6)(2013-1#29)(2013-8#12)
mental health-related##2##2##(2010-6#1)(2012-12#1)
mental healthcare providers##2##3##(1993-12#1)(1993-2#1)
mental healthcare providers?##2##3##(1993-12#2)
mental healthcare service##2##3##(1991-3#1)(1993-12#1)
mental healthcare##11##2##(1991-3#1)(1992-1#1)(1992-2#2)(1993-12#6)(1993-2#1)
mental hospital##3##2##(1996-9#1)(2008-7#1)(2012-3#1)
mental illness and##7##3##(2009-10#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-3#1)
mental illness in##3##3##(1993-5#1)(2012-3#1)(2013-7#1)
mental illness##53##2##(1993-5#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-8#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#3)(2009-7#1)(2011-1#8)(2011-2#8)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-7#2)
mental illnesses##7##2##(1991-1#1)(1993-1#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
mental images##2##2##(1995-11#1)(2008-5#1)
mental impairment and##2##3##(1990-3#1)(2010-3#1)
mental impairment##7##2##(1990-3#5)(2008-7#1)(2010-3#1)
mental impairments##2##2##(1991-3#1)(1997-2#1)
mental processes##6##2##(1992-9#1)(1996-11#1)(2008-6#1)(2013-8#3)
mental properties##2##2##(2012-2#2)
mental representations of sex-typed bodies##2##5##(2013-8#2)
mental representations of##5##3##(2013-8#5)
mental representations##8##2##(2008-9#1)(2012-2#1)(2013-8#6)
mental retardation and##2##3##(1993-3#1)(1995-2#1)
mental retardation from##2##3##(2007-11#1)(2012-2#1)
mental retardation in##2##3##(1993-3#1)(2011-1#1)
mental retardation or##2##3##(1993-3#1)(1997-3#1)
mental retardation##32##2##(1991-3#1)(1992-5#1)(1993-3#6)(1995-1#2)(1995-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-11#1)(2007-7#1)(2008-1#2)(2009-5#4)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#2)(2012-2#1)
mental rotation task##2##3##(1996-2#1)(2008-11#1)
mental rotation##6##2##(1996-2#2)(2008-11#4)
mental state##3##2##(1993-11#1)(2008-7#1)(2011-1#1)
mental states##8##2##(1996-11#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-3#3)
mental status scores (i##3##4##(2010-12#3)
mental status##10##2##(2007-11#1)(2008-1#1)(2009-3#1)(2010-10#1)(2010-12#4)(2012-12#1)(2013-1#1)
mental stress##2##2##(1991-12#1)(2008-5#1)
mental time travel##3##3##(2013-8#3)
mental training##6##2##(2008-7#3)(2009-11#2)(2012-3#1)
mental well-being and##3##3##(1991-8#2)(2010-7#1)
mental well-being##7##2##(1991-8#6)(2010-7#1)
mental work##3##2##(2010-6#1)(2012-2#2)
mental workload condition##2##3##(2011-2#2)
mental workload##3##2##(2011-2#3)
mental##773##1##(1990-3#7)(1990-6#2)(1990-9#1)(1991-1#6)(1991-12#4)(1991-2#2)(1991-3#7)(1991-5#1)(1991-8#9)(1992-1#11)(1992-12#3)(1992-2#7)(1992-3#8)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#7)(1993-10#1)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#10)(1993-5#1)(1993-6#1)(1994-1#16)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1995-1#28)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#8)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#9)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#14)(1997-3#11)(1997-4#2)(1997-5#5)(1997-6#1)(1997-8#4)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#2)(2008-11#51)(2008-12#32)(2008-2#18)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#8)(2008-7#15)(2008-8#4)(2008-9#6)(2009-10#10)(2009-11#4)(2009-2#2)(2009-3#3)(2009-5#14)(2009-6#8)(2009-7#6)(2009-8#3)(2009-9#10)(2010-1#4)(2010-10#4)(2010-12#11)(2010-2#5)(2010-3#2)(2010-4#15)(2010-5#5)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#30)(2011-2#42)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#25)(2012-2#32)(2012-3#24)(2013-1#35)(2013-7#5)(2013-8#35)
mentality##2##1##(1994-12#1)(1995-1#1)
mentalizing##2##1##(2008-11#2)
mentally competent##2##2##(1994-12#1)(1994-7#1)
mentally handicapped persons##2##3##(1997-8#1)(2008-3#1)
mentally ill African##2##3##(2008-4#2)
mentally ill and mentally retarded elderly##2##6##(2008-2#2)
mentally ill and##3##3##(2008-2#2)(2008-7#1)
mentally ill patients##2##3##(1992-3#1)(1996-9#1)
mentally ill people##2##3##(2009-7#2)
mentally ill##28##2##(1990-2#1)(1992-1#2)(1992-3#3)(1994-2#3)(1994-3#1)(1995-2#2)(1996-1#1)(1996-9#1)(1997-2#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-7#3)(2011-2#1)(2013-1#1)
mentally retarded patients##2##3##(1997-8#2)
mentally retarded##17##2##(1991-1#2)(1991-6#2)(1992-5#3)(1993-1#2)(1997-8#5)(2008-2#2)(2011-1#1)
mentally strenuous##2##2##(2013-1#2)
mentally##68##1##(1990-2#2)(1990-3#1)(1991-1#2)(1991-6#2)(1992-1#2)(1992-3#3)(1992-5#3)(1993-1#2)(1994-1#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#4)(1997-8#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-7#3)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
mentee##3##1##(2011-2#1)(2012-3#2)
menthofuran (II)##4##2##(1990-12#3)(1991-5#1)
menthofuran##6##1##(1990-12#4)(1991-5#2)
menthol cigarette##5##2##(2011-1#5)
menthol##11##1##(1994-6#3)(2008-10#2)(2008-11#1)(2011-1#5)
menthone##6##1##(1994-6#1)(2008-10#4)(2008-11#1)
menthyl acetate##2##2##(2008-10#2)
mention of##5##2##(1992-11#1)(2009-9#1)(2013-1#3)
mention the##2##2##(1995-2#1)(2011-2#1)
mention##21##1##(1990-3#1)(1992-1#1)(1992-11#1)(1993-2#1)(1995-2#1)(1996-11#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-9#1)(2011-2#3)(2013-1#4)
mentioned above##10##2##(1990-2#1)(1990-8#1)(1993-9#1)(1994-9#1)(2007-6#1)(2008-10#3)(2008-8#1)(2011-2#1)
mentioned and##2##2##(2007-2#1)(2008-3#1)
mentioned as##2##2##(2008-5#1)(2010-5#1)
mentioned by##4##2##(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
mentioned for##2##2##(2008-12#1)(2013-1#1)
mentioned here##2##2##(2007-11#1)(2012-1#1)
mentioned in the##4##3##(1992-6#1)(2008-5#1)(2008-7#1)(2012-12#1)
mentioned in this##2##3##(1995-1#1)(2011-1#1)
mentioned in##9##2##(1992-6#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-12#1)
mentioned process##2##2##(2011-2#1)(2012-3#1)
mentioned that##3##2##(2010-3#1)(2010-5#1)(2012-3#1)
mentioned the##3##2##(2008-9#1)(2011-2#1)(2013-7#1)
mentioned##119##1##(1990-11#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
mentioning##6##1##(1991-12#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#2)
mentor and##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
mentor in##3##2##(2008-11#2)(2008-6#1)
mentor is a##2##3##(1993-12#1)(2008-7#1)
mentor is##4##2##(1993-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
mentor##33##1##(1993-12#1)(2008-1#1)(2008-11#10)(2008-12#2)(2008-6#1)(2008-7#10)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#5)
mentor's##2##1##(2008-7#2)
mentoring##9##1##(1996-2#1)(1997-2#1)(2008-11#1)(2008-9#3)(2012-3#2)(2013-1#1)
mentors and##2##2##(2010-2#1)(2011-2#1)
mentors to##2##2##(2008-11#2)
mentors who have##2##3##(2008-11#1)(2012-3#1)
mentors##17##1##(1994-2#1)(1995-12#1)(2008-1#1)(2008-11#4)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#6)
mentorship##8##1##(1993-12#1)(1997-3#1)(2008-11#4)(2008-7#1)(2009-4#1)
menu mode##4##2##(1991-12#4)
menu##12##1##(1991-12#4)(1993-3#1)(1996-11#1)(1996-2#2)(1997-3#1)(2008-3#1)(2008-5#1)(2008-9#1)
menuing software##2##2##(1991-12#2)
menus and##2##2##(1992-4#1)(1993-12#1)
menus##6##1##(1991-12#1)(1992-4#2)(1993-12#1)(2008-10#1)(2012-2#1)
menziesii)##2##1##(2008-10#2)
meperidine intrathecally##2##2##(2011-2#2)
meperidine##7##1##(1995-11#1)(2007-10#2)(2011-2#4)
mepyramine##2##1##(1992-11#1)(1995-12#1)
meq of Cl(-) per##2##4##(2008-10#2)
meq##5##1##(2008-10#5)
mequitazine and##3##2##(2008-10#3)
mequitazine in human plasma##3##4##(2008-10#3)
mequitazine##7##1##(2008-10#7)
mer##5##1##(1990-11#4)(2008-10#1)
mer)##5##1##(2008-10#3)(2008-11#2)
mer-Ir(CO)(3)(SO(3)F)(3)##3##1##(1996-2#3)
merA##2##1##(1990-11#2)
merC##5##1##(1990-11#5)
merT##2##1##(1990-11#2)
mercaptans##5##1##(2008-10#3)(2008-6#2)
mercapto##7##1##(2008-10#6)(2008-8#1)
mercaptoacetic##2##1##(2008-10#2)
mercaptoacetyltriglycine##3##1##(2008-10#1)(2012-12#2)
mercaptopicolinate##3##1##(1995-8#3)
mercaptopropionic acid (MPA)##2##3##(2008-10#1)(2013-8#1)
mercapturic##2##1##(1996-12#1)(2008-11#1)
merchant seamen##4##2##(1991-12#4)
merchant##6##1##(1991-12#5)(2008-11#1)
mercuric chloride##5##2##(1990-5#1)(2008-10#2)(2008-7#2)
mercuric iodide (HgI(2))##2##3##(2008-2#1)(2008-3#1)
mercuric iodide##3##2##(2008-2#1)(2008-3#2)
mercuric##15##1##(1990-5#1)(1994-5#1)(2006-6#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#2)
mercury (Hg(2+)) and##2##3##(2008-10#2)
mercury (Hg)##4##2##(1993-8#1)(2006-6#1)(2008-10#1)(2013-1#1)
mercury (II) in##2##3##(2008-10#2)
mercury (II)##7##2##(2008-10#7)
mercury after##3##2##(1995-3#1)(2008-10#2)
mercury and##12##2##(1995-2#2)(1995-3#2)(2008-10#7)(2010-11#1)
mercury are##3##2##(1994-3#1)(2008-10#2)
mercury at##3##2##(2008-10#3)
mercury by solid##3##3##(2008-10#3)
mercury by##13##2##(2008-10#13)
mercury complex##2##2##(2008-10#2)
mercury compounds in water samples##2##5##(2008-10#2)
mercury concentration in##2##3##(1993-6#1)(2008-10#1)
mercury concentration##5##2##(1993-6#4)(2008-10#1)
mercury concentrations##2##2##(1993-6#2)
mercury containing##2##2##(2008-10#2)
mercury cycle##2##2##(2008-10#2)
mercury determination by##3##3##(2008-10#3)
mercury determination in##2##3##(2008-10#2)
mercury determination##8##2##(2008-10#8)
mercury determinations##2##2##(2008-10#2)
mercury drop electrode was##5##4##(2008-10#5)
mercury drop electrode##58##3##(2008-10#58)
mercury drop electrodes##2##3##(2008-10#2)
mercury drop##61##2##(2008-10#61)
mercury electrode and##6##3##(2008-10#6)
mercury electrode at##2##3##(2008-10#2)
mercury electrode##32##2##(1990-5#2)(2008-10#30)
mercury electrodes##4##2##(2008-10#4)
mercury exposure##3##2##(1995-3#1)(2008-10#2)
mercury extraction from##2##3##(2008-10#2)
mercury film electrode (MFE)##3##4##(2008-10#3)
mercury film electrode##9##3##(2008-10#9)
mercury film electrodes for the##2##5##(2008-10#2)
mercury film electrodes##8##3##(2008-10#8)
mercury film on##2##3##(2008-10#2)
mercury film##24##2##(2008-10#24)
mercury from the##2##3##(2008-10#2)
mercury from##14##2##(1991-2#1)(1995-6#3)(2008-10#7)(2008-6#3)
mercury in biological samples##2##4##(2008-10#2)
mercury in biological##3##3##(2008-10#3)
mercury in environmental##3##3##(2008-10#3)
mercury in natural##2##3##(2008-10#2)
mercury in the##4##3##(2008-10#3)(2013-1#1)
mercury in water##4##3##(2008-10#4)
mercury in##51##2##(1993-6#1)(1995-6#2)(2008-10#44)(2008-12#1)(2013-1#3)
mercury ions##14##2##(1991-9#1)(2008-10#13)
mercury is##5##2##(2008-10#5)
mercury lamp##2##2##(2008-10#2)
mercury layers##2##2##(2008-3#2)
mercury prior to##2##3##(2008-10#2)
mercury ranging##2##2##(2008-10#2)
mercury species are##2##3##(2008-10#2)
mercury species##15##2##(2008-10#15)
mercury sphygmomanometer##2##2##(1991-3#1)(2008-11#1)
mercury standard##2##2##(2008-10#2)
mercury surface##3##2##(1990-5#1)(2008-10#2)
mercury thin film electrodes##4##4##(2008-10#4)
mercury thiocyanate##2##2##(2008-10#2)
mercury using##2##2##(2008-10#2)
mercury vapour##4##2##(1995-6#1)(2008-10#3)
mercury was determined##2##3##(2008-10#2)
mercury was##6##2##(2008-10#6)
mercury were##3##2##(2008-10#3)
mercury##453##1##(1990-2#1)(1990-5#3)(1991-2#1)(1991-3#3)(1991-9#1)(1992-11#2)(1993-11#3)(1993-12#2)(1993-6#7)(1993-8#2)(1994-3#1)(1995-2#2)(1995-3#9)(1995-6#8)(1996-2#1)(1996-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#382)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#6)(2008-7#1)(2009-12#1)(2010-11#1)(2013-1#6)
mercury(II) and lead(II)##4##3##(2008-10#4)
mercury(II) and methylmercury##2##3##(2008-10#2)
mercury(II) and##7##2##(2008-10#7)
mercury(II) by##6##2##(2008-10#6)
mercury(II) in aqueous##2##3##(2008-10#2)
mercury(II) in##5##2##(2008-10#5)
mercury(II) ion-selective electrode##2##3##(2008-10#2)
mercury(II) ions##3##2##(2008-10#3)
mercury(II) was##2##2##(2008-10#2)
mercury(II) were also##2##3##(2008-10#2)
mercury(II)##47##1##(2008-10#47)
mercury)##2##1##(2008-10#2)
mercury-film##3##1##(2008-10#3)
mercury-free##2##1##(2008-10#2)
mercury-producing plant##2##2##(1996-3#2)
mercy##6##1##(1993-5#1)(2008-6#1)(2008-8#4)
mere##22##1##(1991-9#1)(1995-12#2)(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
merely a##3##2##(1995-2#1)(2008-11#1)(2009-5#1)
merely as a##2##3##(2008-7#1)(2012-3#1)
merely foreseen##2##2##(2012-2#2)
merely##40##1##(1990-5#2)(1990-8#2)(1991-9#1)(1994-12#3)(1995-1#1)(1995-2#1)(1995-3#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-2#1)(2009-5#2)(2010-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
merge in##3##2##(2008-2#2)(2008-3#1)
merge into##2##2##(2007-12#1)(2008-4#1)
merge the##2##2##(1996-1#1)(2010-3#1)
merge with##3##2##(1996-1#1)(2007-12#1)(2009-9#1)
merge##20##1##(1992-8#1)(1993-12#1)(1996-1#2)(2007-12#5)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-3#1)
merged for##2##2##(2007-7#1)(2008-3#1)
merged streams of##2##3##(2008-10#2)
merged with a##6##3##(2008-10#6)
merged with an##3##3##(2007-12#1)(2008-10#2)
merged with the origin of the##2##6##(2012-2#2)
merged with the##5##3##(2008-10#3)(2012-2#2)
merged with##24##2##(1993-3#1)(2007-12#1)(2007-5#1)(2008-10#17)(2008-2#1)(2011-2#1)(2012-2#2)
merged##38##1##(1992-2#1)(1993-3#1)(1995-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-2#3)(2008-3#1)(2011-2#2)(2012-2#2)
merger##23##1##(1990-4#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-5#2)(1995-3#2)(1996-3#3)(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
mergers and acquisitions##2##3##(2008-1#1)(2008-12#1)
mergers##10##1##(1991-9#1)(1992-3#1)(1994-2#1)(1996-2#1)(1997-1#4)(2008-1#1)(2008-12#1)
merges the##3##2##(1993-2#1)(2008-5#1)(2013-8#1)
merges with the##2##3##(2008-10#2)
merges with##4##2##(2008-10#4)
merges##10##1##(1993-2#1)(1994-3#1)(2008-10#4)(2008-5#1)(2009-10#1)(2013-1#1)(2013-8#1)
merging of##5##2##(1991-3#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-7#1)
merging the##2##2##(1996-2#1)(2008-10#1)
merging with##2##2##(2008-1#1)(2008-11#1)
merging zones##4##2##(2008-10#4)
merging##24##1##(1991-1#1)(1991-3#1)(1995-2#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#1)
merging-zones##2##1##(2008-10#2)
meridian##11##1##(2008-9#9)(2009-7#1)(2011-2#1)
meridians##4##1##(2008-3#1)(2008-9#1)(2010-7#2)
meridional plane##2##2##(2008-2#2)
meridional##5##1##(1992-7#1)(2008-2#2)(2008-7#2)
meridionalis and D##3##3##(2008-10#3)
meridionalis but##2##2##(2008-10#2)
meridionalis##16##1##(2008-10#16)
meristem and the##3##3##(1997-2#1)(1997-8#1)(2009-8#1)
meristem##19##1##(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-8#1)(2009-8#7)(2012-2#3)
meristematic##3##1##(2008-10#1)(2008-5#2)
meristems##5##1##(2007-5#1)(2008-8#1)(2008-9#1)(2009-8#2)
meristic##2##1##(2008-5#1)(2008-8#1)
merit and##4##2##(2008-10#4)
merit as##3##2##(2008-10#2)(2013-8#1)
merit function##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
merit further investigation##3##3##(1995-11#1)(2009-7#1)(2011-2#1)
merit further##4##2##(1995-11#1)(2009-7#1)(2011-2#1)(2012-3#1)
merit of the method##3##4##(2008-10#3)
merit of the##11##3##(2008-10#9)(2008-11#1)(2012-12#1)
merit of##12##2##(2008-10#10)(2008-11#1)(2012-12#1)
merit pay##2##2##(1996-3#1)(1997-1#1)
merit that##2##2##(2008-10#1)(2008-2#1)
merit to##2##2##(2007-11#1)(2008-10#1)
merit##74##1##(1991-1#1)(1992-8#1)(1995-11#1)(1995-12#2)(1996-3#1)(1997-1#1)(2007-11#5)(2007-12#5)(2008-10#35)(2008-11#1)(2008-2#4)(2008-3#9)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
merits and demerits of##2##4##(2008-10#2)
merits and disadvantages##2##3##(2010-12#1)(2012-12#1)
merits and##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
merits further investigation##2##3##(2009-2#1)(2013-8#1)
merits further##3##2##(2006-10#1)(2009-2#1)(2013-8#1)
merits in the##2##3##(2008-10#1)(2012-12#1)
merits in##3##2##(2008-10#2)(2012-12#1)
merits of the##4##3##(2008-3#3)(2010-12#1)
merits of these##2##3##(2008-3#1)(2010-12#1)
merits of this##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
merits of##22##2##(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(2008-10#2)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#2)(2010-3#1)(2011-2#1)(2013-1#1)
merits##46##1##(1991-12#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
merocyanine 540##2##2##(1992-6#1)(1994-12#1)
meropenem##6##1##(2007-7#1)(2008-7#2)(2011-1#1)(2013-8#2)
merozoite surface##2##2##(1994-12#1)(2012-2#1)
mersalyl##4##1##(1994-8#4)
mersilene##2##1##(1993-9#1)(2007-8#1)
merus##2##1##(2008-5#1)(2008-6#1)
mesalazine and##2##2##(2010-11#1)(2010-12#1)
mesalazine##6##1##(2006-10#1)(2010-11#3)(2010-12#2)
mesangial cells and podocytes##2##4##(2008-1#2)
mesangial cells##19##2##(1992-6#2)(1993-8#3)(1995-11#5)(1995-2#1)(2008-1#3)(2008-4#2)(2011-2#3)
mesangial proliferative glomerulonephritis##3##3##(2007-7#3)
mesangial proliferative##5##2##(1997-8#1)(2007-7#3)(2008-1#1)
mesangial##30##1##(1990-9#1)(1992-6#2)(1992-8#1)(1993-8#3)(1995-11#5)(1995-2#1)(1996-6#1)(1997-8#1)(2007-7#3)(2008-1#5)(2008-4#2)(2011-2#5)
mesangiocapillary##2##1##(2008-1#2)
mesangioproliferative##2##1##(2008-1#2)
mesangium##3##1##(1993-2#1)(2008-1#1)(2011-2#1)
mesencephalic##10##1##(1990-9#1)(1992-10#1)(1994-2#1)(1996-2#3)(1997-2#1)(2008-4#1)(2008-7#2)
mesencephalon and##3##2##(1991-12#1)(2008-7#1)(2011-1#1)
mesencephalon##7##1##(1991-12#3)(1996-12#1)(1996-5#1)(2008-7#1)(2011-1#1)
mesenchymal and epithelial##2##3##(1994-5#1)(2013-1#1)
mesenchymal and##3##2##(1994-5#1)(2008-9#1)(2013-1#1)
mesenchymal cell##3##2##(1991-5#1)(1994-5#1)(2008-11#1)
mesenchymal cells inhibited from undergoing##2##5##(1994-11#2)
mesenchymal cells##15##2##(1991-11#1)(1991-9#1)(1994-11#4)(1995-4#1)(2008-11#2)(2008-6#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
mesenchymal elements##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
mesenchymal neoplasms##2##2##(2012-3#1)(2013-1#1)
mesenchymal progenitor cells##4##3##(2008-11#4)
mesenchymal stem cell population##2##4##(2008-11#2)
mesenchymal stem cell##9##3##(2008-11#3)(2010-10#1)(2011-2#1)(2012-12#2)(2012-5#1)(2012-7#1)
mesenchymal stem cells (MSCs) to##2##5##(2008-11#1)(2010-8#1)
mesenchymal stem cells (MSCs)##8##4##(2008-11#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#2)(2012-7#1)
mesenchymal stem cells for##2##4##(2012-12#2)
mesenchymal stem cells from##5##4##(2008-9#2)(2009-12#1)(2012-2#2)
mesenchymal stem cells in fibrin 3D matrix##2##7##(2012-1#2)
mesenchymal stem cells in##5##4##(2012-1#3)(2012-12#2)
mesenchymal stem cells on##4##4##(2008-11#1)(2012-1#2)(2012-3#1)
mesenchymal stem cells##55##3##(2008-11#7)(2008-5#3)(2008-9#8)(2009-10#1)(2009-12#2)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#1)(2012-1#10)(2012-12#8)(2012-2#3)(2012-3#1)(2012-4#1)(2012-7#2)(2013-1#3)
mesenchymal stem##64##2##(2008-11#10)(2008-5#3)(2008-9#8)(2009-10#1)(2009-12#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#2)(2012-1#10)(2012-12#10)(2012-2#3)(2012-3#1)(2012-4#1)(2012-5#1)(2012-7#3)(2013-1#3)
mesenchymal stromal##2##2##(2012-1#2)
mesenchymal tissue##3##2##(1990-5#1)(2008-6#2)
mesenchymal tumor##6##2##(1994-5#1)(2008-7#1)(2009-3#2)(2010-6#1)(2013-1#1)
mesenchymal tumors of the##2##4##(1997-3#1)(2012-12#1)
mesenchymal tumors##6##2##(1997-3#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
mesenchymal tumour##2##2##(2008-6#2)
mesenchymal tumours##2##2##(2008-6#2)
mesenchymal##140##1##(1990-5#1)(1991-11#1)(1991-5#1)(1991-9#1)(1994-11#4)(1994-5#3)(1995-4#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#20)(2008-5#3)(2008-6#11)(2008-7#1)(2008-9#13)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#11)(2012-1#12)(2012-12#13)(2012-2#3)(2012-3#3)(2012-4#1)(2012-5#1)(2012-7#3)(2013-1#7)(2013-7#1)
mesenchyme in##2##2##(2008-11#1)(2008-9#1)
mesenchyme##19##1##(1991-2#3)(1993-3#1)(1995-8#2)(2008-11#5)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2013-1#1)
mesenchymes##3##1##(1997-4#1)(2008-6#2)
mesenchymoma##3##1##(1997-3#2)(2007-8#1)
mesendoblast##2##1##(2007-12#2)
mesenterial##3##1##(1990-6#1)(2012-3#2)
mesenteric arteries##3##2##(1992-3#2)(2008-11#1)
mesenteric artery dissection##2##3##(2013-1#2)
mesenteric artery##16##2##(1991-5#1)(1991-6#2)(1992-3#1)(1992-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2013-1#7)(2013-8#1)
mesenteric fibromatosis##3##2##(1990-6#1)(1994-5#2)
mesenteric ischemia##6##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)
mesenteric lymph node##2##3##(1993-2#1)(2008-5#1)
mesenteric lymph nodes##3##3##(1996-12#1)(2008-11#1)(2012-3#1)
mesenteric lymph##5##2##(1993-2#1)(1996-12#1)(2008-11#1)(2008-5#1)(2012-3#1)
mesenteric vasculature##2##2##(1996-2#2)
mesenteric vein##4##2##(1990-3#1)(2007-7#2)(2011-3#1)
mesenteric##59##1##(1990-3#1)(1990-6#2)(1991-5#1)(1991-6#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1993-2#1)(1993-5#1)(1994-5#3)(1996-12#1)(1996-2#5)(1997-8#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
mesenteries##4##1##(2008-1#3)(2013-1#1)
mesenteritis##2##1##(1992-5#1)(2011-2#1)
mesenteron##5##1##(2008-7#5)
mesentery in##2##2##(1990-8#1)(2011-2#1)
mesentery##15##1##(1990-5#1)(1990-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
mesentery-derived mesothelial cells##2##3##(2008-11#2)
mesentery-derived##4##1##(2008-11#4)
mesh and##2##2##(2008-11#1)(2011-2#1)
mesh has##2##2##(2011-2#2)
mesh in##3##2##(1992-3#1)(2010-11#1)(2011-2#1)
mesh is a##2##3##(2011-2#2)
mesh is##3##2##(2008-6#1)(2011-2#2)
mesh morphing and mapping techniques##2##5##(2013-1#2)
mesh reinforcement##2##2##(2011-2#2)
mesh repair##2##2##(2010-4#1)(2011-2#1)
mesh simplification##3##2##(2008-6#3)
mesh size##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2013-7#1)
mesh was##3##2##(1990-8#1)(2013-1#2)
mesh##86##1##(1990-8#1)(1992-3#1)(1993-9#1)(1996-9#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#2)(2008-6#11)(2008-7#5)(2009-7#1)(2010-11#1)(2010-4#4)(2010-6#2)(2011-2#30)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
mesh)##2##1##(2008-10#2)
meshes and##2##2##(2011-2#1)(2012-1#1)
meshes with##3##2##(2008-6#1)(2012-1#2)
meshes##25##1##(2008-3#1)(2008-6#4)(2009-7#4)(2011-2#8)(2012-1#5)(2012-2#1)(2013-7#1)(2013-8#1)
meshing##3##1##(2008-6#2)(2013-1#1)
meshwork##6##1##(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)
mesial##6##1##(1995-5#2)(2008-11#1)(2012-12#3)
mesially##2##1##(2010-3#1)(2013-1#1)
mesiodistal##4##1##(2010-3#3)(2012-3#1)
mesna and total mesna in urine##2##6##(2008-10#2)
mesna and total mesna##3##4##(2008-10#3)
mesna and##4##2##(2008-10#4)
mesna##18##1##(2007-10#1)(2008-10#17)
meso##5##1##(1992-3#1)(1994-5#1)(2009-12#1)(2009-5#2)
meso-##4##1##(2008-10#1)(2008-7#1)(2010-7#1)(2013-1#1)
meso-2##4##1##(1992-12#3)(1995-3#1)
meso-fluidic##2##1##(2008-10#2)
meso-nitrogen##2##1##(2008-10#2)
meso-tetrakis##4##1##(2008-10#3)(2008-3#1)
mesoamerican##2##1##(2011-2#2)
mesoblastic nephroma##2##2##(2012-3#2)
mesocarp and##3##2##(2008-10#3)
mesocarp##7##1##(2008-10#6)(2008-6#1)
mesocosm period##2##2##(2010-8#2)
mesocosm##4##1##(2008-8#1)(2010-8#2)(2013-1#1)
mesocosms to##2##2##(2008-8#2)
mesocosms##5##1##(2008-8#3)(2010-8#2)
mesoderm##11##1##(1993-12#1)(1994-12#2)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)(2012-12#1)
mesodermal and ectodermal##2##3##(1993-12#1)(2008-12#1)
mesodermal##10##1##(1992-9#1)(1993-12#1)(1996-5#1)(2007-7#1)(2008-12#1)(2012-12#3)(2012-7#1)(2013-1#1)
mesogastrium##2##1##(1995-3#1)(2013-1#1)
mesogenic materials##3##2##(2007-11#1)(2007-12#2)
mesoionic compounds##2##2##(2008-3#2)
mesolimbic dopamine##3##2##(1993-12#1)(1993-6#1)(1997-7#1)
mesolimbic dopaminergic##2##2##(1995-2#1)(2009-8#1)
mesolimbic##8##1##(1991-1#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(1997-7#1)(2009-7#1)(2009-8#1)
mesonephric duct##3##2##(2008-10#3)
mesonephric##4##1##(2008-10#4)
mesons##2##1##(1990-4#2)
mesopause winds##2##2##(2008-3#2)
mesopause##4##1##(2008-3#4)
mesopelagic##3##1##(2008-5#3)
mesophilic##9##1##(1995-5#1)(2008-7#2)(2008-9#2)(2011-2#3)(2013-1#1)
mesophyll and##3##2##(1990-5#1)(2008-10#1)(2008-9#1)
mesophyll cells##7##2##(1994-8#1)(2008-10#5)(2012-2#1)
mesophyll protoplasts of##2##3##(2008-10#1)(2008-9#1)
mesophyll protoplasts##3##2##(2008-10#1)(2008-9#2)
mesophyll##22##1##(1990-5#1)(1994-8#1)(2008-10#15)(2008-9#3)(2012-2#1)(2013-7#1)
mesopic##2##1##(2011-2#2)
mesoporous MCM-41##3##2##(2010-4#3)
mesoporous material##3##2##(2008-10#2)(2010-4#1)
mesoporous materials##4##2##(2008-1#1)(2008-10#3)
mesoporous silica##5##2##(2008-10#3)(2008-7#1)(2010-4#1)
mesoporous structure##2##2##(2008-10#1)(2009-11#1)
mesoporous##26##1##(2008-1#1)(2008-10#17)(2008-7#1)(2009-11#1)(2010-4#6)
mesoscale##4##1##(1992-11#1)(2008-10#2)(2008-3#1)
mesoscopic activity in##2##3##(2008-11#2)
mesoscopic##9##1##(2008-11#5)(2008-7#1)(2010-5#1)(2013-1#2)
mesosphere##4##1##(2008-3#4)
mesospheric##2##1##(2008-2#1)(2008-3#1)
mesostructured tin oxide##3##3##(2008-10#3)
mesotelencephalic##2##1##(1992-10#1)(1996-2#1)
mesothelial cell##2##2##(2011-2#1)(2013-1#1)
mesothelial cells to##2##3##(2013-1#2)
mesothelial cells##14##2##(1991-12#1)(2007-12#1)(2008-11#3)(2011-2#1)(2013-1#8)
mesothelial##18##1##(1991-12#1)(2007-12#1)(2008-11#3)(2011-2#3)(2013-1#10)
mesothelial-cell##4##1##(2008-11#4)
mesothelin##4##1##(2012-2#4)
mesothelioma among##2##2##(1991-12#1)(1995-2#1)
mesothelioma and in##2##3##(1990-12#1)(1992-11#1)
mesothelioma and##5##2##(1990-12#1)(1991-12#1)(1992-11#1)(1995-2#1)(2008-8#1)
mesothelioma associated with chronic empyema with elevation of serum CYFRA19##2##10##(2010-1#2)
mesothelioma had been##2##3##(1992-11#2)
mesothelioma had##3##2##(1992-11#3)
mesothelioma in school teachers##2##4##(1991-12#2)
mesothelioma in##9##2##(1991-12#5)(1995-2#1)(1997-5#1)(2008-8#1)(2011-2#1)
mesothelioma is a##3##3##(1991-12#1)(1993-9#1)(2010-12#1)
mesothelioma is##11##2##(1991-12#2)(1992-11#1)(1993-9#2)(1997-5#1)(2007-8#1)(2010-12#2)(2010-5#1)(2012-2#1)
mesothelioma patients##2##2##(1990-12#2)
mesothelioma tissues##3##2##(1991-12#3)
mesothelioma with##2##2##(2012-2#2)
mesothelioma##94##1##(1990-12#5)(1991-12#32)(1991-2#3)(1992-11#10)(1992-12#3)(1993-9#6)(1995-12#1)(1995-2#3)(1997-5#5)(2007-8#8)(2008-10#1)(2008-8#2)(2010-1#2)(2010-12#4)(2010-5#3)(2011-2#1)(2012-2#5)
mesotheliomas##4##1##(1991-12#2)(1995-10#1)(2010-12#1)
mesotympanum##2##1##(2008-9#2)
mesquite pods##2##2##(2008-10#2)
mesquite##3##1##(2008-10#3)
message about##3##2##(1995-8#1)(1997-6#1)(2013-8#1)
message and##3##2##(1992-7#1)(2007-2#1)(2008-4#1)
message by##2##2##(1994-11#1)(1995-2#1)
message for##2##2##(1991-12#1)(2010-4#1)
message has##2##2##(1991-2#1)(2007-11#1)
message in the##2##3##(1992-12#1)(2007-11#1)
message in##4##2##(1992-12#1)(1992-8#1)(1995-6#1)(2007-11#1)
message is##5##2##(1992-5#1)(1993-8#1)(2007-11#1)(2010-3#1)(2011-2#1)
message levels##2##2##(1990-2#1)(1997-1#1)
message of##4##2##(1991-12#1)(1997-6#1)(1997-7#1)(2008-12#1)
message that##4##2##(2008-4#1)(2008-8#1)(2010-11#1)(2010-8#1)
message to##3##2##(1991-2#1)(2010-11#1)(2011-2#1)
message transmission##2##2##(2007-11#2)
message was##2##2##(1992-12#1)(1997-8#1)
message##80##1##(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#2)(2007-2#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-8#5)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#3)
messages about##3##2##(2007-12#2)(2010-11#1)
messages and##3##2##(2008-7#1)(2009-7#1)(2011-1#1)
messages encouraging physical activity##2##4##(2009-6#2)
messages for##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
messages from##5##2##(2007-12#2)(2008-7#1)(2010-4#1)(2012-3#1)
messages of the##2##3##(2008-10#1)(2010-4#1)
messages of##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
messages on##2##2##(2008-4#1)(2009-6#1)
messages sent by##2##3##(1992-2#1)(2012-3#1)
messages to the##2##3##(2008-4#1)(2010-3#1)
messages to##5##2##(2008-12#1)(2008-2#1)(2008-4#1)(2010-3#1)(2010-8#1)
messages were##2##2##(2007-12#1)(2010-2#1)
messages##63##1##(1990-8#1)(1992-2#1)(1994-11#1)(1994-3#3)(1995-1#1)(1996-1#1)(2007-11#1)(2007-12#9)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#3)(2009-5#3)(2009-6#6)(2009-7#2)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#5)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#4)
messaging##3##1##(2008-7#1)(2013-1#2)
messenger RNA (mRNA)##6##3##(1994-8#1)(2008-4#1)(2008-9#1)(2012-2#2)(2013-1#1)
messenger RNA in##4##3##(1991-9#1)(1993-11#1)(1993-8#1)(1993-9#1)
messenger RNA##30##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
messenger RNAs##3##2##(2008-1#1)(2008-7#1)(2010-9#1)
messenger and##4##2##(1994-2#1)(1995-11#1)(2008-4#1)(2008-8#1)
messenger for##3##2##(1992-9#1)(1994-6#1)(2008-4#1)
messenger in the thyroid##2##4##(1990-2#2)
messenger in the##3##3##(1990-2#2)(1995-8#1)
messenger in##4##2##(1990-2#2)(1993-6#1)(1995-8#1)
messenger ribonucleic acid##2##3##(1992-9#1)(1995-12#1)
messenger system##4##2##(1992-3#1)(1994-9#1)(1996-5#1)(2008-4#1)
messenger that mediates##2##3##(2008-11#1)(2008-4#1)
messenger that##3##2##(2008-11#1)(2008-4#1)(2010-10#1)
messenger##87##1##(1990-11#2)(1990-2#4)(1990-5#1)(1990-7#3)(1991-12#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#9)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-9#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
messengers and##5##2##(1990-2#1)(1995-3#1)(2008-7#1)(2009-6#1)(2013-1#1)
messengers in the##2##3##(2008-2#1)(2008-7#1)
messengers in##5##2##(1990-7#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
messengers that##2##2##(1991-3#1)(2008-5#1)
messengers##28##1##(1990-2#1)(1990-7#1)(1991-3#2)(1991-9#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#4)(2009-6#2)(2009-8#2)(2010-11#2)(2013-1#1)
messengers'##3##1##(1994-6#1)(2008-5#2)
mestizo##3##1##(2006-10#1)(2008-3#1)(2013-1#1)
mesylate and##4##2##(2008-10#2)(2008-7#2)
mesylate##9##1##(1990-11#1)(2008-10#4)(2008-7#2)(2009-4#1)(2010-11#1)
met DSM-III-R criteria for##2##4##(1994-2#1)(2008-7#1)
met at##2##2##(2008-11#1)(2008-3#1)
met by the##3##3##(1992-8#1)(2008-2#1)(2008-9#1)
met by##10##2##(1990-2#1)(1992-8#1)(1995-2#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)
met criteria for LH##2##4##(1996-7#2)
met criteria for##6##3##(1994-2#1)(1996-7#2)(2009-5#1)(2010-2#1)(2013-1#1)
met in##7##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)
met inclusion criteria##5##3##(2007-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
met only##2##2##(2010-12#1)(2012-3#1)
met the DSM-IV criteria##2##4##(2007-7#1)(2011-2#1)
met the criteria for##3##4##(2011-2#1)(2013-1#2)
met the criteria##8##3##(2007-7#1)(2011-2#2)(2012-2#2)(2013-1#3)
met the following criteria##2##4##(1997-5#1)(2013-1#1)
met the inclusion criteria and##2##5##(2010-4#1)(2010-6#1)
met the inclusion criteria##9##4##(2010-12#1)(2010-4#1)(2010-6#3)(2011-2#1)(2012-3#2)(2013-1#1)
met the inclusion##10##3##(2007-11#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-2#1)(2012-3#2)(2013-1#1)
met the study criteria##2##4##(2007-10#1)(2012-12#1)
met the##42##2##(1997-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#2)(2010-4#1)(2010-6#3)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)
met their expectations##2##3##(2008-9#1)(2012-12#1)
met to##3##2##(1995-12#1)(1997-3#1)(2011-2#1)
met with##9##2##(1994-2#1)(1995-12#1)(1996-2#1)(2007-5#2)(2008-1#1)(2009-10#1)(2009-11#1)(2010-3#1)
met within##2##2##(2010-2#1)(2012-3#1)
met##163##1##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-8#2)(1994-2#4)(1994-3#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#4)(1995-3#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-7#2)(1997-1#1)(1997-3#2)(1997-5#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#15)(2013-8#2)
meta##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
meta-analyses and##2##2##(2007-7#1)(2008-6#1)
meta-analyses are##3##2##(1996-6#1)(2013-1#2)
meta-analyses in##3##2##(1993-12#1)(1996-6#1)(2013-1#1)
meta-analyses of##3##2##(1996-6#2)(2010-5#1)
meta-analyses that##2##2##(1993-12#1)(2010-2#1)
meta-analyses##28##1##(1991-3#1)(1993-12#3)(1995-2#1)(1996-6#6)(2007-7#1)(2008-11#1)(2008-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
meta-analysis and##7##2##(1992-2#1)(1996-3#1)(1996-6#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-11#1)
meta-analysis demonstrated that##2##3##(2010-11#1)(2012-12#1)
meta-analysis evaluates the##2##3##(2009-9#1)(2010-11#1)
meta-analysis has##2##2##(2008-2#1)(2012-2#1)
meta-analysis in##3##2##(1996-6#2)(2008-9#1)
meta-analysis of randomized##2##3##(2012-3#1)(2013-1#1)
meta-analysis of studies##2##3##(2008-4#1)(2013-8#1)
meta-analysis of the effect of##2##5##(1991-9#1)(2008-10#1)
meta-analysis of the relationship##2##4##(2008-10#1)(2008-5#1)
meta-analysis of the results of##2##5##(1992-11#1)(2013-1#1)
meta-analysis of the##12##3##(1990-9#1)(1991-9#1)(1992-11#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#1)
meta-analysis of##36##2##(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-11#1)(1995-2#3)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
meta-analysis on##3##2##(1994-2#1)(2008-7#1)(2013-8#1)
meta-analysis suggests##2##2##(2008-8#1)(2011-2#1)
meta-analysis to determine the overall##2##5##(2008-10#2)
meta-analysis to##6##2##(2007-12#1)(2008-10#3)(2008-8#1)(2013-8#1)
meta-analysis was conducted##2##3##(2007-6#1)(2008-2#1)
meta-analysis was performed##2##3##(2008-10#1)(2011-2#1)
meta-analysis was##9##2##(1996-8#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-2#1)(2010-8#1)(2011-2#1)
meta-analysis with##3##2##(1996-3#1)(2012-3#1)(2013-1#1)
meta-analysis##135##1##(1990-9#2)(1991-10#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-2#4)(1996-3#4)(1996-6#5)(1996-8#1)(1997-7#2)(1997-8#4)(2007-12#3)(2007-6#2)(2007-7#4)(2008-10#13)(2008-11#2)(2008-12#5)(2008-2#5)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#3)(2009-11#1)(2009-2#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#4)(2013-8#5)
meta-analysis]##3##1##(1991-9#1)(2013-1#2)
meta-analytic##8##1##(1996-6#3)(2008-11#2)(2008-4#1)(2008-5#1)(2013-8#1)
meta-analytical review##2##2##(1993-6#1)(2008-10#1)
meta-analytical##3##1##(1993-6#1)(2008-10#1)(2008-8#1)
meta-awareness##2##1##(2013-8#2)
meta-regression##2##1##(2013-1#1)(2013-8#1)
metaanalysis##7##1##(2008-2#1)(2008-7#4)(2010-12#1)(2012-2#1)
metabolic abnormalities in##2##3##(1997-7#1)(2008-4#1)
metabolic abnormalities is##2##3##(1997-7#1)(2008-1#1)
metabolic abnormalities##11##2##(1997-7#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2012-3#1)
metabolic acidosis##6##2##(1990-5#1)(1990-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
metabolic activation##12##2##(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#2)(2008-8#2)(2011-1#1)
metabolic activities##2##2##(2011-2#2)
metabolic activity and##2##3##(1991-5#1)(2013-1#1)
metabolic activity in##5##3##(1991-1#1)(1991-10#1)(1997-6#1)(2008-11#1)(2011-1#1)
metabolic activity of the##3##4##(1990-11#1)(2008-10#2)
metabolic activity of##4##3##(1990-11#1)(2008-10#2)(2008-7#1)
metabolic activity##23##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-3#2)(1997-6#1)(2007-8#2)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
metabolic adaptation##2##2##(1996-11#1)(2010-12#1)
metabolic adjustments##3##2##(2008-8#1)(2013-1#2)
metabolic advantage##6##2##(2008-3#5)(2012-2#1)
metabolic alkalosis##2##2##(1996-6#1)(2007-7#1)
metabolic alterations##5##2##(1994-2#1)(2008-3#1)(2009-12#1)(2010-12#1)(2013-1#1)
metabolic and cardiovascular##3##3##(1990-5#1)(2013-1#1)(2013-8#1)
metabolic and hormonal responses##2##4##(1994-12#2)
metabolic and hormonal##4##3##(1994-12#2)(2013-7#2)
metabolic and infectious complications##2##4##(2011-2#1)(2011-3#1)
metabolic and mitogenic##2##3##(2008-9#1)(2010-12#1)
metabolic and regulatory##2##3##(2008-7#2)
metabolic and##40##2##(1990-5#2)(1992-12#1)(1994-12#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#7)(2008-9#1)(2009-5#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
metabolic bone disease##4##3##(2007-11#2)(2012-12#1)(2013-1#1)
metabolic bone##5##2##(1991-5#1)(2007-11#2)(2012-12#1)(2013-1#1)
metabolic capabilities##2##2##(2011-1#1)(2011-2#1)
metabolic changes in##2##3##(2008-10#1)(2012-2#1)
metabolic changes##8##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-7#1)
metabolic complications##11##2##(1990-3#1)(1996-11#1)(2008-3#5)(2011-3#3)(2013-8#1)
metabolic conditions##3##2##(1996-5#1)(2008-3#1)(2013-1#1)
metabolic consequences##2##2##(2008-3#1)(2008-5#1)
metabolic control analysis##3##3##(1990-7#3)
metabolic control and##2##3##(2008-1#1)(2008-3#1)
metabolic control in diabetes##2##4##(1991-2#1)(2012-5#1)
metabolic control in##4##3##(1991-2#1)(1994-12#1)(1994-6#1)(2012-5#1)
metabolic control were##2##3##(1995-2#1)(2011-1#1)
metabolic control##21##2##(1990-7#3)(1991-2#1)(1994-12#3)(1994-6#1)(1995-2#2)(1996-11#2)(2008-1#2)(2008-3#1)(2011-1#2)(2011-2#1)(2012-4#2)(2012-5#1)
metabolic conversion##2##2##(1994-11#1)(1995-12#1)
metabolic data##2##2##(2008-7#1)(2010-12#1)
metabolic defects##2##2##(2008-1#1)(2008-2#1)
metabolic demand##2##2##(2010-12#1)(2010-7#1)
metabolic depression##2##2##(2008-7#1)(2013-1#1)
metabolic derangements##4##2##(1990-6#1)(2008-1#1)(2008-6#2)
metabolic differences between##2##3##(1995-5#1)(2008-10#1)
metabolic differences##3##2##(1995-5#1)(2008-10#1)(2010-5#1)
metabolic disease##2##2##(2006-10#1)(2012-12#1)
metabolic diseases in##2##3##(1990-8#1)(2008-1#1)
metabolic diseases##9##2##(1990-8#1)(2008-1#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
metabolic disorder of##3##3##(1995-3#1)(2008-11#1)(2013-1#1)
metabolic disorder##11##2##(1990-2#3)(1995-3#1)(2007-8#1)(2008-11#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
metabolic disorders and##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
metabolic disorders are##2##3##(1990-2#1)(2010-6#1)
metabolic disorders of##3##3##(1993-8#2)(1997-4#1)
metabolic disorders##29##2##(1990-2#2)(1992-2#1)(1993-8#2)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
metabolic disturbance##2##2##(1991-11#1)(1997-3#1)
metabolic disturbances associated with##2##4##(2008-3#1)(2009-12#1)
metabolic disturbances in##2##3##(2008-10#1)(2009-12#1)
metabolic disturbances##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#2)(2012-1#1)
metabolic dysfunction is##2##3##(2008-3#1)(2012-2#1)
metabolic dysfunction##6##2##(1992-12#1)(2008-3#3)(2012-2#1)(2013-1#1)
metabolic effect##3##2##(1990-2#1)(2008-6#1)(2011-1#1)
metabolic effects of##3##3##(1991-5#1)(2008-4#1)(2008-5#1)
metabolic effects##6##2##(1991-5#1)(1993-1#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)
metabolic energy##2##2##(1994-8#1)(2008-11#1)
metabolic engineering strategies##2##3##(2008-11#1)(2012-3#1)
metabolic engineering##11##2##(2008-11#8)(2008-7#1)(2011-2#1)(2012-3#1)
metabolic enzymes##6##2##(1994-8#1)(2008-11#3)(2008-9#1)(2012-2#1)
metabolic events##2##2##(1994-6#1)(2008-7#1)
metabolic exchange##2##2##(1991-6#1)(2011-1#1)
metabolic factors##2##2##(2010-2#1)(2013-8#1)
metabolic fate##2##2##(1993-12#1)(1996-11#1)
metabolic features##2##2##(2007-5#1)(2011-1#1)
metabolic flux##2##2##(1997-2#1)(2013-1#1)
metabolic fluxes for##2##3##(2008-7#1)(2013-1#1)
metabolic fluxes##4##2##(2008-11#2)(2008-7#1)(2013-1#1)
metabolic footprint of aging##2##4##(2012-2#2)
metabolic functions and##2##3##(1992-5#1)(1992-9#1)
metabolic functions of the##2##4##(1990-11#1)(2012-1#1)
metabolic functions##11##2##(1990-11#1)(1992-5#1)(1992-9#1)(2008-10#2)(2008-11#5)(2012-1#1)
metabolic gases##2##2##(2008-2#2)
metabolic imbalance##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
metabolic inhibition##2##2##(2008-5#1)(2013-1#1)
metabolic inhibitors##2##2##(1994-10#1)(2008-10#1)
metabolic interactions##2##2##(2008-7#2)
metabolic intermediates##2##2##(2012-2#1)(2013-1#1)
metabolic labeling of##2##3##(2008-4#1)(2008-9#1)
metabolic labeling##5##2##(1991-9#1)(1997-1#1)(2008-4#2)(2008-9#1)
metabolic level##2##2##(2008-7#1)(2010-7#1)
metabolic load##6##2##(2008-11#6)
metabolic markers##3##2##(2008-3#1)(2008-5#1)(2013-1#1)
metabolic mechanisms involved##2##3##(1996-9#1)(2008-10#1)
metabolic models##2##2##(2008-7#2)
metabolic modifications##2##2##(2008-11#1)(2010-5#1)
metabolic monitoring##2##2##(2008-8#1)(2011-1#1)
metabolic network and##2##3##(2008-7#1)(2012-2#1)
metabolic network##6##2##(2008-7#3)(2012-2#2)(2013-7#1)
metabolic networks##5##2##(1991-5#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-7#1)
metabolic parameters and##2##3##(2012-12#1)(2012-5#1)
metabolic parameters##7##2##(1990-5#1)(1994-12#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)
metabolic pathway in##2##3##(1990-12#1)(2010-5#1)
metabolic pathway of##2##3##(2011-3#1)(2012-5#1)
metabolic pathway##18##2##(1990-12#1)(1990-6#1)(1993-2#1)(1994-8#1)(1994-9#2)(2008-11#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)
metabolic pathways and##4##3##(2008-10#1)(2011-2#1)(2012-2#2)
metabolic pathways in##3##3##(1993-6#1)(2010-4#1)(2011-2#1)
metabolic pathways involved in##2##4##(2008-8#1)(2011-2#1)
metabolic pathways may##2##3##(2011-2#2)
metabolic pathways of##2##3##(1993-12#1)(2008-8#1)
metabolic pathways##36##2##(1993-12#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#2)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#4)(2013-7#1)
metabolic perturbations##2##2##(1991-12#1)(1991-2#1)
metabolic potential in##2##3##(1995-6#1)(2008-11#1)
metabolic potential##5##2##(1995-6#2)(2008-11#1)(2009-5#1)(2011-2#1)
metabolic process##2##2##(2008-10#1)(2010-4#1)
metabolic processes and##2##3##(1997-1#1)(2008-10#1)
metabolic processes in##2##3##(2012-2#2)
metabolic processes##11##2##(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-2#2)
metabolic products from##2##3##(1990-8#1)(1994-9#1)
metabolic products##4##2##(1990-11#1)(1990-8#1)(1994-9#1)(1996-5#1)
metabolic profile##4##2##(2008-3#1)(2010-4#1)(2013-1#2)
metabolic rate and##3##3##(1997-6#2)(2008-7#1)
metabolic rate during##2##3##(2008-7#1)(2013-1#1)
metabolic rate##24##2##(1991-1#1)(1996-5#1)(1997-6#2)(2007-10#1)(2008-3#1)(2008-4#3)(2008-7#6)(2008-8#1)(2008-9#2)(2010-4#2)(2013-1#3)(2013-8#1)
metabolic rates##6##2##(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-4#1)
metabolic reactions##3##2##(1993-8#1)(2008-7#2)
metabolic recovery##2##2##(1994-2#1)(2012-1#1)
metabolic regulator##2##2##(2012-12#2)
metabolic remission##2##2##(1990-11#2)
metabolic requirements##2##2##(1996-3#1)(2008-1#1)
metabolic response##5##2##(2008-11#2)(2008-12#2)(2012-2#1)
metabolic responses##7##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-8#2)
metabolic risk profile##2##3##(2008-3#2)
metabolic role##3##2##(2008-3#2)(2012-1#1)
metabolic roles##2##2##(1994-8#1)(2008-10#1)
metabolic side##2##2##(2008-8#2)
metabolic signals##2##2##(2008-4#1)(2010-6#1)
metabolic state##5##2##(1994-11#1)(1996-12#1)(2007-10#1)(2008-7#1)(2010-12#1)
metabolic status##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
metabolic stress##5##2##(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
metabolic syndrome (MS) is##2##4##(2008-3#2)
metabolic syndrome (MS)##8##3##(2008-3#5)(2011-1#2)(2013-8#1)
metabolic syndrome (MetS) is##2##4##(2010-10#1)(2012-2#1)
metabolic syndrome (MetS)##5##3##(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#2)
metabolic syndrome (n =##2##4##(2008-11#1)(2008-3#1)
metabolic syndrome among##2##3##(2010-10#1)(2012-2#1)
metabolic syndrome and cardiovascular risk##3##5##(2008-1#2)(2008-3#1)
metabolic syndrome and cardiovascular##5##4##(2008-1#2)(2008-3#2)(2009-2#1)
metabolic syndrome and its components##2##5##(2008-7#1)(2013-1#1)
metabolic syndrome and its##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
metabolic syndrome and##22##3##(2008-1#4)(2008-3#8)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-4#2)(2013-1#3)(2013-8#1)
metabolic syndrome by##2##3##(2008-3#1)(2008-6#1)
metabolic syndrome components##3##3##(2008-3#1)(2012-12#2)
metabolic syndrome group##2##3##(2008-3#2)
metabolic syndrome has##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
metabolic syndrome in asymptomatic##2##4##(2012-3#1)(2013-1#1)
metabolic syndrome in overweight##3##4##(2008-10#1)(2012-12#2)
metabolic syndrome in##20##3##(2007-5#1)(2008-10#2)(2008-3#8)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
metabolic syndrome is##6##3##(2008-1#2)(2008-3#3)(2008-6#1)
metabolic syndrome was##4##3##(2008-11#1)(2008-3#1)(2010-4#1)(2012-12#1)
metabolic syndrome with##2##3##(2008-11#1)(2008-3#1)
metabolic syndrome##195##2##(1990-2#1)(2007-5#1)(2007-7#1)(2008-1#25)(2008-10#5)(2008-11#8)(2008-2#1)(2008-3#75)(2008-5#5)(2008-6#7)(2008-7#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#4)(2010-5#3)(2011-1#8)(2011-2#4)(2012-12#7)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#12)(2013-8#5)
metabolic systems containing covalently modifiable enzymes##2##6##(1990-7#2)
metabolic variables were##2##3##(2011-1#1)(2013-8#1)
metabolic##864##1##(1990-11#9)(1990-12#1)(1990-2#7)(1990-3#1)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#6)(1991-6#1)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#5)(1994-5#3)(1994-6#4)(1994-8#8)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-11#6)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#2)(2006-10#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#37)(2008-10#32)(2008-11#80)(2008-12#2)(2008-2#4)(2008-3#118)(2008-4#16)(2008-5#17)(2008-6#11)(2008-7#65)(2008-8#15)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#6)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#3)(2010-3#1)(2010-4#11)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#28)(2011-2#31)(2011-3#6)(2012-1#7)(2012-12#14)(2012-2#38)(2012-3#12)(2012-4#2)(2012-5#4)(2013-1#43)(2013-7#6)(2013-8#15)
metabolically active apocrine##2##3##(1993-1#1)(2008-4#1)
metabolically active##5##2##(1993-1#1)(2008-11#2)(2008-4#2)
metabolically engineered##2##2##(2008-6#2)
metabolically labeled with##4##3##(1994-11#2)(1994-6#1)(2008-1#1)
metabolically labeled##5##2##(1992-9#1)(1994-11#2)(1994-6#1)(2008-1#1)
metabolically labelled##2##2##(1993-3#1)(1994-2#1)
metabolically stable##4##2##(1994-12#1)(1997-7#2)(2008-4#1)
metabolically##38##1##(1990-11#2)(1990-2#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#1)(1997-7#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2013-1#2)
metabolised by##2##2##(1994-8#1)(2007-11#1)
metabolised mainly by##2##3##(1994-8#2)
metabolised##6##1##(1994-8#4)(1996-12#1)(2007-11#1)
metabolism after##2##2##(2008-10#1)(2008-7#1)
metabolism and are##2##3##(1992-10#1)(2008-10#1)
metabolism and as##2##3##(1991-9#1)(2008-10#1)
metabolism and body growth##2##4##(2013-1#2)
metabolism and increased##2##3##(2008-7#1)(2010-11#1)
metabolism and its##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)
metabolism and lipid peroxidation##2##4##(1994-12#1)(2008-10#1)
metabolism and lipid##3##3##(1994-12#1)(2008-10#1)(2008-7#1)
metabolism and the##3##3##(1993-5#1)(2008-11#1)(2009-9#1)
metabolism and to##3##3##(1991-8#1)(2008-3#1)(2008-7#1)
metabolism and##98##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#2)(1994-12#2)(1994-6#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#9)(2008-11#8)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
metabolism and/or##2##2##(1994-6#1)(2012-2#1)
metabolism are discussed##2##3##(1990-2#1)(2008-10#1)
metabolism are not##2##3##(1991-12#1)(2008-4#1)
metabolism are the##2##3##(1996-6#1)(2008-3#1)
metabolism are##11##2##(1990-2#1)(1991-12#1)(1992-9#1)(1995-12#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-5#1)
metabolism as##6##2##(1992-3#1)(1994-11#1)(1994-6#1)(2008-11#1)(2011-1#1)(2013-1#1)
metabolism associated with##2##3##(2008-11#1)(2008-9#1)
metabolism by the##3##3##(2008-10#2)(2008-4#1)
metabolism by##15##2##(1990-11#1)(1991-12#1)(1991-5#1)(1995-6#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-7#1)(2010-11#1)
metabolism can be##2##3##(1990-9#1)(2012-2#1)
metabolism can##4##2##(1990-9#1)(2008-3#1)(2008-7#1)(2012-2#1)
metabolism during##7##2##(1991-12#1)(1992-5#1)(1996-5#1)(2006-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
metabolism following##2##2##(1993-11#1)(1994-2#1)
metabolism for##4##2##(1994-8#1)(2008-3#1)(2012-1#1)(2012-3#1)
metabolism from##2##2##(2008-11#1)(2011-2#1)
metabolism genes##2##2##(2008-10#1)(2009-12#1)
metabolism has been##2##3##(2008-10#1)(2008-3#1)
metabolism has##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
metabolism have been##2##3##(1994-3#1)(2010-12#1)
metabolism have##3##2##(1994-3#1)(2008-3#1)(2010-12#1)
metabolism in Chinese##2##3##(1995-6#1)(2013-8#1)
metabolism in a##3##3##(1991-10#1)(1991-5#1)(2008-5#1)
metabolism in breast cancer##2##4##(1993-11#2)
metabolism in human##3##3##(1991-4#1)(1995-12#1)(2008-5#1)
metabolism in intact cells##2##4##(1990-11#1)(1994-8#1)
metabolism in liver##3##3##(1990-11#1)(1994-6#1)(2011-3#1)
metabolism in patients with chronic##2##5##(2009-10#1)(2011-1#1)
metabolism in patients with##4##4##(1990-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
metabolism in the brain##4##4##(1992-12#1)(1994-5#1)(2013-1#2)
metabolism in the human##2##4##(1992-6#1)(2011-1#1)
metabolism in the nucleus accumbens##3##5##(1993-12#1)(1997-7#2)
metabolism in the##21##3##(1990-9#1)(1991-12#1)(1992-12#2)(1992-6#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-9#1)(1997-2#1)(1997-7#2)(2008-3#3)(2008-6#2)(2009-8#1)(2011-1#1)(2013-1#2)
metabolism in these##3##3##(1992-10#1)(2008-6#1)(2008-7#1)
metabolism in vivo##3##3##(1991-12#1)(1991-5#2)
metabolism in##107##2##(1990-11#3)(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-4#2)(1991-5#4)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#2)(1993-11#3)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#4)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#5)(1997-2#2)(1997-7#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#4)(2013-8#2)
metabolism include##2##2##(2008-3#1)(2010-10#1)
metabolism is activated in##2##4##(2008-7#2)
metabolism is activated##3##3##(1994-5#1)(2008-7#2)
metabolism is one of the##3##5##(2008-6#1)(2012-3#2)
metabolism is##30##2##(1992-10#1)(1992-11#1)(1992-6#2)(1993-5#1)(1994-11#1)(1994-5#1)(1995-5#2)(1996-5#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
metabolism leading to##2##3##(1995-3#1)(2012-12#1)
metabolism may##3##2##(1994-11#1)(1995-8#1)(2013-7#1)
metabolism might##2##2##(2008-6#1)(2008-7#1)
metabolism of Corynebacterium glutamicum##2##4##(2008-7#2)
metabolism of Corynebacterium##3##3##(2008-5#1)(2008-7#2)
metabolism of NA in hypothalamus##2##5##(2008-8#2)
metabolism of NA##3##3##(2008-8#3)
metabolism of [125I]ET-1 by##2##4##(1995-11#2)
metabolism of [125I]ET-1##3##3##(1995-11#3)
metabolism of a##3##3##(2008-10#1)(2008-11#2)
metabolism of arachidonic acid##3##4##(1991-8#2)(2013-1#1)
metabolism of cinnarizine##2##3##(1993-6#2)
metabolism of fatty##2##3##(2012-3#1)(2013-1#1)
metabolism of glucose and##2##4##(1994-5#1)(2011-2#1)
metabolism of glucose##3##3##(1994-5#1)(2011-2#1)(2012-12#1)
metabolism of the##10##3##(1991-3#1)(1991-5#2)(1993-11#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
metabolism of these##2##3##(1991-12#1)(2008-11#1)
metabolism of vitamin D both##2##5##(2008-7#2)
metabolism of##138##2##(1990-11#1)(1990-6#2)(1991-12#2)(1991-3#1)(1991-5#6)(1991-8#3)(1991-9#2)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#5)(1994-5#2)(1994-6#2)(1994-8#4)(1995-11#3)(1995-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#19)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#9)(2008-8#5)(2008-9#1)(2009-1#3)(2009-4#1)(2009-6#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
metabolism or##4##2##(1990-11#1)(1992-9#1)(2008-4#1)(2012-2#1)
metabolism pathway##2##2##(2008-11#1)(2008-3#1)
metabolism regulation##2##2##(2007-8#1)(2012-3#1)
metabolism sites##2##2##(2012-3#2)
metabolism than##2##2##(1996-5#1)(2012-2#1)
metabolism that##3##2##(1993-6#1)(2008-1#1)(2009-10#1)
metabolism through##2##2##(1991-11#1)(2012-2#1)
metabolism to the##2##3##(1993-9#1)(2009-7#1)
metabolism to##14##2##(1992-11#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
metabolism under##3##2##(1991-12#1)(2008-7#1)(2009-8#1)
metabolism via##4##2##(1995-6#1)(2008-11#2)(2008-5#1)
metabolism was studied in##2##4##(1993-8#1)(1997-1#1)
metabolism was##12##2##(1993-6#2)(1993-8#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2012-1#1)(2012-2#1)
metabolism were investigated##2##3##(1996-6#1)(2011-3#1)
metabolism were##8##2##(1990-12#1)(1994-5#1)(1995-11#1)(1996-6#1)(2008-11#1)(2010-4#1)(2011-3#1)(2012-1#1)
metabolism which##2##2##(2008-4#1)(2008-7#1)
metabolism with##5##2##(1991-5#1)(1996-5#1)(1997-7#1)(2008-7#1)(2011-2#1)
metabolism without##2##2##(1994-5#2)
metabolism##842##1##(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#10)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#17)(1991-6#1)(1991-8#4)(1991-9#5)(1992-10#6)(1992-11#9)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#12)(1993-12#7)(1993-2#2)(1993-3#2)(1993-5#5)(1993-6#14)(1993-8#5)(1993-9#4)(1994-11#7)(1994-12#4)(1994-2#6)(1994-3#4)(1994-5#11)(1994-6#8)(1994-8#18)(1995-11#8)(1995-12#7)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#8)(1995-8#4)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#10)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#7)(1997-8#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#10)(2008-10#50)(2008-11#79)(2008-12#4)(2008-2#2)(2008-3#34)(2008-4#17)(2008-5#23)(2008-6#13)(2008-7#63)(2008-8#18)(2008-9#14)(2009-1#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#5)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#14)(2011-2#30)(2011-3#3)(2012-1#10)(2012-12#2)(2012-2#26)(2012-3#19)(2012-7#2)(2012-9#1)(2013-1#28)(2013-7#2)(2013-8#10)
metabolism)##2##1##(1995-11#1)(2008-11#1)
metabolism-dependent##2##1##(1991-9#1)(1992-8#1)
metabolism]##2##1##(1990-2#1)(2013-1#1)
metabolisms##3##1##(1994-5#1)(2008-9#1)(2011-1#1)
metabolite SK&amp##2##2##(1991-8#2)
metabolite analysis##2##2##(2008-10#1)(2008-7#1)
metabolite and##2##2##(1991-12#1)(2008-10#1)
metabolite concentrations##4##2##(1991-3#1)(2008-10#2)(2012-5#1)
metabolite content##2##2##(1995-6#1)(2013-1#1)
metabolite formed##2##2##(1990-12#1)(1996-12#1)
metabolite has##2##2##(1994-11#1)(2008-10#1)
metabolite in human plasma by##2##5##(2008-10#2)
metabolite in human plasma with##2##5##(2008-10#2)
metabolite in human plasma##5##4##(2008-10#5)
metabolite in urine##2##3##(2008-10#2)
metabolite in##9##2##(1991-1#1)(2008-10#8)
metabolite norfluoxetine##3##2##(2008-10#3)
metabolite of 3##2##3##(1992-3#1)(1994-5#1)
metabolite of MK-447##2##3##(1991-8#2)
metabolite of MPTP##2##3##(1990-7#1)(2008-7#1)
metabolite of NO##2##3##(2008-10#1)(2008-7#1)
metabolite of inorganic arsenics##2##4##(1993-3#2)
metabolite of the##5##3##(1990-7#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-3#1)
metabolite of##36##2##(1990-7#2)(1991-12#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-7#2)(2009-12#1)(2012-2#1)
metabolite pools##2##2##(2008-7#2)
metabolite produced by##2##3##(2008-10#2)
metabolite produced##3##2##(1996-5#1)(2008-10#2)
metabolite production##3##2##(2008-10#3)
metabolite profiles of##2##3##(2008-10#1)(2009-8#1)
metabolite profiles##4##2##(2008-10#2)(2009-8#2)
metabolite that##2##2##(2008-10#1)(2011-2#1)
metabolite was##6##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1994-11#1)(2008-11#1)
metabolite were##2##2##(1990-8#1)(2008-10#1)
metabolite which may##2##3##(1990-8#1)(1991-9#1)
metabolite which##3##2##(1990-11#1)(1990-8#1)(1991-9#1)
metabolite with strong antimicrobial##2##4##(2008-10#1)(2008-11#1)
metabolite with##3##2##(2008-10#2)(2008-11#1)
metabolite##192##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#5)(1991-3#2)(1991-5#5)(1991-8#7)(1991-9#3)(1992-1#3)(1992-11#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#3)(1994-5#2)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#3)(1996-12#2)(1996-5#2)(1997-2#1)(2008-1#1)(2008-10#60)(2008-11#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#3)(2009-10#2)(2009-12#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#2)
metabolite(s)##2##1##(2008-4#1)(2008-8#1)
metabolite)##2##1##(1995-2#1)(2013-1#1)
metabolites and of##2##3##(1991-9#1)(1996-5#1)
metabolites and the##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
metabolites and##24##2##(1991-9#1)(1993-11#1)(1996-5#3)(1996-7#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#2)
metabolites are still present today and continue to contaminate soil and water##2##12##(2008-11#2)
metabolites are##9##2##(1992-1#1)(2008-10#3)(2008-11#3)(2008-7#1)(2010-11#1)
metabolites as##5##2##(1990-3#1)(1995-12#1)(2008-9#1)(2009-5#1)(2011-3#1)
metabolites at##3##2##(2008-10#2)(2010-4#1)
metabolites by capillary##2##3##(2008-10#1)(2010-5#1)
metabolites by##8##2##(1993-8#1)(1995-11#2)(2008-10#2)(2008-11#1)(2009-5#1)(2010-5#1)
metabolites can##2##2##(1990-8#1)(2010-9#1)
metabolites derived from##3##3##(1991-5#1)(2010-11#1)(2011-1#1)
metabolites during##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
metabolites formed by##2##3##(2010-11#1)(2011-1#1)
metabolites formed##7##2##(1990-11#1)(1991-5#1)(1993-8#1)(2008-4#1)(2010-11#2)(2011-1#1)
metabolites found in the##2##4##(2008-10#1)(2011-2#1)
metabolites found##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
metabolites from##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
metabolites generated##2##2##(2011-1#1)(2011-3#1)
metabolites in radish##3##3##(2008-10#3)
metabolites in rat urine by##2##5##(2008-10#2)
metabolites in the rat brain##2##5##(1993-3#2)
metabolites in the##7##3##(1993-3#2)(2008-10#3)(2008-8#1)(2013-1#1)
metabolites in urine##2##3##(1993-8#1)(2008-10#1)
metabolites in##39##2##(1990-12#1)(1990-8#1)(1991-5#1)(1993-3#2)(1993-8#1)(1994-8#2)(1996-5#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-5#1)(2011-3#1)(2013-1#1)
metabolites including##2##2##(1990-8#1)(2008-12#1)
metabolites is##3##2##(2008-10#2)(2008-11#1)
metabolites may##2##2##(1995-9#1)(2008-9#1)
metabolites of BaP 7##2##4##(1992-2#2)
metabolites of BaP##3##3##(1992-2#2)(2011-1#1)
metabolites of trichloroethylene##2##3##(2008-10#2)
metabolites of##27##2##(1990-11#1)(1991-12#2)(1992-2#2)(1993-11#1)(1993-12#1)(1994-8#2)(1995-3#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
metabolites produced by the##2##4##(1993-6#1)(2008-10#1)
metabolites produced by##5##3##(1993-6#2)(2008-10#3)
metabolites produced##6##2##(1993-6#2)(1995-11#1)(2008-10#3)
metabolites such as##2##3##(2008-7#1)(2012-1#1)
metabolites that are##3##3##(1990-5#1)(2008-10#2)
metabolites that can##2##3##(2008-10#1)(2010-11#1)
metabolites that##9##2##(1990-5#1)(2008-10#4)(2010-11#1)(2011-1#1)(2012-1#1)(2013-8#1)
metabolites to##7##2##(1991-1#1)(1991-8#1)(1994-5#1)(1996-5#2)(2008-10#1)(2013-8#1)
metabolites using##3##2##(2008-10#3)
metabolites was##4##2##(1990-6#1)(1996-5#1)(2008-10#1)(2011-2#1)
metabolites were detected in##2##4##(2008-10#1)(2011-3#1)
metabolites were identified##2##3##(1996-5#1)(2008-10#1)
metabolites were investigated##2##3##(1991-5#1)(2008-11#1)
metabolites were not##2##3##(1992-10#1)(2008-11#1)
metabolites were##27##2##(1990-11#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-6#1)(1994-3#1)(1995-11#2)(1996-5#2)(1996-7#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2011-3#2)
metabolites which##2##2##(1993-12#1)(2008-10#1)
metabolites with the##2##3##(1993-8#1)(2008-10#1)
metabolites with##8##2##(1993-8#2)(1996-12#1)(2008-10#3)(2008-7#1)(2010-9#1)
metabolites##351##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#5)(1991-1#1)(1991-12#3)(1991-5#8)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-6#3)(1993-8#6)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#6)(1995-11#10)(1995-12#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#15)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#91)(2008-11#28)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#5)(2009-4#2)(2009-5#3)(2009-8#1)(2010-11#10)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#7)(2011-3#8)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#7)
metabolizable##2##1##(1991-12#1)(2008-6#1)
metabolization##3##1##(1996-12#1)(2008-10#1)(2008-5#1)
metabolize many##2##2##(2008-7#1)(2011-1#1)
metabolize##16##1##(1990-7#1)(1995-11#1)(1997-4#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#2)(2012-2#2)(2012-3#1)
metabolized by##11##2##(1990-5#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2012-12#1)
metabolized from pesticides##2##3##(2008-10#2)
metabolized in the liver##2##4##(2008-3#1)(2008-9#1)
metabolized in the##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
metabolized in##6##2##(1990-2#1)(1992-12#1)(1996-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
metabolized into##2##2##(2008-3#1)(2012-3#1)
metabolized to##8##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-10#1)(1992-11#1)(1995-6#1)(2008-11#1)(2010-11#1)
metabolized##53##1##(1990-11#5)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-11#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
metabolizer##3##1##(2008-11#1)(2008-4#2)
metabolizers##5##1##(2008-10#5)
metabolizes##4##1##(1991-2#1)(1993-3#1)(2008-10#1)(2008-3#1)
metabolizing enzymes##8##2##(1990-11#1)(1993-11#1)(1994-8#1)(1996-12#2)(2008-8#1)(2010-12#1)(2010-3#1)
metabolizing##14##1##(1990-11#2)(1992-6#1)(1993-11#1)(1994-8#1)(1996-12#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#2)
metabolome##6##1##(2009-8#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)
metabolomic approach based on liquid##2##5##(2010-5#2)
metabolomic##5##1##(2008-10#1)(2008-11#1)(2010-5#2)(2012-12#1)
metabolomics in##2##2##(2012-1#1)(2012-3#1)
metabolomics##13##1##(2010-5#2)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#5)
metabonomic##2##1##(2008-10#2)
metabonomics##2##1##(2011-1#2)
metabotropic ATP##2##2##(2008-4#2)
metabotropic glutamate (mGlu)##2##3##(1995-12#1)(2008-11#1)
metabotropic glutamate receptor agonists##2##4##(1995-12#1)(1996-5#1)
metabotropic glutamate receptor##14##3##(1991-2#2)(1992-11#1)(1993-8#3)(1995-12#3)(1996-5#3)(1997-2#2)
metabotropic glutamate receptors (mGluRs)##3##4##(1995-12#2)(2008-4#1)
metabotropic glutamate receptors##7##3##(1995-12#2)(1996-12#2)(2008-4#1)(2008-7#1)(2009-3#1)
metabotropic glutamate##23##2##(1991-2#2)(1992-11#1)(1993-8#3)(1995-12#6)(1996-12#2)(1996-5#3)(1997-2#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)
metabotropic receptors and the PLC pathway##2##6##(2009-3#2)
metabotropic receptors##7##2##(1992-12#1)(1995-12#1)(2008-7#3)(2009-3#2)
metabotropic synaptic potentials##2##3##(2008-7#2)
metabotropic##39##1##(1991-2#2)(1992-11#1)(1992-12#1)(1993-8#3)(1995-12#7)(1996-12#2)(1996-5#3)(1996-9#1)(1997-2#2)(2008-11#1)(2008-4#6)(2008-7#7)(2009-3#3)
metacarpal fracture##2##2##(2007-8#1)(2008-9#1)
metacarpal fractures##3##2##(2007-8#3)
metacarpal##13##1##(1997-3#2)(2006-10#1)(2007-8#4)(2008-9#5)(2009-7#1)
metacarpophalangeal (MP)##2##2##(2008-9#2)
metacarpophalangeal joint##3##2##(2008-9#3)
metacarpophalangeal##8##1##(1992-5#1)(2008-9#6)(2012-3#1)
metacentric##5##1##(2008-12#3)(2008-8#1)(2010-3#1)
metacercariae##2##1##(2008-12#1)(2009-8#1)
metachromatic##6##1##(1997-3#2)(2008-5#1)(2008-9#2)(2012-3#1)
metachronous RCC##2##2##(2013-1#2)
metachronous##15##1##(1990-12#2)(1990-8#2)(1992-8#2)(2007-5#1)(2008-6#1)(2009-12#1)(2010-3#1)(2012-2#1)(2013-1#4)
metacognition##2##1##(2012-1#1)(2013-8#1)
metacognitive##4##1##(2008-11#2)(2008-12#1)(2012-3#1)
metagenome##3##1##(2011-1#3)
metagenomes and##2##2##(2011-2#2)
metagenomes##5##1##(2011-2#4)(2012-2#1)
metagenomic##5##1##(2011-1#2)(2011-2#2)(2012-2#1)
metagenomics##8##1##(2011-1#3)(2011-2#4)(2012-3#1)
metaiodobenzylguanidine##2##1##(2008-7#1)(2012-2#1)
metal Pd##3##2##(2008-10#3)
metal accumulated##2##2##(1995-3#1)(2008-5#1)
metal accumulation##2##2##(2008-7#1)(2009-10#1)
metal affinity chromatography##2##3##(2009-3#1)(2011-2#1)
metal analysis##10##2##(2008-10#9)(2009-2#1)
metal and the##4##3##(2008-10#2)(2010-12#1)(2013-8#1)
metal and##11##2##(1994-6#1)(2008-10#6)(2008-9#1)(2010-11#1)(2010-12#1)(2013-8#1)
metal atom##3##2##(1996-2#2)(2008-5#1)
metal atoms are##2##3##(1997-7#1)(2007-11#1)
metal atoms##7##2##(1996-2#3)(1997-7#1)(2006-4#2)(2007-11#1)
metal availability##2##2##(2008-10#2)
metal based##2##2##(2010-11#2)
metal binding capacity of##2##4##(2008-10#2)
metal binding##10##2##(2008-10#6)(2009-7#1)(2010-11#3)
metal by##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
metal can be##3##3##(1996-12#1)(2007-12#1)(2008-10#1)
metal carbonyls##2##2##(1997-7#1)(2008-10#1)
metal catalysts##2##2##(2008-10#1)(2008-7#1)
metal cations and##3##3##(2008-10#3)
metal cations in##5##3##(2008-10#5)
metal cations is##3##3##(1995-3#1)(2008-10#2)
metal cations such as##2##4##(2008-10#1)(2009-8#1)
metal cations with##2##3##(2008-10#2)
metal cations##40##2##(1990-2#1)(1995-2#1)(1995-3#1)(2008-10#36)(2009-8#1)
metal center##3##2##(1996-2#2)(1997-7#1)
metal centers##3##2##(1997-7#3)
metal chalcogenide##4##2##(2010-5#4)
metal chalcogenides##2##2##(2008-10#1)(2010-5#1)
metal chelate is##2##3##(2008-10#2)
metal chelate##8##2##(1995-8#1)(2008-10#7)
metal chelates were##2##3##(2008-10#2)
metal chelates##9##2##(2008-10#7)(2008-5#2)
metal chelation##2##2##(2008-10#2)
metal chlorides##2##2##(2008-10#1)(2013-1#1)
metal cluster##7##2##(1994-5#5)(1997-7#1)(2009-11#1)
metal coating##2##2##(2007-11#2)
metal complex##9##2##(2008-10#7)(2011-2#2)
metal complex+free##2##2##(2008-10#2)
metal complexation##2##2##(1996-2#1)(2009-7#1)
metal complexes in##3##3##(2008-10#2)(2008-3#1)
metal complexes is##2##3##(2008-10#2)
metal complexes##28##2##(1997-7#2)(2007-11#1)(2008-10#19)(2008-3#2)(2008-7#2)(2010-7#2)
metal complexing##2##2##(2008-10#2)
metal concentration##7##2##(2008-10#4)(2008-5#1)(2013-8#2)
metal concentrations in##4##3##(1997-4#1)(2008-10#3)
metal concentrations were##3##3##(1997-4#1)(2008-10#2)
metal concentrations##17##2##(1994-8#2)(1997-4#2)(2007-5#1)(2008-10#10)(2008-2#1)(2011-2#1)
metal constituents##2##2##(2008-10#1)(2008-12#1)
metal contamination in##2##3##(1994-11#1)(1997-4#1)
metal content of a##2##4##(1991-12#1)(2008-10#1)
metal content of##3##3##(1991-12#1)(2008-10#2)
metal content was##2##3##(2008-10#2)
metal content##9##2##(1991-12#1)(2008-10#7)(2010-11#1)
metal contents in serum and hair samples##2##7##(2008-10#2)
metal contents in serum and hair##3##6##(2008-10#3)
metal contents in##4##3##(2008-10#3)(2010-5#1)
metal contents##8##2##(1997-4#1)(2008-10#5)(2010-5#2)
metal coupons##3##2##(2013-8#3)
metal determination in##3##3##(2008-10#3)
metal determination##6##2##(1993-2#1)(2008-10#5)
metal dissolution##2##2##(2008-10#2)
metal elements##2##2##(2008-10#2)
metal enrichment##3##2##(2008-10#3)
metal exchange##3##2##(2008-10#3)
metal exposure##3##2##(2011-1#3)
metal extraction##5##2##(2008-10#5)
metal extractive behavior##2##3##(2008-10#2)
metal film##12##2##(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#2)(2009-7#1)
metal films##7##2##(1992-8#1)(2007-12#1)(2008-3#5)
metal fractionation in##2##3##(2008-10#2)
metal fractions##3##2##(2008-10#3)
metal from##3##2##(2007-8#1)(2008-10#2)
metal grating##2##2##(2007-11#1)(2008-3#1)
metal homeostasis##5##2##(2008-1#1)(2010-11#3)(2011-2#1)
metal humates##2##2##(2008-10#2)
metal in the##4##3##(1996-2#1)(2008-10#2)(2008-5#1)
metal in##13##2##(1996-2#1)(2007-11#2)(2008-10#6)(2008-5#2)(2008-7#1)(2010-11#1)
metal ion affinity##5##3##(1990-8#2)(1997-2#3)
metal ion and##2##3##(2008-10#2)
metal ion binding##4##3##(1992-3#1)(2008-10#3)
metal ion concentration##3##3##(2008-10#3)
metal ion concentrations##5##3##(1994-8#1)(2008-10#3)(2010-11#1)
metal ion determination##3##3##(2008-10#3)
metal ion extraction##2##3##(2008-10#2)
metal ion in##3##3##(1995-6#1)(2008-10#2)
metal ion is##6##3##(1995-6#1)(2008-10#3)(2010-6#2)
metal ion recovery##3##3##(2008-10#3)
metal ion sorption##4##3##(2008-10#4)
metal ion than##2##3##(1992-11#1)(2008-10#1)
metal ion uptake##2##3##(2008-10#2)
metal ion##96##2##(1990-8#2)(1991-5#1)(1992-11#1)(1992-3#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#3)(1997-2#3)(1997-4#1)(2008-10#73)(2008-4#1)(2010-10#1)(2010-11#2)(2010-6#2)(2012-12#1)
metal ions and anions##3##4##(2008-10#3)
metal ions and could be used in a pH range of 2##3##12##(2008-10#3)
metal ions and could be used in##4##7##(2008-10#4)
metal ions and the##3##4##(2008-10#3)
metal ions and their##2##4##(2008-10#2)
metal ions and##29##3##(2008-10#25)(2008-7#1)(2009-11#1)(2010-12#1)(2013-1#1)
metal ions are extracted into xylene as##2##7##(2008-10#2)
metal ions are extracted into##3##5##(2008-10#3)
metal ions are reported##4##4##(2008-10#4)
metal ions are##13##3##(1995-8#1)(1997-7#1)(2008-10#11)
metal ions at##4##3##(2008-10#4)
metal ions but##2##3##(2008-10#2)
metal ions by##6##3##(2008-10#6)
metal ions could be##3##4##(2008-10#3)
metal ions could##4##3##(1994-6#1)(2008-10#3)
metal ions determination in the##2##5##(2008-10#2)
metal ions do not##2##4##(2008-10#2)
metal ions from aqueous solutions##3##5##(2008-10#3)
metal ions from aqueous##4##4##(2008-10#4)
metal ions from##12##3##(1994-6#1)(2008-10#11)
metal ions has been##3##4##(2008-10#3)
metal ions have been##2##4##(2008-10#2)
metal ions have##5##3##(2008-10#4)(2010-6#1)
metal ions in a##2##4##(2008-10#2)
metal ions in aqueous solution##3##5##(2008-10#2)(2010-2#1)
metal ions in different##2##4##(2008-10#2)
metal ions in natural##2##4##(2008-10#2)
metal ions in river and##2##5##(2008-10#2)
metal ions in several synthetic##2##5##(2008-10#2)
metal ions in the sorption of##2##6##(2008-10#2)
metal ions in the##8##4##(2008-10#8)
metal ions in water##4##4##(2008-10#4)
metal ions in##45##3##(1997-7#1)(2008-10#42)(2010-2#1)(2012-2#1)
metal ions increased##2##3##(1991-5#1)(2008-10#1)
metal ions is less than sorption capacity##2##7##(2008-10#2)
metal ions is##8##3##(1996-2#1)(2008-10#7)
metal ions of the##2##4##(2008-1#1)(2008-3#1)
metal ions of##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
metal ions on a##2##4##(2008-10#2)
metal ions on the##11##4##(2008-10#11)
metal ions on##15##3##(2008-10#14)(2010-11#1)
metal ions or##2##3##(2008-10#2)
metal ions showed that the##2##5##(2008-10#1)(2013-8#1)
metal ions studied##2##3##(2008-10#2)
metal ions such as Cu(II)##2##5##(2008-10#2)
metal ions such as##6##4##(2008-10#6)
metal ions through the##2##4##(2008-10#1)(2011-2#1)
metal ions was studied in##2##5##(2008-10#2)
metal ions was##12##3##(2008-10#12)
metal ions were recovered##2##4##(2008-10#2)
metal ions were studied##2##4##(2008-10#2)
metal ions were##22##3##(2008-10#22)
metal ions with the##2##4##(2008-10#2)
metal ions with##14##3##(2008-10#13)(2008-5#1)
metal ions##384##2##(1991-5#1)(1993-6#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-1#3)(2008-10#343)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-11#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
metal ions/complexes##2##2##(2008-10#2)
metal is##11##2##(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-5#1)
metal island films##2##3##(2008-10#1)(2008-3#1)
metal island##3##2##(2008-10#1)(2008-3#2)
metal layer##3##2##(2008-3#3)
metal loading capacity##2##3##(2008-10#2)
metal loading##4##2##(2008-10#3)(2008-7#1)
metal may##2##2##(2008-10#1)(2012-12#1)
metal metabolism##2##2##(2006-10#1)(2008-10#1)
metal mobility##2##2##(2008-1#1)(2008-10#1)
metal mobilization##2##2##(2008-10#2)
metal nanoclusters##3##2##(2008-10#3)
metal nanoparticles##4##2##(2008-10#1)(2008-6#1)(2010-12#1)(2010-5#1)
metal or##2##2##(2008-10#1)(2008-2#1)
metal oxide semiconductor##3##3##(2007-11#2)(2008-7#1)
metal oxide##7##2##(2007-11#3)(2008-10#2)(2008-3#1)(2008-7#1)
metal oxides##5##2##(2008-10#4)(2008-3#1)
metal particle##2##2##(2008-7#2)
metal particles is##2##3##(2008-6#1)(2008-7#1)
metal particles##4##2##(2008-6#1)(2008-7#2)(2009-7#1)
metal parts##2##2##(2008-10#1)(2008-3#1)
metal picrates (Li(+)##2##3##(2008-10#2)
metal picrates with##4##3##(2008-10#4)
metal picrates##11##2##(2008-10#11)
metal pollutants##3##2##(2007-5#1)(2008-10#1)(2010-11#1)
metal pollution in##3##3##(1994-11#1)(2008-10#1)(2010-11#1)
metal pollution##4##2##(1994-11#1)(2008-10#2)(2010-11#1)
metal preconcentration##3##2##(2008-10#3)
metal profile##2##2##(2008-10#2)
metal radiating##2##2##(2007-12#2)
metal removal##6##2##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)
metal ring##4##2##(2008-3#3)(2009-8#1)
metal salts##5##2##(1994-11#1)(2008-10#3)(2008-7#1)
metal sorption capacity##2##3##(2008-10#2)
metal sorption##5##2##(2008-10#5)
metal speciation analysis##2##3##(2008-10#2)
metal speciation##3##2##(2008-10#3)
metal species and##2##3##(2008-10#2)
metal species in##2##3##(2008-10#2)
metal species##14##2##(2008-10#13)(2010-11#1)
metal stent##2##2##(2010-5#1)(2013-1#1)
metal stents##8##2##(1990-8#1)(2008-11#3)(2008-12#2)(2009-12#1)(2010-5#1)
metal stress##2##2##(1993-12#1)(1994-8#1)
metal strips##2##2##(2008-3#2)
metal surface##6##2##(2007-12#3)(2008-3#1)(2008-5#1)(2008-7#1)
metal surfaces##5##2##(2007-12#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
metal that##2##2##(2007-12#1)(2012-2#1)
metal to the##2##3##(2008-10#1)(2008-11#1)
metal to##6##2##(2007-12#2)(2008-10#3)(2008-11#1)
metal tolerance##3##2##(2011-1#1)(2011-2#2)
metal uptake by##2##3##(2008-10#1)(2008-6#1)
metal uptake##11##2##(2008-10#7)(2008-6#3)(2013-8#1)
metal vapor elution analysis##4##4##(2008-10#4)
metal vapor##6##2##(1992-9#2)(2008-10#4)
metal vapors##3##2##(2008-10#2)(2008-3#1)
metal vapour##3##2##(2009-11#3)
metal was##10##2##(2008-10#10)
metal waveguides##3##2##(2008-3#3)
metal wires##2##2##(1992-8#1)(2012-2#1)
metal with##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
metal##1250##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-12#3)(1991-5#3)(1991-9#1)(1992-11#2)(1992-3#4)(1992-8#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-5#3)(1993-6#1)(1994-11#4)(1994-5#8)(1994-6#3)(1994-8#5)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#14)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#9)(1997-6#1)(1997-7#13)(2006-10#1)(2006-4#2)(2007-11#18)(2007-12#24)(2007-5#4)(2007-8#2)(2008-1#7)(2008-10#816)(2008-11#11)(2008-12#10)(2008-2#11)(2008-3#45)(2008-4#3)(2008-5#19)(2008-6#6)(2008-7#27)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#8)(2009-12#5)(2009-2#1)(2009-3#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#26)(2010-12#4)(2010-2#1)(2010-5#17)(2010-6#5)(2010-7#2)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#12)(2013-8#11)
metal&lt##2##1##(2008-10#2)
metal(II) hexafluoroantimonates(V)##2##2##(2008-10#2)
metal(II)##3##1##(2008-10#3)
metal-##2##1##(2007-12#1)(2008-10#1)
metal-EDTA##2##1##(2008-10#2)
metal-HS species##2##2##(2008-10#2)
metal-HS##3##1##(2008-10#3)
metal-backed acetabular##2##2##(2008-5#1)(2008-8#1)
metal-backed##3##1##(2008-5#2)(2008-8#1)
metal-binding and metalloprotein analysis##2##4##(2008-10#2)
metal-binding sites##3##2##(2008-4#2)(2010-11#1)
metal-binding##16##1##(1991-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-1#2)(2008-10#5)(2008-4#3)(2010-11#2)
metal-containing proteins##2##2##(2010-11#2)
metal-containing##3##1##(2010-11#3)
metal-dependent##2##1##(1994-6#1)(2010-3#1)
metal-dielectric##4##1##(2007-12#1)(2008-3#3)
metal-doped##3##1##(2008-10#3)
metal-enhanced fluorescence##5##2##(2008-7#1)(2009-12#1)(2009-5#3)
metal-humate##2##1##(2008-10#2)
metal-insulator-metal diode##2##2##(2007-11#1)(2007-12#1)
metal-ion transporter##2##2##(1997-7#2)
metal-ion##7##1##(1992-4#1)(1992-6#1)(1997-7#3)(2008-10#1)(2013-1#1)
metal-ligand complexes using the##2##4##(2008-10#2)
metal-ligand complexes##6##2##(2008-10#5)(2010-11#1)
metal-ligand model##2##2##(2008-10#2)
metal-ligand systems##2##2##(2008-10#2)
metal-ligand##13##1##(1996-2#1)(1997-7#1)(2008-10#10)(2010-11#1)
metal-metal##4##1##(1996-2#2)(1997-7#1)(2010-5#1)
metal-on-metal##3##1##(2009-7#2)(2013-1#1)
metal-organic chemical-vapor deposition##2##3##(2007-11#1)(2008-2#1)
metal-organic##6##1##(2007-11#2)(2008-10#1)(2008-2#1)(2010-12#2)
metal-oxide semiconductor##6##2##(2008-3#5)(2008-5#1)
metal-oxide##13##1##(2007-12#1)(2008-2#3)(2008-3#8)(2008-5#1)
metal-oxide-semiconductor##3##1##(2009-5#2)(2012-2#1)
metal-oxide-silicon (MOS)##2##2##(2007-11#1)(2009-5#1)
metal-oxide-silicon##3##1##(2007-11#2)(2009-5#1)
metal-polymer##2##1##(2008-10#2)
metal-porphine##2##1##(2008-10#2)
metal-responsive##2##1##(1993-6#1)(2008-9#1)
metal-semiconductor hybrid structures##2##3##(2009-6#2)
metal-semiconductor##3##1##(2009-6#2)(2012-2#1)
metal-semiconductor-metal##5##1##(2008-2#2)(2008-3#3)
metal-stripe##5##1##(2007-12#2)(2008-3#3)
metal-uptake##2##1##(2008-10#2)
metal/ligand##2##1##(2008-10#2)
metalation##2##1##(1996-2#1)(2008-10#1)
metalaxyl insensitivity##2##2##(2008-10#2)
metalaxyl resistant isolates##2##3##(2008-10#2)
metalaxyl resistant##3##2##(2008-10#3)
metalaxyl sensitive##2##2##(2008-10#2)
metalaxyl sensitivity and##2##3##(2008-10#2)
metalaxyl sensitivity##6##2##(2008-10#6)
metalaxyl##36##1##(2008-10#36)
metalinguistic##5##1##(2012-3#5)
metallic alloy##3##2##(1991-9#1)(2008-10#1)(2008-7#1)
metallic alloys##2##2##(1995-3#1)(2008-10#1)
metallic and##3##2##(2007-11#1)(2008-7#1)(2012-12#1)
metallic cations##7##2##(1990-7#3)(1992-6#1)(2008-10#3)
metallic cobalt##2##2##(2008-10#2)
metallic content##3##2##(2008-10#3)
metallic elements in##3##3##(2008-10#3)
metallic elements##4##2##(2008-10#4)
metallic film##3##2##(2007-11#1)(2008-3#2)
metallic films##4##2##(2008-3#2)(2008-7#1)(2009-5#1)
metallic glasses##3##2##(1995-3#1)(2008-3#1)(2012-2#1)
metallic impurities##3##2##(2008-10#2)(2008-3#1)
metallic ions##5##2##(2008-10#5)
metallic iron##2##2##(1994-5#1)(2008-10#1)
metallic layer##2##2##(2008-10#1)(2008-3#1)
metallic liquid##2##2##(2012-2#2)
metallic nanostructures##3##2##(2008-7#3)
metallic or##3##2##(1992-3#1)(2007-11#1)(2008-7#1)
metallic particles##6##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-6#1)
metallic potentiometric sensors##2##3##(2008-10#2)
metallic sensors##2##2##(2008-10#2)
metallic stent##3##2##(2007-8#2)(2013-1#1)
metallic structures##2##2##(2008-3#2)
metallic substrates##2##2##(2008-7#2)
metallic surface##2##2##(2007-11#1)(2007-12#1)
metallic surfaces##2##2##(2008-2#1)(2008-3#1)
metallic thin film##4##3##(2008-3#4)
metallic tubes##2##2##(2008-10#2)
metallic wires##5##2##(2008-11#1)(2008-3#3)(2012-2#1)
metallic##153##1##(1990-4#1)(1990-7#3)(1991-9#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-3#2)(1996-2#1)(1996-5#1)(2007-11#10)(2007-12#6)(2007-8#2)(2008-10#48)(2008-11#1)(2008-2#6)(2008-3#26)(2008-5#2)(2008-6#1)(2008-7#16)(2008-8#2)(2009-11#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#3)
metallised##3##1##(2008-10#3)
metallization is##2##2##(2010-4#2)
metallization##6##1##(1995-6#1)(2008-2#1)(2010-4#3)(2013-1#1)
metallized##3##1##(2008-10#2)(2008-2#1)
metallo-organic sorbent-iron##2##2##(2008-10#2)
metallochromic indicator##2##2##(2008-10#2)
metallochromic##3##1##(2008-10#3)
metallodielectric or in##2##3##(2008-3#2)
metallodielectric##4##1##(2008-3#4)
metalloendopeptidase##4##1##(1990-2#2)(1991-9#1)(2008-11#1)
metalloenzyme##3##1##(1991-5#1)(1992-3#1)(1995-8#1)
metallofluorescent indicators##2##2##(2008-10#2)
metalloforms##2##1##(2008-10#2)
metalloid##4##1##(2008-10#4)
metalloids and non-volatile ions in airborne particulate matter by a new two-step sequential leaching procedure Part##2##16##(2008-10#2)
metalloids##6##1##(1995-3#1)(2008-10#3)(2010-11#1)(2010-5#1)
metallomics studies of##2##3##(2010-11#2)
metallomics studies##3##2##(2010-11#3)
metallomics##6##1##(2008-10#2)(2010-11#4)
metallopeptidase##2##1##(1991-9#1)(2011-2#1)
metalloporphyrin##5##1##(1997-7#1)(2008-10#3)(2010-6#1)
metalloporphyrins##7##1##(2008-10#3)(2010-6#4)
metalloprotease##8##1##(1992-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
metalloproteases##8##1##(1992-8#1)(2006-6#1)(2008-4#2)(2008-5#3)(2008-7#1)
metalloprotein analysis##3##2##(2008-10#3)
metalloprotein##4##1##(1991-9#1)(2008-10#3)
metalloproteinase 1##2##2##(2012-1#2)
metalloproteinase 2##3##2##(2010-1#2)(2012-3#1)
metalloproteinase activity##3##2##(2008-4#1)(2011-2#2)
metalloproteinase and##3##2##(1992-6#1)(1994-8#1)(2013-1#1)
metalloproteinase in the##2##3##(1992-9#1)(2008-9#1)
metalloproteinase in##3##2##(1991-8#1)(1992-9#1)(2008-9#1)
metalloproteinase with##2##2##(1997-2#1)(2009-7#1)
metalloproteinase##33##1##(1990-8#2)(1991-8#2)(1992-6#2)(1992-9#1)(1994-5#1)(1994-8#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-9#2)(2009-3#1)(2009-7#1)(2010-1#2)(2011-2#4)(2012-1#2)(2012-3#2)(2013-1#2)
metalloproteinase-1##4##1##(1994-3#2)(2008-5#1)(2008-9#1)
metalloproteinase-2 (MMP-2)##3##2##(2008-11#1)(2008-9#1)(2009-3#1)
metalloproteinase-2##9##1##(1997-2#1)(2008-11#1)(2008-9#1)(2009-3#1)(2013-1#3)(2013-7#2)
metalloproteinases (MMPs) are##2##3##(2008-11#1)(2013-1#1)
metalloproteinases (MMPs)##5##2##(2008-11#2)(2008-4#2)(2013-1#1)
metalloproteinases and their##3##3##(1992-6#1)(2008-1#1)(2008-9#1)
metalloproteinases and##6##2##(1992-6#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-3#1)(2013-1#1)
metalloproteinases are##3##2##(2008-1#1)(2009-5#2)
metalloproteinases##40##1##(1992-6#1)(1992-9#2)(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-1#3)(2008-11#2)(2008-4#3)(2008-5#1)(2008-9#4)(2009-3#1)(2009-5#5)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
metalloproteins and##4##2##(2010-11#4)
metalloproteins in##2##2##(2010-11#2)
metalloproteins##15##1##(1990-5#1)(1994-3#1)(1995-5#1)(1997-4#1)(2008-10#3)(2010-11#8)
metalloproteomes##5##1##(2010-11#5)
metallothionein (MT) and##3##3##(1990-5#1)(1995-3#1)(2008-10#1)
metallothionein (MT) proteins##2##3##(2008-10#2)
metallothionein (MT)##13##2##(1990-5#1)(1993-12#1)(1995-3#1)(1996-12#1)(2008-10#8)(2008-7#1)
metallothionein and metallothionein-Ia mRNA in##2##5##(1990-5#2)
metallothionein and metallothionein-Ia mRNA##3##4##(1990-5#3)
metallothionein and##4##2##(1990-5#3)(1994-11#1)
metallothionein in##4##2##(2008-10#4)
metallothionein isoforms##4##2##(2008-10#4)
metallothionein promoter##3##2##(1990-8#1)(2008-11#2)
metallothionein turnover##3##2##(2008-10#3)
metallothionein##57##1##(1990-5#6)(1990-8#1)(1991-12#1)(1991-5#4)(1992-6#1)(1993-12#4)(1994-11#2)(1995-3#1)(1996-12#2)(2008-10#30)(2008-11#3)(2008-7#2)
metallothionein-Ia mRNA##4##2##(1990-5#4)
metallothioneins##15##1##(1990-5#1)(2008-10#13)(2011-2#1)
metallurgical and##2##2##(1991-3#1)(2008-10#1)
metallurgical micrographs##2##2##(2008-3#2)
metallurgical samples##2##2##(2008-10#2)
metallurgical##7##1##(1991-3#1)(2008-10#4)(2008-3#2)
metals (Al##2##2##(2008-10#2)
metals (e##5##2##(2008-10#4)(2009-10#1)
metals (namely##2##2##(2008-10#2)
metals analysis in estuarine and seawater##2##6##(2008-10#2)
metals analysis##3##2##(2008-10#3)
metals and anions in##2##4##(2008-10#2)
metals and anions##5##3##(2008-10#5)
metals and for##2##3##(2008-10#2)
metals and metalloids##3##3##(1995-3#1)(2008-10#1)(2010-11#1)
metals and the##6##3##(1994-6#1)(1995-3#1)(2008-10#2)(2010-11#2)
metals and##36##2##(1994-6#1)(1994-8#1)(1995-3#2)(2008-10#26)(2008-2#1)(2010-11#3)(2010-5#1)(2012-3#1)
metals are##12##2##(1991-12#1)(1992-12#1)(2008-10#6)(2008-12#2)(2008-5#1)(2009-12#1)
metals as##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
metals associated to carbonate##2##4##(2011-2#2)
metals at##7##2##(2008-10#7)
metals bound to MLP-I##2##4##(2010-5#2)
metals bound to##3##3##(2007-11#1)(2010-5#2)
metals bound##4##2##(2007-11#1)(2008-10#1)(2010-5#2)
metals by the chelating groups##2##5##(2008-10#2)
metals by the##5##3##(2008-10#5)
metals by##15##2##(1995-3#1)(2008-10#14)
metals can be##4##3##(2008-10#4)
metals can##5##2##(2008-10#4)(2009-10#1)
metals could be##4##3##(1992-12#1)(2008-10#3)
metals determined##2##2##(2008-10#2)
metals did not##2##3##(2008-10#2)
metals for##2##2##(2008-10#2)
metals from aqueous##2##3##(2008-10#2)
metals from the##2##3##(2008-10#2)
metals from##12##2##(2008-10#11)(2013-1#1)
metals has##3##2##(2008-10#1)(2008-12#2)
metals have been determined##2##4##(2008-10#2)
metals have been##5##3##(1997-4#1)(2008-10#3)(2008-5#1)
metals have##7##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)
metals in air particulate matters##2##5##(2008-10#2)
metals in alloys##2##3##(2008-10#2)
metals in aqueous##2##3##(2008-10#2)
metals in biological##2##3##(2008-10#1)(2010-11#1)
metals in complex##2##3##(2008-10#2)
metals in human##3##3##(2008-10#2)(2008-11#1)
metals in sediments##5##3##(2008-10#5)
metals in soil##2##3##(2008-10#2)
metals in soils and sediments##2##5##(2008-10#2)
metals in soils##3##3##(2008-10#3)
metals in solid samples##2##4##(2008-10#2)
metals in solution##3##3##(2008-10#3)
metals in the##9##3##(1995-3#1)(2008-10#6)(2011-1#1)(2011-2#1)
metals in urine##2##3##(2008-10#2)
metals in used lubricating oils by##2##6##(2008-10#2)
metals in used lubricating oils##3##5##(2008-10#3)
metals in used##4##3##(2008-10#4)
metals in water by##3##4##(2008-10#2)(2013-8#1)
metals in water##4##3##(2008-10#3)(2013-8#1)
metals in waters and##2##4##(2008-10#2)
metals in##103##2##(1994-6#1)(1995-3#1)(2007-5#1)(2008-10#82)(2008-11#2)(2008-12#4)(2008-5#1)(2010-11#5)(2011-1#2)(2011-2#2)(2013-8#2)
metals into##2##2##(1997-4#1)(2008-10#1)
metals ions##3##2##(2008-10#3)
metals is##5##2##(2007-12#1)(2008-10#3)(2008-12#1)
metals may play##2##3##(2010-11#2)
metals measured##2##2##(2008-10#2)
metals on##9##2##(1994-6#1)(2008-10#6)(2008-5#2)
metals or##2##2##(2008-10#2)
metals present in the##2##4##(2008-12#1)(2008-5#1)
metals such as Pd(II) and Pt(IV)##2##6##(2008-10#2)
metals such as##7##3##(2008-10#6)(2008-12#1)
metals that##3##2##(2008-10#3)
metals to be determined##2##4##(2008-10#2)
metals to##5##2##(2008-10#3)(2010-5#1)(2011-2#1)
metals under study##3##3##(2008-10#3)
metals using##6##2##(2008-10#6)
metals was also##2##3##(2008-10#2)
metals was studied##2##3##(2008-10#2)
metals was##12##2##(2008-10#12)
metals were determined by##2##4##(2008-10#2)
metals were determined##4##3##(2008-10#4)
metals were investigated##3##3##(2008-10#3)
metals were##20##2##(1995-3#1)(1997-4#1)(2008-10#18)
metals with the##2##3##(2008-10#1)(2008-11#1)
metals with##10##2##(2007-12#1)(2008-10#8)(2008-11#1)
metals without##2##2##(2008-10#1)(2008-5#1)
metals##495##1##(1991-12#1)(1991-5#1)(1992-12#2)(1992-6#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-3#10)(1997-4#5)(1997-7#2)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#366)(2008-11#7)(2008-12#13)(2008-2#1)(2008-3#1)(2008-5#13)(2008-6#3)(2008-7#4)(2009-10#4)(2009-12#2)(2009-8#1)(2010-11#14)(2010-4#1)(2010-5#4)(2011-1#5)(2011-2#9)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
metals)##3##1##(2008-10#3)
metam sodium##2##2##(2008-10#2)
metam##4##1##(2008-10#4)
metamaterials##11##1##(2007-11#1)(2008-7#4)(2009-5#2)(2012-2#4)
metamere##2##1##(2007-12#2)
metameric spinal AVM##2##3##(2008-7#2)
metameric spinal##4##2##(2008-7#4)
metamorphic##2##1##(2012-2#1)(2012-3#1)
metamorphosis and##2##2##(2007-12#1)(2007-5#1)
metamorphosis in##2##2##(2008-8#1)(2012-2#1)
metamorphosis of##3##2##(1995-11#1)(1995-12#1)(2007-12#1)
metamorphosis##13##1##(1995-11#1)(1995-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#2)(2012-3#1)
metamorphosis)##2##1##(2007-5#1)(2012-2#1)
metanephrine##2##1##(2008-10#2)
metaphase I##5##2##(2008-5#2)(2009-12#2)(2013-1#1)
metaphase II (MII)##2##3##(2013-1#2)
metaphase II##3##2##(1994-8#1)(2013-1#2)
metaphase cells##2##2##(2008-1#2)
metaphase chromosome##2##2##(1990-3#1)(2008-9#1)
metaphase chromosomes##8##2##(1990-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
metaphase##35##1##(1990-3#2)(1991-5#1)(1993-12#1)(1994-8#2)(1995-12#1)(1997-3#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-9#3)(2009-12#2)(2011-2#2)(2013-1#4)
metaphases##3##1##(1990-5#1)(1992-12#1)(2008-6#1)
metaphor##6##1##(1991-3#1)(2008-1#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
metaphorical##3##1##(2008-12#1)(2012-2#2)
metaphors##3##1##(2008-2#1)(2012-12#1)(2012-2#1)
metaphyseal fracture##2##2##(2013-1#2)
metaphyseal fractures##4##2##(2011-2#3)(2013-1#1)
metaphyseal##13##1##(2008-9#1)(2009-4#2)(2010-3#2)(2011-2#4)(2013-1#4)
metaphyses##2##1##(1995-6#2)
metaphysical##2##1##(2010-12#1)(2013-1#1)
metaphysics##2##1##(1990-2#1)(2008-1#1)
metaphysis##5##1##(1991-11#1)(1993-8#1)(1995-6#1)(2009-1#1)(2012-2#1)
metaplasia in a##2##3##(2012-3#2)
metaplasia in##4##2##(1992-9#1)(2012-3#3)
metaplasia of the##3##3##(1992-4#1)(1997-1#1)(2011-1#1)
metaplasia##24##1##(1991-2#1)(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#2)(1994-2#1)(1994-9#2)(1997-1#3)(2007-8#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-1#3)(2012-3#4)
metaplastic##7##1##(2008-11#1)(2008-3#2)(2009-3#1)(2009-5#1)(2012-3#2)
metapopulation dynamics##10##2##(2008-8#8)(2008-9#2)
metapopulation extinction time##2##3##(2008-8#2)
metapopulation is##3##2##(2008-8#1)(2008-9#2)
metapopulation model that##3##3##(2008-8#2)(2012-2#1)
metapopulation model to##2##3##(2008-10#1)(2008-8#1)
metapopulation model##9##2##(2008-10#1)(2008-8#6)(2008-9#1)(2012-2#1)
metapopulation models##6##2##(2008-8#6)
metapopulation structure of##2##3##(2008-10#2)
metapopulation with##3##2##(2008-8#1)(2008-9#2)
metapopulation##66##1##(2008-10#6)(2008-8#41)(2008-9#17)(2011-2#1)(2012-2#1)
metapopulations by##2##2##(2008-10#1)(2008-8#1)
metapopulations##15##1##(2008-10#2)(2008-8#10)(2008-9#3)
metastable##11##1##(1992-5#1)(1992-8#1)(1994-3#1)(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-2#1)
metastasectomy##3##1##(2012-2#1)(2013-1#2)
metastases (n =##2##3##(1990-2#1)(1993-1#1)
metastases after##4##2##(1992-6#1)(1997-4#1)(2010-3#1)(2012-3#1)
metastases and the##2##3##(1994-12#1)(1996-6#1)
metastases and##24##2##(1990-12#1)(1991-4#1)(1991-8#1)(1994-12#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-11#6)(2007-6#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-3#3)(2011-1#1)(2011-2#1)
metastases are##17##2##(1995-4#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-11#9)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
metastases at autopsy##2##3##(1994-7#2)
metastases at##8##2##(1992-5#1)(1994-7#2)(2007-11#1)(2007-8#2)(2009-10#1)(2010-3#1)
metastases caused by prostate cancer##2##5##(2011-2#2)
metastases could##2##2##(2008-7#1)(2011-2#1)
metastases developed##2##2##(1994-12#1)(2007-5#1)
metastases following##2##2##(1992-2#1)(1996-8#1)
metastases from breast cancer were##2##5##(1990-12#1)(1995-4#1)
metastases from breast cancer##6##4##(1990-12#1)(1995-4#2)(2007-11#1)(2008-7#2)
metastases from internal malignancies are##2##5##(1990-8#1)(2010-6#1)
metastases from internal##3##3##(1990-8#1)(2010-11#1)(2010-6#1)
metastases from malignant##2##3##(2007-5#1)(2008-6#1)
metastases from osteogenic sarcoma##2##4##(1992-12#2)
metastases from the##2##3##(2007-11#1)(2008-7#1)
metastases from transitional cell carcinoma##2##5##(2012-1#2)
metastases from##46##2##(1990-12#1)(1990-8#3)(1992-12#5)(1993-8#1)(1994-6#1)(1995-4#2)(2007-10#2)(2007-11#5)(2007-2#1)(2007-5#1)(2007-6#2)(2008-10#1)(2008-6#5)(2008-7#5)(2009-4#1)(2009-9#1)(2010-11#2)(2010-3#2)(2010-6#2)(2012-1#2)(2013-7#1)
metastases had##2##2##(1990-6#1)(2008-9#1)
metastases have been##3##3##(2007-10#2)(2010-11#1)
metastases have##5##2##(2007-10#2)(2008-7#1)(2010-11#1)(2012-2#1)
metastases in patients with##3##4##(1991-6#1)(2008-7#1)(2013-8#1)
metastases in proximal end of the femur##2##7##(2007-11#2)
metastases in proximal##3##3##(2007-11#3)
metastases in the##5##3##(1991-6#1)(2007-11#4)
metastases in##35##2##(1991-6#2)(1992-2#1)(1992-8#1)(1993-12#1)(1995-12#1)(2007-11#12)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#3)(2008-7#3)(2010-3#5)(2012-12#1)(2013-1#1)(2013-8#1)
metastases is##7##2##(1996-6#1)(1997-4#1)(2007-11#2)(2008-6#1)(2010-12#1)(2013-1#1)
metastases located##2##2##(1991-6#1)(2007-11#1)
metastases of breast cancer##3##4##(1990-12#1)(1995-4#1)(2007-11#1)
metastases of breast##4##3##(1990-12#1)(1995-4#1)(1997-3#1)(2007-11#1)
metastases of renal cell carcinoma##2##5##(1990-8#1)(2013-1#1)
metastases of renal##3##3##(1990-8#1)(2007-11#1)(2013-1#1)
metastases of##19##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1993-9#1)(1995-4#1)(1997-3#1)(2007-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
metastases or##2##2##(2007-11#1)(2008-7#1)
metastases secondary to##2##3##(1992-8#1)(2008-7#1)
metastases than##2##2##(2008-10#1)(2013-1#1)
metastases to the liver and##2##5##(1991-4#1)(1994-7#1)
metastases to the##15##3##(1991-4#1)(1994-7#1)(1997-4#1)(2007-11#8)(2008-1#1)(2008-11#1)(2009-10#1)(2013-8#1)
metastases to##25##2##(1990-8#1)(1991-4#1)(1994-7#1)(1997-4#1)(2007-11#13)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-10#1)(2010-3#1)(2013-8#1)
metastases treated with##2##3##(1997-4#1)(2008-7#1)
metastases treated##4##2##(1997-4#1)(2007-11#2)(2008-7#1)
metastases using##2##2##(1995-12#1)(2007-11#1)
metastases was##6##2##(1990-6#1)(1990-8#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-5#1)
metastases were found##2##3##(2007-11#1)(2013-8#1)
metastases were##16##2##(1991-6#1)(1992-10#1)(2007-11#6)(2007-7#1)(2008-4#1)(2010-3#2)(2011-2#1)(2013-1#1)(2013-8#2)
metastases which##2##2##(2008-10#1)(2009-5#1)
metastases within##2##2##(2008-10#1)(2008-6#1)
metastases##480##1##(1990-12#7)(1990-2#3)(1990-6#5)(1990-8#10)(1990-9#4)(1991-12#1)(1991-2#2)(1991-4#3)(1991-6#9)(1991-8#8)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#8)(1994-6#2)(1994-7#4)(1994-8#1)(1995-12#3)(1995-4#5)(1995-8#1)(1995-9#2)(1996-10#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#9)(2007-11#122)(2007-2#2)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#4)(2008-1#10)(2008-10#13)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#33)(2008-7#27)(2008-8#1)(2008-9#4)(2009-10#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-9#1)(2010-11#4)(2010-12#2)(2010-3#33)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#7)
metastases]##4##1##(1992-5#1)(1997-4#1)(2008-10#1)(2011-3#1)
metastasis (p##3##2##(1991-12#1)(1993-11#1)(2008-12#1)
metastasis after##5##2##(1994-7#1)(2007-10#1)(2008-7#1)(2010-3#1)(2012-2#1)
metastasis and invasion##3##3##(2012-12#2)(2012-3#1)
metastasis and##20##2##(1993-12#1)(1993-3#1)(1994-12#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#2)(2010-8#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)
metastasis are##2##2##(2007-8#1)(2012-1#1)
metastasis as a presenting feature of lung adenocarcinoma##2##8##(2008-9#2)
metastasis as a presenting feature of##3##6##(2007-7#1)(2008-9#2)
metastasis as a##6##3##(2007-10#1)(2007-7#1)(2008-9#2)(2011-2#1)(2013-7#1)
metastasis as##7##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-7#1)
metastasis assays##3##2##(2008-1#3)
metastasis by##4##2##(1992-9#1)(1994-12#1)(2013-1#2)
metastasis can##2##2##(2011-2#1)(2012-2#1)
metastasis during##2##2##(2011-1#1)(2011-2#1)
metastasis from a##4##3##(1993-12#1)(1993-8#1)(2008-12#1)(2008-7#1)
metastasis from##18##2##(1991-6#1)(1992-2#1)(1993-12#3)(1993-8#2)(1994-7#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-1#1)(2013-7#2)
metastasis has##3##2##(1994-12#1)(2006-12#1)(2007-7#1)
metastasis in a##4##3##(2008-4#1)(2008-5#1)(2010-12#1)(2012-1#1)
metastasis in some##2##3##(1993-8#1)(2013-1#1)
metastasis in the##6##3##(1996-6#1)(2008-6#2)(2010-11#1)(2011-2#1)(2013-1#1)
metastasis in##31##2##(1992-12#1)(1993-8#1)(1994-12#2)(1996-6#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-1#1)(2013-1#6)(2013-8#1)
metastasis into the##2##3##(1994-12#2)
metastasis is a##2##3##(2007-11#1)(2011-2#1)
metastasis is extremely rare##2##4##(2011-2#1)(2013-1#1)
metastasis is not##2##3##(2010-8#2)
metastasis is##14##2##(1997-3#1)(2007-11#1)(2008-11#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
metastasis model of##2##3##(1994-12#1)(2008-11#1)
metastasis model##3##2##(1994-12#2)(2008-11#1)
metastasis of a##3##3##(1992-6#1)(1996-6#1)(2008-4#1)
metastasis of gastrointestinal##2##3##(1997-3#1)(2008-10#1)
metastasis of ovarian cancer##4##4##(1990-12#1)(1991-6#1)(2011-2#1)(2012-3#1)
metastasis of renal cell carcinoma##2##5##(1990-8#1)(2007-4#1)
metastasis of the##4##3##(1992-6#1)(2008-1#1)(2008-6#1)(2013-1#1)
metastasis of##37##2##(1990-12#1)(1990-8#1)(1991-6#2)(1992-2#1)(1992-6#2)(1993-12#1)(1993-9#1)(1994-12#1)(1996-10#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
metastasis revealing##2##2##(2007-8#2)
metastasis suppressor##2##2##(2008-9#1)(2009-3#1)
metastasis suppressors##2##2##(2009-3#2)
metastasis to the##5##3##(1992-2#1)(1997-8#1)(2008-1#1)(2009-10#1)(2010-6#1)
metastasis to##12##2##(1991-6#1)(1992-2#1)(1997-8#1)(2008-1#1)(2008-8#2)(2009-10#2)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
metastasis was##6##2##(1992-8#2)(2007-11#1)(2008-10#1)(2008-12#1)(2011-3#1)
metastasis were##4##2##(1992-2#1)(1994-12#1)(1994-8#1)(2008-10#1)
metastasis within##2##2##(1992-5#1)(2007-11#1)
metastasis without##2##2##(1990-2#1)(2013-1#1)
metastasis##347##1##(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#6)(1991-8#1)(1992-12#1)(1992-2#5)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#4)(1994-12#16)(1994-7#4)(1994-8#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-6#3)(1997-1#1)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#7)(2007-11#10)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#6)(2008-1#16)(2008-10#5)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#8)(2008-7#11)(2008-8#6)(2008-9#6)(2009-10#4)(2009-12#2)(2009-2#2)(2009-3#8)(2009-4#2)(2009-5#1)(2010-10#4)(2010-11#3)(2010-12#1)(2010-3#13)(2010-6#5)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#28)(2011-3#1)(2012-1#6)(2012-12#7)(2012-2#7)(2012-3#10)(2013-1#26)(2013-7#4)(2013-8#7)
metastasis&quot##4##1##(1990-6#2)(2008-1#2)
metastasis-free survival##3##2##(1993-9#2)(2008-6#1)
metastasis-suppressing##2##1##(2011-2#1)(2013-1#1)
metastasis-suppressor function##2##2##(1993-9#2)
metastasis-suppressor##3##1##(1993-9#3)
metastasis]##4##1##(1990-9#2)(2008-10#1)(2009-5#1)
metastasize to the##2##3##(2007-11#1)(2010-6#1)
metastasize to##3##2##(2007-11#1)(2010-6#1)(2012-3#1)
metastasize##11##1##(1990-8#1)(2007-11#1)(2007-5#1)(2009-3#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
metastasized to the##6##3##(1994-5#1)(2008-3#1)(2008-6#1)(2010-6#1)(2012-3#1)(2013-8#1)
metastasized to##8##2##(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-6#1)(2012-3#1)(2013-8#1)
metastasized##13##1##(1993-11#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-3#1)(2010-6#1)(2012-3#1)(2013-7#1)(2013-8#2)
metastasizing leiomyoma##2##2##(2012-3#2)
metastasizing to the##2##3##(2008-5#1)(2009-10#1)
metastasizing to##5##2##(2008-5#2)(2008-6#1)(2009-10#1)(2013-1#1)
metastasizing##8##1##(1995-11#1)(2008-5#2)(2008-6#1)(2009-10#1)(2012-3#2)(2013-1#1)
metastastectomy##3##1##(2008-6#3)
metastatic adenocarcinoma##5##2##(2007-6#1)(2010-11#1)(2010-7#2)(2013-1#1)
metastatic adrenocortical carcinoma##2##3##(1992-10#1)(1997-5#1)
metastatic adrenocortical##3##2##(1990-9#1)(1992-10#1)(1997-5#1)
metastatic and non-metastatic##2##3##(1992-9#1)(2008-4#1)
metastatic and##5##2##(1992-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
metastatic at presentation##3##3##(1992-6#3)
metastatic behavior##2##2##(2008-4#1)(2010-3#1)
metastatic bone tumors in long bones and pelvic ring##2##9##(2007-11#2)
metastatic bone tumors##4##3##(2007-11#4)
metastatic bone##7##2##(2007-11#5)(2012-3#2)
metastatic bony lesions##2##3##(2008-6#2)
metastatic breast cancer with##2##4##(1990-6#1)(1992-10#1)
metastatic breast cancer##15##3##(1990-6#2)(1991-6#2)(1992-10#3)(1993-8#1)(1994-8#1)(1996-11#1)(2008-3#1)(2009-9#2)(2010-8#1)(2013-8#1)
metastatic breast carcinoma##2##3##(1994-2#1)(2007-10#1)
metastatic breast##18##2##(1990-6#2)(1991-6#2)(1992-10#3)(1993-8#1)(1994-2#1)(1994-8#1)(1996-11#1)(2007-10#1)(2008-3#1)(2009-9#2)(2010-8#1)(2012-12#1)(2013-8#1)
metastatic cancer patients##2##3##(1990-2#1)(1991-4#1)
metastatic cancer##5##2##(1990-2#1)(1991-4#1)(2007-11#1)(2008-7#2)
metastatic carcinoid##2##2##(1990-10#1)(1990-2#1)
metastatic carcinoma##2##2##(2007-5#1)(2010-3#1)
metastatic colon cancer##2##3##(1992-12#1)(2009-5#1)
metastatic colorectal cancer patients##4##4##(1990-2#1)(1991-4#2)(1992-12#1)
metastatic colorectal cancer##10##3##(1990-12#1)(1990-2#2)(1991-4#4)(1992-12#1)(1992-8#1)(2010-9#1)
metastatic colorectal carcinoma##2##3##(1990-2#1)(1992-12#1)
metastatic colorectal##13##2##(1990-12#1)(1990-2#3)(1991-4#4)(1992-12#2)(1992-8#1)(2010-9#1)(2011-1#1)
metastatic compression of the cauda equina##2##6##(2008-3#2)
metastatic disease and##6##3##(1990-11#1)(2007-11#1)(2008-7#2)(2010-3#1)(2010-9#1)
metastatic disease at##2##3##(2008-6#1)(2010-3#1)
metastatic disease of the##2##4##(2007-11#2)
metastatic disease to the##3##4##(1990-12#1)(2008-1#2)
metastatic disease was##2##3##(2008-6#2)
metastatic disease##45##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-4#1)(1994-7#1)(1997-4#1)(1997-5#1)(2007-11#6)(2008-1#4)(2008-6#10)(2008-7#5)(2010-3#6)(2010-9#1)(2011-1#1)(2011-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
metastatic disease) died##2##3##(2010-3#2)
metastatic disease)##3##2##(2010-3#3)
metastatic dissemination##3##2##(1990-2#1)(1993-9#1)(2008-1#1)
metastatic gastric cancer##3##3##(1993-12#1)(2010-12#2)
metastatic hepatocellular carcinoma##3##3##(1990-2#2)(2011-2#1)
metastatic human##2##2##(2008-4#1)(2008-8#1)
metastatic infections##2##2##(2007-12#1)(2011-3#1)
metastatic lesion##2##2##(1993-12#1)(2007-5#1)
metastatic lesions in the##3##4##(2008-8#1)(2010-3#1)(2011-2#1)
metastatic lesions##10##2##(1994-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
metastatic lymph nodes##3##3##(1990-12#1)(1994-12#2)
metastatic malignant melanoma##2##3##(1991-6#1)(2009-3#1)
metastatic malignant##5##2##(1990-10#1)(1991-6#1)(2009-3#1)(2011-3#1)(2013-8#1)
metastatic melanoma cells##5##3##(1997-7#1)(2009-3#3)(2013-1#1)
metastatic melanoma##17##2##(1990-6#1)(1992-2#2)(1994-3#1)(1997-7#3)(2009-3#4)(2010-6#3)(2012-1#1)(2012-2#1)(2013-1#1)
metastatic meningeal hemangiopericytoma##2##3##(2008-6#2)
metastatic nonanaplastic thyroid##2##3##(1990-10#2)
metastatic ovarian yolk sac carcinoma in a##2##7##(2012-1#2)
metastatic pancreatic cancer##2##3##(2011-2#2)
metastatic phenotype##3##2##(1994-5#1)(2009-3#2)
metastatic potential and##2##3##(2008-6#1)(2008-9#1)
metastatic potential of##6##3##(1992-9#2)(2008-1#1)(2008-6#1)(2010-3#1)(2011-2#1)
metastatic potential##19##2##(1990-8#1)(1992-9#3)(1993-9#1)(2008-1#1)(2008-4#2)(2008-6#2)(2008-9#3)(2009-2#1)(2010-3#3)(2011-2#1)(2012-3#1)
metastatic potentials##2##2##(2008-11#1)(2008-9#1)
metastatic process##8##2##(1990-6#1)(1990-8#1)(1993-9#1)(2008-1#1)(2008-4#2)(2010-3#1)(2011-2#1)
metastatic progression##3##2##(2009-3#1)(2013-1#2)
metastatic prostate cancer is##3##4##(1992-2#1)(2007-5#1)(2013-8#1)
metastatic prostate cancer##10##3##(1990-2#1)(1992-2#1)(1995-11#1)(2007-5#4)(2008-11#1)(2013-8#2)
metastatic prostate cancers##3##3##(2011-2#3)
metastatic prostate##14##2##(1990-12#1)(1990-2#1)(1992-2#1)(1995-11#1)(2007-5#4)(2008-11#1)(2011-2#3)(2013-8#2)
metastatic prostatic cancer##2##3##(1991-7#2)
metastatic rate##3##2##(1997-1#1)(2008-11#1)(2012-3#1)
metastatic renal cell carcinoma##8##4##(1990-2#2)(1991-8#3)(1993-12#1)(1994-12#1)(2011-1#1)
metastatic renal cell##11##3##(1990-2#2)(1991-8#3)(1993-12#1)(1994-12#1)(2008-6#2)(2011-1#1)(2011-3#1)
metastatic renal##13##2##(1990-12#1)(1990-2#2)(1991-8#3)(1993-12#1)(1993-8#1)(1994-12#1)(2008-6#2)(2011-1#1)(2011-3#1)
metastatic sites##5##2##(1992-2#1)(1994-7#2)(2008-6#1)(2012-3#1)
metastatic solid##2##2##(1995-9#1)(2008-11#1)
metastatic spinal cord compression##3##4##(1991-9#1)(1993-9#1)(1996-9#1)
metastatic spinal cord##4##3##(1991-9#1)(1993-9#1)(1996-9#1)(2008-6#1)
metastatic spread to##4##3##(1992-10#1)(1994-12#1)(1997-8#1)(2007-6#1)
metastatic spread##10##2##(1990-11#1)(1991-2#1)(1992-10#1)(1994-12#1)(1997-8#1)(2007-6#1)(2008-1#1)(2008-6#1)(2009-9#1)(2010-7#1)
metastatic squamous cell carcinoma of the##2##6##(1993-12#1)(2013-7#1)
metastatic to the##4##3##(1992-2#1)(1994-2#1)(2007-4#1)(2008-12#1)
metastatic tumor##8##2##(1990-12#1)(1992-6#2)(2007-11#2)(2007-12#1)(2013-8#2)
metastatic tumors in the##4##4##(2007-11#1)(2009-9#1)(2010-7#2)
metastatic tumors in##5##3##(2007-11#1)(2008-4#1)(2009-9#1)(2010-7#2)
metastatic tumors##17##2##(1993-9#1)(1994-2#1)(2007-11#6)(2008-1#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)
metastatic tumours in##2##3##(2007-11#2)
metastatic tumours##8##2##(1992-9#1)(2007-11#5)(2013-8#2)
metastatic##408##1##(1990-10#5)(1990-11#2)(1990-12#6)(1990-2#14)(1990-3#1)(1990-6#5)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#6)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#1)(1992-10#5)(1992-12#3)(1992-2#6)(1992-5#1)(1992-6#9)(1992-8#3)(1992-9#13)(1993-1#1)(1993-11#1)(1993-12#5)(1993-5#1)(1993-8#4)(1993-9#5)(1994-10#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#2)(1994-7#3)(1994-8#2)(1995-11#1)(1995-9#1)(1996-11#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2007-10#4)(2007-11#31)(2007-12#2)(2007-4#2)(2007-5#6)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#12)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#8)(2008-6#30)(2008-7#11)(2008-8#3)(2008-9#5)(2009-1#1)(2009-2#1)(2009-3#9)(2009-5#2)(2009-9#4)(2010-11#1)(2010-12#3)(2010-3#21)(2010-6#4)(2010-7#6)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#14)(2011-3#5)(2012-1#5)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#10)(2013-7#2)(2013-8#16)
metatarsal and##2##2##(2010-3#1)(2011-2#1)
metatarsal phalangeal##2##2##(2006-10#1)(2009-6#1)
metatarsal##21##1##(2006-10#1)(2008-12#4)(2009-6#1)(2010-11#2)(2010-3#6)(2011-2#2)(2012-12#1)(2012-2#4)
metatarsals##3##1##(2008-12#1)(2010-3#2)
metatarsophalangeal joint##5##2##(2006-10#1)(2009-10#1)(2010-5#3)
metatarsophalangeal##6##1##(2006-10#1)(2009-10#1)(2010-5#3)(2012-3#1)
metatarsus##3##1##(1991-8#1)(2012-2#2)
metathesis reaction##2##2##(2008-11#1)(2009-10#1)
metathesis##4##1##(2008-11#1)(2009-10#2)(2009-11#1)
metathoracic##2##1##(2007-12#1)(2013-1#1)
metatranscriptomes##3##1##(2011-2#3)
metavanadate##3##1##(2008-10#3)
metazoa##2##1##(2008-11#1)(2010-2#1)
metazoan development##2##2##(2007-12#1)(2008-9#1)
metazoan##6##1##(1996-6#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
metazoans##8##1##(2007-12#1)(2008-1#1)(2008-4#1)(2009-12#2)(2009-8#2)(2010-2#1)
metel contained maximum##2##3##(2013-1#2)
metel##4##1##(2008-10#1)(2013-1#3)
meteorite##3##1##(1995-11#2)(2008-10#1)
meteorites##3##1##(1995-11#1)(2008-10#2)
meteoritic##2##1##(1997-5#2)
meteorological and environmental factors##2##4##(2008-8#2)
meteorological and environmental##4##3##(2008-8#4)
meteorological and##5##2##(2008-2#1)(2008-8#4)
meteorological conditions##4##2##(2008-11#2)(2008-2#1)(2008-3#1)
meteorological parameters##3##2##(2008-10#2)(2008-11#1)
meteorological space instrument##2##3##(2008-3#2)
meteorological variables and##2##3##(2008-10#1)(2008-2#1)
meteorological variables##4##2##(2008-10#2)(2008-2#2)
meteorological##33##1##(2007-11#1)(2008-10#6)(2008-11#4)(2008-2#10)(2008-3#4)(2008-8#6)(2009-7#2)
meter of##2##2##(1995-8#1)(2008-5#1)
meter##24##1##(1995-8#1)(2007-10#1)(2008-10#7)(2008-2#2)(2008-3#6)(2008-5#2)(2009-11#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
metered dose inhaler (MDI) and##2##5##(1992-3#1)(1997-2#1)
metered dose inhaler (MDI)##6##4##(1992-3#2)(1996-1#1)(1996-2#1)(1997-2#2)
metered dose inhaler##7##3##(1992-3#2)(1996-1#1)(1996-2#1)(1997-2#2)(2007-11#1)
metered dose inhalers (MDIs) contain##2##5##(1996-1#2)
metered dose inhalers (MDIs)##7##4##(1992-3#1)(1996-1#5)(1997-1#1)
metered dose inhalers##18##3##(1992-2#3)(1992-3#5)(1993-2#1)(1996-1#8)(1997-1#1)
metered dose##27##2##(1992-2#3)(1992-3#8)(1993-2#1)(1995-12#1)(1996-1#9)(1996-2#1)(1997-1#1)(1997-2#2)(2007-11#1)
metered##29##1##(1991-12#1)(1992-2#3)(1992-3#8)(1993-2#1)(1995-12#1)(1996-1#9)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2007-11#1)
metered-dose inhaler##4##2##(1996-2#1)(1997-1#1)(2008-8#2)
metered-dose inhalers##2##2##(1992-3#1)(1996-2#1)
metered-dose##6##1##(1992-3#1)(1996-2#2)(1997-1#1)(2008-8#2)
metering valve##3##2##(1992-3#1)(1996-1#2)
metering##6##1##(1992-3#1)(1996-1#3)(2008-3#2)
meters above##2##2##(2007-7#1)(2008-3#1)
meters and##3##2##(2008-10#1)(2008-3#2)
meters have been developed##2##4##(2008-3#1)(2008-5#1)
meters in##2##2##(2008-3#2)
meters##29##1##(1990-11#1)(1991-3#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-3#12)(2008-5#5)(2010-8#1)(2012-3#1)
meters)##3##1##(1990-11#1)(2007-11#1)(2009-6#1)
metformin and##2##2##(2008-3#1)(2010-11#1)
metformin hydrochloride##9##2##(2010-5#4)(2011-1#2)(2012-2#2)(2013-1#1)
metformin in##7##2##(1995-8#2)(2008-10#1)(2008-3#3)(2012-3#1)
metformin treatment##3##2##(2011-2#2)(2013-1#1)
metformin##52##1##(1994-8#5)(1995-8#2)(2008-1#5)(2008-10#2)(2008-3#6)(2010-11#1)(2010-5#4)(2011-1#4)(2011-2#6)(2012-2#4)(2012-3#8)(2013-1#5)
meth + marijuana##2##3##(2013-8#2)
meth-only##2##1##(2013-8#2)
methacholine##7##1##(1992-3#1)(1996-1#1)(2008-1#2)(2008-5#1)(2012-3#2)
methacrylate (MMA)##2##2##(2008-10#1)(2009-7#1)
methacrylate groups and DEAE groups##2##5##(2013-1#2)
methacrylate groups and##3##3##(2013-1#3)
methacrylate monoliths##2##2##(2013-1#2)
methacrylate##44##1##(1994-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#11)(2008-2#5)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2012-2#1)(2013-1#7)
methacrylate) (PMMA)##9##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-4#2)
methacrylate)##33##1##(2007-11#4)(2007-12#3)(2008-10#6)(2008-2#7)(2008-3#11)(2010-4#2)
methacrylic acid (MAA)##2##3##(2008-10#2)
methacrylic##3##1##(2008-10#3)
methacrylic-acrylic##2##1##(2008-10#2)
methadone in##3##2##(2008-7#1)(2008-8#1)(2010-5#1)
methadone maintenance treatment program##2##4##(1996-3#2)
methadone maintenance treatment##3##3##(1996-3#3)
methadone maintenance##10##2##(1991-1#4)(1996-3#3)(2008-10#2)(2009-9#1)
methadone patients##2##2##(1991-1#2)
methadone treatment##6##2##(1991-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#1)
methadone##35##1##(1991-1#9)(1996-3#4)(2008-10#3)(2008-12#1)(2008-6#5)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-5#7)(2012-12#2)
methadone-maintained##4##1##(1991-1#3)(2009-9#1)
metham sodium##3##2##(2008-10#3)
methamphetamine (MAP)##2##2##(1996-7#1)(2009-7#1)
methamphetamine and##6##2##(1995-2#1)(1995-3#2)(2008-10#1)(2013-1#2)
methamphetamine use##3##2##(2007-10#1)(2013-1#2)
methamphetamine users##2##2##(2011-2#1)(2013-1#1)
methamphetamine was##3##2##(1995-3#3)
methamphetamine##42##1##(1990-8#2)(1991-1#3)(1995-2#2)(1995-3#14)(1996-7#1)(2007-10#2)(2008-10#5)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#7)(2013-8#2)
methamphetamine-induced##3##1##(1991-1#1)(1996-7#1)(2008-11#1)
methane and##5##2##(2008-10#2)(2008-3#2)(2009-12#1)
methane are##2##2##(2008-3#2)
methane by##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
methane concentration##2##2##(2008-2#1)(2008-3#1)
methane concentrations of##2##3##(2008-2#1)(2008-3#1)
methane consumption##3##2##(2008-6#3)
methane conversion##3##2##(2008-10#3)
methane emissions from rice paddy fields##2##6##(2008-3#2)
methane in the##2##3##(2007-12#1)(2013-1#1)
methane in##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
methane production from##3##3##(2013-1#3)
methane production##7##2##(2008-6#1)(2013-1#6)
methane was##2##2##(2008-2#1)(2008-6#1)
methane##81##1##(1991-12#2)(1992-3#1)(2007-12#6)(2008-10#12)(2008-11#1)(2008-2#15)(2008-3#18)(2008-5#2)(2008-6#12)(2008-7#3)(2009-12#1)(2011-2#1)(2013-1#7)
methane-air and##2##2##(2008-2#1)(2008-3#1)
methane-air diffusion flames are##2##4##(2007-12#1)(2008-2#1)
methane-air flame##6##2##(2008-10#3)(2008-2#3)
methane-air premixed##2##2##(2008-3#2)
methane-air##14##1##(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#4)
methane/air##2##1##(2008-2#2)
methanesulfonate##2##1##(1996-2#1)(1997-4#1)
methanesulfonic acid##2##2##(2008-10#2)
methanethiosulfonate##2##1##(1995-2#1)(2008-11#1)
methanogen##5##1##(1990-2#1)(2008-7#4)
methanogenesis##3##1##(2008-6#2)(2008-7#1)
methanogenic culture##2##2##(2008-7#2)
methanogenic##5##1##(2008-10#1)(2008-6#1)(2008-7#3)
methanogens##3##1##(2008-6#1)(2008-7#2)
methanol and 0##2##3##(1996-5#1)(2011-1#1)
methanol and ethanol were##2##4##(1991-5#1)(2008-10#1)
methanol and ethanol##6##3##(1991-5#1)(2008-10#5)
methanol and the##2##3##(2008-10#1)(2010-12#1)
methanol and water##3##3##(2008-10#2)(2011-1#1)
methanol and##30##2##(1991-5#1)(1994-9#1)(1995-3#2)(1996-5#1)(2007-12#1)(2008-10#17)(2008-2#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#2)
methanol as a##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)
methanol as mobile phase##2##4##(2008-10#1)(2012-2#1)
methanol as the mobile phase##2##5##(1994-9#1)(2011-1#1)
methanol as the##5##3##(1994-9#1)(2008-10#2)(2011-1#1)(2012-2#1)
methanol as##16##2##(1994-9#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#1)(2012-2#2)
methanol at##5##2##(1990-9#1)(1995-3#1)(2008-10#3)
methanol concentration in##3##3##(2008-7#3)
methanol concentration##8##2##(1996-5#2)(2008-10#1)(2008-7#5)
methanol content##4##2##(2008-10#4)
methanol extract of Aegle marmelos##4##5##(2012-2#4)
methanol extract of the##3##4##(2007-11#1)(2008-11#1)(2012-2#1)
methanol extract of##11##3##(2007-11#1)(2008-11#2)(2012-2#6)(2012-3#1)(2013-8#1)
methanol extract##14##2##(2007-11#1)(2008-11#4)(2008-12#1)(2012-2#6)(2012-3#1)(2013-8#1)
methanol gave##2##2##(1996-5#2)
methanol in plasma##3##3##(1991-5#3)
methanol in the mobile phase##2##5##(1996-5#1)(2008-10#1)
methanol in the presence of##2##5##(1995-9#1)(1996-5#1)
methanol in the##6##3##(1995-9#1)(1996-5#2)(2008-10#2)(2012-12#1)
methanol in##18##2##(1991-5#3)(1995-3#3)(1995-9#1)(1996-5#3)(2008-10#7)(2012-12#1)
methanol is##3##2##(1995-6#1)(2008-10#2)
methanol modifier##2##2##(2008-10#2)
methanol on the##2##3##(2008-10#1)(2010-12#1)
methanol on##4##2##(2008-10#2)(2008-5#1)(2010-12#1)
methanol solution##3##2##(2008-10#3)
methanol solutions##2##2##(2008-10#1)(2008-2#1)
methanol to##6##2##(2007-11#2)(2008-10#1)(2008-7#1)(2010-4#1)(2013-1#1)
methanol using##2##2##(2008-10#1)(2013-1#1)
methanol vapor and##2##3##(2008-2#2)
methanol vapor##3##2##(2007-12#1)(2008-2#2)
methanol was added to the surfactant-rich phase##2##7##(2008-10#2)
methanol was##11##2##(1991-12#1)(1991-5#1)(1992-3#1)(1995-2#1)(1996-5#1)(2008-10#5)(2013-1#1)
methanol were##4##2##(1995-2#1)(2007-11#1)(2008-10#2)
methanol##267##1##(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-5#5)(1992-3#2)(1992-6#2)(1993-11#1)(1994-9#3)(1995-2#2)(1995-3#10)(1995-6#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#14)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#7)(2007-12#2)(2008-10#131)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#11)(2012-3#1)(2013-1#5)(2013-8#1)
methanol) and##2##2##(2008-10#2)
methanol)##10##1##(1992-5#1)(1997-7#1)(2008-10#5)(2008-5#1)(2011-1#1)(2013-8#1)
methanol-acetate buffer##3##2##(1990-8#1)(2008-10#2)
methanol-acetonitrile##2##1##(2008-10#2)
methanol-phosphate buffer##3##2##(2008-10#3)
methanol-water mixtures##2##2##(1996-5#1)(2008-10#1)
methanol-water##14##1##(1996-5#1)(2008-10#12)(2011-2#1)
methanol/water##7##1##(2008-10#6)(2008-5#1)
methanolic extract of Equisetum arvense##2##5##(2008-12#2)
methanolic extract of##3##3##(2008-12#3)
methanolic extract##5##2##(2008-12#5)
methanolic extracts of##2##3##(1997-2#1)(2008-10#1)
methanolic solution of the##2##4##(2008-10#1)(2008-11#1)
methanolic solution##6##2##(2006-12#1)(2008-10#4)(2008-11#1)
methanolic solutions##2##2##(2008-10#2)
methanolic##22##1##(1997-2#3)(2006-12#1)(2008-10#11)(2008-11#2)(2008-12#5)
methanolysis##2##1##(2007-11#1)(2008-10#1)
methanotrophic cultures##2##2##(2008-6#2)
methanotrophic mixed culture##2##3##(2008-7#2)
methanotrophic##7##1##(2008-6#3)(2008-7#3)(2009-8#1)
methcathinone##3##1##(1995-2#3)
methemerythrin##2##1##(1992-8#2)
methemoglobin##6##1##(1990-8#3)(2008-11#2)(2010-4#1)
methemoglobinemia##2##1##(2007-8#1)(2008-5#1)
methicillin resistant Staphylococcus aureus (MRSA)##2##5##(2007-7#1)(2010-2#1)
methicillin resistant Staphylococcus aureus##3##4##(2007-7#1)(2009-7#1)(2010-2#1)
methicillin resistant staphylococcus##2##3##(2013-1#2)
methicillin resistant##6##2##(2007-11#1)(2007-7#1)(2009-7#1)(2010-2#1)(2013-1#2)
methicillin##9##1##(2007-11#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-8#1)(2013-1#2)
methicillin-##2##1##(1991-3#1)(2007-12#1)
methicillin-resistant S aureus##4##3##(2007-12#2)(2008-11#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus (MRSA)##7##4##(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus in a Canadian##2##6##(2007-12#1)(2008-10#1)
methicillin-resistant Staphylococcus aureus in a##3##5##(2007-12#1)(2008-10#1)(2008-11#1)
methicillin-resistant Staphylococcus aureus in##7##4##(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2012-1#1)
methicillin-resistant Staphylococcus aureus infections##2##4##(2008-10#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus skin##2##4##(2007-12#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus##32##3##(2007-12#9)(2007-7#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2009-4#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#1)
methicillin-resistant strains##2##2##(1991-3#1)(2008-7#1)
methicillin-resistant##39##1##(1991-3#2)(2007-12#11)(2007-7#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#1)
methicillin-sensitive##2##1##(1997-3#1)(2011-2#1)
methicillin-susceptible##2##1##(2007-12#1)(2010-6#1)
methide radical##2##2##(2008-10#2)
methimazole##5##1##(2011-2#4)(2012-3#1)
methimazole-induced##2##1##(2011-2#1)(2012-3#1)
methine##3##1##(1990-8#1)(1992-3#1)(2009-12#1)
methionine (Met)##2##2##(2008-10#1)(2008-4#1)
methionine adenosyltransferase##2##2##(1992-6#2)
methionine and##4##2##(1990-2#1)(1994-6#1)(2008-10#1)(2008-5#1)
methionine in##4##2##(1991-12#1)(1995-5#2)(2008-10#1)
methionine metabolism##3##2##(1992-8#1)(1993-9#1)(2009-8#1)
methionine residue##2##2##(1993-8#1)(2008-7#1)
methionine residues##2##2##(1995-5#2)
methionine sulphoximine##2##2##(2008-11#2)
methionine synthase##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
methionine was##2##2##(1997-2#2)
methionine##60##1##(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-5#7)(1997-2#2)(1997-6#1)(1997-7#1)(2008-10#14)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
methionine-induced hyperhomocysteinemia##2##2##(2010-5#2)
methionine-induced##3##1##(2010-5#3)
methionyl##3##1##(1990-2#1)(1993-6#1)(2006-6#1)
methocarbamol##3##1##(2008-10#3)
methoctramine##2##1##(1997-2#1)(1997-7#1)
method (BEM)##3##2##(2008-11#1)(2008-3#1)(2009-11#1)
method (DM)##2##2##(2008-10#2)
method (EBCM) to##2##3##(2008-2#1)(2008-3#1)
method (EBCM)##3##2##(2008-2#1)(2008-3#2)
method (GHPSAM)##2##2##(2008-10#2)
method (HPSAM) and##2##3##(2008-10#2)
method (HPSAM)##10##2##(2008-10#10)
method (flow##2##2##(2008-10#1)(2008-9#1)
method (the##3##2##(2008-10#2)(2008-7#1)
method 2##2##2##(2008-10#1)(2008-12#1)
method 2)##2##2##(2008-10#2)
method A##2##2##(2008-10#1)(2008-6#1)
method A)##2##2##(2008-10#2)
method B)##3##2##(2008-10#3)
method C##2##2##(2008-6#2)
method CALUX##2##2##(2008-10#2)
method a##10##2##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
method according to##4##3##(2008-10#4)
method accuracy##3##2##(2008-10#3)
method achieves the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
method across##2##2##(2008-10#1)(2012-2#1)
method after##5##2##(2008-10#4)(2011-2#1)
method against the##2##3##(2012-3#1)(2013-1#1)
method against##5##2##(2008-8#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
method agree##2##2##(2008-10#1)(2008-3#1)
method agreed well with##2##4##(2008-10#2)
method agreed well##3##3##(2008-10#3)
method agreed with##3##3##(2008-10#3)
method agreed##8##2##(2008-10#8)
method allow##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
method allowed a##2##3##(1997-2#1)(2008-10#1)
method allowed the determination of##3##5##(2008-10#3)
method allowed the##7##3##(1996-12#1)(2008-10#6)
method allowed us to determine##2##5##(2008-10#1)(2009-8#1)
method allowed us to##4##4##(1990-2#1)(2008-10#2)(2009-8#1)
method allowed##20##2##(1990-2#1)(1996-12#2)(1997-2#1)(2008-10#14)(2009-8#2)
method allows a rapid##2##4##(2008-10#1)(2008-11#1)
method allows a##8##3##(2008-10#3)(2008-11#2)(2008-4#2)(2011-2#1)
method allows for the detection of##2##6##(2008-10#1)(2008-5#1)
method allows for the##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
method allows for##5##3##(2008-10#2)(2008-5#1)(2010-11#1)(2012-3#1)
method allows one to##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
method allows the determination of 0##2##6##(2008-10#2)
method allows the determination of##16##5##(2008-10#16)
method allows the##23##3##(1990-11#1)(2008-10#20)(2008-2#1)(2009-12#1)
method allows us to##2##4##(2008-2#1)(2008-3#1)
method allows##56##2##(1990-11#1)(2008-10#38)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
method also allows##2##3##(2008-3#1)(2008-4#1)
method also provides##2##3##(2008-10#1)(2008-2#1)
method also##11##2##(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
method and HPLC##2##3##(2008-10#2)
method and a##10##3##(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)
method and an##4##3##(1991-12#1)(2008-10#2)(2008-3#1)
method and analyzed by##2##4##(2008-12#1)(2013-1#1)
method and by##8##3##(1997-2#1)(2008-10#5)(2008-3#2)
method and compared##2##3##(2008-6#1)(2013-1#1)
method and for##2##3##(2008-10#1)(2008-3#1)
method and its##5##3##(2008-10#4)(2010-9#1)
method and other##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
method and refined##2##3##(1992-12#1)(2008-8#1)
method and results from##2##4##(2008-10#1)(2012-2#1)
method and results##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
method and the atomic absorption##2##5##(2008-10#2)
method and the conventional##2##4##(2008-10#1)(2010-6#1)
method and the reference##3##4##(2008-10#3)
method and the results of##2##5##(2008-2#1)(2008-5#1)
method and the results were##2##5##(2008-10#2)
method and the results##8##4##(2008-10#5)(2008-2#1)(2008-5#1)(2013-8#1)
method and the standard##2##4##(1997-4#1)(2008-10#1)
method and the##56##3##(1992-4#1)(1993-12#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-8#1)
method and their##3##3##(2008-10#3)
method and then##2##3##(2007-12#1)(2008-10#1)
method and those##5##3##(2008-1#1)(2008-10#4)
method and to##5##3##(2008-10#2)(2008-3#1)(2010-3#1)(2013-1#1)
method and two##2##3##(2008-3#1)(2008-5#1)
method and##231##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#99)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#25)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#5)
method appeared##3##2##(2007-11#1)(2008-10#1)(2012-1#1)
method appears to be##2##4##(1996-2#1)(2008-10#1)
method appears to##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
method appears##4##2##(1996-2#1)(2008-10#2)(2008-3#1)
method applicable##2##2##(2008-10#1)(2008-5#1)
method applied for##2##3##(2008-10#1)(2008-3#1)
method applied to the##4##4##(1996-6#1)(2008-10#1)(2008-2#2)
method applied to##10##3##(1996-6#1)(2008-10#4)(2008-2#2)(2010-9#1)(2012-2#1)(2012-7#1)
method applied##12##2##(1996-6#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-9#1)(2012-2#1)(2012-7#1)
method applies##3##2##(2008-10#1)(2008-2#2)
method are also discussed##2##4##(2008-3#2)
method are compared with##2##4##(2008-2#1)(2008-3#1)
method are compared##4##3##(2008-2#1)(2008-3#3)
method are considered##2##3##(2008-3#1)(2008-9#1)
method are described##3##3##(1990-8#1)(1995-12#1)(2008-3#1)
method are discussed##5##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#2)
method are given##3##3##(2008-2#1)(2008-3#2)
method are illustrated##2##3##(2008-10#2)
method are in good agreement with##3##6##(2007-11#1)(2008-10#2)
method are in##6##3##(2007-11#1)(2008-10#5)
method are less than##4##4##(2008-10#4)
method are not##2##3##(1992-12#1)(2008-10#1)
method are outlined##2##3##(1994-9#1)(2008-11#1)
method are presented##6##3##(2007-11#1)(2008-10#2)(2008-3#3)
method are shown##4##3##(1992-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
method are that##4##3##(1990-11#1)(1997-6#1)(2008-10#1)(2008-3#1)
method are used##2##3##(1992-6#1)(2008-3#1)
method are##88##2##(1990-11#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#3)(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#35)(2008-11#1)(2008-2#3)(2008-3#20)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
method as a##4##3##(2008-10#2)(2008-3#1)(2010-7#1)
method as well as##4##4##(2008-3#2)(2008-5#1)(2013-7#1)
method as##18##2##(2008-10#7)(2008-3#3)(2008-5#2)(2010-7#1)(2011-3#1)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
method assumes##3##2##(1994-1#1)(2007-12#1)(2008-2#1)
method at the##7##3##(1990-3#1)(2008-10#5)(2008-3#1)
method at##17##2##(1990-3#1)(2008-10#9)(2008-3#4)(2008-8#1)(2010-8#1)(2013-8#1)
method available##5##2##(1990-5#1)(1990-6#1)(1994-5#1)(2008-5#1)(2010-3#1)
method avoids##2##2##(2008-1#1)(2008-10#1)
method based on a##9##4##(2008-10#2)(2008-2#1)(2008-3#3)(2010-5#1)(2010-6#1)(2013-8#1)
method based on an##3##4##(2007-11#1)(2008-3#1)(2010-2#1)
method based on capillary##2##4##(2008-10#1)(2008-5#1)
method based on solid-phase extraction##2##5##(2008-10#2)
method based on solid-phase##3##4##(2008-10#3)
method based on the reaction of luminol with##2##8##(2008-10#2)
method based on the use of##2##6##(2008-10#2)
method based on the##28##4##(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#1)(2008-2#3)(2008-7#1)(2008-9#1)(2009-6#1)
method based on##110##3##(1990-11#1)(1990-9#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#63)(2008-11#2)(2008-2#5)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
method based##111##2##(1990-11#1)(1990-9#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#63)(2008-11#2)(2008-2#5)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
method because##2##2##(1994-7#1)(2008-10#1)
method before##2##2##(1993-6#1)(2008-6#1)
method being##2##2##(2008-10#1)(2011-1#1)
method between the##2##3##(1994-7#1)(2008-10#1)
method by reacting##2##3##(2008-10#1)(2008-7#1)
method by use of##4##4##(2008-2#1)(2008-3#3)
method by using##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
method by which##3##3##(2007-12#1)(2008-4#2)
method by##33##2##(1994-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-7#2)(2010-2#1)(2010-7#1)(2013-8#1)
method called##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
method can also be applied to##2##6##(1991-5#1)(2011-2#1)
method can also be used##4##5##(2008-3#2)(2008-9#1)(2009-5#1)
method can also be##7##4##(1991-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-5#1)(2011-2#1)
method can also##8##3##(1991-5#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-5#1)(2011-2#1)
method can be applied for##2##5##(1995-6#1)(2008-10#1)
method can be applied in##2##5##(2010-8#1)(2013-8#1)
method can be applied to determine##3##6##(1994-9#1)(2008-10#1)(2011-1#1)
method can be applied to other##2##6##(2009-11#1)(2011-2#1)
method can be applied to the determination of##3##8##(2008-10#3)
method can be applied to the determination##4##7##(2008-10#4)
method can be applied to the##6##6##(2008-10#6)
method can be applied to##18##5##(1994-9#1)(2007-12#2)(2008-10#10)(2008-3#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
method can be applied##25##4##(1994-9#1)(1995-6#1)(2007-12#2)(2008-10#13)(2008-3#1)(2008-6#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
method can be considered as a##2##6##(2007-2#1)(2008-5#1)
method can be easily##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
method can be implemented in##2##5##(2011-2#1)(2013-1#1)
method can be implemented##3##4##(2007-12#1)(2011-2#1)(2013-1#1)
method can be recommended for the##2##6##(2008-11#1)(2013-1#1)
method can be successfully applied to the##2##7##(2008-10#2)
method can be successfully applied to##3##6##(2007-12#1)(2008-10#2)
method can be successfully##6##4##(2007-12#1)(2008-10#3)(2010-5#1)(2012-2#1)
method can be used for the##3##6##(1993-9#1)(2008-10#2)
method can be used for##6##5##(1993-9#1)(2008-10#3)(2008-9#1)(2009-9#1)
method can be used to determine##2##6##(2008-10#2)
method can be used to##15##5##(1996-3#1)(1996-5#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2011-2#1)
method can be used##30##4##(1993-9#1)(1994-12#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)
method can be useful##2##4##(2008-3#1)(2008-5#1)
method can be utilized in##2##5##(2008-10#2)
method can be##92##3##(1991-5#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#5)(2007-2#1)(2008-10#38)(2008-11#2)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
method can easily be##2##4##(2008-10#1)(2008-3#1)
method can effectively##2##3##(2008-3#1)(2011-1#1)
method can give##2##3##(2008-10#1)(2013-8#1)
method can provide a##2##4##(2008-10#1)(2008-3#1)
method can provide##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
method can##127##2##(1990-3#1)(1991-5#2)(1992-5#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#6)(2007-2#2)(2008-10#45)(2008-11#3)(2008-2#4)(2008-3#19)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2009-9#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
method capable of##5##3##(2008-10#2)(2008-3#2)(2013-1#1)
method clearly##2##2##(2008-10#1)(2012-12#1)
method combined with##2##3##(1990-8#1)(2008-3#1)
method combined##4##2##(1990-8#1)(1997-3#1)(2008-10#1)(2008-3#1)
method combines##4##2##(2007-12#1)(2008-6#2)(2012-2#1)
method combining##2##2##(2008-10#1)(2008-3#1)
method compared to##2##3##(2007-7#1)(2008-10#1)
method compared well##2##3##(2008-10#1)(2010-5#1)
method compared##5##2##(2007-7#1)(2008-10#2)(2008-2#1)(2010-5#1)
method comparison##3##2##(1995-2#1)(1997-3#1)(2008-10#1)
method confirm##2##2##(2007-11#1)(2008-2#1)
method consistently##2##2##(2008-10#1)(2012-2#1)
method consisting of##2##3##(1990-2#1)(2008-6#1)
method consists of##10##3##(1997-1#1)(2007-11#1)(2008-10#4)(2008-3#4)
method could also##2##3##(1991-5#1)(1995-2#1)
method could be applied in##2##5##(2008-10#2)
method could be applied##5##4##(2008-10#5)
method could be used as##2##5##(2008-10#2)
method could be used for the determination of##2##8##(2008-10#2)
method could be used for the##3##6##(2008-10#3)
method could be used for##5##5##(2008-10#4)(2008-5#1)
method could be used##13##4##(2008-10#10)(2008-11#1)(2008-5#1)(2010-7#1)
method could be##24##3##(2008-10#16)(2008-11#3)(2008-5#1)(2010-12#1)(2010-7#1)(2013-1#1)(2013-8#1)
method could provide##2##3##(1997-4#1)(2008-10#1)
method could##42##2##(1991-12#1)(1991-5#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-10#24)(2008-11#4)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#3)
method coupled with a##3##4##(2008-10#3)
method coupled with##4##3##(2008-10#3)(2010-12#1)
method creates a##2##3##(2008-11#1)(2008-3#1)
method currently##3##2##(2008-10#2)(2008-9#1)
method demonstrated##4##2##(2008-10#3)(2008-9#1)
method depended on##2##3##(2007-11#1)(2008-10#1)
method depends on##2##3##(2008-4#1)(2008-7#1)
method depends##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
method described by##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
method described here is##4##4##(1996-3#1)(2008-11#1)(2008-5#1)(2008-9#1)
method described here##13##3##(1991-12#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-9#1)(2009-4#2)
method described in this paper##2##5##(2008-10#1)(2012-12#1)
method described in this##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
method described in##4##3##(2007-12#1)(2008-10#2)(2012-12#1)
method described##33##2##(1990-2#1)(1991-12#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-4#4)(2008-5#2)(2008-9#2)(2009-3#1)(2009-4#2)(2012-12#2)
method detection limit (MDL)##4##4##(2008-10#4)
method detection limit##12##3##(2008-10#12)
method detection limits were##2##4##(2008-10#2)
method detection limits##3##3##(2008-10#3)
method detection##15##2##(2008-10#15)
method determines the##2##3##(2008-3#1)(2008-5#1)
method developed by##2##3##(2008-10#1)(2013-1#1)
method developed for##3##3##(1996-12#1)(2008-10#1)(2009-6#1)
method developed in this work##2##5##(2008-10#2)
method developed in this##3##4##(2008-10#3)
method developed in##6##3##(2008-10#5)(2008-5#1)
method developed is##2##3##(2008-10#1)(2008-3#1)
method developed to##2##3##(2007-11#1)(2008-10#1)
method developed was found to be##2##6##(2008-10#2)
method developed was##6##3##(2008-10#6)
method developed##34##2##(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#25)(2008-3#2)(2008-5#2)(2009-6#1)(2013-1#1)
method development in##2##3##(2008-11#1)(2012-3#1)
method development##8##2##(2008-10#3)(2008-11#1)(2010-11#3)(2012-3#1)
method did not##3##3##(2008-10#2)(2008-7#1)
method does not require a##2##5##(1992-3#1)(2008-10#1)
method does not require any separation##2##6##(2008-10#2)
method does not require any##3##5##(2008-10#3)
method does not require##7##4##(1992-3#1)(2008-10#5)(2008-3#1)
method does not suffer##3##4##(2008-10#3)
method does not##19##3##(1992-3#1)(1996-3#1)(1997-4#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-5#2)(2013-1#1)
method does##21##2##(1992-3#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-5#2)(2013-1#1)
method due to the##3##4##(2008-10#3)
method due to##5##3##(1997-2#1)(2008-10#4)
method during##2##2##(2008-10#1)(2008-11#1)
method eliminates the need for##4##5##(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)
method employed for the##2##4##(2008-10#1)(2012-2#1)
method employed##6##2##(1994-12#1)(2008-10#4)(2012-2#1)
method employing a##2##3##(2008-10#1)(2008-4#1)
method employing##9##2##(1993-8#1)(2008-10#5)(2008-4#1)(2008-9#1)(2012-12#1)
method employs a##2##3##(2008-10#1)(2008-3#1)
method employs the reaction##2##4##(2008-10#2)
method employs the##3##3##(2008-10#3)
method employs##10##2##(2008-10#7)(2008-3#2)(2009-12#1)
method enabled##5##2##(2008-10#4)(2008-2#1)
method enables one to##2##4##(2008-10#1)(2008-3#1)
method enables##10##2##(1990-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)(2011-2#1)
method established in##2##3##(2008-10#2)
method established##3##2##(2008-10#3)
method evaluated##2##2##(2008-10#2)
method evaluation##2##2##(2008-10#2)
method exhibited##3##2##(2008-10#2)(2008-6#1)
method exhibits##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
method experimentally##2##2##(2008-3#2)
method facilitates the##2##3##(2008-10#1)(2009-10#1)
method features##3##2##(2008-10#2)(2008-7#1)
method following CLSI guidelines##2##4##(2012-3#2)
method for Cd##2##3##(2008-10#2)
method for DNA detection##2##4##(2008-10#2)
method for P##2##3##(2008-10#2)
method for a##15##3##(2007-11#1)(2008-10#6)(2008-2#3)(2008-3#5)
method for absolute measurement of refractive index and thickness of optically transparent media##2##13##(2007-11#2)
method for accurate##2##3##(2008-10#1)(2008-7#1)
method for all##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
method for an##2##3##(2008-3#2)
method for analysing##3##3##(2008-7#2)(2010-2#1)
method for analysis of##8##4##(1995-9#1)(2008-10#7)
method for analyzing##9##3##(1992-3#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-4#2)
method for applying##2##3##(2008-4#1)(2010-12#1)
method for arsenic##3##3##(2008-10#3)
method for ascorbic acid##2##4##(2008-10#2)
method for assessing the##3##4##(2008-4#1)(2008-8#1)(2013-1#1)
method for both##2##3##(1992-6#1)(2008-10#1)
method for calculating the##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
method for calculating##10##3##(2008-10#2)(2008-2#2)(2008-3#4)(2009-12#1)(2010-3#1)
method for calculation of##2##4##(2008-10#1)(2008-3#1)
method for cell##2##3##(2008-11#1)(2008-7#1)
method for characterization of##2##4##(2007-12#1)(2008-10#1)
method for characterizing the structure##2##5##(2007-11#1)(2008-4#1)
method for characterizing the##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
method for clinical##2##3##(1993-12#1)(2008-3#1)
method for collecting##3##3##(2008-3#1)(2008-9#1)(2009-4#1)
method for computing##2##3##(2008-2#1)(2012-3#1)
method for correcting##3##3##(2008-3#3)
method for creating##3##3##(1990-11#1)(2008-3#1)(2008-4#1)
method for delivering##3##3##(1996-1#1)(1996-2#1)(2008-5#1)
method for deriving##2##3##(2008-2#2)
method for designing and##2##4##(1994-3#1)(2008-3#1)
method for designing##7##3##(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-8#2)
method for detecting and##2##4##(2008-10#1)(2008-3#1)
method for detecting##21##3##(1990-2#1)(1995-2#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#2)
method for detection of##6##4##(2007-8#1)(2008-10#2)(2009-6#1)(2011-1#1)(2012-3#1)
method for determination of acid##2##5##(2008-10#2)
method for determination of copper##2##5##(2008-10#2)
method for determination of selenium##2##5##(2008-10#2)
method for determination of the##2##5##(1990-8#1)(2008-3#1)
method for determination of total##2##5##(1995-2#1)(2008-10#1)
method for determination of trace##5##5##(2008-10#5)
method for determination of##53##4##(1990-8#2)(1991-5#1)(1993-8#1)(1995-2#1)(2008-10#44)(2008-3#3)(2012-12#1)
method for determination##54##3##(1990-8#2)(1991-5#1)(1993-8#1)(1995-2#1)(2008-10#45)(2008-3#3)(2012-12#1)
method for determining cell##2##4##(2008-11#1)(2008-9#1)
method for determining the##13##4##(1995-12#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#6)(2013-8#1)
method for determining##40##3##(1991-2#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-7#1)(2006-4#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#11)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
method for diagnosis##3##3##(1994-11#1)(2010-12#1)(2012-3#1)
method for direct determination of the##2##6##(2008-10#1)(2008-3#1)
method for direct determination of##4##5##(2008-10#2)(2008-3#2)
method for direct##7##3##(2008-10#2)(2008-2#1)(2008-3#4)
method for efficiently##3##3##(1994-12#1)(2007-11#1)(2008-2#1)
method for enhancing##2##3##(2007-12#1)(2008-11#1)
method for estimating the##3##4##(1995-3#1)(1997-3#1)(2008-9#1)
method for estimating##12##3##(1992-6#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(2008-2#1)(2008-7#2)(2008-9#1)(2013-1#2)(2013-3#1)
method for estimation of##4##4##(1997-3#1)(2008-10#2)(2010-5#1)
method for evaluating the##5##4##(1992-5#1)(1994-2#1)(2007-10#1)(2011-2#1)(2012-2#1)
method for evaluating##12##3##(1992-5#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
method for examining##2##3##(2008-9#1)(2012-2#1)
method for extracting##2##3##(2007-12#1)(2008-3#1)
method for extraction of##2##4##(2008-10#1)(2012-2#1)
method for fabricating##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
method for fabrication of##2##4##(2008-10#1)(2008-3#1)
method for finding##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
method for flow injection##2##4##(2008-10#2)
method for flow##3##3##(2008-10#2)(2008-9#1)
method for following##2##3##(1991-5#1)(1994-8#1)
method for forming##2##3##(2007-11#1)(2008-11#1)
method for fringe pattern analysis##3##5##(2008-2#1)(2008-3#2)
method for future##2##3##(2012-3#2)
method for generating##7##3##(1990-12#1)(1995-8#2)(2007-11#2)(2008-4#2)
method for genotyping##2##3##(2008-10#1)(2008-4#1)
method for high-resolution##3##3##(2008-3#2)(2008-5#1)
method for holographic##2##3##(2008-3#2)
method for identification of##2##4##(1995-12#1)(2008-10#1)
method for identifying##9##3##(1991-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)(2009-4#1)
method for imaging##2##3##(2007-11#1)(2007-12#1)
method for improving the##8##4##(2007-11#1)(2008-3#5)(2008-9#1)(2012-12#1)
method for improving##9##3##(2007-11#1)(2008-11#1)(2008-3#5)(2008-9#1)(2012-12#1)
method for in situ##3##4##(2008-10#2)(2008-3#1)
method for increasing the##2##4##(2008-3#1)(2012-4#1)
method for increasing##4##3##(2007-11#1)(2008-3#2)(2012-4#1)
method for investigating##3##3##(2010-11#1)(2010-6#1)(2012-2#1)
method for isolating##4##3##(1993-8#1)(1994-2#1)(2008-2#1)(2013-1#1)
method for lead##2##3##(2008-10#1)(2013-8#1)
method for measurement of##3##4##(1995-12#1)(2008-3#1)(2008-6#1)
method for measuring the##17##4##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2011-2#1)
method for measuring##37##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
method for monitoring and##2##4##(1994-9#1)(2008-11#1)
method for monitoring the conservation state of pigmented##2##8##(2008-10#2)
method for monitoring##8##3##(1994-9#1)(2007-8#1)(2008-10#5)(2008-11#1)
method for most##2##3##(1996-5#1)(2008-12#1)
method for nickel##2##3##(2008-10#2)
method for nondestructive##2##3##(2007-11#1)(2007-12#1)
method for numerical##2##3##(2008-2#1)(2008-8#1)
method for obtaining a##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
method for obtaining##11##3##(1996-3#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)
method for on-line##4##3##(2008-10#4)
method for optical##3##3##(2008-3#3)
method for performing##2##3##(2007-11#1)(2008-2#1)
method for phasing segmented##2##4##(2008-2#2)
method for precise##2##3##(2008-10#1)(2008-3#1)
method for preconcentration and##2##4##(2008-10#2)
method for preconcentration##3##3##(2008-10#3)
method for predicting the##2##4##(2008-4#1)(2013-1#1)
method for prediction##2##3##(2008-5#1)(2008-7#1)
method for preparation of##2##4##(2008-10#1)(2008-4#1)
method for preparing the inocula of dematiaceous fungi##2##8##(2008-5#2)
method for preparing the##3##4##(2008-2#1)(2008-5#2)
method for preparing##7##3##(1990-12#1)(2008-2#3)(2008-5#3)
method for preventing##2##3##(2008-9#1)(2013-7#1)
method for primary##3##3##(2008-9#1)(2010-11#1)(2012-2#1)
method for producing##2##3##(2008-2#1)(2008-4#1)
method for purifying##2##3##(1991-8#1)(2008-4#1)
method for quantifying##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
method for quantitation of##2##4##(1993-3#1)(2008-10#1)
method for quantitation##3##3##(1993-3#1)(2008-10#2)
method for quantitative analysis of undefined mixtures##2##7##(2008-10#2)
method for quantitative analysis of##4##5##(2008-10#4)
method for quantitative analysis##5##4##(2008-10#5)
method for quantitative determination##2##4##(1991-5#1)(2008-10#1)
method for quantitative##8##3##(1991-5#1)(2008-10#6)(2008-3#1)
method for rapid and selective extraction##2##6##(2008-10#2)
method for rapid and##3##4##(2008-10#3)
method for rapid extraction##2##4##(2008-10#2)
method for rapid##12##3##(1990-11#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-8#1)
method for real-time##4##3##(2007-11#2)(2007-12#2)
method for removing##2##3##(2008-10#1)(2010-3#1)
method for routine analysis##2##4##(2008-10#2)
method for routine##3##3##(2007-10#1)(2008-10#2)
method for sample##4##3##(2008-10#3)(2008-4#1)
method for screening##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
method for segmentation##3##3##(2010-8#2)(2011-7#1)
method for selecting##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
method for separating the##2##4##(2008-10#1)(2008-2#1)
method for separating##4##3##(1992-6#1)(2008-10#2)(2008-2#1)
method for separation and determination of##2##6##(2008-10#1)(2009-8#1)
method for separation and##3##4##(2008-10#2)(2009-8#1)
method for separation##4##3##(2008-10#3)(2009-8#1)
method for simulating##2##3##(2008-2#1)(2008-3#1)
method for simultaneous determination of five sunscreens##2##7##(2008-5#2)
method for simultaneous determination of uric acid##2##7##(2008-10#2)
method for simultaneous determination of##18##5##(2008-10#13)(2008-5#2)(2011-3#1)(2012-2#1)(2012-3#1)
method for simultaneous quantification of##3##5##(2010-12#2)(2011-3#1)
method for simultaneous##26##3##(2008-10#17)(2008-5#2)(2008-8#1)(2010-12#2)(2011-3#2)(2012-2#1)(2012-3#1)
method for solving##2##3##(1993-5#1)(2008-6#1)
method for speciation##2##3##(2008-10#2)
method for studying the##4##4##(1993-8#1)(1996-12#1)(2008-4#1)(2008-9#1)
method for studying##5##3##(1993-8#1)(1996-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
method for suppressing the##2##4##(2007-11#2)
method for synthesizing##3##3##(1994-11#1)(2008-3#1)(2010-6#1)
method for testing##2##3##(2008-10#1)(2008-3#1)
method for the accurate and precise spectrophotometric determination of##2##9##(2008-10#2)
method for the accurate and precise##3##6##(2008-10#3)
method for the analysis of tetracycline##2##6##(2008-10#2)
method for the analysis of the##2##6##(1992-3#1)(2008-10#1)
method for the analysis of##19##5##(1992-3#1)(1993-8#1)(1997-4#1)(2008-10#14)(2008-7#1)(2011-1#1)
method for the analysis##20##4##(1992-3#1)(1993-8#1)(1997-4#1)(2008-10#14)(2008-4#1)(2008-7#1)(2011-1#1)
method for the assay of perphenazine##3##6##(2008-10#3)
method for the assay of##6##5##(2008-10#6)
method for the assessment of##2##5##(1990-12#1)(2008-10#1)
method for the calculation of##2##5##(2008-3#1)(2010-8#1)
method for the characterization of##3##5##(1994-12#1)(2008-4#2)
method for the design of##4##5##(2008-2#1)(2008-3#3)
method for the detection and##4##5##(1990-12#1)(2008-10#1)(2008-11#2)
method for the detection of##9##5##(1994-2#1)(2007-10#1)(2008-10#4)(2009-1#1)(2010-8#1)(2013-8#1)
method for the detection##13##4##(1990-12#1)(1994-2#1)(2007-10#1)(2008-10#5)(2008-11#2)(2009-1#1)(2010-8#1)(2013-8#1)
method for the determination of Hg(II)##2##6##(2008-10#2)
method for the determination of Se##2##6##(2008-10#2)
method for the determination of a##2##6##(2008-10#2)
method for the determination of acid##2##6##(2008-10#2)
method for the determination of arsenic##3##6##(2008-10#3)
method for the determination of ascorbic acid##2##7##(2008-10#2)
method for the determination of chloride##2##6##(2008-10#2)
method for the determination of cysteine and##2##7##(2008-10#2)
method for the determination of cysteine##5##6##(2008-10#5)
method for the determination of ethanol##2##6##(2008-10#2)
method for the determination of hydroxyl##2##6##(2008-10#2)
method for the determination of inorganic##2##6##(2008-10#2)
method for the determination of lead in##2##7##(2008-10#2)
method for the determination of nitrate in##2##7##(2008-10#2)
method for the determination of nucleic acids##2##7##(2008-10#2)
method for the determination of peroxynitrite##2##6##(2008-10#2)
method for the determination of phosphatidylcholine##2##6##(2008-10#2)
method for the determination of serine using##2##7##(2008-10#2)
method for the determination of some##2##6##(2008-10#2)
method for the determination of the concentration of diethylenetriamine (DETA) in aqueous mineral flotation solutions##2##15##(2008-10#2)
method for the determination of the##12##6##(1991-5#1)(2007-11#1)(2008-10#10)
method for the determination of total##7##6##(2008-10#7)
method for the determination of trace amount of##2##8##(2008-10#2)
method for the determination of trace amounts of##11##8##(2008-10#11)
method for the determination of trace chlorine##2##7##(2008-10#2)
method for the determination of trace mercury##2##7##(2008-10#2)
method for the determination of trace##24##6##(1990-8#1)(2008-10#23)
method for the determination of uric acid##2##7##(2008-10#2)
method for the determination of vanadium##2##6##(2008-10#2)
method for the determination of##258##5##(1990-12#1)(1990-8#3)(1991-5#1)(1992-11#1)(1993-9#1)(1996-5#2)(2007-11#1)(2008-10#245)(2008-3#1)(2008-5#1)(2011-1#1)
method for the determination##259##4##(1990-12#1)(1990-8#3)(1991-5#1)(1992-11#1)(1993-9#1)(1996-5#2)(2007-11#1)(2008-10#246)(2008-3#1)(2008-5#1)(2011-1#1)
method for the direct determination of##2##6##(2008-10#2)
method for the direct##6##4##(2008-10#5)(2011-2#1)
method for the estimation of##4##5##(2008-10#2)(2008-3#1)(2013-7#1)
method for the extraction and##2##5##(2008-10#2)
method for the extraction##3##4##(2008-10#3)
method for the fluorometric determination of##2##6##(2008-10#2)
method for the generation of##2##5##(2007-12#1)(2008-4#1)
method for the identification of##6##5##(1997-2#1)(2008-1#1)(2008-7#2)(2010-12#1)(2012-2#1)
method for the identification##7##4##(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-12#1)(2012-2#1)
method for the in##2##4##(2008-11#1)(2008-5#1)
method for the isolation of##2##5##(2008-10#1)(2010-3#1)
method for the isolation##3##4##(2008-10#1)(2010-3#1)(2011-1#1)
method for the measurement of oxygen##2##6##(1993-1#1)(2008-11#1)
method for the measurement of##14##5##(1990-11#1)(1992-11#1)(1992-12#1)(1993-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)
method for the on-line##3##4##(2008-10#3)
method for the preconcentration of##2##5##(2008-10#2)
method for the preconcentration##4##4##(2008-10#4)
method for the prediction of##2##5##(2008-10#1)(2008-5#1)
method for the preparation of##11##5##(1990-12#1)(1992-9#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2011-1#1)
method for the quantitation of##5##5##(1997-2#2)(2008-10#3)
method for the quantitative analysis of##4##6##(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)
method for the quantitative determination of##9##6##(1997-2#1)(2008-10#7)(2011-1#1)
method for the quantitative##14##4##(1997-2#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-1#1)
method for the rapid and simultaneous##2##6##(2008-10#1)(2008-9#1)
method for the rapid determination of##3##6##(2008-10#3)
method for the rapid##9##4##(2008-10#6)(2008-9#1)(2009-6#1)(2012-3#1)
method for the reduction of##2##5##(2008-2#1)(2010-7#1)
method for the resolution of##2##5##(2008-10#2)
method for the routine##2##4##(2008-10#1)(2010-4#1)
method for the screening of##2##5##(2008-10#2)
method for the selective##5##4##(2008-10#5)
method for the sensitive determination of##3##6##(2008-10#3)
method for the separation and determination of##2##7##(2008-10#2)
method for the separation and##3##5##(2008-10#3)
method for the separation of beryllium from##2##7##(2008-10#2)
method for the separation of##8##5##(1991-12#1)(1991-5#1)(1995-6#1)(2008-10#5)
method for the separation##14##4##(1991-12#1)(1991-5#1)(1995-6#1)(2008-10#10)(2008-5#1)
method for the simultaneous determination of##21##6##(1995-3#1)(2008-10#19)(2011-1#1)
method for the simultaneous##30##4##(1995-3#1)(2008-10#26)(2008-5#1)(2008-9#1)(2011-1#1)
method for the speciation of##3##5##(2008-10#3)
method for the speciation##4##4##(2008-10#4)
method for the spectrophotometric determination of nickel naphthenate in gasoline in a microemulsion##2##13##(2008-10#2)
method for the spectrophotometric determination of nitrite in water##2##9##(2008-10#2)
method for the spectrophotometric determination of##7##6##(2008-10#7)
method for the study of##2##5##(1994-5#1)(2008-10#1)
method for the trace determination of##2##6##(2008-10#2)
method for the trace##7##4##(2008-10#7)
method for the##568##3##(1990-11#1)(1990-12#4)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-2#4)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#427)(2008-11#8)(2008-12#2)(2008-2#8)(2008-3#19)(2008-4#7)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
method for this##2##3##(2008-9#1)(2013-8#1)
method for three-dimensional##2##3##(2008-3#2)
method for total##3##3##(2008-10#3)
method for trace analysis##2##4##(2008-10#2)
method for trace##4##3##(2008-10#4)
method for treating##6##3##(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
method for treatment of##2##4##(2007-12#1)(2012-2#1)
method for use in##2##4##(2008-10#1)(2008-8#1)
method for use##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
method for using##4##3##(2008-3#1)(2008-9#1)(2011-1#1)(2012-5#1)
method for wavelength selection##2##4##(2008-10#2)
method for##1525##2##(1990-11#5)(1990-12#8)(1990-2#2)(1990-5#1)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-5#7)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#3)(1997-7#3)(2006-4#1)(2007-10#3)(2007-11#37)(2007-12#29)(2007-7#2)(2007-8#7)(2008-1#2)(2008-10#755)(2008-11#28)(2008-12#7)(2008-2#63)(2008-3#164)(2008-4#43)(2008-5#22)(2008-6#10)(2008-7#20)(2008-8#12)(2008-9#27)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#9)(2011-2#13)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#14)(2012-3#9)(2012-4#1)(2012-5#1)(2013-1#12)(2013-3#1)(2013-7#2)(2013-8#14)
method from a##2##3##(1992-12#1)(2008-8#1)
method from the##4##3##(2008-10#2)(2010-6#1)(2013-8#1)
method from##11##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2010-6#1)(2013-7#1)(2013-8#1)
method fulfills all the##2##4##(2008-10#2)
method gave a##2##3##(1993-8#1)(2008-10#1)
method gave good results##2##4##(2008-10#2)
method gave##9##2##(1993-8#1)(2008-10#5)(2008-7#1)(2009-6#1)(2013-1#1)
method gives the##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
method gives##11##2##(1990-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)
method had a##3##3##(1992-11#1)(2008-10#1)(2011-2#1)
method had been applied to the determination of trace molybdenum in tungsten##2##12##(2008-10#2)
method had been##4##3##(2008-10#4)
method had##12##2##(1992-11#1)(1993-9#1)(2008-10#8)(2008-5#1)(2011-2#1)
method has a detection limit of##3##6##(2008-10#3)
method has a detection limit##4##5##(2008-10#4)
method has a linear calibration range from##2##7##(2008-10#2)
method has a linear calibration range##3##6##(2008-10#3)
method has a linear##4##4##(2008-10#4)
method has a##22##3##(1990-2#1)(2007-12#1)(2008-10#18)(2009-1#1)(2013-8#1)
method has also been successfully applied##2##6##(2008-10#2)
method has also been##6##4##(2008-10#5)(2008-11#1)
method has an##3##3##(2007-12#1)(2008-10#2)
method has been applied for the##3##6##(2008-10#3)
method has been applied for##6##5##(2008-10#6)
method has been applied in##2##5##(2008-10#2)
method has been applied satisfactorily to the##2##7##(2008-10#2)
method has been applied satisfactorily to##3##6##(2008-10#3)
method has been applied satisfactorily##4##5##(2008-10#4)
method has been applied successfully to the determination of##2##9##(2008-10#2)
method has been applied successfully to the##3##7##(2008-10#3)
method has been applied successfully to##4##6##(2008-10#4)
method has been applied successfully##5##5##(2008-10#5)
method has been applied to determine##5##6##(2008-10#5)
method has been applied to the analysis of##3##8##(2008-10#3)
method has been applied to the determination of total##3##9##(2008-10#3)
method has been applied to the determination of trace mercury in##4##11##(2008-10#4)
method has been applied to the determination of trace##9##9##(2008-10#9)
method has been applied to the determination of##42##8##(2008-10#42)
method has been applied to the##58##6##(2008-10#56)(2009-5#1)(2010-7#1)
method has been applied to##79##5##(2008-10#75)(2008-2#1)(2009-5#1)(2010-7#1)(2010-8#1)
method has been applied##97##4##(2008-10#93)(2008-2#1)(2009-5#1)(2010-7#1)(2010-8#1)
method has been designed to##2##5##(1993-3#1)(2007-11#1)
method has been developed and validated for the estimation of##2##10##(2010-3#1)(2010-5#1)
method has been developed and validated for the##3##8##(2010-3#1)(2010-5#1)(2011-2#1)
method has been developed and validated for##4##7##(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
method has been developed by##3##5##(2008-10#3)
method has been developed for determination of##2##7##(2008-10#2)
method has been developed for spectrophotometric##2##6##(2008-10#2)
method has been developed for the assay of##3##8##(2008-10#3)
method has been developed for the determination of proteins##2##9##(2008-10#2)
method has been developed for the determination of trace amount of##4##11##(2008-10#4)
method has been developed for the determination of trace##6##9##(2008-10#6)
method has been developed for the determination of##25##8##(1991-5#1)(2008-10#24)
method has been developed for the determination##26##7##(1991-5#1)(2008-10#25)
method has been developed for the direct determination of##4##9##(2008-10#4)
method has been developed for the direct##5##7##(2008-10#5)
method has been developed for the quantitative determination of##3##9##(2008-10#2)(2012-12#1)
method has been developed for the separation and determination of##2##10##(2008-10#2)
method has been developed for the separation##3##7##(2008-10#3)
method has been developed for the simultaneous determination of##6##9##(1990-8#1)(2008-10#5)
method has been developed for the simultaneous##8##7##(1990-8#1)(2008-10#6)(2010-3#1)
method has been developed for the##56##6##(1990-8#1)(1991-5#1)(2008-10#51)(2008-11#1)(2010-3#1)(2012-12#1)
method has been developed for##69##5##(1990-8#1)(1991-5#1)(2008-10#61)(2008-11#2)(2008-3#1)(2010-3#1)(2010-5#1)(2012-12#1)
method has been developed in##3##5##(2008-10#3)
method has been developed to determine##2##6##(2008-10#2)
method has been developed to rapidly##2##6##(2008-10#1)(2008-6#1)
method has been developed to selectively separate and concentrate##2##9##(2008-10#2)
method has been developed to##9##5##(1992-12#1)(2008-10#7)(2008-6#1)
method has been developed##93##4##(1990-8#1)(1991-5#1)(1992-12#1)(2008-10#78)(2008-11#2)(2008-3#2)(2008-6#1)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)
method has been employed to the determination of##2##8##(2008-10#2)
method has been employed to##4##5##(1995-5#1)(2008-10#3)
method has been employed##5##4##(1995-5#1)(2008-10#4)
method has been evaluated##3##4##(2008-10#3)
method has been proposed for the##2##6##(2008-10#2)
method has been proposed to##2##5##(1997-7#1)(2008-10#1)
method has been proposed##5##4##(1997-7#1)(2008-10#3)(2008-7#1)
method has been satisfactorily applied to the determination of##7##9##(2008-10#7)
method has been satisfactorily applied to the##10##7##(2008-10#10)
method has been satisfactorily applied to##11##6##(2008-10#11)
method has been satisfactorily applied##12##5##(2008-10#12)
method has been satisfactorily##13##4##(2008-10#13)
method has been shown##2##4##(2008-10#1)(2008-3#1)
method has been studied##3##4##(2008-10#3)
method has been successfully applied for the##4##7##(2008-10#4)
method has been successfully applied for##7##6##(2008-10#7)
method has been successfully applied to determine##4##7##(2008-10#4)
method has been successfully applied to the determination of##17##9##(2008-10#17)
method has been successfully applied to the simultaneous##2##8##(2008-10#2)
method has been successfully applied to the##24##7##(2008-10#24)
method has been successfully applied to##33##6##(2008-10#33)
method has been successfully applied##40##5##(2008-10#40)
method has been successfully used to##4##6##(2008-10#2)(2008-7#1)(2011-2#1)
method has been successfully used##6##5##(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
method has been successfully##47##4##(2008-10#44)(2008-3#1)(2008-7#1)(2011-2#1)
method has been used for the determination of##4##8##(2008-10#4)
method has been used for the determination##5##7##(2008-10#5)
method has been used for##7##5##(1997-3#1)(2008-10#6)
method has been used to determine##4##6##(2008-10#4)
method has been used to##9##5##(2008-10#7)(2008-11#1)(2008-2#1)
method has been used##19##4##(1997-3#1)(2008-10#16)(2008-11#1)(2008-2#1)
method has been validated by##2##5##(2008-10#2)
method has been validated##4##4##(2008-10#4)
method has been##324##3##(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2008-10#283)(2008-11#4)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)
method has demonstrated##2##3##(2008-10#2)
method has high##3##3##(2008-10#3)
method has higher sensitivity and##2##5##(2008-10#2)
method has higher##3##3##(2008-10#2)(2013-8#1)
method has potential applications in##2##5##(2007-11#1)(2013-1#1)
method has potential##4##3##(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
method has several##2##3##(2008-2#1)(2012-2#1)
method has shown##2##3##(2008-10#1)(2010-4#1)
method has the advantage of##3##5##(2008-10#2)(2008-2#1)
method has the advantages of##2##5##(1990-8#1)(2008-10#1)
method has the##9##3##(1990-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-8#1)
method has##407##2##(1990-2#1)(1990-8#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#330)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-5#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
method have been##12##3##(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
method have##15##2##(1994-8#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
method here proposed##2##3##(2008-10#2)
method here##3##2##(2008-10#3)
method holds##2##2##(2008-10#1)(2009-2#1)
method identifies##2##2##(2009-10#1)(2009-9#1)
method in a planar-integrated micro-optics platform##2##6##(2007-11#2)
method in a##13##3##(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-3#2)(2008-9#1)(2010-4#1)(2013-8#1)
method in an##2##3##(2008-10#1)(2008-3#1)
method in clinical##2##3##(1995-2#1)(2008-10#1)
method in combination with##2##4##(2008-10#1)(2008-3#1)
method in conjunction with Arsenazo III procedure was tested by analyzing marine sediment (MESS-3) and soil##2##16##(2008-10#2)
method in conjunction with##3##4##(2008-10#3)
method in industrial##2##3##(2008-10#1)(2008-12#1)
method in order to##4##4##(2008-10#2)(2008-5#2)
method in terms of##3##4##(2008-10#3)
method in the##30##3##(1991-3#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-3#1)
method in this##2##3##(1992-2#1)(2008-10#1)
method in which the##4##4##(2008-2#1)(2008-3#3)
method in which##9##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2012-1#1)
method in##142##2##(1990-10#1)(1990-11#2)(1990-6#1)(1990-9#2)(1991-3#3)(1992-2#1)(1994-12#1)(1994-7#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-11#6)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#53)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
method include##4##2##(1994-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
method includes##6##2##(2007-12#1)(2008-10#3)(2008-3#2)
method including##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
method indicated##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
method into##2##2##(1996-5#1)(2008-3#1)
method introduced##2##2##(1995-6#1)(2008-3#1)
method involves a##13##3##(1990-12#1)(2008-10#10)(2008-3#1)(2011-2#1)
method involves direct##2##3##(1991-5#1)(2009-11#1)
method involves the##16##3##(1990-2#1)(1996-5#1)(2008-10#13)(2008-3#1)
method involves##46##2##(1990-12#1)(1990-2#1)(1991-5#1)(1993-8#1)(1996-5#1)(2008-10#31)(2008-11#1)(2008-3#3)(2008-4#2)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)
method involving##6##2##(2008-10#3)(2008-11#1)(2008-9#1)(2010-5#1)
method is 0##17##3##(2008-10#17)
method is 1##5##3##(2008-10#4)(2008-3#1)
method is 2##2##3##(2008-10#2)
method is a direct##2##4##(2008-10#1)(2008-3#1)
method is a good##2##4##(1994-9#1)(2008-2#1)
method is a powerful tool##2##5##(2008-2#1)(2008-3#1)
method is a##17##3##(1991-12#1)(1993-8#1)(1994-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
method is able to determine##2##5##(2008-10#1)(2013-1#1)
method is able to##3##4##(2008-10#2)(2013-1#1)
method is accurate and precise##2##5##(2008-10#2)
method is accurate and##4##4##(2008-10#4)
method is accurate##9##3##(1997-2#1)(2008-10#4)(2009-9#1)(2010-5#1)(2011-1#2)
method is adequate##2##3##(1991-6#1)(2008-10#1)
method is also applicable to##2##5##(2008-10#1)(2008-2#1)
method is also discussed##2##4##(2008-10#1)(2008-8#1)
method is also suitable for##2##5##(2008-10#2)
method is also##16##3##(1992-9#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)
method is an##6##3##(2007-12#1)(2008-10#2)(2008-2#2)(2012-2#1)
method is applicable for the##2##5##(2008-10#2)
method is applicable for##5##4##(1995-11#1)(1996-12#1)(2008-10#3)
method is applicable to the##3##5##(2008-10#3)
method is applicable to##8##4##(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)
method is applicable##13##3##(1995-11#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)
method is applied for determination of##2##6##(2008-10#1)(2008-3#1)
method is applied for##6##4##(2008-10#3)(2008-3#3)
method is applied to a##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
method is applied to determine the##2##6##(2008-10#1)(2008-3#1)
method is applied to determine##3##5##(2008-10#2)(2008-3#1)
method is applied to the determination of##5##7##(2008-10#5)
method is applied to the##15##5##(2008-10#11)(2008-2#1)(2008-3#2)(2008-7#1)
method is applied to##31##4##(2007-11#1)(2007-12#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2009-12#1)
method is applied##41##3##(2007-11#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-2#3)(2008-3#7)(2008-7#1)(2009-12#1)(2010-7#1)
method is as follows##2##4##(1995-8#1)(2008-2#1)
method is as##4##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-2#1)
method is available##2##3##(2008-1#1)(2008-10#1)
method is based on a##16##5##(2007-11#4)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#3)
method is based on an##3##5##(2007-11#1)(2008-10#2)
method is based on determination of##2##6##(2008-10#1)(2008-3#1)
method is based on selective##2##5##(2008-10#2)
method is based on the application of##2##7##(2008-10#1)(2008-11#1)
method is based on the complexation reaction##2##7##(2008-10#2)
method is based on the continuous precipitation of##2##8##(2008-10#2)
method is based on the detection of##3##7##(2008-10#3)
method is based on the development of the reaction between the analytes and##2##13##(2008-10#2)
method is based on the difference##5##6##(2008-10#5)
method is based on the fact that the##2##8##(2008-10#2)
method is based on the fact that##5##7##(1997-2#1)(2008-10#3)(2008-3#1)
method is based on the formation of a##3##8##(2008-10#3)
method is based on the formation of##8##7##(2008-10#8)
method is based on the interaction of##3##7##(2008-10#3)
method is based on the mean centering of ratio##2##9##(2008-10#2)
method is based on the measurement of##3##7##(1997-4#1)(2008-10#2)
method is based on the reaction between##7##7##(2008-10#7)
method is based on the reaction of##6##7##(2008-10#6)
method is based on the reaction##14##6##(2008-10#14)
method is based on the reduction of##4##7##(2008-10#4)
method is based on the simultaneous##2##6##(2008-10#1)(2010-5#1)
method is based on the use of##7##7##(2008-10#3)(2008-11#1)(2008-3#3)
method is based on the##166##5##(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#143)(2008-11#2)(2008-2#1)(2008-3#9)(2010-5#1)(2011-2#2)
method is based on##242##4##(1990-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-11#9)(2007-12#8)(2008-10#181)(2008-11#2)(2008-2#8)(2008-3#23)(2010-5#1)(2011-2#2)(2012-3#1)
method is based##247##3##(1990-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-11#9)(2007-12#8)(2008-10#186)(2008-11#2)(2008-2#8)(2008-3#23)(2010-5#1)(2011-2#2)(2012-3#1)
method is being##3##3##(1995-2#1)(2008-3#1)(2013-1#1)
method is called##2##3##(2008-3#1)(2010-6#1)
method is capable of##8##4##(1995-3#1)(2007-11#1)(2008-10#3)(2008-3#3)
method is carried out##2##4##(2008-2#1)(2010-5#1)
method is characterized by##3##4##(2008-10#3)
method is compared with the##2##5##(2008-3#2)
method is compared with##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
method is confirmed by##2##4##(2008-10#1)(2008-3#1)
method is convenient##2##3##(2008-10#1)(2008-7#1)
method is demonstrated by the##3##5##(2007-11#1)(2007-12#1)(2008-5#1)
method is demonstrated by##8##4##(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
method is demonstrated for##2##4##(2007-12#1)(2008-2#1)
method is demonstrated to##2##4##(2008-2#1)(2008-7#1)
method is demonstrated using##2##4##(2008-3#1)(2008-7#1)
method is demonstrated with##2##4##(2007-11#1)(2008-8#1)
method is demonstrated##21##3##(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)
method is described and##2##4##(2008-2#1)(2008-3#1)
method is described for measuring##2##5##(2008-2#1)(2008-4#1)
method is described for the detection of##2##7##(2008-10#1)(2012-2#1)
method is described for the determination of trace amounts of##3##10##(2008-10#3)
method is described for the determination of trace##4##8##(2008-10#4)
method is described for the determination of traces of##2##9##(2008-10#2)
method is described for the determination of##31##7##(2008-10#31)
method is described for the simultaneous determination of##2##8##(2008-10#2)
method is described for the##45##5##(2008-10#43)(2008-2#1)(2012-2#1)
method is described for##64##4##(1990-11#1)(1992-8#1)(2007-12#2)(2008-10#48)(2008-11#3)(2008-2#4)(2008-4#4)(2012-2#1)
method is described that allows##2##5##(2008-3#1)(2008-4#1)
method is described that##3##4##(2008-3#1)(2008-4#2)
method is described which##2##4##(1991-2#1)(1992-9#1)
method is described##81##3##(1990-11#1)(1990-8#1)(1991-2#1)(1992-8#1)(1992-9#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-10#50)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#6)(2008-9#1)(2012-2#1)
method is designed to##2##4##(2008-2#1)(2008-4#1)
method is designed##3##3##(2008-2#1)(2008-4#1)(2008-6#1)
method is developed for determination of##2##6##(2008-10#2)
method is developed for the determination of##3##7##(2008-10#3)
method is developed for the on-line determination of##2##8##(2008-10#2)
method is developed for the##8##5##(2008-10#7)(2008-2#1)
method is developed for##15##4##(1992-5#1)(2008-10#10)(2008-2#2)(2008-3#2)
method is developed to simulate the##2##6##(2007-11#1)(2008-3#1)
method is developed to##6##4##(2007-11#1)(2008-2#1)(2008-3#4)
method is developed##27##3##(1992-5#1)(2007-11#1)(2008-10#15)(2008-2#4)(2008-3#6)
method is devised to##2##4##(2009-11#1)(2011-1#1)
method is discussed##4##3##(2007-12#1)(2008-3#3)
method is effective for##3##4##(1996-1#1)(2008-10#1)(2008-3#1)
method is effective##4##3##(1996-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
method is employed to##2##4##(2008-3#2)
method is employed##3##3##(2008-10#1)(2008-3#2)
method is evaluated by##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
method is evaluated using##2##4##(2008-10#2)
method is evaluated##9##3##(2008-10#4)(2008-2#3)(2008-3#1)(2011-2#1)
method is expected to be##2##5##(2008-3#1)(2008-9#1)
method is experimentally verified##2##4##(2008-10#1)(2008-3#1)
method is extremely##2##3##(2007-11#1)(2008-5#1)
method is fast and##2##4##(2008-10#1)(2008-4#1)
method is fast##7##3##(1996-5#1)(2008-10#5)(2008-4#1)
method is first##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
method is free from interference##2##5##(2008-10#2)
method is free from##6##4##(2008-10#6)
method is free##7##3##(2008-10#7)
method is given##3##3##(2008-3#2)(2010-9#1)
method is higher than that##2##5##(1990-8#1)(2008-10#1)
method is highly reliable##2##4##(2008-2#1)(2012-2#1)
method is highly reproducible##2##4##(2008-10#1)(2009-12#1)
method is highly sensitive##2##4##(2008-10#2)
method is highly##10##3##(2008-10#5)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)
method is illustrated by##4##4##(1997-2#1)(2007-11#2)(2012-3#1)
method is illustrated##9##3##(1992-9#1)(1994-11#1)(1997-2#1)(2007-11#2)(2010-1#1)(2010-6#1)(2012-1#1)(2012-3#1)
method is implemented##2##3##(2008-3#1)(2012-3#1)
method is inherently##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
method is introduced##3##3##(2008-3#2)(2008-6#1)
method is its##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
method is known##2##3##(2008-10#1)(2008-11#1)
method is limited##2##3##(1997-2#1)(2011-2#1)
method is more##6##3##(1995-2#1)(2007-2#1)(2008-10#3)(2008-3#1)
method is much more##2##4##(1996-8#1)(2008-10#1)
method is not##10##3##(1990-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
method is of##5##3##(1992-5#1)(2007-11#1)(2008-10#2)(2008-9#1)
method is one of the most##3##6##(2008-10#2)(2013-8#1)
method is one of##4##4##(2008-10#2)(2010-7#1)(2013-8#1)
method is particularly useful##2##4##(2008-10#1)(2008-4#1)
method is particularly##7##3##(1991-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
method is performed##2##3##(2008-10#1)(2008-4#1)
method is potentially##2##3##(2008-10#1)(2008-2#1)
method is presented and##2##4##(2008-10#2)
method is presented for the determination of##5##7##(2008-10#5)
method is presented for the##12##5##(1992-8#1)(2008-10#9)(2008-3#2)
method is presented for##20##4##(1992-8#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#6)
method is presented that##3##4##(2008-2#1)(2008-3#2)
method is presented to##7##4##(2008-2#2)(2008-3#3)(2008-8#1)(2011-2#1)
method is presented##41##3##(1992-8#1)(1994-6#1)(2007-12#2)(2008-10#15)(2008-2#5)(2008-3#13)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
method is proposed as##2##4##(2008-11#1)(2008-2#1)
method is proposed for the determination of trace amounts of##2##10##(2008-10#2)
method is proposed for the determination of##20##7##(2008-10#20)
method is proposed for the extraction##3##6##(2008-10#3)
method is proposed for the simultaneous determination of##5##8##(2008-10#5)
method is proposed for the spectrophotometric determination of##2##8##(2008-10#2)
method is proposed for the successive determination of nanogram levels of##2##11##(2008-10#2)
method is proposed for the##38##5##(2008-1#1)(2008-10#35)(2008-2#1)(2009-11#1)
method is proposed for##46##4##(2007-11#1)(2008-1#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#3)(2009-11#1)(2010-2#1)
method is proposed to##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)
method is proposed##64##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#45)(2008-11#2)(2008-2#3)(2008-3#5)(2008-6#2)(2009-11#1)(2010-2#1)(2012-12#1)
method is provided for##4##4##(2008-4#4)
method is provided##5##3##(2008-2#1)(2008-4#4)
method is quick##2##3##(2008-10#2)
method is quite##2##3##(2008-10#2)
method is rapid and##2##4##(2008-10#2)
method is rapid##13##3##(2008-10#8)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#2)
method is readily##2##3##(2008-10#1)(2008-7#1)
method is relatively fast##2##4##(2008-10#2)
method is relatively##4##3##(2008-10#4)
method is relevant##2##3##(2007-11#1)(2007-12#1)
method is reliable and##2##4##(1990-8#1)(2008-10#1)
method is reliable for##2##4##(1995-6#1)(2008-10#1)
method is reliable##4##3##(1990-8#1)(1995-6#1)(2008-10#2)
method is reported for the determination of##2##7##(2008-10#2)
method is reported for the##5##5##(2008-10#5)
method is reported##7##3##(1990-2#1)(2008-10#5)(2008-2#1)
method is reproducible and##2##4##(2008-10#2)
method is reproducible##3##3##(2008-10#3)
method is robust and##2##4##(2008-3#1)(2012-3#1)
method is safe##2##3##(1990-8#1)(1996-11#1)
method is sensitive enough to detect##2##6##(1995-12#1)(1996-2#1)
method is sensitive to##2##4##(2008-10#1)(2009-5#1)
method is sensitive##17##3##(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#11)(2008-3#1)(2009-5#1)(2011-1#1)
method is shown##2##3##(2008-3#2)
method is similar to##3##4##(1997-3#1)(2008-10#1)(2011-1#1)
method is simple and rapid##2##5##(2008-10#2)
method is simple and reproducible##2##5##(1992-3#1)(2008-10#1)
method is simple and##17##4##(1992-3#1)(1996-2#1)(2008-10#12)(2008-11#1)(2008-3#2)
method is simple to##2##4##(1990-2#1)(2008-10#1)
method is simple##46##3##(1990-2#1)(1992-3#1)(1996-2#1)(2008-10#33)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2011-1#3)(2012-3#1)
method is successfully applied for the determination of##2##8##(2008-10#2)
method is successfully applied to determine##2##6##(2008-10#2)
method is successfully applied to the determination of##2##8##(2008-10#2)
method is successfully applied to the simultaneous##2##7##(2008-10#1)(2008-5#1)
method is successfully applied to the##4##6##(2008-10#3)(2008-5#1)
method is successfully applied to##9##5##(2008-10#7)(2008-3#1)(2008-5#1)
method is successfully applied##11##4##(2008-10#9)(2008-3#1)(2008-5#1)
method is suggested##2##3##(2008-10#2)
method is suitable for routine##2##5##(1996-12#1)(2008-10#1)
method is suitable for the determination of##3##7##(1991-5#1)(2008-10#2)
method is suitable for the simultaneous determination of##2##8##(2008-10#2)
method is suitable for the##8##5##(1991-5#1)(2008-10#6)(2008-3#1)
method is suitable for##24##4##(1991-2#1)(1991-5#1)(1996-12#1)(2008-10#15)(2008-3#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
method is suitable##26##3##(1991-2#1)(1991-5#1)(1996-12#1)(2007-7#1)(2008-10#16)(2008-3#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
method is superior to the##3##5##(2008-10#2)(2008-11#1)
method is superior to##4##4##(2008-10#3)(2008-11#1)
method is superior##6##3##(2008-10#5)(2008-11#1)
method is tested##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
method is that it##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)
method is that the##2##4##(2008-10#2)
method is that##13##3##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#3)(2010-5#1)
method is the##10##3##(1990-8#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#4)(2010-3#1)(2011-1#1)
method is then##3##3##(2008-2#1)(2008-3#2)
method is to display the image##2##6##(2008-3#2)
method is to##7##3##(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)
method is used for##5##4##(2008-10#4)(2008-3#1)
method is used in##3##4##(2008-10#1)(2008-3#2)
method is used to analyze##2##5##(2009-10#1)(2010-2#1)
method is used to calculate the##2##6##(2008-2#1)(2008-3#1)
method is used to##12##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2009-10#1)(2010-2#1)(2012-3#1)
method is used##23##3##(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#7)(2009-10#1)(2010-2#1)(2012-3#1)
method is useful for##6##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
method is usually##2##3##(2008-10#1)(2008-3#1)
method is validated##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
method is very sensitive and##2##5##(2008-10#1)(2008-11#1)
method is very sensitive##4##4##(2008-10#3)(2008-11#1)
method is very simple##3##4##(2008-10#3)
method is very useful for monitoring##2##6##(2008-10#2)
method is very useful for##3##5##(2008-10#2)(2008-7#1)
method is very##15##3##(2007-12#1)(2008-10#12)(2008-11#1)(2008-7#1)
method is##1152##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#6)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-3#2)(1992-5#2)(1992-8#2)(1992-9#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#7)(1997-3#3)(1997-4#2)(2007-10#1)(2007-11#28)(2007-12#30)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#641)(2008-11#19)(2008-12#2)(2008-2#65)(2008-3#140)(2008-4#20)(2008-5#9)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#3)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-5#9)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#13)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#4)(2013-8#5)
method it is##2##3##(2007-12#1)(2008-3#1)
method leads to##2##3##(2009-5#1)(2009-7#1)
method makes use of two##2##5##(2008-10#1)(2008-3#1)
method makes use of##5##4##(2008-10#2)(2008-3#2)(2010-8#1)
method makes##9##2##(1993-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2010-8#1)
method matched##2##2##(2008-10#2)
method may be applied to##2##5##(2008-8#1)(2009-6#1)
method may be applied##3##4##(2008-8#1)(2009-6#1)(2013-1#1)
method may be used to##2##5##(2008-10#1)(2010-7#1)
method may be used##3##4##(1995-2#1)(2008-10#1)(2010-7#1)
method may be##9##3##(1992-5#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-7#1)(2013-1#1)
method may provide a##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
method may##15##2##(1992-5#1)(1995-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
method measures##2##2##(2007-12#1)(2008-10#1)
method meets##2##2##(2008-10#1)(2010-5#1)
method might be##2##3##(2008-11#1)(2008-2#1)
method might##5##2##(1990-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)
method minimizes##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
method needs##2##2##(2008-2#1)(2008-5#1)
method not only for##2##4##(2008-10#1)(2008-3#1)
method not only##6##3##(2008-10#2)(2008-3#3)(2008-7#1)
method of DNA##3##3##(2008-10#2)(2008-11#1)
method of Lan and DeMets##2##5##(1997-3#2)
method of Monte Carlo simulation##2##5##(2008-3#2)
method of a##2##3##(1996-3#1)(2008-10#1)
method of absolute##2##3##(2008-3#2)
method of achieving##3##3##(2007-11#1)(2008-2#1)(2010-4#1)
method of active##2##3##(2008-4#1)(2008-8#1)
method of analysis of##4##4##(2008-10#3)(2008-2#1)
method of analysis##15##3##(2007-11#1)(2008-10#10)(2008-2#1)(2008-9#1)(2009-5#1)(2011-2#1)
method of assessing##5##3##(1994-3#1)(1997-3#1)(2007-8#2)(2008-11#1)
method of beam##2##3##(2007-11#2)
method of blood conservation in##2##5##(2007-9#2)
method of cavitation##2##3##(2008-12#2)
method of characterizing##2##3##(1992-12#1)(2008-3#1)
method of choice for##9##4##(1992-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
method of choice in##6##4##(2007-11#1)(2007-8#3)(2010-12#1)(2011-2#1)
method of choice##22##3##(1992-11#1)(1992-12#1)(1992-9#1)(1996-5#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#2)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-3#1)
method of combining the##2##4##(1995-9#1)(2008-3#1)
method of combining##3##3##(1995-9#1)(2008-3#1)(2008-9#1)
method of comparative##2##3##(1997-6#1)(2008-9#1)
method of composite interval mapping##2##5##(2008-10#2)
method of conducting##2##3##(1995-1#1)(2009-11#1)
method of control of##2##4##(1997-6#1)(2008-10#1)
method of control##3##3##(1997-6#1)(2008-10#2)
method of correcting##2##3##(2008-2#1)(2008-3#1)
method of culture##2##3##(2008-11#1)(2008-5#1)
method of cumulants##3##3##(2008-3#3)
method of data collection##3##4##(1993-3#1)(2008-11#1)(2009-10#1)
method of data##5##3##(1993-3#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-8#1)
method of designing##2##3##(2008-2#1)(2008-3#1)
method of detecting##5##3##(1993-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
method of detection##5##3##(1996-8#1)(1997-2#1)(2008-10#3)
method of determination of##4##4##(2008-10#4)
method of determination##8##3##(2008-10#7)(2008-11#1)
method of determining the##2##4##(2008-10#1)(2011-2#1)
method of determining##7##3##(1994-1#1)(1994-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
method of direct##2##3##(1996-5#1)(2008-3#1)
method of enhancing the##2##4##(1995-5#1)(2007-11#1)
method of equivalent layers##2##4##(2008-3#2)
method of estimating the stress acting on##2##7##(2008-7#2)
method of estimating the##3##4##(2008-10#1)(2008-7#2)
method of evaluating the##2##4##(2007-12#1)(2008-2#1)
method of evaluating##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
method of evaluation##2##3##(2007-8#1)(2012-1#1)
method of explosives##2##3##(2008-10#2)
method of expressing##2##3##(1994-11#1)(2008-1#1)
method of extracting##2##3##(2008-10#2)
method of fixation is##2##4##(1991-9#1)(2007-8#1)
method of fixation##5##3##(1991-9#1)(2007-8#1)(2012-2#1)(2013-1#2)
method of funding##2##3##(1991-1#1)(1993-3#1)
method of gene##2##3##(1994-9#1)(2008-9#1)
method of generating##2##3##(2007-12#1)(2008-7#1)
method of human##2##3##(2008-11#2)
method of identifying##3##3##(1997-4#1)(2008-4#1)(2008-7#1)
method of image##2##3##(2008-2#1)(2008-3#1)
method of improving##2##3##(2007-11#1)(2009-7#1)
method of interferometric length##2##4##(2008-3#2)
method of investigation##2##3##(1991-3#1)(2011-2#1)
method of learning##2##3##(2008-11#1)(2008-12#1)
method of managing##2##3##(2008-12#1)(2011-2#1)
method of measuring surface##2##4##(2008-3#1)(2009-7#1)
method of measuring the##5##4##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
method of measuring##20##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-11#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2009-7#1)
method of obtaining##2##3##(2007-11#1)(2008-3#1)
method of optical##2##3##(2007-11#1)(2008-3#1)
method of performing##2##3##(2007-11#1)(2012-3#1)
method of preparing##4##3##(2008-4#1)(2008-9#2)(2009-12#1)
method of producing##5##3##(2007-11#1)(2007-12#2)(2007-5#1)(2008-4#1)
method of protein##2##3##(2008-10#1)(2010-2#1)
method of providing##2##3##(2008-11#1)(2011-1#1)
method of quantitative estimation of##2##5##(2012-3#2)
method of quantitative##3##3##(2012-3#2)(2013-1#1)
method of rapidly##2##3##(2007-12#1)(2008-10#1)
method of ray tracing##2##4##(2008-2#2)
method of reconstructing##2##3##(2008-3#1)(2011-7#1)
method of reducing##3##3##(2008-2#2)(2013-1#1)
method of sample##2##3##(2008-10#2)
method of screening for##3##4##(1991-7#1)(1994-2#1)(2008-10#1)
method of screening##4##3##(1991-7#1)(1994-2#1)(2008-10#1)(2008-7#1)
method of solventless extraction##2##4##(2008-10#2)
method of spatial##2##3##(2007-12#1)(2013-8#1)
method of spectral##3##3##(2007-11#1)(2013-8#2)
method of stabilizing a##2##4##(2008-2#1)(2008-3#1)
method of standard additions##7##4##(2008-10#7)
method of standard##8##3##(2008-10#8)
method of studying##2##3##(1997-2#1)(2007-12#1)
method of synthesis##3##3##(1990-8#1)(2008-4#1)(2009-8#1)
method of teaching##4##3##(1992-2#1)(1993-12#1)(2007-5#1)(2012-1#1)
method of the##9##3##(1994-12#1)(2007-11#1)(2008-10#5)(2012-2#1)(2013-8#1)
method of treating##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
method of treatment for##3##4##(2007-8#1)(2008-10#1)(2010-7#1)
method of treatment in##2##4##(1992-5#1)(2008-10#1)
method of treatment of##2##4##(2007-12#1)(2008-12#1)
method of treatment##14##3##(1992-5#1)(1995-11#1)(1996-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2010-7#1)(2011-1#1)(2013-1#2)
method of understanding##2##3##(1991-9#1)(2013-8#1)
method of using##4##3##(1996-12#1)(1997-3#1)(2008-3#1)(2010-8#1)
method of##642##2##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#5)(1993-8#1)(1994-1#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#5)(1997-6#4)(1997-7#2)(2006-4#1)(2007-10#1)(2007-11#35)(2007-12#25)(2007-5#2)(2007-8#16)(2007-9#2)(2008-1#6)(2008-10#143)(2008-11#29)(2008-12#14)(2008-2#25)(2008-3#59)(2008-4#17)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#2)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#8)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#1)(2012-2#5)(2012-3#14)(2013-1#16)(2013-8#11)
method offered##3##2##(2008-10#2)(2012-1#1)
method offers a##2##3##(2008-11#1)(2008-3#1)
method offers the##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
method offers##15##2##(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
method on the basis of##3##5##(2008-10#3)
method on the##8##3##(1997-5#1)(2008-10#6)(2008-7#1)
method on##18##2##(1990-2#1)(1997-5#1)(2008-10#9)(2008-11#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
method or##8##2##(2006-4#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)
method over##3##2##(1990-7#1)(2008-10#2)
method owing to##2##3##(2008-10#2)
method performance was evaluated##3##4##(2008-10#3)
method performed##3##2##(2007-7#1)(2012-3#2)
method performs well in##2##4##(1995-2#1)(2008-10#1)
method permits rapid##3##3##(2007-11#1)(2008-10#2)
method permits the determination of##2##5##(2008-10#2)
method permits the##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
method permits##15##2##(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#5)
method permitted the##3##3##(2008-10#3)
method permitted##6##2##(2008-10#6)
method precision##2##2##(2008-10#2)
method presented a linear response##2##5##(2008-10#2)
method presented a##4##3##(2008-10#4)
method presented here is##4##4##(2008-10#3)(2008-2#1)
method presented here##7##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)
method presented in this##2##4##(2008-9#1)(2013-8#1)
method presented in##5##3##(2008-2#1)(2008-3#2)(2008-9#1)(2013-8#1)
method presented##21##2##(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-9#1)(2013-8#1)
method presents a##2##3##(2008-10#2)
method presents##5##2##(2007-11#1)(2008-10#3)(2008-4#1)
method preserves##2##2##(2008-10#1)(2008-9#1)
method previously developed for##2##4##(2008-10#2)
method previously##5##2##(2008-10#5)
method produced a##2##3##(2007-12#1)(2008-10#1)
method produced##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
method produces good##2##3##(2008-4#1)(2008-7#1)
method produces##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
method proposed by##7##3##(2008-10#4)(2008-3#2)(2008-6#1)
method proposed here##4##3##(1991-5#1)(1994-1#1)(2008-10#1)(2011-2#1)
method proposed in this paper##3##5##(2008-10#1)(2008-2#1)(2013-8#1)
method proposed in this##4##4##(2008-10#2)(2008-2#1)(2013-8#1)
method proposed is##3##3##(2008-10#2)(2008-2#1)
method proposed was##7##3##(2008-10#7)
method proposed##33##2##(1991-5#1)(1993-6#1)(1994-1#1)(2008-10#22)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)(2011-2#1)(2013-8#1)
method proved to be##8##4##(1995-12#1)(2007-10#1)(2008-10#5)(2008-2#1)
method proved to##9##3##(1990-6#1)(1995-12#1)(2007-10#1)(2008-10#5)(2008-2#1)
method provided a##4##3##(2008-10#4)
method provided good##2##3##(2008-10#1)(2012-1#1)
method provided very##2##3##(1995-2#1)(2008-10#1)
method provided##12##2##(1995-2#1)(2008-10#8)(2008-11#1)(2008-7#1)(2012-1#1)
method provides a simple way to##2##6##(2008-3#2)
method provides a simple##3##4##(2008-3#2)(2008-4#1)
method provides a##26##3##(1993-1#1)(1995-1#1)(1995-12#1)(1997-6#1)(2008-10#9)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2013-8#1)
method provides an##3##3##(2007-11#1)(2008-4#1)(2012-1#1)
method provides high##2##3##(2007-11#1)(2008-11#1)
method provides information about the##2##5##(2008-10#1)(2008-3#1)
method provides the##2##3##(1994-12#1)(2008-3#1)
method provides##57##2##(1992-11#1)(1993-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#16)(2008-11#2)(2008-3#13)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#2)
method reduces the##3##3##(1991-2#1)(2008-10#1)(2010-3#1)
method reduces##4##2##(1991-2#1)(2008-10#1)(2009-8#1)(2010-3#1)
method relies on the##8##4##(2007-12#1)(2008-10#3)(2008-3#3)(2009-11#1)
method relies on##14##3##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#6)(2009-11#1)(2010-8#1)
method relies##15##2##(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#6)(2009-11#1)(2010-8#1)
method represents a##2##3##(2008-3#1)(2010-4#1)
method represents##4##2##(1995-2#1)(2008-3#2)(2010-4#1)
method requires a##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
method requires only##4##3##(1990-11#1)(2008-3#2)(2011-2#1)
method requires##18##2##(1990-11#1)(1991-7#1)(1994-7#1)(2008-10#5)(2008-2#1)(2008-3#6)(2008-7#1)(2011-2#2)
method resulted in##2##3##(2007-11#1)(2008-4#1)
method resulted##4##2##(2007-11#1)(2008-10#2)(2008-4#1)
method results in##2##3##(2008-10#2)
method revealed##2##2##(2008-10#1)(2008-3#1)
method selects##3##2##(2010-2#1)(2012-3#2)
method should be used##2##4##(1996-9#1)(2008-2#1)
method should be##8##3##(1990-5#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#1)
method should##12##2##(1990-5#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
method show that##2##3##(2007-12#1)(2008-10#1)
method show##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
method showed a good##5##4##(2008-10#4)(2011-3#1)
method showed a##11##3##(2008-10#9)(2008-2#1)(2011-3#1)
method showed excellent##2##3##(2008-10#2)
method showed good##6##3##(1993-8#1)(1996-5#1)(2008-10#3)(2011-2#1)
method showed linear calibration##2##4##(2008-10#2)
method showed linear##3##3##(2008-10#3)
method showed no##2##3##(2008-10#1)(2008-12#1)
method showed that##3##3##(2008-10#3)
method showed to be##2##4##(2008-10#2)
method showed##36##2##(1993-8#1)(1994-11#1)(1994-7#1)(1996-5#1)(2008-10#28)(2008-12#1)(2008-2#1)(2011-2#1)(2011-3#1)
method shows a good##2##4##(2008-10#2)
method shows a linear range between##3##6##(2008-10#3)
method shows a linear##4##4##(2008-10#4)
method shows a##7##3##(2008-10#7)
method shows good##6##3##(2008-10#5)(2013-8#1)
method shows##19##2##(2008-10#16)(2008-3#1)(2012-12#1)(2013-8#1)
method simultaneously##2##2##(2008-3#1)(2012-2#1)
method so that##2##3##(2008-3#1)(2010-3#1)
method so##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
method study##2##2##(2008-10#1)(2008-12#1)
method such as##6##3##(1993-2#1)(2008-10#3)(2010-8#1)(2012-2#1)
method suffers no##2##3##(2008-10#2)
method suffers##4##2##(2008-10#4)
method suitable for determination of##3##5##(2008-10#3)
method suitable for the##2##4##(2008-10#2)
method suitable for##8##3##(1991-2#1)(2008-10#5)(2008-2#1)(2008-3#1)
method takes advantage of the##2##5##(2008-10#1)(2008-2#1)
method takes advantage of##4##4##(2008-10#1)(2008-2#2)(2008-7#1)
method takes##7##2##(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)
method than##3##2##(2008-10#3)
method that allows simultaneous##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
method that allows##9##3##(1995-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#1)
method that attempts to##3##4##(2008-3#2)(2012-1#1)
method that can be applied##2##5##(2008-3#2)
method that can be used to##2##6##(2008-4#2)
method that can be used##4##5##(2008-2#1)(2008-4#2)(2010-10#1)
method that can be##8##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2010-10#1)
method that can##10##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-10#1)(2013-8#1)
method that combines##6##3##(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)
method that gives##5##3##(1994-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
method that has##2##3##(1990-12#1)(1996-9#1)
method that is based on the##2##6##(2008-3#2)
method that is widely used##2##5##(2008-10#1)(2008-2#1)
method that is##10##3##(2008-10#1)(2008-2#3)(2008-3#5)(2010-6#1)
method that measures the##2##4##(2008-3#2)
method that permits the##2##4##(2007-11#1)(2008-10#1)
method that permits##4##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)
method that provides##3##3##(2007-11#1)(2008-3#2)
method that uses a##2##4##(2007-12#1)(2008-3#1)
method that uses##10##3##(1991-5#1)(2007-11#1)(2007-12#1)(2008-3#5)(2008-5#1)(2008-9#1)
method that##107##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#10)(2008-3#29)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2010-10#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
method the##14##2##(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#7)
method to a##7##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)(2010-2#1)
method to achieve##3##3##(1995-3#1)(2008-11#1)(2008-3#1)
method to an##2##3##(2008-10#1)(2008-3#1)
method to analyze the##2##4##(2008-8#1)(2008-9#1)
method to analyze##10##3##(1994-6#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)
method to assay##2##3##(2008-10#2)
method to assess the##4##4##(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
method to assess##9##3##(1995-3#1)(1995-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
method to be##8##3##(1990-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)
method to calculate##4##3##(1990-7#1)(2008-10#2)(2009-9#1)
method to characterize##2##3##(2007-12#2)
method to classify##2##3##(2008-10#1)(2008-5#1)
method to confirm##2##3##(1997-8#1)(2008-10#1)
method to control##2##3##(2008-10#1)(2011-3#1)
method to correct for##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
method to correct##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)
method to couple##2##3##(2008-10#1)(2010-5#1)
method to demonstrate##2##3##(2008-7#1)(2008-9#1)
method to detect and quantify##2##5##(2008-10#1)(2008-5#1)
method to detect and##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
method to detect##14##3##(1991-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-8#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-7#1)
method to determine the##12##4##(1992-11#1)(1993-3#1)(1996-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-7#1)
method to determine##25##3##(1992-11#1)(1993-3#1)(1996-12#1)(2008-10#13)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
method to develop##2##3##(2008-10#2)
method to diagnose##2##3##(1992-5#1)(2007-7#1)
method to ensure that##2##4##(1996-1#1)(1996-12#1)
method to estimate the absorption##2##5##(2008-2#1)(2008-5#1)
method to estimate the##4##4##(1995-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
method to estimate##5##3##(1995-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
method to evaluate lower eyelid##2##5##(2008-5#2)
method to evaluate the##9##4##(1990-12#1)(1994-12#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-9#1)
method to evaluate##16##3##(1990-12#1)(1994-12#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)
method to extract##2##3##(2008-3#1)(2013-8#1)
method to gather##2##3##(1990-3#1)(2007-4#1)
method to generate##5##3##(1994-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-5#1)
method to help##2##3##(2011-2#1)(2012-12#1)
method to identify and##2##4##(1997-8#1)(2009-10#1)
method to identify##5##3##(1993-3#1)(1994-9#1)(1997-8#1)(2008-3#1)(2009-10#1)
method to improve the##3##4##(2008-3#3)
method to improve##6##3##(2008-10#1)(2008-3#4)(2009-3#1)
method to increase the##3##4##(2008-10#1)(2008-2#1)(2012-12#1)
method to increase##7##3##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)
method to induce##2##3##(2008-11#1)(2008-8#1)
method to maintain##2##3##(2008-10#1)(2008-11#1)
method to map##3##3##(1993-11#1)(2008-3#1)(2008-4#1)
method to measure the##9##4##(1995-12#1)(1996-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
method to measure##22##3##(1990-12#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-5#1)(2012-2#1)(2013-7#1)
method to monitor##2##3##(2008-10#1)(2011-2#1)
method to obtain the##2##4##(2008-2#1)(2009-9#1)
method to obtain##5##3##(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)
method to optimize the##2##4##(2008-10#1)(2008-2#1)
method to optimize##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#1)
method to other##2##3##(2008-10#1)(2008-3#1)
method to perform##4##3##(1997-3#1)(2007-11#1)(2008-10#1)(2011-1#1)
method to predict##3##3##(1997-3#1)(1997-4#1)(2008-10#1)
method to prepare##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
method to produce##5##3##(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
method to provide##2##3##(2007-12#1)(2008-3#1)
method to quantify##4##3##(2008-10#2)(2011-1#1)(2012-2#1)
method to quantitatively##2##3##(2008-10#2)
method to rapidly##2##3##(2007-10#1)(2008-2#1)
method to real##5##3##(2008-10#4)(2012-2#1)
method to reduce##4##3##(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
method to screen##4##3##(2006-10#1)(2008-10#2)(2008-4#1)
method to solve##2##3##(1990-12#1)(2008-3#1)
method to study the##4##4##(1990-12#1)(2008-10#2)(2012-2#1)
method to study##11##3##(1990-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2012-9#1)(2013-1#2)
method to suppress the##2##4##(2008-2#2)
method to suppress##3##3##(2008-2#2)(2008-3#1)
method to synthesize##3##3##(2007-11#1)(2008-3#1)(2009-10#1)
method to the analysis of##6##5##(2008-10#5)(2008-3#1)
method to the determination of##5##5##(2008-10#5)
method to the##24##3##(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)
method to treat##2##3##(2008-9#1)(2011-2#1)
method to use##5##3##(1994-12#1)(2008-10#2)(2008-3#1)(2010-8#1)
method to validate##2##3##(2008-2#1)(2008-7#1)
method to##430##2##(1990-10#1)(1990-12#6)(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-3#2)(1995-5#3)(1996-1#1)(1996-12#3)(1996-3#3)(1996-7#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#115)(2008-11#15)(2008-12#2)(2008-2#30)(2008-3#55)(2008-4#7)(2008-5#19)(2008-6#2)(2008-7#10)(2008-8#11)(2008-9#12)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#3)(2012-9#1)(2013-1#6)(2013-7#2)(2013-8#3)
method under##3##2##(2008-10#1)(2008-2#1)(2012-1#1)
method upon##2##2##(1995-12#1)(2008-10#1)
method used a##3##3##(2008-10#2)(2010-4#1)
method used at##2##3##(2008-10#1)(2013-1#1)
method used for the##3##4##(2008-10#1)(2008-11#1)(2010-5#1)
method used for##16##3##(1994-6#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#1)
method used in##6##3##(2007-11#1)(2008-10#1)(2008-3#2)(2012-2#1)(2013-8#1)
method used is a##2##4##(2008-10#1)(2008-3#1)
method used is##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
method used to determine##2##4##(2008-10#1)(2008-8#1)
method used to##10##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
method used was##2##3##(2008-1#1)(2008-10#1)
method used##51##2##(1990-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-3#6)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)(2013-8#1)
method uses a##12##3##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2012-3#2)
method uses an##3##3##(2008-10#2)(2008-3#1)
method uses the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
method uses##26##2##(2007-11#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-9#1)(2012-3#2)
method using a##21##3##(1990-8#1)(1991-3#1)(1994-11#1)(1995-8#1)(2007-11#1)(2008-10#12)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)
method using an##3##3##(2008-10#3)
method using flow injection has been##2##6##(2008-10#2)
method using flow injection##6##4##(2008-10#6)
method using the##8##3##(1993-2#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2012-3#1)
method using##83##2##(1990-5#1)(1990-8#1)(1991-3#1)(1993-2#1)(1994-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#52)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
method utilized##4##2##(1992-3#1)(1994-9#1)(2007-10#1)(2008-10#1)
method utilizes the##4##3##(2008-3#3)(2008-9#1)
method utilizes##9##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2010-8#1)
method utilizing a##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
method utilizing##8##2##(1990-8#1)(1994-9#1)(1996-5#1)(2008-10#2)(2008-3#1)(2010-4#1)(2010-9#1)
method validation##4##2##(2008-10#3)(2012-2#1)
method varied between##2##3##(2008-10#2)
method varied from##3##3##(2008-10#3)
method varied##5##2##(2008-10#5)
method was 0##7##3##(1995-6#1)(2008-10#5)(2011-1#1)
method was 1##3##3##(2008-10#3)
method was 2##4##3##(2008-10#4)
method was 5##2##3##(2008-10#2)
method was a##2##3##(1996-2#1)(2010-4#1)
method was able to##3##4##(1995-2#1)(2008-10#1)(2012-3#1)
method was achieved##2##3##(1994-11#1)(2007-8#1)
method was adopted##2##3##(2008-8#1)(2010-5#1)
method was also applied to##2##5##(2008-10#2)
method was also applied##4##4##(2008-10#4)
method was also used for##2##5##(2008-10#2)
method was also used##3##4##(2008-10#3)
method was also##18##3##(2008-10#14)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
method was applicable to##2##4##(2008-10#2)
method was applicable##5##3##(2008-10#5)
method was applied for metal ion determination from water samples##2##10##(2008-10#2)
method was applied for the analysis of##2##7##(2008-10#2)
method was applied for the determination of##14##7##(2008-10#14)
method was applied for the simultaneous determination of##2##8##(2008-10#2)
method was applied for the##26##5##(2008-10#26)
method was applied for##37##4##(2008-10#36)(2010-4#1)
method was applied in##4##4##(2008-10#3)(2011-3#1)
method was applied on##4##4##(2008-10#4)
method was applied satisfactorily to the determination of##2##8##(2008-10#2)
method was applied satisfactorily to##3##5##(2008-10#3)
method was applied successfully to the determination of##8##8##(2008-10#8)
method was applied successfully to##10##5##(1991-5#1)(2008-10#9)
method was applied successfully##11##4##(1991-5#1)(2008-10#10)
method was applied to a##4##5##(2008-10#2)(2008-3#2)
method was applied to detect##2##5##(2008-10#2)
method was applied to determine the##5##6##(2008-10#4)(2011-1#1)
method was applied to determine##12##5##(2008-10#11)(2011-1#1)
method was applied to estimate##2##5##(2008-10#1)(2008-3#1)
method was applied to the analyses of##2##7##(2008-10#2)
method was applied to the analysis of##14##7##(2008-10#13)(2010-4#1)
method was applied to the determination of As(III) in##2##9##(2008-10#2)
method was applied to the determination of the##2##8##(2008-10#2)
method was applied to the determination of these##4##8##(2008-10#4)
method was applied to the determination of trace##4##8##(2008-10#4)
method was applied to the determination of##63##7##(1996-5#1)(1997-2#1)(2008-10#61)
method was applied to the simultaneous##3##6##(2008-10#3)
method was applied to the##102##5##(1990-8#1)(1996-5#1)(1997-2#1)(2008-10#97)(2008-11#1)(2010-4#1)
method was applied to##166##4##(1990-8#1)(1996-5#1)(1997-2#1)(2008-10#151)(2008-11#2)(2008-2#1)(2008-3#5)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
method was applied##232##3##(1990-8#1)(1991-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#213)(2008-11#2)(2008-2#1)(2008-3#5)(2010-4#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
method was assessed by##3##4##(2008-10#3)
method was assessed##5##3##(1992-3#1)(2008-1#1)(2008-10#3)
method was based on separation of##2##6##(2008-10#2)
method was based on the reaction of##2##7##(2008-10#2)
method was based on the##15##5##(2008-10#14)(2010-4#1)
method was based on##20##4##(2008-10#18)(2008-7#1)(2010-4#1)
method was based##21##3##(2008-10#19)(2008-7#1)(2010-4#1)
method was below##2##3##(2008-10#2)
method was calculated##2##3##(2008-10#2)
method was carried out to##2##5##(2007-11#1)(2008-3#1)
method was carried out##7##4##(2007-11#1)(2008-10#5)(2008-3#1)
method was checked by##4##4##(2008-10#4)
method was checked using##2##4##(2008-10#2)
method was checked##8##3##(2008-10#8)
method was chosen##2##3##(2007-10#1)(2008-3#1)
method was compared with an##2##5##(2008-10#2)
method was compared with the##4##5##(2008-10#4)
method was compared with##13##4##(2008-10#12)(2012-2#1)
method was compared##14##3##(2007-10#1)(2008-10#12)(2012-2#1)
method was confirmed by##3##4##(2008-10#3)
method was confirmed##4##3##(2008-10#4)
method was coupled##2##3##(1995-11#1)(2008-10#1)
method was demonstrated by analyzing##5##5##(2008-10#5)
method was demonstrated by##12##4##(2008-10#12)
method was demonstrated##15##3##(1994-9#1)(2008-10#13)(2008-5#1)
method was described for##2##4##(2008-10#2)
method was described##3##3##(2008-10#3)
method was designed for the##2##5##(2008-10#2)
method was designed for##3##4##(2008-10#3)
method was designed##4##3##(2008-10#3)(2008-3#1)
method was determined by comparison##2##5##(2008-10#1)(2008-3#1)
method was determined##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
method was developed and##2##4##(2008-10#2)
method was developed as##2##4##(1997-2#1)(2008-10#1)
method was developed for determination of##2##6##(2008-10#2)
method was developed for determining##2##5##(2008-10#1)(2008-2#1)
method was developed for on-line##2##5##(2008-10#2)
method was developed for simultaneous##2##5##(2008-10#2)
method was developed for the analysis of##2##7##(2008-10#2)
method was developed for the detection of##2##7##(2008-10#2)
method was developed for the determination of trace##2##8##(2008-10#2)
method was developed for the determination of##23##7##(2008-10#19)(2011-1#3)(2011-3#1)
method was developed for the separation and determination of##2##9##(2008-10#2)
method was developed for the simultaneous determination of##3##8##(2008-10#3)
method was developed for the simultaneous##5##6##(2008-10#5)
method was developed for the##45##5##(1996-5#1)(2008-10#38)(2010-4#1)(2011-1#4)(2011-3#1)
method was developed for##61##4##(1990-2#1)(1996-5#1)(1997-2#1)(2008-10#50)(2008-2#1)(2008-7#1)(2010-4#1)(2011-1#4)(2011-3#1)
method was developed in order to##2##6##(1996-12#1)(2008-11#1)
method was developed to determine the##2##6##(2008-10#1)(2008-5#1)
method was developed to determine##6##5##(2008-10#5)(2008-5#1)
method was developed to quantify##2##5##(2007-12#1)(2008-10#1)
method was developed to separate the##2##6##(2008-3#1)(2011-1#1)
method was developed to##19##4##(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
method was developed##99##3##(1990-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#3)(2007-12#1)(2008-10#74)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#6)(2011-3#1)(2012-2#1)(2013-1#1)
method was directly##2##3##(2008-10#2)
method was employed for the##4##5##(2008-10#3)(2011-1#1)
method was employed for##5##4##(2008-10#3)(2008-5#1)(2011-1#1)
method was employed to##3##4##(2007-11#1)(2008-10#2)
method was employed##9##3##(2007-11#1)(2008-10#6)(2008-5#1)(2011-1#1)
method was established for the determination of##3##7##(2011-1#3)
method was established for##4##4##(2011-1#4)
method was established##9##3##(1990-8#1)(2008-10#3)(2011-1#4)(2013-8#1)
method was evaluated by the##2##5##(2008-10#2)
method was evaluated by##10##4##(2008-10#10)
method was evaluated in##2##4##(2007-11#1)(2008-10#1)
method was evaluated through##2##4##(2008-10#2)
method was evaluated##19##3##(2007-11#1)(2008-10#17)(2011-1#1)
method was examined by the##2##5##(2008-10#2)
method was examined by##3##4##(2008-10#3)
method was extended##3##3##(2008-10#2)(2008-11#1)
method was finally applied to##2##5##(2008-10#2)
method was finally applied##3##4##(2008-10#3)
method was found to be a powerful##2##7##(1993-8#1)(2008-11#1)
method was found to be a quick and effective technique##2##10##(2008-10#1)(2009-8#1)
method was found to be a##4##6##(1993-8#1)(2008-10#1)(2008-11#1)(2009-8#1)
method was found to be applicable##3##6##(2008-10#3)
method was found to be suitable for##3##7##(2008-10#2)(2011-1#1)
method was found to be##25##5##(1990-12#1)(1993-8#1)(2008-10#16)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)
method was found##27##3##(1990-12#1)(1993-8#1)(2008-10#17)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)
method was further validated##2##4##(2008-10#2)
method was further##4##3##(2008-10#4)
method was highly##3##3##(1994-11#1)(2008-10#1)(2013-8#1)
method was implemented by using##2##5##(2008-10#2)
method was implemented##3##3##(2008-10#2)(2010-8#1)
method was in the range##2##5##(2008-10#2)
method was in##3##3##(2008-10#3)
method was linear in the range##2##6##(2008-10#2)
method was linear over the range##3##6##(2008-10#3)
method was linear over the##4##5##(2008-10#4)
method was linear##7##3##(2008-10#7)
method was modified##2##3##(2008-10#1)(2008-6#1)
method was more sensitive than##2##5##(2008-10#1)(2009-6#1)
method was more##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
method was optimized and##2##4##(1995-3#1)(2008-10#1)
method was optimized for##2##4##(2008-10#2)
method was optimized##7##3##(1995-3#1)(2008-10#6)
method was proposed for the determination of##5##7##(2008-10#4)(2013-8#1)
method was proposed for the##6##5##(2008-10#5)(2013-8#1)
method was proposed for##8##4##(2008-10#7)(2013-8#1)
method was required##2##3##(2008-10#2)
method was satisfactorily applied to the determination of##4##8##(2008-10#4)
method was satisfactorily applied to the##5##6##(2008-10#5)
method was satisfactorily applied##6##4##(2008-10#6)
method was satisfactorily used##2##4##(2008-10#2)
method was satisfactorily##8##3##(2008-10#8)
method was selective##4##3##(2008-10#2)(2011-3#2)
method was sensitive to##2##4##(2008-3#1)(2010-3#1)
method was sensitive##6##3##(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-3#1)
method was shown to be##2##5##(2007-12#1)(2008-10#1)
method was significantly##2##3##(1990-8#1)(2013-1#1)
method was simple and##2##4##(2008-10#2)
method was simple##6##3##(2008-10#4)(2013-8#2)
method was specific##2##3##(1990-8#1)(2008-11#1)
method was successfully applied for the determination of##5##8##(2008-10#5)
method was successfully applied for the##10##6##(2008-10#10)
method was successfully applied for##15##5##(2008-10#15)
method was successfully applied in the##2##6##(2008-10#2)
method was successfully applied in##4##5##(2008-10#3)(2011-3#1)
method was successfully applied to determine##6##6##(2008-10#6)
method was successfully applied to the analysis of##9##8##(2008-10#8)(2013-1#1)
method was successfully applied to the determination of low levels of##3##11##(2008-10#3)
method was successfully applied to the determination of nickel##2##9##(2008-10#2)
method was successfully applied to the determination of trace##3##9##(2008-10#3)
method was successfully applied to the determination of vanadium in##3##10##(2008-10#3)
method was successfully applied to the determination of##47##8##(1994-9#1)(1996-5#1)(2008-10#45)
method was successfully applied to the determination##48##7##(1994-9#1)(1996-5#1)(2008-10#46)
method was successfully applied to the extraction and determination of##3##10##(2008-10#3)
method was successfully applied to the extraction##4##7##(2008-10#3)(2012-1#1)
method was successfully applied to the simultaneous##9##7##(2008-10#9)
method was successfully applied to the speciation##2##7##(2008-10#2)
method was successfully applied to the##77##6##(1994-9#1)(1996-5#1)(2008-10#72)(2011-2#1)(2012-1#1)(2013-1#1)
method was successfully applied to##90##5##(1994-9#1)(1996-5#1)(2008-10#84)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
method was successfully applied##110##4##(1994-9#1)(1996-5#1)(2008-10#102)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
method was successfully used for the##3##6##(2008-10#3)
method was successfully used##4##4##(2008-10#4)
method was successfully##119##3##(1994-9#1)(1996-5#1)(2008-10#110)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
method was suitable for##2##4##(2008-10#2)
method was superior in##2##4##(2008-10#2)
method was tested by determining##2##5##(2008-10#2)
method was tested by##9##4##(2008-10#8)(2011-2#1)
method was tested in##2##4##(2008-10#2)
method was tested on##3##4##(2008-10#2)(2008-12#1)
method was tested##22##3##(2008-10#17)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
method was the only##2##4##(1997-5#1)(2008-3#1)
method was then##3##3##(2008-10#3)
method was used for the##8##5##(2008-10#8)
method was used for##17##4##(1996-1#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-7#1)
method was used in the##3##5##(1990-8#1)(2008-10#1)(2008-3#1)
method was used in##8##4##(1990-8#1)(2008-10#3)(2008-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
method was used to compare##2##5##(1991-5#1)(2008-10#1)
method was used to determine the##7##6##(1990-8#1)(2008-10#5)(2008-5#1)
method was used to determine##10##5##(1990-8#1)(2008-10#8)(2008-5#1)
method was used to evaluate the##2##6##(2008-10#1)(2012-12#1)
method was used to examine the##3##6##(1991-10#1)(2008-8#1)(2009-7#1)
method was used to measure##2##5##(2008-10#1)(2008-3#1)
method was used to select##4##5##(2008-10#3)(2010-3#1)
method was used to study the##2##6##(2008-10#1)(2009-6#1)
method was used to the##2##5##(2008-10#2)
method was used to##52##4##(1990-11#1)(1990-8#1)(1991-10#1)(1991-5#1)(2008-10#31)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-8#1)
method was used##94##3##(1990-11#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-5#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-6#1)(2008-1#2)(2008-10#51)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
method was utilized for##2##4##(2008-10#2)
method was utilized to##2##4##(2008-10#1)(2010-3#1)
method was utilized##5##3##(2008-10#3)(2008-11#1)(2010-3#1)
method was validated as per ICH guidelines##2##7##(2011-1#1)(2012-12#1)
method was validated by the##3##5##(2008-10#2)(2012-1#1)
method was validated by##9##4##(1996-3#1)(2008-10#7)(2012-1#1)
method was validated in terms of##4##6##(2008-10#2)(2010-3#1)(2012-2#1)
method was validated using##5##4##(2008-10#5)
method was validated##36##3##(1996-3#1)(1996-5#1)(2008-10#27)(2010-3#2)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
method was##996##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#7)(1991-10#1)(1991-5#2)(1992-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1997-2#6)(1997-5#1)(1997-6#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#783)(2008-11#13)(2008-12#1)(2008-2#6)(2008-3#20)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#8)(2010-4#6)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#17)(2011-2#5)(2011-3#7)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#8)(2013-8#10)
method we have##2##3##(2007-11#1)(2012-2#1)
method we##18##2##(1990-12#2)(1991-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
method were 0##2##3##(1990-2#1)(2008-10#1)
method were compared to##2##4##(2008-10#2)
method were compared with##5##4##(2008-10#5)
method were compared##8##3##(2008-10#8)
method were consistent with##2##4##(2008-10#1)(2008-4#1)
method were demonstrated##2##3##(2008-10#2)
method were determined##2##3##(1990-8#1)(2008-10#1)
method were employed##2##3##(2008-3#1)(2011-3#1)
method were evaluated##2##3##(2008-10#1)(2008-6#1)
method were found to be##2##5##(2008-10#2)
method were found to##3##4##(2008-10#2)(2008-11#1)
method were in good agreement with those obtained by##3##9##(2008-10#3)
method were in good agreement with##6##6##(2008-10#6)
method were in##8##3##(2008-10#6)(2008-5#1)(2013-8#1)
method were investigated##2##3##(1996-5#1)(2008-10#1)
method were used to##2##4##(2008-10#1)(2011-1#1)
method were used##4##3##(1995-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
method were##81##2##(1990-12#1)(1990-2#1)(1990-8#3)(1992-11#1)(1995-6#1)(1996-5#2)(1997-6#1)(2008-10#56)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2011-1#2)(2011-3#1)(2012-2#1)(2013-8#1)
method when the##2##3##(2008-10#1)(2008-2#1)
method when##8##2##(1995-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
method where##2##2##(2008-10#1)(2008-7#1)
method whereby##5##2##(1992-11#1)(1993-11#1)(2008-10#2)(2008-2#1)
method which can be used to##2##6##(1990-12#1)(2011-1#1)
method which has##3##3##(1994-2#1)(2008-10#1)(2009-2#1)
method which takes##2##3##(1993-8#1)(2010-3#1)
method which uses streptavidin-coated magnetic beads##2##6##(1995-6#2)
method which##20##2##(1990-12#2)(1991-9#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-6#2)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2009-2#1)(2010-3#1)(2011-1#1)
method while##2##2##(2008-10#1)(2010-4#1)
method will be useful for##2##5##(2008-10#1)(2011-1#1)
method will be##5##3##(1995-3#1)(2008-10#3)(2011-1#1)
method will facilitate##2##3##(2008-10#1)(2010-12#1)
method will##14##2##(1995-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
method with UV detection##2##4##(2008-10#1)(2011-1#1)
method with a high##2##4##(1996-11#1)(2008-10#1)
method with a##14##3##(1993-8#1)(1996-11#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#2)(2010-3#1)
method with an##4##3##(2007-11#1)(2008-3#2)(2009-5#1)
method with arithmetic averages##2##4##(2008-10#2)
method with arithmetic##8##3##(2008-10#8)
method with direct##2##3##(2008-10#1)(2008-3#1)
method with electrochemical detection##2##4##(1991-5#1)(2008-10#1)
method with fluorescence detection##3##4##(1996-5#1)(2008-10#2)
method with good##3##3##(2008-10#2)(2011-3#1)
method with high##3##3##(2008-10#3)
method with on-line##3##3##(2008-10#3)
method with standard##2##3##(2008-10#2)
method with the##6##3##(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-1#1)
method with those obtained by##2##5##(2008-10#2)
method with those##5##3##(2008-10#4)(2008-3#1)
method with which to##2##4##(2007-12#1)(2008-3#1)
method with which##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
method with##125##2##(1990-8#2)(1991-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-10#64)(2008-11#2)(2008-2#5)(2008-3#13)(2008-5#3)(2008-7#1)(2009-10#1)(2009-5#3)(2009-8#1)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#2)
method within##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
method without##5##2##(2007-8#1)(2008-10#4)
method works##6##2##(2008-11#1)(2008-2#3)(2008-3#2)
method would be more##2##4##(2008-8#1)(2012-3#1)
method would be##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
method would##7##2##(1991-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)
method yielded##4##2##(2008-10#3)(2008-7#1)
method yields a##2##3##(2008-2#2)
method yields##4##2##(1991-5#1)(1993-2#1)(2008-2#2)
method##9497##1##(1990-10#4)(1990-11#25)(1990-12#29)(1990-2#20)(1990-3#7)(1990-5#11)(1990-6#3)(1990-7#5)(1990-8#42)(1990-9#8)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#16)(1991-2#12)(1991-3#10)(1991-5#26)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#12)(1992-12#10)(1992-2#7)(1992-3#12)(1992-4#3)(1992-5#10)(1992-6#8)(1992-8#5)(1992-9#10)(1993-1#4)(1993-10#1)(1993-11#6)(1993-12#15)(1993-2#8)(1993-3#14)(1993-5#2)(1993-6#4)(1993-8#19)(1993-9#5)(1994-1#4)(1994-11#16)(1994-12#23)(1994-2#9)(1994-3#13)(1994-5#3)(1994-6#4)(1994-7#6)(1994-8#7)(1994-9#23)(1995-1#7)(1995-11#10)(1995-12#25)(1995-2#30)(1995-3#10)(1995-5#10)(1995-6#18)(1995-8#10)(1995-9#3)(1996-1#6)(1996-11#6)(1996-12#26)(1996-2#13)(1996-3#19)(1996-5#28)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#6)(1997-2#37)(1997-3#25)(1997-4#20)(1997-5#8)(1997-6#13)(1997-7#15)(1997-8#12)(2006-10#1)(2006-12#1)(2006-4#4)(2006-8#1)(2007-10#15)(2007-11#201)(2007-12#182)(2007-2#4)(2007-4#2)(2007-5#2)(2007-7#20)(2007-8#56)(2007-9#3)(2008-1#40)(2008-10#4749)(2008-11#216)(2008-12#62)(2008-2#366)(2008-3#908)(2008-4#161)(2008-5#150)(2008-6#65)(2008-7#120)(2008-8#84)(2008-9#122)(2009-1#3)(2009-10#15)(2009-11#20)(2009-12#13)(2009-2#3)(2009-3#8)(2009-4#8)(2009-5#21)(2009-6#15)(2009-7#11)(2009-8#21)(2009-9#14)(2010-1#3)(2010-10#7)(2010-11#20)(2010-12#26)(2010-2#12)(2010-3#36)(2010-4#20)(2010-5#36)(2010-6#21)(2010-7#21)(2010-8#52)(2010-9#11)(2011-1#88)(2011-2#98)(2011-3#22)(2011-7#2)(2012-1#33)(2012-12#26)(2012-2#95)(2012-3#81)(2012-4#1)(2012-5#1)(2012-7#2)(2012-9#1)(2013-1#109)(2013-3#1)(2013-7#8)(2013-8#107)
method&quot##4##1##(1990-5#1)(2008-10#1)(2008-4#2)
method'##7##1##(2007-8#1)(2008-10#2)(2008-12#1)(2013-8#3)
method's ability to##2##3##(2008-10#1)(2008-5#1)
method's##12##1##(1997-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2013-1#1)
method) and two##2##3##(2008-10#1)(2008-7#1)
method) and##8##2##(2008-10#4)(2008-5#2)(2008-7#1)(2012-3#1)
method) is##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
method) that##2##2##(2009-6#1)(2010-3#1)
method) was##3##2##(1997-7#1)(2008-8#1)(2011-2#1)
method)##46##1##(1992-11#1)(1992-9#1)(1994-6#1)(1997-7#2)(2007-12#1)(2008-10#21)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
method-related##2##1##(1992-5#2)
method]##9##1##(1990-10#1)(1990-5#1)(1990-6#1)(1994-8#1)(1995-5#1)(2010-12#1)(2011-2#1)(2013-8#2)
methodic##3##1##(1990-3#1)(1990-6#1)(2008-10#1)
methodical##8##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-4#1)(2011-2#1)
methodologic##7##1##(1990-6#1)(1992-9#1)(1993-12#2)(1994-6#1)(1997-1#1)(2007-10#1)
methodological and conceptual##3##3##(2008-8#1)(2009-7#1)(2012-3#1)
methodological and##8##2##(1995-11#1)(1996-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-3#1)(2013-1#1)
methodological approach##5##2##(2008-10#3)(2008-5#1)(2009-8#1)
methodological approaches##3##2##(2009-6#2)(2010-6#1)
methodological aspects of##2##3##(1995-5#1)(2008-4#1)
methodological aspects##3##2##(1995-5#1)(2008-4#1)(2008-5#1)
methodological challenges##4##2##(2008-8#2)(2008-9#1)(2012-12#1)
methodological considerations##3##2##(2008-9#1)(2011-1#1)(2012-3#1)
methodological differences##3##2##(2008-1#1)(2008-11#1)(2012-1#1)
methodological errors##2##2##(1995-5#1)(2011-2#1)
methodological implications for##2##3##(1992-11#1)(2011-1#1)
methodological issues in##3##3##(1997-1#1)(2008-7#1)(2008-9#1)
methodological issues pertaining to##2##4##(2009-8#2)
methodological issues that##2##3##(2008-12#1)(2008-6#1)
methodological issues##11##2##(1997-1#1)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-10#2)
methodological limitations##2##2##(2008-10#1)(2008-7#1)
methodological problems##8##2##(1990-3#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1995-8#1)(2008-3#1)(2008-6#1)
methodological quality of##2##3##(2008-10#1)(2011-2#1)
methodological quality##6##2##(2008-10#3)(2008-12#1)(2011-2#2)
methodological shortcomings##2##2##(1993-11#1)(2008-10#1)
methodological tool##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
methodological##107##1##(1990-3#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#4)(1996-9#1)(1997-1#1)(2007-11#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#8)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
methodologically##6##1##(1994-6#1)(2007-2#1)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
methodologies and##9##2##(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)
methodologies are##7##2##(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
methodologies employed##2##2##(2008-10#1)(2013-1#1)
methodologies for assessing##2##3##(1992-3#1)(2013-1#1)
methodologies for the##4##3##(2008-10#2)(2008-5#1)(2009-6#1)
methodologies for##25##2##(1992-3#1)(1993-3#1)(1996-9#1)(1997-1#2)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-9#1)(2013-1#1)
methodologies have been##2##3##(2008-3#1)(2008-4#1)
methodologies have##3##2##(1992-3#1)(2008-3#1)(2008-4#1)
methodologies that can##2##3##(1996-1#1)(2008-4#1)
methodologies that##5##2##(1996-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#1)
methodologies to##6##2##(2008-10#3)(2008-4#1)(2011-1#1)(2013-8#1)
methodologies used in##2##3##(2008-10#1)(2009-7#1)
methodologies used to##2##3##(1997-3#1)(2008-7#1)
methodologies used##7##2##(1992-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)
methodologies were developed##2##3##(2008-10#2)
methodologies were##8##2##(1993-1#1)(2008-10#6)(2011-2#1)
methodologies with##2##2##(2008-10#1)(2008-5#1)
methodologies##134##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-1#5)(1997-3#1)(2006-10#1)(2008-10#43)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
methodology adopted##2##2##(2007-7#1)(2009-9#1)
methodology allowed##2##2##(2008-10#1)(2011-2#1)
methodology allows the##2##3##(2008-10#2)
methodology allows##5##2##(2008-10#4)(2008-8#1)
methodology and the##6##3##(1990-5#1)(1997-3#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-11#1)
methodology and##33##2##(1990-3#1)(1990-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1997-3#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2012-1#1)(2012-3#1)
methodology are##7##2##(2008-10#4)(2008-2#1)(2010-10#1)(2010-11#1)
methodology based on the##2##4##(2008-10#2)
methodology based on##8##3##(2008-10#6)(2008-6#1)(2011-2#1)
methodology by##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
methodology can be##2##3##(2008-10#1)(2008-3#1)
methodology can##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
methodology could be applied##2##4##(2008-10#1)(2008-6#1)
methodology could be##5##3##(2008-10#3)(2008-6#1)(2012-3#1)
methodology developed by##2##3##(1995-2#1)(2008-5#1)
methodology developed##10##2##(1995-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-10#1)
methodology employed##2##2##(1995-6#1)(2008-10#1)
methodology enables the##2##3##(2008-10#1)(2008-8#1)
methodology enables##3##2##(2008-10#1)(2008-8#2)
methodology exhibited a##2##3##(2008-10#2)
methodology for determining the##2##4##(1994-12#1)(2008-3#1)
methodology for evaluating##2##3##(1996-6#1)(2011-2#1)
methodology for identifying##4##3##(1995-12#1)(1995-3#1)(2008-8#1)(2010-8#1)
methodology for its##2##3##(2009-3#1)(2010-6#1)
methodology for the analysis of##3##5##(2008-10#3)
methodology for the determination of lead##2##6##(2008-10#2)
methodology for the determination of the##2##6##(2008-10#2)
methodology for the determination of##9##5##(2008-10#8)(2011-2#1)
methodology for the direct determination of##2##6##(2008-10#2)
methodology for the##23##3##(2008-10#19)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)
methodology for##75##2##(1990-5#1)(1992-1#1)(1992-12#1)(1992-3#3)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
methodology from##3##2##(1996-2#1)(2008-6#1)(2012-3#1)
methodology has been applied to##2##5##(2008-10#1)(2008-2#1)
methodology has been applied##3##4##(2008-10#2)(2008-2#1)
methodology has been developed for the##2##6##(2008-10#2)
methodology has been##9##3##(2008-10#6)(2008-2#1)(2008-7#1)(2009-10#1)
methodology has##15##2##(1997-3#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-7#1)(2009-10#1)(2012-2#1)
methodology in order to##2##4##(1997-1#1)(2008-10#1)
methodology in the##4##3##(1990-8#1)(1991-3#1)(2008-10#2)
methodology in##19##2##(1990-8#1)(1991-3#1)(1992-3#1)(1993-3#1)(1996-1#1)(1997-1#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2009-8#1)(2012-3#1)(2013-8#1)
methodology including##2##2##(2008-10#2)
methodology involves##3##2##(2007-11#1)(2008-10#2)
methodology is applied to the##3##5##(1992-3#1)(2008-10#1)(2008-8#1)
methodology is applied##5##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
methodology is based on##3##4##(2007-12#1)(2008-10#2)
methodology is described##2##3##(1995-12#1)(2008-10#1)
methodology is not##2##3##(1994-12#1)(2008-10#1)
methodology is presented for##2##4##(1997-4#1)(2008-4#1)
methodology is presented##5##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
methodology is proposed to##2##4##(2008-10#2)
methodology is proposed##4##3##(2008-10#2)(2008-2#1)(2008-6#1)
methodology is##37##2##(1992-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2012-12#1)(2012-2#1)
methodology it is possible to##2##5##(1993-6#1)(2008-9#1)
methodology known as##2##3##(1996-1#1)(2008-10#1)
methodology must be##2##3##(2008-10#1)(2008-9#1)
methodology of##18##2##(1991-11#1)(1991-9#1)(1993-2#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
methodology offers##3##2##(2008-10#2)(2011-1#1)
methodology or##4##2##(1996-12#1)(2008-10#1)(2008-6#2)
methodology overcomes the##2##3##(2008-10#2)
methodology provides##2##2##(1994-12#1)(2008-10#1)
methodology requires##3##2##(1997-4#1)(2008-10#1)(2008-12#1)
methodology suitable for##2##3##(2008-10#1)(2010-12#1)
methodology that allows##2##3##(2007-10#1)(2009-9#1)
methodology that##9##2##(1991-1#1)(1993-3#1)(1997-3#1)(2007-10#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
methodology to assess the##2##4##(1994-3#1)(2008-2#1)
methodology to detect and quantify##2##5##(2008-10#2)
methodology to determine##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
methodology to explore the##2##4##(2007-12#1)(2008-10#1)
methodology to identify##2##3##(2007-6#1)(2008-1#1)
methodology to study##2##3##(2008-10#1)(2010-4#1)
methodology to##43##2##(1990-3#1)(1992-8#1)(1994-3#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
methodology used by##2##3##(2008-4#1)(2013-1#1)
methodology used for##2##3##(2008-4#1)(2011-2#1)
methodology used to##6##3##(1995-2#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
methodology used##14##2##(1991-6#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
methodology using##7##2##(2008-10#7)
methodology was applied##3##3##(2008-10#2)(2013-1#1)
methodology was developed to determine##2##5##(2008-10#2)
methodology was developed##4##3##(2007-10#1)(2008-10#3)
methodology was evaluated##2##3##(2008-10#2)
methodology was successfully applied to the##2##6##(2008-10#2)
methodology was successfully applied to##3##5##(2008-10#2)(2012-2#1)
methodology was successfully##4##3##(2008-10#3)(2012-2#1)
methodology was used to##2##4##(1995-3#1)(2008-9#1)
methodology was used##6##3##(1993-6#1)(1995-3#1)(2008-10#1)(2008-9#2)(2012-12#1)
methodology was validated##2##3##(2008-10#2)
methodology was##36##2##(1990-3#1)(1993-6#1)(1995-3#1)(1996-3#1)(2007-10#1)(2008-10#20)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
methodology we##2##2##(2008-10#1)(2012-2#1)
methodology were##2##2##(2008-10#2)
methodology with those##2##3##(1992-12#1)(2008-10#1)
methodology with which to##2##4##(2008-3#2)
methodology with##8##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-10#1)
methodology would##2##2##(1996-1#1)(1996-3#1)
methodology##592##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#6)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#5)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#5)(1995-6#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#6)(1997-4#3)(1997-8#1)(2006-12#1)(2007-10#4)(2007-11#7)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#235)(2008-11#14)(2008-12#12)(2008-2#22)(2008-3#15)(2008-4#16)(2008-5#8)(2008-6#10)(2008-7#12)(2008-8#13)(2008-9#13)(2009-10#7)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#12)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#5)
methodology]##2##1##(2010-6#1)(2012-3#1)
methods (e##2##2##(2008-10#1)(2010-8#1)
methods (i##5##2##(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#2)
methods A and##4##3##(2008-10#3)(2008-6#1)
methods B and C##2##4##(2008-6#2)
methods according to the##2##4##(1990-10#1)(2011-1#1)
methods according to##3##3##(1990-10#1)(2008-10#1)(2011-1#1)
methods allow##5##2##(2008-1#1)(2008-10#2)(2008-4#1)(2012-2#1)
methods allowing##2##2##(2008-10#2)
methods allows##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
methods alone##2##2##(2009-5#1)(2009-7#1)
methods along with##2##3##(1993-12#1)(2008-10#1)
methods also##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
methods and a##3##3##(1997-4#1)(2008-10#1)(2008-6#1)
methods and by##3##3##(2008-10#3)
methods and can##2##3##(2008-10#1)(2009-9#1)
methods and demonstrate##2##3##(1995-3#1)(2007-11#1)
methods and in##2##3##(2007-12#1)(2008-10#1)
methods and new##2##3##(1996-2#1)(2010-11#1)
methods and payment##2##3##(1992-2#1)(1994-12#1)
methods and principles##2##3##(1993-3#1)(2010-3#1)
methods and processes##2##3##(2010-3#1)(2012-12#1)
methods and results##4##3##(2007-11#1)(2008-1#1)(2008-3#1)(2010-7#1)
methods and show##2##3##(1997-8#1)(2007-12#1)
methods and strategies##2##3##(2008-4#1)(2010-7#1)
methods and techniques##3##3##(1990-12#2)(2008-10#1)
methods and the##13##3##(1990-9#1)(1991-12#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#2)(2013-8#1)
methods and their applications to##2##5##(1992-5#1)(2008-10#1)
methods and their##5##3##(1992-5#1)(2008-10#2)(2008-9#1)(2013-1#1)
methods and##136##2##(1990-12#2)(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#5)(2007-12#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#8)(2009-11#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
methods applied to the##3##4##(2008-10#3)
methods applied to##6##3##(2007-12#1)(2008-10#3)(2008-5#1)(2010-7#1)
methods applied##10##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-5#1)(2010-7#1)
methods are also##5##3##(2007-10#1)(2008-11#1)(2008-4#2)(2012-12#1)
methods are applied to the##2##5##(2008-10#2)
methods are applied to##5##4##(1997-4#2)(2008-10#2)(2009-7#1)
methods are applied##8##3##(1997-4#2)(2008-10#4)(2009-7#1)(2012-1#1)
methods are available##5##3##(1994-1#1)(1997-5#2)(2008-2#1)(2011-1#1)
methods are based on the formation of##2##7##(2008-10#2)
methods are based on the##6##5##(2008-10#4)(2008-11#1)(2012-2#1)
methods are based on##11##4##(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-2#1)
methods are briefly##2##3##(1990-9#1)(1995-12#1)
methods are commonly##2##3##(2008-10#2)
methods are compared##2##3##(2008-1#1)(2008-3#1)
methods are currently##2##3##(2008-10#1)(2009-1#1)
methods are demonstrated##2##3##(2008-3#1)(2012-12#1)
methods are described for the determination of##2##7##(2008-10#2)
methods are described for the##4##5##(2008-10#3)(2008-9#1)
methods are described for##8##4##(2008-10#3)(2008-4#1)(2008-9#4)
methods are described##14##3##(1994-9#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-9#4)(2010-5#1)
methods are developed for the##2##5##(2008-10#1)(2011-2#1)
methods are developed##4##3##(2008-10#1)(2011-2#1)(2011-7#1)(2012-3#1)
methods are different##2##3##(1996-3#1)(2008-2#1)
methods are discussed##4##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-9#1)
methods are equivalent##3##3##(2008-3#2)(2008-4#1)
methods are examined##2##3##(2008-10#1)(2008-12#1)
methods are given for##2##4##(2008-3#1)(2008-4#1)
methods are illustrated##2##3##(1994-11#1)(2009-10#1)
methods are in good agreement##3##5##(2008-10#3)
methods are needed to##2##4##(2007-11#1)(2008-10#1)
methods are needed##3##3##(2007-11#1)(2008-10#2)
methods are not##4##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
methods are often##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
methods are presented for##4##4##(2008-10#1)(2008-3#1)(2008-9#2)
methods are presented in##2##4##(2008-10#1)(2008-9#1)
methods are presented##9##3##(1991-3#1)(2008-10#2)(2008-3#1)(2008-9#4)(2010-5#1)
methods are provided for##3##4##(2008-4#1)(2008-9#2)
methods are provided##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
methods are rapid##2##3##(2008-10#1)(2008-7#1)
methods are required for the##2##5##(2008-10#1)(2008-3#1)
methods are required##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
methods are reviewed##2##3##(2008-10#1)(2008-4#1)
methods are still##2##3##(1991-5#1)(2011-2#1)
methods are suitable for##2##4##(2008-10#1)(2008-4#1)
methods are used for the##2##5##(2008-1#1)(2010-8#1)
methods are used for##5##4##(2007-8#1)(2008-1#1)(2008-3#1)(2010-8#1)(2012-3#1)
methods are used to##8##4##(1993-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)
methods are used##15##3##(1993-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-3#1)
methods are well##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
methods are##204##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1996-12#3)(1996-3#2)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#55)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#21)(2008-4#15)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#14)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
methods as well as##3##4##(2008-10#2)(2009-9#1)
methods as##10##2##(1994-1#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2009-9#1)(2013-1#1)
methods assessed##2##2##(2008-10#1)(2008-7#1)
methods associated with##2##3##(1991-4#1)(1993-3#1)
methods at 95% confidence level##2##5##(2008-10#2)
methods at a##3##3##(2008-10#3)
methods at##11##2##(1991-12#1)(1991-8#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-3#1)
methods available for##6##3##(1997-4#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)
methods available##11##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#3)(2009-10#1)(2012-2#1)(2013-1#1)
methods based on the##5##4##(1994-11#1)(2007-11#1)(2008-10#1)(2009-3#1)(2012-12#1)
methods based on##29##3##(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-12#2)
methods based##30##2##(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-12#2)
methods but##4##2##(1992-9#1)(2008-10#1)(2008-12#1)(2008-3#1)
methods by which the##2##4##(2008-10#1)(2008-7#1)
methods by which##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
methods by##11##2##(1995-4#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2013-8#1)
methods can be applied##3##4##(2009-10#1)(2010-12#1)(2012-2#1)
methods can be used for the##3##6##(2008-10#3)
methods can be used for##4##5##(2008-10#4)
methods can be used to##4##5##(1993-3#1)(2006-4#1)(2008-1#1)(2008-10#1)
methods can be used##12##4##(1990-12#1)(1993-3#1)(2006-4#1)(2008-1#1)(2008-10#6)(2008-4#1)(2013-8#1)
methods can be##19##3##(1990-12#1)(1993-3#1)(1995-5#1)(2006-4#1)(2008-1#1)(2008-10#7)(2008-4#2)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
methods can capture##2##3##(2010-2#1)(2012-12#1)
methods can not##2##3##(2008-8#1)(2008-9#1)
methods can provide##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
methods can##39##2##(1990-11#1)(1990-12#1)(1993-3#1)(1995-5#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
methods commonly used for##2##4##(2008-11#1)(2010-11#1)
methods commonly used to##2##4##(2008-10#1)(2008-5#1)
methods commonly used##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
methods commonly##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
methods could be##6##3##(2008-10#2)(2008-2#1)(2008-4#1)(2010-7#1)(2012-2#1)
methods could detect##2##3##(1991-2#1)(2008-10#1)
methods could##8##2##(1991-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)(2012-2#1)
methods currently##5##2##(1991-9#1)(1994-2#1)(2008-10#1)(2008-2#1)(2009-11#1)
methods demonstrated##2##2##(2008-10#2)
methods depend on the##2##4##(2008-10#2)
methods described for##2##3##(2008-10#2)
methods described in the##2##4##(2008-10#1)(2008-4#1)
methods described in this unit can be used to##2##9##(2008-4#2)
methods described in this unit##3##5##(2008-4#3)
methods described in##6##3##(2008-10#2)(2008-4#4)
methods described##14##2##(2008-10#5)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)
methods developed for##2##3##(1992-12#1)(2008-10#1)
methods developed in this##2##4##(2008-10#1)(2011-2#1)
methods developed in##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
methods developed##10##2##(1992-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)
methods did not##5##3##(1995-2#1)(1997-5#1)(2007-7#1)(2008-10#1)(2011-2#1)
methods discussed are##2##3##(2008-5#1)(2011-2#1)
methods do not exist##2##4##(2008-2#1)(2010-7#1)
methods do not##8##3##(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-7#1)
methods do##9##2##(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)
methods due to##2##3##(2008-10#1)(2008-4#1)
methods employ##2##2##(2008-4#1)(2009-8#1)
methods employed for##4##3##(1994-2#1)(2008-10#2)(2010-7#1)
methods employed to##3##3##(2008-11#1)(2008-12#1)(2008-2#1)
methods employed##12##2##(1991-11#1)(1991-3#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2010-7#1)(2013-8#1)
methods exist for##4##3##(2008-5#1)(2008-9#1)(2009-7#1)(2010-6#1)
methods exist##6##2##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-6#1)
methods fail##2##2##(2008-7#1)(2010-11#1)
methods for a##3##3##(1990-5#1)(1990-9#1)(1992-12#1)
methods for analysing##2##3##(1995-12#1)(1997-4#1)
methods for analysis of##4##4##(2008-10#2)(2008-2#1)(2012-12#1)
methods for analyzing##4##3##(2007-11#1)(2008-4#2)(2010-1#1)
methods for assaying free sulfhydryl content and for reducing disulfide bonds in synthetic peptides##3##14##(2008-2#1)(2008-4#2)
methods for assessing##9##3##(1997-4#1)(1997-5#1)(2008-1#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-8#1)(2012-3#1)
methods for calculating##4##3##(1994-3#1)(2008-2#1)(2013-1#2)
methods for characterization##2##3##(2008-4#1)(2010-6#1)
methods for detecting gene-gene##2##4##(2008-4#2)
methods for detecting##10##3##(1993-9#1)(2008-10#2)(2008-12#1)(2008-4#4)(2008-9#1)(2012-3#1)
methods for detection of##2##4##(1997-4#1)(2012-2#1)
methods for detection##3##3##(1997-4#1)(2008-2#1)(2012-2#1)
methods for determination of##4##4##(1993-2#1)(2008-1#1)(2008-10#2)
methods for determining the##4##4##(2008-3#2)(2008-4#2)
methods for determining##5##3##(1992-9#1)(2008-3#2)(2008-4#2)
methods for diagnosis and##2##4##(2008-3#1)(2010-4#1)
methods for diagnosis##3##3##(2008-3#1)(2010-4#1)(2011-2#1)
methods for estimating##6##3##(1995-9#1)(2008-3#2)(2009-5#1)(2010-3#1)(2013-1#1)
methods for evaluating##2##3##(2008-9#2)
methods for evaluation of##2##4##(2008-7#1)(2008-8#1)
methods for evaluation##4##3##(1995-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
methods for generating##4##3##(2008-2#1)(2008-4#1)(2010-5#1)(2012-12#1)
methods for genetic##2##3##(2007-7#1)(2008-7#1)
methods for identifying##4##3##(2008-10#1)(2008-4#2)(2012-3#1)
methods for improvement##2##3##(2008-3#1)(2009-5#1)
methods for incorporating##2##3##(2008-4#1)(2013-1#1)
methods for increasing##2##3##(2010-2#1)(2013-8#1)
methods for isolating##2##3##(2008-4#1)(2008-9#1)
methods for isolation##2##3##(2008-10#1)(2008-9#1)
methods for its##3##3##(2007-12#1)(2008-10#2)
methods for labeling##2##3##(2008-1#1)(2008-4#1)
methods for laboratory##2##3##(2008-5#1)(2008-9#1)
methods for making such##2##4##(2008-11#1)(2008-4#1)
methods for making##4##3##(2008-11#1)(2008-3#1)(2008-4#2)
methods for measurement of##2##4##(2011-1#1)(2012-2#1)
methods for measuring the##2##4##(2007-12#1)(2008-1#1)
methods for measuring##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)
methods for monitoring the##2##4##(2007-8#1)(2008-4#1)
methods for monitoring##6##3##(2007-8#1)(2008-2#1)(2008-4#3)(2008-9#1)
methods for obtaining##2##3##(1992-5#1)(2008-9#1)
methods for preparing##5##3##(2008-1#1)(2008-4#4)
methods for presbyopia treatment##2##4##(2011-2#2)
methods for processing##2##3##(2008-2#1)(2008-9#1)
methods for quantifying##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
methods for reconstructing##2##3##(2007-12#1)(2008-8#1)
methods for recording##2##3##(2008-10#1)(2008-4#1)
methods for routine##2##3##(2008-10#2)
methods for separation of##2##4##(2008-6#1)(2013-1#1)
methods for studying##2##3##(2008-11#1)(2008-4#1)
methods for such##2##3##(2008-10#1)(2011-3#1)
methods for testing##3##3##(1994-12#1)(2008-4#1)(2008-9#1)
methods for the analysis and##2##5##(2008-4#1)(2010-4#1)
methods for the analysis of##9##5##(1991-5#1)(1992-6#1)(2008-1#2)(2008-10#3)(2008-2#1)(2010-5#1)
methods for the analysis##12##4##(1991-5#1)(1992-6#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2010-4#1)(2010-5#1)(2012-2#1)
methods for the assay of##3##5##(1995-2#1)(2008-10#1)(2008-6#1)
methods for the detection of##8##5##(1992-11#1)(1993-6#1)(2008-10#4)(2008-7#1)(2011-1#1)
methods for the determination of total##3##6##(2008-10#3)
methods for the determination of##32##5##(1992-11#1)(1996-12#1)(2008-10#27)(2008-11#1)(2008-4#1)(2012-2#1)
methods for the diagnosis##3##4##(1997-4#1)(2007-5#1)(2011-1#1)
methods for the identification of##3##5##(2008-5#1)(2008-7#1)(2009-9#1)
methods for the in##2##4##(2008-11#1)(2008-4#1)
methods for the isolation and##2##5##(2008-4#1)(2008-9#1)
methods for the isolation##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
methods for the preparation of##2##5##(2008-4#1)(2008-8#1)
methods for the simultaneous##2##4##(2008-10#2)
methods for the treatment of##2##5##(2007-11#1)(2013-1#1)
methods for the##113##3##(1991-5#1)(1992-11#3)(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-4#2)(2007-11#1)(2007-5#1)(2008-1#4)(2008-10#48)(2008-11#4)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-2#4)(2013-1#2)
methods for their##4##3##(2007-11#1)(2008-10#1)(2011-3#1)(2012-2#1)
methods for these compounds##2##4##(2008-10#2)
methods for these##4##3##(2008-10#3)(2010-8#1)
methods for using the##2##4##(2008-4#1)(2010-12#1)
methods for##488##2##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-5#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-8#1)(1995-9#2)(1996-12#3)(1996-2#1)(1996-9#1)(1997-3#4)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#17)(2008-10#109)(2008-11#9)(2008-12#5)(2008-2#22)(2008-3#21)(2008-4#68)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#33)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#9)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#9)(2012-5#1)(2013-1#10)(2013-8#4)
methods from the##5##3##(1994-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)
methods from##10##2##(1994-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#2)
methods gave rise to##2##4##(2008-10#1)(2012-3#1)
methods gave##6##2##(1997-5#1)(2008-10#3)(2008-5#1)(2012-3#1)
methods generally##2##2##(2008-3#2)
methods give##2##2##(2007-11#1)(2008-5#1)
methods gives##2##2##(2008-10#1)(2008-3#1)
methods has been##3##3##(1990-5#1)(2008-10#1)(2012-3#1)
methods has##5##2##(1990-5#1)(2008-10#1)(2009-11#1)(2012-3#1)(2013-8#1)
methods have also been##2##4##(2008-10#1)(2012-2#1)
methods have become##2##3##(2009-9#1)(2012-12#1)
methods have been applied for the determination of##2##8##(2008-10#2)
methods have been applied to##2##5##(2008-10#2)
methods have been applied##6##4##(2008-10#4)(2008-11#1)(2008-4#1)
methods have been described for##3##5##(2008-10#1)(2008-5#1)(2013-1#1)
methods have been described##4##4##(2008-10#2)(2008-5#1)(2013-1#1)
methods have been developed for the determination of##2##8##(2008-10#2)
methods have been developed for the##4##6##(2008-10#3)(2010-5#1)
methods have been developed for##5##5##(2008-10#3)(2008-9#1)(2010-5#1)
methods have been developed to##5##5##(1990-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
methods have been developed which##2##5##(1995-2#1)(2009-10#1)
methods have been developed##14##4##(1990-7#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-10#2)(2010-5#1)(2011-2#1)
methods have been proposed for##4##5##(1997-3#1)(2009-1#1)(2011-2#1)(2012-2#1)
methods have been proposed##6##4##(1997-3#1)(2008-3#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
methods have been shown to##2##5##(2008-3#1)(2011-2#1)
methods have been successfully applied to##5##6##(2008-10#5)
methods have been used for##2##5##(2008-10#1)(2008-9#1)
methods have been used to##4##5##(1990-9#1)(2007-8#1)(2008-10#2)
methods have been used##6##4##(1990-9#1)(2007-8#1)(2008-10#3)(2008-9#1)
methods have been##55##3##(1990-7#1)(1990-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-8#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
methods have not##2##3##(1994-11#1)(1995-6#1)
methods have recently been developed##2##5##(2008-2#1)(2008-5#1)
methods have recently been##3##4##(1995-12#1)(2008-2#1)(2008-5#1)
methods have recently##5##3##(1995-12#1)(2007-11#1)(2008-2#1)(2008-5#2)
methods have to##2##3##(2008-10#1)(2008-11#1)
methods have##83##2##(1990-7#1)(1990-9#1)(1994-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)
methods identified##2##2##(2008-10#1)(2012-3#1)
methods in a##2##3##(2008-10#1)(2008-8#1)
methods in comparison with##2##4##(2008-10#1)(2013-8#1)
methods in diagnosis of##2##4##(2007-11#1)(2013-7#1)
methods in health##2##3##(1993-3#1)(2012-3#1)
methods in many##2##3##(2008-1#1)(2008-8#1)
methods in order to##2##4##(2008-10#1)(2012-12#1)
methods in terms of##2##4##(2008-10#2)
methods in the##14##3##(1990-5#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-11#1)(2010-5#1)
methods in##82##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-8#2)(1996-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#3)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
methods include##10##2##(1997-3#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-9#2)(2009-11#1)
methods included##4##2##(2008-10#1)(2008-6#1)(2010-7#1)(2013-8#1)
methods including the##2##3##(2008-11#1)(2008-4#1)
methods including##9##2##(1996-2#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)
methods indicated##4##2##(2008-10#3)(2008-3#1)
methods indicates that##2##3##(1992-6#1)(2008-10#1)
methods involved##2##2##(2008-10#1)(2010-7#1)
methods involving##2##2##(2008-11#1)(2008-3#1)
methods is a##4##3##(2008-10#2)(2013-1#2)
methods is presented##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
methods is the##3##3##(2007-8#1)(2008-1#1)(2011-2#1)
methods is used to##2##4##(2008-3#1)(2011-1#1)
methods is##33##2##(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#4)
methods led to a##2##4##(1993-11#1)(2011-2#1)
methods like##9##2##(2007-5#1)(2008-10#6)(2008-11#1)(2013-1#1)
methods may be used to##2##5##(2008-12#1)(2008-4#1)
methods may be used##3##4##(2008-12#1)(2008-2#1)(2008-4#1)
methods may be##7##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
methods may increase##2##3##(1996-11#1)(2008-1#1)
methods may##16##2##(1994-8#1)(1996-11#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
methods need##2##2##(2009-12#1)(2010-12#1)
methods of DNA##2##3##(2008-5#1)(2008-9#1)
methods of a##2##3##(2008-10#1)(2008-11#1)
methods of analysis and##2##4##(1994-12#1)(2012-7#1)
methods of analysis for##2##4##(2008-10#1)(2008-9#1)
methods of analysis##12##3##(1990-2#1)(1994-12#1)(1994-9#1)(1997-5#1)(2008-10#5)(2008-3#1)(2008-9#1)(2012-7#1)
methods of assessing##4##3##(1993-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
methods of assessment##6##3##(1992-3#1)(2008-11#3)(2011-2#1)(2013-7#1)
methods of birth##2##3##(1994-9#1)(2013-8#1)
methods of bone##2##3##(2007-11#1)(2007-8#1)
methods of choice##3##3##(1992-11#1)(2007-11#1)(2007-8#1)
methods of combined inhalational and epidural anesthesia##2##7##(2012-3#2)
methods of combined##4##3##(2011-2#1)(2012-3#3)
methods of control have##2##4##(1997-7#2)
methods of data analysis##3##4##(2008-11#2)(2009-7#1)
methods of detecting##2##3##(2007-10#1)(2008-7#1)
methods of detection##4##3##(2008-1#1)(2008-10#3)
methods of determination##2##3##(1990-6#1)(2009-8#1)
methods of diagnosis and##2##4##(2008-9#1)(2013-8#1)
methods of diagnosis##4##3##(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
methods of disease control##2##4##(2008-10#2)
methods of evaluating and##2##4##(2007-11#1)(2008-6#1)
methods of evaluating##3##3##(1991-12#1)(2007-11#1)(2008-6#1)
methods of evaluation##6##3##(1997-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
methods of immobilization on##2##4##(1997-2#1)(2008-10#1)
methods of investigation##2##3##(1991-11#1)(1993-11#1)
methods of management##3##3##(1994-3#1)(2008-6#1)(2013-8#1)
methods of measurement##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
methods of measuring the##2##4##(2008-2#2)
methods of measuring##5##3##(2008-1#1)(2008-11#1)(2008-2#2)(2012-2#1)
methods of multivariate##2##3##(2008-10#2)
methods of payment##2##3##(1997-1#1)(1997-2#1)
methods of preparation##2##3##(1994-5#1)(2007-11#1)
methods of quality##2##3##(1995-3#1)(2011-3#1)
methods of synthesis##2##3##(2008-10#1)(2010-10#1)
methods of the##5##3##(2008-10#1)(2008-11#1)(2010-8#2)(2013-8#1)
methods of therapy##2##3##(2011-1#1)(2012-2#1)
methods of treating##2##3##(2008-11#1)(2008-7#1)
methods of treatment of the##2##5##(2007-8#1)(2013-1#1)
methods of treatment of##5##4##(2007-8#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
methods of treatment##16##3##(1997-5#1)(1997-6#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
methods of urea kinetics##2##4##(2008-1#2)
methods of##288##2##(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#3)(1997-6#4)(1997-7#3)(2007-10#3)(2007-11#9)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#8)(2008-1#9)(2008-10#47)(2008-11#17)(2008-12#4)(2008-2#7)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#10)(2008-8#6)(2008-9#5)(2009-12#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#13)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#6)
methods offer##2##2##(2007-11#1)(2008-3#1)
methods offers##2##2##(2008-10#1)(2009-12#1)
methods often##2##2##(2009-11#1)(2010-6#1)
methods on the##5##3##(2008-10#2)(2010-4#1)(2012-3#1)(2013-8#1)
methods on##18##2##(1993-12#1)(1995-2#1)(2008-10#8)(2008-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
methods only##2##2##(1995-12#1)(2008-10#1)
methods or##6##2##(1992-8#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-4#1)
methods outlined##2##2##(2008-2#1)(2008-9#1)
methods perform##2##2##(2008-3#2)
methods performed##3##2##(1995-1#1)(2008-3#1)(2012-3#1)
methods presented in##2##3##(2008-10#1)(2008-6#1)
methods presented##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
methods previously##2##2##(1997-3#1)(2008-2#1)
methods produced##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
methods proposed were##2##3##(2008-10#2)
methods proposed##5##2##(2008-10#4)(2012-3#1)
methods provide important##2##3##(1991-2#2)
methods provide##9##2##(1991-2#2)(1995-9#1)(2008-11#1)(2008-9#2)(2009-11#1)(2011-2#1)(2013-1#1)
methods published##2##2##(2011-1#1)(2011-2#1)
methods rely##2##2##(2007-5#1)(2008-2#1)
methods remain##2##2##(2008-10#1)(2010-7#1)
methods reported##4##2##(2008-10#4)
methods require##6##2##(1994-2#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
methods required##2##2##(2008-10#1)(2008-11#1)
methods requires a##2##3##(2008-3#1)(2009-9#1)
methods requiring##2##2##(2008-10#1)(2012-2#1)
methods result in##2##3##(1996-1#1)(2008-4#1)
methods should be##6##3##(1992-12#1)(2007-4#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
methods should##9##2##(1992-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
methods show##3##2##(2008-10#2)(2008-7#1)
methods showed that##2##3##(1993-8#1)(2008-5#1)
methods showed##11##2##(1993-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#2)
methods such as the##2##4##(2008-10#1)(2008-3#1)
methods such as##37##3##(1991-11#1)(1993-3#1)(1996-2#1)(2007-11#1)(2008-10#15)(2008-11#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-7#1)(2013-8#1)
methods such##38##2##(1991-11#1)(1993-3#1)(1996-2#1)(2007-11#1)(2008-10#16)(2008-11#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-7#1)(2013-8#1)
methods suitable for##4##3##(1990-2#1)(1995-2#1)(2008-10#1)(2012-3#1)
methods tested##2##2##(2008-10#1)(2009-8#1)
methods than##4##2##(1990-3#1)(2008-9#2)(2012-7#1)
methods that allow##5##3##(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
methods that are available##2##4##(2008-3#1)(2008-5#1)
methods that are used to##2##5##(2008-3#1)(2010-11#1)
methods that are##9##3##(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-11#1)(2010-11#1)(2011-1#1)
methods that can be used##2##5##(2008-4#1)(2008-9#1)
methods that can##4##3##(2008-4#3)(2008-9#1)
methods that exploit##2##3##(2008-3#1)(2012-2#1)
methods that have been used for##2##6##(2008-8#1)(2012-2#1)
methods that have been##3##4##(2008-4#1)(2008-8#1)(2012-2#1)
methods that have##4##3##(2008-4#1)(2008-8#1)(2012-2#2)
methods that permit##2##3##(2008-12#1)(2008-2#1)
methods that provide##2##3##(2008-10#1)(2008-5#1)
methods that rely on##3##4##(1995-2#1)(2008-10#1)(2008-3#1)
methods that rely##4##3##(1995-2#1)(1995-6#1)(2008-10#1)(2008-3#1)
methods that use##8##3##(2008-10#2)(2008-11#1)(2008-3#3)(2009-7#1)(2012-2#1)
methods that utilize##2##3##(1997-4#1)(2008-4#1)
methods that##66##2##(1990-12#1)(1992-12#1)(1992-9#2)(1994-2#2)(1995-2#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)
methods the##4##2##(2007-11#1)(2007-8#1)(2008-3#1)(2011-1#1)
methods to a##6##3##(2008-10#2)(2008-3#1)(2009-5#1)(2010-3#1)(2010-8#1)
methods to achieve##2##3##(2008-2#1)(2008-5#1)
methods to adjust##2##3##(1991-12#1)(2012-3#1)
methods to analyze##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
methods to assess the##4##4##(1997-4#1)(2008-4#2)(2013-8#1)
methods to assess##9##3##(1997-4#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-8#1)
methods to avoid##2##3##(2007-8#1)(2008-9#1)
methods to be##5##3##(1997-1#1)(2008-10#2)(2008-3#1)(2012-12#1)
methods to characterize##3##3##(2009-6#1)(2010-7#1)(2012-12#1)
methods to classify##2##3##(2008-10#2)
methods to combine##2##3##(1997-8#1)(2008-7#1)
methods to control the##2##4##(1997-7#1)(2008-11#1)
methods to detect##8##3##(1994-11#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-9#2)(2011-2#1)
methods to determine the##2##4##(1995-2#1)(2008-3#1)
methods to determine##5##3##(1990-8#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
methods to develop##2##3##(2007-11#1)(2010-5#1)
methods to evaluate the##3##4##(2008-5#1)(2008-9#1)(2012-3#1)
methods to evaluate##6##3##(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)
methods to examine##2##3##(2008-11#1)(2008-12#1)
methods to gain##3##3##(2008-8#1)(2010-12#1)(2012-3#1)
methods to generate##2##3##(2008-11#1)(2011-2#1)
methods to identify##5##3##(2008-12#1)(2008-7#2)(2010-11#1)(2011-2#1)
methods to improve the##2##4##(2008-3#1)(2008-7#1)
methods to improve##4##3##(1993-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
methods to increase##2##3##(2008-7#1)(2010-7#1)
methods to investigate the##2##4##(2007-12#1)(2008-10#1)
methods to investigate##4##3##(2007-12#2)(2008-10#1)(2010-2#1)
methods to label##2##3##(2008-1#1)(2008-9#1)
methods to measure the##2##4##(2007-8#1)(2008-9#1)
methods to measure##11##3##(1997-1#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-3#1)
methods to obtain##2##3##(1994-8#1)(2008-11#1)
methods to overcome##2##3##(2008-1#1)(2012-2#1)
methods to quantify##2##3##(2008-10#2)
methods to the determination of##2##5##(2008-10#1)(2008-3#1)
methods to the##9##3##(1990-3#1)(1990-8#1)(2008-10#4)(2008-3#2)(2008-4#1)
methods to##187##2##(1990-3#1)(1990-5#1)(1990-8#3)(1991-12#1)(1993-1#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#2)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#10)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#14)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#7)(2013-1#3)(2013-8#1)
methods used and the##2##4##(1991-2#1)(1997-1#1)
methods used are##2##3##(2008-9#1)(2013-1#1)
methods used for the##2##4##(2008-10#1)(2008-11#1)
methods used for##15##3##(1992-4#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2010-3#1)(2011-2#2)(2013-1#1)
methods used in the##7##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
methods used in##16##3##(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#3)
methods used to assess##4##4##(2007-11#2)(2008-11#1)(2008-5#1)
methods used to##22##3##(1990-3#1)(1991-2#1)(1993-2#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-2#1)
methods used##68##2##(1990-3#1)(1991-2#2)(1992-4#1)(1993-2#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
methods using a##2##3##(2008-10#1)(2008-8#1)
methods using an##2##3##(2008-12#1)(2008-5#1)
methods using the##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
methods using##23##2##(1992-3#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-3#2)(2013-1#1)
methods usually##2##2##(2008-10#2)
methods was also##3##3##(1991-6#1)(1993-2#1)(2008-10#1)
methods was compared##2##3##(2008-10#1)(2008-7#1)
methods was observed##2##3##(2008-10#2)
methods was studied##2##3##(2008-10#1)(2009-7#1)
methods was tested##2##3##(2008-10#2)
methods was##25##2##(1991-6#1)(1993-2#1)(1995-2#1)(1997-6#1)(2008-10#16)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
methods we##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
methods were 0##3##3##(2008-10#3)
methods were also used to##3##5##(2008-10#2)(2010-7#1)
methods were applied for##2##4##(2008-10#1)(2011-2#1)
methods were applied to the analysis of##2##7##(2008-10#2)
methods were applied to the determination of the##2##8##(2008-10#2)
methods were applied to the determination of##7##7##(2008-10#7)
methods were applied to the determination##8##6##(2008-10#8)
methods were applied to the##11##5##(2008-10#11)
methods were applied to##19##4##(1992-6#1)(1997-2#1)(2008-10#17)
methods were applied##23##3##(1992-6#1)(1997-2#1)(2008-10#20)(2011-2#1)
methods were compared and##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
methods were compared using##2##4##(2008-10#2)
methods were compared with##3##4##(1994-12#1)(2008-10#1)(2013-8#1)
methods were compared##15##3##(1994-12#1)(1996-5#1)(1997-2#1)(2008-10#6)(2008-12#1)(2008-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
methods were developed for the determination of##2##7##(2008-10#2)
methods were developed for the##4##5##(2008-10#4)
methods were developed##8##3##(1997-3#1)(2008-10#6)(2008-9#1)
methods were employed##2##3##(2008-10#1)(2008-6#1)
methods were evaluated##3##3##(1993-2#1)(2008-10#1)(2008-6#1)
methods were found to be##2##5##(2008-10#2)
methods were found##3##3##(2008-10#3)
methods were in##3##3##(2008-10#3)
methods were investigated##2##3##(2008-10#1)(2011-2#1)
methods were observed##2##3##(2008-10#2)
methods were proposed##2##3##(2008-10#2)
methods were successfully applied to##4##5##(2008-10#4)
methods were tested##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
methods were the##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
methods were then##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
methods were used for the##5##5##(2008-10#4)(2008-11#1)
methods were used for##9##4##(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)
methods were used to prepare##2##5##(2008-10#1)(2008-12#1)
methods were used to study the##2##6##(2008-10#1)(2008-8#1)
methods were used to study##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
methods were used to##18##4##(1992-11#1)(1995-6#1)(1996-5#1)(2007-12#2)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-7#1)
methods were used##33##3##(1992-11#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
methods were utilized to##2##4##(1995-1#1)(2008-8#1)
methods were validated by##3##4##(2008-10#3)
methods were validated##4##3##(2008-10#4)
methods were well##2##3##(2008-10#2)
methods were##169##2##(1990-12#1)(1992-11#1)(1992-6#1)(1993-2#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-2#3)(1997-3#3)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#102)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#5)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-7#2)(2013-8#2)
methods where##2##2##(2008-10#2)
methods which are##3##3##(1990-2#1)(1994-9#1)(1995-5#1)
methods which can be used##2##5##(1991-3#1)(2008-10#1)
methods which##14##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-5#1)(2007-11#1)(2008-10#3)
methods will also##2##3##(1997-1#1)(2008-10#1)
methods will##9##2##(1992-8#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2011-1#1)
methods with a##2##3##(1996-12#1)(2010-11#1)
methods with data##2##3##(2008-8#1)(2012-3#1)
methods with respect to##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
methods with the##2##3##(2008-5#1)(2010-3#1)
methods with those##2##3##(1997-4#1)(2010-8#1)
methods with##31##2##(1992-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
methods within##2##2##(2008-11#1)(2008-12#1)
methods work##2##2##(2012-3#1)(2013-1#1)
methods yield##4##2##(1995-2#1)(1995-6#1)(2008-2#1)(2008-3#1)
methods##3724##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#7)(1990-3#5)(1990-5#4)(1990-6#6)(1990-7#5)(1990-8#12)(1990-9#9)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#9)(1991-3#8)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#7)(1992-12#10)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#5)(1992-6#11)(1992-8#3)(1992-9#8)(1993-1#3)(1993-11#6)(1993-12#10)(1993-2#15)(1993-3#11)(1993-6#4)(1993-8#3)(1993-9#4)(1994-1#5)(1994-11#9)(1994-12#10)(1994-2#19)(1994-3#8)(1994-5#5)(1994-6#3)(1994-8#8)(1994-9#16)(1995-1#9)(1995-11#5)(1995-12#17)(1995-2#25)(1995-3#10)(1995-4#1)(1995-5#8)(1995-6#6)(1995-8#4)(1995-9#6)(1996-1#5)(1996-11#7)(1996-12#18)(1996-2#12)(1996-3#7)(1996-4#2)(1996-5#9)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#8)(1997-2#18)(1997-3#19)(1997-4#22)(1997-5#12)(1997-6#8)(1997-7#12)(1997-8#5)(2006-10#3)(2006-4#2)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#15)(2007-11#133)(2007-12#37)(2007-2#3)(2007-4#1)(2007-5#8)(2007-6#3)(2007-7#7)(2007-8#69)(2008-1#56)(2008-10#1023)(2008-11#110)(2008-12#64)(2008-2#91)(2008-3#179)(2008-4#173)(2008-5#91)(2008-6#51)(2008-7#83)(2008-8#52)(2008-9#133)(2009-1#3)(2009-10#16)(2009-11#17)(2009-12#6)(2009-2#3)(2009-3#6)(2009-4#6)(2009-5#15)(2009-6#1)(2009-7#16)(2009-8#22)(2009-9#13)(2010-1#6)(2010-10#8)(2010-11#26)(2010-12#22)(2010-2#6)(2010-3#17)(2010-4#11)(2010-5#17)(2010-6#11)(2010-7#26)(2010-8#24)(2010-9#6)(2011-1#37)(2011-2#80)(2011-3#8)(2011-7#1)(2012-1#14)(2012-12#73)(2012-2#58)(2012-3#69)(2012-5#1)(2012-7#2)(2013-1#75)(2013-7#10)(2013-8#44)
methods) and##3##2##(2008-10#1)(2010-5#1)(2010-8#1)
methods)##9##1##(1990-12#1)(2008-10#4)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#1)
methods]##3##1##(1991-2#1)(1997-4#1)(2008-5#1)
methohexital##2##1##(1993-1#1)(2008-10#1)
methomyl##4##1##(2008-10#1)(2008-7#3)
methonium ions##3##2##(1991-8#3)
methoprene##3##1##(2007-11#3)
methosulfate##3##1##(1992-3#1)(2008-10#1)(2008-11#1)
methosulphate##2##1##(2008-10#1)(2008-11#1)
methotrexate (MTX)##9##2##(1990-8#1)(1991-4#1)(1992-8#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
methotrexate and IFN-gamma were##2##4##(1993-12#2)
methotrexate and IFN-gamma##3##3##(1993-12#3)
methotrexate and##13##2##(1990-12#1)(1991-5#1)(1993-12#4)(1994-3#1)(1995-8#1)(2007-11#1)(2007-5#1)(2010-12#2)(2010-3#1)
methotrexate in##5##2##(1990-8#1)(1992-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
methotrexate was##3##2##(1993-12#2)(2012-2#1)
methotrexate with##2##2##(2006-10#1)(2010-3#1)
methotrexate##79##1##(1990-12#2)(1990-8#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#8)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#3)(1997-8#1)(2006-10#6)(2007-10#1)(2007-11#4)(2007-5#1)(2008-10#7)(2008-11#7)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-3#7)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
methotrexate-containing##2##1##(1992-12#1)(2008-11#1)
methotrexate-induced pancytopenia##2##2##(2006-10#2)
methotrexate-induced##3##1##(1993-12#1)(2006-10#2)
methoxamine##3##1##(2008-10#3)
methoxy group on the##2##4##(2008-10#2)
methoxy group##3##2##(2008-10#2)(2013-1#1)
methoxy##12##1##(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#4)(2010-12#1)(2013-1#2)
methoxycinnamate##12##1##(2008-5#12)
methoxyindoles##3##1##(1995-12#3)
methoxyl group##2##2##(1993-8#1)(2008-10#1)
methoxyl##5##1##(1993-8#2)(2008-10#1)(2011-2#2)
methoxyresorufin##4##1##(1994-8#4)
methsulfuron-methyl##3##1##(2008-10#3)
methyl 2##4##2##(1995-11#2)(1996-12#2)
methyl 4##2##2##(1996-5#2)
methyl acrylate and##2##3##(1996-5#1)(2008-10#1)
methyl acrylate##4##2##(1996-5#1)(2008-10#2)(2010-8#1)
methyl and##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
methyl borate##3##2##(2008-10#3)
methyl bromide has##2##3##(2008-10#2)
methyl bromide##17##2##(2008-10#17)
methyl chavicol##2##2##(2008-5#2)
methyl chloride##2##2##(2008-11#2)
methyl donor##2##2##(1990-7#1)(2008-3#1)
methyl ester (L-NAME)##5##3##(1992-3#1)(1995-12#2)(1996-5#1)(2008-11#1)
methyl ester and##4##3##(1995-12#2)(2008-10#2)
methyl ester hydrochloride##4##3##(1997-2#1)(2008-10#3)
methyl ester of##4##3##(1990-7#1)(1994-3#1)(1996-7#2)
methyl ester##68##2##(1990-7#1)(1991-12#2)(1992-10#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-9#2)(1995-11#3)(1995-12#6)(1996-5#3)(1996-7#3)(1997-2#2)(2007-11#4)(2008-10#17)(2008-11#8)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
methyl ester)##4##2##(1995-11#1)(1997-2#1)(2008-10#2)
methyl esterification##2##2##(1994-9#1)(2012-12#1)
methyl esters##15##2##(1993-6#1)(2008-10#7)(2008-6#1)(2009-8#3)(2010-12#2)(2013-1#1)
methyl ethyl ketone##5##3##(2008-10#5)
methyl group at##3##3##(1992-6#1)(1995-3#1)(2008-10#1)
methyl group in##2##3##(1996-5#1)(2013-1#1)
methyl group##14##2##(1990-7#2)(1991-5#2)(1992-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
methyl groups of the##2##4##(1994-5#1)(1996-2#1)
methyl groups of##3##3##(1994-5#1)(1996-2#1)(2011-1#1)
methyl groups##8##2##(1992-3#1)(1993-11#1)(1994-5#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2011-1#1)
methyl iodide##3##2##(1995-3#1)(2008-10#2)
methyl isobutyl ketone (MIBK)##3##4##(2008-10#3)
methyl isobutyl ketone and cyclohexanone##4##5##(2008-10#4)
methyl isobutyl ketone and##5##4##(2008-10#5)
methyl isobutyl ketone##10##3##(2008-10#10)
methyl jasmonate (MeJA)##2##3##(2011-10#2)
methyl jasmonate was##2##3##(2008-10#2)
methyl jasmonate##10##2##(2008-10#7)(2011-10#3)
methyl ketone and##2##3##(2008-10#2)
methyl ketone##9##2##(2007-11#1)(2008-10#8)
methyl linoleate##5##2##(1995-2#4)(2008-10#1)
methyl mercury##5##2##(2008-10#5)
methyl methacrylate and##3##3##(1994-8#1)(2008-10#2)
methyl methacrylate solution##2##3##(2008-10#2)
methyl methacrylate were##2##3##(1994-8#1)(2008-7#1)
methyl methacrylate##17##2##(1994-8#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-7#2)(2012-2#1)
methyl orange (MO)##3##3##(2008-10#3)
methyl orange##9##2##(2008-10#8)(2009-11#1)
methyl parathion and malathion##2##4##(1994-5#2)
methyl parathion##3##2##(1994-5#2)(2008-10#1)
methyl prednisolone##2##2##(1995-5#1)(2008-1#1)
methyl substituent##2##2##(1995-3#1)(2007-12#1)
methyl tert-butyl ether##3##3##(2008-12#2)(2011-2#1)
methyl thymol blue##5##3##(2008-10#5)
methyl transferase##3##2##(1991-5#2)(2007-11#1)
methyl vinyl ketone##2##3##(1995-11#1)(1996-5#1)
methyl vinyl##4##2##(1995-11#1)(1996-5#3)
methyl viologen##3##2##(1991-5#1)(2008-10#2)
methyl##317##1##(1990-7#4)(1990-9#1)(1991-12#2)(1991-5#5)(1991-9#1)(1992-10#1)(1992-12#7)(1992-2#1)(1992-3#2)(1992-6#3)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#5)(1994-8#7)(1994-9#3)(1995-11#12)(1995-12#7)(1995-2#5)(1995-3#4)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#11)(1996-7#3)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-11#13)(2007-12#3)(2008-1#1)(2008-10#133)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-10#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
methyl-beta-cyclodextrin##3##1##(2008-10#2)(2008-8#1)
methyl-mercury##4##1##(2008-10#4)
methyl-prednisolone##2##1##(2007-7#1)(2008-4#1)
methyl-β-cyclodextrin##5##1##(2011-2#5)
methylamine##11##1##(1995-9#2)(2007-11#1)(2008-10#7)(2008-11#1)
methylamphetamine and##3##2##(2008-10#3)
methylamphetamine##4##1##(2008-10#4)
methylarsonic acid##2##2##(2008-10#2)
methylase##7##1##(1990-5#3)(1993-6#2)(2008-4#1)(2011-1#1)
methylate##4##1##(1992-3#1)(1994-8#1)(2008-10#2)
methylated CpG##2##2##(1990-8#1)(2008-4#1)
methylated DNA##7##2##(1991-9#1)(1993-11#1)(1995-5#5)
methylated and therefore##2##3##(1990-8#1)(1994-12#1)
methylated and##4##2##(1990-8#2)(1994-12#2)
methylated at##2##2##(2008-7#1)(2008-9#1)
methylated by##2##2##(2008-10#1)(2010-11#1)
methylated in the##2##3##(1994-12#1)(2008-7#1)
methylated in##6##2##(1994-12#1)(1997-4#1)(2008-4#1)(2008-7#3)
methylated or##2##2##(1990-11#1)(1997-4#1)
methylated species##2##2##(2008-10#2)
methylated##48##1##(1990-11#1)(1990-8#4)(1991-6#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#3)(1994-8#1)(1995-5#5)(1997-2#1)(1997-4#2)(2008-10#10)(2008-4#2)(2008-7#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-11#2)
methylation analysis revealed that##2##4##(1993-11#2)
methylation analysis##7##2##(1992-12#2)(1993-11#2)(1995-11#1)(2008-11#1)(2008-9#1)
methylation and##13##2##(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#2)
methylation at lysine##2##3##(2013-1#2)
methylation at##6##2##(1995-12#1)(1997-4#1)(2008-8#2)(2013-1#2)
methylation by##2##2##(1990-7#1)(2010-11#1)
methylation can be##2##3##(2008-4#1)(2009-4#1)
methylation during##3##2##(2009-3#1)(2013-1#2)
methylation in##5##2##(1992-9#1)(1993-6#1)(2007-11#1)(2011-1#1)(2013-8#1)
methylation is an##2##3##(2009-7#1)(2013-1#1)
methylation is##3##2##(1994-12#1)(2009-7#1)(2013-1#1)
methylation of 2-mercaptoethanol##2##3##(1994-8#2)
methylation of a##2##3##(1990-7#1)(1993-2#1)
methylation of several##2##3##(2008-7#1)(2012-12#1)
methylation of the CpG##2##4##(1995-2#1)(1997-4#1)
methylation of the##7##3##(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1997-4#1)(2008-9#1)
methylation of##27##2##(1990-7#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#5)(1995-2#2)(1997-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
methylation on the##2##3##(1994-5#1)(2009-12#1)
methylation on##3##2##(1994-5#1)(2008-8#1)(2009-12#1)
methylation pattern##2##2##(1993-11#1)(2008-8#1)
methylation patterns##5##2##(1995-12#1)(1997-4#1)(2008-7#2)(2011-2#1)
methylation reactions##4##2##(1990-7#1)(1993-6#1)(1993-9#1)(2008-10#1)
methylation to##3##2##(1994-8#1)(2012-12#1)(2013-1#1)
methylation##137##1##(1990-5#2)(1990-7#4)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#9)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-8#1)(1997-2#1)(1997-4#6)(2007-11#5)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#5)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#1)(2010-11#3)(2011-1#1)(2011-2#6)(2011-9#2)(2012-12#5)(2012-2#1)(2013-1#7)(2013-8#3)
methylation-dependent##3##1##(2007-11#2)(2013-8#1)
methylation-sensitive##5##1##(1995-12#1)(1995-2#1)(2007-11#1)(2008-4#1)(2008-7#1)
methylation-specific PCR##2##2##(2008-7#2)
methylations##2##1##(1997-4#1)(2009-12#1)
methylcellulose##4##1##(1995-2#3)(2011-2#1)
methylchloroform##2##1##(1992-3#2)
methylcobalamin##3##1##(2008-10#1)(2010-1#2)
methylcoumarin acetate (MCA)##2##3##(1992-3#1)(1995-6#1)
methylcytosine binding##2##2##(2011-2#2)
methylcytosine##3##1##(2009-3#1)(2011-2#2)
methyldopa and dopamine##4##3##(2008-10#4)
methyldopa in##2##2##(2008-10#2)
methyldopa##12##1##(2008-10#11)(2008-11#1)
methylene bis-benzotriazolyl tetramethylbutylphenol##2##3##(2008-5#2)
methylene blue (MB)##12##3##(2008-10#12)
methylene blue dye##2##3##(2008-10#1)(2008-3#1)
methylene blue in##2##3##(2008-10#1)(2008-2#1)
methylene blue##40##2##(1991-9#1)(1993-8#2)(2008-10#27)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
methylene chloride##10##2##(1996-5#1)(2008-10#7)(2008-2#1)(2011-1#1)
methylene green##2##2##(2008-10#2)
methylene group in the##2##4##(1990-11#1)(2008-10#1)
methylene group in##3##3##(1990-11#1)(1997-1#1)(2008-10#1)
methylene group of##3##3##(1990-7#1)(1997-1#1)(2008-10#1)
methylene group##12##2##(1990-11#1)(1990-7#1)(1995-3#1)(1997-1#2)(1997-3#1)(2008-10#5)(2011-2#1)
methylene groups##4##2##(2007-11#1)(2008-10#2)(2008-5#1)
methylene##84##1##(1990-11#1)(1990-7#2)(1991-9#1)(1992-11#1)(1993-8#2)(1995-3#1)(1996-5#1)(1997-1#4)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#50)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
methylene] thiocarbonohydrazide##2##2##(2008-10#2)
methylenebis(phosphonate)##3##1##(2008-4#3)
methylenetetrahydrofolate reductase##2##2##(2008-11#1)(2012-3#1)
methylenetetrahydrofolate##3##1##(1990-7#1)(2008-11#1)(2012-3#1)
methylglucose##2##1##(2012-2#2)
methylglyoxal##10##1##(1992-5#1)(1992-8#1)(2008-10#1)(2008-11#7)
methylhydrazine##2##1##(1996-5#1)(2007-11#1)
methylisocyanide##2##1##(1990-8#2)
methylmalonic##2##1##(1993-12#1)(2008-10#1)
methylmercaptan##2##1##(2008-6#2)
methylmercuric chloride##3##2##(2006-6#1)(2008-7#2)
methylmercuric##4##1##(2006-6#2)(2008-7#2)
methylmercury and##3##2##(2008-10#3)
methylmercury chloride##3##2##(2008-10#3)
methylmercury##20##1##(2008-10#20)
methylmethacrylate##3##1##(2008-6#3)
methylotrophic yeast Pichia pastoris##6##4##(1994-11#1)(1994-3#1)(1997-4#1)(1997-7#1)(2008-7#1)(2009-9#1)
methylotrophic yeast##12##2##(1994-11#2)(1994-3#1)(1995-8#1)(1997-4#4)(1997-7#1)(2008-7#1)(2009-9#1)(2010-5#1)
methylotropic yeast##2##2##(1995-8#1)(2010-5#1)
methylparaben and thimerosal##2##3##(2008-10#2)
methylparaben and##3##2##(2008-10#3)
methylparaben##9##1##(2008-10#8)(2008-5#1)
methylphenidate (Ritalin)##3##2##(2008-9#3)
methylphenidate hydrochloride##3##2##(1995-11#3)
methylphenidate##17##1##(1995-11#6)(2006-10#1)(2008-9#4)(2011-2#4)(2012-2#2)
methylprednisolone and##3##2##(1996-11#1)(2011-2#1)(2013-8#1)
methylprednisolone##15##1##(1993-6#1)(1996-11#1)(2007-7#2)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
methylprednisolone]##2##1##(1992-5#1)(2012-2#1)
methylpyrrolidone and pyridine##3##3##(2008-10#3)
methylpyrrolidone##4##1##(2008-10#4)
methylthiohydantoin-glycine##2##1##(2008-10#2)
methylthiotriazines and one##2##3##(2008-10#2)
methylthymol blue##3##2##(2008-10#3)
methyltransferase (S-adenosyl-L-methionine##2##2##(1994-8#2)
methyltransferase activity##3##2##(1991-9#2)(1993-8#1)
methyltransferase and##2##2##(1991-2#1)(1994-8#1)
methyltransferase in the##2##3##(1991-9#1)(1994-8#1)
methyltransferase in##5##2##(1991-9#1)(1994-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
methyltransferase##39##1##(1990-5#1)(1991-12#3)(1991-2#2)(1991-9#5)(1992-3#3)(1993-8#3)(1993-9#1)(1994-12#1)(1994-8#7)(1994-9#1)(2007-11#3)(2008-10#3)(2008-5#1)(2008-9#1)(2009-3#1)(2010-11#1)(2013-1#2)
methyltransferase-DNA interactions beyond the site of substitution##2##7##(1992-3#2)
methyltransferase-DNA interactions##5##2##(1992-3#5)
methyltransferase-DNA##6##1##(1992-3#6)
methyltransferases##3##1##(2008-5#1)(2009-7#1)(2011-2#1)
methyltrienolone (R1881)##2##2##(1990-11#1)(1991-5#1)
methyltrioctylammonium##2##1##(2008-10#2)
methylxanthines##4##1##(2008-10#4)
meticlorpindol/methylbenzoquate##3##1##(2007-6#3)
meticulous and##3##2##(2008-10#1)(2008-2#1)(2010-12#1)
meticulous surgical technique##2##3##(1991-3#1)(2013-1#1)
meticulous##12##1##(1991-2#1)(1991-3#1)(1992-11#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
meticulously##2##1##(1991-3#1)(2011-2#1)
metoclopramide (MCP)##2##2##(1995-5#1)(2008-10#1)
metoclopramide and tetracaine hydrochloride##3##4##(2008-10#3)
metoclopramide##26##1##(1990-6#1)(1995-5#1)(2008-10#15)(2008-7#1)(2012-12#8)
metod##2##1##(2007-11#1)(2008-10#1)
metol-sulphanilamide##2##1##(2008-10#2)
metoprolol tartrate##2##2##(2012-2#2)
metoprolol were##2##2##(1995-6#1)(1997-7#1)
metoprolol##19##1##(1992-8#1)(1994-9#1)(1995-6#2)(1996-3#3)(1997-7#2)(2008-10#2)(2010-4#6)(2012-2#2)
metribuzin##6##1##(2008-10#5)(2011-2#1)
metric for optical##2##3##(2008-2#1)(2008-3#1)
metric for##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
metric is presented##2##3##(2007-11#1)(2008-3#1)
metric is##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
metric parameters##2##2##(1995-5#1)(2011-2#1)
metric that##2##2##(2008-2#1)(2008-5#1)
metric with##2##2##(2007-12#1)(2008-3#1)
metric##31##1##(1992-6#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#7)(2008-5#1)(2008-6#4)(2008-9#1)(2009-10#2)(2010-11#1)(2011-2#1)(2012-1#1)
metrics (GMTF##2##2##(2011-1#2)
metrics and##2##2##(2011-2#1)(2012-2#1)
metrics are##2##2##(2008-2#2)
metrics for##5##2##(2007-11#1)(2008-2#3)(2012-12#1)
metrics of##4##2##(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
metrics used to##2##3##(2008-8#1)(2011-1#1)
metrics were selected to track success of pilots and eventual implementation##2##11##(2012-2#2)
metrics##36##1##(1995-3#1)(2007-11#2)(2008-10#2)(2008-2#10)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#1)
metrological##4##1##(2008-10#2)(2008-3#2)
metrologies##2##1##(2008-3#1)(2012-2#1)
metrology and##2##2##(2007-12#1)(2008-5#1)
metrology applications##2##2##(2008-3#2)
metrology in##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
metrology of##2##2##(2008-3#2)
metrology system##2##2##(2008-2#1)(2008-3#1)
metrology##32##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#19)(2008-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
metronidazole and##3##2##(1997-4#1)(2008-12#2)
metronidazole in##3##2##(2008-10#2)(2011-2#1)
metronidazole on##2##2##(1996-6#1)(2008-10#1)
metronidazole resistance##4##2##(1997-7#4)
metronidazole was##2##2##(2008-12#1)(2011-2#1)
metronidazole##38##1##(1996-11#1)(1996-3#1)(1996-6#5)(1997-4#2)(1997-7#4)(2007-6#1)(2008-10#11)(2008-12#3)(2010-12#1)(2011-2#9)
metronome##2##1##(2010-9#1)(2012-2#1)
metroplasty##5##1##(1994-9#5)
metropolis of##3##2##(2010-4#1)(2012-3#1)(2013-7#1)
metropolis##4##1##(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
metropolitan Toronto##2##2##(1992-3#1)(2007-12#1)
metropolitan area in the##2##4##(1993-6#1)(2007-9#1)
metropolitan area##8##2##(1991-6#1)(1993-6#1)(1995-3#1)(1997-8#1)(2007-9#1)(2008-5#1)(2011-1#1)(2013-1#1)
metropolitan areas##11##2##(1991-2#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#2)(1996-3#1)(2008-10#1)(2011-2#2)
metropolitan hospital##2##2##(1994-2#1)(2012-12#1)
metropolitan##40##1##(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-1#2)(1996-3#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
metrorrhagia##2##1##(1994-9#1)(2011-1#1)
metyrapone##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
mev-1##4##1##(2008-3#4)
mevalonate (MVA)##2##2##(1995-12#1)(2012-2#1)
mevalonate was##2##2##(1990-12#1)(1995-12#1)
mevalonate##7##1##(1990-12#3)(1993-8#1)(1995-12#2)(2012-2#1)
mevalonate-5-diphosphate decarboxylase##2##2##(1991-12#2)
mevalonic##2##1##(1993-8#1)(1995-12#1)
mevastatin##2##1##(2008-10#2)
mexicana##3##1##(2008-5#1)(2013-1#2)
mexicanus##4##1##(2008-5#2)(2008-8#2)
meyeriana (Zoll##2##2##(2008-8#2)
meyeriana Baill##2##2##(2008-8#2)
meyeriana##6##1##(2008-8#6)
mfa1 and##2##2##(2008-10#2)
mfa1##4##1##(2008-10#4)
mg (7##2##2##(1994-12#1)(1996-3#1)
mg (KOH) g(-1) (oil)##2##4##(2008-10#2)
mg (g##2##2##(2008-5#2)
mg / kg bw)##2##4##(2013-1#2)
mg 1##2##2##(2008-10#2)
mg Cr##2##2##(2008-10#2)
mg DBTC/L##4##2##(2008-10#4)
mg DBTC/kg BW##3##3##(2008-10#3)
mg DBTC/kg##4##2##(2008-10#4)
mg L(-1) 2##3##3##(2008-12#3)
mg L(-1) BA)##2##3##(2008-12#2)
mg L(-1) BAP + 0##2##5##(2008-12#2)
mg L(-1) BAP##4##3##(2008-12#4)
mg L(-1) NAA and##2##4##(2008-12#2)
mg L(-1) NAA##3##3##(2008-12#3)
mg L(-1) for##5##3##(2008-10#5)
mg L(-1) of N##3##4##(2008-10#3)
mg L(-1)##31##2##(2008-10#10)(2008-11#1)(2008-12#15)(2008-7#1)(2010-5#2)(2012-12#2)
mg L(-1))##4##2##(2008-11#1)(2008-12#3)
mg L-1 at##2##3##(2008-11#2)
mg M/kg feed##2##3##(2008-5#2)
mg M/kg##8##2##(2008-5#8)
mg O(2) kg(-1) m(-1))##2##4##(2010-8#2)
mg Pl(-1) for both##2##4##(2008-10#2)
mg Sb##2##2##(2008-10#2)
mg TNT/kg and the EC50(28d)##2##5##(2008-11#2)
mg TNT/kg soil##2##3##(2008-11#2)
mg TNT/kg##4##2##(2008-11#4)
mg ammonium##2##2##(2008-10#2)
mg and##15##2##(1991-11#1)(1991-3#1)(1993-2#3)(1993-3#1)(1994-11#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)
mg aspirin daily##2##3##(1991-11#2)
mg aspirin##4##2##(1991-11#3)(2008-8#1)
mg at##2##2##(1990-2#1)(2007-7#1)
mg bromodichloromethane/kg body weight in##3##5##(2008-9#3)
mg bromodichloromethane/kg body weight##4##4##(2008-9#4)
mg captopril##2##2##(1990-11#1)(1992-5#1)
mg clopidogrel##2##2##(2011-2#2)
mg cm(-2) is##2##3##(2008-5#2)
mg cm(-2)##5##2##(2008-5#5)
mg concentration##2##2##(2011-1#1)(2012-2#1)
mg daily for##4##3##(1990-5#1)(1990-8#1)(2007-10#1)(2008-1#1)
mg daily##12##2##(1990-11#3)(1990-5#1)(1990-8#1)(1994-3#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
mg daily) and##2##3##(1990-11#1)(1994-3#1)
mg daily)##9##2##(1990-11#1)(1992-11#1)(1992-5#1)(1994-3#1)(1995-3#1)(2006-10#1)(2009-11#1)(2013-1#2)
mg dexamethasone##2##2##(2007-7#1)(2011-2#1)
mg dichloroacetic acid/kg body weight##2##5##(2008-9#2)
mg dicyclohexylcarbodiimide or less revealed treatment-related lesions of the skin at the site of application including epidermal hyperplasia##2##18##(2008-9#2)
mg dicyclohexylcarbodiimide##4##2##(2008-9#4)
mg dicyclohexylcarbodiimide/kg body weight in ethanol##4##6##(2008-9#4)
mg dissolved in##2##3##(1996-12#2)
mg dm(-3)##2##2##(2008-10#2)
mg dose of##3##3##(1993-2#1)(2008-3#1)(2008-5#1)
mg dose##4##2##(1993-2#1)(2008-3#1)(2008-5#2)
mg doses##2##2##(1997-7#1)(2008-5#1)
mg equol/kg/day)##2##2##(2010-1#2)
mg for the##2##3##(1992-12#1)(2007-7#1)
mg for##5##2##(1992-12#2)(1993-2#1)(2007-10#1)(2007-7#1)
mg fresh tissue##3##3##(1996-12#3)
mg fresh##4##2##(1996-12#4)
mg g(-1) (RSD = 3%) for carbon##2##7##(2008-10#2)
mg g(-1) for Ni(II)##2##4##(2008-10#2)
mg g(-1) for Pb(II)##4##4##(2008-10#4)
mg g(-1) for##9##3##(2008-10#9)
mg g(-1)##15##2##(2008-10#14)(2009-11#1)
mg groups##3##2##(2008-9#3)
mg in##4##2##(1995-12#2)(2008-11#1)(2011-2#1)
mg kg(-1) DW##3##3##(2008-12#3)
mg kg(-1) and##2##3##(2008-10#1)(2012-2#1)
mg kg(-1) body##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
mg kg(-1) bw##3##3##(2008-10#3)
mg kg(-1) daily##2##3##(2008-12#2)
mg kg(-1) for##6##3##(2008-12#6)
mg kg(-1) i##3##3##(2008-12#3)
mg kg(-1) of##2##3##(2008-10#1)(2008-11#1)
mg kg(-1)##45##2##(2008-10#18)(2008-11#1)(2008-12#21)(2009-8#1)(2011-1#1)(2012-2#3)
mg kg(-1)) and##3##3##(2008-12#3)
mg kg(-1)) concentrations##2##3##(2008-12#2)
mg kg(-1))##13##2##(1997-4#1)(2008-10#3)(2008-12#9)
mg kg-1##8##2##(1995-12#2)(1995-5#5)(1997-2#1)
mg kg-1)##2##2##(1995-12#2)
mg l(-1) AsA##2##3##(2008-10#2)
mg l(-1) COD (n=11)##2##4##(2008-10#2)
mg l(-1) CPL##2##3##(2008-10#2)
mg l(-1) Cl##3##3##(2008-10#3)
mg l(-1) P(2)O(5) and##2##4##(2008-10#2)
mg l(-1) S(2-)##2##3##(2008-10#2)
mg l(-1) and a##2##4##(2008-10#2)
mg l(-1) and c(L##2##4##(2008-10#2)
mg l(-1) and the##4##4##(2008-10#4)
mg l(-1) and##12##3##(2008-10#12)
mg l(-1) chloride##2##3##(2008-10#2)
mg l(-1) copper##3##3##(2008-10#3)
mg l(-1) for copper##2##4##(2008-10#2)
mg l(-1) for the##2##4##(2008-10#2)
mg l(-1) for##16##3##(2008-10#16)
mg l(-1) in##4##3##(2008-10#4)
mg l(-1) level)##6##3##(2008-10#6)
mg l(-1) of ET##3##4##(2008-10#3)
mg l(-1) of Ponceau 4R##2##5##(2008-10#2)
mg l(-1) of Sunset Yellow##2##5##(2008-10#2)
mg l(-1) of Tartrazine##2##4##(2008-10#2)
mg l(-1) of##23##3##(2008-10#23)
mg l(-1) was obtained##2##4##(2008-10#2)
mg l(-1) was##3##3##(2008-10#3)
mg l(-1) with a##4##4##(2008-10#4)
mg l(-1) with an##2##4##(2008-10#2)
mg l(-1) with the##2##4##(2008-10#2)
mg l(-1) with##9##3##(2008-10#9)
mg l(-1)##194##2##(2008-10#190)(2008-11#4)
mg l(-1)) and##2##3##(2008-10#2)
mg l(-1)) individually##2##3##(2008-10#2)
mg l(-1)) was quite satisfactory##2##5##(2008-10#2)
mg l(-1)) was##5##3##(2008-10#5)
mg l(-1)) were##2##3##(2008-10#2)
mg l(-1))##25##2##(2008-10#24)(2008-11#1)
mg l-1##3##2##(2008-11#3)
mg m(-2) weekm(-1)##2##3##(2008-6#2)
mg m(-2)##3##2##(2008-6#3)
mg m(-3)##4##2##(2008-3#4)
mg mL(-1)##9##2##(2008-10#2)(2008-12#2)(2008-5#5)
mg ml(-1) and##3##3##(2008-10#3)
mg ml(-1) for##2##3##(2008-10#2)
mg ml(-1) in##2##3##(2008-10#1)(2008-11#1)
mg ml(-1) solution (pH##2##4##(2008-10#2)
mg ml(-1) solution##3##3##(2008-10#3)
mg ml(-1)##16##2##(2008-10#13)(2008-11#3)
mg ml(-1))##2##2##(2008-10#2)
mg ml-1)##2##2##(1992-3#2)
mg of C(60) and##2##4##(2008-10#2)
mg of C(70) in##2##4##(2008-10#2)
mg of protein##3##3##(2008-2#1)(2008-7#1)(2010-7#1)
mg of the##7##3##(1995-5#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-1#1)
mg of##80##2##(1990-3#1)(1990-5#3)(1991-11#1)(1991-3#1)(1992-12#1)(1992-8#2)(1993-1#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-10#22)(2008-11#10)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#3)(2009-4#1)(2010-12#4)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
mg on day##2##3##(1991-8#1)(2007-10#1)
mg on##3##2##(1991-8#1)(2007-10#1)(2009-12#1)
mg or##3##2##(1991-3#1)(1994-11#1)(2008-5#1)
mg orally##2##2##(1996-5#1)(2007-8#1)
mg pentaerythritol triacrylate/kg body weight in acetone 5 days per week for##4##12##(2008-9#4)
mg pentaerythritol##5##2##(2008-9#5)
mg per day##3##3##(2008-3#1)(2008-7#1)(2012-12#1)
mg per tablet)##2##3##(2008-10#2)
mg per##14##2##(1991-2#1)(1991-3#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-12#1)
mg prot-1##2##2##(1992-3#2)
mg sodium##3##2##(2008-9#3)
mg t##2##2##(1990-12#1)(1991-2#1)
mg three times daily)##2##4##(1991-9#1)(1995-3#1)
mg three times##3##3##(1991-9#1)(1995-3#1)(2012-12#1)
mg tid##2##2##(1994-6#1)(2008-5#1)
mg to##3##2##(1996-3#1)(2006-10#1)(2008-10#1)
mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for##5##12##(2008-9#5)
mg twice a##2##3##(1993-1#1)(2010-6#1)
mg twice daily##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
mg twice##5##2##(1993-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
mg were##2##2##(2008-10#1)(2008-11#1)
mg x L(-1))##4##3##(2011-3#4)
mg x kg(-1) and &lt##3##5##(2013-8#3)
mg x kg(-1) and##4##4##(2013-8#4)
mg x kg(-1) for##3##4##(2013-8#3)
mg x kg(-1)##9##3##(2013-8#9)
mg x##18##2##(2011-2#3)(2011-3#5)(2013-8#10)
mg##910##1##(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#3)(1990-9#4)(1991-11#6)(1991-12#1)(1991-2#5)(1991-3#7)(1991-4#1)(1991-5#6)(1991-6#6)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#6)(1992-5#3)(1992-8#3)(1993-1#2)(1993-12#5)(1993-2#11)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#7)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#5)(1995-11#2)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#6)(1995-8#2)(1996-11#3)(1996-12#6)(1996-3#3)(1996-5#4)(1997-1#1)(1997-2#2)(1997-4#13)(1997-6#7)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#11)(2007-11#1)(2007-7#6)(2007-8#2)(2008-1#6)(2008-10#375)(2008-11#40)(2008-12#59)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#45)(2008-6#5)(2008-7#17)(2008-8#3)(2008-9#39)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-12#7)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#27)(2011-3#5)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#12)
mg%##4##1##(2008-10#2)(2009-11#2)
mg(-1)##10##1##(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2009-2#1)(2010-7#1)
mg) and##8##2##(1990-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#2)
mg) compared with the##2##4##(2011-2#2)
mg) in##3##2##(1992-12#2)(2008-7#1)
mg) of##3##2##(1990-11#1)(2008-11#1)(2008-12#1)
mg) or##3##2##(1992-8#1)(2007-10#1)(2010-6#1)
mg) orally##2##2##(2008-5#1)(2010-6#1)
mg) was##2##2##(1990-12#1)(2008-7#1)
mg) were##4##2##(1995-2#2)(2008-10#1)(2009-4#1)
mg)##55##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#3)(1991-5#1)(1991-8#1)(1992-12#2)(1992-8#2)(1993-1#1)(1995-12#2)(1995-2#2)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#2)(2009-4#3)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#1)
mg-1##8##1##(1990-11#2)(1990-7#1)(1992-6#1)(1994-11#1)(1996-2#1)(1996-5#2)
mg-1)##3##1##(1991-3#1)(1996-5#2)
mg/0##3##1##(2011-2#3)
mg/1##4##1##(1995-12#1)(2008-1#2)(2008-12#1)
mg/100 ml for##2##3##(2008-7#2)
mg/100 ml##3##2##(2008-10#1)(2008-7#2)
mg/6##2##1##(1993-2#2)
mg/L (final concentration in the chemostat) formaldehyde to the chemostat##2##10##(2008-7#2)
mg/L female##2##2##(2008-9#2)
mg/L females and##3##3##(2008-9#3)
mg/L females at##4##3##(2008-9#4)
mg/L females were less than##2##5##(2008-9#2)
mg/L females were less##3##4##(2008-9#3)
mg/L females were significantly##3##4##(2008-9#3)
mg/L females were##7##3##(2008-9#7)
mg/L females##16##2##(2008-9#16)
mg/L for 1##3##3##(2008-10#2)(2008-9#1)
mg/L for catechol##2##3##(2008-10#2)
mg/L for hydroquinone##2##3##(2008-10#2)
mg/L for resorcinol and##2##4##(2008-10#2)
mg/L for##14##2##(2008-10#8)(2008-8#1)(2008-9#5)
mg/L males and females were less than those of the##2##10##(2008-9#2)
mg/L males and females were##3##5##(2008-9#3)
mg/L males and females##8##4##(2008-9#8)
mg/L males and##10##3##(2008-9#10)
mg/L males##24##2##(2008-9#24)
mg/L respectively##2##2##(2011-1#1)(2011-2#1)
mg/L to##2##2##(2008-1#1)(2013-1#1)
mg/L was##2##2##(2008-7#1)(2008-9#1)
mg/L with the correlation##2##4##(2011-1#2)
mg/L##105##1##(1990-8#1)(2007-10#3)(2008-1#2)(2008-10#9)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#63)(2009-8#1)(2011-1#6)(2011-2#1)(2013-1#1)
mg/L) and##2##2##(2008-7#1)(2013-1#1)
mg/L) gave the highest potentiality of shoot##2##7##(2013-1#2)
mg/L)##17##1##(2008-6#1)(2008-7#6)(2010-4#2)(2011-2#1)(2013-1#7)
mg/body of##5##2##(1994-7#5)
mg/body##6##1##(1994-7#5)(2008-10#1)
mg/cm(2) and##3##2##(2009-12#3)
mg/cm(2) before and after acclimatization in July and September##2##9##(2009-12#2)
mg/cm(2) before##3##2##(2009-12#3)
mg/cm(2)##6##1##(2009-12#6)
mg/d##2##1##(2013-1#2)
mg/d) for##2##2##(1991-11#2)
mg/d)##7##1##(1990-11#1)(1991-11#2)(2008-5#1)(2013-1#3)
mg/dL (normal##2##2##(2013-1#2)
mg/dL (p &lt##2##3##(2006-10#1)(2008-3#1)
mg/dL (p = 0##4##4##(2008-3#2)(2012-3#2)
mg/dL (p##6##2##(2006-10#1)(2008-3#3)(2012-3#2)
mg/dL to##2##2##(2008-7#2)
mg/dL was##2##2##(2010-2#1)(2011-2#1)
mg/dL##26##1##(1997-3#1)(2006-10#2)(2007-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2010-2#2)(2011-1#3)(2011-2#1)(2012-3#5)(2013-1#2)
mg/dL)##4##1##(2008-5#1)(2008-7#1)(2013-1#2)
mg/day and##2##2##(1992-8#1)(2008-5#1)
mg/day for 2 weeks##2##4##(1992-8#2)
mg/day for 2##3##3##(1992-8#3)
mg/day for##4##2##(1992-8#3)(2008-1#1)
mg/day of##4##2##(1990-3#1)(2008-5#3)
mg/day orally##2##2##(1990-2#1)(1992-12#1)
mg/day was##2##2##(2007-8#1)(2008-5#1)
mg/day with##3##2##(1993-1#1)(1994-7#1)(2008-5#1)
mg/day##48##1##(1990-2#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#6)(1992-9#1)(1993-1#2)(1994-7#3)(1996-7#1)(1997-7#3)(2006-10#2)(2007-8#1)(2008-1#8)(2008-3#1)(2008-5#13)(2011-2#1)(2012-2#1)
mg/day) and##4##2##(2006-10#1)(2008-2#1)(2008-6#1)(2011-1#1)
mg/day)##20##1##(1991-11#1)(1991-9#1)(2006-10#2)(2008-1#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
mg/die##2##1##(1991-6#2)
mg/die)##2##1##(1990-3#2)
mg/dl (5##3##2##(1990-2#3)
mg/dl and##6##2##(1993-12#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-7#1)(2013-8#1)
mg/dl##33##1##(1990-2#6)(1993-12#2)(1993-3#2)(1994-11#2)(1994-12#3)(2007-5#1)(2008-1#4)(2008-10#4)(2008-3#1)(2008-7#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
mg/dl) and##6##2##(1990-12#1)(1991-11#3)(1992-11#1)(1995-3#1)
mg/dl)##15##1##(1990-12#1)(1991-11#7)(1992-11#1)(1993-12#2)(1995-3#1)(2011-1#1)(2012-3#2)
mg/g##8##1##(1990-2#3)(1997-3#1)(2008-10#2)(2008-7#1)(2011-2#1)
mg/g)##2##1##(2010-4#2)
mg/g-cell/h##3##1##(2008-6#3)
mg/h##6##1##(1992-5#2)(1995-11#1)(1997-8#1)(2007-8#1)(2008-11#1)
mg/kg B##4##2##(2013-1#4)
mg/kg BW##3##2##(2012-3#2)(2013-8#1)
mg/kg BW) for##2##3##(2012-3#2)
mg/kg BW)##4##2##(2012-3#4)
mg/kg L-deprenyl##2##2##(1994-6#2)
mg/kg NBQX significantly##2##3##(1994-2#2)
mg/kg NBQX##3##2##(1994-2#3)
mg/kg THC##2##2##(1991-10#2)
mg/kg amphetamine in Experiment##2##4##(1994-2#2)
mg/kg and the##3##3##(1992-11#1)(2008-9#1)(2012-2#1)
mg/kg and##12##2##(1992-11#1)(1993-3#1)(1996-2#1)(2008-10#1)(2008-9#4)(2011-1#1)(2012-2#3)
mg/kg animals##2##2##(2008-9#2)
mg/kg at##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
mg/kg b##11##2##(1992-12#1)(1992-8#1)(2010-1#2)(2011-1#2)(2013-1#5)
mg/kg body weight significantly reduced the##2##6##(2008-4#2)
mg/kg body weight##11##3##(1994-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-7#2)(2012-3#1)
mg/kg body weight) was##2##4##(1997-6#1)(2008-10#1)
mg/kg body weight)##5##3##(1997-6#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
mg/kg body wt##10##3##(1992-2#1)(1992-5#4)(1993-11#1)(1995-3#2)(2013-1#2)
mg/kg body##27##2##(1992-2#1)(1992-5#4)(1993-11#2)(1994-6#1)(1995-3#2)(1997-6#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-4#3)(2008-7#2)(2012-2#1)(2012-3#1)(2013-1#3)
mg/kg bw/day##3##2##(2008-7#3)
mg/kg dry soil##2##3##(2008-11#2)
mg/kg every##2##2##(1993-3#1)(2008-10#1)
mg/kg female##3##2##(2008-9#3)
mg/kg females and##5##3##(2008-9#5)
mg/kg females at##2##3##(2008-9#2)
mg/kg females had##2##3##(2008-9#2)
mg/kg females was significantly greater than that in the vehicle##2##10##(2008-9#2)
mg/kg females was significantly greater##3##5##(2008-9#3)
mg/kg females was##4##3##(2008-9#4)
mg/kg females were decreased##2##4##(2008-9#2)
mg/kg females were greater than those of the vehicle controls##2##10##(2008-9#2)
mg/kg females were significantly increased##2##5##(2008-9#2)
mg/kg females were significantly##5##4##(2008-9#5)
mg/kg females were##10##3##(2008-9#10)
mg/kg females##34##2##(2008-9#34)
mg/kg flupirtine##2##2##(1995-12#2)
mg/kg for##5##2##(1995-12#2)(2008-10#1)(2008-9#1)(2011-1#1)
mg/kg group##10##2##(2008-9#10)
mg/kg groups##5##2##(1996-12#1)(2008-9#4)
mg/kg i##44##2##(1990-5#1)(1991-2#2)(1991-6#1)(1992-3#11)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#10)(1996-2#9)(1997-6#1)(1997-7#5)
mg/kg in ethanol##3##3##(2008-9#3)
mg/kg in grain from field trials and from 0##2##9##(2008-10#2)
mg/kg in grain incubated in vitro##2##6##(2008-10#2)
mg/kg in grain##4##3##(2008-10#4)
mg/kg in the##2##3##(2008-10#1)(2011-1#1)
mg/kg in##14##2##(1991-9#2)(1994-8#1)(2008-10#5)(2008-9#5)(2011-1#1)
mg/kg induced##2##2##(1991-7#1)(1997-7#1)
mg/kg male and female##2##4##(2008-9#2)
mg/kg male##6##2##(2008-9#6)
mg/kg males and females at 26 weeks##2##7##(2008-9#2)
mg/kg males and females at##3##5##(2008-9#3)
mg/kg males and females##15##4##(2008-9#15)
mg/kg males and##22##3##(2008-9#22)
mg/kg males was##2##3##(2008-9#2)
mg/kg males were less than those of the vehicle##2##9##(2008-9#2)
mg/kg males were significantly greater than those of the vehicle controls##2##11##(2008-9#2)
mg/kg males were significantly greater than those##4##7##(2008-9#4)
mg/kg males were significantly less than those of the vehicle controls##3##11##(2008-9#3)
mg/kg males were significantly##8##4##(2008-9#8)
mg/kg males were##11##3##(2008-9#11)
mg/kg males##48##2##(2008-9#48)
mg/kg mice##2##2##(2008-9#2)
mg/kg of body##2##3##(1991-5#1)(1992-3#1)
mg/kg of##12##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-2#1)
mg/kg or greater females##3##4##(2008-9#3)
mg/kg or greater males and##2##5##(2008-9#2)
mg/kg or greater were significantly##2##5##(2008-9#2)
mg/kg or greater##12##3##(2008-9#12)
mg/kg or##15##2##(2008-4#1)(2008-9#14)
mg/kg p##4##2##(1997-7#3)(2008-11#1)
mg/kg per day for##2##4##(1992-3#1)(1995-3#1)
mg/kg per day##12##3##(1992-3#2)(1994-6#2)(1995-12#1)(1995-3#7)
mg/kg per day)##4##3##(1995-12#1)(1997-7#2)(2009-12#1)
mg/kg per##18##2##(1992-3#2)(1994-6#2)(1995-12#2)(1995-3#7)(1997-2#1)(1997-7#2)(2009-12#1)(2011-2#1)
mg/kg reduced##2##2##(2008-10#2)
mg/kg respectively##2##2##(1996-2#1)(2011-1#1)
mg/kg rocuronium##3##2##(2011-2#3)
mg/kg s##8##2##(1995-12#3)(1996-2#4)(1997-6#1)
mg/kg sc##3##2##(1994-6#1)(2008-10#2)
mg/kg to female mice)##2##4##(2008-9#2)
mg/kg to females##2##3##(2008-9#2)
mg/kg to females) for 40 weeks##4##6##(2008-8#2)(2008-9#2)
mg/kg to females)##11##3##(2008-8#3)(2008-9#8)
mg/kg to male mice and 15##2##6##(2008-9#2)
mg/kg to males and##9##4##(2008-8#2)(2008-9#7)
mg/kg to##26##2##(2008-8#5)(2008-9#21)
mg/kg was##3##2##(1990-6#1)(2012-2#1)(2013-1#1)
mg/kg were##2##2##(2008-9#1)(2011-2#1)
mg/kg x 3 pairings)##2##4##(1994-2#2)
mg/kg##534##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#2)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#17)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#9)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#3)(1995-11#1)(1995-12#27)(1995-3#17)(1996-12#6)(1996-2#20)(1996-5#1)(1997-2#8)(1997-4#2)(1997-6#6)(1997-7#13)(2006-10#2)(2007-7#4)(2008-1#2)(2008-10#32)(2008-11#12)(2008-12#2)(2008-2#1)(2008-4#8)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#170)(2009-12#1)(2010-1#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#11)(2011-2#16)(2012-2#10)(2012-3#9)(2013-1#18)(2013-8#1)
mg/kg) administration##2##2##(2011-2#1)(2013-1#1)
mg/kg) and D-amphetamine (2 mg/kg)##2##5##(1993-3#2)
mg/kg) and##16##2##(1990-7#1)(1991-7#1)(1992-8#1)(1993-3#3)(1995-12#3)(2007-10#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-1#2)(2011-2#1)
mg/kg) for##4##2##(2008-10#1)(2010-3#1)(2011-1#1)(2012-2#1)
mg/kg) had##2##2##(1995-12#1)(1995-2#1)
mg/kg) increased##2##2##(1997-7#1)(2011-2#1)
mg/kg) inhibited##2##2##(2008-10#1)(2008-6#1)
mg/kg) of##3##2##(2006-6#1)(2012-12#1)(2012-2#1)
mg/kg) on##2##2##(1991-10#1)(2012-2#1)
mg/kg) or saline##2##3##(1994-8#1)(2010-6#1)
mg/kg) or##7##2##(1991-12#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(2010-3#1)(2010-6#1)
mg/kg) significantly##2##2##(1993-3#1)(2011-2#1)
mg/kg) to##2##2##(1995-12#1)(1997-8#1)
mg/kg) was administered##2##3##(1994-2#1)(1995-12#1)
mg/kg) was##3##2##(1992-8#1)(1994-2#1)(1995-12#1)
mg/kg) were##4##2##(1992-9#1)(1993-3#1)(2011-1#1)(2012-2#1)
mg/kg)##111##1##(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#4)(1991-2#1)(1991-7#4)(1992-11#1)(1992-3#1)(1992-8#5)(1992-9#1)(1993-12#2)(1993-3#7)(1993-6#3)(1994-2#2)(1994-5#1)(1994-8#3)(1995-12#17)(1995-2#1)(1996-2#2)(1997-2#1)(1997-7#2)(1997-8#1)(2006-6#2)(2007-10#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-3#4)(2010-6#1)(2011-1#5)(2011-2#9)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#4)
mg/kg/24 h)##2##2##(2011-2#2)
mg/kg/d)##2##1##(2008-6#2)
mg/kg/day for##6##2##(1992-10#3)(1995-11#2)(2008-8#1)
mg/kg/day of##5##2##(1994-6#1)(1995-8#1)(2011-2#3)
mg/kg/day##27##1##(1991-5#1)(1992-10#4)(1992-11#3)(1994-6#1)(1995-11#2)(1995-8#3)(2008-8#1)(2009-12#1)(2010-1#3)(2011-1#1)(2011-2#7)
mg/kg/day)##8##1##(1994-2#1)(1995-12#1)(2008-10#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
mg/kg/min##2##1##(2008-3#2)
mg/l and##5##2##(1990-12#1)(1993-12#1)(1995-11#1)(2008-7#1)(2011-1#1)
mg/l extremity volume)##2##3##(2008-6#2)
mg/l of##3##2##(1990-12#1)(1993-8#1)(1995-11#1)
mg/l respectively##2##2##(2008-1#1)(2008-7#1)
mg/l was##2##2##(2008-7#1)(2012-2#1)
mg/l with a detection limit##2##5##(2008-10#2)
mg/l##43##1##(1990-12#3)(1990-2#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-8#1)(1995-11#4)(1995-2#1)(1996-8#1)(2007-7#4)(2008-1#1)(2008-10#10)(2008-12#1)(2008-6#2)(2008-7#5)(2011-1#1)(2012-2#1)(2013-1#3)
mg/l)##8##1##(1991-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(1996-8#1)(2008-10#2)(2008-7#1)
mg/liter and##4##2##(2008-10#3)(2011-2#1)
mg/liter##22##1##(2008-10#21)(2011-2#1)
mg/m 2 per##2##3##(2007-7#2)
mg/m 2##3##2##(2007-7#3)
mg/m##4##1##(1990-2#1)(2007-7#3)
mg/m(2) of##3##2##(1994-7#2)(1997-7#1)
mg/m(2) or##2##2##(2008-6#1)(2009-4#1)
mg/m(2)##20##1##(1994-7#2)(1997-7#1)(2007-10#2)(2008-3#1)(2008-6#11)(2009-4#2)(2012-1#1)
mg/m(2)) was##2##2##(1997-3#1)(2008-6#1)
mg/m(2))##4##1##(1997-3#1)(2008-6#3)
mg/m(2)/day##3##1##(2007-10#1)(2008-7#1)(2009-12#1)
mg/m(3)##3##1##(2008-10#2)(2008-3#1)
mg/m2 every##2##2##(1991-6#2)
mg/m2 i##9##2##(1990-2#3)(1991-2#1)(1991-6#3)(1992-2#2)
mg/m2 melphalan##2##2##(1991-5#2)
mg/m2 on day##2##3##(1991-4#2)
mg/m2 over##2##2##(2010-3#2)
mg/m2##37##1##(1990-10#2)(1990-12#2)(1990-2#5)(1991-2#4)(1991-4#5)(1991-5#3)(1991-6#5)(1992-12#5)(1992-2#2)(1994-8#1)(2008-5#1)(2010-3#2)
mg/m2)##10##1##(1990-12#1)(1990-2#1)(1990-6#2)(1992-10#2)(1992-8#4)
mg/m2/24##2##1##(1991-3#2)
mg/mL##13##1##(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#6)(2011-1#1)(2011-2#2)(2012-3#1)
mg/ml for##2##2##(2012-2#2)
mg/ml in##3##2##(1990-12#1)(2008-5#1)(2011-1#1)
mg/ml of##2##2##(2008-5#2)
mg/ml##28##1##(1990-12#1)(1990-9#1)(1991-5#1)(1992-9#1)(1994-12#1)(1995-11#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#4)(2008-7#2)(2008-9#1)(2011-1#2)(2012-2#2)(2012-3#3)
mg/ml) in##2##2##(1995-12#1)(2008-7#1)
mg/ml) was##2##2##(1992-3#2)
mg/ml)##11##1##(1992-3#3)(1994-9#1)(1995-12#2)(2008-7#1)(2011-1#1)(2012-3#3)
mg/patch level##2##2##(2008-5#2)
mg/rat) and##2##2##(1997-4#2)
mg/week##3##1##(1991-2#1)(2012-2#2)
mgCl(2)l(-1)##2##1##(2008-10#2)
mgL(-1))##2##1##(2008-10#1)(2013-1#1)
mgkg(-1)##5##1##(2008-10#5)
mgl(-1) (0##3##2##(2008-10#3)
mgl(-1)##20##1##(2008-10#18)(2008-11#2)
mgr##39##1##(1996-2#26)(1997-7#13)
mgs##2##1##(1996-3#2)
mgxl(-1) and##2##2##(2008-5#2)
mgxl(-1)##6##1##(2008-5#6)
miR-210 levels were##2##3##(2012-3#2)
miR-210##6##1##(2012-3#6)
miR-218##3##1##(2011-2#3)
miR-30 family of##2##3##(2010-11#2)
miR-30 family##3##2##(2010-11#3)
miR-541##5##1##(2013-1#5)
miRNA biogenesis##2##2##(2008-11#1)(2013-1#1)
miRNA can bind##2##3##(2011-2#2)
miRNA can##3##2##(2008-11#1)(2011-2#2)
miRNA expression in##3##3##(2013-1#3)
miRNA expression##11##2##(2008-11#1)(2009-5#2)(2010-11#1)(2013-1#6)(2013-8#1)
miRNA genes##2##2##(2008-11#1)(2008-7#1)
miRNA in##2##2##(2008-11#1)(2012-12#1)
miRNA is##2##2##(2008-11#1)(2012-2#1)
miRNA target##2##2##(2013-1#1)(2013-8#1)
miRNA##49##1##(2008-1#1)(2008-11#8)(2008-2#1)(2008-7#3)(2009-5#2)(2010-11#1)(2011-1#1)(2011-2#11)(2012-12#4)(2012-2#1)(2013-1#12)(2013-8#4)
miRNAs are##5##2##(2009-5#1)(2010-7#3)(2011-2#1)
miRNAs can##2##2##(2011-2#1)(2012-2#1)
miRNAs could##2##2##(2010-1#1)(2011-2#1)
miRNAs has##2##2##(2008-11#1)(2013-1#1)
miRNAs have##2##2##(2008-7#1)(2009-5#1)
miRNAs in##6##2##(2008-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
miRNAs is##2##2##(2010-11#1)(2013-1#1)
miRNAs may be##2##3##(2011-2#1)(2013-8#1)
miRNAs may##5##2##(2010-11#1)(2011-2#2)(2013-8#2)
miRNAs of##2##2##(2013-1#1)(2013-8#1)
miRNAs to##2##2##(2010-7#1)(2012-2#1)
miRNAs were##4##2##(2013-1#2)(2013-8#2)
miRNAs##61##1##(2008-1#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-5#5)(2010-1#2)(2010-11#4)(2010-7#7)(2011-1#1)(2011-2#10)(2012-2#4)(2013-1#14)(2013-8#6)
mianserin##11##1##(2008-6#11)
mica##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
micafungin##3##1##(2008-10#3)
mice (BALB/c##2##2##(1990-7#1)(2008-10#1)
mice (P##2##2##(1990-3#1)(2011-3#1)
mice (dermal and drinking water studies) and carcinogenicity studies of##2##10##(2008-9#2)
mice (dermal studies)##4##3##(2008-9#4)
mice (dermal##7##2##(2008-9#7)
mice (feed##2##2##(2008-8#1)(2008-9#1)
mice (n = 20)##2##4##(1993-3#2)
mice a##2##2##(1992-9#1)(2007-8#1)
mice administered 0##2##3##(2008-9#2)
mice administered 4##2##3##(2008-9#2)
mice administered trimethylolpropane triacrylate##2##4##(2008-9#2)
mice administered##9##2##(2008-9#9)
mice after##11##2##(1990-12#1)(1992-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-9#1)(2012-12#1)(2013-8#1)
mice against lethal##2##3##(1992-8#1)(2009-6#1)
mice against##6##2##(1992-8#1)(1994-8#1)(2008-12#1)(2008-7#1)(2009-6#2)
mice aged##2##2##(1990-7#1)(1996-2#1)
mice also##5##2##(1993-2#1)(1997-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
mice and a##2##3##(2008-10#1)(2008-9#1)
mice and carcinogenicity studies of##2##5##(2008-8#1)(2008-9#1)
mice and carcinogenicity study of##2##5##(2008-9#2)
mice and carcinogenicity##4##3##(2008-8#1)(2008-9#3)
mice and grade##2##3##(2008-8#2)
mice and guinea pigs##5##4##(1995-12#5)
mice and in##2##3##(1997-3#1)(2013-1#1)
mice and may have##2##4##(1993-2#1)(2008-10#1)
mice and may##3##3##(1993-2#1)(2008-10#1)(2008-6#1)
mice and rats##13##3##(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)
mice and the##3##3##(2008-4#2)(2010-11#1)
mice and used##2##3##(1992-9#1)(2008-7#1)
mice and##88##2##(1990-5#1)(1990-6#1)(1990-8#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#6)(1996-5#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#1)(2010-11#4)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
mice are##18##2##(1990-5#1)(1993-12#2)(1993-3#1)(1994-3#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#4)(2012-2#1)(2012-3#1)(2013-8#1)
mice as##10##2##(1991-6#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-1#2)(2012-3#1)
mice at day##2##3##(1991-8#2)
mice at the dose##2##4##(1996-2#1)(2013-1#1)
mice at the##6##3##(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(2013-1#1)
mice at##17##2##(1990-5#1)(1991-8#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2013-1#1)
mice bearing Ehrlich ascites tumor##2##5##(1992-3#2)
mice bearing mammary carcinoma##2##4##(1992-9#2)
mice bearing the##2##3##(1995-3#1)(1997-3#1)
mice bearing##14##2##(1992-3#3)(1992-5#1)(1992-9#2)(1994-8#1)(1995-2#2)(1995-3#2)(1997-3#1)(1997-7#1)(2008-4#1)
mice but not in##3##4##(1995-2#1)(2008-10#1)(2009-8#1)
mice but not##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2009-8#1)
mice but##7##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2012-3#1)
mice by injection of##2##4##(1991-6#1)(2008-2#1)
mice by using##2##3##(1995-12#1)(2008-11#1)
mice by##29##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#2)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
mice can##2##2##(1993-12#1)(1995-2#1)
mice carrying a mutation##3##4##(1996-2#1)(1997-3#2)
mice carrying mutations##2##3##(1996-2#1)(2009-9#1)
mice carrying the Wld(S) mutation##2##5##(1997-3#2)
mice carrying##10##2##(1990-8#1)(1993-12#2)(1996-2#2)(1997-3#4)(2009-9#1)
mice caused##2##2##(1992-8#1)(2011-2#1)
mice compared to the##2##4##(1996-12#1)(2008-10#1)
mice compared to##7##3##(1996-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2013-1#2)
mice compared with##2##3##(2010-11#1)(2013-1#1)
mice compared##9##2##(1996-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-11#1)(2013-1#3)
mice contained##3##2##(1991-9#1)(2012-3#2)
mice deficient##2##2##(1993-12#1)(2012-2#1)
mice demonstrated##2##2##(1994-6#1)(2008-8#1)
mice develop thyroiditis##2##3##(1995-12#2)
mice develop##3##2##(1993-3#1)(1995-12#2)
mice developed##7##2##(1991-8#3)(1995-12#1)(2008-10#2)(2013-1#1)
mice did not##5##3##(1993-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2010-3#1)
mice differ in their##2##4##(1996-12#1)(2013-1#1)
mice differ##4##2##(1996-12#1)(1996-5#1)(2008-4#1)(2013-1#1)
mice displayed##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
mice dosed with##4##3##(1994-8#1)(2008-9#3)
mice dosed##5##2##(1994-8#1)(2008-9#4)
mice during the##3##3##(1993-5#1)(1997-4#1)(2008-9#1)
mice during##4##2##(1992-3#1)(1993-5#1)(1997-4#1)(2008-9#1)
mice exhibit##4##2##(1993-12#1)(1994-12#1)(1995-6#1)(2012-2#1)
mice exhibited a##3##3##(2008-4#2)(2012-1#1)
mice exhibited##8##2##(2008-10#1)(2008-4#2)(2009-6#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
mice exposed to 1##2##4##(2008-9#2)
mice exposed to dichloroacetic acid in##2##6##(2008-9#2)
mice exposed to dichloroacetic acid##4##5##(2008-9#4)
mice exposed to near-UV##2##4##(1994-6#2)
mice exposed to##22##3##(1994-6#2)(1996-5#1)(1997-4#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#13)
mice exposed##25##2##(1994-6#2)(1996-5#1)(1997-4#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#16)
mice expressing##9##2##(1992-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-4#1)(2013-8#1)
mice failed to kill##2##4##(1995-2#2)
mice fed a##5##3##(1994-11#1)(1995-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
mice fed either##4##3##(1997-4#3)(2013-1#1)
mice fed the##3##3##(2008-11#1)(2012-2#2)
mice fed##15##2##(1990-7#1)(1994-11#2)(1995-8#1)(1997-4#3)(2008-11#2)(2012-12#1)(2012-2#3)(2013-1#2)
mice following##6##2##(1990-6#1)(1997-2#1)(2007-2#1)(2008-10#2)(2012-3#1)
mice for the##2##3##(2008-4#1)(2011-2#1)
mice for##10##2##(1990-6#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
mice form##2##2##(1992-11#1)(2008-4#1)
mice from candidiasis##3##3##(2008-5#3)
mice from##10##2##(1990-11#1)(1995-5#1)(1996-5#1)(2008-5#3)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
mice had a##2##3##(2012-2#1)(2012-3#1)
mice had epidermal hyperplasia##2##4##(2008-9#2)
mice had##11##2##(1995-11#1)(1995-12#1)(1996-5#1)(2008-9#2)(2009-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
mice has##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
mice have a##2##3##(1993-12#1)(2008-1#1)
mice have been##2##3##(2008-11#1)(2012-2#1)
mice have demonstrated##2##3##(1994-8#1)(2012-2#1)
mice have##9##2##(1993-12#1)(1994-8#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2012-2#2)
mice having##2##2##(1995-11#1)(2008-4#1)
mice homozygous for##4##3##(1995-6#1)(1996-2#1)(2011-2#2)
mice immunized intranasally with##2##4##(1995-2#2)
mice immunized with recombinant##2##4##(2008-11#1)(2011-2#1)
mice immunized with the##2##4##(2008-11#2)
mice immunized with##7##3##(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
mice immunized##9##2##(1995-2#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
mice immunodepressed by aging or by cyclophosphamide treatment##2##8##(1994-5#2)
mice in the##9##3##(1995-5#1)(1995-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)
mice in which##3##3##(1996-2#1)(2008-5#1)(2008-7#1)
mice in##23##2##(1994-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2012-2#1)
mice increased##2##2##(2008-7#1)(2013-8#1)
mice induced##3##2##(1992-2#1)(1996-12#1)(2011-2#1)
mice infected with##6##3##(1993-8#1)(1996-12#3)(1997-4#1)(2009-4#1)
mice infected##8##2##(1993-8#1)(1995-9#1)(1996-12#3)(1997-4#1)(2009-4#1)(2012-3#1)
mice injected with##5##3##(2008-12#1)(2008-8#3)(2012-2#1)
mice intoxicated with bromobenzene##3##4##(1992-3#3)
mice is##11##2##(1992-12#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-4#4)(2009-9#1)(2012-2#1)
mice lacking a##2##3##(1996-6#1)(2010-11#1)
mice lacking both##2##3##(1993-12#1)(2013-1#1)
mice lacking##11##2##(1993-12#1)(1996-2#1)(1996-6#1)(2008-1#2)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
mice leads to##2##3##(1995-2#1)(2012-2#1)
mice may be##2##3##(1990-5#1)(1994-3#1)
mice may##4##2##(1990-5#1)(1994-3#1)(1996-12#1)(2008-9#1)
mice model##3##2##(2008-12#2)(2008-8#1)
mice neonatally exposed to diethylstilbestrol##2##5##(1990-7#2)
mice not only##2##3##(2011-2#2)
mice not##3##2##(2008-10#1)(2011-2#2)
mice of both sexes##2##4##(1993-8#2)
mice of both##3##3##(1993-8#2)(2013-1#1)
mice of##11##2##(1993-8#2)(1994-8#1)(1995-12#2)(1997-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#2)
mice on the##2##3##(1996-6#2)
mice on##4##2##(1996-6#2)(2008-12#1)(2012-2#1)
mice or##4##2##(1994-5#1)(2008-4#1)(2008-8#1)(2011-2#1)
mice presented##2##2##(2008-9#1)(2013-8#1)
mice produced##2##2##(1996-12#1)(2009-9#1)
mice received bromodichloromethane##2##3##(2008-9#2)
mice received dermal applications of 0##3##6##(2008-9#3)
mice received##9##2##(1992-5#1)(2008-10#1)(2008-9#6)(2013-1#1)
mice reduced##2##2##(2008-11#1)(2011-2#1)
mice resulted in##2##3##(1993-9#1)(2010-11#1)
mice results in the##2##4##(2008-11#1)(2008-3#1)
mice results in##4##3##(1991-5#1)(1996-12#1)(2008-11#1)(2008-3#1)
mice revealed##3##2##(1993-12#1)(1995-6#1)(2012-2#1)
mice show reduced##3##3##(2008-4#2)(2010-2#1)
mice show##5##2##(1997-2#1)(2008-12#1)(2008-4#2)(2010-2#1)
mice showed a##2##3##(2008-12#1)(2012-1#1)
mice showed##5##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-1#1)
mice significantly##2##2##(1992-8#1)(1993-5#1)
mice suggest that##2##3##(1995-3#1)(2009-6#1)
mice survived##3##2##(1995-11#1)(2008-9#2)
mice taken in a given round had successively borne litters in that round and all preceding ones##2##17##(1997-4#2)
mice taken##3##2##(1997-4#3)
mice than in##6##3##(2008-10#4)(2008-9#1)(2013-1#1)
mice that are##2##3##(1995-2#1)(1995-6#1)
mice that were##2##3##(1995-2#1)(1996-5#1)
mice that##11##2##(1992-11#1)(1993-12#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-5#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-7#1)
mice the##3##2##(1997-2#1)(2008-10#1)(2009-8#1)
mice to examine##2##3##(2010-11#1)(2012-2#1)
mice to##15##2##(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
mice transgenic for##2##3##(1995-2#1)(2008-8#1)
mice treated by##2##3##(2008-9#2)
mice treated with##11##3##(1990-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#2)(2013-8#1)
mice treated##14##2##(1990-11#1)(1991-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#4)(2013-8#1)
mice under##4##2##(1996-2#1)(1997-7#1)(2012-12#1)(2013-8#1)
mice using the##5##3##(2008-4#2)(2008-7#1)(2008-8#1)(2010-1#1)
mice using##11##2##(1992-5#1)(1994-8#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-1#1)
mice via##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
mice was inhibited##2##3##(2008-10#1)(2008-9#1)
mice was not##3##3##(2012-12#3)
mice was observed##2##3##(1995-12#1)(2008-10#1)
mice was##27##2##(1990-11#1)(1990-12#1)(1990-7#1)(1992-8#1)(1993-3#2)(1995-12#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-9#7)(2009-2#1)(2010-11#1)(2010-6#1)(2011-3#1)(2012-12#3)
mice were administered 0##11##4##(2008-9#11)
mice were administered dicyclohexylcarbodiimide##2##4##(2008-9#2)
mice were administered technical grade pentaerythritol##2##6##(2008-9#2)
mice were administered technical grade trimethylolpropane triacrylate##2##7##(2008-9#2)
mice were administered technical grade##4##5##(2008-9#4)
mice were administered##20##3##(2008-10#1)(2008-11#1)(2008-9#18)
mice were compared##2##3##(1996-12#1)(1996-5#1)
mice were dermally administered 0##5##5##(2008-9#5)
mice were dermally administered##7##4##(2008-9#7)
mice were established##3##3##(1992-3#1)(2008-9#2)
mice were examined##2##3##(1994-7#1)(1994-8#1)
mice were exposed to drinking water containing 0##10##8##(2008-9#10)
mice were exposed to##17##4##(1992-5#1)(2008-10#3)(2008-9#13)
mice were exposed##18##3##(1992-5#1)(2008-10#3)(2008-9#14)
mice were fed diets containing 0##3##6##(2008-8#3)
mice were fed diets containing 0%##2##6##(2008-9#2)
mice were fed diets containing##5##5##(2008-8#3)(2008-9#2)
mice were fed##10##3##(2007-8#1)(2008-10#1)(2008-8#3)(2008-9#2)(2009-12#1)(2013-1#2)
mice were given##4##3##(1997-4#2)(2008-10#1)(2008-8#1)
mice were immunized with##2##4##(1994-9#1)(2007-10#1)
mice were less##2##3##(1996-12#1)(2008-9#1)
mice were protected from##2##4##(1995-2#1)(2008-3#1)
mice were protected##4##3##(1995-2#1)(2008-3#2)(2012-2#1)
mice were sacrificed##7##3##(1995-12#1)(1997-4#3)(2008-10#1)(2012-3#1)(2013-8#1)
mice were similar to those of the##3##7##(2008-8#1)(2008-9#2)
mice were stimulated##2##3##(1993-11#1)(2008-11#1)
mice were treated with##5##4##(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#1)
mice were treated##7##3##(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#2)(2010-6#1)
mice were used##2##3##(1992-9#1)(2008-7#1)
mice were##138##2##(1990-6#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-5#3)(1997-2#1)(1997-4#9)(2007-10#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#5)(2008-9#52)(2009-12#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
mice when##4##2##(1994-5#1)(2008-10#1)(2008-5#2)
mice which##6##2##(1994-6#1)(1995-12#1)(1995-9#1)(1996-12#1)(2007-5#1)(2008-10#1)
mice with a##4##3##(1995-12#1)(1997-8#1)(2011-2#1)(2012-2#1)
mice with an##7##3##(1990-7#4)(1997-8#2)(2007-8#1)
mice with recombinant human##2##4##(1992-9#1)(1995-12#1)
mice with recombinant##3##3##(1992-9#1)(1995-12#1)(2008-4#1)
mice with the##9##3##(1993-9#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
mice with##59##2##(1990-7#4)(1992-8#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#3)(2007-8#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#6)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
mice without##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
mice##1705##1##(1990-11#7)(1990-12#9)(1990-3#7)(1990-5#8)(1990-6#7)(1990-7#14)(1990-8#3)(1991-1#3)(1991-12#12)(1991-5#5)(1991-6#4)(1991-8#17)(1991-9#3)(1992-11#7)(1992-12#3)(1992-2#6)(1992-3#12)(1992-5#7)(1992-7#1)(1992-8#15)(1992-9#11)(1993-1#3)(1993-11#1)(1993-12#27)(1993-2#6)(1993-3#12)(1993-5#8)(1993-8#3)(1993-9#6)(1994-11#9)(1994-12#11)(1994-2#3)(1994-3#13)(1994-5#27)(1994-6#9)(1994-7#2)(1994-8#18)(1994-9#2)(1995-11#13)(1995-12#41)(1995-2#37)(1995-3#11)(1995-5#7)(1995-6#5)(1995-8#2)(1995-9#7)(1996-1#1)(1996-10#1)(1996-12#36)(1996-2#20)(1996-5#24)(1996-6#7)(1997-2#14)(1997-3#12)(1997-4#31)(1997-7#8)(1997-8#11)(2007-10#4)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#7)(2008-1#11)(2008-10#154)(2008-11#63)(2008-12#35)(2008-2#6)(2008-3#13)(2008-4#87)(2008-5#34)(2008-6#10)(2008-7#53)(2008-8#57)(2008-9#176)(2009-10#2)(2009-11#1)(2009-12#8)(2009-2#8)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#11)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#7)(2010-10#5)(2010-11#24)(2010-12#4)(2010-2#5)(2010-3#7)(2010-5#3)(2010-6#7)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#35)(2011-3#5)(2012-1#10)(2012-12#25)(2012-2#53)(2012-3#26)(2013-1#67)(2013-7#9)(2013-8#30)
mice) have##2##2##(2011-2#1)(2012-2#1)
mice)##19##1##(1991-9#1)(1996-5#1)(1997-4#6)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
mice]##7##1##(2011-2#3)(2012-3#3)(2013-8#1)
micellar and submicellar mobile phases##3##5##(1996-5#3)
micellar and##6##2##(1996-5#3)(2008-10#2)(2013-1#1)
micellar catalyzed reactions of 1-fluoro-2##2##5##(2008-10#2)
micellar catalyzed##3##2##(2008-10#3)
micellar electrokinetic capillary chromatography (MECC) method##2##6##(2008-10#2)
micellar electrokinetic capillary chromatography (MECC)##3##5##(1994-9#1)(2008-10#2)
micellar electrokinetic capillary chromatography (MEKC) with##2##6##(2008-10#2)
micellar electrokinetic capillary chromatography##10##4##(1994-9#3)(2008-10#7)
micellar electrokinetic chromatography (MEKC)##9##4##(1990-8#1)(1994-9#2)(2008-10#6)
micellar electrokinetic chromatography##23##3##(1990-8#4)(1994-9#4)(1996-5#1)(2008-10#13)(2010-7#1)
micellar electrokinetic##33##2##(1990-8#4)(1994-9#7)(1996-5#1)(2008-10#20)(2010-7#1)
micellar extraction at cloud point##2##5##(2008-10#2)
micellar extraction##3##2##(2008-10#3)
micellar liquid chromatography##2##3##(2008-10#2)
micellar media##13##2##(1995-3#1)(2008-10#12)
micellar medium as##2##3##(2008-10#2)
micellar medium composed of##2##4##(2008-10#2)
micellar medium of##3##3##(2008-10#3)
micellar medium was##2##3##(2008-10#2)
micellar medium##29##2##(2008-10#29)
micellar mobile phase##2##3##(2008-10#1)(2009-8#1)
micellar mobile##3##2##(2008-10#2)(2009-8#1)
micellar phase##2##2##(1996-5#1)(2008-10#1)
micellar sodium dodecyl sulfate (SDS)##2##5##(2008-10#2)
micellar solubilization##2##2##(2008-10#1)(2008-5#1)
micellar solution of##3##3##(2008-10#3)
micellar solution##9##2##(2008-10#9)
micellar solutions of##4##3##(2008-10#2)(2008-7#2)
micellar solutions##10##2##(1994-9#1)(2008-10#7)(2008-7#2)
micellar system##10##2##(1990-5#5)(1996-5#2)(2008-10#3)
micellar systems##6##2##(1990-5#2)(2008-10#2)(2008-5#2)
micellar##166##1##(1990-5#8)(1990-8#4)(1993-11#3)(1994-12#1)(1994-9#9)(1995-3#1)(1996-5#11)(1997-2#1)(2008-10#117)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-7#1)(2013-1#1)
micellar-enhanced##2##1##(2008-10#2)
micellar-stabilized room temperature phosphorescence##2##4##(2008-10#2)
micelle formation##2##2##(1991-5#1)(2008-10#1)
micelle to##2##2##(1993-11#1)(2010-7#1)
micelle##32##1##(1990-11#1)(1991-5#1)(1991-8#1)(1993-11#3)(1994-9#1)(2008-10#16)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-7#2)(2013-1#1)
micelles and the##2##3##(1994-12#1)(2010-7#1)
micelles and##6##2##(1994-12#1)(1996-5#1)(2008-10#2)(2010-7#1)(2013-1#1)
micelles as a##2##3##(2008-10#2)
micelles as##5##2##(2008-10#4)(2013-1#1)
micelles formed by##2##3##(2008-10#2)
micelles in octane##2##3##(1990-5#2)
micelles in##5##2##(1990-5#2)(2008-10#3)
micelles is##3##2##(1993-11#1)(2008-10#2)
micelles of sodium##2##3##(1990-5#1)(2008-10#1)
micelles of##8##2##(1990-5#1)(1994-9#1)(1995-3#1)(2008-10#4)(2008-12#1)
micelles on the##2##3##(2008-10#2)
micelles to##2##2##(2008-10#2)
micelles was##3##2##(1990-11#1)(1995-2#1)(2008-10#1)
micelles##84##1##(1990-11#3)(1990-2#1)(1990-5#4)(1990-8#1)(1991-8#4)(1992-3#1)(1993-11#4)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#3)(1995-3#4)(1996-5#4)(2008-10#34)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-7#2)(2009-9#1)(2010-7#1)(2011-1#1)(2013-1#2)
micellization##2##1##(2008-10#1)(2008-8#1)
michellamines A and B##2##4##(1994-12#2)
michelson##2##1##(2008-3#2)
michiganensis into##2##2##(2008-10#2)
michiganensis strains##2##2##(2008-10#2)
michiganensis subsp##25##2##(2008-10#25)
michiganensis##43##1##(2008-10#43)
miconazole and forskolin##2##3##(1997-2#2)
miconazole##9##1##(1991-5#2)(1997-2#2)(2008-5#1)(2010-5#4)
micro amounts of nucleic acids##3##5##(2008-10#3)
micro and nano column##2##4##(2013-1#2)
micro and nano##3##3##(2009-12#1)(2013-1#2)
micro catheter into##2##3##(1997-3#2)
micro determination of##3##3##(2008-10#3)
micro flow injection wetting film##2##5##(2008-10#2)
micro flow sensor##2##3##(2008-10#2)
micro flow##4##2##(2008-10#4)
micro gas##2##2##(2011-1#2)
micro hollow##2##2##(2008-11#2)
micro liquid-liquid extraction##2##3##(2008-10#2)
micro organisms##2##2##(2008-7#1)(2012-3#1)
micro ring resonator##2##3##(2011-1#2)
micro shoots##2##2##(2013-1#2)
micro total analysis##2##3##(2008-10#2)
micro##76##1##(1990-5#1)(1990-6#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-10#31)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#6)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
micro(0) is##2##2##(2008-3#2)
micro(0)##3##1##(2008-3#3)
micro(B))##2##1##(2007-11#2)
micro(a)##2##1##(2008-3#2)
micro(calc)##2##1##(2008-7#2)
micro(obs)##2##1##(2008-7#2)
micro(s)'##2##1##(2008-3#2)
micro- and##11##2##(2007-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
micro-##13##1##(2007-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
micro-CT system##2##2##(2011-1#1)(2012-12#1)
micro-CT##4##1##(2011-1#2)(2012-12#1)(2012-4#1)
micro-XRF##4##1##(2008-10#4)
micro-albuminuria##6##1##(2007-7#1)(2012-2#5)
micro-analytical##2##1##(2008-10#2)
micro-architecture##2##1##(1997-8#1)(2009-7#1)
micro-array##2##1##(2008-9#1)(2009-4#1)
micro-cantilever##3##1##(2008-10#3)
micro-carriers or##2##2##(2008-11#2)
micro-colorimetric##4##1##(2008-10#4)
micro-column##8##1##(2008-10#8)
micro-columns##2##1##(2008-10#2)
micro-computed tomography##2##2##(2009-7#1)(2011-2#1)
micro-ecological environmental factors##2##3##(2011-1#2)
micro-ecological##3##1##(2011-1#3)
micro-emulsion##2##1##(2008-5#2)
micro-emulsions##3##1##(2008-5#3)
micro-environment##4##1##(1993-9#1)(2008-11#1)(2008-8#1)(2013-8#1)
micro-extraction##5##1##(2008-10#5)
micro-flow##2##1##(2008-10#2)
micro-focus##2##1##(2008-9#1)(2011-1#1)
micro-gravimetric##2##1##(2008-10#2)
micro-level##2##1##(2009-7#1)(2011-2#1)
micro-objects##4##1##(2007-12#1)(2008-3#1)(2011-1#2)
micro-oil bodies##4##2##(2009-10#4)
micro-optic##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
micro-optical color##2##2##(2008-3#2)
micro-optical components##3##2##(2008-3#3)
micro-optical elements##6##2##(2008-2#1)(2008-3#5)
micro-optical##21##1##(2007-12#1)(2008-2#3)(2008-3#17)
micro-optical-electromechanical systems##2##2##(2008-3#2)
micro-optics components##2##2##(2007-11#1)(2007-12#1)
micro-optics##16##1##(2007-11#5)(2007-12#3)(2008-3#8)
micro-optomechanical##2##1##(2007-12#1)(2008-2#1)
micro-organism##4##1##(2006-6#1)(2008-7#1)(2011-2#2)
micro-organisms and##2##2##(2008-11#1)(2009-12#1)
micro-organisms##9##1##(2008-11#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-4#2)(2011-2#1)
micro-patterned##2##1##(2008-5#2)
micro-probabilities##2##1##(2008-12#2)
micro-pumps##4##1##(2008-10#4)
micro-retroreflectors##3##1##(2011-1#3)
micro-ring##3##1##(2008-7#1)(2013-8#2)
micro-sequential injection##2##2##(2008-10#2)
micro-structural##2##1##(2007-12#1)(2009-7#1)
micro-vesiculation##4##1##(2006-6#4)
micro-volume##4##1##(2008-10#4)
micro-volumes of##2##2##(2008-10#2)
microA##5##1##(1992-8#1)(1994-3#1)(1997-6#1)(2008-10#2)
microCi##3##1##(1993-3#1)(1994-5#1)(1996-2#1)
microJ of##2##2##(2008-3#2)
microJ##5##1##(2007-11#2)(2008-3#3)
microL of##2##2##(2010-8#1)(2011-1#1)
microL##11##1##(2008-10#2)(2008-5#1)(2008-9#1)(2010-5#2)(2010-8#1)(2011-1#3)(2012-3#1)
microM Ca2+##3##2##(1990-2#1)(1990-7#1)(1990-8#1)
microM GTP##2##2##(1990-7#1)(1995-8#1)
microM PQ##3##2##(1995-8#3)
microM [HS]##2##2##(2009-9#2)
microM added##2##2##(1992-3#1)(1993-6#1)
microM and 0##2##3##(1991-5#1)(1992-8#1)
microM and 1##3##3##(1990-7#1)(1992-8#1)(1995-8#1)
microM and 50 microM##2##4##(1990-12#1)(1993-11#1)
microM and 50##3##3##(1990-12#1)(1993-11#1)(1995-6#1)
microM and Vmax values of##2##5##(1995-8#2)
microM and Vmax##3##3##(1995-11#1)(1995-8#2)
microM and a##5##3##(1992-3#2)(1993-12#1)(1994-12#1)(2008-10#1)
microM and incubation time of##2##5##(1996-2#2)
microM and the##2##3##(1990-8#1)(1993-6#1)
microM and##44##2##(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#3)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#4)(2008-10#1)(2008-7#1)
microM arachidonic acid##2##3##(1995-11#2)
microM at##5##2##(1990-10#1)(1991-2#1)(1995-3#1)(2008-10#1)(2009-9#1)
microM atropine##2##2##(1990-5#1)(1995-3#1)
microM calcium##2##2##(1992-3#1)(1994-5#1)
microM carbamazepine##2##2##(1990-5#2)
microM concentration##2##2##(2008-12#2)
microM for the##2##3##(1994-8#2)
microM for##13##2##(1990-7#2)(1992-12#2)(1992-3#1)(1992-8#1)(1994-8#2)(1997-4#3)(2008-10#2)
microM free##2##2##(1994-6#1)(1995-11#1)
microM histamine##3##2##(1995-12#1)(1996-5#2)
microM in domains with##2##4##(1996-2#2)
microM in the absence of##2##5##(1991-8#1)(1995-6#1)
microM in the##4##3##(1991-8#1)(1995-6#3)
microM in##10##2##(1991-8#1)(1992-2#2)(1993-8#1)(1995-12#1)(1995-6#3)(1996-2#2)
microM lead acetate##2##3##(1997-4#2)
microM of the##2##3##(1990-11#1)(1990-7#1)
microM of##10##2##(1990-11#2)(1990-7#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-8#1)(1996-12#1)(1997-4#1)(2010-3#1)
microM peptide##3##2##(1993-11#3)
microM phenytoin##2##2##(1990-5#2)
microM range##2##2##(1997-4#1)(2008-11#1)
microM results##2##2##(1990-8#1)(1994-8#1)
microM sodium##2##2##(1994-11#1)(1995-11#1)
microM to##6##2##(1992-11#1)(1992-3#1)(1993-6#2)(1995-12#1)(1995-5#1)
microM was##4##2##(1991-8#1)(1995-8#1)(2008-10#1)(2009-12#1)
microM while##2##2##(1996-12#1)(1997-2#1)
microM with detection limits of##2##5##(2008-10#2)
microM with##5##2##(1992-3#2)(1994-6#1)(2008-10#2)
microM##412##1##(1990-10#1)(1990-11#3)(1990-12#10)(1990-2#9)(1990-5#14)(1990-7#13)(1990-8#8)(1991-11#3)(1991-12#8)(1991-2#2)(1991-5#8)(1991-8#6)(1991-9#2)(1992-11#7)(1992-12#8)(1992-2#2)(1992-3#24)(1992-5#4)(1992-6#7)(1992-8#10)(1992-9#1)(1993-11#5)(1993-12#3)(1993-3#9)(1993-6#9)(1993-8#8)(1993-9#3)(1994-11#9)(1994-12#3)(1994-2#5)(1994-3#3)(1994-5#5)(1994-6#9)(1994-8#13)(1994-9#2)(1995-11#15)(1995-12#13)(1995-2#9)(1995-3#5)(1995-5#7)(1995-6#8)(1995-8#13)(1996-12#12)(1996-2#7)(1996-5#3)(1996-6#1)(1997-1#3)(1997-2#4)(1997-4#12)(1997-6#4)(1997-7#5)(1997-8#3)(2008-10#19)(2008-11#7)(2008-12#4)(2008-7#3)(2008-8#6)(2009-12#2)(2009-2#1)(2009-6#3)(2009-9#3)(2010-3#2)(2010-6#1)(2011-2#1)
microM) also##3##2##(1994-8#1)(1996-2#1)(1997-1#1)
microM) and##27##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-10#1)(1995-11#4)(1995-8#1)(1996-2#3)(1996-5#2)(1997-2#1)(1997-4#4)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
microM) as##3##2##(1992-9#1)(1996-9#1)(1997-7#1)
microM) blocked##2##2##(1994-11#1)(2009-12#1)
microM) both##2##2##(1996-2#2)
microM) but not##2##3##(1995-2#1)(2009-9#1)
microM) but##3##2##(1992-3#1)(1995-2#1)(2009-9#1)
microM) caused a rapid##2##4##(1991-6#1)(1997-1#1)
microM) caused a##3##3##(1990-6#1)(1991-6#1)(1997-1#1)
microM) did not affect##3##4##(1990-5#1)(1997-4#1)(1997-7#1)
microM) did not##4##3##(1990-5#1)(1995-8#1)(1997-4#1)(1997-7#1)
microM) did##5##2##(1990-5#1)(1995-12#1)(1995-8#1)(1997-4#1)(1997-7#1)
microM) for##3##2##(1993-6#1)(1995-12#1)(1996-2#1)
microM) had no effect##2##4##(1992-11#1)(1997-4#1)
microM) in a##2##3##(1992-12#1)(1997-1#1)
microM) in##8##2##(1990-10#1)(1991-9#2)(1992-12#1)(1995-11#1)(1997-1#1)(1997-7#1)(2013-1#1)
microM) increased##3##2##(1992-8#1)(1995-8#1)(2009-12#1)
microM) inhibited##4##2##(1990-12#2)(1992-3#1)(1997-4#1)
microM) insulin##2##2##(1990-12#2)
microM) is##2##2##(1990-11#1)(1995-5#1)
microM) on##2##2##(1992-8#1)(1994-11#1)
microM) or##11##2##(1990-7#1)(1990-8#1)(1993-3#1)(1993-8#4)(1994-10#1)(1995-12#1)(1995-5#1)(1996-5#1)
microM) produced##3##2##(1992-9#1)(1997-2#1)(1997-4#1)
microM) reduced##2##2##(1995-12#1)(1997-4#1)
microM) was##8##2##(1992-12#1)(1992-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#2)(2009-12#1)
microM) were##4##2##(1990-2#1)(1991-5#1)(1995-11#1)(2008-8#1)
microM) which##2##2##(1992-6#1)(1995-6#1)
microM)##245##1##(1990-10#1)(1990-11#4)(1990-12#7)(1990-2#4)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1991-12#2)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#4)(1992-3#12)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#6)(1993-12#4)(1993-3#5)(1993-6#3)(1993-8#10)(1994-10#3)(1994-11#5)(1994-12#2)(1994-6#5)(1994-8#7)(1994-9#2)(1995-11#12)(1995-12#7)(1995-2#2)(1995-3#9)(1995-5#4)(1995-6#4)(1995-8#3)(1996-2#17)(1996-5#9)(1996-9#1)(1997-1#4)(1997-2#7)(1997-4#18)(1997-7#7)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-12#7)(2009-6#1)(2009-9#1)(2013-1#4)
microM-1 x s-1 of##2##4##(1993-8#2)
microM-1 x s-1##3##3##(1993-8#3)
microM-1##5##1##(1993-8#3)(1994-2#1)(1994-5#1)
microM/5##2##1##(1995-12#2)
microM/s##2##1##(1995-8#2)
microRNA expression in##4##3##(2010-4#1)(2010-7#2)(2012-2#1)
microRNA expression##6##2##(2010-4#2)(2010-7#3)(2012-2#1)
microRNA##17##1##(2008-1#1)(2010-3#1)(2010-4#3)(2010-7#6)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
microRNAs (miRNAs)##7##2##(2008-10#1)(2008-2#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#2)
microRNAs##19##1##(2008-10#1)(2008-2#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#6)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
microT in##2##2##(2008-12#2)
microT##4##1##(2008-12#4)
microU/ml) and##2##2##(1996-5#1)(2007-8#1)
microW of##2##2##(2008-2#1)(2008-9#1)
microW##9##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#2)
microW/cm(2) UVB##2##2##(2008-11#2)
microW/cm(2)##6##1##(2007-12#1)(2008-11#5)
microa and micros'##3##3##(2008-3#3)
microa and##4##2##(2008-3#4)
microactuator##3##1##(2008-3#2)(2012-2#1)
microalbuminuria and##2##2##(1997-8#1)(2008-3#1)
microalbuminuria assay using bromphenol##2##4##(1990-2#2)
microalbuminuria##15##1##(1990-2#2)(1995-11#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-7#3)(2010-4#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
microalbuminuric##5##1##(1992-9#2)(1997-8#2)(2012-1#1)
microalga##3##1##(2008-6#1)(2013-1#2)
microalgae biofilm##2##2##(2013-1#2)
microalgae growth##3##2##(2013-1#3)
microalgae##9##1##(2013-1#9)
microalgal##2##1##(2008-7#1)(2010-11#1)
microamounts of##3##2##(2008-10#3)
microanalysis of##4##2##(1994-9#1)(1995-8#1)(2008-10#2)
microanalysis##14##1##(1994-9#1)(1995-8#1)(2008-10#10)(2008-9#1)(2013-1#1)
microanalytical system##3##2##(2008-10#3)
microanalytical##4##1##(2008-10#4)
microanatomical parameters##2##2##(1994-6#2)
microanatomical##5##1##(1994-6#3)(2008-5#2)
microangiopathic lesions##2##2##(1990-5#1)(1996-11#1)
microangiopathy and##2##2##(1990-2#1)(2013-8#1)
microangiopathy##9##1##(1990-2#1)(1990-5#1)(1997-8#2)(2008-1#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
microaperture optics##2##2##(2008-3#2)
microaperture-per-channel geometry##2##2##(2008-3#2)
microaperture-per-channel##4##1##(2008-3#4)
microarchitecture##2##1##(2008-8#1)(2010-10#1)
microarray analyses##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
microarray analysis of##3##3##(2010-3#1)(2012-12#2)
microarray analysis to##3##3##(2008-11#1)(2008-7#2)
microarray analysis##22##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#6)(2008-8#1)(2009-10#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)
microarray and##5##2##(2008-10#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-3#1)
microarray containing##2##2##(2008-10#1)(2008-7#1)
microarray contains##2##2##(2007-12#1)(2011-2#1)
microarray data and##2##3##(2008-7#1)(2011-2#1)
microarray data from##2##3##(2008-7#1)(2013-1#1)
microarray data##21##2##(2008-4#4)(2008-7#9)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
microarray database##5##2##(2008-4#1)(2008-7#4)
microarray design##2##2##(2008-7#2)
microarray experiment management##2##3##(2008-7#2)
microarray experiment##4##2##(2008-7#3)(2009-9#1)
microarray experiments##15##2##(2008-10#1)(2008-4#4)(2008-7#5)(2008-8#1)(2009-10#2)(2011-2#1)(2013-8#1)
microarray expression profiles##2##3##(2008-7#2)
microarray expression##5##2##(2008-7#3)(2008-9#2)
microarray for the##2##3##(2011-1#1)(2012-3#1)
microarray for##8##2##(2008-7#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-3#1)
microarray format##5##2##(2008-10#2)(2009-10#2)(2009-12#1)
microarray hybridization##2##2##(2008-2#1)(2008-4#1)
microarray in##3##2##(2008-11#2)(2011-1#1)
microarray is a##2##3##(2008-7#1)(2010-4#1)
microarray platform##2##2##(2008-9#1)(2011-1#1)
microarray technique##2##2##(2008-7#1)(2012-3#1)
microarray technologies##4##2##(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)
microarray technology has##3##3##(2008-7#3)
microarray technology to##2##3##(2008-2#1)(2008-7#1)
microarray technology##14##2##(2008-10#1)(2008-2#1)(2008-7#10)(2012-2#1)(2012-3#1)
microarray##174##1##(2007-11#1)(2007-12#3)(2008-10#18)(2008-11#6)(2008-2#5)(2008-4#16)(2008-6#1)(2008-7#54)(2008-8#2)(2008-9#7)(2009-10#10)(2009-12#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#1)(2011-1#5)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#11)(2013-1#1)(2013-8#2)
microarray-based diagnostic tests##2##3##(2008-10#2)
microarray-based##4##1##(2008-10#2)(2010-7#1)(2011-1#1)
microarrays and##4##2##(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
microarrays are##5##2##(2008-4#1)(2008-7#4)
microarrays as##3##2##(2008-4#1)(2008-7#2)
microarrays for the##2##3##(2008-7#2)
microarrays for##9##2##(2007-12#1)(2008-4#1)(2008-7#5)(2008-8#1)(2010-4#1)
microarrays has##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)
microarrays in##4##2##(2008-7#3)(2010-12#1)
microarrays to##5##2##(2008-10#2)(2008-7#1)(2009-12#1)(2012-3#1)
microarrays using##3##2##(2007-12#1)(2008-4#1)(2010-12#1)
microarrays were used to##3##4##(2008-10#1)(2009-12#1)(2010-4#1)
microarrays were##4##2##(2008-10#1)(2008-7#1)(2009-12#1)(2010-4#1)
microarrays##88##1##(2007-12#2)(2008-10#8)(2008-4#13)(2008-7#32)(2008-8#4)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#6)(2010-4#4)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)
microarthropods##2##1##(2008-10#1)(2008-11#1)
microassay for##5##2##(1990-2#1)(1992-11#1)(1992-6#1)(1993-9#1)(1996-12#1)
microassay##11##1##(1990-12#4)(1990-2#1)(1992-11#1)(1992-6#1)(1993-9#1)(1996-12#3)
microautoradiographic##2##1##(2008-5#2)
microautoradiography##3##1##(1993-11#1)(2008-5#2)
microbalance (QCM)##12##2##(2008-10#12)
microbalance and##2##2##(2008-5#1)(2008-6#1)
microbalance##31##1##(2008-10#29)(2008-5#1)(2008-6#1)
microbe being used##2##3##(2011-2#2)
microbe is##2##2##(1991-2#1)(2011-2#1)
microbe##12##1##(1991-2#1)(2008-10#5)(2008-7#1)(2009-6#1)(2011-2#3)(2012-2#1)
microbe-host##2##1##(2008-10#1)(2013-1#1)
microbeads were##2##2##(2008-10#2)
microbeads##15##1##(2007-11#1)(2008-10#10)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)
microbeam free-space optical##2##3##(2008-3#2)
microbeam##8##1##(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#2)
microbending##4##1##(2007-11#3)(2008-3#1)
microbes and##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
microbes are##2##2##(2008-4#1)(2011-2#1)
microbes for##2##2##(2008-10#1)(2011-1#1)
microbes in##4##2##(2008-3#1)(2011-2#1)(2012-2#2)
microbes is##2##2##(2008-10#1)(2008-9#1)
microbes present in##2##3##(2012-2#2)
microbes that are##2##3##(1996-9#1)(2011-1#1)
microbes that##4##2##(1996-9#1)(2009-9#1)(2011-1#1)(2012-2#1)
microbes were##3##2##(2007-7#1)(2008-10#1)(2008-11#1)
microbes##64##1##(1996-9#2)(2007-12#1)(2007-7#2)(2008-10#15)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#4)(2009-6#3)(2009-9#1)(2010-3#2)(2011-1#5)(2011-2#7)(2012-2#7)
microbial DNA##2##2##(2010-5#1)(2012-2#1)
microbial activity were##2##3##(2008-10#2)
microbial activity##13##2##(2008-10#10)(2008-11#1)(2008-5#1)(2013-8#1)
microbial and##4##2##(2008-10#1)(2008-11#3)
microbial antagonism##2##2##(2008-10#2)
microbial antagonists##4##2##(2008-10#4)
microbial biofilm##2##2##(2008-7#2)
microbial biomass##7##2##(2008-10#4)(2008-11#1)(2008-6#2)
microbial cells##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
microbial colonization##2##2##(2013-1#1)(2013-8#1)
microbial communities and##4##3##(2008-10#4)
microbial communities were##2##3##(2008-10#2)
microbial communities##17##2##(2008-10#13)(2011-2#2)(2012-2#1)(2012-3#1)
microbial community structure##3##3##(2008-10#3)
microbial community##17##2##(2008-10#15)(2011-2#1)(2013-8#1)
microbial composition##3##2##(2008-10#1)(2010-5#1)(2012-2#1)
microbial contamination and##2##3##(1994-3#1)(2008-5#1)
microbial contamination##10##2##(1994-3#1)(1997-4#2)(2008-11#1)(2008-5#2)(2012-2#3)(2013-8#1)
microbial contaminations in##2##3##(2008-11#2)
microbial conversion##2##2##(2008-6#2)
microbial counts##2##2##(2007-10#1)(2011-2#1)
microbial detection##2##2##(2007-12#1)(2008-4#1)
microbial disease##2##2##(1996-1#1)(2013-8#1)
microbial diversity within##2##3##(2008-9#1)(2011-2#1)
microbial diversity##7##2##(2008-10#1)(2008-9#3)(2011-2#1)(2012-2#1)(2013-7#1)
microbial ecology##5##2##(2007-12#2)(2008-10#2)(2008-5#1)
microbial enzymatic detection##2##3##(2008-10#2)
microbial enzymatic##3##2##(2008-10#3)
microbial extracellular##3##2##(2008-11#3)
microbial flora in the##2##4##(2008-5#1)(2012-1#1)
microbial flora##4##2##(1990-6#1)(2008-5#1)(2008-9#1)(2012-1#1)
microbial genomes##2##2##(2011-1#2)
microbial groups in##2##3##(2008-10#1)(2012-2#1)
microbial groups##4##2##(2008-10#1)(2008-12#1)(2012-2#2)
microbial growth##7##2##(2007-3#1)(2008-5#1)(2008-7#3)(2011-2#1)(2013-1#1)
microbial invasion##4##2##(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)
microbial load on##2##3##(1997-5#1)(2007-10#1)
microbial load##5##2##(1997-4#1)(1997-5#1)(2007-10#2)(2012-2#1)
microbial metabolism##2##2##(2008-10#1)(2008-5#1)
microbial parameters##2##2##(2008-10#2)
microbial pathogenesis##2##2##(2011-2#1)(2012-2#1)
microbial pathogens for##2##3##(2008-10#2)
microbial pathogens##10##2##(2008-10#4)(2008-11#1)(2008-4#4)(2009-6#1)
microbial phytase##2##2##(2010-2#2)
microbial population##5##2##(1990-9#2)(2008-10#1)(2008-7#1)(2011-2#1)
microbial populations##8##2##(2008-10#5)(2008-8#1)(2012-1#1)(2013-1#1)
microbial processes##2##2##(1990-9#1)(1992-11#1)
microbial quality and##2##3##(2007-3#1)(2011-2#1)
microbial reduction##4##2##(1995-3#1)(1997-4#2)(2008-10#1)
microbial research##2##2##(2008-10#1)(2011-1#1)
microbial screening##2##2##(2007-11#1)(2008-10#1)
microbial sensor##3##2##(2008-10#3)
microbial species##3##2##(2008-10#2)(2012-3#1)
microbial strains##3##2##(1992-11#1)(2008-10#1)(2008-6#1)
microbial systems##2##2##(2008-11#1)(2008-7#1)
microbial transformation of##2##3##(2008-11#2)
microbial transformation##3##2##(2008-10#1)(2008-11#2)
microbial##284##1##(1990-6#1)(1990-9#4)(1991-7#1)(1992-11#4)(1992-8#2)(1993-6#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-4#7)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-3#2)(2008-1#1)(2008-10#99)(2008-11#20)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#10)(2008-6#8)(2008-7#10)(2008-8#2)(2008-9#11)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-4#4)(2010-5#3)(2010-7#2)(2011-1#7)(2011-2#20)(2012-1#2)(2012-12#1)(2012-2#18)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
microbially##4##1##(1990-11#1)(1993-3#1)(2008-10#2)
microbicidal##2##1##(1992-10#1)(2008-4#1)
microbicide##6##1##(1996-9#2)(2007-7#2)(2009-12#2)
microbioassay##2##1##(2008-10#2)
microbiologic diagnosis##2##2##(2011-2#2)
microbiologic study##2##2##(1990-9#2)
microbiologic##11##1##(1990-9#2)(1992-5#1)(2007-10#1)(2008-5#1)(2011-2#4)(2011-3#1)(2013-1#1)
microbiological and biochemical##2##3##(1997-3#1)(2012-2#1)
microbiological and##7##2##(1990-6#1)(1997-3#1)(2008-8#1)(2010-5#1)(2012-2#2)(2013-1#1)
microbiological contamination##3##2##(1994-3#1)(2008-5#1)(2012-2#1)
microbiological data##2##2##(2011-1#1)(2013-1#1)
microbiological diagnosis##2##2##(1990-6#1)(2007-12#1)
microbiological environmental monitoring##2##3##(2012-2#2)
microbiological examination##3##2##(2008-1#1)(2010-4#1)(2011-2#1)
microbiological procedures##2##2##(2007-7#1)(2012-3#1)
microbiological reference methods##2##3##(2011-1#2)
microbiological tests##4##2##(2012-12#1)(2012-2#3)
microbiological##73##1##(1990-6#3)(1990-9#1)(1992-5#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#4)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#9)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
microbiologically##6##1##(1990-9#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
microbiologist and##2##2##(1992-12#1)(1994-6#1)
microbiologist##6##1##(1992-12#1)(1994-6#1)(2008-2#1)(2008-9#1)(2011-1#1)(2013-8#1)
microbiologists##5##1##(1990-6#1)(1996-6#1)(2008-5#1)(2008-9#2)
microbiology and##8##2##(1992-12#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-5#1)(2011-1#1)
microbiology laboratories##6##2##(1995-3#4)(2007-7#1)(2013-1#1)
microbiology laboratory##3##2##(2010-6#1)(2011-2#1)(2013-1#1)
microbiology of##4##2##(1997-5#1)(2007-12#1)(2011-2#1)(2012-2#1)
microbiology##49##1##(1992-12#1)(1994-12#4)(1995-3#4)(1997-3#1)(1997-5#1)(2007-12#5)(2007-7#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#7)(2010-12#1)(2010-6#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
microbiome##4##1##(2010-5#2)(2011-1#1)(2012-2#1)
microbioreactor##3##1##(2008-11#3)
microbiota and##3##2##(2011-2#2)(2012-1#1)
microbiota in the##2##3##(2010-5#1)(2012-1#1)
microbiota in##4##2##(2008-10#1)(2010-5#1)(2012-1#1)(2012-3#1)
microbiota of the gastrointestinal##2##4##(2009-5#1)(2011-2#1)
microbiota of##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
microbiota with##2##2##(2011-2#2)
microbiota##28##1##(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#15)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
microbleeds have##2##2##(2008-8#2)
microbleeds##9##1##(2008-8#8)(2012-2#1)
microbodies##9##1##(2008-10#6)(2011-1#3)
microbody-lipid globule complexes##2##3##(2008-10#2)
microbore##2##1##(2008-10#1)(2008-4#1)
microbubble contrast##2##2##(2008-7#1)(2010-12#1)
microbubbles##2##1##(2008-8#1)(2011-2#1)
microcalcifications##2##1##(1993-5#1)(2011-2#1)
microcalorimetric##4##1##(1995-5#1)(2008-10#3)
microcalorimetry##3##1##(1990-5#1)(2011-3#2)
microcantilever##3##1##(2008-3#1)(2009-5#2)
microcapsule colonization##2##2##(2008-11#2)
microcapsule##5##1##(2008-11#5)
microcapsules are##2##2##(2008-11#1)(2008-5#1)
microcapsules were##2##2##(2008-11#1)(2008-7#1)
microcapsules##17##1##(1991-1#1)(2008-11#9)(2008-5#5)(2008-7#1)(2013-1#1)
microcarrier beads##2##2##(2008-11#2)
microcarrier culture##5##2##(2008-11#5)
microcarrier cultures in##2##3##(2008-11#2)
microcarrier cultures##4##2##(2008-11#4)
microcarrier##25##1##(2008-11#23)(2008-9#2)
microcarriers and##2##2##(2008-11#1)(2010-11#1)
microcarriers are##2##2##(2008-11#2)
microcarriers as##2##2##(1990-2#1)(2008-11#1)
microcarriers by##2##2##(2008-11#2)
microcarriers in##7##2##(2008-11#7)
microcarriers were used##2##3##(1990-2#1)(2008-11#1)
microcarriers##47##1##(1990-2#2)(2008-11#42)(2010-11#2)(2012-3#1)
microcatheter in the##2##3##(1997-3#1)(2008-7#1)
microcatheter into##2##2##(2008-7#2)
microcatheter was##2##2##(1997-6#1)(2008-7#1)
microcatheter##9##1##(1997-3#2)(1997-6#1)(2008-7#6)
microcatheters##3##1##(1997-3#2)(2008-7#1)
microcavities##16##1##(2007-11#5)(2007-12#6)(2008-2#1)(2008-3#4)
microcavity (MC)##2##2##(2007-11#1)(2008-10#1)
microcavity system##2##2##(2007-12#1)(2008-2#1)
microcavity with##2##2##(2007-12#2)
microcavity##27##1##(2007-11#4)(2007-12#14)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#1)
microcavity-enhanced Raman gain##2##3##(2007-12#2)
microcellular##2##1##(1994-7#1)(2008-3#1)
microcephaly##8##1##(1997-3#6)(2008-1#1)(2012-3#1)
microchannel plates##2##2##(2008-3#2)
microchannel##19##1##(2007-10#1)(2008-10#11)(2008-2#1)(2008-3#4)(2009-5#1)(2009-9#1)
microchannels and##2##2##(2007-5#1)(2008-5#1)
microchannels##9##1##(1997-6#1)(2007-5#2)(2008-10#4)(2008-5#1)(2009-2#1)
microchemielectronic devices for##2##3##(2008-10#2)
microchip Nd##3##2##(2007-11#1)(2007-12#2)
microchip and##2##2##(2008-10#2)
microchip capillary electrophoresis (CE)##2##4##(2008-10#2)
microchip capillary electrophoresis with##2##4##(2008-10#2)
microchip capillary electrophoresis##8##3##(2008-10#8)
microchip configuration##2##2##(2007-11#1)(2007-12#1)
microchip electrochromatography with##2##3##(2008-10#2)
microchip electrochromatography##4##2##(2008-10#4)
microchip electrophoresis##3##2##(2008-10#3)
microchip flow cell##2##3##(2008-10#2)
microchip for##2##2##(2008-10#2)
microchip implants##2##2##(2008-12#2)
microchip laser with an##2##4##(2007-11#1)(2007-12#1)
microchip laser with##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
microchip laser##20##2##(2007-11#5)(2007-12#8)(2008-2#2)(2008-3#4)(2011-1#1)
microchip lasers with##2##3##(2007-11#2)
microchip lasers##11##2##(2007-11#4)(2007-12#5)(2008-3#2)
microchip solid-state laser##3##3##(2007-11#3)
microchip solid-state lasers##4##3##(2007-11#3)(2007-12#1)
microchip solid-state##7##2##(2007-11#6)(2007-12#1)
microchip##100##1##(2007-11#18)(2007-12#21)(2007-8#4)(2008-10#45)(2008-12#2)(2008-2#2)(2008-3#6)(2009-5#1)(2011-1#1)
microchips##3##1##(2008-10#1)(2008-2#1)(2013-8#1)
microchromosome##2##1##(2010-3#2)
microchromosomes##5##1##(2010-3#5)
microcircuitry of##2##2##(1993-12#1)(2008-4#1)
microcircuitry##4##1##(1993-12#2)(2008-4#1)(2008-9#1)
microcirculation and##3##2##(2008-5#2)(2010-1#1)
microcirculation in sepsis##2##3##(2010-7#2)
microcirculation in##4##2##(1996-3#1)(2009-11#1)(2010-7#2)
microcirculation##22##1##(1990-8#1)(1992-12#1)(1992-8#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#4)(2011-2#4)(2013-8#1)
microcirculatory disorders##2##2##(2011-2#2)
microcirculatory disturbances##3##2##(2009-7#3)
microcirculatory level##2##2##(2008-5#1)(2011-2#1)
microcirculatory perfusion##2##2##(1997-2#2)
microcirculatory##16##1##(1992-9#1)(1997-2#3)(2008-1#1)(2008-5#3)(2009-7#3)(2011-2#5)
microclimate##7##1##(1996-3#1)(2008-10#5)(2013-7#1)
microclone##2##1##(2008-5#2)
microcloning##6##1##(2008-5#1)(2008-7#3)(2008-9#2)
micrococcal nuclease##4##2##(1997-3#1)(2008-2#1)(2008-8#2)
micrococcal##5##1##(1994-8#1)(1997-3#1)(2008-2#1)(2008-8#2)
microcolumn and##3##2##(2008-10#3)
microcolumn in##2##2##(2008-10#2)
microcolumn packed with activated##2##4##(2008-10#2)
microcolumn packed with##7##3##(2008-10#7)
microcolumn##32##1##(2008-10#30)(2011-1#1)(2012-2#1)
microcolumns and##3##2##(2008-10#3)
microcolumns in a sequential injection system##2##6##(2008-10#2)
microcolumns##9##1##(2008-10#9)
microcomputed tomography##3##2##(2010-10#1)(2011-2#1)(2012-2#1)
microcomputer and##2##2##(2008-10#2)
microcomputer for##2##2##(2008-10#2)
microcomputer##15##1##(1992-2#1)(2008-10#13)(2008-3#1)
microcomputers##2##1##(1991-3#1)(1994-3#1)
microconidia##3##1##(2008-10#3)
microcontact printing##2##2##(2008-10#1)(2010-4#1)
microcontroller##2##1##(2008-10#1)(2011-1#1)
microcosm##8##1##(1991-2#1)(2008-10#3)(2008-5#1)(2008-8#3)
microcosmic##3##1##(2008-8#3)
microcosms##6##1##(2008-10#1)(2008-5#2)(2008-8#3)
microcracks interaction##2##2##(2009-7#2)
microcracks##7##1##(2008-2#1)(2008-7#1)(2009-7#5)
microcrystalline cellulose and soluble starch##2##5##(2013-8#2)
microcrystalline cellulose##5##2##(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#2)
microcrystalline naphthalene or by column method##2##6##(2008-10#2)
microcrystalline naphthalene or by##4##4##(2008-10#4)
microcrystalline naphthalene or##6##3##(2008-10#6)
microcrystalline naphthalene##15##2##(2008-10#15)
microcrystalline phenolphthalein##3##2##(2008-10#3)
microcrystalline##29##1##(1997-7#1)(2008-10#23)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
microcycle conidiation##2##2##(2008-10#2)
microcystin levels in water##2##4##(2008-5#2)
microcystin##5##1##(1995-8#1)(2008-10#1)(2008-5#2)(2012-12#1)
microcystin-LR analysis##2##2##(2008-10#2)
microcystin-LR in##3##2##(2008-10#3)
microcystin-LR##11##1##(1990-12#1)(1995-8#1)(2008-10#7)(2008-2#1)(2008-4#1)
microcystins##6##1##(2008-10#4)(2010-5#2)
microcysts##6##1##(1990-11#5)(2010-6#1)
microcytic##2##1##(2008-4#1)(2012-2#1)
microdebridement for##2##2##(2010-3#2)
microdebrider blade##2##2##(2012-1#2)
microdeletion##4##1##(1993-11#1)(1994-9#1)(1997-3#2)
microdialysate##2##1##(2008-10#2)
microdialysis and##6##2##(1992-8#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#2)
microdialysis for##2##2##(1996-12#1)(2008-8#1)
microdialysis in##4##2##(1992-3#2)(1997-2#1)(2008-8#1)
microdialysis is##2##2##(1994-8#1)(1995-12#1)
microdialysis probe was##2##3##(1997-2#1)(2008-10#1)
microdialysis probe##10##2##(1993-6#1)(1994-8#1)(1997-2#3)(2008-10#3)(2008-7#2)
microdialysis probes##2##2##(1995-5#1)(2008-10#1)
microdialysis sampling coupled with flame atomic absorption spectrometry##2##8##(2008-10#2)
microdialysis sampling coupled##3##3##(2008-10#2)(2008-7#1)
microdialysis sampling has been##2##4##(2008-8#2)
microdialysis sampling##10##2##(2008-10#5)(2008-7#2)(2008-8#3)
microdialysis studies##2##2##(2008-7#2)
microdialysis study##2##2##(1992-7#1)(1997-7#1)
microdialysis technique##3##2##(1994-8#1)(1995-12#1)(2008-8#1)
microdialysis##71##1##(1992-3#2)(1992-7#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-8#4)(1995-12#9)(1995-3#1)(1995-5#1)(1996-12#1)(1997-2#7)(1997-6#1)(1997-7#3)(2008-10#21)(2008-7#8)(2008-8#8)(2010-2#1)
microdiffractive-microrefractive lens with a continuous relief##2##6##(2008-3#2)
microdilution method##2##2##(2008-1#1)(2008-12#1)
microdilution##6##1##(2008-1#1)(2008-12#2)(2008-5#1)(2011-2#1)(2013-1#1)
microdischarge devices##2##2##(2007-12#2)
microdisk electrodes##3##2##(2008-10#3)
microdisk##12##1##(2007-11#1)(2007-12#1)(2008-10#10)
microdissected cells##2##2##(2008-1#1)(2010-12#1)
microdissected##6##1##(2008-1#2)(2008-5#1)(2008-9#1)(2010-12#2)
microdissection (LCM)##2##2##(2009-8#1)(2010-12#1)
microdissection and##4##2##(2008-7#3)(2010-12#1)
microdissection for##2##2##(2008-4#1)(2008-9#1)
microdissection of##4##2##(2008-4#3)(2010-1#1)
microdissection##18##1##(2008-12#2)(2008-2#1)(2008-4#6)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-2#1)
microdistillation##2##1##(2008-10#2)
microdistribution of mineral ions in roots##2##6##(2008-9#2)
microdistribution of mineral ions in##3##5##(2008-9#3)
microdomain structures##2##2##(2009-8#2)
microdomain##5##1##(2008-10#1)(2009-8#2)(2009-9#1)(2012-2#1)
microdomains##4##1##(1995-2#2)(2008-5#1)(2008-8#1)
microdosing is##2##2##(2010-11#2)
microdosing studies##2##2##(2010-11#2)
microdosing##4##1##(2010-11#4)
microdrop and sample##2##3##(2008-10#2)
microdrop and##3##2##(2008-10#3)
microdrop of##3##2##(2008-10#3)
microdrop##12##1##(2008-10#10)(2008-11#2)
microdroplets##12##1##(2007-12#3)(2008-2#7)(2008-3#1)(2008-9#1)
microelectrode array##6##2##(2008-10#3)(2010-2#2)(2013-1#1)
microelectrode arrays##2##2##(2008-10#1)(2013-1#1)
microelectrode in##2##2##(2008-10#2)
microelectrode was##4##2##(2008-10#4)
microelectrode##41##1##(1992-11#1)(1993-12#2)(2008-10#29)(2008-3#1)(2008-7#3)(2010-2#2)(2013-1#3)
microelectrodes and confocal##2##3##(2008-7#2)
microelectrodes##20##1##(2008-10#9)(2008-3#1)(2008-4#2)(2008-7#2)(2009-12#3)(2010-2#2)(2010-6#1)
microelectromechanical mirror##5##2##(2007-11#3)(2007-12#2)
microelectromechanical systems (MEMS)##2##3##(2007-12#1)(2008-2#1)
microelectromechanical##10##1##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)(2009-11#1)(2009-9#1)
microelectronic##3##1##(1990-12#1)(2008-3#2)
microelectronics##2##1##(2008-2#1)(2009-12#1)
microelement metabolism##2##2##(2011-2#2)
microelements##4##1##(2008-10#2)(2008-3#1)(2013-8#1)
microemboli and##2##2##(2007-10#1)(2007-8#1)
microembolic signals##5##2##(2007-10#2)(2007-8#3)
microemulsion and##3##2##(1996-5#1)(2008-10#2)
microemulsion in##2##2##(2008-10#1)(2011-1#1)
microemulsion system##2##2##(2008-10#2)
microemulsion technique##2##2##(2008-10#2)
microemulsion##25##1##(1996-5#3)(2008-10#18)(2008-11#1)(2008-5#2)(2011-1#1)
microemulsions##5##1##(2008-10#3)(2008-5#1)(2012-2#1)
microencapsulated##7##1##(2008-10#1)(2010-11#2)(2010-5#1)(2011-2#3)
microencapsulation##3##1##(1995-3#1)(2010-5#1)(2013-1#1)
microencoder##2##1##(2008-3#2)
microenvironment and##2##2##(2008-10#1)(2009-5#1)
microenvironment as##2##2##(2008-10#1)(2012-2#1)
microenvironment during##2##2##(2010-10#1)(2013-8#1)
microenvironment for##3##2##(2008-11#1)(2009-9#1)(2010-10#1)
microenvironment in the##2##3##(2009-10#1)(2012-2#1)
microenvironment in which##2##3##(1994-9#1)(2010-5#1)
microenvironment in##11##2##(1994-9#3)(2009-10#1)(2010-10#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#2)
microenvironment is##6##2##(1994-9#1)(2009-3#3)(2011-1#2)
microenvironment of a##2##3##(2009-4#1)(2010-1#1)
microenvironment of the##2##3##(2008-10#1)(2011-1#1)
microenvironment of##10##2##(1990-5#1)(1994-5#1)(2008-10#4)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)
microenvironment that##2##2##(2010-3#1)(2012-2#1)
microenvironment to##2##2##(2011-1#1)(2012-2#1)
microenvironment##93##1##(1990-5#3)(1991-5#1)(1991-9#1)(1994-5#1)(1994-7#1)(1994-9#4)(2008-1#1)(2008-10#11)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#12)(2009-4#4)(2009-5#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#2)
microenvironments of##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
microenvironments##16##1##(1990-5#1)(1992-6#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2009-3#2)(2011-1#3)(2012-12#1)(2012-3#1)
microepsilon and##5##2##(2008-3#5)
microepsilon##7##1##(2008-3#7)
microevolutionary forces##2##2##(2008-8#2)
microevolutionary##3##1##(2008-8#3)
microextraction (HSSPME)##3##2##(2008-10#3)
microextraction (SPME) and##2##3##(2008-10#2)
microextraction (SPME) coupled##2##3##(2008-10#2)
microextraction (SPME) fiber##3##3##(2008-10#2)(2012-1#1)
microextraction (SPME) to##3##3##(2008-10#3)
microextraction (SPME) was##2##3##(2008-10#2)
microextraction (SPME)##26##2##(2008-10#23)(2009-8#1)(2012-1#1)(2012-12#1)
microextraction and gas##3##3##(2008-10#3)
microextraction and thermal desorption##2##4##(2008-10#2)
microextraction and##8##2##(2008-10#8)
microextraction coupled to##2##3##(2008-10#2)
microextraction coupled with gas##3##4##(2008-10#3)
microextraction coupled with high-performance liquid chromatography##3##6##(2008-10#3)
microextraction coupled with liquid##2##4##(2008-10#2)
microextraction coupled with##9##3##(2008-10#9)
microextraction coupled##11##2##(2008-10#11)
microextraction for the##2##3##(2008-10#2)
microextraction of##5##2##(2008-10#4)(2012-1#1)
microextraction solvent##2##2##(2008-10#2)
microextraction systems##3##2##(2008-10#3)
microextraction technique##2##2##(2008-10#2)
microextraction with##3##2##(2008-10#3)
microextraction##110##1##(1997-2#1)(2008-10#103)(2009-8#1)(2012-1#3)(2012-12#2)
microextraction-gas##3##1##(2008-10#3)
microfabricated##15##1##(2007-11#1)(2007-12#1)(2008-10#9)(2008-3#3)(2008-7#1)
microfabrication technology##2##2##(2008-10#1)(2008-3#1)
microfabrication##13##1##(2007-11#4)(2007-12#1)(2008-10#3)(2008-3#3)(2008-7#1)(2010-10#1)
microfiber##2##1##(2008-10#2)
microfibers##3##1##(2007-12#3)
microfibril##4##1##(2008-11#1)(2008-5#2)(2012-2#1)
microfibrils##6##1##(1990-11#1)(1993-3#3)(2008-11#1)(2008-5#1)
microfilament##5##1##(1993-8#1)(1994-6#1)(2009-10#1)(2012-7#2)
microfilaments##5##1##(1990-8#4)(1994-11#1)
microfilaraemic patients##4##2##(1994-11#4)
microfilariae##2##1##(1990-8#2)
microfilled##2##1##(2011-2#2)
microfiltration membranes were##2##3##(2008-7#2)
microfiltration membranes##5##2##(2008-7#5)
microfiltration of##2##2##(1992-5#1)(2008-7#1)
microfiltration##10##1##(1992-5#3)(1994-5#1)(2008-7#6)
microfine TiO(2)##3##2##(2008-5#3)
microfine ZnO##2##2##(2008-5#2)
microfine oxides##3##2##(2008-5#3)
microfine##10##1##(2008-5#10)
microflora in##3##2##(2008-10#2)(2012-3#1)
microflora of the##2##3##(2008-5#1)(2012-3#1)
microflora of##6##2##(1993-8#2)(2008-5#3)(2012-3#1)
microflora or##2##2##(2008-10#1)(2008-11#1)
microflora to##2##2##(1993-8#1)(2008-10#1)
microflora was##3##2##(2008-5#3)
microflora were##2##2##(2008-11#1)(2008-5#1)
microflora##46##1##(1993-8#4)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#13)(2008-7#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#5)
microfluidic analysis systems##2##3##(2008-10#2)
microfluidic approach##2##2##(2009-12#2)
microfluidic capillary electrophoresis (CE)##2##4##(2008-10#2)
microfluidic capillary electrophoresis system##2##4##(2008-10#2)
microfluidic capillary electrophoresis##5##3##(2008-10#5)
microfluidic channel##2##2##(2007-10#1)(2009-2#1)
microfluidic channels##10##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#3)(2009-2#1)(2010-8#2)(2011-1#1)
microfluidic chips##2##2##(2008-10#2)
microfluidic device for##2##3##(2008-10#2)
microfluidic device##8##2##(2008-10#7)(2009-5#1)
microfluidic devices##9##2##(2008-10#8)(2009-12#1)
microfluidic flow cells##3##3##(2008-10#3)
microfluidic flow##5##2##(2008-10#5)
microfluidic system##4##2##(2008-10#2)(2009-9#1)(2011-1#1)
microfluidic systems##4##2##(2008-10#4)
microfluidic##74##1##(2007-10#2)(2008-10#45)(2008-12#1)(2008-3#3)(2009-12#9)(2009-2#3)(2009-5#1)(2009-9#1)(2010-8#2)(2011-1#6)(2011-2#1)
microfluidics##3##1##(2008-10#2)(2008-8#1)
microfluorometry##2##1##(1994-6#1)(1996-2#1)
microg Cd/g liver for Cu for females consuming##2##8##(1997-4#2)
microg Cd/g liver for Zn and##2##6##(1997-4#2)
microg Cd/g liver for##4##4##(1997-4#4)
microg Cd/g##5##2##(1997-4#5)
microg L(-1) and##2##3##(2008-10#1)(2010-5#1)
microg L(-1)##10##2##(2007-12#1)(2008-10#7)(2008-9#1)(2010-5#1)
microg L(-1))##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2010-5#1)
microg Pl(-1)##4##2##(2008-10#4)
microg g(-1) level##2##3##(2008-10#2)
microg g(-1) of##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
microg g(-1)##11##2##(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#3)
microg kg(-1)##2##2##(2008-10#1)(2010-5#1)
microg l(-1) Ru##2##3##(2008-10#2)
microg l(-1) and##5##3##(2008-10#5)
microg l(-1) for CK-MB mass)##2##5##(2008-10#2)
microg l(-1) for troponin I##2##5##(2008-10#2)
microg l(-1) for##8##3##(2008-10#8)
microg l(-1) level for##3##4##(2008-10#3)
microg l(-1) of##4##3##(2008-10#4)
microg l(-1)##51##2##(2008-10#51)
microg mL(-1) almost##2##3##(2008-12#1)(2011-2#1)
microg mL(-1) for octyl##2##4##(2008-5#2)
microg mL(-1) for##5##3##(2008-10#1)(2008-5#4)
microg mL(-1)##8##2##(2008-10#1)(2008-12#1)(2008-5#4)(2011-2#1)(2011-3#1)
microg min(-1) mm(-2)##2##3##(2008-5#2)
microg ml(-1) (r=0##2##3##(2008-10#2)
microg ml(-1) for Sb(III) and Sb(V)##2##6##(2008-10#2)
microg ml(-1) for##4##3##(2008-10#4)
microg ml(-1) of V(v)##2##4##(2008-10#2)
microg ml(-1) of##4##3##(2008-10#3)(2008-11#1)
microg ml(-1) with##2##3##(2008-10#2)
microg ml(-1)##32##2##(2008-10#31)(2008-11#1)
microg ml(-1)) and##2##3##(2008-10#2)
microg ml(-1))##3##2##(2008-10#3)
microg of GXM by subcutaneous route##2##6##(2007-10#2)
microg of GXM##3##3##(2007-10#3)
microg of Zineb##2##3##(2008-10#2)
microg of Ziram##2##3##(2008-10#2)
microg of water##2##3##(2008-10#2)
microg of##25##2##(1994-6#1)(1997-4#1)(2007-10#3)(2007-12#4)(2008-1#1)(2008-10#11)(2008-4#1)(2009-5#2)(2011-2#1)
microg x L(-1)##2##3##(2013-8#2)
microg x mL-1##2##3##(2009-6#2)
microg x##7##2##(2009-6#2)(2011-3#2)(2013-8#3)
microg##195##1##(1994-6#1)(1995-12#1)(1997-4#7)(1997-7#1)(2007-10#3)(2007-12#5)(2008-1#2)(2008-10#129)(2008-11#3)(2008-12#5)(2008-4#1)(2008-5#8)(2008-7#3)(2008-9#3)(2009-5#4)(2009-6#2)(2010-5#4)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#3)(2013-8#3)
microg)##10##1##(1995-12#4)(2008-7#2)(2009-4#3)(2010-6#1)
microg/1##2##1##(2007-5#1)(2008-11#1)
microg/10 ml##2##2##(2008-10#2)
microg/L for##3##2##(2008-8#1)(2011-1#2)
microg/L with##2##2##(2008-10#1)(2011-1#1)
microg/L##14##1##(2007-11#2)(2008-10#2)(2008-8#3)(2010-5#2)(2011-1#5)
microg/day administered with a##2##4##(2007-11#2)
microg/day##6##1##(2007-11#4)(2011-2#2)
microg/day)##2##1##(2007-11#1)(2007-8#1)
microg/g for##4##2##(2008-10#2)(2008-11#2)
microg/g##9##1##(2008-10#5)(2008-11#4)
microg/insect for##2##2##(2008-11#2)
microg/kg##10##1##(1997-6#3)(1997-7#2)(2011-1#1)(2011-2#4)
microg/kg/min)##2##1##(1995-12#2)
microg/l (for 1##2##3##(2008-10#2)
microg/l among##2##2##(2009-10#2)
microg/l for 1##2##3##(2008-10#2)
microg/l for##3##2##(2008-10#3)
microg/l##16##1##(2007-5#1)(2008-10#13)(2009-10#2)
microg/l)##2##1##(2007-5#1)(2008-10#1)
microg/m(2)/d)##2##1##(2008-11#2)
microg/m(3)##3##1##(2008-11#3)
microg/mL for##2##2##(2008-10#2)
microg/mL##15##1##(2007-11#1)(2007-7#2)(2008-10#7)(2011-2#1)(2012-3#4)
microg/mL)##5##1##(2007-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
microg/ml and##6##2##(1997-4#1)(2008-10#1)(2008-5#3)(2010-3#1)
microg/ml collagen##4##2##(1997-7#4)
microg/ml for E##2##3##(2008-10#2)
microg/ml for NE##2##3##(2008-10#2)
microg/ml for##6##2##(2008-1#2)(2008-10#4)
microg/ml in the##2##3##(2011-2#2)
microg/ml of##3##2##(2008-10#1)(2008-7#2)
microg/ml##39##1##(1997-4#4)(1997-7#4)(2007-1#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#9)(2008-7#2)(2010-3#1)(2011-2#2)
microg/ml)##10##1##(1994-10#1)(1997-7#1)(2008-5#6)(2008-8#1)(2011-2#1)
microg/rat##2##1##(1995-12#2)
microgL(-1)##3##1##(2008-10#2)(2010-5#1)
microgel##3##1##(1997-4#2)(2008-10#1)
microgels##7##1##(2008-10#7)
microgl(-1)##3##1##(2008-10#3)
microglandular##3##1##(1994-12#2)(2011-2#1)
microglia activation##3##2##(2008-4#2)(2008-8#1)
microglia and##2##2##(1995-12#1)(2008-4#1)
microglia in the##4##3##(2008-6#2)(2008-7#2)
microglia in##10##2##(1997-3#3)(2008-6#4)(2008-7#3)
microglia were##2##2##(1996-5#1)(1997-3#1)
microglia##34##1##(1995-12#3)(1996-5#1)(1997-3#4)(2008-4#5)(2008-6#7)(2008-7#8)(2008-8#2)(2009-12#1)(2010-1#1)(2012-2#1)(2013-7#1)
microglia/macrophages##2##1##(2007-10#1)(2008-7#1)
microglial NADPH##2##2##(2009-12#2)
microglial activation and##2##3##(1996-12#1)(2012-2#1)
microglial activation##5##2##(1996-12#1)(2008-7#2)(2009-12#1)(2012-2#1)
microglial cell##2##2##(1995-12#1)(2008-4#1)
microglial cells##4##2##(1997-2#1)(2008-4#3)
microglial function##2##2##(2008-7#2)
microglial##23##1##(1995-12#2)(1996-12#1)(1997-2#1)(1997-3#1)(2008-4#5)(2008-6#1)(2008-7#8)(2009-12#3)(2012-2#1)
microglobulin##5##1##(1990-12#1)(1995-1#3)(2008-7#1)
microgml(-1) and##2##2##(2008-10#2)
microgml(-1)##6##1##(2008-10#6)
microgram Hg/l##2##2##(1993-8#2)
microgram g-1 Al for##2##4##(1995-6#2)
microgram g-1 Al##4##3##(1995-6#4)
microgram quantities##2##2##(2008-10#1)(2010-3#1)
microgram to##2##2##(2008-1#1)(2008-10#1)
microgram##18##1##(1990-2#1)(1993-8#4)(1995-6#4)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#5)(2010-3#1)
microgram/g creatinine##2##2##(1994-5#2)
microgram/g for Pb and##2##4##(1997-4#2)
microgram/g##6##1##(1991-12#1)(1994-5#2)(1997-4#3)
microgram/microgram for brain and##2##4##(1996-2#2)
microgram/microgram for liver)##2##3##(1996-2#2)
microgram/microgram for##4##2##(1996-2#4)
microgram/ml##6##1##(1990-12#1)(1990-2#1)(1990-5#1)(1995-5#1)(1997-2#1)(1997-4#1)
microgram/ml)##2##1##(1991-5#1)(1995-11#1)
micrograms GLP-1 i##2##3##(1996-2#2)
micrograms Hg/g##2##2##(1993-8#2)
micrograms and##2##2##(1990-6#1)(1992-3#1)
micrograms i##2##2##(1992-3#2)
micrograms in 0##2##3##(1992-2#1)(1993-6#1)
micrograms in##3##2##(1992-2#1)(1993-6#1)(1997-2#1)
micrograms injected##2##2##(1991-5#2)
micrograms kg-1##2##2##(1995-5#2)
micrograms ml-1 for##2##3##(1996-2#2)
micrograms ml-1##5##2##(1990-8#1)(1996-2#4)
micrograms ml-1)##2##2##(1994-3#1)(1996-2#1)
micrograms of PG##2##3##(1990-2#2)
micrograms of boron per g of tissue and tumor/blood boron ratios of approximately##2##13##(1995-2#2)
micrograms of liver protein##2##4##(1992-6#1)(1993-9#1)
micrograms of##20##2##(1990-2#2)(1990-7#2)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#3)(1997-4#1)(2008-10#3)
micrograms per##3##2##(1990-12#1)(1995-2#2)
micrograms side-1)##2##2##(1991-2#2)
micrograms twice daily##2##3##(1996-2#2)
micrograms##86##1##(1990-12#1)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-6#1)(1992-8#3)(1992-9#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#5)(1995-5#5)(1996-1#2)(1996-12#5)(1996-2#10)(1997-2#1)(1997-4#1)(2008-10#3)
micrograms) and##5##2##(1991-12#1)(1992-3#1)(1992-6#1)(1996-1#1)(1996-2#1)
micrograms) into the##2##3##(1991-2#2)
micrograms) twice daily##2##3##(1996-1#2)
micrograms)##18##1##(1990-7#1)(1991-12#1)(1991-2#3)(1992-3#3)(1992-6#1)(1993-6#1)(1995-12#2)(1996-1#4)(1996-2#2)
micrograms/day##3##1##(1992-9#1)(1995-6#2)
micrograms/dl##8##1##(1995-11#1)(1995-3#1)(1997-4#6)
micrograms/g dry##2##2##(1990-5#1)(1992-9#1)
micrograms/g for Cu##2##3##(1997-4#2)
micrograms/g for Ni##2##3##(1997-4#2)
micrograms/g for Zn##2##3##(1997-4#2)
micrograms/g for##6##2##(1997-4#6)
micrograms/g liver at##3##3##(1995-3#3)
micrograms/g liver##4##2##(1995-3#4)
micrograms/g##20##1##(1990-5#5)(1990-8#4)(1992-9#1)(1995-3#4)(1997-4#6)
micrograms/kg i##4##2##(1990-5#1)(1994-8#1)(1996-2#2)
micrograms/kg##19##1##(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-3#1)(1994-8#4)(1995-12#1)(1995-3#4)(1996-2#2)(1996-9#1)
micrograms/kg)##7##1##(1990-5#1)(1991-2#1)(1991-5#1)(1994-5#1)(1994-8#2)(1995-3#1)
micrograms/l##8##1##(1990-9#2)(1994-9#1)(1996-12#5)
micrograms/l)##3##1##(1996-12#2)(1996-5#1)
micrograms/m3##2##1##(1994-9#1)(1997-1#1)
micrograms/mg cell##2##2##(1990-8#2)
micrograms/mg##3##1##(1990-5#1)(1990-8#2)
micrograms/microliter##2##1##(1993-6#1)(1996-5#1)
micrograms/ml and##2##2##(1993-6#1)(1997-4#1)
micrograms/ml conjugate##2##2##(1994-11#2)
micrograms/ml in patients with##2##4##(1995-12#2)
micrograms/ml in##5##2##(1992-2#2)(1995-12#2)(1995-2#1)
micrograms/ml of lipoprotein cholesterol)##2##4##(1990-8#2)
micrograms/ml of##6##2##(1990-12#1)(1990-8#2)(1992-8#1)(1993-8#1)(1994-11#1)
micrograms/ml or more##2##3##(1990-2#1)(1991-8#1)
micrograms/ml or##4##2##(1990-2#1)(1991-8#3)
micrograms/ml were##3##2##(1990-6#1)(1995-12#1)(1997-4#1)
micrograms/ml##37##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#2)(1990-8#3)(1991-2#3)(1991-6#1)(1991-8#3)(1992-2#2)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#4)(1995-12#3)(1995-2#1)(1997-2#1)(1997-4#3)
micrograms/ml) induced##3##2##(1990-2#2)(1993-12#1)
micrograms/ml) significantly##2##2##(1992-3#2)
micrograms/ml) was##2##2##(1990-6#1)(1994-2#1)
micrograms/ml)##29##1##(1990-2#3)(1990-6#1)(1991-2#1)(1991-8#4)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)
micrograph of the##2##3##(2008-9#1)(2009-7#1)
micrograph##5##1##(1994-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-7#1)
micrographic surgery is a##2##4##(2007-12#1)(2010-8#1)
micrographic surgery is##3##3##(2007-12#1)(2010-8#2)
micrographic surgery##15##2##(2007-12#2)(2010-8#13)
micrographic##17##1##(1990-11#1)(1993-12#1)(2007-12#2)(2010-8#13)
micrographs and##3##2##(2008-10#3)
micrographs are##2##2##(2008-3#1)(2008-5#1)
micrographs of the##2##3##(2008-5#1)(2009-11#1)
micrographs of##11##2##(1991-5#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)
micrographs showed that##2##3##(2008-8#1)(2013-1#1)
micrographs showed##4##2##(1995-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
micrographs##32##1##(1991-5#1)(1995-6#2)(1997-3#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-8#1)(2009-11#1)(2009-7#1)(2013-1#1)
microgravimetric##3##1##(2008-10#3)
microgravity and##3##2##(2008-3#2)(2008-9#1)
microgravity on##5##2##(2008-4#1)(2008-8#1)(2008-9#3)
microgravity##19##1##(2007-12#1)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#8)(2009-7#3)
microhabitat##3##1##(2008-10#1)(2011-2#1)(2013-7#1)
microhabitats##3##1##(2010-8#2)(2011-2#1)
microhardness and##3##2##(1997-4#1)(2009-7#1)(2012-2#1)
microhardness ratio##2##2##(2008-12#2)
microhardness test##2##2##(2008-12#2)
microhardness##15##1##(1997-4#1)(2008-12#11)(2008-3#1)(2009-7#1)(2012-2#1)
microhematuria##4##1##(1997-7#4)
microheterogeneity in##2##2##(2008-10#1)(2010-12#1)
microheterogeneity##4##1##(1990-8#1)(2008-10#2)(2010-12#1)
microhybrid composite resin##4##3##(2008-12#2)(2009-8#2)
microhybrid##6##1##(2008-12#3)(2009-8#2)(2012-6#1)
microimaging##2##1##(2008-11#1)(2011-1#1)
microimmunofluorescence test##2##2##(1993-2#2)
microindentation##2##1##(1997-4#1)(2011-2#1)
microinflammation##2##1##(2008-5#2)
microinfusion of##2##2##(1996-12#1)(1997-7#1)
microinfusion##5##1##(1996-12#2)(1996-2#1)(1997-7#1)(2008-5#1)
microinjected into the nucleus tractus solitarius (NTS) of unanesthetized rats##2##10##(1997-2#2)
microinjected into the##6##3##(1990-7#1)(1995-12#1)(1996-5#1)(1997-2#3)
microinjected into##10##2##(1990-7#1)(1991-12#2)(1995-12#1)(1995-3#1)(1996-5#1)(1997-2#3)(2010-5#1)
microinjected##17##1##(1990-7#2)(1991-12#2)(1993-12#1)(1993-6#2)(1994-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-2#4)(2008-11#1)(2010-5#1)
microinjection of the##2##3##(2007-10#1)(2010-5#1)
microinjection of##12##2##(1990-5#1)(1992-5#1)(1993-12#2)(1994-8#1)(1996-5#2)(1996-6#1)(1997-2#1)(2007-10#1)(2008-4#1)(2010-5#1)
microinjection to generate##2##3##(2008-4#1)(2008-9#1)
microinjection to##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
microinjection##30##1##(1990-5#1)(1991-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-8#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-11#2)(2008-2#2)(2008-4#4)(2008-9#3)(2010-4#1)(2010-5#3)
microinjections of bicuculline##2##3##(1993-12#2)
microinjections of##5##2##(1990-7#1)(1993-12#4)
microinjections##8##1##(1990-7#1)(1993-12#6)(1997-7#1)
microjetted microlenses##2##2##(2008-3#2)
microjoule femtosecond##2##2##(2007-11#1)(2008-3#1)
microjoule##5##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
microl 0##2##2##(2008-10#2)
microl l(-1)##3##2##(2008-10#3)
microl min(-1)g(-1)kPa(-1) for the##2##4##(2007-12#2)
microl min(-1)g(-1)kPa(-1)##4##2##(2007-12#4)
microl of##8##2##(2008-10#7)(2010-5#1)
microl sample##2##2##(2008-10#2)
microl##39##1##(1995-12#2)(1997-4#1)(2007-12#4)(2008-10#26)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)
microl) and##2##2##(2008-10#2)
microl)##14##1##(1995-12#3)(1997-4#1)(2008-10#9)(2008-4#1)
microl/ml##2##1##(2008-8#1)(2011-2#1)
microlaser##4##1##(2007-11#3)(2008-3#1)
microlens array and##3##3##(2007-11#2)(2008-10#1)
microlens array##14##2##(2007-11#5)(2008-10#3)(2008-2#1)(2008-3#5)
microlens arrays and##2##3##(2008-3#2)
microlens arrays were##2##3##(2008-2#1)(2008-3#1)
microlens arrays with##2##3##(2008-2#1)(2008-3#1)
microlens arrays##10##2##(2008-2#2)(2008-3#8)
microlens pairs##2##2##(2008-2#2)
microlens was##3##2##(2008-2#2)(2008-3#1)
microlens with##2##2##(2007-12#1)(2008-3#1)
microlens##51##1##(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#13)(2008-3#25)(2011-1#3)
microlenses and##3##2##(2008-2#2)(2008-3#1)
microlenses are##2##2##(2008-2#2)
microlenses by##2##2##(2008-2#1)(2008-3#1)
microlenses on##2##2##(2008-2#1)(2008-3#1)
microlenses were##2##2##(2008-2#1)(2008-3#1)
microlenses with##3##2##(2007-12#1)(2008-3#2)
microlenses without a beam-shaping aperture##2##5##(2008-3#2)
microlenses##38##1##(2007-12#3)(2008-2#12)(2008-3#23)
microliter##7##1##(1993-6#1)(1997-4#2)(1997-6#1)(2008-10#3)
microliter)##4##1##(1994-8#3)(1997-4#1)
microliters of sample##2##3##(2008-10#2)
microliters of##8##2##(1990-5#1)(1990-7#1)(1990-8#1)(1994-2#1)(2008-10#4)
microliters##10##1##(1990-5#1)(1990-7#1)(1990-8#1)(1994-2#1)(1995-5#1)(2008-10#5)
microliters)##6##1##(1990-12#1)(1993-6#1)(1995-12#4)
microliters/mg dry weight##3##3##(1991-11#3)
microliters/mg dry##4##2##(1991-11#4)
microlithography##3##1##(2008-3#3)
microm and a##2##3##(2007-12#1)(2008-3#1)
microm and an##3##3##(2008-3#3)
microm and the##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
microm and##21##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#11)(2008-5#2)
microm are##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
microm at a##2##3##(2008-3#2)
microm at the##2##3##(2007-12#1)(2008-3#1)
microm at##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
microm by a##2##3##(2007-11#1)(2007-12#1)
microm by use of a##3##5##(2007-12#2)(2008-2#1)
microm by use of##4##4##(2007-12#2)(2008-2#2)
microm by##11##2##(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#1)
microm deep##2##2##(2007-12#1)(2008-10#1)
microm diameter##2##2##(2008-10#1)(2010-5#1)
microm for a##2##3##(2008-2#1)(2008-3#1)
microm for an ice particle)##2##5##(2008-3#2)
microm for the##2##3##(2007-12#1)(2008-3#1)
microm for##12##2##(2007-12#1)(2008-2#2)(2008-3#9)
microm from##2##2##(2007-11#1)(2008-2#1)
microm has##2##2##(2007-12#1)(2008-3#1)
microm in a##2##3##(2007-11#1)(2007-12#1)
microm in##12##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#6)(2008-7#1)
microm is presented##3##3##(2007-12#1)(2008-3#2)
microm is used##2##3##(2008-3#2)
microm is##11##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)
microm long##9##2##(2007-12#6)(2008-7#1)(2009-11#1)(2010-10#1)
microm mesh net##3##3##(2011-2#3)
microm mesh##4##2##(2011-2#4)
microm particle packed analytical columns##2##5##(2008-10#2)
microm thick##2##2##(2007-12#1)(2008-3#1)
microm was##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
microm were##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
microm wide##2##2##(2008-10#1)(2010-8#1)
microm with a##3##3##(2008-2#1)(2008-3#2)
microm with##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
microm x 5##2##3##(2008-3#1)(2013-8#1)
microm x 800##2##3##(2008-2#1)(2008-3#1)
microm x##5##2##(2008-2#1)(2008-3#3)(2013-8#1)
microm##315##1##(1991-5#2)(1994-9#1)(1996-12#2)(2007-11#36)(2007-12#50)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#34)(2008-3#137)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#6)
microm(-1)##3##1##(2008-2#1)(2008-3#1)(2009-11#1)
microm(2)##2##1##(2007-11#1)(2007-12#1)
microm) and##4##2##(2007-12#2)(2008-3#1)(2008-8#1)
microm) are##3##2##(2007-12#1)(2008-2#2)
microm) as##2##2##(2008-10#1)(2008-2#1)
microm) in##2##2##(2007-12#1)(2011-1#1)
microm) of the##2##3##(2008-2#1)(2008-3#1)
microm) was##2##2##(2008-3#1)(2008-8#1)
microm) with a gradient##2##4##(2011-1#1)(2012-3#1)
microm) with a##4##3##(2007-12#2)(2011-1#1)(2012-3#1)
microm) with##7##2##(2007-12#2)(2008-2#1)(2008-3#1)(2011-1#2)(2012-3#1)
microm)##59##1##(1997-3#3)(1997-4#1)(2007-12#14)(2008-1#1)(2008-10#4)(2008-2#7)(2008-3#13)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2010-8#1)(2011-1#4)(2011-3#1)(2012-3#1)
microm/bit##3##1##(2008-3#3)
micromachined membrane deformable mirror##6##4##(2007-11#1)(2008-3#5)
micromachined##22##1##(2007-11#5)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#11)
micromachining of##2##2##(2007-11#1)(2007-12#1)
micromachining##8##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
micromanipulation##4##1##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
micromechanical properties of##4##3##(1997-4#1)(2010-4#3)
micromechanical##13##1##(1997-4#2)(2008-3#5)(2009-7#3)(2010-4#3)
micromechanics##7##1##(1995-5#1)(2008-3#1)(2008-8#1)(2009-7#3)(2012-2#1)
micromesh##2##1##(2008-3#2)
micrometastases##8##1##(1996-3#1)(2007-5#2)(2008-10#2)(2010-3#3)
micrometastasis##2##1##(1997-4#1)(2010-8#1)
micrometastatic prostate cells##2##3##(1995-11#2)
micrometeorological data##2##2##(2008-10#2)
micrometeorological##5##1##(2008-10#2)(2008-11#1)(2008-3#2)
micrometer level##2##2##(2008-3#1)(2009-11#1)
micrometer range##4##2##(1997-2#1)(2008-10#2)(2008-2#1)
micrometer scale##2##2##(2007-12#1)(2012-2#1)
micrometer##19##1##(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#4)
micrometer-scale resolution##2##2##(2007-11#1)(2007-12#1)
micrometer-scale##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
micrometer-size tumor##2##2##(2008-11#2)
micrometer-size##7##1##(2007-11#1)(2008-11#3)(2008-2#1)(2008-3#2)
micrometer-sized polymer elements at the##2##5##(2008-3#2)
micrometer-sized polymer##3##2##(2008-10#1)(2008-3#2)
micrometer-sized##8##1##(2007-11#3)(2008-10#1)(2008-3#4)
micrometers and##2##2##(2008-10#1)(2008-2#1)
micrometers to##2##2##(2007-12#1)(2008-2#1)
micrometers##15##1##(1991-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)(2008-4#1)(2012-2#1)
micromethod##3##1##(1992-11#1)(1996-12#2)
micrometric##3##1##(2008-10#1)(2008-3#1)(2008-5#1)
micromirror##16##1##(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#7)
micromirrors fabricated##2##2##(2008-2#1)(2008-3#1)
micromirrors##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
micromol Fe/mg protein)##2##3##(1996-2#2)
micromol L(-1) H(2)O(2) and##2##4##(2008-10#2)
micromol L(-1) NH(4)(+)##2##3##(2008-10#2)
micromol L(-1) and##2##3##(2008-10#1)(2011-3#1)
micromol L(-1) of##2##3##(2008-10#2)
micromol L(-1)##15##2##(2008-10#12)(2011-3#3)
micromol TE/g)##6##2##(2008-10#6)
micromol l(-1)##7##2##(2008-10#7)
micromol of##2##2##(2008-10#2)
micromol x L(-1) x min(-1)##2##5##(2011-3#2)
micromol x L(-1)##4##3##(2011-3#4)
micromol x##5##2##(2011-3#5)
micromol##45##1##(1996-2#3)(1997-1#2)(2008-10#30)(2008-6#2)(2011-3#8)
micromol/L had an increase of##2##5##(2008-1#2)
micromol/L##12##1##(2008-1#5)(2008-2#1)(2008-4#3)(2008-8#3)
micromol/L)##5##1##(2008-10#2)(2008-8#3)
micromol/L/year##3##1##(2008-1#3)
micromol/l +/- std dev##2##4##(2011-1#2)
micromol/l vs##2##2##(2009-4#2)
micromol/l##16##1##(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#3)(2009-4#3)(2011-1#6)
micromol/l)##5##1##(2006-6#1)(2008-7#1)(2011-1#3)
micromolar concentration##5##2##(1990-12#2)(1992-3#1)(2008-10#2)
micromolar concentrations of the##3##4##(1995-11#1)(2008-10#1)(2008-3#1)
micromolar concentrations of##11##3##(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
micromolar concentrations##17##2##(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#2)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
micromolar levels##3##2##(2008-10#2)(2008-7#1)
micromolar range##7##2##(1990-2#1)(1994-12#1)(1994-5#1)(1995-5#1)(2008-10#2)(2008-4#1)
micromolar##37##1##(1990-12#2)(1990-2#2)(1991-9#1)(1992-12#1)(1992-3#2)(1993-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-5#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2012-12#1)
micromole concentrations##2##2##(2008-10#2)
micromotion##2##1##(2008-8#2)
micron sized##3##2##(2008-10#3)
micron thick##2##2##(1993-9#1)(2012-3#1)
micron##22##1##(1992-12#1)(1993-9#2)(1994-6#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-3#4)(2009-5#1)(2012-3#1)
micron)##2##1##(2008-3#2)
micron-sized##4##1##(2008-10#1)(2009-5#1)(2010-10#1)(2011-1#1)
microneedles##2##1##(2009-11#2)
microneurolysis and##2##2##(2008-9#2)
microneurolysis##3##1##(2008-9#3)
micronized##2##1##(2008-5#2)
micronodular##2##1##(1993-6#1)(2010-12#1)
micronodules##3##1##(1993-12#1)(2012-1#1)(2012-12#1)
microns I##3##2##(1994-9#2)(1996-5#1)
microns and##2##2##(1995-3#1)(1996-3#1)
microns diam##2##2##(1996-12#2)
microns diameter##2##2##(1992-11#1)(1995-3#1)
microns in##2##2##(1994-5#1)(2008-1#1)
microns pore size##2##3##(1994-5#2)
microns s-1##7##2##(1991-5#5)(1993-9#2)
microns was##2##2##(1990-8#1)(1991-5#1)
microns##54##1##(1990-8#3)(1991-2#1)(1991-5#10)(1992-11#1)(1993-6#1)(1993-9#6)(1994-11#1)(1994-5#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#4)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1997-1#1)(1997-4#2)(2008-1#1)(2008-5#1)(2011-1#1)(2013-1#2)
microns)##14##1##(1990-5#1)(1990-8#1)(1991-5#2)(1994-12#1)(1995-3#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)
micronsized##3##1##(2008-10#3)
micronucleated cells##2##2##(1992-8#1)(2008-7#1)
micronucleated erythrocytes##9##2##(2008-8#1)(2008-9#8)
micronucleated polychromatic erythrocytes##2##3##(2008-8#1)(2011-2#1)
micronucleated##16##1##(1992-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#9)(2011-2#1)
micronuclei (MN)##3##2##(2008-10#1)(2010-1#1)(2013-1#1)
micronuclei in##3##2##(1993-8#1)(1996-2#1)(2013-1#1)
micronuclei##14##1##(1993-8#1)(1996-2#3)(2008-10#1)(2008-9#4)(2009-12#1)(2010-1#1)(2013-1#3)
micronucleus assay##3##2##(2008-10#1)(2011-1#2)
micronucleus frequency##3##2##(1993-8#2)(2008-9#1)
micronucleus test##4##2##(2008-8#2)(2008-9#1)(2011-1#1)
micronucleus tests##3##2##(2008-8#1)(2008-9#2)
micronucleus##18##1##(1993-8#2)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#7)(2011-1#3)(2012-3#1)
micronucleus-containing##3##1##(2008-9#3)
micronutrient for##2##2##(1993-11#1)(2012-3#1)
micronutrient intake##2##2##(2008-3#1)(2008-5#1)
micronutrient##16##1##(1993-11#1)(2007-11#4)(2008-2#1)(2008-3#1)(2008-5#3)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
micronutrients are##2##2##(2008-12#1)(2013-8#1)
micronutrients in##3##2##(2007-3#1)(2008-10#1)(2013-8#1)
micronutrients##21##1##(1992-9#1)(2007-11#2)(2007-3#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#2)(2010-11#1)(2010-6#1)(2012-2#1)(2013-8#5)
microorganism and##2##2##(2008-6#1)(2012-3#1)
microorganism are##2##2##(2006-6#1)(2008-7#1)
microorganism##29##1##(1991-12#1)(1994-3#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
microorganisms (i##2##2##(2008-7#1)(2012-2#1)
microorganisms and the##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
microorganisms and##12##2##(1990-6#1)(1991-3#1)(1995-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#2)
microorganisms are##2##2##(1995-11#1)(2008-10#1)
microorganisms contaminating cosmetic products##2##4##(2008-5#2)
microorganisms for##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2013-7#1)
microorganisms have been##5##3##(1997-7#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-2#1)
microorganisms have##6##2##(1997-7#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
microorganisms in the##3##3##(2008-10#3)
microorganisms in##13##2##(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
microorganisms involved##2##2##(1995-5#1)(2008-10#1)
microorganisms isolated from##2##3##(2008-10#1)(2008-12#1)
microorganisms that when administered in adequate amounts##2##7##(2011-2#1)(2013-8#1)
microorganisms that##7##2##(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
microorganisms to##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-1#1)
microorganisms under##2##2##(2008-10#1)(2008-7#1)
microorganisms were isolated from##3##4##(2007-7#2)(2008-5#1)
microorganisms were isolated##4##3##(2007-7#2)(2008-12#1)(2008-5#1)
microorganisms were##10##2##(2007-7#2)(2008-10#3)(2008-12#1)(2008-5#2)(2011-1#1)(2013-8#1)
microorganisms which##2##2##(2008-11#1)(2013-8#1)
microorganisms##184##1##(1990-12#2)(1990-6#2)(1991-3#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-7#3)(2008-10#35)(2008-11#10)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#17)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#9)(2009-11#3)(2009-5#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#8)(2011-2#12)(2012-1#1)(2012-2#11)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#4)
microorganisms) did##2##2##(2008-10#2)
microparticle##2##1##(2008-10#1)(2008-9#1)
microparticles are##3##2##(2007-11#1)(2008-3#2)
microparticles were##3##2##(1992-12#1)(2008-10#1)(2008-8#1)
microparticles with##2##2##(2007-12#1)(2008-2#1)
microparticles##27##1##(1992-12#1)(2007-11#4)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#7)(2008-8#1)(2008-9#1)(2010-4#3)(2012-1#2)
micropatterning##7##1##(2008-11#1)(2008-3#4)(2008-5#2)
micropenis##3##1##(2008-10#2)(2011-1#1)
microphone##7##1##(2008-10#3)(2008-9#1)(2011-1#2)(2013-7#1)
microphthalmia##4##1##(1994-9#2)(2009-4#1)(2011-1#1)
microphthalmic##2##1##(1991-9#2)
microphysical properties##5##2##(2008-3#5)
microphysical##6##1##(2008-2#1)(2008-3#5)
microphysics##2##1##(2008-2#1)(2008-3#1)
micropigment##2##1##(2008-5#2)
micropipette##2##1##(1993-12#1)(2008-10#1)
microplate format##2##2##(2008-10#1)(2010-6#1)
microplate##11##1##(1994-6#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#3)(2010-6#2)
microplates##7##1##(1990-12#1)(2008-10#1)(2008-11#4)(2008-9#1)
microplot experiments##2##2##(2008-10#2)
microplot##9##1##(2008-10#9)
microplots##5##1##(2008-10#5)
microplus host##2##2##(2010-10#2)
microplus##7##1##(1994-3#2)(1997-7#1)(2010-10#4)
micropolarizer##4##1##(2008-3#4)
microporous films were##2##3##(2008-10#2)
microporous films##3##2##(2008-10#3)
microporous##16##1##(2006-4#1)(2008-10#11)(2008-6#2)(2008-7#2)
microprism-type##4##1##(2008-2#2)(2008-3#2)
microprobe##9##1##(1990-5#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
microprobes##5##1##(2007-11#1)(2008-2#4)
microprocessor##5##1##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
microprocessor-based##2##1##(2008-10#2)
micropropagated plants##2##2##(2008-10#2)
micropropagated##5##1##(2008-10#4)(2009-8#1)
micropump##5##1##(2008-10#5)
micropylar opening##2##2##(2008-12#2)
micropylar##9##1##(2007-12#2)(2008-11#1)(2008-12#2)(2008-9#1)(2009-12#2)(2009-8#1)
micropyle##4##1##(1994-5#1)(2007-12#1)(2008-12#1)(2009-8#1)
microradians##2##1##(2008-2#1)(2008-3#1)
microreaction chamber and##2##3##(2008-10#2)
microreaction chamber##3##2##(2008-10#3)
microreaction##4##1##(2008-10#3)(2008-4#1)
microreactor##4##1##(1997-6#1)(2008-10#3)
microreactors##6##1##(2008-10#6)
microrelief and##2##2##(2008-3#1)(2008-5#1)
microrelief##6##1##(2008-3#2)(2008-5#4)
microresonator##3##1##(2007-11#2)(2009-6#1)
microresonators##2##1##(2007-11#2)
microrheological characteristics of reticulocytes##2##4##(2008-9#2)
microrheological characteristics##4##2##(2008-9#4)
microring resonator##3##2##(2007-11#3)
microring resonators for##2##3##(2009-5#2)
microring resonators##8##2##(2007-11#2)(2007-12#2)(2009-5#4)
microring##11##1##(2007-11#5)(2007-12#2)(2009-5#4)
microroughness of##2##2##(2007-11#1)(2008-2#1)
microroughness##10##1##(2007-11#1)(2008-2#2)(2008-3#7)
micros##9##1##(2008-10#1)(2008-2#3)(2008-3#5)
micros' coefficients##2##2##(2008-3#2)
micros'##4##1##(2008-3#4)
micros)##6##1##(2008-3#4)(2009-3#2)
microsatellite DNA markers##4##3##(2008-5#2)(2008-9#1)(2011-2#1)
microsatellite DNA##9##2##(1995-2#1)(2008-11#1)(2008-5#4)(2008-9#2)(2011-2#1)
microsatellite analysis##2##2##(2008-5#1)(2013-8#1)
microsatellite and##3##2##(2008-10#2)(2010-5#1)
microsatellite genotyping##2##2##(2009-5#1)(2010-8#1)
microsatellite loci were##3##3##(2008-9#1)(2013-8#2)
microsatellite loci##17##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#4)(2008-9#1)(2009-2#1)(2010-8#1)(2013-8#5)
microsatellite locus##3##2##(2008-10#1)(2010-8#2)
microsatellite marker##7##2##(2008-10#5)(2008-7#1)(2008-9#1)
microsatellite markers and##5##3##(1994-9#1)(2008-10#2)(2008-5#1)(2013-8#1)
microsatellite markers in##3##3##(1994-6#1)(1997-5#1)(2008-5#1)
microsatellite markers to##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
microsatellite markers were##4##3##(1997-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
microsatellite markers##38##2##(1994-6#3)(1994-9#1)(1997-5#2)(1997-9#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-5#5)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#4)
microsatellite polymorphism##2##2##(2008-10#1)(2008-5#1)
microsatellite primers##3##2##(2008-10#2)(2008-5#1)
microsatellite sequences##3##2##(2008-5#3)
microsatellite##114##1##(1994-6#3)(1994-9#1)(1995-2#1)(1997-5#2)(1997-9#1)(2007-7#1)(2008-10#39)(2008-11#3)(2008-12#4)(2008-4#1)(2008-5#24)(2008-7#1)(2008-9#5)(2009-2#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#5)(2011-2#4)(2012-3#2)(2013-8#11)
microsatellite-primed polymerase chain reaction (MP-PCR)##2##5##(2008-10#2)
microsatellite-primed polymerase chain reaction##3##4##(2008-10#3)
microsatellite-primed##4##1##(2008-10#3)(2008-5#1)
microsatellites for##2##2##(2008-10#1)(2008-11#1)
microsatellites in##2##2##(1995-2#1)(2008-10#1)
microsatellites##30##1##(1994-11#1)(1994-3#3)(1995-2#1)(1997-6#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#2)(2010-7#2)(2010-8#1)(2012-3#3)(2013-8#1)
microscale solution isoelectrofocusing (MicroSol-IEF)##2##4##(2008-4#2)
microscale##17##1##(1992-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#2)
microsclerotia in##2##2##(2008-10#2)
microsclerotia of V##3##3##(2008-10#3)
microsclerotia of##4##2##(2008-10#4)
microsclerotia per g of soil##3##5##(2008-10#3)
microsclerotia per g of##4##4##(2008-10#4)
microsclerotia was##2##2##(2008-10#2)
microsclerotia##26##1##(2008-10#25)(2011-1#1)
microscope (AFM)##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
microscope (CLSM)##4##2##(1992-9#1)(2008-4#1)(2008-5#1)(2008-8#1)
microscope and a##3##3##(1991-12#1)(2008-2#1)(2008-3#1)
microscope and the##4##3##(2007-11#1)(2008-12#1)(2008-3#1)(2010-1#1)
microscope and##17##2##(1991-12#1)(1991-9#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-4#1)(2011-2#1)
microscope are##3##2##(2007-11#1)(2008-3#2)
microscope at##2##2##(2008-3#1)(2008-9#1)
microscope based on##3##3##(2007-11#2)(2009-6#1)
microscope did not show any##2##5##(1990-2#2)
microscope equipped with##2##3##(2008-3#1)(2008-9#1)
microscope for imaging##2##3##(2008-2#1)(2008-3#1)
microscope for three-dimensional##2##3##(2007-12#1)(2008-3#1)
microscope for##8##2##(2007-12#2)(2008-2#1)(2008-3#4)(2008-5#1)
microscope has been used to##2##5##(1990-11#1)(1994-9#1)
microscope has##3##2##(1990-11#1)(1994-9#1)(2008-4#1)
microscope images were##2##3##(2008-3#1)(2008-5#1)
microscope images##5##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#1)
microscope in which the##2##4##(2007-12#1)(2008-3#1)
microscope in which##3##3##(2007-12#2)(2008-3#1)
microscope in##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2009-7#1)
microscope is a##5##3##(2008-11#1)(2008-4#2)(2008-9#2)
microscope is also##2##3##(2008-2#1)(2008-3#1)
microscope is##12##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#2)
microscope objective with a##2##4##(2007-12#1)(2008-3#1)
microscope objective##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
microscope objectives##3##2##(2007-12#2)(2008-2#1)
microscope observations of##3##3##(1995-6#2)(2008-10#1)
microscope observations##6##2##(1995-6#2)(2008-10#3)(2012-3#1)
microscope or##2##2##(2008-3#1)(2008-9#1)
microscope performs##2##2##(2008-2#1)(2008-3#1)
microscope slides##5##2##(2008-4#1)(2008-9#2)(2009-12#1)(2011-2#1)
microscope system##4##2##(1992-6#1)(2007-11#1)(2008-10#1)(2008-9#1)
microscope that is##2##3##(2007-12#1)(2008-3#1)
microscope that uses##3##3##(2007-12#1)(2008-3#2)
microscope that##9##2##(2007-12#4)(2008-3#4)(2011-1#1)
microscope to##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
microscope was used##2##3##(2008-10#1)(2008-8#1)
microscope was##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
microscope with a##11##3##(2007-11#1)(2008-2#5)(2008-3#4)(2013-1#1)
microscope with digital##2##3##(2008-3#1)(2008-9#1)
microscope with##22##2##(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#10)(2008-8#1)(2008-9#1)(2013-1#1)
microscope##338##1##(1990-11#1)(1990-2#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#3)(1994-12#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#24)(2007-12#38)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#30)(2008-3#82)(2008-4#9)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#22)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#4)(2009-7#3)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#7)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#2)
microscope's##4##1##(1992-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
microscope-based##2##1##(2007-11#1)(2008-9#1)
microscope-mounted##2##1##(2011-7#2)
microscopes and##3##2##(2008-9#3)
microscopes are##3##2##(2008-1#1)(2008-3#1)(2008-4#1)
microscopes##35##1##(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#1)(2008-7#1)(2008-9#6)(2009-5#4)(2013-1#1)
microscopic activity##4##2##(2008-11#4)
microscopic analyses of##2##3##(1994-9#1)(2009-12#1)
microscopic analyses##3##2##(1994-9#1)(2008-5#1)(2009-12#1)
microscopic analysis of##2##3##(1997-3#1)(2008-11#1)
microscopic analysis##5##2##(1997-3#1)(2008-11#3)(2008-4#1)
microscopic appearance##2##2##(1991-6#1)(2011-2#1)
microscopic changes in the##2##4##(2008-5#1)(2013-1#1)
microscopic determination##2##2##(2008-10#2)
microscopic evaluation##2##2##(2008-3#1)(2008-9#1)
microscopic examination of##11##3##(1993-6#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-7#1)(2012-7#1)
microscopic examination revealed that##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
microscopic examination revealed##4##3##(1995-12#1)(2008-10#1)(2009-1#1)(2011-2#1)
microscopic examination##27##2##(1993-6#1)(1995-12#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-3#1)(2006-10#2)(2008-10#5)(2008-4#2)(2008-5#1)(2008-7#2)(2009-1#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)
microscopic examinations##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
microscopic features##3##2##(1996-5#1)(2008-11#1)(2008-5#1)
microscopic findings##3##2##(2007-4#1)(2008-12#1)(2008-5#1)
microscopic fluorescence imaging##2##3##(2007-12#2)
microscopic haematuria##3##2##(1991-3#2)(2008-8#1)
microscopic hematuria and##2##3##(1990-11#1)(2008-1#1)
microscopic hematuria##4##2##(1990-11#1)(2007-7#1)(2008-1#2)
microscopic imaging of##2##3##(2008-9#1)(2011-1#1)
microscopic imaging##5##2##(2007-12#1)(2008-9#3)(2011-1#1)
microscopic immunocytochemistry##2##2##(1990-11#1)(1994-8#1)
microscopic inspection of##2##3##(2008-11#1)(2008-6#1)
microscopic ionization constants##2##3##(2008-10#2)
microscopic lesion scores regressed with significant##2##6##(2008-5#2)
microscopic lesion scores##4##3##(2008-5#4)
microscopic lesion##5##2##(2008-5#5)
microscopic lesions were restricted to##2##5##(2008-5#2)
microscopic lesions were##3##3##(2008-5#2)(2011-1#1)
microscopic lesions##5##2##(1997-3#1)(2008-12#1)(2008-5#2)(2011-1#1)
microscopic level##8##2##(1991-9#1)(1995-3#1)(2008-3#2)(2008-7#2)(2009-7#1)(2013-8#1)
microscopic method##3##2##(1994-9#1)(2008-10#2)
microscopic objects in a##2##4##(2007-11#1)(2008-3#1)
microscopic objects in##3##3##(2007-11#1)(2008-3#2)
microscopic objects##6##2##(2007-11#1)(2008-3#5)
microscopic observation of##3##3##(2008-10#2)(2008-5#1)
microscopic observation##6##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
microscopic observations of##2##3##(2008-10#2)
microscopic observations##9##2##(1994-2#1)(2008-10#7)(2008-6#1)
microscopic resolution##2##2##(2008-3#2)
microscopic scale##2##2##(2009-7#2)
microscopic structures##2##2##(2008-3#1)(2011-2#1)
microscopic studies of##2##3##(2006-10#1)(2008-9#1)
microscopic studies showed that##2##4##(2008-10#1)(2009-10#1)
microscopic studies##7##2##(2006-10#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
microscopic study##5##2##(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(2012-2#1)
microscopic techniques##4##2##(1991-12#1)(1992-12#1)(2008-3#1)(2008-7#1)
microscopic##243##1##(1990-11#2)(1990-8#4)(1991-12#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-12#2)(1995-3#4)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#1)(2006-10#4)(2007-11#6)(2007-12#9)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#35)(2008-11#13)(2008-12#3)(2008-2#5)(2008-3#27)(2008-4#6)(2008-5#23)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#5)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#5)
microscopical and##2##2##(2007-12#1)(2008-5#1)
microscopical localization of##2##3##(2008-7#2)
microscopical##12##1##(1991-8#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-7#5)
microscopically examined##2##2##(2008-10#1)(2011-2#1)
microscopically##17##1##(1991-11#1)(1995-11#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
microscopists##5##1##(2007-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
microscopy (AFM)##27##2##(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-7#2)(2012-2#1)
microscopy (EM)##5##2##(1992-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
microscopy after##2##2##(2008-10#1)(2009-12#1)
microscopy allows##2##2##(1997-7#1)(2007-11#1)
microscopy analysis of##2##3##(2007-11#1)(2009-7#1)
microscopy analysis##5##2##(2007-11#1)(2008-6#1)(2009-7#2)(2011-2#1)
microscopy and a##2##3##(2009-12#1)(2011-2#1)
microscopy and by##3##3##(2008-10#1)(2008-7#2)
microscopy and compared to the##2##5##(1990-5#1)(2008-9#1)
microscopy and culture##2##3##(2007-10#1)(2007-12#1)
microscopy and image analysis##3##4##(2008-10#1)(2008-9#1)(2010-10#1)
microscopy and image processing##3##4##(1997-4#1)(2008-4#2)
microscopy and image##6##3##(1997-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-10#1)
microscopy and scanning electron microscopy##4##5##(2007-12#1)(2008-10#2)(2009-7#1)
microscopy and scanning##5##3##(2007-12#1)(2008-10#2)(2009-7#1)(2010-7#1)
microscopy and the##3##3##(2007-12#1)(2008-9#2)
microscopy and##97##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-11#1)(1995-6#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
microscopy approaches##2##2##(2008-9#1)(2009-7#1)
microscopy are##5##2##(2008-1#2)(2008-3#1)(2008-4#1)(2011-7#1)
microscopy as##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
microscopy assay##2##2##(2008-1#1)(2013-8#1)
microscopy based on##3##3##(2007-12#2)(2008-4#1)
microscopy based##4##2##(2007-12#2)(2008-11#1)(2008-4#1)
microscopy by##3##2##(2007-11#1)(2008-3#2)
microscopy can be##2##3##(2008-3#1)(2008-9#1)
microscopy combined with##2##3##(2007-12#1)(2008-5#1)
microscopy confirmed##3##2##(2008-10#2)(2013-8#1)
microscopy demonstrated that##2##3##(1992-11#1)(2008-8#1)
microscopy experiments##2##2##(1994-8#1)(2007-12#1)
microscopy for the##3##3##(2008-1#1)(2008-10#2)
microscopy for##13##2##(1991-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#1)(2012-2#1)
microscopy from##2##2##(2008-9#1)(2012-3#1)
microscopy has##5##2##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#2)
microscopy images of##2##3##(2008-10#1)(2010-4#1)
microscopy images##5##2##(1997-2#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)
microscopy imaging of##2##3##(2008-3#1)(2012-2#1)
microscopy in combination with##2##4##(2008-5#1)(2008-8#1)
microscopy in highly scattering media##2##5##(2008-3#2)
microscopy in which the##2##4##(2007-11#1)(2008-3#1)
microscopy in which##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
microscopy in##24##2##(1996-6#1)(1997-5#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
microscopy indicated##2##2##(2008-3#1)(2008-9#1)
microscopy is a valuable tool for##2##6##(2008-9#2)
microscopy is a##3##3##(2008-1#1)(2008-9#2)
microscopy is also##2##3##(2008-1#1)(2008-9#1)
microscopy is an##2##3##(2008-1#1)(2008-3#1)
microscopy is presented##2##3##(2007-11#1)(2008-3#1)
microscopy is##18##2##(2007-11#1)(2007-12#1)(2008-1#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-9#3)(2009-5#1)
microscopy measurements##2##2##(2008-2#1)(2009-5#1)
microscopy observation##3##2##(2006-6#1)(2008-9#2)
microscopy of living##2##3##(2008-9#1)(2009-7#1)
microscopy of##36##2##(1990-12#1)(1991-11#1)(1992-9#1)(1993-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-2#1)
microscopy on##3##2##(1995-12#1)(2008-5#1)(2008-7#1)
microscopy or##2##2##(2008-1#1)(2009-2#1)
microscopy photographs##2##2##(2008-2#1)(2008-7#1)
microscopy reveal##2##2##(2007-12#1)(2008-3#1)
microscopy revealed that##9##3##(1991-2#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
microscopy revealed##17##2##(1991-2#1)(1992-6#1)(1994-7#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#2)(2013-8#1)
microscopy reveals that##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
microscopy reveals##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
microscopy setup##2##2##(2007-12#1)(2008-3#1)
microscopy showed that the##3##4##(1992-9#1)(2008-8#1)(2011-2#1)
microscopy showed that##11##3##(1992-9#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#1)
microscopy showed the##2##3##(1994-8#1)(2011-2#1)
microscopy showed##21##2##(1992-9#1)(1994-8#1)(1996-1#1)(1997-3#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)
microscopy studies##7##2##(1993-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)
microscopy system##3##2##(2007-12#2)(2008-11#1)
microscopy systems##2##2##(2008-9#1)(2011-2#1)
microscopy technique##2##2##(2007-12#1)(2008-5#1)
microscopy techniques##5##2##(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)
microscopy that##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
microscopy the##2##2##(2008-3#1)(2008-7#1)
microscopy through##2##2##(2007-12#1)(2008-3#1)
microscopy to detect##2##3##(1996-12#2)
microscopy to determine##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
microscopy to identify##2##3##(2008-10#1)(2008-4#1)
microscopy to observe##2##3##(1997-8#1)(2008-10#1)
microscopy to##28##2##(1995-12#1)(1996-12#2)(1997-8#1)(2007-11#1)(2007-12#6)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
microscopy using a##2##3##(2007-12#1)(2008-9#1)
microscopy using##9##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)(2013-7#1)
microscopy was used to##9##4##(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-12#1)(2011-3#1)
microscopy was used##10##3##(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-3#1)
microscopy was##13##2##(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#2)(2009-12#1)(2010-6#1)(2011-2#1)(2011-3#1)
microscopy we##5##2##(1992-8#1)(2008-11#1)(2008-5#2)(2008-7#1)
microscopy were used to##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
microscopy were used##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
microscopy were##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
microscopy with a##5##3##(2007-12#2)(2008-3#2)(2008-9#1)
microscopy with##14##2##(1992-11#1)(2007-11#1)(2007-12#4)(2008-3#4)(2008-5#1)(2008-9#1)(2012-1#1)(2012-2#1)
microscopy##969##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-9#2)(1992-11#3)(1992-2#4)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-11#1)(1994-5#2)(1994-7#1)(1994-8#4)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#9)(1996-1#1)(1996-12#4)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#26)(2007-12#89)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#10)(2007-8#2)(2008-1#28)(2008-10#159)(2008-11#40)(2008-12#3)(2008-2#27)(2008-3#106)(2008-4#19)(2008-5#50)(2008-6#7)(2008-7#43)(2008-8#27)(2008-9#60)(2009-10#1)(2009-11#12)(2009-12#6)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#8)(2009-7#21)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#16)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#1)(2012-2#17)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#5)
microscopy)##2##1##(1992-11#1)(1996-12#1)
microscopy-based techniques##2##2##(2008-11#1)(2008-7#1)
microscopy-based##4##1##(2008-1#1)(2008-11#1)(2008-7#2)
microsecond time##4##2##(1990-8#1)(1995-2#1)(2008-2#1)(2009-7#1)
microsecond##9##1##(1990-7#1)(1990-8#1)(1995-2#1)(2008-2#3)(2008-3#2)(2009-7#1)
microseconds##9##1##(1992-6#2)(1994-3#1)(1995-6#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)
microseismicity##3##1##(1996-4#3)
microsensor for pCO(2) measurements##2##4##(2008-10#2)
microsensor for##3##2##(2008-10#3)
microsensor##9##1##(2008-10#8)(2008-2#1)
microsensors##10##1##(1993-6#1)(2008-10#5)(2008-3#2)(2008-7#1)(2010-7#1)
microsequence analysis##3##2##(1990-7#1)(1991-8#1)(2008-9#1)
microsequencing and##2##2##(1991-5#1)(2008-9#1)
microsequencing of##2##2##(1992-3#1)(1994-11#1)
microsequencing##8##1##(1991-5#2)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1997-4#1)(2008-9#1)
microshear bond strength##5##3##(2013-1#5)
microsoma##10##1##(2011-2#10)
microsoma-Gruppe&quot##2##1##(2011-2#2)
microsomal and##2##2##(1991-8#1)(1996-2#1)
microsomal b5 cDNA##2##3##(1992-6#2)
microsomal b5##5##2##(1992-6#5)
microsomal cytochrome P-450##3##3##(1992-11#3)
microsomal cytochrome P450##2##3##(1990-5#1)(2008-8#1)
microsomal cytochrome##6##2##(1990-5#1)(1991-12#1)(1992-11#3)(2008-8#1)
microsomal epoxide hydrolase##4##3##(1997-7#2)(1997-8#1)(2011-2#1)
microsomal fraction##9##2##(1990-11#1)(1993-3#2)(1994-11#1)(1994-6#1)(1996-3#1)(1997-3#2)(1997-4#1)
microsomal fractions of##2##3##(1990-11#1)(1993-8#1)
microsomal fractions##7##2##(1990-11#1)(1991-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)
microsomal glucose-6-phosphatase activity##3##3##(1994-11#3)
microsomal lipid peroxidation##2##3##(1995-6#2)
microsomal lipids##2##2##(1994-5#2)
microsomal membranes from##2##3##(1991-12#1)(1995-2#1)
microsomal membranes##10##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-9#2)(1993-11#2)(1993-3#1)(1994-8#1)(1995-2#1)
microsomal metabolism of##3##3##(1991-9#1)(1993-11#1)(1993-6#1)
microsomal##96##1##(1990-11#2)(1990-2#2)(1990-5#2)(1990-8#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#4)(1992-3#1)(1992-6#7)(1992-8#3)(1992-9#2)(1993-11#6)(1993-12#2)(1993-3#3)(1993-6#3)(1993-8#4)(1994-11#4)(1994-5#2)(1994-6#5)(1994-8#5)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#1)(2008-8#4)(2011-2#1)(2011-3#2)(2012-2#2)
microsome##3##1##(1994-11#1)(2010-12#1)(2011-1#1)
microsomes and##7##2##(1991-9#1)(1994-8#2)(1997-1#1)(1997-7#1)(2011-1#2)
microsomes but##3##2##(1994-11#1)(1994-8#2)
microsomes by##6##2##(1990-12#1)(1991-2#1)(1991-5#2)(1994-6#1)(1994-8#1)
microsomes from##10##2##(1990-7#1)(1991-12#1)(1991-5#3)(1993-11#1)(1993-8#1)(1994-8#1)(1996-12#1)(2011-3#1)
microsomes in the presence of NADPH##3##6##(1990-12#2)(1991-5#1)
microsomes in the presence of##4##5##(1990-12#2)(1991-5#1)(1995-6#1)
microsomes in##5##2##(1990-12#2)(1991-5#1)(1994-11#1)(1995-6#1)
microsomes involves##2##2##(1990-2#1)(1991-5#1)
microsomes is##2##2##(1997-7#2)
microsomes isolated from##2##3##(1991-5#1)(1991-6#1)
microsomes of the##3##3##(1992-12#1)(2011-3#2)
microsomes of##7##2##(1991-12#1)(1991-6#1)(1992-12#1)(2008-8#1)(2011-3#3)
microsomes was##4##2##(1990-2#1)(1992-6#1)(1994-6#1)(2011-3#1)
microsomes were##4##2##(1991-2#1)(1993-8#1)(2011-3#2)
microsomes with##2##2##(1993-11#1)(1994-6#1)
microsomes##109##1##(1990-11#4)(1990-12#3)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#3)(1991-2#4)(1991-5#13)(1991-6#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#4)(1993-6#3)(1993-8#3)(1994-11#5)(1994-6#3)(1994-8#15)(1995-12#1)(1995-6#5)(1996-12#1)(1997-1#1)(1997-7#7)(2008-1#1)(2008-8#1)(2011-1#4)(2011-3#9)
microsource##4##1##(2008-11#4)
microspectrometry##2##1##(2008-5#2)
microspectroscopy##7##1##(2008-3#2)(2008-5#2)(2010-10#3)
microsphere laser##3##2##(2007-11#3)
microsphere size##2##2##(2008-7#2)
microsphere suspensions##2##2##(2008-3#2)
microsphere##26##1##(2007-11#6)(2007-12#8)(2008-3#4)(2008-7#2)(2008-9#4)(2009-6#1)(2013-1#1)
microsphere-based##3##1##(2008-9#3)
microspheres and flow cytometry##2##4##(2008-9#2)
microspheres and##7##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-5#1)
microspheres bearing##2##2##(2008-9#2)
microspheres by##3##2##(2007-12#1)(2008-10#1)(2010-5#1)
microspheres containing##2##2##(1993-1#1)(2008-10#1)
microspheres coupled with##2##3##(2007-12#1)(2008-9#1)
microspheres for##3##2##(2007-11#1)(2007-12#1)(2009-6#1)
microspheres have##2##2##(2013-1#2)
microspheres in the##3##3##(1993-1#1)(2007-12#1)(2010-5#1)
microspheres in##5##2##(1993-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
microspheres was##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
microspheres were##2##2##(1992-10#1)(2009-11#1)
microspheres with an##2##3##(2008-10#1)(2008-2#1)
microspheres with##4##2##(2008-10#2)(2008-2#1)(2013-1#1)
microspheres##83##1##(1992-10#1)(1993-1#2)(1994-12#1)(1994-2#1)(2007-11#5)(2007-12#12)(2008-1#1)(2008-10#14)(2008-2#5)(2008-3#5)(2008-4#3)(2008-7#5)(2008-9#9)(2009-11#1)(2009-6#2)(2010-4#1)(2010-5#5)(2012-3#2)(2013-1#8)
microspore##2##1##(2008-5#1)(2009-10#1)
microspores and##2##2##(1997-2#1)(2009-10#1)
microspores were##2##2##(2008-5#2)
microspores##11##1##(1997-2#1)(2008-5#9)(2009-10#1)
microsporidia##3##1##(2007-7#2)(2009-5#1)
microsporocytes of##2##2##(2009-12#2)
microsporocytes##5##1##(2009-10#1)(2009-12#4)
microsprinklers##2##1##(2008-10#2)
microstereolithography##2##1##(2008-2#1)(2008-3#1)
microstomia##2##1##(2008-5#1)(2013-1#1)
microstructural changes##2##2##(2011-7#1)(2012-2#1)
microstructural##10##1##(2008-10#1)(2008-3#2)(2009-7#4)(2011-7#1)(2012-2#2)
microstructure analysis of technical and##2##5##(2008-3#2)
microstructure analysis##3##2##(2008-3#2)(2010-8#1)
microstructure and##7##2##(2008-2#1)(2008-3#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
microstructure fiber##14##2##(2007-11#12)(2007-12#2)
microstructure of the##5##3##(1995-6#1)(2008-10#1)(2008-5#1)(2009-7#2)
microstructure of##13##2##(1995-6#1)(2008-10#2)(2008-2#1)(2008-5#6)(2009-7#2)(2011-2#1)
microstructure on the##2##3##(2008-2#1)(2013-1#1)
microstructure on##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
microstructure##71##1##(1995-6#1)(2007-11#16)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#14)(2008-5#8)(2009-7#11)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
microstructured optical fiber##2##3##(2007-11#2)
microstructured optical fibers##7##3##(2007-11#7)
microstructured optical##9##2##(2007-11#9)
microstructured##12##1##(2007-11#12)
microstructures that##2##2##(2007-11#1)(2008-3#1)
microstructures with##4##2##(2007-12#2)(2008-3#2)
microstructures##20##1##(1997-6#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#11)(2013-1#1)
microstructuring##2##1##(2007-12#1)(2008-3#1)
microsupport with two-dimensional geometry##2##4##(2008-11#2)
microsupport##3##1##(2008-11#3)
microsurgery and##2##2##(2008-7#1)(2011-2#1)
microsurgery for##3##2##(1993-1#1)(1996-2#1)(2008-7#1)
microsurgery##30##1##(1990-9#1)(1992-3#5)(1992-6#2)(1993-1#1)(1994-12#1)(1996-2#4)(1996-3#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-9#1)(2009-5#1)(2011-2#5)
microsurgical excision##2##2##(2008-7#2)
microsurgical reconstruction##2##2##(2011-2#2)
microsurgical removal of##2##3##(2008-7#1)(2011-2#1)
microsurgical technique##2##2##(1991-4#1)(1996-2#1)
microsurgical##20##1##(1991-4#1)(1991-6#1)(1992-3#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-5#1)(2011-2#4)(2012-2#1)(2012-3#2)
microsurgically##4##1##(1992-3#2)(1994-12#1)(1996-2#1)
microsymbiont of annual##2##3##(2011-2#2)
microsymbiont of##6##2##(2011-2#6)
microsymbiont##7##1##(2011-2#7)
microsyringe and##2##2##(2008-10#1)(2013-1#1)
microsyringe##8##1##(2008-10#7)(2013-1#1)
microsystem##3##1##(2008-10#2)(2008-3#1)
microsystems are##2##2##(2008-10#1)(2008-3#1)
microsystems##5##1##(2008-10#1)(2008-3#4)
microteaching to##2##2##(2008-11#2)
microteaching##6##1##(2008-11#6)
microthermocouple##2##1##(2008-3#2)
microtia reconstruction##2##2##(2009-1#2)
microtia##3##1##(2009-1#3)
microtiter plate##14##2##(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-9#1)
microtiter plates and##2##3##(2008-10#1)(2011-2#1)
microtiter plates or##2##3##(1997-3#1)(2008-4#1)
microtiter plates##12##2##(1993-6#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2010-11#1)(2011-2#3)
microtiter wells##2##2##(1994-5#1)(1994-8#1)
microtiter##32##1##(1990-8#1)(1993-6#1)(1994-5#1)(1994-8#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#3)
microtitration set up##3##3##(2008-10#3)
microtitration##7##1##(2008-10#5)(2008-8#2)
microtome##3##1##(1995-6#1)(2008-4#2)
microtopography is##2##2##(2008-5#2)
microtopography##5##1##(2008-3#1)(2008-5#4)
microtrauma##2##1##(1991-3#1)(2008-9#1)
microtrichia fields##2##2##(2007-12#2)
microtubular##4##1##(2008-11#1)(2010-7#1)(2012-2#2)
microtubule assembly from##2##3##(1991-5#1)(2011-2#1)
microtubule assembly##6##2##(1991-5#3)(2008-11#1)(2008-7#1)(2011-2#1)
microtubule associated protein-2 (MAP-2)##2##4##(1991-1#1)(2008-7#1)
microtubule associated proteins##2##3##(1991-1#1)(2009-8#1)
microtubule associated##4##2##(1991-1#2)(2008-7#1)(2009-8#1)
microtubule depolymerization##2##2##(1997-6#2)
microtubule dynamics##2##2##(1997-6#1)(2013-1#1)
microtubule functions##2##2##(2009-10#2)
microtubule organization##2##2##(1994-9#1)(2011-2#1)
microtubule organizing center##3##3##(1991-5#1)(2008-8#1)(2008-9#1)
microtubule organizing##4##2##(1991-5#2)(2008-8#1)(2008-9#1)
microtubule polymerization##2##2##(1990-7#1)(2009-12#1)
microtubule##50##1##(1990-7#1)(1991-1#2)(1991-2#1)(1991-5#5)(1992-5#3)(1993-6#2)(1993-8#1)(1994-5#1)(1994-9#2)(1995-2#3)(1997-6#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#7)(2009-12#3)(2009-7#2)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
microtubule-associated proteins##2##2##(1993-8#1)(2011-2#1)
microtubule-associated##6##1##(1993-6#1)(1993-8#1)(1996-6#1)(2007-12#1)(2009-10#1)(2011-2#1)
microtubule-based##3##1##(1992-6#1)(1995-2#1)(2009-10#1)
microtubule-dependent##4##1##(1994-12#2)(1994-9#2)
microtubule-disrupting agents##2##2##(1997-6#2)
microtubule-disrupting##3##1##(1997-6#3)
microtubules (MTs)##3##2##(1992-6#1)(2008-11#1)(2009-10#1)
microtubules and##4##2##(1993-8#1)(1995-2#2)(2008-1#1)
microtubules are##3##2##(2008-7#1)(2011-2#2)
microtubules in the##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
microtubules in##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
microtubules were##3##2##(1994-8#1)(2008-7#1)(2009-12#1)
microtubules with##3##2##(1993-8#2)(1995-2#1)
microtubules##51##1##(1991-2#1)(1992-5#2)(1992-6#1)(1993-8#5)(1994-5#2)(1994-8#1)(1995-2#3)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#3)(2009-12#1)(2009-7#2)(2010-11#1)(2010-7#3)(2011-2#4)(2012-2#1)(2012-4#1)
microtubules)##2##1##(2007-12#2)
microvascular and macrovascular##2##3##(2013-1#2)
microvascular and##5##2##(1991-9#1)(2008-1#1)(2008-5#1)(2013-1#2)
microvascular bed##2##2##(1990-6#1)(2011-2#1)
microvascular blood flow##2##3##(2009-11#1)(2012-2#1)
microvascular blood##3##2##(2009-11#1)(2011-2#1)(2012-2#1)
microvascular complications##4##2##(2008-1#2)(2011-2#1)(2012-2#1)
microvascular decompression for trigeminal neuralgia##3##5##(2011-2#2)(2013-1#1)
microvascular decompression##6##2##(2011-2#3)(2012-3#2)(2013-1#1)
microvascular density##2##2##(2011-2#1)(2012-2#1)
microvascular disease##3##2##(2008-1#1)(2009-10#1)(2011-2#1)
microvascular dysfunction##2##2##(2008-1#1)(2009-10#1)
microvascular effects of##2##3##(1994-8#1)(1995-12#1)
microvascular endothelial cells##5##3##(1993-3#1)(2008-5#1)(2013-8#3)
microvascular endothelial##6##2##(1990-4#1)(1993-3#1)(2008-5#1)(2013-8#3)
microvascular leakage##4##2##(1992-3#4)
microvascular pathology and##2##3##(2008-1#1)(2009-10#1)
microvascular##70##1##(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-9#1)(1992-3#4)(1993-3#1)(1994-8#4)(1995-11#1)(1995-12#3)(1996-2#2)(1997-1#1)(1997-2#2)(2007-12#2)(2008-1#6)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#4)(2009-10#3)(2009-11#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#2)(2012-4#2)(2013-1#3)(2013-8#3)
microvascularization##2##1##(2008-5#1)(2012-2#1)
microvasculature##10##1##(1991-9#2)(1992-2#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-12#2)(2011-2#1)(2012-3#1)
microvesicles##12##1##(1990-12#3)(1996-5#2)(1997-3#5)(2010-4#1)(2013-8#1)
microvessel density (MVD)##2##3##(2011-2#2)
microvessel density##5##2##(2009-8#2)(2011-2#3)
microvessel endothelial cells##2##3##(1991-5#2)
microvessel endothelial##3##2##(1991-5#3)
microvessel##10##1##(1991-5#3)(1996-5#1)(2009-8#2)(2011-2#3)(2011-3#1)
microvessels in##2##2##(1994-12#1)(1997-2#1)
microvessels##13##1##(1990-5#1)(1993-3#1)(1994-12#1)(1996-5#2)(1997-2#2)(2008-11#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
microvillar membranes##2##2##(2007-12#2)
microvillar##4##1##(2007-12#3)(2008-7#1)
microvillate##2##1##(2007-12#1)(2008-7#1)
microvilli and##5##2##(1995-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)
microvilli of##3##2##(2007-12#2)(2008-7#1)
microvilli were##2##2##(1995-6#1)(2008-12#1)
microvilli##26##1##(1992-2#1)(1995-2#1)(1995-6#1)(2007-12#8)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#6)(2009-8#2)
microvillous membrane##3##2##(1991-12#3)
microvillous##4##1##(1991-12#3)(2008-6#1)
microvolume back-extraction##2##2##(2008-10#2)
microvolume##4##1##(2008-10#2)(2008-11#1)(2008-4#1)
microwatts##2##1##(2007-11#1)(2007-12#1)
microwave (MW)##4##2##(2008-10#3)(2008-5#1)
microwave ablation##2##2##(2007-12#1)(2007-8#1)
microwave and infrared##2##3##(2010-5#1)(2012-12#1)
microwave and##4##2##(2008-2#1)(2010-5#1)(2012-12#1)(2012-2#1)
microwave assisted acid digestion##2##4##(2010-5#1)(2011-2#1)
microwave assisted digestion##3##3##(2008-10#3)
microwave assisted extraction##4##3##(2008-10#2)(2012-1#2)
microwave assisted##13##2##(2007-11#1)(2008-10#8)(2010-5#1)(2011-2#1)(2012-1#2)
microwave beam##2##2##(2008-3#2)
microwave decomposition##2##2##(2008-10#2)
microwave digested##2##2##(2008-10#2)
microwave digestion for##2##3##(2008-10#2)
microwave digestion method##2##3##(2008-10#2)
microwave digestion of##3##3##(2008-10#3)
microwave digestion procedure##2##3##(2008-10#2)
microwave digestion system##5##3##(2008-10#5)
microwave digestion was##2##3##(2008-10#2)
microwave digestion with##4##3##(2008-10#4)
microwave digestion##29##2##(2008-10#27)(2013-8#2)
microwave digestion-hydride generation##2##3##(2008-10#2)
microwave dissolution##2##2##(2008-10#2)
microwave emissivity##2##2##(2013-8#2)
microwave energy##5##2##(2007-8#1)(2008-10#4)
microwave exposure##3##2##(2008-12#3)
microwave field##2##2##(2008-10#1)(2008-12#1)
microwave frequencies##3##2##(2007-11#1)(2008-3#2)
microwave heating##5##2##(2008-10#5)
microwave induced plasma##3##3##(2008-10#3)
microwave induced##4##2##(2008-10#3)(2012-2#1)
microwave irradiation to##2##3##(2008-10#1)(2009-7#1)
microwave irradiation##17##2##(2007-11#4)(2008-10#8)(2008-12#1)(2009-7#1)(2013-1#3)
microwave oven and##3##3##(2008-10#3)
microwave oven at##3##3##(2008-10#3)
microwave oven for##2##3##(2008-10#2)
microwave oven is##2##3##(2007-11#1)(2008-10#1)
microwave oven##27##2##(1993-12#1)(1997-7#1)(2007-11#1)(2008-10#23)(2013-8#1)
microwave plasma torch atomic emission spectrometry (MPT-AES)##2##7##(2008-10#2)
microwave plasma torch atomic emission spectrometry##4##6##(2008-10#4)
microwave plasma##6##2##(2008-10#6)
microwave power##5##2##(2008-10#5)
microwave procedure##2##2##(2008-10#2)
microwave programs##2##2##(2008-10#2)
microwave radiation##9##2##(2007-12#2)(2008-10#4)(2009-7#1)(2011-2#2)
microwave reference##2##2##(2007-12#2)
microwave signals##2##2##(2008-2#1)(2008-3#1)
microwave system##6##2##(2008-10#5)(2013-8#1)
microwave##220##1##(1993-12#1)(1995-6#1)(1997-7#1)(2007-11#10)(2007-12#8)(2007-8#2)(2008-10#141)(2008-12#6)(2008-2#8)(2008-3#11)(2008-5#3)(2009-10#1)(2009-7#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#7)
microwave-assisted Soxhlet extraction##2##3##(2008-10#2)
microwave-assisted acid digestion##2##3##(2008-10#2)
microwave-assisted acid##4##2##(2008-10#4)
microwave-assisted acid-digestion for the determination of metals in coal by##2##10##(2008-10#2)
microwave-assisted digestion and##2##3##(2008-10#2)
microwave-assisted digestion procedure##2##3##(2008-10#2)
microwave-assisted digestion with##2##3##(2008-10#2)
microwave-assisted digestion##11##2##(2008-10#11)
microwave-assisted extraction (MAE)##2##3##(2008-10#2)
microwave-assisted extraction and##2##3##(2008-10#2)
microwave-assisted extraction of##2##3##(2008-10#2)
microwave-assisted extraction##11##2##(2008-10#11)
microwave-assisted sample digestion##4##3##(2008-10#4)
microwave-assisted sample##5##2##(2008-10#5)
microwave-assisted solvent extraction##2##3##(2008-10#2)
microwave-assisted synthesis of##2##3##(2007-11#1)(2008-9#1)
microwave-assisted##52##1##(2007-11#1)(2008-10#50)(2008-9#1)
microwave-mediated##2##1##(2008-5#2)
microwaves as##2##2##(2008-10#2)
microwaves at##2##2##(1994-2#1)(2008-10#1)
microwaves##21##1##(1990-3#1)(1994-2#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#4)
microwindow boundaries##2##2##(2008-2#1)(2008-3#1)
microwindow##4##1##(2008-2#2)(2008-3#2)
microwindows are##2##2##(2008-2#2)
microwindows for##4##2##(2008-2#1)(2008-3#3)
microwindows##10##1##(2008-2#5)(2008-3#5)
microzone##3##1##(1994-2#1)(2008-10#2)
miction##2##1##(1997-3#1)(2009-3#1)
micturition in the##2##3##(1997-2#2)
micturition reflex##6##2##(1990-5#3)(1992-3#2)(1997-2#1)
micturition##13##1##(1990-5#4)(1992-3#2)(1997-2#4)(1997-7#1)(2008-3#1)(2009-2#1)
mid 1980s##3##2##(1996-1#1)(2007-7#1)(2008-7#1)
mid R##2##2##(2008-10#2)
mid and##2##2##(2007-12#1)(2008-10#1)
mid femur##2##2##(2008-5#2)
mid left##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
mid to late##2##3##(2011-2#1)(2013-7#1)
mid to##5##2##(2008-10#1)(2011-2#2)(2012-3#1)(2013-7#1)
mid vowels ([o##2##3##(2012-12#2)
mid##50##1##(1990-2#1)(1992-9#2)(1995-12#1)(1996-1#1)(1997-8#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
mid- and##4##2##(2008-10#3)(2011-2#1)
mid-##7##1##(2007-8#1)(2008-10#4)(2011-1#1)(2011-2#1)
mid-20th century##2##2##(2008-10#1)(2008-7#1)
mid-Atlantic##2##1##(2008-4#1)(2008-7#1)
mid-Holocene##2##1##(2012-9#2)
mid-IR pulses##2##2##(2007-12#2)
mid-IR spectrometry##2##2##(2008-10#1)(2008-3#1)
mid-IR##29##1##(2007-11#1)(2007-12#10)(2008-10#5)(2008-2#5)(2008-3#8)
mid-January##2##1##(1992-6#2)
mid-May##3##1##(2007-12#1)(2008-10#2)
mid-P)##3##1##(2008-11#3)
mid-elevation##2##1##(2008-10#2)
mid-exponential phase##2##2##(2008-11#2)
mid-exponential##3##1##(1996-7#1)(2008-11#2)
mid-illness##2##1##(1995-2#2)
mid-infrared absorption##2##2##(2008-3#2)
mid-infrared femtosecond optical parametric##2##4##(2007-12#1)(2008-2#1)
mid-infrared interferometric instrument##2##3##(2008-3#2)
mid-infrared laser##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mid-infrared light##2##2##(2007-11#1)(2007-12#1)
mid-infrared optical##2##2##(2007-12#1)(2008-3#1)
mid-infrared pulses by##2##3##(2007-11#1)(2007-12#1)
mid-infrared pulses##5##2##(2007-11#4)(2007-12#1)
mid-infrared quantum cascade lasers##2##4##(2007-11#1)(2007-12#1)
mid-infrared radiation##4##2##(2007-12#3)(2008-10#1)
mid-infrared spectroscopic##2##2##(2008-10#1)(2008-3#1)
mid-infrared spectroscopy##3##2##(2008-10#3)
mid-infrared##64##1##(2007-11#12)(2007-12#17)(2008-10#7)(2008-2#8)(2008-3#19)(2008-5#1)
mid-latitude##3##1##(2008-2#1)(2008-3#2)
mid-latitudes##3##1##(2008-2#1)(2008-3#1)(2012-2#1)
mid-managers##3##1##(1990-12#3)
mid-plane##2##1##(2009-11#2)
mid-point##3##1##(1995-12#2)(2013-8#1)
mid-portion of the##3##3##(2008-12#1)(2008-5#2)
mid-region##4##1##(1990-12#2)(1991-9#1)(2008-4#1)
mid-season assessments of##2##3##(2008-10#2)
mid-season##4##1##(2008-10#4)
mid-sized##2##1##(1995-12#1)(2012-3#1)
mid-summer##2##1##(2012-7#2)
mid-temporal##2##1##(1996-12#2)
mid-term follow-up##3##2##(2009-4#1)(2012-12#1)(2013-1#1)
mid-term##11##1##(1996-6#1)(2007-8#1)(2008-10#1)(2008-12#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
mid-to-late##2##1##(1995-2#1)(2012-3#1)
mid-villus##2##1##(1990-12#2)
mid2-1##2##1##(1994-12#2)
midazolam 0##2##2##(2012-2#2)
midazolam on##2##2##(1997-2#2)
midazolam sedation##2##2##(1993-1#2)
midazolam##31##1##(1990-8#1)(1992-10#1)(1993-1#5)(1994-2#1)(1995-11#1)(1997-2#6)(2009-4#1)(2010-7#1)(2011-2#6)(2012-2#8)
midbrain and##8##2##(1992-1#1)(1995-12#1)(1996-12#1)(1997-2#2)(2008-7#2)(2012-3#1)
midbrain in##2##2##(2013-1#2)
midbrain raphe nuclei##3##3##(1995-12#2)(2008-7#1)
midbrain##37##1##(1992-1#2)(1992-8#1)(1993-12#3)(1993-8#1)(1995-12#5)(1996-12#4)(1997-2#4)(1997-3#1)(2007-10#3)(2008-6#3)(2008-7#5)(2012-3#1)(2013-1#2)(2013-7#2)
midcarpal injection of lidocaine##4##4##(2008-9#4)
midcarpal##7##1##(2008-9#7)
midcycle##3##1##(2008-7#3)
midday##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
middle adolescence##3##2##(2009-7#2)(2010-8#1)
middle adulthood##6##2##(2009-7#6)
middle age males##2##3##(2008-10#2)
middle age##11##2##(1991-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-2#3)
middle aged men##2##3##(1990-9#1)(1997-8#1)
middle aged##8##2##(1990-9#1)(1997-8#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
middle and high school##2##4##(2009-7#2)
middle and high##3##3##(2008-5#1)(2009-7#2)
middle and lower Keys##3##4##(2007-5#3)
middle and lower parts##2##4##(2013-1#2)
middle and lower##6##3##(2007-5#3)(2008-5#1)(2013-1#2)
middle and posterior##3##3##(2008-12#1)(2008-7#1)(2010-6#1)
middle and upper##4##3##(2008-3#3)(2008-9#1)
middle and##29##2##(1992-8#1)(1994-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-6#1)(2011-2#2)(2013-1#3)
middle atmosphere##4##2##(1992-7#2)(2008-3#2)
middle cerebral arteries##2##3##(1996-2#1)(2008-7#1)
middle cerebral artery (MCA)##6##4##(1996-5#1)(2007-10#2)(2008-12#2)(2008-7#1)
middle cerebral artery aneurysms##4##4##(2011-2#3)(2013-8#1)
middle cerebral artery blood velocity##2##5##(2007-10#2)
middle cerebral artery infarction in##2##5##(2007-10#2)
middle cerebral artery infarction##5##4##(2006-7#1)(2007-10#3)(2008-8#1)
middle cerebral artery occlusion (MCAO)##4##5##(1997-2#1)(2007-10#2)(2008-10#1)
middle cerebral artery occlusion##10##4##(1997-2#1)(2007-10#3)(2007-9#1)(2008-10#1)(2008-7#3)(2011-2#1)
middle cerebral artery territory##2##4##(2008-7#2)
middle cerebral artery with##2##4##(2008-7#2)
middle cerebral artery##54##3##(1995-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-10#17)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#14)(2008-8#1)(2010-11#1)(2011-2#5)(2013-8#3)
middle cerebral##58##2##(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-10#17)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#16)(2008-8#1)(2010-11#1)(2011-2#6)(2013-8#3)
middle childhood##2##2##(2008-11#1)(2010-5#1)
middle class##5##2##(1991-1#1)(1996-9#1)(2008-5#1)(2010-1#2)
middle component##2##2##(1992-8#2)
middle cranial fossa##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
middle ear disease##3##3##(1991-3#1)(2012-2#1)(2013-8#1)
middle ear##19##2##(1991-3#4)(1993-9#1)(1994-2#1)(1995-5#1)(1997-3#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
middle fossa##8##2##(2006-12#1)(2008-2#1)(2008-7#1)(2011-2#5)
middle frontal gyrus (BA6)##2##4##(2008-11#2)
middle frontal gyrus##4##3##(1994-8#2)(2008-11#2)
middle infrared##3##2##(2008-10#2)(2008-3#1)
middle layer##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#2)
middle lobe fixation##2##3##(2007-8#2)
middle lobe##5##2##(2007-8#3)(2008-1#2)
middle management##3##2##(1994-1#2)(1995-2#1)
middle managers##2##2##(1993-3#1)(1994-1#1)
middle mesial##2##2##(2012-12#2)
middle of the##26##3##(1991-11#2)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#3)(2011-2#1)(2013-7#1)
middle of##35##2##(1991-11#2)(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#3)(2010-4#1)(2011-2#1)(2011-3#1)(2013-7#1)
middle or##2##2##(2008-1#1)(2010-11#1)
middle portion##3##2##(1991-6#1)(1993-6#1)(2008-7#1)
middle promoters##3##2##(1995-2#3)
middle repetitive##3##2##(1995-2#1)(1995-8#2)
middle school students##4##3##(2009-7#1)(2010-1#1)(2012-12#1)(2013-7#1)
middle school##11##2##(1993-1#1)(2009-7#4)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-7#1)
middle schools##3##2##(2007-12#1)(2012-2#2)
middle section##2##2##(1991-2#1)(1992-5#1)
middle stratosphere##2##2##(2008-3#2)
middle temporal artery##2##3##(2008-9#2)
middle temporal##4##2##(1996-2#1)(2008-9#3)
middle third of##4##3##(1991-4#1)(2007-12#2)(2010-11#1)
middle third##6##2##(1991-4#1)(2007-12#2)(2008-7#1)(2010-11#1)(2013-1#1)
middle to late##3##3##(1990-11#1)(2009-7#1)(2010-7#1)
middle to##4##2##(1990-11#1)(2007-5#1)(2009-7#1)(2010-7#1)
middle trunk of the MCA trifurcation##2##6##(2008-12#2)
middle##348##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#4)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#8)(1995-5#2)(1995-6#5)(1995-8#2)(1996-2#4)(1996-3#3)(1996-5#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-12#4)(2006-7#1)(2007-10#17)(2007-11#2)(2007-12#7)(2007-2#1)(2007-5#4)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#24)(2008-11#9)(2008-12#11)(2008-2#2)(2008-3#13)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#25)(2008-8#6)(2008-9#12)(2009-10#2)(2009-3#2)(2009-7#19)(2009-9#1)(2010-1#4)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#25)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#9)
middle- and##2##2##(1994-1#1)(2010-7#1)
middle-##4##1##(1994-1#1)(2007-11#1)(2010-7#1)(2013-1#1)
middle-aged (12##2##2##(1994-6#1)(2008-3#1)
middle-aged adults##5##2##(2007-8#1)(2008-7#1)(2009-11#1)(2009-12#1)(2013-1#1)
middle-aged and older adults##2##4##(2008-4#1)(2013-1#1)
middle-aged and##5##2##(1995-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
middle-aged man##3##2##(2008-11#2)(2012-12#1)
middle-aged men##4##2##(2008-5#3)(2011-2#1)
middle-aged patients with##2##3##(1997-6#1)(2013-1#1)
middle-aged patients##3##2##(1997-6#1)(2013-1#2)
middle-aged women##3##2##(2009-11#1)(2011-1#1)(2011-2#1)
middle-aged##38##1##(1991-6#2)(1991-8#1)(1994-6#1)(1995-3#1)(1997-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#6)(2009-11#2)(2009-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#4)
middle-class##4##1##(2007-2#1)(2008-11#1)(2009-10#1)(2012-1#1)
middle-ear##5##1##(2008-9#5)
middle-income##9##1##(1993-3#1)(2008-10#3)(2010-11#1)(2011-2#1)(2012-12#3)
middle-third##2##1##(2012-2#2)
midecamycin##4##1##(2008-8#4)
midface deficiency##3##2##(2007-12#3)
midface##10##1##(1996-6#1)(2007-12#6)(2010-8#1)(2012-12#2)
midfacial##8##1##(2007-12#4)(2011-2#4)
midfrequency##2##1##(2008-3#2)
midge##10##1##(1991-8#1)(2008-5#1)(2011-2#8)
midges##3##1##(1991-8#1)(2008-8#2)
midgestation##3##1##(1992-12#1)(1994-11#1)(1995-2#1)
midget chromosome##2##2##(2008-5#2)
midget##5##1##(2008-5#5)
midgut cells##4##2##(2007-12#2)(2008-10#2)
midgut epithelia##3##2##(2008-10#3)
midgut of##3##2##(2007-12#1)(2008-10#2)
midgut walls##2##2##(2007-12#2)
midgut##39##1##(1992-3#1)(1997-3#1)(2007-12#12)(2008-10#17)(2008-12#2)(2008-6#2)(2008-7#2)(2013-1#2)
midguts##2##1##(2007-12#1)(2008-10#1)
midlevel##2##1##(1995-6#1)(2010-12#1)
midlife##4##1##(2012-1#2)(2013-1#2)
midline neuropil in##2##3##(2007-12#2)
midline neuropil##4##2##(2007-12#4)
midline neuropils in##3##3##(2007-12#3)
midline neuropils of##2##3##(2007-12#2)
midline neuropils##5##2##(2007-12#5)
midline suboccipital##2##2##(2011-2#1)(2013-1#1)
midline tissues##2##2##(1994-12#2)
midline##40##1##(1990-5#1)(1990-8#1)(1991-11#1)(1993-12#1)(1994-12#2)(1994-3#1)(1996-9#1)(1997-3#2)(2007-12#16)(2008-10#2)(2008-12#2)(2008-7#2)(2009-1#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#2)
midparent value##2##2##(2008-10#2)
midpiece##5##1##(2008-7#5)
midplane##3##1##(2008-3#2)(2008-6#1)
midpoint of 4##2##3##(1992-6#2)
midpoint of the##3##3##(1990-7#1)(1995-2#1)(1997-2#1)
midpoint of##8##2##(1990-7#1)(1992-6#3)(1993-8#1)(1995-2#1)(1997-2#1)(2008-12#1)
midpoint potential of##2##3##(1991-8#1)(1997-7#1)
midpoint potential##3##2##(1991-8#1)(1997-7#2)
midpoint potentials##5##2##(1993-8#1)(2008-10#3)(2009-9#1)
midpoint urea concentration for the##2##5##(1995-5#2)
midpoint##24##1##(1990-7#1)(1991-8#1)(1992-6#3)(1993-8#2)(1995-2#1)(1995-5#4)(1997-2#1)(1997-7#2)(2008-10#3)(2008-12#1)(2008-2#2)(2009-9#1)(2011-2#1)(2013-8#1)
midportion of##2##2##(1990-12#1)(1996-6#1)
midrange##5##1##(1993-2#4)(2007-12#1)
midregion##2##1##(1991-8#2)
midrib##4##1##(2008-10#1)(2009-8#3)
midsagittal magnetic resonance##2##3##(1995-5#2)
midsagittal##8##1##(1995-5#4)(1996-5#2)(1996-7#2)
midseason##4##1##(2008-10#3)(2008-8#1)
midshaft##4##1##(1995-6#1)(2009-5#1)(2012-2#2)
midterm time horizon##2##3##(2008-11#2)
midterm##6##1##(2008-11#2)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
midtherapy##2##1##(2012-2#2)
midtrimester blood pressure##2##3##(1994-3#2)
midtropospheric aerosol backscatter background mode##2##5##(2008-2#1)(2008-3#1)
midway##4##1##(2007-9#1)(2008-7#1)(2009-9#1)(2012-2#1)
midwest##2##1##(2008-10#1)(2010-9#1)
midwestern United States##2##3##(2009-7#1)(2011-2#1)
midwestern##9##1##(1994-2#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-7#1)(2011-2#1)
midwife##6##1##(1993-3#1)(1995-6#1)(2008-12#1)(2010-3#2)(2013-1#1)
midwifery and##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
midwifery in##2##2##(2008-12#1)(2013-1#1)
midwifery programme##2##2##(2008-12#2)
midwifery##18##1##(1996-12#2)(2007-10#1)(2008-11#5)(2008-12#6)(2010-12#1)(2013-1#3)
midwifes##2##1##(1991-6#1)(2008-11#1)
midwinter##3##1##(1991-5#1)(2013-1#2)
midwives and##6##2##(2007-10#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
midwives in##3##2##(2009-10#1)(2012-12#1)(2012-3#1)
midwives on##2##2##(2007-10#1)(2008-11#1)
midwives##37##1##(1990-6#1)(1993-12#1)(1993-3#2)(1996-12#1)(1997-7#1)(2007-10#4)(2008-11#7)(2008-12#2)(2009-10#4)(2010-12#2)(2011-1#3)(2012-12#2)(2012-3#2)(2013-1#5)
midwives'##2##1##(2012-3#1)(2013-1#1)
miehei##2##1##(2008-6#1)(2013-1#1)
mifepristone and misoprostol##2##3##(2012-12#1)(2013-1#1)
might account for the##2##4##(2008-10#1)(2013-1#1)
might act as a##2##4##(2008-10#1)(2009-10#1)
might act as##4##3##(1990-9#1)(1995-6#1)(2008-10#1)(2009-10#1)
might act##6##2##(1990-9#1)(1993-9#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-10#1)
might affect the##4##3##(1993-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
might affect##8##2##(1993-12#1)(1993-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
might aid in##2##3##(2008-7#2)
might allow##2##2##(1991-6#1)(2013-1#1)
might also be considered##2##4##(2007-11#1)(2013-1#1)
might also be involved in##2##5##(1997-3#1)(2009-7#1)
might also be useful##2##4##(2008-3#1)(2012-1#1)
might also be##18##3##(1990-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
might also have a##2##4##(1996-8#1)(2008-4#1)
might also have##4##3##(1994-6#1)(1996-8#1)(2008-4#1)(2008-7#1)
might also##34##2##(1990-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
might appear##2##2##(1994-5#1)(2008-7#1)
might be a##29##3##(1990-5#1)(1990-6#1)(1992-6#1)(1992-9#1)(1994-2#2)(1995-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#1)
might be able to##4##4##(1991-9#1)(2008-12#1)(2008-5#1)(2008-7#1)
might be achieved##5##3##(1992-2#1)(2008-10#2)(2008-12#1)(2008-5#1)
might be addressed##2##3##(1993-12#1)(2012-12#1)
might be affected##2##3##(2008-10#1)(2008-11#1)
might be an##14##3##(1992-2#1)(1993-11#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)
might be applicable to##2##4##(2008-11#1)(2008-8#1)
might be applied##2##3##(1993-3#1)(2008-6#1)
might be as##2##3##(2008-4#1)(2009-1#1)
might be associated with the##3##5##(2007-10#1)(2008-9#1)(2011-1#1)
might be associated with##10##4##(1992-2#1)(1995-2#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)
might be associated##11##3##(1992-2#1)(1995-2#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
might be attributed to the##2##5##(1990-12#1)(2013-1#1)
might be attributed to##4##4##(1990-12#1)(2008-10#2)(2013-1#1)
might be beneficial##3##3##(2007-10#1)(2008-4#1)(2008-7#1)
might be better##4##3##(1996-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
might be caused by##4##4##(1994-12#1)(1995-3#1)(2008-11#1)(2008-7#1)
might be clinically##2##3##(1992-3#1)(2008-8#1)
might be considered an##2##4##(1991-12#1)(2008-5#1)
might be considered as a##2##5##(2008-10#1)(2010-1#1)
might be considered##9##3##(1991-12#1)(1992-12#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2012-1#1)
might be crucial##2##3##(2008-7#2)
might be dependent##2##3##(1997-1#1)(2008-3#1)
might be derived from pre-karyote##3##5##(2009-6#3)
might be derived from##4##4##(2009-6#3)(2012-2#1)
might be described as##2##4##(2008-7#2)
might be determined##2##3##(2008-10#1)(2008-7#1)
might be directly##3##3##(1995-12#1)(2008-6#1)(2011-2#1)
might be due to a##3##5##(1993-1#1)(1993-8#1)(1994-5#1)
might be due to the##6##5##(1991-2#1)(1993-12#1)(1994-6#1)(1997-4#1)(2008-9#1)(2010-3#1)
might be due to##19##4##(1990-12#1)(1991-2#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#1)
might be expected to##5##4##(1994-5#1)(1994-6#1)(1996-11#1)(2008-7#1)(2012-3#1)
might be expected##11##3##(1991-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#2)
might be explained by the##3##5##(1994-6#1)(2008-10#1)(2011-2#1)
might be explained by##7##4##(1993-1#1)(1994-6#1)(1997-5#1)(2008-10#2)(2011-2#2)
might be helpful to##2##4##(1996-6#1)(2013-1#1)
might be helpful##4##3##(1991-12#1)(1996-12#1)(1996-6#1)(2013-1#1)
might be implicated in the##2##5##(2011-1#1)(2013-8#1)
might be implicated in##3##4##(2010-11#1)(2011-1#1)(2013-8#1)
might be important for##3##4##(1997-2#1)(1997-8#1)(2011-2#1)
might be important##4##3##(1997-2#1)(1997-8#1)(2008-10#1)(2011-2#1)
might be improved##2##3##(2008-10#2)
might be involved in the##12##5##(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#2)(2013-1#2)
might be involved in##18##4##(1990-4#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-11#1)(2013-1#2)
might be involved##21##3##(1990-4#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-11#1)(2013-1#2)
might be linked to the##3##5##(1991-12#1)(2008-4#1)(2010-8#1)
might be mediated by##2##4##(1992-3#1)(1997-5#1)
might be more important##2##4##(2009-2#1)(2011-2#1)
might be more##11##3##(1993-8#1)(1995-8#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-1#1)(2013-1#1)
might be necessary to##3##4##(1995-5#1)(1996-5#1)(2011-2#1)
might be necessary##4##3##(1995-5#1)(1996-5#1)(2008-10#1)(2011-2#1)
might be obtained##2##3##(2008-11#1)(2008-8#1)
might be of##9##3##(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
might be one of the factors##2##6##(1997-8#1)(2008-12#1)
might be one of the##4##5##(1997-8#1)(2008-12#1)(2008-8#2)
might be one##6##3##(1994-9#1)(1997-8#1)(2008-12#1)(2008-8#2)(2011-1#1)
might be overcome##2##3##(2007-8#1)(2009-11#1)
might be owing to the##2##5##(2008-5#1)(2009-2#1)
might be preferable##2##3##(1994-8#1)(2010-5#1)
might be reflected in##2##4##(2008-11#1)(2011-2#1)
might be regarded as##2##4##(1992-2#1)(2008-3#1)
might be regulated##2##3##(2008-11#1)(2011-10#1)
might be related to the##2##5##(2008-7#1)(2009-12#1)
might be related to##9##4##(1995-2#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2011-1#1)
might be relevant to##2##4##(2008-6#1)(2011-2#1)
might be relevant##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
might be responsible for the##4##5##(1991-9#1)(1993-6#1)(2008-10#1)(2013-1#1)
might be responsible for##9##4##(1991-9#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-6#1)(2013-1#1)
might be similar##2##3##(2011-10#1)(2011-2#1)
might be suggested that##2##4##(1993-5#1)(2008-12#1)
might be the best##2##4##(1990-3#1)(1995-4#1)
might be the cause##2##4##(1994-11#1)(2008-1#1)
might be the primary##2##4##(2008-8#1)(2013-1#1)
might be the result of##3##5##(1991-3#1)(1995-8#1)(2008-10#1)
might be the##25##3##(1990-3#2)(1990-4#1)(1990-7#1)(1991-3#1)(1994-11#1)(1995-4#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
might be to##2##3##(2007-12#1)(2009-9#1)
might be too##2##3##(2007-2#1)(2008-2#1)
might be transmitted##2##3##(1995-9#1)(1996-5#1)
might be used as##2##4##(2008-2#1)(2008-8#1)
might be used in##2##4##(1994-12#1)(2011-2#1)
might be used##8##3##(1992-9#1)(1994-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
might be useful for the diagnosis##2##6##(1990-8#1)(2008-4#1)
might be useful for##7##4##(1990-8#1)(1991-2#1)(1994-6#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
might be useful in the##2##5##(2008-10#1)(2011-2#1)
might be useful in##6##4##(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
might be useful to##2##4##(2012-1#1)(2012-2#1)
might be useful##17##3##(1990-8#1)(1991-2#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
might be##443##2##(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#7)(1997-9#1)(2006-10#1)(2007-10#3)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#38)(2008-11#19)(2008-12#8)(2008-2#11)(2008-3#6)(2008-4#8)(2008-5#10)(2008-6#8)(2008-7#24)(2008-8#19)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#10)(2011-10#2)(2011-2#19)(2012-1#4)(2012-12#5)(2012-2#15)(2012-3#6)(2013-1#13)(2013-8#4)
might benefit from##6##3##(1991-12#1)(2007-12#2)(2008-10#1)(2008-8#1)(2012-7#1)
might benefit##8##2##(1991-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-8#1)(2012-7#1)(2013-8#1)
might both##2##2##(1997-6#1)(2008-3#1)
might cause the##2##3##(1997-2#1)(2008-11#1)
might cause##4##2##(1997-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
might contribute to the##5##4##(1993-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
might contribute to##13##3##(1991-5#1)(1993-3#2)(1993-8#1)(1994-5#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#1)
might contribute##14##2##(1991-5#1)(1993-3#2)(1993-8#1)(1994-5#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#1)(2012-2#1)
might correspond to##2##3##(2008-10#1)(2008-5#1)
might decrease##3##2##(2007-8#1)(2008-4#1)(2011-2#1)
might depend on##2##3##(1992-3#1)(2008-3#1)
might emerge##2##2##(2008-11#1)(2009-2#1)
might encode##2##2##(1996-8#1)(2009-8#1)
might exist##4##2##(1992-9#1)(2008-7#1)(2008-9#1)(2011-1#1)
might explain the##10##3##(1990-2#1)(1991-11#1)(1994-5#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)
might explain why##2##3##(2008-10#1)(2010-4#1)
might explain##18##2##(1990-2#1)(1991-11#1)(1992-12#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-4#1)
might facilitate the##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
might facilitate##5##2##(2007-12#1)(2008-12#1)(2008-7#2)(2013-8#1)
might find##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
might form a##2##3##(1995-6#1)(1997-7#1)
might form##5##2##(1995-12#1)(1995-6#1)(1997-7#1)(2008-5#1)(2008-9#1)
might function as a##2##4##(1997-4#1)(2008-5#1)
might function in##2##3##(1993-8#1)(1994-6#1)
might function##5##2##(1993-8#1)(1994-6#1)(1997-4#1)(2008-5#1)(2008-7#1)
might have a common##2##4##(2008-4#1)(2008-8#1)
might have a##9##3##(1993-11#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
might have an important##2##4##(1994-5#1)(2009-6#1)
might have an##3##3##(1994-5#1)(2009-6#1)(2012-2#1)
might have been caused by##2##5##(2007-6#1)(2007-9#1)
might have been expected##3##4##(1992-5#2)(2008-3#1)
might have been##17##3##(1990-3#1)(1991-4#1)(1992-2#1)(1992-5#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-4#1)
might have benefited from##2##4##(1991-6#1)(2010-12#1)
might have contributed to the##4##5##(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)
might have contributed to##6##4##(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
might have the##2##3##(2008-7#1)(2010-5#1)
might have##65##2##(1990-3#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#6)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)
might help to##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
might help##9##2##(1997-6#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#1)(2013-1#1)
might impair##3##2##(1992-12#1)(1992-2#1)(2008-8#1)
might imply##2##2##(2011-2#2)
might improve##5##2##(1995-6#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-9#1)
might in##2##2##(1992-8#1)(2008-7#1)
might include##2##2##(2007-12#1)(2008-2#1)
might indicate that##4##3##(1993-6#1)(1997-7#1)(2006-8#1)(2008-7#1)
might indicate##6##2##(1993-6#1)(1997-7#1)(2006-8#1)(2008-7#1)(2009-8#1)(2011-2#1)
might induce the##2##3##(2008-11#1)(2008-4#1)
might induce##12##2##(1992-8#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)
might influence the##3##3##(1993-12#1)(2010-4#1)(2013-8#1)
might influence##8##2##(1991-12#1)(1993-1#1)(1993-12#1)(2008-10#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
might inhibit the##2##3##(1997-2#1)(2008-1#1)
might interact with##3##3##(1990-2#1)(1995-2#1)(2013-1#1)
might interact##5##2##(1990-2#1)(1995-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
might interfere with##5##3##(1990-8#1)(1991-12#1)(1992-9#1)(2008-10#2)
might involve the regulation of##2##5##(2008-4#2)
might involve the##4##3##(1996-5#1)(2008-4#2)(2008-7#1)
might involve##8##2##(1990-2#1)(1992-3#1)(1996-5#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-1#1)
might lead to the##2##4##(1991-2#1)(1991-6#1)
might lead to##18##3##(1991-2#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#2)
might lead##19##2##(1991-2#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#2)
might limit##2##2##(1994-8#1)(2008-9#1)
might make them##2##3##(1997-6#1)(2008-4#1)
might make##3##2##(1997-6#1)(2008-4#1)(2012-1#1)
might not be##12##3##(1990-8#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
might not have been##2##4##(1997-1#1)(2012-12#1)
might not##22##2##(1990-8#1)(1991-12#1)(1994-5#1)(1996-3#2)(1997-1#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
might occur##6##2##(1994-11#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-9#2)
might originate from##2##3##(1997-3#1)(1997-8#1)
might otherwise##3##2##(1991-6#1)(2008-10#1)(2008-2#1)
might participate in the##3##4##(1993-12#1)(1996-12#1)(2008-11#1)
might permit##2##2##(1993-12#1)(2007-12#1)
might play a critical role in the##2##7##(2008-11#1)(2008-8#1)
might play a critical role in##3##6##(2008-11#1)(2008-8#1)(2008-9#1)
might play a critical role##4##5##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
might play a role in the##3##6##(1992-12#1)(1995-3#1)(2008-7#1)
might play a role in##5##5##(1992-12#1)(1994-6#1)(1995-3#1)(2008-7#1)(2012-2#1)
might play a role##6##4##(1992-12#1)(1994-6#1)(1995-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
might play a##15##3##(1992-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
might play an important role in##3##6##(1997-2#1)(2008-11#1)(2008-9#1)
might play an important role##5##5##(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
might play##25##2##(1992-12#1)(1993-6#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
might possibly##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
might predict##4##2##(2007-4#1)(2008-10#1)(2008-7#1)(2010-4#1)
might predispose to##4##3##(1991-8#1)(1992-2#1)(2008-8#1)(2011-2#1)
might predispose##5##2##(1990-9#1)(1991-8#1)(1992-2#1)(2008-8#1)(2011-2#1)
might prevent##2##2##(2008-10#1)(2012-2#1)
might produce a##2##3##(2008-10#1)(2013-1#1)
might produce##4##2##(2008-10#1)(2009-4#1)(2013-1#1)(2013-8#1)
might promote##3##2##(2009-6#1)(2013-1#2)
might prove##2##2##(1991-5#1)(2008-10#1)
might provide a##5##3##(2008-11#2)(2008-4#1)(2008-9#1)(2010-12#1)
might provide new##3##3##(2008-4#1)(2008-7#2)
might provide##16##2##(1991-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-12#1)(2012-3#1)
might reduce the##4##3##(1995-6#1)(2007-10#1)(2008-10#2)
might reflect the##2##3##(2007-8#1)(2013-8#1)
might reflect##7##2##(1990-6#1)(1991-11#1)(1994-3#1)(2007-8#1)(2008-7#1)(2010-8#1)(2013-8#1)
might regulate##3##2##(1994-12#1)(2008-11#1)(2008-4#1)
might relate to##2##3##(1994-6#1)(2008-11#1)
might represent a##6##3##(1990-8#1)(2008-5#1)(2009-5#1)(2010-11#2)(2011-2#1)
might represent an##2##3##(2008-5#1)(2008-9#1)
might represent##12##2##(1990-8#1)(1994-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#2)(2011-2#2)
might require##4##2##(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
might respond to##2##3##(1991-2#1)(2008-6#1)
might result from the##2##4##(1995-3#1)(2008-11#1)
might result from##3##3##(1995-3#1)(2008-11#1)(2009-8#1)
might result in##2##3##(2010-12#1)(2013-8#1)
might result##5##2##(1995-3#1)(2008-11#1)(2009-8#1)(2010-12#1)(2013-8#1)
might serve as a##2##4##(1994-10#1)(1994-2#1)
might serve as##3##3##(1994-10#1)(1994-2#1)(2010-12#1)
might serve to##3##3##(1997-7#1)(2008-1#1)(2008-8#1)
might serve##6##2##(1994-10#1)(1994-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2010-12#1)
might shed##2##2##(2008-2#1)(2008-8#1)
might show##2##2##(1990-6#1)(2008-10#1)
might stem from##3##3##(1990-11#1)(2008-11#1)(2008-4#1)
might still##2##2##(2008-10#1)(2012-1#1)
might suggest that##2##3##(1991-5#1)(2010-3#1)
might therefore be##4##3##(1991-12#1)(1993-12#1)(2008-9#1)(2012-12#1)
might therefore##9##2##(1991-12#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-12#1)(2007-10#1)(2008-9#1)(2009-7#1)(2012-12#1)
might trigger##2##2##(1995-8#1)(2008-11#1)
might use the##2##3##(1995-5#1)(2008-1#1)
might use##3##2##(1995-5#1)(2007-7#1)(2008-1#1)
might work##3##2##(2007-12#1)(2008-4#1)(2008-5#1)
might##1034##1##(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#5)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#2)(1991-11#3)(1991-12#10)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#4)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#7)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#4)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#9)(1993-3#5)(1993-5#2)(1993-6#6)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#6)(1994-2#7)(1994-3#5)(1994-5#9)(1994-6#10)(1994-8#5)(1994-9#1)(1995-11#4)(1995-12#6)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#6)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#9)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#6)(1997-8#9)(1997-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#7)(2007-11#2)(2007-12#15)(2007-2#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#9)(2008-10#83)(2008-11#44)(2008-12#17)(2008-2#16)(2008-3#15)(2008-4#32)(2008-5#28)(2008-6#12)(2008-7#60)(2008-8#43)(2008-9#32)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#7)(2009-6#16)(2009-7#6)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#10)(2010-2#2)(2010-3#7)(2010-4#11)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#18)(2011-10#2)(2011-2#43)(2012-1#7)(2012-12#9)(2012-2#27)(2012-3#9)(2012-7#1)(2012-8#1)(2013-1#31)(2013-8#13)
migraine across the lifespan##2##4##(2008-9#2)
migraine and##7##2##(1990-3#1)(1991-3#1)(1991-8#1)(2008-5#1)(2008-9#2)(2011-1#1)
migraine as##2##2##(2008-9#2)
migraine attacks##6##2##(1994-11#2)(2008-9#4)
migraine is a##2##3##(2008-9#2)
migraine is##4##2##(2008-9#4)
migraine pain##2##2##(2008-9#2)
migraine patients##2##2##(1994-11#1)(2008-9#1)
migraine plus##2##2##(2012-3#2)
migraine prophylaxis##2##2##(2008-6#1)(2013-7#1)
migraine with and migraine without aura##2##6##(2008-9#2)
migraine with aura##5##3##(2008-9#4)(2011-2#1)
migraine with##9##2##(2008-6#1)(2008-9#7)(2011-2#1)
migraine without aura##4##3##(2008-9#4)
migraine##81##1##(1990-3#2)(1991-3#1)(1991-8#1)(1992-8#1)(1993-3#1)(1994-11#6)(1996-9#1)(2007-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#45)(2009-9#1)(2010-2#6)(2011-1#1)(2011-2#2)(2012-3#6)(2013-7#1)
migraineurs##3##1##(2008-9#2)(2010-9#1)
migrans and##2##2##(2007-2#1)(2008-9#1)
migrans##7##1##(2007-2#3)(2007-7#1)(2008-9#1)(2012-2#2)
migrant adolescents in##2##3##(1997-8#1)(2013-8#1)
migrant experience##2##2##(2013-8#2)
migrant farmworker##5##2##(2008-12#3)(2010-9#2)
migrant women##5##2##(2009-10#1)(2011-2#1)(2012-3#3)
migrant women's##2##2##(2012-3#2)
migrant workers##2##2##(1990-9#1)(2011-2#1)
migrant##28##1##(1990-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-9#2)(2011-2#3)(2012-3#6)(2013-8#4)
migrants and mobile populations##3##4##(2011-2#3)
migrants and the##3##3##(1992-8#1)(1994-2#1)(2008-9#1)
migrants and##8##2##(1992-8#1)(1994-2#1)(2008-9#1)(2010-8#2)(2011-2#3)
migrants from the##3##3##(1992-8#1)(2008-10#1)(2008-6#1)
migrants from##5##2##(1992-8#1)(1994-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
migrants per passage and##2##4##(2013-1#2)
migrants##37##1##(1992-8#3)(1994-12#1)(1994-2#6)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-8#4)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#3)
migrate and##2##2##(2012-12#2)
migrate faster than##2##3##(1996-5#1)(2008-4#1)
migrate from##3##2##(1995-8#1)(2008-10#1)(2010-8#1)
migrate in response to##2##4##(1994-11#1)(2008-2#1)
migrate in##5##2##(1992-10#1)(1994-11#1)(1995-12#1)(2008-2#1)(2012-1#1)
migrate into the##2##3##(1997-8#1)(2008-4#1)
migrate into##4##2##(1997-8#1)(2006-12#1)(2008-4#1)(2008-5#1)
migrate through the##2##3##(2008-11#1)(2008-5#1)
migrate to the##3##3##(1995-12#1)(1996-2#1)(2008-11#1)
migrate to their##2##3##(1996-5#1)(2008-11#1)
migrate to##11##2##(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2011-1#2)(2013-8#1)
migrate towards##2##2##(2013-1#2)
migrate with##2##2##(1992-6#1)(1993-3#1)
migrate##51##1##(1990-3#1)(1992-10#2)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-8#1)(2006-12#1)(2007-12#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
migrated as a single band##2##5##(1991-12#1)(1992-12#1)
migrated as a##4##3##(1991-12#1)(1992-12#1)(1992-3#1)(2008-10#1)
migrated as##6##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(2008-10#1)
migrated at##2##2##(1993-2#1)(2010-8#1)
migrated from##3##2##(2008-10#1)(2010-12#1)(2012-1#1)
migrated microcatheter##2##2##(2008-7#2)
migrated through##2##2##(1992-6#1)(2008-5#1)
migrated to a##2##3##(1994-3#1)(2008-5#1)
migrated to the##2##3##(2008-5#1)(2012-1#1)
migrated to##5##2##(1994-3#1)(1995-12#1)(2008-5#2)(2012-1#1)
migrated towards the##2##3##(2008-10#1)(2010-8#1)
migrated##40##1##(1990-2#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#2)(2013-1#1)
migrates into##2##2##(2008-4#1)(2008-5#1)
migrates on##2##2##(1991-9#1)(1992-11#1)
migrates##6##1##(1991-9#1)(1992-10#1)(1992-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
migrating cells##2##2##(1992-6#1)(2009-8#1)
migrating to and##2##3##(2007-12#1)(2009-4#1)
migrating to##5##2##(2007-12#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-1#1)
migrating##20##1##(1992-6#2)(1993-12#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-3#1)
migration across##3##2##(1990-5#1)(1995-2#1)(2009-9#1)
migration after##3##2##(2010-8#1)(2012-12#2)
migration and coiling##2##3##(2012-12#2)
migration and invasion of##2##4##(2012-3#2)
migration and invasion##3##3##(2008-6#1)(2012-3#2)
migration and proliferation##4##3##(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)
migration and tube formation##3##4##(2008-10#3)
migration and##39##2##(1992-8#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#1)
migration appears to be##2##4##(1992-6#1)(2012-2#1)
migration as##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
migration at##2##2##(1994-11#1)(2007-12#1)
migration began##2##2##(2011-2#2)
migration between sites##2##3##(2008-8#2)
migration between##6##2##(2008-10#3)(2008-8#2)(2009-5#1)
migration by##4##2##(1995-2#1)(2008-10#1)(2008-5#1)(2010-8#1)
migration can##3##2##(2008-8#1)(2013-1#2)
migration could##2##2##(1995-2#1)(2011-2#1)
migration from the##2##3##(2008-12#1)(2008-7#1)
migration from##7##2##(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
migration has been##2##3##(2008-3#1)(2008-7#1)
migration has##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
migration in a##2##3##(1992-6#1)(2008-10#1)
migration in the##9##3##(1996-5#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
migration in turbid media##2##4##(1994-2#1)(2008-2#1)
migration in##29##2##(1992-6#2)(1994-2#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
migration index##2##2##(1992-6#2)
migration inhibition factor activity##2##4##(1991-12#2)
migration inhibition factor##4##3##(1991-12#4)
migration into##4##2##(1992-6#1)(1995-8#1)(1997-8#1)(2008-11#1)
migration is a rare##2##4##(2008-7#1)(2011-2#1)
migration is##6##2##(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#2)
migration occurred in##2##3##(1992-8#1)(2008-4#1)
migration occurs in##2##3##(2008-11#1)(2008-8#1)
migration of Steinman wire##2##4##(2007-8#2)
migration of Steinman##3##3##(2007-8#3)
migration of a##3##3##(1993-9#1)(2008-10#1)(2013-1#1)
migration of cells##2##3##(2008-4#1)(2013-8#1)
migration of hMSCs##2##3##(2010-8#2)
migration of human##3##3##(2008-1#1)(2008-10#1)(2010-8#1)
migration of myogenic precursor cells into the limb##2##8##(1995-8#2)
migration of myogenic precursor cells##4##5##(1995-8#4)
migration of oligodendrocyte precursor cells##2##5##(2008-7#2)
migration of subureterically injected calcium hydroxylapatite##2##6##(2008-10#2)
migration of the pathogen##2##4##(2008-10#2)
migration of the##19##3##(1990-12#1)(1990-9#1)(1992-6#1)(1994-8#1)(1997-6#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#1)(2013-1#1)
migration of these##2##3##(1997-4#1)(2008-12#1)
migration of##90##2##(1990-12#2)(1990-5#1)(1990-9#1)(1991-12#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-8#3)(1995-12#2)(1995-3#2)(1995-8#4)(1996-5#1)(1997-4#1)(1997-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-12#1)(2010-7#2)(2010-8#5)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
migration on##3##2##(1992-8#1)(1997-2#1)(2008-8#1)
migration over##2##2##(2008-9#1)(2010-8#1)
migration parameters##2##2##(2008-1#1)(2008-10#1)
migration patterns##4##2##(2008-5#3)(2011-2#1)
migration project##2##2##(1992-3#2)
migration rate and##3##3##(2008-8#3)
migration rate was##2##3##(2008-10#1)(2010-8#1)
migration rate##22##2##(2008-10#2)(2008-2#1)(2008-8#18)(2010-8#1)
migration rates##4##2##(2008-8#2)(2013-1#2)
migration research##2##2##(1993-6#2)
migration through##3##2##(1994-5#1)(2008-1#1)(2008-2#1)
migration time and peak##3##4##(2008-10#3)
migration time and##9##3##(1996-5#1)(2008-10#8)
migration time of##3##3##(2008-10#3)
migration time##19##2##(1996-5#1)(2008-10#18)
migration times (&lt##2##3##(2008-10#2)
migration times and peak##3##4##(2008-10#3)
migration times and##5##3##(2008-10#5)
migration times of##2##3##(2008-10#2)
migration times##15##2##(1994-9#1)(2008-10#14)
migration to the##5##3##(1990-3#1)(1993-5#1)(2011-2#2)(2013-1#1)
migration to##11##2##(1990-3#1)(1993-5#1)(2007-12#1)(2008-1#1)(2008-4#2)(2009-1#1)(2011-2#3)(2013-1#1)
migration toward##2##2##(1994-1#1)(2012-12#1)
migration towards##2##2##(2008-5#1)(2009-12#1)
migration was##4##2##(1994-8#2)(2008-10#1)(2012-1#1)
migration with##3##2##(2007-8#1)(2011-2#2)
migration within the##2##3##(2008-9#1)(2009-10#1)
migration within##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
migration##500##1##(1990-12#6)(1990-3#1)(1990-5#5)(1990-8#1)(1990-9#1)(1991-12#5)(1991-5#1)(1992-3#3)(1992-6#9)(1992-8#3)(1993-2#1)(1993-5#2)(1993-6#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#12)(1994-9#2)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#3)(1995-8#6)(1995-9#1)(1996-12#3)(1996-2#1)(1996-5#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#8)(2007-7#2)(2007-8#4)(2008-1#9)(2008-10#79)(2008-11#13)(2008-12#5)(2008-2#3)(2008-3#16)(2008-4#14)(2008-5#10)(2008-6#6)(2008-7#21)(2008-8#50)(2008-9#18)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#2)(2010-3#1)(2010-5#4)(2010-7#2)(2010-8#14)(2010-9#1)(2011-1#2)(2011-2#42)(2012-1#5)(2012-12#15)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#19)(2013-7#1)(2013-8#6)
migration/invasion##3##1##(2013-1#3)
migrations of the##2##3##(2008-10#1)(2008-9#1)
migrations of##3##2##(2008-10#1)(2008-9#2)
migrations##10##1##(1994-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#2)(2010-2#1)(2012-1#1)
migratory behavior##3##2##(2008-6#1)(2008-8#1)(2012-3#1)
migratory behaviour##3##2##(2010-8#3)
migratory birds##4##2##(1995-3#1)(1997-4#3)
migratory erythema##2##2##(2013-7#2)
migratory fascia hypothesis##2##3##(2009-9#2)
migratory fascia##3##2##(2009-9#3)
migratory flocks##2##2##(2011-2#2)
migratory species##3##2##(2008-8#2)(2013-7#1)
migratory##39##1##(1991-8#1)(1994-2#1)(1995-3#2)(1997-4#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-8#1)(2009-9#3)(2010-8#6)(2011-2#5)(2012-3#3)(2013-7#4)
mil/raf##4##1##(1993-6#4)
milacemide##3##1##(1994-8#3)
mild Delta5 steroid abnormality##2##4##(2008-4#2)
mild TBI##6##2##(2008-6#2)(2013-8#4)
mild acid hydrolysis##3##3##(1991-12#1)(1994-11#2)
mild acid##5##2##(1991-12#1)(1991-9#1)(1994-11#2)(2008-10#1)
mild and moderate##3##3##(1996-9#1)(1997-8#1)(2008-7#1)
mild and self-limited##2##3##(2010-12#1)(2013-1#1)
mild and severe##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
mild and transient##2##3##(2008-10#1)(2008-7#1)
mild and##25##2##(1992-10#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
mild anemia##7##2##(2008-7#7)
mild blood pressure elevation##3##4##(2009-5#3)
mild but##3##2##(1997-3#1)(2008-6#1)(2012-12#1)
mild cerebral##2##2##(1994-2#1)(1997-3#1)
mild cognitive impairment (MCI) and##2##5##(2010-7#1)(2013-8#1)
mild cognitive impairment (MCI)##4##4##(2008-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
mild cognitive impairment##14##3##(2008-2#1)(2008-6#1)(2009-10#4)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
mild cognitive##16##2##(1994-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#4)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
mild conditions for##3##3##(1997-2#1)(2008-10#2)
mild conditions##16##2##(1990-11#1)(1992-3#1)(1997-2#1)(2007-11#3)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#2)
mild cough##2##2##(1992-5#1)(2008-8#1)
mild curly top virus##4##4##(2008-10#4)
mild deficits##2##2##(1993-12#2)
mild degree of##2##3##(2008-4#1)(2012-2#1)
mild demented##2##2##(2008-7#2)
mild depression##2##2##(2006-10#2)
mild elevation##2##2##(1992-10#1)(2009-3#1)
mild endometriosis##2##2##(1994-9#2)
mild epidemics##4##2##(2008-10#4)
mild form##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
mild forms##5##2##(1994-9#1)(2008-5#1)(2011-1#2)(2013-1#1)
mild head injury##5##3##(2008-7#5)
mild head##6##2##(2008-7#5)(2012-2#1)
mild heart failure##2##3##(1992-6#1)(1995-3#1)
mild heart##3##2##(1992-6#1)(1995-3#1)(2007-2#1)
mild heat stress##2##3##(2008-7#2)
mild heat treatment##2##3##(2011-2#2)
mild heat##6##2##(2008-7#3)(2011-2#3)
mild hypothermia and##2##3##(1995-11#1)(2011-2#1)
mild hypothermia##8##2##(1995-11#1)(2006-10#1)(2007-10#4)(2011-2#2)
mild in both##2##3##(2007-7#1)(2008-6#1)
mild in##5##2##(1997-8#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-12#1)
mild leaf##2##2##(2008-10#2)
mild mosaic##4##2##(2008-10#3)(2008-9#1)
mild mottle virus##7##3##(1997-6#2)(2008-10#5)
mild nervous disorders##2##3##(2008-10#2)
mild or severe##2##3##(2007-12#1)(2012-2#1)
mild or##8##2##(1997-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2011-1#3)(2012-2#1)
mild pain##3##2##(2007-2#1)(2008-9#1)(2012-12#1)
mild proteinuria##2##2##(2008-1#1)(2011-2#1)
mild sensory##3##2##(1991-6#1)(2008-11#1)(2012-12#1)
mild signs of##2##3##(2008-7#1)(2013-1#1)
mild steel##4##2##(2008-10#3)(2011-2#1)
mild strain##4##2##(2008-10#4)
mild stress##5##2##(1994-6#1)(2008-11#2)(2008-7#1)(2013-1#1)
mild stresses##2##2##(2008-7#1)(2009-8#1)
mild symptoms on##2##3##(2008-10#2)
mild symptoms##6##2##(2007-12#1)(2008-10#3)(2010-5#1)(2013-8#1)
mild thiamine deficiency##2##3##(2008-1#2)
mild to moderate asthma##2##4##(1996-1#1)(2008-5#1)
mild to moderate hypertension##2##4##(1994-11#1)(2008-1#1)
mild to moderate##18##3##(1994-11#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2013-1#2)(2013-8#1)
mild to severe type##2##4##(2008-8#1)(2013-1#1)
mild to severe##5##3##(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)
mild to##25##2##(1994-11#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#3)(2013-8#1)
mild traumatic brain injury##5##4##(1991-12#1)(2010-1#2)(2013-1#1)(2013-8#1)
mild traumatic brain-injured##2##3##(2009-8#2)
mild traumatic##7##2##(1991-12#1)(2009-8#2)(2010-1#2)(2013-1#1)(2013-8#1)
mild whole body hyperthermia##2##4##(2008-7#2)
mild##445##1##(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#7)(1996-7#1)(1996-9#3)(1997-2#2)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#5)(1997-8#5)(2006-10#5)(2007-10#10)(2007-11#6)(2007-12#8)(2007-2#3)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#57)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#15)(2008-5#19)(2008-6#8)(2008-7#43)(2008-8#8)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#21)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#18)(2013-8#18)
mild)##2##1##(2008-9#1)(2009-7#1)
mild-moderate##2##1##(2008-7#1)(2010-12#1)
mild-to-moderate##14##1##(1990-3#1)(1991-6#1)(1992-8#3)(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-5#1)(2012-2#1)(2013-1#1)
mild-to-severe##2##1##(1990-3#1)(2010-11#1)
mild/moderate##3##1##(1995-1#1)(2011-2#1)(2013-8#1)
milder and##2##2##(2008-10#2)
milder symptoms##2##2##(2008-10#2)
milder##20##1##(1994-12#1)(1995-1#1)(1995-8#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
mildew and##5##2##(2008-10#5)
mildew caused by##2##3##(2008-10#2)
mildew colonies##6##2##(2008-10#6)
mildew development on##3##3##(2008-10#3)
mildew development##6##2##(2008-10#6)
mildew disease on##2##3##(2008-10#2)
mildew disease##3##2##(2008-10#3)
mildew epidemiology##2##2##(2008-10#2)
mildew for##2##2##(2008-10#2)
mildew in grape berries##2##4##(2008-10#2)
mildew in##8##2##(2008-10#8)
mildew incidence##4##2##(2008-10#4)
mildew infection##2##2##(2008-10#2)
mildew of##6##2##(2008-10#6)
mildew on##5##2##(2008-10#5)
mildew pathogen##3##2##(2008-10#3)
mildew resistance##17##2##(2008-10#15)(2012-3#2)
mildew were##3##2##(2008-10#3)
mildew##144##1##(2008-10#142)(2012-3#2)
mildly acidic##2##2##(2008-10#1)(2008-4#1)
mildly affected##4##2##(1997-3#1)(2007-10#1)(2008-7#1)(2011-1#1)
mildly depressed##2##2##(2010-4#2)
mildly impaired##2##2##(1990-3#1)(2011-2#1)
mildly##29##1##(1990-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
mile##2##1##(1995-12#1)(2006-10#1)
miles of the##2##3##(2006-10#1)(2008-1#1)
miles of##3##2##(2006-10#1)(2008-1#1)(2008-8#1)
miles##11##1##(2006-10#1)(2008-1#2)(2008-11#1)(2008-8#6)(2013-1#1)
milestone in the##3##3##(1995-1#1)(2008-10#1)(2009-10#1)
milestones in##6##2##(1992-1#1)(1995-6#1)(2008-11#1)(2008-4#1)(2010-6#1)(2012-2#1)
milestones of the##2##3##(1990-10#1)(2011-2#1)
milestones##13##1##(1990-10#1)(1992-1#1)(1995-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-6#2)(2011-2#1)(2012-2#3)
miliaceum L##2##2##(1996-10#2)
miliary##2##1##(1996-11#1)(2012-3#1)
milieu and##6##2##(1990-2#1)(1992-6#1)(1993-2#1)(1994-9#1)(2008-11#1)(2010-5#1)
milieu for##3##2##(1996-2#1)(2013-8#2)
milieu in##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
milieu of##5##2##(1997-4#3)(2008-7#1)(2013-1#1)
milieu therapy##2##2##(1991-2#1)(2013-1#1)
milieu to##2##2##(1992-3#1)(2009-8#1)
milieu##44##1##(1990-2#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#3)(1994-9#1)(1996-2#1)(1997-4#5)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#4)(2013-8#4)
milieus##2##1##(1994-3#1)(2010-7#1)
milieux##2##1##(2008-2#1)(2011-2#1)
military expenditures##2##2##(1990-2#2)
military facilities##4##2##(1995-6#1)(1996-5#3)
military hospitals##4##2##(1992-3#1)(1995-6#3)
military medical##3##2##(1992-3#1)(1992-6#1)(2008-6#1)
military orthopaedics##3##2##(2007-8#3)
military personnel##6##2##(1992-12#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#1)
military recruits##3##2##(1996-11#1)(2011-2#2)
military service and##2##3##(2007-8#2)
military service##14##2##(1991-11#2)(1993-8#1)(2007-8#2)(2008-11#1)(2011-2#2)(2013-1#6)
military##76##1##(1990-2#2)(1991-11#3)(1991-3#1)(1992-12#1)(1992-3#4)(1992-6#2)(1993-8#1)(1994-3#1)(1995-6#7)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#5)(1997-6#1)(2007-12#1)(2007-8#6)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-7#2)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#8)(2012-2#1)(2013-1#10)(2013-8#1)
milk (SM)##2##2##(2013-1#2)
milk TG structures##2##3##(2012-2#2)
milk TG##4##2##(2012-2#4)
milk and infant##2##3##(2008-10#2)
milk and plasma of##2##4##(2013-1#2)
milk and the##2##3##(2007-10#1)(2008-10#1)
milk and##35##2##(1991-12#1)(1993-1#1)(1996-8#1)(1997-1#1)(2007-10#1)(2007-11#2)(2008-10#18)(2008-12#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#3)
milk as a##2##3##(2012-2#1)(2013-1#1)
milk as##3##2##(2012-2#1)(2013-1#2)
milk by##10##2##(2008-10#8)(2009-8#1)(2011-2#1)
milk casein##2##2##(2007-11#1)(2012-2#1)
milk consumption##3##2##(2009-2#3)
milk fermentation##2##2##(1995-8#1)(2012-2#1)
milk free formulas for##2##4##(2013-8#2)
milk from Indonesian women##2##4##(2008-11#2)
milk from the##3##3##(1992-3#2)(2008-10#1)
milk from##9##2##(1991-6#1)(1992-3#3)(2008-10#1)(2008-11#2)(2013-1#2)
milk has##2##2##(2008-10#1)(2012-2#1)
milk in##4##2##(1993-6#1)(2008-12#1)(2011-2#1)(2012-2#1)
milk is##7##2##(2008-10#5)(2012-2#2)
milk leucocyte populations and production performance of early lactating dairy##2##10##(2013-1#2)
milk of transgenic animals##2##4##(1994-5#2)
milk of transgenic##3##3##(1994-5#2)(2008-12#1)
milk of##8##2##(1994-5#2)(2008-10#2)(2008-12#2)(2008-8#1)(2013-1#1)
milk powder and##3##3##(2008-10#3)
milk powder##7##2##(2008-10#7)
milk powder)##3##2##(2008-10#3)
milk production in##2##3##(1990-11#1)(2011-2#1)
milk production##7##2##(1990-11#1)(1992-2#1)(2008-12#2)(2010-12#2)(2011-2#1)
milk products##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
milk replacers and skim milk##3##5##(2010-2#3)
milk replacers##8##2##(2010-2#8)
milk sample##4##2##(2008-10#3)(2008-12#1)
milk samples could be##2##4##(1993-2#1)(2008-10#1)
milk samples from##3##3##(1993-2#2)(2012-2#1)
milk samples using##2##3##(2008-10#2)
milk samples were##5##3##(2008-10#4)(2012-2#1)
milk samples##30##2##(1993-2#4)(2008-10#21)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#2)
milk tea powder samples##2##4##(2013-8#2)
milk was##7##2##(1992-3#1)(2008-10#4)(2008-12#1)(2013-1#1)
milk were##5##2##(2008-10#3)(2012-2#1)(2013-1#1)
milk yield##7##2##(1992-2#1)(2010-12#2)(2010-2#3)(2012-2#1)
milk##334##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#5)(1993-1#1)(1993-11#2)(1993-2#4)(1993-6#1)(1993-8#2)(1994-5#4)(1995-10#2)(1995-8#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-8#1)(2008-10#126)(2008-11#8)(2008-12#11)(2008-5#2)(2008-8#12)(2009-2#5)(2009-8#5)(2010-12#4)(2010-2#28)(2010-6#3)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#41)(2012-3#1)(2013-1#27)(2013-8#4)
milk)##7##1##(1996-12#1)(2008-10#5)(2010-2#1)
milkfish Chanos chanos##2##3##(2010-8#2)
milking and maturing stages##2##4##(2008-12#2)
milking machine##2##2##(1990-6#1)(1991-8#1)
milking##7##1##(1990-6#2)(1991-8#1)(1992-2#1)(2008-12#3)
milks##2##1##(2008-5#1)(2013-1#1)
milkvetch##3##1##(2008-10#3)
mill##18##1##(1990-8#1)(1991-12#1)(1993-2#2)(1993-6#1)(1995-11#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2012-3#1)
milled##3##1##(2008-10#1)(2008-11#1)(2010-4#1)
millennia##3##1##(2008-1#1)(2008-10#1)(2008-9#1)
millennium##21##1##(1993-2#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-4#6)(2009-10#1)(2012-9#1)
millerite##2##1##(2008-10#2)
millet##12##1##(2008-10#11)(2008-11#1)
milligram amounts of functional human 1##2##6##(1992-12#2)
milligram amounts of##5##3##(1992-12#2)(2008-11#1)(2008-4#2)
milligram of##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
milligram quantities of##2##3##(1993-8#1)(2008-4#1)
milligram quantities##3##2##(1992-7#1)(1993-8#1)(2008-4#1)
milligram##12##1##(1992-12#2)(1992-7#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#1)
milligrams of purified##2##3##(2008-10#1)(2012-2#1)
milligrams of##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
milligrams##8##1##(1996-2#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#1)
millijoule##2##1##(2007-11#1)(2007-12#1)
millijoules##2##1##(2007-12#2)
milliliters##2##1##(1993-3#1)(1996-9#1)
millimeter scale optics##2##3##(2008-3#2)
millimeter wave##2##2##(2008-10#1)(2013-7#1)
millimeter##11##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2013-7#2)
millimeter-wave##4##1##(2007-11#2)(2008-3#2)
millimeters of##2##2##(2007-12#2)
millimeters per second##3##3##(2007-12#2)(2008-3#1)
millimeters##19##1##(1995-6#2)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)
millimetres##3##1##(2008-5#1)(2008-7#1)(2013-1#1)
millimolar concentrations of##2##3##(1990-11#1)(1990-2#1)
millimolar concentrations##3##2##(1990-11#1)(1990-2#1)(2008-10#1)
millimolar##8##1##(1990-11#1)(1990-2#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(2008-10#1)
millimoles##2##1##(1994-6#1)(2008-10#1)
milling and##2##2##(2010-4#1)(2013-1#1)
milling technique##3##2##(2009-7#1)(2012-3#2)
milling technology##2##2##(2008-11#1)(2008-3#1)
milling##13##1##(2008-11#1)(2008-3#4)(2008-6#1)(2009-7#1)(2010-4#2)(2012-3#2)(2013-1#2)
million Americans##3##2##(1992-6#1)(1992-9#1)(2011-2#1)
million HIV-infected##2##2##(1993-6#2)
million SNPs##2##2##(2012-3#2)
million adults in the##2##4##(1997-1#1)(2008-10#1)
million and##2##2##(1995-6#1)(2011-2#1)
million annually##5##2##(1991-12#1)(1996-3#1)(2007-12#1)(2007-9#1)(2013-1#1)
million by##2##2##(2008-3#1)(2008-7#1)
million cells in##2##3##(1996-12#1)(2008-8#1)
million cells##5##2##(1996-12#2)(2008-11#2)(2008-8#1)
million children##5##2##(1992-1#1)(1992-5#1)(1994-9#1)(1997-2#1)(2008-11#1)
million cycles##2##2##(2009-7#1)(2012-12#1)
million deaths##2##2##(1997-6#1)(2013-8#1)
million diabetics##2##2##(1991-12#1)(2010-8#1)
million dollars##2##2##(1994-5#1)(2012-12#1)
million enrollees##2##2##(1991-3#1)(1997-3#1)
million for##4##2##(1992-8#1)(1995-12#2)(1997-5#1)
million in the US##2##4##(1993-6#1)(2008-5#1)
million in the##4##3##(1992-6#1)(1993-6#1)(1994-9#1)(2008-5#1)
million in##20##2##(1991-12#1)(1992-6#5)(1993-5#1)(1993-6#1)(1994-9#3)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)
million individuals##3##2##(1993-6#1)(1995-1#1)(2009-10#1)
million members##2##2##(1991-3#1)(2013-8#1)
million people are##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
million people every year##2##4##(2008-7#1)(2010-5#1)
million people have##3##3##(2008-2#1)(2012-2#2)
million people in the UK##2##5##(2012-12#2)
million people in the##3##4##(2012-12#2)(2013-8#1)
million people in##5##3##(2008-10#2)(2012-12#2)(2013-8#1)
million people living##2##3##(2008-3#1)(2010-3#1)
million people suffer from##2##4##(2008-9#1)(2012-12#1)
million people worldwide##3##3##(2008-10#2)(2009-5#1)
million people##27##2##(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#3)(2012-2#3)(2013-8#1)
million per##3##2##(1997-5#1)(2008-11#1)(2013-1#1)
million persons##4##2##(2010-3#3)(2012-12#1)
million to##4##2##(1993-5#1)(1995-12#2)(1997-5#1)
million uninsured##3##2##(1997-3#2)(2008-11#1)
million units##4##2##(1996-6#2)(1997-5#1)(2012-12#1)
million years (Myr) ago##2##4##(1993-12#1)(1997-4#1)
million years ago##9##3##(1991-5#1)(1995-11#1)(1995-3#2)(2008-4#1)(2009-10#2)(2009-8#2)
million years of##4##3##(1994-11#1)(1994-3#1)(2007-12#1)(2009-8#1)
million years##26##2##(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#4)(1995-11#2)(1995-3#3)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-10#2)(2009-8#3)(2010-7#1)(2012-2#1)
million##253##1##(1990-11#1)(1990-3#2)(1991-1#3)(1991-12#4)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#12)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-5#2)(1993-6#5)(1993-8#2)(1994-11#1)(1994-3#6)(1994-5#1)(1994-6#1)(1994-9#5)(1995-1#2)(1995-11#3)(1995-12#7)(1995-3#3)(1995-6#3)(1996-1#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#6)(1997-6#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-5#3)(2007-7#1)(2007-9#2)(2008-10#23)(2008-11#11)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#6)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#3)
million)##9##1##(1993-3#1)(1994-9#1)(1996-11#3)(2008-10#1)(2008-8#1)(2010-3#2)
million-fold##2##1##(2008-10#1)(2012-2#1)
millions of individuals##4##3##(1991-2#1)(2008-12#1)(2008-8#1)(2010-1#1)
millions of people##5##3##(2008-1#1)(2008-2#2)(2012-2#1)(2013-8#1)
millions of##27##2##(1991-2#1)(1993-3#1)(1993-6#1)(1995-3#1)(1997-6#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2012-2#2)(2013-8#1)
millions##33##1##(1991-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-6#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2012-2#3)(2013-8#1)
millisecond time scale##2##3##(2008-11#1)(2008-4#1)
millisecond##7##1##(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-2#1)
milliseconds##10##1##(1991-9#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)(2012-2#1)
milliwatt##4##1##(2007-11#2)(2007-12#2)
milliwatts of##3##2##(2007-11#1)(2007-12#2)
milliwatts##5##1##(2007-11#3)(2007-12#2)
mills##3##1##(2008-10#2)(2008-12#1)
milnacipran and##3##2##(2008-6#2)(2012-3#1)
milnacipran##5##1##(2008-4#1)(2008-6#3)(2012-3#1)
miltiorrhiza Bunge##3##2##(2008-10#2)(2008-11#1)
miltiorrhiza##8##1##(2008-10#5)(2008-11#3)
mimetic EUK-134##2##2##(2008-5#2)
mimetic activity##2##2##(2008-7#1)(2012-3#1)
mimetic peroxidase-catalyzed##2##2##(2008-10#2)
mimetic##22##1##(1993-11#1)(1994-6#1)(2008-10#6)(2008-5#3)(2008-7#3)(2008-8#1)(2009-8#1)(2010-5#2)(2012-12#1)(2012-3#2)(2013-1#1)
mimetics of##2##2##(2008-12#1)(2011-2#1)
mimetics##7##1##(1992-5#1)(1993-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#2)
mimic a##4##2##(1991-6#1)(2007-11#1)(2011-2#1)(2012-2#1)
mimic many##2##2##(1995-12#1)(2011-2#1)
mimic natural##2##2##(2008-4#1)(2010-5#1)
mimic of##4##2##(1992-3#1)(1995-3#1)(2008-12#1)(2010-12#1)
mimic osteosarcoma##2##2##(2010-3#2)
mimic other##4##2##(2006-10#1)(2007-5#1)(2008-8#1)(2010-12#1)
mimic the action of##4##4##(1991-5#1)(1995-6#1)(1996-2#1)(2008-5#1)
mimic the effects of##4##4##(1992-4#1)(1996-5#1)(2008-8#1)(2008-9#1)
mimic the extracellular matrix##2##4##(2009-12#1)(2009-7#1)
mimic the natural##2##3##(1997-6#1)(2008-1#1)
mimic the##42##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-4#1)(1994-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-7#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-4#1)(2012-6#1)(2013-1#1)
mimic those##5##2##(1990-12#1)(1992-1#1)(1994-5#1)(2008-4#1)(2013-7#1)
mimic##125##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-5#4)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-4#4)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#1)
mimic-enzyme catalyst in##2##3##(2008-10#2)
mimicked by##12##2##(1990-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#2)(1996-5#1)(1997-1#1)(2008-4#2)(2008-5#1)(2012-2#1)
mimicked the action of##2##4##(1990-5#1)(1995-12#1)
mimicked the##9##2##(1990-5#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-2#1)
mimicked##31##1##(1990-5#1)(1990-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#4)(1996-5#2)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-2#1)
mimicking a##9##2##(1995-11#1)(2007-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
mimicking acute##2##2##(2008-11#1)(2008-12#1)
mimicking an##2##2##(2008-12#1)(2009-5#1)
mimicking cloacal exstrophy##2##3##(2008-10#2)
mimicking other##2##2##(2007-7#1)(2011-1#1)
mimicking pilocytic astrocytoma##3##3##(2013-1#3)
mimicking rectal cancer##2##3##(2013-8#2)
mimicking the##8##2##(1991-12#1)(1991-5#1)(1995-2#2)(2008-12#1)(2008-8#1)(2012-2#1)(2012-4#1)
mimicking##75##1##(1990-5#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-12#2)(1995-11#1)(1995-2#2)(1996-8#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#6)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#3)
mimicks##2##1##(1994-11#1)(2010-4#1)
mimicry evolution##3##2##(2012-3#3)
mimicry of##4##2##(1995-2#1)(1995-3#1)(2010-5#2)
mimicry##25##1##(1994-11#1)(1995-2#1)(1995-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#3)(2011-1#1)(2012-3#10)(2013-1#2)
mimics a##2##2##(1991-2#1)(1993-8#1)
mimics and##2##2##(2006-12#1)(2008-9#1)
mimics of##5##2##(1997-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
mimics the##12##2##(1990-2#1)(1990-7#1)(1992-12#1)(1993-11#1)(1996-5#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-5#1)(2012-2#1)
mimics##51##1##(1990-11#2)(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1996-5#3)(1997-1#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)
mimosine##8##1##(1994-3#1)(2008-10#6)(2008-11#1)
mimotopes##6##1##(1994-12#1)(2008-7#4)(2011-1#1)
min (first##2##2##(1994-12#1)(2008-6#1)
min (range##2##2##(2007-8#1)(2013-1#1)
min +/-##2##2##(1996-2#2)
min a day of##2##4##(2008-12#2)
min a##3##2##(2008-11#1)(2008-12#2)
min accumulation time##2##3##(2008-10#2)
min accumulation##6##2##(2008-10#6)
min after i##2##3##(1996-12#1)(2013-1#1)
min after injection##2##3##(1993-1#1)(1997-2#1)
min after the##14##3##(1990-7#1)(1990-8#1)(1992-12#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
min after##57##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1992-12#4)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-12#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-7#2)(1997-8#1)(2006-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#3)(2010-10#2)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
min and 5##2##3##(1990-8#1)(2008-12#1)
min and a##2##3##(1991-5#1)(2008-10#1)
min and at##2##3##(2012-3#1)(2013-1#1)
min and the##5##3##(1990-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(2008-10#1)
min and then##4##3##(1992-3#1)(1994-8#1)(2008-10#2)
min and was##2##3##(1990-5#1)(2008-10#1)
min and##53##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-5#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
min are##2##2##(2008-10#1)(2008-5#1)
min as compared to##2##4##(2008-10#1)(2008-7#1)
min as##3##2##(2008-10#2)(2008-7#1)
min at 100 degrees C##5##5##(1994-11#4)(2010-2#1)
min at 30##2##3##(1995-12#1)(1997-2#1)
min at 37##2##3##(2010-1#2)
min at##31##2##(1990-7#1)(1992-12#1)(1994-11#4)(1995-12#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#14)(2009-8#1)(2010-1#2)(2010-2#1)(2013-1#1)(2013-8#1)
min before the##7##3##(1993-12#1)(1994-2#1)(1995-12#2)(2006-6#1)(2008-10#1)(2011-2#1)
min before##23##2##(1992-12#1)(1993-12#1)(1993-9#1)(1994-2#2)(1994-5#4)(1995-12#3)(1997-7#2)(2006-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
min by##9##2##(1990-8#1)(1991-5#2)(2008-10#4)(2008-3#1)(2011-1#1)
min during the first 30 min and every##2##8##(2008-5#2)
min during the##4##3##(1997-2#1)(2008-5#3)
min during##5##2##(1991-10#1)(1997-2#1)(2008-5#3)
min dynamic##3##2##(2008-10#3)
min each##2##2##(1991-5#1)(2008-12#1)
min even##3##2##(2007-8#1)(2008-10#2)
min except for##2##3##(2008-10#2)
min exposure##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
min extraction##2##2##(2008-10#2)
min followed by##3##3##(1996-5#1)(2010-1#1)(2013-8#1)
min following##4##2##(1993-1#1)(2008-4#1)(2008-7#1)(2012-3#1)
min for a##2##3##(2008-10#1)(2008-3#1)
min for each##2##3##(2007-8#1)(2008-10#1)
min for females##2##3##(2008-10#2)
min for groups##2##3##(2008-12#2)
min for the##6##3##(1993-2#1)(2007-8#2)(2008-10#2)(2008-7#1)
min for##34##2##(1992-11#1)(1993-2#1)(1994-3#1)(1994-8#1)(1996-1#2)(1996-2#2)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#14)(2008-12#2)(2008-3#3)(2008-7#1)
min from the##2##3##(1991-5#1)(2008-5#1)
min from##4##2##(1991-5#1)(2008-10#1)(2008-5#1)(2013-8#1)
min in a##7##3##(1990-12#1)(2008-10#6)
min in the presence of substrates and the##2##8##(1992-6#1)(1993-9#1)
min in the presence of##3##5##(1992-6#1)(1993-9#1)(2008-10#1)
min in the##10##3##(1990-12#1)(1990-8#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-9#1)(2008-10#3)(2008-2#1)
min in##31##2##(1990-12#2)(1990-8#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-5#1)(1997-1#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)(2012-2#1)
min incubation at 37 degrees##2##5##(1992-3#1)(1994-8#1)
min incubation at##3##3##(1992-3#1)(1994-8#1)(1997-8#1)
min incubation with##4##3##(1994-3#2)(1995-3#1)(1997-4#1)
min incubation##12##2##(1992-3#1)(1994-3#2)(1994-8#1)(1995-3#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
min is##3##2##(2008-10#2)(2008-2#1)
min observations##2##2##(2008-11#1)(2008-12#1)
min of KB##2##3##(1991-12#2)
min of accumulation##2##3##(2008-10#2)
min of exercise##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
min of exposure##2##3##(1996-6#1)(2009-12#1)
min of incubation##6##3##(1990-12#1)(1990-7#1)(1991-2#1)(1993-11#1)(1993-12#1)(1997-2#1)
min of irradiation##2##3##(2008-10#2)
min of ischemia##4##3##(1995-12#3)(1996-9#1)
min of preconcentration time##4##4##(2008-10#4)
min of reperfusion##2##3##(1996-12#1)(2013-1#1)
min of the##3##3##(1991-2#1)(1994-12#2)
min of##72##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#2)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-12#3)(1995-5#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
min on the tongue and##2##5##(1993-1#2)
min on the##3##3##(1993-1#3)
min on##6##2##(1993-1#3)(1995-11#1)(2008-10#1)(2008-3#1)
min or##5##2##(1992-10#1)(2008-10#2)(2010-2#1)(2011-2#1)
min per##13##2##(1991-5#2)(1996-9#2)(1997-6#6)(2008-10#3)
min post-ictal##2##2##(1995-12#2)
min preconcentration##3##2##(2008-10#3)
min prior to the##2##4##(1994-8#1)(1995-12#1)
min prior to##8##3##(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#2)(1997-4#1)(2011-2#2)
min recording##2##2##(1994-6#1)(2008-7#1)
min region on the genetic map of Escherichia coli K-12 (W3110) was determined##2##13##(1996-12#2)
min region on the linkage map (supplement)##3##7##(1996-12#2)(1996-6#1)
min region on the linkage map##6##6##(1996-12#4)(1996-6#2)
min region on the##8##4##(1996-12#6)(1996-6#2)
min region##9##2##(1996-12#7)(1996-6#2)
min resulted in##2##3##(1996-6#1)(2008-10#1)
min static##3##2##(2008-10#3)
min the##4##2##(1993-1#1)(1996-5#1)(2008-10#1)(2008-2#1)
min there##2##2##(1997-1#1)(2010-8#1)
min to##15##2##(1990-12#1)(1992-3#2)(1994-8#2)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
min using a##4##3##(2008-10#3)(2008-7#1)
min using##6##2##(1994-9#1)(2008-10#4)(2008-7#1)
min vs##2##2##(2011-2#1)(2013-1#1)
min was##10##2##(1994-3#3)(2008-10#2)(2008-7#3)(2013-1#1)(2013-8#1)
min were used##2##3##(2008-10#1)(2008-9#1)
min were##4##2##(2008-10#3)(2008-9#1)
min with a relative standard deviation of less than##2##9##(2008-10#2)
min with a relative standard deviation of##3##7##(2008-10#3)
min with only##2##3##(2008-10#2)
min with##18##2##(1990-2#1)(1991-5#1)(1994-3#1)(1994-6#2)(2008-10#11)(2008-7#1)(2009-12#1)
min x##2##2##(1992-2#1)(2011-3#1)
min##967##1##(1990-11#3)(1990-12#8)(1990-2#4)(1990-5#3)(1990-7#9)(1990-8#9)(1991-10#2)(1991-12#5)(1991-2#5)(1991-3#1)(1991-5#13)(1991-6#1)(1991-9#1)(1992-10#5)(1992-11#7)(1992-12#8)(1992-2#1)(1992-3#12)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#3)(1993-1#14)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#4)(1993-8#1)(1993-9#6)(1994-11#8)(1994-12#4)(1994-2#7)(1994-3#13)(1994-5#6)(1994-6#6)(1994-8#13)(1994-9#3)(1995-11#7)(1995-12#32)(1995-2#7)(1995-3#7)(1995-5#6)(1995-6#1)(1995-8#1)(1996-1#7)(1996-12#17)(1996-2#7)(1996-3#2)(1996-5#13)(1996-6#4)(1996-9#6)(1997-1#9)(1997-2#12)(1997-4#4)(1997-6#6)(1997-7#6)(1997-8#4)(2006-11#1)(2006-6#3)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#14)(2008-1#3)(2008-10#306)(2008-11#22)(2008-12#14)(2008-2#7)(2008-3#16)(2008-4#8)(2008-5#16)(2008-6#11)(2008-7#36)(2008-8#5)(2008-9#12)(2009-1#1)(2009-11#1)(2009-12#7)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-2#7)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#15)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#23)(2013-8#18)
min(-1) and UV detection##2##4##(2008-10#1)(2008-5#1)
min(-1) and##11##2##(2008-10#7)(2008-5#3)(2013-8#1)
min(-1) for##8##2##(2008-10#8)
min(-1) was##6##2##(2008-10#3)(2008-3#1)(2008-5#1)(2011-3#1)
min(-1) with##2##2##(2008-10#1)(2012-12#1)
min(-1)##120##1##(2008-10#96)(2008-3#4)(2008-5#6)(2008-8#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-3#6)(2012-12#1)(2012-3#1)(2013-8#2)
min(-1))##12##1##(2008-10#11)(2010-4#1)
min) after##2##2##(1992-8#1)(2008-10#1)
min) and##15##2##(1990-12#1)(1993-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
min) based on the in vitro drug release characteristics compared to##2##11##(2010-3#2)
min) followed by##2##3##(2008-11#1)(2013-1#1)
min) ischaemia##3##2##(2008-7#3)
min) of##4##2##(1992-3#1)(1995-12#1)(1995-5#1)(2008-5#1)
min) resulted in##2##3##(1996-12#1)(2008-6#1)
min) was##2##2##(1990-7#1)(2009-9#1)
min) were##2##2##(1997-2#1)(2008-10#1)
min)##117##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#1)(1993-3#2)(1993-8#2)(1994-3#2)(1994-9#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-9#2)(2010-3#5)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
min-1 and 0##2##3##(1992-6#1)(1993-1#1)
min-1 for##4##2##(1993-1#2)(1997-2#2)
min-1##26##1##(1990-11#2)(1991-12#1)(1991-3#2)(1991-5#2)(1992-3#2)(1992-6#3)(1993-1#6)(1995-12#2)(1995-6#1)(1997-2#4)(2008-3#1)
min-1)##2##1##(1991-12#1)(1991-8#1)
min/cycle)##2##1##(2009-7#1)(2011-2#1)
min/day##2##1##(2012-3#1)(2013-1#1)
min2 and##2##2##(2012-3#2)
min2##3##1##(2012-3#3)
minced fish products##2##3##(2011-2#2)
minced##4##1##(2008-10#1)(2008-4#1)(2011-2#2)
mind and brain##2##3##(2008-11#2)
mind and##7##2##(2008-11#3)(2008-12#1)(2009-10#1)(2013-1#1)(2013-8#1)
mind for##2##2##(2013-1#1)(2013-8#1)
mind in##8##2##(2006-10#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#2)
mind the##10##2##(1995-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-1#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
mind wandering##3##2##(2013-8#3)
mind##104##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-1#1)(2009-10#4)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#9)
mind-body therapies on##2##3##(2010-12#2)
mind-body therapies##4##2##(2010-12#4)
mind-body##6##1##(2010-12#5)(2010-6#1)
mindful awareness##2##2##(2012-2#2)
mindful of##4##2##(1991-2#2)(2008-11#1)(2011-2#1)
mindful##7##1##(1991-2#2)(2008-11#1)(2011-2#1)(2012-2#3)
mindfulness practice and##2##3##(2013-1#2)
mindfulness##9##1##(2012-2#2)(2013-1#7)
mindfulness-based teachers##2##2##(2013-1#2)
mindfulness-based training##2##2##(2013-1#2)
mindfulness-based##8##1##(2013-1#8)
minds##8##1##(1991-3#1)(1995-12#1)(2008-2#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
mindset##6##1##(1994-1#1)(1994-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2012-12#1)
mine in##2##2##(1991-2#1)(2013-1#1)
mine##25##1##(1991-2#1)(1992-6#3)(2008-10#16)(2008-6#2)(2008-7#1)(2011-2#1)(2013-1#1)
minefield##2##1##(1992-2#1)(2008-10#1)
mineral acid##3##2##(2008-10#3)
mineral acids and##2##3##(2008-10#1)(2013-1#1)
mineral acids##7##2##(2008-10#5)(2013-1#2)
mineral and##6##2##(2008-10#4)(2008-3#1)(2008-7#1)
mineral aragonite##2##2##(2008-7#2)
mineral bioavailability##2##2##(2008-10#1)(2013-8#1)
mineral components##2##2##(2008-3#1)(2013-8#1)
mineral composition##4##2##(2008-10#2)(2010-2#1)(2012-2#1)
mineral content##18##2##(1990-11#3)(1991-11#2)(1993-11#1)(1994-7#2)(2008-10#5)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-8#1)
mineral density (BMD) was measured##3##5##(2007-11#1)(2008-12#1)(2008-4#1)
mineral density (BMD) was##4##4##(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)
mineral density (BMD)##17##3##(1991-11#1)(1993-11#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-3#2)(2011-2#5)(2012-2#2)
mineral density and##6##3##(1995-11#1)(2007-11#1)(2008-11#1)(2008-8#2)(2011-2#1)
mineral density in##10##3##(2007-11#1)(2007-7#1)(2008-5#1)(2010-3#2)(2011-2#3)(2012-12#1)(2012-2#1)
mineral density##52##2##(1991-11#2)(1993-11#1)(1995-11#1)(1995-9#1)(1996-8#2)(1997-8#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2010-1#2)(2010-10#1)(2010-3#4)(2011-1#1)(2011-2#11)(2012-12#2)(2012-2#4)(2012-3#1)
mineral deposits##3##2##(2008-10#1)(2009-7#1)(2009-8#1)
mineral dissolution##2##2##(1995-3#1)(2008-7#1)
mineral elements##2##2##(2010-2#1)(2012-3#1)
mineral feed additives##4##3##(2008-10#4)
mineral for##2##2##(2008-10#1)(2013-8#1)
mineral ion##2##2##(2008-4#1)(2009-8#1)
mineral metabolism##6##2##(2007-12#1)(2008-4#1)(2009-1#4)
mineral oil but not 17-MT##2##5##(2013-7#2)
mineral oil##8##2##(2008-10#4)(2013-7#4)
mineral ore##3##2##(2008-10#3)
mineral phases##4##2##(2008-10#4)
mineral salts##6##2##(1997-2#1)(2008-10#2)(2008-6#2)(2008-7#1)
mineral sample##3##2##(2008-10#3)
mineral samples##2##2##(2008-10#2)
mineral soil fraction##3##3##(2008-10#3)
mineral soil##4##2##(2008-10#4)
mineral supplementation##4##2##(1990-3#3)(2008-5#1)
mineral trioxide aggregate (MTA)##2##4##(2012-12#1)(2013-1#1)
mineral trioxide aggregate##5##3##(2012-12#2)(2013-1#3)
mineral water and##2##3##(2008-10#2)
mineral water samples##4##3##(2008-10#4)
mineral water##14##2##(2008-10#11)(2008-11#2)(2008-4#1)
mineral waters using##2##3##(2008-10#2)
mineral waters with##2##3##(2008-10#2)
mineral waters##12##2##(2008-10#11)(2008-4#1)
mineral##246##1##(1990-11#5)(1990-3#3)(1991-11#4)(1991-12#2)(1991-6#1)(1992-3#1)(1993-11#2)(1994-7#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#94)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#7)(2008-9#3)(2009-1#4)(2009-7#4)(2009-8#4)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#4)(2011-1#1)(2011-2#15)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#7)
mineralisation and##2##2##(2007-8#2)
mineralisation rate##2##2##(2010-5#2)
mineralisation##15##1##(1997-7#1)(2007-8#5)(2008-10#3)(2010-5#6)
mineralised##6##1##(1995-6#1)(2008-10#5)
mineralization and##6##2##(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)
mineralization in##4##2##(1995-3#1)(2008-11#1)(2009-7#1)(2009-8#1)
mineralization is##3##2##(2008-10#2)(2009-8#1)
mineralization of the##3##3##(2008-10#2)(2008-11#1)
mineralization of##8##2##(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2009-8#1)
mineralization process##2##2##(2009-7#1)(2013-8#1)
mineralization was##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-4#1)
mineralization with##2##2##(2008-10#2)
mineralization##54##1##(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-4#3)(2008-7#3)(2009-11#1)(2009-7#10)(2009-8#4)(2011-1#1)(2011-2#1)(2012-4#2)(2012-6#1)(2013-8#2)
mineralize##2##1##(2008-11#2)
mineralized by##2##2##(2008-10#1)(2008-11#1)
mineralized collagen##2##2##(2009-8#2)
mineralized in##3##2##(2009-11#2)(2011-2#1)
mineralized rock##6##2##(2013-8#6)
mineralized tissue##2##2##(2007-12#1)(2013-1#1)
mineralized tissues##2##2##(2008-11#1)(2009-8#1)
mineralized##28##1##(2007-12#1)(2008-10#5)(2008-11#3)(2008-7#2)(2009-11#2)(2009-8#4)(2011-2#1)(2012-4#1)(2013-1#1)(2013-8#8)
mineralocorticoid deficiency##2##2##(2008-8#2)
mineralocorticoid receptor##2##2##(1996-5#1)(2013-1#1)
mineralocorticoid##12##1##(1990-11#1)(1993-8#1)(1994-2#1)(1996-5#1)(1997-1#2)(2008-4#2)(2008-8#2)(2011-1#1)(2013-1#1)
mineralogical and morphological##2##3##(2008-10#2)
mineralogical and##3##2##(2008-10#3)
mineralogical composition##2##2##(2008-10#2)
mineralogical##11##1##(2008-10#10)(2008-12#1)
minerals and##2##2##(2008-10#1)(2008-3#1)
minerals are the##2##3##(2008-10#1)(2008-5#1)
minerals are##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
minerals by##3##2##(2008-10#3)
minerals containing##2##2##(2008-10#2)
minerals in##2##2##(1993-8#1)(2008-12#1)
minerals to##2##2##(2008-10#1)(2013-8#1)
minerals##41##1##(1990-12#3)(1993-8#1)(1994-6#2)(1996-12#1)(1997-4#1)(1997-5#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#3)
minerals)##3##1##(2008-10#1)(2011-1#1)(2013-8#1)
miners##5##1##(1991-12#3)(1997-5#1)(2013-1#1)
mines and spas##2##3##(2008-7#1)(2013-1#1)
mines and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
mines in##3##2##(2008-10#2)(2008-7#1)
mines were##2##2##(1992-6#1)(2008-10#1)
mines##20##1##(1990-12#1)(1992-6#2)(2008-10#13)(2008-7#2)(2011-2#1)(2013-1#1)
mingling##2##1##(1991-5#1)(2008-8#1)
mini dental implants##3##3##(2013-1#3)
mini review##2##2##(2008-7#1)(2011-2#1)
mini tube##2##2##(2010-5#2)
mini##13##1##(2008-1#2)(2008-10#2)(2008-7#2)(2010-5#3)(2011-2#1)(2013-1#3)
mini-Ad##2##1##(2008-9#2)
mini-Mu derivatives##2##2##(1994-12#2)
mini-Mu vectors##2##2##(1994-12#2)
mini-Mu##6##1##(1990-11#1)(1994-12#5)
mini-PACS##2##1##(1996-2#2)
mini-Tn5-phoA##2##1##(2008-10#2)
mini-adenoviral vector##2##2##(2008-9#2)
mini-column and##2##2##(1990-8#1)(2008-10#1)
mini-column filled with##2##3##(2008-10#2)
mini-column in the flow##2##4##(2008-10#2)
mini-column to be##2##3##(2008-10#2)
mini-column##28##1##(1990-8#2)(2008-10#25)(2011-1#1)
mini-columns for##2##2##(1996-5#1)(2008-10#1)
mini-columns##3##1##(1996-5#1)(2008-10#2)
mini-exome##2##1##(2012-3#2)
mini-gene##5##1##(1993-8#3)(2008-9#2)
mini-internship program##3##2##(2013-7#3)
mini-orchards of##3##2##(2008-10#3)
mini-orchards##5##1##(2008-10#5)
mini-review##9##1##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2012-3#1)
mini-thoracotomy##5##1##(2007-8#2)(2013-1#3)
mini-white repression##2##2##(2012-3#2)
mini-white##4##1##(2012-3#4)
miniature CCD spectrometer##2##3##(2008-10#2)
miniature currents##2##2##(1992-12#2)
miniature endoscopy##2##2##(2007-11#2)
miniature gamma camera##2##3##(1994-5#2)
miniature mass##3##2##(2010-7#3)
miniature optical##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
miniature roses##2##2##(2008-10#2)
miniature size of##2##3##(2007-11#1)(2008-10#1)
miniature wireless receiver##2##3##(2009-10#2)
miniature##43##1##(1992-12#2)(1994-5#2)(1994-9#1)(1996-2#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#4)(2008-4#1)(2009-10#2)(2010-2#1)(2010-7#3)(2011-2#1)(2012-12#1)(2012-2#1)
miniaturisation##6##1##(2007-12#2)(2008-10#2)(2008-12#2)
miniaturised##2##1##(2008-10#1)(2008-11#1)
miniaturization and##7##2##(2007-11#1)(2008-10#5)(2009-4#1)
miniaturization of##3##2##(2008-10#2)(2010-11#1)
miniaturization##19##1##(2007-11#1)(2008-10#10)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#2)
miniaturized analytical##2##2##(2008-10#2)
miniaturized and##3##2##(2008-4#2)(2009-11#1)
miniaturized device##2##2##(2007-11#1)(2008-10#1)
miniaturized##34##1##(1992-3#1)(2007-11#2)(2008-10#17)(2008-3#2)(2008-4#2)(2009-11#1)(2009-12#1)(2010-2#1)(2010-5#3)(2010-6#2)(2011-1#1)(2013-1#1)
minibioreactor for the culture of human hematopoietic cells##2##8##(2008-11#2)
minibioreactor##3##1##(2008-11#3)
minicircle replication##2##2##(2010-2#2)
minicircle##7##1##(2010-2#7)
minicircles##2##1##(2010-2#2)
minicolumn is proposed##3##3##(2008-10#3)
minicolumn packed with##9##3##(2008-10#9)
minicolumn with##4##2##(2008-10#4)
minicolumn##39##1##(2008-10#39)
minicolumns##2##1##(1990-2#1)(2008-10#1)
minicontainers##2##1##(2008-11#2)
minicraniotomy##2##1##(2011-2#2)
minified pupil##2##2##(2008-3#2)
minified##3##1##(2008-3#3)
minigel##2##1##(2008-2#1)(2008-4#1)
minigene##8##1##(2008-11#2)(2008-8#6)
minigenes##4##1##(2008-8#4)
miniinvasive##5##1##(2008-10#2)(2012-12#3)
minilaparotomy##4##1##(1992-2#1)(1993-3#1)(1995-1#1)(1996-2#1)
minilaser at 1064 nm##2##4##(2008-3#2)
minima and maxima##2##3##(2007-11#1)(2008-3#1)
minima and##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
minima in the intensity##2##4##(2007-11#1)(2008-3#1)
minima in##4##2##(2007-11#2)(2008-3#1)(2008-7#1)
minima of##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
minima##24##1##(1993-11#1)(1995-3#1)(2007-11#4)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-7#2)
minimal access##2##2##(2008-9#1)(2013-1#1)
minimal additional##2##2##(1996-11#1)(2007-11#1)
minimal amino acid##2##3##(1990-7#1)(2008-10#1)
minimal amount of##8##3##(1995-11#1)(2008-10#7)
minimal and##7##2##(1990-12#1)(1991-6#1)(2008-3#2)(2008-7#2)(2011-2#1)
minimal basal##2##2##(1996-5#1)(2009-12#1)
minimal bias##2##2##(2008-12#1)(2010-8#1)
minimal blood loss##2##3##(2013-1#2)
minimal cell##2##2##(2008-11#1)(2009-4#1)
minimal change disease and##3##4##(2007-7#1)(2008-1#2)
minimal change disease##8##3##(2007-7#2)(2008-1#5)(2013-8#1)
minimal change##12##2##(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#6)(2011-2#1)(2013-8#1)
minimal changes in##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
minimal changes##7##2##(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-4#1)(2013-8#1)
minimal compared with##2##3##(2008-10#1)(2008-7#1)
minimal complications##3##2##(1993-3#1)(2011-2#1)(2012-12#1)
minimal contamination##3##2##(1990-11#1)(1995-5#1)(2008-3#1)
minimal decrease in##3##3##(2008-9#3)
minimal effect on the##3##4##(1994-6#1)(2008-10#1)(2008-3#1)
minimal effect on##8##3##(1994-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-12#1)(2013-1#2)
minimal effects on the##2##4##(1995-6#1)(1996-2#1)
minimal effects on##4##3##(1995-6#1)(1996-2#1)(2008-3#1)(2013-8#1)
minimal essential##2##2##(1997-4#1)(2010-3#1)
minimal for##2##2##(1997-3#1)(2008-2#1)
minimal impact on##2##3##(2008-10#1)(2008-7#1)
minimal inhibitory concentration (MIC)##4##4##(2008-5#2)(2009-6#1)(2013-8#1)
minimal inhibitory concentration##6##3##(2008-5#2)(2009-6#1)(2010-5#1)(2011-2#1)(2013-8#1)
minimal inhibitory concentrations##2##3##(2008-10#1)(2008-5#1)
minimal inhibitory##8##2##(2008-10#1)(2008-5#3)(2009-6#1)(2010-5#1)(2011-2#1)(2013-8#1)
minimal instrumentation##2##2##(2008-11#1)(2013-1#1)
minimal interference##2##2##(1996-12#1)(2008-10#1)
minimal invasive##8##2##(2007-8#1)(2008-10#1)(2008-3#2)(2010-8#1)(2011-2#3)
minimal irritating##2##2##(2008-9#2)
minimal loss of##3##3##(2007-11#3)
minimal loss##4##2##(2007-11#3)(2007-12#1)
minimal manipulation##2##2##(2008-11#1)(2008-9#1)
minimal media##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
minimal medium containing##3##3##(2008-10#2)(2012-2#1)
minimal medium##9##2##(2008-10#6)(2012-2#3)
minimal model of##2##3##(2008-8#1)(2009-5#1)
minimal model##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
minimal number of##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
minimal nutrient##2##2##(2013-1#2)
minimal or no##2##3##(2008-12#1)(2009-12#1)
minimal or##3##2##(1992-3#1)(2008-12#1)(2009-12#1)
minimal potassium##2##2##(1994-12#2)
minimal promoter##6##2##(1994-11#1)(1994-2#2)(1996-5#1)(1997-6#2)
minimal residual disease monitoring and##2##5##(2010-11#1)(2011-3#1)
minimal residual disease##8##3##(1995-12#1)(2008-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#2)(2011-3#1)
minimal residual##12##2##(1992-2#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-3#1)
minimal risk of##3##3##(1995-2#1)(2007-8#1)(2011-1#1)
minimal risk##4##2##(1995-2#1)(2007-8#1)(2010-6#1)(2011-1#1)
minimal sample preparation##2##3##(2008-10#2)
minimal sample pretreatment##2##3##(2008-10#2)
minimal sample##5##2##(2008-10#5)
minimal side effects##5##3##(2008-1#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)
minimal soft tissue##2##3##(2007-12#1)(2013-1#1)
minimal thermal##2##2##(1992-12#1)(2008-3#1)
minimal to moderate##2##3##(2008-10#1)(2008-9#1)
minimal to##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
minimal trauma##3##2##(1990-2#1)(2007-11#1)(2007-12#1)
minimal volume of##2##3##(2008-10#1)(2008-8#1)
minimal##424##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#4)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#4)(2006-8#3)(2007-10#1)(2007-11#8)(2007-12#12)(2007-7#3)(2007-8#3)(2008-1#12)(2008-10#57)(2008-11#16)(2008-12#4)(2008-2#8)(2008-3#20)(2008-4#2)(2008-5#8)(2008-6#9)(2008-7#11)(2008-8#8)(2008-9#19)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#26)(2011-3#2)(2012-12#6)(2012-2#13)(2012-3#10)(2013-1#23)(2013-8#6)
minimal-scan reconstruction algorithms##2##3##(2008-3#2)
minimal-scan##4##1##(2008-3#4)
minimalism##4##1##(2008-10#4)
minimally invasive and##4##3##(2012-1#1)(2012-12#1)(2012-2#2)
minimally invasive approach to##3##4##(2008-12#1)(2011-2#2)
minimally invasive approach##6##3##(2008-12#1)(2011-2#4)(2013-1#1)
minimally invasive approaches to##4##4##(2011-2#2)(2013-1#2)
minimally invasive approaches##7##3##(2008-10#1)(2011-2#2)(2013-1#4)
minimally invasive direct coronary artery surgery (MIDCAB)##2##7##(2007-8#2)
minimally invasive direct coronary artery##3##5##(1997-8#1)(2007-8#2)
minimally invasive lateral##2##3##(2012-3#1)(2013-1#1)
minimally invasive manner##2##3##(2008-8#1)(2009-11#1)
minimally invasive method##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
minimally invasive procedures in##3##4##(2009-12#1)(2011-2#1)(2012-3#1)
minimally invasive procedures##4##3##(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
minimally invasive spinal surgery##2##4##(2007-8#2)
minimally invasive spinal##3##3##(2007-8#2)(2011-2#1)
minimally invasive surgeries##2##3##(2011-1#1)(2012-1#1)
minimally invasive surgery (MIS)##2##4##(2008-8#1)(2011-2#1)
minimally invasive surgery##8##3##(2007-8#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
minimally invasive surgical techniques##3##4##(2007-9#1)(2008-8#1)(2011-2#1)
minimally invasive surgical##7##3##(2007-9#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
minimally invasive technique##3##3##(2011-2#2)(2012-2#1)
minimally invasive techniques##6##3##(2007-8#2)(2008-11#1)(2008-8#1)(2010-8#1)(2013-1#1)
minimally invasive##93##2##(1991-6#1)(1996-12#1)(1997-8#1)(2007-11#2)(2007-8#11)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-9#1)(2010-8#1)(2011-1#3)(2011-2#18)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#6)(2013-1#12)
minimally##118##1##(1990-11#1)(1991-6#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#11)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-9#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#19)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#14)(2013-8#1)
minimally-invasive##3##1##(2011-2#1)(2013-8#2)
minimax##4##1##(2009-9#3)(2012-3#1)
minimisation##4##1##(1992-5#2)(2008-10#1)(2011-2#1)
minimise the##8##2##(1997-7#1)(2007-2#1)(2008-10#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
minimise##16##1##(1997-7#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#2)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
minimised##4##1##(1996-1#1)(2007-11#1)(2008-10#1)(2008-7#1)
minimises the##2##2##(2008-10#2)
minimises##3##1##(2008-10#3)
minimising the##2##2##(2008-10#1)(2009-3#1)
minimising##12##1##(1996-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
minimization and##2##2##(1992-4#1)(2008-8#1)
minimization of the##5##3##(2006-6#1)(2008-10#1)(2008-3#2)(2012-3#1)
minimization of##19##2##(1993-2#1)(1996-5#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2012-3#1)(2013-1#1)
minimization##41##1##(1991-5#1)(1992-4#2)(1993-11#1)(1993-2#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-8#1)(2011-1#2)(2012-1#4)(2012-3#2)(2013-1#1)
minimize complications##2##2##(2008-7#1)(2012-3#1)
minimize long-term hydrostatic-pressure-induced microbending losses##3##5##(2007-11#3)
minimize non-specific adsorption##2##3##(2008-10#2)
minimize the costs of##2##4##(2008-10#1)(2008-6#1)
minimize the effect of##4##4##(1995-3#1)(2008-10#2)(2008-3#1)
minimize the influence of##2##4##(2008-2#1)(2008-5#1)
minimize the morbidity##2##3##(2007-11#1)(2012-12#1)
minimize the need##2##3##(2008-10#1)(2011-2#1)
minimize the negative##2##3##(1997-1#1)(2008-1#1)
minimize the overall##2##3##(2008-3#1)(2008-8#1)
minimize the risk of complications##2##5##(2007-8#1)(2013-1#1)
minimize the risk of liability##2##5##(1992-2#1)(1993-1#1)
minimize the risk of##10##4##(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1996-3#1)(2007-8#1)(2008-6#1)(2010-7#1)(2013-1#1)
minimize the##84##2##(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#11)(2008-5#4)(2008-6#4)(2008-8#3)(2008-9#4)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2013-1#3)
minimize their##2##2##(2008-8#1)(2008-9#1)
minimize##181##1##(1991-12#1)(1991-3#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#3)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#28)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#6)(2008-9#9)(2009-10#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#2)
minimized and##3##2##(2008-3#1)(2012-2#2)
minimized by the use of##2##5##(2008-10#1)(2008-5#1)
minimized by the##5##3##(1992-3#1)(2008-10#3)(2008-5#1)
minimized by use of an##2##5##(2008-3#2)
minimized by using##2##3##(2008-10#1)(2008-8#1)
minimized by##23##2##(1992-3#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-3#5)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
minimized in the##2##3##(2008-2#1)(2008-3#1)
minimized in##4##2##(1993-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
minimized or##2##2##(2008-2#1)(2008-4#1)
minimized the##4##2##(1990-7#1)(1993-1#2)(2008-10#1)
minimized through##2##2##(2007-11#1)(2008-2#1)
minimized with##3##2##(1992-12#1)(1995-5#1)(2008-3#1)
minimized##77##1##(1990-10#1)(1990-7#1)(1992-12#2)(1992-3#1)(1993-1#2)(1993-12#2)(1995-3#1)(1995-5#2)(1995-9#1)(1997-2#1)(2007-11#3)(2008-10#23)(2008-11#1)(2008-2#5)(2008-3#17)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2013-8#1)
minimizes potential##2##2##(2008-10#2)
minimizes the effects of##2##4##(2008-3#2)
minimizes the likelihood##2##3##(2007-12#1)(2007-4#1)
minimizes the number of##3##4##(2008-2#1)(2008-3#1)(2010-9#1)
minimizes the##21##2##(1990-8#1)(1993-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
minimizes##45##1##(1990-8#1)(1993-12#1)(1996-12#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#10)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)
minimizing complications##2##2##(2008-9#1)(2013-1#1)
minimizing neuroleptic##2##2##(1996-7#2)
minimizing risk##4##2##(1996-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
minimizing risks##2##2##(1993-2#1)(1995-12#1)
minimizing the##25##2##(1993-1#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
minimizing##68##1##(1990-9#1)(1992-12#2)(1993-1#1)(1993-2#1)(1995-12#1)(1996-2#1)(1996-7#2)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2010-8#1)(2011-2#3)(2011-9#2)(2012-1#1)(2013-1#3)(2013-8#1)
minimum FWHM##2##2##(2007-11#1)(2008-3#1)
minimum L(0)-norm##2##2##(2008-2#2)
minimum air temperature##2##3##(2008-10#1)(2013-1#1)
minimum amount##6##2##(1994-5#1)(1997-8#1)(2008-10#3)(2008-4#1)
minimum and maximum##7##3##(2008-10#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
minimum and##8##2##(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
minimum are##2##2##(2008-10#1)(2008-3#1)
minimum at##2##2##(2008-3#2)
minimum concentration##5##2##(1993-1#1)(2008-10#3)(2008-5#1)
minimum cost##2##2##(1991-12#1)(2012-12#1)
minimum data set##2##3##(1994-12#1)(2012-12#1)
minimum data##3##2##(1994-12#1)(2008-3#1)(2012-12#1)
minimum detectability##3##2##(2008-10#3)
minimum detectable absorption##3##3##(2008-3#3)
minimum detectable signal##3##3##(2008-2#3)
minimum detectable##16##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#7)(2013-7#1)
minimum distance##2##2##(1995-6#1)(2008-3#1)
minimum expected##2##2##(1992-3#1)(1997-3#1)
minimum feature sizes##2##3##(2008-10#1)(2008-2#1)
minimum feature##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
minimum follow-up##3##2##(2007-11#2)(2008-6#1)
minimum in the##4##3##(2008-2#3)(2008-3#1)
minimum in##6##2##(2008-2#4)(2008-3#1)(2012-1#1)
minimum infection times##2##3##(2008-10#2)
minimum infective dose##4##3##(2009-6#4)
minimum inhibitory concentration (MIC) of##2##5##(1991-8#1)(2008-10#1)
minimum inhibitory concentration (MIC)##4##4##(1991-8#1)(1994-12#1)(2008-10#1)(2012-3#1)
minimum inhibitory concentration##6##3##(1991-8#1)(1994-12#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-3#1)
minimum inhibitory concentrations (MICs)##3##4##(2008-5#1)(2011-2#1)(2012-3#1)
minimum inhibitory##11##2##(1991-8#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
minimum is##4##2##(2008-2#2)(2008-5#1)(2009-9#1)
minimum legal##2##2##(2013-1#2)
minimum length##3##2##(1996-3#1)(2008-5#1)(2012-2#1)
minimum level of##2##3##(1992-9#1)(2008-2#1)
minimum level##3##2##(1992-9#1)(2008-2#1)(2008-5#1)
minimum loss##2##2##(2007-12#1)(2008-2#1)
minimum number of control lines##2##5##(2008-2#2)
minimum number of##16##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2010-6#1)
minimum number##17##2##(1992-9#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2010-6#1)
minimum of 0##2##3##(2008-10#1)(2008-2#1)
minimum of the##3##3##(2008-2#1)(2008-3#2)
minimum of##39##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
minimum pulse##2##2##(2007-11#1)(2008-3#1)
minimum requirement##2##2##(2008-10#1)(2008-3#1)
minimum requirements for##2##3##(2008-7#1)(2012-2#1)
minimum resources##2##2##(1991-8#1)(1993-6#1)
minimum sample size##3##3##(1992-9#2)(2013-1#1)
minimum sample##5##2##(1992-9#2)(2008-10#1)(2009-6#1)(2013-1#1)
minimum sampling##3##2##(2012-2#3)
minimum sensitivity##2##2##(2008-10#1)(2008-3#1)
minimum sexable size##2##3##(2013-7#2)
minimum size of ovigerous females##2##5##(2013-7#2)
minimum size of##3##3##(1993-6#1)(2013-7#2)
minimum size##4##2##(1990-8#1)(1993-6#1)(2013-7#2)
minimum spectral##2##2##(2008-3#1)(2009-8#1)
minimum standard##2##2##(2008-3#1)(2011-2#1)
minimum standards##2##2##(1997-1#1)(1997-7#1)
minimum temperature##9##2##(1995-6#2)(2008-10#1)(2008-2#1)(2008-8#4)(2012-3#1)
minimum tillage##4##2##(2008-10#4)
minimum value of##3##3##(2008-2#1)(2008-3#1)(2009-9#1)
minimum value##6##2##(1992-11#1)(1995-2#1)(2008-2#1)(2008-3#1)(2009-9#1)(2013-8#1)
minimum values of##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-6#1)
minimum values##8##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)
minimum volume##2##2##(2008-3#1)(2009-5#1)
minimum wage##2##2##(1993-6#1)(2013-8#1)
minimum waste generation##2##3##(2008-10#2)
minimum waste##3##2##(2008-10#3)
minimum##391##1##(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#3)(1992-9#6)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-2#3)(1995-6#4)(1996-1#1)(1996-12#2)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#10)(2007-12#6)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#78)(2008-11#8)(2008-12#6)(2008-2#35)(2008-3#57)(2008-4#1)(2008-5#11)(2008-6#6)(2008-7#10)(2008-8#12)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#18)(2013-7#6)(2013-8#6)
minimum-variance##2##1##(2008-3#2)
minimums##2##1##(2008-1#1)(2011-2#1)
mining activities##3##2##(2008-12#3)
mining and##5##2##(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#2)
mining area in the province of##2##6##(1997-5#1)(2008-10#1)
mining area##3##2##(1997-5#1)(2008-10#1)(2013-8#1)
mining is##2##2##(2008-9#1)(2011-1#1)
mining of##2##2##(2010-10#1)(2012-1#1)
mining to##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
mining##53##1##(1991-12#1)(1997-5#1)(2008-10#7)(2008-12#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-9#4)(2010-10#2)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
miniorbitofrontal craniotomy##2##2##(2011-2#2)
miniplates##4##1##(2007-12#1)(2008-7#3)
miniprep procedure##2##2##(2008-10#2)
minipump##3##1##(1994-8#1)(1995-12#1)(2011-2#1)
minireview##8##1##(1993-9#1)(1994-12#1)(1994-9#1)(1997-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)
minisatellite##5##1##(1990-12#1)(2008-10#1)(2008-7#3)
minister and##2##2##(1995-12#1)(1996-1#1)
minister##4##1##(1992-2#1)(1993-12#1)(1995-12#1)(1996-1#1)
ministerial##2##1##(2008-10#1)(2012-12#1)
ministernotomy##2##1##(2007-8#2)
ministry of care##2##3##(1993-12#2)
ministry of##3##2##(1992-2#1)(1993-12#2)
ministry##10##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#4)(1996-8#1)(1997-6#1)
minitans and##4##2##(2008-10#4)
minitans applied as a##2##4##(2008-10#2)
minitans##22##1##(2008-10#22)
mink GH##2##2##(1990-12#2)
mink M##2##2##(2008-6#2)
mink growth hormone##2##3##(1990-12#2)
mink##7##1##(1990-12#5)(2008-6#2)
minnesota##4##1##(1990-5#1)(1993-11#3)
minnows##2##1##(2008-8#2)
minocycline hydrochloride##3##2##(2010-5#2)(2012-3#1)
minocycline##13##1##(1997-8#1)(2008-7#7)(2010-5#3)(2012-3#2)
minor NORs##3##2##(1993-12#3)
minor QTL were##2##3##(2008-10#2)
minor QTL##4##2##(2008-10#2)(2009-10#2)
minor accumulated##2##2##(2011-1#2)
minor allele##2##2##(2011-2#1)(2012-1#1)
minor and S##8##3##(2008-10#5)(2011-1#3)
minor and major##3##3##(2008-12#1)(2008-9#1)(2009-3#1)
minor and trace elements##3##4##(2008-10#2)(2008-12#1)
minor and trace##5##3##(2008-10#4)(2008-12#1)
minor and##22##2##(2007-11#1)(2008-10#11)(2008-12#3)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#4)
minor band##2##2##(1992-3#1)(1997-7#1)
minor bleeding##2##2##(2008-10#1)(2009-8#1)
minor brain##2##2##(1993-12#1)(1996-8#1)
minor categories##2##2##(2008-11#2)
minor change##2##2##(1995-2#1)(2008-10#1)
minor changes in the##4##4##(1990-8#1)(2008-10#2)(2008-4#1)
minor changes in##7##3##(1990-8#1)(1994-5#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-8#1)
minor changes##8##2##(1990-8#1)(1994-5#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
minor cognitive-motor disorder##2##3##(2008-1#1)(2008-2#1)
minor complications in##3##3##(1990-9#2)(2008-5#1)
minor complications##10##2##(1990-9#2)(1995-3#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-3#2)(2012-2#1)(2013-1#1)
minor components##5##2##(1994-5#1)(2008-10#4)
minor criteria##2##2##(1997-8#2)
minor damage##2##2##(2008-10#1)(2011-2#1)
minor differences in##3##3##(2008-10#3)
minor differences##6##2##(1995-6#1)(2008-10#4)(2008-6#1)
minor effect on##5##3##(2008-10#3)(2008-3#1)(2009-8#1)
minor effect##10##2##(1993-8#1)(1995-2#1)(1997-7#1)(2008-10#5)(2008-3#1)(2009-8#1)
minor effects on the##2##4##(2008-10#1)(2013-1#1)
minor effects on##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
minor effects##7##2##(2008-10#4)(2008-11#1)(2011-1#1)(2013-1#1)
minor elements##3##2##(2008-10#3)
minor genes##5##2##(2008-10#5)
minor genetic##2##2##(2008-10#1)(2011-1#1)
minor groove of##9##3##(1992-3#2)(1993-1#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-4#1)
minor groove##20##2##(1990-7#1)(1992-3#2)(1993-1#2)(1993-3#1)(1993-8#1)(1994-5#2)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#2)(2008-10#2)(2008-4#3)
minor groups of##2##3##(2008-10#2)
minor groups##3##2##(2008-10#3)
minor head injuries##3##3##(1996-8#1)(2008-11#2)
minor head injury##6##3##(1991-3#1)(1992-6#3)(2008-7#1)(2008-8#1)
minor head##11##2##(1991-3#1)(1992-6#3)(1996-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)
minor heavy##2##2##(2009-12#2)
minor in##3##2##(1991-8#1)(1993-11#1)(2008-10#1)
minor influence on the##2##4##(2008-10#2)
minor injuries##4##2##(1990-2#1)(1992-6#1)(2007-8#1)(2012-1#1)
minor intron-containing##2##2##(2013-8#2)
minor introns##2##2##(2013-8#2)
minor ischaemic stroke##2##3##(2008-8#2)
minor loci##4##2##(2008-10#3)(2010-5#1)
minor metabolite##3##2##(1990-12#1)(2008-10#1)(2011-1#1)
minor metabolites##2##2##(1990-12#1)(1990-5#1)
minor modification##2##2##(2007-11#1)(2008-10#1)
minor modifications##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
minor new##2##2##(2011-2#2)
minor nucleoli##2##2##(1993-12#2)
minor or major##5##3##(1994-6#1)(2007-10#1)(2008-1#1)(2009-5#1)(2012-2#1)
minor or##8##2##(1994-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2009-5#1)(2012-2#2)
minor pathogens##3##2##(1990-6#1)(2008-10#1)(2010-3#1)
minor postoperative##2##2##(1994-2#1)(2013-1#1)
minor process##2##2##(1997-3#1)(2008-11#1)
minor responses##2##2##(1990-12#1)(1991-2#1)
minor risk of##2##3##(1996-3#1)(2008-10#1)
minor role in##6##3##(1992-10#1)(1995-6#1)(2008-10#2)(2008-9#1)(2009-9#1)
minor role##13##2##(1992-10#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-9#1)(2009-9#1)(2012-12#1)
minor salivary gland of the cheek##2##6##(2008-4#2)
minor salivary gland of the##4##5##(2008-4#2)(2013-1#2)
minor salivary gland##5##3##(2007-11#1)(2008-4#2)(2013-1#2)
minor salivary glands##3##3##(1990-6#2)(1991-11#1)
minor salivary##8##2##(1990-6#2)(1991-11#1)(2007-11#1)(2008-4#2)(2013-1#2)
minor sclerotia##4##2##(2008-10#4)
minor sequence##2##2##(1997-3#1)(2008-10#1)
minor species in##2##3##(2008-10#2)
minor species##4##2##(2008-10#4)
minor spliceosome's##2##2##(2013-8#2)
minor stroke##5##2##(1991-11#2)(2008-8#3)
minor surgery##2##2##(2008-11#2)
minor symptoms and##2##3##(1994-2#1)(2007-10#1)
minor symptoms##4##2##(1991-9#1)(1994-2#1)(1995-6#1)(2007-10#1)
minor thalassemic##2##2##(2011-2#2)
minor to##4##2##(1997-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
minor trauma##3##2##(1991-11#2)(1991-8#1)
minor variations in##2##3##(1992-9#1)(2008-10#1)
minor was##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
minor##452##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#5)(1991-2#1)(1991-3#3)(1991-8#3)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#8)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#8)(1993-3#2)(1993-6#1)(1993-8#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#4)(1996-8#3)(1996-9#2)(1997-2#2)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#121)(2008-11#19)(2008-12#5)(2008-2#5)(2008-3#6)(2008-4#12)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#10)(2008-9#5)(2009-10#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#5)(2011-1#12)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#17)(2013-8#9)
minor)##2##1##(2008-10#1)(2012-2#1)
minor-groove binding##2##2##(1992-3#2)
minorities in##2##2##(1991-8#1)(2008-8#1)
minorities##27##1##(1990-6#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-12#3)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#5)(2009-5#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#2)
minority adolescents##3##2##(2010-1#2)(2011-1#1)
minority are##2##2##(1992-3#1)(2007-11#1)
minority children##3##2##(2009-11#2)(2010-1#1)
minority composition##2##2##(2011-2#2)
minority groups##3##2##(1991-9#1)(2012-3#2)
minority health care##3##3##(1997-2#2)(2012-3#1)
minority health##4##2##(1997-2#2)(2012-3#2)
minority individuals##2##2##(2008-12#1)(2013-1#1)
minority of patients##9##3##(1990-6#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
minority of the##4##3##(1992-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
minority of##23##2##(1990-6#1)(1992-8#1)(1993-1#1)(1994-8#1)(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
minority participation##2##2##(2010-10#1)(2012-3#1)
minority population##4##2##(2010-8#2)(2011-1#1)(2011-2#1)
minority populations##7##2##(2011-1#7)
minority smokers##5##2##(2010-11#4)(2012-3#1)
minority species in multicomponent microdroplets##2##5##(2008-2#2)
minority students##2##2##(1997-2#2)
minority were##2##2##(2011-1#1)(2013-1#1)
minority women##2##2##(1995-9#1)(2008-12#1)
minority youth##2##2##(2012-2#1)(2013-1#1)
minority youths##2##2##(2009-7#1)(2011-1#1)
minority##100##1##(1990-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-2#4)(1997-3#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-2#2)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#1)(2010-5#1)(2010-8#5)(2011-1#11)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#11)(2013-1#6)(2013-8#2)
minors to##2##2##(1994-2#1)(1996-1#1)
minors##10##1##(1991-8#1)(1994-2#3)(1996-1#2)(1996-5#2)(2008-10#1)(2008-11#1)
minors'##4##1##(1991-5#2)(1994-2#2)
minoxidil##6##1##(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)
mins##3##1##(1996-2#1)(2008-8#1)(2013-1#1)
mint##6##1##(2008-10#5)(2009-12#1)
minus the##6##2##(1996-4#1)(1996-5#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-8#1)
minus##17##1##(1990-9#1)(1991-8#1)(1992-3#1)(1995-3#1)(1996-4#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
minus-strand##3##1##(2008-9#3)
minute after##4##2##(1990-5#1)(2008-7#2)(2011-2#1)
minute amount of##3##3##(1990-11#1)(2008-10#2)
minute amounts of##4##3##(1993-11#1)(1997-6#1)(2007-12#1)(2009-11#1)
minute amounts##5##2##(1990-11#1)(1993-11#1)(1997-6#1)(2007-12#1)(2009-11#1)
minute changes in the refractive index of##2##7##(2007-11#1)(2008-2#1)
minute of##2##2##(2008-6#1)(2011-2#1)
minute patch test##2##3##(2008-5#2)
minute pattern of changes occurring##2##5##(2008-11#2)
minute quantities of##3##3##(1991-12#1)(1992-9#1)(2008-10#1)
minute ventilation##3##2##(2012-2#1)(2012-3#1)(2013-7#1)
minute##75##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#13)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-7#1)
minute)##2##1##(2008-10#2)
minutes (range##5##2##(1992-2#1)(2007-7#1)(2013-1#2)(2013-8#1)
minutes after lactulose##2##3##(1996-6#2)
minutes after the initiation of##2##5##(1992-1#1)(2010-5#1)
minutes after the##9##3##(1990-5#1)(1990-8#1)(1992-1#1)(1995-12#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-3#1)
minutes after##25##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1995-12#2)(1996-1#1)(1996-6#2)(1996-9#1)(2007-10#2)(2007-9#1)(2008-5#2)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-8#1)
minutes and offers##2##3##(1993-12#1)(2008-11#1)
minutes and the##3##3##(1991-2#1)(2008-2#1)(2008-4#1)
minutes and##17##2##(1991-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-11#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
minutes at 37 degrees C##2##5##(1994-3#1)(1994-6#1)
minutes at room temperature##2##4##(2008-11#1)(2010-5#1)
minutes at the##2##3##(2008-7#1)(2012-2#1)
minutes at##11##2##(1990-7#1)(1992-6#1)(1994-3#2)(1994-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)
minutes before##4##2##(1996-12#1)(2008-5#1)(2010-5#1)(2010-7#1)
minutes by##2##2##(1990-2#1)(2007-11#1)
minutes can##2##2##(1993-12#2)
minutes for##4##2##(1994-3#1)(2011-2#2)(2013-8#1)
minutes in the##2##3##(1991-1#1)(1991-6#1)
minutes in##3##2##(1991-1#1)(1991-6#1)(2012-3#1)
minutes later##4##2##(1990-5#1)(1993-1#1)(2009-6#1)(2013-8#1)
minutes of MPA/VPA##2##3##(2013-1#2)
minutes of anoxia and##2##4##(1996-9#2)
minutes of reoxygenation##2##3##(1996-9#2)
minutes of##33##2##(1991-12#2)(1994-11#2)(1994-3#1)(1994-7#1)(1995-6#1)(1996-9#5)(1997-2#1)(2006-12#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#6)
minutes on average##2##3##(2008-7#1)(2010-6#1)
minutes on##4##2##(1991-3#1)(1996-6#1)(2008-7#1)(2010-6#1)
minutes prior to##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
minutes to##4##2##(2007-12#1)(2008-4#2)(2010-7#1)
minutes with a##2##3##(1997-3#1)(2008-10#1)
minutes##231##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#4)(1993-3#1)(1993-6#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#7)(1994-5#1)(1994-6#1)(1994-7#4)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#3)(1996-9#7)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-12#3)(2007-10#9)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#11)(2013-8#6)
minutes' of##2##2##(2012-2#2)
minutes'##5##1##(1990-8#1)(2012-2#4)
minutes) and after##2##3##(2011-2#2)
minutes) and##3##2##(2008-10#1)(2011-2#2)
minutes) for the##2##3##(2013-1#2)
minutes)##18##1##(1990-5#3)(1990-8#1)(1993-6#1)(2008-10#2)(2008-3#2)(2010-5#1)(2011-2#4)(2012-2#2)(2013-1#2)
minutus##3##1##(2008-5#2)(2008-8#1)
mirabilis##5##1##(2008-10#1)(2009-6#2)(2010-4#1)(2010-6#1)
miracle##4##1##(1990-10#1)(2007-5#1)(2010-3#1)(2011-2#1)
mirage in which##2##3##(2008-2#2)
mirage in##3##2##(2008-2#2)(2010-8#1)
mirage##9##1##(2008-2#6)(2008-3#2)(2010-8#1)
mirages##6##1##(2008-2#5)(2008-3#1)
mirror and a##4##3##(2008-3#4)
mirror and an##2##3##(2008-3#2)
mirror and the##2##3##(2007-11#1)(2008-3#1)
mirror and##13##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#8)
mirror are presented##2##3##(2007-11#1)(2008-2#1)
mirror are##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
mirror array##4##2##(2007-11#4)
mirror as an##2##3##(2008-2#1)(2008-3#1)
mirror as##3##2##(2008-2#1)(2008-3#2)
mirror by##2##2##(2007-11#1)(2008-3#1)
mirror design##2##2##(2008-3#2)
mirror effect##2##2##(2008-6#2)
mirror effects##3##2##(2008-6#3)
mirror fabrication##2##2##(2008-2#1)(2008-3#1)
mirror for the##2##3##(2007-11#1)(2008-3#1)
mirror for wave-front##2##3##(2008-2#1)(2008-3#1)
mirror for##15##2##(2007-11#5)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
mirror has a##2##3##(2008-2#1)(2008-3#1)
mirror has##3##2##(2008-2#1)(2008-3#2)
mirror image of the##2##4##(2008-10#1)(2008-3#1)
mirror image##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#3)
mirror images##6##2##(1996-2#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)
mirror in a##2##3##(2007-11#1)(2008-3#1)
mirror in the##3##3##(2007-11#1)(2008-3#2)
mirror in##10##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)
mirror is used to##2##4##(2007-11#1)(2007-12#1)
mirror is used##3##3##(2007-11#2)(2007-12#1)
mirror is##20##2##(2007-11#5)(2007-12#7)(2008-2#4)(2008-3#4)
mirror neuron system (MNS)##2##4##(2008-11#2)
mirror neuron system##5##3##(2008-11#5)
mirror neurons##3##2##(2008-11#2)(2008-2#1)
mirror of the##2##3##(2008-3#1)(2008-7#1)
mirror of##6##2##(2008-3#2)(2008-7#1)(2012-3#1)(2013-8#2)
mirror or##2##2##(2007-12#1)(2008-2#1)
mirror plane##3##2##(1997-7#3)
mirror pyramid cameras##2##3##(2008-6#2)
mirror pyramid##5##2##(2008-6#5)
mirror reflectivity##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
mirror scan##2##2##(2007-11#2)
mirror scanner##2##2##(2008-3#2)
mirror segments of the Keck telescopes##2##6##(2008-3#2)
mirror structure##2##2##(2007-11#1)(2007-12#1)
mirror substrates##3##2##(2008-2#1)(2008-3#2)
mirror surface##4##2##(2008-2#1)(2008-3#3)
mirror surfaces##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mirror telescopes##2##2##(2008-2#1)(2008-3#1)
mirror that##6##2##(2007-11#2)(2007-12#1)(2008-3#2)(2008-5#1)
mirror the##2##2##(1995-1#1)(2012-12#1)
mirror to##10##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
mirror was##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
mirror with a##7##3##(2007-11#2)(2008-2#2)(2008-3#3)
mirror with thermal actuators##2##4##(2007-11#2)
mirror with##19##2##(2007-11#4)(2007-12#2)(2008-2#5)(2008-3#8)
mirror##363##1##(1990-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-2#2)(1997-7#3)(2007-11#53)(2007-12#43)(2008-10#8)(2008-11#7)(2008-2#80)(2008-3#129)(2008-4#1)(2008-5#2)(2008-6#14)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
mirror)##2##1##(2008-2#1)(2012-12#1)
mirror-image##3##1##(1993-12#1)(1994-11#1)(1996-6#1)
mirrored by##2##2##(1997-7#1)(2008-6#1)
mirrored in##2##2##(1996-2#1)(2008-8#1)
mirrored the##2##2##(2010-4#1)(2012-5#1)
mirrored##10##1##(1996-2#1)(1996-5#1)(1997-7#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2012-5#1)
mirroring##3##1##(1992-10#2)(2008-11#1)
mirrorless##3##1##(2007-11#3)
mirrors and##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
mirrors are##8##2##(2008-2#3)(2008-3#5)
mirrors as##2##2##(2008-2#1)(2008-3#1)
mirrors for a##2##3##(2008-3#2)
mirrors for the##2##3##(2007-11#2)
mirrors for use in tunable##2##5##(2007-12#2)
mirrors for##15##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#7)
mirrors have a##2##3##(2008-3#2)
mirrors have##3##2##(2008-3#3)
mirrors in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
mirrors in the##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
mirrors in##10##2##(2007-11#2)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#3)
mirrors is##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
mirrors of the##2##3##(2008-3#2)
mirrors of##3##2##(2008-3#3)
mirrors that of##2##3##(1993-8#1)(2008-10#1)
mirrors that##4##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
mirrors the##2##2##(2008-11#1)(2008-4#1)
mirrors to##3##2##(2008-2#1)(2008-3#2)
mirrors was##2##2##(2008-3#2)
mirrors were used##2##3##(2008-3#2)
mirrors were##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
mirrors with##4##2##(2008-2#1)(2008-3#3)
mirrors would##2##2##(2008-3#2)
mirrors##156##1##(1993-8#1)(2007-11#24)(2007-12#20)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#32)(2008-3#73)(2008-4#1)(2012-3#1)
mirtazapine##8##1##(2008-6#4)(2008-7#1)(2010-5#2)(2013-7#1)
mis-match ODN##2##2##(2011-2#2)
misakiensis##5##1##(2008-5#5)
misaligned##5##1##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
misalignment and##6##2##(2007-11#1)(2008-3#5)
misalignment are##3##2##(2008-3#3)
misalignment between the##3##3##(1997-6#1)(2008-2#1)(2008-3#1)
misalignment between##4##2##(1997-6#1)(2008-2#1)(2008-3#2)
misalignment errors##2##2##(2008-2#2)
misalignment in##4##2##(2008-3#3)(2011-2#1)
misalignment of the##4##3##(1992-12#1)(2007-11#1)(2008-3#2)
misalignment of##7##2##(1992-12#1)(2007-11#1)(2008-2#1)(2008-3#4)
misalignment tolerances##2##2##(2008-3#2)
misalignment##50##1##(1992-12#1)(1997-6#1)(2007-11#2)(2007-5#1)(2008-2#5)(2008-3#39)(2011-2#1)
misalignments and##3##2##(2008-3#3)
misalignments of the##3##3##(2008-2#1)(2008-3#2)
misalignments##16##1##(2007-11#2)(2008-2#3)(2008-3#11)
misbehaviors##2##1##(2010-11#2)
misbehaviour in##2##2##(2012-12#2)
misbehaviour is##2##2##(2012-12#2)
misbehaviour was##2##2##(2012-12#2)
misbehaviour##13##1##(2012-12#13)
miscarriage and##2##2##(1995-8#1)(2010-11#1)
miscarriage in##2##2##(2008-9#1)(2010-11#1)
miscarriage##15##1##(1990-2#1)(1994-9#2)(1995-8#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-11#2)(2011-2#1)(2012-3#2)
miscarriages##8##1##(1994-9#1)(1995-2#1)(2008-9#1)(2012-3#1)(2013-8#4)
miscellaneous disorders##2##2##(2011-2#1)(2012-2#1)
miscellaneous##16##1##(1991-11#1)(1991-3#1)(1995-2#1)(1996-6#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
miscibility##3##1##(2008-10#3)
miscible with##3##2##(1993-8#1)(2008-10#2)
miscible##11##1##(1993-8#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2010-4#1)(2011-2#1)
misclassification is##2##2##(1992-6#1)(1996-3#1)
misclassification of##3##2##(2008-10#1)(2009-9#1)(2012-2#1)
misclassification rate##3##2##(2008-6#2)(2012-2#1)
misclassification to##2##2##(1992-6#1)(2008-10#1)
misclassification##17##1##(1991-6#1)(1992-6#5)(1996-3#1)(2008-10#3)(2008-6#2)(2009-9#1)(2011-2#2)(2012-2#2)
misclassified as##4##2##(1993-8#2)(1996-3#1)(2008-10#1)
misclassified by the##2##3##(1993-8#1)(2008-10#1)
misclassified##7##1##(1991-6#1)(1993-8#3)(1996-3#1)(2008-10#2)
misclassify##2##1##(1994-2#1)(2008-10#1)
miscommunication##2##1##(2007-9#1)(2010-4#1)
misconception##4##1##(2009-6#3)(2012-2#1)
misconceptions about##4##2##(2010-11#1)(2010-3#2)(2011-2#1)
misconceptions##14##1##(1997-1#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-12#1)(2010-3#6)(2010-7#1)(2011-2#1)
misconduct##7##1##(1992-12#1)(1992-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-12#2)
misdiagnosed as a##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
misdiagnosed as anorexia nervosa##2##4##(2007-12#2)
misdiagnosed as##11##2##(1991-9#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)
misdiagnosed##23##1##(1991-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
misdiagnosis of##4##2##(1991-8#1)(2008-6#1)(2012-2#1)(2013-1#1)
misdiagnosis##8##1##(1991-8#1)(2007-11#1)(2008-2#1)(2008-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
misfit##2##1##(2008-3#1)(2013-1#1)
misfolded##2##1##(2009-8#1)(2011-2#1)
misfolding##4##1##(1992-3#2)(2008-11#1)(2013-1#1)
mishandling##2##1##(2008-7#1)(2013-8#1)
misidentification and##2##2##(2008-11#2)
misidentification of##2##2##(2008-10#1)(2011-2#1)
misidentification##7##1##(2008-10#2)(2008-11#2)(2011-2#3)
misidentified##2##1##(2008-11#1)(2010-1#1)
misinformation about##2##2##(1992-2#1)(1993-1#1)
misinformation##5##1##(1992-2#1)(1992-5#1)(1993-1#3)
misinterpretation of##4##2##(1993-3#1)(2008-12#1)(2008-2#1)(2009-8#1)
misinterpretation##8##1##(1992-1#1)(1993-3#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2013-7#1)
misinterpretations of##2##2##(1994-5#1)(2008-10#1)
misinterpretations##6##1##(1991-12#1)(1994-5#1)(2008-10#2)(2012-2#1)(2013-7#1)
misinterpreted and##2##2##(2010-12#1)(2010-3#1)
misinterpreted as##2##2##(1995-11#1)(2009-3#1)
misinterpreted##6##1##(1995-11#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)
mislead##2##1##(2010-3#2)
misleading if##3##2##(1994-12#1)(1997-8#1)(2008-11#1)
misleading##35##1##(1990-6#1)(1992-11#1)(1992-6#1)(1994-12#2)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#1)
mislocalization##2##1##(1995-5#1)(2009-3#1)
mislocalized##3##1##(1995-5#1)(2009-10#1)(2012-3#1)
mismanagement##3##1##(1992-3#1)(1995-6#1)(2008-12#1)
mismatch and##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-3#1)
mismatch are discussed##2##3##(2007-11#1)(2008-12#1)
mismatch are##3##2##(2007-11#1)(2008-12#1)(2008-3#1)
mismatch between fundamental##2##3##(2007-11#1)(2008-3#1)
mismatch between the signal and the reference##2##7##(2008-3#2)
mismatch between the signal and the##3##6##(2008-2#1)(2008-3#2)
mismatch between the##9##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-8#1)(2011-2#1)
mismatch between##16##2##(1996-1#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#4)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#2)
mismatch hypothesis -##2##3##(2009-9#2)
mismatch hypothesis##4##2##(2009-9#4)
mismatch in the##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
mismatch in##6##2##(2008-10#2)(2008-3#3)(2012-2#1)
mismatch is##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-9#1)
mismatch negativity (MMN)##5##3##(1995-12#1)(1995-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
mismatch negativity in##2##3##(2008-9#1)(2013-8#1)
mismatch negativity##9##2##(1995-12#1)(1995-5#1)(2008-8#1)(2008-9#2)(2013-8#4)
mismatch of the##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
mismatch of##5##2##(2008-2#2)(2008-3#2)(2012-12#1)
mismatch repair##3##2##(2008-11#1)(2013-1#2)
mismatch responses##2##2##(1993-9#1)(2009-2#1)
mismatch that##2##2##(1994-2#1)(2007-11#1)
mismatch##92##1##(1993-11#3)(1993-9#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-1#2)(1997-1#1)(2007-11#9)(2007-12#7)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#20)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-5#3)(2009-9#6)(2010-8#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#5)
mismatch)##2##1##(2008-2#1)(2008-3#1)
mismatched and random targets##2##4##(2008-10#2)
mismatched cords##2##2##(2010-11#2)
mismatched##25##1##(1990-11#2)(1993-11#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#5)(2008-9#1)(2009-9#1)(2010-11#5)(2011-2#1)(2012-2#1)(2013-1#2)
mismatches and##2##2##(1990-11#1)(1993-11#1)
mismatches can##2##2##(2008-2#1)(2008-4#1)
mismatches in RNA##2##3##(1991-8#1)(1993-11#1)
mismatches in##4##2##(1991-8#2)(1993-11#1)(2008-10#1)
mismatches##22##1##(1990-11#1)(1991-8#4)(1993-11#3)(1993-12#1)(1995-12#3)(1995-5#1)(2008-10#2)(2008-2#1)(2008-4#4)(2008-7#1)(2008-9#1)
mismatching##3##1##(2008-1#1)(2008-2#1)(2008-3#1)
misogynist theme##2##2##(2009-10#2)
misogynist##3##1##(2009-10#3)
misogyny##2##1##(2009-10#2)
misoprostol for##2##2##(1995-8#1)(2009-7#1)
misoprostol##15##1##(1995-8#7)(2006-10#2)(2008-11#2)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
misperception##2##1##(2008-1#1)(2012-12#1)
misperceptions and##2##2##(2010-4#1)(2011-2#1)
misperceptions##5##1##(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
misplaced##4##1##(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#1)
misplacement##2##1##(2008-9#1)(2012-12#1)
misregistrations between a detector array and the coherent image of a pixelated two-dimensional data page##2##15##(2007-11#2)
misrepresentation##3##1##(1996-12#2)(2011-2#1)
miss the##3##2##(1994-1#1)(2007-12#1)(2012-12#1)
miss this##2##2##(2008-3#1)(2012-2#1)
miss##12##1##(1990-12#1)(1991-1#1)(1994-1#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-12#1)(2012-2#2)
missed a##2##2##(1997-2#1)(2008-10#1)
missed an opportunity##2##3##(1997-5#1)(2013-1#1)
missed and##2##2##(2008-7#1)(2009-4#1)
missed by##6##2##(1996-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
missed diagnosis##2##2##(1995-8#1)(2012-12#1)
missed if##2##2##(2007-7#1)(2008-7#1)
missed in##3##2##(2007-2#1)(2009-4#1)(2013-1#1)
missed on##2##2##(2008-11#1)(2008-7#1)
missed opportunities##8##2##(1996-12#8)
missed or significantly delayed##2##4##(2012-12#2)
missed or##4##2##(2008-9#1)(2010-1#1)(2012-12#2)
missed##60##1##(1991-1#1)(1991-11#1)(1991-12#1)(1994-12#1)(1994-9#1)(1995-8#2)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#4)(2013-8#2)
missense mutation in##5##3##(1994-12#1)(1996-2#1)(2008-12#1)(2008-8#1)(2012-12#1)
missense mutation of the##2##4##(1993-3#1)(1994-12#1)
missense mutation##19##2##(1993-3#3)(1993-6#2)(1994-12#2)(1996-2#1)(1997-7#1)(2008-12#2)(2008-2#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-1#1)(2012-12#1)
missense mutations in##2##3##(1995-8#2)
missense mutations##12##2##(1992-3#1)(1993-3#1)(1995-12#1)(1995-8#2)(1997-7#1)(1997-8#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#1)
missense##34##1##(1992-3#1)(1993-3#4)(1993-6#2)(1994-12#2)(1995-12#1)(1995-8#3)(1996-2#1)(1997-7#2)(1997-8#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#3)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)
misses##4##1##(1997-1#1)(2008-7#2)(2011-2#1)
missile##2##1##(1996-5#1)(2008-9#1)
missing at random##3##3##(1995-12#1)(1997-3#1)(2009-5#1)
missing completely at random##3##4##(1997-8#2)(2009-12#1)
missing data and##2##3##(1995-12#1)(2008-6#1)
missing data mechanisms##2##3##(1995-12#2)
missing data patterns##3##3##(1994-9#1)(2012-2#2)
missing data##31##2##(1994-9#2)(1995-12#7)(1997-8#1)(2007-10#2)(2008-10#1)(2008-6#1)(2009-12#4)(2011-2#1)(2012-12#7)(2012-2#4)(2012-3#1)
missing from the##2##3##(1996-2#2)
missing from##4##2##(1996-2#2)(2008-8#1)(2009-10#1)
missing genetic##2##2##(2010-5#1)(2012-3#1)
missing in##4##2##(1990-5#1)(2007-12#1)(2008-11#1)(2012-2#1)
missing link between##3##3##(1994-3#1)(1997-4#1)(2009-8#1)
missing link##5##2##(1994-3#1)(1997-4#1)(2009-6#1)(2009-8#2)
missing observations##3##2##(1992-6#1)(1997-8#2)
missing of##3##2##(2008-9#1)(2009-8#1)(2011-1#1)
missing teeth in##2##3##(2008-7#1)(2013-1#1)
missing teeth##6##2##(2007-12#1)(2008-1#1)(2008-7#2)(2013-1#2)
missing the##2##2##(2010-10#1)(2013-7#1)
missing values##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
missing##142##1##(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#3)(1995-11#1)(1995-12#9)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#5)(2007-10#3)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#2)(2009-10#2)(2009-12#7)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#7)(2012-12#10)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
missingness##4##1##(1994-9#3)(2009-12#1)
mission and##9##2##(1996-3#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2013-1#1)
mission education##3##2##(1991-3#1)(1992-2#2)
mission in the##3##3##(1991-3#1)(1992-3#1)(1992-6#1)
mission of the##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
mission of##14##2##(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2012-3#2)(2013-1#1)
mission statement##4##2##(1995-12#1)(1996-1#1)(1997-1#1)(2010-6#1)
mission to##7##2##(1993-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-3#1)(2010-5#1)(2012-3#1)
mission were##2##2##(1996-12#1)(1996-2#1)
mission##96##1##(1991-2#1)(1991-3#3)(1991-8#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#4)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#2)(1997-1#4)(1997-2#2)(1997-3#2)(2008-1#1)(2008-11#8)(2008-2#4)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-3#5)(2013-1#3)
missions and##2##2##(1995-2#1)(1996-1#1)
missions##12##1##(1995-2#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-8#1)(2011-3#1)(2012-3#1)
misspecification##7##1##(1990-11#1)(1992-6#2)(1992-9#1)(1997-3#3)
misspecified##2##1##(2008-11#1)(2011-1#1)
mist and##2##2##(2008-10#1)(2011-2#1)
mist##15##1##(1990-3#1)(1991-2#3)(1996-12#1)(2008-10#6)(2008-9#1)(2010-12#1)(2011-2#2)
mistake##2##1##(2007-8#1)(2008-10#1)
mistaken for a##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
mistaken for##8##2##(2007-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-2#1)
mistaken##13##1##(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)
mistakenly##5##1##(1995-11#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
mistakes and##2##2##(2008-3#1)(2012-12#1)
mistakes in##2##2##(2008-7#1)(2012-3#1)
mistakes of the past##2##4##(1993-12#1)(2011-2#1)
mistakes of##4##2##(1993-12#1)(2011-2#2)(2012-3#1)
mistakes##25##1##(1991-12#1)(1992-1#1)(1993-12#2)(1994-2#1)(1997-6#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)
mistletoe incidence on white fir##2##5##(2008-10#2)
mistletoe incidence##3##2##(2008-10#3)
mistletoe##14##1##(1992-9#1)(1993-3#2)(2008-10#11)
mistreated##3##1##(2007-11#1)(2010-4#1)(2011-2#1)
mistrusted##2##1##(2012-3#2)
misty mesentery##2##2##(2011-2#2)
misty##3##1##(2011-2#3)
misunderstanding of the crystal-meth##2##4##(2012-12#2)
misunderstanding of the##3##3##(1995-1#1)(2012-12#2)
misunderstanding of##4##2##(1995-1#1)(1996-3#1)(2012-12#2)
misunderstanding##8##1##(1995-1#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-12#2)
misunderstandings##2##1##(1994-12#1)(2010-12#1)
misunderstood##7##1##(1993-1#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#1)(2013-8#1)
misuse and##5##2##(2007-12#1)(2008-11#1)(2009-9#2)(2013-8#1)
misuse of the##2##3##(1991-12#1)(2007-11#1)
misuse of##8##2##(1991-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
misuse##29##1##(1991-12#2)(1992-5#1)(1993-3#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#4)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#4)
misused in##4##2##(2010-5#1)(2013-1#1)(2013-8#2)
misused##7##1##(1995-2#1)(1996-2#1)(2010-5#1)(2013-1#2)(2013-8#2)
misusers##6##1##(1992-5#2)(1993-12#2)(1993-3#1)(1996-3#1)
misusing##3##1##(1993-12#1)(1997-5#1)(2013-8#1)
mite Varroa destructor##3##3##(2008-6#2)(2013-1#1)
mite allergen##4##2##(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)
mite allergens##3##2##(2010-5#1)(2011-2#2)
mite hypersensitivity##2##2##(1990-3#2)
mite species##5##2##(2008-8#1)(2011-2#2)(2013-1#2)
mite##37##1##(1990-3#2)(1997-3#3)(1997-5#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#3)(2008-8#3)(2010-5#3)(2011-2#7)(2012-3#1)(2013-1#7)
mite-transmitted##5##1##(2008-10#5)
mites and##2##2##(1994-9#1)(2008-8#1)
mites are##2##2##(1997-3#1)(2008-8#1)
mites but##2##2##(2008-10#2)
mites in##2##2##(1995-6#1)(2011-2#1)
mites that were##2##3##(2008-8#2)
mites were##2##2##(2008-12#1)(2008-8#1)
mites##35##1##(1990-3#1)(1991-11#1)(1994-9#2)(1995-6#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-12#6)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#6)(2011-2#4)(2013-1#1)(2013-8#1)
mitigate against##2##2##(1991-2#1)(2008-12#1)
mitigate loss of##2##3##(1996-6#1)(2007-5#1)
mitigate the problem##2##3##(2008-11#1)(2009-4#1)
mitigate the##12##2##(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
mitigate them##2##2##(2008-11#1)(2012-3#1)
mitigate these##3##2##(1994-2#1)(2008-11#1)(2009-5#1)
mitigate this##3##2##(2010-5#1)(2011-2#1)(2012-3#1)
mitigate##36##1##(1991-2#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-6#1)(2007-5#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
mitigated by##2##2##(2008-10#1)(2011-2#1)
mitigated##10##1##(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-1#1)
mitigates##2##1##(1991-9#1)(2008-2#1)
mitigating the##2##2##(2007-7#1)(2008-3#1)
mitigating##6##1##(1994-11#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)
mitigation##12##1##(2007-5#1)(2007-7#2)(2008-3#1)(2008-8#1)(2009-10#2)(2012-2#2)(2012-3#2)(2013-1#1)
mitochondria and ATPases##6##3##(2008-7#6)
mitochondria and peroxisomes##2##3##(2007-12#1)(2009-8#1)
mitochondria and##31##2##(1990-2#1)(1991-11#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
mitochondria are##4##2##(1994-12#1)(2009-10#1)(2009-12#1)(2010-3#1)
mitochondria as##2##2##(2009-11#1)(2013-8#1)
mitochondria by##2##2##(1990-11#1)(1994-12#1)
mitochondria contain##2##2##(1994-8#1)(2008-7#1)
mitochondria from 3- and 30-month-old##2##5##(1990-3#2)
mitochondria from different##3##3##(1995-11#1)(2008-1#1)(2008-9#1)
mitochondria from normoxic hearts##2##4##(1994-5#2)
mitochondria from rats fed vitamin E sufficient##2##7##(1994-5#2)
mitochondria from rats##3##3##(1994-5#3)
mitochondria from vitamin E sufficient##2##5##(1994-5#2)
mitochondria from vitamin E##3##4##(1994-5#3)
mitochondria from##19##2##(1990-3#2)(1992-11#1)(1994-5#10)(1995-11#1)(1996-10#1)(2008-1#1)(2008-10#2)(2008-9#1)
mitochondria have##3##2##(1997-2#1)(2008-1#1)(2008-7#1)
mitochondria in the presence of##3##5##(1991-5#1)(1994-8#1)(2009-11#1)
mitochondria in the##6##3##(1991-5#1)(1992-9#1)(1994-8#1)(2008-7#1)(2009-11#1)(2009-8#1)
mitochondria in##16##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-8#1)
mitochondria is##3##2##(1990-3#1)(1994-12#1)(1994-8#1)
mitochondria isolated from##5##3##(1990-11#1)(1993-6#1)(1994-8#1)(2008-7#1)(2013-1#1)
mitochondria of Physarum##2##3##(1997-2#2)
mitochondria of##5##2##(1990-3#1)(1992-9#1)(1994-11#1)(1997-2#2)
mitochondria was##3##2##(1990-2#1)(1994-6#1)(2013-8#1)
mitochondria were##3##2##(1991-2#1)(1995-12#1)(2008-6#1)
mitochondria##195##1##(1990-11#3)(1990-2#4)(1990-3#7)(1990-5#1)(1990-7#3)(1991-11#2)(1991-2#2)(1991-3#3)(1991-5#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#5)(1994-12#7)(1994-5#11)(1994-6#5)(1994-8#10)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-2#4)(2007-10#1)(2007-12#7)(2008-1#3)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#27)(2008-8#4)(2008-9#6)(2009-10#5)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#5)(2009-8#3)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
mitochondria-targeted##2##1##(2008-11#1)(2012-2#1)
mitochondrial (mt) DNA##2##3##(2008-10#1)(2008-12#1)
mitochondrial (mt)##7##2##(1991-6#1)(1993-12#1)(1993-2#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
mitochondrial 12S rRNA gene##2##4##(2008-6#1)(2010-4#1)
mitochondrial C1-THF synthase##2##3##(1992-10#2)
mitochondrial DNA (mtDNA) haplotype##2##4##(2008-10#2)
mitochondrial DNA (mtDNA)##14##3##(1995-11#1)(1997-2#1)(2008-10#4)(2008-12#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2013-8#1)
mitochondrial DNA 4977-bp deletion and##2##5##(1994-11#2)
mitochondrial DNA from##2##3##(1990-12#1)(1996-9#1)
mitochondrial DNA haplotype##4##3##(1992-9#2)(2008-10#2)
mitochondrial DNA in##5##3##(1994-11#2)(1995-12#1)(2008-2#1)(2008-8#1)
mitochondrial DNA mutation##3##3##(1992-9#2)(2010-11#1)
mitochondrial DNA mutations##3##3##(1992-9#1)(1996-9#2)
mitochondrial DNA of##2##3##(1994-11#1)(2010-2#1)
mitochondrial DNA polymorphisms##2##3##(2008-10#2)
mitochondrial DNA replication##2##3##(2008-7#1)(2009-2#1)
mitochondrial DNA restriction fragment length##2##5##(2008-10#2)
mitochondrial DNA revealed##2##3##(2008-10#1)(2013-8#1)
mitochondrial DNA sequence variation##2##4##(2010-6#1)(2010-8#1)
mitochondrial DNA sequence##4##3##(2008-10#1)(2008-4#1)(2010-6#1)(2010-8#1)
mitochondrial DNA sequences##4##3##(1991-5#1)(1995-11#2)(2008-10#1)
mitochondrial DNA##79##2##(1990-12#2)(1990-7#1)(1991-5#3)(1992-9#5)(1994-11#7)(1995-11#3)(1995-12#2)(1995-6#1)(1996-6#1)(1996-9#4)(1997-2#1)(2007-10#1)(2008-10#18)(2008-12#6)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2013-8#3)
mitochondrial NADH##2##2##(1995-3#1)(1995-8#1)
mitochondrial alterations observed in##2##4##(2008-1#2)
mitochondrial and ER##2##3##(1991-11#2)
mitochondrial and cytoplasmic##3##3##(1993-2#1)(2008-6#1)(2008-7#1)
mitochondrial and nuclear DNA##2##4##(2008-10#1)(2013-8#1)
mitochondrial and nuclear gene##2##4##(2008-7#1)(2010-4#1)
mitochondrial and nuclear##7##3##(2008-10#2)(2008-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-8#1)
mitochondrial and##16##2##(1991-11#2)(1992-3#1)(1993-2#1)(1994-6#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-8#2)
mitochondrial aspartate aminotransferase to##2##4##(1990-7#1)(1994-6#1)
mitochondrial aspartate aminotransferase##5##3##(1990-7#1)(1994-6#4)
mitochondrial aspartate##6##2##(1990-7#1)(1991-3#1)(1994-6#4)
mitochondrial biogenesis##5##2##(1994-11#1)(2008-1#2)(2012-3#2)
mitochondrial calcium overload##3##3##(2008-1#1)(2010-3#2)
mitochondrial calcium##5##2##(1990-2#1)(2008-1#1)(2010-3#3)
mitochondrial citrate synthase##3##3##(1997-4#1)(1997-8#2)
mitochondrial contact##2##2##(1990-12#2)
mitochondrial cristae##3##2##(2008-12#2)(2008-7#1)
mitochondrial cytochrome b gene##7##4##(2008-10#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#2)
mitochondrial cytochrome oxidase II##3##4##(2008-10#2)(2008-8#1)
mitochondrial cytochrome oxidase##8##3##(1990-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#3)
mitochondrial cytochrome##16##2##(1990-3#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#2)(2008-8#1)(2010-4#1)(2010-8#2)(2011-2#3)
mitochondrial damage##2##2##(2006-10#1)(2013-1#1)
mitochondrial derivatives##8##2##(2007-12#7)(2008-7#1)
mitochondrial diseases##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
mitochondrial disorders##3##2##(1990-12#1)(2007-10#1)(2008-11#1)
mitochondrial diversity##2##2##(2008-10#1)(2008-9#1)
mitochondrial dysfunction and cell death##2##5##(1995-5#1)(2008-1#1)
mitochondrial dysfunction and##3##3##(1995-5#1)(1997-1#1)(2008-1#1)
mitochondrial dysfunction in##2##3##(2007-8#1)(2013-1#1)
mitochondrial dysfunction##12##2##(1995-5#1)(1997-1#1)(2007-8#3)(2008-1#4)(2009-11#1)(2011-2#1)(2013-1#1)
mitochondrial electron transport##4##3##(1995-2#1)(2009-9#1)(2010-12#1)(2013-1#1)
mitochondrial electron##5##2##(1995-2#1)(2006-10#1)(2009-9#1)(2010-12#1)(2013-1#1)
mitochondrial encephalomyopathy##2##2##(1991-5#1)(2008-8#1)
mitochondrial fatty acid oxidation##2##4##(1996-5#1)(2008-1#1)
mitochondrial fractions##2##2##(1992-3#1)(1996-2#1)
mitochondrial function and the##2##4##(1994-5#1)(2007-12#1)
mitochondrial function##17##2##(1991-9#1)(1994-5#3)(1997-1#1)(2007-12#1)(2008-1#2)(2008-7#3)(2008-9#2)(2009-12#1)(2010-3#1)(2013-1#2)
mitochondrial functions##2##2##(2008-1#1)(2013-1#1)
mitochondrial gene##10##2##(1990-12#1)(1993-2#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
mitochondrial genes##7##2##(1991-6#1)(2008-10#1)(2008-6#2)(2008-7#1)(2010-4#1)(2012-2#1)
mitochondrial genome in##2##3##(1995-12#1)(2012-3#1)
mitochondrial genome##12##2##(1995-11#1)(1995-12#1)(1995-6#3)(1996-10#2)(2008-2#1)(2009-8#1)(2010-3#1)(2012-3#2)
mitochondrial genomes##5##2##(2010-3#5)
mitochondrial glycerophosphate acyltransferase##2##3##(1991-2#2)
mitochondrial intermembrane##2##2##(1993-2#1)(1995-12#1)
mitochondrial localization##2##2##(2008-10#1)(2011-2#1)
mitochondrial matrix##5##2##(1990-2#2)(1994-11#1)(1994-8#1)(2010-12#1)
mitochondrial membrane depolarisation##2##3##(2008-11#2)
mitochondrial membrane of##2##3##(1990-11#1)(2012-2#1)
mitochondrial membrane potential (ΔΨm)##2##4##(2012-2#2)
mitochondrial membrane potential##20##3##(1993-11#4)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#6)(2011-2#1)(2012-2#2)(2013-1#2)
mitochondrial membrane##42##2##(1990-11#2)(1990-2#2)(1993-11#5)(1993-6#2)(1994-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-9#1)(2011-2#1)(2012-2#7)(2013-1#2)
mitochondrial membranes##11##2##(1990-11#1)(1990-12#1)(1990-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-3#1)(2012-2#1)
mitochondrial metabolism##6##2##(1994-8#4)(2008-1#1)(2008-7#1)
mitochondrial myopathy##2##2##(1990-3#1)(1994-11#1)
mitochondrial outer membrane##2##3##(2012-2#1)(2013-1#1)
mitochondrial pathways##3##2##(1992-10#1)(2013-1#1)(2013-8#1)
mitochondrial permeability transition (MPT)##2##4##(2008-1#1)(2008-11#1)
mitochondrial permeability transition pore##3##4##(2010-12#1)(2010-3#1)(2012-2#1)
mitochondrial permeability transition##8##3##(2008-1#2)(2008-11#2)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#1)
mitochondrial phosphoenol-pyruate carboxykinase##2##3##(2008-12#2)
mitochondrial plasmid##2##2##(1997-2#2)
mitochondrial protein##5##2##(1994-11#1)(1995-8#1)(2008-7#1)(2012-2#1)(2013-8#1)
mitochondrial respiration by##2##3##(1990-5#2)
mitochondrial respiration##5##2##(1990-5#3)(2008-7#1)(2012-2#1)
mitochondrial respiratory##4##2##(1994-11#1)(1996-5#1)(2008-10#1)(2011-2#1)
mitochondrial ribosomal##2##2##(1995-6#1)(2013-8#1)
mitochondrial sequences##2##2##(2008-10#1)(2008-9#1)
mitochondrial small subunit##4##3##(2008-10#4)
mitochondrial structure and##4##3##(1994-11#1)(2012-3#3)
mitochondrial structure##5##2##(1994-11#1)(2012-3#4)
mitochondrial structures##2##2##(1994-11#1)(2008-7#1)
mitochondrial targeting##3##2##(1994-8#1)(1995-11#1)(1997-4#1)
mitochondrial translation##3##2##(1995-6#1)(2008-7#2)
mitochondrial volume##2##2##(2012-3#2)
mitochondrial##510##1##(1990-11#3)(1990-12#11)(1990-2#7)(1990-3#2)(1990-5#4)(1990-7#2)(1991-11#5)(1991-2#3)(1991-3#2)(1991-5#8)(1991-6#2)(1991-9#2)(1992-10#7)(1992-11#2)(1992-3#2)(1992-9#5)(1993-11#5)(1993-12#1)(1993-2#8)(1993-3#1)(1993-6#4)(1994-11#16)(1994-5#4)(1994-6#7)(1994-8#14)(1995-11#11)(1995-12#7)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#13)(1995-8#3)(1996-10#5)(1996-2#2)(1996-5#5)(1996-6#1)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#3)(2007-12#9)(2007-8#3)(2008-1#18)(2008-10#46)(2008-11#13)(2008-12#13)(2008-2#5)(2008-4#1)(2008-5#6)(2008-6#7)(2008-7#25)(2008-8#13)(2008-9#15)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-4#2)(2009-8#7)(2009-9#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#14)(2010-4#7)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#10)(2012-2#19)(2012-3#14)(2013-1#12)(2013-7#1)(2013-8#14)
mitochondrially encoded##2##2##(2008-10#1)(2013-8#1)
mitochondrially##4##1##(1995-6#1)(1996-6#1)(2008-10#1)(2013-8#1)
mitochondrion##5##1##(2008-11#1)(2008-2#1)(2008-7#2)(2009-8#1)
mitogen activated protein kinase##3##4##(1994-11#1)(2012-2#1)(2013-7#1)
mitogen activated protein##4##3##(1994-11#1)(1996-2#1)(2012-2#1)(2013-7#1)
mitogen for hepatocytes##2##3##(1990-12#1)(1993-8#1)
mitogen for##4##2##(1990-12#2)(1993-8#1)(1997-1#1)
mitogen##32##1##(1990-12#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-2#4)(1995-6#2)(1996-2#1)(1997-1#1)(1997-6#3)(2007-2#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-2#1)(2011-2#3)(2012-2#1)(2013-7#1)
mitogen-activated protein (MAP) kinase##5##4##(1992-8#1)(1994-11#1)(2008-4#2)(2008-7#1)
mitogen-activated protein (MAP)##6##3##(1992-8#1)(1993-8#1)(1994-11#1)(2008-4#2)(2008-7#1)
mitogen-activated protein kinase (MAPK)##12##4##(1995-2#2)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-7#1)
mitogen-activated protein kinase in##3##4##(1992-8#1)(1993-8#1)(2010-10#1)
mitogen-activated protein kinase##28##3##(1992-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#3)(2013-7#1)
mitogen-activated protein kinases (MAPKs)##5##4##(1995-2#1)(1995-6#1)(1996-2#1)(2008-9#1)(2010-10#1)
mitogen-activated protein kinases##7##3##(1995-2#1)(1995-6#1)(1996-2#2)(2008-8#1)(2008-9#1)(2010-10#1)
mitogen-activated protein##41##2##(1992-8#2)(1993-8#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-2#3)(1995-6#3)(1996-2#3)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-3#3)(2013-7#1)
mitogen-activated##42##1##(1992-8#2)(1993-8#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-2#3)(1995-6#3)(1996-2#3)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-3#3)(2013-7#1)
mitogen-inducible##2##1##(1991-10#1)(1992-8#1)
mitogen-stimulated##4##1##(1994-3#1)(1995-12#1)(2008-10#2)
mitogenesis and##4##2##(1993-8#2)(1997-7#2)
mitogenesis in Swiss 3T3 cells##2##5##(1990-2#1)(1997-7#1)
mitogenesis in##7##2##(1990-2#1)(1993-8#2)(1997-7#3)(2008-4#1)
mitogenesis through the##2##3##(1997-7#2)
mitogenesis was##2##2##(1990-11#1)(1994-6#1)
mitogenesis##30##1##(1990-11#2)(1990-2#1)(1991-3#1)(1992-8#1)(1993-8#4)(1994-6#3)(1995-2#1)(1995-8#1)(1997-7#11)(2008-1#1)(2008-4#4)
mitogenic action##2##2##(1995-11#1)(1995-6#1)
mitogenic activity and stability##2##4##(1994-11#2)
mitogenic activity of##5##3##(1990-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
mitogenic activity##14##2##(1990-11#1)(1990-12#1)(1990-4#1)(1992-12#1)(1993-3#1)(1994-11#3)(1995-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)
mitogenic agents##3##2##(1991-1#1)(1992-5#2)
mitogenic and##2##2##(1995-2#1)(2008-5#1)
mitogenic effect of##4##3##(1994-12#1)(1997-1#2)(2008-6#1)
mitogenic effect on##2##3##(2008-11#2)
mitogenic effect##8##2##(1990-12#1)(1994-12#1)(1995-2#1)(1997-1#2)(2008-11#2)(2008-6#1)
mitogenic effects##4##2##(2008-11#1)(2008-6#3)
mitogenic for human##2##3##(1990-2#1)(1992-2#1)
mitogenic for##5##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-2#1)(2010-3#1)
mitogenic peptides##2##2##(1990-11#2)
mitogenic response of##2##3##(1994-12#1)(2008-10#1)
mitogenic response##3##2##(1992-10#1)(1994-12#1)(2008-10#1)
mitogenic signal##3##2##(1990-12#1)(1993-6#1)(2008-4#1)
mitogenic signaling##2##2##(1997-7#1)(2010-12#1)
mitogenic stimuli##2##2##(1990-11#1)(1996-2#1)
mitogenic##69##1##(1990-11#4)(1990-12#5)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-1#2)(1997-7#2)(2008-10#1)(2008-11#7)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-9#2)(2010-12#1)(2010-3#1)(2013-7#1)
mitogens in##2##2##(1991-1#1)(2008-4#1)
mitogens##18##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#4)(2009-5#1)(2011-2#1)
mitomycin C (MMC)##3##3##(1992-12#1)(1997-7#1)(2008-11#1)
mitomycin C and##2##3##(1992-3#1)(1993-8#1)
mitomycin C instillation##3##3##(2008-11#1)(2011-2#2)
mitomycin C##24##2##(1990-2#3)(1992-12#1)(1992-3#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-5#3)(1995-8#1)(1997-7#2)(2008-11#2)(2008-4#1)(2011-2#3)
mitomycin##31##1##(1990-2#3)(1992-12#1)(1992-3#3)(1993-11#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-5#7)(1995-8#1)(1996-2#1)(1997-7#2)(2008-11#2)(2008-4#1)(2011-2#3)
mitomycin-C##2##1##(1991-4#1)(2008-11#1)
mitosenes##2##1##(1995-2#2)
mitoses##9##1##(1992-6#1)(2012-1#1)(2012-3#4)(2013-1#3)
mitosis and##6##2##(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)
mitosis in##6##2##(1993-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)
mitosis##55##1##(1991-2#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-9#3)(1994-8#3)(1995-11#3)(1995-2#3)(1995-6#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#3)(2009-3#2)(2009-5#2)(2009-8#1)(2011-2#5)(2012-12#2)(2012-2#4)(2013-1#1)
mitotane##3##1##(1992-10#3)
mitotic activity and##2##3##(1994-12#1)(2007-12#1)
mitotic activity##6##2##(1991-8#1)(1991-9#1)(1994-12#1)(1995-11#1)(2007-12#1)(2009-1#1)
mitotic and meiotic divisions##3##4##(2008-5#1)(2008-7#1)(2009-10#1)
mitotic and meiotic##6##3##(2007-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)
mitotic and##9##2##(1990-8#1)(1992-12#1)(1995-6#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)
mitotic cell cycle##2##3##(2008-10#2)
mitotic cell##3##2##(2008-10#2)(2008-4#1)
mitotic cells##9##2##(1990-11#2)(1994-8#1)(1995-5#3)(2008-4#1)(2008-9#2)
mitotic chromosomes in##2##3##(2008-1#1)(2008-12#1)
mitotic chromosomes##8##2##(2008-1#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
mitotic count ≥2/10 hpf##2##3##(2011-2#2)
mitotic entry##4##2##(2011-2#1)(2012-12#3)
mitotic figures##8##2##(1997-6#5)(2008-11#1)(2008-6#1)(2008-7#1)
mitotic index (MI)##2##3##(2008-10#1)(2010-1#1)
mitotic index was##2##3##(1993-6#1)(2008-11#1)
mitotic index##8##2##(1993-6#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#2)(2010-1#1)(2012-3#1)
mitotic progression##2##2##(1994-8#2)
mitotic rearrangement##2##2##(1995-8#2)
mitotic recombination##5##2##(1993-12#1)(1994-9#1)(1995-9#1)(2008-10#2)
mitotic spermatogonia##2##2##(2009-10#1)(2012-2#1)
mitotic spindle##7##2##(2008-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#3)
mitotic stability##2##2##(1993-9#1)(2008-10#1)
mitotic##110##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#4)(1995-6#4)(1995-8#2)(1995-9#2)(1996-9#1)(1997-6#6)(1997-8#1)(2007-12#3)(2008-1#6)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#2)(2010-1#1)(2010-3#2)(2010-5#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
mitotically stable##3##2##(1993-9#1)(2008-10#2)
mitotically##8##1##(1990-5#1)(1991-9#1)(1992-9#1)(1993-9#1)(1995-9#2)(2008-10#2)
mitovirus##4##1##(2008-10#4)
mitoxantrone##19##1##(1991-12#2)(1991-4#2)(1991-6#6)(1994-12#1)(1994-8#1)(2008-5#2)(2010-12#1)(2012-3#4)
mitragynaline##4##1##(2011-2#4)
mitragynine##4##1##(2011-2#4)
mitral and aortic##2##3##(2007-8#1)(2011-2#1)
mitral annulus##3##2##(2008-10#3)
mitral cells##5##2##(2012-2#4)(2013-1#1)
mitral insufficiency##3##2##(1990-3#1)(2007-12#1)(2007-8#1)
mitral layer##2##2##(1993-3#2)
mitral leaflet##2##2##(2008-10#2)
mitral position##3##2##(2007-8#1)(2009-12#1)(2013-1#1)
mitral regurgitation (MR)##2##3##(1995-3#1)(2009-4#1)
mitral regurgitation and##3##3##(2008-7#1)(2010-5#1)(2012-2#1)
mitral regurgitation##14##2##(1990-3#1)(1995-3#2)(1997-5#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#3)(2010-5#3)(2012-2#1)
mitral stenosis##5##2##(1994-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
mitral valve disease##2##3##(1994-3#1)(2011-2#1)
mitral valve insufficiency##2##3##(2011-2#1)(2012-2#1)
mitral valve prolapse##2##3##(1992-11#1)(2007-8#1)
mitral valve regurgitation##4##3##(2007-8#3)(2013-1#1)
mitral valve repair##11##3##(2007-8#2)(2008-10#2)(2009-7#1)(2011-2#5)(2013-1#1)
mitral valve replacement in##2##4##(2011-2#2)
mitral valve replacement##8##3##(1990-3#1)(2007-8#2)(2011-2#3)(2012-12#1)(2013-1#1)
mitral valve surgery##3##3##(2007-8#2)(2010-8#1)
mitral valve##60##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-11#1)(1992-9#1)(1994-3#3)(2007-12#2)(2007-8#14)(2008-10#2)(2008-11#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#12)
mitral valve]##2##2##(1990-3#1)(2009-5#1)
mitral valves##3##2##(2007-8#1)(2010-12#2)
mitral valvuloplasty##4##2##(2007-8#1)(2008-12#1)(2011-2#2)
mitral##120##1##(1990-12#1)(1990-3#4)(1990-9#1)(1992-11#1)(1992-9#1)(1993-3#2)(1994-3#4)(1995-3#3)(1997-5#1)(2007-12#3)(2007-8#22)(2008-10#9)(2008-11#3)(2008-12#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#4)(2009-5#2)(2009-7#1)(2010-12#3)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#17)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#16)(2013-7#1)
mitral/tufted cells##2##2##(2009-12#2)
mivacurium in##3##2##(2008-10#3)
mivacurium##4##1##(2008-10#4)
mix and##12##2##(1992-12#2)(1992-3#1)(1993-12#2)(1995-2#1)(1996-12#2)(2007-7#2)(2008-10#1)(2008-2#1)
mix for##2##2##(1992-5#1)(2008-10#1)
mix in##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
mix management##4##2##(1992-12#2)(1994-3#2)
mix measures##3##2##(1995-2#3)
mix of students##2##3##(2008-11#2)
mix of##21##2##(1992-4#1)(1993-1#1)(1993-3#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
mix or##2##2##(2008-10#2)
mix than##2##2##(1991-3#1)(2008-10#1)
mix to##2##2##(1996-1#1)(2008-10#1)
mix was##5##2##(1992-8#1)(2008-10#4)
mix were##3##2##(2008-10#3)
mix with##3##2##(2008-10#3)
mix##159##1##(1991-12#3)(1991-3#1)(1992-12#7)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-3#3)(1994-1#1)(1994-12#3)(1994-3#3)(1995-1#1)(1995-2#23)(1995-3#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(2007-7#2)(2008-10#53)(2008-11#6)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
mix)##2##1##(1992-12#1)(2008-11#1)
mixed LB films##2##3##(2008-10#2)
mixed adlayer##2##2##(2009-6#2)
mixed and the##2##3##(2008-10#2)
mixed and##13##2##(1990-12#1)(2007-11#1)(2008-10#5)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#2)
mixed aza-thioether crowns containing a 1##2##6##(2008-10#2)
mixed by##2##2##(2008-10#1)(2008-11#1)
mixed cation sodalites##3##3##(2008-10#3)
mixed cation##5##2##(2008-10#5)
mixed chimera##2##2##(2013-1#2)
mixed complexes of##2##3##(2008-10#1)(2008-5#1)
mixed complexes##5##2##(2008-10#4)(2008-5#1)
mixed connective tissue disease##2##4##(1991-11#1)(2012-3#1)
mixed cropping##3##2##(2008-10#3)
mixed culture of##2##3##(2008-6#2)
mixed culture##9##2##(2008-6#5)(2008-7#4)
mixed cultures of two genetically engineered Zymomonas mobilis strains##2##9##(2008-6#2)
mixed cultures##13##2##(1997-6#1)(2008-10#3)(2008-6#3)(2011-1#1)(2013-1#5)
mixed cystomas##2##2##(1990-2#2)
mixed dentition##3##2##(2007-12#1)(2012-12#1)(2012-2#1)
mixed dissociation##3##2##(2008-10#2)(2012-12#1)
mixed disulfides##2##2##(1991-9#1)(2008-10#1)
mixed drinks##3##2##(2009-7#1)(2012-2#2)
mixed effects model##2##3##(2008-11#2)
mixed effects models for##2##4##(1997-7#2)
mixed effects models##4##3##(1997-7#3)(2012-3#1)
mixed effects##11##2##(1995-2#1)(1997-4#1)(1997-7#3)(2008-10#1)(2008-11#3)(2012-3#2)
mixed emulsifier##2##2##(2008-5#2)
mixed findings##3##2##(2008-1#1)(2012-1#1)(2012-12#1)
mixed form##2##2##(2008-7#1)(2008-9#1)
mixed function oxidases##2##3##(1990-7#1)(2008-8#1)
mixed genotype infection##2##3##(2008-10#2)
mixed hardwood##2##2##(2013-1#2)
mixed hydrolytic species##2##3##(2008-10#2)
mixed in a##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
mixed in sandy soil at concentrations of##2##7##(2008-10#2)
mixed in suitable proportions##2##4##(1990-12#1)(2008-2#1)
mixed in##16##2##(1990-12#1)(1991-8#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#1)(2013-8#1)
mixed infected##2##2##(2008-10#2)
mixed infection of##2##3##(2008-10#2)
mixed infection with ZYMV##2##4##(2008-10#2)
mixed infection with##5##3##(1996-12#1)(2008-10#4)
mixed infection##11##2##(1996-12#1)(2008-10#9)(2008-5#1)
mixed infections and##2##3##(2007-12#1)(2013-1#1)
mixed infections by##2##3##(2008-10#2)
mixed infections of##6##3##(2008-10#5)(2013-8#1)
mixed infections##23##2##(2007-12#1)(2008-10#18)(2012-3#1)(2013-1#2)(2013-8#1)
mixed interdigitated##3##2##(1990-7#1)(1993-8#2)
mixed into the##2##3##(2008-10#1)(2008-8#1)
mixed into##3##2##(2008-10#1)(2008-8#2)
mixed ion-pair reversed phase##2##4##(2008-10#2)
mixed laser##2##2##(2008-3#2)
mixed light##2##2##(2008-11#2)
mixed liposomes##4##2##(1990-8#1)(1991-5#1)(1994-12#2)
mixed lymphocyte##4##2##(1991-9#1)(1993-9#1)(2008-10#1)(2008-11#1)
mixed meal##5##2##(1994-12#4)(2012-3#1)
mixed method##3##2##(2008-12#1)(2013-1#2)
mixed methods##5##2##(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#2)
mixed micellar medium##2##3##(2008-10#2)
mixed micellar##4##2##(2008-10#4)
mixed micelles is##2##3##(1993-11#1)(2008-10#1)
mixed micelles##11##2##(1990-11#2)(1990-2#1)(1993-11#4)(1994-5#1)(2008-10#2)(2013-1#1)
mixed mode matrices##2##3##(2008-7#2)
mixed mode##3##2##(2008-7#3)
mixed model##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
mixed models##7##2##(2008-10#2)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
mixed modifier components##2##3##(2008-10#2)
mixed monolayers##5##2##(1990-2#4)(2008-10#1)
mixed mullerian##2##2##(2008-6#1)(2011-1#1)
mixed multilayer LB films is##2##5##(2008-10#2)
mixed multilayer##3##2##(2008-10#3)
mixed on-line with ammonium pyrrolidine dithiocarbamate (APDC) and the##2##9##(2008-10#2)
mixed on-line with##5##3##(2008-10#5)
mixed or applied##2##3##(2008-12#2)
mixed or##6##2##(1996-12#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-6#1)
mixed picture##3##2##(2008-10#1)(2008-4#2)
mixed population##5##2##(1992-6#1)(1994-11#1)(1994-9#1)(1995-5#1)(2008-10#1)
mixed populations of##2##3##(2008-5#1)(2008-8#1)
mixed populations##4##2##(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
mixed results##7##2##(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)
mixed samples##4##2##(1990-8#1)(1996-7#1)(2008-10#1)(2008-12#1)
mixed signals##3##2##(2008-10#3)
mixed solution of##4##3##(2008-10#4)
mixed solution##10##2##(2008-10#10)
mixed solutions##2##2##(2008-10#2)
mixed solvent of##2##3##(2008-10#2)
mixed solvent##8##2##(2008-10#8)
mixed solvents##12##2##(1990-8#2)(2008-10#10)
mixed strategy##3##2##(2008-8#3)
mixed surfactant##2##2##(2008-10#2)
mixed thoroughly##2##2##(2008-8#1)(2009-7#1)
mixed to##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
mixed together##3##2##(1992-8#1)(2008-10#1)(2008-9#1)
mixed tungsten##2##2##(2008-10#2)
mixed type##7##2##(1990-11#1)(1990-12#1)(1990-2#2)(1995-4#1)(1996-6#1)(2011-1#1)
mixed valence form of##2##4##(1991-5#2)
mixed valence##3##2##(1991-5#2)(2009-5#1)
mixed venous##2##2##(1997-5#1)(2010-8#1)
mixed vesicles##3##2##(1994-12#3)
mixed viral##2##2##(2008-10#2)
mixed virus infection##2##3##(2008-10#2)
mixed virus##3##2##(2008-10#3)
mixed with 0##3##3##(2008-10#3)
mixed with 100##2##3##(2008-10#1)(2008-3#1)
mixed with HCl-iodine##2##3##(2008-10#2)
mixed with a large##2##4##(2008-2#1)(2008-8#1)
mixed with a##7##3##(1994-5#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-8#1)
mixed with fibrin##4##3##(2008-11#4)
mixed with the##14##3##(1995-3#1)(2008-10#10)(2008-3#1)(2010-5#1)(2011-1#1)
mixed with various##2##3##(2008-10#2)
mixed with##88##2##(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-1#1)(1994-5#3)(1994-8#1)(1995-3#1)(1997-6#1)(2007-12#1)(2007-5#2)(2008-10#44)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#2)
mixed α##2##2##(2013-1#2)
mixed##665##1##(1990-11#5)(1990-12#5)(1990-2#14)(1990-7#2)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#5)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#3)(1992-8#3)(1993-11#7)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#12)(1994-2#1)(1994-5#5)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#4)(2007-10#2)(2007-11#6)(2007-12#6)(2007-5#3)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#257)(2008-11#17)(2008-12#10)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#12)(2008-7#19)(2008-8#17)(2008-9#14)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#13)(2011-2#13)(2011-3#2)(2012-1#2)(2012-12#9)(2012-2#17)(2012-3#11)(2012-5#2)(2013-1#33)(2013-8#6)
mixed-bed##2##1##(2008-10#2)
mixed-chain phosphatidylcholines##8##2##(1990-7#8)
mixed-chain phospholipids are##2##3##(1990-7#2)
mixed-chain##11##1##(1990-7#11)
mixed-composite material##2##2##(2008-2#2)
mixed-composite##3##1##(2008-2#3)
mixed-conifer##2##1##(2008-10#2)
mixed-family groups##2##2##(2010-8#2)
mixed-field agglutination##2##2##(1992-9#2)
mixed-field##6##1##(1992-6#1)(1992-9#5)
mixed-function##3##1##(1990-7#1)(1996-12#1)(2008-8#1)
mixed-grade classrooms##2##2##(2008-12#2)
mixed-handedness##2##1##(1995-11#2)
mixed-iodide##2##1##(2008-10#2)
mixed-metal complexes##2##2##(2008-10#2)
mixed-metal##3##1##(2008-10#3)
mixed-method##2##1##(2009-5#2)
mixed-methods approach##2##2##(2008-12#1)(2013-8#1)
mixed-methods##4##1##(2008-12#1)(2009-7#1)(2010-10#1)(2013-8#1)
mixed-mode##5##1##(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)
mixed-nativity##4##1##(2011-2#4)
mixed-phase##4##1##(2008-2#3)(2012-3#1)
mixed-species microarray##2##2##(2011-2#2)
mixed-species##4##1##(2008-8#1)(2011-2#3)
mixed-substrate maximum specific growth##2##4##(2008-7#2)
mixed-substrate##4##1##(1990-5#1)(2008-7#3)
mixed-type##3##1##(1992-8#1)(2008-6#1)(2008-7#1)
mixer##13##1##(1993-2#1)(2007-12#1)(2008-10#2)(2008-5#3)(2008-7#2)(2009-4#1)(2010-5#2)(2011-1#1)
mixes prepared with##2##3##(2008-10#2)
mixes with a##2##3##(2008-10#1)(2011-2#1)
mixes with##5##2##(2008-10#4)(2011-2#1)
mixes##24##1##(1995-5#1)(1997-3#1)(2008-10#17)(2008-3#1)(2009-11#1)(2010-4#1)(2011-2#2)
mixing and##16##2##(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#1)(2010-4#1)
mixing as a##3##3##(1990-4#1)(2007-11#1)(2008-3#1)
mixing between the##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
mixing between##9##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#3)(2010-8#1)
mixing chamber##3##2##(2008-10#3)
mixing coil##3##2##(2008-10#3)
mixing conditions##3##2##(2008-10#3)
mixing efficiency##9##2##(2007-11#2)(2008-2#7)
mixing for##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
mixing in a cerium-doped potassium sodium strontium barium niobate (Ce##2##10##(2007-12#1)(2008-3#1)
mixing in a cerium-doped potassium sodium strontium barium niobate##3##9##(2007-12#1)(2008-3#2)
mixing in a##17##3##(2007-10#1)(2007-11#4)(2007-12#7)(2008-10#2)(2008-2#1)(2008-3#2)
mixing in an##7##3##(2007-11#1)(2007-12#3)(2008-2#3)
mixing in microstructure fiber##3##4##(2007-11#2)(2007-12#1)
mixing in the##2##3##(2007-11#1)(2008-10#1)
mixing in##51##2##(2007-10#2)(2007-11#14)(2007-12#14)(2008-10#4)(2008-2#7)(2008-3#10)
mixing induced by gas##2##4##(2008-6#2)
mixing is##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
mixing it with##3##3##(2007-11#1)(2008-10#2)
mixing it##4##2##(2007-11#1)(2008-10#3)
mixing of the##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
mixing of two##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
mixing of##25##2##(1995-5#1)(1997-7#1)(2007-11#4)(2007-12#5)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#1)(2010-8#1)
mixing on##2##2##(2008-3#1)(2008-6#1)
mixing pattern##2##2##(1992-9#1)(1997-3#1)
mixing process##7##2##(2007-11#1)(2007-12#2)(2008-3#3)(2008-5#1)
mixing processes##3##2##(2008-2#2)(2008-8#1)
mixing ratio of##3##3##(2008-2#1)(2013-1#2)
mixing ratio profiles##2##3##(2008-3#2)
mixing ratio##17##2##(2008-2#1)(2008-3#12)(2010-5#1)(2013-1#3)
mixing ratios on##2##3##(2010-5#1)(2013-1#1)
mixing ratios##6##2##(2008-10#2)(2008-3#2)(2010-5#1)(2013-1#1)
mixing scheme##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mixing speed and time##4##4##(2008-5#4)
mixing technique with##2##3##(2007-11#1)(2008-10#1)
mixing technique##9##2##(2007-11#1)(2008-10#8)
mixing the reagents##3##3##(2008-10#3)
mixing the##14##2##(1993-8#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-5#1)(2009-6#1)
mixing time and##2##3##(2008-5#1)(2008-7#1)
mixing time##7##2##(2007-10#1)(2008-5#2)(2008-7#4)
mixing times##2##2##(2008-11#1)(2008-7#1)
mixing was##2##2##(1997-2#1)(2008-10#1)
mixing with a##3##3##(2007-12#2)(2008-3#1)
mixing with the##2##3##(2008-10#1)(2009-7#1)
mixing with##17##2##(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2009-7#1)(2011-1#1)
mixing zone##2##2##(2008-10#2)
mixing##360##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-9#1)(1992-9#2)(1993-8#1)(1994-5#1)(1994-9#1)(1995-5#2)(1997-2#3)(1997-3#2)(1997-7#2)(2007-10#6)(2007-11#49)(2007-12#49)(2008-1#1)(2008-10#80)(2008-11#5)(2008-12#1)(2008-2#40)(2008-3#52)(2008-4#1)(2008-5#13)(2008-6#9)(2008-7#9)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#6)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#6)
mixing-ratio measurements##2##2##(2007-12#2)
mixture analysis##3##2##(2008-10#3)
mixture and the##3##3##(1995-8#1)(2008-10#2)
mixture and##25##2##(1992-4#1)(1995-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#3)
mixture as a mobile phase##2##5##(2008-10#2)
mixture as a##3##3##(2008-10#3)
mixture as##5##2##(2008-10#5)
mixture at##4##2##(2008-10#3)(2008-5#1)
mixture by##5##2##(2008-10#5)
mixture can be##2##3##(2008-10#2)
mixture can##3##2##(2008-10#3)
mixture components##2##2##(1994-9#1)(2008-10#1)
mixture composition##2##2##(2008-10#1)(2008-2#1)
mixture consisting of##4##3##(2008-10#3)(2008-7#1)
mixture containing##15##2##(1993-3#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)
mixture could##2##2##(2008-10#1)(2008-3#1)
mixture designs##2##2##(2008-10#2)
mixture for##3##2##(1990-12#1)(2008-10#1)(2008-4#1)
mixture from##5##2##(1990-2#1)(1995-3#1)(2008-9#2)(2013-8#1)
mixture has##3##2##(2008-10#2)(2008-5#1)
mixture have##2##2##(2008-10#1)(2013-8#1)
mixture in the##5##3##(1997-8#1)(2007-12#1)(2008-10#3)
mixture in##6##2##(1997-8#1)(2007-12#1)(2008-10#3)(2008-2#1)
mixture into##2##2##(1994-12#1)(2008-10#1)
mixture is the##2##3##(1993-8#1)(2008-10#1)
mixture is##16##2##(1990-12#2)(1991-5#1)(1993-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)
mixture model##2##2##(2010-9#1)(2013-1#1)
mixture modelling framework##2##3##(2012-3#2)
mixture of 0##6##3##(2008-10#4)(2010-3#1)(2010-5#1)
mixture of 2-propanol with water##2##5##(2008-10#2)
mixture of 2-propanol##3##3##(2008-10#3)
mixture of 5%##2##3##(2008-10#2)
mixture of HNO(3)##2##3##(2008-10#2)
mixture of a##4##3##(1990-9#1)(2008-10#1)(2010-3#1)(2013-1#1)
mixture of acetone##2##3##(2008-10#2)
mixture of all##2##3##(2008-10#2)
mixture of both##5##3##(1990-5#1)(2008-10#4)
mixture of compounds##2##3##(2008-10#2)
mixture of concentrated##2##3##(2008-10#2)
mixture of ethyl acetate##2##4##(2008-10#1)(2012-2#1)
mixture of ethyl##3##3##(2008-10#2)(2012-2#1)
mixture of five##4##3##(2008-10#3)(2008-11#1)
mixture of free TNT##2##4##(2008-10#2)
mixture of free##3##3##(2008-10#3)
mixture of lysozyme and ovalbumin##2##5##(2008-7#2)
mixture of oxygen and##3##4##(2007-11#1)(2007-8#1)(2008-6#1)
mixture of phenols##2##3##(2008-10#2)
mixture of regioisomers##2##3##(2009-12#1)(2010-7#1)
mixture of six##3##3##(2008-10#2)(2013-1#1)
mixture of sodium bicarbonate and tartaric acid (each of 12%##2##10##(2010-3#2)
mixture of sodium##3##3##(1997-2#1)(2010-3#2)
mixture of the three##2##4##(2008-10#2)
mixture of the two for##2##5##(1994-2#1)(2008-10#1)
mixture of the two##7##4##(1994-2#1)(2007-6#1)(2008-10#4)(2008-9#1)
mixture of the##20##3##(1990-7#1)(1994-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-8#1)(2008-9#1)
mixture of three##2##3##(1990-12#1)(2008-11#1)
mixture of trace##3##3##(1994-8#1)(2008-10#2)
mixture of two##2##3##(1990-3#1)(2008-10#1)
mixture of##304##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#175)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#5)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
mixture on##3##2##(1997-7#1)(2008-10#1)(2009-4#1)
mixture or##3##2##(1994-6#1)(1997-4#1)(2009-11#1)
mixture ratio##2##2##(2008-10#1)(2008-3#1)
mixture samples##3##2##(2008-10#3)
mixture solution##4##2##(2008-10#4)
mixture solutions in##2##3##(2008-10#2)
mixture solutions##5##2##(2008-10#5)
mixture the##2##2##(2008-10#2)
mixture to##8##2##(1991-5#1)(2007-11#2)(2008-10#5)
mixture using##3##2##(2008-10#3)
mixture was found to be##3##5##(2008-10#3)
mixture was found to##5##4##(2008-10#5)
mixture was used##3##3##(1993-11#1)(2008-9#2)
mixture was##30##2##(1990-2#2)(1991-2#1)(1993-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#17)(2008-5#1)(2008-9#3)(2010-4#1)
mixture were##7##2##(1990-12#1)(1994-5#1)(2008-10#4)(2008-11#1)
mixture where##2##2##(2008-10#2)
mixture with the##2##3##(1994-12#1)(1997-4#1)
mixture with##12##2##(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1997-4#2)(2008-10#4)(2008-8#1)(2008-9#1)
mixture without##2##2##(2008-10#1)(2008-5#1)
mixture##689##1##(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#4)(1997-2#3)(1997-4#5)(1997-7#3)(1997-8#4)(2006-6#1)(2007-11#5)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#404)(2008-11#14)(2008-12#7)(2008-2#14)(2008-3#11)(2008-4#7)(2008-5#17)(2008-6#10)(2008-7#11)(2008-8#10)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#7)(2013-8#3)
mixture)##4##1##(1990-8#1)(2008-10#2)(2008-12#1)
mixtures and commercial formulations were##2##5##(2008-10#2)
mixtures and subsequent##2##3##(2008-10#1)(2008-5#1)
mixtures and the##7##3##(2008-10#6)(2008-5#1)
mixtures and##36##2##(1990-12#1)(2008-10#29)(2008-2#1)(2008-3#1)(2008-5#4)
mixtures are##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
mixtures as eluents##3##3##(1990-8#1)(1996-5#2)
mixtures as well as##2##4##(2008-10#2)
mixtures as well##3##3##(2008-10#3)
mixtures as##10##2##(1990-8#1)(1994-3#1)(1996-5#2)(2008-10#5)(2008-2#1)
mixtures at##7##2##(2008-10#5)(2008-12#1)(2010-4#1)
mixtures by using spectrophotometric methods is a difficult problem in analytical chemistry##2##12##(2008-10#2)
mixtures by using##3##3##(2008-10#3)
mixtures by##11##2##(1994-9#1)(1995-11#1)(2008-10#9)
mixtures can be##2##3##(2008-2#2)
mixtures can##4##2##(2008-10#2)(2008-2#2)
mixtures composed of##2##3##(2008-10#1)(2013-8#1)
mixtures containing##21##2##(1992-3#1)(1994-3#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
mixtures developed##2##2##(2008-10#2)
mixtures followed by##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
mixtures followed##4##2##(1994-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
mixtures for the##3##3##(2008-10#3)
mixtures for##9##2##(1992-5#1)(2008-10#6)(2008-11#1)(2008-8#1)
mixtures from##2##2##(2008-10#2)
mixtures has been##2##3##(2008-10#2)
mixtures have been##2##3##(2008-10#1)(2008-3#1)
mixtures have##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
mixtures in reducing##2##3##(2008-10#2)
mixtures in the##5##3##(2008-10#4)(2008-4#1)
mixtures in##20##2##(1990-5#1)(1996-5#1)(2008-10#15)(2008-3#1)(2008-4#2)
mixtures is##4##2##(2008-10#3)(2009-7#1)
mixtures of 3-phenyl-4-benzoyl-5-isoxazolone##2##3##(2008-10#2)
mixtures of both##2##3##(2008-10#1)(2012-7#1)
mixtures of host genotypes##2##4##(2008-10#2)
mixtures of organic##2##3##(2008-7#2)
mixtures of the two##2##4##(1994-5#1)(2008-10#1)
mixtures of the##11##3##(1994-5#1)(2007-11#1)(2008-10#7)(2008-4#1)(2009-11#1)
mixtures of these##5##3##(2008-10#5)
mixtures of three##3##3##(2008-10#2)(2008-3#1)
mixtures of two##5##3##(2008-10#2)(2008-12#2)(2011-1#1)
mixtures of various##2##3##(2008-10#2)
mixtures of weak acids##2##4##(2008-10#1)(2008-9#1)
mixtures of##167##2##(1990-12#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#109)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#7)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-7#1)
mixtures on##2##2##(2008-10#2)
mixtures or##2##2##(2008-10#2)
mixtures such as##2##3##(2008-10#1)(2008-4#1)
mixtures that are##2##3##(1994-9#1)(2008-10#1)
mixtures thereof##2##2##(1990-8#1)(2008-7#1)
mixtures to##5##2##(1994-3#1)(2007-11#1)(2008-10#3)
mixtures under##3##2##(2008-10#3)
mixtures used for##2##3##(2008-10#2)
mixtures used##4##2##(2008-10#4)
mixtures using a##2##3##(1992-10#1)(2008-10#1)
mixtures using the##2##3##(2008-10#2)
mixtures using##15##2##(1991-12#1)(1992-10#1)(2008-1#1)(2008-10#11)(2011-2#1)
mixtures was investigated##2##3##(2008-10#1)(2011-2#1)
mixtures was##8##2##(1994-3#1)(2008-10#6)(2011-2#1)
mixtures were analyzed##2##3##(1995-5#1)(2008-10#1)
mixtures were studied##6##3##(1990-5#1)(2008-10#3)(2008-2#1)(2011-2#1)
mixtures were used to##2##4##(2008-10#2)
mixtures were used##3##3##(2008-10#3)
mixtures were##26##2##(1990-5#1)(1993-8#1)(1995-5#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
mixtures with different##2##3##(1996-2#1)(2008-10#1)
mixtures with high##2##3##(2007-12#1)(2008-5#1)
mixtures with similar##2##3##(1994-12#1)(2008-10#1)
mixtures with water##2##3##(2008-10#2)
mixtures with##28##2##(1994-12#2)(1996-2#1)(2007-12#2)(2008-10#21)(2008-3#1)(2008-5#1)
mixtures without##2##2##(2008-10#2)
mixtures##597##1##(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-5#3)(1992-6#1)(1993-8#4)(1994-12#3)(1994-3#7)(1994-5#1)(1994-9#2)(1995-11#1)(1995-3#3)(1995-5#2)(1996-12#2)(1996-2#1)(1996-5#5)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#5)(2007-12#9)(2008-1#2)(2008-10#411)(2008-11#5)(2008-12#9)(2008-2#13)(2008-3#15)(2008-4#8)(2008-5#17)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#5)(2012-3#1)(2012-7#1)(2013-8#5)
mixtures' components##2##2##(2013-8#2)
mixtures'##3##1##(2008-10#1)(2013-8#2)
mixtures)##3##1##(2008-10#2)(2008-6#1)
miyabeanus##13##1##(2008-10#13)
mkmol/l##2##1##(2011-1#2)
ml (1##2##2##(2008-10#1)(2008-5#1)
ml 10kg-1 body weight per animal##2##6##(1996-12#2)
ml 48% HF and##2##4##(2008-10#2)
ml aliquot of##2##3##(2008-10#2)
ml and##11##2##(1990-2#1)(1993-2#1)(1993-3#1)(2008-10#5)(2008-11#1)(2010-5#2)
ml aqueous##3##2##(2008-10#3)
ml at##3##2##(1994-5#1)(1995-6#1)(2008-10#1)
ml bags)##2##2##(2008-11#2)
ml before##2##2##(1990-2#1)(2007-8#1)
ml fRBCs##3##2##(2011-2#3)
ml for the##2##3##(2008-10#2)
ml for##7##2##(2008-1#1)(2008-10#3)(2008-7#2)(2011-2#1)
ml in a##2##3##(2008-10#1)(2008-11#1)
ml in##5##2##(1991-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
ml instead of##2##3##(2008-10#2)
ml kg(-1))##2##2##(2008-10#2)
ml min(-1) and##4##3##(2008-10#4)
ml min(-1) at##2##3##(2008-10#2)
ml min(-1) flow rate##2##4##(2008-10#2)
ml min(-1) flow##3##3##(2008-10#3)
ml min(-1) for##7##3##(2008-10#7)
ml min(-1) the##2##3##(2008-10#2)
ml min(-1)##69##2##(2008-10#68)(2010-4#1)
ml min(-1)) and##2##3##(2008-10#2)
ml min(-1))##8##2##(2008-10#7)(2010-4#1)
ml of 0##9##3##(1995-3#1)(2008-10#8)
ml of 1 M##3##4##(2008-10#3)
ml of 1##7##3##(2008-10#7)
ml of 2##3##3##(2008-10#2)(2008-7#1)
ml of 2%##2##3##(2008-10#2)
ml of 4 M##3##4##(2008-10#3)
ml of 5%##2##3##(1992-5#1)(2007-7#1)
ml of 50%##2##3##(1994-5#1)(2008-10#1)
ml of 6 M##2##4##(2008-10#2)
ml of a##7##3##(2008-10#6)(2008-2#1)
ml of aqueous##2##3##(2008-10#2)
ml of blood##2##3##(1993-3#1)(2013-1#1)
ml of digested blood##2##4##(2008-10#2)
ml of digested sample##2##4##(2008-10#2)
ml of digested##4##3##(2008-10#4)
ml of irrigation##2##3##(2008-10#2)
ml of methanol##3##3##(2008-10#3)
ml of methanol-acetate buffer##2##4##(2008-10#2)
ml of sample solution is##2##5##(2008-10#2)
ml of sample solution##6##4##(2008-10#6)
ml of sample##12##3##(2008-10#12)
ml of serum##2##3##(1992-3#1)(2008-10#1)
ml of the final DMF solution##3##6##(2008-10#3)
ml of the##5##3##(2008-10#5)
ml of virus harvest##2##4##(2008-11#2)
ml of water sample##2##4##(2008-10#2)
ml of water##4##3##(2008-10#3)(2008-5#1)
ml of##136##2##(1990-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(2007-7#1)(2008-10#109)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
ml per##2##2##(2007-11#1)(2008-1#1)
ml saline##2##2##(1996-2#1)(2011-2#1)
ml sample consumed per determination##2##5##(2008-10#2)
ml sample volume##7##3##(2008-10#7)
ml sample##17##2##(1994-2#1)(2008-10#16)
ml solution##2##2##(2008-10#2)
ml solvent##2##2##(1994-9#1)(2008-10#1)
ml spinner flask##2##3##(2008-11#2)
ml sterile water with##2##4##(1996-12#2)
ml volume##2##2##(2008-10#2)
ml was##3##2##(1993-3#1)(2008-10#2)
ml##413##1##(1990-11#1)(1990-2#3)(1991-2#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#4)(1993-3#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#4)(1996-2#2)(1996-9#1)(1997-1#2)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#305)(2008-11#15)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#3)(2010-5#5)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)
ml(-1) (0##2##2##(2008-10#2)
ml(-1) (3##2##2##(2008-10#2)
ml(-1) (3S/N)##2##2##(2008-10#2)
ml(-1) (S/N=3)##5##2##(2008-10#5)
ml(-1) (r=0##4##2##(2008-10#4)
ml(-1) and 0##6##3##(2008-10#6)
ml(-1) and 1##8##3##(2008-10#8)
ml(-1) and a sample##2##4##(2008-10#2)
ml(-1) and a##5##3##(2008-10#4)(2008-11#1)
ml(-1) and the detection limit is##2##6##(2008-10#2)
ml(-1) and the detection limit was 0##2##7##(2008-10#2)
ml(-1) and the detection limit was##3##6##(2008-10#3)
ml(-1) and the detection limit##5##5##(2008-10#5)
ml(-1) and the relative standard deviation##4##6##(2008-10#4)
ml(-1) and the relative standard##6##5##(2008-10#6)
ml(-1) and the##23##3##(2008-10#23)
ml(-1) and##58##2##(2008-10#57)(2008-11#1)
ml(-1) at##2##2##(2008-10#2)
ml(-1) by##2##2##(2008-10#2)
ml(-1) can be determined##2##4##(2008-10#2)
ml(-1) can be##3##3##(2008-10#3)
ml(-1) concentration##3##2##(2008-10#2)(2008-11#1)
ml(-1) each##3##2##(2008-10#3)
ml(-1) for 2##3##3##(2008-10#2)(2008-11#1)
ml(-1) for Mn(II)##2##3##(2008-10#2)
ml(-1) for calf thymus DNA##5##5##(2008-10#5)
ml(-1) for each##4##3##(2008-10#4)
ml(-1) for fish sperm DNA##5##5##(2008-10#5)
ml(-1) for human##2##3##(2008-10#2)
ml(-1) for nitrite##2##3##(2008-10#2)
ml(-1) for the##6##3##(2008-10#6)
ml(-1) for yeast RNA##5##4##(2008-10#5)
ml(-1) for##108##2##(2008-10#107)(2008-11#1)
ml(-1) in the##4##3##(2008-10#3)(2008-11#1)
ml(-1) in##12##2##(2008-10#9)(2008-11#3)
ml(-1) is##5##2##(2008-10#5)
ml(-1) level were##4##3##(2008-10#4)
ml(-1) level##10##2##(2008-10#10)
ml(-1) levels in##2##3##(2008-10#1)(2008-11#1)
ml(-1) levels##5##2##(2008-10#4)(2008-11#1)
ml(-1) nitrite##3##2##(2008-10#3)
ml(-1) of CTAB##2##3##(2008-11#2)
ml(-1) of iron##2##3##(2008-10#2)
ml(-1) of manganese##3##3##(2008-10#3)
ml(-1) of mercury##2##3##(2008-10#2)
ml(-1) of mercury(II)##2##3##(2008-10#2)
ml(-1) of nitrite##4##3##(2008-10#4)
ml(-1) of selenium##2##3##(2008-10#2)
ml(-1) of##75##2##(2008-10#71)(2008-11#4)
ml(-1) on##3##2##(2008-10#2)(2008-11#1)
ml(-1) range##4##2##(2008-10#4)
ml(-1) the##3##2##(2008-10#2)(2008-11#1)
ml(-1) to##3##2##(2008-10#1)(2008-11#2)
ml(-1) using##3##2##(2008-10#2)(2008-11#1)
ml(-1) vanadium##4##2##(2008-10#4)
ml(-1) was##6##2##(2008-10#5)(2008-11#1)
ml(-1) were obtained##2##3##(2008-10#1)(2008-11#1)
ml(-1) were##4##2##(2008-10#3)(2008-11#1)
ml(-1) when##2##2##(2008-10#2)
ml(-1) with a detection limit of 0##4##7##(2008-10#4)
ml(-1) with a detection limit of 6##2##7##(2008-10#2)
ml(-1) with a detection limit of##10##6##(2008-10#10)
ml(-1) with a limit of detection of 0##2##8##(2008-10#2)
ml(-1) with a limit of detection of##3##7##(2008-10#3)
ml(-1) with a limit of detection##5##6##(2008-10#5)
ml(-1) with a relative standard deviation of##2##7##(2008-10#2)
ml(-1) with a relative standard deviation##3##6##(2008-10#3)
ml(-1) with a##22##3##(2008-10#22)
ml(-1) with an##2##3##(2008-10#2)
ml(-1) with detection limits##2##4##(2008-10#2)
ml(-1) with detection##3##3##(2008-10#3)
ml(-1) with##34##2##(2008-10#33)(2008-11#1)
ml(-1)##706##1##(2008-10#646)(2008-11#59)(2008-5#1)
ml(-1)) and a detection limit of##2##6##(2008-10#2)
ml(-1)) and##16##2##(2008-10#15)(2008-11#1)
ml(-1)) or##2##2##(2008-10#2)
ml(-1)) to##2##2##(2008-10#2)
ml(-1)) were##2##2##(2008-10#2)
ml(-1)) with##2##2##(2008-10#1)(2008-11#1)
ml(-1))##66##1##(2008-10#54)(2008-11#12)
ml(-1)and the##2##2##(2008-10#1)(2008-11#1)
ml) and the##2##3##(2008-7#2)
ml) and##5##2##(2008-10#2)(2008-11#1)(2008-7#2)
ml) at##3##2##(2008-10#2)(2008-2#1)
ml) is##2##2##(2008-10#2)
ml) of##3##2##(2008-10#3)
ml) was##3##2##(1993-9#1)(2008-10#2)
ml) were##2##2##(1993-2#1)(2008-10#1)
ml)##36##1##(1993-2#1)(1993-3#1)(1993-9#1)(1997-2#1)(2007-7#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-5#4)(2008-7#2)(2011-2#3)(2013-1#1)
ml-1 and##2##2##(1990-5#1)(1996-2#1)
ml-1 of beads##3##3##(1997-2#3)
ml-1 of##4##2##(1997-2#4)
ml-1##23##1##(1990-5#1)(1990-8#4)(1994-5#5)(1995-11#1)(1996-12#1)(1996-2#7)(1997-2#4)
ml-1)##11##1##(1990-5#1)(1992-3#2)(1994-3#1)(1995-5#5)(1996-2#1)(2008-11#1)
ml/100##3##1##(2007-10#2)(2008-7#1)
ml/kg##7##1##(1994-5#1)(1995-3#2)(2008-10#2)(2008-4#2)
ml/kg)##4##1##(1992-5#1)(1994-5#1)(2008-7#2)
ml/m2 in patients with AR##2##5##(1995-3#2)
ml/m2 in those with MR (P = 0##2##8##(1995-3#2)
ml/m2 in##4##2##(1995-3#4)
ml/min for##2##2##(2008-4#2)
ml/min##23##1##(1991-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-2#3)(2007-8#3)(2008-10#3)(2008-4#5)(2009-8#2)(2010-3#2)(2012-2#1)
ml/min) and##2##2##(2008-10#1)(2008-7#1)
ml/min)##5##1##(2007-7#1)(2008-10#2)(2008-7#2)
mlambda rms##2##2##(2008-3#2)
mlmin(-1)##7##1##(2008-10#7)
mlrA##5##1##(1994-12#5)
mlt1##3##1##(2012-3#3)
mm (+/-##2##2##(2012-2#2)
mm (No##2##2##(2007-8#2)
mm (range##7##2##(1995-3#2)(2008-7#1)(2008-9#2)(2013-8#2)
mm 3 ±##4##3##(2013-8#4)
mm FWHM##2##2##(1994-5#1)(2012-12#1)
mm Hg after##2##3##(1992-6#1)(1995-12#1)
mm Hg and##5##3##(1995-12#1)(2007-9#2)(2008-11#1)(2010-4#1)
mm Hg it was##2##4##(1997-5#2)
mm Hg pCO2##2##3##(2008-11#2)
mm Hg with##3##3##(1994-11#2)(2008-11#1)
mm Hg##40##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-5#2)(1992-6#1)(1994-11#2)(1994-6#1)(1995-12#2)(1996-6#1)(1997-5#2)(2007-10#2)(2007-9#2)(2008-1#2)(2008-11#7)(2008-3#2)(2008-5#3)(2010-4#5)(2011-1#1)(2013-8#2)
mm Hg)##9##2##(1990-3#1)(1991-5#1)(1994-11#1)(1995-12#1)(2007-10#2)(2009-5#1)(2010-4#1)(2013-8#1)
mm I##8##2##(1990-8#1)(1991-5#3)(1996-5#2)(1997-2#2)
mm Phi##2##2##(2008-10#2)
mm after##4##2##(1996-6#1)(2007-2#1)(2008-7#1)(2011-2#1)
mm and 23##2##3##(1992-5#1)(2013-1#1)
mm and 3##2##3##(2013-1#2)
mm and a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
mm and an##2##3##(2008-2#1)(2008-3#1)
mm and the mean##2##4##(2007-8#1)(2008-2#1)
mm and the##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
mm and##41##2##(1992-5#1)(1994-7#1)(1996-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#7)(2008-3#7)(2008-5#2)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#8)
mm apart##2##2##(2007-12#1)(2008-3#1)
mm aperture##2##2##(2008-3#2)
mm at the##3##3##(1994-9#1)(2008-8#1)(2012-12#1)
mm at##8##2##(1992-9#2)(1994-9#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-8#1)(2012-12#1)
mm beyond the tip##2##4##(1995-2#2)
mm beyond the##3##3##(1995-2#3)
mm by##3##2##(1991-1#1)(1996-6#1)(2008-7#1)
mm can be##2##3##(2007-12#1)(2008-3#1)
mm cumulative evaporation from class A evaporation##2##7##(2008-12#2)
mm day(-1) (January) to 0##2##5##(2010-8#2)
mm day(-1)##6##2##(2008-10#2)(2010-8#4)
mm diameter and##2##3##(1990-2#2)
mm diameter wire was##2##4##(2007-8#2)
mm diameter wire##3##3##(2007-8#3)
mm diameter##13##2##(1990-2#3)(1990-7#1)(1991-2#1)(2007-8#3)(2008-10#1)(2009-5#1)(2009-8#2)(2012-2#1)
mm for both##2##3##(2008-12#1)(2013-1#1)
mm for steel wire and UHMWPE cable##2##7##(2009-3#2)
mm for the##3##3##(2007-7#1)(2008-12#1)(2010-7#1)
mm for##19##2##(1993-1#1)(2007-7#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-2#2)(2009-3#2)(2010-7#1)(2011-1#3)(2012-1#1)(2013-1#1)
mm from a##2##3##(2008-2#1)(2008-3#1)
mm from the center of the dish were 6 and##2##10##(2011-2#2)
mm from the##8##3##(1990-7#1)(1992-1#1)(1994-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#2)
mm from##11##2##(1990-7#1)(1992-1#1)(1994-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#2)
mm h(-1)##2##2##(2008-10#2)
mm have##2##2##(2008-3#1)(2008-5#1)
mm height and##2##3##(2012-2#1)(2013-1#1)
mm height##3##2##(2009-12#1)(2012-2#1)(2013-1#1)
mm high##2##2##(2008-3#2)
mm i##14##2##(2008-10#12)(2008-5#1)(2010-3#1)
mm in diameter and##5##4##(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)
mm in diameter were##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
mm in diameter##26##3##(1990-11#1)(1995-12#4)(2007-8#2)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
mm in diameter) and##2##4##(2008-10#2)
mm in diameter)##6##3##(2008-10#5)(2013-1#1)
mm in dimension##3##3##(2007-8#2)(2008-10#1)
mm in length##5##3##(2007-12#1)(2008-10#1)(2008-8#2)(2013-1#1)
mm in size##5##3##(1990-2#2)(1994-5#1)(2007-12#1)(2008-3#1)
mm in the first##2##4##(1990-11#1)(2010-12#1)
mm in the##11##3##(1990-11#1)(2007-11#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-7#1)
mm in##69##2##(1990-11#2)(1990-2#2)(1991-2#1)(1994-5#1)(1995-12#5)(2007-11#2)(2007-12#2)(2007-8#4)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#2)(2009-4#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#3)
mm inhibition zone by##2##4##(2008-8#2)
mm internal##2##2##(2008-10#2)
mm is##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
mm long##8##2##(1990-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
mm of the##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
mm of##12##2##(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
mm or##6##2##(1990-5#1)(1992-5#2)(2008-10#1)(2008-2#1)(2008-8#1)
mm path length##2##3##(2008-10#2)
mm path##3##2##(2008-10#3)
mm ranging from##3##3##(2010-8#1)(2013-8#2)
mm respectively and##2##3##(2013-1#2)
mm respectively##7##2##(2009-2#1)(2013-1#6)
mm standard length (L(S))##2##4##(2010-8#2)
mm standard##4##2##(2008-11#1)(2008-5#1)(2010-8#2)
mm thick)##4##2##(2008-10#1)(2009-7#2)(2010-9#1)
mm to 25##2##3##(2007-11#1)(2009-3#1)
mm to##10##2##(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-3#1)(2009-7#1)(2012-1#1)
mm total length##4##3##(2007-5#1)(2009-4#1)(2010-8#2)
mm was used##2##3##(2007-12#1)(2008-2#1)
mm was##4##2##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#1)
mm were##2##2##(2008-11#1)(2013-1#1)
mm with a##2##3##(2008-2#1)(2011-2#1)
mm with##5##2##(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#2)
mm x 0##4##3##(2008-2#2)(2008-3#1)(2011-1#1)
mm x 1##4##3##(2007-11#1)(2008-3#2)(2011-1#1)
mm x 2##3##3##(2008-3#1)(2011-1#1)(2011-3#1)
mm x 3 mm I##2##5##(1991-5#2)
mm x 3 mm##5##4##(1991-5#2)(2008-3#3)
mm x 4 mm##3##4##(2007-12#3)
mm x 4##7##3##(1991-5#1)(1997-2#1)(2007-12#3)(2008-5#1)(2011-1#1)
mm x 40 mm x##2##5##(2008-10#1)(2008-3#1)
mm x 40 mm##3##4##(2008-10#1)(2008-3#2)
mm x##36##2##(1991-5#3)(1994-5#3)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#13)(2008-5#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-3#1)
mm x4##4##2##(2008-10#4)
mm##709##1##(1990-11#3)(1990-2#8)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#5)(1991-5#8)(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#5)(1992-6#1)(1992-9#2)(1993-1#2)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#7)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#2)(1995-12#9)(1995-2#3)(1995-3#3)(1995-4#1)(1996-11#1)(1996-2#4)(1996-5#2)(1996-6#6)(1997-2#3)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#1)(2007-10#6)(2007-11#19)(2007-12#19)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#20)(2007-9#2)(2008-1#9)(2008-10#87)(2008-11#22)(2008-12#25)(2008-2#30)(2008-3#78)(2008-4#1)(2008-5#23)(2008-6#1)(2008-7#28)(2008-8#10)(2008-9#9)(2009-11#4)(2009-12#2)(2009-2#6)(2009-3#6)(2009-4#4)(2009-5#3)(2009-7#6)(2009-8#8)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#6)(2010-5#2)(2010-7#3)(2010-8#18)(2010-9#1)(2011-1#12)(2011-2#18)(2011-3#2)(2012-1#6)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#53)(2013-8#15)
mm(-1) and##2##2##(2008-2#1)(2008-3#1)
mm(-1)##9##1##(2007-12#1)(2008-2#3)(2008-3#4)(2013-8#1)
mm(-2)##5##1##(2007-12#1)(2008-5#4)
mm(2) and##2##2##(2008-2#1)(2008-7#1)
mm(2) of##5##2##(2008-10#5)
mm(2)##12##1##(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#1)
mm(2))##3##1##(2008-12#1)(2008-2#1)(2008-5#1)
mm(3)##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
mm) allowed##2##2##(2008-11#1)(2008-5#1)
mm) and##7##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2010-9#1)
mm) areas##2##2##(2008-10#2)
mm) at##2##2##(2007-12#2)
mm) is##2##2##(2013-1#2)
mm) or##2##2##(1990-7#1)(2008-9#1)
mm) using a##2##3##(2008-11#1)(2009-8#1)
mm) was used##2##3##(1990-11#1)(2013-1#1)
mm) was##3##2##(1990-11#1)(2007-8#1)(2013-1#1)
mm) were used##2##3##(2008-3#1)(2009-8#1)
mm) were##5##2##(2008-12#2)(2008-3#1)(2009-8#1)(2011-1#1)
mm) with##2##2##(2008-10#1)(2008-5#1)
mm)##96##1##(1990-11#1)(1990-7#2)(1991-4#2)(1995-3#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#8)(2008-5#6)(2008-7#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#5)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#7)(2012-3#3)(2013-1#7)(2013-8#1)
mm-1)##2##1##(2008-11#2)
mm/dL) compared with those who did not##2##7##(2007-10#2)
mm/dL)##3##1##(2007-10#3)
mm/day)##5##1##(2008-10#5)
mm/h in##3##2##(2007-7#3)
mm/h##7##1##(2007-7#4)(2008-10#3)
mm/s in##2##2##(1992-6#2)
mm/s##8##1##(1992-6#3)(2008-3#3)(2012-12#2)
mm/year (range##2##2##(2008-8#2)
mm/year##3##1##(2008-8#3)
mm/year)##2##1##(2008-8#2)
mm0##2##1##(2011-1#2)
mm2##4##1##(1995-12#3)(1996-12#1)
mm3 at##2##2##(1996-5#2)
mm3##4##1##(1996-5#2)(1997-6#2)
mm3)##2##1##(2007-10#2)
mmHg (P=0##2##2##(2007-8#2)
mmHg and the##2##3##(1991-6#1)(2007-8#1)
mmHg and##5##2##(1991-3#1)(1991-6#1)(2007-7#1)(2007-8#2)
mmHg at##3##2##(2008-11#3)
mmHg for##5##2##(2007-8#3)(2008-5#1)(2013-1#1)
mmHg is##2##2##(2008-7#1)(2010-5#1)
mmHg on the##2##3##(2011-2#2)
mmHg or##2##2##(1997-5#1)(2008-7#1)
mmHg to##5##2##(1990-11#2)(1991-6#2)(1997-6#1)
mmHg##70##1##(1990-11#4)(1990-3#1)(1991-10#1)(1991-2#2)(1991-3#3)(1991-6#6)(1992-6#1)(1995-12#1)(1997-5#1)(1997-6#2)(2007-10#4)(2007-7#2)(2007-8#9)(2008-1#5)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#6)(2013-1#1)
mmHg)##20##1##(1991-6#2)(1992-2#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#3)(2011-2#1)(2012-12#1)(2012-3#1)
mmoL/L##2##1##(2008-10#2)
mmol L(-1) iodate##2##3##(2008-10#2)
mmol L(-1)##6##2##(2008-10#6)
mmol dm(-3) potassium##2##3##(2008-10#2)
mmol dm(-3) with##2##3##(2008-10#2)
mmol dm(-3)##8##2##(2008-10#8)
mmol g(-1) (log##2##3##(2008-10#2)
mmol g(-1) for##3##3##(2008-10#3)
mmol g(-1) of##4##3##(2008-10#4)
mmol g(-1)##19##2##(2008-10#17)(2008-5#2)
mmol l(-1) of##2##3##(2008-10#2)
mmol l(-1) tetrabutylammonium bromide##2##4##(2008-10#2)
mmol l(-1)##27##2##(2008-10#27)
mmol m(-2) for##3##3##(2008-10#3)
mmol##85##1##(1990-8#1)(1991-12#1)(1994-2#1)(1994-3#1)(1997-8#1)(2008-10#71)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#3)(2010-11#1)
mmol/1##3##1##(1995-12#3)
mmol/L CdCl(2))##2##2##(2008-9#2)
mmol/L ammonium acetate##2##3##(2011-1#2)
mmol/L ammonium##3##2##(2011-1#3)
mmol/L##44##1##(1991-9#1)(1993-1#4)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#9)(2008-8#4)(2008-9#7)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#1)
mmol/L)##3##1##(2008-8#3)
mmol/kg treatment group##2##3##(1994-5#2)
mmol/kg##17##1##(1992-12#3)(1994-2#1)(1994-5#5)(1995-3#1)(1996-12#2)(2008-11#2)(2008-5#2)(2009-12#1)
mmol/kg) and##3##2##(1992-12#1)(2008-11#2)
mmol/kg)##14##1##(1992-12#2)(1994-5#5)(1995-3#2)(2008-10#1)(2008-11#4)
mmol/l [normal &lt##2##3##(1994-3#2)
mmol/l and##3##2##(1990-3#1)(1993-12#1)(1995-11#1)
mmol/l for##4##2##(1990-6#2)(1991-6#2)
mmol/l glucose##2##2##(1992-12#1)(1993-3#1)
mmol/l had##2##2##(1990-6#1)(1994-12#1)
mmol/l in men and##3##4##(1991-6#2)(1995-11#1)
mmol/l in women)##2##3##(1991-6#2)
mmol/l in##7##2##(1991-6#5)(1995-11#2)
mmol/l to##2##2##(1991-8#2)
mmol/l with human##2##3##(1991-8#2)
mmol/l with porcine insulin##2##4##(1991-8#2)
mmol/l with##4##2##(1991-8#4)
mmol/l##57##1##(1990-2#2)(1990-3#1)(1990-6#3)(1991-11#8)(1991-6#7)(1991-8#6)(1992-11#3)(1992-12#3)(1993-12#2)(1993-3#1)(1994-12#2)(1994-3#2)(1994-6#2)(1995-11#6)(1995-2#1)(1996-5#3)(2008-7#2)(2010-4#2)(2011-2#1)
mmol/l) and##3##2##(1990-2#1)(1994-12#1)(2010-3#1)
mmol/l) are &quot##3##3##(1990-2#3)
mmol/l)##20##1##(1990-2#9)(1990-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-12#1)(2007-8#1)(2010-3#1)
mmole l(-1)##2##2##(2008-5#2)
mmole l(-1))##3##2##(2008-5#3)
mmole##5##1##(2008-5#5)
mmoll(-1)##2##1##(2008-10#2)
mms was obtained##2##3##(2011-2#2)
mmx10 mm##2##2##(2007-11#2)
mn##6##1##(1991-9#1)(2007-11#1)(2007-8#4)
mnemonic##9##1##(1991-2#1)(1992-11#2)(1993-5#1)(1993-9#1)(1994-3#1)(2007-8#1)(2008-11#1)(2008-8#1)
mnp3##3##1##(2011-1#3)
mo and##2##2##(2010-12#1)(2010-3#1)
mo##8##1##(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#3)(2013-1#1)
mo) and##2##2##(1994-6#1)(2010-3#1)
mo)##4##1##(1994-6#2)(2008-10#1)(2010-3#1)
mo1(1) and mo1(2)##2##3##(2008-10#2)
mo1(1)##5##1##(2008-10#5)
mo1(2)##6##1##(2008-10#6)
mo1-carrying##2##1##(2008-10#2)
mobile bearing in a medial unicompartmental knee replacement##2##8##(2012-12#2)
mobile bearing##3##2##(2012-12#2)(2013-1#1)
mobile carrier##6##2##(1992-6#2)(2008-10#4)
mobile devices##2##2##(2009-3#1)(2012-2#1)
mobile drilling units##2##3##(2009-10#2)
mobile facilities##5##2##(1992-5#5)
mobile genetic##2##2##(1995-8#1)(2009-3#1)
mobile group I intron##2##4##(1995-6#2)
mobile in the##3##3##(2008-1#1)(2008-10#2)
mobile offshore drilling units##2##4##(2009-10#2)
mobile phase A##3##3##(2008-5#2)(2011-1#1)
mobile phase B##3##3##(2008-5#2)(2011-1#1)
mobile phase additive##3##3##(2008-10#1)(2010-4#1)(2011-1#1)
mobile phase additives##2##3##(2008-10#1)(2010-4#1)
mobile phase and UV detection##2##5##(2008-10#1)(2011-1#1)
mobile phase and a##2##4##(2008-10#2)
mobile phase and the##3##4##(2008-10#1)(2011-1#2)
mobile phase and##19##3##(2008-10#13)(2010-5#1)(2011-1#4)(2011-3#1)
mobile phase at a flow rate of##2##7##(2011-1#1)(2011-2#1)
mobile phase at a##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
mobile phase at##6##3##(2008-10#3)(2008-5#1)(2011-1#1)(2011-2#1)
mobile phase by##2##3##(2008-10#1)(2008-5#1)
mobile phase composition##7##3##(1996-5#1)(2007-12#1)(2008-10#5)
mobile phase consisted of##3##4##(2008-10#1)(2011-2#1)(2011-3#1)
mobile phase consisting of##8##4##(1991-5#1)(2008-10#4)(2010-3#1)(2011-1#1)(2012-12#1)
mobile phase containing a##2##4##(2008-10#1)(2010-3#1)
mobile phase containing##11##3##(1990-8#1)(2008-10#9)(2010-3#1)
mobile phase for the##3##4##(1990-8#2)(2008-10#1)
mobile phase for##6##3##(1990-8#4)(2008-10#2)
mobile phase in the##2##4##(2008-10#2)
mobile phase in##5##3##(2008-10#5)
mobile phase is##7##3##(2008-10#7)
mobile phase of acetonitrile##2##4##(2008-10#1)(2011-1#1)
mobile phase of methanol-water##2##4##(2008-10#2)
mobile phase of pH##2##4##(1990-8#2)
mobile phase of##18##3##(1990-8#2)(1996-5#1)(2008-10#12)(2008-5#1)(2011-1#1)(2013-1#1)
mobile phase on##3##3##(2008-10#2)(2010-11#1)
mobile phase pH##3##3##(2008-10#3)
mobile phase used was##8##4##(1997-2#1)(2008-10#5)(2010-5#1)(2012-2#1)
mobile phase was##12##3##(1990-8#1)(2008-10#9)(2010-3#1)(2013-1#1)
mobile phase were##4##3##(2008-10#4)
mobile phase with##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)
mobile phase within##2##3##(2008-10#2)
mobile phase##228##2##(1990-8#9)(1991-5#2)(1991-7#1)(1993-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#4)(1997-2#2)(2007-12#2)(2008-10#155)(2008-11#1)(2008-5#9)(2008-7#1)(2009-8#2)(2010-11#1)(2010-3#3)(2010-4#3)(2010-5#2)(2011-1#16)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
mobile phase)##5##2##(2008-10#5)
mobile phases and##4##3##(1996-5#1)(2008-10#2)(2010-11#1)
mobile phases containing methanol##2##4##(1996-5#2)
mobile phases containing##4##3##(1996-5#3)(2008-10#1)
mobile phases of##4##3##(1996-5#1)(2008-10#1)(2010-11#1)(2011-1#1)
mobile phases##30##2##(1990-8#1)(1996-5#9)(2007-12#2)(2008-10#14)(2010-11#2)(2011-1#2)
mobile phone has##2##3##(2010-8#1)(2012-3#1)
mobile phone##5##2##(2010-8#1)(2012-2#1)(2012-3#3)
mobile phones##4##2##(2008-12#3)(2013-8#1)
mobile species##2##2##(2008-9#2)
mobile teeth##2##2##(2008-1#2)
mobile telemedicine##3##2##(2007-9#2)(2010-8#1)
mobile workers##2##2##(2011-2#2)
mobile##389##1##(1990-8#10)(1991-4#1)(1991-5#4)(1991-7#1)(1992-11#1)(1992-5#10)(1992-6#2)(1993-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#4)(1995-8#2)(1996-3#1)(1996-5#13)(1997-2#2)(2007-11#1)(2007-12#5)(2007-9#3)(2008-1#5)(2008-10#188)(2008-11#1)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#13)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#4)(2009-3#2)(2009-8#2)(2010-11#6)(2010-3#6)(2010-4#3)(2010-5#2)(2010-8#6)(2011-1#18)(2011-2#15)(2011-3#3)(2012-12#4)(2012-2#4)(2012-3#6)(2012-5#1)(2013-1#9)(2013-8#1)
mobile-wireless infrastructure and mobile health care computing devices##2##8##(2010-8#2)
mobile-wireless infrastructure##3##2##(2010-8#3)
mobilis and glucoamylase##2##3##(2008-6#2)
mobilis and##3##2##(1995-3#1)(2008-6#2)
mobilis in##2##2##(2008-6#2)
mobilis##25##1##(1995-3#1)(2008-6#17)(2008-7#4)(2009-5#2)(2011-2#1)
mobilisation of the trunk##2##4##(2007-8#2)
mobilisation of the##3##3##(1997-6#1)(2007-8#2)
mobilisation of##4##2##(1997-6#1)(1997-7#1)(2007-8#2)
mobilisation##9##1##(1997-6#1)(1997-7#2)(2007-8#3)(2008-7#1)(2010-5#1)(2012-1#1)
mobilities and##2##2##(2008-10#1)(2008-7#1)
mobilities in##2##2##(2008-10#2)
mobilities of the##3##3##(1990-7#2)(2008-10#1)
mobilities of##6##2##(1990-7#2)(1994-11#1)(2008-10#3)
mobilities were##2##2##(2008-10#1)(2010-9#1)
mobilities##19##1##(1990-7#2)(1994-11#1)(1994-9#1)(2008-10#9)(2008-3#3)(2008-7#2)(2010-9#1)
mobility (p=0##3##2##(2008-10#3)
mobility and##16##2##(1992-6#1)(1994-2#1)(1996-9#2)(2007-11#1)(2008-11#2)(2008-8#1)(2009-6#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
mobility are##2##2##(2008-10#1)(2008-7#1)
mobility assessment##4##2##(1993-12#3)(2008-10#1)
mobility at##2##2##(2008-8#1)(2013-1#1)
mobility compared##2##2##(2008-9#1)(2011-2#1)
mobility decline##3##2##(2008-7#3)
mobility in the##6##3##(1994-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#1)
mobility in##12##2##(1992-6#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#2)(2010-3#1)
mobility increment##3##2##(2008-10#3)
mobility of the chain##2##4##(1994-3#2)
mobility of the##10##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#2)(2007-11#2)(2008-10#2)(2010-2#1)
mobility of##38##2##(1991-12#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1997-2#1)(2007-11#2)(2008-1#2)(2008-10#11)(2008-4#1)(2008-7#2)(2008-8#3)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
mobility patterns##2##2##(2008-10#1)(2012-2#1)
mobility shift assay revealed##2##4##(2008-11#2)
mobility shift assay showed that##2##5##(2008-9#1)(2011-2#1)
mobility shift assay showed##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
mobility shift assay##12##3##(1992-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-11#4)(2008-4#1)(2008-9#2)(2011-2#1)
mobility shift assays using##3##4##(1995-6#2)(2011-1#1)
mobility shift assays##9##3##(1991-11#1)(1994-6#1)(1994-9#1)(1995-6#2)(1997-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
mobility shift##27##2##(1991-11#1)(1992-12#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-6#2)(1995-8#1)(1997-7#1)(2008-11#5)(2008-4#1)(2008-8#1)(2008-9#4)(2011-1#1)(2011-2#1)
mobility spectra##4##2##(2008-10#4)
mobility spectrometer##8##2##(2008-10#7)(2010-9#1)
mobility spectrometers##3##2##(2008-10#3)
mobility spectrometry for the##2##4##(2008-10#1)(2010-9#1)
mobility spectrometry##28##2##(2008-10#26)(2010-9#2)
mobility was##3##2##(1994-7#1)(2008-7#1)(2013-1#1)
mobility were##4##2##(1994-9#1)(2008-10#1)(2008-7#2)
mobility##267##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#3)(1992-12#1)(1992-6#6)(1992-8#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#5)(1994-6#2)(1994-7#1)(1994-9#7)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-7#2)(2006-10#1)(2007-11#10)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#86)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#21)(2008-8#8)(2008-9#10)(2009-12#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)
mobilization and mitogen-activated protein##2##4##(2008-4#1)(2009-6#1)
mobilization and##14##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-11#1)(1995-3#1)(1996-2#2)(2007-11#1)(2008-1#2)(2008-12#1)(2008-4#1)(2009-6#1)(2010-5#1)
mobilization by##3##2##(1992-6#3)
mobilization from##3##2##(1992-6#2)(2008-7#1)
mobilization in whole-blood platelets##2##4##(2008-9#2)
mobilization in##8##2##(1990-8#1)(1991-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)
mobilization of the##4##3##(1993-3#1)(2007-11#1)(2008-12#1)(2013-8#1)
mobilization of##23##2##(1990-8#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-11#2)(1996-3#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-12#2)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
mobilization on##2##2##(2008-12#1)(2012-2#1)
mobilization results##2##2##(2011-2#2)
mobilization was##2##2##(1993-11#1)(2011-2#1)
mobilization##96##1##(1990-2#1)(1990-5#2)(1990-8#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#8)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#3)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#3)(1996-3#1)(1997-5#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-12#5)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#3)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
mobilizations in##2##2##(2008-10#1)(2012-2#1)
mobilizations##7##1##(2008-10#3)(2008-12#1)(2009-4#1)(2012-2#2)
mobilize##13##1##(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
mobilized aortic arches##2##3##(2007-8#2)
mobilized##12##1##(1992-6#1)(1993-6#1)(2007-8#4)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2012-3#1)
mobilizes##3##1##(1991-12#1)(2008-10#1)(2011-1#1)
mobilizing##8##1##(1992-12#3)(1994-11#1)(1994-6#1)(1995-3#1)(2007-8#1)(2008-7#1)
mock##11##1##(1993-12#2)(1996-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
mock-inoculated plants##3##2##(2008-10#2)(2012-2#1)
mock-inoculated##4##1##(2008-10#3)(2012-2#1)
moclobemide or omeprazole##2##3##(2008-11#2)
moclobemide##5##1##(2008-11#2)(2008-7#3)
modafinil for cocaine##2##3##(2009-7#2)
modafinil##7##1##(2009-7#7)
modal Zernike##2##2##(2007-12#1)(2008-3#1)
modal analysis##3##2##(2008-2#2)(2008-3#1)
modal birefringence##5##2##(2008-3#5)
modal coupling##2##2##(2007-11#2)
modal discrimination##2##2##(2008-3#2)
modal dispersion##2##2##(2008-2#1)(2008-3#1)
modal field##2##2##(2007-11#1)(2008-3#1)
modal interference##2##2##(2007-11#1)(2008-3#1)
modal structure##2##2##(2007-12#1)(2008-3#1)
modal##56##1##(1991-4#1)(2007-11#8)(2007-12#8)(2008-10#1)(2008-12#2)(2008-2#11)(2008-3#25)
modalities and combinations##2##3##(1995-5#1)(2008-3#1)
modalities and##15##2##(1990-5#1)(1993-2#1)(1995-5#1)(1996-2#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)
modalities are available##2##3##(2007-7#1)(2008-7#1)
modalities are reviewed##2##3##(2007-8#1)(2009-4#1)
modalities are##13##2##(1995-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2011-1#1)(2011-2#1)
modalities depending on##2##3##(1993-11#1)(2009-8#1)
modalities for the##4##3##(2008-1#1)(2009-11#1)(2010-6#1)(2011-2#1)
modalities for##13##2##(1990-6#1)(1993-1#1)(1994-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)
modalities have been used##3##4##(1995-1#1)(2007-11#1)(2010-8#1)
modalities have been##4##3##(1995-1#1)(1997-8#1)(2007-11#1)(2010-8#1)
modalities have not been##2##4##(1990-10#1)(2010-6#1)
modalities have##8##2##(1990-10#1)(1995-1#1)(1997-8#1)(2007-11#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#1)
modalities in the##3##3##(2007-4#1)(2008-7#1)(2013-1#1)
modalities in##7##2##(2007-4#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
modalities including##2##2##(1990-6#1)(2009-3#1)
modalities like##3##2##(2009-5#1)(2010-7#1)(2012-2#1)
modalities may##3##2##(2007-8#1)(2011-2#2)
modalities of the##2##3##(2011-2#1)(2013-1#1)
modalities of treatment##3##3##(2007-12#1)(2007-7#1)(2008-7#1)
modalities of##18##2##(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
modalities require##2##2##(1995-12#1)(2008-7#1)
modalities such as##5##3##(1995-5#1)(2007-11#1)(2008-3#1)(2010-12#1)(2013-1#1)
modalities that##2##2##(2012-2#1)(2012-3#1)
modalities to##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
modalities under##2##2##(2008-8#2)
modalities used##5##2##(1994-5#1)(1996-1#1)(2008-1#1)(2011-2#1)(2012-12#1)
modalities##182##1##(1990-10#1)(1990-5#1)(1990-6#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-12#5)(1995-5#4)(1996-1#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-8#2)(2006-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#6)(2007-8#4)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#4)(2009-1#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#5)(2011-2#15)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#15)(2013-8#3)
modality as##2##2##(2008-8#2)
modality for the##4##3##(1990-11#1)(2007-7#1)(2010-6#1)(2012-2#1)
modality for##19##2##(1990-11#1)(1991-4#1)(1997-1#1)(2007-12#1)(2007-7#5)(2008-7#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
modality has##3##2##(1992-1#1)(2007-12#1)(2009-11#1)
modality in the##3##3##(2009-10#1)(2010-12#1)(2011-7#1)
modality in##5##2##(2007-7#2)(2009-10#1)(2010-12#1)(2011-7#1)
modality is useful##2##3##(2007-7#1)(2008-7#1)
modality is##6##2##(2007-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-7#1)
modality of choice##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
modality of the##2##3##(2008-3#1)(2013-1#1)
modality of treatment for##2##4##(2012-3#1)(2013-1#1)
modality of treatment##4##3##(1994-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
modality of##12##2##(1994-12#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
modality that##3##2##(2010-6#1)(2011-2#1)(2013-1#1)
modality therapy##2##2##(2007-8#1)(2008-12#1)
modality to##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
modality##120##1##(1990-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#5)(1995-12#2)(1996-2#1)(1997-1#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#8)(2011-7#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#3)
modality-specific##3##1##(1990-11#1)(1991-2#2)
mode (in##2##2##(2008-2#1)(2011-1#1)
mode (with##2##2##(2008-3#2)
mode AFM##2##2##(2008-10#2)
mode I fracture energy##2##4##(2009-7#2)
mode amplitude##2##2##(2008-2#1)(2008-3#1)
mode amplitudes##2##2##(2007-12#1)(2008-2#1)
mode and a##5##3##(2007-11#1)(2007-12#2)(2008-7#1)(2011-1#1)
mode and the##9##3##(1993-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#4)
mode and##41##2##(1990-8#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-6#1)(2007-11#2)(2007-12#5)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
mode are##3##2##(2007-12#1)(2008-10#1)(2009-7#1)
mode as##2##2##(2008-2#1)(2008-9#1)
mode at 230 nm##2##4##(2008-10#2)
mode at a##2##3##(2007-12#1)(2008-2#1)
mode at the##2##3##(2008-10#1)(2011-1#1)
mode at##17##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#2)(2009-12#1)(2011-1#1)
mode based on the##2##4##(2007-11#1)(2008-10#1)
mode beating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mode by the##2##3##(1995-12#1)(2007-11#1)
mode by##8##2##(1995-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
mode can be used##2##4##(2008-10#1)(2008-3#1)
mode can be##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
mode cleaner cavity##2##3##(2008-2#2)
mode cleaner##4##2##(2008-2#4)
mode conversion##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
mode converter##2##2##(2007-12#1)(2011-1#1)
mode converters##6##2##(2007-11#3)(2007-12#3)
mode coupling in##2##3##(2008-3#2)
mode coupling##11##2##(2007-11#2)(2008-2#1)(2008-3#8)
mode dispersion (PMD)##8##3##(2007-11#6)(2007-12#2)
mode dispersion in##3##3##(2007-12#3)
mode dispersion of spun fibers##2##5##(2007-11#2)
mode dispersion of##3##3##(2007-11#3)
mode dispersion##27##2##(2007-11#16)(2007-12#11)
mode during##2##2##(2007-11#1)(2010-10#1)
mode fields##2##2##(2008-3#2)
mode for the##2##3##(1992-3#1)(2008-10#1)
mode for##10##2##(1992-3#2)(2008-10#4)(2008-11#1)(2008-3#2)(2009-5#1)
mode from the##2##3##(2008-3#1)(2010-11#1)
mode from##3##2##(2008-3#2)(2010-11#1)
mode has##2##2##(2007-12#1)(2008-10#1)
mode have been investigated##2##4##(2007-12#1)(2008-10#1)
mode have been##3##3##(2007-12#1)(2008-10#2)
mode hopping##11##2##(2007-12#5)(2008-2#2)(2008-3#4)
mode in a##6##3##(2007-11#2)(2007-12#3)(2008-2#1)
mode in the##5##3##(2007-11#1)(2007-12#2)(2008-3#1)(2012-3#1)
mode in which##2##3##(1997-2#1)(2007-11#1)
mode in##24##2##(1991-12#1)(1992-5#1)(1995-5#1)(1997-2#2)(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
mode into a##2##3##(2007-11#2)
mode into##3##2##(2007-11#3)
mode is described##3##3##(2008-10#1)(2008-2#2)
mode is dominant##2##3##(2008-2#1)(2008-3#1)
mode is excited##2##3##(2007-1#1)(2008-3#1)
mode is##21##2##(1991-12#1)(1994-11#1)(1996-5#1)(2007-1#3)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2010-3#1)
mode laser##2##2##(2008-3#2)
mode locked by a##2##4##(2007-12#1)(2008-3#1)
mode locked by##6##3##(2007-11#3)(2007-12#2)(2008-3#1)
mode locked with a##2##4##(2007-12#2)
mode locked with##3##3##(2007-12#2)(2008-2#1)
mode locked##12##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#1)
mode locking and##2##3##(2008-3#2)
mode locking in a##2##4##(2007-11#2)
mode locking of Cr(4+)##2##4##(2007-11#2)
mode locking of a##6##4##(2007-11#3)(2007-12#2)(2008-2#1)
mode locking of an##2##4##(2007-11#1)(2007-12#1)
mode locking of##12##3##(2007-11#7)(2007-12#4)(2008-2#1)
mode locking to##2##3##(2007-11#2)
mode locking was##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
mode locking with##2##3##(2007-11#1)(2007-12#1)
mode locking##36##2##(2007-11#21)(2007-12#11)(2008-2#1)(2008-3#3)
mode matching into optical cavities##2##5##(2007-12#2)
mode matching##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
mode mixing##2##2##(2007-11#1)(2008-2#1)
mode network##3##2##(2013-8#3)
mode number##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mode of Melbourne Categories in this group (n =##2##9##(2008-9#2)
mode of a##4##3##(2007-11#1)(2008-3#2)(2009-11#1)
mode of action and##2##4##(1991-12#1)(2008-8#1)
mode of action as well as their##2##7##(2011-2#2)
mode of action is##2##4##(1990-12#1)(2008-6#1)
mode of action of the##4##5##(1997-1#1)(1997-7#1)(2008-10#1)(2008-2#1)
mode of action of##19##4##(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)
mode of action##33##3##(1990-12#1)(1991-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#2)(2011-2#3)(2013-1#1)
mode of activation##2##3##(2010-11#1)(2012-2#1)
mode of administration in##2##4##(1996-2#1)(2008-1#1)
mode of administration##4##3##(1992-5#1)(1992-9#1)(1996-2#1)(2008-1#1)
mode of cell death##2##4##(2008-1#1)(2008-4#1)
mode of cell##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
mode of chelation##2##3##(2008-10#2)
mode of communication##3##3##(2008-9#3)
mode of death in##2##4##(1992-8#1)(2011-2#1)
mode of death##3##3##(1992-8#1)(2008-11#1)(2011-2#1)
mode of delivery##12##3##(1993-10#1)(1993-11#1)(2007-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
mode of extraction##2##3##(2008-10#2)
mode of failure##2##3##(2008-12#1)(2008-9#1)
mode of infection##2##3##(2008-10#1)(2008-8#1)
mode of inheritance is##2##4##(1997-3#1)(2011-2#1)
mode of inheritance##10##3##(1994-8#1)(1997-3#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-7#1)(2011-2#1)
mode of interaction##3##3##(1993-11#1)(1997-2#1)(2008-10#1)
mode of its##2##3##(2007-7#1)(2010-4#1)
mode of operation and##4##4##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
mode of operation is##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
mode of operation##9##3##(1997-2#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#2)
mode of presentation of##2##4##(2008-1#2)
mode of presentation##7##3##(1997-8#1)(2007-7#1)(2008-1#3)(2011-1#2)
mode of processing##2##3##(2008-1#1)(2010-10#1)
mode of production##2##3##(2013-1#2)
mode of speech##6##3##(2011-1#6)
mode of the##11##3##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)
mode of therapy##2##3##(1991-6#1)(2007-12#1)
mode of this##2##3##(2008-3#1)(2013-1#1)
mode of transmission##4##3##(1996-1#1)(2008-10#2)(2010-8#1)
mode of treatment##4##3##(1991-5#1)(1996-3#1)(2008-12#1)(2008-3#1)
mode of##225##2##(1990-12#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#5)(2007-12#6)(2007-6#1)(2007-7#3)(2008-1#10)(2008-10#41)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#19)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#9)(2009-10#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#5)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#13)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
mode operation##5##2##(2008-10#2)(2008-3#3)
mode output##3##2##(2008-3#3)
mode over##3##2##(2008-10#2)(2008-9#1)
mode partition noise##2##3##(2007-11#2)
mode radius##3##2##(2008-2#2)(2008-3#1)
mode relaxes in##3##3##(2007-1#3)
mode sampling##4##2##(2008-10#4)
mode selection##4##2##(2008-3#4)
mode shaping##3##2##(2007-11#1)(2008-2#2)
mode size##2##2##(2007-11#1)(2008-3#1)
mode spacing##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
mode starts to##2##3##(2007-12#1)(2008-3#1)
mode structure##2##2##(2008-2#1)(2008-7#1)
mode that##2##2##(2007-11#1)(2008-10#1)
mode to##14##2##(1990-8#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-5#1)(2011-1#1)(2013-1#1)
mode using##7##2##(2008-10#6)(2008-11#1)
mode was applied##2##3##(2008-10#1)(2013-1#1)
mode was used for##2##4##(2008-10#1)(2008-11#1)
mode was##13##2##(1996-5#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-7#1)(2011-1#1)(2013-1#2)
mode were##2##2##(1996-5#1)(2008-10#1)
mode with a##9##3##(2007-12#3)(2008-10#3)(2008-3#3)
mode with an##3##3##(2008-10#3)
mode with the CD4000##2##4##(2008-10#2)
mode with the##5##3##(2008-10#4)(2008-2#1)
mode with##28##2##(2007-11#1)(2007-12#4)(2008-10#14)(2008-2#1)(2008-3#4)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
mode##943##1##(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#9)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#6)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#5)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-4#1)(2007-1#6)(2007-11#107)(2007-12#110)(2007-6#1)(2007-7#3)(2008-1#10)(2008-10#204)(2008-11#29)(2008-12#2)(2008-2#61)(2008-3#123)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#19)(2008-8#7)(2008-9#20)(2009-10#5)(2009-11#2)(2009-12#1)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#8)(2010-10#6)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#32)(2011-2#15)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#22)(2013-8#5)
mode(s) of action##3##3##(2008-7#3)
mode(s) of##4##2##(2008-7#4)
mode)##5##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
mode-coherence coefficients of##2##3##(2007-12#2)
mode-coupled##2##1##(2008-3#2)
mode-coupling length##2##2##(2007-11#2)
mode-field diameter##3##2##(2008-2#3)
mode-field##4##1##(2008-2#4)
mode-hop-free tuning over##2##3##(2007-12#1)(2008-3#1)
mode-hop-free tuning range##2##3##(2007-11#2)
mode-hop-free tuning##8##2##(2007-11#3)(2007-12#4)(2008-3#1)
mode-hop-free##9##1##(2007-11#4)(2007-12#4)(2008-3#1)
mode-lock frequency can be##2##4##(2007-12#2)
mode-lock frequency##3##2##(2007-12#3)
mode-locked Cr##9##2##(2007-11#1)(2007-12#8)
mode-locked Cr(4+)##3##2##(2008-3#3)
mode-locked Er-doped fiber laser##2##4##(2007-12#2)
mode-locked Er-doped fiber##3##3##(2007-12#3)
mode-locked Er-fiber##2##2##(2007-11#1)(2007-12#1)
mode-locked Nd##6##2##(2007-11#4)(2008-2#2)
mode-locked Ti##15##2##(2007-11#7)(2007-12#7)(2008-3#1)
mode-locked Yb##6##2##(2007-11#2)(2007-12#4)
mode-locked diode-pumped##2##2##(2007-12#1)(2008-2#1)
mode-locked femtosecond laser is##2##4##(2007-12#1)(2008-3#1)
mode-locked femtosecond laser##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
mode-locked fiber laser##4##3##(2007-11#4)
mode-locked fiber##5##2##(2007-11#4)(2007-12#1)
mode-locked high-power##2##2##(2007-11#2)
mode-locked laser are##2##3##(2007-12#2)
mode-locked laser##17##2##(2007-11#7)(2007-12#7)(2008-2#1)(2008-3#2)
mode-locked lasers with##2##3##(2007-11#1)(2007-12#1)
mode-locked lasers##15##2##(2007-11#9)(2007-12#6)
mode-locked operation##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
mode-locked oscillator##3##2##(2007-11#3)
mode-locked picosecond##2##2##(2007-11#2)
mode-locked pulse##2##2##(2007-11#1)(2008-3#1)
mode-locked pulses##2##2##(2007-11#1)(2007-12#1)
mode-locked semiconductor##4##2##(2007-12#3)(2008-3#1)
mode-locked thin-disk Yb##4##3##(2007-11#4)
mode-locked##139##1##(2007-11#65)(2007-12#57)(2008-2#6)(2008-3#11)
mode-locking element##2##2##(2007-11#2)
mode-locking mechanism##3##2##(2007-11#2)(2007-12#1)
mode-locking operation##2##2##(2007-11#1)(2008-3#1)
mode-locking##11##1##(2007-11#7)(2007-12#3)(2008-3#1)
mode-matching##3##1##(2008-3#3)
mode-mismatched##5##1##(2007-12#1)(2008-3#4)
mode-selecting##2##1##(2007-11#1)(2008-3#1)
model (TTM)##4##2##(2008-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
model (e##2##2##(2007-10#1)(2008-8#1)
model (in the limit v →##2##6##(2013-8#2)
model (in##3##2##(2009-9#1)(2013-8#2)
model (mx =##2##3##(2008-9#2)
model 1##4##2##(2008-10#2)(2008-8#2)
model 2##3##2##(2008-10#2)(2008-8#1)
model CA3 pyramidal cell##3##4##(2008-11#3)
model FAD##2##2##(2008-10#2)
model HMO)##2##2##(1996-3#2)
model SC lipid##2##3##(2008-5#2)
model [Appl##2##2##(2008-2#1)(2008-3#1)
model [J##2##2##(2008-3#1)(2008-5#1)
model a##4##2##(1990-8#1)(1993-6#1)(2008-7#1)(2013-1#1)
model about the##2##3##(1995-12#1)(2007-7#1)
model accounted for##3##3##(1992-2#1)(2008-10#2)
model accounts for##6##3##(2007-11#1)(2008-3#2)(2008-7#1)(2013-8#2)
model accounts##8##2##(2007-11#1)(2008-3#2)(2008-7#1)(2010-11#1)(2011-3#1)(2013-8#2)
model accuracy##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
model accurately##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
model adequately##2##2##(2008-7#1)(2011-2#1)
model against##2##2##(2007-5#1)(2008-8#1)
model agree well with the##2##5##(2008-2#1)(2008-3#1)
model agree well with##3##4##(2008-2#1)(2008-3#2)
model aimed##2##2##(1997-8#1)(2013-1#1)
model allowed##5##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
model allows for##4##3##(1997-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
model allows##8##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#2)(2013-8#1)
model also##14##2##(1993-9#1)(1994-3#1)(1995-2#1)(1996-3#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
model analysis tools##2##3##(2013-1#2)
model analysis##7##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
model analyte##3##2##(2008-10#3)
model analytes##3##2##(2008-10#3)
model and a##13##3##(1992-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2009-8#3)
model and an##3##3##(2008-1#1)(2008-3#1)(2009-5#1)
model and discuss##2##3##(1991-2#1)(2008-8#1)
model and experimental##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
model and has##2##3##(1992-3#1)(2007-12#1)
model and human##2##3##(2008-5#1)(2012-2#1)
model and its##4##3##(1992-12#1)(1995-9#1)(2008-3#1)(2012-2#1)
model and methods##3##3##(2008-10#1)(2010-11#1)(2010-2#1)
model and show that##2##4##(2008-10#1)(2008-2#1)
model and show##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
model and task taxonomy##2##4##(2010-8#2)
model and the##26##3##(1991-9#1)(1992-5#1)(1994-2#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#5)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-7#1)
model and##148##2##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-2#2)(1994-9#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#3)(2008-2#9)(2008-3#19)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#7)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
model applied to##2##3##(2008-10#2)
model applied##4##2##(2008-10#4)
model are discussed##2##3##(1996-1#1)(2008-3#1)
model are in##2##3##(2008-10#1)(2008-3#1)
model are its##2##3##(1991-5#1)(2008-3#1)
model are##26##2##(1991-5#1)(1992-12#2)(1992-6#1)(1996-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-1#1)
model as a##8##3##(1990-8#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-11#1)(2013-1#1)
model as well as##3##4##(2007-12#1)(2008-11#1)(2008-9#1)
model as##14##2##(1990-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
model assessment##9##2##(1994-12#1)(2008-11#1)(2008-3#2)(2011-1#3)(2012-5#1)(2013-8#1)
model assumed##2##2##(2008-12#1)(2008-8#1)
model assumes that##5##3##(1994-5#1)(1995-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
model assumes##6##2##(1994-5#1)(1995-12#1)(2008-3#2)(2008-8#1)(2008-9#1)
model assumptions##5##2##(1995-9#3)(2008-8#1)(2013-1#1)
model at##7##2##(1993-8#1)(2008-11#1)(2008-2#3)(2008-3#1)(2011-1#1)
model averaging##4##2##(2009-10#1)(2010-11#1)(2012-3#2)
model based on a##2##4##(2009-8#1)(2010-7#1)
model based on the##23##4##(1994-3#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#4)(2008-8#1)(2009-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
model based on##57##3##(1994-3#1)(1997-7#2)(2007-11#8)(2007-12#4)(2007-7#1)(2008-10#10)(2008-12#2)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#2)(2010-8#3)(2011-1#1)(2012-2#1)(2013-1#2)
model based##59##2##(1994-3#1)(1997-7#2)(2007-11#8)(2007-12#4)(2007-7#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#2)(2010-8#3)(2011-1#1)(2012-2#1)(2013-1#2)
model because of##2##3##(2008-10#1)(2008-3#1)
model because##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
model behavior##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
model best described the##2##4##(2008-10#2)
model best##4##2##(1991-1#1)(2008-10#2)(2008-9#1)
model between##3##2##(1996-2#1)(1997-4#1)(2008-5#1)
model bilayer lipid membranes##2##4##(1997-7#2)
model building##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
model built##2##2##(2007-11#1)(2012-2#1)
model by a##2##3##(2008-10#1)(2008-7#1)
model by assuming that##2##4##(1995-9#1)(2011-2#1)
model by assuming##3##3##(1995-9#2)(2011-2#1)
model by means of##2##4##(1995-9#1)(2008-5#1)
model by which##2##3##(1994-2#1)(2012-2#1)
model by##19##2##(1993-11#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-9#3)(2006-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
model calculates the##2##3##(2008-10#1)(2008-7#1)
model calculation##2##2##(2008-10#1)(2008-3#1)
model calculations##6##2##(1997-6#1)(2007-11#1)(2008-2#2)(2008-3#2)
model can be applied to##2##5##(1996-12#1)(2008-2#1)
model can be applied##4##4##(1996-12#1)(2008-10#2)(2008-2#1)
model can be expressed##2##4##(1994-9#1)(2008-10#1)
model can be extended to##2##5##(2008-11#1)(2008-6#1)
model can be parameterized##2##4##(1997-4#1)(2008-3#1)
model can be used for##3##5##(2007-10#1)(2008-10#1)(2008-2#1)
model can be used to##5##5##(2008-10#1)(2008-3#2)(2010-8#1)(2013-8#1)
model can be used##9##4##(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)(2013-8#1)
model can be##28##3##(1992-6#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#2)(2009-11#1)(2010-8#1)(2013-8#2)
model can only##2##3##(2009-8#1)(2009-9#1)
model can##40##2##(1992-6#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-6#2)(2008-7#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
model captures##2##2##(2009-5#1)(2010-6#1)
model combined with##2##3##(2008-10#1)(2012-2#1)
model combining##2##2##(2008-6#1)(2009-6#1)
model compares favorably with##2##4##(2007-11#1)(2008-3#1)
model complexes##2##2##(1990-5#1)(1991-8#1)
model compound to##2##3##(1994-9#1)(2009-11#1)
model compound##16##2##(1993-8#1)(1994-9#1)(1995-12#1)(1995-5#3)(1996-2#1)(1997-2#1)(2008-10#6)(2008-6#1)(2009-11#1)
model compounds##14##2##(1993-11#1)(1994-5#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#1)
model considered##4##2##(1990-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
model considers##3##2##(2008-10#1)(2008-2#1)(2009-8#1)
model consisting of##2##3##(1992-8#1)(2011-1#1)
model consists of three##2##4##(1993-11#1)(1995-9#1)
model consists of##4##3##(1992-4#1)(1993-11#1)(1995-9#1)(1997-4#1)
model constructed##4##2##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
model containing##2##2##(2008-2#1)(2008-3#1)
model contains##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
model correctly predicts##2##3##(2008-10#1)(2008-3#1)
model correctly##5##2##(1993-12#2)(2008-10#2)(2008-3#1)
model could be##5##3##(1995-2#1)(2008-10#1)(2008-5#2)(2011-3#1)
model could##11##2##(1995-2#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-3#1)(2012-2#1)
model data##2##2##(2007-11#1)(2008-10#1)
model demonstrated##3##2##(2008-3#1)(2008-9#1)(2009-3#1)
model derived from##3##3##(2008-3#1)(2008-8#1)(2009-12#1)
model derived##5##2##(2008-3#3)(2008-8#1)(2009-12#1)
model described in this unit##2##5##(2008-4#2)
model described the##2##3##(2008-10#2)
model described##6##2##(1994-5#1)(2008-10#2)(2008-11#1)(2008-4#2)
model describes the##4##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)
model describes##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
model describing the##7##3##(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)
model describing##15##2##(1995-6#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)
model designed to simulate the##2##5##(1996-12#1)(2008-9#1)
model designed to##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
model designed##4##2##(1996-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
model developed and##2##3##(1994-3#1)(2008-10#1)
model developed by##4##3##(1997-3#1)(2007-12#1)(2008-3#1)(2010-5#1)
model developed for##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
model developed to##2##3##(1992-3#1)(1997-2#1)
model developed##16##2##(1992-3#1)(1994-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-5#1)
model discrimination##4##2##(2008-11#1)(2008-7#3)
model does##2##2##(1994-6#1)(2008-3#1)
model drug##4##2##(2008-5#2)(2008-7#1)(2013-1#1)
model due to##2##3##(2008-11#1)(2009-11#1)
model ecosystem##2##2##(2008-9#1)(2012-9#1)
model ecosystems##3##2##(2008-11#1)(2008-9#1)(2012-9#1)
model encompasses##2##2##(2010-6#1)(2010-8#1)
model enzyme##2##2##(2008-10#2)
model equation##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
model equations##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
model estimates the##2##3##(1997-4#1)(2010-6#1)
model estimates##3##2##(1992-3#1)(1997-4#1)(2010-6#1)
model exhibited##2##2##(2008-11#1)(2013-1#1)
model experiments##2##2##(1994-6#1)(2009-8#1)
model explained##3##2##(1996-3#1)(2008-10#2)
model explaining##2##2##(2008-10#1)(2010-2#1)
model explains##2##2##(2007-11#1)(2008-1#1)
model expresses##2##2##(2008-10#1)(2008-3#1)
model failed to predict##2##4##(2008-10#1)(2008-7#1)
model fails to##2##3##(2007-8#1)(2008-3#1)
model fit##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
model fits##5##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
model fitted##2##2##(2008-3#1)(2008-5#1)
model fitting##5##2##(2006-4#1)(2008-8#2)(2010-4#1)(2010-8#1)
model for a##13##3##(1990-7#1)(1990-8#1)(1996-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
model for aging research##2##4##(2009-5#1)(2012-3#1)
model for aging##3##3##(2009-12#1)(2009-5#1)(2012-3#1)
model for an##4##3##(1992-6#1)(1993-11#1)(1996-3#1)(2011-2#1)
model for analyzing the##3##4##(2008-4#1)(2009-11#1)(2013-1#1)
model for analyzing##4##3##(2007-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
model for assessing##2##3##(2008-5#1)(2008-7#1)
model for assessment of##2##4##(1993-1#1)(2008-12#1)
model for chemiluminescence##2##3##(2008-10#2)
model for clinical##2##3##(1995-12#1)(1997-2#1)
model for cometabolism##2##3##(2008-7#2)
model for delivering##2##3##(1992-2#1)(2011-2#1)
model for development##2##3##(1996-2#1)(2010-5#1)
model for disease##2##3##(2008-10#2)
model for emerging##5##3##(2010-8#5)
model for estimating the##3##4##(2008-3#2)(2013-1#1)
model for estimating##6##3##(1992-6#1)(1997-4#1)(2008-3#2)(2008-5#1)(2013-1#1)
model for evaluating the##2##4##(2008-2#1)(2012-12#1)
model for evaluating##5##3##(1994-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2012-12#1)
model for evolution of male parental care and female multiple mating##2##11##(2008-8#2)
model for exploring##2##3##(2008-4#1)(2008-8#1)
model for further##2##3##(1994-5#1)(2008-10#1)
model for gain##2##3##(2008-9#2)
model for health care##3##4##(1994-12#1)(1995-3#1)(2010-8#1)
model for health##4##3##(1994-12#1)(1995-3#1)(2010-8#2)
model for hospital##2##3##(1994-3#1)(2013-1#1)
model for how##3##3##(1995-2#1)(1996-2#1)(2011-2#1)
model for human##5##3##(2007-5#1)(2008-4#2)(2011-1#1)(2011-2#1)
model for infection##2##3##(2007-6#1)(2008-10#1)
model for investigating##2##3##(1992-5#1)(1997-4#1)
model for light distribution##2##4##(2008-2#1)(2008-7#1)
model for long-term##4##3##(2007-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
model for managing##2##3##(1991-1#1)(2012-3#1)
model for multiple sclerosis (MS)##2##5##(1995-12#1)(2007-11#1)
model for multiple sclerosis##3##4##(1995-12#1)(2007-11#1)(2010-12#1)
model for post-crash aircraft##2##4##(1996-12#2)
model for predicting the##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
model for predicting##8##3##(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
model for prediction of##2##4##(1990-3#1)(2008-10#1)
model for rating##2##3##(2008-10#1)(2012-2#1)
model for repeated##3##3##(1997-8#1)(2008-10#1)(2013-8#1)
model for research on##2##4##(2008-10#1)(2013-1#1)
model for risk##2##3##(1992-3#1)(1992-9#1)
model for screening##3##3##(1995-2#1)(1996-12#1)(2008-5#1)
model for stem##2##3##(2008-10#1)(2011-1#1)
model for stroke##2##3##(2007-10#1)(2013-1#1)
model for studies of##4##4##(1992-8#1)(1993-11#1)(1994-3#1)(2008-2#1)
model for studies##5##3##(1992-8#1)(1993-11#1)(1994-3#1)(1995-8#1)(2008-2#1)
model for studying scar tissue behavior##2##6##(2008-9#2)
model for studying the##7##4##(1990-5#1)(1992-5#1)(1994-11#1)(2008-11#1)(2009-2#1)(2009-5#1)(2012-12#1)
model for studying##16##3##(1990-5#2)(1992-5#1)(1994-11#1)(1995-2#2)(1995-3#1)(1996-12#1)(2008-11#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#1)(2012-12#1)
model for the analysis of##2##5##(2008-10#1)(2008-2#1)
model for the assessment of##3##5##(1991-1#1)(2008-11#2)
model for the continuous##2##4##(1993-12#1)(1997-4#1)
model for the evolution of##2##5##(2008-10#1)(2008-9#1)
model for the formation of##2##5##(1994-2#1)(2008-2#1)
model for the future##3##4##(1993-3#1)(2008-11#1)(2013-7#1)
model for the prediction of##2##5##(2008-10#1)(2008-7#1)
model for the solution structure of oxidized putidaredoxin##2##8##(1994-5#2)
model for the solution structure of##3##6##(1994-5#3)
model for the solution structure##4##5##(1994-5#4)
model for the study of the##3##6##(1994-9#1)(2008-7#1)(2012-3#1)
model for the study of##14##5##(1991-12#1)(1994-9#1)(1997-4#1)(2008-1#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-9#1)(2012-3#2)
model for the##136##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#7)(1994-9#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-3#3)(1997-2#1)(1997-3#1)(1997-4#4)(2007-10#1)(2007-11#3)(2007-12#6)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#17)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#5)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
model for these##2##3##(2008-7#1)(2010-2#1)
model for this##5##3##(1990-5#1)(1994-5#1)(2008-10#1)(2008-6#1)(2009-3#1)
model for understanding the##2##4##(2008-11#1)(2012-12#1)
model for##539##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#3)(1990-8#5)(1991-1#3)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#6)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#13)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#6)(1995-2#8)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#4)(1996-12#4)(1996-2#10)(1996-3#7)(1996-4#1)(1996-6#2)(1996-9#1)(1997-2#6)(1997-3#3)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#11)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#8)(2008-10#60)(2008-11#14)(2008-12#6)(2008-2#24)(2008-3#39)(2008-4#11)(2008-5#11)(2008-6#6)(2008-7#25)(2008-8#15)(2008-9#15)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#16)(2010-9#1)(2011-1#7)(2011-2#14)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#8)
model formulation##3##2##(2008-10#2)(2008-8#1)
model found##2##2##(1995-1#1)(2008-9#1)
model from which##2##3##(2007-11#1)(2008-9#1)
model from##4##2##(2007-11#1)(2008-9#1)(2009-2#1)(2012-2#1)
model function##2##2##(2008-3#1)(2013-8#1)
model further##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
model gave a##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
model gave##7##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#1)
model genetic##2##2##(2008-8#1)(2008-9#1)
model genome##2##2##(1995-2#1)(2008-7#1)
model gives##3##2##(1996-4#1)(2008-10#1)(2008-3#1)
model had##3##2##(2008-10#2)(2011-2#1)
model has a##7##3##(1995-5#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
model has been applied to the##2##6##(2007-12#1)(2008-10#1)
model has been applied to##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
model has been developed for##4##5##(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)
model has been developed to predict the##2##7##(2008-10#1)(2008-6#1)
model has been developed to##3##5##(2008-10#2)(2008-6#1)
model has been developed##9##4##(2007-8#1)(2008-10#3)(2008-3#2)(2008-6#2)(2009-7#1)
model has been used to##2##5##(1990-11#1)(2008-7#1)
model has been used##3##4##(1990-11#1)(2008-4#1)(2008-7#1)
model has been##30##3##(1990-11#1)(1992-9#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
model has the##2##3##(1994-2#1)(2008-10#1)
model has two##2##3##(2008-10#1)(2008-6#1)
model has##60##2##(1990-11#1)(1991-11#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-5#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
model have been evaluated##2##4##(1994-2#1)(2008-10#1)
model have##6##2##(1990-7#1)(1991-6#1)(1992-11#1)(1994-2#1)(2008-10#1)(2008-7#1)
model helps##2##2##(2008-2#1)(2008-5#1)
model identified##2##2##(2008-11#1)(2008-3#1)
model in a##2##3##(1996-5#1)(2008-10#1)
model in an##2##3##(2010-8#1)(2012-12#1)
model in both##2##3##(2007-11#1)(2012-12#1)
model in terms of##2##4##(2008-10#1)(2009-7#1)
model in the rabbit ear##3##5##(2008-9#3)
model in the##14##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-9#3)(2009-10#1)(2009-11#1)(2011-2#1)(2013-8#1)
model in time and##2##4##(2008-1#1)(2008-11#1)
model in vitro##3##3##(1990-5#1)(1993-3#1)(2008-11#1)
model in which a##2##4##(2008-10#1)(2008-8#1)
model in which both##2##4##(1995-2#1)(2010-5#1)
model in which the host##2##5##(2008-8#2)
model in which the##13##4##(1993-11#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-7#1)
model in which to study##2##5##(1994-8#1)(2008-2#1)
model in which to##3##4##(1994-8#1)(2008-2#1)(2009-5#1)
model in which##27##3##(1990-2#1)(1992-2#1)(1993-11#2)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#1)(2009-7#2)(2010-5#1)(2010-7#1)
model in##83##2##(1990-2#2)(1990-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#2)(2009-5#1)(2009-7#3)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
model include##3##2##(1997-4#1)(2008-3#1)(2008-4#1)
model included##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#1)
model includes the##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
model includes##10##2##(1992-12#1)(1993-8#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
model including the##3##3##(2007-12#1)(2008-7#2)
model including##7##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2011-2#1)
model incorporating##11##2##(1992-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2013-8#1)
model input##3##2##(2008-3#2)(2013-8#1)
model integrating##2##2##(2008-10#1)(2010-4#1)
model into##3##2##(1991-1#1)(2008-10#1)(2009-5#1)
model involving##5##2##(1990-11#1)(1990-7#1)(2007-12#2)(2008-11#1)
model is a##9##3##(1994-8#1)(1995-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-1#1)
model is able to##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
model is also##2##3##(2008-2#1)(2011-1#1)
model is an##2##3##(2008-10#1)(2010-2#1)
model is applied to##5##4##(2008-11#1)(2008-3#3)(2013-8#1)
model is based on a##2##5##(2008-10#1)(2008-3#1)
model is based on the assumption##2##6##(2008-10#2)
model is based on the##9##5##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
model is based on##16##4##(1990-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2011-2#1)(2013-1#1)
model is being##2##3##(1997-1#1)(1997-4#1)
model is compared with experimental##2##5##(2007-11#1)(2008-2#1)
model is compatible with##2##4##(1995-6#1)(2008-7#1)
model is consistent with##2##4##(2008-8#1)(2010-10#1)
model is constructed##2##3##(1995-9#1)(2011-2#1)
model is demonstrated to##2##4##(2007-12#1)(2008-6#1)
model is demonstrated##3##3##(2007-12#1)(2008-6#1)(2009-9#1)
model is derived##2##3##(1997-5#1)(1997-8#1)
model is described##3##3##(1995-12#1)(2008-1#1)(2008-2#1)
model is determined##2##3##(1996-4#1)(2008-3#1)
model is developed for a##2##5##(1993-12#1)(2008-3#1)
model is developed for##7##4##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)
model is developed that accounts for the##2##7##(2008-2#1)(2008-3#1)
model is developed that##3##4##(2008-2#2)(2008-3#1)
model is developed to describe the##2##6##(1992-6#1)(2010-5#1)
model is developed to##3##4##(1992-6#1)(2008-3#1)(2010-5#1)
model is developed##17##3##(1992-12#1)(1992-6#1)(1993-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)
model is extended##2##3##(1992-6#1)(2009-12#1)
model is formulated##2##3##(2008-2#1)(2008-7#1)
model is intended for use in##2##6##(2008-10#1)(2008-2#1)
model is intended##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
model is introduced##2##3##(1997-8#1)(2010-11#1)
model is not##3##3##(1990-8#1)(1992-8#1)(2008-2#1)
model is of##2##3##(2012-2#1)(2013-1#1)
model is particularly##2##3##(2008-10#1)(2008-9#1)
model is presented and##2##4##(2008-11#1)(2011-1#1)
model is presented to##5##4##(2008-10#1)(2008-2#3)(2008-7#1)
model is presented together with##2##5##(2008-2#1)(2008-3#1)
model is presented##13##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#2)(2011-1#1)
model is proposed for##3##4##(1990-8#1)(1996-2#1)(2008-10#1)
model is proposed to describe##2##5##(2008-10#2)
model is proposed to##3##4##(2007-11#1)(2008-10#2)
model is proposed##11##3##(1990-2#1)(1990-8#1)(1992-3#1)(1995-1#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-8#1)(2012-3#1)
model is robust##2##3##(2008-4#1)(2008-8#1)
model is studied##2##3##(2008-10#1)(2008-2#1)
model is suggested##2##3##(2008-3#1)(2008-5#1)
model is tested##2##3##(1997-3#1)(2008-7#1)
model is that##6##3##(1995-1#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)
model is the##2##3##(1993-11#1)(2011-2#1)
model is then##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
model is to##3##3##(1996-12#2)(2008-1#1)
model is used to compare the##2##6##(1990-7#1)(2009-7#1)
model is used to describe##2##5##(2008-10#1)(2008-2#1)
model is used to obtain##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
model is used to predict##2##5##(2008-11#1)(2008-6#1)
model is used to##22##4##(1990-7#1)(1992-6#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2013-8#1)
model is used##30##3##(1990-7#1)(1992-6#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2013-8#1)
model is useful##4##3##(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
model is valid##2##3##(2007-12#1)(2008-2#1)
model is##242##2##(1990-2#1)(1990-7#1)(1990-8#3)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#3)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2007-11#6)(2007-12#6)(2007-6#1)(2008-1#3)(2008-10#31)(2008-11#10)(2008-2#25)(2008-3#38)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#15)(2008-8#11)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#6)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#5)
model it is##2##3##(1995-12#1)(2008-11#1)
model it##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
model leads to##2##3##(2008-2#1)(2008-3#1)
model leads##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
model lipid##5##2##(2008-10#1)(2008-4#1)(2008-5#3)
model made##2##2##(2008-2#1)(2011-2#1)
model make it##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
model makes the##2##3##(2008-8#1)(2013-8#1)
model makes##5##2##(2008-8#3)(2008-9#1)(2013-8#1)
model may be used to##2##5##(1992-6#1)(2011-1#1)
model may be used##3##4##(1992-6#1)(2008-10#1)(2011-1#1)
model may be##8##3##(1992-6#1)(2008-10#3)(2008-7#1)(2009-11#1)(2010-2#1)(2011-1#1)
model may##16##2##(1991-2#1)(1992-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#1)(2012-3#1)
model membrane##4##2##(1990-2#1)(1991-9#1)(1994-5#1)(2008-10#1)
model membranes##7##2##(1994-12#1)(1997-2#1)(2008-10#3)(2009-7#1)(2012-2#1)
model might be##2##3##(1994-6#1)(2008-5#1)
model might##3##2##(1994-12#1)(1994-6#1)(2008-5#1)
model mimics the##2##3##(2008-7#1)(2008-8#1)
model misspecification and##2##3##(1997-3#2)
model misspecification##4##2##(1992-6#1)(1992-9#1)(1997-3#2)
model monocot##2##2##(2008-10#1)(2013-8#1)
model most##2##2##(2008-10#1)(2013-8#1)
model must##3##2##(1997-3#1)(2008-5#1)(2010-6#1)
model observer##4##2##(2012-1#4)
model obtained##3##2##(2007-11#1)(2008-10#1)(2013-7#1)
model of &quot##2##3##(1991-1#1)(2008-12#1)
model of Alzheimer's disease##3##4##(2008-10#2)(2008-5#1)
model of HA##2##3##(2008-10#1)(2011-2#1)
model of Parkinson's disease##3##4##(1995-12#1)(2008-12#1)(2013-7#1)
model of Rett syndrome##2##4##(2012-2#2)
model of a red blood cell##2##6##(2013-1#2)
model of a##22##3##(1991-2#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
model of acculturation##2##3##(2008-8#2)
model of acute##3##3##(2006-6#1)(2008-8#2)
model of an##6##3##(1993-8#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-3#1)(2011-2#1)
model of assessment##2##3##(2008-11#2)
model of atherosclerosis##3##3##(1993-6#1)(2008-11#1)(2008-6#1)
model of autobiographical memory##3##4##(2008-2#3)
model of binding equilibria##2##4##(2012-2#2)
model of bone##2##3##(1991-5#1)(2009-4#1)
model of care##4##3##(1997-3#1)(2007-10#1)(2008-1#1)(2009-10#1)
model of case##2##3##(1996-1#1)(2008-2#1)
model of choice for##2##4##(2008-7#1)(2008-9#1)
model of chronic##4##3##(2008-4#1)(2009-6#1)(2011-2#2)
model of coupled##3##3##(2007-12#1)(2009-8#1)(2013-1#1)
model of cutaneous candidosis##2##4##(2008-5#2)
model of degenerative disc disease##2##5##(2012-3#2)
model of depression##3##3##(1996-7#1)(2008-6#1)(2011-2#1)
model of epilepsy##2##3##(1994-2#2)
model of focal cerebral ischemia##3##5##(1995-12#1)(1997-6#2)
model of heart failure##3##4##(2010-6#3)
model of heart##4##3##(2007-8#1)(2010-6#3)
model of homosexuality##4##3##(2008-12#4)
model of how##3##3##(2009-9#1)(2010-5#1)(2013-1#1)
model of human##12##3##(1992-11#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-2#2)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)
model of illness##2##3##(1997-1#1)(2013-8#1)
model of insulin resistance##2##4##(2008-3#1)(2010-10#1)
model of interpersonal##2##3##(2009-9#1)(2012-3#1)
model of invasive##2##3##(2013-8#2)
model of ischemic retinopathy##2##4##(2012-2#2)
model of laser##2##3##(2008-3#2)
model of leptospirosis##2##3##(2008-9#2)
model of light scattering by an oriented monodisperse system of triaxial dielectric ellipsoids##2##13##(2008-2#2)
model of memory##2##3##(1993-12#1)(1994-6#1)
model of mononeuropathy##3##3##(1993-12#1)(1997-2#2)
model of multiple sclerosis##2##4##(2012-2#2)
model of myocardial IR##2##4##(2012-2#2)
model of neointima formation in##2##5##(2007-8#2)
model of neural##3##3##(2008-11#2)(2010-1#1)
model of neuropathic##2##3##(1993-12#1)(1996-5#1)
model of obesity##2##3##(2008-4#1)(2011-2#1)
model of osteosarcoma##2##3##(2008-6#1)(2010-3#1)
model of overall acceptability##2##4##(2010-4#2)
model of primary##2##3##(1995-3#1)(2008-11#1)
model of regulation of##2##4##(2008-11#1)(2008-9#1)
model of rehabilitation##2##3##(2007-11#2)
model of resource##2##3##(1995-2#1)(2008-8#1)
model of scientific##2##3##(1991-5#1)(2009-11#1)
model of service##2##3##(2011-1#2)
model of sex chromosome evolution##2##5##(2010-5#2)
model of social##3##3##(2010-2#1)(2012-3#1)(2013-1#1)
model of suicide##2##3##(2010-6#1)(2012-12#1)
model of support##2##3##(1992-3#1)(1994-3#1)
model of temperature##2##3##(2008-1#1)(2013-8#1)
model of the NPC##3##4##(2011-2#3)
model of the complex##4##4##(2008-1#1)(2008-10#1)(2009-8#1)(2011-1#1)
model of the effects of##2##5##(1992-1#1)(2008-10#1)
model of the human##4##4##(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
model of the##105##3##(1990-6#1)(1990-8#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#16)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-5#2)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#4)(2013-8#1)
model of this##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
model of tumor##2##3##(2007-5#1)(2013-8#1)
model of type##2##3##(2008-10#1)(2012-12#1)
model of ulcerative##2##3##(2008-12#2)
model of visual##2##3##(2008-11#2)
model of##635##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#8)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#5)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-6#2)(2007-10#3)(2007-11#5)(2007-12#14)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#8)(2008-10#39)(2008-11#38)(2008-12#13)(2008-2#21)(2008-3#44)(2008-4#19)(2008-5#14)(2008-6#12)(2008-7#22)(2008-8#41)(2008-9#23)(2009-10#1)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#5)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#8)(2010-6#6)(2010-8#4)(2011-1#5)(2011-2#18)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#26)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#21)
model on the##4##3##(1994-2#1)(1997-3#1)(2008-10#2)
model on##8##2##(1994-2#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2012-3#1)
model only##2##2##(2008-10#1)(2013-1#1)
model or##6##2##(1992-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-8#1)
model organism for studying##2##4##(2011-2#2)
model organism for##4##3##(2008-10#1)(2009-12#1)(2011-2#2)
model organism to##4##3##(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#1)
model organism##18##2##(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-3#1)
model organisms for##2##3##(2008-10#1)(2008-8#1)
model organisms##13##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-6#1)(2012-2#1)
model originally##3##2##(1997-2#1)(2008-1#1)(2013-8#1)
model outputs##3##2##(2008-10#1)(2013-1#2)
model over the##2##3##(2008-10#1)(2008-3#1)
model parameter values##2##3##(2008-10#1)(2008-3#1)
model parameter##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2010-9#1)(2013-8#1)
model parameters to##3##3##(1997-8#1)(2008-3#1)(2011-1#1)
model parameters##33##2##(1994-11#1)(1997-8#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#9)(2008-8#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
model peptide##5##2##(1990-7#1)(1991-9#1)(1992-6#1)(1993-11#2)
model peptides##2##2##(1995-11#1)(2008-5#1)
model performance was##2##3##(2008-10#1)(2009-7#1)
model performance##5##2##(2008-10#1)(2009-7#2)(2013-8#2)
model permitted the##2##3##(1990-12#1)(2008-10#1)
model phenotypes##2##2##(1997-6#1)(2011-1#1)
model plant##11##2##(1996-12#1)(2008-10#2)(2008-7#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#2)
model predicted a##2##3##(2008-7#1)(2008-9#1)
model predicted that the optimal offspring size##2##7##(2008-8#2)
model predicted that##4##3##(2008-7#1)(2008-8#3)
model predicted the##2##3##(2008-10#1)(2008-7#1)
model predicted##11##2##(2008-10#2)(2008-3#1)(2008-7#4)(2008-8#3)(2008-9#1)
model predicting the##2##3##(1993-2#1)(2007-12#1)
model predicting##3##2##(1993-2#1)(2007-12#1)(2008-10#1)
model prediction##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
model predictions are##2##3##(2008-7#1)(2008-8#1)
model predictions were less##2##4##(2008-8#1)(2009-7#1)
model predictions were##3##3##(2008-10#1)(2008-8#1)(2009-7#1)
model predictions##19##2##(2008-10#4)(2008-11#1)(2008-2#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#1)(2013-8#1)
model predictive performance##2##3##(2008-7#2)
model predictive##4##2##(2008-7#2)(2009-11#1)(2013-1#1)
model predicts a##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
model predicts that the##3##4##(1992-12#1)(2008-2#1)(2008-8#1)
model predicts that##14##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#6)(2008-9#2)(2011-2#1)(2013-1#1)
model predicts the##4##3##(2008-2#1)(2008-3#2)(2008-8#1)
model predicts##29##2##(1992-12#1)(1992-6#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#3)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
model presented##2##2##(2008-10#1)(2008-11#1)
model previously##3##2##(2008-10#3)
model proposed by##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
model proposed##5##2##(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
model protein##8##2##(1992-6#1)(1996-12#1)(1997-8#2)(2008-10#2)(2008-11#1)(2009-9#1)
model proteins##4##2##(1990-12#1)(1992-6#1)(1995-2#2)
model provided a better fit##2##5##(2008-10#1)(2009-8#1)
model provided a##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
model provided the best fit in##2##6##(2008-10#2)
model provided the best##3##4##(2008-10#3)
model provided the##4##3##(2008-10#4)
model provided##9##2##(2008-10#6)(2008-11#1)(2009-8#1)(2011-2#1)
model provides a useful##2##4##(1997-3#1)(2007-8#1)
model provides a##7##3##(1992-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
model provides an##4##3##(1995-9#1)(2008-10#1)(2008-3#2)
model provides##20##2##(1992-5#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)
model quality##2##2##(1997-1#1)(2008-10#1)
model ranged from 0##3##4##(2008-10#1)(2011-2#2)
model ranged from##4##3##(2008-10#2)(2011-2#2)
model rats with##2##3##(2008-8#1)(2013-8#1)
model rats##6##2##(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
model reaction##2##2##(2008-10#1)(2008-7#1)
model recombination and repair intermediates##2##5##(1994-9#2)
model reduces##2##2##(2008-10#1)(2008-5#1)
model relating##2##2##(2008-10#1)(2008-3#1)
model relative##4##2##(1992-6#1)(2008-10#2)(2013-7#1)
model remains##2##2##(2007-8#1)(2011-2#1)
model represents an##2##3##(1997-4#1)(2008-9#1)
model represents##3##2##(1997-4#1)(2008-10#1)(2008-9#1)
model reproduces##3##2##(1997-3#1)(2007-12#1)(2008-10#1)
model requires##4##2##(1996-2#1)(2008-10#2)(2008-3#1)
model resulted in##2##3##(2008-10#1)(2012-12#1)
model results indicate that##2##4##(2008-3#1)(2008-8#1)
model results indicate##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
model results##12##2##(1996-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)
model revealed a##2##3##(2008-10#1)(2008-11#1)
model revealed##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)
model reveals##2##2##(2008-8#1)(2010-8#1)
model rural hospitals##3##3##(1993-12#3)
model sample##3##2##(2008-10#3)
model seems##2##2##(2008-3#1)(2008-7#1)
model selected##2##2##(2008-10#2)
model selection and model averaging##2##5##(2009-10#1)(2012-3#1)
model selection and##7##3##(2008-4#1)(2009-10#1)(2010-8#1)(2011-1#3)(2012-3#1)
model selection##15##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#5)(2009-12#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-3#1)
model should be useful##2##4##(1995-6#1)(2008-10#1)
model should be##7##3##(1995-6#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
model should##10##2##(1995-6#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
model showed that##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
model showed##7##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#2)(2013-1#1)
model showing##2##2##(1992-12#1)(2008-9#1)
model shows that the##3##4##(2008-4#1)(2008-8#2)
model shows that##12##3##(2007-11#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#1)
model shows##14##2##(2007-11#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#6)(2008-9#1)
model simulates##3##2##(2008-10#2)(2013-8#1)
model simulation##3##2##(2008-7#3)
model simulations##4##2##(2008-10#1)(2008-3#2)(2012-2#1)
model so that##2##3##(2008-2#1)(2008-9#1)
model solution##2##2##(2008-10#1)(2008-7#1)
model solutions##5##2##(2008-10#5)
model species##4##2##(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)
model specifications##2##2##(2009-11#1)(2011-1#1)
model states that##2##3##(1997-1#1)(2008-8#1)
model structure##3##2##(1992-2#1)(2008-8#2)
model studied##2##2##(2008-9#1)(2009-1#1)
model studies##3##2##(1995-6#1)(2007-7#1)(2008-7#1)
model study##8##2##(1990-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
model substrate##5##2##(1997-6#1)(2008-10#3)(2008-4#1)
model successfully##2##2##(2008-3#1)(2008-7#1)
model such##2##2##(2008-10#1)(2008-6#1)
model suggesting that##2##3##(1990-11#1)(1997-4#1)
model suggests a##3##3##(1990-8#1)(1991-9#1)(2007-12#1)
model suggests that##11##3##(1992-4#1)(1995-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
model suggests##17##2##(1990-7#1)(1990-8#1)(1991-9#1)(1992-4#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
model system for investigating##2##4##(2007-12#1)(2008-4#1)
model system for studying##4##4##(1995-3#1)(2008-10#1)(2009-2#1)(2009-8#1)
model system for the study of##2##6##(2008-4#1)(2012-3#1)
model system for the##5##4##(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#1)
model system for##22##3##(1992-6#1)(1994-9#1)(1995-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)
model system in which##2##4##(1992-12#1)(1997-3#1)
model system in##4##3##(1992-12#1)(1994-8#1)(1997-3#1)(2008-9#1)
model system to study##5##4##(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#2)
model system to##14##3##(1995-9#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
model system was##3##3##(1990-11#1)(1997-4#1)(2008-10#1)
model system##98##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#5)(2008-10#21)(2008-11#10)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)
model systems and##2##3##(1996-12#1)(2009-3#1)
model systems by##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
model systems for##5##3##(1996-2#1)(2008-10#1)(2008-4#2)(2008-9#1)
model systems may##2##3##(2008-6#1)(2009-3#1)
model systems using##2##3##(2008-10#1)(2008-7#1)
model systems with##2##3##(1997-6#1)(2008-10#1)
model systems##39##2##(1990-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-6#3)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-10#2)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
model takes##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
model taking##2##2##(1990-8#1)(2008-11#1)
model that accounts for##2##4##(1992-9#1)(2008-3#1)
model that allows##6##3##(1992-6#1)(1994-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-9#1)
model that assumes##3##3##(2008-2#1)(2008-3#2)
model that can be##2##4##(2008-11#1)(2008-3#1)
model that can##4##3##(1997-3#1)(2008-11#1)(2008-3#1)(2008-7#1)
model that contains##2##3##(2008-3#1)(2009-9#1)
model that describes the##6##4##(2007-11#3)(2008-10#1)(2008-2#1)(2008-8#1)
model that describes##8##3##(2007-11#3)(2008-10#1)(2008-2#1)(2008-8#1)(2009-9#1)(2013-8#1)
model that explains##2##3##(2007-12#1)(2012-2#1)
model that has##2##3##(2008-3#1)(2008-8#1)
model that includes the effects of##2##6##(2008-2#1)(2010-10#1)
model that includes##9##3##(1991-5#1)(1994-1#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-10#2)
model that incorporates the##2##4##(2008-11#1)(2008-7#1)
model that incorporates##5##3##(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
model that is used to##2##5##(2008-3#1)(2008-4#1)
model that is##7##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-2#1)
model that may##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
model that predicts the##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
model that predicts##8##3##(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)
model that provides##3##3##(2008-3#2)(2011-2#1)
model that simulates the##5##4##(1994-6#1)(2008-10#4)
model that takes into account the##2##6##(2008-3#1)(2009-2#1)
model that takes into account##4##5##(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)
model that uses##5##3##(1997-2#1)(2007-12#1)(2008-3#1)(2008-8#2)
model that utilizes##2##3##(1996-3#1)(2010-8#1)
model that was developed##2##4##(2008-1#1)(2008-10#1)
model that was##5##3##(2008-1#1)(2008-10#3)(2011-2#1)
model that##129##2##(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#5)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#20)(2008-4#1)(2008-7#5)(2008-8#14)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
model the omitted variables are assumed to be##2##8##(1992-6#2)
model the response##2##3##(2008-7#1)(2008-8#1)
model the##58##2##(1992-6#2)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-2#6)(2008-3#16)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#4)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
model therefore##2##2##(2013-1#2)
model this##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
model through##2##2##(1997-1#1)(2013-1#1)
model to a set of##2##5##(2008-10#1)(2013-8#1)
model to a##9##3##(1996-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-8#1)
model to accommodate##2##3##(1995-2#1)(2008-10#1)
model to analyze the##2##4##(1997-1#1)(2012-2#1)
model to analyze##3##3##(1997-1#1)(2008-10#1)(2012-2#1)
model to assess the effects of##2##6##(1997-8#1)(2008-8#1)
model to assess the##3##4##(1997-8#1)(2008-5#1)(2008-8#1)
model to assess##4##3##(1997-8#1)(2008-3#1)(2008-5#1)(2008-8#1)
model to data##4##3##(1994-2#1)(2008-10#1)(2008-8#1)(2009-9#1)
model to derive##2##3##(1997-2#1)(2008-2#1)
model to describe the##4##4##(1991-11#1)(1992-9#1)(2008-10#1)(2012-2#1)
model to describe##7##3##(1991-11#1)(1992-9#1)(2008-10#2)(2008-7#2)(2012-2#1)
model to determine##2##3##(1993-12#1)(2011-2#1)
model to estimate the##4##4##(1994-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
model to estimate##5##3##(1993-12#1)(1994-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
model to evaluate the##2##4##(2008-4#1)(2011-2#1)
model to evaluate##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
model to explain the##3##4##(2008-3#1)(2012-3#1)(2013-1#1)
model to explain##4##3##(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
model to fit##2##3##(1997-8#1)(2008-10#1)
model to generate##2##3##(2008-8#1)(2008-9#1)
model to guide##2##3##(1993-12#1)(2008-10#1)
model to handle##2##3##(2008-6#2)
model to illustrate##2##3##(2010-8#1)(2012-2#1)
model to include##4##3##(1992-3#1)(1994-2#1)(2008-11#1)(2009-7#1)
model to investigate the##3##4##(2008-10#1)(2008-3#1)(2012-1#1)
model to investigate##5##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#1)
model to link##2##3##(2008-10#1)(2012-3#1)
model to optimize the##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
model to optimize##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
model to predict the##8##4##(1997-4#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-8#1)(2011-2#1)
model to predict##14##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-2#1)
model to provide a##2##4##(2008-3#2)
model to provide##3##3##(2008-3#3)
model to quantify##2##3##(2008-3#2)
model to show##2##3##(2008-8#2)
model to simulate the##2##4##(2008-11#1)(2008-2#1)
model to simulate##5##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)
model to study the##10##4##(1993-9#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#1)
model to study##21##3##(1993-9#1)(1994-5#2)(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
model to test##2##3##(2008-8#1)(2013-7#1)
model to the measured##2##4##(2008-2#2)
model to the##8##3##(1991-1#1)(1994-2#1)(2008-2#2)(2008-3#2)(2011-2#1)(2012-3#1)
model to understand##3##3##(1990-7#1)(1995-12#1)(2011-10#1)
model to##196##2##(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-12#4)(1993-9#1)(1994-11#1)(1994-2#4)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-9#1)(1996-2#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#3)(2008-2#10)(2008-3#24)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#14)(2008-9#8)(2009-10#1)(2009-11#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#5)(2011-1#1)(2011-10#1)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#3)
model together with##2##3##(2008-3#1)(2013-1#1)
model under##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
model used by##2##3##(1997-3#1)(2008-3#1)
model used to##6##3##(1995-2#1)(1995-6#1)(2008-11#1)(2008-4#1)(2010-9#1)(2012-2#1)
model used##13##2##(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-9#1)(2012-2#1)
model uses##5##2##(1996-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
model using a##2##3##(2007-11#1)(2011-2#1)
model using the##7##3##(1994-5#1)(2008-10#2)(2008-5#1)(2008-8#3)
model using##28##2##(1992-9#1)(1994-5#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#1)
model utilizing##2##2##(1993-12#1)(1995-8#1)
model variables##3##2##(2008-7#1)(2009-10#1)(2012-3#1)
model via the##2##3##(2008-3#2)
model via##3##2##(2008-3#2)(2008-7#1)
model was able to explain##2##5##(2008-10#1)(2008-6#1)
model was able to##5##4##(2008-10#3)(2008-6#1)(2013-1#1)
model was also##6##3##(1995-8#1)(2008-10#2)(2008-3#2)(2008-7#1)
model was applied to##6##4##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-3#1)
model was applied##7##3##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-3#1)
model was built##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
model was constructed##5##3##(1993-12#1)(2008-12#1)(2008-6#1)(2010-8#1)(2011-1#1)
model was designed##2##3##(1995-2#1)(2012-12#1)
model was developed and##2##4##(2008-10#2)
model was developed for##4##4##(2008-10#1)(2008-3#2)(2008-9#1)
model was developed in##4##4##(1996-2#1)(2008-10#2)(2008-11#1)
model was developed relating##2##4##(2008-10#1)(2008-2#1)
model was developed to describe the##2##6##(2008-10#1)(2008-3#1)
model was developed to simulate##3##5##(2008-10#2)(2008-3#1)
model was developed to##13##4##(1992-2#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)
model was developed##33##3##(1992-2#1)(1996-2#1)(2008-10#15)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#2)(2008-9#2)(2012-2#1)(2013-1#1)
model was employed to##4##4##(2008-10#1)(2008-8#1)(2009-5#1)(2013-8#1)
model was employed##5##3##(2008-10#1)(2008-8#1)(2009-5#1)(2012-12#1)(2013-8#1)
model was found to##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
model was generated##2##3##(2008-1#1)(2009-3#1)
model was of a##2##4##(2008-7#2)
model was proposed##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
model was tested against##2##4##(2008-10#2)
model was tested in the##2##5##(2008-10#1)(2008-7#1)
model was tested in##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
model was tested##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
model was then used to predict the##2##7##(2008-3#1)(2008-7#1)
model was then##4##3##(1992-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
model was used for##5##4##(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)
model was used to assess##2##5##(1995-2#1)(2013-1#1)
model was used to construct a##2##6##(2008-10#2)
model was used to##13##4##(1991-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#2)
model was used##22##3##(1991-2#1)(1995-2#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
model was validated by##2##4##(2008-10#1)(2008-7#1)
model was validated##6##3##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
model was##168##2##(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-2#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#56)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#4)(2008-6#7)(2008-7#16)(2008-8#5)(2008-9#4)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#5)
model we##8##2##(1992-9#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-3#1)
model well##2##2##(2008-11#1)(2011-2#1)
model were compared##2##3##(1990-5#1)(2008-3#1)
model were used##2##3##(2008-10#1)(2013-1#1)
model were##17##2##(1990-5#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-10#8)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#2)
model when the##2##3##(2008-3#1)(2009-5#1)
model when##10##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#2)(2009-5#1)(2011-2#2)
model where the##2##3##(1991-8#1)(1994-2#1)
model where##12##2##(1991-8#1)(1994-2#1)(1995-2#1)(1995-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-1#1)
model which could##2##3##(2008-10#1)(2010-8#1)
model which makes it##2##4##(2008-10#1)(2013-8#1)
model which##23##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-4#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
model will be##7##3##(1995-2#1)(1997-3#1)(2006-10#1)(2008-11#1)(2010-4#1)(2010-8#1)(2013-1#1)
model will##13##2##(1992-1#1)(1992-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
model with a##15##3##(1994-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-7#2)(2009-7#1)(2009-8#1)(2011-3#1)(2013-8#1)
model with an##6##3##(1994-2#1)(1996-3#1)(2008-7#1)(2010-1#1)(2010-10#1)(2012-2#1)
model with separate##3##3##(2008-3#2)(2009-7#1)
model with the##4##3##(2008-3#2)(2008-8#1)(2011-2#1)
model with three##2##3##(2008-10#1)(2008-9#1)
model with two##2##3##(2008-10#2)
model with##82##2##(1992-9#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-4#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-2#3)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#7)
model without##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
model would##3##2##(1994-11#1)(2008-11#1)(2008-6#1)
model yields##2##2##(2008-3#1)(2010-9#1)
model##5215##1##(1990-11#8)(1990-12#12)(1990-2#10)(1990-3#1)(1990-5#10)(1990-6#1)(1990-7#17)(1990-8#23)(1991-1#16)(1991-11#2)(1991-12#10)(1991-2#7)(1991-3#1)(1991-5#12)(1991-6#5)(1991-7#1)(1991-8#6)(1991-9#13)(1992-1#15)(1992-10#2)(1992-11#6)(1992-12#21)(1992-2#15)(1992-3#18)(1992-4#6)(1992-5#11)(1992-6#28)(1992-8#8)(1992-9#21)(1993-1#7)(1993-11#19)(1993-12#30)(1993-2#7)(1993-3#3)(1993-5#2)(1993-6#5)(1993-8#15)(1993-9#3)(1994-1#5)(1994-10#1)(1994-11#8)(1994-12#17)(1994-2#28)(1994-3#16)(1994-5#31)(1994-6#8)(1994-7#2)(1994-8#10)(1994-9#13)(1995-1#9)(1995-11#3)(1995-12#25)(1995-2#43)(1995-3#18)(1995-4#1)(1995-5#18)(1995-6#9)(1995-8#4)(1995-9#24)(1996-1#13)(1996-10#1)(1996-12#43)(1996-2#39)(1996-3#31)(1996-4#17)(1996-5#11)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#19)(1997-2#39)(1997-3#33)(1997-4#24)(1997-5#7)(1997-6#13)(1997-7#20)(1997-8#20)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#4)(2007-1#1)(2007-10#16)(2007-11#92)(2007-12#86)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#15)(2008-1#33)(2008-10#779)(2008-11#208)(2008-12#59)(2008-2#209)(2008-3#451)(2008-4#107)(2008-5#113)(2008-6#80)(2008-7#268)(2008-8#298)(2008-9#162)(2009-1#1)(2009-10#24)(2009-11#34)(2009-12#18)(2009-2#11)(2009-3#18)(2009-4#6)(2009-5#25)(2009-6#10)(2009-7#40)(2009-8#43)(2009-9#25)(2010-1#7)(2010-10#17)(2010-11#18)(2010-12#9)(2010-2#20)(2010-3#5)(2010-4#25)(2010-5#30)(2010-6#18)(2010-7#11)(2010-8#64)(2010-9#8)(2011-1#72)(2011-10#1)(2011-2#124)(2011-3#16)(2012-1#22)(2012-12#41)(2012-2#94)(2012-3#58)(2012-4#4)(2012-5#1)(2012-9#2)(2013-1#136)(2013-7#16)(2013-8#116)
model'##3##1##(1992-9#1)(2008-11#1)(2008-9#1)
model's predictions##3##2##(1995-2#1)(2008-3#1)(2008-8#1)
model's##16##1##(1992-2#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2010-4#1)(2010-8#1)(2011-3#1)(2012-12#1)(2013-8#2)
model) for##2##2##(2008-3#1)(2008-7#1)
model)##17##1##(1993-11#2)(1995-11#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2013-8#3)
model-based approach to##2##3##(1994-11#1)(2008-10#1)
model-based approach##5##2##(1994-11#2)(2008-10#1)(2008-8#1)(2013-8#1)
model-based##19##1##(1994-11#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
model-based&quot##2##1##(2008-4#1)(2011-1#1)
model-free##2##1##(2008-3#1)(2008-4#1)
model-free&quot##2##1##(2008-4#1)(2011-1#1)
model]##5##1##(1992-11#1)(1997-6#1)(2011-3#1)(2012-3#1)(2013-1#1)
modeled UV##2##2##(2008-3#2)
modeled aerosol##2##2##(2008-3#2)
modeled and measured UV##2##4##(2008-3#2)
modeled and measured##3##3##(2008-3#3)
modeled and##8##2##(2008-3#6)(2010-5#1)(2011-2#1)
modeled as a function of##2##5##(2008-10#2)
modeled as a##10##3##(1996-4#1)(2008-10#3)(2008-3#3)(2008-8#1)(2010-3#1)(2013-1#1)
modeled as##15##2##(1996-4#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-8#1)(2010-3#1)(2013-1#1)
modeled by an##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
modeled by the##2##3##(2008-2#1)(2009-9#1)
modeled by##18##2##(1994-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#1)(2009-8#1)(2009-9#1)(2010-4#1)
modeled from##2##2##(2011-1#1)(2013-1#1)
modeled in##3##2##(2008-11#1)(2009-9#1)(2012-1#1)
modeled on##3##2##(1993-1#1)(1994-8#1)(2012-3#1)
modeled the##10##2##(2008-10#1)(2008-2#1)(2008-3#6)(2008-8#1)(2010-10#1)
modeled through a stratified medium##2##5##(2008-3#2)
modeled to##3##2##(2008-10#1)(2008-2#2)
modeled using a##2##3##(1992-12#1)(2009-11#1)
modeled using the##2##3##(2008-7#1)(2011-2#1)
modeled using##11##2##(1992-12#1)(2007-10#1)(2008-10#3)(2008-7#3)(2009-11#1)(2011-2#1)(2013-1#1)
modeled versus##2##2##(2008-10#1)(2008-2#1)
modeled with a##4##3##(2008-10#3)(2008-3#1)
modeled with the##2##3##(2008-3#1)(2010-3#1)
modeled with##14##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-8#1)(2010-3#1)(2013-1#1)
modeled##141##1##(1992-12#1)(1993-1#1)(1994-5#1)(1994-8#1)(1996-4#2)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#21)(2008-11#6)(2008-2#14)(2008-3#50)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-3#2)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#6)(2013-7#1)
modeled-unmodeled##3##1##(2008-3#3)
modelers##2##1##(2010-5#2)
modeless##6##1##(2008-2#6)
modeling analyses##2##2##(2009-7#1)(2010-9#1)
modeling and design of##2##4##(2008-3#2)
modeling and design##3##3##(2008-3#3)
modeling and experiment##2##3##(2007-12#2)
modeling and experimental uncertainty##2##4##(2008-7#2)
modeling and experimental##4##3##(2008-7#2)(2012-2#1)(2012-3#1)
modeling and simulation of soft##2##5##(2011-1#2)
modeling and simulation of##3##4##(2008-3#1)(2011-1#2)
modeling and simulation##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#2)
modeling and the##2##3##(1997-3#1)(2011-2#1)
modeling and##43##2##(1997-3#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#4)(2009-5#1)(2009-6#1)(2010-10#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
modeling applications##2##2##(2008-10#1)(2009-11#1)
modeling approach was##2##3##(2008-10#1)(2013-8#1)
modeling approach##12##2##(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-1#1)(2013-8#3)
modeling approaches to##2##3##(2012-2#1)(2013-8#1)
modeling approaches were##2##3##(2008-10#2)
modeling approaches##6##2##(1994-5#1)(2008-10#2)(2012-2#1)(2013-8#2)
modeling as##2##2##(1991-2#1)(2008-10#1)
modeling by using##2##3##(2008-10#1)(2013-8#1)
modeling by##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
modeling can##3##2##(2008-4#1)(2009-10#1)(2009-5#1)
modeling for the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
modeling for##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
modeling framework is##2##3##(1994-3#1)(2010-9#1)
modeling framework##8##2##(1994-3#2)(2008-10#1)(2008-7#2)(2009-12#1)(2010-9#1)(2012-2#1)
modeling frameworks##2##2##(2008-9#1)(2012-2#1)
modeling has##3##2##(2007-8#1)(2009-10#1)(2013-1#1)
modeling in##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
modeling indicated##2##2##(2008-12#1)(2010-10#1)
modeling is used##2##3##(1997-3#1)(2007-11#1)
modeling is##5##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-3#1)
modeling methods##6##2##(1992-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
modeling motion fields##2##3##(2008-10#2)
modeling of epithelial tissues##2##4##(2010-9#2)
modeling of nucleic##4##3##(2008-4#4)
modeling of sensor##2##3##(2009-9#2)
modeling of spectral data##2##4##(2008-10#2)
modeling of such systems##2##4##(1997-6#1)(2009-8#1)
modeling of such##4##3##(1993-12#1)(1997-6#1)(2008-3#1)(2009-8#1)
modeling of the##17##3##(1992-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)(2009-10#1)(2009-7#1)(2012-1#1)(2013-1#1)
modeling of##101##2##(1992-12#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-6#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-10#9)(2008-11#4)(2008-2#11)(2008-3#21)(2008-4#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#5)
modeling on##2##2##(2008-12#1)(2010-9#1)
modeling predicts##2##2##(2008-3#1)(2008-4#1)
modeling procedure##2##2##(2008-10#1)(2008-7#1)
modeling program##2##2##(2008-3#2)
modeling results##6##2##(1993-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
modeling revealed that the##2##4##(2008-10#1)(2008-12#1)
modeling revealed that##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
modeling studies##6##2##(1992-3#1)(1994-5#2)(2008-3#1)(2012-2#1)(2013-1#1)
modeling suggest that##2##3##(1995-2#1)(2008-3#1)
modeling technique##2##2##(2008-3#1)(2008-8#1)
modeling techniques##5##2##(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)
modeling that##2##2##(2008-3#1)(2009-9#1)
modeling the propagation of##2##4##(2007-12#1)(2008-3#1)
modeling the##21##2##(1990-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#6)(2008-9#1)(2009-7#1)(2010-3#1)(2013-1#2)(2013-8#1)
modeling to##8##2##(2008-10#2)(2008-3#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#2)
modeling tools##2##2##(2008-11#1)(2008-3#1)
modeling using##2##2##(2007-12#1)(2008-4#1)
modeling was used to##2##4##(1994-5#1)(2010-6#1)
modeling was##7##2##(1994-5#1)(2008-3#2)(2008-4#1)(2009-7#1)(2010-6#1)(2013-1#1)
modeling with the##2##3##(2008-10#1)(2013-8#1)
modeling with##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
modeling##463##1##(1990-2#2)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-9#3)(1994-12#1)(1994-3#3)(1994-5#5)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#4)(1997-6#2)(1997-8#1)(2007-11#11)(2007-12#17)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#59)(2008-11#15)(2008-12#6)(2008-2#24)(2008-3#81)(2008-4#20)(2008-5#5)(2008-6#7)(2008-7#15)(2008-8#16)(2008-9#9)(2009-10#4)(2009-11#5)(2009-12#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#9)(2009-8#8)(2009-9#4)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#13)(2011-1#5)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#15)(2012-3#3)(2013-1#16)(2013-8#20)
modeling)##2##1##(1992-4#1)(2008-10#1)
modelled by##4##2##(1997-7#1)(2008-10#2)(2008-7#1)
modelled on the##2##3##(1997-8#1)(2009-4#1)
modelled the##2##2##(1992-9#1)(2008-11#1)
modelled using##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
modelled with##3##2##(2008-10#2)(2008-7#1)
modelled##20##1##(1992-9#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#3)(2009-4#1)(2010-4#2)(2010-6#1)(2011-2#1)
modelling analysis##2##2##(1995-3#1)(2012-2#1)
modelling and##9##2##(1995-11#2)(2008-10#1)(2008-11#3)(2008-8#1)(2011-3#1)(2012-1#1)
modelling approach##2##2##(2012-3#1)(2013-1#1)
modelling are##2##2##(2008-10#1)(2009-4#1)
modelling as##2##2##(2007-12#1)(2012-3#1)
modelling based on##2##3##(2008-7#1)(2008-9#1)
modelling based##3##2##(1994-11#1)(2008-7#1)(2008-9#1)
modelling cataractogenesis##2##2##(2011-1#2)
modelling demonstrated a##2##3##(2007-12#2)
modelling demonstrated##3##2##(2007-12#2)(2009-7#1)
modelling framework for##2##3##(2008-7#1)(2012-3#1)
modelling framework##3##2##(2008-7#1)(2012-3#2)
modelling has been##2##3##(2008-7#1)(2008-8#1)
modelling in##3##2##(2008-10#1)(2008-12#1)(2009-4#1)
modelling of protein##2##3##(1994-8#1)(2009-12#1)
modelling of the##5##3##(2008-10#2)(2011-1#1)(2012-2#1)(2013-1#1)
modelling of##33##2##(1994-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
modelling strategies##2##2##(1997-4#1)(2010-11#1)
modelling studies##2##2##(1994-11#1)(1995-11#1)
modelling techniques##2##2##(1996-2#1)(2008-7#1)
modelling the##8##2##(1992-9#1)(1993-9#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-8#1)
modelling to##2##2##(1996-1#1)(2007-8#1)
modelling was used to##2##4##(1997-4#1)(2010-10#1)
modelling was##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2010-10#1)
modelling##147##1##(1992-9#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-7#4)(1997-8#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#7)(2008-12#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#4)(2009-6#1)(2009-7#4)(2009-9#1)(2010-10#5)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#6)(2011-2#3)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#5)(2013-8#1)
modelof##2##1##(2008-11#2)
models (the##2##2##(1997-7#1)(2008-3#1)
models allow##2##2##(2007-11#1)(2008-9#1)
models allowed us to##2##4##(2009-3#1)(2009-5#1)
models along with##2##3##(2008-2#1)(2008-4#1)
models also##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
models and in##2##3##(1995-5#1)(2012-12#1)
models and methods##3##3##(2008-8#1)(2009-5#1)(2010-1#1)
models and model##2##3##(2008-7#1)(2013-1#1)
models and numerical simulations##2##4##(2008-10#2)
models and sensitivity##2##3##(2007-7#1)(2011-1#1)
models and suggest##2##3##(2008-8#1)(2008-9#1)
models and that##2##3##(2008-5#1)(2008-9#1)
models and the##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
models and to##2##3##(1994-1#1)(2008-3#1)
models and treatment##2##3##(1992-1#1)(2011-2#1)
models and##88##2##(1992-1#2)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-1#2)(1997-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#4)(2009-10#2)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
models are also##2##3##(2008-10#1)(2009-7#1)
models are available for##2##4##(1995-8#1)(2008-7#1)
models are built##2##3##(1993-12#1)(2008-10#1)
models are compared##2##3##(2008-10#1)(2008-7#1)
models are composed of##2##4##(1996-4#1)(2008-5#1)
models are developed##2##3##(2008-2#1)(2008-9#1)
models are discussed##5##3##(1994-3#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-8#1)
models are estimated##2##3##(1995-3#1)(2011-2#1)
models are found to##2##4##(2008-2#1)(2008-9#1)
models are not##2##3##(2007-12#1)(2008-11#1)
models are obtained##2##3##(2007-11#1)(2008-10#1)
models are often##2##3##(2008-3#1)(2008-8#1)
models are presented##5##3##(1991-12#1)(1993-1#1)(2007-12#1)(2008-12#1)(2008-8#1)
models are proposed##2##3##(1991-12#1)(2008-3#1)
models are required to##2##4##(2008-10#1)(2008-7#1)
models are required##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
models are suitable for##2##4##(2008-10#1)(2008-11#1)
models are unable to##2##4##(2008-2#1)(2012-2#1)
models are used in##2##4##(1996-6#1)(2008-7#1)
models are used to investigate the##2##6##(1995-2#1)(2008-7#1)
models are used to##5##4##(1995-2#1)(2008-7#2)(2008-8#1)(2009-12#1)
models are used##9##3##(1995-2#1)(1996-6#1)(2007-10#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-9#1)
models are useful for##2##4##(2007-11#1)(2008-7#1)
models are##93##2##(1991-12#2)(1993-1#1)(1993-12#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#3)(1996-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#4)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
models as well as##3##4##(2007-7#1)(2008-11#1)(2010-6#1)
models as##9##2##(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
models assume that##2##3##(1997-8#1)(2008-8#1)
models assume##3##2##(1997-8#1)(2008-8#2)
models at##2##2##(1996-9#1)(2008-12#1)
models based on the combination of band depth analysis and PLSR##2##11##(2013-8#2)
models based on the##7##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#2)
models based on##20##3##(1992-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2013-8#3)
models based##23##2##(1992-9#1)(1993-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)(2009-8#1)(2013-8#3)
models because##3##2##(2008-8#2)(2011-2#1)
models built##2##2##(2008-10#1)(2013-8#1)
models but also##2##3##(2011-1#1)(2011-2#1)
models but##3##2##(1994-12#1)(2011-1#1)(2011-2#1)
models by##13##2##(1997-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-8#1)(2013-8#1)
models can be used to##5##5##(1994-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
models can be##11##3##(1994-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
models can##16##2##(1994-11#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
models cannot account for##2##4##(2008-8#1)(2008-9#1)
models cannot explain##2##3##(2010-10#1)(2012-2#1)
models cannot##5##2##(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
models correctly classified##3##3##(2008-10#3)
models correctly##4##2##(2008-10#3)(2008-8#1)
models could##2##2##(2008-10#1)(2008-3#1)
models dealing with##2##3##(2008-9#2)
models defined##2##2##(1997-5#1)(2008-11#1)
models derived##2##2##(2008-10#1)(2008-2#1)
models developed##2##2##(2007-11#1)(2008-3#1)
models did not##2##3##(2008-12#1)(2008-8#1)
models do not##2##3##(2009-7#1)(2010-10#1)
models estimated##2##2##(2008-10#1)(2012-3#1)
models examined##2##2##(1994-1#1)(1995-5#1)
models exhibiting##2##2##(2008-7#1)(2010-5#1)
models explained##4##2##(2008-10#3)(2010-8#1)
models fitted##2##2##(1994-2#1)(2008-10#1)
models for a##5##3##(1990-8#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
models for analysing such data##2##5##(1992-6#1)(1997-7#1)
models for clinical##2##3##(1990-9#1)(2008-12#1)
models for predicting##2##3##(2007-11#1)(2008-10#1)
models for research and##2##4##(2008-11#1)(2011-1#1)
models for studying thyroid biology and disorders##2##7##(2012-3#2)
models for studying##3##3##(2012-3#3)
models for the analysis of human disease##2##7##(2008-4#2)
models for the detection of##2##5##(2008-10#1)(2008-4#1)
models for the development of##2##5##(2008-1#1)(2008-4#1)
models for the study of##3##5##(2008-11#1)(2008-9#1)(2010-6#1)
models for the##33##3##(1991-9#2)(1994-11#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
models for these##2##3##(1991-1#1)(1996-3#1)
models for wheat##2##3##(2008-10#2)
models for##144##2##(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#1)(1991-9#2)(1992-3#1)(1992-6#2)(1993-1#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#4)(1997-8#2)(2007-11#6)(2007-12#3)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#8)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#3)(2012-4#2)(2013-1#2)(2013-8#3)
models from##7##2##(2008-6#1)(2008-9#1)(2009-11#2)(2010-10#1)(2011-2#2)
models gave##2##2##(2008-10#1)(2008-12#1)
models generated by##2##3##(2008-11#1)(2012-2#1)
models had##5##2##(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)
models has##8##2##(1995-2#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
models have been created##2##4##(2010-6#2)
models have been developed to##3##5##(2008-3#1)(2008-6#1)(2010-4#1)
models have been developed##4##4##(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)
models have been proposed for the##2##6##(1990-5#1)(1991-5#1)
models have been proposed##3##4##(1990-5#1)(1991-5#1)(1994-3#1)
models have been used to##2##5##(2008-10#1)(2008-9#1)
models have been used##3##4##(2008-10#2)(2008-9#1)
models have been##20##3##(1990-5#1)(1991-5#1)(1992-11#1)(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
models have potential##2##3##(2008-10#1)(2008-5#1)
models have shown that##4##4##(2008-2#1)(2008-8#1)(2009-10#1)(2013-7#1)
models have##40##2##(1990-5#1)(1991-5#1)(1992-11#1)(1994-3#1)(1996-3#1)(1996-4#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
models in a##2##3##(2008-1#1)(2013-1#1)
models in health##2##3##(1996-3#1)(2008-11#1)
models in the##8##3##(1995-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
models in which the##3##4##(2008-3#1)(2008-5#1)(2010-1#1)
models in which##10##3##(1994-12#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-1#2)
models in##45##2##(1992-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
models include##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
models included##2##2##(2008-8#1)(2010-1#1)
models including##2##2##(1994-11#1)(2008-5#1)
models indicate that the##2##4##(2008-11#1)(2008-3#1)
models indicate that##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
models indicated that the##2##4##(2008-10#1)(2009-8#1)
models indicated that##3##3##(2008-10#1)(2009-8#1)(2010-10#1)
models is to##2##3##(2008-11#2)
models is##19##2##(1996-9#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2012-2#1)(2013-1#2)
models make##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
models may##7##2##(1993-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#1)
models mimicking##2##2##(2012-4#1)(2013-1#1)
models of ADHD##2##3##(2008-2#2)
models of ALS##2##3##(2008-4#2)
models of HTN##2##3##(2010-4#2)
models of Parkinson's##2##3##(2009-3#1)(2010-5#1)
models of a##2##3##(2008-2#1)(2008-4#1)
models of adaptive##3##3##(2008-8#2)(2011-1#1)
models of affected status##2##4##(1997-5#2)
models of asthma##2##3##(2010-5#1)(2012-3#1)
models of cancer##3##3##(2008-11#1)(2012-12#1)(2013-8#1)
models of carcinogenesis##2##3##(2008-7#2)
models of care##2##3##(2006-10#1)(2008-7#1)
models of competition##2##3##(2008-8#1)(2008-9#1)
models of complex##2##3##(1991-5#1)(2008-2#1)
models of disease progression##2##4##(2008-7#2)
models of disease##4##3##(1995-5#1)(2008-7#2)(2008-9#1)
models of earthquake faults##2##4##(1996-4#2)
models of health##3##3##(2010-2#1)(2010-3#1)(2011-1#1)
models of hepatic##2##3##(2008-10#1)(2009-8#1)
models of human disease##8##4##(2008-11#1)(2008-4#4)(2008-9#1)(2009-3#1)(2012-12#1)
models of human##18##3##(1993-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-7#2)(2008-9#1)(2009-3#2)(2009-8#1)(2010-8#1)(2012-12#1)
models of infection##4##3##(2008-7#4)
models of interacting phenotypes##2##4##(2008-8#2)
models of multiple##2##3##(2008-3#1)(2009-4#1)
models of myelopoiesis##2##3##(2008-4#2)
models of natural enemies##2##4##(2008-8#2)
models of permanent##2##3##(2008-4#1)(2011-2#1)
models of plant disease epidemics##2##5##(2008-10#2)
models of population##2##3##(2008-9#2)
models of screening##3##3##(2010-5#1)(2010-8#1)(2011-1#1)
models of signal##2##3##(2008-3#1)(2012-2#1)
models of social phobia##2##4##(2008-4#2)
models of social##5##3##(2008-4#2)(2012-3#3)
models of species##2##3##(2008-8#1)(2010-6#1)
models of stem cell##3##4##(2008-11#2)(2013-8#1)
models of the evolution of##2##5##(2008-8#2)
models of the hospital##2##4##(1991-1#1)(1992-5#1)
models of the relationship between##2##5##(1993-10#1)(2008-11#1)
models of the##36##3##(1991-1#1)(1991-12#1)(1992-5#1)(1993-10#1)(1994-5#1)(1995-2#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#5)(2009-1#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
models of these##2##3##(2007-12#1)(2009-12#1)
models of ultrasonograph##2##3##(2007-10#2)
models of##339##2##(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-4#8)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#3)(1997-7#1)(2006-10#2)(2007-10#6)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#15)(2008-12#7)(2008-2#6)(2008-3#11)(2008-4#26)(2008-5#8)(2008-6#1)(2008-7#23)(2008-8#27)(2008-9#18)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#6)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#7)(2012-4#1)(2013-1#3)(2013-8#3)
models often##2##2##(2008-4#1)(2009-9#1)
models on##4##2##(1991-12#1)(2007-12#1)(2008-12#1)(2008-2#1)
models or##6##2##(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-12#1)
models perform##2##2##(2007-11#1)(2008-11#1)
models predict that##7##3##(2008-10#1)(2008-8#3)(2008-9#3)
models predict##14##2##(1990-12#1)(1997-1#3)(2008-10#1)(2008-3#1)(2008-8#5)(2008-9#3)
models predicting the##2##3##(2007-12#1)(2008-11#1)
models predicting##4##2##(1997-1#1)(2007-12#1)(2008-11#1)(2013-1#1)
models presented here##2##3##(1996-4#1)(2013-8#1)
models presented##3##2##(1996-4#1)(2009-3#1)(2013-8#1)
models provide##3##2##(2008-8#1)(2008-9#1)(2010-10#1)
models regarding##2##2##(2008-2#1)(2012-12#1)
models represent##2##2##(2008-12#1)(2008-8#1)
models require##2##2##(2007-11#1)(2008-7#1)
models requires##2##2##(2008-11#1)(2008-5#1)
models revealed that##2##3##(2008-12#1)(2009-8#1)
models should be##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
models should##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
models show that##2##3##(2008-8#1)(2012-3#1)
models show##3##2##(1996-4#1)(2008-8#1)(2012-3#1)
models showed a##2##3##(2008-10#1)(2011-2#1)
models studied##2##2##(2010-12#1)(2012-1#1)
models such as the##2##4##(2008-11#1)(2008-7#1)
models such as##8##3##(1992-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
models suggest that the##3##4##(1995-12#1)(2008-8#2)
models suggest that##6##3##(1995-12#1)(2008-8#4)(2010-5#1)
models suggest##9##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#5)(2010-5#1)
models suggested that##2##3##(2008-10#1)(2009-2#1)
models that allow for##2##4##(1994-9#1)(2008-2#1)
models that allow##3##3##(1994-9#1)(2008-2#1)(2010-11#1)
models that are##6##3##(1991-8#1)(1997-7#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
models that assume##2##3##(2008-4#1)(2008-8#1)
models that can##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
models that employ##2##3##(2007-8#1)(2013-1#1)
models that explain##2##3##(2008-2#1)(2011-2#1)
models that include##3##3##(2007-11#1)(2008-9#2)
models that incorporate##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-9#1)
models that recapitulate##2##3##(2012-2#1)(2013-1#1)
models that##63##2##(1991-5#1)(1991-8#1)(1994-11#1)(1994-9#1)(1996-4#2)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-11#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-5#1)(2010-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
models the##6##2##(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
models to assess the##2##4##(2008-10#1)(2010-2#1)
models to determine##2##3##(2008-7#1)(2008-9#1)
models to estimate##2##3##(2008-10#1)(2012-8#1)
models to evaluate the##3##4##(2008-1#1)(2008-8#1)(2008-9#1)
models to evaluate##4##3##(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
models to examine the##2##4##(2008-8#1)(2012-12#1)
models to explore the##2##4##(2008-8#1)(2008-9#1)
models to explore##3##3##(2008-8#2)(2008-9#1)
models to generate##2##3##(1997-7#1)(2011-1#1)
models to improve##2##3##(2008-11#2)
models to investigate the##2##4##(1994-11#1)(2008-8#1)
models to predict the##2##4##(2008-10#2)
models to predict##4##3##(2008-10#3)(2008-8#1)
models to study the##3##4##(1991-5#1)(2008-11#1)(2008-9#1)
models to study##9##3##(1991-5#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)
models to the##2##3##(2007-12#1)(2008-8#1)
models to##80##2##(1991-12#1)(1991-2#1)(1991-5#2)(1992-6#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#11)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#3)(2012-8#1)
models used in##3##3##(2008-4#1)(2011-1#1)(2012-2#1)
models used to##2##3##(2007-8#1)(2008-10#1)
models used##7##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)
models using a##4##3##(2008-10#1)(2008-6#1)(2008-8#2)
models using an##2##3##(2007-11#1)(2008-9#1)
models using the##2##3##(2008-10#1)(2008-4#1)
models using##14##2##(1997-1#1)(2007-11#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-5#1)
models usually##2##2##(2008-3#1)(2008-5#1)
models was##7##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-2#1)
models were adjusted##2##3##(2011-2#1)(2013-7#1)
models were also##2##3##(2008-3#1)(2010-8#1)
models were analyzed under##2##4##(2011-2#1)(2013-1#1)
models were applied to##2##4##(1994-9#1)(2007-8#1)
models were built##2##3##(2008-10#2)
models were constructed to##2##4##(2010-8#1)(2013-1#1)
models were constructed##3##3##(2010-8#1)(2012-12#1)(2013-1#1)
models were designed to##2##4##(2008-5#1)(2009-8#1)
models were developed to##4##4##(1992-1#1)(1994-9#1)(2008-10#1)(2010-4#1)
models were developed##11##3##(1992-1#1)(1994-9#1)(2007-11#1)(2008-10#4)(2008-8#2)(2010-4#1)(2011-2#1)
models were estimated##2##3##(1993-3#1)(2013-1#1)
models were evaluated by##2##4##(2008-10#2)
models were fit to##2##4##(2008-10#1)(2013-1#1)
models were obtained##4##3##(2007-11#1)(2008-10#2)(2011-3#1)
models were used for the##2##5##(2008-10#2)
models were used for##3##4##(2008-10#3)
models were used in##2##4##(2009-2#1)(2011-3#1)
models were used to analyze##2##5##(2008-12#1)(2013-1#1)
models were used to##13##4##(2008-10#3)(2008-12#2)(2008-5#1)(2009-5#1)(2009-6#1)(2012-2#2)(2013-1#3)
models were used##20##3##(1995-9#1)(2008-10#6)(2008-12#2)(2008-5#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
models were validated##2##3##(2008-10#2)
models were##90##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-9#2)(1995-9#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#37)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#1)
models when##3##2##(1995-5#1)(2008-8#1)(2010-2#1)
models where##2##2##(1992-6#1)(2008-8#1)
models which have been developed##2##5##(1991-12#1)(1994-3#1)
models which##9##2##(1991-12#1)(1992-9#1)(1994-3#1)(1997-3#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)
models will##4##2##(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
models with a##4##3##(1993-1#1)(1994-3#1)(2008-5#1)(2012-2#1)
models with measurement error##2##4##(1997-4#1)(2012-1#1)
models with measurement##3##3##(1997-4#1)(2012-1#2)
models with the##2##3##(1996-3#1)(2013-7#1)
models with##34##2##(1993-1#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#2)(2013-7#1)
models within##2##2##(2008-10#1)(2012-3#1)
models would##2##2##(2008-10#1)(2008-8#1)
models##2007##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#9)(1991-2#3)(1991-5#7)(1991-8#2)(1991-9#6)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#11)(1992-8#1)(1992-9#10)(1993-1#5)(1993-10#1)(1993-11#2)(1993-12#11)(1993-2#3)(1993-3#3)(1993-5#1)(1993-8#3)(1994-1#3)(1994-11#8)(1994-12#8)(1994-2#5)(1994-3#7)(1994-5#8)(1994-8#1)(1994-9#8)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#12)(1995-3#4)(1995-5#9)(1995-6#3)(1995-8#3)(1995-9#5)(1996-1#2)(1996-11#5)(1996-12#6)(1996-2#1)(1996-3#9)(1996-4#20)(1996-5#1)(1996-6#6)(1996-9#4)(1997-1#16)(1997-2#11)(1997-3#5)(1997-4#4)(1997-5#7)(1997-6#1)(1997-7#15)(1997-8#3)(2006-10#2)(2006-12#1)(2006-6#2)(2007-10#19)(2007-11#43)(2007-12#26)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#11)(2008-10#271)(2008-11#81)(2008-12#35)(2008-2#57)(2008-3#79)(2008-4#69)(2008-5#44)(2008-6#15)(2008-7#89)(2008-8#158)(2008-9#96)(2009-1#1)(2009-10#12)(2009-11#8)(2009-12#7)(2009-2#9)(2009-3#12)(2009-4#10)(2009-5#16)(2009-6#6)(2009-7#15)(2009-8#22)(2009-9#17)(2010-1#12)(2010-10#21)(2010-11#7)(2010-12#12)(2010-2#6)(2010-3#7)(2010-4#15)(2010-5#16)(2010-6#11)(2010-7#13)(2010-8#14)(2010-9#7)(2011-1#30)(2011-2#50)(2011-3#5)(2011-9#1)(2012-1#17)(2012-12#24)(2012-2#44)(2012-3#29)(2012-4#8)(2012-8#1)(2013-1#51)(2013-7#8)(2013-8#31)
models)##8##1##(1994-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-4#1)
models-the##2##1##(2008-10#2)
models]##3##1##(1993-11#1)(1995-6#1)(2012-12#1)
modem##3##1##(1991-12#1)(2008-8#1)(2008-9#1)
moderate ( approximately##2##3##(2006-4#1)(2008-12#1)
moderate (0##2##2##(1991-11#1)(2009-9#1)
moderate GI##2##2##(2008-1#2)
moderate activities##2##2##(1995-3#1)(2013-1#1)
moderate activity against##2##3##(2008-5#1)(2010-3#1)
moderate activity##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-5#1)
moderate agreement##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
moderate alcohol##2##2##(1993-9#1)(2008-7#1)
moderate amount##2##2##(2008-3#1)(2012-2#1)
moderate and severe airways obstruction##3##5##(2008-7#3)
moderate and severe heart failure##2##5##(1992-6#2)
moderate and severe##12##3##(1992-6#2)(1996-7#1)(2007-10#1)(2008-4#1)(2008-7#3)(2010-5#1)(2011-2#3)
moderate and##29##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-6#2)(1993-8#1)(1996-7#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-5#2)(2011-2#4)(2012-1#1)(2013-1#1)
moderate aortic##2##2##(2012-2#1)(2012-3#1)
moderate carrier pressure##2##3##(2008-10#2)
moderate concentrations##2##2##(1992-3#1)(2008-10#1)
moderate consumption##2##2##(1994-2#1)(2013-1#1)
moderate correlations##2##2##(1991-3#1)(1995-2#1)
moderate doses##2##2##(1990-12#1)(2008-7#1)
moderate effectiveness##2##2##(1994-12#1)(2008-10#1)
moderate expression##2##2##(1996-12#2)
moderate for##2##2##(2008-10#1)(2012-5#1)
moderate growth##2##2##(1994-3#1)(2010-6#1)
moderate hydronephrosis##2##2##(2008-10#1)(2008-4#1)
moderate hypothermia##3##2##(2006-7#1)(2010-1#1)(2011-2#1)
moderate in##3##2##(1995-10#1)(2008-4#1)(2011-2#1)
moderate increases in##2##3##(1992-10#1)(1997-4#1)
moderate intake of alcohol##2##4##(2008-10#2)
moderate intake##3##2##(1994-2#1)(2008-10#2)
moderate intensity##3##2##(1990-12#1)(1994-6#1)(2012-12#1)
moderate ionic##2##2##(1991-5#1)(1992-8#1)
moderate level of##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-6#1)(2013-1#1)
moderate level##7##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-6#1)(2013-1#1)
moderate levels of##11##3##(1990-3#1)(2008-10#6)(2008-8#2)(2008-9#1)(2013-8#1)
moderate or high##2##3##(1996-12#1)(2008-7#1)
moderate or severe hypothermia##3##4##(2011-2#3)
moderate or severe##11##3##(1990-12#1)(1990-3#1)(2006-10#1)(2008-11#4)(2010-11#1)(2011-2#3)
moderate or vigorous physical activity##4##5##(2010-11#4)
moderate or##23##2##(1990-12#1)(1990-3#1)(1993-8#1)(1994-2#1)(1996-12#1)(2006-10#1)(2008-11#4)(2008-7#1)(2009-4#1)(2010-1#2)(2010-11#5)(2011-2#3)(2012-1#1)
moderate proteinuria##2##2##(2007-7#1)(2008-1#1)
moderate relationship##2##2##(1991-2#2)
moderate resistance to##3##3##(2008-10#3)
moderate resistance##6##2##(2008-10#6)
moderate severity##2##2##(1996-9#1)(2008-6#1)
moderate size##3##2##(2008-10#1)(2008-3#2)
moderate temperatures and##2##3##(1995-5#1)(2008-10#1)
moderate temperatures##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
moderate the effects of physical activity on neurocognitive##2##8##(2013-1#2)
moderate the effects of##3##4##(2009-7#1)(2013-1#2)
moderate the relationship between##2##4##(2009-11#1)(2009-8#1)
moderate the##9##2##(2008-10#1)(2009-11#1)(2009-7#3)(2009-8#1)(2012-1#1)(2013-1#2)
moderate to excellent##2##3##(2008-10#1)(2008-9#1)
moderate to good##3##3##(2008-5#1)(2008-7#2)
moderate to high##6##3##(2008-10#3)(2010-10#1)(2010-4#1)(2012-3#1)
moderate to severe ACR##2##4##(2008-10#2)
moderate to severe rheumatoid arthritis##2##5##(2012-3#2)
moderate to severe##20##3##(1990-3#1)(1991-11#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-2#2)(2012-3#3)(2013-1#1)
moderate to strong##2##3##(2008-4#1)(2012-12#1)
moderate to##40##2##(1990-3#1)(1991-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
moderate variation##2##2##(1993-12#1)(2008-5#1)
moderate weight##2##2##(2012-3#1)(2013-8#1)
moderate##408##1##(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#7)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#4)(2007-11#8)(2007-12#6)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#60)(2008-11#7)(2008-12#7)(2008-2#5)(2008-3#22)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#15)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#14)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#9)(2012-5#5)(2013-1#16)(2013-7#1)(2013-8#3)
moderate&quot##3##1##(1993-2#1)(2007-11#2)
moderate-severe##4##1##(2012-12#1)(2012-2#1)(2013-1#2)
moderate-sized##3##1##(2007-10#1)(2008-10#1)(2008-3#1)
moderate-to-high##2##1##(1992-12#1)(1995-2#1)
moderate-to-severe##4##1##(1990-3#1)(2008-3#1)(2010-5#1)(2013-1#1)
moderated by##4##2##(1993-11#1)(1995-3#1)(2010-1#1)(2010-2#1)
moderated the impact of treatment on##2##6##(2013-1#2)
moderated the influence of##2##4##(2010-1#1)(2010-3#1)
moderated the##8##2##(2007-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2012-2#1)(2013-1#2)
moderated##19##1##(1993-11#1)(1995-3#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-11#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-2#2)(2010-3#1)(2012-2#1)(2013-1#3)
moderately abundant##2##2##(1993-9#1)(2008-8#1)
moderately active in##2##3##(1990-2#1)(2010-2#1)
moderately active##3##2##(1990-2#1)(2010-12#1)(2010-2#1)
moderately alkaline##2##2##(2008-10#2)
moderately and##3##2##(1995-2#1)(2007-10#1)(2010-12#1)
moderately depressed##3##2##(1992-12#1)(2010-4#2)
moderately differentiated##5##2##(1993-6#1)(1993-9#1)(2008-10#2)(2009-5#1)
moderately disabled##4##2##(1997-3#1)(2013-8#3)
moderately elevated##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
moderately good##2##2##(2008-3#1)(2009-2#1)
moderately high##6##2##(2008-10#2)(2008-11#2)(2010-4#1)(2011-2#1)
moderately in##2##2##(2008-8#1)(2011-10#1)
moderately large##2##2##(2007-11#1)(2008-3#1)
moderately or##2##2##(2008-10#1)(2013-1#1)
moderately positive##2##2##(1990-8#1)(2007-10#1)
moderately resistant cultivars##2##3##(2008-10#2)
moderately resistant##15##2##(2008-10#15)
moderately severe##6##2##(1994-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)
moderately susceptible##3##2##(2008-10#3)
moderately to highly##2##3##(2007-7#1)(2008-7#1)
moderately##121##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-6#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#38)(2008-11#5)(2008-12#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#4)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#3)
moderates##3##1##(2007-9#1)(2008-11#1)(2012-12#1)
moderating effect of##4##3##(2007-12#1)(2010-10#1)(2010-6#1)(2010-7#1)
moderating effects of resources on the stress-depression relationship##2##8##(2011-2#2)
moderating effects of the##3##4##(2007-12#1)(2011-2#2)
moderating effects of##7##3##(1996-1#1)(1996-2#1)(2007-12#1)(2011-2#4)
moderating effects##9##2##(1996-1#1)(1996-2#2)(2007-12#1)(2009-7#1)(2011-2#4)
moderating role##2##2##(1996-2#1)(2008-12#1)
moderating##23##1##(1995-1#1)(1996-1#1)(1996-2#3)(2007-12#3)(2008-11#1)(2008-12#2)(2008-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#4)
moderation##4##1##(2008-7#1)(2011-2#2)(2012-2#1)
moderator of##2##2##(2008-6#1)(2009-7#1)
moderator##7##1##(2007-12#1)(2008-6#2)(2009-11#1)(2009-7#1)(2010-1#2)
moderators of##7##2##(1995-12#1)(2008-12#1)(2013-1#5)
moderators##10##1##(1995-12#1)(2008-12#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#5)
modern American##3##2##(1994-2#1)(2008-7#2)
modern Western##2##2##(2008-7#1)(2012-1#1)
modern amphibian##2##2##(2010-6#2)
modern analytical##3##2##(2008-10#2)(2010-7#1)
modern and##6##2##(1990-2#1)(1995-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2012-9#1)
modern animals##2##2##(2010-4#2)
modern applications##2##2##(2008-3#1)(2008-9#1)
modern approaches##2##2##(1991-8#1)(2008-12#1)
modern biology##5##2##(1993-6#1)(2008-2#2)(2008-4#1)(2012-3#1)
modern cardiac##2##2##(2006-10#1)(2010-8#1)
modern clinical practice##2##3##(2012-2#1)(2013-8#1)
modern clinical##3##2##(1994-12#1)(2012-2#1)(2013-8#1)
modern clothes##2##2##(2011-1#2)
modern cochlear implant##2##3##(2008-9#2)
modern concepts of##2##3##(2006-12#1)(2008-8#1)
modern concepts##3##2##(1994-12#1)(2006-12#1)(2008-8#1)
modern cultivars##2##2##(2008-10#2)
modern diagnostic##3##2##(1992-9#1)(1997-5#1)(2011-2#1)
modern drug discovery##2##3##(2008-10#1)(2008-9#1)
modern drug##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
modern environment##2##2##(2008-10#1)(2008-5#1)
modern examinations##2##2##(2011-3#2)
modern expression##2##2##(1995-2#1)(2008-7#1)
modern forensic psychiatry##2##3##(2011-2#2)
modern health care##2##3##(1994-12#1)(2008-1#1)
modern health##4##2##(1994-12#1)(1996-8#1)(2008-1#2)
modern healthcare systems##2##3##(2009-12#1)(2013-8#1)
modern human##7##2##(1994-3#1)(2008-8#1)(2009-10#1)(2011-2#3)(2012-1#1)
modern humans##10##2##(1994-3#2)(1995-11#1)(2008-8#1)(2010-5#2)(2011-2#3)(2012-2#1)
modern man##2##2##(1990-5#1)(2008-8#1)
modern mass##2##2##(2008-10#1)(2011-2#1)
modern medical##8##2##(2008-10#2)(2008-6#1)(2009-11#1)(2013-1#4)
modern medicine##11##2##(1991-11#1)(1994-1#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)(2013-8#2)
modern mental health##2##3##(2008-11#2)
modern methods of##3##3##(1993-6#1)(2008-6#1)(2011-2#1)
modern methods##4##2##(1993-6#1)(2008-6#1)(2011-2#1)(2011-3#1)
modern molecular##4##2##(1997-4#1)(2008-4#1)(2008-5#1)(2013-1#1)
modern science##2##2##(1991-8#1)(2013-1#1)
modern society##5##2##(1991-6#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
modern state##2##2##(2008-11#1)(2011-2#1)
modern techniques##5##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)
modern technologies##2##2##(2008-12#2)
modern technology##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
modern times##3##2##(1990-6#1)(2008-10#1)(2012-2#1)
modern total knee designs##2##4##(2008-8#2)
modern##308##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#40)(2008-11#13)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#5)(2011-2#24)(2011-3#4)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#5)(2012-9#4)(2013-1#17)(2013-7#1)(2013-8#6)
modernisation##2##1##(2008-11#1)(2011-2#1)
modernity##6##1##(1991-9#1)(2008-7#1)(2008-9#4)
modernization act##2##2##(2008-6#1)(2008-8#1)
modernization##6##1##(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-3#1)
modes and the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
modes and##21##2##(1996-1#1)(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#7)(2008-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
modes are discussed##2##3##(2008-10#1)(2008-4#1)
modes are observed##2##3##(2007-11#1)(2008-2#1)
modes are##17##2##(1992-1#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)
modes at##6##2##(1995-3#1)(1996-2#1)(2008-10#1)(2008-3#3)
modes by##2##2##(2007-12#2)
modes can be##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
modes excited by##3##3##(2007-12#2)(2008-3#1)
modes excited##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
modes for the##5##3##(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#1)
modes for##10##2##(1994-5#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-6#1)
modes in a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
modes in photonic crystal fibers##2##5##(2007-12#2)
modes in photonic crystal##3##4##(2007-11#1)(2007-12#2)
modes in the##9##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#4)
modes in##39##2##(1992-8#1)(2007-11#10)(2007-12#9)(2008-10#1)(2008-2#5)(2008-3#10)(2011-2#1)(2012-3#1)(2013-7#1)
modes indicates that##2##3##(2008-3#1)(2008-5#1)
modes inside##2##2##(2007-12#1)(2008-3#1)
modes is##12##2##(2007-11#2)(2007-12#5)(2008-10#2)(2008-3#2)(2008-5#1)
modes may##2##2##(1997-2#1)(2008-9#1)
modes observed##2##2##(1992-8#1)(2007-12#1)
modes of a##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
modes of action and##2##4##(2008-10#1)(2008-3#1)
modes of action of##3##4##(2008-10#2)(2010-5#1)
modes of action##13##3##(1995-2#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2010-5#1)(2012-1#1)
modes of both##2##3##(2008-3#1)(2009-8#1)
modes of cell death##2##4##(2008-8#1)(2008-9#1)
modes of inactivation##2##3##(1993-11#2)
modes of operation##2##3##(2008-3#2)
modes of selection##2##3##(2008-4#1)(2012-3#1)
modes of the##20##3##(1990-7#1)(1992-6#2)(1996-2#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2009-7#1)(2010-7#1)(2011-1#1)
modes of transmission##3##3##(1997-5#1)(2007-7#1)(2011-2#1)
modes of ventilation##2##3##(2008-8#1)(2010-7#1)
modes of water##2##3##(2011-2#2)
modes of##118##2##(1990-7#1)(1992-3#1)(1992-6#4)(1993-11#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(2007-11#5)(2007-12#9)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#8)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#4)(2009-10#5)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
modes or##3##2##(2008-2#1)(2010-9#1)(2011-2#1)
modes that are##3##3##(2007-1#1)(2007-12#2)
modes that belong to different transitions##2##6##(2007-12#2)
modes that##12##2##(2007-1#1)(2007-11#2)(2007-12#5)(2008-3#2)(2008-9#1)(2009-10#1)
modes the##3##2##(2007-11#2)(2008-2#1)
modes through##2##2##(2008-2#1)(2008-3#1)
modes to increase the##2##4##(2008-3#2)
modes to##4##2##(2008-3#3)(2009-3#1)
modes using##2##2##(2008-11#1)(2011-1#1)
modes was##6##2##(1990-7#1)(1994-8#1)(2007-11#1)(2007-12#2)(2008-2#1)
modes were classified##2##3##(2013-1#2)
modes were##8##2##(2007-11#3)(2007-12#2)(2008-10#1)(2013-1#2)
modes will##2##2##(1992-3#1)(2007-11#1)
modes with a##2##3##(2008-3#2)
modes with##8##2##(2007-11#2)(2007-12#1)(2008-3#5)
modes within the##2##3##(2008-2#1)(2008-3#1)
modes##460##1##(1990-7#2)(1992-1#1)(1992-3#2)(1992-6#4)(1992-8#2)(1993-11#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#4)(1995-5#1)(1996-1#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-11#60)(2007-12#78)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#48)(2008-11#10)(2008-2#29)(2008-3#98)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#11)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-3#4)(2010-5#2)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#8)(2012-1#2)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#3)(2013-8#1)
modes'##2##1##(2010-10#1)(2012-2#1)
modes)##3##1##(2007-11#2)(2008-10#1)
modest and##4##2##(1990-3#1)(1994-12#1)(2007-11#1)(2008-2#1)
modest but significant##3##3##(2008-10#2)(2009-7#1)
modest but##6##2##(2008-10#2)(2008-2#1)(2009-7#1)(2010-12#1)(2011-2#1)
modest changes##2##2##(1990-12#1)(2008-7#1)
modest effect##3##2##(1994-5#1)(1997-5#1)(2012-1#1)
modest effects##2##2##(1992-3#1)(2009-4#1)
modest efficacy and##2##3##(2011-2#1)(2013-1#1)
modest growth in vesicle size##2##5##(1992-3#2)
modest growth##3##2##(1992-3#2)(2007-12#1)
modest hypothermia##3##2##(2008-9#3)
modest improvement##2##2##(2009-5#1)(2012-2#1)
modest increases##2##2##(1997-3#1)(2008-11#1)
modest loss##2##2##(2008-10#1)(2010-4#1)
modest to##2##2##(1992-12#1)(2010-3#1)
modest##112##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#4)(1993-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
modestly hypoglycemic piglets##2##3##(1994-2#2)
modestly##15##1##(1990-11#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-2#2)(2008-2#1)(2008-3#3)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-1#1)
modifiability of##2##2##(1994-8#2)
modifiability##3##1##(1994-8#2)(2008-7#1)
modifiable risk factor##2##3##(2007-10#1)(2011-1#1)
modifiable risk factors##7##3##(2008-1#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
modifiable risk##9##2##(2007-10#1)(2008-1#2)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
modifiable##21##1##(1990-7#4)(2007-10#1)(2008-1#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
modification and the##2##3##(1995-6#1)(2008-11#1)
modification and##23##2##(1990-7#1)(1991-12#2)(1992-5#2)(1992-6#1)(1994-8#1)(1995-6#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-11#1)(2011-2#1)
modification are##5##2##(1992-3#1)(2008-10#3)(2008-5#1)
modification as##2##2##(1993-3#1)(2013-1#1)
modification at the##3##3##(1990-8#1)(1994-5#1)(2009-8#1)
modification at##5##2##(1990-5#1)(1990-8#1)(1992-3#1)(1994-5#1)(2009-8#1)
modification by the##2##3##(1990-11#1)(2008-10#1)
modification by##15##2##(1990-11#2)(1992-5#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1995-2#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-8#1)
modification catalyzed##2##2##(1991-2#1)(2008-1#1)
modification consists of##2##3##(2008-3#1)(2013-1#1)
modification for##5##2##(1991-12#1)(2006-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
modification has##2##2##(1990-2#1)(2010-1#1)
modification in the##5##3##(2008-10#4)(2009-8#1)
modification in##12##2##(1991-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
modification include##2##2##(1995-3#1)(2011-1#1)
modification is not##2##3##(1990-8#1)(1991-12#1)
modification is##12##2##(1990-8#1)(1991-12#1)(1994-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)
modification may##3##2##(1994-6#1)(2008-10#1)(2009-10#1)
modification method##2##2##(2008-10#2)
modification of 1##2##3##(1990-11#1)(1990-2#1)
modification of DNA##2##3##(1992-3#1)(1994-12#1)
modification of HLA##2##3##(2008-10#2)
modification of LDL##5##3##(1991-5#1)(2008-10#2)(2009-8#1)(2013-1#1)
modification of a previously##2##4##(2008-2#1)(2012-12#1)
modification of a##6##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
modification of cell##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
modification of hemoglobin##2##3##(1990-8#1)(2008-10#1)
modification of our##2##3##(2008-10#1)(2011-2#1)
modification of proteins##3##3##(1992-6#1)(2008-1#1)(2008-11#1)
modification of risk factors may##2##5##(2012-3#1)(2013-1#1)
modification of risk##3##3##(2012-3#1)(2013-1#2)
modification of specific##2##3##(1990-7#1)(1990-8#1)
modification of stroke risk factors##2##5##(2007-9#1)(2008-2#1)
modification of the conventional##2##4##(2008-3#1)(2008-4#1)
modification of the expansion order##2##5##(2008-2#2)
modification of the method of##2##5##(1993-8#1)(2008-10#1)
modification of the method##4##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
modification of the model##2##4##(2007-11#1)(2008-9#1)
modification of the original##2##4##(1994-8#1)(2008-10#1)
modification of the protein##2##4##(1990-7#1)(1993-11#1)
modification of the remaining##2##4##(1992-5#1)(1993-11#1)
modification of the surface##2##4##(2008-10#2)
modification of the##99##3##(1990-2#1)(1990-7#2)(1992-11#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#4)(1993-11#3)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#9)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#3)(2013-1#1)
modification of this##5##3##(2008-10#1)(2008-2#2)(2008-4#2)
modification of##244##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-7#4)(1990-8#2)(1991-12#1)(1991-5#4)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#4)(1992-6#3)(1992-8#1)(1992-9#8)(1993-11#5)(1993-12#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-11#8)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#45)(2008-11#13)(2008-12#1)(2008-2#13)(2008-3#11)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#3)
modification on##2##2##(1991-12#1)(1995-3#1)
modification or##2##2##(1997-7#1)(2008-10#1)
modification procedure##2##2##(2008-10#2)
modification process##3##2##(2008-10#3)
modification that##3##2##(2008-2#1)(2008-4#1)(2010-12#1)
modification to be##2##3##(1993-8#1)(2008-9#1)
modification to prevent##2##3##(2008-11#1)(2008-3#1)
modification to the##2##3##(1992-12#1)(2011-7#1)
modification to##13##2##(1992-12#1)(1993-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#1)
modification was##5##2##(1990-8#1)(1991-2#1)(2008-1#1)(2008-10#2)
modification with##6##2##(1990-12#1)(1990-5#1)(2008-10#3)(2013-1#1)
modification##491##1##(1990-11#3)(1990-12#4)(1990-2#5)(1990-5#6)(1990-7#5)(1990-8#7)(1991-1#1)(1991-12#6)(1991-2#5)(1991-3#1)(1991-5#4)(1991-8#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#7)(1992-5#7)(1992-6#6)(1992-8#1)(1992-9#8)(1993-11#7)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#5)(1993-8#4)(1994-11#5)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-12#2)(1995-2#7)(1995-3#4)(1995-5#1)(1995-6#9)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#2)(1997-9#1)(2006-4#1)(2007-11#9)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#101)(2008-11#22)(2008-12#3)(2008-2#19)(2008-3#18)(2008-4#23)(2008-5#5)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#8)(2009-10#6)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#9)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#11)(2013-8#4)
modification)##5##1##(1992-6#1)(2008-10#2)(2008-6#2)
modifications and##8##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
modifications are##6##2##(2008-10#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-2#1)
modifications by##2##2##(2008-11#1)(2008-3#1)
modifications can be##3##3##(1994-2#1)(2008-7#1)(2008-9#1)
modifications can##4##2##(1994-2#1)(2008-7#2)(2008-9#1)
modifications for##4##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
modifications have been##5##3##(1995-3#1)(1997-4#1)(1997-8#1)(2010-8#1)(2011-2#1)
modifications have##6##2##(1995-3#1)(1997-4#1)(1997-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
modifications in patients with##2##4##(1990-5#1)(1990-6#1)
modifications in the##12##3##(1990-8#2)(1992-6#1)(1995-12#1)(1995-3#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
modifications in##37##2##(1990-5#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-8#2)(2009-9#2)(2010-5#1)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
modifications include##2##2##(1997-8#1)(2008-11#1)
modifications is##4##2##(1994-8#1)(2008-10#1)(2008-5#1)(2009-5#1)
modifications observed##3##2##(1990-12#1)(1996-12#1)(2008-7#1)
modifications of birch##2##3##(2008-11#2)
modifications of the##24##3##(1991-12#2)(1992-3#1)(1992-5#1)(1994-8#2)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)(2013-8#1)
modifications of these##2##3##(2008-10#1)(2008-6#1)
modifications of##54##2##(1990-8#1)(1991-12#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#2)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#4)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
modifications on the##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
modifications on##5##2##(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
modifications or##2##2##(2008-11#1)(2013-1#1)
modifications that##4##2##(2008-11#1)(2008-2#1)(2009-5#1)(2012-2#1)
modifications to the##9##3##(1993-12#1)(1996-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-6#1)
modifications to##14##2##(1991-12#1)(1993-12#1)(1996-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2009-6#1)
modifications were##6##2##(1993-12#1)(1994-12#1)(2009-10#1)(2009-8#3)
modifications##252##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#4)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#3)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#5)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-4#1)(1997-8#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#30)(2008-11#17)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#12)(2008-5#4)(2008-6#6)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#1)(2009-8#12)(2009-9#4)(2010-12#3)(2010-2#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#8)(2011-9#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#10)(2013-8#3)
modified &quot##4##2##(2011-2#4)
modified American Orthopaedic Foot and Ankle Society##3##7##(2009-10#3)
modified BCR##2##2##(2008-10#1)(2011-2#1)
modified Boyden##2##2##(1990-12#1)(2008-10#1)
modified CBH I##2##3##(1993-8#2)
modified CCE prepared##2##3##(2008-10#2)
modified CCEs##2##2##(2008-10#2)
modified CHO##2##2##(2008-11#2)
modified CPE##3##2##(2008-10#2)(2008-6#1)
modified DNA##4##2##(1991-5#2)(2008-10#1)(2008-4#1)
modified GCE##3##2##(2008-10#3)
modified Gran I method##2##4##(2008-10#2)
modified HA##2##2##(2008-10#2)
modified Kaolinite##2##2##(2008-10#2)
modified Koyanagi##2##2##(2009-5#2)
modified LRH filter##2##3##(2008-3#2)
modified Luneburg##2##2##(2008-3#2)
modified McBride procedure##2##3##(2009-10#2)
modified McBride##3##2##(2009-10#3)
modified NEECHAM##2##2##(2010-10#2)
modified PLGA particles##4##3##(2009-7#4)
modified PQC##3##2##(2008-10#3)
modified Quad procedure in##2##4##(2013-1#2)
modified Quad procedure##4##3##(2013-1#4)
modified Quad##5##2##(2013-1#5)
modified Rankin Scale (mRS)##2##4##(2012-3#1)(2013-1#1)
modified Rankin Scale##4##3##(2012-3#3)(2013-1#1)
modified Wendan decoction##2##3##(2008-10#2)
modified Wollaston prism##2##3##(2008-3#2)
modified Wollaston##4##2##(2008-3#4)
modified ZN staining with##2##4##(2013-8#2)
modified ZN staining##4##3##(2013-8#4)
modified ZN##5##2##(2013-8#5)
modified Ziehl-Neelsen##2##2##(1996-12#1)(2012-12#1)
modified a##3##2##(1996-2#1)(2007-12#1)(2008-3#1)
modified after##2##2##(1994-3#1)(2008-10#1)
modified alkaline comet assay##2##4##(1997-4#2)
modified amino##2##2##(1995-5#1)(2008-4#1)
modified amperometric##2##2##(2008-10#2)
modified analogs##2##2##(1992-9#1)(2008-5#1)
modified and unmodified##5##3##(1993-11#1)(1995-12#1)(2008-10#3)
modified and##13##2##(1992-2#1)(1993-11#1)(1995-12#1)(2008-10#8)(2013-1#1)(2013-7#1)
modified approach##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
modified as##3##2##(1991-2#1)(1995-1#1)(2011-2#1)
modified at its##2##3##(1995-6#1)(1996-6#1)
modified at##5##2##(1992-3#1)(1993-11#1)(1995-6#1)(1996-6#1)(2008-10#1)
modified based on##2##3##(1996-2#1)(2008-12#1)
modified by Gregor et al##2##5##(2008-10#2)
modified by a recently synthesized##3##5##(2008-10#3)
modified by a##11##3##(1997-2#1)(2007-11#1)(2008-10#8)(2008-3#1)
modified by changing the##2##4##(2008-7#1)(2011-2#1)
modified by one##2##3##(2008-5#1)(2009-5#1)
modified by surface##2##3##(2008-10#1)(2008-3#1)
modified by the##12##3##(1991-5#1)(1992-7#1)(1992-9#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)
modified by these##2##3##(1992-6#1)(1994-8#1)
modified by using##3##3##(1991-12#1)(2008-10#2)
modified by##125##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-7#1)(2008-10#50)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
modified cDNA RDA##2##3##(2008-9#2)
modified cam clay##2##3##(2009-7#2)
modified carbon ceramic electrode##3##4##(2008-10#3)
modified carbon electrode##2##3##(1995-6#1)(2008-10#1)
modified carbon electrodes##2##3##(2008-10#2)
modified carbon fiber##3##3##(2008-10#3)
modified carbon paste electrode for determination of##2##7##(2008-10#2)
modified carbon paste electrode for the determination of##2##8##(2008-10#2)
modified carbon paste electrode for##6##5##(2008-10#6)
modified carbon paste electrode has been developed##2##7##(2008-10#2)
modified carbon paste electrode in##2##5##(2008-10#2)
modified carbon paste electrode was##4##5##(2008-10#4)
modified carbon paste electrode##28##4##(2008-10#28)
modified carbon##43##2##(1995-6#1)(2008-10#41)(2009-3#1)
modified cells##2##2##(2008-2#1)(2008-4#1)
modified cellulose##2##2##(2008-10#1)(2008-7#1)
modified ceria-zirconia##2##2##(2008-10#2)
modified cyclodextrins##2##2##(2008-10#2)
modified dramatically##2##2##(2007-11#1)(2008-1#1)
modified during##2##2##(2008-5#1)(2010-7#1)
modified either with##2##3##(2008-10#2)
modified electrode and its application##2##5##(2008-10#2)
modified electrode and##5##3##(2008-10#5)
modified electrode as##2##3##(2008-10#2)
modified electrode by##3##3##(2008-10#3)
modified electrode can be used##4##5##(2008-10#4)
modified electrode can##5##3##(2008-10#5)
modified electrode exhibited##2##3##(2008-10#2)
modified electrode exhibits a##2##4##(2008-10#2)
modified electrode exhibits##4##3##(2008-10#4)
modified electrode for the determination of##2##6##(2008-10#2)
modified electrode for the##4##4##(1995-6#1)(2008-10#3)
modified electrode for##5##3##(1995-6#1)(2008-10#4)
modified electrode has been##3##4##(2008-10#3)
modified electrode in##4##3##(2008-10#4)
modified electrode is##4##3##(1995-6#2)(2008-10#2)
modified electrode showed an##2##4##(2008-10#2)
modified electrode showed##7##3##(2008-10#7)
modified electrode to##2##3##(2008-10#2)
modified electrode was prepared##2##4##(2008-10#2)
modified electrode was studied##2##4##(2008-10#2)
modified electrode was##16##3##(2008-10#16)
modified electrode were studied##2##4##(2008-10#2)
modified electrode were##4##3##(2008-10#4)
modified electrode with a##2##4##(2008-10#2)
modified electrode##117##2##(1995-6#4)(2008-10#113)
modified electrodes are##2##3##(2008-10#2)
modified electrodes exhibited good##2##4##(2008-10#2)
modified electrodes for##2##3##(2008-10#1)(2010-6#1)
modified electrodes have been##2##4##(2008-10#2)
modified electrodes were##3##3##(2008-10#3)
modified electrodes##34##2##(2008-10#33)(2010-6#1)
modified enzyme##7##2##(1990-11#1)(1990-7#2)(1993-6#1)(2008-10#3)
modified films were##3##3##(2008-10#2)(2008-5#1)
modified films##5##2##(2008-10#2)(2008-5#3)
modified for##7##2##(1994-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)
modified form of##5##3##(2007-11#1)(2008-10#1)(2009-10#1)(2013-1#2)
modified form##6##2##(2007-11#1)(2008-10#2)(2009-10#1)(2013-1#2)
modified forms of##2##3##(1992-11#1)(2011-2#1)
modified glassy carbon electrode##11##4##(2008-10#11)
modified glassy carbon##13##3##(2008-10#13)
modified gold electrode##8##3##(2008-10#8)
modified gold electrodes##4##3##(2008-10#4)
modified gold##16##2##(2008-10#16)
modified in patients with##2##4##(1991-2#1)(2008-7#1)
modified in response to##2##4##(1991-1#1)(2008-4#1)
modified in the presence of##2##5##(1990-12#1)(1996-12#1)
modified in the##4##3##(1990-12#1)(1993-11#1)(1995-2#1)(1996-12#1)
modified in##13##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-11#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
modified into a##2##3##(2007-12#1)(2008-2#1)
modified inverse power##2##3##(2008-10#2)
modified low-density lipoprotein##2##3##(1993-6#1)(1993-8#1)
modified low-density##3##2##(1993-6#1)(1993-8#2)
modified matrixes##2##2##(2008-10#2)
modified method of##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
modified method##8##2##(1994-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
modified microwave##2##2##(2008-10#2)
modified nucleosides##4##2##(1993-8#1)(1997-2#1)(2008-4#2)
modified nucleotide##4##2##(1993-11#2)(2008-2#2)
modified nucleotides T(54) and Psi(55)##2##5##(2008-8#2)
modified nucleotides of##2##3##(1992-11#1)(2008-8#1)
modified nucleotides##8##2##(1992-11#1)(2008-4#4)(2008-8#3)
modified oligodeoxynucleotides##3##2##(2008-4#3)
modified oligonucleotides##2##2##(2008-10#1)(2008-11#1)
modified only##2##2##(1997-2#1)(2008-10#1)
modified operator##2##2##(1992-6#1)(1995-8#1)
modified optical system##2##3##(2008-2#2)
modified optical##3##2##(2008-10#1)(2008-2#2)
modified or not by##2##4##(2008-10#1)(2008-5#1)
modified or##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)
modified peptide##4##2##(1995-5#2)(2008-5#1)(2010-2#1)
modified power law##6##3##(2008-10#6)
modified proteins##7##2##(1995-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-2#1)
modified radical mastectomy##4##3##(1994-12#2)(1995-4#1)(2008-10#1)
modified radical mastoidectomy##3##3##(2008-9#3)
modified radical##9##2##(1992-9#1)(1994-12#2)(1995-4#1)(2008-10#2)(2008-9#3)
modified reaction##2##2##(1995-11#1)(2008-10#1)
modified residues##4##2##(2008-2#1)(2008-4#2)(2011-1#1)
modified resin was##2##3##(2008-10#2)
modified resin##9##2##(2008-10#9)
modified screen-printed carbon electrode##2##4##(2008-10#2)
modified screen-printed carbon electrodes (SPCEs)##2##5##(2008-10#2)
modified screen-printed carbon electrodes##5##4##(2008-10#5)
modified screen-printed carbon##7##3##(2008-10#7)
modified screen-printed##9##2##(2008-10#9)
modified sensor##2##2##(2008-10#2)
modified sensors##2##2##(2008-10#2)
modified signed-digit (MSD)##2##3##(2008-3#2)
modified signed-digit##4##2##(2008-3#4)
modified silica gel##9##3##(2008-10#9)
modified silica##15##2##(2008-10#14)(2011-1#1)
modified silicon##2##2##(2008-10#1)(2008-7#1)
modified simplex algorithm##2##3##(2008-10#2)
modified simplex method##4##3##(2008-10#4)
modified simplex##10##2##(2008-10#9)(2008-5#1)
modified strains##3##2##(2007-10#2)(2011-2#1)
modified surface##6##2##(2007-11#1)(2008-10#4)(2010-4#1)
modified surgical technique##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
modified surgical##4##2##(2007-8#1)(2008-7#1)(2008-9#1)(2012-2#1)
modified technique##8##2##(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
modified test##7##2##(2011-2#7)
modified the effect of##2##4##(2008-8#1)(2010-6#1)
modified the##19##2##(1992-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#2)(2010-6#2)(2013-1#1)
modified their##2##2##(2008-10#1)(2011-2#1)
modified through##2##2##(1993-6#1)(2008-10#1)
modified tissue##2##2##(2009-3#1)(2012-12#1)
modified to 0##2##3##(2008-10#2)
modified to account for##2##4##(2008-10#1)(2008-4#1)
modified to achieve##2##3##(2008-2#1)(2008-9#1)
modified to allow##2##3##(1996-12#1)(2008-2#1)
modified to minimize the##2##4##(2008-8#1)(2008-9#1)
modified to permit##2##3##(1992-8#1)(2008-10#1)
modified to provide##2##3##(2008-7#2)
modified to represent the##2##4##(2008-10#1)(2008-9#1)
modified to work with##2##4##(1997-6#1)(2008-3#1)
modified to work##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
modified to##43##2##(1990-7#1)(1992-8#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)
modified trichromic Gomori stain##2##4##(1990-3#2)
modified using##2##2##(1993-6#1)(2008-6#1)
modified version of the##15##4##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)
modified version of##18##3##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-2#1)
modified version##19##2##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-2#1)
modified with 10% methanol##2##4##(2008-10#2)
modified with 8-hydroxy quinoline##2##4##(2008-10#2)
modified with Co(3+)-TCPP##2##3##(2008-10#2)
modified with Prussian##2##3##(2008-10#2)
modified with a##19##3##(2008-10#15)(2009-11#1)(2009-5#1)(2009-6#1)(2013-1#1)
modified with acetonitrile##2##3##(2008-10#2)
modified with advanced glycation end products##2##6##(1994-6#2)
modified with manganese##2##3##(2008-10#2)
modified with molecular sieves##2##4##(2008-10#2)
modified with niobium(V) oxide (Nb(2)O(5)-SiO(2))##2##5##(2008-10#2)
modified with single layer##2##4##(2008-10#2)
modified with the self-assembled##2##4##(2008-10#2)
modified with the##5##3##(1997-2#1)(2008-10#2)(2008-3#1)(2009-6#1)
modified with zirconium phosphate##2##4##(2008-10#2)
modified with zirconium##4##3##(2008-10#4)
modified with##152##2##(1992-11#1)(1992-3#1)(1993-11#2)(1994-6#2)(1994-9#1)(1995-2#1)(1997-2#1)(2008-10#130)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-6#2)(2010-4#1)(2013-1#1)(2013-8#1)
modified zirconia##3##2##(2008-10#3)
modified##1468##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#6)(1990-8#6)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-5#7)(1991-9#2)(1992-11#3)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#11)(1993-12#3)(1993-3#4)(1993-6#7)(1993-8#6)(1993-9#2)(1994-11#2)(1994-12#7)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#8)(1995-8#2)(1996-12#5)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#10)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#2)(2006-12#1)(2007-10#4)(2007-11#16)(2007-12#21)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#688)(2008-11#25)(2008-12#9)(2008-2#40)(2008-3#72)(2008-4#37)(2008-5#31)(2008-6#7)(2008-7#25)(2008-8#25)(2008-9#34)(2009-10#11)(2009-11#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#9)(2009-6#6)(2009-7#14)(2009-8#1)(2009-9#4)(2010-10#4)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#6)(2010-6#4)(2010-7#1)(2010-8#7)(2011-1#10)(2011-2#38)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#14)(2012-3#7)(2012-7#1)(2013-1#27)(2013-7#1)(2013-8#10)
modified-signed-digit arithmetic-logic array processor##2##4##(2008-3#2)
modifiedphyA2##3##1##(2008-4#3)
modifier (e##2##2##(1990-8#2)
modifier and its##2##3##(2008-10#2)
modifier and##17##2##(1993-11#1)(2008-10#15)(2008-5#1)
modifier concentration##6##2##(2008-10#6)
modifier content##2##2##(2008-10#2)
modifier for the determination of trace##2##6##(2008-10#2)
modifier for the determination of##4##5##(2008-10#4)
modifier for the##7##3##(2008-10#7)
modifier for##12##2##(2008-10#11)(2008-9#1)
modifier from##2##2##(2008-5#1)(2010-12#1)
modifier in the case of##2##5##(2008-10#2)
modifier in the##5##3##(2008-10#5)
modifier in##9##2##(1996-5#1)(2008-10#8)
modifier is 0##2##3##(1996-5#1)(2008-10#1)
modifier is##4##2##(1996-5#1)(1997-2#1)(2008-10#2)
modifier mixture was found to be preferable for the determination of##2##11##(2008-10#2)
modifier mixture##4##2##(2008-10#4)
modifier of##2##2##(2008-10#1)(2009-7#1)
modifier such as##2##3##(2008-10#2)
modifier to##3##2##(2008-10#3)
modifier use##2##2##(2008-10#2)
modifier was added##2##3##(2008-10#2)
modifier was introduced##2##3##(2008-10#2)
modifier was used for##2##4##(2008-10#2)
modifier was##12##2##(2008-10#12)
modifier were##4##2##(1994-9#1)(2008-10#3)
modifier##188##1##(1990-11#1)(1990-8#2)(1991-12#1)(1993-11#1)(1994-9#2)(1996-5#4)(1997-2#2)(1997-4#1)(2008-10#158)(2008-4#1)(2008-5#3)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#6)
modifier)##5##1##(2008-10#3)(2008-4#1)(2009-7#1)
modifiers and##6##2##(1994-8#1)(2008-10#3)(2010-1#1)(2010-5#1)
modifiers are##2##2##(1991-3#1)(2008-10#1)
modifiers for the##2##3##(2008-10#2)
modifiers for##9##2##(2008-10#8)(2008-5#1)
modifiers in the determination of##2##5##(2008-10#2)
modifiers in the##4##3##(2008-10#4)
modifiers in##8##2##(2008-10#7)(2010-12#1)
modifiers of##6##2##(1991-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-3#2)
modifiers such as##2##3##(1994-9#1)(2008-10#1)
modifiers were##3##2##(2008-10#3)
modifiers##79##1##(1991-3#2)(1994-8#1)(1994-9#1)(1996-5#1)(2007-4#1)(2008-1#1)(2008-10#55)(2008-11#1)(2008-5#3)(2008-6#1)(2009-5#2)(2010-1#2)(2010-12#2)(2010-5#2)(2012-3#3)(2013-1#1)
modifies its##2##2##(2008-3#1)(2009-11#1)
modifies the##15##2##(1992-6#1)(1995-2#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-2#3)(2008-5#1)(2009-8#1)(2012-2#2)(2013-1#1)
modifies##31##1##(1992-12#1)(1992-6#2)(1993-11#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-2#2)(2013-1#1)
modify a##3##2##(2008-10#1)(2008-11#2)
modify disease##3##2##(2007-7#1)(2008-4#1)(2011-2#1)
modify its##4##2##(1996-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
modify the beam##2##3##(2007-12#1)(2008-2#1)
modify the course##2##3##(1991-8#1)(2010-3#1)
modify the natural##2##3##(1990-6#1)(2013-7#1)
modify the previous##2##3##(2007-12#1)(2008-10#1)
modify the surface of##2##4##(2008-1#1)(2008-10#1)
modify the surface##3##3##(2008-1#1)(2008-10#1)(2009-7#1)
modify the##66##2##(1990-6#3)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#3)(2010-3#2)(2011-10#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
modify their##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
modify this process##2##3##(1994-9#1)(2007-11#1)
modify your##2##2##(1993-12#1)(1995-2#1)
modify##146##1##(1990-12#1)(1990-6#3)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#4)(1996-12#1)(1996-2#3)(1996-9#1)(1997-2#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-10#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#2)
modifying a##2##2##(1993-11#1)(2010-2#1)
modifying agents##2##2##(2008-5#1)(2011-1#1)
modifying drug##2##2##(2007-11#2)
modifying effects##2##2##(1990-6#1)(2012-1#1)
modifying its##3##2##(1993-12#2)(2008-10#1)
modifying material##2##2##(2009-11#2)
modifying synaptic strength##2##3##(2008-9#2)
modifying the##26##2##(1991-12#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2009-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
modifying##77##1##(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#3)(1995-12#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
modiolus##2##1##(2008-9#2)
modular and##2##2##(2008-3#1)(2012-2#1)
modular construction of##2##3##(2008-3#1)(2009-5#1)
modular neck##5##2##(2011-2#5)
modular##51##1##(1991-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
modularity##8##1##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#2)
modulate cell function##2##3##(2008-11#2)
modulate cell##5##2##(1995-5#1)(1995-8#1)(1996-2#1)(2008-11#2)
modulate cellular##7##2##(1993-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)
modulate cortical##2##2##(2008-11#1)(2008-9#1)
modulate enzyme##3##2##(1994-8#1)(1994-9#1)(2008-5#1)
modulate neuronal activity##2##3##(2008-5#1)(2009-3#1)
modulate neuronal##4##2##(2008-5#1)(2008-7#2)(2009-3#1)
modulate signal transduction##2##3##(1991-12#1)(1992-8#1)
modulate the degree of##2##4##(2007-11#1)(2008-11#1)
modulate the degree##3##3##(1997-2#1)(2007-11#1)(2008-11#1)
modulate the expression of key##2##5##(2008-10#1)(2008-4#1)
modulate the expression of the##2##5##(2008-5#1)(2013-1#1)
modulate the expression of##7##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
modulate the phase##3##3##(2007-11#1)(2008-3#2)
modulate the release of##2##4##(1997-4#2)
modulate the##54##2##(1990-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-9#1)(1997-2#1)(1997-4#3)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
modulate their##3##2##(1997-7#1)(2008-10#1)(2012-2#1)
modulate this##3##2##(1991-12#1)(1994-9#1)(1995-6#1)
modulate##167##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#16)(2008-2#2)(2008-3#8)(2008-4#8)(2008-5#6)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
modulated and##2##2##(2008-2#1)(2008-5#1)
modulated at the##2##3##(1992-10#1)(2008-10#1)
modulated at##8##2##(1992-10#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
modulated by a##7##3##(1990-7#1)(1993-3#1)(1995-2#1)(2008-3#1)(2008-5#2)(2009-9#1)
modulated by the##16##3##(1990-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)
modulated by various##3##3##(1991-12#1)(1993-11#1)(2011-2#1)
modulated by##76##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#3)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#6)
modulated in##6##2##(1990-11#1)(1990-8#1)(1994-5#1)(2007-12#1)(2008-3#1)(2013-1#1)
modulated laser##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
modulated lattice structure##2##3##(2007-11#2)
modulated phase##2##2##(2008-2#1)(2008-3#1)
modulated reflectance near the critical angle##3##6##(2008-3#3)
modulated regions##2##2##(2007-12#2)
modulated release##2##2##(1992-3#1)(2008-5#1)
modulated the expression of##2##4##(1991-5#1)(2008-10#1)
modulated the##6##2##(1991-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
modulated with a square wave at the proper frequency##2##9##(2007-12#2)
modulated with a square##3##4##(2007-11#1)(2007-12#2)
modulated with a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
modulated with##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
modulated##186##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#5)(1996-9#1)(1997-2#1)(2007-11#11)(2007-12#14)(2007-9#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#15)(2008-3#21)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#6)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#7)
modulates cell##2##2##(1992-9#1)(2012-12#1)
modulates its binding##2##3##(1991-12#1)(1992-12#1)
modulates many##2##2##(1993-8#1)(1995-8#1)
modulates protein##2##2##(1994-12#1)(1996-5#1)
modulates the activity of the##2##5##(1992-8#1)(2013-1#1)
modulates the function of##2##4##(1997-4#1)(2008-10#1)
modulates the functions of##2##4##(1993-8#1)(1997-7#1)
modulates the##27##2##(1991-1#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-8#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)
modulates##86##1##(1990-5#1)(1990-7#2)(1991-1#2)(1991-12#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-6#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
modulating activity of##2##3##(2008-11#1)(2009-10#1)
modulating and##2##2##(2008-3#2)
modulating both##2##2##(2007-12#1)(2008-10#1)
modulating effects##2##2##(2008-10#1)(2009-5#1)
modulating the activity##2##3##(1994-6#1)(2009-10#1)
modulating the central##2##3##(2008-10#2)
modulating the effects of##2##4##(1994-5#1)(2008-10#1)
modulating the expression of##6##4##(1992-8#1)(1996-2#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)
modulating the expression##7##3##(1992-8#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)
modulating the properties of##2##4##(1992-1#1)(2013-8#1)
modulating the##37##2##(1990-12#1)(1992-1#1)(1992-11#1)(1992-8#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-3#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-11#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#2)
modulating wire##2##2##(2009-11#2)
modulating##101##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-12#1)(1994-5#1)(1994-6#3)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#3)(2009-10#5)(2009-11#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-5#1)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#4)
modulation along##2##2##(2008-3#2)
modulation amplitude##5##2##(2008-2#1)(2008-3#4)
modulation amplitudes##3##2##(2008-2#1)(2008-3#2)
modulation and a##2##3##(2007-11#1)(2007-12#1)
modulation and demodulation##2##3##(2008-3#2)
modulation and of##2##3##(2008-5#1)(2013-1#1)
modulation and the##4##3##(2007-12#2)(2008-3#1)(2008-5#1)
modulation and##32##2##(1997-2#2)(2007-11#5)(2007-12#8)(2008-1#1)(2008-3#11)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)
modulation are discussed##2##3##(2007-12#1)(2008-3#1)
modulation are##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#3)
modulation as##3##2##(2008-3#2)(2008-7#1)
modulation at the filter plane##2##5##(2008-3#2)
modulation at the##3##3##(2008-3#3)
modulation at##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
modulation bandwidth beyond the relaxation oscillation frequency##2##7##(2007-11#2)
modulation bandwidth##3##2##(2007-11#2)(2008-2#1)
modulation by 2##2##3##(1990-8#1)(2008-3#1)
modulation by different##2##3##(1990-3#1)(2008-5#1)
modulation by spermine##2##3##(1990-3#1)(1991-5#1)
modulation by use of a##2##5##(2007-12#1)(2008-3#1)
modulation by use of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
modulation by##25##2##(1990-11#1)(1990-3#2)(1990-8#1)(1991-1#1)(1991-5#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2013-8#1)
modulation capabilities##2##2##(2007-11#2)
modulation code##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
modulation depth and##2##3##(2007-11#1)(2007-12#1)
modulation depth of the optical##2##5##(2008-3#2)
modulation depth##11##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
modulation effect##3##2##(2007-12#2)(2008-3#1)
modulation efficiency of##2##3##(2008-2#2)
modulation for##2##2##(2007-11#1)(2008-10#1)
modulation frequencies##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
modulation frequency is##2##3##(2007-11#1)(2008-2#1)
modulation frequency of##2##3##(2008-3#2)
modulation frequency##14##2##(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#6)(2012-2#1)
modulation from##4##2##(2007-12#2)(2008-11#1)(2012-2#1)
modulation grating for sinusoidal structure illumination##2##6##(2008-3#2)
modulation grating##5##2##(2008-3#5)
modulation has been##2##3##(2008-3#2)
modulation has##3##2##(2008-3#3)
modulation in a##3##3##(2007-12#2)(2008-5#1)
modulation in the##10##3##(1990-7#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-5#1)
modulation in##29##2##(1990-7#1)(1990-8#1)(1993-12#2)(1994-9#1)(1996-12#1)(2007-11#5)(2007-12#7)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
modulation induced by##3##3##(1994-6#1)(2007-11#1)(2007-12#1)
modulation instability in##2##3##(2007-11#2)
modulation instability##3##2##(2007-11#2)(2007-12#1)
modulation is discussed##2##3##(2007-11#1)(2008-3#1)
modulation is##22##2##(2007-11#6)(2007-12#4)(2008-2#4)(2008-3#6)(2009-8#1)(2013-8#1)
modulation measurement profilometry##2##3##(2008-2#2)
modulation measurements##2##2##(2007-11#1)(2008-2#1)
modulation of Ca2+##2##3##(1994-6#1)(1995-11#1)
modulation of a laser diode##2##5##(2008-2#1)(2008-3#1)
modulation of a laser##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
modulation of a##9##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2009-8#1)
modulation of aging##2##3##(1990-3#1)(2008-7#1)
modulation of apoptosis##2##3##(1995-2#1)(2009-3#1)
modulation of both##2##3##(1996-2#1)(2008-3#1)
modulation of cell##5##3##(1991-9#1)(1992-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
modulation of channel activity##2##4##(2008-8#2)
modulation of channel##3##3##(2008-8#3)
modulation of cytoskeleton assembly-disassembly##2##4##(1993-6#2)
modulation of gene expression##2##4##(1994-5#1)(2008-7#1)
modulation of glucagon secretion##2##4##(2010-11#2)
modulation of human breast cancer cell growth##2##7##(2008-11#2)
modulation of human##4##3##(1994-3#1)(1994-5#1)(2008-11#2)
modulation of insulin##2##3##(2008-4#1)(2009-12#1)
modulation of ion##2##3##(1995-8#1)(2008-4#1)
modulation of its##2##3##(1993-12#1)(2007-12#1)
modulation of light##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
modulation of neuronal##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
modulation of pain##2##3##(2008-11#1)(2008-4#1)
modulation of ryanodine binding##2##4##(1990-2#2)
modulation of synaptic##2##3##(1990-9#1)(2008-5#1)
modulation of the expression of##2##5##(1992-9#1)(2008-10#1)
modulation of the index##2##4##(2008-2#2)
modulation of the laser##2##4##(2007-11#1)(2007-12#1)
modulation of the light##2##4##(2007-12#1)(2008-3#1)
modulation of the polarization state##2##5##(2007-11#1)(2007-12#1)
modulation of the probe##2##4##(2007-11#1)(2008-3#1)
modulation of the pump##2##4##(2007-12#2)
modulation of the relaxation rate of##2##6##(1994-8#2)
modulation of the transmission##2##4##(2007-12#1)(2008-3#1)
modulation of the##63##3##(1990-8#1)(1992-8#1)(1992-9#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#1)(1997-3#1)(1997-5#1)(2007-11#6)(2007-12#13)(2008-10#3)(2008-2#5)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
modulation of this##3##3##(1993-6#1)(1995-12#1)(2008-11#1)
modulation of visual##3##3##(2008-11#1)(2012-2#2)
modulation of##265##2##(1990-12#4)(1990-2#2)(1990-3#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#5)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#6)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#8)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(2007-11#16)(2007-12#18)(2008-1#3)(2008-10#3)(2008-11#8)(2008-2#10)(2008-3#26)(2008-4#9)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#9)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#4)(2009-6#1)(2009-8#4)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#5)(2011-2#6)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#8)
modulation on the##2##3##(2007-11#1)(2007-12#1)
modulation on##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
modulation or##2##2##(2007-12#1)(2008-2#1)
modulation process##2##2##(2008-2#1)(2008-4#1)
modulation response##2##2##(2008-2#1)(2008-3#1)
modulation scheme##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
modulation sidebands##3##2##(2008-2#2)(2008-3#1)
modulation signals##2##2##(2007-12#1)(2008-2#1)
modulation skewing effect in white-light vertical scanning interferometry##2##8##(2008-3#2)
modulation spectroscopy##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
modulation technique##10##2##(2008-2#3)(2008-3#6)(2013-8#1)
modulation techniques##2##2##(2008-2#1)(2008-3#1)
modulation that##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
modulation to##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
modulation transfer function (MTF) of##4##5##(2008-2#3)(2008-3#1)
modulation transfer function (MTF)##7##4##(2008-2#5)(2008-3#2)
modulation transfer function for##3##4##(2008-3#3)
modulation transfer function##20##3##(2008-2#8)(2008-3#12)
modulation transfer##21##2##(2008-2#8)(2008-3#13)
modulation was observed##2##3##(2011-2#1)(2013-8#1)
modulation was##7##2##(2007-11#2)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#2)
modulation were##2##2##(2007-11#1)(2008-3#1)
modulation with a##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
modulation with an##2##3##(2007-11#1)(2007-12#1)
modulation with##13##2##(2007-11#4)(2007-12#3)(2008-2#3)(2008-3#3)
modulation within the##2##3##(2008-3#1)(2013-1#1)
modulation##753##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#5)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#4)(1993-6#6)(1993-8#1)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#8)(1994-8#6)(1994-9#3)(1995-11#2)(1995-12#8)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(2007-11#83)(2007-12#88)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#22)(2008-11#13)(2008-2#79)(2008-3#191)(2008-4#11)(2008-5#11)(2008-6#2)(2008-7#15)(2008-8#12)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#5)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#7)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#2)(2010-9#1)(2011-1#6)(2011-2#13)(2012-12#7)(2012-2#10)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#21)
modulation-free##2##1##(2007-11#2)
modulational instability in##4##3##(2007-11#1)(2007-12#3)
modulational instability laser##2##3##(2007-11#2)
modulational instability of##3##3##(2007-11#2)(2007-12#1)
modulational instability##16##2##(2007-11#10)(2007-12#6)
modulational##17##1##(2007-11#11)(2007-12#6)
modulations in the##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
modulations in##4##2##(2008-10#1)(2008-3#2)(2009-5#1)
modulations of the##2##3##(1994-8#1)(2008-3#1)
modulations of##5##2##(1994-8#1)(1995-2#1)(2007-11#1)(2008-3#2)
modulations##34##1##(1994-8#3)(1995-2#1)(2007-11#6)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#13)(2009-5#1)
modulator and a##2##3##(2007-12#1)(2008-2#1)
modulator and##7##2##(1993-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
modulator are##2##2##(2007-11#1)(2008-2#1)
modulator at##4##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
modulator based on##2##3##(2007-12#1)(2008-3#1)
modulator by##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
modulator for##3##2##(2007-12#1)(2008-3#2)
modulator in the##4##3##(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
modulator in##9##2##(1990-2#1)(1993-8#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
modulator is used##2##3##(2007-11#1)(2008-3#1)
modulator is##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
modulator of the##3##3##(1993-8#1)(1995-12#1)(2011-2#1)
modulator of##10##2##(1990-12#1)(1992-6#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
modulator operating##2##2##(2008-2#1)(2008-3#1)
modulator that##5##2##(2008-2#3)(2008-3#2)
modulator to##3##2##(1991-4#1)(2008-3#2)
modulator with a##3##3##(2007-12#1)(2008-2#2)
modulator with##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
modulator##150##1##(1990-12#1)(1990-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#6)(1993-9#1)(1995-12#2)(2007-11#18)(2007-12#24)(2008-10#2)(2008-2#33)(2008-3#49)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
modulator-based free-space##3##2##(2008-2#1)(2008-3#2)
modulators and##4##2##(2008-2#2)(2009-4#1)(2010-5#1)
modulators are##5##2##(1996-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
modulators based on##3##3##(2007-12#1)(2008-3#2)
modulators for##2##2##(2008-3#1)(2008-5#1)
modulators in a##2##3##(2008-2#2)
modulators in the##3##3##(2007-12#1)(2012-12#2)
modulators in##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2012-12#2)
modulators of##15##2##(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-8#1)
modulators on the##2##3##(1994-8#1)(2008-3#1)
modulators on##3##2##(1994-8#1)(2008-2#1)(2008-3#1)
modulators with##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-4#1)
modulators##109##1##(1992-3#6)(1992-8#1)(1992-9#1)(1994-8#1)(1996-11#1)(1997-7#1)(2007-11#5)(2007-12#13)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#25)(2008-3#25)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#3)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
modulatory action##4##2##(1990-5#1)(1993-12#1)(2008-11#1)(2008-7#1)
modulatory effect of##4##3##(1993-3#1)(1995-11#1)(2008-8#1)(2013-8#1)
modulatory effect on##2##3##(1992-7#1)(2008-7#1)
modulatory effect##7##2##(1992-7#1)(1993-12#1)(1993-3#1)(1995-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
modulatory effects of##3##3##(1991-1#1)(2008-12#1)(2008-7#1)
modulatory mechanisms##2##2##(2009-12#1)(2013-8#1)
modulatory role of##3##3##(1994-8#1)(1996-2#1)(2011-2#1)
modulatory role##6##2##(1993-12#1)(1993-5#1)(1994-8#1)(1996-2#1)(2008-5#1)(2011-2#1)
modulatory sites on##2##3##(2011-1#2)
modulatory systems##2##2##(2009-12#2)
modulatory##40##1##(1990-2#1)(1990-5#1)(1991-1#1)(1992-7#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-11#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#6)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
module and the##2##3##(2008-11#1)(2008-3#1)
module and##3##2##(2008-11#2)(2008-3#1)
module based on##2##3##(2008-3#2)
module based##3##2##(2008-3#2)(2008-9#1)
module can##2##2##(2009-8#1)(2012-3#1)
module for##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
module has##2##2##(1996-1#1)(2008-3#1)
module in the##2##3##(1997-6#1)(2012-3#1)
module in##4##2##(1997-6#1)(2008-11#2)(2012-3#1)
module is presented##2##3##(2008-11#1)(2008-2#1)
module is##12##2##(2007-12#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#3)
module of study##3##3##(2008-11#3)
module of the##2##3##(2008-3#1)(2012-1#1)
module of##5##2##(2008-11#3)(2008-3#1)(2012-1#1)
module on##2##2##(1996-1#1)(2008-12#1)
module system##2##2##(2013-1#2)
module that##5##2##(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)
module to##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
module was##4##2##(1992-3#1)(1997-6#1)(2010-5#1)(2012-3#1)
module##109##1##(1991-1#1)(1992-3#2)(1993-8#1)(1994-9#1)(1996-1#4)(1996-7#2)(1997-6#2)(2007-10#1)(2007-11#1)(2007-12#5)(2008-10#11)(2008-11#20)(2008-12#5)(2008-2#3)(2008-3#17)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-8#5)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
module)##2##1##(2008-6#1)(2012-3#1)
modules and##2##2##(2008-2#1)(2013-1#1)
modules are##4##2##(1992-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
modules can##2##2##(2008-2#1)(2008-3#1)
modules for##10##2##(2007-11#1)(2008-2#3)(2008-3#3)(2008-9#1)(2010-5#1)(2012-3#1)
modules in##4##2##(1994-5#1)(1997-6#1)(2008-3#1)(2008-6#1)
modules of##2##2##(2008-11#2)
modules that##4##2##(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
modules to##3##2##(2008-6#1)(2008-7#1)(2008-9#1)
modules were##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
modules with##2##2##(2008-3#1)(2008-9#1)
modules##71##1##(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-3#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#17)(2008-6#2)(2008-7#3)(2008-9#5)(2009-5#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)
moduli and##2##2##(2008-3#1)(2010-4#1)
moduli of the##3##3##(2009-7#2)(2010-4#1)
moduli of##4##2##(2009-7#3)(2010-4#1)
moduli##8##1##(2008-3#1)(2009-7#5)(2010-4#2)
modulo 2pi##2##2##(2008-2#1)(2008-3#1)
modulus and strength##2##3##(2012-2#1)(2013-1#1)
modulus and##9##2##(2007-11#1)(2008-10#1)(2009-11#1)(2009-7#2)(2010-10#1)(2012-2#2)(2013-1#1)
modulus at##2##2##(2009-7#2)
modulus in##3##2##(2008-10#1)(2009-7#2)
modulus increases##2##2##(2009-7#1)(2011-3#1)
modulus is##2##2##(2008-3#1)(2009-7#1)
modulus of the##10##3##(2008-2#1)(2008-3#3)(2009-4#1)(2009-7#3)(2010-4#2)
modulus of##23##2##(1996-12#2)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#4)(2009-4#2)(2009-7#5)(2010-4#3)(2010-8#1)(2010-9#1)(2012-2#1)
modulus or##2##2##(2008-5#1)(2009-7#1)
modulus values##4##2##(2009-4#2)(2009-7#1)(2012-2#1)
modulus##96##1##(1991-10#1)(1996-12#2)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#7)(2008-9#2)(2009-11#1)(2009-4#6)(2009-5#2)(2009-7#29)(2010-10#3)(2010-4#9)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#8)(2012-3#1)(2013-1#1)
modulus)##3##1##(2009-7#2)(2013-1#1)
moenomycin A concentrations##2##3##(1997-2#2)
moenomycin A##5##2##(1997-2#5)
moenomycin##6##1##(1997-2#6)
mofetil and##3##2##(2007-11#2)(2008-3#1)
mofetil##10##1##(2007-11#3)(2008-1#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#2)
mohs micrographic surgery##2##3##(2010-8#2)
moieties are##4##2##(1990-5#1)(1997-4#1)(2006-12#1)(2009-8#1)
moieties by##2##2##(1997-4#1)(2010-4#1)
moieties in a##2##3##(2008-10#1)(2008-7#1)
moieties in the##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
moieties in##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2009-5#1)
moieties of the##5##3##(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(2010-4#1)
moieties of##9##2##(1992-8#1)(1993-8#2)(1994-3#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-7#1)(2010-4#1)
moieties on##2##2##(1992-3#1)(2008-10#1)
moieties with##2##2##(1995-3#1)(2008-10#1)
moieties##59##1##(1990-2#1)(1990-5#2)(1991-8#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#3)(2006-12#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-3#1)
moiety and##3##2##(1990-8#1)(1993-6#1)(2009-2#1)
moiety at##3##2##(1991-5#1)(1995-5#1)(2008-11#1)
moiety for##3##2##(1995-3#1)(1995-5#1)(2008-10#1)
moiety in the##5##3##(1992-8#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-10#1)
moiety in##9##2##(1990-11#1)(1992-8#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
moiety is attached to##2##4##(2008-10#2)
moiety is##12##2##(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-4#1)(2012-2#1)(2013-1#1)
moiety of both##3##3##(1993-6#2)(2008-11#1)
moiety of the##13##3##(1990-5#1)(1991-5#1)(1992-3#2)(1993-11#1)(1994-6#1)(1994-8#1)(2008-10#5)(2011-2#1)
moiety of##36##2##(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-3#2)(1993-11#3)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#8)(2008-11#6)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
moiety on the##3##3##(1996-5#1)(2008-10#2)
moiety on##5##2##(1995-3#2)(1996-5#1)(2008-10#2)
moiety to##3##2##(1990-8#1)(2008-10#1)(2008-4#1)
moiety was##7##2##(1990-7#2)(1992-10#1)(1992-5#1)(1995-12#1)(2008-10#2)
moiety were##2##2##(1990-7#1)(1992-8#1)
moiety with##4##2##(1992-6#1)(1994-8#1)(2008-10#1)(2008-4#1)
moiety##139##1##(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-12#3)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#3)(1993-11#5)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#7)(1995-5#3)(1995-6#1)(1996-5#4)(1997-2#1)(1997-6#1)(2006-6#1)(2007-11#3)(2008-1#1)(2008-10#36)(2008-11#8)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
moiré deflectometry phase-shifting##2##3##(2008-2#2)
moiré deflectometry##3##2##(2007-12#1)(2008-2#2)
moiré fringes are##3##3##(2008-3#3)
moiré fringes in Talbot interferometry are analyzed##2##7##(2008-3#2)
moiré fringes in Talbot interferometry are discussed##2##7##(2008-3#2)
moiré fringes in Talbot interferometry are##4##6##(2008-3#4)
moiré fringes in Talbot interferometry##5##5##(2008-3#5)
moiré fringes in##8##3##(2008-3#8)
moiré fringes##18##2##(2008-2#1)(2008-3#17)
moiré pattern##4##2##(2008-3#4)
moiré patterns##4##2##(2008-2#2)(2008-3#2)
moiré profile##4##2##(2008-3#4)
moiré topography##2##2##(2008-3#2)
moiré##52##1##(2007-12#1)(2008-2#8)(2008-3#43)
moist incubation##3##2##(2008-10#3)
moist stratification##2##2##(2006-11#2)
moist##20##1##(1994-12#1)(2006-11#2)(2008-10#17)
moistened##2##1##(1992-1#1)(2008-10#1)
moisture and temperature##6##3##(2008-10#5)(2008-12#1)
moisture and##19##2##(2008-10#12)(2008-12#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-4#1)(2012-7#1)
moisture content and##4##3##(2008-12#1)(2009-7#1)(2012-7#1)(2013-8#1)
moisture content##20##2##(1997-2#1)(2008-10#2)(2008-12#4)(2009-7#1)(2010-4#3)(2012-2#1)(2012-7#2)(2013-7#5)(2013-8#1)
moisture contents##3##2##(2008-10#2)(2012-2#1)
moisture deficit stress##2##3##(2008-10#2)
moisture during the##2##3##(2008-10#2)
moisture in the##3##3##(2008-10#2)(2008-5#1)
moisture in##7##2##(2008-10#5)(2008-5#2)
moisture is##2##2##(1996-2#1)(2008-10#1)
moisture loss##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
moisture occurrence##3##2##(2008-10#3)
moisture on##4##2##(2008-10#4)
moisture regime##2##2##(2008-10#1)(2011-1#1)
moisture sensor##3##2##(2007-11#1)(2008-10#2)
moisture sorption##2##2##(2008-2#1)(2008-6#1)
moisture were##2##2##(1997-6#1)(2011-1#1)
moisture##139##1##(1992-2#2)(1995-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#3)(2007-11#1)(2008-10#73)(2008-12#5)(2008-2#5)(2008-3#1)(2008-5#11)(2008-6#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#6)(2010-7#1)(2011-1#3)(2012-2#5)(2012-7#3)(2013-7#7)(2013-8#1)
moisture)##2##1##(2008-10#1)(2012-3#1)
moisture-sensitive##2##1##(2008-10#2)
moistures##2##1##(1997-2#1)(2008-10#1)
moisturisation and elasticity are##2##4##(2008-5#2)
moisturisation and elasticity##3##3##(2008-5#3)
moisturisation and##4##2##(2008-5#4)
moisturisation##8##1##(2008-5#8)
moisturization and##2##2##(2008-5#2)
moisturization##11##1##(2008-5#11)
moisturizer control product##2##3##(2008-5#2)
moisturizer##20##1##(2008-10#1)(2008-5#19)
moisturizers##2##1##(2008-5#2)
moisturizing and##2##2##(2008-5#2)
moisturizing cream##2##2##(2008-5#2)
moisturizing effect##2##2##(2008-5#2)
moisturizing efficacy and##2##3##(2008-5#2)
moisturizing##17##1##(2007-7#1)(2008-5#16)
mojavensis##6##1##(2008-8#3)(2008-9#3)
mol % of 3HV##2##4##(2008-6#2)
mol % of the##2##4##(2010-4#2)
mol % of##4##3##(2008-6#2)(2010-4#2)
mol %##9##2##(1994-5#2)(2007-12#3)(2008-6#2)(2010-4#2)
mol 1(-1) with a detection limit##2##6##(1996-5#1)(2008-10#1)
mol 1(-1) with##3##3##(1996-5#1)(2008-10#2)
mol 1(-1)##13##2##(1996-5#2)(2008-10#11)
mol L(-1)##6##2##(2008-10#6)
mol dm(-3) NH(4)NO(3)##2##3##(2008-10#2)
mol dm(-3) and##2##3##(2008-10#2)
mol dm(-3) in##2##3##(2008-10#2)
mol dm(-3) of##6##3##(2008-10#6)
mol dm(-3) sulphuric acid##3##4##(2008-10#3)
mol dm(-3) with##3##3##(2008-10#3)
mol dm(-3)##54##2##(1996-5#2)(2008-10#52)
mol dm(-3)) and##2##3##(2008-10#2)
mol dm(-3))##10##2##(2008-10#10)
mol each of##4##3##(1990-10#1)(1990-7#1)(1992-3#1)(2008-6#1)
mol fraction of##2##3##(2008-10#1)(2008-6#1)
mol fraction##3##2##(1991-8#1)(2008-10#1)(2008-6#1)
mol g(-1)##2##2##(2008-10#2)
mol kg(-1)##6##2##(2008-10#6)
mol l(-1) (Cd(2+))##2##3##(2008-10#2)
mol l(-1) (N=11)##2##3##(2008-10#2)
mol l(-1) (Pb(2+)) and##2##4##(2008-10#2)
mol l(-1) H(2)SO(4)##3##3##(2008-10#3)
mol l(-1) HCl and##2##4##(2008-10#2)
mol l(-1) HCl were##2##4##(2008-10#2)
mol l(-1) HCl##18##3##(2008-10#18)
mol l(-1) HNO(3)##6##3##(2008-10#6)
mol l(-1) NaCl##6##3##(2008-10#6)
mol l(-1) NaOH solution##3##4##(2008-10#3)
mol l(-1) NaOH##7##3##(2008-10#7)
mol l(-1) UO(2)(2+) with##2##4##(2008-10#2)
mol l(-1) ammonium##3##3##(2008-10#3)
mol l(-1) and 4##2##4##(2008-10#2)
mol l(-1) and the detection##2##5##(2008-10#2)
mol l(-1) and the relative standard deviation##2##7##(2008-10#2)
mol l(-1) and the##7##4##(2008-10#7)
mol l(-1) and##17##3##(2008-10#17)
mol l(-1) ascorbic acid##2##4##(2008-10#2)
mol l(-1) at pH##2##4##(2008-10#2)
mol l(-1) at##4##3##(2008-10#4)
mol l(-1) carminic acid##2##4##(2008-10#2)
mol l(-1) citric acid##2##4##(2008-10#2)
mol l(-1) cobalt(II)##2##3##(2008-10#2)
mol l(-1) concentration range##3##4##(2008-10#3)
mol l(-1) for 3 min##2##5##(2008-10#2)
mol l(-1) for the##2##4##(2008-10#2)
mol l(-1) for##20##3##(2008-10#20)
mol l(-1) fosfestrol##2##3##(2008-10#2)
mol l(-1) hydrochloric acid##4##4##(2008-10#4)
mol l(-1) hydrochloric##5##3##(2008-10#5)
mol l(-1) hydrogen peroxide##2##4##(2008-10#2)
mol l(-1) in##4##3##(2008-10#4)
mol l(-1) nitric acid##2##4##(2008-10#2)
mol l(-1) of ascorbic acid##2##5##(2008-10#2)
mol l(-1) of##12##3##(2008-10#12)
mol l(-1) permanganate##2##3##(2008-10#2)
mol l(-1) phosphate buffer##4##4##(2008-10#4)
mol l(-1) phosphoric acid##2##4##(2008-10#2)
mol l(-1) recovery##2##3##(2008-10#2)
mol l(-1) sodium fluoride##2##4##(2008-10#2)
mol l(-1) sodium hydroxide##2##4##(2008-10#2)
mol l(-1) sodium##6##3##(2008-10#6)
mol l(-1) sulfuric acid##4##4##(2008-10#4)
mol l(-1) with a detection limit of 1##4##8##(2008-10#4)
mol l(-1) with a detection limit of##5##7##(2008-10#5)
mol l(-1) with a##8##4##(2008-10#8)
mol l(-1) with the detection limit of##2##7##(2008-10#2)
mol l(-1) with the detection limit##3##6##(2008-10#3)
mol l(-1) with the##5##4##(2008-10#5)
mol l(-1) with##15##3##(2008-10#15)
mol l(-1)##322##2##(2008-10#322)
mol l(-1)) and##4##3##(2008-10#4)
mol l(-1)) with##2##3##(2008-10#2)
mol l(-1))##19##2##(2008-10#19)
mol l(-3)##2##2##(2008-10#2)
mol of succinic acid##2##4##(1990-8#1)(2008-6#1)
mol of zinc per##3##4##(1994-5#3)
mol of##32##2##(1990-10#4)(1990-2#2)(1990-7#1)(1990-8#2)(1991-5#3)(1992-3#1)(1992-6#1)(1993-11#2)(1994-11#2)(1994-5#6)(1994-9#2)(1995-6#2)(2008-10#2)(2008-6#2)
mol ratio of##2##3##(2008-10#2)
mol x L(-1)##2##3##(2013-8#2)
mol##524##1##(1990-10#5)(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-5#3)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#4)(1994-11#2)(1994-5#8)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-5#4)(2007-11#1)(2007-12#6)(2008-10#451)(2008-2#1)(2008-6#7)(2008-9#2)(2009-2#2)(2010-4#2)(2013-8#2)
mol%##16##1##(1992-6#1)(1997-4#4)(2008-10#1)(2008-5#2)(2008-8#8)
mol%)##7##1##(1992-12#2)(1992-6#1)(2008-10#4)
mol%/h##3##1##(2008-6#3)
mol(-)(1)##4##1##(1996-2#1)(1997-7#3)
mol(-1) * L * s(-1)##2##5##(2008-9#2)
mol(-1) *##3##2##(2008-8#1)(2008-9#2)
mol(-1) at##5##2##(1996-2#1)(2008-10#4)
mol(-1) cm(-1) and 0##4##4##(2008-10#4)
mol(-1) cm(-1) and##14##3##(2008-10#14)
mol(-1) cm(-1) at##13##3##(2008-10#13)
mol(-1) cm(-1)##51##2##(2008-10#51)
mol(-1) cm(-1))##4##2##(2008-10#4)
mol(-1) dm(3) and##2##3##(2008-10#2)
mol(-1) dm(3)##3##2##(2008-10#3)
mol(-1) dm(3))##2##2##(2008-10#2)
mol(-1) per##2##2##(2008-10#1)(2012-2#1)
mol(-1) respectively##2##2##(2008-10#2)
mol(-1) tetrameric enzyme##2##3##(2009-2#2)
mol(-1)##122##1##(1996-2#7)(2008-10#102)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#3)(2009-2#2)(2012-2#2)
mol(-1))##4##1##(2008-10#2)(2011-1#2)
mol(-1)cm(-1)##3##1##(2008-10#3)
mol(-1)cm(-1))##3##1##(2008-10#3)
mol(-2) dm(6)##2##2##(2008-10#2)
mol(-2)##3##1##(2008-10#3)
mol(t-1)##2##1##(2008-9#2)
mol-1##17##1##(1990-8#2)(1992-10#4)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-5#2)(1997-2#5)
mol-1)##2##1##(1993-11#1)(1995-2#1)
mol/L##13##1##(2008-10#3)(2008-4#3)(2008-8#2)(2008-9#2)(2011-1#3)
mol/kg##2##1##(1993-2#1)(1995-12#1)
mol/l (0##3##2##(2008-10#3)
mol/l MgCl2##5##2##(1995-12#5)
mol/l and##3##2##(2008-10#1)(2011-2#2)
mol/l for##3##2##(2008-10#3)
mol/l##34##1##(1995-12#5)(2008-10#24)(2008-11#1)(2011-2#4)
mol/mol of##2##2##(1990-7#1)(1991-5#1)
mol/mol##3##1##(1990-11#1)(1990-7#1)(1991-5#1)
molar absorbance of##2##3##(1994-12#1)(2008-10#1)
molar absorption coefficient and##4##4##(2008-10#3)(2008-4#1)
molar absorption coefficient##9##3##(2008-10#7)(2008-4#1)(2008-5#1)
molar absorption##10##2##(2007-12#1)(2008-10#7)(2008-4#1)(2008-5#1)
molar absorptivities of the##4##4##(2008-10#4)
molar absorptivities of##7##3##(2008-10#7)
molar absorptivities##12##2##(2008-10#12)
molar absorptivity 1##2##3##(2008-10#2)
molar absorptivity and Sandell's sensitivity are##4##6##(2008-10#4)
molar absorptivity and Sandell's sensitivity of##2##6##(2008-10#2)
molar absorptivity and Sandell's sensitivity##8##5##(2008-10#8)
molar absorptivity and##10##3##(2008-10#10)
molar absorptivity being##3##3##(2008-10#3)
molar absorptivity for##4##3##(2008-10#4)
molar absorptivity is 2##2##4##(2008-10#2)
molar absorptivity is##12##3##(2008-10#12)
molar absorptivity of 1##4##4##(2008-10#4)
molar absorptivity of 2##2##4##(2008-10#2)
molar absorptivity of the##7##4##(2008-10#7)
molar absorptivity of##17##3##(2008-10#17)
molar absorptivity value of##2##4##(2008-10#2)
molar absorptivity value##3##3##(2008-10#3)
molar absorptivity##63##2##(2008-10#63)
molar concentration##3##2##(1990-11#1)(2008-4#1)(2012-2#1)
molar excess of##6##3##(1990-11#1)(1993-11#1)(1994-5#1)(1995-12#1)(2008-10#2)
molar excess##10##2##(1990-11#2)(1992-6#1)(1993-11#1)(1994-5#1)(1995-12#1)(1997-4#1)(2008-10#3)
molar extinction##2##2##(2008-10#2)
molar input rates##3##3##(2008-10#3)
molar mass of the##2##4##(1992-5#1)(2013-1#1)
molar mass of##3##3##(1992-5#1)(2008-10#1)(2013-1#1)
molar mass##7##2##(1992-5#2)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
molar masses##2##2##(2008-4#1)(2013-1#1)
molar ratio 1##2##3##(2008-10#2)
molar ratio and##3##3##(1991-12#1)(2008-6#2)
molar ratio between the##2##4##(2008-10#2)
molar ratio of 1##2##4##(2008-10#1)(2008-11#1)
molar ratio of the inclusion complex was 1##2##8##(2008-10#2)
molar ratio of the##8##4##(2008-10#6)(2012-2#1)(2013-1#1)
molar ratio of##32##3##(1990-5#1)(1990-7#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(2008-10#17)(2008-11#3)(2008-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
molar ratio was##2##3##(2008-8#1)(2010-4#1)
molar ratio##56##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1991-12#1)(1992-12#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-5#1)(2008-10#26)(2008-11#3)(2008-4#1)(2008-6#3)(2008-8#2)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
molar ratios in##2##3##(2008-10#1)(2012-2#1)
molar ratios of##8##3##(1995-5#1)(1997-3#1)(2008-10#4)(2008-8#1)(2009-8#1)
molar ratios##18##2##(1990-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-8#2)(2009-8#2)(2010-4#1)(2012-2#1)
molar reagent excess##2##3##(2008-10#2)
molar refractivity##2##2##(2008-3#2)
molar region##2##2##(2012-3#1)(2013-1#1)
molar teeth##2##2##(2012-12#1)(2013-1#1)
molar volume##5##2##(1990-7#1)(2008-10#4)
molar volumes and##2##3##(2008-10#2)
molar was restored with a##2##5##(2013-1#2)
molar with two palatal##3##4##(2013-1#3)
molar with two##4##3##(2013-1#4)
molar with##6##2##(2012-12#2)(2013-1#4)
molar##251##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#2)(1991-12#1)(1991-9#2)(1992-12#2)(1992-5#2)(1992-6#3)(1993-11#3)(1993-6#1)(1993-8#1)(1994-12#3)(1994-5#2)(1995-12#1)(1995-5#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#148)(2008-11#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#4)(2008-8#4)(2009-8#2)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#17)
molarity##3##1##(2008-1#1)(2008-10#2)
molars and##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
molars##29##1##(1993-1#1)(1995-2#1)(2007-12#1)(2008-12#4)(2009-2#3)(2011-2#2)(2012-12#5)(2013-1#12)
molasses##4##1##(2008-10#1)(2008-12#1)(2008-5#2)
molasses-based additive##2##2##(2008-10#2)
mold Aspergillus giganteus##2##3##(1997-4#1)(2008-10#1)
mold and##4##2##(2007-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
mold caused by Penicillium expansum##2##5##(2008-10#2)
mold disease##5##2##(1997-4#1)(2008-10#4)
mold in##2##2##(2008-10#1)(2008-6#1)
mold was##2##2##(2008-10#2)
mold##49##1##(1991-12#1)(1995-6#1)(1997-4#2)(2007-3#1)(2008-10#29)(2008-11#2)(2008-12#7)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#3)
mold)##2##1##(2008-10#2)
moldboard plow##2##2##(2008-12#2)
molded into##2##2##(1997-4#1)(2008-2#1)
molded plastic##2##2##(2008-2#1)(2008-3#1)
molded##7##1##(1997-4#1)(2008-2#4)(2008-3#2)
molding temperature##3##2##(2008-5#3)
molding##10##1##(2008-2#1)(2008-3#4)(2008-5#4)(2012-3#1)
molds are##2##2##(2008-10#2)
molds inside##2##2##(2008-3#2)
molds was##2##2##(2008-10#1)(2013-1#1)
molds##23##1##(1993-2#1)(2008-10#8)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)(2013-1#4)
mole fraction of##8##3##(2008-10#8)
mole fraction##22##2##(1990-8#2)(1992-3#1)(2007-12#2)(2008-10#11)(2008-2#3)(2008-8#3)
mole fractions##7##2##(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)
mole of##14##2##(1992-6#1)(1993-11#2)(1993-6#1)(1993-8#2)(1994-5#2)(2008-10#4)(2008-4#1)(2010-11#1)
mole percent##7##2##(1990-2#3)(1992-6#3)(2008-10#1)
mole ratio of##6##3##(1992-3#1)(2008-10#5)
mole ratio##10##2##(1990-2#1)(1992-3#1)(2008-10#8)
mole ratios##2##2##(1992-6#2)
mole which##2##2##(2013-8#2)
mole##75##1##(1990-2#5)(1990-8#2)(1992-3#2)(1992-6#6)(1993-11#2)(1993-6#1)(1993-8#2)(1994-3#2)(1994-5#2)(1997-4#1)(2007-12#2)(2008-10#25)(2008-2#7)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2010-11#1)(2011-2#1)(2013-8#6)
molecular MRI##3##2##(2010-9#2)(2012-12#1)
molecular absorption is##3##3##(2008-10#2)(2008-3#1)
molecular absorption spectrometry as##2##4##(2008-10#2)
molecular absorption spectrometry using##2##4##(2008-10#2)
molecular absorption spectrometry##15##3##(2008-10#15)
molecular absorption##26##2##(2008-10#22)(2008-2#1)(2008-3#3)
molecular action##2##2##(2012-2#1)(2013-1#1)
molecular alteration##2##2##(2008-8#1)(2011-2#1)
molecular alterations##3##2##(2009-12#1)(2012-2#1)(2013-7#1)
molecular analyses##12##2##(1993-12#1)(1995-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2009-8#1)(2011-1#1)
molecular analysis of the##2##4##(1994-6#1)(2013-1#1)
molecular analysis of##10##3##(1993-2#1)(1994-6#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular analysis##23##2##(1993-2#1)(1994-6#1)(1994-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular and biochemical##4##3##(1990-5#1)(1997-7#1)(2008-9#1)(2009-11#1)
molecular and cellular biology##4##4##(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
molecular and cellular events##2##4##(2008-7#2)
molecular and cellular##16##3##(1997-6#1)(1997-7#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
molecular and clinical##2##3##(2008-4#1)(2011-2#1)
molecular and functional##3##3##(2008-11#1)(2009-5#1)(2010-12#1)
molecular and genetic studies##2##4##(2007-12#1)(2008-1#1)
molecular and genetic##6##3##(2007-10#1)(2007-12#2)(2008-1#1)(2011-1#1)(2012-3#1)
molecular and genomic##2##3##(2008-8#1)(2009-8#1)
molecular and morphological##2##3##(2008-7#1)(2010-4#1)
molecular and phylogenetic relationships##2##4##(2008-10#2)
molecular and physiological##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
molecular and##58##2##(1990-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
molecular and/or##2##2##(1997-1#1)(2008-5#1)
molecular approaches##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
molecular architecture##3##2##(2009-11#3)
molecular areas##2##2##(1991-3#1)(1995-5#1)
molecular aspects of##2##3##(2008-6#1)(2009-4#1)
molecular assays##3##2##(2008-9#1)(2010-5#1)(2013-1#1)
molecular assemblies##3##2##(2008-10#3)
molecular assessment of##2##3##(2013-7#2)
molecular asymmetry##2##2##(1997-6#1)(2010-12#1)
molecular backscattering##2##2##(2008-3#2)
molecular bases##3##2##(2008-10#1)(2008-4#1)(2010-3#1)
molecular basis for the##8##4##(1991-8#1)(1996-12#1)(1997-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)
molecular basis for##14##3##(1991-8#1)(1996-12#1)(1997-2#1)(2008-7#1)(2008-8#3)(2008-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
molecular basis of the##10##4##(1990-8#3)(1993-2#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
molecular basis of##40##3##(1990-8#3)(1991-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#2)(2010-1#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
molecular basis##58##2##(1990-8#3)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-12#1)(2009-5#2)(2010-1#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
molecular beacon##4##2##(2008-10#4)
molecular beacons (MB)##2##3##(2008-10#2)
molecular beacons for##2##3##(2007-11#1)(2008-10#1)
molecular beacons##8##2##(2007-11#1)(2008-10#6)(2008-9#1)
molecular beam epitaxy##7##3##(1995-3#1)(2007-11#1)(2007-12#1)(2009-11#4)
molecular beam##8##2##(1992-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2009-11#4)
molecular binding##2##2##(2009-12#1)(2013-1#1)
molecular biological and##4##3##(1994-3#1)(2007-2#1)(2008-7#1)(2008-8#1)
molecular biological techniques##2##3##(2008-11#1)(2008-9#1)
molecular biological##8##2##(1992-6#1)(1994-3#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)
molecular biologist##2##2##(1994-3#1)(2008-9#1)
molecular biologists##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
molecular biology and##6##3##(1994-3#1)(1997-4#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-3#1)
molecular biology have provided##2##4##(2006-10#1)(2007-7#1)
molecular biology have##5##3##(2006-10#1)(2007-7#1)(2009-1#1)(2010-5#1)(2012-3#1)
molecular biology is##2##3##(2008-4#1)(2009-12#1)
molecular biology of##7##3##(1996-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-6#1)(2009-5#1)(2010-3#1)
molecular biology research##2##3##(2008-2#1)(2011-2#1)
molecular biology techniques##4##3##(1997-6#1)(1997-7#1)(2010-12#1)(2012-2#1)
molecular biology to the##2##4##(1997-7#1)(2007-5#1)
molecular biology to##5##3##(1995-9#1)(1997-7#1)(2007-5#1)(2008-10#1)(2011-2#1)
molecular biology##72##2##(1990-12#1)(1991-11#1)(1994-3#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#6)(2006-10#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#3)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
molecular biomarkers in##2##3##(2011-2#1)(2012-2#1)
molecular biomarkers##4##2##(2010-5#1)(2011-2#1)(2012-2#2)
molecular bridge##2##2##(2008-10#2)
molecular chains##2##2##(2009-7#2)
molecular changes and##2##3##(2009-4#2)
molecular changes in##2##3##(1990-2#1)(2010-1#1)
molecular changes of##2##3##(1992-6#1)(2008-5#1)
molecular changes##13##2##(1990-2#1)(1992-6#1)(1997-7#1)(2008-5#2)(2008-7#2)(2009-4#2)(2009-6#1)(2010-1#1)(2012-12#1)(2012-2#1)
molecular chaperone##4##2##(1997-4#2)(2008-4#1)(2011-2#1)
molecular chaperones and##3##3##(2008-1#1)(2008-4#1)(2008-7#1)
molecular chaperones in the##2##4##(2008-7#1)(2009-6#1)
molecular chaperones play a##2##4##(1994-11#1)(2009-5#1)
molecular chaperones##15##2##(1994-11#3)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-5#2)(2009-6#1)
molecular characteristics of the##2##4##(2009-2#1)(2010-4#1)
molecular characteristics##8##2##(1990-5#1)(2007-7#1)(2008-10#2)(2009-2#1)(2010-4#1)(2010-7#1)(2013-8#1)
molecular characterization of a##6##4##(1990-7#1)(1995-12#1)(1995-6#1)(2008-10#2)(2012-12#1)
molecular characterization of the##3##4##(1995-11#1)(1995-2#1)(2010-12#1)
molecular characterization of##20##3##(1990-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#8)(2008-8#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
molecular characterization##25##2##(1990-11#1)(1990-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#8)(2008-8#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
molecular characterizations of human##2##4##(2013-8#2)
molecular chlorine##2##2##(2008-10#2)
molecular classification of##2##3##(2008-8#1)(2010-3#1)
molecular classification##3##2##(2008-4#1)(2008-8#1)(2010-3#1)
molecular clock##4##2##(1995-3#2)(2008-4#1)(2008-5#1)
molecular clones of##2##3##(1991-9#1)(2008-8#1)
molecular cloning and characterization of##2##5##(1994-12#1)(2010-5#1)
molecular cloning and##5##3##(1991-2#1)(1991-5#1)(1994-12#1)(1997-4#1)(2010-5#1)
molecular cloning of a##2##4##(1993-12#1)(1995-2#1)
molecular cloning of the##5##4##(1991-12#1)(1992-9#1)(1994-11#1)(1997-7#1)(2008-4#1)
molecular cloning of##10##3##(1991-12#1)(1991-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-4#1)
molecular cloning##20##2##(1991-12#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-4#1)(2010-5#1)
molecular combing##2##2##(2008-9#2)
molecular complexes were##2##3##(2008-10#2)
molecular complexes##6##2##(1995-5#2)(2008-10#2)(2008-4#1)(2008-7#1)
molecular complexity##2##2##(2012-2#2)
molecular components of##2##3##(2009-3#1)(2012-2#1)
molecular components##7##2##(1993-12#1)(1994-8#1)(2008-1#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
molecular composition of##2##3##(1990-12#1)(2008-11#1)
molecular composition##4##2##(1990-12#1)(1994-11#1)(2008-11#1)(2008-12#1)
molecular conformation##2##2##(2008-10#1)(2008-4#1)
molecular connectivity calculations##2##3##(2008-10#2)
molecular connectivity indices##2##3##(2008-10#2)
molecular connectivity##4##2##(2008-10#4)
molecular constituents##2##2##(2008-10#1)(2010-10#1)
molecular cues##2##2##(2009-8#1)(2010-10#1)
molecular cytogenetic##4##2##(2008-9#1)(2010-1#1)(2010-3#1)(2013-1#1)
molecular cytogenetics##6##2##(1997-3#1)(2008-11#1)(2008-9#4)
molecular data in##2##3##(2010-3#1)(2011-1#1)
molecular data##11##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)
molecular defect##2##2##(1990-5#1)(1997-3#1)
molecular defects##4##2##(2007-7#1)(2008-1#1)(2008-4#1)(2009-5#1)
molecular depth##2##2##(2009-10#1)(2009-2#1)
molecular descriptors were##2##3##(2007-11#1)(2008-10#1)
molecular descriptors##15##2##(2007-11#6)(2008-10#5)(2008-5#2)(2008-8#1)(2009-3#1)
molecular detection techniques##2##3##(2010-3#1)(2012-3#1)
molecular detection##5##2##(2008-10#2)(2010-3#1)(2010-5#1)(2012-3#1)
molecular determinants of##4##3##(1995-5#1)(1995-8#1)(2007-10#1)(2008-6#1)
molecular diagnosis of##3##3##(1997-4#1)(2012-12#1)(2013-8#1)
molecular diagnosis##7##2##(1997-4#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
molecular diagnostic techniques##2##3##(2011-1#1)(2013-8#1)
molecular diagnostic##8##2##(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
molecular diagnostics was##2##3##(2008-10#1)(2009-12#1)
molecular diagnostics##8##2##(2008-10#3)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
molecular differences##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
molecular diffusion##2##2##(2008-10#2)
molecular distillation##5##2##(2008-6#5)
molecular diversity of##2##3##(2008-10#2)
molecular diversity##5##2##(1997-3#1)(1997-4#1)(2008-10#2)(2008-7#1)
molecular docking##3##2##(2012-2#1)(2013-7#2)
molecular dynamic##2##2##(2008-8#1)(2012-2#1)
molecular dynamics (MD)##3##3##(1992-9#1)(2008-10#2)
molecular dynamics and##3##3##(1993-11#1)(1994-8#1)(2008-10#1)
molecular dynamics in##4##3##(1992-8#1)(2008-1#1)(2008-7#1)(2010-12#1)
molecular dynamics simulation##4##3##(1992-3#1)(1993-11#1)(2008-8#1)(2009-11#1)
molecular dynamics simulations of the##2##5##(1995-5#2)
molecular dynamics simulations of##8##4##(1992-6#1)(1993-11#1)(1993-5#1)(1995-5#2)(2012-2#1)(2013-1#2)
molecular dynamics simulations##20##3##(1992-11#1)(1992-6#2)(1993-11#4)(1993-5#1)(1995-3#1)(1995-5#2)(2008-7#1)(2009-5#1)(2009-9#2)(2012-2#1)(2013-1#3)(2013-8#1)
molecular dynamics trajectories##2##3##(1992-11#1)(2008-4#1)
molecular dynamics##56##2##(1991-8#2)(1992-11#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#7)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(2008-1#1)(2008-10#3)(2008-4#5)(2008-7#2)(2008-8#2)(2009-11#1)(2009-5#1)(2009-9#3)(2010-12#1)(2010-2#2)(2012-2#5)(2013-1#3)(2013-8#1)
molecular ecology##2##2##(1997-6#1)(2013-1#1)
molecular effects##3##2##(1997-3#1)(2008-7#1)(2013-1#1)
molecular electronic device use##2##4##(2009-11#2)
molecular environment##7##2##(1990-2#3)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
molecular epidemiology of##3##3##(2008-10#2)(2013-1#1)
molecular epidemiology##8##2##(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#2)(2010-11#1)(2011-1#1)(2013-1#1)
molecular events involved in##2##4##(1994-11#1)(2008-10#1)
molecular events that##6##3##(1994-11#2)(2008-7#2)(2009-8#1)(2010-8#1)
molecular events##15##2##(1994-11#3)(1994-6#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
molecular evidence##4##2##(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)
molecular evolution and##3##3##(2008-11#1)(2008-7#1)(2009-5#1)
molecular evolution of##3##3##(2008-1#1)(2008-9#1)(2012-2#1)
molecular evolution##16##2##(1994-8#1)(1997-6#5)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
molecular evolutionary##3##2##(2008-7#1)(2010-3#2)
molecular features of##4##3##(2008-7#1)(2011-2#3)
molecular features##8##2##(2008-10#1)(2008-7#2)(2011-2#5)
molecular field analysis##5##3##(1995-3#1)(2009-3#2)(2010-12#1)(2011-2#1)
molecular fluorescence##4##2##(2008-10#3)(2008-3#1)
molecular form of##3##3##(1990-7#1)(1991-5#1)(1992-12#1)
molecular form##4##2##(1990-7#1)(1991-5#1)(1992-12#1)(2008-10#1)
molecular forms of##8##3##(1990-12#1)(1990-8#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-8#1)(2008-4#1)
molecular forms##15##2##(1990-12#2)(1990-5#2)(1990-8#3)(1991-5#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(2008-4#1)(2008-6#1)
molecular function##6##2##(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
molecular functions##4##2##(2007-12#1)(2009-9#1)(2012-2#1)(2013-1#1)
molecular genetic analysis of##3##4##(1997-6#1)(2007-7#1)(2008-10#1)
molecular genetic analysis##4##3##(1997-6#1)(2007-7#1)(2008-10#1)(2008-5#1)
molecular genetic approaches##3##3##(1991-10#1)(2008-4#1)(2008-9#1)
molecular genetic diagnosis##2##3##(2008-4#2)
molecular genetic techniques##4##3##(1997-4#1)(2008-8#1)(2008-9#2)
molecular genetic testing##2##3##(2008-4#1)(2011-2#1)
molecular genetic##34##2##(1991-10#1)(1991-11#1)(1994-5#1)(1995-2#1)(1997-4#1)(1997-6#2)(2007-12#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2010-11#1)(2010-3#1)(2011-2#4)
molecular genetics and##2##3##(1997-4#1)(2012-3#1)
molecular genetics have greatly increased our understanding of the basic mechanisms in cancer development and utilizing these molecular techniques for cancer screening##2##22##(2013-1#2)
molecular genetics of##5##3##(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)
molecular genetics##15##2##(1991-11#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-8#1)(2012-3#2)(2013-1#2)
molecular geometry##2##2##(2013-1#2)
molecular haplotypes##2##2##(2008-10#2)
molecular hybridization and multiplex reverse-transcription polymerase chain reaction##2##8##(2008-10#2)
molecular hydrogen##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-3#1)
molecular hyperpolarizabilities##2##2##(2007-11#1)(2007-12#1)
molecular imaging in##2##3##(2008-2#1)(2012-12#1)
molecular imaging techniques##2##3##(2011-1#2)
molecular imaging##12##2##(2008-2#2)(2008-8#1)(2009-12#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
molecular imprinted##2##2##(2008-10#2)
molecular imprinting##11##2##(2008-10#9)(2008-8#1)(2010-7#1)
molecular information##5##2##(1997-7#1)(2007-11#1)(2010-7#1)(2011-2#1)(2013-7#1)
molecular interaction pathways using a##2##5##(2008-11#2)
molecular interaction##7##2##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-10#1)
molecular interactions and##2##3##(2009-12#1)(2010-10#1)
molecular interactions between##6##3##(1992-9#1)(2007-12#1)(2008-10#2)(2008-8#1)(2013-8#1)
molecular interactions with##2##3##(2011-2#1)(2012-2#1)
molecular interactions##15##2##(1992-9#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
molecular interventions##2##2##(2008-11#1)(2009-4#1)
molecular iodine##3##2##(2007-11#2)(2008-2#1)
molecular ion peak##2##3##(2009-12#2)
molecular ion##6##2##(2008-10#4)(2009-12#2)
molecular layer of the##3##4##(1995-12#2)(2009-8#1)
molecular layer##9##2##(1991-10#1)(1993-9#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-5#1)(2009-8#1)(2013-8#1)
molecular lesion##2##2##(1990-12#1)(1990-8#1)
molecular level##40##2##(1990-2#2)(1992-6#1)(1993-11#1)(1993-9#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-6#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
molecular linkage map##5##3##(1996-10#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
molecular logic##2##2##(2013-7#2)
molecular machinery is##2##3##(2008-7#1)(2009-8#1)
molecular machinery##6##2##(1993-12#1)(2008-7#3)(2009-8#2)
molecular machines##4##2##(2008-7#3)(2010-7#1)
molecular manipulations of##2##3##(2011-1#1)(2012-3#1)
molecular manipulations##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
molecular mapping of##3##3##(2008-10#3)
molecular mapping##5##2##(2008-10#5)
molecular marker for##4##3##(2008-10#2)(2008-9#1)(2013-8#1)
molecular marker to##2##3##(1992-5#1)(2008-10#1)
molecular marker##19##2##(1992-5#1)(2007-10#1)(2008-10#9)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
molecular markers and genetic##2##4##(2008-10#1)(2011-2#1)
molecular markers and##5##3##(2008-10#4)(2011-2#1)
molecular markers for##8##3##(1997-8#1)(2008-10#6)(2008-6#1)
molecular markers in order to##2##5##(2008-10#1)(2008-5#1)
molecular markers in##6##3##(2008-10#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-5#1)
molecular markers linked to a##2##5##(2008-10#1)(2008-5#1)
molecular markers linked to##6##4##(2008-10#4)(2008-5#1)(2008-8#1)
molecular markers of##2##3##(2008-8#1)(2012-3#1)
molecular markers that##2##3##(1997-8#1)(2008-10#1)
molecular markers to##6##3##(1997-7#1)(2008-10#4)(2011-2#1)
molecular markers were used to##3##5##(2008-10#3)
molecular markers##58##2##(1997-7#1)(1997-8#2)(2008-10#34)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-3#2)(2012-5#1)(2013-8#1)
molecular mass and##4##3##(1992-9#1)(1993-12#1)(1996-5#1)(2008-10#1)
molecular mass cut-off##2##3##(1992-12#1)(2008-10#1)
molecular mass is##2##3##(1994-12#1)(2008-10#1)
molecular mass of 21##2##4##(1993-6#1)(2008-10#1)
molecular mass of 27 kDa##2##5##(1996-5#1)(2008-10#1)
molecular mass of 47##2##4##(1991-12#1)(1997-4#1)
molecular mass of 55##2##4##(1996-6#1)(1997-4#1)
molecular mass of 60##3##4##(1990-7#1)(1995-2#1)(2008-11#1)
molecular mass of the##11##4##(1990-7#1)(1991-8#1)(1992-9#1)(1995-6#2)(1996-10#1)(1997-4#1)(2008-10#3)(2008-4#1)
molecular mass of##70##3##(1990-5#5)(1990-7#3)(1991-12#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-6#3)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-7#1)(2008-10#18)(2008-11#3)(2008-4#2)(2009-2#1)(2013-1#1)
molecular mass protein##2##3##(1993-9#1)(1995-6#1)
molecular mass was##2##3##(1994-6#1)(1997-4#1)
molecular mass##113##2##(1990-11#1)(1990-12#1)(1990-5#6)(1990-7#4)(1991-12#3)(1991-2#2)(1991-8#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#6)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#4)(1996-10#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-4#4)(1997-7#1)(2008-10#26)(2008-11#5)(2008-4#2)(2008-5#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
molecular masses of approximately##2##4##(1993-11#1)(2008-10#1)
molecular masses of##14##3##(1990-12#1)(1990-5#2)(1991-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1996-5#1)(2008-10#5)(2008-8#1)
molecular masses##26##2##(1990-12#3)(1990-5#3)(1990-8#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-8#1)
molecular mechanical##3##2##(2008-10#1)(2008-11#2)
molecular mechanics calculation##2##3##(2008-10#2)
molecular mechanics calculations were##2##4##(1995-5#1)(1996-5#1)
molecular mechanics calculations##4##3##(1995-5#2)(1996-5#2)
molecular mechanics##13##2##(1994-3#1)(1995-11#1)(1995-5#3)(1996-5#3)(2008-10#2)(2008-4#1)(2008-8#1)(2010-2#1)
molecular mechanism behind##2##3##(2008-10#1)(2012-2#1)
molecular mechanism for##2##3##(2008-10#1)(2012-12#1)
molecular mechanism of action of##2##5##(2008-10#1)(2008-11#1)
molecular mechanism of action##4##4##(1990-2#1)(2008-10#2)(2008-11#1)
molecular mechanism of the##4##4##(1990-2#1)(1993-8#1)(1996-4#1)(2009-12#1)
molecular mechanism of##28##3##(1990-2#2)(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#2)
molecular mechanism underlying##7##3##(1991-9#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
molecular mechanism##53##2##(1990-2#2)(1991-9#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)
molecular mechanisms and##2##3##(2008-11#1)(2012-2#1)
molecular mechanisms by which they##2##5##(2011-2#2)
molecular mechanisms by which##7##4##(1994-8#1)(2008-10#1)(2008-9#1)(2011-2#3)(2013-1#1)
molecular mechanisms by##8##3##(1994-8#1)(2008-10#1)(2008-9#1)(2011-2#3)(2011-3#1)(2013-1#1)
molecular mechanisms controlling##2##3##(2008-10#1)(2012-2#1)
molecular mechanisms in##2##3##(2008-3#1)(2009-11#1)
molecular mechanisms involved in##4##4##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
molecular mechanisms involving##2##3##(2008-11#1)(2009-3#1)
molecular mechanisms of action of##3##5##(1995-6#1)(2009-8#2)
molecular mechanisms of the##2##4##(2008-7#1)(2010-12#1)
molecular mechanisms of##30##3##(1993-2#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#2)
molecular mechanisms regulating##2##3##(2007-12#1)(2011-10#1)
molecular mechanisms that regulate##5##4##(1997-6#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular mechanisms that##12##3##(1994-2#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular mechanisms underlying the##6##4##(1992-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)
molecular mechanisms underlying##13##3##(1992-3#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)
molecular mechanisms##96##2##(1991-6#1)(1992-3#2)(1993-2#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-6#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#1)
molecular medicine##5##2##(1991-11#1)(2007-7#1)(2008-5#1)(2009-11#2)
molecular memory in the##2##4##(2012-2#2)
molecular memory in##3##3##(2012-2#3)
molecular memory##4##2##(2012-2#4)
molecular methods in##2##3##(2008-10#1)(2009-4#1)
molecular methods of##2##3##(2008-6#1)(2011-2#1)
molecular methods##15##2##(2007-12#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-6#2)(2009-4#1)(2011-2#2)
molecular mimicry of##2##3##(1995-2#1)(1995-3#1)
molecular mimicry##5##2##(1994-11#1)(1995-2#1)(1995-3#2)(2011-1#1)
molecular mobility##2##2##(1994-3#2)
molecular model##3##2##(1994-3#1)(1997-2#1)(2008-5#1)
molecular modeling and##2##3##(2011-2#1)(2012-12#1)
molecular modeling studies##2##3##(1994-5#1)(2013-1#1)
molecular modeling##18##2##(1992-3#1)(1992-4#1)(1993-11#1)(1994-5#2)(1994-8#1)(1995-3#2)(1996-5#1)(2008-10#1)(2008-4#3)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
molecular modelling and thermodynamics##2##4##(1995-11#2)
molecular modelling and##3##3##(1995-11#2)(2008-8#1)
molecular modelling##8##2##(1994-11#1)(1995-11#4)(1995-3#1)(1997-2#1)(2008-8#1)
molecular models of the##2##4##(1994-5#1)(2009-5#1)
molecular models of##3##3##(1992-4#1)(1994-5#1)(2009-5#1)
molecular models##5##2##(1992-4#1)(1994-3#1)(1994-5#1)(2008-11#1)(2009-5#1)
molecular motion##2##2##(1994-5#1)(2008-7#1)
molecular motors that##2##3##(2008-7#1)(2010-12#1)
molecular motors##7##2##(2008-7#1)(2009-12#5)(2010-12#1)
molecular nature of##2##3##(2012-12#2)
molecular nature##3##2##(1996-2#1)(2012-12#2)
molecular nitrogen##4##2##(2008-3#4)
molecular or##4##2##(1996-5#1)(2008-2#2)(2013-8#1)
molecular orbital calculations##2##3##(1991-5#1)(1996-2#1)
molecular orbital method##2##3##(1993-8#1)(2008-11#1)
molecular orbital theory##2##3##(1994-5#1)(2008-10#1)
molecular orbital##16##2##(1991-5#1)(1993-8#2)(1994-5#1)(1996-2#2)(2008-10#1)(2008-11#1)(2012-12#6)(2013-1#2)
molecular organization of the##3##4##(1997-2#1)(2008-5#1)(2013-8#1)
molecular orientation and##2##3##(2008-10#1)(2008-2#1)
molecular orientation for##2##3##(2008-10#2)
molecular orientation is##2##3##(2008-2#2)
molecular orientation##10##2##(2008-10#3)(2008-2#5)(2008-3#1)(2012-1#1)
molecular origin of##2##3##(2008-12#1)(2010-7#1)
molecular oxygen as##2##3##(1990-7#2)
molecular oxygen##11##2##(1990-7#2)(1992-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)
molecular packing of##2##3##(1992-6#1)(2008-8#1)
molecular packing##4##2##(1991-3#1)(1992-6#2)(2008-8#1)
molecular pathogenesis##5##2##(1992-6#1)(1995-2#1)(2007-12#2)(2010-4#1)
molecular pathology of##3##3##(2007-12#2)(2008-9#1)
molecular pathway##5##2##(2008-9#1)(2009-12#1)(2010-4#1)(2012-1#2)
molecular pathways involved in##2##4##(2008-7#1)(2010-4#1)
molecular pathways underlying##2##3##(2008-7#1)(2009-8#1)
molecular pathways##18##2##(1997-7#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
molecular patterns##6##2##(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
molecular phenotype##3##2##(1994-11#1)(2009-6#1)(2013-1#1)
molecular phylogenetic analysis##2##3##(1994-8#1)(2008-5#1)
molecular phylogenetic##8##2##(1994-8#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-2#1)
molecular phylogenies of##2##3##(2008-10#1)(2012-3#1)
molecular phylogenies##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
molecular phylogeny##4##2##(2007-12#1)(2008-10#2)(2008-6#1)
molecular players##2##2##(2008-7#1)(2009-6#1)
molecular polymorphism and##2##3##(2008-10#2)
molecular probe##5##2##(2008-10#2)(2008-11#1)(2013-8#2)
molecular processes##12##2##(1990-8#1)(1992-10#1)(1992-6#1)(1994-5#1)(2008-2#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
molecular profiles##5##2##(2009-4#1)(2010-12#2)(2010-3#1)(2010-6#1)
molecular properties of##5##3##(1992-3#1)(1994-3#1)(2008-10#2)(2008-2#1)
molecular properties##7##2##(1992-3#1)(1994-3#1)(2008-10#3)(2008-2#1)(2012-2#1)
molecular pseudograph's atom adjacency##2##4##(2007-11#2)
molecular ratios##2##2##(2008-10#2)
molecular reactions##2##2##(2008-4#2)
molecular recognition between##2##3##(1992-6#1)(2008-10#1)
molecular recognition of##2##3##(2008-8#1)(2013-1#1)
molecular recognition##15##2##(1992-6#1)(1994-5#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-3#4)(2010-12#1)(2013-1#1)(2013-7#1)
molecular regulation of##2##3##(2009-3#1)(2011-2#1)
molecular remission##2##2##(2009-3#1)(2010-11#1)
molecular replacement method##2##3##(2008-8#1)(2008-9#1)
molecular replacement##14##2##(1992-4#2)(1992-8#1)(1992-9#1)(1993-8#2)(2008-4#2)(2008-8#4)(2008-9#2)
molecular research##3##2##(1997-3#3)
molecular rotational##2##2##(2007-11#1)(2007-12#1)
molecular ruler##4##2##(2008-6#1)(2008-7#1)(2012-2#2)
molecular scattering is##2##3##(2008-2#2)
molecular scattering##7##2##(2008-2#4)(2008-3#3)
molecular self-assembly on##2##3##(2013-8#2)
molecular self-assembly##5##2##(2013-8#5)
molecular sensing##2##2##(2008-7#1)(2012-2#1)
molecular sensitivity##2##2##(2007-12#1)(2012-12#1)
molecular shapes##2##2##(1991-7#1)(1992-6#1)
molecular sieves##3##2##(2008-10#3)
molecular signaling##2##2##(1996-9#1)(2008-10#1)
molecular signals governing##2##3##(2008-4#1)(2008-9#1)
molecular signals that##2##3##(2008-5#1)(2010-10#1)
molecular signals##5##2##(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2013-1#1)
molecular signature of##2##3##(2010-1#1)(2011-2#1)
molecular signature##3##2##(2010-1#1)(2011-2#1)(2013-8#1)
molecular signatures##4##2##(2008-4#1)(2010-1#1)(2013-8#2)
molecular similarities##2##2##(1991-5#1)(2008-10#1)
molecular simulations##4##2##(2008-12#1)(2012-2#1)(2013-1#2)
molecular size of the##2##4##(1997-1#1)(2008-10#1)
molecular size of##6##3##(1990-12#2)(1995-2#1)(1997-1#1)(2008-10#2)
molecular size##20##2##(1990-12#2)(1990-8#1)(1991-7#1)(1991-9#1)(1995-2#1)(1997-1#1)(2007-11#2)(2008-10#9)(2008-7#1)(2012-2#1)
molecular sizes##3##2##(1992-9#1)(2007-12#1)(2008-10#1)
molecular species composition of##3##4##(1990-2#2)(1995-8#1)
molecular species composition##4##3##(1990-2#3)(1995-8#1)
molecular species in the##2##4##(1990-2#1)(2008-11#1)
molecular species in##3##3##(1990-2#1)(2008-11#1)(2008-2#1)
molecular species of##7##3##(1991-5#2)(1992-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(2008-10#1)
molecular species##21##2##(1990-2#4)(1991-5#2)(1992-9#1)(1994-12#2)(1995-12#1)(1995-8#2)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
molecular spectra##2##2##(2008-3#1)(2009-4#1)
molecular spectroscopy##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
molecular strategies##2##2##(2008-10#2)
molecular structure of silk##2##4##(2012-2#2)
molecular structure of##12##3##(1991-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-7#1)(2012-2#3)
molecular structure##27##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-5#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-7#2)(2006-6#1)(2007-11#2)(2008-10#6)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#3)(2013-1#1)
molecular structures and##2##3##(2008-10#1)(2012-2#1)
molecular structures of##3##3##(1993-2#1)(1995-3#2)
molecular structures##11##2##(1990-8#1)(1993-2#1)(1995-3#2)(1996-2#1)(2008-10#4)(2012-2#2)
molecular studies have##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
molecular studies of##2##3##(2008-10#1)(2008-4#1)
molecular studies to##2##3##(2007-12#1)(2008-10#1)
molecular studies##14##2##(1996-6#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-3#1)(2011-2#1)
molecular substances##2##2##(2007-11#1)(2008-10#1)
molecular subtypes of##2##3##(1997-8#1)(2009-4#1)
molecular switch##4##2##(2008-7#2)(2009-6#1)(2012-2#1)
molecular switches that##2##3##(2012-12#2)
molecular switches##6##2##(2010-12#1)(2012-12#3)(2013-8#2)
molecular symmetry##2##2##(1997-6#1)(2008-9#1)
molecular systems##9##2##(1995-11#1)(1997-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2013-1#2)
molecular target for##3##3##(2007-4#1)(2010-10#1)(2010-7#1)
molecular target##6##2##(2007-4#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-3#1)
molecular targeted therapies for##2##4##(2009-1#1)(2012-1#1)
molecular targeted##3##2##(2009-1#1)(2010-12#1)(2012-1#1)
molecular targets for##6##3##(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
molecular targets in##2##3##(2009-1#1)(2013-1#1)
molecular targets of adjudin##2##4##(2012-2#2)
molecular targets of##4##3##(1997-4#1)(2008-7#1)(2012-2#2)
molecular targets that##2##3##(2008-2#1)(2008-6#1)
molecular targets to##4##3##(1994-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
molecular targets##25##2##(1994-8#2)(1997-4#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-1#1)(2009-12#3)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
molecular technique##2##2##(2008-3#1)(2008-5#1)
molecular techniques are##2##3##(2008-10#1)(2013-1#1)
molecular techniques for the##2##4##(2011-2#2)
molecular techniques for##5##3##(2008-10#1)(2011-2#2)(2013-1#2)
molecular techniques##20##2##(1996-12#1)(2008-10#4)(2008-4#1)(2008-5#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
molecular tests##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
molecular to##2##2##(2008-5#1)(2010-7#1)
molecular tools##8##2##(2008-10#4)(2010-10#2)(2011-1#2)
molecular transitions##2##2##(2008-2#1)(2008-3#1)
molecular transport##4##2##(2008-10#1)(2008-7#1)(2010-7#2)
molecular tweezer-type neutral##2##3##(2008-10#2)
molecular tweezer-type##3##2##(2008-10#3)
molecular typing##2##2##(2011-2#2)
molecular understanding of##2##3##(1992-6#1)(2009-8#1)
molecular understanding##3##2##(1992-6#1)(2009-8#1)(2011-2#1)
molecular variability##3##2##(2008-10#3)
molecular variance (AMOVA)##5##3##(2008-10#4)(2008-12#1)
molecular variance##19##2##(2008-10#16)(2008-12#1)(2011-2#2)
molecular variation##6##2##(2008-10#6)
molecular virus clone##2##3##(1995-2#2)
molecular weight (MW)##3##3##(2008-10#2)(2008-3#1)
molecular weight (apo##2##3##(1990-7#2)
molecular weight B cell growth factor (HMW-BCGF) and the complement##2##10##(1991-3#2)
molecular weight HA##2##3##(2008-5#1)(2010-8#1)
molecular weight HA-based##3##3##(2008-5#3)
molecular weight about##2##3##(1994-11#1)(2012-3#1)
molecular weight activity##2##3##(1993-3#2)
molecular weight and the##2##4##(1990-12#1)(2008-5#1)
molecular weight and##19##3##(1990-12#1)(1991-2#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2010-2#1)(2010-4#2)
molecular weight complexes##2##3##(1992-2#1)(2008-4#1)
molecular weight compounds##6##3##(2008-10#6)
molecular weight determinations##2##3##(2008-5#2)
molecular weight distribution##2##3##(2008-10#2)
molecular weight for##2##3##(1995-2#1)(2010-4#1)
molecular weight form of##3##4##(1990-11#1)(1991-9#2)
molecular weight fraction##2##3##(1993-11#1)(1996-2#1)
molecular weight fractions##3##3##(2008-10#3)
molecular weight heparin (LMWH)##4##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)
molecular weight heparin and##3##4##(1995-5#1)(2007-7#1)(2008-10#1)
molecular weight heparin##20##3##(1995-5#1)(1996-6#1)(1997-2#2)(2007-10#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#3)
molecular weight is##2##3##(2008-10#1)(2008-8#1)
molecular weight of 1##2##4##(2008-8#2)
molecular weight of 13##2##4##(1993-11#1)(1995-6#1)
molecular weight of 27##2##4##(1990-11#1)(2008-8#1)
molecular weight of 28##2##4##(1990-7#1)(1993-8#1)
molecular weight of 37##3##4##(1990-7#1)(1994-6#1)(2008-12#1)
molecular weight of the##18##4##(1990-11#1)(1990-2#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#2)(1994-2#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)
molecular weight of##92##3##(1990-11#4)(1990-12#2)(1990-2#2)(1990-7#5)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-6#1)(1997-2#2)(1997-6#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#3)(2012-3#1)
molecular weight on##2##3##(1995-8#1)(2008-6#1)
molecular weight polyethylene (UHMWPE)##2##4##(2008-5#1)(2009-3#1)
molecular weight protein##3##3##(1991-5#1)(1996-2#1)(2008-10#1)
molecular weight proteins in##2##4##(2008-1#1)(2008-7#1)
molecular weight proteins##4##3##(1991-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
molecular weight range##3##3##(1990-11#1)(2008-11#2)
molecular weight selenium##5##3##(2010-11#5)
molecular weight substances##2##3##(1990-2#1)(2008-1#1)
molecular weight was##5##3##(1990-11#1)(1992-8#1)(1992-9#2)(1997-8#1)
molecular weight which##2##3##(1990-7#1)(1996-12#1)
molecular weight##343##2##(1990-11#8)(1990-12#20)(1990-2#5)(1990-5#2)(1990-6#1)(1990-7#10)(1991-10#1)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#4)(1991-9#5)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#4)(1993-11#4)(1993-12#1)(1993-3#5)(1993-6#2)(1993-8#3)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#5)(1995-5#3)(1995-6#2)(1995-8#3)(1996-12#3)(1996-2#3)(1996-6#1)(1997-2#6)(1997-6#2)(1997-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#60)(2008-11#14)(2008-12#4)(2008-3#4)(2008-4#8)(2008-5#23)(2008-6#5)(2008-7#7)(2008-8#14)(2008-9#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-9#2)(2010-11#6)(2010-2#2)(2010-3#2)(2010-4#4)(2010-8#2)(2011-2#4)(2012-1#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
molecular weights and##2##3##(2008-5#1)(2013-1#1)
molecular weights are##3##3##(2008-8#1)(2008-9#1)(2011-3#1)
molecular weights in the##2##4##(1990-12#1)(2008-2#1)
molecular weights in##3##3##(1990-12#1)(2008-2#1)(2008-5#1)
molecular weights of the##4##4##(1993-6#1)(1997-7#1)(2008-11#1)(2008-5#1)
molecular weights of##26##3##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#3)(2010-12#1)
molecular weights ranging##2##3##(1992-6#1)(2008-10#1)
molecular weights##51##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-6#2)(1997-7#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-3#1)(2013-1#1)
molecular wires##3##2##(2007-12#1)(2008-7#1)(2009-11#1)
molecular##2573##1##(1990-11#13)(1990-12#35)(1990-2#18)(1990-5#17)(1990-6#2)(1990-7#20)(1990-8#12)(1991-10#3)(1991-11#4)(1991-12#9)(1991-2#12)(1991-3#5)(1991-5#14)(1991-6#2)(1991-7#2)(1991-8#5)(1991-9#10)(1992-10#4)(1992-11#6)(1992-12#11)(1992-2#3)(1992-3#9)(1992-4#4)(1992-5#2)(1992-6#21)(1992-7#1)(1992-8#14)(1992-9#17)(1993-11#15)(1993-12#9)(1993-2#6)(1993-3#8)(1993-5#2)(1993-6#10)(1993-8#13)(1993-9#5)(1994-1#1)(1994-11#23)(1994-12#5)(1994-2#9)(1994-3#12)(1994-5#10)(1994-6#9)(1994-8#18)(1994-9#4)(1995-11#17)(1995-12#7)(1995-2#22)(1995-3#15)(1995-5#16)(1995-6#12)(1995-8#7)(1995-9#1)(1996-10#3)(1996-12#8)(1996-2#15)(1996-4#1)(1996-5#12)(1996-6#6)(1996-9#3)(1997-1#3)(1997-2#21)(1997-3#15)(1997-4#16)(1997-5#2)(1997-6#21)(1997-7#28)(1997-8#7)(2006-10#2)(2006-6#1)(2007-10#7)(2007-11#29)(2007-12#32)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#14)(2007-8#2)(2008-1#20)(2008-10#478)(2008-11#65)(2008-12#14)(2008-2#40)(2008-3#44)(2008-4#79)(2008-5#72)(2008-6#29)(2008-7#99)(2008-8#81)(2008-9#67)(2009-1#3)(2009-10#13)(2009-11#24)(2009-12#23)(2009-2#6)(2009-3#16)(2009-4#14)(2009-5#15)(2009-6#12)(2009-7#5)(2009-8#24)(2009-9#9)(2010-1#8)(2010-10#12)(2010-11#15)(2010-12#35)(2010-2#5)(2010-3#19)(2010-4#16)(2010-5#17)(2010-6#4)(2010-7#15)(2010-8#4)(2010-9#10)(2011-1#30)(2011-10#1)(2011-2#86)(2011-3#5)(2012-1#13)(2012-12#35)(2012-2#69)(2012-3#28)(2012-5#2)(2013-1#66)(2013-7#12)(2013-8#31)
molecular-based factors##2##2##(2009-4#2)
molecular-based##6##1##(2008-10#3)(2009-12#1)(2009-4#2)
molecular-beam epitaxy##2##2##(2007-11#2)
molecular-level##2##1##(1991-11#1)(2012-2#1)
molecular-mass distribution of food-grade protein hydrolyzates##2##6##(1997-2#2)
molecular-scale##4##1##(2007-12#2)(2008-7#1)(2012-2#1)
molecular-size##3##1##(2008-10#3)
molecular-weight##6##1##(1995-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)
molecularly characterize the##2##3##(1997-7#1)(2012-3#1)
molecularly characterized##2##2##(2008-10#1)(2012-12#1)
molecularly cloned and sequenced##2##4##(1995-2#1)(2008-10#1)
molecularly cloned##5##2##(1995-2#1)(1997-8#1)(2007-6#2)(2008-10#1)
molecularly imprinted polymer (MIP) as the##2##6##(2008-10#2)
molecularly imprinted polymer (MIP)##3##4##(2008-10#3)
molecularly imprinted polymer##4##3##(2008-10#4)
molecularly imprinted polymers##2##3##(2008-10#2)
molecularly imprinted##10##2##(2008-10#10)
molecularly similar##2##2##(2008-10#2)
molecularly smooth titanium##2##3##(2012-2#2)
molecularly##36##1##(1994-9#2)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-6#2)(2008-10#16)(2008-4#2)(2009-8#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
molecule L1##3##2##(1996-12#1)(2008-7#2)
molecule and a##2##3##(1990-11#1)(1995-5#1)
molecule and the##5##3##(1996-2#1)(2008-10#2)(2009-11#1)(2009-12#1)
molecule and##23##2##(1990-11#1)(1990-12#1)(1992-4#1)(1994-12#1)(1994-6#1)(1995-5#2)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2012-12#1)
molecule appears##2##2##(1990-5#1)(1993-9#1)
molecule are##6##2##(1990-11#1)(1991-5#1)(1993-8#1)(1995-12#1)(2008-1#1)(2008-7#1)
molecule as a##2##3##(2008-6#1)(2008-8#1)
molecule as an##2##3##(1993-9#1)(2008-7#1)
molecule as##6##2##(1993-9#1)(1995-2#1)(1996-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
molecule at the##2##3##(2008-10#1)(2008-8#1)
molecule at##9##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2012-2#1)
molecule bound to##2##3##(2008-4#1)(2011-1#1)
molecule bound##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
molecule by the##3##3##(2008-10#1)(2012-2#2)
molecule by##7##2##(1993-12#1)(2008-10#2)(2008-8#1)(2012-2#2)(2012-3#1)
molecule can##2##2##(2007-11#1)(2013-8#1)
molecule contains##2##2##(1995-3#1)(2013-1#1)
molecule derived from##2##3##(1994-2#1)(2008-4#1)
molecule detection##3##2##(2012-2#3)
molecule expression##2##2##(1996-2#2)
molecule for the##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
molecule for##8##2##(1993-3#1)(1994-2#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)
molecule from the##2##3##(2008-10#1)(2009-11#1)
molecule generated##2##2##(1996-12#1)(1996-2#1)
molecule has been##4##3##(1993-2#1)(1993-6#1)(1995-2#1)(2008-11#1)
molecule has##6##2##(1993-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-11#1)(2012-1#1)
molecule have a##2##3##(1993-8#1)(1994-2#1)
molecule have##3##2##(1993-8#1)(1994-2#1)(2008-10#1)
molecule in different##2##3##(2007-12#1)(2010-5#1)
molecule in solution##2##3##(1990-7#1)(2008-10#1)
molecule in the##8##3##(1990-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(2008-10#2)(2008-9#1)(2010-6#1)
molecule in##26##2##(1990-4#1)(1990-7#2)(1991-9#1)(1992-3#2)(1992-5#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-2#1)
molecule indicate that the##2##4##(1992-6#1)(1994-3#1)
molecule into a##2##3##(1993-8#1)(1997-2#1)
molecule into##5##2##(1992-12#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-3#1)
molecule involved in##3##3##(1993-3#1)(1997-2#1)(2008-11#1)
molecule is a##3##3##(1992-8#1)(1994-12#1)(2013-8#1)
molecule is an##2##3##(2008-10#1)(2008-4#1)
molecule is reported##2##3##(1996-2#1)(2008-10#1)
molecule is##32##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-2#3)(2010-7#1)(2013-8#1)
molecule may be##2##3##(1990-5#1)(2008-10#1)
molecule may##4##2##(1990-5#1)(1991-11#1)(1993-11#1)(2008-10#1)
molecule of interest##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
molecule of the##6##3##(1991-9#1)(1993-3#1)(1995-11#1)(2008-1#1)(2008-4#1)(2013-1#1)
molecule of##28##2##(1990-9#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#2)(1993-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2013-1#1)
molecule on the##2##3##(2008-10#1)(2008-5#1)
molecule on##5##2##(1993-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
molecule target##3##2##(2008-11#1)(2008-4#2)
molecule that can##2##3##(2008-4#1)(2010-12#1)
molecule that is##5##3##(1994-5#1)(2008-2#1)(2008-4#2)(2008-5#1)
molecule that##17##2##(1992-3#1)(1993-9#1)(1994-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-7#1)
molecule through##2##2##(1990-7#1)(1997-6#1)
molecule to bind##2##3##(1995-3#1)(2013-1#1)
molecule to the substrate##2##4##(2008-10#1)(2008-7#1)
molecule to the##4##3##(1992-12#1)(2008-10#2)(2008-7#1)
molecule to##16##2##(1990-5#1)(1992-12#1)(1995-3#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
molecule was##10##2##(1990-4#1)(1990-5#1)(1990-7#1)(1992-6#1)(1992-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-8#1)(2009-6#1)
molecule were synthesized##2##3##(1992-8#1)(1993-3#1)
molecule were##5##2##(1992-8#2)(1993-3#2)(2013-1#1)
molecule which##6##2##(1991-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-9#1)
molecule with a##2##3##(1997-2#1)(2012-2#1)
molecule with##11##2##(1993-8#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
molecule##593##1##(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#9)(1990-7#6)(1990-8#6)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#7)(1991-6#2)(1991-9#7)(1992-11#2)(1992-12#5)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#8)(1992-9#8)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#3)(1993-8#7)(1993-9#4)(1994-11#3)(1994-12#4)(1994-2#7)(1994-3#3)(1994-5#6)(1994-6#6)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#13)(1995-3#9)(1995-5#5)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#8)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#8)(1997-3#1)(1997-4#6)(1997-6#5)(1997-7#2)(1997-8#3)(1997-9#2)(2007-11#5)(2007-12#4)(2007-2#1)(2008-1#9)(2008-10#87)(2008-11#26)(2008-12#3)(2008-2#2)(2008-3#12)(2008-4#28)(2008-5#23)(2008-6#4)(2008-7#16)(2008-8#20)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#8)(2010-10#2)(2010-12#2)(2010-2#8)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#16)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#5)
molecule&quot##2##1##(2008-10#1)(2008-11#1)
molecule's##2##1##(2007-11#1)(2008-1#1)
molecule-based##2##1##(2008-5#1)(2010-5#1)
molecules (e##2##2##(2008-10#1)(2008-4#1)
molecules able to##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
molecules against##2##2##(2007-11#1)(2013-8#1)
molecules and suggests##2##3##(1993-8#1)(2008-11#1)
molecules and the##9##3##(1990-11#1)(1990-3#1)(1990-8#1)(1994-11#1)(1994-9#1)(1997-2#1)(2008-10#2)(2009-9#1)
molecules and their##3##3##(1997-6#1)(2008-10#1)(2010-2#1)
molecules and##73##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1992-3#2)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
molecules and/or##2##2##(2008-10#1)(2008-5#1)
molecules are formed in the mixtures##2##6##(2008-10#2)
molecules are formed in##3##4##(2008-10#2)(2008-9#1)
molecules are highly##2##3##(1997-7#1)(2010-9#1)
molecules are involved##2##3##(2007-10#1)(2007-12#1)
molecules are located##2##3##(2008-10#1)(2012-12#1)
molecules are strongly##2##3##(1994-9#1)(2008-10#1)
molecules are the##2##3##(2011-1#1)(2012-2#1)
molecules are##47##2##(1990-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#5)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
molecules as well as##3##4##(2008-4#1)(2010-7#1)(2010-9#1)
molecules as##13##2##(1990-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-3#1)(2013-1#1)
molecules at the##4##3##(1991-3#1)(1993-8#1)(2008-4#1)(2013-8#1)
molecules at##12##2##(1990-2#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-5#1)(2012-1#1)(2013-8#1)
molecules based on the##3##4##(1996-2#1)(2007-11#1)(2008-10#1)
molecules based##4##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-4#1)
molecules between the two##2##4##(1990-11#1)(2008-5#1)
molecules between the##3##3##(1990-11#1)(2008-5#1)(2011-2#1)
molecules between##7##2##(1990-11#1)(1994-12#1)(1995-3#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
molecules bind##2##2##(2008-7#1)(2008-8#1)
molecules bound to the##2##4##(1990-12#1)(1990-2#1)
molecules by##12##2##(1993-11#1)(1993-6#1)(1994-2#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)
molecules can be detected##2##4##(2008-10#1)(2008-3#1)
molecules can be##9##3##(1992-6#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
molecules can##12##2##(1992-6#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
molecules causing##2##2##(2009-5#1)(2012-2#1)
molecules containing##7##2##(1992-6#1)(1996-2#1)(1997-9#1)(2008-4#3)(2010-11#1)
molecules could be##2##3##(1992-9#1)(2012-2#1)
molecules could##3##2##(1992-9#1)(2009-12#1)(2012-2#1)
molecules during##2##2##(1994-9#1)(2008-6#1)
molecules endowed with##2##3##(2008-4#1)(2009-12#1)
molecules exhibit##3##2##(1997-6#1)(2008-1#1)(2009-6#1)
molecules expressed in##2##3##(1995-5#1)(2008-11#1)
molecules expressed##5##2##(1995-5#1)(2008-11#2)(2008-7#1)(2013-1#1)
molecules for##12##2##(1996-5#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
molecules from the##4##3##(1990-11#1)(1993-3#1)(2008-7#1)(2012-2#1)
molecules from##12##2##(1990-11#1)(1993-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
molecules fused to the##2##4##(2009-2#1)(2012-2#1)
molecules have been##3##3##(1992-9#1)(1994-5#1)(2013-7#1)
molecules have##9##2##(1992-9#1)(1993-11#1)(1994-5#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#1)(2013-7#1)
molecules having##2##2##(2008-10#1)(2011-1#1)
molecules in a##8##3##(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
molecules in an##2##3##(2008-10#1)(2008-4#1)
molecules in aqueous##2##3##(2008-10#2)
molecules in cardiovascular##2##3##(2008-5#1)(2009-10#1)
molecules in the asymmetric unit##3##5##(1992-4#1)(2008-8#1)(2008-9#1)
molecules in the cladding##2##4##(2007-11#2)
molecules in the solution##2##4##(1992-5#1)(2008-5#1)
molecules in the##39##3##(1990-11#2)(1990-5#1)(1992-4#1)(1992-5#1)(1992-9#3)(1993-8#1)(1994-6#1)(1995-5#2)(1997-3#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#2)(2008-8#3)(2008-9#2)(2009-9#1)(2010-1#1)(2010-11#1)(2012-2#1)
molecules in which the##2##4##(1997-7#1)(2008-7#1)
molecules in##90##2##(1990-11#4)(1990-12#1)(1990-5#2)(1991-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#4)(1993-8#1)(1994-6#1)(1995-5#2)(1996-12#1)(1997-3#1)(1997-6#2)(1997-7#2)(2007-11#5)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#5)
molecules including##2##2##(1991-12#1)(2008-5#1)
molecules intercalated##2##2##(2008-10#1)(2008-3#1)
molecules into##6##2##(1994-8#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-1#1)(2010-12#1)
molecules involved in##9##3##(2008-1#1)(2008-4#2)(2008-5#2)(2009-12#2)(2009-4#1)(2013-8#1)
molecules involved##10##2##(2008-1#1)(2008-4#2)(2008-5#2)(2009-12#2)(2009-4#1)(2012-2#1)(2013-8#1)
molecules is##14##2##(1993-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#1)
molecules linked together##2##3##(2007-11#1)(2008-4#1)
molecules linked##3##2##(1997-7#1)(2007-11#1)(2008-4#1)
molecules may be involved in##2##5##(1991-3#1)(1994-11#1)
molecules may be##3##3##(1991-3#1)(1994-11#1)(1995-8#1)
molecules may##8##2##(1991-3#1)(1994-11#2)(1995-8#2)(2007-8#1)(2008-1#1)(2008-5#1)
molecules might##3##2##(1994-10#1)(2008-1#1)(2008-7#1)
molecules more##2##2##(2008-10#1)(2009-2#1)
molecules of pharmaceutical interest##2##4##(2008-10#2)
molecules of target antigen per cell##2##6##(2008-9#2)
molecules of the major histocompatibility##2##5##(1990-5#1)(2008-4#1)
molecules of the##12##3##(1990-5#1)(1990-7#1)(1994-2#1)(1994-9#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)
molecules of##58##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#1)(1992-2#3)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#12)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)
molecules on a##3##3##(1995-3#1)(2008-10#1)(2009-11#1)
molecules on the surface of##4##5##(1993-6#1)(1996-2#1)(2008-10#1)(2008-11#1)
molecules on the surface##5##4##(1993-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
molecules on the##12##3##(1990-2#2)(1993-6#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#1)
molecules on##24##2##(1990-2#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#1)
molecules onto##2##2##(2008-10#1)(2008-7#1)
molecules or by##2##3##(2008-11#1)(2008-7#1)
molecules or their##2##3##(2008-4#1)(2009-8#1)
molecules or##8##2##(1991-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-7#1)
molecules pass through##2##3##(2008-7#2)
molecules per asymmetric unit##2##4##(1995-2#1)(2008-9#1)
molecules per##8##2##(1990-12#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-9#2)(2012-2#1)
molecules play a##2##3##(1997-4#1)(2008-5#1)
molecules play##3##2##(1997-4#1)(2008-5#1)(2009-11#1)
molecules present in##2##3##(1997-3#1)(2008-10#1)
molecules present##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
molecules released##2##2##(2008-10#1)(2010-8#1)
molecules should##2##2##(2008-5#1)(2009-6#1)
molecules such as##19##3##(1992-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(2007-5#1)(2008-10#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2012-12#1)
molecules tested##3##2##(1995-6#1)(2008-8#1)(2012-12#1)
molecules that are important##2##4##(2010-11#1)(2013-1#1)
molecules that are##9##3##(2008-10#2)(2008-2#2)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
molecules that bind to##2##4##(1993-6#1)(1995-2#1)
molecules that bind##3##3##(1993-6#1)(1995-2#1)(2008-4#1)
molecules that have##2##3##(2012-3#2)
molecules that may##2##3##(1992-9#1)(2008-1#1)
molecules that regulate##3##3##(1997-4#1)(2008-11#1)(2012-12#1)
molecules that specifically##2##3##(1993-9#1)(2008-4#1)
molecules that##46##2##(1990-5#1)(1992-9#1)(1993-6#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
molecules through the##2##3##(2007-11#1)(2010-4#1)
molecules through##5##2##(1991-5#1)(2007-11#2)(2008-7#1)(2010-4#1)
molecules to induce##2##3##(2008-2#1)(2012-12#1)
molecules to the##3##3##(1995-8#1)(2007-11#1)(2013-1#1)
molecules to##21##2##(1994-8#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#2)(2012-12#1)(2013-1#2)(2013-8#1)
molecules under##2##2##(2008-10#1)(2008-2#1)
molecules using the##2##3##(2008-10#1)(2008-5#1)
molecules using##5##2##(2008-10#2)(2008-5#1)(2011-2#2)
molecules was##6##2##(1991-12#1)(1991-2#1)(1994-11#1)(2008-10#2)(2012-12#1)
molecules were##18##2##(1990-2#1)(1994-12#2)(1997-4#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
molecules which##7##2##(1991-2#1)(1993-11#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-5#1)
molecules will##2##2##(1996-4#1)(2008-7#1)
molecules with a##3##3##(2008-10#2)(2008-11#1)
molecules with the##2##3##(1994-8#1)(2007-11#1)
molecules with##33##2##(1990-2#1)(1992-3#1)(1994-8#1)(1995-2#1)(1997-6#1)(2007-11#3)(2007-12#3)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-7#1)
molecules within a##3##3##(1990-7#1)(1992-9#1)(2008-3#1)
molecules within the##2##3##(1994-9#1)(2008-8#1)
molecules within##6##2##(1990-7#1)(1992-9#1)(1994-9#1)(2008-1#1)(2008-3#1)(2008-8#1)
molecules##1112##1##(1990-11#10)(1990-12#8)(1990-2#11)(1990-3#3)(1990-4#1)(1990-5#12)(1990-7#3)(1990-8#5)(1990-9#2)(1991-12#2)(1991-2#7)(1991-3#2)(1991-5#5)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#9)(1992-4#4)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#13)(1993-11#6)(1993-12#2)(1993-3#3)(1993-6#7)(1993-8#11)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#6)(1994-3#1)(1994-5#6)(1994-6#4)(1994-8#8)(1994-9#9)(1995-11#3)(1995-12#4)(1995-2#14)(1995-3#5)(1995-5#13)(1995-6#3)(1995-8#7)(1996-1#2)(1996-12#7)(1996-2#8)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#8)(1997-7#9)(1997-9#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#26)(2007-12#23)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#24)(2008-10#168)(2008-11#36)(2008-12#2)(2008-2#26)(2008-3#27)(2008-4#57)(2008-5#44)(2008-6#4)(2008-7#54)(2008-8#34)(2008-9#32)(2009-10#6)(2009-11#6)(2009-12#10)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#9)(2009-6#5)(2009-7#4)(2009-8#15)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#9)(2010-12#14)(2010-2#7)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#9)(2010-8#2)(2010-9#2)(2011-1#12)(2011-2#19)(2011-3#2)(2012-1#4)(2012-12#10)(2012-2#26)(2012-3#4)(2012-6#2)(2013-1#22)(2013-7#2)(2013-8#17)
molecules'##2##1##(2008-2#1)(2008-5#1)
molecules)##7##1##(2008-10#4)(2008-4#1)(2008-8#1)(2009-12#1)
molecules/pg##2##1##(1990-5#2)
moles of PAR##2##3##(2008-10#2)
moles of aldolase per mole of tubulin dimer##2##8##(1993-8#2)
moles of##12##2##(1993-6#1)(1993-8#2)(1994-5#1)(1997-2#1)(2008-10#6)(2010-11#1)
molitor##3##1##(2007-12#3)
moll(-1) HNO(3)##3##2##(2008-10#3)
moll(-1) Mn(II) for##2##3##(2008-10#2)
moll(-1) Mn(II)##3##2##(2008-10#3)
moll(-1) for Ru(bpy)(3)(2+)/TPrA system##2##4##(2008-10#2)
moll(-1) for Ru(phen)(3)(2+)/TPrA system##2##4##(2008-10#2)
moll(-1) for##6##2##(2008-10#6)
moll(-1) with DL of##3##4##(2008-10#3)
moll(-1) with##4##2##(2008-10#4)
moll(-1)##28##1##(2008-10#28)
moll(-1))##2##1##(2008-10#2)
mollicute##2##1##(2008-10#2)
mollicutes##2##1##(2008-10#2)
mollies##2##1##(2009-2#1)(2009-6#1)
mollusc##6##1##(1990-2#1)(1990-5#2)(1994-8#1)(1997-6#2)
molluscan hemocytes##3##2##(1995-8#1)(2008-7#2)
molluscan##7##1##(1990-2#2)(1991-1#1)(1995-8#1)(2008-7#2)(2013-8#1)
molluscs##5##1##(1995-5#2)(2008-10#1)(2008-7#2)
molluscum contagiosum##2##2##(2007-7#2)
mollusk Helix##2##2##(2013-1#2)
mollusk##5##1##(1994-2#1)(2008-5#2)(2013-1#2)
mollusks##6##1##(2008-5#3)(2011-2#3)
mols##2##1##(1991-5#1)(2008-10#1)
molsidomine##4##1##(1991-5#4)
molt cycle##4##2##(2008-6#4)
molt##16##1##(1992-6#1)(1993-12#1)(2007-12#3)(2008-12#3)(2008-6#7)(2008-7#1)
molt-inhibiting hormone immunoreactive neurons in##2##5##(2007-12#2)
molt-inhibiting hormone of##2##3##(2007-12#2)
molt-inhibiting hormone##10##2##(2007-12#8)(2008-5#1)(2008-6#1)
molted##3##1##(1997-4#1)(2007-12#1)(2008-10#1)
molten globule##3##2##(1993-11#2)(1995-5#1)
molten##15##1##(1993-11#4)(1995-5#1)(2006-4#1)(2008-10#7)(2008-3#1)(2010-4#1)
molting to##2##2##(2007-12#1)(2008-10#1)
molting##9##1##(1995-11#2)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-7#1)
molts##3##1##(1993-12#1)(2007-12#1)(2012-2#1)
molybdate and##3##2##(2008-10#3)
molybdate as##2##2##(2008-10#2)
molybdate concentration in the carrier##2##5##(2008-10#2)
molybdate concentration##3##2##(2008-10#3)
molybdate in##4##2##(2008-10#4)
molybdate to##4##2##(2008-10#4)
molybdate was##2##2##(1991-8#1)(2008-10#1)
molybdate##50##1##(1990-11#4)(1991-8#3)(1992-3#3)(1993-12#1)(1993-8#2)(2008-10#37)
molybdenite##6##1##(2008-10#6)
molybdenum and tungsten in##2##4##(2008-10#2)
molybdenum and tungsten##4##3##(2008-10#4)
molybdenum and##10##2##(2008-10#9)(2009-7#1)
molybdenum at##2##2##(2008-10#2)
molybdenum blue method##6##3##(2008-10#6)
molybdenum blue##14##2##(2008-10#14)
molybdenum by catalytic adsorptive stripping voltammetry##2##6##(2008-10#2)
molybdenum by##4##2##(2008-10#4)
molybdenum column##2##2##(2008-10#2)
molybdenum concentration##3##2##(2008-10#3)
molybdenum determination##3##2##(2008-10#3)
molybdenum dioxide nanoparticles##2##3##(2008-10#2)
molybdenum disulfide##2##2##(2008-10#1)(2010-4#1)
molybdenum in blood serum and whole blood##2##7##(2008-10#2)
molybdenum in human##2##3##(2008-10#2)
molybdenum in##22##2##(2008-10#22)
molybdenum using##2##2##(2008-10#2)
molybdenum was##3##2##(2008-10#3)
molybdenum with##5##2##(2008-10#5)
molybdenum##108##1##(1993-11#1)(1997-7#1)(2008-10#104)(2009-7#1)(2010-4#1)
molybdenum(VI) and tungsten(VI)##3##3##(2008-10#3)
molybdenum(VI) and##4##2##(2008-10#4)
molybdenum(VI) in natural##3##3##(2008-10#3)
molybdenum(VI) in the##2##3##(2008-10#2)
molybdenum(VI) in##5##2##(2008-10#5)
molybdenum(VI)##17##1##(2008-10#16)(2010-11#1)
molybdenum-3-methoxy-4-hydroxymandelic acid##2##2##(2008-10#2)
molybdenum-silicon##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
molybdoarsenate##3##1##(2008-10#3)
molybdophosphate and##2##2##(2008-10#2)
molybdophosphate##4##1##(2008-10#4)
molybdotungsten##2##1##(2008-10#2)
molybdotungstophosphate-3##2##1##(2008-10#2)
moment analysis of correlation##3##4##(2008-2#3)
moment analysis##5##2##(2008-2#5)
moment and##2##2##(2011-2#1)(2012-2#1)
moment conditions##2##2##(2012-3#2)
moment detectors##2##2##(2008-2#2)
moment equations##2##2##(2007-11#1)(2008-8#1)
moment in the##2##3##(2008-1#1)(2010-8#1)
moment in##4##2##(1996-3#1)(2008-1#1)(2008-10#1)(2010-8#1)
moment of the##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
moment of##17##2##(1990-3#1)(1990-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
moment the##2##2##(2008-10#2)
moment to##2##2##(2007-10#1)(2007-12#1)
moment##83##1##(1990-3#2)(1990-5#1)(1990-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-4#2)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#3)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2010-10#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
moment)##2##1##(1997-4#1)(2008-4#1)
moment-generating##2##1##(2008-8#2)
momenta##4##1##(2007-11#2)(2007-12#1)(2012-2#1)
momentary##5##1##(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
moments and##3##2##(1991-12#1)(2008-3#1)(2010-3#1)
moments of the##4##3##(1997-6#1)(2008-3#1)(2008-8#1)(2011-2#1)
moments of##11##2##(1990-5#1)(1997-6#3)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
moments##43##1##(1990-5#1)(1991-12#1)(1996-2#1)(1996-5#1)(1997-6#6)(2007-11#6)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#1)
momentum mismatch##2##2##(2007-12#1)(2012-2#1)
momentum of##4##2##(2007-11#1)(2007-8#2)(2008-7#1)
momentum space##2##2##(2012-2#2)
momentum term##3##2##(2008-10#3)
momentum theory##4##2##(2007-11#1)(2010-10#3)
momentum to##2##2##(2008-3#1)(2008-9#1)
momentum transfer##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
momentum##44##1##(1991-12#1)(1992-7#2)(1992-9#1)(1994-2#2)(2007-11#6)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#5)(2010-8#1)(2012-2#5)(2013-1#1)
mometasone##3##1##(2007-11#2)(2012-3#1)
moms##3##1##(1997-1#1)(1997-3#1)(2008-9#1)
monastery##3##1##(2011-2#3)
monaural cochlear##2##2##(2008-9#2)
monaural##3##1##(2008-9#3)
monazite sand##3##2##(2008-10#3)
monazite##5##1##(2008-10#4)(2013-1#1)
monensin (1/4) and narasin (1/4)##2##5##(2007-6#2)
monensin##8##1##(1992-8#1)(1995-11#1)(2007-6#6)
monetary gain##2##2##(2008-11#2)
monetary limitations##2##2##(1991-1#1)(2010-4#1)
monetary##8##1##(1991-1#1)(1992-1#1)(2007-4#1)(2008-11#2)(2009-6#1)(2010-4#1)(2013-8#1)
money for##6##2##(1994-12#1)(1994-3#1)(1997-8#1)(2008-6#2)(2011-2#1)
money from##5##2##(1992-11#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-9#1)
money in##4##2##(1992-8#1)(1995-12#1)(1997-3#1)(2008-6#1)
money or##2##2##(1990-4#1)(1995-2#1)
money than##2##2##(1996-5#1)(1997-8#1)
money to##3##2##(1991-1#1)(1995-2#1)(1996-9#1)
money##65##1##(1990-3#1)(1990-4#2)(1991-1#1)(1991-12#2)(1992-11#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-8#2)(2008-11#3)(2008-4#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
mongoose##2##1##(2008-8#1)(2009-8#1)
mongrel dogs##2##2##(1992-3#1)(2008-6#1)
moniliforme in##2##2##(2008-10#2)
moniliforme treatment##2##2##(2008-10#2)
moniliforme##29##1##(1995-3#1)(2008-10#27)(2008-5#1)
moniliforme) and##2##2##(2008-10#2)
moniliformin##6##1##(2008-10#3)(2008-5#3)
monitor a##2##2##(1992-3#1)(2011-2#1)
monitor and control##4##3##(2008-11#2)(2008-2#1)(2011-1#1)
monitor and##16##2##(1992-3#1)(1994-1#2)(1994-3#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2009-11#1)(2010-9#1)(2011-1#1)(2012-2#1)
monitor changes in##2##3##(1994-12#1)(1996-12#1)
monitor changes##3##2##(1994-12#1)(1996-12#1)(2008-7#1)
monitor chemical##2##2##(2008-2#2)
monitor expression of##2##3##(2008-10#1)(2008-7#1)
monitor for##14##2##(2007-11#1)(2008-10#3)(2008-3#6)(2008-4#2)(2008-7#2)
monitor of##3##2##(2007-11#1)(2008-3#1)(2010-8#1)
monitor patients##4##2##(1990-2#1)(1993-12#1)(2008-10#1)(2008-6#1)
monitor response to treatment of##2##5##(2008-10#1)(2011-7#1)
monitor response to treatment##3##4##(2008-10#1)(2011-7#1)(2012-2#1)
monitor response to##4##3##(2008-10#1)(2011-7#1)(2012-2#1)(2012-3#1)
monitor the concentrations of succinic acid in##2##7##(2008-10#2)
monitor the concentrations of##3##4##(2008-10#3)
monitor the evolution of##2##4##(1993-2#1)(2010-4#1)
monitor the presence of##2##4##(1997-2#1)(2013-8#1)
monitor the quality##2##3##(2008-10#1)(2008-3#1)
monitor the treatment of##2##4##(2008-10#1)(2008-4#1)
monitor the treatment##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
monitor the##96##2##(1991-12#1)(1992-3#1)(1992-6#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-12#1)(1997-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-8#3)
monitor their##4##2##(2008-11#1)(2008-9#2)(2013-1#1)
monitor these##3##2##(1996-12#1)(2008-1#1)(2008-3#1)
monitor to##3##2##(2008-2#1)(2008-3#2)
monitor was##2##2##(1997-8#1)(2010-8#1)
monitor##307##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#2)(1991-5#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-6#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#5)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#67)(2008-11#11)(2008-12#4)(2008-2#19)(2008-3#29)(2008-4#12)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#4)(2010-8#3)(2010-9#6)(2011-1#5)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#5)(2013-8#6)
monitored amperometrically##2##2##(2008-10#2)
monitored and related to the glucose concentration##2##7##(2008-10#2)
monitored and the##2##3##(2008-10#2)
monitored and##14##2##(1993-12#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-6#1)(2010-5#1)(2013-1#2)
monitored as##2##2##(2008-10#2)
monitored at 435 nm##2##4##(2008-10#2)
monitored at 503nm##2##3##(2008-10#2)
monitored at the##3##3##(2008-10#3)
monitored at##34##2##(2008-10#31)(2008-2#1)(2008-8#1)(2010-3#1)
monitored by UV-Vis##2##3##(2008-10#2)
monitored by a##9##3##(1993-2#1)(1995-11#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
monitored by an##2##3##(2008-10#1)(2008-11#1)
monitored by difference##2##3##(1990-7#1)(1991-3#1)
monitored by integrated optical##2##4##(2008-10#1)(2008-3#1)
monitored by means of high-performance capillary electrophoresis##2##7##(1996-12#2)
monitored by means of##5##4##(1995-2#1)(1996-12#2)(2008-10#2)
monitored by measuring the##4##4##(2008-10#4)
monitored by measuring##5##3##(2008-10#5)
monitored by optical##2##3##(2008-10#2)
monitored by the##14##3##(1990-2#1)(1990-8#1)(1993-12#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2010-4#1)(2010-8#1)(2011-1#1)
monitored by##97##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-2#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2007-10#1)(2007-5#2)(2007-6#2)(2007-7#1)(2008-10#35)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-4#1)(2010-8#2)(2011-1#1)(2013-1#1)
monitored during##10##2##(1991-2#1)(1992-9#1)(2008-10#4)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
monitored every##2##2##(2008-5#1)(2009-4#1)
monitored fluorimetrically##2##2##(2008-10#2)
monitored for continued health status##2##5##(2008-4#2)
monitored for##21##2##(1994-5#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2011-2#1)
monitored in a##3##3##(1994-9#1)(2008-5#1)(2008-8#1)
monitored in real time##7##4##(1995-12#1)(2008-10#4)(2008-4#1)(2012-2#1)
monitored in situ by##2##4##(1993-6#1)(2013-8#1)
monitored in situ##6##3##(1993-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
monitored in soil##2##3##(2008-10#2)
monitored in the##5##3##(1990-12#1)(1990-7#1)(2008-10#2)(2012-2#1)
monitored in this##2##3##(1994-11#1)(2008-5#1)
monitored in##43##2##(1990-12#1)(1990-7#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#2)(2013-8#2)
monitored on a weekly basis over the first nine rounds##2##10##(1997-4#2)
monitored on a##4##3##(1997-4#2)(2008-10#1)(2008-3#1)
monitored on##7##2##(1997-4#2)(2008-10#2)(2008-3#1)(2009-4#1)(2011-1#1)
monitored on-line##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
monitored parameters##2##2##(1993-8#1)(2007-11#1)
monitored postoperatively##3##2##(1993-1#1)(2007-11#1)(2012-2#1)
monitored simultaneously##6##2##(1993-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)
monitored since##3##2##(1997-4#1)(2008-5#1)(2011-2#1)
monitored spectrophotometrically (at##2##3##(2008-10#2)
monitored spectrophotometrically at##9##3##(2008-10#9)
monitored spectrophotometrically by measuring the decrease in absorbance of##3##9##(2008-10#3)
monitored spectrophotometrically by measuring the decrease in absorbance##4##8##(2008-10#4)
monitored spectrophotometrically by measuring the decrease in the absorbance of##2##10##(2008-10#2)
monitored spectrophotometrically by measuring the decrease in##6##7##(2008-10#6)
monitored spectrophotometrically by measuring the##9##5##(2008-10#9)
monitored spectrophotometrically##22##2##(2008-10#22)
monitored the##7##2##(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#1)
monitored through the##2##3##(2008-10#2)
monitored through##6##2##(1997-2#1)(2008-10#2)(2008-6#1)(2012-12#1)(2012-7#1)
monitored throughout the##5##3##(2008-10#2)(2008-3#1)(2008-6#2)
monitored throughout##6##2##(2008-10#2)(2008-3#1)(2008-6#3)
monitored to assess##2##3##(2008-10#2)
monitored to##4##2##(2008-1#1)(2008-10#3)
monitored using##16##2##(1990-8#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#7)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
monitored with a##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
monitored with the##2##3##(2008-10#1)(2008-2#1)
monitored with##21##2##(1990-8#2)(1990-9#1)(1996-5#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2012-2#3)
monitored##450##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#5)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#7)(1997-6#7)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-5#3)(2007-6#2)(2007-7#4)(2008-1#3)(2008-10#202)(2008-11#19)(2008-2#7)(2008-3#14)(2008-4#8)(2008-5#9)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#6)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#4)(2013-8#3)
monitoring (SIM) mode##5##3##(2008-10#4)(2008-5#1)
monitoring (SIM)##9##2##(2008-10#8)(2008-5#1)
monitoring a##2##2##(1994-11#1)(2011-1#1)
monitoring access in Medicare managed care##2##6##(1997-2#2)
monitoring access##4##2##(1997-2#4)
monitoring an##4##2##(1994-9#1)(2008-10#2)(2008-7#1)
monitoring and control##6##3##(2008-10#3)(2008-11#2)(2008-7#1)
monitoring and controlling##2##3##(2008-10#1)(2008-11#1)
monitoring and data##2##3##(2008-11#1)(2010-3#1)
monitoring and evaluating##2##3##(1997-2#1)(2012-12#1)
monitoring and evaluation##4##3##(1993-2#1)(2008-7#1)(2010-5#1)(2012-12#1)
monitoring and management##2##3##(1990-3#1)(2011-1#1)
monitoring and rational##2##3##(2011-2#2)
monitoring and treatment devices##2##4##(1997-2#1)(2010-8#1)
monitoring and treatment of##2##4##(2008-11#1)(2011-1#1)
monitoring and treatment##4##3##(1997-2#1)(2008-11#1)(2010-8#1)(2011-1#1)
monitoring and##69##2##(1990-3#1)(1993-2#1)(1994-3#1)(1994-9#2)(1996-11#1)(1996-3#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)
monitoring applications##4##2##(2008-10#1)(2008-2#2)(2008-8#1)
monitoring as a surrogate marker for##2##6##(2007-10#2)
monitoring as a##5##3##(1994-3#1)(2007-10#2)(2008-10#1)(2010-8#1)
monitoring as the##2##3##(1994-8#1)(2008-11#1)
monitoring as##8##2##(1994-3#1)(1994-8#1)(1994-9#1)(2007-10#2)(2008-10#1)(2008-11#1)(2010-8#1)
monitoring at##5##2##(2007-12#2)(2008-10#2)(2008-8#1)
monitoring atrial##2##2##(1990-12#1)(2007-8#1)
monitoring based on##2##3##(2008-3#1)(2011-2#1)
monitoring blood pressure##4##3##(1990-8#1)(2008-10#3)
monitoring boundaries##2##2##(1995-2#2)
monitoring by##8##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-7#1)(2011-2#1)
monitoring can be##3##3##(1993-11#1)(1996-3#1)(2008-7#1)
monitoring cell##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
monitoring data##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
monitoring devices##5##2##(2008-10#2)(2008-7#1)(2010-8#1)(2012-3#1)
monitoring did not##2##3##(1994-3#1)(2008-10#1)
monitoring during##3##2##(2008-2#1)(2008-7#2)
monitoring environmental##5##2##(2008-10#3)(2008-3#1)(2012-3#1)
monitoring for the##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
monitoring for##14##2##(1991-3#1)(1994-3#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#2)(2011-1#1)
monitoring formaldehyde##4##2##(2008-10#4)
monitoring has##7##2##(1992-11#1)(2007-9#1)(2008-10#3)(2009-4#2)
monitoring have been##2##3##(2008-1#1)(2011-2#1)
monitoring health##2##2##(1996-1#1)(2008-10#1)
monitoring in food and feed##2##5##(2008-10#2)
monitoring in situations where##2##4##(1997-3#1)(2009-3#1)
monitoring in the intensive care unit##2##6##(2010-11#2)
monitoring in the##8##3##(2008-10#2)(2008-3#1)(2009-1#1)(2010-1#2)(2010-11#2)
monitoring in vivo##2##3##(2006-6#1)(2008-2#1)
monitoring in##44##2##(1991-5#1)(1994-3#1)(1994-9#1)(1996-2#3)(1997-3#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-8#2)(2009-1#1)(2009-11#1)(2009-3#1)(2010-1#2)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
monitoring is a##4##3##(1996-12#2)(2010-11#1)(2011-2#1)
monitoring is##16##2##(1992-5#1)(1992-9#1)(1996-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#3)(2012-2#1)
monitoring key##2##2##(1994-2#1)(2008-10#1)
monitoring light##2##2##(2007-12#1)(2008-10#1)
monitoring may##3##2##(1997-8#1)(2007-11#1)(2008-11#1)
monitoring method##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
monitoring mode##11##2##(2008-10#8)(2008-11#1)(2011-1#2)
monitoring necessary##2##2##(1992-11#1)(2008-10#1)
monitoring of 13C-labeled##2##3##(1993-3#2)
monitoring of DNA##2##3##(2011-1#1)(2013-8#1)
monitoring of a##4##3##(1996-6#1)(2007-8#2)(2008-10#1)
monitoring of adverse##2##3##(2008-11#1)(2010-2#1)
monitoring of blood pressure##3##4##(2008-1#1)(2008-10#2)
monitoring of blood##7##3##(1990-10#1)(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)
monitoring of carbon dioxide##2##4##(1995-6#1)(2013-8#1)
monitoring of clinical trials##2##4##(1996-6#2)
monitoring of continuous beer fermentation##2##5##(2008-10#2)
monitoring of dissolution profiles##2##4##(2008-10#2)
monitoring of drug##2##3##(1997-7#1)(2008-4#1)
monitoring of fish##2##3##(2008-10#2)
monitoring of glucose##2##3##(2007-11#1)(2008-10#1)
monitoring of health status##2##4##(1997-1#2)
monitoring of health##3##3##(1995-3#1)(1997-1#2)
monitoring of high-temperature##2##3##(2007-12#2)
monitoring of individual##3##3##(2008-1#1)(2008-9#1)(2012-2#1)
monitoring of intracellular##2##3##(2008-1#1)(2009-6#1)
monitoring of mutagenic process##2##4##(2008-10#2)
monitoring of nitrate##2##3##(2008-10#2)
monitoring of nitric oxide##2##4##(1993-6#1)(2008-10#1)
monitoring of organic##2##3##(2008-10#2)
monitoring of patient##2##3##(1997-2#1)(2009-5#1)
monitoring of patients with##3##4##(1990-9#1)(2013-1#2)
monitoring of patients##5##3##(1990-9#1)(2008-10#1)(2008-4#1)(2013-1#2)
monitoring of several##2##3##(2008-10#1)(2012-3#1)
monitoring of social##2##3##(2009-4#2)
monitoring of the brain and##2##5##(2010-8#2)
monitoring of the disease##2##4##(1992-3#1)(1992-9#1)
monitoring of the##50##3##(1990-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1997-8#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#17)(2008-2#1)(2008-3#7)(2008-4#2)(2008-7#2)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
monitoring of their##2##3##(1992-12#1)(2012-2#1)
monitoring of these##2##3##(2008-10#1)(2012-3#1)
monitoring of this##3##3##(1990-6#1)(1994-3#1)(2008-10#1)
monitoring of treatment##2##3##(2007-11#1)(2007-8#1)
monitoring of urea concentration in##2##5##(2008-1#2)
monitoring of urea##3##3##(2008-1#3)
monitoring of vaccine##2##3##(1995-5#1)(1997-8#1)
monitoring of various##2##3##(2008-10#1)(2010-5#1)
monitoring of waste water##3##4##(2008-10#3)
monitoring of water##2##3##(2008-10#2)
monitoring of##311##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-3#3)(1993-6#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#5)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#7)(2008-10#108)(2008-11#13)(2008-2#5)(2008-3#18)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-8#3)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#13)(2013-8#7)
monitoring on##2##2##(2007-10#1)(2008-7#1)
monitoring or##2##2##(2008-7#1)(2011-2#1)
monitoring patients##2##2##(1995-3#1)(2008-3#1)
monitoring performance##2##2##(1993-12#1)(1994-12#1)
monitoring period##2##2##(1997-4#1)(2008-7#1)
monitoring procedure##2##2##(2008-10#2)
monitoring program of##2##3##(2008-10#2)
monitoring program to##2##3##(1997-4#1)(2007-5#1)
monitoring program##6##2##(1997-4#2)(2007-5#1)(2007-7#1)(2008-10#2)
monitoring programme##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
monitoring programmes##2##2##(1997-4#1)(2008-10#1)
monitoring programs##2##2##(2008-10#2)
monitoring quality##3##2##(1996-12#1)(1996-3#1)(1997-1#1)
monitoring requirements##2##2##(2008-10#1)(2012-12#1)
monitoring schemes##2##2##(2008-10#2)
monitoring should help to##2##4##(2011-2#1)(2012-3#1)
monitoring should##4##2##(2009-8#1)(2011-2#2)(2012-3#1)
monitoring sites##4##2##(2008-10#4)
monitoring station##3##2##(2008-5#1)(2011-2#2)
monitoring stations##3##2##(2008-10#1)(2008-11#2)
monitoring system and##2##3##(2008-1#1)(2012-3#1)
monitoring system for##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
monitoring system has been##2##4##(1994-6#1)(2008-3#1)
monitoring system##24##2##(1994-6#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-7#1)(2009-10#3)(2009-11#1)(2009-2#1)(2010-11#1)(2010-8#1)(2012-3#1)(2012-5#1)
monitoring systems have##2##3##(2008-1#1)(2010-8#1)
monitoring systems##9##2##(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2009-11#1)(2010-11#1)(2010-8#1)
monitoring technique##2##2##(1997-8#1)(2008-10#1)
monitoring techniques##4##2##(2008-10#1)(2011-1#1)(2012-3#2)
monitoring the absorbance of##2##4##(2008-10#2)
monitoring the absorbance##3##3##(2008-10#3)
monitoring the change in##6##4##(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
monitoring the response to##2##4##(1991-4#1)(2012-3#1)
monitoring the response##5##3##(1991-4#1)(2006-6#1)(2012-2#1)(2012-3#1)(2013-7#1)
monitoring the##100##2##(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#5)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#3)(2008-9#1)(2009-5#2)(2010-2#1)(2011-2#1)(2012-2#5)(2012-3#3)(2013-7#1)(2013-8#4)
monitoring their##4##2##(1992-1#1)(1994-12#1)(2008-11#1)(2008-7#1)
monitoring therapy##2##2##(2008-2#1)(2010-12#1)
monitoring time##2##2##(2008-7#1)(2012-3#1)
monitoring to##4##2##(1992-5#1)(1994-1#1)(2008-8#1)(2010-1#1)
monitoring tool##2##2##(2008-10#1)(2008-11#1)
monitoring tools that##2##3##(2008-10#1)(2011-1#1)
monitoring using##3##2##(2007-7#1)(2008-10#2)
monitoring utilization##2##2##(1994-1#1)(1996-1#1)
monitoring was performed##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
monitoring was##8##2##(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
monitoring were##3##2##(2007-9#1)(2009-4#1)(2011-1#1)
monitoring with near-infrared##2##3##(2008-3#2)
monitoring with##9##2##(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)
monitoring##1116##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#8)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#9)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#8)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#4)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#5)(1996-5#1)(1996-6#7)(1996-7#1)(1997-1#4)(1997-2#14)(1997-3#4)(1997-4#6)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#4)(2006-6#3)(2007-10#14)(2007-11#19)(2007-12#15)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#10)(2007-9#2)(2008-1#19)(2008-10#345)(2008-11#49)(2008-12#6)(2008-2#20)(2008-3#51)(2008-4#23)(2008-5#11)(2008-6#2)(2008-7#34)(2008-8#15)(2008-9#9)(2009-1#1)(2009-10#5)(2009-11#9)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#3)(2009-6#6)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#7)(2010-10#3)(2010-11#11)(2010-12#1)(2010-2#6)(2010-3#2)(2010-4#4)(2010-5#10)(2010-6#1)(2010-7#2)(2010-8#15)(2011-1#21)(2011-2#47)(2011-3#4)(2012-12#5)(2012-2#20)(2012-3#22)(2012-4#2)(2012-5#1)(2013-1#21)(2013-7#3)(2013-8#18)
monitoring)##2##1##(2008-4#1)(2012-3#1)
monitoring]##3##1##(1991-2#1)(2012-2#1)(2012-3#1)
monitors (who are more##2##4##(2008-4#2)
monitors and##3##2##(2008-3#1)(2010-8#1)(2011-2#1)
monitors for##3##2##(1990-8#1)(1992-3#1)(1996-6#1)
monitors in##2##2##(1996-6#1)(2008-3#1)
monitors the##5##2##(1994-2#1)(2008-10#2)(2008-3#1)(2010-12#1)
monitors##31##1##(1990-3#1)(1990-8#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-6#2)(2008-10#6)(2008-11#1)(2008-3#4)(2008-4#3)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#4)(2011-7#1)
monkey (Macaca##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
monkey and human retina##2##4##(1991-10#2)
monkey and human##5##3##(1991-10#3)(1997-2#1)(1997-7#1)
monkey and mouse##2##3##(1991-1#1)(1994-8#1)
monkey and##8##2##(1991-1#1)(1991-10#3)(1994-8#1)(1997-2#1)(1997-7#1)(2008-8#1)
monkey brain##2##2##(1997-2#1)(2009-5#1)
monkey erythrocytes##2##2##(1990-2#2)
monkey kidney##3##2##(1991-9#1)(1992-6#1)(1993-3#1)
monkey to##2##2##(1991-5#1)(2008-11#1)
monkey##69##1##(1990-2#2)(1990-7#3)(1991-1#2)(1991-10#3)(1991-2#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-6#1)(1996-5#1)(1997-2#6)(1997-7#1)(2008-10#7)(2008-11#3)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-6#1)(2009-7#2)(2011-2#2)(2012-2#4)
monkey's##2##1##(2009-5#2)
monkeys (Macaca fascicularis)##2##3##(1992-11#1)(1994-3#1)
monkeys and humans##3##3##(1992-11#1)(1997-2#1)(2010-5#1)
monkeys and##9##2##(1990-11#1)(1992-11#1)(1993-8#1)(1994-3#1)(1995-11#2)(1997-2#1)(2008-8#1)(2010-5#1)
monkeys exhibit##2##2##(1990-7#1)(2008-4#1)
monkeys performing a##2##3##(1995-12#1)(1995-5#1)
monkeys performing##3##2##(1991-6#1)(1995-12#1)(1995-5#1)
monkeys that had##2##3##(1990-2#1)(2008-7#1)
monkeys to##3##2##(1990-5#1)(1995-2#1)(2008-10#1)
monkeys were##3##2##(1994-3#2)(2008-10#1)
monkeys with V4 lesions##2##4##(1992-11#2)
monkeys with##5##2##(1992-11#4)(2008-10#1)
monkeys##104##1##(1990-11#3)(1990-2#3)(1990-5#1)(1990-7#2)(1991-1#6)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#8)(1993-12#3)(1993-6#2)(1993-8#1)(1994-3#7)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#7)(1995-3#1)(1995-5#3)(1996-2#4)(1996-5#1)(1997-2#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-4#5)(2008-5#4)(2008-7#6)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-3#3)(2013-1#3)
mono and bicyclic beta-lactams##2##4##(2007-11#2)
mono and##3##2##(1994-11#1)(2007-11#2)
mono##10##1##(1990-8#1)(1994-11#2)(2007-11#3)(2008-10#2)(2008-2#1)(2008-7#1)
mono(ADP-ribosyl)ation##2##1##(1991-12#2)
mono- and disaccharides##3##3##(1992-6#1)(2008-10#1)(2008-6#1)
mono- and disubstituted##2##3##(2009-9#2)
mono- and divalent##2##3##(2008-10#2)
mono- and##27##2##(1991-7#1)(1992-6#1)(1993-11#1)(1993-8#1)(1997-2#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#2)(2010-11#1)(2011-1#1)
mono-##45##1##(1990-7#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-8#2)(1996-5#2)(1997-1#2)(1997-2#1)(2007-11#1)(2008-10#20)(2008-11#2)(2008-4#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-6#1)(2011-1#1)
mono-female lines of a M##2##5##(2008-10#2)
mono-female lines of##3##3##(2008-10#3)
mono-isopropylamine salt##3##2##(2008-10#3)
mono-unsaturated##2##1##(1990-8#1)(1993-9#1)
monoalkyl esters of meso-2##2##4##(1992-12#2)
monoalkyl##3##1##(1992-12#2)(2008-10#1)
monoallelic##3##1##(2008-5#2)(2011-2#1)
monoamine metabolites##2##2##(1993-1#1)(1996-7#1)
monoamine neurotransmitters##4##2##(1996-12#1)(2008-10#3)
monoamine oxidase (MAO)##4##3##(1991-12#1)(1994-3#1)(1995-11#1)(2008-3#1)
monoamine oxidase A##2##3##(1991-12#1)(2009-8#1)
monoamine oxidase B (MAO-B)##3##4##(1992-11#2)(1996-5#1)
monoamine oxidase B##4##3##(1992-11#2)(1996-5#1)(2009-12#1)
monoamine oxidase and##2##3##(1995-11#1)(2008-7#1)
monoamine oxidase inhibitors##2##3##(2008-6#1)(2011-2#1)
monoamine oxidase inhibitory drugs##2##4##(1996-5#2)
monoamine oxidase type##2##3##(1990-12#1)(2008-7#1)
monoamine oxidase##24##2##(1990-12#1)(1991-12#2)(1992-11#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-5#4)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
monoamine oxidases##3##2##(1990-12#1)(1992-11#1)(1994-8#1)
monoamine transporter##9##2##(1995-12#7)(1996-12#2)
monoamine transporters##2##2##(1995-12#1)(1996-5#1)
monoamine##56##1##(1990-12#2)(1991-12#2)(1992-11#3)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#3)(1995-12#9)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#5)(1996-7#2)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
monoamine-oxidase##2##1##(1994-6#1)(2008-7#1)
monoamines in##3##2##(1993-1#2)(2008-10#1)
monoamines##5##1##(1993-1#2)(1993-3#1)(2008-10#2)
monoanion##3##1##(2008-10#3)
monoarthritis##4##1##(1993-9#1)(2008-12#2)(2013-8#1)
monoaza crown ethers##2##3##(2008-10#2)
monoaza##3##1##(2008-10#3)
monoaza-12-crown-4 ether##2##2##(2008-10#2)
monoaza-15-crown-5 with##2##2##(2008-10#2)
monobasic##3##1##(1994-11#1)(1994-12#1)(2008-10#1)
monobromobenzoic acids##3##2##(2008-10#3)
monobutyltin chloride##2##2##(2008-10#2)
monobutyltin hydride##2##2##(2008-10#2)
monobutyltin##4##1##(2008-10#4)
monobutyrin##2##1##(1990-4#2)
monocapillary##3##1##(2008-10#1)(2008-3#2)
monocarboxylic acids##2##2##(2008-10#2)
monochannel##3##1##(2008-10#3)
monochloramine in##2##2##(2008-7#2)
monochloramine##5##1##(2008-10#1)(2008-7#4)
monochloro-##2##1##(2008-10#2)
monochlorobenzene##2##1##(2008-10#2)
monochromatic AOD##2##2##(2008-2#2)
monochromatic illuminator with##2##3##(2008-3#2)
monochromatic images##2##2##(2007-11#1)(2008-3#1)
monochromatic spectrum##2##2##(2013-8#2)
monochromatic##29##1##(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#11)(2008-3#10)(2011-2#1)(2013-8#2)
monochromator for##3##2##(2008-2#2)(2008-3#1)
monochromator is##2##2##(2008-10#1)(2008-3#1)
monochromator with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
monochromator with##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
monochromator##23##1##(2007-12#2)(2008-10#2)(2008-2#8)(2008-3#9)(2011-1#2)
monochromators for##2##2##(2008-3#2)
monochromators##4##1##(2008-10#2)(2008-3#2)
monochrome##4##1##(2008-12#1)(2008-3#2)(2008-5#1)
monocistronic expression vectors##2##3##(1993-6#2)
monocistronic##3##1##(1993-6#2)(2008-9#1)
monoclinic space group##10##3##(1992-8#1)(1996-2#4)(1997-7#3)(2007-11#1)(2010-10#1)
monoclinic space##11##2##(1992-8#1)(1996-2#4)(1997-7#4)(2007-11#1)(2010-10#1)
monoclinic##32##1##(1992-8#1)(1993-8#1)(1996-2#14)(1996-5#1)(1997-7#8)(2007-11#1)(2008-10#2)(2008-3#2)(2010-10#1)(2013-1#1)
monoclonal IgG##2##2##(1994-2#1)(1994-6#1)
monoclonal IgG1 antibody##2##3##(2008-5#1)(2010-12#1)
monoclonal and polyclonal antibodies for##2##5##(1992-8#1)(2008-1#1)
monoclonal and polyclonal antibodies##5##4##(1990-5#2)(1992-8#1)(1997-3#1)(2008-1#1)
monoclonal and##8##2##(1990-5#2)(1992-8#1)(1994-7#1)(1997-3#1)(2008-1#1)(2008-5#2)
monoclonal anti-fluorescein##2##2##(1992-6#2)
monoclonal antibodies (MAb)##2##3##(1996-12#1)(2008-2#1)
monoclonal antibodies (MAbs) to##2##4##(2008-10#2)
monoclonal antibodies (MAbs)##13##3##(1990-12#1)(1992-2#1)(1994-3#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)
monoclonal antibodies (MoAbs)##4##3##(1990-7#1)(1993-1#1)(1995-12#1)(2008-7#1)
monoclonal antibodies (mAb)##4##3##(1997-4#1)(2008-4#1)(2008-7#1)(2011-2#1)
monoclonal antibodies (mAbs) against##2##4##(1996-12#2)
monoclonal antibodies (mAbs)##10##3##(1994-2#1)(1994-5#1)(1996-12#2)(1997-6#1)(2008-10#1)(2008-11#3)(2008-8#1)
monoclonal antibodies against adenylate kinase##2##5##(2008-8#2)
monoclonal antibodies against##18##3##(1990-11#1)(1990-2#1)(1993-9#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
monoclonal antibodies and others##2##4##(2008-8#1)(2011-1#1)
monoclonal antibodies and##13##3##(1990-11#1)(1990-12#1)(1991-6#1)(1995-5#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
monoclonal antibodies directed against##4##4##(1992-12#1)(1992-2#1)(1994-5#1)(2008-9#1)
monoclonal antibodies directed##5##3##(1992-12#1)(1992-2#1)(1994-5#1)(1994-9#1)(2008-9#1)
monoclonal antibodies for##5##3##(1993-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
monoclonal antibodies from##2##3##(1994-5#1)(2008-11#1)
monoclonal antibodies in combination with##2##5##(1993-12#1)(2008-9#1)
monoclonal antibodies in##7##3##(1990-12#1)(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
monoclonal antibodies obtained##2##3##(1995-2#1)(1997-8#1)
monoclonal antibodies or##2##3##(1994-8#1)(2012-12#1)
monoclonal antibodies raised against##3##4##(1995-12#1)(2008-10#2)
monoclonal antibodies specific##2##3##(1991-5#1)(1992-6#1)
monoclonal antibodies that recognize##2##4##(1994-9#1)(1996-12#1)
monoclonal antibodies that##7##3##(1991-5#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-12#1)(2008-4#1)(2008-6#1)
monoclonal antibodies to##9##3##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(1995-3#1)(2008-11#1)(2010-5#1)
monoclonal antibodies used##2##3##(1994-2#1)(2011-2#1)
monoclonal antibodies was##2##3##(2007-12#1)(2008-10#1)
monoclonal antibodies were used to##2##5##(2008-10#1)(2008-9#1)
monoclonal antibodies were##5##3##(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
monoclonal antibodies which##2##3##(1996-5#1)(2008-10#1)
monoclonal antibodies with##2##3##(1995-3#1)(2008-9#1)
monoclonal antibodies##210##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#4)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#4)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#28)(2008-11#24)(2008-12#1)(2008-2#2)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#15)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)
monoclonal antibody (MAb) against##3##4##(1994-5#2)(2008-7#1)
monoclonal antibody (MAb) was produced##2##5##(2008-10#1)(2008-11#1)
monoclonal antibody (MAb)##11##3##(1993-9#1)(1994-5#3)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)
monoclonal antibody (Mab)##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
monoclonal antibody (mAb)##8##3##(1994-12#1)(1996-12#1)(1997-4#1)(2008-11#3)(2008-5#1)(2009-8#1)
monoclonal antibody 4-4-20##4##3##(1991-8#4)
monoclonal antibody 6B10 was##2##4##(2008-8#2)
monoclonal antibody 6B10##4##3##(2008-8#4)
monoclonal antibody MIB1##2##3##(1997-7#2)
monoclonal antibody P37##2##3##(2006-6#2)
monoclonal antibody against a##2##4##(1995-6#1)(2008-11#1)
monoclonal antibody against the##4##4##(1992-3#1)(1992-8#1)(1993-8#1)(1993-9#1)
monoclonal antibody against##14##3##(1990-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-11#4)
monoclonal antibody alpha##2##3##(1994-5#2)
monoclonal antibody and##7##3##(1990-12#1)(1993-1#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-9#2)
monoclonal antibody at##2##3##(1990-12#1)(2008-11#1)
monoclonal antibody directed against the catalytic##2##6##(1992-3#1)(1995-3#1)
monoclonal antibody directed against the##3##5##(1992-3#1)(1995-3#1)(2008-7#1)
monoclonal antibody directed against##4##4##(1992-3#1)(1993-12#1)(1995-3#1)(2008-7#1)
monoclonal antibody for##4##3##(1994-2#1)(2008-10#1)(2008-11#2)
monoclonal antibody in##5##3##(1990-2#1)(1993-2#1)(1994-10#1)(2008-11#1)(2009-4#1)
monoclonal antibody on the##3##4##(1991-5#1)(2008-10#2)
monoclonal antibody on##5##3##(1991-5#3)(2008-10#2)
monoclonal antibody or##2##3##(1993-8#1)(2008-4#1)
monoclonal antibody production by##3##4##(2008-11#3)
monoclonal antibody production##16##3##(1994-2#1)(2008-11#12)(2008-7#2)(2011-2#1)
monoclonal antibody specific for##7##4##(1990-12#2)(1992-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
monoclonal antibody specific to##2##4##(2008-10#1)(2008-7#1)
monoclonal antibody specific##9##3##(1990-12#2)(1992-8#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)
monoclonal antibody that##4##3##(1992-9#1)(1993-12#1)(1994-2#1)(2012-3#1)
monoclonal antibody to##14##3##(1992-6#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
monoclonal antibody using##2##3##(2008-11#2)
monoclonal antibody was immobilized##2##4##(2008-10#2)
monoclonal antibody was purified##2##4##(1994-2#1)(2008-8#1)
monoclonal antibody was##11##3##(1990-12#1)(1990-5#1)(1992-11#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-8#2)
monoclonal antibody were##3##3##(2008-10#2)(2011-2#1)
monoclonal antibody with##3##3##(1995-2#1)(2010-12#1)(2013-1#1)
monoclonal antibody##255##2##(1990-11#3)(1990-12#7)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#4)(1991-8#5)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-6#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#8)(1994-5#6)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#5)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2006-6#2)(2007-10#2)(2008-10#32)(2008-11#58)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#5)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
monoclonal blocking##2##2##(1992-5#2)
monoclonal from##2##2##(1997-2#1)(2008-5#1)
monoclonal gammapathy##2##2##(1993-2#2)
monoclonal gammopathy##2##2##(1992-12#1)(2008-9#1)
monoclonal immunoglobulins##2##2##(1993-9#1)(2013-8#1)
monoclonal nodules##2##2##(2008-5#2)
monoclonal or polyclonal antibodies##3##4##(1991-5#1)(1991-8#1)(2008-9#1)
monoclonal or polyclonal##5##3##(1991-5#1)(1991-8#1)(2008-5#1)(2008-9#1)(2012-2#1)
monoclonal or##7##2##(1991-5#1)(1991-8#1)(1993-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
monoclonal##558##1##(1990-11#5)(1990-12#11)(1990-2#4)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#5)(1991-5#9)(1991-6#1)(1991-8#8)(1991-9#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#8)(1992-5#2)(1992-6#6)(1992-8#8)(1992-9#4)(1993-1#2)(1993-12#7)(1993-2#7)(1993-6#4)(1993-8#8)(1993-9#9)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#11)(1994-3#3)(1994-5#9)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#6)(1995-11#2)(1995-12#11)(1995-2#8)(1995-3#8)(1995-5#2)(1995-6#4)(1995-9#1)(1996-11#2)(1996-12#9)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#6)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#1)(1997-9#1)(2006-6#4)(2007-10#4)(2007-12#2)(2008-1#2)(2008-10#63)(2008-11#85)(2008-12#1)(2008-2#2)(2008-4#15)(2008-5#20)(2008-6#4)(2008-7#12)(2008-8#21)(2008-9#24)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#10)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#1)(2013-8#2)
monoclonalantibody production##2##2##(2008-11#2)
monoclonalantibody##4##1##(2008-11#4)
monocolor##2##1##(2008-1#1)(2008-3#1)
monoconidial isolates##2##2##(2008-10#2)
monocot##4##1##(1991-6#1)(2008-10#1)(2008-9#1)(2013-8#1)
monocot-infecting##2##1##(2008-10#2)
monocots and##2##2##(2010-5#2)
monocots##5##1##(2008-10#2)(2008-9#1)(2010-5#2)
monocotyledon##2##1##(2008-7#2)
monocotyledonous##4##1##(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)
monocotyledons##2##1##(2008-10#1)(2008-9#1)
monocrystalline##2##1##(2008-10#2)
monocular deprivation##2##2##(1994-8#2)
monocular oscillations##2##2##(2008-7#2)
monocular##8##1##(1994-8#4)(2008-7#2)(2010-3#1)(2013-8#1)
monocularly##2##1##(1992-10#1)(2012-2#1)
monoculture##8##1##(2008-10#3)(2008-11#1)(2008-8#4)
monocultures##2##1##(2008-10#1)(2008-5#1)
monocyclic beta-lactam##2##2##(2007-11#2)
monocyclic beta-lactams##2##2##(1993-8#2)
monocyclic##9##1##(1993-8#2)(2007-11#2)(2008-10#2)(2010-11#1)(2011-2#1)(2013-1#1)
monocyte adhesion to endothelial cells##3##5##(1992-12#1)(1995-12#2)
monocyte adhesion to##5##3##(1992-12#3)(1995-12#2)
monocyte adhesion##6##2##(1992-12#4)(1995-12#2)
monocyte and basophil counts##2##4##(2011-1#2)
monocyte and basophil##3##3##(2011-1#3)
monocyte and neutrophil counts##2##4##(2008-10#1)(2011-2#1)
monocyte and##7##2##(2006-6#1)(2008-10#1)(2011-1#3)(2011-2#1)(2012-1#1)
monocyte chemoattractant protein-1##3##3##(2012-2#1)(2013-1#2)
monocyte chemoattractant protein-2 (MCP-2)##2##4##(1994-11#2)
monocyte chemoattractant##7##2##(1994-11#2)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#2)
monocyte chemotactic protein-1##2##3##(2011-2#2)
monocyte chemotactic##3##2##(1994-9#1)(2011-2#2)
monocyte esterase##2##2##(1992-2#2)
monocyte monolayer assay##2##3##(1994-6#1)(1994-9#1)
monocyte stimulatory activity##2##3##(1993-6#2)
monocyte##51##1##(1990-2#1)(1991-7#1)(1992-12#5)(1992-2#2)(1993-12#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-4#1)(1995-6#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#3)
monocyte-derived dendritic cells##3##3##(2008-11#3)
monocyte-derived##6##1##(2008-11#3)(2008-5#1)(2010-3#1)(2011-2#1)
monocyte-macrophages##4##1##(2008-1#1)(2008-11#2)(2008-4#1)
monocyte/macrophage##3##1##(1991-2#1)(1995-3#2)
monocytes and T##2##3##(1997-8#1)(2008-1#1)
monocytes and macrophages##2##3##(1994-11#1)(2008-5#1)
monocytes and neutrophils##2##3##(2008-9#1)(2011-2#1)
monocytes and##16##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)
monocytes by##4##2##(1991-2#1)(1994-8#1)(2008-4#2)
monocytes from##2##2##(1993-9#2)
monocytes of##3##2##(1991-12#1)(1993-9#2)
monocytes that##3##2##(1991-7#1)(1992-12#1)(1994-5#1)
monocytes to##5##2##(1992-12#1)(1993-6#1)(1995-12#2)(2012-2#1)
monocytes via##2##2##(1995-8#1)(2008-11#1)
monocytes was##2##2##(1991-8#1)(1995-8#1)
monocytes were##2##2##(1991-12#1)(2013-1#1)
monocytes##97##1##(1990-12#1)(1990-5#2)(1990-7#2)(1991-12#4)(1991-2#5)(1991-6#1)(1991-7#2)(1991-8#3)(1992-12#6)(1992-2#3)(1993-12#1)(1993-6#2)(1993-9#7)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-12#7)(1995-2#1)(1995-6#2)(1995-8#5)(1996-12#1)(1997-8#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#7)(2008-5#2)(2008-9#7)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)
monocytes/macrophages in##2##2##(2008-9#1)(2010-1#1)
monocytes/macrophages##7##1##(2008-10#2)(2008-5#1)(2008-9#1)(2010-1#2)(2013-8#1)
monocytic cell line##2##3##(1993-3#1)(1994-2#1)
monocytic differentiation and##2##3##(1995-6#1)(1997-7#1)
monocytic differentiation in##2##3##(1993-12#1)(1997-7#1)
monocytic differentiation##11##2##(1992-12#1)(1993-12#1)(1993-8#1)(1995-6#2)(1997-7#6)
monocytic erlychiosis##3##2##(2013-1#3)
monocytic leukemia cell line##2##4##(1993-12#1)(1993-6#1)
monocytic leukemia##4##2##(1991-4#2)(1993-12#1)(1993-6#1)
monocytic##25##1##(1990-2#1)(1991-4#2)(1992-12#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-6#3)(1997-1#1)(1997-7#6)(2008-10#1)(2013-1#4)
monocytogenes in mice##2##3##(1996-12#2)
monocytogenes in##9##2##(1993-2#1)(1996-12#3)(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
monocytogenes infection##3##2##(1996-12#2)(2012-12#1)
monocytogenes is##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
monocytogenes was##2##2##(1996-12#2)
monocytogenes were##5##2##(1996-12#1)(2008-10#1)(2009-5#1)(2010-4#2)
monocytogenes##61##1##(1990-3#1)(1993-2#1)(1994-12#2)(1994-8#1)(1996-12#15)(2006-10#5)(2006-5#1)(2008-10#6)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#7)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)
monocytoid cells##2##2##(1995-8#1)(2007-8#1)
monodansylcadaverine##3##1##(1990-8#2)(1994-6#1)
monodii##2##1##(2008-10#2)
monodisperse aerosol##2##2##(1996-2#1)(2008-7#1)
monodisperse silica nanoparticles##3##3##(2010-12#3)
monodisperse##28##1##(1990-6#1)(1992-12#2)(1994-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2010-10#1)(2010-12#4)(2010-5#2)(2010-8#2)(2012-2#1)(2013-1#1)
monodispersed silver nanocubes##2##3##(2008-5#2)
monodispersed##4##1##(2008-3#2)(2008-5#2)
monodominant##2##1##(2008-8#2)
monoecious##2##1##(2009-12#1)(2012-3#1)
monoenic##2##1##(2008-10#1)(2013-1#1)
monoenzyme electrode##2##2##(2008-10#2)
monoenzyme##3##1##(2008-10#3)
monoester##5##1##(1992-6#1)(2008-10#1)(2008-4#2)(2008-7#1)
monoesters##12##1##(1992-12#6)(1992-6#1)(2008-4#5)
monoethylene glycol##2##2##(2008-10#2)
monoexponential##2##1##(2008-3#2)
monofumarate##2##1##(1997-7#2)
monofunctional##8##1##(1990-7#3)(1993-12#2)(2008-10#2)(2008-11#1)
monogamous and##3##2##(2008-8#2)(2012-2#1)
monogamous species##2##2##(2008-9#1)(2009-5#1)
monogamous##8##1##(2008-8#3)(2008-9#3)(2009-5#1)(2012-2#1)
monogamy##4##1##(2008-9#4)
monogenean##2##1##(2010-8#1)(2013-1#1)
monogenic control##2##2##(2008-10#2)
monogenic inheritance of resistance##2##4##(2008-10#2)
monogenic##10##1##(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#1)(2009-3#1)(2012-3#1)
monoglucoside (TMG)##2##2##(2008-10#2)
monoglucoside##3##1##(2008-10#2)(2008-11#1)
monoglycerides##4##1##(2008-5#3)(2008-6#1)
monograph##2##1##(2009-9#1)(2011-2#1)
monographs##4##1##(2008-10#2)(2012-2#2)
monohydrate in##2##2##(2008-10#2)
monohydrate##21##1##(1992-12#1)(1995-8#2)(2008-10#7)(2008-2#2)(2008-5#1)(2009-6#1)(2010-3#1)(2012-2#2)(2013-8#4)
monohydrochloride##6##1##(1993-1#1)(1996-2#1)(2008-10#4)
monokaryotic##2##1##(2008-10#2)
monolayer (SAM) of##5##3##(2008-10#5)
monolayer (SAM)##11##2##(2008-10#11)
monolayer adsorption##2##2##(2007-12#1)(2013-1#1)
monolayer and the##2##3##(2007-12#1)(2008-10#1)
monolayer and##12##2##(1992-6#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2009-12#1)(2011-2#1)(2012-3#1)
monolayer at##2##2##(1990-5#1)(2007-12#1)
monolayer by##4##2##(1994-3#1)(2008-10#1)(2008-11#2)
monolayer cell cultures##5##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
monolayer cell##6##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#2)
monolayer culture##17##2##(1990-2#1)(1990-8#1)(1992-9#1)(1997-1#1)(2008-11#12)(2008-4#1)
monolayer cultures of##3##3##(1990-5#1)(1992-6#1)(1992-9#1)
monolayer cultures##7##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(2008-4#1)(2008-9#1)
monolayer film##6##2##(1997-2#1)(2008-10#3)(2008-8#2)
monolayer for##2##2##(2008-10#2)
monolayer fusion##3##2##(1990-11#3)
monolayer in the presence of##2##5##(2008-10#1)(2008-11#1)
monolayer in the##5##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
monolayer in##8##2##(1992-6#1)(1992-9#1)(1994-5#1)(2008-10#2)(2008-11#2)(2008-5#1)
monolayer is##9##2##(1991-5#2)(1994-3#1)(1994-6#3)(2007-12#1)(2008-10#2)
monolayer modified chitosan-entrapped carbon paste electrode##2##6##(2008-10#2)
monolayer modified gold electrode##2##4##(2008-10#2)
monolayer modified gold##3##3##(2008-10#3)
monolayer modified##6##2##(2008-10#6)
monolayer of cultured cells##2##4##(2008-10#1)(2008-7#1)
monolayer of##25##2##(1992-6#1)(1995-2#2)(2007-11#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)(2012-2#1)
monolayer on the##2##3##(2008-10#2)
monolayer on##5##2##(2008-10#5)
monolayer was##4##2##(1990-5#1)(2007-11#1)(2009-5#1)(2013-8#1)
monolayer with##2##2##(2007-12#1)(2010-4#1)
monolayer##221##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-5#4)(1990-8#1)(1991-3#2)(1991-5#4)(1991-6#1)(1992-5#1)(1992-6#7)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#11)(1994-5#1)(1994-6#5)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#2)(2007-11#5)(2007-12#9)(2007-6#1)(2008-1#1)(2008-10#60)(2008-11#37)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#5)(2010-4#1)(2011-2#1)(2011-3#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
monolayer)##2##1##(2008-10#2)
monolayer-protected##2##1##(2008-10#2)
monolayered##4##1##(2007-12#1)(2008-5#1)(2008-7#1)(2010-11#1)
monolayers and##8##2##(1994-3#1)(1994-5#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#2)
monolayers are##2##2##(1990-2#1)(2007-12#1)
monolayers at the##3##3##(1995-5#1)(2008-11#1)(2008-2#1)
monolayers deposited##2##2##(2007-12#1)(2008-10#1)
monolayers in a##2##3##(1990-5#1)(2008-11#1)
monolayers in##3##2##(1990-5#1)(2007-12#1)(2008-11#1)
monolayers is##3##2##(1994-6#1)(2007-12#2)
monolayers of Caco-2 cells##2##4##(2007-12#1)(2008-11#1)
monolayers of##18##2##(1990-2#2)(1991-3#1)(1992-12#1)(1992-5#2)(1992-6#2)(1994-11#2)(1994-3#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#2)
monolayers on##3##2##(1990-2#1)(1994-6#1)(2010-10#1)
monolayers to##5##2##(1990-2#1)(1990-5#1)(2007-12#1)(2008-10#1)(2009-12#1)
monolayers was##2##2##(2007-6#1)(2008-11#1)
monolayers were##6##2##(1990-2#1)(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
monolayers##120##1##(1990-11#2)(1990-2#6)(1990-5#3)(1991-3#2)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#6)(1992-8#1)(1993-8#1)(1994-11#3)(1994-3#6)(1994-5#5)(1994-6#2)(1994-9#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(2007-12#14)(2007-6#1)(2008-1#1)(2008-10#23)(2008-11#14)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2009-12#1)(2010-10#1)(2010-11#4)(2010-4#2)(2010-7#2)(2011-2#1)
monolingual##4##1##(1993-9#1)(2008-11#1)(2008-2#1)(2010-5#1)
monolith and##2##2##(2013-1#2)
monolith bearing combination of##3##4##(2013-1#3)
monolith for##2##2##(2008-10#2)
monolith was##2##2##(2008-10#1)(2013-1#1)
monolith with##3##2##(2008-10#3)
monolith##15##1##(2008-10#7)(2013-1#8)
monolith-based##2##1##(2008-10#2)
monolithic column##12##2##(2008-10#11)(2013-1#1)
monolithic columns##4##2##(2008-10#4)
monolithic multiple-face##2##2##(2008-3#2)
monolithic optical parametric##2##3##(2007-12#2)
monolithic periodically poled lithium niobate##2##5##(2007-12#2)
monolithic precolumn##3##2##(2008-10#3)
monolithic silica column##3##3##(2008-10#3)
monolithic silica columns##2##3##(2008-10#2)
monolithic silica##8##2##(2008-10#8)
monolithic##66##1##(2007-11#3)(2007-12#13)(2008-10#33)(2008-2#3)(2008-3#11)(2009-7#1)(2010-4#1)(2013-1#1)
monolithically integrated##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
monolithically##7##1##(2007-11#3)(2008-2#2)(2008-3#2)
monoliths were##2##2##(2008-10#1)(2013-1#1)
monoliths##12##1##(2007-12#2)(2008-10#4)(2010-4#2)(2013-1#4)
monomer and dimer##2##3##(2008-10#2)
monomer and the##2##3##(2008-10#2)
monomer and##9##2##(1996-2#1)(2008-10#7)(2012-1#1)
monomer concentration##2##2##(1994-11#1)(2008-10#1)
monomer contains##2##2##(1992-4#1)(1993-8#1)
monomer in##4##2##(1993-8#1)(1995-2#1)(2008-7#1)(2008-8#1)
monomer of##9##2##(1991-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2013-1#1)
monomer solution##2##2##(2008-3#2)
monomer that##2##2##(1992-4#1)(2007-12#1)
monomer unit##2##2##(1990-7#1)(2007-12#1)
monomer was##2##2##(2008-10#1)(2008-5#1)
monomer with##3##2##(1992-6#1)(2008-3#1)(2008-9#1)
monomer##110##1##(1990-12#2)(1990-5#1)(1990-7#4)(1991-2#1)(1991-5#3)(1992-12#4)(1992-4#4)(1992-6#1)(1993-11#1)(1993-8#3)(1994-11#2)(1994-6#3)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#3)(1997-4#1)(1997-7#1)(2007-12#3)(2008-10#30)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#2)
monomer-dimer##3##1##(1993-8#1)(2008-10#2)
monomer-monomer##2##1##(1992-4#1)(1994-5#1)
monomer-tetramer transition##2##2##(1992-6#2)
monomer-tetramer##3##1##(1992-6#2)(1993-8#1)
monomeric Al species##2##3##(2008-10#2)
monomeric Al##3##2##(2008-10#3)
monomeric alpha##2##2##(2008-7#2)
monomeric analogs##2##2##(2008-10#2)
monomeric and dimeric forms##2##4##(2008-10#1)(2013-1#1)
monomeric and##10##2##(1990-2#1)(1992-6#3)(1994-11#1)(1995-6#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
monomeric in##2##2##(2008-5#1)(2009-9#1)
monomeric subunits of##2##3##(1997-2#1)(2008-10#1)
monomeric subunits##3##2##(1992-3#1)(1997-2#1)(2008-10#1)
monomeric##61##1##(1990-2#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#4)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#2)(1997-4#2)(1997-6#2)(2007-11#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
monomers added to##2##3##(2011-2#1)(2012-12#1)
monomers and##4##2##(1993-8#1)(1997-2#1)(2008-10#1)(2008-4#1)
monomers are##2##2##(2008-4#2)
monomers in the asymmetric unit##2##5##(1992-4#1)(1993-8#1)
monomers in the##3##3##(1992-4#1)(1993-8#1)(1994-11#1)
monomers in##8##2##(1992-4#1)(1993-8#1)(1994-11#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)
monomers is##3##2##(1993-8#1)(2008-2#1)(2008-4#1)
monomers of##3##2##(1991-12#1)(1991-2#1)(1994-5#1)
monomers on##2##2##(2008-10#1)(2011-2#1)
monomers used##2##2##(2008-10#1)(2013-1#1)
monomers with##4##2##(1992-6#1)(2008-10#2)(2009-12#1)
monomers within##2##2##(1994-5#2)
monomers##84##1##(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-8#4)(1994-11#1)(1994-2#2)(1994-5#3)(1994-6#1)(1995-2#2)(1997-2#5)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#5)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
monomethyl##2##1##(2008-10#2)
monomethylarsonate and dimethylarsinate)##2##3##(2008-10#2)
monomethylarsonate##3##1##(2008-10#3)
monomethylarsonic acid (MMA)##5##3##(2008-10#5)
monomethylarsonic acid and dimethylarsinic acid)##2##5##(2008-10#2)
monomethylarsonic acid and dimethylarsinic##3##4##(2008-10#3)
monomethylarsonic acid and##4##3##(2008-10#4)
monomethylarsonic acid##16##2##(2008-10#16)
monomethylarsonic##17##1##(2008-10#17)
monomodal and bimodal logarithmic-normal##2##4##(2008-3#2)
monomodal and##3##2##(2008-10#1)(2008-3#2)
monomodal##4##1##(2008-10#1)(2008-3#2)(2009-7#1)
monomode##8##1##(2007-11#2)(2007-12#3)(2008-3#2)(2008-5#1)
monomolecular films##3##2##(1994-3#3)
monomolecular model##2##2##(2008-10#2)
monomolecular##13##1##(1994-3#3)(2008-10#8)(2008-8#1)(2012-2#1)
monomorphic and polymorphic##2##3##(1992-6#2)
monomorphic and##3##2##(1992-6#2)(2008-10#1)
monomorphic##9##1##(1992-6#3)(1995-3#1)(2008-10#3)(2008-5#1)(2008-8#1)
mononeuritis##3##1##(1997-2#1)(2008-7#2)
mononeuropathy and##2##2##(1997-2#1)(2008-7#1)
mononeuropathy##6##1##(1993-12#1)(1996-5#1)(1997-2#2)(2008-7#1)(2010-11#1)
mononuclear blood cells##2##3##(1991-11#2)
mononuclear bone marrow cells##3##4##(2012-1#3)
mononuclear cell##9##2##(1995-3#1)(1997-2#1)(1997-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-6#2)
mononuclear cells and##8##3##(1991-5#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2010-6#1)
mononuclear cells are##2##3##(2008-4#2)
mononuclear cells by##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
mononuclear cells from human##2##4##(1994-11#1)(2008-9#1)
mononuclear cells from##10##3##(1992-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-4#5)(2008-9#1)
mononuclear cells in##5##3##(1995-3#1)(2008-1#1)(2008-7#1)(2010-6#1)(2012-1#1)
mononuclear cells of##4##3##(1993-3#1)(2008-11#1)(2011-1#1)(2013-7#1)
mononuclear cells##73##2##(1990-2#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-6#2)(1995-2#1)(1995-3#4)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-4#19)(2008-5#2)(2008-7#2)(2008-9#6)(2009-10#1)(2009-3#1)(2010-6#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-3#1)(2013-7#1)
mononuclear complexes##2##2##(2007-11#1)(2009-11#1)
mononuclear phagocytes##2##2##(1991-11#1)(2008-4#1)
mononuclear##113##1##(1990-2#1)(1991-11#6)(1991-5#2)(1992-12#4)(1992-3#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-6#2)(1995-2#1)(1995-3#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-4#23)(2008-5#2)(2008-7#4)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#1)(2010-6#6)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
mononucleosis and##3##2##(1992-4#1)(2011-2#2)
mononucleosis syndrome##4##2##(2011-2#4)
mononucleosis##15##1##(1992-2#1)(1992-4#2)(1993-11#1)(2007-2#1)(2008-5#2)(2008-9#1)(2011-2#7)
mononucleotide##4##1##(1991-5#1)(1992-12#1)(2008-10#1)(2009-3#1)
mononucleotides##2##1##(1991-12#1)(1991-5#1)
monooleate##2##1##(2008-10#1)(2009-11#1)
monooxygenase activity##3##2##(1991-12#1)(1992-3#1)(1994-8#1)
monooxygenase and##2##2##(1993-5#1)(2008-11#1)
monooxygenase system##2##2##(1990-7#1)(1992-8#1)
monooxygenase was##2##2##(1990-7#1)(1992-8#1)
monooxygenase##23##1##(1990-11#1)(1990-7#3)(1991-12#3)(1991-5#1)(1992-3#1)(1992-8#3)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(2008-11#1)(2009-6#2)
monooxygenases in##2##2##(1990-7#1)(2009-9#1)
monooxygenases##10##1##(1990-7#1)(1991-2#1)(1991-5#1)(1994-5#1)(2008-11#2)(2009-8#1)(2009-9#3)
monoparentalité et##2##2##(2008-11#2)
monoparesis##3##1##(1992-5#1)(2007-10#2)
monopartite begomoviruses##3##2##(2008-10#3)
monopartite##10##1##(2008-10#10)
monophasic##12##1##(1994-2#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-2#2)(2008-7#1)(2010-8#1)(2013-1#1)
monophosphate (IMP)##2##2##(1995-12#1)(2008-10#1)
monophosphate (cAMP)##3##2##(1994-11#1)(1994-8#1)(1995-8#1)
monophosphate (cGMP)##3##2##(1991-9#1)(1995-8#1)(2008-4#1)
monophosphate and##2##2##(1990-7#1)(1995-8#1)
monophosphate##28##1##(1990-7#1)(1991-9#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#4)(2007-10#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-7#1)(2009-3#1)
monophosphate)##2##1##(1994-2#1)(1997-7#1)
monophosphates##2##1##(1991-5#1)(1996-5#1)
monophosphorothioate##2##1##(1995-8#1)(2009-2#1)
monophosphoryl lipid A##3##3##(1991-5#2)(1996-9#1)
monophosphosphorothioate##2##1##(1993-6#2)
monophyletic cluster##2##2##(2013-8#2)
monophyletic group##8##2##(1996-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-8#1)
monophyletic groups##4##2##(2008-10#3)(2008-8#1)
monophyletic origin of##2##3##(2007-12#1)(2008-10#1)
monophyletic##31##1##(1996-4#1)(2007-12#3)(2008-10#13)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#2)(2013-8#3)
monophyly of##8##2##(2007-12#2)(2008-10#3)(2008-6#1)(2010-3#2)
monophyly##9##1##(2007-12#3)(2008-10#3)(2008-6#1)(2010-3#2)
monoplex##2##1##(2008-10#1)(2011-2#1)
monopolar modes##2##2##(2008-9#2)
monopolar##5##1##(1992-12#1)(1994-9#1)(2008-9#2)(2010-7#1)
monopole##3##1##(2007-11#2)(2007-12#1)
monopoly##4##1##(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
monoprocessors##2##1##(2008-3#2)
monoracial/ethnic##3##1##(2013-8#3)
monosaccharide and##3##2##(1992-12#1)(2008-7#1)(2008-8#1)
monosaccharide composition analysis##2##3##(1997-2#2)
monosaccharide composition##4##2##(1995-11#1)(1997-2#3)
monosaccharide##18##1##(1990-8#1)(1992-12#1)(1993-11#1)(1993-8#2)(1994-3#2)(1995-11#1)(1997-2#4)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-11#1)
monosaccharides were##2##2##(1992-5#1)(1997-2#1)
monosaccharides##12##1##(1991-7#1)(1992-5#1)(1992-6#1)(1997-2#1)(2008-10#4)(2008-6#1)(2009-10#1)(2011-2#2)
monosegmented flow analysis##3##3##(2008-10#3)
monosegmented flow system##2##3##(2008-10#2)
monosegmented flow##6##2##(2008-10#6)
monoselenophosphate in##2##2##(1993-11#2)
monoselenophosphate##5##1##(1993-11#5)
monosialoganglioside##2##1##(1990-5#1)(1993-3#1)
monosodium glutamate##3##2##(2008-10#1)(2009-11#1)(2012-3#1)
monosodium urate##2##2##(1991-8#1)(2006-10#1)
monosodium##8##1##(1990-5#1)(1991-8#1)(1995-12#1)(2006-10#1)(2008-10#2)(2009-11#1)(2012-3#1)
monosomic##3##1##(2008-10#2)(2008-5#1)
monosomy 7##2##2##(2013-1#2)
monosomy##6##1##(1991-3#1)(1992-12#1)(2008-7#1)(2012-3#1)(2013-1#2)
monospecific polyclonal antibody prepared against##2##5##(1990-8#1)(1996-2#1)
monospecific polyclonal antibody##3##3##(1990-8#1)(1996-2#2)
monospecific##12##1##(1990-11#1)(1990-8#1)(1992-3#1)(1996-2#2)(2007-5#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
monostatic lidars##2##2##(2008-3#2)
monostatic##5##1##(2008-3#5)
monosubstituted β-cyclodextrin##2##2##(2013-1#2)
monosubstituted##7##1##(1996-2#1)(2008-10#2)(2008-8#1)(2010-3#1)(2013-1#2)
monosyllabic##3##1##(2008-9#3)
monosyllable##2##1##(2008-9#2)
monosymptomatic nocturnal enuresis##2##3##(2013-8#2)
monosynaptic##3##1##(1993-12#1)(1996-2#1)(1997-3#1)
monoterpene##10##1##(2007-11#1)(2008-10#2)(2008-11#5)(2008-12#1)(2011-10#1)
monoterpenes were##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
monoterpenes##17##1##(2008-10#7)(2008-11#2)(2008-12#1)(2011-10#2)(2013-1#3)(2013-8#2)
monoterpenic compounds##2##2##(2008-10#2)
monoterpenoid##2##1##(2008-10#1)(2010-2#1)
monoterpenoids##2##1##(2008-10#1)(2013-1#1)
monotherapy and##4##2##(2008-10#1)(2008-5#1)(2009-9#1)(2012-2#1)
monotherapy for##2##2##(1995-12#1)(2008-10#1)
monotherapy in##5##2##(1994-6#1)(2008-8#1)(2011-10#1)(2011-2#1)(2012-3#1)
monotherapy is##3##2##(2007-7#2)(2009-9#1)
monotherapy or##4##2##(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
monotherapy with##5##2##(1990-2#1)(1990-8#1)(1996-3#1)(2013-8#2)
monotherapy##45##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-3#1)(1994-6#3)(1995-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-10#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
monothiol glutaredoxins##5##2##(2008-7#5)
monothiol##6##1##(2008-7#6)
monotone systems##3##2##(2008-11#1)(2008-8#2)
monotone##11##1##(2008-11#5)(2008-8#4)(2009-9#1)(2010-2#1)
monotonic loading##2##2##(2009-3#2)
monotonic##12##1##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#2)(2009-7#1)
monotonically with##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
monotonically##18##1##(1993-12#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-2#1)
monotonicity##3##1##(2008-2#2)(2009-9#1)
monotonous##3##1##(2007-2#1)(2010-9#1)(2012-2#1)
monotonously##3##1##(2008-11#2)(2013-8#1)
monotropic##2##1##(2009-4#2)
monounsaturated fatty acid (MUFA)##2##4##(2010-2#1)(2010-4#1)
monounsaturated fatty acids##3##3##(1990-2#1)(2009-5#1)(2010-4#1)
monounsaturated fatty##5##2##(1990-2#1)(2009-5#1)(2010-2#1)(2010-4#2)
monounsaturated##8##1##(1990-2#1)(2008-10#1)(2009-5#1)(2010-2#1)(2010-4#2)(2012-2#1)(2013-1#1)
monovalent and divalent cations##2##4##(2008-10#2)
monovalent and divalent##4##3##(2008-10#2)(2011-2#2)
monovalent anions and cations##2##4##(2008-10#2)
monovalent cation##3##2##(1992-6#1)(2008-10#2)
monovalent cations##9##2##(1990-7#2)(1992-6#1)(1993-6#1)(1994-12#1)(2008-10#2)(2008-8#2)
monovalent ions##6##2##(1994-5#1)(2008-10#4)(2010-7#1)
monovalent##38##1##(1990-3#1)(1990-7#3)(1992-6#2)(1993-6#1)(1994-12#2)(1994-5#1)(1995-11#1)(1997-6#1)(2008-1#1)(2008-10#18)(2008-8#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
monovanadate##3##1##(1994-11#3)
monovision##6##1##(2011-2#6)
monoxide (CO)##10##2##(1990-5#1)(1994-2#1)(1995-2#1)(1996-12#4)(2008-3#1)(2008-4#1)(2010-12#1)
monoxide poisoning is##3##3##(1991-9#1)(1997-6#1)(2009-11#1)
monoxide poisoning##9##2##(1990-5#3)(1991-9#1)(1997-6#2)(2009-11#3)
monoxide was##3##2##(1997-6#1)(2008-10#1)(2010-10#1)
monoxide##51##1##(1990-3#1)(1990-5#4)(1991-12#1)(1991-3#1)(1991-9#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-2#2)(1995-3#1)(1996-12#6)(1996-2#1)(1997-6#5)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2009-11#3)(2009-5#1)(2010-10#1)(2010-12#3)(2012-12#1)(2013-1#1)
monozygotic twin##4##2##(2008-12#1)(2010-12#3)
monozygotic twins##8##2##(2008-7#3)(2010-1#2)(2010-12#1)(2011-1#2)
monozygotic##18##1##(1997-5#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#4)(2010-1#3)(2010-12#4)(2010-8#1)(2011-1#2)
monster##7##1##(2009-10#7)
montage##3##1##(2008-10#2)(2010-8#1)
montane##2##1##(2008-8#2)
montanus)##2##1##(2008-5#2)
monte carlo##4##2##(2008-2#1)(2008-3#3)
montelukast##5##1##(2008-1#3)(2008-11#2)
month after cauliflower transplanting and##2##5##(2008-10#2)
month after inoculation##2##3##(2008-10#1)(2008-8#1)
month after operation##2##3##(1993-2#1)(2007-11#1)
month after the operation##2##4##(2008-10#1)(2008-7#1)
month after the##7##3##(1990-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
month after##30##2##(1990-9#1)(1991-2#1)(1991-3#1)(1993-2#1)(1997-3#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#8)(2008-5#2)(2008-7#3)(2008-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
month alcohol##2##2##(2010-9#1)(2012-12#1)
month and##18##2##(1990-12#1)(1990-8#1)(1992-11#1)(1993-9#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
month at##2##2##(2008-10#1)(2011-1#1)
month before##3##2##(1993-6#1)(2008-10#1)(2013-1#1)
month duration##2##2##(1997-8#1)(2008-6#1)
month follow-up##8##2##(1990-3#1)(1993-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
month following treatment##2##3##(1996-3#1)(2008-10#1)
month following##3##2##(1996-3#1)(2008-10#1)(2010-6#1)
month for##7##2##(1996-3#1)(1996-8#1)(1997-8#3)(2007-7#1)(2013-1#1)
month from##4##2##(1993-9#1)(2008-10#2)(2008-11#1)
month history of##3##3##(1993-9#2)(2012-2#1)
month in a##2##3##(2008-11#1)(2012-12#1)
month in##14##2##(1990-2#1)(1994-7#1)(1995-12#2)(2007-11#1)(2008-11#2)(2008-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
month it was not significant##2##5##(2011-2#2)
month it was significant##2##4##(2011-2#2)
month it was##4##3##(2011-2#4)
month it##5##2##(2011-2#5)
month later##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
month of age for##2##4##(2013-1#2)
month of age##8##3##(1990-2#1)(2007-11#1)(2012-2#3)(2013-1#3)
month of life##2##3##(1990-8#1)(2007-8#1)
month of pregnancy##2##3##(1992-12#1)(2013-8#1)
month of the##3##3##(2007-8#1)(2008-6#1)(2008-9#1)
month of treatment##5##3##(1993-2#1)(1996-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
month of##40##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-2#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-6#1)(2011-1#3)(2012-2#3)(2013-1#4)(2013-8#1)
month old rats##2##3##(1996-5#1)(1997-2#1)
month old##8##2##(1990-2#1)(1993-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-5#1)(2010-4#1)
month or##3##2##(2007-2#1)(2008-9#1)(2012-12#1)
month period##6##2##(1990-6#1)(1992-5#1)(1994-3#1)(2008-12#1)(2012-2#2)
month to##8##2##(1991-9#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#4)
month was##3##2##(2007-8#1)(2011-1#1)(2013-1#1)
month##300##1##(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#3)(1990-8#4)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#2)(1993-1#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-9#4)(1994-12#1)(1994-3#2)(1994-6#2)(1994-7#2)(1995-12#4)(1995-2#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-8#6)(2006-12#1)(2007-10#1)(2007-11#10)(2007-2#4)(2007-7#8)(2007-8#9)(2008-1#1)(2008-10#35)(2008-11#16)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#6)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#6)(2011-1#7)(2011-2#21)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#17)(2013-8#5)
month) of##2##2##(2008-10#2)
month)##8##1##(1990-12#1)(1990-8#1)(1991-5#1)(2007-11#1)(2008-10#3)(2008-11#1)
month-old##2##1##(2012-2#1)(2013-8#1)
monthly and##4##2##(2007-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
monthly for##2##2##(2008-5#1)(2013-1#1)
monthly from##5##2##(2008-10#4)(2008-6#1)
monthly measurements##2##2##(2008-3#1)(2008-5#1)
monthly samples##2##2##(2010-8#1)(2011-2#1)
monthly with##2##2##(2008-5#1)(2011-2#1)
monthly##76##1##(1991-1#1)(1991-11#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#7)(2008-6#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#7)
months (av##2##2##(2008-7#2)
months (mean##6##2##(1990-2#1)(1990-6#1)(2007-7#1)(2009-3#1)(2013-1#2)
months (median##2##2##(1994-12#1)(2011-1#1)
months (p &lt##2##3##(1995-12#1)(1997-5#1)
months (p##4##2##(1995-12#1)(1997-5#3)
months (range 3-7 months)##2##4##(1993-2#1)(2010-3#1)
months (range 4##2##3##(2007-8#1)(2012-3#1)
months (range 7 months to##2##5##(1990-12#1)(2012-2#1)
months (range##54##2##(1990-12#2)(1990-2#2)(1990-8#2)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-11#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#6)(2008-9#6)(2009-10#2)(2009-3#2)(2010-1#1)(2010-12#1)(2010-3#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
months a##7##2##(1990-3#1)(1992-10#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
months after MI)##2##3##(2013-1#2)
months after PTCA##2##3##(1992-4#1)(1992-9#1)
months after a##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
months after birth##2##3##(1991-11#1)(2008-6#1)
months after completion of##2##4##(1991-6#2)
months after diagnosis##5##3##(1991-6#1)(2008-4#1)(2008-6#1)(2009-8#1)(2012-3#1)
months after discharge##3##3##(1996-3#1)(2010-10#1)(2013-1#1)
months after discontinuing##2##3##(2007-12#1)(2008-1#1)
months after embolisation##3##3##(1997-3#2)(1997-6#1)
months after his##2##3##(2008-11#1)(2011-2#1)
months after initial##4##3##(2009-1#1)(2011-2#2)(2013-1#1)
months after initiation of therapy##2##5##(1996-11#1)(2007-7#1)
months after initiation of##4##4##(1996-11#1)(2007-7#1)(2008-8#1)(2010-8#1)
months after initiation##5##3##(1996-11#1)(2007-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
months after intervention##2##3##(2013-1#2)
months after operation##6##3##(1995-11#1)(2007-11#1)(2007-8#1)(2008-9#2)(2011-2#1)
months after release from prison##2##5##(2009-11#2)
months after stopping##2##3##(1995-3#1)(2007-7#1)
months after stroke##3##3##(2007-10#1)(2008-7#1)(2009-10#1)
months after surgery and##3##4##(1993-3#2)(2008-6#1)
months after surgery##27##3##(1990-6#1)(1992-9#1)(1993-3#3)(1994-12#1)(1994-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-6#2)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
months after surgery)##2##3##(1995-4#1)(2008-1#1)
months after surgical##2##3##(2009-2#1)(2011-2#1)
months after the acute episode##2##5##(1991-8#1)(2010-10#1)
months after the end of##2##5##(2007-10#1)(2008-1#1)
months after the first##3##4##(1990-8#1)(1994-6#1)(2011-2#1)
months after the onset of##3##5##(2008-1#1)(2008-7#1)(2012-12#1)
months after the operation##8##4##(1991-12#1)(2007-8#2)(2008-10#1)(2011-2#3)(2013-1#1)
months after the procedure##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
months after the second injection##2##5##(1996-12#2)
months after the second##3##4##(1996-12#2)(2007-5#1)
months after the surgery##2##4##(2013-1#1)(2013-8#1)
months after the treatment##3##4##(1997-8#1)(2007-11#2)
months after the##63##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
months after treatment##9##3##(1990-2#1)(1994-12#1)(1995-2#1)(2013-1#5)(2013-8#1)
months after undergoing##2##3##(2008-7#1)(2011-2#1)
months after##229##2##(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-12#5)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#2)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2008-1#7)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#8)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#1)(2009-8#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#22)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#23)(2013-7#1)(2013-8#10)
months ago##3##2##(2007-8#1)(2012-2#2)
months and 11##2##3##(2007-7#1)(2008-4#1)
months and 12 months##2##4##(2008-11#1)(2008-12#1)
months and 2##6##3##(1992-10#1)(2007-10#4)(2012-3#1)
months and five years##2##4##(1992-4#1)(2008-9#1)
months and four##2##3##(1990-9#1)(2008-11#1)
months and in##2##3##(1991-3#1)(2010-3#1)
months and median##2##3##(1990-2#1)(2011-2#1)
months and more##2##3##(2007-11#1)(2008-10#1)
months and of##2##3##(1990-6#1)(2008-9#1)
months and one year##3##4##(1991-11#2)(2009-10#1)
months and the##7##3##(2008-10#4)(2008-5#1)(2008-6#1)(2013-1#1)
months and their neonates##2##4##(2011-1#2)
months and their##4##3##(2007-10#1)(2011-1#2)(2013-8#1)
months and was##2##3##(2008-5#1)(2008-7#1)
months and##74##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-3#1)(1991-8#2)(1992-10#1)(1992-4#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-3#1)(2007-10#5)(2007-11#3)(2007-7#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#1)
months apart##2##2##(2008-3#1)(2008-7#1)
months as##3##2##(1995-8#1)(2008-10#1)(2012-2#1)
months at -20##5##3##(2008-10#1)(2013-7#4)
months at 4 degrees C##2##5##(2008-10#2)
months at the##2##3##(2007-8#1)(2011-2#1)
months at##18##2##(2007-11#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-7#4)
months before the month##2##4##(1994-7#1)(2008-4#1)
months before the##6##3##(1992-10#1)(1994-7#1)(2008-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
months before they##2##3##(2008-10#1)(2012-12#1)
months before##20##2##(1990-9#1)(1992-10#1)(1993-6#1)(1994-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
months between the##2##3##(2009-7#1)(2012-3#1)
months between##5##2##(1991-8#1)(2008-12#1)(2008-6#1)(2009-7#1)(2012-3#1)
months but##3##2##(1992-5#1)(2008-7#1)(2012-12#1)
months compared with##5##3##(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#2)
months duration which was##2##4##(2010-11#1)(2012-12#1)
months duration##6##2##(2008-7#1)(2009-2#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
months during##3##2##(2009-8#1)(2011-2#1)(2012-3#1)
months earlier than##2##3##(1997-2#1)(2008-10#1)
months earlier##5##2##(1997-2#1)(2008-10#2)(2009-2#1)(2012-2#1)
months follow-up were considered##2##4##(2008-7#1)(2012-12#1)
months follow-up##12##2##(1993-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
months following surgery##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
months following the##5##3##(2008-1#1)(2008-10#1)(2008-12#2)(2010-3#1)
months following##18##2##(1992-1#1)(1995-2#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#2)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#2)
months for the##3##3##(2007-7#1)(2008-1#2)
months for those treated##2##4##(2008-6#2)
months for those##3##3##(1994-8#1)(2008-6#2)
months for##17##2##(1991-11#1)(1991-4#1)(1991-8#2)(1994-8#2)(2007-7#1)(2008-1#2)(2008-4#1)(2008-6#2)(2011-2#3)(2013-1#2)
months from the first##2##4##(1991-6#1)(2013-1#1)
months from the##6##3##(1990-12#2)(1991-6#1)(2007-11#1)(2010-4#1)(2013-1#1)
months from##12##2##(1990-12#2)(1991-6#1)(1991-8#1)(1992-5#1)(1996-6#1)(1997-7#1)(2007-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2013-1#1)
months had##3##2##(1990-12#1)(2008-9#2)
months in PACT##2##3##(2013-1#2)
months in a##2##3##(1990-6#1)(1995-6#1)
months in cold storage##2##4##(2008-10#2)
months in group##2##3##(2007-8#2)
months in the##11##3##(1992-12#1)(1993-2#1)(1997-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2012-12#1)
months in##55##2##(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#1)(1992-12#2)(1993-1#1)(1993-2#1)(1994-6#3)(1994-8#1)(1995-6#3)(1996-3#1)(1997-3#1)(2007-8#5)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#3)
months into program)##2##3##(2011-2#2)
months into the##2##3##(1997-2#1)(2008-11#1)
months into##4##2##(1997-2#1)(2008-11#1)(2011-2#2)
months is##4##2##(1991-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
months later and##4##3##(1996-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
months later showed##3##3##(1994-12#1)(1997-5#1)(2007-8#1)
months later the##4##3##(1990-2#1)(1992-5#1)(2007-4#1)(2008-7#1)
months later##73##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-10#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-1#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#6)(2013-8#3)
months later)##2##2##(2007-11#1)(2012-1#1)
months of age and##3##4##(2007-8#1)(2008-9#1)(2010-11#1)
months of age in##4##4##(1990-3#2)(2010-11#1)(2010-6#1)
months of age is##3##4##(1995-8#2)(2008-10#1)
months of age was##2##4##(1991-11#1)(2012-3#1)
months of age were##2##4##(1994-6#1)(2012-12#1)
months of age##67##3##(1990-3#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#2)(1993-12#3)(1994-11#1)(1994-6#2)(1995-12#1)(1995-5#1)(1995-8#3)(1997-4#1)(2006-5#2)(2007-11#1)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#3)(2008-9#5)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)
months of diagnosis##3##3##(2008-6#3)
months of follow up##2##4##(2008-10#1)(2013-1#1)
months of follow-up in##2##4##(1991-3#1)(2013-1#1)
months of follow-up##11##3##(1990-2#1)(1990-8#1)(1991-3#1)(1993-1#1)(1993-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2010-9#1)(2013-1#2)
months of intervention##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
months of life is##2##4##(1995-1#1)(2008-10#1)
months of life##13##3##(1993-6#1)(1995-1#2)(2007-7#1)(2008-10#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
months of median follow-up##2##4##(1992-5#2)
months of storage at 4 degrees C##3##7##(2008-10#3)
months of the##9##3##(1990-12#1)(1990-6#1)(2008-3#2)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
months of therapy##6##3##(1990-10#1)(1991-12#1)(1991-6#1)(2008-3#1)(2013-1#2)
months of treatment was##2##4##(1991-8#1)(2013-1#1)
months of treatment##22##3##(1991-8#2)(1992-1#1)(1994-6#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-8#2)(2012-3#2)(2013-1#2)(2013-8#1)
months of##214##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#4)(1992-1#1)(1992-2#2)(1992-5#4)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-5#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#10)(2007-8#6)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#4)(2008-3#8)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-11#2)(2010-5#4)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#11)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#18)(2013-8#5)
months old for##2##3##(2013-1#2)
months old##16##2##(1990-12#1)(1991-2#1)(1993-12#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
months old) and old##2##4##(2008-7#2)
months old) and##4##3##(1993-12#1)(1994-6#1)(2008-7#2)
months old) animals##3##3##(1993-12#3)
months old)##13##2##(1993-12#4)(1994-6#2)(1996-5#1)(2008-7#6)
months on ART##2##3##(2012-12#2)
months on##6##2##(1990-3#1)(2008-1#1)(2012-12#3)(2012-3#1)
months or longer##3##3##(1990-5#1)(2008-6#1)(2011-2#1)
months or more##2##3##(1990-12#1)(2013-1#1)
months or##8##2##(1990-12#1)(1990-5#1)(1991-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
months period of##2##3##(2007-10#1)(2007-7#1)
months period##4##2##(1995-4#1)(2007-10#1)(2007-7#1)(2008-4#1)
months post##5##2##(1990-6#1)(2007-11#2)(2008-6#1)(2008-9#1)
months post-operatively##3##2##(1996-3#1)(2008-6#1)(2012-2#1)
months post-stroke##3##2##(2007-10#2)(2009-10#1)
months postoperatively and##3##3##(1990-6#1)(2007-8#1)(2008-9#1)
months postoperatively##16##2##(1990-6#1)(1991-3#1)(1994-3#2)(2007-8#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#3)(2010-12#1)(2012-3#1)(2013-1#1)
months previously and##2##3##(2008-5#1)(2010-6#1)
months previously##7##2##(1990-8#1)(1994-2#1)(1995-9#1)(2008-5#1)(2010-6#3)
months prior to##5##3##(1995-1#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)
months product use##2##3##(2008-10#2)
months respectively##7##2##(1991-3#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2013-1#2)
months revealed##3##2##(2007-8#1)(2008-9#1)(2013-1#1)
months showed##5##2##(1990-6#1)(1992-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
months study##3##2##(1990-3#1)(1991-6#1)(2007-11#1)
months the##10##2##(1990-11#1)(1990-3#1)(1993-3#1)(1994-11#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-7#1)
months to 16##2##3##(1990-12#1)(2010-5#1)
months to 6 years##3##4##(1996-12#1)(2007-7#1)(2007-8#1)
months to 6##4##3##(1996-12#1)(2007-7#1)(2007-8#1)(2008-9#1)
months to years##2##3##(1991-11#1)(2008-11#1)
months to##35##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-8#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-3#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
months up to##2##3##(2007-11#1)(2008-4#1)
months using the##2##3##(2008-10#1)(2012-3#1)
months using##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
months versus##2##2##(1992-2#1)(1997-5#1)
months vs##2##2##(2007-8#1)(2008-7#1)
months was found##2##3##(2008-10#1)(2011-1#1)
months was##22##2##(1992-11#2)(1992-8#1)(1994-6#1)(2007-7#3)(2008-10#3)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
months were enrolled##2##3##(1997-2#1)(2008-6#1)
months were found##2##3##(2011-2#1)(2012-12#1)
months were##19##2##(1991-12#1)(1991-8#1)(1994-12#1)(1997-2#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-6#2)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#2)
months when##4##2##(2008-10#2)(2012-12#1)(2013-1#1)
months with a##3##3##(2007-7#1)(2008-6#1)(2008-7#1)
months with good reproducibility##6##4##(2008-10#6)
months with##20##2##(1994-6#1)(2007-7#1)(2008-10#9)(2008-12#2)(2008-6#2)(2008-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
months without any considerable change in##2##6##(2008-10#2)
months without any considerable divergence in##3##6##(2008-10#3)
months without any considerable##5##4##(2008-10#5)
months without any measurable divergence in##2##6##(2008-10#2)
months without any significant##3##4##(2008-10#2)(2008-2#1)
months without any##14##3##(2008-10#12)(2008-2#1)(2011-2#1)
months without observing any divergence##2##5##(2008-10#2)
months without observing any##4##4##(2008-10#4)
months without##22##2##(1997-6#1)(2008-10#18)(2008-2#1)(2008-4#1)(2011-2#1)
months##1826##1##(1990-10#2)(1990-11#3)(1990-12#16)(1990-2#12)(1990-3#9)(1990-5#10)(1990-6#19)(1990-8#6)(1990-9#9)(1991-1#1)(1991-11#17)(1991-12#7)(1991-2#19)(1991-3#9)(1991-4#4)(1991-6#12)(1991-8#24)(1991-9#1)(1992-1#2)(1992-10#10)(1992-11#4)(1992-12#4)(1992-2#8)(1992-3#1)(1992-4#2)(1992-5#12)(1992-6#2)(1992-8#5)(1992-9#4)(1993-1#6)(1993-11#4)(1993-12#14)(1993-2#3)(1993-3#10)(1993-6#5)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#5)(1994-12#12)(1994-2#4)(1994-3#2)(1994-6#17)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#4)(1995-11#5)(1995-12#3)(1995-2#12)(1995-3#7)(1995-4#4)(1995-5#1)(1995-6#6)(1995-8#7)(1995-9#3)(1996-1#3)(1996-11#3)(1996-12#11)(1996-2#7)(1996-3#12)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#9)(1997-1#2)(1997-2#7)(1997-3#15)(1997-4#5)(1997-5#9)(1997-6#5)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#6)(2006-12#1)(2006-5#2)(2007-10#24)(2007-11#51)(2007-12#6)(2007-2#7)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#47)(2007-8#66)(2008-1#43)(2008-10#166)(2008-11#38)(2008-12#24)(2008-2#6)(2008-3#25)(2008-4#20)(2008-5#42)(2008-6#53)(2008-7#59)(2008-8#20)(2008-9#56)(2009-1#3)(2009-10#10)(2009-11#6)(2009-12#6)(2009-2#4)(2009-3#9)(2009-4#2)(2009-5#9)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#7)(2010-10#9)(2010-11#7)(2010-12#3)(2010-2#5)(2010-3#15)(2010-4#3)(2010-5#8)(2010-6#20)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#29)(2011-2#101)(2011-3#2)(2012-1#4)(2012-12#34)(2012-2#37)(2012-3#36)(2013-1#134)(2013-7#10)(2013-8#35)
months' follow-up##4##2##(1991-8#1)(1995-11#1)(2007-8#1)(2008-6#1)
months'##9##1##(1990-9#1)(1991-8#1)(1992-6#1)(1992-9#1)(1995-11#2)(2007-8#1)(2008-11#1)(2008-6#1)
months) after##3##2##(1993-2#1)(1996-1#1)(2008-6#1)
months) and average patient age at surgery was##2##8##(2009-3#2)
months) and mortality##2##3##(2008-1#1)(2008-6#1)
months) and##13##2##(1991-12#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-3#2)(2009-5#1)
months) for##2##2##(1993-1#1)(2008-3#1)
months) of##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
months) than##2##2##(1996-9#1)(2006-10#1)
months) to##3##2##(1996-11#1)(2007-7#1)(2008-7#1)
months) with good reproducibility (S##3##5##(2008-10#3)
months)##132##1##(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#3)(1994-12#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-5#1)(1996-9#4)(1997-3#2)(1997-4#1)(1997-9#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-6#7)(2008-7#9)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#4)(2009-5#3)(2009-7#1)(2010-12#1)(2010-3#3)(2011-2#5)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)
months)]##2##1##(2011-2#2)
months]##3##1##(1991-9#1)(1992-11#1)(2013-7#1)
monticola##6##1##(2008-10#5)(2008-6#1)
montmorillonite clay##2##2##(2007-11#1)(2008-10#1)
montmorillonite suspensions##2##2##(2008-10#2)
montmorillonite##8##1##(1994-11#1)(2007-11#2)(2008-10#5)
monuments##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
mood after##2##2##(1997-8#1)(2008-11#1)
mood and anxiety disorders##2##4##(1993-2#1)(2010-2#1)
mood and cognition##2##3##(2012-1#1)(2012-3#1)
mood and##15##2##(1991-5#1)(1993-2#1)(1996-7#2)(2007-12#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
mood changes##2##2##(2008-6#1)(2008-7#1)
mood disorder##4##2##(2008-1#1)(2008-11#2)(2013-8#1)
mood disorders and##3##3##(2008-7#3)
mood disorders in##2##3##(1996-7#1)(2012-3#1)
mood disorders##25##2##(1995-5#1)(1996-7#2)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#11)(2009-7#3)(2012-3#2)(2013-8#1)
mood disorders)##2##2##(2008-6#1)(2008-7#1)
mood is##2##2##(2008-11#1)(2013-8#1)
mood modulation##2##2##(2012-12#1)(2013-8#1)
mood of##2##2##(2008-5#1)(2011-2#1)
mood regulatory sensorimotor stimulation##2##4##(2013-8#2)
mood scales##3##2##(1991-8#2)(2008-11#1)
mood stabilizers##3##2##(2008-3#1)(2008-7#2)
mood stabilizing##2##2##(2008-4#1)(2011-2#1)
mood states##3##2##(2007-12#1)(2008-12#1)(2012-12#1)
mood to##2##2##(2008-6#1)(2013-1#1)
mood was##2##2##(1996-7#2)
mood##124##1##(1991-1#2)(1991-5#1)(1991-8#8)(1993-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-7#7)(1997-8#1)(2007-12#3)(2007-6#1)(2008-1#2)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#20)(2009-10#1)(2009-11#2)(2009-3#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#2)(2013-8#11)
moods##3##1##(2013-1#3)
moon face##2##2##(2011-2#1)(2013-1#1)
moon##11##1##(2008-2#3)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
moor frog##4##2##(2011-2#2)(2012-3#2)
moored spectral##2##2##(2008-3#2)
moored##4##1##(2008-3#4)
moose and sheep##3##3##(1995-6#3)
moose and##5##2##(1995-6#4)(2008-4#1)
mopping and##2##2##(1997-2#2)
mopping##7##1##(1997-2#7)
moral actions##3##2##(2013-8#3)
moral and##2##2##(2007-11#1)(2013-8#1)
moral awareness##2##2##(2008-11#2)
moral dilemmas##4##2##(2008-11#4)
moral emotion expectancies##5##3##(2013-8#5)
moral faculty##2##2##(2008-11#2)
moral hazard##2##2##(1992-1#1)(2008-7#1)
moral issues##3##2##(2008-11#2)(2008-12#1)
moral judgment##3##2##(2008-11#3)
moral judgments##3##2##(2008-11#2)(2011-2#1)
moral organ##2##2##(2008-11#2)
moral reasoning##2##2##(2008-11#2)
moral##92##1##(1991-12#1)(1991-2#3)(1992-1#1)(1992-3#1)(1993-2#1)(1994-1#4)(1994-9#1)(1996-2#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-11#38)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-2#6)(2013-1#1)(2013-8#12)
morale and##4##2##(1992-12#1)(1997-3#1)(2007-10#1)(2010-10#1)
morale##10##1##(1991-3#1)(1992-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-3#2)(2007-10#1)(2008-9#1)(2010-10#1)
morality in##3##2##(1991-2#1)(1997-2#1)(2009-10#1)
morality##9##1##(1991-2#1)(1997-2#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
morally##6##1##(1991-2#2)(1992-1#1)(1992-3#1)(2012-2#1)(2013-8#1)
morals##2##1##(1996-8#1)(2013-1#1)
morbid condition##3##2##(1997-8#2)(2013-1#1)
morbid conditions##2##2##(1994-11#1)(2011-7#1)
morbid obesity##7##2##(1993-3#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
morbid state##2##2##(2008-3#1)(2008-7#1)
morbid states##2##2##(1994-11#1)(1994-12#1)
morbid##20##1##(1992-8#1)(1993-3#1)(1994-11#2)(1994-12#1)(1997-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-7#1)(2012-12#1)(2013-1#4)(2013-7#2)
morbidities and##2##2##(1994-2#1)(2009-7#1)
morbidities of##2##2##(2009-10#1)(2012-3#1)
morbidities##11##1##(1994-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#2)
morbidity after##6##2##(2007-8#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
morbidity among the exposed workers##2##5##(2009-12#2)
morbidity among the##3##3##(2009-12#2)(2013-1#1)
morbidity among##6##2##(2008-7#1)(2009-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
morbidity and complete##2##3##(1992-5#1)(2008-6#1)
morbidity and improve##2##3##(2008-2#1)(2012-12#1)
morbidity and mortality after##4##4##(2006-10#1)(2007-8#1)(2012-2#1)(2013-1#1)
morbidity and mortality and##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)
morbidity and mortality associated with##3##5##(1993-9#1)(1996-9#1)(2012-2#1)
morbidity and mortality can be##2##5##(2011-2#1)(2013-1#1)
morbidity and mortality due to gastrointestinal##2##6##(2013-8#2)
morbidity and mortality due to##7##5##(1992-8#1)(2009-4#1)(2011-2#1)(2013-7#1)(2013-8#3)
morbidity and mortality from##2##4##(1993-2#1)(2011-2#1)
morbidity and mortality globally##2##4##(2008-8#1)(2009-9#1)
morbidity and mortality in patients with##2##6##(2008-3#1)(2009-8#1)
morbidity and mortality in patients##3##5##(2008-3#2)(2009-8#1)
morbidity and mortality in the##8##5##(1993-5#1)(1996-9#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)
morbidity and mortality in##24##4##(1993-3#1)(1993-5#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#2)(2011-2#1)(2013-8#1)
morbidity and mortality is##2##4##(2008-11#1)(2008-2#1)
morbidity and mortality of the##10##5##(2011-2#1)(2012-3#1)(2013-8#8)
morbidity and mortality of##14##4##(1990-2#1)(1992-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#8)
morbidity and mortality rates##5##4##(2006-10#2)(2007-10#1)(2011-2#1)(2012-2#1)
morbidity and mortality were##2##4##(2008-1#1)(2008-7#1)
morbidity and mortality worldwide##4##4##(2010-11#1)(2011-2#3)
morbidity and mortality##169##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1996-3#1)(1996-9#2)(1997-1#3)(2006-10#5)(2007-10#1)(2007-12#4)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#11)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#12)
morbidity and no mortality##2##4##(2007-7#1)(2008-7#1)
morbidity and premature mortality##2##4##(1995-9#1)(1997-8#1)
morbidity and the##3##3##(1990-3#1)(1993-6#1)(2007-7#1)
morbidity and##216##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-9#2)(1997-1#3)(1997-3#1)(1997-8#1)(2006-10#6)(2006-8#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-7#8)(2007-8#4)(2008-1#14)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#21)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#20)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#12)
morbidity as well as##3##4##(1991-9#1)(2007-10#1)(2012-3#1)
morbidity as##4##2##(1991-9#1)(2007-10#1)(2008-7#1)(2012-3#1)
morbidity associated with these##2##4##(1990-11#1)(2008-7#1)
morbidity associated with##6##3##(1990-11#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
morbidity but##2##2##(2008-7#1)(2012-12#1)
morbidity caused by##2##3##(2008-5#1)(2010-7#1)
morbidity data##2##2##(1990-9#1)(1994-11#1)
morbidity due to##5##3##(1997-3#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
morbidity during##2##2##(2010-5#1)(2012-12#1)
morbidity for##6##2##(1992-3#1)(1993-5#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
morbidity from##4##2##(1997-2#1)(2007-2#1)(2011-1#1)(2011-2#1)
morbidity in patients with##2##4##(2008-3#1)(2009-5#1)
morbidity in the##3##3##(2011-2#1)(2012-12#2)
morbidity in##22##2##(1990-8#1)(1993-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#4)(2012-12#4)(2013-1#1)(2013-8#1)
morbidity including##4##2##(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
morbidity is##5##2##(1991-8#1)(2007-6#1)(2009-2#1)(2012-3#1)(2013-1#1)
morbidity of the##4##3##(1991-9#2)(2007-8#1)(2008-8#1)
morbidity of##13##2##(1991-9#2)(1993-1#1)(1996-3#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
morbidity or mortality##2##3##(1993-11#1)(1996-9#1)
morbidity or##3##2##(1993-11#1)(1996-9#1)(2010-3#1)
morbidity rate and a##2##4##(1995-12#1)(2011-2#1)
morbidity rate was##2##3##(1991-2#1)(2008-7#1)
morbidity rate##9##2##(1991-2#1)(1992-9#1)(1994-2#1)(1995-12#1)(2007-10#1)(2008-7#2)(2011-2#2)
morbidity rates##7##2##(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
morbidity ratios##2##2##(2008-7#1)(2011-2#1)
morbidity was##9##2##(1991-6#1)(1994-2#1)(1994-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#3)
morbidity were##2##2##(2008-10#1)(2008-7#1)
morbidity##470##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#3)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#7)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#11)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#12)(2008-1#19)(2008-10#14)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#51)(2008-8#9)(2008-9#2)(2009-10#3)(2009-12#4)(2009-2#1)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#52)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#17)(2012-2#15)(2012-3#22)(2012-8#1)(2013-1#14)(2013-7#3)(2013-8#19)
morbidly obese patients##3##3##(2009-2#1)(2012-5#2)
morbidly obese##7##2##(2008-5#1)(2008-9#1)(2009-2#1)(2012-12#2)(2012-5#2)
morbidly##8##1##(2008-5#1)(2008-9#1)(2009-2#1)(2012-12#2)(2012-5#2)(2013-1#1)
morbosa populations##2##2##(2008-10#2)
morbosa##5##1##(2008-10#5)
more &quot##3##2##(1995-12#1)(2008-9#1)(2009-5#1)
more (P##2##2##(2010-2#2)
more (p ・・0##2##3##(2011-2#2)
more IAA than the wild type##2##6##(2008-10#2)
more a##2##2##(2008-10#1)(2010-12#1)
more about the##9##3##(1990-2#1)(1993-11#1)(1996-3#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-8#1)
more about their##3##3##(1995-2#1)(2008-7#1)(2011-2#1)
more about##19##2##(1990-2#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#3)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-8#1)
more abstract##2##2##(1995-3#1)(2008-2#1)
more abundant in the##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
more abundant in##5##3##(2008-10#2)(2008-8#1)(2009-10#1)(2013-7#1)
more abundant than the##3##4##(1991-5#1)(1994-11#1)(2008-10#1)
more abundant than##5##3##(1991-5#1)(1994-11#1)(2008-10#2)(2010-5#1)
more abundant##18##2##(1991-5#1)(1992-3#1)(1994-11#2)(2008-10#6)(2008-8#2)(2009-10#2)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#1)
more abundantly##2##2##(2008-10#2)
more acceptable to##2##3##(1990-11#1)(2010-5#1)
more acceptable##6##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
more accessible to##2##3##(2008-7#1)(2013-8#1)
more accessible##10##2##(1991-12#1)(1993-12#1)(1993-3#1)(1996-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2013-8#1)
more accurate and##8##3##(1991-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)
more accurate at##2##3##(2007-12#1)(2008-10#1)
more accurate data##2##3##(1991-11#1)(2011-1#1)
more accurate estimation of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
more accurate identification of##5##4##(1990-11#1)(1994-3#1)(2008-12#1)(2012-2#2)
more accurate information on the##2##5##(1992-9#1)(1993-12#1)
more accurate information##3##3##(1992-9#1)(1993-12#1)(2010-6#1)
more accurate results##5##3##(1990-3#1)(2008-10#4)
more accurate risk##2##3##(2008-5#1)(2009-6#1)
more accurate than the##2##4##(2008-10#2)
more accurate than##9##3##(2008-1#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
more accurate##75##2##(1990-11#1)(1990-3#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-2#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
more accurately and##2##3##(2007-12#1)(2012-2#1)
more accurately than##4##3##(1993-12#1)(1997-1#1)(2007-12#1)(2012-4#1)
more accurately the##2##3##(2008-2#1)(2011-3#1)
more accurately##22##2##(1990-8#1)(1991-11#1)(1991-12#1)(1993-12#1)(1997-1#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-2#2)(2008-6#1)(2008-9#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-4#1)(2013-1#1)
more acidic##5##2##(1990-8#1)(1991-2#1)(2008-10#2)(2010-4#1)
more active in the##4##4##(1991-3#1)(1993-12#1)(1993-6#1)(1995-8#1)
more active in##7##3##(1991-3#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-8#1)(2008-11#1)(2011-2#1)
more active than the##2##4##(1990-11#1)(1991-12#1)
more active than##8##3##(1990-11#1)(1991-12#1)(1992-10#1)(1992-9#1)(1994-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
more active##32##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#1)(1991-3#2)(1992-10#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-2#2)(1997-3#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#3)
more actively##6##2##(1991-12#1)(1997-8#1)(2008-11#2)(2009-9#1)(2011-2#1)
more activity##2##2##(1994-9#1)(2013-8#1)
more acute##3##2##(1995-5#1)(1997-5#1)(2013-1#1)
more adaptive##4##2##(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
more adequate##6##2##(1995-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#2)
more adolescents##2##2##(2008-11#1)(2009-7#1)
more advanced disease and##2##4##(1990-8#1)(2012-2#1)
more advanced disease##3##3##(1990-8#1)(2012-2#2)
more advanced in##3##3##(1990-12#1)(2008-11#1)(2008-9#1)
more advanced##17##2##(1990-12#1)(1990-8#1)(1993-11#1)(1993-2#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-8#2)
more advantageous in##2##3##(2008-8#1)(2011-2#1)
more advantageous##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
more adverse##2##2##(2008-11#1)(2008-7#1)
more affected by##5##3##(2010-2#1)(2011-2#3)(2012-7#1)
more affected than##3##3##(2008-10#1)(2008-2#1)(2010-11#1)
more affected##10##2##(2008-1#2)(2008-10#1)(2008-2#1)(2010-11#1)(2010-2#1)(2011-2#3)(2012-7#1)
more affordable##6##2##(1994-2#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-11#2)
more after##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
more aggressive and##3##3##(1990-2#1)(1991-12#1)(2010-12#1)
more aggressive behavior##2##3##(1991-4#1)(1997-8#1)
more aggressive than##3##3##(2008-10#3)
more aggressive##29##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1993-11#1)(1993-2#1)(1997-8#1)(2008-10#11)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
more aggressively##2##2##(2008-1#1)(2008-3#1)
more alkaline##4##2##(1990-11#1)(1994-3#1)(2008-5#2)
more amenable to##3##3##(2008-10#2)(2013-1#1)
more and more important to##2##5##(2008-3#1)(2010-8#1)
more and more important##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#1)
more and more in##2##4##(2008-5#1)(2011-3#1)
more and more often##2##4##(1991-9#1)(2010-4#1)
more and more popular##3##4##(2007-11#1)(2009-12#1)(2013-8#1)
more and more##37##3##(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
more and##45##2##(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
more antihypertensive##2##2##(2008-1#1)(2008-2#1)
more apparent in##2##3##(2007-2#1)(2012-12#1)
more apparent##5##2##(1995-1#1)(2007-2#1)(2008-2#1)(2009-12#1)(2012-12#1)
more applied##2##2##(2008-8#1)(2009-4#1)
more appropriate for##3##3##(2008-3#1)(2009-11#1)(2009-8#1)
more appropriate than the##2##4##(2008-10#1)(2008-2#1)
more appropriate than##5##3##(2008-10#3)(2008-2#1)(2011-2#1)
more appropriate to##2##3##(2008-10#1)(2008-8#1)
more appropriate##37##2##(1993-3#1)(1994-1#1)(1994-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-3#2)
more appropriately##2##2##(2008-10#1)(2010-5#1)
more are##3##2##(2010-3#1)(2011-1#1)(2012-3#1)
more areas##2##2##(2008-6#1)(2010-8#1)
more arid##2##2##(2012-7#1)(2012-9#1)
more as##2##2##(1991-11#1)(1992-3#1)
more at risk##2##3##(2008-12#1)(2012-12#1)
more at##4##2##(1994-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
more attention in##2##3##(2008-10#1)(2013-1#1)
more attention to the##5##4##(2008-1#2)(2008-11#1)(2012-2#1)(2013-1#1)
more attention to##10##3##(1995-1#1)(2008-1#2)(2008-11#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
more attention##24##2##(1995-1#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
more attractive than the buffer##2##5##(2008-10#2)
more attractive than the##3##4##(2008-10#2)(2008-5#1)
more attractive to females##2##4##(1990-8#1)(2009-8#1)
more attractive to##3##3##(1990-8#1)(1994-1#1)(2009-8#1)
more attractive##14##2##(1990-8#1)(1994-1#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#1)
more aware of##5##3##(2008-10#1)(2010-6#2)(2010-9#1)(2013-1#1)
more aware##6##2##(2008-10#1)(2010-6#2)(2010-9#1)(2012-2#1)(2013-1#1)
more awareness##2##2##(2008-11#1)(2011-1#1)
more balanced##4##2##(2007-8#1)(2008-9#1)(2009-3#1)(2009-9#1)
more basal##4##2##(2008-8#3)(2011-2#1)
more basic##3##2##(1990-8#1)(1996-2#1)(2010-11#1)
more beneficial than##2##3##(2012-2#1)(2013-1#1)
more beneficial##5##2##(1996-11#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
more benign##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
more biocompatible##3##2##(2009-11#1)(2011-2#2)
more biological##2##2##(1993-5#1)(2009-7#1)
more biologically##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
more broadly##6##2##(1997-3#1)(2009-3#1)(2010-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
more by the##2##3##(2008-3#1)(2013-8#1)
more by##7##2##(1990-11#1)(1996-7#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2013-8#1)
more carefully##2##2##(2008-10#1)(2008-11#1)
more cases of##3##3##(2007-5#1)(2011-1#1)(2011-2#1)
more cases##7##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
more cell##3##2##(1995-8#1)(2008-10#1)(2013-1#1)
more challenging##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#1)
more chemical##2##2##(2008-10#2)
more children##14##2##(1990-6#1)(1994-2#1)(1994-6#1)(1997-2#2)(1997-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
more chronic##5##2##(1991-6#1)(1992-4#1)(1993-3#1)(1994-6#1)(2011-1#1)
more clearly defined##2##3##(2008-11#1)(2008-5#1)
more clearly##10##2##(1991-6#1)(1991-9#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-1#1)
more clinical##5##2##(1996-12#1)(2008-11#2)(2010-8#1)(2011-2#1)
more clinically relevant##2##3##(2008-5#1)(2009-11#1)
more clinically##6##2##(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2013-1#1)
more closely reflects##2##3##(1990-8#1)(2011-2#1)
more closely related to each other than##2##7##(2008-10#1)(2008-8#1)
more closely related to each other##4##6##(2008-10#2)(2008-8#1)(2011-2#1)
more closely related to the##2##5##(2008-5#1)(2011-2#1)
more closely related to##16##4##(1995-6#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#4)
more closely related##18##3##(1995-6#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#4)
more closely together##2##3##(1996-1#1)(2008-11#1)
more closely with##4##3##(1991-12#1)(1992-3#1)(2008-12#1)(2012-12#1)
more closely##42##2##(1990-8#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#2)(1994-1#2)(1995-12#1)(1995-6#1)(1996-1#1)(1997-2#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2011-2#6)(2012-12#1)
more coarticulation than##2##3##(2013-8#2)
more collaborative##4##2##(2008-11#1)(2009-3#1)(2009-9#1)(2012-3#1)
more combinations##2##2##(2008-3#1)(2008-9#1)
more comfortable##4##2##(1992-11#1)(1994-1#1)(2011-2#1)(2012-3#1)
more common among##7##3##(1997-4#1)(2007-10#1)(2008-1#2)(2011-1#1)(2012-3#1)(2013-8#1)
more common in children##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
more common in females##3##4##(2008-3#1)(2010-4#1)(2012-3#1)
more common in patients with##2##5##(2010-12#1)(2013-1#1)
more common in patients##4##4##(2007-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
more common in the elderly##2##5##(2008-1#2)
more common in the##9##4##(1991-11#1)(2006-8#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)
more common in##50##3##(1990-2#3)(1991-11#1)(1992-2#2)(1993-10#1)(1993-12#2)(1996-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
more common than##6##3##(2006-10#1)(2007-11#1)(2007-4#1)(2008-8#2)(2011-2#1)
more common with##3##3##(1993-11#1)(2008-8#1)(2008-9#1)
more common##107##2##(1990-2#3)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#2)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#5)(2009-3#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#5)
more commonly in the##2##4##(2008-8#1)(2011-2#1)
more commonly in##5##3##(2007-7#2)(2008-8#1)(2011-2#1)(2012-1#1)
more commonly seen in##3##4##(2008-8#1)(2009-1#1)(2012-3#1)
more commonly used##7##3##(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-5#1)
more commonly##33##2##(1990-5#1)(1995-1#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-1#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
more communication##4##2##(2007-12#1)(2009-11#1)(2011-1#2)
more compact in##2##3##(2008-3#1)(2008-7#1)
more compact than##2##3##(2008-3#1)(2008-8#1)
more compact##9##2##(1994-5#1)(1996-5#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)
more compatible with##2##3##(2008-10#1)(2009-7#1)
more competent##4##2##(1990-2#1)(1993-2#1)(2008-10#1)(2012-3#1)
more competitive##5##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
more complete analysis##2##3##(2008-10#1)(2008-3#1)
more complete picture##3##3##(2009-8#2)(2010-4#1)
more complete understanding of the##6##5##(1992-3#1)(1996-12#1)(1996-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
more complete understanding of##9##4##(1992-3#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#1)
more complete version of the##2##5##(2008-4#1)(2008-7#1)
more complete##28##2##(1990-12#1)(1990-7#1)(1992-3#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
more complex EVAR##2##3##(2012-2#2)
more complex and##7##3##(1992-3#2)(2008-10#2)(2009-10#1)(2009-2#1)(2011-2#1)
more complex in##4##3##(2007-4#1)(2009-12#1)(2009-7#1)(2010-4#1)
more complex methods##2##3##(1993-3#1)(2008-6#1)
more complex techniques##2##3##(1993-11#1)(2008-5#1)
more complex than a##2##4##(2008-10#1)(2008-9#1)
more complex than for##2##4##(1994-3#1)(2010-12#1)
more complex than##15##3##(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2012-12#1)(2013-8#1)
more complex to##2##3##(2008-11#1)(2009-5#1)
more complex##96##2##(1990-8#1)(1992-1#1)(1992-3#2)(1993-11#1)(1993-3#2)(1993-5#1)(1994-1#2)(1994-2#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#3)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
more complicated than a##2##4##(1992-8#1)(2008-10#1)
more complicated than##8##3##(1992-3#1)(1992-8#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-2#1)
more complicated##22##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#2)(2012-2#2)
more complications##3##2##(2008-7#1)(2013-1#2)
more comprehensive and##2##3##(1995-2#1)(2013-1#1)
more comprehensive information##2##3##(1993-2#1)(2008-3#1)
more comprehensive##21##2##(1992-11#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
more concentrated in the##2##4##(2008-11#1)(2008-8#1)
more concentrated##6##2##(2008-10#3)(2008-11#2)(2008-8#1)
more concerned with##4##3##(1994-12#1)(1997-1#1)(2009-5#1)(2010-8#1)
more concerned##5##2##(1994-12#1)(1997-1#1)(2008-7#1)(2009-5#1)(2010-8#1)
more conductive than##2##3##(1996-4#2)
more confident##5##2##(2008-11#1)(2008-7#2)(2010-8#1)(2013-7#1)
more conflictual relationships with##2##4##(2008-12#2)
more conflictual##3##2##(2008-12#3)
more confusion##2##2##(2008-11#1)(2013-1#1)
more conidia in##2##3##(2008-10#2)
more conscious about##2##3##(2010-3#1)(2012-3#1)
more conservative##6##2##(1993-6#1)(1994-6#1)(1997-8#1)(2008-10#1)(2009-8#1)(2010-12#1)
more consistent and##2##3##(1996-7#1)(2008-10#1)
more consistent##11##2##(1994-8#1)(1995-5#1)(1996-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-1#1)(2012-12#1)
more consistently##2##2##(2008-9#2)
more controversial##2##2##(2008-2#1)(2010-5#1)
more convenient##6##2##(2008-10#4)(2008-11#1)(2011-2#1)
more conveniently##2##2##(2008-2#1)(2012-12#1)
more conventional##8##2##(1994-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2012-12#1)
more correlated##3##2##(1992-11#1)(2008-3#1)(2013-1#1)
more cost effective##5##3##(1994-1#2)(2008-7#1)(2011-2#2)
more cost##6##2##(1994-1#2)(2007-12#1)(2008-7#1)(2011-2#2)
more cost-effective than##3##3##(1991-2#1)(2008-2#1)(2011-2#1)
more cost-effective##7##2##(1991-2#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
more costly##7##2##(1991-1#1)(1992-3#1)(1993-1#1)(1996-2#1)(2010-10#1)(2010-12#1)(2010-4#1)
more could##2##2##(1994-2#1)(2008-9#1)
more creative##2##2##(1992-12#1)(2013-1#1)
more critical than##2##3##(2008-10#1)(2008-8#1)
more critical##9##2##(1992-12#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
more cytotoxic than##5##3##(1990-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-3#1)
more cytotoxic##7##2##(1990-5#1)(1994-8#1)(1995-3#2)(1996-12#1)(1997-3#1)(2009-9#1)
more damage##2##2##(2008-10#1)(2008-11#1)
more dangerous##2##2##(2008-10#1)(2008-9#1)
more data are available##2##4##(2008-10#1)(2011-2#1)
more data are needed##3##4##(1992-10#1)(2008-11#1)(2011-2#1)
more data are##6##3##(1992-10#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)
more data##9##2##(1992-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#3)(2012-12#1)
more days##5##2##(1993-12#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#1)
more decades##2##2##(1990-2#1)(2013-8#1)
more decisively##2##2##(1993-12#1)(2008-8#1)
more deeply##4##2##(1990-5#1)(1990-7#1)(2008-10#2)
more definitive##5##2##(1991-1#1)(1994-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
more delayed##2##2##(1992-9#1)(2008-10#1)
more deleterious##2##2##(2007-12#1)(2009-11#1)
more demanding##4##2##(1993-12#1)(1996-2#1)(2007-11#1)(2013-1#1)
more dependent on##7##3##(1994-7#1)(1996-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-9#1)(2013-1#1)
more dependent##9##2##(1993-3#1)(1994-7#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-9#1)(2013-1#1)
more depressive symptoms##2##3##(2009-7#2)
more derived##3##2##(2009-8#2)(2011-2#1)
more desirable##3##2##(1995-11#1)(2008-10#1)(2010-12#1)
more detail##21##2##(1990-8#1)(1991-2#1)(1993-9#1)(1995-6#1)(1997-3#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)
more detailed analysis of##2##4##(1995-12#1)(2008-4#1)
more detailed analysis##3##3##(1991-9#1)(1995-12#1)(2008-4#1)
more detailed description of##2##4##(1996-3#1)(2008-4#1)
more detailed information##6##3##(1993-2#1)(1996-3#1)(1997-6#1)(2008-10#1)(2010-3#1)(2011-2#1)
more detailed studies##2##3##(2008-10#1)(2008-8#1)
more detailed understanding of##2##4##(2010-12#1)(2010-2#1)
more detailed##40##2##(1990-6#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-12#2)(1996-3#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-12#3)(2013-8#1)
more detectable##2##2##(1990-5#1)(2008-3#1)
more developed##3##2##(1991-6#1)(1995-3#1)(2010-7#1)
more differentiated##2##2##(1992-9#1)(2008-5#1)
more difficult and##3##3##(2007-7#1)(2008-1#1)(2012-1#1)
more difficult for##2##3##(1997-2#1)(2008-10#1)
more difficult than##5##3##(1992-1#1)(1993-12#1)(2008-7#1)(2010-4#1)(2012-2#1)
more difficult to control##2##4##(2007-6#1)(2011-2#1)
more difficult to estimate##2##4##(1990-9#1)(2008-11#1)
more difficult to##20##3##(1990-3#1)(1990-9#1)(1992-6#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-6#3)(2011-2#1)
more difficult##43##2##(1990-3#1)(1990-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1996-2#1)(1997-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
more diffuse##2##2##(2008-11#1)(2008-3#1)
more diffusely##3##2##(1994-2#1)(2007-12#1)(2011-2#1)
more diluted##2##2##(1997-3#1)(2008-10#1)
more direct##4##2##(1994-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
more directly in##2##3##(1995-12#1)(2013-1#1)
more directly##8##2##(1990-11#1)(1994-2#1)(1995-12#1)(2007-12#2)(2010-8#1)(2011-2#1)(2013-1#1)
more disabled##4##2##(1995-11#1)(2007-10#2)(2013-8#1)
more disease##2##2##(2008-10#2)
more diseased##4##2##(2008-10#4)
more dispersed##2##2##(2008-10#1)(2008-7#1)
more dissatisfied with their##3##4##(2007-12#1)(2008-9#2)
more distal##4##2##(2007-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
more distally##2##2##(2008-9#1)(2010-3#1)
more distant from##2##3##(1992-12#1)(2008-8#1)
more distant##5##2##(1992-12#1)(1993-6#1)(2008-10#1)(2008-8#2)
more distantly related##2##3##(2008-10#2)
more distinct##5##2##(1997-4#1)(2008-10#2)(2011-2#1)(2012-2#1)
more distress##2##2##(2008-12#1)(2008-9#1)
more distributed##2##2##(2011-1#1)(2013-1#1)
more diverse than##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
more diverse##11##2##(1990-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
more diversified##3##2##(2008-2#1)(2011-2#2)
more double##2##2##(1994-11#1)(2011-2#1)
more dramatic##5##2##(1991-12#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
more drastic##2##2##(1992-8#1)(2008-5#1)
more durable##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
more dynamic##3##2##(2008-11#1)(2010-12#1)(2012-3#1)
more easily and##2##3##(2011-2#1)(2012-3#1)
more easily than##3##3##(1997-3#1)(2008-8#1)(2012-2#1)
more easily##19##2##(1990-8#1)(1993-5#1)(1994-1#1)(1994-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
more ecologically##2##2##(2008-11#1)(2013-1#1)
more economical##6##2##(2008-10#2)(2008-11#2)(2008-3#1)(2009-12#1)
more educated##2##2##(1994-6#2)
more education##2##2##(1992-3#1)(2011-1#1)
more effective and##8##3##(1996-3#1)(1997-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
more effective anticancer therapies##2##4##(2009-12#1)(2012-2#1)
more effective at inhibiting##2##4##(2008-10#1)(2008-5#1)
more effective at preventing##3##4##(2008-10#2)(2013-1#1)
more effective at##12##3##(1990-5#1)(2008-10#6)(2008-5#1)(2010-4#1)(2012-3#1)(2013-1#2)
more effective disease##2##3##(2008-10#2)
more effective for##7##3##(1991-3#1)(2008-10#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-2#1)
more effective in preventing##3##4##(1992-9#1)(2006-10#1)(2007-8#1)
more effective in suppressing the##2##5##(2008-10#1)(2008-3#1)
more effective in the##3##4##(1993-8#1)(1995-8#1)(2008-10#1)
more effective in##27##3##(1992-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#4)(2009-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
more effective method to##2##4##(1990-12#1)(2008-10#1)
more effective methods##2##3##(2007-12#1)(2013-1#1)
more effective than others##2##4##(2007-11#1)(2008-7#1)
more effective than that##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
more effective than the other##2##5##(1995-2#1)(2008-11#1)
more effective than the##11##4##(1995-2#2)(1995-9#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
more effective than##60##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
more effective therapy##2##3##(2007-7#1)(2011-2#1)
more effective training##2##3##(1996-12#1)(2008-12#1)
more effective treatment##7##3##(2006-10#1)(2007-8#1)(2008-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
more effective treatments for##2##4##(2008-6#1)(2012-3#1)
more effective use of##2##4##(1993-2#1)(2008-10#1)
more effective with the##2##4##(1993-12#1)(2008-10#1)
more effective with##3##3##(1993-12#1)(2008-10#2)
more effective##210##2##(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#41)(2008-11#8)(2008-12#4)(2008-3#9)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#12)(2013-8#2)
more effectively than the##3##4##(1993-2#1)(1994-8#1)(1997-6#1)
more effectively than##5##3##(1993-2#1)(1994-8#1)(1996-2#1)(1997-6#1)(2010-4#1)
more effectively with##5##3##(1994-3#1)(1995-1#1)(2008-11#1)(2008-6#1)(2013-1#1)
more effectively##27##2##(1991-3#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
more efficacious in##2##3##(2008-8#2)
more efficacious##8##2##(1995-11#2)(2008-10#2)(2008-3#1)(2008-8#2)(2011-2#1)
more efficient and effective##2##4##(2008-2#1)(2012-3#1)
more efficient and##7##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-3#1)
more efficient at##4##3##(1992-11#1)(1994-3#1)(2008-5#1)(2011-2#1)
more efficient for##3##3##(2008-12#2)(2011-2#1)
more efficient in the##2##4##(2008-10#1)(2012-2#1)
more efficient in##8##3##(1992-8#1)(2008-10#3)(2008-3#1)(2009-3#1)(2012-2#1)(2012-3#1)
more efficient than Cartapip 97##2##5##(2008-10#2)
more efficient than the##6##4##(1990-5#1)(2008-10#2)(2009-2#1)(2009-9#2)
more efficient than##24##3##(1990-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#2)(2011-1#1)(2012-3#1)
more efficient use of##2##4##(1995-1#1)(1996-1#1)
more efficient##95##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-9#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)
more efficiently and##4##3##(1997-1#1)(2008-12#1)(2008-7#1)(2009-8#1)
more efficiently than##8##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
more efficiently##31##2##(1991-7#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
more effort##3##2##(1996-11#1)(2008-1#1)(2008-7#1)
more efforts are needed to##2##5##(2007-12#1)(2008-1#1)
more efforts to##2##3##(1995-1#1)(2008-4#1)
more efforts##4##2##(1995-1#1)(2007-12#1)(2008-1#1)(2008-4#1)
more elaborate##6##2##(1992-2#1)(1992-6#1)(1997-3#1)(2007-11#1)(2008-3#1)(2010-1#1)
more emphasis on##3##3##(1995-9#1)(2008-10#1)(2008-3#1)
more emphasis##5##2##(1995-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
more empirical##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-9#1)
more encouraging results##2##3##(2008-8#1)(2010-3#1)
more energy than##2##3##(2008-9#1)(2009-8#1)
more energy##6##2##(2008-9#3)(2009-8#2)(2010-8#1)
more enhanced than##2##3##(2008-10#2)
more enhanced##3##2##(2007-11#1)(2008-10#2)
more episodes of##2##3##(1993-1#1)(1994-6#1)
more equitable##5##2##(1991-1#1)(1995-12#1)(1996-1#1)(2008-11#1)(2010-10#1)
more error##2##2##(2008-2#1)(2008-8#1)
more errors##3##2##(1992-11#1)(1996-5#1)(2008-7#1)
more essential##2##2##(2008-1#1)(2012-2#1)
more established##3##2##(2008-10#2)(2008-3#1)
more even##2##2##(2008-10#1)(2008-8#1)
more evenly##3##2##(1995-2#1)(2007-12#1)(2009-9#1)
more evidence##3##2##(1997-5#1)(2008-8#1)(2012-2#1)
more evident in##4##3##(1992-12#1)(2008-10#2)(2010-7#1)
more evident##9##2##(1992-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-7#1)
more exact##2##2##(2008-2#1)(2008-9#1)
more expensive than##3##3##(1994-12#1)(1996-2#1)(2008-8#1)
more expensive##15##2##(1991-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
more experience##2##2##(1992-2#1)(1996-2#1)
more experienced##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
more experimental##2##2##(2008-11#1)(2009-10#1)
more expert##2##2##(1995-3#1)(2008-11#1)
more explicit##5##2##(1997-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)
more exposed to the sun radiation##2##6##(2011-2#2)
more exposed to the##3##4##(1994-2#1)(2011-2#2)
more exposed to##4##3##(1994-2#1)(2007-2#1)(2011-2#2)
more exposed##5##2##(1994-2#1)(1995-5#1)(2007-2#1)(2011-2#2)
more expressed in##2##3##(2008-7#1)(2010-11#1)
more expressed##4##2##(2008-7#1)(2010-11#1)(2011-1#1)(2012-5#1)
more extended##6##2##(1996-8#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)
more extensive and##2##3##(1996-12#1)(2008-10#1)
more extensive than##2##3##(1994-5#1)(2008-10#1)
more extensive##23##2##(1990-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-3#1)(1996-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#1)
more extensively than##3##3##(2007-12#1)(2008-10#2)
more extensively##9##2##(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2011-1#1)(2012-12#1)
more externalizing problems##2##3##(2008-9#2)
more extreme##2##2##(2008-8#2)
more facile##2##2##(2008-10#1)(2009-12#1)
more familiar with##2##3##(2008-11#1)(2008-7#1)
more familiar##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)
more favorable for##4##3##(1992-3#2)(1993-11#1)(2010-4#1)
more favorable than##2##3##(1991-3#1)(2008-10#1)
more favorable##21##2##(1990-8#1)(1991-3#1)(1991-8#1)(1992-3#2)(1993-11#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2009-4#1)(2010-4#1)(2013-1#2)(2013-8#1)
more favourable##10##2##(1990-9#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
more feasible##3##2##(1997-1#1)(2011-2#2)
more female##4##2##(1993-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
more females than males##3##4##(2008-1#1)(2008-5#1)(2010-4#1)
more females##5##2##(1997-2#1)(2008-1#1)(2008-5#1)(2009-9#1)(2010-4#1)
more fit than##2##3##(2008-10#1)(2013-8#1)
more flexibility in##2##3##(1991-1#1)(2013-8#1)
more flexibility##3##2##(1991-1#1)(2008-10#1)(2013-8#1)
more flexible##9##2##(1992-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#3)
more fluctuations in their tremor at rest##2##7##(2008-7#2)
more fluctuations in their##4##4##(2008-7#4)
more fluctuations in##5##3##(2008-7#5)
more focused on##3##3##(2008-10#2)(2009-8#1)
more focused##7##2##(1994-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
more food##2##2##(2008-7#1)(2009-8#1)
more for##10##2##(1994-1#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#1)
more formally##2##2##(2010-4#1)(2010-8#1)
more freely in##2##3##(1992-1#1)(1995-5#1)
more frequent among##5##3##(1997-3#1)(2008-9#2)(2009-5#1)(2013-8#1)
more frequent and##2##3##(2011-1#1)(2012-3#1)
more frequent daily##2##3##(2009-11#2)
more frequent disease##2##3##(2007-8#1)(2011-1#1)
more frequent in females##2##4##(1996-3#1)(2011-2#1)
more frequent in patients##2##4##(1990-2#1)(2010-3#1)
more frequent in the##4##4##(1991-3#1)(1993-12#1)(2008-3#1)(2011-2#1)
more frequent in women##3##4##(1990-8#1)(1992-5#1)(2013-1#1)
more frequent in##24##3##(1990-2#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-7#1)(1996-3#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
more frequent than expected##2##4##(2008-10#1)(2011-1#1)
more frequent than in##2##4##(1990-6#1)(2007-10#1)
more frequent than##13##3##(1990-6#1)(1994-3#1)(1995-2#1)(1997-3#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-2#2)
more frequent##80##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-3#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-3#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#1)
more frequently as##2##3##(2008-7#1)(2012-2#1)
more frequently associated with##3##4##(2008-7#1)(2013-1#2)
more frequently by##2##3##(1992-8#1)(1996-6#1)
more frequently encountered##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
more frequently from##3##3##(1991-4#1)(2008-10#1)(2008-5#1)
more frequently have##3##3##(2006-10#1)(2011-2#1)(2013-1#1)
more frequently in the##5##4##(1993-6#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
more frequently in##12##3##(1993-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2009-6#1)(2011-2#2)(2012-12#1)
more frequently observed##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
more frequently on the##2##4##(1991-6#1)(2012-3#1)
more frequently performed##2##3##(2007-12#1)(2013-8#1)
more frequently reported##2##3##(2008-8#1)(2013-1#1)
more frequently than females##2##4##(2009-2#1)(2010-3#1)
more frequently than in##2##4##(1994-5#1)(2007-11#1)
more frequently than##16##3##(1990-6#1)(1993-11#1)(1994-5#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
more frequently used##2##3##(2007-8#1)(2011-2#1)
more frequently with##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
more frequently##96##2##(1990-11#1)(1990-12#3)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-7#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-2#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
more from the##4##3##(1990-11#1)(1996-2#1)(1996-6#1)(2008-9#1)
more from##7##2##(1990-11#1)(1996-2#1)(1996-6#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)
more fully##7##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-2#1)
more functional##6##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
more fundamental##5##2##(1993-6#1)(1997-3#1)(2008-3#1)(2009-4#1)(2011-2#1)
more general approach##3##3##(1995-8#1)(2008-3#1)(2009-3#1)
more general##26##2##(1991-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
more generalized##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
more generally##10##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-1#3)(2011-2#1)(2012-2#1)
more generic##2##2##(2008-9#1)(2009-3#1)
more genes##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)
more genetically diverse##2##3##(2008-10#2)
more global##4##2##(2006-6#1)(2007-6#1)(2009-10#1)(2013-1#1)
more gradual##3##2##(1997-4#1)(2008-3#1)(2008-8#1)
more hazardous than##2##3##(1995-5#1)(2008-12#1)
more health care workers##2##4##(2008-10#1)(2011-1#1)
more health care##3##3##(2008-10#1)(2011-1#2)
more help##3##2##(1994-1#2)(1997-2#1)
more high-quality##2##2##(2008-8#1)(2010-11#1)
more highly concentrated##2##3##(2008-10#1)(2008-3#1)
more highly expressed in##2##4##(1997-2#1)(2013-8#1)
more highly phosphorylated##2##3##(1995-2#1)(2010-12#1)
more highly##15##2##(1991-12#1)(1994-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
more holistic##6##2##(2008-11#1)(2009-8#2)(2010-12#1)(2010-8#1)(2012-12#1)
more homogeneous groups of##2##4##(1993-12#1)(2010-12#1)
more homogeneous##8##2##(1990-12#1)(1993-12#1)(2008-10#3)(2009-9#1)(2010-12#1)(2011-2#1)
more homogenous##2##2##(2008-11#1)(2008-5#1)
more hospitals##3##2##(1992-12#1)(1994-1#1)(1995-2#1)
more human##2##2##(2008-9#1)(2012-3#1)
more hydrogen was exhaled##2##4##(1996-6#2)
more hydrophobic##2##2##(1992-6#1)(2008-10#1)
more images##2##2##(2008-12#1)(2008-6#1)
more impaired in##3##3##(2008-12#3)
more impaired than##4##3##(1996-7#1)(2008-12#3)
more impaired##8##2##(1996-7#1)(2008-12#6)(2008-7#1)
more importance in the##2##4##(1997-3#1)(2011-2#1)
more importance##5##2##(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
more important because##2##3##(1992-3#1)(2008-7#1)
more important for##5##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-2#1)
more important in the##2##4##(1991-11#1)(2008-7#1)
more important in##14##3##(1991-11#1)(1995-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
more important ones were Aseptic technique(4##2##6##(1991-2#2)
more important than the##5##4##(1990-7#1)(1994-7#1)(1995-1#1)(2008-11#1)(2008-8#1)
more important than##12##3##(1990-7#1)(1993-1#1)(1994-7#1)(1995-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
more important to##4##3##(1991-7#1)(2008-10#1)(2008-3#1)(2010-8#1)
more important##75##2##(1990-7#1)(1991-11#1)(1991-2#3)(1991-7#1)(1992-3#2)(1993-1#1)(1993-11#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#5)(2009-2#1)(2009-3#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#4)(2013-8#3)
more importantly##14##2##(1992-4#1)(1995-2#1)(1995-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
more improvement##3##2##(1990-5#1)(2008-10#1)(2011-2#1)
more in patients##2##3##(1992-12#1)(1994-7#1)
more in the##7##3##(1994-8#1)(1995-2#1)(2007-7#1)(2008-10#1)(2011-3#1)(2012-12#1)(2013-8#1)
more in##31##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-2#1)(1994-7#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
more in-depth##4##2##(1993-2#1)(2008-10#1)(2011-1#1)(2013-1#1)
more inappropriate##2##2##(1993-1#2)
more inclined##2##2##(2010-6#1)(2012-2#1)
more inclusive##2##2##(2010-2#1)(2013-1#1)
more individual##2##2##(2009-10#1)(2011-7#1)
more individualistic##3##2##(1996-2#1)(2008-5#1)(2010-12#1)
more individualized##3##2##(1992-8#1)(2008-11#1)(2010-12#1)
more individuals##2##2##(2008-8#1)(2008-9#1)
more infected##2##2##(2008-10#2)
more infection##2##2##(2007-7#1)(2008-10#1)
more information about the##3##4##(1995-5#1)(2008-12#1)(2008-3#1)
more information about##11##3##(1994-1#1)(1995-5#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)
more information from##2##3##(2008-1#1)(2008-12#1)
more information is##3##3##(1996-1#1)(2008-12#1)(2009-5#1)
more information on the##2##4##(1996-3#1)(1997-7#1)
more information##29##2##(1993-2#1)(1994-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-8#1)
more informative##5##2##(2008-10#3)(2008-11#1)(2008-6#1)
more informed##4##2##(1993-12#1)(1993-2#1)(1997-3#1)(2012-3#1)
more inhibitory than the##2##4##(1997-1#1)(2008-10#1)
more inhibitory than##4##3##(1997-1#1)(2008-10#2)(2008-11#1)
more injuries##2##2##(2012-1#1)(2013-1#1)
more insight into the##5##4##(1991-6#1)(1994-8#1)(2008-10#2)(2008-11#1)
more insight##6##2##(1991-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2009-4#1)
more intense for##2##3##(2008-10#1)(2012-2#1)
more intense in##3##3##(1993-11#1)(1996-12#1)(2012-7#1)
more intense##25##2##(1991-6#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-7#2)(2013-1#1)
more intensive##10##2##(1994-3#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-8#2)(2011-2#3)(2013-1#1)
more interested in##3##3##(1997-8#1)(2010-8#1)(2011-2#1)
more internal##6##2##(1994-11#2)(1995-12#1)(1996-1#1)(2008-10#1)(2013-1#1)
more into##2##2##(1992-1#1)(1993-12#1)
more invasive than##2##3##(1997-3#1)(2011-2#1)
more invasive##4##2##(1997-3#1)(2007-8#1)(2010-12#1)(2011-2#1)
more investigation##2##2##(2008-10#1)(2013-1#1)
more involved in the##3##4##(1991-12#1)(2007-2#1)(2011-1#1)
more involved##4##2##(1991-12#1)(2007-2#1)(2008-10#1)(2011-1#1)
more is##3##2##(2007-8#1)(2011-2#2)
more isolated##2##2##(1994-5#1)(2013-7#1)
more job##2##2##(2008-6#1)(2013-1#1)
more knowledge about##2##3##(1993-12#1)(2008-8#1)
more knowledge##3##2##(1993-12#1)(1993-2#1)(2008-8#1)
more knowledgeable##2##2##(1993-1#1)(2007-10#1)
more known##2##2##(2013-8#2)
more liberal##3##2##(1995-5#1)(1997-8#1)(2007-12#1)
more light on the##3##4##(1992-9#1)(1997-3#1)(2008-1#1)
more light on##4##3##(1992-9#1)(1997-3#1)(2008-1#1)(2008-8#1)
more light##5##2##(1992-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-8#1)
more like a##2##3##(1992-4#1)(1996-5#1)
more like##5##2##(1992-4#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-12#1)
more likely in##2##3##(2008-8#1)(2008-9#1)
more likely than men to##3##5##(2008-12#2)(2008-4#1)
more likely than##16##3##(1990-3#1)(1991-8#1)(1993-1#1)(1993-8#1)(2007-10#1)(2008-12#5)(2008-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
more likely that##3##3##(1991-2#1)(1994-12#1)(2008-5#1)
more likely to achieve##3##4##(2007-2#1)(2009-7#1)(2013-1#1)
more likely to affect##2##4##(2008-8#1)(2013-8#1)
more likely to be admitted to##2##6##(1996-3#1)(2007-12#1)
more likely to be assisted by##2##6##(2011-1#2)
more likely to be male##2##5##(2008-11#1)(2013-1#1)
more likely to be married##2##5##(1995-2#1)(2011-2#1)
more likely to be##45##4##(1993-12#2)(1994-3#1)(1995-2#2)(1995-3#1)(1996-3#2)(2007-12#1)(2007-2#2)(2007-4#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#3)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#7)(2013-8#1)
more likely to become##3##4##(1993-12#1)(2008-8#1)(2009-7#1)
more likely to cause##2##4##(1991-12#1)(2008-8#1)
more likely to develop##4##4##(2008-4#1)(2009-7#1)(2010-12#1)(2013-8#1)
more likely to die from##2##5##(2008-4#1)(2009-5#1)
more likely to die##5##4##(1994-7#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-12#1)
more likely to engage in##4##5##(2008-1#1)(2009-7#1)(2011-2#1)(2013-1#1)
more likely to evolve##3##4##(2010-10#2)(2010-3#1)
more likely to experience##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
more likely to have a##3##5##(2007-11#1)(2008-3#1)(2008-6#1)
more likely to have an##2##5##(1991-12#1)(2013-1#1)
more likely to have##20##4##(1991-12#1)(1992-2#1)(1993-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-2#2)(2013-1#3)(2013-8#1)
more likely to involve##2##4##(1997-3#1)(2008-11#1)
more likely to occur in##2##5##(1990-6#1)(2008-10#1)
more likely to occur##3##4##(1990-6#1)(1996-11#1)(2008-10#1)
more likely to possess##2##4##(2008-1#1)(2008-12#1)
more likely to practice##2##4##(2010-11#1)(2013-1#1)
more likely to present with##3##5##(2008-4#1)(2009-11#1)(2011-2#1)
more likely to provide##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
more likely to receive##5##4##(2011-2#2)(2012-3#1)(2013-1#2)
more likely to report multiple##2##5##(2011-1#1)(2011-2#1)
more likely to report##11##4##(1995-12#1)(2008-12#1)(2009-5#3)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
more likely to result##2##4##(2009-2#1)(2010-10#1)
more likely to succeed##2##4##(2008-8#2)
more likely to suffer##3##4##(2009-6#1)(2013-8#2)
more likely to utilize##2##4##(2008-8#2)
more likely to##180##3##(1990-6#1)(1991-12#4)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#4)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#15)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#8)(2009-6#1)(2009-7#5)(2010-10#4)(2010-11#2)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#18)(2013-8#6)
more likely##215##2##(1990-3#1)(1990-6#1)(1991-12#4)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#8)(2008-12#16)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#19)(2008-9#11)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#8)(2009-6#1)(2009-7#5)(2010-10#5)(2010-11#2)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#19)(2013-8#6)
more limited in##2##3##(2011-2#1)(2012-2#1)
more limited##13##2##(1991-1#1)(1992-3#1)(1993-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#2)
more lipophilic##4##2##(1995-3#1)(2008-10#3)
more logical##2##2##(1997-3#1)(2013-1#1)
more malignant##2##2##(1990-2#1)(2008-6#1)
more marked in##3##3##(1990-11#1)(1991-12#1)(2008-10#1)
more marked##10##2##(1990-11#1)(1991-12#2)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
more mature##10##2##(1992-9#1)(1993-12#1)(1995-8#1)(1996-5#2)(2008-4#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
more medial##2##2##(1992-10#1)(2007-12#1)
more medical##2##2##(2008-12#1)(2008-8#1)
more minor##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
more modern##6##2##(1993-2#1)(2008-8#2)(2009-10#1)(2012-2#2)
more motion##2##2##(1993-8#1)(2008-8#1)
more natural resources for fulfillment of##2##6##(1992-3#2)
more natural##5##2##(1992-3#2)(2008-11#1)(2008-9#2)
more needs##2##2##(1995-1#1)(2011-2#1)
more negative than those##2##4##(1995-5#1)(2008-10#1)
more negative than##6##3##(1993-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#2)
more negative##24##2##(1990-5#2)(1991-8#1)(1993-3#1)(1995-5#2)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-1#2)(2010-12#1)(2011-2#1)
more negatively and##3##3##(2007-12#3)
more negatively##5##2##(2007-12#3)(2008-4#1)(2011-1#1)
more new##7##2##(1993-1#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
more noise##2##2##(2008-3#2)
more normal##3##2##(2007-12#1)(2008-7#1)(2009-2#1)
more numerous in##2##3##(1993-12#1)(2008-10#1)
more numerous##8##2##(1993-12#1)(1994-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
more objective and##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
more objective##11##2##(1991-12#1)(1992-3#1)(1993-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)
more obvious##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
more of a problem with##2##5##(2008-9#1)(2012-2#1)
more of a##4##3##(1996-9#1)(2008-9#1)(2009-6#1)(2012-2#1)
more of an##2##3##(2008-11#1)(2008-7#1)
more of the##29##3##(1990-8#1)(1991-9#1)(1992-5#1)(1992-6#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#2)(2010-6#1)(2011-1#1)(2011-2#1)
more of these##9##3##(1994-1#1)(1994-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
more of##51##2##(1990-8#1)(1991-9#1)(1992-5#1)(1992-6#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
more offspring##2##2##(2008-10#1)(2009-8#1)
more often affected##3##3##(1990-6#1)(2007-2#1)(2008-5#1)
more often as##3##3##(2009-12#1)(2011-2#1)(2012-3#1)
more often associated with##2##4##(2008-4#1)(2009-3#1)
more often had##2##3##(1991-11#1)(1994-12#1)
more often in the##3##4##(1994-6#1)(2007-8#1)(2013-1#1)
more often in younger##2##4##(1993-9#1)(2008-4#1)
more often in##15##3##(1990-6#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
more often than the##4##4##(1993-2#1)(1994-12#1)(1997-4#1)(2008-10#1)
more often than##20##3##(1990-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-3#1)
more often with##2##3##(1997-8#1)(2011-2#1)
more often##89##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#4)(2012-3#5)(2012-7#1)(2013-1#8)
more on health##2##3##(1991-3#1)(2013-7#1)
more on the##8##3##(1992-1#2)(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#2)
more on##21##2##(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(1996-3#2)(2008-10#3)(2008-3#1)(2008-5#3)(2008-8#1)(2010-3#1)(2012-2#2)(2013-1#2)(2013-7#1)
more open##4##2##(1990-11#1)(1994-1#1)(2011-2#1)(2013-1#1)
more options##2##2##(1991-1#1)(2008-7#1)
more or less the same##3##5##(2008-10#2)(2009-4#1)
more or less##27##3##(1990-5#1)(1991-2#1)(1992-9#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
more or##28##2##(1990-5#1)(1991-2#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
more ordered##2##2##(2008-10#1)(2008-5#1)
more organic##2##2##(2008-9#1)(2013-7#1)
more oriented##2##2##(1993-2#1)(2011-2#1)
more out of##2##3##(1994-2#1)(2007-8#1)
more painful##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
more participatory##2##2##(1992-1#1)(2008-11#1)
more particularly##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
more pathogenic##4##2##(2008-10#4)
more patient-friendly##2##2##(1997-4#1)(2009-5#1)
more patients achieving##2##3##(2008-3#1)(2008-8#1)
more patients in##2##3##(1991-2#1)(2007-7#1)
more patients with##4##3##(1994-12#1)(1995-10#1)(2008-1#1)(2011-1#1)
more patients##24##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
more people##5##2##(1992-2#1)(1995-1#1)(1996-1#1)(1996-5#1)(2008-3#1)
more peroxidation-resistant membrane composition##2##4##(2009-5#2)
more peroxidation-resistant##3##2##(2009-5#3)
more persistent than those##2##4##(1996-5#1)(2008-8#1)
more persistent than##3##3##(1996-5#1)(2008-7#1)(2008-8#1)
more persistent##5##2##(1996-5#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)
more personalized##4##2##(1992-3#1)(2008-10#1)(2010-4#1)(2013-8#1)
more persons##2##2##(1996-3#1)(1997-2#1)
more phenotypic##2##2##(2008-10#1)(2008-9#1)
more physical activity##2##3##(1994-11#1)(2013-1#1)
more physical symptoms##2##3##(1994-12#1)(2009-12#1)
more physical##8##2##(1993-2#1)(1994-11#1)(1994-12#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#2)
more physically##2##2##(2008-10#1)(2008-3#1)
more pixels##2##2##(2008-3#1)(2012-1#1)
more plausible##2##2##(1994-8#1)(2009-6#1)
more polar##6##2##(1991-5#2)(1993-11#1)(2008-10#1)(2008-7#1)(2010-7#1)
more poorly##2##2##(1993-2#1)(1995-11#1)
more popular among##2##3##(1992-2#1)(2007-11#1)
more popular in the##2##4##(2008-8#1)(2008-9#1)
more popular in##4##3##(1995-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
more popular##7##2##(1992-2#1)(1995-2#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-8#1)
more positive potential##2##3##(2008-10#2)
more positive potentials##2##3##(1990-5#2)
more positive reactions##2##3##(1997-6#1)(2007-7#1)
more positive than##5##3##(1993-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#1)
more positive##31##2##(1990-2#1)(1990-5#2)(1991-3#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-5#2)(2009-6#1)(2010-2#1)(2013-1#3)
more positively##2##2##(2008-12#1)(2008-4#1)
more postoperative complications##2##3##(2008-8#1)(2011-2#1)
more postoperative##3##2##(1995-3#1)(2008-8#1)(2011-2#1)
more potent activity##2##3##(2008-11#1)(2008-5#1)
more potent and more effective##2##5##(1991-12#2)
more potent at##2##3##(1994-8#1)(1996-2#1)
more potent in the##2##4##(1990-12#1)(1992-3#1)
more potent in##8##3##(1990-12#1)(1991-2#1)(1992-3#2)(1995-3#1)(2008-12#1)(2008-3#1)(2008-7#1)
more potent inhibitors of##3##4##(1992-8#1)(2009-9#2)
more potent inhibitors##4##3##(1992-8#1)(2009-9#2)(2012-2#1)
more potent than the parent##2##5##(1990-12#1)(1992-4#1)
more potent than the##3##4##(1990-12#1)(1992-4#1)(1994-5#1)
more potent than##21##3##(1990-12#2)(1991-1#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-4#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1996-2#1)(1996-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
more potent##64##2##(1990-11#1)(1990-12#3)(1990-5#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-3#3)(1996-2#2)(1996-5#1)(1997-7#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-9#2)(2012-12#1)(2012-2#1)(2012-3#1)
more potently##2##2##(1991-12#1)(2011-2#1)
more powerful than##3##3##(2007-11#1)(2009-8#1)(2012-1#1)
more powerful##14##2##(1993-11#1)(1996-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)
more practical##7##2##(1997-7#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-5#1)
more precise and##5##3##(1995-2#1)(2008-10#4)
more precise evaluation of the##2##5##(1994-12#1)(2007-11#1)
more precise evaluation of##3##4##(1994-12#1)(2007-11#1)(2011-7#1)
more precise than##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
more precise##31##2##(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1997-2#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#2)
more precisely the##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
more precisely##17##2##(1990-6#1)(1991-9#1)(1993-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#3)(2009-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
more precision##2##2##(2008-5#1)(2011-2#1)
more predictable##3##2##(2009-3#1)(2012-3#1)(2013-1#1)
more prepared to##2##3##(2008-11#1)(2008-7#1)
more pressing##2##2##(2008-7#1)(2013-8#1)
more prevalent in the##2##4##(2007-2#1)(2011-2#1)
more prevalent in women##2##4##(2008-5#1)(2009-5#1)
more prevalent in##23##3##(1991-1#1)(1994-3#1)(1996-12#2)(2007-2#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
more prevalent than##2##3##(2008-7#1)(2011-2#1)
more prevalent##36##2##(1991-1#1)(1991-6#1)(1993-3#1)(1994-3#1)(1996-12#2)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2010-1#1)(2010-6#1)(2011-2#4)(2012-12#3)(2013-1#1)
more problems than##2##3##(1992-1#1)(1994-3#1)
more problems##4##2##(1990-12#1)(1992-1#1)(1994-2#1)(1994-3#1)
more productive sites##2##3##(2008-9#2)
more productive##6##2##(1991-9#1)(1994-5#1)(1997-1#1)(2008-9#3)
more profound##5##2##(1991-6#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
more prolonged##3##2##(2007-10#1)(2008-1#1)(2008-5#1)
more prominent and##2##3##(2008-11#1)(2008-7#1)
more prominent at##2##3##(2008-10#1)(2012-3#1)
more prominent##12##2##(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2012-3#1)
more promising strategy##2##3##(2008-10#1)(2008-5#1)
more promising##8##2##(1992-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)
more prone to##3##3##(2007-7#1)(2008-4#1)(2011-2#1)
more pronounced after##2##3##(2008-7#2)
more pronounced among##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
more pronounced at##9##3##(1991-2#1)(1992-11#1)(2008-10#5)(2008-2#1)(2008-5#1)
more pronounced in the case of##2##6##(1995-12#1)(2008-7#1)
more pronounced in the##6##4##(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-3#1)
more pronounced in##21##3##(1993-2#2)(1993-5#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)
more pronounced with##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
more pronounced##52##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)
more protective##3##2##(2011-2#3)
more protein##3##2##(1991-6#1)(2008-10#1)(2008-11#1)
more protracted##2##2##(1992-4#1)(2009-7#1)
more proximal##4##2##(2007-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
more proximally##2##2##(1992-11#1)(2008-9#1)
more prudent##2##2##(1997-3#1)(2008-8#1)
more psychological##2##2##(1995-4#1)(2007-12#1)
more quickly and easily##2##4##(2008-12#1)(2008-9#1)
more quickly and##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
more quickly in##3##3##(1993-12#1)(1996-9#1)(2008-2#1)
more quickly than##4##3##(1994-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
more quickly##20##2##(1993-12#1)(1993-2#1)(1994-1#1)(1994-8#1)(1996-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-2#2)
more radical##3##2##(2007-8#1)(2010-5#1)(2012-3#1)
more rapid and##5##3##(1991-6#1)(2007-7#1)(2008-10#2)(2008-9#1)
more rapid recovery##2##3##(1995-5#1)(2012-2#1)
more rapid##30##2##(1991-6#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2012-2#2)(2013-1#1)
more rapidly and more##2##4##(2008-10#1)(2010-8#1)
more rapidly and##9##3##(1991-8#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2010-6#1)(2010-8#1)
more rapidly by the##2##4##(1992-5#1)(2008-11#1)
more rapidly in##2##3##(1995-3#1)(2008-9#1)
more rapidly than the##2##4##(1992-3#1)(2007-12#1)
more rapidly than##15##3##(1992-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
more rapidly when##2##3##(2008-10#1)(2012-2#1)
more rapidly##47##2##(1990-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#3)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
more rare##5##2##(1990-6#1)(1991-11#1)(2008-5#1)(2013-1#2)
more rarely##12##2##(1990-3#1)(1990-6#1)(1990-8#1)(1994-9#1)(1995-3#1)(1996-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2012-12#2)
more rational##8##2##(1995-3#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
more rationally##2##2##(1993-12#1)(2008-7#1)
more reactive than##2##3##(1993-8#1)(2008-5#1)
more reactive##5##2##(1993-8#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-12#1)
more readily available##2##3##(2008-5#1)(2008-9#1)
more readily##14##2##(1991-5#1)(1995-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-8#1)
more realistic and##2##3##(2008-10#1)(2011-2#1)
more realistic##16##2##(1993-12#2)(1995-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
more reasons##2##2##(2008-3#1)(2008-9#1)
more recent findings##2##3##(1991-2#1)(2011-2#1)
more recent##27##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
more recently and##2##3##(2008-9#1)(2009-12#1)
more recently been##3##3##(1995-2#1)(1997-8#1)(2008-7#1)
more recently developed##2##3##(2008-9#1)(2012-2#1)
more recently##39##2##(1991-12#1)(1994-1#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
more receptive##3##2##(1994-9#1)(2010-11#1)(2010-8#1)
more reduction in##2##3##(2010-4#2)
more reference##2##2##(2008-2#1)(2008-5#1)
more refined##4##2##(1990-8#1)(1997-8#1)(2011-1#1)(2012-7#1)
more regular##2##2##(2008-7#1)(2008-8#1)
more regularly##3##2##(1993-11#1)(2011-1#1)(2012-2#1)
more related to the##3##4##(1991-5#1)(1997-6#1)(2008-8#1)
more related to##7##3##(1991-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
more related##8##2##(1991-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-12#1)
more relevant##5##2##(1990-3#1)(1990-9#1)(1993-2#1)(1995-5#1)(2008-10#1)
more reliable and##5##3##(1997-4#1)(2008-10#2)(2008-6#1)(2008-8#1)
more reliable for##2##3##(2007-11#1)(2008-5#1)
more reliable than##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2010-6#1)
more reliable##25##2##(1992-1#1)(1993-12#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
more reliably##2##2##(2008-7#1)(2008-8#1)
more religious##2##2##(2009-7#2)
more remarkable##4##2##(1997-2#1)(2007-6#1)(2008-10#1)(2008-11#1)
more representative##2##2##(2008-10#1)(2008-6#1)
more reproducible##5##2##(1997-2#1)(2008-10#2)(2008-4#1)(2008-7#1)
more research in##3##3##(2008-2#1)(2008-4#1)(2010-3#1)
more research is needed to further##2##6##(2008-11#1)(2012-2#1)
more research is needed to##5##5##(1994-2#1)(2008-11#2)(2012-12#1)(2012-2#1)
more research is needed##8##4##(1994-2#1)(2008-11#3)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
more research##21##2##(1992-12#1)(1993-1#1)(1994-2#1)(1995-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
more resistant than##10##3##(1990-12#1)(1990-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
more resistant to the##2##4##(1996-5#1)(2008-10#1)
more resistant to##22##3##(1993-12#1)(1994-2#1)(1994-5#1)(1996-5#1)(1997-4#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)
more resistant##39##2##(1990-12#1)(1990-2#2)(1993-12#1)(1994-2#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-4#2)(2007-12#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
more resources and##2##3##(2008-10#1)(2012-2#1)
more resources to##3##3##(1992-1#1)(2008-8#2)
more resources##9##2##(1992-1#1)(2007-7#1)(2008-10#1)(2008-8#2)(2008-9#2)(2009-5#1)(2012-2#1)
more respiratory##3##2##(1997-2#1)(2007-8#1)(2012-2#1)
more responsibility for##3##3##(1994-2#1)(2008-11#1)(2008-6#1)
more responsive to the##5##4##(1995-3#1)(1995-8#1)(1996-3#1)(2008-9#1)(2013-8#1)
more responsive to##10##3##(1993-12#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#2)(2008-9#1)(2012-2#1)(2013-8#1)
more restricted##2##2##(2008-10#1)(2008-5#1)
more restrictive##5##2##(1995-3#1)(1995-5#1)(1997-5#1)(2008-2#1)(2010-8#1)
more rigid and##2##3##(2008-10#1)(2008-4#1)
more rigid##7##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)
more rigorous##10##2##(1991-11#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-5#2)(2013-8#1)
more rigorously##2##2##(2008-7#1)(2011-2#1)
more robust and##3##3##(2008-11#1)(2008-3#2)
more robust than##2##3##(2008-10#1)(2008-11#1)
more robust##17##2##(1994-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2012-3#1)
more root##2##2##(2008-10#2)
more routine##2##2##(1993-9#1)(2008-9#1)
more rural##2##2##(2007-2#1)(2012-1#1)
more salient##4##2##(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
more satisfied than Asians##2##4##(2012-2#2)
more satisfied than##3##3##(2009-11#1)(2012-2#2)
more satisfied with their##4##4##(1993-3#1)(1996-9#1)(2007-1#2)
more satisfied with##5##3##(1993-3#1)(1996-3#1)(1996-9#1)(2007-1#2)
more satisfied##8##2##(1993-3#1)(1996-3#1)(1996-9#1)(2007-1#2)(2009-11#1)(2012-2#2)
more scientific##4##2##(1993-3#2)(2008-12#1)(2009-4#1)
more secure##3##2##(1995-2#1)(2008-11#1)(2008-12#1)
more selective for##2##3##(1995-12#1)(1995-6#1)
more selective in##2##3##(1995-6#1)(2009-6#1)
more selective##17##2##(1990-2#1)(1995-11#1)(1995-12#1)(1995-6#2)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#1)
more selectively##3##2##(2008-10#2)(2008-5#1)
more sensible##2##2##(2009-4#1)(2011-2#1)
more sensitive and less time-consuming than the##2##7##(1992-6#1)(1993-9#1)
more sensitive and less##3##4##(1992-6#1)(1993-9#1)(2008-10#1)
more sensitive and##9##3##(1990-12#1)(1992-6#2)(1993-9#1)(2008-10#3)(2008-2#1)(2011-2#1)
more sensitive diagnostic##2##3##(2006-10#1)(2011-2#1)
more sensitive for##2##3##(2008-10#1)(2008-11#1)
more sensitive methods##2##3##(2008-4#1)(2011-2#1)
more sensitive than a##3##4##(2008-10#2)(2008-11#1)
more sensitive than the##9##4##(1994-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2011-2#1)
more sensitive than##42##3##(1990-12#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-12#1)(1996-8#2)(1997-4#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#3)(2012-1#1)
more sensitive to effects of therapy than##2##7##(2008-8#2)
more sensitive to the##11##4##(1991-5#1)(1992-5#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-9#2)(2010-8#1)(2012-2#1)(2013-1#1)
more sensitive to##54##3##(1991-10#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-5#1)(1997-7#1)(2007-10#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#4)(2010-6#1)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
more sensitive##137##2##(1990-12#3)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#2)(2008-10#38)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#4)(2009-3#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#1)
more sensitively##4##2##(1994-12#1)(2007-11#1)(2008-10#1)(2010-4#1)
more serious than##5##3##(1990-6#1)(1992-6#1)(2008-10#2)(2009-7#1)
more serious##18##2##(1990-5#1)(1990-6#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-7#1)(1995-11#1)(1996-11#1)(1997-4#2)(2008-10#2)(2008-2#2)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
more severe adverse##2##3##(2008-11#1)(2008-7#1)
more severe and##5##3##(1991-8#1)(1994-3#1)(1994-5#1)(2008-5#1)(2008-7#1)
more severe at##2##3##(1995-11#1)(2008-5#1)
more severe disease and##2##4##(2008-10#1)(2011-2#1)
more severe disease##5##3##(2008-10#2)(2010-8#1)(2011-2#1)(2013-8#1)
more severe grades##2##3##(2012-2#2)
more severe in##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
more severe symptoms and##2##4##(2008-10#1)(2012-2#1)
more severe symptoms##4##3##(2007-8#1)(2008-10#2)(2012-2#1)
more severe than##3##3##(1992-10#1)(2008-10#1)(2011-2#1)
more severe##64##2##(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-6#1)(2013-1#2)(2013-8#1)
more severely##7##2##(1994-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
more sex##2##2##(2008-5#1)(2012-1#1)
more side effects##2##3##(2007-7#1)(2010-12#1)
more significant than##2##3##(2008-3#1)(2008-9#1)
more significant##16##2##(1995-6#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
more significantly by##2##3##(2008-10#1)(2008-7#1)
more significantly##4##2##(2008-10#2)(2008-7#1)(2012-1#1)
more similar to each other than##2##6##(1993-6#1)(2008-10#1)
more similar to each other##3##5##(1993-6#1)(2008-10#2)
more similar to the##2##4##(2008-5#1)(2010-4#1)
more similar to##12##3##(1993-6#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-2#1)
more similar##17##2##(1993-6#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)
more simple##3##2##(1994-7#1)(2008-9#1)(2010-8#1)
more simply##2##2##(2008-10#1)(2008-4#1)
more slowly by##2##3##(1991-2#1)(2009-10#1)
more slowly in the##2##4##(1996-12#1)(2008-10#1)
more slowly in##5##3##(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
more slowly than did##3##4##(1994-8#1)(2008-10#1)(2008-6#1)
more slowly than the##3##4##(1993-3#1)(2008-3#1)(2008-9#1)
more slowly than their##2##4##(1995-11#1)(2008-4#1)
more slowly than those##2##4##(1992-9#1)(2008-10#1)
more slowly than##12##3##(1992-9#1)(1993-3#1)(1994-8#1)(1995-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
more slowly##32##2##(1991-2#2)(1991-9#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-7#1)(1994-8#3)(1995-11#1)(1996-12#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)
more so in the##2##4##(2008-5#1)(2013-1#1)
more so in##4##3##(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
more so than##3##3##(2008-10#1)(2009-11#1)(2013-1#1)
more so##14##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
more soluble##2##2##(2008-11#1)(2008-6#1)
more sophisticated and##3##3##(2007-5#1)(2008-11#1)(2008-7#1)
more sophisticated than##2##3##(2010-3#1)(2012-2#1)
more sophisticated##22##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#3)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
more specialized##2##2##(1996-2#1)(2008-10#1)
more species were##2##3##(2011-2#1)(2013-7#1)
more species##12##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-7#2)
more specific and##2##3##(2008-10#1)(2013-8#1)
more specific than##3##3##(1990-2#1)(2008-3#1)(2010-5#1)
more specific##35##2##(1990-2#1)(1991-12#1)(1992-6#1)(1993-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
more specifically##4##2##(1994-8#1)(1995-8#1)(2008-10#1)(2008-6#1)
more stable and##6##3##(1993-11#1)(1994-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)
more stable complexes with##2##4##(2008-10#2)
more stable in##3##3##(1995-2#1)(2008-5#2)
more stable than the##7##4##(1996-2#1)(1997-2#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-8#1)
more stable than##14##3##(1992-11#1)(1994-11#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#1)
more stable with##2##3##(2008-10#1)(2008-3#1)
more stable##64##2##(1990-12#1)(1991-12#1)(1992-11#1)(1993-11#1)(1994-11#2)(1995-12#1)(1995-2#1)(1995-5#4)(1996-2#3)(1997-2#2)(2007-12#2)(2007-5#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2012-3#2)
more steeply declining size distributions##2##5##(2008-9#2)
more steeply##3##2##(2008-3#1)(2008-9#2)
more stem##2##2##(2008-10#1)(2012-5#1)
more strategic##2##2##(1997-1#1)(2008-12#1)
more stress than##2##3##(2008-4#2)
more stress##4##2##(2008-4#2)(2008-6#1)(2013-1#1)
more striking##2##2##(1993-5#1)(2012-2#1)
more stringent than##2##3##(2008-8#1)(2008-9#1)
more stringent##9##2##(1991-6#1)(1996-9#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-11#1)
more strongly associated##2##3##(2008-4#1)(2009-9#1)
more strongly correlated with##3##4##(2008-9#1)(2012-3#2)
more strongly linked to##2##4##(2009-7#1)(2009-8#1)
more strongly related to##3##4##(2009-7#1)(2010-2#1)(2011-2#1)
more strongly than##9##3##(1990-7#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-3#1)(2008-11#2)(2008-12#1)(2009-6#1)
more strongly to##4##3##(2008-10#1)(2008-8#1)(2010-4#2)
more strongly with##2##3##(2008-7#1)(2010-2#1)
more strongly##35##2##(1990-7#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#2)(2012-5#1)(2013-8#1)
more structural information on##2##4##(1991-6#1)(2008-10#1)
more structural##3##2##(1991-6#1)(1996-12#1)(2008-10#1)
more structure##2##2##(2006-12#1)(2008-2#1)
more structured##3##2##(1996-3#1)(2008-1#1)(2011-2#1)
more studies are##2##3##(2008-2#1)(2012-2#1)
more studies##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#2)
more subtle##7##2##(1991-2#1)(1996-2#1)(1997-2#1)(2007-5#1)(2008-3#1)(2009-9#1)(2012-12#1)
more successful in##2##3##(1994-2#1)(2007-2#1)
more successful##12##2##(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-3#2)(2007-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
more successfully##3##2##(1995-12#1)(1996-3#1)(2011-2#1)
more such##3##2##(2006-4#1)(2007-5#1)(2008-3#1)
more suitable for the##2##4##(2008-10#1)(2010-7#1)
more suitable for##12##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#2)(2010-7#1)(2011-2#1)(2013-1#1)
more suitable than##2##3##(1990-5#1)(2008-8#1)
more suitable##22##2##(1990-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
more suited to##3##3##(2006-10#1)(2008-9#1)(2009-10#1)
more suited##4##2##(2006-10#1)(2008-2#1)(2008-9#1)(2009-10#1)
more support for##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
more supportive##6##2##(1991-2#1)(1997-2#1)(2009-7#2)(2010-1#1)(2011-1#1)
more suppressive##2##2##(2008-10#2)
more susceptible to infection##2##4##(2008-10#1)(2009-5#1)
more susceptible to the##3##4##(1992-11#1)(2008-10#1)(2012-1#1)
more susceptible to##32##3##(1990-7#1)(1991-12#1)(1992-11#2)(1992-3#1)(1994-11#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
more susceptible##38##2##(1990-7#1)(1991-12#1)(1992-11#2)(1992-3#1)(1994-11#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
more sustained##2##2##(1994-2#1)(2008-4#1)
more symptoms##4##2##(1992-6#1)(1995-6#1)(1995-8#1)(2008-4#1)
more systematic##6##2##(1995-2#1)(1997-2#1)(2008-5#1)(2010-1#1)(2013-1#2)
more systemic##2##2##(2008-8#1)(2012-3#1)
more tailored##3##2##(2007-10#1)(2010-12#1)(2011-1#1)
more targeted##4##2##(1991-2#1)(2008-7#2)(2011-2#1)
more technical##2##2##(1992-2#1)(2008-10#1)
more than 0##7##3##(2008-10#3)(2008-5#1)(2008-6#1)(2013-8#2)
more than 1 order of magnitude larger than##2##8##(2007-12#1)(2008-3#1)
more than 1 order of magnitude##4##6##(2007-12#1)(2008-3#3)
more than 1 year##6##4##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)
more than 1##33##3##(1990-7#1)(1993-6#1)(1994-2#1)(1997-4#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
more than 1% of##2##4##(1991-12#1)(2009-4#1)
more than 1%##3##3##(1991-12#1)(2007-12#1)(2009-4#1)
more than 10 dB##2##4##(2007-12#2)
more than 10 days##3##4##(2008-10#2)(2008-11#1)
more than 10 times##2##4##(1994-11#1)(2008-8#1)
more than 10##21##3##(1990-8#1)(1990-9#1)(1994-11#1)(1995-6#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#2)
more than 10%##4##3##(1991-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
more than 10-fold##5##3##(1990-7#1)(1992-3#1)(1996-3#1)(2008-10#2)
more than 100 different##3##4##(2008-7#1)(2011-2#2)
more than 100 years##3##4##(2008-10#1)(2008-7#1)(2010-5#1)
more than 100##28##3##(1992-9#1)(1993-2#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
more than 1000##5##3##(1991-12#1)(1994-12#1)(1995-5#1)(2007-12#1)(2013-1#1)
more than 11##2##3##(1993-12#1)(1996-12#1)
more than 110##2##3##(1992-8#1)(2011-2#1)
more than 12##9##3##(1990-12#1)(1991-11#1)(1992-4#1)(1996-6#1)(2008-11#2)(2008-2#1)(2008-8#1)(2012-2#1)
more than 15 years##4##4##(2008-10#2)(2012-2#1)(2013-1#1)
more than 15##7##3##(2008-10#3)(2008-9#2)(2012-2#1)(2013-1#1)
more than 15% of##3##4##(1997-6#1)(2008-9#1)(2013-1#1)
more than 15%##5##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-9#1)(2013-1#1)
more than 150##5##3##(1991-11#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
more than 1500##2##3##(2007-12#1)(2008-5#1)
more than 18##3##3##(2008-1#1)(2009-10#1)(2013-1#1)
more than 2 times##2##4##(2008-11#1)(2008-6#1)
more than 2##22##3##(1993-9#1)(1994-3#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-6#2)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
more than 2% of##2##4##(1994-6#1)(2012-12#1)
more than 20 years##8##4##(1991-2#1)(1993-3#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#2)
more than 20##27##3##(1990-2#2)(1991-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
more than 20% of the##2##5##(1992-5#1)(2007-11#1)
more than 20%##3##3##(1992-5#1)(1996-3#1)(2007-11#1)
more than 20-fold##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
more than 200 patients##3##4##(1996-3#2)(1997-8#1)
more than 200##13##3##(1993-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-1#1)
more than 2000##3##3##(1995-12#1)(2008-3#1)(2011-2#1)
more than 24 h##2##4##(2008-10#1)(2008-11#1)
more than 24##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
more than 25 years##4##4##(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
more than 25##7##3##(1990-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)
more than 25%##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
more than 250##2##3##(2008-10#1)(2008-3#1)
more than 28##2##3##(1993-2#1)(2008-10#1)
more than 3 mm in diameter##2##6##(2007-8#2)
more than 3 months##8##4##(1991-8#1)(2007-11#1)(2008-10#5)(2008-5#1)
more than 3##16##3##(1991-8#1)(1994-2#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
more than 30 years ago##2##5##(2007-6#1)(2011-2#1)
more than 30 years##8##4##(1996-11#1)(2007-6#1)(2008-6#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
more than 30##19##3##(1992-8#1)(1994-3#1)(1996-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#2)
more than 30% of##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
more than 30%##5##3##(1995-6#1)(2007-4#1)(2008-11#1)(2011-2#1)(2013-1#1)
more than 300##7##3##(1997-3#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
more than 3000##2##3##(1997-6#1)(2012-2#1)
more than 350##5##3##(2007-8#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-5#1)
more than 4 days##2##4##(1992-7#1)(2013-1#1)
more than 4##14##3##(1990-12#1)(1992-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-1#1)
more than 40 years ago##2##5##(2010-3#1)(2012-1#1)
more than 40 years##3##4##(2010-3#1)(2012-1#1)(2012-2#1)
more than 40##9##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-3#2)(2012-1#1)(2012-2#1)
more than 40% of##3##4##(2008-3#1)(2010-10#1)(2013-1#1)
more than 40%##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
more than 400##3##3##(2008-1#1)(2008-10#2)
more than 48##2##3##(1993-12#1)(2008-10#1)
more than 5 orders of magnitude##2##6##(2007-12#1)(2008-2#1)
more than 5 times##2##4##(2008-11#1)(2008-8#1)
more than 5 years##5##4##(1990-6#1)(1991-6#1)(1991-8#1)(1995-2#1)(2008-6#1)
more than 5##14##3##(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
more than 5%##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
more than 50 and##2##4##(2008-10#2)
more than 50 years##2##4##(2008-10#1)(2011-3#1)
more than 50##19##3##(1990-2#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-12#2)
more than 50% of the##8##5##(1994-11#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
more than 50% of##15##4##(1990-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
more than 50%##30##3##(1990-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-6#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-3#1)
more than 50-fold##2##3##(1997-8#1)(2008-10#1)
more than 500##3##3##(1993-2#1)(1993-3#1)(2008-8#1)
more than 6 months##5##4##(1991-2#1)(2008-10#3)(2012-12#1)
more than 6##12##3##(1991-2#1)(1993-12#1)(2007-12#2)(2008-10#5)(2008-5#1)(2012-12#1)(2012-2#1)
more than 60##10##3##(1991-12#1)(1994-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
more than 60% of the##4##5##(1990-12#1)(1996-10#1)(1997-4#1)(2012-12#1)
more than 60% of##7##4##(1990-12#1)(1996-10#1)(1997-4#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
more than 60%##11##3##(1990-12#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
more than 600##4##3##(2007-12#2)(2010-7#1)(2010-8#1)
more than 65%##2##3##(2008-5#1)(2009-7#1)
more than 70##5##3##(1991-12#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
more than 70% of the##5##5##(2008-10#4)(2008-8#1)
more than 70% of##7##4##(2007-8#1)(2008-10#4)(2008-8#1)(2011-2#1)
more than 70%##8##3##(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)
more than 75 years##3##4##(2007-8#1)(2011-2#2)
more than 75##7##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
more than 75%##2##3##(2011-1#1)(2011-3#1)
more than 80 years##3##4##(1995-11#1)(2012-2#1)(2013-1#1)
more than 80##6##3##(1995-11#1)(1996-3#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
more than 80% of the##3##5##(1993-6#1)(1995-2#1)(2010-8#1)
more than 80% of##8##4##(1993-6#1)(1995-2#1)(2007-2#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)
more than 80%##13##3##(1993-6#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
more than 800##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
more than 85% of##2##4##(2008-10#1)(2008-8#1)
more than 9##3##3##(1993-3#1)(2011-1#1)(2013-1#1)
more than 90##4##3##(1993-12#1)(2008-10#2)(2013-1#1)
more than 90% at##2##4##(2008-10#2)
more than 90% in##2##4##(1992-12#1)(1997-4#1)
more than 90% of the##9##5##(1991-12#1)(1993-11#1)(1994-9#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
more than 90% of##17##4##(1991-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#2)
more than 90%##26##3##(1991-12#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#3)(2013-7#1)
more than 95% of the##2##5##(2008-10#1)(2008-6#1)
more than 95% of##6##4##(1992-8#1)(2008-10#2)(2008-6#2)(2012-2#1)
more than 95%##10##3##(1991-5#1)(1992-8#1)(2008-10#4)(2008-2#1)(2008-6#2)(2012-2#1)
more than 97%##3##3##(2008-10#2)(2009-5#1)
more than 98%##3##3##(1993-11#1)(2008-10#1)(2008-2#1)
more than 99%##3##3##(1996-12#1)(2012-12#1)(2012-2#1)
more than a 3-fold##2##4##(1990-7#1)(2008-10#1)
more than a century ago##2##5##(1997-3#1)(2008-3#1)
more than a century##10##4##(1992-5#1)(1994-3#2)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#2)(2013-8#1)
more than a decade ago##2##5##(2009-3#1)(2012-2#1)
more than a decade of##2##5##(2011-2#1)(2013-1#1)
more than a decade##9##4##(1993-12#1)(1994-12#1)(1996-2#1)(1996-5#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
more than a factor of##4##5##(1990-8#1)(1997-2#1)(2008-10#2)
more than a few nanometers##2##5##(2007-12#1)(2008-10#1)
more than a single##2##4##(2008-3#1)(2011-1#1)
more than a thousand##2##4##(1992-6#1)(2008-7#1)
more than a year##2##4##(2010-10#1)(2012-3#1)
more than a##47##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-3#2)(1994-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-3#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
more than adequate##2##3##(1992-12#1)(2008-5#1)
more than an exotic##2##4##(2007-2#2)
more than an order-of-magnitude##2##4##(2007-11#1)(2007-12#1)
more than an##10##3##(1991-11#1)(1997-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2008-3#1)
more than any##2##3##(2008-10#1)(2008-8#1)
more than compensated for##2##4##(2008-8#1)(2008-9#1)
more than did##5##3##(2008-10#1)(2008-11#1)(2009-11#2)(2009-4#1)
more than do##2##3##(2007-12#2)
more than double that of##2##5##(1994-6#1)(2008-1#1)
more than doubled in##3##4##(1991-9#1)(1992-3#1)(2008-12#1)
more than doubled##7##3##(1990-8#1)(1991-9#1)(1992-3#1)(1995-11#1)(1996-12#1)(2008-12#1)(2011-1#1)
more than eight##3##3##(1990-2#1)(1992-5#1)(2008-10#1)
more than ever##2##3##(2012-3#1)(2013-1#1)
more than females##2##3##(2008-11#1)(2012-12#1)
more than five##5##3##(1990-7#1)(1996-3#1)(2008-10#2)(2008-2#1)
more than forty##2##3##(2008-11#1)(2008-9#1)
more than four primary##2##4##(1990-12#2)
more than four##11##3##(1990-12#2)(1992-4#1)(2008-10#2)(2008-4#1)(2011-2#2)(2012-12#2)(2012-3#1)
more than half of the patients##2##6##(2007-12#1)(2012-3#1)
more than half of the units##2##6##(1995-6#2)
more than half of the##11##5##(1991-5#1)(1995-6#2)(1996-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-3#1)
more than half of whom were##2##6##(2009-7#1)(2013-1#1)
more than half of##19##4##(1991-5#1)(1995-6#2)(1996-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
more than half the##6##4##(1990-11#1)(1992-11#1)(1994-12#1)(1997-4#1)(2011-2#1)(2013-1#1)
more than half##31##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-12#1)(1995-6#2)(1996-10#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
more than in##5##3##(1994-7#1)(2008-12#1)(2011-1#2)(2012-3#1)
more than just a##2##4##(2010-10#1)(2013-8#1)
more than just the##2##4##(2008-11#1)(2011-2#1)
more than just##4##3##(2008-11#1)(2010-10#1)(2011-2#1)(2013-8#1)
more than likely##2##3##(1995-12#1)(2008-10#1)
more than offset by##2##4##(1993-12#1)(1993-3#1)
more than offset##4##3##(1993-12#1)(1993-3#1)(2010-2#2)
more than once##6##3##(1991-8#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-12#1)
more than one developmental##2##4##(1997-6#1)(2009-11#1)
more than one isolate##2##4##(2008-10#2)
more than one of these##2##5##(1997-6#1)(2008-2#1)
more than one reproduction##2##4##(2008-8#2)
more than one type of##2##5##(1991-1#1)(2012-12#1)
more than one year##3##4##(1992-5#1)(2009-12#1)(2010-8#1)
more than one##90##3##(1990-2#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#3)(2007-12#3)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#6)(2013-1#1)(2013-8#1)
more than one-half##2##3##(1994-12#1)(2007-7#1)
more than one-third of the##2##5##(1992-3#1)(1997-2#1)
more than one-third of##3##4##(1992-3#1)(1995-1#1)(1997-2#1)
more than seven##2##3##(2008-10#1)(2012-2#1)
more than six##3##3##(2007-12#1)(2008-1#1)(2008-7#1)
more than ten times##3##4##(1990-6#2)(2008-3#1)
more than ten##9##3##(1990-2#1)(1990-6#2)(1991-11#1)(1994-9#1)(2008-3#2)(2008-8#1)(2008-9#1)
more than that of the control##2##6##(2008-9#1)(2011-2#1)
more than that of the##5##5##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
more than that of##8##4##(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#1)
more than that##11##3##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#1)
more than the control##2##4##(2008-10#1)(2013-1#1)
more than the##19##3##(1994-1#1)(1994-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#2)
more than their##4##3##(1991-3#1)(2007-12#1)(2009-11#2)
more than thirty##2##3##(2007-7#1)(2013-1#1)
more than those##2##3##(2008-8#1)(2013-1#1)
more than three decades##3##4##(1997-1#1)(1997-3#1)(2008-1#1)
more than three months##6##4##(1990-12#2)(1996-3#2)(2007-2#1)(2012-3#1)
more than three##19##3##(1990-12#2)(1992-9#1)(1996-3#2)(1997-1#1)(1997-3#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2012-3#2)(2013-1#1)
more than twenty##2##3##(1993-12#1)(2010-11#1)
more than twice as high##3##5##(2007-12#1)(2008-10#1)(2013-1#1)
more than twice the##6##4##(1990-11#1)(2007-11#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-2#1)
more than twice##12##3##(1990-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
more than two times##2##4##(2007-12#1)(2012-2#1)
more than two years##2##4##(1990-9#1)(2011-2#1)
more than two##17##3##(1990-6#1)(1990-9#1)(1991-9#1)(1994-6#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)
more than twofold##2##3##(2008-10#1)(2009-5#1)
more than##1061##2##(1990-11#2)(1990-12#9)(1990-2#7)(1990-5#1)(1990-6#6)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#3)(1991-11#6)(1991-12#8)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#6)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#4)(1993-11#5)(1993-12#7)(1993-2#7)(1993-3#7)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#9)(1994-3#5)(1994-5#2)(1994-6#6)(1994-7#2)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#13)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#8)(1997-4#7)(1997-6#9)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#16)(2007-12#48)(2007-2#7)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#14)(2008-10#171)(2008-11#37)(2008-12#17)(2008-2#31)(2008-3#33)(2008-4#3)(2008-5#27)(2008-6#17)(2008-7#28)(2008-8#30)(2008-9#23)(2009-10#2)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#6)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#6)(2010-5#5)(2010-7#5)(2010-8#10)(2010-9#1)(2011-1#14)(2011-2#59)(2011-3#6)(2012-1#2)(2012-12#20)(2012-2#23)(2012-3#13)(2012-9#2)(2013-1#35)(2013-7#1)(2013-8#9)
more the##10##2##(1991-6#1)(1994-5#1)(1995-11#1)(2008-5#1)(2010-3#1)(2011-1#2)(2012-12#1)(2013-8#2)
more tightly than##2##3##(1994-5#1)(1996-5#1)
more tightly##4##2##(1994-5#1)(1996-5#1)(2008-9#2)
more time in the##2##4##(1992-3#1)(2009-8#1)
more time in##8##3##(1992-3#1)(2008-7#1)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
more time indoors##2##3##(2008-11#1)(2013-8#1)
more time than##2##3##(1991-6#1)(2008-11#1)
more time to##5##3##(1996-5#1)(2008-5#3)(2008-7#1)
more time with patients##2##4##(1996-9#1)(2011-1#1)
more time with##3##3##(1996-9#1)(2009-9#1)(2011-1#1)
more time##30##2##(1991-6#1)(1992-3#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-7#4)(2009-8#1)(2009-9#2)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
more to the##9##3##(1991-4#1)(1994-12#2)(1995-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-3#1)
more to##25##2##(1991-4#1)(1994-12#2)(1995-1#1)(1995-2#2)(1996-3#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
more tolerant to##3##3##(1996-5#1)(2012-9#1)(2013-7#1)
more tolerant##5##2##(1996-5#1)(2008-10#1)(2008-12#1)(2012-9#1)(2013-7#1)
more total walking##2##3##(2013-1#2)
more total##5##2##(1990-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
more toxic than##4##3##(1990-5#1)(1990-6#1)(2008-10#1)(2008-11#1)
more toxic##8##2##(1990-5#1)(1990-6#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
more toxicity##3##2##(1994-7#1)(1995-4#1)(2008-6#1)
more traditional##10##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2013-1#1)
more training##2##2##(2010-11#1)(2010-8#1)
more troublesome##2##2##(2009-7#1)(2013-8#1)
more trustworthy##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
more typical of##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
more typical##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)
more typically##2##2##(1992-6#1)(2007-4#1)
more uncertain##3##2##(1993-2#1)(2008-5#1)(2010-3#1)
more uniform and##3##3##(2008-10#3)
more uniform##10##2##(1995-3#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-7#1)(2011-2#1)
more uniformly##2##2##(2008-8#1)(2009-10#1)
more unstable than##2##3##(1995-5#1)(2008-10#1)
more unstable##3##2##(1995-5#1)(2007-8#1)(2008-10#1)
more urgent##2##2##(1997-7#1)(2010-1#1)
more useful for##7##3##(1993-9#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)
more useful if##2##3##(2008-10#1)(2011-2#1)
more useful in##2##3##(1991-4#1)(2013-1#1)
more useful than##5##3##(1994-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)
more useful##25##2##(1991-4#1)(1993-2#1)(1993-9#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
more user-friendly##3##2##(1997-8#1)(2009-11#2)
more usually##3##2##(2008-2#1)(2008-7#1)(2009-5#1)
more valid##2##2##(1994-11#1)(2009-4#1)
more valuable##2##2##(2008-11#1)(2008-7#1)
more variability in##2##3##(2008-10#1)(2008-11#1)
more variable among##3##3##(2008-3#2)(2008-9#1)
more variable and##2##3##(2008-10#1)(2012-12#1)
more variable than##2##3##(2007-8#1)(2008-10#1)
more variable##15##2##(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-8#1)(2012-12#1)
more variation##4##2##(1993-12#1)(2008-10#2)(2008-5#1)
more viable##2##2##(2008-1#1)(2013-8#1)
more virulent on##2##3##(2008-10#2)
more virulent than the##2##4##(2008-10#1)(2008-5#1)
more virulent than##7##3##(2008-10#5)(2008-5#1)(2013-1#1)
more virulent##18##2##(2006-6#1)(2008-10#12)(2008-4#1)(2008-5#1)(2008-9#2)(2013-1#1)
more voluminous##2##2##(1996-5#1)(2010-3#1)
more vulnerable to the impact of##2##6##(2007-12#1)(2013-1#1)
more vulnerable to##10##3##(1993-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#2)
more vulnerable##15##2##(1990-2#1)(1993-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
more weakly##6##2##(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-6#1)(2010-7#1)
more weeks##2##2##(2008-9#1)(2012-2#1)
more weight##3##2##(1991-12#1)(2008-3#2)
more were##2##2##(1991-12#1)(1994-12#1)
more when it##2##3##(1996-9#1)(2008-9#1)
more when##6##2##(1994-2#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-6#1)(2008-9#1)
more widely distributed##2##3##(2008-11#1)(2011-2#1)
more widely used##4##3##(1997-1#1)(2008-2#1)(2011-2#1)(2012-3#1)
more widely##11##2##(1990-9#1)(1992-2#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
more widespread than previously##3##4##(1996-3#1)(2008-10#2)
more widespread than##4##3##(1996-3#1)(2008-10#2)(2008-8#1)
more widespread use of##2##4##(2008-11#1)(2013-1#1)
more widespread use##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
more widespread##13##2##(1990-2#1)(1990-6#1)(1991-12#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#3)
more willing to##2##3##(2008-11#1)(2008-4#1)
more with less##4##3##(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#1)
more with##13##2##(1993-3#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#3)(2011-1#1)
more women##9##2##(1992-2#1)(1993-8#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
more work is needed##2##4##(2008-5#1)(2008-7#1)
more work##5##2##(1992-12#1)(1993-2#1)(2008-5#1)(2008-7#2)
more years of##3##3##(2008-12#1)(2012-12#2)
more years##8##2##(1991-12#3)(1992-10#1)(2008-12#1)(2012-12#2)(2013-1#1)
more you##2##2##(2008-11#2)
more##7188##1##(1990-10#2)(1990-11#19)(1990-12#34)(1990-2#30)(1990-3#10)(1990-4#2)(1990-5#25)(1990-6#22)(1990-7#12)(1990-8#23)(1990-9#12)(1991-1#14)(1991-10#1)(1991-11#19)(1991-12#53)(1991-2#26)(1991-3#22)(1991-4#5)(1991-5#16)(1991-6#28)(1991-7#3)(1991-8#17)(1991-9#23)(1992-1#12)(1992-10#8)(1992-11#21)(1992-12#35)(1992-2#17)(1992-3#49)(1992-4#9)(1992-5#14)(1992-6#22)(1992-7#2)(1992-8#19)(1992-9#23)(1993-1#17)(1993-10#1)(1993-11#30)(1993-12#65)(1993-2#42)(1993-3#35)(1993-5#10)(1993-6#19)(1993-8#16)(1993-9#11)(1994-1#34)(1994-10#1)(1994-11#23)(1994-12#42)(1994-2#56)(1994-3#33)(1994-5#33)(1994-6#22)(1994-7#15)(1994-8#21)(1994-9#14)(1995-1#18)(1995-10#2)(1995-11#24)(1995-12#31)(1995-2#54)(1995-3#32)(1995-4#3)(1995-5#42)(1995-6#20)(1995-8#12)(1995-9#3)(1996-1#17)(1996-10#3)(1996-11#11)(1996-12#42)(1996-2#43)(1996-3#47)(1996-4#7)(1996-5#19)(1996-6#12)(1996-7#6)(1996-8#8)(1996-9#14)(1997-1#28)(1997-2#51)(1997-3#56)(1997-4#31)(1997-5#12)(1997-6#26)(1997-7#19)(1997-8#28)(2006-10#14)(2006-12#3)(2006-4#3)(2006-6#5)(2006-8#2)(2007-1#5)(2007-10#30)(2007-11#57)(2007-12#134)(2007-2#30)(2007-4#9)(2007-5#7)(2007-6#7)(2007-7#38)(2007-8#54)(2007-9#6)(2008-1#99)(2008-10#979)(2008-11#299)(2008-12#141)(2008-2#120)(2008-3#222)(2008-4#95)(2008-5#208)(2008-6#86)(2008-7#205)(2008-8#229)(2008-9#190)(2009-1#2)(2009-10#27)(2009-11#36)(2009-12#22)(2009-2#16)(2009-3#21)(2009-4#20)(2009-5#50)(2009-6#20)(2009-7#48)(2009-8#49)(2009-9#35)(2010-1#27)(2010-10#22)(2010-11#30)(2010-12#46)(2010-2#19)(2010-3#33)(2010-4#44)(2010-5#28)(2010-6#18)(2010-7#31)(2010-8#71)(2010-9#8)(2011-1#106)(2011-2#336)(2011-3#14)(2011-7#6)(2012-1#30)(2012-12#112)(2012-2#162)(2012-3#97)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#7)(2012-8#1)(2012-9#7)(2013-1#257)(2013-7#22)(2013-8#113)
more)##8##1##(1991-6#1)(1991-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
more-accurate##2##1##(2008-3#2)
more-complex##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
more-general##2##1##(2007-12#1)(2008-2#1)
more?##3##1##(1995-11#1)(1995-8#1)(2008-11#1)
moreover##37##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-12#2)(1993-9#1)(1994-2#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#2)
morhua##7##1##(2010-8#7)
mori was##2##2##(2008-5#1)(2008-7#1)
mori##33##1##(1995-11#2)(1995-6#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#7)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)
moribund##9##1##(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#5)
morin##6##1##(2008-10#6)
morin-APSG##2##1##(2008-10#2)
moritzianum##2##1##(2013-7#2)
morning and evening##2##3##(2008-10#1)(2008-5#1)
morning and##4##2##(2008-10#1)(2008-5#2)(2010-5#1)
morning glory##6##2##(2008-8#2)(2008-9#4)
morning hours##5##2##(2008-10#1)(2012-12#1)(2012-5#2)(2013-1#1)
morning leaf wetness##2##3##(2008-10#2)
morning spot##2##2##(2012-2#2)
morning urine sample##2##3##(1996-12#1)(2013-1#1)
morning urine##4##2##(1995-12#1)(1996-12#2)(2013-1#1)
morning##62##1##(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-5#2)(2013-1#3)(2013-7#1)
morningness and##2##2##(2011-2#2)
morosus##5##1##(1992-12#1)(2007-12#4)
morph##10##1##(2007-12#2)(2008-1#1)(2008-5#2)(2008-8#1)(2012-12#4)
morphant##2##1##(2012-12#2)
morphed model##2##2##(2013-1#2)
morphed##6##1##(2012-12#2)(2013-1#4)
morphemes##2##1##(2008-10#1)(2008-2#1)
morphine (10##3##2##(1990-7#1)(1995-5#1)(1997-2#1)
morphine administration##3##2##(1995-12#2)(2007-11#1)
morphine and beta-endorphin##4##3##(1992-3#4)
morphine and noscapine##2##3##(2008-10#2)
morphine and other##2##3##(1995-6#2)
morphine and##18##2##(1991-1#2)(1992-3#4)(1993-12#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#3)(1996-2#1)(2008-10#2)(2008-7#1)
morphine antinociception and##2##3##(1997-2#2)
morphine antinociception##6##2##(1996-2#1)(1997-2#5)
morphine at##2##2##(2008-10#1)(2008-12#1)
morphine concentration##2##2##(2008-10#2)
morphine for##4##2##(1995-11#1)(2007-11#2)(2009-5#1)
morphine in the##4##3##(1991-1#1)(1995-12#1)(1997-2#1)(2008-7#1)
morphine in##11##2##(1991-1#3)(1995-12#1)(1996-2#2)(1997-2#2)(2008-10#2)(2008-7#1)
morphine induction of c-fos and junB in##2##7##(1994-8#2)
morphine induction of##3##3##(1994-8#3)
morphine inhibited##3##2##(2008-12#3)
morphine injections##2##2##(1993-12#2)
morphine levels##3##2##(1995-12#1)(1997-2#2)
morphine on##5##2##(1994-2#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-12#1)
morphine or##2##2##(1993-12#1)(1996-2#1)
morphine sulfate on##2##3##(1996-2#1)(2008-7#1)
morphine sulfate##5##2##(1993-12#1)(1995-11#1)(1996-2#2)(2008-7#1)
morphine tolerance##2##2##(1991-1#1)(2009-7#1)
morphine treatment##2##2##(1995-12#2)
morphine were##4##2##(1990-8#1)(1995-11#2)(2008-12#1)
morphine with##2##2##(2008-10#1)(2009-7#1)
morphine withdrawal##2##2##(1991-1#1)(2008-7#1)
morphine##157##1##(1990-7#2)(1990-8#1)(1991-1#14)(1992-3#5)(1993-12#13)(1994-2#7)(1994-8#3)(1995-11#9)(1995-12#13)(1995-3#1)(1995-5#2)(1995-6#3)(1996-2#20)(1997-2#13)(2007-11#5)(2008-10#16)(2008-11#2)(2008-12#11)(2008-7#9)(2008-8#2)(2009-4#1)(2009-5#1)(2009-7#3)(2012-2#1)
morphine- and stress-induced analgesia##2##4##(1990-7#2)
morphine- and##3##2##(1990-7#3)
morphine-##4##1##(1990-7#3)(1992-3#1)
morphine-induced##5##1##(1991-1#1)(1994-2#1)(1995-5#1)(1997-2#1)(2009-7#1)
morphine-tolerant##2##1##(1991-1#1)(1996-2#1)
morphine-treated##2##1##(1991-5#2)
morphing##4##1##(2008-1#1)(2008-6#1)(2013-1#2)
morphofunctional##3##1##(2008-11#1)(2008-7#1)(2013-1#1)
morphogenesis and growth of the male phallus##2##7##(2008-10#2)
morphogenesis and##8##2##(2008-10#2)(2008-7#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
morphogenesis in##5##2##(2008-10#2)(2009-10#1)(2011-2#1)(2012-12#1)
morphogenesis of the##2##3##(2007-12#2)
morphogenesis of##7##2##(1990-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)
morphogenesis##35##1##(1990-11#1)(1991-5#1)(1992-6#1)(1993-12#1)(1996-3#1)(1996-5#1)(2007-12#4)(2008-10#5)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)
morphogenetic changes##2##2##(2007-12#2)
morphogenetic events##2##2##(1992-6#1)(2008-10#1)
morphogenetic processes##2##2##(1990-8#1)(2009-8#1)
morphogenetic protein##4##2##(1994-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
morphogenetic protein-7##2##2##(2011-2#2)
morphogenetic proteins (BMPs)##4##3##(1994-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
morphogenetic proteins##8##2##(1991-5#1)(1994-12#1)(2007-12#1)(2008-8#1)(2011-2#3)(2012-12#1)
morphogenetic##29##1##(1990-8#1)(1991-5#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-11#1)(2007-12#4)(2008-10#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#8)(2012-1#1)(2012-12#1)(2013-8#1)
morphogenic proteins##2##2##(2008-8#2)
morphogenic##6##1##(1991-9#1)(1994-8#1)(2008-8#2)(2012-2#1)(2012-3#1)
morpholine##3##1##(1992-8#1)(1994-11#1)(2007-11#1)
morpholine-4-carbodithioates##2##1##(2008-10#2)
morpholine-4-dithiocarbamate##2##1##(2008-10#2)
morphologic abnormalities##2##2##(1993-8#1)(1996-3#1)
morphologic and functional##3##3##(1993-12#1)(2012-3#2)
morphologic and##7##2##(1992-9#1)(1993-12#1)(1996-7#1)(2007-10#1)(2008-10#1)(2012-3#2)
morphologic changes##3##2##(1990-12#1)(1996-3#1)(2008-7#1)
morphologic characteristics##2##2##(2010-12#1)(2010-8#1)
morphologic features##5##2##(1994-8#1)(2007-5#1)(2010-9#1)(2011-2#2)
morphologic forms##2##2##(1991-12#1)(1997-5#1)
morphologic studies##2##2##(1995-6#1)(2009-8#1)
morphologic##47##1##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-8#1)(1995-6#1)(1996-3#2)(1996-7#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#1)(2009-8#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#8)(2012-3#4)
morphological affinities among the##2##4##(2011-2#2)
morphological analysis##5##2##(1997-2#1)(2008-5#2)(2008-9#1)(2012-3#1)
morphological and biochemical changes of Dahlgren cells##2##7##(2008-7#2)
morphological and biochemical changes##3##4##(1996-5#1)(2008-7#2)
morphological and biochemical##5##3##(1992-11#1)(1996-5#1)(2008-11#1)(2008-7#2)
morphological and clinical##2##3##(2007-7#1)(2011-2#1)
morphological and functional##7##3##(1990-11#1)(1991-6#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
morphological and molecular##2##3##(2008-7#1)(2011-1#1)
morphological and physiological traits##2##4##(2008-10#2)
morphological and physiological##8##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)
morphological and ultrastructural changes##3##4##(2008-10#2)(2011-1#1)
morphological and ultrastructural##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
morphological and##54##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#3)(2007-7#2)(2008-10#8)(2008-11#4)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
morphological as well as##2##4##(1991-12#1)(2013-7#1)
morphological aspect of the##2##4##(2007-12#1)(2008-6#1)
morphological aspects of##3##3##(1997-6#1)(2008-7#1)(2009-8#1)
morphological aspects##5##2##(1991-8#1)(1995-3#1)(1997-6#1)(2008-7#1)(2009-8#1)
morphological change##4##2##(1994-8#1)(1995-6#1)(2008-11#2)
morphological changes in the##3##4##(2008-12#2)(2008-5#1)
morphological changes in##13##3##(1991-2#1)(1992-12#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-5#2)(2009-2#1)(2012-3#1)(2013-7#1)
morphological changes induced##2##3##(2008-11#1)(2008-2#1)
morphological changes of the##2##4##(2008-5#1)(2011-1#1)
morphological changes of##5##3##(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
morphological changes that##2##3##(2007-12#1)(2008-10#1)
morphological changes##45##2##(1990-12#1)(1991-2#1)(1992-12#1)(1994-11#1)(1994-6#2)(1994-8#2)(1995-8#2)(1997-3#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#6)(2008-9#2)(2009-2#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
morphological character##2##2##(2008-8#1)(2008-9#1)
morphological characteristics and##3##3##(1994-8#1)(1995-6#1)(2008-12#1)
morphological characteristics of the##5##4##(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
morphological characteristics of##7##3##(1995-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#2)
morphological characteristics##18##2##(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)
morphological characterization##2##2##(2008-10#2)
morphological characters and the##2##4##(1995-6#1)(1996-12#1)
morphological characters of##2##3##(2008-10#1)(2008-5#1)
morphological characters##16##2##(1995-6#1)(1996-12#2)(2008-10#4)(2008-5#2)(2008-7#1)(2009-8#1)(2010-3#2)(2011-2#1)(2013-1#2)
morphological correlation is##3##3##(2008-3#3)
morphological correlation##10##2##(2008-2#2)(2008-3#8)
morphological correlator##2##2##(2008-2#2)
morphological criteria##12##2##(1996-6#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#3)
morphological damage##2##2##(1994-11#2)
morphological data##3##2##(2008-7#1)(2008-8#1)(2009-10#1)
morphological differences##3##2##(2008-10#1)(2010-10#1)(2012-5#1)
morphological differentiation of##2##3##(1994-8#1)(2011-2#1)
morphological differentiation##8##2##(1992-6#1)(1993-3#1)(1994-8#1)(1996-5#1)(2009-8#1)(2011-2#2)(2012-3#1)
morphological diversity##2##2##(2008-11#1)(2011-2#1)
morphological evidence that##2##3##(1992-3#1)(1997-4#1)
morphological evidence##3##2##(1992-3#1)(1997-4#1)(2010-10#1)
morphological evolution of##2##3##(2008-3#1)(2010-3#1)
morphological evolution##4##2##(2008-3#2)(2010-3#1)(2010-5#1)
morphological features described##3##3##(2010-8#2)(2013-7#1)
morphological features of the##2##4##(2009-10#1)(2013-1#1)
morphological features of##5##3##(1997-1#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
morphological features that##2##3##(2007-12#1)(2008-5#1)
morphological features which##2##3##(2012-3#1)(2013-1#1)
morphological features##22##2##(1993-3#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-8#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
morphological findings##3##2##(1991-3#1)(1993-12#1)(2007-12#1)
morphological identification##6##2##(2008-10#4)(2008-12#1)(2010-6#1)
morphological index and its related taxonomic traits##2##7##(2008-8#2)
morphological index##3##2##(2008-8#3)
morphological marker##2##2##(2008-10#2)
morphological markers##5##2##(2008-10#3)(2008-8#2)
morphological neuronal differentiation##2##3##(1992-5#2)
morphological observation##2##2##(2008-4#1)(2013-1#1)
morphological or functional##2##3##(1990-11#2)
morphological or##3##2##(1990-11#2)(1997-4#1)
morphological parameters and##2##3##(2008-3#1)(2012-3#1)
morphological parameters of the##2##4##(2008-3#1)(2011-2#1)
morphological parameters##8##2##(1997-8#1)(2008-11#1)(2008-3#2)(2011-2#3)(2012-3#1)
morphological pattern of##2##3##(2011-2#1)(2013-7#1)
morphological pattern##3##2##(2011-2#2)(2013-7#1)
morphological patterns##2##2##(2008-8#2)
morphological plasticity##4##2##(2008-7#1)(2008-8#2)(2010-8#1)
morphological properties and##2##3##(2008-12#1)(2012-12#1)
morphological properties##4##2##(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
morphological responses##2##2##(2008-8#2)
morphological signs of##2##3##(2008-7#1)(2012-1#1)
morphological species##2##2##(2008-10#2)
morphological structure##3##2##(1997-5#1)(2008-3#1)(2008-5#1)
morphological studies##3##2##(2008-6#1)(2010-3#1)(2013-7#1)
morphological study of the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
morphological study##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
morphological traits can##2##3##(2008-10#1)(2008-8#1)
morphological traits of##2##3##(2008-9#1)(2012-9#1)
morphological traits that##2##3##(2008-5#1)(2012-5#1)
morphological traits##10##2##(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2012-3#1)(2012-5#1)(2012-9#1)
morphological transformation in C3H/10T1/2##2##4##(1992-5#2)
morphological transformation of##2##3##(1990-7#1)(1992-5#1)
morphological transformation##6##2##(1990-7#1)(1992-2#1)(1992-5#3)(2008-11#1)
morphological type##2##2##(1991-12#1)(2008-12#1)
morphological types and six VCGs##2##5##(2008-10#2)
morphological types and##3##3##(2008-10#3)
morphological types of the##2##4##(2007-12#1)(2008-12#1)
morphological types of##3##3##(2007-12#2)(2008-12#1)
morphological types##7##2##(1996-6#1)(2007-12#2)(2008-10#3)(2008-12#1)
morphological variability##3##2##(2008-7#1)(2008-9#1)(2013-7#1)
morphological##406##1##(1990-11#5)(1990-12#1)(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#5)(1992-6#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#7)(1994-9#1)(1995-12#1)(1995-3#3)(1995-6#3)(1995-8#3)(1996-12#2)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-12#18)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#54)(2008-11#17)(2008-12#11)(2008-2#9)(2008-3#20)(2008-4#2)(2008-5#23)(2008-6#5)(2008-7#18)(2008-8#25)(2008-9#16)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-8#7)(2010-10#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#6)(2011-2#18)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#10)(2012-5#2)(2012-9#2)(2013-1#10)(2013-7#7)(2013-8#1)
morphologically ambiguous endometrial##2##3##(2011-2#2)
morphologically and functionally##4##3##(1990-12#1)(2006-10#1)(2008-5#1)(2008-6#1)
morphologically and phylogenetically##2##3##(2010-3#2)
morphologically and##13##2##(1990-12#2)(1990-3#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-3#2)
morphologically as##2##2##(2008-10#1)(2008-11#1)
morphologically distinct##8##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-2#1)(2012-3#1)
morphologically indistinguishable from F##2##4##(2008-10#2)
morphologically indistinguishable from##3##3##(2008-10#3)
morphologically indistinguishable##5##2##(2008-10#5)
morphologically mature##2##2##(2008-10#1)(2011-1#1)
morphologically normal cells##2##3##(2011-2#2)
morphologically normal##6##2##(1993-5#1)(2008-10#1)(2011-2#4)
morphologically resembling##2##2##(2008-10#2)
morphologically similar to psittacine beak and feather disease##2##8##(2008-5#2)
morphologically similar to the##2##4##(1997-4#1)(2009-8#1)
morphologically similar to##8##3##(1997-4#1)(2008-10#1)(2008-5#3)(2009-8#1)(2010-3#2)
morphologically similar##19##2##(1997-4#1)(2007-12#1)(2008-10#9)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-3#2)
morphologically##100##1##(1990-12#2)(1990-3#1)(1993-5#1)(1994-2#1)(1995-2#3)(1996-6#1)(1997-4#1)(2006-10#1)(2007-12#4)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-3#6)(2010-4#2)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
morphologies and##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
morphologies as##2##2##(1994-8#1)(2008-3#1)
morphologies of##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
morphologies were##5##2##(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)
morphologies##31##1##(1994-8#2)(1995-6#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
morphology alone##2##2##(2008-10#1)(2010-3#1)
morphology and dynamic##2##3##(2008-3#1)(2008-9#1)
morphology and evolution##2##3##(2007-12#2)
morphology and function##5##3##(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
morphology and its##2##3##(2008-3#1)(2012-2#1)
morphology and the##9##3##(1990-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
morphology and##84##2##(1990-5#1)(1990-8#3)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#10)(2008-1#2)(2008-10#12)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#2)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
morphology are not##2##3##(2008-10#1)(2010-6#1)
morphology are##5##2##(1995-2#1)(1995-6#1)(2008-10#1)(2009-8#1)(2010-6#1)
morphology as well as##2##4##(1990-8#1)(2012-2#1)
morphology as##3##2##(1990-8#1)(1995-6#1)(2012-2#1)
morphology but##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
morphology during##3##2##(1996-6#1)(2008-5#1)(2011-1#1)
morphology for##2##2##(1996-2#1)(2008-10#1)
morphology from##3##2##(2008-11#1)(2009-7#1)(2011-1#1)
morphology has been##2##3##(2008-3#1)(2011-2#1)
morphology has##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
morphology have##2##2##(2011-2#1)(2012-1#1)
morphology in the##2##3##(2008-7#1)(2011-2#1)
morphology in##11##2##(1997-3#1)(2008-11#2)(2008-5#1)(2008-7#3)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)
morphology is##9##2##(2007-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
morphology observed##2##2##(2008-10#1)(2010-8#1)
morphology of a##3##3##(2008-11#1)(2008-7#1)(2009-12#1)
morphology of genetic tumours was##2##5##(2008-7#2)
morphology of the PbO2##2##4##(2008-10#2)
morphology of the cells##2##4##(2008-11#1)(2008-8#1)
morphology of the gland opening##2##5##(2007-12#2)
morphology of the##49##3##(1994-5#1)(1995-12#1)(2007-11#1)(2007-12#11)(2007-8#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-7#1)
morphology of these##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2013-1#1)
morphology of##110##2##(1991-12#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#11)(2007-8#4)(2008-10#22)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#7)(2011-3#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
morphology on the##2##3##(2010-4#1)(2011-2#1)
morphology on##10##2##(1997-8#1)(2008-10#4)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)
morphology or##3##2##(2008-9#1)(2009-11#1)(2010-8#1)
morphology shows##2##2##(2008-5#1)(2009-3#1)
morphology similar##2##2##(1991-6#1)(1994-12#1)
morphology that##2##2##(1994-8#1)(2009-8#1)
morphology through##2##2##(1996-2#1)(2010-8#1)
morphology to##5##2##(1992-12#1)(2008-10#1)(2010-11#1)(2010-4#1)(2011-2#1)
morphology under##2##2##(2012-1#1)(2013-1#1)
morphology was not##2##3##(1996-6#1)(2008-10#1)
morphology was studied##2##3##(1992-2#1)(2013-1#1)
morphology was##11##2##(1992-2#1)(1994-8#1)(1996-6#2)(2008-10#3)(2008-8#1)(2011-2#1)(2013-1#2)
morphology were observed##2##3##(1994-5#1)(2008-10#1)
morphology were##7##2##(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
morphology with##2##2##(2011-2#1)(2013-1#1)
morphology##451##1##(1990-5#1)(1990-8#5)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#4)(1995-12#2)(1995-2#1)(1995-6#5)(1995-9#1)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#4)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#4)(2007-11#4)(2007-12#25)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#73)(2008-11#27)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#25)(2008-6#5)(2008-7#24)(2008-8#19)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#1)(2009-7#6)(2009-8#10)(2010-10#2)(2010-11#2)(2010-3#4)(2010-4#6)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#9)(2011-1#5)(2011-2#22)(2011-3#1)(2012-1#8)(2012-12#4)(2012-2#8)(2012-3#4)(2012-7#2)(2013-1#20)(2013-7#3)(2013-8#5)
morphology)##2##1##(2008-10#1)(2009-7#1)
morphology-dependent##2##1##(2008-3#1)(2010-4#1)
morphometric analysis of##2##3##(2007-12#1)(2008-6#1)
morphometric analysis##4##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-6#1)
morphometric and stereological studies##2##4##(2008-5#2)
morphometric and stereological##4##3##(2007-12#1)(2008-5#3)
morphometric and##7##2##(2007-12#1)(2008-5#4)(2008-7#1)(2011-2#1)
morphometric data##2##2##(2008-7#2)
morphometric indices##4##2##(2008-12#2)(2008-7#2)
morphometric methods##3##2##(2007-12#2)(2012-3#1)
morphometric parameters##4##2##(1996-5#1)(2008-7#2)(2013-7#1)
morphometric relationships##2##2##(2013-7#2)
morphometric study of##3##3##(1995-6#1)(2012-3#2)
morphometric##46##1##(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#3)(2006-6#1)(2007-11#1)(2007-12#5)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#7)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-7#8)(2013-8#2)
morphometry and##4##2##(1995-6#1)(2008-7#1)(2009-12#1)(2013-1#1)
morphometry in##3##2##(1994-8#1)(2007-12#1)(2009-9#1)
morphometry of##5##2##(1996-2#1)(1997-5#1)(2011-2#2)(2013-1#1)
morphometry##26##1##(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#3)(1997-2#3)(1997-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#2)(2011-2#3)(2013-1#4)(2013-8#1)
morphospecies##6##1##(2007-12#1)(2008-6#4)(2013-7#1)
morphotype A##6##2##(2008-10#6)
morphotype##8##1##(1991-11#1)(2008-10#7)
morphotypes were##2##2##(2013-1#2)
morphotypes##9##1##(2008-10#1)(2010-8#2)(2013-1#4)(2013-7#2)
morphs##6##1##(2008-1#1)(2008-8#1)(2008-9#1)(2012-12#3)
morsellized bone graft##2##3##(2010-5#2)
morsitans##7##1##(1997-4#2)(2010-4#5)
mortalin from##2##2##(1993-11#2)
mortalin##6##1##(1993-11#5)(2008-8#1)
mortalins##2##1##(1993-11#2)
mortalities and##2##2##(2009-7#1)(2010-1#1)
mortalities in##3##2##(2009-5#1)(2009-6#1)(2010-1#1)
mortalities occurred##2##2##(2011-2#1)(2012-12#1)
mortalities##12##1##(2007-5#1)(2007-8#2)(2008-5#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2011-2#1)(2012-12#1)
mortality after##13##2##(1990-12#1)(1992-12#1)(1992-5#2)(2006-10#1)(2007-10#3)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#2)
mortality among##11##2##(1991-6#1)(1992-5#1)(1993-12#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
mortality and a##2##3##(2007-12#1)(2008-3#1)
mortality and cancer##2##3##(2008-7#1)(2013-8#1)
mortality and complications##2##3##(1993-2#1)(2007-8#1)
mortality and cost##2##3##(2008-1#1)(2008-7#1)
mortality and host encounter rates##2##5##(2008-9#2)
mortality and incidence rates##2##4##(2012-3#2)
mortality and major##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
mortality and morbidity after##3##4##(2009-10#1)(2011-2#2)
mortality and morbidity due to##2##5##(2008-1#1)(2013-8#1)
mortality and morbidity from##2##4##(1997-2#1)(2011-2#1)
mortality and morbidity in##6##4##(1990-8#1)(1997-4#1)(2007-2#1)(2009-5#1)(2011-2#1)(2012-12#1)
mortality and morbidity rates##5##4##(2007-8#1)(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#1)
mortality and morbidity##38##3##(1990-8#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-10#1)(2009-4#2)(2009-5#1)(2010-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
mortality and no##2##3##(1991-6#1)(2007-8#1)
mortality and reduced##2##3##(1993-3#1)(2008-11#1)
mortality and the##4##3##(1997-6#1)(2008-7#1)(2008-8#1)(2010-11#1)
mortality and##117##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#5)(2009-10#1)(2009-4#3)(2009-5#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
mortality are##5##2##(1995-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
mortality as##2##2##(2007-7#1)(2008-8#1)
mortality associated with##10##3##(1993-9#1)(1994-3#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
mortality at all##2##3##(1991-3#1)(1993-9#1)
mortality at##11##2##(1991-3#1)(1993-9#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#4)(2012-3#1)(2013-8#1)
mortality becomes##2##2##(1991-3#1)(2008-8#1)
mortality benefit##2##2##(2007-12#1)(2010-8#1)
mortality between the##2##3##(2006-8#1)(2012-3#1)
mortality between##6##2##(1990-8#1)(1992-12#1)(1994-2#1)(2006-8#1)(2011-2#1)(2012-3#1)
mortality by cancer##2##3##(2008-1#2)
mortality by malaria##2##3##(2012-12#2)
mortality by##11##2##(1990-11#1)(1995-12#1)(2007-2#1)(2008-1#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2012-12#2)
mortality can be##4##3##(1993-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
mortality cannot be##2##3##(1997-4#1)(2008-8#1)
mortality data##11##2##(1991-8#1)(1992-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
mortality declined##2##2##(1990-6#1)(1996-7#1)
mortality decreased##2##2##(2008-12#1)(2011-2#1)
mortality due to cardiovascular disease##3##5##(1994-5#1)(2008-3#1)(2009-5#1)
mortality due to cardiovascular##4##4##(1994-5#1)(2008-3#1)(2009-5#1)(2013-7#1)
mortality due to the##2##4##(2011-1#1)(2011-2#1)
mortality due to##17##3##(1991-6#1)(1992-8#1)(1994-5#1)(1996-3#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#4)
mortality due##18##2##(1991-6#1)(1992-8#1)(1994-5#1)(1996-3#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#4)
mortality during migration##2##3##(2008-8#2)
mortality during the first##3##4##(2008-10#1)(2011-2#2)
mortality during##9##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-1#1)
mortality even##2##2##(1991-12#1)(1996-8#1)
mortality exceeds##2##2##(2008-12#1)(2008-8#1)
mortality following##2##2##(1990-12#1)(2008-11#1)
mortality for all##2##3##(2011-2#2)
mortality for##14##2##(2008-10#1)(2008-12#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)
mortality from a##2##3##(1995-3#1)(2008-8#1)
mortality from carcinoma of the prostate##2##6##(1995-8#2)
mortality from colorectal cancer##2##4##(1995-9#1)(2009-12#1)
mortality from ischemic heart disease##2##5##(1996-3#1)(2011-2#1)
mortality from stroke##2##3##(1993-2#1)(1995-5#1)
mortality from##27##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-6#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-7#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#4)(2013-1#1)
mortality has not been##2##4##(2008-6#1)(2011-2#1)
mortality has##5##2##(1995-9#1)(2008-6#1)(2011-2#2)(2011-3#1)
mortality have been##2##3##(1991-8#1)(1997-1#1)
mortality in Italian##2##3##(1994-2#2)
mortality in Italy##4##3##(1991-2#1)(1993-3#1)(1994-12#1)(1994-2#1)
mortality in a##2##3##(2008-7#1)(2011-2#1)
mortality in both##2##3##(2009-4#1)(2011-2#1)
mortality in critically ill patients##2##5##(2007-12#1)(2010-7#1)
mortality in industrialized##2##3##(2009-12#1)(2012-2#1)
mortality in men##2##3##(1994-5#1)(2011-2#1)
mortality in merchant seamen##2##4##(1991-12#2)
mortality in patients undergoing##2##4##(1993-9#1)(2008-3#1)
mortality in patients with##7##4##(1992-5#1)(2008-3#2)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)
mortality in patients##14##3##(1992-5#1)(1993-12#2)(1993-9#1)(2007-10#1)(2008-3#3)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#3)
mortality in the 21st century##2##5##(2013-1#2)
mortality in the United States##4##5##(1992-3#1)(1997-1#1)(2008-1#1)(2011-1#1)
mortality in the United##6##4##(1992-3#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2011-1#1)
mortality in the##25##3##(1990-11#2)(1990-2#1)(1992-3#1)(1993-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#6)(2013-1#2)
mortality in these##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
mortality in this##3##3##(1990-5#1)(1996-3#1)(2008-7#1)
mortality in wave 2##2##4##(2011-2#2)
mortality in wave##3##3##(2011-2#3)
mortality in##150##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-7#1)(1995-12#1)(1996-11#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#26)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#9)(2013-8#3)
mortality induced by##2##3##(2011-2#1)(2012-2#1)
mortality is not##3##3##(1994-11#1)(2008-8#1)(2009-10#1)
mortality is reduced##2##3##(2008-7#1)(2011-2#1)
mortality is the##2##3##(2008-10#1)(2008-2#1)
mortality is##26##2##(1991-5#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#2)(2011-2#4)(2013-1#1)
mortality observed in##2##3##(1997-8#1)(2013-1#1)
mortality occurred##3##2##(2008-5#1)(2008-9#1)(2012-12#1)
mortality of about##2##3##(1992-9#1)(2010-12#1)
mortality of elderly##2##3##(1990-5#1)(2011-2#1)
mortality of the##14##3##(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#8)
mortality of##60##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-9#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-2#2)(1995-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-2#1)(2010-12#1)(2010-2#3)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#8)
mortality on the##2##3##(2008-8#1)(2009-10#1)
mortality on##3##2##(2008-8#2)(2009-10#1)
mortality or development of##2##4##(2008-7#2)
mortality or fecundity##2##3##(2008-9#1)(2011-2#1)
mortality or morbidity##3##3##(2008-7#3)
mortality or##17##2##(2007-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
mortality over the##2##3##(2008-9#1)(2013-8#1)
mortality over##4##2##(1996-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
mortality patterns##2##2##(1991-6#1)(1995-3#1)
mortality pockets##3##2##(2008-10#3)
mortality rate and##5##3##(2007-12#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-2#1)
mortality rate associated with##2##4##(1995-12#1)(2007-8#1)
mortality rate decreased##3##3##(1995-6#1)(1996-11#1)(2012-12#1)
mortality rate for##2##3##(1992-5#1)(2008-8#1)
mortality rate from##3##3##(1995-8#1)(2007-12#1)(2008-9#1)
mortality rate in Cuba##2##4##(2013-1#2)
mortality rate in##4##3##(2008-3#1)(2011-2#1)(2013-1#2)
mortality rate is high##2##4##(2008-1#1)(2012-1#1)
mortality rate is##7##3##(1992-9#1)(1993-9#1)(2008-1#1)(2008-4#1)(2012-1#1)(2013-1#2)
mortality rate of the##2##4##(1994-7#1)(2008-1#1)
mortality rate of##10##3##(1992-9#1)(1994-3#1)(1994-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-10#1)(2013-1#1)(2013-7#1)
mortality rate was 1##2##4##(1994-11#1)(2008-7#1)
mortality rate was 4##2##4##(1992-9#1)(2008-7#1)
mortality rate was##19##3##(1990-12#1)(1990-3#2)(1991-2#1)(1992-9#2)(1993-5#1)(1994-11#1)(1994-7#1)(1995-12#2)(2007-7#2)(2008-1#1)(2008-5#1)(2008-7#3)(2011-3#1)
mortality rate##125##2##(1990-12#1)(1990-3#2)(1991-2#1)(1992-5#1)(1992-9#5)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#4)(1995-12#4)(1995-3#5)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(2006-10#2)(2007-10#1)(2007-12#5)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#8)(2009-10#1)(2010-10#2)(2010-12#2)(2010-5#3)(2010-7#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#1)
mortality rates after##2##3##(2006-10#1)(2009-6#1)
mortality rates are##6##3##(1991-6#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-12#1)
mortality rates for##3##3##(1991-6#1)(2008-5#1)(2011-2#1)
mortality rates in the##2##4##(1993-12#1)(2008-3#1)
mortality rates in##9##3##(1993-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
mortality rates of##7##3##(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#2)(2013-8#1)
mortality rates were##3##3##(1994-3#1)(2007-8#1)(2008-7#1)
mortality rates##49##2##(1990-2#1)(1991-6#2)(1993-12#2)(1993-2#1)(1994-3#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
mortality ratio (SMR)##2##3##(1995-2#1)(2008-8#1)
mortality ratio##4##2##(1995-2#1)(2008-8#2)(2011-1#1)
mortality ratios##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
mortality reduction##2##2##(2013-1#1)(2013-8#1)
mortality related to##3##3##(1994-2#1)(1994-5#1)(2006-10#1)
mortality remains##3##2##(2008-7#1)(2011-2#2)
mortality resulting from##2##3##(2008-7#1)(2010-7#1)
mortality risk##6##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
mortality started##2##2##(2008-10#1)(2008-6#1)
mortality statistics##3##2##(1992-6#1)(1993-2#1)(2007-12#1)
mortality studies##3##2##(1991-12#1)(1992-2#1)(1992-3#1)
mortality than the##2##3##(2008-7#1)(2013-7#1)
mortality than##4##2##(2007-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
mortality throughout##2##2##(1996-3#1)(2011-2#1)
mortality to the##2##3##(1995-8#1)(2008-6#1)
mortality to##4##2##(1990-8#1)(1995-8#1)(2008-6#1)(2011-2#1)
mortality trend##2##2##(2011-2#1)(2013-8#1)
mortality trends##2##2##(2007-7#1)(2012-12#1)
mortality using a##2##3##(2008-8#1)(2009-7#1)
mortality using##5##2##(1996-2#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)
mortality was 0##2##3##(2007-8#1)(2009-9#1)
mortality was 1##4##3##(2007-8#2)(2008-7#1)(2011-3#1)
mortality was 11##2##3##(1991-6#1)(2007-8#1)
mortality was 2##2##3##(2007-8#2)
mortality was 3##3##3##(2007-8#3)
mortality was 34##2##3##(1993-9#1)(2013-1#1)
mortality was 5##2##3##(2007-8#2)
mortality was found##2##3##(1992-6#1)(1995-3#1)
mortality was higher##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
mortality was observed in##2##4##(1996-6#1)(2008-10#1)
mortality was observed##4##3##(1991-12#1)(1996-6#1)(2008-10#2)
mortality was recorded##2##3##(1997-3#1)(2008-7#1)
mortality was reported##2##3##(2007-8#1)(2009-9#1)
mortality was significantly higher##2##4##(2007-8#1)(2008-3#1)
mortality was significantly increased in##2##5##(2008-7#1)(2011-2#1)
mortality was significantly##5##3##(1990-5#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
mortality was##72##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#2)(1992-11#1)(1992-6#2)(1993-3#1)(1993-9#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-8#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#16)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-9#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2013-1#2)
mortality were observed##2##3##(1996-3#1)(2013-1#1)
mortality were##12##2##(1996-3#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#6)
mortality when##4##2##(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
mortality while##3##2##(1997-3#1)(2008-9#1)(2012-1#1)
mortality with##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
mortality within##4##2##(1990-12#1)(1993-12#1)(1994-12#1)(1995-1#1)
mortality##1272##1##(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#3)(1990-5#7)(1990-6#7)(1990-8#7)(1990-9#4)(1991-1#1)(1991-12#8)(1991-2#2)(1991-3#6)(1991-5#1)(1991-6#14)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#2)(1992-5#5)(1992-6#5)(1992-8#3)(1992-9#9)(1993-1#1)(1993-11#1)(1993-12#14)(1993-2#8)(1993-3#3)(1993-5#3)(1993-6#2)(1993-9#5)(1994-11#5)(1994-12#5)(1994-2#6)(1994-3#10)(1994-5#4)(1994-7#8)(1994-8#1)(1994-9#2)(1995-1#4)(1995-12#8)(1995-2#7)(1995-3#14)(1995-5#3)(1995-6#1)(1995-8#5)(1995-9#2)(1996-11#5)(1996-12#1)(1996-2#4)(1996-3#9)(1996-6#5)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#11)(1997-2#3)(1997-3#8)(1997-4#6)(1997-6#7)(1997-7#5)(1997-8#7)(2006-10#8)(2006-8#3)(2007-10#14)(2007-11#2)(2007-12#19)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#45)(2008-1#37)(2008-10#47)(2008-11#19)(2008-12#17)(2008-2#6)(2008-3#21)(2008-4#8)(2008-5#22)(2008-6#13)(2008-7#85)(2008-8#73)(2008-9#36)(2009-10#8)(2009-12#3)(2009-2#2)(2009-4#10)(2009-5#4)(2009-6#8)(2009-7#9)(2009-8#3)(2009-9#8)(2010-1#5)(2010-10#5)(2010-11#6)(2010-12#12)(2010-2#13)(2010-3#3)(2010-4#3)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#8)(2011-1#19)(2011-2#114)(2011-3#7)(2012-1#4)(2012-12#33)(2012-2#24)(2012-3#22)(2013-1#75)(2013-7#5)(2013-8#32)
mortality)##7##1##(1994-2#1)(1995-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2011-2#1)
mortality/morbidity##3##1##(2008-7#2)(2009-5#1)
mortalité##4##1##(2009-10#1)(2011-2#1)(2013-1#2)
mortem examination##3##2##(1993-2#1)(2010-10#1)(2011-1#1)
mortem##15##1##(1991-11#1)(1991-9#1)(1993-2#1)(1995-9#2)(2008-11#1)(2008-7#3)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-3#1)
morula-like cells##3##2##(2008-5#3)
morula-like##5##1##(2008-5#5)
morule-like features and##2##3##(2008-11#2)
morule-like features##4##2##(2008-11#4)
mos##3##1##(1994-8#3)
mosaic and##4##2##(2008-10#2)(2008-12#1)(2008-6#1)
mosaic disease##3##2##(2008-10#2)(2008-9#1)
mosaic geminivirus##2##2##(2008-10#2)
mosaic in##2##2##(2008-10#1)(2010-3#1)
mosaic is##2##2##(2008-10#2)
mosaic mutation in mice##2##4##(2008-12#2)
mosaic of##6##2##(1996-9#2)(2008-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
mosaic pattern##2##2##(1997-3#1)(2010-12#1)
mosaic potexvirus##2##2##(2008-10#2)
mosaic potyvirus##3##2##(2008-10#3)
mosaic symptoms##10##2##(2008-10#10)
mosaic tobamovirus (TMV)##2##3##(2008-10#2)
mosaic virus (CMV)##14##3##(1997-6#1)(2008-10#10)(2008-8#2)(2012-2#1)
mosaic virus (CaMV)##4##3##(2008-10#4)
mosaic virus (SCMV)##2##3##(2008-10#1)(2008-9#1)
mosaic virus (SMV)##5##3##(2008-10#5)
mosaic virus (TMV)##4##3##(2008-10#4)
mosaic virus (TuMV)##3##3##(2008-10#3)
mosaic virus Resistance in##2##4##(2008-10#2)
mosaic virus Resistance##3##3##(2008-10#3)
mosaic virus and Cucumber##2##4##(2008-10#2)
mosaic virus and##13##3##(2008-10#11)(2008-8#1)(2012-2#1)
mosaic virus for##2##3##(2008-10#2)
mosaic virus in##13##3##(2008-10#13)
mosaic virus isolate##2##3##(2008-8#1)(2008-9#1)
mosaic virus mixed with Blackeye cowpea mosaic virus##2##8##(2008-10#2)
mosaic virus mixed with##3##4##(2008-10#3)
mosaic virus##222##2##(1995-2#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(2008-10#182)(2008-12#2)(2008-7#2)(2008-8#14)(2008-9#10)(2012-2#2)
mosaic##303##1##(1991-5#1)(1994-12#1)(1995-2#1)(1996-9#2)(1997-2#3)(1997-3#5)(1997-4#1)(1997-6#3)(2008-10#238)(2008-12#6)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#14)(2008-9#12)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2012-2#3)
mosaic)##2##1##(2008-10#2)
mosaicism##8##1##(1991-3#1)(2008-12#2)(2009-6#1)(2010-3#3)(2012-3#1)
mosaics##5##1##(2010-3#5)
moschata##2##1##(2008-10#2)
moshavot##5##1##(2011-2#5)
mosquito adulticides##2##2##(2007-5#2)
mosquito bites##6##2##(2007-2#1)(2011-1#5)
mosquito larvae##4##2##(2007-10#1)(2008-12#1)(2008-5#2)
mosquito populations##2##2##(2008-12#1)(2008-8#1)
mosquito species##3##2##(2007-12#1)(2007-7#1)(2013-1#1)
mosquito##44##1##(1991-5#1)(1992-6#1)(1992-8#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#3)(2007-7#2)(2008-10#1)(2008-12#2)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-2#2)(2011-1#5)(2011-2#3)(2011-3#2)(2013-1#1)(2013-8#2)
mosquito-borne##2##1##(1996-8#1)(2008-5#1)
mosquitoes in the##2##3##(2007-2#1)(2012-12#1)
mosquitoes in##4##2##(2007-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
mosquitoes were##4##2##(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
mosquitoes##34##1##(1992-8#1)(2007-10#4)(2007-12#2)(2007-2#2)(2007-7#4)(2008-10#1)(2008-12#4)(2008-5#3)(2008-7#1)(2008-8#3)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#5)
moss Physcomitrella patens gametophytes##2##4##(2010-2#2)
moss Physcomitrella patens##9##3##(2010-2#9)
moss amended with compost##2##4##(2008-10#2)
moss and vascular plants##2##4##(2008-8#2)
moss and##6##2##(2008-10#2)(2008-7#1)(2008-8#3)
moss monoculture and##3##3##(2008-8#3)
moss samples##2##2##(2008-10#2)
moss##34##1##(2008-10#14)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#1)(2010-2#9)
mosses##3##1##(2008-10#1)(2008-8#2)
mossy fibers##2##2##(1993-5#1)(1994-6#1)
mossy fibre LTP##5##3##(2012-2#5)
mossy fibre##7##2##(2012-2#7)
mossy##9##1##(1993-5#1)(1994-6#1)(2012-2#7)
most 2##3##2##(2008-10#2)(2008-11#1)
most IHs##2##2##(2013-8#2)
most New##2##2##(2007-12#1)(2008-10#1)
most REEs##2##2##(2008-10#2)
most S##2##2##(1993-12#1)(2008-11#1)
most abundant and##4##3##(1992-9#1)(1994-2#1)(2010-11#1)(2013-1#1)
most abundant in##4##3##(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#1)
most abundant protein in human##2##5##(1996-2#1)(2013-8#1)
most abundant protein in##3##4##(1996-2#1)(2011-2#1)(2013-8#1)
most abundant species##8##3##(2008-5#3)(2011-2#3)(2013-1#1)(2013-7#1)
most abundant##72##2##(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#5)(2008-6#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#2)
most acceptable##2##2##(2013-1#2)
most accurate measurement of##2##4##(1994-9#1)(2007-12#1)
most accurate##18##2##(1991-6#1)(1993-11#2)(1994-9#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#4)(2008-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
most accurately##4##2##(1995-1#1)(2008-11#1)(2008-4#1)(2008-6#1)
most acidic##2##2##(1990-8#1)(2008-10#1)
most active##30##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-4#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
most adequate##3##2##(1992-1#1)(1996-5#1)(2013-1#1)
most advanced##5##2##(1992-5#1)(2008-5#1)(2008-8#2)(2011-2#1)
most affected and the##2##4##(2010-3#1)(2011-2#1)
most affected by the disease##2##5##(2008-10#1)(2008-7#1)
most affected by##5##3##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
most affected##16##2##(1992-5#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
most aggressive##7##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-3#1)
most amino acids##2##3##(1994-6#1)(2008-11#1)
most analyzed##2##2##(2009-8#1)(2013-1#1)
most and least##2##3##(1992-12#1)(1994-12#1)
most and##5##2##(1992-12#1)(1994-12#1)(1997-6#1)(2008-12#2)
most animal##2##2##(2008-11#1)(2008-9#1)
most animals##3##2##(2008-6#1)(2008-8#2)
most apparent##5##2##(1995-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
most applications##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
most appropriate for##4##3##(1990-2#1)(1992-12#1)(2008-10#1)(2008-3#1)
most appropriate to##4##3##(1994-12#1)(1995-1#1)(2008-11#1)(2008-2#1)
most appropriate##57##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-1#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-8#2)(2011-2#7)(2012-12#2)(2012-2#2)(2012-9#1)(2013-1#1)
most are##7##2##(1992-12#1)(1994-1#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-1#2)
most ascospores were##2##3##(2008-10#2)
most associated with##2##3##(2007-12#1)(2011-2#1)
most associated##3##2##(2007-12#1)(2010-10#1)(2011-2#1)
most at risk##6##3##(1996-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
most attention##2##2##(1994-3#1)(2011-1#1)
most attractive##5##2##(1992-3#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)
most bacteria##2##2##(1990-2#1)(2010-12#1)
most basal##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
most basic##5##2##(1994-1#1)(1994-12#1)(2008-1#1)(2008-5#1)(2008-9#1)
most beneficial##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
most benefit from##3##3##(2008-3#1)(2011-2#1)(2012-3#1)
most biochemical##2##2##(1994-3#1)(2008-10#1)
most cancer##2##2##(2008-7#1)(2009-11#1)
most cancers##3##2##(1990-12#1)(2008-3#1)(2009-3#1)
most cases are##2##3##(1994-3#1)(2010-8#1)
most cases of##6##3##(1991-11#1)(1997-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-2#1)
most cases##106##2##(1990-12#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
most cells and##2##3##(1992-5#1)(2008-11#1)
most cells##6##2##(1992-5#1)(1996-12#2)(2008-10#1)(2008-11#1)(2012-1#1)
most centers##3##2##(1992-12#1)(1994-3#1)(2011-2#1)
most central nervous##2##3##(1997-7#1)(2007-7#1)
most challenging##10##2##(1991-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#3)(2012-2#1)
most characteristic feature of##2##4##(1997-8#1)(2008-7#1)
most characteristic##7##2##(1992-3#1)(1997-8#1)(2008-10#3)(2008-6#1)(2008-7#1)
most chemotherapy agents##2##3##(2008-8#2)
most chicks##2##2##(2008-6#2)
most children##4##2##(1990-8#1)(2008-10#1)(2008-11#2)
most cited##2##2##(2008-2#1)(2009-4#1)
most clearly##2##2##(2010-3#1)(2012-2#1)
most clinical laboratories##2##3##(2008-10#1)(2008-9#1)
most clinical studies##2##3##(1997-3#1)(2009-10#1)
most clinical##6##2##(1992-11#1)(1997-3#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-1#1)
most clinically##4##2##(2008-10#1)(2008-4#1)(2008-8#2)
most closely associated with##2##4##(1995-2#1)(2009-12#1)
most closely correlated with histologic evidence of##2##7##(2008-5#2)
most closely related to the##5##5##(2008-10#4)(2010-6#1)
most closely related to##18##4##(1990-11#1)(1997-8#1)(2008-10#12)(2008-5#1)(2008-9#1)(2010-6#1)(2013-1#1)
most closely related##20##3##(1990-11#1)(1997-8#1)(2008-10#13)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
most closely resembles##2##3##(1993-6#1)(1994-5#1)
most closely##32##2##(1990-11#1)(1990-5#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#14)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
most collected##2##2##(2008-5#1)(2008-6#1)
most commercially available##2##3##(2008-7#1)(2008-9#1)
most common adverse##4##3##(2008-3#1)(2010-12#1)(2011-2#2)
most common and##11##3##(1996-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#2)
most common being##3##3##(2008-12#1)(2010-8#1)(2012-1#1)
most common cancer##6##3##(2007-8#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
most common cause for##2##4##(1990-6#1)(2008-11#1)
most common cause of death##3##5##(1991-6#1)(1993-9#1)(2008-11#1)
most common cause of renal failure##2##6##(2007-7#1)(2008-1#1)
most common cause of##28##4##(1991-6#1)(1993-9#1)(1996-11#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
most common cause##33##3##(1990-6#1)(1991-6#1)(1993-9#1)(1996-11#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
most common causes of##8##4##(1990-3#1)(1990-6#1)(1997-8#1)(2007-7#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
most common chronic##5##3##(1991-2#1)(2008-1#1)(2008-9#1)(2011-1#1)(2012-2#1)
most common clinical presentations##2##4##(2008-3#1)(2012-3#1)
most common clinical sign##3##4##(1991-8#1)(2008-1#1)(2008-10#1)
most common clinical##8##3##(1991-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
most common complaint##3##3##(1990-6#1)(2008-9#1)(2013-8#1)
most common complication of##5##4##(1991-6#1)(2007-11#2)(2008-6#1)(2008-7#1)
most common complication##6##3##(1991-6#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-9#1)
most common conditions##2##3##(2012-12#2)
most common diagnosis##3##3##(2006-8#1)(2011-2#2)
most common disease##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
most common form of##14##4##(1991-11#1)(1992-4#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
most common gastrointestinal##2##3##(2008-7#1)(2011-2#1)
most common genetic##3##3##(2008-8#1)(2010-4#1)(2012-12#1)
most common histological##6##3##(2008-1#2)(2008-8#1)(2008-9#1)(2012-2#2)
most common in##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
most common isoproteins##2##3##(1990-8#1)(1991-8#1)
most common location##2##3##(2008-6#1)(2013-1#1)
most common malignancy##8##3##(2008-1#1)(2008-4#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
most common manifestation##2##3##(2007-10#1)(2008-4#1)
most common medical##2##3##(2008-1#1)(2008-7#1)
most common metabolic##3##3##(1990-2#1)(2007-11#1)(2008-1#1)
most common musculoskeletal##2##3##(2006-10#1)(2013-1#1)
most common pathogens##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
most common places##2##3##(1991-6#1)(2007-11#1)
most common presenting##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
most common primary malignant##2##4##(2008-6#1)(2013-1#1)
most common primary##6##3##(2008-12#1)(2008-6#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
most common problems##5##3##(2007-11#1)(2008-12#1)(2010-12#2)(2011-2#1)
most common procedure##3##3##(1992-5#1)(2010-8#1)(2011-1#1)
most common reason for##3##4##(2009-5#1)(2010-8#1)(2013-1#1)
most common reasons for##4##4##(2007-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
most common renal##2##3##(1997-7#1)(2013-1#1)
most common risk##3##3##(2007-10#2)(2011-2#1)
most common site of##3##4##(2007-11#1)(2008-6#1)(2011-2#1)
most common site##4##3##(2007-11#1)(2008-6#2)(2011-2#1)
most common sites##4##3##(2010-3#1)(2013-1#2)(2013-8#1)
most common sources of##3##4##(2008-11#1)(2008-12#1)(2012-1#1)
most common species##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
most common stroke##2##3##(2007-10#2)
most common symptom##3##3##(1990-9#1)(2007-2#1)(2008-1#1)
most common type of##14##4##(2007-7#1)(2008-1#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#3)
most common type##15##3##(2007-7#1)(2008-1#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
most common types of##3##4##(2008-6#1)(2010-10#1)(2013-1#1)
most common types##7##3##(2008-1#1)(2008-6#1)(2010-10#1)(2012-3#1)(2013-1#3)
most common viral types##2##4##(2008-11#1)(2013-1#1)
most common##524##2##(1990-2#2)(1990-3#1)(1990-6#5)(1990-8#3)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#4)(1991-8#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-6#2)(1993-9#4)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#9)(2007-11#14)(2007-12#7)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#27)(2008-10#33)(2008-11#17)(2008-12#10)(2008-2#4)(2008-3#9)(2008-4#11)(2008-5#9)(2008-6#11)(2008-7#13)(2008-8#4)(2008-9#21)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#9)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#17)(2010-9#1)(2011-1#15)(2011-2#50)(2011-3#1)(2012-1#4)(2012-12#13)(2012-2#18)(2012-3#13)(2013-1#38)(2013-7#5)(2013-8#14)
most commonly adopted##2##3##(2009-11#1)(2013-1#1)
most commonly affected##3##3##(2008-5#1)(2008-6#1)(2010-12#1)
most commonly affects##2##3##(1992-4#1)(2010-4#1)
most commonly applied##3##3##(1995-2#1)(2008-4#1)(2011-1#1)
most commonly associated with##3##4##(1991-12#1)(1992-2#1)(2008-1#1)
most commonly associated##4##3##(1991-12#1)(1992-2#1)(2008-1#1)(2012-3#1)
most commonly caused by##3##4##(2008-1#1)(2008-2#1)(2011-2#1)
most commonly detected##2##3##(2008-11#1)(2011-2#1)
most commonly diagnosed##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
most commonly found in##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
most commonly found##5##3##(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-1#1)
most commonly in patients##2##4##(2007-10#1)(2009-3#1)
most commonly in the##6##4##(1993-6#1)(2008-10#1)(2008-12#2)(2011-1#1)(2011-2#1)
most commonly in##10##3##(1993-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
most commonly involved##3##3##(2007-5#1)(2008-9#1)(2013-1#1)
most commonly isolated##3##3##(2008-10#3)
most commonly occur in##2##4##(2012-1#1)(2013-1#1)
most commonly performed##4##3##(2009-7#1)(2011-2#2)(2012-2#1)
most commonly reported in the##2##5##(2013-1#1)(2013-8#1)
most commonly reported##6##3##(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
most commonly seen in##2##4##(2008-9#1)(2010-8#1)
most commonly seen##5##3##(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#2)
most commonly used in##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
most commonly used to##2##4##(2008-1#2)
most commonly used##41##3##(1990-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
most commonly##144##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#15)(2008-11#4)(2008-12#4)(2008-2#4)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#9)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#11)(2012-1#2)(2012-2#4)(2012-3#5)(2013-1#13)(2013-8#4)
most compatible with##2##3##(2007-7#1)(2008-1#1)
most competitive##3##2##(1995-3#1)(1997-1#1)(2011-2#1)
most complex##10##2##(1995-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#1)(2012-3#2)
most comprehensive##5##2##(1997-3#1)(2007-11#2)(2008-10#1)(2008-3#1)
most conducive##3##2##(1994-12#1)(2008-10#2)
most conserved##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
most consistent with##3##3##(1993-8#1)(2008-10#1)(2012-3#1)
most consistent##9##2##(1993-8#1)(2007-11#1)(2008-10#5)(2012-2#1)(2012-3#1)
most conspicuous##6##2##(1994-12#1)(1996-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)
most correlated with##2##3##(2008-10#2)
most cost-effective##9##2##(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
most costly##2##2##(1996-11#1)(2013-8#1)
most countries##11##2##(1990-8#1)(1992-11#1)(1994-3#1)(1996-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2013-8#1)
most critical factors##2##3##(2008-12#1)(2012-3#1)
most critical##17##2##(1991-3#1)(1994-3#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-8#1)
most crops##2##2##(2008-10#2)
most crucial##5##2##(1993-8#1)(1996-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
most cultures##2##2##(2008-11#1)(2008-4#1)
most current##9##2##(1991-12#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#1)(2012-1#1)(2012-3#1)
most cytotoxic##2##2##(1995-5#1)(2013-1#1)
most damaging##5##2##(2008-1#1)(2008-10#4)
most dangerous##5##2##(1991-8#1)(2007-11#1)(2009-3#1)(2011-2#1)(2013-8#1)
most deaths were##2##3##(1991-12#1)(2012-3#1)
most densely##3##2##(1994-9#1)(2008-2#1)(2013-1#1)
most desirable##2##2##(2008-10#1)(2008-5#1)
most devastating##7##2##(1997-7#1)(2008-10#4)(2011-2#1)(2012-3#1)
most developed countries##2##3##(2006-10#1)(2012-3#1)
most developed##4##2##(1994-2#1)(2006-10#1)(2008-2#1)(2012-3#1)
most difficult challenge##2##3##(2007-11#1)(2011-1#1)
most difficult##19##2##(1992-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
most discriminant##3##2##(2008-10#2)(2011-2#1)
most distant from##3##3##(2008-10#3)
most distantly related##2##3##(1995-6#1)(2008-5#1)
most disturbing##2##2##(2008-1#1)(2008-10#1)
most divergent##2##2##(1991-12#1)(1993-12#1)
most diverse##6##2##(2008-10#3)(2008-5#1)(2011-2#1)(2013-7#1)
most dramatic##5##2##(1995-12#1)(1995-8#1)(2008-10#3)
most easily##2##2##(2008-10#2)
most economical##5##2##(1995-3#1)(1996-1#1)(2008-3#1)(2008-4#1)(2009-10#1)
most economically##2##2##(2008-10#2)
most effective and##9##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
most effective in reducing##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
most effective in##15##3##(1992-2#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-4#2)(2013-8#1)
most effective means of##2##4##(1996-3#1)(2008-3#1)
most effective means##6##3##(1993-12#1)(1996-3#1)(2008-10#3)(2008-3#1)
most effective measure##2##3##(2008-12#1)(2011-3#1)
most effective methods for##2##4##(2007-11#1)(2011-1#1)
most effective methods##4##3##(2007-11#2)(2007-8#1)(2011-1#1)
most effective treatment##4##3##(1993-2#1)(2007-7#1)(2008-12#1)(2009-3#1)
most effective use##3##3##(1993-12#1)(2008-10#2)
most effective when it##2##4##(1994-1#1)(2008-10#1)
most effective when##4##3##(1994-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
most effective##143##2##(1990-5#2)(1991-3#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-10#1)(2011-1#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#5)(2013-8#3)
most effectively##8##2##(1992-3#2)(1996-1#1)(1997-1#2)(2008-10#1)(2008-9#1)(2010-7#1)
most efficacious method##2##3##(1990-5#1)(2011-2#1)
most efficacious##4##2##(1990-5#1)(2010-12#1)(2011-2#2)
most efficient in influencing##2##4##(2009-11#2)
most efficient in##3##3##(2008-10#1)(2009-11#2)
most efficient separation##3##3##(1996-12#1)(2008-10#2)
most efficient##28##2##(1992-2#1)(1993-11#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2010-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
most efficiently##3##2##(2008-10#2)(2008-2#1)
most elements##5##2##(2008-10#5)
most employed##2##2##(2008-10#2)
most endemic##2##2##(2008-8#2)
most errors##2##2##(2008-3#1)(2013-8#1)
most essential##3##2##(2008-10#1)(2008-9#1)(2009-12#1)
most eukaryotic cells##3##3##(2008-1#1)(2011-2#1)(2011-3#1)
most evident in##2##3##(1996-12#1)(2013-8#1)
most evident##5##2##(1996-12#1)(2008-11#1)(2009-2#1)(2011-1#1)(2013-8#1)
most exciting##5##2##(2008-9#3)(2009-6#1)(2010-7#1)
most expensive##4##2##(1992-12#2)(1993-2#1)(1993-3#1)
most experimental##2##2##(2008-10#1)(2008-3#1)
most extended##2##2##(1990-8#1)(2008-10#1)
most extreme##3##2##(2008-8#2)(2008-9#1)
most families##2##2##(2011-2#1)(2012-2#1)
most famous##2##2##(1993-3#1)(2012-2#1)
most favorable##11##2##(1997-3#1)(2006-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
most feared##3##2##(1996-8#1)(2007-12#1)(2011-3#1)
most feasible##2##2##(1992-12#1)(1992-6#1)
most fields##2##2##(2008-10#2)
most frequent abnormality##2##3##(2007-8#1)(2011-2#1)
most frequent cause of death##2##5##(2011-2#1)(2012-12#1)
most frequent cause of##7##4##(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
most frequent clinical##3##3##(1990-8#1)(2007-7#1)(2013-1#1)
most frequent complication of##2##4##(2011-2#1)(2013-1#1)
most frequent complication##4##3##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
most frequent diagnosis##2##3##(1996-9#1)(2008-11#1)
most frequent disease##2##3##(1993-3#1)(2012-3#1)
most frequent diseases##3##3##(1991-12#2)(2010-12#1)
most frequent in##4##3##(1996-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
most frequent opportunistic##2##3##(1991-6#1)(2007-7#1)
most frequent pathogens##2##3##(2008-10#1)(2012-2#1)
most frequent symptom##3##3##(1991-8#1)(1995-11#1)(2007-11#1)
most frequent symptoms were##2##4##(1992-9#1)(2008-6#1)
most frequent symptoms##3##3##(1992-9#1)(2008-6#1)(2011-2#1)
most frequent type of##2##4##(2007-11#1)(2010-8#1)
most frequent##137##2##(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-9#2)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-3#2)(2007-10#1)(2007-11#5)(2007-4#1)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#16)(2011-3#3)(2012-12#8)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#2)
most frequently affected##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
most frequently as##2##3##(1996-6#1)(2013-1#1)
most frequently associated with##4##4##(2006-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
most frequently detected in##2##4##(1996-12#1)(2008-10#1)
most frequently detected##8##3##(1996-12#1)(2008-10#6)(2011-2#1)
most frequently diagnosed##3##3##(2010-6#1)(2011-1#1)(2012-12#1)
most frequently for##2##3##(2009-11#1)(2012-2#1)
most frequently found##5##3##(1994-3#1)(1996-8#2)(2008-10#2)
most frequently identified##2##3##(2007-10#1)(2012-12#1)
most frequently in##3##3##(1991-10#1)(2007-12#2)
most frequently isolated##5##3##(1991-11#1)(2007-7#2)(2008-10#2)
most frequently mentioned##3##3##(1991-8#1)(2008-12#1)(2011-1#1)
most frequently met##2##3##(2007-11#1)(2008-10#1)
most frequently observed##8##3##(1990-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-1#2)(2010-4#1)
most frequently performed##4##3##(1992-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
most frequently prescribed##6##3##(2008-11#4)(2008-7#1)(2010-5#1)
most frequently reported adverse##2##4##(2008-11#1)(2008-6#1)
most frequently reported##4##3##(2008-11#1)(2008-6#2)(2008-7#1)
most frequently used are##2##4##(2008-10#1)(2013-7#1)
most frequently used in##3##4##(2007-11#1)(2008-5#1)(2008-9#1)
most frequently used##23##3##(1990-10#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-6#1)(2011-2#3)(2013-7#1)
most frequently##129##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#2)(1992-5#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#2)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#2)(2010-1#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
most from##7##2##(1991-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-2#1)
most gene##2##2##(2008-10#1)(2009-6#1)
most genes##3##2##(1997-6#1)(2008-10#2)
most have##3##2##(1992-9#1)(2009-10#1)(2009-11#1)
most health care##4##3##(1992-2#1)(1995-1#1)(1996-2#1)(2008-12#1)
most health##9##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1995-1#1)(1996-2#1)(2008-12#2)(2012-12#1)
most healthy##2##2##(1994-9#1)(2008-5#1)
most heavily##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
most helpful##2##2##(2008-5#1)(2008-7#1)
most higher##2##2##(1994-5#1)(2007-8#1)
most highly conserved##2##3##(1993-12#1)(2008-10#1)
most highly expressed in##3##4##(1994-12#1)(2013-8#2)
most highly expressed##4##3##(1991-11#1)(1994-12#1)(2013-8#2)
most highly##12##2##(1991-11#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(2007-9#1)(2008-10#3)(2013-1#1)(2013-8#2)
most homogeneous##2##2##(1990-12#1)(2008-10#1)
most hospital##2##2##(1995-2#1)(2008-11#1)
most hospitals##2##2##(1990-4#1)(1997-3#1)
most human##4##2##(1995-11#1)(2008-11#1)(2008-9#1)(2012-2#1)
most implementations##2##2##(2008-4#1)(2009-12#1)
most important and##10##3##(1994-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#2)(2010-7#1)(2012-2#1)
most important are##4##3##(1991-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
most important aspect##3##3##(1997-3#1)(2013-7#1)(2013-8#1)
most important aspects of the##3##5##(1991-5#1)(2008-4#1)(2013-1#1)
most important aspects of##5##4##(1991-5#1)(1992-2#1)(2008-4#1)(2011-7#1)(2013-1#1)
most important cause of##2##4##(1995-8#1)(2010-8#1)
most important characteristics##3##3##(1992-9#1)(2007-8#1)(2013-8#1)
most important component##3##3##(2008-12#2)(2008-5#1)
most important components of##2##4##(2008-5#1)(2008-9#1)
most important factor in##5##4##(1990-8#1)(1992-6#1)(2010-3#1)(2011-1#1)(2011-2#1)
most important factor##8##3##(1990-8#1)(1992-6#1)(1993-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
most important factors that##3##4##(1993-1#1)(2008-3#2)
most important factors##13##3##(1993-1#1)(1994-1#2)(1996-2#1)(2007-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2013-1#2)(2013-8#1)
most important for##5##3##(1994-6#1)(1995-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
most important goals of##2##4##(1992-5#1)(1993-6#1)
most important groups##2##3##(1993-11#1)(2008-9#1)
most important in the##3##4##(1994-3#1)(2008-10#2)
most important in##7##3##(1990-11#1)(1994-3#1)(1994-9#1)(2007-8#1)(2008-10#3)
most important is to##2##4##(2010-8#1)(2012-3#1)
most important is##4##3##(1997-5#1)(2010-8#1)(2012-3#2)
most important methods##2##3##(2007-10#1)(2011-2#1)
most important predictor##2##3##(1994-11#1)(1995-2#1)
most important reasons for##2##4##(1992-5#1)(1993-1#1)
most important reasons##3##3##(1992-5#1)(1993-1#1)(2013-1#1)
most important##315##2##(1990-11#1)(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#3)(1991-3#3)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#5)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#3)(2007-11#9)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#53)(2008-11#9)(2008-12#8)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#14)(2008-6#4)(2008-7#10)(2008-8#9)(2008-9#7)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#16)(2011-3#2)(2011-4#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#6)(2013-8#6)
most importantly##15##2##(1995-12#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-8#1)
most in need##2##3##(2007-7#1)(2011-2#1)
most in vitro##2##3##(2008-5#1)(2008-7#1)
most in##5##2##(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
most individuals##2##2##(2010-4#1)(2012-3#1)
most influenced##2##2##(1995-2#1)(2010-7#1)
most influential##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
most informative##7##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
most inhibitory to##2##3##(2008-10#2)
most inhibitory##3##2##(1991-2#1)(2008-10#2)
most instances##8##2##(1992-1#1)(1997-4#1)(1997-5#1)(2007-6#1)(2008-10#3)(2012-3#1)
most intense in##2##3##(1991-5#1)(2008-9#1)
most intense peak##2##3##(2008-10#2)
most intense##11##2##(1991-5#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
most intensely##3##2##(1995-5#1)(2010-10#1)(2012-2#1)
most intensively##2##2##(1996-2#1)(2008-5#1)
most interesting and##2##3##(2007-5#1)(2008-8#1)
most interesting##12##2##(1990-5#1)(1991-6#1)(1994-12#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-8#1)
most intriguing##3##2##(1992-2#1)(2008-4#1)(2008-5#1)
most ions##2##2##(2008-10#2)
most isolates##6##2##(2008-10#6)
most laboratories##2##2##(1997-5#1)(2012-2#1)
most last##2##2##(2008-2#1)(2008-9#1)
most lesions are##2##3##(1997-8#1)(2013-8#1)
most lesions##3##2##(1997-8#1)(2008-5#1)(2013-8#1)
most likely a##5##3##(1995-11#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-1#1)
most likely as a##2##4##(2008-10#1)(2008-5#1)
most likely by##2##3##(2008-8#1)(2011-1#1)
most likely caused##2##3##(2008-10#1)(2009-3#1)
most likely due to the##4##5##(2008-10#2)(2011-1#1)(2013-8#1)
most likely due to##12##4##(1993-6#1)(2007-10#1)(2008-10#4)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-6#1)(2013-8#1)
most likely explanation for##3##4##(1991-8#1)(2008-10#1)(2012-3#1)
most likely explanation##4##3##(1991-8#1)(1997-1#1)(2008-10#1)(2012-3#1)
most likely not##2##3##(2008-10#2)
most likely of##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
most likely related to##2##4##(1997-2#1)(2008-7#1)
most likely the result of##2##5##(1993-3#1)(2008-10#1)
most likely the##8##3##(1992-3#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
most likely through##2##3##(1992-2#1)(2011-2#1)
most likely to be##7##4##(1991-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2012-2#2)(2013-1#1)
most likely to benefit from##4##5##(1997-6#1)(2007-10#1)(2007-2#1)(2013-8#1)
most likely to benefit##5##4##(1997-3#1)(1997-6#1)(2007-10#1)(2007-2#1)(2013-8#1)
most likely to have##3##4##(2008-1#1)(2008-2#1)(2008-5#1)
most likely to occur##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
most likely to##37##3##(1990-2#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-12#2)(1994-8#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
most likely##161##2##(1990-12#2)(1990-2#2)(1991-11#3)(1991-12#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#3)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#28)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#7)(2008-8#8)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#4)(2013-8#2)
most lipoproteins##2##2##(1993-12#1)(1996-11#1)
most liver##2##2##(2006-10#1)(2010-6#1)
most living cells##2##3##(2008-4#1)(2008-9#1)
most locations##3##2##(2008-10#2)(2008-5#1)
most major##2##2##(2008-10#1)(2013-1#1)
most mammalian##3##2##(1992-11#1)(1995-2#1)(2008-7#1)
most marked##4##2##(1995-11#1)(1997-2#1)(2008-11#1)(2008-7#1)
most methods##3##2##(1991-3#1)(2012-3#2)
most models##3##2##(2008-9#1)(2009-7#1)(2012-3#1)
most modern##4##2##(1992-9#1)(1996-4#1)(2008-10#1)(2008-9#1)
most natural##4##2##(2008-10#2)(2008-3#1)(2011-3#1)
most needed##3##2##(1995-3#1)(1996-4#1)(2008-10#1)
most notable##5##2##(1997-7#1)(2007-2#1)(2008-4#1)(2008-9#1)(2010-8#1)
most notably in the##2##4##(1997-7#1)(2008-1#1)
most notably in##3##3##(1997-7#1)(2008-1#1)(2008-7#1)
most notably the##4##3##(1997-8#1)(2008-12#1)(2008-6#1)(2009-9#1)
most notably##18##2##(1991-6#1)(1993-8#1)(1994-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-9#1)(2011-2#1)(2013-7#1)
most numerous species##2##3##(2011-1#1)(2013-7#1)
most numerous##6##2##(1991-2#1)(2007-12#1)(2007-8#1)(2008-8#1)(2011-1#1)(2013-7#1)
most obvious##7##2##(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)
most obviously##2##2##(1993-12#1)(1997-4#1)
most ocean##2##2##(2008-2#1)(2008-3#1)
most oceanic##2##2##(2008-3#2)
most of it##2##3##(1994-12#1)(2009-6#1)
most of its##3##3##(2007-12#1)(2010-7#1)(2013-8#1)
most of that##2##3##(1994-12#1)(2011-2#1)
most of the amino##2##4##(2008-11#1)(2009-8#1)
most of the cases##8##4##(1990-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-1#1)
most of the cells##3##4##(1993-8#1)(2008-10#1)(2008-12#1)
most of the common##2##4##(2008-10#1)(2011-1#1)
most of the complications##2##4##(1994-6#1)(2010-1#1)
most of the current##2##4##(2008-10#1)(2010-12#1)
most of the drugs##2##4##(1992-3#1)(1995-6#1)
most of the elements were##2##5##(2008-10#2)
most of the elements##4##4##(2008-10#4)
most of the genetic##2##4##(2008-10#1)(2013-1#1)
most of the human##2##4##(1996-10#1)(2008-10#1)
most of the information##2##4##(2008-1#1)(2011-2#1)
most of the isolates##2##4##(2007-7#1)(2008-10#1)
most of the known##2##4##(1995-2#1)(2008-4#1)
most of the light##2##4##(1990-11#1)(2008-3#1)
most of the literature##2##4##(1995-9#1)(2011-2#1)
most of the metal ions##4##5##(2008-10#4)
most of the methods described##2##5##(2008-10#1)(2010-5#1)
most of the methods##4##4##(2008-10#2)(2008-4#1)(2010-5#1)
most of the patients##5##4##(1990-10#1)(1992-2#1)(2008-1#1)(2011-2#2)
most of the phenotypic variance##2##5##(2008-10#2)
most of the populations##2##4##(2008-10#1)(2008-8#1)
most of the potential##2##4##(1994-3#1)(2008-10#1)
most of the research##2##4##(2008-10#1)(2012-2#1)
most of the samples##3##4##(2008-10#2)(2008-11#1)
most of the studied##3##4##(2008-10#2)(2009-2#1)
most of the studies##5##4##(1992-11#1)(1992-3#1)(2008-9#1)(2011-1#1)(2013-1#1)
most of the study##4##4##(2008-9#3)(2012-2#1)
most of the techniques##2##4##(2008-9#1)(2011-2#1)
most of the time##3##4##(2008-4#1)(2008-8#1)(2009-8#1)
most of the variability in##2##5##(2008-10#2)
most of the variability##3##4##(2008-10#3)
most of the variation in##2##5##(2008-10#1)(2008-8#1)
most of the variation##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
most of the year##3##4##(2008-3#2)(2012-3#1)
most of the##286##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-6#1)(1992-9#3)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#73)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#11)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#6)
most of their##5##3##(1994-8#1)(1996-2#1)(1996-3#1)(2008-8#1)(2012-2#1)
most of them considered##2##4##(2011-1#1)(2012-4#1)
most of them were##5##4##(2008-10#2)(2008-5#1)(2009-9#1)(2012-3#1)
most of them##27##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1993-2#1)(1995-12#1)(1996-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-3#1)(2012-4#1)(2013-7#1)
most of these elements##2##4##(2008-10#1)(2012-3#1)
most of these genes##3##4##(1993-12#1)(2008-8#1)(2008-9#1)
most of these patients##2##4##(1997-8#1)(2008-6#1)
most of these studies##2##4##(2008-5#1)(2012-2#1)
most of these##40##3##(1991-10#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#2)(2012-2#2)(2012-3#2)
most of this##2##3##(1991-12#1)(1991-8#1)
most of those##2##3##(1992-8#1)(1994-1#1)
most of which are##2##4##(1995-6#1)(2008-11#1)
most of which were##2##4##(1990-11#1)(2008-10#1)
most of which##12##3##(1990-11#1)(1993-2#1)(1993-9#1)(1995-6#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-9#1)
most of whom are##3##4##(1993-6#1)(2009-5#1)(2012-12#1)
most of your##2##3##(1991-1#1)(2008-1#1)
most of##415##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#8)(2008-10#96)(2008-11#15)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#10)(2008-5#13)(2008-6#3)(2008-7#6)(2008-8#13)(2008-9#16)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#3)(2011-1#10)(2011-2#14)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#5)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#7)
most often as##2##3##(1994-11#1)(2010-4#1)
most often associated with##3##4##(2007-5#1)(2008-10#1)(2008-11#1)
most often in##4##3##(1991-6#1)(1992-3#1)(2006-10#1)(2008-3#1)
most often involved##3##3##(2008-7#1)(2010-1#1)(2010-12#1)
most often seen in##2##4##(1992-5#1)(2012-12#1)
most often seen##3##3##(1992-5#1)(2008-10#1)(2012-12#1)
most often the##2##3##(1992-8#1)(2008-10#1)
most often used##5##3##(2008-10#2)(2008-5#2)(2009-8#1)
most often##69##2##(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-2#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(2006-10#3)(2007-11#3)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)
most optimal##2##2##(2008-7#1)(2008-9#1)
most or all##2##3##(2008-10#1)(2008-7#1)
most or##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
most organisms##3##2##(2008-7#1)(2009-2#1)(2012-2#1)
most other##13##2##(1991-10#1)(1993-6#1)(1995-1#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)
most part##25##2##(1990-6#1)(1991-1#1)(1991-3#2)(1992-1#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
most particularly##2##2##(1993-5#1)(2008-11#1)
most parts##2##2##(2007-12#1)(2010-8#1)
most patients had##2##3##(1992-8#1)(2008-5#1)
most patients the##3##3##(1990-9#1)(1994-5#1)(2013-1#1)
most patients with##13##3##(1991-11#1)(1991-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
most patients would##2##3##(1997-4#1)(2008-6#1)
most patients##43##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-12#2)(1992-8#2)(1994-5#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
most people##6##2##(1993-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)
most peripheral##2##2##(1993-11#1)(1996-3#1)
most persistent##4##2##(1992-2#1)(2007-6#1)(2008-8#1)(2012-2#1)
most pesticides##2##2##(2008-10#2)
most plant##2##2##(2008-8#1)(2011-1#1)
most plants##3##2##(2008-10#2)(2008-8#1)
most plausible##4##2##(1990-12#1)(2007-2#1)(2008-12#1)(2008-3#1)
most popular##30##2##(1995-3#2)(1996-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#2)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
most population##2##2##(2011-2#1)(2012-3#1)
most populations##2##2##(1991-12#1)(2011-2#1)
most populous country##2##3##(1994-3#1)(1994-9#1)
most populous##3##2##(1994-3#1)(1994-9#1)(2011-2#1)
most positive##4##2##(1996-2#1)(1997-5#1)(2008-5#1)(2009-7#1)
most potent in##4##3##(1991-5#1)(1993-1#1)(2013-1#1)(2013-8#1)
most potent inhibitors##5##3##(1994-11#1)(1994-8#1)(2008-10#1)(2010-4#1)(2013-1#1)
most potent of the##2##4##(2008-8#1)(2013-1#1)
most potent of##3##3##(1994-11#1)(2008-8#1)(2013-1#1)
most potent##46##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-8#4)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#4)(2013-8#1)
most powerful predictor of##2##4##(2008-3#1)(2010-5#1)
most powerful predictor##3##3##(2008-3#1)(2010-5#1)(2011-2#1)
most powerful##19##2##(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
most practical##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
most predictive of##2##3##(1993-12#1)(2009-7#1)
most predictive##3##2##(1993-12#1)(2009-4#1)(2009-7#1)
most predominant##4##2##(2008-10#1)(2009-3#1)(2009-7#1)(2013-8#1)
most preferred##5##2##(1997-6#1)(2007-8#1)(2013-1#1)(2013-8#2)
most prescribed##2##2##(1996-3#1)(2008-11#1)
most prevalent in##4##3##(2008-10#2)(2010-5#1)(2011-1#1)
most prevalent organisms##2##3##(1990-6#1)(2012-3#1)
most prevalent##62##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-7#2)(2008-1#3)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#3)
most previous##4##2##(1991-11#1)(1997-7#1)(2008-10#1)(2013-8#1)
most private##2##2##(1992-2#1)(2012-2#1)
most probable number##2##3##(2008-10#2)
most probable##16##2##(1991-10#1)(1991-12#1)(1994-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-1#1)
most probably the##3##3##(1992-8#1)(2006-6#1)(2007-11#1)
most probably##20##2##(1990-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-6#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
most problematic##2##2##(2008-3#1)(2012-12#1)
most products##2##2##(2007-6#2)
most profound##3##2##(1995-11#1)(2008-5#2)
most profoundly##4##2##(1997-6#1)(2011-2#3)
most prominent factors##2##3##(2008-1#1)(2008-10#1)
most prominent in the##2##4##(2008-5#1)(2008-6#1)
most prominent in##3##3##(1992-6#1)(2008-5#1)(2008-6#1)
most prominent##30##2##(1992-6#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
most prominently##2##2##(2008-7#1)(2012-2#1)
most promising##23##2##(1997-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#2)(2008-7#2)(2009-2#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#2)(2013-7#1)
most pronounced at##3##3##(1994-11#1)(1994-8#1)(2008-8#1)
most pronounced in the##3##4##(1990-7#1)(2008-2#1)(2008-3#1)
most pronounced in##10##3##(1990-7#1)(1993-8#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
most pronounced##22##2##(1990-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
most proteins##4##2##(2008-11#2)(2008-4#1)(2008-7#1)
most published##2##2##(2007-10#1)(2012-2#1)
most rapid##5##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)
most rapidly##8##2##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
most reactive##2##2##(1993-11#1)(2008-10#1)
most readily available##2##3##(2008-4#1)(2012-2#1)
most recent acquisitions##2##3##(1991-2#1)(2008-1#1)
most recent data##4##3##(2008-1#1)(2008-3#1)(2008-4#1)(2011-3#1)
most recent studies##4##3##(1995-6#1)(2007-11#1)(2010-5#1)(2012-1#1)
most recent##69##2##(1991-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-11#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
most recently acquired##2##3##(1990-5#1)(2009-8#1)
most recently##18##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
most related to##2##3##(1993-12#1)(2007-12#1)
most relevant manuscripts##2##3##(2008-10#2)
most relevant to##3##3##(1992-1#1)(2007-12#1)(2012-3#1)
most relevant##26##2##(1992-1#1)(1993-2#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
most reliable##18##2##(1993-12#3)(1993-2#1)(1993-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
most reliably##3##2##(1990-12#1)(2008-4#1)(2008-7#1)
most remain##2##2##(2008-7#1)(2008-8#1)
most remarkable##5##2##(1993-8#1)(1994-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
most reported##2##2##(2007-2#1)(2013-8#1)
most representative##5##2##(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
most reproductive##2##2##(1997-4#1)(2012-1#1)
most research##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
most resemble##2##2##(1992-6#1)(2008-4#1)
most respected##2##2##(2008-10#1)(2008-9#1)
most responsible for##2##3##(1991-12#1)(2008-10#1)
most responsible##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
most responsive##3##2##(1991-6#1)(1997-3#1)(2008-9#1)
most robust##9##2##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2012-3#1)
most salient##4##2##(1994-1#1)(1994-10#1)(2008-10#1)(2010-5#1)
most samples##3##2##(2008-10#2)(2008-11#1)
most selective##2##2##(1996-2#1)(2008-10#1)
most sensitive and##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2010-6#1)
most sensitive to##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
most sensitive##46##2##(1990-12#1)(1992-11#1)(1992-9#1)(1995-12#2)(1995-5#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
most serious complication##8##3##(1991-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-7#1)(2009-2#1)(2011-2#1)
most serious complications##2##3##(1991-3#1)(2011-3#1)
most serious problem##2##3##(1991-2#1)(1991-3#1)
most serious##28##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)
most severe cases##2##3##(1994-9#1)(2013-8#1)
most severe in the##3##4##(1996-5#2)(2008-10#1)
most severe in##4##3##(1996-5#2)(2006-10#1)(2008-10#1)
most severe##35##2##(1990-8#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-5#2)(1996-6#1)(1997-3#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
most significant##59##2##(1990-11#1)(1990-6#1)(1991-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
most significantly##2##2##(1995-2#1)(2010-3#1)
most similar to that of##2##5##(1992-9#1)(1995-5#1)
most similar to the##4##4##(1995-5#1)(1995-8#1)(2008-10#2)
most similar to##11##3##(1992-9#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-5#1)
most similar##15##2##(1992-9#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-5#2)(2010-4#1)(2011-2#1)
most sites##3##2##(2008-10#3)
most situations##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
most sophisticated##3##2##(1994-2#1)(2008-1#1)(2010-8#1)
most species##5##2##(2008-10#1)(2009-3#1)(2009-5#1)(2010-8#1)(2012-3#1)
most species-rich##3##2##(2010-6#2)(2013-1#1)
most specific##4##2##(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)
most sporadic##2##2##(1995-12#1)(1996-5#1)
most stable##9##2##(1996-2#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)
most strains##2##2##(2008-10#2)
most stressful##4##2##(1992-2#2)(1994-12#1)(2012-1#1)
most striking##12##2##(1991-8#1)(1992-3#1)(1992-5#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
most strongly##8##2##(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-9#1)(2012-1#1)(2013-1#1)
most students##2##2##(2008-12#1)(2012-2#1)
most studied and##2##3##(2008-12#1)(2010-7#1)
most studied##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-7#1)
most studies have been##2##4##(2010-12#1)(2012-2#1)
most studies have##6##3##(2007-12#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
most studies##19##2##(1992-9#1)(1994-2#1)(1994-6#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
most subjects##2##2##(2010-12#1)(2012-12#1)
most successful##15##2##(1993-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-2#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
most suitable for the##7##4##(1990-8#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
most suitable for##13##3##(1990-8#1)(1993-12#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
most suitable##44##2##(1990-8#1)(1991-11#1)(1991-5#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
most surgeons##2##2##(1990-2#1)(2012-12#1)
most susceptible to##5##3##(2008-10#4)(2013-8#1)
most susceptible##15##2##(1994-8#1)(1995-6#1)(2008-10#11)(2008-12#1)(2013-8#1)
most symptomatic##2##2##(1991-2#1)(2008-10#1)
most symptoms##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
most temperatures##2##2##(2008-10#2)
most therapeutic##2##2##(2008-11#1)(2010-12#1)
most timely##2##2##(1995-12#1)(2008-9#1)
most to the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
most to##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)
most toxic##7##2##(1993-11#1)(2007-11#1)(2008-10#5)
most types of##3##3##(2007-8#1)(2008-6#1)(2008-9#1)
most typical##3##2##(2008-9#1)(2009-4#1)(2013-7#1)
most units##2##2##(1992-4#1)(2010-3#1)
most used##9##2##(1990-5#1)(2008-10#4)(2008-7#1)(2009-1#1)(2012-2#1)(2013-7#1)
most useful for##2##3##(2008-10#2)
most useful in the##3##4##(2008-2#1)(2008-8#1)(2010-6#1)
most useful in##5##3##(2008-2#2)(2008-8#1)(2010-6#1)(2012-3#1)
most useful to##2##3##(2008-1#1)(2012-2#1)
most useful##31##2##(1991-3#1)(1991-6#2)(1992-1#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
most usual##3##2##(1990-9#1)(1997-7#1)(2008-12#1)
most valuable##5##2##(1991-1#1)(1991-2#1)(1992-2#1)(1994-5#1)(2008-9#1)
most valued##2##2##(2011-2#1)(2012-12#1)
most variance in##3##3##(2007-6#1)(2008-9#2)
most variance##4##2##(2007-6#1)(2008-9#3)
most versatile##3##2##(1997-2#1)(2008-10#1)(2008-2#1)
most volatile##2##2##(2008-10#2)
most vulnerable##7##2##(1994-5#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2012-12#1)(2012-2#1)
most were##7##2##(1992-1#1)(1993-3#1)(1995-5#1)(2008-11#1)(2011-2#2)(2012-12#1)
most widely accepted##3##3##(2008-1#1)(2008-4#1)(2013-8#1)
most widely distributed##5##3##(1995-5#1)(2008-10#3)(2013-7#1)
most widely grown##2##3##(2008-10#2)
most widely prescribed##2##3##(1996-2#1)(2008-11#1)
most widely studied##2##3##(2008-5#1)(2012-12#1)
most widely used##32##3##(1991-3#1)(1992-6#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-8#2)(2008-9#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
most widely##57##2##(1991-3#2)(1992-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
most widely-used##2##2##(2008-4#1)(2008-7#1)
most widespread used##2##3##(2010-10#1)(2012-2#1)
most widespread##9##2##(1991-3#1)(1993-11#1)(1994-3#1)(2008-10#2)(2010-10#1)(2011-2#1)(2012-2#2)
most with##2##2##(2008-10#1)(2013-1#1)
most yeasts##2##2##(2008-6#2)
most##5087##1##(1990-10#2)(1990-11#14)(1990-12#14)(1990-2#16)(1990-3#5)(1990-4#1)(1990-5#15)(1990-6#18)(1990-7#3)(1990-8#22)(1990-9#11)(1991-1#5)(1991-10#6)(1991-11#14)(1991-12#25)(1991-2#17)(1991-3#22)(1991-4#3)(1991-5#8)(1991-6#19)(1991-8#11)(1991-9#4)(1992-1#10)(1992-10#2)(1992-11#7)(1992-12#24)(1992-2#25)(1992-3#20)(1992-4#4)(1992-5#20)(1992-6#13)(1992-8#13)(1992-9#20)(1993-1#12)(1993-11#14)(1993-12#34)(1993-2#18)(1993-3#23)(1993-5#5)(1993-6#16)(1993-8#14)(1993-9#9)(1994-1#16)(1994-10#1)(1994-11#15)(1994-12#29)(1994-2#21)(1994-3#31)(1994-5#12)(1994-6#14)(1994-7#1)(1994-8#13)(1994-9#15)(1995-1#16)(1995-11#12)(1995-12#29)(1995-2#25)(1995-3#22)(1995-4#1)(1995-5#20)(1995-6#21)(1995-8#10)(1995-9#3)(1996-1#12)(1996-10#2)(1996-11#12)(1996-12#19)(1996-2#31)(1996-3#25)(1996-4#3)(1996-5#17)(1996-6#11)(1996-7#8)(1996-8#9)(1996-9#4)(1997-1#19)(1997-2#27)(1997-3#26)(1997-4#19)(1997-5#12)(1997-6#16)(1997-7#20)(1997-8#19)(1997-9#2)(2006-10#22)(2006-4#1)(2006-6#3)(2006-8#1)(2007-10#21)(2007-11#83)(2007-12#54)(2007-2#14)(2007-4#5)(2007-5#12)(2007-6#8)(2007-7#37)(2007-8#39)(2007-9#2)(2008-1#89)(2008-10#870)(2008-11#158)(2008-12#83)(2008-2#58)(2008-3#103)(2008-4#104)(2008-5#164)(2008-6#65)(2008-7#154)(2008-8#139)(2008-9#157)(2009-1#3)(2009-10#18)(2009-11#18)(2009-12#13)(2009-2#16)(2009-3#17)(2009-4#14)(2009-5#26)(2009-6#16)(2009-7#14)(2009-8#28)(2009-9#8)(2010-1#13)(2010-10#20)(2010-11#15)(2010-12#37)(2010-2#6)(2010-3#19)(2010-4#31)(2010-5#23)(2010-6#20)(2010-7#18)(2010-8#64)(2010-9#6)(2011-1#92)(2011-10#3)(2011-2#246)(2011-3#18)(2011-4#1)(2011-7#1)(2012-1#23)(2012-12#67)(2012-2#125)(2012-3#93)(2012-4#2)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#179)(2013-7#35)(2013-8#91)
most-used##2##1##(1995-3#1)(2011-2#1)
mostly European##2##2##(2008-10#1)(2010-1#1)
mostly along##2##2##(1990-8#1)(2007-12#1)
mostly as a##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
mostly asymptomatic##2##2##(1993-11#1)(2013-7#1)
mostly at the##2##3##(2008-10#2)
mostly at##3##2##(2008-10#3)
mostly attributed to##2##3##(2008-10#1)(2008-12#1)
mostly based on##3##3##(1992-11#1)(2010-7#1)(2011-2#1)
mostly between##2##2##(1996-5#1)(2008-10#1)
mostly by the##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
mostly by##8##2##(1995-11#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)
mostly caused by##2##3##(2008-1#1)(2010-12#1)
mostly collected##2##2##(2008-10#1)(2011-2#1)
mostly concerned with##2##3##(2008-5#1)(2008-9#1)
mostly due to a##2##4##(1990-11#1)(2010-6#1)
mostly due to the##2##4##(2008-1#1)(2011-3#1)
mostly due to##10##3##(1990-11#1)(1993-8#1)(2008-1#1)(2008-10#3)(2009-12#1)(2010-6#1)(2011-3#1)(2013-1#1)
mostly expressed##2##2##(2010-4#1)(2013-1#1)
mostly focused on##2##3##(2008-11#1)(2008-8#1)
mostly for##3##2##(1994-9#1)(2008-7#1)(2011-2#1)
mostly found in the##3##4##(1991-2#1)(2008-12#1)(2011-2#1)
mostly found in##5##3##(1991-2#1)(1996-12#1)(1997-8#1)(2008-12#1)(2011-2#1)
mostly from##7##2##(1995-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)
mostly in the form of##2##5##(2008-10#2)
mostly in the##11##3##(1991-12#1)(1992-11#1)(1993-11#1)(2007-11#1)(2008-10#5)(2011-2#1)(2012-2#1)
mostly in##34##2##(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-2#2)(1995-11#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
mostly increased##2##2##(1997-7#1)(2007-9#1)
mostly of##11##2##(1991-8#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
mostly on the##6##3##(1990-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-6#1)
mostly on##10##2##(1990-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
mostly primary##2##2##(1997-4#1)(2009-10#1)
mostly reactive##2##2##(2009-3#1)(2012-3#1)
mostly reported##2##2##(2012-12#1)(2013-1#1)
mostly similar##3##2##(1997-2#1)(2008-7#1)(2011-2#1)
mostly submitted##2##2##(1992-5#2)
mostly the##2##2##(1991-11#1)(2008-10#1)
mostly through##2##2##(1996-11#1)(2008-10#1)
mostly to the##2##3##(2008-10#1)(2010-8#1)
mostly to##7##2##(1992-8#1)(1993-5#1)(2008-10#2)(2009-12#1)(2010-8#1)(2012-3#1)
mostly used##5##2##(1995-5#1)(2008-11#1)(2010-8#1)(2012-12#1)(2012-3#1)
mostly viable myocardium##4##3##(2007-8#4)
mostly with the##2##3##(1992-12#1)(2008-10#1)
mostly with##5##2##(1992-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
mostly within##3##2##(2009-12#1)(2011-2#1)(2013-1#1)
mostly young women##2##3##(1997-8#1)(2012-3#1)
mostly##292##1##(1990-11#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-5#3)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-5#1)(1993-8#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#3)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#56)(2008-11#11)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#5)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#16)(2011-3#2)(2012-12#5)(2012-2#6)(2012-3#15)(2013-1#12)(2013-7#1)(2013-8#2)
moth larvae##2##2##(2008-5#1)(2008-9#1)
moth##21##1##(1990-8#2)(1991-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-8#1)(2010-4#1)(2011-2#4)(2013-8#1)
mother and child##6##3##(1990-6#1)(1994-6#1)(1994-9#1)(1995-1#1)(2008-8#1)(2012-12#1)
mother and fetus##2##3##(2008-10#1)(2008-7#1)
mother and foetus##4##3##(1992-5#1)(1993-6#1)(2007-2#1)(2008-1#1)
mother and her infant##2##4##(1990-12#1)(2010-10#1)
mother and her##4##3##(1990-12#1)(2008-7#1)(2008-9#1)(2010-10#1)
mother and the##4##3##(1997-8#1)(2008-12#1)(2008-2#1)(2011-1#1)
mother and##36##2##(1990-12#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-8#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-10#1)(2011-1#2)(2012-12#2)(2012-3#2)
mother as##3##2##(1991-9#1)(1996-2#1)(2013-1#1)
mother cell##2##2##(2008-7#1)(2011-2#1)
mother cells of##2##3##(2008-10#1)(2009-12#1)
mother cells##6##2##(2007-12#3)(2008-10#2)(2009-12#1)
mother condition##2##2##(2008-9#2)
mother had##3##2##(1991-11#1)(1992-4#1)(1995-8#1)
mother has##2##2##(1997-3#1)(2012-2#1)
mother is##2##2##(1991-9#1)(2012-2#1)
mother liquor containing##2##3##(1993-8#1)(2008-9#1)
mother or##2##2##(1994-2#1)(2008-8#1)
mother plants##4##2##(2008-10#4)
mother plates##2##2##(2008-10#2)
mother present as##3##3##(1996-2#3)
mother to##5##2##(1990-9#1)(1992-6#1)(2007-8#1)(2008-8#1)(2013-1#1)
mother was##5##2##(1990-5#1)(1993-6#1)(2008-7#1)(2011-1#2)
mother##151##1##(1990-10#2)(1990-12#2)(1990-5#1)(1990-6#3)(1990-7#1)(1990-9#4)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-4#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-2#7)(1997-3#4)(1997-5#2)(1997-8#1)(2007-10#1)(2007-12#3)(2007-2#4)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)
mother's age##2##2##(1992-11#1)(2008-11#1)
mother's milk##2##2##(2007-10#1)(2008-10#1)
mother's##24##1##(1990-10#1)(1990-12#1)(1992-11#1)(1992-12#1)(1992-4#3)(1994-12#1)(1994-2#1)(1995-4#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
mother-child##7##1##(1996-1#2)(2008-2#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-2#1)
mother-infant interaction in teaching##2##4##(1990-12#2)
mother-infant interaction in##3##3##(1990-12#3)
mother-infant interaction##6##2##(1990-12#5)(2010-10#1)
mother-infant##8##1##(1990-12#5)(2009-11#1)(2009-9#1)(2010-10#1)
mother-offspring##2##1##(2008-8#2)
mother-preterm infant##2##2##(1992-2#2)
mother-to-child transmission##11##2##(1990-9#1)(2009-4#7)(2009-7#2)(2012-2#1)
mother-to-child##13##1##(1990-9#1)(2009-4#8)(2009-7#3)(2012-2#1)
motherhood##8##1##(1994-3#2)(1995-1#2)(2008-10#1)(2012-12#2)(2013-8#1)
mothering loss##2##2##(2009-9#2)
mothers after##2##2##(2008-2#1)(2011-2#1)
mothers and a##2##3##(1997-5#1)(2007-2#1)
mothers and children##3##3##(1992-2#1)(2008-6#1)(2012-12#1)
mothers and fathers##5##3##(1994-12#1)(2007-5#1)(2009-5#2)(2009-7#1)
mothers and their neonates##2##4##(2011-1#2)
mothers and their##6##3##(1992-2#1)(2007-2#1)(2009-11#2)(2011-1#2)
mothers and##36##2##(1992-12#1)(1992-2#3)(1994-12#2)(1997-5#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#3)
mothers are##4##2##(2008-11#1)(2009-9#1)(2010-5#1)(2012-3#1)
mothers as##5##2##(2009-7#2)(2010-1#1)(2010-2#1)(2011-2#1)
mothers completed##2##2##(2007-2#1)(2010-6#1)
mothers could##2##2##(1993-12#2)
mothers did not have##4##4##(2011-2#3)(2012-2#1)
mothers from##3##2##(1990-2#1)(2011-2#1)(2012-3#1)
mothers had##6##2##(1990-12#1)(1993-12#1)(1993-6#1)(2008-12#1)(2011-2#2)
mothers in caring for their##2##5##(2011-2#1)(2012-3#1)
mothers in the##4##3##(1994-2#1)(1995-1#1)(2007-2#1)(2010-2#1)
mothers in##16##2##(1991-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(2007-2#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
mothers of children with##8##4##(1996-1#2)(2008-9#1)(2010-1#1)(2010-9#1)(2011-2#3)
mothers of sexually abused children##2##5##(2008-2#2)
mothers of very low birthweight infants##2##6##(2010-10#2)
mothers of##24##2##(1990-10#1)(1990-2#1)(1991-1#2)(1991-9#1)(1993-12#1)(1996-1#2)(1997-3#1)(2008-11#1)(2008-2#2)(2008-9#2)(2010-1#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)
mothers on##2##2##(1992-5#1)(2008-10#1)
mothers reported##3##2##(2009-10#1)(2009-9#2)
mothers to##6##2##(1990-10#1)(1995-1#1)(1997-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
mothers use##2##2##(1997-4#1)(2011-1#1)
mothers was##2##2##(1996-12#1)(2009-7#1)
mothers were##10##2##(1990-10#1)(1994-1#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-4#1)(2009-5#2)(2011-2#1)(2013-8#1)
mothers who had##2##3##(1991-11#1)(2011-2#1)
mothers who have##3##3##(1990-10#2)(2011-2#1)
mothers who were##2##3##(2007-2#1)(2012-3#1)
mothers who##19##2##(1990-10#2)(1990-9#1)(1991-11#2)(1993-6#1)(2007-2#3)(2008-10#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
mothers whose children##2##3##(2008-9#1)(2009-6#1)
mothers with a##2##3##(1990-10#1)(2013-8#1)
mothers with depression##2##3##(2009-12#1)(2012-2#1)
mothers with diabetes##2##3##(1996-11#2)
mothers with##21##2##(1990-10#2)(1993-6#1)(1996-11#2)(2007-2#2)(2009-11#1)(2009-12#1)(2009-8#2)(2011-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
mothers##292##1##(1990-10#8)(1990-11#1)(1990-12#1)(1990-2#5)(1990-6#2)(1990-9#1)(1991-1#3)(1991-11#6)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#3)(1992-5#4)(1993-12#5)(1993-3#3)(1993-6#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-1#5)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#1)(2007-2#11)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#8)(2008-4#3)(2008-6#1)(2008-8#6)(2008-9#8)(2009-10#3)(2009-11#12)(2009-12#3)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#10)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-5#4)(2010-6#5)(2010-7#1)(2010-9#1)(2011-1#18)(2011-2#25)(2012-12#5)(2012-2#5)(2012-3#11)(2013-1#12)(2013-8#4)
mothers' and##2##2##(2007-2#1)(2009-7#1)
mothers' attitudes##2##2##(2009-11#2)
mothers' confidence to care for##3##5##(2012-2#3)
mothers' intention to vaccinate their daughters##3##6##(2011-1#3)
mothers'##33##1##(1991-1#1)(1996-1#1)(1996-2#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-5#2)(2009-7#7)(2010-10#1)(2011-1#4)(2012-2#4)(2012-3#2)(2013-1#4)
moths to##2##2##(2007-11#1)(2009-8#1)
moths##11##1##(1991-12#1)(2007-11#1)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#4)(2013-1#1)
motif and a##3##3##(1992-3#1)(1993-12#1)(2010-11#1)
motif and##14##2##(1992-12#1)(1992-3#1)(1993-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
motif are##2##2##(1997-7#1)(2009-6#1)
motif as##3##2##(1990-7#1)(1997-8#1)(2008-7#1)
motif based##2##2##(2008-11#1)(2010-12#1)
motif between##2##2##(1991-6#1)(1994-9#1)
motif characteristic of##2##3##(1994-12#1)(2008-10#1)
motif database##2##2##(1996-10#1)(2008-10#1)
motif for##5##2##(1990-11#2)(1994-9#1)(1995-1#1)(2008-9#1)
motif found in##2##3##(1993-2#1)(2008-8#1)
motif found##3##2##(1993-2#1)(2008-8#1)(2012-12#1)
motif in the##5##3##(1991-9#1)(1993-11#1)(1993-9#1)(2008-8#1)(2008-9#1)
motif in##12##2##(1991-12#1)(1991-9#1)(1993-11#1)(1993-9#1)(1996-8#1)(1997-3#1)(2008-8#1)(2008-9#3)(2009-8#1)(2013-1#1)
motif is required for##2##4##(1995-6#1)(2008-8#1)
motif is##8##2##(1990-7#1)(1995-6#1)(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)
motif of the##4##3##(1990-11#1)(1993-3#1)(1994-11#1)(2008-10#1)
motif of##7##2##(1990-11#1)(1992-4#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-8#2)
motif that is##4##3##(1997-2#1)(1997-7#2)(2008-7#1)
motif that##5##2##(1994-8#1)(1997-2#1)(1997-7#2)(2008-7#1)
motif was##7##2##(1991-7#1)(1995-6#2)(1997-7#1)(2007-11#1)(2012-12#1)(2012-2#1)
motif with##3##2##(1996-2#1)(2008-9#1)(2010-12#1)
motif##179##1##(1990-11#4)(1990-7#3)(1991-12#4)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#3)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-9#2)(1994-11#3)(1994-12#6)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-2#2)(1995-6#14)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-2#6)(1997-3#3)(1997-4#2)(1997-7#6)(1997-8#4)(1997-9#1)(2007-11#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#6)(2008-8#10)(2008-9#11)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#5)
motif)##2##1##(1995-6#1)(2008-10#1)
motifs A##2##2##(1997-8#1)(2008-5#1)
motifs and##6##2##(1995-5#1)(1996-2#2)(2008-4#1)(2008-8#1)(2013-1#1)
motifs are##5##2##(1997-7#1)(2008-7#2)(2012-2#1)(2013-1#1)
motifs can be##2##3##(2008-11#1)(2008-7#1)
motifs can##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
motifs characteristic of the##2##4##(1997-7#1)(2008-8#1)
motifs conserved##2##2##(1995-9#1)(2008-10#1)
motifs found in##3##3##(1992-3#1)(1997-4#1)(2009-11#1)
motifs found##4##2##(1992-3#1)(1997-4#1)(2008-4#1)(2009-11#1)
motifs have##2##2##(1997-4#1)(2008-4#1)
motifs in DNA##2##3##(1994-12#1)(1995-2#1)
motifs in a##2##3##(2008-4#1)(2008-9#1)
motifs in the promoter region##2##5##(1991-6#1)(1995-8#1)
motifs in the##6##3##(1991-6#1)(1993-12#1)(1995-8#1)(2008-10#2)(2008-11#1)
motifs in##26##2##(1991-6#1)(1992-6#1)(1993-12#1)(1994-12#3)(1994-8#1)(1995-2#2)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#2)(2010-6#1)(2012-2#1)(2013-1#1)
motifs of the##5##3##(1991-2#1)(2007-12#1)(2008-10#2)(2008-8#1)
motifs of##14##2##(1991-2#1)(1994-8#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-11#1)(2010-7#2)(2013-1#1)
motifs on##3##2##(1996-2#1)(2008-1#1)(2010-11#1)
motifs present##2##2##(1992-3#1)(2008-4#1)
motifs that##5##2##(1995-6#1)(1996-10#1)(2008-1#1)(2009-2#1)(2010-11#1)
motifs to be##2##3##(2008-4#1)(2012-2#1)
motifs to##3##2##(2008-4#2)(2012-2#1)
motifs with##2##2##(2008-4#1)(2008-9#1)
motifs##146##1##(1990-4#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-3#3)(1992-6#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#4)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#9)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#5)(1997-8#2)(1997-9#1)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#9)(2008-11#6)(2008-4#12)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#4)(2009-11#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#4)(2010-6#1)(2010-7#4)(2011-2#1)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#5)
motile responses of chromatophores##2##4##(2008-5#2)
motile##23##1##(1994-6#1)(1995-2#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#4)(2008-9#1)(2009-4#1)(2011-2#6)(2012-2#2)
motilin 1-12 [CH2 NH]10-11##4##4##(1994-11#4)
motilin 1-12 [CH2##5##3##(1994-11#5)
motilin receptor##4##2##(1994-11#4)
motilin##12##1##(1994-11#12)
motility and invasion##5##3##(2013-8#5)
motility and the##2##3##(1994-8#1)(2011-2#1)
motility and##21##2##(1994-8#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#5)
motility assay##4##2##(1993-9#1)(1995-2#1)(2008-1#2)
motility assays##2##2##(1997-7#1)(2008-11#1)
motility disorder##4##2##(1994-2#1)(2011-1#1)(2011-2#2)
motility disorders##3##2##(2009-10#1)(2013-8#2)
motility factor##2##2##(2008-5#2)
motility in the##2##3##(1992-6#1)(2013-8#1)
motility in vitro##3##3##(1990-4#2)(2008-12#1)
motility in##12##2##(1990-4#2)(1992-6#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#3)
motility is##2##2##(2008-1#1)(2013-8#1)
motility of the##2##3##(1992-12#1)(2011-2#1)
motility of##6##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
motility was##5##2##(1995-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
motility were##2##2##(2008-7#1)(2012-2#1)
motility##129##1##(1990-4#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#3)(1995-11#2)(1995-2#4)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#3)(2007-12#3)(2008-1#4)(2008-10#3)(2008-11#8)(2008-12#9)(2008-4#3)(2008-5#6)(2008-7#14)(2008-9#1)(2009-10#2)(2009-4#2)(2009-6#1)(2009-8#5)(2009-9#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#15)
motion analysis system##2##3##(2011-2#2)
motion analysis to##2##3##(1997-8#1)(2008-3#1)
motion analysis##5##2##(1997-8#1)(2008-3#2)(2011-2#2)
motion and strain quantification##2##4##(2010-6#2)
motion and strain##3##3##(2010-6#3)
motion and the##2##3##(2007-11#1)(2008-8#1)
motion and##21##2##(1993-11#2)(1996-12#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-12#2)(2010-6#3)(2010-9#1)(2012-2#1)
motion are##4##2##(2007-12#1)(2008-3#2)(2008-6#1)
motion artifacts##3##2##(2010-8#1)(2011-1#1)(2012-12#1)
motion as##2##2##(2008-11#1)(2008-12#1)
motion at the##4##3##(2007-11#1)(2008-7#1)(2008-9#1)(2010-1#1)
motion at##5##2##(2007-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)
motion blur##4##2##(2008-2#3)(2008-6#1)
motion by##3##2##(1997-8#1)(2007-12#1)(2008-3#1)
motion cycle##2##2##(2012-1#2)
motion deblurring##2##2##(2008-6#2)
motion detection##3##2##(2008-3#1)(2011-2#2)
motion during##7##2##(1995-5#1)(2008-2#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
motion estimation##5##2##(2008-3#3)(2012-2#2)
motion events##5##2##(2008-4#5)
motion for summary judgment##2##4##(1995-12#1)(1996-12#1)
motion for summary##3##3##(1995-12#2)(1996-12#1)
motion for##6##2##(1995-12#2)(1996-12#1)(2007-12#1)(2008-3#1)(2008-6#1)
motion function##2##2##(2008-2#2)
motion has##2##2##(2007-12#1)(2010-4#1)
motion in a##2##3##(2007-12#1)(2008-12#1)
motion in the##7##3##(1995-5#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
motion in##23##2##(1995-5#2)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#3)(2013-1#1)
motion information##2##2##(2007-8#1)(2008-6#1)
motion is##10##2##(1994-5#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)
motion model and##2##3##(2008-3#1)(2008-8#1)
motion model to##2##3##(2008-3#2)
motion model##7##2##(2008-3#4)(2008-8#3)
motion of a##4##3##(2010-4#1)(2012-2#2)(2013-1#1)
motion of air##2##3##(1996-12#1)(2012-2#1)
motion of the##19##3##(1994-3#1)(1995-5#2)(2007-12#3)(2007-8#2)(2008-3#3)(2008-5#1)(2009-11#1)(2009-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
motion of##39##2##(1994-3#2)(1995-5#2)(1996-12#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#8)(2008-5#1)(2009-11#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)
motion on##3##2##(2007-8#1)(2010-4#1)(2011-1#1)
motion picture of##2##3##(2007-11#1)(2010-8#1)
motion predicted##2##2##(2008-6#1)(2012-3#1)
motion primitives##2##2##(2008-11#2)
motion segment##2##2##(2011-2#1)(2012-2#1)
motion sickness##3##2##(1991-2#1)(2007-2#1)(2008-8#1)
motion that##3##2##(1997-6#1)(2008-11#1)(2008-8#1)
motion to##4##2##(1995-5#1)(2008-11#1)(2008-6#1)(2011-1#1)
motion tracking##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
motion was measured##2##3##(1995-5#2)
motion was##8##2##(1995-5#3)(2007-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
motion were##5##2##(2007-11#2)(2007-8#1)(2008-6#1)(2012-12#1)
motion within the##2##3##(1995-5#1)(2011-2#1)
motion within##3##2##(1995-5#1)(2008-3#1)(2011-2#1)
motion##386##1##(1990-2#1)(1991-2#1)(1992-8#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-12#2)(1995-5#16)(1995-6#1)(1996-12#4)(1996-3#1)(1997-3#3)(1997-6#2)(1997-8#3)(2006-10#1)(2007-11#13)(2007-12#11)(2007-2#1)(2007-8#21)(2008-10#11)(2008-11#19)(2008-12#10)(2008-2#17)(2008-3#39)(2008-4#7)(2008-5#2)(2008-6#26)(2008-7#5)(2008-8#12)(2008-9#17)(2009-1#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#21)(2012-1#11)(2012-12#6)(2012-2#24)(2012-3#10)(2013-1#15)(2013-8#2)
motional resistance##2##2##(2008-10#2)
motionless##3##1##(2008-10#1)(2008-3#1)(2010-12#1)
motions and##5##2##(1995-2#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
motions in##4##2##(1993-11#1)(1995-11#1)(2008-3#1)(2010-8#1)
motions introduced##2##2##(2007-8#1)(2011-1#1)
motions is##2##2##(2008-4#1)(2008-8#1)
motions of the object in two-dimensional space##2##7##(2008-11#2)
motions of the##6##3##(1997-7#1)(2008-11#2)(2009-9#2)(2013-1#1)
motions of##13##2##(1995-5#1)(1997-7#1)(2008-11#4)(2008-3#1)(2009-9#4)(2013-1#2)
motions that##2##2##(1992-9#1)(2009-5#1)
motions were##2##2##(2007-12#1)(2013-8#1)
motions##48##1##(1990-2#1)(1992-9#3)(1993-11#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#5)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
motivate the##5##2##(1995-11#1)(1996-3#1)(2008-3#1)(2008-8#1)(2010-5#1)
motivate##11##1##(1993-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-5#1)(2013-1#1)
motivated by a##2##3##(1992-3#1)(2012-12#1)
motivated by the##3##3##(2008-2#2)(2008-3#1)
motivated by##12##2##(1991-12#1)(1992-3#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-12#1)
motivated patients##3##2##(1990-2#1)(1995-11#1)(2008-3#1)
motivated responding for##2##3##(2009-8#2)
motivated responding##3##2##(2009-8#3)
motivated the##4##2##(1996-6#1)(2008-7#2)(2009-4#1)
motivated to##7##2##(2009-5#1)(2009-6#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
motivated##41##1##(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-3#1)(1995-11#1)(1996-6#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
motivates the##2##2##(2008-11#1)(2008-3#1)
motivates##6##1##(1992-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
motivating##6##1##(1993-2#1)(1996-3#1)(2008-11#3)(2008-4#1)
motivation and##14##2##(1994-1#2)(1994-9#1)(2007-11#1)(2008-12#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
motivation for the##2##3##(2008-2#1)(2008-3#1)
motivation for##11##2##(1990-6#1)(1992-12#1)(1997-3#1)(2008-2#1)(2008-3#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
motivation in the##2##3##(2013-1#2)
motivation in##5##2##(1996-7#1)(2008-12#1)(2013-1#3)
motivation of the##2##3##(1990-3#1)(2010-9#1)
motivation of##4##2##(1990-3#1)(1997-5#1)(2008-4#1)(2010-9#1)
motivation system##2##2##(2008-11#2)
motivation to change##2##3##(2013-8#2)
motivation to##11##2##(1992-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
motivation were##2##2##(2011-1#1)(2013-1#1)
motivation##86##1##(1990-12#1)(1990-3#1)(1990-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-6#3)(1994-1#2)(1994-9#1)(1995-2#1)(1996-3#1)(1996-7#2)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#4)
motivation-related##3##1##(2008-4#3)
motivational and##3##2##(1996-5#1)(2008-1#1)(2010-1#1)
motivational approach##3##2##(2008-4#2)(2008-6#1)
motivational beliefs and##2##3##(2010-1#2)
motivational beliefs##3##2##(2010-1#3)
motivational factors##2##2##(1991-1#1)(2008-12#1)
motivational interventions##2##2##(2008-11#1)(2008-6#1)
motivational interviewing##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
motivational needs##3##2##(1995-2#3)
motivational or##2##2##(1994-3#1)(2008-4#1)
motivational orientation##2##2##(2013-1#2)
motivational processes##2##2##(1994-3#1)(2007-8#1)
motivational stepped care##2##3##(2008-6#2)
motivational systems##2##2##(2007-8#2)
motivational videotape##2##2##(2008-8#2)
motivational##52##1##(1991-1#1)(1993-2#2)(1994-3#2)(1995-2#4)(1996-12#1)(1996-5#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#4)(2008-4#6)(2008-6#6)(2008-8#2)(2010-1#4)(2010-10#1)(2011-2#1)(2013-1#6)(2013-8#3)
motivations and##3##2##(1995-12#1)(2009-7#1)(2009-8#1)
motivations for##3##2##(2007-2#1)(2009-8#1)(2013-1#1)
motivations of##2##2##(1992-2#1)(1993-12#1)
motivations underlying##2##2##(2008-1#1)(2010-12#1)
motivations##20##1##(1992-2#1)(1993-12#3)(1993-2#2)(1995-12#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-7#2)(2009-8#4)(2010-12#1)(2011-1#1)(2013-1#1)
motive##4##1##(1991-2#1)(1996-3#1)(1997-6#1)(2007-12#1)
motives and##2##2##(1992-3#1)(1996-11#1)
motives for##4##2##(1991-12#1)(1993-6#1)(2010-11#2)
motives in##2##2##(1996-3#1)(2007-12#1)
motives##18##1##(1991-12#3)(1992-3#1)(1993-6#1)(1995-12#1)(1996-11#1)(1996-3#3)(2007-12#2)(2009-5#1)(2010-11#5)
motoneuron##7##1##(2007-12#5)(2008-6#2)
motoneuronal##2##1##(1990-5#1)(1996-5#1)
motoneurone##3##1##(1996-2#1)(1996-5#1)(1997-2#1)
motoneurones were##2##2##(1995-12#1)(1997-2#1)
motoneurones##9##1##(1995-12#1)(1995-5#1)(1996-2#1)(1997-2#6)
motoneurons are##2##2##(1990-9#1)(2007-12#1)
motoneurons in the central nervous system##2##6##(2007-12#2)
motoneurons in the##3##3##(1990-7#1)(2007-12#2)
motoneurons in##5##2##(1990-7#1)(1997-2#1)(2007-12#3)
motoneurons##16##1##(1990-7#2)(1990-9#1)(1992-6#1)(1997-2#2)(2007-12#10)
motor abilities##3##2##(1997-2#1)(2008-2#1)(2008-7#1)
motor activity and##7##3##(1991-2#4)(1995-12#1)(2007-8#2)
motor activity in##3##3##(1997-4#1)(2008-12#1)(2011-2#1)
motor activity##21##2##(1990-5#1)(1991-2#5)(1994-2#1)(1994-8#1)(1995-12#1)(1997-4#1)(2007-11#4)(2007-8#2)(2008-12#3)(2008-7#1)(2011-2#1)
motor and cognitive##2##3##(1995-2#1)(2008-7#1)
motor and nonmotor functions and##2##5##(2007-8#2)
motor and premotor##2##3##(2008-11#1)(2012-1#1)
motor and sensory neuropathy##3##4##(1995-5#1)(2009-10#1)(2013-1#1)
motor and sensory symptoms##2##4##(2007-10#2)
motor and sensory##7##3##(1995-5#1)(2007-10#2)(2009-10#1)(2013-1#3)
motor and##20##2##(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-5#1)(2007-10#2)(2007-11#3)(2007-8#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)(2012-1#1)(2013-1#3)
motor area##6##2##(2008-11#2)(2008-9#2)(2009-6#2)
motor areas was##2##3##(2008-1#1)(2009-6#1)
motor areas##3##2##(2008-1#2)(2009-6#1)
motor axonal polyneuropathy##2##3##(2012-3#2)
motor axonal##3##2##(2008-7#1)(2012-3#2)
motor behaviors##3##2##(1993-12#1)(2007-12#1)(2012-2#1)
motor behaviour in##2##3##(1993-3#1)(2007-12#1)
motor behaviour##4##2##(1993-3#1)(2007-12#1)(2008-7#2)
motor branch of the##2##4##(2008-9#2)
motor branch##3##2##(2008-9#3)
motor complications##8##2##(2008-7#3)(2010-12#5)
motor control##9##2##(1990-5#1)(1994-8#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2013-1#1)
motor coordination and balance##2##4##(2008-4#2)
motor coordination and##4##3##(1993-12#1)(2008-12#1)(2008-4#2)
motor coordination##8##2##(1993-12#1)(1996-7#1)(1997-2#1)(2008-12#1)(2008-4#2)(2009-2#1)(2013-1#1)
motor cortex in##2##3##(1991-6#1)(2009-5#1)
motor cortex neurons##2##3##(1991-6#2)
motor cortex stimulation##4##3##(2010-7#4)
motor cortex##23##2##(1991-6#5)(1997-2#1)(2008-7#3)(2009-5#1)(2010-7#8)(2011-2#2)(2012-2#1)(2013-8#2)
motor cortical##2##2##(2008-11#1)(2010-7#1)
motor cortices##2##2##(1996-5#1)(2008-11#1)
motor deficit##3##2##(2008-7#2)(2010-7#1)
motor deficits in##2##3##(1994-5#1)(2008-7#1)
motor deficits##5##2##(1994-5#1)(1996-5#1)(2008-7#3)
motor development milestones##2##3##(2010-6#2)
motor development##4##2##(2007-12#1)(2010-6#2)(2012-3#1)
motor difficulties##2##2##(2008-5#1)(2013-1#1)
motor disability##4##2##(2008-7#4)
motor disorders##2##2##(1996-2#1)(1997-6#1)
motor dysfunction##2##2##(1991-5#1)(2008-7#1)
motor engrams##2##2##(1994-8#1)(2013-8#1)
motor evoked potential##4##3##(2008-7#2)(2011-2#2)
motor evoked potentials in##2##4##(1996-6#1)(2011-2#1)
motor evoked potentials##4##3##(1996-6#2)(2010-8#1)(2011-2#1)
motor evoked##8##2##(1996-6#2)(2008-7#2)(2010-8#1)(2011-2#3)
motor features##2##2##(2010-12#2)
motor fluctuation##9##2##(2013-1#9)
motor fluctuations##5##2##(2008-7#5)
motor function by##2##3##(2011-2#1)(2012-2#1)
motor function in##3##3##(2008-7#1)(2011-2#2)
motor function##27##2##(1993-5#1)(1994-3#1)(1994-5#2)(1995-5#1)(1997-2#1)(2008-11#1)(2008-7#5)(2010-11#1)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
motor functions##3##2##(2008-7#2)(2010-9#1)
motor imagery (MI)##2##3##(2013-8#2)
motor imagery##7##2##(2009-6#3)(2013-8#4)
motor impairment by intracerebellar##2##4##(1997-2#2)
motor impairment by##3##3##(1997-2#3)
motor impairment##9##2##(1992-3#1)(1995-2#1)(1997-2#7)
motor initiation##3##2##(1991-6#3)
motor involvement##2##2##(1991-6#1)(2008-7#1)
motor manifestations##2##2##(1990-5#1)(2011-8#1)
motor map##2##2##(1991-5#2)
motor nerve endings##2##3##(2008-4#1)(2008-8#1)
motor nerve terminals##2##3##(2008-8#1)(2012-3#1)
motor nerve##6##2##(2008-4#1)(2008-8#3)(2010-11#1)(2012-3#1)
motor nerves in##2##3##(1993-5#1)(2008-9#1)
motor nerves##6##2##(1993-5#1)(2007-12#2)(2008-7#1)(2008-9#1)(2010-1#1)
motor neuron disease##2##3##(1996-12#1)(2008-5#1)
motor neuron diseases##2##3##(2008-7#1)(2012-3#1)
motor neuron##12##2##(1990-5#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#3)(2012-3#2)(2013-1#2)
motor neurone disease##3##3##(2011-2#3)
motor neurone loss##2##3##(1996-5#2)
motor neurone##10##2##(1994-11#1)(1995-12#3)(1996-5#3)(2011-2#3)
motor neurones##3##2##(1995-12#3)
motor neurons and##2##3##(1990-5#1)(2009-8#1)
motor neurons is##3##3##(1990-5#1)(2008-7#1)(2013-1#1)
motor neurons##11##2##(1990-5#4)(1996-12#1)(2008-4#1)(2008-7#3)(2009-8#1)(2013-1#1)
motor nucleus of the vagus##3##5##(1993-12#2)(1994-2#1)
motor nucleus##6##2##(1990-9#1)(1993-12#2)(1994-2#1)(1997-2#2)
motor output##3##2##(1993-6#1)(1994-2#1)(2008-4#1)
motor output/response organization##3##3##(2008-2#3)
motor outputs##3##2##(2007-12#3)
motor patterns##2##2##(1993-6#1)(1994-8#1)
motor performance##9##2##(1991-12#1)(1991-2#1)(2008-7#2)(2009-12#2)(2011-2#3)
motor preparation##2##2##(2008-7#2)
motor protein##2##2##(1995-2#1)(2008-11#1)
motor proteins##7##2##(2008-11#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#2)
motor recovery##2##2##(2013-1#2)
motor regulation##2##2##(2008-1#2)
motor response##4##2##(1990-5#2)(2008-9#1)(2010-1#1)
motor responses were##2##3##(1993-12#1)(1996-2#1)
motor responses##5##2##(1993-12#3)(1994-9#1)(1996-2#1)
motor scores##2##2##(2008-7#2)
motor seizure##4##2##(1994-2#2)(2010-1#2)
motor seizures##2##2##(2008-4#1)(2010-1#1)
motor set##2##2##(1995-5#2)
motor skill##2##2##(1992-11#1)(2009-6#1)
motor skills in##2##3##(1994-8#1)(2009-10#1)
motor skills##4##2##(1994-8#1)(2008-12#1)(2009-10#1)(2010-8#1)
motor stimulating effects##2##3##(1994-2#1)(1996-5#1)
motor strategies##2##2##(1993-3#1)(2009-2#1)
motor symptoms of##2##3##(2008-7#2)
motor symptoms##6##2##(2008-7#2)(2009-6#1)(2010-12#2)(2013-8#1)
motor system##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
motor systems##3##2##(1990-11#1)(2008-12#1)(2008-7#1)
motor unit##2##2##(1993-12#1)(1993-9#1)
motor units and##2##3##(1993-12#1)(2013-8#1)
motor units##12##2##(1993-12#3)(1993-9#2)(1995-12#1)(1996-5#2)(2013-1#1)(2013-8#3)
motor vehicle accident##4##3##(2008-7#2)(2009-4#1)(2012-3#1)
motor vehicle accidents##5##3##(1990-9#1)(1994-3#1)(2009-3#1)(2009-4#1)(2010-12#1)
motor vehicle traffic##2##3##(1992-3#1)(2008-11#1)
motor vehicle##13##2##(1990-9#1)(1992-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-4#2)(2010-12#1)(2012-2#1)(2012-3#1)
motor vehicles##3##2##(1990-6#1)(1996-1#1)(2011-1#1)
motor weakness##4##2##(2007-10#2)(2008-7#1)(2013-8#1)
motor##506##1##(1990-11#1)(1990-12#1)(1990-5#14)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#6)(1991-5#5)(1991-6#9)(1992-11#2)(1992-3#2)(1992-6#2)(1993-12#15)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#3)(1994-11#1)(1994-2#7)(1994-3#3)(1994-5#3)(1994-8#6)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#3)(1995-5#6)(1996-1#1)(1996-12#4)(1996-2#4)(1996-5#10)(1996-6#2)(1996-7#1)(1997-2#20)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2007-10#7)(2007-11#8)(2007-12#14)(2007-8#8)(2008-1#4)(2008-10#4)(2008-11#13)(2008-12#7)(2008-2#5)(2008-3#6)(2008-4#11)(2008-5#3)(2008-7#72)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#10)(2009-8#2)(2010-1#5)(2010-11#3)(2010-12#13)(2010-5#3)(2010-6#3)(2010-7#12)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#28)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#11)(2013-1#30)(2013-8#15)
motor'##2##1##(2008-7#2)
motor-driven##2##1##(1994-8#1)(2007-11#1)
motor-evoked potentials (MEPs)##2##3##(2010-7#1)(2011-2#1)
motor-evoked potentials##3##2##(2010-7#2)(2011-2#1)
motor-evoked##6##1##(2008-7#1)(2010-7#2)(2011-2#3)
motorcycle accidents##2##2##(2012-12#2)
motorcycle##4##1##(2008-10#1)(2012-12#2)(2013-1#1)
motorcyclists##2##1##(2012-12#2)
motorized##6##1##(2008-10#2)(2008-2#1)(2008-9#3)
motors are##2##2##(2008-10#1)(2009-12#1)
motors that move##2##3##(2008-7#1)(2010-12#1)
motors that##3##2##(2008-7#2)(2010-12#1)
motors##14##1##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-12#5)(2009-8#1)(2010-12#3)
motorways##2##1##(2008-10#1)(2008-11#1)
mottle mosaic virus and##2##4##(2008-10#2)
mottle mosaic virus##8##3##(2008-10#8)
mottle potyvirus##3##2##(2008-10#3)
mottle virus and##3##3##(2008-10#3)
mottle virus in##2##3##(2008-10#2)
mottle virus##52##2##(1992-8#2)(1997-6#2)(2008-10#45)(2008-9#3)
mottle##76##1##(1992-8#2)(1995-12#2)(1997-6#2)(2008-10#67)(2008-9#3)
mottled##4##1##(1997-6#1)(2008-10#1)(2008-12#2)
mottling##3##1##(2008-10#3)
mould and##2##2##(2008-11#1)(2008-5#1)
mould##5##1##(1997-5#1)(2008-11#1)(2008-5#3)
moulds##4##1##(2008-11#1)(2008-5#2)(2013-8#1)
moulting##2##1##(1995-8#1)(2007-12#1)
mounds##12##1##(2008-12#12)
mount a##7##2##(1995-12#1)(1995-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)
mount an##2##2##(2008-4#1)(2008-7#1)
mount##32##1##(1995-12#1)(1995-2#1)(1996-5#2)(1997-1#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#2)(2013-8#3)
mountain range##2##2##(2008-8#1)(2013-1#1)
mountain##26##1##(1991-2#1)(1992-2#3)(1995-2#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#4)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
mountainous regions of##2##3##(1996-12#1)(2008-1#1)
mountainous##11##1##(1996-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2013-7#1)
mountains##7##1##(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2013-8#1)
mounted a##2##2##(1992-2#1)(1994-12#1)
mounted at##2##2##(2008-2#1)(2008-3#1)
mounted in a##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
mounted in##7##2##(1993-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
mounted on a##7##3##(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)
mounted on the##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
mounted on##14##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
mounted onto##2##2##(2008-5#1)(2012-1#1)
mounted with its tangential##2##4##(2008-3#2)
mounted##40##1##(1992-2#1)(1993-8#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#11)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#4)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
mounting for##3##2##(2008-3#3)
mounting the##2##2##(2008-8#1)(2008-9#1)
mounting##23##1##(1991-3#1)(1994-2#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#9)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)
mounts and##3##2##(1991-2#2)(2007-12#1)
mounts##9##1##(1991-2#2)(1992-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#2)(2013-1#1)
mouse 2##2##2##(1990-8#2)
mouse 5'##2##2##(1991-6#1)(1992-11#1)
mouse DNA##3##2##(1990-7#2)(1991-12#1)
mouse E-selectin was##2##3##(1993-8#2)
mouse E-selectin##4##2##(1993-8#4)
mouse ES cell lines##2##4##(2012-2#2)
mouse ES cells##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
mouse ES##6##2##(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#2)
mouse IL-18##3##2##(2008-4#3)
mouse IL-6##2##2##(2008-4#2)
mouse IgG##9##2##(1994-5#1)(2008-10#7)(2008-12#1)
mouse IgM##2##2##(1991-9#1)(1994-2#1)
mouse L cells##3##3##(1990-2#2)(1993-11#1)
mouse Leydig tumor cells##2##4##(1996-5#2)
mouse Leydig##3##2##(1996-5#3)
mouse S-adenosylmethionine decarboxylase##2##3##(1992-11#2)
mouse TrkB mRNA##2##3##(2008-9#2)
mouse TrkB##3##2##(2008-9#3)
mouse alpha##2##2##(1993-3#1)(1996-12#1)
mouse and human##27##3##(1991-6#2)(1992-8#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-5#1)(1997-7#2)(1997-8#1)(2008-11#1)(2008-4#5)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
mouse and rabbit##2##3##(1991-6#1)(1997-7#1)
mouse and rat##13##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-2#3)(1995-11#1)(1996-5#1)(2008-7#1)(2008-9#1)
mouse and##52##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-7#3)(1997-8#1)(2008-11#1)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#4)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
mouse anterior pituitary cells##2##4##(1990-5#2)
mouse anterior pituitary##4##3##(1990-5#4)
mouse at a##3##3##(1990-7#2)(2008-4#1)
mouse beta2m##2##2##(1997-9#2)
mouse bioassay##3##2##(1997-4#3)
mouse blastocyst##2##2##(2008-5#2)
mouse blastocysts##4##2##(2008-11#2)(2008-5#1)(2013-8#1)
mouse blood##2##2##(2008-10#2)
mouse bone marrow##8##3##(1993-8#1)(2008-11#3)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
mouse bone marrow-derived##2##3##(1992-10#1)(2008-11#1)
mouse bone##10##2##(1992-10#1)(1993-8#1)(2008-11#4)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
mouse bone-marrow##2##2##(1990-11#1)(1993-9#1)
mouse brain by##3##3##(1990-11#1)(1995-2#1)(1996-12#1)
mouse brain were##2##3##(1990-11#1)(1996-2#1)
mouse brain##25##2##(1990-11#2)(1990-7#2)(1991-1#1)(1992-11#1)(1992-6#1)(1993-8#2)(1994-5#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
mouse c-kit promoter##2##3##(1993-3#2)
mouse cDNA##3##2##(1992-12#1)(1993-8#1)(1997-7#1)
mouse cancer##3##2##(2008-8#2)(2008-9#1)
mouse cell lines##2##3##(1990-2#1)(1991-5#1)
mouse cell##3##2##(1990-2#1)(1991-5#1)(1992-6#1)
mouse cells and##2##3##(1997-7#1)(2012-1#1)
mouse cells##11##2##(1990-2#1)(1990-7#1)(1992-6#1)(1993-12#1)(1994-8#1)(1997-7#3)(2008-11#1)(2008-3#1)(2012-1#1)
mouse cerebral cortex slices##2##4##(1994-8#2)
mouse cerebral cortex##3##3##(1994-8#2)(2008-11#1)
mouse cerebral##4##2##(1994-8#2)(1995-12#1)(2008-11#1)
mouse chromosome 6##2##3##(1995-2#2)
mouse chromosome##8##2##(1993-2#1)(1995-2#2)(1995-6#1)(1996-10#1)(1997-2#1)(2008-7#2)
mouse chromosomes##2##2##(2008-11#1)(2008-9#1)
mouse development##2##2##(1994-9#1)(1995-2#1)
mouse dorsal##2##2##(2008-10#1)(2013-8#1)
mouse ear swelling test##2##4##(2008-9#2)
mouse ear##4##2##(1991-8#1)(1992-9#1)(2008-9#2)
mouse embryo fibroblasts##2##3##(1991-6#1)(2007-8#1)
mouse embryo##9##2##(1991-12#2)(1991-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)
mouse embryonic fibroblasts enhanced##2##4##(2013-1#2)
mouse embryonic fibroblasts##5##3##(1993-11#1)(2008-2#2)(2013-1#2)
mouse embryonic stem (ES) cells##5##5##(1992-12#1)(1995-2#1)(2008-11#2)(2009-3#1)
mouse embryonic stem cells##7##4##(1995-2#3)(2008-11#3)(2008-9#1)
mouse embryonic stem##12##3##(1992-12#1)(1995-2#4)(2008-11#5)(2008-9#1)(2009-3#1)
mouse embryonic##22##2##(1992-12#1)(1993-11#1)(1995-2#5)(1997-4#1)(2008-11#5)(2008-2#2)(2008-8#2)(2008-9#1)(2009-3#1)(2013-1#3)
mouse embryos exposed##2##3##(1995-3#1)(1996-5#1)
mouse embryos were##2##3##(1995-3#2)
mouse embryos##23##2##(1992-5#1)(1993-9#1)(1995-3#5)(1995-8#1)(1996-5#2)(1997-6#2)(1997-7#2)(2008-10#2)(2008-2#3)(2008-5#2)(2008-6#1)(2012-3#1)
mouse erythroleukemia cell line##2##4##(2008-9#2)
mouse erythroleukemia cells##2##3##(1992-8#2)
mouse erythroleukemia##4##2##(1992-8#2)(2008-9#2)
mouse fetus##2##2##(1992-11#1)(2012-12#1)
mouse fibroblast cells##2##3##(1995-11#1)(2012-12#1)
mouse fibroblast##6##2##(1990-11#1)(1990-7#1)(1993-6#1)(1995-11#1)(2008-8#1)(2012-12#1)
mouse fibroblasts##6##2##(1991-2#1)(1993-11#1)(1994-9#1)(1997-7#1)(2008-8#1)(2013-1#1)
mouse for##2##2##(1993-3#1)(2013-1#1)
mouse gene##5##2##(1992-6#1)(1995-6#1)(1997-7#1)(2008-4#2)
mouse genomic DNA##3##3##(1993-12#1)(1997-2#1)(2008-4#1)
mouse genomic##5##2##(1993-12#1)(1996-10#1)(1997-2#1)(2008-4#1)(2009-5#1)
mouse glioma G-26 and##2##4##(1994-11#2)
mouse glioma G-26##3##3##(1994-11#3)
mouse glioma##5##2##(1994-11#4)(1995-2#1)
mouse glycophorin A##2##3##(1991-5#2)
mouse glycophorin gene##2##3##(1991-5#2)
mouse glycophorin##4##2##(1991-5#4)
mouse hepa 1 cells##2##4##(2008-11#2)
mouse hepatoma##3##2##(1992-8#1)(2012-3#2)
mouse hippocampal##2##2##(1995-8#1)(2012-2#1)
mouse homologues##3##2##(1993-8#1)(1997-7#1)(2008-7#1)
mouse hybridoma cell##2##3##(1990-8#1)(2008-10#1)
mouse hybridoma##4##2##(1990-8#1)(2008-10#1)(2008-11#2)
mouse hypothalamus and cortex##2##4##(1994-2#2)
mouse immunoglobulin G##2##3##(2008-10#2)
mouse in##2##2##(2008-4#1)(2008-8#1)
mouse inhibin alpha-subunit##2##3##(1996-5#2)
mouse is##3##2##(1992-9#1)(2008-11#1)(2008-4#1)
mouse islet insulin secretion##2##4##(2010-11#2)
mouse islet##3##2##(2010-11#3)
mouse islets##5##2##(1994-8#3)(2008-1#1)(2010-11#1)
mouse kidney##8##2##(1990-12#1)(1990-2#1)(1992-3#1)(1996-5#2)(1997-4#1)(1997-7#1)(2012-12#1)
mouse lens##4##2##(1991-9#3)(1993-2#1)
mouse limb mesenchyme##2##3##(2008-11#2)
mouse liver and skeletal muscle##2##5##(1990-5#2)
mouse liver and##3##3##(1990-5#2)(2008-9#1)
mouse liver microsomes##2##3##(1994-8#1)(1997-7#1)
mouse liver##19##2##(1990-5#2)(1991-8#2)(1992-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-7#4)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
mouse low density lipoprotein receptor##2##5##(1993-3#2)
mouse low##3##2##(1993-3#2)(1997-2#1)
mouse lung##6##2##(1990-7#2)(1991-8#1)(1994-8#1)(1995-3#1)(1996-12#1)
mouse lymphocytes##2##2##(1992-5#2)
mouse mRNA##2##2##(1997-7#1)(2012-2#1)
mouse macrophage J774 cells##2##4##(1990-7#2)
mouse macrophage##4##2##(1990-7#2)(1993-3#1)(1995-2#1)
mouse macrophages##7##2##(1994-11#1)(1994-8#1)(1995-2#4)(2012-12#1)
mouse mammary gland##3##3##(2008-7#1)(2008-8#1)(2009-12#1)
mouse mammary tumor virus (MMTV)##3##5##(1994-11#1)(1994-12#1)(1994-7#1)
mouse mammary tumor virus##4##4##(1994-11#2)(1994-12#1)(1994-7#1)
mouse mammary tumor##5##3##(1990-11#1)(1994-11#2)(1994-12#1)(1994-7#1)
mouse mammary##15##2##(1990-11#1)(1991-12#2)(1991-2#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-7#1)(1995-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)
mouse melanoma cell##2##3##(2008-11#2)
mouse melanoma cells##2##3##(1993-5#1)(2008-11#1)
mouse melanoma##7##2##(1993-5#2)(2008-11#4)(2008-9#1)
mouse midbrain##2##2##(1995-12#1)(1996-12#1)
mouse model and##2##3##(2008-2#1)(2011-2#1)
mouse model for studying##2##4##(1994-11#1)(1995-2#1)
mouse model for##7##3##(1994-11#1)(1995-2#1)(1995-6#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
mouse model of##16##3##(1992-8#1)(1995-2#1)(1996-5#1)(2008-10#2)(2009-6#1)(2012-12#2)(2012-2#6)(2013-1#1)(2013-7#1)
mouse model with##2##3##(2013-1#1)(2013-8#1)
mouse model would be##2##4##(1994-11#1)(2008-6#1)
mouse model##56##2##(1992-2#1)(1992-8#1)(1994-11#3)(1994-5#1)(1995-2#3)(1995-6#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#5)(2012-2#7)(2013-1#5)(2013-7#1)(2013-8#2)
mouse models of human disease##3##5##(2008-11#1)(2008-4#2)
mouse models of human##4##4##(2008-11#1)(2008-4#2)(2008-7#1)
mouse models of##12##3##(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
mouse models##33##2##(1994-5#1)(1997-1#1)(2008-11#2)(2008-2#3)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-5#1)(2010-7#6)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#2)
mouse monoclonal antibodies##5##3##(1993-12#1)(1996-5#1)(1997-6#1)(2008-10#2)
mouse monoclonal antibody##3##3##(1991-5#1)(1996-12#1)(2008-7#1)
mouse monoclonal##9##2##(1991-5#1)(1993-12#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-7#1)
mouse muscle##2##2##(1991-11#1)(2008-4#1)
mouse mutant##4##2##(1990-12#2)(1996-2#2)
mouse myeloma cell line##4##4##(2008-11#4)
mouse myeloma cells##4##3##(1994-5#1)(2008-11#3)
mouse myeloma##8##2##(1994-5#1)(2008-11#7)
mouse neocortex##3##2##(1996-6#1)(2008-11#2)
mouse neuroblastoma cells##2##3##(1991-6#1)(1992-6#1)
mouse neuroblastoma##4##2##(1991-2#1)(1991-6#1)(1992-6#1)(1994-11#1)
mouse oocytes##2##2##(2008-8#1)(2008-9#1)
mouse organs##2##2##(1991-8#1)(1997-7#1)
mouse ornithine decarboxylase gene##2##4##(1991-2#2)
mouse ovaries and##2##3##(1994-2#1)(1995-2#1)
mouse ovaries##3##2##(1994-2#1)(1995-2#1)(2012-3#1)
mouse pancreas##4##2##(2010-11#4)
mouse peripheral blood erythrocytes##8##4##(2008-8#1)(2008-9#7)
mouse peripheral##9##2##(2008-7#1)(2008-8#1)(2008-9#7)
mouse peritoneal macrophages##7##3##(1993-6#2)(1994-9#1)(1995-2#2)(2007-2#1)(2008-10#1)
mouse peritoneal##9##2##(1992-5#1)(1993-6#2)(1994-9#1)(1995-2#2)(2007-2#1)(2008-10#1)(2008-11#1)
mouse phenotyping##3##2##(2008-2#3)
mouse pituitary##2##2##(1992-12#1)(1993-3#1)
mouse plasma##3##2##(1992-11#1)(1996-5#1)(2008-9#1)
mouse pneumonitis biovar##2##3##(1991-9#2)
mouse purH-negative mutant##2##3##(1995-12#2)
mouse retinas##2##2##(1994-9#1)(2010-1#1)
mouse s-SOD##3##2##(1997-4#3)
mouse salivary mesenchyme cells##2##4##(1991-2#2)
mouse salivary##3##2##(1991-2#2)(2008-4#1)
mouse serum##5##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-5#1)
mouse skeletal muscle##2##3##(2008-3#1)(2008-7#1)
mouse skeletal##3##2##(2008-3#2)(2008-7#1)
mouse skin##16##2##(1990-11#3)(1990-7#1)(1992-2#3)(1992-9#2)(1994-2#1)(1995-9#1)(1997-4#3)(2008-5#1)(2012-2#1)
mouse small##4##2##(1993-11#1)(1993-6#1)(1993-9#2)
mouse spinal cord##2##3##(1993-9#1)(2008-11#1)
mouse splenocytes##3##2##(1991-1#1)(2008-10#1)(2008-9#1)
mouse stocks##4##2##(2009-5#4)
mouse stomach##2##2##(1995-2#1)(1995-6#1)
mouse strain##6##2##(1991-1#1)(1993-3#1)(1996-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
mouse strains with##2##3##(2008-2#1)(2008-8#1)
mouse strains##18##2##(1990-12#2)(1991-1#2)(1991-5#1)(1996-12#2)(1997-7#2)(2008-10#2)(2008-2#3)(2008-5#2)(2008-8#1)(2011-2#1)
mouse tail-flick test##3##3##(1991-1#2)(1992-8#1)
mouse testis##2##2##(1995-6#1)(1995-8#1)
mouse that##2##2##(1992-3#1)(2008-5#1)
mouse thymic dendritic cells##2##4##(2008-8#2)
mouse thymic medullary##2##3##(2008-8#2)
mouse thymic##5##2##(2008-8#5)
mouse thymocytes to##2##3##(1994-2#1)(1995-8#1)
mouse thymocytes##4##2##(1994-2#1)(1994-3#1)(1995-8#2)
mouse thymus##4##2##(1997-4#2)(2008-4#1)(2008-9#1)
mouse tissues and##2##3##(1993-8#1)(1995-6#1)
mouse tissues by##2##3##(2008-11#2)
mouse tissues##12##2##(1990-3#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-6#1)(2008-11#4)(2008-9#3)
mouse to##2##2##(2008-2#1)(2008-4#1)
mouse transformant cells##2##3##(1995-12#2)
mouse transformant##3##2##(1995-12#3)
mouse urine##3##2##(1990-12#2)(1992-3#1)
mouse uterine##2##2##(2008-6#1)(2012-2#1)
mouse visual cortex##2##3##(2008-11#2)
mouse was##4##2##(1991-6#1)(1995-11#1)(2008-9#2)
mouse##1084##1##(1990-11#14)(1990-12#10)(1990-2#6)(1990-3#1)(1990-5#9)(1990-7#16)(1990-8#5)(1991-1#8)(1991-11#1)(1991-12#12)(1991-2#11)(1991-5#10)(1991-6#14)(1991-8#6)(1991-9#14)(1992-10#1)(1992-11#12)(1992-12#9)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#5)(1992-6#10)(1992-8#12)(1992-9#9)(1993-1#2)(1993-11#6)(1993-12#8)(1993-2#11)(1993-3#17)(1993-5#4)(1993-6#13)(1993-8#21)(1993-9#5)(1994-11#14)(1994-12#12)(1994-2#12)(1994-3#3)(1994-5#11)(1994-6#1)(1994-7#1)(1994-8#11)(1994-9#9)(1995-11#5)(1995-12#8)(1995-2#37)(1995-3#15)(1995-5#2)(1995-6#14)(1995-8#9)(1995-9#3)(1996-10#3)(1996-12#15)(1996-2#4)(1996-5#19)(1996-6#3)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#18)(1997-6#3)(1997-7#28)(1997-8#4)(1997-9#7)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#49)(2008-11#71)(2008-12#4)(2008-2#24)(2008-3#8)(2008-4#68)(2008-5#12)(2008-6#6)(2008-7#24)(2008-8#38)(2008-9#47)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#13)(2010-12#1)(2010-3#3)(2010-5#2)(2010-6#4)(2010-7#6)(2010-8#2)(2011-1#2)(2011-2#16)(2011-9#1)(2012-1#1)(2012-12#17)(2012-2#28)(2012-3#8)(2013-1#16)(2013-7#1)(2013-8#9)
mouse)##7##1##(1994-12#1)(1995-2#1)(1997-9#1)(2008-11#1)(2010-11#3)
mouse-mouse##4##1##(1990-12#1)(1994-2#2)(1994-5#1)
mouse/human##2##1##(1994-12#1)(2010-12#1)
mouth and cervix##3##3##(2013-1#3)
mouth and pharynx##3##3##(1990-8#2)(2011-2#1)
mouth and##16##2##(1990-6#1)(1990-8#2)(1995-3#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#3)
mouth cancer incidence##2##3##(2008-1#2)
mouth feel##2##2##(2010-3#1)(2010-5#1)
mouth for##2##2##(2008-10#1)(2010-5#1)
mouth in##10##2##(2006-10#1)(2008-11#2)(2008-5#3)(2010-5#2)(2012-2#1)(2013-1#1)
mouth opening##3##2##(1991-2#2)(2008-5#1)
mouth parts##2##2##(2008-10#2)
mouth system##4##2##(2008-10#4)
mouth##120##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#3)(1991-2#3)(1991-4#1)(1991-9#1)(1993-12#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#5)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#6)(2008-3#1)(2008-5#17)(2008-6#1)(2008-8#1)(2009-10#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#8)(2010-8#3)(2011-2#9)(2012-12#1)(2012-2#3)(2013-1#8)(2013-8#2)
mouth-opening##3##1##(2008-10#1)(2008-5#2)
mouthguards##3##1##(2008-11#3)
mouthparts and##2##2##(2007-12#1)(2008-12#1)
mouthparts##5##1##(2007-12#4)(2008-12#1)
mouthrinse##2##1##(2012-3#2)
mouths##3##1##(2008-10#2)(2010-5#1)
mouthwash##2##1##(1991-3#1)(2013-1#1)
movable##13##1##(1994-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)
move across##2##2##(2007-11#1)(2008-9#1)
move away from##2##3##(2008-1#1)(2008-11#1)
move beyond##6##2##(1992-2#1)(1993-12#1)(1994-1#1)(2008-12#1)(2009-8#1)(2013-1#1)
move forward##3##2##(1996-1#1)(2011-1#2)
move freely##2##2##(2008-10#1)(2008-8#1)
move from##11##2##(1993-12#1)(1995-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
move in a##3##3##(1994-12#1)(2008-3#1)(2008-7#1)
move in##6##2##(1994-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
move into the##4##3##(1995-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
move into##8##2##(1994-5#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#1)
move the##4##2##(2008-12#1)(2008-6#1)(2011-1#2)
move this##2##2##(2008-11#1)(2011-2#1)
move through a##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
move to a##4##3##(1997-8#1)(2008-11#1)(2008-7#1)(2010-10#1)
move to neighboring cells##2##4##(2008-10#2)
move to##14##2##(1993-8#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)
move together##2##2##(2007-12#1)(2008-9#1)
move toward##6##2##(1994-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)
move towards##6##2##(1996-7#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-3#1)(2012-3#1)
move with##3##2##(2007-11#1)(2008-6#1)(2008-8#1)
move within##2##2##(1997-1#1)(2012-3#1)
move##118##1##(1990-3#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-5#1)(1995-1#2)(1995-2#2)(1996-1#2)(1996-7#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#6)(2007-5#1)(2008-1#3)(2008-10#13)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
moved at##2##2##(1996-12#1)(2008-5#1)
moved away from##4##3##(1991-3#1)(2008-3#1)(2010-7#1)(2011-2#1)
moved away##5##2##(1991-3#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
moved from the##2##3##(2008-9#1)(2011-2#1)
moved from##5##2##(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
moved in the##2##3##(1995-2#1)(2008-8#1)
moved into the##2##3##(2008-10#2)
moved out of##2##3##(1991-1#1)(2007-10#1)
moved the##4##2##(2007-12#1)(2008-10#2)(2010-8#1)
moved through##2##2##(1994-2#1)(2008-1#1)
moved to the##5##3##(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
moved to##18##2##(1994-3#2)(1997-4#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-5#1)
moved with##3##2##(1996-12#1)(2008-10#1)(2012-1#1)
moved##72##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#1)(1994-2#1)(1994-3#3)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-4#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#1)(2009-4#2)(2009-7#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#2)
movement across the##2##3##(1990-12#1)(2009-10#1)
movement after##2##2##(2008-7#1)(2011-2#1)
movement among##2##2##(2008-10#1)(2011-2#1)
movement amplitude##3##2##(1990-11#1)(2008-7#2)
movement analysis##4##2##(1994-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
movement and the##2##3##(1994-8#1)(2007-8#1)
movement and##21##2##(1990-9#1)(1993-12#1)(1993-2#1)(1994-8#1)(1997-3#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
movement are controlled by##2##4##(1990-5#2)
movement are##5##2##(1990-5#2)(2007-12#1)(2008-3#1)(2013-8#1)
movement as##3##2##(2008-12#1)(2008-7#1)(2009-8#1)
movement at##3##2##(1991-2#1)(2011-2#1)(2012-2#1)
movement away from##2##3##(1993-3#1)(1995-3#1)
movement between##2##2##(2008-10#1)(2008-8#1)
movement by##4##2##(1991-3#1)(1995-11#1)(1995-5#1)(2007-12#1)
movement can be##2##3##(2008-1#1)(2009-12#1)
movement can##3##2##(2008-1#1)(2008-8#1)(2009-12#1)
movement direction##2##2##(1995-5#1)(2008-6#1)
movement disorder##5##2##(2008-7#3)(2012-3#1)(2013-8#1)
movement disorders and##2##3##(1995-3#1)(2010-5#1)
movement disorders##12##2##(1995-3#2)(1997-5#1)(2008-12#1)(2008-7#4)(2010-12#1)(2010-5#2)(2011-2#1)
movement during##6##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)
movement dysfunction##3##2##(2008-12#2)(2013-1#1)
movement for##5##2##(1993-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
movement from a##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
movement from##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
movement has##2##2##(1992-1#1)(1994-3#1)
movement in a##2##3##(1996-4#1)(2008-8#1)
movement in the opposite##2##4##(1991-5#2)
movement in the##11##3##(1991-5#2)(1994-8#1)(2007-8#3)(2008-10#1)(2009-8#1)(2012-2#3)
movement in##23##2##(1990-5#1)(1991-5#2)(1994-8#1)(1996-3#1)(1996-4#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-8#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
movement into the##2##3##(1991-5#1)(2008-11#1)
movement is a##2##3##(2007-11#1)(2008-10#1)
movement is##13##2##(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2013-8#1)
movement may be##2##3##(1990-5#1)(2007-12#1)
movement observation and##2##3##(2013-8#2)
movement observation or MI##2##4##(2013-8#2)
movement observation##5##2##(2013-8#5)
movement of a##3##3##(1991-5#1)(2008-1#1)(2008-10#1)
movement of individual##2##3##(1996-12#1)(2008-11#1)
movement of the virus##2##4##(2008-10#2)
movement of the##31##3##(1992-1#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
movement of valeric acid##2##4##(1991-5#2)
movement of##89##2##(1990-2#1)(1991-5#4)(1992-1#1)(1992-11#1)(1992-3#2)(1994-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#2)(1996-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#26)(2008-11#3)(2008-2#2)(2008-3#4)(2008-7#2)(2008-8#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#1)
movement on the##3##3##(2008-2#1)(2008-3#1)(2010-3#1)
movement on##5##2##(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-2#1)
movement onset##4##2##(1991-6#1)(1996-2#1)(2008-7#1)(2010-3#1)
movement onset-related neurons##2##3##(1991-6#2)
movement over time##2##3##(2007-11#1)(2008-10#1)
movement over##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
movement pattern##2##2##(2013-8#2)
movement patterns##6##2##(2008-12#2)(2008-8#1)(2009-9#1)(2010-5#1)(2013-1#1)
movement protein (MP) genes of##2##5##(2008-10#1)(2008-9#1)
movement protein (MP)##4##3##(2008-10#3)(2008-9#1)
movement protein##12##2##(1997-3#1)(2008-10#8)(2008-9#2)(2010-9#1)
movement related##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
movement restriction##2##2##(1993-12#2)
movement restrictions##2##2##(2011-2#2)
movement strategy##3##2##(2010-3#2)(2011-2#1)
movement the##2##2##(1990-6#1)(1997-3#1)
movement therapies##2##2##(2008-12#1)(2010-6#1)
movement through##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
movement to the##3##3##(1994-12#1)(2008-10#2)
movement to##14##2##(1994-12#1)(1995-3#1)(1997-3#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#1)
movement toward##4##2##(1994-2#1)(1996-2#1)(1997-1#1)(2013-8#1)
movement trajectories##3##2##(1994-8#2)(2008-7#1)
movement was##12##2##(1991-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)
movement when##2##2##(2008-11#1)(2008-7#1)
movement with##2##2##(1996-2#1)(2007-2#1)
movement within##2##2##(2008-10#1)(2010-3#1)
movement##470##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-9#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#10)(1991-6#4)(1991-9#1)(1992-1#3)(1992-11#2)(1992-3#2)(1992-9#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#3)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#2)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#2)(1997-3#6)(1997-5#1)(2007-10#3)(2007-11#13)(2007-12#14)(2007-2#2)(2007-6#4)(2007-8#12)(2008-1#6)(2008-10#74)(2008-11#17)(2008-12#15)(2008-2#10)(2008-3#10)(2008-4#1)(2008-6#3)(2008-7#30)(2008-8#19)(2008-9#8)(2009-1#1)(2009-10#5)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#10)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#21)(2012-1#1)(2012-12#1)(2012-2#13)(2012-3#5)(2013-1#12)(2013-8#16)
movement) and##2##2##(2008-10#1)(2012-12#1)
movement)##4##1##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
movement-based##2##1##(2008-2#1)(2010-4#1)
movement-defective##3##1##(2008-10#3)
movement-related##3##1##(1994-2#1)(2008-11#1)(2008-7#1)
movements and##13##2##(1992-8#1)(1993-12#1)(1994-3#1)(1995-12#2)(1995-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
movements are##5##2##(1994-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
movements at##3##2##(1991-10#1)(1994-3#2)
movements by##2##2##(1996-2#1)(2010-6#1)
movements can##2##2##(1995-6#1)(2011-2#1)
movements during##6##2##(1993-12#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#2)
movements from the##2##3##(1994-3#1)(2010-8#1)
movements in Parkinson's disease##2##4##(2008-7#2)
movements in a 2-dimensional##2##4##(1990-11#2)
movements in sleep##2##3##(1997-4#1)(2008-11#1)
movements in the##4##3##(1990-9#1)(1995-5#1)(2007-10#1)(2009-8#1)
movements in##23##2##(1990-11#2)(1990-5#1)(1990-9#1)(1993-12#3)(1995-5#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
movements involving##2##2##(1996-6#1)(1997-2#1)
movements is##3##2##(1993-12#1)(1994-8#1)(1996-2#1)
movements may##2##2##(2007-12#1)(2008-7#1)
movements of both##2##3##(2007-12#1)(2013-8#1)
movements of the head##2##4##(1990-5#1)(1991-11#1)
movements of the##13##3##(1990-5#1)(1991-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-7#1)(2009-6#1)(2010-9#1)(2011-1#2)
movements of##22##2##(1990-5#1)(1991-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(2007-12#6)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
movements on##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
movements to##3##2##(2008-11#2)(2008-7#1)
movements were recorded in##2##4##(1993-12#1)(2011-2#1)
movements were recorded##4##3##(1993-12#1)(2008-7#2)(2011-2#1)
movements were##11##2##(1991-5#1)(1993-12#1)(1994-3#1)(1995-5#1)(2008-11#2)(2008-7#4)(2011-2#1)
movements with##3##2##(2008-7#1)(2009-2#1)(2010-9#1)
movements##169##1##(1990-11#3)(1990-5#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-5#3)(1992-11#1)(1992-8#2)(1993-1#1)(1993-12#9)(1993-3#1)(1994-11#3)(1994-3#7)(1994-8#1)(1995-12#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#5)(1996-6#1)(1997-2#1)(1997-4#2)(2007-10#2)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#15)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#22)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#4)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#5)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#3)
moves are predicted by perceived declines in productivity##2##8##(2011-2#2)
moves are##3##2##(2008-7#1)(2011-2#2)
moves at##2##2##(2008-10#1)(2008-3#1)
moves away from##2##3##(2008-9#1)(2013-1#1)
moves from the##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
moves from##4##2##(1997-2#1)(2007-12#1)(2008-10#1)(2010-12#1)
moves into the##2##3##(2008-10#1)(2008-11#1)
moves the##2##2##(2008-10#1)(2008-9#1)
moves to##5##2##(1997-3#1)(2008-4#1)(2008-7#1)(2009-12#2)
moves toward##2##2##(1991-3#1)(2008-11#1)
moves##38##1##(1991-3#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
movie and##2##2##(2008-8#1)(2010-8#1)
movie##6##1##(2007-11#1)(2008-3#1)(2008-8#3)(2010-8#1)
movies of facial expressions##2##4##(2008-11#2)
movies of##3##2##(2008-11#2)(2012-1#1)
movies##9##1##(1990-11#1)(1994-3#1)(2008-11#2)(2008-6#1)(2012-1#3)(2012-2#1)
moving and handling##4##3##(2008-11#4)
moving and##5##2##(2008-11#4)(2010-2#1)
moving at a##3##3##(1997-3#1)(2008-3#2)
moving average##3##2##(2008-10#1)(2009-9#1)(2012-2#1)
moving components##2##2##(2007-12#1)(2008-3#1)
moving forward with##2##3##(2009-3#1)(2009-5#1)
moving forward##5##2##(2008-12#1)(2009-3#1)(2009-5#1)(2010-9#1)(2012-3#1)
moving from the##2##3##(2007-12#1)(2008-10#1)
moving from##7##2##(1993-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
moving gratings##7##2##(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)
moving in##3##2##(2008-10#2)(2009-12#1)
moving into##3##2##(1994-3#1)(2008-1#1)(2010-4#1)
moving masks such as##2##4##(2008-3#2)
moving mirror##2##2##(2008-2#1)(2008-3#1)
moving muscles##2##2##(2008-7#2)
moving object##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
moving objects##8##2##(2008-2#1)(2008-3#6)(2011-2#1)
moving over##2##2##(1997-7#1)(2008-3#1)
moving part##2##2##(2007-12#1)(2008-2#1)
moving rats were##2##3##(1995-12#1)(1995-5#1)
moving rats##10##2##(1990-7#1)(1992-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#2)
moving sample##2##2##(2008-3#1)(2011-1#1)
moving surface##2##2##(2008-10#1)(2008-3#1)
moving target##7##2##(2008-11#4)(2008-2#1)(2008-3#1)(2009-8#1)
moving the records to storage and retrieving them if the patient is re-established##2##13##(1994-3#2)
moving the##9##2##(1991-1#1)(1994-3#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)
moving through##3##2##(2007-10#2)(2007-12#1)
moving to the##5##3##(1993-12#1)(1996-1#1)(2007-7#1)(2008-8#1)(2009-12#1)
moving to##6##2##(1993-12#1)(1996-1#1)(2007-7#1)(2008-8#2)(2009-12#1)
moving toward##6##2##(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2010-12#1)(2010-9#1)
moving towards##2##2##(2008-10#1)(2009-5#1)
moving up##2##2##(1997-2#1)(2010-8#1)
moving vehicles##2##2##(2008-12#1)(2008-2#1)
moving water##2##2##(2008-10#2)
moving window##3##2##(2008-10#1)(2010-6#1)(2010-9#1)
moving##205##1##(1990-7#2)(1991-1#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#3)(2007-10#2)(2007-11#6)(2007-12#13)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#18)(2008-11#9)(2008-12#2)(2008-2#14)(2008-3#43)(2008-4#2)(2008-5#1)(2008-7#9)(2008-8#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-10#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
moving-object trajectory estimation##2##3##(2008-3#2)
moxibustion for##2##2##(2008-10#1)(2013-1#1)
moxibustion##11##1##(2008-10#8)(2012-3#1)(2013-1#2)
moxonidine##2##1##(1997-2#2)
moyamoya disease in the##3##4##(2007-10#3)
moyamoya disease##17##2##(2007-10#11)(2007-8#3)(2008-7#2)(2009-6#1)
mrad for##3##2##(2008-2#1)(2008-3#2)
mrad##9##1##(2007-12#1)(2008-2#4)(2008-3#3)(2013-8#1)
mrad/mum##2##1##(2007-12#2)
mreD##2##1##(1991-9#2)
mrf-1 mRNA##2##2##(2008-6#2)
mrf-1##4##1##(2008-6#4)
mrr##4##1##(2008-11#4)
mrrH-RNA##2##1##(2008-11#2)
mrrH-RNAs##2##1##(2008-11#2)
mrrL-RNAs##2##1##(2008-11#2)
ms after##2##2##(1992-8#1)(1994-11#1)
ms and (0##2##3##(2008-8#2)
ms and a##2##3##(2008-10#1)(2013-8#1)
ms and##8##2##(1993-12#1)(1994-3#1)(2008-10#2)(2008-3#1)(2008-8#2)(2013-8#1)
ms at 0##3##3##(1996-5#2)(2008-2#1)
ms at##9##2##(1992-11#1)(1995-5#2)(1996-5#2)(1997-2#1)(2008-2#2)(2008-8#1)
ms for##3##2##(2008-10#3)
ms in##4##2##(1993-3#2)(2008-10#2)
ms is##2##2##(2007-11#1)(2008-3#1)
ms post-stimulus period##2##3##(1996-2#2)
ms to##3##2##(1991-2#1)(2008-11#2)
ms was measured at##2##4##(2007-12#2)
ms was##3##2##(2007-12#3)
ms##85##1##(1991-2#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#3)(1994-11#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-5#2)(1996-2#3)(1996-5#3)(1997-2#1)(1997-6#1)(1997-8#3)(2007-11#3)(2007-12#6)(2008-1#2)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#12)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
ms(-1)##3##1##(2008-2#2)(2008-3#1)
ms) and##3##2##(1997-8#1)(2007-11#1)(2008-3#1)
ms)##22##1##(1993-12#1)(1994-8#2)(1996-5#3)(1997-2#1)(1997-8#2)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#2)(2013-1#2)
ms/mmHg##2##1##(2008-7#2)
msDNA and##2##2##(1997-6#2)
msDNA was##2##2##(1997-6#2)
msDNA##8##1##(1997-6#8)
msec##6##1##(1994-6#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-4#1)
mt##7##1##(1991-6#1)(1993-12#1)(1993-2#1)(1995-8#2)(2008-10#1)(2008-2#1)
mt-haplotype##3##1##(2008-10#3)
mtDNA RFLP and##2##3##(2008-5#2)
mtDNA RFLP haplotypes##2##3##(2008-10#2)
mtDNA RFLP##5##2##(2008-10#3)(2008-5#2)
mtDNA SNP##2##2##(2008-12#2)
mtDNA and##2##2##(1994-11#1)(2013-1#1)
mtDNA control region##6##3##(2008-12#3)(2010-8#3)
mtDNA haplotype##5##2##(2008-10#5)
mtDNA haplotypes##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
mtDNA profiles##2##2##(2008-12#2)
mtDNA##59##1##(1994-11#3)(1994-8#1)(1995-11#3)(1995-6#1)(1997-2#2)(2008-10#12)(2008-12#17)(2008-5#4)(2008-8#5)(2009-11#1)(2009-8#2)(2010-8#7)(2013-1#1)
mtDNA-encoded##2##1##(1994-8#1)(1995-6#1)
mtDNAs##4##1##(1994-8#1)(2008-5#2)(2009-8#1)
mtRNA(Leu(M))##3##1##(2008-8#3)
mtRNA(Leu(UUR)) and##2##2##(2008-8#2)
mtRNA(Leu(UUR))##3##1##(2008-8#3)
mtSSU rDNA haplotypes##2##3##(2008-10#2)
mtSSU rDNA##4##2##(2008-10#4)
mtSSU##5##1##(2008-10#5)
mtrm(126)##2##1##(2012-3#2)
mu = 0##2##3##(2008-10#1)(2008-3#1)
mu = 1##2##3##(2007-12#2)
mu =##5##2##(1994-9#1)(2007-12#2)(2008-10#1)(2008-3#1)
mu M##6##2##(1995-12#4)(2008-10#2)
mu M) failed to inhibit it##2##6##(1995-12#2)
mu M) failed to##3##4##(1995-12#3)
mu M)##16##2##(1995-12#15)(2008-11#1)
mu and delta opioid receptors##3##5##(2009-7#3)
mu and delta##5##3##(1991-1#1)(2009-7#4)
mu and##11##2##(1991-1#1)(1993-3#1)(1994-2#1)(2008-10#3)(2008-3#1)(2009-7#4)
mu class GST##2##3##(1997-7#2)
mu g kg-1 h-1)##3##4##(1995-12#3)
mu g ml(-1)##3##3##(2008-11#3)
mu g##13##2##(1990-9#1)(1995-12#9)(2008-11#3)
mu g/kg##3##2##(1995-12#2)(2008-10#1)
mu heavy chain##2##3##(1991-9#2)
mu in the##2##3##(2008-11#1)(2008-2#1)
mu in##3##2##(1996-5#1)(2008-11#1)(2008-2#1)
mu is##3##2##(1991-9#2)(1994-9#1)
mu opioid receptor gene##2##4##(1995-6#2)
mu opioid receptor##6##3##(1995-6#4)(2008-11#2)
mu opioid receptors##2##3##(1995-6#1)(1996-2#1)
mu opioid##9##2##(1995-6#5)(1996-2#1)(2008-11#2)(2008-8#1)
mu receptor##5##2##(1992-3#1)(1995-6#3)(2009-7#1)
mu was##6##2##(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)
mu wave##2##2##(2008-11#2)
mu##129##1##(1990-9#1)(1991-1#3)(1991-12#1)(1991-6#1)(1991-9#5)(1992-3#1)(1993-12#4)(1993-3#2)(1994-2#2)(1994-9#2)(1995-12#36)(1995-3#1)(1995-6#9)(1996-2#1)(1996-5#2)(1997-2#1)(1997-7#4)(2007-12#3)(2008-10#22)(2008-11#11)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#5)(2010-4#1)
mu(a) and mu(s)'##6##3##(2008-3#6)
mu(a)##7##1##(2008-3#7)
mu(d)##2##1##(2008-3#2)
mu(m)##2##1##(2008-10#2)
mu(s)'##8##1##(2008-3#8)
mu- and##3##2##(1995-12#1)(1996-2#2)
mu-##10##1##(1991-1#1)(1995-11#5)(1995-12#2)(1996-2#2)
mu-GIIIA##2##1##(2008-8#2)
mu-opioid receptor agonist##2##3##(1996-2#1)(1997-2#1)
mu-opioid receptor agonists##3##3##(1993-3#1)(1996-2#2)
mu-opioid receptor antagonist##2##3##(1996-2#2)
mu-opioid receptor##9##2##(1993-3#1)(1995-11#1)(1996-2#6)(1997-2#1)
mu-opioid##14##1##(1993-3#1)(1995-11#1)(1996-2#8)(1997-2#3)(2008-7#1)
mu-receptor agonists##2##2##(1991-1#2)
mu-selective##2##1##(1995-12#1)(1995-6#1)
mu=0##2##1##(2008-10#2)
muA mM(-1) cm(-2)##2##3##(2008-10#2)
muA mM(-1)##3##2##(2008-10#3)
muA mug(-1)##2##2##(2008-10#2)
muA##9##1##(2008-10#7)(2008-2#1)(2008-4#1)
muCTIS##2##1##(2008-2#2)
muIMERs were##2##2##(2008-10#2)
muIMERs##3##1##(2008-10#3)
muJ in##2##2##(2007-12#1)(2008-2#1)
muJ was##2##2##(2007-11#2)
muJ##9##1##(2007-11#4)(2007-12#3)(2008-2#2)
muL##3##1##(2008-11#1)(2008-9#2)
muM CN(-)##2##2##(2008-10#2)
muM H(2)O(2)##2##2##(2008-10#2)
muM and##6##2##(2008-10#3)(2008-11#2)(2009-8#1)
muM at##2##2##(2008-10#2)
muM concentrations##2##2##(2008-10#1)(2008-11#1)
muM for##9##2##(2008-10#8)(2008-11#1)
muM in##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
muM linoleic acid##2##3##(2008-11#2)
muM of##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
muM to 1 mM##3##4##(2008-10#3)
muM were##2##2##(2008-10#2)
muM with a##2##3##(2008-10#2)
muM with##5##2##(2008-10#5)
muM##148##1##(2007-11#1)(2008-10#101)(2008-11#33)(2008-4#1)(2008-6#5)(2008-7#6)(2009-8#1)
muM) for##2##2##(2008-10#2)
muM) in##2##2##(2008-10#2)
muM) showed##3##2##(2008-10#1)(2008-11#2)
muM)##30##1##(2008-10#17)(2008-11#5)(2008-4#1)(2008-5#3)(2008-8#2)(2010-6#2)
muO-conotoxins##3##1##(2008-8#3)
muSv##2##1##(2009-11#2)
muTAS##2##1##(2008-10#2)
muU/mL##3##1##(2008-3#2)(2010-4#1)
muW of##3##2##(2007-11#1)(2007-12#2)
muW##6##1##(2007-11#1)(2007-12#2)(2008-2#2)(2009-5#1)
muW/cm(2) at 725 nm##2##4##(2008-10#2)
muW/cm(2)##3##1##(2008-10#2)(2008-9#1)
muatm##2##1##(2008-10#2)
much about the##2##3##(2008-10#1)(2012-2#1)
much about their##2##3##(2008-4#1)(2011-2#1)
much about##7##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
much ado about nothing?##2##4##(2008-8#1)(2012-2#1)
much an##2##2##(1997-1#1)(2013-1#1)
much as 1##10##3##(1992-6#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
much as 3##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
much as 30##3##3##(2007-12#1)(2008-3#2)
much as 55##2##3##(2007-12#1)(2008-3#1)
much as a##9##3##(1994-8#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#5)
much as##167##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#28)(2007-12#28)(2008-10#9)(2008-11#1)(2008-2#13)(2008-3#34)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
much attention as##3##3##(1993-1#1)(1996-6#1)(2008-3#1)
much attention has been##3##4##(2008-11#2)(2013-8#1)
much attention in##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
much attention##14##2##(1993-1#1)(1996-12#1)(1996-6#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
much better in##2##3##(2008-10#1)(2008-3#1)
much better than the##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
much better than##12##3##(1995-2#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2012-3#1)
much better##28##2##(1992-2#1)(1995-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
much broader##7##2##(1992-10#1)(1994-6#1)(2009-5#2)(2010-1#1)(2010-3#1)(2012-3#1)
much change##2##2##(1995-11#1)(1996-3#1)
much closer##2##2##(2008-5#1)(2012-7#1)
much commoner##2##2##(1996-12#1)(2008-8#1)
much concern about##2##3##(1993-6#1)(1994-2#1)
much controversy and##2##3##(2009-10#1)(2011-1#1)
much controversy##4##2##(1990-9#1)(2008-9#1)(2009-10#1)(2011-1#1)
much debate##4##2##(2008-11#2)(2012-12#1)(2013-7#1)
much debated##3##2##(1993-3#1)(2008-8#1)(2010-11#1)
much different from##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
much different##7##2##(1994-5#1)(1995-6#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#2)
much discussion##3##2##(1992-4#1)(2008-5#1)(2012-2#1)
much do##2##2##(1994-2#1)(2008-8#1)
much earlier##7##2##(1993-12#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
much easier##2##2##(2008-10#1)(2008-7#1)
much effort has been directed##2##5##(2008-1#1)(2008-7#1)
much effort has been##5##4##(1992-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)
much effort##6##2##(1992-9#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-8#1)
much enhanced##3##2##(1994-11#1)(1995-12#1)(2008-10#1)
much faster and easier##2##4##(2008-4#1)(2010-6#1)
much faster and more##3##4##(2008-10#2)(2008-7#1)
much faster and##6##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-6#1)
much faster than that of##2##5##(1993-8#1)(2008-2#1)
much faster than the##2##4##(1997-4#1)(2008-3#1)
much faster than##8##3##(1993-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#1)
much faster##23##2##(1990-5#1)(1992-12#1)(1993-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-10#2)(2010-6#1)(2012-3#1)
much fewer##3##2##(1992-2#1)(2008-5#1)(2008-9#1)
much greater in the##2##4##(2008-10#1)(2008-5#1)
much greater than that of##2##5##(2008-10#2)
much greater than that##5##4##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
much greater than the##2##4##(2007-12#1)(2008-10#1)
much greater than##13##3##(1990-11#2)(1992-3#1)(1992-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)
much greater##37##2##(1990-11#2)(1991-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-8#2)(1995-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2009-8#1)(2012-5#1)
much has been learned about the##2##6##(1993-12#1)(2008-4#1)
much has been learned about##4##5##(1993-12#1)(2008-4#1)(2008-8#1)(2011-3#1)
much has been learned##5##4##(1993-12#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-3#1)
much has been##7##3##(1993-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-3#1)
much has##8##2##(1993-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-3#1)(2013-1#1)
much higher concentration##2##3##(1991-9#1)(2008-10#1)
much higher concentrations##3##3##(1990-12#1)(1994-3#1)(2011-2#1)
much higher in the##2##4##(1997-6#1)(2008-10#1)
much higher in##8##3##(1997-2#1)(1997-6#1)(2008-10#4)(2008-9#1)(2011-2#1)
much higher level of##2##4##(1995-8#1)(2008-5#1)
much higher levels of##2##4##(1993-6#1)(1994-11#1)
much higher levels##3##3##(1990-8#1)(1993-6#1)(1994-11#1)
much higher than in##3##4##(1990-11#1)(2007-7#1)(2008-10#1)
much higher than previously##2##4##(1991-11#1)(2008-8#1)
much higher than that of the##2##6##(2008-10#1)(2010-3#1)
much higher than that of##6##5##(2007-11#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-3#1)
much higher than that##7##4##(2007-11#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-3#1)
much higher than the one##2##5##(2008-8#1)(2008-9#1)
much higher than the##6##4##(1995-2#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)
much higher than those in the##2##6##(2008-10#2)
much higher than those of##2##5##(2008-10#1)(2008-8#1)
much higher than those##5##4##(1991-12#1)(2008-10#3)(2008-8#1)
much higher than##30##3##(1990-11#1)(1991-11#1)(1991-12#1)(1993-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2010-3#1)
much higher##85##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-11#3)(2007-7#1)(2008-10#23)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
much improved##7##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
much in common with##2##4##(1994-11#1)(2008-10#1)
much in common##4##3##(1994-11#1)(1995-1#1)(1996-1#1)(2008-10#1)
much in##6##2##(1990-9#1)(1994-11#1)(1995-1#1)(1996-1#1)(2008-10#1)(2008-4#1)
much influence##2##2##(2008-10#2)
much information about the##2##4##(2008-2#1)(2009-12#1)
much information on the##2##4##(1994-3#1)(2008-6#1)
much information##8##2##(1990-3#1)(1994-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)
much insurance is##2##3##(1992-12#1)(1993-3#1)
much insurance to buy##2##4##(1992-12#2)
much insurance##4##2##(1992-12#3)(1993-3#1)
much interest in##2##3##(2008-3#1)(2013-1#1)
much interest##4##2##(1993-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
much is known about the##2##5##(2012-2#1)(2013-8#1)
much is known about##3##4##(2010-12#1)(2012-2#1)(2013-8#1)
much is##4##2##(2008-1#1)(2010-12#1)(2012-2#1)(2013-8#1)
much larger for##2##3##(1997-2#1)(2008-10#1)
much larger numbers##2##3##(2008-10#1)(2008-3#1)
much larger than that##2##4##(1995-6#1)(2008-3#1)
much larger than the##5##4##(2007-12#2)(2008-3#2)(2012-2#1)
much larger than##13##3##(1992-3#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#4)(2010-7#1)(2012-2#1)
much larger##33##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#2)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-2#3)(2008-3#6)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
much later##3##2##(1993-3#1)(2008-10#1)(2008-4#1)
much less active##2##3##(1994-8#1)(2007-11#1)
much less attention##2##3##(1993-12#1)(2008-9#1)
much less common##3##3##(1993-9#1)(2008-5#1)(2009-1#1)
much less computer##2##3##(2008-10#1)(2008-3#1)
much less effect##2##3##(1994-9#1)(1995-12#1)
much less effective##3##3##(1994-8#1)(1995-2#1)(2008-8#1)
much less is known about the##2##6##(2008-4#1)(2012-3#1)
much less is known about##4##5##(1995-6#1)(2008-4#1)(2008-7#1)(2012-3#1)
much less likely##3##3##(1994-2#1)(2008-2#1)(2011-2#1)
much less potent##2##3##(1992-1#1)(1994-11#1)
much less prominent##2##3##(2008-7#1)(2010-3#1)
much less pronounced##2##3##(1992-11#1)(2007-12#1)
much less than##10##3##(1990-12#1)(1990-3#1)(1992-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-4#1)
much less##83##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-6#1)(1997-4#2)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-6#2)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)
much like##3##2##(2008-10#1)(2009-10#1)(2009-9#1)
much longer period##2##3##(1994-3#1)(2008-11#1)
much longer than the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
much longer##19##2##(1992-8#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2012-8#1)
much lower (0##2##3##(1995-3#1)(2008-6#1)
much lower compared with##2##4##(2011-1#1)(2011-3#1)
much lower compared##3##3##(2008-5#1)(2011-1#1)(2011-3#1)
much lower cost##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
much lower doses##2##3##(1991-11#1)(1995-3#1)
much lower in##3##3##(1997-7#1)(2008-10#1)(2010-6#1)
much lower levels of##2##4##(2008-11#1)(2012-3#1)
much lower levels##4##3##(1990-12#1)(1995-2#1)(2008-11#1)(2012-3#1)
much lower than in the##2##5##(1990-8#1)(2011-1#1)
much lower than in##3##4##(1990-8#1)(1992-3#1)(2011-1#1)
much lower than its##2##4##(2008-5#1)(2008-6#1)
much lower than that in##3##5##(1993-11#1)(2008-7#1)(2010-8#1)
much lower than that of##4##5##(1994-2#1)(2008-5#1)(2008-8#2)
much lower than that##11##4##(1993-11#1)(1994-2#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)
much lower than the##4##4##(2008-10#1)(2008-8#2)(2012-1#1)
much lower than those in##2##5##(2008-10#1)(2010-5#1)
much lower than those##3##4##(2008-10#1)(2008-6#1)(2010-5#1)
much lower than##29##3##(1990-8#1)(1992-3#1)(1993-11#1)(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#7)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2010-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-8#1)
much lower##85##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#6)(2009-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
much more abundant than the##2##5##(1991-5#1)(2008-10#1)
much more attention##2##3##(1995-5#1)(2008-3#1)
much more attractive##2##3##(2008-10#1)(2008-7#1)
much more common in the##2##5##(2009-9#1)(2010-8#1)
much more common in##3##4##(2009-9#1)(2010-8#1)(2012-3#1)
much more complex##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
much more difficult than##2##4##(2008-7#1)(2010-4#1)
much more difficult##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
much more efficient##2##3##(1994-3#1)(2008-10#1)
much more efficiently##2##3##(1991-9#1)(2008-3#1)
much more frequently##2##3##(1995-5#1)(2013-8#1)
much more important##4##3##(1991-11#1)(1992-3#1)(2008-8#1)(2011-2#1)
much more information##4##3##(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)
much more likely to##3##4##(2008-12#1)(2008-8#1)(2009-12#1)
much more likely##4##3##(2008-12#1)(2008-8#2)(2009-12#1)
much more negative than##2##4##(2008-10#2)
much more negative##3##3##(1995-5#1)(2008-10#2)
much more positive##2##3##(1990-2#1)(2008-11#1)
much more potent than##2##4##(1991-1#1)(2008-7#1)
much more potent##3##3##(1991-1#1)(1991-8#1)(2008-7#1)
much more prominent##2##3##(2008-10#1)(2008-7#1)
much more rapid and simpler##2##5##(2008-10#2)
much more rapid##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
much more rapidly##4##3##(1994-5#1)(1994-8#1)(1995-3#1)(2007-12#1)
much more sensitive than##2##4##(1996-8#1)(2008-10#1)
much more sensitive to##6##4##(1993-8#1)(1994-5#1)(1995-2#1)(2008-2#1)(2008-8#1)(2013-1#1)
much more sensitive##8##3##(1993-8#1)(1994-5#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
much more slowly than##2##4##(2008-10#1)(2008-3#1)
much more slowly##4##3##(1991-9#1)(1994-5#1)(2008-10#1)(2008-3#1)
much more stable##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
much more than##7##3##(1990-6#1)(1991-3#1)(1993-2#1)(1995-12#1)(2007-2#1)(2008-3#1)(2008-8#1)
much more##155##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#2)(1992-8#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1996-11#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#3)(2008-10#24)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#7)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
much needed##2##2##(2012-12#1)(2013-7#1)
much of his##2##3##(1993-5#1)(2010-5#1)
much of the current##2##4##(1993-12#1)(1996-2#1)
much of the existing##2##4##(1993-12#1)(1995-1#1)
much of the research##3##4##(1996-2#1)(2009-7#1)(2013-1#1)
much of the##42##3##(1990-11#1)(1991-12#1)(1992-1#1)(1993-11#3)(1993-12#2)(1995-1#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
much of their##5##3##(1990-5#1)(1994-2#1)(2008-10#2)(2010-5#1)
much of this##3##3##(1992-2#1)(2008-11#1)(2008-4#1)
much of which can be##2##5##(1994-2#1)(2008-7#1)
much of which##3##3##(1994-2#1)(1995-2#1)(2008-7#1)
much of##62##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-11#3)(1993-12#2)(1993-5#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
much older##2##2##(2009-7#1)(2010-3#1)
much potential for##2##3##(1995-3#1)(2012-12#1)
much potential##3##2##(1995-3#1)(2012-12#2)
much progress in##2##3##(2008-10#1)(2008-11#1)
much progress##4##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
much promise for##2##3##(1991-3#1)(2008-8#1)
much public attention##2##3##(1990-6#1)(1991-12#1)
much reduced##8##2##(1991-12#1)(1992-10#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-7#1)
much remains to be##3##4##(1992-3#1)(2008-8#1)(2013-1#1)
much research##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)
much shorter than the##2##4##(1991-12#1)(2010-10#1)
much shorter than##3##3##(1991-12#1)(2008-10#1)(2010-10#1)
much shorter##7##2##(1991-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-10#1)
much simpler than##2##3##(2008-11#1)(2008-9#1)
much simpler##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
much slower than##3##3##(1992-6#1)(2008-2#1)(2008-8#1)
much slower##11##2##(1990-9#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-2#1)(2013-1#1)
much smaller than that of the##2##6##(2008-10#1)(2008-6#1)
much smaller than the##10##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2012-1#1)(2013-7#1)
much smaller than##16##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-6#1)(2011-2#1)(2012-1#1)(2013-7#1)
much smaller##23##2##(1991-12#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
much stronger##11##2##(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-3#1)
much superior##2##2##(2008-10#2)
much the same##2##3##(1992-4#1)(2008-5#1)
much the##6##2##(1992-4#1)(1994-9#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-5#1)
much thicker than##2##3##(2008-3#2)
much thinner than that of##2##5##(2008-5#1)(2011-3#1)
much time##3##2##(1995-3#1)(2008-12#1)(2012-3#1)
much to be##2##3##(1992-3#1)(2009-12#1)
much to offer##6##3##(1993-12#1)(2008-12#2)(2008-7#1)(2009-5#1)(2012-2#1)
much to##20##2##(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
much uncertainty##2##2##(2008-11#1)(2009-10#1)
much weaker than##2##3##(2008-10#1)(2008-3#1)
much weaker##7##2##(1990-7#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#2)
much wider range##2##3##(2007-11#1)(2008-8#1)
much wider##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
much with##2##2##(2008-11#1)(2009-3#1)
much work remains to##2##4##(2009-7#1)(2012-3#1)
much work remains##3##3##(2008-7#1)(2009-7#1)(2012-3#1)
much worse than##2##3##(1992-6#1)(1996-5#1)
much worse##4##2##(1992-6#1)(1996-5#1)(2009-10#1)(2013-1#1)
much younger##3##2##(2007-10#1)(2008-8#1)(2009-4#1)
much##1206##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#1)(1991-11#4)(1991-12#9)(1991-2#1)(1991-3#4)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#9)(1992-2#7)(1992-3#9)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#3)(1993-1#5)(1993-11#5)(1993-12#10)(1993-2#6)(1993-3#7)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#9)(1993-9#2)(1994-1#4)(1994-11#6)(1994-12#1)(1994-2#10)(1994-3#9)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#4)(1995-11#2)(1995-12#7)(1995-2#15)(1995-3#9)(1995-5#8)(1995-6#7)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#10)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#2)(2006-10#2)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#47)(2007-12#47)(2007-2#2)(2007-7#11)(2007-8#2)(2008-1#14)(2008-10#167)(2008-11#49)(2008-12#11)(2008-2#38)(2008-3#99)(2008-4#16)(2008-5#34)(2008-6#11)(2008-7#35)(2008-8#41)(2008-9#20)(2009-1#3)(2009-10#8)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#11)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#4)(2010-3#8)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#29)(2011-3#3)(2011-4#1)(2012-1#4)(2012-12#13)(2012-2#15)(2012-3#13)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#22)(2013-7#5)(2013-8#11)
much-needed##2##1##(2007-7#1)(2009-4#1)
mucilage##9##1##(2009-8#7)(2011-1#2)
mucilaginosa##3##1##(2008-10#1)(2009-11#2)
mucin MUC-1##2##2##(1994-9#2)
mucin and##3##2##(1991-12#1)(1993-1#1)(1994-9#1)
mucin cDNAs##2##2##(1991-12#1)(1993-8#1)
mucin gene##7##2##(1990-12#1)(1990-8#2)(1993-8#2)(1997-7#2)
mucin genes##3##2##(1990-8#1)(1991-12#1)(2013-1#1)
mucin glycoprotein##2##2##(1994-11#2)
mucin is##2##2##(1992-11#1)(1993-1#1)
mucin##50##1##(1990-12#2)(1990-8#5)(1991-12#7)(1992-11#6)(1993-1#5)(1993-2#3)(1993-8#5)(1994-11#3)(1994-9#5)(1997-7#4)(2008-7#2)(2009-5#1)(2013-1#1)(2013-8#1)
mucin)##3##1##(1997-1#1)(2013-8#2)
mucin-like##5##1##(1992-11#3)(1993-8#1)(2013-1#1)
mucin-type sugar chains##2##3##(1994-9#2)
mucinous adenocarcinoma of the##2##4##(2009-5#1)(2012-3#1)
mucinous adenocarcinoma##3##2##(2009-5#2)(2012-3#1)
mucinous cystic##4##2##(1990-2#1)(2008-12#1)(2010-12#1)(2013-8#1)
mucinous ovarian cystomas##3##3##(1990-2#3)
mucinous##24##1##(1990-2#6)(1990-6#1)(1993-8#1)(1994-9#1)(2006-8#2)(2008-12#1)(2009-5#2)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
mucins##7##1##(1991-12#1)(1992-11#1)(1993-1#2)(1993-2#2)(1994-9#1)
muco-cutaneous##2##1##(2008-11#1)(2012-2#1)
muco-inositol##3##1##(2008-11#3)
mucoadhesive##2##1##(2008-8#1)(2010-5#1)
mucocele##3##1##(2013-1#3)
mucoceles are##2##2##(2013-1#2)
mucoceles##6##1##(2006-12#1)(2013-1#5)
mucocellular##2##1##(1997-3#2)
mucociliary clearance##4##2##(1996-1#1)(1997-1#3)
mucociliary transport##3##2##(1991-9#1)(1997-1#2)
mucociliary##11##1##(1991-9#2)(1995-8#1)(1996-1#1)(1997-1#7)
mucocoele##3##1##(2008-7#3)
mucocutaneous candidiasis##2##2##(2012-3#2)
mucocutaneous malignancies##2##2##(2007-12#2)
mucocutaneous##11##1##(1991-2#1)(2007-12#2)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-3#3)
mucoepidermoid carcinoma of the liver##2##5##(1992-2#2)
mucoepidermoid carcinoma##5##2##(1992-2#3)(2009-6#1)(2012-2#1)
mucoepidermoid##6##1##(1991-11#1)(1992-2#3)(2009-6#1)(2012-2#1)
mucoid##8##1##(1991-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
mucolytic##3##1##(1991-11#1)(1991-9#1)(2009-7#1)
mucormycosis in a##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
mucormycosis##19##1##(1995-8#1)(2008-12#2)(2010-10#3)(2011-2#10)(2013-1#2)(2013-8#1)
mucosa and the##3##3##(1991-12#1)(1993-8#1)(1996-6#1)
mucosa and##14##2##(1990-3#1)(1990-9#1)(1991-12#2)(1991-5#1)(1993-8#1)(1996-6#1)(1997-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
mucosa associated lymphoid tissue (MALT)##2##5##(1991-6#1)(1997-1#1)
mucosa at the##2##3##(2008-5#1)(2009-3#1)
mucosa at##3##2##(2008-5#1)(2009-3#1)(2013-8#1)
mucosa from##2##2##(1997-7#1)(2011-3#1)
mucosa harboring##2##2##(2013-8#2)
mucosa in##6##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
mucosa is a##2##3##(2008-10#1)(2008-12#1)
mucosa is##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
mucosa of mice##2##3##(1992-8#1)(2013-8#1)
mucosa of the##2##3##(2008-4#1)(2013-8#1)
mucosa of##12##2##(1990-9#1)(1991-12#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-6#1)(2008-3#1)(2008-4#1)(2012-1#1)(2013-1#1)(2013-8#2)
mucosa revealed##2##2##(1991-11#1)(2008-5#1)
mucosa that##2##2##(1990-9#1)(2012-12#1)
mucosa to##4##2##(1990-9#1)(1991-5#1)(1997-2#1)(2008-7#1)
mucosa was##9##2##(1990-2#1)(1995-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-5#2)(2012-1#1)(2012-3#1)
mucosa were##6##2##(1991-11#1)(1991-3#1)(1993-11#1)(1994-2#1)(2012-1#1)(2013-1#1)
mucosa with##3##2##(2008-2#1)(2009-3#1)(2010-12#1)
mucosa##170##1##(1990-11#1)(1990-2#3)(1990-3#3)(1990-5#1)(1990-7#1)(1990-9#7)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#3)(1993-8#2)(1994-2#5)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#3)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#8)(2009-5#3)(2009-8#1)(2010-12#8)(2010-5#3)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#9)(2013-8#11)
mucosa-associated lymphoid tissue (MALT)##3##4##(2009-8#2)(2013-1#1)
mucosa-associated lymphoid tissue lymphoma##2##4##(2009-3#1)(2009-5#1)
mucosa-associated lymphoid tissue##6##3##(2009-3#1)(2009-5#1)(2009-8#3)(2013-1#1)
mucosa]##2##1##(1990-6#1)(1997-5#1)
mucosae##6##1##(1993-3#2)(1995-12#2)(1997-1#1)(1997-3#1)
mucosal DNA##2##2##(1993-8#2)
mucosal IgA##3##2##(2008-10#1)(2008-11#2)
mucosal LP##2##2##(2007-7#2)
mucosal adjuvants##2##2##(1995-2#2)
mucosal and##7##2##(1990-6#1)(1993-8#1)(2007-7#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
mucosal atrophy##3##2##(1990-9#1)(1991-11#1)(1997-1#1)
mucosal biopsies##2##2##(1994-2#1)(2013-8#1)
mucosal blood flow##4##3##(1992-6#2)(1997-1#1)(1997-4#1)
mucosal cells of##3##3##(1994-6#1)(2013-8#2)
mucosal cells##9##2##(1991-12#2)(1992-9#1)(1994-6#2)(1994-8#1)(1996-5#1)(2013-8#2)
mucosal damage##3##2##(1997-1#1)(2011-2#1)(2012-2#1)
mucosal dissection##3##2##(2008-5#3)
mucosal guanabenz##3##2##(2008-5#3)
mucosal immune response##2##3##(2010-9#1)(2013-8#1)
mucosal immune##3##2##(1995-6#1)(2010-9#1)(2013-8#1)
mucosal immunity##7##2##(1995-5#1)(1995-6#1)(2008-5#3)(2013-1#2)
mucosal inflammation##2##2##(2012-2#2)
mucosal injury##6##2##(1995-12#3)(1997-1#1)(2008-11#1)(2012-2#1)
mucosal integrity##4##2##(1997-1#2)(1997-7#1)(2013-8#1)
mucosal layer##3##2##(2008-12#1)(2009-8#1)(2012-12#1)
mucosal lesions##3##2##(1990-3#1)(1997-8#1)(2007-7#1)
mucosal mast cells##2##3##(1995-12#2)
mucosal mast##4##2##(1995-12#4)
mucosal prolapse and hemorrhoidal prolapse##3##5##(2013-1#3)
mucosal prolapse and##4##3##(2013-1#4)
mucosal prolapse was##3##3##(2013-1#3)
mucosal prolapse##13##2##(1992-5#1)(2013-1#12)
mucosal surfaces##2##2##(1994-8#1)(2008-5#1)
mucosal##160##1##(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-8#2)(1992-10#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#4)(1993-8#3)(1994-2#1)(1994-6#2)(1994-8#2)(1995-12#7)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#7)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#4)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#18)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#14)(2013-8#9)
mucositis and##3##2##(2008-7#3)
mucositis##15##1##(1990-6#1)(1994-8#1)(2008-7#13)
mucous and##2##2##(2008-6#1)(2011-2#1)
mucous cells##3##2##(1993-11#1)(1995-2#1)(2008-6#1)
mucous membrane##2##2##(2007-8#1)(2013-1#1)
mucous membranes##5##2##(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
mucous velocity##5##2##(1991-9#5)
mucous##24##1##(1991-9#5)(1993-11#1)(1995-2#1)(1997-1#3)(1997-2#1)(2007-8#1)(2008-6#3)(2008-7#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
mucoviscidosis##2##1##(1992-6#1)(1994-3#1)
mucus film##3##2##(2008-5#3)
mucus is##2##2##(1997-1#2)
mucus production##2##2##(2008-10#1)(2008-4#1)
mucus proteinase inhibitor##4##3##(1991-9#2)(1995-2#2)
mucus##28##1##(1991-9#2)(1992-11#2)(1992-5#1)(1994-11#1)(1995-2#2)(1996-1#3)(1996-7#2)(1996-9#1)(1997-1#2)(2008-10#1)(2008-4#1)(2008-5#4)(2008-8#1)(2011-1#1)(2012-1#3)(2013-7#1)
mucus-producing##3##1##(1995-6#1)(2009-3#2)
mud##5##1##(1997-7#1)(2008-2#1)(2008-3#2)(2010-5#1)
muddy##2##1##(2008-10#1)(2008-5#1)
mueller matrix imaging##2##3##(2008-3#2)
mueller matrix##6##2##(2008-2#1)(2008-3#5)
mueller##8##1##(2008-2#1)(2008-3#7)
muelleri bags##2##2##(2012-1#2)
muelleri##6##1##(2012-1#6)
muepsilon##2##1##(2007-12#2)
mug (Sn) kg(-1)##2##3##(2008-10#2)
mug / g BW)##3##4##(2008-5#3)
mug 1(-1)##2##2##(2008-10#2)
mug 10 ml(-1)##2##3##(2008-10#2)
mug 10(-6)##2##2##(2008-11#2)
mug As l(-1) range##2##4##(2008-10#2)
mug As l(-1)##3##3##(2008-10#3)
mug As##6##2##(2008-10#6)
mug Cd l(-1)##3##3##(2008-10#3)
mug Cr##2##2##(2008-10#2)
mug Mo l(-1)##3##3##(2008-10#3)
mug Mo##4##2##(2008-10#4)
mug Sb(V)##2##2##(2008-10#2)
mug Se/g sample##2##3##(2008-10#2)
mug a##10##2##(2008-10#10)
mug and##5##2##(2008-10#4)(2010-2#1)
mug cm(-2)##10##2##(2008-10#9)(2008-5#1)
mug cm(-3) for##2##3##(2010-8#2)
mug cm(-3)##4##2##(2008-10#2)(2010-8#2)
mug cyanide##3##2##(2008-10#3)
mug for##2##2##(2008-10#2)
mug g (-)(1) creatinine##2##4##(2008-10#2)
mug g(-1) and##2##3##(2008-10#2)
mug g(-1) for Mg##2##4##(2008-10#2)
mug g(-1) for the procedure##2##5##(2008-10#2)
mug g(-1) for##8##3##(2008-10#8)
mug g(-1) in##3##3##(2008-10#3)
mug g(-1) level##4##3##(2008-10#4)
mug g(-1)##41##2##(2008-10#41)
mug g(-1))##4##2##(2008-10#4)
mug hIL-6##2##2##(2008-11#2)
mug in the##3##3##(2008-10#3)
mug in##6##2##(2008-10#6)
mug kg(-1) for the##3##4##(2008-10#3)
mug kg(-1) for##5##3##(2008-10#5)
mug kg(-1)##11##2##(2008-10#9)(2008-5#2)
mug kg(-1))##2##2##(2008-10#2)
mug l(-1) (for##2##3##(2008-10#2)
mug l(-1) As##4##3##(2008-10#4)
mug l(-1) Cr(VI)##2##3##(2008-10#2)
mug l(-1) Cu(II)##2##3##(2008-10#2)
mug l(-1) N##3##3##(2008-10#3)
mug l(-1) and a relative standard deviation##2##7##(2008-10#2)
mug l(-1) and a##3##4##(2008-10#3)
mug l(-1) and the##3##4##(2008-10#3)
mug l(-1) and##14##3##(2008-10#14)
mug l(-1) by##3##3##(2008-10#3)
mug l(-1) cobalt##2##3##(2008-10#2)
mug l(-1) concentration##2##3##(2008-10#2)
mug l(-1) for 20 mul##2##5##(2008-10#2)
mug l(-1) for Cd and##2##5##(2008-10#2)
mug l(-1) for Cd##3##4##(2008-10#3)
mug l(-1) for Cr(III)##2##4##(2008-10#2)
mug l(-1) for Cu##2##4##(2008-10#2)
mug l(-1) for Zn##3##4##(2008-10#3)
mug l(-1) for monoterpenes to##2##5##(2008-10#2)
mug l(-1) for most of the analytes##2##7##(2008-10#2)
mug l(-1) for supernatant and slurry analysis##2##7##(2008-10#2)
mug l(-1) for the##4##4##(2008-10#4)
mug l(-1) for##44##3##(2008-10#44)
mug l(-1) in the##2##4##(2008-10#2)
mug l(-1) in##3##3##(2008-10#3)
mug l(-1) level of cobalt##2##5##(2008-10#2)
mug l(-1) level##9##3##(2008-10#9)
mug l(-1) levels using##2##4##(2008-10#2)
mug l(-1) levels##5##3##(2008-10#5)
mug l(-1) of##8##3##(2008-10#8)
mug l(-1) was achieved##2##4##(2008-10#2)
mug l(-1) was##4##3##(2008-10#4)
mug l(-1) were##2##3##(2008-10#2)
mug l(-1) with a detection limit of##2##7##(2008-10#2)
mug l(-1) with a##3##4##(2008-10#3)
mug l(-1) with##5##3##(2008-10#5)
mug l(-1)##218##2##(2008-10#218)
mug l(-1)) and##4##3##(2008-10#4)
mug l(-1))##12##2##(2008-10#12)
mug mL(-1) for HNE)##2##4##(2008-5#2)
mug mL(-1) for PPE##2##4##(2008-5#2)
mug mL(-1) for##6##3##(2008-5#6)
mug mL(-1)##8##2##(2008-5#8)
mug ml(-1) (SD=0##2##3##(2008-10#2)
mug ml(-1) (r=0##2##3##(2008-10#2)
mug ml(-1) NO(2)(-)##2##3##(2008-10#2)
mug ml(-1) Pb(II)##3##3##(2008-10#3)
mug ml(-1) and 0##2##4##(2008-10#2)
mug ml(-1) and a##2##4##(2008-10#2)
mug ml(-1) and relative##2##4##(2008-10#2)
mug ml(-1) and the relative standard deviation##2##7##(2008-10#2)
mug ml(-1) and the##9##4##(2008-10#9)
mug ml(-1) and##20##3##(2008-10#20)
mug ml(-1) cobalt##3##3##(2008-10#3)
mug ml(-1) concentration of##2##4##(2008-10#1)(2008-11#1)
mug ml(-1) each##2##3##(2008-10#2)
mug ml(-1) for 2##2##4##(2008-10#1)(2008-11#1)
mug ml(-1) for calf thymus DNA##3##6##(2008-10#3)
mug ml(-1) for the##3##4##(2008-10#3)
mug ml(-1) for##42##3##(2008-10#41)(2008-11#1)
mug ml(-1) hr(-1)##2##3##(2008-11#2)
mug ml(-1) level##2##3##(2008-10#2)
mug ml(-1) of B(2)O(3)##3##4##(2008-10#3)
mug ml(-1) of I##3##4##(2008-10#3)
mug ml(-1) of Si(IV)##2##4##(2008-10#2)
mug ml(-1) of europium (III)##2##5##(2008-10#2)
mug ml(-1) of manganese##2##4##(2008-10#2)
mug ml(-1) of nitrite##2##4##(2008-10#2)
mug ml(-1) of the analyte##2##5##(2008-10#2)
mug ml(-1) of the##3##4##(2008-10#3)
mug ml(-1) of##40##3##(2008-10#40)
mug ml(-1) protein##2##3##(2008-10#2)
mug ml(-1) range##2##3##(2008-10#2)
mug ml(-1) with a detection limit of 0##3##8##(2008-10#3)
mug ml(-1) with a detection limit of##5##7##(2008-10#5)
mug ml(-1) with a limit of detection 0##2##8##(2008-10#2)
mug ml(-1) with a limit of detection##3##7##(2008-10#3)
mug ml(-1) with a##10##4##(2008-10#10)
mug ml(-1) with detection##2##4##(2008-10#2)
mug ml(-1) with##16##3##(2008-10#16)
mug ml(-1)##278##2##(2008-10#265)(2008-11#13)
mug ml(-1)) and##5##3##(2008-10#5)
mug ml(-1))##17##2##(2008-10#16)(2008-11#1)
mug of CBZ##2##3##(2008-10#2)
mug of total Se/g sample##2##5##(2008-10#2)
mug of##32##2##(2008-10#29)(2008-11#2)(2008-7#1)
mug s(-1)##2##2##(2008-10#2)
mug##761##1##(2008-10#706)(2008-11#31)(2008-5#15)(2008-7#1)(2008-9#2)(2009-7#2)(2010-2#2)(2010-8#2)
mug(-1)##4##1##(2008-10#4)
mug) and##2##2##(2008-10#2)
mug) or W##2##3##(2008-10#2)
mug)##8##1##(2008-10#8)
mug/0##3##1##(2010-5#3)
mug/L for##3##2##(2008-10#1)(2008-2#2)
mug/L##4##1##(2008-10#2)(2008-2#2)
mug/L(-1)##2##1##(2009-8#2)
mug/g (0##4##2##(2008-10#4)
mug/g##8##1##(2008-10#8)
mug/kg##10##1##(2008-10#3)(2008-11#3)(2008-7#4)
mug/l for##5##2##(2008-10#5)
mug/l##11##1##(2008-10#10)(2008-4#1)
mug/l)##2##1##(2008-10#2)
mug/mL##5##1##(2008-11#3)(2008-9#1)(2009-6#1)
mug/ml DNA##2##2##(2008-11#2)
mug/ml and 1##2##3##(2008-11#1)(2010-3#1)
mug/ml and##8##2##(2008-10#2)(2008-11#1)(2010-3#3)(2010-5#2)
mug/ml compared##3##2##(2008-10#3)
mug/ml concentration##2##2##(2008-11#1)(2008-5#1)
mug/ml for cefepime##2##3##(2008-7#2)
mug/ml for cefotaxime and ceftriaxone##2##5##(2008-7#2)
mug/ml for##13##2##(2008-10#5)(2008-5#2)(2008-7#4)(2010-5#2)
mug/ml of##5##2##(2008-10#2)(2008-11#3)
mug/ml showed##2##2##(2008-10#1)(2010-5#1)
mug/ml##78##1##(2008-10#40)(2008-11#14)(2008-2#1)(2008-5#4)(2008-7#5)(2010-3#6)(2010-5#7)(2010-6#1)
mug/ml) and##6##2##(2008-10#4)(2008-5#2)
mug/ml) of##2##2##(2008-10#1)(2008-11#1)
mug/ml) were##2##2##(2008-10#1)(2008-11#1)
mug/ml)##31##1##(2008-10#16)(2008-11#2)(2008-5#13)
mugL(-1) and##2##2##(2008-10#2)
mugL(-1)##3##1##(2008-10#3)
mugSil(-1)##2##1##(2008-10#2)
mugdm(-3)##3##1##(2008-10#3)
muggings##2##1##(2007-2#2)
mugkg(-1)##2##1##(2008-10#2)
mugl(-1) and the##2##3##(2008-10#2)
mugl(-1) and##3##2##(2008-10#3)
mugl(-1) for##8##2##(2008-10#8)
mugl(-1) level##2##2##(2008-10#2)
mugl(-1) with a##2##3##(2008-10#2)
mugl(-1) with##3##2##(2008-10#3)
mugl(-1)##24##1##(2008-10#24)
mugml(-1) for##5##2##(2008-10#5)
mugml(-1) of Pb##2##3##(2008-10#2)
mugml(-1) of TCMTB##2##3##(2008-10#2)
mugml(-1) of##4##2##(2008-10#4)
mugml(-1)##25##1##(2008-10#25)
mugml(-1))##3##1##(2008-10#3)
mugwort##2##1##(2008-10#2)
mul and##3##2##(2008-10#3)
mul for##2##2##(2008-10#2)
mul injection volume##3##3##(2008-10#3)
mul injection##5##2##(2008-10#5)
mul min(-1)##3##2##(2008-10#3)
mul of 0##4##3##(2008-10#4)
mul of 5##2##3##(2008-10#2)
mul of a test##2##4##(2008-10#1)(2008-11#1)
mul of a##3##3##(2008-10#2)(2008-11#1)
mul of ethyl acetate##2##4##(2008-10#2)
mul of sample##7##3##(2008-10#7)
mul of the##2##3##(2008-10#2)
mul of##36##2##(2008-10#34)(2008-11#2)
mul s(-1) and##2##3##(2008-10#2)
mul s(-1)##4##2##(2008-10#4)
mul sample##4##2##(2008-10#4)
mul volumes##4##2##(2008-10#4)
mul was injected##2##3##(2008-10#2)
mul was##3##2##(2008-10#3)
mul##105##1##(2008-10#95)(2008-11#8)(2008-4#2)
mul) of##2##2##(2008-10#2)
mul) on##2##2##(2008-10#1)(2008-11#1)
mul) was##6##2##(2008-10#6)
mul)##22##1##(2008-10#21)(2008-11#1)
mul/liter##2##1##(2008-10#2)
mul/ml##2##1##(2008-10#1)(2010-5#1)
mulberrofuran##2##1##(2011-3#2)
mulberry anthracnose##3##2##(2008-10#3)
mulberry leaves##9##2##(2008-10#9)
mulberry##18##1##(2008-10#17)(2008-11#1)
mulch and##2##2##(2008-10#2)
mulch layers##3##2##(2008-10#3)
mulch##10##1##(2008-10#9)(2010-7#1)
mulched##2##1##(2008-10#2)
mulches##3##1##(2008-10#3)
mull(-1)##2##1##(2008-10#2)
mullerian##3##1##(2007-9#1)(2008-6#1)(2011-1#1)
multi##14##1##(1997-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
multi-analyte##4##1##(2008-10#3)(2013-1#1)
multi-array chemical##2##2##(2008-10#2)
multi-basic##2##1##(2008-8#2)
multi-bilinear model##3##2##(2008-10#3)
multi-cellular##2##1##(2013-1#2)
multi-center prospective##2##2##(2008-8#1)(2010-5#1)
multi-center##10##1##(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-11#1)(2010-5#1)
multi-centre study##2##2##(1997-6#1)(2012-2#1)
multi-centre##3##1##(1997-2#1)(1997-6#1)(2012-2#1)
multi-centric##2##1##(2008-10#1)(2008-8#1)
multi-channel cochlear##2##2##(2008-9#2)
multi-channel##9##1##(1994-12#1)(2008-10#3)(2008-9#3)(2013-1#2)
multi-class##3##1##(2008-10#1)(2013-8#2)
multi-color##2##1##(2008-1#1)(2008-9#1)
multi-commutation##3##1##(2008-10#3)
multi-component analysis##2##2##(2008-10#2)
multi-component##6##1##(1994-3#1)(2008-10#4)(2012-2#1)
multi-criteria##3##1##(2008-10#1)(2010-8#1)(2013-1#1)
multi-cultural##2##1##(1995-3#1)(2007-8#1)
multi-datatype analysis##2##2##(2011-2#2)
multi-detector computed tomography##2##3##(2008-7#1)(2012-2#1)
multi-detector row CT##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
multi-detector##7##1##(2008-7#2)(2010-8#1)(2011-2#3)(2012-2#1)
multi-dimensional##2##1##(1997-2#1)(2008-10#1)
multi-directional##2##1##(2010-8#1)(2012-2#1)
multi-disciplinary care##2##2##(2008-1#1)(2012-12#1)
multi-disciplinary team##5##2##(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#2)
multi-disciplinary##16##1##(1996-3#1)(2007-6#3)(2008-1#1)(2008-11#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)
multi-domain##2##1##(2012-2#2)
multi-dose powder##2##2##(1996-2#2)
multi-drug resistant##4##2##(2010-2#1)(2012-2#2)(2013-8#1)
multi-drug##7##1##(2010-2#1)(2010-3#2)(2011-3#1)(2012-2#2)(2013-8#1)
multi-electrode switch##2##2##(2008-10#2)
multi-electrode##5##1##(2008-10#2)(2008-4#2)(2013-8#1)
multi-element analysis of glass##2##4##(2008-10#2)
multi-element analysis of##4##3##(2008-10#4)
multi-element analysis##5##2##(2008-10#5)
multi-element determination in##3##3##(2008-10#3)
multi-element determination##4##2##(2008-10#4)
multi-element standard##2##2##(2008-10#2)
multi-element##20##1##(2007-12#1)(2008-10#19)
multi-elemental##2##1##(2008-10#2)
multi-ethnic##4##1##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
multi-faceted##11##1##(1992-11#1)(1993-12#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
multi-factorial##10##1##(1995-6#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
multi-frequency laser##5##2##(2008-10#5)
multi-frequency##6##1##(2008-10#5)(2008-11#1)
multi-function##2##1##(1994-11#1)(2008-9#1)
multi-functional##2##1##(2008-8#1)(2011-2#1)
multi-gene##5##1##(1994-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
multi-hospital arrangements literature##2##3##(1996-3#2)
multi-hospital arrangements##4##2##(1996-3#4)
multi-hospital##5##1##(1992-1#1)(1996-3#4)
multi-injection##2##1##(2008-10#2)
multi-institutional arrangements##2##2##(1996-12#1)(1996-3#1)
multi-institutional studies##2##2##(2008-6#1)(2010-12#1)
multi-institutional##10##1##(1991-3#1)(1993-12#1)(1994-2#2)(1996-12#1)(1996-3#1)(2008-6#1)(2010-12#1)(2010-5#1)(2013-8#1)
multi-layer##2##1##(2008-11#1)(2010-8#1)
multi-layered##3##1##(2008-12#2)(2009-11#1)
multi-level##5##1##(2007-8#2)(2009-10#1)(2009-8#1)(2012-2#1)
multi-locus DNA##2##2##(1995-6#1)(2008-10#1)
multi-locus##4##1##(1995-6#1)(2008-10#2)(2008-9#1)
multi-method approach to data collection##2##5##(2008-11#2)
multi-method research##2##2##(2008-11#1)(2008-12#1)
multi-method##4##1##(2008-11#3)(2008-12#1)
multi-modality imaging##2##2##(2012-2#2)
multi-modality##5##1##(1990-6#1)(1994-1#1)(2010-3#1)(2012-2#2)
multi-organ failure##2##2##(1993-2#1)(2008-4#1)
multi-organ injuries##2##2##(2007-8#2)
multi-organ system##3##2##(1990-11#2)(2008-11#1)
multi-organ##12##1##(1990-11#2)(1993-2#1)(2007-8#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
multi-parameter observation of##2##3##(2008-8#2)
multi-parameter##3##1##(1994-8#1)(2008-8#2)
multi-phase##2##1##(2008-10#1)(2008-5#1)
multi-planar##2##1##(2008-2#1)(2008-7#1)
multi-port selection valve##2##3##(2008-10#2)
multi-port selection##3##2##(2008-10#3)
multi-potent##2##1##(2008-11#1)(2009-12#1)
multi-professional##4##1##(2008-11#3)(2008-12#1)
multi-protein##5##1##(2008-7#2)(2012-2#2)(2013-8#1)
multi-pumping flow##3##2##(2008-10#3)
multi-purpose##2##1##(2008-7#1)(2010-9#1)
multi-residue##3##1##(2008-10#3)
multi-sample##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
multi-segment hybrid orthosis-stimulation system##2##4##(2007-10#2)
multi-segment##3##1##(2007-10#3)
multi-sensor##2##1##(2008-10#2)
multi-site evaluation##2##2##(1995-3#1)(2009-5#1)
multi-site##14##1##(1995-2#1)(1995-3#3)(1996-3#1)(2008-1#1)(2008-10#1)(2009-5#2)(2012-3#1)(2013-1#4)
multi-skilled##3##1##(1997-3#2)(2008-11#1)
multi-skilling##2##1##(1993-12#1)(2008-12#1)
multi-slice##2##1##(2007-8#1)(2013-8#1)
multi-source##3##1##(2008-8#1)(2009-5#2)
multi-species##2##1##(2008-5#1)(2008-9#1)
multi-spectral canopy##2##2##(2008-10#2)
multi-stable##2##1##(2008-8#1)(2013-8#1)
multi-stage##5##1##(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
multi-stakeholder alliances##4##2##(2013-1#4)
multi-stakeholder##6##1##(2013-1#6)
multi-state model##2##2##(1995-9#2)
multi-state##6##1##(1995-2#2)(1995-9#2)(2009-4#1)(2013-1#1)
multi-step process##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
multi-step##15##1##(1994-12#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
multi-syringe flow injection##2##3##(2008-10#2)
multi-syringe flow##3##2##(2008-10#3)
multi-syringe flow-injection##2##2##(2008-10#2)
multi-syringe##6##1##(2008-10#6)
multi-tau##2##1##(2008-3#2)
multi-unit##4##1##(1993-12#1)(1994-1#1)(1996-9#1)(2008-1#1)
multi-user##2##1##(1992-2#1)(2008-10#1)
multi-vessel##2##1##(2006-10#1)(2008-11#1)
multi-wall carbon nanotubes##2##3##(2008-10#2)
multi-wall carbon##4##2##(2008-10#4)
multi-wall##5##1##(2008-10#4)(2008-12#1)
multi-walled carbon nanotubes (MWNTs)##2##4##(2008-10#1)(2010-5#1)
multi-walled carbon nanotubes##3##3##(2008-10#2)(2010-5#1)
multi-walled carbon nanotubes/(3-mercaptopropyl)trimethoxysilane##2##3##(2008-10#2)
multi-walled carbon##5##2##(2008-10#4)(2010-5#1)
multi-wavelength##3##1##(2008-10#2)(2009-11#1)
multi-well##4##1##(2008-11#3)(2008-9#1)
multi-year##2##1##(1995-12#1)(2012-2#1)
multiallelic##2##1##(1992-8#1)(2008-10#1)
multianalyte##9##1##(2008-10#7)(2008-4#1)(2008-7#1)
multiangle light scattering##3##3##(2008-2#1)(2011-2#2)
multiangle##4##1##(2008-2#2)(2011-2#2)
multiangular##2##1##(2008-2#1)(2008-3#1)
multiaperture##3##1##(2008-2#2)(2008-3#1)
multiaxial##3##1##(2008-11#2)(2013-8#1)
multibacillary##2##1##(2011-2#2)
multiband infrared systems##2##3##(2008-3#2)
multiband systems##2##2##(2008-3#2)
multiband##9##1##(1993-5#1)(2008-3#8)
multibeam##4##1##(2008-3#4)
multibiosensor##2##1##(2008-10#2)
multicatalytic proteinase complex##2##3##(1994-5#2)
multicellular aggregates##3##2##(2008-11#3)
multicellular hypersensitive##2##2##(2008-10#2)
multicellular organisms##9##2##(1997-2#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-8#1)(2010-3#1)
multicellular resistance##2##2##(2008-11#2)
multicellular spheroids##2##2##(1992-9#1)(2008-11#1)
multicellular##37##1##(1992-9#2)(1993-6#1)(1997-2#1)(2008-10#2)(2008-11#12)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#5)(2010-3#2)(2011-2#1)(2012-3#1)
multicenter clinical##2##2##(1994-6#1)(1994-8#1)
multicenter phase##3##2##(2007-4#1)(2007-7#1)(2008-5#1)
multicenter pilot study##2##3##(2008-7#1)(2009-10#1)
multicenter randomized##4##2##(1993-1#2)(2013-1#2)
multicenter series of 350##3##4##(1990-12#2)(1991-8#1)
multicenter series of##4##3##(1990-12#3)(1991-8#1)
multicenter studies##4##2##(1992-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
multicenter study in##2##3##(2010-6#1)(2012-3#1)
multicenter study##11##2##(1990-6#1)(2007-7#2)(2008-5#1)(2008-6#2)(2009-10#1)(2009-8#1)(2010-6#1)(2012-2#1)(2012-3#1)
multicenter trial is##2##3##(2007-10#1)(2008-7#1)
multicenter trial##6##2##(1994-6#1)(2007-10#3)(2008-10#1)(2008-7#1)
multicenter trials##2##2##(2011-2#1)(2012-12#1)
multicenter##66##1##(1990-12#3)(1990-6#1)(1991-8#1)(1992-11#2)(1992-8#1)(1993-1#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-5#1)(2007-10#4)(2007-12#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
multicentered##2##1##(1990-6#1)(2010-8#1)
multicentre clinical##2##2##(1996-3#1)(2012-3#1)
multicentre studies##2##2##(1997-2#1)(2008-4#1)
multicentre study##9##2##(1990-3#2)(1992-2#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-5#2)(2012-3#1)
multicentre##33##1##(1990-3#2)(1991-11#1)(1992-2#2)(1992-5#1)(1993-2#1)(1993-3#1)(1994-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#3)
multicentric study##2##2##(2007-7#1)(2008-7#1)
multicentric##18##1##(1992-10#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-7#3)(2007-8#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)
multichain##2##1##(1994-2#1)(2012-2#1)
multichannel acousto-optic Bragg cell##4##4##(2008-3#4)
multichannel cochlear implants on the##2##5##(2008-9#2)
multichannel cochlear##3##2##(2008-9#3)
multichannel detection##2##2##(1997-6#1)(2007-12#1)
multichannel diffractive optic rotary joint##2##5##(2008-2#2)
multichannel images##3##2##(2007-12#2)(2008-3#1)
multichannel parallel##2##2##(2008-3#2)
multichannel time-resolved##2##2##(2008-3#2)
multichannel##51##1##(1997-6#1)(2007-11#1)(2007-12#6)(2008-10#4)(2008-2#8)(2008-3#25)(2008-4#1)(2008-9#4)(2009-2#1)
multichip modules##3##2##(2008-2#2)(2008-3#1)
multichip##8##1##(2007-12#1)(2008-2#3)(2008-3#4)
multicistronic expression technology##4##3##(2008-11#4)
multicistronic expression units##2##3##(2008-11#2)
multicistronic expression##9##2##(2008-11#8)(2012-2#1)
multicistronic##11##1##(2008-11#9)(2012-2#2)
multiclass##2##1##(2008-6#2)
multicollector##2##1##(2008-10#2)
multicollinearity##3##1##(1994-12#2)(2008-10#1)
multicolor flow cytometry##3##3##(2008-4#1)(2008-9#2)
multicolor flow##4##2##(2008-4#1)(2008-9#3)
multicolor imaging##2##2##(2008-9#1)(2009-9#1)
multicolor polarizing##2##2##(2008-3#2)
multicolor##24##1##(2007-12#1)(2008-1#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-6#3)(2008-9#8)(2009-11#1)(2009-4#1)(2009-9#1)(2013-8#1)
multicombinatorial libraries of##2##3##(1994-12#2)
multicommutated##5##1##(2008-10#5)
multicommutation and##3##2##(2008-10#3)
multicommutation approach allowed##2##3##(2008-10#2)
multicommutation approach##5##2##(2008-10#5)
multicommutation for the##2##3##(2008-10#2)
multicommutation to##2##2##(2008-10#2)
multicommutation##24##1##(2008-10#24)
multicommuted flow system##4##3##(2008-10#4)
multicommuted flow##5##2##(2008-10#5)
multicommuted##8##1##(2008-10#8)
multicomparand word-parallel bit-parallel equality##2##4##(2008-3#2)
multicomparand##4##1##(2007-12#1)(2008-3#3)
multicomponent analysis of a##2##4##(2008-10#1)(2008-3#1)
multicomponent analysis of##4##3##(2008-10#3)(2008-3#1)
multicomponent determination##2##2##(2008-10#2)
multicomponent mixtures##4##2##(1991-9#1)(2007-12#1)(2008-10#1)(2013-8#1)
multicomponent systems##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
multicomponent##44##1##(1990-8#1)(1991-9#1)(1997-4#1)(2007-11#4)(2007-12#3)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#2)(2013-8#3)
multicopper oxidases##3##2##(2008-10#1)(2012-2#2)
multicopper##4##1##(2008-10#2)(2012-2#2)
multicopy plasmid##8##2##(1990-11#2)(1990-5#1)(1993-9#1)(1995-5#2)(1997-3#2)
multicopy plasmids##2##2##(1991-12#1)(2008-10#1)
multicopy suppressor gene of the pop2 mutation##2##7##(1995-6#2)
multicopy##23##1##(1990-11#2)(1990-5#2)(1991-12#3)(1991-2#1)(1993-9#1)(1995-11#1)(1995-5#2)(1995-6#3)(1996-10#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-4#1)(2008-6#2)
multicore fiber##3##2##(2007-11#2)(2008-3#1)
multicore##4##1##(2007-11#2)(2008-3#2)
multicriteria approach to the iterative##2##5##(2008-3#2)
multicriteria optimization##2##2##(2008-10#2)
multicriteria##7##1##(2008-10#2)(2008-3#5)
multicultural groups##2##2##(2008-11#2)
multicultural##8##1##(1993-12#1)(1995-3#1)(2008-11#3)(2010-3#1)(2012-12#1)(2013-8#1)
multicystic dysplastic kidney##3##3##(2008-10#3)
multicystic##7##1##(1992-8#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
multidetection##2##1##(2008-10#2)
multidetector CT (MDCT)##2##3##(2008-7#1)(2011-2#1)
multidetector CT is##2##3##(2008-7#2)
multidetector CT##8##2##(2008-7#4)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
multidetector computed tomography (MDCT) in##2##5##(2011-2#2)
multidetector computed tomography (MDCT)##3##4##(2011-2#2)(2012-2#1)
multidetector computed tomography##9##3##(2008-12#3)(2008-7#1)(2011-2#2)(2012-2#3)
multidetector##20##1##(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#5)(2009-10#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#4)
multidetector-row computed tomography##3##3##(2011-2#1)(2012-2#2)
multidetector-row##4##1##(2011-2#2)(2012-2#2)
multidimensional analysis##3##2##(2008-10#2)(2008-9#1)
multidimensional approach##2##2##(1994-1#1)(1997-1#1)
multidimensional chromatographic##2##2##(1997-2#1)(1997-4#1)
multidimensional counseling##2##2##(2008-7#2)
multidimensional data##2##2##(2008-10#2)
multidimensional index tree##2##3##(2009-9#2)
multidimensional measure of##3##3##(2009-5#1)(2012-2#2)
multidimensional measure##4##2##(2009-5#1)(2012-2#3)
multidimensional scaling##9##2##(1995-5#4)(1996-7#1)(2008-10#2)(2008-4#1)(2011-2#1)
multidimensional##72##1##(1992-12#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)
multidirectional##4##1##(2008-2#1)(2008-6#1)(2012-2#1)(2013-8#1)
multidisciplinary European expert panel##2##4##(2010-12#2)
multidisciplinary and##5##2##(1995-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-3#1)
multidisciplinary approach is##3##3##(2009-4#1)(2011-2#1)(2012-3#1)
multidisciplinary approach to the management##3##5##(2008-1#1)(2010-3#1)(2013-1#1)
multidisciplinary approach to##11##3##(1994-1#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2010-3#1)(2011-2#1)(2013-1#1)
multidisciplinary approach##29##2##(1991-2#1)(1991-3#1)(1991-5#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#3)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)
multidisciplinary cancer##2##2##(2008-6#1)(2012-12#1)
multidisciplinary care##5##2##(1996-1#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-8#1)
multidisciplinary clinic##3##2##(1996-3#3)
multidisciplinary documentation##2##2##(2008-3#2)
multidisciplinary field##2##2##(2008-2#1)(2011-2#1)
multidisciplinary management##2##2##(2009-1#1)(2011-1#1)
multidisciplinary pain rehabilitation##4##3##(2013-1#4)
multidisciplinary pain##5##2##(1994-1#1)(2013-1#4)
multidisciplinary program to quit smoking##2##5##(2013-8#2)
multidisciplinary program to quit##3##4##(2013-8#3)
multidisciplinary program##5##2##(1992-1#1)(1993-2#1)(2013-8#3)
multidisciplinary project##2##2##(2008-8#2)
multidisciplinary research##2##2##(2008-11#1)(2009-11#1)
multidisciplinary study##2##2##(1991-6#1)(2013-1#1)
multidisciplinary team members who##2##4##(2007-11#1)(2011-1#1)
multidisciplinary team members##3##3##(2007-10#1)(2007-11#1)(2011-1#1)
multidisciplinary team##24##2##(1990-6#1)(1996-7#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)
multidisciplinary teams and##2##3##(1993-2#1)(2008-8#1)
multidisciplinary teams of##3##3##(2008-2#1)(2008-6#1)(2011-2#1)
multidisciplinary teams##11##2##(1993-2#1)(1994-1#1)(1996-1#1)(1996-7#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#3)(2011-2#1)
multidisciplinary treatment##9##2##(1993-11#1)(1993-6#1)(2008-7#1)(2009-9#1)(2010-3#1)(2012-3#4)
multidisciplinary##173##1##(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#4)(1996-7#3)(1997-2#3)(1997-3#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#5)(2008-7#6)(2008-8#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#5)(2010-5#1)(2010-6#1)(2011-1#6)(2011-2#10)(2011-3#2)(2011-8#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#9)(2012-8#2)(2013-1#17)(2013-8#4)
multidistance##3##1##(2007-12#2)(2008-3#1)
multidomain##5##1##(1994-5#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-6#1)
multidrug chemotherapy##4##2##(1992-10#1)(1996-8#1)(2010-3#1)(2011-2#1)
multidrug resistance (MDR)##2##3##(2008-11#1)(2012-3#1)
multidrug resistance (MDR1) gene##2##4##(1991-12#1)(1994-5#1)
multidrug resistance gene##2##3##(1991-12#1)(2008-11#1)
multidrug resistance##27##2##(1990-2#1)(1991-12#2)(1994-5#1)(1996-8#1)(1997-4#1)(2007-10#2)(2008-11#13)(2011-2#1)(2012-3#3)(2013-1#2)
multidrug resistance-associated protein (MRP)##2##4##(1997-4#1)(2008-11#1)
multidrug resistance-associated protein##3##3##(1997-4#1)(2008-11#2)
multidrug resistant##18##2##(1990-2#1)(1991-12#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-11#2)(2008-8#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
multidrug##61##1##(1990-2#2)(1991-12#3)(1991-8#1)(1992-10#1)(1994-5#1)(1996-3#1)(1996-8#2)(1997-4#3)(2007-10#2)(2007-7#2)(2008-11#19)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#2)
multidrug-resistant (MDR)##2##2##(1993-3#1)(2011-2#1)
multidrug-resistant TB##2##2##(2008-10#1)(2010-5#1)
multidrug-resistant phenotype##3##2##(1993-3#1)(1995-11#1)(2008-11#1)
multidrug-resistant##19##1##(1993-3#2)(1994-6#1)(1995-11#5)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)
multielectrode##3##1##(2007-12#1)(2008-2#1)(2009-12#1)
multielement analysis##2##2##(2008-10#1)(2010-11#1)
multielement determination##6##2##(2008-10#6)
multielement##18##1##(2008-10#13)(2008-2#1)(2008-3#3)(2010-11#1)
multielemental analysis by##2##3##(2008-10#2)
multielemental analysis##8##2##(2008-10#8)
multielemental##14##1##(2008-10#14)
multienzyme redox system##2##3##(2008-10#2)
multienzyme##4##1##(1991-5#1)(1996-6#1)(2008-10#2)
multiethnic##3##1##(2008-1#1)(2010-4#1)(2012-12#1)
multiexponential diffusion##2##2##(2012-2#2)
multiexponential##3##1##(1995-2#1)(2012-2#2)
multifaceted and##2##2##(2008-10#1)(2012-2#1)
multifaceted##31##1##(1994-1#1)(1994-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
multifactor##3##1##(2008-10#2)(2012-3#1)
multifactorial disease##4##2##(2008-1#1)(2009-10#1)(2012-2#1)(2013-7#1)
multifactorial diseases##2##2##(2011-2#1)(2012-2#1)
multifactorial etiology##2##2##(1990-3#1)(2008-8#1)
multifactorial##33##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-5#1)(1992-9#1)(1997-7#1)(2007-11#2)(2008-1#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
multifiber##5##1##(2008-11#1)(2008-3#4)
multifilter rotating shadow-band radiometer##2##4##(2008-2#2)
multiflorum Lam##2##2##(2008-10#1)(2012-2#1)
multifocal avascular necrosis##2##3##(2006-10#2)
multifocal intraocular lens##3##3##(2011-2#3)
multifocal motor neuropathy##2##3##(2008-7#2)
multifocal multiphoton##2##2##(2007-12#2)
multifocal osteomyelitis##2##2##(2006-10#1)(2007-12#1)
multifocal renal cell##2##3##(2011-2#2)
multifocal##35##1##(1992-5#1)(1994-5#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-10#4)(2007-10#1)(2007-12#4)(2007-8#1)(2008-3#2)(2008-7#5)(2009-3#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-8#1)
multifold##3##1##(2008-10#2)(2011-2#1)
multiform##2##1##(1990-8#1)(2011-2#1)
multiforme##13##1##(1994-2#1)(1995-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#2)(2011-3#2)(2013-1#1)
multifractal##3##1##(2008-8#3)
multifractals##2##1##(2008-8#2)
multifractional Fourier transform##2##3##(2007-12#2)
multifractional Fourier##3##2##(2007-12#3)
multifrequency grating projection profilometry##2##4##(2008-3#2)
multifrequency##4##1##(2007-11#1)(2008-10#1)(2008-3#2)
multifringe##2##1##(2008-2#2)
multifunction cable##2##2##(2010-9#2)
multifunction##4##1##(2008-2#1)(2008-3#1)(2010-9#2)
multifunctional anaesthesia system##2##3##(2011-2#2)
multifunctional anaesthesia##3##2##(2011-2#3)
multifunctional column##4##2##(2008-10#4)
multifunctional hydrazones##2##2##(2008-9#2)
multifunctional magnetic##2##2##(2009-11#1)(2010-5#1)
multifunctional molecules##2##2##(2007-11#1)(2008-5#1)
multifunctional nature of##2##3##(1997-4#1)(2009-6#1)
multifunctional plant##2##2##(2008-5#2)
multifunctional protein CAD##2##3##(1990-7#1)(1995-5#1)
multifunctional protein##7##2##(1990-7#3)(1995-5#1)(1995-8#1)(2008-9#1)(2009-3#1)
multifunctional roles##2##2##(2008-11#1)(2012-2#1)
multifunctional transcription factor##2##3##(1994-10#1)(2008-11#1)
multifunctional##55##1##(1990-7#3)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#2)(2009-3#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#2)
multifunctionality##3##1##(2008-3#1)(2008-7#1)(2008-9#1)
multifunctionalization of##2##2##(1995-3#1)(2008-7#1)
multigene expression vectors and##2##4##(1997-4#2)
multigene expression##3##2##(1997-4#2)(2008-11#1)
multigene families##2##2##(1994-8#1)(2009-9#1)
multigene family in##2##3##(1994-11#1)(1997-7#1)
multigene family##14##2##(1991-6#1)(1993-6#1)(1993-9#2)(1994-11#4)(1995-2#1)(1996-12#1)(1997-7#2)(2008-11#1)(2008-8#1)
multigene metabolic engineering##4##3##(2008-11#4)
multigene##29##1##(1991-6#1)(1993-6#1)(1993-9#3)(1994-11#4)(1994-8#1)(1995-2#1)(1996-12#2)(1997-4#3)(1997-7#2)(2008-10#1)(2008-11#6)(2008-8#1)(2009-9#1)(2010-6#1)(2011-2#1)
multigenerational##2##1##(1997-5#1)(2009-12#1)
multigenic families##4##2##(1995-6#1)(1997-9#3)
multigenic##7##1##(1994-12#2)(1995-6#1)(1997-9#3)(2008-9#1)
multigenomic##2##1##(2008-8#2)
multigrating periodically poled##3##3##(2007-12#3)
multigrating##5##1##(2007-12#5)
multigravid rats##2##2##(1992-5#2)
multihop packet switches##2##3##(2008-3#2)
multihop##3##1##(2008-3#3)
multihospital systems##2##2##(1991-1#1)(1997-3#1)
multihospital##7##1##(1991-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-3#1)
multijoint multiwaveform##3##2##(2013-1#3)
multilamellar liposomes##3##2##(1990-2#2)(2008-10#1)
multilamellar vesicle##2##2##(1993-9#1)(2007-11#1)
multilamellar vesicles##3##2##(2008-10#1)(2008-5#2)
multilamellar##11##1##(1990-2#2)(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
multilateral##2##1##(2009-5#1)(2011-2#1)
multilayer Langmuir-Blodgett##2##2##(2008-10#2)
multilayer and##4##2##(2008-2#3)(2008-3#1)
multilayer coating and the##2##4##(2008-2#1)(2008-3#1)
multilayer coating was##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
multilayer coating##16##2##(2007-11#1)(2008-2#8)(2008-3#7)
multilayer coatings in##2##3##(2008-2#1)(2008-3#1)
multilayer coatings was##2##3##(2008-2#2)
multilayer coatings were##2##3##(2008-3#1)(2010-4#1)
multilayer coatings##22##2##(2008-2#9)(2008-3#11)(2010-4#2)
multilayer deposition##3##2##(2008-3#3)
multilayer designs for##2##3##(2008-3#2)
multilayer designs##3##2##(2008-3#3)
multilayer dielectric Fabry-Perot##2##3##(2007-12#1)(2008-3#1)
multilayer film##5##2##(2008-10#5)
multilayer films on##2##3##(2008-10#2)
multilayer films##8##2##(2008-10#6)(2008-3#2)
multilayer highly reflecting mirror##2##4##(2008-3#2)
multilayer interference coatings##5##3##(2007-11#1)(2008-3#4)
multilayer mirror##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
multilayer mirrors for##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
multilayer mirrors##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
multilayer neural networks##2##3##(2008-2#1)(2010-8#1)
multilayer neural##3##2##(2008-2#1)(2008-3#1)(2010-8#1)
multilayer optical coatings##2##3##(2008-3#2)
multilayer optical##7##2##(2007-11#1)(2007-12#2)(2008-3#4)
multilayer optics##2##2##(2007-11#1)(2008-3#1)
multilayer perceptron neural network##2##4##(2008-3#1)(2010-8#1)
multilayer perceptron##4##2##(2008-10#1)(2008-3#2)(2010-8#1)
multilayer perceptrons##2##2##(2008-10#1)(2008-3#1)
multilayer recording##2##2##(2007-12#1)(2008-3#1)
multilayer stack##4##2##(2008-3#4)
multilayer structure##4##2##(2007-12#2)(2008-3#2)
multilayer structures deposited on##2##4##(2008-2#2)
multilayer structures##3##2##(2008-2#2)(2008-3#1)
multilayer system is##2##3##(2008-3#2)
multilayer system##6##2##(2008-2#2)(2008-3#4)
multilayer systems##2##2##(2008-2#2)
multilayer thin films##3##3##(2008-3#3)
multilayer was##2##2##(2008-2#1)(2008-3#1)
multilayer##198##1##(2007-11#11)(2007-12#12)(2007-8#2)(2008-10#24)(2008-11#4)(2008-2#41)(2008-3#92)(2008-5#1)(2008-6#2)(2009-11#1)(2009-5#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
multilayer-coated##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
multilayer-mirror##2##1##(2008-3#2)
multilayered films##2##2##(2008-12#2)
multilayered structures##3##2##(2008-2#1)(2008-3#2)
multilayered##16##1##(2007-12#1)(2008-10#2)(2008-12#4)(2008-2#2)(2008-3#4)(2008-7#1)(2009-9#1)(2010-4#1)
multilayers and##2##2##(2007-11#1)(2010-4#1)
multilayers decreased##2##2##(2007-11#1)(2008-10#1)
multilayers for the##2##3##(2008-2#1)(2008-3#1)
multilayers for##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
multilayers of##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
multilayers on##3##2##(2008-10#2)(2008-2#1)
multilayers were##6##2##(2007-11#1)(2008-10#3)(2008-2#2)
multilayers##46##1##(1995-5#1)(2007-11#9)(2007-12#5)(2008-10#10)(2008-2#7)(2008-3#13)(2010-4#1)
multilevel C-ADR with multilevel##2##4##(2012-12#2)
multilevel C-ADR with##3##3##(2012-12#3)
multilevel C-ADR##7##2##(2012-12#7)
multilevel analysis##7##2##(2008-12#1)(2008-7#1)(2010-1#2)(2011-1#2)(2013-8#1)
multilevel approach##2##2##(2008-11#1)(2008-3#1)
multilevel intervention##2##2##(2012-12#2)
multilevel logistic regression##2##3##(2009-6#1)(2013-1#1)
multilevel modeling##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
multilevel phase##2##2##(2008-3#2)
multilevel regression##2##2##(2008-7#1)(2009-12#1)
multilevel selection##3##2##(2008-8#3)
multilevel signal##2##2##(2008-3#2)
multilevel##49##1##(2007-11#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#10)(2008-7#2)(2008-8#3)(2009-12#1)(2009-6#1)(2010-1#3)(2011-1#2)(2011-2#1)(2012-12#15)(2013-1#1)(2013-8#1)
multiligand-binding site in##2##3##(2008-8#2)
multiline population##2##2##(2008-10#2)
multiline##5##1##(2008-10#4)(2008-2#1)
multilineage differentiation##2##2##(2011-2#1)(2012-12#1)
multilineage##3##1##(2008-11#1)(2011-2#1)(2012-12#1)
multilinear regression##2##2##(2008-10#2)
multilinear##4##1##(2008-10#3)(2009-8#1)
multilingual##4##1##(1993-12#1)(2007-8#1)(2008-7#1)(2008-9#1)
multilocular##2##1##(2013-1#1)(2013-7#1)
multilocularis##6##1##(1996-12#3)(2008-7#1)(2010-11#1)(2011-2#1)
multilocus AFLP genotypes##2##3##(2008-10#2)
multilocus association and##2##3##(2008-10#2)
multilocus genotypes##4##2##(2008-10#4)
multilocus haplotypes were identified##2##4##(2008-10#2)
multilocus haplotypes##5##2##(2008-10#5)
multilocus sequence##2##2##(2008-10#1)(2011-2#1)
multilocus##41##1##(2008-10#33)(2008-9#2)(2011-2#2)(2012-3#4)
multilongitudinal-mode##3##1##(2007-12#3)
multimask lithography##2##2##(2007-11#1)(2008-3#1)
multimedia learning##5##2##(2013-8#5)
multimedia##21##1##(1995-2#1)(2007-2#1)(2008-11#5)(2008-12#2)(2008-3#3)(2008-7#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-8#5)
multimember VCGs##3##2##(2008-10#3)
multimember##4##1##(2008-10#4)
multimer##3##1##(2008-2#1)(2011-2#2)
multimeric form##2##2##(2008-10#2)
multimeric protein##2##2##(1990-12#1)(1990-5#1)
multimeric##6##1##(1990-12#1)(1990-5#1)(1990-8#1)(1997-4#1)(2008-10#2)
multimerization function of NifA central domain##3##6##(2008-9#3)
multimerization##11##1##(1993-8#4)(1995-2#1)(2008-10#1)(2008-9#5)
multimerized##2##1##(1993-8#1)(1995-6#1)
multimers of##4##2##(1990-5#1)(1994-11#2)(1997-2#1)
multimers##12##1##(1990-5#1)(1993-3#2)(1994-11#3)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2009-7#1)(2009-9#1)
multimodal and##2##2##(2008-12#1)(2012-3#1)
multimodal distributions##2##2##(1992-2#1)(2008-3#1)
multimodal pathway##2##2##(2012-2#2)
multimodal therapy in##2##3##(2010-3#1)(2010-8#1)
multimodal therapy##7##2##(2010-12#1)(2010-3#4)(2010-8#1)(2012-12#1)
multimodal treatment with##2##3##(2012-3#2)
multimodal treatment##3##2##(2012-3#3)
multimodal##36##1##(1991-8#1)(1992-2#1)(1994-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2010-12#1)(2010-3#4)(2010-8#1)(2011-1#2)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-8#2)
multimodality therapy for##2##3##(2008-6#1)(2008-8#1)
multimodality therapy##3##2##(2007-8#1)(2008-6#1)(2008-8#1)
multimodality treatment##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
multimodality##11##1##(1991-2#1)(1994-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#2)
multimode deformable mirror##3##3##(2008-2#1)(2008-3#2)
multimode deformable##4##2##(2008-2#1)(2008-3#3)
multimode emissions##2##2##(2008-2#2)
multimode excitation##2##2##(2008-3#2)
multimode fiber##12##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#9)
multimode fibers##10##2##(2007-11#2)(2008-2#2)(2008-3#6)
multimode interference coupler##3##3##(2007-11#3)
multimode interference##6##2##(2007-11#3)(2007-12#2)(2008-2#1)
multimode laser##10##2##(1992-11#1)(2008-2#4)(2008-3#5)
multimode optical fiber##6##3##(2007-12#1)(2008-3#5)
multimode optical fibers##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
multimode optical##11##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)
multimode output power with##2##4##(2007-11#1)(2008-2#1)
multimode output power##3##3##(2007-11#2)(2008-2#1)
multimode output##4##2##(2007-11#2)(2008-2#2)
multimode waveguide##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
multimode##112##1##(1992-11#1)(2007-11#20)(2007-12#16)(2008-10#1)(2008-2#21)(2008-3#50)(2010-4#2)(2013-1#1)
multimodulation##2##1##(2008-2#2)
multinational##13##1##(1994-2#1)(2007-7#1)(2008-2#1)(2008-5#2)(2008-7#2)(2010-3#3)(2011-2#2)(2011-8#1)
multinodular goiter##2##2##(1990-6#1)(2012-3#1)
multinodular##9##1##(1990-6#1)(1990-9#1)(1993-6#2)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
multinomial logistic regression##4##3##(2012-1#1)(2012-3#1)(2013-1#2)
multinomial probit models##2##3##(2009-4#2)
multinomial probit##3##2##(2009-4#3)
multinomial##11##1##(1995-9#1)(2008-8#1)(2009-4#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
multinuclear MRS##3##2##(2012-2#3)
multinuclear NMR##2##2##(1996-2#1)(2009-7#1)
multinuclear##6##1##(1995-5#1)(1996-2#1)(2009-7#1)(2012-2#3)
multinucleate##4##1##(1994-8#1)(2008-10#2)(2013-1#1)
multinucleated cells##4##2##(1993-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
multinucleated giant cells##6##3##(1991-12#1)(2008-4#1)(2009-3#1)(2012-2#1)(2013-1#2)
multinucleated osteoclasts##2##2##(2008-11#1)(2008-4#1)
multinucleated##17##1##(1991-11#1)(1991-12#1)(1993-8#1)(1995-2#1)(2008-11#3)(2008-12#2)(2008-4#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#3)
multinucleatedcells##2##1##(2008-11#2)
multiorgan dysfunction syndrome##2##3##(2008-10#1)(2008-12#1)
multiorgan failure (MOF)##2##3##(1992-5#1)(2009-7#1)
multiorgan failure##5##2##(1992-5#1)(1995-8#1)(1997-3#1)(2009-7#1)(2012-12#1)
multiorgan involvement##2##2##(2008-7#1)(2012-3#1)
multiorgan##12##1##(1990-6#1)(1992-5#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#2)(2012-1#1)(2012-12#1)(2012-3#1)
multiparameter analysis##2##2##(2008-11#1)(2008-4#1)
multiparameter flow##2##2##(2008-9#2)
multiparameter##9##1##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#5)
multiparametric##7##1##(1991-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)
multiparas##5##1##(2008-4#5)
multiparasitised hosts##2##2##(2010-2#2)
multiparasitised##3##1##(2010-2#3)
multiparity and ovariectomy##4##3##(1997-4#4)
multiparity##6##1##(1992-5#1)(1997-4#4)(2012-12#1)
multiparous women##2##2##(2011-1#1)(2013-1#1)
multiparous##13##1##(1992-5#2)(1997-4#4)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
multiparticle##2##1##(1993-5#1)(2008-3#1)
multipartite##4##1##(2007-12#1)(2008-9#1)(2011-2#2)
multipass absorption cell##3##3##(2008-2#2)(2008-3#1)
multipass cell##6##2##(2008-2#2)(2008-3#4)
multipass pumping##2##2##(2007-11#2)
multipass##18##1##(2007-11#3)(2007-12#2)(2008-2#6)(2008-3#7)
multiphase##5##1##(2007-12#1)(2008-3#1)(2009-10#2)(2013-1#1)
multiphasic##4##1##(1991-6#1)(1992-6#1)(2008-7#1)(2010-1#1)
multiphonon absorption##2##2##(2008-3#2)
multiphonon##3##1##(2008-2#1)(2008-3#2)
multiphoton absorption##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
multiphoton fluorescence microscopy##3##3##(2008-9#1)(2012-2#2)
multiphoton fluorescence##8##2##(2007-12#4)(2008-2#1)(2008-9#1)(2012-2#2)
multiphoton imaging##3##2##(2007-12#1)(2008-9#2)
multiphoton ionization##4##2##(1992-11#1)(2008-3#2)(2011-1#1)
multiphoton microscope##2##2##(2007-11#1)(2007-12#1)
multiphoton microscopy and##2##3##(2007-11#1)(2007-12#1)
multiphoton microscopy##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2008-9#1)
multiphoton##30##1##(1992-11#1)(2007-11#5)(2007-12#8)(2008-10#1)(2008-2#1)(2008-3#5)(2008-9#6)(2011-1#1)(2012-2#2)
multipin##2##1##(2008-4#2)
multipinhole circular##2##2##(2009-8#2)
multipinhole##4##1##(2009-8#4)
multiplanar technology##2##2##(2008-3#2)
multiplanar##12##1##(2008-1#1)(2008-12#1)(2008-3#3)(2008-8#1)(2010-12#1)(2011-2#4)(2012-2#1)
multiplane##2##1##(2008-3#1)(2009-10#1)
multiple &quot##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
multiple DNA##4##2##(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#1)
multiple Rayleigh scattering##2##3##(2008-3#2)
multiple absorption##2##2##(2008-2#1)(2008-3#1)
multiple activities in##2##3##(2012-2#1)(2012-3#1)
multiple activities##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
multiple age-related##2##2##(2008-7#1)(2012-2#1)
multiple alignment##2##2##(2008-4#1)(2008-9#1)
multiple alignments##2##2##(2008-4#1)(2008-9#1)
multiple alleles##3##2##(2008-10#1)(2012-3#2)
multiple alternative##2##2##(2008-4#1)(2010-12#1)
multiple analyses of the spiked samples##4##6##(2008-10#4)
multiple analytes in a##2##4##(2008-10#1)(2008-9#1)
multiple analytes in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
multiple analytes##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
multiple and##8##2##(1991-2#1)(1996-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-2#2)
multiple antibodies##3##2##(1992-12#1)(2008-9#2)
multiple antigenic peptide (MAP)##3##4##(2008-4#3)
multiple applications##3##2##(2008-3#2)(2011-2#1)
multiple areas of##2##3##(2008-11#1)(2011-2#1)
multiple array sensing and##2##4##(2010-8#2)
multiple aspects of##4##3##(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
multiple bacterial##2##2##(2007-8#1)(2008-10#1)
multiple bands of zebrafish##2##4##(2008-9#2)
multiple bands of##3##3##(2008-5#1)(2008-9#2)
multiple bands##5##2##(2008-5#2)(2008-9#3)
multiple basal cell carcinomas##2##4##(1997-3#1)(2010-8#1)
multiple beam generation##2##3##(2008-3#2)
multiple beams##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
multiple benefits##4##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)
multiple bilateral##5##2##(2007-10#1)(2007-12#1)(2008-10#2)(2013-1#1)
multiple biological##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
multiple biomarkers##2##2##(2012-1#2)
multiple births##3##2##(1991-3#1)(1995-6#2)
multiple bonds and##2##3##(1996-5#1)(2007-11#1)
multiple bonds##3##2##(1996-5#1)(2007-11#1)(2011-1#1)
multiple bone##5##2##(2007-11#5)
multiple brain abscesses in a##2##5##(2007-12#1)(2007-7#1)
multiple brain##5##2##(1996-12#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-9#1)
multiple branches##2##2##(2008-7#1)(2013-1#1)
multiple branching of##2##3##(2008-7#2)
multiple cameras##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
multiple cardiac##4##2##(2008-7#2)(2010-11#1)(2013-7#1)
multiple causes of##3##3##(2007-12#1)(2008-1#1)(2010-10#1)
multiple causes##6##2##(2007-12#1)(2008-1#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-8#1)
multiple cell surface##2##3##(2008-8#1)(2011-2#1)
multiple cell##5##2##(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
multiple cells##2##2##(2008-10#1)(2010-5#1)
multiple cellular processes##2##3##(2012-12#2)
multiple cellular##6##2##(1994-8#1)(1996-2#1)(2008-9#1)(2009-5#1)(2012-12#2)
multiple central##2##2##(1997-3#1)(2007-11#1)
multiple choice##5##2##(1991-12#1)(1991-3#1)(1993-2#1)(1994-2#1)(2012-12#1)
multiple chronic##3##2##(2008-10#2)(2008-5#1)
multiple clinical##3##2##(2008-3#1)(2010-3#1)(2012-1#1)
multiple cloning site (MCS)##3##4##(1994-12#3)
multiple cloning site##8##3##(1990-5#1)(1991-6#1)(1994-12#4)(1995-8#1)(1997-4#1)
multiple cloning sites (MCS)##2##4##(1993-12#1)(1994-12#1)
multiple cloning sites##3##3##(1993-12#1)(1994-12#1)(2011-1#1)
multiple cloning##12##2##(1990-5#2)(1991-6#1)(1993-12#1)(1994-12#5)(1995-8#1)(1997-4#1)(2011-1#1)
multiple coexisting##2##2##(1991-3#1)(1997-1#1)
multiple components##3##2##(1996-2#1)(2008-10#1)(2010-8#1)
multiple conformations##2##2##(1993-11#1)(2012-2#1)
multiple congenital##3##2##(1997-6#1)(2010-7#1)(2013-1#1)
multiple copies of the##3##4##(1993-12#1)(1995-8#1)(1997-7#1)
multiple copies of this##2##4##(2008-10#2)
multiple copies of##9##3##(1993-12#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-4#1)(2011-2#1)
multiple copies##11##2##(1990-6#1)(1991-2#1)(1993-12#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-4#1)(2011-2#1)
multiple corona radiata infarcts##2##4##(2007-10#2)
multiple correlation coefficients##2##3##(2008-10#1)(2008-12#1)
multiple correlation##4##2##(1993-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
multiple correspondence analysis##3##3##(2008-10#1)(2008-5#2)
multiple cranial nerve palsies##2##4##(2008-7#2)
multiple cranial##3##2##(2008-11#1)(2008-7#2)
multiple cucumber pathogens##3##3##(2008-10#3)
multiple cutaneous##4##2##(1992-12#1)(2007-4#1)(2012-3#1)(2013-8#1)
multiple daily injections##3##3##(2008-8#1)(2009-11#1)(2012-4#1)
multiple daily##4##2##(2008-8#1)(2009-11#2)(2012-4#1)
multiple data##4##2##(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
multiple databases##3##2##(2008-2#1)(2008-4#1)(2009-10#1)
multiple detection##2##2##(2008-10#2)
multiple determinants##2##2##(2008-10#1)(2008-7#1)
multiple diagnostic tests##3##3##(2009-9#2)(2013-8#1)
multiple diffraction##2##2##(2007-12#1)(2008-3#1)
multiple dimensions##3##2##(2008-2#1)(2012-2#1)(2013-8#1)
multiple disciplines##2##2##(1996-1#1)(2012-3#1)
multiple discrete##2##2##(2008-1#1)(2008-9#1)
multiple disease##2##2##(1997-8#1)(2008-10#1)
multiple diseases##3##2##(2008-10#2)(2008-7#1)
multiple dose##3##2##(1996-3#1)(2008-9#1)(2012-3#1)
multiple doses##3##2##(1993-6#1)(1996-3#1)(2008-10#1)
multiple drug##4##2##(1990-9#1)(1992-9#1)(2008-1#1)(2010-9#1)
multiple elements##2##2##(1997-7#1)(2007-12#1)
multiple emulsion##8##2##(2008-5#8)
multiple emulsions##4##2##(2008-5#4)
multiple endocrine abnormalities##4##3##(2007-7#1)(2009-4#3)
multiple endocrine neoplasia type##4##4##(1990-3#1)(1997-1#1)(2007-12#1)(2013-1#1)
multiple endocrine neoplasia##7##3##(1990-3#1)(1997-1#1)(2007-12#1)(2009-1#1)(2009-4#1)(2013-1#2)
multiple endocrine##12##2##(1990-3#1)(1990-6#1)(1997-1#1)(2007-12#1)(2007-7#1)(2009-1#1)(2009-4#4)(2013-1#2)
multiple enhancing##2##2##(2013-8#2)
multiple episodes of##2##3##(2008-11#1)(2013-1#1)
multiple event data##3##3##(1997-4#3)
multiple event##4##2##(1997-4#4)
multiple events##2##2##(1997-4#1)(2007-12#1)
multiple evolutionary##2##2##(2008-10#1)(2012-3#1)
multiple explanations##2##2##(2009-9#2)
multiple factors##3##2##(1991-12#1)(1994-8#1)(2012-3#1)
multiple failed##3##2##(2007-7#2)(2011-2#1)
multiple failure time data##4##4##(1997-4#4)
multiple failure##5##2##(1997-4#5)
multiple filamentation##3##2##(2007-11#3)
multiple flow reversals##2##3##(2008-10#2)
multiple forms of##7##3##(1990-7#1)(1991-5#2)(2006-6#1)(2007-8#1)(2011-2#1)(2013-1#1)
multiple forms##8##2##(1990-7#1)(1991-5#2)(2006-6#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
multiple four-wave mixing##2##3##(2007-11#1)(2007-12#1)
multiple fragments##2##2##(1991-2#1)(2008-10#1)
multiple frames of##2##3##(2008-11#1)(2008-3#1)
multiple frames##3##2##(2008-11#1)(2008-3#2)
multiple functional##3##2##(1991-9#1)(2008-10#2)
multiple functions in##3##3##(1991-2#1)(1994-8#1)(2011-2#1)
multiple functions##7##2##(1991-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
multiple gels##2##2##(2008-2#1)(2008-7#1)
multiple gene##5##2##(1997-7#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
multiple generations##3##2##(2008-10#2)(2011-2#1)
multiple genes##9##2##(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-3#2)
multiple genetic and environmental factors##3##5##(2008-4#1)(2008-7#1)(2010-3#1)
multiple genetic and##4##3##(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)
multiple genetic##9##2##(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-3#2)(2013-8#1)
multiple genotypes##2##2##(2008-10#2)
multiple gestation##2##2##(2012-3#2)
multiple goals##3##2##(1992-12#1)(1995-3#1)(2010-8#1)
multiple handicap signals##2##3##(2008-8#2)
multiple harvest process mode##2##4##(2008-11#2)
multiple harvest process##4##3##(2008-11#4)
multiple host##3##2##(2008-10#3)
multiple hot##2##2##(2008-10#2)
multiple human##2##2##(2008-10#1)(2008-9#1)
multiple hydatid cysts localizing in the petroclival##2##7##(2008-7#2)
multiple hydatid cysts##5##3##(2008-7#5)
multiple images##4##2##(2008-2#1)(2008-3#3)
multiple imaging##2##2##(2008-2#1)(2008-3#1)
multiple independent##3##2##(2007-9#1)(2008-12#1)(2009-10#1)
multiple individuals##2##2##(2008-5#1)(2009-6#1)
multiple infarcts in the##2##4##(2007-10#1)(2012-3#1)
multiple infarcts in##4##3##(2007-10#3)(2012-3#1)
multiple infarcts##5##2##(2007-10#4)(2012-3#1)
multiple infections do##2##3##(2008-10#2)
multiple infections within a single gall##2##6##(2008-10#2)
multiple infections##9##2##(1997-4#1)(2008-10#6)(2008-9#2)
multiple injection##6##2##(2008-10#6)
multiple injuries##5##2##(1990-2#2)(1992-4#1)(1992-6#1)(2007-8#1)
multiple interacting##2##2##(2008-9#1)(2012-1#1)
multiple interference##2##2##(2007-12#2)
multiple internal reflections##2##3##(2008-11#1)(2008-3#1)
multiple interventions##2##2##(1991-2#1)(2010-8#1)
multiple intracellular##2##2##(1991-6#1)(1994-8#1)
multiple isolates##3##2##(2008-10#3)
multiple isomorphous replacement##3##3##(1992-8#1)(1995-3#1)(1997-4#1)
multiple joint##2##2##(1996-6#1)(2012-3#1)
multiple laboratories##2##2##(2008-10#1)(2008-9#1)
multiple large intestinal perforations##2##4##(2011-2#2)
multiple layers of##2##3##(1992-8#1)(2009-6#1)
multiple layers##3##2##(1992-8#1)(2008-3#1)(2009-6#1)
multiple lectins of##2##3##(1990-5#2)
multiple lectins##3##2##(1990-5#3)
multiple lesions in the##2##4##(1997-1#1)(2013-1#1)
multiple lesions##8##2##(1997-1#1)(2007-7#3)(2010-6#1)(2011-2#2)(2013-1#1)
multiple levels of##6##3##(1996-3#1)(2007-11#1)(2008-1#1)(2012-1#2)(2012-12#1)
multiple levels##12##2##(1994-3#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-1#2)(2012-12#1)
multiple light scattering in a disperse medium##2##7##(2008-3#2)
multiple light scattering in##3##4##(2008-3#3)
multiple light scattering##5##3##(2008-10#1)(2008-3#4)
multiple light##7##2##(2008-10#1)(2008-3#5)(2012-3#1)
multiple lineages##4##2##(2008-11#2)(2010-6#1)(2013-1#1)
multiple linear regression (MLR)##4##4##(2008-10#4)
multiple linear regression analyses##2##4##(2009-9#1)(2013-1#1)
multiple linear regression analysis##2##4##(2008-10#2)
multiple linear regression and##2##4##(2008-10#2)
multiple linear regression models##3##4##(2008-10#2)(2011-3#1)
multiple linear regression##20##3##(2007-12#1)(2008-10#13)(2008-3#1)(2009-7#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
multiple linear##21##2##(2007-12#1)(2008-10#13)(2008-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-1#1)
multiple local##2##2##(2007-9#1)(2008-6#1)
multiple locations##4##2##(2008-10#4)
multiple loci##5##2##(1991-6#1)(1995-2#1)(2008-9#1)(2012-3#1)(2013-1#1)
multiple logistic regression analysis##3##4##(2007-10#1)(2008-11#2)
multiple logistic regression##6##3##(1991-3#1)(1993-9#1)(2007-10#1)(2008-11#2)(2011-2#1)
multiple logistic##7##2##(1991-3#1)(1993-9#1)(1997-8#1)(2007-10#1)(2008-11#2)(2011-2#1)
multiple lots of##2##3##(2008-10#1)(2008-11#1)
multiple low##2##2##(2008-10#1)(2008-4#1)
multiple lung metastases##2##3##(2007-10#1)(2008-6#1)
multiple lung##3##2##(1992-10#1)(2007-10#1)(2008-6#1)
multiple mRNAs##2##2##(1993-2#2)
multiple males##4##2##(1997-3#1)(2008-8#3)
multiple markers##4##2##(2007-7#1)(2008-10#1)(2012-12#2)
multiple mating in##2##3##(2008-8#2)
multiple mating##11##2##(2008-8#10)(2009-6#1)
multiple measurements##2##2##(1994-9#1)(2008-8#1)
multiple measures of##2##3##(2008-5#1)(2013-1#1)
multiple measures##4##2##(2008-5#1)(2008-8#1)(2013-1#2)
multiple mechanisms of##4##3##(2008-1#1)(2008-11#1)(2010-1#1)(2012-2#1)
multiple mechanisms##16##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
multiple media##2##2##(2010-5#1)(2012-3#1)
multiple medications##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
multiple members of the##2##4##(2008-10#1)(2009-5#1)
multiple members##4##2##(2008-10#2)(2008-4#1)(2009-5#1)
multiple meningiomas##2##2##(2008-10#2)
multiple metabolic##4##2##(2008-1#1)(2011-1#2)(2011-2#1)
multiple metastases##3##2##(2007-11#1)(2011-1#1)(2011-2#1)
multiple methods##2##2##(2008-11#1)(2008-4#1)
multiple modes of##4##3##(1993-11#1)(1995-3#1)(2008-10#1)(2009-10#1)
multiple molecular##3##2##(2009-11#1)(2009-5#1)(2013-1#1)
multiple mutations in##2##3##(2008-9#1)(2013-8#1)
multiple mutations##4##2##(1993-2#2)(2008-9#1)(2013-8#1)
multiple myeloma (MM)##4##3##(2008-1#1)(2008-7#1)(2010-12#1)(2012-12#1)
multiple myeloma in##4##3##(2011-2#4)
multiple myeloma##38##2##(1990-9#1)(1991-12#2)(1991-5#1)(1997-5#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#7)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#7)(2012-12#5)(2012-3#1)
multiple myeloma]##2##2##(1992-5#1)(2011-1#1)
multiple myelomas##2##2##(1991-5#1)(2012-12#1)
multiple neurofibromas##2##2##(1994-12#1)(2008-10#1)
multiple nodes##2##2##(2010-8#1)(2012-12#1)
multiple nodules##4##2##(2007-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
multiple nuclear##3##2##(1995-12#1)(2008-8#1)(2012-3#1)
multiple nucleoli##3##2##(2007-12#3)
multiple object##2##2##(2008-3#1)(2008-9#1)
multiple objective optimization##2##3##(2008-11#2)
multiple objects##4##2##(2008-3#4)
multiple of the##4##3##(1996-12#1)(2007-12#1)(2008-2#2)
multiple of##5##2##(1996-12#1)(2007-12#2)(2008-2#2)
multiple operations##2##2##(2008-7#2)
multiple optical##2##2##(2008-12#1)(2008-3#1)
multiple orders##2##2##(2008-2#1)(2010-10#1)
multiple organ failure##4##3##(1996-3#1)(1997-1#1)(2009-5#1)(2011-2#1)
multiple organ systems##4##3##(2008-1#1)(2008-3#1)(2011-1#1)(2012-12#1)
multiple organ##13##2##(1995-8#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
multiple outcome##2##2##(1995-2#1)(2011-1#1)
multiple outcomes##3##2##(1993-12#1)(1995-2#2)
multiple outputs##4##2##(2008-10#3)(2008-6#1)
multiple parallel synthesis##3##3##(2008-10#3)
multiple parallel##4##2##(2008-10#3)(2009-12#1)
multiple parameters##2##2##(2008-11#1)(2008-12#1)
multiple partners##3##2##(1997-3#1)(2011-1#1)(2013-1#1)
multiple pathological##3##2##(2008-12#1)(2013-1#2)
multiple pathways##3##2##(1995-6#1)(2008-1#1)(2011-2#1)
multiple peaks##2##2##(2008-3#1)(2013-1#1)
multiple perspectives imaging##2##3##(2008-3#2)
multiple perspectives##4##2##(2008-12#1)(2008-3#2)(2010-12#1)
multiple phase##4##2##(2007-12#2)(2008-3#1)(2008-5#1)
multiple phase-stepping##2##2##(2007-12#2)
multiple pituitary hormone##2##3##(2011-1#1)(2013-1#1)
multiple pituitary##3##2##(1996-11#1)(2011-1#1)(2013-1#1)
multiple points##3##2##(1993-2#1)(2007-11#1)(2007-12#1)
multiple populations of##2##3##(2008-10#1)(2012-2#1)
multiple populations##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
multiple posterior extension osteotomies##2##4##(2008-8#2)
multiple pregnancies and##2##3##(1992-5#1)(1997-2#1)
multiple pregnancies##8##2##(1992-5#1)(1996-11#1)(1997-2#3)(2008-11#2)(2010-8#1)
multiple primary malignancies##2##3##(2011-2#2)
multiple primary melanoma##2##3##(2011-2#2)
multiple primary##6##2##(2007-8#1)(2008-6#1)(2011-2#4)
multiple processes##3##2##(1997-3#2)(2008-9#1)
multiple processors##2##2##(2007-9#1)(2010-8#1)
multiple protein##2##2##(1995-2#1)(1996-2#1)
multiple proteins##5##2##(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#2)
multiple publications##2##2##(2008-10#1)(2008-4#1)
multiple publics##2##2##(1992-3#1)(1997-1#1)
multiple pulmonary##2##2##(2012-12#1)(2013-8#1)
multiple punishments##2##2##(1992-1#2)
multiple putative##2##2##(1997-2#1)(2008-10#1)
multiple quantitative##3##2##(2008-9#1)(2010-11#1)(2013-8#1)
multiple quantum##2##2##(1993-3#1)(2007-12#1)
multiple rare variants##3##3##(2012-3#3)
multiple rare##5##2##(2012-3#5)
multiple reaction monitoring (MRM) mode##4##5##(2011-1#3)(2013-1#1)
multiple reaction monitoring (MRM)##7##4##(2008-10#1)(2011-1#3)(2011-3#2)(2013-1#1)
multiple reaction monitoring in##2##4##(2008-10#1)(2011-2#1)
multiple reaction monitoring##11##3##(2008-10#3)(2011-1#4)(2011-2#1)(2011-3#2)(2013-1#1)
multiple reaction##13##2##(2008-10#4)(2008-3#1)(2011-1#4)(2011-2#1)(2011-3#2)(2013-1#1)
multiple reactions##2##2##(1992-6#1)(2011-2#1)
multiple reflection##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
multiple reflections in##2##3##(2008-2#2)
multiple reflections##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
multiple regions##2##2##(1992-6#1)(2012-3#1)
multiple regression analyses were##2##4##(2008-4#1)(2010-4#1)
multiple regression analyses##8##3##(1992-2#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-1#1)
multiple regression analysis revealed##2##4##(1992-6#1)(2010-2#1)
multiple regression analysis was##2##4##(2007-11#1)(2013-1#1)
multiple regression analysis##14##3##(1992-6#1)(1992-9#1)(1994-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
multiple regression results##2##3##(2008-10#1)(2011-2#1)
multiple regression##37##2##(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
multiple regulatory##4##2##(1992-12#1)(2008-1#1)(2009-3#1)(2010-7#1)
multiple resistance##2##2##(2008-10#1)(2008-11#1)
multiple risk factors for##2##4##(1996-2#1)(2008-7#1)
multiple risk factors##5##3##(1996-2#1)(2008-7#1)(2011-1#2)(2013-1#1)
multiple roles in##2##3##(2008-7#1)(2010-5#1)
multiple roles##4##2##(1994-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
multiple rounds of##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
multiple samples simultaneously##2##3##(2008-1#1)(2008-10#1)
multiple samples##6##2##(2008-1#1)(2008-10#4)(2008-4#1)
multiple sampling##2##2##(2008-6#1)(2008-8#1)
multiple scales##5##2##(2008-10#1)(2009-12#1)(2009-5#1)(2010-9#1)(2012-2#1)
multiple scattering and##2##3##(2008-3#2)
multiple scattering are##2##3##(2008-3#2)
multiple scattering by##2##3##(2008-3#2)
multiple scattering from##3##3##(2008-3#3)
multiple scattering is##2##3##(2008-2#1)(2008-3#1)
multiple scattering of##2##3##(2008-3#2)
multiple scattering##31##2##(2007-11#1)(2008-2#8)(2008-3#21)(2013-8#1)
multiple sclerosis (MS) patients##4##4##(2010-12#1)(2010-2#1)(2012-3#2)
multiple sclerosis (MS)##18##3##(1995-12#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#6)
multiple sclerosis and##4##3##(1995-12#1)(1997-8#1)(2010-12#1)(2011-2#1)
multiple sclerosis lesions##2##3##(2008-12#1)(2008-7#1)
multiple sclerosis patients in##2##4##(1996-8#1)(2012-12#1)
multiple sclerosis patients who##2##4##(2013-8#2)
multiple sclerosis patients##7##3##(1996-8#2)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
multiple sclerosis##82##2##(1994-9#1)(1995-12#5)(1996-8#2)(1997-5#2)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-11#1)(2010-12#15)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#7)(2011-7#2)(2012-12#3)(2012-2#6)(2012-3#13)(2013-1#2)(2013-8#4)
multiple sclerosis]##4##2##(1994-12#1)(1996-3#1)(2007-10#1)(2008-11#1)
multiple sequence alignments and##2##4##(2008-4#2)
multiple sequence alignments##5##3##(2008-4#4)(2010-4#1)
multiple sequence##8##2##(2008-4#7)(2010-4#1)
multiple sex partners##4##3##(1993-6#1)(2007-12#1)(2011-2#2)
multiple sex partnerships##2##3##(2011-2#2)
multiple sex##7##2##(1993-6#1)(2007-12#1)(2011-2#5)
multiple shoot clumps##5##3##(2008-8#2)(2008-9#3)
multiple signaling pathways##5##3##(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
multiple signaling##6##2##(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
multiple simultaneous##2##2##(1995-2#1)(2008-3#1)
multiple sites of##4##3##(1993-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
multiple sites##14##2##(1990-12#1)(1990-7#1)(1993-6#1)(1994-9#1)(1995-11#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
multiple skeletal dissemination##3##3##(2007-11#3)
multiple small##3##2##(2008-1#1)(2012-12#1)(2013-1#1)
multiple small-angle##2##2##(2008-2#1)(2008-3#1)
multiple solenoid##2##2##(2008-10#2)
multiple solid##2##2##(2013-1#2)
multiple solutions##3##2##(2008-10#1)(2008-3#2)
multiple sources of##3##3##(2010-1#1)(2011-3#1)(2012-12#1)
multiple sources##12##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
multiple species of##2##3##(1992-9#1)(2008-10#1)
multiple species##6##2##(1992-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
multiple sperm##2##2##(2007-12#1)(2008-8#1)
multiple square##2##2##(2008-10#2)
multiple stages of##3##3##(1992-12#1)(2008-7#1)(2012-12#1)
multiple stages##4##2##(1992-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
multiple standard##2##2##(2008-10#1)(2013-8#1)
multiple steps##3##2##(2009-12#1)(2009-3#2)
multiple strains of##2##3##(2008-10#2)
multiple studies##6##2##(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-12#2)
multiple subcutaneous##2##2##(1990-2#1)(2008-7#1)
multiple substitutions##2##2##(1995-11#1)(2013-1#1)
multiple surgical##3##2##(1991-12#1)(2008-9#1)(2011-1#1)
multiple symmetric lipomatosis##2##3##(1993-12#2)
multiple synchronous##2##2##(1991-6#1)(2008-6#1)
multiple system atrophy##8##3##(2008-7#7)(2009-11#1)
multiple systems##3##2##(2008-5#2)(2012-3#1)
multiple tactics##2##2##(2008-10#2)
multiple target##2##2##(2008-4#1)(2012-1#1)
multiple targets and##2##3##(2008-7#1)(2009-12#1)
multiple targets##8##2##(2008-10#2)(2008-7#1)(2009-12#1)(2010-5#2)(2011-2#1)(2011-3#1)
multiple territories##2##2##(2008-9#1)(2010-8#1)
multiple testing##5##2##(2009-9#2)(2010-2#1)(2011-2#1)(2012-3#1)
multiple times##5##2##(2008-3#1)(2008-9#2)(2009-9#1)(2010-5#1)
multiple tissues##5##2##(1994-12#1)(1996-10#2)(1997-7#1)(2010-3#1)
multiple total internal##2##3##(2007-12#2)
multiple trials##3##2##(1994-2#1)(1994-6#1)(2008-12#1)
multiple tumors##3##2##(2007-7#1)(2008-8#1)(2011-2#1)
multiple types of##6##3##(2007-12#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-2#2)
multiple unit##2##2##(2008-4#2)
multiple variables can be##2##4##(2008-3#1)(2008-8#1)
multiple vertebral hemangiomas##2##3##(2009-3#2)
multiple vertebral##3##2##(2009-3#2)(2011-2#1)
multiple wavelengths##8##2##(2007-12#1)(2008-2#3)(2008-3#4)
multiple ways##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
multiple writer##2##2##(2008-6#2)
multiple years##2##2##(2008-10#1)(2010-8#1)
multiple##1873##1##(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#7)(1991-2#9)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#6)(1991-9#2)(1992-1#4)(1992-10#5)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#9)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#10)(1993-2#8)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#14)(1994-2#7)(1994-3#4)(1994-5#4)(1994-6#5)(1994-8#6)(1994-9#5)(1995-11#2)(1995-12#9)(1995-2#14)(1995-3#6)(1995-5#4)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#8)(1996-3#10)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#7)(1997-3#12)(1997-4#16)(1997-5#6)(1997-6#3)(1997-7#7)(1997-8#5)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#14)(2007-11#36)(2007-12#51)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#16)(2007-8#12)(2007-9#3)(2008-1#23)(2008-10#237)(2008-11#51)(2008-12#17)(2008-2#41)(2008-3#111)(2008-4#57)(2008-5#44)(2008-6#18)(2008-7#81)(2008-8#55)(2008-9#59)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#9)(2009-2#3)(2009-3#11)(2009-4#9)(2009-5#8)(2009-6#8)(2009-7#5)(2009-8#8)(2009-9#13)(2010-1#6)(2010-10#10)(2010-11#11)(2010-12#24)(2010-2#5)(2010-3#11)(2010-4#11)(2010-5#10)(2010-6#5)(2010-7#8)(2010-8#15)(2010-9#6)(2011-1#35)(2011-2#89)(2011-3#5)(2011-7#2)(2012-1#11)(2012-12#39)(2012-2#43)(2012-3#60)(2012-4#1)(2013-1#64)(2013-7#3)(2013-8#27)
multiple)##3##1##(1990-11#1)(1991-2#1)(1997-5#1)
multiple-access##5##1##(2007-11#1)(2008-2#2)(2008-3#2)
multiple-beam delivery##2##2##(2008-2#2)
multiple-beam fiber-optic##3##2##(2008-2#3)
multiple-beam shearing interferometry##2##3##(2008-3#2)
multiple-beam##11##1##(1995-5#1)(2007-11#1)(2008-2#5)(2008-3#4)
multiple-channel##2##1##(2007-11#1)(2008-4#1)
multiple-choice questions##5##2##(1991-2#1)(2008-11#2)(2008-12#2)
multiple-choice##8##1##(1991-2#1)(1992-4#1)(1997-3#1)(2008-11#2)(2008-12#2)(2010-8#1)
multiple-component intervention##2##2##(2008-8#2)
multiple-component##4##1##(1995-6#1)(2008-7#1)(2008-8#2)
multiple-copy##2##1##(2008-9#1)(2012-2#1)
multiple-dose##2##1##(2008-3#1)(2008-5#1)
multiple-event analysis##2##2##(2008-7#2)
multiple-event##4##1##(2008-7#4)
multiple-eyespot##2##1##(2012-3#2)
multiple-ion-sensing##3##1##(2007-8#3)
multiple-object##3##1##(2008-2#1)(2008-3#2)
multiple-pass absorption##2##2##(2007-12#1)(2008-3#1)
multiple-pass cavity##3##2##(2007-11#1)(2007-12#2)
multiple-pass cell based on the use of##2##7##(2008-3#2)
multiple-pass cell##4##2##(2008-3#4)
multiple-pass##12##1##(2007-11#1)(2007-12#6)(2008-3#5)
multiple-prism grating##2##2##(2008-3#2)
multiple-pulse##8##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
multiple-quantum-well modulators##2##2##(2008-2#1)(2008-3#1)
multiple-quantum-well##17##1##(2007-11#1)(2007-12#8)(2008-2#5)(2008-3#3)
multiple-reflection##3##1##(2008-3#3)
multiple-return-pass##2##1##(2008-3#2)
multiple-scattering parameters##3##2##(2008-3#3)
multiple-scattering regime##2##2##(2008-3#2)
multiple-scattering suppression by a##2##4##(2008-2#2)
multiple-scattering##27##1##(2006-4#1)(2007-11#1)(2008-2#12)(2008-3#13)
multiple-stage MS(n)##2##2##(2011-2#2)
multiple-stage mass##2##2##(2008-10#1)(2011-2#1)
multiple-stage##5##1##(2008-10#1)(2008-12#1)(2011-2#3)
multiple-step##6##1##(1992-8#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-8#1)
multiple-target##2##1##(2008-10#1)(2008-3#1)
multiple-use##2##1##(2008-10#2)
multiple-wavelength##5##1##(2008-3#4)(2010-10#1)
multiples of 2pi##2##3##(2008-2#1)(2008-3#1)
multiples of body mass##2##4##(1995-2#2)
multiples of the##3##3##(1993-2#1)(1996-1#1)(1996-12#1)
multiples of##10##2##(1992-3#1)(1993-2#1)(1995-2#2)(1996-1#1)(1996-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
multiples##15##1##(1992-3#1)(1993-2#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-8#1)
multiplets##3##1##(1997-2#2)(1997-7#1)
multiplex PCR##12##2##(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
multiplex RT-PCR##7##2##(2008-10#4)(2008-9#1)(2011-2#1)(2013-8#1)
multiplex and##2##2##(2008-10#1)(2008-2#1)
multiplex assay##3##2##(2008-10#2)(2008-12#1)
multiplex coherent anti-Stokes Raman scattering microscopy##2##6##(2007-11#2)
multiplex coherent anti-Stokes Raman##3##4##(2007-11#2)(2008-3#1)
multiplex detection##2##2##(2007-12#1)(2008-10#1)
multiplex families##2##2##(1997-5#2)
multiplex hologram##2##2##(2008-3#2)
multiplex nested##2##2##(2008-10#2)
multiplex polymerase chain reaction (PCR)##2##5##(2012-2#1)(2013-1#1)
multiplex polymerase chain reaction assays##2##5##(2008-10#2)
multiplex polymerase chain reaction##5##4##(2008-10#2)(2009-8#1)(2012-2#1)(2013-1#1)
multiplex reaction##2##2##(1995-11#1)(2008-10#1)
multiplex reactions##2##2##(2008-7#1)(2008-9#1)
multiplex real-time polymerase chain reaction (PCR)##2##6##(2008-10#2)
multiplex real-time##5##2##(2008-10#5)
multiplex reverse transcription-polymerase chain reaction##3##5##(2008-10#3)
multiplex the information of the deflections in two orthogonal directions in##2##11##(2008-2#1)(2008-3#1)
multiplex with##2##2##(2008-10#1)(2012-3#1)
multiplex##81##1##(1995-11#1)(1997-5#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#38)(2008-12#5)(2008-2#2)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#5)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
multiplexed assays##2##2##(2008-4#1)(2010-11#1)
multiplexed channels##2##2##(2008-2#1)(2008-3#1)
multiplexed holograms##2##2##(2008-2#1)(2008-3#1)
multiplexed in a##2##3##(2007-12#1)(2008-3#1)
multiplexed multiwavelength holographic memory##2##4##(2008-2#2)
multiplexed multiwavelength##3##2##(2008-2#2)(2008-3#1)
multiplexed##63##1##(2007-11#8)(2007-12#6)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#18)(2008-4#1)(2008-9#10)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)
multiplexer##8##1##(2007-11#1)(2008-2#4)(2008-3#3)
multiplexing (WDM)##2##2##(2008-2#1)(2008-3#1)
multiplexing and##4##2##(2007-12#1)(2008-3#3)
multiplexing can be##2##3##(2007-12#1)(2008-2#1)
multiplexing capability##2##2##(2007-11#1)(2012-2#1)
multiplexing for##2##2##(2007-12#1)(2008-3#1)
multiplexing in a##2##3##(2008-3#2)
multiplexing in##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
multiplexing is##4##2##(2008-2#1)(2008-3#3)
multiplexing of##9##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
multiplexing provides a##2##3##(2008-2#1)(2009-10#1)
multiplexing systems##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
multiplexing technique##2##2##(2008-2#1)(2011-1#1)
multiplexing to##2##2##(2008-2#1)(2008-3#1)
multiplexing with##2##2##(2007-12#2)
multiplexing##99##1##(2007-11#14)(2007-12#25)(2008-1#1)(2008-2#20)(2008-3#34)(2008-4#1)(2009-10#1)(2011-1#1)(2012-2#2)
multiplexing-demultiplexing##2##1##(2008-2#1)(2008-3#1)
multiplicate##2##1##(2008-10#1)(2008-8#1)
multiplication and##8##2##(2007-11#1)(2007-12#1)(2008-10#6)
multiplication by##2##2##(2008-2#1)(2011-2#1)
multiplication of the pathogen##2##4##(2008-10#2)
multiplication of the##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
multiplication of##12##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2009-2#1)(2010-11#1)(2012-12#1)
multiplication was##3##2##(2008-10#1)(2008-11#2)
multiplication##49##1##(2007-11#2)(2007-12#5)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
multiplications##4##1##(2008-10#1)(2008-2#2)(2008-3#1)
multiplicative model##2##2##(1996-3#2)
multiplicative##12##1##(1990-8#1)(1994-9#1)(1996-3#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
multiplicities of infection##2##3##(2007-10#1)(2008-11#1)
multiplicities of##3##2##(1997-3#1)(2007-10#1)(2008-11#1)
multiplicity and##2##2##(2008-4#1)(2011-2#1)
multiplicity of factors##2##3##(1992-9#1)(2013-1#1)
multiplicity of infection (MOI)##3##4##(2008-11#3)
multiplicity of infection##8##3##(1995-12#1)(1997-3#1)(2008-11#5)(2008-4#1)
multiplicity of the##2##3##(1993-2#1)(1997-4#1)
multiplicity of##25##2##(1990-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-11#8)(2008-3#2)(2008-4#1)(2008-9#2)(2010-9#1)(2012-2#1)(2013-1#1)
multiplicity##36##1##(1990-8#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-5#2)(1995-12#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-10#2)(2007-12#1)(2008-11#8)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#4)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
multiplied by a##2##3##(2008-12#1)(2008-2#1)
multiplied by the##2##3##(2008-3#1)(2012-2#1)
multiplied by##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
multiplied in##3##2##(2007-6#1)(2008-10#2)
multiplied##22##1##(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-2#2)
multiplier##6##1##(2008-2#1)(2008-3#3)(2013-1#2)
multipliers##5##1##(2008-2#3)(2008-3#1)(2008-5#1)
multiply backscattered light##2##3##(2008-2#2)
multiply in##6##2##(1995-2#1)(1996-3#1)(2008-10#3)(2013-8#1)
multiply scattered lidar##2##3##(2008-2#2)
multiply scattered light in##2##4##(2008-2#1)(2008-3#1)
multiply scattered light##3##3##(2008-2#2)(2008-3#1)
multiply scattered##8##2##(2008-2#5)(2008-3#3)
multiply scattering##2##2##(2008-2#1)(2008-3#1)
multiply the number of##2##4##(2008-4#1)(2009-10#1)
multiply the##3##2##(2008-3#1)(2008-4#1)(2009-10#1)
multiply within##2##2##(2008-9#2)
multiply##40##1##(1990-12#1)(1993-2#1)(1995-2#2)(1996-3#1)(2008-1#1)(2008-10#7)(2008-2#9)(2008-3#7)(2008-4#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
multiplying the##2##2##(1993-9#1)(2008-3#1)
multiplying##11##1##(1992-5#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2010-5#1)
multipoint affected sib-pair##2##3##(1997-5#2)
multipoint affected##3##2##(1997-5#3)
multipoint##10##1##(1996-2#1)(1997-5#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)
multipolar neuron##4##2##(2007-12#4)
multipolar##12##1##(1991-7#1)(1994-11#1)(1994-2#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#1)(2010-2#1)(2013-8#1)
multiporous##2##1##(2007-12#1)(2008-7#1)
multiporphyrin##2##1##(2008-10#2)
multiport##3##1##(2008-3#1)(2012-12#2)
multiposition##3##1##(2008-10#3)
multipotent cells##3##2##(2008-5#1)(2008-9#2)
multipotent mesenchymal stem cells##2##4##(2012-1#1)(2012-12#1)
multipotent stem cells##2##3##(2012-12#1)(2012-3#1)
multipotent stem##3##2##(1995-6#1)(2012-12#1)(2012-3#1)
multipotent##14##1##(1995-6#1)(2008-11#1)(2008-5#2)(2008-9#3)(2012-1#1)(2012-12#4)(2012-3#1)(2012-4#1)
multipotential##7##1##(1993-3#1)(1995-3#1)(2007-8#1)(2008-7#2)(2010-10#1)(2012-12#1)
multiprobe##2##1##(2008-11#1)(2008-4#1)
multiprocessor##10##1##(2008-2#1)(2008-3#9)
multiprocessors##5##1##(2008-3#5)
multiprofessional##4##1##(1997-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
multiprojector display##2##2##(2008-6#2)
multiprojector##3##1##(2008-6#3)
multiprotein complex##3##2##(1993-12#1)(2010-5#1)(2012-2#1)
multiprotein complexes##3##2##(1992-6#1)(2008-4#1)(2008-7#1)
multiprotein##6##1##(1992-6#1)(1993-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)
multipulse##2##1##(2008-2#1)(2008-3#1)
multipurpose##7##1##(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)
multiradiatus##3##1##(2008-5#3)
multireflected components##2##2##(2008-3#2)
multiresidue##2##1##(2008-10#1)(2011-2#1)
multiresistant bacteria##3##2##(2009-5#1)(2012-1#1)(2013-8#1)
multiresistant##11##1##(1991-2#1)(1997-2#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-8#2)
multiresolution analysis##3##2##(2008-10#2)(2008-2#1)
multiresolution histogram##4##2##(2008-6#4)
multiresolution meshing##2##2##(2008-6#2)
multiresolution representation##2##2##(2008-6#2)
multiresolution##17##1##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#9)
multiscale soft matter##2##3##(2011-1#2)
multiscale##7##1##(2009-7#1)(2011-1#3)(2013-1#3)
multisection##2##1##(2007-12#1)(2008-2#1)
multisensor array##2##2##(2008-10#2)
multisensor system##4##2##(2008-10#4)
multisensor systems like an &quot##2##5##(2008-10#2)
multisensor systems##3##2##(2008-10#3)
multisensor##17##1##(2008-10#17)
multisensory##3##1##(1990-11#1)(1991-2#1)(2012-1#1)
multishot##2##1##(2007-12#2)
multisite##3##1##(1996-3#1)(2007-2#1)(2012-12#1)
multiskilling##2##1##(1996-2#2)
multislice CT##2##2##(2008-11#1)(2008-2#1)
multislice computed tomography##6##3##(2008-2#1)(2008-7#2)(2009-5#1)(2010-6#1)(2011-2#1)
multislice helical computed##2##3##(2008-2#1)(2009-8#1)
multislice##12##1##(2007-8#1)(2008-11#1)(2008-2#3)(2008-7#3)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)
multisoliton##4##1##(2007-11#1)(2007-12#3)
multispecialty group practice##2##3##(1991-1#1)(1996-1#1)
multispecialty group##7##2##(1991-1#1)(1996-1#3)(1996-2#1)(1997-3#1)(2008-11#1)
multispecialty physician##2##2##(1997-1#1)(2008-11#1)
multispecialty##12##1##(1991-1#1)(1995-2#1)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#2)(2008-8#1)(2012-1#1)
multispecies competition##3##2##(2008-8#3)
multispecies##10##1##(2007-12#1)(2008-2#2)(2008-8#5)(2008-9#2)
multispecific##2##1##(2008-11#1)(2012-2#1)
multispectral images##3##2##(2007-12#1)(2008-2#1)(2009-10#1)
multispectral imaging##2##2##(2007-12#1)(2008-9#1)
multispectral radiometry##2##2##(2008-10#2)
multispectral scanners##3##2##(2008-10#2)(2008-3#1)
multispectral##24##1##(2007-12#3)(2008-10#5)(2008-2#7)(2008-3#5)(2008-9#1)(2009-10#1)(2011-1#2)
multistability##2##1##(2007-12#1)(2009-8#1)
multistable##2##1##(2007-12#1)(2009-8#1)
multistage cluster##2##2##(2011-1#1)(2011-2#1)
multistage interconnection network##3##3##(2008-2#3)
multistage interconnection##4##2##(2008-2#4)
multistage process for the##2##4##(2013-1#2)
multistage process##4##2##(2009-11#1)(2013-1#3)
multistage ultrafiltration##2##2##(2008-10#2)
multistage ultramarathon competition##2##3##(2013-8#2)
multistage ultramarathon##3##2##(2013-8#3)
multistage##27##1##(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#1)(2008-7#2)(2009-11#2)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#3)
multistate life##2##2##(2011-2#2)
multistate##5##1##(1995-12#1)(2011-2#4)
multistep extraction##2##2##(2008-10#1)(2008-6#1)
multistep process of##2##3##(1995-9#1)(2007-10#1)
multistep process##6##2##(1992-2#1)(1993-8#1)(1995-9#1)(2007-10#1)(2008-10#1)(2008-12#1)
multistep##27##1##(1992-2#1)(1993-8#1)(1995-9#1)(2007-10#2)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#2)
multistripe##2##1##(2007-11#1)(2008-2#1)
multisubunit protein complex##3##3##(2008-2#3)
multisubunit protein complexes from mammalian cells##3##6##(2008-2#3)
multisubunit protein complexes##4##3##(2008-2#3)(2011-2#1)
multisubunit protein##7##2##(2008-2#6)(2011-2#1)
multisubunit##12##1##(1991-2#2)(1997-2#1)(2008-2#6)(2008-4#1)(2010-7#1)(2011-2#1)
multisyringe FIA (MSFIA)##2##3##(2008-10#2)
multisyringe flow injection analysis (MSFIA)##2##5##(2008-10#2)
multisyringe flow injection analysis##3##4##(2008-10#3)
multisyringe flow injection system##3##4##(2008-10#3)
multisyringe flow injection##10##3##(2008-10#10)
multisyringe flow##11##2##(2008-10#11)
multisyringe##17##1##(2008-10#17)
multisystem disease##4##2##(1997-8#1)(2012-3#3)
multisystem disorder##4##2##(1993-12#1)(2008-9#1)(2012-3#2)
multisystem##17##1##(1993-12#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#6)
multisystemic disease##2##2##(1990-2#1)(2011-2#1)
multisystemic##6##1##(1990-2#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-3#2)
multitarget##6##1##(1993-11#1)(2008-3#3)(2008-9#1)(2013-1#1)
multitemporal synthetic aperture radar##2##4##(2008-3#2)
multiterawatt##2##1##(2007-11#2)
multitransition-oscillation##2##1##(2007-12#2)
multitrophic##6##1##(2008-8#1)(2008-9#5)
multitude of##19##2##(1992-12#1)(1992-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
multitude##20##1##(1992-12#1)(1992-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
multivalent frequency##3##2##(2008-5#3)
multivalent##10##1##(1995-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-2#2)
multivalently##2##1##(2012-12#1)(2013-1#1)
multivariable analyses##2##2##(2012-1#1)(2012-12#1)
multivariable analysis##2##2##(2012-1#1)(2013-8#1)
multivariable linear##2##2##(2008-10#2)
multivariable logistic regression##5##3##(2012-12#1)(2013-1#3)(2013-8#1)
multivariable model##2##2##(2013-8#2)
multivariable##18##1##(2007-11#1)(2008-10#4)(2008-8#1)(2012-1#2)(2012-12#2)(2013-1#4)(2013-8#4)
multivariate Cox##2##2##(1996-9#1)(2013-1#1)
multivariate Shewhart##3##2##(2008-10#3)
multivariate analyses##19##2##(1993-5#1)(1994-6#1)(2007-10#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
multivariate analysis in##2##3##(2008-10#1)(2009-2#1)
multivariate analysis of the##2##4##(1997-4#1)(2009-9#1)
multivariate analysis of variance##3##4##(1990-3#2)(2008-10#1)
multivariate analysis of##11##3##(1990-3#2)(1995-8#1)(1997-4#1)(2008-10#2)(2008-7#1)(2009-7#1)(2009-9#1)(2013-1#2)
multivariate analysis were##5##3##(1991-8#1)(2007-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
multivariate analysis##60##2##(1990-3#2)(1990-8#1)(1991-8#2)(1993-1#1)(1993-9#2)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-4#2)(1995-8#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-2#1)(2007-8#2)(2008-10#10)(2008-3#2)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#7)
multivariate analytical techniques##2##3##(2008-10#1)(2008-9#1)
multivariate analytical##3##2##(2008-10#2)(2008-9#1)
multivariate approach##2##2##(2008-10#2)
multivariate calibration and##2##3##(2008-10#1)(2008-2#1)
multivariate calibration in the##2##4##(2008-10#2)
multivariate calibration in##5##3##(2008-10#5)
multivariate calibration method##3##3##(2008-10#3)
multivariate calibration methods to##2##4##(2008-10#2)
multivariate calibration methods##16##3##(2008-1#2)(2008-10#13)(2013-8#1)
multivariate calibration model##3##3##(2008-10#3)
multivariate calibration techniques##2##3##(2008-10#1)(2008-3#1)
multivariate calibration to##2##3##(2008-10#2)
multivariate calibration with##2##3##(2008-10#2)
multivariate calibration##69##2##(2008-1#2)(2008-10#61)(2008-2#2)(2008-3#2)(2010-5#1)(2013-8#1)
multivariate chemical##2##2##(2008-11#1)(2010-7#1)
multivariate classification of##2##3##(2008-10#2)
multivariate classification##5##2##(1991-3#1)(2008-10#4)
multivariate control charts##5##3##(2008-10#5)
multivariate correlation##2##2##(2009-4#1)(2009-8#1)
multivariate curve resolution##3##3##(2007-12#2)(2008-10#1)
multivariate curve##4##2##(2007-12#2)(2008-10#2)
multivariate data analysis##6##3##(2008-10#5)(2012-1#1)
multivariate data##9##2##(1997-4#1)(2008-10#5)(2008-6#1)(2010-2#1)(2012-1#1)
multivariate dependent##2##2##(2008-8#1)(2010-1#1)
multivariate experimental design##2##3##(2008-10#2)
multivariate logistic regression analysis of##2##5##(2012-3#2)
multivariate logistic regression analysis##3##4##(2011-1#1)(2012-3#2)
multivariate logistic regression models##2##4##(2010-12#1)(2013-1#1)
multivariate logistic regression##11##3##(2007-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
multivariate logistic##12##2##(2007-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)
multivariate methods##9##2##(1995-2#1)(2008-10#6)(2008-11#2)
multivariate model##4##2##(1992-12#1)(1993-12#1)(1996-12#1)(2008-6#1)
multivariate modelling##2##2##(2008-10#1)(2013-1#1)
multivariate nominal##2##2##(2009-12#1)(2009-4#1)
multivariate normal distribution##2##3##(1997-3#1)(1997-4#1)
multivariate optimization of the main variables##2##6##(2008-10#2)
multivariate optimization of##3##3##(2008-10#3)
multivariate optimization##4##2##(2008-10#4)
multivariate partial least squares (PLS)##2##5##(2008-10#2)
multivariate prediction of##2##3##(2008-10#1)(2008-7#1)
multivariate prediction##3##2##(2008-10#2)(2008-7#1)
multivariate reference regions##3##3##(2012-1#3)
multivariate regression##7##2##(1990-3#1)(1991-1#1)(2007-10#1)(2007-11#1)(2008-10#3)
multivariate spectrophotometric calibration##4##3##(2008-10#4)
multivariate statistical analysis methods##2##4##(2008-7#1)(2010-5#1)
multivariate statistical analysis##4##3##(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
multivariate statistical methods##2##3##(2008-10#2)
multivariate statistical techniques##2##3##(2007-12#1)(2008-10#1)
multivariate statistical tools##2##3##(2008-10#1)(2010-8#1)
multivariate statistical##15##2##(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-8#2)
multivariate statistics##4##2##(2008-10#2)(2009-10#1)(2012-1#1)
multivariate technique##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
multivariate techniques##3##2##(2008-10#2)(2008-3#1)
multivariate##341##1##(1990-3#4)(1990-8#1)(1991-1#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-6#6)(1993-1#1)(1993-12#2)(1993-5#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-8#1)(1996-12#1)(1996-9#1)(1997-3#4)(1997-4#6)(1997-7#1)(2007-10#6)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#156)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#3)(2008-6#7)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#7)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#6)(2012-12#3)(2012-2#2)(2012-3#8)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#5)
multivesicular bodies##2##2##(2008-10#1)(2008-6#1)
multivesicular##4##1##(2008-10#2)(2008-6#1)(2008-7#1)
multivessel coronary##2##2##(2007-8#1)(2008-11#1)
multivessel disease##2##2##(2007-8#2)
multivessel##8##1##(2007-8#4)(2008-10#2)(2008-11#1)(2011-2#1)
multiview panoramic##3##2##(2008-6#3)
multiview##7##1##(2008-2#2)(2008-6#4)(2008-7#1)
multivisceral##2##1##(2008-10#1)(2009-5#1)
multivitamin and multimineral supplementation##2##4##(1994-6#2)
multivitamin and##4##2##(1994-6#2)(2008-3#1)(2009-9#1)
multivitamin##10##1##(1994-6#2)(1995-6#1)(2008-10#4)(2008-3#1)(2009-9#2)
multivora is##2##2##(2010-3#2)
multivora##4##1##(2010-3#4)
multivorans##4##1##(2007-12#1)(2011-1#3)
multiwall carbon nanotubes##8##3##(2007-11#1)(2008-10#6)(2011-2#1)
multiwall carbon##10##2##(2007-11#1)(2008-10#7)(2009-11#1)(2011-2#1)
multiwall##12##1##(2007-11#1)(2008-10#7)(2008-12#1)(2009-11#2)(2011-2#1)
multiwalled CNTs##2##2##(2008-7#2)
multiwalled carbon nanotubes as the##2##5##(2008-10#2)
multiwalled carbon nanotubes as##3##4##(2008-10#3)
multiwalled carbon nanotubes##9##3##(2008-10#4)(2008-3#4)(2009-3#1)
multiwalled carbon##10##2##(2008-10#4)(2008-3#5)(2009-3#1)
multiwalled nanotubes##2##2##(2008-7#2)
multiwalled##14##1##(2008-10#4)(2008-3#5)(2008-7#4)(2009-3#1)
multiwaveform##4##1##(2013-1#4)
multiwavelength conversion##2##2##(2007-11#2)
multiwavelength excitation process##2##3##(2007-11#2)
multiwavelength laser##2##2##(2007-12#1)(2008-3#1)
multiwavelength mode-locked semiconductor laser##2##4##(2007-12#1)(2008-3#1)
multiwavelength mode-locked semiconductor##3##3##(2007-12#2)(2008-3#1)
multiwavelength photonic##2##2##(2008-3#2)
multiwavelength spectrophotometric##3##2##(2008-10#3)
multiwavelength##54##1##(2007-11#11)(2007-12#8)(2008-10#11)(2008-2#8)(2008-3#16)
multiwell plate##2##2##(2007-11#2)
multocida##9##1##(2008-5#7)(2011-2#1)(2012-2#1)
mum and a##10##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)
mum and the##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
mum and##34##2##(1993-2#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-11#3)(2008-2#7)(2008-3#12)(2008-5#1)
mum are presented##2##3##(2008-3#2)
mum are reported##2##3##(2007-11#1)(2008-2#1)
mum are##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
mum at##2##2##(2008-2#1)(2008-3#1)
mum by##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
mum channel##2##2##(2008-10#2)
mum diameter##2##2##(2008-10#2)
mum for the##2##3##(1993-2#1)(2008-3#1)
mum for##6##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
mum from a##3##3##(2007-12#2)(2008-3#1)
mum has been##2##3##(2008-10#1)(2008-3#1)
mum have been##2##3##(2007-12#1)(2008-3#1)
mum i##4##2##(2008-10#4)
mum in a periodically poled##2##5##(2007-11#1)(2007-12#1)
mum in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
mum in diameter##6##3##(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#2)
mum in diameter)##4##3##(2008-10#2)(2008-5#2)
mum in the##7##3##(2007-12#4)(2008-2#1)(2008-3#2)
mum in##28##2##(2007-11#1)(2007-12#6)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#5)(2008-5#4)(2010-3#1)
mum into##2##2##(2007-12#1)(2008-5#1)
mum is##4##2##(2007-12#2)(2008-2#2)
mum liquid core microcapsules##3##4##(2008-11#3)
mum long and##2##3##(2008-7#2)
mum long##7##2##(2008-7#6)(2008-8#1)
mum of##2##2##(2008-10#1)(2008-11#1)
mum pore diameter)##2##3##(2008-11#2)
mum pore##6##2##(2008-11#5)(2008-5#1)
mum the##2##2##(2007-12#2)
mum thickness##2##2##(2008-10#2)
mum to##2##2##(2008-2#1)(2008-3#1)
mum was observed##2##3##(2007-11#1)(2007-12#1)
mum was used as a##2##5##(2008-3#2)
mum was##8##2##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#2)
mum wavelengths##2##2##(2007-11#2)
mum were##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
mum wide##3##2##(2008-3#2)(2008-8#1)
mum with a resolution of##2##5##(2008-2#1)(2008-3#1)
mum with a##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
mum with##9##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)
mum##383##1##(1992-1#1)(1992-2#8)(1993-2#4)(2007-11#30)(2007-12#54)(2008-10#52)(2008-11#23)(2008-2#78)(2008-3#100)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#2)(2009-5#4)(2009-8#3)(2010-3#2)(2010-4#1)
mum(2)##2##1##(2008-10#2)
mum) and##4##2##(2007-12#2)(2008-10#1)(2008-2#1)
mum) of##2##2##(2008-10#1)(2008-3#1)
mum) was##2##2##(2008-10#1)(2008-2#1)
mum) were##3##2##(2008-10#2)(2009-8#1)
mum)##41##1##(1991-2#3)(1992-2#2)(2007-11#2)(2007-12#6)(2008-10#15)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)
mummies in the##2##3##(2008-10#2)
mummies in##3##2##(1997-3#1)(2008-10#2)
mummies##7##1##(1992-2#1)(1997-3#1)(2008-10#5)
mummification##2##1##(2008-10#1)(2008-5#1)
mummified##2##1##(2008-10#2)
mummy berry disease of blueberry##2##5##(2008-10#2)
mummy berry disease##4##3##(2008-10#4)
mummy berry##5##2##(2008-10#5)
mummy##11##1##(1991-2#1)(1995-3#1)(2007-12#1)(2008-10#7)(2008-8#1)
mumol Al/g diet with##2##4##(1992-11#2)
mumol Al/g diet##3##3##(1992-11#3)
mumol NAG/min/1)##2##2##(1996-12#2)
mumol dm(-3)##3##2##(2008-10#3)
mumol for 2-mercapto-4-methylpyrimidine (II)##2##4##(2008-10#2)
mumol for 4##3##3##(2008-10#3)
mumol for##7##2##(2008-10#7)
mumol g(-1) and##2##3##(2008-10#2)
mumol g(-1) for##2##3##(2008-10#2)
mumol g(-1)##5##2##(2008-10#5)
mumol l(-1) and##3##3##(2008-10#3)
mumol l(-1) dipyrone##2##3##(2008-10#2)
mumol l(-1) for##5##3##(2008-10#5)
mumol l(-1) of##3##3##(2008-10#3)
mumol l(-1) with a detection limit of 0##2##8##(2008-10#2)
mumol l(-1) with a detection limit of##3##7##(2008-10#3)
mumol l(-1) with a##4##4##(2008-10#4)
mumol l(-1)##28##2##(2008-10#28)
mumol m(-2) s(-1)##3##3##(2008-10#3)
mumol ml(-1)##3##2##(2008-10#3)
mumol mol(-1) creatinine##2##3##(2008-10#2)
mumol mol(-1)##3##2##(2008-10#3)
mumol of##5##2##(2008-10#5)
mumol##81##1##(1990-7#4)(1992-11#4)(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#1)(1996-12#4)(2006-11#1)(2008-10#63)(2008-9#1)
mumol)##4##1##(2008-4#4)
mumol/(min##2##1##(1995-2#2)
mumol/L [Ca(2+)](o)##2##2##(2008-8#2)
mumol/L riboflavin##3##2##(2008-9#3)
mumol/L##16##1##(2007-10#6)(2007-12#2)(2008-8#3)(2008-9#5)
mumol/L) or##2##2##(2008-8#2)
mumol/L)##8##1##(2008-8#7)(2008-9#1)
mumol/gm dry wt)##2##3##(1996-9#2)
mumol/kg##5##1##(1993-12#4)(1993-5#1)
mumol/kg)##2##1##(1996-12#2)
mumol/l (median =##2##3##(1991-2#2)
mumol/l AG##2##2##(1995-2#2)
mumol/l for##7##2##(1992-3#2)(1994-5#2)(1994-6#3)
mumol/l in##2##2##(1993-12#2)
mumol/l##30##1##(1991-12#1)(1991-2#2)(1992-3#3)(1992-9#1)(1993-12#2)(1993-8#6)(1993-9#1)(1994-5#2)(1994-6#5)(1995-12#1)(1995-2#3)(2008-10#2)(2009-8#1)
mumol/l) and##4##2##(1992-3#2)(1996-5#1)(2008-11#1)
mumol/l)##9##1##(1992-3#3)(1993-3#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#1)
mumol/ml for##2##2##(2008-10#2)
mumol/ml##3##1##(2008-10#3)
mumoles##2##1##(1993-8#1)(2008-10#1)
mumoll(-1)##2##1##(2008-10#2)
mumoll(-1))##4##1##(2008-10#4)
mumps and rubella##2##3##(2008-4#1)(2009-5#1)
mumps##9##1##(1992-5#1)(1993-12#1)(1995-3#1)(2007-2#3)(2008-4#2)(2009-5#1)
mung bean##6##2##(2008-10#2)(2008-11#1)(2008-9#3)
municipal health##3##2##(1992-11#2)(2011-2#1)
municipal sewage##2##2##(2008-10#1)(2008-6#1)
municipal solid waste##2##3##(2008-10#1)(2008-6#1)
municipal waste##2##2##(1995-11#1)(2008-10#1)
municipal wastewater##3##2##(1997-4#1)(2012-1#2)
municipal##37##1##(1991-12#1)(1991-6#2)(1992-11#2)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-9#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-8#2)(2011-2#3)(2012-1#2)(2013-1#1)
municipalities in##2##2##(2008-9#1)(2012-12#1)
municipalities of the##3##3##(1991-6#1)(1992-2#1)(2012-12#1)
municipalities of##5##2##(1991-6#1)(1992-2#1)(1993-2#1)(2012-12#2)
municipalities on the##2##3##(1992-11#1)(1995-5#1)
municipalities##48##1##(1990-2#3)(1991-6#2)(1991-8#1)(1992-11#3)(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-6#4)(1995-11#1)(1995-5#1)(1996-6#1)(2007-7#2)(2008-7#2)(2008-9#3)(2010-12#2)(2012-12#12)(2013-8#5)
municipalities]##2##1##(1992-11#1)(1997-8#1)
municipality of##14##2##(1990-6#1)(1991-9#1)(1992-10#1)(1995-6#3)(1997-4#1)(2008-12#1)(2011-2#1)(2012-12#4)(2013-7#1)
municipality##33##1##(1990-11#1)(1990-6#2)(1991-6#1)(1991-9#1)(1992-10#1)(1995-6#3)(1996-11#1)(1996-9#1)(1997-4#1)(2007-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#8)(2012-3#1)(2013-7#1)
mupirocin##3##1##(1991-8#1)(2007-12#1)(2011-2#1)
murad##3##1##(2008-2#2)(2008-3#1)
mural nodule##4##2##(1992-2#1)(2008-12#1)(2012-12#2)
mural side##2##2##(1991-12#2)
mural thrombi##2##2##(2008-11#1)(2008-7#1)
mural##18##1##(1991-12#3)(1992-2#1)(1992-9#1)(1996-9#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#4)(2013-8#1)
murale##2##1##(2013-1#2)
muramic acid##2##2##(1996-12#2)
muramyl dipeptide##2##2##(1995-5#1)(2008-11#1)
muramyl dipeptides##2##2##(2008-11#1)(2009-8#1)
muramyl tripeptide##2##2##(1993-9#1)(2010-3#1)
muramyl##6##1##(1993-9#1)(1995-5#1)(2008-11#2)(2009-8#1)(2010-3#1)
murder##2##1##(1990-7#1)(2008-12#1)
murderers##2##1##(2009-9#2)
murdochii##3##1##(2011-2#3)
murein##2##1##(1991-9#1)(1997-8#1)
murexide##7##1##(2008-10#7)
murine B cell##2##3##(2008-11#1)(2008-4#1)
murine B##5##2##(1993-11#1)(1993-2#1)(2008-11#1)(2008-4#2)
murine IL-10##5##2##(1993-8#5)
murine TNF##2##2##(1990-12#2)
murine alpha##3##2##(1992-12#1)(1996-12#1)(1997-1#1)
murine and human melanoma cell##2##5##(1992-2#2)
murine and human##13##3##(1992-2#2)(1992-5#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-4#3)(2008-9#1)(2010-6#1)
murine and##14##2##(1992-2#3)(1992-5#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-4#3)(2008-9#1)(2010-6#1)
murine bone marrow##2##3##(2008-11#1)(2008-8#1)
murine bone##3##2##(2008-11#2)(2008-8#1)
murine brain##2##2##(2008-7#1)(2012-2#1)
murine cDNA##2##2##(1993-9#1)(1997-7#1)
murine cell line##2##3##(1992-3#1)(2008-11#1)
murine cells##4##2##(1991-2#1)(1992-2#1)(1993-2#1)(2008-3#1)
murine cyclin D2##2##3##(1997-8#2)
murine cyclin D3 cDNA##2##4##(1997-4#2)
murine cyclin D3##5##3##(1997-4#5)
murine cyclin##7##2##(1997-4#5)(1997-8#2)
murine cytotoxic T-cell line##2##4##(1993-6#2)
murine embryonal carcinoma##3##3##(1990-11#1)(1993-9#2)
murine embryonal##4##2##(1990-11#1)(1993-9#2)(2011-2#1)
murine embryonic fibroblasts##2##3##(1997-1#1)(2008-4#1)
murine embryonic stem cells##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
murine embryonic stem##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
murine embryonic##7##2##(1992-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
murine endothelial cells##2##3##(1993-8#1)(1994-11#1)
murine erythroleukemia (MEL) cells##2##4##(1991-2#1)(1993-6#1)
murine erythroleukemia cells##4##3##(1990-11#1)(1991-2#1)(1993-6#1)(1993-8#1)
murine erythroleukemia##8##2##(1990-11#3)(1991-2#2)(1993-6#2)(1993-8#1)
murine fibroblasts##3##2##(1992-5#1)(2008-6#1)(2013-1#1)
murine gene encoding##2##3##(1993-6#2)
murine hematopoietic stem cells##5##4##(1993-2#2)(1994-5#1)(2008-4#1)(2008-9#1)
murine hematopoietic##6##2##(1993-2#2)(1994-5#1)(1997-4#1)(2008-4#1)(2008-9#1)
murine hybridoma cell line##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
murine hybridoma cell##5##3##(2008-10#1)(2008-11#3)(2008-7#1)
murine hybridoma cells##4##3##(1991-9#1)(2008-11#3)
murine hybridoma##14##2##(1991-9#1)(2008-10#1)(2008-11#11)(2008-7#1)
murine hybridomas##4##2##(1991-9#2)(1994-3#1)(2008-11#1)
murine insulin-like growth factor-binding protein-2##2##5##(1993-2#2)
murine insulinoma##2##2##(2008-11#2)
murine interferon##2##2##(1997-1#2)
murine intestinal##3##2##(2008-11#3)
murine leukemia virus##6##3##(1990-12#1)(1990-8#1)(1991-5#1)(1994-8#1)(1997-8#1)(2008-11#1)
murine liver##2##2##(1992-12#1)(1997-4#1)
murine macrophages##7##2##(1990-12#2)(1990-8#2)(1994-6#1)(1994-8#1)(2007-7#1)
murine mammary##3##2##(1990-8#1)(2008-11#1)(2012-2#1)
murine melanoma cells##3##3##(1993-5#1)(1997-4#2)
murine melanoma##4##2##(1991-5#1)(1993-5#1)(1997-4#2)
murine model of retroviral encephalopathy##2##5##(2008-4#2)
murine model of##12##3##(1991-12#1)(2006-10#1)(2008-4#2)(2008-6#1)(2010-6#2)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
murine model systems##2##3##(2008-11#1)(2008-9#1)
murine model##20##2##(1991-12#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-9#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
murine models##9##2##(1991-8#1)(1995-5#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
murine monoclonal antibodies##4##3##(1996-12#1)(2006-6#1)(2008-10#2)
murine monoclonal antibody##2##3##(1992-8#1)(1993-2#1)
murine monoclonal##6##2##(1992-8#1)(1993-2#1)(1996-12#1)(2006-6#1)(2008-10#2)
murine mu opioid receptor##2##4##(1995-6#2)
murine myeloma##2##2##(1995-8#1)(2008-11#1)
murine peritoneal macrophages##2##3##(2008-8#1)(2008-9#1)
murine peritoneal##3##2##(2008-8#2)(2008-9#1)
murine producer cell##2##3##(2008-11#2)
murine thymocytes##2##2##(2008-9#2)
murine tumor##3##2##(1990-12#1)(1990-8#1)(1992-8#1)
murine tumors##2##2##(1992-5#1)(1995-2#1)
murine tumour##2##2##(1992-8#1)(2008-4#1)
murine tumours##2##2##(1997-4#2)
murine typhus##2##2##(1997-6#2)
murine xenograft##2##2##(2010-3#1)(2011-1#1)
murine##368##1##(1990-11#5)(1990-12#9)(1990-5#3)(1990-8#5)(1991-1#1)(1991-12#3)(1991-2#5)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#5)(1992-2#9)(1992-3#2)(1992-5#5)(1992-6#1)(1992-8#12)(1992-9#5)(1993-11#1)(1993-2#12)(1993-3#6)(1993-5#1)(1993-6#7)(1993-8#9)(1993-9#3)(1994-11#7)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#4)(1995-11#5)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#4)(1997-1#4)(1997-4#16)(1997-6#2)(1997-7#6)(1997-8#6)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-11#43)(2008-3#1)(2008-4#27)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#11)(2009-2#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#9)(2013-1#5)(2013-7#1)(2013-8#3)
muris##4##1##(2012-2#1)(2013-1#3)
murismusculi##2##1##(2007-12#2)
mus and##2##2##(2008-2#1)(2008-3#1)
mus##7##1##(2007-11#1)(2008-2#3)(2008-3#3)
mus)##3##1##(1991-2#1)(2008-2#1)(2008-3#1)
musayevi##2##1##(2012-2#2)
muscarinic K+##2##2##(1996-2#2)
muscarinic M2 and##3##3##(1995-12#3)
muscarinic M2 receptors##4##3##(1995-12#4)
muscarinic M2##10##2##(1995-12#10)
muscarinic M3 receptors##5##3##(1995-12#2)(1997-7#3)
muscarinic M3##7##2##(1995-12#3)(1997-7#4)
muscarinic acetylcholine##3##2##(1995-6#1)(1997-4#1)(2008-5#1)
muscarinic and##3##2##(1990-9#1)(1992-3#1)(1995-11#1)
muscarinic antagonist##2##2##(1993-12#1)(1996-12#1)
muscarinic antagonists##2##2##(1995-11#1)(1996-5#1)
muscarinic cholinergic##2##2##(2006-10#1)(2008-3#1)
muscarinic receptor and##2##3##(1995-12#1)(2008-10#1)
muscarinic receptor antagonist##2##3##(1992-11#1)(1996-2#1)
muscarinic receptor binding##4##3##(1993-12#4)
muscarinic receptor##16##2##(1990-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#4)(1995-12#1)(1995-6#2)(1996-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2010-5#1)
muscarinic receptors can##2##3##(1995-11#1)(1996-12#1)
muscarinic receptors in the CNS##2##5##(1992-10#2)
muscarinic receptors in the##4##4##(1990-5#2)(1992-10#2)
muscarinic receptors in##6##3##(1990-5#3)(1992-10#2)(1995-11#1)
muscarinic receptors##18##2##(1990-5#3)(1990-7#1)(1992-10#2)(1995-11#4)(1996-12#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#2)
muscarinic##87##1##(1990-5#4)(1990-7#1)(1990-9#1)(1992-10#3)(1992-11#2)(1992-3#2)(1993-11#1)(1993-12#7)(1993-9#1)(1995-11#8)(1995-12#16)(1995-6#3)(1996-12#4)(1996-2#3)(1996-5#2)(1997-4#1)(1997-7#12)(2006-10#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)
muscimol##3##1##(1993-12#2)(2008-8#1)
muscle (n =##2##3##(2010-9#2)
muscle (n##3##2##(2010-9#3)
muscle actin##12##2##(1990-7#1)(1994-12#1)(2008-11#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
muscle activation##3##2##(1994-2#1)(1995-12#1)(2007-12#1)
muscle activity and##2##3##(2011-2#1)(2013-7#1)
muscle activity in##3##3##(2008-5#1)(2010-7#2)
muscle activity of##2##3##(1994-9#1)(2009-6#1)
muscle activity was##3##3##(2008-5#1)(2012-12#2)
muscle activity##20##2##(1994-9#1)(1997-2#1)(2008-5#4)(2008-7#1)(2009-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#7)(2013-7#1)
muscle actuators##2##2##(2007-12#1)(2008-6#1)
muscle afferents##4##2##(1997-2#4)
muscle after##2##2##(2008-10#1)(2008-8#1)
muscle alpha##3##2##(1991-6#2)(1994-9#1)
muscle and heart##3##3##(1990-11#1)(1992-11#2)
muscle and liver##3##3##(1990-5#1)(2008-3#1)(2008-5#1)
muscle and marbling##4##3##(2010-4#4)
muscle and the##6##3##(1996-2#1)(2008-5#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-1#1)
muscle and##65##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-3#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-4#6)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#1)
muscle are##8##2##(1991-12#1)(1994-8#2)(2007-12#1)(2008-3#1)(2009-3#1)(2010-1#1)(2012-3#1)
muscle as a##2##3##(2007-11#1)(2013-8#1)
muscle as##5##2##(1994-8#1)(2007-11#1)(2009-4#1)(2011-1#1)(2013-8#1)
muscle at##2##2##(1994-8#1)(2012-2#1)
muscle atrophy##4##2##(2008-7#1)(2010-5#1)(2011-2#2)
muscle atypical protein kinase C##2##5##(2008-3#2)
muscle biopsies##2##2##(2008-3#1)(2008-7#1)
muscle biopsy##6##2##(1997-3#1)(2006-10#2)(2008-7#2)(2013-8#1)
muscle blood flow##2##3##(2011-1#2)
muscle bulk##2##2##(2008-9#1)(2012-2#1)
muscle by##11##2##(1990-8#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-5#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-4#1)
muscle cell##21##2##(1990-7#2)(1991-11#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
muscle cells and the##2##4##(2007-8#1)(2008-10#1)
muscle cells and##9##3##(1990-2#2)(1994-11#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
muscle cells as well as##2##5##(1992-12#1)(2009-2#1)
muscle cells of##3##3##(1992-12#1)(1997-7#1)(2008-10#1)
muscle cells to##5##3##(1990-12#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
muscle cells were##4##3##(1990-8#2)(1992-8#1)(1994-5#1)
muscle cells##136##2##(1990-12#5)(1990-2#4)(1990-5#2)(1990-7#6)(1990-8#5)(1991-11#1)(1991-12#2)(1991-5#1)(1992-12#4)(1992-3#1)(1992-8#3)(1992-9#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#2)(1994-11#9)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-11#7)(1995-12#5)(1995-2#8)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-7#2)(2006-6#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#9)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
muscle compared##2##2##(1993-12#2)
muscle contractility##2##2##(1997-7#1)(2009-2#1)
muscle contraction in##3##3##(1990-12#1)(1990-5#1)(1991-12#1)
muscle contraction##17##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-5#1)(1992-3#1)(1994-8#1)(1997-7#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
muscle contractions##8##2##(1994-11#1)(1994-8#2)(1996-5#1)(2008-3#1)(2009-11#1)(2010-1#1)(2012-2#1)
muscle creatine kinase##2##3##(1993-11#1)(2008-8#1)
muscle damage##6##2##(2008-5#3)(2012-1#1)(2012-12#1)(2013-1#1)
muscle degeneration##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
muscle development##3##2##(1996-2#1)(2010-7#2)
muscle differentiation##4##2##(1991-6#1)(1992-6#1)(1994-11#1)(2013-1#1)
muscle disease##2##2##(2006-10#1)(2009-3#1)
muscle diseases##2##2##(1990-9#1)(2013-1#1)
muscle during##5##2##(1991-2#2)(1994-8#1)(2008-10#1)(2010-8#1)
muscle dysfunction##3##2##(2013-7#1)(2013-8#2)
muscle energy##3##2##(2013-1#3)
muscle enzymes##2##2##(2006-10#1)(2011-2#1)
muscle facilitated##2##2##(2008-11#1)(2009-9#1)
muscle fatigue is##2##3##(1992-2#1)(2010-8#1)
muscle fatigue##5##2##(1991-6#1)(1992-2#2)(2010-8#1)(2013-7#1)
muscle fiber characteristics##2##3##(2010-4#2)
muscle fiber motion)##2##3##(2011-1#2)
muscle fiber##11##2##(1991-12#2)(1993-5#1)(2007-12#1)(2010-4#3)(2011-1#4)
muscle fibers##20##2##(1990-7#1)(1991-12#1)(1992-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-1#3)(2010-12#2)(2010-5#1)(2011-2#2)(2013-1#2)
muscle fibre##4##2##(1991-12#1)(1995-12#1)(2010-4#1)(2013-1#1)
muscle fibres##10##2##(1996-2#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
muscle flap##12##2##(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#2)
muscle flaps##4##2##(2010-6#1)(2012-2#3)
muscle force##4##2##(1993-12#1)(2008-6#1)(2009-3#1)(2012-7#1)
muscle from the##3##3##(1993-12#1)(2011-2#1)(2013-1#1)
muscle from##9##2##(1990-8#1)(1993-12#1)(1995-2#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
muscle function##9##2##(1991-6#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
muscle glucose##2##2##(1990-8#2)
muscle glycogen##6##2##(1991-11#4)(2013-1#1)(2013-8#1)
muscle group##3##2##(2010-3#1)(2010-7#2)
muscle groups##7##2##(1995-8#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#3)
muscle growth##4##2##(2008-5#1)(2010-4#1)(2012-12#2)
muscle has been##2##3##(1995-12#1)(2008-11#1)
muscle in a##2##3##(2007-6#1)(2013-1#1)
muscle in this##2##3##(2012-2#1)(2013-1#1)
muscle in##17##2##(1993-12#1)(1993-2#1)(1995-12#3)(1997-7#1)(2007-6#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#2)
muscle increased the phosphorylation##2##4##(1990-11#2)
muscle injury##3##2##(2008-5#1)(2011-2#1)(2012-7#1)
muscle is not##2##3##(1991-9#1)(1994-8#1)
muscle is##24##2##(1990-8#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-1#8)(2008-7#2)(2009-3#1)(2011-1#1)(2012-2#1)
muscle length and gluteal muscle strength##2##6##(2012-2#2)
muscle length##9##2##(2008-12#3)(2012-2#6)
muscle mass##9##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#1)(2013-1#2)
muscle may be##3##3##(1991-12#1)(1992-12#1)(2008-7#1)
muscle membranes##4##2##(1991-6#1)(1993-11#2)(1994-12#1)
muscle microsomes##2##2##(1991-6#2)
muscle myosin light##6##3##(1991-2#2)(1992-9#1)(1993-8#2)(1993-9#1)
muscle myosin##12##2##(1991-2#2)(1991-5#1)(1992-9#1)(1993-6#1)(1993-8#2)(1993-9#2)(1995-12#3)
muscle nAChR##2##2##(2008-8#2)
muscle of rats##2##3##(2008-8#1)(2012-3#1)
muscle of the##12##3##(1990-2#1)(1991-5#1)(1993-12#1)(1994-8#1)(1996-6#2)(1997-4#3)(2007-11#2)(2013-1#1)
muscle of##33##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-6#2)(1997-4#4)(2007-11#2)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2009-2#1)(2011-1#1)(2012-3#2)(2013-1#1)
muscle on##2##2##(2008-10#1)(2012-2#1)
muscle or##5##2##(1997-7#1)(2008-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
muscle pain and##2##3##(2006-10#1)(2008-4#1)
muscle pain##9##2##(1994-2#3)(1997-4#2)(2006-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
muscle performance##2##2##(2013-1#2)
muscle phosphoglucomutase##2##2##(1992-4#2)
muscle power in the trunk##2##5##(1995-8#2)
muscle power##7##2##(1995-8#6)(2009-1#1)
muscle precursor cells##2##3##(1992-8#1)(2008-11#1)
muscle precursors##2##2##(2008-11#2)
muscle proliferation##2##2##(1992-9#1)(2008-3#1)
muscle protein is##2##3##(1992-9#1)(2008-5#1)
muscle protein##5##2##(1992-9#2)(1994-8#1)(2008-5#2)
muscle proteins##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
muscle regeneration by##2##3##(1995-12#2)
muscle regeneration##4##2##(1995-12#3)(2012-7#1)
muscle relaxant##6##2##(1992-3#2)(1992-9#1)(1996-2#2)(1997-4#1)
muscle relaxation##6##2##(1991-12#1)(1991-9#1)(1992-6#2)(1993-6#1)(2012-3#1)
muscle resection##2##2##(2007-6#2)
muscle rigidity##2##2##(1995-2#1)(2008-7#1)
muscle specific##2##2##(1997-8#1)(2010-7#1)
muscle strength and##5##3##(2008-7#1)(2009-1#1)(2009-3#1)(2012-2#1)(2012-3#1)
muscle strength as measured##2##4##(2008-12#1)(2013-1#1)
muscle strength in##5##3##(2009-3#1)(2011-2#2)(2012-2#2)
muscle strength were##2##3##(2007-11#1)(2012-2#1)
muscle strength##27##2##(1993-11#1)(2007-11#3)(2008-12#2)(2008-7#1)(2009-1#1)(2009-3#3)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
muscle strengthening##4##2##(2011-2#4)
muscle tension##10##2##(1994-2#3)(1994-6#1)(2008-7#1)(2009-3#1)(2010-12#3)(2013-1#1)
muscle that##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
muscle tissue##19##2##(1990-6#1)(1992-9#2)(1994-11#1)(1994-5#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
muscle tissues##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
muscle to##9##2##(1990-8#1)(1991-12#1)(1993-5#1)(1995-6#1)(1995-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
muscle tone of injecting##2##4##(1995-2#2)
muscle tone##14##2##(1990-9#1)(1991-5#2)(1995-2#9)(2008-12#2)
muscle toxicity##2##2##(2013-1#2)
muscle transplantation##3##2##(2010-4#1)(2011-2#2)
muscle transposition##2##2##(2011-1#2)
muscle tumors of##2##3##(1994-6#2)
muscle tumours##2##2##(2008-12#2)
muscle undergoes##2##2##(2008-5#1)(2011-2#1)
muscle was determined##2##3##(1992-12#1)(2013-1#1)
muscle was performed##2##3##(1997-2#1)(2008-10#1)
muscle was significantly##2##3##(2008-3#1)(2010-4#1)
muscle was##14##2##(1992-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
muscle wasting##3##2##(1994-9#1)(1997-3#1)(2007-11#1)
muscle weakness and##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
muscle weakness##19##2##(1990-9#1)(1991-12#2)(1997-8#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#6)(2012-3#1)
muscle were##6##2##(1990-9#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)
muscle when##2##2##(1991-5#1)(1994-11#1)
muscle with##11##2##(1991-12#1)(1993-12#2)(1996-2#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
muscle work##2##2##(1990-6#2)
muscle##1313##1##(1990-10#1)(1990-11#9)(1990-12#9)(1990-2#7)(1990-3#1)(1990-5#10)(1990-6#4)(1990-7#11)(1990-8#16)(1990-9#5)(1991-11#8)(1991-12#25)(1991-2#6)(1991-5#12)(1991-6#12)(1991-8#1)(1991-9#6)(1992-11#6)(1992-12#9)(1992-2#5)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#6)(1992-8#6)(1992-9#19)(1993-11#13)(1993-12#15)(1993-2#5)(1993-3#7)(1993-5#4)(1993-6#6)(1993-8#10)(1993-9#8)(1994-11#18)(1994-12#8)(1994-2#8)(1994-3#1)(1994-5#6)(1994-6#9)(1994-8#16)(1994-9#12)(1995-11#9)(1995-12#35)(1995-2#33)(1995-3#1)(1995-6#6)(1995-8#11)(1996-1#2)(1996-10#1)(1996-12#6)(1996-2#15)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#1)(1997-1#4)(1997-2#12)(1997-3#8)(1997-4#10)(1997-7#13)(1997-8#7)(1997-9#1)(2006-10#7)(2006-6#2)(2007-10#2)(2007-11#15)(2007-12#19)(2007-6#4)(2007-7#1)(2007-8#10)(2008-1#22)(2008-10#37)(2008-11#38)(2008-12#19)(2008-2#6)(2008-3#23)(2008-4#17)(2008-5#39)(2008-6#14)(2008-7#46)(2008-8#22)(2008-9#31)(2009-1#4)(2009-11#1)(2009-12#7)(2009-2#6)(2009-3#18)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#7)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#17)(2010-2#3)(2010-3#2)(2010-4#24)(2010-5#3)(2010-6#8)(2010-7#8)(2010-8#6)(2010-9#10)(2011-1#25)(2011-2#53)(2011-3#2)(2012-1#6)(2012-12#15)(2012-2#52)(2012-3#24)(2012-7#5)(2013-1#52)(2013-7#5)(2013-8#25)
muscle)##7##1##(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)
muscle-specific expression of##2##3##(2008-8#2)
muscle-specific expression##3##2##(1995-2#1)(2008-8#2)
muscle-specific##16##1##(1990-5#1)(1993-12#1)(1993-8#3)(1995-2#3)(1995-6#1)(1996-2#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)
muscle-type nAChR##2##2##(2008-8#2)
muscles and its##2##3##(1994-8#1)(2008-7#1)
muscles and other##2##3##(2008-7#1)(2012-3#1)
muscles and the##5##3##(1996-6#1)(2007-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
muscles and##24##2##(1991-11#1)(1991-6#1)(1994-5#1)(1994-8#1)(1996-6#1)(2007-11#2)(2007-12#2)(2008-12#1)(2008-7#3)(2008-9#2)(2009-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
muscles are##4##2##(1990-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
muscles during##2##2##(1995-8#1)(2010-6#1)
muscles for##3##2##(2007-12#1)(2008-12#1)(2010-4#1)
muscles have been##2##3##(1990-6#1)(2012-2#1)
muscles have##4##2##(1990-6#1)(2010-12#1)(2012-2#2)
muscles in a##3##3##(2006-10#1)(2008-9#1)(2012-12#1)
muscles in patients##2##3##(2008-10#1)(2009-6#1)
muscles in the##6##3##(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#2)
muscles in##20##2##(1993-5#1)(1995-12#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#3)(2009-6#1)(2010-4#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
muscles is##4##2##(1995-12#1)(2007-12#1)(2008-7#1)(2012-1#1)
muscles may##4##2##(1994-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
muscles of the neck##2##4##(1990-6#1)(2010-9#1)
muscles of the##14##3##(1990-6#1)(1994-5#1)(1995-8#2)(1996-8#1)(2007-12#2)(2008-8#1)(2008-9#2)(2010-9#1)(2012-7#1)(2013-1#1)(2013-8#1)
muscles of##28##2##(1990-6#1)(1990-7#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-8#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-7#1)(2013-1#3)(2013-8#1)
muscles on##3##2##(2006-10#1)(2009-6#1)(2012-2#1)
muscles that##5##2##(1995-8#1)(2007-8#1)(2008-5#1)(2010-3#1)(2013-1#1)
muscles was##5##2##(2008-5#1)(2008-9#1)(2009-3#1)(2010-4#1)(2013-8#1)
muscles were##10##2##(1995-12#1)(2007-12#2)(2009-3#1)(2009-4#1)(2010-4#2)(2010-9#2)(2011-2#1)
muscles which##2##2##(2007-12#1)(2009-3#1)
muscles with##2##2##(1990-6#1)(2011-2#1)
muscles##286##1##(1990-2#1)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-12#3)(1993-5#1)(1993-9#1)(1994-11#3)(1994-2#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#15)(1995-2#7)(1995-8#7)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#7)(2007-12#19)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#7)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#11)(2009-1#4)(2009-11#1)(2009-12#1)(2009-3#7)(2009-4#2)(2009-6#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#15)(2010-6#2)(2010-8#1)(2010-9#11)(2011-1#4)(2011-2#10)(2012-1#8)(2012-12#8)(2012-2#16)(2012-3#5)(2012-7#3)(2013-1#9)(2013-7#2)(2013-8#6)
muscovy duckling liver##2##3##(1997-1#2)
muscovy duckling##3##2##(1997-1#3)
muscular (patho)physiology##2##2##(2012-2#2)
muscular actins##2##2##(1990-5#2)
muscular activity##5##2##(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#1)
muscular atrophy##3##2##(1996-12#1)(2009-10#1)(2012-2#1)
muscular biopsy##2##2##(1990-3#1)(2011-2#1)
muscular disorders##2##2##(1990-9#1)(2012-2#1)
muscular dystrophies##8##2##(2008-7#2)(2012-2#1)(2012-3#2)(2013-8#3)
muscular dystrophy##21##2##(1990-7#2)(1991-3#1)(1993-3#1)(1994-8#1)(1995-12#4)(1996-8#1)(1997-3#3)(2008-7#3)(2011-2#4)(2012-3#1)
muscular endurance##4##2##(2008-12#1)(2008-5#3)
muscular fibers##3##2##(2011-2#1)(2013-1#2)
muscular force##2##2##(2013-1#2)
muscular hypertrophy##2##2##(2008-5#1)(2013-1#1)
muscular layers##2##2##(1992-12#1)(2009-10#1)
muscular protein##2##2##(2008-5#1)(2010-2#1)
muscular strength and##2##3##(2008-4#1)(2008-5#1)
muscular strength##4##2##(2008-4#1)(2008-5#2)(2013-1#1)
muscular tissue##4##2##(1995-3#1)(2007-10#1)(2010-5#1)(2012-3#1)
muscular weakness##2##2##(1996-11#1)(2007-8#1)
muscular##118##1##(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-8#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#7)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#9)(2012-12#2)(2012-2#12)(2012-3#6)(2013-1#7)(2013-8#3)
muscularis##5##1##(1990-6#1)(1995-12#2)(2010-12#1)(2013-1#1)
muscularity##5##1##(2007-12#4)(2011-1#1)
musculature of the##3##3##(2007-12#3)
musculature##14##1##(1997-6#1)(2007-12#7)(2009-8#1)(2011-2#2)(2012-2#3)
musculo-skeletal system##3##2##(2007-11#1)(2007-8#2)
musculo-skeletal##7##1##(1995-5#1)(2007-11#2)(2007-8#3)(2008-6#1)
musculocutaneous flap##2##2##(2007-5#2)
musculocutaneous##6##1##(2007-5#2)(2008-9#1)(2011-2#1)(2012-2#2)
musculoskeletal and##2##2##(2006-10#1)(2013-1#1)
musculoskeletal conditions##3##2##(2008-3#2)(2012-2#1)
musculoskeletal discomfort##3##2##(1996-9#3)
musculoskeletal disorders##6##2##(1990-9#1)(2008-12#1)(2008-5#1)(2009-12#1)(2012-2#2)
musculoskeletal injuries in##3##3##(2013-1#3)
musculoskeletal injuries##7##2##(2007-11#1)(2008-12#1)(2013-1#5)
musculoskeletal injury##4##2##(2013-1#4)
musculoskeletal manifestations##3##2##(2006-10#2)(2012-2#1)
musculoskeletal pain and##3##3##(2008-12#2)(2013-1#1)
musculoskeletal pain##6##2##(1997-4#1)(2008-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
musculoskeletal symptoms##2##2##(2008-3#1)(2008-8#1)
musculoskeletal system diseases##2##3##(2013-1#2)
musculoskeletal system##13##2##(1990-6#1)(1997-6#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#2)
musculoskeletal tumors##3##2##(2007-11#1)(2008-6#1)(2010-3#1)
musculoskeletal##71##1##(1990-6#1)(1990-9#1)(1994-12#1)(1994-2#1)(1996-3#1)(1996-9#3)(1997-4#1)(1997-6#1)(2006-10#3)(2007-11#6)(2008-12#8)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-12#1)(2009-7#1)(2010-3#2)(2010-9#2)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#13)
musculus flexor digitorum##2##3##(2008-5#2)
musculus##4##1##(1991-5#1)(2008-5#2)(2008-9#1)
museum##3##1##(2008-10#1)(2008-9#1)(2009-7#1)
mushroom (Agaricus bisporus) tissue##2##4##(2008-10#2)
mushroom (Agaricus bisporus)##3##3##(2008-10#3)
mushroom Thelephora ganbajun##2##3##(2008-11#2)
mushroom and##2##2##(2008-10#1)(2008-12#1)
mushroom bodies are##2##3##(2007-12#2)
mushroom bodies##6##2##(2007-12#6)
mushroom body##3##2##(2007-12#2)(2008-10#1)
mushroom compost##2##2##(2008-10#2)
mushroom farms##2##2##(2008-10#2)
mushroom species##3##2##(1994-9#1)(2011-2#1)(2013-8#1)
mushroom tyrosinase activity##3##3##(2008-5#2)(2013-1#1)
mushroom tyrosinase##4##2##(2008-5#3)(2013-1#1)
mushroom was##2##2##(2008-10#2)
mushroom##52##1##(1991-5#1)(1994-9#1)(1997-2#1)(2007-12#8)(2008-10#24)(2008-11#2)(2008-12#2)(2008-5#3)(2008-8#1)(2010-11#1)(2010-3#2)(2011-2#2)(2013-1#1)(2013-8#3)
mushrooms by##2##2##(2008-10#2)
mushrooms with neurotropic##2##3##(2011-2#2)
mushrooms with##3##2##(2011-2#3)
mushrooms##21##1##(1991-11#1)(1994-9#3)(2008-10#3)(2008-5#3)(2010-10#3)(2011-2#6)(2012-3#1)(2013-8#1)
music activities##2##2##(2007-6#2)
music after##4##2##(2008-9#4)
music and the##2##3##(2007-6#1)(2009-5#1)
music and##7##2##(2007-6#3)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
music appreciation##3##2##(2008-9#3)
music during##2##2##(2007-6#1)(2008-5#1)
music groups in##2##3##(2007-6#2)
music groups##3##2##(2007-6#2)(2013-1#1)
music in##3##2##(2007-6#1)(2008-9#2)
music is##2##2##(2008-11#1)(2008-5#1)
music on##7##2##(1991-12#2)(2007-6#3)(2008-5#1)(2008-9#1)
music promotes##3##2##(2007-6#3)
music stimulation##3##2##(1991-12#3)
music therapists##4##2##(1991-12#3)(1993-2#1)
music therapy##9##2##(1991-12#1)(1993-2#4)(1995-1#1)(2007-6#2)(2009-3#1)
music used##2##2##(2007-6#2)
music was played##2##3##(1993-1#2)
music was##3##2##(1993-1#2)(2007-6#1)
music were played##3##3##(1993-1#3)
music were##4##2##(1993-1#4)
music##121##1##(1991-12#11)(1992-3#13)(1993-1#7)(1993-2#5)(1995-1#1)(1997-6#1)(2007-6#42)(2008-11#3)(2008-5#5)(2008-9#20)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#4)
musical cues##3##2##(2013-8#3)
musical instrument##3##2##(2008-9#1)(2012-12#2)
musical instruments##5##2##(2008-9#4)(2012-12#1)
musical##30##1##(1992-3#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#7)(2012-12#3)(2012-2#1)(2013-1#5)(2013-8#6)
musician##2##1##(2010-3#2)
musicians##7##1##(2010-3#7)
musicola in Australia##2##3##(2008-10#2)
musicola##7##1##(2008-10#7)
musiva##3##1##(2008-10#3)
musk##2##1##(2008-5#1)(2009-3#1)
muskmelon cultivars##4##2##(2008-10#4)
muskmelon seedlings##2##2##(2008-10#2)
muskmelon##13##1##(2008-10#13)
mussel samples##3##2##(2008-10#3)
mussel soft tissue by##2##4##(2008-10#2)
mussel soft tissue##3##3##(2008-10#3)
mussel tissue##3##2##(2008-10#3)
mussel tissues##2##2##(2008-10#2)
mussel##28##1##(1990-9#1)(1992-6#1)(1995-8#1)(2008-10#15)(2008-12#1)(2009-6#2)(2010-8#2)(2013-1#2)(2013-7#3)
mussel)##2##1##(1995-8#1)(2008-10#1)
mussels##20##1##(1997-4#1)(2008-10#13)(2008-9#1)(2010-5#4)(2010-8#1)
must act##2##2##(1997-3#1)(2008-9#1)
must adapt to##3##3##(1992-5#1)(2008-8#1)(2008-9#1)
must address the##2##3##(2009-10#1)(2011-2#1)
must address##4##2##(2009-10#1)(2010-3#1)(2011-2#2)
must adopt##6##2##(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-2#1)(2011-2#1)
must all##3##2##(2008-5#1)(2012-12#1)(2013-8#1)
must allow##2##2##(2008-7#1)(2009-8#1)
must also be addressed as##2##5##(1994-7#1)(2008-7#1)
must also be addressed##3##4##(1994-7#1)(2008-7#1)(2010-3#1)
must also be considered##4##4##(2006-10#1)(2008-11#1)(2011-2#2)
must also be taken into##2##5##(2008-10#1)(2008-9#1)
must also be##17##3##(1991-3#1)(1992-12#1)(1992-9#1)(1994-6#1)(1994-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)
must also##30##2##(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-12#2)
must always be##2##3##(1997-8#1)(2011-2#1)
must always##3##2##(1997-8#1)(2008-2#1)(2011-2#1)
must approach##2##2##(1994-5#1)(2011-2#1)
must assess##2##2##(1996-3#1)(2011-1#1)
must balance##2##2##(1996-1#1)(2013-8#1)
must be a##6##3##(1992-5#1)(1995-3#1)(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
must be able to##8##4##(1992-12#1)(1993-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
must be achieved##2##3##(1994-3#1)(2008-9#1)
must be acknowledged##2##3##(1994-12#1)(2013-1#1)
must be added to the##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
must be added##4##3##(1990-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
must be addressed in##3##4##(2007-12#1)(2007-5#1)(2009-12#1)
must be addressed##10##3##(1995-2#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)
must be adequately##2##3##(2007-7#1)(2008-2#1)
must be adopted##2##3##(1996-12#1)(2008-3#1)
must be aligned##2##3##(2008-2#1)(2008-3#1)
must be an##2##3##(1992-11#1)(1995-12#1)
must be anticipated##2##3##(1993-1#1)(2007-12#1)
must be applied##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
must be assessed##3##3##(1990-9#1)(1994-2#1)(2011-2#1)
must be aware of the##3##5##(1994-3#1)(1996-12#1)(2007-12#1)
must be aware of##6##4##(1994-3#1)(1996-12#1)(2007-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
must be balanced against the##2##5##(1997-3#1)(2008-3#1)
must be based on a##2##5##(1997-4#1)(2007-12#1)
must be based on the##2##5##(1991-6#1)(1996-4#1)
must be based on##9##4##(1991-6#1)(1994-8#1)(1996-4#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
must be capable of##2##4##(1995-5#1)(2009-8#1)
must be carefully considered when designing##2##6##(1997-3#1)(2008-9#1)
must be carefully evaluated##2##4##(2008-9#1)(2011-2#1)
must be carefully selected##2##4##(2010-11#1)(2010-6#1)
must be carefully##14##3##(1994-3#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#2)
must be combined##2##3##(1990-12#1)(1995-12#1)
must be comfortable##2##3##(2008-8#1)(2011-2#1)
must be compared with##2##4##(1990-3#1)(1994-3#1)
must be competent to##2##4##(1992-11#1)(2008-12#1)
must be competent##3##3##(1992-11#1)(2008-12#1)(2011-2#1)
must be concerned##2##3##(1992-3#1)(1994-1#1)
must be considered and##2##4##(1992-2#1)(1997-1#1)
must be considered as##4##4##(1990-8#1)(2007-12#1)(2008-7#1)(2008-8#1)
must be considered in the design##2##6##(2008-4#1)(2013-8#1)
must be considered in the differential diagnosis of##2##8##(1996-11#1)(2006-10#1)
must be considered in the##5##5##(1993-11#1)(1996-11#1)(2006-10#1)(2008-4#1)(2013-8#1)
must be considered in##9##4##(1993-11#1)(1996-11#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-8#1)
must be considered to##2##4##(1994-9#1)(2006-12#1)
must be considered when##9##4##(1994-5#1)(1997-8#1)(2008-4#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
must be considered##46##3##(1990-11#1)(1990-8#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
must be continued for##2##4##(1994-9#1)(2008-4#1)
must be controlled##4##3##(2007-11#2)(2008-12#1)(2011-2#1)
must be coordinated##2##3##(1994-12#1)(1997-3#1)
must be delivered##2##3##(1995-5#1)(2010-6#1)
must be demonstrated##2##3##(1992-12#1)(2008-10#1)
must be designed and##2##4##(2008-11#1)(2008-3#1)
must be designed to##2##4##(1994-3#1)(1996-2#1)
must be designed##4##3##(1994-3#1)(1996-2#1)(2008-11#1)(2008-3#1)
must be determined in##2##4##(2008-10#1)(2012-2#1)
must be determined##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
must be developed##6##3##(1993-3#1)(1996-1#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-11#1)
must be directed##2##3##(1992-3#1)(1995-3#1)
must be distinguished from##3##4##(1994-9#1)(2007-6#1)(2009-3#1)
must be done##6##3##(1997-2#1)(2007-12#1)(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
must be embolized##2##3##(2008-7#2)
must be engineered##2##3##(2008-11#1)(2012-3#1)
must be established##4##3##(1992-9#1)(1994-12#2)(2007-6#1)
must be evaluated for##2##4##(1992-8#1)(2008-11#1)
must be evaluated in##3##4##(2007-7#1)(2008-2#1)(2008-4#1)
must be evaluated##14##3##(1992-8#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)
must be excluded##3##3##(1990-6#1)(1997-2#1)(2010-3#1)
must be explored##2##3##(1991-3#1)(2008-2#1)
must be familiar with##2##4##(2008-8#1)(2012-2#1)
must be fitted##2##3##(2008-3#1)(2008-9#1)
must be focused on##2##4##(1992-12#1)(1997-1#1)
must be followed##3##3##(2011-1#1)(2012-1#1)(2013-8#1)
must be free##2##3##(1993-8#1)(2012-2#1)
must be given the##2##4##(2008-11#1)(2008-3#1)
must be given to##2##4##(1991-2#1)(2010-5#1)
must be given##6##3##(1991-2#1)(1993-2#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
must be held to##2##4##(2008-2#2)
must be held##3##3##(2008-1#1)(2008-2#2)
must be identified and##2##4##(1994-6#1)(2011-2#1)
must be identified##5##3##(1994-6#1)(2007-12#1)(2008-3#1)(2011-2#2)
must be implemented to reduce##2##5##(2013-1#2)
must be implemented##4##3##(2007-12#1)(2013-1#3)
must be improved##4##3##(1990-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
must be in place for##2##5##(2008-10#1)(2008-7#1)
must be in place##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
must be in##6##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
must be included in the##4##5##(2008-10#1)(2008-3#1)(2013-8#2)
must be included in##7##4##(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
must be included##8##3##(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
must be incorporated##2##3##(2008-11#1)(2008-4#1)
must be individualized##2##3##(2009-10#1)(2011-2#1)
must be integrated with##2##4##(1994-1#1)(2009-10#1)
must be investigated##2##3##(2010-11#1)(2011-1#1)
must be isolated##2##3##(2008-9#1)(2009-11#1)
must be known##4##3##(1996-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
must be made to##3##4##(1994-5#1)(2008-4#2)
must be made##7##3##(1994-5#1)(1997-8#1)(2007-4#1)(2008-4#2)(2010-8#1)(2011-2#1)
must be maintained##2##3##(2008-12#1)(2009-10#1)
must be measured##2##3##(2008-10#1)(2008-3#1)
must be met for##2##4##(2008-7#1)(2010-3#1)
must be met##8##3##(1991-12#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-3#1)
must be modified to##2##4##(1990-7#1)(2008-4#1)
must be modified##4##3##(1990-7#1)(2008-10#1)(2008-3#1)(2008-4#1)
must be more##4##3##(1997-1#1)(1997-3#1)(2008-11#1)(2008-8#1)
must be overcome before##2##4##(1994-2#1)(2012-3#1)
must be paid to##8##4##(1992-3#1)(1993-6#1)(1995-5#1)(2008-7#2)(2010-11#1)(2011-1#1)(2013-1#1)
must be part##2##3##(1990-5#1)(1997-3#1)
must be performed in order to##3##6##(1996-6#1)(2013-1#2)
must be performed in##4##4##(1996-6#1)(2012-3#1)(2013-1#2)
must be performed##14##3##(1991-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
must be prepared to##4##4##(1991-1#1)(2006-10#1)(2008-1#1)(2008-10#1)
must be prepared##8##3##(1991-1#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
must be prevented##2##3##(2007-8#1)(2011-2#1)
must be properly##2##3##(2008-10#1)(2008-2#1)
must be realigned##2##3##(1993-3#1)(2009-3#1)
must be recognized##3##3##(1995-3#1)(2008-11#1)(2010-8#1)
must be removed from##3##4##(2008-10#2)(2008-5#1)
must be removed##5##3##(1996-2#2)(2008-10#2)(2008-5#1)
must be replaced##3##3##(1991-3#1)(1996-1#1)(2007-7#1)
must be responsible for##2##4##(2008-10#2)
must be ruled##2##3##(2011-2#2)
must be seen##2##3##(1996-9#1)(2010-8#1)
must be selected##3##3##(1995-5#1)(2008-10#1)(2010-12#1)
must be similarly##2##3##(1991-3#1)(2007-12#1)
must be sought##2##3##(1995-5#1)(2008-8#1)
must be sufficiently##2##3##(2009-7#1)(2010-3#1)
must be supplemented##2##3##(1997-4#1)(2008-3#1)
must be supported by##2##4##(1993-12#1)(2008-4#1)
must be suspected##2##3##(2008-7#1)(2013-1#1)
must be synthesized##2##3##(1994-3#1)(2008-10#1)
must be taken into account in the##2##7##(1995-3#1)(2008-10#1)
must be taken into account when##2##6##(2008-10#1)(2008-9#1)
must be taken into account##11##5##(1995-2#1)(1995-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
must be taken into##12##4##(1991-11#1)(1995-2#1)(1995-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
must be taken to ensure##2##5##(2008-4#1)(2008-9#1)
must be taken to##6##4##(1992-3#1)(1993-12#1)(2008-10#2)(2008-4#1)(2008-9#1)
must be taken when##2##4##(1995-1#1)(2008-9#1)
must be taken##24##3##(1991-11#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2011-3#1)(2012-3#1)(2013-1#1)
must be the##4##3##(1996-1#1)(2007-11#1)(2008-3#1)(2011-2#1)
must be to##2##3##(1990-5#1)(1997-7#1)
must be transported##2##3##(2008-11#1)(2008-9#1)
must be used in##3##4##(2007-10#1)(2008-6#1)(2013-1#1)
must be used##11##3##(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2013-1#1)
must be validated##2##3##(1991-3#1)(2013-1#1)
must be viewed as##3##4##(1992-12#1)(2008-11#1)(2010-4#1)
must be viewed##7##3##(1992-12#1)(1993-11#1)(1997-3#1)(1997-5#1)(2008-11#1)(2009-6#1)(2010-4#1)
must be weighed against the##3##5##(1994-6#1)(2007-11#1)(2013-1#1)
must be well##3##3##(2007-12#1)(2007-7#1)(2011-2#1)
must be##632##2##(1990-11#3)(1990-12#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#5)(1991-6#2)(1992-1#2)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#12)(1994-5#3)(1994-6#6)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#8)(1995-8#1)(1996-1#8)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#7)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#6)(1997-2#4)(1997-3#9)(1997-4#3)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#3)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#20)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#53)(2008-11#26)(2008-12#8)(2008-2#20)(2008-3#31)(2008-4#16)(2008-5#6)(2008-6#4)(2008-7#24)(2008-8#14)(2008-9#18)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#6)(2010-12#2)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#32)(2011-3#4)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#12)(2013-1#21)(2013-7#1)(2013-8#13)
must bear##3##2##(1996-2#1)(2011-1#1)(2011-2#1)
must become##3##2##(1992-6#1)(1993-11#1)(2011-2#1)
must begin to##2##3##(1992-1#1)(2010-12#1)
must begin##3##2##(1992-1#1)(1995-12#1)(2010-12#1)
must change##2##2##(1996-1#1)(1997-2#1)
must comply with##2##3##(1993-1#1)(1993-12#1)
must conclude that##2##3##(1991-12#1)(2008-10#1)
must confront##2##2##(1995-2#1)(2013-1#1)
must consider the##2##3##(1995-3#1)(2009-5#1)
must consider##13##2##(1991-3#1)(1992-3#1)(1993-1#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#1)
must contain##2##2##(2008-10#1)(2012-12#1)
must continue to##4##3##(1991-12#1)(1995-12#1)(1995-2#1)(2008-4#1)
must continue##5##2##(1991-12#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-4#1)
must cover##3##2##(1990-2#1)(1992-11#1)(2008-12#1)
must decide whether##2##3##(1993-2#1)(1994-1#1)
must decide##4##2##(1993-2#1)(1994-1#2)(2007-11#1)
must determine##2##2##(1997-8#1)(2010-3#1)
must develop##3##2##(1993-3#1)(2008-1#1)(2010-3#1)
must do##2##2##(1991-3#1)(1994-1#1)
must embrace##2##2##(1994-2#1)(2008-10#1)
must ensure##3##2##(2008-5#1)(2009-8#1)(2010-3#1)
must estimate the##2##3##(1992-3#1)(2010-8#1)
must exist##3##2##(1991-3#1)(1992-12#1)(2008-5#1)
must face the##2##3##(1990-6#1)(1997-5#1)
must find##3##2##(1997-2#1)(2010-3#1)(2011-2#1)
must first##5##2##(1995-2#1)(1996-3#1)(2008-10#1)(2009-10#1)(2010-2#1)
must focus on##6##3##(1993-12#1)(1994-1#1)(1994-12#1)(1997-3#1)(2008-12#1)(2011-2#1)
must for the##2##3##(1992-3#1)(1996-11#1)
must for##4##2##(1992-3#1)(1996-11#1)(2008-11#1)(2008-3#1)
must form the##2##3##(1991-2#1)(1995-5#1)
must have a##6##3##(2007-12#1)(2008-11#1)(2009-6#1)(2010-5#1)(2010-8#1)(2013-8#1)
must have been##4##3##(1990-6#1)(1997-5#1)(2008-7#1)(2012-3#1)
must have the##3##3##(1993-8#1)(2008-8#1)(2012-3#1)
must have##30##2##(1990-2#1)(1990-6#2)(1993-8#1)(1994-5#1)(1996-11#1)(1996-5#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
must identify##2##2##(1993-2#1)(2010-12#1)
must in##2##2##(1991-3#1)(2012-3#1)
must include the##2##3##(2008-9#1)(2010-6#1)
must include##12##2##(1991-11#1)(1994-12#1)(1996-3#1)(1997-1#1)(2007-2#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
must incorporate##2##2##(2008-4#1)(2011-1#1)
must increase##2##2##(1995-3#1)(2008-8#1)
must invest in##2##3##(1995-2#1)(2011-1#1)
must learn##2##2##(2010-6#1)(2012-12#1)
must look at##2##3##(1992-1#1)(2008-7#1)
must look##3##2##(1992-1#1)(2008-7#1)(2010-8#1)
must maintain##3##2##(2007-12#1)(2008-3#1)(2010-1#1)
must make the##2##3##(1994-8#1)(1996-3#1)
must make##7##2##(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2008-4#1)(2012-12#1)
must meet certain##2##3##(1992-5#1)(2009-8#1)
must meet the##2##3##(1995-5#1)(2010-7#1)
must meet##5##2##(1992-5#1)(1993-2#1)(1995-5#1)(2009-8#1)(2010-7#1)
must not be##9##3##(1991-1#1)(1995-9#2)(1996-11#1)(1996-6#1)(1997-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
must not only##2##3##(1994-5#1)(2008-2#1)
must not##13##2##(1991-1#1)(1991-12#1)(1994-5#1)(1995-9#2)(1996-11#1)(1996-6#1)(1997-5#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)
must now##2##2##(1993-12#1)(2010-12#1)
must occur to##2##3##(2009-10#2)
must occur##6##2##(1991-3#1)(1994-2#1)(1996-9#1)(2008-7#1)(2009-10#2)
must offer##2##2##(1992-2#1)(2012-12#1)
must often##2##2##(2008-4#1)(2008-9#1)
must overcome##2##2##(1993-12#1)(1993-2#1)
must pay for##2##3##(1995-2#1)(2008-8#1)
must pay##4##2##(1995-2#1)(1996-5#1)(2008-11#1)(2008-8#1)
must place##2##2##(1996-11#1)(2008-8#1)
must play a role in##2##5##(1996-2#1)(2010-3#1)
must possess##2##2##(1996-1#1)(2008-1#1)
must provide##4##2##(1995-3#1)(2007-10#1)(2008-2#1)(2009-11#1)
must realize that##2##3##(1994-12#1)(2008-8#1)
must receive##3##2##(1995-1#1)(1995-12#1)(2008-4#1)
must recognize the##2##3##(1991-2#1)(2007-12#1)
must recognize##3##2##(1991-2#1)(2007-11#1)(2007-12#1)
must reduce##2##2##(1991-7#1)(2012-3#1)
must reflect##2##2##(1992-3#1)(1996-1#1)
must rely on##4##3##(1996-4#1)(2008-11#2)(2013-1#1)
must respond to##2##3##(1991-1#1)(1994-12#1)
must respond##3##2##(1991-1#1)(1991-3#1)(1994-12#1)
must satisfy the##2##3##(1997-6#1)(2007-12#1)
must shift##2##2##(1992-12#1)(1993-12#1)
must take a##2##3##(1993-1#1)(1993-2#1)
must take into account the##3##5##(1996-6#1)(2008-7#1)(2009-12#1)
must take into account##5##4##(1996-6#1)(2008-11#1)(2008-7#1)(2009-12#1)(2011-2#1)
must take into consideration the##3##5##(1996-3#1)(2008-1#1)(2008-11#1)
must take into##8##3##(1996-3#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-12#1)(2011-2#1)
must take responsibility for##3##4##(1995-1#1)(1995-3#1)(2008-12#1)
must take the##2##3##(2007-11#1)(2008-3#1)
must take##19##2##(1992-3#1)(1993-1#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)
must the##2##2##(2008-7#1)(2010-3#1)
must therefore be##6##3##(1990-12#1)(1992-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
must therefore##8##2##(1990-12#1)(1992-5#1)(1994-2#1)(1994-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
must to##2##2##(2008-10#2)
must undergo a##2##3##(1994-3#1)(1994-5#1)
must undergo##7##2##(1992-6#1)(1993-6#1)(1994-3#1)(1994-5#1)(2007-12#1)(2008-7#1)(2012-3#1)
must understand the##3##3##(1996-1#1)(2008-7#1)(2010-8#1)
must understand##9##2##(1990-10#1)(1993-2#1)(1994-2#1)(1996-1#1)(1997-1#1)(2008-2#1)(2008-7#1)(2010-8#1)(2013-8#1)
must use##5##2##(1994-1#1)(1994-3#1)(1997-2#1)(2008-3#1)(2012-2#1)
must wait##2##2##(1993-3#1)(2007-9#1)
must we##3##2##(1994-1#1)(2006-10#1)(2008-11#1)
must work more closely##2##4##(1991-12#1)(1996-1#1)
must work together to##3##4##(1995-1#1)(1995-2#1)(1996-3#1)
must work together##5##3##(1991-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)
must work##8##2##(1991-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2010-10#1)
must##1127##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#3)(1990-6#7)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#6)(1991-12#8)(1991-2#7)(1991-3#14)(1991-6#3)(1991-7#2)(1992-1#5)(1992-11#5)(1992-12#10)(1992-2#6)(1992-3#13)(1992-4#1)(1992-5#6)(1992-6#3)(1992-8#1)(1992-9#4)(1993-1#5)(1993-11#4)(1993-12#11)(1993-2#15)(1993-3#7)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#11)(1994-11#1)(1994-12#13)(1994-2#13)(1994-3#17)(1994-5#8)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#6)(1995-11#2)(1995-12#9)(1995-2#11)(1995-3#9)(1995-4#1)(1995-5#12)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#14)(1996-11#7)(1996-12#6)(1996-2#12)(1996-3#15)(1996-4#5)(1996-5#3)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#12)(1997-2#9)(1997-3#15)(1997-4#3)(1997-5#10)(1997-6#2)(1997-7#1)(1997-8#6)(2006-10#5)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#30)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#4)(2007-9#3)(2008-1#13)(2008-10#72)(2008-11#42)(2008-12#13)(2008-2#26)(2008-3#39)(2008-4#26)(2008-5#13)(2008-6#5)(2008-7#38)(2008-8#27)(2008-9#33)(2009-10#12)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#7)(2010-12#7)(2010-2#1)(2010-3#16)(2010-4#1)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#10)(2011-2#56)(2011-3#4)(2012-1#3)(2012-12#15)(2012-2#14)(2012-3#19)(2013-1#29)(2013-7#1)(2013-8#18)
mustard##10##1##(1995-3#2)(2008-10#6)(2008-2#1)(2010-4#1)
mustards##3##1##(1992-11#3)
mutability (i##2##2##(2008-6#2)
mutability##6##1##(2008-12#1)(2008-6#3)(2008-8#1)(2013-8#1)
mutagen##3##1##(1996-2#1)(2008-4#1)(2013-1#1)
mutagenesis and carcinogenesis##2##3##(1993-11#1)(1995-9#1)
mutagenesis and expression##2##3##(1992-3#1)(1994-12#1)
mutagenesis and##14##2##(1992-3#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1995-9#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
mutagenesis at##4##2##(1992-1#1)(1992-8#1)(2008-9#1)(2011-1#1)
mutagenesis by##2##2##(1997-6#1)(2008-10#1)
mutagenesis experiments##2##2##(1994-8#1)(2008-10#1)
mutagenesis for##2##2##(2007-6#1)(2008-4#1)
mutagenesis in the##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
mutagenesis in##12##2##(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-4#1)(2008-8#1)(2012-3#2)
mutagenesis is##2##2##(1990-8#1)(2008-7#1)
mutagenesis of double-stranded DNA##2##4##(1994-12#2)
mutagenesis of the##7##3##(1990-5#1)(1992-8#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-9#1)
mutagenesis of##21##2##(1990-10#1)(1990-5#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#1)(1994-12#3)(1995-3#1)(1995-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)
mutagenesis on##2##2##(1990-11#1)(1993-8#1)
mutagenesis showing##2##2##(2008-8#1)(2012-2#1)
mutagenesis studies##7##2##(1992-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(2011-2#2)
mutagenesis to##7##2##(1992-1#1)(1993-11#1)(1995-5#1)(2008-1#1)(2008-10#3)
mutagenesis using##6##2##(1990-11#2)(1992-2#1)(2007-6#1)(2008-10#1)(2011-1#1)
mutagenesis was performed##2##3##(1997-2#1)(2008-8#1)
mutagenesis was used to investigate the##2##6##(1994-5#1)(1994-6#1)
mutagenesis was used to##5##4##(1993-8#1)(1994-5#1)(1994-6#1)(1995-2#1)(2008-4#1)
mutagenesis was##10##2##(1993-8#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#1)(1997-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
mutagenesis were##3##2##(1990-5#1)(1992-3#1)(2013-8#1)
mutagenesis which##2##2##(1991-5#1)(2012-2#1)
mutagenesis##182##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-5#6)(1990-7#4)(1990-8#1)(1991-10#2)(1991-2#1)(1991-5#3)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#7)(1992-6#2)(1992-8#5)(1992-9#2)(1993-11#3)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#13)(1995-3#1)(1995-5#9)(1995-6#2)(1995-8#3)(1995-9#2)(1996-12#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-6#2)(2008-1#1)(2008-10#18)(2008-2#2)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#11)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#1)
mutagenic DNA##2##2##(1990-7#1)(1995-6#1)
mutagenic activity##3##2##(1996-2#2)(2008-4#1)
mutagenic and carcinogenic##2##3##(1996-6#1)(2008-7#1)
mutagenic and##3##2##(1993-11#1)(1996-6#1)(2008-7#1)
mutagenic effect##4##2##(1992-5#1)(1996-2#1)(2008-7#1)(2013-1#1)
mutagenic effects##3##2##(1992-9#1)(1996-2#1)(2009-6#1)
mutagenic heterocyclic##2##2##(1997-2#2)
mutagenic in Salmonella typhimurium strains##2##5##(2008-9#2)
mutagenic in##7##2##(1995-11#1)(1997-6#1)(2008-7#1)(2008-9#4)
mutagenic process of##2##3##(2008-10#2)
mutagenic process##5##2##(2008-10#5)
mutagenic##55##1##(1990-11#1)(1990-6#2)(1990-7#1)(1991-12#1)(1992-5#2)(1992-9#1)(1993-11#5)(1993-8#1)(1995-11#1)(1995-6#1)(1996-2#6)(1996-6#1)(1997-2#3)(1997-6#1)(2008-10#9)(2008-11#5)(2008-4#2)(2008-7#3)(2008-9#4)(2009-6#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
mutagenicity of##2##2##(1992-9#1)(1996-2#1)
mutagenicity was detected##3##3##(1996-2#1)(2008-8#2)
mutagenicity##10##1##(1992-9#1)(1996-2#3)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#2)
mutagenized##4##1##(1992-9#1)(1995-2#1)(1997-8#1)(2008-10#1)
mutagens##11##1##(1992-5#1)(1992-8#1)(1996-2#5)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)
mutans##13##1##(1992-9#2)(1997-8#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-1#6)(2013-8#1)
mutant (Rev##2##2##(1993-8#2)
mutant 10##5##2##(2008-10#5)
mutant DPR1 gene##2##3##(1995-2#2)
mutant EF-3s did not##2##4##(1996-2#2)
mutant Hb##2##2##(1992-3#2)
mutant LPL##3##2##(1992-3#2)(1994-11#1)
mutant PCV2b##2##2##(2013-1#2)
mutant TRbeta1##2##2##(1995-8#2)
mutant ZnT4##2##2##(2008-10#2)
mutant a##2##2##(1990-7#1)(2009-5#1)
mutant allele in##2##3##(2012-3#2)
mutant allele##5##2##(1990-11#1)(2008-10#1)(2008-4#1)(2012-3#2)
mutant alleles were##2##3##(1993-3#1)(2008-9#1)
mutant alleles##13##2##(1990-5#1)(1993-3#3)(1995-9#1)(1997-3#3)(2008-10#2)(2008-8#1)(2008-9#1)(2012-12#1)
mutant alpha2Ms##2##2##(2008-11#2)
mutant also##2##2##(1997-2#1)(2009-10#1)
mutant analysis##2##2##(2009-10#2)
mutant and the##6##3##(1993-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(2008-10#2)
mutant and wild-type##4##3##(1995-5#1)(2008-10#2)(2008-7#1)
mutant and##18##2##(1991-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#7)(2008-4#1)(2008-7#1)(2011-1#1)
mutant animals##3##2##(1993-12#2)(2011-1#1)
mutant antibodies##3##2##(1992-8#3)
mutant as##2##2##(1993-8#1)(2009-5#1)
mutant asb##2##2##(2008-5#2)
mutant background##4##2##(1990-5#1)(2008-8#1)(2009-10#1)(2009-8#1)
mutant by##2##2##(1995-2#1)(2008-9#1)
mutant cell line##4##3##(1994-12#1)(1995-12#1)(2008-4#1)(2012-2#1)
mutant cell##6##2##(1994-12#1)(1995-12#1)(1996-2#1)(2008-4#1)(2012-2#1)(2013-8#1)
mutant cells##10##2##(1992-8#2)(1995-12#1)(1996-3#1)(1997-3#3)(1997-7#1)(2012-3#1)(2013-8#1)
mutant classes##2##2##(2008-10#2)
mutant colonies##2##2##(1995-6#1)(2008-8#1)
mutant containing##3##2##(1995-2#2)(2008-10#1)
mutant could##2##2##(1991-2#1)(2008-8#1)
mutant defective in##2##3##(1997-2#1)(1997-7#1)
mutant derivatives of##2##3##(1997-3#2)
mutant devoid of##2##3##(1993-11#1)(2008-6#1)
mutant did not##2##3##(2008-10#2)
mutant differentially##2##2##(1990-12#1)(2013-8#1)
mutant displayed##2##2##(1995-2#2)
mutant enzyme showed##2##3##(1990-10#1)(1992-6#1)
mutant enzyme was##4##3##(1990-10#2)(1990-12#1)(1990-8#1)
mutant enzyme with##2##3##(1993-6#1)(1995-6#1)
mutant enzyme##20##2##(1990-10#5)(1990-12#1)(1990-8#1)(1992-6#3)(1993-6#1)(1994-5#2)(1995-2#2)(1995-6#4)(1997-7#1)
mutant enzymes were##5##3##(1994-5#1)(1995-2#2)(1995-5#2)
mutant enzymes with##2##3##(1992-6#2)
mutant enzymes##11##2##(1990-12#1)(1990-8#1)(1992-6#2)(1994-5#1)(1995-2#2)(1995-5#2)(1995-6#1)(1997-7#1)
mutant exhibited##2##2##(1994-12#1)(2008-3#1)
mutant exhibits##3##2##(1990-7#1)(1993-11#1)(2008-9#1)
mutant failed to form##2##4##(2008-8#2)
mutant failed to##5##3##(1997-4#1)(2008-10#2)(2008-8#2)
mutant for##2##2##(1991-5#1)(2008-7#1)
mutant forms of##4##3##(1995-6#1)(1997-4#1)(2009-5#1)(2011-2#1)
mutant forms##5##2##(1994-12#1)(1995-6#1)(1997-4#1)(2009-5#1)(2011-2#1)
mutant frequency##4##2##(2008-4#4)
mutant gene##4##2##(1995-12#1)(1995-2#2)(2008-8#1)
mutant genes##5##2##(1991-9#1)(1992-6#1)(1994-5#1)(2008-9#1)(2011-2#1)
mutant had##2##2##(1993-8#1)(2008-10#1)
mutant has been##2##3##(1995-2#1)(1996-2#1)
mutant has##7##2##(1990-7#2)(1995-2#1)(1996-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
mutant human cell##2##3##(1990-5#1)(1996-2#1)
mutant human##5##2##(1990-5#1)(1992-3#1)(1996-2#1)(2008-6#1)(2008-9#1)
mutant in a##2##3##(2008-10#1)(2008-9#1)
mutant in the##4##3##(1994-11#1)(1995-2#1)(2008-9#1)(2009-8#1)
mutant in##9##2##(1992-9#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-9#3)(2009-10#1)(2009-8#1)
mutant induced##2##2##(2008-10#2)
mutant insulin##2##2##(1995-6#2)
mutant is##2##2##(1995-2#1)(1997-2#1)
mutant libraries that##2##3##(1997-6#2)
mutant line##2##2##(2008-10#2)
mutant lines##3##2##(1992-8#1)(2008-7#1)(2009-10#1)
mutant may be##2##3##(1995-5#1)(2008-10#1)
mutant mice##13##2##(1993-12#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#5)(2009-8#1)(2012-2#1)
mutant mouse##5##2##(1991-9#1)(1992-9#2)(1996-12#1)(2008-2#1)
mutant of Arabidopsis##4##3##(1996-10#1)(2008-9#1)(2009-8#1)(2012-2#1)
mutant of Escherichia coli##3##4##(1990-11#1)(1995-8#2)
mutant of F##2##3##(2008-10#2)
mutant of Saccharomyces##2##3##(1993-12#1)(2011-1#1)
mutant of the##6##3##(1995-11#1)(1997-8#1)(2008-10#2)(2009-7#2)
mutant of##52##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-8#2)(1992-3#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#4)(2009-7#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
mutant ofGossypium hirsutum L##2##4##(2008-8#2)
mutant or##3##2##(2008-10#1)(2008-8#1)(2009-4#1)
mutant p53 protein##4##3##(1990-12#1)(1991-2#3)
mutant p53##16##2##(1990-12#1)(1991-2#5)(1991-5#3)(2009-4#4)(2009-5#1)(2011-2#2)
mutant peptide##2##2##(1995-5#1)(1995-6#1)
mutant phenotype##5##2##(1994-8#1)(1996-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
mutant phenotypes##5##2##(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
mutant plants##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
mutant precursor##2##2##(1991-9#1)(2008-4#1)
mutant produced aflatoxin in##2##4##(2008-10#2)
mutant promoter##2##2##(1990-5#1)(1991-9#1)
mutant protein was##4##3##(1993-11#1)(1994-5#1)(1995-5#1)(2013-7#1)
mutant protein with##2##3##(1992-3#1)(1993-8#1)
mutant protein##18##2##(1991-12#1)(1991-5#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#2)(1997-7#1)(2008-9#2)(2009-2#1)(2011-1#2)(2011-2#1)(2013-7#2)
mutant proteins##20##2##(1990-5#1)(1990-8#1)(1991-6#1)(1993-11#3)(1994-6#3)(1994-8#1)(1995-2#2)(1995-5#2)(2008-1#1)(2008-2#3)(2011-1#2)
mutant rats##2##2##(2009-11#2)
mutant receptor##6##2##(1992-12#1)(1993-11#1)(1993-12#1)(1995-6#2)(1996-2#1)
mutant receptors##5##2##(1995-6#5)
mutant reduced##2##2##(2008-10#1)(2009-6#1)
mutant showed a##2##3##(1995-2#1)(2008-10#1)
mutant showed##3##2##(1995-2#1)(2008-10#2)
mutant showing##2##2##(1992-3#1)(2008-7#1)
mutant shows##2##2##(1995-6#1)(1996-10#1)
mutant strain (BDCS-N-M36)##3##3##(2008-12#3)
mutant strain of##5##3##(1994-12#1)(1997-3#1)(2006-10#1)(2008-10#2)
mutant strain##28##2##(1990-11#1)(1994-12#2)(1995-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#7)(2008-12#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2011-2#1)
mutant strains is##2##3##(1990-5#1)(2009-10#1)
mutant strains of C##2##4##(2009-10#1)(2009-2#1)
mutant strains of##4##3##(2008-10#1)(2009-10#1)(2009-2#1)(2012-3#1)
mutant strains##20##2##(1990-5#4)(1997-4#1)(2008-10#5)(2008-7#1)(2009-10#3)(2009-2#2)(2012-3#4)
mutant subunit##3##2##(2008-8#3)
mutant that##6##2##(1993-11#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#2)
mutant the##3##2##(2008-8#3)
mutant to##4##2##(1990-7#1)(1995-5#1)(2008-10#1)(2012-3#1)
mutant virus##3##2##(2008-10#1)(2013-1#2)
mutant viruses##3##2##(2008-10#1)(2013-1#2)
mutant was also##2##3##(1995-2#1)(1995-8#1)
mutant was crossed##2##3##(2008-10#1)(2009-10#1)
mutant was found##2##3##(1995-2#1)(2008-4#1)
mutant was shown to be##2##5##(1990-7#1)(2008-8#1)
mutant was##22##2##(1990-7#1)(1991-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#4)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)
mutant were##5##2##(2008-10#4)(2008-8#1)
mutant which##2##2##(1995-3#1)(2008-7#1)
mutant wing phenotype##2##3##(2008-9#2)
mutant with##4##2##(1992-6#1)(1993-8#1)(2008-7#1)(2008-8#1)
mutant##807##1##(1990-10#5)(1990-11#10)(1990-12#10)(1990-2#1)(1990-5#14)(1990-7#8)(1990-8#7)(1991-12#1)(1991-2#9)(1991-5#8)(1991-6#1)(1991-8#4)(1991-9#12)(1992-12#2)(1992-3#11)(1992-4#2)(1992-6#11)(1992-8#7)(1992-9#3)(1993-11#15)(1993-12#7)(1993-3#7)(1993-6#2)(1993-8#10)(1993-9#4)(1994-11#3)(1994-12#11)(1994-5#10)(1994-6#4)(1994-8#6)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#33)(1995-3#2)(1995-5#14)(1995-6#26)(1995-8#20)(1995-9#2)(1996-10#3)(1996-12#1)(1996-2#9)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#13)(1997-3#16)(1997-4#4)(1997-6#3)(1997-7#13)(1997-8#7)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#134)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#15)(2008-5#4)(2008-6#6)(2008-7#16)(2008-8#60)(2008-9#40)(2009-10#19)(2009-11#4)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#9)(2009-9#1)(2010-10#3)(2010-5#1)(2011-1#9)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#16)(2013-1#11)(2013-7#2)(2013-8#4)
mutant&quot##3##1##(1994-9#2)(2011-2#1)
mutant)##8##1##(1991-8#1)(1992-6#1)(1993-11#1)(1995-6#3)(1996-3#1)(2008-8#1)
mutant-STAT1 transfected HSG cells##2##4##(2011-2#2)
mutant-STAT1##3##1##(2011-2#3)
mutants affected in##2##3##(2008-10#2)
mutants also##4##2##(1997-3#1)(2008-10#2)(2011-1#1)
mutants and the##2##3##(2008-10#1)(2009-10#1)
mutants and wild-type##2##3##(2008-10#1)(2008-5#1)
mutants and##24##2##(1990-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2012-2#1)
mutants appear to##2##3##(1995-5#1)(2008-9#1)
mutants are complemented by##2##4##(1995-6#1)(1997-7#1)
mutants are not##3##3##(1992-6#1)(2008-10#1)(2008-9#1)
mutants are sensitive to##2##4##(1995-2#1)(2011-1#1)
mutants are##18##2##(1990-5#1)(1992-6#1)(1993-11#1)(1995-2#3)(1995-6#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-9#3)(2011-1#1)
mutants at##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
mutants by##4##2##(1990-12#1)(1993-2#1)(2008-10#1)(2008-9#1)
mutants can be##2##3##(2008-10#1)(2008-7#1)
mutants carrying##2##2##(1991-9#1)(1997-4#1)
mutants could not##2##3##(1991-2#1)(2011-2#1)
mutants could##4##2##(1991-2#2)(1992-3#1)(2011-2#1)
mutants defective in##3##3##(1996-3#2)(2008-10#1)
mutants did not##3##3##(2008-10#3)
mutants displayed##3##2##(1995-2#1)(2008-4#1)(2013-1#1)
mutants exhibited##2##2##(1994-12#1)(2008-10#1)
mutants for##7##2##(2008-10#4)(2008-7#1)(2008-9#1)(2011-1#1)
mutants formed##2##2##(1995-6#1)(2008-10#1)
mutants had##2##2##(1993-8#1)(1995-2#1)
mutants has##2##2##(1996-3#1)(2009-10#1)
mutants have been##4##3##(1993-11#1)(1995-6#1)(2008-7#1)(2009-9#1)
mutants have##9##2##(1993-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)
mutants impaired in##2##3##(2008-10#1)(2009-10#1)
mutants in Loop7 region##2##4##(2008-9#2)
mutants in a##2##3##(2008-10#1)(2008-9#1)
mutants in which##2##3##(2009-10#1)(2009-5#1)
mutants in##25##2##(1992-3#1)(1992-9#1)(1993-8#1)(1995-6#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#8)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
mutants induced##3##2##(2008-10#2)(2008-8#1)
mutants is##7##2##(1990-7#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-9#2)(2013-1#1)
mutants lacking##2##2##(1992-3#1)(2008-10#1)
mutants may be##2##3##(1990-11#1)(2008-9#1)
mutants of Escherichia coli##2##4##(1990-11#2)
mutants of Saccharomyces cerevisiae##2##4##(1990-5#1)(1995-6#1)
mutants of Vibrio cholerae##2##4##(1990-5#1)(1993-9#1)
mutants of X##3##3##(2008-10#3)
mutants of recombinant##2##3##(1994-11#1)(1995-2#1)
mutants of the##9##3##(1990-11#2)(1991-2#1)(1992-6#1)(1993-11#1)(1997-4#1)(1997-7#1)(2008-10#1)(2011-1#1)
mutants of##57##2##(1990-11#4)(1990-5#4)(1991-2#1)(1992-6#1)(1993-11#1)(1993-9#2)(1994-11#2)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#2)(1997-2#1)(1997-4#1)(1997-7#2)(1997-9#1)(2008-10#18)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-7#2)
mutants on##2##2##(1992-8#1)(2008-8#1)
mutants retained##2##2##(1991-8#1)(2008-9#1)
mutants reveal that the##2##4##(1993-3#1)(2007-12#1)
mutants reveal##4##2##(1993-11#1)(1993-3#1)(2007-12#1)(2011-1#1)
mutants revealed##2##2##(1995-8#1)(2008-9#1)
mutants show##3##2##(1990-11#1)(1996-2#1)(2011-2#1)
mutants showed that##2##3##(1995-6#1)(1995-9#1)
mutants showed##4##2##(1995-6#1)(1995-9#1)(2008-10#1)(2008-4#1)
mutants shows that##2##3##(1994-8#1)(2008-10#1)
mutants suggests that the##2##4##(1995-6#1)(1995-8#1)
mutants suggests##3##2##(1995-6#1)(1995-8#1)(1996-3#1)
mutants tested##2##2##(1994-12#1)(2008-10#1)
mutants than in##2##3##(2008-7#1)(2009-6#1)
mutants than##7##2##(2008-10#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#2)
mutants that lack##2##3##(1992-3#1)(2008-7#1)
mutants that##9##2##(1992-3#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-7#2)(2012-3#1)
mutants to##6##2##(1990-5#1)(1993-2#1)(1995-2#2)(2008-10#2)
mutants was constructed##3##3##(1994-5#1)(1995-2#1)(1995-6#1)
mutants was##9##2##(1994-5#1)(1995-2#3)(1995-6#1)(2008-10#4)
mutants were active##2##3##(1992-3#1)(1997-6#1)
mutants were assayed##2##3##(1993-11#1)(1994-11#1)
mutants were characterized##2##3##(1995-6#1)(2008-10#1)
mutants were constructed##2##3##(1995-2#1)(2008-10#1)
mutants were examined##2##3##(1992-12#1)(2008-10#1)
mutants were identified##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
mutants were isolated##2##3##(1991-10#1)(2008-10#1)
mutants were obtained##2##3##(1995-2#1)(2008-12#1)
mutants were used to assess vegetative compatibility##2##7##(2008-10#2)
mutants were##44##2##(1991-10#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#2)(1994-11#1)(1995-2#5)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#11)(2008-12#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#2)
mutants which##4##2##(1995-6#1)(1995-8#1)(1996-2#1)(2008-9#1)
mutants with a##2##3##(1990-5#1)(1995-2#1)
mutants with altered##2##3##(1995-8#1)(2008-4#1)
mutants with##14##2##(1990-5#1)(1990-7#1)(1993-8#1)(1995-2#3)(1995-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#2)
mutants without##2##2##(2008-10#1)(2008-9#1)
mutants##541##1##(1990-11#8)(1990-12#3)(1990-5#11)(1990-7#6)(1990-8#2)(1991-10#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-12#4)(1992-3#6)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#12)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#6)(1993-9#4)(1994-11#4)(1994-12#7)(1994-5#3)(1994-8#4)(1995-12#2)(1995-2#30)(1995-3#4)(1995-5#6)(1995-6#19)(1995-8#18)(1995-9#8)(1996-11#1)(1996-2#3)(1996-3#5)(1997-2#3)(1997-3#10)(1997-4#8)(1997-6#1)(1997-7#7)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#130)(2008-12#8)(2008-3#3)(2008-4#9)(2008-5#3)(2008-7#21)(2008-8#15)(2008-9#45)(2009-10#9)(2009-12#3)(2009-5#3)(2009-6#8)(2009-8#5)(2009-9#5)(2010-11#1)(2011-1#8)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#10)(2013-1#4)(2013-7#2)
mutants'##2##1##(2007-11#2)
mutants)##3##1##(1994-11#1)(1995-9#1)(2008-8#1)
mutarotase##2##1##(2008-10#2)
mutase##8##1##(1990-5#1)(1993-3#1)(2008-10#2)(2010-12#2)(2011-1#1)(2012-2#1)
mutated and##5##2##(1992-6#1)(2008-10#1)(2009-4#1)(2011-1#1)(2013-8#1)
mutated channels##2##2##(2008-8#2)
mutated form of##2##3##(1996-5#1)(2008-10#1)
mutated gene in##2##3##(1994-9#1)(2012-12#1)
mutated gene##6##2##(1994-9#1)(1997-3#1)(2008-2#1)(2009-10#1)(2012-12#1)(2013-1#1)
mutated in the##3##3##(1992-9#1)(1994-11#1)(1995-2#1)
mutated in##8##2##(1990-8#1)(1992-9#1)(1994-11#2)(1995-2#1)(2008-10#1)(2008-9#1)(2009-6#1)
mutated or##2##2##(1997-7#2)
mutated to##5##2##(1992-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-4#1)
mutated##82##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#5)(1995-5#1)(1995-6#3)(1996-5#1)(1997-3#2)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
mutating##5##1##(1993-8#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-5#1)
mutation (position##2##2##(2008-10#2)
mutation Pro115Gln##3##2##(2006-8#3)
mutation accumulation##2##2##(2008-8#1)(2008-9#1)
mutation affects##2##2##(1992-3#1)(2009-6#1)
mutation analysis is##2##3##(1997-3#1)(2008-4#1)
mutation analysis of##2##3##(2008-10#1)(2008-9#1)
mutation analysis##12##2##(1997-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#5)(2008-9#1)(2013-8#1)
mutation and the##4##3##(1992-6#1)(2007-12#1)(2008-4#1)(2009-8#1)
mutation and##17##2##(1991-9#2)(1992-6#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-6#1)(1997-8#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-3#1)
mutation appears to##2##3##(1992-9#1)(1997-2#1)
mutation as##2##2##(1994-8#1)(2008-8#1)
mutation assay##2##2##(2008-7#2)
mutation associated with##3##3##(1992-8#1)(1992-9#1)(1994-8#1)
mutation at codon##2##3##(1991-11#1)(1997-2#1)
mutation at nucleotide position##3##4##(1992-9#2)(1994-11#1)
mutation at nucleotide##4##3##(1992-9#2)(1994-11#1)(2007-6#1)
mutation at position 15##2##4##(1991-12#2)
mutation at position a##2##4##(1992-6#2)
mutation at position##8##3##(1991-12#3)(1992-6#3)(1992-8#1)(2008-10#1)
mutation at the##7##3##(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-2#1)(2008-4#1)
mutation at this site##2##4##(1993-3#1)(2008-4#1)
mutation at##31##2##(1990-5#1)(1991-11#2)(1991-12#3)(1992-2#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2011-3#1)
mutation background##2##2##(1997-4#2)
mutation because##2##2##(1995-6#1)(1996-12#1)
mutation by##2##2##(1992-2#1)(1997-3#1)
mutation carriers##4##2##(2008-8#1)(2011-2#3)
mutation caused a##2##3##(1991-7#1)(1995-9#1)
mutation caused##3##2##(1991-7#1)(1995-2#1)(1995-9#1)
mutation causes##2##2##(1990-5#1)(1996-2#1)
mutation could##3##2##(1993-11#1)(1993-6#1)(2008-12#1)
mutation creates a##2##3##(1990-8#1)(1992-8#1)
mutation data##4##2##(2008-4#2)(2008-7#2)
mutation databases##4##2##(2008-4#4)
mutation detection in##2##3##(2006-8#1)(2008-4#1)
mutation detection##6##2##(2006-8#2)(2008-4#4)
mutation disrupts##2##2##(2008-8#1)(2010-4#1)
mutation for##2##2##(2008-10#1)(2010-4#1)
mutation found##2##2##(2008-1#1)(2013-1#1)
mutation frequency##8##2##(1997-3#6)(2008-9#1)(2012-3#1)
mutation has been##3##3##(1996-5#1)(2012-12#1)(2012-3#1)
mutation identified in##3##3##(1993-3#1)(2010-7#1)(2012-12#1)
mutation identified##4##2##(1993-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
mutation in a##6##3##(1991-12#1)(1993-3#1)(1995-8#1)(2007-8#1)(2008-9#1)(2013-1#1)
mutation in exon##6##3##(1991-12#1)(2008-1#1)(2008-12#1)(2008-2#3)
mutation in patients with##2##4##(1990-8#1)(2008-1#1)
mutation in the gene##4##4##(1991-12#1)(2008-4#1)(2009-10#1)(2011-1#1)
mutation in the mitochondrial##2##4##(1990-12#2)
mutation in the zinc##2##4##(1990-11#1)(2008-10#1)
mutation in the##50##3##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
mutation in this##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
mutation in##106##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#4)(2008-2#7)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#2)
mutation into##2##2##(1993-8#1)(1995-2#1)
mutation is##12##2##(1990-5#1)(1991-12#1)(1991-6#1)(1994-12#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-12#1)(2009-8#1)(2012-12#1)(2012-2#2)
mutation leading to##2##3##(1997-3#1)(2011-1#1)
mutation leads##2##2##(1990-8#1)(1995-8#1)
mutation locus##3##2##(2008-8#3)
mutation may##3##2##(1993-8#1)(1996-5#1)(2011-2#1)
mutation occurred in##2##3##(1991-12#1)(1992-8#1)
mutation occurred##3##2##(1991-12#1)(1992-8#1)(2008-9#1)
mutation of T to C at position##2##7##(2008-12#2)
mutation of the five##2##4##(2008-8#2)
mutation of the p53##3##4##(1991-11#1)(2008-6#1)(2010-3#1)
mutation of the##30##3##(1991-11#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-2#2)(1995-8#2)(1997-2#1)(1997-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2010-3#2)(2012-2#2)(2013-1#1)
mutation of these##2##3##(1993-3#1)(2008-4#1)
mutation of##59##2##(1991-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#2)(1994-12#2)(1995-2#2)(1995-3#1)(1995-8#2)(1997-2#1)(1997-3#2)(1997-7#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#3)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
mutation on the##3##3##(1993-8#1)(1996-12#1)(2010-4#1)
mutation on##7##2##(1993-8#1)(1996-12#1)(1997-3#1)(2007-7#1)(2009-10#1)(2009-4#1)(2010-4#1)
mutation or##2##2##(2008-10#2)
mutation osteopetrosis##2##2##(1990-5#2)
mutation parameters##2##2##(2008-12#2)
mutation per##2##2##(2007-11#1)(2008-7#1)
mutation rate is##2##3##(1990-8#1)(2012-3#1)
mutation rate##4##2##(1990-8#1)(2008-8#1)(2010-3#1)(2012-3#1)
mutation rates and##2##3##(2008-10#1)(2008-8#1)
mutation rates from paternity casework##2##5##(2008-12#2)
mutation rates of##3##3##(1990-8#1)(2008-8#2)
mutation rates##12##2##(1990-8#1)(2008-10#2)(2008-12#4)(2008-8#3)(2012-3#2)
mutation resulted in##3##3##(1995-2#1)(1997-4#1)(2008-8#1)
mutation resulting in##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
mutation scanning##2##2##(2008-4#1)(2008-7#1)
mutation screening##2##2##(2008-4#1)(2010-5#1)
mutation sites of##2##3##(2008-8#1)(2012-3#1)
mutation sites##3##2##(1997-7#1)(2008-8#1)(2012-3#1)
mutation spectra##2##2##(2008-4#2)
mutation spectrum##3##2##(1995-9#1)(2008-4#1)(2011-1#1)
mutation status##3##2##(2008-10#1)(2009-4#2)
mutation studies##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
mutation that causes##4##3##(1991-7#1)(2008-10#2)(2012-3#1)
mutation that results in##2##4##(1994-12#1)(1997-7#1)
mutation that##14##2##(1991-12#1)(1991-7#1)(1993-9#1)(1994-12#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-12#1)(2009-8#1)(2010-4#1)(2012-3#1)
mutation to##2##2##(1990-5#1)(1992-12#1)
mutation was detected##3##3##(1992-8#1)(1996-5#1)(2013-1#1)
mutation was found in##3##4##(2008-10#1)(2009-8#1)(2011-1#1)
mutation was present in##2##4##(1990-8#1)(2008-10#1)
mutation was##12##2##(1990-8#1)(1991-8#1)(1992-8#1)(1995-12#1)(1996-5#2)(2008-10#2)(2009-8#2)(2011-1#1)(2013-1#1)
mutation were##2##2##(1994-8#1)(1995-2#1)
mutation which##2##2##(1992-8#1)(1997-3#1)
mutation with##3##2##(1990-5#1)(1997-3#1)(2012-3#1)
mutation within##2##2##(1990-5#1)(1996-2#1)
mutation would##2##2##(2008-1#1)(2008-5#1)
mutation##619##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#13)(1990-7#2)(1990-8#8)(1991-11#8)(1991-12#9)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#6)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#6)(1992-8#10)(1992-9#8)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#7)(1993-6#5)(1993-8#4)(1993-9#4)(1994-11#7)(1994-12#7)(1994-3#1)(1994-5#1)(1994-8#8)(1994-9#3)(1995-10#1)(1995-12#3)(1995-2#14)(1995-3#3)(1995-5#3)(1995-6#9)(1995-8#7)(1995-9#4)(1996-12#4)(1996-2#7)(1996-3#1)(1996-5#8)(1997-1#1)(1997-2#6)(1997-3#26)(1997-4#6)(1997-7#11)(1997-8#6)(2006-8#7)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#14)(2008-10#46)(2008-11#4)(2008-12#22)(2008-2#12)(2008-3#1)(2008-4#34)(2008-5#2)(2008-6#2)(2008-7#16)(2008-8#35)(2008-9#19)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#4)(2009-6#3)(2009-8#6)(2009-9#1)(2010-11#1)(2010-3#6)(2010-4#9)(2010-5#2)(2010-7#1)(2011-1#9)(2011-2#14)(2011-3#4)(2012-1#3)(2012-12#13)(2012-2#8)(2012-3#17)(2013-1#20)(2013-8#5)
mutation)##8##1##(1994-12#1)(1995-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-1#1)
mutational alterations##2##2##(1992-3#1)(2008-5#1)
mutational analysis of##2##3##(2008-4#1)(2009-6#1)
mutational analysis##3##2##(2008-4#1)(2009-6#1)(2010-10#1)
mutational effect of##3##3##(2008-7#3)
mutational effects##2##2##(1992-6#1)(2012-12#1)
mutational events##2##2##(2008-12#1)(2010-8#1)
mutational inactivation##2##2##(1991-6#1)(1994-8#1)
mutational##29##1##(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-6#1)(1995-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2012-12#2)(2013-1#2)(2013-8#1)
mutationally altered enzymes##3##3##(1990-8#3)
mutationally altered##4##2##(1990-8#4)
mutations affecting##4##2##(1990-5#1)(2008-4#1)(2008-5#1)(2012-2#1)
mutations also##2##2##(2008-1#1)(2011-1#1)
mutations among##2##2##(1991-5#1)(2013-1#1)
mutations and polymorphisms##2##3##(2008-2#1)(2010-8#1)
mutations and the##5##3##(1993-2#1)(1996-2#1)(2008-12#1)(2008-6#1)(2011-1#1)
mutations and##33##2##(1991-12#1)(1991-9#1)(1993-2#1)(1994-12#1)(1996-2#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#2)
mutations are associated with##2##4##(2008-8#1)(2013-1#1)
mutations are found##2##3##(2009-10#1)(2012-2#1)
mutations are of##2##3##(2008-4#1)(2013-1#1)
mutations are selfish##2##3##(2008-8#2)
mutations are##27##2##(1992-6#1)(1993-11#1)(1994-11#1)(1997-2#1)(2007-7#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)
mutations as##4##2##(1990-5#2)(2010-4#1)(2013-1#1)
mutations associated with##2##3##(2012-3#1)(2013-1#1)
mutations at the##8##3##(1990-5#1)(1990-7#1)(1992-9#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-8#2)
mutations at##17##2##(1990-5#1)(1990-7#1)(1992-9#1)(1993-3#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2011-1#2)
mutations can be##2##3##(2007-7#1)(2010-8#1)
mutations can##6##2##(1990-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-8#1)
mutations cause a##2##3##(2009-8#1)(2013-1#1)
mutations cause##6##2##(1990-8#1)(1992-8#1)(1993-6#1)(2008-1#1)(2009-8#1)(2013-1#1)
mutations found in##4##3##(1991-5#1)(1995-12#1)(1997-6#1)(2009-9#1)
mutations from##2##2##(1991-7#1)(2013-8#1)
mutations has##2##2##(1995-12#1)(2008-4#1)
mutations have been described##2##4##(1995-12#1)(2008-4#1)
mutations have been##8##3##(1990-12#1)(1993-11#1)(1995-12#1)(1995-8#1)(2008-4#2)(2008-5#1)(2008-7#1)
mutations have not##2##3##(1995-5#1)(2008-5#1)
mutations have##12##2##(1990-12#1)(1993-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)
mutations in a##5##3##(1990-12#1)(1995-8#1)(1996-2#1)(2011-1#1)(2013-8#1)
mutations in alpha-tropomyosin##2##3##(1997-7#2)
mutations in both##2##3##(1990-8#1)(2011-1#1)
mutations in codon##2##3##(1991-9#2)
mutations in either the##2##4##(2007-7#1)(2008-9#1)
mutations in four##3##3##(1990-5#1)(2013-1#2)
mutations in genes##2##3##(2008-10#1)(2011-2#1)
mutations in the EGFR##2##4##(2010-5#1)(2012-1#1)
mutations in the gene encoding the##3##6##(1997-3#2)(2013-1#1)
mutations in the gene encoding##4##5##(1997-3#3)(2013-1#1)
mutations in the gene for##3##5##(1990-5#1)(2008-7#2)
mutations in the gene##12##4##(1990-5#1)(1994-2#1)(1996-2#1)(1997-3#3)(2008-4#2)(2008-7#2)(2011-1#1)(2013-1#1)
mutations in the genes encoding##2##5##(2008-3#1)(2008-4#1)
mutations in the vasopressin V2 receptor gene##2##7##(1994-11#2)
mutations in the##92##3##(1990-5#2)(1990-8#4)(1991-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#1)(2006-10#1)(2007-7#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
mutations in these genes##2##4##(2008-4#1)(2009-8#1)
mutations in these##3##3##(2008-4#2)(2009-8#1)
mutations in this gene##3##4##(1994-11#1)(1996-2#1)(1997-7#1)
mutations in this##6##3##(1994-11#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#2)
mutations in two##2##3##(1990-11#1)(2008-7#1)
mutations in##195##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#5)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#3)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#2)(1995-8#4)(1996-2#4)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2006-10#1)(2007-12#2)(2007-7#4)(2008-1#4)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-4#6)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#12)(2013-8#6)
mutations induce##2##2##(1994-9#1)(2008-8#1)
mutations into##3##2##(1993-11#1)(2008-4#2)
mutations is##5##2##(1994-12#1)(1996-2#1)(2008-7#1)(2008-8#1)(2009-5#1)
mutations may##7##2##(1992-3#1)(1992-9#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
mutations occur##3##2##(1990-8#1)(1991-12#1)(2008-8#1)
mutations of a##2##3##(1993-3#1)(1995-2#1)
mutations of the##12##3##(1991-9#2)(1993-3#1)(1994-11#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-1#1)
mutations of##34##2##(1990-7#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
mutations on the##8##3##(1992-9#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#2)(2013-1#1)
mutations on##13##2##(1991-10#1)(1992-9#1)(1994-11#1)(1995-6#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2012-2#2)(2013-1#1)
mutations or##9##2##(1992-12#1)(1994-5#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)
mutations rather than##2##3##(2008-1#1)(2008-10#1)
mutations responsible for##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
mutations resulted in##4##3##(2008-12#1)(2011-1#2)(2012-3#1)
mutations resulting in##2##3##(1992-3#1)(2012-2#1)
mutations show##2##2##(1994-12#1)(2009-5#1)
mutations that can##2##3##(2008-1#1)(2008-4#1)
mutations that increase##2##3##(1990-5#2)
mutations that##25##2##(1990-5#2)(1991-4#1)(1992-9#1)(1993-11#1)(1993-8#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-1#3)
mutations to the##3##3##(2007-12#1)(2008-11#2)
mutations to##11##2##(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2010-4#2)(2012-3#1)
mutations was observed##2##3##(2008-9#2)
mutations was##6##2##(1990-8#1)(1993-9#1)(1997-8#1)(2008-10#1)(2008-9#2)
mutations were found at##2##4##(1992-3#1)(2008-12#1)
mutations were found##4##3##(1992-3#1)(1994-8#1)(1997-4#1)(2008-12#1)
mutations were identified##2##3##(1993-11#1)(2007-7#1)
mutations were##28##2##(1991-12#1)(1991-5#1)(1992-3#2)(1993-11#3)(1993-3#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
mutations which##2##2##(1995-12#1)(2008-9#1)
mutations with##4##2##(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
mutations within the##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
mutations within this##2##3##(1994-8#1)(2008-8#1)
mutations within##7##2##(1992-9#1)(1994-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#1)
mutations without##2##2##(1990-11#1)(2008-1#1)
mutations##721##1##(1990-11#5)(1990-12#4)(1990-5#13)(1990-7#2)(1990-8#12)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#2)(1991-4#1)(1991-5#10)(1991-7#1)(1991-8#3)(1991-9#7)(1992-12#2)(1992-2#1)(1992-3#8)(1992-6#2)(1992-8#2)(1992-9#5)(1993-11#14)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#1)(1993-8#6)(1993-9#3)(1994-11#7)(1994-12#6)(1994-2#1)(1994-5#1)(1994-8#4)(1994-9#3)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#12)(1995-8#5)(1995-9#1)(1996-2#10)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#16)(1997-4#10)(1997-5#1)(1997-6#4)(1997-7#12)(1997-8#3)(1997-9#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#10)(2008-1#18)(2008-10#36)(2008-11#10)(2008-12#12)(2008-2#7)(2008-3#3)(2008-4#42)(2008-5#8)(2008-6#9)(2008-7#33)(2008-8#29)(2008-9#26)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#6)(2009-7#2)(2009-8#9)(2009-9#5)(2010-11#1)(2010-3#2)(2010-4#15)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#25)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#11)(2012-2#24)(2012-3#19)(2013-1#46)(2013-8#9)
mutator effects##2##2##(1997-4#2)
mutator##4##1##(1997-4#2)(2011-2#1)(2012-3#1)
mute##2##1##(2011-2#1)(2012-2#1)
mutica##3##1##(2008-5#3)
mutilating##3##1##(1991-11#1)(2012-2#2)
mutilation##6##1##(2007-8#1)(2008-6#1)(2009-10#1)(2012-2#3)
mutism##7##1##(2007-8#4)(2009-11#3)
mutual aid and social support##2##5##(1996-3#2)
mutual aid and##3##3##(1995-3#1)(1996-3#2)
mutual aid##6##2##(1994-2#1)(1995-3#1)(1996-3#4)
mutual assessment##2##2##(2009-9#2)
mutual benefit to##2##3##(1995-6#1)(2008-11#1)
mutual concern##2##2##(1990-12#1)(1992-2#1)
mutual influence of##2##3##(2008-10#1)(2008-11#1)
mutual information##5##2##(1996-6#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-8#1)
mutual intensity function##3##3##(2007-12#3)
mutual intensity##6##2##(2007-12#5)(2008-2#1)
mutual interaction of##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
mutual interaction##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)
mutual interactions##4##2##(1990-11#1)(1992-8#1)(2007-12#1)(2008-9#1)
mutual proportions##2##2##(2008-10#2)
mutual separation of##2##3##(2008-10#2)
mutual separation##3##2##(2008-10#3)
mutual support##3##2##(1992-3#1)(1994-12#1)(2011-2#1)
mutual##87##1##(1990-11#1)(1990-12#1)(1990-8#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#3)(1996-3#5)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-6#2)(2009-9#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
mutual-aid##3##1##(1996-3#3)
mutualism##11##1##(2008-8#9)(2008-9#2)
mutualistic##6##1##(2008-10#1)(2008-8#4)(2008-9#1)
mutually acceptable##2##2##(1994-1#1)(2011-2#1)
mutually beneficial##5##2##(1994-1#1)(1996-1#1)(2008-8#3)
mutually coherent##2##2##(2007-11#1)(2008-3#1)
mutually exclusive and##2##3##(1992-3#1)(2011-2#1)
mutually exclusive home ranges##3##4##(2008-8#1)(2008-9#2)
mutually exclusive##19##2##(1992-3#1)(1995-3#1)(1995-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2010-10#1)(2010-9#1)(2011-2#2)(2013-1#1)
mutually orthogonal##2##2##(2007-12#2)
mutually perpendicular##2##2##(2007-11#1)(2007-12#1)
mutually##54##1##(1990-6#1)(1992-3#1)(1994-1#2)(1994-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
muzzle into the##2##3##(1997-6#2)
muzzle withdrawal##2##2##(1997-6#2)
muzzle##6##1##(1997-6#6)
my knowledge##5##2##(2008-12#1)(2008-2#2)(2008-3#1)(2013-1#1)
my last##2##2##(2008-6#1)(2010-9#1)
my mind##2##2##(2008-10#1)(2011-2#1)
my own##4##2##(2008-9#1)(2009-10#1)(2012-12#2)
my perspective##12##2##(1994-8#1)(2008-4#7)(2008-6#4)
my risk##2##2##(2010-9#1)(2013-7#1)
my view##2##2##(2007-11#1)(2009-4#1)
my##92##1##(1991-8#1)(1992-12#1)(1992-3#2)(1994-2#2)(1994-8#1)(1997-2#2)(2007-11#1)(2007-2#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#9)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-8#1)(2010-1#6)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-9#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#7)(2013-8#1)
my-clobutanil##2##1##(2008-10#2)
mya##3##1##(2009-10#2)(2009-8#1)
myalgia and##2##2##(1991-2#1)(2007-7#1)
myalgia##7##1##(1990-3#1)(1991-2#1)(2007-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
myalgias which##2##2##(2008-7#2)
myalgias##4##1##(1994-9#1)(2008-7#2)(2013-1#1)
myastenia gravis##2##2##(1997-5#2)
myasthenia gravis and##3##3##(1997-8#1)(2008-5#1)(2010-11#1)
myasthenia gravis##21##2##(1991-2#1)(1996-12#1)(1997-8#1)(2007-8#7)(2008-5#2)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#5)
myasthenia##22##1##(1991-2#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-8#7)(2008-5#2)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#5)
myasthenic syndromes##2##2##(2008-5#1)(2013-1#1)
myasthenic##8##1##(1993-9#1)(2007-8#1)(2008-5#1)(2012-12#1)(2013-1#4)
myb##2##1##(1990-6#1)(2008-8#1)
myc##4##1##(1991-5#2)(1995-9#1)(2008-11#1)
mycarofaciens 1748##7##2##(2008-8#7)
mycelia and##2##2##(2008-10#1)(2008-7#1)
mycelia in##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
mycelia of##4##2##(2008-10#3)(2012-3#1)
mycelia were##2##2##(2008-10#2)
mycelia##28##1##(1992-8#2)(2008-10#18)(2008-6#3)(2008-7#2)(2008-9#1)(2011-10#1)(2012-3#1)
mycelial colonies##2##2##(2008-10#2)
mycelial colonization of##4##3##(2008-10#4)
mycelial colonization##6##2##(2008-10#6)
mycelial compatibility groups (MCGs)##3##4##(2008-10#3)
mycelial compatibility groups##4##3##(2008-10#4)
mycelial compatibility##7##2##(2008-10#7)
mycelial density##2##2##(2008-10#1)(2008-12#1)
mycelial growth and##4##3##(2008-10#3)(2008-7#1)
mycelial growth of R##3##4##(2008-10#3)
mycelial growth of##5##3##(2008-10#5)
mycelial growth rate##2##3##(2008-10#2)
mycelial growth##25##2##(2008-10#23)(2008-6#1)(2008-7#1)
mycelial mass##4##2##(2008-10#3)(2008-7#1)
mycelial phase##2##2##(2008-5#2)
mycelial##62##1##(2008-10#53)(2008-12#1)(2008-5#3)(2008-6#3)(2008-7#2)
mycelium and##5##2##(2008-10#5)
mycelium at##2##2##(2008-10#2)
mycelium in##6##2##(1994-3#1)(2008-10#4)(2008-8#1)
mycelium morphological##2##2##(1994-8#2)
mycelium of P##4##3##(2008-10#4)
mycelium of the##3##3##(2008-10#3)
mycelium of##15##2##(1997-1#1)(2008-10#13)(2011-2#1)
mycelium was##5##2##(2008-10#5)
mycelium were##2##2##(2008-10#2)
mycelium##67##1##(1994-3#1)(1994-8#2)(1997-1#1)(2008-10#54)(2008-11#3)(2008-7#1)(2008-8#3)(2011-2#2)
mycetisms and##2##2##(2008-5#2)
mycetisms##3##1##(2008-5#3)
mycetoma##2##1##(2008-5#2)
myclobutanil##3##1##(2008-10#2)(2011-2#1)
mycobacteria (NTM)##3##2##(2007-7#1)(2011-2#2)
mycobacteria and##2##2##(1991-5#1)(2008-8#1)
mycobacteria are##2##2##(1997-4#1)(2007-12#1)
mycobacteria##28##1##(1991-5#1)(1993-11#1)(1995-5#2)(1997-4#5)(2007-12#3)(2007-7#2)(2008-11#1)(2008-7#1)(2008-8#3)(2010-4#1)(2011-2#6)(2013-1#2)
mycobacterial gene expression##2##3##(2008-7#2)
mycobacterial infection##2##2##(2007-12#1)(2008-1#1)
mycobacterial infections##4##2##(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
mycobacterial proteins##4##2##(2011-2#4)
mycobacterial##32##1##(1991-5#1)(1995-5#2)(1997-4#3)(2007-12#6)(2008-1#1)(2008-12#1)(2008-7#3)(2008-9#2)(2011-2#8)(2012-2#3)(2012-3#1)(2013-1#1)
mycobacteriophage##2##1##(1995-5#1)(2007-7#1)
mycobacteriosis##5##1##(1992-2#1)(1996-11#2)(2008-11#2)
mycobacterium tuberculosis##2##2##(2007-8#1)(2008-7#1)
mycobacterium##5##1##(2007-8#1)(2008-10#1)(2008-7#2)(2010-8#1)
mycoflora##3##1##(2008-10#1)(2008-12#1)(2008-5#1)
mycoherbicide##6##1##(2008-10#6)
mycoides and##2##2##(2008-10#1)(2012-2#1)
mycoides##9##1##(1997-3#2)(2008-10#6)(2012-2#1)
mycolic acids and##2##3##(2008-9#1)(2013-1#1)
mycolic acids##5##2##(2008-9#4)(2013-1#1)
mycolic##6##1##(2008-9#5)(2013-1#1)
mycological##11##1##(2008-10#2)(2008-5#8)(2009-2#1)
mycologists##2##1##(2008-10#1)(2010-2#1)
mycology##4##1##(2008-5#4)
mycoparasite##14##1##(2008-10#14)
mycoparasitism and##2##2##(2008-10#2)
mycoparasitism##11##1##(2008-10#10)(2013-8#1)
mycophagous Drosophila and##2##3##(2008-8#2)
mycophagous Drosophila##3##2##(2008-8#2)(2008-9#1)
mycophagous##4##1##(2008-8#2)(2008-9#1)(2012-3#1)
mycophenolate mofetil and sirolimus##2##4##(2007-11#2)
mycophenolate mofetil##7##2##(2007-11#3)(2008-1#1)(2010-12#1)(2012-3#2)
mycophenolate##8##1##(2007-11#3)(2008-1#1)(2010-12#1)(2012-3#3)
mycophenolic acid##4##2##(1990-10#1)(2010-3#2)(2012-12#1)
mycoplasma and##2##2##(1994-11#1)(2008-11#1)
mycoplasma##14##1##(1993-12#1)(1994-11#2)(1997-3#5)(2008-11#6)
mycoplasmas##10##1##(1993-12#2)(2008-10#1)(2008-11#5)(2010-9#1)(2011-2#1)
mycorrhizae##4##1##(2008-10#2)(2008-12#1)(2010-10#1)
mycorrhizal (AM)##2##2##(2008-11#1)(2008-12#1)
mycorrhizal colonization##3##2##(2008-10#3)
mycorrhizal fungi##7##2##(2008-11#1)(2008-12#2)(2008-8#2)(2013-1#1)(2013-8#1)
mycorrhizal fungus Laccaria bicolor##2##4##(2011-1#2)
mycorrhizal fungus##5##2##(2008-10#1)(2008-12#2)(2011-1#2)
mycorrhizal##25##1##(2008-10#9)(2008-11#2)(2008-12#6)(2008-8#2)(2010-10#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
mycorrhizosphere soil##2##2##(2008-10#2)
mycorrhizosphere##5##1##(2008-10#5)
mycoses in##3##2##(2009-7#1)(2011-2#2)
mycoses##13##1##(2008-5#8)(2009-7#1)(2011-2#4)
mycosis fungoides##5##2##(1992-5#2)(2010-6#3)
mycosis in##3##2##(2007-10#1)(2011-2#1)(2012-3#1)
mycosis##12##1##(1992-5#2)(2007-10#1)(2008-5#4)(2010-6#3)(2011-2#1)(2012-3#1)
mycotic aneurysm##2##2##(2009-4#1)(2012-1#1)
mycotic aneurysms##2##2##(1997-8#1)(2009-4#1)
mycotic##8##1##(1997-3#1)(1997-8#1)(2008-5#2)(2009-4#2)(2012-1#1)(2012-3#1)
mycotoxin contamination##4##2##(2008-10#3)(2011-10#1)
mycotoxin produced##2##2##(1993-12#1)(2008-10#1)
mycotoxin production##4##2##(2008-10#1)(2010-3#1)(2010-7#1)(2011-10#1)
mycotoxin##25##1##(1993-12#1)(1993-3#1)(2008-10#17)(2010-3#1)(2010-7#2)(2011-10#2)(2011-2#1)
mycotoxins in##3##2##(2008-10#1)(2010-3#1)(2010-7#1)
mycotoxins produced by##2##3##(1995-3#1)(2008-10#1)
mycotoxins##28##1##(1993-12#1)(1993-3#3)(1995-3#1)(2008-10#12)(2008-11#2)(2008-8#1)(2010-3#2)(2010-4#1)(2010-7#5)
mydriatic response to##2##3##(2008-7#2)
mydriatic##3##1##(2008-7#2)(2011-2#1)
myectomy##3##1##(1992-9#2)(2011-1#1)
myelin basic protein (MBP)##2##4##(1995-12#1)(2008-8#1)
myelin basic protein##8##3##(1990-10#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-7#1)(2008-8#1)
myelin formation##2##2##(2008-7#2)
myelin is##2##2##(1995-12#1)(2008-7#1)
myelin oligodendrocyte glycoprotein (MOG)##2##4##(1995-12#1)(1996-12#1)
myelin oligodendrocyte glycoprotein##3##3##(1995-12#1)(1996-12#2)
myelin protein##2##2##(2008-7#1)(2009-6#1)
myelin proteins##5##2##(1992-12#4)(2008-7#1)
myelin##53##1##(1990-10#1)(1992-12#4)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#4)(1995-5#1)(1996-12#4)(1996-5#1)(1996-6#1)(2007-11#1)(2008-7#21)(2008-8#1)(2009-6#8)(2010-12#1)(2012-2#2)
myelinated axons##2##2##(2008-7#2)
myelinated primary afferents##2##3##(1997-3#2)
myelinated primary##3##2##(1997-3#3)
myelinated sensory fibers##2##3##(2006-12#2)
myelinated##12##1##(1993-12#1)(1997-3#5)(2006-12#2)(2008-7#4)
myelinating cells##4##2##(2008-7#4)
myelinating##6##1##(2008-7#6)
myelination and##2##2##(2008-7#1)(2009-6#1)
myelination of##5##2##(1996-5#3)(2008-5#2)
myelination##28##1##(1996-12#1)(1996-5#7)(2008-5#7)(2008-7#11)(2009-6#2)
myelitis##13##1##(1996-11#1)(1996-8#2)(2007-7#2)(2012-3#8)
myelo-meningo-radiculitis##2##1##(1992-11#2)
myeloblast counts##3##2##(2008-11#3)
myeloblast##4##1##(2008-11#4)
myeloblastic leukaemia##2##2##(2011-3#1)(2013-7#1)
myeloblastic##6##1##(1993-3#1)(1997-5#1)(2007-10#1)(2011-3#1)(2012-12#1)(2013-7#1)
myeloblasts##3##1##(2008-11#2)(2010-4#1)
myelocytes##2##1##(2008-11#1)(2010-8#1)
myelocytic leukemia##10##2##(1991-2#2)(1992-10#2)(2007-11#1)(2008-7#2)(2011-2#3)
myelocytic##11##1##(1991-2#2)(1992-10#2)(2007-11#1)(2008-7#2)(2011-2#4)
myelodysplastic syndrome##7##2##(1992-10#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#2)
myelodysplastic syndromes (MDS)##3##3##(2008-11#1)(2009-8#1)(2010-1#1)
myelodysplastic syndromes and acute##2##4##(2007-5#1)(2010-1#1)
myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria##2##6##(1992-12#2)
myelodysplastic syndromes and##5##3##(1992-12#2)(2007-5#1)(2010-1#1)(2010-11#1)
myelodysplastic syndromes##15##2##(1990-8#1)(1992-12#2)(1994-10#1)(2007-5#1)(2008-11#1)(2009-8#2)(2010-1#2)(2010-11#5)
myelodysplastic syndromes]##2##2##(1990-11#1)(2012-2#1)
myelodysplastic##27##1##(1990-11#1)(1990-8#3)(1992-10#1)(1992-12#2)(1994-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-8#2)(2010-1#2)(2010-11#6)(2011-2#2)(2012-2#1)
myelogenous leukemia (CML)##4##3##(2006-10#1)(2009-7#1)(2010-4#1)(2012-12#1)
myelogenous leukemia##16##2##(1992-9#1)(1994-12#2)(1997-4#1)(2006-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#5)(2012-12#1)
myelogenous##19##1##(1992-9#1)(1994-12#2)(1997-4#1)(2006-10#2)(2006-6#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#5)(2012-12#1)
myelography##3##1##(2007-11#1)(2008-10#1)(2008-7#1)
myeloid and##2##2##(1991-2#1)(2012-3#1)
myeloid cell lines##2##3##(1995-6#1)(2008-10#1)
myeloid cell##7##2##(1992-3#1)(1994-6#1)(1995-6#1)(1996-10#1)(2008-10#1)(2010-11#1)(2013-1#1)
myeloid cells##5##2##(1992-3#1)(1992-8#1)(2008-10#1)(2008-4#1)(2010-10#1)
myeloid development##3##2##(2008-4#3)
myeloid differentiation##3##2##(1992-3#2)(2008-4#1)
myeloid leukaemia (AML)##2##3##(2008-5#1)(2011-2#1)
myeloid leukaemia##10##2##(1990-9#1)(1997-8#1)(2008-5#2)(2009-3#2)(2011-2#1)(2011-3#1)(2013-8#2)
myeloid leukemia (AML)##9##3##(2007-10#1)(2010-1#1)(2010-4#1)(2011-2#3)(2012-12#2)(2013-1#1)
myeloid leukemia (CML)##7##3##(1990-2#1)(1991-4#1)(2007-11#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
myeloid leukemia and##2##3##(2011-2#1)(2012-2#1)
myeloid leukemia or##3##3##(2010-11#1)(2011-2#1)(2012-12#1)
myeloid leukemia patients##2##3##(2008-7#1)(2012-2#1)
myeloid leukemia##56##2##(1990-2#2)(1990-8#2)(1991-4#1)(1993-3#2)(1993-8#2)(1994-5#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2010-1#2)(2010-11#3)(2010-4#4)(2011-1#1)(2011-2#15)(2012-12#5)(2012-2#3)(2013-1#1)
myeloid maturation##2##2##(2008-4#2)
myeloid progenitor cells##4##3##(1994-5#1)(1997-7#2)(2012-2#1)
myeloid progenitor##6##2##(1994-10#2)(1994-5#1)(1997-7#2)(2012-2#1)
myeloid##114##1##(1990-2#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-3#4)(1992-8#1)(1993-3#2)(1993-8#3)(1994-10#3)(1994-5#2)(1994-6#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#8)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-4#6)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#3)
myelolipoma##2##1##(1993-3#1)(2007-10#1)
myeloma (MM)##5##2##(2008-1#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
myeloma and##3##2##(1991-12#1)(2008-11#2)
myeloma cell line##5##3##(2008-11#5)
myeloma cell##8##2##(2008-11#6)(2008-3#1)(2009-4#1)
myeloma cells##19##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-5#1)(1995-8#2)(1997-4#1)(2008-11#5)(2008-7#2)(2011-2#1)(2013-1#4)
myeloma group##2##2##(1991-12#2)
myeloma in##5##2##(2009-5#1)(2011-2#4)
myeloma kidney&quot##2##2##(2008-1#2)
myeloma with##2##2##(2008-7#1)(2011-1#1)
myeloma##100##1##(1990-12#1)(1990-9#2)(1991-12#7)(1991-5#2)(1991-9#1)(1993-9#1)(1994-5#1)(1995-8#3)(1997-4#1)(1997-5#1)(2007-11#4)(2008-1#4)(2008-11#15)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#11)(2008-9#3)(2009-3#1)(2009-4#5)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#6)(2011-1#1)(2011-2#8)(2012-12#5)(2012-3#1)(2013-1#5)
myelomas##6##1##(1991-5#1)(2008-11#4)(2012-12#1)
myelomeningocele##4##1##(2008-10#1)(2009-3#1)(2011-2#1)(2013-7#1)
myelomonocytic leukemia##5##2##(1992-10#2)(1994-11#1)(2013-1#2)
myelomonocytic##9##1##(1992-10#2)(1992-3#1)(1992-9#1)(1994-11#1)(1995-2#1)(2008-10#1)(2013-1#2)
myelopathy or##2##2##(2007-10#1)(2012-12#1)
myelopathy##10##1##(1991-3#1)(1991-8#1)(2007-10#1)(2008-12#2)(2008-7#1)(2012-12#3)(2013-1#1)
myelopathy/tropical spastic paraparesis##2##3##(2012-12#2)
myeloperoxidase (MPO)##2##2##(2011-1#1)(2013-1#1)
myeloperoxidase##9##1##(1991-3#1)(1992-10#1)(1995-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#2)(2013-1#1)
myeloproliferative disorders##2##2##(2008-10#1)(2010-11#1)
myeloproliferative neoplasms##2##2##(2009-8#2)
myeloproliferative##8##1##(1993-9#1)(1997-5#1)(2008-10#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-2#1)
myelosuppression##9##1##(1991-2#1)(1997-3#1)(1997-7#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-1#2)
myelosuppressive chemotherapy##3##2##(2008-7#2)(2010-9#1)
myelosuppressive##4##1##(1991-8#1)(2008-7#2)(2010-9#1)
myelotoxicity##4##1##(1990-2#1)(2006-10#1)(2008-8#1)(2013-1#1)
myenteric plexus##2##2##(1996-5#1)(1997-4#1)
myenteric##6##1##(1990-5#1)(1994-12#1)(1996-5#1)(1997-4#1)(2009-12#1)(2013-8#1)
myiasis##6##1##(2008-2#4)(2010-10#1)(2013-1#1)
mykiss were##2##2##(2010-8#2)
mykiss##10##1##(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#2)(2009-6#1)(2010-8#4)
mykiss)##8##1##(1993-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-8#1)
myo-cutaneous flap##2##2##(1990-9#2)
myo-inositol##9##1##(1992-12#4)(1993-6#1)(1995-6#1)(2008-11#2)(2008-7#1)
myoD enhancer and promoter##2##4##(1992-5#2)
myoD##7##1##(1992-5#7)
myoblast 45Ca2+ uptake##2##3##(1997-1#2)
myoblast cell line##2##3##(2008-11#2)
myoblast##8##1##(1997-1#3)(2008-11#3)(2008-4#1)(2008-8#1)
myoblasts and##3##2##(1995-8#1)(2008-4#1)(2010-10#1)
myoblasts cultured on##2##3##(2009-9#2)
myoblasts cultured##3##2##(2009-12#1)(2009-9#2)
myoblasts for##2##2##(2008-11#2)
myoblasts with##2##2##(1993-3#1)(1997-1#1)
myoblasts##38##1##(1990-12#4)(1990-5#1)(1991-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-8#2)(1997-1#6)(2008-1#1)(2008-11#6)(2008-4#7)(2008-8#2)(2009-12#1)(2009-9#3)(2010-10#1)
myocardiac##3##1##(1990-8#2)(1991-6#1)
myocardial abscess##2##2##(2011-2#2)
myocardial and##3##2##(1990-11#1)(1996-6#1)(1996-9#1)
myocardial beta-adrenergic##4##2##(1991-12#1)(1997-6#3)
myocardial cell##6##2##(1991-9#1)(1992-3#2)(2008-1#1)(2008-5#1)(2011-2#1)
myocardial cells##5##2##(1996-9#2)(1997-6#1)(2008-5#1)(2013-1#1)
myocardial contractility##6##2##(1996-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
myocardial contrast##2##2##(2010-8#1)(2013-8#1)
myocardial damage and##2##3##(2011-2#1)(2012-2#1)
myocardial damage##7##2##(1991-9#1)(2008-10#2)(2010-5#1)(2011-2#2)(2012-2#1)
myocardial disease##2##2##(1992-9#1)(2013-7#1)
myocardial dysfunction##5##2##(1996-9#1)(2008-11#1)(2008-3#1)(2009-5#1)(2013-7#1)
myocardial function and##2##3##(1995-3#1)(2011-2#1)
myocardial function in##2##3##(2009-10#1)(2013-8#1)
myocardial function##9##2##(1995-3#1)(1996-3#1)(2007-11#1)(2009-10#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
myocardial infarct##5##2##(1990-12#1)(1990-9#1)(1991-6#1)(1992-5#1)(1996-9#1)
myocardial infarct]##3##2##(1990-8#1)(1994-3#1)(1997-3#1)
myocardial infarction (MI) and##2##4##(2008-11#1)(2013-1#1)
myocardial infarction (MI)##16##3##(1990-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
myocardial infarction (NSTEMI)##2##3##(2011-2#1)(2012-3#1)
myocardial infarction and heart failure##3##5##(2011-1#1)(2011-2#2)
myocardial infarction and stroke in Chinese men##2##7##(2009-9#2)
myocardial infarction and stroke in##3##5##(2009-9#3)
myocardial infarction and stroke##5##4##(2009-9#5)
myocardial infarction and##24##3##(1990-2#1)(1993-2#1)(1995-12#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-8#1)(2009-9#5)(2011-1#2)(2011-2#3)(2012-2#1)
myocardial infarction but##2##3##(2008-7#1)(2013-1#1)
myocardial infarction by##4##3##(1991-11#1)(1991-6#1)(2008-3#1)(2011-2#1)
myocardial infarction can##2##3##(1994-3#1)(2009-12#1)
myocardial infarction complicated by##2##4##(2007-10#1)(2013-8#1)
myocardial infarction detection##2##3##(2008-10#1)(2008-3#1)
myocardial infarction during##3##3##(1990-5#1)(1991-3#1)(1995-12#1)
myocardial infarction in the##2##4##(1994-12#1)(2008-3#1)
myocardial infarction in##20##3##(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#2)(1997-8#3)(2006-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2009-4#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
myocardial infarction is a##3##4##(1991-9#1)(2011-2#1)(2013-1#1)
myocardial infarction is##6##3##(1991-6#1)(1991-9#1)(1994-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
myocardial infarction or##3##3##(1992-9#1)(2008-3#1)(2009-6#1)
myocardial infarction patients##3##3##(1995-2#1)(2012-3#1)(2013-1#1)
myocardial infarction were##5##3##(1996-9#1)(2008-3#1)(2011-1#3)
myocardial infarction with##5##3##(1990-9#1)(1997-3#1)(2008-11#1)(2010-5#1)(2011-2#1)
myocardial infarction##265##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#4)(1990-9#5)(1991-11#1)(1991-3#3)(1991-4#1)(1991-6#6)(1991-9#5)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#2)(1993-9#1)(1994-11#5)(1994-12#3)(1994-3#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-8#2)(1996-2#3)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#5)(1997-5#1)(1997-8#4)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#5)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#3)(2008-3#41)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#8)(2010-10#2)(2010-11#4)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#10)(2011-2#16)(2012-1#4)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#7)
myocardial infarction)##2##2##(1990-5#1)(1991-11#1)
myocardial infarction?##2##2##(1993-2#1)(2009-5#1)
myocardial infarction]##7##2##(1990-12#1)(1993-2#1)(1994-6#1)(1995-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
myocardial infarctions##4##2##(2007-8#1)(2008-3#3)
myocardial infraction##2##2##(2007-11#1)(2008-4#1)
myocardial injury and##2##3##(2010-8#2)
myocardial injury##4##2##(2010-8#3)(2012-2#1)
myocardial ischaemia in a patient##2##5##(1990-9#1)(2009-11#1)
myocardial ischaemia##6##2##(1990-9#1)(1991-2#1)(1994-11#1)(2009-11#1)(2012-2#1)(2013-8#1)
myocardial ischemia and##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)
myocardial ischemia in##3##3##(1991-9#1)(1996-9#1)(2008-3#1)
myocardial ischemia##31##2##(1991-3#1)(1991-9#1)(1992-11#1)(1992-6#1)(1994-11#1)(1996-9#2)(1997-2#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#5)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-8#1)
myocardial ischemia/reperfusion injury##2##3##(1996-9#1)(2010-12#1)
myocardial ischemia/reperfusion##3##2##(1996-9#1)(2010-12#1)(2010-8#1)
myocardial ischemic##3##2##(1991-3#1)(2009-10#1)(2013-1#1)
myocardial metabolism##2##2##(2012-3#2)
myocardial performance##4##2##(2008-12#3)(2011-2#1)
myocardial perfusion imaging##5##3##(2009-10#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
myocardial perfusion##15##2##(1996-3#1)(1997-8#2)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-4#2)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
myocardial protection##6##2##(1991-3#2)(1996-9#4)
myocardial protective##2##2##(1996-9#2)
myocardial regeneration##4##2##(2010-10#1)(2010-6#3)
myocardial reperfusion##2##2##(1990-3#1)(2008-3#1)
myocardial revascularisation##2##2##(2007-9#2)
myocardial revascularization##6##2##(1993-12#1)(2007-8#2)(2009-4#2)(2013-8#1)
myocardial stress##2##2##(1996-9#1)(2008-7#1)
myocardial stunning##7##2##(1991-3#3)(1996-9#1)(2008-10#1)(2008-3#2)
myocardial sympathetic##3##2##(2008-11#2)(2008-7#1)
myocardial tissue pressure##2##3##(2007-8#2)
myocardial tissue##4##2##(1990-5#1)(2007-8#2)(2012-2#1)
myocardial viability##4##2##(1992-5#1)(2009-10#1)(2012-2#2)
myocardial##531##1##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#4)(1990-5#6)(1990-8#1)(1990-9#7)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#11)(1991-4#1)(1991-6#7)(1991-9#11)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#2)(1992-9#4)(1993-1#1)(1993-12#5)(1993-2#4)(1993-9#1)(1994-11#8)(1994-12#3)(1994-3#2)(1994-6#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#3)(1996-2#3)(1996-3#3)(1996-6#2)(1996-8#1)(1996-9#29)(1997-2#3)(1997-3#7)(1997-5#1)(1997-6#4)(1997-8#7)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-5#2)(2007-8#14)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#15)(2008-12#7)(2008-3#53)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#16)(2008-8#2)(2009-10#6)(2009-11#1)(2009-12#3)(2009-4#6)(2009-5#9)(2009-6#2)(2009-7#1)(2009-9#9)(2010-10#3)(2010-11#5)(2010-12#4)(2010-4#1)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#19)(2011-1#10)(2011-2#33)(2012-1#5)(2012-12#4)(2012-2#20)(2012-3#9)(2013-1#17)(2013-7#5)(2013-8#20)
myocarditis and##2##2##(1997-8#1)(2010-5#1)
myocarditis presenting as##2##3##(2008-11#2)
myocarditis##14##1##(1996-8#1)(1997-8#1)(2008-11#2)(2010-5#1)(2010-7#3)(2011-2#1)(2012-3#4)(2013-8#1)
myocardium and##7##2##(1990-2#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
myocardium following##2##2##(2010-6#1)(2012-12#1)
myocardium in##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
myocardium of##3##2##(1996-9#1)(2012-3#1)(2013-7#1)
myocardium was##4##2##(2007-8#1)(2013-1#3)
myocardium were##3##2##(2007-8#1)(2011-2#1)(2012-1#1)
myocardium##79##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-9#2)(1991-9#2)(1992-10#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-8#2)(1996-6#1)(1996-9#6)(2007-12#1)(2007-8#9)(2008-1#2)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#1)
myoclonic jerk response##2##3##(1995-12#2)
myoclonic jerks and##2##3##(1995-12#1)(2007-7#1)
myoclonic jerks##4##2##(1995-12#3)(2007-7#1)
myoclonic##9##1##(1990-9#1)(1995-12#5)(2007-7#1)(2010-1#1)(2013-8#1)
myoclonus##5##1##(1991-12#2)(1995-8#1)(2008-5#1)(2008-7#1)
myocutaneous flap##9##2##(1990-9#2)(1993-11#1)(2007-12#4)(2013-1#2)
myocutaneous##10##1##(1990-9#2)(1993-11#1)(1994-12#1)(2007-12#4)(2013-1#2)
myocyte##6##1##(1994-11#1)(1995-8#1)(2008-10#3)(2008-7#1)
myocytes and##2##2##(1993-6#1)(2008-9#1)
myocytes by##2##2##(1995-5#1)(1996-9#1)
myocytes in##5##2##(1993-3#1)(2008-3#1)(2008-7#2)(2008-8#1)
myocytes were##3##2##(1994-12#1)(1996-9#2)
myocytes##51##1##(1992-3#1)(1992-6#2)(1993-3#10)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-5#1)(1996-2#1)(1996-9#8)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#6)(2008-9#3)(2010-7#1)(2013-1#1)
myoelectric activity##3##2##(2008-12#2)(2008-9#1)
myoelectric##5##1##(2008-12#3)(2008-9#2)
myoepithelial cell differentiation##2##3##(2007-5#2)
myoepithelial cells##7##2##(1990-12#1)(1994-12#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
myoepithelial##18##1##(1990-12#1)(1994-12#1)(2007-5#5)(2008-7#1)(2009-12#1)(2011-2#4)(2012-3#2)(2013-8#3)
myoepithelioma of the##2##3##(2008-4#1)(2013-8#1)
myoepithelioma of##3##2##(2008-4#1)(2013-1#1)(2013-8#1)
myoepithelioma##7##1##(2008-4#1)(2013-1#3)(2013-8#3)
myofascial pain##3##2##(1991-2#1)(2008-10#1)(2008-12#1)
myofascial trigger points in##2##4##(2008-12#1)(2010-9#1)
myofascial trigger points##6##3##(2008-12#2)(2010-12#2)(2010-9#2)
myofascial trigger##7##2##(2008-12#2)(2010-12#2)(2010-9#2)(2013-1#1)
myofascial##14##1##(1991-2#1)(2008-10#1)(2008-12#3)(2009-1#3)(2009-9#1)(2010-12#2)(2010-9#2)(2013-1#1)
myofibrillar##6##1##(2008-5#2)(2010-12#1)(2010-4#2)(2011-2#1)
myofibrils##8##1##(1994-5#1)(2008-5#1)(2008-7#1)(2009-7#3)(2010-12#1)(2010-8#1)
myofibroblastic##2##1##(2010-12#1)(2013-1#1)
myofibroblasts##3##1##(1997-8#2)(2006-10#1)
myofibroma originating from the conjunctiva and##2##6##(2011-1#2)
myofibroma##5##1##(2010-6#3)(2011-1#2)
myofibromatosis##3##1##(2007-12#1)(2010-6#1)(2011-1#1)
myofilaments##2##1##(1991-12#1)(1996-9#1)
myogenesis and lipogenesis##2##3##(2012-2#2)
myogenesis and##3##2##(2008-9#1)(2012-2#2)
myogenesis##10##1##(1992-6#1)(1993-12#3)(1993-3#2)(2008-11#1)(2008-9#1)(2012-2#2)
myogenic activity of the heart##2##5##(2008-5#2)
myogenic activity of##3##3##(1993-8#1)(2008-5#2)
myogenic autoregulation##3##2##(2009-1#3)
myogenic cells##6##2##(1992-8#3)(1993-8#1)(2008-11#1)(2009-3#1)
myogenic determination##2##2##(1992-5#1)(2009-3#1)
myogenic differentiation##4##2##(1992-6#1)(1993-3#1)(1996-2#1)(2010-12#1)
myogenic factors##5##2##(1995-6#5)
myogenic precursor cells##5##3##(1995-8#5)
myogenic regulatory factors##2##3##(1993-12#1)(1995-6#1)
myogenic##46##1##(1990-8#1)(1992-5#2)(1992-6#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-12#3)(1995-6#6)(1995-8#5)(1996-2#2)(2008-11#4)(2008-5#3)(2008-6#1)(2009-1#4)(2009-3#3)(2010-12#1)(2010-8#1)
myogenin and MRF4##2##3##(1996-2#1)(2009-3#1)
myogenin##7##1##(1996-2#5)(2009-3#1)(2011-1#1)
myoglobin (MG)##2##2##(2008-10#2)
myoglobin (Mb)##5##2##(1994-5#1)(2008-10#3)(2010-4#1)
myoglobin and##5##2##(1991-6#1)(1992-3#1)(1997-7#1)(2007-11#1)(2008-10#1)
myoglobin in##2##2##(1995-2#1)(2008-10#1)
myoglobin with##2##2##(1990-8#1)(1994-5#1)
myoglobin##38##1##(1990-8#5)(1991-6#1)(1992-3#1)(1993-11#3)(1994-5#3)(1995-2#5)(1995-3#2)(1997-7#4)(2007-11#1)(2008-10#9)(2010-4#2)(2011-1#1)(2011-2#1)
myoglobins##5##1##(1990-8#1)(1995-3#2)(2010-4#2)
myohemerythrin##4##1##(1992-8#4)
myoid##5##1##(1993-9#1)(2009-10#2)(2010-6#2)
myoinositol supplementation##3##2##(2008-8#3)
myoinositol##6##1##(2008-7#2)(2008-8#4)
myolipoma##4##1##(2008-7#4)
myolysis##3##1##(1994-2#3)
myomatous polyps##2##2##(1994-2#2)
myomatous##4##1##(1994-2#3)(2011-2#1)
myomectomy for##2##2##(1993-3#1)(2012-3#1)
myomectomy using the argon beam coagulator##2##6##(1993-12#2)
myomectomy##9##1##(1991-8#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-9#1)(2011-1#1)(2012-3#1)
myometrial activity and##2##3##(1994-3#2)
myometrial activity##5##2##(1994-3#4)(1994-9#1)
myometrial contractions##2##2##(1994-11#2)
myometrial invasion##5##2##(1994-9#3)(2011-2#2)
myometrial##24##1##(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#4)(1994-3#8)(1994-8#1)(1994-9#5)(2011-2#3)
myometrium by##2##2##(1994-3#2)
myometrium##14##1##(1990-11#1)(1991-12#1)(1993-12#1)(1994-3#2)(1994-8#3)(1994-9#3)(2009-5#1)(2012-2#1)(2013-7#1)
myonecrosis##5##1##(2007-7#2)(2010-12#1)(2011-2#2)
myopathic##2##1##(2008-7#1)(2012-2#1)
myopathies##8##1##(1995-2#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-7#1)(2013-1#2)
myopathy and##4##2##(2006-10#3)(2008-4#1)
myopathy has been##2##3##(2008-5#1)(2013-1#1)
myopathy in##4##2##(1990-3#1)(1995-12#1)(2006-10#1)(2013-1#1)
myopathy with##5##2##(2008-10#1)(2008-7#4)
myopathy##36##1##(1990-12#2)(1990-3#2)(1994-11#1)(1995-12#2)(2006-10#5)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#10)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#5)
myopathy'##2##1##(2008-7#2)
myopia and##2##2##(1991-2#1)(2008-3#1)
myopia by##2##2##(2012-12#2)
myopia progression##9##2##(2010-1#4)(2012-12#5)
myopia##24##1##(1991-2#1)(2008-3#1)(2010-1#6)(2011-2#1)(2012-12#14)(2013-1#1)
myopic shift in absence of anterior##2##6##(2011-2#2)
myopic##7##1##(2010-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
myosarcoma##2##1##(2008-6#2)
myosin II##6##2##(1991-2#5)(2012-2#1)
myosin S1##2##2##(1994-5#2)
myosin head##4##2##(1991-5#3)(1993-9#1)
myosin heads were##2##3##(1991-5#1)(1995-2#1)
myosin heads##3##2##(1991-5#1)(1994-5#1)(1995-2#1)
myosin heavy chain gene expression##4##5##(1992-3#4)
myosin heavy chain gene##5##4##(1992-3#5)
myosin heavy chain##15##3##(1992-3#7)(1995-6#1)(1995-8#1)(2008-5#2)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
myosin in##2##2##(1990-5#2)
myosin isozymes##3##2##(1996-9#3)
myosin light chain kinase in##2##5##(1990-11#1)(1995-12#1)
myosin light chain kinase##17##4##(1990-11#3)(1991-2#4)(1992-6#2)(1992-9#1)(1993-8#4)(1995-12#3)
myosin light chain##22##3##(1990-11#4)(1990-5#1)(1991-2#4)(1992-6#2)(1992-9#1)(1993-8#4)(1994-11#3)(1995-12#3)
myosin light##23##2##(1990-11#4)(1990-5#1)(1991-2#4)(1992-6#2)(1992-9#1)(1993-8#4)(1993-9#1)(1994-11#3)(1995-12#3)
myosin light-chain kinase from##2##4##(1991-5#1)(1994-8#1)
myosin light-chain kinase##3##3##(1991-5#2)(1994-8#1)
myosin subfragment 1##4##3##(1992-4#1)(1994-5#1)(1994-8#2)
myosin subfragment-1##2##2##(1992-3#1)(1995-2#1)
myosin was##2##2##(1990-5#1)(1996-9#1)
myosin##103##1##(1990-11#4)(1990-5#5)(1991-2#11)(1991-5#7)(1992-2#2)(1992-3#8)(1992-4#2)(1992-6#2)(1992-9#2)(1993-6#4)(1993-8#4)(1993-9#5)(1994-11#3)(1994-5#4)(1994-8#4)(1995-12#7)(1995-2#6)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1996-9#5)(2008-11#1)(2008-5#5)(2008-9#1)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
myosin-dependent##2##1##(2008-11#2)
myosins##7##1##(1991-2#1)(2008-10#1)(2008-11#5)
myositis and##3##2##(1992-11#1)(2006-10#1)(2013-1#1)
myositis is##4##2##(2011-2#3)(2013-1#1)
myositis ossificans in##2##3##(2013-1#1)(2013-8#1)
myositis ossificans##5##2##(1992-2#3)(2013-1#1)(2013-8#1)
myositis##28##1##(1992-11#1)(1992-2#4)(2006-10#4)(2008-7#2)(2008-8#1)(2011-2#6)(2012-2#3)(2013-1#6)(2013-8#1)
myostatin##4##1##(2010-4#3)(2012-12#1)
myotatic reflexes##2##2##(1995-8#2)
myotatic##3##1##(1995-8#3)
myotomy and##3##2##(1992-9#2)(2011-2#1)
myotomy of the##2##3##(1992-6#1)(1997-2#1)
myotomy with##3##2##(1992-9#1)(2011-1#2)
myotomy##13##1##(1990-12#4)(1992-6#2)(1992-9#3)(1997-2#1)(2011-1#2)(2011-2#1)
myotonic dystrophy##8##2##(1992-2#1)(1994-9#1)(2008-7#4)(2013-1#2)
myotonic myopathy##2##2##(2008-7#2)
myotonic##13##1##(1992-2#1)(1993-9#1)(1994-9#1)(2008-7#8)(2013-1#2)
myotubes and##2##2##(1993-3#1)(1995-6#1)
myotubes as##2##2##(1990-5#1)(2008-11#1)
myotubes in culture##2##3##(1995-6#2)
myotubes in##5##2##(1991-12#1)(1994-11#1)(1995-6#2)(2008-11#1)
myotubes##36##1##(1990-5#1)(1991-11#1)(1991-12#1)(1992-12#2)(1993-3#1)(1994-11#4)(1995-6#5)(1995-8#1)(2008-11#16)(2008-4#2)(2009-9#2)
myriad of##16##2##(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
myriad##20##1##(1992-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
myringoplasty##5##1##(2008-7#1)(2012-8#4)
myringotomy##2##1##(1991-1#1)(2013-8#1)
myriotylum##3##1##(2008-10#3)
myristate acetate (PMA)##6##3##(1991-2#1)(1991-9#1)(1993-6#1)(1994-6#1)(1997-4#1)(2006-6#1)
myristate acetate##11##2##(1991-2#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#2)(1997-4#1)(2006-6#1)
myristate##18##1##(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-6#4)(1994-8#2)(1995-6#1)(1997-4#1)(2006-6#1)(2008-10#1)
myristic acid co-chemisorption##3##3##(2008-10#3)
myristic acid##7##2##(1994-9#1)(2008-10#6)
myristic acids##2##2##(2008-10#2)
myristic##12##1##(1994-9#1)(2008-10#11)
myristicin##4##1##(1997-7#4)
myristicin-treated##2##1##(1997-7#2)
myristoyl##2##1##(1990-12#2)
myristoylated pp60c-src##2##2##(1990-12#2)
myristoylated##4##1##(1990-10#1)(1990-12#2)(2008-9#1)
myristoylation of##2##2##(1990-12#2)
myristoylation##5##1##(1990-12#3)(2009-8#2)
myrmecophagy##2##1##(2012-3#2)
myrrha##3##1##(2008-5#3)
myrtillus##4##1##(2008-10#2)(2009-6#2)
myself##2##1##(1990-10#1)(2013-8#1)
mysteries##5##1##(1997-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-1#1)
mysterious##2##1##(1993-6#1)(2010-4#1)
mystery##12##1##(1990-11#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
mysticism##3##1##(1990-2#1)(2008-4#2)
myth of##2##2##(2007-12#1)(2008-11#1)
myth or reality?##3##3##(1991-1#1)(1991-8#1)(2008-11#1)
myth or##4##2##(1991-1#1)(1991-8#1)(1996-1#1)(2008-11#1)
myth##11##1##(1991-1#1)(1991-8#1)(1993-3#1)(1995-1#2)(1996-1#1)(2007-12#1)(2008-11#2)(2010-4#1)(2011-2#1)
myths about##3##2##(1992-1#1)(1993-3#1)(1997-6#1)
myths and##5##2##(1992-1#1)(1993-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
myths that##2##2##(1991-6#1)(2010-3#1)
myths##20##1##(1991-6#1)(1992-1#2)(1993-2#1)(1993-3#1)(1995-1#2)(1997-1#1)(1997-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-3#1)(2010-4#1)(2011-1#1)(2013-8#2)
myxoedema##2##1##(1993-6#1)(1996-3#1)
myxoid and##3##2##(2008-4#1)(2008-6#1)(2010-6#1)
myxoid background##2##2##(1993-8#1)(2008-6#1)
myxoid stroma##2##2##(1993-2#1)(2012-3#1)
myxoid##16##1##(1993-2#2)(1993-8#3)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#1)(2010-6#2)(2012-3#1)(2013-1#2)
myxoma arising from the inferior vena cava##2##7##(2008-11#2)
myxoma##20##1##(2007-12#2)(2007-8#4)(2008-11#4)(2008-7#4)(2009-6#1)(2009-7#2)(2012-12#2)(2013-1#1)
myxomatous##8##1##(2007-8#4)(2008-11#1)(2008-12#1)(2010-12#2)
myxome##2##1##(2013-1#2)
mécanique##3##1##(2011-2#1)(2013-1#2)
médicale##3##1##(2011-2#2)(2013-1#1)
müllerian##3##1##(1990-2#1)(2011-2#2)
n &lt##2##2##(2008-10#1)(2008-3#1)
n = 1##3##3##(2008-2#2)(2008-3#1)
n = 10##4##3##(2010-1#2)(2011-2#2)
n = 10) and##2##4##(2008-10#2)
n = 10)##7##3##(1992-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)
n = 11) was##2##4##(1993-3#1)(2010-4#1)
n = 11)##4##3##(1993-3#1)(2008-1#1)(2008-5#1)(2010-4#1)
n = 12)##2##3##(1994-3#1)(2008-10#1)
n = 13##2##3##(2008-10#1)(2008-7#1)
n = 14##2##3##(1990-8#1)(2008-5#1)
n = 15##3##3##(2008-10#3)
n = 15)##2##3##(1990-8#1)(2008-10#1)
n = 16)##2##3##(1990-8#1)(1997-1#1)
n = 17##2##3##(2011-2#2)
n = 18##2##3##(2008-10#2)
n = 19##4##3##(1994-6#2)(1995-8#1)(2008-10#1)
n = 2##4##3##(1997-7#1)(2008-2#3)
n = 20)##4##3##(2009-8#4)
n = 21##2##3##(1994-6#1)(1995-12#1)
n = 21)##2##3##(1990-8#1)(1993-11#1)
n = 3##4##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
n = 3)##2##3##(1991-8#1)(2008-10#1)
n = 30) and##3##4##(2008-4#2)(2008-5#1)
n = 30)##5##3##(1993-8#1)(2008-4#2)(2008-5#2)
n = 4##2##3##(1994-3#1)(1995-8#1)
n = 4)##3##3##(1991-8#1)(1995-8#1)(1997-1#1)
n = 43)##2##3##(2008-3#1)(2013-1#1)
n = 5##2##3##(1994-6#1)(2008-10#1)
n = 5)##7##3##(2008-10#1)(2008-5#1)(2009-11#3)(2011-1#2)
n = 6)##3##3##(1992-3#1)(2008-10#2)
n = 62)##3##3##(1996-2#1)(2008-8#2)
n = 7##2##3##(1995-8#1)(2008-7#1)
n = 7)##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
n = 8##2##3##(1990-11#1)(1995-8#1)
n = 8)##4##3##(1991-9#1)(2008-5#2)(2009-11#1)
n = 86)##2##3##(1991-8#1)(2008-8#1)
n = 9##2##3##(2010-2#1)(2011-2#1)
n = 9)##5##3##(1993-3#1)(2008-1#1)(2008-10#3)
n = 92)##2##3##(2008-5#2)
n =##166##2##(1990-11#1)(1990-2#2)(1990-8#4)(1991-5#1)(1991-8#4)(1991-9#1)(1992-11#2)(1992-3#1)(1993-11#2)(1993-3#2)(1993-8#3)(1994-12#1)(1994-3#4)(1994-6#5)(1995-12#3)(1995-8#6)(1996-12#2)(1996-2#5)(1996-9#1)(1997-1#2)(1997-7#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#4)(2009-2#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#7)(2012-3#1)(2013-1#4)
n and##7##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#4)
n beams are combined##2##4##(2008-3#2)
n for##2##2##(2007-12#1)(2008-3#1)
n in##3##2##(1994-1#1)(2008-10#1)(2008-3#1)
n is the number of##4##5##(1991-8#1)(2008-8#1)(2010-2#2)
n is the##5##3##(1991-8#1)(2007-12#1)(2008-8#1)(2010-2#2)
n is##8##2##(1991-8#1)(2007-11#2)(2007-12#1)(2008-8#1)(2009-12#1)(2010-2#2)
n of the##2##3##(1991-7#1)(2008-2#1)
n of##3##2##(1990-11#1)(1991-7#1)(2008-2#1)
n to##2##2##(2008-3#1)(2008-7#1)
n value##2##2##(1994-5#2)
n values##3##2##(2008-10#1)(2008-2#2)
n varies from 2 to##2##5##(1992-11#1)(2007-11#1)
n was##2##2##(1994-8#1)(2007-11#1)
n##281##1##(1990-11#2)(1990-2#2)(1990-3#3)(1990-8#4)(1990-9#3)(1991-5#1)(1991-7#2)(1991-8#5)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#3)(1994-1#1)(1994-12#2)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#2)(1995-12#3)(1995-8#6)(1996-12#2)(1996-2#5)(1996-9#1)(1997-1#2)(1997-7#2)(2007-10#1)(2007-11#7)(2007-12#4)(2008-1#3)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#31)(2008-4#4)(2008-5#16)(2008-6#2)(2008-7#18)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#1)(2009-5#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#2)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#9)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
n(0)##4##1##(2008-3#4)
n(1)##2##1##(2008-7#2)
n(2) of##3##2##(2007-11#2)(2007-12#1)
n(2)##14##1##(2007-11#6)(2007-12#2)(2008-2#2)(2008-3#3)(2008-7#1)
n(3)(2)##2##1##(2007-12#2)
n(c) and##2##2##(2008-3#2)
n(c)##4##1##(2008-3#4)
n(e)##3##1##(2008-3#3)
n(v)##2##1##(2008-3#2)
n(z)##2##1##(2008-3#2)
n)##5##1##(2007-11#4)(2008-2#1)
n- and##3##2##(1994-8#1)(1996-12#1)(2012-2#1)
n-3 FAs##2##2##(2013-1#2)
n-3 PUFA##6##2##(2010-6#2)(2013-1#4)
n-3 PUFAs##9##2##(2010-6#1)(2013-1#8)
n-3 fatty acids##3##3##(2010-2#1)(2012-12#1)(2013-1#1)
n-3 fatty##4##2##(2010-2#1)(2012-12#1)(2013-1#2)
n-3##26##1##(1994-2#1)(1996-7#1)(2010-2#1)(2010-6#3)(2012-12#1)(2013-1#18)(2013-8#1)
n-3)##3##1##(1994-11#3)
n-6 fatty##2##2##(2008-3#1)(2010-4#1)
n-6##6##1##(1994-2#1)(2008-3#1)(2010-2#1)(2010-4#1)(2013-1#2)
n-6) and##2##2##(1994-11#2)
n-6/n-3 ratio##2##2##(2010-4#2)
n-6/n-3##3##1##(2010-4#2)(2013-1#1)
n-Bu##4##1##(1996-2#4)
n-Propylamine##2##1##(1996-2#2)
n-alcohol##2##1##(1990-11#2)
n-alcohols on the##2##3##(1990-11#2)
n-alcohols##5##1##(1990-11#5)
n-alkane assimilation##3##2##(1991-9#1)(1993-12#2)
n-alkane##5##1##(1991-9#2)(1993-12#2)(2008-10#1)
n-alkanes##7##1##(2008-10#3)(2010-3#3)(2013-8#1)
n-alkanols##2##1##(1990-11#1)(2008-10#1)
n-butanol fraction##3##2##(2008-10#3)
n-butanol##7##1##(1990-11#1)(1996-5#1)(2008-10#4)(2008-5#1)
n-butyl##6##1##(1992-12#1)(2008-10#5)
n-butylamine and##2##2##(1990-8#1)(2008-10#1)
n-butylamine in the range of##2##5##(2008-10#2)
n-butylamine##5##1##(1990-8#1)(2008-10#4)
n-butyric##4##1##(2008-10#4)
n-decane droplets##2##2##(2008-10#2)
n-dodecane##2##1##(1996-5#2)
n-heptane##5##1##(2007-12#3)(2008-10#2)
n-hexadecane##3##1##(1994-11#3)
n-hexane and dichloromethane volumes##2##4##(2008-10#2)
n-hexane and dichloromethane##3##3##(2008-10#3)
n-hexane and##6##2##(2008-10#6)
n-hexane##26##1##(1990-8#1)(1997-7#2)(2008-10#19)(2008-2#1)(2008-7#2)(2009-9#1)
n-hexane-soluble##2##1##(1997-7#2)
n-hexanol##2##1##(1990-11#1)(1996-5#1)
n-hexanoyl cystamine is##2##3##(2011-2#2)
n-hexanoyl cystamine##6##2##(2011-2#6)
n-hexanoyl##7##1##(2011-2#7)
n-octanol##2##1##(1990-11#1)(2008-5#1)
n-octanoyl or n-hexanoyl##2##3##(2011-2#2)
n-octanoyl##3##1##(2011-2#3)
n-octylphenol##2##1##(2008-11#2)
n-pi interaction##2##2##(2007-11#2)
n-pi##3##1##(1996-5#1)(2007-11#2)
n-propanol##3##1##(2008-2#2)(2008-7#1)
n-type##3##1##(1991-9#1)(2008-7#1)(2013-8#1)
n-valeric##2##1##(2008-10#2)
n2##2##1##(2008-3#1)(2008-7#1)
n=1##3##1##(2007-11#1)(2008-10#1)(2013-8#1)
n=10##2##1##(2008-10#2)
n=10) and in agreement with##2##5##(2008-10#2)
n=10)##15##1##(1994-10#2)(1997-7#1)(2008-10#12)
n=11)##5##1##(2008-10#5)
n=12) and##2##2##(2008-10#1)(2010-4#1)
n=12)##3##1##(2008-10#2)(2010-4#1)
n=14)##2##1##(2008-10#2)
n=2##2##1##(2008-10#1)(2013-8#1)
n=20)##2##1##(2008-10#2)
n=3##3##1##(2008-10#2)(2008-6#1)
n=3) and##2##2##(2008-10#2)
n=3)##6##1##(2008-10#5)(2013-1#1)
n=30) as##2##2##(2010-7#2)
n=30)##4##1##(2008-10#1)(2010-7#3)
n=36##2##1##(2008-10#2)
n=36)##2##1##(2008-10#2)
n=4 for##2##2##(2008-10#2)
n=4##5##1##(2008-10#5)
n=5) was##2##2##(2008-10#2)
n=5) were##3##2##(2008-10#3)
n=5)##11##1##(2008-10#9)(2008-12#1)(2013-1#1)
n=6 per concentration level)##3##4##(2008-10#3)
n=6##4##1##(2007-8#1)(2008-10#3)
n=6)##7##1##(2007-8#1)(2008-10#6)
n=7##2##1##(2008-10#2)
n=7) and##2##2##(2008-10#2)
n=7)##9##1##(2008-10#9)
n=8)##3##1##(2008-10#3)
nA and##2##2##(2008-10#2)
nA microg(-1) ml(-1)##2##3##(2008-10#2)
nA##17##1##(1990-7#1)(1991-5#1)(1993-12#1)(2007-8#1)(2008-10#12)(2008-7#1)
nA/muM for##2##2##(2008-10#2)
nAChR agonists would be potential therapeutic drugs for##2##8##(2011-1#2)
nAChR agonists##5##2##(2007-8#1)(2011-1#4)
nAChR alpha1##3##2##(2008-8#3)
nAChR##16##1##(2007-8#3)(2008-8#6)(2009-6#1)(2010-8#1)(2011-1#4)(2011-2#1)
nAChRs are##2##2##(2007-8#1)(2009-6#1)
nAChRs##13##1##(2007-8#5)(2008-8#1)(2009-6#2)(2011-1#5)
nCDHA was##2##2##(2012-2#2)
nCDHA##5##1##(2012-2#5)
nG-hPRL##2##1##(2008-11#2)
nH = 1##2##3##(1994-5#2)
nH(2)O##6##1##(1997-7#3)(2008-10#2)(2010-4#1)
nJ are##2##2##(2007-12#2)
nJ##11##1##(2007-11#4)(2007-12#5)(2008-3#2)
nL cell(-1) day(-1)##3##3##(2008-11#3)
nLM##2##1##(2008-8#2)
nM (mean +/-##2##3##(1991-9#1)(1994-6#1)
nM TPA##3##2##(1993-9#2)(1994-9#1)
nM against##3##2##(1992-6#1)(2008-9#2)
nM and Bmax of##2##4##(1991-5#1)(1993-12#1)
nM and a binding capacity of##2##6##(1990-5#2)
nM and a##4##3##(1990-2#1)(1990-5#2)(2008-4#1)
nM and the##2##3##(1992-9#1)(2008-10#1)
nM and##22##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#3)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1997-4#1)(2008-10#3)(2008-4#1)
nM are##2##2##(2008-10#1)(2009-11#1)
nM at A3 receptors##2##4##(1995-3#2)
nM at##4##2##(1992-6#1)(1995-3#3)
nM detection##2##2##(2008-10#2)
nM estradiol##3##2##(1994-9#1)(2008-11#2)
nM for##6##2##(1990-2#1)(1990-8#1)(1994-3#2)(1995-3#1)(2008-4#1)
nM in the##2##3##(1990-5#1)(1995-12#1)
nM in##4##2##(1990-2#1)(1990-5#1)(1994-8#1)(1995-12#1)
nM neuropeptide Y##3##3##(1995-12#3)
nM neuropeptide##4##2##(1995-12#4)
nM of##3##2##(1992-6#1)(2008-11#1)(2008-5#1)
nM to 1##2##3##(2008-10#1)(2008-4#1)
nM to##9##2##(1993-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
nM versus##2##2##(1990-5#1)(2008-10#1)
nM were##2##2##(1991-2#1)(1995-6#1)
nM with##4##2##(1990-11#1)(1990-12#2)(1995-8#1)
nM##235##1##(1990-11#1)(1990-12#9)(1990-2#7)(1990-5#9)(1990-7#4)(1990-8#7)(1991-2#2)(1991-5#7)(1991-8#3)(1991-9#6)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#7)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#8)(1994-9#10)(1995-11#6)(1995-12#20)(1995-2#8)(1995-3#13)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#5)(1996-5#2)(1997-4#3)(1997-6#1)(1997-7#1)(2007-11#2)(2008-10#23)(2008-11#10)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-8#1)(2008-9#2)(2009-11#1)
nM) and okadaic acid##2##4##(1995-8#2)
nM) and##18##2##(1990-5#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#4)(1997-2#1)(2006-6#1)(2008-6#1)
nM) in the##2##3##(1994-11#1)(1994-2#1)
nM) in##7##2##(1992-3#1)(1994-11#1)(1994-2#1)(1995-12#2)(1996-5#1)(1997-4#1)
nM) is##3##2##(1990-11#1)(1992-8#1)(1993-11#1)
nM) of##2##2##(1991-5#1)(1994-9#1)
nM) on##2##2##(1995-3#1)(2009-12#1)
nM) or##2##2##(1994-6#1)(1997-7#1)
nM) produced a concentration-dependent potentiation of the##2##7##(1997-4#2)
nM) receptors##2##2##(1995-3#2)
nM) that##2##2##(1997-2#1)(2013-1#1)
nM) to##3##2##(1993-11#1)(1995-5#1)(2010-12#1)
nM) with a##2##3##(1994-11#1)(1994-8#1)
nM)##134##1##(1990-11#3)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-5#5)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#5)(1993-1#1)(1993-11#6)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#7)(1994-9#3)(1995-11#4)(1995-12#10)(1995-2#3)(1995-3#9)(1995-5#5)(1995-6#1)(1995-8#7)(1996-12#1)(1996-5#5)(1997-1#2)(1997-2#3)(1997-4#7)(1997-7#3)(2006-6#1)(2008-10#4)(2008-11#3)(2008-6#2)(2009-12#1)(2010-12#2)(2013-1#2)
nM-1##2##1##(1995-11#1)(1997-4#1)
nNOS protein##3##2##(1996-12#3)
nNOS##10##1##(1996-12#6)(2008-10#1)(2008-4#1)(2009-10#1)(2012-3#1)
nPEP##2##1##(2012-3#2)
nW of##2##2##(2008-3#2)
nW##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
na##4##1##(2007-11#1)(2008-12#1)(2008-2#1)(2012-12#1)
nabumetone in##2##2##(1990-6#1)(2010-4#1)
nabumetone##3##1##(1990-6#2)(2010-4#1)
nacrants##4##1##(2008-5#4)
nacre##7##1##(2008-5#3)(2012-2#4)
nadir of##3##2##(1991-8#1)(1997-6#1)(2007-12#1)
nadir radiance##2##2##(2008-3#2)
nadir##15##1##(1991-8#1)(1997-6#3)(2007-12#1)(2008-2#3)(2008-3#7)
nadir-viewing##3##1##(2008-2#1)(2008-3#2)
nadirs##2##1##(2008-8#1)(2009-11#1)
naevi##3##1##(2011-2#2)(2012-3#1)
naevus##6##1##(1990-9#1)(2007-7#4)(2010-6#1)
nafion coating##2##2##(2008-10#2)
nafion film coated glassy carbon electrode##2##6##(2008-10#2)
nafion##15##1##(2008-10#15)
nagging problems##2##2##(1995-1#1)(2008-8#1)
nagging##4##1##(1995-1#1)(2008-8#1)(2010-6#1)(2012-12#1)
nail breakage##2##2##(2007-7#1)(2008-8#1)
nail changes##2##2##(2007-7#1)(2011-2#1)
nail enamel##2##2##(2008-5#2)
nail enamels##3##2##(2008-5#3)
nail fixation##5##2##(2010-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
nail in the##2##3##(2009-3#2)
nail in##7##2##(2007-11#1)(2007-8#2)(2009-3#2)(2010-11#1)(2012-2#1)
nail is##2##2##(2007-11#1)(2013-1#1)
nail was##3##2##(2009-3#2)(2013-1#1)
nail##66##1##(2007-11#7)(2007-7#3)(2007-8#4)(2008-3#1)(2008-5#10)(2008-8#3)(2008-9#2)(2009-3#7)(2010-11#1)(2010-5#3)(2010-6#2)(2011-2#3)(2012-2#9)(2013-1#7)(2013-8#4)
nailing for metastatic##2##3##(2007-11#2)
nailing for##4##2##(2007-11#2)(2009-3#1)(2012-2#1)
nailing in##3##2##(2008-6#1)(2013-8#2)
nailing was##2##2##(2007-11#2)
nailing with##3##2##(2007-11#1)(2008-6#1)(2012-2#1)
nailing##21##1##(2007-11#9)(2007-8#1)(2008-6#2)(2008-8#1)(2009-3#1)(2012-2#5)(2013-8#2)
nails and##3##2##(1996-6#1)(2009-2#1)(2013-8#1)
nails for##2##2##(2007-11#1)(2009-2#1)
nails##24##1##(1990-11#1)(1996-6#1)(2007-11#5)(2007-7#1)(2008-5#9)(2008-7#2)(2009-2#2)(2012-2#2)(2013-8#1)
naive CD4(+) T cells##5##4##(2008-11#5)
naive and##3##2##(1994-11#1)(1995-12#2)
naive animals##2##2##(1995-12#2)
naive controls##2##2##(1993-12#2)
naive mice##4##2##(2008-10#4)
naive or##2##2##(1995-12#1)(2009-9#1)
naive rats##5##2##(1994-2#2)(1994-3#1)(1995-12#2)
naive##37##1##(1993-12#2)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#10)(1996-3#1)(2008-10#5)(2008-11#6)(2008-6#1)(2008-7#2)(2009-9#1)(2011-2#3)(2013-1#2)
naked and##2##2##(1994-11#1)(1995-3#1)
naked eye##8##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-5#1)
naked##20##1##(1992-12#1)(1994-11#2)(1995-3#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-8#3)(2010-5#1)(2013-1#1)
naked-eye##2##1##(1995-11#1)(2008-10#1)
nalbuphine##10##1##(1992-5#6)(1993-1#4)
nalidixic acid (NA) and##2##4##(2008-10#1)(2011-1#1)
nalidixic acid and cotrimoxazole##2##4##(2007-7#1)(2012-3#1)
nalidixic acid and##6##3##(1995-8#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-3#1)
nalidixic acid##17##2##(1991-8#1)(1995-8#1)(2007-7#1)(2008-10#6)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)
nalidixic##18##1##(1991-8#1)(1995-8#2)(2007-7#1)(2008-10#6)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)
naloxonazine##5##1##(1996-2#5)
naloxone (1##2##2##(1990-7#1)(1992-3#1)
naloxone and##2##2##(1991-1#2)
naloxone in##2##2##(1991-8#1)(1995-12#1)
naloxone##16##1##(1990-7#1)(1991-1#4)(1991-8#1)(1992-3#1)(1992-5#2)(1994-8#1)(1995-12#4)(1996-2#2)
naloxone-induced jumping behaviour in morphine-dependent mice##2##6##(1996-2#2)
naloxone-induced jumping##3##2##(1996-2#3)
naloxone-reversible##2##1##(1991-1#2)
naltrexone and##2##2##(1991-1#1)(2008-2#1)
naltrexone##13##1##(1991-1#5)(1993-6#1)(2008-12#2)(2008-2#3)(2008-6#1)(2009-7#1)
name A##2##2##(2008-10#2)
name Tomato leaf curl##2##4##(2008-10#2)
name Tomato##3##2##(2008-10#3)
name a##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)
name and##5##2##(1990-9#1)(2008-11#1)(2010-4#1)(2013-8#2)
name are##2##2##(2008-10#1)(2008-4#1)
name changed to##2##3##(2008-5#1)(2009-7#1)
name for a##3##3##(1990-11#1)(1991-11#1)(2008-10#1)
name for the##2##3##(2008-10#1)(2011-2#1)
name for##6##2##(1990-11#1)(1991-11#1)(2008-10#3)(2011-2#1)
name in##2##2##(1990-2#1)(2007-11#1)
name is##3##2##(1991-3#1)(2007-2#1)(2013-7#1)
name of P##3##3##(2008-10#3)
name of the##6##3##(1990-11#1)(1992-5#1)(1993-12#1)(1995-3#1)(2008-11#1)(2012-12#1)
name of##15##2##(1990-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
name the##4##2##(1995-11#1)(2007-12#1)(2008-11#1)(2008-5#1)
name to##3##2##(2008-10#1)(2012-3#1)(2013-7#1)
name##134##1##(1990-11#4)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-5#2)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#36)(2008-11#8)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#5)
named &quot##4##2##(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
named a##2##2##(2008-10#1)(2008-6#1)
named after A##2##3##(2011-1#2)
named as &quot##2##3##(2010-7#1)(2011-1#1)
named as##9##2##(1990-7#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)
named by##2##2##(2007-12#1)(2010-1#1)
named gene##2##2##(2008-10#2)
named group##2##2##(2007-11#2)
named human##2##2##(2008-11#1)(2008-8#1)
named species and##3##3##(2008-10#2)(2011-2#1)
named species##4##2##(2008-10#3)(2011-2#1)
named the##11##2##(1991-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)
named##180##1##(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#2)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#2)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#49)(2008-11#8)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#14)(2008-9#4)(2009-10#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
namely a##7##2##(1990-5#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-8#2)
namely gallic acid##2##3##(2008-10#1)(2011-1#1)
namely in the##2##3##(2008-10#1)(2008-5#1)
namely in##5##2##(1997-7#1)(2008-10#2)(2008-5#1)(2009-6#1)
namely that##2##2##(2011-2#1)(2013-8#1)
namely the input layer##2##4##(2010-8#2)
namely the##31##2##(1996-3#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
namely those##2##2##(1993-3#1)(2012-1#1)
namely##296##1##(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#2)(2006-10#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-1#5)(2008-10#78)(2008-11#21)(2008-12#8)(2008-2#5)(2008-3#13)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#4)(2009-11#1)(2009-2#1)(2009-6#3)(2009-7#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#9)(2011-1#8)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#3)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#9)
names and##2##2##(1991-2#1)(2012-2#1)
names for##3##2##(1990-11#2)(2012-2#1)
names of cities##2##3##(1990-11#2)
names of several##2##3##(2008-10#2)
names of the##2##3##(1993-12#1)(2012-3#1)
names of##9##2##(1990-11#2)(1993-12#1)(2008-10#5)(2012-3#1)
names##29##1##(1990-11#4)(1991-2#1)(1993-12#1)(1995-6#1)(1996-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-8#3)
naming and##3##2##(1994-3#1)(2009-2#1)(2011-1#1)
naming task##2##2##(1996-2#1)(2013-8#1)
naming##20##1##(1994-3#4)(1996-2#4)(1997-3#1)(2007-12#3)(2008-10#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
nanjiensis##2##1##(2008-8#2)
nano column##3##2##(2013-1#3)
nano to##2##2##(2009-7#1)(2012-2#1)
nano##8##1##(2009-12#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#3)
nano- and##2##2##(2012-1#1)(2013-1#1)
nano-Al(2)O(3)##2##1##(2008-5#2)
nano-Au##4##1##(2008-10#4)
nano-HA/collagen/PLA##2##1##(2008-5#2)
nano-LC and##2##2##(2010-11#2)
nano-crystals##2##1##(2009-7#2)
nano-fibrous##2##1##(2009-7#2)
nano-particle##2##1##(2013-8#2)
nano-particles##2##1##(2009-7#1)(2013-8#1)
nano-scale approach##2##2##(2013-1#2)
nano-scale##9##1##(2008-10#2)(2009-11#1)(2009-12#1)(2010-9#1)(2012-2#1)(2013-1#3)
nano-scaled##2##1##(2008-10#1)(2009-11#1)
nano-sized##2##1##(2008-10#1)(2008-8#1)
nano-structured##2##1##(2008-10#1)(2009-12#1)
nanoFePc##2##1##(2008-10#2)
nanoadjuvants##2##1##(2012-2#2)
nanoarrays##3##1##(2008-10#3)
nanobeads##2##1##(2008-10#1)(2009-11#1)
nanobiotechnology##4##1##(2008-11#4)
nanocapsule##3##1##(2008-7#1)(2009-12#2)
nanocapsules##2##1##(2008-10#1)(2013-1#1)
nanocarbons##2##1##(2012-2#2)
nanocarrier binding##3##2##(2008-12#3)
nanocarrier##11##1##(2008-12#4)(2009-11#4)(2009-8#2)(2013-1#1)
nanocarriers##4##1##(2008-12#3)(2008-7#1)
nanocavities##4##1##(2007-11#4)
nanoceria particles##3##2##(2008-7#3)
nanocermet##2##1##(2008-3#2)
nanochannel##2##1##(2008-10#2)
nanochannels##12##1##(2008-10#4)(2008-7#8)
nanoclusters as the##2##3##(2008-10#1)(2013-1#1)
nanoclusters of gold##2##3##(2008-7#1)(2011-1#1)
nanoclusters was##3##2##(2008-10#2)(2013-1#1)
nanoclusters##21##1##(2007-12#2)(2008-10#12)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-1#3)
nanocolloids##3##1##(2011-2#3)
nanocomplexation##2##1##(2013-1#2)
nanocomplexes##2##1##(2013-1#2)
nanocomposite##8##1##(2007-11#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-6#1)(2012-2#1)
nanocomposites by##3##2##(2008-3#1)(2008-8#2)
nanocomposites can be##2##3##(2008-3#1)(2008-8#1)
nanocomposites for##2##2##(2009-11#2)
nanocomposites##16##1##(2007-12#1)(2008-10#3)(2008-3#4)(2008-8#5)(2009-11#2)(2012-7#1)
nanocracks and nanoholes##2##3##(2009-11#2)
nanocracks##3##1##(2009-11#3)
nanocrystal##5##1##(2008-10#2)(2008-2#1)(2012-2#1)(2013-8#1)
nanocrystalline TiO(2)##2##2##(2008-2#2)
nanocrystalline calcium deficient hydroxyapatite##2##4##(2012-2#2)
nanocrystalline##18##1##(1995-3#1)(2008-10#3)(2008-2#2)(2009-11#7)(2010-4#2)(2012-2#3)
nanocrystallites##3##1##(2007-11#1)(2008-3#1)(2008-5#1)
nanocrystals could be##2##3##(2008-10#1)(2009-7#1)
nanocrystals were prepared##2##3##(2013-8#2)
nanocrystals were synthesized##2##3##(2008-10#2)
nanocrystals were##5##2##(2008-10#2)(2013-8#3)
nanocrystals with##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
nanocrystals##36##1##(2007-11#5)(2007-12#3)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#3)(2009-7#2)(2010-7#1)(2012-2#2)(2013-8#7)
nanocrystals]##2##1##(2013-8#2)
nanocubes##7##1##(2008-5#4)(2013-1#3)
nanodevices##6##1##(2008-7#3)(2009-12#3)
nanodots##6##1##(2008-7#2)(2009-11#1)(2009-6#2)(2010-4#1)
nanoelectrode##2##1##(2008-10#2)
nanoelectrodes##6##1##(2008-10#6)
nanoelectromechanical##2##1##(2008-7#1)(2010-12#1)
nanoelectronics##4##1##(2008-10#1)(2008-4#1)(2008-7#2)
nanoemulsion##3##1##(2008-5#2)(2011-3#1)
nanoemulsion-in situ gel system##2##4##(2011-3#2)
nanoemulsion-in situ gel##3##3##(2011-3#3)
nanofabrication##4##1##(2008-7#2)(2008-8#1)(2009-12#1)
nanofiber##9##1##(2009-11#6)(2009-12#1)(2012-1#2)
nanofibers can serve as an##2##5##(2009-11#1)(2009-12#1)
nanofibers can##3##2##(2009-11#1)(2009-12#2)
nanofibers inside liposomes##2##3##(2009-5#2)
nanofibers with##2##2##(2009-12#1)(2012-1#1)
nanofibers##11##1##(2009-11#1)(2009-12#3)(2009-5#2)(2012-1#5)
nanofibres can be##2##3##(2008-7#2)
nanofibres##6##1##(2007-12#1)(2008-7#5)
nanofilled##4##1##(2008-12#3)(2012-6#1)
nanofilter array chip##2##3##(2008-10#2)
nanofilter##4##1##(2008-10#4)
nanofluidic##5##1##(2008-10#2)(2008-7#3)
nanoformulations##2##1##(2013-1#2)
nanogap##6##1##(2008-7#1)(2013-1#5)
nanogram amounts of##4##3##(1990-12#1)(2008-10#2)(2009-12#1)
nanogram amounts##5##2##(1990-12#1)(1991-2#1)(2008-10#2)(2009-12#1)
nanogram level of##3##3##(2008-10#3)
nanogram level##7##2##(2008-10#7)
nanogram levels##4##2##(2008-10#4)
nanogram per##4##2##(2008-10#4)
nanogram quantities##4##2##(2008-10#4)
nanogram range##3##2##(1991-5#1)(2008-2#1)(2008-4#1)
nanogram##29##1##(1990-12#1)(1991-2#1)(1991-5#1)(1993-1#1)(1997-2#1)(2008-10#21)(2008-2#1)(2008-4#1)(2009-12#1)
nanograms per milliliter##2##3##(2008-10#2)
nanograms per##5##2##(2008-1#1)(2008-10#4)
nanoholes##3##1##(2008-7#1)(2009-11#2)
nanohybrids##2##1##(2008-5#1)(2009-3#1)
nanoindentation and Raman microspectroscopy##2##4##(2010-10#2)
nanoindentation techniques##3##2##(2008-10#1)(2008-3#1)(2009-7#1)
nanoindentation##11##1##(2008-10#1)(2008-3#1)(2009-7#2)(2010-10#3)(2010-4#3)(2012-2#1)
nanojoule##2##1##(2007-11#1)(2007-12#1)
nanojoule-energy##2##1##(2007-12#2)
nanoliter##2##1##(1990-9#1)(2008-10#1)
nanolithography##6##1##(2008-7#5)(2009-11#1)
nanomachines##3##1##(2008-7#2)(2010-12#1)
nanomaterial##6##1##(2008-10#3)(2008-8#1)(2010-4#1)(2013-1#1)
nanomaterials and##2##2##(2008-12#1)(2008-7#1)
nanomaterials##16##1##(2008-12#2)(2008-7#2)(2008-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#6)(2013-1#1)
nanomatrices##2##1##(2010-6#2)
nanomechanical##2##1##(2008-4#1)(2008-7#1)
nanometer level of##2##3##(2008-3#1)(2008-7#1)
nanometer level##3##2##(2008-3#2)(2008-7#1)
nanometer measurement##2##2##(2008-3#2)
nanometer scale and##2##3##(2008-3#1)(2009-12#1)
nanometer scale##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)
nanometer##26##1##(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#1)(2009-11#4)(2009-12#1)(2010-5#1)(2012-2#1)
nanometer-level accuracy##2##2##(2008-3#2)
nanometer-scale##6##1##(2008-4#1)(2008-5#2)(2010-4#1)(2010-7#1)(2012-2#1)
nanometer-sized particles##2##2##(2008-12#1)(2008-3#1)
nanometer-sized##7##1##(2008-10#4)(2008-12#2)(2008-3#1)
nanometers##13##1##(1995-6#1)(2007-12#2)(2008-10#5)(2008-3#4)(2012-1#1)
nanometre##3##1##(2008-7#2)(2009-11#1)
nanometre-sized##2##1##(2008-10#1)(2008-7#1)
nanometric##6##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
nanomolar affinities##2##2##(1990-7#1)(2008-5#1)
nanomolar and##2##2##(2008-10#2)
nanomolar concentrations of##5##3##(1990-12#1)(1994-6#1)(2008-10#2)(2008-6#1)
nanomolar concentrations##9##2##(1990-12#1)(1994-6#1)(2008-10#4)(2008-6#1)(2008-7#1)(2012-2#1)
nanomolar levels##2##2##(2008-10#2)
nanomolar range##5##2##(1992-12#1)(1994-5#1)(1995-5#1)(2008-10#1)(2012-2#1)
nanomolar##32##1##(1990-12#4)(1990-7#1)(1992-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(2008-10#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#2)
nanomoles##2##1##(1993-8#2)
nanooctahedra##5##1##(2008-10#5)
nanoparticle array##2##2##(2008-10#1)(2008-7#1)
nanoparticle arrays##5##2##(2009-11#5)
nanoparticle assemblies##3##2##(2008-7#3)
nanoparticle on##2##2##(2011-1#2)
nanoparticle##52##1##(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#7)(2008-8#1)(2009-11#7)(2009-9#1)(2010-12#1)(2010-5#3)(2010-6#1)(2011-1#6)(2011-2#1)(2012-2#1)(2013-1#4)
nanoparticle-DNA conjugates##2##2##(2008-4#2)
nanoparticle-based electrode##2##2##(2008-12#2)
nanoparticle-based##3##1##(2008-10#1)(2008-12#2)
nanoparticle-fluorescent polymer##2##2##(2008-7#2)
nanoparticles (MNPs)##3##2##(2009-11#1)(2013-1#2)
nanoparticles (NPs)##2##2##(2010-5#1)(2012-6#1)
nanoparticles and##15##2##(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#3)(2010-4#1)(2010-6#1)
nanoparticles are##14##2##(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#2)(2012-2#1)
nanoparticles as##6##2##(2008-10#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-2#1)
nanoparticles by##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
nanoparticles can##2##2##(2008-10#1)(2008-7#1)
nanoparticles doped with##2##3##(2009-2#2)
nanoparticles for##11##2##(2008-10#4)(2008-7#1)(2009-11#2)(2012-12#1)(2012-6#1)(2013-1#1)(2013-8#1)
nanoparticles form##2##2##(2008-10#2)
nanoparticles has been##2##3##(2008-10#1)(2008-8#1)
nanoparticles has##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
nanoparticles have been##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
nanoparticles have##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2010-6#1)
nanoparticles in the##3##3##(2007-11#1)(2009-11#1)(2011-2#1)
nanoparticles in##12##2##(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#3)(2011-2#1)(2012-2#3)(2013-1#2)
nanoparticles makes##2##2##(2008-10#1)(2008-7#1)
nanoparticles modified##3##2##(2008-10#2)(2011-2#1)
nanoparticles network##2##2##(2008-10#2)
nanoparticles of##5##2##(2008-10#2)(2009-2#1)(2010-12#1)(2010-4#1)
nanoparticles on##4##2##(2009-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
nanoparticles that have been##2##4##(2008-10#1)(2010-6#1)
nanoparticles that##4##2##(2008-10#1)(2010-12#2)(2010-6#1)
nanoparticles to##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
nanoparticles using##2##2##(1997-1#1)(2010-4#1)
nanoparticles via##2##2##(2008-7#1)(2012-2#1)
nanoparticles was determined##2##3##(2008-10#1)(2008-11#1)
nanoparticles was investigated##2##3##(2008-10#1)(2010-4#1)
nanoparticles was##7##2##(2008-10#5)(2008-11#1)(2010-4#1)
nanoparticles were prepared##3##3##(2008-10#2)(2009-9#1)
nanoparticles were synthesized and##2##4##(2008-10#1)(2013-1#1)
nanoparticles were##16##2##(2008-10#7)(2008-7#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-2#2)(2013-1#3)
nanoparticles with a high##2##4##(2008-3#1)(2010-12#1)
nanoparticles with a##4##3##(2008-3#1)(2010-12#1)(2010-4#1)(2012-2#1)
nanoparticles with##9##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#1)
nanoparticles##288##1##(1997-1#2)(2007-11#6)(2007-12#3)(2008-10#97)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#31)(2008-8#3)(2008-9#1)(2009-11#18)(2009-12#1)(2009-2#7)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#18)(2010-2#2)(2010-4#15)(2010-5#4)(2010-6#7)(2011-1#6)(2011-2#8)(2012-12#3)(2012-2#13)(2012-3#2)(2012-6#2)(2013-1#13)(2013-8#3)
nanoparticulate systems##2##2##(2008-5#1)(2013-1#1)
nanoparticulate##7##1##(2007-11#2)(2008-5#1)(2010-4#2)(2012-6#1)(2013-1#1)
nanopatterning##3##1##(2008-10#3)
nanopatterns##2##1##(2008-7#1)(2010-4#1)
nanophase##2##1##(2007-11#1)(2008-10#1)
nanopillars can##2##2##(2009-11#2)
nanopillars##5##1##(2009-11#5)
nanopore channels##2##2##(2008-7#2)
nanopore sensor array##2##3##(2009-11#2)
nanopore sensor##3##2##(2009-11#2)(2012-2#1)
nanopore##16##1##(2008-7#6)(2009-11#3)(2009-7#3)(2012-2#4)
nanopores have##2##2##(2008-7#2)
nanopores to##2##2##(2008-7#1)(2009-11#1)
nanopores##8##1##(2008-7#5)(2009-11#1)(2012-2#2)
nanoporous TiO2##2##2##(2008-5#1)(2010-5#1)
nanoporous##12##1##(2007-12#1)(2008-5#2)(2010-2#1)(2010-5#2)(2012-2#6)
nanoprobes for##2##2##(2008-12#1)(2008-2#1)
nanoprobes with##2##2##(2008-12#1)(2008-2#1)
nanoprobes##6##1##(2008-10#1)(2008-12#2)(2008-2#3)
nanoprocessing of##2##2##(2007-11#2)
nanoribbons##4##1##(2008-7#3)(2012-2#1)
nanorods##9##1##(2007-11#1)(2008-10#1)(2008-7#3)(2010-1#1)(2012-12#2)(2013-1#1)
nanorose##5##1##(2011-1#5)
nanoscale devices##2##2##(2008-7#1)(2010-12#1)
nanoscale electronics##2##2##(2008-7#1)(2012-2#1)
nanoscale films##2##2##(2010-4#2)
nanoscale structures##2##2##(2008-7#1)(2010-7#1)
nanoscale##44##1##(2007-12#2)(2008-10#3)(2008-7#15)(2009-11#6)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-12#2)(2010-4#5)(2010-6#1)(2010-7#2)(2012-2#2)
nanoscopic##7##1##(2007-11#4)(2008-4#1)(2008-7#2)
nanosecond laser pulse##2##3##(2007-12#2)
nanosecond laser pulses##2##3##(2007-12#1)(2008-3#1)
nanosecond laser##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
nanosecond optical parametric oscillator##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
nanosecond optical parametric##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
nanosecond pulsed##2##2##(2007-11#1)(2008-2#1)
nanosecond pulses in##2##3##(2007-12#2)
nanosecond pulses##7##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
nanosecond time##3##2##(1990-8#2)(1997-2#1)
nanosecond##33##1##(1990-8#2)(1996-5#1)(1997-2#1)(2007-11#5)(2007-12#11)(2008-10#2)(2008-2#2)(2008-3#7)(2009-9#1)(2012-2#1)
nanoseconds##6##1##(2008-2#3)(2008-3#2)(2011-1#1)
nanosensor##5##1##(2008-10#5)
nanosensors and##2##2##(2008-10#2)
nanosensors based on##3##3##(2008-10#2)(2010-2#1)
nanosensors##8##1##(2008-10#7)(2010-2#1)
nanosheet colloids with##3##3##(2008-10#3)
nanosheet colloids##4##2##(2008-10#4)
nanosheet##5##1##(2008-10#5)
nanosheets##5##1##(2008-10#5)
nanosize##2##1##(2009-7#2)
nanosized LaCoO(3)##2##2##(2008-10#2)
nanosized Y(2)O(3)-based catalytic##2##3##(2008-10#2)
nanosized catalysts##2##2##(2008-10#2)
nanosized gamma-Fe(2)O(3)##2##2##(2008-10#2)
nanosized materials##2##2##(2008-10#2)
nanosized##16##1##(2008-10#13)(2008-7#2)(2013-1#1)
nanosphere##2##1##(2008-10#2)
nanospheres##7##1##(2008-1#1)(2008-10#5)(2008-7#1)
nanostructure##13##1##(1992-11#1)(2007-11#1)(2008-10#3)(2008-3#3)(2010-12#2)(2010-4#1)(2012-2#2)
nanostructured biomaterials##2##2##(2008-5#1)(2009-12#1)
nanostructured diamond##3##2##(2008-10#3)
nanostructured electrochemical##2##2##(2008-10#2)
nanostructured films##6##2##(2009-11#1)(2009-12#5)
nanostructured gold##2##2##(2008-10#2)
nanostructured materials##3##2##(2008-7#1)(2009-12#1)(2009-8#1)
nanostructured##32##1##(2008-10#12)(2008-5#2)(2008-7#4)(2009-11#3)(2009-12#8)(2009-2#1)(2009-8#1)(2010-4#1)
nanostructures and##2##2##(2008-10#1)(2008-4#1)
nanostructures that are##2##3##(2008-10#1)(2011-2#1)
nanostructures that##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
nanostructures with##5##2##(2007-12#1)(2008-7#3)(2009-6#1)
nanostructures##49##1##(2007-12#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#19)(2009-11#2)(2009-12#2)(2009-6#1)(2009-9#1)(2010-12#7)(2010-7#3)(2011-2#3)(2012-2#1)
nanosystems##2##1##(2008-7#2)
nanotech familiarity##2##2##(2010-12#2)
nanotech##3##1##(2008-7#1)(2010-12#2)
nanotechnologies##2##1##(2008-9#1)(2010-12#1)
nanotechnology and##2##2##(2008-10#1)(2008-4#1)
nanotechnology development##2##2##(2010-12#2)
nanotechnology has been##2##3##(2008-7#1)(2010-7#1)
nanotechnology in##3##2##(2008-7#1)(2008-9#1)(2010-12#1)
nanotechnology patent applications##4##3##(2010-12#4)
nanotechnology##58##1##(1994-8#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-4#5)(2008-7#15)(2008-9#1)(2009-5#1)(2010-12#19)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)
nanotopography##2##1##(2011-2#2)
nanotrenches can##2##2##(2008-7#2)
nanotrenches##5##1##(2008-7#5)
nanotube and##2##2##(2008-10#2)
nanotube cables##4##2##(2012-2#4)
nanotube electronics##2##2##(2008-7#2)
nanotube powder##2##2##(2008-10#2)
nanotube transistors##2##2##(2008-7#2)
nanotube##51##1##(2007-11#2)(2008-10#15)(2008-3#1)(2008-7#25)(2009-11#2)(2010-2#1)(2012-2#4)(2013-8#1)
nanotube-based##2##1##(2008-7#1)(2010-2#1)
nanotubes (MWNTs)##7##2##(2008-10#4)(2008-7#1)(2009-3#1)(2010-5#1)
nanotubes (SWNTs)##8##2##(2008-10#1)(2008-7#6)(2009-11#1)
nanotubes and nanotori##2##3##(2009-3#2)
nanotubes and the##2##3##(2008-7#2)
nanotubes and##14##2##(2008-10#4)(2008-3#1)(2008-7#7)(2009-3#2)
nanotubes are##4##2##(2008-10#1)(2008-7#2)(2010-2#1)
nanotubes by##5##2##(2008-10#1)(2008-7#3)(2009-3#1)
nanotubes can act as##2##4##(2008-7#2)
nanotubes can##3##2##(2008-7#2)(2010-2#1)
nanotubes during##2##2##(2008-10#2)
nanotubes have##2##2##(2008-10#1)(2008-7#1)
nanotubes to##3##2##(2008-10#1)(2008-7#2)
nanotubes was##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
nanotubes with##3##2##(2009-11#1)(2009-3#1)(2010-2#1)
nanotubes##146##1##(2007-11#4)(2008-10#50)(2008-12#1)(2008-3#4)(2008-7#50)(2009-10#2)(2009-11#6)(2009-3#6)(2010-12#1)(2010-2#9)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
nanovesicles as universal##2##3##(2008-10#2)
nanovesicles as##3##2##(2008-10#3)
nanovesicles##16##1##(2008-10#15)(2008-5#1)
nanowells##2##1##(2008-10#2)
nanowire arrays on##2##3##(2009-11#2)
nanowire arrays##3##2##(2008-7#1)(2009-11#2)
nanowire##16##1##(2008-7#12)(2009-11#4)
nanowires and carbon nanotubes##2##4##(2008-7#2)
nanowires and##5##2##(2008-7#5)
nanowires are converted to##2##4##(2009-11#2)
nanowires are##3##2##(2008-7#1)(2009-11#2)
nanowires can be##2##3##(2008-7#1)(2009-11#1)
nanowires can##3##2##(2008-7#1)(2009-11#2)
nanowires of##3##2##(2008-10#1)(2009-11#2)
nanowires through##2##2##(2009-11#2)
nanowires using##2##2##(2008-10#1)(2008-7#1)
nanowires##47##1##(2008-10#9)(2008-7#19)(2009-11#13)(2010-3#3)(2010-7#1)(2012-2#1)(2013-1#1)
napellus##3##1##(2008-10#3)
naphazoline nitrate and##3##3##(2008-10#3)
naphazoline##10##1##(2008-10#9)(2008-5#1)
naphthaldehyde##2##1##(2008-10#2)
naphthalene and 10 derivatives##2##4##(2011-2#2)
naphthalene and##5##2##(2008-10#2)(2008-11#1)(2011-2#2)
naphthalene derivatives##3##2##(1993-8#1)(2008-10#2)
naphthalene diimide endcap##2##3##(2008-4#2)
naphthalene diimide##3##2##(2008-10#1)(2008-4#2)
naphthalene in the pH range of##3##6##(2008-10#3)
naphthalene in the pH range##7##5##(2008-10#7)
naphthalene is##2##2##(2008-10#1)(2008-11#1)
naphthalene was##4##2##(2008-10#4)
naphthalene##55##1##(1993-8#1)(1994-5#1)(1994-9#1)(2008-10#42)(2008-11#5)(2008-12#1)(2008-4#2)(2011-2#2)
naphthalene-2##2##1##(2008-10#2)
naphthalenesulfonate derivatives##3##2##(2008-10#3)
naphthalocyanine##3##1##(2007-12#1)(2008-10#2)
naphthenate in gasoline##5##3##(2008-10#5)
naphtho[1##2##1##(1990-7#2)
naphthol green B##3##3##(2008-10#3)
naphthol##7##1##(1996-5#1)(2008-10#6)
naphthyl group##3##2##(2008-10#3)
naphthyl##9##1##(1997-7#2)(2008-10#5)(2008-11#1)(2011-2#1)
naproxen amide to S-naproxen##2##4##(1994-3#2)
naproxen amide to##3##3##(1994-3#3)
naproxen amide was##2##3##(1994-3#2)
naproxen amide##6##2##(1994-3#6)
naproxen and indomethacin##2##3##(2008-11#2)
naproxen and##3##2##(2008-10#1)(2008-11#2)
naproxen in pharmaceutical##2##3##(2008-10#2)
naproxen in##3##2##(2008-10#2)(2010-5#1)
naproxen nitrile and naproxen amide##2##5##(1994-3#2)
naproxen nitrile##7##2##(1994-3#7)
naproxen##45##1##(1991-8#1)(1994-3#17)(2008-10#19)(2008-11#4)(2010-5#4)
naproxen-induced##2##1##(2008-11#2)
napus (AC genome)##2##3##(2008-10#2)
napus L##3##2##(2008-12#2)(2011-2#1)
napus cv##4##2##(2008-10#4)
napus from the##2##3##(2008-10#2)
napus plants##2##2##(2008-10#2)
napus seed meal amendments##2##4##(2008-10#2)
napus seed meal##7##3##(2008-10#7)
napus##45##1##(1997-2#1)(2008-10#40)(2008-12#2)(2011-2#1)(2012-3#1)
napus-B##6##1##(2008-10#6)
narasin##10##1##(2007-6#10)
narcolepsy##6##1##(1991-5#1)(1997-9#4)(2011-2#1)
narcotic plant##2##2##(2008-10#2)
narcotic##13##1##(1991-11#1)(1991-6#1)(1996-12#4)(1996-6#1)(2008-10#3)(2012-12#2)(2012-3#1)
narcotics and other##2##3##(2008-10#2)
narcotics and##3##2##(2008-10#3)
narcotics##6##1##(1993-8#1)(2008-10#3)(2013-1#2)
naringenin##5##1##(2008-11#3)(2011-2#1)(2013-8#1)
naringin##4##1##(2008-10#1)(2008-11#3)
narrate their experiences##2##3##(2010-10#1)(2013-1#1)
narrated##3##1##(2009-10#1)(2009-5#1)(2010-3#1)
narrative analysis##5##2##(2008-12#1)(2013-1#4)
narrative devices##2##2##(2010-3#2)
narrative of a##2##3##(2009-11#1)(2012-12#1)
narrative of the##2##3##(2009-10#1)(2009-8#1)
narrative of##7##2##(2008-12#1)(2009-10#1)(2009-11#1)(2009-8#1)(2012-12#1)(2013-1#2)
narrative review of##2##3##(2012-3#1)(2013-1#1)
narrative review##4##2##(2012-1#1)(2012-3#2)(2013-1#1)
narrative review&quot##2##2##(2007-5#2)
narrative stories##2##2##(2008-2#1)(2009-9#1)
narrative##40##1##(1992-2#1)(1996-3#3)(2007-5#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#11)
narratives of##5##2##(1996-3#1)(1997-5#1)(2008-12#1)(2011-2#1)(2013-1#1)
narratives were##2##2##(1996-3#1)(2012-3#1)
narratives##22##1##(1991-9#1)(1993-1#1)(1994-6#2)(1996-3#3)(1997-5#1)(2008-12#4)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
narrow QRS##3##2##(2007-5#2)(2008-11#1)
narrow and##8##2##(2007-12#2)(2008-10#3)(2008-7#2)(2013-1#1)
narrow annular##2##2##(2008-3#1)(2009-8#1)
narrow as##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
narrow atmosphere and solar absorptions##2##5##(2008-2#2)
narrow band imaging##3##3##(2011-2#2)(2012-2#1)
narrow band##5##2##(2008-2#1)(2008-3#1)(2011-2#2)(2012-2#1)
narrow bandwidth of##2##3##(2007-11#1)(2007-12#1)
narrow bandwidth##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2013-8#1)
narrow bandwidths##2##2##(1991-2#1)(2008-2#1)
narrow beam##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
narrow correlation##2##2##(2009-12#2)
narrow down the##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
narrow emission##2##2##(2008-11#1)(2008-7#1)
narrow in##4##2##(1997-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
narrow light beam that propagates##2##5##(2008-3#2)
narrow light beam##3##3##(2008-3#3)
narrow linewidth##4##2##(2007-12#1)(2008-2#3)
narrow peak at##2##3##(2007-12#1)(2008-3#1)
narrow peak##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
narrow range of##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
narrow range##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
narrow size distribution##5##3##(2008-10#1)(2008-5#1)(2009-11#1)(2010-5#1)(2013-1#1)
narrow spectral response##3##3##(2007-12#2)(2008-3#1)
narrow spectral##9##2##(2007-12#2)(2008-2#1)(2008-3#5)(2009-6#1)
narrow the##9##2##(1993-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)
narrow therapeutic##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
narrow time##2##2##(1997-1#1)(2008-10#1)
narrow##188##1##(1991-2#1)(1992-12#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1996-3#1)(1997-1#3)(1997-3#4)(1997-5#1)(2006-6#1)(2007-11#11)(2007-12#22)(2007-5#2)(2008-1#4)(2008-10#23)(2008-11#6)(2008-12#5)(2008-2#22)(2008-3#20)(2008-4#1)(2008-5#5)(2008-7#8)(2008-8#7)(2008-9#6)(2009-11#3)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
narrow-band algorithm##3##2##(2008-3#1)(2008-6#2)
narrow-band filter##2##2##(2007-12#1)(2008-10#1)
narrow-band laser##3##2##(2008-2#2)(2008-3#1)
narrow-band spectral filters##2##3##(2007-11#2)
narrow-band terahertz##2##2##(2007-11#1)(2007-12#1)
narrow-band##44##1##(2007-11#9)(2007-12#5)(2008-10#1)(2008-2#14)(2008-3#10)(2008-5#1)(2008-6#2)(2011-1#2)
narrow-bandpass filter##4##2##(2007-12#1)(2008-3#3)
narrow-bandpass filters##2##2##(2008-3#2)
narrow-bandpass optical detection system##2##4##(2008-3#2)
narrow-bandpass##11##1##(2007-12#1)(2008-3#10)
narrow-bandwidth blue##2##2##(2007-11#1)(2008-2#1)
narrow-bandwidth##12##1##(2007-11#6)(2007-12#1)(2008-2#2)(2008-3#3)
narrow-bore column##2##2##(2008-5#2)
narrow-bore##4##1##(1997-2#1)(2008-4#1)(2008-5#2)
narrow-linewidth laser##2##2##(2007-12#1)(2008-2#1)
narrow-linewidth##11##1##(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#1)
narrow-sense heritability##5##2##(2008-10#4)(2008-8#1)
narrow-sense##6##1##(2008-10#5)(2008-8#1)
narrowband##4##1##(2007-11#4)
narrowed at##2##2##(2008-7#2)
narrowed down to##2##3##(1996-4#1)(2009-10#1)
narrowed##17##1##(1995-12#1)(1995-8#1)(1996-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)(2012-12#1)(2013-1#1)
narrower and##2##2##(2008-10#1)(2008-7#1)
narrower than for the##2##4##(1996-2#2)
narrower than the##2##3##(2007-12#1)(2008-3#1)
narrower than those##2##3##(2008-10#1)(2008-12#1)
narrower than##10##2##(1996-2#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#3)
narrower##19##1##(1994-5#1)(1995-5#1)(1996-2#2)(1997-3#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)
narrowest##4##1##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
narrowing and##2##2##(2007-12#1)(2011-2#1)
narrowing can##2##2##(2007-12#1)(2008-2#1)
narrowing in##6##2##(1995-9#1)(2007-12#1)(2008-2#1)(2011-2#3)
narrowing of the left##2##4##(2008-6#1)(2008-7#1)
narrowing of the lumen##2##4##(1992-5#1)(1996-3#1)
narrowing of the##18##3##(1992-5#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#2)(2011-2#2)(2012-3#1)
narrowing of##22##2##(1992-5#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#2)(2011-2#2)(2012-3#1)
narrowing##52##1##(1992-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#2)(2010-1#1)(2010-7#1)(2011-2#8)(2012-3#1)(2013-1#1)
narrowly on##2##2##(2008-11#1)(2009-5#1)
narrowly##6##1##(1993-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-5#1)
narrows the##2##2##(1993-1#1)(2009-9#1)
narrows##3##1##(1993-1#1)(2007-12#1)(2009-9#1)
nasal airway##5##2##(2008-11#3)(2013-1#2)
nasal and oral##4##3##(2008-11#2)(2011-2#1)(2012-12#1)
nasal and##6##2##(2007-12#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)
nasal breathing##2##2##(1990-7#1)(2008-11#1)
nasal bridge##2##2##(1997-3#1)(2011-1#1)
nasal calcitonin##2##2##(1993-11#2)
nasal carriers##2##2##(2011-2#2)
nasal cavity and##5##3##(1990-6#1)(1992-10#2)(2008-11#1)(2011-1#1)
nasal cavity##15##2##(1990-6#1)(1992-10#2)(1993-8#1)(1995-9#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#3)(2013-1#2)
nasal congestion##5##2##(2007-11#1)(2008-3#2)(2011-2#1)(2012-3#1)
nasal decongestants##2##2##(1993-2#2)
nasal discharge##7##2##(1993-2#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
nasal endoscopy##2##2##(2008-7#1)(2012-1#1)
nasal flow##2##2##(2008-4#2)
nasal itching##3##2##(2008-3#1)(2011-1#1)(2012-12#1)
nasal mass##2##2##(2011-1#2)
nasal mucosa##6##2##(1993-8#1)(1996-3#1)(1996-5#1)(2012-1#1)(2012-3#2)
nasal mucosal##2##2##(1993-8#1)(2011-1#1)
nasal obstruction and foul smell##2##5##(2013-1#2)
nasal obstruction and##4##3##(2008-11#1)(2008-2#1)(2013-1#2)
nasal obstruction##9##2##(2008-11#1)(2008-2#2)(2011-1#3)(2012-12#1)(2013-1#2)
nasal polyps##3##2##(1991-4#1)(2012-1#2)
nasal septal##2##2##(2008-2#2)
nasal septum##9##2##(2007-5#3)(2009-1#1)(2011-1#1)(2012-12#4)
nasal spray was##2##3##(2013-1#2)
nasal spray##8##2##(2008-10#2)(2008-5#1)(2012-1#1)(2013-1#4)
nasal swab##2##2##(2011-2#2)
nasal swabs##4##2##(2010-4#1)(2011-2#3)
nasal symptom score##2##3##(2008-11#1)(2012-3#1)
nasal symptom##3##2##(2008-11#2)(2012-3#1)
nasal symptoms##2##2##(2008-3#1)(2013-1#1)
nasal tip##5##2##(1995-6#1)(1997-3#2)(2008-5#1)(2010-8#1)
nasal##176##1##(1990-6#1)(1990-7#3)(1990-9#2)(1991-3#1)(1991-4#1)(1992-10#6)(1992-11#3)(1993-11#4)(1993-2#4)(1993-8#4)(1993-9#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#8)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#3)(2007-7#2)(2008-10#5)(2008-11#12)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#15)(2011-2#18)(2012-1#9)(2012-12#8)(2012-3#6)(2013-1#16)(2013-8#1)
nascent RNA##2##2##(2008-9#1)(2011-2#1)
nascent polypeptide chains##2##3##(1994-11#2)
nascent protein##2##2##(1995-2#2)
nascent proteins##2##2##(1994-12#1)(1995-2#1)
nascent transcript##2##2##(1994-8#2)
nascent##28##1##(1990-5#1)(1991-5#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
nashicola##14##1##(2008-10#14)
nasi##2##1##(1995-6#1)(2012-12#1)
nasobiliary drainage##2##2##(2013-1#2)
nasogastric tube##3##2##(1992-5#1)(2007-8#1)(2012-3#1)
nasolabial flap##3##2##(2007-12#3)
nasolabial fold and chin of##2##5##(2008-5#2)
nasolabial fold and chin##5##4##(2008-5#5)
nasolabial fold##7##2##(2008-5#7)
nasolabial##12##1##(2007-12#3)(2008-5#9)
nasopharyngeal carcinoma and##2##3##(2007-2#1)(2008-4#1)
nasopharyngeal carcinoma##17##2##(1991-2#2)(1991-8#2)(1993-9#1)(2007-2#1)(2007-4#1)(2008-4#1)(2008-8#2)(2008-9#4)(2012-1#1)(2012-2#1)(2013-1#1)
nasopharyngeal lymphoepithelioma##2##2##(2007-5#2)
nasopharyngeal##37##1##(1991-2#2)(1991-8#2)(1993-6#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#4)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
nasopharynx##5##1##(1993-12#1)(1993-9#1)(1994-2#1)(1995-5#2)
nasus)##2##1##(2008-10#2)
nat##8##1##(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#2)
natal philopatry##2##2##(2008-8#2)
natal##12##1##(1990-11#1)(2008-4#1)(2008-8#5)(2008-9#1)(2010-3#2)(2010-4#1)(2013-8#1)
natalizumab##3##1##(2008-4#1)(2010-12#1)(2012-3#1)
nation and##2##2##(2008-1#1)(2008-3#1)
nation##25##1##(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
nation's health care##3##3##(1995-2#1)(1995-3#1)(1996-2#1)
nation's health##9##2##(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2010-1#1)
nation's##27##1##(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-12#2)(1995-2#3)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-7#1)
nation-wide register##2##2##(1995-8#2)
nation-wide##9##1##(1990-9#1)(1991-9#1)(1993-6#1)(1994-12#2)(1995-8#2)(2008-1#1)(2011-2#1)
national 5 A Day##2##4##(1997-1#2)
national ADR##2##2##(2008-3#1)(2011-2#1)
national GN registry##2##3##(2008-1#2)
national agenda##3##2##(2008-1#1)(2008-11#2)
national and international##14##3##(1994-12#1)(1997-7#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
national and local##3##3##(1994-3#1)(2012-12#1)(2013-8#1)
national and regional##3##3##(2008-1#1)(2011-1#1)(2011-2#1)
national and state##3##3##(1995-1#1)(2008-11#2)
national and##30##2##(1991-1#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-7#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-9#1)(2009-4#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
national attention##2##2##(1993-12#1)(2009-5#1)
national average##8##2##(1992-12#1)(1993-12#1)(2008-10#4)(2008-11#1)(2008-6#1)
national averages##2##2##(2008-10#1)(2012-12#1)
national cancer control##2##3##(2011-3#2)
national commitment##2##2##(1993-12#1)(1994-2#1)
national conference##2##2##(2008-10#1)(2013-1#1)
national data on##2##3##(1991-6#1)(2008-11#1)
national data##6##2##(1991-6#1)(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-11#1)
national debate##2##2##(1991-3#1)(1993-12#1)
national diet##2##2##(2008-3#2)
national differences##2##2##(1995-6#2)
national economic indicators##6##3##(1991-1#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
national economy##3##2##(1994-2#1)(2008-9#1)(2010-1#1)
national experts##2##2##(1990-6#1)(1994-12#1)
national fee##2##2##(1992-12#1)(1992-3#1)
national governments##2##2##(2008-12#1)(2011-1#1)
national guidelines##7##2##(1996-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
national health accounts##2##3##(1993-2#1)(2012-12#1)
national health authorities##3##3##(1992-11#1)(1994-2#1)(2012-12#1)
national health care reform##4##4##(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)
national health care system##2##4##(1994-2#2)
national health care##11##3##(1993-12#1)(1994-2#3)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(2008-11#1)
national health expenditure##2##3##(1992-3#1)(1993-12#1)
national health expenditures##6##3##(1991-2#1)(1992-3#4)(1994-3#1)
national health information##2##3##(1994-12#1)(2011-1#1)
national health insurance##5##3##(1991-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(2008-11#1)
national health objectives##2##3##(1991-5#1)(1996-9#1)
national health surveys##2##3##(1993-2#1)(1993-6#1)
national health##50##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#7)(1993-12#3)(1993-2#2)(1993-6#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#2)(1995-12#3)(1995-2#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-2#1)(2008-1#3)(2008-11#2)(2008-7#2)(2008-8#2)(2011-1#2)(2011-2#1)(2012-12#2)
national hospital##2##2##(1992-2#1)(2013-1#1)
national identity##2##2##(2008-10#1)(2011-2#1)
national immunization##2##2##(2007-11#1)(2007-12#1)
national income##2##2##(1993-3#1)(2013-7#1)
national level##11##2##(1994-2#1)(1995-12#1)(1995-2#1)(2007-11#3)(2008-10#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-12#1)
national monitoring##2##2##(1995-12#1)(2008-10#1)
national network##3##2##(1991-1#1)(1993-12#1)(2008-7#1)
national norms and recommendations##2##4##(2010-3#2)
national norms and##3##3##(1996-2#1)(2010-3#2)
national norms##5##2##(1994-3#2)(1996-2#1)(2010-3#2)
national organizations##3##2##(1994-12#1)(1994-2#1)(2008-10#1)
national policy##5##2##(2008-1#1)(2008-11#1)(2010-10#1)(2010-3#1)(2010-7#1)
national population##2##2##(2008-1#1)(2013-8#1)
national practice##3##2##(1991-1#1)(1996-12#1)(2010-9#1)
national prevalence##2##2##(2007-12#2)
national priorities##2##2##(1994-2#1)(2008-11#1)
national priority##4##2##(1994-7#1)(1996-9#1)(2009-5#1)(2011-3#1)
national problem##2##2##(2011-2#2)
national program of##2##3##(1997-2#1)(2008-3#1)
national program##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
national project##2##2##(1996-9#1)(2011-2#1)
national public health surveillance##3##4##(1997-3#3)
national public health##6##3##(1997-3#4)(2007-2#1)(2008-11#1)
national rates##3##2##(2007-10#1)(2007-12#1)(2012-3#1)
national requirements##2##2##(1994-12#1)(2009-12#1)
national sample of##5##3##(1992-12#1)(1993-12#1)(2008-12#1)(2009-2#1)(2012-1#1)
national sample##11##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(2008-12#1)(2009-2#1)(2009-7#1)(2012-1#1)(2012-3#1)
national setting##2##2##(2010-11#1)(2011-2#1)
national standard##3##2##(1996-12#1)(2008-10#1)(2012-1#1)
national standards for##2##3##(1996-12#1)(2008-11#1)
national standards##10##2##(1993-1#1)(1994-3#2)(1995-3#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2012-3#2)
national statistics##2##2##(2013-1#1)(2013-8#1)
national strategy##3##2##(1993-12#1)(2007-12#1)(2007-8#1)
national study##2##2##(1992-12#1)(1994-3#1)
national surveillance##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
national survey of##9##3##(1991-11#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(2010-2#1)(2012-12#1)
national survey##19##2##(1991-11#2)(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-11#1)(1997-3#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
national surveys to##2##3##(1991-9#1)(1992-1#1)
national surveys##4##2##(1991-9#1)(1992-1#1)(2007-11#1)(2012-1#1)
national system##2##2##(1992-1#1)(1994-6#1)
national##485##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#4)(1991-11#5)(1991-12#4)(1991-2#3)(1991-3#6)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#12)(1992-5#2)(1992-6#2)(1992-9#2)(1993-1#5)(1993-11#1)(1993-12#14)(1993-2#3)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#13)(1994-2#16)(1994-3#8)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#4)(1995-12#7)(1995-2#7)(1995-3#5)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#4)(1996-8#1)(1996-9#5)(1997-1#6)(1997-2#6)(1997-3#8)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#3)(2007-11#10)(2007-12#8)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#16)(2008-10#22)(2008-11#23)(2008-12#8)(2008-2#1)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#4)(2009-7#4)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#9)(2011-2#24)(2011-3#3)(2012-1#5)(2012-12#16)(2012-2#7)(2012-3#17)(2013-1#12)(2013-7#2)(2013-8#9)
nationalism##5##1##(2008-2#1)(2008-7#1)(2011-1#3)
nationalities in the##2##3##(1995-6#2)
nationalities in##3##2##(1995-6#3)
nationalities##10##1##(1992-5#1)(1995-6#9)
nationality or##2##2##(2008-5#1)(2011-2#1)
nationality##8##1##(1991-2#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#2)
nationally and internationally##3##3##(1993-2#1)(2008-12#1)(2011-2#1)
nationally in the##2##3##(2012-12#1)(2013-1#1)
nationally representative sample of##6##4##(1993-1#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
nationally representative sample##7##3##(1993-1#1)(2009-7#1)(2010-3#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
nationally representative surveys##2##3##(1993-1#1)(2011-2#1)
nationally representative##16##2##(1993-1#2)(1997-1#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
nationally##41##1##(1992-12#1)(1992-2#1)(1993-1#2)(1993-2#1)(1994-12#2)(1994-3#2)(1996-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
nationals##3##1##(1992-5#2)(2013-8#1)
nations across the##2##3##(2010-5#1)(2012-2#1)
nations and##2##2##(2009-6#1)(2013-7#1)
nations are##2##2##(1992-1#1)(2007-12#1)
nations have##2##2##(2008-11#2)
nations in the##2##3##(2008-1#1)(2009-4#1)
nations to##2##2##(1993-2#1)(2008-11#1)
nations with##3##2##(2012-12#1)(2012-3#1)(2013-7#1)
nations##35##1##(1992-1#2)(1993-2#1)(1995-3#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-11#3)(2009-4#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#5)
nationwide and##2##2##(1991-3#1)(1992-12#1)
nationwide study##2##2##(2010-3#1)(2013-1#1)
nationwide##38##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-3#1)(1992-11#1)(1992-12#1)(1993-12#2)(1994-12#1)(1995-1#2)(1997-1#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-2#3)(2011-9#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
nativa (T2)##2##2##(1996-12#2)
native 23 kDa##2##3##(1993-8#2)
native AVFs##4##2##(2007-7#4)
native Amazonians##4##2##(1991-12#4)
native Arabic##2##2##(2013-8#2)
native LDL##4##2##(1993-6#1)(2008-10#1)(2009-8#2)
native PDMS##2##2##(2009-2#2)
native Solanum spp##2##3##(2008-10#2)
native Ssh7##2##2##(2008-9#2)
native and denatured##5##3##(1990-5#1)(1995-3#1)(2008-10#2)(2008-8#1)
native and introduced##2##3##(2008-5#1)(2008-6#1)
native and recombinant##2##3##(2008-9#1)(2011-2#1)
native and unfolded##2##3##(1995-5#1)(1997-2#1)
native and##30##2##(1990-5#2)(1990-7#1)(1992-11#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
native arteries##5##2##(2011-2#5)
native arteriovenous##5##2##(2007-7#5)
native conformation##4##2##(1992-6#2)(1995-2#1)(2008-8#1)
native disease##2##2##(2011-2#2)
native enzyme and##3##3##(1992-11#1)(1993-11#1)(1995-6#1)
native enzyme or##2##3##(1990-12#1)(1995-6#1)
native enzyme##31##2##(1990-11#4)(1990-12#1)(1990-5#3)(1992-11#1)(1992-3#1)(1993-11#2)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#4)(1995-5#1)(1995-6#4)(1997-4#1)(1997-6#1)(2008-10#1)(2008-8#1)
native extracellular matrix##2##3##(2010-9#1)(2012-6#1)
native fish##2##2##(2008-5#1)(2012-2#1)
native fluorescence of##3##3##(2008-10#3)
native fluorescence##12##2##(1990-8#1)(2008-10#11)
native form##6##2##(1990-2#2)(1995-2#1)(1995-3#1)(2008-10#1)(2010-5#1)
native gel##6##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)
native grasslands##2##2##(2013-7#2)
native habitats##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
native host isolates##2##3##(2008-10#2)
native host##3##2##(2008-10#3)
native human##8##2##(1990-12#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-11#2)(2008-11#1)(2008-5#1)
native kidney biopsies##2##3##(2008-1#2)
native kidney##3##2##(2008-1#3)
native kidneys##2##2##(2008-1#2)
native language##2##2##(2008-2#1)(2013-8#1)
native liver##2##2##(1993-8#1)(1994-8#1)
native or cloned muscarinic M3/m3##2##5##(1997-7#2)
native or##6##2##(1992-8#1)(1995-5#1)(1997-7#2)(2008-10#1)(2008-4#1)
native peptide##2##2##(1994-8#1)(2011-2#1)
native phycoerythrin##2##2##(2008-8#2)
native plant##2##2##(2008-10#1)(2011-2#1)
native polyacrylamide gel electrophoresis##2##4##(2008-11#1)(2010-3#1)
native polyacrylamide gels##2##3##(1992-2#1)(2008-2#1)
native polyacrylamide##4##2##(1992-2#1)(2008-11#1)(2008-2#1)(2010-3#1)
native populations##4##2##(1991-12#1)(2008-10#3)
native promoter##2##2##(2008-7#1)(2009-8#1)
native protein##17##2##(1990-5#1)(1990-7#1)(1990-8#2)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)
native proteins##3##2##(1994-5#1)(2007-11#1)(2008-4#1)
native receptors##2##2##(1993-8#1)(1995-11#1)
native secondary structure##2##3##(1992-12#2)
native secondary##3##2##(1992-12#2)(1995-3#1)
native speakers of##2##3##(2013-8#2)
native species##3##2##(2008-5#1)(2008-8#1)(2013-7#1)
native state##14##2##(1992-3#1)(1992-6#2)(1993-11#3)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2013-8#1)
native structure##4##2##(1993-11#2)(1997-4#1)(2008-9#1)
native tissues##3##2##(2008-8#2)(2013-8#1)
native to the##7##3##(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)
native to##13##2##(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
native tree species##2##3##(2008-10#1)(2008-5#1)
native tricuspid valve endocarditis caused by viridans##2##7##(2007-12#2)
native uPA##4##2##(2008-11#4)
native vessel##3##2##(2008-5#3)
native virus and##2##3##(2008-10#2)
native yeast##2##2##(1997-4#1)(2008-10#1)
native##474##1##(1990-11#9)(1990-12#4)(1990-2#5)(1990-5#11)(1990-7#8)(1990-8#6)(1991-10#1)(1991-12#5)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#4)(1992-6#7)(1992-8#6)(1993-1#1)(1993-11#14)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#13)(1994-11#7)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#10)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#14)(1995-3#7)(1995-5#7)(1995-6#6)(1995-8#3)(1996-12#1)(1997-2#6)(1997-3#2)(1997-4#7)(1997-6#1)(1997-7#3)(1997-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#12)(2007-8#1)(2008-1#8)(2008-10#74)(2008-11#13)(2008-12#1)(2008-2#4)(2008-4#12)(2008-5#16)(2008-6#3)(2008-7#10)(2008-8#26)(2008-9#14)(2009-11#1)(2009-2#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-6#1)(2013-1#7)(2013-7#4)(2013-8#9)
native&quot##2##1##(1990-5#1)(2008-6#1)
native-born##5##1##(2011-2#5)
native-like##5##1##(1995-3#3)(1997-2#1)(2008-7#1)
nativity couples##2##2##(2012-12#2)
nativity##6##1##(1994-12#1)(2011-2#1)(2012-12#3)(2013-8#1)
natriuretic factor##5##2##(1990-2#1)(1990-9#2)(1994-8#1)(1996-9#1)
natriuretic peptide (ANP)##7##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-8#1)(2008-5#1)(2009-5#1)(2011-2#1)
natriuretic peptide (BNP)##5##3##(1991-2#1)(1991-5#1)(2008-3#1)(2008-7#1)(2009-5#1)
natriuretic peptide (CNP) and##2##4##(1994-8#1)(2009-5#1)
natriuretic peptide (CNP)##3##3##(1993-11#1)(1994-8#1)(2009-5#1)
natriuretic peptide (NT-proBNP)##2##3##(2008-3#1)(2011-2#1)
natriuretic peptide and##5##3##(1993-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
natriuretic peptide in##3##3##(1991-5#1)(1994-11#1)(2008-3#1)
natriuretic peptide levels##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
natriuretic peptide##53##2##(1990-12#4)(1990-3#1)(1990-7#3)(1991-2#2)(1991-5#3)(1992-3#2)(1993-11#2)(1993-12#1)(1993-8#2)(1994-11#1)(1994-8#4)(1995-11#1)(1996-8#1)(2007-5#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#6)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
natriuretic peptides##9##2##(1990-12#2)(1994-8#1)(1997-6#1)(2009-5#4)(2011-2#1)
natriuretic##76##1##(1990-12#6)(1990-2#2)(1990-3#1)(1990-7#4)(1990-9#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-8#6)(1995-11#2)(1996-8#1)(1996-9#1)(1997-6#1)(2007-5#1)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#10)(2010-4#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)
natural H1N1 infection##2##3##(2012-12#2)
natural abundance##5##2##(1992-4#1)(2008-10#3)(2012-8#1)
natural active##2##2##(2008-5#1)(2008-7#1)
natural aerated reactor##2##3##(2008-12#2)
natural agents##4##2##(2009-1#3)(2010-7#1)
natural allogeneic mature DCs##2##4##(2011-2#2)
natural allogeneic mature##3##3##(2011-2#3)
natural analogs of##2##3##(1995-2#2)
natural and artificial##3##3##(1992-5#1)(2008-3#1)(2011-1#1)
natural and industrial##3##3##(2008-10#3)
natural and man-made##2##3##(2008-11#2)
natural and recombinant##2##3##(1992-8#1)(1997-2#1)
natural and sexual selection##4##4##(2008-8#2)(2012-3#2)
natural and synthetic estrogen concentrations##2##5##(2013-1#2)
natural and synthetic##17##3##(1991-12#1)(1991-5#1)(1993-3#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
natural and the##2##3##(2008-10#1)(2008-11#1)
natural and waste waters##2##4##(2008-10#2)
natural and##62##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#21)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-7#1)(2011-1#3)(2012-2#2)(2012-3#3)(2013-1#3)
natural antibodies##3##2##(1991-5#1)(1994-11#1)(1997-9#1)
natural anticancer defenses##2##3##(2013-1#2)
natural antioxidant##4##2##(2008-5#1)(2009-8#1)(2010-4#1)(2013-1#1)
natural arteriovenous fistula##3##3##(2007-7#3)
natural arteriovenous##5##2##(2007-7#5)
natural background##3##2##(1994-9#1)(2008-10#1)(2008-7#1)
natural bacterial##3##2##(2008-10#1)(2010-6#1)(2011-1#1)
natural barrier##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
natural barriers##3##2##(1996-9#1)(2008-11#1)(2011-3#1)
natural bases##2##2##(2008-4#2)
natural biological##2##2##(2008-10#1)(2008-11#1)
natural brines##4##2##(2008-10#4)
natural caregivers##5##2##(1992-3#5)
natural causes##2##2##(2009-4#1)(2010-10#1)
natural chemicals##2##2##(2008-11#1)(2011-1#1)
natural chilling##2##2##(2008-10#2)
natural clouds##2##2##(2008-2#2)
natural color##2##2##(2008-11#1)(2008-5#1)
natural communities##2##2##(2008-8#1)(2008-9#1)
natural compounds derived from traditional Chinese##2##6##(2011-3#2)
natural compounds from traditional Chinese medicines##2##6##(2011-3#2)
natural compounds##10##2##(1994-11#2)(2011-2#1)(2011-3#6)(2012-2#1)
natural condition##2##2##(1994-9#1)(2009-9#1)
natural conditions##15##2##(1997-6#1)(2008-10#9)(2008-11#1)(2008-9#1)(2013-1#2)(2013-7#1)
natural cooling##2##2##(2008-10#1)(2008-5#1)
natural cosmetics##2##2##(2008-5#2)
natural course##7##2##(1990-6#1)(1992-9#1)(1997-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
natural cytotoxicity##3##2##(1995-3#1)(2008-4#2)
natural dead wood##2##3##(2008-10#2)
natural debris flow##3##3##(2008-2#1)(2008-3#2)
natural dentition##2##2##(2007-12#2)
natural diamond##2##2##(2008-10#2)
natural disaster##5##2##(1991-2#2)(2008-2#2)(2008-9#1)
natural disasters affect##2##3##(2013-1#2)
natural disasters and##2##3##(2012-3#1)(2013-1#1)
natural disasters in##2##3##(1991-2#1)(2008-2#1)
natural disasters##18##2##(1991-2#1)(2008-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#12)
natural dye##2##2##(2008-10#1)(2013-1#1)
natural ecosystem##2##2##(2008-10#1)(2008-12#1)
natural ecosystems##3##2##(2008-10#2)(2008-8#1)
natural enemies in##2##3##(2008-8#1)(2008-9#1)
natural enemies of##3##3##(1990-11#1)(2008-12#1)(2008-5#1)
natural enemies that##2##3##(2008-8#1)(2009-8#1)
natural enemies##12##2##(1990-11#1)(2008-12#1)(2008-5#1)(2008-8#6)(2008-9#2)(2009-8#1)
natural enemy##3##2##(2008-8#2)(2013-8#1)
natural environment in##2##3##(1997-7#1)(2007-5#1)
natural environment##11##2##(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-6#1)(2011-1#1)
natural environmental##3##2##(2008-10#2)(2008-5#1)
natural estrogens##2##2##(2010-5#1)(2013-1#1)
natural evolution of##4##3##(1991-12#1)(1991-3#1)(1994-12#1)(1997-8#1)
natural evolution##5##2##(1991-12#1)(1991-3#1)(1994-12#1)(1997-6#1)(1997-8#1)
natural evolutionary##2##2##(1997-6#1)(2008-10#1)
natural experiment##3##2##(1992-2#1)(1997-3#1)(2008-12#1)
natural experiments##3##2##(1994-2#1)(2010-3#1)(2011-1#1)
natural exposure##2##2##(2008-11#1)(2008-12#1)
natural extension##2##2##(2008-3#2)
natural fluids##3##2##(2008-10#3)
natural food samples##3##3##(2008-10#3)
natural food##5##2##(2008-10#4)(2008-6#1)
natural forces##2##2##(2008-11#1)(2013-8#1)
natural forest##3##2##(2012-2#2)(2012-6#1)
natural forests and##2##3##(2008-10#1)(2010-4#1)
natural forests##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
natural gas##8##2##(2008-10#1)(2008-2#4)(2012-12#2)(2013-1#1)
natural groundwater##2##2##(2008-10#1)(2013-1#1)
natural growth##2##2##(2008-1#1)(2012-3#1)
natural guide star##2##3##(2008-2#1)(2008-3#1)
natural gynogenesis##2##2##(2008-9#2)
natural gynogenetic##2##2##(2008-8#1)(2008-9#1)
natural habitat##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
natural habitats##5##2##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-7#1)
natural health##3##2##(2008-11#2)(2010-3#1)
natural heme##3##2##(1990-8#3)
natural history and##6##3##(1992-8#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2012-12#1)
natural history is not##2##4##(2009-4#1)(2011-7#1)
natural history of infection##2##4##(2008-10#1)(2008-7#1)
natural history of the disease##3##5##(1991-6#1)(1993-11#1)(2007-8#1)
natural history of the##9##4##(1991-6#1)(1993-11#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2012-3#1)
natural history of##38##3##(1990-12#1)(1991-1#1)(1991-6#2)(1992-12#1)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#3)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-3#1)(2013-1#2)(2013-8#2)
natural history##62##2##(1990-12#1)(1991-1#1)(1991-6#2)(1992-12#1)(1992-8#1)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#1)(2009-4#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
natural host##3##2##(1995-2#1)(2008-10#2)
natural hosts##2##2##(2011-1#1)(2013-1#1)
natural human IFNalpha##2##3##(2007-11#2)
natural human##3##2##(2007-11#2)(2008-11#1)
natural humic acids##2##3##(2008-10#2)
natural humic##3##2##(2008-10#3)
natural hybrid zones##4##3##(2008-8#4)
natural image##2##2##(2008-11#1)(2008-8#1)
natural images##4##2##(2008-11#2)(2008-3#1)(2008-6#1)
natural increase##4##2##(1993-12#1)(2008-8#1)(2011-2#2)
natural infection by##2##3##(2008-7#1)(2012-12#1)
natural infection##4##2##(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
natural infections in##2##3##(2008-5#1)(2012-12#1)
natural infections of##2##3##(2008-10#1)(2013-1#1)
natural infections##5##2##(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
natural inoculum in##2##3##(2008-10#2)
natural inoculum##5##2##(2008-10#5)
natural isolates##2##2##(2012-3#2)
natural killer (NK) cell##5##4##(2008-10#2)(2008-9#1)(2013-1#2)
natural killer (NK) cells from##2##5##(1995-2#1)(2008-4#1)
natural killer (NK) cells##6##4##(1992-2#1)(1995-2#1)(2008-4#1)(2010-1#1)(2012-3#1)(2013-1#1)
natural killer (NK) or lymphokine-activated killer (LAK) cells##2##8##(2008-4#2)
natural killer (NK)##13##3##(1992-2#1)(1995-2#1)(2008-10#2)(2008-4#3)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#3)
natural killer activity##3##3##(1994-6#1)(1995-3#1)(2008-7#1)
natural killer cell activity##5##4##(1994-5#1)(2007-11#1)(2008-10#3)
natural killer cell assay##2##4##(2008-10#2)
natural killer cell##17##3##(1994-5#1)(1995-3#2)(2006-10#1)(2007-11#1)(2008-10#6)(2008-4#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
natural killer cells and##4##4##(1993-6#1)(1995-3#1)(2008-7#1)(2013-1#1)
natural killer cells##18##3##(1990-12#3)(1993-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#3)
natural killer enhancing factor as##2##5##(1994-2#2)
natural killer enhancing factor##5##4##(1994-2#5)
natural killer receptors and##2##4##(2008-4#1)(2008-7#1)
natural killer##61##2##(1990-12#3)(1992-2#1)(1993-6#1)(1994-2#5)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#4)(1996-12#2)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#10)(2008-4#6)(2008-6#1)(2008-7#4)(2008-9#3)(2010-1#1)(2010-5#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#6)
natural killer-like activity of##2##4##(2008-11#2)
natural killer-like activity##5##3##(2008-11#5)
natural language##3##2##(1991-8#1)(1994-3#1)(2008-11#1)
natural ligand##3##2##(2007-7#1)(2008-11#1)(2010-1#1)
natural light##3##2##(2008-3#2)(2013-1#1)
natural membranes##2##2##(1991-5#2)
natural mixed infections##2##3##(2008-10#2)
natural moisturizing##2##2##(2008-5#2)
natural nests##2##2##(2008-8#1)(2012-2#1)
natural occurrence of##2##3##(2008-12#1)(2010-8#1)
natural or synthetic##2##3##(2009-3#1)(2012-12#1)
natural or technological##2##3##(2008-2#1)(2011-1#1)
natural or##12##2##(1997-3#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#2)(2012-12#1)(2013-1#1)
natural organic matter##7##3##(1992-5#1)(2008-10#4)(2008-11#2)
natural organic##8##2##(1992-5#1)(2008-10#5)(2008-11#2)
natural origin##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
natural pasture##2##2##(2010-2#2)
natural pastures##2##2##(2010-2#2)
natural peptides##2##2##(2008-5#1)(2013-1#1)
natural peptides/proteins##2##2##(2006-12#2)
natural perturbations are##2##3##(2008-10#2)
natural perturbations##4##2##(2008-10#4)
natural phenomena##2##2##(1992-3#1)(2008-11#1)
natural plant##3##2##(2008-5#1)(2008-8#1)(2011-1#1)
natural polymers##6##2##(2008-10#3)(2008-5#1)(2012-2#2)
natural population of##5##3##(2008-10#1)(2008-5#1)(2008-9#3)
natural population##7##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)
natural populations from Novosibirsk and its##2##6##(2013-1#2)
natural populations is##2##3##(2008-10#1)(2013-7#1)
natural populations of An##2##4##(2012-12#2)
natural populations of the##3##4##(2008-10#2)(2008-9#1)
natural populations of##13##3##(2008-10#5)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#2)(2012-3#2)
natural populations##40##2##(1995-2#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#6)(2008-9#10)(2011-2#1)(2012-12#2)(2012-3#6)(2013-1#2)(2013-7#1)
natural preservative system##3##3##(2008-5#3)
natural preservative##5##2##(2008-5#3)(2008-8#2)
natural process of##2##3##(2008-10#1)(2008-5#1)
natural product HIF-1 inhibitors##2##4##(2010-7#2)
natural product##22##2##(1991-5#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#1)(2009-5#2)(2009-8#1)(2010-2#2)(2010-7#2)(2011-2#2)
natural products and chemical entities##2##5##(2009-2#2)
natural products and##3##3##(2009-10#1)(2009-2#2)
natural products have##2##3##(2010-7#2)
natural products in##2##3##(2008-11#1)(2009-11#1)
natural products often##2##3##(1997-2#1)(2010-2#1)
natural products that##2##3##(1995-3#1)(2009-6#1)
natural products##36##2##(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-10#2)(2009-11#3)(2009-2#2)(2009-6#1)(2010-2#5)(2010-7#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
natural progression##3##2##(2008-7#1)(2010-12#1)(2013-7#1)
natural protection##2##2##(2008-12#1)(2008-8#1)
natural protein##2##2##(2008-5#2)
natural pyrophosphates##2##2##(2008-4#2)
natural rainfall##2##2##(2008-10#2)
natural range##2##2##(2008-12#1)(2013-1#1)
natural reservoir##3##2##(2008-10#2)(2008-12#1)
natural resistance to##2##3##(2008-10#1)(2010-8#1)
natural resistance##5##2##(1990-5#1)(2008-10#2)(2009-6#1)(2010-8#1)
natural resources##10##2##(1992-3#2)(2007-5#2)(2008-1#1)(2008-11#1)(2010-7#2)(2013-7#2)
natural route of##2##3##(2008-9#2)
natural samples with##2##3##(1994-8#1)(2008-10#1)
natural samples##6##2##(1994-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
natural science##2##2##(2008-12#2)
natural sciences##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
natural scientists##2##2##(2008-12#1)(2009-8#1)
natural secretions##2##2##(2008-5#2)
natural selection acting##2##3##(2008-8#1)(2012-3#1)
natural selection favors##3##3##(1995-2#1)(2008-8#1)(2009-8#1)
natural selection has##2##3##(2008-8#1)(2012-3#1)
natural selection in##6##3##(2008-9#3)(2010-4#1)(2010-5#1)(2012-3#1)
natural selection on##5##3##(2008-8#1)(2008-9#2)(2010-4#1)(2012-3#1)
natural selection should##2##3##(2008-9#1)(2012-3#1)
natural selection##49##2##(1995-2#1)(1997-4#1)(2008-10#3)(2008-4#2)(2008-8#10)(2008-9#6)(2009-5#1)(2009-8#1)(2010-2#2)(2010-4#3)(2010-5#3)(2012-12#2)(2012-3#13)(2013-1#1)
natural shampoos##4##2##(2008-5#4)
natural soil##5##2##(2008-10#4)(2008-11#1)
natural source##3##2##(1994-11#2)(2008-10#1)
natural sources)##2##2##(2008-4#1)(2008-5#1)
natural spiked samples##2##3##(2008-10#2)
natural spiked##3##2##(2008-10#3)
natural spring water##2##3##(2008-10#2)
natural stimuli##8##2##(2008-7#8)
natural substances##2##2##(2008-10#1)(2008-5#1)
natural substrate##2##2##(1995-12#1)(1995-2#1)
natural succession##2##2##(2008-10#1)(2008-9#1)
natural sunlight##2##2##(2008-5#1)(2011-2#1)
natural surfactants##2##2##(2011-1#2)
natural systems##11##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#2)
natural teeth##2##2##(2008-7#1)(2011-2#1)
natural tendency to##2##3##(2008-10#1)(2013-1#1)
natural tooth##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
natural transformation and electro-transformation##2##4##(1993-9#2)
natural transmission##2##2##(2008-10#1)(2012-12#1)
natural variants##3##2##(1991-8#1)(2008-10#1)(2009-6#1)
natural variation in##2##3##(2008-8#2)
natural variation##3##2##(2008-8#2)(2012-3#1)
natural virulent##2##2##(2008-10#2)
natural water sample##3##3##(2008-10#3)
natural water samples and##2##4##(2008-10#2)
natural water samples were##3##4##(2008-10#2)(2008-11#1)
natural water samples##40##3##(2008-10#39)(2008-11#1)
natural water##79##2##(2008-10#77)(2008-11#1)(2013-8#1)
natural waters and biological samples##3##5##(2008-10#3)
natural waters and soils##2##4##(2008-10#2)
natural waters and urine##2##4##(2008-10#2)
natural waters and##16##3##(2008-10#16)
natural waters##88##2##(1994-8#1)(2008-10#82)(2008-12#1)(2008-2#1)(2008-3#3)
natural##1402##1##(1990-11#1)(1990-12#6)(1990-2#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#3)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#6)(1991-6#5)(1991-8#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#6)(1994-2#6)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#8)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#11)(1995-3#8)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#3)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#4)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#8)(1997-4#8)(1997-6#6)(1997-7#2)(1997-8#2)(1997-9#1)(2006-10#3)(2006-12#4)(2006-4#3)(2007-10#3)(2007-11#9)(2007-12#9)(2007-2#2)(2007-5#4)(2007-7#9)(2007-8#3)(2008-1#6)(2008-10#427)(2008-11#59)(2008-12#21)(2008-2#22)(2008-3#19)(2008-4#24)(2008-5#70)(2008-6#14)(2008-7#38)(2008-8#62)(2008-9#50)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#10)(2009-9#2)(2010-1#3)(2010-10#6)(2010-12#6)(2010-2#14)(2010-3#3)(2010-4#7)(2010-5#9)(2010-6#2)(2010-7#11)(2010-8#3)(2010-9#2)(2011-1#21)(2011-2#32)(2011-3#9)(2011-7#2)(2012-1#2)(2012-12#19)(2012-2#23)(2012-3#34)(2012-6#1)(2012-8#1)(2013-1#57)(2013-7#10)(2013-8#10)
natural&quot##3##1##(2008-1#1)(2008-10#1)(2008-9#1)
natural-based##2##1##(2008-10#1)(2008-5#1)
naturalism##2##1##(2008-12#1)(2013-8#1)
naturalist##3##1##(2008-12#1)(2008-4#1)(2012-2#1)
naturalistic study##4##2##(1993-12#1)(2008-6#1)(2008-9#1)(2009-11#1)
naturalistic##14##1##(1991-1#1)(1993-12#1)(1995-3#1)(1995-9#1)(1996-7#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
naturalizations##3##1##(2008-8#3)
naturalized##2##1##(2008-10#1)(2008-8#1)
naturally acquired##3##2##(1997-3#1)(2008-7#1)(2011-1#1)
naturally and artificially infected##2##4##(2008-10#2)
naturally and##4##2##(2008-10#3)(2011-2#1)
naturally by##2##2##(1995-2#1)(2008-10#1)
naturally contaminated raisins##4##3##(2008-10#4)
naturally contaminated##9##2##(1997-6#1)(2008-10#7)(2011-1#1)
naturally in##5##2##(2007-7#1)(2008-10#2)(2008-7#1)(2009-8#1)
naturally infected mouse##2##3##(1995-9#2)
naturally infected vines##2##3##(2008-10#2)
naturally infected with##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
naturally infected##33##2##(1992-8#1)(1995-9#2)(1997-3#1)(2008-10#27)(2008-12#1)(2008-7#1)
naturally infects##2##2##(2008-9#1)(2012-12#1)
naturally infested field##2##3##(2008-10#2)
naturally infested with##2##3##(2008-10#1)(2008-6#1)
naturally infested##14##2##(1996-12#1)(2008-10#12)(2008-6#1)
naturally inoculated##2##2##(2008-10#2)
naturally occurring compounds##2##3##(1995-9#1)(2009-2#1)
naturally occurring dietary##2##3##(1993-11#1)(1995-9#1)
naturally occurring epidemics##2##3##(2008-10#2)
naturally occurring fatty acid##2##4##(1993-9#2)
naturally occurring flightless##2##3##(2008-9#2)
naturally occurring human##2##3##(1991-12#1)(2008-8#1)
naturally occurring in the##2##4##(1992-6#1)(1995-6#1)
naturally occurring in##3##3##(1992-6#1)(1995-6#1)(2011-1#1)
naturally occurring intramammary infections##2##4##(2012-3#2)
naturally occurring mutant human##2##4##(1992-3#1)(2008-6#1)
naturally occurring polyphenols##2##3##(2008-5#1)(2009-12#1)
naturally occurring populations##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
naturally occurring radionuclides##2##3##(1994-9#2)
naturally occurring resistance##2##3##(2008-10#2)
naturally occurring species in##2##4##(2008-10#1)(2008-3#1)
naturally occurring strains of##2##4##(2007-6#1)(2008-10#1)
naturally occurring##110##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-5#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-6#1)(2008-10#28)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
naturally or##2##2##(1992-2#1)(1996-12#1)
naturally ordered individuals##2##3##(1997-7#2)
naturally present in##2##3##(1995-2#1)(2008-10#1)
naturally to##3##2##(1997-3#1)(2008-11#1)(2009-5#1)
naturally##259##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#5)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#101)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#6)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#2)
naturally-occurring##7##1##(1990-12#1)(1993-12#1)(2008-11#3)(2008-5#2)
nature and composition of the##4##5##(2008-10#3)(2013-1#1)
nature and concentration of the##3##5##(1994-9#1)(2008-10#2)
nature and concentration of##4##4##(1994-9#1)(2008-10#3)
nature and concentration##5##3##(1994-9#1)(2008-10#4)
nature and extent of##7##4##(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
nature and may##3##3##(1991-2#1)(2008-8#2)
nature and origin of##2##4##(2007-5#1)(2008-10#1)
nature and properties of the##2##5##(1994-5#1)(1995-11#1)
nature and the##7##3##(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(2008-3#1)(2008-5#1)(2010-4#1)
nature and##96##2##(1990-3#1)(1991-2#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
nature are##3##2##(1991-9#1)(2011-2#1)(2012-3#1)
nature as##5##2##(1994-1#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
nature has##4##2##(1992-11#1)(1996-2#1)(2008-8#1)(2009-7#1)
nature in a##2##3##(2008-12#1)(2008-5#1)
nature in the##2##3##(2007-11#1)(2010-5#1)
nature in##8##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
nature is the##2##3##(1994-11#1)(2008-12#1)
nature is##7##2##(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#2)
nature of B##2##3##(2008-10#1)(2011-2#1)
nature of PVY##2##3##(2008-10#2)
nature of a##8##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#2)
nature of blood##2##3##(2008-3#1)(2013-1#1)
nature of clinical##3##3##(2008-11#3)
nature of his##2##3##(2008-11#1)(2008-8#1)
nature of its##2##3##(1995-6#1)(1996-5#1)
nature of many##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
nature of membrane##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
nature of serum##2##3##(1995-5#1)(2008-11#1)
nature of sorption##3##3##(2008-10#3)
nature of such##2##3##(1990-8#1)(2008-11#1)
nature of the beta##2##4##(1992-9#1)(1993-8#1)
nature of the buffer was investigated##2##6##(2008-10#2)
nature of the buffer##4##4##(2008-10#4)
nature of the data##2##4##(2008-10#1)(2008-8#1)
nature of the disease##6##4##(1990-10#1)(1990-3#1)(1991-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
nature of the extracted species##2##5##(2008-10#2)
nature of the extracting##2##4##(2008-10#2)
nature of the genetic##3##4##(2008-10#2)(2010-4#1)
nature of the interaction##2##4##(2008-10#1)(2008-9#1)
nature of the neoplasm##2##4##(1997-8#1)(2011-2#1)
nature of the observed##2##4##(1995-12#1)(2008-7#1)
nature of the protein##2##4##(1994-8#1)(1996-10#1)
nature of the proteins lost from##2##6##(1991-2#2)
nature of the supporting##2##4##(2008-10#2)
nature of the technique##2##4##(1997-2#1)(2008-10#1)
nature of the tumor##2##4##(1991-12#1)(1994-7#1)
nature of the work of##2##5##(1996-1#1)(2007-10#1)
nature of the work##4##4##(1996-1#1)(2007-10#2)(2008-1#1)
nature of the##234##3##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#2)(1993-11#2)(1993-5#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-3#5)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#55)(2008-11#13)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#4)(2009-1#1)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#5)(2012-2#4)(2013-1#1)(2013-8#3)
nature of their production##2##4##(1996-2#1)(2008-4#1)
nature of their##8##3##(1996-2#1)(2008-10#1)(2008-4#1)(2010-12#2)(2013-1#2)(2013-8#1)
nature of these relationships##2##4##(2009-8#1)(2010-2#1)
nature of these##22##3##(1990-2#1)(1991-12#1)(1991-6#1)(1993-8#1)(1995-1#1)(1996-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
nature of this disorder##2##4##(2008-3#1)(2008-5#1)
nature of this##23##3##(1990-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)
nature of##517##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#3)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#4)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#3)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#2)(2007-10#4)(2007-11#9)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#106)(2008-11#36)(2008-12#6)(2008-2#8)(2008-3#16)(2008-4#7)(2008-5#8)(2008-6#7)(2008-7#15)(2008-8#12)(2008-9#14)(2009-1#1)(2009-11#3)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#14)(2012-1#4)(2012-12#8)(2012-2#10)(2012-3#3)(2013-1#9)(2013-8#9)
nature or##3##2##(1995-1#1)(1996-9#1)(2008-10#1)
nature than##2##2##(1996-12#1)(2008-8#1)
nature that##2##2##(2008-12#1)(2013-1#1)
nature was##2##2##(1990-11#1)(2008-12#1)
nature water##2##2##(2008-10#2)
nature will##2##2##(1992-12#1)(2012-3#1)
nature##850##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#5)(1991-3#4)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#7)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#4)(1993-2#3)(1993-3#4)(1993-5#2)(1993-8#4)(1993-9#3)(1994-1#5)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#7)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#6)(1996-3#3)(1996-4#5)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2007-10#5)(2007-11#14)(2007-12#14)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#171)(2008-11#48)(2008-12#21)(2008-2#9)(2008-3#20)(2008-4#10)(2008-5#20)(2008-6#9)(2008-7#31)(2008-8#34)(2008-9#20)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#5)(2010-10#4)(2010-11#7)(2010-12#8)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#23)(2011-3#1)(2012-1#4)(2012-12#10)(2012-2#24)(2012-3#11)(2013-1#20)(2013-8#11)
nature's##2##1##(1997-6#1)(2008-10#1)
nature)##2##1##(1997-6#1)(2008-10#1)
naturelle##2##1##(2008-12#1)(2010-1#1)
natures##5##1##(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)
naturopathy##3##1##(1991-2#1)(2010-3#1)(2011-2#1)
nauplii##6##1##(2008-5#4)(2010-2#1)(2010-8#1)
nauplius larva##2##2##(2007-12#1)(2010-2#1)
nauplius##4##1##(2007-12#1)(2010-2#3)
nausea and vomiting (CINV)##2##4##(2008-7#2)
nausea and vomiting and##2##4##(1992-10#1)(2011-2#1)
nausea and vomiting##24##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1992-10#1)(1992-5#1)(1995-9#1)(2008-10#3)(2008-7#4)(2010-12#3)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#3)
nausea and##28##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1992-10#1)(1992-12#2)(1992-5#1)(1995-9#1)(2008-10#3)(2008-5#1)(2008-7#4)(2010-12#3)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#3)
nausea in##2##2##(2008-5#1)(2013-8#1)
nausea or vomiting##6##3##(2008-10#1)(2008-7#5)
nausea or##7##2##(2007-11#1)(2008-10#1)(2008-7#5)
nausea were##2##2##(2012-2#2)
nausea with##2##2##(2007-12#2)
nausea##74##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-3#1)(1992-10#1)(1992-12#3)(1992-5#1)(1995-5#1)(1995-9#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#15)(2008-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#6)
nausea/vomiting##6##1##(1990-12#1)(1991-6#1)(1991-9#1)(1992-8#1)(1997-7#1)(2007-7#1)
nautilei##4##1##(2008-6#4)
nautilus##4##1##(2009-8#4)
naval##2##1##(1991-12#1)(2012-2#1)
navel orange worm##2##3##(2009-7#2)
navel##3##1##(1996-8#1)(2009-7#2)
navigate a##2##2##(1997-3#1)(2009-2#1)
navigate and##2##2##(2008-4#1)(2009-8#1)
navigate the##4##2##(1994-8#1)(1997-1#1)(1997-3#1)(2007-12#1)
navigate through##2##2##(2008-4#1)(2008-6#1)
navigate##11##1##(1994-8#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)
navigated##3##1##(2006-12#1)(2007-7#1)(2011-2#1)
navigating and##2##2##(2012-1#1)(2012-2#1)
navigating the##3##2##(2010-9#1)(2011-1#1)(2013-1#1)
navigating##7##1##(1992-12#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
navigation and##3##2##(1993-12#1)(2010-6#1)(2012-2#1)
navigation group##3##2##(2013-1#3)
navigation in##2##2##(2007-12#1)(2013-1#1)
navigation of the##2##3##(1997-1#1)(1997-3#1)
navigation of##3##2##(1997-1#1)(1997-3#1)(2008-6#1)
navigation on##2##2##(1994-3#1)(2009-12#1)
navigation surgery##2##2##(2010-8#2)
navigation system in##3##3##(2008-9#1)(2009-4#1)(2013-1#1)
navigation system##9##2##(2007-8#3)(2008-8#1)(2008-9#1)(2009-4#2)(2013-1#2)
navigation task##3##2##(2008-11#3)
navigation##50##1##(1993-12#1)(1994-3#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-8#7)(2008-11#3)(2008-3#2)(2008-6#2)(2008-8#3)(2008-9#4)(2009-12#2)(2009-4#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-1#10)
navigational##5##1##(1990-11#2)(1994-2#1)(2007-8#1)(2011-2#1)
naïve CD4(+) T cells##3##4##(2008-11#3)
naïve T cells##3##3##(2008-4#3)
naïve T##4##2##(2008-4#3)(2010-2#1)
naïve patients##2##2##(2010-12#1)(2012-2#1)
naïve##20##1##(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#3)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
nbsp##2##1##(2011-2#2)
ncRNA##5##1##(2007-11#2)(2008-1#1)(2012-3#2)
ncRNAs and##2##2##(2008-1#1)(2012-3#1)
ncRNAs are##2##2##(2012-3#2)
ncRNAs has##2##2##(2012-3#2)
ncRNAs##15##1##(2008-1#2)(2008-4#3)(2012-3#10)
nci##2##1##(2008-7#2)
nd##2##1##(1993-2#1)(2008-4#1)
ndsu-1A##3##1##(2008-10#3)
ne##3##1##(1994-12#1)(1995-12#1)(2008-5#1)
near 0##6##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-3#2)
near 1##19##2##(2007-11#4)(2007-12#3)(2008-2#4)(2008-3#8)
near 1%##2##2##(1996-2#1)(2007-7#1)
near 10##2##2##(2007-12#1)(2008-3#1)
near 100 nm##3##3##(2007-11#1)(2007-12#2)
near 100%##7##2##(2007-11#3)(2008-10#4)
near 1064##2##2##(2007-12#1)(2008-3#1)
near 11##2##2##(2007-11#1)(2008-3#1)
near 120##2##2##(2008-2#1)(2008-3#1)
near 13 nm##2##3##(2007-12#2)
near 13##3##2##(2007-12#2)(2008-2#1)
near 150##2##2##(2007-12#1)(2008-2#1)
near 1550 nm##4##3##(2007-12#3)(2008-3#1)
near 2 mum##2##3##(2007-12#1)(2008-3#1)
near 2##10##2##(2007-12#3)(2008-2#1)(2008-3#5)(2011-2#1)
near 225##2##2##(2008-3#2)
near 226 nm##2##3##(2008-2#2)
near 227 nm##3##3##(2008-3#3)
near 25##2##2##(1997-7#1)(2008-10#1)
near 3##3##2##(2007-12#2)(2008-2#1)
near 30##3##2##(1992-3#1)(1996-2#1)(2008-10#1)
near 4##5##2##(2007-11#3)(2007-12#1)(2008-10#1)
near 500##2##2##(2008-3#2)
near 760 nm##2##3##(2008-2#1)(2008-3#1)
near 778 nm##2##3##(2007-11#1)(2007-12#1)
near 800 nm##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
near Brewster's angle##2##3##(2008-2#2)
near IR##5##2##(2007-12#2)(2008-3#3)
near Nernstian response##2##3##(2008-10#2)
near Nernstian##3##2##(2008-10#3)
near Quito##2##2##(2008-10#2)
near a##11##2##(1990-7#1)(1992-3#1)(1995-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#2)
near an##3##2##(1997-3#1)(2007-11#1)(2008-10#1)
near and far##2##3##(2008-11#1)(2008-2#1)
near and##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2011-2#1)
near complete##4##2##(2008-8#1)(2009-7#2)(2011-2#1)
near control values##2##3##(1992-3#1)(1995-3#1)
near degeneracy##2##2##(2007-11#2)
near each##2##2##(2008-7#1)(2012-1#1)
near equal##3##2##(2008-10#1)(2011-1#1)(2011-10#1)
near field and##2##3##(2007-12#1)(2008-3#1)
near field of the##2##4##(2007-11#1)(2008-2#1)
near field of##7##3##(2007-11#2)(2008-2#1)(2008-3#3)(2013-8#1)
near field##19##2##(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#8)(2013-8#1)
near fields##4##2##(2007-12#4)
near full-length##2##2##(1994-12#1)(2009-6#1)
near future##41##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2013-1#1)(2013-7#1)
near ideal##2##2##(2008-2#2)
near infra-red spectroscopy##2##3##(2008-10#1)(2013-1#1)
near infra-red##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
near infrared (NIR) spectroscopy##2##4##(2008-10#1)(2011-1#1)
near infrared (NIR)##4##3##(2008-10#2)(2010-1#1)(2011-1#1)
near infrared reflectance spectroscopy (NIRS)##2##5##(2008-10#2)
near infrared reflectance spectroscopy##3##4##(2008-10#2)(2010-4#1)
near infrared reflectance##4##3##(2008-10#2)(2010-4#2)
near infrared region##2##3##(2008-10#2)
near infrared spectra##2##3##(2013-8#2)
near infrared spectrometer##2##3##(2013-8#2)
near infrared spectroscopic##2##3##(2008-10#1)(2013-8#1)
near infrared spectroscopy##4##3##(2008-10#4)
near infrared##59##2##(2007-11#4)(2007-12#6)(2008-10#17)(2008-2#6)(2008-3#9)(2010-1#1)(2010-2#1)(2010-4#2)(2011-1#4)(2013-8#9)
near isogenic lines for##2##4##(2008-10#2)
near isogenic lines##3##3##(2008-10#2)(2008-8#1)
near its##5##2##(1993-3#1)(1995-2#1)(2008-2#1)(2009-8#1)(2011-2#1)
near neutral##6##2##(2008-10#4)(2011-2#1)(2012-3#1)
near normal incidence in the##2##5##(2007-11#1)(2008-3#1)
near normal##12##2##(1991-9#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#1)(2010-5#1)(2010-7#1)(2012-2#3)(2013-8#1)
near nuclear##3##2##(1991-3#3)
near one##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
near or##2##2##(1995-12#1)(2008-10#1)
near ore body rock##3##4##(2013-8#3)
near ore body##4##3##(2013-8#4)
near physiological##2##2##(2008-10#1)(2009-12#1)
near real time##4##3##(2008-2#1)(2008-3#3)
near resonance##3##2##(2007-11#1)(2008-3#2)
near room temperature##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
near term##4##2##(1992-12#1)(1994-3#1)(2009-11#1)(2010-12#1)
near the 3' end##2##4##(1993-9#1)(2008-10#1)
near the 3'##3##3##(1993-9#1)(2008-10#2)
near the C terminus##2##4##(1993-6#1)(1994-8#1)
near the IL28B##2##3##(2012-2#2)
near the active site##5##4##(1995-2#2)(1995-5#2)(1997-4#1)
near the active##6##3##(1995-2#2)(1995-5#2)(1997-4#1)(2008-8#1)
near the base of the##2##5##(2008-10#1)(2010-11#1)
near the brain##2##3##(2008-1#1)(2008-5#1)
near the cell##2##3##(1991-5#1)(2008-10#1)
near the center##3##3##(1993-11#1)(1997-5#1)(2008-7#1)
near the central##2##3##(1993-11#1)(2008-7#1)
near the crack##2##3##(2008-2#1)(2008-8#1)
near the critical angle##6##4##(2008-3#6)
near the critical##9##3##(1994-9#1)(2008-3#7)(2012-2#1)
near the end of the##4##5##(1992-12#2)(1997-2#1)(2008-3#1)
near the end of##7##4##(1992-12#2)(1997-1#1)(1997-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
near the end##8##3##(1992-12#2)(1997-1#1)(1997-2#1)(1997-6#1)(2008-3#1)(2008-8#1)(2011-2#1)
near the fundamental##2##3##(2008-3#2)
near the ground##2##3##(2008-10#1)(2008-3#1)
near the interface##3##3##(1990-7#1)(2007-12#1)(2008-3#1)
near the left##2##3##(1990-6#1)(1997-7#1)
near the photonic band edge##2##5##(2007-12#2)
near the replication##2##3##(1994-11#1)(1996-12#1)
near the site of##3##4##(1990-11#1)(2007-10#1)(2008-9#1)
near the subsolar point##2##4##(2008-3#2)
near the surface##2##3##(1994-11#1)(2008-3#1)
near the telomeric region##2##4##(2008-11#2)
near the top##2##3##(1993-3#1)(2008-8#1)
near the zero-dispersion wavelength##2##4##(2007-11#1)(2007-12#1)
near the##238##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#2)(1991-12#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#5)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2007-10#1)(2007-11#14)(2007-12#21)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#31)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#7)(2008-9#4)(2009-12#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
near their##5##2##(1994-12#1)(1996-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
near to term##2##3##(1990-5#2)
near to the##4##3##(1990-2#1)(2008-11#1)(2008-6#1)(2012-2#1)
near to##12##2##(1990-2#1)(1990-5#2)(1992-9#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-6#2)(2012-2#1)
near total##2##2##(2008-10#2)
near vision##2##2##(2011-1#1)(2011-2#1)
near wild-type##3##2##(1995-6#1)(2007-11#2)
near zero##5##2##(1990-5#1)(1993-12#1)(2008-10#2)(2008-9#1)
near##803##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#8)(1990-6#2)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#5)(1991-5#4)(1991-6#2)(1991-9#3)(1992-10#1)(1992-12#4)(1992-3#8)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#9)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#3)(1994-3#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#7)(1995-5#5)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#2)(1997-9#1)(2007-10#1)(2007-11#59)(2007-12#69)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#112)(2008-11#12)(2008-12#4)(2008-2#57)(2008-3#118)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#15)(2008-9#9)(2009-11#4)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#9)(2011-10#1)(2011-2#15)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#18)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#22)
near- and far-field detection##2##4##(2008-3#2)
near- and far-field profiles##2##4##(2007-11#1)(2008-2#1)
near- and far-field##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2012-2#1)
near- and##9##2##(2007-11#1)(2008-2#3)(2008-3#4)(2012-2#1)
near-##11##1##(2007-11#2)(2008-2#3)(2008-3#5)(2012-2#1)
near-Gaussian##2##1##(2007-11#1)(2008-3#1)
near-IR spectral##2##2##(2007-12#1)(2008-3#1)
near-IR##15##1##(1997-7#1)(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#5)(2012-12#1)
near-Nernstian response for##2##3##(2008-10#2)
near-Nernstian response over the concentration##2##5##(2008-10#2)
near-Nernstian response over the##3##4##(2008-10#3)
near-Nernstian response over##4##3##(2008-10#4)
near-Nernstian response to##2##3##(2008-10#2)
near-Nernstian response##8##2##(2008-10#8)
near-Nernstian slope of##4##3##(2008-10#4)
near-Nernstian slope##5##2##(2008-10#5)
near-Nernstian##17##1##(2008-10#17)
near-UV exposure##2##2##(1994-6#2)
near-UV##8##1##(1992-6#1)(1994-6#4)(2007-12#2)(2008-3#1)
near-backward##2##1##(2008-2#1)(2008-3#1)
near-colorless##2##1##(2012-3#2)
near-degenerate##2##1##(2007-11#1)(2008-3#1)
near-diffraction-limited##6##1##(2007-12#2)(2008-2#2)(2008-3#2)
near-elimination##2##1##(2007-11#2)
near-field and far-field##2##3##(2008-2#1)(2008-3#1)
near-field and##3##2##(2008-2#1)(2008-3#2)
near-field data##4##2##(2008-3#4)
near-field detection##3##2##(2007-12#2)(2008-3#1)
near-field fluorescence##2##2##(2008-2#1)(2008-3#1)
near-field holography##2##2##(2007-12#2)
near-field imaging##2##2##(2008-2#1)(2008-3#1)
near-field intensity##3##2##(2007-12#2)(2008-3#1)
near-field lidar##2##2##(2008-2#1)(2008-3#1)
near-field microscopy##3##2##(2007-12#2)(2008-3#1)
near-field optical microscope##7##3##(2007-11#2)(2007-12#2)(2008-3#3)
near-field optical microscopy##9##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
near-field optical probe##2##3##(2008-2#2)
near-field optical probes##3##3##(2007-12#2)(2008-2#1)
near-field optical storage##4##3##(2008-3#4)
near-field optical##31##2##(2007-11#3)(2007-12#8)(2008-2#5)(2008-3#15)
near-field optical-fiber##3##2##(2007-12#2)(2008-2#1)
near-field phase##2##2##(2008-2#1)(2008-3#1)
near-field photochromic memory with##2##4##(2008-3#2)
near-field photochromic memory##3##3##(2008-3#3)
near-field probe##3##2##(2007-12#2)(2008-2#1)
near-field profiles##2##2##(2008-3#2)
near-field recording##2##2##(2007-12#2)
near-field scanning optical microscope##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
near-field scanning optical microscopy##4##4##(2007-12#2)(2008-3#2)
near-field scanning optical##8##3##(2007-12#3)(2008-2#2)(2008-3#3)
near-field scanning##9##2##(2007-12#3)(2008-2#3)(2008-3#3)
near-field scattering##2##2##(2007-11#1)(2008-3#1)
near-field spatial##2##2##(2008-2#2)
near-field##111##1##(2007-11#6)(2007-12#30)(2008-2#21)(2008-3#51)(2008-7#1)(2009-5#1)(2010-10#1)
near-forward and##2##2##(2008-2#1)(2008-3#1)
near-ideal##2##1##(2007-11#1)(2008-2#1)
near-infrared (NIR) spectra##2##3##(2008-1#1)(2008-10#1)
near-infrared (NIR) spectroscopy##3##3##(2007-12#1)(2008-10#2)
near-infrared (NIR)##15##2##(2007-12#2)(2008-1#1)(2008-10#7)(2008-3#3)(2009-12#1)(2012-2#1)
near-infrared InGaAs laser diodes##2##4##(2008-3#2)
near-infrared Raman spectroscopy##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
near-infrared absorption of##2##3##(2008-3#2)
near-infrared absorption##4##2##(2008-3#4)
near-infrared bands##3##2##(2008-3#3)
near-infrared cyanine##2##2##(2008-10#1)(2009-12#1)
near-infrared diffusive light##2##3##(2008-3#2)
near-infrared diffusive##3##2##(2007-11#1)(2008-3#2)
near-infrared diode laser##2##3##(2008-3#2)
near-infrared diode##3##2##(2008-3#3)
near-infrared emission##2##2##(2007-12#1)(2008-12#1)
near-infrared fluorescence##3##2##(2007-11#2)(2008-10#1)
near-infrared imaging##2##2##(2008-2#1)(2008-3#1)
near-infrared laser##2##2##(2008-3#2)
near-infrared lasers##2##2##(2008-3#2)
near-infrared light##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
near-infrared optical parametric oscillator##2##4##(2007-12#1)(2008-3#1)
near-infrared optical tomography##2##3##(2011-1#2)
near-infrared optical##6##2##(2007-12#1)(2008-12#2)(2008-3#1)(2011-1#2)
near-infrared pulses##2##2##(2007-12#2)
near-infrared reflectance spectroscopy##2##3##(2008-10#1)(2008-5#1)
near-infrared reflectance##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
near-infrared regions##3##2##(2008-2#1)(2008-3#2)
near-infrared spectra##2##2##(2008-1#1)(2008-10#1)
near-infrared spectral region##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
near-infrared spectral regions##3##3##(2008-2#1)(2008-3#2)
near-infrared spectral##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
near-infrared spectroscopy (NIRS)##2##3##(2008-10#1)(2008-3#1)
near-infrared spectroscopy and##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
near-infrared spectroscopy##10##2##(2007-10#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-7#1)
near-infrared wavelengths##7##2##(2007-11#1)(2008-2#3)(2008-3#3)
near-infrared##141##1##(2007-10#1)(2007-11#16)(2007-12#14)(2008-1#2)(2008-10#26)(2008-12#3)(2008-2#15)(2008-3#52)(2008-5#3)(2008-7#1)(2009-11#1)(2009-12#2)(2011-1#3)(2012-2#1)(2013-8#1)
near-isogenic line##2##2##(2011-2#2)
near-isogenic lines (NILs)##2##3##(2008-10#2)
near-isogenic lines of Thatcher##2##4##(2008-10#2)
near-isogenic lines of##4##3##(2008-10#4)
near-isogenic lines##11##2##(2008-10#11)
near-isogenic##21##1##(2008-10#17)(2011-2#3)(2012-3#1)
near-lasing##2##1##(2007-11#2)
near-maximal##2##1##(1992-3#1)(1993-1#1)
near-neutral pH##3##2##(2008-5#1)(2010-4#2)
near-neutral##4##1##(2008-10#1)(2008-5#1)(2010-4#2)
near-normal##3##1##(2008-3#2)(2009-7#1)
near-patient##2##1##(1996-8#1)(2009-4#1)
near-physiological conditions##2##2##(2008-9#2)
near-physiological##3##1##(2008-10#1)(2008-9#2)
near-real-time##4##1##(2008-3#4)
near-resonant##2##1##(1994-2#1)(2007-12#1)
near-stoichiometric LiNbO(3) crystals##2##3##(2007-11#1)(2008-3#1)
near-stoichiometric LiNbO(3)##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
near-stoichiometric lithium niobate##2##3##(2008-2#2)
near-stoichiometric##7##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
near-surface##6##1##(2007-12#1)(2008-10#1)(2008-3#4)
near-term##5##1##(2008-10#1)(2008-11#2)(2010-12#1)(2012-12#1)
near-threshold##2##1##(1991-2#1)(2009-5#1)
near-total##2##1##(1992-3#1)(2012-12#1)
near-transform-limited##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
near-ultraviolet##10##1##(1990-5#1)(1993-8#1)(1994-6#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#4)
near-unity##3##1##(2007-11#2)(2008-2#1)
near-velocity-matched##2##1##(2007-12#2)
near-zero##3##1##(1992-3#1)(2008-11#1)(2008-3#1)
nearby islands##2##2##(2008-8#2)
nearby light sources##2##3##(2008-2#2)
nearby managed groves##2##3##(2011-2#2)
nearby managed##3##2##(2011-2#3)
nearby neurons##2##2##(2009-12#1)(2012-2#1)
nearby non-AP site##3##3##(2008-10#3)
nearby residues##2##2##(1990-7#1)(2010-10#1)
nearby the##2##2##(2008-11#1)(2009-2#1)
nearby##57##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1993-9#1)(1995-5#1)(1997-5#1)(2007-12#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-7#1)(2010-10#1)(2011-2#6)(2012-2#2)
neared##2##1##(2008-10#2)
nearer to##3##2##(2008-10#3)
nearest neighbors##3##2##(2008-2#1)(2008-9#1)(2009-4#1)
nearest##16##1##(1992-12#1)(1997-4#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-1#1)
nearest-neighbor interactions##2##2##(1992-3#1)(2008-10#1)
nearest-neighbor##4##1##(1992-3#1)(1994-9#1)(2008-10#1)(2008-3#1)
nearly 1##7##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
nearly 10##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2011-2#1)
nearly 100##2##2##(2007-8#1)(2008-11#1)
nearly 100%##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
nearly 15%##2##2##(1992-1#1)(2008-10#1)
nearly 2 orders of magnitude##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
nearly 2##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2010-5#1)(2013-1#1)
nearly 2-fold##2##2##(1990-12#1)(2008-5#1)
nearly 20 percent##2##3##(1994-12#1)(1996-1#1)
nearly 20 years ago##2##4##(1997-5#1)(2008-10#1)
nearly 20 years##3##3##(1997-5#1)(2008-10#1)(2008-7#1)
nearly 20##8##2##(1992-8#1)(1994-12#1)(1996-1#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
nearly 30 years##3##3##(1995-1#1)(1996-3#1)(2008-4#1)
nearly 4##2##2##(1993-11#1)(1997-5#1)
nearly 50% of the##2##4##(1992-3#1)(2009-8#1)
nearly 50% of##4##3##(1992-3#1)(1995-6#1)(2009-8#1)(2011-2#1)
nearly 50%##6##2##(1992-3#1)(1995-6#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
nearly 500##2##2##(2008-3#1)(2012-2#1)
nearly 6 weeks before##2##4##(2008-10#2)
nearly 6##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
nearly 60##2##2##(2008-10#1)(2008-4#1)
nearly 60%##2##2##(1992-1#1)(2008-3#1)
nearly 80%##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
nearly Gaussian##5##2##(2007-11#3)(2008-2#2)
nearly a##5##2##(1997-7#1)(2007-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
nearly abolished##2##2##(1994-6#1)(1994-8#1)
nearly all##27##2##(1990-7#1)(1990-8#1)(1990-9#1)(1993-9#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-10#1)(2010-2#1)(2011-3#1)(2012-2#2)
nearly always##2##2##(2008-8#1)(2010-4#1)
nearly as common as##2##4##(1992-11#1)(2010-6#1)
nearly as effective##2##3##(1997-4#1)(2008-10#1)
nearly as well as##2##4##(1997-1#1)(2008-10#1)
nearly as##9##2##(1990-4#1)(1992-11#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-6#1)
nearly asymptomatic##2##2##(1997-3#1)(2008-10#1)
nearly complete##14##2##(1990-2#1)(1992-1#1)(1993-11#1)(1996-9#1)(2007-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-7#4)(2012-3#1)
nearly completely##4##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-8#1)
nearly constant##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2009-1#1)
nearly diffraction-limited##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
nearly disappeared##2##2##(1993-2#1)(2008-10#1)
nearly doubled##3##2##(1990-12#1)(2007-8#1)(2008-11#1)
nearly equal to##2##3##(2008-11#1)(2008-2#1)
nearly equal##7##2##(1990-11#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-5#1)
nearly every##4##2##(1994-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
nearly half of patients with##2##5##(1996-11#1)(2008-7#1)
nearly half of##4##3##(1993-6#1)(1996-11#1)(2008-10#1)(2008-7#1)
nearly half the##2##3##(2008-10#1)(2008-7#1)
nearly half##9##2##(1993-6#2)(1996-11#1)(2008-10#2)(2008-7#2)(2009-8#1)(2013-8#1)
nearly homogenous##2##2##(2008-3#1)(2008-4#1)
nearly ideal##4##2##(1991-5#1)(1994-2#1)(2007-12#1)(2008-3#1)
nearly identical in##2##3##(1991-12#1)(2008-10#1)
nearly identical to that of##2##5##(1997-2#1)(2008-10#1)
nearly identical to those##3##4##(1992-3#1)(1995-2#1)(2008-3#1)
nearly identical to##8##3##(1992-3#1)(1995-2#1)(1996-8#1)(1997-2#1)(2008-10#3)(2008-3#1)
nearly identical##28##2##(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-11#3)(1995-2#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
nearly immune to infection within 4 weeks after##2##8##(2008-10#2)
nearly immune to infection within##3##5##(2008-10#3)
nearly immune to infection##5##4##(2008-10#5)
nearly immune##6##2##(2008-10#6)
nearly in the##2##3##(2008-10#1)(2008-3#1)
nearly independent of the##4##4##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
nearly independent of##7##3##(1997-7#1)(2007-12#2)(2008-2#1)(2008-3#3)
nearly native##2##2##(2008-8#1)(2013-8#1)
nearly nine##2##2##(1992-1#1)(2009-5#1)
nearly normal life##2##3##(1996-11#1)(2011-3#1)
nearly normal##4##2##(1995-8#1)(1996-11#1)(2008-3#1)(2011-3#1)
nearly one-half##2##2##(1992-1#1)(2012-2#1)
nearly parallel to the##2##4##(2008-3#1)(2008-4#1)
nearly perfect##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
nearly planar##3##2##(1991-3#1)(1996-2#1)(2008-3#1)
nearly quantitative##2##2##(2008-10#1)(2010-2#1)
nearly reversible##2##2##(2008-10#2)
nearly temperature independent##2##3##(1995-2#1)(2009-5#1)
nearly the same as that##2##5##(2007-11#1)(2008-2#1)
nearly the same##6##3##(1990-10#1)(1992-7#1)(2007-11#2)(2008-2#1)(2008-3#1)
nearly the##7##2##(1990-10#1)(1992-7#1)(2007-11#2)(2008-2#1)(2008-3#1)(2009-3#1)
nearly twice##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
nearly two decades##2##3##(1992-12#1)(2011-1#1)
nearly two##3##2##(1992-12#1)(2009-11#1)(2011-1#1)
nearly uniform##2##2##(2007-11#1)(2008-8#1)
nearly##376##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-1#5)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#2)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#3)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#22)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#66)(2008-11#9)(2008-2#15)(2008-3#35)(2008-4#9)(2008-5#6)(2008-6#5)(2008-7#12)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#4)(2009-8#2)(2010-10#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
nearshore##2##1##(2008-9#1)(2010-8#1)
neat##10##1##(1992-6#1)(1994-3#1)(1996-2#4)(2008-10#1)(2008-5#1)(2009-10#1)(2011-1#1)
nebraskensis and P##2##3##(2008-10#2)
nebraskensis##5##1##(2008-10#5)
nebulin##10##1##(2008-6#10)
nebulisation##7##1##(1995-3#2)(2008-10#5)
nebulised##4##1##(1995-3#1)(1995-8#1)(2008-10#2)
nebuliser##2##1##(1995-3#2)
nebulisers##3##1##(1991-6#1)(1995-3#1)(1997-1#1)
nebulization and##3##2##(2008-10#3)
nebulization inductively coupled plasma atomic emission##2##6##(2008-10#2)
nebulization of##2##2##(1995-3#1)(1996-3#1)
nebulization were##2##2##(1993-2#1)(2008-10#1)
nebulization##29##1##(1991-1#2)(1992-3#1)(1993-2#2)(1995-3#2)(1996-3#1)(2008-10#21)
nebulized pentamidine##2##2##(1993-2#2)
nebulized##11##1##(1991-1#1)(1992-3#1)(1993-2#3)(1996-1#1)(1996-3#3)(2008-10#2)
nebulizer and countercurrent gas flow##2##5##(2008-10#2)
nebulizer and##3##2##(1995-12#1)(2008-10#2)
nebulizer function##2##2##(1992-3#2)
nebulizer gas flow rate##2##4##(2008-10#2)
nebulizer gas flow rates##2##4##(2008-10#2)
nebulizer gas flow##4##3##(2008-10#4)
nebulizer in##2##2##(2008-8#1)(2012-1#1)
nebulizer is##2##2##(1994-12#1)(2008-10#1)
nebulizer of##3##2##(2008-10#3)
nebulizer output##2##2##(1994-12#2)
nebulizer system##3##2##(1995-3#3)
nebulizer systems##3##2##(1992-3#1)(1995-3#1)(1997-2#1)
nebulizer with##2##2##(1995-12#1)(2008-10#1)
nebulizer##67##1##(1991-1#6)(1992-3#6)(1993-2#3)(1994-12#10)(1995-12#4)(1995-3#5)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(2007-6#1)(2008-10#22)(2008-8#1)(2012-1#1)(2013-8#1)
nebulizer)##4##1##(1994-12#1)(1996-12#2)(2008-10#1)
nebulizers and##2##2##(1992-3#2)
nebulizers for##3##2##(1994-12#1)(1996-12#1)(1997-1#1)
nebulizers the##2##2##(1992-3#1)(1995-3#1)
nebulizers were##2##2##(1995-3#1)(2013-8#1)
nebulizers##37##1##(1991-1#1)(1992-3#5)(1993-2#6)(1994-12#2)(1995-3#12)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2013-8#3)
nebulizing##2##1##(1995-3#1)(1996-3#1)
nec1##3##1##(2008-10#3)
necator from other##2##3##(2008-10#2)
necator in##3##2##(2008-10#3)
necator##29##1##(2008-10#29)
necator)##3##1##(2008-10#3)
necatrix##9##1##(2008-10#9)
necessarily be##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
necessarily mean##2##2##(1996-5#1)(2010-9#1)
necessarily reflect##2##2##(2008-4#1)(2008-6#1)
necessarily to##2##2##(1996-6#1)(2013-7#1)
necessarily##96##1##(1991-1#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
necessary and sufficient for##6##4##(1991-2#2)(1995-2#1)(2009-10#1)(2012-3#2)
necessary and sufficient to##4##4##(1995-2#1)(1997-2#1)(1997-3#1)(2008-7#1)
necessary and sufficient##13##3##(1991-2#2)(1992-9#1)(1993-8#1)(1995-2#2)(1997-2#1)(1997-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-3#2)
necessary and welcome##2##3##(1995-2#1)(2007-2#1)
necessary and##26##2##(1991-11#1)(1991-2#2)(1992-9#1)(1993-8#1)(1995-2#3)(1996-3#2)(1997-2#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#2)(2013-1#1)
necessary as##3##2##(1992-9#1)(2008-10#1)(2008-2#1)
necessary because of the##3##4##(2007-12#1)(2008-2#1)(2011-1#1)
necessary because of##4##3##(1997-3#1)(2007-12#1)(2008-2#1)(2011-1#1)
necessary because##6##2##(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-7#1)(2011-1#1)
necessary before the##2##3##(2008-10#2)
necessary before##6##2##(1995-12#1)(2007-12#1)(2008-10#2)(2009-8#1)(2012-12#1)
necessary but##2##2##(1990-10#1)(1994-3#1)
necessary chemicals##2##2##(2008-10#2)
necessary condition for##3##3##(2007-11#1)(2008-8#1)(2009-8#1)
necessary condition##5##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)
necessary conditions for##3##3##(2008-3#2)(2010-3#1)
necessary conditions##4##2##(2008-2#1)(2008-3#2)(2010-3#1)
necessary data##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
necessary during##3##2##(2008-10#1)(2009-2#1)(2011-2#1)
necessary element##3##2##(1991-12#1)(2007-11#1)(2008-11#1)
necessary for a better understanding of the##2##7##(1991-12#1)(2010-11#1)
necessary for a##10##3##(1991-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-8#1)
necessary for achieving satisfactory perceived##2##5##(2008-5#2)
necessary for achieving##3##3##(2008-3#1)(2008-5#2)
necessary for activity##2##3##(1995-6#1)(2010-4#1)
necessary for all##3##3##(2008-10#2)(2012-2#1)
necessary for an##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
necessary for bacterial##2##3##(2008-7#1)(2009-5#1)
necessary for both##3##3##(1994-8#1)(2008-12#1)(2009-1#1)
necessary for determining the##2##4##(1994-3#1)(2008-3#1)
necessary for determining##3##3##(1994-3#1)(2008-3#1)(2010-9#1)
necessary for diagnosis##3##3##(1996-6#1)(2008-1#1)(2009-5#1)
necessary for efficient##4##3##(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#1)
necessary for full##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
necessary for half-maximal##2##3##(1995-2#2)
necessary for infection##3##3##(2008-10#3)
necessary for its##3##3##(1990-11#1)(1994-6#1)(1997-4#1)
necessary for normal##3##3##(2008-6#1)(2012-2#1)(2012-3#1)
necessary for obtaining##2##3##(2008-10#1)(2008-9#1)
necessary for optimal##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#1)
necessary for replication##2##3##(2008-10#2)
necessary for routine##2##3##(2008-5#1)(2008-9#1)
necessary for successful##2##3##(2007-12#1)(2008-1#1)
necessary for the development of##2##5##(2008-10#1)(2010-12#1)
necessary for the development##3##4##(2008-10#1)(2008-9#1)(2010-12#1)
necessary for the expression of##3##5##(1993-3#1)(1994-2#1)(2008-1#1)
necessary for the formation of##2##5##(1994-8#1)(2012-2#1)
necessary for the in##2##4##(1991-9#1)(2008-6#1)
necessary for the initiation##2##4##(1994-11#1)(2008-8#1)
necessary for the##55##3##(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#2)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
necessary for their##4##3##(1993-3#1)(2007-4#1)(2010-12#1)(2010-5#1)
necessary for this##3##3##(1992-11#1)(1992-8#1)(2008-5#1)
necessary for##263##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#2)(2007-8#2)(2008-1#6)(2008-10#38)(2008-11#9)(2008-12#5)(2008-2#5)(2008-3#9)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-8#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#7)(2013-8#3)
necessary if##2##2##(2008-10#1)(2008-5#1)
necessary in establishing##2##3##(2007-7#1)(2013-8#1)
necessary in order to evaluate##2##5##(1992-5#1)(2012-3#1)
necessary in order to##10##4##(1992-5#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2011-1#1)(2012-3#1)
necessary in some##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
necessary in the##2##3##(1995-1#1)(1996-3#1)
necessary in##40##2##(1991-11#1)(1992-5#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-3#3)(2007-10#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-3#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
necessary information##4##2##(1997-6#1)(2008-5#1)(2011-2#1)(2012-12#1)
necessary oxygen##2##2##(2007-12#1)(2008-11#1)
necessary prerequisite##2##2##(1994-12#1)(2008-8#1)
necessary resources##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
necessary so##2##2##(2008-10#1)(2012-3#1)
necessary step in the##2##4##(1993-11#1)(1994-1#1)
necessary step in##3##3##(1993-11#1)(1993-8#1)(1994-1#1)
necessary step##6##2##(1993-11#1)(1993-8#1)(1994-1#2)(1994-11#1)(2012-2#1)
necessary steps in##2##3##(2008-7#1)(2013-8#1)
necessary steps##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
necessary that a##2##3##(1991-3#1)(2008-2#1)
necessary that##4##2##(1991-3#1)(2008-2#1)(2012-3#1)(2013-1#1)
necessary to achieve a##3##4##(1992-3#1)(2008-11#1)(2013-7#1)
necessary to achieve##9##3##(1992-3#1)(1993-3#1)(1997-5#1)(2006-5#1)(2007-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
necessary to assess##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
necessary to avoid##2##3##(2008-10#2)
necessary to be##2##3##(1993-2#1)(2009-9#1)
necessary to carry out the##2##5##(2008-10#1)(2008-3#1)
necessary to carry out##5##4##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
necessary to carry##6##3##(1991-9#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
necessary to clarify##2##3##(2007-10#1)(2009-7#1)
necessary to confirm the diagnosis##2##5##(1990-9#1)(2008-11#1)
necessary to confirm the##3##4##(1990-9#1)(2008-11#1)(2012-12#1)
necessary to confirm##6##3##(1990-9#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
necessary to consider the##2##4##(1992-8#1)(2008-3#1)
necessary to consider##5##3##(1992-8#1)(1992-9#1)(1996-11#1)(2008-3#1)(2008-5#1)
necessary to continue##2##3##(1991-1#1)(2012-12#1)
necessary to control##2##3##(2008-8#1)(2008-9#1)
necessary to convert##2##3##(2008-10#2)
necessary to describe##2##3##(2008-2#2)
necessary to design##3##3##(2008-5#2)(2011-2#1)
necessary to detect and##2##4##(2008-4#1)(2008-8#1)
necessary to detect##5##3##(1990-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)
necessary to determine the##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
necessary to determine whether##2##4##(1991-8#1)(2008-10#1)
necessary to determine##10##3##(1991-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
necessary to develop an##2##4##(1992-6#1)(2008-1#1)
necessary to develop##8##3##(1992-6#1)(2008-1#1)(2008-10#2)(2008-9#2)(2012-2#1)(2013-8#1)
necessary to discontinue##2##3##(1990-2#1)(1991-3#1)
necessary to elucidate##2##3##(2009-5#1)(2010-6#1)
necessary to ensure that##3##4##(1992-12#1)(2008-9#1)(2013-7#1)
necessary to ensure##8##3##(1992-12#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-7#2)(2013-8#1)
necessary to establish a##2##4##(1994-3#1)(2011-2#1)
necessary to establish the##2##4##(2008-2#1)(2008-7#1)
necessary to establish##5##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
necessary to evaluate##4##3##(1990-8#1)(1996-3#1)(2008-12#1)(2011-1#1)
necessary to examine##4##3##(1996-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
necessary to explain the##3##4##(1990-8#1)(2008-10#2)
necessary to find a##2##4##(2008-10#1)(2011-2#1)
necessary to find##4##3##(2008-10#1)(2011-2#3)
necessary to further##3##3##(2008-10#1)(2009-2#1)(2011-2#1)
necessary to identify##8##3##(1990-6#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-5#1)(2013-8#1)
necessary to improve the##2##4##(2009-5#1)(2013-1#1)
necessary to improve##5##3##(2007-7#1)(2008-11#1)(2009-5#1)(2009-6#1)(2013-1#1)
necessary to induce##3##3##(1991-5#1)(1993-12#1)(2012-3#1)
necessary to inhibit##3##3##(1992-9#1)(1995-2#1)(2008-10#1)
necessary to investigate##2##3##(2012-12#1)(2012-2#1)
necessary to keep##2##3##(2008-1#1)(2008-10#1)
necessary to know the##4##4##(1997-8#1)(2007-7#1)(2008-8#1)(2012-2#1)
necessary to locate##3##3##(2007-5#2)(2011-2#1)
necessary to maintain the##2##4##(1996-12#1)(2008-5#1)
necessary to maintain##7##3##(1990-2#1)(1991-1#1)(1994-12#1)(1996-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
necessary to make a##3##4##(1994-1#2)(1995-5#1)
necessary to make##4##3##(1994-1#2)(1995-5#1)(2007-11#1)
necessary to manage##2##3##(2008-1#1)(2013-1#1)
necessary to measure##3##3##(1990-5#1)(2008-7#1)(2010-7#1)
necessary to obtain an##2##4##(1996-12#1)(2007-11#1)
necessary to obtain quantitative##3##4##(1990-5#1)(2008-10#2)
necessary to obtain##8##3##(1990-5#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-5#1)(2013-8#1)
necessary to overcome##3##3##(1995-5#1)(2008-3#1)(2008-7#1)
necessary to perform##6##3##(1997-2#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-8#1)
necessary to prevent##6##3##(1994-10#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
necessary to produce a##3##4##(2008-10#2)(2008-7#1)
necessary to produce##5##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-7#1)
necessary to promote the##2##4##(2008-4#1)(2013-8#1)
necessary to provide##2##3##(2010-5#1)(2012-2#1)
necessary to reconstruct##2##3##(2008-3#2)
necessary to retrieve##2##3##(2008-2#1)(2008-3#1)
necessary to save lives##2##4##(1991-3#1)(2010-8#1)
necessary to save##3##3##(1991-3#1)(1997-7#1)(2010-8#1)
necessary to specify the##3##4##(1994-12#1)(2008-3#2)
necessary to support##4##3##(1997-1#1)(2008-10#1)(2012-2#2)
necessary to the##3##3##(1991-1#1)(2011-2#2)
necessary to understand the##4##4##(2007-8#1)(2008-9#1)(2013-1#2)
necessary to understand##11##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2013-1#3)
necessary to use a##2##4##(1990-3#1)(2008-10#1)
necessary to use the##3##4##(1992-9#1)(2008-10#1)(2012-3#1)
necessary to use##8##3##(1990-2#1)(1990-3#1)(1992-9#1)(1997-3#1)(2008-10#2)(2010-5#1)(2012-3#1)
necessary to verify##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
necessary to##352##2##(1990-2#4)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#5)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1995-2#3)(1995-5#3)(1995-6#2)(1996-11#2)(1996-12#4)(1996-3#3)(1996-5#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#3)(2007-7#2)(2007-8#5)(2008-1#8)(2008-10#48)(2008-11#15)(2008-12#3)(2008-2#11)(2008-3#16)(2008-4#11)(2008-5#11)(2008-7#9)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#4)(2011-2#20)(2011-3#1)(2012-12#3)(2012-2#10)(2012-3#6)(2013-1#13)(2013-7#4)(2013-8#9)
necessary treatment##2##2##(1997-2#1)(2012-2#1)
necessary when one##2##3##(2007-2#1)(2008-2#1)
necessary when##4##2##(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)
necessary##1023##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#7)(1990-3#4)(1990-5#3)(1990-6#1)(1990-8#9)(1990-9#4)(1991-1#6)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#5)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#4)(1993-9#3)(1994-1#4)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#3)(1994-3#9)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#1)(1995-12#6)(1995-2#13)(1995-3#1)(1995-5#6)(1995-6#4)(1996-1#3)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#11)(1996-4#1)(1996-5#5)(1996-6#3)(1996-9#1)(1997-1#5)(1997-2#8)(1997-3#7)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#5)(2007-11#13)(2007-12#23)(2007-2#5)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#17)(2008-10#134)(2008-11#43)(2008-12#12)(2008-2#33)(2008-3#43)(2008-4#22)(2008-5#25)(2008-6#11)(2008-7#24)(2008-8#17)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#11)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#2)(2010-7#9)(2010-8#5)(2010-9#2)(2011-1#10)(2011-2#45)(2011-3#3)(2012-1#1)(2012-12#12)(2012-2#29)(2012-3#18)(2013-1#34)(2013-7#6)(2013-8#21)
necessary)##2##1##(2008-10#2)
necessary?##2##1##(1990-8#1)(2011-2#1)
necessary]##4##1##(1994-3#1)(1995-8#1)(1996-3#1)(2010-3#1)
necessitate a##4##2##(1990-2#1)(2008-3#1)(2008-8#1)(2012-1#1)
necessitate the##2##2##(2008-10#1)(2008-3#1)
necessitate##12##1##(1990-2#1)(1993-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-9#1)(2012-1#1)
necessitated a##2##2##(1995-9#1)(2008-2#1)
necessitated the development of##2##4##(2008-1#1)(2008-7#1)
necessitated the##6##2##(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)
necessitated##15##1##(1994-9#1)(1995-9#1)(1996-3#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)
necessitates a##3##2##(2008-10#1)(2008-4#1)(2009-11#1)
necessitates the##4##2##(1996-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
necessitates##16##1##(1991-6#1)(1992-4#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
necessitating a##4##2##(1991-11#1)(2010-7#1)(2012-12#1)(2013-1#1)
necessitating##16##1##(1991-11#1)(1994-3#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#2)
necessities##5##1##(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
necessity for##18##2##(1991-1#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-9#1)(2009-3#1)(2009-8#1)(2011-3#1)(2012-12#1)
necessity of the##3##3##(2008-7#1)(2009-5#1)(2011-1#1)
necessity of##47##2##(1990-6#1)(1990-8#1)(1991-2#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#4)(2011-2#2)(2013-1#1)
necessity to##17##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
necessity##96##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-12#2)(2013-1#1)
neck and back##5##3##(2007-11#1)(2008-12#1)(2010-6#1)(2011-2#2)
neck and shoulder##2##3##(2010-9#2)
neck and shoulders##2##3##(1994-2#1)(2008-12#1)
neck and##28##2##(1994-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-12#1)(2013-1#2)
neck are##4##2##(1993-8#1)(1995-8#1)(2007-8#1)(2010-12#1)
neck blast##3##2##(2008-10#3)
neck closure##2##2##(1997-6#1)(2008-10#1)
neck contracture##2##2##(2013-8#2)
neck dissection##6##2##(2007-5#1)(2012-2#2)(2012-3#1)(2013-1#2)
neck during##2##2##(1990-6#1)(1997-3#1)
neck exploration##2##2##(2008-10#1)(2011-1#1)
neck femur##2##2##(2012-2#2)
neck fracture##4##2##(2007-11#1)(2007-8#2)(2011-2#1)
neck function##2##2##(2010-12#2)
neck hip##2##2##(2007-8#1)(2011-2#1)
neck in a##2##3##(2006-10#1)(2008-12#1)
neck in##4##2##(2006-10#1)(2008-1#1)(2008-12#1)(2009-3#1)
neck infections##3##2##(2007-12#2)(2012-2#1)
neck injury##2##2##(1996-6#1)(2010-12#1)
neck is a##2##3##(2007-5#1)(2008-3#1)
neck is##4##2##(1995-8#1)(2007-5#1)(2008-11#1)(2008-3#1)
neck mass##5##2##(2007-7#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
neck muscles were##2##3##(2009-4#1)(2010-9#1)
neck nodes##2##2##(1991-8#1)(2007-5#1)
neck of incompletely occluded##2##4##(2013-1#2)
neck of the##5##3##(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2013-1#1)
neck of##9##2##(1991-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2013-1#3)
neck or##2##2##(1997-3#1)(2011-2#1)
neck pain##19##2##(1991-8#1)(2008-11#1)(2008-12#8)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#5)(2010-8#1)
neck region##15##2##(1992-5#1)(1992-6#2)(1992-9#1)(1997-6#1)(2007-12#2)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#2)
neck surgery##4##2##(1991-4#1)(2008-12#1)(2009-7#1)(2013-8#1)
neck swelling##2##2##(2011-1#2)
neck that##2##2##(1997-3#1)(2006-10#1)
neck to##3##2##(1995-6#1)(2008-1#1)(2008-7#1)
neck trauma##3##2##(2010-7#1)(2010-9#2)
neck tumor##2##2##(1993-8#1)(2013-1#1)
neck was##3##2##(1991-8#1)(2007-8#1)(2011-2#1)
neck##377##1##(1990-12#6)(1990-6#6)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#4)(1991-9#4)(1992-10#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-6#3)(1995-8#6)(1995-9#3)(1996-11#1)(1996-6#1)(1997-3#6)(1997-6#7)(1997-7#2)(1997-8#1)(2006-10#4)(2007-10#1)(2007-11#9)(2007-12#9)(2007-5#6)(2007-7#3)(2007-8#17)(2008-1#8)(2008-10#11)(2008-11#6)(2008-12#21)(2008-2#8)(2008-3#3)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#12)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#9)(2009-4#2)(2009-7#4)(2010-1#1)(2010-11#1)(2010-12#11)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#8)(2011-1#10)(2011-2#29)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#27)(2013-7#1)(2013-8#16)
neck-shaft angle and neck centering##2##5##(2007-8#2)
neck-shaft angle##5##2##(2007-8#5)
necks##2##1##(2008-11#1)(2010-12#1)
necrogenic satRNAs##3##2##(2008-10#3)
necrogenic##4##1##(1994-5#1)(2008-10#3)
necropsied##4##1##(1993-3#1)(2007-6#1)(2008-5#2)
necropsies##3##1##(1991-11#1)(2008-5#1)(2013-1#1)
necropsy and##2##2##(2008-5#1)(2010-7#1)
necropsy##18##1##(1990-12#1)(1991-11#1)(1991-3#1)(1991-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#1)(2010-7#1)(2011-1#2)(2012-2#1)(2012-3#3)
necrosed##2##1##(2008-12#1)(2011-2#1)
necroses##9##1##(1992-4#1)(1992-9#1)(2007-11#4)(2008-1#1)(2008-10#2)
necrosis after an immediate##2##4##(2011-2#2)
necrosis after##5##2##(1996-11#1)(2007-8#1)(2008-7#1)(2011-2#2)
necrosis and chlorosis in its wheat host##2##7##(2008-10#2)
necrosis and chlorosis##3##3##(2008-10#3)
necrosis and gliosis##3##3##(1996-5#3)
necrosis and##42##2##(1991-8#3)(1992-9#1)(1994-6#1)(1996-5#3)(2007-5#1)(2007-8#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#4)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
necrosis are##2##2##(1994-8#1)(2007-11#1)
necrosis around##2##2##(2008-10#2)
necrosis by##2##2##(1994-5#1)(2008-1#1)
necrosis component##2##2##(2008-10#2)
necrosis disease##2##2##(2008-10#2)
necrosis factor (TNF)##19##3##(1990-12#2)(1990-2#1)(1992-12#1)(1992-3#1)(1994-2#2)(1994-8#1)(1996-2#2)(1997-2#1)(1997-4#1)(2008-4#1)(2008-9#1)(2011-2#3)(2012-3#2)
necrosis factor (TNF)-alpha##6##3##(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(2008-5#1)(2011-2#1)
necrosis factor alpha (TNF alpha)##3##5##(1991-9#1)(1993-6#1)(1995-2#1)
necrosis factor alpha##16##3##(1990-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(2008-11#2)(2008-8#2)(2011-2#1)(2013-8#1)
necrosis factor therapies##2##3##(2011-2#2)
necrosis factor##77##2##(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-7#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-8#2)(1995-12#3)(1995-2#3)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
necrosis factor-alpha (TNF-alpha)##18##3##(1992-12#1)(1992-3#1)(1992-8#2)(1995-12#2)(1995-9#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-7#1)(2012-2#1)
necrosis factor-alpha (TNF-α)##2##3##(2010-12#1)(2012-3#1)
necrosis factor-alpha##42##2##(1992-12#2)(1992-3#1)(1992-8#4)(1994-11#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-9#1)(1996-12#2)(1996-2#1)(1997-7#2)(2007-11#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-9#2)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
necrosis factor-related apoptosis-inducing ligand (TRAIL)##2##5##(2009-3#2)
necrosis factor-α##10##2##(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#1)
necrosis in the##6##3##(1994-5#1)(1996-12#1)(1997-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
necrosis in##24##2##(1992-11#1)(1993-12#1)(1994-5#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-9#2)(2012-1#2)(2012-3#1)(2013-1#2)
necrosis index##3##2##(1992-5#1)(1993-2#2)
necrosis induced by##4##3##(2008-10#4)
necrosis is caused##2##3##(2007-11#1)(2008-10#1)
necrosis is##4##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)
necrosis may be##2##3##(2008-10#1)(2012-1#1)
necrosis may##3##2##(1994-8#1)(2008-10#1)(2012-1#1)
necrosis of the femoral head##3##5##(2007-8#1)(2008-5#1)(2009-3#1)
necrosis of the tumor##2##4##(1992-9#2)
necrosis of the##20##3##(1992-9#2)(1996-11#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-5#2)(2008-6#1)(2009-3#1)(2011-2#3)(2012-2#2)
necrosis of##31##2##(1990-8#1)(1992-9#2)(1993-12#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-5#2)(2008-6#2)(2008-9#1)(2009-3#1)(2011-2#4)(2012-2#2)(2013-1#1)
necrosis on##3##2##(2008-10#3)
necrosis or##6##2##(2008-10#4)(2012-1#1)(2012-2#1)
necrosis that##2##2##(2008-10#2)
necrosis virus##20##2##(2008-10#18)(2009-5#2)
necrosis was also##2##3##(2008-10#2)
necrosis was found in##2##4##(2007-8#2)
necrosis was##14##2##(1992-9#1)(1994-5#1)(2007-8#2)(2008-10#7)(2008-9#1)(2010-3#1)(2011-1#1)
necrosis were##3##2##(2008-10#1)(2008-5#1)(2010-11#1)
necrosis with##4##2##(2007-10#1)(2008-1#1)(2009-1#1)(2013-1#1)
necrosis##467##1##(1990-12#6)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#7)(1993-12#4)(1993-2#2)(1993-6#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-5#4)(1994-6#2)(1994-7#2)(1994-8#7)(1995-10#1)(1995-12#5)(1995-2#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#4)(1996-2#3)(1996-5#5)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(2006-10#6)(2007-10#5)(2007-11#9)(2007-5#1)(2007-8#9)(2008-1#7)(2008-10#125)(2008-11#8)(2008-12#8)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#6)(2008-7#12)(2008-8#4)(2008-9#21)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#5)(2009-5#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#5)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#24)(2012-1#6)(2012-12#4)(2012-2#11)(2012-3#9)(2013-1#19)(2013-8#3)
necrosis) are randomized to##2##4##(2010-3#2)
necrosis)##10##1##(1990-12#1)(1991-8#1)(1992-6#1)(2008-1#1)(2008-10#2)(2010-3#2)(2012-3#1)(2013-1#1)
necrosis-inducing##3##1##(2008-10#3)
necrosis-regeneration##2##1##(1995-12#2)
necrotic and##6##2##(2008-10#4)(2008-12#1)(2008-8#1)
necrotic areas of##2##3##(2008-10#1)(2008-5#1)
necrotic areas##7##2##(2008-10#5)(2008-5#1)(2010-12#1)
necrotic cell death##2##3##(1995-12#1)(2008-7#1)
necrotic cells##2##2##(2008-10#2)
necrotic changes##2##2##(1997-8#1)(2008-7#1)
necrotic flecking##3##2##(2008-10#3)
necrotic leaf tissues##2##3##(2008-10#2)
necrotic leaf##6##2##(2008-10#6)
necrotic lesion##2##2##(2008-10#1)(2008-8#1)
necrotic lesions on susceptible##2##4##(2008-10#2)
necrotic lesions on the##2##4##(2008-10#2)
necrotic lesions on##5##3##(2008-10#5)
necrotic lesions##14##2##(1997-6#1)(2008-10#13)
necrotic mass##2##2##(2013-1#2)
necrotic material##2##2##(1990-3#1)(1990-8#1)
necrotic neuronal death##2##3##(2008-6#2)
necrotic response##2##2##(2008-10#2)
necrotic ringspot##7##2##(2008-10#7)
necrotic spot virus##5##3##(2008-10#5)
necrotic spots or##2##3##(2008-10#2)
necrotic spots##9##2##(2008-10#9)
necrotic symptoms##4##2##(2008-10#4)
necrotic tissue##6##2##(2008-10#4)(2011-2#1)(2013-8#1)
necrotic tissues##2##2##(2008-10#2)
necrotic yellow vein virus (BNYVV)##2##5##(2008-10#2)
necrotic yellow vein virus##5##4##(2008-10#5)
necrotic##134##1##(1990-3#1)(1990-8#2)(1995-12#2)(1997-6#1)(1997-8#1)(2007-6#1)(2008-1#1)(2008-10#97)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2010-12#3)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
necroticans##2##1##(2009-5#2)
necroticoinflammatory##2##1##(2007-8#2)
necrotizing lymphadenitis (Kikuchi's##3##3##(1991-3#1)(1991-9#2)
necrotizing lymphadenitis##5##2##(1991-3#2)(1991-9#3)
necrotizing pancreatitis##2##2##(2012-3#2)
necrotizing pathogens##2##2##(2008-10#2)
necrotizing sialometaplasia##2##2##(1991-11#1)(2009-1#1)
necrotizing##29##1##(1991-11#1)(1991-3#2)(1991-9#3)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-5#3)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-3#3)(2013-1#1)
necrotrophic fungi##2##2##(2008-10#1)(2009-6#1)
necrotrophic fungus##3##2##(2008-10#3)
necrotrophic growth##2##2##(2008-10#2)
necrotrophic pathogen##2##2##(2008-10#2)
necrotrophic pathogens##2##2##(2008-10#2)
necrotrophic##19##1##(2008-10#18)(2009-6#1)
nectar and pollen##2##3##(2007-12#1)(2008-10#1)
nectar and##4##2##(2007-12#1)(2008-10#2)(2008-6#1)
nectar##14##1##(1992-3#1)(2007-12#2)(2008-10#7)(2008-6#2)(2008-8#1)(2009-6#1)
nectarine fruit##2##2##(2008-10#2)
nectarine##3##1##(2008-10#3)
need a special##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
need a##18##2##(1991-1#1)(1991-12#1)(1991-3#2)(1994-1#1)(1995-1#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#3)(2013-1#2)(2013-7#1)
need accurate##2##2##(2011-2#1)(2012-12#1)
need additional##4##2##(1992-10#1)(1994-3#1)(2008-10#1)(2008-11#1)
need among##3##2##(1994-1#1)(1996-3#1)(2008-5#1)
need an##4##2##(2008-2#1)(2008-8#1)(2011-2#2)
need and##11##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-5#2)(2009-5#1)(2012-12#1)
need be##3##2##(2008-3#2)(2010-10#1)
need better##2##2##(2007-12#1)(2008-10#1)
need both##3##2##(1995-9#1)(1997-3#1)(2008-2#1)
need due to##2##3##(2010-8#2)
need exists##3##2##(1996-2#1)(2008-7#1)(2008-9#1)
need for SLT##2##3##(2012-2#2)
need for a continuous##3##4##(2008-11#1)(2008-3#1)(2013-8#1)
need for a global##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
need for a new##4##4##(1994-1#1)(1996-12#1)(1996-2#1)(2008-10#1)
need for a rapid##2##4##(2008-10#2)
need for a regular##2##4##(2008-7#1)(2011-2#1)
need for a systematic##3##4##(1994-2#1)(2008-10#1)(2010-8#1)
need for a##78##3##(1990-5#1)(1990-6#1)(1991-6#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-2#2)(1995-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
need for accurate##5##3##(1994-2#1)(1995-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
need for additional##6##3##(1997-2#1)(2007-12#1)(2008-10#2)(2010-10#1)(2011-2#1)
need for aggressive##2##3##(2008-11#1)(2008-7#1)
need for alternatives to##2##4##(1994-9#1)(1995-2#1)
need for alternatives##3##3##(1994-9#1)(1995-2#1)(2008-11#1)
need for an##18##3##(1991-3#2)(1992-8#1)(1994-3#1)(1994-9#1)(1997-3#1)(1997-7#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
need for and##6##3##(1992-12#1)(1993-1#1)(1996-1#1)(1997-3#1)(2008-3#1)(2008-8#1)
need for any##6##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)
need for better##5##3##(1995-2#1)(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
need for careful##5##3##(1991-2#1)(1995-1#1)(2009-4#1)(2009-8#1)(2013-1#1)
need for case##2##3##(1993-12#1)(1996-1#1)
need for caution in##3##4##(2008-11#1)(2008-9#1)(2009-9#1)
need for caution##6##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-9#1)
need for change##2##3##(1996-1#1)(1997-8#1)
need for clinical##3##3##(1991-10#1)(2008-10#1)(2012-2#1)
need for collaboration##2##3##(1992-12#1)(1993-12#1)
need for culturally relevant##2##4##(1992-2#1)(2010-3#1)
need for data##2##3##(1994-9#1)(2008-11#1)
need for development##3##3##(2009-4#1)(2009-8#1)(2011-1#1)
need for early##4##3##(1993-5#1)(2007-12#1)(2009-8#1)(2013-1#1)
need for family##2##3##(2008-7#1)(2013-1#1)
need for formal##2##3##(1992-1#1)(2010-12#1)
need for further studies##2##4##(2010-10#1)(2010-8#1)
need for further##21##3##(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
need for future##3##3##(2008-12#1)(2008-3#1)(2013-1#1)
need for general##2##3##(2009-5#1)(2013-1#1)
need for greater##5##3##(1996-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
need for health education##2##4##(1995-12#1)(2008-9#1)
need for health##5##3##(1993-2#1)(1995-12#1)(2008-11#1)(2008-9#1)(2009-5#1)
need for in##2##3##(2008-10#1)(2011-2#1)
need for increased##7##3##(1997-4#1)(2008-3#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
need for increasing##2##3##(2009-10#1)(2013-8#1)
need for information##3##3##(1994-6#1)(1995-12#1)(2008-10#1)
need for innovative##2##3##(2011-2#1)(2012-3#1)
need for invasive procedures##2##4##(2012-2#1)(2013-1#1)
need for long-term##5##3##(1992-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
need for more comprehensive##2##4##(1995-2#1)(2006-10#1)
need for more research in this##2##6##(2008-4#1)(2010-3#1)
need for more##17##3##(1995-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-3#1)(2011-2#1)
need for multiple##2##3##(1991-12#1)(2009-11#1)
need for national##2##3##(2008-11#1)(2012-12#1)
need for new##8##3##(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#1)(2010-12#1)(2012-1#1)
need for novel##2##3##(2011-2#1)(2012-12#1)
need for ongoing##4##3##(1996-2#1)(2008-11#2)(2013-1#1)
need for policies##2##3##(1991-5#1)(1993-2#1)
need for precise##3##3##(2007-11#1)(2008-10#2)
need for preconcentration##2##3##(2008-10#2)
need for preventive care##2##4##(1996-1#1)(1996-3#1)
need for preventive##4##3##(1995-12#1)(1996-1#1)(1996-3#1)(2009-10#1)
need for prior##3##3##(2008-2#1)(2008-3#1)(2010-6#1)
need for radical surgery##2##4##(2008-10#1)(2012-2#1)
need for real-time##2##3##(2008-11#1)(2009-6#1)
need for repeated##3##3##(2008-1#1)(2008-3#1)(2012-2#1)
need for research##6##3##(1994-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#1)(2008-11#1)
need for sensitive##2##3##(2007-2#1)(2008-10#1)
need for specialized##2##3##(1992-1#1)(1993-12#1)
need for standards##2##3##(1996-2#1)(2013-8#1)
need for such##4##3##(1991-11#1)(2007-10#1)(2007-12#1)(2008-9#1)
need for the development of##2##5##(1994-9#1)(2011-1#1)
need for the##25##3##(1992-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-1#2)(2012-2#1)(2013-1#2)
need for this##2##3##(1996-6#1)(2007-7#1)
need for thorough##4##3##(1991-12#1)(1991-2#1)(1996-3#1)(2008-4#1)
need for treatment##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
need for understanding##2##3##(1991-3#1)(2012-12#1)
need for##705##2##(1990-10#2)(1990-11#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#6)(1991-3#5)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#8)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#1)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#8)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#10)(1996-12#4)(1996-2#7)(1996-3#7)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#8)(1997-4#5)(1997-6#3)(1997-7#3)(1997-8#3)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#6)(2007-11#13)(2007-12#11)(2007-2#4)(2007-5#3)(2007-7#9)(2007-8#8)(2008-1#17)(2008-10#83)(2008-11#40)(2008-12#17)(2008-2#15)(2008-3#22)(2008-4#12)(2008-5#11)(2008-6#4)(2008-7#18)(2008-8#9)(2008-9#17)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#8)(2010-11#4)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#15)(2011-2#29)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#19)(2012-3#9)(2013-1#26)(2013-8#13)
need further##6##2##(1997-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#2)
need in health##2##3##(1995-1#2)
need in##8##2##(1994-1#1)(1995-1#2)(2008-10#2)(2009-10#1)(2013-7#1)(2013-8#1)
need information##2##2##(1996-3#1)(2007-2#1)
need is##2##2##(2008-11#1)(2008-9#1)
need it##2##2##(1991-3#1)(1994-9#1)
need more##6##2##(2008-12#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
need no##2##2##(2008-10#1)(2010-12#1)
need not be##14##3##(1990-8#1)(1992-2#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
need not##22##2##(1990-8#1)(1992-2#1)(1992-6#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-7#2)(2008-8#3)(2009-3#1)(2013-8#1)
need of a##9##3##(1994-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2011-1#1)(2013-1#1)
need of further##3##3##(1995-3#1)(2008-10#1)(2012-3#1)
need of high##2##3##(1993-2#1)(2010-8#1)
need of home##2##3##(1995-2#2)
need of improvement##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
need of intensive care##2##4##(1990-11#1)(2013-1#1)
need of sample##2##3##(2008-10#1)(2010-5#1)
need of##78##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#2)(1991-8#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#2)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#4)(2008-10#13)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
need only##2##2##(1997-6#1)(2008-2#1)
need protection##2##2##(2008-10#1)(2011-2#1)
need special##3##2##(1996-12#1)(2008-10#1)(2009-6#1)
need surgery##2##2##(2008-1#1)(2011-2#1)
need the##7##2##(1993-1#1)(1995-1#2)(2007-10#1)(2008-10#2)(2011-1#1)
need them##3##2##(1994-3#1)(2008-1#1)(2012-2#1)
need this##2##2##(2008-11#1)(2011-2#1)
need to achieve##3##3##(2007-11#1)(2008-11#2)
need to actively##2##3##(1995-3#1)(2008-11#1)
need to address##4##3##(1991-12#1)(1992-1#1)(2008-11#1)(2011-1#1)
need to analyze##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
need to assess the##3##4##(1993-2#1)(1995-12#1)(1995-3#1)
need to be able to##2##5##(2008-12#1)(2011-2#1)
need to be adapted to##2##5##(2008-7#1)(2012-12#1)
need to be addressed for##2##5##(2007-12#1)(2013-8#1)
need to be addressed in the##3##6##(1992-9#1)(1997-5#1)(2008-4#1)
need to be addressed in##4##5##(1992-9#1)(1997-5#1)(2008-4#1)(2011-2#1)
need to be addressed##32##4##(1992-9#1)(1993-11#1)(1993-3#1)(1994-1#3)(1994-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-8#11)
need to be adjusted##2##4##(2008-12#1)(2012-12#1)
need to be answered##2##4##(1995-11#1)(2013-1#1)
need to be aware of the##3##6##(2008-8#1)(2012-2#1)(2012-3#1)
need to be aware of this##3##6##(2007-10#1)(2007-7#1)(2012-3#1)
need to be aware of##7##5##(1995-1#1)(2007-10#1)(2007-7#1)(2008-8#1)(2012-2#1)(2012-3#2)
need to be aware##9##4##(1995-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-8#1)(2012-2#2)(2012-3#2)
need to be carried out to##2##6##(2008-12#1)(2010-12#1)
need to be carried out##3##5##(2008-10#1)(2008-12#1)(2010-12#1)
need to be changed##2##4##(2007-7#1)(2008-3#1)
need to be clarified##2##4##(2009-6#1)(2013-8#1)
need to be clearly##2##4##(2007-2#1)(2011-2#1)
need to be conducted##3##4##(2008-10#1)(2008-9#1)(2010-11#1)
need to be confirmed by##2##5##(1992-10#1)(2008-12#1)
need to be considered for##2##5##(2008-3#1)(2008-8#1)
need to be considered in##2##5##(2008-1#1)(2011-2#1)
need to be considered##8##4##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-1#1)(2011-2#1)
need to be defined##2##4##(2008-7#1)(2013-1#1)
need to be determined experimentally##2##5##(2008-7#1)(2013-1#1)
need to be developed##6##4##(1992-12#1)(1992-8#1)(1995-1#1)(2007-2#1)(2008-10#1)(2010-11#1)
need to be distinguished##2##4##(2008-8#1)(2008-9#1)
need to be evaluated##5##4##(1991-11#1)(1996-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
need to be further investigated##2##5##(2008-8#1)(2011-1#1)
need to be hospitalized##2##4##(1995-6#1)(2008-3#1)
need to be identified##2##4##(2010-11#1)(2011-1#1)
need to be incorporated in the##2##6##(2008-12#1)(2009-7#1)
need to be incorporated##4##4##(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
need to be increased##2##4##(2008-7#1)(2013-8#1)
need to be investigated##3##4##(2007-12#1)(2008-10#1)(2010-10#1)
need to be made##2##4##(1996-1#1)(2008-9#1)
need to be modified##2##4##(2008-3#1)(2013-1#1)
need to be overcome##3##4##(2008-2#1)(2009-3#1)(2010-6#1)
need to be removed##2##4##(2008-10#1)(2008-2#1)
need to be taken##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
need to be trained##2##4##(2008-11#1)(2011-2#1)
need to be used##2##4##(2007-12#1)(2011-1#1)
need to be##203##3##(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-2#3)(1994-3#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#4)(2007-4#1)(2007-7#4)(2008-1#4)(2008-10#13)(2008-11#12)(2008-12#5)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#10)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#9)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#15)
need to become##2##3##(1994-2#1)(2008-11#1)
need to better understand##2##4##(2012-3#1)(2013-1#1)
need to broaden##2##3##(1995-1#1)(2008-11#1)
need to care for##3##4##(1995-12#1)(2008-4#1)(2010-7#1)
need to carry##2##3##(1993-3#1)(2008-12#1)
need to change the##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
need to change##5##3##(1996-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
need to consider how##2##4##(1996-2#1)(2013-1#1)
need to consider the##5##4##(2007-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-8#1)
need to consider##17##3##(1991-12#1)(1995-1#1)(1996-2#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
need to continue##3##3##(1991-12#1)(2008-12#1)(2012-12#1)
need to control##2##3##(2008-2#1)(2009-10#1)
need to define##4##3##(2008-2#1)(2010-12#1)(2010-5#1)(2013-1#1)
need to deliver##4##3##(1994-1#1)(1997-1#1)(2008-4#1)(2008-7#1)
need to design##2##3##(1997-1#1)(2008-5#1)
need to determine##8##3##(1990-5#1)(2008-10#4)(2008-5#1)(2010-4#1)(2010-6#1)
need to develop a##2##4##(1992-2#1)(1997-2#1)
need to develop an##2##4##(1997-2#1)(2008-11#1)
need to develop more##3##4##(1994-1#1)(2008-11#1)(2008-12#1)
need to develop reliable##2##4##(1997-4#1)(2008-10#1)
need to develop##26##3##(1991-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#2)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#2)
need to do##3##3##(1996-3#1)(2008-4#1)(2012-12#1)
need to educate##3##3##(1993-12#2)(1995-2#1)
need to engage##2##3##(2007-8#1)(2010-4#1)
need to evaluate##4##3##(2007-9#1)(2008-7#2)(2011-2#1)
need to evolve to##2##4##(1997-3#1)(2011-2#1)
need to examine the##2##4##(2008-11#2)
need to examine##3##3##(1996-12#1)(2008-11#2)
need to find ways##2##4##(1990-9#1)(1995-9#1)
need to find##3##3##(1990-9#1)(1992-12#1)(1995-9#1)
need to focus on##2##4##(2008-1#1)(2011-1#1)
need to focus##5##3##(1996-1#1)(2007-7#2)(2008-1#1)(2011-1#1)
need to go##2##3##(1995-9#1)(2012-2#1)
need to identify new##2##4##(2010-7#1)(2011-2#1)
need to identify##6##3##(1991-1#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-7#1)(2011-2#1)
need to implement##3##3##(1994-7#1)(2007-12#1)(2008-10#1)
need to improve their##2##4##(1994-1#1)(2008-10#1)
need to improve##7##3##(1993-12#1)(1994-1#1)(1995-6#1)(1996-1#1)(2008-10#1)(2010-5#1)(2011-2#1)
need to increase the##3##4##(2007-11#1)(2011-2#1)(2012-3#1)
need to increase##5##3##(2007-11#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
need to integrate the##2##4##(2008-7#1)(2009-8#1)
need to integrate##5##3##(1994-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
need to keep##2##3##(1995-3#1)(2008-7#1)
need to know about##2##4##(1995-1#1)(2010-5#1)
need to know how to##2##5##(1992-12#1)(2013-8#1)
need to know##16##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
need to learn how to##2##5##(1991-3#1)(1995-9#1)
need to learn##3##3##(1991-3#1)(1995-9#1)(2010-11#1)
need to limit##2##3##(2008-12#1)(2012-12#1)
need to make##5##3##(1991-6#1)(1992-2#1)(1993-1#1)(2008-1#1)(2010-12#1)
need to monitor##4##3##(2008-10#2)(2009-11#1)(2013-1#1)
need to move beyond##2##4##(1994-1#1)(2009-8#1)
need to move##3##3##(1994-1#1)(1997-4#1)(2009-8#1)
need to obtain##2##3##(1991-2#1)(2007-9#1)
need to pay more attention to##2##6##(2008-1#1)(2010-4#1)
need to pay##3##3##(2008-1#1)(2010-4#1)(2012-2#1)
need to prepare##2##3##(2008-11#1)(2010-4#1)
need to prevent and##2##4##(2008-8#1)(2008-9#1)
need to produce##3##3##(1995-2#1)(2008-11#1)(2009-9#1)
need to provide##7##3##(1995-2#1)(1995-9#1)(2007-7#1)(2008-11#1)(2012-1#1)(2013-8#2)
need to pursue##2##3##(1996-3#1)(2010-12#1)
need to put##3##3##(1991-3#1)(2008-10#1)(2010-5#1)
need to re-examine##2##3##(1992-12#1)(1996-3#1)
need to reassess##3##3##(1991-3#1)(2009-8#1)(2013-1#1)
need to recognize and##3##4##(2008-11#1)(2010-9#1)(2012-3#1)
need to recognize##7##3##(1994-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-9#1)(2012-3#1)
need to reduce##4##3##(1996-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
need to remove the##2##4##(2008-10#2)
need to rethink the##2##4##(1991-12#1)(2011-3#1)
need to rethink##3##3##(1991-12#1)(2010-3#1)(2011-3#1)
need to search for##2##4##(1997-1#1)(2008-10#1)
need to seek##3##3##(1993-1#1)(2007-2#1)(2012-3#1)
need to share##2##3##(2008-11#1)(2010-11#1)
need to shift##2##3##(1997-1#1)(2013-8#1)
need to support##2##3##(1993-12#1)(1997-1#1)
need to take##5##3##(1995-5#1)(2008-12#1)(2009-4#1)(2010-10#1)(2011-1#1)
need to understand and##3##4##(1994-2#1)(2010-7#1)(2011-1#1)
need to understand the##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
need to understand##15##3##(1994-2#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
need to unify##2##3##(2007-8#1)(2008-1#1)
need to use##5##3##(1991-8#1)(1995-1#1)(2008-12#1)(2010-5#1)(2013-1#1)
need to work##3##3##(1991-3#1)(2008-7#1)(2013-7#1)
need to##627##2##(1990-5#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#7)(1991-6#3)(1991-8#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#3)(1994-1#9)(1994-12#3)(1994-2#8)(1994-3#5)(1994-6#1)(1994-7#1)(1995-1#8)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#4)(1996-1#7)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#11)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-8#3)(2006-10#1)(2006-7#1)(2007-10#3)(2007-11#7)(2007-12#12)(2007-2#7)(2007-4#1)(2007-7#7)(2007-8#3)(2007-9#3)(2008-1#11)(2008-10#41)(2008-11#45)(2008-12#19)(2008-2#13)(2008-3#15)(2008-4#7)(2008-5#10)(2008-6#5)(2008-7#25)(2008-8#14)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#7)(2010-12#8)(2010-3#4)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#16)(2011-2#25)(2011-3#1)(2012-1#3)(2012-12#10)(2012-2#15)(2012-3#10)(2013-1#20)(2013-7#2)(2013-8#22)
need##1684##1##(1990-10#3)(1990-11#5)(1990-12#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#5)(1991-12#12)(1991-2#9)(1991-3#15)(1991-5#2)(1991-6#7)(1991-8#2)(1991-9#2)(1992-1#9)(1992-10#2)(1992-11#3)(1992-12#12)(1992-2#11)(1992-3#6)(1992-6#3)(1992-8#5)(1992-9#4)(1993-1#8)(1993-11#2)(1993-12#19)(1993-2#10)(1993-3#8)(1993-5#2)(1993-6#1)(1993-8#1)(1994-1#17)(1994-11#1)(1994-12#6)(1994-2#17)(1994-3#14)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#23)(1995-11#6)(1995-12#12)(1995-2#15)(1995-3#7)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#5)(1996-1#17)(1996-11#4)(1996-12#11)(1996-2#12)(1996-3#21)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#9)(1997-2#5)(1997-3#14)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#6)(2006-10#7)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#10)(2007-11#25)(2007-12#27)(2007-2#15)(2007-4#2)(2007-5#4)(2007-7#18)(2007-8#15)(2007-9#3)(2008-1#38)(2008-10#155)(2008-11#105)(2008-12#43)(2008-2#35)(2008-3#45)(2008-4#21)(2008-5#28)(2008-6#10)(2008-7#49)(2008-8#30)(2008-9#40)(2009-1#1)(2009-10#5)(2009-11#7)(2009-12#3)(2009-2#1)(2009-3#7)(2009-4#6)(2009-5#7)(2009-6#8)(2009-7#3)(2009-8#12)(2009-9#4)(2010-1#3)(2010-10#19)(2010-11#11)(2010-12#20)(2010-2#3)(2010-3#9)(2010-4#7)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#16)(2010-9#5)(2011-1#36)(2011-2#84)(2011-3#2)(2012-1#6)(2012-12#31)(2012-2#38)(2012-3#23)(2013-1#57)(2013-7#6)(2013-8#38)
need-free##2##1##(1993-12#2)
need-induced NaCl intake##2##3##(1993-12#2)
need?##2##1##(1995-2#1)(2012-2#1)
needed a##2##2##(2008-10#1)(2010-12#1)
needed after##2##2##(1992-5#1)(2011-2#1)
needed and the##2##3##(2008-10#1)(2008-3#1)
needed and##12##2##(1996-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
needed are##3##2##(2008-3#1)(2013-1#2)
needed at##4##2##(1993-6#1)(1996-8#1)(2008-10#1)(2009-11#1)
needed before##3##2##(1993-3#1)(2008-3#1)(2010-10#1)
needed by##6##2##(1991-1#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-3#1)(2012-1#1)
needed during##2##2##(2009-3#1)(2011-1#1)
needed for a##5##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-3#1)
needed for accurate##2##3##(2008-10#1)(2008-2#1)
needed for an##2##3##(1997-2#1)(2008-10#1)
needed for cell##2##3##(2009-12#1)(2012-2#1)
needed for quantitative##3##3##(2008-10#2)(2008-9#1)
needed for the##13##3##(1994-8#1)(2008-10#8)(2008-2#2)(2008-4#1)(2013-1#1)
needed for##106##2##(1990-5#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
needed in future determinations##2##4##(2008-10#2)
needed in order to make##2##5##(2008-10#1)(2010-9#1)
needed in order to##16##4##(1994-1#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-3#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#2)
needed in the health care industry##2##6##(1992-3#1)(1995-3#1)
needed in the way##2##4##(1991-3#1)(2008-3#1)
needed in the##14##3##(1991-3#1)(1992-3#1)(1995-3#3)(1995-6#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
needed in##54##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-3#1)(2013-1#2)
needed is##4##2##(1992-3#1)(1994-1#1)(1994-2#1)(1996-3#1)
needed on the##4##3##(1995-11#1)(2008-11#1)(2011-1#1)(2013-8#1)
needed on##12##2##(1990-9#1)(1992-9#1)(1993-1#1)(1994-2#1)(1995-11#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
needed only##2##2##(2008-2#1)(2008-3#1)
needed that##3##2##(1991-2#1)(2009-7#1)(2012-12#1)
needed to achieve##2##3##(2008-10#1)(2008-8#1)
needed to address the##5##4##(1993-1#1)(1994-12#1)(1997-1#1)(2008-11#1)(2010-9#1)
needed to address##7##3##(1993-1#1)(1994-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-12#1)
needed to analyze##2##3##(2008-8#1)(2012-3#1)
needed to apply the##2##4##(1997-3#1)(2008-10#1)
needed to assess##4##3##(2007-10#1)(2007-8#1)(2008-11#1)(2010-10#1)
needed to avoid##2##3##(1990-2#1)(2008-12#1)
needed to be##11##3##(1993-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-7#1)(2010-3#2)(2011-1#1)
needed to better understand the##3##5##(2008-11#1)(2009-5#1)(2013-1#1)
needed to better understand##4##4##(2007-12#1)(2008-11#1)(2009-5#1)(2013-1#1)
needed to better##5##3##(2007-12#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
needed to build a##2##4##(2008-3#1)(2008-4#1)
needed to build##3##3##(2008-3#2)(2008-4#1)
needed to clarify the##6##4##(2008-1#1)(2008-10#2)(2010-12#1)(2012-3#1)(2013-8#1)
needed to clarify##7##3##(1991-3#1)(2008-1#1)(2008-10#2)(2010-12#1)(2012-3#1)(2013-8#1)
needed to compare##2##3##(2007-10#1)(2007-8#1)
needed to confirm the##4##4##(1991-12#1)(2010-12#1)(2011-2#2)
needed to confirm these##3##4##(2008-2#1)(2009-7#1)(2011-2#1)
needed to confirm whether##2##4##(2008-10#2)
needed to confirm##12##3##(1991-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#3)(2013-1#1)
needed to control the disease##2##5##(2011-2#2)
needed to correct##2##3##(2008-2#1)(2008-3#1)
needed to describe the##2##4##(2008-7#1)(2011-2#1)
needed to determine if##3##4##(1994-12#1)(1997-3#1)(2008-10#1)
needed to determine the##10##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
needed to determine whether the##2##5##(1992-8#1)(2008-10#1)
needed to determine whether##5##4##(1992-8#1)(1993-8#1)(2008-10#2)(2012-2#1)
needed to determine##23##3##(1992-8#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
needed to develop##4##3##(1996-2#1)(2008-1#2)(2010-11#1)
needed to elucidate the##4##4##(1994-5#1)(1995-6#1)(2009-8#1)(2012-12#1)
needed to elucidate##5##3##(1994-5#1)(1995-6#1)(2007-4#1)(2009-8#1)(2012-12#1)
needed to ensure##4##3##(1995-6#1)(2008-8#1)(2013-1#2)
needed to establish the##4##4##(2007-10#1)(2008-7#1)(2012-2#2)
needed to establish##7##3##(2007-10#1)(2008-5#1)(2008-7#2)(2012-2#2)(2012-3#1)
needed to evaluate the##5##4##(1994-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2013-1#1)
needed to evaluate##10##3##(1994-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)(2013-1#1)
needed to fully##4##3##(2008-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
needed to further##5##3##(2007-12#1)(2008-11#1)(2010-12#1)(2012-2#2)
needed to get##2##3##(1991-1#1)(2007-9#1)
needed to guide##2##3##(1994-3#1)(2012-3#1)
needed to identify and##2##4##(2008-7#1)(2010-11#1)
needed to identify optimal##2##4##(2007-10#1)(2008-9#1)
needed to identify potential##2##4##(2009-12#1)(2011-1#1)
needed to identify the##3##4##(2007-11#1)(2008-3#1)(2010-10#1)
needed to identify##15##3##(1992-11#1)(1994-9#1)(2007-10#2)(2007-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
needed to improve##12##3##(1993-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#2)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#3)
needed to increase##2##3##(2008-10#1)(2013-8#1)
needed to maintain the##2##4##(2008-12#1)(2011-2#1)
needed to maintain##4##3##(1990-4#1)(2007-12#1)(2008-12#1)(2011-2#1)
needed to make##2##3##(2008-2#1)(2008-7#1)
needed to measure##2##3##(2008-10#1)(2008-9#1)
needed to meet##3##3##(1991-8#1)(2008-2#1)(2011-1#1)
needed to observe##2##3##(2008-10#1)(2008-11#1)
needed to obtain a##2##4##(1994-3#1)(2009-9#1)
needed to obtain##3##3##(1994-3#1)(2008-10#1)(2009-9#1)
needed to overcome the##2##4##(2010-10#1)(2010-8#1)
needed to promote##3##3##(2008-1#1)(2010-5#1)(2011-1#1)
needed to provide##7##3##(1994-9#1)(1995-12#1)(1996-2#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
needed to quantify##2##3##(1991-12#1)(2008-3#1)
needed to reduce the##2##4##(2008-10#1)(2008-9#1)
needed to render##2##3##(1994-2#1)(1997-5#1)
needed to restore##2##3##(2007-12#1)(2008-6#1)
needed to separate##2##3##(2008-10#2)
needed to simulate##2##3##(1994-12#1)(2008-8#1)
needed to substantiate##2##3##(2008-11#1)(2012-12#1)
needed to successfully##2##3##(1994-1#1)(2008-4#1)
needed to support##6##3##(1994-1#1)(1994-12#1)(1997-1#1)(2007-12#1)(2009-11#1)(2011-2#1)
needed to understand the##3##4##(1997-3#1)(2012-2#1)(2013-1#1)
needed to understand##7##3##(1997-3#1)(2008-10#1)(2010-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
needed to##326##2##(1990-2#1)(1990-4#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#6)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#2)(1996-2#3)(1997-1#2)(1997-2#3)(1997-3#4)(1997-5#1)(2006-10#2)(2007-10#7)(2007-11#2)(2007-12#9)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#37)(2008-11#16)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#10)(2008-9#10)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#8)(2012-2#14)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#6)
needed using##2##2##(2008-10#2)
needed when##2##2##(2010-8#1)(2011-2#1)
needed with##2##2##(1992-1#1)(1996-5#1)
needed##815##1##(1990-11#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#3)(1991-12#4)(1991-2#2)(1991-3#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#2)(1993-12#6)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#5)(1994-12#7)(1994-2#5)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#7)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#10)(1997-2#7)(1997-3#8)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#2)(2006-10#2)(2006-12#2)(2007-10#7)(2007-11#7)(2007-12#18)(2007-2#5)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#22)(2008-10#113)(2008-11#38)(2008-12#11)(2008-2#23)(2008-3#36)(2008-4#19)(2008-5#14)(2008-6#5)(2008-7#18)(2008-8#17)(2008-9#16)(2009-10#1)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#3)(2009-5#5)(2009-6#1)(2009-7#6)(2009-8#5)(2009-9#2)(2010-10#7)(2010-11#6)(2010-12#8)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#12)(2011-2#36)(2012-1#2)(2012-12#16)(2012-2#26)(2012-3#16)(2013-1#36)(2013-7#4)(2013-8#11)
needed?##2##1##(1993-1#1)(2008-9#1)
needing further##2##2##(2007-11#1)(2008-5#1)
needing more##3##2##(1994-1#1)(2008-11#1)(2008-8#1)
needing support##2##2##(2008-12#1)(2012-3#1)
needing the##2##2##(2008-10#1)(2011-2#1)
needing##26##1##(1994-1#1)(1994-3#1)(1995-3#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
needle and##6##2##(1994-5#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
needle aspiration biopsy##4##3##(1991-6#1)(1992-8#1)(1994-7#1)(1997-2#1)
needle aspiration cytology (FNAC)##3##4##(1990-6#1)(2008-7#1)(2009-7#1)
needle aspiration cytology and##3##4##(2010-11#1)(2013-8#2)
needle aspiration cytology##15##3##(1990-10#1)(1990-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-8#4)
needle aspiration##31##2##(1990-10#2)(1990-6#2)(1991-3#1)(1991-6#2)(1992-8#1)(1994-7#1)(1996-9#1)(1997-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-8#2)(2011-2#1)(2013-8#4)
needle biopsy##11##2##(1990-3#2)(1991-2#1)(1991-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2009-10#1)
needle blight##6##2##(2008-10#6)
needle cannulation of the internal jugular vein##2##7##(1992-12#2)
needle cast disease##2##3##(2008-10#2)
needle cast##6##2##(2008-10#6)
needle electrode##2##2##(1993-9#1)(1995-8#1)
needle exchange##2##2##(1991-1#1)(1996-11#1)
needle in the haystack##2##4##(1997-8#1)(2007-5#1)
needle in##4##2##(1997-8#1)(2007-5#1)(2007-8#1)(2012-2#1)
needle insertion##2##2##(2009-12#1)(2012-3#1)
needle method##3##2##(2008-3#3)
needle of##2##2##(1990-2#1)(2008-10#1)
needle or##2##2##(2008-6#1)(2013-1#1)
needle over##2##2##(2008-10#1)(2008-4#1)
needle pain in clinical settings##2##5##(2008-11#2)
needle pain##4##2##(2008-11#4)
needle procedures##4##2##(2008-11#4)
needle puncture##4##2##(1990-10#1)(1991-12#1)(2008-10#2)
needle stick injuries##2##3##(2007-7#2)
needle stick##3##2##(2007-7#2)(2009-11#1)
needle that##2##2##(2007-12#1)(2013-1#1)
needle to##2##2##(2008-10#2)
needle with##2##2##(2007-12#1)(2008-10#1)
needle##170##1##(1990-10#3)(1990-2#2)(1990-3#3)(1990-6#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1992-12#4)(1992-5#1)(1992-8#1)(1993-10#1)(1993-9#2)(1994-5#2)(1994-7#3)(1994-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-5#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#43)(2008-11#9)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-8#6)(2011-2#4)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#4)
needle-exchange programs##2##2##(1997-5#2)
needle-exchange##3##1##(1997-5#3)
needlelike##2##1##(2008-3#2)
needles and##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-10#1)(2011-2#1)(2013-1#1)
needles contaminated with##2##3##(2007-7#2)
needles from a##2##3##(2008-10#2)
needles from seedlings that##2##4##(2008-10#2)
needles from##4##2##(2008-10#4)
needles in##2##2##(2008-9#1)(2013-1#1)
needles was##2##2##(2008-10#2)
needles##50##1##(1990-2#1)(1990-3#2)(1992-9#1)(2007-11#2)(2007-7#7)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-7#1)(2011-10#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
needlestick injuries##6##2##(1991-3#1)(1991-6#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
needlestick injury rate##2##3##(2012-12#2)
needlestick injury##5##2##(1996-5#1)(2012-12#4)
needlestick##13##1##(1991-3#1)(1991-6#1)(1996-5#2)(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#6)
needlestick-prevention##2##1##(2010-9#2)
needs a new##2##3##(2007-8#1)(2008-6#1)
needs a##11##2##(1995-11#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-12#1)(2011-3#1)
needs and also##2##3##(1991-1#1)(2012-3#1)
needs and expectations of##4##4##(1995-1#1)(2008-5#1)(2010-4#1)(2011-1#1)
needs and expectations##6##3##(1994-3#1)(1995-1#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
needs and health##2##3##(1991-3#1)(2008-12#1)
needs and in##2##3##(1993-1#1)(1994-12#1)
needs and preferences##2##3##(2012-12#1)(2012-3#1)
needs and the##4##3##(1992-3#1)(1993-12#2)(1993-2#1)
needs and their families##2##4##(2008-11#2)
needs and their##4##3##(1993-1#1)(1997-3#1)(2008-11#2)
needs and to##2##3##(1993-12#1)(2008-10#1)
needs and##66##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#2)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-5#2)(2008-7#2)(2009-5#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
needs are discussed##3##3##(1994-1#1)(1995-2#1)(2011-1#1)
needs are##11##2##(1992-1#1)(1993-12#2)(1994-1#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#2)(2010-2#1)(2011-1#1)
needs as well as the##2##5##(1994-1#1)(2011-1#1)
needs as##3##2##(1994-1#1)(2010-3#1)(2011-1#1)
needs assessment and##3##3##(1994-3#2)(1996-2#1)
needs assessment survey##2##3##(1994-3#1)(2013-1#1)
needs assessment##15##2##(1994-3#3)(1995-12#2)(1995-2#1)(1996-2#1)(1997-1#2)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#3)
needs behind##2##2##(1995-2#1)(2012-3#1)
needs do##2##2##(1997-3#1)(2009-5#1)
needs during the##2##3##(1994-2#1)(2007-2#1)
needs during##4##2##(1994-2#1)(1995-12#1)(2007-2#1)(2010-8#1)
needs for health##3##3##(1992-3#1)(1997-1#1)(1997-3#1)
needs for new##2##3##(1996-2#1)(2012-12#1)
needs for the##5##3##(1994-2#1)(1997-1#1)(1997-3#1)(2009-12#1)(2013-8#1)
needs for##37##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-8#1)(1993-1#2)(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#3)(1997-3#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-12#1)(2010-2#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
needs further evaluation##2##3##(2008-1#1)(2008-7#1)
needs further investigation##6##3##(1990-6#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
needs further study##2##3##(2008-7#1)(2012-3#1)
needs further##16##2##(1990-6#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
needs has##2##2##(2012-2#1)(2013-1#1)
needs have##4##2##(1992-2#1)(1994-3#3)
needs in a##3##3##(1996-1#1)(1997-3#1)(2012-3#1)
needs in relation to##2##4##(1992-3#1)(2013-1#1)
needs in the##6##3##(1992-3#1)(1993-2#1)(2008-9#1)(2009-4#1)(2010-6#1)(2010-8#1)
needs in this area##2##4##(2010-7#1)(2012-12#1)
needs in this##3##3##(2008-4#1)(2010-7#1)(2012-12#1)
needs in##25##2##(1992-3#2)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-3#2)(2007-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#2)
needs is##3##2##(1990-11#1)(1991-12#1)(1993-3#1)
needs more##4##2##(1996-8#1)(2008-10#1)(2010-8#1)(2011-1#1)
needs not##2##2##(1993-1#1)(2010-10#1)
needs of a##9##3##(1991-3#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-12#1)
needs of children in##2##4##(1992-3#1)(2011-1#1)
needs of children with##2##4##(1997-2#1)(2008-11#1)
needs of children##7##3##(1992-1#1)(1992-3#1)(1994-1#1)(1997-2#1)(2008-11#1)(2011-1#1)(2012-3#1)
needs of chronically ill patients##3##5##(1997-1#2)(2012-3#1)
needs of consumers##2##3##(1996-3#1)(2011-2#1)
needs of dyslexic##2##3##(2010-2#2)
needs of its customers##2##4##(1994-12#1)(1994-2#1)
needs of its##3##3##(1994-12#1)(1994-2#1)(1996-3#1)
needs of nurses##2##3##(2010-11#2)
needs of patients with##2##4##(2010-3#1)(2012-3#1)
needs of patients##11##3##(1992-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-4#1)(2010-1#1)(2010-10#1)(2010-3#1)(2012-3#1)
needs of persons##2##3##(1994-2#1)(1994-3#1)
needs of the child##2##4##(1993-12#1)(2008-11#1)
needs of the community and##2##5##(1995-2#1)(1995-3#1)
needs of the elderly##2##4##(1991-3#1)(2007-10#1)
needs of the homebound##2##4##(1995-12#1)(1996-3#1)
needs of the patient##7##4##(1995-1#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2013-1#2)
needs of the##49##3##(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-12#4)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
needs of their##10##3##(1992-1#1)(1993-1#1)(1994-1#1)(1994-3#3)(1997-3#1)(2007-10#1)(2010-3#1)(2013-7#1)
needs of these patients##2##4##(1997-8#1)(2013-1#1)
needs of these##4##3##(1990-10#1)(1992-3#1)(1997-8#1)(2013-1#1)
needs of this population##2##4##(1993-12#1)(2009-11#1)
needs of this##3##3##(1992-1#1)(1993-12#1)(2009-11#1)
needs of those##2##3##(2010-8#1)(2011-2#1)
needs of women##4##3##(1996-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
needs of##203##2##(1990-10#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#4)(1993-1#3)(1993-12#8)(1993-2#2)(1993-6#2)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#11)(1994-9#1)(1995-1#5)(1995-12#3)(1995-2#6)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#7)(1997-1#4)(1997-2#3)(1997-3#5)(1997-8#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#13)(2008-12#4)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#1)
needs program##2##2##(1994-7#1)(1995-12#1)
needs related to their children's disorders##2##6##(1995-1#2)
needs related to##3##3##(1995-1#2)(1995-2#1)
needs should##2##2##(1992-4#1)(1994-2#1)
needs that##6##2##(1993-12#1)(1995-1#1)(2008-6#1)(2010-9#1)(2012-2#2)
needs the##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2011-3#1)
needs through##2##2##(1996-2#1)(2010-8#1)
needs to a##2##3##(1991-12#1)(1994-2#1)
needs to be addressed##5##4##(1991-3#1)(2008-1#1)(2009-12#1)(2010-3#1)(2011-1#1)
needs to be carefully##2##4##(1990-12#1)(2007-11#1)
needs to be confirmed##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
needs to be considered in##2##5##(1992-9#1)(2012-3#1)
needs to be considered##4##4##(1992-9#1)(1996-8#1)(2008-12#1)(2012-3#1)
needs to be determined##2##4##(2008-3#1)(2009-5#1)
needs to be developed##2##4##(2009-4#1)(2012-3#1)
needs to be done##3##4##(1994-3#1)(2008-7#1)(2011-2#1)
needs to be explored##2##4##(2013-1#1)(2013-7#1)
needs to be further##3##4##(2008-12#1)(2008-5#1)(2013-1#1)
needs to be given to the##2##6##(1992-12#1)(2011-1#1)
needs to be given to##4##5##(1992-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
needs to be improved##2##4##(2008-10#1)(2009-7#1)
needs to be incorporated##2##4##(1991-12#1)(2012-12#1)
needs to be increased##2##4##(2008-10#1)(2008-7#1)
needs to be properly##2##4##(2008-10#2)
needs to be solved##2##4##(2008-3#1)(2010-8#1)
needs to be taken##2##4##(1996-12#1)(1997-3#1)
needs to be the##2##4##(2007-10#1)(2013-1#1)
needs to be validated##2##4##(2008-6#1)(2011-7#1)
needs to be##107##3##(1990-12#1)(1991-12#2)(1991-3#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#6)(2008-3#8)(2008-5#5)(2008-6#3)(2008-7#6)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#2)
needs to consider##2##3##(2008-8#1)(2013-1#1)
needs to focus on the##2##5##(1994-2#1)(2008-8#1)
needs to include##2##3##(1997-3#1)(2008-11#1)
needs to provide##2##3##(2008-8#1)(2010-3#1)
needs to##150##2##(1990-12#1)(1991-12#3)(1991-3#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-12#8)(2008-3#10)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-8#2)(2011-1#3)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#2)
needs under##2##2##(1995-1#1)(1995-12#1)
needs were identified##3##3##(1995-1#1)(2013-8#2)
needs were##5##2##(1995-1#1)(2008-1#1)(2012-2#1)(2013-8#2)
needs will##3##2##(1992-3#1)(1994-1#2)
needs with##2##2##(2010-1#1)(2011-1#1)
needs##832##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#3)(1991-12#8)(1991-2#2)(1991-3#8)(1991-6#2)(1991-9#1)(1992-1#10)(1992-11#1)(1992-12#11)(1992-2#7)(1992-3#19)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#9)(1993-11#1)(1993-12#20)(1993-2#8)(1993-3#6)(1993-6#2)(1993-7#1)(1994-1#15)(1994-12#6)(1994-2#16)(1994-3#27)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#18)(1995-11#1)(1995-12#16)(1995-2#15)(1995-3#11)(1995-5#1)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#4)(1996-2#12)(1996-3#15)(1996-4#1)(1996-8#2)(1997-1#17)(1997-2#9)(1997-3#27)(1997-4#2)(1997-7#3)(1997-8#3)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#6)(2007-2#5)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#17)(2008-10#35)(2008-11#45)(2008-12#24)(2008-2#2)(2008-3#16)(2008-4#7)(2008-5#15)(2008-6#11)(2008-7#21)(2008-8#8)(2008-9#7)(2009-11#2)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#1)(2010-1#4)(2010-10#6)(2010-11#8)(2010-12#1)(2010-2#5)(2010-3#8)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#14)(2010-9#1)(2011-1#18)(2011-2#16)(2011-3#2)(2011-7#1)(2012-12#19)(2012-2#18)(2012-3#25)(2013-1#34)(2013-7#3)(2013-8#11)
needs-based##5##1##(1994-1#2)(1997-1#2)(2011-2#1)
needs?##2##1##(2013-7#1)(2013-8#1)
needy recipients##2##2##(1995-1#2)
needy##6##1##(1994-2#2)(1995-1#2)(2008-9#2)
neem leaf##2##2##(2011-2#2)
neem##5##1##(2011-2#5)
negate the##2##2##(2009-10#1)(2010-4#1)
negate##7##1##(1994-9#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
negated the##3##2##(2008-10#1)(2008-8#2)
negated##8##1##(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#2)
negation of##3##2##(2013-1#3)
negative (no##2##2##(1990-5#1)(2008-10#1)
negative (p##2##2##(2008-12#1)(2008-3#1)
negative T waves##4##3##(1991-3#1)(1993-1#3)
negative activation##2##2##(1993-8#1)(2013-8#1)
negative activity on##2##3##(1993-11#1)(1995-8#1)
negative adjustment##2##2##(2009-11#1)(2009-8#1)
negative affect and##2##3##(2009-11#1)(2010-1#1)
negative affect##14##2##(1994-2#2)(2008-11#2)(2008-12#1)(2009-11#2)(2009-5#2)(2009-7#1)(2010-1#1)(2013-8#3)
negative affectivity##6##2##(2010-6#6)
negative allometry##2##2##(2008-5#1)(2011-2#1)
negative and positive##8##3##(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#3)
negative and##19##2##(1995-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-9#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-1#2)
negative antagonism##2##2##(1995-6#2)
negative arterial##2##2##(2007-7#1)(2013-8#1)
negative as##2##2##(1990-5#1)(2008-12#1)
negative association of##2##3##(2008-1#1)(2008-7#1)
negative association with##2##3##(1996-9#1)(2010-1#1)
negative association##6##2##(1994-2#1)(1995-12#1)(1996-9#1)(2008-1#1)(2008-7#1)(2010-1#1)
negative at the##2##3##(1991-2#1)(2011-2#1)
negative at##3##2##(1991-2#1)(1997-2#1)(2011-2#1)
negative attitude towards screening##2##4##(1992-2#2)
negative attitude towards##3##3##(1992-2#2)(2010-3#1)
negative attitude##4##2##(1992-2#2)(2010-12#1)(2010-3#1)
negative attitudes toward##7##3##(1993-1#1)(1996-2#1)(2007-12#1)(2008-11#1)(2010-8#1)(2011-1#2)
negative attitudes##12##2##(1993-1#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-11#3)(2010-3#1)(2010-8#1)(2011-1#2)
negative attributional style and##2##4##(2010-10#2)
negative attributional style##5##3##(2010-10#5)
negative bacilli##2##2##(1997-3#1)(2007-8#1)
negative bacteria##15##2##(1994-11#1)(1995-11#1)(1997-8#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
negative bacteria)##2##2##(2010-10#2)
negative binomial distribution for##2##4##(2008-10#1)(2008-6#1)
negative binomial distribution##8##3##(2008-10#4)(2008-3#1)(2008-6#2)(2013-1#1)
negative biopsy##2##2##(1991-6#1)(2010-12#1)
negative blood group and##2##4##(2007-9#2)
negative by##4##2##(1991-8#1)(1992-6#1)(1997-6#1)(2013-8#1)
negative cases##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
negative cell lines##3##3##(1992-12#2)(2010-1#1)
negative cell##5##2##(1992-12#2)(2008-4#1)(2008-5#1)(2010-1#1)
negative cells##2##2##(1990-5#1)(1992-9#1)
negative charge of##3##3##(1990-5#1)(2008-11#1)(2008-5#1)
negative charge on the##4##4##(1995-5#1)(2008-10#1)(2008-5#1)(2010-5#1)
negative charge##11##2##(1990-5#1)(1990-8#1)(1995-5#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#2)(2011-2#1)
negative charges of##2##3##(2008-10#1)(2008-4#1)
negative charges##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
negative clinical##2##2##(1991-6#1)(2010-7#1)
negative cognitive style##2##3##(2010-10#2)
negative cognitive##3##2##(2009-10#1)(2010-10#2)
negative component##3##2##(1995-5#2)(1996-5#1)
negative conditional cognitions about blushing##2##5##(2010-4#2)
negative consequences associated with##2##4##(2008-6#1)(2010-11#1)
negative consequences for##3##3##(1997-2#2)(2007-12#1)
negative consequences of the##2##4##(1990-6#1)(1993-3#1)
negative consequences of##4##3##(1990-6#1)(1993-3#1)(2007-8#1)(2008-11#1)
negative consequences##13##2##(1990-6#1)(1993-3#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#2)(2010-11#1)(2010-3#1)(2013-7#1)
negative contrast##2##2##(2008-7#1)(2010-9#1)
negative control group##2##3##(2008-10#1)(2013-1#1)
negative control of##3##3##(1993-3#1)(1997-1#1)(2008-7#1)
negative control##17##2##(1990-6#1)(1992-11#1)(1993-3#1)(1997-1#1)(2008-10#4)(2008-7#1)(2008-8#2)(2009-2#1)(2010-2#2)(2010-5#1)(2010-7#1)(2013-1#1)
negative controls##6##2##(1993-3#1)(2008-10#2)(2010-4#1)(2012-3#2)
negative cooperativity and##3##3##(1993-11#1)(1997-2#2)
negative cooperativity##4##2##(1993-11#1)(1997-2#3)
negative corona discharge ion mobility spectrometry##2##6##(2008-10#2)
negative corona discharge##3##3##(2008-10#3)
negative correlation between the##8##4##(1994-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#2)
negative correlation between##21##3##(1991-11#1)(1992-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-6#1)(2013-1#1)(2013-8#2)
negative correlation in##2##3##(2008-9#1)(2012-3#1)
negative correlation was found##3##4##(1996-12#1)(2008-11#1)(2008-7#1)
negative correlation was##4##3##(1996-12#1)(2008-11#1)(2008-7#1)(2010-8#1)
negative correlation with the##2##4##(1991-11#1)(2010-6#1)
negative correlation with##5##3##(1991-11#1)(2010-6#1)(2011-1#1)(2011-2#2)
negative correlation##43##2##(1990-12#1)(1991-11#2)(1992-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#2)
negative correlations between##3##3##(2008-7#1)(2008-9#2)
negative correlations were##2##3##(2008-10#1)(2011-3#1)
negative correlations##9##2##(1996-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#3)(2011-3#1)
negative delta##3##2##(1990-8#1)(1993-12#1)(2008-11#1)
negative deviations##2##2##(1990-8#2)
negative dimensions##3##2##(2007-12#1)(2013-1#2)
negative direction##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)
negative dispersion##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
negative effect of##13##3##(1992-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)
negative effect on##17##3##(1991-2#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#1)
negative effect##35##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-6#2)(1994-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
negative effects of##8##3##(2008-10#1)(2008-12#2)(2008-7#1)(2010-7#1)(2011-2#2)(2012-3#1)
negative effects on the##3##4##(1996-5#1)(2008-10#2)
negative effects on##11##3##(1992-3#1)(1994-9#1)(1996-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
negative effects##25##2##(1991-1#1)(1992-3#1)(1994-9#1)(1996-5#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-7#3)(2011-2#3)(2012-3#2)(2013-1#2)
negative element##3##2##(2008-11#3)
negative emotionality##2##2##(2009-8#1)(2009-9#1)
negative emotions##4##2##(2008-11#2)(2010-11#1)(2011-1#1)
negative events##2##2##(2008-1#1)(2009-8#1)
negative explicit attitudes##4##3##(2007-12#2)(2009-9#2)
negative exponential##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
negative expression##2##2##(1994-11#1)(2008-12#1)
negative factor##2##2##(1991-2#1)(2009-8#1)
negative factors##3##2##(1993-9#1)(2009-8#2)
negative family history##2##3##(2008-4#1)(2008-6#1)
negative family##3##2##(2008-4#1)(2008-6#1)(2008-9#1)
negative feedback mechanism is##2##4##(2010-10#2)
negative feedback mechanism##4##3##(2010-10#4)
negative feedback regulation of##2##4##(1990-8#1)(2012-2#1)
negative feedback signals##3##3##(2008-11#3)
negative feedback##16##2##(1990-8#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#7)(2012-2#1)
negative feelings##4##2##(2007-2#2)(2010-3#1)(2012-3#1)
negative findings##3##2##(1994-3#2)(2008-10#1)
negative for PTHrP##2##3##(1994-7#2)
negative for S-100##2##3##(2006-12#1)(2008-11#1)
negative for all##4##3##(1990-12#1)(1993-9#1)(2010-4#1)(2011-2#1)
negative for both##2##3##(1997-5#1)(2009-8#1)
negative for endotoxins##2##3##(2013-1#2)
negative for the##5##3##(1997-2#1)(2008-12#1)(2011-2#2)(2012-2#1)
negative for##48##2##(1990-12#1)(1990-2#1)(1991-6#1)(1992-2#1)(1993-9#2)(1994-12#1)(1994-7#2)(1995-4#1)(1997-2#1)(1997-5#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
negative frequency-dependent selection##2##3##(2008-9#1)(2009-2#1)
negative genetic correlation##2##3##(2008-8#1)(2008-9#1)
negative genetic##3##2##(2008-8#2)(2008-9#1)
negative group##3##2##(2008-1#2)(2011-1#1)
negative health outcomes##4##3##(2009-5#1)(2010-10#1)(2012-1#1)(2013-7#1)
negative health##5##2##(2008-1#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-7#1)
negative images##2##2##(2008-7#2)
negative impact of##10##3##(1991-3#1)(1993-1#1)(1996-1#1)(1997-1#1)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
negative impact on the##4##4##(1994-12#1)(2008-10#1)(2008-12#1)(2011-7#1)
negative impact on##15##3##(1992-1#1)(1992-3#1)(1994-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-8#1)
negative impact##26##2##(1991-3#1)(1992-1#2)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#1)(1996-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
negative implications of##2##3##(1997-2#1)(2008-1#1)
negative implications##3##2##(1997-2#1)(2008-1#1)(2012-2#1)
negative in all the##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
negative in the##2##3##(1995-8#1)(2011-10#1)
negative in##17##2##(1993-5#2)(1995-4#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2011-10#1)(2011-2#2)
negative index##6##2##(2007-11#2)(2007-12#1)(2008-2#3)
negative indirect##2##2##(1992-6#1)(2008-9#1)
negative influence of the##3##4##(2007-11#1)(2008-10#2)
negative influence of##6##3##(2007-11#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)
negative influence on the##2##4##(1990-2#1)(2010-8#1)
negative influence on##5##3##(1990-2#1)(2007-11#1)(2008-10#1)(2010-8#2)
negative influence##13##2##(1990-2#1)(1993-8#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-4#1)(2010-8#2)(2011-1#1)(2012-2#1)
negative information##4##2##(1993-12#3)(2012-12#1)
negative inotropic effects of##2##4##(1995-12#2)
negative inotropic##3##2##(1995-12#2)(2009-2#1)
negative interpretations##2##2##(2009-11#1)(2011-2#1)
negative ion##3##2##(1994-3#1)(2008-10#1)(2011-1#1)
negative ionization##2##2##(2008-10#2)
negative linear relation##2##3##(1997-6#2)
negative linear##4##2##(1997-6#2)(2008-10#1)(2008-11#1)
negative margins##7##2##(1994-6#1)(1995-4#1)(1997-7#2)(2008-6#1)(2008-9#1)(2011-2#1)
negative messages##2##2##(2008-11#1)(2010-11#1)
negative mode at##2##3##(2008-10#1)(2009-12#1)
negative mode##5##2##(2008-10#4)(2009-12#1)
negative modulation##2##2##(1993-6#1)(2008-3#1)
negative modulators##2##2##(1992-3#2)
negative mood and##2##3##(2007-12#1)(2009-11#1)
negative mood##6##2##(2007-12#2)(2009-11#1)(2012-12#2)(2012-2#1)
negative nonlinear##3##2##(2007-12#3)
negative on##2##2##(1993-2#1)(1995-4#1)
negative ones##3##2##(1997-2#1)(2008-5#1)(2008-6#1)
negative opinion of##2##3##(1993-12#1)(2011-2#1)
negative or##2##2##(1996-12#1)(2011-2#1)
negative outcomes##3##2##(1992-2#1)(2009-5#1)(2013-8#1)
negative patients with##3##3##(1990-8#1)(1993-11#1)(2007-10#1)
negative patients##7##2##(1990-8#2)(1993-11#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-3#1)
negative peak##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
negative peaks##2##2##(1990-5#2)
negative perceptions of##2##3##(1991-2#1)(2012-3#1)
negative performance##2##2##(1997-3#2)
negative phototropism of rice root##2##5##(2008-9#2)
negative phototropism##6##2##(2008-9#6)
negative potential##6##2##(2007-12#1)(2008-10#4)(2008-8#1)
negative potentials##4##2##(1990-7#1)(2008-10#3)
negative predictive value (NPV)##2##4##(2008-10#1)(2011-2#1)
negative predictive value and##2##4##(2010-4#1)(2013-8#1)
negative predictive value of##7##4##(1993-2#1)(2007-5#1)(2007-8#1)(2008-3#1)(2011-2#2)(2013-1#1)
negative predictive value##21##3##(1992-11#1)(1993-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-4#1)(2011-2#8)(2012-12#2)(2013-1#1)(2013-8#1)
negative predictive##29##2##(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2010-4#1)(2011-1#1)(2011-2#8)(2012-12#2)(2013-1#1)(2013-8#1)
negative predictors of FGT removal prior to discharge from##2##9##(2007-10#2)
negative pressure##6##2##(2008-10#3)(2008-11#1)(2010-3#1)(2012-2#1)
negative prognosis##3##2##(1991-6#1)(1992-8#1)(2008-10#1)
negative prognostic factor##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
negative prognostic##4##2##(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
negative proteome##2##2##(2008-9#2)
negative psychological##2##2##(1991-12#1)(1995-9#1)
negative rate##3##2##(1994-9#1)(1997-4#1)(2012-12#1)
negative regression##2##2##(2008-10#1)(2008-12#1)
negative regulation of##2##3##(2007-5#1)(2008-11#1)
negative regulation##5##2##(1990-11#1)(1993-2#1)(2007-5#1)(2008-11#1)(2008-4#1)
negative regulator of the##2##4##(2008-7#1)(2009-8#1)
negative regulator of##12##3##(1990-11#1)(1991-2#1)(1995-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
negative regulator##13##2##(1990-11#1)(1991-12#1)(1991-2#1)(1995-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
negative regulators of##5##3##(2007-12#1)(2008-7#1)(2009-8#2)(2011-2#1)
negative regulators##7##2##(1997-7#1)(2007-12#1)(2008-7#1)(2009-8#3)(2011-2#1)
negative regulatory region##3##3##(1993-8#1)(1997-7#1)(2008-11#1)
negative regulatory regions##2##3##(1994-6#1)(2008-11#1)
negative regulatory##7##2##(1993-8#1)(1994-6#1)(1997-7#1)(2007-12#1)(2008-11#2)(2013-1#1)
negative relation to the##2##4##(1994-12#2)
negative relationship between the##2##4##(2008-5#1)(2008-8#1)
negative relationship between##4##3##(1996-3#1)(2008-5#1)(2008-8#2)
negative relationship##8##2##(1996-3#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)
negative religious coping##4##3##(2008-12#3)(2008-4#1)
negative response##2##2##(2008-10#1)(2010-4#1)
negative responses to##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
negative responses##6##2##(1992-12#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
negative results of##2##3##(1996-6#1)(2013-1#1)
negative results##16##2##(1990-6#1)(1991-6#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
negative role##3##2##(2008-11#1)(2010-11#1)(2013-1#1)
negative selection of##3##3##(2008-8#2)(2008-9#1)
negative selection##8##2##(1990-12#1)(2008-4#3)(2008-8#3)(2008-9#1)
negative side##2##2##(1992-6#2)
negative slope##5##2##(1990-7#2)(1995-3#2)(1995-5#1)
negative social interactions##2##3##(2010-4#2)
negative social##6##2##(1995-5#1)(2007-12#1)(2010-2#1)(2010-4#3)
negative splenic culture for Leishmania##2##5##(2008-7#2)
negative staining##2##2##(2008-11#1)(2008-8#1)
negative stereotypes##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
negative strand##4##2##(1990-11#1)(1994-8#3)
negative strands were##2##3##(1994-8#2)
negative strands##4##2##(1994-8#4)
negative supercoils##2##2##(1995-6#1)(2008-9#1)
negative symptoms and##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
negative symptoms##15##2##(1995-3#1)(2008-12#1)(2008-6#7)(2008-8#1)(2011-2#4)(2012-2#1)
negative thermal ion mass spectrometry##2##5##(2008-10#2)
negative thermal##3##2##(2008-10#3)
negative to##3##2##(1997-6#1)(2008-1#1)(2008-10#1)
negative tone##2##2##(2007-12#2)
negative transcriptional##2##2##(1993-2#1)(1995-8#1)
negative values for##2##3##(2007-2#1)(2013-1#1)
negative values##6##2##(2007-2#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
negative when##2##2##(2007-12#1)(2008-5#1)
negative with the##2##3##(1992-6#1)(2008-5#1)
negative##1210##1##(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#8)(1990-6#5)(1990-7#3)(1990-8#8)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#8)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#5)(1992-2#7)(1992-3#11)(1992-4#1)(1992-5#5)(1992-6#8)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#7)(1993-11#4)(1993-12#5)(1993-2#9)(1993-3#9)(1993-5#3)(1993-6#4)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#16)(1994-2#4)(1994-3#8)(1994-5#2)(1994-6#4)(1994-7#3)(1994-8#8)(1994-9#3)(1995-1#1)(1995-11#11)(1995-12#5)(1995-2#3)(1995-3#5)(1995-4#4)(1995-5#10)(1995-6#3)(1995-8#7)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#2)(1996-5#8)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#13)(1997-3#6)(1997-4#1)(1997-5#5)(1997-6#6)(1997-7#7)(1997-8#5)(2006-12#1)(2007-10#9)(2007-11#15)(2007-12#32)(2007-2#10)(2007-5#5)(2007-7#18)(2007-8#7)(2007-9#2)(2008-1#14)(2008-10#119)(2008-11#54)(2008-12#24)(2008-2#8)(2008-3#17)(2008-4#13)(2008-5#22)(2008-6#19)(2008-7#27)(2008-8#33)(2008-9#37)(2009-10#2)(2009-11#10)(2009-12#10)(2009-2#5)(2009-3#3)(2009-5#6)(2009-6#4)(2009-7#8)(2009-8#18)(2009-9#5)(2010-1#5)(2010-10#21)(2010-11#7)(2010-12#4)(2010-2#7)(2010-3#7)(2010-4#13)(2010-5#7)(2010-6#8)(2010-7#8)(2010-8#7)(2010-9#1)(2011-1#18)(2011-10#1)(2011-2#64)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#12)(2012-2#20)(2012-3#20)(2012-6#1)(2013-1#44)(2013-7#7)(2013-8#19)
negative)##5##1##(1991-12#1)(1992-6#1)(1995-11#1)(1997-5#1)(2008-8#1)
negative-branch##4##1##(2008-3#4)
negative-dispersion##3##1##(2007-12#3)
negative-ion##4##1##(1991-5#1)(1991-9#1)(2008-10#2)
negative-sense##4##1##(2008-10#2)(2008-9#1)(2010-5#1)
negative-strand RNA##2##2##(2008-10#1)(2013-8#1)
negative-strand##3##1##(1994-8#1)(2008-10#1)(2013-8#1)
negatively affect the##6##3##(1995-1#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-5#1)
negatively affect their##2##3##(2008-11#1)(2011-2#1)
negatively affect##14##2##(1995-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-5#1)
negatively affected by the##2##4##(2008-10#1)(2008-5#1)
negatively affected by##5##3##(1993-3#2)(2008-10#2)(2008-5#1)
negatively affected##7##2##(1993-3#2)(2008-10#3)(2008-11#1)(2008-5#1)
negatively affects##2##2##(2007-12#1)(2009-8#1)
negatively and positively##2##3##(1990-5#1)(2008-11#1)
negatively and##7##2##(1990-5#1)(2007-12#3)(2008-11#1)(2008-7#1)(2010-4#1)
negatively as##3##2##(2008-10#2)(2010-3#1)
negatively associated with age##2##4##(2010-3#1)(2011-2#1)
negatively associated with##12##3##(1992-9#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#3)(2013-1#1)(2013-8#1)
negatively associated##13##2##(1992-9#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#3)(2013-1#1)(2013-8#1)
negatively biased##2##2##(2008-4#1)(2012-1#1)
negatively by##2##2##(1990-5#1)(2008-10#1)
negatively charged Al complexes##3##4##(2008-10#3)
negatively charged complexes##2##3##(2008-10#2)
negatively charged lipids##5##3##(1996-8#1)(2010-5#4)
negatively charged phosphate##2##3##(2008-10#2)
negatively charged phospholipids##2##3##(1993-3#1)(1995-8#1)
negatively charged residues##2##3##(1997-7#2)
negatively charged surfaces##2##3##(1992-12#1)(2008-10#1)
negatively charged##45##2##(1990-8#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-3#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#2)(2010-5#4)(2011-1#2)(2013-8#1)
negatively correlated (P &lt##2##4##(2008-10#1)(2011-2#1)
negatively correlated with metal exposure##2##5##(2011-1#2)
negatively correlated with plant##3##4##(2008-10#3)
negatively correlated with soil pH##2##5##(2008-10#2)
negatively correlated with the##6##4##(2008-10#3)(2008-3#1)(2008-8#2)
negatively correlated with##44##3##(1992-5#1)(2008-10#19)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
negatively correlated##56##2##(1992-5#1)(1993-12#1)(2008-10#23)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#4)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
negatively coupled to adenylate cyclase##2##5##(1993-5#1)(2008-4#1)
negatively impact##5##2##(2008-12#1)(2010-7#1)(2013-1#2)(2013-8#1)
negatively impacted by##3##3##(2007-5#1)(2008-2#1)(2013-1#1)
negatively impacting the##2##3##(2008-2#1)(2009-9#1)
negatively impacts##2##2##(2011-2#1)(2012-3#1)
negatively influence##2##2##(2007-2#1)(2008-11#1)
negatively influenced##2##2##(2009-3#1)(2011-2#1)
negatively influences##2##2##(2007-2#1)(2008-10#1)
negatively regulate the##3##3##(1994-9#1)(1995-6#1)(2008-8#1)
negatively regulate##7##2##(1994-9#1)(1995-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
negatively regulated by##4##3##(1991-5#1)(1993-6#1)(1995-8#1)(2007-12#1)
negatively regulated##6##2##(1991-5#1)(1993-6#1)(1995-6#1)(1995-8#1)(2007-12#1)(2009-8#1)
negatively regulates##5##2##(1995-12#1)(1995-2#1)(2009-6#1)(2012-12#1)(2013-1#1)
negatively related to the##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
negatively related to##11##3##(1991-12#1)(1992-2#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
negatively related##13##2##(1991-12#1)(1992-2#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
negatively supercoiled##3##2##(1990-11#1)(2008-9#2)
negatively to##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
negatively with the##2##3##(1991-12#1)(1994-3#1)
negatively with##12##2##(1991-12#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-8#2)(1996-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#2)
negatively##253##1##(1990-11#3)(1990-5#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#4)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#60)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#6)(2008-7#7)(2008-8#7)(2008-9#9)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#2)(2011-1#6)(2011-2#16)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#7)
negatives and##2##2##(1997-8#1)(2009-12#1)
negatives were##2##2##(2008-10#2)
negatives##18##1##(1990-8#1)(1991-4#2)(1994-11#1)(1995-3#1)(1995-8#1)(1996-9#2)(1997-3#1)(1997-8#1)(2007-7#2)(2008-10#3)(2008-7#1)(2009-12#1)(2011-2#1)
negatives)##2##1##(1991-12#1)(2008-10#1)
negativity (MMN)##6##2##(1995-12#1)(1995-5#2)(2008-8#1)(2008-9#1)(2013-8#1)
negativity and##2##2##(2007-8#1)(2008-9#1)
negativity in##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
negativity of##2##2##(2008-5#1)(2008-8#1)
negativity##23##1##(1991-2#1)(1995-12#1)(1995-5#2)(2007-7#1)(2007-8#1)(2008-11#3)(2008-5#1)(2008-8#3)(2008-9#3)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#4)
neglect and##2##2##(2010-7#1)(2011-2#1)
neglect in##2##2##(1995-12#1)(1995-5#1)
neglect nor##2##2##(2009-2#1)(2009-7#1)
neglect of the##4##3##(1991-12#1)(1993-11#1)(1995-5#1)(2008-2#1)
neglect of##5##2##(1991-12#1)(1993-11#1)(1995-5#2)(2008-2#1)
neglect to##3##2##(1994-3#1)(1996-5#1)(2009-7#1)
neglect##44##1##(1991-12#1)(1991-6#1)(1993-11#1)(1994-3#1)(1995-12#3)(1995-5#3)(1996-2#5)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-8#1)(2009-10#6)(2009-2#3)(2009-4#1)(2009-7#4)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
neglected area of##3##3##(1991-6#1)(2008-10#1)(2008-5#1)
neglected area##4##2##(1991-6#1)(2008-10#1)(2008-5#1)(2010-2#1)
neglected by##2##2##(1995-12#1)(1995-9#1)
neglected disease##2##2##(1996-12#1)(2010-5#1)
neglected for##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
neglected in the##2##3##(2008-2#1)(2011-2#1)
neglected in##4##2##(1996-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
neglected the##3##2##(1993-11#1)(2010-10#1)(2011-1#1)
neglected until##2##2##(2008-8#1)(2011-2#1)
neglected##56##1##(1991-6#1)(1993-11#2)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#5)(1995-9#1)(1996-12#3)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#3)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
neglecting the##3##2##(1990-8#1)(1994-2#1)(2008-8#1)
neglecting##7##1##(1990-8#1)(1993-11#1)(1994-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
neglects##4##1##(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
neglectus##6##1##(2008-10#2)(2013-7#4)
negligence and##2##2##(1991-7#1)(2008-10#1)
negligence in##2##2##(1992-1#1)(2008-10#1)
negligence##19##1##(1991-3#1)(1991-7#2)(1992-1#2)(1992-2#7)(1993-12#1)(1994-1#2)(1995-12#1)(1996-2#1)(2008-10#2)
negligent medical care##2##3##(1991-12#2)
negligent##8##1##(1991-12#2)(1991-7#1)(1993-12#1)(1995-3#1)(1995-6#2)(2011-2#1)
negligible amount##2##2##(2008-11#1)(2008-3#1)
negligible amounts##3##2##(1991-12#1)(1995-11#1)(1996-12#1)
negligible and##3##2##(1991-8#1)(1996-8#1)(2008-3#1)
negligible at##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
negligible changes in##2##3##(2008-10#1)(2008-2#1)
negligible effect on the##2##4##(1993-3#1)(2007-11#1)
negligible effect on##6##3##(1991-3#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
negligible energy loss##2##3##(2012-2#2)
negligible for most##2##3##(1991-9#1)(2008-3#1)
negligible for##8##2##(1991-5#1)(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#3)
negligible in the##2##3##(1996-12#1)(2008-10#1)
negligible in##8##2##(1990-12#1)(1993-11#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-6#1)
negligible influence##2##2##(1995-11#1)(2008-3#1)
negligible interference##3##2##(2008-10#3)
negligible level##2##2##(2008-3#1)(2010-6#1)
negligible proportion##2##2##(1990-6#1)(1990-9#1)
negligible##141##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#24)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#2)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#3)
negligibly small##2##2##(1990-8#2)
negligibly##5##1##(1990-8#2)(2008-10#2)(2008-11#1)
negotiate a##2##2##(1991-12#1)(2011-2#1)
negotiate the##2##2##(1994-1#1)(2010-9#1)
negotiate##10##1##(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1996-3#1)(1996-5#1)(2008-7#1)(2010-9#1)(2011-2#2)
negotiated##12##1##(1991-3#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-12#2)(2008-11#1)(2008-12#1)
negotiating a##2##2##(1991-1#1)(1991-12#1)
negotiating and##2##2##(1991-6#1)(1992-2#1)
negotiating for##2##2##(1993-2#1)(1993-8#1)
negotiating the##3##2##(1991-9#1)(1996-2#1)(2008-11#1)
negotiating with##3##2##(1994-2#1)(1996-12#1)(1996-3#1)
negotiating##26##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#4)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-6#1)(2008-11#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)
negotiation and##5##2##(1991-3#1)(1992-2#1)(1995-1#1)(1995-12#1)(2008-10#1)
negotiation of##3##2##(1994-1#1)(1996-3#1)(2008-11#1)
negotiation process##2##2##(1994-1#1)(1996-1#1)
negotiation##13##1##(1991-3#1)(1992-2#4)(1994-1#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)
negotiations between##2##2##(1994-12#1)(2008-7#1)
negotiations with##3##2##(1992-12#1)(1994-2#1)(1996-12#1)
negotiations##10##1##(1991-6#1)(1992-12#1)(1992-2#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-7#1)
neighbor joining##2##2##(2008-10#1)(2008-5#1)
neighbor##9##1##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#1)
neighbor-joining and##2##2##(2008-10#1)(2008-6#1)
neighbor-joining phylogenetic tree##2##3##(2013-8#2)
neighbor-joining##8##1##(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2013-8#2)
neighborhood analysis##2##2##(2010-10#2)
neighborhood density##3##2##(2008-11#3)
neighborhood disadvantage##5##2##(2009-7#5)
neighborhood environment##2##2##(2009-9#1)(2011-2#1)
neighborhood residents##4##2##(2008-1#1)(2009-9#2)(2011-2#1)
neighborhood safety and##2##3##(2008-5#1)(2011-2#1)
neighborhood safety##4##2##(2008-5#2)(2009-7#1)(2011-2#1)
neighborhood##65##1##(1990-2#1)(1991-12#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-1#4)(2008-11#6)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#1)(2008-9#1)(2009-7#12)(2009-9#10)(2010-10#2)(2010-9#2)(2011-2#7)(2012-12#1)(2013-1#2)
neighborhood-level economic disadvantage##2##3##(2007-10#2)
neighborhood-level##4##1##(2007-10#2)(2012-12#2)
neighborhoods and health##3##3##(2012-12#3)
neighborhoods were##3##2##(2009-9#3)
neighborhoods##21##1##(1997-5#1)(1997-6#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#4)(2010-7#1)(2012-12#3)(2012-2#1)(2013-1#1)
neighboring cells##6##2##(2008-10#2)(2008-4#3)(2010-5#1)
neighboring countries##4##2##(1997-6#2)(2008-12#1)(2008-8#1)
neighboring dimers##2##2##(2008-10#2)
neighboring pixels##2##2##(2007-11#1)(2008-3#1)
neighboring populations##2##2##(2008-12#1)(2008-9#1)
neighboring segments##2##2##(1991-8#1)(2009-6#1)
neighboring##67##1##(1991-1#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#9)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#1)
neighbors present##2##2##(2008-9#2)
neighbors##22##1##(1996-1#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#7)(2008-9#6)(2009-10#1)(2009-4#1)(2012-2#1)
neighbour##2##1##(1992-3#1)(2008-12#1)
neighbourhood in##2##2##(1995-3#1)(2007-2#1)
neighbourhood##9##1##(1995-3#2)(1996-6#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-9#1)(2012-1#1)(2013-8#1)
neighbourhoods##6##1##(2008-11#3)(2009-10#1)(2010-10#1)(2011-2#1)
neighbouring areas of##2##3##(1997-3#1)(2011-2#1)
neighbouring areas##3##2##(1997-3#1)(2007-7#1)(2011-2#1)
neighbouring organs##3##2##(1990-8#1)(2007-12#1)(2008-7#1)
neighbouring##25##1##(1990-8#1)(1991-6#1)(1992-11#1)(1993-9#1)(1995-8#1)(1996-12#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)
neighbours and##3##2##(1992-3#2)(1997-1#1)
neighbours in##2##2##(2010-3#1)(2011-3#1)
neighbours##11##1##(1991-5#1)(1992-3#3)(1997-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#1)(2011-3#2)
neither SA nor##2##3##(2008-10#2)
neither a##9##2##(1991-12#1)(1993-3#1)(1993-8#1)(2008-11#1)(2008-3#2)(2009-5#1)(2011-2#1)(2013-8#1)
neither an##2##2##(1990-11#1)(1997-6#1)
neither by the##2##3##(2008-2#1)(2008-7#1)
neither by##3##2##(2007-5#1)(2008-2#1)(2008-7#1)
neither did##2##2##(1993-12#1)(2008-10#1)
neither had##2##2##(1994-12#1)(2008-10#1)
neither in the##5##3##(1992-3#1)(1994-2#1)(2007-5#1)(2008-11#1)(2012-2#1)
neither in##12##2##(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1994-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)(2012-8#1)
neither inhibited##2##2##(1995-3#1)(1995-6#1)
neither necessary nor##2##3##(1991-3#1)(2008-3#1)
neither of the##4##3##(1994-6#1)(2008-11#1)(2009-1#1)(2009-3#1)
neither of these##2##3##(1991-9#1)(1994-2#1)
neither of which##3##3##(1991-5#1)(2009-3#1)(2012-3#1)
neither of##10##2##(1991-5#1)(1991-9#1)(1992-6#1)(1994-2#1)(1994-6#1)(2008-11#1)(2009-1#1)(2009-3#2)(2012-3#1)
neither requires##2##2##(1990-12#2)
neither the presence##2##3##(1991-3#1)(1994-8#1)
neither the##36##2##(1991-12#1)(1991-3#2)(1992-3#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-8#1)
neither was##4##2##(1991-4#1)(1992-6#1)(2008-10#1)(2009-3#1)
neither##255##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#3)(1993-12#5)(1993-3#2)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#8)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-5#4)(2008-1#4)(2008-10#29)(2008-11#8)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#10)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#5)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#3)
nematic director##3##2##(2007-12#2)(2008-2#1)
nematic liquid crystal##6##3##(2007-11#2)(2007-12#2)(2008-2#2)
nematic liquid crystals##13##3##(2007-11#3)(2007-12#8)(2008-2#2)
nematic liquid##19##2##(2007-11#5)(2007-12#10)(2008-2#4)
nematic liquid-crystal film##3##3##(2007-12#1)(2008-3#2)
nematic liquid-crystal##8##2##(2007-12#2)(2008-2#1)(2008-3#5)
nematic##39##1##(1995-6#1)(2007-11#7)(2007-12#18)(2008-2#7)(2008-3#6)
nematicidal activity of##2##3##(2008-10#1)(2011-2#1)
nematicidal activity##4##2##(2008-10#3)(2011-2#1)
nematicidal##5##1##(2008-10#4)(2011-2#1)
nematicide##4##1##(2008-10#4)
nematicides##3##1##(2008-10#3)
nematode (Meloidogyne incognita)##2##3##(2008-10#2)
nematode (Meloidogyne##3##2##(2008-10#3)
nematode +##2##2##(2008-12#2)
nematode Caenorhabditis elegans was##2##4##(1995-3#1)(2008-7#1)
nematode Caenorhabditis elegans##11##3##(1990-5#1)(1995-3#1)(1996-6#2)(1997-7#1)(2007-8#2)(2008-10#1)(2008-7#2)(2012-12#1)
nematode H##2##2##(2008-10#1)(2011-2#1)
nematode Meloidogyne incognita##4##3##(1994-12#2)(2008-10#2)
nematode Meloidogyne##9##2##(1994-12#2)(2008-10#7)
nematode Xiphinema##3##2##(2008-10#3)
nematode and##4##2##(2008-10#1)(2008-12#2)(2011-1#1)
nematode behavior##2##2##(2008-10#2)
nematode eggs and##2##3##(2008-10#1)(2013-1#1)
nematode eggs##3##2##(2008-10#2)(2013-1#1)
nematode feeding sites##2##3##(2008-10#2)
nematode generations##2##2##(2008-10#2)
nematode infections##3##2##(1996-12#2)(1997-3#1)
nematode infestation##3##2##(1996-6#1)(2008-10#2)
nematode invasion and##2##3##(2008-10#2)
nematode invasion##3##2##(2008-10#3)
nematode management##3##2##(2008-10#3)
nematode parasite##4##2##(1992-9#1)(1996-12#1)(1997-7#1)(2008-9#1)
nematode parasites of##2##3##(1996-12#1)(1997-7#1)
nematode parasites##3##2##(1996-12#1)(1997-7#1)(2008-8#1)
nematode plus fungus##2##3##(2008-12#2)
nematode population densities##2##3##(2008-10#2)
nematode population##9##2##(2008-10#9)
nematode populations were##2##3##(2008-10#2)
nematode populations##9##2##(2008-10#9)
nematode reproduction##2##2##(2008-10#2)
nematode resistance##2##2##(2008-10#2)
nematode species##9##2##(2008-10#7)(2011-1#1)(2011-2#1)
nematode to##3##2##(2008-10#3)
nematode##186##1##(1990-5#2)(1990-8#1)(1992-9#3)(1993-12#1)(1994-11#4)(1994-12#3)(1995-3#2)(1995-6#1)(1996-12#4)(1996-6#3)(1997-3#1)(1997-7#3)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#124)(2008-11#1)(2008-12#9)(2008-3#1)(2008-7#3)(2008-8#4)(2008-9#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#1)
nematode-susceptible##2##1##(2008-10#2)
nematode-trapping fungi##6##2##(2008-10#6)
nematode-trapping##7##1##(2008-10#7)
nematodes (Meloidogyne##2##2##(2008-10#2)
nematodes Heterodera##2##2##(2008-10#2)
nematodes and##7##2##(2008-10#6)(2008-5#1)
nematodes as##2##2##(2008-10#1)(2008-12#1)
nematodes did not##2##3##(2008-10#2)
nematodes from##2##2##(2008-10#2)
nematodes in soil##2##3##(2008-10#2)
nematodes in the##2##3##(2008-10#2)
nematodes in##8##2##(1996-11#1)(1996-12#1)(2008-10#6)
nematodes is##2##2##(2008-10#2)
nematodes of##4##2##(1996-12#2)(2008-10#2)
nematodes per cm(3) of soil##2##5##(2008-10#2)
nematodes per cm(3) of##3##4##(2008-10#3)
nematodes per##4##2##(2008-10#4)
nematodes were found at##2##4##(2008-10#2)
nematodes were##11##2##(2008-10#10)(2008-12#1)
nematodes##119##1##(1991-6#1)(1994-12#1)(1996-11#1)(1996-12#4)(2008-10#91)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#3)(2010-8#1)(2011-2#3)(2013-1#1)(2013-7#1)
nematophagous fungi##2##2##(2008-10#2)
nematophagous##4##1##(2008-10#4)
nemorosa##3##1##(2008-10#3)
neo gene##6##2##(1993-12#1)(1993-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-8#1)
neo##11##1##(1992-12#1)(1993-12#1)(1993-2#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-8#2)(2008-11#1)(2008-8#1)(2009-12#1)
neo-adipogenesis##2##1##(2012-8#2)
neo-adjuvant chemotherapy##3##2##(1990-12#1)(1990-6#1)(2008-6#1)
neo-adjuvant##4##1##(1990-12#1)(1990-6#1)(2008-6#2)
neo-epitopes##3##1##(2013-8#3)
neoGL##2##1##(1994-3#2)
neoadjuvant chemoradiotherapy##4##2##(2013-8#4)
neoadjuvant chemotherapy##16##2##(1990-12#1)(1992-12#2)(1992-6#1)(1993-11#4)(1994-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-3#1)
neoadjuvant therapy##5##2##(2007-8#1)(2010-12#3)(2013-8#1)
neoadjuvant treatment##5##2##(1992-6#1)(2010-12#1)(2010-7#2)(2012-3#1)
neoadjuvant##44##1##(1990-12#1)(1992-12#2)(1992-6#2)(1993-11#5)(1994-2#2)(2007-5#1)(2007-8#1)(2009-4#3)(2009-5#1)(2010-12#5)(2010-3#3)(2010-7#2)(2011-2#1)(2011-3#1)(2012-3#4)(2013-1#1)(2013-8#9)
neoangiogenesis in##2##2##(2009-11#1)(2011-2#1)
neoangiogenesis##4##1##(2009-11#1)(2010-5#1)(2011-2#1)(2012-1#1)
neoantigens##3##1##(1992-12#1)(1997-8#1)(2013-7#1)
neobrevipes##2##1##(2008-10#2)
neoclerodane##2##1##(2009-12#2)
neocortex in##2##2##(1993-12#1)(1997-2#1)
neocortex is##5##2##(1994-3#2)(2008-11#2)(2009-5#1)
neocortex##34##1##(1990-5#1)(1993-12#1)(1994-3#3)(1995-12#1)(1995-2#1)(1996-5#3)(1996-6#1)(1997-2#1)(2007-8#2)(2008-1#2)(2008-11#13)(2009-5#3)(2010-7#2)
neocortical and hippocampal##2##3##(1993-6#1)(2008-1#1)
neocortical and##3##2##(1993-6#1)(1996-5#1)(2008-1#1)
neocortical neurons##2##2##(1990-5#1)(2008-11#1)
neocortical##27##1##(1990-5#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-6#1)(1994-3#1)(1996-5#5)(1997-2#2)(2007-9#1)(2008-1#1)(2008-11#6)(2009-5#1)(2010-7#1)(2012-2#1)
neocuproine##4##1##(2008-10#4)
neodymium lasers##2##2##(2007-11#1)(2008-3#1)
neodymium magnet##3##2##(2008-10#3)
neodymium yttrium aluminum borate##2##4##(2008-2#2)
neodymium yttrium aluminum##3##3##(2008-2#2)(2010-8#1)
neodymium##15##1##(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2010-8#1)(2012-2#1)
neodymium(III)##2##1##(2008-10#2)
neodymium-doped fiber laser##2##3##(2008-2#2)
neodymium-doped##12##1##(2007-11#6)(2008-2#3)(2008-3#3)
neoformans and##3##2##(2007-7#1)(2008-5#2)
neoformans from bronchial##2##3##(2008-5#2)
neoformans in##2##2##(2008-5#2)
neoformans var##14##2##(2008-5#14)
neoformans was isolated##3##3##(2007-8#2)(2008-5#1)
neoformans was##5##2##(2007-8#3)(2008-5#2)
neoformans were##2##2##(2008-5#1)(2009-2#1)
neoformans##48##1##(2007-10#2)(2007-7#3)(2007-8#4)(2008-11#1)(2008-5#33)(2009-2#4)(2010-7#1)
neoformed bone tissue around##2##4##(2008-5#2)
neoformed bone##3##2##(2008-5#3)
neogenesis##4##1##(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
neoglycolipids##2##1##(1994-3#2)
neoglycoprotein##2##1##(1991-12#1)(2008-7#1)
neoglycoproteins##3##1##(1991-12#1)(1992-12#1)(2008-7#1)
neointima formation##7##2##(1992-9#3)(2007-8#4)
neointima##11##1##(1992-9#3)(1994-11#1)(1997-8#1)(2007-8#5)(2009-5#1)
neointimal##2##1##(1996-8#1)(2009-12#1)
neoliberal##5##1##(1993-6#1)(1997-2#1)(2008-7#1)(2013-1#2)
neoliberalism##2##1##(2013-1#2)
neomycin##19##1##(1990-8#1)(1992-3#5)(1994-11#4)(1995-8#1)(2008-11#5)(2008-12#1)(2008-8#1)(2011-2#1)
neon##3##1##(2007-12#2)(2008-2#1)
neonatal and adult##2##3##(1990-11#1)(1994-3#1)
neonatal and embryonic##2##3##(1996-5#2)
neonatal and maternal health##2##4##(2010-5#2)
neonatal and pediatric##2##3##(2008-11#1)(2011-2#1)
neonatal and##13##2##(1990-11#1)(1991-2#2)(1994-3#1)(1994-6#1)(1996-5#2)(2008-11#1)(2010-12#1)(2010-5#2)(2011-2#1)(2013-1#1)
neonatal anoxia##2##2##(1997-2#2)
neonatal calves and##2##3##(2011-1#2)
neonatal calves##3##2##(2011-1#3)
neonatal cardiac fibroblasts##2##3##(1994-11#2)
neonatal cardiac##3##2##(1994-11#2)(2012-1#1)
neonatal cardiomyocytes##2##2##(2010-12#1)(2010-6#1)
neonatal care##6##2##(1991-3#1)(1993-6#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-3#1)
neonatal cord blood HBV-DNA##5##4##(2011-1#5)
neonatal development##2##2##(2008-10#1)(2012-3#1)
neonatal follow-up programs##3##3##(2008-11#3)
neonatal follow-up##8##2##(2008-11#8)
neonatal hypertension##2##2##(1997-3#2)
neonatal intensive care unit (NICU)##3##5##(1991-1#1)(1993-3#1)(1994-2#1)
neonatal intensive care unit##13##4##(1991-1#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-3#1)(2008-11#3)(2008-5#1)(2010-10#1)(2010-8#1)
neonatal intensive care units (NICUs)##3##5##(1994-3#1)(1995-1#1)(2008-10#1)
neonatal intensive care units##12##4##(1991-12#1)(1991-2#1)(1992-3#1)(1994-3#2)(1995-1#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-8#2)
neonatal intensive care##42##3##(1990-6#1)(1991-1#2)(1991-12#8)(1991-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#10)(2008-5#1)(2010-10#1)(2010-8#3)
neonatal isoerythrolysis##2##2##(2012-3#2)
neonatal isosporosis##3##2##(1996-12#3)
neonatal life##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
neonatal morbidity##3##2##(1994-12#1)(2012-3#2)
neonatal mortality in##2##3##(1996-6#1)(2010-12#1)
neonatal mortality##4##2##(1990-11#1)(1996-11#1)(1996-6#1)(2010-12#1)
neonatal mouse##4##2##(1990-11#1)(1993-6#1)(1993-8#1)(2008-8#1)
neonatal neutropenia##4##2##(2012-3#4)
neonatal or##2##2##(2008-11#1)(2010-3#1)
neonatal patients##2##2##(1995-8#1)(2008-10#1)
neonatal period and early##2##4##(1997-3#1)(2012-3#1)
neonatal period and##4##3##(1997-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
neonatal period##14##2##(1992-2#1)(1992-8#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)
neonatal porcine##2##2##(2010-11#2)
neonatal problems##2##2##(1996-11#1)(2008-1#1)
neonatal rat cardiac myocytes##2##4##(1993-3#2)
neonatal rat cardiac##3##3##(1993-3#2)(1994-11#1)
neonatal rat cardiomyocytes##3##3##(1995-11#1)(2010-12#2)
neonatal rat retinal##3##3##(1996-5#3)
neonatal rat##23##2##(1992-3#1)(1993-3#4)(1994-11#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-5#5)(1997-2#2)(2008-10#1)(2009-12#1)(2010-12#2)(2013-7#1)(2013-8#1)
neonatal rats##14##2##(1992-8#2)(1993-12#2)(1993-5#1)(1996-12#2)(1996-5#1)(1997-2#2)(2008-7#1)(2009-12#1)(2013-1#2)
neonatal respiratory##2##2##(1992-2#1)(1997-1#1)
neonatal sciatic neurectomy##2##3##(1993-12#2)
neonatal screening for congenital##3##4##(2007-11#3)
neonatal screening for##4##3##(1991-2#1)(2007-11#3)
neonatal screening##9##2##(1990-6#1)(1991-2#2)(1991-8#1)(2007-11#3)(2011-1#1)(2012-12#1)
neonatal sepsis and meningitis##2##4##(2009-12#2)
neonatal sepsis##5##2##(2008-5#1)(2008-7#1)(2009-12#2)(2011-1#1)
neonatal surgery##2##2##(2008-11#2)
neonatal unit##4##2##(1995-5#3)(2008-11#1)
neonatal variables##3##2##(2008-12#3)
neonatal ward##2##2##(2010-8#2)
neonatal##315##1##(1990-11#4)(1990-2#1)(1990-3#3)(1990-6#3)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#4)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-8#4)(1993-12#6)(1993-3#7)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#6)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#3)(1995-5#6)(1995-8#1)(1996-11#3)(1996-12#5)(1996-3#1)(1996-5#10)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#6)(1997-4#1)(1997-6#2)(2007-10#3)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#36)(2008-12#4)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#4)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-8#9)(2011-1#20)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#16)(2013-1#9)(2013-7#1)(2013-8#1)
neonatally##5##1##(1990-7#2)(1992-10#1)(1994-3#1)(2013-8#1)
neonate and##4##2##(1991-12#1)(1992-6#1)(1994-2#1)(2008-5#1)
neonate born from an##2##4##(2012-3#2)
neonate in##2##2##(1993-6#1)(2012-12#1)
neonate with##6##2##(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
neonate##36##1##(1990-11#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#8)(2013-1#1)(2013-8#2)
neonates and infants##2##3##(1994-6#1)(2007-7#1)
neonates and##8##2##(1994-6#1)(1996-9#1)(2007-7#1)(2008-11#1)(2010-11#1)(2011-1#2)(2013-1#1)
neonates born##3##2##(1994-9#1)(2007-11#2)
neonates during sleep##2##3##(2009-8#2)
neonates had##3##2##(2011-1#2)(2011-2#1)
neonates in a##2##3##(1991-12#1)(2007-7#1)
neonates in the##2##3##(1990-12#1)(1996-6#1)
neonates in##5##2##(1990-12#1)(1991-12#1)(1996-6#1)(2007-11#1)(2007-7#1)
neonates with##7##2##(2008-10#1)(2008-11#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
neonates##54##1##(1990-12#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(2007-11#5)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#9)(2009-8#2)(2010-10#1)(2010-11#1)(2011-1#11)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
neonatology]##2##1##(1993-6#1)(1994-6#1)
neonicotinoid##3##1##(2011-2#3)
neoplasia (CIN)##4##2##(1991-2#1)(1996-8#1)(2011-1#1)(2011-2#1)
neoplasia and##11##2##(1990-6#1)(1991-2#1)(1992-8#2)(2008-2#1)(2008-8#2)(2011-1#2)(2013-1#1)(2013-8#1)
neoplasia grade##4##2##(1992-8#1)(1994-2#1)(2012-3#1)(2013-1#1)
neoplasia in Barrett's esophagus##2##4##(2008-12#1)(2010-12#1)
neoplasia in##7##2##(1992-10#1)(1992-9#1)(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#2)
neoplasia is##3##2##(1990-6#1)(1991-2#1)(2013-8#1)
neoplasia or##3##2##(1991-8#1)(2008-7#1)(2011-2#1)
neoplasia was##2##2##(1992-9#1)(2013-8#1)
neoplasia##103##1##(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#2)(1991-2#7)(1991-8#2)(1992-10#1)(1992-2#1)(1992-8#3)(1992-9#4)(1993-5#1)(1993-9#4)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1996-8#3)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#6)(2009-4#1)(2010-12#2)(2011-1#6)(2011-2#9)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#12)
neoplasias##11##1##(1990-6#1)(1996-8#1)(2008-11#1)(2009-7#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#2)
neoplasm and the##3##3##(1991-6#1)(1996-12#1)(2008-12#1)
neoplasm and##9##2##(1991-6#1)(1992-5#1)(1994-2#1)(1996-12#2)(2008-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
neoplasm are##2##2##(1991-5#1)(2009-3#1)
neoplasm in a##3##3##(1991-3#1)(2007-10#1)(2011-2#1)
neoplasm in##8##2##(1991-3#1)(1992-2#1)(2007-10#1)(2007-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
neoplasm is##4##2##(1990-10#1)(1993-8#1)(2006-12#1)(2009-12#1)
neoplasm of the##4##3##(2008-4#1)(2013-1#2)(2013-7#1)
neoplasm of##7##2##(1990-5#1)(2008-4#1)(2010-6#1)(2012-1#1)(2013-1#2)(2013-7#1)
neoplasm that##5##2##(1997-8#1)(2007-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
neoplasm was##4##2##(1992-9#1)(2008-7#2)(2011-2#1)
neoplasm with##5##2##(1992-5#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
neoplasm##112##1##(1990-10#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-2#4)(1992-5#2)(1992-9#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1996-12#5)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#4)(2010-3#3)(2010-6#1)(2010-8#3)(2011-2#11)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
neoplasm]##2##1##(1990-9#1)(1991-6#1)
neoplasma##3##1##(2008-7#1)(2008-9#2)
neoplasmatic##4##1##(2007-11#3)(2007-8#1)
neoplasms and##5##2##(1990-5#1)(2006-10#1)(2009-8#1)(2010-8#1)(2012-2#1)
neoplasms are characterized by##2##4##(2011-2#1)(2012-3#1)
neoplasms are##7##2##(2007-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
neoplasms in the##2##3##(1991-11#1)(1995-2#1)
neoplasms in##7##2##(1991-11#1)(1995-2#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)
neoplasms involving the##2##3##(2008-9#1)(2011-2#1)
neoplasms is##3##2##(1991-4#1)(1994-6#1)(2010-8#1)
neoplasms of the pancreas##2##4##(1992-5#1)(2012-2#1)
neoplasms of the##10##3##(1990-3#1)(1992-5#1)(1993-9#1)(2006-12#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
neoplasms of##14##2##(1990-3#1)(1992-5#1)(1993-1#1)(1993-8#1)(1993-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
neoplasms or nonneoplastic lesions in##2##5##(2008-9#2)
neoplasms or nonneoplastic lesions##8##4##(2008-8#2)(2008-9#6)
neoplasms or##9##2##(1990-8#1)(2008-8#2)(2008-9#6)
neoplasms that##4##2##(1991-2#1)(1991-8#1)(2010-8#2)
neoplasms were not##2##3##(1992-5#1)(1995-11#1)
neoplasms were##8##2##(1991-6#1)(1992-5#1)(1993-9#1)(1995-11#1)(2008-9#4)
neoplasms with##2##2##(2007-10#1)(2013-1#1)
neoplasms##149##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#5)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#6)(1992-8#2)(1993-1#1)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#5)(1994-2#1)(1994-6#3)(1995-11#1)(1995-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-5#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#17)(2009-3#1)(2009-8#2)(2010-1#1)(2010-3#3)(2010-8#6)(2010-9#1)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#4)(2013-1#5)(2013-8#2)
neoplasms]##3##1##(1991-3#1)(1991-5#1)(1992-9#1)
neoplastic MC##3##2##(2011-2#3)
neoplastic and##3##2##(2008-4#1)(2012-2#2)
neoplastic cell##2##2##(2008-10#1)(2008-7#1)
neoplastic cells and##3##3##(1993-9#1)(2008-4#1)(2010-3#1)
neoplastic cells were##2##3##(1992-8#1)(2012-1#1)
neoplastic cells##23##2##(1990-6#2)(1991-6#1)(1992-2#2)(1992-8#1)(1993-9#1)(1995-3#1)(1997-1#1)(2008-4#3)(2009-1#1)(2009-8#1)(2010-3#2)(2010-6#1)(2011-2#3)(2012-1#2)(2013-7#1)
neoplastic conditions##2##2##(1996-8#1)(2010-3#1)
neoplastic disease##15##2##(1992-11#1)(1992-12#1)(1994-5#1)(2006-10#1)(2007-11#7)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)
neoplastic diseases##7##2##(1990-12#1)(1994-5#1)(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#2)
neoplastic endometrium##2##2##(1994-3#1)(1995-12#1)
neoplastic growth##2##2##(1992-3#1)(2012-12#1)
neoplastic lesions##7##2##(2007-8#1)(2008-4#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
neoplastic metastases##2##2##(2007-11#2)
neoplastic nodules and##2##3##(1990-7#1)(1992-3#1)
neoplastic process##5##2##(1990-3#1)(1991-12#2)(2008-6#1)(2010-12#1)
neoplastic thymocytes##3##2##(1992-8#3)
neoplastic transformation and##2##3##(2008-7#2)
neoplastic transformation in vitro##7##4##(2008-7#7)
neoplastic transformation in##9##3##(2008-7#8)(2012-12#1)
neoplastic transformation##18##2##(1992-2#2)(1997-1#1)(2008-7#13)(2010-3#1)(2012-12#1)
neoplastic##137##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#2)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#4)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-8#1)(1997-1#3)(1997-8#1)(2006-10#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-4#7)(2008-6#2)(2008-7#16)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#3)(2010-3#4)(2010-6#1)(2011-1#1)(2011-2#12)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
neopteran insect##2##2##(2013-1#2)
neopteran##3##1##(2013-1#3)
neopterin and##4##2##(1992-12#1)(1996-12#1)(2008-10#2)
neopterin concentrations in##2##3##(1990-2#2)
neopterin concentrations##5##2##(1990-2#5)
neopterin##17##1##(1990-2#5)(1992-12#1)(1996-12#4)(2008-10#5)(2009-12#2)
neopulchra hemipopulation##2##2##(2011-2#2)
neopulchra##4##1##(2011-2#4)
neosalpingostomy##5##1##(1991-12#3)(1994-12#2)
neostigmine##5##1##(2008-10#5)
neostriatal##4##1##(1991-1#1)(1992-3#1)(1993-12#1)(1993-3#1)
neostriatum in a##2##3##(1992-3#1)(2009-12#1)
neostriatum in##3##2##(1992-3#2)(2009-12#1)
neostriatum##12##1##(1991-2#1)(1992-3#2)(1993-3#2)(1994-8#4)(1997-6#1)(2009-12#2)
neosynthesized subunits##2##2##(1996-2#2)
neosynthesized##4##1##(1990-7#1)(1996-2#3)
neotenic reproductives##3##2##(2007-12#3)
neotenic##5##1##(2007-12#3)(2010-6#2)
neotenics##2##1##(2007-12#2)
neotropical##10##1##(2008-5#5)(2008-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2013-1#1)
neotype##3##1##(2008-10#2)(2013-8#1)
neovascular AMD##6##2##(2010-2#5)(2011-7#1)
neovascular ARMD##4##2##(2011-1#4)
neovascular age-related macular degeneration##3##4##(2010-2#1)(2011-7#2)
neovascular##19##1##(2008-10#1)(2010-10#2)(2010-2#6)(2010-9#1)(2011-1#6)(2011-7#3)
neovascularization of##3##2##(1992-2#1)(2010-11#2)
neovascularization##17##1##(1992-2#1)(1992-3#1)(1995-3#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-11#3)(2010-2#1)(2010-9#1)(2011-1#3)(2012-12#1)(2012-3#1)
nephelauxetic##2##1##(1997-7#2)
nephelometer for##2##2##(2007-11#2)
nephelometer is##2##2##(2008-3#2)
nephelometer##10##1##(2007-11#2)(2008-2#2)(2008-3#6)
nephelometric##2##1##(1993-12#2)
nephrectomies and##2##2##(1996-9#1)(2008-10#1)
nephrectomies##4##1##(1996-9#1)(2007-7#2)(2008-10#1)
nephrectomy and##7##2##(1997-8#1)(2008-1#1)(2011-2#5)
nephrectomy as##2##2##(2011-2#1)(2012-12#1)
nephrectomy for##4##2##(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#1)
nephrectomy has##2##2##(2011-2#2)
nephrectomy in children##2##3##(2008-10#2)
nephrectomy in living donor##2##4##(2007-7#1)(2011-2#1)
nephrectomy in the##2##3##(2008-10#1)(2012-2#1)
nephrectomy in##9##2##(2007-7#2)(2008-10#3)(2011-2#1)(2012-2#2)(2013-1#1)
nephrectomy is##6##2##(2007-7#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
nephrectomy was performed##4##3##(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
nephrectomy was##6##2##(2007-7#2)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
nephrectomy##58##1##(1997-8#1)(2007-7#8)(2007-8#1)(2008-1#4)(2008-10#8)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#17)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
nephrin##3##1##(2007-7#2)(2008-1#1)
nephritic syndrome##2##2##(2008-1#2)
nephritic##5##1##(2008-1#4)(2008-4#1)
nephritis (LN)##3##2##(2008-1#3)
nephritis and acute##2##3##(2007-6#1)(2008-1#1)
nephritis and##4##2##(2006-10#1)(2007-6#1)(2008-1#1)(2008-4#1)
nephritis in##5##2##(2008-1#3)(2008-10#2)
nephritis was the##3##3##(2007-7#1)(2008-1#2)
nephritis which##2##2##(2007-7#1)(2008-5#1)
nephritis with##3##2##(1992-5#1)(2008-1#1)(2008-5#1)
nephritis##53##1##(1990-9#1)(1991-8#1)(1992-5#1)(1997-6#1)(2006-10#5)(2007-6#1)(2007-7#9)(2008-1#19)(2008-10#2)(2008-4#2)(2008-5#2)(2008-8#2)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#1)
nephroblastoma##3##1##(2008-1#2)(2012-1#1)
nephrocalcinosis##3##1##(2008-1#1)(2008-4#1)(2011-2#1)
nephrogenic adenoma of the##2##4##(2008-10#2)
nephrogenic adenoma##4##2##(2008-10#4)
nephrogenic diabetes insipidus##8##3##(1993-6#2)(1994-11#2)(1994-8#1)(1997-3#2)(2013-1#1)
nephrogenic diabetes##9##2##(1993-6#2)(1994-11#2)(1994-8#1)(1997-3#2)(2013-1#2)
nephrogenic##15##1##(1993-6#2)(1994-11#2)(1994-8#1)(1997-3#2)(2008-10#6)(2013-1#2)
nephrolithiasis treatment##2##2##(2008-12#2)
nephrolithiasis##13##1##(1991-12#2)(2007-7#1)(2008-10#2)(2008-12#4)(2008-8#1)(2011-2#2)(2012-12#1)
nephrolithotomy##6##1##(2007-10#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-12#1)
nephrologists and patients##2##3##(2008-1#1)(2011-2#1)
nephrologists and##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
nephrologists##12##1##(2007-12#1)(2007-7#2)(2008-1#4)(2008-4#4)(2011-2#1)
nephrology##13##1##(1991-11#1)(1991-3#1)(2007-7#2)(2008-1#6)(2008-10#1)(2008-11#1)(2011-2#1)
nephrology]##2##1##(1997-5#1)(1997-7#1)
nephron##5##1##(1991-5#1)(2007-7#1)(2008-6#1)(2010-9#1)(2013-1#1)
nephronophthisis##2##1##(2007-7#1)(2008-4#1)
nephropathies in##3##2##(2008-1#3)
nephropathies were##2##2##(2008-1#2)
nephropathies##12##1##(1997-3#2)(2007-7#1)(2008-1#8)(2011-2#1)
nephropathy (IgAN)##6##2##(2008-1#4)(2008-8#1)(2009-6#1)
nephropathy and##16##2##(1990-9#1)(1997-5#1)(1997-8#1)(2007-7#3)(2008-1#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
nephropathy are##3##2##(2007-7#1)(2009-6#1)(2012-2#1)
nephropathy can##2##2##(1990-9#1)(2007-7#1)
nephropathy has##2##2##(1993-2#1)(2007-7#1)
nephropathy in a##2##3##(2012-3#1)(2013-1#1)
nephropathy in the##2##3##(2008-1#1)(2011-2#1)
nephropathy in##10##2##(2007-7#2)(2008-1#2)(2008-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
nephropathy is the##2##3##(2007-7#1)(2012-3#1)
nephropathy is##8##2##(1990-9#1)(1997-3#1)(2007-7#1)(2008-1#3)(2012-2#1)(2012-3#1)
nephropathy was##4##2##(2007-7#1)(2008-1#2)(2008-9#1)
nephropathy##120##1##(1990-5#1)(1990-9#5)(1991-11#1)(1992-8#1)(1993-2#1)(1994-3#3)(1997-3#1)(1997-5#2)(1997-8#3)(2007-12#1)(2007-7#20)(2008-1#35)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#6)(2008-9#5)(2009-12#2)(2009-6#2)(2010-12#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#2)
nephropathy&quot##2##1##(2008-1#2)
nephropathy]##4##1##(1991-5#1)(1997-8#1)(2013-8#2)
nephrosclerosis and##2##2##(1990-7#1)(2011-2#1)
nephrosclerosis##9##1##(1990-7#3)(1992-8#1)(2007-7#2)(2008-12#1)(2011-2#1)(2012-12#1)
nephrosis##7##1##(1993-12#1)(1996-6#1)(2008-1#1)(2009-6#3)(2011-2#1)
nephrotic state##2##2##(2008-1#2)
nephrotic syndrome and##3##3##(1992-5#1)(2007-8#1)(2008-1#1)
nephrotic syndrome associated with##2##4##(1997-3#1)(2007-7#1)
nephrotic syndrome in children##2##4##(2007-8#1)(2008-1#1)
nephrotic syndrome in##6##3##(2007-8#1)(2008-1#4)(2011-2#1)
nephrotic syndrome induced by##2##4##(2008-4#1)(2009-6#1)
nephrotic syndrome was the##2##4##(2008-1#2)
nephrotic syndrome with##2##3##(1996-6#1)(2008-1#1)
nephrotic syndrome##50##2##(1990-10#1)(1992-5#1)(1995-12#1)(1996-6#4)(1997-3#1)(1997-7#1)(2006-10#1)(2007-7#10)(2007-8#3)(2008-1#20)(2008-4#2)(2009-6#2)(2011-2#1)(2013-8#2)
nephrotic##54##1##(1990-10#1)(1992-5#1)(1995-12#1)(1996-6#4)(1997-3#1)(1997-7#1)(2006-10#1)(2007-7#11)(2007-8#3)(2008-1#23)(2008-4#2)(2009-6#2)(2011-2#1)(2013-8#2)
nephrotoxic##8##1##(1994-5#1)(2008-4#3)(2008-8#2)(2012-3#1)(2013-1#1)
nephrotoxicity and hepatotoxicity##2##3##(1994-5#2)
nephrotoxicity in##2##2##(1996-8#1)(2008-8#1)
nephrotoxicity##15##1##(1990-12#3)(1993-12#1)(1994-5#3)(1995-3#1)(1996-12#1)(1996-8#1)(2007-7#2)(2008-8#3)
neplanocin A##3##2##(1994-8#1)(2008-11#2)
nepovirus##2##1##(2008-10#2)
nepoviruses##2##1##(2008-10#2)
nerfs à fleur de##2##4##(2008-5#2)
nerka##4##1##(2010-8#4)
nernstian##2##1##(2008-10#2)
nerve activities##2##2##(1997-6#1)(2007-10#1)
nerve activity was##2##3##(1997-2#1)(1997-7#1)
nerve activity##15##2##(1990-12#1)(1995-12#5)(1997-2#1)(1997-6#3)(1997-7#3)(2008-4#1)(2008-7#1)
nerve after##2##2##(2008-2#1)(2008-9#1)
nerve agent##2##2##(2008-10#1)(2008-11#1)
nerve agents##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
nerve and muscle##2##3##(1993-5#1)(1994-12#1)
nerve and the##5##3##(1996-5#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
nerve and##22##2##(1991-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-9#7)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
nerve aplasia##3##2##(2008-9#2)(2011-1#1)
nerve are##2##2##(2008-8#1)(2012-3#1)
nerve as##3##2##(2007-12#1)(2008-7#1)(2008-9#1)
nerve at the##2##3##(2008-9#1)(2012-2#1)
nerve at##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
nerve axons##2##2##(2009-6#1)(2013-1#1)
nerve block##7##2##(1993-1#1)(1996-5#2)(2009-4#2)(2010-3#1)(2012-2#1)
nerve blocks and##2##3##(2008-7#1)(2009-3#1)
nerve branches##3##2##(1996-2#1)(2011-2#2)
nerve bundles##2##2##(1990-7#1)(1993-3#1)
nerve by the##3##3##(2008-2#1)(2008-9#2)
nerve by##5##2##(2008-12#1)(2008-2#1)(2008-9#3)
nerve causing##2##2##(2009-7#1)(2011-2#1)
nerve cell##9##2##(1994-6#2)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
nerve cells by##2##3##(1995-8#2)
nerve cells within##2##3##(1995-8#1)(2008-11#1)
nerve cells##13##2##(1994-5#1)(1995-8#5)(1997-2#1)(2008-11#4)(2008-7#2)
nerve compression by##2##3##(2008-7#1)(2008-9#1)
nerve compression##10##2##(1992-6#1)(2008-12#1)(2008-7#1)(2008-9#6)(2011-1#1)
nerve conduction studies##5##3##(2008-6#4)(2012-3#1)
nerve conduction##8##2##(1997-3#1)(2008-5#1)(2008-6#4)(2012-1#1)(2012-3#1)
nerve cord##10##2##(1997-7#1)(2007-12#6)(2008-5#1)(2008-7#1)(2008-9#1)
nerve cords##3##2##(2007-12#2)(2008-5#1)
nerve damage##5##2##(1995-9#1)(2008-2#2)(2010-5#1)(2012-2#1)
nerve developed##2##2##(2006-12#1)(2008-9#1)
nerve disease##3##2##(1995-5#1)(2008-9#2)
nerve distribution (n = 55)##2##5##(2008-9#2)
nerve endings##13##2##(1990-11#2)(1992-6#3)(1995-12#1)(1997-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)
nerve fiber layer##6##3##(1991-10#1)(2007-11#3)(2008-3#1)(2012-12#1)
nerve fiber##7##2##(1991-10#1)(2007-11#3)(2008-3#1)(2010-1#1)(2012-12#1)
nerve fibers in the##2##4##(1992-6#1)(1997-4#1)
nerve fibers of##2##3##(1990-5#2)
nerve fibers were##2##3##(1990-5#1)(1992-12#1)
nerve fibers##19##2##(1990-5#5)(1992-12#1)(1992-6#2)(1994-5#1)(1996-5#3)(1997-4#2)(2007-12#1)(2010-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
nerve fibre##2##2##(1996-5#1)(2009-9#1)
nerve fibres##11##2##(1994-9#1)(1997-3#4)(1997-4#1)(2008-12#1)(2008-5#3)(2013-8#1)
nerve for##2##2##(2008-12#1)(2008-9#1)
nerve from##2##2##(2008-12#1)(2008-7#1)
nerve function in##4##3##(2008-11#1)(2008-7#2)(2008-9#1)
nerve function##15##2##(1995-5#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-7#4)(2008-9#2)(2009-7#1)(2012-2#2)(2012-3#2)
nerve graft##3##2##(2008-7#1)(2011-2#2)
nerve grafting##7##2##(2008-8#1)(2008-9#5)(2011-2#1)
nerve grafts##2##2##(2008-9#1)(2011-2#1)
nerve growth factor (NGF) are##2##5##(1995-12#1)(2010-8#1)
nerve growth factor (NGF) in##3##5##(1992-9#1)(1995-5#1)(1996-12#1)
nerve growth factor (NGF)##22##4##(1991-12#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-11#2)(2008-4#1)(2008-5#3)(2010-8#2)
nerve growth factor##43##3##(1990-5#1)(1990-8#1)(1991-12#2)(1992-9#2)(1993-12#2)(1993-5#1)(1993-9#1)(1994-6#1)(1994-8#5)(1995-12#2)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#2)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#5)(2010-8#2)
nerve growth##44##2##(1990-5#1)(1990-8#1)(1991-12#2)(1992-9#2)(1993-12#2)(1993-5#1)(1993-9#1)(1994-6#1)(1994-8#5)(1995-12#2)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#2)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#5)(2010-8#2)
nerve has##2##2##(2008-1#1)(2011-7#1)
nerve head##3##2##(2007-11#1)(2011-1#1)(2011-2#1)
nerve hypoplasia##3##2##(1997-3#1)(2008-9#1)(2011-1#1)
nerve imaging##2##2##(2011-2#1)(2012-2#1)
nerve in the##10##3##(1992-6#1)(1993-12#1)(1995-12#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-9#1)
nerve in##15##2##(1992-6#1)(1993-12#1)(1995-12#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#4)(2013-1#1)
nerve injuries##5##2##(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)
nerve injury in##4##3##(1993-12#1)(1994-5#1)(2010-8#1)(2011-2#1)
nerve injury##26##2##(1993-12#1)(1993-5#1)(1994-5#1)(1995-12#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2010-8#1)(2011-2#4)(2011-7#1)(2012-2#4)
nerve is##8##2##(1996-2#1)(2008-2#1)(2008-5#1)(2008-9#4)(2011-2#1)
nerve lesion##2##2##(1993-12#1)(2008-9#1)
nerve lesions##2##2##(2011-2#1)(2012-2#1)
nerve neuropathy##3##2##(2007-5#2)(2008-10#1)
nerve of the##4##3##(1993-12#1)(1997-3#1)(2008-5#2)
nerve of##7##2##(1993-12#2)(1997-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
nerve or##2##2##(1996-8#1)(2012-3#1)
nerve palsies##16##2##(1996-9#2)(2007-10#1)(2008-7#4)(2010-11#1)(2011-2#6)(2012-2#1)(2012-3#1)
nerve palsy and##2##3##(2007-8#1)(2011-2#1)
nerve palsy following##3##3##(2009-3#1)(2012-2#1)(2012-3#1)
nerve palsy##22##2##(1996-9#1)(2007-8#3)(2008-1#1)(2008-9#1)(2009-3#5)(2011-2#5)(2012-2#1)(2012-3#3)(2013-8#2)
nerve paresis##7##2##(2011-2#2)(2013-1#5)
nerve regeneration##11##2##(1992-6#1)(1993-5#3)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#4)
nerve repair##2##2##(2008-8#1)(2011-2#1)
nerve response to##3##3##(2008-5#1)(2008-7#1)(2009-12#1)
nerve root and##2##3##(2012-2#1)(2012-3#1)
nerve root##7##2##(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
nerve roots##8##2##(2006-12#3)(2007-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
nerve schwannoma##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
nerve segment##2##2##(2011-2#1)(2013-1#1)
nerve sheath diameter##2##3##(2010-5#2)
nerve sheath tumor##4##3##(1991-2#2)(2008-8#1)(2009-1#1)
nerve sheath##9##2##(1991-2#2)(1997-8#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-5#2)
nerve stimulation (VNS)##2##3##(2008-1#1)(2008-7#1)
nerve stimulation and##3##3##(2008-1#1)(2008-9#2)
nerve stimulation was##2##3##(1995-12#2)
nerve stimulation##22##2##(1992-6#1)(1993-12#1)(1995-12#5)(2008-1#3)(2008-7#4)(2008-9#6)(2011-1#1)(2012-3#1)
nerve stimulators##3##2##(2008-10#2)(2008-7#1)
nerve supply##2##2##(1993-1#1)(2008-10#1)
nerve system##5##2##(1990-6#1)(2008-5#2)(2008-8#1)(2012-3#1)
nerve terminal##9##2##(1993-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-7#1)(2008-8#2)(2012-3#1)
nerve terminals of##3##3##(1990-5#1)(1996-5#1)(2008-8#1)
nerve terminals##20##2##(1990-5#1)(1991-2#1)(1993-12#1)(1993-9#1)(1995-11#2)(1995-12#3)(1995-5#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-7#2)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
nerve that##3##2##(1992-3#1)(2008-5#2)
nerve thickening##2##2##(2007-7#2)
nerve tissue##4##2##(1994-3#1)(1996-10#1)(1997-3#1)(2006-12#1)
nerve to the##4##3##(1994-8#1)(2008-9#2)(2012-3#1)
nerve to##9##2##(1994-8#1)(2008-8#1)(2008-9#5)(2010-1#1)(2012-3#1)
nerve transfer##9##2##(2008-8#2)(2008-9#6)(2011-2#1)
nerve transfers##4##2##(2008-9#4)
nerve trunk##3##2##(1997-3#1)(2008-7#1)(2008-9#1)
nerve tumors##2##2##(2008-8#2)
nerve was##11##2##(1990-7#1)(1992-11#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-7#3)(2008-9#1)
nerve were##2##2##(1992-3#1)(1996-5#1)
nerve with##8##2##(1990-9#1)(1997-8#1)(2008-6#1)(2008-9#3)(2010-5#1)(2011-2#1)
nerve without##2##2##(2011-2#1)(2012-3#1)
nerve##775##1##(1990-11#4)(1990-12#2)(1990-5#8)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1992-11#3)(1992-12#1)(1992-3#4)(1992-6#12)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#16)(1993-3#2)(1993-5#9)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#26)(1995-5#6)(1995-6#1)(1995-8#6)(1995-9#1)(1996-10#2)(1996-12#10)(1996-2#6)(1996-3#1)(1996-5#18)(1996-8#1)(1996-9#3)(1997-2#6)(1997-3#18)(1997-4#3)(1997-6#7)(1997-7#8)(1997-8#2)(2006-12#11)(2007-10#2)(2007-11#4)(2007-12#20)(2007-5#2)(2007-7#3)(2007-8#6)(2008-1#5)(2008-10#9)(2008-11#21)(2008-12#11)(2008-2#7)(2008-3#2)(2008-4#9)(2008-5#30)(2008-6#8)(2008-7#60)(2008-8#23)(2008-9#111)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#10)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#4)(2010-11#1)(2010-3#1)(2010-5#5)(2010-8#4)(2011-1#7)(2011-2#68)(2011-7#2)(2012-1#1)(2012-12#4)(2012-2#21)(2012-3#30)(2013-1#16)(2013-8#7)
nerve)##3##1##(1990-11#1)(2008-9#1)(2009-3#1)
nerve-repair##2##1##(2008-3#2)
nerves and ganglia##2##3##(1996-5#2)
nerves and the##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
nerves and##12##2##(1996-5#2)(1997-1#1)(2007-11#1)(2008-7#3)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
nerves are##6##2##(2007-12#2)(2008-1#1)(2008-5#1)(2012-3#2)
nerves at the##2##3##(2011-2#2)
nerves because##2##2##(1992-6#1)(2011-2#1)
nerves by##4##2##(1993-6#1)(2008-7#2)(2013-1#1)
nerves from the##2##3##(2008-5#2)
nerves have##2##2##(1997-3#1)(2008-9#1)
nerves in all##2##3##(2008-7#2)
nerves in the##3##3##(1992-6#1)(2008-4#1)(2008-9#1)
nerves in##8##2##(1992-6#1)(1993-5#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)
nerves may##3##2##(1992-6#1)(2008-2#2)
nerves of the##3##3##(1993-2#1)(1993-9#1)(2010-1#1)
nerves of##4##2##(1993-2#1)(1993-9#1)(2008-5#1)(2010-1#1)
nerves on##2##2##(1992-6#1)(2008-9#1)
nerves that release##3##3##(1997-1#3)
nerves to##2##2##(1995-11#1)(2008-2#1)
nerves##123##1##(1990-12#1)(1990-7#1)(1991-3#1)(1992-6#5)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#17)(2008-8#1)(2008-9#6)(2009-11#1)(2009-5#1)(2010-1#1)(2011-1#2)(2011-2#15)(2012-12#1)(2012-3#4)(2013-1#6)(2013-8#2)
nerves/ganglia##3##1##(1996-5#3)
nervosa is##4##2##(1992-11#2)(2007-7#1)(2012-3#1)
nervosa##42##1##(1991-1#1)(1991-11#2)(1992-11#4)(1993-12#1)(1996-8#1)(1996-9#1)(2007-12#2)(2007-7#12)(2007-8#2)(2008-5#6)(2008-6#1)(2011-2#2)(2012-3#4)(2013-1#3)
nervous and immune systems##2##4##(1990-7#1)(2008-5#1)
nervous and immune##3##3##(1990-7#1)(1995-12#1)(2008-5#1)
nervous and##7##2##(1990-7#1)(1994-2#1)(1995-12#1)(1997-5#1)(2008-5#2)(2011-2#1)
nervous formations which##2##3##(1990-11#2)
nervous formations##3##2##(1990-11#3)
nervous pathway##2##2##(1996-5#2)
nervous pathways##2##2##(1996-5#2)
nervous system (CNS) involvement in##2##5##(2011-2#1)(2012-2#1)
nervous system (CNS) involvement##3##4##(2007-10#1)(2011-2#1)(2012-2#1)
nervous system (CNS)##51##3##(1991-12#2)(1991-2#1)(1991-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#3)(1997-2#1)(1997-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
nervous system activity##6##3##(2008-3#2)(2008-4#1)(2008-7#2)(2011-2#1)
nervous system and##24##3##(1992-4#1)(1993-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
nervous system are##10##3##(1995-2#1)(2007-12#1)(2007-8#1)(2008-5#2)(2008-7#3)(2010-12#1)(2012-2#1)
nervous system as##5##3##(1995-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
nervous system can be##2##4##(2008-7#1)(2008-9#1)
nervous system can##4##3##(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
nervous system development and function##2##5##(2008-7#2)
nervous system development##5##3##(2008-10#1)(2008-7#4)
nervous system diseases##2##3##(1993-5#1)(1994-9#1)
nervous system effects##3##3##(2008-4#2)(2009-12#1)
nervous system function##2##3##(1996-5#1)(2009-8#1)
nervous system have##3##3##(2008-4#2)(2008-7#1)
nervous system in the##4##4##(1997-2#1)(2007-12#2)(2013-1#1)
nervous system in##10##3##(1994-11#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-8#2)(2009-2#1)(2012-2#1)(2013-1#1)
nervous system involvement##6##3##(1993-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
nervous system is##4##3##(1990-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
nervous system may be##2##4##(1996-2#1)(2012-3#1)
nervous system may##4##3##(1996-11#1)(1996-2#1)(2012-3#1)(2013-1#1)
nervous system metastases##2##3##(1993-12#1)(2011-3#1)
nervous system of the##6##4##(1992-6#1)(1992-9#1)(1997-3#1)(1997-6#1)(2007-12#2)
nervous system of##14##3##(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-7#2)(2011-2#1)
nervous system plays##2##3##(1993-12#1)(2007-8#1)
nervous system that##4##3##(2008-12#1)(2008-9#1)(2012-2#2)
nervous system tissues##2##3##(1994-12#1)(2012-3#1)
nervous system was##3##3##(1997-4#1)(2008-2#1)(2008-5#1)
nervous system with##2##3##(1995-5#1)(2008-7#1)
nervous system##426##2##(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#3)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#2)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#4)(1993-9#1)(1994-11#5)(1994-12#3)(1994-2#3)(1994-5#3)(1994-8#1)(1994-9#3)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#5)(1995-8#4)(1996-11#2)(1996-12#13)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-6#6)(1997-7#2)(1997-8#1)(2007-10#4)(2007-11#1)(2007-12#14)(2007-7#1)(2007-8#7)(2008-1#4)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#21)(2008-5#16)(2008-6#2)(2008-7#54)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#4)(2009-6#2)(2009-7#2)(2009-8#6)(2010-1#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#17)(2011-3#2)(2011-7#1)(2012-12#5)(2012-2#14)(2012-3#13)(2013-1#14)(2013-7#1)(2013-8#6)
nervous system)##2##2##(2008-3#1)(2008-9#1)
nervous systems of##3##3##(1997-6#2)(2007-12#1)
nervous systems##14##2##(1990-5#1)(1993-6#1)(1997-6#3)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-2#1)
nervous tissue##12##2##(1990-3#1)(1994-11#1)(1995-12#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-4#2)(2011-1#2)(2012-1#2)
nervous##493##1##(1990-11#3)(1990-3#3)(1990-5#3)(1990-7#5)(1990-8#3)(1990-9#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#3)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#2)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#5)(1993-9#1)(1994-11#6)(1994-12#3)(1994-2#5)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#5)(1995-12#8)(1995-2#4)(1995-3#3)(1995-5#5)(1995-6#1)(1995-8#4)(1996-11#2)(1996-12#13)(1996-2#4)(1996-3#1)(1996-5#7)(1996-6#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#9)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#4)(2007-11#2)(2007-12#15)(2007-7#2)(2007-8#7)(2008-1#5)(2008-10#17)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#24)(2008-5#20)(2008-6#2)(2008-7#55)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#4)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#5)(2010-3#2)(2010-5#3)(2010-7#1)(2011-1#4)(2011-2#18)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#15)(2012-3#13)(2013-1#16)(2013-7#1)(2013-8#7)
nesiritide##3##1##(2008-3#3)
nest distribution##2##2##(2007-5#2)
nest in the##2##3##(2008-6#1)(2012-2#1)
nest in##3##2##(2008-6#2)(2012-2#1)
nest of##5##2##(2008-6#1)(2008-8#2)(2008-9#2)
nest parasitism##5##2##(2008-9#5)
nest##39##1##(1992-6#1)(1994-9#1)(2007-5#2)(2008-10#1)(2008-5#3)(2008-6#3)(2008-8#11)(2008-9#14)(2012-2#3)
nested PCR and##2##3##(2009-3#1)(2012-12#1)
nested PCR for##2##3##(1996-12#1)(2012-3#1)
nested PCR with type specific primers##2##6##(2008-12#2)
nested PCR##15##2##(1993-12#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
nested RT-PCR##4##2##(2008-10#2)(2011-1#1)(2013-8#1)
nested allosteric model##2##3##(1997-2#2)
nested case-control study##4##3##(2008-8#1)(2010-6#1)(2011-1#2)
nested deletion method##2##3##(1996-2#2)
nested deletion##4##2##(1995-8#1)(1996-2#3)
nested deletions from##2##3##(1994-12#1)(1996-12#1)
nested deletions##5##2##(1994-12#1)(1995-8#2)(1996-12#2)
nested gene-specific##2##2##(1994-12#1)(1997-7#1)
nested in##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
nested polymerase chain reaction (PCR)##6##5##(1992-9#1)(2008-10#4)(2011-2#1)
nested polymerase chain reaction assay##2##5##(2007-6#1)(2008-10#1)
nested polymerase chain reaction##13##4##(1992-9#2)(2007-6#1)(2008-10#6)(2008-11#1)(2011-2#2)(2012-3#1)
nested primers##2##2##(1997-4#2)
nested reverse transcription-polymerase chain reaction (RT-PCR)##3##6##(2008-10#3)
nested reverse##5##2##(1995-11#1)(2008-10#3)(2013-8#1)
nested within the##2##3##(2008-10#1)(2013-8#1)
nested within##6##2##(2008-1#1)(2008-10#2)(2008-7#1)(2010-6#1)(2013-8#1)
nested##93##1##(1990-7#1)(1992-9#2)(1993-12#1)(1994-12#4)(1994-9#1)(1995-11#1)(1995-8#3)(1996-12#3)(1996-2#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#33)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#2)(2011-1#4)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#3)
nested-PCR protocol##2##2##(2008-10#2)
nested-PCR##5##1##(2008-10#2)(2008-12#3)
nestin##2##1##(1996-5#1)(2009-10#1)
nesting guilds##2##2##(2008-9#2)
nesting in##2##2##(2008-6#2)
nesting season##2##2##(2007-5#2)
nesting##22##1##(1990-8#1)(1995-3#2)(2007-5#5)(2008-10#1)(2008-5#1)(2008-6#6)(2008-9#6)
nestling##2##1##(1994-3#1)(2008-8#1)
nestlings##7##1##(1994-3#4)(2008-5#2)(2008-8#1)
nests and##2##2##(2008-8#1)(2012-1#1)
nests of the##2##3##(2008-8#1)(2012-2#1)
nests of##5##2##(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#1)
nests were##4##2##(2007-5#2)(2008-6#1)(2008-9#1)
nests##33##1##(1990-6#1)(2007-5#4)(2008-10#1)(2008-5#3)(2008-6#5)(2008-8#9)(2008-9#6)(2010-6#1)(2010-8#1)(2012-1#1)(2012-2#1)
nests)##2##1##(2008-9#1)(2010-8#1)
net CO(2) assimilation##2##3##(2008-10#2)
net analyte signal regression##2##4##(2008-10#2)
net analyte signal##4##3##(2008-10#4)
net analyte##5##2##(2008-10#5)
net assimilation rate##3##3##(2008-12#1)(2008-8#1)(2012-5#1)
net balance##2##2##(2008-2#1)(2008-5#1)
net blotch pathogen##2##3##(2008-10#2)
net blotch##5##2##(2008-10#5)
net cell##2##2##(2008-7#1)(2011-1#1)
net charge##6##2##(1991-10#1)(1991-2#1)(2008-10#1)(2008-4#3)
net cost savings##4##3##(2008-11#4)
net effect of##7##3##(1995-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
net effect##8##2##(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
net effects##3##2##(2008-8#2)(2012-2#1)
net energy##3##2##(2013-1#2)(2013-8#1)
net flux##3##2##(2008-10#1)(2008-7#2)
net for##2##2##(2008-10#1)(2011-2#1)
net form##2##2##(2008-10#2)
net gain##2##2##(2007-11#1)(2008-9#1)
net has been##2##3##(1997-6#1)(2007-8#1)
net income##2##2##(2008-12#2)
net increase in olfactory sensory units in##2##7##(2007-12#2)
net increase in##3##3##(2007-12#2)(2008-7#1)
net increase of##2##3##(2007-12#1)(2008-1#1)
net increase##5##2##(2007-12#3)(2008-1#1)(2008-7#1)
net joint moments##2##3##(2011-2#2)
net losses##2##2##(1993-3#2)
net mucosal-to-serosal flux of##2##4##(2008-6#2)
net mucosal-to-serosal##3##2##(2008-6#3)
net of##2##2##(1992-12#1)(2011-2#1)
net photosynthesis##6##2##(2008-10#3)(2008-12#1)(2012-5#1)(2012-7#1)
net photosynthetic rate##2##3##(2008-10#1)(2008-5#1)
net positive##2##2##(2007-11#1)(2008-8#1)
net present value##2##3##(1992-12#1)(2008-6#1)
net profit##2##2##(2008-12#2)
net profits##3##2##(1993-1#1)(1993-3#2)
net reproductive rate (R0)##2##4##(2011-2#2)
net reproductive rate##6##3##(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)
net result of##3##3##(2008-10#1)(2008-5#2)
net result##5##2##(1992-9#1)(2008-10#2)(2008-5#2)
net retardance##2##2##(2007-12#2)
net return##2##2##(2008-10#2)
net revenue and##2##3##(2008-11#2)
net revenue##4##2##(2008-11#4)
net two-beam coupling gain of##2##5##(2007-11#1)(2007-12#1)
net uptake of##2##3##(1990-11#1)(1995-5#1)
net was##3##2##(2007-12#1)(2011-2#1)(2013-7#1)
net yield##2##2##(2008-11#2)
net##215##1##(1990-11#3)(1990-3#1)(1991-10#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-12#3)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#4)(1994-12#2)(1994-6#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#6)(2007-12#10)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#16)(2008-12#11)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#7)(2008-7#4)(2008-8#13)(2008-9#4)(2009-5#1)(2009-7#1)(2009-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-2#4)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#3)
net&quot##2##1##(1994-3#1)(1996-3#1)
net-IR##2##1##(2008-3#2)
nets and##2##2##(2011-2#1)(2013-8#1)
nets for##2##2##(2007-5#1)(2013-1#1)
nets##18##1##(1997-4#1)(2006-12#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
netted##2##1##(2008-10#2)
network (PNN)##3##2##(2008-10#2)(2010-8#1)
network activity##5##2##(1995-11#1)(2008-2#1)(2013-8#3)
network alone##2##2##(1994-8#1)(2008-8#1)
network analysis to##2##3##(2008-3#1)(2013-8#1)
network analysis##11##2##(2008-12#2)(2008-3#1)(2008-8#3)(2010-1#1)(2010-8#2)(2013-7#1)(2013-8#1)
network and the##6##3##(1993-12#1)(2008-3#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
network and##34##2##(1990-12#1)(1993-12#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
network approach##3##2##(2010-8#1)(2011-3#1)(2012-2#1)
network architecture##5##2##(2008-1#1)(2008-10#2)(2008-8#2)
network are described##2##3##(2007-12#1)(2008-10#1)
network are##6##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
network as an example##2##4##(2008-11#1)(2010-1#1)
network as##3##2##(2008-11#1)(2010-1#1)(2013-8#1)
network based on a##2##4##(2007-11#1)(2007-12#1)
network based on##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-9#1)
network based##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-3#1)(2010-8#1)(2011-9#1)
network between##2##2##(1991-3#1)(2008-10#1)
network by##4##2##(2008-10#1)(2008-2#2)(2008-7#1)
network can be##5##3##(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#1)
network can##9##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#2)
network consisting of##5##3##(2008-10#3)(2008-12#1)(2012-2#1)
network could##3##2##(2008-10#1)(2008-3#2)
network data##6##2##(2008-11#1)(2010-1#4)(2012-3#1)
network dynamics##3##2##(2008-11#1)(2009-8#1)(2012-12#1)
network enables##2##2##(1996-12#1)(2013-1#1)
network for the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
network for##15##2##(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#3)
network formation##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
network from##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
network has##3##2##(1996-5#1)(2010-8#1)(2011-2#1)
network in the##4##3##(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
network in##17##2##(1991-9#1)(1995-5#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#2)
network including##2##2##(2008-11#1)(2008-7#1)
network infrastructure##2##2##(2008-10#1)(2008-7#1)
network involved in##3##3##(2007-12#1)(2010-3#1)(2012-12#1)
network involving the##2##3##(1996-5#1)(2008-11#1)
network is a##3##3##(1996-12#1)(1996-3#1)(2008-10#1)
network is presented##2##3##(2008-2#1)(2009-7#1)
network is used to##2##4##(2008-12#1)(2010-8#1)
network is##32##2##(1994-8#1)(1995-2#1)(1996-12#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-8#4)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
network level##2##2##(2008-11#1)(2008-7#1)
network linking##3##2##(1992-2#1)(1993-2#1)(2008-7#1)
network management##3##2##(1992-3#3)
network model for##2##3##(2008-1#1)(2008-7#1)
network model is##2##3##(2008-11#1)(2008-2#1)
network model of##6##3##(2008-11#6)
network model##16##2##(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#9)(2008-2#1)(2008-7#1)(2008-8#2)
network models##4##2##(2008-10#1)(2009-8#1)(2010-9#1)(2013-8#1)
network neurons##3##2##(1995-11#3)
network nodes##2##2##(2008-1#1)(2012-2#1)
network of the##8##3##(1997-2#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
network of##88##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#3)(2007-12#5)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
network on the##2##3##(1996-12#1)(2008-5#1)
network on##6##2##(1996-1#1)(1996-12#1)(2008-5#3)(2009-8#1)
network or##2##2##(1992-12#1)(2008-10#1)
network organization##2##2##(2009-9#1)(2010-4#1)
network oscillations##5##2##(1990-5#2)(2008-2#2)(2013-8#1)
network parameters##2##2##(2008-10#2)
network pattern recognition##2##3##(2008-2#1)(2008-3#1)
network performance##2##2##(1996-2#1)(2008-2#1)
network provided a##2##3##(2007-12#1)(2008-10#1)
network reconstruction##2##2##(2008-7#1)(2008-8#1)
network size##3##2##(2008-1#2)(2008-3#1)
network strategy for##2##3##(1994-12#1)(2008-10#1)
network structure##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#3)(2012-3#2)
network structures##2##2##(2010-10#1)(2010-5#1)
network systems##2##2##(2007-8#1)(2008-3#1)
network technology##2##2##(2008-10#2)
network that is##3##3##(2008-1#1)(2010-10#1)(2012-2#1)
network that uses##2##3##(2008-2#1)(2008-3#1)
network that##14##2##(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-8#1)
network theory##2##2##(2012-2#1)(2013-8#1)
network to be##2##3##(2008-10#1)(2008-5#1)
network to the##2##3##(2008-1#1)(2013-8#1)
network to##17##2##(1993-12#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
network topologies##2##2##(2008-3#1)(2012-2#1)
network training##3##2##(2008-10#2)(2008-3#1)
network verifies##2##2##(2012-2#2)
network was applied to##3##4##(2008-10#2)(2008-3#1)
network was used##2##3##(2008-10#2)
network was##14##2##(1992-12#1)(2008-10#11)(2008-3#1)(2013-1#1)
network which##6##2##(1996-2#1)(1997-7#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
network with a##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
network with the##2##3##(2008-10#1)(2013-8#1)
network with##19##2##(1996-12#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#7)(2008-7#1)(2012-2#1)(2013-8#1)
network##801##1##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#5)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#4)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#2)(1996-1#5)(1996-12#10)(1996-2#5)(1996-3#9)(1996-4#2)(1996-5#2)(1996-7#3)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#5)(2007-12#17)(2007-8#2)(2008-1#16)(2008-10#102)(2008-11#55)(2008-12#4)(2008-2#56)(2008-3#59)(2008-4#5)(2008-5#22)(2008-6#5)(2008-7#36)(2008-8#25)(2008-9#11)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#9)(2009-9#4)(2010-1#9)(2010-10#11)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#21)(2010-9#2)(2011-1#4)(2011-2#32)(2011-3#2)(2011-9#2)(2012-1#4)(2012-12#11)(2012-2#37)(2012-3#16)(2013-1#17)(2013-7#3)(2013-8#29)
network's##8##1##(1996-12#1)(1997-2#2)(2008-10#1)(2008-11#1)(2010-10#2)(2012-12#1)
network)##8##1##(1996-1#5)(2008-10#1)(2010-10#1)(2010-4#1)
network-based drug discovery##2##3##(2011-3#2)
network-based##7##1##(1994-1#2)(1996-12#1)(2007-11#1)(2008-10#1)(2011-3#2)
networked##8##1##(1993-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#1)
networking and##2##2##(1996-4#1)(2010-3#1)
networking##17##1##(1994-2#1)(1995-2#1)(1996-4#1)(2008-10#1)(2008-3#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)
networks and the##3##3##(2009-12#1)(2010-10#1)(2011-2#1)
networks and their##2##3##(2009-5#1)(2011-3#1)
networks and##29##2##(1993-2#1)(1994-8#1)(1995-2#1)(1996-2#2)(1997-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
networks are##15##2##(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-6#1)(2008-7#2)(2010-10#1)(2010-8#1)(2012-3#1)
networks as##4##2##(1996-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
networks based on##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
networks can##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)
networks controlling##2##2##(2009-3#1)(2011-2#1)
networks for##15##2##(1994-8#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2010-10#1)(2010-6#1)(2010-8#1)(2012-1#1)(2013-8#1)
networks from##3##2##(2008-7#3)
networks has##2##2##(2008-10#1)(2009-7#1)
networks have been##6##3##(2008-10#2)(2009-6#1)(2009-9#1)(2010-8#2)
networks have##8##2##(2008-10#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#2)
networks in simulated neural systems##2##5##(2008-11#2)
networks in the##9##3##(1994-1#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
networks in##31##2##(1992-11#1)(1994-1#1)(1995-2#1)(1997-8#1)(2008-10#3)(2008-11#4)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)
networks is##12##2##(1996-3#1)(1996-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
networks may##2##2##(1996-3#1)(2008-10#1)
networks might##2##2##(2008-7#1)(2013-1#1)
networks of##20##2##(1990-5#1)(1992-3#2)(1996-4#1)(1996-7#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-2#2)(2013-1#1)
networks on##3##2##(2008-10#1)(2008-8#2)
networks operating in the##2##4##(2008-7#1)(2011-2#1)
networks provide##2##2##(2008-11#1)(2012-2#1)
networks studied##2##2##(2008-10#1)(2010-10#1)
networks than##2##2##(1996-7#1)(2012-12#1)
networks that are##4##3##(1996-12#1)(1997-2#1)(2008-3#1)(2008-6#1)
networks that control##2##3##(2008-7#1)(2010-4#1)
networks that##15##2##(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
networks to##6##2##(1996-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)
networks using##3##2##(2008-7#2)(2009-8#1)
networks via##2##2##(2008-1#1)(2010-8#1)
networks was##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#1)
networks were##5##2##(2008-10#4)(2011-2#1)
networks which##2##2##(2008-10#1)(2008-11#1)
networks will##2##2##(1992-3#1)(2008-3#1)
networks with##14##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-2#1)
networks within the##2##3##(1992-2#1)(2008-11#1)
networks within##3##2##(1992-2#1)(2008-11#1)(2012-2#1)
networks##505##1##(1990-11#1)(1990-5#3)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-2#2)(1994-1#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#5)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1996-1#3)(1996-12#3)(1996-2#10)(1996-3#11)(1996-4#3)(1996-7#3)(1997-2#8)(1997-3#1)(1997-7#2)(1997-8#2)(2007-11#4)(2007-12#5)(2008-1#7)(2008-10#99)(2008-11#36)(2008-2#18)(2008-3#17)(2008-4#12)(2008-5#2)(2008-6#6)(2008-7#43)(2008-8#13)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#12)(2009-9#5)(2010-1#2)(2010-10#22)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#16)(2010-9#1)(2011-1#1)(2011-2#13)(2011-3#2)(2012-1#3)(2012-12#5)(2012-2#21)(2012-3#3)(2013-1#14)(2013-8#4)
networks)##3##1##(1996-1#1)(2008-10#2)
neural action##2##2##(1994-11#1)(2008-7#1)
neural activation##3##2##(2008-11#2)(2008-3#1)
neural activities##3##2##(1996-2#1)(2008-11#2)
neural activity and##3##3##(2007-8#1)(2008-11#1)(2013-8#1)
neural activity following##2##3##(2008-11#1)(2009-3#1)
neural activity in##4##3##(1991-2#1)(2008-11#1)(2008-4#1)(2012-3#1)
neural activity##21##2##(1990-5#1)(1991-2#2)(1995-5#1)(1996-5#3)(2007-8#1)(2008-11#7)(2008-4#1)(2009-3#2)(2012-12#1)(2012-3#1)(2013-8#1)
neural and vascular##2##3##(2007-8#1)(2012-3#1)
neural and##10##2##(1992-6#1)(1994-2#1)(1994-9#1)(2007-8#1)(2008-4#1)(2008-8#2)(2010-11#1)(2012-3#1)(2013-8#1)
neural architectures##2##2##(2007-8#1)(2008-4#1)
neural cell adhesion molecule##3##4##(1995-12#1)(1996-12#1)(2009-8#1)
neural cell##7##2##(1992-6#1)(1994-8#1)(1995-12#1)(1996-12#2)(2009-8#1)(2012-1#1)
neural cells##15##2##(1992-6#1)(1993-12#2)(1995-12#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-1#1)(2009-3#1)(2009-7#1)
neural circuit##4##2##(2007-8#1)(2008-11#3)
neural circuitries##2##2##(2009-6#2)
neural circuitry##9##2##(1994-8#2)(1997-2#1)(2008-11#3)(2008-7#1)(2009-9#1)(2013-8#1)
neural circuits of##2##3##(1997-6#1)(2008-11#1)
neural circuits that##2##3##(2008-11#1)(2013-8#1)
neural circuits##14##2##(1990-5#3)(1993-12#1)(1997-6#2)(2008-1#1)(2008-11#3)(2008-2#1)(2008-9#1)(2009-2#1)(2013-8#1)
neural coding and##2##3##(2008-11#1)(2008-8#1)
neural coding##8##2##(2008-1#3)(2008-11#4)(2008-8#1)
neural control of the##2##4##(1997-4#1)(2008-7#1)
neural control of##4##3##(1997-4#1)(2007-7#1)(2008-4#1)(2008-7#1)
neural control##8##2##(1993-6#1)(1997-4#1)(2007-12#3)(2007-7#1)(2008-4#1)(2008-7#1)
neural correlates of##9##3##(2007-8#3)(2008-11#1)(2008-6#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
neural crest induction##2##3##(2012-12#2)
neural crest##8##2##(1992-3#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2012-12#3)
neural crest-derived cell lineages##2##4##(1994-12#2)
neural damage##2##2##(1997-2#1)(2008-6#1)
neural development in##2##3##(1997-7#1)(2008-9#1)
neural development##10##2##(1992-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)
neural diagnostic tree##3##3##(2008-3#3)
neural differentiation##5##2##(1990-11#3)(2008-10#1)(2008-9#1)
neural dynamics##4##2##(2008-11#2)(2013-8#2)
neural ensembles##2##2##(2013-8#2)
neural filters##2##2##(2008-7#2)
neural foramen##2##2##(1997-8#1)(2008-1#1)
neural foraminal widening##2##3##(1997-8#2)
neural function##2##2##(2008-7#1)(2008-9#1)
neural hypothesis##2##2##(2008-9#2)
neural identity##2##2##(2007-12#2)
neural indices of##2##3##(2008-11#1)(2012-3#1)
neural injury##2##2##(2011-2#2)
neural lesions##3##2##(2008-12#1)(2011-2#2)
neural mechanisms of##3##3##(1992-3#1)(1995-12#1)(2013-1#1)
neural mechanisms underlying the##2##4##(2012-2#1)(2013-1#1)
neural mechanisms underlying##6##3##(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
neural mechanisms##20##2##(1990-11#1)(1992-3#1)(1995-12#1)(1996-5#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
neural model##3##2##(2007-12#1)(2008-6#2)
neural net##3##2##(2007-8#1)(2008-11#2)
neural network (ANN) and##2##4##(2008-10#2)
neural network (ANN)##16##3##(2008-10#14)(2010-8#1)(2013-1#1)
neural network algorithm##2##3##(2008-10#2)
neural network analysis##5##3##(2008-3#1)(2008-8#3)(2010-8#1)
neural network and##5##3##(2008-10#2)(2008-11#1)(2009-2#1)(2011-2#1)
neural network architecture##3##3##(2008-1#1)(2008-8#2)
neural network based##3##3##(2008-3#1)(2009-3#1)(2010-8#1)
neural network can##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
neural network controller##2##3##(2007-12#2)
neural network for##7##3##(1993-12#1)(2008-10#2)(2008-11#2)(2008-3#2)
neural network is##7##3##(2008-10#1)(2008-3#2)(2010-8#4)
neural network model of##2##4##(2008-11#2)
neural network model##7##3##(2008-11#5)(2008-8#2)
neural network of##2##3##(2008-10#1)(2008-2#1)
neural network to##4##3##(1994-8#1)(2008-10#2)(2013-8#1)
neural network using a##2##4##(2008-10#1)(2008-2#1)
neural network was applied to##2##5##(2008-10#1)(2008-3#1)
neural network was##5##3##(2008-10#4)(2008-3#1)
neural network with a##3##4##(2008-2#1)(2008-3#2)
neural network with##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)
neural network##140##2##(1993-12#2)(1994-8#1)(1995-11#2)(1997-7#1)(2007-12#2)(2008-1#3)(2008-10#53)(2008-11#10)(2008-2#6)(2008-3#24)(2008-8#9)(2009-2#2)(2009-3#1)(2009-5#1)(2010-8#15)(2011-2#1)(2013-1#2)(2013-8#5)
neural networks (ANNs)##12##3##(2008-10#12)
neural networks and##7##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-8#1)
neural networks are##3##3##(2008-2#1)(2008-6#1)(2010-8#1)
neural networks based on##2##4##(2008-10#1)(2008-2#1)
neural networks for##8##3##(1994-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2010-8#1)(2012-1#1)
neural networks have been trained to quantify considered metal ions in mixtures under optimum conditions##2##15##(2008-10#2)
neural networks have been##4##4##(2008-10#2)(2010-8#2)
neural networks is##2##3##(2008-10#1)(2008-2#1)
neural networks models##2##3##(2008-10#2)
neural networks to##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
neural networks trained##3##3##(2008-10#2)(2008-8#1)
neural networks with##2##3##(2008-10#1)(2010-8#1)
neural networks##123##2##(1990-11#1)(1994-8#3)(1995-5#2)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#72)(2008-11#5)(2008-2#8)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-8#14)(2012-1#1)
neural optimal control system##2##4##(2009-5#2)
neural optimal control systems##2##4##(2009-5#2)
neural optimal control##4##3##(2009-5#4)
neural pathway of##2##3##(2007-12#1)(2009-5#1)
neural pathway##3##2##(1996-2#1)(2007-12#1)(2009-5#1)
neural pathways##5##2##(1997-2#2)(2007-12#1)(2008-4#1)(2008-7#1)
neural plasticity##2##2##(2008-9#1)(2009-8#1)
neural populations##4##2##(2007-8#1)(2009-8#2)(2012-2#1)
neural precursor cell lines##3##4##(1995-2#1)(2008-11#2)
neural precursor cells##11##3##(1992-12#1)(2007-12#1)(2008-11#7)(2008-7#1)(2013-1#1)
neural precursor##15##2##(1992-12#1)(1995-2#1)(2007-12#1)(2008-11#10)(2008-7#1)(2013-1#1)
neural precursors##5##2##(2007-12#3)(2008-11#1)(2008-8#1)
neural processes##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
neural processing of##4##3##(1996-5#1)(2008-11#3)
neural processing##6##2##(1996-5#1)(2007-8#1)(2008-11#3)(2010-7#1)
neural recordings##2##2##(2013-8#2)
neural regulation##2##2##(1990-11#1)(2008-7#1)
neural response telemetry##3##3##(2008-9#3)
neural response##6##2##(2008-11#1)(2008-9#5)
neural responses to##5##3##(2008-11#4)(2009-2#1)
neural responses##11##2##(2008-11#6)(2008-7#2)(2008-9#1)(2009-2#2)
neural retina##3##2##(1996-12#2)(2008-4#1)
neural source of##2##3##(1992-8#2)
neural stem cell##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)
neural stem cells and##4##4##(2008-11#2)(2008-4#1)(2008-7#1)
neural stem cells from##2##4##(1994-11#1)(2012-1#1)
neural stem cells##18##3##(1994-11#3)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-1#2)
neural stem##24##2##(1994-11#3)(2008-10#3)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2011-2#2)(2012-1#3)
neural stimulation##2##2##(1990-5#1)(2010-6#1)
neural structures##7##2##(1996-12#1)(1996-5#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
neural substrate of##2##3##(1993-5#1)(2007-8#1)
neural substrate##4##2##(1992-11#1)(1993-5#1)(1994-2#1)(2007-8#1)
neural substrates##3##2##(2008-11#1)(2008-4#1)(2009-9#1)
neural system##4##2##(1993-6#2)(1995-8#1)(2007-12#1)
neural systems of##2##3##(2008-11#1)(2011-1#1)
neural systems##13##2##(1991-2#1)(1993-3#2)(2007-8#2)(2008-11#4)(2008-4#1)(2008-7#2)(2011-1#1)
neural tissue and##2##3##(1990-9#1)(1994-12#1)
neural tissue##12##2##(1990-9#1)(1991-2#1)(1994-12#2)(1994-2#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2012-1#1)
neural tissues of##2##3##(1992-9#1)(1997-4#1)
neural tissues##6##2##(1991-7#1)(1992-9#3)(1997-4#1)(2008-6#1)
neural tree##2##2##(2008-3#2)
neural tube defects##5##3##(1995-3#1)(1996-5#1)(2010-5#1)(2012-12#1)(2013-1#1)
neural tube##13##2##(1994-12#1)(1995-3#1)(1996-12#1)(1996-5#2)(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)(2012-1#1)(2012-12#2)(2013-1#1)
neural underpinnings##2##2##(2008-11#1)(2012-2#1)
neural##733##1##(1990-10#1)(1990-11#8)(1990-5#6)(1990-8#1)(1990-9#1)(1991-2#5)(1991-7#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-12#6)(1993-3#2)(1993-5#2)(1993-6#3)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#1)(1994-8#8)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#4)(1995-8#1)(1996-12#9)(1996-2#3)(1996-3#1)(1996-5#11)(1997-2#4)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#4)(2007-11#2)(2007-12#22)(2007-7#1)(2007-8#17)(2007-9#1)(2008-1#9)(2008-10#134)(2008-11#102)(2008-12#1)(2008-2#16)(2008-3#35)(2008-4#15)(2008-5#5)(2008-6#11)(2008-7#25)(2008-8#23)(2008-9#17)(2009-1#1)(2009-10#2)(2009-2#7)(2009-3#6)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#4)(2010-1#2)(2010-11#3)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#30)(2011-1#1)(2011-2#13)(2012-1#10)(2012-12#9)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#12)(2013-7#2)(2013-8#21)
neural-network model##2##2##(2008-3#2)
neural-network##10##1##(2008-2#1)(2008-3#8)(2008-6#1)
neural-networks##3##1##(2008-6#3)
neural-specific##3##1##(1994-12#1)(1995-2#2)
neural-tube##4##1##(1997-8#4)
neuralgia##17##1##(1996-6#2)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#9)(2013-1#1)
neurally evoked##3##2##(1990-5#3)
neurally##4##1##(1990-5#3)(1990-7#1)
neuralprecursor cell lines##2##3##(2008-11#2)
neuralprecursor##3##1##(2008-11#3)
neuraminic acid##2##2##(1990-11#1)(1992-11#1)
neuraminidase (NA)##2##2##(2008-11#1)(2008-9#1)
neuraminidase activity##4##2##(1990-11#1)(1990-5#1)(2008-7#2)
neuraminidase inhibitor##5##2##(1990-11#2)(1990-5#2)(2008-5#1)
neuraminidase or virus##2##3##(1990-5#2)
neuraminidase treatment##4##2##(1990-12#3)(1992-6#1)
neuraminidase##28##1##(1990-11#3)(1990-12#3)(1990-5#6)(1992-6#1)(1992-9#1)(1994-11#1)(1995-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#4)(2008-9#1)(2011-2#2)(2012-12#1)
neurasthenia was##2##2##(2008-7#2)
neurasthenia##3##1##(2008-7#3)
neurasthenic discourse##2##2##(2008-7#2)
neurectomy of the##2##3##(1993-12#2)
neurectomy##14##1##(1993-12#4)(1994-3#5)(2008-9#5)
neurinosarcoma##2##1##(1990-5#2)
neurite formation##5##2##(1992-6#1)(1996-12#4)
neurite growth##4##2##(1995-11#3)(2013-1#1)
neurite length##4##2##(2013-1#4)
neurite outgrowth and##5##3##(1990-2#1)(1992-6#1)(1995-6#1)(1996-12#1)(2008-11#1)
neurite outgrowth but##2##3##(2008-11#1)(2008-4#1)
neurite outgrowth from PC12 cells##2##5##(1990-8#1)(2008-10#1)
neurite outgrowth from PC12##3##4##(1990-8#1)(2008-10#1)(2008-11#1)
neurite outgrowth from##5##3##(1990-8#1)(1993-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
neurite outgrowth in PC12##3##4##(2008-11#2)(2008-4#1)
neurite outgrowth in##7##3##(1991-6#1)(1992-6#1)(1995-6#1)(2008-11#3)(2008-4#1)
neurite outgrowth of##3##3##(1997-6#1)(2008-11#2)
neurite outgrowth promoting activity##2##4##(2008-11#2)
neurite outgrowth was observed during cultivation##2##6##(2008-11#2)
neurite outgrowth was##4##3##(2008-11#4)
neurite outgrowth##40##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-6#2)(1993-5#1)(1995-6#3)(1996-12#1)(1997-6#2)(2008-10#3)(2008-11#16)(2008-4#7)(2008-5#2)
neurite outgrowth-promoting activity##2##3##(2008-10#1)(2008-11#1)
neurite patterning##2##2##(2008-11#2)
neurite##67##1##(1990-2#1)(1990-8#1)(1991-6#1)(1992-6#3)(1993-5#1)(1995-11#3)(1995-6#4)(1996-12#7)(1997-6#2)(2008-10#4)(2008-11#23)(2008-4#7)(2008-5#3)(2008-7#1)(2008-9#1)(2013-1#5)
neurite-like##2##1##(2008-7#2)
neurites from##2##2##(1997-3#1)(2008-11#1)
neurites in##2##2##(1993-12#1)(2013-1#1)
neurites of##4##2##(1995-2#1)(2007-12#1)(2008-11#1)(2009-10#1)
neurites##28##1##(1990-2#1)(1991-1#1)(1991-10#1)(1992-12#1)(1993-12#1)(1995-2#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2013-1#1)
neuritic plaques##4##2##(1991-1#1)(1992-12#1)(1996-12#1)(1996-2#1)
neuritis (ON)##2##2##(1995-12#1)(2011-7#1)
neuritis in##2##2##(1995-12#1)(2011-1#1)
neuritis##18##1##(1992-3#1)(1993-5#1)(1994-6#1)(1995-12#3)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#2)(2011-1#3)(2011-7#2)(2012-3#1)(2013-1#1)
neuritogenic effect##3##2##(1993-12#2)(2008-4#1)
neuritogenic##6##1##(1993-12#2)(1995-12#3)(2008-4#1)
neuro-behavioral##3##1##(1991-3#1)(1993-5#2)
neuro-endocrine##2##1##(1990-3#1)(1993-6#1)
neuro-muscular##5##1##(1995-12#1)(2008-9#4)
neuro-vertebral##2##1##(2007-11#2)
neuroactive steroids##5##2##(2008-7#4)(2008-8#1)
neuroactive##10##1##(1992-8#2)(1995-12#2)(2008-7#5)(2008-8#1)
neuroanatomic##3##1##(1996-5#2)(2008-4#1)
neuroanatomical bases and its##2##4##(2013-7#2)
neuroanatomical studies##2##2##(1995-5#1)(2007-12#1)
neuroanatomical##18##1##(1990-7#1)(1990-8#1)(1995-5#4)(2007-12#3)(2008-4#4)(2008-7#1)(2009-9#1)(2013-1#1)(2013-7#2)
neuroanatomy##2##1##(2008-9#1)(2009-8#1)
neuroaxial block##2##2##(2008-7#1)(2012-3#1)
neurobehavioral toxicity##3##2##(1996-12#2)(2008-7#1)
neurobehavioral##17##1##(1992-6#1)(1993-5#1)(1996-12#8)(1997-2#1)(2007-10#1)(2007-8#1)(2008-7#2)(2009-9#1)(2012-2#1)
neurobiologic##2##1##(2008-2#2)
neurobiological mechanisms##3##2##(1993-12#1)(2009-10#1)(2012-3#1)
neurobiological models of##2##3##(1993-12#1)(2008-2#1)
neurobiological substrate of##2##3##(2008-12#1)(2008-7#1)
neurobiological##32##1##(1992-10#1)(1993-12#2)(1994-2#1)(1994-6#1)(1997-6#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
neurobiologically##2##1##(1992-3#1)(2008-11#1)
neurobiology of##11##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#2)(2009-10#1)(2011-2#1)
neurobiology##23##1##(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#5)(2008-6#3)(2008-7#2)(2009-10#1)(2009-6#1)(2009-7#2)(2011-2#2)
neuroblast##5##1##(1990-11#1)(2007-12#4)
neuroblastoma cell line##8##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1996-10#2)(2008-7#2)
neuroblastoma cell lines##4##3##(1990-11#1)(1996-10#1)(2011-2#2)
neuroblastoma cell##12##2##(1990-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1996-10#3)(2008-7#2)(2011-2#2)
neuroblastoma cells in bone marrow##2##5##(2011-2#2)
neuroblastoma cells in##3##3##(2010-6#1)(2011-2#2)
neuroblastoma cells induced by dimethyl sulfoxide and##2##7##(1993-3#2)
neuroblastoma cells with##2##3##(1994-10#1)(2008-8#1)
neuroblastoma cells##19##2##(1991-6#1)(1992-5#1)(1992-6#1)(1993-3#4)(1994-10#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-8#2)(2010-6#1)(2011-2#3)
neuroblastoma in children]##2##3##(2011-2#2)
neuroblastoma in##3##2##(2008-11#1)(2011-2#2)
neuroblastoma patients##3##2##(1994-5#1)(2011-2#2)
neuroblastoma##62##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-5#3)(1992-6#2)(1992-8#1)(1993-3#4)(1994-10#3)(1994-11#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-2#1)(1996-10#3)(1996-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#2)(2009-1#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#16)(2013-1#1)
neuroblastoma-specific##2##1##(1996-10#1)(2011-2#1)
neuroblastoma]##3##1##(1991-3#1)(2011-2#2)
neuroblastomas##10##1##(1990-2#1)(1990-8#2)(1994-10#3)(1995-12#2)(1996-10#2)
neuroblasts and##2##2##(2007-12#2)
neuroblasts##20##1##(1993-8#1)(2007-12#19)
neurochemical and##2##2##(1995-11#1)(2008-7#1)
neurochemical systems##2##2##(1991-5#1)(2008-2#1)
neurochemical transmission in the##2##4##(2008-7#2)
neurochemical##36##1##(1991-5#1)(1992-7#2)(1993-12#3)(1993-6#1)(1995-11#2)(1995-3#1)(1996-12#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#4)(2008-6#3)(2008-7#4)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
neurochemistry##2##1##(1990-5#1)(1995-6#1)
neurocognition##3##1##(2013-1#3)
neurocognitive deficits##2##2##(2008-2#1)(2009-10#1)
neurocognitive performance##2##2##(2009-10#2)
neurocognitive##20##1##(1996-3#1)(2008-11#1)(2008-2#2)(2009-10#5)(2010-1#2)(2011-1#4)(2011-2#2)(2013-1#3)
neurocysticercosis##3##1##(2008-7#1)(2009-7#1)(2011-2#1)
neurodeficit##2##1##(2009-5#1)(2012-2#1)
neurodegeneration and##2##2##(1996-5#1)(2008-6#1)
neurodegeneration in AD##3##3##(1995-12#1)(2008-7#2)
neurodegeneration in##7##2##(1990-5#1)(1992-9#1)(1995-12#1)(1996-5#1)(2008-7#2)(2010-12#1)
neurodegeneration of##2##2##(1992-12#1)(1995-5#1)
neurodegeneration##33##1##(1990-5#1)(1992-12#1)(1992-9#2)(1995-12#1)(1995-5#3)(1996-5#2)(2008-4#2)(2008-6#1)(2008-7#7)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-9#1)(2012-3#1)(2013-7#1)(2013-8#3)
neurodegenerative and##2##2##(2008-10#1)(2008-7#1)
neurodegenerative conditions##3##2##(2008-11#1)(2011-9#1)(2012-1#1)
neurodegenerative disease##8##2##(1994-5#1)(1997-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-7#1)
neurodegenerative diseases and##2##3##(2008-11#1)(2012-2#1)
neurodegenerative diseases such as Alzheimer's disease##2##6##(1994-9#1)(2008-11#1)
neurodegenerative diseases such as##3##4##(1994-9#1)(2008-11#1)(2008-4#1)
neurodegenerative diseases##31##2##(1990-5#1)(1991-12#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
neurodegenerative disorder characterized by##2##4##(2008-7#1)(2009-6#1)
neurodegenerative disorder##8##2##(1993-3#1)(2008-7#3)(2009-6#1)(2010-12#1)(2013-1#1)(2013-7#1)
neurodegenerative disorders of##2##3##(1994-11#1)(2009-5#1)
neurodegenerative disorders that are##2##4##(2008-7#1)(2009-8#1)
neurodegenerative disorders##18##2##(1993-12#1)(1994-11#3)(2008-11#1)(2008-12#1)(2008-7#6)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-1#1)(2012-2#1)
neurodegenerative processes##3##2##(1995-12#2)(2008-6#1)
neurodegenerative##81##1##(1990-5#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#2)(1994-11#3)(1994-5#1)(1994-9#1)(1995-12#3)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#14)(2008-8#5)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-2#2)(2011-9#2)(2012-1#3)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#1)
neurodevelopment##5##1##(2008-11#2)(2012-1#1)(2013-1#2)
neurodevelopmental disorder##4##2##(2008-11#1)(2011-2#1)(2012-3#2)
neurodevelopmental disorders##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
neurodevelopmental##18##1##(1995-11#1)(2008-11#4)(2008-6#3)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#1)
neurodynamic##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
neurodynamical##2##1##(2008-11#2)
neurodynamics##6##1##(2008-11#6)
neuroectoderm##4##1##(1997-7#1)(2007-12#1)(2008-4#1)(2008-8#1)
neuroectodermal tumor##6##2##(2007-12#1)(2007-7#1)(2009-1#3)(2011-1#1)
neuroectodermal tumours##2##2##(1994-10#1)(2008-7#1)
neuroectodermal##14##1##(1994-10#1)(2007-12#1)(2007-7#2)(2008-6#2)(2008-7#2)(2009-1#3)(2011-1#1)(2012-12#2)
neuroendocrine activity##2##2##(1996-12#1)(2008-5#1)
neuroendocrine and##2##2##(1992-11#1)(1997-7#1)
neuroendocrine carcinoma of the##5##4##(1991-6#1)(1993-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
neuroendocrine carcinoma of##6##3##(1991-6#1)(1993-6#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
neuroendocrine carcinoma##8##2##(1991-6#2)(1993-6#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
neuroendocrine cells and##2##3##(1992-11#1)(1995-2#1)
neuroendocrine cells##7##2##(1990-11#1)(1992-11#1)(1994-8#2)(1995-2#1)(2008-9#1)(2013-1#1)
neuroendocrine function##2##2##(1993-12#1)(2008-8#1)
neuroendocrine markers##2##2##(1992-2#1)(2008-11#1)
neuroendocrine neoplasms##3##2##(2011-2#2)(2012-3#1)
neuroendocrine regulation##2##2##(2011-2#1)(2012-2#1)
neuroendocrine responses##2##2##(1996-12#1)(2008-11#1)
neuroendocrine stress response##2##3##(1997-2#1)(2008-10#1)
neuroendocrine system##5##2##(1995-12#1)(2007-12#3)(2008-5#1)
neuroendocrine systems##2##2##(2008-2#2)
neuroendocrine tumor of the##2##4##(1993-6#1)(2007-10#1)
neuroendocrine tumor##13##2##(1993-6#1)(1997-1#6)(1997-7#1)(1997-8#1)(2007-10#2)(2012-3#1)(2013-8#1)
neuroendocrine tumors##20##2##(1993-12#1)(1997-1#2)(1997-8#1)(2008-3#2)(2010-9#3)(2011-2#7)(2012-3#1)(2013-1#3)
neuroendocrine tumors]##4##2##(2010-9#4)
neuroendocrine tumour of##2##3##(2008-12#1)(2013-1#1)
neuroendocrine tumours##4##2##(1992-11#4)
neuroendocrine##111##1##(1990-11#1)(1991-1#2)(1991-3#1)(1991-6#2)(1992-11#6)(1992-12#1)(1992-2#1)(1993-12#2)(1993-6#2)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#3)(1997-1#8)(1997-2#1)(1997-7#3)(1997-8#2)(2007-10#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-2#1)(2010-9#7)(2011-2#14)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#1)
neuroendocrine-immune##2##1##(1994-5#1)(2013-7#1)
neuroendocrine-thymus interaction in ageing##2##4##(2013-7#2)
neuroendocrine-thymus##3##1##(2013-7#3)
neuroendovascular##2##1##(1996-6#1)(2011-2#1)
neuroepithelial cell##2##2##(2008-8#2)
neuroepithelial##9##1##(1996-5#1)(2008-11#1)(2008-7#2)(2008-8#3)(2012-2#1)(2013-1#1)
neuroepithelium##6##1##(1991-2#1)(1995-3#1)(2008-11#1)(2012-12#3)
neuroethics as##2##2##(2012-2#1)(2013-1#1)
neuroethics##5##1##(2008-11#1)(2012-2#2)(2013-1#2)
neurofibrillary changes##3##2##(1996-5#3)
neurofibrillary tangles in##2##3##(1991-1#1)(2008-7#1)
neurofibrillary tangles##10##2##(1991-1#3)(1992-12#1)(1992-8#1)(2008-5#1)(2008-7#3)(2009-11#1)
neurofibrillary##15##1##(1991-1#3)(1992-12#1)(1992-8#1)(1996-5#4)(2008-5#1)(2008-7#4)(2009-11#1)
neurofibroma cells##3##2##(2008-8#3)
neurofibroma##9##1##(1992-9#3)(2008-10#1)(2008-8#4)(2011-2#1)
neurofibromas##5##1##(1992-9#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-8#1)
neurofibromatosis type 1 (NF1)##3##4##(1991-5#1)(1992-8#1)(2012-3#1)
neurofibromatosis type 1 and goblet cell##2##6##(2013-1#2)
neurofibromatosis type 1 gene##2##4##(1991-5#1)(1992-8#1)
neurofibromatosis type 1##15##3##(1991-5#2)(1992-8#2)(2007-8#1)(2008-6#1)(2009-1#2)(2011-1#2)(2012-3#1)(2013-1#4)
neurofibromatosis type##16##2##(1991-5#2)(1992-8#2)(2007-8#1)(2008-6#1)(2008-9#1)(2009-1#2)(2011-1#2)(2012-3#1)(2013-1#4)
neurofibromatosis##38##1##(1991-5#2)(1992-8#2)(1997-3#5)(2007-12#1)(2007-8#1)(2008-10#5)(2008-6#4)(2008-9#1)(2009-1#3)(2010-11#2)(2011-1#2)(2011-2#4)(2012-3#2)(2013-1#4)
neurofibromatosis]##3##1##(1991-3#1)(1997-3#1)(2008-10#1)
neurofibromin##7##1##(1994-12#6)(2008-7#1)
neurofilament light chain##2##3##(1996-12#1)(1996-5#1)
neurofilament phosphorylation##2##2##(1996-12#2)
neurofilament protein##4##2##(1996-12#3)(1996-5#1)
neurofilament proteins##3##2##(1991-5#1)(1995-12#1)(1996-12#1)
neurofilament##19##1##(1991-1#1)(1991-5#2)(1993-5#1)(1995-12#3)(1995-3#1)(1996-12#7)(1996-5#3)(1997-2#1)
neurofilaments##6##1##(1990-8#1)(1991-12#2)(1991-5#1)(1993-9#1)(1995-12#1)
neurofunctional performance##2##2##(2012-3#2)
neurofunctional##3##1##(2012-3#3)
neurogenesis and##5##2##(2007-12#1)(2008-7#2)(2008-8#1)(2008-9#1)
neurogenesis in the telencephalon of a lizard##2##7##(1996-5#2)
neurogenesis in the telencephalon of##3##5##(1996-5#3)
neurogenesis in the##7##3##(1993-3#1)(1996-5#3)(2007-12#3)
neurogenesis in##11##2##(1993-3#1)(1996-5#3)(2007-12#5)(2008-11#1)(2008-7#1)
neurogenesis to##2##2##(2007-12#1)(2008-7#1)
neurogenesis##37##1##(1993-12#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-5#6)(2007-12#7)(2008-11#3)(2008-7#7)(2008-8#2)(2008-9#2)(2010-4#1)(2012-2#3)(2013-7#1)
neurogenetic##2##1##(1993-5#1)(2007-8#1)
neurogenic bladder##4##2##(2008-10#1)(2008-7#3)
neurogenic claudication##2##2##(2007-8#1)(2009-3#1)
neurogenic genes##2##2##(2007-12#1)(2012-7#1)
neurogenic inflammation##2##2##(2008-9#1)(2009-2#1)
neurogenic##30##1##(1990-6#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-3#1)(2012-1#4)(2012-7#3)(2013-7#1)
neuroglial##2##1##(2010-12#1)(2013-1#1)
neurohemal sinus##2##2##(2007-12#1)(2008-6#1)
neurohormetic phytochemicals##2##2##(2008-7#2)
neurohormonal##8##1##(1992-8#1)(1996-6#2)(1997-7#1)(2008-3#2)(2008-7#1)(2010-3#1)
neurohormone##2##1##(1993-12#1)(2008-7#1)
neurohumoral##2##1##(2006-10#1)(2008-7#1)
neurohypophyseal diabetes insipidus##3##3##(1997-8#1)(2008-4#2)
neurohypophyseal##8##1##(1995-12#1)(1997-8#5)(2008-4#2)
neuroimaging and##7##2##(1995-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2012-12#1)(2013-8#2)
neuroimaging data##2##2##(2008-11#1)(2010-7#1)
neuroimaging findings##3##2##(2008-4#1)(2011-1#1)(2013-8#1)
neuroimaging has##2##2##(2007-8#1)(2011-2#1)
neuroimaging investigations##2##2##(2008-11#1)(2012-2#1)
neuroimaging of##4##2##(2007-10#1)(2008-11#1)(2009-9#1)(2010-9#1)
neuroimaging research##2##2##(2008-11#1)(2008-6#1)
neuroimaging studies of##2##3##(2008-11#1)(2012-1#1)
neuroimaging studies##9##2##(2008-11#3)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-1#2)
neuroimaging techniques##6##2##(1996-7#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)
neuroimaging##59##1##(1995-5#1)(1996-7#1)(2007-10#4)(2007-8#2)(2008-1#1)(2008-11#12)(2008-2#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
neuroimmunoendocrine##2##1##(2013-7#2)
neuroinflammation and##3##2##(2008-7#2)(2012-2#1)
neuroinflammation in##2##2##(2008-8#1)(2010-2#1)
neuroinflammation##9##1##(2008-7#2)(2008-8#3)(2010-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
neuroinflammatory##3##1##(2012-2#1)(2013-1#1)(2013-7#1)
neurointermediate lobe##2##2##(1992-12#1)(1993-5#1)
neurointermediate lobes of##2##3##(1992-12#1)(1993-5#1)
neurointermediate##5##1##(1992-12#2)(1993-5#3)
neuroinvasive Borrelia##3##2##(2012-2#3)
neuroinvasive##4##1##(2012-2#4)
neurokinin A##8##2##(1993-8#1)(1994-8#1)(1995-12#2)(1997-1#1)(1997-4#1)(2008-4#1)(2008-8#1)
neurokinin##11##1##(1993-8#1)(1994-8#3)(1995-12#2)(1997-1#1)(1997-4#1)(2008-4#1)(2008-7#1)(2008-8#1)
neurokinin-1##3##1##(2008-7#3)
neurolathyrism##2##1##(2008-7#2)
neuroleptic malignant syndrome and##2##4##(1990-9#1)(2009-11#1)
neuroleptic malignant syndrome##3##3##(1990-9#1)(2008-3#1)(2009-11#1)
neuroleptic##16##1##(1990-9#1)(1992-12#1)(1992-6#1)(1995-12#1)(1995-2#1)(1996-7#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#1)(2012-2#2)(2012-3#1)
neuroleptic-free##2##1##(1995-5#1)(2008-7#1)
neuroleptics on##2##2##(1995-2#1)(1996-7#1)
neuroleptics##14##1##(1993-9#1)(1995-12#3)(1995-2#2)(1995-8#2)(1996-7#1)(2008-10#1)(2008-9#3)(2012-3#1)
neurologic and psychiatric##2##3##(2008-2#1)(2008-8#1)
neurologic and##4##2##(2008-1#1)(2008-2#1)(2008-8#1)(2011-2#1)
neurologic complications##3##2##(1996-9#1)(2008-2#1)(2011-2#1)
neurologic damage##2##2##(2008-12#1)(2009-8#1)
neurologic deficit in##2##3##(1993-2#1)(2007-10#1)
neurologic deficit##5##2##(1992-12#1)(1993-2#1)(2007-10#2)(2008-7#1)
neurologic deficits as##2##3##(2008-3#1)(2011-2#1)
neurologic deficits##17##2##(1997-3#1)(2007-10#4)(2008-3#2)(2008-7#3)(2011-2#3)(2012-3#4)
neurologic disease##6##2##(1990-9#1)(1995-3#1)(2008-7#2)(2011-2#1)(2012-3#1)
neurologic diseases##6##2##(2007-10#1)(2007-7#1)(2008-7#1)(2012-3#3)
neurologic dysfunction##4##2##(1990-5#1)(1997-3#1)(2007-10#1)(2009-3#1)
neurologic examination##2##2##(2012-3#2)
neurologic function in his##2##4##(2008-6#2)
neurologic function##4##2##(1992-6#1)(2008-6#2)(2013-8#1)
neurologic motor function##3##3##(2008-7#3)
neurologic motor##5##2##(2008-7#5)
neurologic outcome##2##2##(2007-10#1)(2008-7#1)
neurologic problems -##2##3##(2007-11#2)
neurologic sequelae##3##2##(1997-3#1)(2006-10#1)(2007-10#1)
neurologic signs##2##2##(2008-7#1)(2010-6#1)
neurologic symptoms##2##2##(2008-7#1)(2009-3#1)
neurologic##88##1##(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-3#4)(2006-10#1)(2006-12#1)(2007-10#12)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#15)(2008-8#2)(2009-3#2)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-3#15)(2013-1#1)(2013-8#1)
neurological abnormalities##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2010-3#1)
neurological and psychiatric disorders##2##4##(2008-5#1)(2008-9#1)
neurological and##11##2##(1990-2#1)(1994-6#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
neurological complication##2##2##(2008-2#1)(2008-3#1)
neurological complications##9##2##(2006-10#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
neurological condition##4##2##(1996-9#1)(2008-11#1)(2008-7#1)(2011-2#1)
neurological conditions and##2##3##(1997-6#1)(2010-8#1)
neurological conditions##5##2##(1992-12#1)(1993-2#1)(1997-6#1)(2010-8#1)(2013-1#1)
neurological consequences##2##2##(2007-11#1)(2013-1#1)
neurological decompression sickness##2##3##(1991-6#2)
neurological defects##2##2##(2007-11#2)
neurological deficit and##2##3##(2007-10#1)(2011-2#1)
neurological deficit due to##4##4##(1996-8#1)(2007-11#1)(2008-12#1)(2013-1#1)
neurological deficit in##2##3##(2007-10#1)(2011-2#1)
neurological deficit was##3##3##(2008-7#1)(2011-2#2)
neurological deficit##33##2##(1992-6#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-6#2)(2007-10#4)(2007-11#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-7#3)(2011-2#8)(2012-12#1)(2013-1#1)
neurological deficits and##2##3##(1996-9#1)(2007-10#1)
neurological deficits in##2##3##(2008-7#1)(2011-2#1)
neurological deficits were##3##3##(1993-12#1)(1995-12#1)(2007-10#1)
neurological deficits##30##2##(1991-9#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-9#2)(2007-10#7)(2007-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#3)(2013-1#1)
neurological departments##2##2##(1997-8#2)
neurological deterioration with##2##3##(2007-10#2)
neurological deterioration##7##2##(1996-9#1)(2007-10#3)(2008-12#1)(2011-2#1)(2012-12#1)
neurological development##3##2##(2008-11#1)(2008-2#1)(2011-1#1)
neurological disability##2##2##(2011-7#1)(2012-2#1)
neurological disease and##2##3##(1996-11#1)(2013-1#1)
neurological disease in##2##3##(1990-11#1)(1991-8#1)
neurological disease##19##2##(1990-11#1)(1991-8#1)(1995-12#1)(1996-11#2)(2007-2#1)(2008-7#5)(2008-9#2)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
neurological diseases with##2##3##(1993-8#1)(2011-2#1)
neurological diseases##9##2##(1993-8#3)(1995-8#1)(1996-12#1)(2008-11#1)(2009-8#1)(2011-2#2)
neurological disorder##7##2##(1991-5#1)(1992-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)
neurological disorders are##2##3##(2008-4#1)(2009-11#1)
neurological disorders in##2##3##(1997-8#1)(2007-8#1)
neurological disorders##25##2##(1990-2#2)(1992-5#2)(1994-11#2)(1995-12#1)(1996-12#1)(1996-6#2)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#3)(2012-12#1)
neurological disturbances##2##2##(1997-3#1)(2011-1#1)
neurological dysfunction##3##2##(1996-3#2)(2010-4#1)
neurological emergency##2##2##(2006-7#1)(2012-2#1)
neurological events##3##2##(1997-5#1)(2007-8#1)(2008-7#1)
neurological examination##4##2##(2007-9#1)(2008-12#1)(2008-7#2)
neurological function##6##2##(1991-9#1)(1997-6#1)(2007-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
neurological impairment and##2##3##(2008-11#1)(2012-12#1)
neurological impairment##8##2##(1991-11#1)(1997-6#1)(2007-10#1)(2008-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
neurological improvement and##2##3##(2007-11#1)(2008-6#1)
neurological injury##2##2##(2007-8#1)(2012-2#1)
neurological lesions##2##2##(1991-11#1)(1992-5#1)
neurological manifestations##3##2##(2008-6#1)(2010-9#1)(2013-1#1)
neurological or##4##2##(1992-6#1)(1997-8#1)(2008-9#1)(2013-1#1)
neurological problems and##2##3##(2007-8#1)(2008-9#1)
neurological problems##3##2##(2007-8#1)(2008-9#1)(2010-12#1)
neurological recovery##4##2##(1997-6#1)(2012-12#1)(2012-2#2)
neurological signs##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
neurological state##2##2##(2007-11#1)(2008-7#1)
neurological status##5##2##(2007-11#2)(2013-1#3)
neurological surgery##2##2##(2008-7#1)(2011-2#1)
neurological symptoms and##3##3##(2007-11#1)(2008-7#2)
neurological symptoms were##3##3##(2008-7#2)(2011-2#1)
neurological symptoms##20##2##(1991-6#1)(1991-8#1)(1992-5#1)(1997-6#1)(2007-11#4)(2008-12#1)(2008-7#5)(2008-8#1)(2010-12#1)(2011-2#4)
neurological syndrome##2##2##(2008-7#1)(2013-1#1)
neurological syndromes##6##2##(1996-11#4)(2008-11#1)(2013-1#1)
neurological toxicity##2##2##(2008-7#2)
neurological##331##1##(1990-11#2)(1990-2#3)(1990-8#1)(1990-9#1)(1991-11#4)(1991-5#1)(1991-6#3)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#7)(1992-6#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#4)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-11#9)(1996-12#2)(1996-3#4)(1996-6#2)(1996-8#2)(1996-9#4)(1997-3#1)(1997-5#2)(1997-6#8)(1997-8#5)(2006-10#1)(2006-7#1)(2007-10#16)(2007-11#16)(2007-2#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-12#9)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#39)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#28)(2011-7#1)(2012-12#12)(2012-2#7)(2012-3#5)(2013-1#19)(2013-7#1)(2013-8#4)
neurologically intact and##2##3##(2009-3#1)(2011-2#1)
neurologically intact##5##2##(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#2)
neurologically normal and##2##3##(1997-2#1)(1997-6#1)
neurologically normal##5##2##(1995-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-5#1)
neurologically##19##1##(1993-12#1)(1995-11#1)(1995-12#1)(1996-3#2)(1997-2#1)(1997-6#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-3#1)
neurologique##2##1##(2013-1#2)
neurologist##6##1##(2007-9#2)(2010-12#2)(2010-5#1)(2011-1#1)
neurologists##16##1##(1994-11#1)(1996-8#1)(2006-7#1)(2007-10#6)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#2)(2011-2#1)
neurology clinic##4##2##(2008-8#2)(2010-12#2)
neurology services##2##2##(2010-12#2)
neurology##28##1##(1991-8#1)(1993-2#1)(2007-10#3)(2007-11#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-8#1)(2010-12#7)(2010-5#1)(2010-7#1)(2010-9#1)(2013-1#1)
neurolysis##5##1##(2008-8#1)(2008-9#2)(2013-1#2)
neuroma in##2##2##(2008-7#1)(2011-2#1)
neuroma is##2##2##(2007-11#1)(2009-3#1)
neuroma##23##1##(2007-11#3)(2008-10#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-3#4)(2011-2#4)(2012-2#1)
neuromas##4##1##(2006-12#2)(2007-12#1)(2008-9#1)
neuromediators##7##1##(2008-10#4)(2008-2#1)(2008-5#2)
neuromedin##4##1##(1994-8#1)(1996-2#2)(2008-9#1)
neuromere##5##1##(2007-12#5)
neurometabolic##3##1##(1994-6#3)
neuromodulation##7##1##(1993-12#1)(1997-3#1)(2009-10#1)(2011-1#4)
neuromodulator##9##1##(1993-12#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2013-8#1)
neuromodulators in##2##2##(2007-8#2)
neuromodulators##3##1##(2007-8#2)(2008-4#1)
neuromodulatory factors##2##2##(1991-12#2)
neuromodulatory interventions##2##2##(2009-10#2)
neuromodulatory##10##1##(1990-12#1)(1991-12#2)(1995-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#3)
neuromorphic##2##1##(2009-5#2)
neuromuscular blockade with##2##3##(1993-1#1)(2012-12#1)
neuromuscular blockade##7##2##(1993-1#2)(2010-7#3)(2012-12#2)
neuromuscular blocking agents##5##3##(1993-1#2)(2008-8#1)(2010-11#1)(2013-1#1)
neuromuscular control##4##2##(2007-11#3)(2013-1#1)
neuromuscular disease##7##2##(2007-10#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-11#1)(2013-1#1)
neuromuscular diseases##5##2##(2008-11#1)(2008-7#4)
neuromuscular disorders##12##2##(1993-9#1)(1994-3#1)(1994-8#1)(2007-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#2)
neuromuscular junction (NMJ)##4##3##(1990-5#1)(1992-8#1)(2009-11#1)(2009-8#1)
neuromuscular junction##17##2##(1990-5#1)(1992-8#2)(1993-5#1)(2008-4#2)(2008-7#2)(2009-11#2)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#4)
neuromuscular junctions##2##2##(1992-8#1)(2012-12#1)
neuromuscular or##2##2##(2008-12#1)(2011-1#1)
neuromuscular stimulation systems##3##3##(2010-8#3)
neuromuscular stimulation##5##2##(2010-8#3)(2013-1#2)
neuromuscular system##7##2##(1993-5#2)(2007-12#3)(2008-12#1)(2009-12#1)
neuromuscular transmission##4##2##(1997-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
neuromuscular##98##1##(1990-5#2)(1992-8#3)(1993-1#4)(1993-5#3)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#3)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#10)(2013-1#9)(2013-8#1)
neuromusculoskeletal##2##1##(2008-12#1)(2008-3#1)
neuromyelitis optica##6##2##(2010-12#1)(2011-1#2)(2012-3#2)(2013-8#1)
neuron and##5##2##(1997-7#2)(2007-12#1)(2008-3#1)(2009-9#1)
neuron are##2##2##(1997-3#1)(2007-12#1)
neuron based on##2##3##(2008-3#2)
neuron cell##3##2##(2008-10#1)(2008-7#2)
neuron in the##4##3##(2007-12#1)(2008-11#1)(2008-5#1)(2010-8#1)
neuron in##7##2##(1994-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
neuron loss is##2##3##(1991-9#1)(2013-7#1)
neuron model##3##2##(2007-8#1)(2008-3#2)
neuron models##4##2##(2008-11#4)
neuron population##2##2##(2007-12#1)(2008-8#1)
neuron responses were##2##3##(1992-11#2)
neuron specific enolase##4##3##(1990-2#3)(2012-2#1)
neuron specific##5##2##(1990-2#3)(2008-11#1)(2012-2#1)
neuron was##2##2##(1993-12#1)(1994-2#1)
neuron##123##1##(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#4)(1992-12#1)(1993-12#10)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#4)(1995-2#2)(1995-3#1)(1996-12#4)(1996-5#2)(1997-3#2)(1997-7#4)(2007-12#9)(2007-8#2)(2008-10#3)(2008-11#19)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-9#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
neuron-glia interactions##4##2##(1992-3#1)(2008-7#3)
neuron-glia##6##1##(1992-3#1)(2008-5#1)(2008-7#4)
neuron-glial communication##2##2##(2008-7#2)
neuron-glial interactions##3##2##(2008-7#2)(2009-3#1)
neuron-glial signaling##2##2##(2009-3#2)
neuron-glial##7##1##(2008-7#4)(2009-3#3)
neuron-like##3##1##(1992-12#1)(2012-7#2)
neuron-specific enolase (NSE)##2##3##(2011-2#2)
neuron-specific enolase##11##2##(1990-6#1)(1991-6#1)(1991-8#1)(1992-2#1)(1996-5#1)(2009-8#1)(2011-2#5)
neuron-specific##15##1##(1990-6#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-8#2)(1994-8#1)(1995-5#1)(1996-5#1)(2009-8#1)(2011-2#5)
neuronal NOS (nNOS)##2##3##(2008-8#1)(2009-10#1)
neuronal NOS##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)
neuronal activities of the##2##4##(1992-11#1)(2008-12#1)
neuronal activities##4##2##(1992-11#1)(1996-12#1)(2008-12#1)(2008-4#1)
neuronal activity and##3##3##(2008-5#1)(2008-7#1)(2009-5#1)
neuronal activity in##4##3##(1990-7#1)(2008-4#2)(2009-8#1)
neuronal activity##30##2##(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1993-12#1)(1995-12#2)(1995-5#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#2)
neuronal and glial cells##6##4##(1990-7#4)(2008-4#1)(2008-8#1)
neuronal and glial##10##3##(1990-7#5)(1991-6#1)(1994-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
neuronal and##23##2##(1990-7#5)(1991-1#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-1#1)(2013-1#2)
neuronal apoptosis and##2##3##(2013-1#2)
neuronal apoptosis##4##2##(2008-4#1)(2013-1#3)
neuronal cell adhesion##3##3##(1993-6#2)(2009-8#1)
neuronal cell bodies and##2##4##(1995-5#1)(2008-7#1)
neuronal cell bodies in the##2##5##(1995-12#1)(1995-6#1)
neuronal cell bodies in##3##4##(1995-12#2)(1995-6#1)
neuronal cell bodies##6##3##(1991-12#1)(1995-12#2)(1995-5#1)(1995-6#1)(2008-7#1)
neuronal cell death##11##3##(1995-12#1)(1995-5#2)(1996-12#1)(2008-2#1)(2008-4#1)(2008-7#4)(2009-12#1)
neuronal cell line##6##3##(1991-12#2)(2008-11#3)(2009-12#1)
neuronal cell loss##2##3##(1996-5#1)(2008-5#1)
neuronal cell##39##2##(1991-12#3)(1992-6#1)(1993-6#2)(1993-8#2)(1995-12#4)(1995-2#2)(1995-5#3)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#6)(2009-12#2)(2009-8#1)
neuronal cells and##2##3##(1992-12#1)(1993-6#1)
neuronal cells in##3##3##(1991-2#1)(1994-12#1)(1995-12#1)
neuronal cells##20##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-12#2)(1995-6#2)(1997-2#1)(2008-11#1)(2009-10#1)(2009-12#2)
neuronal circuitry##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
neuronal circuits##6##2##(1994-8#1)(1996-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)
neuronal contact##4##2##(2008-7#4)
neuronal cultures##11##2##(1994-8#1)(1995-12#1)(1995-5#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)
neuronal cytoskeleton##3##2##(1990-5#1)(1996-5#1)(1997-2#1)
neuronal damage caused by##2##4##(1990-7#1)(1995-5#1)
neuronal damage was##2##3##(2008-6#1)(2009-12#1)
neuronal damage##11##2##(1990-7#1)(1995-12#3)(1995-5#1)(1997-2#1)(2008-6#1)(2009-12#2)(2010-2#1)(2012-2#1)
neuronal death and##2##3##(2008-7#1)(2010-1#1)
neuronal death following cerebral ischaemia##2##5##(2008-7#2)
neuronal death following##4##3##(1990-7#1)(1996-12#1)(2008-7#2)
neuronal death in the##4##4##(1994-11#1)(1996-12#2)(2009-12#1)
neuronal death induced by##2##4##(1995-5#1)(2008-7#1)
neuronal death##23##2##(1990-7#3)(1994-11#1)(1995-5#1)(1996-12#3)(1996-6#1)(2008-5#1)(2008-6#2)(2008-7#9)(2009-12#1)(2010-1#1)
neuronal degeneration##4##2##(2008-4#1)(2008-7#1)(2011-2#2)
neuronal dendrites##4##2##(1996-6#1)(2008-10#1)(2008-4#2)
neuronal development##6##2##(1994-12#1)(1995-3#1)(1997-7#1)(2007-12#1)(2010-12#1)(2011-1#1)
neuronal differentiation and##2##3##(1992-5#1)(2009-10#1)
neuronal differentiation in##2##3##(1994-11#1)(2008-4#1)
neuronal differentiation of human##3##4##(2009-10#2)(2012-7#1)
neuronal differentiation of##5##3##(2008-10#1)(2009-10#3)(2012-7#1)
neuronal differentiation##21##2##(1991-8#1)(1992-5#3)(1994-11#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-4#2)(2009-10#5)(2010-11#1)(2012-12#1)(2012-2#1)(2012-7#1)
neuronal discharge rate##2##3##(1996-2#2)
neuronal discharges##2##2##(2009-8#2)
neuronal excitability and##2##3##(2008-7#1)(2008-8#1)
neuronal excitability##9##2##(1992-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
neuronal firing in##2##3##(1992-3#1)(1995-12#1)
neuronal firing##5##2##(1992-3#1)(1995-12#1)(1996-2#1)(2008-7#1)(2009-10#1)
neuronal function##6##2##(1995-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-7#2)
neuronal functions##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
neuronal genes##2##2##(2008-9#1)(2012-3#1)
neuronal glycoprotein##2##2##(1996-2#1)(2009-6#1)
neuronal growth##5##2##(1996-11#2)(2008-6#1)(2008-9#2)
neuronal injury##8##2##(1994-11#1)(1995-12#4)(1995-5#1)(2008-4#1)(2012-3#1)
neuronal ion channels via P2Y receptors##2##6##(2008-4#2)
neuronal labeling##4##2##(1991-12#3)(1997-2#1)
neuronal layers##2##2##(1996-12#2)
neuronal loss in the##2##4##(2008-7#1)(2013-1#1)
neuronal loss in##3##3##(2008-7#2)(2013-1#1)
neuronal loss is##2##3##(2008-7#2)
neuronal loss##11##2##(1991-5#1)(1995-5#1)(1997-2#1)(2008-7#7)(2013-1#1)
neuronal mechanisms##4##2##(2007-12#3)(2008-7#1)
neuronal migration and##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
neuronal migration##5##2##(1995-5#2)(2008-11#1)(2008-7#1)(2013-1#1)
neuronal morphology and##2##3##(2008-11#1)(2008-7#1)
neuronal network##5##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-9#1)
neuronal networks##9##2##(1990-5#1)(1995-12#1)(1996-2#1)(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
neuronal nicotinic acetylcholine receptors##4##4##(1995-11#3)(2009-6#1)
neuronal nicotinic acetylcholine##5##3##(1995-11#4)(2009-6#1)
neuronal nicotinic##6##2##(1995-11#4)(1996-12#1)(2009-6#1)
neuronal numbers##2##2##(2013-1#2)
neuronal or##2##2##(1994-11#1)(2008-3#1)
neuronal outgrowths##2##2##(2008-11#2)
neuronal pathways##2##2##(1996-12#1)(2007-12#1)
neuronal perikarya##3##2##(1990-5#1)(1991-12#1)(1993-9#1)
neuronal phenotype##2##2##(1994-10#1)(2012-2#1)
neuronal plasticity##2##2##(2008-7#2)
neuronal population##2##2##(1993-12#1)(2009-8#1)
neuronal populations##7##2##(1991-12#1)(1991-6#1)(1995-5#1)(2008-11#2)(2008-4#2)
neuronal processes##2##2##(1995-12#2)
neuronal properties and##2##3##(1992-6#1)(2008-11#1)
neuronal properties##6##2##(1992-6#2)(1997-6#1)(2008-11#1)(2008-7#1)(2009-8#1)
neuronal relay##2##2##(2010-11#2)
neuronal responses to##2##3##(1994-2#1)(1997-7#1)
neuronal responses##4##2##(1994-2#1)(1996-7#1)(1997-2#1)(1997-7#1)
neuronal somata##6##2##(1995-12#5)(2008-7#1)
neuronal storage diseases##2##3##(1996-5#2)
neuronal structures and##2##3##(1993-9#1)(2008-11#1)
neuronal support cells##2##3##(2007-12#1)(2008-7#1)
neuronal survival and##2##3##(2010-8#1)(2012-1#1)
neuronal survival in the##2##4##(2012-1#2)
neuronal survival in##3##3##(2012-1#3)
neuronal survival##8##2##(1993-3#1)(2008-7#2)(2010-8#1)(2012-1#4)
neuronal synapses##2##2##(2008-7#1)(2013-1#1)
neuronal synaptic##2##2##(1995-12#1)(1997-1#1)
neuronal system##2##2##(2008-1#1)(2012-2#1)
neuronal viability##2##2##(2008-7#2)
neuronal##506##1##(1990-5#4)(1990-7#14)(1991-1#2)(1991-12#11)(1991-2#1)(1991-5#2)(1991-6#5)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#3)(1992-6#4)(1993-11#1)(1993-12#7)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#7)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#6)(1995-12#30)(1995-2#3)(1995-3#2)(1995-5#18)(1995-6#4)(1995-8#3)(1996-11#2)(1996-12#12)(1996-2#5)(1996-5#9)(1996-6#4)(1996-7#1)(1997-1#1)(1997-2#12)(1997-3#2)(1997-6#4)(1997-7#3)(2007-10#2)(2007-12#9)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#29)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#26)(2008-5#9)(2008-6#6)(2008-7#73)(2008-8#9)(2008-9#5)(2009-10#9)(2009-12#7)(2009-3#2)(2009-5#3)(2009-6#3)(2009-8#16)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-9#1)(2012-1#4)(2012-12#1)(2012-2#12)(2012-3#2)(2012-7#2)(2013-1#14)(2013-8#3)
neuronal-glial##2##1##(2008-7#2)
neuronal-like##2##1##(2008-7#1)(2010-3#1)
neuronal-specific##2##1##(1994-2#2)
neuronally##2##1##(1993-1#1)(1996-12#1)
neuronatin##2##1##(1994-6#2)
neurone and##2##2##(1994-11#1)(2008-1#1)
neurone loss in##2##3##(1995-5#1)(1996-5#1)
neurone loss##5##2##(1995-5#3)(1996-5#2)
neurone##20##1##(1991-5#1)(1994-11#1)(1994-2#1)(1995-12#3)(1995-5#3)(1995-8#1)(1996-5#4)(2008-1#2)(2008-11#1)(2011-2#3)
neurone-specific enolase##2##2##(1992-11#2)
neurones and##3##2##(1993-12#1)(2008-11#2)
neurones but##2##2##(1996-5#2)
neurones in rat##2##3##(1995-12#1)(1996-2#1)
neurones in the##5##3##(1992-8#1)(1993-9#1)(1994-2#2)(1997-3#1)
neurones in##11##2##(1992-8#1)(1993-9#1)(1994-2#2)(1995-12#2)(1995-5#2)(1996-2#2)(1997-3#1)
neurones of##2##2##(1995-12#1)(1995-5#1)
neurones to##4##2##(1992-8#1)(1995-12#1)(1996-5#1)(1997-3#1)
neurones was##2##2##(1996-5#2)
neurones were##7##2##(1993-12#2)(1994-2#3)(1995-12#1)(1996-5#1)
neurones whose activity differed when##2##5##(1995-5#2)
neurones##84##1##(1991-5#1)(1992-10#1)(1992-8#6)(1993-12#5)(1993-9#7)(1994-2#10)(1995-12#14)(1995-5#10)(1995-8#1)(1996-2#3)(1996-5#18)(1997-3#5)(2008-11#3)
neurons after##2##2##(1990-5#1)(1991-12#1)
neurons against glutamate##2##3##(2008-7#1)(2009-12#1)
neurons against##4##2##(1995-12#2)(2008-7#1)(2009-12#1)
neurons also express##2##3##(2008-4#1)(2008-7#1)
neurons also##4##2##(1992-3#1)(2008-4#1)(2008-7#2)
neurons and astrocytes##7##3##(1994-2#1)(2008-7#5)(2009-3#1)
neurons and can##2##3##(2008-2#1)(2008-8#1)
neurons and glia##5##3##(1995-12#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
neurons and glial cells are##2##5##(2008-11#1)(2008-7#1)
neurons and glial cells##8##4##(1990-11#1)(1993-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)
neurons and neuronal##2##3##(2008-11#1)(2013-1#1)
neurons and oligodendrocytes##2##3##(2008-11#2)
neurons and the##2##3##(1996-2#1)(2009-3#1)
neurons and their##3##3##(1997-6#1)(2008-4#1)(2009-8#1)
neurons and##72##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-3#1)(1993-12#3)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-2#2)(1997-2#2)(1997-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#12)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-8#4)(2012-3#1)(2013-1#1)(2013-7#1)
neurons are not##2##3##(1994-2#1)(2013-7#1)
neurons are##25##2##(1990-11#1)(1990-7#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-2#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-2#1)(2010-11#1)(2011-9#1)(2012-2#2)(2013-7#1)(2013-8#2)
neurons arising##2##2##(2007-12#2)
neurons as well as##2##4##(1990-5#1)(2008-4#1)
neurons as##7##2##(1990-5#1)(1997-3#1)(2007-12#1)(2008-4#2)(2008-8#1)(2013-1#1)
neurons at##5##2##(1991-12#1)(1995-11#1)(1996-12#2)(2009-12#1)
neurons but not##2##3##(1995-5#1)(1996-5#1)
neurons but##5##2##(1995-5#1)(1996-5#1)(2007-12#1)(2008-7#1)(2009-8#1)
neurons by means##2##3##(2008-8#2)
neurons by##12##2##(1991-12#1)(1992-11#1)(1992-6#1)(1992-7#1)(1995-2#1)(1996-12#2)(2008-4#1)(2008-8#2)(2009-8#1)(2013-1#1)
neurons can be##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
neurons can##7##2##(1992-3#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-8#1)
neurons containing##3##2##(1995-12#1)(1996-12#1)(1996-5#1)
neurons derived from##2##3##(2008-7#1)(2011-2#1)
neurons displaying##2##2##(1995-8#1)(2008-7#1)
neurons during##4##2##(1994-2#1)(1996-5#2)(2012-2#1)
neurons exhibit##3##2##(1990-7#1)(1996-2#1)(2008-11#1)
neurons express a##2##3##(1991-5#1)(2008-7#1)
neurons express multiple sodium channel##2##5##(1996-12#2)
neurons express##8##2##(1991-5#1)(1996-12#4)(2008-11#2)(2008-7#1)
neurons expressing##6##2##(1996-12#2)(1997-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
neurons following##2##2##(1996-12#1)(2008-7#1)
neurons for##2##2##(1997-2#1)(2008-11#1)
neurons from ischemic damage##2##4##(2008-11#2)
neurons from ischemic##3##3##(2008-11#2)(2009-12#1)
neurons from the##2##3##(1990-7#1)(2013-8#1)
neurons from##16##2##(1990-7#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-11#4)(2008-4#1)(2008-7#3)(2009-12#1)(2009-5#1)(2012-2#1)(2013-8#1)
neurons had been##2##3##(1997-3#1)(2008-5#1)
neurons had##3##2##(1994-2#1)(1997-3#1)(2008-5#1)
neurons have been##2##3##(2008-11#1)(2008-7#1)
neurons have##6##2##(2007-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
neurons in a##3##3##(1992-6#1)(2007-12#1)(2008-11#1)
neurons in all##2##3##(1996-6#1)(1997-7#1)
neurons in cortex##2##3##(2008-4#1)(2008-8#1)
neurons in culture##3##3##(1995-12#2)(1997-3#1)
neurons in dissociated##2##3##(1996-12#1)(1997-6#1)
neurons in peripheral##2##3##(2008-6#1)(2011-2#1)
neurons in primary##2##3##(1996-5#1)(2008-7#1)
neurons in the CNS##3##4##(1991-12#2)(2008-8#1)
neurons in the brain of##2##5##(1996-2#1)(1997-3#1)
neurons in the brain##4##4##(1993-12#1)(1996-2#1)(1997-3#1)(2009-5#1)
neurons in the central nervous system##3##6##(1993-3#1)(1996-12#1)(1997-6#1)
neurons in the central##4##4##(1990-5#1)(1993-3#1)(1996-12#1)(1997-6#1)
neurons in the cerebral cortex##2##5##(1997-2#2)
neurons in the dorsal##3##4##(1993-12#1)(1994-2#1)(1997-6#1)
neurons in the hidden layer and##2##6##(2008-10#1)(2010-8#1)
neurons in the hidden layer##3##5##(2008-10#2)(2010-8#1)
neurons in the pePOA##2##4##(1992-3#2)
neurons in the preoptic area##2##5##(1992-3#1)(2008-8#1)
neurons in the presence of##2##5##(1992-3#1)(1997-7#1)
neurons in the raphe nuclei##2##5##(2008-7#2)
neurons in the rat##3##4##(1996-2#1)(2008-4#1)(2009-10#1)
neurons in the substantia nigra##4##5##(1995-3#1)(2008-7#3)
neurons in the trigeminal nucleus caudalis##2##6##(1997-2#1)(2008-9#1)
neurons in the##88##3##(1990-5#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-3#5)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#5)(1994-8#1)(1995-12#4)(1995-3#2)(1995-5#1)(1996-12#4)(1996-2#3)(1996-5#2)(1997-2#6)(1997-3#3)(1997-6#2)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#4)(2009-5#2)(2010-8#2)(2012-2#2)(2013-7#1)(2013-8#1)
neurons in vitro##4##3##(1993-5#1)(1996-12#1)(1996-2#1)(2008-11#1)
neurons in vivo##5##3##(1993-12#1)(2008-11#1)(2008-4#1)(2009-12#2)
neurons in##145##2##(1990-5#4)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#5)(1992-6#1)(1993-12#5)(1993-3#1)(1993-5#2)(1993-6#1)(1994-2#5)(1994-8#2)(1995-12#7)(1995-3#2)(1995-5#1)(1996-12#8)(1996-2#4)(1996-5#4)(1996-6#1)(1997-2#8)(1997-3#4)(1997-6#3)(1997-7#2)(2007-12#9)(2008-1#1)(2008-10#2)(2008-11#6)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#13)(2008-8#9)(2008-9#2)(2009-10#4)(2009-12#2)(2009-5#2)(2010-8#2)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
neurons induced by##3##3##(1992-12#1)(1997-3#1)(2008-11#1)
neurons is##11##2##(1990-5#1)(1991-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2013-1#1)
neurons may##3##2##(1991-2#1)(2008-11#1)(2008-7#1)
neurons migrate##2##2##(1995-12#2)
neurons near##3##2##(2008-11#1)(2012-2#2)
neurons of cold-exposed##2##3##(2008-7#2)
neurons of rat##3##3##(1990-5#1)(1992-12#2)
neurons of rats##2##3##(1994-2#1)(2008-10#1)
neurons of the central##2##4##(2008-4#2)
neurons of the olfactory bulb##2##5##(2009-12#2)
neurons of the##37##3##(1991-12#1)(1991-7#1)(1992-3#2)(1992-8#2)(1993-12#3)(1994-3#1)(1994-8#2)(1995-12#2)(1995-3#2)(1996-12#6)(1997-4#1)(1997-7#1)(2007-12#3)(2008-11#1)(2008-4#2)(2008-7#4)(2009-12#2)(2013-8#1)
neurons of##55##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#2)(1992-8#2)(1993-12#3)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#2)(1995-3#2)(1996-12#6)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#8)(2009-12#2)(2009-8#1)(2010-12#1)(2013-8#1)
neurons on##4##2##(1997-3#3)(2007-12#1)
neurons or in##2##3##(1997-3#1)(2008-4#1)
neurons or##6##2##(1994-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-4#1)
neurons plated##2##2##(1997-3#2)
neurons projected to the##2##4##(1993-12#2)
neurons projected to##3##3##(1993-12#3)
neurons projecting to##2##3##(1996-5#2)
neurons receive##2##2##(2008-11#1)(2013-8#1)
neurons remains##2##2##(1994-5#1)(1996-12#1)
neurons represent##3##2##(1991-6#2)(1996-5#1)
neurons responded to##3##3##(1993-12#1)(1993-6#1)(2008-11#1)
neurons responded##4##2##(1992-11#1)(1993-12#1)(1993-6#1)(2008-11#1)
neurons show##3##2##(1994-2#1)(1997-7#1)(2009-10#1)
neurons showed##2##2##(1993-12#1)(1994-2#1)
neurons take##2##2##(1995-12#2)
neurons tested##3##2##(1992-11#1)(1993-12#1)(1997-7#1)
neurons than in##4##3##(1996-12#2)(2008-1#1)(2008-7#1)
neurons than##6##2##(1994-3#1)(1996-12#3)(2008-1#1)(2008-7#1)
neurons that##17##2##(1991-2#1)(1991-5#1)(1993-12#2)(1995-12#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#1)
neurons to noxious##2##3##(1997-2#1)(2008-7#1)
neurons to optic flow##2##4##(2008-9#2)
neurons to the##2##3##(2008-11#1)(2008-7#1)
neurons to##20##2##(1990-5#1)(1992-11#1)(1993-12#1)(1995-12#1)(1996-2#2)(1997-2#2)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2011-2#1)
neurons using##3##2##(1997-6#1)(2008-8#2)
neurons varied##2##2##(1993-12#1)(2008-8#1)
neurons was observed for##2##4##(1991-12#2)
neurons was significantly##2##3##(1997-2#1)(2009-10#1)
neurons was##13##2##(1991-12#2)(1993-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#3)(1997-7#1)(2009-10#1)(2009-12#1)(2012-3#1)
neurons were also##2##3##(1994-2#1)(1997-2#1)
neurons were detected in##2##4##(1996-5#1)(1997-2#1)
neurons were distributed in the##2##5##(1996-12#1)(2013-8#1)
neurons were found in the##2##5##(1995-12#1)(1997-3#1)
neurons were inhibited by electrical stimulation of the hepatic branch of the vagus nerve##2##14##(1993-12#2)
neurons were inhibited##3##3##(1993-12#2)(2009-10#1)
neurons were labeled##2##3##(1996-5#1)(1997-3#1)
neurons were located in the##2##5##(1993-12#1)(1994-2#1)
neurons were observed##2##3##(1992-8#1)(1997-2#1)
neurons were recorded##2##3##(1993-6#1)(2009-5#1)
neurons were##38##2##(1992-3#1)(1992-8#1)(1993-12#8)(1993-6#1)(1994-2#3)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#4)(1997-2#6)(1997-3#2)(2008-10#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
neurons which##4##2##(1991-6#1)(1993-6#1)(1997-2#1)(2007-12#1)
neurons whose##3##2##(1991-6#1)(1995-3#1)(2007-12#1)
neurons with a##2##3##(1997-3#1)(2008-11#1)
neurons with similar##2##3##(2009-12#1)(2009-5#1)
neurons with##15##2##(1993-12#1)(1993-6#1)(1996-12#1)(1997-3#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
neurons within the##4##3##(1991-7#1)(1993-12#1)(1996-5#1)(2007-12#1)
neurons##989##1##(1990-11#3)(1990-12#1)(1990-5#12)(1990-7#13)(1990-8#1)(1991-12#22)(1991-2#8)(1991-5#6)(1991-6#8)(1991-7#2)(1991-9#1)(1992-11#7)(1992-12#9)(1992-3#17)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#1)(1993-12#46)(1993-3#2)(1993-5#5)(1993-6#6)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#26)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#6)(1995-11#5)(1995-12#32)(1995-2#6)(1995-3#11)(1995-5#9)(1995-6#1)(1995-8#9)(1996-12#61)(1996-2#16)(1996-5#35)(1996-6#3)(1997-2#30)(1997-3#23)(1997-4#1)(1997-6#5)(1997-7#12)(2007-10#4)(2007-12#47)(2007-8#5)(2008-1#6)(2008-10#9)(2008-11#65)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#38)(2008-5#12)(2008-6#4)(2008-7#103)(2008-8#39)(2008-9#9)(2009-10#20)(2009-12#20)(2009-2#1)(2009-3#9)(2009-5#9)(2009-8#28)(2009-9#1)(2010-11#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-9#1)(2012-12#3)(2012-2#18)(2012-3#3)(2013-1#12)(2013-7#4)(2013-8#18)
neurons)##5##1##(1993-12#2)(1993-6#1)(1997-2#1)(2013-8#1)
neurons?##2##1##(2008-7#2)
neurons]##2##1##(2010-12#2)
neurootological##2##1##(2011-2#2)
neuropathic pain in##6##3##(2008-4#3)(2008-7#1)(2008-9#2)
neuropathic pain model##2##3##(2008-7#1)(2008-9#1)
neuropathic pain syndromes##2##3##(2008-12#1)(2009-12#1)
neuropathic pain with##3##3##(1997-3#1)(2008-12#1)(2008-9#1)
neuropathic pain##61##2##(1996-5#2)(1997-3#2)(2006-12#4)(2007-7#1)(2008-12#5)(2008-4#8)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#18)(2009-12#3)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-3#1)
neuropathic##78##1##(1990-9#1)(1991-11#1)(1993-12#1)(1993-9#2)(1996-5#3)(1997-3#2)(2006-12#4)(2007-7#1)(2008-10#2)(2008-12#5)(2008-4#8)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#20)(2009-12#4)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
neuropathies and##2##2##(2008-1#1)(2010-1#1)
neuropathies are##2##2##(2008-1#1)(2008-7#1)
neuropathies such as##2##3##(2008-7#2)
neuropathies##23##1##(1993-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#10)(2008-8#1)(2010-1#1)(2012-12#1)(2012-3#2)
neuropathologic##8##1##(1991-1#2)(1996-5#2)(2008-4#1)(2008-7#3)
neuropathological examination##3##2##(2008-7#2)(2008-9#1)
neuropathological studies of##2##3##(2008-6#1)(2008-7#1)
neuropathological##13##1##(1995-12#1)(1996-11#1)(1997-2#1)(2008-12#1)(2008-6#1)(2008-7#5)(2008-9#1)(2013-1#1)(2013-8#1)
neuropathology in##4##2##(1996-5#1)(2007-8#1)(2008-7#2)
neuropathology of##3##2##(1996-2#1)(2008-7#1)(2009-10#1)
neuropathology##13##1##(1994-5#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-2#1)(2008-7#3)(2009-10#1)(2009-12#1)(2013-1#1)
neuropathy (SFN) is##2##3##(2013-1#2)
neuropathy and the##2##3##(1992-9#1)(2008-8#1)
neuropathy and##18##2##(1991-12#1)(1992-9#2)(2007-7#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-2#1)(2012-2#3)
neuropathy are##3##2##(2008-1#1)(2012-2#1)(2012-3#1)
neuropathy associated with##5##3##(2008-2#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#1)
neuropathy have been##2##3##(2008-1#1)(2012-2#1)
neuropathy in the##2##3##(2008-12#1)(2008-8#1)
neuropathy in##12##2##(2008-11#2)(2008-12#1)(2008-7#5)(2008-8#1)(2011-1#1)(2012-2#2)
neuropathy induced by##2##3##(2008-7#2)
neuropathy is a##2##3##(2008-4#1)(2011-2#1)
neuropathy of##3##2##(2008-9#1)(2013-1#2)
neuropathy should##2##2##(2008-1#1)(2009-3#1)
neuropathy was found in##2##4##(2012-2#2)
neuropathy was##5##2##(1990-9#1)(2008-8#1)(2012-2#3)
neuropathy with##3##2##(1997-3#1)(2008-7#1)(2013-1#1)
neuropathy##155##1##(1990-2#1)(1990-9#5)(1991-11#1)(1991-12#4)(1992-9#3)(1993-12#1)(1994-11#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-3#2)(2007-10#1)(2007-5#2)(2007-7#3)(2008-1#11)(2008-10#1)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#25)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#16)(2012-3#5)(2013-1#10)(2013-8#3)
neuropathy) and##2##2##(2008-9#2)
neuropathy)##3##1##(2008-9#3)
neuropeptide Y (NPY)##7##3##(1992-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-8#1)
neuropeptide Y Y1 receptor##3##4##(1995-12#3)
neuropeptide Y Y1##5##3##(1995-12#5)
neuropeptide Y Y2 receptor##2##4##(1995-12#2)
neuropeptide Y and##3##3##(1995-12#1)(1997-2#1)(2012-3#1)
neuropeptide Y receptor subtypes##2##4##(1995-12#2)
neuropeptide Y with##3##3##(1995-11#1)(1995-12#1)(1995-3#1)
neuropeptide Y##39##2##(1990-5#1)(1992-12#2)(1993-5#1)(1994-8#1)(1995-11#1)(1995-12#21)(1995-3#2)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#2)(2008-4#1)(2008-8#1)(2009-8#1)(2012-3#1)
neuropeptide Y-(13-36)##2##2##(1995-12#2)
neuropeptide galanin##2##2##(1993-3#1)(1994-8#1)
neuropeptide prothoracicotropic##2##2##(1995-11#2)
neuropeptide with##2##2##(1990-7#1)(1991-1#1)
neuropeptide##80##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-1#2)(1991-2#1)(1992-12#3)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#5)(1995-11#3)(1995-12#25)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#3)(2007-12#2)(2007-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-7#1)
neuropeptidergic##2##1##(2013-8#2)
neuropeptides and##3##2##(2008-4#1)(2008-5#1)(2009-12#1)
neuropeptides in the##2##3##(2008-7#1)(2013-8#1)
neuropeptides in##5##2##(1997-4#1)(2008-7#1)(2008-9#1)(2013-8#2)
neuropeptides on##3##2##(1995-11#1)(2008-10#1)(2008-4#1)
neuropeptides were##2##2##(1994-2#1)(2013-8#1)
neuropeptides##39##1##(1991-12#1)(1992-6#2)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#4)(1996-12#1)(1996-2#1)(1997-4#1)(2007-2#4)(2008-10#1)(2008-4#8)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#5)
neuropharmacological##4##1##(1993-12#1)(2008-4#1)(2009-7#2)
neuropharmacology##3##1##(1990-3#1)(1996-12#1)(2008-7#1)
neurophysiologic##3##1##(2008-4#1)(2010-7#1)(2011-2#1)
neurophysiological##12##1##(1991-1#1)(1994-8#1)(1995-12#1)(1995-8#1)(2007-8#3)(2008-9#3)(2010-1#1)(2013-8#1)
neurophysiology##5##1##(1995-12#1)(1996-12#1)(2007-12#1)(2007-8#1)(2010-6#1)
neuropil in##4##2##(1997-3#1)(2007-12#2)(2008-7#1)
neuropil of##3##2##(1997-3#1)(2007-12#1)(2013-8#1)
neuropil##27##1##(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#9)(2007-12#11)(2008-7#3)(2013-8#1)
neuropile of the##2##3##(2007-12#1)(2008-5#1)
neuropils in##4##2##(2007-12#4)
neuropils##7##1##(2007-12#7)
neuroprostheses##3##1##(2008-11#1)(2012-12#1)(2013-1#1)
neuroprosthesis##3##1##(2007-10#1)(2013-1#2)
neuroprosthetic##2##1##(2009-5#1)(2010-10#1)
neuroprotection against glutamate##2##3##(2008-7#2)
neuroprotection against##3##2##(1995-12#1)(2008-7#2)
neuroprotection and##2##2##(2008-7#1)(2013-7#1)
neuroprotection in##4##2##(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
neuroprotection##22##1##(1995-12#2)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
neuroprotective action##3##2##(2008-11#2)(2013-1#1)
neuroprotective activity against##3##3##(2008-11#1)(2013-8#2)
neuroprotective activity##5##2##(2008-11#1)(2008-7#1)(2013-8#3)
neuroprotective agents##6##2##(2007-10#1)(2007-9#2)(2008-7#2)(2013-1#1)
neuroprotective drugs##2##2##(2007-10#1)(2008-8#1)
neuroprotective effect of##5##3##(2008-4#1)(2008-7#1)(2009-12#2)(2012-2#1)
neuroprotective effect##9##2##(1994-11#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#2)(2012-12#1)(2012-2#1)
neuroprotective effects of##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
neuroprotective effects##7##2##(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
neuroprotective processes##2##2##(2008-7#1)(2011-9#1)
neuroprotective role of##3##3##(2008-2#1)(2010-2#1)(2013-7#1)
neuroprotective strategy##2##2##(2008-4#2)
neuroprotective therapies have been##2##4##(2008-2#1)(2008-7#1)
neuroprotective therapy##3##2##(2008-7#1)(2008-8#2)
neuroprotective##56##1##(1994-11#1)(1995-12#1)(2006-10#1)(2007-10#2)(2007-8#1)(2007-9#3)(2008-11#7)(2008-12#1)(2008-2#2)(2008-4#3)(2008-7#12)(2008-8#3)(2009-12#2)(2010-2#1)(2011-2#2)(2011-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
neuropsychiatric complications##2##2##(2010-12#1)(2012-2#1)
neuropsychiatric conditions##2##2##(1990-2#1)(2008-12#1)
neuropsychiatric disease##3##2##(2008-4#2)(2012-12#1)
neuropsychiatric diseases##2##2##(2008-8#1)(2011-1#1)
neuropsychiatric disorders##8##2##(1997-5#1)(2008-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
neuropsychiatric functioning##2##2##(2008-2#2)
neuropsychiatric manifestations##3##2##(1993-11#1)(2008-8#1)(2012-3#1)
neuropsychiatric sequelae##2##2##(1991-9#1)(2008-2#1)
neuropsychiatric##36##1##(1990-2#1)(1991-9#1)(1993-11#1)(1997-5#1)(2008-1#1)(2008-12#3)(2008-2#3)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
neuropsychiatry##6##1##(1996-11#3)(2008-1#1)(2008-6#1)(2009-10#1)
neuropsychological and##4##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-9#1)
neuropsychological assessment and##2##3##(2009-10#1)(2013-8#1)
neuropsychological assessment showed##2##3##(2008-6#1)(2009-6#1)
neuropsychological assessment##7##2##(1990-2#1)(2008-6#2)(2009-10#1)(2009-6#1)(2013-8#2)
neuropsychological data##2##2##(1996-2#1)(2008-10#1)
neuropsychological deficits##4##2##(1992-6#1)(2007-10#1)(2010-12#1)(2013-8#1)
neuropsychological disorders of##2##3##(1991-2#1)(1995-12#1)
neuropsychological functioning##3##2##(2008-7#3)
neuropsychological impairment##4##2##(1991-1#1)(2007-10#1)(2008-2#1)(2008-9#1)
neuropsychological measures##2##2##(1996-7#1)(2009-10#1)
neuropsychological sequelae##2##2##(1994-5#1)(1994-6#1)
neuropsychological studies##2##2##(1996-7#1)(2007-8#1)
neuropsychological test performance##2##3##(1996-7#1)(2008-7#1)
neuropsychological test##4##2##(1996-11#1)(1996-7#1)(2008-7#1)(2010-1#1)
neuropsychological testing##2##2##(2010-1#1)(2011-2#1)
neuropsychological tests##5##2##(2008-11#1)(2008-2#1)(2008-7#2)(2012-1#1)
neuropsychological##67##1##(1990-2#4)(1991-1#1)(1991-2#1)(1992-6#1)(1994-5#2)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-7#3)(1997-2#1)(2007-10#2)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#4)(2008-6#4)(2008-7#8)(2008-9#3)(2009-10#3)(2009-6#1)(2010-1#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#3)
neuropsychology and##2##2##(1996-11#1)(2008-2#1)
neuropsychology##5##1##(1990-2#1)(1996-11#3)(2008-2#1)
neuroradiological and##2##2##(2008-7#2)
neuroradiological findings##2##2##(2008-7#2)
neuroradiological##7##1##(2008-7#5)(2009-10#1)(2013-1#1)
neuroradiologists##3##1##(1995-11#1)(1996-3#1)(2009-2#1)
neuroradiology##6##1##(1991-3#2)(1997-6#2)(2008-7#1)(2011-2#1)
neuroreceptor imaging##3##2##(2011-1#3)
neuroreceptor##4##1##(2008-7#1)(2011-1#3)
neuroreceptors##4##1##(1991-12#2)(1993-3#1)(1993-9#1)
neurorehabilitation##4##1##(2007-11#1)(2013-1#2)(2013-7#1)
neurorepair##3##1##(2013-7#3)
neurosarcoidosis##4##1##(2008-7#1)(2012-3#3)
neuroscience has##2##2##(2008-11#1)(2011-2#1)
neuroscience is to##2##3##(2007-8#1)(2008-11#1)
neuroscience is##5##2##(2007-8#1)(2008-11#3)(2009-8#1)
neuroscience of##2##2##(2012-1#1)(2013-1#1)
neuroscience research##4##2##(2008-4#4)
neuroscience##38##1##(1995-2#1)(1997-6#1)(2007-10#2)(2007-8#2)(2008-11#6)(2008-4#6)(2008-6#1)(2008-9#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
neurosciences that##3##2##(2008-4#1)(2009-5#1)(2010-12#1)
neurosciences##9##1##(1992-12#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-10#1)(2009-5#1)(2010-12#1)(2012-3#1)
neuroscientific##2##1##(2008-11#1)(2011-2#1)
neuroscientists##3##1##(2008-11#1)(2010-7#1)(2012-2#1)
neurosecretory cells of##3##3##(1991-12#1)(2008-5#1)(2008-6#1)
neurosecretory cells which##3##3##(1995-11#1)(2008-5#2)
neurosecretory cells##11##2##(1990-5#1)(1991-12#1)(1993-12#1)(1995-11#2)(2008-5#5)(2008-6#1)
neurosecretory##16##1##(1990-5#3)(1991-12#1)(1993-12#1)(1995-11#2)(2007-12#1)(2008-5#5)(2008-6#1)(2008-7#2)
neuroselective effects of tourniquet##2##4##(2006-12#2)
neurosis##2##1##(1991-6#1)(2008-4#1)
neurospheres##2##1##(2009-10#2)
neurostatin##2##1##(2008-7#2)
neurostimulation##2##1##(2010-7#1)(2013-1#1)
neurostimulator##2##1##(2011-1#2)
neurosurgeon##2##1##(2007-12#1)(2008-9#1)
neurosurgeons and##2##2##(1996-3#1)(2013-1#1)
neurosurgeons##8##1##(1996-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#2)(2013-1#2)
neurosurgery in the##2##3##(2009-9#1)(2011-2#1)
neurosurgery is##2##2##(2007-12#1)(2009-9#1)
neurosurgery##31##1##(1991-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
neurosurgical emergency##2##2##(1995-5#1)(2013-1#1)
neurosurgical patients##2##2##(2008-11#1)(2010-7#1)
neurosurgical procedures are##2##3##(2009-9#1)(2011-1#1)
neurosurgical procedures##5##2##(2009-9#1)(2011-1#3)(2012-1#1)
neurosurgical##32##1##(1990-9#1)(1995-5#1)(1996-11#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#5)(2009-9#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)
neurosyphilis##6##1##(1997-5#1)(2010-3#3)(2012-12#2)
neurotensin (NT)##2##2##(1994-3#1)(1996-2#1)
neurotensin receptor##6##2##(1997-2#5)(2008-4#1)
neurotensin receptors##2##2##(1991-1#1)(1997-2#1)
neurotensin##22##1##(1991-1#1)(1991-5#1)(1994-3#1)(1994-8#1)(1995-2#2)(1996-2#2)(1997-2#8)(1997-7#4)(2008-4#2)
neurotensin-like immunoreactivity levels##2##3##(1997-7#2)
neurotensin-like immunoreactivity##7##2##(1997-7#7)
neuroticism may##2##2##(2008-6#2)
neuroticism##16##1##(2007-12#2)(2008-11#7)(2008-6#6)(2009-8#1)
neurotomy##3##1##(1994-3#3)
neurotoxic action of##2##3##(1995-5#1)(2008-7#1)
neurotoxic action##3##2##(1990-5#1)(1995-5#1)(2008-7#1)
neurotoxic and##2##2##(1995-3#1)(2012-12#1)
neurotoxic effect of the##2##4##(1995-5#1)(2008-7#1)
neurotoxic effect of##4##3##(1994-11#1)(1995-11#1)(1995-5#1)(2008-7#1)
neurotoxic effect##5##2##(1993-12#1)(1994-11#1)(1995-11#1)(1995-5#1)(2008-7#1)
neurotoxic effects of##3##3##(1993-12#1)(1994-2#1)(2008-7#1)
neurotoxic effects##9##2##(1990-3#1)(1993-12#1)(1994-2#1)(2008-7#6)
neurotoxic lesions of the##2##4##(1993-3#1)(1993-6#1)
neurotoxic lesions of##3##3##(1991-2#1)(1993-3#1)(1993-6#1)
neurotoxic lesions##4##2##(1991-2#1)(1992-11#1)(1993-3#1)(1993-6#1)
neurotoxic properties##2##2##(1994-8#1)(1996-12#1)
neurotoxic stimuli##2##2##(2011-9#2)
neurotoxic##40##1##(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-12#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#8)(2011-9#2)(2012-12#1)(2012-3#1)
neurotoxicity after##2##2##(1991-1#1)(2007-7#1)
neurotoxicity and the##2##3##(2008-7#2)
neurotoxicity from oxaliplatin##2##3##(2008-3#2)
neurotoxicity from##3##2##(2008-3#2)(2013-1#1)
neurotoxicity in##3##2##(2007-7#1)(2008-7#1)(2012-2#1)
neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas##2##15##(2008-6#2)
neurotoxicity of##6##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-6#3)
neurotoxicity##46##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-8#2)(1992-12#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-5#1)(2007-7#3)(2008-10#1)(2008-3#4)(2008-5#2)(2008-6#4)(2008-7#13)(2009-12#2)(2009-7#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
neurotoxin and##4##2##(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)
neurotoxin in##2##2##(2008-7#1)(2008-9#1)
neurotoxin that##2##2##(1991-12#1)(2008-5#1)
neurotoxin##35##1##(1990-5#4)(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1994-11#7)(1996-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#3)(2012-3#1)
neurotoxins##5##1##(1990-5#1)(1992-11#1)(1993-3#1)(2008-5#1)(2008-9#1)
neurotransmission and##4##2##(1997-1#1)(2008-7#2)(2009-8#1)
neurotransmission in the##5##3##(1990-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)
neurotransmission in##6##2##(1990-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(2008-2#1)
neurotransmission or##2##2##(1994-11#1)(1995-12#1)
neurotransmission to##2##2##(1997-4#1)(2012-3#1)
neurotransmission via##2##2##(2011-1#1)(2012-3#1)
neurotransmission##41##1##(1990-12#1)(1990-5#1)(1991-12#1)(1993-12#2)(1994-11#2)(1994-2#1)(1994-6#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#2)(2012-2#3)(2012-3#2)(2013-8#2)
neurotransmitter from the##2##3##(1994-8#1)(2008-7#1)
neurotransmitter glutamate was##2##3##(2008-4#1)(2008-7#1)
neurotransmitter glutamate##3##2##(1990-8#1)(2008-4#1)(2008-7#1)
neurotransmitter in the##7##3##(1991-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-5#2)(2008-11#1)
neurotransmitter in##8##2##(1991-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-5#2)(2008-11#1)
neurotransmitter metabolites##3##2##(2008-10#2)(2008-3#1)
neurotransmitter receptors and##2##3##(1993-8#1)(1995-11#1)
neurotransmitter receptors##7##2##(1993-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(2008-4#1)(2008-7#2)
neurotransmitter release##12##2##(1994-11#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2013-1#1)
neurotransmitter synthesis##2##2##(1991-6#1)(2013-8#1)
neurotransmitter systems##5##2##(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
neurotransmitter##76##1##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#3)(1991-6#1)(1993-12#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#6)(1996-5#3)(1996-7#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#11)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
neurotransmitters and##5##2##(1991-12#1)(2008-7#3)(2012-1#1)
neurotransmitters in the##5##3##(1992-12#1)(1993-3#1)(2008-10#2)(2008-7#1)
neurotransmitters in##6##2##(1992-12#1)(1993-3#1)(2008-10#2)(2008-4#1)(2008-7#1)
neurotransmitters or##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
neurotransmitters such as##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
neurotransmitters that##2##2##(1993-12#1)(2008-4#1)
neurotransmitters##48##1##(1991-12#4)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#2)(1997-2#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-4#4)(2008-7#5)(2008-8#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
neurotrauma##2##1##(2008-7#1)(2008-9#1)
neurotrophic activity in##2##3##(1990-5#1)(2008-11#1)
neurotrophic activity##4##2##(1990-5#1)(1995-5#2)(2008-11#1)
neurotrophic factor (BDNF)##15##3##(1994-8#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-6#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
neurotrophic factor (CNTF)##4##3##(1990-5#1)(1991-6#1)(1996-2#1)(1996-5#1)
neurotrophic factor##38##2##(1990-5#2)(1991-6#2)(1993-5#1)(1994-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-2#4)(1997-6#3)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
neurotrophic factors##9##2##(2008-5#1)(2008-7#3)(2013-1#4)(2013-7#1)
neurotrophic molecule##2##2##(1990-5#1)(1997-2#1)
neurotrophic##60##1##(1990-5#4)(1991-6#2)(1993-5#3)(1994-8#2)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#4)(1996-5#2)(1997-2#5)(1997-6#3)(2008-11#2)(2008-5#2)(2008-7#6)(2009-3#2)(2009-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#9)(2013-7#1)
neurotrophin is##2##2##(1996-2#1)(2009-8#1)
neurotrophin receptor##4##2##(1995-8#1)(1996-12#1)(2008-7#1)(2008-9#1)
neurotrophin receptors in##2##3##(1995-8#1)(1996-12#1)
neurotrophin receptors##6##2##(1994-8#1)(1995-8#1)(1996-12#4)
neurotrophin##23##1##(1994-8#4)(1995-8#2)(1996-12#6)(1996-2#1)(1996-5#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2012-12#1)(2013-8#1)
neurotrophin-3 (NT-3)##2##2##(2008-5#1)(2009-10#1)
neurotrophin-3##5##1##(1996-5#1)(2008-5#2)(2009-10#2)
neurotrophins (NT)##2##2##(2008-5#1)(2010-8#1)
neurotrophins in the##2##3##(1994-8#1)(1996-12#1)
neurotrophins in##5##2##(1994-8#1)(1995-8#1)(1996-12#2)(2008-7#1)
neurotrophins##26##1##(1994-8#3)(1995-8#2)(1996-12#4)(1996-2#3)(1996-5#2)(2008-5#3)(2008-7#6)(2008-9#1)(2009-10#1)(2010-8#1)
neurotropic##3##1##(2007-12#1)(2011-2#2)
neurovascular complications##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
neurovascular unit##2##2##(2013-1#2)
neurovascular units##2##2##(2013-1#2)
neurovascular##16##1##(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
neurula stage##2##2##(1992-9#1)(1997-7#1)
neurula##4##1##(1992-9#1)(1997-7#2)(2008-6#1)
neutral acidities##2##2##(2008-10#2)
neutral amino acids##5##3##(1994-5#3)(1994-9#1)(2008-10#1)
neutral amino##6##2##(1994-5#4)(1994-9#1)(2008-10#1)
neutral analytes##2##2##(2008-10#1)(2010-7#1)
neutral and acidic##3##3##(1993-11#1)(2008-10#1)(2010-3#1)
neutral and alkaline##5##3##(1990-7#1)(2008-10#3)(2008-11#1)
neutral and cationic##2##3##(2008-10#2)
neutral and charged##2##3##(2010-12#1)(2010-7#1)
neutral and##21##2##(1990-5#1)(1990-7#1)(1992-10#1)(1993-11#3)(2008-10#9)(2008-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-1#2)
neutral anion##2##2##(2008-10#2)
neutral atoms##2##2##(2007-12#1)(2012-2#1)
neutral carrier for##2##3##(2008-10#2)
neutral carrier##17##2##(2008-10#17)
neutral carriers in##2##3##(2008-10#2)
neutral carriers##11##2##(2008-10#11)
neutral compounds##2##2##(2008-10#2)
neutral conditions##7##2##(1990-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-11#1)
neutral donor##2##2##(2008-10#1)(2009-11#1)
neutral effect##3##2##(2008-3#1)(2012-2#1)(2012-9#1)
neutral endopeptidase 24##2##3##(1990-5#1)(1992-6#1)
neutral endopeptidase##7##2##(1990-5#4)(1991-2#2)(1992-6#1)
neutral evolution##2##2##(2013-1#2)
neutral faces##3##2##(2008-1#1)(2008-2#1)(2012-2#1)
neutral facial expressions##2##3##(2009-4#1)(2012-2#1)
neutral form##5##2##(2008-10#4)(2011-1#1)
neutral frame##2##2##(2008-4#2)
neutral gaze##2##2##(2007-4#2)
neutral genetic markers##2##3##(2008-8#1)(2013-1#1)
neutral genetic##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
neutral ionophores were##2##3##(2008-10#2)
neutral ionophores##5##2##(2008-10#5)
neutral lipid##5##2##(1992-9#2)(1994-3#1)(2008-11#1)(2009-8#1)
neutral lipids##7##2##(1992-10#1)(1994-3#1)(1995-5#1)(2008-11#3)(2009-7#1)
neutral lipophilic##2##2##(2008-10#2)
neutral loci##2##2##(2012-3#2)
neutral markers##3##2##(2008-10#2)(2012-3#1)
neutral media##3##2##(2008-10#3)
neutral molecules##2##2##(1997-7#1)(2008-10#1)
neutral pH and##6##3##(1992-9#1)(1993-11#1)(1994-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
neutral pH range##2##3##(1990-7#1)(2008-10#1)
neutral pH##40##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#5)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-4#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
neutral processes##2##2##(2012-3#2)
neutral protease##3##2##(1991-6#1)(1991-9#2)
neutral red (NR)##2##3##(2008-10#1)(2010-5#1)
neutral red##8##2##(1992-11#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-11#1)(2010-5#2)
neutral saccharides##2##2##(1991-7#2)
neutral site##2##2##(2008-10#1)(2012-3#1)
neutral solution##2##2##(2008-10#2)
neutral solutions##2##2##(2008-10#2)
neutral species##4##2##(2008-10#4)
neutral stimulus##2##2##(1993-6#1)(2008-4#1)
neutral surfactant##3##2##(2008-10#3)
neutral to##2##2##(1990-5#1)(1990-8#1)
neutral##357##1##(1990-12#1)(1990-2#1)(1990-5#7)(1990-7#2)(1990-8#3)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#3)(1992-3#1)(1992-6#5)(1992-9#3)(1993-11#8)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#5)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#3)(2007-11#3)(2007-12#6)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#130)(2008-11#13)(2008-2#5)(2008-3#8)(2008-4#7)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#3)(2009-6#1)(2009-7#4)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#8)(2012-3#10)(2012-9#1)(2013-1#9)(2013-8#3)
neutral)##5##1##(2008-11#2)(2008-2#1)(2008-6#1)(2010-8#1)
neutral- and##2##2##(1997-2#1)(2008-11#1)
neutralisation##8##1##(1991-3#4)(2008-10#4)
neutralising##4##1##(1996-12#1)(2008-10#2)(2011-1#1)
neutrality in##2##2##(2009-8#1)(2012-3#1)
neutrality##6##1##(2008-4#1)(2009-8#1)(2010-8#1)(2012-3#2)(2013-8#1)
neutralization assay##4##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#1)
neutralization of the##3##3##(1994-3#1)(2008-10#1)(2010-6#1)
neutralization of##9##2##(1993-5#1)(1994-3#1)(1996-12#2)(2008-10#3)(2010-6#1)(2013-1#1)
neutralization test##3##2##(1997-6#1)(2008-12#1)(2011-1#1)
neutralization##31##1##(1993-5#1)(1994-3#1)(1995-5#2)(1996-12#2)(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#12)(2008-12#2)(2008-4#2)(2008-5#2)(2009-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
neutralize the##8##2##(1991-8#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
neutralize##15##1##(1991-5#1)(1991-8#1)(1993-3#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2012-12#2)
neutralized by##5##2##(1994-8#1)(1996-12#1)(1997-1#1)(2008-5#1)(2009-8#1)
neutralized to##2##2##(2008-10#1)(2008-11#1)
neutralized##14##1##(1994-8#2)(1996-12#3)(1997-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)
neutralizes the##2##2##(1992-9#1)(2008-5#1)
neutralizes##3##1##(1992-9#1)(2008-5#1)(2010-12#1)
neutralizing IgG##2##2##(1995-2#2)
neutralizing and##2##2##(1995-5#1)(2011-2#1)
neutralizing antibodies against##2##3##(1992-8#1)(2008-8#1)
neutralizing antibodies##12##2##(1992-8#1)(1993-3#1)(1995-2#2)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
neutralizing antibody against##2##3##(1995-5#1)(2013-1#1)
neutralizing antibody##4##2##(1995-5#3)(2013-1#1)
neutralizing capacity of##3##3##(2008-10#1)(2008-5#2)
neutralizing capacity##4##2##(2008-10#1)(2008-5#3)
neutralizing##40##1##(1992-8#1)(1993-3#1)(1995-2#7)(1995-5#6)(2007-10#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#2)
neutrino##4##1##(1991-9#1)(1992-11#2)(2008-3#1)
neutron activation analysis##5##3##(1991-12#1)(2008-10#4)
neutron capture therapy (BNCT)##4##4##(1994-3#3)(2013-1#1)
neutron capture therapy##16##3##(1994-3#14)(1995-2#1)(2013-1#1)
neutron capture##17##2##(1994-3#15)(1995-2#1)(2013-1#1)
neutron irradiation##2##2##(1994-3#1)(1995-8#1)
neutron scattering experiments on##2##4##(1995-3#1)(2012-2#1)
neutron scattering##9##2##(1995-3#2)(1996-2#1)(2008-10#4)(2009-12#1)(2012-2#1)
neutron therapy##3##2##(2008-6#2)(2010-3#1)
neutron##50##1##(1991-12#1)(1991-5#1)(1993-5#1)(1994-3#18)(1995-2#1)(1995-3#2)(1995-8#2)(1996-2#1)(2008-10#12)(2008-6#2)(2008-7#3)(2009-12#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#2)
neutrons##6##1##(1994-3#1)(1995-8#1)(2008-5#1)(2008-6#2)(2013-1#1)
neutropenia (n =##4##3##(2008-7#4)
neutropenia and##8##2##(2008-10#1)(2008-5#1)(2008-7#5)(2012-3#1)
neutropenia can##2##2##(2008-7#1)(2012-3#1)
neutropenia in the##5##3##(2007-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
neutropenia in##8##2##(2007-10#1)(2008-11#2)(2008-7#4)(2012-3#1)
neutropenia risk##2##2##(2008-7#2)
neutropenia to##2##2##(2008-7#2)
neutropenia was##2##2##(2008-7#1)(2012-3#1)
neutropenia with##2##2##(2006-10#1)(2008-7#1)
neutropenia##72##1##(1991-3#1)(1992-10#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-5#2)(2008-6#2)(2008-7#44)(2012-3#6)(2013-1#1)
neutropenic children with cancer##2##4##(2008-11#1)(2008-5#1)
neutropenic##5##1##(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
neutrophil NADPH oxidase##2##3##(1991-5#2)
neutrophil activating##2##2##(1990-5#2)
neutrophil activation##3##2##(1992-3#1)(1997-1#1)(2008-11#1)
neutrophil and##2##2##(2008-10#1)(2011-2#1)
neutrophil apoptosis##2##2##(2008-11#1)(2009-10#1)
neutrophil chemoattractant##2##2##(1994-12#1)(2013-1#1)
neutrophil chemotaxis in##2##3##(1994-11#2)
neutrophil chemotaxis##4##2##(1994-11#4)
neutrophil collagenase activity##2##3##(1992-5#1)(1994-3#1)
neutrophil collagenase##4##2##(1992-5#3)(1994-3#1)
neutrophil count##6##2##(2008-9#4)(2012-3#2)
neutrophil counts##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
neutrophil cytosol##3##2##(1992-6#1)(1994-11#2)
neutrophil elastase and##2##3##(1994-5#1)(2008-6#1)
neutrophil elastase##11##2##(1993-3#1)(1994-5#4)(1994-6#1)(1995-2#1)(2008-5#2)(2008-6#1)(2008-7#1)
neutrophil functions##2##2##(1993-3#1)(2008-10#1)
neutrophil gelatinase-associated lipocalin##2##3##(2010-5#1)(2012-2#1)
neutrophil membranes##6##2##(1991-2#3)(1993-6#1)(1993-8#1)(1994-8#1)
neutrophil migration##4##2##(1994-11#1)(1994-8#3)
neutrophil progenitors##2##2##(2008-11#2)
neutrophil suspensions##2##2##(1994-11#1)(2008-4#1)
neutrophil##107##1##(1990-5#4)(1991-12#1)(1991-2#4)(1991-5#2)(1991-9#1)(1992-3#2)(1992-5#4)(1992-6#4)(1992-8#2)(1993-3#3)(1993-6#2)(1993-8#5)(1994-11#10)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#6)(1995-2#1)(1996-11#1)(1996-2#1)(1997-1#2)(2008-1#1)(2008-10#5)(2008-11#11)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)
neutrophil-activating peptide##2##2##(1994-11#1)(1994-12#1)
neutrophilia##3##1##(1995-11#1)(1995-3#1)(2008-10#1)
neutrophilic##6##1##(1995-12#1)(2009-8#2)(2011-2#3)
neutrophils (PMNs)##3##2##(1992-5#1)(1993-6#1)(2009-10#1)
neutrophils and monocytes##2##3##(1992-12#1)(2008-4#1)
neutrophils and other##2##3##(2008-5#1)(2008-7#1)
neutrophils and##17##2##(1991-2#1)(1992-12#1)(1994-8#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
neutrophils by##7##2##(1991-12#1)(1991-2#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#2)
neutrophils from healthy controls and SLE patients were stimulated with different IC##2##12##(2008-10#2)
neutrophils from##4##2##(2008-10#4)
neutrophils in response to##3##4##(1993-6#1)(1994-11#1)(2008-4#1)
neutrophils in##6##2##(1991-9#1)(1993-6#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
neutrophils isolated##2##2##(1991-8#1)(2008-10#1)
neutrophils or monocytes##2##3##(1990-12#1)(2011-2#1)
neutrophils to##2##2##(1991-9#1)(1993-8#1)
neutrophils using##2##2##(1992-12#1)(2011-2#1)
neutrophils was##7##2##(1991-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(2008-10#1)
neutrophils with##4##2##(1993-6#1)(2008-4#2)(2012-3#1)
neutrophils##138##1##(1990-12#3)(1990-2#5)(1991-12#2)(1991-2#3)(1991-8#1)(1991-9#10)(1992-10#1)(1992-12#5)(1992-3#5)(1992-5#2)(1992-8#3)(1993-11#4)(1993-3#1)(1993-6#7)(1993-8#3)(1994-11#1)(1994-6#2)(1994-8#3)(1995-6#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#22)(2008-11#5)(2008-4#16)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
never associated with##2##3##(2008-5#1)(2012-3#1)
never be##5##2##(1996-1#1)(1996-6#1)(2007-2#2)(2008-2#1)
never been described in##3##4##(1993-9#1)(2008-5#1)(2012-12#1)
never been observed##2##3##(2008-10#1)(2008-5#1)
never been reported##6##3##(1997-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2013-8#1)
never been studied in##2##4##(1996-12#1)(2012-5#1)
never been##45##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
never before been##2##3##(2008-7#1)(2012-1#1)
never before##5##2##(1991-2#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-1#1)
never cleaned##2##2##(2009-6#2)
never exceeded##2##2##(2008-10#2)
never had a##2##3##(1990-6#1)(2013-1#1)
never had any##2##3##(2007-7#1)(2009-12#1)
never had##6##2##(1990-6#1)(1990-8#1)(1993-9#1)(2007-7#1)(2009-12#1)(2013-1#1)
never heard of##3##3##(2009-5#1)(2011-1#1)(2013-1#1)
never in##4##2##(1992-6#1)(2008-10#2)(2011-2#1)
never occurred##3##2##(1992-2#1)(1994-3#1)(2008-10#1)
never previously##3##2##(2008-7#1)(2009-2#1)(2011-1#1)
never reached the##2##3##(1996-11#1)(2011-2#1)
never really##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
never received##2##2##(2008-11#1)(2010-5#1)
never seen##2##2##(2008-6#1)(2010-12#1)
never tobacco users##2##3##(2007-12#2)
never too##2##2##(1993-11#2)
never used##5##2##(1992-3#1)(2013-1#2)(2013-8#2)
never##175##1##(1990-2#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-6#1)(1993-9#2)(1994-2#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#8)(2013-8#3)
never-ending##2##1##(2008-9#1)(2011-2#1)
nevertheless the##3##2##(1991-3#1)(1995-3#1)(2008-10#1)
nevertheless##41##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-6#1)(1993-8#1)(1993-9#2)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
nevi and##2##2##(2011-2#1)(2012-3#1)
nevi are##3##2##(2011-2#3)
nevi##21##1##(2007-4#1)(2007-7#1)(2011-2#12)(2012-3#6)(2013-8#1)
nevirapine##6##1##(2008-10#4)(2009-7#1)(2011-2#1)
nevoid basal cell carcinoma syndrome (NBCCS)##2##6##(1997-3#1)(2007-4#1)
nevoid basal cell carcinoma syndrome##3##5##(1997-3#2)(2007-4#1)
nevoid basal cell carcinoma##4##4##(1997-3#2)(2007-12#1)(2007-4#1)
nevoid basal cell##5##3##(1997-3#2)(2007-12#1)(2007-4#2)
nevoid melanoma##7##2##(2011-2#7)
nevoid##13##1##(1997-3#2)(2007-12#2)(2007-4#2)(2011-2#7)
nevus sebaceous syndrome##3##3##(2011-1#3)
nevus sebaceous##4##2##(2011-1#4)
nevus##10##1##(2007-7#2)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#1)
new &quot##6##2##(1994-9#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-4#1)(2011-2#1)
new 1##2##2##(2008-10#1)(2012-3#1)
new 14- and 15-crown-formazans##3##4##(2008-10#3)
new 4##2##2##(2007-11#1)(2008-11#1)
new AIDS##3##2##(1991-11#1)(1993-9#1)(1995-6#1)
new DNA##3##2##(2008-12#1)(2008-4#1)(2011-2#1)
new Ektacytometry##3##2##(2008-8#3)
new FFT-based method##2##3##(2008-3#2)
new FFT-based##3##2##(2008-3#2)(2009-12#1)
new German##3##2##(2012-1#3)
new H-bond##2##2##(1993-11#2)
new HIV-1 nonnucleoside reverse transcriptase##2##5##(2011-3#2)
new HIV-1##4##2##(1992-9#1)(2011-3#3)
new IPAs##2##2##(1994-3#2)
new Joint Commission##2##3##(1993-2#1)(2006-5#1)
new Korean isolate of cymbidium mosaic virus##2##7##(1997-2#2)
new Medicare drug benefit##2##4##(2008-4#2)
new Medicare##7##2##(1992-1#2)(1992-12#1)(2007-9#2)(2008-4#2)
new Mu##2##2##(2012-3#2)
new ORFs##3##2##(1996-6#2)(1997-3#1)
new Phytophthora##2##2##(2008-10#1)(2010-3#1)
new QTL##2##2##(2008-10#2)
new RNA##2##2##(2008-10#1)(2008-7#1)
new T-type calcium channel blockers##2##5##(2008-8#2)
new TB infection##2##3##(2007-2#2)
new TB##3##2##(1996-3#1)(2007-2#2)
new absorption peaks##2##3##(2013-8#2)
new active##2##2##(2008-3#1)(2010-3#1)
new administrative##2##2##(1994-7#1)(2008-11#1)
new adult##3##2##(1994-1#1)(2007-12#1)(2008-7#1)
new age##3##2##(2008-1#2)(2012-3#1)
new agent##3##2##(1994-9#1)(2008-5#1)(2012-3#1)
new agents for##2##3##(2008-10#2)
new agents##8##2##(1996-9#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-7#1)
new algorithm are##3##3##(2008-2#2)(2008-3#1)
new algorithm for the##2##4##(2008-10#1)(2008-2#1)
new algorithm for##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
new algorithm is##8##3##(2008-10#1)(2008-3#5)(2008-6#1)(2009-4#1)
new algorithm##31##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#15)(2008-6#2)(2009-4#1)(2012-12#1)(2013-8#2)
new algorithms for##2##3##(2008-3#1)(2008-4#1)
new algorithms##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
new alloy##3##2##(2009-7#3)
new amperometric##4##2##(2008-10#4)
new analytical method for the##5##5##(2008-10#5)
new analytical method for##6##4##(2008-10#6)
new analytical method##8##3##(2008-10#7)(2008-3#1)
new analytical results##2##3##(2008-3#1)(2009-9#1)
new analytical##26##2##(2007-12#1)(2008-10#18)(2008-3#3)(2008-7#1)(2009-9#1)(2010-11#1)(2010-5#1)
new and better##3##3##(1995-2#1)(2008-6#1)(2011-1#1)
new and effective##4##3##(2007-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
new and efficient##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
new and highly##2##3##(2009-12#1)(2012-2#1)
new and improved##2##3##(1992-9#1)(1994-9#1)
new and innovative##6##3##(1995-3#1)(1996-3#1)(1997-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
new and more effective##3##4##(1994-1#1)(2010-11#1)(2012-3#1)
new and more##7##3##(1994-1#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-1#1)(2012-3#1)
new and old##2##3##(2008-12#1)(2008-8#1)
new and powerful##2##3##(2008-2#1)(2011-2#1)
new and promising##2##3##(1991-5#1)(2008-4#1)
new and simple method for##3##5##(2008-10#1)(2008-3#1)(2008-6#1)
new and simple method##6##4##(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)
new and simple##9##3##(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
new and very##2##3##(2008-10#2)
new and##103##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-6#1)(1992-9#1)(1994-1#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#5)(2008-8#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#4)(2013-8#1)
new antibacterial antibiotic##2##3##(2008-8#2)
new antibiotics##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
new antibody##3##2##(2008-10#3)
new anticancer##4##2##(1994-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
new antifungal agents##3##3##(2008-7#2)(2011-2#1)
new antifungal##4##2##(2007-7#1)(2008-7#2)(2011-2#1)
new antigens##2##2##(1995-5#1)(1997-8#1)
new antimicrobial##2##2##(2008-10#1)(2012-3#1)
new antioxidant##2##2##(1991-9#1)(2008-11#1)
new antiretroviral##2##2##(2008-2#1)(2008-3#1)
new antiviral##2##2##(1995-2#1)(2008-11#1)
new application of##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
new application##8##2##(1991-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
new applications##6##2##(1991-2#1)(1992-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
new approach are##2##3##(2008-10#1)(2010-3#1)
new approach based on the##2##5##(2008-10#1)(2008-2#1)
new approach for the##7##4##(2007-12#1)(2008-10#5)(2008-3#1)
new approach for##24##3##(1996-5#1)(1997-3#2)(2007-12#3)(2007-7#2)(2008-10#8)(2008-12#1)(2008-3#2)(2008-5#2)(2009-7#1)(2011-1#1)(2012-2#1)
new approach in##2##3##(2008-10#1)(2008-11#1)
new approach is##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
new approach to modeling##2##4##(2007-12#1)(2008-8#1)
new approach to the##8##4##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#1)
new approach to##44##3##(1992-1#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-11#6)(2007-12#4)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
new approach##115##2##(1992-1#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#10)(2007-7#2)(2007-8#3)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2009-10#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
new approaches and##2##3##(1995-12#1)(2010-7#1)
new approaches for##7##3##(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-12#1)(2013-1#1)
new approaches in the##2##4##(2008-1#1)(2010-3#1)
new approaches in##3##3##(2007-8#1)(2008-1#1)(2010-3#1)
new approaches to acne management##2##5##(2008-5#2)
new approaches to the##4##4##(1992-3#1)(2007-10#1)(2009-6#1)(2010-3#1)
new approaches to##13##3##(1992-3#1)(1993-2#1)(1995-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-2#1)
new approaches##30##2##(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-6#1)(2009-8#2)(2010-12#2)(2010-3#2)(2010-7#1)(2012-2#1)(2013-1#1)
new aqueous two-phase system##2##4##(2008-10#1)(2012-1#1)
new area of research##3##4##(1995-8#1)(2008-11#1)(2008-7#1)
new area of##4##3##(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
new area##7##2##(1995-8#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-8#1)
new areas of##2##3##(1994-12#1)(2012-2#1)
new areas##6##2##(1994-12#1)(2008-10#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
new aspect##4##2##(1993-8#1)(1994-3#1)(2008-11#1)(2013-7#1)
new aspects of##4##3##(1994-11#1)(1994-9#1)(1995-5#1)(2008-7#1)
new aspects##6##2##(1994-11#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-7#1)(2013-1#1)
new assay for##2##3##(1991-12#2)
new assay##9##2##(1991-11#1)(1991-12#2)(1992-9#1)(2008-10#5)
new attitude##2##2##(1991-12#2)
new automated##3##2##(1997-2#1)(2008-10#1)(2010-11#1)
new avenue##3##2##(1991-1#1)(2007-11#1)(2008-4#1)
new avenues for##7##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)
new avenues of research##2##4##(2008-2#1)(2008-7#1)
new avenues of##5##3##(2008-2#1)(2008-3#1)(2008-7#2)(2009-6#1)
new avenues##14##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-5#1)(2009-6#1)(2009-8#1)(2012-2#1)
new bacterial life model##3##4##(2008-8#3)
new bacterial##4##2##(1994-3#1)(2008-8#3)
new baculovirus##2##2##(2008-8#2)
new benthos-based SQG approach##2##4##(2012-1#2)
new biological agents##2##3##(2012-1#1)(2012-3#1)
new biological##8##2##(1990-9#1)(2007-12#1)(2008-10#2)(2008-4#2)(2012-1#1)(2012-3#1)
new biomarker##2##2##(2010-12#1)(2012-2#1)
new biomarkers##3##2##(2010-11#1)(2011-2#1)(2012-12#1)
new bioprosthesis##2##2##(2007-7#2)
new bone formation##3##3##(2008-5#2)(2009-3#1)
new bone##4##2##(2008-5#2)(2008-8#1)(2009-3#1)
new book##2##2##(2008-10#1)(2008-11#1)
new born##2##2##(1995-12#1)(2009-9#1)
new brain##2##2##(2008-5#1)(2009-5#1)
new branch of##3##3##(2008-11#2)(2011-2#1)
new branch##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
new bulk##3##2##(2008-10#3)
new bundle##2##2##(2008-2#2)
new calibration method based on linear correlation##2##7##(2008-10#2)
new calibration method##3##3##(2008-10#3)
new calibration##6##2##(2007-12#1)(2008-10#4)(2008-6#1)
new capillary electrophoresis (CE) method##2##5##(2008-10#2)
new capillary electrophoresis (CE) procedure##2##5##(2008-10#2)
new capillary electrophoresis (CE)##4##4##(2008-10#4)
new case of##6##3##(1990-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)
new case##9##2##(1990-12#1)(1991-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-8#1)
new cases and a review of the literature##2##8##(2008-10#1)(2009-3#1)
new cases and##3##3##(2008-10#1)(2008-6#1)(2009-3#1)
new cases of##10##3##(1992-2#1)(1992-9#1)(2006-12#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
new cases##27##2##(1992-2#1)(1992-9#1)(1994-12#1)(1996-11#3)(1997-6#4)(2006-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
new cavity##2##2##(2007-11#1)(2008-3#1)
new cell line##2##3##(2008-11#2)
new cell##8##2##(2008-10#1)(2008-11#5)(2008-4#1)(2010-2#1)
new central##2##2##(1997-3#1)(2008-7#1)
new centrally acting##4##3##(1992-3#2)(1996-2#1)(2008-7#1)
new century##5##2##(1995-9#1)(2008-1#2)(2008-10#1)(2008-9#1)
new challenges and##3##3##(1993-1#1)(2008-12#1)(2013-8#1)
new challenges for##5##3##(1992-3#2)(1993-1#1)(2008-7#1)(2009-9#1)
new challenges to##2##3##(2007-4#1)(2008-7#1)
new challenges##24##2##(1991-1#1)(1991-9#1)(1992-3#3)(1993-1#2)(1993-2#1)(1994-1#1)(1995-3#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2013-8#1)
new chelating ion-exchange##2##3##(2008-10#2)
new chelating resin##6##3##(2008-10#6)
new chelating sorbent##2##3##(2008-10#2)
new chelating##16##2##(2008-10#16)
new chemical##8##2##(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2009-6#1)(2010-7#1)
new chemiluminescence##4##2##(2008-10#4)
new chemiluminescent##2##2##(2008-10#2)
new chemotherapy##3##2##(1992-2#2)(2012-1#1)
new chromatographic##3##2##(2008-10#1)(2010-11#1)(2010-7#1)
new chromatography##2##2##(2008-10#2)
new chromogenic reagent##4##3##(2008-10#4)
new chromogenic##5##2##(1996-5#1)(2008-10#4)
new circuit##2##2##(2010-8#1)(2011-1#1)
new class of antitumor agents##2##5##(2008-5#2)
new class of genes##2##4##(1992-12#1)(2010-4#1)
new class of optical##3##4##(2007-11#3)
new class of therapeutic##2##4##(2008-5#1)(2008-7#1)
new class of##56##3##(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-8#3)(1992-9#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-4#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
new classes of##4##3##(1994-6#1)(1997-1#1)(2007-11#1)(2008-3#1)
new classification of##4##3##(1991-1#1)(2008-6#1)(2008-7#1)(2012-3#1)
new classification##9##2##(1991-1#1)(1991-9#2)(1997-8#3)(2008-6#1)(2008-7#1)(2012-3#1)
new clinical##6##2##(1992-3#2)(1996-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
new clinically##2##2##(2008-7#1)(2012-3#1)
new coating##2##2##(2012-1#2)
new code##3##2##(2007-10#1)(2008-3#2)
new coding regions##2##3##(1995-12#1)(2012-3#1)
new coding##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
new column##2##2##(1993-1#2)
new combinations##2##2##(1995-5#1)(2007-7#1)
new community##3##2##(1992-1#1)(1992-12#1)(2007-5#1)
new compensation##2##2##(1996-3#1)(2008-3#1)
new competitive##2##2##(1996-12#1)(2008-10#1)
new compound##6##2##(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-3#1)
new compounds and##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
new compounds in the##2##4##(1991-1#1)(1997-7#1)
new compounds##23##2##(1991-1#2)(1992-3#1)(1995-3#2)(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#3)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
new computer program##2##3##(2008-10#2)
new concentration##2##2##(2008-10#2)
new concept for##8##3##(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
new concept in##6##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
new concept of the brain##2##5##(2009-5#2)
new concept of the##3##4##(2007-8#1)(2009-5#2)
new concept of##8##3##(1995-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-2#1)
new concept##36##2##(1991-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)
new concepts of##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
new concepts##11##2##(1994-3#1)(1997-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
new conceptual##5##2##(1996-12#1)(2008-8#1)(2009-5#2)(2012-3#1)
new conditions##2##2##(1997-3#1)(2008-10#1)
new configuration##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
new consensus##2##2##(1994-6#1)(2008-6#1)
new construction##3##2##(1990-10#1)(2008-10#1)(2008-6#1)
new context##2##2##(1996-1#1)(2012-2#1)
new contraceptive##3##2##(1994-9#1)(1996-11#1)(1996-9#1)
new control##4##2##(1990-8#1)(2008-10#1)(2011-3#1)(2012-3#1)
new convexity measure for##2##4##(2008-6#2)
new convexity measure##7##3##(2008-6#7)
new copolymer##2##2##(2008-10#2)
new cosmetic##4##2##(2008-5#3)(2011-1#1)
new criteria##2##2##(1995-1#1)(2008-3#1)
new crown-formazans##3##2##(2008-10#3)
new crystal forms##3##3##(2009-11#3)
new crystal##4##2##(1996-2#1)(2009-11#3)
new cultivars##2##2##(2008-10#1)(2012-4#1)
new culture##2##2##(2008-11#1)(2011-2#1)
new curriculum##3##2##(2007-5#1)(2008-11#1)(2011-1#1)
new cytotoxic##2##2##(2010-8#1)(2012-1#1)
new data for##2##3##(2008-3#1)(2012-3#1)
new data from##4##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-9#1)
new data on the##2##4##(2008-2#1)(2009-8#1)
new data on##5##3##(1991-5#1)(1995-11#1)(1997-5#1)(2008-2#1)(2009-8#1)
new data supporting the##2##4##(2008-7#1)(2008-9#1)
new data##30##2##(1991-5#1)(1995-11#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-8#3)(2012-3#1)(2013-8#2)
new day##2##2##(2012-3#1)(2013-8#1)
new definition##3##2##(1996-3#1)(2007-8#1)(2013-8#1)
new delivery system##3##3##(1997-2#1)(2008-5#1)(2011-2#1)
new delivery##6##2##(1994-9#1)(1997-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
new demands##3##2##(1991-2#1)(1996-2#1)(2010-7#1)
new derivation##2##2##(2007-12#1)(2008-3#1)
new derivatives of##2##3##(2008-10#2)
new derivatives##4##2##(2007-11#1)(2008-10#2)(2008-4#1)
new design can##2##3##(2012-2#2)
new design for an##3##4##(2008-2#1)(2008-3#2)
new design for##10##3##(2007-11#1)(2008-2#4)(2008-3#5)
new design##19##2##(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#6)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
new designs##2##2##(2009-7#1)(2012-3#1)
new detector##3##2##(2008-10#3)
new developed##2##2##(2008-10#1)(2011-1#1)
new development in the##2##4##(1991-12#1)(2008-10#1)
new development##6##2##(1991-12#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-7#1)
new developments have##2##3##(2007-12#1)(2008-6#1)
new developments in##6##3##(1990-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
new developments##9##2##(1990-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)
new device for##2##3##(2008-5#1)(2009-3#1)
new device##11##2##(1995-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-2#1)(2009-3#1)(2013-1#1)
new devices##5##2##(1991-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
new diagnoses##2##2##(2008-11#1)(2008-4#1)
new diagnostic tool##2##3##(2007-11#1)(2008-5#1)
new diagnostic##6##2##(1992-9#1)(2007-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#1)
new dialysis##2##2##(2008-1#1)(2011-2#1)
new diet##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
new diethyl##3##2##(2012-3#3)
new dimension to##2##3##(1997-2#1)(2008-11#1)
new dimension##4##2##(1991-5#1)(1997-2#1)(2008-11#1)(2008-2#1)
new dimensions of##2##3##(2008-10#1)(2008-5#1)
new dimensions##3##2##(2008-10#2)(2008-5#1)
new direct##3##2##(2008-10#2)(2008-3#1)
new directions for##3##3##(1991-2#1)(2008-9#1)(2013-1#1)
new directions in##5##3##(1996-9#1)(2008-4#1)(2010-2#1)(2010-3#1)(2012-2#1)
new directions##11##2##(1991-2#1)(1995-3#1)(1996-9#1)(2008-4#1)(2008-9#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
new discipline##4##2##(2008-11#1)(2008-4#1)(2010-1#1)(2013-1#1)
new discoveries##3##2##(1994-3#1)(2008-10#1)(2011-1#1)
new disease##4##2##(2007-12#1)(2008-10#2)(2008-12#1)
new dispersion function##2##3##(2008-2#2)
new dominant##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
new donors##2##2##(1996-2#1)(1997-3#1)
new drug development##2##3##(2008-4#1)(2013-1#1)
new drug##16##2##(1991-2#1)(1993-2#1)(1995-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-3#1)(2013-1#1)
new drugs are##2##3##(2011-2#1)(2012-12#1)
new drugs can be##2##4##(2008-10#1)(2008-11#1)
new drugs for##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
new drugs in##2##3##(2008-8#1)(2012-3#1)
new drugs##29##2##(1990-9#1)(1993-1#1)(1997-7#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
new dynamic##4##2##(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)
new ecological##2##2##(2008-10#1)(2009-8#1)
new educational##2##2##(1990-2#1)(2013-1#1)
new effect##2##2##(2008-3#1)(2012-2#1)
new efficacy measure##2##3##(1994-9#2)
new efficient##2##2##(2008-10#1)(2008-3#1)
new effort##2##2##(1995-12#1)(1997-2#1)
new electrochemical##4##2##(2008-10#4)
new electrode material##2##3##(2008-10#2)
new electrode##4##2##(2008-10#4)
new electrolytic dissolution##2##3##(2008-10#2)
new emerging##4##2##(1996-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
new emphasis on quality##2##4##(1993-2#1)(1996-12#1)
new emphasis on##4##3##(1993-2#1)(1995-1#1)(1996-12#1)(1997-3#1)
new empirical##3##2##(2008-10#2)(2013-1#1)
new employees##2##2##(1995-3#1)(2008-11#1)
new endemic##2##2##(1996-11#2)
new energy##2##2##(1990-11#1)(2008-10#1)
new environment##4##2##(1995-5#1)(2008-11#1)(2008-6#1)(2012-2#1)
new environments##2##2##(2008-9#1)(2013-8#1)
new enzymatic##4##2##(1990-2#1)(1991-5#1)(1992-11#1)(1993-12#1)
new enzyme##4##2##(1991-9#1)(1992-6#1)(2008-10#1)(2011-1#1)
new equations for##2##3##(2008-2#1)(2011-2#1)
new era for##7##3##(1993-12#1)(1994-3#1)(1995-8#1)(2008-1#1)(2008-8#1)(2011-2#2)
new era in##5##3##(1991-2#1)(1991-8#1)(1997-2#1)(2008-11#1)(2009-5#1)
new era of##7##3##(1992-2#1)(1992-3#1)(1997-2#1)(2008-6#1)(2008-9#2)(2011-7#1)
new era##27##2##(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-2#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)
new estimates of##2##3##(1991-2#1)(2008-3#1)
new estimates##4##2##(1991-2#1)(2008-3#3)
new estimation##2##2##(2008-6#1)(2010-12#1)
new evidence of##2##3##(2008-11#1)(2008-6#1)
new evidence on the##2##4##(2008-1#1)(2009-9#1)
new evidence that the##2##4##(1995-5#1)(2008-12#1)
new evidence that##3##3##(1995-5#1)(2008-12#1)(2008-9#1)
new evidence##12##2##(1993-11#1)(1993-12#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
new evolutionary##2##2##(2010-3#1)(2011-2#1)
new excipients##3##2##(2012-2#3)
new experimental design##2##3##(2008-10#1)(2008-5#1)
new experimental##9##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)
new experiments##2##2##(1996-12#1)(2008-2#1)
new explanation for the##2##4##(1995-6#1)(2008-3#1)
new expression##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
new external##2##2##(1991-12#1)(2010-10#1)
new extraction chromatographic##2##3##(2008-10#2)
new extraction##4##2##(2008-10#4)
new facilities##2##2##(1994-3#1)(1997-3#1)
new factor##2##2##(1991-12#1)(1993-6#1)
new family of##11##3##(1991-9#1)(1993-2#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2012-2#1)
new family##15##2##(1991-9#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2012-2#1)(2013-8#1)
new feature##4##2##(2007-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
new features##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
new federal##2##2##(1996-3#1)(2010-4#1)
new feeding strategy##2##3##(2008-7#2)
new female##2##2##(2008-9#1)(2011-2#1)
new field of##5##3##(1997-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)
new field##9##2##(1996-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-1#1)
new filter##5##2##(2008-2#5)
new financial##2##2##(1997-2#1)(2008-6#1)
new financing##2##2##(1996-3#1)(1997-5#1)
new findings##5##2##(1991-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#1)
new flow cell##2##3##(2008-10#2)
new flow injection chemiluminescence##2##4##(2008-10#2)
new flow injection##7##3##(2008-10#7)
new flow##11##2##(1995-9#1)(2008-10#10)
new flow-injection##3##2##(2008-10#3)
new fluorescence probe##2##3##(2008-10#2)
new fluorescence##5##2##(2008-10#4)(2013-8#1)
new fluorescent probe 1##3##4##(2008-10#3)
new fluorescent##7##2##(2008-10#5)(2008-4#1)(2010-2#1)
new focus of cutaneous leishmaniasis##2##5##(2007-7#2)
new focus on##2##3##(1991-1#1)(1991-12#1)
new focus##7##2##(1991-1#1)(1991-12#1)(1995-3#1)(2007-7#2)(2008-4#1)(2012-2#1)
new food acceptance##4##3##(2008-4#4)
new food##9##2##(2008-4#5)(2009-8#1)(2011-2#2)(2012-2#1)
new for##3##2##(2008-10#1)(2008-5#2)
new form of##4##3##(1996-11#1)(2007-12#1)(2008-1#1)(2008-11#1)
new form##5##2##(1990-8#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-11#1)
new formalism##2##2##(2008-3#2)
new forms of##3##3##(1991-3#1)(2007-12#1)(2013-1#1)
new formula##2##2##(2008-12#1)(2008-5#1)
new formulation of the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
new formulation of##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-6#1)(2013-1#1)
new formulation##12##2##(1992-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-12#1)(2012-6#1)(2013-1#1)
new formulations##4##2##(1997-7#1)(2008-11#2)(2008-5#1)
new framework for##3##3##(2008-12#1)(2010-6#1)(2012-3#1)
new framework##4##2##(2008-12#1)(2008-4#1)(2010-6#1)(2012-3#1)
new frontier##2##2##(2008-11#1)(2010-12#1)
new frontiers##2##2##(1993-1#1)(2008-10#1)
new fruits and##2##3##(2008-4#2)
new function to##2##3##(2008-2#1)(2013-8#1)
new function##5##2##(2008-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
new functional##2##2##(2010-4#1)(2011-3#1)
new functions of##2##3##(2008-1#1)(2011-2#1)
new functions##6##2##(2008-1#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
new fundamental##2##2##(2007-12#1)(2013-8#1)
new fungal##2##2##(2008-10#1)(2009-9#1)
new gas##2##2##(2008-10#1)(2008-11#1)
new gene family##4##3##(1993-3#2)(2008-8#1)(2008-9#1)
new gene origination in rice##2##5##(2009-10#2)
new gene was##2##3##(1995-6#1)(2008-10#1)
new gene with WD domains##2##5##(2008-8#2)
new gene##19##2##(1993-3#2)(1995-6#1)(1997-7#1)(2008-10#5)(2008-4#1)(2008-8#5)(2008-9#2)(2009-10#2)
new general##3##2##(1994-3#1)(2008-3#1)(2008-8#1)
new generation of##18##3##(1991-12#1)(1993-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
new generation##22##2##(1991-12#1)(1993-6#1)(1996-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)
new genes##17##2##(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#4)
new genetic##4##2##(1995-12#1)(1996-6#1)(2011-2#1)(2011-3#1)
new genotypes##7##2##(2008-10#6)(2011-2#1)
new genus##9##2##(1997-4#2)(2008-10#2)(2008-12#1)(2008-5#2)(2010-10#2)
new glucolipidic surfactant##2##3##(2008-5#2)
new glycoside##2##2##(2007-11#1)(2008-11#1)
new graduate nurses##2##3##(2007-10#2)
new graduates##4##2##(1993-11#1)(1995-1#1)(2008-11#1)(2012-12#1)
new graphical##5##2##(1995-12#1)(2008-10#2)(2008-7#1)(2009-7#1)
new group of##6##3##(1991-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#1)
new group##8##2##(1991-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-4#1)
new groups##2##2##(2008-10#1)(2011-2#1)
new guidelines##6##2##(2008-11#1)(2008-3#2)(2008-6#1)(2009-8#1)(2010-5#1)
new health care##4##3##(1994-12#1)(1995-12#1)(1995-2#1)(2008-1#1)
new health##10##2##(1992-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(2008-1#1)(2008-2#1)(2013-8#1)
new healthcare##2##2##(2008-10#1)(2013-1#1)
new heights##2##2##(2008-2#1)(2013-1#1)
new high##3##2##(2007-7#1)(2008-10#2)
new highly##7##2##(1992-2#1)(2008-10#5)(2008-2#1)
new hope for##2##3##(2008-4#1)(2011-3#1)
new hope##3##2##(1996-9#1)(2008-4#1)(2011-3#1)
new horizons for##2##3##(2008-11#1)(2008-9#1)
new horizons##4##2##(2008-1#1)(2008-11#2)(2008-9#1)
new host##13##2##(2008-10#3)(2008-8#5)(2011-1#1)(2011-2#1)(2012-2#3)
new host-vector systems##2##3##(1993-12#2)
new human##4##2##(1993-3#1)(1994-12#1)(2007-11#1)(2008-9#1)
new hybrid##3##2##(2008-3#3)
new hydrogen bond##2##3##(1990-7#1)(2008-8#1)
new hypotheses##2##2##(2008-11#1)(2008-4#1)
new idea of##2##3##(1994-12#1)(2007-12#1)
new idea##3##2##(1994-12#1)(2007-12#1)(2008-2#1)
new ideas and##2##3##(1996-12#1)(2012-3#1)
new ideas##8##2##(1995-1#1)(1996-12#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-3#1)(2013-1#1)
new image##7##2##(1992-1#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-9#1)
new imaging technologies##3##3##(2008-2#3)
new imaging##9##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-6#1)(2010-8#1)(2012-2#1)
new immobilized##2##2##(2008-10#2)
new implant##3##2##(2008-9#2)(2009-7#1)
new in vitro##2##3##(1996-5#1)(2008-10#1)
new in##10##2##(1994-10#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#3)(2009-5#1)(2009-8#1)(2013-1#1)
new index##3##2##(2008-3#1)(2009-11#1)(2013-7#1)
new indications for##2##3##(2008-10#1)(2008-7#1)
new indicator##2##2##(2008-10#1)(2013-1#1)
new indices##2##2##(2008-3#1)(2009-8#1)
new infected##2##2##(2008-10#2)
new infection##3##2##(1997-5#1)(2008-10#1)(2013-1#1)
new infections##4##2##(1990-6#1)(2008-10#1)(2009-4#1)(2012-2#1)
new information about the##3##4##(1997-7#1)(2006-10#1)(2012-2#1)
new information concerning the##2##4##(2008-2#1)(2008-8#1)
new information on the##2##4##(2008-10#1)(2012-12#1)
new information on##6##3##(2008-10#1)(2008-3#2)(2012-12#1)(2012-2#1)(2013-7#1)
new information system will##2##4##(1992-11#1)(1994-12#1)
new information##29##2##(1992-11#1)(1993-2#1)(1994-12#3)(1994-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
new inhibitors of##2##3##(1997-3#1)(2013-1#1)
new inhibitors##4##2##(1997-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
new initiatives##2##2##(1995-12#1)(2008-11#1)
new insight into the##14##4##(1993-2#1)(1993-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)
new insight into##19##3##(1991-5#1)(1993-2#1)(1993-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
new insight##24##2##(1991-5#1)(1993-2#1)(1993-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
new insights in the##3##4##(2008-10#1)(2009-5#1)(2011-2#1)
new insights in##8##3##(2008-10#2)(2008-11#2)(2009-5#1)(2011-2#2)(2012-2#1)
new insights into risk factors##2##5##(2008-8#1)(2011-2#1)
new insights into the pathophysiology##2##5##(2007-7#1)(2009-7#1)
new insights into the##25##4##(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#2)(2010-12#1)(2011-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
new insights into##33##3##(1996-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
new insights that##2##3##(2008-10#1)(2008-2#1)
new insights##53##2##(1992-3#1)(1993-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
new instrument for##2##3##(1992-3#1)(2009-3#1)
new instrument to measure##2##4##(1997-1#1)(2008-3#1)
new instrument##8##2##(1992-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)
new instrumentation and##2##3##(2008-10#1)(2008-8#1)
new integrated##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
new interface##2##2##(2009-10#1)(2010-10#1)
new interpretation##2##2##(1992-8#1)(2007-12#1)
new ion-selective##3##2##(2008-10#3)
new isoform##3##2##(1992-3#2)(1993-6#1)
new isolates and##2##3##(2008-10#2)
new isolates##3##2##(2008-10#2)(2011-1#1)
new issues##2##2##(1994-1#1)(1997-1#1)
new joint##3##2##(2008-2#2)(2009-7#1)
new journal##3##2##(2008-7#2)(2009-4#1)
new kind of##11##3##(1994-3#1)(1995-6#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)
new kinds of##2##3##(1997-3#1)(2008-7#1)
new kinetic method##2##3##(2008-10#2)
new kinetic##3##2##(2008-10#3)
new knowledge related to##2##4##(2011-2#1)(2012-2#1)
new knowledge##11##2##(1990-6#1)(1991-3#2)(1995-12#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
new laser##8##2##(1992-12#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
new law##5##2##(1992-1#1)(1996-5#2)(1997-5#1)(2013-1#1)
new leads for##2##3##(2008-4#2)
new leaf rust resistance##2##4##(2008-10#2)
new learning##4##2##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
new lesions##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
new level of##6##3##(1993-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)
new level##7##2##(1993-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
new life##3##2##(1997-3#1)(2008-1#1)(2008-10#1)
new light on the##8##4##(1997-2#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#3)
new light on##13##3##(1994-12#1)(1997-2#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
new light##15##2##(1994-12#1)(1997-2#2)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
new linear##2##2##(2008-10#1)(2008-9#1)
new lipophilic##3##2##(2008-10#3)
new locality##4##2##(1990-8#1)(2008-5#1)(2011-1#2)
new location-scale test##2##3##(2012-1#2)
new loci##2##2##(1991-5#1)(2008-1#1)
new look at##4##3##(1993-2#1)(1996-2#1)(2008-4#1)(2008-9#1)
new look##5##2##(1993-2#1)(1996-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
new luminescence##2##2##(1996-12#1)(2008-10#1)
new major##2##2##(2008-10#2)
new management##2##2##(1995-3#1)(2009-3#1)
new marker of##3##3##(1995-2#1)(2008-5#1)(2011-2#1)
new markers and##2##3##(1997-9#1)(2008-7#1)
new markers##7##2##(1994-12#1)(1996-12#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
new markets##3##2##(1992-2#1)(1997-3#1)(2011-2#1)
new material for##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
new material##9##2##(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)
new materials and##3##3##(2010-10#1)(2010-7#1)(2012-3#1)
new materials for##5##3##(2009-8#1)(2010-11#1)(2010-7#1)(2013-1#2)
new materials##9##2##(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#2)(2012-3#1)(2013-1#3)
new mathematical##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
new means##3##2##(1990-12#1)(1990-5#1)(2008-3#1)
new measure##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
new measurement##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
new measures of##3##3##(1992-9#1)(1995-2#1)(2007-12#1)
new measures##4##2##(1992-9#2)(1995-2#1)(2007-12#1)
new mechanism for##5##3##(2007-11#1)(2008-2#1)(2008-4#1)(2012-2#1)(2012-3#1)
new mechanism of action for##2##5##(2008-5#1)(2010-9#1)
new mechanism of action##3##4##(2008-10#1)(2008-5#1)(2010-9#1)
new mechanism of##7##3##(1990-8#1)(1992-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)
new mechanism##13##2##(1990-8#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#1)(2012-3#1)
new mechanisms##2##2##(2008-3#1)(2013-1#1)
new mechanistic##2##2##(2008-11#1)(2008-7#1)
new medical physicists##2##3##(2007-4#2)
new medical##10##2##(1991-3#1)(1992-2#1)(1993-2#1)(2007-4#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
new medicines##2##2##(2008-12#1)(2008-8#1)
new medium##3##2##(2007-7#2)(2008-11#1)
new member of the genus##7##5##(2008-10#7)
new member of the##13##4##(1994-12#1)(1995-12#1)(1995-6#1)(1997-3#1)(2008-10#7)(2008-4#1)(2009-3#1)
new member of##16##3##(1994-12#1)(1995-12#1)(1995-6#1)(1997-3#1)(2008-10#7)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)
new member##17##2##(1994-12#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)
new members of the##5##4##(1993-6#1)(1993-9#2)(2008-10#1)(2013-8#1)
new members##9##2##(1993-1#1)(1993-6#1)(1993-9#2)(1996-3#1)(1997-9#2)(2008-10#1)(2013-8#1)
new membrane##3##2##(2008-10#1)(2008-7#2)
new merit function##2##3##(2008-3#2)
new metabolite##4##2##(1994-8#1)(2008-11#2)(2009-10#1)
new metal##2##2##(2008-10#1)(2010-5#1)
new metastases##2##2##(1997-4#1)(2007-11#1)
new method and##2##3##(2008-10#1)(2013-8#1)
new method based on##2##4##(2007-11#1)(2008-10#1)
new method based##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
new method called##3##3##(2008-10#2)(2008-5#1)
new method can be##2##4##(2008-10#1)(2008-3#1)
new method can##3##3##(2008-10#1)(2008-3#2)
new method enables##2##3##(1990-8#1)(2010-8#1)
new method for estimating the##2##5##(1995-3#1)(2008-9#1)
new method for measuring##4##4##(1996-12#1)(2007-12#1)(2008-2#1)(2012-2#1)
new method for rapid##2##4##(2007-11#1)(2008-10#1)
new method for the analysis of##2##6##(1993-8#1)(2008-10#1)
new method for the determination of the##2##7##(2008-10#2)
new method for the determination of trace##2##7##(2008-10#2)
new method for the determination of##13##6##(2008-10#12)(2008-3#1)
new method for the preparation of##2##6##(2008-10#2)
new method for the treatment of##2##6##(2007-11#1)(2008-10#1)
new method for the##30##4##(1993-11#2)(1993-8#1)(2007-11#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
new method for##77##3##(1990-12#1)(1992-5#1)(1993-11#2)(1993-8#1)(1994-11#1)(1995-3#1)(1996-12#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#36)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2010-9#1)(2012-2#2)
new method has##8##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
new method is described for the determination of##2##8##(2008-10#2)
new method is described for##4##5##(1990-11#1)(2007-12#1)(2008-10#2)
new method is fast##2##4##(1996-5#1)(2008-4#1)
new method is presented to##2##5##(2008-2#1)(2011-2#1)
new method is presented##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
new method is##25##3##(1990-11#1)(1996-5#1)(2007-11#2)(2007-12#3)(2008-10#10)(2008-2#3)(2008-3#3)(2008-4#1)(2011-2#1)
new method of marking##2##4##(2007-8#1)(2010-8#1)
new method of measuring##2##4##(1990-2#1)(2007-11#1)
new method of##31##3##(1990-2#1)(1994-9#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#7)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#2)(2010-8#1)(2012-3#1)
new method proposed##2##3##(2008-10#2)
new method that##3##3##(1992-3#1)(2007-11#1)(2008-11#1)
new method to evaluate##3##4##(2008-5#2)(2009-11#1)
new method to measure##3##4##(2008-2#1)(2008-5#2)
new method to##22##3##(1993-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#4)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#1)
new method using##6##3##(2008-10#5)(2008-7#1)
new method was developed for##2##5##(2008-10#2)
new method was developed##3##4##(2008-10#3)
new method was##8##3##(2008-10#5)(2008-7#1)(2009-9#1)(2011-2#1)
new method##236##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#2)(2007-11#12)(2007-12#11)(2007-8#4)(2008-1#1)(2008-10#87)(2008-11#2)(2008-12#1)(2008-2#17)(2008-3#27)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
new methodological##2##2##(1996-2#1)(2013-8#1)
new methodology##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
new methods are##2##3##(1991-5#1)(2008-10#1)
new methods for##5##3##(1993-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
new methods of treatment##3##4##(2007-11#1)(2007-8#2)
new methods of##8##3##(2007-11#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2011-1#2)
new methods to##4##3##(1997-1#1)(1997-3#1)(2008-3#1)(2009-6#1)
new methods##27##2##(1991-5#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-11#1)(1997-1#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-1#1)(2011-1#2)(2013-8#1)
new methylene##3##2##(2006-6#1)(2008-10#2)
new mindset##2##2##(1994-1#1)(1994-12#1)
new mini-Mu##2##2##(1994-12#2)
new mode of##3##3##(1995-11#1)(2007-12#1)(2008-11#1)
new model for##7##3##(1991-7#1)(1994-12#1)(1996-9#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)
new model of##11##3##(1991-5#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
new model##34##2##(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
new models of##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
new models##5##2##(2008-11#1)(2008-9#1)(2009-7#1)(2010-8#1)(2013-1#1)
new modes of##2##3##(1997-3#1)(2010-5#1)
new modes##3##2##(1997-3#1)(2010-5#1)(2010-7#1)
new modified##7##2##(1993-8#1)(2007-7#1)(2008-10#4)(2008-3#1)
new modulation##2##2##(2008-3#2)
new molecular entities##2##3##(2008-10#1)(2010-10#1)
new molecular targets for##2##4##(2008-7#1)(2010-12#1)
new molecular targets##5##3##(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
new molecular##14##2##(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
new molecules##5##2##(1990-2#1)(2009-12#1)(2010-11#1)(2011-3#1)(2012-12#1)
new monoclonal##2##2##(1992-2#1)(1993-12#1)
new moon##2##2##(2008-5#1)(2010-8#1)
new movement##2##2##(1992-1#1)(2008-2#1)
new murine##2##2##(1990-8#1)(1991-12#1)
new mutations##2##2##(2010-4#2)
new national##7##2##(1994-9#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)
new natural product##2##3##(2010-2#1)(2011-2#1)
new natural##3##2##(2008-5#1)(2010-2#1)(2011-2#1)
new neurological deficit##2##3##(1997-6#1)(2007-10#1)
new neurological deficits##3##3##(2007-10#3)
new neurological##7##2##(1997-6#1)(2007-10#4)(2007-8#1)(2012-12#1)
new neurons from##2##3##(2008-7#1)(2012-2#1)
new neurons##4##2##(1996-5#1)(2008-7#1)(2012-2#2)
new noise-reduction##2##2##(2008-3#2)
new non-cavitated caries##3##3##(2012-2#3)
new non-cavitated##4##2##(2012-2#4)
new nucleic acid##2##3##(2010-6#1)(2012-12#1)
new nucleic##3##2##(2008-10#1)(2010-6#1)(2012-12#1)
new nurses##2##2##(2011-2#2)
new nursing curriculum##2##3##(2008-11#2)
new nursing roles##2##3##(2008-11#2)
new nursing##6##2##(1995-3#1)(2008-11#4)(2010-3#1)
new observations##6##2##(1990-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
new one##5##2##(1992-9#1)(1996-6#2)(2008-10#1)(2008-11#1)
new ones##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
new online##3##2##(1991-2#1)(1994-1#1)(2008-12#1)
new onset##4##2##(2008-7#2)(2012-12#2)
new open reading frames (ORFs)##2##5##(1996-3#1)(1997-3#1)
new open reading frames and##2##5##(1997-3#2)
new open reading frames including##2##5##(1995-6#1)(1996-6#1)
new open reading frames##9##4##(1995-6#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-3#4)
new opportunities for##8##3##(1993-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
new opportunities in the##2##4##(2008-7#1)(2010-2#1)
new opportunities to explore the##2##5##(2009-11#1)(2010-3#1)
new opportunities to##4##3##(1997-8#1)(2009-11#1)(2010-3#1)(2011-2#1)
new opportunities##19##2##(1993-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#1)
new opportunity to##3##3##(2008-10#2)(2010-11#1)
new opportunity##5##2##(1994-3#1)(2008-10#2)(2008-2#1)(2010-11#1)
new optical implementation of##2##4##(2007-12#1)(2008-2#1)
new optical system##3##3##(2008-3#3)
new optical##16##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#7)
new option for the treatment of##3##6##(2006-10#1)(2008-3#1)(2013-1#1)
new option##4##2##(2006-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
new or ancient##2##3##(2013-1#2)
new or##13##2##(1994-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
new organizational structure##3##3##(1992-5#2)(1995-1#1)
new organizational structures##2##3##(1991-3#1)(1995-1#1)
new organizational##6##2##(1991-3#1)(1992-5#2)(1995-1#2)(1996-1#1)
new organizations##3##2##(1996-12#1)(1997-2#1)(2008-7#1)
new original##2##2##(2008-7#1)(2012-3#1)
new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase (CABS)##2##7##(2008-10#2)
new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##3##6##(2008-10#3)
new packets##2##2##(2008-3#2)
new packing material##2##3##(2008-10#2)
new packing##4##2##(2008-10#4)
new paradigm for insulin resistance##2##5##(2008-3#2)
new paradigm for##13##3##(1993-2#1)(1996-11#1)(1996-3#1)(2008-3#3)(2008-4#2)(2009-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
new paradigm in##2##3##(2012-3#2)
new paradigm##20##2##(1991-3#1)(1993-2#1)(1996-11#1)(1996-3#1)(2008-3#4)(2008-4#2)(2008-8#2)(2009-12#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
new paradigms in##2##3##(2007-9#1)(2009-12#1)
new paradigms##4##2##(1994-2#1)(2007-9#1)(2008-9#1)(2009-12#1)
new parameter##5##2##(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
new parameters##2##2##(2008-9#1)(2011-1#1)
new parents##3##2##(1995-1#1)(2007-2#1)(2008-11#1)
new path##2##2##(1994-2#1)(2008-3#1)
new pathway for##2##3##(1990-8#1)(2010-11#1)
new pathway##5##2##(1990-8#1)(1991-12#1)(2008-7#1)(2010-11#1)(2012-2#1)
new patient##2##2##(1997-1#1)(2011-2#1)
new pattern of##2##3##(1992-1#1)(2008-10#1)
new pattern##3##2##(1992-1#1)(2008-10#1)(2008-6#1)
new payment##5##2##(1992-12#1)(1992-2#1)(1997-1#1)(2012-3#1)(2013-7#1)
new peak##2##2##(2008-10#2)
new peaks##2##2##(2008-10#1)(2008-3#1)
new peptide##3##2##(1992-8#1)(1994-11#1)(2008-7#1)
new perspective on the##2##4##(2008-3#1)(2008-8#1)
new perspective on##4##3##(1996-3#1)(2008-3#1)(2008-8#1)(2009-5#1)
new perspective##8##2##(1994-1#1)(1996-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-3#2)
new perspectives for##4##3##(2007-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
new perspectives in the##3##4##(2007-12#1)(2008-5#1)(2010-4#1)
new perspectives in##4##3##(2007-12#1)(2007-7#1)(2008-5#1)(2010-4#1)
new perspectives##14##2##(1993-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)
new phage##2##2##(1994-12#1)(2007-7#1)
new pharmaceutical##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
new phase separator##2##3##(2008-10#2)
new phase##3##2##(1992-5#1)(2008-10#2)
new phase-matching##2##2##(2007-12#2)
new phenotypes##2##2##(2010-4#2)
new physical##4##2##(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#1)
new physician##5##2##(1992-2#1)(1992-8#1)(1993-2#1)(1994-3#2)
new physiological##3##2##(1990-11#1)(1997-6#1)(2013-1#1)
new plan of care destined to adults at the Pavillon Albert-Prévost##2##11##(2008-2#2)
new plan##5##2##(1991-1#1)(1992-12#1)(2008-2#3)
new plant##2##2##(2008-5#2)
new plants##2##2##(2008-10#2)
new polymeric##2##2##(2007-11#1)(2008-10#1)
new polypeptide##2##2##(2008-10#2)
new polyps##2##2##(2012-1#2)
new positions were advertised in##2##5##(1990-6#2)
new positions##4##2##(1990-6#2)(2007-4#1)(2012-12#1)
new possibilities for##4##3##(2007-12#2)(2008-11#1)(2008-3#1)
new possibilities in##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
new possibilities##10##2##(1991-11#1)(1991-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
new possible##3##2##(1990-8#1)(2012-2#2)
new potential##7##2##(1991-2#1)(1996-5#1)(1997-3#1)(2008-8#1)(2011-2#2)(2012-3#1)
new practice##3##2##(1992-8#1)(2008-11#2)
new prescription##2##2##(1996-11#1)(2008-11#1)
new preventive##3##2##(2007-12#2)(2008-11#1)
new primary##7##2##(1990-12#1)(1991-8#4)(1995-3#1)(2013-7#1)
new primer##2##2##(1992-3#1)(2008-10#1)
new primers##5##2##(1993-9#1)(2008-10#2)(2012-12#2)
new principle##2##2##(2008-3#1)(2010-5#1)
new probes##3##2##(2008-10#3)
new problems##3##2##(1990-12#1)(1996-3#1)(2008-10#1)
new procedure for the determination of##2##6##(2008-10#2)
new procedure for the##3##4##(2008-10#2)(2008-12#1)
new procedure for##6##3##(2008-10#4)(2008-12#1)(2011-2#1)
new procedure in##2##3##(1990-8#1)(2008-10#1)
new procedure is##4##3##(2008-10#3)(2008-3#1)
new procedure was applied to##2##5##(2008-10#2)
new procedure##25##2##(1990-3#1)(1990-8#1)(1992-3#1)(2008-10#15)(2008-12#1)(2008-3#2)(2008-5#1)(2009-9#1)(2011-2#2)
new procedures##6##2##(1991-3#2)(1994-11#1)(1994-3#1)(2008-10#1)(2008-7#1)
new product##5##2##(1992-2#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
new products have been approved##2##5##(2012-2#2)
new products##5##2##(1992-2#1)(1992-6#1)(2010-8#1)(2012-2#2)
new professional##2##2##(1997-2#1)(2008-11#1)
new prognostic##3##2##(2007-10#1)(2010-11#1)(2011-2#1)
new program##5##2##(1991-2#1)(1995-4#1)(1996-2#1)(2008-2#1)(2008-8#1)
new programme##2##2##(1990-12#1)(1995-11#1)
new programs and##2##3##(1992-8#1)(1994-1#1)
new programs##6##2##(1991-1#1)(1992-1#1)(1992-8#1)(1994-1#1)(1996-1#1)(1996-2#1)
new project##2##2##(2008-10#2)
new promising##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
new properties##2##2##(2008-10#1)(2011-2#1)
new prospective##2##2##(2010-8#1)(2011-2#1)
new prospects for the##2##4##(2008-2#1)(2008-5#1)
new prospects for##3##3##(2008-2#1)(2008-5#1)(2008-9#1)
new prospects##5##2##(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
new protein##6##2##(2008-10#3)(2008-2#1)(2008-4#1)(2009-3#1)
new proteins has been##2##4##(1997-6#2)
new proteins has##3##3##(1997-6#2)(2010-4#1)
new proteins##4##2##(1997-6#2)(2008-10#1)(2010-4#1)
new protocol##6##2##(2007-11#1)(2008-10#4)(2008-9#1)
new public health##6##3##(1992-1#6)
new public##7##2##(1992-1#6)(1997-2#1)
new putative##2##2##(1991-5#1)(1995-12#1)
new quality##2##2##(1993-2#1)(2007-11#1)
new quantitative##7##2##(1996-12#1)(1997-6#1)(2008-10#3)(2008-5#1)(2012-2#1)
new questions##4##2##(1993-12#1)(2008-11#1)(2010-5#1)(2012-3#1)
new races##4##2##(2008-10#4)
new radiation##2##2##(2008-12#1)(2008-3#1)
new radiologic##2##2##(1990-10#1)(2012-3#1)
new range of##2##3##(2007-11#1)(2008-10#1)
new rapid##3##2##(1994-5#1)(2008-10#2)
new reagent##6##2##(2008-10#6)
new real-time##3##2##(2007-11#1)(2008-6#2)
new records for##6##3##(2008-10#1)(2008-5#4)(2008-6#1)
new records##7##2##(2008-10#1)(2008-12#1)(2008-5#4)(2008-6#1)
new redox##2##2##(2008-10#2)
new refractometer##2##2##(2007-11#2)
new regression method##2##3##(2008-10#2)
new regulations##2##2##(1991-1#2)
new regulatory##2##2##(2007-5#1)(2008-7#1)
new relationship##2##2##(1995-1#1)(2008-5#1)
new reports##4##2##(2006-10#1)(2008-5#3)
new research and##2##3##(2008-3#1)(2010-5#1)
new research##12##2##(1995-6#1)(1996-11#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2013-7#1)
new resin##5##2##(2008-10#5)
new resistance gene##3##3##(2008-10#3)
new resistance##5##2##(2008-10#5)
new resonance##2##2##(2008-10#2)
new resources##2##2##(2008-1#1)(2009-7#1)
new responsibilities##2##2##(1995-12#1)(2007-12#1)
new result##2##2##(2008-3#1)(2012-3#1)
new results##5##2##(2008-2#1)(2008-3#3)(2010-9#1)
new retroviral vector##2##3##(1997-8#1)(2008-11#1)
new retroviral##4##2##(1997-8#3)(2008-11#1)
new risk##6##2##(1994-2#1)(2007-9#1)(2009-7#1)(2011-2#2)(2012-2#1)
new role for##6##3##(1990-11#1)(1991-3#1)(1992-6#1)(1996-12#1)(1996-2#1)(1997-6#1)
new role##7##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-6#1)(1996-12#1)(1996-2#1)(1997-6#1)
new roles and##2##3##(1993-12#1)(1995-12#1)
new roles for##6##3##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(2008-11#1)(2008-7#1)
new roles##11##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-11#2)(2008-7#1)(2012-12#1)
new root-knot nematode##2##3##(2008-10#2)
new route##6##2##(1991-1#1)(2007-11#2)(2008-5#2)(2012-12#1)
new routine##2##2##(1992-6#1)(1995-3#1)
new sample##7##2##(2007-12#1)(2008-10#5)(2012-2#1)
new sampling methods for##2##4##(2008-10#2)
new sampling##4##2##(2008-10#4)
new schedule##4##2##(1992-2#3)(1993-11#1)
new scheme for##5##3##(2007-12#1)(2008-3#3)(2010-3#1)
new scheme to##2##3##(2007-12#1)(2008-2#1)
new scheme##14##2##(1993-12#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#4)(2010-3#1)
new science##5##2##(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-9#1)
new scientific##7##2##(2008-11#3)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)
new screening##4##2##(2008-10#1)(2008-8#1)(2009-6#1)(2009-9#1)
new selective##4##2##(1997-6#1)(2008-10#3)
new semi-dwarf gene##2##3##(2008-9#2)
new sensing##2##2##(2008-10#2)
new sensitive and selective##3##4##(2008-10#3)
new sensitive##12##2##(1990-2#1)(1995-11#1)(1996-5#1)(2008-10#9)
new sensor##5##2##(2007-11#1)(2008-10#3)(2010-2#1)
new sequence##3##2##(1992-6#1)(1996-3#1)(2008-7#1)
new sequences##2##2##(2008-10#1)(2012-3#1)
new series of##5##3##(1991-9#1)(1996-6#1)(2008-11#1)(2008-4#1)(2009-9#1)
new serotypes##2##2##(1996-12#1)(2013-8#1)
new serum-free##2##2##(2008-11#2)
new service delivery##2##3##(2008-6#1)(2012-12#1)
new service##4##2##(1993-12#1)(1997-3#1)(2008-6#1)(2012-12#1)
new services##4##2##(1994-2#1)(1997-3#3)
new set of##9##3##(1993-2#1)(1996-2#1)(1996-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2013-1#1)
new sets of##2##3##(2008-10#1)(2011-2#1)
new setup##2##2##(2008-2#1)(2008-3#1)
new ship was##2##3##(2009-7#2)
new short-acting##2##2##(1997-4#2)
new simple and##7##3##(1990-5#1)(2008-10#6)
new simple##12##2##(1990-5#1)(2008-10#9)(2008-2#1)(2008-9#1)
new single-well potential stochastic resonance algorithm (SSR)##2##7##(2008-10#2)
new single-well potential stochastic resonance algorithm##3##6##(2008-10#3)
new skill##3##2##(1995-2#1)(1996-2#1)(2008-11#1)
new skills and##3##3##(1993-12#1)(1996-2#1)(2008-11#1)
new skills##6##2##(1993-12#1)(1996-2#1)(2007-8#1)(2008-11#2)(2011-2#1)
new social##3##2##(1997-1#1)(2010-12#1)(2012-12#1)
new software##6##2##(1991-2#1)(1992-12#1)(2008-2#2)(2009-1#1)(2011-2#1)
new solid supports##2##3##(1997-4#2)
new solid##4##2##(1997-4#2)(1997-7#1)(2008-10#1)
new solid-phase##3##2##(1995-6#2)(2008-10#1)
new solutions for##2##3##(2007-8#1)(2012-12#1)
new solutions##3##2##(2007-8#1)(2008-3#1)(2012-12#1)
new sorbent##2##2##(2008-10#1)(2009-8#1)
new source of##5##3##(1995-2#1)(2008-10#2)(2012-2#2)
new source##7##2##(1995-2#1)(1995-8#1)(2008-10#3)(2012-2#2)
new sources of##4##3##(1991-1#1)(2008-10#1)(2008-11#1)(2010-11#1)
new sources##5##2##(1991-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-11#1)
new spatial##2##2##(2007-11#1)(2008-2#1)
new species as##2##3##(1993-11#1)(2008-12#1)
new species have##2##3##(2008-10#2)
new species in##4##3##(2008-10#3)(2010-9#1)
new species of the genus##2##5##(2008-5#1)(2008-6#1)
new species of the##3##4##(2008-5#2)(2008-6#1)
new species of##18##3##(2008-10#2)(2008-5#10)(2008-6#3)(2008-8#1)(2011-2#1)(2013-7#1)
new species##53##2##(1993-11#1)(2008-10#16)(2008-12#1)(2008-5#19)(2008-6#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#3)(2013-8#3)
new specific##3##2##(2008-10#2)(2008-5#1)
new specimens##2##2##(1994-3#2)
new spectrofluorimetric method for the determination of##3##7##(2008-10#3)
new spectrofluorimetric##4##2##(2008-10#4)
new spectrophotometric method for the##2##5##(2008-10#2)
new spectrophotometric method##4##3##(2008-10#4)
new spectrophotometric##6##2##(2008-10#6)
new spiro##2##2##(2007-11#1)(2008-11#1)
new spray reagent for##2##4##(2008-10#2)
new staging##3##2##(1990-9#1)(2007-8#2)
new standard of##3##3##(2008-1#2)(2010-3#1)
new standard##5##2##(2008-1#2)(2008-7#1)(2010-3#1)(2011-2#1)
new standards##4##2##(1996-2#1)(2006-5#1)(2009-10#1)(2010-11#1)
new stationary##3##2##(2008-10#3)
new steady-state pHi##2##3##(1990-2#2)
new steady-state##3##2##(1990-2#2)(2008-10#1)
new steroid##2##2##(1991-8#1)(1991-9#1)
new strain##6##2##(1993-9#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#2)
new strains##2##2##(2008-10#1)(2008-5#1)
new strategies and##4##3##(1995-12#1)(2008-11#2)(2011-10#1)
new strategies for the##2##4##(2008-4#1)(2011-2#1)
new strategies for##5##3##(2008-10#1)(2008-4#1)(2009-3#1)(2010-5#1)(2011-2#1)
new strategies in##2##3##(2008-8#1)(2010-12#1)
new strategies to##3##3##(1997-8#1)(2013-1#2)
new strategies##19##2##(1993-2#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-2#3)(2013-1#2)
new strategy for the##2##4##(2008-10#1)(2011-1#1)
new strategy for##11##3##(1995-3#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
new strategy to##2##3##(1993-9#1)(2008-10#1)
new strategy##18##2##(1991-1#1)(1993-9#1)(1995-3#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
new strong cancer rescue mutants than##2##6##(2009-9#2)
new structural##4##2##(1992-6#1)(1994-9#1)(2008-8#1)(2011-3#1)
new structure##5##2##(1992-5#1)(2008-12#1)(2011-3#1)(2013-8#2)
new studies##4##2##(2008-10#1)(2009-10#1)(2011-2#2)
new study##4##2##(1994-8#1)(2008-10#2)(2013-1#1)
new subgroup##2##2##(2008-10#2)
new substrate##2##2##(1991-5#1)(2008-10#1)
new sunscreen of the cinnamate class##2##6##(2008-5#2)
new surface##2##2##(2008-10#1)(2008-11#1)
new surgery##2##2##(1993-2#1)(2010-12#1)
new surgical devices##2##3##(1993-6#1)(2010-8#1)
new surgical technique##3##3##(2011-7#1)(2012-2#2)
new surgical techniques##3##3##(1994-6#1)(2007-8#1)(2011-2#1)
new surgical##11##2##(1993-6#1)(1994-6#1)(2007-8#2)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)
new survey##2##2##(1993-12#1)(2008-10#1)
new synthesis of##3##3##(1997-2#2)(2009-9#1)
new synthetic##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
new system can##2##3##(2008-3#1)(2010-8#1)
new system is##2##3##(2008-10#1)(2008-9#1)
new system of##4##3##(1995-12#1)(1996-2#1)(2008-10#1)(2008-6#1)
new system##21##2##(1991-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-9#2)(2010-4#1)(2010-8#2)(2010-9#1)
new systems and##2##3##(1997-3#1)(2011-2#1)
new systems##7##2##(1993-2#1)(1997-3#3)(2008-11#2)(2011-2#1)
new targets for##4##3##(1994-9#1)(2008-8#1)(2010-3#1)(2012-2#1)
new targets##8##2##(1994-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2012-2#2)
new taxa##2##2##(1997-5#1)(2008-5#1)
new technique for the study of##2##6##(2013-1#2)
new technique for the##7##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#2)
new technique for##33##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#7)(2008-6#1)(2008-9#1)(2010-1#1)(2010-8#1)(2013-1#2)
new technique in##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
new technique is##4##3##(2008-10#2)(2008-2#2)
new technique of##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
new technique that##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
new technique to##6##3##(1990-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
new technique##87##2##(1990-3#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-2#1)(1997-3#2)(2007-11#7)(2007-12#4)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#11)(2008-3#21)(2008-4#1)(2008-6#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
new techniques and##4##3##(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#1)
new techniques of##2##3##(1996-9#1)(2011-2#1)
new techniques##19##2##(1991-3#1)(1994-2#2)(1996-9#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
new technologies and##4##3##(1993-2#1)(1996-1#1)(2008-10#1)(2008-7#1)
new technologies for##2##3##(2008-10#1)(2008-6#1)
new technologies in##3##3##(1992-2#1)(2008-11#1)(2010-7#1)
new technologies such as##2##4##(2008-10#1)(2013-1#1)
new technologies##30##2##(1992-2#1)(1993-2#1)(1994-5#1)(1996-1#1)(1996-8#1)(2008-10#4)(2008-11#6)(2008-6#1)(2008-7#3)(2009-12#1)(2010-11#1)(2010-7#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#4)
new technology for##3##3##(1997-7#1)(2007-8#1)(2008-10#1)
new technology in##2##3##(2008-10#2)
new technology of##3##3##(1994-1#1)(2008-11#1)(2008-5#1)
new technology to##2##3##(1990-4#1)(2007-9#1)
new technology##26##2##(1990-4#1)(1991-12#1)(1994-1#1)(1997-7#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2013-8#1)
new term##2##2##(1990-11#1)(2008-7#1)
new test##6##2##(1992-9#1)(1996-5#1)(2008-5#1)(2008-9#1)(2012-1#2)
new theoretical##3##2##(2008-2#1)(2008-3#2)
new theories##2##2##(1995-1#1)(2009-8#1)
new theory##5##2##(2008-1#1)(2008-10#1)(2009-3#1)(2009-8#1)(2012-2#1)
new therapeutic agents##4##3##(2008-7#1)(2010-5#2)(2010-7#1)
new therapeutic approach##4##3##(1994-5#1)(1997-8#1)(2008-7#1)(2013-8#1)
new therapeutic approaches to##4##4##(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)
new therapeutic approaches##8##3##(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-3#1)
new therapeutic options##2##3##(2008-3#1)(2013-1#1)
new therapeutic strategies##7##3##(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
new therapeutic target##2##3##(2008-5#1)(2011-2#1)
new therapeutic targets in##2##4##(2008-7#1)(2012-2#1)
new therapeutic targets##3##3##(2008-7#1)(2009-5#1)(2012-2#1)
new therapeutic##48##2##(1991-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#2)
new therapies for##2##3##(2009-10#1)(2010-5#1)
new therapies in##2##3##(2008-4#1)(2011-2#1)
new therapies that##2##3##(2008-8#1)(2011-2#1)
new therapies##20##2##(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#2)
new therapy##4##2##(1990-3#1)(1994-11#1)(2012-3#1)(2013-8#1)
new to the##2##3##(2008-7#1)(2013-8#1)
new to##12##2##(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
new tombusvirus##2##2##(2008-10#2)
new tool for improving##2##4##(1994-8#1)(2010-2#1)
new tool for the##3##4##(1996-12#1)(2007-8#1)(2011-2#1)
new tool for##12##3##(1993-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)
new tool in##5##3##(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#1)
new tool to##6##3##(1996-12#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)(2012-12#1)
new tool##28##2##(1993-3#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
new tools for the##2##4##(2007-6#1)(2008-11#1)
new tools for##5##3##(1995-12#1)(2007-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
new tools##11##2##(1995-12#1)(1996-2#1)(1996-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-9#1)
new toothpaste##3##2##(2011-2#3)
new tospovirus species##4##3##(2008-10#4)
new tospovirus##5##2##(2008-10#5)
new training##2##2##(1994-12#1)(2008-11#1)
new traits##5##2##(2010-4#5)
new transvaginal##2##2##(2011-2#2)
new treatment approaches##2##3##(2010-3#1)(2012-3#1)
new treatment modalities##3##3##(1997-8#1)(2008-8#1)(2011-2#1)
new treatment of##2##3##(1996-8#1)(2010-3#1)
new treatment strategies##2##3##(1994-5#1)(2008-9#1)
new treatment##26##2##(1990-6#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-3#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
new treatments for##3##3##(2010-7#1)(2012-1#1)(2013-8#1)
new treatments##8##2##(2008-11#1)(2009-7#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-8#2)
new trends##4##2##(1995-2#1)(1996-1#1)(2007-11#1)(2008-10#1)
new trial##6##2##(1992-2#1)(1996-6#4)(1997-5#1)
new tunable##2##2##(2008-3#1)(2013-8#1)
new twist##2##2##(1990-8#1)(2008-7#1)
new type of##49##3##(1990-12#1)(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-5#1)(2007-11#2)(2007-12#4)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-8#2)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#2)
new type##52##2##(1990-12#1)(1990-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-5#1)(2007-11#2)(2007-12#4)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-8#2)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
new types of human adenovirus##3##5##(2013-8#3)
new types of human##4##4##(2013-8#4)
new types of##13##3##(1993-2#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-11#1)(2013-8#4)
new types##14##2##(1993-2#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-11#1)(2010-8#1)(2013-8#4)
new understanding of the##3##4##(1990-2#1)(2008-5#1)(2009-5#1)
new understanding of##5##3##(1990-2#1)(2008-11#2)(2008-5#1)(2009-5#1)
new understanding##6##2##(1990-2#1)(2008-11#2)(2008-5#2)(2009-5#1)
new uses##2##2##(1996-12#1)(2012-1#1)
new utility for multipurpose analysis##2##5##(2008-10#2)
new vaccine##2##2##(2009-12#2)
new vaccines and##2##3##(1996-6#1)(2008-11#1)
new vaccines##4##2##(1995-5#1)(1996-6#1)(2007-11#1)(2008-11#1)
new variant of##2##3##(1997-6#1)(2007-11#1)
new variant##5##2##(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)
new variants##2##2##(1997-3#1)(2008-10#1)
new varieties##3##2##(2008-12#1)(2008-8#2)
new variety of##2##3##(2008-10#1)(2008-8#1)
new variety##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
new vectors##3##2##(1991-9#1)(1994-12#1)(2012-2#1)
new verb##3##2##(2008-4#3)
new version of the##2##4##(1997-2#1)(2013-1#1)
new version of##4##3##(1997-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
new version##5##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
new viral##2##2##(2008-10#1)(2011-3#1)
new virulence##2##2##(2008-10#2)
new virus##4##2##(2008-10#3)(2008-8#1)
new wave##3##2##(1993-6#1)(2008-10#2)
new wave-front##2##2##(2007-12#1)(2008-2#1)
new way of doing##2##4##(1991-3#1)(2012-2#1)
new way of##7##3##(1991-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
new way to##8##3##(1991-2#1)(1995-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-7#1)
new way##16##2##(1991-2#1)(1991-3#1)(1995-12#1)(2008-10#2)(2008-2#1)(2008-6#2)(2008-8#2)(2008-9#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
new ways of##5##3##(1992-1#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
new ways to improve##2##4##(2008-3#1)(2010-4#1)
new ways to##5##3##(1992-1#1)(1995-1#1)(2008-3#1)(2008-7#1)(2010-4#1)
new ways##13##2##(1992-1#2)(1995-1#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#1)
new words##4##2##(2008-7#2)(2011-1#2)
new workers##2##2##(1991-9#1)(1997-3#1)
new world##8##2##(1991-3#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
new zirconia stationary phase##2##4##(2008-10#2)
new##5617##1##(1990-10#4)(1990-11#9)(1990-12#21)(1990-2#12)(1990-3#11)(1990-4#2)(1990-5#6)(1990-6#11)(1990-7#8)(1990-8#19)(1990-9#7)(1991-1#19)(1991-11#8)(1991-12#28)(1991-2#22)(1991-3#23)(1991-5#18)(1991-6#4)(1991-7#3)(1991-8#13)(1991-9#20)(1992-1#24)(1992-10#3)(1992-11#9)(1992-12#23)(1992-2#20)(1992-3#33)(1992-4#2)(1992-5#7)(1992-6#15)(1992-8#22)(1992-9#17)(1993-1#9)(1993-11#12)(1993-12#25)(1993-2#28)(1993-3#16)(1993-5#1)(1993-6#19)(1993-8#9)(1993-9#8)(1994-1#16)(1994-10#1)(1994-11#18)(1994-12#30)(1994-2#13)(1994-3#26)(1994-5#6)(1994-6#9)(1994-7#3)(1994-8#9)(1994-9#18)(1995-1#20)(1995-10#1)(1995-11#8)(1995-12#34)(1995-2#25)(1995-3#26)(1995-4#1)(1995-5#13)(1995-6#20)(1995-8#18)(1995-9#10)(1996-1#19)(1996-10#1)(1996-11#18)(1996-12#37)(1996-2#40)(1996-3#39)(1996-4#2)(1996-5#22)(1996-6#16)(1996-7#1)(1996-8#7)(1996-9#7)(1997-1#21)(1997-2#41)(1997-3#59)(1997-4#17)(1997-5#9)(1997-6#22)(1997-7#24)(1997-8#28)(1997-9#7)(2006-10#9)(2006-12#3)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#4)(2007-10#13)(2007-11#124)(2007-12#134)(2007-2#12)(2007-4#6)(2007-5#5)(2007-6#3)(2007-7#29)(2007-8#41)(2007-9#9)(2008-1#58)(2008-10#1042)(2008-11#220)(2008-12#50)(2008-2#180)(2008-3#359)(2008-4#86)(2008-5#187)(2008-6#75)(2008-7#138)(2008-8#141)(2008-9#95)(2009-1#4)(2009-10#28)(2009-11#18)(2009-12#24)(2009-2#3)(2009-3#19)(2009-4#11)(2009-5#25)(2009-6#16)(2009-7#20)(2009-8#30)(2009-9#22)(2010-1#6)(2010-10#19)(2010-11#26)(2010-12#32)(2010-2#15)(2010-3#25)(2010-4#36)(2010-5#28)(2010-6#12)(2010-7#20)(2010-8#33)(2010-9#10)(2011-1#60)(2011-10#2)(2011-2#170)(2011-3#34)(2011-7#4)(2012-1#27)(2012-12#61)(2012-2#128)(2012-3#90)(2012-4#1)(2012-6#1)(2013-1#107)(2013-7#14)(2013-8#74)
new&quot##3##1##(1996-8#1)(2008-10#1)(2012-2#1)
new-generation##5##1##(1995-5#1)(2007-11#1)(2008-3#2)(2013-1#1)
new-onset##5##1##(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
new-parent##2##1##(2007-2#2)
newborn Turkish boys##3##3##(2011-1#3)
newborn abandonment##3##2##(2007-2#3)
newborn and adult##4##3##(1993-6#2)(1994-2#1)(2008-4#1)
newborn and##5##2##(1993-6#2)(1994-2#1)(2008-4#1)(2012-12#1)
newborn babies##2##2##(1991-8#1)(1996-6#1)
newborn calves##4##2##(1994-7#3)(2010-2#1)
newborn cells##4##2##(2008-11#3)(2012-2#1)
newborn children in##2##3##(1990-11#1)(2011-2#1)
newborn children##4##2##(1990-11#2)(2011-2#2)
newborn guinea##2##2##(1991-12#1)(2009-9#1)
newborn has##2##2##(2009-9#1)(2011-1#1)
newborn hearing screening##2##3##(2008-9#2)
newborn infant##5##2##(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
newborn infants (group##2##3##(1990-8#2)
newborn infants with##2##3##(1990-8#2)
newborn infants##23##2##(1990-8#5)(1993-6#1)(1994-6#4)(1995-2#1)(1995-5#1)(2007-12#1)(2008-11#2)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)
newborn infants]##3##2##(1990-11#1)(1990-8#1)(1994-6#1)
newborn intensive care##4##3##(1991-12#4)
newborn mice##3##2##(1993-2#1)(2008-7#1)(2008-9#1)
newborn or##2##2##(2008-10#1)(2013-1#1)
newborn pig##2##2##(2008-11#2)
newborn rat##5##2##(1990-11#1)(1990-5#1)(1992-8#1)(1996-2#1)(2008-7#1)
newborn rats##3##2##(1994-5#2)(1995-12#1)
newborn screening##9##2##(2008-4#2)(2010-8#6)(2012-3#1)
newborn to##2##2##(1994-5#1)(1996-5#1)
newborn was##2##2##(1997-8#1)(2012-3#1)
newborn##165##1##(1990-11#4)(1990-5#3)(1990-8#6)(1990-9#1)(1991-12#5)(1991-3#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#5)(1994-7#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-2#4)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-9#4)(2010-11#2)(2010-2#1)(2010-3#1)(2010-8#6)(2011-1#9)(2011-2#7)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#5)
newborn]##2##1##(1997-3#1)(2012-12#1)
newborns and their##2##3##(2007-2#1)(2011-1#1)
newborns and##10##2##(1991-3#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)
newborns delivered by mothers with preeclampsia##2##6##(2009-8#2)
newborns delivered by##3##3##(2009-8#3)
newborns from##3##2##(2007-11#2)(2011-1#1)
newborns hips##2##2##(2007-11#2)
newborns in##2##2##(1991-12#1)(1992-4#1)
newborns is##2##2##(2007-11#1)(2008-8#1)
newborns of mothers with##2##4##(2011-1#1)(2012-12#1)
newborns of mothers##3##3##(2011-1#1)(2012-12#1)(2012-3#1)
newborns of##4##2##(2011-1#1)(2012-12#1)(2012-3#2)
newborns were divided into##2##4##(2007-11#1)(2011-1#1)
newborns were##5##2##(1993-3#1)(2007-11#1)(2011-1#3)
newborns with##7##2##(1992-4#1)(2008-12#2)(2011-1#3)(2011-2#1)
newborns##78##1##(1990-12#3)(1991-12#2)(1991-3#3)(1992-11#2)(1992-4#3)(1993-2#1)(1993-3#2)(1994-6#2)(1996-3#1)(2007-11#9)(2007-2#3)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#3)(2009-8#3)(2009-9#1)(2011-1#16)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)
newcomers##3##1##(1993-1#1)(1995-3#1)(2008-11#1)
newer agents##7##2##(2007-11#2)(2007-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)
newer and better ways##2##4##(1991-1#1)(1996-3#1)
newer and more##2##3##(1991-12#1)(2007-12#1)
newer and##5##2##(1991-1#1)(1991-12#1)(1996-3#1)(1997-8#1)(2007-12#1)
newer antiepileptic drugs##2##3##(2008-11#1)(2008-7#1)
newer approaches##2##2##(1993-3#1)(2008-1#1)
newer forms of##2##3##(1994-1#2)
newer generation antiepileptic##2##3##(2013-1#2)
newer generation##3##2##(2010-6#1)(2013-1#2)
newer modalities##4##2##(2009-5#1)(2011-2#3)
newer models##2##2##(2008-10#1)(2008-9#1)
newer techniques##4##2##(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)
newer technologies##2##2##(2008-3#1)(2011-2#1)
newer technology##2##2##(2011-2#1)(2012-2#1)
newer##94##1##(1991-1#4)(1991-12#1)(1993-11#2)(1993-3#1)(1994-1#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-8#1)(2006-10#4)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#3)(2008-1#4)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#6)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2010-5#1)(2010-6#4)(2010-7#1)(2011-1#2)(2011-2#11)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#1)
newest developments in##2##3##(2008-4#1)(2011-3#1)
newest##11##1##(1991-9#1)(1992-9#1)(1996-2#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)
newly admitted##3##2##(1991-1#2)(2011-2#1)
newly available##2##2##(2007-8#1)(2011-10#1)
newly constructed##2##2##(1996-2#1)(2008-8#1)
newly described HG-III##2##3##(2008-10#2)
newly described##22##2##(1990-5#1)(1991-5#1)(1993-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#11)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
newly designed cochlear implant electrodes##2##5##(2008-9#2)
newly designed##10##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)
newly detected##3##2##(1990-11#1)(2012-2#1)(2012-3#1)
newly developed flow##2##3##(2008-10#2)
newly developed method was##5##4##(2008-10#5)
newly developed method##10##3##(2008-10#10)
newly developed##71##2##(1991-1#1)(1994-11#2)(1994-12#2)(1995-4#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#2)(2009-10#1)(2009-4#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#3)
newly devised##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
newly diagnosed and##2##3##(1991-2#2)
newly diagnosed diabetic##2##3##(1993-11#1)(2013-1#1)
newly diagnosed non-metastatic##2##3##(2010-3#2)
newly diagnosed patients##2##3##(2008-1#1)(2008-7#1)
newly diagnosed type 1 diabetes##4##5##(2009-8#1)(2011-1#3)
newly diagnosed type##5##3##(2009-8#1)(2011-1#3)(2012-3#1)
newly diagnosed with##2##3##(1993-1#1)(2008-10#1)
newly diagnosed##42##2##(1991-2#4)(1993-1#3)(1993-11#1)(1994-12#2)(1996-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
newly discovered##17##2##(1990-7#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2009-5#1)(2009-7#1)(2011-2#3)(2013-1#1)
newly diseased plants##2##3##(2008-10#2)
newly diseased##3##2##(2008-10#3)
newly emerged##6##2##(1997-8#1)(2007-12#1)(2008-10#4)
newly emerging##6##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
newly established##11##2##(1990-7#1)(1991-2#1)(1991-9#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2012-12#1)(2013-8#1)
newly formed material##2##3##(2008-10#2)
newly formed##13##2##(1991-2#1)(1994-3#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
newly forming##2##2##(2008-7#2)
newly found##4##2##(1991-5#1)(1996-5#1)(2008-10#2)
newly graduated##2##2##(2008-11#2)
newly hatched##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
newly identified ORFs##2##3##(1996-6#2)
newly identified gene##3##3##(1995-12#1)(2008-10#2)
newly identified marine##2##3##(2010-7#1)(2011-2#1)
newly identified##20##2##(1995-12#2)(1995-2#1)(1996-6#2)(1997-3#1)(1997-9#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
newly infected trees##2##3##(2008-10#2)
newly infected##5##2##(2007-2#1)(2008-10#3)(2012-3#1)
newly introduced##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
newly isolated##7##2##(1994-12#3)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
newly opened flowers##2##3##(2008-10#2)
newly prepared##5##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
newly prescribed antihypertensive##3##3##(2008-11#3)
newly presented##2##2##(2008-11#1)(2013-1#1)
newly proposed##7##2##(2008-10#3)(2008-3#3)(2012-12#1)
newly qualified##2##2##(1997-5#1)(2008-11#1)
newly replicated##2##2##(1994-6#1)(2012-2#1)
newly reported##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
newly sequenced##2##2##(2008-7#1)(2012-12#1)
newly synthesised##2##2##(2008-10#2)
newly synthesized compounds were##2##4##(2007-11#1)(2010-3#1)
newly synthesized compounds##3##3##(2007-11#1)(2010-3#1)(2012-2#1)
newly synthesized probe##2##3##(1994-5#1)(2008-4#1)
newly synthesized silica gel phases (I-V)##2##6##(2008-10#2)
newly synthesized##37##2##(1990-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-2#3)
newly##383##1##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#3)(1991-2#6)(1991-5#4)(1991-9#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#8)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#5)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#110)(2008-11#20)(2008-12#4)(2008-2#7)(2008-3#16)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#4)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#8)(2011-10#1)(2011-2#16)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#7)(2012-5#1)(2013-1#10)(2013-8#6)
newly-developed##3##1##(2008-10#1)(2011-1#1)(2013-8#1)
newly-formed##3##1##(1997-8#1)(2008-5#1)(2012-2#1)
news and##2##2##(2007-2#1)(2007-4#1)
news in##3##2##(2008-7#2)(2013-1#1)
news media##3##2##(1992-12#1)(2010-2#1)(2010-8#1)
news##36##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1993-12#2)(1993-8#1)(1996-4#1)(1996-8#1)(1997-6#4)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#2)(2010-2#2)(2010-6#1)(2010-8#1)(2012-3#2)(2013-1#3)(2013-8#1)
newsletter##9##1##(1994-12#1)(1995-1#2)(1996-12#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
newspaper articles##2##2##(2008-9#2)
newspaper##10##1##(1995-2#1)(1997-6#2)(2006-5#1)(2007-2#1)(2008-8#1)(2008-9#4)
newspapers and##2##2##(2008-9#1)(2011-2#1)
newspapers##16##1##(1992-6#2)(1992-9#3)(1996-5#1)(1997-3#1)(1997-5#1)(2008-9#2)(2009-10#2)(2009-4#1)(2011-2#2)(2013-1#1)
newt##4##1##(2008-5#1)(2008-6#3)
nexin##3##1##(1992-12#1)(2009-10#2)
nexin-2/amyloid beta-protein precursor##2##3##(1991-2#1)(1992-12#1)
next after##2##2##(2007-11#2)
next century##6##2##(1995-12#1)(2008-3#1)(2008-4#3)(2008-9#1)
next day##6##2##(1994-3#1)(1996-7#1)(2007-12#2)(2007-8#1)(2013-8#1)
next decade##15##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-9#3)(2011-1#1)
next frontier##3##2##(1996-3#1)(1997-2#1)(2009-9#1)
next generation of##18##3##(1991-6#1)(1992-3#1)(1994-3#1)(1996-11#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2012-2#2)(2013-1#1)
next generation sequencing##3##3##(2010-10#1)(2012-2#2)
next generation##34##2##(1991-6#1)(1992-3#2)(1994-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#3)(2010-10#2)(2011-1#1)(2012-2#6)(2013-1#1)
next in##2##2##(1990-5#1)(2009-1#1)
next month##3##2##(1994-12#1)(1994-3#1)(2008-7#1)
next most##2##2##(1995-2#1)(2008-11#1)
next phase##2##2##(2008-11#1)(2008-7#1)
next section##3##2##(2008-10#1)(2008-8#1)(2009-4#1)
next step in##4##3##(2007-8#2)(2008-10#2)
next step##13##2##(1995-9#1)(1996-3#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2009-2#1)
next steps##3##2##(1994-2#1)(2008-7#1)(2012-12#1)
next ten##3##2##(1991-6#1)(1993-12#1)(1993-2#1)
next three##4##2##(1991-11#1)(2007-7#1)(2008-4#1)(2012-12#1)
next to a##2##3##(2008-3#1)(2008-7#1)
next to the##11##3##(1992-10#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-2#2)
next to##21##2##(1992-10#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#3)
next two##6##2##(1990-11#1)(1991-5#1)(1995-12#1)(2007-11#1)(2008-12#1)(2009-3#1)
next wave##2##2##(1994-3#1)(1996-3#1)
next year##10##2##(1992-8#1)(1994-1#1)(1996-5#1)(2008-11#1)(2008-3#1)(2009-6#1)(2009-9#1)(2011-1#2)(2011-2#1)
next years##2##2##(2013-1#1)(2013-8#1)
next##297##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#6)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#5)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#17)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#14)(2008-5#13)(2008-6#1)(2008-7#15)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#5)(2010-10#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#14)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#4)
next-generation NNRTIs##2##2##(2011-3#2)
next-generation sequencing technology##2##3##(2012-3#2)
next-generation sequencing##3##2##(2012-2#1)(2012-3#2)
next-generation##16##1##(2008-10#1)(2008-3#2)(2008-7#4)(2009-5#1)(2010-10#1)(2011-3#4)(2012-2#1)(2012-3#2)
next?##3##1##(1993-1#1)(1997-2#1)(2008-1#1)
nexus between##4##2##(1991-12#1)(2009-4#1)(2009-8#1)(2010-10#1)
nexus##7##1##(1991-12#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-10#2)(2013-1#1)
nf WM##2##2##(2008-3#2)
nf##5##1##(2008-3#5)
ng As##2##2##(2008-10#2)
ng L(-1)##5##2##(2008-10#3)(2008-12#2)
ng L(-1))##2##2##(2008-10#1)(2008-12#1)
ng NO(2)-N ml(-1) and 0##2##5##(2008-10#2)
ng NO(2)-N ml(-1) and 1##2##5##(2008-10#2)
ng NO(2)-N ml(-1) and##4##4##(2008-10#4)
ng NO(2)-N##5##2##(2008-10#5)
ng NO(3)-N ml(-1) for##3##4##(2008-10#3)
ng NO(3)-N ml(-1)##4##3##(2008-10#4)
ng NO(3)-N##5##2##(2008-10#5)
ng Se(IV) ml(-1)##2##3##(2008-10#2)
ng cm(-2)##7##2##(2008-10#7)
ng cm(-3)##6##2##(2008-10#6)
ng for##8##2##(2008-10#6)(2008-5#2)
ng g(-1) and 0##2##4##(2010-5#2)
ng g(-1) and##3##3##(2008-10#1)(2010-5#2)
ng g(-1) for##4##3##(2008-10#4)
ng g(-1) range##2##3##(2008-10#2)
ng g(-1)##22##2##(2008-10#19)(2010-5#2)(2012-12#1)
ng g(-1))##2##2##(2008-10#2)
ng in##4##2##(2008-10#2)(2012-3#2)
ng l(-1) (as##2##3##(2008-10#2)
ng l(-1) and the relative standard##2##6##(2008-10#2)
ng l(-1) for##6##3##(2008-10#6)
ng l(-1) in HG mode##2##5##(2008-10#2)
ng l(-1) in##3##3##(2008-10#3)
ng l(-1) was obtained##2##4##(2008-10#2)
ng l(-1)##34##2##(2008-10#34)
ng m(-3)##10##2##(2008-10#10)
ng m(-3))##2##2##(2010-5#2)
ng mL(-1) for##6##3##(2008-10#4)(2011-3#2)
ng mL(-1) in dust and juice##2##6##(2010-5#2)
ng mL(-1)##9##2##(2008-10#5)(2010-5#2)(2011-3#2)
ng ml(-1) (S/N=3)##4##3##(2008-10#4)
ng ml(-1) Se##2##3##(2008-10#2)
ng ml(-1) The##2##3##(2008-10#2)
ng ml(-1) and 1##4##4##(2008-10#4)
ng ml(-1) and a##2##4##(2008-10#2)
ng ml(-1) and determination limits of##2##6##(2008-10#2)
ng ml(-1) and the detection limit was##2##7##(2008-10#2)
ng ml(-1) and the detection limit##3##6##(2008-10#3)
ng ml(-1) and the relative standard deviation was 1##2##9##(2008-10#2)
ng ml(-1) and the relative standard deviations were 1##2##9##(2008-10#2)
ng ml(-1) and the relative standard##4##6##(2008-10#4)
ng ml(-1) and the##11##4##(2008-10#11)
ng ml(-1) and##22##3##(2008-10#22)
ng ml(-1) can be##2##4##(2008-10#2)
ng ml(-1) for AM1##2##4##(2008-10#2)
ng ml(-1) for Cu(II) and##2##5##(2008-10#2)
ng ml(-1) for Cu(II)##3##4##(2008-10#3)
ng ml(-1) for NAA and##2##5##(2008-10#2)
ng ml(-1) for NAD##2##4##(2008-10#2)
ng ml(-1) for all##2##4##(2008-10#2)
ng ml(-1) for calf thymus DNA##2##6##(2008-10#2)
ng ml(-1) for each##3##4##(2008-10#3)
ng ml(-1) for fish sperm DNA##2##6##(2008-10#2)
ng ml(-1) for the##2##4##(2008-10#2)
ng ml(-1) for yeast RNA##2##5##(2008-10#2)
ng ml(-1) for##49##3##(2008-10#49)
ng ml(-1) in##5##3##(2008-10#5)
ng ml(-1) is##3##3##(2008-10#3)
ng ml(-1) level##5##3##(2008-10#5)
ng ml(-1) levels##3##3##(2008-10#3)
ng ml(-1) nitrite##2##3##(2008-10#2)
ng ml(-1) of Be(II)##2##4##(2008-10#2)
ng ml(-1) of copper(II)##2##4##(2008-10#2)
ng ml(-1) of nitrite##2##4##(2008-10#2)
ng ml(-1) of##23##3##(2008-10#22)(2008-11#1)
ng ml(-1) range##2##3##(2008-10#2)
ng ml(-1) vanadium##3##3##(2008-10#3)
ng ml(-1) vanadium(IV) and##2##4##(2008-10#2)
ng ml(-1) was##5##3##(2008-10#5)
ng ml(-1) were##3##3##(2008-10#3)
ng ml(-1) with a detection limit of##3##7##(2008-10#3)
ng ml(-1) with a limit of detection of##2##8##(2008-10#2)
ng ml(-1) with a relative standard deviation##2##7##(2008-10#2)
ng ml(-1) with a##10##4##(2008-10#10)
ng ml(-1) with##14##3##(2008-10#14)
ng ml(-1)##258##2##(2008-10#253)(2008-11#4)(2008-5#1)
ng ml(-1)) and##5##3##(2008-10#5)
ng ml(-1))##16##2##(2008-10#15)(2008-11#1)
ng ml-1##5##2##(1990-8#3)(1996-2#2)
ng ml-1)##4##2##(1995-5#4)
ng of total##2##3##(1997-4#1)(2012-3#1)
ng of##26##2##(1991-8#1)(1994-7#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#17)(2008-11#1)(2012-3#1)
ng per injection (5 microl)##2##5##(2008-10#2)
ng per##6##2##(2008-10#5)(2008-8#1)
ng to##2##2##(2008-10#1)(2008-11#1)
ng x mL(-1) for##2##4##(2011-3#2)
ng x mL(-1)##3##3##(2011-3#2)(2013-8#1)
ng##505##1##(1990-12#1)(1990-8#4)(1991-2#1)(1991-8#1)(1994-7#2)(1995-12#5)(1995-2#1)(1995-5#4)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-4#1)(2008-10#442)(2008-11#10)(2008-12#3)(2008-5#3)(2008-8#1)(2009-6#3)(2010-5#6)(2011-3#4)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
ng)##7##1##(1993-6#2)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
ng/0##7##1##(1995-12#7)
ng/10(6) cell/24 h##2##3##(2008-9#2)
ng/10(6)##5##1##(1995-8#1)(2008-8#1)(2008-9#3)
ng/L##5##1##(2008-10#5)
ng/dL##2##1##(2011-1#1)(2012-12#1)
ng/dL) babies##2##2##(2011-1#2)
ng/dL)##3##1##(2011-1#3)
ng/dl##2##1##(1990-3#1)(2013-1#1)
ng/dl)##3##1##(1994-3#1)(2008-4#2)
ng/g for##6##2##(2008-10#2)(2008-11#4)
ng/g of PhIP##2##3##(1997-2#2)
ng/g##23##1##(1995-2#1)(1997-2#5)(2008-10#9)(2008-11#7)(2008-6#1)
ng/g)##2##1##(1997-2#1)(2008-10#1)
ng/kg##2##1##(2008-11#2)
ng/l##2##1##(2008-10#2)
ng/mL and##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
ng/mL for the##2##3##(2010-4#2)
ng/mL in##4##2##(1993-1#4)
ng/mL with a detection limit of##2##6##(2008-10#1)(2010-5#1)
ng/mL with##3##2##(2008-10#2)(2010-5#1)
ng/mL##26##1##(1993-1#5)(2008-10#5)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#4)(2010-5#1)(2011-1#5)(2012-12#1)
ng/mL)##4##1##(1992-8#1)(2011-1#2)(2013-1#1)
ng/mg##3##1##(1990-11#1)(1996-5#2)
ng/ml (normal range##2##3##(1993-3#1)(1994-11#1)
ng/ml CP-870##2##2##(2008-10#2)
ng/ml TGF alpha)##2##3##(1997-1#2)
ng/ml and##7##2##(1992-8#1)(1993-2#1)(2008-10#1)(2008-5#2)(2011-1#1)(2012-12#1)
ng/ml could be##2##3##(1990-12#1)(1990-2#1)
ng/ml could##3##2##(1990-12#1)(1990-2#1)(1995-6#1)
ng/ml for##5##2##(2008-10#2)(2008-5#1)(2008-9#2)
ng/ml in patients treated with##2##5##(2008-1#2)
ng/ml in##7##2##(1990-12#2)(1992-2#1)(1992-8#1)(1993-3#1)(2008-1#2)
ng/ml of##7##2##(1995-11#1)(1996-5#1)(2008-10#3)(2008-11#1)(2013-1#1)
ng/ml or##3##2##(1995-6#1)(1996-5#2)
ng/ml to##2##2##(1992-8#1)(2008-7#1)
ng/ml vs##3##2##(1994-11#1)(2009-3#1)(2012-12#1)
ng/ml##115##1##(1990-12#5)(1990-2#2)(1990-8#2)(1991-4#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#5)(1993-1#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-6#3)(1996-5#5)(1997-1#2)(1997-2#1)(1997-4#1)(2007-7#5)(2007-8#2)(2008-1#5)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-3#1)(2011-1#5)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#1)
ng/ml) and##8##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(2009-3#1)(2010-5#1)(2012-12#1)
ng/ml) or##4##2##(1990-7#1)(1992-12#1)(1993-2#2)
ng/ml) was##3##2##(1992-3#1)(1993-2#1)(1997-4#1)
ng/ml)##42##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1993-12#1)(1993-2#8)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-3#1)(1997-4#1)(2008-11#1)(2008-6#2)(2009-3#1)(2010-5#1)(2012-12#2)
ng/spot for##2##2##(2012-2#2)
ng/spot##4##1##(2012-2#4)
ngcm(-3) and##3##2##(2008-10#3)
ngcm(-3)##10##1##(2008-10#10)
ngcm(-3))##4##1##(2008-10#4)
ngl(-1)##5##1##(2008-10#5)
ngml(-1) and##2##2##(2008-10#2)
ngml(-1) for##2##2##(2008-10#2)
ngml(-1) of##2##2##(2008-10#2)
ngml(-1)##24##1##(2008-10#24)
ng·L(-1)##2##1##(2013-7#2)
nia##3##1##(1993-6#3)
niacin##2##1##(2008-1#1)(2010-9#1)
niacinamide##5##1##(2008-11#1)(2008-5#4)
nibbling##4##1##(2008-12#4)
nicarbazin##5##1##(2007-6#5)
nicardipine##7##1##(1990-12#4)(1996-2#2)(2008-10#1)
nice##5##1##(1992-4#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-1#1)
nicely##3##1##(2008-10#2)(2008-3#1)
nicergoline##2##1##(1994-6#2)
niche and##3##2##(1991-1#1)(2009-3#1)(2009-8#1)
niche differentiation##2##2##(2008-8#1)(2012-2#1)
niche for##3##2##(2009-6#1)(2012-1#2)
niche in the##2##3##(2008-1#1)(2013-1#1)
niche in##3##2##(2008-1#1)(2008-8#1)(2013-1#1)
niche of##2##2##(2009-8#1)(2012-2#1)
niche space##4##2##(1997-4#1)(2008-1#3)
niche##46##1##(1991-1#1)(1994-5#1)(1997-4#2)(1997-7#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#6)(2008-9#5)(2009-12#2)(2009-3#4)(2009-6#2)(2009-8#3)(2010-10#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#1)
niches and##3##2##(2008-10#2)(2008-8#1)
niches in the##2##3##(2007-12#1)(2008-10#1)
niches in##4##2##(2007-12#1)(2008-10#1)(2010-10#2)
niches##27##1##(2007-12#1)(2008-10#10)(2008-11#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#4)(2011-2#2)(2012-12#1)(2012-2#1)
nick end labeling (TUNEL)##3##4##(2008-8#2)(2008-9#1)
nick end labeling##4##3##(2008-10#1)(2008-8#2)(2008-9#1)
nick translation##4##2##(2008-4#4)
nick##12##1##(1993-11#1)(2008-10#1)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
nicked##2##1##(1990-5#1)(1990-7#1)
nickel (II)##2##2##(2008-10#2)
nickel (Ni)##2##2##(1997-4#1)(2008-10#1)
nickel and 0##2##3##(2008-10#2)
nickel and chromium##3##3##(2008-10#3)
nickel and cobalt##2##3##(2008-10#2)
nickel and copper using##2##4##(2008-10#2)
nickel and copper##8##3##(2008-10#8)
nickel and iron##2##3##(2008-10#2)
nickel and palladium##3##3##(2008-10#3)
nickel and zinc in##2##4##(2008-10#1)(2011-2#1)
nickel and zinc##8##3##(2008-10#7)(2011-2#1)
nickel and##34##2##(1994-5#1)(2008-10#31)(2008-6#1)(2011-2#1)
nickel by##10##2##(2008-10#8)(2008-12#2)
nickel chelate##2##2##(1996-12#1)(1997-2#1)
nickel compounds in##3##3##(1994-9#1)(2008-10#2)
nickel compounds##5##2##(1994-9#1)(1995-3#1)(2008-10#3)
nickel determination##7##2##(2008-10#7)
nickel films##3##2##(2007-12#3)
nickel hydroxide##2##2##(2008-10#2)
nickel in aqueous solutions##2##4##(2008-10#2)
nickel in aqueous##3##3##(2008-10#3)
nickel in table salt and baking soda##3##7##(2008-10#3)
nickel in the##4##3##(2008-10#4)
nickel in##41##2##(2008-10#41)
nickel ion##4##2##(2008-10#3)(2009-3#1)
nickel levels##3##2##(1994-9#2)(2008-10#1)
nickel on##2##2##(1995-3#1)(2008-10#1)
nickel oxide##3##2##(2008-10#2)(2008-3#1)
nickel phthalocyanine##4##2##(2008-10#4)
nickel preconcentration##2##2##(2008-10#2)
nickel salts##4##2##(1995-3#4)
nickel subsulfide##2##2##(1994-5#1)(1995-3#1)
nickel sulphide fire assay##2##4##(2008-10#2)
nickel sulphide##3##2##(2008-10#3)
nickel to##2##2##(2008-10#1)(2008-3#1)
nickel was##4##2##(2008-10#4)
nickel were##6##2##(2008-10#6)
nickel with##4##2##(2008-10#4)
nickel##255##1##(1994-5#3)(1994-9#7)(1995-3#9)(1995-5#1)(1996-12#2)(1997-2#1)(1997-4#2)(1997-7#2)(2007-12#3)(2007-7#1)(2008-10#203)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#5)(2008-6#2)(2008-7#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
nickel(II) and copper(II)##2##3##(2008-10#2)
nickel(II) and##8##2##(2007-11#1)(2008-10#7)
nickel(II) complex##3##2##(2008-10#3)
nickel(II) hexacyanoferrate (NiHCF)##2##3##(2008-10#2)
nickel(II) hexacyanoferrate-modified##2##2##(2008-10#2)
nickel(II) in##7##2##(2008-10#7)
nickel(II) ions##2##2##(2008-10#2)
nickel(II) or##2##2##(1997-7#1)(2008-10#1)
nickel(II)##49##1##(1997-7#2)(2007-11#1)(2008-10#46)
nickel)##2##1##(2008-10#2)
nickel-like xenon-ion x-ray laser##2##4##(2007-11#2)
nickel-like##4##1##(2007-11#4)
nickel-silica composite hollow nanospheres##2##4##(2008-10#2)
nicotianae and P##6##3##(2008-10#6)
nicotianae and##14##2##(2008-10#14)
nicotianae in##4##2##(2008-10#4)
nicotianae was##3##2##(2008-10#3)
nicotianae x P##2##3##(2008-10#2)
nicotianae##46##1##(2008-10#46)
nicotinamide adenine dinucleotide phosphate##4##4##(1992-12#1)(2008-5#1)(2011-2#2)
nicotinamide adenine dinucleotide##8##3##(1991-9#1)(1992-12#1)(1997-2#1)(2008-10#1)(2008-5#2)(2011-2#2)
nicotinamide adenine##10##2##(1991-9#1)(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#2)
nicotinamide##21##1##(1991-9#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-2#2)(1997-2#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-5#4)(2008-8#1)(2011-2#2)
nicotine a##2##2##(2013-1#2)
nicotine addiction in##2##3##(2008-6#1)(2009-6#1)
nicotine addiction##4##2##(2008-6#3)(2009-6#1)
nicotine and##10##2##(1990-7#2)(2008-5#1)(2008-8#2)(2009-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
nicotine dependence##3##2##(2009-6#1)(2011-2#2)
nicotine in##7##2##(1990-7#1)(1995-5#1)(1995-6#1)(2008-10#1)(2009-7#3)
nicotine increased##2##2##(1990-7#1)(2010-8#1)
nicotine metabolites##2##2##(1993-8#2)
nicotine on##8##2##(1991-1#1)(1996-2#2)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)
nicotine replacement therapy (NRT)##4##4##(2008-6#1)(2011-2#1)(2012-3#2)
nicotine replacement therapy##8##3##(2008-6#2)(2009-7#1)(2011-2#1)(2012-3#3)(2013-8#1)
nicotine##103##1##(1990-6#1)(1990-7#4)(1991-1#5)(1992-6#1)(1993-8#3)(1995-12#7)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#5)(2008-1#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-6#9)(2008-7#1)(2008-8#7)(2009-6#5)(2009-7#8)(2010-8#4)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#9)(2013-8#3)
nicotine's##2##1##(1991-1#1)(2008-12#1)
nicotinic acetylcholine receptor subunit##2##4##(1995-11#1)(1996-12#1)
nicotinic acetylcholine receptor was##2##4##(2008-8#2)
nicotinic acetylcholine receptor##14##3##(1994-5#2)(1995-11#1)(1996-12#1)(2008-7#1)(2008-8#6)(2010-8#1)(2012-2#2)
nicotinic acetylcholine receptors (nAChRs)##2##4##(2008-8#1)(2011-2#1)
nicotinic acetylcholine receptors##8##3##(1990-8#1)(1995-11#3)(2007-8#1)(2008-8#1)(2009-6#1)(2011-2#1)
nicotinic acetylcholine##23##2##(1990-8#1)(1994-5#2)(1995-11#5)(1996-12#1)(2007-8#1)(2008-7#1)(2008-8#7)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#2)
nicotinic acid##9##2##(1991-6#1)(1994-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
nicotinic antagonist##3##2##(1995-12#1)(1996-2#2)
nicotinic receptor antagonist##2##3##(1996-12#2)
nicotinic receptor##9##2##(1995-11#1)(1996-12#6)(2008-8#1)(2009-6#1)
nicotinic receptor-mediated inward currents##3##4##(1995-11#3)
nicotinic receptor-mediated inward##4##3##(1995-11#4)
nicotinic receptors##12##2##(1994-5#1)(1995-11#2)(1995-5#2)(1996-12#5)(1996-2#1)(2011-1#1)
nicotinic##67##1##(1990-7#2)(1990-8#1)(1991-6#1)(1992-3#2)(1993-9#2)(1994-5#4)(1994-6#2)(1995-11#12)(1995-12#1)(1995-5#2)(1996-12#12)(1996-2#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#8)(2009-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
nictitating##4##1##(1990-9#3)(2008-5#1)
nidation##3##1##(1992-3#2)(1996-2#1)
nidi##4##1##(2008-7#4)
nidulans and##4##2##(1997-4#1)(2008-5#3)
nidulans##33##1##(1991-5#3)(1996-6#1)(1997-2#2)(1997-4#6)(1997-7#2)(1997-8#3)(2008-10#1)(2008-5#4)(2009-6#1)(2009-8#4)(2010-2#1)(2010-7#4)(2011-1#1)
nidus and surrounding brain tissue##2##5##(2008-7#2)
nidus and the##2##3##(2008-7#2)
nidus and##7##2##(2008-7#6)(2008-9#1)
nidus for##2##2##(2008-3#1)(2008-7#1)
nidus in the##2##3##(2008-7#2)
nidus in##4##2##(1996-3#1)(2008-7#2)(2012-2#1)
nidus of##2##2##(1997-3#1)(2011-2#1)
nidus##35##1##(1991-2#1)(1996-3#1)(1997-3#1)(2008-3#1)(2008-7#23)(2008-9#4)(2011-2#1)(2012-2#1)(2012-3#2)
nifedipine (1 microM)##3##3##(1996-5#1)(1997-2#1)(2009-12#1)
nifedipine and##2##2##(1990-7#1)(1991-2#1)
nifedipine in the##2##3##(1990-8#1)(1991-11#1)
nifedipine in##4##2##(1990-8#1)(1991-11#1)(1997-8#1)(2007-7#1)
nifedipine##34##1##(1990-7#2)(1990-8#2)(1991-11#1)(1991-2#1)(1992-2#1)(1992-8#1)(1994-11#7)(1994-9#3)(1995-12#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-7#1)(2008-10#1)(2009-12#2)(2012-12#1)(2013-1#1)
nifekalant##3##1##(2008-8#3)
niflumic acid##2##2##(1990-5#1)(1995-11#1)
niger T21##3##2##(2008-8#2)(2008-9#1)
niger glucoamylase were##2##3##(2008-8#2)
niger glucoamylase##5##2##(2008-7#2)(2008-8#3)
niger was##2##2##(1991-9#1)(2008-7#1)
niger were##2##2##(2008-5#2)
niger##50##1##(1991-9#4)(1993-2#2)(1993-8#4)(1994-12#3)(1997-2#4)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#2)(2010-4#1)(2010-5#1)(2012-2#1)
niger)##2##1##(2008-5#1)(2008-9#1)
nigericin##3##1##(1993-11#2)(2008-9#1)
night and##6##2##(1990-2#1)(1997-4#1)(2008-3#2)(2009-3#1)(2010-7#1)
night before##2##2##(1990-6#1)(2008-1#1)
night in##2##2##(2008-10#1)(2011-1#1)
night nursing##5##2##(2010-7#5)
night shifts##4##2##(2009-5#2)(2010-10#1)(2011-2#1)
night sweats##3##2##(1997-4#1)(2008-11#1)(2010-12#1)
night temperatures##5##2##(2008-10#1)(2012-5#4)
night work##4##2##(1997-6#3)(2010-7#1)
night##90##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#2)(1991-8#2)(1992-3#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-10#2)(1995-12#3)(1995-6#1)(1997-4#4)(1997-6#4)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#4)(2008-5#5)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#1)(2012-5#5)(2013-1#1)
night-time##2##1##(1997-8#1)(2013-1#1)
nightly##5##1##(2008-10#2)(2008-7#1)(2009-7#1)(2009-8#1)
nightmare##6##1##(1992-12#1)(1992-3#1)(1993-12#1)(1996-2#1)(1996-3#1)(2008-7#1)
nights and##2##2##(2008-10#1)(2012-5#1)
nights were##2##2##(2008-3#1)(2012-12#1)
nights##13##1##(1990-2#1)(2008-10#1)(2008-3#5)(2008-8#1)(2012-12#4)(2012-5#1)
nightshade##2##1##(2008-10#2)
nighttime and##2##2##(2008-3#1)(2013-7#1)
nighttime performance##4##2##(2008-2#3)(2008-3#1)
nighttime##20##1##(1991-6#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-6#1)(2009-9#1)(2010-7#2)(2013-1#1)(2013-7#1)
nigra 63/135##3##2##(2011-2#3)
nigra L##4##2##(2011-2#1)(2013-8#3)
nigra addition line##2##3##(2008-10#2)
nigra chromosome##2##2##(2008-10#2)
nigra pars compacta (SNpc)##3##4##(1995-3#1)(1996-12#1)(2013-7#1)
nigra pars compacta##5##3##(1995-3#1)(1996-12#2)(2008-7#1)(2013-7#1)
nigra pars##7##2##(1995-2#1)(1995-3#1)(1996-12#2)(2008-12#1)(2008-7#1)(2013-7#1)
nigra was not##2##3##(1990-5#1)(1997-7#1)
nigra##76##1##(1990-5#9)(1991-12#1)(1992-10#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-6#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#6)(1997-3#1)(1997-7#1)(2008-10#12)(2008-12#1)(2008-5#2)(2008-7#12)(2011-2#7)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
nigral cell death in Parkinson's disease##2##6##(2008-7#2)
nigral cell degeneration##3##3##(2008-7#3)
nigral cell##6##2##(1995-8#1)(2008-7#5)
nigral dopamine neurons##3##3##(1992-11#1)(1996-2#2)
nigral dopaminergic neurons##4##3##(1992-11#1)(1997-6#1)(2008-7#2)
nigral grafts##3##2##(1997-2#3)
nigral##18##1##(1992-11#2)(1995-8#2)(1996-2#3)(1997-2#3)(1997-6#1)(2008-7#7)
nigrescens and##3##2##(2008-5#1)(2013-1#2)
nigrescens##5##1##(2008-5#2)(2013-1#3)
nigricans##5##1##(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#2)
nigrificans##2##1##(2008-10#2)
nigrispinus##4##1##(2008-6#4)
nigrivenella##2##1##(2008-10#2)
nigrosin##3##1##(2008-11#2)(2008-12#1)
nigrostriatal dopamine##3##2##(1992-10#1)(1996-12#1)(2008-7#1)
nigrostriatal dopaminergic##5##2##(1992-7#1)(1996-12#1)(2008-11#2)(2013-7#1)
nigrostriatal lesion##2##2##(1995-12#2)
nigrostriatal pathway##2##2##(1991-12#1)(1996-12#1)
nigrostriatal##25##1##(1991-12#1)(1992-10#1)(1992-11#1)(1992-7#1)(1993-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#3)(1997-7#1)(2008-11#2)(2008-7#3)(2012-12#1)(2012-2#2)(2013-7#4)
nigrum L##2##2##(2012-4#1)(2013-8#1)
nih##4##1##(2008-3#1)(2008-7#2)(2013-1#1)
nihilism##2##1##(1991-3#1)(2008-8#1)
nikkomycin biosynthesis##3##2##(2008-9#3)
nikkomycin##7##1##(1992-8#1)(1997-4#1)(2008-9#5)
nil was##2##2##(2008-10#2)
nil##15##1##(1991-6#1)(1994-6#1)(2008-10#8)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#1)
nile##5##1##(2008-10#4)(2010-8#1)
niloticus##7##1##(2008-7#2)(2010-8#2)(2013-7#3)
nilotinib##5##1##(2011-2#1)(2012-12#4)
nimesulide##2##1##(2008-7#2)
nimodipine##5##1##(1990-7#1)(1991-2#1)(1996-9#1)(1997-2#1)(2007-10#1)
nine European##2##2##(2008-10#1)(2009-8#1)
nine ORFs##2##2##(1994-12#1)(1996-3#1)
nine States##2##2##(1991-12#1)(1997-2#1)
nine and##3##2##(2008-4#1)(2009-8#1)(2013-1#1)
nine cases##7##2##(1997-3#1)(2008-7#3)(2008-9#1)(2013-1#1)(2013-8#1)
nine commercial##2##2##(2008-10#2)
nine commonly used##3##3##(2008-10#2)(2008-4#1)
nine days##3##2##(1994-2#1)(2008-6#1)(2012-3#1)
nine different##10##2##(1990-5#1)(1993-2#1)(2007-11#1)(2008-10#6)(2008-3#1)
nine female##2##2##(2008-12#1)(2008-5#1)
nine field sites##2##3##(2008-10#2)
nine field##3##2##(2008-10#3)
nine genes##6##2##(1994-8#1)(2008-10#2)(2008-7#1)(2011-1#2)
nine genotypes of Phaseolus vulgaris##2##5##(2008-12#2)
nine genotypes##3##2##(2008-10#1)(2008-12#2)
nine groups##2##2##(1992-2#1)(2008-10#1)
nine had##2##2##(2008-10#1)(2008-7#1)
nine hospitals in##3##3##(1993-2#2)(2011-2#1)
nine introns##2##2##(1990-12#1)(2008-6#1)
nine isolates of##2##3##(2008-10#2)
nine isolates were##2##3##(1997-3#1)(1997-8#1)
nine isolates##5##2##(1997-3#1)(1997-8#1)(2008-10#3)
nine kinds of##2##3##(2008-10#1)(2008-11#1)
nine major##3##2##(1990-3#1)(1992-2#1)(2009-10#1)
nine men##3##2##(1993-3#1)(2008-9#1)(2011-2#1)
nine microsatellite##2##2##(1997-5#1)(2013-8#1)
nine monoclonal antibodies##2##3##(2008-10#1)(2008-5#1)
nine months after##3##3##(1992-5#1)(2007-2#1)(2011-1#1)
nine months of follow-up##2##4##(1993-3#1)(2007-7#1)
nine months of##3##3##(1993-3#1)(2007-7#1)(2013-1#1)
nine months##16##2##(1992-5#1)(1993-1#2)(1993-3#1)(2007-2#1)(2007-7#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
nine mutations##2##2##(2012-3#2)
nine new##2##2##(2008-12#1)(2009-2#1)
nine of ten##2##3##(1992-1#1)(2006-11#1)
nine of the##4##3##(1992-12#1)(1993-2#1)(2008-2#1)(2008-7#1)
nine of them##2##3##(1996-8#1)(2008-7#1)
nine of these genes##2##4##(2008-10#1)(2008-8#1)
nine of these##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
nine of##14##2##(1992-1#1)(1992-12#1)(1993-2#1)(1996-8#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2012-3#1)
nine patients were##2##3##(2007-7#1)(2012-12#1)
nine patients with##7##3##(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-12#1)
nine patients##23##2##(1991-5#1)(1993-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
nine percent of##3##3##(2007-12#1)(2007-2#1)(2013-8#1)
nine populations from##2##3##(2008-10#2)
nine populations of##2##3##(2008-5#1)(2012-3#1)
nine populations##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
nine random##2##2##(2008-10#2)
nine selected##4##2##(2008-10#2)(2012-12#2)
nine service areas##2##3##(1995-3#2)
nine species##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2013-7#1)
nine standards##2##2##(2008-10#2)
nine strains of##2##3##(1993-9#1)(1997-2#1)
nine strains##3##2##(1993-9#1)(1997-2#1)(2008-10#1)
nine studies##2##2##(1993-1#1)(2012-2#1)
nine subjects##5##2##(1996-5#1)(1996-7#1)(2008-11#1)(2008-7#1)(2009-1#1)
nine subpopulations##2##2##(2008-10#2)
nine such##2##2##(1995-2#1)(2008-9#1)
nine surfactants##2##2##(2008-10#2)
nine times##3##2##(2008-10#2)(2013-8#1)
nine trials##3##2##(2008-5#3)
nine visits##2##2##(2012-2#2)
nine weeks##3##2##(1991-6#1)(1996-12#2)
nine were##3##2##(1996-12#1)(2007-7#1)(2008-10#1)
nine years##8##2##(1992-5#2)(1996-3#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
nine##398##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#3)(1993-1#3)(1993-2#5)(1993-3#4)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#7)(1996-2#1)(1996-3#3)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-8#2)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#7)(2007-8#5)(2008-1#5)(2008-10#114)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#26)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#7)
nine-amino-acid##5##1##(1992-9#5)
nine-banded##3##1##(2008-5#2)(2008-9#1)
nine-year-old##3##1##(2007-12#2)(2008-1#1)
nineteen##6##1##(1991-4#1)(1993-12#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
nineteenth century##18##2##(1991-12#2)(2008-2#1)(2009-10#3)(2009-7#1)(2010-1#5)(2011-2#4)(2012-2#1)(2013-7#1)
nineteenth##21##1##(1991-12#2)(2008-2#1)(2009-10#4)(2009-7#1)(2010-1#7)(2011-2#4)(2012-2#1)(2013-7#1)
ninety##8##1##(1992-9#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-6#1)(2008-12#1)(2011-2#1)(2012-3#1)
ninety-seven##3##1##(1993-12#1)(1993-5#1)(2012-12#1)
ninety-three##2##1##(1990-10#1)(1992-2#1)
ninhydrin##7##1##(2007-2#1)(2008-10#3)(2008-4#1)(2008-9#1)(2012-2#1)
ninth##8##1##(1992-3#1)(1992-8#1)(1994-3#1)(1996-3#1)(1997-7#1)(2011-2#1)(2013-1#2)
ninth-grade students##2##2##(1996-1#2)
ninth-grade##3##1##(1996-1#2)(2009-7#1)
niobate crystal is##3##3##(2007-11#1)(2008-3#2)
niobate crystal##13##2##(2007-11#5)(2007-12#4)(2008-3#4)
niobate crystals##3##2##(2007-12#3)
niobate##94##1##(2007-11#24)(2007-12#42)(2008-10#3)(2008-2#8)(2008-3#17)
niobium##3##1##(2008-10#3)
niobium(V) oxide##5##2##(2008-10#5)
niobium(V)##6##1##(2008-10#6)
nioxime##3##1##(2008-10#3)
niponensis##5##1##(2011-2#5)
nipple and areolar##2##3##(2011-2#2)
nipple##14##1##(1990-11#1)(1994-12#2)(1997-5#1)(2007-11#1)(2009-6#1)(2010-5#4)(2011-2#4)
nipple-areola complex##2##2##(1994-12#2)
nisin##7##1##(2008-6#4)(2011-2#3)
nisoldipine##4##1##(1993-3#4)
nit mutants##7##2##(2008-10#7)
nit##13##1##(2008-10#13)
nit1 and NitM##2##3##(2008-10#2)
nit1##3##1##(2008-10#3)
nitens##11##1##(2008-10#5)(2008-5#1)(2013-7#5)
nitida##4##1##(2008-8#4)
nitinol stents##2##2##(2011-2#2)
nitinol##7##1##(2007-7#1)(2007-8#2)(2008-11#1)(2011-2#3)
nitramine##4##1##(2008-10#4)
nitrate and ammonium##3##3##(2008-10#3)
nitrate and nitrite was##2##4##(2008-10#2)
nitrate and nitrite##10##3##(2008-10#10)
nitrate and sodium##2##3##(2008-10#2)
nitrate and sulfate)##2##3##(2008-10#2)
nitrate and##41##2##(1993-12#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-3#1)(2013-8#1)
nitrate and/or##2##2##(2008-10#1)(2008-11#1)
nitrate as##4##2##(2008-10#3)(2008-11#1)
nitrate by##2##2##(2008-10#2)
nitrate determination##4##2##(2008-10#4)
nitrate from##5##2##(2006-8#1)(2008-10#3)(2008-12#1)
nitrate in natural waters##2##4##(2008-10#2)
nitrate in the##2##3##(2008-10#2)
nitrate in water samples##3##4##(2008-10#3)
nitrate in water##5##3##(2008-10#5)
nitrate in##31##2##(2008-10#31)
nitrate ion##3##2##(2008-10#3)
nitrate ions was##2##3##(2008-10#2)
nitrate ions##4##2##(2008-10#4)
nitrate is described##2##3##(2008-10#2)
nitrate is##3##2##(2008-10#2)(2008-11#1)
nitrate level##3##2##(2009-8#3)
nitrate media##2##2##(2008-10#2)
nitrate metabolism##2##2##(1991-9#2)
nitrate nonutilizing (nit) mutants##2##4##(2008-10#2)
nitrate nonutilizing (nit)##5##3##(2008-10#5)
nitrate reductase (NR)##2##3##(1993-6#1)(2008-10#1)
nitrate reductase##8##2##(1992-6#1)(1993-6#2)(2008-10#3)(2011-1#2)
nitrate reduction##4##2##(2008-10#2)(2011-2#2)
nitrate sensing system##2##3##(2008-10#2)
nitrate solution##3##2##(2008-10#3)
nitrate supporting electrolytes##2##3##(2008-10#2)
nitrate to##8##2##(2008-10#7)(2011-2#1)
nitrate tolerance##3##2##(1991-9#3)
nitrate uptake##2##2##(2008-10#1)(2013-8#1)
nitrate was less##2##3##(1995-6#1)(2008-10#1)
nitrate was used as the chemical modifier to determine##2##9##(2008-10#2)
nitrate was##8##2##(1995-6#1)(2008-10#6)(2011-2#1)
nitrate were##3##2##(2008-10#3)
nitrate with a##2##3##(2008-10#2)
nitrate with##5##2##(2008-10#5)
nitrate##283##1##(1991-12#3)(1991-9#8)(1992-6#6)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#2)(1995-6#2)(1996-11#1)(1997-4#1)(2006-8#1)(2008-10#207)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#5)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#7)(2012-3#1)(2013-1#1)(2013-8#3)
nitrate) and##2##2##(2008-10#1)(2012-2#1)
nitrate)##4##1##(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
nitrate-nitrogen##3##1##(2008-10#2)(2008-12#1)
nitrate-selective##2##1##(2008-10#2)
nitrate/nitrite (NOx)##2##2##(2007-10#1)(2011-2#1)
nitrate/nitrite##3##1##(2007-10#1)(2008-10#1)(2011-2#1)
nitrated##2##1##(2008-11#1)(2008-5#1)
nitrates and##6##2##(1991-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-5#1)
nitrates##25##1##(1991-9#4)(1992-6#1)(1994-2#1)(1994-3#1)(2006-8#1)(2008-10#8)(2008-3#5)(2008-5#2)(2009-5#2)
nitration of tyrosine##2##3##(2008-5#1)(2008-7#1)
nitration of##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
nitration##4##1##(2008-5#2)(2008-7#1)(2012-3#1)
nitrendipine##6##1##(1991-5#1)(1994-8#2)(1996-5#1)(2008-10#2)
nitrergic##2##1##(1995-12#1)(2008-6#1)
nitric acid and determined spectrophotometrically##2##5##(2008-10#2)
nitric acid and hydrogen peroxide##3##5##(2008-10#3)
nitric acid and##14##3##(2008-10#13)(2008-5#1)
nitric acid as##2##3##(2008-10#2)
nitric acid at pH##2##4##(2008-10#2)
nitric acid at##4##3##(2008-10#4)
nitric acid concentrations##2##3##(2008-10#2)
nitric acid digestion##2##3##(2008-10#2)
nitric acid in##2##3##(2008-10#2)
nitric acid medium was##2##4##(2008-10#2)
nitric acid medium##7##3##(2008-10#7)
nitric acid solution and##2##4##(2008-10#2)
nitric acid solution##9##3##(2008-10#9)
nitric acid solutions##2##3##(2008-10#2)
nitric acid to##2##3##(2008-10#2)
nitric acid was##2##3##(2008-10#2)
nitric acid were##3##3##(2008-10#3)
nitric acid##98##2##(1995-6#1)(2008-10#95)(2008-5#1)(2008-8#1)
nitric acid)##2##2##(2008-10#2)
nitric and hydrochloric##3##3##(2008-10#3)
nitric and##7##2##(2008-10#7)
nitric oxide (NO) and nitrite (NO(2)(-))##2##6##(2008-10#2)
nitric oxide (NO) and##5##4##(1996-5#1)(2008-10#3)(2008-3#1)
nitric oxide (NO) from##2##4##(1992-12#1)(1992-5#1)
nitric oxide (NO) in##4##4##(2008-10#3)(2008-8#1)
nitric oxide (NO) levels##2##4##(2011-1#1)(2013-1#1)
nitric oxide (NO) production##4##4##(1994-11#1)(1995-11#1)(2008-10#1)(2010-4#1)
nitric oxide (NO) synthase##5##4##(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(2011-1#1)
nitric oxide (NO)##51##3##(1991-9#1)(1992-12#2)(1992-5#1)(1992-9#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-7#1)(2007-10#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2010-4#1)(2011-1#2)(2012-8#1)(2013-1#1)
nitric oxide and##17##3##(1994-6#1)(1995-12#1)(1996-2#1)(1997-4#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
nitric oxide bioavailability##3##3##(2009-4#1)(2010-10#1)(2012-3#1)
nitric oxide disturbances##2##3##(2009-8#2)
nitric oxide donor##3##3##(1997-4#1)(2007-10#1)(2013-7#1)
nitric oxide donors##2##3##(1997-4#1)(2008-5#1)
nitric oxide for##2##3##(1997-1#1)(2008-10#1)
nitric oxide in a##2##4##(2008-10#1)(2008-2#1)
nitric oxide in##10##3##(1992-8#1)(1993-6#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
nitric oxide is##3##3##(2007-10#1)(2008-10#1)(2008-12#1)
nitric oxide production in##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
nitric oxide production##10##3##(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
nitric oxide radical##3##3##(2010-5#2)(2011-1#1)
nitric oxide reductase##2##3##(1992-3#2)
nitric oxide release##3##3##(1993-6#1)(2008-11#1)(2012-2#1)
nitric oxide synthase (NOS)##11##4##(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#2)(1996-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-7#1)
nitric oxide synthase (iNOS) is##2##5##(1993-8#1)(2011-1#1)
nitric oxide synthase (iNOS) was##2##5##(1995-12#1)(1996-12#1)
nitric oxide synthase (iNOS)##9##4##(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
nitric oxide synthase activity in##2##5##(1993-3#1)(1995-12#1)
nitric oxide synthase activity##3##4##(1993-11#1)(1993-3#1)(1995-12#1)
nitric oxide synthase and##4##4##(1992-12#1)(1994-8#1)(1995-12#1)(2008-5#1)
nitric oxide synthase gene##5##4##(1993-3#1)(1993-8#1)(1996-12#1)(2008-12#1)(2008-7#1)
nitric oxide synthase in##4##4##(1995-12#1)(1996-12#1)(1997-3#1)(2008-5#1)
nitric oxide synthase inhibitor##3##4##(1996-5#2)(1997-2#1)
nitric oxide synthase mRNA##2##4##(1995-12#2)
nitric oxide synthase##49##3##(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#4)(1993-8#4)(1994-11#1)(1994-8#1)(1995-12#9)(1996-12#4)(1996-5#3)(1997-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#2)
nitric oxide synthase) (10##2##4##(1995-12#2)
nitric oxide synthases (NOS)##3##4##(2008-10#2)(2009-4#1)
nitric oxide synthases##5##3##(1995-11#1)(2008-10#3)(2009-4#1)
nitric oxide synthesis##6##3##(1992-3#1)(1995-12#1)(2010-4#1)(2013-1#3)
nitric oxide system##3##3##(2010-8#1)(2012-8#2)
nitric oxide##257##2##(1991-6#1)(1991-9#3)(1992-12#4)(1992-3#4)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#8)(1993-6#2)(1993-8#4)(1994-11#2)(1994-6#4)(1994-8#1)(1995-11#4)(1995-12#14)(1995-2#1)(1995-5#3)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#7)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#7)(1997-7#2)(2007-10#8)(2008-1#2)(2008-10#36)(2008-11#7)(2008-12#6)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#3)(2009-4#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#3)(2012-8#3)(2013-1#9)(2013-7#4)(2013-8#1)
nitric##380##1##(1991-3#1)(1991-6#1)(1991-9#3)(1992-12#4)(1992-3#5)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#8)(1993-6#2)(1993-8#4)(1994-11#2)(1994-6#4)(1994-8#1)(1995-11#4)(1995-12#14)(1995-2#1)(1995-5#3)(1995-6#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#7)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#7)(1997-7#2)(2007-10#8)(2008-1#2)(2008-10#151)(2008-11#7)(2008-12#6)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#3)(2009-4#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#3)(2012-8#3)(2013-1#9)(2013-7#5)(2013-8#1)
nitric-oxide##2##1##(1996-11#2)
nitride whiskers##2##2##(2008-10#2)
nitride##11##1##(1997-7#1)(2007-12#2)(2008-10#3)(2008-3#4)(2009-2#1)
nitrifying and##2##2##(2012-3#1)(2013-7#1)
nitrile group##2##2##(2008-10#2)
nitrile groups##2##2##(2008-10#2)
nitrile oxides##3##2##(2007-11#3)
nitrile##19##1##(1994-3#7)(1996-5#2)(2007-11#3)(2007-12#1)(2008-10#5)(2009-8#1)
nitriles with##2##2##(2009-6#1)(2009-8#1)
nitriles##13##1##(1994-3#1)(1996-2#2)(1996-5#1)(2009-6#1)(2009-8#3)(2012-3#5)
nitrilotriacetate##4##1##(2008-10#2)(2008-4#2)
nitrilotriacetic acid##3##2##(2008-10#3)
nitrite (NO(2)(-))##4##2##(2008-10#4)
nitrite IRMs are##2##3##(2008-10#2)
nitrite accumulated##2##2##(2008-10#2)
nitrite and 0##2##3##(2008-10#2)
nitrite and citrulline levels##7##4##(2006-10#3)(2008-7#4)
nitrite and citrulline##8##3##(2006-10#4)(2008-7#4)
nitrite and nitrate in##12##4##(2008-10#12)
nitrite and nitrate##26##3##(2008-10#26)
nitrite and##45##2##(2006-10#4)(2008-10#37)(2008-7#4)
nitrite based on##5##3##(2008-10#5)
nitrite by##6##2##(2008-10#6)
nitrite concentration##7##2##(2008-10#7)
nitrite determination in##4##3##(2008-10#4)
nitrite determination##6##2##(2008-10#6)
nitrite formation##2##2##(1995-11#1)(2008-10#1)
nitrite in a##2##3##(2008-10#2)
nitrite in the##6##3##(1993-11#1)(2008-10#5)
nitrite in water##5##3##(2008-10#5)
nitrite in##31##2##(1990-6#1)(1993-11#1)(2008-10#29)
nitrite ion in##3##3##(2008-10#3)
nitrite ion##14##2##(2008-10#14)
nitrite ionophore##2##2##(2008-10#2)
nitrite ions##3##2##(2008-10#3)
nitrite is##6##2##(2008-10#6)
nitrite levels##2##2##(2006-10#1)(2008-7#1)
nitrite on##5##2##(1990-6#1)(2008-10#4)
nitrite plus nitrate##2##3##(1996-11#1)(2008-10#1)
nitrite production##6##2##(1993-11#3)(1996-12#3)
nitrite reductase##4##2##(1994-11#3)(2011-2#1)
nitrite release by Kupffer cells##2##5##(1997-4#2)
nitrite release by##3##3##(1996-2#1)(1997-4#2)
nitrite solution##2##2##(2008-10#2)
nitrite solutions##2##2##(2008-10#2)
nitrite using a##3##3##(2008-10#3)
nitrite using the##2##3##(2008-10#2)
nitrite using##6##2##(2008-10#6)
nitrite was##7##2##(1990-6#1)(2008-10#6)
nitrite were##5##2##(1990-6#1)(1996-2#1)(2008-10#3)
nitrite with a##2##3##(2008-10#2)
nitrite with##3##2##(2008-10#3)
nitrite##261##1##(1990-6#6)(1992-12#1)(1992-8#1)(1993-11#4)(1993-3#1)(1993-8#2)(1994-11#3)(1995-11#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-9#1)(1997-4#3)(1997-7#1)(2006-10#5)(2008-10#212)(2008-11#1)(2008-5#2)(2008-7#5)(2011-2#2)(2012-2#1)
nitrite-nitrogen##4##1##(2008-10#4)
nitrites##5##1##(2007-10#2)(2008-10#2)(2008-11#1)
nitro group##8##2##(1994-11#1)(1995-6#1)(1996-2#1)(2008-10#5)
nitro groups##5##2##(1995-3#1)(1996-5#1)(2008-10#2)(2010-11#1)
nitro##18##1##(1993-11#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-4#1)(2008-10#8)(2008-4#1)(2010-11#1)
nitro-PAHs##3##1##(2008-11#3)
nitroalkenes##2##1##(1996-5#2)
nitroaniline##7##1##(2008-10#7)
nitroaromatic and nitramine explosives##2##4##(2008-10#2)
nitroaromatic compounds in landfill gas##2##5##(2008-10#2)
nitroaromatic compounds##3##2##(2008-10#3)
nitroaromatic pollutants##2##2##(2008-10#2)
nitroaromatic##16##1##(1991-3#1)(2008-10#10)(2008-11#2)(2008-12#1)(2012-2#2)
nitrobenzene##10##1##(2008-10#9)(2008-11#1)
nitrobenzenes##2##1##(2008-10#2)
nitrobenzyl alcohols##2##2##(1990-7#2)
nitrobenzyl##3##1##(1990-7#2)(1994-6#1)
nitrobenzylthioinosine##2##1##(1994-8#1)(1995-8#1)
nitrobestatin##2##1##(1992-5#2)
nitroblue tetrazolium (NBT)##2##3##(1992-3#1)(2008-10#1)
nitroblue tetrazolium reduction##2##3##(1993-12#1)(2008-4#1)
nitroblue tetrazolium##4##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-4#1)
nitroblue##6##1##(1992-3#1)(1992-5#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
nitrocellulose membrane in##2##3##(2008-4#2)
nitrocellulose membrane##3##2##(1995-2#1)(2008-4#2)
nitrocellulose##11##1##(1990-12#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-4#3)(2012-2#1)
nitrocompounds##5##1##(1995-8#5)
nitrofigilis##3##1##(2011-2#3)
nitroflurbiprofen##2##1##(2008-5#2)
nitrofurantoin and##4##2##(2008-10#3)(2008-11#1)
nitrofurantoin##7##1##(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#1)
nitrofurazone##7##1##(2007-7#1)(2012-2#6)
nitrogen (BUN)##3##2##(1994-12#1)(1994-5#2)
nitrogen (N) composition##2##3##(2012-8#1)(2012-9#1)
nitrogen (N)##7##2##(2008-2#1)(2012-1#1)(2012-2#1)(2012-5#1)(2012-8#1)(2012-9#1)(2013-8#1)
nitrogen and a##2##3##(1992-6#1)(2008-10#1)
nitrogen and carbon##2##3##(1994-12#1)(2008-10#1)
nitrogen and methane##3##3##(2008-2#3)
nitrogen and oxygen as##2##4##(2008-10#1)(2008-3#1)
nitrogen and oxygen##4##3##(2008-10#3)(2008-3#1)
nitrogen and phosphorus forms##2##4##(2008-10#2)
nitrogen and phosphorus##7##3##(2008-10#3)(2008-12#1)(2008-5#2)(2013-1#1)
nitrogen and sulfur##2##3##(1997-7#1)(2013-1#1)
nitrogen and##37##2##(1992-6#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#17)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2012-5#1)(2013-1#3)
nitrogen application rate##2##3##(2008-12#2)
nitrogen application##3##2##(2008-12#3)
nitrogen as##2##2##(2008-10#2)
nitrogen assimilation##2##2##(2009-5#1)(2011-2#1)
nitrogen at##3##2##(1993-1#1)(2007-12#1)(2008-3#1)
nitrogen atmosphere##2##2##(2008-10#2)
nitrogen atom##4##2##(1993-6#1)(1995-3#2)(2008-10#1)
nitrogen atoms of the##2##4##(1993-12#1)(2007-11#1)
nitrogen atoms of##3##3##(1993-12#1)(1997-7#1)(2007-11#1)
nitrogen atoms##8##2##(1993-12#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#2)(2010-11#1)
nitrogen balance##5##2##(2007-12#1)(2008-12#1)(2008-3#1)(2013-8#2)
nitrogen catabolite repression##2##3##(1990-5#2)
nitrogen compounds in##3##3##(2008-10#3)
nitrogen compounds##5##2##(2008-10#5)
nitrogen concentration##2##2##(2008-10#1)(2008-2#1)
nitrogen containing##2##2##(2008-10#1)(2009-11#1)
nitrogen content may be##2##4##(2008-8#2)
nitrogen content##14##2##(2008-10#9)(2008-12#1)(2008-8#4)
nitrogen contents (%)##2##3##(2008-12#2)
nitrogen contents of##3##3##(2008-10#1)(2008-12#2)
nitrogen contents##7##2##(2008-10#2)(2008-12#4)(2008-5#1)
nitrogen deprivation##3##2##(2008-7#3)
nitrogen determination in bean samples##2##5##(2008-10#2)
nitrogen determination in##5##3##(2008-10#5)
nitrogen dioxide (NO2)##3##3##(1996-12#3)
nitrogen dioxide in air##2##4##(2008-10#2)
nitrogen dioxide in##3##3##(2008-10#3)
nitrogen dioxide##17##2##(1991-3#1)(1996-12#3)(2008-10#11)(2008-11#1)(2008-5#1)
nitrogen donor atoms##2##3##(1996-2#2)
nitrogen evaporation##2##2##(2008-11#2)
nitrogen fertilization##3##2##(2008-10#3)
nitrogen fixation in the##2##4##(2008-11#1)(2009-7#1)
nitrogen fixation##10##2##(2008-11#1)(2008-7#3)(2008-9#2)(2009-7#2)(2011-2#2)
nitrogen fixing microsymbiont of a##3##5##(2011-2#3)
nitrogen flow##4##2##(2008-10#2)(2008-2#1)(2008-6#1)
nitrogen for##3##2##(1990-11#1)(1991-2#1)(2008-8#1)
nitrogen gas##4##2##(2008-10#3)(2008-2#1)
nitrogen in the##2##3##(1995-11#1)(2008-3#1)
nitrogen in##8##2##(1994-8#1)(1995-11#2)(2008-10#4)(2008-3#1)
nitrogen is##2##2##(1996-5#1)(2008-2#1)
nitrogen metabolism##3##2##(1991-5#1)(1997-1#1)(2008-11#1)
nitrogen of the##2##3##(1992-3#2)
nitrogen of##6##2##(1992-3#2)(1992-6#2)(2008-9#1)(2010-8#1)
nitrogen or##6##2##(1995-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
nitrogen oxides##9##2##(1991-6#2)(1996-12#1)(2008-10#4)(2012-2#2)
nitrogen source##4##2##(1993-6#1)(1995-8#1)(1995-9#1)(2008-10#1)
nitrogen sources##4##2##(1995-9#2)(2008-10#1)(2008-6#1)
nitrogen species##5##2##(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#2)
nitrogen to cause a dramatic decrease in##2##7##(2008-10#2)
nitrogen to##7##2##(1993-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)
nitrogen utilization##4##2##(2012-2#1)(2012-3#3)
nitrogen was##7##2##(1991-5#1)(1995-11#1)(1996-5#1)(2008-10#3)(2008-7#1)
nitrogen were##2##2##(2008-10#1)(2009-9#1)
nitrogen with##4##2##(1995-3#1)(2007-12#2)(2008-10#1)
nitrogen##375##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#3)(1993-6#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#7)(1995-3#6)(1995-8#1)(1995-9#3)(1996-11#2)(1996-12#4)(1996-2#4)(1996-5#4)(1997-1#1)(1997-2#2)(1997-7#5)(2007-11#2)(2007-12#7)(2007-2#1)(2008-1#1)(2008-10#125)(2008-11#8)(2008-12#18)(2008-2#15)(2008-3#20)(2008-4#2)(2008-5#10)(2008-6#9)(2008-7#10)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-1#1)(2012-2#6)(2012-3#5)(2012-5#2)(2012-8#1)(2012-9#1)(2013-1#8)(2013-8#4)
nitrogen)##4##1##(2008-10#2)(2013-1#2)
nitrogen-15 chemical-exchange line broadening##2##4##(1995-2#2)
nitrogen-15 chemical-exchange##3##2##(1995-2#3)
nitrogen-15 relaxation##2##2##(1995-2#2)
nitrogen-15##6##1##(1995-2#6)
nitrogen-centered radical##6##2##(1993-11#6)
nitrogen-centered##7##1##(1993-11#6)(1997-7#1)
nitrogen-containing polycyclic aromatic compounds##2##4##(2008-10#2)
nitrogen-containing##3##1##(2007-11#1)(2008-10#2)
nitrogen-fixing##4##1##(1994-8#1)(2008-11#2)(2011-2#1)
nitrogen-regulatory/oxygen-sensing consensus sequences##2##3##(1993-12#2)
nitrogen-vacancy##3##1##(2007-11#2)(2007-12#1)
nitrogenase activity##3##2##(2008-6#2)(2008-7#1)
nitrogenase##5##1##(1997-7#1)(2008-6#3)(2008-7#1)
nitrogenous waste##2##2##(2008-7#1)(2008-9#1)
nitrogenous##5##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
nitrogens##3##1##(1997-7#2)(2008-10#1)
nitroglycerin and##2##2##(2008-3#1)(2011-2#1)
nitroglycerin##6##1##(1992-5#2)(1996-3#1)(2008-3#1)(2011-2#1)(2012-12#1)
nitroheterocycle##3##1##(1993-6#3)
nitroimidazole##2##1##(1993-6#2)
nitrone##2##1##(1993-6#1)(2010-2#1)
nitrones##3##1##(1993-6#2)(2007-11#1)
nitrophenol isomers##2##2##(2008-10#2)
nitroprusside or##2##2##(1995-11#1)(2007-8#1)
nitroprusside was##2##2##(2007-8#1)(2012-3#1)
nitroprusside##23##1##(1990-12#1)(1991-9#1)(1995-11#2)(1995-12#1)(1995-8#3)(2007-11#1)(2007-8#3)(2008-10#4)(2008-11#3)(2008-3#1)(2012-3#1)(2013-7#2)
nitroreductase activity##2##2##(1990-6#1)(1994-11#1)
nitroreductase##5##1##(1990-6#2)(1994-11#2)(2008-11#1)
nitrosamine##4##1##(1992-8#1)(1992-9#1)(1993-11#1)(2008-10#1)
nitrosamines in##2##2##(2008-10#1)(2013-8#1)
nitrosamines##7##1##(1992-8#3)(2008-10#2)(2008-5#1)(2013-8#1)
nitrosation of##2##2##(1992-8#1)(2008-10#1)
nitrosation##5##1##(1992-8#3)(2008-10#2)
nitrosative##2##1##(2008-10#1)(2013-7#1)
nitroso##6##1##(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-2#1)
nitroso-cyclopentadiene##2##1##(2009-12#2)
nitrosothiols##2##1##(2008-10#1)(2010-5#1)
nitrosyl##5##1##(1992-3#1)(1996-2#3)(1997-4#1)
nitrosylation##2##1##(2008-10#1)(2013-7#1)
nitrotriazole explosives##2##2##(2008-11#2)
nitrotyrosine formation##2##2##(2007-10#2)
nitrotyrosine##6##1##(2007-10#3)(2008-1#1)(2010-2#1)(2011-2#1)
nitrous acid accumulated##2##3##(2008-10#2)
nitrous acid and##2##3##(2008-10#1)(2011-2#1)
nitrous acid was##2##3##(2008-10#2)
nitrous acid##9##2##(2008-10#8)(2011-2#1)
nitrous oxide and##2##3##(2008-11#1)(2011-2#1)
nitrous oxide reductase from Wolinella succinogenes##2##6##(1992-8#2)
nitrous oxide##25##2##(1991-6#3)(1992-3#1)(1992-8#3)(1993-1#2)(1996-6#3)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#3)(2008-8#3)(2009-12#1)(2011-2#3)
nitrous##36##1##(1991-6#3)(1992-3#1)(1992-8#3)(1993-1#2)(1996-6#3)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-7#3)(2008-8#3)(2009-12#1)(2011-2#4)
nitrovasodilators##2##1##(1991-9#1)(1995-11#1)
nitroxide##8##1##(1993-8#1)(1994-3#1)(1996-5#1)(2007-11#2)(2008-10#2)(2008-8#1)
nitroxides##3##1##(1993-6#1)(1994-3#1)(1996-10#1)
nitroxyl##3##1##(1992-3#1)(1992-9#2)
nivale##5##1##(2008-10#5)
nivalenol (NIV)##4##2##(2008-10#4)
nivalenol##8##1##(1997-6#2)(2008-10#6)
nivalis##2##1##(2006-12#1)(2008-6#1)
nivea##3##1##(2010-3#3)
niveau##2##1##(2009-10#1)(2011-2#1)
niveum race 1##3##3##(2008-10#3)
niveum race##4##2##(2008-10#4)
niveum##11##1##(2008-10#11)
niviguttella##2##1##(2013-8#2)
nkx-2##6##1##(1995-6#6)
nl##2##1##(1994-9#1)(2008-10#1)
nl)##4##1##(1997-2#2)(1997-6#1)(2008-6#1)
nm &lt##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
nm (##2##2##(2008-10#2)
nm (FWHM)##2##2##(2008-2#1)(2008-3#1)
nm (OI##2##2##(2008-3#2)
nm (idler)##3##2##(2007-11#1)(2007-12#2)
nm (lambda(max) of##3##3##(2010-5#3)
nm (signal) and##3##3##(2007-11#1)(2007-12#2)
nm (zero cross for##2##4##(2010-5#2)
nm CaWO(4)##2##2##(2009-11#2)
nm FWHM)##2##2##(2008-2#1)(2008-3#1)
nm Insulin treatment##2##3##(2011-1#2)
nm after 3 min of mixing the reagents##2##8##(2008-10#2)
nm after##10##2##(1990-12#1)(1993-11#1)(2008-10#6)(2008-3#1)(2010-1#1)
nm against a##2##3##(2008-10#2)
nm and 0##3##3##(2007-12#1)(2008-3#2)
nm and 1##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
nm and 2##3##3##(2007-12#1)(2008-8#2)
nm and Beer's law##2##4##(2008-10#2)
nm and a numerical aperture of 0##2##7##(2007-11#1)(2008-2#1)
nm and a shoulder at##2##5##(2008-10#2)
nm and a tuning range of##2##6##(2008-2#1)(2008-3#1)
nm and a##20##3##(2007-11#4)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#6)(2013-8#1)
nm and an emission wavelength##2##5##(2008-10#2)
nm and an##8##3##(1990-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-7#1)
nm and at##2##3##(2008-2#1)(2008-3#1)
nm and emission##2##3##(1997-2#1)(2008-10#1)
nm and has##2##3##(2007-12#1)(2008-2#1)
nm and in##2##3##(2007-11#1)(2007-12#1)
nm and lambda (em##2##4##(2008-10#2)
nm and lambda##3##3##(2008-10#2)(2008-3#1)
nm and less##2##3##(2008-2#1)(2008-7#1)
nm and measured at##2##4##(2008-10#2)
nm and measured##3##3##(2007-11#1)(2008-10#2)
nm and the average transmissions strength is##2##7##(2013-8#2)
nm and the average##3##4##(2009-7#1)(2013-8#2)
nm and the emission##4##4##(1996-2#1)(2008-10#3)
nm and the other##2##4##(2007-11#1)(2008-2#1)
nm and the##20##3##(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-8#3)
nm and##147##2##(1990-5#1)(1993-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(2007-11#9)(2007-12#18)(2008-10#41)(2008-11#2)(2008-2#17)(2008-3#30)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-3#1)(2011-1#2)(2013-1#1)(2013-8#5)
nm are##14##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#6)(2009-11#1)(2013-8#1)
nm as well as##3##4##(1993-11#1)(2007-11#1)(2008-2#1)
nm as##7##2##(1993-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)
nm at 25##2##3##(2008-3#1)(2008-8#1)
nm at a##4##3##(1995-5#1)(2008-10#1)(2008-3#2)
nm at the##2##3##(2007-12#1)(2008-3#1)
nm at##18##2##(1995-5#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-8#1)
nm based on a##2##4##(2008-3#2)
nm being##2##2##(1995-3#1)(2008-10#1)
nm but##2##2##(2008-10#1)(2009-11#1)
nm by frequency doubling##2##4##(2007-11#2)
nm by frequency mixing##2##4##(2008-2#2)
nm by frequency##4##3##(2007-11#2)(2008-2#2)
nm by single-pass##2##3##(2007-12#2)
nm by the##2##3##(2007-11#1)(2008-10#1)
nm by use of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
nm by using##2##3##(2008-2#1)(2008-3#1)
nm by##24##2##(2007-11#5)(2007-12#6)(2008-10#1)(2008-2#7)(2008-3#4)(2008-6#1)
nm can be##3##3##(2008-3#3)
nm deep##2##2##(2007-12#1)(2008-10#1)
nm diameter##4##2##(2008-8#1)(2009-2#1)(2010-4#1)(2013-8#1)
nm due to##2##3##(2008-10#1)(2009-11#1)
nm during the##2##3##(2008-2#2)
nm during##3##2##(2007-11#1)(2008-2#2)
nm emission##3##2##(2008-10#2)(2011-1#1)
nm excitation##2##2##(2008-10#2)
nm for a##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
nm for bond lengths and##2##5##(2008-8#1)(2008-9#1)
nm for the##11##3##(2007-11#1)(2008-10#3)(2008-3#6)(2008-9#1)
nm for##58##2##(2007-11#8)(2007-12#4)(2008-10#22)(2008-2#6)(2008-3#15)(2008-8#1)(2008-9#2)
nm from a##7##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
nm from##16##2##(2007-11#7)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)
nm full width at half-maximum##2##5##(2007-12#1)(2008-2#1)
nm has been##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
nm have been generated from a Kerr-lens mode-locked Ti##2##9##(2007-11#1)(2007-12#1)
nm have been obtained##2##4##(2007-12#1)(2008-2#1)
nm have been##9##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
nm have##10##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)
nm in a##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
nm in aqueous solution##3##4##(1996-12#1)(2008-10#2)
nm in aqueous##4##3##(1996-12#1)(2008-10#3)
nm in diameter and##2##4##(2008-10#2)
nm in diameter were##2##4##(2008-7#1)(2009-11#1)
nm in diameter with##2##4##(1994-3#1)(2008-10#1)
nm in diameter##20##3##(1994-3#1)(1997-8#1)(2008-10#9)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-6#1)
nm in diameter)##2##3##(2009-11#1)(2010-12#1)
nm in length##4##3##(2007-11#1)(2008-10#2)(2008-8#1)
nm in most##2##3##(2008-10#1)(2008-2#1)
nm in the##9##3##(1995-2#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2013-8#1)
nm in wavelength##2##3##(2007-11#1)(2008-3#1)
nm in width##2##3##(2008-10#1)(2009-12#1)
nm in##83##2##(1994-3#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#6)(2007-12#10)(2008-10#23)(2008-2#8)(2008-3#9)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-7#1)(2010-11#3)(2010-12#2)(2010-6#1)(2013-8#1)
nm is demonstrated##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2009-11#1)
nm is linear##2##3##(2008-10#2)
nm is obtained##2##3##(2008-2#1)(2008-3#1)
nm is##31##2##(1992-6#2)(1996-12#1)(2007-11#4)(2007-12#8)(2008-10#6)(2008-2#5)(2008-3#4)(2009-11#1)
nm light##2##2##(1994-12#1)(2008-5#1)
nm long##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
nm may##2##2##(2008-11#1)(2008-2#1)
nm near##2##2##(2007-12#1)(2008-3#1)
nm of a##2##3##(2007-11#1)(2007-12#1)
nm of the##7##3##(1992-6#1)(1992-8#1)(1994-5#1)(2008-1#1)(2008-10#2)(2008-2#1)
nm of##13##2##(1992-6#1)(1992-8#1)(1994-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)
nm on the##2##3##(2007-12#1)(2008-1#1)
nm on##4##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#1)
nm or less##2##3##(2007-11#1)(2008-2#1)
nm or##5##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
nm over##2##2##(2007-11#1)(2008-3#1)
nm peak##3##2##(1992-6#2)(2008-10#1)
nm range##3##2##(2008-10#2)(2011-1#1)
nm resolution##9##2##(2008-4#2)(2008-8#4)(2008-9#2)(2009-5#1)
nm spectral##2##2##(2008-10#1)(2008-3#1)
nm that##5##2##(2007-12#2)(2008-10#2)(2008-3#1)
nm the##2##2##(2007-12#1)(2008-3#1)
nm thick##6##2##(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#2)
nm through a##2##3##(2007-12#1)(2007-8#1)
nm to##20##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#9)(2008-3#3)(2008-8#1)(2009-10#1)
nm using a##3##3##(2008-10#3)
nm using##9##2##(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
nm was also##2##3##(2007-11#1)(2008-3#1)
nm was measured##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
nm was observed##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-7#1)
nm was obtained##3##3##(2007-11#2)(2007-12#1)
nm was used for##4##4##(2007-11#1)(2007-12#1)(2008-10#2)
nm was used to test##2##5##(2008-2#1)(2008-3#1)
nm was used to##4##4##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
nm was used##10##3##(1991-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)
nm was##45##2##(1991-3#1)(1992-12#1)(1992-8#1)(1997-7#1)(2007-11#10)(2007-12#5)(2008-10#10)(2008-2#7)(2008-3#6)(2008-9#1)(2009-7#1)(2012-2#1)
nm wavelength##6##2##(1990-8#1)(1991-12#1)(2007-11#1)(2008-10#2)(2008-2#1)
nm were 3##2##3##(2008-10#2)
nm were measured##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
nm were observed##2##3##(2008-10#1)(2008-5#1)
nm were##24##2##(1993-11#1)(1994-6#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#5)(2008-5#1)(2009-11#1)(2013-8#1)
nm when excited at##5##4##(1996-12#1)(2007-11#3)(2008-10#1)
nm when##7##2##(1996-12#1)(2007-11#4)(2008-10#1)(2008-3#1)
nm wide)##2##2##(2007-11#1)(2008-10#1)
nm with a molar absorptivity##2##5##(2008-10#2)
nm with a repetition rate##2##5##(2007-12#1)(2008-3#1)
nm with a##16##3##(1994-6#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#2)(2008-8#1)(2012-2#1)
nm with an excitation wavelength of##2##6##(2008-10#2)
nm with an##11##3##(2006-4#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#2)
nm with excitation at##4##4##(1997-2#1)(2008-10#3)
nm with molar absorptivity##3##4##(2008-10#3)
nm with the##3##3##(2008-10#3)
nm with##63##2##(1994-6#1)(1997-2#1)(2006-4#1)(2007-11#12)(2007-12#8)(2008-10#21)(2008-2#9)(2008-3#8)(2008-8#1)(2012-2#1)
nm without##2##2##(2007-11#1)(2008-3#1)
nm##1700##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1992-12#6)(1992-6#11)(1992-8#3)(1992-9#1)(1993-11#9)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#2)(1994-9#2)(1995-2#5)(1995-3#1)(1995-5#6)(1996-11#1)(1996-12#4)(1996-2#5)(1996-4#1)(1996-5#5)(1997-2#5)(1997-3#2)(1997-7#2)(1997-8#1)(2006-4#1)(2007-11#176)(2007-12#190)(2007-8#1)(2008-1#6)(2008-10#494)(2008-11#15)(2008-12#1)(2008-2#181)(2008-3#301)(2008-4#5)(2008-5#24)(2008-6#2)(2008-7#17)(2008-8#38)(2008-9#12)(2009-10#2)(2009-11#20)(2009-12#3)(2009-2#2)(2009-5#8)(2009-7#6)(2009-8#2)(2009-9#4)(2010-1#2)(2010-11#6)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#8)(2010-6#3)(2010-8#1)(2011-1#13)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#23)
nm) Ag##2##2##(2007-12#2)
nm) after##3##2##(2008-10#3)
nm) and Q(Y)##2##3##(2008-9#2)
nm) and a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
nm) and of##2##3##(2007-12#1)(2008-2#1)
nm) and##31##2##(1996-2#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-2#5)(2008-3#7)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#1)(2012-12#1)
nm) as##2##2##(2008-10#2)
nm) at##3##2##(2008-10#2)(2008-3#1)
nm) between##2##2##(1994-5#1)(2008-10#1)
nm) by##2##2##(1990-8#1)(2008-3#1)
nm) coated##2##2##(2008-10#1)(2009-7#1)
nm) for##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
nm) has been##2##3##(2008-10#1)(2008-3#1)
nm) has##3##2##(2008-10#1)(2008-3#1)(2011-7#1)
nm) in the presence of hydrogen peroxide##3##7##(2008-10#3)
nm) in the presence of##5##5##(2008-10#4)(2008-11#1)
nm) in the##7##3##(2008-10#6)(2008-11#1)
nm) in##9##2##(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)
nm) is##4##2##(2008-12#1)(2008-2#1)(2008-3#2)
nm) light##2##2##(2008-10#1)(2008-12#1)
nm) of a Nd##2##4##(2008-3#2)
nm) of a##3##3##(2007-12#1)(2008-3#2)
nm) of pure water##2##4##(2008-2#2)
nm) of the##4##3##(1994-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
nm) of##16##2##(1994-5#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2008-5#1)(2008-9#2)(2010-4#1)
nm) or##3##2##(1991-7#1)(2008-10#1)(2008-3#1)
nm) that are##2##3##(2007-12#1)(2010-11#1)
nm) to##3##2##(1994-6#1)(2008-2#1)(2008-3#1)
nm) under##2##2##(1990-8#1)(2007-11#1)
nm) was investigated##2##3##(2008-11#1)(2009-12#1)
nm) was used##2##3##(2007-12#1)(2009-7#1)
nm) was##11##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2009-12#1)(2009-7#1)(2010-4#1)
nm) were##3##2##(2007-12#1)(2008-3#2)
nm) with a relative standard deviation of 1##2##8##(2008-10#2)
nm) with a##4##3##(1995-5#1)(2008-10#2)(2008-3#1)
nm) with##12##2##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)
nm)##253##1##(1990-11#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-11#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-5#3)(1997-2#1)(2007-11#15)(2007-12#20)(2007-8#1)(2008-10#86)(2008-11#4)(2008-12#2)(2008-2#24)(2008-3#49)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2013-8#2)
nm/ degrees C##3##3##(2007-12#2)(2008-3#1)
nm23 expression##3##2##(1993-8#1)(1993-9#2)
nm23 genes##2##2##(1993-9#2)
nm23 mRNA##2##2##(1993-9#2)
nm23##12##1##(1993-8#5)(1993-9#7)
nm23-H1##2##1##(1993-9#2)
nm23-H2##4##1##(1993-9#4)
nm23/NDP-K##2##1##(1993-8#2)
nm2798##2##1##(2008-8#2)
nmol BSP##2##2##(1992-3#2)
nmol CO2 incorporated per min per mg protein##2##8##(1997-6#2)
nmol L(-1)##6##2##(2008-10#5)(2008-12#1)
nmol LTE4/mol creatinine (range##2##4##(1993-9#2)
nmol Pi/mg of protein per min##2##6##(2008-10#2)
nmol for##2##2##(1991-5#2)
nmol h(-1) for##2##3##(2008-10#2)
nmol i##3##2##(1997-2#3)
nmol l(-1) (S/N=3)##2##3##(2008-10#2)
nmol l(-1) with a detection limit of 0##2##8##(2008-10#2)
nmol l(-1)##14##2##(2008-10#14)
nmol min-1 mg-1##2##3##(1990-11#2)
nmol of##4##2##(1991-8#1)(1992-6#1)(1993-8#1)(1997-2#1)
nmol per min per mg protein##4##6##(1997-6#4)
nmol protoporphyrin IX per min per mg protein##2##8##(1991-5#2)
nmol##77##1##(1990-11#2)(1991-12#2)(1991-3#2)(1991-5#8)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#2)(1997-2#7)(1997-6#6)(2008-10#28)(2008-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2013-8#1)
nmol) and##3##2##(1996-2#1)(1997-2#1)(1997-4#1)
nmol) into the##2##3##(1993-12#1)(1997-2#1)
nmol) or##2##2##(1995-12#1)(1997-4#1)
nmol)##21##1##(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#3)(1994-8#1)(1995-12#2)(1996-2#2)(1997-2#2)(1997-4#7)(2008-10#1)
nmol/##2##1##(2008-1#1)(2013-1#1)
nmol/10##2##1##(1997-4#2)
nmol/10(6) cells##2##2##(1990-7#1)(1994-8#1)
nmol/100 nl)##2##2##(1997-2#2)
nmol/h/mg protein##3##2##(1990-5#1)(1991-12#2)
nmol/h/mg##4##1##(1990-5#1)(1991-12#3)
nmol/hour/mg protein##2##2##(1993-3#2)
nmol/kg##2##1##(1991-12#1)(1992-3#1)
nmol/l in##3##2##(1990-12#2)(2011-2#1)
nmol/l##14##1##(1990-11#2)(1990-12#2)(1992-6#1)(1994-6#1)(1995-8#3)(2008-10#1)(2011-2#2)(2012-3#2)
nmol/l)##6##1##(1990-11#1)(1993-3#2)(1994-12#1)(2012-2#1)(2012-3#1)
nmol/mg protein) or##2##3##(1996-9#2)
nmol/mg protein)##4##2##(1996-9#4)
nmol/min per mg protein##2##4##(1990-8#2)
nmol/min/gHb##2##1##(1990-11#2)
nmol/min/mg protein##5##2##(1991-11#2)(1996-12#3)
nmol/min/mg##7##1##(1991-11#2)(1993-6#1)(1996-12#3)(2008-5#1)
nmol/mol creatinine)##2##2##(1993-9#2)
nmol/mol##6##1##(1993-9#2)(2008-3#4)
nmol/mouse)##3##1##(1995-12#3)
nmolar range##2##2##(2008-10#2)
nmole##4##1##(1994-11#1)(1997-6#2)(2008-10#1)
nmole)##2##1##(1994-11#2)
nmoll(-1)##3##1##(2008-10#3)
nmol·l-1##2##1##(2013-1#2)
nmol·l-1)##3##1##(2013-1#3)
nmr##2##1##(1991-5#1)(2008-3#1)
no &quot##4##2##(1993-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
no A5'ppA-containing##2##2##(1994-11#2)
no Al##2##2##(2008-10#2)
no CO(2) supply was about##2##5##(2008-11#2)
no CO(2) supply was##4##4##(2008-11#4)
no CO(2) supply##6##3##(2008-11#6)
no CO(2)##7##2##(2008-11#7)
no DNA##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
no GTN##2##2##(2008-8#2)
no ST-segment elevation##3##3##(2008-3#3)
no TATA##2##2##(1993-2#1)(1994-12#1)
no a priori##2##3##(2008-3#1)(2008-7#1)
no a##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
no ability to##3##3##(2008-11#1)(2008-5#1)(2010-11#1)
no abnormalities##3##2##(1993-1#1)(2007-8#1)(2013-1#1)
no abnormality##3##2##(1990-6#1)(2008-12#1)(2008-7#1)
no absolute##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
no accumulation of##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
no accumulation##4##2##(1990-12#1)(2008-10#1)(2008-11#2)
no activation of##2##3##(1990-5#1)(2008-10#1)
no activation##4##2##(1990-5#1)(1992-12#1)(1995-2#1)(2008-10#1)
no activity##11##2##(1992-1#1)(1992-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
no added##3##2##(1997-7#1)(1997-8#1)(2010-2#1)
no additional##9##2##(1993-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
no advanced##2##2##(2012-12#1)(2012-3#1)
no advantage over##3##3##(1994-2#2)(1996-2#1)
no advantage##5##2##(1994-2#2)(1996-2#1)(2008-10#1)(2009-10#1)
no adverse effects##2##3##(1993-1#1)(2012-3#1)
no adverse events##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
no adverse impact on##2##4##(1996-1#1)(2013-1#1)
no adverse##11##2##(1993-1#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#2)
no affinity for##4##3##(1993-6#1)(1995-6#1)(2008-10#2)
no affinity##5##2##(1992-3#1)(1993-6#1)(1995-6#1)(2008-10#2)
no age##4##2##(1991-12#1)(1991-8#1)(2008-7#1)(2010-2#1)
no aggregation##2##2##(1990-5#1)(2008-10#1)
no agreement on##2##3##(2008-7#1)(2011-2#1)
no alteration in##4##3##(1997-7#1)(2007-7#2)(2008-9#1)
no alternative to##2##3##(1996-1#1)(2008-7#1)
no alternative##5##2##(1992-3#1)(1996-1#1)(2007-10#1)(2008-7#1)(2010-6#1)
no animal##2##2##(2008-10#1)(2008-11#1)
no antecedent##2##2##(1992-2#1)(2008-9#1)
no antifungal activity##2##3##(2008-10#2)
no apparent changes in##2##4##(1992-7#1)(2008-11#1)
no apparent changes##3##3##(1992-7#1)(2008-11#1)(2008-5#1)
no apparent correlation between genetic distance and##2##7##(2008-10#2)
no apparent difference in##2##4##(2008-10#1)(2008-11#1)
no apparent effects##2##3##(1994-9#1)(2008-11#1)
no apparent similarity to any##2##5##(1995-8#1)(1996-6#1)
no apparent##32##2##(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)
no appreciable effect##2##3##(2008-10#1)(2008-11#1)
no appreciable##7##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
no approved##2##2##(2008-8#1)(2009-7#1)
no artificial##2##2##(1996-3#1)(2012-3#1)
no associated##2##2##(1990-11#1)(1994-12#1)
no association between##8##3##(1993-1#1)(1997-8#1)(2008-8#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
no association was found between the##3##6##(1990-8#1)(2008-10#1)(2012-12#1)
no association was##5##3##(1990-8#1)(1991-12#1)(2007-6#1)(2008-10#1)(2012-12#1)
no association with the##2##4##(2008-11#1)(2011-1#1)
no association with##7##3##(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)
no association##23##2##(1990-8#1)(1991-12#1)(1993-1#1)(1997-1#1)(1997-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#3)(2012-12#3)(2013-1#1)(2013-8#1)
no attempt##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
no attention##2##2##(1990-6#1)(2013-1#1)
no available##3##2##(1991-5#1)(2012-2#1)(2012-3#1)
no background##2##2##(2012-12#1)(2013-1#1)
no bacteria##2##2##(2008-5#2)
no bacterial##2##2##(1991-3#1)(1993-2#1)
no beneficial effect##2##3##(1996-7#1)(2009-2#1)
no benefit##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
no better than##5##3##(1993-1#1)(1994-12#1)(1997-2#1)(2008-2#1)(2008-5#1)
no better##6##2##(1992-3#1)(1993-1#1)(1994-12#1)(1997-2#1)(2008-2#1)(2008-5#1)
no binding##2##2##(1993-6#1)(1994-9#1)
no biochemical##2##2##(1995-12#1)(2008-1#1)
no biological##2##2##(1991-8#1)(2008-10#1)
no broccoli##2##2##(2008-10#2)
no case of##2##3##(1995-3#1)(2008-10#1)
no case##12##2##(1990-2#1)(1991-3#1)(1991-8#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
no cases of##8##3##(1991-2#1)(1995-4#1)(1997-8#1)(2008-1#1)(2008-7#2)(2011-2#2)
no cases##10##2##(1991-2#1)(1995-4#1)(1997-8#1)(2008-1#1)(2008-7#3)(2011-1#1)(2011-2#2)
no casting##2##2##(2008-9#2)
no cause##2##2##(1992-3#1)(2008-8#1)
no cell##3##2##(1993-9#1)(2008-4#1)(2008-6#1)
no cells##3##2##(1992-8#1)(1993-12#1)(2012-3#1)
no central##2##2##(1994-11#1)(2007-11#1)
no change in the number of##3##6##(1990-6#1)(1997-2#1)(2008-7#1)
no change in the##17##4##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)
no change in their##2##4##(1992-6#1)(1995-3#1)
no change in##41##3##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
no change of##2##3##(1995-5#1)(2012-3#1)
no change was observed in the##3##6##(1990-12#1)(1992-8#1)(1994-3#1)
no change was observed in##4##5##(1990-12#1)(1992-8#1)(1993-11#1)(1994-3#1)
no change was observed##5##4##(1990-12#1)(1992-8#1)(1993-11#1)(1994-3#1)(2009-1#1)
no change was seen##2##4##(1994-12#1)(1996-2#1)
no change was##8##3##(1990-12#1)(1990-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1996-2#1)(2009-1#1)
no change##60##2##(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
no changes in the##4##4##(2008-12#1)(2008-3#1)(2009-11#1)(2013-8#1)
no changes in##16##3##(1990-11#1)(1991-8#1)(1994-11#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)(2012-3#1)(2013-8#1)
no changes were observed in##5##5##(1994-8#1)(1995-3#1)(2008-7#1)(2013-1#2)
no changes were##9##3##(1990-3#1)(1991-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
no changes##32##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
no characteristic##2##2##(2009-5#1)(2012-12#1)
no chemical##5##2##(2008-10#5)
no clear association##2##3##(2008-7#2)
no clear evidence##4##3##(1996-3#1)(2008-11#1)(2013-1#2)
no clear physical##2##3##(2008-6#1)(2012-5#1)
no clear##24##2##(1990-11#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-5#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-5#1)(2013-1#2)(2013-8#1)
no clear-cut##2##2##(2008-12#1)(2009-3#1)
no clearly defined##2##3##(2008-7#1)(2009-8#1)
no clearly##3##2##(2008-7#1)(2008-9#1)(2009-8#1)
no clinical data##2##3##(1990-9#1)(2008-11#1)
no clinical or##5##3##(1992-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
no clinical signs##2##3##(1991-3#1)(2012-3#1)
no clinical symptoms##2##3##(1997-3#1)(2013-1#1)
no clinical##17##2##(1990-11#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-2#1)(1997-3#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#2)
no clinically significant##3##3##(1996-1#1)(2007-11#1)(2008-5#1)
no clinically##4##2##(1996-1#1)(2007-11#1)(2008-5#1)(2012-2#1)
no close affected relatives##3##4##(2008-1#3)
no close##4##2##(2008-1#3)(2008-10#1)
no clustering##2##2##(1996-12#1)(2008-10#1)
no cognitive##2##2##(1994-6#1)(2011-2#1)
no common##6##2##(2008-10#2)(2008-6#1)(2008-7#1)(2011-4#1)(2013-8#1)
no comparable##2##2##(1996-5#1)(2008-10#1)
no compelling evidence##2##3##(1995-3#1)(2007-5#1)
no compelling##3##2##(1995-3#1)(2007-5#1)(2008-10#1)
no competition##3##2##(1993-2#1)(2008-8#1)(2010-8#1)
no complete##3##2##(1990-12#1)(1991-2#1)(2007-10#1)
no complications were##2##3##(2007-8#1)(2013-1#1)
no complications##13##2##(1993-10#1)(1996-3#1)(1997-8#1)(2007-8#3)(2008-1#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
no compounds##2##2##(2008-10#2)
no comprehensive##3##2##(1991-3#1)(1996-5#1)(2008-7#1)
no conclusions can be drawn##2##5##(1994-11#1)(2008-5#1)
no conclusive##2##2##(2008-5#1)(2012-12#1)
no concomitant##2##2##(1992-6#1)(2011-2#1)
no conflict occurred##2##3##(2009-7#2)
no conflict##4##2##(1995-12#1)(2008-9#1)(2009-7#2)
no connection##2##2##(2006-12#1)(2008-7#1)
no consensus has##2##3##(1995-2#1)(2013-8#1)
no consensus on##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
no consensus##13##2##(1994-12#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
no considerable##3##2##(2008-10#1)(2008-2#1)(2010-3#1)
no consistent effects on##2##4##(1995-12#1)(2008-10#1)
no consistent##13##2##(1990-12#1)(1993-9#1)(1995-12#1)(2008-10#4)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
no consumption##2##2##(2013-1#1)(2013-7#1)
no contact##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
no contamination or##2##3##(2008-12#1)(2008-6#1)
no contamination##4##2##(2008-10#1)(2008-12#2)(2008-6#1)
no control##3##2##(1996-2#1)(2008-7#1)(2009-12#1)
no convincing evidence of##2##4##(1992-2#1)(2013-1#1)
no convincing evidence##6##3##(1992-2#1)(1995-11#1)(2007-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
no convincing##7##2##(1992-2#1)(1995-11#1)(2007-8#2)(2009-5#1)(2011-2#1)(2013-1#1)
no correlation between the##8##4##(1992-10#1)(1992-11#1)(1994-6#1)(2008-10#4)(2008-5#1)
no correlation between##24##3##(1990-3#1)(1991-11#1)(1991-5#1)(1991-8#3)(1992-10#1)(1992-11#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#3)
no correlation in##2##3##(1993-5#1)(2011-2#1)
no correlation was found between the##3##6##(1992-2#1)(1994-7#1)(2008-11#1)
no correlation with age##2##4##(1990-2#1)(2011-2#1)
no correlation with the##2##4##(1991-2#1)(1993-11#1)
no correlation with##9##3##(1990-2#1)(1991-2#1)(1993-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
no correlation##41##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#5)(2012-3#1)(2013-1#1)
no correlations between##2##3##(2007-11#1)(2011-2#1)
no corresponding##2##2##(1996-2#1)(2008-4#1)
no cost of##2##3##(2008-10#1)(2008-3#1)
no cost##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
no cross##3##2##(1995-2#1)(2008-2#1)(2008-3#1)
no cross-reaction##2##2##(2008-11#1)(2010-4#1)
no cross-reactivity with##2##3##(1990-11#1)(2008-10#1)
no curative##3##2##(2008-1#1)(2008-5#2)
no damage##4##2##(1994-8#1)(1995-2#1)(2008-10#1)(2009-12#1)
no data are##2##3##(2013-1#1)(2013-7#1)
no data on##3##3##(1990-2#1)(1993-3#1)(2008-5#1)
no data##10##2##(1990-2#1)(1993-3#1)(1994-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#2)(2013-7#1)
no deaths##7##2##(1993-9#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
no decline in##2##3##(2008-10#1)(2010-8#1)
no decrease in##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
no deficits in##2##3##(1994-3#1)(1994-8#1)
no deficits##3##2##(1994-3#1)(1994-6#1)(1994-8#1)
no definitive treatments##2##3##(2008-5#1)(2010-5#1)
no definitive##11##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-12#3)(2010-5#1)
no degradation##2##2##(2008-10#1)(2008-5#1)
no demonstrable##3##2##(1991-3#1)(1996-6#1)(2008-1#1)
no detailed##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
no detectable activity in##2##4##(2009-6#2)
no detectable change in the##2##5##(1994-3#1)(2008-8#1)
no detectable change in##3##4##(1994-3#1)(2008-8#1)(2008-9#1)
no detectable effect on##4##4##(1991-9#1)(1994-2#1)(2007-5#1)(2008-8#1)
no detectable##35##2##(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-5#1)(2007-5#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#2)(2012-2#1)(2013-1#1)(2013-7#1)
no detrimental##2##2##(1991-3#1)(2011-2#1)
no dialysis##2##2##(2007-8#1)(2008-10#1)
no difference among the##2##4##(1991-9#1)(2008-12#1)
no difference among##3##3##(1991-1#1)(1991-9#1)(2008-12#1)
no difference between the two##2##5##(1995-8#1)(2008-7#1)
no difference between the##9##4##(1990-2#1)(1990-5#1)(1990-7#1)(1995-8#1)(1996-7#1)(2007-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
no difference between##20##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-7#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-5#1)(2012-2#1)(2013-1#1)
no difference could be##2##4##(1996-5#1)(2008-10#1)
no difference for##2##3##(1992-10#1)(2008-12#1)
no difference in mean##2##4##(2008-7#1)(2012-12#1)
no difference in postoperative##2##4##(1992-3#1)(2010-8#1)
no difference in the pattern##2##5##(2008-10#1)(2011-2#1)
no difference in the##20##4##(1990-6#1)(1991-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
no difference in##62##3##(1990-11#1)(1990-6#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-3#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#6)
no difference of##2##3##(2008-9#1)(2009-6#1)
no difference regarding##2##3##(1997-3#1)(2010-1#1)
no difference was found in the##2##6##(1996-2#1)(2012-12#1)
no difference was found##3##4##(1996-2#1)(2011-2#1)(2012-12#1)
no difference was seen##2##4##(1991-6#1)(2008-5#1)
no difference was##5##3##(1991-6#1)(1996-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
no difference##107##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-2#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#2)(1997-6#1)(2007-10#2)(2007-2#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#6)
no differences among##3##3##(1990-3#1)(1993-3#1)(2008-4#1)
no differences between the##7##4##(1995-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
no differences between##16##3##(1991-2#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
no differences in serum cholesterol##2##5##(1993-9#1)(1997-7#1)
no differences in the##12##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
no differences in##34##3##(1990-11#1)(1990-8#1)(1993-1#1)(1993-9#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-10#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
no differences were found between##4##5##(1992-5#1)(1996-1#1)(2008-11#1)(2010-12#1)
no differences were found in##2##5##(1990-5#1)(1994-2#1)
no differences were found##7##4##(1990-5#1)(1992-5#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2010-12#1)
no differences were observed between##2##5##(2008-7#2)
no differences were observed in##2##5##(1995-11#1)(2010-4#1)
no differences were observed##5##4##(1995-11#1)(2008-10#1)(2008-7#2)(2010-4#1)
no differences were##13##3##(1990-5#1)(1992-5#1)(1994-2#1)(1995-11#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-12#1)(2010-4#1)(2013-1#1)
no differences##71##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-5#1)(1993-1#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-7#1)(2007-10#2)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
no different from##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
no different##5##2##(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
no differentiation##2##2##(2008-10#1)(2009-5#1)
no differently##2##2##(1990-2#1)(1993-3#1)
no direct effect##2##3##(1992-6#1)(1995-2#1)
no direct evidence to support##2##5##(2008-10#2)
no direct relationship between##3##4##(1996-2#1)(2008-5#1)(2008-7#1)
no direct##13##2##(1990-2#1)(1992-6#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-2#1)
no discernable##2##2##(2008-10#1)(2008-9#1)
no disease##4##2##(2008-10#3)(2012-12#1)
no displacement##2##2##(2008-10#1)(2013-1#1)
no distinct##5##2##(1993-3#1)(2007-12#1)(2008-10#2)(2008-9#1)
no distinction##2##2##(1997-4#1)(2011-2#1)
no documented##2##2##(1993-11#1)(1996-5#1)
no donor##2##2##(1997-3#1)(2011-2#1)
no doubt that##7##3##(1992-6#1)(1995-4#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#2)
no doubt##14##2##(1992-1#1)(1992-6#1)(1995-4#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
no duty to##2##3##(1994-3#1)(1997-5#1)
no easy##2##2##(1994-3#1)(2012-3#1)
no effect at##5##3##(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-2#1)
no effect is observed##2##4##(1992-9#1)(2008-10#1)
no effect of the##2##4##(2008-10#1)(2008-11#1)
no effect of##8##3##(1991-11#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)
no effect on DNA##2##4##(1993-3#1)(2008-8#1)
no effect on basal##2##4##(1994-3#1)(1995-11#1)
no effect on channel##2##4##(1995-5#1)(2008-8#1)
no effect on growth##3##4##(1995-2#1)(2008-10#1)(2010-2#1)
no effect on lesion development##2##5##(2008-10#2)
no effect on lesion##3##4##(1995-12#1)(2008-10#2)
no effect on locomotor activity##2##5##(1993-5#1)(1994-8#1)
no effect on the determination##3##5##(2008-10#3)
no effect on the levels of##2##6##(1992-8#1)(1995-11#1)
no effect on the secretion##2##5##(1990-5#1)(1995-8#1)
no effect on the##63##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1991-12#1)(1991-8#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-8#3)
no effect on##211##3##(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#6)(1990-7#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#10)(1995-3#3)(1995-5#4)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#3)(1996-2#4)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-6#2)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#29)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
no effect was observed for##2##5##(2008-10#1)(2008-11#1)
no effect was observed on the##2##6##(1995-2#1)(1995-3#1)
no effect was observed##6##4##(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#1)
no effect was##7##3##(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)
no effect##286##2##(1990-11#3)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#7)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#6)(1994-9#1)(1995-11#10)(1995-12#8)(1995-2#11)(1995-3#5)(1995-5#6)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#5)(1996-2#6)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(2006-6#2)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
no effective treatment##2##3##(2012-2#1)(2013-1#1)
no effective##8##2##(1990-2#1)(1990-9#1)(1991-11#1)(1995-9#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
no effects on the##6##4##(1991-2#3)(1997-4#1)(2008-10#1)(2008-9#1)
no effects on##13##3##(1991-2#4)(1996-5#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-4#1)
no effects##18##2##(1991-2#4)(1991-5#1)(1995-12#1)(1996-5#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2010-1#1)(2012-3#1)(2012-4#1)
no efficient##2##2##(1995-12#1)(2008-6#1)
no empirical studies##2##3##(1996-1#1)(2008-7#1)
no empirical##5##2##(1996-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
no enhancer##3##2##(1990-11#1)(1994-6#1)(2008-10#1)
no enzymatic##2##2##(1991-3#1)(2008-10#1)
no established##2##2##(2008-7#1)(2008-8#1)
no etiology##2##2##(1991-8#1)(2009-5#1)
no eutectic formation##2##3##(2013-1#2)
no evidence for a##5##4##(1995-5#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)
no evidence for an##4##4##(1995-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
no evidence for any##2##4##(2007-8#1)(2008-2#1)
no evidence for the##2##4##(1997-5#1)(2011-2#1)
no evidence for##25##3##(1990-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-3#1)
no evidence of a##7##4##(1991-12#1)(1995-11#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
no evidence of adverse##3##4##(1991-1#1)(2007-11#1)(2007-12#1)
no evidence of any##5##4##(1990-3#1)(1995-2#1)(1996-3#1)(2010-12#1)(2012-2#1)
no evidence of disease recurrence##2##5##(2012-2#1)(2013-1#1)
no evidence of disease##9##4##(1992-9#1)(2007-5#1)(2008-10#2)(2008-6#3)(2012-2#1)(2013-1#1)
no evidence of excess##2##4##(1991-6#1)(1992-6#1)
no evidence of local recurrence##3##5##(2007-12#1)(2010-3#1)(2013-1#1)
no evidence of local##4##4##(2007-12#1)(2007-4#1)(2010-3#1)(2013-1#1)
no evidence of malignancy##2##4##(1994-12#1)(2008-10#1)
no evidence of recurrence##5##4##(1993-1#1)(2008-10#1)(2011-2#2)(2013-8#1)
no evidence of the##3##4##(2008-3#1)(2008-6#1)(2011-1#1)
no evidence of##112##3##(1990-2#1)(1990-3#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
no evidence that C##2##4##(2008-10#2)
no evidence that the##2##4##(1991-8#1)(1996-3#1)
no evidence that##17##3##(1991-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2012-12#1)
no evidence to suggest that##2##5##(2008-10#1)(2009-9#1)
no evidence to support the use of##2##7##(2007-8#1)(2013-1#1)
no evidence to##5##3##(2007-8#1)(2008-10#1)(2009-9#1)(2010-11#1)(2013-1#1)
no evidence was found##2##4##(2008-10#2)
no evidence was##3##3##(2008-10#2)(2010-11#1)
no evidence##171##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#6)(2008-7#4)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#2)
no evident##2##2##(1994-9#1)(2008-10#1)
no exception##3##2##(1991-6#1)(2008-9#1)(2010-10#1)
no excipient##2##2##(2008-10#2)
no exercise##2##2##(2008-7#1)(2011-1#1)
no experience##2##2##(1991-2#1)(2008-11#1)
no experimental##2##2##(2008-10#1)(2008-9#1)
no explanation##2##2##(2008-2#1)(2013-1#1)
no explicit##2##2##(2010-12#1)(2012-3#1)
no exposure##4##2##(1992-11#1)(1994-2#1)(2008-5#1)(2011-2#1)
no expression##3##2##(1991-2#1)(1996-2#1)(2008-7#1)
no external##3##2##(1993-12#1)(2007-11#2)
no extra##2##2##(2008-3#1)(2010-5#1)
no extraction##2##2##(2008-10#2)
no family history of##2##4##(2012-3#1)(2013-1#1)
no family history##5##3##(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#2)
no family##7##2##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#2)
no fatal##2##2##(2007-11#1)(2012-3#1)
no feedback##2##2##(2007-12#1)(2010-3#1)
no fertilizer plots##2##3##(2008-12#2)
no fever##2##2##(1990-11#1)(2012-3#1)
no fluorescence##2##2##(1995-2#1)(2013-8#1)
no formal##9##2##(1991-12#1)(1992-3#1)(1994-12#2)(1995-6#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
no free parameters##2##3##(2008-2#1)(2012-2#1)
no free##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
no functional##9##2##(1990-11#1)(1991-5#1)(2010-3#1)(2010-5#1)(2013-8#5)
no fungus##2##2##(2013-1#2)
no further evidence of##2##4##(2008-5#1)(2008-8#1)
no further improvement was##2##4##(2008-10#1)(2010-3#1)
no further increase in##2##4##(2008-10#1)(2008-5#1)
no further increase##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
no further signs of##2##4##(2011-2#2)
no further treatment##2##3##(1991-6#1)(2010-8#1)
no further##23##2##(1990-6#1)(1991-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
no gap##3##2##(2007-10#3)
no gender##2##2##(2007-12#1)(2008-5#1)
no gene##2##2##(2008-10#1)(2010-4#1)
no general##5##2##(1991-12#1)(2008-7#2)(2008-8#1)(2008-9#1)
no genetic differentiation##2##3##(2008-10#1)(2011-2#1)
no genetic variation##2##3##(2008-9#1)(2012-2#1)
no genetic##8##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
no good##2##2##(1995-5#1)(2012-2#1)
no greater than##4##3##(1990-8#1)(1995-3#1)(2008-3#1)(2008-4#1)
no greater##7##2##(1990-8#1)(1995-2#1)(1995-3#2)(1997-4#1)(2008-3#1)(2008-4#1)
no gross##3##2##(1993-12#1)(1995-12#1)(2008-11#1)
no group##2##2##(1992-12#1)(2013-1#1)
no growth##7##2##(1990-12#1)(2008-10#4)(2008-11#1)(2009-7#1)
no guidelines for##3##3##(2007-8#1)(2012-12#1)(2012-3#1)
no guidelines##4##2##(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
no harm##2##2##(2008-11#1)(2008-7#1)
no heart disease##3##3##(1990-3#1)(1996-9#2)
no heat##2##2##(1995-6#1)(2009-7#1)
no higher than the##2##4##(2008-10#2)
no higher than##4##3##(2008-10#2)(2012-2#2)
no history of##21##3##(1994-12#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
no homologous##2##2##(1990-2#1)(1991-9#1)
no homology with any##2##4##(1996-3#1)(2008-9#1)
no homology with the##2##4##(2008-10#1)(2008-8#1)
no homology with##5##3##(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#2)
no homology##8##2##(1993-6#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-8#1)(2008-9#2)
no immunological##2##2##(1992-3#1)(1997-6#1)
no impact on the##5##4##(1995-5#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
no impact on##8##3##(1991-6#1)(1995-5#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
no impact##10##2##(1991-6#1)(1993-6#1)(1995-5#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)(2012-3#1)
no important##2##2##(1994-5#1)(1997-2#1)
no improvement in##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
no improvement of##3##3##(1990-12#1)(2008-12#1)(2012-2#1)
no improvement##10##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
no improvements##2##2##(2008-3#1)(2008-6#1)
no incidence of##3##3##(2008-7#2)(2009-12#1)
no increase in the##2##4##(1994-3#1)(1996-6#1)
no increase in##20##3##(1991-3#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)
no increase##23##2##(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)
no increased##6##2##(1991-12#1)(1994-2#1)(2008-2#1)(2008-7#1)(2008-9#2)
no increases in##3##3##(1995-3#1)(2007-12#1)(2013-1#1)
no indication of a##2##4##(1990-5#1)(1995-2#1)
no indication of the##2##4##(1990-9#1)(2008-11#1)
no indication of##7##3##(1990-5#1)(1990-9#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)
no indication##8##2##(1990-5#1)(1990-9#1)(1992-6#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)
no indications for##2##3##(1990-11#1)(2008-11#1)
no individuals##2##2##(1997-6#1)(2013-7#1)
no infection##5##2##(2008-10#3)(2010-8#2)
no infested##2##2##(2008-6#2)
no influence of##2##3##(2008-10#1)(2008-3#1)
no influence on the##5##4##(1992-3#1)(1993-9#1)(1994-3#1)(2008-3#2)
no influence on##12##3##(1992-3#1)(1993-9#1)(1994-3#1)(1995-2#2)(2007-8#2)(2008-11#2)(2008-3#2)(2008-4#1)
no influence##16##2##(1990-3#1)(1992-3#1)(1993-9#1)(1994-3#1)(1995-2#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)
no information on the##3##4##(1996-11#1)(2008-10#1)(2008-5#1)
no information on##5##3##(1996-11#1)(2008-10#1)(2008-5#2)(2008-7#1)
no information##12##2##(1996-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2013-7#1)
no inhibition was##2##3##(1994-8#2)
no inhibition##6##2##(1990-11#1)(1990-5#1)(1994-8#2)(1995-11#1)(1995-3#1)
no inhibitory effect##5##3##(1991-12#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-4#1)
no inhibitory##7##2##(1991-12#1)(1992-8#1)(1994-6#1)(1994-8#2)(1995-6#1)(2008-4#1)
no instance##2##2##(1994-6#1)(1997-7#1)
no interaction between##4##3##(1990-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
no interaction##7##2##(1990-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
no interference by##2##3##(2008-10#2)
no interference can be observed from##2##6##(2008-10#2)
no interference from excipients##2##4##(2008-10#2)
no interference from##10##3##(2008-10#9)(2010-5#1)
no interference in the determination of these ions by##2##9##(2008-10#2)
no interference of##3##3##(2008-10#3)
no interference was observed##2##4##(2008-10#2)
no interference##29##2##(1993-2#1)(2008-10#27)(2010-5#1)
no interferences##3##2##(2008-10#3)
no intervention##2##2##(1997-2#1)(2013-1#1)
no intrinsic effects##2##3##(1991-9#1)(1996-2#1)
no intrinsic##6##2##(1991-9#1)(1992-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-8#1)
no introns##2##2##(2008-6#1)(2010-5#1)
no known sexual stage##2##4##(2008-10#2)
no known sexual##3##3##(2008-10#3)
no known##20##2##(1993-2#1)(1995-6#1)(1997-4#1)(2006-6#1)(2008-10#8)(2008-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
no laboratory tests##2##3##(2010-12#1)(2010-5#1)
no larvae##2##2##(2011-2#2)
no less##4##2##(1993-12#1)(1995-3#1)(1995-5#1)(2009-7#1)
no limitations##2##2##(1993-1#1)(2008-2#1)
no line##2##2##(2007-12#1)(2008-3#1)
no linear##2##2##(1991-12#1)(2009-3#1)
no linkage##2##2##(1997-5#1)(2008-4#1)
no local or systemic side-effects and toxicity associated with the gene transfer were found##2##14##(2008-9#2)
no local recurrence##2##3##(2007-6#1)(2013-8#1)
no local##4##2##(2007-6#1)(2008-9#2)(2013-8#1)
no long-term##3##2##(2008-4#1)(2011-2#2)
no longer a##3##3##(1994-2#1)(1996-2#1)(2008-8#1)
no longer an##3##3##(2008-10#1)(2010-8#1)(2011-3#1)
no longer appears to be##2##5##(2010-6#1)(2012-12#1)
no longer be considered##2##4##(2008-11#1)(2013-8#1)
no longer be##9##3##(1994-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-8#1)
no longer considered##5##3##(1991-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-12#1)
no longer detectable##3##3##(1994-12#1)(1994-6#1)(1996-12#1)
no longer just##2##3##(1994-3#1)(2007-12#1)
no longer possible##2##3##(1990-8#1)(1992-5#1)
no longer significant##3##3##(1996-7#1)(2010-8#1)(2012-5#1)
no longer than##3##3##(2007-6#1)(2008-10#1)(2009-4#1)
no longer##110##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-5#1)(2013-1#2)(2013-8#1)
no loss in the##2##4##(2008-10#1)(2008-3#1)
no loss in##4##3##(2008-10#2)(2008-3#2)
no loss of##6##3##(1996-2#1)(2008-10#3)(2008-7#1)(2010-3#1)
no loss##11##2##(1996-2#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-7#1)(2010-3#1)
no major##15##2##(1990-6#1)(1991-12#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
no make-up##2##2##(2008-5#2)
no males##2##2##(2008-9#2)
no marked##6##2##(1995-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
no maternal##3##2##(1996-3#1)(2008-10#2)
no matter how the inoculum is precultured##2##7##(2008-7#2)
no matter how##6##3##(1994-12#1)(2008-10#1)(2008-7#4)
no matter which##2##3##(2008-10#1)(2011-2#1)
no matter##12##2##(1994-12#1)(1995-12#1)(2007-2#1)(2008-10#3)(2008-7#4)(2008-9#1)(2011-2#1)
no meaning##3##2##(2008-5#1)(2013-1#2)
no means##9##2##(1990-12#1)(1994-1#1)(1995-1#1)(1996-5#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-3#1)
no measurable##8##2##(1992-12#1)(1993-1#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
no measurement##3##2##(2008-10#1)(2013-1#2)
no mechanism##2##2##(1994-9#1)(2008-3#1)
no medical##3##2##(1993-2#1)(1995-6#1)(2009-5#1)
no method##2##2##(2008-10#1)(2011-1#1)
no methods##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
no mode##2##2##(2007-11#1)(2007-12#1)
no modification##3##2##(1991-3#1)(1994-8#1)(2008-4#1)
no modifier was##2##3##(2008-10#2)
no molecular##3##2##(1997-2#1)(1997-7#1)(2010-11#1)
no more than 24##2##4##(2007-12#1)(2008-11#1)
no more than an##2##4##(1991-11#1)(1997-1#1)
no more than##12##3##(1991-11#1)(1991-8#1)(1992-4#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
no more##28##2##(1990-5#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-4#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#2)(2013-1#1)(2013-7#1)
no morphological##3##2##(1990-11#1)(2008-10#1)(2012-1#1)
no mortality and##3##3##(1991-6#1)(2007-8#1)(2008-7#1)
no mortality at##2##3##(1993-9#1)(2008-5#1)
no mortality##12##2##(1991-6#1)(1993-9#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#3)
no moving parts##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
no moving##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
no music##3##2##(2007-6#3)
no mutation##2##2##(1993-3#1)(1993-6#1)
no mutations in##2##3##(1997-4#1)(1997-7#1)
no mutations were found##2##4##(1994-8#1)(2008-12#1)
no mutations##5##2##(1994-8#1)(1997-4#1)(1997-7#1)(2008-12#1)(2011-2#1)
no need for##7##3##(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)
no need of##4##3##(2007-8#2)(2008-10#1)(2012-3#1)
no need to##6##3##(1994-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2011-2#1)
no need##17##2##(1994-1#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
no negative effect on##3##4##(1993-2#1)(2007-10#1)(2008-9#1)
no negative influence on##2##4##(1990-2#1)(2008-10#1)
no negative##8##2##(1990-2#1)(1993-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2011-2#1)
no neurologic##2##2##(1996-9#1)(2010-6#1)
no neurological deficits##3##3##(2008-7#1)(2009-3#1)(2013-1#1)
no neurological##8##2##(1995-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
no new##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
no nuclear##2##2##(2008-11#1)(2008-12#1)
no nucleotide##3##2##(1994-12#1)(2011-2#1)(2013-8#1)
no objective##8##2##(1992-8#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
no observable##3##2##(2008-3#1)(2008-8#1)(2009-11#1)
no observed##5##2##(2007-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
no obvious difference##5##3##(1995-3#1)(2008-11#1)(2008-9#1)(2012-2#2)
no obvious reason##3##3##(1992-5#1)(2008-11#1)(2010-12#1)
no obvious##28##2##(1990-5#1)(1992-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#2)(2012-2#2)
no occurrence of##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
no one##11##2##(1994-12#1)(1995-12#1)(1996-1#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#1)
no or little##5##3##(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)
no or minimal##2##3##(2010-1#1)(2013-1#1)
no or only##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
no or very##4##3##(1992-12#1)(1997-6#1)(2009-2#1)(2010-12#1)
no or weak##2##3##(2008-11#1)(2013-8#1)
no or##24##2##(1990-2#1)(1992-12#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
no other cause for##2##4##(1991-4#1)(2012-3#1)
no other treatment##2##3##(2007-8#1)(2008-5#1)
no other##34##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-9#2)(1997-7#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
no overall##5##2##(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#2)
no overlap##2##2##(2008-10#1)(2009-8#1)
no pain##6##2##(2007-11#3)(2008-6#1)(2012-12#1)(2012-2#1)
no parental##2##2##(1995-6#1)(2010-4#1)
no particular##3##2##(2007-12#1)(2009-10#1)(2012-2#1)
no patient had##2##3##(1990-10#1)(2008-7#1)
no patient##7##2##(1990-10#1)(1990-6#1)(1993-1#1)(1995-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
no patients##3##2##(1994-11#1)(2007-11#1)(2012-3#1)
no perioperative##3##2##(1990-2#1)(1996-9#1)(2012-12#1)
no personal##2##2##(2008-11#1)(2010-6#1)
no phase##3##2##(2008-2#1)(2008-3#2)
no physical##2##2##(1994-7#1)(2011-2#1)
no point##2##2##(1992-8#1)(1994-11#1)
no population##3##2##(2008-10#3)
no population-based data##2##3##(2007-10#1)(2008-3#1)
no positive##4##2##(1996-9#1)(1997-5#1)(1997-7#1)(2008-10#1)
no possible##2##2##(1991-6#1)(2012-2#1)
no potential for##4##3##(1997-7#1)(2007-11#1)(2008-10#2)
no practical##3##2##(2008-10#1)(2008-3#2)
no precise##2##2##(2007-11#1)(2011-1#1)
no predilection for##2##3##(1991-8#1)(1997-1#1)
no predisposing##2##2##(1990-11#1)(2008-11#1)
no preference##2##2##(2008-10#1)(2009-9#1)
no preoperative##2##2##(2008-7#1)(2013-8#1)
no prevention##4##2##(2010-6#3)(2012-12#1)
no previous case##2##3##(2012-2#1)(2013-8#1)
no previous reports##2##3##(2008-10#1)(2008-12#1)
no previous##12##2##(1991-2#1)(1992-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
no previously reported##2##3##(2008-10#1)(2013-1#1)
no previously##4##2##(1993-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
no primary site##2##3##(2013-8#2)
no prior##11##2##(1990-8#1)(1992-10#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
no problems in##2##3##(2007-2#1)(2008-10#1)
no problems##4##2##(1997-5#1)(2007-2#1)(2008-10#2)
no processing##2##2##(1991-10#1)(2008-11#1)
no progression##2##2##(2008-6#1)(2008-7#1)
no prospective##2##2##(2008-7#1)(2009-5#1)
no protection##2##2##(1995-5#1)(2008-11#1)
no protein##2##2##(1993-8#1)(2008-10#1)
no published##5##2##(1990-2#1)(2007-8#1)(2008-7#1)(2010-1#1)(2013-1#1)
no qualitative##2##2##(2008-10#1)(2013-7#1)
no question that##2##3##(2008-6#1)(2013-1#1)
no quick##2##2##(1995-5#1)(1995-8#1)
no race##2##2##(2008-10#1)(2008-7#1)
no radiation##2##2##(1992-11#1)(2012-12#1)
no reaction##4##2##(1990-12#1)(2008-11#1)(2008-5#1)(2008-6#1)
no reactive##2##2##(1990-2#1)(2008-11#1)
no reactivity##3##2##(1991-9#1)(1992-8#1)(1993-8#1)
no real##3##2##(1996-2#1)(1997-7#1)(2011-2#1)
no reason to##3##3##(1993-11#1)(1996-5#1)(1997-5#1)
no reason##4##2##(1993-11#1)(1996-5#1)(1997-5#1)(2010-8#1)
no recurrence has been##2##4##(2008-10#1)(2010-8#1)
no recurrence of the##2##4##(2007-8#1)(2009-5#1)
no recurrence of##6##3##(2007-11#3)(2007-8#1)(2008-9#1)(2009-5#1)
no recurrence or##2##3##(2008-10#1)(2013-8#1)
no recurrence was seen##2##4##(1990-12#1)(2008-10#1)
no recurrence was##6##3##(1990-12#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
no recurrence##26##2##(1990-11#1)(1990-12#1)(1993-1#1)(1993-9#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
no reduction in the##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
no reduction in##6##3##(1990-6#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-2#1)
no reduction##8##2##(1990-6#1)(1992-12#1)(1993-8#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
no reference##2##2##(2008-3#1)(2013-1#1)
no reflux##3##2##(2008-10#2)(2008-4#1)
no regular##3##2##(1994-9#1)(1996-1#1)(2007-12#1)
no relation between##3##3##(1994-6#1)(1995-8#1)(1997-3#1)
no relation##4##2##(1994-6#1)(1995-8#1)(1997-3#1)(2008-10#1)
no relationship between the number of##3##6##(1990-2#1)(2008-11#1)(2008-12#1)
no relationship between the##8##4##(1990-2#1)(1991-11#1)(2008-11#1)(2008-12#2)(2008-8#2)(2013-1#1)
no relationship between##27##3##(1990-2#1)(1991-11#1)(1996-7#1)(1997-2#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#5)(2008-9#1)(2010-8#1)(2011-2#3)(2013-1#2)
no relationship##31##2##(1990-2#1)(1991-11#1)(1993-12#1)(1996-7#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#5)(2008-9#2)(2010-8#1)(2011-2#4)(2013-1#2)
no relevant##4##2##(1992-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
no reliable##2##2##(2008-7#2)
no remarkable##2##2##(1993-8#1)(2008-1#1)
no report of##2##3##(2012-12#1)(2012-3#1)
no report on##2##3##(2008-11#1)(2013-8#1)
no report##5##2##(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
no reported case##2##3##(2008-10#1)(2012-2#1)
no reported##9##2##(2007-12#1)(2008-10#3)(2011-2#2)(2012-2#2)(2013-1#1)
no reports of##6##3##(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
no reports##11##2##(1994-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
no research##3##2##(2007-4#1)(2008-11#2)
no residual shunt##2##3##(2007-8#1)(2008-11#1)
no residual##6##2##(1995-8#1)(2007-8#2)(2008-11#1)(2008-7#1)(2011-2#1)
no resistance##6##2##(1997-5#1)(2008-10#3)(2008-8#2)
no response in##3##3##(2007-11#1)(2007-7#1)(2010-12#1)
no response to##7##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)
no response##18##2##(1992-6#1)(1996-5#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#2)
no responses##2##2##(1990-10#1)(2008-9#1)
no restrictions##3##2##(2007-12#1)(2008-10#1)(2010-5#1)
no reward##2##2##(2008-9#1)(2013-8#1)
no right or wrong##3##4##(1991-3#1)(1994-1#2)
no right##4##2##(1991-3#1)(1993-12#1)(1994-1#2)
no risk##4##2##(1991-7#1)(1997-5#1)(2007-12#1)(2008-12#1)
no role in##6##3##(1992-8#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-7#1)
no role##8##2##(1992-8#1)(1997-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
no sample pretreatment##2##3##(2008-10#1)(2008-4#1)
no sample##8##2##(2008-10#7)(2008-4#1)
no scientific##2##2##(2008-11#1)(2009-7#1)
no seasonal##3##2##(2007-10#1)(2008-5#1)(2009-4#1)
no secondary##3##2##(2008-10#3)
no sensitive##2##2##(1993-2#1)(2007-11#1)
no separation##3##2##(2008-10#1)(2011-2#2)
no sequence similarity##2##3##(1991-2#1)(1992-8#1)
no sequence##7##2##(1990-11#1)(1991-2#1)(1992-8#1)(1993-6#1)(1997-7#1)(2008-10#1)(2010-3#1)
no serious adverse effects##2##4##(2007-7#1)(2011-2#1)
no serious adverse events##2##4##(2007-11#1)(2008-3#1)
no serious adverse##4##3##(2007-11#1)(2007-7#1)(2008-3#1)(2011-2#1)
no serious##14##2##(1990-11#1)(1990-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#2)(2012-2#1)(2013-1#1)
no set##3##2##(2008-12#1)(2010-3#1)(2011-2#1)
no severe##2##2##(2008-3#1)(2008-7#1)
no sex differences##2##3##(1993-12#1)(2008-7#1)
no sex##4##2##(1993-12#1)(2008-7#1)(2010-3#2)
no shift##2##2##(1993-6#1)(2007-11#1)
no side effect##2##3##(1997-3#2)
no side effects##5##3##(1990-12#1)(1990-3#1)(1992-10#1)(2008-1#1)(2008-5#1)
no side##8##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-10#1)(1997-3#2)(2008-1#1)(2008-5#1)
no sign of##10##3##(1990-9#1)(1992-9#1)(1994-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
no signal##2##2##(2008-4#1)(2011-2#1)
no signals##2##2##(2008-10#2)
no significant (P&gt##2##3##(2013-1#2)
no significant adverse##2##3##(2008-12#1)(2008-4#1)
no significant association between##3##4##(1994-7#1)(2011-1#1)(2013-8#1)
no significant association with##4##4##(1994-12#1)(1995-8#2)(2008-12#1)
no significant association##9##3##(1990-6#1)(1991-6#1)(1994-12#1)(1994-7#1)(1995-8#2)(2008-12#1)(2011-1#1)(2013-8#1)
no significant change in the##7##5##(1990-3#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
no significant change in##18##4##(1990-3#1)(1991-9#1)(1993-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#3)(2013-8#1)
no significant change was observed in##2##6##(1993-12#1)(2011-1#1)
no significant change##22##3##(1990-3#1)(1991-9#1)(1993-12#2)(1997-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
no significant changes in the##3##5##(1990-7#1)(2008-7#1)(2010-3#1)
no significant changes in##15##4##(1990-7#1)(1993-12#1)(1994-2#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)
no significant changes occurred in##2##5##(1993-12#1)(2008-11#1)
no significant changes were found##2##5##(2012-3#1)(2013-1#1)
no significant changes were##4##4##(1996-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
no significant changes##25##3##(1990-7#1)(1993-12#2)(1994-2#1)(1996-2#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
no significant complications##3##3##(1993-1#1)(2008-9#1)(2013-1#1)
no significant contribution of##2##4##(1993-11#1)(2009-9#1)
no significant correlation between##15##4##(1994-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)
no significant correlation with##3##4##(2006-6#1)(2008-8#1)(2010-10#1)
no significant correlation##20##3##(1994-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-3#1)(2013-1#1)
no significant correlations between##2##4##(2011-2#2)
no significant correlations##4##3##(1995-12#1)(2008-10#1)(2011-2#2)
no significant difference among the##2##5##(2008-10#2)
no significant difference among##4##4##(2008-10#3)(2013-1#1)
no significant difference at 95% confidence level##3##7##(2008-10#3)
no significant difference at the 95% confidence level was observed##2##10##(2008-10#2)
no significant difference at##6##4##(2008-10#6)
no significant difference between patients##2##5##(2011-2#1)(2013-8#1)
no significant difference between the two groups##3##7##(2007-9#1)(2010-8#1)(2011-1#1)
no significant difference between the##14##5##(1993-8#1)(1997-8#1)(1997-9#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
no significant difference between##38##4##(1991-11#1)(1991-8#3)(1993-12#1)(1993-2#1)(1993-8#1)(1997-8#1)(1997-9#1)(2007-9#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
no significant difference in the##25##5##(1990-7#1)(1991-2#1)(1991-8#2)(1991-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-8#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)
no significant difference in##65##4##(1990-7#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-4#1)(1996-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#1)
no significant difference of##3##4##(1996-7#1)(2008-9#1)(2011-2#1)
no significant difference was found between the##2##7##(2008-12#1)(2010-12#1)
no significant difference was found between##3##6##(2008-10#1)(2008-12#1)(2010-12#1)
no significant difference was found##6##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
no significant difference was observed##2##5##(1993-11#1)(1996-12#1)
no significant difference was##10##4##(1993-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)
no significant difference##136##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#6)(1991-9#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-8#2)(1997-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#7)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#12)(2012-12#1)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#1)
no significant differences among##6##4##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
no significant differences at##2##4##(1993-12#1)(2008-10#1)
no significant differences between groups##5##5##(1994-5#1)(2011-2#1)(2013-1#3)
no significant differences between the two##4##6##(1991-3#1)(1993-8#1)(1995-4#1)(2007-2#1)
no significant differences between the##9##5##(1991-3#1)(1993-8#1)(1995-4#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
no significant differences between these##2##5##(1997-7#1)(2008-10#1)
no significant differences between##24##4##(1990-12#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-4#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#4)
no significant differences in outcome##2##5##(1990-2#1)(1997-3#1)
no significant differences in the frequency of##2##7##(1991-8#1)(2008-10#1)
no significant differences in the##14##5##(1991-8#1)(1994-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
no significant differences in##41##4##(1990-2#1)(1991-2#1)(1991-8#1)(1993-1#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
no significant differences were found between##2##6##(2008-10#1)(2011-3#1)
no significant differences were found in##2##6##(2008-10#1)(2013-1#1)
no significant differences were found##6##5##(1993-2#1)(2008-10#3)(2011-3#1)(2013-1#1)
no significant differences were observed##3##5##(1995-11#1)(2008-10#1)(2008-5#1)
no significant differences were seen##2##5##(2008-12#1)(2008-5#1)
no significant differences were##14##4##(1993-2#1)(1994-2#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-5#2)(2011-3#1)(2013-1#1)(2013-7#1)
no significant differences##106##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#4)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#4)
no significant effect of##3##4##(2008-10#2)(2013-8#1)
no significant effect on the##10##5##(1990-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-10#3)(2008-7#1)(2011-3#1)
no significant effect on##26##4##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
no significant effect##42##3##(1990-5#1)(1990-6#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#2)(1996-12#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
no significant effects of temperature##2##5##(2008-10#1)(2011-2#1)
no significant effects of##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
no significant effects on the##2##5##(2008-11#2)
no significant effects on##5##4##(2007-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
no significant effects##9##3##(2007-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
no significant gender##2##3##(2008-1#1)(2008-12#1)
no significant homology to##2##4##(1995-2#1)(1995-9#1)
no significant homology##3##3##(1995-2#1)(1995-9#1)(2008-8#1)
no significant impact on##4##4##(1994-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
no significant impact##5##3##(1994-12#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
no significant improvement in##2##4##(2008-10#1)(2012-1#1)
no significant improvement##4##3##(2008-10#2)(2012-1#1)(2012-2#1)
no significant increase in##5##4##(1997-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
no significant increase##8##3##(1990-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#2)
no significant influence on the##4##5##(1990-2#1)(1997-7#1)(2008-5#1)(2011-2#1)
no significant influence on##5##4##(1990-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
no significant influence##6##3##(1990-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-6#1)
no significant interaction##5##3##(1997-4#1)(2008-10#2)(2008-12#1)(2011-2#1)
no significant interference from##2##4##(1990-2#1)(2008-10#1)
no significant interference##4##3##(1990-2#2)(2008-10#2)
no significant loss of##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
no significant relationship##5##3##(1992-2#1)(2007-5#1)(2008-10#2)(2008-6#1)
no significant sequence##2##3##(1994-12#1)(2008-10#1)
no significant similarity to##2##4##(1995-2#1)(2008-10#1)
no significant similarity##3##3##(1995-2#1)(1995-9#1)(2008-10#1)
no significant statistical difference##2##4##(2011-2#1)(2013-8#1)
no significant statistical##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
no significant variation##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
no significant##522##2##(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#1)(1990-6#5)(1990-7#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#7)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#4)(1993-1#4)(1993-11#7)(1993-12#6)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#6)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#4)(1994-7#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-6#3)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#4)(1997-9#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#9)(2008-10#95)(2008-11#16)(2008-12#17)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#18)(2008-6#8)(2008-7#15)(2008-8#11)(2008-9#13)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#34)(2011-3#3)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#9)(2012-6#1)(2012-7#1)(2013-1#29)(2013-7#5)(2013-8#10)
no significantly##2##2##(2008-10#1)(2008-11#1)
no signs of recurrence##2##4##(2008-6#2)
no signs of##20##3##(1991-2#1)(1993-1#1)(1993-6#1)(1994-6#1)(1994-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
no signs##21##2##(1991-2#1)(1993-1#1)(1993-6#1)(1994-6#1)(1994-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
no similar##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
no similarity to##5##3##(1993-6#1)(1996-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
no simple##5##2##(1994-8#1)(1995-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
no single set of##2##4##(1997-7#1)(2012-12#1)
no single##22##2##(1992-3#1)(1993-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
no skin##2##2##(2007-8#1)(2008-10#1)
no small##3##2##(1991-6#1)(1995-12#1)(2012-12#1)
no solution##2##2##(2008-10#1)(2008-3#1)
no special##3##2##(1994-8#1)(2008-9#1)(2011-2#1)
no specialized##2##2##(2008-10#1)(2010-3#1)
no specific role##2##3##(2008-6#1)(2011-2#1)
no specific treatment##6##3##(1994-9#1)(2007-2#1)(2008-7#1)(2011-2#2)(2013-1#1)
no specific##27##2##(1990-12#1)(1990-2#1)(1992-11#2)(1993-8#1)(1994-11#1)(1994-9#1)(1996-2#1)(1997-2#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#4)(2012-2#1)(2013-1#3)
no standard treatment##2##3##(1990-2#1)(2009-3#1)
no standard##6##2##(1990-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-3#1)(2013-1#1)
no standardized##2##2##(2011-2#1)(2013-1#1)
no statistical correlation##2##3##(2008-7#1)(2013-1#1)
no statistical difference between groups##2##5##(2012-3#1)(2013-1#1)
no statistical difference between the##3##5##(1996-12#1)(2008-7#1)(2012-2#1)
no statistical difference between##8##4##(1996-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
no statistical difference##12##3##(1990-12#1)(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
no statistical differences##3##3##(2008-10#2)(2008-12#1)
no statistical significance##2##3##(2008-11#1)(2013-1#1)
no statistical##22##2##(1990-12#1)(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
no statistically significant change##2##4##(2007-10#1)(2013-1#1)
no statistically significant difference between the##3##6##(2007-7#1)(2008-4#1)(2012-3#1)
no statistically significant difference between##5##5##(2007-7#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-3#1)
no statistically significant difference in the##2##6##(2008-11#1)(2013-1#1)
no statistically significant difference in##8##5##(1994-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
no statistically significant difference##19##4##(1994-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
no statistically significant differences between the two groups##3##8##(2007-9#1)(2013-1#2)
no statistically significant differences between the##4##6##(2007-9#1)(2009-10#1)(2013-1#2)
no statistically significant differences between##11##5##(1997-7#1)(2007-9#1)(2008-5#1)(2009-10#1)(2010-12#2)(2012-3#1)(2013-1#4)
no statistically significant differences in##6##5##(1996-1#1)(1996-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
no statistically significant differences##18##4##(1996-1#1)(1996-7#1)(1997-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
no statistically significant##48##3##(1994-2#1)(1994-3#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#3)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#1)
no statistically##52##2##(1994-2#1)(1994-3#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#3)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#1)
no strain##2##2##(2008-7#1)(2013-8#1)
no strict##2##2##(2007-11#1)(2008-10#1)
no strong evidence##5##3##(2007-8#1)(2008-8#2)(2012-12#2)
no strong##8##2##(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-8#2)(2012-12#2)
no studies have##5##3##(2008-8#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
no studies of##2##3##(2008-10#1)(2008-9#1)
no studies on##2##3##(2008-10#1)(2011-1#1)
no studies##12##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
no study has##2##3##(2008-10#2)
no study##3##2##(2008-10#2)(2008-12#1)
no subsequent##2##2##(2008-2#1)(2008-7#1)
no substantial##3##2##(1992-3#1)(1996-2#1)(2013-8#1)
no such case has been reported##2##6##(2010-6#1)(2013-1#1)
no such##34##2##(1990-2#1)(1992-9#3)(1993-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2010-6#1)(2011-2#2)(2013-1#3)
no sufficient##3##2##(2007-2#1)(2009-5#1)(2013-1#1)
no sugary##2##2##(2010-8#2)
no suitable##2##2##(2008-10#2)
no support for the##3##4##(2008-5#1)(2009-11#1)(2009-2#1)
no support for##6##3##(1997-5#2)(2008-12#1)(2008-5#1)(2009-11#1)(2009-2#1)
no support##8##2##(1997-5#2)(2007-2#2)(2008-12#1)(2008-5#1)(2009-11#1)(2009-2#1)
no surgical##3##2##(1994-8#1)(2007-8#1)(2008-6#1)
no symptoms in##3##3##(2008-10#3)
no symptoms on##2##3##(2008-10#2)
no symptoms were##2##3##(2008-10#1)(2013-1#1)
no symptoms##13##2##(1995-6#1)(2006-10#1)(2008-10#7)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
no synergistic effect##2##3##(2007-2#1)(2008-10#1)
no synergistic##3##2##(2007-2#1)(2008-10#2)
no systematic errors##3##3##(1992-11#1)(2008-10#2)
no systematic##8##2##(1992-11#1)(1996-2#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#1)
no systemic##3##2##(2008-5#1)(2011-2#2)
no tendency##2##2##(2013-1#1)(2013-7#1)
no theoretical##2##2##(2008-3#2)
no therapy##2##2##(2010-6#1)(2011-2#1)
no threshold (LNT) model##2##4##(2008-7#1)(2013-1#1)
no threshold (LNT)##3##3##(2008-7#2)(2013-1#1)
no threshold##4##2##(2008-1#1)(2008-7#2)(2013-1#1)
no tillage and ridge tillage treatments##2##6##(2008-10#2)
no tillage and ridge tillage##3##5##(2008-10#3)
no tillage##7##2##(2008-10#7)
no time##5##2##(1991-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2013-8#1)
no training##2##2##(2008-11#1)(2012-12#1)
no transformation##2##2##(1992-3#1)(2008-10#1)
no transmission##4##2##(2008-10#4)
no treatment differences##2##3##(2006-11#1)(2008-10#1)
no treatment is##2##3##(1997-2#1)(2008-3#1)
no treatment or##2##3##(1995-12#1)(2008-10#1)
no treatment##17##2##(1992-11#1)(1995-12#1)(1997-2#1)(2006-11#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
no treatment-related clinical findings##2##4##(2008-9#2)
no treatment-related##5##2##(1997-1#1)(2008-9#4)
no trend##2##2##(1990-12#1)(2010-8#1)
no true##2##2##(2008-11#1)(2013-1#1)
no tumor recurrence##2##3##(2011-2#2)
no tumor##3##2##(2011-2#2)(2012-3#1)
no tumors##2##2##(1992-2#1)(1994-7#1)
no typical##3##2##(1996-10#1)(2007-10#1)(2012-3#1)
no tyrosine##2##2##(1991-12#1)(1992-8#1)
no universal##5##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-9#1)(2013-1#1)
no universally##2##2##(2008-1#1)(2008-11#1)
no unusual##2##2##(1990-11#1)(2010-3#1)
no urinary##2##2##(2008-1#1)(2008-10#1)
no use##4##2##(2008-10#1)(2009-5#3)
no useful##2##2##(1991-4#1)(2008-10#1)
no vaccine##3##2##(2011-1#1)(2011-3#1)(2012-2#1)
no validated##2##2##(2008-10#1)(2010-3#1)
no variation in the##2##4##(1993-2#1)(2008-10#1)
no variation in##4##3##(1990-5#1)(1993-2#1)(2008-10#1)(2008-9#1)
no vascular##3##2##(1992-9#1)(1993-2#1)(2007-7#1)
no viable##2##2##(1995-2#1)(2008-9#1)
no virus##2##2##(2008-10#1)(2008-5#1)
no visible reaction##2##3##(2008-10#2)
no visible symptoms##2##3##(2008-10#2)
no visible##9##2##(1991-2#1)(2008-10#6)(2008-5#1)(2010-7#1)
no visual##2##2##(2008-10#1)(2008-11#1)
no way##2##2##(2010-4#1)(2010-7#1)
no##4540##1##(1990-10#3)(1990-11#32)(1990-12#20)(1990-2#31)(1990-3#13)(1990-4#2)(1990-5#25)(1990-6#20)(1990-7#13)(1990-8#9)(1990-9#7)(1991-1#4)(1991-10#1)(1991-11#12)(1991-12#24)(1991-2#29)(1991-3#15)(1991-4#4)(1991-5#12)(1991-6#16)(1991-7#2)(1991-8#25)(1991-9#13)(1992-1#4)(1992-10#7)(1992-11#12)(1992-12#17)(1992-2#14)(1992-3#23)(1992-4#5)(1992-5#10)(1992-6#15)(1992-7#1)(1992-8#19)(1992-9#21)(1993-1#18)(1993-10#1)(1993-11#22)(1993-12#31)(1993-2#20)(1993-3#16)(1993-5#4)(1993-6#24)(1993-8#21)(1993-9#12)(1994-1#6)(1994-10#1)(1994-11#19)(1994-12#35)(1994-2#25)(1994-3#21)(1994-5#11)(1994-6#20)(1994-7#7)(1994-8#24)(1994-9#12)(1995-1#4)(1995-11#29)(1995-12#31)(1995-2#49)(1995-3#26)(1995-4#4)(1995-5#26)(1995-6#23)(1995-8#19)(1995-9#6)(1996-1#13)(1996-10#3)(1996-11#4)(1996-12#30)(1996-2#32)(1996-3#15)(1996-4#4)(1996-5#19)(1996-6#11)(1996-7#8)(1996-8#3)(1996-9#9)(1997-1#11)(1997-2#26)(1997-3#21)(1997-4#18)(1997-5#13)(1997-6#10)(1997-7#30)(1997-8#14)(1997-9#1)(2006-10#9)(2006-11#1)(2006-12#4)(2006-6#6)(2006-8#3)(2007-1#1)(2007-10#31)(2007-11#52)(2007-12#60)(2007-2#15)(2007-3#1)(2007-4#2)(2007-5#6)(2007-6#9)(2007-7#29)(2007-8#67)(2007-9#4)(2008-1#54)(2008-10#717)(2008-11#159)(2008-12#79)(2008-2#47)(2008-3#103)(2008-4#56)(2008-5#115)(2008-6#64)(2008-7#166)(2008-8#101)(2008-9#142)(2009-1#2)(2009-10#14)(2009-11#9)(2009-12#9)(2009-2#11)(2009-3#13)(2009-4#10)(2009-5#19)(2009-6#5)(2009-7#16)(2009-8#15)(2009-9#11)(2010-1#11)(2010-10#8)(2010-11#15)(2010-12#23)(2010-2#6)(2010-3#29)(2010-4#19)(2010-5#15)(2010-6#23)(2010-7#8)(2010-8#29)(2010-9#6)(2011-1#52)(2011-10#1)(2011-2#194)(2011-3#7)(2011-4#1)(2012-1#6)(2012-12#59)(2012-2#87)(2012-3#82)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#173)(2013-7#18)(2013-8#83)
no-VO##2##1##(1997-2#2)
no-choice##2##1##(2011-2#1)(2013-8#1)
no-load##2##1##(2008-9#1)(2013-8#1)
no-show rate##2##2##(2012-3#2)
no-show##4##1##(2012-3#4)
no-shows##2##1##(1996-1#1)(1997-1#1)
no-till fields##4##2##(2008-10#4)
no-till##9##1##(2008-10#8)(2010-7#1)
no-tillage##2##1##(2008-10#2)
no-treatment##3##1##(1992-8#1)(2008-10#1)(2008-5#1)
nobilis##3##1##(2008-5#1)(2013-8#2)
noble and##2##2##(2008-10#2)
noble metal permanent##2##3##(2008-10#2)
noble metal##6##2##(2008-10#5)(2008-6#1)
noble metals was##2##3##(2008-10#2)
noble metals##8##2##(2008-10#8)
noble##22##1##(2008-10#16)(2008-11#2)(2008-6#1)(2010-6#1)(2013-8#2)
nocardial##5##1##(2007-7#1)(2008-1#2)(2008-7#2)
nocardioform##2##1##(2008-11#1)(2008-5#1)
nocardioforms##2##1##(2008-11#1)(2008-5#1)
nocardiosis in a##2##3##(2006-10#1)(2008-1#1)
nocardiosis is an opportunistic##2##4##(2007-7#1)(2009-9#1)
nocardiosis with##2##2##(2007-7#2)
nocardiosis##10##1##(2006-10#2)(2007-2#1)(2007-7#4)(2008-1#1)(2009-9#2)
nocere##2##1##(1994-6#1)(2008-11#1)
nociception##6##1##(1990-11#1)(1990-7#1)(1991-1#1)(1996-2#1)(1997-2#2)
nociceptive inputs##3##2##(1993-12#1)(2008-8#1)(2010-9#1)
nociceptive responses##2##2##(1990-7#1)(1997-2#1)
nociceptive sensitivity##3##2##(1990-7#3)
nociceptive stimuli##2##2##(1991-1#1)(2009-12#1)
nociceptive threshold##2##2##(1996-2#1)(2008-7#1)
nociceptive##40##1##(1990-7#4)(1991-1#1)(1993-12#3)(1995-12#2)(1996-2#1)(1997-2#4)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#5)(2008-7#7)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#3)(2010-9#1)(2011-1#1)
nociceptors of the skin##2##4##(1995-12#2)
nociceptors##8##1##(1993-12#1)(1995-12#3)(1996-6#1)(2008-8#2)(2008-9#1)
nocodazole##3##1##(1992-12#1)(1994-11#1)(1996-3#1)
noctilio and##2##2##(2011-2#2)
noctilio##5##1##(2011-2#5)
nocturnal enuresis##9##2##(1997-5#1)(2007-7#2)(2008-10#1)(2013-8#5)
nocturnal foragers##2##2##(2007-12#2)
nocturnal hemoglobinuria (PNH)##2##3##(2008-4#1)(2008-9#1)
nocturnal hemoglobinuria##5##2##(1992-12#2)(2008-4#2)(2008-9#1)
nocturnal pineal##3##2##(1995-3#2)(2013-7#1)
nocturnal rhythm in LD##2##4##(2008-5#2)
nocturnal##46##1##(1990-7#1)(1991-11#1)(1992-12#2)(1994-8#2)(1995-3#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#2)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-9#1)(2009-8#1)(2010-6#2)(2010-8#1)(2012-2#2)(2013-7#2)(2013-8#6)
nodD3 P1##2##2##(2008-8#1)(2008-9#1)
nodD3 gene##2##2##(2008-8#1)(2008-9#1)
nodD3##6##1##(2008-8#3)(2008-9#3)
nodal and##3##2##(2008-5#1)(2012-2#1)(2012-3#1)
nodal involvement##3##2##(1990-12#1)(2008-10#2)
nodal irradiation##2##2##(1993-9#1)(2008-10#1)
nodal metastasis##5##2##(2008-2#3)(2013-8#2)
nodal or##2##2##(1997-7#1)(2008-2#1)
nodal segments##3##2##(2013-1#3)
nodal staging##3##2##(1990-2#1)(2008-10#2)
nodal status of the first##2##5##(1990-8#2)
nodal status was##2##3##(1994-7#2)
nodal status##7##2##(1990-8#2)(1994-7#2)(1997-8#1)(2007-8#1)(2008-10#1)
nodal##47##1##(1990-12#3)(1990-2#1)(1990-8#2)(1993-9#1)(1994-7#2)(1995-4#1)(1997-7#1)(1997-8#2)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-5#1)(2008-7#3)(2010-4#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
node and##5##2##(1995-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-3#1)
node biopsies##4##2##(2008-5#1)(2010-11#1)(2012-12#1)(2013-7#1)
node biopsy##13##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
node cells##3##2##(1993-2#1)(2008-11#2)
node degree##2##2##(2008-2#1)(2008-4#1)
node detection in##2##3##(2008-10#1)(2010-11#1)
node detection##3##2##(2008-10#1)(2010-11#1)(2010-12#1)
node disease##3##2##(1992-4#1)(2008-10#1)(2008-3#1)
node dissection##11##2##(1990-8#3)(1994-2#3)(1994-7#1)(1995-5#1)(2007-5#1)(2010-8#1)(2013-1#1)
node estimates##2##2##(2008-8#2)
node in the##2##3##(2008-10#1)(2009-9#1)
node in##5##2##(2008-10#1)(2008-3#2)(2009-9#1)(2013-1#1)
node involvement##7##2##(1990-2#1)(1990-6#1)(1994-12#1)(2011-2#4)
node localization of gastrinoma##2##4##(1991-6#2)
node metastases##19##2##(1990-6#1)(1990-8#1)(1992-5#1)(1994-12#1)(1997-3#2)(2008-10#2)(2008-4#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
node metastasis##25##2##(1990-12#1)(1990-2#1)(1991-12#1)(1994-12#1)(1994-7#1)(1996-6#1)(2007-10#1)(2008-12#1)(2009-12#1)(2009-2#1)(2010-6#2)(2010-8#1)(2011-2#6)(2013-1#4)(2013-8#2)
node of##5##2##(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
node status##3##2##(2008-10#2)(2011-1#1)
node values##4##2##(2008-8#4)
node was##2##2##(1993-6#1)(2008-9#1)
node##204##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#4)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#3)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#3)(1994-2#3)(1994-7#2)(1995-1#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#5)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#9)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#15)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#7)
node-negative breast##2##2##(1995-4#2)
node-negative patients##5##2##(1992-10#1)(1993-1#3)(1997-7#1)
node-negative##9##1##(1992-10#1)(1993-1#3)(1995-4#2)(1997-7#1)(2008-10#1)(2009-2#1)
node-positive breast##2##2##(1993-9#2)
node-positive##5##1##(1992-10#1)(1993-9#2)(1996-10#1)(2008-10#1)
nodes and##16##2##(1990-12#1)(1990-8#2)(1992-2#1)(2007-10#1)(2008-1#4)(2008-10#2)(2008-12#1)(2010-8#2)(2012-12#2)
nodes are##3##2##(1997-8#1)(2008-1#1)(2010-7#1)
nodes containing##2##2##(1990-12#1)(2013-1#1)
nodes of the##3##3##(2008-10#2)(2013-1#1)
nodes of##9##2##(2007-8#1)(2008-10#4)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
nodes on##5##2##(2007-9#1)(2011-2#4)
nodes the survival rate was##2##5##(2011-2#2)
nodes was##10##2##(1994-12#2)(2008-10#4)(2008-7#1)(2011-2#2)(2013-1#1)
nodes were found##2##3##(1990-8#1)(1994-7#1)
nodes were free of##2##4##(1994-12#1)(2013-7#1)
nodes were##18##2##(1990-8#1)(1993-2#1)(1994-12#1)(1994-7#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
nodes where##2##2##(1997-4#1)(2013-8#1)
nodes within##2##2##(2008-11#1)(2009-9#1)
nodes without##2##2##(1996-3#1)(2007-11#1)
nodes##183##1##(1990-12#4)(1990-3#1)(1990-8#6)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-12#5)(1994-7#2)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#3)(2007-10#3)(2007-11#1)(2007-5#3)(2007-8#2)(2007-9#2)(2008-1#13)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#16)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#5)
nodes)##4##1##(1997-8#1)(2007-11#1)(2008-10#2)
nodorum across##2##2##(2008-10#2)
nodorum and##3##2##(2008-10#3)
nodorum blotch in##2##3##(2008-10#2)
nodorum blotch##4##2##(2008-10#4)
nodorum in##3##2##(2008-10#3)
nodorum isolates##2##2##(2008-10#2)
nodorum was##3##2##(2008-10#3)
nodorum were##3##2##(2008-10#3)
nodorum##51##1##(2008-10#51)
nodosa is a##2##3##(1990-9#1)(1997-8#1)
nodosa##8##1##(1990-9#1)(1997-8#3)(2006-10#4)
nodose ganglion##5##2##(1996-12#2)(1996-5#3)
nodose##7##1##(1990-8#1)(1996-12#2)(1996-5#4)
nodosum##14##1##(1993-8#2)(1997-8#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-5#2)(2012-12#5)(2013-1#1)
nodosus##4##1##(1993-12#3)(2011-2#1)
nodular goiter##3##2##(2010-7#1)(2013-8#2)
nodular lesion##2##2##(2010-3#1)(2013-1#1)
nodular lesions on##2##3##(2008-1#1)(2009-2#1)
nodular sclerosis##2##2##(1993-9#2)
nodular shadow##2##2##(2008-1#2)
nodular##40##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-2#1)(1993-5#1)(1993-9#2)(1995-8#1)(1996-12#1)(2007-2#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-2#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#4)
nodularity##5##1##(1994-5#5)
nodulation##6##1##(1994-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)
nodule and##2##2##(2008-7#1)(2012-3#1)
nodule displayed##2##2##(2008-1#1)(2010-9#1)
nodule formation##6##2##(2008-11#4)(2008-6#1)(2011-2#1)
nodule in a##3##3##(2008-1#2)(2008-12#1)
nodule in the left##2##4##(2008-12#1)(2012-12#1)
nodule in##6##2##(2008-1#2)(2008-12#2)(2012-12#1)(2012-3#1)
nodule on the##2##3##(2007-7#1)(2010-6#1)
nodule on##5##2##(2007-7#1)(2007-8#2)(2010-6#1)(2012-12#1)
nodule over the##2##3##(2007-7#1)(2012-12#1)
nodule with##2##2##(1992-2#1)(2007-8#1)
nodule##58##1##(1990-2#1)(1992-2#1)(1992-9#1)(1994-5#1)(1997-2#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-11#4)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#3)(2011-1#1)(2011-2#3)(2012-12#4)(2012-3#7)(2013-8#1)
nodules and##7##2##(1990-7#1)(1992-3#1)(2008-5#2)(2008-6#1)(2010-7#1)(2011-1#1)
nodules are the##2##3##(2008-10#1)(2008-11#1)
nodules are##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
nodules by##2##2##(2008-6#1)(2013-8#1)
nodules in the##4##3##(2008-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
nodules in##10##2##(2008-1#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#1)
nodules involving the##2##3##(2007-7#1)(2012-12#1)
nodules of##2##2##(1991-11#1)(2008-5#1)
nodules on##2##2##(2007-10#1)(2012-12#1)
nodules over##2##2##(2007-7#1)(2011-2#1)
nodules showed a##2##3##(2008-5#2)
nodules was##2##2##(2008-11#1)(2012-3#1)
nodules were##8##2##(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-1#2)
nodules with##3##2##(1997-2#1)(2008-5#1)(2013-7#1)
nodules##111##1##(1990-10#1)(1990-2#2)(1990-6#1)(1990-7#2)(1991-11#2)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-8#1)(1997-2#2)(1997-6#5)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#9)(2008-2#1)(2008-5#13)(2008-6#9)(2008-7#3)(2008-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-1#4)(2012-12#5)(2012-3#12)(2013-1#4)(2013-7#2)(2013-8#3)
nogo##4##1##(2013-8#4)
noise (SIN)##2##2##(2008-3#2)
noise added in the##2##4##(2007-11#2)
noise added in##3##3##(2007-11#3)
noise added##4##2##(2007-11#3)(2008-2#1)
noise after##2##2##(2013-1#2)
noise amplification##2##2##(2007-12#1)(2008-10#1)
noise and dose##2##3##(2012-1#2)
noise and low##2##3##(2008-3#1)(2009-12#1)
noise and##37##2##(1993-2#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#12)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
noise are##6##2##(2008-2#1)(2008-3#5)
noise as a##2##3##(2007-12#1)(2008-3#1)
noise associated with##2##3##(2008-2#2)
noise at##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
noise background##3##2##(2008-10#2)(2008-3#1)
noise becomes##2##2##(2008-3#1)(2008-9#1)
noise behavior##2##2##(2007-12#1)(2009-11#1)
noise by##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)
noise can be##2##3##(2007-12#1)(2008-11#1)
noise cancellation##2##2##(2008-3#2)
noise caused by##2##3##(2008-10#1)(2008-3#1)
noise caused##3##2##(2008-10#1)(2008-3#2)
noise characteristics of a##2##4##(2007-11#1)(2007-12#1)
noise characteristics##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
noise components##2##2##(2008-3#1)(2008-8#1)
noise conversion in##2##3##(2007-11#1)(2007-12#1)
noise conversion##3##2##(2007-11#1)(2007-12#2)
noise due to##2##3##(2008-10#1)(2008-8#1)
noise during##2##2##(2013-1#2)
noise ensembles and##2##3##(2008-7#2)
noise ensembles##3##2##(2008-7#3)
noise equivalent##4##2##(2007-12#1)(2008-3#2)(2013-8#1)
noise error on##3##3##(2008-3#3)
noise exposure##5##2##(2008-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
noise figure of merit##2##4##(2008-2#2)
noise figure of##3##3##(2007-11#1)(2008-2#2)
noise figure##6##2##(2007-11#4)(2008-2#2)
noise floor##3##2##(2008-3#3)
noise for##3##2##(2007-12#2)(2008-2#1)
noise from##5##2##(2007-12#3)(2008-2#1)(2013-1#1)
noise generated##2##2##(2007-11#1)(2007-12#1)
noise has##2##2##(2007-11#1)(2011-2#1)
noise in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
noise in fiber-optic##2##3##(2008-2#2)
noise in the data##2##4##(2007-11#1)(2007-12#1)
noise in the optical heterodyne##2##5##(2008-3#2)
noise in the##15##3##(1997-3#1)(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#5)(2010-10#1)
noise in##43##2##(1992-8#1)(1997-3#1)(2007-11#8)(2007-12#5)(2008-2#10)(2008-3#13)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-3#1)
noise induced by##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
noise induced##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
noise into the##2##3##(2008-3#2)
noise into##4##2##(2007-11#2)(2008-3#2)
noise is calculated##2##3##(2008-2#2)
noise is##24##2##(2007-11#2)(2007-12#4)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-9#2)(2009-9#1)(2010-10#2)(2011-2#1)
noise level and##2##3##(2008-10#2)
noise level as##2##3##(2007-11#1)(2009-8#1)
noise level is##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2012-1#1)
noise level of##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)
noise level##23##2##(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#6)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)
noise levels were##2##3##(2008-3#1)(2008-8#1)
noise levels##11##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
noise limit##2##2##(2008-10#1)(2008-3#1)
noise limitation##2##2##(2008-2#1)(2008-3#1)
noise measured##2##2##(2008-2#1)(2008-3#1)
noise model##3##2##(2007-12#1)(2008-6#1)(2011-1#1)
noise models##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
noise of a##2##3##(2007-12#1)(2008-2#1)
noise of the##8##3##(1997-2#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
noise of##20##2##(1997-2#1)(2007-11#2)(2007-12#6)(2008-10#4)(2008-2#4)(2008-3#3)
noise on the input##2##4##(2007-11#1)(2007-12#1)
noise on the##11##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
noise on##15##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-9#1)(2011-2#1)
noise or##2##2##(2008-4#1)(2008-9#1)
noise patterns##2##2##(2008-3#2)
noise performance of##2##3##(2007-12#1)(2008-2#1)
noise performance##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
noise power##2##2##(2007-12#1)(2008-2#1)
noise produced##2##2##(2008-11#1)(2008-3#1)
noise properties of##3##3##(2008-3#3)
noise properties##4##2##(2008-3#3)(2009-5#1)
noise ratio (SNR)##2##3##(2008-10#1)(2008-9#1)
noise ratio of the##2##4##(1997-5#1)(2008-7#1)
noise ratio of##5##3##(1997-5#1)(2008-10#2)(2008-7#1)(2011-1#1)
noise ratio##13##2##(1997-5#1)(2008-10#8)(2008-7#1)(2008-9#1)(2011-1#2)
noise reduction and##2##3##(2007-11#1)(2008-10#1)
noise reduction in the##2##4##(2008-2#1)(2008-3#1)
noise reduction in##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
noise reduction##11##2##(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)
noise robustness of the##2##4##(2008-3#2)
noise robustness##3##2##(2008-3#3)
noise sensitivity##3##2##(2008-2#3)
noise sources##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
noise spectra##5##2##(2007-11#2)(2007-12#1)(2008-2#2)
noise spectral density##3##3##(2007-11#2)(2008-3#1)
noise suppression in##3##3##(2007-12#1)(2011-1#2)
noise suppression is##3##3##(2007-12#2)(2011-1#1)
noise suppression##12##2##(2007-12#4)(2008-3#2)(2008-7#1)(2008-9#2)(2011-1#3)
noise than##3##2##(2008-2#2)(2008-3#1)
noise that is due to##2##5##(2007-11#1)(2008-3#1)
noise that is##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
noise that##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2009-8#1)
noise to be##2##3##(2007-11#1)(2008-3#1)
noise to##8##2##(2007-11#2)(2007-12#2)(2008-3#3)(2009-9#1)
noise was##6##2##(2008-10#1)(2008-2#3)(2008-3#1)(2011-2#1)
noise with##7##2##(2007-11#1)(2008-3#3)(2008-9#3)
noise without##2##2##(2008-3#1)(2010-2#1)
noise##669##1##(1990-12#1)(1991-2#1)(1992-8#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-11#66)(2007-12#70)(2007-7#1)(2008-10#50)(2008-11#7)(2008-2#110)(2008-3#204)(2008-4#7)(2008-6#7)(2008-7#11)(2008-8#13)(2008-9#28)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#9)(2009-7#1)(2009-8#6)(2009-9#5)(2010-10#4)(2010-2#2)(2010-8#9)(2011-1#13)(2011-2#10)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#4)
noise)##4##1##(2008-10#1)(2008-3#3)
noise-equivalent absorption coefficient##3##3##(2007-12#1)(2008-3#2)
noise-equivalent absorption##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
noise-equivalent power of##2##3##(2008-3#2)
noise-equivalent power##3##2##(2007-12#1)(2008-3#2)
noise-equivalent temperature difference##2##3##(2008-3#2)
noise-equivalent##12##1##(2007-12#2)(2008-2#1)(2008-3#8)(2009-5#1)
noise-free##2##1##(2008-2#2)
noise-induced hearing loss in children##2##5##(2009-5#2)
noise-induced hearing loss##5##3##(2008-8#1)(2009-5#3)(2013-8#1)
noise-limited##2##1##(2008-2#1)(2008-3#1)
noise-reduction##6##1##(2007-12#1)(2008-3#5)
noiseless##3##1##(2008-3#3)
noisemakers##2##1##(1994-2#2)
noises in##2##2##(2008-10#2)
noises of a##2##3##(2007-12#2)
noises of##7##2##(2007-11#2)(2007-12#5)
noises##14##1##(1990-11#1)(2007-11#2)(2007-12#6)(2008-10#3)(2008-2#1)(2008-3#1)
noisy and##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
noisy data##3##2##(2008-11#1)(2008-3#2)
noisy environment##2##2##(2008-10#1)(2008-11#1)
noisy images##5##2##(2008-2#2)(2008-3#2)(2008-6#1)
noisy##39##1##(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#14)(2008-4#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-5#2)(2009-8#2)(2010-8#2)(2012-12#1)
noma##2##1##(2013-1#2)
nomadic##7##1##(2008-9#1)(2011-2#6)
nomads and##2##2##(2011-2#2)
nombreuses##3##1##(2008-5#1)(2009-4#1)(2013-1#1)
nomenclature and##4##2##(2008-11#1)(2008-3#1)(2008-4#1)(2013-7#1)
nomenclature is##2##2##(2008-4#2)
nomenclature of##2##2##(2008-10#1)(2008-4#1)
nomenclature system##2##2##(2008-5#1)(2010-3#1)
nomenclature##25##1##(1990-5#1)(1990-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#12)(2008-5#1)(2010-3#1)(2013-7#2)
nominal P =##2##3##(2010-2#2)
nominal level##3##2##(2008-7#1)(2012-1#2)
nominal resolution##3##2##(2008-10#3)
nominal##56##1##(1990-8#1)(1991-2#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#4)(2009-12#3)(2009-4#3)(2009-7#1)(2009-9#1)(2010-2#2)(2011-2#1)(2012-1#2)(2012-3#1)
nominally##15##1##(1993-11#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#3)(2009-8#1)(2010-2#1)(2011-2#1)
nominated a##2##2##(2009-7#1)(2013-1#1)
nominated by##4##2##(2008-9#3)(2009-7#1)
nominated##14##1##(2008-9#9)(2009-7#2)(2012-12#2)(2013-1#1)
nominations##4##1##(1996-1#2)(2009-7#1)(2013-1#1)
nomogram##3##1##(1994-6#1)(2008-10#1)(2012-12#1)
nomograms##3##1##(2007-7#1)(2008-10#1)(2010-12#1)
non alcoholic steatohepatitis##2##3##(2007-8#2)
non aqueous solution##2##3##(2010-5#2)
non aqueous solvents##3##3##(2008-10#3)
non aqueous##5##2##(2008-10#3)(2010-5#2)
non classical##2##2##(2008-1#2)
non complementary target##2##3##(2008-10#2)
non faradaic electrochemical impedance spectroscopy##2##5##(2008-10#2)
non fat milk and##2##4##(2008-10#2)
non fat milk##3##3##(2008-10#3)
non genomic effects##2##3##(2008-4#2)
non genomic##3##2##(2008-4#3)
non gland-bearing##2##2##(2007-12#2)
non gonococcal urethritis in##3##4##(2007-7#3)
non infected##3##2##(1996-12#1)(2008-11#2)
non invasive and##2##3##(2008-1#1)(2011-2#1)
non invasive##4##2##(1995-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
non linear##2##2##(2008-10#1)(2009-3#1)
non obese diabetic (NOD) mice##2##5##(2008-10#1)(2010-11#1)
non polluted river waters##2##4##(2008-10#2)
non reactional patients##3##3##(2011-2#3)
non reactional##4##2##(2011-2#4)
non related##2##2##(2011-2#2)
non reversible##2##2##(1996-11#1)(2008-10#1)
non selective##2##2##(2008-10#2)
non significant##2##2##(2007-11#1)(2013-1#1)
non small cell lung cancer (NSCLC)##3##6##(1993-2#1)(2008-10#1)(2010-8#1)
non small cell lung cancer##5##5##(1990-2#1)(1993-2#1)(2008-10#2)(2010-8#1)
non small cell lung##7##4##(1990-12#1)(1990-2#1)(1993-2#1)(2008-10#2)(2008-4#1)(2010-8#1)
non small cell##8##3##(1990-12#1)(1990-2#1)(1993-2#1)(2007-6#1)(2008-10#2)(2008-4#1)(2010-8#1)
non smoker##2##2##(1996-1#1)(2012-3#1)
non smokers##2##2##(1991-4#1)(2008-7#1)
non specific##8##2##(1991-11#1)(1992-9#1)(1995-1#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#2)
non steroidal anti-inflammatory##2##3##(2010-4#1)(2012-12#1)
non steroidal##3##2##(1990-9#1)(2010-4#1)(2012-12#1)
non union##2##2##(2013-8#2)
non users##2##2##(2013-1#2)
non variceal##3##2##(2011-2#3)
non##176##1##(1990-12#5)(1990-2#2)(1990-6#4)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-5#3)(2007-6#1)(2007-7#10)(2007-8#3)(2008-1#5)(2008-10#32)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#5)(2008-7#6)(2008-8#1)(2009-1#1)(2009-3#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#15)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#3)
non- or##3##2##(1994-12#1)(2009-8#1)(2012-3#1)
non-##14##1##(1994-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
non-A beta component of Alzheimer's disease amyloid (NACP)##2##8##(1997-2#2)
non-A##7##1##(1992-12#2)(1993-8#1)(1995-9#1)(1997-2#2)(2007-7#1)
non-ADP-ribosylatable##2##1##(1993-3#2)
non-AM plants##4##2##(2008-12#4)
non-B cells showed##2##3##(1992-2#2)
non-B hepatitis##3##2##(1992-12#1)(1995-9#1)(2007-7#1)
non-B##7##1##(1992-12#2)(1992-2#2)(1995-9#1)(2007-7#1)(2008-10#1)
non-Bayesian analysis##3##2##(2008-10#3)
non-Bayesian and Bayesian methods##2##4##(2008-10#2)
non-Bayesian and Bayesian##3##3##(2008-10#3)
non-Bayesian##6##1##(2008-10#6)
non-CFC propellants##3##2##(1992-3#2)(1996-1#1)
non-CFC##6##1##(1992-3#2)(1996-1#4)
non-Caucasian##3##1##(2008-1#1)(2009-7#1)(2011-2#1)
non-Chinese##3##1##(1996-12#1)(2008-5#2)
non-CpG ODN##2##2##(2008-10#2)
non-CpG##3##1##(2008-10#3)
non-English##4##1##(2008-11#1)(2008-12#2)(2012-12#1)
non-European##5##1##(1991-11#2)(2008-10#1)(2008-7#2)
non-GM Prunus##2##2##(2011-2#2)
non-Gaussian##5##1##(2007-11#2)(2008-3#1)(2008-7#1)(2009-9#1)
non-HDL cholesterol##4##2##(1993-12#1)(2013-1#3)
non-Hispanic Whites##8##2##(2009-11#1)(2010-10#3)(2012-12#4)
non-Hispanic whites##2##2##(2010-12#1)(2010-3#1)
non-Hispanic##14##1##(2008-12#1)(2009-11#1)(2010-10#3)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#5)
non-Hodgkin lymphoma (NHL)##3##3##(1996-8#1)(2009-11#1)(2013-7#1)
non-Hodgkin lymphoma and##5##3##(1994-3#1)(2009-8#1)(2013-7#1)(2013-8#2)
non-Hodgkin lymphoma##17##2##(1990-11#1)(1990-9#1)(1991-6#1)(1992-2#1)(1994-3#1)(1996-8#1)(2009-10#2)(2009-11#1)(2009-8#2)(2013-1#2)(2013-7#2)(2013-8#2)
non-Hodgkin lymphomas of the digestive tract##2##6##(1990-8#1)(1991-6#1)
non-Hodgkin lymphomas of the##3##4##(1990-8#2)(1991-6#1)
non-Hodgkin##22##1##(1990-11#1)(1990-8#2)(1990-9#1)(1991-6#2)(1992-2#1)(1994-3#1)(1996-8#1)(2009-10#2)(2009-11#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
non-Hodgkin's lymphoma (NHL)##2##3##(2007-10#1)(2013-1#1)
non-Hodgkin's lymphoma in##2##3##(1993-6#1)(1994-2#1)
non-Hodgkin's lymphoma is##2##3##(1991-6#1)(2013-8#1)
non-Hodgkin's lymphoma of the##2##4##(1993-6#1)(2007-10#1)
non-Hodgkin's lymphoma##23##2##(1990-3#1)(1991-6#1)(1992-12#2)(1993-6#2)(1994-10#1)(1994-2#1)(2007-10#3)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
non-Hodgkin's lymphomas##10##2##(1990-12#2)(1990-3#1)(1992-2#2)(1992-8#1)(1993-6#1)(2007-10#1)(2009-8#2)
non-Hodgkin's##36##1##(1990-12#2)(1990-3#2)(1991-6#2)(1992-12#2)(1992-2#2)(1992-8#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-2#1)(2007-10#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-8#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
non-IDU##2##1##(2012-1#2)
non-Lambertian##2##1##(2008-3#2)
non-MIP active##2##2##(2009-9#2)
non-Medicaid##2##1##(1992-2#1)(1997-1#1)
non-Medicare patients##2##2##(1991-12#1)(1994-12#1)
non-Medicare payers##3##2##(1994-12#3)
non-Medicare##10##1##(1991-12#2)(1992-2#1)(1993-3#1)(1994-12#4)(1995-12#1)(1997-3#1)
non-Māori##4##1##(2012-12#4)
non-N-methyl-D-aspartate##2##1##(1995-2#2)
non-NHS##3##1##(2013-8#3)
non-NMDA receptors in##2##3##(1994-2#1)(1995-12#1)
non-NMDA receptors##8##2##(1994-2#2)(1995-12#3)(1997-2#1)(2008-7#2)
non-NMDA type glutamate##2##3##(1995-5#1)(2008-11#1)
non-NMDA##12##1##(1994-2#2)(1994-8#1)(1995-12#3)(1995-5#1)(1997-2#2)(2008-11#1)(2008-7#2)
non-Nernstian##2##1##(2008-10#2)
non-PD##2##1##(2008-7#2)
non-PMWS-affected pigs##2##2##(2012-3#2)
non-Q-wave myocardial infarction##2##3##(2008-3#1)(2008-5#1)
non-REM sleep##2##2##(1994-8#1)(2012-3#1)
non-REM##3##1##(1994-8#1)(2012-3#2)
non-SCLC##2##1##(1996-9#2)
non-ST elevation acute##2##3##(2012-3#1)(2013-8#1)
non-ST elevation##7##2##(2008-3#5)(2012-3#1)(2013-8#1)
non-ST segment elevation##2##3##(2008-3#2)
non-ST##10##1##(2008-3#7)(2011-2#1)(2012-3#1)(2013-8#1)
non-ST-segment##3##1##(2008-3#3)
non-Saudi##3##1##(2007-7#1)(2008-1#1)(2008-4#1)
non-Serpulina##2##1##(1996-11#2)
non-T##2##1##(1992-2#2)
non-Watson-Crick base-pairs##2##2##(2008-7#2)
non-absorbing##3##1##(2008-10#3)
non-acceptance of hepatitis B vaccine among##2##6##(2008-9#2)
non-acceptance of hepatitis B##3##4##(2008-9#3)
non-acceptance of##4##2##(2007-11#1)(2008-9#3)
non-acetylated##2##1##(1991-8#1)(1994-3#1)
non-activated##3##1##(1992-12#1)(1993-8#1)(1995-12#1)
non-acute settings##2##2##(2010-5#1)(2013-8#1)
non-acute##4##1##(2010-5#1)(2011-3#1)(2013-8#2)
non-addictive##4##1##(2012-3#4)
non-additive effects##3##2##(2008-10#3)
non-additive##7##1##(2008-10#6)(2009-2#1)
non-additivity##4##1##(1992-6#1)(1995-11#3)
non-adherence to##3##2##(2007-7#1)(2008-7#1)(2009-5#1)
non-adherence##5##1##(2007-7#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
non-adhesive material##2##2##(2008-7#2)
non-adhesive##3##1##(2008-11#1)(2008-7#2)
non-adipogenic##2##1##(2008-11#2)
non-adoption##2##1##(2010-8#1)(2012-3#1)
non-adult exposures##2##2##(2008-10#2)
non-adult##3##1##(2008-10#3)
non-aggressive##2##1##(1993-12#1)(2009-8#1)
non-albicans spp##2##2##(2008-5#2)
non-albicans##4##1##(2008-5#2)(2011-2#1)(2013-1#1)
non-alcoholic fatty disease of liver##2##5##(2013-1#2)
non-alcoholic fatty liver disease##3##4##(2010-10#1)(2011-2#1)(2013-1#1)
non-alcoholic fatty##5##2##(2010-10#1)(2011-2#1)(2013-1#3)
non-alcoholic##16##1##(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#7)
non-alerting##2##1##(1995-6#2)
non-allelic##3##1##(1992-8#1)(1994-12#1)(2008-9#1)
non-allergic rhinitis##5##2##(1996-3#1)(2011-1#4)
non-allergic rhinopathy##2##2##(2011-1#2)
non-allergic##11##1##(1996-3#3)(2011-1#8)
non-ambulatory##2##1##(1996-9#1)(1997-2#1)
non-amphiphilic##2##1##(1990-5#2)
non-analytes##2##1##(2008-10#2)
non-animal##4##1##(2008-10#3)(2008-11#1)
non-antibiotic##2##1##(1993-3#1)(2008-5#1)
non-apex##3##1##(2009-2#3)
non-apoptotic##2##1##(2008-10#1)(2008-8#1)
non-aqueous media##5##2##(2008-10#5)
non-aqueous medium up to##2##4##(2008-10#2)
non-aqueous medium##6##2##(2008-10#6)
non-aqueous solvents##5##2##(2007-11#2)(2008-10#3)
non-aqueous##24##1##(2007-11#2)(2008-10#21)(2008-5#1)
non-aromatisable androgens##3##2##(1991-5#3)
non-asthma##2##1##(2010-5#2)
non-athlete)##2##1##(2009-7#2)
non-athletes##3##1##(2009-7#3)
non-attendance to mammographic##2##3##(1992-2#2)
non-attendance##6##1##(1991-6#3)(1992-2#3)
non-attenders##5##1##(1991-6#2)(1992-2#3)
non-auditory##3##1##(2008-4#1)(2008-9#2)
non-autoimmune##5##1##(1996-5#1)(2008-10#1)(2008-4#1)(2008-6#2)
non-autonomous##2##1##(2012-12#1)(2013-1#1)
non-availability of##3##2##(2008-1#1)(2008-7#1)(2010-10#1)
non-bacterial##3##1##(1992-5#2)(2006-6#1)
non-beating##2##1##(1996-2#2)
non-bilayer##3##1##(1994-12#1)(2008-8#2)
non-biodegradable##3##1##(1997-1#1)(2008-10#1)(2010-6#1)
non-biological influences##2##2##(1997-3#2)
non-biological##10##1##(1997-3#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-12#1)
non-black women##2##2##(2013-1#2)
non-black##4##1##(2009-5#2)(2013-1#2)
non-blood contacting pneumatic ventricle assistance device##2##6##(2012-3#2)
non-blood contacting pneumatic ventricle assistance##3##5##(2012-3#3)
non-bonded##3##1##(2008-10#1)(2008-7#1)(2012-2#1)
non-cancer##2##1##(1994-12#1)(2013-1#1)
non-cancerous##3##1##(1993-8#2)(2011-2#1)
non-cardiac death##2##2##(2007-8#2)
non-cardiac surgery##3##2##(2010-5#1)(2012-3#1)(2013-1#1)
non-cardiac##9##1##(2007-8#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
non-carriers##2##1##(2010-4#1)(2013-8#1)
non-caseating granulomas##2##2##(2008-4#1)(2010-6#1)
non-catalytic binding##2##2##(1992-12#2)
non-catalytic##3##1##(1992-12#2)(1997-2#1)
non-cavitated caries##4##2##(2012-2#4)
non-cavitated##6##1##(2012-2#6)
non-certified##2##1##(2008-10#2)
non-charged##4##1##(2008-10#4)
non-chemotactic##3##1##(1995-8#3)
non-cholesterol##2##1##(1992-6#2)
non-chromatographic##2##1##(2008-10#2)
non-classical##5##1##(2008-1#1)(2008-5#1)(2012-2#3)
non-clinical sample##2##2##(2008-1#2)
non-clinical samples##2##2##(2008-1#1)(2010-4#1)
non-clinical##11##1##(1993-3#1)(1996-12#1)(2007-12#1)(2008-1#4)(2009-6#1)(2010-4#1)(2011-1#1)(2012-1#1)
non-coated##2##1##(2008-11#2)
non-coded amino##2##2##(2013-1#2)
non-coders were##2##2##(2007-12#2)
non-coders##5##1##(2007-12#5)
non-coding RNA molecules##2##3##(2008-7#1)(2009-5#1)
non-coding RNA##6##2##(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#2)
non-coding RNAs that##3##3##(2008-11#2)(2010-7#1)
non-coding RNAs##6##2##(2008-1#2)(2008-11#2)(2008-4#1)(2010-7#1)
non-coding overlapping##2##2##(2008-7#2)
non-coding region##8##2##(1990-7#1)(1991-9#2)(1993-12#1)(1995-6#1)(2008-8#2)(2010-7#1)
non-coding regions##7##2##(1991-12#1)(1991-2#1)(1994-12#2)(1997-6#1)(2007-6#1)(2008-7#1)
non-coding sequence of the##2##4##(1993-12#1)(1997-7#1)
non-coding sequence##3##2##(1993-12#1)(1997-7#1)(2008-8#1)
non-coding sequences##2##2##(2007-12#1)(2008-1#1)
non-coding##46##1##(1990-7#2)(1991-12#1)(1991-2#1)(1991-9#2)(1993-12#2)(1994-12#3)(1995-6#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#7)(2008-8#3)(2009-5#1)(2010-11#1)(2010-7#2)(2011-2#3)(2012-2#3)(2012-5#1)
non-collagenous##3##1##(1992-3#2)(2009-8#1)
non-colorectal neoplasia and##2##3##(1992-8#2)
non-commercial##2##1##(2008-10#1)(2008-7#1)
non-communicable diseases (NCDs)##2##3##(2008-1#1)(2012-12#1)
non-communicable diseases##16##2##(1993-2#1)(2008-1#1)(2008-8#1)(2012-12#3)(2013-8#10)
non-communicable##17##1##(1993-2#1)(2008-1#1)(2008-8#1)(2010-8#1)(2012-12#3)(2013-8#10)
non-competitive NMDA receptor antagonist##4##4##(1990-5#2)(1992-3#1)(1997-7#1)
non-competitive NMDA##5##2##(1990-5#2)(1992-3#1)(1997-7#2)
non-competitive inhibitor##3##2##(1990-5#1)(1991-5#1)(2010-2#1)
non-competitive##20##1##(1990-5#6)(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#3)(1992-6#1)(1997-7#2)(2008-10#3)(2008-5#1)(2010-2#1)
non-complementing cell##2##2##(2008-11#2)
non-compliance with##4##2##(1994-11#1)(1997-1#1)(2011-2#1)(2012-2#1)
non-compliance##13##1##(1990-6#1)(1994-11#1)(1996-3#3)(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-2#2)
non-conclusive aspirates##3##2##(2008-6#3)
non-conclusive##5##1##(2008-6#5)
non-conjugated##2##1##(2007-11#1)(2011-1#1)
non-conscious##4##1##(2008-11#1)(2009-8#1)(2010-4#1)(2010-6#1)
non-conserved##2##1##(1994-11#1)(2011-2#1)
non-constant##3##1##(2008-10#2)(2013-1#1)
non-contact aggression##4##2##(2009-4#4)
non-contact mode##2##2##(2008-10#2)
non-contact zone of the##2##4##(2009-7#2)
non-contact##14##1##(1990-6#1)(1997-6#1)(2008-10#2)(2009-4#4)(2009-7#4)(2010-12#1)(2013-1#1)
non-contiguous##2##1##(2008-1#1)(2008-11#1)
non-controlled##2##1##(1991-11#1)(2008-1#1)
non-conventional##7##1##(1994-8#1)(2007-11#1)(2008-10#3)(2008-4#1)(2012-2#1)
non-convulsive##2##1##(2010-11#2)
non-coronal consonants##2##2##(2009-12#2)
non-covalent binding##3##2##(1992-11#1)(1996-8#1)(2013-1#1)
non-covalent bond complex of rhFKBP12##2##5##(2008-9#2)
non-covalent bond complex of##3##4##(2008-9#3)
non-covalent##16##1##(1992-11#1)(1996-12#1)(1996-8#1)(2006-12#1)(2008-10#4)(2008-7#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2013-1#1)
non-covalently##4##1##(1996-8#1)(2008-9#1)(2009-11#1)(2011-1#1)
non-crystallographic##3##1##(2008-4#1)(2008-8#1)(2008-9#1)
non-cultured autologous tumor cells##2##4##(1993-9#2)
non-curative##2##1##(1995-1#1)(2011-2#1)
non-cytotoxic##4##1##(1990-5#1)(2008-11#1)(2008-5#1)(2012-6#1)
non-cytotoxic&quot##2##1##(1991-8#2)
non-dairy##2##1##(2009-11#2)
non-defective##3##1##(2008-5#3)
non-degraded##2##1##(2008-12#2)
non-demented controls##2##2##(1995-5#1)(1996-12#1)
non-demented patients##5##2##(2008-7#5)
non-demented##15##1##(1995-5#1)(1996-12#1)(2008-7#13)
non-denaturing polyacrylamide gel##2##3##(1991-12#1)(1992-8#1)
non-denaturing##4##1##(1991-12#1)(1991-7#1)(1992-8#1)(2010-11#1)
non-deoxygenated##2##1##(2008-10#2)
non-depressed PD patients##2##3##(2008-7#2)
non-depressed##4##1##(2007-12#1)(2008-7#3)
non-desmoplastic##3##1##(1991-2#3)
non-destructive and##4##2##(2008-10#2)(2008-9#1)(2010-5#1)
non-destructive means of##2##3##(2008-10#2)
non-destructive##15##1##(2008-10#9)(2008-11#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-2#1)
non-detachable balloon catheter##3##3##(1997-3#3)
non-detachable balloon##4##2##(1997-3#4)
non-detectable##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
non-deterministic Cannon's##2##2##(2009-12#2)
non-diabetic controls##2##2##(2012-2#1)(2012-5#1)
non-diabetic ddY mice##2##3##(2010-11#2)
non-diabetic patients##2##2##(2008-1#1)(2011-2#1)
non-diabetic subjects##3##2##(1994-12#1)(2008-1#1)(2008-7#1)
non-diabetic##14##1##(1994-12#2)(2008-1#2)(2008-12#1)(2008-7#1)(2010-11#2)(2011-2#2)(2012-2#1)(2012-5#1)(2012-7#1)(2013-8#1)
non-diabetics with CAD##2##3##(2008-3#2)
non-diabetics##3##1##(2007-7#1)(2008-3#2)
non-diagnostic##2##1##(1991-11#1)(2008-3#1)
non-diapause eggs##4##2##(2008-5#4)
non-differentially expressed genes##2##3##(2010-3#2)
non-displaced hip fracture##3##3##(2008-12#3)
non-displaced southern##3##2##(2013-1#3)
non-displaced##11##1##(1993-11#1)(2008-12#3)(2013-1#7)
non-dividing cells##2##2##(2008-5#2)
non-dog##3##1##(2013-1#3)
non-drinkers##4##1##(2008-1#1)(2008-10#1)(2013-1#2)
non-drug-related behaviors##2##2##(2012-3#2)
non-drug-using##2##1##(1992-9#2)
non-ectopic##2##1##(1996-5#2)
non-egg layers##2##2##(2008-3#1)(2008-9#1)
non-elastic##2##1##(1997-6#1)(2008-7#1)
non-elasticity index##2##2##(2008-5#2)
non-elasticity##5##1##(2008-5#5)
non-electroactive##2##1##(1990-8#1)(2008-5#1)
non-electrolytic preconcentration via##2##3##(2008-10#2)
non-emergency situations##2##2##(2009-6#2)
non-emergency##4##1##(2008-8#1)(2009-6#2)(2011-2#1)
non-empirical##2##1##(1992-12#2)
non-encapsulated##2##1##(2009-5#1)(2012-3#1)
non-endemic areas##2##2##(2008-8#1)(2012-12#1)
non-endemic##4##1##(2007-2#1)(2007-7#1)(2008-8#1)(2012-12#1)
non-enzymatic antioxidant##2##2##(2008-5#1)(2013-1#1)
non-enzymatic##13##1##(1992-9#1)(1993-6#1)(1993-8#1)(2008-10#2)(2008-12#1)(2008-5#4)(2010-5#1)(2011-2#1)(2013-1#1)
non-epitaxially-grown##2##1##(2007-11#2)
non-epithelial##3##1##(1992-5#1)(1994-7#1)(1994-9#1)
non-equilibrium conditions##2##2##(1995-11#1)(2008-5#1)
non-equilibrium##10##1##(1995-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2010-8#1)(2012-2#1)
non-equivalence##2##1##(2009-11#2)
non-equivalent##2##1##(2008-11#1)(2008-8#1)
non-erosive##3##1##(1990-6#1)(2006-10#1)(2009-8#1)
non-esterified fatty acids in plasma##2##5##(1991-12#2)
non-esterified fatty acids in##3##4##(1991-12#2)(1996-5#1)
non-esterified fatty##4##2##(1991-12#2)(1994-12#1)(1996-5#1)
non-esterified##5##1##(1991-12#2)(1992-5#1)(1994-12#1)(1996-5#1)
non-etherified fatty acids##2##3##(2013-1#2)
non-existent##5##1##(1994-3#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
non-exposed populations##2##2##(2011-2#2)
non-exposed##5##1##(2008-10#1)(2011-2#3)(2013-1#1)
non-extractable##4##1##(2008-10#1)(2008-11#3)
non-extraction##2##1##(2008-10#1)(2013-1#1)
non-fat milk##2##2##(2008-10#2)
non-fat##3##1##(2008-10#3)
non-fatal##10##1##(1990-9#1)(1994-11#1)(2007-2#5)(2007-8#1)(2011-2#1)(2012-2#1)
non-fermented##2##1##(2008-1#1)(2011-2#1)
non-fluent aphasia##3##2##(2013-1#3)
non-fluorescent##12##1##(1993-11#1)(2008-10#11)
non-food packaging materials##2##3##(2008-10#2)
non-food##4##1##(1993-6#2)(2008-10#2)
non-freezing##2##1##(1995-11#2)
non-fucosylated##3##1##(2008-11#3)
non-functional iron##3##2##(1992-8#3)
non-functional##7##1##(1992-8#4)(2008-4#1)(2008-5#1)(2009-11#1)
non-functioning kidney in##2##3##(2008-1#1)(2013-1#1)
non-functioning paraganglioma of##2##3##(2012-2#2)
non-functioning paraganglioma##3##2##(1990-6#1)(2012-2#2)
non-functioning##12##1##(1990-6#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#2)(2012-2#3)(2013-1#1)
non-genomic##3##1##(1996-5#1)(2008-4#1)(2008-7#1)
non-genomovar III##2##2##(2007-12#2)
non-genotoxic##3##1##(1995-6#1)(2008-7#1)(2011-2#1)
non-glial##3##1##(1995-12#1)(2008-7#1)(2011-2#1)
non-glomerular##2##1##(1997-7#2)
non-glycosylated##2##1##(1995-8#2)
non-government organisations##2##2##(2012-12#2)
non-governmental organisations (NGOs)##2##3##(2007-2#2)
non-growing##4##1##(1990-7#1)(1991-11#2)(2008-11#1)
non-healing##2##1##(2007-8#1)(2008-9#1)
non-health##2##1##(1994-2#1)(2013-1#1)
non-helical##6##1##(1991-2#1)(1995-11#1)(1995-3#4)
non-heme iron enzymes##2##3##(1991-8#1)(2012-12#1)
non-heme iron##3##2##(1991-8#1)(1992-8#1)(2012-12#1)
non-heme##7##1##(1991-12#2)(1991-8#1)(1992-8#1)(1994-8#1)(2012-12#2)
non-hemophiliac##2##1##(2007-8#2)
non-hepatic##4##1##(1990-11#1)(1990-3#1)(2008-8#1)(2010-7#1)
non-high risk pulmonary embolism##2##4##(2013-8#2)
non-high##3##1##(1995-11#1)(2013-8#2)
non-high-density##2##1##(2008-7#2)
non-histone proteins##3##2##(1990-3#1)(1990-5#1)(2008-8#1)
non-histone##5##1##(1990-3#1)(1990-5#1)(1991-5#1)(1993-2#1)(2008-8#1)
non-homogeneous##5##1##(1997-3#1)(2008-10#2)(2008-7#1)(2013-8#1)
non-homologous##8##1##(1996-10#1)(1997-7#2)(2008-10#2)(2008-9#1)(2010-8#1)(2011-1#1)
non-hormetic##2##1##(2008-7#2)
non-hormonal regulation of glutamine synthetase##2##5##(1996-12#2)
non-hospital sites and##2##3##(1996-1#2)
non-hospital sites##5##2##(1996-1#5)
non-hospital##8##1##(1995-11#1)(1996-1#7)
non-host plants##2##2##(2008-10#1)(2009-6#1)
non-host##6##1##(2007-12#2)(2008-10#2)(2009-6#1)(2012-2#1)
non-human animals##2##2##(2009-5#2)
non-human primates##9##2##(1991-6#1)(1993-5#1)(1994-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-3#2)
non-human species##2##2##(1993-12#2)
non-human subjects##3##2##(2010-10#1)(2012-12#2)
non-human##20##1##(1991-6#1)(1993-12#2)(1993-5#1)(1994-2#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#2)(2009-5#2)(2010-10#1)(2010-3#1)(2012-12#2)(2013-8#1)
non-hydrolysable GTP##2##2##(1992-8#2)
non-hydrolysable##5##1##(1992-8#2)(1994-8#1)(1995-3#2)
non-hydrolyzable##3##1##(1993-6#1)(1995-8#1)(2008-4#1)
non-hydrolyzed##2##1##(2008-11#1)(2008-5#1)
non-hypertensive patients##6##2##(2007-10#6)
non-ideal conditions##2##2##(2008-10#2)
non-ideal##4##1##(2008-10#2)(2008-5#1)(2012-2#1)
non-ideality##2##1##(1991-11#1)(2008-4#1)
non-identical##2##1##(1992-8#1)(2007-12#1)
non-identified##3##1##(1993-11#1)(2008-5#2)
non-ignorable##2##1##(1995-12#1)(1997-7#1)
non-immune##5##1##(1990-12#1)(1992-3#1)(1993-6#1)(2007-2#2)
non-immunized##3##1##(2008-9#3)
non-immunosuppressed##2##1##(2008-5#2)
non-imprinted##5##1##(2008-10#3)(2008-7#2)
non-inactivated closed-states##2##2##(2008-8#2)
non-indigenous fish species##2##3##(2008-12#2)
non-indigenous##4##1##(1991-12#1)(2008-12#2)(2008-7#1)
non-induced##2##1##(1994-8#1)(2008-10#1)
non-infected##7##1##(2007-8#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2012-2#1)
non-infectious##6##1##(1992-2#1)(1996-3#1)(1997-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
non-inferiority##2##1##(2008-10#1)(2012-3#1)
non-infiltrating##3##1##(1991-6#1)(1993-9#2)
non-inflamed##3##1##(1997-8#1)(2008-10#2)
non-inflammatory##5##1##(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
non-informative and##2##2##(1994-9#1)(2008-7#1)
non-informative##3##1##(1994-9#1)(1995-2#1)(2008-7#1)
non-inherited##2##1##(1990-11#2)
non-inoculated##2##1##(2008-10#1)(2011-10#1)
non-institutionalized##2##1##(1994-2#1)(1996-3#1)
non-insulin dependent diabetes mellitus (NIDDM)##4##5##(2008-11#1)(2008-5#1)(2008-7#2)
non-insulin dependent diabetes mellitus##9##4##(1994-12#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2013-8#1)
non-insulin dependent diabetes##12##3##(1994-12#2)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2013-8#1)
non-insulin dependent##13##2##(1994-12#2)(1996-11#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2013-8#1)
non-insulin##15##1##(1994-12#2)(1996-11#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2011-1#2)(2013-8#1)
non-insulin-dependent diabetes mellitus (NIDDM)##2##4##(1991-12#1)(1992-9#1)
non-insulin-dependent diabetes mellitus##12##3##(1991-12#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#2)(2008-10#1)(2011-1#1)
non-insulin-dependent diabetes##13##2##(1991-12#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-8#2)(2008-10#1)(2011-1#1)
non-insulin-dependent diabetic patients##3##3##(1994-8#2)(1997-7#1)
non-insulin-dependent##17##1##(1991-12#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#2)(1994-8#3)(1995-8#2)(1997-7#1)(2008-10#1)(2008-4#1)(2011-1#1)
non-integer search grid##2##3##(2012-2#2)
non-integer search##3##2##(2012-2#3)
non-interactive VR##2##2##(2010-4#2)
non-intrusive##2##1##(2008-10#2)
non-intubated subjects##2##2##(2007-10#2)
non-intubated##3##1##(2007-10#3)
non-invasive and##5##2##(1991-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2013-8#1)
non-invasive breast cancer##3##3##(2013-1#3)
non-invasive breast##4##2##(2013-1#4)
non-invasive cell##2##2##(2008-11#1)(2010-3#1)
non-invasive diagnostic method##2##3##(1997-2#1)(2010-10#1)
non-invasive diagnostic##4##2##(1993-3#1)(1997-2#1)(2010-10#1)(2010-6#1)
non-invasive evaluation in##2##3##(2008-5#2)
non-invasive evaluation##4##2##(1993-6#1)(2008-5#2)(2008-7#1)
non-invasive imaging of##2##3##(1990-3#1)(2011-1#1)
non-invasive imaging techniques##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
non-invasive imaging##8##2##(1990-3#1)(1997-8#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-3#2)(2013-1#1)
non-invasive in vivo##2##3##(2008-4#1)(2008-5#1)
non-invasive method##7##2##(1990-3#1)(1992-5#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-6#1)
non-invasive methods##5##2##(1990-9#1)(1993-12#1)(1996-7#1)(2008-10#1)(2008-5#1)
non-invasive monitoring of##2##3##(1993-3#1)(2008-7#1)
non-invasive monitoring##3##2##(1993-3#1)(2006-10#1)(2008-7#1)
non-invasive nature##2##2##(1990-11#1)(2010-10#1)
non-invasive predictor for##2##3##(2009-8#2)
non-invasive screening##2##2##(2008-4#1)(2012-3#1)
non-invasive techniques##2##2##(1990-5#1)(2008-5#1)
non-invasive ventilation##3##2##(2013-7#3)
non-invasive way for##2##3##(2008-8#1)(2013-8#1)
non-invasive way to##2##3##(2008-4#1)(2008-8#1)
non-invasive way##4##2##(2008-4#1)(2008-8#2)(2013-8#1)
non-invasive##106##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#9)(2008-7#7)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#3)
non-invasively in##3##2##(1996-2#1)(2007-8#1)(2008-9#1)
non-invasively monitor##2##2##(2008-7#1)(2010-11#1)
non-invasively##14##1##(1993-10#1)(1995-2#1)(1996-2#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
non-invasiveness##2##1##(2008-10#1)(2008-8#1)
non-involved adolescents##3##2##(2009-7#3)
non-involved##5##1##(2009-7#5)
non-ionic contrast##2##2##(1990-3#1)(2012-12#1)
non-ionic detergent##3##2##(1994-11#1)(1994-6#1)(1997-7#1)
non-ionic detergents##3##2##(1990-11#1)(1994-9#1)(2008-10#1)
non-ionic sorbing solids##2##3##(2008-10#2)
non-ionic sorbing##3##2##(2008-10#3)
non-ionic surfactant Triton X-100##2##4##(2008-10#1)(2008-12#1)
non-ionic surfactant Triton##3##3##(2008-10#2)(2008-12#1)
non-ionic surfactant##20##2##(1994-9#2)(2008-10#15)(2008-12#1)(2008-5#2)
non-ionic surfactants in##2##3##(2008-10#2)
non-ionic surfactants##12##2##(2008-10#11)(2008-5#1)
non-ionic##59##1##(1990-11#1)(1990-3#1)(1994-11#1)(1994-6#1)(1994-9#3)(1996-5#1)(1997-7#2)(2008-10#42)(2008-12#1)(2008-5#4)(2009-11#1)(2012-12#1)
non-irradiated control##2##2##(2008-7#1)(2009-7#1)
non-irradiated skin##2##2##(2008-5#2)
non-irradiated##7##1##(2008-5#2)(2008-7#1)(2009-7#2)(2012-12#1)(2012-2#1)
non-irritant##2##1##(2008-5#2)
non-ischaemic cardiomyopathy##2##2##(2008-10#2)
non-ischaemic##7##1##(1994-11#1)(2008-10#6)
non-ischemic##2##1##(1997-2#1)(2011-2#1)
non-islet cells##3##2##(1995-8#3)
non-islet##4##1##(1995-8#3)(2008-6#1)
non-junctional channels that##2##3##(2008-7#2)
non-kin##2##1##(2008-10#1)(2009-10#1)
non-labeled##2##1##(1990-12#1)(2008-10#1)
non-lacunar symptoms##2##2##(2007-10#2)
non-lacunar##3##1##(2007-10#3)
non-lamellar##2##1##(1990-2#1)(2008-5#1)
non-learning##2##1##(2012-3#2)
non-lethal##3##1##(2008-9#1)(2010-8#1)(2011-2#1)
non-ligand-binding##2##1##(1993-11#2)
non-linear and##5##2##(1995-8#1)(2007-8#1)(2009-9#1)(2010-2#1)(2010-8#1)
non-linear calibration##2##2##(2008-10#2)
non-linear classifier##2##2##(2008-10#2)
non-linear curve fitting##2##3##(1993-12#1)(2008-10#1)
non-linear dose response##2##3##(2008-11#1)(2008-7#1)
non-linear equations##2##2##(2008-10#2)
non-linear least squares regression##3##4##(2008-10#3)
non-linear least-squares##3##2##(2008-10#3)
non-linear method##6##2##(2008-10#4)(2008-5#1)(2010-8#1)
non-linear model##2##2##(1997-2#1)(2008-10#1)
non-linear optical single crystal of L-lysine acetate##2##7##(2013-1#2)
non-linear optical##3##2##(2013-1#3)
non-linear regression analysis##4##3##(2008-10#3)(2012-2#1)
non-linear regression##9##2##(2008-10#8)(2012-2#1)
non-linear spectral subtraction##2##3##(2008-9#2)
non-linear##89##1##(1991-5#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-5#2)(1997-2#3)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#38)(2008-11#6)(2008-5#3)(2008-7#5)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#2)
non-linearly##2##1##(1997-2#1)(2009-3#1)
non-linguistic##2##1##(1996-5#1)(2013-8#1)
non-living##2##1##(2008-1#1)(2009-5#1)
non-local##2##1##(2012-12#1)(2013-8#1)
non-lymphoid##3##1##(1991-2#1)(1992-12#1)(2012-3#1)
non-lysosomal##2##1##(1990-7#1)(1991-12#1)
non-malarial fevers##2##2##(1994-11#2)
non-malarial##3##1##(1994-11#2)(2010-1#1)
non-malignant diseases##2##2##(2008-5#1)(2010-11#1)
non-malignant pain##2##2##(2012-3#2)
non-malignant##15##1##(1990-2#2)(1993-2#2)(2007-5#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#2)(2012-2#1)(2012-3#3)(2013-1#1)
non-mammalian##3##1##(1995-11#1)(2008-10#1)(2013-8#1)
non-matching##6##1##(1992-11#2)(1993-3#2)(1994-3#2)
non-mature##2##1##(1994-11#2)
non-medical expenses##3##2##(2008-12#3)
non-medical##12##1##(1991-11#1)(1993-6#1)(1994-12#4)(2008-11#1)(2008-12#4)(2012-12#1)
non-melanoma##3##1##(1992-3#1)(2008-4#1)(2011-2#1)
non-metastatic counterparts##2##2##(1992-9#1)(2009-3#1)
non-metastatic malignant fibrous histiocytoma##2##4##(1990-12#2)
non-metastatic osteosarcoma##4##2##(1992-6#1)(2008-6#1)(2010-3#2)
non-metastatic patients##2##2##(2010-3#2)
non-metastatic##17##1##(1990-12#2)(1992-6#2)(1992-9#2)(2008-10#1)(2008-4#3)(2008-6#1)(2009-3#1)(2010-3#5)
non-metric multidimensional scaling (NMDS)##2##4##(1995-5#2)
non-metropolitan##6##1##(1994-1#2)(1996-3#3)(2009-8#1)
non-modified##4##1##(1993-11#1)(2008-10#3)
non-monomorphous&quot##3##1##(1992-8#3)
non-motile##2##1##(2011-2#2)
non-muscle cells##2##2##(1992-2#1)(1996-2#1)
non-muscle##4##1##(1992-2#1)(1993-12#1)(1996-2#1)(2008-11#1)
non-mycorrhizal##2##1##(2008-12#2)
non-native disulfide bridge##3##3##(1990-12#3)
non-native structure##2##2##(1995-3#2)
non-native##12##1##(1990-12#3)(1994-11#1)(1995-3#3)(2007-7#2)(2008-7#1)(2008-8#1)(2008-9#1)
non-natural##2##1##(1990-8#1)(2008-1#1)
non-negative##4##1##(1997-7#1)(2008-10#2)(2013-1#1)
non-negativity##2##1##(2008-10#2)
non-neoplastic##14##1##(1990-10#1)(1990-3#1)(1992-2#1)(1993-9#2)(1995-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
non-neovascular ARMD##3##2##(2011-1#3)
non-neovascular##4##1##(2011-1#4)
non-nephrotic proteinuria##2##2##(2008-1#1)(2013-8#1)
non-neural cells##2##2##(2008-4#1)(2008-9#1)
non-neural##8##1##(1994-2#2)(1994-9#1)(2008-4#1)(2008-9#1)(2010-8#2)(2012-12#1)
non-neuroendocrine##3##1##(1992-11#2)(1997-7#1)
non-neurogenic##2##1##(2008-11#1)(2008-6#1)
non-neurological brain tissues##2##3##(1997-2#2)
non-neurological##4##1##(1997-2#3)(2008-7#1)
non-neuronal##3##1##(1994-11#1)(1995-8#1)(2009-10#1)
non-normal data with unequal covariances and variances of post-treatment measurements##2##10##(2012-1#2)
non-normal##4##1##(1991-12#1)(2012-1#2)(2013-1#1)
non-nuclear##2##1##(1994-9#1)(2008-8#1)
non-nucleoside reverse transcriptase inhibitor##3##4##(2008-5#1)(2011-2#2)
non-nucleoside reverse transcriptase inhibitors##4##4##(2011-2#2)(2011-3#2)
non-nucleoside reverse transcriptase##8##3##(2007-12#1)(2008-5#1)(2011-2#4)(2011-3#2)
non-nucleoside##10##1##(1992-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#4)(2011-3#2)
non-nucleosidic##2##1##(2008-4#2)
non-nursing##2##1##(1996-1#1)(2013-8#1)
non-nutritional##2##1##(2008-11#1)(2008-7#1)
non-nutritive sucking##2##2##(2007-10#1)(2008-10#1)
non-nutritive##4##1##(2007-10#1)(2008-10#1)(2009-6#1)(2013-1#1)
non-obese subjects##3##2##(2012-12#1)(2012-2#1)(2013-7#1)
non-obese##12##1##(1991-12#1)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#1)(2013-7#1)
non-oliguric##2##1##(2008-4#2)
non-operative treatment##4##2##(2007-8#2)(2010-11#1)(2012-3#1)
non-opioid##2##1##(1991-1#1)(1995-5#1)
non-optimised##2##1##(2008-10#2)
non-organic##2##1##(2007-8#1)(2008-5#1)
non-overlapping##10##1##(1990-12#1)(1994-11#1)(1995-8#1)(1995-9#1)(1997-4#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
non-overweight children##2##2##(2009-8#2)
non-overweight##3##1##(2009-8#3)
non-oxidative##5##1##(1992-6#1)(2008-10#4)
non-oxidized##2##1##(2008-10#1)(2013-1#1)
non-painful##2##1##(1995-12#2)
non-parametric method##3##2##(1995-12#2)(1997-3#1)
non-parametric statistic##2##2##(2008-10#2)
non-parametric##18##1##(1995-12#2)(1996-2#1)(1997-3#2)(1997-7#3)(2008-10#3)(2008-5#1)(2009-9#1)(2010-6#1)(2012-12#1)(2013-1#3)
non-parasitic##4##1##(2007-12#1)(2010-8#2)(2013-1#1)
non-participants##2##1##(2007-11#1)(2012-12#1)
non-pathogenic##6##1##(1997-4#1)(2008-7#1)(2008-9#1)(2011-2#3)
non-patients##2##1##(2011-2#1)(2012-1#1)
non-peptide##6##1##(1994-6#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-8#2)
non-performed chipmunks##2##2##(2008-5#2)
non-permissive culture conditions##3##3##(1995-11#3)
non-permissive##8##1##(1993-8#1)(1995-11#3)(1995-6#1)(1997-6#1)(2008-5#1)(2013-1#1)
non-phagocytic cell infections##2##3##(2012-2#2)
non-phagocytic##6##1##(2009-5#2)(2012-2#4)
non-pharmacologic##2##1##(2008-12#1)(2009-9#1)
non-pharmacological measures##2##2##(2008-1#1)(2008-7#1)
non-pharmacological treatment of##2##3##(1993-2#1)(2009-9#1)
non-pharmacological treatment##5##2##(1993-2#1)(2008-7#2)(2009-9#1)(2012-3#1)
non-pharmacological##16##1##(1992-6#1)(1993-2#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#1)
non-phase-matched second-harmonic generation##2##3##(2008-2#2)
non-phorbol-ester-type tumor promoters##2##3##(1992-9#2)
non-phosphorylatable##2##1##(1992-6#1)(2010-11#1)
non-phosphorylating##3##1##(1991-12#3)
non-photosynthetic##2##1##(2011-2#2)
non-physician##2##1##(1991-1#1)(1994-12#1)
non-phytate-phosphorus##2##1##(2010-2#2)
non-polar I-compounds##2##2##(1992-11#2)
non-polar and##2##2##(2008-10#1)(2008-11#1)
non-polar solvents##3##2##(2008-5#1)(2008-7#1)(2009-12#1)
non-polar##31##1##(1992-11#2)(1994-3#1)(1995-3#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-2#3)(2012-1#1)
non-porous poly(glycidylmethacrylate-co-ethylenedimethacrylate)##2##2##(2008-10#2)
non-porous##5##1##(1996-12#1)(2008-10#4)
non-potato##2##1##(2008-10#2)
non-pregnant controls (NP mice)##3##4##(1997-4#3)
non-pregnant females##2##2##(1992-3#1)(2011-2#1)
non-pregnant patients##2##2##(1990-11#1)(1993-10#1)
non-pregnant women##4##2##(1994-8#1)(2010-6#2)(2013-1#1)
non-pregnant##21##1##(1990-11#2)(1992-3#1)(1993-10#2)(1993-12#1)(1994-3#1)(1994-8#3)(1997-4#3)(2007-2#1)(2010-3#1)(2010-6#2)(2011-2#3)(2013-1#1)
non-probabilistic##3##1##(2009-11#2)(2012-12#1)
non-producing cells##3##2##(2008-11#3)
non-producing##4##1##(2008-11#4)
non-profit organization##2##2##(2008-10#1)(2012-2#1)
non-profit##11##1##(1991-3#1)(1994-3#1)(1996-3#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2012-2#2)
non-proportional hazards##4##2##(1997-3#2)(1997-8#2)
non-protein##7##1##(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)(2012-1#1)
non-proteolytic C##4##2##(2011-2#4)
non-proteolytic##8##1##(1997-4#2)(2011-2#6)
non-proven therapies##10##2##(1997-6#10)
non-pulsatile##2##1##(2010-8#2)
non-pyramidal##2##1##(1996-2#1)(1996-5#1)
non-radiative energy##2##2##(2008-10#1)(2008-9#1)
non-radiative##3##1##(2008-10#1)(2008-9#1)(2009-12#1)
non-radioactive##7##1##(1994-2#1)(1996-12#2)(1997-4#1)(2008-1#2)(2008-9#1)
non-random missing data##2##3##(1995-12#1)(2012-2#1)
non-random##10##1##(1995-12#1)(1995-2#1)(2008-11#1)(2009-10#1)(2009-8#2)(2010-3#1)(2012-2#2)(2012-5#1)
non-randomized controlled##2##2##(2011-1#1)(2012-2#1)
non-randomized study##2##2##(2008-4#1)(2013-8#1)
non-randomized##9##1##(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
non-randomly missing data on##2##4##(1995-12#2)
non-randomly##3##1##(1995-12#2)(2012-2#1)
non-randomness##3##1##(1995-12#3)
non-reactive##3##1##(2008-10#1)(2009-6#1)(2013-1#1)
non-receptor protein##2##2##(1995-11#1)(2008-9#1)
non-receptor tyrosine##4##2##(1991-11#1)(1995-8#1)(2012-12#2)
non-receptor##7##1##(1991-11#1)(1992-6#1)(1995-11#1)(1995-8#1)(2008-9#1)(2012-12#2)
non-recommended##2##1##(2010-12#2)
non-reducing conditions##4##2##(1990-12#1)(1995-12#2)(1995-8#1)
non-reducing##7##1##(1990-12#1)(1992-12#1)(1995-11#2)(1995-12#2)(1995-8#1)
non-redundant functions##2##2##(2008-4#1)(2012-2#1)
non-redundant##5##1##(1997-8#1)(2008-4#1)(2011-2#2)(2012-2#1)
non-refluxing##3##1##(2008-10#3)
non-related##2##1##(2008-1#2)
non-renal##2##1##(2008-5#1)(2008-7#1)
non-resolving##2##1##(2010-12#1)(2013-1#1)
non-resonant##5##1##(2009-7#3)(2012-2#2)
non-responders##13##1##(1991-2#1)(1991-8#1)(1992-10#1)(2007-10#1)(2007-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
non-responding##2##1##(1992-8#1)(2012-2#1)
non-responsive##2##1##(2011-2#1)(2012-2#1)
non-reward##3##1##(1993-6#2)(2009-9#1)
non-ribosomal##3##1##(2008-8#2)(2011-1#1)
non-risk##2##1##(1991-3#1)(1997-1#1)
non-saponifiable lipids##2##2##(1994-11#1)(2008-5#1)
non-selectable##2##1##(1993-9#2)
non-selected##3##1##(1991-11#1)(1993-3#1)(1996-5#1)
non-selective COX-2 inhibitor##2##3##(2008-12#2)
non-selective NSAID##2##2##(2011-2#2)
non-selective NSAIDs##4##2##(2011-2#4)
non-selective cation channel##3##3##(1995-12#1)(2008-8#2)
non-selective medium##2##2##(2008-7#2)
non-selective##30##1##(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#3)(1996-12#1)(1997-7#1)(2008-10#2)(2008-12#4)(2008-4#1)(2008-7#3)(2008-8#3)(2009-7#1)(2010-11#1)(2011-2#6)(2013-1#1)
non-self##4##1##(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)
non-self-specific stimuli##2##2##(2013-8#2)
non-self-specific##4##1##(2013-8#4)
non-seminoma##2##1##(1994-7#1)(1995-5#1)
non-septic patients after major surgery##2##5##(2009-6#2)
non-septic patients##3##2##(1997-8#1)(2009-6#2)
non-significant effects##2##2##(1997-4#1)(2012-2#1)
non-significant trend for##2##3##(1992-11#1)(2008-9#1)
non-significant##19##1##(1990-3#1)(1992-11#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)
non-significantly##2##1##(2008-12#1)(2008-5#1)
non-small cell lung cancer (NSCLC) cell##2##6##(2008-11#1)(2012-2#1)
non-small cell lung cancer (NSCLC)##6##5##(1990-2#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
non-small cell lung cancer in##2##5##(1994-12#1)(2010-8#1)
non-small cell lung cancer##30##4##(1990-2#2)(1993-9#1)(1994-12#2)(1994-8#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2010-8#3)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
non-small cell lung cancer]##5##4##(1997-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
non-small cell lung##39##3##(1990-2#2)(1993-9#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-5#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2010-8#4)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#3)(2013-8#2)
non-small cell##40##2##(1990-2#2)(1993-9#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-5#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2010-8#4)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#3)(2013-8#2)
non-small lung cancer##3##3##(2008-5#1)(2009-4#1)(2013-1#1)
non-small lung##4##2##(2008-5#1)(2009-4#1)(2013-1#2)
non-small##44##1##(1990-2#2)(1993-9#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-5#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2009-4#1)(2010-8#4)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#5)(2013-8#2)
non-small-cell lung cancer (NSCLC)##4##4##(1991-2#1)(1993-9#1)(2012-1#1)(2012-3#1)
non-small-cell lung cancer patients##2##4##(2010-5#1)(2010-8#1)
non-small-cell lung cancer##14##3##(1991-2#2)(1992-12#2)(1993-9#2)(1994-12#1)(1994-6#1)(2010-5#1)(2010-8#1)(2012-1#2)(2012-2#1)(2012-3#1)
non-small-cell lung##17##2##(1991-2#2)(1992-12#2)(1993-9#3)(1994-12#1)(1994-6#1)(2010-5#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
non-smoker##4##1##(2008-10#1)(2008-12#2)(2013-8#1)
non-smokers and##5##2##(2008-10#1)(2008-12#1)(2013-1#3)
non-smokers at##2##2##(1993-2#2)
non-smokers##34##1##(1991-1#1)(1991-11#1)(1992-9#1)(1993-2#2)(1993-8#3)(1996-3#3)(2008-10#6)(2008-12#9)(2008-7#1)(2011-2#3)(2013-1#3)(2013-8#1)
non-smoking female physicians##2##3##(2011-2#2)
non-smoking##8##1##(1991-11#2)(1991-4#1)(1991-8#1)(1993-8#1)(1995-6#1)(2011-2#2)
non-spatial memory##2##2##(1993-5#2)
non-spatial working memory##2##3##(1992-10#1)(1993-3#1)
non-spatial##9##1##(1992-10#2)(1993-3#4)(1993-5#2)(1995-5#1)
non-spatial&quot##2##1##(1993-5#2)
non-specialist documents##2##2##(2011-1#2)
non-specialist##3##1##(1990-2#1)(2011-1#2)
non-specific adsorption of protein and##2##5##(2008-10#2)
non-specific adsorption of##3##3##(1990-2#1)(2008-10#2)
non-specific adsorption##6##2##(1990-2#2)(2008-10#3)(2009-2#1)
non-specific and##3##2##(1990-5#1)(1997-4#1)(2011-1#1)
non-specific binding of##2##3##(1997-2#1)(2010-2#1)
non-specific binding##5##2##(1991-5#1)(1997-2#1)(2008-10#2)(2010-2#1)
non-specific clinical##2##2##(1997-8#1)(2011-1#1)
non-specific inflammatory##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
non-specific low back pain##2##4##(2010-12#1)(2013-1#1)
non-specific or##2##2##(2011-2#2)
non-specific protein adsorption from serum##2##5##(2008-10#2)
non-specific protein adsorption##3##3##(2008-10#3)
non-specific##93##1##(1990-11#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-5#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#3)(1997-8#2)(2007-11#1)(2008-10#24)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#8)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
non-specifically##2##1##(2008-10#1)(2008-11#1)
non-specificity##2##1##(1997-2#1)(2008-7#1)
non-spore forming##3##2##(2008-1#1)(2011-2#2)
non-sporulating##4##1##(2008-10#1)(2011-2#3)
non-standard##3##1##(2008-10#1)(2008-11#2)
non-stationary model##2##2##(2008-8#2)
non-stationary##5##1##(2008-11#1)(2008-8#2)(2009-9#1)(2010-8#1)
non-sterile##2##1##(2012-2#2)
non-steroid##3##1##(1992-5#1)(1993-2#1)(1996-6#1)
non-steroidal anti-inflammatory drug##3##3##(2008-10#1)(2008-5#2)
non-steroidal anti-inflammatory drugs (NSAIDs)##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
non-steroidal anti-inflammatory drugs##16##3##(1991-3#1)(1993-11#1)(1995-5#2)(1997-1#1)(1997-6#1)(2008-10#5)(2008-12#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
non-steroidal anti-inflammatory##24##2##(1991-3#1)(1991-8#1)(1993-11#1)(1995-5#3)(1995-6#1)(1997-1#2)(1997-6#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
non-steroidal##29##1##(1991-3#1)(1991-8#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1997-1#2)(1997-6#1)(2008-10#8)(2008-12#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
non-stimulated##7##1##(1990-12#2)(1990-7#3)(1995-11#1)(1996-12#1)
non-stoichiometric##3##1##(1995-11#1)(2008-10#2)
non-stomatal##2##1##(2012-5#1)(2012-7#1)
non-stop##2##1##(2008-10#2)
non-storers##2##1##(1994-3#2)
non-storing species##2##2##(1994-3#2)
non-storing##3##1##(1994-3#3)
non-structural protein##3##2##(2008-10#2)(2009-7#1)
non-structural##6##1##(2008-10#2)(2008-8#2)(2009-7#1)(2012-5#1)
non-stunted##2##1##(2010-6#2)
non-sulfur diiron site##2##3##(1991-12#2)
non-supine##2##1##(2011-1#2)
non-suppressed##3##1##(2008-10#3)
non-surgical methods##2##2##(1991-3#1)(2008-9#1)
non-surgical therapy##4##2##(1991-3#1)(1991-6#1)(2008-10#2)
non-surgical treatment##8##2##(1991-8#1)(2007-8#6)(2008-10#1)
non-surgical##21##1##(1991-3#2)(1991-6#1)(1991-8#1)(1993-12#1)(1994-3#1)(2007-11#1)(2007-8#6)(2008-10#3)(2008-9#1)(2010-3#2)(2011-3#1)(2013-1#1)
non-sustained ventricular tachycardia##2##3##(2007-8#2)
non-symmetrical##2##1##(1995-12#1)(2008-11#1)
non-synaptic##7##1##(1990-3#5)(1992-3#1)(2008-7#1)
non-synonymous##4##1##(2009-11#1)(2011-1#1)(2012-5#2)
non-target##4##1##(2008-11#1)(2010-4#1)(2011-2#2)
non-targeted effects##2##2##(2008-7#2)
non-targeted##4##1##(2008-7#4)
non-tender##2##1##(2012-2#1)(2012-3#1)
non-thermal##4##1##(1993-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
non-threatening##3##1##(1996-12#1)(2008-12#1)(2009-4#1)
non-thrust##4##1##(2008-12#4)
non-thyroidal illness##3##2##(1993-12#2)(2008-6#1)
non-tolerant cultivars##2##2##(2011-10#2)
non-tolerant##4##1##(2008-12#1)(2011-10#3)
non-toxic concentrations##3##2##(1992-2#1)(1992-9#1)(2010-8#1)
non-toxic to##2##2##(1992-3#1)(2008-5#1)
non-toxic##28##1##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-6#2)(1994-6#1)(1996-1#1)(2008-10#8)(2008-5#5)(2008-6#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
non-traditional##3##1##(1996-3#2)(2008-9#1)
non-transfers##2##1##(1993-12#2)
non-transformed NIH-3T3##2##2##(1992-8#2)
non-transformed##7##1##(1992-8#2)(1992-9#2)(1993-6#1)(1993-8#1)(2008-7#1)
non-transgenic##6##1##(2008-11#1)(2008-12#3)(2008-5#1)(2010-5#1)
non-translated##3##1##(2008-1#1)(2008-9#1)(2013-8#1)
non-transmural##2##1##(2009-6#1)(2010-8#1)
non-transparent##2##1##(2010-3#1)(2011-2#1)
non-transplant cardiac surgery##2##3##(2007-8#2)
non-traumatic MO##2##2##(2013-8#2)
non-traumatic thoracic emergencies##2##3##(2012-2#2)
non-traumatic##11##1##(1990-9#1)(2007-8#1)(2008-12#2)(2008-7#1)(2012-2#3)(2013-1#1)(2013-8#2)
non-treated##17##1##(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-5#1)(2008-6#1)
non-treatment##4##1##(1990-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
non-tuberculous##2##1##(2007-7#1)(2008-10#1)
non-tumor##3##1##(1993-9#1)(2008-11#1)(2008-4#1)
non-tumor-bearing##2##1##(2012-2#2)
non-tumorigenic clones##2##2##(1992-9#2)
non-tumorigenic##3##1##(1992-3#1)(1992-9#2)
non-tweezer-type ionophores##2##2##(2008-10#2)
non-twin siblings##2##2##(1997-7#1)(2008-7#1)
non-type 1 diabetes in##2##4##(2008-11#1)(2008-4#1)
non-type 1 diabetes##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
non-typhoid salmonellosis##2##2##(1997-3#2)
non-ulcer dyspepsia##2##2##(1995-6#1)(1997-1#1)
non-ulcer##3##1##(1995-6#1)(1997-1#1)(2012-12#1)
non-ulcerous##2##1##(1995-6#2)
non-uniform##4##1##(2008-10#1)(2008-3#1)(2009-10#1)(2013-8#1)
non-union in##2##2##(2012-2#2)
non-union##8##1##(1994-3#2)(2008-7#1)(2012-2#4)(2013-1#1)
non-unique landmarks##2##2##(2012-12#2)
non-use of##3##2##(1997-6#1)(2008-9#1)(2013-8#1)
non-use##8##1##(1991-1#1)(1997-6#1)(2008-5#1)(2008-9#4)(2013-8#1)
non-users##8##1##(1996-7#1)(1997-6#1)(2008-11#1)(2008-9#1)(2013-8#4)
non-vaccinated broilers##2##2##(1997-3#2)
non-vaccinated hens##2##2##(2008-5#2)
non-vaccinated##8##1##(1997-3#2)(1997-6#3)(2008-5#3)
non-vascular##3##1##(1992-12#1)(2008-7#1)(2012-2#1)
non-verbal reasoning##2##2##(1990-3#2)
non-verbal signals##2##2##(1990-3#1)(2007-11#1)
non-verbal##15##1##(1990-11#1)(1990-3#4)(1997-6#1)(2007-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)
non-vertebral##2##1##(2008-11#1)(2011-1#1)
non-viable##2##1##(1994-3#1)(2008-5#1)
non-victims##6##1##(2008-2#6)
non-viral gene delivery##2##3##(2008-11#2)
non-viral gene##3##2##(2008-11#2)(2008-5#1)
non-viral##7##1##(1994-12#1)(1997-4#1)(2008-11#3)(2008-5#2)
non-virulent NDV##2##2##(2008-5#2)
non-virulent##7##1##(1993-12#1)(2008-5#6)
non-visual##3##1##(2008-11#2)(2012-2#1)
non-vital##3##1##(1994-7#2)(2008-9#1)
non-vocationally registered##2##2##(1994-12#2)
non-volatile ions##4##2##(2008-10#4)
non-volatile##6##1##(2008-10#6)
non-white rot##2##2##(2008-10#2)
non-white##5##1##(1997-2#1)(2008-10#2)(2009-7#1)(2009-9#1)
non-whitening##2##1##(2011-2#2)
non-words##2##1##(1996-2#2)
non-zero##4##1##(1993-8#1)(1995-2#1)(1995-9#1)(2008-7#1)
nonabsorbing and weakly absorbing##3##4##(2008-2#1)(2008-3#2)
nonabsorbing and##4##2##(2008-2#1)(2008-3#3)
nonabsorbing##13##1##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#6)
nonactin##3##1##(2008-10#3)
nonactivated##2##1##(1994-8#1)(2008-11#1)
nonadaptive##2##1##(2008-8#2)
nonadditive##5##1##(2008-3#1)(2008-8#4)
nonadherence to##3##2##(1994-3#1)(2008-3#1)(2008-4#1)
nonadherence##11##1##(1992-12#2)(1994-3#3)(2008-3#3)(2008-4#1)(2009-9#2)
nonadherent populations of##2##3##(2008-10#2)
nonadherent##5##1##(1994-3#1)(2008-10#3)(2008-4#1)
nonadiabatic##3##1##(2007-12#3)
nonadiabatically##2##1##(2007-11#2)
nonadopted##2##1##(2008-11#1)(2009-8#1)
nonadrenergic##2##1##(1992-6#1)(1997-4#1)
nonagenarians##7##1##(2008-10#5)(2008-7#1)(2009-5#1)
nonaggressive bark beetles##3##3##(2008-10#3)
nonaggressive bark##4##2##(2008-10#4)
nonagricultural environments##3##2##(2008-10#3)
nonalcoholic##4##1##(1996-7#1)(2006-10#1)(2010-6#1)(2013-1#1)
nonalcoholics##2##1##(1993-2#1)(1994-2#1)
nonallelic##3##1##(1993-3#1)(2008-10#1)(2008-4#1)
nonalternant PAHs##5##2##(2008-10#5)
nonalternant polycyclic aromatic hydrocarbons (PAHs)##3##5##(2008-10#3)
nonalternant polycyclic aromatic hydrocarbons##5##4##(2008-10#5)
nonalternant##11##1##(2008-10#11)
nonamended##9##1##(2008-10#9)
nonamer##4##1##(1990-11#1)(1990-7#1)(1995-2#2)
nonamers##3##1##(1990-11#2)(2008-7#1)
nonanaplastic##3##1##(1990-10#3)
nonantigenic sites##3##2##(1994-8#3)
nonantineoplastic##2##1##(2011-2#2)
nonapeptide##5##1##(1990-5#1)(1991-8#1)(1994-3#2)(2008-10#1)
nonapeptides##2##1##(1996-5#2)
nonaphasic##4##1##(2009-10#2)(2009-9#2)
nonaqueous capillary electrophoresis (NACE)##2##4##(2008-10#2)
nonaqueous capillary electrophoresis##5##3##(2008-10#5)
nonaqueous media##2##2##(2008-10#1)(2008-7#1)
nonaqueous solution##4##2##(2008-10#2)(2013-1#2)
nonaqueous solvents##2##2##(2008-10#1)(2008-7#1)
nonaqueous##19##1##(2008-10#12)(2008-7#4)(2013-1#3)
nonathletes##2##1##(2012-1#2)
nonautoclaved##6##1##(2008-10#6)
nonautoimmune##2##1##(2012-3#2)
nonaxisymmetric##2##1##(1994-2#1)(2007-12#1)
nonbacterial##4##1##(1996-11#1)(2008-10#2)(2011-2#1)
nonbacterized##2##1##(2008-10#2)
nonbeating HL-1##2##2##(2008-7#2)
nonbilayer lipids##2##2##(1997-2#2)
nonbilayer##3##1##(1997-2#3)
nonbiological##4##1##(2008-3#2)(2010-3#1)(2010-4#1)
nonbonded interactions##2##2##(1993-11#1)(1995-5#1)
nonbonded##3##1##(1993-11#1)(1993-8#1)(1995-5#1)
nonbreeders##2##1##(2008-8#2)
nonbusiness bankruptcy filings##2##3##(2008-11#2)
nonbusiness bankruptcy##4##2##(2008-11#4)
noncancer##3##1##(1993-11#1)(2008-11#1)(2013-1#1)
noncancerous##2##1##(1994-11#1)(2008-10#1)
noncanonical##7##1##(2007-11#3)(2007-12#3)(2013-1#1)
noncardiac surgery##4##2##(2006-10#1)(2008-3#2)(2012-3#1)
noncardiac##9##1##(1992-6#1)(2006-10#3)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
noncardiogenic pulmonary##2##2##(2010-1#1)(2011-2#1)
noncaseating##2##1##(2011-2#1)(2012-3#1)
noncatalytic##4##1##(1992-3#1)(1992-6#1)(1993-11#1)(2008-2#1)
nonchaotic##2##1##(2007-11#1)(2008-9#1)
nonchilled##2##1##(2008-10#2)
noncholinergic##4##1##(1991-5#1)(1992-6#1)(1994-8#1)(1997-4#1)
nonclassical class I##2##3##(2008-4#2)
nonclassical##4##1##(2007-12#1)(2007-6#1)(2008-4#2)
noncleavable##2##1##(1991-10#1)(1995-2#1)
nonclinical safety##3##2##(1992-3#1)(2010-11#2)
nonclinical##10##1##(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(2008-1#1)(2010-11#4)
noncoated##2##1##(1995-2#1)(2008-3#1)
noncoding RNA##3##2##(2007-11#2)(2012-3#1)
noncoding RNAs##5##2##(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-3#1)
noncoding region##3##2##(1995-5#1)(2008-9#2)
noncoding regions of the##2##4##(2008-10#2)
noncoding regions of##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
noncoding regions##6##2##(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
noncoding sequences##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-9#1)
noncoding##30##1##(1993-8#1)(1995-2#2)(1995-5#1)(2007-10#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-3#2)
noncollagen protein synthesis##2##3##(2008-9#2)
noncollinear optical parametric##4##3##(2007-11#1)(2007-12#3)
noncollinear parametric##2##2##(2007-12#2)
noncollinear phase matching##2##3##(2007-11#1)(2007-12#1)
noncollinear phase##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
noncollinear phase-matching##2##2##(2008-2#2)
noncollinear##19##1##(2007-11#4)(2007-12#9)(2008-2#2)(2008-3#4)
noncollinearly pumped##3##2##(2007-11#1)(2008-3#2)
noncollinearly##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
noncompetitive and##2##2##(1992-3#1)(1992-6#1)
noncompetitive antagonist of##2##3##(1991-5#1)(2012-12#1)
noncompetitive antagonist##3##2##(1991-5#1)(1995-11#1)(2012-12#1)
noncompetitive with##2##2##(1995-3#1)(1995-8#1)
noncompetitive##18##1##(1990-11#2)(1991-5#2)(1992-3#6)(1992-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
noncompliance and##2##2##(2007-11#1)(2009-11#1)
noncompliance##11##1##(1992-12#1)(2007-11#8)(2008-10#1)(2009-11#1)
noncompliant##3##1##(2006-10#1)(2007-8#1)(2008-11#1)
nonconducive##3##1##(2008-10#3)
nonconformity##4##1##(2008-12#4)
nonconfrontation##3##1##(2011-2#3)
nonconservative##3##1##(1994-5#1)(1994-8#1)(2012-3#1)
nonconserved residues##2##2##(1993-11#1)(2008-10#1)
nonconserved##3##1##(1993-11#2)(2008-10#1)
nonconstant phase shift##2##3##(2008-2#2)
nonconstant##4##1##(2007-12#1)(2008-10#1)(2008-2#2)
noncontact and##2##2##(2007-12#1)(2008-3#1)
noncontact mapping##2##2##(2009-10#2)
noncontact optical##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
noncontact##24##1##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#13)(2009-10#2)(2010-8#1)(2013-1#1)
noncontinuous particulate##2##2##(2009-5#2)
noncooperative##5##1##(1993-1#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
noncoplanar##4##1##(2007-11#2)(2008-10#2)
noncovalent interaction##2##2##(1992-6#1)(1995-6#1)
noncovalent interactions##2##2##(1992-4#1)(2008-10#1)
noncovalent##13##1##(1992-4#1)(1992-6#2)(1993-11#1)(1995-6#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)
noncovalently##2##1##(1994-8#1)(2008-10#1)
noncovered##2##1##(2008-10#2)
noncritical phase matching##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
noncritical##8##1##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
noncritically phase-matched##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
noncritically##7##1##(2007-11#3)(2007-12#2)(2008-3#1)(2009-11#1)
noncruciferous hosts##4##2##(2008-10#4)
noncruciferous##5##1##(2008-10#5)
noncrystalline##2##1##(1991-11#1)(2008-7#1)
noncrystallographic##2##1##(1991-12#1)(1992-8#1)
noncultivated and##2##2##(2008-10#2)
noncultivated hosts##7##2##(2008-10#7)
noncultivated orchard soil##2##3##(2008-10#2)
noncultivated soil##4##2##(2008-10#4)
noncultivated##17##1##(2008-10#17)
nonculturable##3##1##(2008-10#2)(2010-9#1)
nondegenerate four-wave mixing##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
nondegenerate optical parametric##2##3##(2007-11#2)
nondegenerate##16##1##(1992-11#1)(2007-11#8)(2007-12#3)(2008-2#4)
nondemented elderly controls##2##3##(1994-8#2)
nondemented##3##1##(1994-8#3)
nondenaturing##8##1##(1992-2#1)(1994-6#1)(1995-6#1)(2008-2#1)(2008-4#3)(2010-11#1)
nondestructive determination of##2##3##(2007-11#1)(2008-3#1)
nondestructive evaluation of##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
nondestructive evaluation##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
nondestructive testing##4##2##(2008-11#2)(2008-2#2)
nondestructive##35##1##(2007-11#4)(2007-12#4)(2008-10#3)(2008-11#3)(2008-2#7)(2008-3#10)(2008-8#1)(2010-5#1)(2013-8#2)
nondestructively##4##1##(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
nondiabetic subjects##2##2##(1997-7#1)(2009-11#1)
nondiabetic##8##1##(1997-7#1)(2008-3#2)(2009-11#1)(2009-5#1)(2009-9#1)(2012-12#2)
nondiabetics##2##1##(2011-2#2)
nondiagnostic information##3##2##(2008-11#3)
nondiagnostic##6##1##(2008-11#5)(2008-3#1)
nondifferentiated PC12##2##2##(1993-8#2)
nondifferentiated##4##1##(1993-8#4)
nondiffracting##6##1##(2007-11#5)(2008-3#1)
nondigested##2##1##(1994-8#1)(2008-6#1)
nondirect##2##1##(1992-1#1)(1996-12#1)
nondisabled##7##1##(1993-3#2)(2013-1#5)
nondisplaced fractures of##2##3##(2008-9#2)
nondisplaced##5##1##(2008-9#5)
nondividing##6##1##(1994-5#1)(2008-2#2)(2008-4#1)(2009-8#1)(2012-3#1)
nondominant eye##2##2##(2011-2#2)
nondominant##4##1##(2008-7#1)(2008-9#1)(2011-2#2)
nondopaminergic neurons##5##2##(2008-7#5)
none are##4##2##(1993-12#1)(2008-1#1)(2010-1#1)(2012-3#1)
none at all##2##3##(1995-6#1)(1996-2#1)
none at##4##2##(1995-6#1)(1996-2#1)(2008-10#1)(2008-8#1)
none by##2##2##(1997-2#1)(2008-11#1)
none had##4##2##(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
none have been##2##3##(2008-3#1)(2008-9#1)
none have##4##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
none in##3##2##(2008-5#1)(2008-9#1)(2010-12#1)
none is##2##2##(1991-5#1)(2011-2#1)
none of the cases##2##4##(1991-9#1)(2011-2#1)
none of the compounds##2##4##(1993-6#1)(2009-8#1)
none of the other##2##4##(1993-9#1)(2011-2#1)
none of the patients##2##4##(1990-12#1)(1991-6#1)
none of the side-effects##2##4##(2007-8#1)(2008-5#1)
none of the strains##2##4##(2007-6#1)(2008-5#1)
none of the##76##3##(1990-12#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-4#2)(1997-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
none of them##6##3##(1995-12#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
none of these were##2##4##(1997-2#1)(1997-8#1)
none of these##16##3##(1991-2#1)(1991-9#1)(1997-2#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-12#2)(2012-2#1)
none of which showed##2##4##(1991-3#1)(1994-12#1)
none of which##9##3##(1991-3#1)(1994-12#1)(1995-11#1)(1995-9#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
none of whom##2##3##(1996-7#1)(2008-7#1)
none of##120##2##(1990-12#4)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#5)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
none received##2##2##(2007-7#2)
none the less##2##3##(1991-1#1)(1996-6#1)
none to##4##2##(2008-10#2)(2008-9#1)(2011-1#1)
none was##3##2##(1990-5#1)(1991-7#1)(2011-1#1)
none were positive##2##3##(1995-12#1)(2011-2#1)
none were##5##2##(1994-2#1)(1995-12#1)(2008-10#2)(2011-2#1)
none##195##1##(1990-12#4)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#23)(2008-11#7)(2008-12#8)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#6)(2008-9#10)(2009-11#2)(2009-12#1)(2009-2#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
noneconomic damages##6##2##(1991-1#2)(1992-1#4)
noneconomic##8##1##(1991-1#3)(1992-1#4)(2008-4#1)
nonelderly##3##1##(2013-8#3)
nonelectrolyte##2##1##(2008-2#1)(2008-4#1)
nonelectrostatic##2##1##(2008-10#1)(2008-7#1)
nonenzymatic##3##1##(1991-9#1)(1994-11#1)(1996-9#1)
nonepithelial##3##1##(1993-9#1)(2008-10#1)(2012-1#1)
nonequilibrium##8##1##(1992-8#1)(2008-3#3)(2008-8#3)(2008-9#1)
nonessential##9##1##(1994-5#1)(1997-3#2)(2008-5#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#2)
nonesterified fatty acids##2##3##(1991-12#1)(2012-2#1)
nonetheless##12##1##(1991-12#1)(1992-5#1)(1993-3#1)(1995-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)
nonexercised##3##1##(2008-10#3)
nonexistent##3##1##(1994-12#1)(2008-10#1)(2011-2#1)
nonexperimental##2##1##(2008-8#1)(2008-9#1)
nonexposed roots##2##2##(2008-10#2)
nonexposed##6##1##(2008-10#3)(2011-1#1)(2012-1#2)
nonfasting TG##2##2##(2010-8#2)
nonfasting##3##1##(2010-8#3)
nonfatal myocardial##2##2##(1990-5#1)(2008-3#1)
nonfatal##3##1##(1990-5#1)(2008-3#1)(2011-2#1)
nonfederally funded research##2##3##(1995-2#2)
nonfederally funded##3##2##(1995-2#3)
nonfertilized##2##1##(2008-10#2)
nonfinancial##2##1##(1992-3#1)(1993-12#1)
nonfluent aphasia##4##2##(2008-4#1)(2009-9#2)(2013-1#1)
nonfluent##6##1##(2007-10#1)(2008-4#1)(2008-9#1)(2009-9#2)(2013-1#1)
nonfluorescent##5##1##(1995-5#1)(2007-11#1)(2008-10#3)
nonflying##2##1##(2008-8#2)
nonfumigated soil##5##2##(2008-10#5)
nonfumigated##8##1##(2008-10#8)
nonfunctional in##2##2##(1990-11#1)(1994-8#1)
nonfunctional tumors##3##2##(2008-3#3)
nonfunctional##16##1##(1990-11#1)(1991-5#2)(1992-12#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-3#3)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#2)
nongenomic##8##1##(1992-12#3)(1994-8#1)(2008-4#4)
nongenotoxic compounds##2##2##(1990-8#2)
nongenotoxic##4##1##(1990-8#3)(1995-11#1)
nonglutinous##5##1##(2008-10#5)
nonglycosylated##5##1##(1991-9#2)(1992-8#2)(2008-4#1)
nongonococcal urethritis##2##2##(2007-7#1)(2011-2#1)
nongovernmental organizations##3##2##(1994-7#1)(1996-1#1)(1996-4#1)
nongovernmental##5##1##(1994-7#1)(1996-1#1)(1996-4#1)(2009-12#1)(2011-1#1)
nongrooved regions of##2##3##(2008-2#2)
nonhealing##3##1##(2008-8#1)(2012-2#1)(2013-1#1)
nonheated##3##1##(1990-12#1)(2008-10#1)(2008-3#1)
nonhistone##2##1##(1993-3#1)(2006-10#1)
nonhomogeneous##6##1##(2007-12#2)(2008-2#2)(2008-3#1)(2008-5#1)
nonhomologous DNA##5##2##(1993-2#2)(2008-10#3)
nonhomologous EJ##2##2##(1993-2#2)
nonhomologous end-joining##2##2##(2008-7#1)(2013-1#1)
nonhomologous recombination##4##2##(1994-8#4)
nonhomologous##16##1##(1993-2#4)(1994-8#4)(2008-10#4)(2008-5#2)(2008-7#1)(2013-1#1)
nonhospital facilities##2##2##(1995-3#1)(1996-1#1)
nonhospital##7##1##(1991-12#1)(1992-12#1)(1993-6#1)(1995-3#3)(1996-1#1)
nonhospitals##5##1##(1995-3#5)
nonhost plants and##3##3##(2008-10#3)
nonhost plants##4##2##(2008-10#4)
nonhost resistance##2##2##(2008-10#2)
nonhost##20##1##(2008-10#19)(2011-2#1)
nonhosts##3##1##(2008-10#3)
nonhuman primate##4##2##(1993-6#1)(1997-8#1)(2008-9#2)
nonhuman primates##5##2##(1994-8#2)(1996-6#1)(2007-8#1)(2008-9#1)
nonhuman##11##1##(1993-6#1)(1994-8#2)(1996-6#1)(1997-8#1)(2007-8#1)(2008-4#1)(2008-9#3)(2009-2#1)
nonhydrolysable##2##1##(1994-8#1)(1997-7#1)
nonhydrolyzable analogs of GTP##2##4##(1991-5#1)(1993-6#1)
nonhydrolyzable##6##1##(1991-5#1)(1991-6#1)(1992-5#1)(1993-6#1)(1995-3#1)(2013-8#1)
nonhypersensitive##2##1##(2008-10#2)
noni##3##1##(2008-10#3)
nonideal##3##1##(2008-2#2)(2008-3#1)
nonidentical subunits of molecular weights##2##5##(1997-6#2)
nonidentical subunits##5##2##(1990-5#1)(1992-9#1)(1997-6#2)(2008-8#1)
nonidentical##11##1##(1990-5#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-5#1)(1997-6#2)(2007-12#2)(2008-2#1)(2008-8#1)
nonignorable missing data##2##3##(2009-12#2)
nonimaging optics##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
nonimaging##10##1##(2007-11#1)(2008-2#2)(2008-3#7)
nonimmunogenic##3##1##(2008-4#1)(2008-9#1)(2009-2#1)
nonimpaired&quot##2##1##(1994-6#2)
noninduced control##2##2##(2008-10#2)
noninduced##3##1##(2008-10#3)
noninfected##10##1##(1995-2#1)(1997-3#1)(2008-10#7)(2008-7#1)
noninfectious disease##3##2##(1993-12#1)(2009-5#2)
noninfectious##7##1##(1993-12#1)(1997-3#1)(2008-9#1)(2009-5#3)(2011-1#1)
noninfested soil##3##2##(2008-10#3)
noninfested##5##1##(2008-10#5)
noninflammatory##4##1##(1995-5#1)(2008-10#1)(2008-9#2)
noninoculated leaves was significantly##2##4##(2008-10#2)
noninoculated leaves was##3##3##(2008-10#3)
noninoculated leaves##6##2##(2008-10#6)
noninoculated plants##2##2##(2008-10#2)
noninoculated trees##2##2##(2008-10#2)
noninoculated##23##1##(2008-10#23)
noninstitutionalization##2##1##(1993-1#2)
noninstitutionalized##2##1##(1993-3#1)(1995-1#1)
noninsulin##2##1##(2009-11#2)
noninsulin-dependent##2##1##(1990-11#1)(1996-2#1)
noninteracting##4##1##(1992-3#1)(2007-11#1)(2008-2#2)
noninterferometric##3##1##(2008-2#3)
nonintrusive##16##1##(1995-1#1)(2007-12#1)(2008-2#4)(2008-3#10)
noninvasive and##5##2##(1990-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-5#1)
noninvasive biochemical analysis##3##3##(2013-8#3)
noninvasive biochemical##4##2##(2013-8#4)
noninvasive detection of##2##3##(2007-11#1)(2013-8#1)
noninvasive detection##3##2##(2007-11#1)(2010-9#1)(2013-8#1)
noninvasive diagnostic##2##2##(1991-3#1)(1995-12#1)
noninvasive ductal carcinoma##2##3##(1994-7#2)
noninvasive evaluation of##4##3##(1996-3#1)(2007-4#1)(2008-3#1)(2009-4#1)
noninvasive imaging##5##2##(2008-12#2)(2010-9#1)(2012-2#1)(2013-1#1)
noninvasive in vivo##2##3##(2007-11#1)(2009-10#1)
noninvasive management##2##2##(2006-10#1)(2010-11#1)
noninvasive means##2##2##(2008-3#1)(2008-4#1)
noninvasive measurement of##2##3##(2007-10#1)(2007-12#1)
noninvasive method for##2##3##(2008-3#1)(2012-1#1)
noninvasive method##4##2##(2008-3#2)(2012-1#1)(2013-7#1)
noninvasive monitoring of##2##3##(1995-2#1)(2012-2#1)
noninvasive monitoring##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
noninvasive optical##2##2##(2008-2#1)(2008-3#1)
noninvasive technology##2##2##(2010-9#1)(2013-7#1)
noninvasive tool for monitoring##2##4##(2008-3#1)(2011-2#1)
noninvasive tool to##2##3##(2012-1#1)(2013-1#1)
noninvasive tool##4##2##(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
noninvasive##101##1##(1990-10#1)(1991-3#1)(1993-1#1)(1993-11#2)(1994-7#2)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#5)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#14)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#2)(2009-4#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#3)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#5)
noninvasive&quot##2##1##(1992-8#2)
noninvasively in##2##2##(1997-1#1)(1997-8#1)
noninvasively the##2##2##(2008-2#1)(2012-2#1)
noninvasively with##2##2##(2007-11#1)(2008-8#1)
noninvasively##13##1##(1997-1#1)(1997-8#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-2#2)
nonionic detergent##3##2##(1994-11#1)(2008-8#1)(2013-1#1)
nonionic detergents##2##2##(1990-2#1)(2008-11#1)
nonionic microemulsion##3##2##(2008-10#3)
nonionic surfactant##8##2##(2008-10#5)(2008-5#2)(2011-2#1)
nonionic surfactants##9##2##(2008-10#8)(2008-5#1)
nonionic##30##1##(1990-2#1)(1994-11#1)(2008-10#21)(2008-11#1)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#1)
nonionizing##2##1##(1990-10#1)(2011-2#1)
nonirradiated##5##1##(1995-5#1)(2007-12#1)(2008-7#2)(2011-2#1)
nonisotopic##3##1##(2008-1#1)(2008-10#1)(2008-11#1)
noniterative##7##1##(2007-11#1)(2007-12#2)(2008-3#4)
nonketotic hyperglycinemia##5##2##(1990-12#2)(2010-12#3)
nonketotic##7##1##(1990-12#2)(1990-3#1)(2008-1#1)(2010-12#3)
nonlinear Fabry-Perot##3##2##(2007-11#2)(2007-12#1)
nonlinear Fourier-transform spectroscopy##2##3##(2011-1#2)
nonlinear Schrödinger equation##6##3##(2007-11#3)(2007-12#3)
nonlinear Schrödinger##7##2##(2007-11#3)(2007-12#4)
nonlinear absorbing##2##2##(2007-11#1)(2007-12#1)
nonlinear absorption by##2##3##(2007-11#1)(2008-3#1)
nonlinear absorption coefficient##4##3##(2007-11#1)(2008-3#3)
nonlinear absorption of##2##3##(2008-3#2)
nonlinear absorption##18##2##(2007-11#6)(2007-12#3)(2008-3#9)
nonlinear absorptions of##2##3##(2007-11#2)
nonlinear and##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
nonlinear beam##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear behavior##2##2##(2007-12#1)(2008-2#1)
nonlinear calibration##4##2##(2008-10#4)
nonlinear characteristics##2##2##(2007-12#1)(2008-3#1)
nonlinear cladding##3##2##(2007-12#1)(2008-3#2)
nonlinear coefficient of##3##3##(2007-11#2)(2007-12#1)
nonlinear coefficient##11##2##(2007-11#3)(2007-12#5)(2008-2#3)
nonlinear coefficients##4##2##(2007-11#4)
nonlinear correlation##3##2##(2008-10#2)(2008-3#1)
nonlinear coupled-wave equations##2##3##(2007-12#1)(2008-2#1)
nonlinear crystal##13##2##(2007-11#2)(2007-12#6)(2008-2#4)(2008-3#1)
nonlinear crystals##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
nonlinear delayed feedback##4##3##(2009-8#4)
nonlinear dependence##2##2##(1990-7#1)(2007-12#1)
nonlinear deterministic##2##2##(2009-8#2)
nonlinear dispersive##2##2##(2007-12#2)
nonlinear dose-response relationships##2##3##(2008-7#2)
nonlinear dynamical systems##2##3##(2009-8#2)
nonlinear dynamical##3##2##(2009-8#3)
nonlinear dynamics##2##2##(2008-8#1)(2009-8#1)
nonlinear effect in##2##3##(2007-12#1)(2008-3#1)
nonlinear effect##3##2##(2007-12#2)(2008-3#1)
nonlinear effects##5##2##(2007-11#5)
nonlinear elasticity##2##2##(2009-5#2)
nonlinear equations for##2##3##(2008-2#1)(2008-3#1)
nonlinear equations##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
nonlinear experiments##2##2##(2007-12#1)(2008-2#1)
nonlinear fiber##4##2##(2007-11#2)(2007-12#2)
nonlinear filtering##5##2##(2008-2#4)(2008-3#1)
nonlinear fitting##3##2##(1997-2#1)(2008-2#1)(2008-8#1)
nonlinear for##2##2##(2008-2#1)(2008-3#1)
nonlinear frequency##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear frequency-conversion##2##2##(2007-12#1)(2008-2#1)
nonlinear function##5##2##(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)
nonlinear gain##2##2##(2007-11#1)(2008-3#1)
nonlinear in the##2##3##(1990-8#1)(2008-2#1)
nonlinear in##4##2##(1990-8#1)(2008-2#2)(2008-7#1)
nonlinear inhibitory processes##2##3##(2008-7#2)
nonlinear inhibitory##3##2##(2008-7#3)
nonlinear interaction##2##2##(2007-12#2)
nonlinear interactions between##2##3##(2008-3#1)(2008-8#1)
nonlinear interactions##6##2##(2007-12#2)(2008-3#1)(2008-8#2)(2010-11#1)
nonlinear intrachannel interactions in##2##4##(2007-11#1)(2007-12#1)
nonlinear joint transform correlator##5##4##(2008-2#5)
nonlinear least squares##4##3##(2008-3#1)(2008-7#2)(2011-1#1)
nonlinear least-squares analysis##2##3##(1990-8#1)(2008-3#1)
nonlinear least-squares fit to the##3##5##(2008-3#3)
nonlinear least-squares fit to##4##4##(2007-12#1)(2008-3#3)
nonlinear least-squares##12##2##(1990-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#7)
nonlinear lensing##3##2##(2008-3#3)
nonlinear material##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
nonlinear media##3##2##(2007-11#1)(2007-12#2)
nonlinear medium##8##2##(2007-11#2)(2007-12#4)(2008-3#2)
nonlinear mixing##2##2##(2007-12#2)
nonlinear mode##4##2##(2007-12#3)(2008-3#1)
nonlinear model##2##2##(2008-10#1)(2008-2#1)
nonlinear models##6##2##(2008-10#2)(2008-7#1)(2008-9#2)(2009-8#1)
nonlinear morphological correlation##2##3##(2008-3#2)
nonlinear operations##2##2##(2008-2#1)(2008-3#1)
nonlinear optical crystal##8##3##(2007-11#1)(2007-12#2)(2008-3#5)
nonlinear optical crystals##2##3##(2008-2#2)
nonlinear optical effects##2##3##(2008-2#1)(2008-3#1)
nonlinear optical fibers##2##3##(2007-11#1)(2007-12#1)
nonlinear optical loop mirror (NOLM)##3##5##(2007-11#2)(2007-12#1)
nonlinear optical loop mirror demultiplexer##2##5##(2007-12#1)(2008-3#1)
nonlinear optical loop mirror##12##4##(2007-11#6)(2007-12#4)(2008-3#2)
nonlinear optical loop##14##3##(2007-11#6)(2007-12#6)(2008-3#2)
nonlinear optical material##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear optical materials##3##3##(2008-2#1)(2008-3#2)
nonlinear optical processes##2##3##(2007-12#2)
nonlinear optical properties of##8##4##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
nonlinear optical properties##9##3##(2007-11#5)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
nonlinear optical response of##3##4##(2007-11#2)(2007-12#1)
nonlinear optical response##5##3##(2007-11#3)(2007-12#2)
nonlinear optical scanning microscopy##2##4##(2008-3#2)
nonlinear optical susceptibility##4##3##(2007-11#2)(2007-12#2)
nonlinear optical tensor##2##3##(2007-11#1)(2007-12#1)
nonlinear optical##88##2##(2007-11#25)(2007-12#29)(2008-10#1)(2008-2#13)(2008-3#17)(2008-7#1)(2009-5#1)(2009-7#1)
nonlinear optics in##2##3##(2007-11#1)(2007-12#1)
nonlinear optics##7##2##(2007-11#4)(2007-12#2)(2008-3#1)
nonlinear phase shift is##2##4##(2007-12#2)
nonlinear phase shift of##2##4##(2007-11#1)(2008-2#1)
nonlinear phase shift##11##3##(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#1)
nonlinear phase shifts##3##3##(2007-12#2)(2008-2#1)
nonlinear phase##17##2##(2007-11#8)(2007-12#6)(2008-2#2)(2008-3#1)
nonlinear photonic crystal##6##3##(2007-11#3)(2007-12#3)
nonlinear photonic##8##2##(2007-11#4)(2007-12#4)
nonlinear piecewise##2##2##(2007-11#2)
nonlinear polarization rotation##2##3##(2007-11#1)(2007-12#1)
nonlinear polarization##6##2##(2007-11#1)(2007-12#5)
nonlinear process##4##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
nonlinear processes##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
nonlinear profile and##2##3##(2007-12#2)
nonlinear profile##3##2##(2007-12#3)
nonlinear propagation##5##2##(2007-12#5)
nonlinear properties##2##2##(2007-12#2)
nonlinear public goods games##2##4##(2012-3#2)
nonlinear pulse##3##2##(2007-11#1)(2007-12#2)
nonlinear refractive index of the Yb(3+)/Al (3+) codoped fiber near 1580 nm##2##12##(2007-11#2)
nonlinear refractive index of##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
nonlinear refractive index##9##3##(2007-11#6)(2007-12#2)(2008-3#1)
nonlinear refractive indices##2##3##(2007-12#2)
nonlinear refractive##12##2##(2007-11#7)(2007-12#4)(2008-3#1)
nonlinear refractive-index coefficient##2##3##(2007-12#2)
nonlinear regression of the##2##4##(2008-10#1)(2008-3#1)
nonlinear regression##13##2##(1993-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)
nonlinear relationship between##4##3##(2008-10#1)(2008-9#1)(2009-2#2)
nonlinear relationship##8##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2011-1#1)
nonlinear relationships##2##2##(2008-7#1)(2008-8#1)
nonlinear response of the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
nonlinear response of##7##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
nonlinear response##11##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#2)
nonlinear scattering##4##2##(2007-11#2)(2008-3#2)
nonlinear semiconductor##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear social effects##2##3##(2008-8#2)
nonlinear spectral microscopy based on a femtosecond Cr##2##8##(2007-12#2)
nonlinear spectral##3##2##(2007-12#3)
nonlinear susceptibility of the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
nonlinear susceptibility of##7##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)
nonlinear susceptibility##9##2##(2007-11#3)(2007-12#4)(2008-10#1)(2008-3#1)
nonlinear systems##3##2##(1996-2#1)(1996-4#1)(2007-11#1)
nonlinear threshold##2##2##(2008-3#2)
nonlinear transmission##3##2##(2007-11#1)(2008-2#2)
nonlinear uniaxial crystal##2##3##(2008-3#2)
nonlinear wave equation##3##3##(2008-3#3)
nonlinear wave equations##3##3##(2007-11#2)(2008-3#1)
nonlinear wave##6##2##(2007-11#2)(2008-3#4)
nonlinear waveguide##3##2##(2007-12#3)
nonlinear waveguides##4##2##(2007-12#4)
nonlinear##643##1##(1990-12#1)(1990-7#1)(1990-8#3)(1993-3#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-4#2)(1997-2#2)(2007-11#143)(2007-12#170)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#69)(2008-3#131)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#18)(2008-8#11)(2008-9#5)(2009-12#1)(2009-2#2)(2009-5#3)(2009-7#2)(2009-8#12)(2009-9#1)(2010-11#1)(2010-8#2)(2011-1#4)(2012-1#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
nonlinear-optical##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
nonlinearities are##2##2##(2007-12#1)(2008-3#1)
nonlinearities in##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
nonlinearities of##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
nonlinearities##34##1##(1990-8#2)(2007-11#11)(2007-12#8)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#5)(2011-1#1)
nonlinearity and##8##2##(2007-12#2)(2008-2#2)(2008-3#3)(2012-2#1)
nonlinearity are##2##2##(2007-12#1)(2008-9#1)
nonlinearity by##2##2##(2007-11#1)(2007-12#1)
nonlinearity error of##2##3##(2008-2#1)(2008-3#1)
nonlinearity for##2##2##(2007-11#1)(2008-2#1)
nonlinearity in the##2##3##(2008-2#1)(2008-3#1)
nonlinearity in##12##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)(2008-9#3)
nonlinearity is##5##2##(2007-12#4)(2008-3#1)
nonlinearity of the camera##2##4##(2008-2#2)
nonlinearity of the##9##3##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)
nonlinearity of##20##2##(2007-11#3)(2007-12#9)(2008-2#3)(2008-3#5)
nonlinearity on the##2##3##(2007-12#1)(2008-2#1)
nonlinearity on##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
nonlinearity that##3##2##(1990-8#1)(2007-11#1)(2007-12#1)
nonlinearity was##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
nonlinearity##106##1##(1990-8#3)(1996-3#1)(2007-11#22)(2007-12#39)(2008-2#17)(2008-3#17)(2008-9#4)(2010-9#1)(2012-2#2)
nonlinearity)##2##1##(2007-12#2)
nonlinearly##9##1##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-9#1)
nonlipid##2##1##(2008-7#2)
nonliving##3##1##(2008-10#1)(2008-3#2)
nonlocal##6##1##(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#2)
nonmagnetic##3##1##(2008-2#1)(2008-3#2)
nonmaleficence##2##1##(2008-10#1)(2008-9#1)
nonmalignant disease##2##2##(1997-6#1)(2008-8#1)
nonmalignant##12##1##(1990-12#4)(1997-6#1)(2008-8#1)(2010-3#5)(2011-2#1)
nonmammalian##5##1##(1994-5#3)(2008-1#1)(2008-8#1)
nonmatrix##2##1##(1997-2#2)
nonmechanical##4##1##(2008-3#2)(2013-1#2)
nonmedical##7##1##(1997-1#2)(2008-1#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
nonmelanoma skin cancer##2##3##(2007-12#1)(2010-8#1)
nonmelanoma skin cancers##4##3##(2010-8#3)(2013-1#1)
nonmelanoma skin##6##2##(2007-12#1)(2010-8#4)(2013-1#1)
nonmemory##2##1##(2008-2#1)(2008-3#1)
nonmetastatic disease##5##2##(2010-3#5)
nonmetastatic osteosarcoma of the extremity##2##5##(2010-3#2)
nonmetastatic osteosarcoma of the##3##4##(1992-6#1)(2010-3#2)
nonmetastatic##13##1##(1992-6#1)(2008-9#1)(2010-3#11)
nonmethane hydrocarbons##2##2##(2008-11#2)
nonmigrant##2##1##(2012-3#2)
nonmonogamous##2##1##(2008-12#2)
nonmonotonic##4##1##(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
nonmotile##4##1##(1994-6#1)(2011-2#3)
nonmotor##3##1##(2007-8#3)
nonmyeloid##3##1##(2008-7#3)
nonnative##8##1##(1992-3#1)(1993-11#2)(1995-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
nonnatural amino acids##3##3##(1997-3#1)(2009-9#2)
nonnecrogenic##2##1##(2008-10#2)
nonnecrotic##2##1##(2008-10#2)
nonnegligible##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
nonneoplastic lesions in##3##3##(2008-9#3)
nonneoplastic lesions##10##2##(2008-8#2)(2008-9#8)
nonneoplastic##16##1##(1990-12#1)(2008-8#2)(2008-9#8)(2011-1#2)(2011-2#2)(2013-1#1)
nonneural##2##1##(1994-9#1)(1995-2#1)
nonneuronal cells##4##2##(1994-8#2)(1995-5#2)
nonneuronal##7##1##(1993-8#1)(1994-8#2)(1995-2#1)(1995-5#2)(2008-3#1)
nonnormal##3##1##(1991-12#1)(2008-3#2)
nonnucleoside reverse transcriptase inhibitors##2##4##(2008-1#1)(2011-3#1)
nonnucleoside reverse transcriptase##3##3##(2008-1#1)(2011-3#2)
nonobese diabetic##2##2##(1995-2#1)(2011-2#1)
nonobese patients##6##2##(2011-2#5)(2013-1#1)
nonobese##15##1##(1995-2#1)(2011-2#9)(2012-12#1)(2013-1#4)
nonobservable fringes##2##2##(2008-2#2)
nonoffenders##3##1##(2007-9#3)
nonoperative and operative##2##3##(1993-5#1)(2008-7#1)
nonoperative management##6##2##(2008-7#1)(2008-8#1)(2009-3#2)(2012-3#1)(2013-1#1)
nonoperative treatments of##2##3##(2008-7#1)(2008-9#1)
nonoperative##11##1##(1993-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#1)(2012-3#1)(2013-1#1)
nonoptimal##2##1##(2007-11#1)(2008-10#1)
nonoverlapping data)##2##2##(2009-11#2)
nonoverlapping host ranges##2##3##(2008-10#2)
nonoverlapping noise##5##2##(2007-12#3)(2008-2#2)
nonoverlapping##16##1##(1995-2#1)(2007-12#4)(2008-10#2)(2008-2#6)(2008-8#1)(2009-11#2)
nonpalpable##3##1##(1997-8#2)(2011-1#1)
nonparametric affected##2##2##(1997-5#2)
nonparametric analysis of##2##3##(2008-10#2)
nonparametric approaches##2##2##(2008-10#2)
nonparametric component estimator##2##3##(2009-10#2)
nonparametric component##3##2##(2009-10#3)
nonparametric estimation schemes##2##3##(2010-12#2)
nonparametric estimation##3##2##(2008-7#1)(2010-12#2)
nonparametric methods##2##2##(2008-10#2)
nonparametric procedures##2##2##(2012-1#1)(2013-1#1)
nonparametric##39##1##(1991-12#1)(1997-5#4)(2007-10#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#4)(2009-5#1)(2010-12#4)(2010-3#1)(2010-9#3)(2012-1#2)(2013-1#2)
nonparanoid##2##1##(1996-7#2)
nonparasitic##3##1##(1991-3#2)(2008-9#1)
nonparaxial correction##2##2##(2007-11#2)
nonparaxial corrections##2##2##(2007-11#2)
nonparaxial scalar diffraction theory##2##4##(2008-3#2)
nonparaxial scalar##3##2##(2008-2#1)(2008-3#2)
nonparaxial##12##1##(2007-11#6)(2007-12#2)(2008-2#2)(2008-3#2)
nonparenchymal##2##1##(1993-3#1)(1993-6#1)
nonparental##3##1##(2009-10#1)(2009-7#2)
nonpathogenic F##5##2##(2008-10#5)
nonpathogenic Fusarium oxysporum##4##3##(2008-10#4)
nonpathogenic Fusarium##5##2##(2008-10#5)
nonpathogenic and##2##2##(2008-10#2)
nonpathogenic binucleate Rhizoctonia##2##3##(2008-10#2)
nonpathogenic isolates of##2##3##(2008-10#2)
nonpathogenic isolates##9##2##(2008-10#9)
nonpathogenic mutant##5##2##(2008-10#5)
nonpathogenic on##8##2##(2008-10#8)
nonpathogenic or##2##2##(2008-10#2)
nonpathogenic strain##2##2##(2008-10#2)
nonpathogenic strains from carnation and lily##2##6##(2008-10#2)
nonpathogenic strains of##3##3##(2008-10#3)
nonpathogenic strains##5##2##(2008-10#5)
nonpathogenic to##4##2##(2008-10#4)
nonpathogenic##69##1##(1997-8#1)(2008-10#68)
nonpathogens or##2##2##(2008-10#2)
nonpathogens##5##1##(2008-10#5)
nonpeptide angiotensin II receptor##2##4##(1991-5#1)(1995-12#1)
nonpeptide angiotensin II##3##3##(1991-5#2)(1995-12#1)
nonpeptide##7##1##(1991-5#2)(1993-3#2)(1995-12#2)(2012-2#1)
nonperiodic phase structures##2##3##(2008-3#2)
nonperiodic##6##1##(1996-4#1)(2008-3#5)
nonpermissive temperature##2##2##(1990-5#1)(1994-12#1)
nonpersistent##2##1##(2007-12#1)(2008-8#1)
nonperspective##2##1##(2008-6#2)
nonpharmacologic therapies##3##2##(2010-11#2)(2010-12#1)
nonpharmacologic##8##1##(2008-4#1)(2008-7#1)(2010-11#2)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
nonpharmacological interventions##2##2##(1991-12#1)(2009-11#1)
nonpharmacological##12##1##(1991-12#1)(1992-12#3)(1993-2#1)(2008-11#2)(2009-11#1)(2010-7#1)(2013-1#2)(2013-8#1)
nonplanar##7##1##(2007-12#2)(2008-2#4)(2008-3#1)
nonplanarity of##2##2##(1996-4#1)(1996-5#1)
nonpolar and polar surface area##2##5##(1992-5#2)
nonpolar and polar surface##4##4##(1992-5#4)
nonpolar and##6##2##(1990-11#1)(1992-5#4)(2008-3#1)
nonpolar compounds##4##2##(2008-10#4)
nonpolar fraction##3##2##(2013-8#3)
nonpolar lipids in##2##3##(1990-7#2)
nonpolar organic##2##2##(2008-10#1)(2008-3#1)
nonpolar solvents and##2##3##(2008-11#2)
nonpolar##28##1##(1990-11#2)(1990-7#2)(1991-2#1)(1992-5#5)(1994-3#1)(1995-2#2)(2008-10#5)(2008-11#2)(2008-3#2)(2010-2#2)(2011-1#1)(2013-8#3)
nonpolarized light##2##2##(2007-11#1)(2008-3#1)
nonpolarizing##4##1##(2008-2#3)(2008-3#1)
nonpolyadenylated##5##1##(2008-10#1)(2008-9#4)
nonpolyposis colorectal##3##2##(1994-6#1)(2009-12#1)(2011-2#1)
nonpolyposis##5##1##(1994-6#1)(2009-12#2)(2011-2#2)
nonporous##2##1##(2008-4#1)(2008-7#1)
nonprecooled donor cells##3##3##(2008-9#3)
nonprecooled##4##1##(2008-9#4)
nonpreferred resources##3##2##(2008-9#3)
nonpregnant female##2##2##(1990-11#2)
nonpregnant##5##1##(1990-11#2)(1990-12#1)(2011-1#1)(2011-2#1)
nonpremixed flames##2##2##(2008-3#2)
nonpremixed##3##1##(2008-3#3)
nonprescription##5##1##(1995-2#4)(2013-8#1)
nonprimed##2##1##(2008-10#2)
nonproducers##2##1##(2012-2#2)
nonproducing##3##1##(1990-11#1)(2008-10#2)
nonproductive##2##1##(1997-7#1)(2008-9#1)
nonprofit agencies##2##2##(1993-2#2)
nonprofit and##3##2##(1993-1#1)(1993-2#1)(1996-3#1)
nonprofit boards##3##2##(1992-3#2)(1994-12#1)
nonprofit firm##2##2##(1997-1#2)
nonprofit firms##2##2##(1997-1#2)
nonprofit health care##2##3##(2008-11#2)
nonprofit health##3##2##(1994-1#1)(2008-11#2)
nonprofit hospices##2##2##(1995-2#2)
nonprofit hospital##7##2##(1991-1#1)(1991-3#1)(1992-3#2)(1993-2#1)(1996-2#1)(2008-11#1)
nonprofit hospitals and medical groups##2##5##(2008-11#2)
nonprofit hospitals and##3##3##(1993-1#1)(2008-11#2)
nonprofit hospitals are##2##3##(1995-1#1)(1997-1#1)
nonprofit hospitals##14##2##(1992-3#2)(1993-1#2)(1993-2#1)(1994-3#1)(1995-1#2)(1996-2#2)(1997-1#1)(2008-11#3)
nonprofit human service organizations##3##4##(1991-12#1)(1994-12#1)(1996-2#1)
nonprofit managers##3##2##(1991-12#1)(1994-12#2)
nonprofit marketing##2##2##(1992-3#2)
nonprofit nursing homes pay higher##2##5##(1992-3#2)
nonprofit nursing homes##4##3##(1992-3#4)
nonprofit organization##2##2##(1992-3#1)(1995-12#1)
nonprofit organizations##11##2##(1991-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)
nonprofit sector##3##2##(1993-1#1)(1994-2#2)
nonprofit##83##1##(1991-1#1)(1991-12#4)(1991-3#1)(1992-12#3)(1992-3#14)(1993-1#5)(1993-12#4)(1993-2#6)(1994-1#1)(1994-12#5)(1994-2#5)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#7)(1995-3#2)(1996-2#6)(1996-3#1)(1997-1#5)(2008-11#7)
nonprofits and##2##2##(1992-3#1)(1996-2#1)
nonprofits are##2##2##(1992-3#1)(1994-2#1)
nonprofits in##2##2##(1994-2#1)(1995-3#1)
nonprofits that##2##2##(1992-3#1)(1995-3#1)
nonprofits##17##1##(1992-12#1)(1992-3#3)(1994-12#1)(1994-2#7)(1995-3#4)(1996-2#1)
nonprofits?##2##1##(1993-2#1)(1994-2#1)
nonproliferating##2##1##(1995-6#1)(2008-9#1)
nonprotected##2##1##(2008-10#2)
nonpsychiatric settings##2##2##(2009-6#1)(2009-9#1)
nonpsychotic##4##1##(2008-6#1)(2009-10#3)
nonpurulent##2##1##(1990-6#1)(1993-2#1)
nonradiating##2##1##(2007-12#2)
nonradiative energy transfer##3##3##(1991-5#2)(2008-4#1)
nonradiative##4##1##(1991-5#2)(1991-9#1)(2008-4#1)
nonradioactive detection##2##2##(2008-10#1)(2008-2#1)
nonradioactive##6##1##(1990-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
nonradiolabeled##2##1##(1992-2#1)(1995-6#1)
nonrandom dropouts##2##2##(2011-1#2)
nonrandom##16##1##(2008-10#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#2)(2011-2#2)
nonrandomized case series##2##3##(2007-10#2)
nonrandomized trials##2##2##(2008-7#2)
nonrandomized##7##1##(1996-12#1)(2007-10#2)(2008-7#3)(2012-12#1)
nonrandomly##2##1##(2012-3#1)(2013-8#1)
nonrandomness caused by the##2##4##(2008-10#2)
nonreactive with##4##2##(1994-12#2)(1994-6#1)(1994-9#1)
nonreactive##13##1##(1994-12#4)(1994-6#1)(1994-9#2)(1997-3#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-8#1)(2008-9#1)
nonreceptor tyrosine##2##2##(2012-12#1)(2012-3#1)
nonreceptor##3##1##(2012-12#1)(2012-2#1)(2012-3#1)
nonreciprocal effect##2##2##(2008-3#2)
nonreciprocal phase shift##4##3##(2008-3#4)
nonreciprocal phase shifter##2##3##(2008-3#2)
nonreciprocal phase shifters##2##3##(2008-3#2)
nonreciprocal phase##8##2##(2008-3#8)
nonreciprocal##14##1##(2007-11#1)(2008-3#13)
nonrecovered patients##3##2##(1996-7#3)
nonrecovered##5##1##(1996-7#5)
nonrecursive##2##1##(1995-1#1)(2008-6#1)
nonreducing conditions##2##2##(1994-11#1)(2008-4#1)
nonreducing##10##1##(1992-12#1)(1994-11#1)(1994-5#4)(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#1)
nonreferred##2##1##(2009-11#1)(2010-8#1)
nonreflective##2##1##(2008-3#2)
nonreleased genotypes##2##2##(2008-10#2)
nonreleased##3##1##(2008-10#3)
nonresident fathers##2##2##(2008-2#2)
nonresident##3##1##(2008-2#3)
nonresonant contribution##2##2##(2007-11#2)
nonresonant laser-induced thermal acoustics##2##4##(2008-3#2)
nonresonant signal was##2##3##(2008-10#2)
nonresonant signal##5##2##(2008-10#5)
nonresonant##25##1##(2007-11#2)(2007-12#9)(2008-10#6)(2008-2#3)(2008-3#4)(2012-2#1)
nonresorbable##2##1##(2007-12#2)
nonresponders##10##1##(1990-2#1)(1993-11#1)(1994-2#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-3#1)(2011-2#1)
nonresponding patients##2##2##(1993-11#1)(2007-11#1)
nonresponding##3##1##(1993-11#1)(2007-11#1)(2012-3#1)
nonresponse##4##1##(2008-12#1)(2009-12#1)(2012-3#2)
nonretarded##2##1##(2008-2#1)(2008-3#1)
nonrhizosphere soil##2##2##(2008-10#2)
nonrhizosphere##3##1##(2008-10#3)
nonrice##2##1##(2008-10#2)
nonrotational aspheric surfaces##2##3##(2008-3#2)
nonrotational##3##1##(2008-3#3)
nonrotationally##2##1##(2008-3#2)
nonroutine##2##1##(2010-11#2)
nonscattering##4##1##(2008-2#1)(2008-3#3)
nonscientific##2##1##(2010-8#1)(2012-2#1)
nonsecreted##2##1##(1995-2#2)
nonsecretory RNase##6##2##(1990-7#6)
nonsecretory##7##1##(1990-7#7)
nonselectable##2##1##(1994-5#1)(2008-2#1)
nonselected##3##1##(2008-10#1)(2008-4#1)(2012-12#1)
nonselective and##2##2##(2008-10#1)(2008-2#1)
nonselective media##5##2##(2008-10#1)(2008-12#4)
nonselective##19##1##(1994-2#1)(2006-10#1)(2008-10#5)(2008-12#4)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2013-1#1)
nonselenoprotein##2##1##(2012-2#2)
nonsense mutations##5##2##(2008-1#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
nonsense##10##1##(1990-7#1)(1990-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
nonsense-prone##3##1##(2013-8#3)
nonsevere##2##1##(2013-1#2)
nonsexters##2##1##(2013-1#2)
nonsexual contacts##2##2##(2008-9#2)
nonsexual transmission##2##2##(2008-9#2)
nonsexual##7##1##(2008-9#5)(2012-3#2)
nonsignificant##8##1##(1994-1#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-7#1)(2013-1#1)
nonsimultaneous##2##1##(2007-11#1)(2007-12#1)
nonsinusoidal profile##3##2##(2008-2#1)(2008-3#2)
nonsinusoidal##4##1##(2008-2#2)(2008-3#2)
nonsmall cell lung##3##3##(1994-3#1)(1995-8#1)(1995-9#1)
nonsmoker men##2##2##(2008-12#2)
nonsmoker##3##1##(2008-12#3)
nonsmokers in##2##2##(1993-1#1)(2009-5#1)
nonsmokers##11##1##(1991-1#1)(1992-9#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-12#2)(2009-5#1)(2012-12#1)(2013-8#1)
nonsocial##3##1##(2008-11#1)(2009-8#2)
nonspatial##3##1##(1993-3#1)(2008-8#2)
nonspecific COX inhibitor##2##3##(2011-2#2)
nonspecific COX##3##2##(2011-2#3)
nonspecific adsorption##2##2##(2008-10#2)
nonspecific and##3##2##(2008-10#2)(2009-5#1)
nonspecific binding constant to##2##4##(1995-2#2)
nonspecific binding##9##2##(1993-11#2)(1995-2#3)(2008-10#3)(2008-7#1)
nonspecific clinical##2##2##(2011-2#1)(2012-12#1)
nonspecific esterase##2##2##(2008-9#2)
nonspecific factors##2##2##(1990-12#1)(1993-3#1)
nonspecific lipid-transfer protein##4##3##(1990-5#2)(1992-6#2)
nonspecific lipid-transfer##5##2##(1990-5#3)(1992-6#2)
nonspecific##84##1##(1990-11#2)(1990-12#1)(1990-5#3)(1990-6#1)(1991-12#1)(1991-5#2)(1992-3#1)(1992-6#3)(1993-11#2)(1993-3#1)(1993-8#2)(1995-2#5)(1997-3#2)(1997-7#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#10)(2012-12#3)(2013-1#1)(2013-7#1)
nonspecifically##7##1##(1991-12#1)(1991-9#1)(1992-11#1)(1993-11#1)(2008-10#1)(2008-4#2)
nonspherical droplets##2##2##(2008-2#1)(2008-3#1)
nonspherical particle##4##2##(2008-3#4)
nonspherical particles with flat surfaces##2##5##(2008-3#2)
nonspherical particles with##4##3##(2008-3#4)
nonspherical particles##12##2##(2007-11#1)(2008-2#4)(2008-3#7)
nonspherical##30##1##(2007-11#1)(2008-2#10)(2008-3#18)(2008-7#1)
nonsphericity##3##1##(2008-2#1)(2008-3#2)
nonspiral phase##2##2##(2008-2#2)
nonspotted kernels##2##2##(2012-3#2)
nonstandard##3##1##(1994-12#2)(2008-6#1)
nonstarved##2##1##(2008-4#2)
nonstationary##9##1##(1996-4#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
nonsteroid##3##1##(1990-11#1)(1996-3#1)(1997-3#1)
nonsteroidal anti-inflammatory drug (NSAID)##2##4##(2008-10#1)(2008-11#1)
nonsteroidal anti-inflammatory drug##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
nonsteroidal anti-inflammatory drugs (NSAIDs)##2##4##(2007-4#1)(2010-1#1)
nonsteroidal anti-inflammatory drugs##12##3##(1992-9#1)(1994-2#1)(2007-4#1)(2008-10#2)(2008-7#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
nonsteroidal anti-inflammatory##20##2##(1992-9#1)(1994-2#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#3)(2009-5#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
nonsteroidal antiinflammatory drugs (NSAIDs)##2##4##(2008-11#1)(2008-3#1)
nonsteroidal antiinflammatory drugs##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-2#1)
nonsteroidal antiinflammatory##6##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-2#1)
nonsteroidal##30##1##(1992-9#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#3)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
nonstress environment##3##2##(2008-9#3)
nonstress##6##1##(2008-3#1)(2008-9#4)(2011-2#1)
nonstructural (NSs) protein##2##3##(2008-10#2)
nonstructural protein##4##2##(2008-10#3)(2009-7#1)
nonstructural##13##1##(1994-11#2)(2008-10#10)(2009-7#1)
nonsuppression##2##1##(1995-11#1)(2008-10#1)
nonsuppressive soils##2##2##(2008-10#2)
nonsuppressive##3##1##(2008-10#3)
nonsurgical##11##1##(1996-6#1)(1997-3#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-12#1)
nonsurvivors##3##1##(1991-6#2)(2012-3#1)
nonsusceptible##2##1##(2008-10#2)
nonsustained##3##1##(1995-12#1)(2008-12#1)(2013-8#1)
nonsymmetrical##5##1##(1992-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
nonsyndromic hearing loss##3##3##(2008-4#2)(2012-12#1)
nonsyndromic##6##1##(2007-12#1)(2008-4#2)(2009-6#1)(2012-12#2)
nonsynonymous sites##3##2##(1994-8#3)
nonsynonymous##6##1##(1994-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
nontarget##3##1##(1991-9#1)(2008-2#1)(2010-1#1)
nonteaching##2##1##(1994-3#1)(2012-3#1)
nontechnical##2##1##(1993-12#1)(2006-10#1)
nonthermal##2##1##(1991-9#1)(1995-6#1)
nonthyroidal illness##3##2##(2008-4#1)(2008-7#2)
nontoxic concentrations##2##2##(1994-11#1)(1995-3#1)
nontoxic crop protection##2##3##(2008-10#2)
nontoxic regimen##2##2##(1992-10#1)(2010-4#1)
nontoxic##18##1##(1992-10#1)(1994-11#1)(1994-6#1)(1995-2#4)(1995-3#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#2)
nontoxic-nonhemagglutinin component of Clostridium botulinum type C progenitor toxin##2##9##(1992-3#2)
nontraditional designs##2##2##(2008-3#2)
nontraditional##9##1##(1992-1#1)(1994-2#1)(1996-12#2)(1997-7#1)(2008-10#1)(2008-3#2)(2009-5#1)
nontranscribed##2##1##(1994-8#1)(1995-2#1)
nontransformed and transformed##2##3##(1993-8#1)(1997-1#1)
nontransformed and##4##2##(1993-8#1)(1997-1#1)(2008-10#2)
nontransformed cells##4##2##(1995-2#3)(2012-12#1)
nontransformed plants##3##2##(2008-10#3)
nontransformed##18##1##(1993-8#2)(1995-2#3)(1997-1#1)(2008-10#11)(2012-12#1)
nontransgender##6##1##(2008-12#6)
nontransgenic hybrids##2##2##(2008-10#2)
nontransgenic littermates##6##2##(1992-11#1)(1992-8#3)(1994-8#1)(1995-2#1)
nontransgenic ones##2##2##(2008-10#1)(2008-8#1)
nontransgenic tomato##2##2##(2008-10#2)
nontransgenic##23##1##(1992-11#1)(1992-8#4)(1994-8#1)(1995-2#2)(1997-7#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-8#1)
nontranslatable##2##1##(1997-3#2)
nontranslated region##3##2##(2008-10#3)
nontranslated##5##1##(1992-12#1)(1993-3#1)(2008-10#3)
nontransmissible viruses in##2##3##(2008-10#2)
nontransmissible##4##1##(2008-10#4)
nontreated cells##3##2##(1994-6#1)(2008-11#1)(2008-9#1)
nontreated control##3##2##(2008-10#3)
nontreated plots in##2##3##(2008-10#2)
nontreated##22##1##(1994-6#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-9#1)
nontrivial##3##1##(2007-11#2)(2012-1#1)
nontuberculous mycobacteria##2##2##(2007-12#1)(2011-2#1)
nontuberculous mycobacterial disease##4##3##(2007-12#3)(2011-2#1)
nontuberculous mycobacterial##6##2##(2007-12#5)(2011-2#1)
nontuberculous##8##1##(2007-12#6)(2011-2#2)
nontwist##2##1##(2007-12#2)
nonuniform arrays##2##2##(2008-3#2)
nonuniform##41##1##(1996-4#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#11)(2008-3#16)(2008-5#1)(2008-6#2)(2010-4#2)
nonuniformities in##2##2##(2008-3#2)
nonuniformities##8##1##(2007-12#1)(2008-3#7)
nonuniformity and##3##2##(2008-2#1)(2008-3#2)
nonuniformity correction##3##2##(2008-2#1)(2008-3#2)
nonuniformity of##8##2##(2008-2#2)(2008-3#5)(2010-4#1)
nonuniformity that##3##2##(2008-3#3)
nonuniformity##29##1##(2007-11#1)(2008-2#6)(2008-3#21)(2010-4#1)
nonuniformly illuminated##2##2##(2008-3#2)
nonuniformly in##2##2##(2008-3#1)(2008-8#1)
nonuniformly##5##1##(2008-3#4)(2008-8#1)
nonunion of the ulna in a child##2##7##(2011-2#2)
nonunion of the##4##3##(2009-3#1)(2011-2#2)(2013-8#1)
nonunion of##5##2##(2009-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
nonunion##22##1##(2008-12#2)(2008-5#1)(2008-8#2)(2009-10#2)(2009-3#2)(2011-2#4)(2012-2#5)(2013-1#3)(2013-8#1)
nonunions##3##1##(2008-9#2)(2013-1#1)
nonunique##2##1##(2008-3#2)
nonusers##2##1##(1997-1#1)(2006-10#1)
nonutilizing##7##1##(2008-10#7)
nonvaccinated##2##1##(2009-6#1)(2013-1#1)
nonvalidated instruments##4##2##(2013-1#4)
nonvascularized bone##2##2##(2010-6#2)
nonvascularized##3##1##(2009-3#1)(2010-6#2)
nonvector species##2##2##(2008-10#2)
nonvector whiteflies##4##2##(2008-10#4)
nonvector##11##1##(2008-10#11)
nonverbal##6##1##(1996-2#3)(2008-11#1)(2010-4#1)(2012-3#1)
nonviable cells##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
nonviable##12##1##(1994-3#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#2)(2009-10#1)(2010-6#1)(2012-2#1)
nonviral DNA##2##2##(2008-8#2)
nonviral gene delivery##2##3##(2009-10#2)
nonviral##8##1##(1990-5#1)(1997-3#2)(2008-4#1)(2008-8#2)(2009-10#2)
nonvisible##2##1##(1993-12#1)(2008-10#1)
nonvital teeth##2##2##(2008-7#1)(2009-8#1)
nonvital tooth##2##2##(2008-7#1)(2009-8#1)
nonvital##6##1##(2008-7#2)(2008-9#1)(2009-8#3)
nonvolatile##6##1##(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
nonvolitional##2##1##(2008-11#2)
nonwhite##2##1##(2012-3#1)(2013-1#1)
nonword##2##1##(2012-1#1)(2012-2#1)
nonwords##4##1##(1990-8#1)(2008-11#3)
nonworking##2##1##(1995-12#1)(2013-1#1)
nonwoven##2##1##(2008-11#1)(2008-9#1)
nonylphenol ethoxylates##2##2##(2008-10#1)(2008-5#1)
nonylphenol##9##1##(2008-10#6)(2008-11#2)(2008-5#1)
nonylphenoxypolyethoxyethanol (OP)##2##2##(2008-10#2)
nonzero dispersion-shifted fiber##3##3##(2007-11#2)(2007-12#1)
nonzero##12##1##(2007-11#5)(2007-12#1)(2008-2#2)(2008-3#3)(2010-1#1)
nootropic##5##1##(1994-6#4)(2008-5#1)
nopaline##3##1##(1997-2#2)(2008-10#1)
nor GTP##2##2##(1991-6#1)(1995-5#1)
nor a##9##2##(1990-11#1)(1990-12#1)(1993-3#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-3#1)(2009-5#1)
nor an##6##2##(1991-12#1)(1993-8#1)(1994-2#1)(2008-3#2)(2013-8#1)
nor any##5##2##(1991-8#1)(1992-1#1)(1992-8#1)(2008-5#1)(2008-9#1)
nor are they##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
nor are##6##2##(1990-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-12#1)
nor between##2##2##(1990-3#1)(1993-11#1)
nor by the##3##3##(1990-7#1)(2008-7#1)(2009-3#1)
nor by##8##2##(1990-7#2)(1996-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)
nor caffeic acid##2##3##(2008-11#2)
nor cell##2##2##(1997-7#1)(2008-4#1)
nor did it affect##3##4##(1991-8#1)(1992-8#1)(2008-10#1)
nor did it##6##3##(1991-8#1)(1992-8#1)(1996-12#1)(2008-10#3)
nor did they##3##3##(1995-8#1)(2008-10#2)
nor did##14##2##(1991-8#1)(1992-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#7)(2009-11#1)(2011-2#1)
nor do they##3##3##(1990-3#1)(2008-5#1)(2009-9#1)
nor do##4##2##(1990-3#1)(2008-10#1)(2008-5#1)(2009-9#1)
nor does it##6##3##(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#1)(2008-11#1)
nor does##7##2##(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#1)(2008-11#1)(2008-4#1)
nor even##3##2##(1993-12#1)(1995-12#1)(2008-9#1)
nor for##2##2##(1997-4#1)(2008-9#1)
nor has the##2##3##(1992-3#1)(2008-7#1)
nor has##4##2##(1992-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
nor have##2##2##(1991-8#1)(1995-12#1)
nor in the##6##3##(1994-2#1)(1995-5#1)(2007-5#1)(2008-11#2)(2011-2#1)
nor in##20##2##(1990-8#2)(1991-5#1)(1991-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(2007-5#1)(2008-10#3)(2008-11#2)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-8#1)
nor is it##2##3##(2008-7#1)(2011-1#1)
nor is##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
nor its subsequent##2##3##(1994-6#2)
nor its##4##2##(1993-12#1)(1994-6#2)(2008-10#1)
nor of##3##2##(1994-8#1)(2009-6#1)(2011-2#1)
nor on##4##2##(1991-9#1)(1993-12#1)(1994-6#1)(2008-12#1)
nor other##2##2##(2008-5#1)(2008-9#1)
nor previous##2##2##(1990-12#1)(2007-8#1)
nor the negative##2##3##(2008-1#1)(2008-10#1)
nor the presence of##2##4##(1990-5#1)(1996-12#1)
nor the two##2##3##(2008-7#1)(2008-8#1)
nor the##59##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#2)(2013-1#3)(2013-8#2)
nor to the##2##3##(1990-5#1)(2008-5#1)
nor to##8##2##(1990-5#1)(1991-11#1)(2007-5#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)
nor was##2##2##(2008-10#1)(2011-2#1)
nor were##5##2##(1991-12#1)(2008-10#1)(2008-6#1)(2009-7#1)(2011-3#1)
nor with the##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
nor with##8##2##(1990-5#1)(1995-11#1)(1996-12#2)(1996-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
nor##409##1##(1990-11#1)(1990-12#5)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#2)(1991-8#5)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#2)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#13)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#9)(1995-2#3)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#4)(1997-6#1)(1997-7#5)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#5)(2007-5#4)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#46)(2008-11#13)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#9)(2013-8#3)
nor-HN2##2##1##(2008-4#2)
norBNI##2##1##(1991-1#2)
noradrenaline (NA)##5##2##(1994-6#1)(1995-3#1)(1997-7#1)(2008-7#2)
noradrenaline and adrenaline##3##3##(1994-2#1)(2008-10#2)
noradrenaline and dopamine were##2##4##(1990-8#2)
noradrenaline and dopamine##6##3##(1990-8#2)(2008-10#3)(2008-7#1)
noradrenaline and##10##2##(1990-8#2)(1994-2#1)(2008-10#5)(2008-7#1)(2009-7#1)
noradrenaline concentration##3##2##(1995-12#1)(2008-7#2)
noradrenaline in the##2##3##(1997-3#1)(2008-10#1)
noradrenaline in##3##2##(1995-12#1)(1997-3#1)(2008-10#1)
noradrenaline levels##2##2##(1991-2#1)(2008-7#1)
noradrenaline responses##3##2##(1991-8#1)(1997-4#2)
noradrenaline vasoconstriction##3##2##(1995-12#2)(1997-4#1)
noradrenaline was##3##2##(1990-8#2)(1995-12#1)
noradrenaline will##2##2##(2008-6#2)
noradrenaline##67##1##(1990-5#2)(1990-8#5)(1991-2#2)(1991-8#1)(1992-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#16)(1995-3#1)(1996-2#4)(1997-3#2)(1997-4#7)(1997-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#8)(2009-7#1)(2013-1#1)
noradrenergic and specific serotonergic##2##4##(2008-6#1)(2012-3#1)
noradrenergic and##3##2##(1996-12#1)(2008-6#1)(2012-3#1)
noradrenergic cell bodies##2##3##(1996-5#2)
noradrenergic cell##3##2##(1996-5#3)
noradrenergic function##3##2##(2008-6#3)
noradrenergic innervation##2##2##(1993-12#1)(2008-7#1)
noradrenergic locus##2##2##(1995-12#1)(1996-12#1)
noradrenergic neurotransmission##2##2##(1991-12#1)(1995-12#1)
noradrenergic system##2##2##(1995-5#1)(2008-7#1)
noradrenergic##30##1##(1991-12#1)(1993-12#1)(1993-3#2)(1995-12#5)(1995-5#1)(1996-12#2)(1996-5#3)(1996-7#2)(1997-2#1)(2008-6#4)(2008-7#6)(2012-12#1)(2012-3#1)
norbornadienes##3##1##(2009-9#3)
norcantharidin##3##1##(2011-3#3)
nordihydroguaiaretic acid##2##2##(1992-5#1)(1995-5#1)
norepinephrine (NE) and##2##3##(1996-12#1)(2008-7#1)
norepinephrine (NE)##9##2##(1993-3#1)(1996-12#1)(1996-7#1)(2008-10#3)(2008-3#2)(2008-7#1)
norepinephrine and##8##2##(1990-8#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-5#1)(1997-1#1)(2008-3#2)
norepinephrine in##2##2##(1990-5#1)(2008-11#1)
norepinephrine reduced##2##2##(2008-4#2)
norepinephrine release##4##2##(1990-5#1)(1992-3#1)(1993-8#2)
norepinephrine turnover in the spleen##2##5##(1990-12#2)
norepinephrine turnover in##3##3##(1990-12#3)
norepinephrine turnover##4##2##(1990-12#4)
norepinephrine##59##1##(1990-12#5)(1990-5#3)(1990-8#1)(1991-5#1)(1992-3#1)(1992-8#3)(1993-1#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
norfloxacin (NOR)##3##2##(2008-10#3)
norfloxacin (P = 0##2##4##(1993-2#2)
norfloxacin (P##3##2##(1993-2#3)
norfloxacin and ciprofloxacin##3##3##(2008-10#3)
norfloxacin and ornidazole##3##3##(2010-5#3)
norfloxacin and##6##2##(2008-10#3)(2010-5#3)
norfloxacin##24##1##(1993-2#5)(2007-7#1)(2008-10#11)(2010-5#3)(2012-2#3)(2012-3#1)
norfloxacin) and##2##2##(2010-5#2)
norfluoxetine##6##1##(2008-10#5)(2010-8#1)
norm and##4##2##(1993-12#2)(2008-10#1)(2008-11#1)
norm##22##1##(1992-12#2)(1993-12#3)(1994-7#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-10#3)(2011-1#1)(2012-2#1)
normal AER##2##2##(2012-1#2)
normal B cells##4##3##(1992-12#3)(1995-2#1)
normal B##7##2##(1992-12#5)(1995-2#1)(2007-10#1)
normal BMI##2##2##(2008-10#1)(2008-9#1)
normal CT##2##2##(1996-9#1)(2008-9#1)
normal Ca2+ medium##3##3##(1993-11#2)(1993-12#1)
normal FIA and reversed FIA##3##5##(2008-10#3)
normal T cells##2##3##(1994-8#1)(2008-4#1)
normal VLDL##2##2##(1993-8#2)
normal a##2##2##(1997-8#1)(2010-10#1)
normal activities##3##2##(1996-3#1)(2008-10#1)(2008-7#1)
normal activity##3##2##(1994-3#1)(2011-2#1)(2013-1#1)
normal adjacent tissues##2##3##(1992-8#1)(1992-9#1)
normal adult human##2##3##(1991-7#1)(2008-7#1)
normal adult##8##2##(1990-5#1)(1990-8#1)(1991-7#1)(1994-2#1)(1996-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
normal aerobic##2##2##(1991-9#1)(2007-7#1)
normal ageing and##2##3##(2009-10#2)
normal ageing##6##2##(2009-10#4)(2009-12#2)
normal aging and##2##3##(1994-6#1)(2008-7#1)
normal aging##14##2##(1991-12#2)(1994-6#2)(1994-8#1)(1996-2#1)(2008-5#1)(2008-7#4)(2010-11#1)(2011-2#1)(2012-3#1)
normal alpha##2##2##(1990-8#1)(2013-7#1)
normal anatomy and##3##3##(1996-9#1)(2008-1#1)(2012-2#1)
normal anatomy##4##2##(1996-9#1)(2008-1#1)(2009-8#1)(2012-2#1)
normal and Graves'##2##3##(1995-12#2)
normal and a##2##3##(1994-8#1)(2008-10#1)
normal and abnormal##14##3##(1990-10#1)(2008-1#1)(2008-4#3)(2008-7#2)(2008-9#1)(2010-8#5)(2012-2#1)
normal and alloxan-induced diabetic rats##4##5##(2011-1#1)(2012-2#3)
normal and cancer groups##2##4##(2008-10#2)
normal and cancer##6##3##(2008-10#5)(2008-11#1)
normal and cancerous##2##3##(1993-3#1)(2008-11#1)
normal and diabetic hepatocytes##2##4##(1994-8#2)
normal and diabetic##5##3##(1994-8#2)(2007-11#1)(2011-1#1)(2013-8#1)
normal and disease##2##3##(1993-12#1)(2011-2#1)
normal and diseased states##3##4##(2008-2#1)(2008-4#1)(2013-1#1)
normal and diseased##4##3##(2007-7#1)(2008-2#1)(2008-4#1)(2013-1#1)
normal and injured##2##3##(2008-4#1)(2013-8#1)
normal and malignant human bladder##2##5##(1994-2#2)
normal and malignant##4##3##(1994-2#2)(1994-3#1)(1994-5#1)
normal and neoplastic bladder tissues##2##5##(1994-2#2)
normal and neoplastic##9##3##(1990-7#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-2#2)(1995-12#1)(2011-2#1)
normal and pathologic conditions##2##4##(1990-12#1)(2007-11#1)
normal and pathological behaviors##3##4##(2009-5#3)
normal and pathological tissues##2##4##(2010-8#1)(2012-3#1)
normal and pathological##9##3##(1990-9#1)(1991-5#1)(2009-5#3)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
normal and pre-malignant##2##3##(1994-2#2)
normal and shear##3##3##(2009-11#1)(2009-7#2)
normal and supernumerary eyes##2##4##(2008-5#2)
normal and transformed epithelium##2##4##(2010-12#2)
normal and transformed##6##3##(1992-3#2)(1993-11#1)(1994-5#1)(2010-12#2)
normal and transgenic mice##2##4##(1995-6#1)(2008-9#1)
normal and##165##2##(1990-10#1)(1990-12#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-3#4)(1992-5#1)(1992-8#4)(1993-11#3)(1993-12#2)(1993-3#3)(1993-9#1)(1994-2#6)(1994-3#1)(1994-5#2)(1994-8#4)(1995-11#2)(1995-12#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#4)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
normal animal##2##2##(2008-10#1)(2011-1#1)
normal animals##9##2##(1991-2#2)(1992-10#2)(1993-6#1)(1995-12#1)(1995-2#1)(2008-4#2)
normal ano-genital##3##2##(2010-4#3)
normal aorta##3##2##(1993-3#1)(1994-11#1)(2007-11#1)
normal apo##2##2##(1993-6#2)
normal arterial##2##2##(2008-10#1)(2008-7#1)
normal as well as##2##4##(2008-10#1)(2012-3#1)
normal as##4##2##(1993-11#1)(1997-8#1)(2008-10#1)(2012-3#1)
normal bacterial##2##2##(2008-5#1)(2009-5#1)
normal behavior##2##2##(1995-8#1)(2008-8#1)
normal binding##3##2##(1990-3#1)(1992-12#1)(1993-6#1)
normal biological processes##2##3##(2008-4#1)(2009-5#1)
normal biological##3##2##(2008-4#1)(2009-5#1)(2011-2#1)
normal birth weight##2##3##(2008-12#1)(2011-1#1)
normal birth##4##2##(2007-2#2)(2008-12#1)(2011-1#1)
normal bladder##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
normal blood glucose##3##3##(1990-5#1)(2008-3#2)
normal blood pressure##3##3##(1996-6#1)(2007-7#1)(2008-7#1)
normal blood##9##2##(1990-5#1)(1995-11#1)(1996-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)
normal body mass##2##3##(2008-3#1)(2013-8#1)
normal body weight##2##3##(2008-10#1)(2008-3#1)
normal body##7##2##(2008-10#2)(2008-3#2)(2010-3#1)(2011-2#1)(2013-8#1)
normal boiling points of##3##4##(2007-11#3)
normal boiling points##4##3##(2007-11#4)
normal bone marrow cells##3##4##(1990-5#1)(2008-9#1)(2011-2#1)
normal bone marrow##4##3##(1990-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
normal bone##8##2##(1990-5#1)(2007-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
normal brain##10##2##(1994-6#1)(1995-12#1)(1996-5#2)(1996-6#1)(2008-7#3)(2011-2#1)(2013-1#1)
normal breast epithelial and stromal cells##2##6##(2011-2#2)
normal breast epithelial##3##3##(1990-12#1)(2011-2#2)
normal breast tissue##3##3##(1990-12#1)(1991-12#1)(2008-3#1)
normal breast##9##2##(1990-12#4)(1991-12#1)(1993-11#1)(2008-3#1)(2011-2#2)
normal breathing##2##2##(2008-1#1)(2012-3#1)
normal but##4##2##(2007-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
normal by##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
normal cardiac output##2##3##(2008-7#1)(2012-3#1)
normal cardiac##3##2##(1997-6#1)(2008-7#1)(2012-3#1)
normal cell functions##2##3##(2008-5#1)(2012-3#1)
normal cell growth in##3##4##(1990-11#1)(1994-12#1)(2008-11#1)
normal cell growth##4##3##(1990-11#1)(1991-9#1)(1994-12#1)(2008-11#1)
normal cell##17##2##(1990-11#1)(1991-9#1)(1994-11#1)(1994-12#1)(2007-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-3#2)(2013-1#2)
normal cells##23##2##(1990-11#1)(1991-5#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-5#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
normal cellular##6##2##(1990-4#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
normal children and##2##3##(1995-5#1)(2011-2#1)
normal children##7##2##(1991-12#1)(1995-5#1)(2011-2#3)(2013-1#1)(2013-8#1)
normal cognitive function##2##3##(2009-10#1)(2013-8#1)
normal collagen##2##2##(2008-9#1)(2012-3#1)
normal colonic mucosa##3##3##(2008-3#1)(2010-12#2)
normal colonoscopy##4##2##(2012-3#4)
normal comparison (NC)##2##3##(1996-7#1)(2008-11#1)
normal comparison subjects##3##3##(1995-11#1)(1996-7#2)
normal comparison##6##2##(1995-11#2)(1996-7#3)(2008-11#1)
normal component of##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
normal components of the##2##4##(2008-5#1)(2013-8#1)
normal concentration##2##2##(2007-10#1)(2008-10#1)
normal concentrations of##2##3##(1991-12#1)(1991-2#1)
normal condition##9##2##(1991-12#1)(1991-9#1)(2008-11#1)(2008-12#2)(2008-5#1)(2012-3#3)
normal conditions##10##2##(1994-11#1)(1994-6#1)(2007-11#2)(2008-8#2)(2008-9#2)(2010-10#1)(2010-9#1)
normal contralateral##2##2##(1996-6#1)(2009-4#1)
normal control group##3##3##(2011-3#3)
normal control subjects##4##3##(1995-5#3)(1996-7#1)
normal control##11##2##(1995-5#3)(1996-7#1)(1997-3#1)(2008-1#1)(2011-3#5)
normal controls and patients##2##4##(1993-9#1)(2012-3#1)
normal controls and##5##3##(1993-9#1)(1996-12#1)(1997-8#1)(2010-12#1)(2012-3#1)
normal controls on##2##3##(2008-11#1)(2008-2#1)
normal controls were##4##3##(1991-12#1)(1992-8#1)(1997-5#1)(2008-7#1)
normal controls##35##2##(1991-12#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-12#2)(1995-5#1)(1996-12#3)(1997-5#3)(1997-8#3)(2007-10#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#7)(2008-8#1)(2009-2#1)(2010-12#1)(2012-3#1)(2013-1#1)
normal coordinate##2##2##(2008-10#2)
normal coronary arteries##4##3##(1991-3#1)(2007-8#1)(2008-12#1)(2011-2#1)
normal cortisol##2##2##(2008-8#1)(2011-2#1)
normal creatinine levels##2##3##(1993-2#1)(2012-3#1)
normal creatinine##3##2##(1993-2#1)(2008-1#1)(2012-3#1)
normal delivery##5##2##(1991-3#1)(1992-12#1)(2011-2#2)(2013-1#1)
normal developing##2##2##(1996-5#1)(2008-8#1)
normal development and##2##3##(2009-3#1)(2009-4#1)
normal development of the##3##4##(1991-9#1)(2010-11#1)(2011-1#1)
normal development of##6##3##(1991-9#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#1)
normal development##15##2##(1991-9#1)(1993-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#1)
normal developmental##2##2##(2009-7#1)(2011-2#1)
normal diet##5##2##(1991-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
normal diploid##2##2##(1991-2#1)(1994-12#1)
normal dispersion##5##2##(2007-11#4)(2007-12#1)
normal distribution##9##2##(1993-5#1)(1997-3#1)(1997-4#1)(2008-10#4)(2012-3#2)
normal dog##2##2##(1992-5#1)(2008-7#1)
normal dogs##2##2##(1994-9#1)(2012-3#1)
normal donors##5##2##(1990-12#2)(1995-3#1)(2008-10#1)(2011-1#1)
normal during##2##2##(1990-5#1)(2008-10#1)
normal effects of##2##3##(1995-8#1)(2007-8#1)
normal endometrial##2##2##(1990-5#1)(1995-12#1)
normal environmental##3##2##(1990-8#1)(2008-11#1)(2008-5#1)
normal erythrocytes##2##2##(1991-2#1)(1992-6#1)
normal except for##2##3##(2007-12#1)(2008-7#1)
normal except##3##2##(1995-8#1)(2007-12#1)(2008-7#1)
normal feeding##2##2##(1997-2#1)(2011-1#1)
normal female##2##2##(1992-12#1)(1993-1#1)
normal fetal##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
normal fetus##2##2##(1994-12#1)(1994-5#1)
normal fibroblasts##6##2##(1992-8#3)(1992-9#1)(1994-11#1)(1997-7#1)
normal fimbrial epithelial cells of HGSCs##2##6##(2012-12#2)
normal fimbrial epithelial cells of##4##5##(2012-12#4)
normal fimbrial epithelial cells##5##4##(2012-12#5)
normal flora##3##2##(2007-7#1)(2009-5#1)(2012-2#1)
normal for##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
normal force##2##2##(2008-5#2)
normal function of the##3##4##(1992-6#1)(1997-5#1)(2007-8#1)
normal function of##4##3##(1992-6#1)(1997-5#1)(2007-8#1)(2012-3#1)
normal function##10##2##(1992-6#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-3#1)
normal functional##2##2##(1994-5#1)(2010-11#1)
normal gallbladder##2##2##(2008-5#2)
normal gastric mucosa##3##3##(1990-2#1)(1994-2#1)(2013-8#1)
normal genes##2##2##(1996-12#1)(2007-10#1)
normal glass##3##2##(2008-3#3)
normal glucose##3##2##(1994-12#1)(2011-2#1)(2012-7#1)
normal glycophorin C and the##2##5##(1992-6#2)
normal glycophorin##3##2##(1992-6#2)(1993-12#1)
normal group##6##2##(1990-12#1)(1995-11#2)(1996-7#2)(2008-3#1)
normal groups##5##2##(1993-12#1)(2008-7#3)(2013-1#1)
normal growth and development##2##4##(1990-6#1)(2008-4#1)
normal growth and##7##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2013-8#1)
normal growth of##2##3##(1993-11#1)(2011-1#1)
normal growth##18##2##(1990-6#1)(1991-9#1)(1993-11#1)(1994-8#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
normal guinea pig##2##3##(1992-8#1)(1992-9#1)
normal healthy subjects##3##3##(2007-2#1)(2011-1#1)(2012-3#1)
normal healthy##8##2##(1992-8#1)(1995-3#1)(2007-2#1)(2008-5#2)(2011-1#1)(2012-3#2)
normal hearing##6##2##(2008-9#5)(2010-10#1)
normal heart and##2##3##(2008-12#1)(2010-10#1)
normal heart##9##2##(2008-12#3)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#1)
normal hearts##2##2##(1992-4#1)(2013-7#1)
normal height and##2##3##(1996-2#1)(1997-8#1)
normal hepatocytes##6##2##(1992-6#1)(1994-8#2)(2008-4#3)
normal hormonal##2##2##(1990-2#1)(1991-2#1)
normal human epidermal keratinocytes##5##4##(1992-2#2)(2008-4#2)(2008-5#1)
normal human fibroblasts##6##3##(1997-7#1)(2008-5#3)(2009-8#2)
normal human keratinocytes (NHK)##2##4##(1994-3#1)(1994-6#1)
normal human keratinocytes##8##3##(1994-3#1)(1994-6#1)(2008-4#1)(2008-5#4)(2008-7#1)
normal human lung##2##3##(2008-11#1)(2008-8#1)
normal human plasma##2##3##(1992-3#2)
normal human serum (NHS)##2##4##(1994-8#1)(2008-10#1)
normal human serum##6##3##(1990-9#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-8#1)(2008-10#1)
normal human skin##12##3##(1990-2#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#5)(2009-8#1)(2010-10#1)
normal human subjects##3##3##(1992-11#1)(1995-9#1)(1996-5#1)
normal human##75##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#6)(2008-5#15)(2008-7#1)(2008-8#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
normal imaging appearances and##2##4##(2011-2#1)(2012-2#1)
normal immune response in##2##4##(2008-10#1)(2008-11#1)
normal immune##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
normal in the##3##3##(2006-6#1)(2007-8#1)(2008-9#1)
normal in two cases##2##4##(2008-3#1)(2008-7#1)
normal in##31##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1996-2#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
normal incidence##19##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#10)(2008-7#1)
normal individuals and##2##3##(1991-9#1)(2011-2#1)
normal individuals##14##2##(1991-5#1)(1991-9#1)(1992-3#2)(1992-9#1)(1994-12#1)(1995-5#1)(2008-1#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#3)
normal insulin##3##2##(1994-12#1)(1995-6#1)(2008-4#1)
normal intelligence##5##2##(1997-3#5)
normal karyotype in##2##3##(1993-9#1)(2008-11#1)
normal karyotype##6##2##(1992-10#2)(1993-9#1)(2007-11#1)(2007-4#1)(2008-11#1)
normal kidney and##2##3##(2008-1#1)(2011-2#1)
normal kidney##4##2##(2008-1#1)(2011-2#3)
normal left ventricular function##3##4##(2010-5#1)(2012-2#1)(2013-1#1)
normal left ventricular##5##3##(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal left##6##2##(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal level##7##2##(1991-5#1)(1991-9#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-3#1)(2013-8#1)
normal levels of glucose##2##4##(1990-5#1)(2011-2#1)
normal levels of serum##2##4##(2008-1#1)(2012-3#1)
normal levels of##11##3##(1990-5#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
normal levels##18##2##(1990-5#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#2)
normal life##6##2##(1992-2#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-3#1)
normal limb##2##2##(2008-7#1)(2010-3#1)
normal limits##6##2##(1990-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-7#1)
normal lipid metabolism##2##3##(1992-3#1)(2012-2#1)
normal lipid##3##2##(1992-3#1)(2008-1#1)(2012-2#1)
normal liver##11##2##(1990-2#2)(1990-5#3)(1990-7#1)(2006-6#1)(2010-3#1)(2012-12#3)
normal liver)##2##2##(1997-8#1)(2007-12#1)
normal living##2##2##(1992-3#1)(2012-1#1)
normal lung tissues##2##3##(1993-8#1)(2008-4#1)
normal lung##4##2##(1993-8#1)(1996-2#2)(2008-4#1)
normal lymphocytes##2##2##(1991-4#1)(2007-2#1)
normal male##4##2##(1992-3#1)(1997-3#1)(2008-11#1)(2012-2#1)
normal mammalian##3##2##(1990-5#1)(1994-11#1)(2008-11#1)
normal mammary epithelial cells##2##4##(1993-11#2)
normal maturation##2##2##(1994-8#1)(1995-11#1)
normal mature##2##2##(1990-7#1)(2008-5#1)
normal melanocytes##2##2##(2008-10#1)(2009-3#1)
normal men##2##2##(1995-5#1)(2008-7#1)
normal mice and##2##3##(1992-3#1)(1997-3#1)
normal mice of##2##3##(1993-8#1)(1997-3#1)
normal mice##13##2##(1990-11#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#3)(1997-3#3)(2008-11#1)(2011-2#1)
normal mode##6##2##(1995-3#1)(2007-12#1)(2008-10#4)
normal modes##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
normal morphology##2##2##(2008-12#1)(2011-1#1)
normal mouse##6##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#1)(1995-2#1)(2008-7#1)
normal mucosa##4##2##(1991-11#2)(1997-5#1)(2008-7#1)
normal muscle##3##2##(1992-12#1)(2006-10#1)(2012-2#1)
normal neurons##2##2##(1995-5#1)(1996-5#1)
normal numbers of##2##3##(1994-3#2)
normal on the##2##3##(1990-12#1)(2013-1#1)
normal on##4##2##(1990-12#1)(1997-8#1)(2006-10#1)(2013-1#1)
normal one##4##2##(1991-2#1)(2009-4#2)(2011-1#1)
normal operating##2##2##(2008-7#1)(2008-9#1)
normal operation of##2##3##(2008-2#1)(2008-9#1)
normal or high##4##3##(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
normal or##23##2##(1990-2#1)(1991-11#1)(1992-5#1)(1993-12#1)(1993-2#1)(1996-2#1)(1996-6#1)(2008-1#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
normal oral##3##2##(2007-6#1)(2011-2#1)(2013-1#1)
normal organ##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
normal organs##2##2##(2008-6#2)
normal patients##2##2##(1993-11#1)(2010-10#1)
normal pattern of##2##3##(1993-12#1)(2013-8#1)
normal persons##4##2##(1992-6#1)(2008-3#1)(2008-9#2)
normal phase##5##2##(2008-10#5)
normal phenotype##3##2##(2008-11#2)(2012-3#1)
normal physiological conditions##2##3##(2008-7#1)(2011-2#1)
normal physiological flow conditions##2##4##(2007-7#1)(2008-9#1)
normal physiological##9##2##(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
normal physiology##2##2##(2006-10#1)(2008-2#1)
normal pituitary##2##2##(1990-12#1)(2011-2#1)
normal plasma##9##2##(1992-9#2)(1993-11#1)(1994-2#2)(1995-2#1)(2010-12#3)
normal platelets on##2##3##(2006-6#2)
normal platelets##5##2##(1990-5#1)(2006-6#4)
normal population is##2##3##(1990-6#1)(2008-12#1)
normal population##13##2##(1990-6#1)(1993-1#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)
normal position##2##2##(1996-5#1)(1997-7#1)
normal post-operative##4##2##(2008-2#1)(2012-2#3)
normal pregnancy##7##2##(1990-9#1)(1993-2#1)(1994-5#1)(1994-9#1)(1996-11#1)(2011-2#1)(2013-1#1)
normal pregnant women##2##3##(2008-10#1)(2012-2#1)
normal pregnenolone production&quot##3##3##(2012-2#3)
normal pregnenolone##4##2##(2012-2#4)
normal process of##4##3##(2008-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
normal process##5##2##(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
normal protein##2##2##(1990-5#1)(2008-5#1)
normal random##2##2##(1992-9#1)(2010-8#1)
normal range for##2##3##(2006-6#1)(2010-3#1)
normal range of##2##3##(1997-6#1)(2009-7#1)
normal range were##2##3##(2012-2#2)
normal range##34##2##(1991-5#1)(1992-9#2)(1997-5#1)(1997-6#2)(2006-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-7#1)(2010-3#2)(2011-2#3)(2012-2#2)(2013-1#2)
normal ranges of##2##3##(2010-1#1)(2010-4#1)
normal ranges##6##2##(1997-5#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-4#1)
normal rat kidney (NRK)##2##4##(1991-12#1)(1992-9#1)
normal rat kidney##4##3##(1991-12#2)(1991-2#1)(1992-9#1)
normal rat liver and##2##4##(1990-7#2)
normal rat liver##5##3##(1990-7#2)(1992-6#1)(1996-5#1)(2008-8#1)
normal rat pituitary cells##3##4##(1992-6#3)
normal rat trachea##2##3##(2008-9#2)
normal rat##21##2##(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-6#4)(1992-9#1)(1996-2#2)(1996-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2013-7#1)
normal rats and##2##3##(2012-2#1)(2013-1#1)
normal rats##7##2##(1990-7#1)(1994-2#1)(1994-8#1)(1997-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
normal reference##2##2##(1991-5#1)(2008-7#1)
normal renal function##5##3##(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
normal renal##7##2##(1993-9#1)(2007-7#1)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
normal respiratory##2##2##(2008-4#1)(2010-5#1)
normal response to##3##3##(1990-8#1)(1992-6#1)(2008-12#1)
normal resting##2##2##(1990-11#1)(1995-12#1)
normal saline and##2##3##(2007-7#1)(2008-10#1)
normal saline with##2##3##(2010-7#2)
normal saline##12##2##(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#2)(2010-7#3)(2011-2#1)(2012-3#2)
normal sample##2##2##(2008-11#1)(2008-4#1)
normal scans##2##2##(1995-5#1)(2007-11#1)
normal serum creatinine##3##3##(2008-8#2)(2009-5#1)
normal serum prolactin##2##3##(2011-1#2)
normal serum##12##2##(1990-2#1)(1990-6#1)(1990-8#1)(1993-6#1)(2008-10#1)(2008-8#2)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
normal sexual##2##2##(1996-12#1)(2008-1#1)
normal shoulder##2##2##(1992-9#1)(2012-2#1)
normal skin and##4##3##(1990-3#2)(1992-9#1)(2008-5#1)
normal skin##26##2##(1990-3#2)(1992-8#2)(1992-9#1)(2008-5#14)(2008-6#1)(2008-9#2)(2012-3#4)
normal sleepers##2##2##(2012-12#2)
normal stem cells##2##3##(2009-3#2)
normal stem##3##2##(2008-7#1)(2009-3#2)
normal stress##2##2##(2009-11#1)(2009-7#1)
normal structure##2##2##(2008-10#1)(2008-9#1)
normal subjects and##8##3##(1990-5#1)(1990-6#1)(1996-5#1)(2006-6#1)(2008-2#1)(2008-4#2)(2008-7#1)
normal subjects performed##2##3##(2008-7#1)(2009-8#1)
normal subjects was##3##3##(1992-6#1)(1996-5#1)(2008-2#1)
normal subjects##58##2##(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#10)(1996-7#3)(2006-6#1)(2008-1#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#9)(2008-9#1)(2009-2#1)(2009-8#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
normal systolic function##2##3##(2010-5#1)(2012-12#1)
normal testicular##3##2##(2008-10#1)(2009-10#2)
normal thyroid tissue##2##3##(1994-11#1)(2008-12#1)
normal thyroid##7##2##(1991-8#1)(1992-8#1)(1993-3#1)(1994-11#1)(2008-12#1)(2009-4#1)(2013-8#1)
normal tissue samples##2##3##(2009-4#1)(2010-3#1)
normal tissue structures##2##3##(2008-2#1)(2009-10#1)
normal tissue##28##2##(1990-5#1)(1992-3#1)(1994-2#1)(1994-3#2)(1995-8#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
normal tissues##21##2##(1990-12#1)(1990-5#1)(1994-2#3)(1994-5#2)(2007-4#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
normal to the##6##3##(1995-5#1)(2008-2#1)(2008-3#3)(2009-11#1)
normal to##13##2##(1994-11#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2009-11#1)(2013-8#1)
normal total##2##2##(2010-1#1)(2012-12#1)
normal upright##2##2##(1994-8#2)
normal usage##3##2##(2008-10#1)(2008-5#2)
normal vaginal delivery##2##3##(1993-6#1)(2011-2#1)
normal value in##2##3##(1992-9#1)(1993-3#1)
normal value##4##2##(1992-9#1)(1993-3#1)(2009-7#1)(2013-1#1)
normal values for##2##3##(2013-3#2)
normal values##17##2##(1990-2#1)(1993-6#1)(1994-3#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-3#2)
normal variants##6##2##(1996-9#1)(2010-1#4)(2010-4#1)
normal vessels##2##2##(2007-8#1)(2012-1#1)
normal video##2##2##(2008-2#1)(2008-3#1)
normal visual##2##2##(1992-6#1)(2008-7#1)
normal vitamin##2##2##(1991-12#1)(1991-5#1)
normal volunteers were##2##3##(1991-2#1)(1993-9#1)
normal volunteers##11##2##(1991-2#1)(1993-9#1)(1995-11#3)(1996-2#2)(1996-7#2)(2007-10#1)(2008-6#1)
normal vulvar tissues##3##3##(1993-9#3)
normal weight subjects##2##3##(2008-6#2)
normal weight women##5##3##(2007-12#1)(2007-7#3)(2013-1#1)
normal weight##16##2##(1993-2#1)(2007-11#1)(2007-12#4)(2007-7#3)(2008-6#2)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
normal when##3##2##(1990-8#1)(1991-7#1)(2008-6#1)
normal with##2##2##(2010-4#1)(2013-1#1)
normal women (n =##2##4##(1990-11#1)(1995-11#1)
normal women##4##2##(1990-11#1)(1991-5#1)(1995-11#1)(2008-10#1)
normal young##2##2##(2008-8#1)(2009-12#1)
normal##2222##1##(1990-10#1)(1990-11#9)(1990-12#23)(1990-2#14)(1990-3#4)(1990-4#1)(1990-5#21)(1990-6#6)(1990-7#10)(1990-8#13)(1990-9#7)(1991-1#2)(1991-11#11)(1991-12#18)(1991-2#16)(1991-3#8)(1991-4#2)(1991-5#18)(1991-6#8)(1991-7#4)(1991-8#6)(1991-9#12)(1992-1#1)(1992-10#8)(1992-11#10)(1992-12#12)(1992-2#3)(1992-3#22)(1992-4#1)(1992-5#5)(1992-6#15)(1992-7#1)(1992-8#19)(1992-9#17)(1993-1#6)(1993-11#20)(1993-12#22)(1993-2#9)(1993-3#14)(1993-5#3)(1993-6#14)(1993-8#7)(1993-9#10)(1994-11#15)(1994-12#11)(1994-2#17)(1994-3#9)(1994-5#11)(1994-6#13)(1994-7#1)(1994-8#26)(1994-9#5)(1995-11#15)(1995-12#16)(1995-2#20)(1995-3#5)(1995-5#14)(1995-6#8)(1995-8#11)(1995-9#2)(1996-1#1)(1996-11#6)(1996-12#8)(1996-2#14)(1996-3#5)(1996-4#4)(1996-5#26)(1996-6#9)(1996-7#11)(1996-8#1)(1996-9#6)(1997-1#6)(1997-2#8)(1997-3#19)(1997-4#4)(1997-5#7)(1997-6#5)(1997-7#10)(1997-8#26)(2006-10#4)(2006-12#2)(2006-6#9)(2007-10#8)(2007-11#27)(2007-12#26)(2007-2#12)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#19)(2007-8#21)(2008-1#35)(2008-10#122)(2008-11#67)(2008-12#26)(2008-2#29)(2008-3#62)(2008-4#52)(2008-5#86)(2008-6#33)(2008-7#108)(2008-8#32)(2008-9#56)(2009-1#3)(2009-10#14)(2009-11#4)(2009-12#5)(2009-2#5)(2009-3#9)(2009-4#10)(2009-5#14)(2009-7#9)(2009-8#15)(2009-9#5)(2010-1#8)(2010-10#10)(2010-11#13)(2010-12#17)(2010-2#2)(2010-3#12)(2010-4#7)(2010-5#8)(2010-6#4)(2010-7#10)(2010-8#11)(2010-9#5)(2011-1#40)(2011-2#86)(2011-3#7)(2012-1#7)(2012-12#25)(2012-2#53)(2012-3#54)(2012-7#2)(2013-1#64)(2013-3#2)(2013-7#6)(2013-8#27)
normal&quot##14##1##(1990-2#1)(1992-1#1)(1995-9#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#3)
normal)##7##1##(1991-11#1)(1994-9#1)(1996-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
normal-appearing##4##1##(1992-8#1)(1993-11#1)(2008-7#1)(2011-2#1)
normal-dispersion fiber##2##2##(2007-12#2)
normal-dispersion##9##1##(2007-11#2)(2007-12#7)
normal-hearing adults were##2##3##(2008-9#2)
normal-hearing adults##4##2##(2008-9#4)
normal-hearing##6##1##(2008-2#1)(2008-9#5)
normal-incidence efficiency in the##2##4##(2008-2#1)(2008-3#1)
normal-incidence efficiency near##2##3##(2007-11#2)
normal-incidence efficiency##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
normal-incidence reflectance at##2##3##(2008-2#1)(2008-3#1)
normal-incidence reflectance##3##2##(2008-2#2)(2008-3#1)
normal-incidence##22##1##(2007-11#4)(2008-2#9)(2008-3#9)
normal-phase HPLC##2##2##(2008-10#2)
normal-phase LC##2##2##(2008-10#2)
normal-phase##8##1##(1997-2#1)(2008-10#7)
normal-sized##2##1##(2007-12#1)(2011-2#1)
normal-weight##6##1##(1990-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-2#1)
normalcy##2##1##(1993-1#1)(1997-6#1)
normalisation of##4##2##(1995-3#1)(2008-1#1)(2013-1#1)(2013-8#1)
normalise##3##1##(1991-5#1)(1995-3#1)(2012-12#1)
normalised after##2##2##(1992-5#1)(1993-8#1)
normalised peak areas##2##3##(1994-9#1)(2008-10#1)
normalised##8##1##(1992-5#1)(1993-8#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
normalising effect on##2##3##(2011-1#2)
normalising##3##1##(2008-11#1)(2011-1#2)
normality of the##2##3##(2009-10#1)(2009-5#1)
normality of##3##2##(2008-10#1)(2009-10#1)(2009-5#1)
normality##11##1##(1990-9#1)(1996-3#1)(1996-7#1)(1997-7#1)(2008-10#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)
normalization and##3##2##(2008-7#3)
normalization for##4##2##(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
normalization of the##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
normalization of##31##2##(1991-11#1)(1992-2#1)(1994-9#2)(1996-12#1)(1996-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)
normalization to##2##2##(2008-2#1)(2012-12#1)
normalization##56##1##(1991-11#1)(1992-2#1)(1994-9#2)(1995-12#1)(1996-12#1)(1996-9#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#14)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)
normalize the##7##2##(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)
normalize##16##1##(1991-7#1)(1993-1#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-3#3)(2008-7#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
normalized by##5##2##(1993-2#1)(1996-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
normalized concentrations##2##2##(2008-10#2)
normalized conversion efficiency##2##3##(2007-11#1)(2007-12#1)
normalized difference vegetation index##3##4##(2008-8#3)
normalized for##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
normalized height of##3##3##(2008-10#3)
normalized integrated amplitude##2##3##(1990-9#2)
normalized ratio##5##2##(2007-10#3)(2011-1#1)(2013-1#1)
normalized the##4##2##(1996-2#1)(2008-7#1)(2009-4#1)(2011-2#1)
normalized to a##2##3##(1993-12#1)(2008-11#1)
normalized to##7##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
normalized with##2##2##(1994-8#1)(2011-2#1)
normalized##108##1##(1990-6#1)(1990-7#1)(1990-9#3)(1993-12#2)(1993-2#3)(1994-11#1)(1994-8#1)(1996-2#3)(1996-3#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#12)(2008-3#15)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#5)
normalizes##2##1##(1993-12#1)(1997-6#1)
normalizing effect##2##2##(1995-11#1)(2012-1#1)
normalizing the##2##2##(2008-3#1)(2008-7#1)
normalizing##13##1##(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-1#2)
normally a##2##2##(1994-11#1)(2008-10#1)
normally associated with##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
normally at##2##2##(2008-10#1)(2008-11#1)
normally conducting##3##2##(2008-3#3)
normally degraded##2##2##(1992-12#1)(2007-7#1)
normally delivered##2##2##(1990-12#1)(2008-2#1)
normally distributed data##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
normally distributed response variables##2##4##(1995-12#2)
normally distributed##17##2##(1992-11#1)(1992-6#1)(1994-2#1)(1995-12#2)(1995-5#1)(1997-3#1)(2008-10#3)(2008-3#4)(2012-1#1)(2013-1#2)
normally found in the##2##4##(2008-1#1)(2008-10#1)
normally functioning##2##2##(1992-4#1)(2007-12#1)
normally have##4##2##(1993-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
normally hearing##3##2##(2007-7#2)(2008-9#1)
normally heterothallic##2##2##(2008-10#2)
normally illuminated##3##2##(2008-2#2)(2008-3#1)
normally in##5##2##(1992-12#1)(1993-6#1)(1996-6#1)(2008-11#1)(2008-9#1)
normally incident light##2##3##(2008-2#1)(2008-3#1)
normally incident plane##3##3##(2008-3#3)
normally incident upon a##3##4##(2007-11#2)(2008-2#1)
normally incident##10##2##(2007-11#2)(2008-2#3)(2008-3#5)
normally induced##2##2##(1996-5#1)(2012-12#1)
normally involved in the regulation of the##2##7##(1993-6#2)
normally is##3##2##(1992-3#1)(2008-10#1)(2008-2#1)
normally not##4##2##(1993-1#1)(2008-10#1)(2008-8#1)(2009-11#1)
normally observed##2##2##(1994-6#1)(2011-1#1)
normally occurs in##2##3##(1995-6#1)(2008-5#1)
normally occurs##5##2##(1994-11#1)(1995-6#1)(2008-5#1)(2009-10#1)(2009-5#1)
normally only##2##2##(1997-3#2)
normally present in the##2##4##(1992-9#1)(1995-3#1)
normally present in##5##3##(1990-12#1)(1992-9#1)(1995-3#1)(2008-10#2)
normally present##6##2##(1990-12#1)(1991-5#1)(1992-9#1)(1995-3#1)(2008-10#2)
normally produce##2##2##(2008-2#1)(2008-4#1)
normally sustain lactation##2##3##(2008-9#2)
normally the##2##2##(2008-10#1)(2008-4#1)
normally to the##2##3##(2008-3#1)(2008-7#1)
normally to##5##2##(1992-6#1)(1993-6#2)(2008-3#1)(2008-7#1)
normally used in##4##3##(2008-10#2)(2010-1#1)(2013-1#1)
normally used##7##2##(1990-12#1)(1995-2#1)(2008-10#2)(2008-3#1)(2010-1#1)(2013-1#1)
normally##243##1##(1990-11#1)(1990-12#3)(1990-5#2)(1991-12#1)(1991-5#2)(1991-9#3)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#3)(1993-1#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#6)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#5)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#7)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#27)(2008-11#16)(2008-2#9)(2008-3#23)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#8)(2009-10#5)(2009-11#3)(2009-12#3)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
normals and##3##2##(1993-9#1)(1995-12#1)(2008-6#1)
normals##6##1##(1990-9#1)(1993-9#1)(1995-12#1)(2008-6#3)
normative agency##3##2##(2012-2#3)
normative data for##3##3##(1994-12#1)(2011-1#2)
normative data##9##2##(1994-12#1)(1996-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#3)
normative##36##1##(1994-12#1)(1996-1#1)(1996-7#2)(1997-6#2)(2007-12#2)(2008-1#1)(2008-11#3)(2008-12#4)(2008-5#1)(2008-9#2)(2009-10#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#1)
normativity##7##1##(2012-2#7)
normo- and##2##2##(2008-10#1)(2011-2#1)
normoalbuminuric AER##2##2##(2012-1#2)
normoalbuminuric patients##2##2##(1992-9#1)(1997-8#1)
normoalbuminuric##5##1##(1992-9#1)(1997-8#1)(2012-1#3)
normobaric##2##1##(2008-8#1)(2009-11#1)
normocalcemic##2##1##(1990-2#1)(2008-4#1)
normocapnia and##2##2##(1997-6#1)(2008-7#1)
normocapnia##3##1##(1995-11#1)(1997-6#1)(2008-7#1)
normochromic##2##1##(1990-11#1)(2009-10#1)
normocytic##2##1##(1990-11#1)(2009-10#1)
normoglycaemic##2##1##(1992-6#2)
normoglycemia##2##1##(2009-3#2)
normoglycemic##5##1##(1990-7#1)(1992-8#1)(1994-8#1)(2010-11#1)(2010-8#1)
normokinesis##2##1##(1997-3#2)
normolipidemic subjects##2##2##(1993-12#1)(1993-9#1)
normolipidemic##4##1##(1993-12#1)(1993-9#1)(1995-12#1)(1995-6#1)
normotensive and##4##2##(1994-2#1)(2008-8#1)(2010-4#1)(2013-8#1)
normotensive females##3##2##(2010-7#3)
normotensive group of##2##3##(2008-7#2)
normotensive group##3##2##(2008-1#1)(2008-7#2)
normotensive individuals##3##2##(1992-6#1)(2011-2#1)(2012-2#1)
normotensive pregnant##2##2##(1990-3#2)
normotensive rats##3##2##(1997-6#2)(2008-11#1)
normotensive subjects##5##2##(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#2)
normotensive##36##1##(1990-2#1)(1990-3#2)(1990-7#1)(1992-6#1)(1994-2#1)(1997-6#2)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2010-4#3)(2010-7#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#5)
normotensives##4##1##(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)
normothermia##2##1##(1995-11#1)(2013-8#1)
normothermic CA1##2##2##(1996-12#2)
normothermic ischemic brains##2##3##(1995-12#2)
normothermic##17##1##(1990-11#1)(1994-2#2)(1995-12#5)(1996-12#4)(1996-9#3)(2008-7#2)
normovolemic##2##1##(1990-11#1)(1992-3#1)
normoxia##3##1##(1994-5#1)(1996-12#1)(2010-8#1)
normoxic and hypoxic##2##3##(1997-1#1)(2013-1#1)
normoxic hearts##3##2##(1993-6#1)(1994-5#2)
normoxic##15##1##(1992-10#2)(1993-12#1)(1993-6#1)(1994-5#6)(1997-1#1)(2009-11#1)(2010-4#1)(2011-1#1)(2013-1#1)
normozoospermic##2##1##(1997-4#2)
norms against smoking##2##3##(2010-2#2)
norms and##13##2##(1993-3#2)(1996-2#1)(2007-12#1)(2008-1#2)(2008-7#1)(2009-5#1)(2010-2#1)(2010-3#2)(2011-1#1)(2013-1#1)
norms are##3##2##(1990-2#1)(1994-3#2)
norms for##7##2##(2008-10#1)(2008-4#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-3#1)
norms in##4##2##(1995-6#1)(2008-1#1)(2010-10#1)(2010-5#1)
norms of##4##2##(2007-2#1)(2008-12#1)(2008-3#1)(2010-5#1)
norms regarding##3##2##(2009-7#1)(2013-1#2)
norms that##4##2##(2007-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
norms were flat##2##3##(2008-8#2)
norms were##3##2##(2008-8#2)(2013-1#1)
norms##85##1##(1990-2#1)(1991-12#1)(1993-2#1)(1993-3#3)(1994-3#5)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#8)(2009-5#3)(2009-7#2)(2010-10#1)(2010-2#4)(2010-3#2)(2010-5#3)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#11)
norovirus##8##1##(2009-3#1)(2013-8#7)
norscopolamine##2##1##(2008-10#2)
north India##2##2##(2007-7#1)(2012-12#1)
north Indian##4##2##(2008-12#2)(2009-6#1)(2013-1#1)
north america##7##2##(2008-10#6)(2011-2#1)
north and south of##2##4##(2008-10#2)
north and west##2##3##(1991-4#1)(2008-10#1)
north and##7##2##(1991-4#1)(2007-1#1)(2008-10#3)(2008-12#1)(2012-3#1)
north central cancer treatment group##2##5##(2008-12#1)(2008-7#1)
north central division meeting##7##4##(2008-11#7)
north central##12##2##(2008-10#2)(2008-11#7)(2008-12#1)(2008-7#1)(2011-1#1)
north coast of##2##3##(2008-5#1)(2011-2#1)
north in##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
north of Iran##2##3##(2008-10#2)
north of the##2##3##(1995-6#1)(2008-12#1)
north of##12##2##(1990-3#1)(1995-6#1)(2008-10#5)(2008-12#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-2#1)
north##78##1##(1990-3#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-3#1)(1995-6#1)(1996-8#1)(2007-1#1)(2007-7#3)(2008-10#22)(2008-11#9)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
north-central United States##4##3##(2008-10#4)
north-central##11##1##(2008-10#10)(2008-12#1)
north-east##2##1##(1997-5#1)(2008-8#1)
north-south##3##1##(2008-10#3)
north-west##8##1##(1996-11#2)(2010-8#5)(2012-2#1)
north-western Nigeria##3##2##(2010-4#2)(2013-1#1)
north-western##12##1##(2008-8#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#4)(2013-1#1)
northeast Pacific##2##2##(2008-9#1)(2009-2#1)
northeast of##3##2##(2008-10#2)(2008-12#1)
northeast##9##1##(1995-6#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-9#1)(2009-2#1)
northeastern Brazil##2##2##(2013-8#2)
northeastern United States##5##3##(1996-1#1)(2008-10#2)(2011-2#2)
northeastern and potomac divisions meeting##2##5##(2008-11#2)
northeastern and##4##2##(2008-11#2)(2009-7#1)(2011-2#1)
northeastern division meeting##6##3##(2008-11#6)
northeastern states##2##2##(1993-3#1)(1995-2#1)
northeastern##39##1##(1993-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-4#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#5)(2013-1#1)(2013-8#2)
northern California##7##2##(1991-7#1)(1992-2#1)(2008-10#5)
northern Europe and##2##3##(2008-9#1)(2010-3#1)
northern Europe##4##2##(1991-11#1)(2008-9#1)(2010-3#1)(2012-2#1)
northern Great Plains of##2##4##(2008-10#2)
northern Great Plains##3##3##(2008-10#3)
northern Gulf of Mexico##2##4##(2008-3#1)(2008-5#1)
northern India##2##2##(2007-12#1)(2008-11#1)
northern Italy##9##2##(1990-2#1)(1990-8#1)(1993-2#2)(1994-8#1)(2008-8#2)(2011-2#1)(2012-7#1)
northern Japan##3##2##(2008-10#1)(2010-8#2)
northern Natives##2##2##(2012-3#2)
northern Sudanese women##3##3##(2013-1#3)
northern United States##2##3##(2008-10#2)
northern analysis##2##2##(1994-11#1)(2008-9#1)
northern and central##2##3##(2008-10#1)(2008-5#1)
northern and southern##2##3##(2008-10#2)
northern and##6##2##(1990-12#1)(2008-10#3)(2008-4#1)(2008-5#1)
northern blot analysis##2##3##(2008-10#2)
northern blot hybridization##3##3##(2008-10#2)(2008-4#1)
northern blot##9##2##(2008-10#7)(2008-4#1)(2008-7#1)
northern countries##2##2##(2011-2#2)
northern populations##2##2##(2007-1#1)(2008-8#1)
northern regions##2##2##(2008-10#1)(2011-2#1)
northern##150##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-4#2)(1997-6#2)(1997-8#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#47)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#8)(2008-7#2)(2008-8#7)(2008-9#5)(2009-5#1)(2010-3#2)(2010-8#5)(2010-9#4)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#4)(2012-7#2)(2013-1#6)(2013-8#4)
northward##3##1##(2008-10#1)(2008-8#1)(2010-1#1)
northwest United States##2##3##(2008-10#1)(2013-1#1)
northwest of Iran##2##3##(2008-12#2)
northwest of##4##2##(2008-12#2)(2008-9#1)(2012-2#1)
northwest##13##1##(1995-6#1)(1996-8#1)(2007-5#1)(2008-10#4)(2008-12#2)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
northwestern California##3##2##(2010-6#3)
northwestern##15##1##(1992-1#1)(2008-10#3)(2008-3#1)(2008-5#4)(2010-6#3)(2011-1#1)(2012-12#2)
nortriptyline##2##1##(1996-7#1)(2008-10#1)
norvaline amide##2##2##(1991-5#2)
norvaline##5##1##(1991-5#3)(1992-3#1)(1994-9#1)
norvancomycin##2##1##(2008-10#2)
norvancomycin-bonded chiral stationary phase##2##4##(2008-10#2)
norway##2##1##(2008-10#2)
nos promoter##3##2##(1997-2#3)
nos##6##1##(1997-2#3)(2008-11#2)(2009-4#1)
noscapine##8##1##(2008-10#3)(2008-11#5)
nose and mouth##2##3##(2008-5#1)(2010-5#1)
nose and throat specialists##4##4##(1993-2#4)
nose and##10##2##(1993-2#4)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
nose is##2##2##(2008-10#1)(2010-8#1)
nose was##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
nose##65##1##(1990-9#3)(1993-12#1)(1993-2#4)(1995-3#1)(1997-3#1)(1997-8#1)(2007-12#3)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#4)(2010-5#1)(2010-8#7)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
nose]##2##1##(1990-3#1)(2012-2#1)
noses##6##1##(1995-6#1)(2008-7#1)(2010-4#1)(2010-8#3)
nosocomial and##3##2##(2007-12#1)(2010-4#2)
nosocomial infection##5##2##(1996-3#1)(2007-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
nosocomial infections are##2##3##(2010-4#1)(2013-8#1)
nosocomial infections in##3##3##(1990-6#1)(2008-5#1)(2013-8#1)
nosocomial infections##15##2##(1990-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-8#4)
nosocomial transmission##2##2##(1995-6#1)(2007-7#1)
nosocomial##42##1##(1990-6#1)(1992-9#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#3)(2007-7#3)(2008-10#3)(2008-5#1)(2009-6#2)(2010-11#2)(2010-4#5)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#6)
nosological classification##3##2##(1990-3#1)(1990-6#1)(1991-2#1)
nosological##6##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1994-2#1)
nosology of##2##2##(1993-11#1)(2008-7#1)
nosology##4##1##(1993-11#1)(2008-7#2)(2011-1#1)
nostrils##2##1##(1997-3#1)(2012-12#1)
not &quot##5##2##(1995-3#1)(1997-3#1)(2008-11#1)(2008-8#1)(2013-8#1)
not 1##3##2##(1996-9#1)(1997-7#1)(2008-10#1)
not M##2##2##(2008-10#1)(2010-2#1)
not a common##2##3##(2008-7#1)(2013-1#1)
not a consequence of##3##4##(1991-5#1)(2008-10#2)
not a constraint##2##3##(2008-10#1)(2008-9#1)
not a direct##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
not a general##3##3##(1995-2#1)(2007-12#1)(2008-8#1)
not a good##6##3##(1992-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
not a major##6##3##(1994-1#2)(1994-8#1)(2008-10#1)(2008-3#1)(2010-11#1)
not a new##3##3##(1994-2#1)(2008-11#1)(2008-4#1)
not a panacea##5##3##(1993-7#1)(1994-2#1)(1997-3#1)(2008-7#1)(2010-1#1)
not a prerequisite for##3##4##(1991-8#1)(1995-11#1)(1996-5#1)
not a prerequisite##4##3##(1991-8#1)(1991-9#1)(1995-11#1)(1996-5#1)
not a problem##2##3##(1997-1#1)(2008-10#1)
not a significant##4##3##(1996-1#1)(2008-5#1)(2011-2#2)
not a single##4##3##(2008-11#1)(2009-10#1)(2010-3#1)(2013-1#1)
not a source of##2##4##(1996-3#1)(2007-5#1)
not a strong##2##3##(1995-6#1)(2008-10#1)
not a substitute for##3##4##(1991-1#1)(2007-10#1)(2008-5#1)
not a typical##2##3##(1995-6#1)(2008-7#1)
not a##189##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-7#1)(1994-8#2)(1995-11#3)(1995-2#2)(1995-6#5)(1996-1#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#16)(2008-11#15)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#7)(2008-7#9)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#1)
not able to be##4##4##(1992-1#1)(2010-10#1)(2011-1#1)(2012-3#1)
not able to##29##3##(1992-1#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#3)
not abolish##3##2##(1994-3#1)(1996-5#1)(1997-4#1)
not abolished##2##2##(1994-3#1)(1996-5#1)
not absolutely##4##2##(1990-8#1)(1993-1#1)(1997-3#1)(2008-4#1)
not absorbed by the##2##4##(2008-3#2)
not absorbed##3##2##(2008-3#3)
not abstract##2##2##(2009-4#1)(2009-6#1)
not abundant##3##2##(2008-12#1)(2008-6#1)(2009-7#1)
not accelerate the##2##3##(2008-10#1)(2008-4#1)
not accept##3##2##(1990-6#1)(2008-12#1)(2008-5#1)
not acclimated to##2##3##(2008-7#1)(2008-8#1)
not accompanied by any##2##4##(1995-2#1)(2008-10#1)
not accompanied by##6##3##(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
not accompanied##7##2##(1991-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
not account for the##6##4##(1994-3#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
not account for##11##3##(1994-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
not accounted for in##2##4##(2010-11#1)(2010-6#1)
not accounted for##6##3##(1993-12#1)(2008-12#2)(2008-2#1)(2010-11#1)(2010-6#1)
not accumulate in##2##3##(1994-5#1)(2008-10#1)
not accumulate##4##2##(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)
not accurately##3##2##(1997-4#1)(2008-8#1)(2010-5#1)
not achieve##8##2##(1994-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#3)
not achieved##10##2##(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)
not act by##2##3##(1990-7#1)(1993-8#1)
not act##10##2##(1990-7#2)(1993-8#2)(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-10#1)
not activate##5##2##(1993-3#1)(1993-8#1)(1997-6#1)(2008-10#1)(2008-9#1)
not activated by##5##3##(1990-8#1)(1995-5#2)(1997-2#1)(2008-4#1)
not active##4##2##(1995-6#1)(2008-11#1)(2011-3#2)
not actually##4##2##(1991-11#1)(1994-8#1)(2008-11#1)(2012-12#1)
not addicted to drugs##2##4##(2011-1#2)
not addicted to##3##3##(2011-1#2)(2013-1#1)
not additive##2##2##(1992-6#1)(1995-11#1)
not address the##2##3##(2009-5#1)(2011-2#1)
not address##4##2##(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)
not addressed by##2##3##(1993-1#1)(2011-2#1)
not addressed##3##2##(1993-1#1)(2008-10#1)(2011-2#1)
not addressing##2##2##(1995-3#1)(1996-2#1)
not adequate to##2##3##(2008-10#1)(2008-3#1)
not adequate##7##2##(1993-3#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-3#2)
not adequately##18##2##(1990-11#1)(1993-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
not adhere to##3##3##(1992-3#1)(1996-3#1)(2012-3#1)
not adopt##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
not adversely##3##2##(1991-1#1)(1992-2#1)(2010-11#1)
not advised##2##2##(2008-10#1)(2012-2#1)
not advocated##2##2##(1991-12#1)(2008-4#1)
not affect body##2##3##(1994-12#1)(2008-5#1)
not affect cell growth##2##4##(1995-6#1)(2008-11#1)
not affect cell##3##3##(1994-11#1)(1995-6#1)(2008-11#1)
not affect growth rate##2##4##(1996-3#1)(2007-11#1)
not affect the activity of##3##5##(1990-2#1)(1992-3#1)(2011-1#1)
not affect the determination##2##4##(2008-10#2)
not affect the fluorescence properties##2##5##(1994-5#1)(1997-2#1)
not affect the overall##2##4##(1991-2#1)(2011-2#1)
not affect the primary##2##4##(1996-12#1)(2012-2#1)
not affect the##116##3##(1990-2#1)(1990-5#2)(1991-12#3)(1991-2#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#3)(1993-11#4)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
not affect this##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
not affect##231##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#5)(1990-8#3)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1993-11#5)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#6)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#44)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)
not affected by an##2##4##(2008-3#1)(2009-6#1)
not affected by the age##2##5##(2008-4#1)(2008-5#1)
not affected by the##29##4##(1990-11#1)(1992-8#2)(1994-11#1)(1994-9#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)
not affected by##90##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-2#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#19)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
not affected in##4##3##(2008-10#2)(2012-12#1)(2012-2#1)
not affected significantly by##3##4##(1997-7#2)(2008-12#1)
not affected##139##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-12#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#5)(1997-8#1)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
not affecting##4##2##(1990-7#1)(1993-9#1)(2007-8#1)(2008-10#1)
not after##7##2##(1993-12#2)(1994-2#1)(1995-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
not age##3##2##(1990-11#1)(2008-9#1)(2011-2#1)
not agree##3##2##(2008-8#1)(2011-10#1)(2013-1#1)
not all of the##5##4##(1994-5#1)(2007-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
not all of##6##3##(1994-5#1)(2007-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
not all the##4##3##(1995-2#1)(1995-9#1)(2008-7#1)(2013-8#1)
not all##70##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-9#1)(1997-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
not allow for##5##3##(1995-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
not allow the##3##3##(1997-6#1)(2008-10#2)
not allow us to##5##4##(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
not allow##27##2##(1990-9#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#2)
not allowed to##2##3##(1995-1#1)(2008-10#1)
not already##2##2##(1993-1#1)(2008-3#1)
not alter either##2##3##(1992-3#1)(1993-12#1)
not alter the##36##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1994-2#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#2)(2012-2#1)
not alter##62##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-6#2)(2007-10#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
not altered by preincubation##2##4##(1994-6#1)(1995-11#1)
not altered by the##2##4##(1997-7#1)(2008-11#1)
not altered by##13##3##(1990-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
not altered in the##2##4##(1997-2#1)(2008-12#1)
not altered in##4##3##(1994-12#1)(1997-2#1)(2008-12#1)(2011-2#1)
not altered##25##2##(1990-5#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#2)(2010-3#2)(2011-2#2)
not always be##3##3##(1996-12#1)(1997-3#1)(2009-1#1)
not always been##4##3##(1993-12#1)(1994-12#1)(2007-10#1)(2008-1#1)
not always correlate##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
not always easy##6##3##(1991-3#1)(1997-3#1)(2008-11#2)(2008-9#1)(2010-9#1)
not always effective##2##3##(2007-8#1)(2008-3#1)
not always give the##2##4##(2008-2#1)(2008-9#1)
not always lead to##2##4##(1990-11#1)(1991-2#1)
not always necessary##2##3##(2007-2#1)(2008-6#1)
not always present##2##3##(1992-3#1)(2008-10#1)
not always successful##2##3##(1993-9#1)(2008-10#1)
not always yield##2##3##(2008-10#2)
not always##101##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#2)(1995-2#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
not amenable to##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
not among##5##2##(1994-3#1)(2007-11#1)(2008-11#2)(2012-2#1)
not amplified##3##2##(2008-10#3)
not amplify##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2009-6#1)
not an important##3##3##(1992-2#1)(2008-10#1)(2011-3#1)
not an##42##2##(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
not and##5##2##(2007-7#1)(2007-9#1)(2008-8#1)(2009-3#1)(2011-2#1)
not answer##2##2##(1991-12#1)(1993-12#1)
not any##6##2##(1995-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
not apparent from##2##3##(1994-8#1)(1996-2#1)
not apparent in##4##3##(1994-3#1)(1997-3#1)(2007-12#1)(2008-9#1)
not apparent until##2##3##(1995-11#1)(2008-7#1)
not apparent##14##2##(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
not appear in##2##3##(1997-8#1)(2010-10#1)
not appear to affect##3##4##(1994-3#1)(2008-7#1)(2008-9#1)
not appear to be a##5##5##(1993-12#1)(1995-1#1)(2008-10#1)(2008-3#2)
not appear to be an##2##5##(2008-7#2)
not appear to be associated with##2##6##(1994-2#1)(2008-7#1)
not appear to be involved in the##2##7##(1992-3#1)(2008-10#1)
not appear to be involved in##3##6##(1992-3#1)(2008-10#2)
not appear to be involved##4##5##(1992-3#1)(2008-10#3)
not appear to be##36##4##(1991-2#1)(1991-4#2)(1991-6#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2013-1#3)
not appear to have##3##4##(1994-2#1)(2006-8#1)(2008-12#1)
not appear to influence##5##4##(1996-2#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#1)
not appear to limit##2##4##(2007-12#1)(2012-2#1)
not appear to result in##2##5##(1997-1#1)(2012-3#1)
not appear to##81##3##(1990-7#2)(1991-2#1)(1991-4#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-4#2)(1997-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
not appear##89##2##(1990-7#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-4#2)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
not applicable for##2##3##(1995-3#1)(2008-10#1)
not applicable to##5##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
not applicable##10##2##(1991-11#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-12#1)
not applied in##2##3##(2008-10#1)(2010-3#1)
not applied##4##2##(2008-10#2)(2010-3#1)(2010-5#1)
not apply to the##3##4##(1995-2#1)(2008-2#1)(2008-4#1)
not apply to##10##3##(1995-12#2)(1995-2#2)(1996-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
not apply##14##2##(1994-12#1)(1995-12#2)(1995-2#2)(1996-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-12#1)(2013-1#1)
not appreciably##3##2##(1992-6#1)(1993-9#1)(2010-10#1)
not approach##2##2##(2008-11#1)(2012-3#1)
not appropriate for##6##3##(1996-7#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#2)
not appropriate##10##2##(1995-5#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#2)
not approved for##2##3##(1993-12#1)(2008-7#1)
not arise##2##2##(1996-5#1)(2008-10#1)
not as a##10##3##(1992-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#1)
not as clear as##2##4##(2008-5#1)(2010-6#1)
not as clear##3##3##(2008-10#1)(2008-5#1)(2010-6#1)
not as common as##3##4##(2008-1#2)(2008-7#1)
not as common##4##3##(2008-1#2)(2008-4#1)(2008-7#1)
not as effective as##6##4##(1992-5#1)(2007-11#1)(2008-10#3)(2013-1#1)
not as effective##7##3##(1992-5#1)(2007-11#1)(2008-10#3)(2013-1#2)
not as good as##3##4##(1995-4#1)(1996-11#1)(2009-6#1)
not as good##4##3##(1995-4#1)(1996-11#1)(2009-6#1)(2010-7#1)
not as high as##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
not as significant##2##3##(2008-10#1)(2010-7#1)
not as the##2##3##(2008-3#1)(2008-5#1)
not as##65##2##(1990-12#1)(1990-6#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
not assessed for##2##3##(1996-3#1)(2008-12#1)
not assessed##5##2##(1996-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2012-5#1)
not assigned##3##2##(1997-5#1)(1997-6#1)(2011-2#1)
not associate with the##2##4##(1994-8#1)(1996-5#1)
not associated with a##4##4##(1992-8#1)(2008-12#1)(2008-4#1)(2012-2#1)
not associated with any##5##4##(2008-10#2)(2008-12#1)(2008-9#1)(2012-3#1)
not associated with high##2##4##(1995-11#1)(2008-10#1)
not associated with increased##2##4##(1995-12#1)(2007-10#1)
not associated with significant##2##4##(2008-7#1)(2011-1#1)
not associated with the##8##4##(1992-8#1)(1996-12#1)(2007-8#1)(2008-10#2)(2009-8#1)(2012-3#1)(2013-1#1)
not associated with##79##3##(1990-3#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-9#2)(1995-11#2)(1995-12#1)(1995-5#1)(1996-12#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
not associated##80##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-9#2)(1995-11#2)(1995-12#1)(1995-5#1)(1996-12#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
not at all in##3##4##(1990-11#1)(1996-7#1)(1997-8#1)
not at all##12##3##(1990-11#2)(1992-10#1)(1994-8#1)(1996-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#2)
not at##45##2##(1990-11#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-7#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)
not attached to##3##3##(2008-10#1)(2013-1#2)
not attain##3##2##(1995-6#1)(2007-7#1)(2008-7#1)
not attempted##2##2##(2007-10#1)(2008-11#1)
not attended##2##2##(1991-6#2)
not attending a cancer centre##2##5##(2008-6#2)
not attenuate the##3##3##(1990-2#1)(2008-4#1)(2013-1#1)
not attributable to##5##3##(1993-12#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
not attributed to##2##3##(1995-6#1)(2009-10#1)
not automatically##2##2##(1993-12#1)(2010-2#1)
not available for##7##3##(1993-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-12#1)
not available in most##2##4##(2008-9#1)(2010-3#1)
not available in##9##3##(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#2)
not available to##2##3##(2007-7#1)(2008-7#1)
not available##57##2##(1990-6#1)(1993-1#1)(1993-2#2)(1993-3#1)(1997-3#1)(2007-2#3)(2007-5#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2010-11#1)(2010-3#3)(2010-5#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#4)
not avoid##2##2##(1995-12#1)(2008-10#1)
not aware of##7##3##(1990-6#1)(1991-3#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
not based on scientific##2##4##(1994-2#1)(2008-7#1)
not based on##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
not based##7##2##(1994-2#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
not be &quot##2##3##(1995-1#1)(1995-3#1)
not be able to##9##4##(1991-3#1)(1994-2#2)(1996-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-8#1)
not be advised##2##3##(2012-2#1)(2013-1#1)
not be affected##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
not be applied##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
not be appropriate for##3##4##(2007-11#1)(2008-10#1)(2008-8#1)
not be appropriate##4##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-8#1)
not be associated with the##2##5##(2006-6#1)(2011-1#1)
not be associated with##7##4##(1992-12#1)(1997-5#1)(2006-6#1)(2008-8#1)(2011-1#1)(2013-1#2)
not be assumed##2##3##(1991-1#1)(1995-12#1)
not be attributed to##3##4##(1993-6#1)(1994-5#1)(2008-7#1)
not be available##4##3##(1997-8#1)(2008-10#2)(2008-12#1)
not be avoided##2##3##(1993-11#1)(1995-2#1)
not be calculated##2##3##(2008-10#1)(2008-2#1)
not be considered as##2##4##(2008-8#1)(2013-1#1)
not be considered##12##3##(1991-2#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
not be cultured##2##3##(1990-6#1)(2008-7#1)
not be detected by##5##4##(1991-3#1)(1996-12#1)(1996-5#1)(2008-10#1)(2010-12#1)
not be detected##17##3##(1991-3#1)(1991-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-8#1)
not be dismissed as##2##4##(2008-1#1)(2008-5#1)
not be dismissed##3##3##(2008-1#1)(2008-12#1)(2008-5#1)
not be done##2##3##(2011-1#2)
not be effective##3##3##(2008-12#1)(2011-3#1)(2012-2#1)
not be eliminated##3##3##(1997-4#1)(2008-10#1)(2012-1#1)
not be excluded##4##3##(1997-5#1)(2007-4#1)(2008-7#1)(2009-12#1)
not be expected to##2##4##(1993-1#1)(2008-10#1)
not be extrapolated to##2##4##(2008-3#1)(2008-5#1)
not be followed##2##3##(2007-10#1)(2008-3#1)
not be fully##3##3##(2008-11#1)(2009-7#1)(2010-8#1)
not be ignored##2##3##(2008-10#1)(2013-8#1)
not be in##2##3##(1992-12#1)(2008-10#1)
not be included##2##3##(2007-7#1)(2013-7#1)
not be involved in the##3##5##(1992-3#1)(2008-8#1)(2011-2#1)
not be involved in##4##4##(1992-3#1)(1994-6#1)(2008-8#1)(2011-2#1)
not be involved##5##3##(1992-3#1)(1994-6#1)(2008-8#2)(2011-2#1)
not be limited to##2##4##(1996-6#1)(1997-1#1)
not be made##2##3##(2008-1#1)(2008-12#1)
not be measured##2##3##(2008-10#1)(2008-9#1)
not be necessary to##3##4##(1990-8#1)(1996-12#1)(2008-10#1)
not be necessary##4##3##(1990-8#1)(1992-12#1)(1996-12#1)(2008-10#1)
not be neglected##2##3##(2008-11#1)(2012-3#1)
not be observed##3##3##(1994-11#1)(2007-12#1)(2008-10#1)
not be obtained##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
not be performed##3##3##(2007-8#1)(2008-10#1)(2009-10#1)
not be possible##3##3##(2007-12#1)(2007-2#1)(2008-2#1)
not be present in##2##4##(2008-10#1)(2010-11#1)
not be reached##2##3##(2011-1#1)(2013-8#1)
not be recovered##2##3##(2008-10#1)(2008-12#1)
not be rejected##2##3##(1996-6#1)(2008-10#1)
not be related##6##3##(1990-12#1)(1991-8#1)(1992-10#1)(1996-12#1)(2012-12#1)(2013-1#1)
not be required to##2##4##(1996-1#1)(2008-7#1)
not be resolved##2##3##(2008-10#2)
not be seen##2##3##(2011-2#1)(2012-1#1)
not be sufficient to##4##4##(2007-6#1)(2008-7#1)(2010-11#1)(2010-3#1)
not be sufficient##6##3##(1992-3#1)(1992-8#1)(2007-6#1)(2008-7#1)(2010-11#1)(2010-3#1)
not be the case##2##4##(2008-2#1)(2011-2#1)
not be the only##2##4##(1997-3#1)(2008-9#1)
not be the primary##2##4##(2008-10#1)(2008-9#1)
not be the##14##3##(1996-1#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-12#1)(2012-3#1)
not be tolerated##2##3##(2008-12#1)(2008-8#1)
not be underestimated##2##3##(2008-11#1)(2013-1#1)
not be used as##2##4##(2008-5#1)(2012-12#1)
not be used for the##2##5##(2008-10#1)(2008-8#1)
not be used for##4##4##(1997-5#1)(2007-12#1)(2008-10#1)(2008-8#1)
not be used in##5##4##(1992-6#1)(1993-2#1)(2007-8#1)(2008-11#1)(2008-8#1)
not be used to##4##4##(2008-2#1)(2008-7#1)(2010-11#1)(2012-2#1)
not be used##19##3##(1992-6#1)(1993-2#1)(1994-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2012-12#2)(2012-2#1)
not be useful##2##3##(2008-10#1)(2008-4#1)
not be##491##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#5)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#11)(2007-2#2)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#6)(2008-10#88)(2008-11#14)(2008-12#12)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#22)(2008-8#21)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#5)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#12)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#6)
not bear##3##2##(2006-10#1)(2008-1#1)(2009-4#1)
not because##4##2##(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
not become##13##2##(1990-9#1)(1993-12#1)(1997-2#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)
not been achieved##4##3##(1995-3#1)(2008-2#1)(2008-3#1)(2010-8#1)
not been adequately##6##3##(1992-6#1)(2008-11#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
not been appreciated##2##3##(2008-8#1)(2012-12#1)
not been assessed##3##3##(2008-10#1)(2009-5#1)(2012-1#1)
not been associated##2##3##(2009-6#1)(2012-3#1)
not been available##2##3##(2008-10#1)(2012-3#1)
not been characterized##4##3##(1990-11#1)(1995-6#1)(2007-11#1)(2008-9#1)
not been clarified##2##3##(2012-2#1)(2013-1#1)
not been clearly defined##3##4##(2011-2#2)(2012-2#1)
not been clearly elucidated##2##4##(2008-11#1)(2011-2#1)
not been clearly##6##3##(2008-10#1)(2008-11#1)(2011-2#3)(2012-2#1)
not been completed##2##3##(1996-3#1)(2008-10#1)
not been completely##3##3##(1997-4#1)(2008-10#1)(2010-6#1)
not been conducted##3##3##(2008-12#2)(2012-2#1)
not been considered##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
not been defined##3##3##(1995-6#1)(1995-8#1)(2008-6#1)
not been described in other##2##5##(2007-12#1)(2011-2#1)
not been described in##3##4##(2007-12#1)(2011-2#1)(2012-2#1)
not been described previously##4##4##(1995-6#1)(1997-3#1)(2008-10#1)(2008-12#1)
not been described##13##3##(1991-6#1)(1995-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
not been detected##4##3##(2006-10#1)(2008-10#2)(2013-1#1)
not been determined##12##3##(1992-10#1)(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-7#2)(2010-4#1)(2012-1#1)(2012-3#1)
not been discussed in##2##4##(2008-3#1)(2008-7#1)
not been documented##6##3##(1996-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-6#1)(2013-7#1)
not been established##13##3##(1995-12#1)(1996-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
not been evaluated##4##3##(2008-11#1)(2008-3#1)(2009-11#1)(2013-1#1)
not been examined in##2##4##(1993-2#1)(2008-8#1)
not been extensively##6##3##(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
not been formally##3##3##(2006-10#1)(2008-10#1)(2012-1#1)
not been found in##2##4##(1993-6#1)(2008-6#1)
not been found##6##3##(1993-6#1)(1996-4#1)(2008-10#2)(2008-4#1)(2008-6#1)
not been fulfilled##2##3##(1997-1#1)(2012-12#1)
not been fully elucidated##5##4##(1990-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)
not been fully established##4##4##(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
not been fully##19##3##(1990-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
not been identified##9##3##(1992-6#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)
not been implemented##3##3##(1994-1#1)(2010-4#1)(2011-2#1)
not been implicated##2##3##(2008-10#1)(2011-2#1)
not been investigated experimentally##2##4##(2007-11#1)(2009-10#1)
not been investigated##11##3##(1994-12#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#1)
not been measured##2##3##(2008-11#1)(2008-9#1)
not been observed in##3##4##(1993-2#1)(2008-2#1)(2008-7#1)
not been observed##8##3##(1993-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
not been performed##4##3##(1994-6#1)(1994-7#1)(2007-11#1)(2007-12#1)
not been previously described##3##4##(2008-7#2)(2010-1#1)
not been previously reported in the##5##6##(2007-8#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#1)
not been previously reported##15##4##(1996-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#1)(2013-8#1)
not been previously##27##3##(1995-5#1)(1996-12#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
not been reported for##3##4##(2008-10#3)
not been reported previously##3##4##(1997-3#1)(2008-1#1)(2008-10#1)
not been reported##37##3##(1991-11#1)(1993-12#1)(1997-3#1)(1997-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)
not been rigorously##4##3##(1991-8#1)(1997-3#1)(2008-10#1)(2009-7#1)
not been shown to be##2##5##(1994-6#1)(2012-12#1)
not been shown to##5##4##(1994-6#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-12#1)
not been studied in##3##4##(2008-5#1)(2011-1#1)(2012-1#1)
not been studied well##2##4##(2008-1#1)(2008-10#1)
not been studied##13##3##(1996-1#1)(1997-1#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
not been subjected to##4##4##(2008-11#2)(2012-3#2)
not been systematically##2##3##(2007-11#1)(2010-11#1)
not been tested##5##3##(1990-6#1)(2008-8#2)(2013-1#1)(2013-8#1)
not been thoroughly##2##3##(2008-10#1)(2012-2#1)
not been used##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)
not been validated##5##3##(2008-5#1)(2011-2#2)(2013-1#2)
not been very##2##3##(2008-10#1)(2008-5#1)
not been well characterized##2##4##(2006-10#1)(2009-4#1)
not been well documented in##2##5##(1997-8#1)(2008-12#1)
not been well documented##3##4##(1997-8#1)(2008-12#1)(2012-12#1)
not been well studied##3##4##(1991-12#1)(1997-3#1)(2012-2#1)
not been well##14##3##(1991-12#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
not been widely##6##3##(1992-1#1)(2008-12#1)(2009-4#1)(2009-6#1)(2010-6#1)(2011-1#1)
not been yet##3##3##(2009-6#1)(2010-12#1)(2011-2#1)
not been##421##2##(1990-10#1)(1990-11#6)(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-12#4)(1994-2#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#9)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#5)(1997-4#2)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#3)(2007-11#8)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#60)(2008-11#28)(2008-12#10)(2008-2#2)(2008-3#11)(2008-4#5)(2008-5#8)(2008-6#8)(2008-7#22)(2008-8#13)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#7)(2010-7#1)(2010-8#5)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#16)(2012-3#8)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#3)
not before##3##2##(1992-11#1)(2008-2#1)(2010-9#1)
not begin##2##2##(2007-2#1)(2009-3#1)
not being able to##2##4##(2011-2#2)
not being met##2##3##(2010-10#1)(2013-1#1)
not being##25##2##(1991-9#1)(1992-1#1)(1992-9#2)(1994-1#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
not believe in##2##3##(2007-7#1)(2008-12#1)
not believe that##2##3##(1993-6#1)(2010-8#1)
not believe##4##2##(1993-6#1)(2007-7#1)(2008-12#1)(2010-8#1)
not belonging to the FS##2##5##(1991-12#2)
not benefit##5##2##(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
not between##7##2##(1991-12#1)(1994-8#1)(2007-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)
not bind##20##2##(1990-5#1)(1990-8#1)(1992-11#1)(1992-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#2)(1995-2#3)(1995-5#1)(1996-2#1)(1996-5#1)(1997-3#2)(2008-10#1)(2008-8#1)
not block the##4##3##(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)
not block##7##2##(1994-12#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-6#1)(1996-2#1)
not blocked by##4##3##(1990-5#1)(1993-6#1)(1994-8#1)(1995-5#1)
not borne out##2##3##(2008-8#1)(2011-2#1)
not bound##2##2##(1990-12#1)(1991-9#1)
not bring about##2##3##(2008-10#1)(2013-8#1)
not bring##4##2##(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
not by a##4##3##(1994-2#2)(1995-6#1)(2008-5#1)
not by an##3##3##(1991-2#1)(1992-12#1)(1994-8#1)
not by increased##2##3##(1991-11#1)(2008-9#1)
not by the##4##3##(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#1)
not by##108##2##(1990-11#4)(1990-2#1)(1990-7#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-9#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-8#4)(1992-9#2)(1993-12#1)(1993-3#4)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#6)(1996-12#1)(1996-2#3)(1996-7#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#11)(2008-11#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#2)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2013-1#1)
not called##2##2##(1991-1#1)(2012-12#1)
not capable of##3##3##(1992-6#1)(2008-11#1)(2009-5#1)
not capture the##2##3##(1997-2#1)(2013-1#1)
not capture##3##2##(1996-2#1)(1997-2#1)(2013-1#1)
not carry out##2##3##(1997-6#1)(2008-5#1)
not carry the##3##3##(1991-3#1)(1995-12#1)(2008-7#1)
not carry##6##2##(1991-3#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-5#1)(2008-7#1)
not catalyze the##2##3##(1992-3#1)(2008-10#1)
not catalyze##5##2##(1992-3#2)(1994-8#1)(1996-2#1)(2008-10#1)
not cause a##2##3##(1991-5#1)(1996-6#1)
not cause aggregation##2##3##(1994-11#1)(2013-8#1)
not cause an##3##3##(1990-11#1)(1994-5#1)(2008-4#1)
not cause any##9##3##(1990-2#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
not cause cell##3##3##(2008-10#2)(2013-1#1)
not cause symptoms##3##3##(2008-10#3)
not cause##48##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-6#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#19)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#4)(2013-8#2)
not caused by##9##3##(1996-3#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
not change either the##2##4##(1992-3#1)(2008-5#1)
not change in the##7##4##(1992-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
not change in##12##3##(1991-12#1)(1992-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-10#1)(2011-2#2)(2013-1#1)
not change or##2##3##(1993-11#1)(2011-1#1)
not change over##3##3##(1996-3#1)(2007-12#1)(2008-11#1)
not change significantly##16##3##(1991-12#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
not change substantially##2##3##(2008-3#1)(2008-7#1)
not change the##27##3##(1990-11#1)(1991-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
not change their##2##3##(2008-5#1)(2008-9#1)
not change with##7##3##(1990-3#2)(1994-2#1)(1994-5#1)(2008-10#2)(2008-8#1)
not change##113##2##(1990-11#1)(1990-3#2)(1991-12#5)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-5#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#5)(2008-3#3)(2008-4#1)(2008-5#9)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#6)(2011-10#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
not changed by##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
not changed in##3##3##(1991-12#1)(1992-3#1)(1997-2#1)
not changed significantly##4##3##(1991-6#1)(1993-11#1)(2008-1#1)(2008-11#1)
not changed##25##2##(1991-12#2)(1991-6#1)(1992-3#2)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
not changing##2##2##(1994-11#1)(2012-3#1)
not clear how##2##3##(1991-12#1)(2009-6#1)
not clear what##2##3##(1993-12#1)(2009-5#1)
not clear yet##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
not clear##55##2##(1990-10#1)(1990-6#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
not clearly defined##2##3##(1995-12#1)(1997-4#1)
not clearly documented##2##3##(2008-6#2)
not clearly understood##3##3##(1992-2#1)(1997-2#1)(2011-1#1)
not clearly##18##2##(1990-7#1)(1992-2#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
not cleaved by##2##3##(1991-2#1)(1991-9#1)
not closely related to##4##4##(1990-5#1)(1991-4#1)(2008-10#2)
not closely##5##2##(1990-5#1)(1991-11#1)(1991-4#1)(2008-10#2)
not coded or incorrectly coded##2##5##(2007-12#2)
not coincide with the##2##4##(2008-10#1)(2010-8#1)
not coincide with##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
not colonized##2##2##(1995-8#1)(2008-10#1)
not come from##4##3##(1995-6#1)(1996-2#2)(2008-6#1)
not come into contact with##2##5##(2008-10#1)(2012-12#1)
not come##7##2##(1995-6#1)(1996-2#2)(2008-10#2)(2008-6#1)(2012-12#1)
not comfortable with##3##3##(1996-5#1)(2009-11#1)(2011-2#1)
not common in Kent County##2##5##(2008-10#2)
not common in##3##3##(2008-10#2)(2008-5#1)
not common##8##2##(1991-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2013-8#1)
not commonly used in##3##4##(1993-12#2)(2008-10#1)
not commonly##8##2##(1993-12#2)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
not communicate##3##2##(1995-12#1)(1997-6#1)(2008-5#1)
not compatible with##5##3##(1995-6#1)(2008-3#1)(2008-5#1)(2008-7#2)
not compete for##2##3##(2008-10#1)(2008-4#1)
not compete with the##2##4##(2008-11#1)(2008-6#1)
not compete with##3##3##(1990-8#1)(2008-11#1)(2008-6#1)
not compete##7##2##(1990-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)
not complement##3##2##(1994-12#1)(1994-8#1)(1997-3#1)
not complete##6##2##(1995-9#1)(2008-10#3)(2008-4#1)(2008-6#1)
not completely elucidated##4##3##(2008-1#1)(2008-10#1)(2009-12#1)(2010-7#1)
not completely inhibit##2##3##(1991-5#1)(2010-4#1)
not completely understood##10##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2013-8#1)
not completely##47##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-4#1)(1992-9#1)(1994-2#2)(1994-9#1)(1995-2#1)(1997-3#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
not comply with the##3##4##(1991-8#1)(2008-9#1)(2011-2#1)
not comply with##5##3##(1991-8#1)(1996-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
not comprehensively##2##2##(2012-12#1)(2013-1#1)
not compromise##4##2##(1991-8#1)(2007-10#1)(2008-1#1)(2008-3#1)
not compromised##7##2##(1993-1#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-6#1)
not concentrated enough##2##3##(1991-12#1)(2008-10#1)
not conclusive##5##2##(1991-12#1)(1997-4#2)(2012-2#1)(2013-1#1)
not conclusively##2##2##(2008-5#1)(2008-9#1)
not conducted##3##2##(1991-12#1)(2008-10#1)(2011-1#1)
not confer##3##2##(1994-9#1)(2008-10#1)(2009-6#1)
not confined to the##2##4##(1994-12#1)(2008-3#1)
not confined to##4##3##(1994-12#1)(1995-9#1)(2007-12#1)(2008-3#1)
not confined##5##2##(1991-6#1)(1994-12#1)(1995-9#1)(2007-12#1)(2008-3#1)
not confirm##7##2##(1991-8#1)(1992-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#2)
not confirmed##9##2##(1990-6#2)(1992-2#1)(1992-4#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
not conform to the##2##4##(1995-8#1)(2011-2#1)
not conform to##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
not connected##2##2##(2008-11#1)(2013-8#1)
not consider##7##2##(1990-10#1)(1996-1#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-8#1)
not considered a##4##3##(2007-7#1)(2008-7#1)(2012-3#1)(2013-1#1)
not considered in##2##3##(2008-10#1)(2008-8#1)
not considered to be##2##4##(1990-5#1)(2008-10#1)
not considered to##3##3##(1990-5#1)(2008-10#1)(2013-1#1)
not considered##27##2##(1990-5#1)(1992-5#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#3)
not consistent across##2##3##(2008-10#1)(2013-8#1)
not consistent with the hypothesis##2##5##(2008-10#2)
not consistent with the##8##4##(1993-12#1)(1993-9#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-11#1)
not consistent with##21##3##(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)
not consistent##30##2##(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
not consistently reported##2##3##(2009-2#1)(2012-12#1)
not consistently##23##2##(1990-3#1)(1990-5#1)(1993-2#1)(1994-3#1)(1995-2#1)(2008-10#11)(2008-2#1)(2008-8#2)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
not constant##5##2##(1993-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
not constitute a##2##3##(1997-5#1)(2008-10#1)
not constitute##4##2##(1997-5#1)(2008-10#1)(2010-10#1)(2011-2#1)
not contain a##2##3##(1991-6#1)(2008-10#1)
not contain any##4##3##(1992-6#1)(1993-12#1)(2008-11#1)(2011-1#1)
not contain the##8##3##(1992-3#1)(1996-12#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#1)
not contain##32##2##(1990-8#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)
not containing##6##2##(1994-11#1)(2008-10#4)(2008-11#1)
not contaminated##2##2##(2008-11#1)(2008-12#1)
not contraindicate##2##2##(2011-2#2)
not contribute equally to the##2##5##(2008-11#1)(2013-8#1)
not contribute to##9##3##(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-8#1)(2009-8#1)
not contribute##14##2##(1991-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-8#1)
not control##5##2##(1994-9#1)(2008-10#2)(2008-12#1)(2011-1#1)
not controlled by##6##3##(1994-2#1)(1997-4#1)(2008-10#3)(2011-2#1)
not controlled##9##2##(1994-2#1)(1997-4#1)(2008-10#3)(2010-4#1)(2011-2#2)(2012-2#1)
not conventionally##2##2##(2008-12#1)(2010-5#1)
not convert##2##2##(2008-10#2)
not cooperative##2##2##(2006-12#1)(2008-10#1)
not correct##2##2##(1997-7#1)(2008-2#1)
not correlate to##2##3##(2011-2#1)(2012-2#1)
not correlate with the##12##4##(1990-11#1)(1991-12#2)(1991-5#1)(1994-2#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)(2013-8#1)
not correlate with##30##3##(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-6#1)(1992-9#1)(1994-2#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
not correlate##42##2##(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-6#1)(1992-9#1)(1993-3#2)(1994-2#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
not correlated to##3##3##(1994-6#1)(2008-10#2)
not correlated with##17##3##(1991-8#1)(1992-9#1)(1995-12#1)(1995-8#1)(2008-10#9)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
not correlated##26##2##(1990-12#1)(1991-8#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-8#1)(2008-10#15)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
not correspond to the##6##4##(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
not correspond to##10##3##(1997-3#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)
not correspond##11##2##(1997-3#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2010-8#1)
not cost-effective in##2##3##(1997-3#1)(2008-9#1)
not coupled##4##2##(1992-6#1)(1995-11#1)(2008-10#1)(2008-8#1)
not cover##4##2##(1994-8#2)(2008-10#1)(2008-5#1)
not covered by##3##3##(1994-3#1)(1995-12#1)(2007-3#1)
not covered##5##2##(1994-3#1)(1995-12#1)(2007-3#1)(2010-11#1)(2012-12#1)
not critical##3##2##(1992-6#1)(2007-11#1)(2008-12#1)
not cross##2##2##(1990-8#1)(2009-4#1)
not cross-react with##4##3##(1992-6#1)(1995-11#2)(2008-4#1)
not currently##9##2##(1991-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-7#1)
not cytotoxic##4##2##(1993-9#1)(1994-8#1)(1997-4#1)(2008-11#1)
not decide##2##2##(1990-11#1)(2008-11#1)
not decline##5##2##(1991-8#1)(1992-5#1)(2008-10#2)(2008-4#1)
not decrease in##2##3##(2008-10#1)(2012-12#1)
not decrease the##5##3##(1990-12#1)(1990-7#1)(1995-5#1)(1997-4#1)(2008-5#1)
not decrease##19##2##(1990-12#1)(1990-7#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-5#1)
not decreased##3##2##(1993-12#1)(1993-3#1)(1994-8#1)
not defined##4##2##(1990-3#1)(1995-12#1)(1997-4#1)(2008-7#1)
not definitive##2##2##(1990-11#1)(2008-6#1)
not degrade##2##2##(2008-10#1)(2008-6#1)
not degraded by##3##3##(1992-3#1)(1993-3#1)(1993-6#1)
not degraded##5##2##(1992-3#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-2#1)
not demonstrated##4##2##(1992-6#1)(1994-6#1)(1995-5#1)(2009-4#1)
not depend on the##8##4##(1992-12#1)(1993-3#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
not depend on##20##3##(1992-12#1)(1993-12#1)(1993-3#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
not depend upon##2##3##(1992-6#1)(2008-7#1)
not depend##26##2##(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)
not dependent on the##7##4##(1994-12#1)(1994-9#1)(1995-6#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
not dependent on##22##3##(1990-12#1)(1990-7#1)(1990-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
not dependent upon the##2##4##(2008-5#1)(2008-7#1)
not dependent upon##5##3##(1991-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
not dependent##27##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
not depurinate##2##2##(2008-10#2)
not derived from##2##3##(2008-10#2)
not describe##2##2##(1997-2#1)(2010-7#1)
not described in the##2##4##(2008-1#1)(2008-10#1)
not described in##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
not described##6##2##(1991-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
not designed to##4##3##(1992-11#1)(1994-3#1)(2008-7#1)(2008-9#1)
not designed##5##2##(1992-11#1)(1994-3#1)(2008-7#1)(2008-9#1)(2009-10#1)
not desired##2##2##(2008-5#1)(2008-6#1)
not destroyed##2##2##(1990-5#1)(2008-10#1)
not detect##16##2##(1990-5#1)(1993-8#1)(1994-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)
not detectable by##5##3##(2007-11#1)(2008-10#2)(2008-9#1)(2012-3#1)
not detectable in the##3##4##(1991-5#1)(1992-9#1)(2007-12#1)
not detectable in##6##3##(1991-5#1)(1992-9#1)(1994-11#2)(2007-12#1)(2008-10#1)
not detectable on the##2##4##(1997-4#1)(2011-2#1)
not detectable when##2##3##(1991-12#1)(2010-12#1)
not detectable##21##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-11#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
not detected any##2##3##(2008-10#1)(2012-2#1)
not detected at all##3##4##(1995-11#1)(2008-10#2)
not detected at##6##3##(1995-11#1)(2008-10#3)(2008-5#2)
not detected by##8##3##(1994-11#1)(1995-12#1)(2008-10#2)(2008-12#1)(2010-5#1)(2011-1#1)(2012-12#1)
not detected in any of##3##5##(1993-9#1)(1996-12#1)(2007-7#1)
not detected in any sample##2##5##(1997-6#1)(2008-12#1)
not detected in any##5##4##(1993-9#1)(1996-12#1)(1997-6#1)(2007-7#1)(2008-12#1)
not detected in either##2##4##(2008-10#2)
not detected in the##12##4##(1990-9#1)(1994-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
not detected in##43##3##(1990-9#1)(1991-12#2)(1991-2#1)(1992-10#1)(1993-9#1)(1994-12#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#2)(2007-5#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
not detected with##2##3##(1995-2#1)(2012-12#1)
not detected##96##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#4)(2007-12#1)(2007-5#2)(2007-7#1)(2008-10#31)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
not determine##3##2##(1992-1#1)(1994-2#1)(2007-7#1)
not determined##6##2##(1991-12#1)(1995-11#1)(1995-9#1)(1997-3#1)(2008-10#2)
not develop in##4##3##(1996-12#1)(2008-10#2)(2008-12#1)
not develop##13##2##(1990-11#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-2#1)
not developed##5##2##(1995-3#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-10#1)
not die##2##2##(1996-12#1)(2007-12#1)
not differ between the 2 groups##2##6##(1991-11#1)(2013-1#1)
not differ between the 2##3##5##(1991-11#1)(2007-10#1)(2013-1#1)
not differ between the##11##4##(1991-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
not differ between##31##3##(1990-2#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-3#1)(1996-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
not differ from that for##2##5##(2011-2#1)(2012-2#1)
not differ from that##7##4##(1991-3#1)(1994-3#1)(1996-9#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
not differ from##25##3##(1991-3#1)(1991-6#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-9#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
not differ in##19##3##(1991-3#1)(1991-7#1)(1993-12#1)(1993-2#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#1)(2013-8#2)
not differ significantly between##19##4##(1993-12#1)(1994-2#1)(2007-1#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#3)(2010-3#1)(2011-1#1)(2011-2#2)(2013-7#1)
not differ significantly from the##4##5##(2008-10#4)
not differ significantly from those##3##5##(1995-11#1)(1996-3#1)(2008-8#1)
not differ significantly from##14##4##(1994-2#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(2008-10#6)(2008-8#1)(2010-12#1)
not differ significantly##57##3##(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#3)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-6#1)(2007-1#1)(2007-11#1)(2008-10#17)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
not differ substantially##2##3##(1994-5#1)(2013-1#1)
not differ##164##2##(1990-2#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
not different between the##3##4##(1991-11#1)(2007-9#1)(2008-7#1)
not different between##6##3##(1991-11#1)(1994-5#1)(2007-9#1)(2008-7#1)(2012-3#1)(2013-8#1)
not different from that of##2##5##(1994-8#1)(1995-12#1)
not different from##6##3##(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#1)(2008-10#2)
not different than##2##3##(2007-10#1)(2013-1#1)
not different to##2##3##(2007-5#1)(2008-7#1)
not different with##2##3##(2008-10#1)(2008-12#1)
not different##26##2##(1990-2#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-7#2)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
not differentiate between##2##3##(2008-11#1)(2008-8#1)
not differentiate##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
not diminish##6##2##(1991-2#1)(1993-6#1)(1994-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
not diminished##4##2##(1992-3#1)(2008-10#2)(2009-12#1)
not directly affect##2##3##(1997-2#1)(2008-8#1)
not directly involved in the##2##5##(1993-5#1)(2012-3#1)
not directly involved in##6##4##(1993-5#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-11#1)(2012-3#1)
not directly involved##7##3##(1992-8#1)(1993-5#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-11#1)(2012-3#1)
not directly related to the##2##5##(1997-6#1)(2008-7#1)
not directly related to##5##4##(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
not directly##38##2##(1990-8#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#2)
not discernible##2##2##(2007-12#1)(2008-8#1)
not discernibly##2##2##(1990-5#1)(1994-2#1)
not disclose##3##2##(2006-12#1)(2007-12#2)
not discriminate between##2##3##(1990-12#1)(1994-8#1)
not discriminate##4##2##(1990-12#1)(1994-8#1)(2008-8#1)(2011-10#1)
not discussed in##2##3##(2008-10#1)(2012-2#1)
not discussed##3##2##(1994-12#1)(2008-10#1)(2012-2#1)
not displaced by##2##3##(1993-1#1)(2008-10#1)
not displaced##4##2##(1993-1#1)(1993-9#1)(2008-10#1)(2008-5#1)
not display##7##2##(1993-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-3#1)(2009-3#1)(2013-8#1)
not displayed##3##2##(2008-10#2)(2011-2#1)
not dissimilar from##2##3##(1990-8#1)(1994-2#1)
not distinct##3##2##(2008-10#1)(2011-2#2)
not distinguish between##5##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
not distinguish##7##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
not disturb the##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
not disturb##5##2##(2007-12#1)(2008-10#2)(2008-6#1)(2012-3#1)
not do##6##2##(1990-10#1)(1995-11#1)(1995-3#1)(2008-11#1)(2009-7#1)(2013-8#1)
not documented##2##2##(2008-1#1)(2008-11#1)
not done##6##2##(1992-2#1)(1994-8#1)(1995-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
not dose related and was##2##5##(2008-10#2)
not drink##2##2##(1993-12#1)(2011-2#1)
not drug##2##2##(2008-11#1)(2012-3#1)
not due to a##14##4##(1990-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-4#1)(2009-6#1)
not due to an##6##4##(1990-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1997-1#1)(1997-7#1)
not due to any##2##4##(1995-11#1)(2008-10#1)
not due to changes in##2##5##(1993-6#1)(2008-10#1)
not due to the##9##4##(1991-10#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-1#1)(2013-1#1)
not due to##65##3##(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-2#1)(2011-1#2)(2013-1#2)
not due##68##2##(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-2#1)(2011-1#2)(2013-1#2)
not during##4##2##(1994-8#1)(2008-10#2)(2011-2#1)
not easily counted##2##3##(2012-2#2)
not easily distinguishable from##2##4##(2008-10#1)(2012-2#1)
not easily##16##2##(1995-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-6#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-8#1)(2012-2#4)
not easy to##3##3##(1993-11#1)(1994-1#1)(2008-10#1)
not easy##8##2##(1993-11#1)(1994-1#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-7#1)(2013-1#1)
not economically##2##2##(2008-10#1)(2008-7#1)
not effective in##8##3##(1993-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-1#1)(2012-1#1)
not effective to##3##3##(1992-8#1)(2010-3#1)(2010-6#1)
not effective##23##2##(1992-12#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-9#1)(1997-1#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)
not effectively##3##2##(1994-8#1)(1994-9#1)(2009-9#1)
not efficient##3##2##(1997-8#1)(2008-10#1)(2009-11#1)
not elevated##5##2##(1992-8#1)(1993-6#1)(1995-2#1)(1995-5#1)(2011-2#1)
not elicit a##2##3##(2008-10#1)(2010-4#1)
not elicit##7##2##(1991-4#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2010-6#1)
not eligible for##3##3##(1990-6#1)(1995-12#1)(2012-12#1)
not eliminate##3##2##(1994-6#1)(1995-2#1)(2008-3#1)
not eliminated##4##2##(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
not employed##2##2##(2008-12#1)(2011-2#1)
not encode##3##2##(1993-2#1)(2008-10#1)(2008-8#1)
not encountered in##3##3##(1992-3#1)(1992-4#1)(1994-8#1)
not encountered##4##2##(1990-3#1)(1992-3#1)(1992-4#1)(1994-8#1)
not engage in##5##3##(2007-6#1)(2008-11#1)(2008-3#1)(2010-7#1)(2013-8#1)
not engage##6##2##(2007-6#1)(2008-11#1)(2008-3#1)(2010-7#1)(2013-8#2)
not enhance##14##2##(1990-6#1)(1992-3#1)(1993-8#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)
not enough for##2##3##(2008-4#1)(2013-1#1)
not enough to induce##2##4##(1990-12#1)(1996-5#1)
not enough to meet##2##4##(1994-1#1)(2008-9#1)
not enough to##8##3##(1990-12#1)(1994-1#1)(1996-2#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
not enough##17##2##(1990-12#1)(1992-5#1)(1992-8#1)(1994-1#1)(1996-2#1)(1996-5#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
not enrolled##2##2##(1992-2#1)(2010-8#1)
not ensure##4##2##(1992-6#1)(1994-3#1)(2008-10#1)(2008-3#1)
not enter the##7##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)
not enter##8##2##(1991-5#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)
not entirely clear##2##3##(2009-10#1)(2011-2#1)
not entirely##7##2##(1990-11#1)(1990-6#1)(2007-8#1)(2008-5#1)(2009-10#2)(2011-2#1)
not equal to##2##3##(2008-10#1)(2012-2#1)
not equally##3##2##(1993-8#1)(2009-8#1)(2011-2#1)
not equipped##2##2##(2008-12#1)(2011-1#1)
not equivalent##4##2##(2007-12#1)(2008-10#1)(2008-5#2)
not essential for##17##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-6#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-3#1)(2008-10#2)
not essential##19##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-6#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
not established##6##2##(1990-12#2)(1996-7#1)(2008-7#1)(2008-8#1)(2012-2#1)
not even##6##2##(1993-2#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-12#1)
not evenly distributed##2##3##(2008-5#1)(2008-7#1)
not evident in##3##3##(2008-10#2)(2011-1#1)
not evident##12##2##(1994-6#1)(2007-12#1)(2008-10#4)(2008-7#1)(2011-1#3)(2011-2#2)
not evolve##4##2##(2008-10#2)(2009-8#1)(2011-1#1)
not evolved##2##2##(1995-2#1)(2013-8#1)
not exactly##5##2##(1990-12#1)(2008-10#1)(2009-7#1)(2010-5#1)(2011-2#1)
not examined##2##2##(2007-12#1)(2008-12#1)
not exceed 0##2##3##(2008-10#1)(2008-2#1)
not exceed the##3##3##(1996-12#1)(2011-1#1)(2013-1#1)
not exceed##28##2##(1990-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-10#13)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
not exceeding 0##2##3##(2008-3#1)(2012-3#1)
not exceeding##5##2##(1991-11#1)(2008-3#1)(2009-2#1)(2012-1#1)(2012-3#1)
not exclude##5##2##(1991-12#1)(1997-3#1)(2008-3#1)(2008-4#1)(2011-1#1)
not excluded##2##2##(1996-6#1)(1996-9#1)
not exclusively##4##2##(1990-5#1)(1994-12#1)(2008-4#1)(2008-7#1)
not exert##5##2##(1995-6#1)(2008-10#1)(2011-1#1)(2013-1#2)
not exhibit a##2##3##(2008-1#1)(2008-7#1)
not exhibit any##4##3##(1997-3#1)(1997-6#1)(2008-1#1)(2011-2#1)
not exhibit the##4##3##(1992-6#1)(1993-11#1)(2008-10#1)(2009-5#1)
not exhibit##26##2##(1990-8#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#4)(2009-5#1)(2011-2#1)
not exist in##7##3##(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)
not exist##17##2##(1990-3#1)(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
not expect##2##2##(2008-8#2)
not expensive##4##2##(2008-10#4)
not experience##5##2##(1991-12#1)(1995-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
not explain the##6##3##(1990-6#1)(1996-12#1)(1997-8#1)(2008-3#1)(2008-8#1)(2009-7#1)
not explain##7##2##(1990-6#1)(1996-12#1)(1997-8#1)(2008-3#1)(2008-8#2)(2009-7#1)
not explained by the##2##4##(2009-5#1)(2011-1#1)
not explained by##3##3##(2008-3#1)(2009-5#1)(2011-1#1)
not explicitly##4##2##(1994-2#1)(1996-1#1)(2008-10#1)(2011-2#1)
not exposed to the##4##4##(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
not exposed to##6##3##(1995-12#1)(2008-10#2)(2008-12#1)(2008-7#2)
not exposed##10##2##(1994-2#1)(1995-12#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2013-1#1)
not express##16##2##(1991-2#2)(1994-2#1)(1996-5#3)(2008-10#1)(2008-11#3)(2008-8#2)(2009-12#1)(2010-11#1)(2012-12#1)(2013-1#1)
not expressed in normal##3##4##(1994-8#1)(2008-9#1)(2013-1#1)
not expressed in the##2##4##(2008-8#1)(2012-12#1)
not expressed in##7##3##(1994-8#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
not expressed##12##2##(1992-5#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-6#1)(2008-11#1)(2008-8#2)(2008-9#1)(2012-12#1)(2013-1#1)
not extend beyond##2##3##(2011-2#1)(2013-1#1)
not extend to##3##3##(2008-10#1)(2009-7#1)(2010-8#1)
not extend##5##2##(2008-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
not extent##2##2##(2011-2#1)(2013-8#1)
not facilitate the induction of##2##5##(1995-12#2)
not facilitate##3##2##(1995-12#2)(2007-10#1)
not fall##3##2##(2007-12#1)(2008-1#1)(2008-4#1)
not familiar with##4##3##(2008-4#1)(2010-12#1)(2010-8#1)(2013-8#1)
not far from##2##3##(2008-10#1)(2008-7#1)
not far##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
not feasible##13##2##(1990-10#1)(1991-8#1)(1995-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
not feel##4##2##(2007-5#1)(2008-5#2)(2013-7#1)
not find a##8##3##(1990-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
not find any significant##3##4##(2008-5#1)(2009-10#1)(2012-3#1)
not find any##5##3##(2008-12#1)(2008-5#1)(2009-10#2)(2012-3#1)
not find statistically significant##2##4##(1997-1#1)(2008-6#1)
not find##25##2##(1990-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
not fit the##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
not fit##11##2##(1990-7#1)(1991-3#1)(1993-6#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-8#1)(2013-1#1)
not follow##13##2##(1991-12#1)(1992-3#1)(1992-5#1)(1994-9#1)(1997-4#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2013-1#1)
not followed by##6##3##(1995-5#1)(1997-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#1)
not for the##11##3##(1992-11#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
not for##59##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-8#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
not form a##7##3##(1994-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-3#1)
not form any##2##3##(1997-2#1)(2010-2#1)
not form complexes with##2##4##(1991-2#1)(2008-10#1)
not form complexes##3##3##(1991-2#1)(2008-10#2)
not form##27##2##(1990-5#1)(1991-2#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#2)(2010-3#1)
not formally##3##2##(2008-3#1)(2013-1#2)
not formed in##2##3##(1993-9#1)(2008-10#1)
not formed##8##2##(1993-9#1)(1994-12#1)(2008-10#5)(2012-2#1)
not found by##2##3##(1992-2#1)(2008-10#1)
not found for##2##3##(1996-2#1)(2008-10#1)
not found in a##2##4##(1990-3#1)(2010-8#1)
not found in any of the##4##6##(1991-8#1)(1992-5#1)(2006-8#1)(2008-8#1)
not found in any##6##4##(1991-4#1)(1991-8#1)(1992-5#1)(2006-8#1)(2008-10#1)(2008-8#1)
not found in normal##2##4##(2008-11#1)(2008-9#1)
not found in other##2##4##(1993-12#1)(2008-8#1)
not found in the##5##4##(1993-12#1)(1995-6#1)(2008-4#1)(2010-4#1)(2012-3#1)
not found in##37##3##(1990-3#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1995-6#1)(1996-5#1)(2006-8#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
not found to be related to##2##6##(2008-9#1)(2009-7#1)
not found to be significantly##2##5##(1997-3#1)(2010-11#1)
not found to be##11##4##(1995-6#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
not found to##20##3##(1991-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
not found with##2##3##(1991-2#1)(2011-2#1)
not found##83##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
not free##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
not frequent##6##2##(1993-5#1)(1994-12#1)(2007-8#1)(2008-10#1)(2009-10#1)(2012-6#1)
not frequently observed##2##3##(1991-4#1)(1996-8#1)
not from the##6##3##(1990-5#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-5#2)
not from##24##2##(1990-12#1)(1990-2#1)(1990-5#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-5#2)(2008-7#1)(2009-9#1)(2011-2#1)
not fulfil the criteria for##2##5##(1992-11#1)(2008-10#1)
not fulfil##3##2##(1992-11#1)(1994-7#1)(2008-10#1)
not fulfilled##2##2##(1991-3#1)(2008-12#1)
not fully account for##2##4##(1991-5#1)(2007-12#1)
not fully developed##2##3##(2008-4#1)(2011-2#1)
not fully explain the##3##4##(2008-7#1)(2010-9#1)(2013-8#1)
not fully explained##2##3##(1992-8#1)(2009-12#1)
not fully known##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
not fully understood##28##3##(1993-12#1)(1993-6#1)(1994-11#1)(1995-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
not fully##65##2##(1991-5#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
not function in##2##3##(1994-12#1)(1996-5#1)
not function##5##2##(1994-12#1)(1996-5#1)(1997-2#1)(2011-2#1)(2012-12#1)
not functional##2##2##(2007-12#1)(2011-1#1)
not further##8##2##(1996-2#1)(2008-10#1)(2008-11#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
not fused##2##2##(1995-6#1)(2008-8#1)
not gender##3##2##(2007-10#1)(2009-7#1)(2011-2#1)
not generally##10##2##(1991-12#1)(1994-2#2)(1996-2#1)(1997-3#1)(2007-2#1)(2007-5#1)(2008-2#1)(2008-4#1)(2008-7#1)
not generate##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
not genetically##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
not genotoxic in##2##3##(1997-4#2)
not genotoxic##3##2##(1997-4#2)(2013-1#1)
not get##3##2##(2008-12#1)(2013-1#1)(2013-8#1)
not give a##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
not give##11##2##(1994-6#1)(1995-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2012-2#1)(2012-3#1)
not given##7##2##(1990-6#1)(1992-9#1)(1994-2#1)(1994-6#1)(1997-5#1)(2011-1#1)(2011-2#1)
not glycosylated and##2##3##(1992-8#1)(1997-4#1)
not glycosylated##3##2##(1992-8#1)(1997-4#1)(2008-10#1)
not good##3##2##(2007-8#1)(2008-10#1)(2009-9#1)
not greater than##2##3##(2008-10#1)(2008-2#1)
not greater##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
not greatly##7##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
not grow in##4##3##(1994-5#1)(2008-11#2)(2008-5#1)
not grow on##2##3##(2008-7#1)(2011-1#1)
not grow##9##2##(1994-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
not guilty##2##2##(2008-8#1)(2011-1#1)
not had##10##2##(1991-2#1)(1992-2#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-3#1)(2010-6#1)
not happen##3##2##(1995-1#1)(1997-2#1)(2008-9#1)
not have a history of##2##5##(2011-2#1)(2012-12#1)
not have a##38##3##(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
not have an##11##3##(1993-6#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
not have any significant effect on##5##6##(1995-3#1)(2008-10#1)(2008-12#2)(2011-3#1)
not have any##21##3##(1990-12#1)(1991-9#1)(1992-9#1)(1994-5#1)(1995-3#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#2)(2010-12#1)(2011-1#1)(2011-3#1)(2012-2#1)
not have been##6##3##(1992-6#1)(1993-12#1)(1997-1#1)(2008-1#1)(2008-3#1)(2012-12#1)
not have enough##2##3##(2008-10#1)(2008-7#1)
not have had##2##3##(1994-12#1)(2009-3#1)
not have important##2##3##(1990-2#1)(2008-12#1)
not have such##3##3##(2008-12#1)(2009-2#1)(2012-2#1)
not have the ability to##2##5##(2008-12#1)(2008-9#1)
not have the##13##3##(1992-12#1)(1992-9#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)(2011-1#2)
not have to##4##3##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
not have##163##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#4)(2008-12#9)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#6)
not having##6##2##(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#2)
not help to##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
not help##5##2##(1996-12#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-8#1)
not helped##2##2##(2008-11#1)(2013-8#1)
not high##5##2##(1993-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
not higher in##2##3##(2008-11#1)(2010-2#1)
not higher than 0##2##4##(2008-10#2)
not higher than##6##3##(1990-5#1)(1993-5#1)(1994-5#1)(2008-10#3)
not higher##10##2##(1990-5#1)(1993-5#1)(1994-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2010-2#1)(2013-1#1)
not highly##3##2##(2010-5#1)(2013-1#2)
not hold for##2##3##(1990-8#1)(2008-5#1)
not hold##6##2##(1990-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
not homogeneous##2##2##(1990-8#1)(1991-1#1)
not host##3##2##(2008-10#2)(2008-5#1)
not however##2##2##(1993-5#1)(2008-11#1)
not hybridize to##3##3##(1992-11#1)(1995-2#1)(2008-10#1)
not hybridize##8##2##(1992-11#1)(1995-2#1)(2008-10#6)
not hydrolyze##3##2##(1990-11#1)(1990-2#1)(1995-6#1)
not ideal for##2##3##(1992-3#1)(2008-1#1)
not identical to the##3##4##(1990-7#1)(1993-9#1)(2008-2#1)
not identical to##6##3##(1990-2#1)(1990-7#1)(1993-9#1)(1997-3#1)(2008-2#1)(2012-2#1)
not identical with##2##3##(1990-5#1)(1996-5#1)
not identical##13##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1993-11#1)(1993-9#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-5#1)(2012-2#1)
not identified by##3##3##(1992-2#1)(2007-8#1)(2008-11#1)
not identified##12##2##(1990-11#1)(1992-2#1)(1994-9#1)(1995-4#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-1#1)(2012-3#1)
not identify##7##2##(1990-6#2)(1991-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
not immediately##5##2##(1994-12#1)(1995-2#1)(2007-8#1)(2010-8#1)(2012-12#1)
not immune##2##2##(1992-1#1)(2007-12#1)
not impact##3##2##(2008-5#1)(2012-2#2)
not impair##7##2##(1991-8#1)(1992-10#1)(1993-1#1)(1995-2#1)(1997-7#1)(2008-7#1)(2011-2#1)
not impaired in##2##3##(2008-10#1)(2008-7#1)
not impaired when##2##3##(1994-3#1)(2008-7#1)
not impaired##6##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-7#2)
not impede##4##2##(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
not implicated in##2##3##(2008-10#1)(2008-11#1)
not implicated##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
not imply a##2##3##(1997-5#1)(2009-6#1)
not imply##4##2##(1990-11#1)(1991-6#1)(1997-5#1)(2009-6#1)
not important in the##2##4##(1992-8#1)(2008-10#1)
not important##5##2##(1992-8#1)(1994-12#1)(2008-10#1)(2008-8#2)
not improve the##9##3##(1990-3#1)(1991-6#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)
not improve##34##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-6#1)(1996-12#1)(1997-4#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#3)
not improved by##2##3##(1995-12#1)(2012-2#1)
not improved##7##2##(1995-12#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-1#1)(2012-2#1)
not improving##2##2##(1992-4#1)(2013-1#1)
not in a##5##3##(1991-12#1)(1994-11#1)(1994-8#1)(2008-10#1)(2012-1#1)
not in fact##2##3##(1993-6#1)(2009-6#1)
not in itself##3##3##(1990-12#1)(2007-6#1)(2008-9#1)
not in the brain##2##4##(1991-9#1)(1997-2#1)
not in the nuclear##2##4##(1995-6#2)
not in the##84##3##(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1993-12#5)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-5#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
not in their##4##3##(1991-8#1)(1995-2#1)(2008-8#1)(2009-8#1)
not in##285##2##(1990-11#2)(1990-12#3)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#3)(1991-12#6)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#7)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#6)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#5)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#53)(2008-11#9)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#13)(2008-8#10)(2008-9#7)(2009-1#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
not include an##2##3##(1995-1#1)(2010-10#1)
not include##12##2##(1993-3#1)(1995-1#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#2)(2013-8#1)
not included in the##7##4##(2007-6#1)(2007-7#2)(2008-7#1)(2010-1#1)(2011-2#2)
not included in##11##3##(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-3#1)
not included##18##2##(1990-9#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-1#1)(2011-2#3)(2012-3#1)
not including##2##2##(1990-12#1)(2008-10#1)
not incorporate##2##2##(1992-9#1)(1994-6#1)
not incorporated into the##2##4##(2008-10#1)(2008-3#1)
not increase in##4##3##(1992-3#1)(2008-7#1)(2008-8#2)
not increase significantly##2##3##(2008-10#2)
not increase the##19##3##(1990-11#1)(1991-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-5#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)
not increase##55##2##(1990-11#1)(1991-12#2)(1992-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#3)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)
not increased by##2##3##(1995-12#1)(1997-1#1)
not increased with the##2##4##(2007-7#1)(2008-8#1)
not increased##10##2##(1990-2#1)(1992-12#1)(1995-12#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
not indicate##4##2##(1992-3#1)(1997-3#1)(2008-4#1)(2013-1#1)
not indicated##5##2##(1990-10#1)(1994-9#1)(1996-9#1)(2008-6#1)(2010-6#1)
not induce a##5##3##(1993-2#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
not induce##44##2##(1990-5#2)(1991-12#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#12)(2008-11#3)(2008-6#1)(2008-8#4)(2009-8#1)(2011-2#1)(2013-1#2)
not induced by##5##3##(1993-8#1)(1995-5#1)(1996-12#1)(2011-2#1)(2012-2#1)
not induced##11##2##(1993-8#1)(1994-8#1)(1995-5#1)(1996-12#2)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
not infect##3##2##(2008-10#2)(2010-10#1)
not infected##4##2##(1992-2#1)(2008-10#2)(2008-5#1)
not infectious##2##2##(1997-3#2)
not inferior to##2##3##(2008-11#1)(2013-1#1)
not influence the##23##3##(1990-8#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
not influence##37##2##(1990-8#1)(1991-4#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
not influenced by the##9##4##(1991-12#1)(1991-9#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2013-7#1)
not influenced by##18##3##(1990-12#1)(1991-12#2)(1991-6#1)(1991-9#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
not influenced##23##2##(1990-12#1)(1991-12#2)(1991-6#1)(1991-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
not infrequently##2##2##(2008-1#1)(2008-4#1)
not inherited##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
not inhibit the growth of##2##5##(1990-8#1)(2009-2#1)
not inhibit the##10##3##(1990-8#1)(1991-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(2008-10#2)(2009-2#1)
not inhibit##37##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2006-6#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-4#1)
not inhibited by##14##3##(1990-2#1)(1990-8#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
not inhibited##22##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-11#2)(1995-12#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
not inhibitors##2##2##(1992-3#1)(1995-3#1)
not inhibitory##2##2##(1994-11#2)
not inoculated with the##2##4##(2008-10#2)
not inoculated##4##2##(2008-10#4)
not instituted##2##2##(1997-3#1)(2007-8#1)
not intended to##3##3##(1991-1#1)(2008-3#1)(2013-8#1)
not intended##4##2##(1991-1#1)(2008-3#1)(2008-6#1)(2013-8#1)
not interact with the##2##4##(1994-5#1)(2008-8#1)
not interact with##8##3##(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
not interact##12##2##(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
not interfere in the determination of##2##6##(2008-10#2)
not interfere in the determination##3##5##(2008-10#3)
not interfere in the##10##4##(2008-10#9)(2008-5#1)
not interfere in##13##3##(2008-10#11)(2008-5#1)(2010-5#1)
not interfere the determination##2##4##(2008-10#2)
not interfere the##5##3##(2008-10#5)
not interfere with determination##3##4##(2008-10#3)
not interfere with the proposed method##2##6##(2008-10#2)
not interfere with the##25##4##(1990-12#3)(1993-2#1)(1997-2#1)(2008-10#17)(2008-4#2)(2008-8#1)
not interfere with##43##3##(1990-12#3)(1991-5#1)(1992-3#1)(1993-2#1)(1995-2#2)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-4#2)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
not interfere##75##2##(1990-12#3)(1991-5#1)(1992-3#1)(1993-2#1)(1995-2#2)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#54)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
not interfered##2##2##(2008-10#2)
not into the##2##3##(1993-12#1)(2008-5#1)
not into##3##2##(1993-12#1)(2008-5#1)(2013-1#1)
not invade##2##2##(1991-7#1)(2008-9#1)
not investigated##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
not involve an##2##3##(2008-11#1)(2008-12#1)
not involve##23##2##(1992-3#1)(1992-4#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
not involved in the##8##4##(1992-8#1)(1992-9#1)(1993-3#1)(1995-2#1)(2008-10#3)(2008-4#1)
not involved in##21##3##(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#1)
not involved with##2##3##(2008-8#1)(2008-9#1)
not involved##30##2##(1991-2#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
not involving##5##2##(1991-11#1)(1993-9#1)(2007-11#1)(2008-4#1)(2008-7#1)
not its##7##2##(1990-8#1)(1993-3#1)(1995-11#1)(1995-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
not just a##4##3##(1996-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
not just to##3##3##(1990-4#1)(2008-11#1)(2010-10#1)
not just##21##2##(1990-4#1)(1990-9#1)(1993-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
not justified##4##2##(1992-2#1)(1992-6#1)(2008-10#2)
not justify the##2##3##(2008-6#1)(2008-7#1)
not kept##2##2##(2008-10#1)(2008-3#1)
not know about##2##3##(1991-12#1)(2013-1#1)
not know that##2##3##(1993-3#1)(2011-1#1)
not know the##2##3##(2008-10#2)
not know##19##2##(1990-6#1)(1991-12#1)(1991-3#2)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(2008-10#4)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
not known exactly##2##3##(2008-2#1)(2008-3#1)
not known in##2##3##(1992-3#1)(2013-1#1)
not known to be##2##4##(2007-12#1)(2010-10#1)
not known to have##2##4##(2008-4#1)(2012-3#1)
not known to##5##3##(2007-12#1)(2008-4#1)(2010-10#1)(2012-2#1)(2012-3#1)
not known whether the##2##4##(2008-11#1)(2008-12#1)
not known whether##5##3##(1990-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
not known##78##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-7#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#8)(2009-11#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#4)(2012-3#3)(2013-1#2)
not label##2##2##(2007-7#1)(2008-7#1)
not labeled##2##2##(1992-8#1)(2008-4#1)
not large##3##2##(1992-6#1)(1993-6#1)(2007-5#1)
not lead to##17##3##(1992-6#1)(1994-11#1)(1994-7#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
not lead##20##2##(1992-6#1)(1994-11#1)(1994-7#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
not least of##2##3##(1991-3#1)(2008-5#1)
not least##8##2##(1991-3#1)(1992-3#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-11#1)(2011-1#1)
not legal##3##2##(1994-1#1)(2008-11#1)(2008-9#1)
not lend##2##2##(1991-1#1)(1996-3#1)
not less than##2##3##(2008-10#2)
not less##3##2##(1990-6#1)(2008-10#2)
not lethal##3##2##(1995-8#1)(2008-10#2)
not lie##3##2##(1995-6#1)(2008-7#1)(2011-2#1)
not like##2##2##(1992-2#1)(2012-2#1)
not likely to be##7##4##(1992-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(2008-10#1)(2008-11#1)(2009-6#1)
not likely to##11##3##(1992-12#1)(1992-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-6#1)
not likely##14##2##(1992-12#1)(1992-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#1)
not limit the##3##3##(2008-2#1)(2008-3#2)
not limit##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
not limited by the##2##4##(2008-10#1)(2008-2#1)
not limited by##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
not limited to the##2##4##(2008-10#1)(2008-3#1)
not limited to##16##3##(1991-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
not limited##21##2##(1991-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#2)
not limiting##2##2##(2009-10#1)(2013-8#1)
not linear##5##2##(1992-5#1)(1996-5#1)(2008-10#3)
not linearly correlated##2##3##(2008-10#1)(2008-5#1)
not linked to the##3##4##(2008-10#3)
not linked to##8##3##(1995-2#1)(1996-3#1)(2008-10#5)(2010-1#1)
not listening to music##2##4##(2007-6#2)
not listening to##3##3##(1991-2#1)(2007-6#2)
not live##2##2##(1996-2#1)(2009-6#1)
not loaded##2##2##(2013-1#2)
not located##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
not long##2##2##(2008-8#1)(2012-2#1)
not lose the##2##3##(1990-5#1)(2008-10#1)
not lose##5##2##(1990-5#1)(1995-5#1)(2008-10#2)(2009-5#1)
not lost##2##2##(2008-9#1)(2011-2#1)
not lower than##2##3##(2008-10#1)(2008-9#1)
not lower##5##2##(1992-3#1)(2008-10#2)(2008-9#1)(2012-12#1)
not made##3##2##(2008-7#1)(2009-10#1)(2010-3#1)
not maintained##4##2##(1994-6#1)(2008-11#1)(2008-4#1)(2009-12#1)
not major contributors to##2##4##(2008-10#2)
not major##3##2##(2008-10#2)(2009-6#1)
not make a##3##3##(1994-9#1)(2007-11#1)(2008-1#1)
not make full use of the##3##6##(1997-4#1)(2008-8#1)(2013-8#1)
not make##15##2##(1992-11#1)(1994-9#1)(1995-3#1)(1996-5#2)(1997-4#1)(2007-11#1)(2008-1#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
not managed##3##2##(1994-3#1)(1995-1#1)(2013-1#1)
not manifest##2##2##(1997-3#1)(2008-10#1)
not manually##2##2##(2008-10#1)(2010-4#1)
not many##4##2##(1997-2#1)(2008-5#1)(2010-5#1)(2013-7#1)
not markedly##4##2##(1994-9#1)(1995-12#1)(1996-10#1)(2008-7#1)
not married##2##2##(1992-4#1)(2013-8#1)
not match the##5##3##(1997-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
not match##9##2##(1990-2#1)(1993-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
not matched##2##2##(2008-10#1)(2010-9#1)
not materially##2##2##(1992-2#1)(2008-11#1)
not mean##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-7#1)
not measurably##3##2##(1994-6#1)(2008-11#1)(2008-6#1)
not measured##2##2##(1991-11#1)(2008-10#1)
not mediate the##4##3##(1990-7#1)(2008-4#1)(2010-11#1)(2012-1#1)
not mediate##8##2##(1990-7#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-4#1)(2010-11#1)(2011-1#1)(2012-1#1)
not mediated by##13##3##(1991-9#1)(1992-8#1)(1993-9#1)(1994-3#2)(1994-8#3)(1995-5#1)(1996-12#1)(2007-10#1)(2008-7#1)(2009-7#1)
not mediated##15##2##(1991-9#1)(1992-8#1)(1993-9#1)(1994-3#2)(1994-8#4)(1995-5#1)(1996-12#1)(2007-10#1)(2008-5#1)(2008-7#1)(2009-7#1)
not meet the##4##3##(1991-8#1)(2008-11#1)(2008-3#1)(2012-2#1)
not meet##10##2##(1991-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
not meeting##3##2##(2012-2#2)(2013-1#1)
not mention##2##2##(1995-2#1)(2011-2#1)
not mentioned in the##2##4##(2008-5#1)(2008-7#1)
not mentioned in##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
not mentioned##6##2##(2007-12#1)(2008-5#1)(2008-7#3)(2012-12#1)
not merely due to##2##4##(1990-5#2)
not merely##8##2##(1990-5#2)(1990-8#1)(1995-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-3#1)
not met##4##2##(1991-1#1)(1994-2#1)(2010-3#1)(2013-8#1)
not metabolized##3##2##(2008-6#1)(2008-8#1)(2008-9#1)
not migrate##2##2##(1992-6#1)(2008-10#1)
not mimicked by##3##3##(1993-3#1)(1995-12#1)(2008-5#1)
not modified by##6##3##(1994-3#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-4#1)(2009-9#1)
not modified##10##2##(1994-3#1)(1994-8#2)(1995-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)
not more effective than##3##4##(2008-8#3)
not more than##8##3##(1990-2#2)(1994-3#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)
not more##20##2##(1990-2#2)(1991-3#1)(1992-11#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#5)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
not move##3##2##(2008-10#3)
not much##8##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
not naturally##2##2##(2008-10#2)
not necessarily be##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
not necessarily correlate with##2##4##(1991-9#1)(2008-10#1)
not necessarily equivalent##2##3##(2008-10#2)
not necessarily imply the##2##4##(1997-8#1)(2008-4#1)
not necessarily imply##6##3##(1991-2#2)(1997-8#1)(2008-10#1)(2008-4#1)(2009-5#1)
not necessarily indicate##3##3##(1994-11#1)(2010-5#1)(2013-8#1)
not necessarily show the##2##4##(1996-9#1)(2008-10#1)
not necessarily the##6##3##(1992-3#1)(1996-3#1)(1997-5#1)(2007-11#1)(2008-10#2)
not necessarily##73##2##(1991-1#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
not necessary for##9##3##(1994-2#1)(2007-12#1)(2008-10#4)(2011-2#1)(2012-2#1)(2013-1#1)
not necessary in##2##3##(2011-1#1)(2013-8#1)
not necessary to explain the##2##5##(2008-10#2)
not necessary to##9##3##(1992-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2010-7#1)(2012-2#1)(2013-8#1)
not necessary##32##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-5#1)(1994-2#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
not need any##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
not need the##2##3##(2008-10#2)
not need to be##6##4##(1991-11#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
not need to##10##3##(1991-11#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#2)
not need##31##2##(1991-11#1)(1994-3#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2013-7#1)
not needed for##4##3##(1994-8#1)(1995-2#1)(2007-12#1)(2008-5#1)
not needed in##2##3##(1995-3#1)(1995-8#1)
not needed##11##2##(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
not negligible##7##2##(1990-6#1)(1990-9#1)(1993-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-10#1)
not new##6##2##(1994-12#1)(1994-3#1)(2008-12#1)(2009-10#1)(2009-8#1)(2010-2#1)
not normally distributed##2##3##(2008-3#1)(2013-1#1)
not normally##9##2##(1995-6#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
not now##4##2##(1991-12#1)(1994-3#1)(2008-3#1)(2008-6#1)
not obligated to##2##3##(1992-1#1)(1996-5#1)
not observed between##2##3##(1995-3#1)(2011-1#1)
not observed for##4##3##(2007-10#1)(2007-12#1)(2008-10#2)
not observed in any##4##4##(1995-3#1)(1996-5#1)(2008-2#1)(2009-5#1)
not observed in the control##2##5##(1992-8#1)(2010-12#1)
not observed in the##17##4##(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#2)(1995-11#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-11#2)(2010-10#1)(2010-12#1)(2011-1#1)
not observed in treatments with##2##5##(2008-10#2)
not observed in##54##3##(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-11#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
not observed on##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
not observed with##5##3##(1990-5#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-2#1)
not observed##118##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
not obtainable##3##2##(2007-12#1)(2010-8#1)(2011-2#1)
not obtained in##2##3##(2007-5#1)(2008-10#1)
not obtained##7##2##(1994-9#1)(2007-5#1)(2008-10#2)(2008-12#2)(2009-5#1)
not obvious in##2##3##(1990-7#1)(2008-7#1)
not obvious##7##2##(1990-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
not occur during the##2##4##(2007-5#1)(2008-10#1)
not occur during##3##3##(2007-10#1)(2007-5#1)(2008-10#1)
not occur in isolation##3##4##(2010-10#1)(2013-1#2)
not occur in the##2##4##(1991-8#1)(2008-5#1)
not occur in##17##3##(1990-3#1)(1990-9#1)(1991-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
not occur##54##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
not occurred##3##2##(2008-10#2)(2008-11#1)
not of the##5##3##(1991-12#1)(1993-3#1)(2008-10#2)(2013-7#1)
not of##35##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-8#1)(1996-3#1)(1997-7#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
not offer any##2##3##(1997-3#1)(2008-9#1)
not offer##8##2##(1996-1#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-9#2)
not offered##2##2##(1994-3#1)(2007-6#1)
not often##2##2##(1993-3#1)(2008-10#1)
not omit##2##2##(1990-11#1)(1996-3#1)
not on HRT##3##3##(2008-5#3)
not on an inhaled##2##4##(2012-1#2)
not on any##2##3##(2008-9#1)(2010-12#1)
not on the##7##3##(1992-6#1)(1993-1#1)(1993-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
not on their##2##3##(1991-2#1)(1993-1#1)
not on##45##2##(1990-3#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-1#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2010-12#1)(2012-1#3)(2012-2#1)(2013-1#2)(2013-8#1)
not one##4##2##(1996-12#1)(2007-11#1)(2008-4#1)(2010-12#1)
not only a##11##3##(1990-11#1)(1990-6#1)(1991-9#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)
not only able to##2##4##(2008-8#1)(2012-2#1)
not only affects##2##3##(2008-11#1)(2012-3#1)
not only against##2##3##(1992-8#1)(2008-4#1)
not only allows the##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
not only an##5##3##(1994-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)
not only as a##7##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)
not only as an##3##4##(1992-11#1)(2008-2#1)(2008-4#1)
not only as##15##3##(1992-11#1)(1992-12#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)
not only at the##4##4##(2007-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
not only be##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
not only because of##2##4##(1995-2#1)(1996-12#1)
not only because##4##3##(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)
not only by the##8##4##(1990-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
not only by##17##3##(1990-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-3#1)
not only can##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
not only direct##2##3##(1991-12#1)(2009-9#1)
not only enhanced##2##3##(1992-9#1)(2008-8#1)
not only enhances##2##3##(2008-10#1)(2012-12#1)
not only fluorescence##2##3##(2008-10#1)(2008-2#1)
not only for mothers but for caregivers##2##7##(2013-1#2)
not only for research##2##4##(2008-4#1)(2012-1#1)
not only for the##4##4##(1994-2#1)(1997-4#1)(1997-7#1)(2008-7#1)
not only for##35##3##(1991-2#1)(1991-6#1)(1993-3#1)(1994-2#1)(1995-9#1)(1996-5#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
not only from the##5##4##(1991-5#1)(1992-6#2)(1996-12#1)(2008-10#1)
not only from##12##3##(1991-5#1)(1992-6#3)(1995-5#1)(1996-12#1)(2008-10#2)(2008-3#2)(2008-7#2)
not only has##2##3##(2008-10#1)(2013-8#1)
not only have the##2##4##(2008-11#1)(2008-7#1)
not only help##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
not only helps in##2##4##(2013-8#2)
not only important##3##3##(1992-8#1)(2008-7#1)(2013-1#1)
not only improve##2##3##(2011-1#1)(2013-1#1)
not only in fibroblastic cells##2##5##(2008-4#2)
not only in patients with##2##5##(1996-6#1)(2008-7#1)
not only in the##12##4##(1994-9#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#3)(2008-9#1)(2011-2#1)
not only in##43##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
not only increase the##2##4##(2008-10#1)(2008-4#1)
not only increase##3##3##(1997-1#1)(2008-10#1)(2008-4#1)
not only increased##2##3##(2008-10#2)
not only individual##2##3##(1996-2#1)(2008-7#1)
not only inhibited##2##3##(2008-10#2)
not only inhibits##2##3##(1997-6#1)(2012-2#1)
not only involve##2##3##(1990-12#1)(1995-12#1)
not only involved in##2##4##(1997-7#1)(2012-2#1)
not only is the##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
not only is##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2013-1#1)
not only its own##2##4##(2008-9#1)(2010-6#1)
not only its##4##3##(1992-3#1)(1994-11#1)(2008-9#1)(2010-6#1)
not only left##2##3##(2012-1#1)(2013-8#1)
not only of the##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
not only of##12##3##(1991-11#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)
not only on the##10##4##(1991-2#2)(1995-5#1)(1997-1#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-3#1)
not only on##18##3##(1991-12#1)(1991-2#2)(1995-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
not only provide##3##3##(1994-2#1)(2008-8#1)(2008-9#1)
not only provided a##2##4##(2008-10#1)(2008-3#1)
not only provided##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
not only provides##4##3##(2008-1#1)(2008-8#1)(2008-9#1)(2012-3#1)
not only recognize##2##3##(1993-11#1)(1995-3#1)
not only reduce##2##3##(2007-12#1)(2010-10#1)
not only results in##3##4##(1993-3#1)(2008-8#1)(2011-2#1)
not only served##2##3##(1997-3#1)(2008-12#1)
not only that the##2##4##(2008-2#1)(2008-3#1)
not only the most##2##4##(1992-6#1)(2013-7#1)
not only the##50##3##(1991-2#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-6#1)(1997-3#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-6#1)(2013-1#2)(2013-7#1)
not only their##2##3##(2008-1#2)
not only to a##3##4##(1991-6#1)(2008-2#1)(2011-2#1)
not only to be##2##4##(2009-7#1)(2012-12#1)
not only to cations but also to low-molecular-weight solutes##2##9##(1990-5#2)
not only to enhance##2##4##(1997-8#1)(2011-2#1)
not only to identify##2##4##(1991-5#1)(2008-9#1)
not only to more##2##4##(2008-7#1)(2011-2#1)
not only to reduce##2##4##(2008-10#1)(2009-11#1)
not only to study##2##4##(2008-11#1)(2010-3#1)
not only to test for##2##5##(1997-5#1)(2008-7#1)
not only to the##10##4##(1991-3#1)(1993-6#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)
not only to##62##3##(1990-5#2)(1991-3#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-2#2)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#2)(2011-2#8)(2012-12#1)(2012-2#2)(2013-8#1)
not only via##2##3##(1990-5#1)(2011-2#1)
not only with respect to the##2##6##(2008-4#1)(2013-1#1)
not only with the##2##4##(2008-3#1)(2008-8#1)
not only with##10##3##(1990-7#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
not only##613##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#7)(1991-2#6)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#3)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#3)(1994-5#3)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#2)(1995-5#7)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#3)(2007-11#5)(2007-12#9)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#62)(2008-11#35)(2008-12#7)(2008-2#24)(2008-3#28)(2008-4#15)(2008-5#13)(2008-6#4)(2008-7#32)(2008-8#23)(2008-9#16)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#5)(2009-3#3)(2009-5#3)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#7)(2011-1#8)(2011-2#34)(2012-1#6)(2012-12#7)(2012-2#15)(2012-3#14)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#8)
not optimal##2##2##(2008-3#1)(2009-5#1)
not or##10##2##(1990-2#1)(1992-5#1)(1995-6#1)(2008-10#5)(2008-9#1)(2011-2#1)
not other##4##2##(1993-3#1)(1994-8#2)(2008-7#1)
not others##2##2##(1991-2#1)(2007-12#1)
not otherwise specified##5##3##(1993-12#1)(2007-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
not otherwise##12##2##(1991-8#2)(1993-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
not over##2##2##(1992-9#1)(1996-5#1)
not overlap with the##2##4##(1993-11#1)(2011-2#1)
not overlap##6##2##(1993-11#1)(2007-12#1)(2008-3#1)(2008-6#2)(2011-2#1)
not ozone##2##2##(1996-1#1)(2008-10#1)
not paid##2##2##(1996-12#1)(2008-3#1)
not parallel##3##2##(1991-5#1)(2008-11#2)
not part of##3##3##(1993-12#1)(2011-2#2)
not participate in the##2##4##(1997-2#1)(2008-10#1)
not participate in##3##3##(1995-6#1)(1997-2#1)(2008-10#1)
not particularly##2##2##(2007-11#1)(2008-9#1)
not pass through##3##3##(1990-5#1)(2008-10#1)(2008-6#1)
not pass##5##2##(1990-5#1)(1991-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
not pathogenic##4##2##(2008-10#4)
not penetrate into the##2##4##(2008-10#1)(2008-5#1)
not penetrate##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
not perfect##2##2##(1994-3#1)(1997-3#1)
not perform##6##2##(2008-10#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-3#1)(2009-9#1)
not performed for##2##3##(1996-3#1)(2007-11#1)
not performed##5##2##(1992-9#1)(1994-12#1)(1996-3#2)(2007-11#1)
not permit##7##2##(1991-2#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
not place##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
not planning##2##2##(1993-1#1)(1997-3#1)
not play a major role in mediating##2##7##(2008-7#1)(2013-1#1)
not play a major role in##5##6##(2008-4#1)(2008-7#1)(2009-8#2)(2013-1#1)
not play a role in##8##5##(1990-7#1)(1993-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)
not play a##15##3##(1990-7#1)(1993-3#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#2)(2010-8#1)(2013-1#1)
not play an important role##2##5##(1992-3#1)(2008-10#1)
not play##18##2##(1990-7#1)(1992-3#1)(1993-3#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#2)(2010-8#1)(2013-1#1)
not pose##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
not possess the##2##3##(2008-10#2)
not possess##5##2##(1992-9#1)(2008-10#3)(2008-8#1)
not possible and##2##3##(2007-7#1)(2008-4#1)
not possible for##4##3##(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)
not possible in##2##3##(2008-8#1)(2011-1#1)
not possible to analyse##2##4##(2008-10#1)(2008-7#1)
not possible to ascertain##2##4##(1990-5#1)(2007-8#1)
not possible to confirm its##2##5##(2008-10#1)(2011-2#1)
not possible to##23##3##(1990-5#1)(1992-9#1)(1993-9#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#2)(2012-12#1)
not possible with the##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
not possible with##7##3##(1993-3#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-1#1)(2011-2#1)
not possible##59##2##(1990-11#1)(1990-5#1)(1991-11#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#5)(2012-12#1)
not potentiate the##4##3##(1992-3#1)(1993-3#1)(1996-2#1)(2008-5#1)
not practical for##2##3##(2007-12#1)(2013-1#1)
not practical##3##2##(2007-12#1)(2008-11#1)(2013-1#1)
not practicing##2##2##(1992-1#2)
not practising##2##2##(1993-1#2)
not precisely known##3##3##(1993-6#1)(1994-5#1)(2010-6#1)
not predict the##3##3##(2007-12#1)(2007-7#1)(2008-11#1)
not predict##23##2##(1994-12#1)(1995-12#2)(1995-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#2)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
not predicted by##3##3##(1996-12#1)(1996-7#1)(2012-2#1)
not predicted##4##2##(1996-12#1)(1996-7#1)(2008-10#1)(2012-2#1)
not predictive of##7##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
not predictive##8##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
not present any significant##2##4##(2008-10#2)
not present any##5##3##(1992-10#1)(2008-10#3)(2008-8#1)
not present in the##12##4##(1990-11#1)(1993-6#1)(1994-12#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
not present in##20##3##(1990-11#1)(1993-6#1)(1994-12#1)(1995-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
not present##53##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-8#2)(1997-8#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
not prevent##22##2##(1991-9#1)(1992-9#2)(1993-3#2)(1994-10#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-11#2)(2011-2#1)(2012-3#1)
not prevented by##3##3##(1990-12#1)(1992-3#1)(1997-4#1)
not prevented##4##2##(1990-12#1)(1992-3#1)(1995-1#1)(1997-4#1)
not previously been detected##2##4##(1996-5#1)(2008-10#1)
not previously been reported in##2##5##(2012-8#1)(2013-8#1)
not previously been reported##6##4##(1990-7#1)(2007-10#1)(2008-10#1)(2011-1#1)(2012-8#1)(2013-8#1)
not previously been##18##3##(1990-7#1)(1994-1#1)(1994-6#1)(1996-1#1)(1996-5#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-8#1)(2013-1#1)(2013-8#1)
not previously described##5##3##(2007-12#1)(2008-10#3)(2008-7#1)
not previously known##3##3##(1991-5#1)(1993-12#1)(2008-9#1)
not previously possible##2##3##(2010-4#1)(2012-2#1)
not previously reported in the##2##5##(2007-11#1)(2008-10#1)
not previously reported in##3##4##(2007-11#1)(2008-10#2)
not previously reported##7##3##(1994-8#1)(2007-11#1)(2008-10#4)(2008-8#1)
not previously##49##2##(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
not primarily##2##2##(1994-9#1)(2008-7#1)
not processed##2##2##(1992-3#1)(2009-2#1)
not produce a##2##3##(1993-6#1)(2008-8#1)
not produce any##7##3##(1992-9#1)(1995-12#2)(1995-2#1)(1997-1#1)(2008-10#1)(2013-1#1)
not produce significant##2##3##(2008-10#1)(2008-4#1)
not produce the##3##3##(2008-10#2)(2012-12#1)
not produce##48##2##(1990-12#1)(1991-1#1)(1991-3#2)(1991-7#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-12#2)(1995-2#2)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#3)
not produced by the##2##4##(1994-2#1)(2008-5#1)
not produced by##3##3##(1994-2#1)(1995-12#1)(2008-5#1)
not produced##8##2##(1994-2#1)(1995-12#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
not prominent##2##2##(1991-12#1)(2012-3#1)
not promote##12##2##(1995-12#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-5#3)(2008-9#1)(2013-1#1)
not properly##7##2##(1995-6#2)(2008-10#2)(2008-11#2)(2008-2#1)
not proportional##2##2##(2008-10#1)(2008-7#1)
not protect##6##2##(1991-12#1)(1992-9#1)(1993-6#1)(1994-10#1)(1995-11#1)(1996-12#1)
not prove##9##2##(1990-2#1)(1991-12#1)(1991-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(2007-6#1)(2008-10#1)(2008-4#1)
not proven##3##2##(1992-8#1)(2011-2#1)(2013-1#1)
not provide a good##2##4##(1990-3#1)(2013-1#1)
not provide a##10##3##(1990-3#1)(1995-12#1)(1996-3#1)(1997-2#2)(2008-2#2)(2008-7#1)(2010-9#1)(2013-1#1)
not provide an##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
not provide any protection##2##4##(1995-11#1)(2008-10#1)
not provide any##5##3##(1995-11#1)(2008-10#1)(2008-12#1)(2009-4#1)(2013-1#1)
not provide evidence for##2##4##(1992-9#1)(1993-8#1)
not provide evidence##3##3##(1992-9#1)(1993-8#1)(2008-10#1)
not provide information for##2##4##(1995-2#1)(2008-11#1)
not provide information##3##3##(1995-2#1)(2008-11#1)(2008-4#1)
not provide support##2##3##(2008-5#1)(2010-3#1)
not provide the##2##3##(2008-10#2)
not provide##52##2##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#3)(2013-1#2)
not provided by##4##3##(2008-1#1)(2008-4#2)(2009-3#1)
not provided##10##2##(1990-11#1)(1991-2#1)(1992-3#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)
not providing benefit for weight-loss outpatient services##2##7##(2010-8#2)
not providing##4##2##(1996-2#1)(2010-11#1)(2010-8#2)
not purely##2##2##(2012-3#2)
not quite##4##2##(1991-6#1)(1992-11#1)(2008-9#1)(2013-8#1)
not random##3##2##(2008-10#2)(2008-8#1)
not rare in##2##3##(2008-10#1)(2013-7#1)
not rare##6##2##(1990-2#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-7#1)
not rate-limiting##2##2##(1991-5#1)(2008-8#1)
not reach##16##2##(1991-2#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
not reached at##2##3##(2007-12#1)(2008-10#1)
not reached##10##2##(1993-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-12#1)
not react with##18##3##(1993-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-4#1)
not react##22##2##(1990-8#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-4#1)
not read##3##2##(1994-2#1)(1996-2#1)(2012-2#1)
not readily available##4##3##(1995-12#1)(2008-11#1)(2008-3#1)(2009-11#1)
not readily##16##2##(1990-5#1)(1991-5#1)(1992-8#1)(1993-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)
not ready##3##2##(1991-9#1)(1995-5#1)(2010-4#1)
not real##2##2##(2009-3#1)(2013-8#1)
not realize##3##2##(1993-3#1)(1997-8#1)(2013-1#1)
not realized##2##2##(1994-11#1)(2013-1#1)
not really##7##2##(1990-8#1)(1991-12#1)(1994-1#1)(1994-12#1)(2008-11#1)(2008-6#1)(2012-2#1)
not receive##27##2##(1993-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-6#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
not received previous##2##3##(1992-10#1)(2012-12#1)
not received the##2##3##(2010-11#1)(2013-1#1)
not received##14##2##(1990-2#1)(1991-4#1)(1992-10#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
not receiving chemotherapy##3##3##(2008-7#3)
not receiving##13##2##(1993-12#1)(1994-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#4)(2011-2#1)(2013-7#1)
not recognize the##3##3##(1992-3#1)(1996-2#1)(2008-3#1)
not recognize##6##2##(1992-3#1)(1995-6#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
not recognized by an##2##4##(1993-11#1)(1993-8#1)
not recognized by##3##3##(1993-11#1)(1993-8#1)(2013-1#1)
not recognized##7##2##(1993-11#1)(1993-8#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
not recommend##3##2##(1996-6#1)(2012-3#2)
not recommended as##2##3##(2008-3#1)(2011-2#1)
not recommended by the##2##4##(2007-7#1)(2012-3#1)
not recommended for##2##3##(1993-6#1)(2008-6#1)
not recommended##19##2##(1993-6#1)(1993-8#1)(1997-4#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-2#1)(2011-2#5)(2012-3#1)(2013-1#1)
not recover the##3##3##(2008-5#1)(2008-8#2)
not recover##8##2##(1991-9#2)(2008-5#1)(2008-7#1)(2008-8#2)(2012-1#1)(2013-8#1)
not recovered from##2##3##(2008-10#2)
not recovered##3##2##(2008-10#3)
not recur##2##2##(1993-3#1)(2008-7#1)
not reduce the##10##3##(1991-12#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-1#1)
not reduce##36##2##(1990-11#1)(1990-2#1)(1991-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-8#1)(2013-1#1)
not reduced in##4##3##(1993-12#2)(1993-3#1)(2011-2#1)
not reduced##15##2##(1991-5#1)(1992-11#1)(1993-12#2)(1993-3#1)(1995-2#2)(1996-11#1)(1996-12#1)(2007-4#1)(2008-10#3)(2011-2#1)(2013-7#1)
not reflect the##4##3##(2008-5#2)(2008-7#1)(2009-5#1)
not reflect##10##2##(1996-6#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)
not reflected in the##2##4##(1996-2#1)(2009-7#1)
not reflected##4##2##(1996-2#1)(2008-11#1)(2009-7#1)(2011-2#1)
not regarded##2##2##(1993-1#1)(1996-3#1)
not registered##3##2##(1993-8#1)(1994-9#1)(2008-6#1)
not regularly##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
not regulated by##5##3##(1994-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(2012-2#1)
not relate to##3##3##(1992-9#1)(1996-2#1)(2008-7#1)
not related to an##2##4##(2008-10#1)(2009-3#1)
not related to diastolic suction##5##5##(2011-2#5)
not related to the total##2##5##(1991-12#1)(2009-5#1)
not related to the##18##4##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-8#1)(2008-10#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)
not related to##65##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2013-1#1)(2013-7#1)
not related##68##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#1)(2013-1#1)(2013-7#1)
not release##5##2##(1990-11#2)(1990-2#1)(1996-2#1)(2008-11#1)
not released from the##2##4##(1992-6#1)(2008-10#1)
not released##3##2##(1991-8#1)(1992-6#1)(2008-10#1)
not relevant##3##2##(2008-7#1)(2010-3#1)(2011-2#1)
not reliable##2##2##(1996-5#1)(2008-5#1)
not reliably##4##2##(1994-8#1)(1996-11#1)(1996-3#1)(1997-5#1)
not rely on a##3##4##(1992-6#1)(2007-12#1)(2008-8#1)
not rely on##8##3##(1990-12#1)(1992-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)
not rely##9##2##(1990-12#1)(1992-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2009-5#1)
not removed##5##2##(1991-10#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-2#1)
not replace##6##2##(1990-5#1)(1991-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)
not replaced##2##2##(1993-8#1)(2008-11#1)
not replicate##2##2##(1997-3#1)(2008-11#1)
not report##8##2##(1995-12#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
not reported in##3##3##(1991-6#1)(2008-10#1)(2010-12#1)
not reported##14##2##(1991-6#1)(1993-3#1)(1994-3#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
not represent a##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#3)
not represent the##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2010-9#1)
not represent##18##2##(1992-5#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-5#4)(2010-11#1)(2010-3#1)(2010-9#1)
not represented in##2##3##(2008-7#1)(2008-9#1)
not require a##12##3##(1992-3#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#2)
not require any separation step##3##5##(2008-10#3)
not require any separation##5##4##(2008-10#5)
not require any special##2##4##(2008-10#2)
not require any##20##3##(1991-2#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
not require pretreatment of##2##4##(2008-10#2)
not require special##3##3##(1996-12#1)(1997-2#1)(2008-3#1)
not require the addition of##2##5##(1992-9#1)(2012-3#1)
not require the##15##3##(1991-2#1)(1992-12#2)(1992-6#1)(1992-9#1)(1995-6#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
not require##120##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#3)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#2)(2008-10#30)(2008-11#2)(2008-2#2)(2008-3#11)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
not required for the##5##4##(1991-5#1)(1992-10#1)(1994-8#1)(1995-6#1)(2008-11#1)
not required for##19##3##(1991-5#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
not required in##3##3##(2007-12#1)(2008-4#1)(2013-1#1)
not required to obtain##3##4##(2008-10#2)(2008-2#1)
not required to##6##3##(1993-9#1)(1995-2#1)(2008-10#3)(2008-2#1)
not required##48##2##(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#3)
not requiring##8##2##(1990-12#1)(1990-8#1)(1993-12#1)(2008-10#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
not rescue##3##2##(1994-8#1)(2008-8#1)(2010-6#1)
not resistant to##4##3##(1993-8#2)(2007-10#1)(2008-10#1)
not resolvable##2##2##(2008-10#1)(2008-7#1)
not resolve##4##2##(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)
not resolved##3##2##(1991-3#1)(2008-4#1)(2011-1#1)
not respond to any of the##2##6##(1992-11#1)(2007-12#1)
not respond to conventional##2##4##(2011-2#1)(2012-12#1)
not respond to medical treatment##2##5##(1991-11#1)(1997-8#1)
not respond to##33##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-8#1)
not respond##36##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#3)(2013-8#1)
not responded to##3##3##(1997-7#1)(2011-2#1)(2013-7#1)
not responding to##3##3##(2007-7#1)(2008-1#1)(2008-9#1)
not responsible for the##2##4##(1995-2#1)(2010-6#1)
not responsible for##3##3##(1994-8#1)(1995-2#1)(2010-6#1)
not responsive to##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
not restricted to the##2##4##(1997-7#1)(2008-7#1)
not restricted to##15##3##(1991-1#1)(1992-9#1)(1994-3#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
not restricted##16##2##(1991-1#1)(1992-9#1)(1994-3#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
not result from##3##3##(1990-5#1)(1992-2#1)(1996-5#1)
not result in a significant##2##5##(2008-10#1)(2008-6#1)
not result in a##5##4##(1996-8#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
not result in an##2##4##(1995-6#1)(2008-10#1)
not result in improved##2##4##(1997-1#1)(2009-6#1)
not result in significant##2##4##(2011-2#1)(2012-3#1)
not result in##40##3##(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-8#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-3#1)
not result##43##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-3#1)
not retained##5##2##(1992-6#1)(2008-10#4)
not reveal a##4##3##(1996-12#1)(1997-5#1)(2008-10#1)(2008-12#1)
not reveal any##14##3##(1992-1#1)(1993-6#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
not reveal##36##2##(1991-6#1)(1992-1#1)(1992-5#1)(1993-6#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(1997-9#2)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
not revealed by##2##3##(2008-10#1)(2013-1#1)
not reverse the##2##3##(1997-1#1)(2013-1#1)
not reverse##3##2##(1996-2#1)(1997-1#1)(2013-1#1)
not reversed##3##2##(1992-3#1)(1994-2#1)(2013-1#1)
not reversible##3##2##(1992-3#1)(1996-5#1)(2012-3#1)
not risk##2##2##(1997-1#1)(2013-8#1)
not routine##2##2##(1993-2#1)(2012-3#1)
not routinely used##2##3##(2008-6#1)(2011-2#1)
not routinely##9##2##(1992-6#1)(1996-11#1)(2007-2#2)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
not rule out the possibility of##2##6##(2008-1#1)(2011-2#1)
not rule out the##3##4##(1990-10#1)(2008-1#1)(2011-2#1)
not rule out##5##3##(1990-10#1)(1996-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
not satisfactory for##2##3##(2008-7#1)(2008-9#1)
not satisfactory##10##2##(1991-6#1)(2008-10#1)(2008-7#2)(2008-9#2)(2011-1#2)(2011-2#1)(2012-2#1)
not satisfied with##3##3##(2007-10#2)(2012-3#1)
not satisfied##4##2##(1990-6#1)(2007-10#2)(2012-3#1)
not scale##2##2##(2010-10#1)(2010-2#1)
not scientifically##2##2##(2008-12#1)(2013-1#1)
not seek##2##2##(2008-5#1)(2008-7#1)
not seem to be a##3##5##(1994-11#1)(1995-12#1)(2011-2#1)
not seem to be influenced##3##5##(1990-9#1)(1995-5#1)(2009-11#1)
not seem to be##19##4##(1990-10#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(2007-4#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
not seem to have a##2##5##(1990-8#1)(2009-6#1)
not seem to have##5##4##(1990-8#1)(1992-6#1)(1994-3#1)(2008-10#1)(2009-6#1)
not seem to##45##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
not seem##48##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
not seen by##2##3##(2010-12#1)(2010-8#1)
not seen in the##2##4##(1995-5#1)(2007-12#1)
not seen in##8##3##(1990-3#1)(1992-7#1)(1994-5#2)(1995-11#1)(1995-5#1)(2007-12#1)(2008-1#1)
not seen on##2##3##(1997-8#1)(2012-2#1)
not seen until##3##3##(1997-3#2)(2008-3#1)
not seen with##4##3##(1990-5#1)(1997-8#1)(2008-6#1)(2008-8#1)
not seen##28##2##(1990-12#2)(1990-3#1)(1990-5#1)(1992-7#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-5#1)(1997-3#3)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
not selected##4##2##(2007-8#1)(2008-10#1)(2013-1#2)
not selective##2##2##(2008-10#2)
not sensitive to##13##3##(1991-6#1)(1992-8#1)(1993-9#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
not sensitive##17##2##(1991-6#1)(1992-8#1)(1993-9#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
not separate##7##2##(1995-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2010-8#1)
not serve as##2##3##(1996-3#1)(2008-7#1)
not serve##3##2##(1992-9#1)(1996-3#1)(2008-7#1)
not settled##2##2##(1996-9#1)(2008-5#1)
not share##6##2##(1992-5#1)(1994-2#1)(2008-3#1)(2013-1#1)(2013-8#2)
not shared by##3##3##(1992-6#1)(1995-11#1)(1996-5#1)
not shift##4##2##(1994-6#1)(1995-5#1)(2007-12#1)(2008-10#1)
not short-term memory##2##3##(1992-11#1)(1993-12#1)
not show a significant similarity to any other gene##3##9##(1996-12#2)(1996-6#1)
not show a significant##5##4##(1996-12#2)(1996-6#1)(2007-7#1)(2008-5#1)
not show a##14##3##(1992-9#1)(1996-12#2)(1996-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-2#2)
not show adverse##2##3##(1992-3#1)(2012-3#1)
not show an association##2##4##(2012-2#1)(2013-8#1)
not show any major##2##4##(2008-8#1)(2010-6#1)
not show any##44##3##(1990-2#2)(1990-6#1)(1992-6#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
not show evidence of##2##4##(1990-8#1)(2008-4#1)
not show immunoreactivity##2##3##(1993-6#1)(1996-5#1)
not show significant differences##5##4##(1995-12#1)(2007-10#1)(2008-10#1)(2011-2#1)(2013-7#1)
not show significant##16##3##(1991-12#1)(1995-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
not show the expected##2##4##(1992-9#1)(2012-12#1)
not show the##7##3##(1992-9#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
not show##130##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-6#2)(1993-8#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#3)
not showing##2##2##(2012-3#1)(2013-1#1)
not shown##10##2##(1992-3#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-3#2)(2013-1#1)
not significant and##3##3##(1993-12#1)(1997-4#1)(2008-10#1)
not significant in##3##3##(1994-11#1)(2009-2#2)
not significant##74##2##(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#5)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#2)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
not significant)##2##2##(1992-5#1)(2008-7#1)
not significantly affect the##5##4##(1997-7#1)(2007-12#1)(2008-2#1)(2010-4#1)(2010-8#1)
not significantly affect##9##3##(1993-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
not significantly affected by addition of##2##6##(2008-12#1)(2010-2#1)
not significantly affected by dietary Cd level or nutrient deficiencies##2##10##(1997-4#2)
not significantly affected by the##3##5##(1996-12#1)(2008-10#1)(2008-2#1)
not significantly affected by##17##4##(1990-5#1)(1993-3#1)(1995-8#1)(1996-12#1)(1997-4#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2010-2#1)(2010-5#1)
not significantly affected##25##3##(1990-5#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-2#1)
not significantly alter the##4##4##(1992-3#1)(1995-11#1)(2008-10#2)
not significantly alter##10##3##(1991-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-11#2)(1997-4#1)(2008-10#2)
not significantly altered by##3##4##(1992-1#1)(1992-3#1)(1995-12#1)
not significantly altered##9##3##(1992-1#1)(1992-3#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
not significantly associated with##4##4##(2007-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
not significantly associated##5##3##(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
not significantly change the##4##4##(1994-5#1)(1995-1#1)(1995-12#1)(2008-10#1)
not significantly change##7##3##(1994-5#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-2#2)(2010-8#1)
not significantly changed by##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
not significantly changed##6##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
not significantly correlated with##4##4##(2008-10#1)(2008-7#2)(2008-8#1)
not significantly correlated##5##3##(1990-8#1)(2008-10#1)(2008-7#2)(2008-8#1)
not significantly decreased in the##2##5##(1990-7#1)(1997-2#1)
not significantly different (p&gt##2##4##(2008-12#1)(2008-5#1)
not significantly different among the##5##5##(2008-10#1)(2008-12#1)(2008-7#2)(2013-1#1)
not significantly different among##9##4##(2008-10#4)(2008-12#1)(2008-7#2)(2008-9#1)(2013-1#1)
not significantly different between the##4##5##(1995-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
not significantly different between##12##4##(1991-8#1)(1993-11#1)(1995-12#1)(1996-12#1)(1996-7#1)(2008-10#2)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
not significantly different for##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
not significantly different from 1##2##5##(2008-10#2)
not significantly different from controls##3##5##(1991-12#1)(1995-8#1)(2008-7#1)
not significantly different from that of the##3##7##(2008-10#1)(2008-5#1)(2008-7#1)
not significantly different from that of##4##6##(1990-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
not significantly different from that##8##5##(1990-8#1)(1992-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)
not significantly different from the##10##5##(1993-1#1)(1993-6#1)(2007-7#2)(2008-10#3)(2008-6#1)(2008-8#1)(2012-3#1)
not significantly different from those of##2##6##(1997-6#1)(2010-8#1)
not significantly different from those##4##5##(1990-12#1)(1997-6#1)(2008-8#1)(2010-8#1)
not significantly different from##39##4##(1990-12#1)(1990-8#1)(1991-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-7#2)(2008-10#15)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
not significantly different in##6##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
not significantly different##91##3##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-12#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-6#2)(2007-7#2)(2008-10#29)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
not significantly higher than##2##4##(1991-5#1)(2008-10#1)
not significantly improve##3##3##(1995-2#1)(2013-1#2)
not significantly increase the##3##4##(1992-5#1)(2008-2#1)(2008-3#1)
not significantly induced##2##3##(2008-10#2)
not significantly influence survival##2##4##(1991-2#1)(2007-11#1)
not significantly influence##6##3##(1991-2#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-9#1)(2010-7#1)
not significantly inhibit##3##3##(1991-11#1)(1997-4#1)(2012-2#1)
not significantly lower than##2##4##(1991-11#1)(2008-10#1)
not significantly lower##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
not significantly modified##2##3##(1997-7#1)(2008-10#1)
not significantly perturb the##2##4##(1990-2#1)(2010-4#1)
not significantly reduced by##2##4##(1992-12#1)(2008-10#1)
not significantly reduced##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
not significantly related to##3##4##(1991-8#1)(2007-7#1)(2012-12#1)
not significantly##248##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#4)(1997-6#2)(1997-7#4)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#4)(2008-1#1)(2008-10#58)(2008-11#5)(2008-12#9)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#6)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
not simple##2##2##(2007-11#1)(2008-5#1)
not simply a##2##3##(2007-11#1)(2008-10#1)
not simply##13##2##(1991-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-7#1)(2012-12#1)(2013-1#1)
not small##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
not so much##2##3##(1991-6#1)(2008-4#1)
not so obvious##2##3##(2010-12#1)(2013-8#1)
not so significant##2##3##(2008-10#2)
not so##24##2##(1991-12#1)(1991-6#2)(1992-2#1)(1993-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#1)(2013-8#1)
not solely##10##2##(1994-5#1)(1995-11#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
not spatially##3##2##(2008-10#3)
not specific for##3##3##(1993-8#1)(1994-11#1)(2009-11#1)
not specific to##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
not specific##10##2##(1993-8#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
not specifically##7##2##(1994-9#1)(1996-4#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)
not spontaneously##2##2##(1997-7#1)(2008-11#1)
not stable##5##2##(2007-11#1)(2008-10#1)(2009-12#1)(2009-9#1)(2013-8#1)
not standardized##6##2##(1992-3#1)(1993-12#1)(1996-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
not statistically different between##3##4##(1990-3#1)(2012-3#2)
not statistically different from##5##4##(1992-5#1)(2008-10#3)(2012-3#1)
not statistically different##14##3##(1990-3#1)(1991-12#1)(1992-5#1)(1994-2#1)(1997-8#1)(2008-10#4)(2009-1#1)(2011-2#1)(2012-3#3)
not statistically significant in##2##4##(2008-7#1)(2011-2#1)
not statistically significant##55##3##(1990-11#1)(1990-6#1)(1991-6#1)(1992-2#1)(1992-4#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-8#6)(2008-1#2)(2008-10#7)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#5)(2012-2#1)(2013-1#4)(2013-8#3)
not statistically##72##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-5#1)(1994-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#2)(2006-12#1)(2007-10#2)(2007-2#1)(2007-8#6)(2008-1#2)(2008-10#11)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-3#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
not stimulate the##3##3##(1994-12#1)(1994-9#1)(2008-11#1)
not stimulate##13##2##(1990-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-3#1)(2008-10#3)(2008-11#1)
not stimulated by##3##3##(1990-11#1)(1992-11#1)(1992-3#1)
not stimulated##4##2##(1990-11#1)(1992-11#1)(1992-3#1)(1997-6#1)
not stop##3##2##(1990-12#1)(2008-3#1)(2008-5#1)
not straightforward##7##2##(1990-12#1)(1994-5#1)(2008-10#1)(2009-9#1)(2010-3#1)(2010-5#1)(2013-1#1)
not strictly##6##2##(1992-11#1)(1995-9#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)
not strong enough to##3##4##(1997-7#1)(2008-3#1)(2008-7#1)
not strong##4##2##(1997-7#1)(2008-3#1)(2008-7#1)(2009-7#1)
not strongly##4##2##(1992-3#1)(1994-9#1)(2008-10#2)
not structured##2##2##(2008-10#2)
not studies##2##2##(1990-11#1)(2009-8#1)
not subject to##9##3##(1991-3#1)(1991-7#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
not subject##10##2##(1991-3#1)(1991-7#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
not subjected to##2##3##(1993-6#1)(2008-2#1)
not substantially##4##2##(1992-4#1)(1994-1#1)(2008-10#1)(2012-1#1)
not substitute##2##2##(1992-3#1)(2008-11#1)
not successful in preventing##2##4##(2008-10#1)(2009-3#1)
not successful in##3##3##(1992-2#1)(2008-10#1)(2009-3#1)
not successful##13##2##(1990-5#1)(1991-2#1)(1992-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
not suffer from##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2009-10#1)
not suffer##8##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#1)(2009-10#1)
not suffice##2##2##(1991-12#1)(1991-2#1)
not sufficient for##9##3##(1992-3#1)(1992-6#1)(1994-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)
not sufficient in##3##3##(1992-3#1)(1994-3#1)(2011-2#1)
not sufficient to account for the##2##6##(1991-3#1)(1995-3#1)
not sufficient to induce##2##4##(1997-7#1)(2012-12#1)
not sufficient to##20##3##(1991-3#1)(1992-12#1)(1994-8#1)(1995-3#1)(1996-12#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#2)(2009-8#2)(2012-12#1)
not sufficient##40##2##(1991-3#2)(1992-12#1)(1992-3#2)(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2009-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
not sufficiently##3##2##(1990-9#1)(1997-4#1)(2008-10#1)
not suggest any##2##3##(1990-12#1)(1990-6#1)
not suggest##5##2##(1990-12#1)(1990-6#2)(2007-12#1)(2009-4#1)
not suitable for##13##3##(1996-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#2)(2010-4#1)(2010-6#1)(2012-12#1)
not suitable##18##2##(1996-7#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-9#2)(2010-4#1)(2010-6#1)(2012-12#1)(2013-8#1)
not suited for the##2##4##(2008-10#1)(2008-3#1)
not suited##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
not superior to aspirin##2##4##(2008-8#2)
not superior to the##2##4##(1997-8#1)(2007-8#1)
not superior to##7##3##(1997-8#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)
not superior##8##2##(1996-12#1)(1997-8#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)
not supplant##2##2##(1997-1#1)(2013-1#1)
not support a##4##3##(1991-6#1)(1997-5#1)(2007-12#1)(2012-2#1)
not support the argument that##2##5##(1997-1#1)(2008-8#1)
not support the assumption##2##4##(1992-8#1)(2013-8#1)
not support the hypothesis of##3##5##(1991-12#1)(1992-5#1)(1994-6#1)
not support the hypothesis##5##4##(1991-12#1)(1992-5#1)(1994-6#1)(2008-7#1)(2008-8#1)
not support the idea that##2##5##(1992-11#1)(2008-9#1)
not support the notion that##3##5##(1990-2#1)(1993-11#1)(1993-3#1)
not support the##26##3##(1990-2#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-6#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#1)(2013-8#1)
not support##51##2##(1990-2#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-5#3)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
not supported##3##2##(1996-1#1)(1997-5#1)(2012-3#1)
not suppress the##4##3##(1993-12#1)(1995-2#1)(1996-12#1)(2008-11#1)
not suppress##11##2##(1992-8#2)(1992-9#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)
not suppressed##6##2##(1993-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2011-1#1)
not suppressive##2##2##(2008-10#2)
not surprising that most##2##4##(2007-12#1)(2011-2#1)
not surprising that##6##3##(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)
not surprising##11##2##(1991-12#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)
not survive after##2##3##(1992-6#1)(2008-5#1)
not survive##10##2##(1992-6#1)(1993-3#1)(1996-4#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#2)
not susceptible to##3##3##(2008-10#2)(2010-5#1)
not susceptible##4##2##(1996-12#1)(2008-10#2)(2010-5#1)
not suspected##6##2##(1996-1#2)(2007-12#1)(2007-7#2)(2011-1#1)
not systematically##2##2##(2008-7#1)(2012-4#1)
not take into account the##2##5##(2008-10#1)(2011-2#1)
not take into account##4##4##(2008-10#1)(2009-2#1)(2009-4#1)(2011-2#1)
not take into##5##3##(2008-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2011-2#1)
not take place in##2##4##(2008-10#1)(2009-6#1)
not take place##5##3##(1990-10#1)(2008-10#2)(2009-6#1)(2011-2#1)
not take this##2##3##(1992-1#1)(2012-2#1)
not take##14##2##(1990-10#1)(1992-1#1)(1996-3#1)(2008-10#3)(2008-3#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-2#1)
not taken##9##2##(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-5#1)(2008-11#1)(2011-1#1)(2013-1#1)
not taking drugs##2##3##(2008-7#2)
not taking##8##2##(2008-10#2)(2008-7#2)(2010-1#4)
not teach##2##2##(2009-2#2)
not the 1##2##3##(1995-12#1)(1995-8#1)
not the case for the##2##5##(2008-11#2)
not the case for##4##4##(2008-10#1)(2008-11#2)(2011-2#1)
not the case##9##3##(1991-6#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)
not the cause of##5##4##(1992-12#1)(1995-2#1)(1995-5#1)(2008-10#1)(2012-3#1)
not the consequence of##3##4##(1990-12#1)(1995-12#1)(2011-1#1)
not the direct cause of death##2##6##(1996-12#1)(2008-1#1)
not the limiting##2##3##(2008-10#2)
not the native##2##3##(1990-5#1)(2008-8#1)
not the only##6##3##(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#1)
not the other##3##3##(1990-5#1)(2008-8#1)(2008-9#1)
not the physiological in vivo equilibrium volume and##5##8##(2011-2#5)
not the primary##2##3##(1996-12#1)(2008-10#1)
not the result of##8##4##(1995-11#2)(1996-2#1)(1997-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
not the same as the##2##5##(1995-3#1)(2008-3#1)
not the same as##4##4##(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
not the same for##2##4##(1997-8#1)(2013-8#1)
not the same##11##3##(1995-3#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-7#1)(2013-8#1)
not the sole##5##3##(1992-9#1)(1993-3#1)(1994-8#1)(2007-7#1)(2011-2#1)
not the##210##2##(1990-11#1)(1990-12#1)(1990-5#4)(1990-6#1)(1990-7#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#6)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-10#1)(2007-12#2)(2007-7#2)(2008-1#4)(2008-10#28)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-7#1)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#10)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
not their##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
not therefore##2##2##(2008-7#1)(2011-2#1)
not those##6##2##(1992-8#2)(1993-9#1)(1995-5#1)(2009-10#1)(2012-3#1)
not thought to##2##3##(2008-5#1)(2009-12#1)
not through##3##2##(1990-12#1)(2008-8#1)(2010-8#1)
not tightly##2##2##(1992-4#1)(2008-9#1)
not time and labor consuming##2##5##(2008-10#2)
not time##4##2##(1990-12#1)(2008-10#2)(2008-3#1)
not time-consuming##2##2##(2008-10#2)
not to a change in##2##5##(1993-12#1)(2011-2#1)
not to a##5##3##(1991-6#1)(1993-12#1)(1997-6#1)(2007-12#1)(2011-2#1)
not to affect##3##3##(2007-11#1)(2009-8#1)(2011-2#1)
not to be &quot##2##4##(1991-3#1)(2013-1#1)
not to be statistically##2##4##(2008-10#1)(2008-5#1)
not to be##21##3##(1990-3#1)(1990-5#1)(1991-3#2)(1992-11#2)(1992-12#1)(1992-5#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
not to cause##3##3##(1994-3#1)(2007-11#1)(2008-10#1)
not to differ##2##3##(2007-12#1)(2008-8#1)
not to follow##2##3##(1996-3#1)(2011-2#1)
not to function##2##3##(1993-9#1)(2009-9#1)
not to have##4##3##(1990-8#1)(1991-2#1)(2008-1#1)(2008-8#1)
not to increase the##2##4##(2008-3#1)(2012-3#1)
not to know##3##3##(2013-1#3)
not to participate in##4##4##(1994-1#1)(2012-2#1)(2013-1#2)
not to participate##5##3##(1994-1#1)(2010-11#1)(2012-2#1)(2013-1#2)
not to respond##2##3##(2010-4#1)(2010-5#1)
not to share##2##3##(2008-10#1)(2011-2#1)
not to the##7##3##(1992-3#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-7#1)(2009-2#1)
not to##171##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-2#2)(1994-3#5)(1994-8#1)(1994-9#1)(1995-11#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
not too small##2##3##(2008-3#1)(2008-8#1)
not too##12##2##(1994-3#1)(1996-4#1)(2007-11#1)(2008-3#2)(2008-8#5)(2010-2#1)(2011-3#1)
not total##2##2##(1996-12#1)(2008-5#1)
not totally##5##2##(1991-12#1)(1996-11#1)(2008-10#2)(2012-3#1)
not toxic to##3##3##(2008-10#2)(2008-7#1)
not toxic##4##2##(1990-12#1)(2008-10#2)(2008-7#1)
not traditionally##5##2##(1991-12#1)(1993-1#1)(1996-1#1)(2008-11#1)(2008-3#1)
not translate into##2##3##(2009-4#1)(2011-2#1)
not translate to##2##3##(2012-12#1)(2013-8#1)
not translate##4##2##(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
not translated into##2##3##(2008-6#1)(2010-6#1)
not transmit##3##2##(2008-10#3)
not transmitted by##2##3##(2008-10#2)
not transmitted##6##2##(2008-10#5)(2008-11#1)
not treat##3##2##(1995-12#1)(2008-7#2)
not treated with##9##3##(2008-10#4)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
not treated##16##2##(1990-9#1)(1991-5#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
not true##4##2##(1992-9#1)(2008-10#2)(2008-2#1)
not uncommon in##5##3##(1992-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
not uncommon##16##2##(1992-5#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
not under##3##2##(1995-3#1)(2008-10#1)(2012-3#1)
not underestimate the##3##3##(1991-12#1)(2007-9#1)(2008-9#1)
not undergo any##2##3##(1997-4#1)(2012-3#1)
not undergo the##3##3##(1992-8#1)(1995-6#1)(2009-5#1)
not undergo##15##2##(1992-8#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
not undergone any##2##3##(2008-11#1)(2012-1#1)
not undergone##5##2##(1992-2#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)
not understand##3##2##(2008-1#1)(2008-9#1)(2010-8#1)
not understood##11##2##(1992-3#1)(1992-9#1)(1997-3#2)(2006-6#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-5#1)(2013-1#1)
not unequivocally##2##2##(2008-10#1)(2011-2#1)
not uniform##9##2##(1991-1#1)(1994-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-8#1)(2011-2#1)
not uniformly##5##2##(1990-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
not unique to##2##3##(2008-10#1)(2008-11#1)
not unique##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
not universally##5##2##(1991-11#1)(2008-10#1)(2008-12#1)(2009-9#1)(2013-8#1)
not until##4##2##(1994-12#1)(1995-2#1)(1996-3#1)(2008-7#1)
not use the##2##3##(1994-2#1)(2008-3#1)
not use##22##2##(1991-6#1)(1992-9#1)(1994-2#1)(1996-1#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
not used as##2##3##(1992-11#1)(2008-7#1)
not used for##2##3##(2008-10#1)(2009-7#1)
not used to##3##3##(1992-3#1)(1996-12#1)(2008-9#1)
not used##23##2##(1992-11#1)(1992-3#1)(1993-10#1)(1993-2#1)(1994-12#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
not useful as a##2##4##(1994-2#1)(2008-7#1)
not useful for##2##3##(2008-10#1)(2013-8#1)
not useful in##2##3##(2008-9#1)(2011-2#1)
not useful to##2##3##(2006-10#1)(2010-11#1)
not useful##10##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
not using condoms during##3##4##(2010-7#2)(2011-1#1)
not using condoms##6##3##(1997-3#1)(1997-6#1)(2010-7#3)(2011-1#1)
not using##11##2##(1991-12#1)(1991-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-6#1)
not usually associated with##2##4##(2008-12#1)(2008-5#1)
not usually considered to##2##4##(2009-2#2)
not usually considered##3##3##(2008-4#1)(2009-2#2)
not usually observed in##2##4##(2012-12#1)(2012-3#1)
not usually##17##2##(1991-3#1)(1992-9#1)(1993-1#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#2)(2011-2#1)(2012-12#1)(2012-3#1)
not utilize##4##2##(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
not utilized##3##2##(1994-11#1)(1994-12#1)(2008-10#1)
not vaccinated##2##2##(1997-3#1)(2007-2#1)
not valid for##2##3##(2008-4#1)(2008-7#1)
not valid##3##2##(1990-11#1)(2008-4#1)(2008-7#1)
not validated##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
not vary as##2##3##(2008-11#1)(2009-4#1)
not vary by##6##3##(1997-2#1)(2008-1#2)(2008-10#1)(2010-11#1)(2012-12#1)
not vary significantly##7##3##(1996-1#1)(2008-10#1)(2008-8#3)(2009-7#1)(2013-7#1)
not vary strongly##2##3##(2008-2#1)(2008-8#1)
not vary with##5##3##(1995-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
not vary##30##2##(1990-3#1)(1990-5#1)(1991-2#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
not verified##2##2##(2008-10#2)
not very effective##3##3##(2007-11#1)(2010-9#1)(2013-8#1)
not very##16##2##(1990-12#1)(1990-5#1)(1991-2#1)(1994-3#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-10#4)(2009-5#1)(2009-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
not via##3##2##(1992-8#1)(1993-12#1)(2010-10#1)
not viable##2##2##(2008-10#1)(2010-4#1)
not view##2##2##(2007-10#1)(2010-7#1)
not visible at##2##3##(1993-12#1)(2012-2#1)
not visible in##5##3##(1990-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
not visible##10##2##(1990-7#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#2)
not visualize##2##2##(1990-12#1)(1997-8#1)
not want##4##2##(1994-7#1)(1996-1#1)(1996-8#1)(2012-3#1)
not warranted##3##2##(1990-12#1)(1996-12#1)(2008-7#1)
not wear##3##2##(2008-9#1)(2010-1#1)(2012-2#1)
not well defined##7##3##(1990-11#1)(1990-12#1)(1990-2#1)(1993-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
not well described##3##3##(2008-9#1)(2009-11#1)(2011-2#1)
not well documented##5##3##(1997-4#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
not well known##6##3##(1994-1#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
not well suited##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
not well understood and##2##4##(1996-6#1)(1997-3#1)
not well understood in##2##4##(2008-10#2)
not well understood##35##3##(1993-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
not well##71##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1993-12#1)(1993-9#1)(1994-1#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
not when##9##2##(1990-7#1)(1991-3#1)(1992-6#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-5#1)
not widely appreciated##2##3##(1997-8#1)(2008-10#1)
not widely##8##2##(1997-8#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-6#1)(2010-8#1)(2013-1#2)
not with that of##2##4##(1990-5#1)(2008-10#1)
not with the##7##3##(1997-7#1)(2008-10#3)(2010-2#1)(2011-1#1)(2013-8#1)
not with##60##2##(1990-3#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-6#2)(1994-2#1)(1994-6#3)(1994-8#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#3)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-4#1)(2012-5#2)(2013-8#1)
not within the##4##3##(1995-12#1)(2007-10#1)(2008-9#1)(2009-3#1)
not within##9##2##(1995-12#1)(1997-9#1)(2007-10#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-4#1)
not without##9##2##(1996-1#1)(1996-6#1)(2008-10#1)(2008-12#2)(2009-10#1)(2010-10#1)(2010-11#1)(2013-8#1)
not work and##2##3##(2008-7#1)(2013-1#1)
not work for##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
not work in##2##3##(1992-12#1)(2008-5#1)
not work##12##2##(1992-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
not working in physiotherapy##2##4##(1993-1#2)
not working in##3##3##(1993-1#2)(2007-8#1)
not working##4##2##(1993-1#3)(2007-8#1)
not yet available for##2##4##(2007-11#1)(2011-2#1)
not yet available##8##3##(1997-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#2)
not yet been clearly##3##4##(1990-8#1)(1991-5#1)(2008-6#1)
not yet been elucidated##2##4##(1990-11#1)(1993-1#1)
not yet been fully##2##4##(1995-6#1)(2012-2#1)
not yet been investigated##3##4##(2007-7#1)(2009-5#1)(2013-1#1)
not yet been published##3##4##(1990-11#1)(2007-8#1)(2008-10#1)
not yet been tested##2##4##(1993-9#1)(2008-10#1)
not yet been##64##3##(1990-11#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)(2009-5#2)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
not yet fully understood##4##4##(1991-2#1)(1994-8#1)(2008-7#1)(2009-11#1)
not yet fully##8##3##(1991-2#1)(1994-8#1)(1997-8#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2011-1#1)
not yet proven##2##3##(1991-6#1)(2008-7#1)
not yet reached##3##3##(1994-3#1)(2007-12#1)(2012-12#1)
not yet ready to##2##4##(1995-5#1)(2008-6#1)
not yet solved##2##3##(1992-11#1)(1997-8#1)
not yet well##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
not yet##164##2##(1990-11#4)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#2)(1992-5#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
not yield##9##2##(1992-3#1)(1997-5#1)(2006-12#1)(2008-10#4)(2008-3#1)(2013-1#1)
not##12803##1##(1990-10#15)(1990-11#70)(1990-12#65)(1990-2#62)(1990-3#30)(1990-4#1)(1990-5#76)(1990-6#40)(1990-7#42)(1990-8#61)(1990-9#21)(1991-1#29)(1991-10#6)(1991-11#26)(1991-12#117)(1991-2#72)(1991-3#44)(1991-4#10)(1991-5#44)(1991-6#49)(1991-7#9)(1991-8#36)(1991-9#50)(1992-1#22)(1992-10#18)(1992-11#52)(1992-12#66)(1992-2#42)(1992-3#107)(1992-4#14)(1992-5#34)(1992-6#74)(1992-7#3)(1992-8#57)(1992-9#71)(1993-1#35)(1993-10#2)(1993-11#52)(1993-12#128)(1993-2#40)(1993-3#73)(1993-5#11)(1993-6#71)(1993-7#1)(1993-8#59)(1993-9#58)(1994-1#28)(1994-10#7)(1994-11#61)(1994-12#76)(1994-2#97)(1994-3#79)(1994-5#55)(1994-6#71)(1994-7#7)(1994-8#110)(1994-9#52)(1995-1#28)(1995-11#81)(1995-12#137)(1995-2#126)(1995-3#53)(1995-4#6)(1995-5#61)(1995-6#107)(1995-8#57)(1995-9#14)(1996-1#31)(1996-10#1)(1996-11#16)(1996-12#97)(1996-2#90)(1996-3#52)(1996-4#12)(1996-5#86)(1996-6#34)(1996-7#20)(1996-8#17)(1996-9#16)(1997-1#50)(1997-2#73)(1997-3#98)(1997-4#65)(1997-5#34)(1997-6#52)(1997-7#71)(1997-8#53)(1997-9#6)(2006-10#16)(2006-12#7)(2006-5#1)(2006-6#8)(2006-8#3)(2007-1#2)(2007-10#68)(2007-11#122)(2007-12#168)(2007-2#39)(2007-3#1)(2007-4#8)(2007-5#23)(2007-6#11)(2007-7#81)(2007-8#83)(2007-9#8)(2008-1#138)(2008-10#2036)(2008-11#493)(2008-12#194)(2008-2#162)(2008-3#306)(2008-4#179)(2008-5#331)(2008-6#147)(2008-7#450)(2008-8#340)(2008-9#251)(2009-1#10)(2009-10#59)(2009-11#31)(2009-12#38)(2009-2#23)(2009-3#35)(2009-4#40)(2009-5#49)(2009-6#42)(2009-7#49)(2009-8#53)(2009-9#30)(2010-1#34)(2010-10#43)(2010-11#42)(2010-12#43)(2010-2#35)(2010-3#58)(2010-4#38)(2010-5#44)(2010-6#39)(2010-7#30)(2010-8#99)(2010-9#18)(2011-1#133)(2011-10#4)(2011-2#463)(2011-3#15)(2011-7#3)(2012-1#47)(2012-12#161)(2012-2#230)(2012-3#161)(2012-4#2)(2012-5#7)(2012-6#5)(2012-7#2)(2012-8#2)(2013-1#373)(2013-7#38)(2013-8#147)
not)##7##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)
not-DT##2##1##(2011-1#2)
not-certified metals##2##2##(2008-10#2)
not-for-profit health care##2##3##(1997-1#1)(2008-11#1)
not-for-profit hospital##2##2##(1997-3#1)(2008-11#1)
not-for-profit hospitals##2##2##(1992-8#1)(2008-11#1)
not-for-profit##14##1##(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#4)
not?##8##1##(1991-3#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-11#2)(2010-4#1)(2011-2#1)
notable cases##2##2##(1997-7#1)(2013-1#1)
notable differences##3##2##(1995-6#1)(2008-10#1)(2012-3#1)
notable exception##3##2##(1991-5#1)(2008-1#1)(2012-3#1)
notable exceptions##2##2##(1994-12#1)(2011-2#1)
notable findings##2##2##(1993-1#1)(1996-1#1)
notable for##4##2##(1997-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
notable in##2##2##(1992-8#1)(1996-12#1)
notable##49##1##(1990-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-8#2)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
notably at##2##2##(2010-3#1)(2011-1#1)
notably by the##2##3##(2008-12#1)(2008-5#1)
notably by##3##2##(2008-12#1)(2008-3#1)(2008-5#1)
notably for##2##2##(2008-10#1)(2008-3#1)
notably in##5##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
notably on##2##2##(2008-10#1)(2012-2#1)
notably the proopiomelanocortin (POMC) cells##2##5##(2008-4#2)
notably the##11##2##(1997-8#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)
notably those##4##2##(1990-9#1)(2008-8#1)(2012-12#1)(2013-7#1)
notably##88##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-9#4)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
notamment##2##1##(2008-11#1)(2013-1#1)
notanthes##3##1##(2008-10#3)
notation##3##1##(1995-2#1)(2013-1#2)
notch and##2##2##(1996-3#1)(2012-3#1)
notch filters##6##2##(2007-12#3)(2008-3#3)
notch##19##1##(1996-3#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#2)(2013-1#1)
notched tunnel##2##2##(2013-1#2)
notches##2##1##(2007-11#1)(2007-12#1)
notching##4##1##(2007-11#1)(2013-1#3)
note from##3##2##(1995-6#1)(2008-6#2)
note is the##2##3##(2008-12#1)(2013-1#1)
note of##5##2##(1991-3#1)(2007-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
note on the##3##3##(1990-2#1)(1992-1#1)(1992-9#1)
note on##6##2##(1990-2#1)(1992-1#1)(1992-9#1)(1995-2#1)(2007-12#1)(2008-12#1)
note that if the##2##4##(2008-10#1)(2011-1#1)
note that the##4##3##(1990-12#1)(1995-11#1)(2008-4#1)(2012-2#1)
note that there is a##2##5##(1994-9#1)(2008-1#1)
note that##19##2##(1990-12#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
note the##2##2##(1997-3#1)(2010-6#1)
note their##2##2##(2010-10#1)(2013-1#1)
note##87##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#4)(2009-10#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#5)(2011-2#9)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#1)
note]##3##1##(1992-9#2)(2013-1#1)
notebooks##2##1##(2008-10#1)(2012-2#1)
noted a##4##2##(1990-11#1)(1993-2#1)(2008-10#1)(2013-8#1)
noted above##2##2##(1992-8#1)(1994-12#1)
noted after##3##2##(2006-10#1)(2008-5#1)(2008-7#1)
noted among##5##2##(1994-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-8#1)
noted and##5##2##(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
noted at the##6##3##(1990-3#1)(2008-7#1)(2008-9#3)(2013-1#1)
noted at##14##2##(1990-3#1)(1993-12#1)(2006-10#2)(2008-10#1)(2008-7#1)(2008-9#4)(2009-7#1)(2010-8#1)(2013-1#2)
noted between these two##2##4##(2008-1#1)(2008-11#1)
noted between##13##2##(1995-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-7#1)(2013-1#1)
noted by##4##2##(2008-11#2)(2008-12#1)(2008-4#1)
noted down##3##2##(2007-11#1)(2010-7#2)
noted during the##2##3##(1993-1#1)(1995-3#1)
noted during##4##2##(1990-3#1)(1990-8#1)(1993-1#1)(1995-3#1)
noted following##3##2##(1997-7#1)(2008-10#1)(2012-3#1)
noted for##14##2##(1990-6#1)(1993-3#1)(1993-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2013-1#1)
noted in 7 patients##2##4##(2007-11#1)(2013-1#1)
noted in a##2##3##(1993-11#1)(2008-7#1)
noted in any##2##3##(2011-2#2)
noted in control cells##2##4##(1994-6#1)(1997-4#1)
noted in sitting position##3##4##(2012-3#3)
noted in the group##2##4##(2010-3#1)(2013-8#1)
noted in the##31##3##(1991-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
noted in these##2##3##(1993-9#1)(2008-6#1)
noted in three##2##3##(1990-8#1)(2008-7#1)
noted in##106##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#1)
noted on##5##2##(1994-12#1)(1996-12#1)(2007-12#1)(2008-8#1)(2012-8#1)
noted pain relief##2##3##(1997-7#1)(2007-11#1)
noted several##2##2##(1997-3#1)(2012-12#1)
noted that the##9##3##(1993-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#2)
noted that there##3##3##(1994-5#1)(1995-12#1)(2008-11#1)
noted that##27##2##(1991-9#1)(1993-11#1)(1994-5#1)(1995-12#3)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)
noted the##2##2##(2009-10#1)(2010-4#1)
noted to be##2##3##(2008-9#1)(2013-1#1)
noted to have##4##3##(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
noted to##9##2##(1992-1#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
noted were##3##2##(1995-8#1)(1997-3#1)(2010-8#1)
noted when##6##2##(1992-3#1)(1993-12#1)(1996-3#1)(1997-2#1)(2008-10#2)
noted with##8##2##(1991-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-10#1)
noted##364##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#5)(1991-3#3)(1991-4#2)(1991-9#1)(1992-1#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-9#4)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#5)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#3)(2006-10#4)(2007-10#1)(2007-11#10)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#8)(2008-1#7)(2008-10#29)(2008-11#9)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#3)(2009-5#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#15)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#8)(2012-7#1)(2012-8#1)(2013-1#23)(2013-7#1)(2013-8#9)
notes and##5##2##(1991-6#1)(2007-2#1)(2008-1#1)(2012-2#1)(2013-1#1)
notes for##4##2##(1991-9#1)(2008-11#2)(2011-1#1)
notes in##2##2##(2011-1#1)(2011-2#1)
notes of##3##2##(1995-9#1)(2007-12#1)(2012-2#1)
notes on the##2##3##(1992-3#1)(2008-11#1)
notes on##3##2##(1992-3#1)(2008-11#1)(2009-4#1)
notes or##2##2##(2009-12#1)(2011-2#1)
notes that##5##2##(1995-12#1)(1995-3#2)(1995-9#1)(2010-12#1)
notes the importance of##3##4##(1991-12#1)(1994-12#1)(2010-10#1)
notes##49##1##(1991-1#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#2)(1994-12#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-9#2)(1996-9#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-2#4)(2008-6#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)
notes]##2##1##(1991-5#1)(1993-9#1)
noteworthy that the##3##3##(1993-2#1)(2008-6#1)(2009-2#1)
noteworthy that##13##2##(1992-12#1)(1993-2#1)(1995-8#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-12#1)(2012-2#1)
noteworthy##21##1##(1992-12#1)(1993-2#1)(1995-8#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-10#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
nothing about##2##2##(1990-11#1)(2008-5#1)
nothing more##2##2##(2007-12#1)(2008-10#1)
nothing##17##1##(1990-11#1)(1992-10#1)(1992-2#1)(1993-3#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#2)
nothing?##3##1##(2008-8#1)(2012-2#2)
notice and comment##3##3##(1996-12#3)
notice of##2##2##(1991-3#1)(2008-10#1)
notice##12##1##(1990-7#1)(1991-3#1)(1995-6#1)(1996-12#3)(1996-5#1)(1997-6#2)(2008-1#1)(2008-10#1)(2013-7#1)
noticeable and##2##2##(2009-5#1)(2010-4#1)
noticeable differences##3##2##(1990-11#1)(1991-6#1)(2008-10#1)
noticeable improvement##2##2##(2008-2#1)(2008-5#1)
noticeable in the##3##3##(1994-6#1)(2007-8#1)(2008-5#1)
noticeable in##5##2##(1994-6#2)(2007-8#1)(2008-5#1)(2012-12#1)
noticeable##39##1##(1990-11#1)(1990-8#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-6#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
noticeably##10##1##(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)
noticed a##5##2##(1995-4#1)(1997-3#1)(2007-10#1)(2011-2#1)(2012-12#1)
noticed after##2##2##(2007-11#1)(2010-6#1)
noticed before##2##2##(2008-10#1)(2010-8#1)
noticed in the##3##3##(1996-1#1)(2007-11#1)(2013-1#1)
noticed in##12##2##(1990-8#1)(1996-1#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
noticed that##8##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)
noticed with##2##2##(1997-8#1)(2008-6#1)
noticed##60##1##(1990-12#1)(1990-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
notices##2##1##(2009-4#1)(2011-2#1)
notifiable diseases##3##2##(1997-3#3)
notifiable##7##1##(1994-9#1)(1997-3#4)(2011-2#1)(2013-1#1)
notification laws##3##2##(1994-2#2)(1997-3#1)
notification of##4##2##(1992-9#1)(1994-6#1)(1996-3#1)(2010-6#1)
notification rates in##2##3##(2013-8#2)
notification##24##1##(1990-3#1)(1992-9#1)(1994-2#3)(1994-6#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#5)(2012-3#1)(2013-8#2)
notifications##4##1##(2008-9#1)(2011-2#3)
notified to the population-based##2##4##(1993-9#2)
notified to the##6##3##(1992-11#2)(1993-9#2)(2008-11#2)
notified to##7##2##(1992-11#2)(1993-9#2)(2008-11#2)(2008-8#1)
notified##18##1##(1990-3#1)(1991-6#1)(1991-9#1)(1992-11#3)(1993-9#2)(1996-5#1)(1997-5#1)(2008-11#2)(2008-8#1)(2010-10#1)(2012-12#3)(2013-8#1)
noting that##5##2##(1993-11#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-2#1)
noting the##3##2##(1990-10#1)(1990-3#1)(2008-12#1)
noting##14##1##(1990-10#1)(1990-3#1)(1993-11#1)(2008-1#1)(2008-12#4)(2008-6#2)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
notion of &quot##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
notion of a##2##3##(2011-1#1)(2012-1#1)
notion of##27##2##(1992-1#1)(1992-2#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
notion that the##11##3##(1990-8#1)(1992-3#1)(1993-11#1)(1997-3#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
notion that##33##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-3#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
notion##67##1##(1990-2#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
notions of##8##2##(1994-3#1)(1997-6#1)(2007-3#1)(2008-1#1)(2008-11#1)(2009-3#1)(2010-10#1)(2012-2#1)
notions##13##1##(1992-3#1)(1994-3#2)(1997-6#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-10#1)(2012-2#1)
notochord and floor plate##4##4##(1994-12#4)
notochord##8##1##(1993-12#1)(1994-12#5)(2007-5#1)(2008-6#1)
notorious##5##1##(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)
notoriously difficult to study##2##4##(2008-9#1)(2009-9#1)
notoriously difficult to##5##3##(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
notoriously difficult##7##2##(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
notoriously##8##1##(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
noun##4##1##(1991-2#1)(2007-12#3)
nouns##4##1##(1991-2#1)(1995-2#1)(2008-2#1)(2008-4#1)
nourished##4##1##(1990-9#1)(2007-12#1)(2008-10#1)(2009-11#1)
nourishing##4##1##(1993-12#1)(2008-10#2)(2011-2#1)
nous##2##1##(2011-2#1)(2013-1#1)
nouveau-né##5##1##(2013-1#5)
nov##20##1##(2008-10#3)(2008-5#2)(2008-6#3)(2010-10#2)(2010-3#2)(2011-2#2)(2013-8#6)
novalgin concentration##2##2##(2008-10#2)
novalgin in##2##2##(2008-10#2)
novalgin##9##1##(2008-10#9)
novel &quot##2##2##(1994-11#1)(2009-11#1)
novel 1##3##2##(1994-12#1)(2007-11#1)(2008-10#1)
novel 11b-substituted##2##2##(2007-11#2)
novel CL##2##2##(2008-10#2)
novel DNA##4##2##(1990-5#1)(1991-12#1)(1995-6#1)(2007-11#1)
novel H1N1##2##2##(2010-9#1)(2011-2#1)
novel ICS##2##2##(2008-8#2)
novel L##2##2##(2008-10#2)
novel LQT-3 mutation##2##3##(2008-8#2)
novel RNA-binding proteins##2##3##(1992-8#2)
novel active##2##2##(2008-3#1)(2009-9#1)
novel adjuvant##3##2##(1990-12#1)(1995-5#1)(2007-11#1)
novel affinity##2##2##(1993-8#1)(2009-11#1)
novel agents##5##2##(2008-11#1)(2008-7#3)(2010-4#1)
novel alternated dual task##2##4##(2012-2#2)
novel amperometric biosensor based on##2##5##(2008-10#2)
novel amperometric##4##2##(2008-10#4)
novel analytical##8##2##(2007-11#1)(2008-10#3)(2008-2#2)(2008-4#1)(2009-9#1)
novel and effective##2##3##(2013-1#1)(2013-8#1)
novel and highly efficient production system for##2##7##(2008-9#2)
novel and highly##3##3##(2007-12#1)(2008-9#2)
novel and selective##2##3##(2008-10#1)(2011-1#1)
novel and sensitive##2##3##(2008-10#2)
novel and simple##6##3##(2007-12#1)(2008-10#3)(2008-3#1)(2010-4#1)
novel and##47##2##(1990-5#2)(1992-11#2)(1996-10#1)(1997-4#2)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2013-1#2)(2013-8#2)
novel antagonist##2##2##(1994-11#1)(2008-8#1)
novel anti-HIV-1 drugs##2##3##(2011-2#1)(2011-3#1)
novel anti-HIV-1##3##2##(2011-2#1)(2011-3#2)
novel antibiotic##3##2##(1991-12#2)(2008-7#1)
novel antimicrobial##2##2##(1994-5#1)(2012-3#1)
novel application of##3##3##(2008-4#1)(2009-11#1)(2013-1#1)
novel application##4##2##(2007-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
novel applications##4##2##(1996-1#1)(2007-12#1)(2008-11#1)(2008-7#1)
novel approach based on##2##4##(2012-1#1)(2013-8#1)
novel approach for the##2##4##(2008-10#1)(2008-8#1)
novel approach for##15##3##(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-1#4)
novel approach involving##2##3##(1993-8#1)(2008-10#1)
novel approach of##4##3##(2007-6#1)(2008-10#2)(2008-4#1)
novel approach to study the##2##5##(2008-10#1)(2010-11#1)
novel approach to the##4##4##(1991-11#1)(1991-5#1)(2008-10#1)(2009-7#1)
novel approach to##23##3##(1991-11#1)(1991-5#1)(1995-9#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
novel approach##60##2##(1991-11#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-9#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#15)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
novel approaches in##2##3##(2008-5#1)(2011-2#1)
novel approaches##6##2##(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#2)
novel architecture##3##2##(2008-11#2)(2008-3#1)
novel aspects of##2##3##(2010-5#1)(2012-12#1)
novel aspects##3##2##(2010-5#1)(2011-2#1)(2012-12#1)
novel assay##3##2##(2008-10#2)(2008-11#1)
novel behavior of##2##3##(2007-11#1)(2008-3#1)
novel biological therapies##2##3##(2009-12#2)
novel biological##4##2##(2009-12#2)(2010-10#1)(2010-3#1)
novel biomarkers##3##2##(2010-5#1)(2011-2#1)(2012-2#1)
novel bioreactor##2##2##(2008-11#2)
novel cDNA##7##2##(1994-11#1)(1995-6#1)(2008-4#1)(2008-8#3)(2008-9#1)
novel calix[4]arene##2##2##(2008-10#2)
novel carbon##2##2##(2008-10#2)
novel carrier##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
novel case##2##2##(2008-10#1)(2011-1#1)
novel cell death receptor##2##4##(2008-11#2)
novel cell##6##2##(1994-11#1)(1997-6#1)(2008-11#4)
novel chemiluminescence (CL)##10##3##(2008-10#10)
novel chemiluminescence##12##2##(2008-10#12)
novel class of compounds##2##4##(1996-5#1)(2008-10#1)
novel class of##18##3##(1990-12#2)(1990-7#2)(1991-2#1)(1991-5#1)(1994-3#1)(1994-6#1)(1996-5#1)(2007-12#2)(2008-10#3)(2009-3#2)(2010-11#1)(2012-2#1)
novel class##19##2##(1990-12#2)(1990-7#2)(1991-2#1)(1991-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-5#1)(2007-12#2)(2008-10#3)(2009-3#2)(2010-11#1)(2012-2#1)
novel combined pretreatment of ball milling##2##6##(2013-1#2)
novel compound##2##2##(1993-9#1)(2012-2#1)
novel compounds##3##2##(2008-5#3)
novel computational##5##2##(2008-10#1)(2009-12#1)(2010-10#1)(2010-2#1)(2013-1#1)
novel concept of##3##3##(2007-11#1)(2007-12#1)(2007-5#1)
novel concept##7##2##(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#2)
novel configuration##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
novel data##2##2##(2008-3#1)(2008-4#1)
novel dehalogenases##2##2##(2011-1#2)
novel deodorant##4##2##(2008-5#4)
novel design for##2##3##(2007-12#1)(2008-3#1)
novel design of##2##3##(2008-2#1)(2010-8#1)
novel design##7##2##(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-8#1)
novel detection##2##2##(1991-2#1)(2007-12#1)
novel developments in##2##3##(2007-12#1)(2008-3#1)
novel diagnostic##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
novel disease##5##2##(1993-3#2)(2008-1#1)(2008-7#1)(2011-2#1)
novel drug delivery##2##3##(2009-7#1)(2013-1#1)
novel drug targets##2##3##(2008-7#1)(2013-1#1)
novel drug##8##2##(2008-7#2)(2009-10#1)(2009-7#1)(2010-2#1)(2012-1#1)(2013-1#2)
novel drugs##3##2##(2008-4#1)(2009-12#1)(2012-2#1)
novel electrochemical##9##2##(2007-12#1)(2008-10#8)
novel electrode##2##2##(2008-3#1)(2013-1#1)
novel environments##3##2##(2008-8#2)(2013-1#1)
novel epigenetic mechanism##2##3##(2009-3#2)
novel erythroid differentiation related##2##4##(2008-8#1)(2008-9#1)
novel evolutionary##3##2##(2008-8#1)(2009-9#1)(2011-2#1)
novel experimental approach##2##3##(1994-8#1)(2012-2#1)
novel experimental##3##2##(1994-8#1)(2008-3#1)(2012-2#1)
novel feature##2##2##(2008-7#1)(2008-8#1)
novel fiber##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
novel finding##4##2##(1993-3#1)(1996-2#1)(2008-10#1)(2011-1#1)
novel flow##4##2##(1990-12#1)(2008-10#2)(2010-8#1)
novel flow-injection##5##2##(2008-10#5)
novel fluorescence##3##2##(1997-7#1)(2007-11#1)(2008-10#1)
novel fluorescent##6##2##(1992-3#1)(1992-9#1)(2007-12#1)(2008-10#3)
novel function of##3##3##(1992-6#1)(2008-8#1)(2012-12#1)
novel functional##6##2##(1994-12#1)(2008-10#2)(2009-10#1)(2010-4#1)(2013-1#1)
novel functions##2##2##(2009-6#1)(2011-2#1)
novel gene encoding##3##3##(1992-9#1)(1997-7#1)(2008-8#1)
novel gene which##2##3##(1996-2#1)(2008-9#1)
novel gene##19##2##(1992-9#1)(1995-8#2)(1996-10#3)(1996-2#1)(1997-7#2)(2008-10#1)(2008-6#1)(2008-8#3)(2008-9#4)(2012-12#1)
novel genes##17##2##(1993-8#1)(1994-9#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#3)(2008-9#1)
novel geometry of the##2##4##(2008-10#1)(2008-7#1)
novel geometry##3##2##(2008-10#2)(2008-7#1)
novel glandular epithelium lining the infrabuccal cavity##2##7##(2007-12#2)
novel habitats##2##2##(2008-8#2)
novel highly sensitive##2##3##(2007-11#1)(2008-10#1)
novel host##10##2##(2008-10#1)(2008-8#4)(2013-1#5)
novel hosts##3##2##(2008-8#3)
novel human gene##5##3##(1996-2#1)(1997-7#1)(1997-8#1)(2008-7#1)(2008-8#1)
novel human##15##2##(1990-8#2)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-7#1)(2008-8#2)(2011-1#1)
novel hybrid organic-inorganic##2##3##(2008-5#2)
novel hybrid##8##2##(2007-11#3)(2008-5#2)(2008-7#3)
novel hydrogen peroxide (H(2)O(2))##2##4##(2008-10#1)(2013-1#1)
novel hydrogen-bonded##2##2##(2008-10#2)
novel images##2##2##(2013-8#2)
novel in##3##2##(2008-5#2)(2008-9#1)
novel inducible nuclear factors##2##4##(1992-12#2)
novel influenza##2##2##(2011-1#1)(2013-8#1)
novel information##2##2##(2012-2#1)(2013-8#1)
novel inhibitor##6##2##(1991-12#1)(1994-2#1)(1995-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
novel inhibitors##4##2##(1994-2#1)(2013-1#1)(2013-7#2)
novel inoculation techniques##2##3##(2008-10#2)
novel insights into the##3##4##(2010-12#1)(2013-1#1)(2013-8#1)
novel insights into##5##3##(2010-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
novel insights##10##2##(1993-12#2)(2010-11#1)(2010-12#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
novel instrumental##2##2##(2008-10#2)
novel integrated##2##2##(2007-11#1)(2008-3#1)
novel interaction with B23##2##4##(2011-2#2)
novel interferometric##2##2##(2007-12#1)(2008-3#1)
novel ion##2##2##(2008-10#2)
novel laser##2##2##(2008-10#1)(2008-3#1)
novel loop configuration##3##3##(2007-12#3)
novel low-loss##2##2##(2007-11#1)(2008-3#1)
novel mRNA##2##2##(1994-6#2)
novel mathematical##2##2##(2008-10#1)(2008-2#1)
novel means of##3##3##(1996-9#1)(2007-12#1)(2008-10#1)
novel mechanism for##4##3##(1990-5#2)(1991-5#1)(1992-12#1)
novel mechanism of action##3##4##(2008-5#1)(2009-7#1)(2012-12#1)
novel mechanism of##9##3##(1993-3#1)(1994-3#1)(1997-3#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-7#1)(2012-12#1)
novel mechanism##18##2##(1990-5#2)(1991-5#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(1997-3#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
novel mechanisms of##2##3##(2008-10#1)(2011-3#1)
novel mechanisms##4##2##(2008-10#1)(2010-10#1)(2011-3#1)(2012-2#1)
novel mechanistic approach##2##3##(2010-7#1)(2013-1#1)
novel medications##2##2##(2008-4#1)(2008-7#1)
novel member of##11##3##(1990-2#1)(1993-11#1)(1994-11#1)(1994-12#2)(1995-12#1)(2008-10#2)(2008-9#2)(2013-1#1)
novel members##2##2##(1995-6#1)(2008-9#1)
novel method for the determination of##6##6##(2007-11#1)(2008-10#5)
novel method for the synthesis of##2##6##(2009-11#1)(2012-2#1)
novel method for the##15##4##(1994-2#1)(2007-11#1)(2008-10#10)(2008-8#1)(2009-11#1)(2012-2#1)
novel method for##49##3##(1990-11#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-3#1)(2007-11#5)(2007-12#2)(2007-7#1)(2008-10#16)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#2)(2009-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-7#1)(2012-2#2)
novel method of wavelength selection##2##5##(2008-10#2)
novel method of##13##3##(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
novel method to##2##3##(2007-12#1)(2008-3#1)
novel method using##2##3##(2008-6#1)(2010-8#1)
novel method##87##2##(1990-11#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-11#7)(2007-12#9)(2007-7#1)(2008-10#23)(2008-11#3)(2008-2#3)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#4)(2012-3#1)(2013-1#2)
novel methodology for##3##3##(2007-12#1)(2008-10#2)
novel methods for##3##3##(2007-12#1)(2008-1#1)(2010-2#1)
novel methods##7##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-7#1)
novel mirror##2##2##(2007-11#1)(2008-3#1)
novel missense mutation##2##3##(2008-12#2)
novel molecular##3##2##(2007-11#1)(2008-6#1)(2011-2#1)
novel molecule##2##2##(1996-12#1)(2012-2#1)
novel monoclonal antibody##3##3##(1992-8#1)(1995-12#1)(1996-12#1)
novel mutant##2##2##(2008-10#1)(2013-1#1)
novel mutations in the##2##4##(1994-11#1)(1996-2#1)
novel mutations##6##2##(1994-11#1)(1996-2#1)(1997-4#1)(2008-8#1)(2011-1#2)
novel nanocrystalline Pb(2)Sn(2)O(6) photocatalyst##2##4##(2009-11#2)
novel neuropeptide##2##2##(1990-7#1)(1992-9#1)
novel nonpeptide##2##2##(1991-5#1)(1995-12#1)
novel observation##2##2##(2007-12#1)(2011-1#1)
novel on-line##2##2##(2008-10#2)
novel ones##2##2##(2008-9#1)(2013-7#1)
novel optical##20##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#5)(2008-7#1)(2009-2#1)(2011-1#1)
novel or##3##2##(1995-12#1)(1997-7#1)(2008-11#1)
novel oral##2##2##(2008-8#1)(2012-12#1)
novel pH sensor##2##3##(2008-10#2)
novel paclitaxel##2##2##(2008-3#1)(2008-7#1)
novel pathogenic##2##2##(2008-10#2)
novel pathway##3##2##(2011-2#1)(2012-2#2)
novel pathways##4##2##(1995-2#1)(2010-10#1)(2010-6#1)(2011-2#1)
novel patterns##2##2##(2008-8#1)(2008-9#1)
novel pharmacological##3##2##(1995-3#1)(2008-7#1)(2009-12#1)
novel physical##4##2##(2007-12#1)(2008-1#1)(2010-7#1)(2013-1#1)
novel plant##4##2##(1995-6#1)(2008-10#2)(2009-6#1)
novel polymeric##2##2##(1990-8#1)(2008-10#1)
novel post-transcriptional splicing form of##2##5##(2008-9#2)
novel post-transcriptional##3##2##(2008-9#2)(2013-8#1)
novel preparation##4##2##(1994-12#1)(2008-5#1)(2011-2#1)(2011-3#1)
novel probe##4##2##(1995-11#1)(2007-12#1)(2008-8#2)
novel procedure for##2##3##(2008-10#1)(2008-3#1)
novel procedure##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)
novel prognostic##2##2##(2008-2#1)(2010-11#1)
novel properties##2##2##(2008-10#1)(2008-4#1)
novel property of##2##3##(1994-11#1)(2010-7#1)
novel protein of 81 amino##2##5##(1993-8#1)(1994-6#1)
novel protein of##3##3##(1993-8#1)(1993-9#1)(1994-6#1)
novel protein##11##2##(1990-5#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(2007-7#1)(2008-4#1)
novel proteins##5##2##(1995-6#1)(2008-4#1)(2008-7#2)(2009-10#1)
novel reversed-phase##3##2##(2008-10#3)
novel ring##2##2##(2008-3#2)
novel role for##5##3##(1991-12#1)(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#1)
novel role##7##2##(1991-12#1)(1995-12#1)(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#2)
novel roles for##2##3##(2009-9#1)(2011-2#1)
novel roles##3##2##(1993-6#1)(2009-9#1)(2011-2#1)
novel scheme for##3##3##(2007-11#3)
novel scheme##6##2##(2007-11#6)
novel secreted human##2##3##(1997-4#2)
novel selective##2##2##(2008-10#2)
novel sensing##2##2##(2008-10#2)
novel sensor##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
novel sequence##2##2##(2008-4#1)(2008-9#1)
novel sites##2##2##(1995-6#2)
novel small##2##2##(1997-7#1)(2013-8#1)
novel snoRNA##2##2##(2008-8#2)
novel solid##2##2##(2008-10#1)(2012-1#1)
novel solution##2##2##(1993-8#1)(2010-10#1)
novel sorbent##2##2##(2008-10#2)
novel spectrofluorometric technique##2##3##(2008-11#2)
novel spectrophotometric method for##2##4##(2008-10#2)
novel spectrophotometric##3##2##(2008-10#3)
novel statistical model##2##3##(2009-5#1)(2010-11#1)
novel stimulus##2##2##(2008-5#2)
novel stomach##2##2##(1997-7#1)(2008-3#1)
novel strains##2##2##(2008-10#1)(2008-5#1)
novel strategies##3##2##(2008-3#1)(2008-7#1)(2009-12#1)
novel strategy for##6##3##(2008-10#3)(2008-8#1)(2010-5#1)(2011-2#1)
novel strategy##13##2##(1992-3#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)
novel structural element##2##3##(1992-12#1)(1992-3#1)
novel structural##5##2##(1992-12#1)(1992-3#1)(1995-8#1)(2008-5#1)(2011-2#1)
novel sulphonylurea##2##2##(1994-8#2)
novel surface##2##2##(2008-10#1)(2008-11#1)
novel susceptibility##2##2##(2009-4#1)(2010-2#1)
novel synthetic##4##2##(1991-9#1)(2008-1#1)(2008-10#1)(2010-10#1)
novel system##5##2##(2008-2#1)(2008-3#3)(2012-3#1)
novel target for##6##3##(1997-1#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
novel targets for therapeutic intervention##2##5##(2008-8#1)(2010-3#1)
novel targets for##3##3##(1997-6#1)(2008-8#1)(2010-3#1)
novel targets##4##2##(1997-6#1)(2008-8#1)(2010-3#1)(2010-6#1)
novel technique for the##3##4##(1990-5#1)(2007-11#1)(2007-12#1)
novel technique for##17##3##(1990-5#1)(2007-11#6)(2007-12#6)(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#1)
novel technique is##3##3##(2007-11#1)(2008-3#1)(2012-3#1)
novel technique of##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
novel technique to measure##2##4##(2008-3#2)
novel technique to##5##3##(2008-10#1)(2008-3#2)(2008-9#1)(2010-8#1)
novel technique##38##2##(1990-5#1)(1997-4#1)(2007-11#7)(2007-12#8)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
novel techniques for the##2##4##(1997-6#1)(2008-10#1)
novel techniques for##4##3##(1997-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
novel technologies##3##2##(2011-1#2)(2011-2#1)
novel therapeutic agents##3##3##(1994-12#1)(2009-1#1)(2009-6#1)
novel therapeutic approaches##4##3##(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
novel therapeutic strategies for##4##4##(2008-4#3)(2010-10#1)
novel therapeutic strategies##8##3##(2007-7#1)(2008-4#3)(2008-7#1)(2010-10#1)(2010-5#1)(2013-1#1)
novel therapeutic targets##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
novel therapeutic##32##2##(1990-7#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#2)(2010-5#2)(2010-6#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
novel therapeutics##3##2##(2008-7#2)(2012-2#1)
novel therapies for##4##3##(1996-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
novel therapies##6##2##(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
novel thermostable##2##2##(1995-8#2)
novel three-dimensional##2##2##(2007-12#1)(2008-3#1)
novel thrombolytic agents##2##3##(2008-7#2)
novel treatment approaches##2##3##(2010-12#1)(2011-2#1)
novel treatment##7##2##(2008-2#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
novel treatments##5##2##(2007-10#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
novel two-component system##2##3##(2009-6#2)
novel type of##11##3##(1990-5#1)(1990-7#1)(1993-5#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#2)(2013-8#1)
novel type##13##2##(1990-5#2)(1990-7#1)(1993-5#1)(1996-2#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#2)(2013-8#1)
novel tyrosine kinase##2##3##(1992-12#2)
novel tyrosine##3##2##(1992-12#2)(1997-7#1)
novel uranyl##2##2##(2008-10#2)
novel use of##2##3##(2008-8#1)(2012-3#1)
novel variant of##2##3##(1990-5#1)(2010-10#1)
novel visual stimuli##3##3##(1993-6#3)
novel wavelength##2##2##(2007-12#1)(2008-10#1)
novel ways##2##2##(2009-6#1)(2012-2#1)
novel whitefly-transmitted member of the family##2##6##(2008-10#2)
novel α##2##2##(2009-11#2)
novel##2055##1##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#20)(1990-7#12)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#2)(1991-5#9)(1991-6#1)(1991-9#8)(1992-11#6)(1992-12#7)(1992-3#7)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#16)(1992-9#10)(1993-1#1)(1993-11#9)(1993-12#5)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#13)(1993-8#8)(1993-9#4)(1994-1#2)(1994-11#14)(1994-12#16)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#7)(1994-8#7)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#11)(1995-2#1)(1995-3#9)(1995-5#2)(1995-6#11)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#5)(1996-12#5)(1996-2#17)(1996-3#2)(1996-5#7)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#19)(1997-6#5)(1997-7#15)(1997-8#4)(2006-6#1)(2007-10#2)(2007-11#103)(2007-12#93)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#9)(2008-10#375)(2008-11#70)(2008-12#8)(2008-2#58)(2008-3#120)(2008-4#29)(2008-5#45)(2008-6#27)(2008-7#68)(2008-8#83)(2008-9#45)(2009-1#2)(2009-10#8)(2009-11#17)(2009-12#12)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#5)(2009-6#14)(2009-7#6)(2009-8#8)(2009-9#9)(2010-1#1)(2010-10#14)(2010-11#17)(2010-12#12)(2010-2#9)(2010-3#6)(2010-4#7)(2010-5#13)(2010-6#8)(2010-7#11)(2010-8#8)(2010-9#3)(2011-1#31)(2011-2#56)(2011-3#8)(2011-7#3)(2011-9#1)(2012-1#13)(2012-12#27)(2012-2#55)(2012-3#29)(2013-1#68)(2013-7#5)(2013-8#23)
novels and##2##2##(1992-3#1)(2011-2#1)
novels##3##1##(1992-3#1)(2011-2#1)(2012-2#1)
novelties##2##1##(2008-10#1)(2011-1#1)
novelty filter to##3##3##(2008-2#3)
novelty filter##11##2##(2008-2#6)(2008-3#5)
novelty of##5##2##(2008-2#2)(2008-7#1)(2008-8#1)(2010-11#1)
novelty seeking##2##2##(1994-2#1)(2013-7#1)
novelty were##2##2##(1990-11#1)(1993-6#1)
novelty##32##1##(1990-11#1)(1993-5#1)(1993-6#3)(1994-2#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#5)(2008-7#2)(2008-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-7#1)
novice and experienced nurses##2##4##(2008-12#1)(2008-9#1)
novice and experienced##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
novice teacher##3##2##(2008-11#1)(2008-12#2)
novice##14##1##(1991-1#1)(2008-11#2)(2008-12#5)(2008-4#1)(2008-7#2)(2008-9#2)(2010-11#1)
novo adipogenesis##3##2##(2008-11#3)
novo##86##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-12#2)(1992-6#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#2)
novo-ulmi mitovirus 3a-Ld from##2##4##(2008-10#2)
novo-ulmi mitovirus##3##2##(2008-10#3)
novo-ulmi##7##1##(2008-10#7)
now a##16##2##(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
now able to##2##3##(1991-3#1)(2008-11#1)
now about##2##2##(1997-5#1)(2008-11#1)
now acquired##2##2##(2011-1#1)(2012-3#1)
now allow##2##2##(1990-8#1)(2008-7#1)
now almost##2##2##(1997-6#1)(2008-12#1)
now and in the##2##4##(1991-11#1)(1993-2#1)
now and##3##2##(1991-11#1)(1993-2#1)(2012-12#1)
now appear to##2##3##(1994-11#1)(2009-6#1)
now appears that##2##3##(2009-5#1)(2012-2#1)
now appears##3##2##(1993-11#1)(2009-5#1)(2012-2#1)
now approved for##2##3##(2009-8#1)(2010-5#1)
now are##2##2##(2008-10#1)(2010-5#1)
now as##2##2##(1996-12#1)(2009-3#1)
now available can##2##3##(1992-12#1)(2011-2#1)
now available for##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
now available##21##2##(1990-2#1)(1990-3#1)(1991-3#2)(1992-12#1)(1995-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#3)(2012-12#1)
now based on##2##3##(2007-8#1)(2008-10#1)
now be tested##2##3##(1996-12#1)(2010-12#1)
now be##37##2##(1990-11#2)(1990-12#2)(1990-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
now becoming available##3##3##(2008-3#1)(2008-6#1)(2008-7#1)
now becoming##9##2##(1990-5#1)(1993-11#1)(1997-2#1)(1997-3#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)
now been described##3##3##(1994-2#1)(2006-10#1)(2008-3#1)
now been recognized##2##3##(2009-12#1)(2012-3#1)
now been shown##3##3##(1995-6#1)(1995-8#1)(2010-5#1)
now been well established##2##4##(2008-9#1)(2011-2#1)
now been##32##2##(1992-12#2)(1993-9#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
now being developed##2##3##(1994-9#1)(2010-4#1)
now being used in##2##4##(2008-10#1)(2008-11#1)
now being used to##6##4##(1990-11#1)(1994-5#1)(2008-7#2)(2010-3#1)(2011-2#1)
now being used##10##3##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-3#1)(2011-2#2)
now being##35##2##(1990-11#1)(1991-12#2)(1992-2#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#2)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
now commonplace##2##2##(1991-3#1)(2012-2#1)
now considered a##7##3##(2006-7#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-3#1)
now considered##15##2##(1996-8#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#2)(2011-2#1)(2011-3#1)
now demonstrate##5##2##(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(2008-3#1)
now describe the##2##3##(1995-2#1)(2011-2#1)
now describe##3##2##(1995-2#1)(2011-2#2)
now detected##2##2##(1990-2#1)(1993-9#1)
now emerging##4##2##(2008-11#1)(2008-8#2)(2010-10#1)
now enables##2##2##(2010-11#1)(2010-12#1)
now established##6##2##(1992-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
now exists##4##2##(1993-12#1)(2007-2#1)(2008-7#1)(2010-6#1)
now finds##2##2##(1995-2#1)(2008-11#1)
now for##3##2##(2008-10#1)(2008-7#1)(2010-8#1)
now found##3##2##(1997-1#1)(2008-10#1)(2008-2#1)
now generally accepted as##2##4##(2007-11#1)(2008-5#1)
now generally accepted##3##3##(1996-4#1)(2007-11#1)(2008-5#1)
now generally##6##2##(1995-12#1)(1996-4#1)(2007-11#2)(2008-5#1)(2012-1#1)
now has been##2##3##(1992-11#1)(2008-3#1)
now has the##2##3##(1991-11#1)(2011-3#1)
now has##8##2##(1991-11#1)(1992-11#1)(1995-6#1)(2008-3#2)(2008-7#2)(2011-3#1)
now have a##2##3##(1990-9#1)(2010-8#1)
now have the##2##3##(1991-2#1)(2008-3#1)
now have##11##2##(1990-2#1)(1990-9#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-7#1)(2008-3#3)(2010-8#1)
now identified as##2##3##(1993-12#1)(1993-6#1)
now identified##4##2##(1993-12#1)(1993-2#1)(1993-6#1)(1997-7#1)
now in place##3##3##(1995-1#1)(2009-3#1)(2011-2#1)
now in use##4##3##(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
now in##16##2##(1994-3#1)(1995-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#2)
now include##4##2##(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
now includes##2##2##(2008-5#1)(2012-3#1)
now indicates that##2##3##(2012-12#1)(2012-2#1)
now investigating##2##2##(2008-7#1)(2010-3#1)
now is##5##2##(2008-4#2)(2008-8#1)(2008-9#1)(2012-2#1)
now isolated##3##2##(1993-3#1)(1994-8#1)(1995-2#1)
now it is##2##3##(2008-11#1)(2012-12#1)
now it##3##2##(1993-11#1)(2008-11#1)(2012-12#1)
now know it##2##3##(2013-7#1)(2013-8#1)
now know that##3##3##(1993-2#1)(1997-1#1)(2008-1#1)
now know##7##2##(1991-12#1)(1993-2#1)(1997-1#1)(2008-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
now known as##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
now known to be##3##4##(2008-6#1)(2009-4#1)(2010-7#1)
now known to##5##3##(1993-6#1)(2006-10#1)(2008-6#1)(2009-4#1)(2010-7#1)
now known##12##2##(1993-6#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2010-7#1)(2011-2#1)(2013-1#1)
now made##2##2##(2007-12#1)(2008-2#1)
now make it##2##3##(2008-10#1)(2008-4#1)
now more##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
now needed to##2##3##(2010-12#1)(2011-1#1)
now only##3##2##(1995-6#1)(2010-12#1)(2012-2#1)
now permits the##2##3##(1997-2#1)(2008-11#1)
now possible##13##2##(1990-12#1)(1991-1#1)(1991-12#1)(1993-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
now provide##3##2##(1994-3#1)(2007-12#1)(2009-8#1)
now provides##2##2##(2008-3#1)(2008-9#1)
now rare##2##2##(1997-3#1)(2011-3#1)
now recognized as##5##3##(2007-7#1)(2008-12#1)(2008-4#2)(2008-5#1)
now recognized to##4##3##(1990-6#1)(2008-7#2)(2012-12#1)
now recognized##13##2##(1990-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2012-1#1)(2012-12#1)
now report that##6##3##(1990-2#1)(1991-12#2)(1991-2#1)(2008-7#1)(2009-10#1)
now report the##8##3##(1990-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(2008-10#2)
now report##22##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1997-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)
now routinely##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
now seems##2##2##(1990-11#1)(1991-3#1)
now show that##8##3##(1992-6#2)(1993-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(2008-7#1)(2012-2#1)
now suggest that##2##3##(1991-2#1)(1994-5#1)
now suggests that##2##3##(2008-8#1)(2009-6#1)
now that##6##2##(1994-12#1)(1996-5#1)(2007-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
now the##13##2##(1992-11#1)(1992-12#1)(1992-5#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#1)(2013-1#1)
now there are##3##3##(2009-10#1)(2010-8#1)(2011-2#1)
now there##4##2##(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
now to##5##2##(1995-12#1)(1995-5#1)(1996-3#1)(2007-12#1)(2009-7#1)
now used in##2##3##(1993-1#1)(2011-7#1)
now used##4##2##(1993-1#1)(2008-10#1)(2008-7#1)(2011-7#1)
now well##10##2##(1994-11#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-6#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
now widely accepted as the most##2##6##(1993-12#1)(2008-11#1)
now widely accepted##5##3##(1993-12#1)(2008-11#2)(2011-2#1)(2012-3#1)
now widely available##2##3##(1993-11#1)(1997-4#1)
now widely used##3##3##(1990-2#1)(1993-2#1)(2008-4#1)
now widely##11##2##(1990-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1997-4#1)(2008-11#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-3#1)
now within##2##2##(2008-4#1)(2010-2#1)
now##832##1##(1990-11#6)(1990-12#8)(1990-2#7)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#7)(1991-2#3)(1991-3#9)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#8)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#4)(1992-6#4)(1992-9#3)(1993-1#3)(1993-11#6)(1993-12#10)(1993-2#7)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#4)(1994-1#2)(1994-11#6)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#3)(1995-9#1)(1996-11#5)(1996-12#6)(1996-2#2)(1996-3#13)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#9)(1997-2#7)(1997-3#5)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#10)(1997-8#5)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#2)(2007-3#1)(2007-6#4)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#9)(2008-10#58)(2008-11#31)(2008-12#11)(2008-2#9)(2008-3#23)(2008-4#16)(2008-5#25)(2008-6#8)(2008-7#53)(2008-8#17)(2008-9#19)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#7)(2009-4#6)(2009-5#8)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#17)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#9)(2011-1#10)(2011-2#43)(2011-3#5)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#15)(2012-3#10)(2012-7#1)(2013-1#20)(2013-7#3)(2013-8#5)
now)##2##1##(2008-1#1)(2010-4#1)
now?##3##1##(1994-3#1)(2008-10#1)(2008-11#1)
nowadays is##3##2##(2011-1#1)(2011-3#1)(2012-2#1)
nowadays##28##1##(1992-3#1)(1993-11#2)(1993-3#1)(1994-5#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)
noxious brain conditions##2##3##(2008-4#2)
noxious heat##2##2##(1996-5#1)(2008-7#1)
noxious stimuli##4##2##(1995-12#1)(1997-2#1)(2008-4#1)(2008-7#1)
noxious##25##1##(1995-12#4)(1996-3#1)(1996-5#3)(1997-2#2)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#4)(2011-2#1)(2013-7#1)
nozzle##13##1##(1994-2#3)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2011-1#2)
np-BNR isolates##4##2##(2008-10#4)
np-BNR##13##1##(2008-10#13)
npPLA2##4##1##(1992-8#4)
ns (FWHM)##2##2##(2007-11#1)(2008-3#1)
ns FWHM##2##2##(2008-2#2)
ns and a##2##3##(2008-2#1)(2008-3#1)
ns and##8##2##(1994-11#1)(1995-3#1)(2007-11#2)(2008-2#1)(2008-3#2)(2010-8#1)
ns at 25 degrees C##2##5##(1995-5#2)
ns at##3##2##(1995-5#2)(2008-2#1)
ns have been##2##3##(2007-12#1)(2008-3#1)
ns in##3##2##(2008-3#2)(2009-9#1)
ns time##2##2##(1991-3#1)(1997-6#1)
ns was##2##2##(2008-3#2)
ns were obtained##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
ns were##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
ns##62##1##(1991-3#1)(1993-11#2)(1993-6#1)(1994-11#1)(1995-3#1)(1995-5#4)(1997-6#1)(2007-11#4)(2007-12#8)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#23)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-8#1)(2013-8#1)
ns) than##4##2##(1991-5#3)(2008-3#1)
ns)##17##1##(1991-12#1)(1991-5#6)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#6)(2009-3#1)
nt 8993 T--&gt##2##3##(1994-8#2)
nt 8993##5##2##(1994-8#5)
nt and aa##2##3##(2011-1#1)(2013-1#1)
nt and##6##2##(1990-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
nt differences##2##2##(1991-6#1)(2008-10#1)
nt downstream##2##2##(1995-2#1)(1995-8#1)
nt encoding a##2##3##(1994-8#1)(1997-4#1)
nt identity##2##2##(2008-10#2)
nt in##2##2##(1990-5#1)(1993-2#1)
nt long and##2##3##(2008-10#2)
nt long##3##2##(2008-10#2)(2008-11#1)
nt of exon##2##3##(1993-6#1)(2008-9#1)
nt of the 5' end of the TYLCV Rep##2##9##(2008-10#2)
nt of the 5'##3##4##(2008-10#3)
nt of the IR##2##4##(2008-10#2)
nt of the##8##3##(1991-6#1)(1997-4#1)(2008-10#5)(2008-8#1)
nt of##10##2##(1991-6#1)(1993-6#1)(1997-4#1)(2008-10#5)(2008-8#1)(2008-9#1)
nt sequence of the##2##4##(1994-12#1)(1995-8#1)
nt sequence of##3##3##(1990-5#1)(1994-12#1)(1995-8#1)
nt sequence##11##2##(1990-5#1)(1991-6#2)(1993-12#4)(1994-12#2)(1995-8#2)
nt sequences##2##2##(1993-12#1)(1993-6#1)
nt upstream##2##2##(1990-11#1)(1995-8#1)
nt##82##1##(1990-11#3)(1990-5#2)(1991-6#6)(1991-9#1)(1992-8#1)(1993-12#7)(1993-2#4)(1993-3#1)(1993-6#5)(1994-11#1)(1994-12#2)(1994-8#7)(1994-9#1)(1995-2#2)(1995-8#6)(1997-4#4)(1997-7#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-8#4)(2008-9#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
nt)##6##1##(1993-6#1)(2008-10#2)(2008-9#2)(2012-3#1)
ntra ntrb mutant##6##3##(2009-10#6)
ntra ntrb plants##2##3##(2009-10#2)
ntra ntrb##9##2##(2009-10#9)
nts##3##1##(2008-10#1)(2008-9#2)
nts)##4##1##(2008-10#3)(2008-9#1)
nu##5##1##(2008-10#2)(2008-3#2)(2008-5#1)
nu(1) + 2nu(2)##2##3##(2008-2#1)(2008-3#1)
nu(3)##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
nu(C&amp##2##1##(1996-2#2)
nu(C=O)##2##1##(1996-2#2)
nu(p)##3##1##(2007-12#1)(2008-2#2)
nu)##3##1##(2008-3#3)
nu3 mode at##2##3##(2008-10#2)
nu3##3##1##(2008-10#2)(2008-2#1)
nuTH01##2##1##(2008-12#2)
nuance##2##1##(2008-2#1)(2008-5#1)
nuanced##2##1##(2008-12#1)(2011-1#1)
nuances of##2##2##(2008-1#1)(2012-2#1)
nuances##4##1##(2007-7#1)(2008-1#1)(2008-9#1)(2012-2#1)
nucellus##2##1##(2008-10#1)(2009-8#1)
nuchal translucency thickness (r =##2##5##(1995-8#2)
nuchal translucency##5##2##(1995-8#2)(2008-11#1)(2013-1#2)
nuchal##7##1##(1995-8#2)(1997-3#1)(2008-11#1)(2008-7#1)(2013-1#2)
nucifera)##3##1##(2008-10#1)(2008-5#1)(2009-8#1)
nuclear 1##2##2##(1992-12#2)
nuclear DNA content and##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
nuclear DNA content in##2##4##(1991-6#1)(2008-9#1)
nuclear DNA content##14##3##(1991-6#1)(1992-9#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#4)(2009-8#1)
nuclear DNA synthesis##2##3##(1994-5#2)
nuclear DNA##33##2##(1991-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-5#2)(1995-6#2)(2008-10#6)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
nuclear Overhauser effect##3##3##(1993-11#2)(1994-5#1)
nuclear Overhauser effects and##3##4##(1992-4#1)(1993-11#1)(1994-5#1)
nuclear Overhauser effects##4##3##(1992-4#1)(1993-11#2)(1994-5#1)
nuclear Overhauser enhancement##2##3##(1990-5#1)(1993-8#1)
nuclear Overhauser##10##2##(1990-5#1)(1992-3#1)(1992-4#1)(1993-11#4)(1993-8#1)(1994-5#2)
nuclear accumulation of p53##2##4##(1997-7#2)
nuclear accumulation of##4##3##(1997-7#2)(2011-2#2)
nuclear accumulation##5##2##(1994-11#1)(1997-7#2)(2011-2#2)
nuclear alleles##2##2##(2008-9#2)
nuclear and cytoplasmic##4##3##(1996-2#1)(2008-2#2)(2011-2#1)
nuclear and cytosolic##3##3##(1992-8#2)(1996-2#1)
nuclear and mitochondrial DNA##3##4##(2008-10#3)
nuclear and mitochondrial gene##3##4##(2008-10#2)(2008-7#1)
nuclear and mitochondrial##6##3##(2008-10#5)(2008-7#1)
nuclear and##21##2##(1991-2#1)(1992-8#2)(1994-11#1)(1994-8#1)(1996-2#2)(2008-10#8)(2008-12#1)(2008-2#2)(2008-7#1)(2009-8#1)(2011-2#1)
nuclear antigen##15##2##(1991-8#1)(1992-10#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
nuclear area##2##2##(2008-6#1)(2009-7#1)
nuclear assembly in vitro##2##4##(2008-8#2)
nuclear assembly##5##2##(2008-8#3)(2010-5#1)(2011-2#1)
nuclear bodies##2##2##(2007-12#2)
nuclear cataract in##2##3##(2011-1#2)
nuclear chromatin##2##2##(1995-2#1)(2008-9#1)
nuclear complex##3##2##(1991-2#1)(1996-12#2)
nuclear condensation##5##2##(2008-1#1)(2008-4#1)(2008-8#1)(2010-2#1)(2013-1#1)
nuclear development##2##2##(2009-8#2)
nuclear envelope and nuclear##2##4##(2008-8#1)(2008-9#1)
nuclear envelope and##4##3##(2008-8#1)(2008-9#1)(2011-2#2)
nuclear envelope in the##2##4##(1995-2#1)(2008-9#1)
nuclear envelope proteins##2##3##(1995-2#1)(2011-2#1)
nuclear envelope##24##2##(1994-11#1)(1995-2#4)(2007-12#1)(2008-8#3)(2008-9#2)(2011-2#13)
nuclear enzymes##2##2##(1991-9#1)(1994-8#1)
nuclear estrogen##2##2##(1996-5#1)(2008-11#1)
nuclear exclusion of p53##3##4##(1993-9#3)
nuclear exclusion of##4##3##(1993-9#3)(2011-2#1)
nuclear export of##3##3##(1992-11#1)(2011-2#1)(2011-3#1)
nuclear export##10##2##(1992-11#1)(2011-2#4)(2011-3#4)(2012-2#1)
nuclear expression##2##2##(1991-2#1)(2010-3#1)
nuclear extract##2##2##(1990-12#1)(1995-2#1)
nuclear extracts from both##2##4##(1993-6#1)(1997-7#1)
nuclear extracts from##7##3##(1993-6#2)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
nuclear extracts were##2##3##(1993-6#1)(1995-2#1)
nuclear extracts##19##2##(1992-8#1)(1993-6#7)(1993-8#1)(1995-2#3)(1995-6#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-2#1)
nuclear facilities and##2##3##(1996-6#1)(2008-10#1)
nuclear facilities in##2##3##(1991-3#1)(2008-10#1)
nuclear facilities##6##2##(1991-3#3)(1996-6#1)(2008-10#2)
nuclear factor kappa B (NF-kappa B)##2##6##(1992-12#1)(1993-3#1)
nuclear factor kappa B ligand##4##5##(2010-10#1)(2011-1#2)(2013-1#1)
nuclear factor kappa B was##2##5##(2007-8#2)
nuclear factor kappa B##11##4##(1992-12#1)(1993-3#1)(1994-6#3)(2007-8#2)(2010-10#1)(2011-1#2)(2013-1#1)
nuclear factor##20##2##(1991-11#1)(1992-12#1)(1993-3#1)(1994-6#3)(1995-6#1)(2007-8#3)(2008-6#1)(2009-8#1)(2010-10#2)(2010-8#1)(2011-1#3)(2012-3#1)(2013-1#1)
nuclear factor-κB (NF-κB)##2##3##(2012-2#1)(2012-3#1)
nuclear factor-κB##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
nuclear factors##9##2##(1992-12#2)(1992-6#2)(1993-8#1)(1994-11#1)(1996-2#1)(2008-10#2)
nuclear foci##2##2##(2011-2#1)(2013-1#1)
nuclear fractions##4##2##(1992-3#1)(1993-8#1)(1994-11#2)
nuclear fuel##2##2##(2013-1#2)
nuclear gene encoding##3##3##(1994-12#1)(1995-6#1)(1995-8#1)
nuclear gene##14##2##(1991-2#2)(1994-12#2)(1995-6#2)(1995-8#2)(2008-10#2)(2008-7#2)(2010-4#1)(2012-3#1)
nuclear genes##10##2##(1991-2#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#3)(2011-2#1)(2013-1#1)
nuclear genome##6##2##(1995-11#1)(1995-6#2)(2008-5#1)(2009-10#1)(2010-6#1)
nuclear genomes##3##2##(1994-12#1)(1995-11#1)(2008-10#1)
nuclear hormone receptor##5##3##(1993-6#1)(1994-12#1)(1995-2#2)(2006-8#1)
nuclear hormone receptors that##2##4##(2008-1#1)(2008-5#1)
nuclear hormone receptors##7##3##(1993-6#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-5#3)
nuclear hormone##12##2##(1993-6#2)(1994-12#1)(1995-2#3)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#3)
nuclear imaging techniques##2##3##(1991-2#1)(2008-7#1)
nuclear imaging##3##2##(1991-2#1)(2008-7#1)(2008-8#1)
nuclear import substrate##2##3##(1995-2#2)
nuclear import##3##2##(1995-2#2)(2012-2#1)
nuclear inclusions##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
nuclear installations##2##2##(1991-3#2)
nuclear irradiation##3##2##(2008-8#3)
nuclear lamina assembly##3##3##(2008-8#3)
nuclear lamina in##2##3##(2008-8#2)
nuclear lamina was##2##3##(2008-8#2)
nuclear lamina##12##2##(1990-11#1)(1992-12#1)(2007-12#1)(2008-8#9)
nuclear layer##3##2##(1991-10#2)(2010-1#1)
nuclear level##3##2##(1994-6#1)(2008-4#1)(2008-6#1)
nuclear lipoapoptosis##3##2##(2008-3#3)
nuclear localization of 4##2##4##(2010-5#2)
nuclear localization of##6##3##(1994-5#1)(1994-6#1)(2009-4#1)(2009-8#1)(2010-5#2)
nuclear localization signal##9##3##(1991-12#1)(1994-11#4)(1994-9#1)(1997-7#1)(2011-2#1)(2012-2#1)
nuclear localization##19##2##(1991-12#1)(1991-5#1)(1994-11#4)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#1)(1997-7#1)(2009-4#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#2)
nuclear loci in##2##3##(2012-3#2)
nuclear loci##6##2##(2008-9#3)(2012-3#3)
nuclear magnetic resonance (NMR) spectroscopy##3##5##(1995-5#1)(2008-5#1)(2010-8#1)
nuclear magnetic resonance (NMR)##17##4##(1992-3#1)(1992-4#1)(1993-3#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
nuclear magnetic resonance and##4##4##(1997-8#1)(2008-10#1)(2010-5#1)(2012-2#1)
nuclear magnetic resonance experiments##2##4##(2008-8#1)(2011-1#1)
nuclear magnetic resonance imaging##2##4##(1992-12#1)(2008-9#1)
nuclear magnetic resonance of##2##4##(1994-2#1)(2008-10#1)
nuclear magnetic resonance spectroscopy and mass spectrometry##2##7##(2010-5#2)
nuclear magnetic resonance spectroscopy combined with##2##6##(1994-5#1)(1995-5#1)
nuclear magnetic resonance spectroscopy##15##4##(1992-12#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(2008-10#4)(2008-5#1)(2010-5#2)(2013-8#1)
nuclear magnetic resonance spin-lattice relaxation##2##5##(2008-10#2)
nuclear magnetic resonance##69##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-11#3)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-5#3)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#4)(2010-8#2)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
nuclear magnetic##71##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-11#3)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-5#3)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#4)(2010-8#2)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
nuclear markers that##2##3##(2008-8#2)
nuclear markers##5##2##(1994-3#1)(2008-10#1)(2008-8#3)
nuclear matrix##11##2##(1990-5#2)(1993-8#1)(2008-11#1)(2008-8#7)
nuclear maturation##2##2##(2013-1#2)
nuclear medicine departments##2##3##(1993-2#2)
nuclear medicine techniques##3##3##(2008-1#1)(2008-8#1)(2010-9#1)
nuclear medicine##21##2##(1993-2#3)(1994-2#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#3)(2010-9#2)(2011-2#1)(2012-2#3)(2013-1#1)
nuclear membrane##15##2##(1994-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#4)(2011-2#6)
nuclear membranes##4##2##(1991-12#1)(2008-1#2)(2008-10#1)
nuclear migration in##3##3##(2008-9#3)
nuclear migration##5##2##(2008-9#5)
nuclear morphology##7##2##(1991-2#1)(1997-2#1)(2008-8#1)(2009-12#1)(2009-8#2)(2011-1#1)
nuclear pitch##2##2##(2013-8#2)
nuclear plant##2##2##(2008-10#1)(2010-4#1)
nuclear polyhedrosis virus (AcMNPV)##3##4##(1993-12#1)(1995-12#1)(1997-4#1)
nuclear polyhedrosis virus##19##3##(1993-12#2)(1994-11#1)(1995-12#2)(1997-3#1)(1997-4#7)(2008-11#2)(2008-7#3)(2008-8#1)
nuclear pore complex##7##3##(1994-11#3)(1995-2#2)(2011-2#2)
nuclear pore##10##2##(1994-11#3)(1995-2#2)(2011-2#5)
nuclear pores##2##2##(2008-10#1)(2011-2#1)
nuclear power plant##2##3##(2008-4#1)(2009-10#1)
nuclear power plants##4##3##(2008-10#1)(2008-7#1)(2009-12#2)
nuclear power##9##2##(2008-10#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#2)(2013-1#1)
nuclear profile##2##2##(1996-9#2)
nuclear protein complexes##2##3##(1993-8#1)(1995-8#1)
nuclear protein that##2##3##(1995-6#1)(2012-2#1)
nuclear protein##14##2##(1990-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1997-3#1)(2007-12#1)(2009-7#1)(2012-2#1)
nuclear protein(s)##2##2##(1991-11#1)(1993-6#1)
nuclear proteins by##3##3##(1993-3#1)(2008-1#1)(2008-2#1)
nuclear proteins extracted##2##3##(1997-2#1)(2008-9#1)
nuclear proteins from##3##3##(1993-12#2)(1994-9#1)
nuclear proteins of terminal differentiated erythroid cells##2##7##(2008-8#1)(2008-9#1)
nuclear proteins which##2##3##(1991-2#1)(1993-6#1)
nuclear proteins##30##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-2#2)(1996-5#1)(1997-2#4)(1997-6#1)(1997-7#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#3)
nuclear proto-oncogene##2##2##(1992-2#1)(1994-6#1)
nuclear rDNA##6##2##(2008-10#5)(2008-5#1)
nuclear reassembly##3##2##(2008-8#3)
nuclear receptor##20##2##(1991-2#1)(1994-11#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#6)(2011-2#1)(2013-1#1)
nuclear receptors##11##2##(1994-12#1)(1994-6#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-7#1)
nuclear region##2##2##(1995-3#1)(1997-4#1)
nuclear retention of##3##3##(1994-8#2)(2011-2#1)
nuclear retention##5##2##(1994-8#4)(2011-2#1)
nuclear ribonucleoprotein##6##2##(1991-6#1)(1993-8#1)(2007-12#1)(2008-8#2)(2008-9#1)
nuclear ribosomal DNA##9##3##(2008-10#5)(2008-12#2)(2010-3#1)(2013-1#1)
nuclear ribosomal RNA##4##3##(2008-10#3)(2008-5#1)
nuclear ribosomal internal transcribed spacer##2##5##(2008-10#1)(2008-9#1)
nuclear ribosomal##17##2##(2008-10#10)(2008-12#2)(2008-5#1)(2008-9#1)(2010-3#2)(2013-1#1)
nuclear run-on##2##2##(2012-3#2)
nuclear scaffold protein##2##3##(1993-11#2)
nuclear scaffold##5##2##(1993-11#3)(1995-8#1)(2008-8#1)
nuclear spent fuel##2##3##(2008-10#2)
nuclear spent##3##2##(2008-10#3)
nuclear spins##4##2##(2008-7#3)(2012-2#1)
nuclear staining##2##2##(1991-5#1)(2007-12#1)
nuclear structure##6##2##(1993-8#1)(1995-2#1)(2011-1#1)(2011-2#3)
nuclear targeting##2##2##(1991-6#1)(1994-12#1)
nuclear traffic##2##2##(2011-2#2)
nuclear transcription factors##3##3##(1995-8#1)(2008-10#1)(2009-6#1)
nuclear transfer in the mouse##2##5##(2008-8#2)
nuclear transfer##11##2##(1995-11#1)(2008-11#4)(2008-8#2)(2008-9#3)(2013-1#1)
nuclear translation elongation factor##3##4##(2008-10#3)
nuclear translocation of##2##3##(2010-10#2)
nuclear translocation##9##2##(1994-9#1)(2010-10#6)(2010-3#1)(2012-2#1)
nuclear transport of##2##3##(1994-11#1)(1997-3#1)
nuclear transport receptors##2##3##(2011-2#2)
nuclear transport##8##2##(1991-2#2)(1994-11#1)(1995-2#1)(1997-3#1)(2011-2#3)
nuclear volume##7##2##(1996-9#2)(2008-12#3)(2008-7#1)(2010-8#1)
nuclear waste##2##2##(2008-10#2)
nuclear wastes##2##2##(2008-10#2)
nuclear workers and the public##2##5##(2008-12#2)
nuclear workers##4##2##(2008-12#2)(2008-7#2)
nuclear##916##1##(1990-11#3)(1990-12#5)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#3)(1990-8#2)(1991-10#2)(1991-11#2)(1991-12#10)(1991-2#14)(1991-3#5)(1991-5#8)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#10)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#11)(1993-12#6)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#11)(1993-8#13)(1993-9#4)(1994-10#1)(1994-11#19)(1994-12#11)(1994-2#3)(1994-3#5)(1994-5#7)(1994-6#11)(1994-7#1)(1994-8#10)(1994-9#6)(1995-11#8)(1995-12#4)(1995-2#33)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#15)(1995-8#6)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#5)(1997-2#5)(1997-3#3)(1997-4#8)(1997-6#2)(1997-7#9)(1997-8#3)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#16)(2008-10#91)(2008-11#20)(2008-12#13)(2008-2#4)(2008-3#8)(2008-4#15)(2008-5#14)(2008-6#3)(2008-7#42)(2008-8#57)(2008-9#46)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#13)(2010-1#1)(2010-10#11)(2010-12#2)(2010-2#2)(2010-3#9)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#16)(2011-2#60)(2011-3#5)(2012-1#1)(2012-12#3)(2012-2#18)(2012-3#9)(2013-1#22)(2013-7#2)(2013-8#5)
nuclear-coded subunits##3##2##(1990-2#3)
nuclear-encoded##5##1##(1990-5#1)(1991-6#1)(1994-8#1)(2008-1#1)(2010-4#1)
nuclease S1##2##2##(1990-11#1)(1990-7#1)
nuclease activity##3##2##(1995-8#2)(2008-7#1)
nuclease hypersensitive site##2##3##(1997-3#1)(2008-8#1)
nuclease hypersensitive##4##2##(1990-7#1)(1997-3#1)(1997-7#1)(2008-8#1)
nuclease protection analysis##3##3##(1992-3#1)(1993-3#1)(2008-2#1)
nuclease protection assays##2##3##(1995-2#1)(2008-4#1)
nuclease protection##11##2##(1991-11#1)(1992-3#1)(1993-3#1)(1995-2#1)(2008-2#2)(2008-4#5)
nuclease##42##1##(1990-11#1)(1990-7#2)(1991-11#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#4)(1993-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-8#3)(1997-2#3)(1997-3#2)(1997-7#1)(2008-10#1)(2008-2#4)(2008-4#6)(2008-7#1)(2008-8#4)(2008-9#2)
nuclease-resistant##2##1##(1994-8#1)(2008-9#1)
nucleases and##2##2##(2008-10#1)(2008-11#1)
nucleases##7##1##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2013-1#2)
nucleated cell##3##2##(2008-10#2)(2011-2#1)
nucleated cells##7##2##(1991-2#1)(1991-5#1)(2008-11#2)(2008-8#1)(2011-2#2)
nucleated differential cell count##2##4##(2008-11#2)
nucleated red blood cells##3##4##(1996-12#1)(1997-8#1)(2008-10#1)
nucleated red##4##2##(1996-12#1)(1997-8#1)(2008-10#1)(2008-4#1)
nucleated##21##1##(1991-2#1)(1991-5#1)(1996-12#2)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#3)
nucleation activity##5##2##(2008-10#5)
nucleation and growth##4##3##(2008-10#2)(2008-3#2)
nucleation and##7##2##(2008-10#4)(2008-3#2)(2012-2#1)
nucleation of##5##2##(1996-4#1)(2007-11#1)(2008-10#1)(2008-7#2)
nucleation process##5##2##(1992-5#1)(1996-4#4)
nucleation to##2##2##(1996-4#2)
nucleation zone##3##2##(1996-4#3)
nucleation##46##1##(1992-5#1)(1993-11#1)(1996-4#14)(2007-11#1)(2008-10#14)(2008-2#1)(2008-3#4)(2008-7#2)(2009-2#1)(2009-7#1)(2009-9#1)(2012-2#5)
nucleator of##2##2##(1991-5#1)(2009-10#1)
nuclei after##2##2##(1996-2#1)(2008-9#1)
nuclei along##2##2##(2008-11#2)
nuclei also##2##2##(1994-8#1)(2008-7#1)
nuclei and##24##2##(1990-5#1)(1991-2#1)(1991-8#1)(1994-8#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
nuclei are##5##2##(1990-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
nuclei as##3##2##(1993-12#1)(1994-2#1)(1994-6#1)
nuclei by##4##2##(1994-2#1)(2008-8#1)(2009-12#1)(2011-2#1)
nuclei density##2##2##(2011-1#2)
nuclei detection##2##2##(2009-10#2)
nuclei do not##2##3##(2007-12#1)(2008-9#1)
nuclei during##2##2##(1990-3#1)(2007-12#1)
nuclei for##2##2##(2008-10#1)(2010-8#1)
nuclei from##6##2##(1991-12#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-9#2)
nuclei in a##2##3##(2008-2#1)(2008-7#1)
nuclei in the##6##3##(1993-6#1)(1997-2#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-7#1)
nuclei in##15##2##(1991-12#1)(1993-3#1)(1993-6#1)(1997-2#1)(2007-12#2)(2008-2#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)
nuclei is##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
nuclei isolated from##2##3##(1991-12#1)(2008-9#1)
nuclei of Meynert##3##3##(1995-5#2)(1997-2#1)
nuclei of cells##3##3##(1991-2#1)(1992-3#1)(1994-2#1)
nuclei of the hypothalamus##3##4##(1993-12#2)(2008-7#1)
nuclei of the rat##2##4##(1995-12#1)(2008-7#1)
nuclei of the##14##3##(1990-7#1)(1993-12#2)(1993-6#1)(1995-12#1)(1996-12#3)(1997-2#1)(2008-7#3)(2008-8#1)(2009-3#1)
nuclei of##36##2##(1990-11#2)(1990-7#1)(1991-2#1)(1992-3#2)(1993-12#3)(1993-6#2)(1993-8#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-5#2)(1996-12#3)(1997-2#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-2#1)
nuclei or##3##2##(1990-7#1)(1997-2#1)(2010-6#1)
nuclei per##2##2##(2008-10#2)
nuclei to##2##2##(2008-11#1)(2010-8#1)
nuclei were##13##2##(1991-5#1)(1992-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-8#1)(2012-3#1)
nuclei with##7##2##(1991-9#1)(1997-7#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-2#1)
nuclei within##2##2##(1995-2#1)(2008-11#1)
nuclei##269##1##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#7)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-2#7)(1994-6#5)(1994-8#4)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#8)(1996-2#7)(1997-2#7)(1997-3#2)(1997-5#1)(1997-7#1)(2006-12#1)(2007-10#4)(2007-12#10)(2007-8#1)(2008-1#6)(2008-10#16)(2008-11#17)(2008-12#2)(2008-2#8)(2008-3#2)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#19)(2008-8#15)(2008-9#13)(2009-10#5)(2009-12#4)(2009-3#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#5)(2011-1#4)(2011-2#4)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
nucleic acid amplification##3##3##(2009-6#1)(2010-6#1)(2011-2#1)
nucleic acid analysis##2##3##(2008-9#2)
nucleic acid and##4##3##(1993-6#1)(1994-3#1)(2008-10#1)(2008-9#1)
nucleic acid detection##2##3##(2012-3#1)(2013-8#1)
nucleic acid extraction##2##3##(2008-4#1)(2008-9#1)
nucleic acid extracts from##3##4##(1996-12#1)(2008-10#2)
nucleic acid extracts of##2##4##(2008-10#2)
nucleic acid extracts##6##3##(1996-12#1)(2008-10#5)
nucleic acid hybridization analysis##2##4##(2008-10#2)
nucleic acid hybridization##4##3##(2008-10#3)(2008-4#1)
nucleic acid in an##2##4##(1995-2#1)(2008-4#1)
nucleic acid in##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
nucleic acid libraries##2##3##(2008-4#2)
nucleic acid molecular 'light switch'##2##5##(2008-10#2)
nucleic acid probes##2##3##(2008-10#1)(2008-9#1)
nucleic acid purification##2##3##(2008-10#1)(2008-2#1)
nucleic acid samples##3##3##(2008-10#1)(2008-4#2)
nucleic acid sequence##2##3##(1996-12#1)(1996-6#1)
nucleic acid sequences##5##3##(1995-5#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-9#1)
nucleic acid stain##2##3##(2008-3#1)(2008-9#1)
nucleic acid structures##4##3##(2008-4#3)(2008-9#1)
nucleic acid synthesis##2##3##(2008-3#1)(2008-4#1)
nucleic acid##107##2##(1990-11#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-2#2)(1995-5#1)(1996-12#2)(1996-6#2)(2008-1#1)(2008-10#32)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#22)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#13)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
nucleic acid-based##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
nucleic acid-binding property##2##3##(2008-8#2)
nucleic acid-binding proteins##2##3##(1993-2#1)(2008-8#1)
nucleic acid-binding##5##2##(1993-2#1)(2008-10#1)(2008-8#3)
nucleic acids (LNAs)##3##3##(2008-4#3)
nucleic acids (PNAs)##2##3##(2008-4#2)
nucleic acids and##5##3##(1990-11#1)(1991-5#1)(2008-10#1)(2008-2#1)(2010-5#1)
nucleic acids by##4##3##(2008-10#4)
nucleic acids can##3##3##(2007-11#1)(2008-10#2)
nucleic acids has##2##3##(2008-10#1)(2008-8#1)
nucleic acids in##7##3##(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)
nucleic acids into##2##3##(2008-5#1)(2008-9#1)
nucleic acids is##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-10#1)
nucleic acids to##5##3##(1994-3#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-2#1)
nucleic acids was##5##3##(2008-10#4)(2008-6#1)
nucleic acids##102##2##(1990-11#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-8#1)(1994-3#2)(1995-11#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-6#4)(2007-11#1)(2008-10#36)(2008-2#4)(2008-4#17)(2008-5#3)(2008-6#3)(2008-8#1)(2008-9#6)(2009-5#1)(2010-10#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
nucleic##220##1##(1990-11#2)(1991-12#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#4)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#2)(1996-6#3)(1996-9#1)(1997-6#4)(2007-11#1)(2008-1#1)(2008-10#70)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#40)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#19)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
nucleic-acid##3##1##(2008-9#3)
nucleobase and##2##2##(1996-5#1)(2008-4#1)
nucleobase##8##1##(1995-6#1)(1996-5#1)(2008-10#1)(2008-4#5)
nucleobases##9##1##(1995-6#1)(2008-10#3)(2008-4#4)(2012-2#1)
nucleobindin##2##1##(1992-8#2)
nucleocapsid (N) protein##4##3##(2008-10#4)
nucleocapsid (N)##8##2##(2008-10#8)
nucleocapsid protein##5##2##(1996-12#1)(2008-10#4)
nucleocapsid##20##1##(1992-12#1)(1993-12#1)(1995-5#1)(1996-12#1)(2008-10#13)(2008-5#1)(2008-8#1)(2009-7#1)
nucleocapsids##2##1##(1993-12#1)(2008-10#1)
nucleocytoplasmic polymorphism##2##2##(2008-9#2)
nucleocytoplasmic transport##4##2##(2011-2#4)
nucleocytoplasmic##10##1##(1995-2#1)(2008-9#2)(2011-2#7)
nucleofection##3##1##(2008-11#3)
nucleoid##6##1##(1992-11#1)(1995-2#1)(2008-7#1)(2009-2#1)(2009-8#2)
nucleoids##5##1##(2008-7#1)(2009-2#1)(2009-8#3)
nucleolar RNAs (snoRNAs)##2##3##(1997-7#1)(2008-8#1)
nucleolar dominance##3##2##(2011-2#3)
nucleolar organizer region (NOR)##3##4##(2008-12#1)(2008-5#2)
nucleolar organizer##5##2##(1993-12#1)(2007-12#1)(2008-12#1)(2008-5#2)
nucleolar protein##3##2##(1990-11#2)(2011-2#1)
nucleolar skeleton (nucleolar matrix)##2##4##(2008-8#2)
nucleolar skeleton of HeLa cells##3##5##(2008-8#3)
nucleolar skeleton##6##2##(2008-8#6)
nucleolar##33##1##(1990-11#2)(1991-2#3)(1993-12#1)(1994-9#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#12)(2011-2#4)
nucleolar-organizing regions of chromosomes##2##4##(2013-1#2)
nucleolar-organizing regions of##3##3##(2013-1#3)
nucleoli and##2##2##(1991-12#1)(2008-7#1)
nucleoli were significantly greater##2##4##(2008-10#1)(2008-7#1)
nucleoli were##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
nucleoli##22##1##(1991-12#2)(1992-11#1)(1993-12#7)(2007-12#4)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
nucleolin##2##1##(2010-12#2)
nucleolus and##3##2##(1991-2#2)(2008-8#1)
nucleolus in##2##2##(2008-12#1)(2008-8#1)
nucleolus organizing region##2##3##(2008-12#1)(2008-5#1)
nucleolus##22##1##(1991-2#3)(1994-9#5)(2007-12#2)(2008-12#4)(2008-5#2)(2008-7#3)(2008-8#3)
nucleolytic activity##2##2##(1991-9#2)
nucleolytic##8##1##(1991-9#7)(2008-11#1)
nucleophagy##5##1##(2011-2#5)
nucleophile of##3##2##(1995-2#1)(1995-6#1)(2010-11#1)
nucleophile##12##1##(1991-5#1)(1995-2#3)(1995-6#2)(2008-7#4)(2010-11#1)(2010-2#1)
nucleophiles##5##1##(1990-8#2)(1992-6#1)(2008-11#1)(2009-9#1)
nucleophilic attack of##3##3##(1996-2#1)(2008-11#1)(2010-12#1)
nucleophilic attack##6##2##(1994-5#2)(1996-2#1)(2008-11#1)(2010-12#1)(2010-2#1)
nucleophilic displacement##2##2##(1992-6#1)(1997-3#1)
nucleophilic substitution of##2##3##(2008-10#2)
nucleophilic substitution##3##2##(2008-10#2)(2008-6#1)
nucleophilic##18##1##(1992-11#1)(1992-6#1)(1994-5#2)(1995-2#2)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#3)
nucleophilicities of the##2##3##(1996-2#2)
nucleophilicities##3##1##(1996-2#3)
nucleophilicity##4##1##(2008-11#1)(2008-4#1)(2011-1#2)
nucleoplasm##3##1##(1991-2#1)(2008-12#1)(2009-6#1)
nucleoplasmic##5##1##(1993-8#3)(2008-8#2)
nucleopolyhedrovirus##12##1##(2008-11#10)(2008-12#2)
nucleoporin##4##1##(1995-2#2)(2011-2#2)
nucleoporins and##3##2##(2011-2#3)
nucleoporins##10##1##(1995-2#3)(2011-2#7)
nucleoprotein complex##3##2##(1995-8#1)(2008-11#2)
nucleoprotein complexes##2##2##(1996-3#2)
nucleoprotein##11##1##(1995-8#1)(1996-3#2)(2008-10#2)(2008-11#2)(2008-5#1)(2009-11#1)(2013-8#2)
nucleos(t)ide##3##1##(2013-8#3)
nucleoside 2-deoxyribosyltransferase##3##2##(1995-6#3)
nucleoside H-phosphonate##2##2##(2008-4#2)
nucleoside analogs##2##2##(2008-4#1)(2011-3#1)
nucleoside analogues##5##2##(1992-8#1)(1994-8#1)(1996-11#1)(1996-5#1)(2012-3#1)
nucleoside diphosphate kinase##2##3##(1994-8#1)(1996-2#1)
nucleoside diphosphates##4##2##(1997-2#1)(1997-7#1)(2008-4#1)(2008-7#1)
nucleoside in##3##2##(2008-10#2)(2008-4#1)
nucleoside phosphorylase##7##2##(1993-12#2)(1994-8#2)(2008-10#1)(2010-4#2)
nucleoside reverse transcriptase inhibitors##3##4##(2008-1#1)(2008-3#1)(2011-2#1)
nucleoside transport##3##2##(1994-8#3)
nucleoside transporter##3##2##(1994-8#2)(1995-8#1)
nucleoside triphosphate##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
nucleoside triphosphates and##2##3##(2008-4#1)(2008-7#1)
nucleoside triphosphates##5##2##(2008-4#3)(2008-7#1)(2010-8#1)
nucleoside##79##1##(1990-10#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-8#12)(1995-11#2)(1995-3#2)(1995-6#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#24)(2008-7#3)(2010-4#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
nucleosides and##5##2##(1990-11#1)(1993-12#1)(2008-10#2)(2009-2#1)
nucleosides are##2##2##(2008-4#2)
nucleosides by##2##2##(1997-2#1)(2008-4#1)
nucleosides in Asterias rollestoni##3##4##(2011-1#3)
nucleosides in##5##2##(1997-2#1)(2008-4#1)(2011-1#3)
nucleosides is##3##2##(2008-4#3)
nucleosides with##2##2##(2008-4#2)
nucleosides##48##1##(1990-11#1)(1990-7#1)(1990-8#2)(1992-3#3)(1992-6#1)(1993-12#1)(1993-8#1)(1996-5#1)(1997-2#6)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#17)(2009-12#2)(2009-2#1)(2010-4#1)(2011-1#3)
nucleosomal##4##1##(1991-5#1)(1997-3#1)(2008-8#1)(2011-2#1)
nucleosome positioning##2##2##(1997-3#1)(2008-2#1)
nucleosome##8##1##(1997-3#1)(2008-2#2)(2008-8#2)(2009-5#1)(2011-2#1)(2011-9#1)
nucleosome/chromatin assembly##2##2##(2008-8#2)
nucleosomes##11##1##(1994-6#1)(1994-9#1)(1997-3#1)(2008-2#3)(2008-8#5)
nucleotidase activity##3##2##(2008-4#3)
nucleotidase##10##1##(1996-9#1)(2008-4#9)
nucleotide (nt) sequence of the##7##5##(1991-6#2)(1993-12#3)(1994-12#1)(1997-4#1)
nucleotide (nt) sequence of##10##4##(1991-6#2)(1991-7#1)(1993-12#3)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
nucleotide (nt) sequence##16##3##(1990-11#1)(1991-6#2)(1991-7#1)(1993-12#5)(1993-2#1)(1994-12#2)(1997-4#2)(1997-7#1)(2008-10#1)
nucleotide (nt) sequences##6##3##(1993-12#1)(1993-6#2)(1994-12#2)(2008-10#1)
nucleotide (nt)##31##2##(1990-11#1)(1990-5#1)(1991-6#3)(1991-7#1)(1993-12#7)(1993-2#2)(1993-6#4)(1994-12#4)(1994-9#1)(1997-4#2)(1997-7#1)(2008-10#3)(2013-1#1)
nucleotide 1497##2##2##(1997-3#2)
nucleotide 5'-monophosphates##2##2##(2008-11#2)
nucleotide acid##2##2##(2013-8#2)
nucleotide agonists##2##2##(2008-4#2)
nucleotide analogue##2##2##(2008-11#2)
nucleotide and amino acid sequence##2##5##(1990-7#1)(2008-10#1)
nucleotide and amino acid sequences were##2##6##(2011-1#1)(2013-8#1)
nucleotide and amino acid sequences##4##5##(1991-5#1)(2011-1#2)(2013-8#1)
nucleotide and amino acid##10##4##(1990-7#1)(1990-8#1)(1991-5#1)(1995-8#1)(2008-10#2)(2011-1#3)(2013-8#1)
nucleotide and deduced amino acid sequences##2##6##(1993-12#1)(1994-11#1)
nucleotide and deduced##4##3##(1993-12#1)(1994-11#3)
nucleotide and protein##2##3##(2008-4#1)(2008-9#1)
nucleotide and the deduced##2##4##(1990-12#1)(1996-12#1)
nucleotide and the##4##3##(1990-12#1)(1991-9#1)(1996-12#1)(2013-8#1)
nucleotide and##25##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-12#2)(1994-11#3)(1995-8#3)(1996-12#1)(2008-10#4)(2008-4#1)(2008-9#1)(2011-1#3)(2013-8#2)
nucleotide binding fold##2##3##(2008-11#1)(2008-8#1)
nucleotide binding site##5##3##(1991-12#1)(1992-6#2)(2008-10#1)(2010-10#1)
nucleotide binding##21##2##(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1994-2#1)(1994-6#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-10#1)
nucleotide change##4##2##(1993-3#1)(1993-6#1)(1994-11#1)(2008-10#1)
nucleotide difference##4##2##(1990-12#1)(1996-12#1)(2008-10#1)(2008-8#1)
nucleotide differences##7##2##(1993-3#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-5#1)
nucleotide diversities##3##2##(1994-8#3)
nucleotide diversity of##3##3##(2008-10#2)(2010-8#1)
nucleotide diversity##6##2##(2008-10#3)(2010-8#2)(2012-3#1)
nucleotide exchange factor##9##3##(1991-12#1)(1994-8#3)(1995-2#1)(2010-11#1)(2012-12#2)(2013-8#1)
nucleotide exchange factors that have##2##5##(1995-2#1)(2013-8#1)
nucleotide exchange factors that##3##4##(1995-2#1)(2009-5#1)(2013-8#1)
nucleotide exchange factors##4##3##(1994-8#1)(1995-2#1)(2009-5#1)(2013-8#1)
nucleotide exchange on##3##3##(1994-12#1)(1996-2#1)(2008-1#1)
nucleotide exchange##16##2##(1991-12#1)(1994-12#1)(1994-8#4)(1995-2#2)(1996-2#1)(2008-1#1)(2009-5#1)(2010-11#1)(2012-12#2)(2013-8#2)
nucleotide excision repair (NER)##2##4##(2008-11#2)
nucleotide excision repair##6##3##(1994-9#2)(2008-11#4)
nucleotide hydrolysis##3##2##(1994-8#1)(2008-4#1)(2011-2#1)
nucleotide identities and##4##3##(2008-10#4)
nucleotide identities##5##2##(2008-10#5)
nucleotide identity with##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
nucleotide identity##14##2##(1993-3#1)(2008-10#9)(2008-5#2)(2008-8#1)(2013-8#1)
nucleotide is##2##2##(1990-12#1)(2008-4#1)
nucleotide level##4##2##(1994-12#1)(1997-4#1)(1997-6#1)(2009-10#1)
nucleotide long##2##2##(1992-6#1)(2008-10#1)
nucleotide metabolism and##2##3##(1991-8#1)(2008-4#1)
nucleotide metabolism##6##2##(1991-4#2)(1991-8#1)(1996-5#1)(1997-2#1)(2008-4#1)
nucleotide number 3##2##3##(1990-12#2)
nucleotide or protein sequence##2##4##(2008-4#2)
nucleotide or##6##2##(2008-4#4)(2008-9#2)
nucleotide polymorphism analysis##2##3##(2008-8#1)(2010-11#1)
nucleotide polymorphism in##2##3##(2008-9#1)(2011-2#1)
nucleotide polymorphism##20##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
nucleotide polymorphisms (SNPs) in##2##4##(2008-10#1)(2010-6#1)
nucleotide polymorphisms (SNPs) of##4##4##(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)
nucleotide polymorphisms (SNPs)##17##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
nucleotide polymorphisms##35##2##(1997-9#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
nucleotide pool and##2##3##(1995-8#1)(2008-11#1)
nucleotide pools##3##2##(2008-11#3)
nucleotide position##10##2##(1992-9#2)(1993-3#2)(1994-11#2)(2008-10#1)(2008-11#2)(2013-8#1)
nucleotide positions##4##2##(1993-3#1)(1997-4#1)(2008-11#1)(2008-12#1)
nucleotide product##3##2##(1994-8#3)
nucleotide pyrophosphatase/phosphodiesterase##2##2##(2008-4#2)
nucleotide ratios##2##2##(2008-11#2)
nucleotide receptor##3##2##(2008-4#3)
nucleotide receptors##6##2##(2008-4#6)
nucleotide regulatory##2##2##(1993-6#1)(2008-3#1)
nucleotide residue##4##2##(2007-6#1)(2008-10#3)
nucleotide sequence analysis##5##3##(1990-8#1)(2008-10#4)
nucleotide sequence and##2##3##(1990-12#1)(2008-8#1)
nucleotide sequence data##9##3##(1991-5#1)(1992-3#1)(1997-6#5)(2008-10#1)(2008-9#1)
nucleotide sequence homologies##2##3##(1996-12#1)(1997-2#1)
nucleotide sequence homology##2##3##(2008-8#1)(2010-5#1)
nucleotide sequence identities##4##3##(2008-10#3)(2008-11#1)
nucleotide sequence identity in##2##4##(1993-6#1)(2008-10#1)
nucleotide sequence identity##12##3##(1993-6#1)(2008-10#11)
nucleotide sequence of Saccharomyces cerevisiae chromosome VIII##2##7##(1994-9#2)
nucleotide sequence of a cDNA encoding the##2##7##(1992-11#1)(1993-3#1)
nucleotide sequence of a cDNA##4##5##(1990-2#1)(1992-11#1)(1993-3#1)(1996-2#1)
nucleotide sequence of a##19##4##(1990-2#1)(1991-2#1)(1992-11#1)(1993-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#1)(2008-10#4)(2009-3#1)
nucleotide sequence of the cloned##3##5##(1990-2#1)(1991-9#1)(1997-4#1)
nucleotide sequence of the coding region of##2##7##(1993-2#1)(1993-6#1)
nucleotide sequence of the##54##4##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#5)(1994-8#1)(1995-6#1)(1995-8#2)(1996-8#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-10#13)(2008-8#1)(2009-2#1)
nucleotide sequence of this##6##4##(1990-12#1)(1990-2#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-8#1)
nucleotide sequence of wheat##2##4##(2008-10#1)(2008-8#1)
nucleotide sequence of##105##3##(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-11#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#7)(1994-8#1)(1994-9#4)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#4)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-10#22)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)
nucleotide sequence revealed##4##3##(1994-12#2)(1997-2#1)(1997-4#1)
nucleotide sequence showed a##2##4##(1996-2#1)(2008-5#1)
nucleotide sequence was determined##5##4##(1993-9#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
nucleotide sequence was##7##3##(1993-6#2)(1993-9#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
nucleotide sequence##187##2##(1990-11#7)(1990-12#4)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#2)(1991-2#2)(1991-5#3)(1991-7#1)(1991-9#5)(1992-11#2)(1992-12#3)(1992-3#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#2)(1994-12#10)(1994-8#1)(1994-9#5)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-8#4)(1997-2#5)(1997-3#2)(1997-4#6)(1997-6#8)(1997-7#2)(1997-8#1)(2007-6#1)(2008-10#52)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#5)(2009-2#1)(2009-3#1)(2010-5#1)
nucleotide sequences and##4##3##(1996-10#1)(2008-10#1)(2009-11#1)(2012-12#1)
nucleotide sequences in##3##3##(1995-2#1)(2008-10#1)(2013-1#1)
nucleotide sequences of the##23##4##(1991-6#1)(1991-9#1)(1993-12#1)(1994-8#2)(1997-7#1)(2007-10#1)(2007-6#1)(2008-10#10)(2008-5#2)(2008-6#3)
nucleotide sequences of##39##3##(1990-5#1)(1990-8#1)(1991-6#2)(1991-9#1)(1993-12#2)(1994-6#1)(1994-8#2)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-6#1)(2008-10#16)(2008-11#1)(2008-5#3)(2008-6#3)(2013-8#1)
nucleotide sequences were determined##4##4##(1992-11#1)(1996-10#1)(1997-6#1)(1997-8#1)
nucleotide sequences were##8##3##(1992-11#1)(1994-8#1)(1996-10#1)(1997-3#1)(1997-6#1)(1997-8#1)(2009-5#2)
nucleotide sequences##77##2##(1990-11#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#3)(1994-6#1)(1994-8#3)(1995-2#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-6#1)(2008-10#24)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
nucleotide sequencing of##2##3##(1992-8#1)(1994-12#1)
nucleotide sequencing##5##2##(1990-12#1)(1992-8#1)(1994-12#1)(1995-12#1)(1996-12#1)
nucleotide substitution of##2##3##(1993-8#1)(2010-2#1)
nucleotide substitution##9##2##(1991-2#1)(1991-8#1)(1993-8#1)(1995-8#1)(2008-4#2)(2008-6#1)(2010-2#1)(2010-3#1)
nucleotide substitutions in##3##3##(1993-12#1)(1994-12#1)(2008-10#1)
nucleotide substitutions##9##2##(1993-12#1)(1993-2#1)(1994-12#1)(2008-10#4)(2008-6#1)(2008-8#1)
nucleotide to##2##2##(1992-1#1)(2008-4#1)
nucleotide variation was##2##3##(2008-10#1)(2011-2#1)
nucleotide variation##5##2##(1994-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
nucleotide##693##1##(1990-11#10)(1990-12#12)(1990-2#3)(1990-5#6)(1990-7#4)(1990-8#7)(1991-11#1)(1991-12#2)(1991-2#8)(1991-4#2)(1991-5#6)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#3)(1992-11#3)(1992-12#3)(1992-3#6)(1992-6#4)(1992-8#5)(1992-9#2)(1993-11#10)(1993-12#15)(1993-2#6)(1993-3#8)(1993-6#12)(1993-8#3)(1993-9#5)(1994-11#11)(1994-12#20)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#18)(1994-9#8)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#4)(1995-8#10)(1995-9#1)(1996-10#3)(1996-12#7)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#5)(1997-2#17)(1997-3#7)(1997-4#11)(1997-6#10)(1997-7#5)(1997-8#4)(1997-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#6)(2008-1#2)(2008-10#132)(2008-11#26)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#44)(2008-5#8)(2008-6#5)(2008-7#5)(2008-8#17)(2008-9#14)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#2)(2010-3#4)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#11)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#8)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#13)
nucleotide)##3##1##(1993-8#2)(2008-9#1)
nucleotide- or fMLP-induced ERK phosphorylation##2##5##(2008-4#2)
nucleotide- or##3##2##(2008-4#3)
nucleotide-##4##1##(2008-4#4)
nucleotide-binding domains of##2##3##(2008-11#2)
nucleotide-binding domains##3##2##(1997-4#1)(2008-11#2)
nucleotide-binding proteins##2##2##(1991-9#1)(1997-7#1)
nucleotide-binding site on##2##3##(1991-8#2)
nucleotide-binding site##3##2##(1991-8#2)(1995-6#1)
nucleotide-binding sites##5##2##(1990-7#3)(1995-6#2)
nucleotide-binding##22##1##(1990-7#4)(1990-8#2)(1991-8#2)(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1995-6#3)(1997-4#1)(1997-7#1)(2008-11#2)(2009-8#1)
nucleotide-free##2##1##(1994-12#1)(2008-11#1)
nucleotide-gated##2##1##(2009-10#2)
nucleotide-induced##4##1##(2008-4#4)
nucleotide-sized##2##1##(2012-2#2)
nucleotides (nt) and##3##3##(1993-2#1)(2008-8#2)
nucleotides (nt) in##2##3##(1994-12#1)(2008-10#1)
nucleotides (nt)##11##2##(1991-6#2)(1991-9#1)(1993-2#3)(1994-12#1)(1997-4#1)(2008-10#1)(2008-8#2)
nucleotides [nt]##2##2##(2008-10#2)
nucleotides and##13##2##(1990-7#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)
nucleotides are##7##2##(1992-6#1)(1994-8#1)(1997-2#1)(2008-1#1)(2008-4#3)
nucleotides as##3##2##(1994-8#1)(2008-4#2)
nucleotides between##2##2##(1993-11#1)(2008-7#1)
nucleotides encoding a##3##3##(1992-3#1)(1995-2#1)(2008-8#1)
nucleotides encoding##5##2##(1992-3#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-8#1)
nucleotides from the##6##3##(1990-11#1)(1992-3#1)(1994-11#1)(1997-3#2)(2008-10#1)
nucleotides from##9##2##(1990-11#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-6#1)(1997-3#3)(2008-10#1)
nucleotides have been##2##3##(2008-4#1)(2008-7#1)
nucleotides have##3##2##(2008-4#2)(2008-7#1)
nucleotides in a##5##3##(1990-8#1)(1992-8#1)(2008-4#2)(2010-6#1)
nucleotides in length and##2##4##(1997-7#1)(2011-2#1)
nucleotides in length##8##3##(1992-8#1)(1997-7#1)(2008-10#3)(2008-2#1)(2011-2#1)(2013-8#1)
nucleotides in length)##2##3##(2008-10#1)(2008-4#1)
nucleotides in the##8##3##(1990-5#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-8#1)
nucleotides in##33##2##(1990-5#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-8#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2008-10#6)(2008-2#1)(2008-4#8)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#2)
nucleotides is##2##2##(2008-4#2)
nucleotides long##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
nucleotides may##4##2##(2008-10#1)(2008-4#3)
nucleotides of the 5'##2##4##(1992-11#1)(1993-3#1)
nucleotides of the##8##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-3#1)(1996-12#1)(1996-5#1)(2007-6#1)
nucleotides of##15##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-11#2)(1993-3#1)(1996-12#1)(1996-5#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
nucleotides on the##2##3##(1997-7#1)(2008-11#1)
nucleotides on##4##2##(1992-11#1)(1997-7#1)(2008-11#1)(2008-4#1)
nucleotides per hundred##5##3##(2008-5#5)
nucleotides per##7##2##(1991-5#1)(1994-3#1)(2008-5#5)
nucleotides that##5##2##(1992-6#1)(2008-4#3)(2008-7#1)
nucleotides to the##2##3##(1992-6#1)(2008-11#1)
nucleotides to##5##2##(1992-6#1)(1993-1#1)(1993-11#1)(2008-11#1)(2008-4#1)
nucleotides upstream of the translation##2##5##(1992-11#1)(2008-9#1)
nucleotides upstream of the##4##4##(1990-8#1)(1992-11#1)(1993-3#1)(2008-9#1)
nucleotides upstream##5##2##(1990-8#1)(1992-11#2)(1993-3#1)(2008-9#1)
nucleotides was##5##2##(1992-6#1)(1993-8#1)(1995-8#1)(1997-2#1)(2008-11#1)
nucleotides were##7##2##(1990-12#1)(1990-8#1)(1992-6#1)(2008-10#1)(2008-8#1)(2009-2#1)(2012-2#1)
nucleotides with##6##2##(1990-8#1)(1991-12#1)(1991-5#1)(1993-11#1)(1995-5#2)
nucleotides##269##1##(1990-11#3)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#8)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#6)(1992-3#2)(1992-6#9)(1992-8#3)(1993-1#2)(1993-11#3)(1993-2#4)(1993-3#2)(1993-6#4)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#3)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#4)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#7)(1996-6#2)(1996-8#1)(1997-2#6)(1997-3#4)(1997-4#1)(1997-7#3)(2007-6#1)(2008-1#1)(2008-10#37)(2008-11#13)(2008-2#3)(2008-4#49)(2008-5#6)(2008-7#6)(2008-8#12)(2008-9#5)(2009-10#3)(2009-2#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-8#2)
nucleotides) of the##2##3##(2008-10#2)
nucleotides)##8##1##(1997-7#1)(2008-10#6)(2008-5#1)
nucleotidic variation between##2##3##(2008-5#2)
nucleotidic variation##4##2##(2008-5#4)
nucleotomy##3##1##(1996-6#3)
nucleus (PVN)##6##2##(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-4#1)(2008-8#1)
nucleus (SCN)##4##2##(1993-12#1)(1993-9#1)(1994-5#1)(2008-9#1)
nucleus 24 cochlear##2##3##(2008-9#2)
nucleus 24##5##2##(2008-9#5)
nucleus accumbens (NAC)##3##3##(1996-5#1)(2008-6#2)
nucleus accumbens (NAS)##2##3##(1993-12#1)(1993-6#1)
nucleus accumbens and striatum##3##4##(1993-12#2)(1997-7#1)
nucleus accumbens and##9##3##(1993-12#2)(1993-6#3)(1994-2#1)(1997-7#1)(2007-8#1)(2008-7#1)
nucleus accumbens as##2##3##(1997-7#1)(2008-4#1)
nucleus accumbens in vivo##2##4##(1991-1#1)(1994-8#1)
nucleus accumbens in##4##3##(1991-1#1)(1993-6#1)(1994-3#1)(1994-8#1)
nucleus accumbens or caudate nucleus##2##5##(1995-5#2)
nucleus accumbens were##2##3##(1995-2#1)(1997-2#1)
nucleus accumbens##71##2##(1991-1#1)(1991-2#5)(1991-5#2)(1993-12#5)(1993-6#16)(1994-2#4)(1994-3#2)(1994-8#7)(1995-12#1)(1995-2#2)(1995-5#2)(1996-12#2)(1996-5#2)(1997-2#2)(1997-3#3)(1997-7#5)(2007-8#2)(2008-4#2)(2008-6#2)(2008-7#4)
nucleus ambiguus##2##2##(1993-12#1)(2007-10#1)
nucleus and a##2##3##(1996-12#1)(2013-8#1)
nucleus and the##9##3##(1991-12#1)(1994-2#1)(1996-5#1)(2008-1#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
nucleus and##43##2##(1991-12#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-9#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#4)(2008-7#6)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
nucleus as##3##2##(1993-12#1)(1994-6#1)(2008-9#1)
nucleus basalis lesions##3##3##(1990-5#2)(1991-9#1)
nucleus basalis magnocellularis (NBM)##4##4##(1991-12#1)(1993-3#1)(1995-12#1)(2008-8#1)
nucleus basalis magnocellularis##8##3##(1991-12#1)(1993-12#3)(1993-3#2)(1995-12#1)(2008-8#1)
nucleus basalis##16##2##(1990-5#3)(1991-12#1)(1991-9#2)(1992-10#2)(1993-12#3)(1993-3#2)(1994-8#1)(1995-12#1)(2008-8#1)
nucleus by##4##2##(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#1)
nucleus can##2##2##(2008-9#1)(2011-2#1)
nucleus changes shape##2##3##(2011-2#2)
nucleus gigantocellularis##2##2##(1990-9#2)
nucleus hole##2##2##(1992-5#2)
nucleus in the##5##3##(1993-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
nucleus in##20##2##(1993-12#2)(1994-8#1)(1995-12#1)(1997-1#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-9#2)(2009-10#1)(2011-2#3)
nucleus is##10##2##(1992-11#1)(1993-5#1)(1993-8#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2011-2#1)
nucleus lesions##3##2##(1991-3#1)(1992-11#1)(1993-12#1)
nucleus may##2##2##(1994-3#1)(1997-6#1)
nucleus neurons##2##2##(1993-12#1)(1993-5#1)
nucleus of the amygdala##13##4##(1993-12#6)(1993-6#3)(1995-12#1)(1996-12#1)(2007-10#2)
nucleus of the hypothalamus##3##4##(1993-5#1)(1995-12#1)(1996-12#1)
nucleus of the stria terminalis##3##5##(1993-12#1)(1994-2#1)(2008-9#1)
nucleus of the thalamus##2##4##(2012-12#1)(2012-3#1)
nucleus of the##46##3##(1991-2#1)(1992-11#1)(1993-12#12)(1993-5#1)(1993-6#3)(1994-2#2)(1994-3#2)(1995-12#2)(1996-12#3)(1996-5#2)(1997-3#5)(2007-10#2)(2008-11#1)(2008-3#1)(2008-9#4)(2012-12#1)(2012-2#1)(2012-3#2)
nucleus of##62##2##(1990-9#1)(1991-2#1)(1991-7#1)(1992-11#2)(1993-12#13)(1993-5#1)(1993-6#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#3)(1996-12#3)(1996-5#3)(1997-3#5)(2007-10#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#5)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
nucleus on##2##2##(1992-11#1)(1993-12#1)
nucleus or##6##2##(1994-8#1)(1995-8#1)(2008-4#1)(2009-9#1)(2011-2#2)
nucleus paragigantocellularis##2##2##(1994-2#1)(1997-2#1)
nucleus posterioris##2##2##(2008-6#2)
nucleus preopticus##2##2##(2008-6#2)
nucleus pulposus##8##2##(2007-11#1)(2007-8#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
nucleus reticularis##2##2##(1997-2#1)(2008-6#1)
nucleus than##2##2##(1992-11#1)(2008-8#1)
nucleus that is##2##3##(1992-3#1)(2012-2#1)
nucleus that##3##2##(1992-12#1)(1992-3#1)(2012-2#1)
nucleus through##2##2##(2011-2#2)
nucleus to the##6##3##(1992-3#1)(1993-9#1)(1997-3#1)(2009-10#1)(2009-7#1)(2011-2#1)
nucleus to##12##2##(1990-5#1)(1991-2#1)(1992-3#1)(1993-9#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)
nucleus tractus solitarius##5##3##(1994-2#1)(1997-2#2)(2007-10#2)
nucleus tractus##7##2##(1992-3#2)(1994-2#1)(1997-2#2)(2007-10#2)
nucleus were##2##2##(1992-8#1)(2008-5#1)
nucleus##579##1##(1990-11#1)(1990-12#1)(1990-5#4)(1990-9#6)(1991-1#1)(1991-12#11)(1991-2#11)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#2)(1991-9#3)(1992-10#4)(1992-11#14)(1992-12#1)(1992-3#5)(1992-5#2)(1992-6#1)(1992-8#3)(1993-12#50)(1993-3#3)(1993-5#7)(1993-6#19)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#16)(1994-3#11)(1994-5#2)(1994-6#4)(1994-8#14)(1994-9#3)(1995-12#13)(1995-2#3)(1995-5#6)(1995-8#3)(1996-12#14)(1996-2#5)(1996-5#14)(1997-1#3)(1997-2#15)(1997-3#13)(1997-4#1)(1997-6#4)(1997-7#6)(2007-10#8)(2007-11#1)(2007-12#14)(2007-8#7)(2008-1#4)(2008-10#12)(2008-11#11)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#8)(2008-5#5)(2008-6#13)(2008-7#30)(2008-8#19)(2008-9#43)(2009-10#7)(2009-11#1)(2009-12#4)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#25)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#2)(2013-8#4)
nucleus-side chain and side chain-side chain cross-linkages##2##7##(2008-10#2)
nuda##5##1##(2008-10#5)
nude mice##40##2##(1991-8#2)(1992-9#4)(1993-1#2)(1993-9#3)(1994-11#1)(1994-12#3)(1994-5#1)(1995-2#1)(1995-3#2)(1995-9#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#8)(2010-1#4)(2011-2#1)(2013-1#2)(2013-8#1)
nude mouse model##2##3##(1992-2#1)(2008-11#1)
nude mouse##4##2##(1992-2#1)(1995-3#1)(2008-11#1)(2008-9#1)
nude rat##2##2##(2008-6#2)
nude rats##5##2##(1995-2#1)(2008-6#3)(2012-12#1)
nude##54##1##(1991-8#4)(1992-2#1)(1992-9#4)(1993-1#2)(1993-9#3)(1994-11#1)(1994-12#3)(1994-5#1)(1995-2#2)(1995-3#3)(1995-9#1)(2008-11#2)(2008-5#1)(2008-6#7)(2008-8#8)(2008-9#1)(2010-1#4)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
nudel##2##1##(1991-5#2)
nuisance##8##1##(2007-2#2)(2008-10#2)(2010-2#1)(2010-5#2)(2012-2#1)
nujol-graphite and diphenylether-graphite##2##3##(2008-10#2)
null alleles##6##2##(1995-6#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-1#1)
null correctors##8##2##(2008-3#8)
null ellipsometry##5##2##(2008-3#5)
null genotype was##2##3##(2008-12#2)
null genotype##3##2##(2008-12#3)
null genotypes##2##2##(2008-12#2)
null hypotheses##3##2##(2010-3#2)(2011-2#1)
null hypothesis of no difference##2##5##(1995-5#1)(1995-9#1)
null hypothesis of##6##3##(1995-5#1)(1995-9#2)(1997-3#1)(2008-10#2)
null hypothesis##17##2##(1995-2#1)(1995-5#2)(1995-9#3)(1996-4#2)(1997-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)
null lens##4##2##(2008-3#4)
null mice##4##2##(2008-3#2)(2009-2#1)(2010-2#1)
null model##5##2##(1993-12#1)(2008-10#1)(2008-8#3)
null models##4##2##(2008-8#3)(2009-8#1)
null mutant##2##2##(1994-8#1)(1996-3#1)
null mutants##5##2##(1996-3#1)(1997-4#2)(2007-12#1)(2012-1#1)
null mutation##3##2##(1996-5#2)(2009-10#1)
null mutations in##2##3##(1993-12#1)(2009-8#1)
null mutations##4##2##(1993-12#1)(2008-9#1)(2009-5#1)(2009-8#1)
null test##2##2##(2008-3#2)
null##98##1##(1993-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#3)(1996-3#2)(1996-4#2)(1996-5#2)(1997-3#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#6)(2008-2#1)(2008-3#28)(2008-5#2)(2008-7#1)(2008-8#8)(2008-9#6)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#3)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
nullified the##2##2##(2008-10#1)(2010-4#1)
nullified##3##1##(2008-10#2)(2010-4#1)
nulling beam##2##2##(2008-3#2)
nulling of##2##2##(2008-3#2)
nulling stellar coronagraph##2##3##(2007-11#2)
nulling##16##1##(2007-11#5)(2008-3#11)
nulliparous adolescents##3##2##(2013-1#3)
nulliparous and ovariectomized mice fed either a nutrient-sufficient or -deficient diet containing cadmium##3##13##(1997-4#3)
nulliparous female##2##2##(2011-1#1)(2012-3#1)
nulliparous women##3##2##(2013-1#2)(2013-8#1)
nulliparous##13##1##(1992-5#1)(1997-4#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
nullisomic##4##1##(2008-10#4)
nullisomic-tetrasomic##2##1##(2008-10#2)
nulls##3##1##(2008-3#3)
num##2##1##(2008-3#2)
number N##2##2##(2008-10#1)(2008-2#1)
number and distribution of##4##4##(1994-9#1)(2007-12#1)(2008-3#1)(2008-8#1)
number and function##2##3##(2006-10#1)(2008-11#1)
number and length of##3##4##(1997-6#1)(1997-8#1)(2008-5#1)
number and length##4##3##(1997-6#1)(1997-8#1)(2008-5#2)
number and location##3##3##(1995-12#1)(1996-5#1)(2008-6#1)
number and size of##9##4##(1990-5#1)(1995-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
number and size##10##3##(1990-5#1)(1995-8#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
number and the binding##2##4##(1993-12#1)(2008-10#1)
number and the relevant positions of the alpha-helices and##2##9##(2008-10#2)
number and the##12##3##(1993-12#1)(1994-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)(2012-12#1)(2013-8#1)
number and thickness of##2##4##(2008-10#1)(2013-8#1)
number and type of##4##4##(1994-2#1)(1996-3#1)(2008-11#1)(2008-5#1)
number and type##6##3##(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
number and viability##2##3##(2008-11#1)(2008-5#1)
number and##123##2##(1990-3#1)(1990-5#1)(1991-6#3)(1991-9#1)(1992-9#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#3)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
number are##4##2##(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#1)
number by##2##2##(2008-11#1)(2008-3#1)
number concentration of##2##3##(1993-8#1)(1995-3#1)
number concentration##3##2##(1993-8#1)(1995-3#1)(2008-3#1)
number densities##6##2##(2008-2#2)(2008-3#3)(2013-1#1)
number density measurements##4##3##(2008-3#4)
number density of##3##3##(2008-3#2)(2010-12#1)
number density##19##2##(2008-10#1)(2008-2#2)(2008-3#15)(2010-12#1)
number detected##2##2##(2008-1#1)(2008-10#1)
number determination##4##2##(2008-10#3)(2008-9#1)
number during##2##2##(1992-11#1)(1993-12#1)
number fluctuations in photon-correlation spectroscopy##2##5##(2008-3#2)
number fluctuations##3##2##(2008-3#3)
number for each##2##3##(1990-5#1)(2008-10#1)
number for the##2##3##(2008-11#1)(2008-7#1)
number for##5##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
number from##2##2##(2008-5#1)(2008-6#1)
number have##3##2##(1993-8#1)(2007-8#1)(2008-10#1)
number higher than##2##3##(2008-10#1)(2008-12#1)
number in the##12##3##(1992-3#1)(1994-10#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)
number in##36##2##(1992-3#1)(1992-9#1)(1993-12#2)(1994-10#1)(1994-3#1)(1995-8#2)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
number increased##4##2##(2008-11#1)(2008-7#2)(2010-11#1)
number increases##2##2##(2008-12#1)(2008-5#1)
number is##13##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#2)(2009-7#1)(2010-10#1)(2012-2#1)(2012-3#2)
number may be##2##3##(1994-3#1)(2006-4#1)
number nor the##2##3##(1991-6#1)(1995-8#1)
number nor##4##2##(1991-6#1)(1995-8#1)(2009-6#1)(2010-8#1)
number of &quot##3##3##(1992-2#1)(2008-1#1)(2008-3#1)
number of 12##2##3##(1994-8#1)(2008-10#1)
number of B##3##3##(1997-9#1)(2007-10#1)(2008-5#1)
number of Bs##3##3##(2008-12#1)(2008-5#2)
number of CTLs##2##3##(2008-11#2)
number of DNA##2##3##(1994-8#1)(2008-7#1)
number of ER-L##2##3##(2010-12#2)
number of Fos-lacZ-positive cells##2##4##(1996-5#2)
number of H##2##3##(1996-5#1)(2008-10#1)
number of HIV##3##3##(1993-8#1)(2008-7#1)(2012-12#1)
number of ICSS trains##4##4##(1991-2#4)
number of LS-11 cells##2##4##(2008-10#2)
number of O-linked##2##3##(1994-5#1)(1994-9#1)
number of T##2##3##(1991-12#1)(1991-6#1)
number of a##2##3##(2008-3#1)(2008-8#1)
number of abortions has##2##4##(1991-3#2)
number of active##10##3##(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#2)(2010-8#1)(2010-9#1)(2011-1#1)
number of actual alleles##2##4##(2008-12#2)
number of actual##3##3##(1996-4#1)(2008-12#2)
number of additional##3##3##(1997-2#1)(2007-11#1)(2008-5#1)
number of admissions##4##3##(1993-12#1)(1996-3#2)(1997-4#1)
number of adult##5##3##(1994-3#1)(1994-5#1)(1996-12#1)(2008-8#1)(2008-9#1)
number of advantages##12##3##(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-3#1)
number of alleles per locus##3##5##(2008-10#1)(2013-8#2)
number of alleles##4##3##(2008-10#1)(2008-12#1)(2013-8#2)
number of amino acids##4##4##(1991-2#1)(1994-6#1)(1997-7#1)(2011-2#1)
number of amino##6##3##(1991-2#1)(1994-6#1)(1997-7#1)(2008-10#2)(2011-2#1)
number of analyses##2##3##(1993-12#1)(2008-4#1)
number of analytical##2##3##(2008-10#2)
number of anamorph genera##2##4##(2008-10#2)
number of animal studies##2##4##(1991-9#1)(2008-8#1)
number of animal##3##3##(1991-9#1)(2008-2#1)(2008-8#1)
number of apoptotic cells##2##4##(2010-1#1)(2011-2#1)
number of apothecia##5##3##(2008-10#5)
number of applications##6##3##(1997-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)
number of arrivals##2##3##(2010-8#2)
number of ascospores discharged##2##4##(2008-10#2)
number of ascospores##4##3##(2008-10#4)
number of aspects##2##3##(2008-10#1)(2008-5#1)
number of assays##2##3##(2008-1#2)
number of astrocytes##2##3##(2008-12#1)(2009-3#1)
number of athletes##2##3##(1993-3#1)(2010-1#1)
number of audible pops##3##4##(2008-12#3)
number of available##5##3##(2008-3#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-8#1)
number of avoidances##2##3##(1991-2#2)
number of bacteria##5##3##(2008-10#3)(2008-12#1)(2008-9#1)
number of bands##4##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
number of barriers##2##3##(1993-12#1)(2008-1#1)
number of beds##3##3##(1993-1#1)(1995-1#1)(1997-4#1)
number of beneficiaries##2##3##(1997-2#1)(1997-3#1)
number of bifidobacteria##2##3##(2008-12#2)
number of biological processes##3##4##(1995-11#1)(1996-6#1)(2008-4#1)
number of biological##6##3##(1995-11#1)(1996-6#1)(2008-10#1)(2008-4#2)(2010-3#1)
number of biologically##2##3##(1994-8#1)(2011-1#1)
number of biomedical##2##3##(2008-7#1)(2009-6#1)
number of biopsies##2##3##(1991-2#1)(2013-8#1)
number of births##3##3##(1990-12#1)(1990-6#1)(1995-12#1)
number of bites##2##3##(2008-4#2)
number of brain regions##2##4##(1995-12#1)(1996-12#1)
number of brain##3##3##(1994-2#1)(1995-12#1)(1996-12#1)
number of branches plant(-1)##2##4##(2008-12#2)
number of branches##3##3##(2008-12#3)
number of bundles##2##3##(2008-10#2)
number of cancer survivors##3##4##(2008-7#1)(2008-8#1)(2011-2#1)
number of carbon atoms##4##4##(1990-7#1)(2008-10#3)
number of carbon##5##3##(1990-7#1)(2008-10#3)(2008-6#1)
number of cardiac##4##3##(1995-12#1)(2006-10#1)(2007-8#1)(2008-7#1)
number of case reports of##2##5##(1991-12#1)(2013-1#1)
number of case reports##3##4##(1991-12#1)(2013-1#2)
number of cases and##3##4##(1992-9#1)(1994-3#1)(2013-8#1)
number of cases in the##2##5##(1994-9#1)(1997-6#1)
number of cases in##3##4##(1994-9#2)(1997-6#1)
number of cases is##3##4##(1990-10#1)(1992-9#1)(2007-10#1)
number of cases of##9##4##(1991-8#1)(1992-11#1)(1992-9#1)(2007-7#1)(2008-11#1)(2011-2#3)(2013-8#1)
number of cases that##2##4##(1993-12#1)(2008-6#1)
number of cases##42##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#2)(1991-8#1)(1992-11#1)(1992-9#5)(1993-12#1)(1994-3#1)(1994-9#5)(1995-2#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-6#3)(2008-7#1)(2010-12#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#2)
number of cell lines##2##4##(1992-8#1)(2008-10#1)
number of cell types##2##4##(1995-6#1)(2008-9#1)
number of cell##8##3##(1992-3#1)(1992-8#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-9#1)
number of cells differentiating to the##2##6##(2008-5#2)
number of cells##17##3##(1990-12#1)(1990-3#1)(1992-6#2)(1993-6#1)(1995-9#1)(1997-1#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-1#1)
number of cellular##4##3##(1993-8#1)(2008-11#1)(2010-11#2)
number of challenges##2##3##(2008-7#1)(2013-8#1)
number of changes in##3##4##(1995-2#1)(2008-10#1)(2010-12#1)
number of changes##4##3##(1995-2#1)(2008-10#1)(2010-12#1)(2012-3#1)
number of channels and##2##4##(2008-9#2)
number of channels##8##3##(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#4)
number of children##10##3##(1990-6#1)(1992-4#2)(2007-11#1)(2008-8#1)(2009-7#1)(2010-6#2)(2011-1#1)(2011-2#1)
number of chromosomes##7##3##(1991-4#1)(1997-5#1)(2008-12#2)(2008-8#1)(2009-12#1)(2010-3#1)
number of cigarettes##2##3##(1994-6#1)(2013-1#1)
number of cigarettes/day##2##3##(1997-4#2)
number of citations##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
number of claims an employee submitted##2##6##(1994-2#2)
number of claims an employee##3##5##(1994-2#3)
number of claims##4##3##(1994-2#4)
number of clinical##6##3##(2007-8#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
number of clusters##2##3##(2008-5#1)(2013-1#1)
number of colonies per leaf##2##5##(2008-10#2)
number of colonies##3##3##(2008-10#3)
number of commercial##2##3##(2008-10#1)(2010-4#1)
number of commercially available##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
number of comorbidities##2##3##(2008-8#1)(2012-12#1)
number of complications##4##3##(2007-8#1)(2008-11#1)(2013-1#2)
number of components and##2##4##(2008-10#2)
number of components##6##3##(2008-10#5)(2008-4#1)
number of compounds##7##3##(1990-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
number of conidia and appressoria##3##5##(2008-10#3)
number of conidia per##2##4##(2008-10#2)
number of conidia##13##3##(2008-10#13)
number of contact##2##3##(1991-2#1)(2007-12#1)
number of continuous rainy days in April and May##4##9##(2008-10#4)
number of continuous##5##3##(2008-10#4)(2010-11#1)
number of core##2##3##(2008-7#1)(2010-11#1)
number of corpora lutea in each ovary##2##7##(1992-3#2)
number of correct responses##2##4##(1991-2#1)(1993-3#1)
number of correct##3##3##(1991-2#1)(1993-3#1)(1996-7#1)
number of correctly##2##3##(1992-9#1)(2013-1#1)
number of countries##2##3##(2007-12#1)(2008-11#1)
number of covariates##3##3##(1994-2#1)(2008-8#1)(2009-10#1)
number of cryptic species##2##4##(2008-10#1)(2012-3#1)
number of cycles##2##3##(1992-2#1)(2009-4#1)
number of cytoplasmic##2##3##(2007-12#1)(2008-12#1)
number of data##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
number of days to##2##4##(1996-1#1)(2008-10#1)
number of days##11##3##(1990-5#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2012-2#1)
number of deaths from breast cancer##2##6##(1997-7#2)
number of deaths from##3##4##(1997-7#2)(2011-1#1)
number of deaths in##3##4##(1991-9#1)(2008-8#1)(2011-3#1)
number of deaths##9##3##(1990-9#1)(1991-9#1)(1997-7#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-3#1)
number of degenerative##2##3##(2008-10#1)(2008-8#1)
number of detected##4##3##(1996-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
number of diabetic patients##2##4##(1990-11#1)(2012-2#1)
number of diabetic##3##3##(1990-11#1)(2010-8#1)(2012-2#1)
number of differences##2##3##(1994-11#1)(2011-2#1)
number of different strategies##2##4##(2008-11#1)(2008-9#1)
number of different##39##3##(1990-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-2#2)(1995-12#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
number of dimensions##2##3##(2008-2#1)(2012-2#1)
number of disease##2##3##(2008-10#1)(2008-7#1)
number of diseased trees##2##4##(2008-10#2)
number of diseases per##2##4##(2008-10#2)
number of diseases##12##3##(1991-9#1)(1994-2#1)(1994-6#1)(2006-6#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)
number of dissected lymph nodes##3##5##(2011-2#3)
number of distinct##2##3##(2009-10#1)(2010-10#1)
number of drugs have been##2##5##(2008-8#1)(2009-12#1)
number of drugs##9##3##(1993-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-12#1)(2011-2#1)(2012-3#1)
number of effective##3##3##(2008-12#2)(2008-3#1)
number of eggs##5##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
number of elastin fibers##2##4##(2008-5#2)
number of elderly patients##4##4##(1991-11#1)(1994-3#2)(2011-2#1)
number of elderly##5##3##(1991-11#1)(1994-3#2)(2011-2#1)(2012-3#1)
number of electrons involved in the electrode reduction##2##8##(2008-10#2)
number of electrons##4##3##(2007-12#1)(2008-10#3)
number of elements##5##3##(2008-10#2)(2008-2#1)(2009-5#1)(2011-2#1)
number of eligible##2##3##(2008-12#1)(2010-3#1)
number of embryos in each uterine horn##2##7##(1992-3#2)
number of embryos##4##3##(1992-3#2)(2008-12#2)
number of emerged##2##3##(2008-6#2)
number of enrolled patients##2##4##(2008-7#1)(2010-8#1)
number of entries into##2##4##(1993-6#1)(2008-8#1)
number of events##4##3##(1993-12#1)(1997-4#1)(2008-3#1)(2008-5#1)
number of examples##3##3##(1991-5#1)(1996-6#1)(2008-6#1)
number of experimental and##2##4##(2008-10#1)(2012-12#1)
number of experimental##6##3##(1995-6#1)(1997-3#1)(2008-10#2)(2008-8#1)(2012-12#1)
number of experiments##6##3##(2008-10#3)(2008-4#1)(2008-5#2)
number of external##3##3##(2009-5#1)(2011-2#2)
number of factors##27##3##(1992-12#1)(1992-6#1)(1994-3#1)(1994-8#1)(1997-2#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
number of failures##2##3##(1994-3#1)(2011-2#1)
number of false positives and negatives##2##6##(2008-10#2)
number of false rejections V##2##5##(2010-3#2)
number of false##6##3##(1997-2#2)(2008-10#2)(2010-3#2)
number of families##2##3##(1996-2#1)(1997-5#1)
number of features##7##3##(1994-2#1)(1995-2#1)(1997-7#1)(2008-3#2)(2008-6#1)(2012-3#1)
number of female##6##3##(1993-9#1)(2008-10#1)(2008-12#2)(2009-7#1)(2013-1#1)
number of females that##2##4##(2010-8#1)(2013-1#1)
number of females##5##3##(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
number of fertilized eggs##2##4##(1997-2#1)(2010-8#1)
number of flowers produced##2##4##(2008-9#1)(2011-2#1)
number of flowers##4##3##(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)
number of fluorescent##3##3##(2007-10#1)(2008-9#2)
number of foci##4##3##(2007-11#1)(2008-10#3)
number of food##4##3##(1990-8#1)(1997-4#1)(2009-5#1)(2010-6#1)
number of foods##2##3##(2008-4#2)
number of fractions##3##3##(2007-10#1)(2008-10#2)
number of fringes##2##3##(2008-3#2)
number of fungal##2##3##(2008-10#2)
number of gene##3##3##(1990-11#1)(1993-3#1)(2012-3#1)
number of generated##2##3##(2007-11#1)(2008-7#1)
number of genes and##2##4##(1996-12#1)(1997-7#1)
number of genes in##3##4##(1996-12#1)(2008-6#1)(2011-2#1)
number of genes that##3##4##(2008-11#1)(2008-4#1)(2011-1#1)
number of genes##28##3##(1992-8#1)(1996-12#3)(1996-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
number of genetic##4##3##(1994-12#1)(2010-5#1)(2012-1#1)(2013-8#1)
number of genotypes observed in a sample##2##7##(2008-10#2)
number of genotypes observed##3##4##(2008-10#3)
number of genotypes##5##3##(2008-10#5)
number of grains##2##3##(1990-12#1)(2008-12#1)
number of grid points##2##4##(2008-2#1)(2012-2#1)
number of groups are##2##4##(2008-11#1)(2008-7#1)
number of groups##5##3##(1991-12#1)(2008-11#1)(2008-7#1)(2009-1#1)(2012-2#1)
number of habitat patches##2##4##(2008-8#2)
number of health##4##3##(1990-11#1)(1990-6#1)(1992-3#1)(2008-11#1)
number of healthy and##2##4##(2008-10#1)(2008-5#1)
number of healthy##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
number of hepatic##3##3##(1994-11#1)(2011-2#2)
number of holograms##3##3##(2008-2#1)(2008-3#2)
number of hospitals are##2##4##(1993-3#1)(1997-1#1)
number of hospitals##5##3##(1993-3#1)(1994-2#1)(1997-1#1)(2008-11#1)(2011-2#1)
number of hours##3##3##(2008-10#3)
number of human##6##3##(1993-3#1)(1993-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)
number of hypothetical##2##3##(2008-10#1)(2011-1#1)
number of important##12##3##(1991-3#1)(1992-9#1)(1997-3#1)(2008-10#4)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
number of independent##2##3##(2008-3#1)(2008-4#1)
number of index subjects##4##4##(1996-3#4)
number of individual##2##3##(2007-12#1)(2008-5#1)
number of individuals and##2##4##(2008-4#1)(2008-8#1)
number of individuals introduced##2##4##(2008-8#2)
number of individuals with##3##4##(2008-1#1)(2012-2#1)(2013-8#1)
number of individuals##21##3##(1996-3#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#5)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
number of induced abortions##2##4##(2013-1#2)
number of industrial##3##3##(1996-1#1)(2009-8#1)(2011-2#1)
number of infected plants##3##4##(2008-10#3)
number of infected##8##3##(2008-10#8)
number of infection##2##3##(2008-10#2)
number of infections##4##3##(1992-6#1)(1994-6#1)(1997-2#1)(2008-10#1)
number of infective second-stage juveniles##2##5##(2008-10#2)
number of information##2##3##(2008-7#1)(2010-4#1)
number of injections##2##3##(1997-5#1)(2011-2#1)
number of input##2##3##(2008-10#1)(2008-2#1)
number of insects##2##3##(2008-10#2)
number of institutions##2##3##(1995-12#1)(2008-6#1)
number of instruments##2##3##(2008-3#1)(2008-7#1)
number of integrated##2##3##(2008-10#1)(2008-2#1)
number of intensity##5##3##(2007-11#2)(2008-3#3)
number of interacting##2##3##(2008-3#1)(2008-5#1)
number of interfering##3##3##(2008-10#3)
number of international##2##3##(1991-8#1)(2007-8#1)
number of invasive##2##3##(2008-11#1)(2012-3#1)
number of involved##4##3##(1993-9#1)(2007-8#3)
number of ions##4##3##(2008-10#2)(2008-3#1)(2010-7#1)
number of irradiation##2##3##(2008-10#2)
number of isolates##3##3##(2008-10#2)(2008-5#1)
number of items in##2##4##(2012-2#2)
number of items##3##3##(2009-5#1)(2012-2#2)
number of its##3##3##(1990-2#1)(2008-5#1)(2010-1#1)
number of joints##2##3##(2007-12#1)(2007-8#1)
number of key##8##3##(1992-8#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#2)(2011-1#2)
number of known genes##2##4##(1994-12#1)(1995-5#1)
number of laboratory##2##3##(2008-10#1)(2008-7#1)
number of large##2##3##(2008-10#1)(2011-1#1)
number of larvae##2##3##(2008-6#1)(2013-1#1)
number of laser shots##2##4##(2008-2#1)(2008-3#1)
number of laser##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
number of layers##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
number of leaves##4##3##(2008-10#4)
number of legal##3##3##(1996-11#2)(2008-7#1)
number of lesions on##2##4##(1997-6#1)(2008-10#1)
number of lesions per##3##4##(2008-10#3)
number of lesions##15##3##(1994-11#2)(1997-6#2)(2008-10#10)(2013-1#1)
number of levels##2##3##(1995-5#1)(2008-11#1)
number of lines##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
number of lipid droplets##2##4##(2007-12#1)(2009-3#1)
number of live births##2##4##(1991-3#2)
number of live##4##3##(1991-3#2)(2008-11#1)(2011-1#1)
number of loci##2##3##(1994-3#1)(2008-8#1)
number of long-term survivors##2##4##(2010-11#1)(2010-3#1)
number of long-term##3##3##(1994-5#1)(2010-11#1)(2010-3#1)
number of lymphocytes##2##3##(1992-12#1)(2008-7#1)
number of major##3##3##(1993-9#1)(1994-11#1)(2008-10#1)
number of male##2##3##(1993-9#1)(2008-12#1)
number of males##3##3##(2008-8#1)(2009-9#1)(2013-1#1)
number of managed care##2##4##(1995-12#1)(2008-11#1)
number of mates##2##3##(2008-8#2)
number of matings##2##3##(2008-8#1)(2013-1#1)
number of meals##3##3##(1994-6#1)(2008-4#2)
number of measurement##2##3##(2008-10#1)(2008-7#1)
number of measurements##2##3##(2008-10#1)(2008-5#1)
number of medical##2##3##(1990-12#1)(1991-12#1)
number of metabolic##3##3##(2008-10#2)(2009-8#1)
number of metal ions on the determination of##5##8##(2008-10#5)
number of metal ions on the##6##6##(2008-10#6)
number of metal ions##8##4##(2008-10#8)
number of methods based on##2##5##(2008-7#1)(2010-11#1)
number of methods##5##3##(1995-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)
number of microorganisms##4##3##(2007-12#1)(2008-5#2)(2011-1#1)
number of migrants##5##3##(2008-10#2)(2008-8#1)(2013-1#2)
number of mitotic##2##3##(1990-8#1)(2008-6#1)
number of modes##3##3##(2007-11#1)(2008-3#2)
number of molecular##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
number of multiple nucleoli##2##4##(2007-12#2)
number of multiple##4##3##(1997-2#1)(2007-12#2)(2008-9#1)
number of muscles##2##3##(2010-12#1)(2010-9#1)
number of negative##3##3##(2008-6#1)(2012-1#1)(2013-8#1)
number of neurons in the##2##5##(1990-5#1)(2008-10#1)
number of neurons##4##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-4#1)
number of new cases##2##4##(1992-2#1)(1997-6#1)
number of new##20##3##(1990-6#2)(1992-2#1)(1994-3#1)(1997-3#1)(1997-6#2)(2007-11#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)
number of nodes##3##3##(2007-11#1)(2007-9#1)(2008-10#1)
number of notified cases##2##4##(2012-12#1)(2013-8#1)
number of nuclear proteins##2##4##(1997-2#1)(2008-1#1)
number of nuclear##3##3##(1997-2#1)(2008-1#1)(2011-2#1)
number of nucleotide substitutions##2##4##(2008-6#1)(2008-8#1)
number of nucleotide##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
number of nursing##3##3##(1996-2#1)(2007-10#1)(2010-3#1)
number of observations##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)
number of observed##2##3##(2008-7#1)(2011-1#1)
number of offspring##5##3##(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)
number of older persons in##2##5##(1997-2#1)(2010-10#1)
number of older##4##3##(1997-2#1)(2008-7#1)(2010-10#1)(2010-11#1)
number of olfactory##2##3##(2007-12#1)(2012-2#1)
number of ommatidia per eye##3##5##(2007-12#3)
number of online##2##3##(1994-12#1)(2010-10#1)
number of oospores per leaflet##2##5##(2008-10#2)
number of oospores produced##2##4##(2008-10#2)
number of oospores##5##3##(2008-10#5)
number of optical##2##3##(2008-2#1)(2008-3#1)
number of other##25##3##(1990-11#1)(1991-3#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1994-12#1)(1995-4#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2012-2#1)
number of panicles##2##3##(2008-12#1)(2008-8#1)
number of papers##8##3##(1991-5#1)(2008-10#6)(2012-2#1)
number of papillomas##2##3##(1992-8#1)(2013-1#1)
number of parameters##7##3##(1991-3#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
number of participants##4##3##(2007-11#1)(2010-11#1)(2010-7#1)(2012-3#1)
number of particle##2##3##(1992-3#1)(2008-8#1)
number of patches##6##3##(2008-8#6)
number of patients are##3##4##(2008-4#1)(2011-2#2)
number of patients in##3##4##(2008-1#1)(2008-12#1)(2011-1#1)
number of patients presenting##2##4##(2007-10#1)(2011-2#1)
number of patients receiving##2##4##(2010-5#1)(2013-8#1)
number of patients suffering from##2##5##(1993-11#1)(2011-3#1)
number of patients treated with##2##5##(1995-2#1)(2007-10#1)
number of patients treated##5##4##(1994-5#1)(1995-2#1)(2007-10#1)(2008-7#1)(2011-2#1)
number of patients was##3##4##(1994-12#1)(1996-12#1)(2011-2#1)
number of patients were##2##4##(2008-7#1)(2011-1#1)
number of patients who##3##4##(2007-8#1)(2008-1#1)(2012-3#1)
number of patients with##14##4##(1992-2#1)(1993-1#1)(1994-12#1)(1996-3#1)(2007-11#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#3)(2011-2#1)
number of patients##79##3##(1991-11#3)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#2)(1994-12#2)(1994-5#2)(1994-6#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-8#3)(2008-1#7)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
number of pecks##2##3##(2008-6#2)
number of people with dementia in##2##6##(2011-1#1)(2013-8#1)
number of people with dementia##3##5##(2008-6#1)(2011-1#1)(2013-8#1)
number of people with##6##4##(1996-2#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
number of people##12##3##(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2006-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
number of perfused##2##3##(1997-2#2)
number of persistent##2##3##(2007-11#1)(2013-8#1)
number of personal##2##3##(2008-11#1)(2009-5#1)
number of persons##2##3##(1996-3#1)(2007-8#1)
number of phase levels##2##4##(2008-2#1)(2008-3#1)
number of phase##4##3##(2008-2#1)(2008-3#3)
number of photons in##2##4##(2007-11#1)(2008-3#1)
number of photons##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
number of physicians##2##3##(1994-1#1)(2008-4#1)
number of physiological##2##3##(1993-5#1)(2008-5#1)
number of plant species##2##4##(2008-10#1)(2009-8#1)
number of plant##5##3##(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)
number of plants##3##3##(2008-10#3)
number of points##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
number of polymorphic loci##3##4##(2008-10#2)(2008-9#1)
number of polymorphisms##2##3##(2008-10#2)
number of pores##2##3##(2008-10#2)
number of positive##3##3##(1990-8#2)(2010-4#1)
number of possible##10##3##(1991-3#1)(1995-12#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-9#1)
number of potential mates##3##4##(2008-8#3)
number of potential##13##3##(1994-6#1)(1995-5#1)(1996-3#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#4)(2010-4#1)(2012-12#1)
number of potentially##5##3##(1993-11#1)(2006-10#1)(2008-9#1)(2011-3#1)(2012-1#1)
number of predictors##2##3##(2011-2#1)(2012-12#1)
number of pregnancies and##2##4##(2011-1#1)(2011-2#1)
number of pregnancies on bone mineral density##2##7##(2011-2#2)
number of pregnancies##7##3##(1995-6#1)(2011-1#1)(2011-2#5)
number of previous##6##3##(1991-2#2)(2008-1#2)(2008-8#1)(2012-2#1)
number of primary particles##2##4##(2008-3#2)
number of primary##3##3##(1995-3#1)(2008-3#2)
number of problems##4##3##(1995-12#1)(2007-11#1)(2008-11#2)
number of procedures##4##3##(1993-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
number of processors##2##3##(2008-2#1)(2010-8#1)
number of products##2##3##(2008-10#1)(2008-5#1)
number of proliferating##2##3##(2008-11#1)(2008-9#1)
number of propagules##4##3##(2008-10#3)(2008-8#1)
number of protein##6##3##(1990-8#1)(1995-2#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)
number of proteins##4##3##(1995-2#1)(2008-11#2)(2010-12#1)
number of protocols##2##3##(2008-10#1)(2010-10#1)
number of publications##5##3##(1995-2#1)(2007-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
number of purine units within the##2##6##(2008-10#2)
number of pustules per##2##4##(2008-10#2)
number of pustules##3##3##(2008-10#3)
number of putative##2##3##(1991-9#1)(2008-10#1)
number of rCBF defects##2##4##(1996-5#2)
number of races##2##3##(2008-10#2)
number of rays##2##3##(2008-2#1)(2013-7#1)
number of recent studies have##2##5##(2006-10#1)(2011-2#1)
number of recent studies##4##4##(1995-12#1)(2006-10#1)(2009-8#1)(2011-2#1)
number of recent##6##3##(1992-1#1)(1995-12#1)(2006-10#1)(2009-2#1)(2009-8#1)(2011-2#1)
number of recently##2##3##(1994-12#1)(2008-11#1)
number of receptors##2##3##(1992-12#1)(1995-6#1)
number of recommendations that##2##4##(2007-10#1)(2008-11#1)
number of recommendations##4##3##(2007-10#1)(2008-11#2)(2008-9#1)
number of regulatory agencies##2##4##(2008-10#2)
number of regulatory##3##3##(2008-10#2)(2010-10#1)
number of related##2##3##(2008-6#1)(2013-1#1)
number of relevant##2##3##(2008-7#1)(2012-8#1)
number of removed lymph nodes##3##5##(2011-2#3)
number of renal##2##3##(2008-4#2)
number of repeated##3##3##(2008-10#3)
number of reported##3##3##(2007-2#1)(2008-11#1)(2008-6#1)
number of reports of##2##4##(2008-7#1)(2011-2#1)
number of reports##10##3##(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#3)
number of research##3##3##(1992-12#1)(1997-3#1)(2011-2#1)
number of researchers##2##3##(2008-10#1)(2008-3#1)
number of resolvable points##2##4##(2007-11#2)
number of risk factors##2##4##(2008-7#1)(2011-2#1)
number of risk##3##3##(2008-7#1)(2011-2#1)(2012-1#1)
number of sample##2##3##(2008-10#1)(2010-11#1)
number of samples in a##2##5##(2008-11#1)(2010-11#1)
number of samples##21##3##(1997-4#1)(2008-10#15)(2008-11#3)(2008-9#1)(2010-11#1)
number of sampling units##2##4##(2008-10#1)(2011-2#1)
number of sampling##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
number of scales between the lateral line and the dorsal fin##2##11##(2013-7#2)
number of scales between the lateral line and the##3##9##(2013-7#3)
number of scattering events##2##4##(2008-3#2)
number of scattering##5##3##(2007-12#1)(2008-3#4)
number of sclerotia##6##3##(2008-10#6)
number of screening##2##3##(2012-12#1)(2013-1#1)
number of sections##2##3##(2007-11#2)
number of seemingly##2##3##(1993-3#1)(2011-2#1)
number of serious##2##3##(2011-2#1)(2013-1#1)
number of sessions##5##3##(2009-9#1)(2010-8#1)(2013-8#3)
number of sex partners and##2##5##(2011-1#2)
number of sex partners##3##4##(2011-1#2)(2013-1#1)
number of significant##5##3##(1994-3#1)(2008-11#1)(2008-4#2)(2008-9#1)
number of single cells decreases##2##5##(2008-7#2)
number of single cells##5##4##(2008-7#5)
number of single##8##3##(1993-12#1)(1994-3#1)(1996-12#1)(2008-7#5)
number of sites##3##3##(2008-10#2)(2012-5#1)
number of small amplitude oscillations##2##5##(2008-10#2)
number of small##8##3##(1990-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-6#1)
number of smokers##2##3##(2008-10#1)(2010-7#1)
number of solutions##2##3##(2008-2#1)(2008-3#1)
number of sources##4##3##(1993-12#1)(2008-12#1)(2008-4#1)(2010-11#1)
number of species and##2##4##(1993-2#1)(2008-5#1)
number of species in##4##4##(2008-10#1)(2008-8#3)
number of species of##3##4##(1993-2#1)(2008-10#2)
number of species##22##3##(1993-2#2)(1995-12#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-8#5)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#2)
number of specific##5##3##(1992-9#1)(1995-8#1)(2008-11#1)(2008-3#2)
number of spermatozoa##3##3##(2008-7#3)
number of sporangia produced##2##4##(2008-10#2)
number of sporangia##4##3##(2008-10#4)
number of spores per##3##4##(2008-10#3)
number of spores##6##3##(1997-4#1)(2008-10#5)
number of spurious##2##3##(2008-7#1)(2009-8#1)
number of staff who##2##4##(2008-11#2)
number of standard##3##3##(2008-10#2)(2008-4#1)
number of stem##2##3##(2008-7#1)(2010-6#1)
number of steps in##2##4##(2008-10#2)
number of steps##9##3##(2007-10#3)(2008-10#2)(2008-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
number of stimuli##2##3##(1993-12#1)(2008-9#1)
number of stipes##2##3##(2008-10#2)
number of strains##3##3##(1993-9#1)(2008-10#2)
number of striga##2##3##(2008-10#2)
number of structurally##2##3##(2008-5#1)(2010-8#1)
number of studies have been##2##5##(1995-5#1)(2008-4#1)
number of studies have shown that##2##6##(2008-11#1)(2012-12#1)
number of studies have shown##3##5##(1992-2#1)(2008-11#1)(2012-12#1)
number of studies have##10##4##(1992-2#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#2)
number of studies on##3##4##(2008-1#1)(2008-5#2)
number of studies that##3##4##(2008-7#1)(2009-10#1)(2012-2#1)
number of studies##30##3##(1992-2#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
number of study##2##3##(1993-12#1)(2008-12#1)
number of subjects in##2##4##(1995-5#1)(1995-9#1)
number of subjects studied##2##4##(2008-12#1)(2012-1#1)
number of subjects##13##3##(1990-3#1)(1995-5#1)(1995-9#3)(1996-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-8#1)
number of such##5##3##(1997-4#1)(2008-11#2)(2008-7#1)(2011-1#1)
number of sulfur donors is##2##5##(1997-7#2)
number of syllables##2##3##(2008-9#1)(2013-8#1)
number of symptoms##5##3##(2008-7#2)(2009-9#2)(2013-7#1)
number of system##2##3##(2008-10#2)
number of tandem##4##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-11#1)
number of target##2##3##(2008-11#1)(2010-9#1)
number of targets##3##3##(2008-11#1)(2008-2#1)(2009-8#1)
number of techniques##2##3##(1992-12#1)(2010-7#1)
number of teeth##2##3##(2008-5#1)(2013-7#1)
number of terms##2##3##(1995-3#1)(2008-2#1)
number of tests##5##3##(1990-9#1)(1994-3#1)(1996-11#1)(2008-10#2)
number of the functional##2##4##(1992-6#1)(2008-10#1)
number of the##41##3##(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-3#1)(1997-3#4)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
number of theoretical plates for##2##5##(1994-9#1)(2008-10#1)
number of theoretical plates was##2##5##(2008-10#2)
number of theoretical plates##5##4##(1994-9#1)(1996-5#1)(2008-10#3)
number of these##11##3##(1991-3#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-4#2)(2009-5#1)(2011-2#1)(2013-8#1)
number of this##2##3##(1993-6#1)(2008-12#1)
number of times##4##3##(1996-2#1)(1996-3#1)(1997-1#1)(2010-6#1)
number of total coverings##2##4##(1990-2#2)
number of total##6##3##(1990-2#2)(1997-3#1)(2008-7#2)(2008-8#1)
number of traits##3##3##(2008-8#2)(2012-3#1)
number of transcripts##2##3##(2008-7#1)(2011-2#1)
number of traps##3##3##(2013-7#3)
number of treatment fields##2##4##(2007-10#2)
number of treatment##4##3##(1995-8#1)(2007-10#2)(2008-1#1)
number of trees##4##3##(2008-10#4)
number of trials on##2##4##(2011-1#1)(2013-8#1)
number of trials##10##3##(1990-11#2)(1993-12#1)(1993-3#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#2)
number of tumor##3##3##(1992-8#1)(1992-9#1)(2010-11#1)
number of tunnels per stalk was 0##2##7##(2011-2#2)
number of tunnels per stalk##3##5##(2011-2#3)
number of uninsured##3##3##(1993-12#1)(1995-1#1)(1997-2#1)
number of unique##3##3##(1997-4#1)(2008-7#2)
number of units of blood##2##5##(2007-7#1)(2008-12#1)
number of units##4##3##(2007-7#1)(2008-12#1)(2008-2#1)(2011-2#1)
number of unprotected##2##3##(2013-1#2)
number of users##3##3##(2008-1#1)(2008-2#1)(2010-8#1)
number of variables##5##3##(2008-10#3)(2008-7#1)(2008-9#1)
number of various##2##3##(2008-10#1)(2008-7#1)
number of viable cells##2##4##(2008-10#1)(2008-7#1)
number of viable##9##3##(1993-3#1)(1995-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)
number of virulence alleles per isolate##2##6##(2008-10#2)
number of virulence factors##2##4##(2008-10#1)(2009-2#1)
number of virulence##5##3##(2008-10#4)(2009-2#1)
number of virus##2##3##(1990-6#1)(1997-6#1)
number of visits##4##3##(1991-12#1)(1995-3#2)(2008-1#1)
number of water molecules##2##4##(1995-11#1)(2008-10#1)
number of wells##2##3##(2007-12#1)(2008-10#1)
number of white##3##3##(1996-2#1)(2009-7#1)(2013-8#1)
number of wire twists##4##4##(2007-8#4)
number of wire##5##3##(2007-8#4)(2011-2#1)
number of women with##2##4##(1993-8#1)(2012-2#1)
number of women##7##3##(1991-6#1)(1993-6#2)(1993-8#1)(2007-4#1)(2008-11#1)(2012-2#1)
number of working##4##3##(1990-11#1)(1995-8#1)(2008-10#2)
number of wrinkles##2##3##(2008-5#2)
number of years of##3##4##(1991-12#1)(1993-12#2)
number of years##11##3##(1991-12#2)(1992-1#1)(1992-12#1)(1993-12#3)(1993-3#1)(1995-8#1)(2008-2#2)
number of young##2##3##(2008-11#1)(2008-9#1)
number of youth##2##3##(2008-11#1)(2009-8#1)
number of##3242##2##(1990-10#1)(1990-11#15)(1990-12#15)(1990-2#9)(1990-3#6)(1990-5#8)(1990-6#10)(1990-7#5)(1990-8#14)(1990-9#7)(1991-1#1)(1991-11#8)(1991-12#15)(1991-2#20)(1991-3#18)(1991-4#2)(1991-5#9)(1991-6#7)(1991-7#3)(1991-8#14)(1991-9#4)(1992-1#6)(1992-10#1)(1992-11#8)(1992-12#12)(1992-2#9)(1992-3#18)(1992-4#4)(1992-5#6)(1992-6#13)(1992-8#8)(1992-9#12)(1993-1#5)(1993-11#9)(1993-12#31)(1993-2#7)(1993-3#14)(1993-5#1)(1993-6#8)(1993-8#5)(1993-9#7)(1994-1#2)(1994-11#10)(1994-12#14)(1994-2#16)(1994-3#15)(1994-5#10)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#9)(1995-1#3)(1995-11#12)(1995-12#31)(1995-2#20)(1995-3#15)(1995-4#1)(1995-5#15)(1995-6#9)(1995-8#14)(1995-9#10)(1996-1#4)(1996-11#4)(1996-12#15)(1996-2#16)(1996-3#19)(1996-4#1)(1996-5#12)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#27)(1997-3#16)(1997-4#19)(1997-5#6)(1997-6#18)(1997-7#15)(1997-8#4)(1997-9#2)(2006-10#6)(2006-12#2)(2006-6#1)(2007-10#18)(2007-11#43)(2007-12#55)(2007-2#5)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#13)(2007-8#27)(2007-9#2)(2008-1#37)(2008-10#578)(2008-11#136)(2008-12#81)(2008-2#78)(2008-3#127)(2008-4#64)(2008-5#89)(2008-6#40)(2008-7#133)(2008-8#110)(2008-9#86)(2009-1#1)(2009-10#14)(2009-11#8)(2009-12#11)(2009-2#9)(2009-3#9)(2009-4#5)(2009-5#20)(2009-6#5)(2009-7#9)(2009-8#14)(2009-9#11)(2010-1#10)(2010-10#17)(2010-11#19)(2010-12#18)(2010-2#5)(2010-3#12)(2010-4#9)(2010-5#10)(2010-6#8)(2010-7#5)(2010-8#25)(2010-9#4)(2011-1#53)(2011-2#118)(2011-3#5)(2012-1#13)(2012-12#37)(2012-2#45)(2012-3#43)(2012-4#3)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#72)(2013-7#23)(2013-8#35)
number on##3##2##(2008-7#1)(2010-8#1)(2011-1#1)
number or##9##2##(1990-12#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
number over##2##2##(1997-6#1)(2012-2#1)
number per##6##2##(1992-5#1)(1993-11#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-1#1)
number sequences##2##2##(2013-8#2)
number should##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
number tandem repeat##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
number that##2##2##(1996-2#1)(2008-10#1)
number to##5##2##(1996-12#1)(2007-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
number two##2##2##(2007-8#2)
number was##5##2##(1992-12#1)(1994-5#1)(2008-10#1)(2008-12#1)(2009-9#1)
number were##3##2##(2007-10#1)(2008-4#1)(2010-1#1)
number with##5##2##(1996-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
number within##2##2##(2008-10#1)(2008-11#1)
number##3795##1##(1990-10#1)(1990-11#15)(1990-12#19)(1990-2#9)(1990-3#7)(1990-5#13)(1990-6#11)(1990-7#6)(1990-8#15)(1990-9#7)(1991-1#1)(1991-11#8)(1991-12#17)(1991-2#20)(1991-3#18)(1991-4#2)(1991-5#12)(1991-6#12)(1991-7#3)(1991-8#14)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#9)(1992-12#13)(1992-2#9)(1992-3#20)(1992-4#4)(1992-5#7)(1992-6#15)(1992-8#9)(1992-9#14)(1993-1#5)(1993-11#10)(1993-12#38)(1993-2#7)(1993-3#16)(1993-5#2)(1993-6#10)(1993-8#7)(1993-9#8)(1994-1#2)(1994-10#1)(1994-11#10)(1994-12#16)(1994-2#19)(1994-3#17)(1994-5#11)(1994-6#12)(1994-7#1)(1994-8#8)(1994-9#10)(1995-1#3)(1995-11#14)(1995-12#35)(1995-2#21)(1995-3#17)(1995-4#1)(1995-5#18)(1995-6#11)(1995-8#21)(1995-9#11)(1996-1#4)(1996-11#4)(1996-12#22)(1996-2#19)(1996-3#21)(1996-4#2)(1996-5#16)(1996-6#5)(1996-7#5)(1996-8#3)(1996-9#3)(1997-1#7)(1997-2#29)(1997-3#16)(1997-4#19)(1997-5#7)(1997-6#23)(1997-7#15)(1997-8#6)(1997-9#2)(2006-10#7)(2006-12#2)(2006-4#2)(2006-6#1)(2007-10#22)(2007-11#47)(2007-12#65)(2007-2#6)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#14)(2007-8#33)(2007-9#2)(2008-1#41)(2008-10#653)(2008-11#172)(2008-12#96)(2008-2#91)(2008-3#173)(2008-4#77)(2008-5#114)(2008-6#46)(2008-7#162)(2008-8#123)(2008-9#97)(2009-1#1)(2009-10#16)(2009-11#13)(2009-12#12)(2009-2#11)(2009-3#9)(2009-4#5)(2009-5#25)(2009-6#7)(2009-7#12)(2009-8#14)(2009-9#12)(2010-1#11)(2010-10#21)(2010-11#22)(2010-12#21)(2010-2#6)(2010-3#15)(2010-4#10)(2010-5#10)(2010-6#8)(2010-7#5)(2010-8#31)(2010-9#5)(2011-1#59)(2011-2#131)(2011-3#7)(2012-1#15)(2012-12#45)(2012-2#53)(2012-3#56)(2012-4#3)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#78)(2013-7#25)(2013-8#49)
number)##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
number-average molecular weight##2##3##(1993-6#1)(2008-12#1)
numbered##6##1##(1991-11#1)(1992-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-2#1)
numbering##3##1##(1996-2#1)(2008-10#1)(2010-3#1)
numbers and##32##2##(1993-9#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-2#2)(2012-5#1)(2013-1#2)
numbers are##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
numbers as##2##2##(1991-12#1)(1991-3#1)
numbers at##2##2##(2008-10#1)(2008-2#1)
numbers between the##2##3##(1996-12#1)(2008-2#1)
numbers between##3##2##(1996-12#1)(2008-10#1)(2008-2#1)
numbers did##2##2##(2009-2#1)(2013-8#1)
numbers for both##2##3##(1990-2#1)(2008-10#1)
numbers for##4##2##(1990-2#1)(2008-10#3)
numbers from##2##2##(1997-3#1)(2012-2#1)
numbers in the##7##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
numbers in##24##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2010-10#1)(2011-2#2)(2013-1#2)(2013-7#1)
numbers may##2##2##(2008-12#1)(2008-5#1)
numbers of C##3##3##(2008-10#2)(2008-5#1)
numbers of Indigenous##2##3##(2011-1#2)
numbers of L##2##3##(1996-12#1)(2013-8#1)
numbers of P##2##3##(2008-10#2)
numbers of R##2##3##(2008-10#2)
numbers of T cells and##2##5##(2008-10#1)(2011-2#1)
numbers of T cells##4##4##(2008-10#1)(2008-4#2)(2011-2#1)
numbers of animals##3##3##(1992-12#1)(2007-6#1)(2012-2#1)
numbers of ascospores were##3##4##(2008-10#3)
numbers of ascospores##4##3##(2008-10#4)
numbers of both##2##3##(1993-12#1)(2008-10#1)
numbers of cells##7##3##(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#2)
numbers of compounds##2##3##(1997-4#1)(2008-10#1)
numbers of conidia##5##3##(2008-10#5)
numbers of genes##2##3##(2008-7#1)(2012-2#1)
numbers of individuals are##2##4##(1997-4#1)(2009-11#1)
numbers of individuals##4##3##(1996-12#1)(1997-4#1)(2008-10#1)(2009-11#1)
numbers of layers of##3##4##(2008-12#3)
numbers of layers##4##3##(2008-12#3)(2008-3#1)
numbers of leprosy##2##3##(1995-9#1)(2007-7#1)
numbers of lymphocytes##2##3##(2008-4#1)(2010-8#1)
numbers of medical##2##3##(1996-1#1)(2008-7#1)
numbers of motor neuron cell bodies##2##6##(2008-7#2)
numbers of nematodes##2##3##(2008-10#2)
numbers of oospores##2##3##(2008-10#2)
numbers of participants##2##3##(2007-11#1)(2008-7#1)
numbers of patients with##2##4##(1992-2#1)(2010-10#1)
numbers of patients##13##3##(1991-11#1)(1992-2#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)
numbers of resident##2##3##(2008-10#1)(2008-5#1)
numbers of samples##5##3##(2008-10#3)(2008-9#2)
numbers of shoots)##2##3##(2013-1#2)
numbers of species##2##3##(2008-10#1)(2008-9#1)
numbers of splenocytes##2##3##(2008-10#2)
numbers of studies##2##3##(2008-9#1)(2009-11#1)
numbers of the##6##3##(1994-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
numbers of these##3##3##(1996-5#1)(2008-11#1)(2013-1#1)
numbers of total##2##3##(2008-10#1)(2013-1#1)
numbers of women##4##3##(1995-12#1)(2007-4#1)(2008-2#1)(2011-2#1)
numbers of##319##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-11#2)(1991-12#3)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#7)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#73)(2008-11#9)(2008-12#10)(2008-2#4)(2008-3#10)(2008-4#12)(2008-5#12)(2008-7#11)(2008-8#3)(2008-9#19)(2009-10#1)(2009-11#2)(2009-3#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#11)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
numbers or##2##2##(1991-7#1)(2008-10#1)
numbers than##3##2##(2008-10#2)(2008-8#1)
numbers vary##3##2##(2008-12#2)(2008-8#1)
numbers was##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
numbers were determined by##2##4##(1996-12#1)(2008-11#1)
numbers were##11##2##(1996-12#2)(1997-6#1)(2008-10#5)(2008-11#1)(2013-7#1)(2013-8#1)
numbers##528##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1991-11#2)(1991-12#7)(1991-3#1)(1991-5#3)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#11)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#7)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#3)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#118)(2008-11#20)(2008-12#16)(2008-2#9)(2008-3#21)(2008-4#14)(2008-5#18)(2008-6#3)(2008-7#18)(2008-8#7)(2008-9#22)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#19)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#4)(2012-5#1)(2013-1#19)(2013-7#4)(2013-8#10)
numbers)##4##1##(1995-3#1)(2008-10#1)(2008-2#1)(2010-3#1)
numbness and##2##2##(1990-9#1)(2012-3#1)
numbness in the##2##3##(1992-6#1)(2008-12#1)
numbness in##3##2##(1992-6#1)(2008-12#1)(2012-3#1)
numbness of the##2##3##(1991-6#1)(2007-7#1)
numbness##14##1##(1990-9#1)(1991-6#1)(1992-6#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-3#2)(2013-8#1)
numeric pain rating scale##2##4##(2008-12#2)
numeric pain rating##3##3##(2008-12#3)
numeric##11##1##(1995-12#1)(1997-2#1)(2008-12#3)(2008-5#2)(2008-7#2)(2012-2#1)(2012-3#1)
numerical analyses##3##2##(2008-3#2)(2009-4#1)
numerical analysis of the##3##4##(2008-10#1)(2008-3#2)
numerical analysis of##9##3##(1990-8#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-5#1)(2009-7#1)
numerical analysis##20##2##(1990-8#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-3#6)(2008-5#1)(2008-9#3)(2009-7#1)(2011-1#1)
numerical and##5##2##(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)
numerical aperture (N##2##3##(2008-2#1)(2008-3#1)
numerical aperture (NA) of##3##4##(2007-11#1)(2008-3#2)
numerical aperture (NA)##4##3##(2007-11#1)(2008-3#3)
numerical aperture and##2##3##(2008-2#1)(2008-3#1)
numerical aperture in##2##3##(2007-12#2)
numerical aperture is##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
numerical aperture of the##6##4##(2007-11#2)(2007-12#2)(2008-3#2)
numerical aperture of##18##3##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#9)
numerical aperture##47##2##(2007-11#5)(2007-12#9)(2008-2#9)(2008-3#20)(2008-9#1)(2009-12#1)(2012-2#1)(2013-8#1)
numerical apertures##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
numerical approach##2##2##(2008-2#1)(2009-11#1)
numerical calculation##4##2##(2008-3#4)
numerical calculations##8##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
numerical changes##2##2##(1993-9#2)
numerical chromosomal abnormalities##4##3##(2010-1#1)(2012-3#3)
numerical computation of the##2##4##(2008-2#2)
numerical computations##2##2##(2008-2#1)(2008-3#1)
numerical data##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
numerical derivative##2##2##(2008-3#2)
numerical evaluation of the##2##4##(2007-12#1)(2008-3#1)
numerical evaluation of##3##3##(2007-12#1)(2008-3#2)
numerical example##3##2##(1992-6#1)(2008-10#1)(2008-2#1)
numerical experiments are##2##3##(2008-3#2)
numerical experiments##7##2##(2008-2#1)(2008-3#3)(2008-6#1)(2009-5#1)(2013-8#1)
numerical filtering##3##2##(2008-3#3)
numerical image reconstruction##2##3##(2008-3#2)
numerical implementation##2##2##(2008-3#1)(2008-6#1)
numerical integration and##2##3##(1997-2#1)(2008-10#1)
numerical integration of the##3##4##(2007-11#1)(2008-2#1)(2008-9#1)
numerical integration##13##2##(1990-11#1)(1991-5#1)(1995-12#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)
numerical inversion##2##2##(2008-3#2)
numerical magnitude##2##2##(2013-8#2)
numerical method for##2##3##(2008-2#2)
numerical method##9##2##(2007-12#1)(2008-2#2)(2008-3#4)(2009-6#1)(2009-7#1)
numerical methods##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)
numerical model that##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
numerical model with##2##3##(2008-2#1)(2008-3#1)
numerical model##20##2##(1990-11#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#12)
numerical modeling of##2##3##(2008-2#1)(2008-3#1)
numerical modeling##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
numerical models##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
numerical optimization##2##2##(2007-12#1)(2008-3#1)
numerical predictions##3##2##(1992-6#1)(2008-2#1)(2008-7#1)
numerical problems##2##2##(2008-2#2)
numerical procedure##3##2##(1996-4#1)(2008-3#2)
numerical processing of##2##3##(2007-11#1)(2008-2#1)
numerical processing##3##2##(2007-11#1)(2008-2#1)(2013-8#1)
numerical ray-tracing simulations##2##3##(2007-12#1)(2008-3#1)
numerical reconstruction of##3##3##(2008-3#3)
numerical reconstruction##10##2##(2008-3#10)
numerical results are presented##2##4##(2008-2#2)
numerical results are##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
numerical results concerning##2##3##(2008-2#1)(2008-3#1)
numerical results obtained##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
numerical results show##2##3##(2008-3#1)(2013-8#1)
numerical results with##3##3##(2008-2#1)(2008-3#2)
numerical results##30##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#12)(2008-3#12)(2013-8#1)
numerical simulation and##4##3##(2008-3#4)
numerical simulation of the##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
numerical simulation of##9##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#2)(2009-8#1)
numerical simulation that##2##3##(2008-3#2)
numerical simulation##27##2##(2007-11#7)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#12)(2009-8#1)
numerical simulations and##2##3##(2008-3#2)
numerical simulations applied##2##3##(2007-12#1)(2008-3#1)
numerical simulations are##2##3##(2007-12#1)(2008-3#1)
numerical simulations based on##3##4##(2007-12#2)(2008-3#1)
numerical simulations demonstrate##2##3##(2007-12#1)(2010-12#1)
numerical simulations for##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
numerical simulations of the##2##4##(2007-12#1)(2008-2#1)
numerical simulations of##7##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2013-8#1)
numerical simulations that##6##3##(2007-11#1)(2007-12#2)(2008-3#2)(2012-2#1)
numerical simulations with##2##3##(2008-10#1)(2008-11#1)
numerical simulations##58##2##(2007-11#8)(2007-12#18)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#16)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
numerical solution of the model##2##5##(2008-7#1)(2008-9#1)
numerical solution##11##2##(1992-9#2)(2008-10#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-10#1)
numerical solutions of the##4##4##(2007-11#3)(2008-10#1)
numerical solutions##5##2##(2007-11#3)(2008-10#1)(2008-7#1)
numerical studies are##2##3##(1995-5#1)(2012-12#1)
numerical studies##3##2##(1995-5#1)(2008-2#1)(2012-12#1)
numerical study##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
numerical taxonomy##2##2##(2008-10#2)
numerical technique##2##2##(2008-2#1)(2008-3#1)
numerical techniques##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)
numerical values##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
numerical##444##1##(1990-11#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#2)(1992-9#2)(1993-9#3)(1994-12#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#3)(1997-2#1)(2007-11#46)(2007-12#48)(2008-10#24)(2008-11#2)(2008-12#2)(2008-2#66)(2008-3#158)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#14)
numerical-aperture##3##1##(2007-12#2)(2008-3#1)
numerically analyzed##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
numerically and experimentally##4##3##(2007-11#3)(2008-3#1)
numerically and##9##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-8#1)
numerically as##2##2##(2008-3#1)(2008-8#1)
numerically by##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
numerically calculated##2##2##(2008-2#1)(2008-3#1)
numerically evaluated##2##2##(2007-11#1)(2008-3#1)
numerically for##2##2##(2007-11#1)(2008-2#1)
numerically investigated the##2##3##(2008-3#1)(2011-1#1)
numerically investigated##4##2##(2008-3#3)(2011-1#1)
numerically obtained##2##2##(2007-11#1)(2008-10#1)
numerically reconstructed with a##2##4##(2008-3#2)
numerically reconstructed##3##2##(2008-3#3)
numerically studied##2##2##(2008-3#2)
numerically that a##2##3##(2007-12#2)
numerically that the##2##3##(2007-11#1)(2008-3#1)
numerically that##7##2##(2007-11#1)(2007-12#4)(2008-3#2)
numerically the##3##2##(2008-3#2)(2010-2#1)
numerically##100##1##(2007-11#16)(2007-12#15)(2007-5#1)(2008-10#5)(2008-2#12)(2008-3#38)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
numerous advantages over##2##3##(2008-10#1)(2008-8#1)
numerous advantages##4##2##(2008-10#2)(2008-4#1)(2008-8#1)
numerous alterations##2##2##(2008-1#1)(2008-11#1)
numerous and##6##2##(1993-12#1)(1994-2#1)(1995-1#1)(2008-11#1)(2008-7#2)
numerous applications##4##2##(2007-11#1)(2009-10#1)(2010-7#1)(2012-2#1)
numerous approaches to##2##3##(2008-10#1)(2008-7#1)
numerous articles##2##2##(1991-2#1)(2012-2#1)
numerous aspects of##2##3##(1995-2#1)(2007-12#1)
numerous aspects##3##2##(1995-2#1)(2007-12#1)(2012-12#1)
numerous biological processes##2##3##(2008-10#2)
numerous biological##4##2##(1991-12#1)(1993-2#1)(2008-10#2)
numerous cell##2##2##(1992-2#1)(1993-6#1)
numerous cells##4##2##(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
numerous changes in##2##3##(2011-2#1)(2012-3#1)
numerous changes##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
numerous chemical##2##2##(2008-3#1)(2010-7#1)
numerous class##2##2##(2007-12#1)(2008-11#1)
numerous clinical##3##2##(2008-6#1)(2010-6#1)(2013-1#1)
numerous data##2##2##(1997-4#1)(2013-1#1)
numerous effects##2##2##(1991-4#1)(2008-10#1)
numerous experimental##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
numerous factors##2##2##(2009-10#1)(2010-9#1)
numerous genes##3##2##(2010-4#1)(2011-2#1)(2012-2#1)
numerous in the##2##3##(1993-12#1)(2011-1#1)
numerous in vitro##2##3##(1994-9#1)(2008-10#1)
numerous in##5##2##(1993-12#1)(1994-9#1)(2008-10#2)(2011-1#1)
numerous key##2##2##(2008-7#1)(2013-8#1)
numerous methods##3##2##(1997-7#1)(2007-8#1)(2008-4#1)
numerous mitochondria##3##2##(2007-12#1)(2008-4#1)(2008-7#1)
numerous molecular##4##2##(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
numerous new##2##2##(1991-3#1)(2010-12#1)
numerous ornamental##2##2##(2008-10#2)
numerous other##10##2##(1991-2#1)(2008-10#4)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
numerous pathways##2##2##(2010-10#1)(2011-1#1)
numerous physiological##3##2##(1994-8#1)(2008-10#1)(2009-5#1)
numerous possible##2##2##(1991-2#1)(2008-5#1)
numerous potential##2##2##(1991-7#1)(2012-2#1)
numerous procedures##2##2##(1997-3#1)(2007-12#1)
numerous proteins##3##2##(1993-6#1)(1994-12#1)(2011-2#1)
numerous questions##3##2##(1993-11#1)(1994-11#1)(1995-12#1)
numerous short##2##2##(1995-12#1)(2007-12#1)
numerous small##3##2##(1990-7#1)(2008-10#1)(2008-7#1)
numerous sources##2##2##(2010-4#1)(2011-8#1)
numerous species of##2##3##(1993-12#1)(2007-2#1)
numerous species##6##2##(1993-12#1)(2007-2#1)(2011-1#1)(2012-2#1)(2013-7#2)
numerous studies have##4##3##(1990-6#1)(2007-10#1)(2008-1#1)(2008-10#1)
numerous studies##11##2##(1990-6#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)(2011-2#2)(2012-3#1)
numerous than##2##2##(1996-3#1)(2008-2#1)
numerous types of##2##3##(2011-2#1)(2013-1#1)
numerous vascular##2##2##(2008-7#1)(2010-6#1)
numerous ways##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
numerous##386##1##(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-6#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#62)(2008-11#12)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#11)(2008-5#9)(2008-6#2)(2008-7#24)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#14)(2011-8#1)(2011-9#1)(2012-1#3)(2012-12#6)(2012-2#15)(2012-3#8)(2013-1#12)(2013-7#3)(2013-8#9)
nummularis##2##1##(2011-2#2)
nuns##2##1##(2008-10#1)(2009-10#1)
nuptial##2##1##(2008-5#1)(2008-8#1)
nurse academics##2##2##(2008-11#1)(2008-12#1)
nurse administrators##3##2##(2008-1#3)
nurse and by##2##3##(2008-11#1)(2010-7#1)
nurse and##9##2##(1991-6#1)(1994-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-7#2)(2011-1#1)
nurse anesthesia programs##2##3##(2011-2#2)
nurse anesthesia##4##2##(2011-2#4)
nurse anesthetists##2##2##(2011-2#2)
nurse assistants##3##2##(2008-11#1)(2010-11#2)
nurse case manager##2##3##(1997-2#1)(2008-1#1)
nurse cell nuclei##4##3##(2007-12#4)
nurse cell##5##2##(2007-12#5)
nurse cells##7##2##(2007-12#5)(2008-10#1)(2008-9#1)
nurse education and##4##3##(2008-11#2)(2008-12#2)
nurse education in##3##3##(2008-11#2)(2008-12#1)
nurse education to##2##3##(2008-12#2)
nurse education##49##2##(2007-10#1)(2008-11#32)(2008-12#14)(2012-3#1)(2013-8#1)
nurse educationalists##2##2##(2008-11#2)
nurse educator##5##2##(2008-11#4)(2008-12#1)
nurse educators and##2##3##(2008-11#1)(2008-12#1)
nurse educators are##4##3##(2008-11#1)(2008-12#2)(2012-3#1)
nurse educators can use##2##4##(2008-12#1)(2010-3#1)
nurse educators can##3##3##(2008-12#2)(2010-3#1)
nurse educators who##2##3##(2008-11#1)(2008-12#1)
nurse educators##27##2##(2008-11#13)(2008-12#10)(2010-3#1)(2012-3#3)
nurse educators' experience##2##3##(2012-3#2)
nurse educators'##5##2##(2008-11#2)(2012-3#3)
nurse employee##2##2##(2008-11#2)
nurse examinations##2##2##(2008-11#2)
nurse executives##3##2##(1993-12#3)
nurse for##2##2##(1992-3#1)(2008-12#1)
nurse in the##3##3##(2008-1#1)(2008-11#1)(2011-1#1)
nurse in##10##2##(1994-2#1)(1996-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
nurse is a##2##3##(1997-5#1)(2012-3#1)
nurse is##5##2##(1997-5#1)(2007-12#2)(2008-12#1)(2012-3#1)
nurse leader##3##2##(2008-1#1)(2012-3#2)
nurse leaders##5##2##(2012-3#5)
nurse leaders'##3##2##(2012-3#3)
nurse lecturer##2##2##(2008-11#2)
nurse lecturers##7##2##(2008-11#7)
nurse managers##5##2##(1990-12#1)(1997-2#2)(2008-1#2)
nurse midwives##3##2##(1993-3#2)(2012-3#1)
nurse personnel##2##2##(2008-11#2)
nurse plays##2##2##(2007-12#1)(2010-3#1)
nurse practice##2##2##(2007-10#1)(2008-12#1)
nurse practitioner and##3##3##(1996-3#1)(2008-1#1)(2008-12#1)
nurse practitioner in##3##3##(1993-2#1)(2009-9#1)(2010-10#1)
nurse practitioner##11##2##(1993-2#1)(1996-3#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-10#1)(2013-1#1)
nurse practitioner's role in##2##4##(1990-10#1)(1997-1#1)
nurse practitioners and##2##3##(2010-7#1)(2012-3#1)
nurse practitioners##16##2##(1991-1#2)(1997-1#1)(1997-3#1)(2007-10#1)(2008-3#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
nurse practitioners'##2##2##(2009-6#2)
nurse researchers##3##2##(1994-3#1)(2008-11#1)(2010-9#1)
nurse scientists##2##2##(2010-4#1)(2011-1#1)
nurse teachers and##2##3##(2008-11#2)
nurse teachers##4##2##(2008-11#4)
nurse to##4##2##(2008-11#2)(2013-8#2)
nurse who##2##2##(1996-1#1)(2007-12#1)
nurse##347##1##(1990-10#1)(1990-12#1)(1991-1#2)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#2)(1993-12#5)(1993-2#2)(1993-3#2)(1994-1#1)(1994-2#3)(1994-3#2)(1995-3#3)(1996-1#1)(1996-11#2)(1996-3#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(2007-10#6)(2007-11#1)(2007-12#15)(2008-1#19)(2008-10#3)(2008-11#117)(2008-12#42)(2008-3#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-9#3)(2010-10#4)(2010-11#4)(2010-2#2)(2010-3#4)(2010-4#3)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#12)(2012-12#1)(2012-3#26)(2013-1#7)(2013-8#11)
nurse'##2##1##(2008-11#2)
nurse's knowledge##2##2##(2007-2#1)(2012-3#1)
nurse's role##3##2##(1995-3#1)(2008-1#1)(2008-12#1)
nurse's support##2##2##(1995-1#2)
nurse's##21##1##(1990-2#1)(1991-1#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-1#2)(1995-3#1)(1995-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#2)(2010-10#4)(2012-3#2)
nurse-managed secondary prevention program on lifestyle and risk factors##2##9##(2010-7#2)
nurse-midwives##2##1##(1994-1#1)(1994-3#1)
nurse-patient##2##1##(2007-10#1)(2008-8#1)
nursed##3##1##(2007-12#1)(2007-2#1)(2008-10#1)
nurseries and##2##2##(2008-10#2)
nurseries on##2##2##(2008-10#2)
nurseries##19##1##(1995-1#1)(2008-10#17)(2009-2#1)
nursery houses##2##2##(1996-12#2)
nursery in##3##2##(2008-10#2)(2012-3#1)
nursery stock##3##2##(2008-10#3)
nursery##34##1##(1991-12#1)(1993-3#2)(1995-1#2)(1996-12#2)(2008-10#22)(2008-12#1)(2008-5#2)(2011-1#1)(2012-3#1)
nurses (RNs)##6##2##(1991-2#1)(2008-12#1)(2008-7#1)(2010-10#1)(2013-1#2)
nurses about##2##2##(1997-4#1)(2010-10#1)
nurses also##2##2##(2008-12#1)(2009-5#1)
nurses and doctors##2##3##(2007-10#1)(2012-3#1)
nurses and medical students##2##4##(2008-11#2)
nurses and midwives working##2##4##(1997-7#1)(2007-10#1)
nurses and midwives##9##3##(1997-7#1)(2007-10#2)(2008-11#2)(2011-1#3)(2012-12#1)
nurses and occupational therapists##2##4##(2008-11#2)
nurses and other##2##3##(1997-2#1)(2008-11#1)
nurses and patients/families##2##3##(2008-1#2)
nurses and the##4##3##(1992-2#1)(2008-11#1)(2008-12#1)(2008-6#1)
nurses and their##3##3##(2008-11#3)
nurses and##63##2##(1992-2#2)(1993-1#1)(1993-2#1)(1994-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-10#5)(2008-1#3)(2008-10#1)(2008-11#14)(2008-12#7)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2010-9#4)(2011-1#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
nurses are interested in##2##4##(2007-11#1)(2008-12#1)
nurses are##17##2##(1995-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2010-5#1)(2010-8#2)(2011-1#1)(2013-1#2)
nurses as##6##2##(2007-10#1)(2008-11#2)(2012-3#1)(2013-1#2)
nurses at a##3##3##(1997-1#1)(2008-11#2)
nurses at##8##2##(1997-1#1)(1997-8#1)(2008-11#3)(2012-3#1)(2013-1#2)
nurses bring##2##2##(2008-12#1)(2011-1#1)
nurses can develop##2##3##(1990-10#1)(2008-11#1)
nurses can##12##2##(1990-10#1)(1997-3#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
nurses do not##2##3##(2008-12#1)(2013-8#1)
nurses during##2##2##(2007-10#1)(2010-4#1)
nurses employed##2##2##(2008-9#1)(2010-10#1)
nurses experienced##2##2##(2007-10#1)(2012-1#1)
nurses face in##2##3##(1996-7#1)(2008-11#1)
nurses felt##2##2##(2008-11#1)(2013-1#1)
nurses following##2##2##(2012-1#1)(2013-8#1)
nurses for##5##2##(1990-2#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-5#1)
nurses from##7##2##(1990-2#1)(1993-12#1)(1993-3#1)(2007-11#1)(2008-11#1)(2010-10#1)(2010-8#1)
nurses has##4##2##(2007-11#1)(2008-11#2)(2008-12#1)
nurses have been##2##3##(2008-11#1)(2010-3#1)
nurses have##5##2##(2008-11#1)(2010-3#2)(2012-12#1)(2012-3#1)
nurses in a##4##3##(2007-10#1)(2007-2#1)(2011-2#1)(2012-3#1)
nurses in aged-care##2##3##(2010-10#2)
nurses in an##2##3##(2008-11#1)(2011-2#1)
nurses in managing##2##3##(1995-2#1)(2008-7#1)
nurses in the UK##2##4##(2008-11#2)
nurses in the##11##3##(2007-10#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
nurses in##46##2##(1991-2#1)(1992-12#1)(1992-3#2)(1995-2#1)(1996-2#1)(2007-10#3)(2007-2#1)(2008-10#2)(2008-11#8)(2008-12#3)(2008-7#5)(2010-10#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
nurses is that##2##3##(2008-11#2)
nurses is##4##2##(1996-2#1)(2008-11#2)(2011-1#1)
nurses learn##2##2##(2008-11#2)
nurses must##4##2##(2008-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
nurses need to##3##3##(2008-11#3)
nurses need##4##2##(2008-11#3)(2011-2#1)
nurses of the##2##3##(2008-10#1)(2008-11#1)
nurses of##6##2##(1990-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#2)
nurses on the##3##3##(1990-2#1)(1991-2#1)(2008-11#1)
nurses on##9##2##(1990-2#1)(1991-2#1)(2008-1#1)(2008-11#1)(2008-12#4)(2009-5#1)
nurses or##2##2##(2007-10#1)(2010-10#1)
nurses participated##4##2##(2008-11#1)(2008-7#1)(2010-7#1)(2010-8#1)
nurses provide##2##2##(2008-11#1)(2008-7#1)
nurses receive##2##2##(2008-11#1)(2012-3#1)
nurses reported##2##2##(2012-1#1)(2013-1#1)
nurses responded##2##2##(1990-2#1)(2010-11#1)
nurses should##4##2##(2007-12#1)(2008-12#1)(2008-4#1)(2010-10#1)
nurses support##2##2##(2010-5#2)
nurses that##4##2##(2008-11#2)(2011-1#1)(2011-2#1)
nurses themselves##2##2##(2008-11#1)(2012-12#1)
nurses to be##2##3##(2008-1#1)(2008-12#1)
nurses to deliver##2##3##(2008-11#1)(2011-1#1)
nurses to develop##4##3##(2008-11#2)(2010-7#1)(2013-8#1)
nurses to initiate thrombolytic therapy for patients with an acute myocardial infarction - is there a##2##16##(2008-11#2)
nurses to initiate thrombolytic therapy##3##5##(2008-11#3)
nurses to provide##3##3##(2008-11#1)(2012-3#2)
nurses to the##3##3##(1993-2#1)(2008-11#1)(2008-7#1)
nurses to use##2##3##(2008-11#1)(2010-11#1)
nurses to work##4##3##(2008-11#2)(2008-12#1)(2011-1#1)
nurses to##45##2##(1993-2#1)(1995-3#2)(1996-7#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#19)(2008-12#4)(2008-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#3)(2012-3#4)(2013-8#3)
nurses understood##2##2##(2010-8#1)(2013-1#1)
nurses using##2##2##(2010-10#1)(2013-1#1)
nurses was##5##2##(1991-2#1)(2007-10#2)(2008-1#1)(2010-10#1)
nurses were##16##2##(1991-2#2)(1992-2#1)(1994-2#1)(1995-2#1)(2007-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2010-11#2)(2010-3#1)(2012-1#1)
nurses who are##4##3##(1996-2#1)(2008-11#1)(2008-12#2)
nurses who care for##2##4##(2008-11#1)(2012-3#1)
nurses who provide##2##3##(2008-9#1)(2009-11#1)
nurses who were involved in a##2##6##(2008-11#1)(2010-11#1)
nurses who were##3##3##(1994-2#1)(2008-11#1)(2010-11#1)
nurses who##29##2##(1994-2#1)(1996-2#2)(2007-11#1)(2008-1#2)(2008-11#7)(2008-12#4)(2008-9#2)(2009-11#1)(2009-5#1)(2010-11#2)(2010-3#1)(2012-3#3)(2013-1#1)(2013-8#1)
nurses will##4##2##(2008-1#2)(2008-11#2)
nurses with##8##2##(2008-11#4)(2008-3#1)(2010-10#1)(2010-4#1)(2013-1#1)
nurses within the##2##3##(2008-11#1)(2008-12#1)
nurses working in an##3##4##(2009-5#1)(2010-10#2)
nurses working in the##3##4##(2008-1#1)(2011-1#1)(2013-8#1)
nurses working in##10##3##(2007-10#1)(2008-1#2)(2008-11#1)(2009-5#1)(2010-10#2)(2010-9#1)(2011-1#1)(2013-8#1)
nurses working##12##2##(1992-12#1)(2007-10#1)(2008-1#2)(2008-11#2)(2009-5#1)(2010-10#2)(2010-9#1)(2011-1#1)(2013-8#1)
nurses would##2##2##(2008-11#1)(2011-1#1)
nurses##626##1##(1990-10#1)(1990-12#1)(1990-2#11)(1991-12#1)(1991-2#8)(1991-3#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#2)(1993-1#2)(1993-12#1)(1993-2#4)(1993-3#4)(1994-12#1)(1994-2#3)(1994-3#2)(1995-12#1)(1995-2#3)(1995-3#9)(1995-9#1)(1996-2#8)(1996-3#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#2)(2007-10#26)(2007-11#8)(2007-12#5)(2007-2#2)(2007-3#1)(2008-1#26)(2008-10#6)(2008-11#147)(2008-12#59)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#17)(2008-8#1)(2008-9#7)(2009-11#1)(2009-12#2)(2009-4#4)(2009-5#8)(2009-6#4)(2009-9#1)(2010-10#19)(2010-11#10)(2010-3#11)(2010-4#3)(2010-5#7)(2010-6#1)(2010-7#5)(2010-8#10)(2010-9#7)(2011-1#24)(2011-2#10)(2012-1#9)(2012-12#4)(2012-2#4)(2012-3#24)(2013-1#37)(2013-8#19)
nurses' ability to##3##3##(2008-11#2)(2008-7#1)
nurses' assumptions##3##2##(1993-12#3)
nurses' decisions to adopt##2##4##(2010-11#2)
nurses' decisions##3##2##(2010-11#2)(2012-3#1)
nurses' experiences of##2##3##(2013-8#2)
nurses' experiences##6##2##(2008-11#1)(2010-7#2)(2010-8#1)(2013-8#2)
nurses' knowledge of##2##3##(1996-1#1)(2007-10#1)
nurses' perception##2##2##(2010-11#1)(2011-1#1)
nurses' perceptions of##4##3##(2007-11#1)(2008-11#1)(2008-12#1)(2012-3#1)
nurses' perceptions regarding the implementation of a best practice guideline##2##10##(2010-10#2)
nurses' perceptions##7##2##(2007-11#1)(2008-11#1)(2008-12#1)(2010-10#2)(2012-3#1)(2013-1#1)
nurses' perspectives toward providing spiritual care##3##6##(2011-1#3)
nurses' practices##2##2##(2012-3#2)
nurses' salaries##2##2##(1991-1#1)(1992-3#1)
nurses' understanding of##3##3##(2008-11#1)(2013-1#2)
nurses'##78##1##(1991-1#1)(1992-2#3)(1992-3#1)(1993-12#4)(1995-2#1)(1996-1#1)(1996-2#3)(2007-10#6)(2007-11#2)(2008-1#1)(2008-11#11)(2008-12#4)(2008-7#1)(2010-10#4)(2010-11#6)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#6)(2012-3#6)(2013-1#6)(2013-8#4)
nurses) of##2##2##(2009-12#1)(2013-1#1)
nurses)##3##1##(2009-12#2)(2013-1#1)
nurses?##2##1##(2008-11#1)(2008-12#1)
nurses]##5##1##(1990-2#1)(1991-2#1)(1993-8#2)(2012-3#1)
nursing (adult) students##2##3##(2008-12#2)
nursing -##2##2##(2008-12#2)
nursing actions##3##2##(2008-11#1)(2010-10#1)(2012-3#1)
nursing activities##7##2##(1991-2#6)(2007-10#1)
nursing administration##5##2##(1990-12#1)(1990-2#1)(1993-12#1)(2008-1#2)
nursing advocacy##4##2##(2009-12#4)
nursing and health care##2##4##(2008-11#1)(2008-12#1)
nursing and health##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2012-3#1)
nursing and medical##6##3##(1992-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
nursing and medicine##2##3##(2008-11#2)
nursing and midwifery##5##3##(2007-10#1)(2008-11#3)(2008-12#1)
nursing and nurses##2##3##(2008-1#2)
nursing and occupational therapy##2##4##(2008-11#2)
nursing and social work programs across Canada##2##7##(2012-12#2)
nursing and social work programs##3##5##(2012-12#3)
nursing and social work##4##4##(2010-3#1)(2012-12#3)
nursing and weaned piglets##2##4##(1996-12#2)
nursing and##45##2##(1990-12#1)(1992-12#1)(1994-2#1)(1996-1#1)(1996-12#2)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-11#15)(2008-12#7)(2008-7#1)(2009-7#1)(2010-10#2)(2010-3#1)(2012-12#3)(2012-3#1)(2013-1#2)
nursing are##8##2##(2007-10#2)(2008-11#2)(2008-12#3)(2010-8#1)
nursing as a##2##3##(2008-11#1)(2012-3#1)
nursing as##4##2##(2008-1#2)(2008-11#1)(2012-3#1)
nursing assessments##2##2##(2008-12#2)
nursing at##2##2##(1994-1#1)(2008-1#1)
nursing care and the##3##4##(1995-1#1)(2007-10#1)(2008-12#1)
nursing care and##4##3##(1991-3#1)(1995-1#1)(2007-10#1)(2008-12#1)
nursing care during##3##3##(2012-3#1)(2013-1#2)
nursing care in##4##3##(1990-2#1)(1991-2#1)(2008-12#1)(2012-3#1)
nursing care is##2##3##(2009-10#1)(2010-10#1)
nursing care of older adults##3##5##(2008-11#3)
nursing care of##8##3##(2008-11#4)(2009-10#1)(2012-3#1)(2013-1#2)
nursing care to##2##3##(1995-3#1)(2007-11#1)
nursing care##57##2##(1990-2#2)(1991-12#1)(1991-2#3)(1991-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#2)(2007-10#3)(2007-11#1)(2008-1#2)(2008-11#7)(2008-12#4)(2008-4#1)(2009-10#2)(2010-10#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#8)(2013-1#9)(2013-8#1)
nursing community##2##2##(2008-11#1)(2013-1#1)
nursing costs##2##2##(1994-3#1)(1995-2#1)
nursing course##7##2##(2008-11#4)(2008-12#2)(2010-3#1)
nursing courses##4##2##(2008-11#3)(2011-1#1)
nursing coverage##3##2##(2010-7#3)
nursing curricula##8##2##(2008-11#4)(2008-12#3)(2012-3#1)
nursing curriculum##17##2##(2008-11#10)(2008-12#6)(2010-3#1)
nursing degree##2##2##(2008-11#2)
nursing department##2##2##(1991-1#1)(2008-12#1)
nursing development##4##2##(1996-7#1)(1997-4#1)(2008-1#1)(2008-12#1)
nursing diagnoses in##3##3##(2012-3#1)(2013-1#2)
nursing diagnoses were##2##3##(2012-3#2)
nursing diagnoses##13##2##(2010-3#1)(2012-3#4)(2013-1#8)
nursing diagnosis##14##2##(1990-2#9)(2010-3#3)(2013-1#2)
nursing education and care delivery##2##5##(2008-1#2)
nursing education and##7##3##(2008-1#3)(2008-11#3)(2008-12#1)
nursing education is##4##3##(1996-3#1)(2008-11#1)(2008-12#1)(2010-3#1)
nursing education program and##2##4##(2008-11#1)(2008-12#1)
nursing education programme##2##3##(2008-11#2)
nursing education programs##2##3##(2008-12#1)(2010-3#1)
nursing education##59##2##(1990-2#1)(1991-2#1)(1996-3#4)(2008-1#4)(2008-11#18)(2008-12#23)(2008-3#1)(2010-3#4)(2011-2#2)(2012-3#1)
nursing educators##4##2##(2008-11#2)(2008-12#2)
nursing facilities##6##2##(1991-2#1)(1992-2#1)(1994-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
nursing facility##13##2##(1991-1#2)(1992-1#3)(1994-12#1)(1994-2#2)(1995-3#2)(1996-3#2)(2008-5#1)
nursing faculty are##2##3##(2008-11#1)(2012-3#1)
nursing faculty members##2##3##(2008-11#1)(2008-12#1)
nursing faculty regarding student assignment to a patient with AIDS##2##10##(2008-11#2)
nursing faculty##10##2##(2008-11#6)(2008-12#3)(2012-3#1)
nursing for##3##2##(1995-2#1)(2008-12#1)(2008-4#1)
nursing has##2##2##(1996-2#1)(2008-11#1)
nursing have been##2##3##(2007-11#1)(2008-11#1)
nursing have##3##2##(2007-11#1)(2008-1#1)(2008-11#1)
nursing home admission##3##3##(1997-2#2)(2010-12#1)
nursing home care##15##3##(1991-1#1)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2009-3#1)(2012-12#1)
nursing home costs##3##3##(1991-1#1)(1994-2#1)(1995-2#1)
nursing home employees##2##3##(1997-3#2)
nursing home in##3##3##(1991-2#1)(2008-12#1)(2010-10#1)
nursing home patients##6##3##(1994-12#2)(1994-2#1)(2007-12#1)(2008-7#2)
nursing home payment##6##3##(1991-2#1)(1992-3#5)
nursing home placement##5##3##(1990-5#5)
nursing home quality##6##3##(1992-2#1)(1996-2#2)(2008-11#3)
nursing home residents##10##3##(1991-3#1)(1993-3#1)(1993-8#1)(1995-2#2)(1996-2#1)(2009-2#1)(2010-10#3)
nursing home staff##4##3##(1997-1#1)(2010-10#3)
nursing home##113##2##(1990-5#7)(1991-1#5)(1991-2#3)(1991-3#3)(1991-9#1)(1992-1#3)(1992-2#1)(1992-3#7)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#1)(1994-12#4)(1994-2#11)(1995-1#1)(1995-2#9)(1995-3#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#4)(1997-3#3)(2007-12#1)(2008-1#1)(2008-11#8)(2008-12#5)(2008-7#4)(2009-2#1)(2009-3#2)(2010-10#11)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
nursing homes and their##2##4##(1994-12#1)(2008-11#1)
nursing homes and##5##3##(1991-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-11#1)
nursing homes for##2##3##(1992-3#1)(1994-12#1)
nursing homes in##6##3##(1992-3#1)(2008-12#1)(2010-10#3)(2010-11#1)
nursing homes or##2##3##(1996-1#2)
nursing homes##60##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#7)(1993-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-2#5)(1996-1#2)(1996-2#4)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2009-3#2)(2010-10#7)(2010-11#2)(2010-8#1)(2012-12#4)
nursing in South Africa##2##4##(2011-1#2)
nursing in the##2##3##(2007-11#1)(2012-3#1)
nursing in##10##2##(1991-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-12#2)(2008-3#1)(2011-1#2)(2012-3#1)
nursing intervention in##3##3##(1990-12#1)(2010-7#1)(2011-2#1)
nursing intervention##6##2##(1990-10#1)(1990-12#2)(1992-2#1)(2010-7#1)(2011-2#1)
nursing interventions for##3##3##(2010-4#1)(2013-1#2)
nursing interventions that##3##3##(2007-12#1)(2013-1#2)
nursing interventions##11##2##(2007-12#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-1#6)
nursing is a##2##3##(2008-11#1)(2008-12#1)
nursing is##7##2##(1995-3#1)(2007-8#1)(2008-11#4)(2008-12#1)
nursing journals##3##2##(1996-3#1)(2010-11#2)
nursing knowledge##5##2##(2008-11#1)(2008-12#4)
nursing leaders##2##2##(2008-1#1)(2010-3#1)
nursing leadership##5##2##(2008-1#3)(2008-12#1)(2012-3#1)
nursing literature to##2##3##(1996-7#1)(2008-11#1)
nursing literature##10##2##(1994-3#2)(1996-7#1)(2007-10#1)(2008-11#2)(2008-12#1)(2010-3#1)(2013-1#2)
nursing management##5##2##(1993-2#1)(2007-10#2)(2008-1#1)(2008-11#1)
nursing management ##3##2##(2012-3#3)
nursing need##3##2##(1990-10#1)(1995-9#1)(2008-12#1)
nursing outcomes and##4##3##(2013-1#4)
nursing personnel##4##2##(1991-11#2)(1991-2#2)
nursing practice and##4##3##(2008-11#2)(2008-12#2)
nursing practice in##2##3##(2008-11#1)(2008-4#1)
nursing practice##43##2##(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#3)(2008-1#2)(2008-11#17)(2008-12#7)(2008-4#1)(2010-10#2)(2012-3#1)(2013-1#5)(2013-8#2)
nursing practitioners##2##2##(2008-11#1)(2008-12#1)
nursing profession##9##2##(1994-2#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-12#2)(2011-1#2)(2012-3#1)
nursing program for##2##3##(2008-11#1)(2012-1#1)
nursing program##5##2##(2008-11#4)(2012-1#1)
nursing programme##2##2##(2008-11#2)
nursing programmes##8##2##(2008-11#3)(2008-12#1)(2012-3#2)(2013-8#2)
nursing programs##4##2##(2008-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
nursing records##2##2##(1990-10#1)(2011-2#1)
nursing research##15##2##(1996-3#1)(2007-10#2)(2008-1#1)(2008-12#3)(2010-10#1)(2010-3#1)(2010-9#4)(2013-1#2)
nursing roles##7##2##(2008-11#2)(2008-8#4)(2011-1#1)
nursing satisfaction##2##2##(2008-12#2)
nursing school##2##2##(2008-12#1)(2012-3#1)
nursing schools##4##2##(2010-10#1)(2012-3#3)
nursing science in##2##3##(1997-3#2)
nursing service##2##2##(2008-1#2)
nursing services##6##2##(1996-6#1)(2007-10#1)(2008-1#1)(2012-3#3)
nursing shortage##5##2##(1991-2#1)(1993-3#1)(2008-12#2)(2009-4#1)
nursing staff members'##2##3##(2010-10#2)
nursing staff were##2##3##(2008-12#1)(2010-10#1)
nursing staff##22##2##(1991-11#1)(1991-2#1)(1993-3#1)(1995-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#6)(2010-11#1)(2012-12#1)
nursing student##9##2##(2007-10#2)(2008-11#4)(2008-12#2)(2010-3#1)
nursing students and##5##3##(2008-11#2)(2008-12#3)
nursing students at##2##3##(2008-11#1)(2008-12#1)
nursing students can##2##3##(2008-11#2)
nursing students during##2##3##(2007-10#1)(2010-3#1)
nursing students enrolled in##2##4##(2008-11#1)(2011-1#1)
nursing students in the##2##4##(2008-11#2)
nursing students in##4##3##(2008-11#2)(2008-12#1)(2010-3#1)
nursing students to##8##3##(2008-11#2)(2008-12#2)(2010-3#2)(2013-8#2)
nursing students who##4##3##(2008-11#3)(2010-3#1)
nursing students##83##2##(2007-10#2)(2008-11#45)(2008-12#24)(2010-10#2)(2010-3#7)(2011-1#1)(2013-8#2)
nursing students' experiences##2##3##(2008-11#1)(2008-12#1)
nursing students' perceptions##2##3##(2008-1#1)(2008-11#1)
nursing students'##14##2##(2008-1#1)(2008-11#10)(2008-12#2)(2011-1#1)
nursing support##3##2##(2010-7#3)
nursing survey results##2##3##(2013-1#2)
nursing team##2##2##(2011-1#1)(2012-3#1)
nursing theory and practice##2##4##(2008-11#2)
nursing to##5##2##(1990-12#1)(2008-1#1)(2008-12#2)(2013-1#1)
nursing unit##2##2##(1992-2#1)(1994-3#1)
nursing was##3##2##(1994-12#1)(2008-11#2)
nursing with##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
nursing within the##2##3##(1996-2#1)(2013-1#1)
nursing within##3##2##(1996-2#2)(2013-1#1)
nursing work##5##2##(2008-9#1)(2010-5#2)(2012-3#2)
nursing workforce##10##2##(2008-11#1)(2008-12#2)(2011-1#2)(2012-3#5)
nursing workload and##2##3##(1994-3#2)
nursing workload data##2##3##(1994-3#2)
nursing workload##5##2##(1994-3#5)
nursing##1133##1##(1990-10#4)(1990-12#8)(1990-2#20)(1990-4#1)(1990-5#7)(1990-8#1)(1991-1#10)(1991-11#4)(1991-12#3)(1991-2#25)(1991-3#6)(1991-9#1)(1992-1#6)(1992-12#3)(1992-2#5)(1992-3#14)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#5)(1993-8#1)(1994-1#2)(1994-12#9)(1994-2#19)(1994-3#17)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#19)(1995-3#9)(1995-5#1)(1995-9#9)(1996-1#7)(1996-12#4)(1996-2#14)(1996-3#12)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#8)(1997-3#13)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-10#32)(2007-11#11)(2007-12#3)(2007-5#1)(2007-8#3)(2008-1#53)(2008-10#3)(2008-11#245)(2008-12#165)(2008-2#2)(2008-3#2)(2008-4#11)(2008-5#2)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#39)(2010-11#6)(2010-12#1)(2010-3#29)(2010-4#1)(2010-5#3)(2010-7#12)(2010-8#2)(2010-9#6)(2011-1#19)(2011-2#7)(2012-1#1)(2012-12#12)(2012-2#3)(2012-3#54)(2013-1#66)(2013-8#8)
nursing's##6##1##(2007-10#1)(2008-1#5)
nursing-home##2##1##(1992-6#1)(2008-6#1)
nursing-specific##2##1##(2008-1#1)(2010-7#1)
nurture##5##1##(1993-12#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)
nurtured##3##1##(1994-12#1)(2008-12#1)(2010-4#1)
nurturing##3##1##(1995-12#1)(1997-1#1)(2009-9#1)
nut proteins##2##2##(2008-10#2)
nut sites##2##2##(1995-3#2)
nut##29##1##(1992-2#4)(1995-3#3)(1996-8#1)(2008-1#6)(2008-10#8)(2009-2#1)(2010-1#1)(2011-2#5)
nutans##2##1##(2008-5#2)
nutraceuticals##4##1##(2006-12#1)(2008-10#1)(2008-11#1)(2009-5#1)
nutrient P##2##2##(2008-10#2)
nutrient acquisition##2##2##(2008-8#1)(2009-8#1)
nutrient activation##2##2##(2008-10#2)
nutrient addition##3##2##(2008-7#1)(2011-1#2)
nutrient agar##2##2##(1993-12#1)(2008-10#1)
nutrient and##8##2##(2008-11#3)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#1)
nutrient availability##10##2##(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
nutrient concentration in##2##3##(2008-11#1)(2011-1#1)
nutrient concentration##4##2##(2008-11#2)(2008-12#1)(2011-1#1)
nutrient concentrations##2##2##(2008-10#1)(2013-7#1)
nutrient consumption##4##2##(2008-11#1)(2008-7#3)
nutrient content##7##2##(1993-9#1)(2008-11#1)(2008-12#2)(2008-8#3)
nutrient cycling##7##2##(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2012-2#1)
nutrient deficiencies##4##2##(1995-3#1)(1997-4#2)(2008-12#1)
nutrient depletion##9##2##(2008-7#9)
nutrient deprivation##4##2##(2008-5#1)(2008-7#2)(2013-1#1)
nutrient digestibility and##2##3##(2009-4#1)(2012-2#1)
nutrient digestibility##7##2##(2008-10#1)(2009-4#1)(2010-2#1)(2012-2#4)
nutrient feeding##2##2##(2008-11#1)(2008-7#1)
nutrient foramen##8##2##(2013-8#8)
nutrient intake in##2##3##(1994-12#2)
nutrient intake of##2##3##(2010-6#1)(2013-1#1)
nutrient intake##11##2##(1994-12#4)(2008-12#1)(2009-4#1)(2010-6#3)(2012-2#1)(2013-1#1)
nutrient intakes were##2##3##(2010-6#1)(2013-1#1)
nutrient intakes##6##2##(1995-2#1)(2008-7#1)(2010-6#2)(2011-2#1)(2013-1#1)
nutrient levels favored##2##3##(2008-10#2)
nutrient levels##3##2##(2008-10#2)(2008-11#1)
nutrient media##8##2##(2008-10#2)(2008-11#3)(2013-1#3)
nutrient or##2##2##(2008-8#1)(2011-1#1)
nutrient removal##2##2##(2008-12#2)
nutrient requirements##3##2##(1993-3#1)(2008-9#1)(2010-2#1)
nutrient signaling system##2##3##(2009-5#2)
nutrient solution and##3##3##(2008-10#2)(2008-12#1)
nutrient solution containing##2##3##(2008-10#1)(2008-12#1)
nutrient solution##14##2##(2008-10#11)(2008-12#2)(2008-8#1)
nutrient source##5##2##(1997-2#1)(2008-6#1)(2008-7#2)(2008-9#1)
nutrient supply to##2##3##(2008-9#1)(2013-8#1)
nutrient supply##6##2##(2008-11#2)(2008-9#2)(2013-8#2)
nutrient transportation##2##2##(2008-6#1)(2009-12#1)
nutrient transporters##2##2##(2013-1#2)
nutrient uptake by##2##3##(2008-10#1)(2008-12#1)
nutrient uptake##6##2##(2008-10#2)(2008-12#4)
nutrient use##2##2##(2008-9#2)
nutrient##236##1##(1990-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#4)(1995-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#3)(2007-12#2)(2008-10#48)(2008-11#20)(2008-12#15)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#27)(2008-8#20)(2008-9#12)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-2#3)(2010-6#6)(2011-1#6)(2011-2#1)(2012-12#1)(2012-2#9)(2013-1#14)(2013-7#2)(2013-8#18)
nutrient-deficient diet##3##2##(1997-4#3)
nutrient-deficient##4##1##(1997-4#3)(2008-10#1)
nutrient-enriched##2##1##(1992-8#1)(2007-5#1)
nutrient-limited##2##1##(2008-11#1)(2008-7#1)
nutrient-poor##3##1##(2008-10#1)(2008-9#1)(2013-8#1)
nutrient-rich soil##3##2##(2008-5#3)
nutrient-rich##6##1##(2008-10#2)(2008-5#4)
nutrient-sufficient (+) or -deficient (-)##3##5##(1997-4#3)
nutrient-sufficient##6##1##(1997-4#6)
nutrients and the##2##3##(2008-7#2)
nutrients and##18##2##(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-1#1)
nutrients are##2##2##(2008-11#1)(2012-3#1)
nutrients at##2##2##(2007-12#1)(2008-11#1)
nutrients from##3##2##(2008-10#1)(2008-8#1)(2012-1#1)
nutrients has##2##2##(1995-6#1)(2008-11#1)
nutrients in the##2##3##(2008-10#1)(2008-9#1)
nutrients in##7##2##(1992-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)
nutrients on##3##2##(1997-4#1)(2008-5#1)(2012-1#1)
nutrients or##2##2##(2008-11#1)(2013-8#1)
nutrients that##4##2##(1994-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
nutrients to##5##2##(2008-11#1)(2008-7#2)(2008-9#2)
nutrients was##3##2##(1992-8#1)(2008-7#1)(2011-1#1)
nutrients were##3##2##(1995-2#1)(2008-3#1)(2013-7#1)
nutrients##112##1##(1991-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#2)(1994-8#3)(1995-2#1)(1995-6#1)(1997-4#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#18)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#6)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#5)(2011-2#4)(2012-1#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
nutrigenomics##8##1##(2008-10#8)
nutrition (TPN)##5##2##(1992-9#2)(1994-6#1)(2008-10#1)(2009-9#1)
nutrition and exercise##2##3##(2008-5#1)(2012-12#1)
nutrition and health##3##3##(2008-10#2)(2012-2#1)
nutrition and hydration##3##3##(1990-11#2)(1991-12#1)
nutrition and the##2##3##(2008-12#1)(2008-5#1)
nutrition and##32##2##(1990-11#2)(1991-12#1)(1991-6#2)(1992-2#1)(1996-8#2)(1997-1#1)(2007-12#1)(2008-10#4)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
nutrition as##2##2##(1992-2#1)(2011-1#1)
nutrition assessment##3##2##(1992-12#2)(1995-12#1)
nutrition care should be incorporated into HEDIS 3##2##8##(1997-3#2)
nutrition care##10##2##(1992-12#1)(1994-2#1)(1994-3#4)(1995-3#2)(1997-3#2)
nutrition during##2##2##(2007-2#1)(2012-2#1)
nutrition education##6##2##(1991-2#2)(1991-3#2)(1993-2#1)(2008-1#1)
nutrition for children##2##3##(1993-6#1)(1997-4#1)
nutrition for##7##2##(1991-2#1)(1993-6#1)(1997-4#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
nutrition habits##2##2##(1991-2#1)(2011-2#1)
nutrition in Norway##2##3##(1991-6#2)
nutrition in##13##2##(1991-6#2)(1993-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-7#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
nutrition intervention in##2##3##(1995-3#2)
nutrition intervention##8##2##(1991-3#1)(1995-2#2)(1995-3#2)(1995-9#1)(1997-1#1)(2008-7#1)
nutrition interventions for##2##3##(2008-5#1)(2008-7#1)
nutrition interventions##4##2##(1995-3#1)(2008-5#1)(2008-7#1)(2010-9#1)
nutrition is##3##2##(1991-2#1)(1991-6#1)(2008-10#1)
nutrition knowledge##3##2##(1991-2#1)(1991-3#1)(1995-3#1)
nutrition of the##4##3##(2007-11#1)(2008-5#2)(2010-11#1)
nutrition of##6##2##(2007-11#1)(2008-5#3)(2010-11#1)(2013-7#1)
nutrition plays##2##2##(2008-10#1)(2010-6#1)
nutrition research##3##2##(1995-3#1)(1995-6#1)(2012-2#1)
nutrition screen##2##2##(1992-12#2)
nutrition screening##2##2##(1992-12#1)(1997-3#1)
nutrition services##2##2##(1991-3#1)(1994-3#1)
nutrition status and##2##3##(2011-2#2)
nutrition status##5##2##(1995-2#1)(2011-2#3)(2013-1#1)
nutrition therapy##2##2##(1992-3#1)(1995-3#1)
nutrition training##2##2##(1991-3#1)(1992-2#1)
nutrition##240##1##(1990-11#2)(1991-12#2)(1991-2#6)(1991-3#9)(1991-6#7)(1992-12#9)(1992-2#5)(1992-3#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#8)(1994-6#2)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#12)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-3#1)(1996-8#2)(1997-1#2)(1997-3#3)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#1)(2008-12#4)(2008-3#2)(2008-5#9)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#6)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#14)(2012-12#8)(2012-2#14)(2012-3#2)(2012-8#1)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#2)
nutritional and lifestyle##2##3##(2008-3#1)(2012-2#1)
nutritional and##11##2##(2007-7#1)(2008-3#2)(2010-11#1)(2010-12#1)(2010-6#1)(2012-1#2)(2012-2#2)(2013-8#1)
nutritional assessment##2##2##(1991-12#1)(1993-3#1)
nutritional care##2##2##(1992-2#1)(1993-3#1)
nutritional composition##4##2##(1997-4#3)(2011-2#1)
nutritional condition##3##2##(2007-12#1)(2010-8#1)(2011-1#1)
nutritional conditions##2##2##(1991-12#1)(2008-6#1)
nutritional control##4##2##(2008-11#1)(2008-7#2)(2010-10#1)
nutritional counseling in##2##3##(2007-7#1)(2010-1#1)
nutritional counseling##6##2##(2007-7#5)(2010-1#1)
nutritional deficiencies##7##2##(1995-3#4)(2008-10#2)(2008-2#1)
nutritional deficiency##3##2##(1991-12#1)(2008-10#1)(2012-1#1)
nutritional education##3##2##(2011-2#2)(2013-1#1)
nutritional factors##5##2##(1994-5#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-7#1)
nutritional groups##2##2##(2008-11#2)
nutritional indices##2##2##(1993-12#1)(2013-8#1)
nutritional intake was##2##3##(1991-2#1)(2008-1#1)
nutritional intake##6##2##(1991-2#1)(2008-1#3)(2010-9#2)
nutritional intervention##3##2##(1993-12#1)(2011-2#1)(2012-2#1)
nutritional interventions##5##2##(2008-1#1)(2010-6#3)(2013-7#1)
nutritional management##2##2##(2012-2#1)(2013-1#1)
nutritional or##3##2##(2010-7#1)(2011-1#1)(2012-1#1)
nutritional parameters##5##2##(2007-7#2)(2011-2#2)(2013-1#1)
nutritional problems##2##2##(1991-12#1)(2011-1#1)
nutritional properties##2##2##(2008-7#1)(2011-2#1)
nutritional requirements##3##2##(2008-9#1)(2010-6#1)(2012-12#1)
nutritional rickets##2##2##(2008-1#1)(2011-1#1)
nutritional risk##4##2##(1992-12#1)(1994-3#1)(1997-3#1)(2012-2#1)
nutritional screening##2##2##(2012-12#2)
nutritional state##2##2##(2007-12#1)(2007-7#1)
nutritional status and##4##3##(1990-12#1)(1994-6#1)(2006-10#1)(2012-12#1)
nutritional status in##10##3##(1991-12#1)(1993-12#1)(1997-4#1)(1997-8#1)(2007-12#1)(2011-1#1)(2012-12#2)(2013-1#2)
nutritional status is##2##3##(1997-3#1)(2007-7#1)
nutritional status of beef patties##2##5##(2010-4#2)
nutritional status of the##3##4##(1991-12#1)(2008-10#1)(2008-7#1)
nutritional status of##14##3##(1991-12#3)(1997-4#1)(2008-10#1)(2008-7#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#2)
nutritional status##48##2##(1990-12#1)(1990-3#1)(1991-12#5)(1993-12#1)(1994-6#1)(1996-2#1)(1997-3#1)(1997-4#3)(1997-8#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-9#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#5)(2012-12#8)(2013-1#2)(2013-7#1)(2013-8#1)
nutritional supplement##8##2##(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#4)
nutritional supplementation##2##2##(2009-11#1)(2009-7#1)
nutritional supplements##6##2##(1995-2#2)(2008-10#3)(2008-5#1)
nutritional support##8##2##(1993-9#1)(2007-11#1)(2008-7#1)(2009-9#1)(2011-3#1)(2012-12#2)(2013-1#1)
nutritional value and##3##3##(1997-4#1)(2008-10#1)(2010-11#1)
nutritional value of the##3##4##(1994-3#1)(2010-11#1)(2011-2#1)
nutritional value of##6##3##(1994-3#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)(2011-2#1)
nutritional value##13##2##(1994-3#1)(1997-4#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-2#1)
nutritional##249##1##(1990-12#1)(1990-2#3)(1990-3#1)(1991-12#9)(1991-2#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#4)(1993-3#2)(1993-9#2)(1994-3#3)(1994-5#1)(1994-6#1)(1995-2#4)(1995-3#5)(1995-6#1)(1996-2#1)(1997-3#2)(1997-4#8)(1997-8#3)(2006-10#1)(2007-11#1)(2007-12#7)(2007-6#1)(2007-7#10)(2008-1#8)(2008-10#22)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#5)(2010-5#1)(2010-6#7)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#13)(2011-3#1)(2012-1#6)(2012-12#13)(2012-2#13)(2013-1#11)(2013-7#3)(2013-8#8)
nutritionally enriched##2##2##(2008-5#2)
nutritionally##10##1##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-8#1)(2012-2#1)(2013-7#1)
nutritionists who##2##2##(1991-2#1)(1993-2#1)
nutritionists##15##1##(1991-2#4)(1993-1#6)(1993-2#5)
nutritious and##2##2##(1995-2#1)(2012-2#1)
nutritive##9##1##(2007-12#1)(2008-10#5)(2008-9#1)(2010-7#2)
nuts and bolts##2##3##(2008-10#1)(2011-2#1)
nuts and bolts&quot##3##3##(1991-12#1)(1992-12#1)(1992-3#1)
nuts and##6##2##(1991-12#1)(1992-12#1)(1992-3#1)(2008-10#1)(2011-2#2)
nuts were##2##2##(1994-3#1)(2008-10#1)
nuts##15##1##(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(2008-10#4)(2009-11#1)(2010-7#1)(2011-2#4)(2012-2#1)
nws1##4##1##(2008-10#4)
nygamai##3##1##(2008-10#3)
nylon membrane substrate##2##3##(2008-11#2)
nylon membrane##5##2##(1995-6#1)(2008-10#1)(2008-11#2)(2008-4#1)
nylon membranes##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
nylon wool##2##2##(1992-2#1)(2008-4#1)
nylon##21##1##(1990-2#2)(1992-2#1)(1995-6#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#1)(2012-1#1)(2013-1#1)
nymph##5##1##(2007-12#3)(2008-8#2)
nymphal survivorship was##2##3##(2011-2#2)
nymphal##8##1##(2007-12#2)(2008-12#1)(2008-6#1)(2011-2#4)
nymphs and adults of R##2##5##(2013-7#2)
nymphs and adults of##3##4##(2008-6#1)(2013-7#2)
nymphs and adults##7##3##(2008-6#1)(2013-7#6)
nymphs and##11##2##(2008-6#1)(2008-8#1)(2013-7#7)(2013-8#2)
nymphs by##3##2##(2007-12#2)(2008-6#1)
nymphs on##2##2##(2008-10#1)(2011-2#1)
nymphs##27##1##(2007-12#5)(2008-10#4)(2008-6#2)(2008-8#2)(2008-9#2)(2011-2#1)(2013-7#8)(2013-8#3)
nystagmus and##2##2##(1993-5#1)(1997-8#1)
nystagmus was##3##2##(2008-4#1)(2010-9#1)(2011-1#1)
nystagmus##22##1##(1993-5#1)(1993-9#2)(1995-8#1)(1997-8#1)(2008-4#7)(2008-7#4)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
nystatin##4##1##(2008-5#4)
o and##2##2##(2008-10#1)(2008-7#1)
o##64##1##(1990-11#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#3)(1992-5#1)(1994-11#1)(1994-7#3)(1995-12#1)(1996-12#1)(1997-3#1)(1997-7#3)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
o') tri(phenylmethyl)tin##3##2##(2008-10#3)
o)##2##1##(2008-10#1)(2008-7#1)
o-##5##1##(2008-10#5)
o-NPOE and##2##2##(2008-10#2)
o-NPOE##12##1##(2008-10#12)
o-catechol##3##1##(2008-10#3)
o-cresol in##2##2##(2008-10#1)(2011-1#1)
o-cresolphthalein##2##1##(2008-10#2)
o-dianisidine##6##1##(2008-10#5)(2010-5#1)
o-dimethyldithiophosphoric acid (DMDTPA)##2##3##(2008-10#2)
o-nitroaniline and p-nitroaniline##2##3##(2008-10#2)
o-nitrophenyl octyl ether##4##3##(2008-10#4)
o-nitrophenyloctyl ether (o-NPOE) as solvent mediator and##2##7##(2008-10#2)
o-nitrophenyloctyl ether (o-NPOE) as##3##4##(2008-10#3)
o-nitrophenyloctyl ether (o-NPOE)##4##3##(2008-10#4)
o-nitrophenyloctyl ether##6##2##(2008-10#6)
o-phenanthroline##4##1##(2008-10#4)
o-phenylenediamine##12##1##(2008-10#12)
o-phtalaldehyde##2##1##(2008-10#2)
o-phthalaldehyde and##2##2##(1990-8#1)(1991-12#1)
o-phthalaldehyde##9##1##(1990-8#1)(1991-12#1)(1996-5#1)(2008-10#6)
o-phthalaldialdehyde and##2##2##(2008-10#2)
o-phthaldialdehyde##2##1##(2008-10#1)(2008-11#1)
o-quinone was##2##2##(2008-10#2)
o-quinone##4##1##(2008-10#4)
o-tolidine##6##1##(2008-10#6)
o-xylene##6##1##(2008-10#6)
o/w and w/o emulsions##2##4##(2008-5#2)
o/w emulsion and##2##3##(2008-5#2)
o/w emulsion##5##2##(2008-5#5)
o/w##11##1##(2008-5#11)
o/w/o##2##1##(2008-5#2)
oFSHbeta##2##1##(1995-8#2)
oGDP##2##1##(1991-5#2)
oICH and##2##2##(2012-3#2)
oICH##8##1##(2012-3#8)
oPRL##2##1##(1995-11#2)
oak (Quercus##3##2##(2008-10#3)
oak bark##3##2##(2008-10#3)
oak death##9##2##(2008-10#7)(2009-2#2)
oak leaves##2##2##(2012-9#2)
oak species##9##2##(2012-5#2)(2012-6#4)(2012-7#1)(2012-9#2)
oak trees##2##2##(2008-10#1)(2012-9#1)
oak woodlands##2##2##(2008-5#1)(2010-6#1)
oak##51##1##(2008-10#27)(2008-5#2)(2009-2#2)(2010-6#1)(2012-5#5)(2012-6#4)(2012-7#1)(2012-9#9)
oaks in##2##2##(2008-10#1)(2012-9#1)
oaks##6##1##(2008-10#1)(2009-2#1)(2012-7#2)(2012-9#2)
oat (Avena sativa L##2##4##(2008-10#2)
oat (Avena##3##2##(2008-10#3)
oat and##5##2##(2008-10#4)(2011-2#1)
oat cell##2##2##(1990-5#2)
oat cells##2##2##(1990-5#1)(2008-10#1)
oat products##2##2##(1991-6#1)(2011-2#1)
oat##48##1##(1990-5#3)(1991-6#1)(2008-10#33)(2008-5#4)(2008-9#2)(2011-1#1)(2011-2#4)
oatmeal agar##2##2##(2008-10#2)
oats on##2##2##(1991-6#1)(2008-10#1)
oats##12##1##(1991-6#2)(2008-10#10)
ob##3##1##(1997-4#1)(2008-4#1)(2008-5#1)
obese (BMI##2##2##(2009-9#1)(2012-12#1)
obese (fa/fa) and lean (Fa/Fa) Zucker rats##2##7##(1996-12#2)
obese (fa/fa)##5##2##(1996-12#4)(2011-2#1)
obese African##2##2##(2012-3#1)(2013-1#1)
obese Zucker rats##2##3##(1995-5#2)
obese Zucker##3##2##(1995-5#2)(1996-12#1)
obese adults##3##2##(2008-3#1)(2010-8#1)(2011-1#1)
obese and lean Zucker rats##2##5##(1995-5#2)
obese and lean##3##3##(1995-5#2)(1996-12#1)
obese and non-obese##3##3##(2012-12#1)(2012-2#1)(2013-7#1)
obese and nonobese patients##3##4##(2011-2#2)(2013-1#1)
obese and##15##2##(1995-5#2)(1996-12#1)(2007-12#1)(2008-10#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
obese animals##3##2##(2012-3#3)
obese binge eaters##2##3##(2007-7#2)
obese children and adolescents##2##4##(2011-1#2)
obese children##11##2##(2008-12#1)(2009-9#1)(2010-8#2)(2011-1#6)(2012-3#1)
obese compared to##2##3##(2013-1#2)
obese diabetic##3##2##(2008-1#1)(2008-10#1)(2010-11#1)
obese group##3##2##(2011-1#1)(2012-2#2)
obese individuals with PHA##2##4##(2013-1#2)
obese individuals##13##2##(1996-12#1)(2008-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
obese male##2##2##(1996-12#1)(2013-1#1)
obese males##2##2##(2012-2#1)(2013-1#1)
obese or##3##2##(1993-2#1)(1996-12#1)(2008-3#1)
obese participants##3##2##(2013-8#3)
obese patients with##4##3##(2008-3#1)(2009-2#1)(2011-2#1)(2013-1#1)
obese patients##16##2##(1993-3#1)(1993-5#1)(2008-3#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-5#2)(2013-1#1)
obese patients)##2##2##(2011-2#2)
obese patients]##2##2##(1993-11#1)(1993-5#1)
obese people##6##2##(1993-3#1)(1993-5#2)(2010-10#1)(2010-8#1)(2013-8#1)
obese persons##3##2##(2008-5#1)(2010-8#1)(2012-2#1)
obese rats and##2##3##(1994-11#1)(1995-5#1)
obese rats##6##2##(1994-11#2)(1995-5#1)(1996-12#3)
obese subjects and##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
obese subjects##16##2##(1990-9#1)(1992-12#1)(1997-7#1)(2008-10#2)(2008-3#2)(2012-12#2)(2012-2#5)(2013-1#2)
obese than##5##2##(1995-5#3)(2011-2#2)
obese with##2##2##(2008-7#1)(2013-8#1)
obese women##10##2##(1990-9#1)(2007-12#1)(2008-4#1)(2011-1#2)(2011-2#1)(2013-1#4)
obese young women with Down syndrome##2##6##(2013-1#2)
obese young##3##2##(2013-1#3)
obese##201##1##(1990-9#2)(1992-12#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#4)(1994-11#2)(1995-5#8)(1996-12#14)(1996-6#1)(1997-7#1)(2006-8#1)(2007-12#4)(2007-7#2)(2008-1#3)(2008-10#8)(2008-12#3)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-8#7)(2011-1#14)(2011-2#19)(2012-12#9)(2012-2#18)(2012-3#8)(2012-5#2)(2013-1#23)(2013-7#1)(2013-8#15)
obesity among##6##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
obesity and cholesterol##2##3##(2009-7#2)
obesity and diabetes##3##3##(2008-1#1)(2008-11#1)(2013-8#1)
obesity and insulin resistance##3##4##(2010-7#1)(2011-1#2)
obesity and its##2##3##(2008-3#1)(2009-11#1)
obesity and metabolic syndrome##3##4##(2008-1#1)(2008-3#1)(2013-1#1)
obesity and other##3##3##(1991-6#1)(2008-3#1)(2013-1#1)
obesity and physical##4##3##(2008-12#3)(2008-7#1)
obesity and the metabolic syndrome##3##5##(2008-10#1)(2008-3#2)
obesity and the##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
obesity and type 2 diabetes##2##5##(2008-3#2)
obesity and##59##2##(1991-6#1)(1994-6#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#2)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#9)
obesity are##6##2##(2008-1#1)(2008-11#1)(2012-2#2)(2013-7#1)(2013-8#1)
obesity associated##2##2##(2008-3#1)(2013-1#1)
obesity did not##2##3##(2008-12#1)(2011-1#1)
obesity epidemic##11##2##(2008-10#1)(2008-3#1)(2009-3#1)(2011-1#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
obesity has been##2##3##(2008-3#1)(2010-5#1)
obesity has##6##2##(2008-3#2)(2010-5#1)(2010-6#1)(2011-1#2)
obesity in rats##5##3##(2011-2#4)(2013-1#1)
obesity in the United States##2##5##(2009-11#1)(2009-6#1)
obesity in the##5##3##(1993-11#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-3#1)
obesity in this##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
obesity in##32##2##(1993-11#1)(2006-8#1)(2007-3#1)(2008-1#4)(2008-3#3)(2008-5#1)(2009-11#1)(2009-6#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
obesity is a##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
obesity is not yet##2##4##(2008-1#2)
obesity is not##3##3##(2008-1#2)(2012-12#1)
obesity is##14##2##(2007-8#1)(2008-1#2)(2008-10#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)
obesity may be##3##3##(2006-8#1)(2009-10#1)(2010-4#1)
obesity may##4##2##(2006-8#1)(2009-10#1)(2010-4#1)(2011-1#1)
obesity measures##2##2##(2013-1#2)
obesity models##2##2##(2008-4#1)(2010-11#1)
obesity on the##6##3##(2010-3#1)(2011-1#1)(2011-2#3)(2013-8#1)
obesity on##11##2##(2007-12#1)(2008-10#1)(2010-3#2)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#1)
obesity or##4##2##(2008-7#3)(2010-5#1)
obesity prevention programs##5##3##(2009-6#2)(2012-2#1)(2013-1#2)
obesity prevention##7##2##(2009-6#2)(2011-2#1)(2012-2#2)(2013-1#2)
obesity research##2##2##(2008-4#1)(2008-5#1)
obesity that##2##2##(2008-10#1)(2012-2#1)
obesity to##2##2##(2008-4#1)(2009-11#1)
obesity was##7##2##(2007-8#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#3)
obesity were found##2##3##(2012-12#1)(2013-1#1)
obesity were##8##2##(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
obesity with##3##2##(2006-8#1)(2012-12#1)(2012-2#1)
obesity##380##1##(1991-3#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-5#1)(1996-12#2)(1997-4#1)(2006-8#7)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#29)(2008-10#15)(2008-11#8)(2008-12#8)(2008-2#2)(2008-3#38)(2008-4#13)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#4)(2009-7#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#3)(2011-1#26)(2011-2#33)(2012-1#3)(2012-12#12)(2012-2#28)(2012-3#12)(2013-1#29)(2013-7#4)(2013-8#22)
obesity)##2##1##(2008-4#1)(2011-1#1)
obesity-associated##2##1##(2012-2#2)
obesity-promoting behaviors##2##2##(2011-2#2)
obesity-related insulin resistance##2##3##(2010-11#2)
obesity-related##6##1##(2008-4#1)(2010-11#2)(2010-6#1)(2011-1#1)(2013-7#1)
obesity]##3##1##(1990-5#1)(2007-3#1)(2013-7#1)
obesogenic##3##1##(2008-10#2)(2013-1#1)
obey a##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
obey the##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
obey##13##1##(1990-8#1)(1992-6#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2011-2#1)(2012-2#1)
obeyed Beer's law##2##3##(2008-10#2)
obeyed between##2##2##(2008-10#2)
obeyed for##4##2##(2008-10#4)
obeyed in a concentration##3##4##(2008-10#3)
obeyed in a##5##3##(2008-10#5)
obeyed in the range 0##3##5##(2008-10#3)
obeyed in the range##9##4##(2008-10#9)
obeyed in the##12##3##(2008-10#12)
obeyed in##17##2##(2008-10#17)
obeyed over the concentration range of##5##6##(2008-10#5)
obeyed over the concentration range##8##5##(2008-10#8)
obeyed over the range from##3##5##(2008-10#3)
obeyed over the range of 0##3##6##(2008-10#3)
obeyed over the range##10##4##(2008-10#10)
obeyed over the##19##3##(2008-10#19)
obeyed up to##2##3##(2008-10#2)
obeyed##50##1##(2008-10#49)(2008-9#1)
obeys Beer's law from 0##3##5##(2008-10#3)
obeys Beer's law in the range of 0##2##8##(2008-10#2)
obeys Beer's law in the range##4##6##(2008-10#4)
obeys Beer's law in the##5##5##(2008-10#5)
obeys Beer's law##12##3##(2008-10#11)(2008-2#1)
obeys Beer's##13##2##(2008-10#12)(2008-2#1)
obeys a simple##2##3##(1995-5#1)(2008-10#1)
obeys a##4##2##(1995-5#1)(2008-10#2)(2009-8#1)
obeys the##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
obeys##27##1##(1993-2#1)(1995-5#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
object and a##3##3##(2007-12#1)(2008-3#2)
object and reference##2##3##(2007-12#2)
object and spatial recognition##2##4##(1992-10#2)
object and the##5##3##(2008-2#3)(2008-3#2)
object and##20##2##(1992-10#2)(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2009-2#1)(2009-5#1)(2013-8#1)
object are determined##2##3##(2008-11#1)(2008-3#1)
object are##8##2##(2007-11#1)(2008-11#2)(2008-3#3)(2008-6#1)(2011-1#1)
object at##4##2##(2007-12#1)(2008-3#3)
object beam is##2##3##(2007-12#1)(2008-2#1)
object beam##8##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
object beams##2##2##(2007-12#1)(2008-2#1)
object by the##2##3##(2008-3#1)(2008-9#1)
object by##7##2##(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)
object can be##5##3##(1991-3#1)(2008-2#1)(2008-3#2)(2012-1#1)
object can##7##2##(1991-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2012-1#1)
object deformation is##2##3##(2008-2#1)(2008-3#1)
object deformation##3##2##(2008-2#1)(2008-3#2)
object diameters &gt##3##3##(2012-1#3)
object directly##2##2##(1996-2#1)(2008-3#1)
object field##2##2##(2008-3#2)
object for##3##2##(1995-5#1)(2009-12#1)(2009-8#1)
object from##7##2##(2008-2#2)(2008-3#5)
object identity##2##2##(1992-11#1)(2011-1#1)
object in a##2##3##(2007-12#2)
object in the presence of##2##5##(2008-3#2)
object in the##7##3##(1995-2#1)(2008-2#1)(2008-3#5)
object in##16##2##(1995-2#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#8)(2008-5#1)(2012-2#1)
object inspection##3##2##(2008-11#3)
object is measured by##2##4##(2008-2#1)(2008-3#1)
object is placed in the##2##5##(2008-3#2)
object is placed##3##3##(2008-3#3)
object is##29##2##(1996-2#1)(2007-11#1)(2008-2#3)(2008-3#19)(2009-10#1)(2009-11#1)(2011-1#1)(2012-2#2)
object knowledge##2##2##(2009-12#2)
object lift##2##2##(2007-10#2)
object of##25##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-6#2)(1992-12#2)(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
object point##3##2##(2007-12#1)(2008-3#2)
object recall##2##2##(2008-7#2)
object recognition by##3##3##(2007-12#1)(2008-3#2)
object recognition##19##2##(1992-10#1)(1993-3#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-3#8)(2008-6#3)(2008-9#1)(2009-12#1)
object sections##2##2##(2007-11#1)(2008-2#1)
object shape and##2##3##(2008-2#1)(2008-3#1)
object shape##3##2##(2008-2#1)(2008-3#2)
object size##3##2##(2008-7#2)(2011-1#1)
object surface##9##2##(2008-2#1)(2008-3#8)
object that is##3##3##(2008-2#1)(2008-9#1)(2012-12#1)
object that##5##2##(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)
object through a##2##3##(2008-3#2)
object to be##5##3##(2008-3#2)(2011-1#1)(2012-12#2)
object to track a moving target##2##6##(2008-11#2)
object to##10##2##(1990-2#1)(2008-11#2)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#2)
object under##3##2##(2008-2#1)(2008-3#2)
object using##2##2##(2008-10#1)(2012-2#1)
object was##6##2##(2007-12#3)(2008-7#1)(2011-1#1)(2013-1#1)
object when##3##2##(1992-10#1)(2008-2#1)(2008-3#1)
object with a##3##3##(2007-11#1)(2008-2#2)
object with##12##2##(2007-11#3)(2008-2#3)(2008-3#5)(2012-12#1)
object without##4##2##(2008-3#2)(2008-6#1)(2011-1#1)
object##415##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-10#4)(1992-11#2)(1992-12#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#7)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#17)(2007-12#29)(2008-10#5)(2008-11#13)(2008-12#3)(2008-2#65)(2008-3#152)(2008-4#1)(2008-5#3)(2008-6#8)(2008-7#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#6)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#12)(2011-2#6)(2011-3#1)(2012-1#5)(2012-12#9)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#3)
object's##7##1##(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#1)(2011-1#1)
object-beam intensities##2##2##(2007-12#2)
object-beam##3##1##(2007-12#2)(2008-2#1)
object-directed hand movements##4##3##(2008-11#4)
object-oriented##3##1##(1996-2#1)(2008-10#1)(2008-12#1)
objectified##2##1##(2007-8#1)(2013-8#1)
objection##3##1##(1997-4#1)(2008-11#2)
objections to the##2##3##(1995-5#1)(2010-4#1)
objections to##5##2##(1995-5#1)(1996-2#2)(2008-11#1)(2010-4#1)
objections##10##1##(1994-2#1)(1995-5#1)(1996-2#2)(2008-11#1)(2010-4#2)(2013-1#2)(2013-8#1)
objective and quantifiable##2##3##(2011-1#2)
objective and quantitative##2##3##(2007-11#1)(2008-5#1)
objective and subjective##6##3##(1991-6#1)(2007-11#1)(2007-12#1)(2008-7#2)(2013-8#1)
objective and##27##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-6#1)(1993-11#1)(1995-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#5)(2009-7#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
objective are##2##2##(2007-11#1)(2008-2#1)
objective assessment of##4##3##(2007-8#1)(2008-5#1)(2008-8#1)(2013-1#1)
objective clinical##4##2##(1990-3#1)(2008-10#1)(2008-9#1)(2012-2#1)
objective criteria##6##2##(1991-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
objective data to##3##3##(1994-1#1)(2008-10#1)(2010-7#1)
objective data##4##2##(1994-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
objective detection of##2##3##(1990-12#1)(2008-10#1)
objective estimates of##2##3##(1995-12#1)(2008-9#1)
objective evaluation of##3##3##(1996-5#1)(2007-12#1)(2008-5#1)
objective evidence of##4##3##(2008-3#3)(2008-6#1)
objective evidence that##2##3##(2008-11#1)(2013-8#1)
objective evidence##6##2##(2008-11#1)(2008-3#3)(2008-6#1)(2013-8#1)
objective for both##2##3##(2007-12#1)(2008-3#1)
objective for##8##2##(1991-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
objective function##5##2##(2008-3#2)(2010-8#1)(2012-3#2)
objective housing accessibility##3##3##(2008-7#3)
objective improvement##2##2##(1992-9#1)(2008-7#1)
objective in the##3##3##(1992-2#1)(2007-11#1)(2008-7#1)
objective in##6##2##(1992-2#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
objective is the##2##3##(2008-9#1)(2010-12#1)
objective is to develop a##2##5##(2008-5#1)(2009-8#1)
objective is to provide##2##4##(2008-6#1)(2011-3#1)
objective is to##18##3##(1994-1#1)(1995-12#2)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
objective is##26##2##(1993-2#1)(1994-1#1)(1995-12#2)(2006-10#1)(2007-10#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
objective lens for##2##3##(2008-2#2)
objective lens tilt##3##3##(2008-2#3)
objective lens##20##2##(2007-12#2)(2008-2#8)(2008-3#10)
objective lenses for##2##3##(2008-3#2)
objective lenses##8##2##(2007-12#1)(2008-3#7)
objective measurements##3##2##(2008-5#1)(2008-7#1)(2009-9#1)
objective measures of body##2##4##(2007-12#2)
objective measures of##6##3##(1992-12#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-5#1)
objective measures##12##2##(1992-12#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-9#3)(2010-6#1)(2011-1#1)
objective memory##4##2##(2009-11#3)(2010-7#1)
objective method for measuring##2##4##(2012-12#1)(2012-2#1)
objective method for##4##3##(2007-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
objective method to##2##3##(1997-4#1)(2007-8#1)
objective method##8##2##(1997-4#1)(2007-10#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
objective numerical aperture##2##3##(2008-3#2)
objective of determining##2##3##(1996-12#1)(2008-7#1)
objective of improving##2##3##(2008-2#1)(2012-12#1)
objective of reducing##2##3##(1994-6#1)(2011-1#1)
objective of the present study was to##11##7##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#4)
objective of the present study was##12##6##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#4)(2012-2#1)
objective of the present study##14##5##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#4)(2012-2#1)
objective of the present##21##4##(1991-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#1)
objective of the program is to##2##6##(1993-12#1)(2008-11#1)
objective of the program##3##4##(1993-12#2)(2008-11#1)
objective of the study was to compare##2##7##(2008-5#1)(2011-2#1)
objective of the study was to determine the##2##8##(2010-8#1)(2011-1#1)
objective of the study was to##6##6##(1990-2#1)(1996-9#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
objective of the study was##7##5##(1990-2#1)(1996-9#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
objective of the study##9##4##(1990-2#1)(1992-11#1)(1996-9#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
objective of the##44##3##(1990-2#1)(1991-9#2)(1992-11#1)(1993-12#2)(1995-3#1)(1996-5#1)(1996-9#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#2)(2013-1#1)
objective of this article is to##4##6##(2007-11#1)(2009-10#1)(2012-12#1)(2013-1#1)
objective of this article is##5##5##(2007-11#1)(2009-10#1)(2012-12#2)(2013-1#1)
objective of this paper is to##9##6##(1992-3#1)(1993-1#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
objective of this paper is##12##5##(1992-3#1)(1993-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
objective of this paper##13##4##(1992-3#1)(1993-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
objective of this research was to##6##6##(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)
objective of this research was##8##5##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
objective of this research##9##4##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
objective of this study is to assess the##2##8##(2008-5#1)(2012-3#1)
objective of this study is to investigate the##2##8##(2008-7#1)(2010-8#1)
objective of this study is to##8##6##(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
objective of this study was to analyze the##2##8##(2008-10#1)(2012-3#1)
objective of this study was to analyze##3##7##(2008-10#1)(2009-4#1)(2012-3#1)
objective of this study was to determine the##13##8##(1991-8#1)(2008-1#1)(2008-10#4)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
objective of this study was to determine##20##7##(1991-8#1)(1994-11#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
objective of this study was to develop a##2##8##(2008-5#1)(2010-2#1)
objective of this study was to develop##5##7##(2008-10#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-2#1)
objective of this study was to evaluate the##13##8##(1996-1#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
objective of this study was to evaluate##18##7##(1996-1#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
objective of this study was to investigate the effects##2##9##(2008-10#1)(2008-3#1)
objective of this study was to investigate the##14##8##(1994-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)
objective of this study was to investigate##18##7##(1994-12#1)(2006-8#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2013-1#1)
objective of this study was to use##2##7##(2008-10#2)
objective of this study was to##109##6##(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
objective of this study was##111##5##(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
objective of this study##121##4##(1991-2#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-8#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
objective of this work is to##3##6##(2008-7#1)(2009-6#1)(2011-2#1)
objective of this work is##4##5##(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
objective of this work was to study##2##7##(2008-6#1)(2013-7#1)
objective of this work was to##12##6##(1993-12#1)(1995-12#1)(1995-5#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
objective of this work##18##4##(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
objective of this##189##3##(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#1)(1997-3#2)(1997-8#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#4)(2009-10#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#5)
objective of##261##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#3)(1997-5#1)(1997-8#3)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#31)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#16)(2008-6#4)(2008-7#14)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#2)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#7)
objective physical health##2##3##(2011-2#2)
objective physical##3##2##(2007-12#1)(2011-2#2)
objective quality##2##2##(2008-3#2)
objective response rate##3##3##(1992-2#1)(2008-3#1)(2008-6#1)
objective response was##2##3##(1992-12#1)(1992-8#1)
objective response##5##2##(1992-12#1)(1992-2#1)(1992-8#1)(2008-3#1)(2008-6#1)
objective severity##2##2##(2007-12#1)(2012-1#1)
objective signal##3##2##(2008-3#3)
objective structured clinical examination (OSCE) in the assessment of mental health nursing##2##12##(2008-11#2)
objective structured clinical examination (OSCE)##4##5##(1994-2#1)(2008-11#3)
objective structured clinical examination##5##4##(1994-2#2)(2008-11#3)
objective test##3##2##(2008-10#1)(2010-12#2)
objective tests##3##2##(1991-6#2)(2008-12#1)
objective than##2##2##(2008-9#1)(2011-2#1)
objective the##2##2##(2008-3#1)(2008-8#1)
objective to##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
objective tumor##2##2##(1991-6#1)(1992-12#1)
objective tumour##2##2##(2008-6#2)
objective was achieved##2##3##(2008-10#1)(2008-5#1)
objective was to analyze##3##4##(2008-11#1)(2008-3#1)(2012-3#1)
objective was to characterize##2##4##(2008-10#1)(2010-4#1)
objective was to determine how##2##5##(1991-2#1)(2008-10#1)
objective was to determine if the##2##6##(2008-10#1)(2008-11#1)
objective was to determine if##4##5##(1995-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
objective was to determine the##2##5##(2008-10#1)(2008-5#1)
objective was to determine##10##4##(1991-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)
objective was to evaluate the##3##5##(1996-2#1)(2008-3#1)(2012-2#1)
objective was to evaluate##5##4##(1992-2#1)(1996-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
objective was to examine the##3##5##(2007-10#1)(2008-12#1)(2013-1#1)
objective was to examine##5##4##(2007-10#1)(2008-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
objective was to explore##2##4##(2008-2#1)(2009-6#1)
objective was to identify##2##4##(2008-10#1)(2013-1#1)
objective was to review##2##4##(2008-8#1)(2010-5#1)
objective was to study the##4##5##(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
objective was to study##5##4##(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
objective was to##57##3##(1991-2#1)(1992-2#1)(1993-11#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#3)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
objective was##60##2##(1991-2#1)(1992-2#1)(1993-11#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
objective with a numerical aperture of##2##6##(2008-2#1)(2008-3#1)
objective with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
objective with##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
objective##675##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-6#1)(1994-7#2)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1996-1#4)(1996-12#1)(1996-2#2)(1996-5#4)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#3)(2006-10#2)(2006-8#1)(2007-10#9)(2007-11#12)(2007-12#20)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#9)(2008-1#4)(2008-10#60)(2008-11#20)(2008-12#7)(2008-2#25)(2008-3#59)(2008-4#3)(2008-5#38)(2008-6#11)(2008-7#38)(2008-8#12)(2008-9#14)(2009-10#5)(2009-11#5)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#12)(2010-9#1)(2011-1#14)(2011-2#32)(2011-3#2)(2012-1#8)(2012-12#10)(2012-2#18)(2012-3#12)(2013-1#29)(2013-7#2)(2013-8#11)
objectively defined##2##2##(1994-2#1)(2013-1#1)
objectively rated##2##2##(2007-12#2)
objectively##22##1##(1990-3#1)(1992-11#1)(1994-2#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-5#4)(2008-9#1)(2009-1#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
objectives and##9##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1995-3#2)(1996-12#1)(2007-12#2)
objectives are met##2##3##(1992-1#1)(2013-1#1)
objectives are##9##2##(1992-1#3)(2007-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
objectives for the##2##3##(1991-5#1)(1995-2#1)
objectives for##9##2##(1991-5#1)(1992-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-9#2)(2011-1#1)
objectives in##6##2##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
objectives of our##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
objectives of the##16##3##(1996-1#1)(1996-4#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#1)
objectives of this study were to determine the##6##8##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
objectives of this study were to##23##6##(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
objectives of this study were##24##5##(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
objectives of this study##28##4##(1996-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
objectives of this##40##3##(1996-1#1)(1997-1#1)(2007-4#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
objectives of##68##2##(1994-12#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-4#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-4#2)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#4)
objectives that##2##2##(1991-12#1)(2008-3#1)
objectives were to determine the##2##5##(2009-10#1)(2011-2#1)
objectives were to determine##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
objectives were to##9##3##(2008-10#5)(2009-10#1)(2011-2#1)(2013-1#2)
objectives were##13##2##(1994-9#1)(1997-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
objectives with##6##2##(1993-12#1)(1994-12#1)(2007-12#1)(2008-3#3)
objectives##217##1##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#4)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#6)(1996-1#4)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#3)(1997-5#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#7)(2009-10#1)(2009-8#1)(2010-10#4)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
objectivity and##2##2##(2008-10#1)(2008-9#1)
objectivity in##3##2##(2012-2#3)
objectivity##9##1##(1997-3#1)(2008-10#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-2#3)
objects and the##2##3##(2007-11#1)(2008-2#1)
objects and their##2##3##(2007-11#1)(2008-9#1)
objects and##16##2##(1996-12#1)(1996-2#1)(2007-11#2)(2008-2#1)(2008-3#7)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)
objects are##16##2##(1994-8#1)(2007-12#1)(2008-2#2)(2008-3#7)(2008-6#1)(2009-11#2)(2011-2#1)(2012-1#1)
objects as##5##2##(1990-3#1)(2007-12#1)(2008-3#2)(2012-12#1)
objects at##2##2##(2008-3#1)(2008-7#1)
objects by use of##2##4##(2007-12#1)(2008-3#1)
objects by##9##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-6#1)
objects can be##3##3##(2007-12#1)(2008-3#2)
objects can##4##2##(2007-12#1)(2008-3#3)
objects embedded in##2##3##(2007-12#2)
objects for##2##2##(2008-3#1)(2011-1#1)
objects from##4##2##(1992-11#1)(2008-3#3)
objects having##2##2##(2007-12#1)(2008-3#1)
objects hidden##2##2##(2007-12#1)(2008-2#1)
objects in a##7##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-3#4)
objects in real##2##3##(2008-3#1)(2008-9#1)
objects in the##5##3##(1992-11#1)(2008-3#2)(2008-6#2)
objects in##29##2##(1992-11#1)(1992-3#1)(1993-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#14)(2008-6#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)
objects inside a##2##3##(2008-3#2)
objects is presented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
objects is##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
objects observed##2##2##(2008-2#1)(2008-3#1)
objects of interest##2##3##(2008-3#2)
objects of the##3##3##(1996-2#1)(2008-3#2)
objects of##16##2##(1996-1#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#5)(2010-1#2)(2010-10#1)(2012-12#2)
objects on the bottom##2##4##(2008-3#2)
objects on the##3##3##(2008-10#1)(2008-3#2)
objects or##3##2##(1993-2#1)(2007-12#2)
objects over##2##2##(2008-3#1)(2013-1#1)
objects such as##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
objects that are##3##3##(2008-3#2)(2008-6#1)
objects that comprise##2##3##(2007-12#1)(2013-1#1)
objects that have##2##3##(2008-3#2)
objects that##10##2##(2007-11#1)(2007-12#1)(2008-3#5)(2008-6#1)(2008-7#1)(2013-1#1)
objects through scattering##2##3##(2007-11#1)(2007-12#1)
objects through##3##2##(2007-11#1)(2007-12#2)
objects was##2##2##(2008-3#1)(2008-9#1)
objects were imaged##2##3##(2007-12#1)(2008-3#1)
objects were##10##2##(1992-11#1)(1993-6#1)(2007-12#3)(2008-3#1)(2008-9#1)(2012-1#1)(2012-12#2)
objects whose##3##2##(2008-3#2)(2009-8#1)
objects with the##2##3##(2008-10#1)(2012-1#1)
objects with##16##2##(2008-10#1)(2008-2#3)(2008-3#9)(2009-4#1)(2012-1#2)
objects##327##1##(1990-3#1)(1991-2#1)(1991-9#1)(1992-11#3)(1992-3#2)(1993-12#1)(1993-2#1)(1993-6#4)(1994-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#5)(1997-5#2)(1997-8#2)(2006-4#1)(2007-11#17)(2007-12#31)(2007-8#3)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#28)(2008-3#118)(2008-4#1)(2008-5#3)(2008-6#14)(2008-7#5)(2008-8#1)(2008-9#5)(2009-10#3)(2009-11#3)(2009-12#2)(2009-4#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-12#6)(2012-2#9)(2012-3#1)(2013-1#3)
oblast##2##1##(2013-1#2)
oblate spheroidal##2##2##(2007-12#1)(2008-2#1)
oblate##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
obligate biotrophic##5##2##(2008-10#1)(2010-3#3)(2012-2#1)
obligate brood parasitism##2##3##(2008-8#2)
obligate brood##3##2##(2008-8#2)(2010-8#1)
obligate heterozygotes and##2##3##(1990-8#1)(1996-12#1)
obligate heterozygotes##5##2##(1990-8#3)(1996-12#2)
obligate intracellular bacterium##2##3##(1994-12#1)(2008-9#1)
obligate intracellular##8##2##(1994-12#2)(2008-9#4)(2009-8#1)(2012-3#1)
obligate parasite##4##2##(2008-10#3)(2011-2#1)
obligate plant##2##2##(2008-10#2)
obligate##34##1##(1990-8#3)(1994-12#2)(1996-12#2)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-8#1)(2010-10#1)(2010-3#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
obligated to##3##2##(1992-1#2)(1996-5#1)
obligately anaerobic##3##2##(1990-11#2)(2011-2#1)
obligately##7##1##(1990-11#2)(2008-10#2)(2011-2#3)
obligation in##3##2##(1994-12#1)(2008-11#1)(2008-5#1)
obligation of##4##2##(1990-2#1)(1993-6#1)(2007-11#1)(2008-1#1)
obligation to ensure##2##3##(2008-12#1)(2008-8#1)
obligation to##6##2##(1992-3#1)(1995-12#1)(1995-6#1)(2008-12#1)(2008-7#1)(2008-8#1)
obligation##18##1##(1990-2#1)(1992-3#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
obligations of##2##2##(1991-2#1)(1996-2#1)
obligations to##3##2##(1994-1#1)(2007-4#1)(2008-11#1)
obligations under##2##2##(1991-2#1)(1993-3#1)
obligations##17##1##(1991-2#2)(1993-3#3)(1994-1#1)(1994-12#1)(1996-2#1)(1997-4#1)(2007-4#1)(2008-11#1)(2008-6#2)(2009-6#1)(2012-1#1)(2012-12#1)(2013-8#1)
obligatoriness of moral actions##2##4##(2013-8#2)
obligatory military service for##2##4##(1991-11#1)(2008-11#1)
obligatory##17##1##(1991-11#2)(1991-9#1)(1993-11#1)(1995-1#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
obliged to##6##2##(1991-12#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-7#1)(2009-7#1)
obliges manufacturers##2##2##(2010-4#2)
obliges##3##1##(2007-11#1)(2010-4#2)
oblique and##4##2##(1995-6#1)(2008-3#1)(2012-12#1)(2012-2#1)
oblique angle##4##2##(1994-12#1)(2008-12#2)(2008-6#1)
oblique effect##2##2##(1990-11#2)
oblique incidence##14##2##(2008-2#5)(2008-3#9)
oblique muscle##4##2##(1993-9#1)(2008-7#1)(2010-9#1)(2011-2#1)
oblique projection##2##2##(2008-10#2)
oblique reference##2##2##(1990-11#2)
oblique##66##1##(1990-11#5)(1993-9#1)(1994-12#2)(1995-4#1)(1995-6#2)(2007-8#3)(2008-10#2)(2008-12#2)(2008-2#8)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-9#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)
oblique-incidence##2##1##(2008-2#2)
obliquely incident##2##2##(2008-2#1)(2008-3#1)
obliquely##10##1##(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)
obliquity##4##1##(2007-11#1)(2009-9#1)(2012-2#1)(2013-1#1)
obliterans (Buerger's disease)##3##3##(1996-8#2)(1997-8#1)
obliterans##19##1##(1996-8#3)(1997-8#2)(2006-10#2)(2008-1#2)(2009-5#2)(2011-3#3)(2012-12#2)(2012-2#1)(2013-1#2)
obliterate the##3##2##(1990-5#1)(1995-11#1)(2008-7#1)
obliterate##4##1##(1990-5#1)(1995-11#1)(2007-8#1)(2008-7#1)
obliterated##7##1##(1996-2#1)(2006-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-6#1)
obliterating##2##1##(1990-8#1)(1991-2#1)
obliteration in##2##2##(1997-6#1)(2012-3#1)
obliteration of the##3##3##(2008-7#2)(2010-5#1)
obliteration of##8##2##(2007-10#1)(2008-1#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-5#1)
obliteration rate##4##2##(2008-7#4)
obliteration was##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
obliteration##34##1##(1997-6#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-7#16)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#5)(2013-1#2)
obliterative##5##1##(1991-6#1)(1997-8#1)(2008-11#1)(2008-7#1)(2011-3#1)
oblivion##2##1##(1991-8#1)(2011-2#1)
oblivious##2##1##(1991-1#1)(2008-6#1)
oblong##2##1##(2008-5#1)(2012-1#1)
obscura##4##1##(2010-8#2)(2013-1#2)
obscuration and##2##2##(1996-12#2)
obscuration##6##1##(1996-12#2)(2007-11#1)(2008-2#2)(2008-3#1)
obscure gastrointestinal bleeding##2##3##(2011-2#2)
obscure gastrointestinal##3##2##(2011-2#2)(2012-2#1)
obscure the##5##2##(1993-2#1)(1995-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
obscure##39##1##(1990-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-5#2)(2006-10#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)
obscured by several##2##3##(2008-2#1)(2008-4#1)
obscured by##6##2##(1990-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2012-3#1)
obscured when##2##2##(2008-10#1)(2008-8#1)
obscured##13##1##(1990-2#1)(1991-8#1)(1993-9#1)(1995-11#1)(1997-4#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-8#1)(2012-3#1)
obscurus##5##1##(1991-12#1)(1997-2#1)(2011-2#3)
observable effect##2##2##(2008-11#1)(2008-3#1)
observable in##4##2##(1993-12#1)(1995-3#1)(2008-5#2)
observable##33##1##(1991-2#1)(1993-12#1)(1995-3#1)(1997-4#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
observables##4##1##(1993-5#1)(1997-2#1)(2008-10#1)(2008-7#1)
observance of##2##2##(2008-10#2)
observation allows##2##2##(2008-10#1)(2012-3#1)
observation alone##2##2##(1991-6#2)
observation and analysis of the more common features of##2##9##(2008-12#2)
observation and execution of both##2##5##(2008-11#2)
observation and execution of##3##4##(2008-11#3)
observation and##24##2##(1991-1#1)(1992-4#1)(1992-6#1)(2006-5#1)(2006-6#1)(2007-12#2)(2008-11#4)(2008-12#2)(2008-5#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-8#4)
observation angles##2##2##(2007-11#1)(2008-2#1)
observation are##3##2##(1991-6#1)(2008-2#1)(2008-3#1)
observation bandwidth##2##2##(2007-11#2)
observation by##4##2##(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
observation for##2##2##(1991-5#1)(2013-8#1)
observation in the##2##3##(2009-7#1)(2012-12#1)
observation in which##2##3##(1996-3#1)(1996-6#1)
observation in##7##2##(1996-3#1)(1996-6#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-12#1)
observation is##10##2##(1991-2#1)(1991-8#1)(1993-6#1)(1995-11#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-7#1)
observation it##2##2##(1990-10#1)(1990-12#1)
observation length##2##2##(2008-3#2)
observation notes##2##2##(2012-2#1)(2013-1#1)
observation of a##17##3##(1990-3#1)(1991-12#1)(1991-5#2)(1994-2#1)(1997-2#1)(2007-11#3)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
observation of an##3##3##(1993-6#1)(2007-11#1)(2007-12#1)
observation of cell##2##3##(2008-11#1)(2009-5#1)
observation of coherent##2##3##(1992-8#1)(2007-11#1)
observation of internal defects in semiconductor crystals##2##7##(2007-11#2)
observation of periodic##2##3##(2007-11#1)(2007-12#1)
observation of spatial##2##3##(2007-12#1)(2009-2#1)
observation of stable##2##3##(2007-11#2)
observation of the effects##2##4##(1992-3#1)(2007-12#1)
observation of the first##2##4##(2007-8#1)(2008-10#1)
observation of the##25##3##(1990-6#1)(1991-5#1)(1992-3#1)(1996-2#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2011-2#1)
observation of thin layers and##2##5##(2008-10#2)
observation of##163##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#22)(2007-12#25)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#3)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)
observation on the##3##3##(2008-10#2)(2010-8#1)
observation on##5##2##(2008-10#3)(2010-8#1)(2011-2#1)
observation period compared##2##3##(1992-6#1)(2013-8#1)
observation period of##5##3##(1991-6#1)(1992-11#1)(1997-4#1)(2008-5#1)(2008-6#1)
observation period##28##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1996-3#1)(1997-3#1)(1997-4#3)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#1)(2008-6#2)(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
observation plane##3##2##(2008-2#2)(2008-3#1)
observation planes##2##2##(2008-3#2)
observation points that are not in the immediate vicinity of the optical axis##2##13##(2008-3#2)
observation showed that the##2##4##(2008-10#1)(2008-8#1)
observation showed that##4##3##(1997-6#1)(2008-10#1)(2008-8#2)
observation showed##5##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#2)
observation that the##12##3##(1990-7#1)(1991-9#1)(1995-2#1)(1995-9#1)(1997-7#1)(2007-10#1)(2008-11#2)(2008-6#2)(2008-9#1)(2009-9#1)
observation that##50##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-8#1)
observation time of##3##3##(1997-3#1)(2007-11#1)(2007-12#1)
observation time##7##2##(1993-11#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-3#1)(2011-2#1)
observation unit management of heart##2##5##(2008-3#2)
observation unit##8##2##(2008-3#8)
observation units##2##2##(1992-9#1)(2008-3#1)
observation using##2##2##(1990-12#1)(2008-7#1)
observation was##2##2##(1994-7#1)(2008-11#1)
observation were##3##2##(2008-1#1)(2008-11#1)(2008-6#1)
observation with##2##2##(2007-12#1)(2011-2#1)
observation##504##1##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#5)(1991-6#5)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-7#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-6#2)(1997-2#3)(1997-3#5)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#3)(2007-11#31)(2007-12#38)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#43)(2008-11#27)(2008-12#5)(2008-2#21)(2008-3#51)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#17)(2008-8#10)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#15)(2012-12#10)(2012-2#4)(2012-3#9)(2013-1#14)(2013-7#1)(2013-8#11)
observation]##2##1##(2013-8#2)
observational and##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
observational cohort study##2##3##(1995-9#1)(2013-1#1)
observational cohort##3##2##(1995-9#1)(2008-11#1)(2013-1#1)
observational data##6##2##(1996-4#1)(2007-10#2)(2008-3#1)(2008-8#1)(2009-12#1)
observational noise##3##2##(2009-8#3)
observational or##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
observational studies have##2##3##(2008-9#1)(2011-2#1)
observational studies##17##2##(1990-3#2)(1995-2#1)(2007-12#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)
observational study in##3##3##(1990-9#1)(2008-11#1)(2011-2#1)
observational study of##6##3##(2011-2#4)(2012-12#1)(2013-1#1)
observational study on##2##3##(2011-2#1)(2013-1#1)
observational study was performed##2##4##(2011-2#1)(2013-1#1)
observational study was##5##3##(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#1)
observational study##37##2##(1990-9#1)(1991-3#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2010-11#1)(2010-4#1)(2011-2#10)(2012-12#4)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#1)
observational##107##1##(1990-3#2)(1990-9#2)(1991-3#1)(1991-9#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-8#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#14)(2012-12#8)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#15)(2013-8#3)
observations about##3##2##(1997-2#1)(2008-4#1)(2008-9#1)
observations after##2##2##(2008-7#2)
observations also##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
observations and a##2##3##(1995-5#1)(1996-8#1)
observations and recommendations##3##3##(2013-1#3)
observations and those##2##3##(1995-12#1)(2008-3#1)
observations and##32##2##(1991-1#1)(1991-2#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-1#1)(2013-1#3)
observations are in agreement with##3##5##(1995-3#1)(2006-6#1)(2008-3#1)
observations are in##5##3##(1990-12#1)(1995-11#1)(1995-3#1)(2006-6#1)(2008-3#1)
observations are made##2##3##(1990-3#1)(1991-2#1)
observations are offered##2##3##(1992-12#1)(1992-2#1)
observations are then##2##3##(2008-3#1)(2008-8#1)
observations are##34##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#2)(1995-11#2)(1995-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
observations at four##2##3##(2008-10#1)(2008-11#1)
observations at##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2012-6#1)
observations based on##2##3##(1990-11#1)(2012-2#1)
observations by##4##2##(2008-3#4)
observations can##2##2##(2008-8#1)(2011-2#1)
observations confirmed##2##2##(1994-6#1)(2008-3#1)
observations demonstrate##4##2##(1995-2#1)(1996-12#1)(1997-6#1)(2008-10#1)
observations for##12##2##(1996-2#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-8#1)(2010-9#1)
observations from the##4##3##(1996-12#1)(2007-11#1)(2011-1#1)(2011-2#1)
observations from##14##2##(1991-9#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
observations have been published##2##4##(1994-8#1)(2010-12#1)
observations have##8##2##(1992-3#1)(1994-5#1)(1994-8#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
observations in the##5##3##(1997-2#1)(2007-10#2)(2008-10#1)(2008-3#1)
observations in##13##2##(1995-12#1)(1996-5#1)(1997-2#1)(2007-10#2)(2007-6#1)(2008-10#3)(2008-3#2)(2008-8#1)(2011-1#1)
observations indicate that the##2##4##(1995-2#1)(2008-4#1)
observations indicate that##11##3##(1990-11#1)(1990-2#1)(1991-5#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-12#1)
observations indicate##12##2##(1990-11#1)(1990-2#1)(1991-5#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-12#1)
observations indicated that the##2##4##(2008-10#1)(2008-11#1)
observations indicated that##5##3##(2007-7#1)(2008-10#3)(2008-11#1)
observations into##3##2##(1995-12#1)(2010-11#1)(2010-12#1)
observations is##4##2##(1992-6#1)(1996-4#1)(1997-6#1)(2008-3#1)
observations made on##2##3##(2008-10#1)(2009-11#1)
observations made##3##2##(1995-8#1)(2008-10#1)(2009-11#1)
observations of a##2##3##(2006-10#1)(2007-11#1)
observations of increasing##2##3##(2008-3#1)(2008-8#1)
observations of the##13##3##(1992-5#1)(1994-1#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
observations of##82##2##(1990-5#1)(1991-5#1)(1992-1#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
observations on the##12##3##(1990-2#1)(1992-5#1)(1993-2#1)(1994-12#1)(1996-2#2)(1996-3#1)(2008-11#3)(2008-7#1)(2008-9#1)
observations on##25##2##(1990-2#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-4#1)(2007-12#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#4)(2012-7#1)
observations or##2##2##(1992-3#1)(2010-3#1)
observations performed##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
observations provide##3##2##(1993-2#1)(2012-2#1)(2013-1#1)
observations raise the##2##3##(2008-5#1)(2010-4#1)
observations reflect##2##2##(2008-11#1)(2008-7#1)
observations regarding the##2##3##(2008-10#1)(2009-10#1)
observations regarding##3##2##(2008-10#1)(2008-6#1)(2009-10#1)
observations reveal that the##2##4##(2008-10#1)(2009-7#1)
observations reveal that##4##3##(1991-8#1)(2008-10#1)(2009-7#1)(2012-12#1)
observations revealed that##3##3##(2008-10#2)(2012-3#1)
observations revealed##4##2##(2007-11#1)(2008-10#2)(2012-3#1)
observations show that the##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
observations show##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
observations showed that the##3##4##(2008-10#1)(2008-7#2)
observations showed that##5##3##(1994-2#1)(2008-10#1)(2008-7#2)(2013-7#1)
observations showed##7##2##(1994-2#1)(2008-10#2)(2008-7#2)(2008-8#1)(2013-7#1)
observations strongly suggest##2##3##(1993-12#1)(2008-7#1)
observations suggest that the##8##4##(1992-10#1)(1992-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
observations suggest that##39##3##(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#2)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
observations suggest##48##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
observations suggested that##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
observations suggested##4##2##(1995-5#1)(1997-2#1)(2008-10#1)(2008-7#1)
observations support the##2##3##(2008-10#2)
observations support##4##2##(1992-6#1)(1995-8#1)(2008-10#2)
observations that the##2##3##(1993-12#1)(1997-1#1)
observations that##16##2##(1991-12#2)(1992-6#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-8#1)(2012-2#1)
observations to##4##2##(1997-3#1)(2008-7#2)(2011-2#1)
observations were conducted##2##3##(2008-10#1)(2008-3#1)
observations were further##3##3##(1991-4#1)(2008-10#1)(2010-5#1)
observations were made##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
observations were used to##3##4##(2007-2#1)(2010-4#1)(2012-3#1)
observations were##16##2##(1990-11#1)(1991-4#1)(1995-6#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
observations will##2##2##(1991-1#1)(2012-2#1)
observations with the##3##3##(1995-12#1)(2008-3#1)(2009-8#1)
observations with##14##2##(1991-12#1)(1991-5#1)(1995-12#1)(1997-2#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-5#1)(2009-8#1)(2011-10#1)(2012-3#1)
observations##595##1##(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1991-1#2)(1991-12#4)(1991-2#5)(1991-4#1)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#5)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#7)(1993-2#2)(1993-3#4)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#3)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#5)(1995-5#5)(1995-6#7)(1995-8#3)(1995-9#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#7)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#6)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#9)(2007-12#7)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#69)(2008-11#21)(2008-12#4)(2008-2#25)(2008-3#52)(2008-4#6)(2008-5#11)(2008-6#12)(2008-7#26)(2008-8#14)(2008-9#15)(2009-10#6)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#15)(2012-3#6)(2012-6#1)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#5)
observatory##4##1##(2008-10#1)(2008-3#2)(2011-1#1)
observe a##5##2##(1997-4#1)(2008-2#1)(2008-3#2)(2008-8#1)
observe an##3##2##(1995-3#1)(2007-11#1)(2008-10#1)
observe and characterize##2##3##(2007-11#1)(2007-12#1)
observe and##9##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
observe any##2##2##(1997-3#1)(2009-9#1)
observe in##2##2##(2008-10#1)(2012-2#1)
observe its##2##2##(2011-3#1)(2013-1#1)
observe that the##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
observe that##8##2##(1992-6#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2012-2#1)
observe the##45##2##(1991-8#1)(1994-8#1)(1997-8#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)
observe variations in the##2##4##(2008-11#1)(2008-3#1)
observe variations in##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
observe##129##1##(1991-8#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#10)(2007-12#4)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
observed (P = 0##2##4##(2013-1#2)
observed (P##4##2##(1994-12#1)(2011-1#1)(2013-1#2)
observed (p##2##2##(2008-11#1)(2012-12#1)
observed 1##2##2##(2008-10#1)(2008-11#1)
observed 2##2##2##(1996-2#1)(2012-3#1)
observed 24##2##2##(1997-7#1)(2008-10#1)
observed 3##2##2##(2007-5#1)(2008-10#1)
observed 6 to##2##3##(2008-10#2)
observed 7 to##2##3##(2008-10#1)(2011-2#1)
observed DNA##2##2##(1992-6#1)(1997-4#1)
observed a significant##4##3##(1991-6#1)(2007-10#1)(2008-11#1)(2012-3#1)
observed a strong##2##3##(2008-12#1)(2010-11#1)
observed a##41##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
observed aberrations##2##2##(2007-11#1)(2010-1#1)
observed above##2##2##(2008-11#1)(2013-8#1)
observed across##10##2##(1996-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
observed adaptive##2##2##(2008-7#1)(2011-1#1)
observed after 48##2##3##(2008-12#1)(2008-5#1)
observed after 5 days##2##4##(1995-3#1)(2008-10#1)
observed after a##3##3##(1992-5#1)(1995-12#1)(1995-5#1)
observed after addition of##4##4##(1993-8#1)(1994-6#1)(2008-5#1)(2013-1#1)
observed after administration of##2##4##(2008-10#1)(2008-5#1)
observed after the##4##3##(1995-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
observed after treatment with##2##4##(1995-8#1)(2008-4#1)
observed after##69##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
observed against##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
observed along the##3##3##(2008-12#1)(2008-2#1)(2010-8#1)
observed along##5##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-8#1)
observed also##2##2##(1994-6#1)(2008-5#1)
observed among isolates from##2##4##(2008-10#2)
observed among isolates##8##3##(2008-10#7)(2012-2#1)
observed among the##6##3##(2008-10#3)(2008-6#1)(2010-1#1)(2012-2#1)
observed among these##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
observed among##39##2##(1991-6#1)(1992-9#1)(1997-2#1)(2007-7#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
observed an improvement of##3##4##(1990-3#1)(1997-6#1)(2007-10#1)
observed an improvement##4##3##(1990-3#1)(1997-6#1)(2007-10#1)(2008-3#1)
observed an increase in the amount of##2##7##(1992-6#1)(1994-6#1)
observed an increase in##4##4##(1992-6#1)(1994-6#1)(1995-12#1)(2008-3#1)
observed an##15##2##(1990-3#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#2)
observed and analyzed##2##3##(2008-2#1)(2008-8#1)
observed and evaluated##2##3##(1990-2#1)(2008-10#1)
observed and is##2##3##(1990-7#1)(2008-5#1)
observed and it##2##3##(1993-2#1)(2008-10#1)
observed and no##2##3##(2008-10#2)
observed and photographed##2##3##(2008-2#2)
observed and predicted##2##3##(2008-10#1)(2008-8#1)
observed and the##10##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-8#1)
observed and##66##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-6#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#5)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
observed approximately##2##2##(2007-12#1)(2008-10#1)
observed are##5##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
observed around##4##2##(1996-5#1)(2008-10#3)
observed as early as##2##4##(1994-12#1)(2013-1#1)
observed as the##6##3##(2007-11#1)(2008-10#3)(2008-5#1)(2009-4#1)
observed as well##2##3##(2008-10#2)
observed as##21##2##(1991-2#1)(1994-12#1)(1996-12#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
observed associations##2##2##(2008-8#2)
observed at -0##2##3##(2008-10#2)
observed at 0##4##3##(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
observed at 1##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
observed at 10##2##3##(1991-8#1)(2008-10#1)
observed at 30##2##3##(1996-12#1)(2008-5#1)
observed at a##3##3##(1992-8#1)(2007-11#1)(2008-5#1)
observed at all##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
observed at both##3##3##(1995-6#1)(2008-10#1)(2010-8#1)
observed at concentrations##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
observed at day##3##3##(2007-2#1)(2008-10#1)(2008-7#1)
observed at different##2##3##(2008-10#1)(2008-2#1)
observed at doses##2##3##(1995-2#1)(2008-10#1)
observed at elevated##2##3##(2008-10#1)(2008-2#1)
observed at high salt concentrations##2##5##(1990-5#1)(2008-10#1)
observed at high##7##3##(1990-5#2)(1994-5#1)(2008-10#1)(2008-12#2)(2013-1#1)
observed at higher##3##3##(2008-10#2)(2008-5#1)
observed at low##4##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
observed at most##2##3##(2008-10#1)(2008-5#1)
observed at neutral pH##2##4##(1992-11#1)(1995-2#1)
observed at pH##2##3##(2008-10#2)
observed at room temperature##3##4##(2007-12#2)(2008-10#1)
observed at the end of the##3##6##(2008-8#1)(2011-1#1)(2013-1#1)
observed at the end of##4##5##(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
observed at the level of##2##5##(2008-7#1)(2012-2#1)
observed at the##42##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1996-5#1)(1997-6#2)(2007-11#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
observed at week##2##3##(2008-5#1)(2013-1#1)
observed at##177##2##(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#5)(2007-11#7)(2007-12#4)(2007-2#1)(2008-10#49)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#3)(2009-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
observed bands##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
observed based on##2##3##(2008-10#2)
observed because of##2##3##(1997-2#1)(2008-12#1)
observed because##4##2##(1997-2#1)(2008-10#2)(2008-12#1)
observed before##4##2##(1995-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
observed behavior##6##2##(1990-12#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-6#1)
observed behavioral##2##2##(2007-12#1)(2008-8#1)
observed between 3##2##3##(1993-3#1)(2008-5#1)
observed between PgR##2##3##(2008-12#2)
observed between the G x A mismatches##2##7##(1993-11#2)
observed between the different##2##4##(1994-2#1)(2008-10#1)
observed between the dually entitled and other Medicare##2##8##(1995-3#2)
observed between the results obtained##2##5##(2008-10#2)
observed between the two groups##3##5##(1990-2#1)(2008-10#1)(2011-2#1)
observed between the two methods##2##5##(2008-10#2)
observed between the two##11##4##(1990-2#1)(1992-10#1)(1993-1#1)(1994-6#1)(1995-5#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
observed between the##61##3##(1990-2#1)(1990-7#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-2#1)(1994-6#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#3)(2011-2#4)(2013-1#1)
observed between##154##2##(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-4#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-12#1)(1997-4#2)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#41)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#1)(2008-5#10)(2008-7#7)(2008-8#4)(2009-2#1)(2009-4#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#5)
observed both##3##2##(1993-9#1)(2008-10#1)(2008-5#1)
observed by Western##2##3##(1992-2#1)(2011-3#1)
observed by a##2##3##(2008-3#1)(2009-1#1)
observed by both##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
observed by dark-field microscopy##2##4##(2008-6#2)
observed by electron microscopy##2##4##(2008-10#1)(2008-5#1)
observed by light##2##3##(1997-3#1)(2010-8#1)
observed by means of##5##4##(1994-5#1)(1995-6#1)(2007-11#1)(2010-10#1)(2012-12#1)
observed by multiple cameras##2##4##(2008-2#1)(2008-3#1)
observed by optical##2##3##(2008-10#2)
observed by single##2##3##(1995-6#1)(2009-9#1)
observed by the##8##3##(1991-5#1)(1992-6#1)(1993-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-3#2)
observed by##67##2##(1991-5#2)(1992-2#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-8#1)(1994-5#1)(1995-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
observed cell##4##2##(1995-11#1)(1997-1#1)(1997-3#1)(1997-7#1)
observed changes in##6##3##(1991-2#1)(1994-9#1)(2006-8#1)(2007-12#1)(2008-8#1)(2012-2#1)
observed changes##12##2##(1991-2#1)(1993-11#1)(1994-9#1)(1995-12#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
observed clinical##2##2##(2008-12#1)(2008-5#1)
observed could be##2##3##(1991-5#1)(2007-11#1)
observed counts##2##2##(2008-10#2)
observed covariates##3##2##(2011-1#3)
observed data##12##2##(1995-2#1)(2008-10#5)(2008-7#1)(2008-8#3)(2011-1#1)(2011-2#1)
observed degradation##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
observed depending on the##2##4##(1993-8#1)(2008-10#1)
observed difference in##4##3##(1990-8#1)(1993-3#1)(1997-7#1)(2013-1#1)
observed differences are##2##3##(1991-3#1)(2012-2#1)
observed differences between##3##3##(1995-3#1)(2007-12#1)(2009-11#1)
observed differences in##6##3##(1992-2#1)(1993-11#1)(1994-2#1)(1995-5#1)(2008-3#1)(2008-9#1)
observed differences##12##2##(1991-3#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#1)
observed disease##5##2##(2008-10#5)
observed distinct##2##2##(2008-10#1)(2013-1#1)
observed distributions of##2##3##(1990-8#1)(2008-9#1)
observed droplet##2##2##(1995-3#1)(2008-3#1)
observed due to the##3##4##(1993-8#1)(2008-10#1)(2009-5#1)
observed due to##5##3##(1993-8#1)(2008-10#2)(2009-5#1)(2011-1#1)
observed due##6##2##(1993-8#1)(2008-10#3)(2009-5#1)(2011-1#1)
observed during a##2##3##(1992-3#1)(2012-12#1)
observed during cultivation##3##3##(2008-11#2)(2011-1#1)
observed during follow up##3##4##(1990-9#1)(2007-7#1)(2007-8#1)
observed during the course of##2##5##(1994-5#1)(2008-10#1)
observed during the first##3##4##(1993-12#1)(2009-4#1)(2012-3#1)
observed during the interaction##2##4##(1993-8#1)(2008-10#1)
observed during the study##2##4##(2008-4#1)(2013-1#1)
observed during the##35##3##(1993-11#1)(1993-12#1)(1993-8#2)(1994-5#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
observed during this period##2##4##(2008-10#1)(2011-2#1)
observed during##85##2##(1990-9#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#4)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#4)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#14)(2008-11#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
observed effect of##2##3##(1992-2#1)(1995-9#1)
observed effect##4##2##(1992-2#1)(1995-9#1)(2008-3#1)(2008-8#1)
observed effects##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
observed either##3##2##(1991-5#1)(2008-8#1)(2012-2#1)
observed even in the presence of##2##6##(1994-5#1)(2009-12#1)
observed even when##2##3##(1995-12#1)(2007-11#1)
observed even##6##2##(1994-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2009-12#1)(2012-1#1)
observed except##2##2##(1992-8#1)(2013-1#1)
observed experimentally and##2##3##(2007-11#1)(2008-3#1)
observed experimentally##11##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)
observed fluorescence##3##2##(1992-6#1)(1996-12#1)(2008-2#1)
observed following the##2##3##(1993-3#1)(2008-7#1)
observed following##12##2##(1990-7#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-3#1)
observed for 10##2##3##(1990-12#1)(1993-3#1)
observed for 2##2##3##(2008-11#2)
observed for Cu##2##3##(2013-8#2)
observed for a##4##3##(1992-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
observed for all the##3##4##(1990-6#1)(2008-10#2)
observed for all##6##3##(1990-6#1)(1997-4#1)(2008-10#4)
observed for both analytes##2##4##(2008-10#2)
observed for both##10##3##(1993-11#1)(1995-2#1)(1996-2#1)(2008-10#5)(2008-3#1)(2011-2#1)
observed for many##3##3##(2007-11#1)(2008-5#1)(2012-3#1)
observed for other##3##3##(1990-7#1)(1994-12#1)(1997-3#1)
observed for patients##2##3##(2007-10#1)(2008-6#1)
observed for the control##3##4##(1995-8#1)(2008-10#1)(2009-1#1)
observed for the first time in##2##6##(1991-2#1)(2008-10#1)
observed for the first time##5##5##(1991-2#1)(1992-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
observed for the other##2##4##(1993-11#1)(1995-11#1)
observed for the##58##3##(1991-1#2)(1991-2#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#4)(1992-8#1)(1993-11#1)(1993-6#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
observed for these##2##3##(1990-7#1)(2008-10#1)
observed for what is believed to be the first time##2##10##(2007-11#1)(2007-12#1)
observed for##259##2##(1990-12#2)(1990-3#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#6)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#2)(1996-7#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#6)(2007-12#5)(2008-10#81)(2008-11#12)(2008-12#3)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#3)
observed frequencies##2##2##(2008-10#2)
observed frequency of##2##3##(1996-4#1)(2008-9#1)
observed from all##2##3##(2008-10#1)(2008-12#1)
observed from the##10##3##(1991-9#1)(1992-5#1)(2007-12#1)(2008-10#3)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
observed from##44##2##(1990-6#1)(1991-9#1)(1992-5#1)(1995-12#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-7#1)
observed good##2##2##(1990-3#1)(2008-2#1)
observed greater##2##2##(1994-12#1)(2008-10#1)
observed have been##2##3##(1994-6#1)(2007-11#1)
observed here##3##2##(1990-12#1)(1992-6#1)(2008-9#1)
observed high##2##2##(2008-10#1)(2008-8#1)
observed higher##3##2##(1992-8#1)(2011-1#1)(2011-2#1)
observed if the##3##3##(1996-12#1)(2008-10#1)(2008-6#1)
observed if##6##2##(1990-11#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
observed image##3##2##(2007-11#1)(2008-3#2)
observed in 10##4##3##(1990-6#1)(1991-2#1)(1994-7#1)(2009-5#1)
observed in 22%##2##3##(1995-11#1)(2010-11#1)
observed in 3##4##3##(1991-8#1)(1992-8#1)(1997-7#1)(2012-12#1)
observed in 30% of##2##4##(1993-11#1)(2007-10#1)
observed in 35% of##2##4##(2009-8#1)(2011-2#1)
observed in 4 cases##2##4##(1991-2#1)(2013-8#1)
observed in 4##3##3##(1991-2#1)(2008-1#1)(2013-8#1)
observed in 40% of##2##4##(2008-5#1)(2009-8#1)
observed in Cuba##2##3##(2008-5#1)(2013-1#1)
observed in E##2##3##(1993-9#1)(1995-5#1)
observed in a laser-diode-pumped microchip##2##5##(2007-12#2)
observed in a limited##2##4##(2008-10#2)
observed in a patient with##2##5##(2007-8#1)(2013-8#1)
observed in a variety of##2##5##(2012-12#2)
observed in a##43##3##(1990-3#1)(1990-5#1)(1991-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-6#1)(1996-2#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
observed in all three##3##4##(1990-5#1)(2008-10#2)
observed in all##24##3##(1990-5#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
observed in animal##2##3##(1996-12#1)(2008-1#1)
observed in animals##3##3##(1993-6#1)(1994-7#1)(1995-3#1)
observed in any##8##3##(1993-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
observed in both groups##2##4##(1993-12#1)(1997-3#1)
observed in both##19##3##(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1996-12#2)(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
observed in cases##2##3##(1990-8#1)(1995-12#1)
observed in cells expressing the##2##5##(1995-6#1)(1996-5#1)
observed in cells##10##3##(1990-8#1)(1992-8#1)(1992-9#1)(1994-10#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-4#1)(2012-12#1)
observed in certain##2##3##(1993-6#1)(1997-8#1)
observed in children##5##3##(1995-8#1)(2007-7#1)(2008-8#1)(2010-10#1)(2012-3#1)
observed in clinical trials##3##4##(1991-6#1)(2006-10#1)(2008-5#1)
observed in clinical##4##3##(1990-5#1)(1991-6#1)(2006-10#1)(2008-5#1)
observed in commercial##2##3##(2008-10#2)
observed in comparison to##2##4##(1992-5#1)(2008-10#1)
observed in comparison##3##3##(1992-5#1)(2008-10#1)(2013-7#1)
observed in control##6##3##(1994-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-4#1)(2011-1#1)
observed in cyclic##2##3##(2008-10#2)
observed in different##2##3##(2008-10#1)(2008-3#1)
observed in each##3##3##(2008-10#3)
observed in either##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
observed in epidermal cells##2##4##(2008-10#2)
observed in fish##2##3##(1997-4#1)(2008-10#1)
observed in five##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
observed in four##5##3##(1994-12#1)(2007-8#2)(2008-5#1)(2008-8#1)
observed in groups##2##3##(2007-11#1)(2008-12#1)
observed in hams##2##3##(2010-4#2)
observed in human##6##3##(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(2009-12#1)(2011-2#1)
observed in humans##4##3##(1996-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
observed in intestinal##4##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-7#1)
observed in leaf##3##3##(2008-10#3)
observed in liver##2##3##(1993-11#1)(2011-3#1)
observed in male and female mice##2##6##(1995-11#1)(2008-9#1)
observed in male and female##3##5##(1995-11#1)(2008-9#2)
observed in male##4##3##(1995-11#1)(1995-8#1)(2008-9#2)
observed in mammalian##2##3##(1994-11#1)(1997-3#1)
observed in many patients##2##4##(1994-12#1)(2007-11#1)
observed in many##8##3##(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-8#2)(2009-12#1)(2013-8#1)
observed in men and women##2##5##(2008-7#1)(2009-8#1)
observed in more than##2##4##(2008-9#1)(2011-3#1)
observed in more##3##3##(2008-9#2)(2011-3#1)
observed in most of the##4##5##(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
observed in most##7##3##(1990-2#1)(1993-8#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
observed in natural##2##3##(2008-8#1)(2008-9#1)
observed in neuronal##2##3##(1990-7#1)(1991-2#1)
observed in newborn##2##3##(1991-12#1)(1993-6#1)
observed in nontransfected cells##2##4##(1992-9#2)
observed in nontransfected##3##3##(1992-9#2)(2008-11#1)
observed in normal##4##3##(1992-12#1)(1994-6#1)(1995-12#1)(1997-7#1)
observed in older##2##3##(2012-12#1)(2013-1#1)
observed in one of the##2##5##(1997-8#1)(2007-11#1)
observed in one of##4##4##(1997-8#1)(2007-11#1)(2008-4#2)
observed in one##7##3##(1997-8#1)(2007-11#1)(2008-4#3)(2008-7#1)(2008-9#1)
observed in only a##2##4##(1990-2#1)(1995-2#1)
observed in only##8##3##(1990-2#1)(1990-9#1)(1991-4#1)(1992-6#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-4#1)
observed in organic##3##3##(2008-10#2)(2008-3#1)
observed in other studies##2##4##(2008-1#1)(2008-5#1)
observed in other##18##3##(1990-12#1)(1991-6#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#3)(2008-7#2)(2010-4#1)(2011-1#1)(2012-1#1)
observed in our case##2##4##(2008-1#1)(2008-12#1)
observed in our##8##3##(1990-12#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2013-7#1)
observed in patients at##2##4##(1991-9#1)(2008-7#1)
observed in patients who##3##4##(1996-7#1)(2008-7#1)(2011-2#1)
observed in patients with##17##4##(1990-12#1)(1993-12#1)(1993-2#1)(1997-7#2)(2007-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)
observed in patients##25##3##(1990-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1996-6#1)(1996-7#1)(1997-7#2)(2007-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)
observed in plants##3##3##(2008-10#3)
observed in rat##2##3##(1995-6#1)(2008-2#1)
observed in real##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
observed in recombinant##2##3##(2008-11#1)(2008-8#1)
observed in response to##5##4##(1992-8#1)(2008-10#3)(2008-6#1)
observed in schizophrenia##2##3##(1995-11#1)(2010-6#1)
observed in several##6##3##(1992-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-3#1)
observed in severe##4##3##(2007-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
observed in some cases##3##4##(2007-11#1)(2008-10#2)
observed in some##14##3##(1990-7#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-12#1)(2007-11#3)(2008-10#3)(2008-3#1)(2009-4#1)(2009-7#1)
observed in subjects##4##3##(1992-2#1)(1992-3#1)(1995-5#1)(2008-7#1)
observed in the 0##3##4##(1994-5#1)(2008-10#2)
observed in the CHX##2##4##(2013-1#2)
observed in the absence of##4##5##(1990-5#1)(2008-10#1)(2008-11#2)
observed in the absence##5##4##(1990-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
observed in the area##2##4##(1996-2#1)(2009-12#1)
observed in the cell##2##4##(1997-1#1)(2008-7#1)
observed in the concentration range##2##5##(1995-11#1)(2008-10#1)
observed in the control##5##4##(1992-8#1)(1994-5#1)(2008-10#2)(2010-12#1)
observed in the culture##2##4##(2008-11#1)(2010-10#1)
observed in the experiment##2##4##(2008-10#1)(2008-3#1)
observed in the field and##2##5##(2008-10#2)
observed in the field##9##4##(2008-10#6)(2008-7#1)(2008-8#1)(2012-3#1)
observed in the group of patients##2##6##(1992-8#1)(2011-1#1)
observed in the initial##2##4##(2007-11#1)(2008-10#1)
observed in the majority of patients##2##6##(1994-5#1)(2008-6#1)
observed in the measured##2##4##(2008-2#1)(2012-3#1)
observed in the microsomal##2##4##(1990-11#1)(1993-8#1)
observed in the middle##2##4##(1993-8#1)(2008-2#1)
observed in the nucleus accumbens##3##5##(1994-8#2)(1995-5#1)
observed in the olfactory bulb##3##5##(1997-4#1)(2008-6#1)(2008-7#1)
observed in the patients##2##4##(2008-3#1)(2008-7#1)
observed in the period##2##4##(1992-8#1)(2008-3#1)
observed in the periphery##2##4##(2007-12#1)(2012-3#1)
observed in the presence of TGF beta##2##7##(1991-12#1)(1992-8#1)
observed in the presence of##20##5##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-2#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-10#1)
observed in the presence##21##4##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-2#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-10#1)
observed in the present study##3##5##(1990-2#1)(1990-6#1)(2008-11#1)
observed in the range##4##4##(2008-10#3)(2008-2#1)
observed in the rat##2##4##(1996-12#1)(1996-5#1)
observed in the resistant##4##4##(1992-2#1)(2008-10#3)
observed in the same##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
observed in the sawdust##2##4##(2008-12#2)
observed in the spleen##2##4##(1992-9#1)(2010-5#1)
observed in the stomach##2##4##(1992-9#1)(2011-2#1)
observed in the study##2##4##(2010-4#1)(2011-1#1)
observed in the subjects##2##4##(2008-5#1)(2008-7#1)
observed in the tubular##2##4##(2011-2#1)(2013-7#1)
observed in the vicinity of##2##5##(1995-2#1)(1997-4#1)
observed in the wild##2##4##(1991-2#1)(2008-5#1)
observed in the##349##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#3)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#7)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#5)(1996-2#4)(1996-5#5)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#4)(1997-6#1)(1997-8#1)(1997-9#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#76)(2008-11#12)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#8)(2012-1#5)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
observed in their##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
observed in these cells##3##4##(1994-11#1)(1996-12#1)(2008-11#1)
observed in these experiments##2##4##(1994-3#1)(2008-10#1)
observed in these##10##3##(1994-11#1)(1994-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#1)
observed in this case##2##4##(2008-10#1)(2009-3#1)
observed in this study##5##4##(1993-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2010-5#1)
observed in this##17##3##(1992-3#1)(1992-6#1)(1993-12#2)(1995-2#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2013-7#1)
observed in those##2##3##(2008-10#1)(2013-1#1)
observed in three##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
observed in tomato##4##3##(2008-10#4)
observed in transmission electron microscopy##2##5##(2008-10#1)(2008-3#1)
observed in treatments with##3##4##(2008-10#3)
observed in two##5##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
observed in urine##2##3##(2008-7#1)(2010-5#1)
observed in various##5##3##(1990-5#1)(1992-2#1)(1997-8#1)(2008-10#1)(2008-8#1)
observed in vitro##7##3##(1992-12#1)(1992-8#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2010-11#1)
observed in vivo in response to##2##6##(1996-2#1)(1996-5#1)
observed in vivo##6##3##(1994-3#1)(1996-2#1)(1996-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
observed in western countries##3##4##(1990-3#1)(2009-2#2)
observed in women with##2##4##(1995-9#2)
observed in women##3##3##(1995-9#2)(2012-3#1)
observed in##1293##2##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#6)(1990-3#5)(1990-5#12)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#2)(1991-11#2)(1991-12#12)(1991-2#9)(1991-3#1)(1991-4#4)(1991-5#6)(1991-6#5)(1991-8#5)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#9)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#13)(1992-9#10)(1993-10#1)(1993-11#6)(1993-12#15)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#6)(1993-8#7)(1993-9#4)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#8)(1994-6#11)(1994-7#2)(1994-8#11)(1994-9#4)(1995-1#1)(1995-11#12)(1995-12#11)(1995-2#9)(1995-3#11)(1995-4#1)(1995-5#8)(1995-6#5)(1995-8#10)(1995-9#2)(1996-1#1)(1996-12#23)(1996-2#9)(1996-3#3)(1996-5#14)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#13)(1997-4#11)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#10)(1997-9#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#5)(2007-11#31)(2007-12#22)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#13)(2008-10#239)(2008-11#38)(2008-12#18)(2008-2#19)(2008-3#34)(2008-4#11)(2008-5#43)(2008-6#17)(2008-7#45)(2008-8#27)(2008-9#20)(2009-10#1)(2009-11#4)(2009-12#10)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#6)(2010-4#12)(2010-5#10)(2010-6#5)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#21)(2011-2#29)(2011-3#3)(2011-9#1)(2012-1#9)(2012-12#15)(2012-2#16)(2012-3#11)(2012-5#1)(2012-7#1)(2013-1#33)(2013-7#7)(2013-8#15)
observed incidence##4##2##(2008-10#4)
observed include##2##2##(2008-10#1)(2008-8#1)
observed increase in##6##3##(1995-3#1)(1997-1#1)(2008-4#1)(2009-8#1)(2010-5#1)(2013-8#1)
observed increased##3##2##(1994-9#1)(2008-3#1)(2008-7#1)
observed increases in##2##3##(2007-9#1)(2008-1#1)
observed increases##3##2##(2007-12#1)(2007-9#1)(2008-1#1)
observed inhibition##3##2##(1991-9#2)(1992-3#1)
observed inside the##2##3##(2008-10#1)(2012-3#1)
observed interactions##4##2##(2008-7#1)(2009-5#1)(2012-4#1)(2013-8#1)
observed is##9##2##(1992-5#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
observed just##2##2##(2008-1#1)(2008-3#1)
observed latent periods##2##3##(2008-10#2)
observed less##2##2##(2008-10#1)(2011-2#1)
observed levels of##2##3##(2008-9#1)(2009-8#1)
observed local##2##2##(2007-11#1)(2008-3#1)
observed lower##2##2##(2007-10#1)(2013-8#1)
observed maximal##2##2##(2007-10#1)(2010-11#1)
observed may##2##2##(1993-2#1)(2008-11#1)
observed more frequently in the##2##5##(2008-12#1)(2011-2#1)
observed more frequently##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
observed more##5##2##(1995-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
observed mortality##3##2##(1994-12#1)(2007-8#1)(2008-8#1)
observed near the##4##3##(2007-11#1)(2008-11#1)(2009-12#1)(2013-1#1)
observed near##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2009-12#1)(2013-1#1)
observed no##5##2##(1996-6#1)(2008-7#1)(2008-8#1)(2011-2#2)
observed on both##3##3##(1990-8#1)(2008-10#1)(2008-5#1)
observed on day##4##3##(1992-3#1)(1994-2#1)(2006-6#1)(2008-7#1)
observed on foliage##3##3##(2008-10#3)
observed on leaves of##2##4##(2008-10#2)
observed on leaves##3##3##(2008-10#3)
observed on plants##2##3##(2008-10#2)
observed on the surface##3##4##(1996-4#1)(2008-10#1)(2008-11#1)
observed on the##28##3##(1991-6#1)(1995-2#1)(1995-3#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2012-2#1)
observed on##102##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-3#4)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-4#1)(1997-6#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
observed once##4##2##(2008-10#1)(2011-2#1)(2012-6#1)(2013-1#1)
observed only after##2##3##(1990-11#1)(1997-4#1)
observed only at##5##3##(1994-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
observed only in the##9##4##(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2013-1#1)
observed only in##18##3##(1990-3#1)(1990-8#1)(1991-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-6#1)(2013-1#1)
observed only under##2##3##(1992-8#1)(1993-8#1)
observed only when##4##3##(1992-9#1)(2008-10#2)(2008-3#1)
observed only with##2##3##(1991-9#1)(2008-2#1)
observed only##41##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#4)(2008-9#1)(2009-2#1)(2009-6#1)(2013-1#2)(2013-8#1)
observed optical##2##2##(2007-11#1)(2008-3#1)
observed over a##4##3##(1990-8#1)(2007-12#1)(2008-10#2)
observed over the concentration range##2##5##(2008-10#2)
observed over the years##2##4##(2008-10#1)(2008-7#1)
observed over the##6##3##(2008-10#4)(2008-2#1)(2008-7#1)
observed over time##2##3##(1990-12#1)(2008-10#1)
observed over##16##2##(1990-12#1)(1990-8#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-7#1)(2013-8#1)
observed patterns of##4##3##(2008-10#1)(2008-8#2)(2009-7#1)
observed patterns##9##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-8#4)(2009-7#1)(2009-8#1)
observed phenomena##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
observed prevalence of##2##3##(2008-9#1)(2013-8#1)
observed previously##2##2##(1993-12#1)(2008-10#1)
observed radiance##2##2##(2008-3#2)
observed reduction##2##2##(2007-8#1)(2008-10#1)
observed regardless of the##2##4##(2008-10#1)(2008-9#1)
observed regardless of##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
observed regardless##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
observed relative to##2##3##(2007-11#1)(2008-10#1)
observed relative##4##2##(2007-11#1)(2008-10#2)(2012-12#1)
observed respectively##2##2##(2010-7#1)(2012-3#1)
observed response##4##2##(1997-8#1)(2008-10#1)(2008-3#1)(2009-8#1)
observed scattering##2##2##(2008-3#2)
observed seroprevalence##3##2##(2011-2#3)
observed signal##5##2##(1992-6#1)(1997-2#1)(2008-3#3)
observed significant##2##2##(2009-5#1)(2012-2#1)
observed significantly##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
observed spectral##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-9#1)
observed spectrum##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
observed subsequently##2##2##(1991-8#1)(2009-11#1)
observed surface##3##2##(1990-11#1)(2008-3#2)
observed that DEX treatment##2##4##(1994-9#2)
observed that Hg(II)##2##3##(2008-10#2)
observed that after##2##3##(2008-11#1)(2012-1#1)
observed that cells##2##3##(1992-8#1)(2010-10#1)
observed that in##6##3##(2008-10#2)(2008-11#1)(2009-10#1)(2009-3#1)(2011-2#1)
observed that some##2##3##(2008-10#1)(2012-3#1)
observed that the increase##2##4##(2008-10#1)(2008-3#1)
observed that the rate##2##4##(2008-10#1)(2009-4#1)
observed that the##43##3##(1991-5#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-11#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
observed that there##2##3##(2008-10#1)(2010-5#1)
observed that these##4##3##(1996-2#1)(1997-7#1)(2008-10#1)(2012-6#1)
observed that with##2##3##(1994-8#1)(2008-10#1)
observed that##142##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-4#2)(1997-7#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#34)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2012-6#1)(2013-1#4)(2013-8#3)
observed the effect of##2##4##(2008-10#1)(2008-5#1)
observed the##18##2##(1997-2#1)(2007-12#3)(2008-10#3)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
observed therapy (DOT) to##2##4##(1996-3#2)
observed therapy (DOT)##8##3##(1996-11#1)(1996-3#6)(2010-4#1)
observed therapy##21##2##(1996-11#1)(1996-3#17)(1997-8#1)(2008-10#1)(2010-4#1)
observed this##2##2##(2007-12#1)(2008-10#1)
observed through the##2##3##(2008-10#1)(2008-3#1)
observed through##5##2##(2008-10#2)(2008-3#2)(2010-8#1)
observed to be an##2##4##(2008-10#1)(2012-12#1)
observed to be in##2##4##(2008-10#1)(2008-3#1)
observed to be##27##3##(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1996-4#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#3)(2013-1#1)
observed to cause##3##3##(2007-12#1)(2008-10#2)
observed to depend on the##2##5##(2007-11#1)(2008-3#1)
observed to grow##2##3##(1993-6#1)(2007-12#1)
observed to have##2##3##(2010-2#1)(2012-2#1)
observed to increase##2##3##(2008-2#1)(2012-2#1)
observed to occur##4##3##(1995-3#1)(1997-4#1)(2007-12#1)(2009-5#1)
observed to penetrate##2##3##(2008-10#1)(2013-1#1)
observed to recover##2##3##(2008-10#1)(2008-5#1)
observed to##84##2##(1990-8#2)(1991-5#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#3)(1995-3#1)(1996-4#1)(1996-7#1)(1997-4#3)(2007-11#2)(2007-12#4)(2008-10#16)(2008-11#6)(2008-2#1)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)
observed two##6##2##(1995-5#1)(2007-11#3)(2011-2#1)(2013-1#1)
observed under a##2##3##(1992-9#1)(2007-12#1)
observed under conditions##3##3##(1992-3#1)(1993-1#1)(2007-11#1)
observed under the##3##3##(1993-6#1)(2008-10#1)(2009-7#1)
observed under this condition##2##4##(2008-10#1)(2011-2#1)
observed under##23##2##(1991-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-7#1)
observed until##2##2##(1997-2#1)(2008-9#1)
observed up to 1##2##4##(2008-10#1)(2013-8#1)
observed up to##10##3##(1990-5#1)(2008-10#5)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
observed upon the##2##3##(1992-11#1)(2008-10#1)
observed upon##11##2##(1990-11#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-12#1)
observed using the##2##3##(1992-5#1)(1994-3#1)
observed using##17##2##(1991-9#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
observed values for##2##3##(1997-2#1)(2010-3#1)
observed values of##3##3##(2008-10#3)
observed values##10##2##(1997-2#2)(2008-10#5)(2008-3#1)(2008-8#1)(2010-3#1)
observed variability in##2##3##(1994-2#1)(2008-10#1)
observed variation in##2##3##(2008-5#1)(2010-8#1)
observed variation##5##2##(1995-3#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-7#1)
observed variations in##2##3##(2008-10#2)
observed variations##3##2##(2008-10#2)(2009-7#1)
observed versus##2##2##(2008-10#2)
observed via##2##2##(2008-10#2)
observed was##9##2##(1992-12#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2013-1#1)
observed weak##2##2##(2008-11#1)(2008-3#1)
observed were##15##2##(1990-12#1)(1990-2#1)(1991-2#1)(2007-7#1)(2008-10#4)(2008-3#1)(2009-8#1)(2010-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
observed when a mixture of##2##5##(2008-2#1)(2013-1#1)
observed when a##5##3##(1994-5#1)(1997-4#1)(2008-10#1)(2008-2#1)(2013-1#1)
observed when the samples were##2##5##(2008-3#1)(2008-5#1)
observed when the##25##3##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#2)(1991-8#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)
observed when##86##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-10#23)(2008-11#11)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-4#3)(2011-2#1)(2012-2#1)(2013-1#3)
observed where##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
observed which##6##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#2)
observed while##3##2##(1992-11#1)(2008-10#1)(2011-1#1)
observed with a##15##3##(1990-5#2)(1992-6#1)(1993-9#1)(1994-3#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#2)
observed with higher##2##3##(2008-10#1)(2008-5#1)
observed with increasing##4##3##(2008-10#3)(2008-2#1)
observed with no##2##3##(1993-3#1)(2008-10#1)
observed with the native##2##4##(1990-2#1)(1992-6#1)
observed with the##32##3##(1990-2#1)(1991-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#5)(2009-9#1)(2012-3#1)(2013-1#2)
observed with these two##2##4##(1990-5#1)(2008-10#1)
observed with##153##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#5)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(1997-9#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#36)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#13)(2008-7#3)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
observed within the##7##3##(1991-12#1)(1991-6#1)(1997-8#1)(2007-11#1)(2008-10#3)
observed within##24##2##(1991-12#2)(1991-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
observed without treatment##2##3##(1990-11#1)(2008-7#1)
observed without##6##2##(1990-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
observed##4753##1##(1990-10#5)(1990-11#13)(1990-12#27)(1990-2#20)(1990-3#14)(1990-5#34)(1990-6#12)(1990-7#18)(1990-8#21)(1990-9#9)(1991-1#4)(1991-10#1)(1991-11#7)(1991-12#29)(1991-2#24)(1991-3#4)(1991-4#7)(1991-5#26)(1991-6#15)(1991-7#2)(1991-8#18)(1991-9#15)(1992-10#10)(1992-11#9)(1992-12#23)(1992-2#13)(1992-3#36)(1992-4#4)(1992-5#14)(1992-6#36)(1992-7#2)(1992-8#29)(1992-9#22)(1993-1#6)(1993-10#1)(1993-11#23)(1993-12#34)(1993-2#11)(1993-3#18)(1993-5#1)(1993-6#20)(1993-8#34)(1993-9#16)(1994-1#1)(1994-10#4)(1994-11#23)(1994-12#18)(1994-2#18)(1994-3#21)(1994-5#27)(1994-6#25)(1994-7#4)(1994-8#18)(1994-9#15)(1995-1#1)(1995-11#22)(1995-12#34)(1995-2#28)(1995-3#33)(1995-4#1)(1995-5#20)(1995-6#26)(1995-8#20)(1995-9#4)(1996-1#2)(1996-11#3)(1996-12#40)(1996-2#29)(1996-3#28)(1996-4#6)(1996-5#30)(1996-6#8)(1996-7#5)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#32)(1997-3#28)(1997-4#38)(1997-5#4)(1997-6#16)(1997-7#23)(1997-8#22)(1997-9#6)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#18)(2007-11#127)(2007-12#124)(2007-2#4)(2007-5#5)(2007-6#1)(2007-7#12)(2007-8#32)(2007-9#1)(2008-1#36)(2008-10#1040)(2008-11#173)(2008-12#70)(2008-2#93)(2008-3#179)(2008-4#32)(2008-5#165)(2008-6#55)(2008-7#155)(2008-8#106)(2008-9#66)(2009-1#4)(2009-10#8)(2009-11#15)(2009-12#20)(2009-2#9)(2009-3#2)(2009-4#9)(2009-5#13)(2009-6#8)(2009-7#14)(2009-8#25)(2009-9#11)(2010-1#11)(2010-10#7)(2010-11#12)(2010-12#19)(2010-2#10)(2010-3#11)(2010-4#29)(2010-5#19)(2010-6#12)(2010-7#5)(2010-8#22)(2010-9#1)(2011-1#57)(2011-2#120)(2011-3#10)(2011-7#1)(2011-9#1)(2012-1#20)(2012-12#38)(2012-2#64)(2012-3#49)(2012-4#2)(2012-5#3)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#123)(2013-7#22)(2013-8#54)
observer from##2##2##(2007-12#1)(2008-2#1)
observer study##3##2##(2012-1#2)(2012-2#1)
observer variation##2##2##(1990-2#1)(1993-1#1)
observer##40##1##(1990-2#1)(1993-1#1)(1994-3#1)(1996-2#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#2)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-1#6)(2012-12#1)(2012-2#2)
observers from##2##2##(2008-10#1)(2008-5#1)
observers to identify##2##3##(2008-11#1)(2008-5#1)
observers##28##1##(1993-12#1)(1997-8#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#7)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)
observes##4##1##(1994-12#1)(1995-12#1)(2008-2#1)(2008-3#1)
observing a##5##2##(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-3#1)
observing others##2##2##(2008-11#1)(2013-8#1)
observing such##2##2##(2008-8#1)(2013-8#1)
observing the##16##2##(1990-8#1)(1991-12#1)(1992-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-8#1)(2012-1#1)(2013-8#1)
observing##58##1##(1990-8#1)(1991-12#1)(1992-5#1)(1993-9#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#5)(2008-3#11)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#4)
observé##2##1##(2013-1#2)
obsession with##3##2##(1992-2#1)(1996-12#1)(2012-12#1)
obsession##4##1##(1992-2#1)(1996-12#1)(2008-10#1)(2012-12#1)
obsessive compulsive disorder##3##3##(2009-9#2)(2012-2#1)
obsessive compulsive##5##2##(1997-6#1)(2008-1#1)(2009-9#2)(2012-2#1)
obsessive##7##1##(1994-12#1)(1997-6#1)(2007-8#1)(2008-1#1)(2009-9#2)(2012-2#1)
obsessive-compulsive (OC)##2##2##(2008-1#1)(2008-3#1)
obsessive-compulsive disorder (OCD)##4##3##(2008-1#1)(2008-3#1)(2008-6#2)
obsessive-compulsive disorder and##3##3##(2008-1#1)(2011-2#1)(2012-1#1)
obsessive-compulsive disorder##18##2##(2008-1#6)(2008-11#1)(2008-3#3)(2008-6#3)(2011-2#3)(2012-1#1)(2012-12#1)
obsessive-compulsive##23##1##(2008-1#7)(2008-11#1)(2008-3#4)(2008-6#4)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#2)
obsignata##2##1##(2011-1#2)
obsolescence##3##1##(1994-1#1)(2008-1#1)(2011-2#1)
obsolete##3##1##(1991-3#1)(1995-2#1)(1997-4#1)
obstacle for##2##2##(2008-5#1)(2010-11#1)
obstacle in the##2##3##(2008-10#1)(2012-12#1)
obstacle to##15##2##(1994-12#1)(1995-2#1)(1996-3#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#1)(2010-5#1)(2012-12#1)(2012-2#1)
obstacle##26##1##(1991-1#1)(1994-12#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
obstacles and##4##2##(1996-3#1)(2008-11#1)(2009-5#1)(2012-12#1)
obstacles are##2##2##(1996-1#1)(1997-8#1)
obstacles encountered##2##2##(2008-4#1)(2012-12#1)
obstacles experienced##2##2##(1995-3#1)(1996-1#1)
obstacles for##3##2##(1991-3#1)(1993-12#1)(1993-2#1)
obstacles in##3##2##(1992-12#1)(1996-12#1)(2008-4#1)
obstacles to the##5##3##(1996-1#1)(1996-2#1)(2007-11#1)(2009-2#1)(2010-10#1)
obstacles to##26##2##(1991-12#1)(1991-3#1)(1994-2#2)(1995-1#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2012-2#1)
obstacles##60##1##(1991-12#1)(1991-3#3)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#4)(2012-2#3)
obstetric and neonatal outcomes##2##4##(2011-2#1)(2013-1#1)
obstetric and neonatal##3##3##(1990-3#1)(2011-2#1)(2013-1#1)
obstetric and##5##2##(1990-3#2)(1992-1#1)(2011-2#1)(2013-1#1)
obstetric brachial plexus##2##3##(2010-9#1)(2013-1#1)
obstetric care and##2##3##(2011-1#2)
obstetric care##12##2##(1991-6#1)(1993-6#1)(2008-7#1)(2009-2#1)(2010-11#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-8#1)
obstetric complications##2##2##(2008-2#1)(2010-8#1)
obstetric history##4##2##(2007-7#3)(2013-1#1)
obstetric patient##2##2##(1993-10#2)
obstetric patients##5##2##(1993-10#3)(2012-2#1)(2013-1#1)
obstetric services##3##2##(1991-9#1)(1993-10#1)(1994-3#1)
obstetric units##5##2##(2008-4#1)(2010-3#2)(2013-1#2)
obstetric##61##1##(1990-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1993-10#8)(1993-6#1)(1994-1#1)(1994-3#1)(1996-2#1)(1996-6#1)(2007-2#1)(2007-7#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-11#3)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#11)(2013-8#1)
obstetrical care##2##2##(1992-2#1)(1994-1#1)
obstetrical population##3##2##(2007-12#3)
obstetrical services##2##2##(1994-1#1)(1996-2#1)
obstetrical##18##1##(1992-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1996-2#2)(2007-12#4)(2008-4#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
obstetricians##9##1##(1990-3#1)(1993-6#1)(1994-3#1)(1996-1#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
obstetrics and gynaecology##3##3##(2008-12#1)(2010-8#2)
obstetrics and##8##2##(1990-3#1)(1993-12#1)(2008-12#1)(2010-8#2)(2012-3#1)(2013-1#2)
obstetrics in##2##2##(1990-3#1)(1991-6#1)
obstetrics##16##1##(1990-3#3)(1991-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(2007-7#1)(2008-12#1)(2009-10#1)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#2)
obstructed by##2##2##(2008-1#1)(2013-1#1)
obstructed##17##1##(1991-3#1)(1992-9#2)(1993-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#2)
obstructing the##5##2##(2007-5#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
obstructing##12##1##(1994-8#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
obstruction and##23##2##(1992-2#2)(1995-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
obstruction are important##2##3##(2008-7#1)(2012-2#1)
obstruction are##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
obstruction by##3##2##(1993-1#1)(1993-12#1)(2011-1#1)
obstruction caused by##4##3##(1990-3#1)(1990-6#1)(2008-10#1)(2013-8#1)
obstruction due to##4##3##(1992-3#1)(1992-5#1)(2008-10#1)(2008-7#1)
obstruction for##2##2##(2011-1#1)(2011-2#1)
obstruction in a##2##3##(2008-10#1)(2008-11#1)
obstruction in the##3##3##(2010-6#1)(2011-2#2)
obstruction in##17##2##(1992-5#1)(1997-8#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
obstruction is##3##2##(1991-4#1)(1997-8#1)(2011-2#1)
obstruction occurred##2##2##(2007-7#1)(2007-8#1)
obstruction of the SVC##2##4##(2007-8#1)(2008-1#1)
obstruction of the biliary##2##4##(1990-8#1)(2013-1#1)
obstruction of the pulmonary vascular bed##2##6##(1991-8#1)(2008-10#1)
obstruction of the##13##3##(1990-8#1)(1991-11#1)(1991-8#1)(1992-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
obstruction of##17##2##(1990-8#1)(1991-11#1)(1991-8#2)(1992-4#1)(1992-5#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#2)(2013-1#1)
obstruction or##3##2##(2008-1#1)(2008-10#2)
obstruction secondary to a##2##4##(2008-12#1)(2009-8#1)
obstruction secondary to##8##3##(1996-8#1)(2007-10#2)(2008-10#1)(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
obstruction that##2##2##(2008-10#1)(2011-1#1)
obstruction was##2##2##(1990-6#1)(1990-8#1)
obstruction who##2##2##(2013-1#2)
obstruction##234##1##(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-11#3)(1991-4#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#5)(1993-1#4)(1993-12#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-8#10)(2007-10#3)(2007-12#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#29)(2008-11#5)(2008-12#10)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#14)(2009-4#1)(2009-5#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#5)(2010-7#1)(2011-1#11)(2011-2#16)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#27)(2013-7#1)(2013-8#3)
obstruction)##2##1##(2007-4#1)(2011-3#1)
obstructions in the##2##3##(2008-3#1)(2013-1#1)
obstructions in two horses and a donkey##2##7##(1990-3#2)
obstructions in##4##2##(1990-3#2)(2008-3#1)(2013-1#1)
obstructions##14##1##(1990-3#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-1#1)(2012-3#1)(2013-1#3)
obstructive airway diseases##3##3##(2006-10#1)(2008-3#2)
obstructive airway##4##2##(1993-2#1)(2006-10#1)(2008-3#2)
obstructive and##2##2##(1997-3#1)(2010-6#1)
obstructive cardiomyopathy##3##2##(1992-9#2)(2010-12#1)
obstructive coronary artery disease##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
obstructive coronary##4##2##(2008-7#1)(2011-2#2)(2012-2#1)
obstructive disease##2##2##(2010-5#1)(2011-2#1)
obstructive diseases in##2##3##(1996-7#1)(2011-2#1)
obstructive hydrocephalus##2##2##(2008-7#2)
obstructive jaundice##4##2##(1991-3#1)(2007-10#1)(2008-12#1)(2013-1#1)
obstructive lesions##3##2##(1996-6#1)(2010-6#1)(2012-3#1)
obstructive lung disease##6##3##(1990-6#1)(1995-2#1)(1997-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
obstructive lung diseases##2##3##(1995-2#1)(2008-6#1)
obstructive lung##10##2##(1990-6#1)(1995-2#2)(1997-4#1)(2008-1#2)(2008-6#2)(2008-7#1)(2011-2#1)
obstructive pulmonary disease (COPD) is##3##5##(2011-2#2)(2013-1#1)
obstructive pulmonary disease (COPD)##26##4##(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-7#1)(2008-1#1)(2008-7#2)(2010-10#1)(2010-5#1)(2011-2#8)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
obstructive pulmonary disease and##6##4##(2007-10#1)(2008-7#2)(2009-1#1)(2011-2#2)
obstructive pulmonary disease in##5##4##(1992-1#1)(1995-12#1)(2010-2#1)(2012-2#2)
obstructive pulmonary disease##66##3##(1991-4#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-12#3)(1996-1#2)(1996-5#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-5#2)(2011-2#17)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
obstructive pulmonary##73##2##(1991-4#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#3)(1996-1#2)(1996-5#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-5#2)(2011-2#21)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
obstructive sleep apnea (OSA)##2##4##(2009-9#1)(2012-2#1)
obstructive sleep apnea syndrome##5##4##(2007-12#2)(2010-5#3)
obstructive sleep apnea##18##3##(2007-12#9)(2009-9#1)(2010-5#3)(2012-2#2)(2013-1#1)(2013-7#2)
obstructive sleep##20##2##(2007-12#9)(2009-9#1)(2010-5#3)(2010-6#2)(2012-2#2)(2013-1#1)(2013-7#2)
obstructive symptoms and##2##3##(1990-3#1)(2013-8#1)
obstructive syndromes##2##2##(1991-4#2)
obstructive uropathy and##2##3##(2007-7#2)
obstructive uropathy in##2##3##(2008-10#1)(2008-4#1)
obstructive uropathy##13##2##(1990-8#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-4#2)(2009-5#1)
obstructive##171##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#5)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-2#1)(1995-12#3)(1995-2#2)(1996-1#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#10)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-5#6)(2010-6#5)(2011-2#28)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#4)
obtain a consistent##2##3##(2008-2#2)
obtain a continuous##2##3##(2008-2#1)(2008-3#1)
obtain a homogeneous##4##3##(2008-10#2)(2009-7#1)(2011-2#1)
obtain a large##2##3##(2007-12#1)(2008-3#1)
obtain a more##2##3##(2008-1#1)(2008-10#1)
obtain a##123##2##(1991-2#2)(1991-3#3)(1991-5#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#2)(2008-2#11)(2008-3#15)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
obtain accuracies##2##2##(2007-12#1)(2008-3#1)
obtain accurate estimates of##2##4##(1992-6#1)(2008-4#1)
obtain accurate estimates##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
obtain accurate##12##2##(1990-8#1)(1992-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
obtain an adequate##2##3##(2008-10#1)(2012-2#1)
obtain an efficient##2##3##(2008-3#2)
obtain an overall##3##3##(1995-6#1)(1997-3#1)(2008-10#1)
obtain an##34##2##(1991-2#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2009-7#1)(2011-2#3)(2012-2#1)
obtain and analyze##2##3##(1996-3#1)(2008-2#1)
obtain and##3##2##(1996-3#1)(2008-2#1)(2008-5#1)
obtain better##7##2##(1997-7#1)(2008-10#4)(2008-7#1)(2012-3#1)
obtain efficient##2##2##(1997-4#1)(2009-8#1)
obtain exact##2##2##(2008-2#1)(2008-3#1)
obtain feedback##5##2##(1995-12#1)(2013-1#4)
obtain for##2##2##(2008-3#2)
obtain good##5##2##(1990-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)
obtain high##10##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
obtain high-quality##2##2##(2008-2#1)(2008-3#1)
obtain information about the##5##4##(1990-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
obtain information about##6##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
obtain information from##2##3##(2008-11#1)(2012-12#1)
obtain information##17##2##(1990-8#1)(1991-1#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)
obtain longer##2##2##(2010-8#1)(2012-12#1)
obtain low##2##2##(2007-12#1)(2008-10#1)
obtain monoclonal antibodies##2##3##(1994-9#1)(2007-10#1)
obtain monoclonal##3##2##(1994-9#1)(2007-10#1)(2008-9#1)
obtain more information about##3##4##(1995-5#1)(1996-11#1)(2008-6#1)
obtain more information##4##3##(1995-5#1)(1996-11#1)(2008-6#1)(2013-8#1)
obtain more##11##2##(1991-6#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2009-4#1)(2010-1#1)(2013-8#1)
obtain near-diffraction-limited output##2##3##(2008-2#1)(2008-3#1)
obtain qualitative##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
obtain quantitative data##2##3##(1990-5#1)(2008-10#1)
obtain quantitative##7##2##(1990-5#1)(2008-10#6)
obtain recombinant##2##2##(2009-3#1)(2012-3#1)
obtain relevant information##2##3##(1993-12#1)(1997-6#1)
obtain relevant##3##2##(1993-12#1)(1993-3#1)(1997-6#1)
obtain reliable##6##2##(1992-9#1)(2007-12#1)(2008-10#2)(2010-12#1)(2013-7#1)
obtain results##2##2##(2008-2#1)(2008-3#1)
obtain some of the##2##4##(1994-12#1)(2008-10#1)
obtain some##5##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
obtain stable##2##2##(2007-11#1)(2008-10#1)
obtain the best##4##3##(1990-10#1)(2008-10#2)(2013-8#1)
obtain the full-length##2##3##(1996-2#1)(2008-10#1)
obtain the optimum##7##3##(2007-12#1)(2008-10#3)(2008-2#1)(2010-2#1)(2013-1#1)
obtain the required##3##3##(1993-12#1)(2008-2#1)(2008-3#1)
obtain the results##2##3##(2008-10#1)(2008-4#1)
obtain the##122##2##(1990-10#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-5#1)(1996-2#1)(2007-10#2)(2007-11#5)(2007-12#2)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#19)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-9#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
obtain two##2##2##(2008-3#2)
obtain##698##1##(1990-10#1)(1990-12#1)(1990-5#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#4)(1991-5#2)(1991-6#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#5)(1995-6#4)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#4)(1997-2#3)(1997-3#4)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#3)(2006-12#1)(2006-6#1)(2007-10#5)(2007-11#21)(2007-12#23)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#150)(2008-11#24)(2008-12#8)(2008-2#53)(2008-3#77)(2008-4#20)(2008-5#22)(2008-6#5)(2008-7#16)(2008-8#12)(2008-9#19)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#2)(2011-2#24)(2011-3#1)(2012-12#9)(2012-2#8)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#8)
obtainable by##2##2##(2008-10#1)(2010-8#1)
obtainable with the##2##3##(2007-12#1)(2009-5#1)
obtainable with##5##2##(2007-11#1)(2007-12#2)(2008-7#1)(2009-5#1)
obtainable##17##1##(1992-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-6#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
obtained (0##2##2##(2008-10#2)
obtained 2##3##2##(1990-3#1)(2007-10#1)(2008-11#1)
obtained DNA##2##2##(2008-5#1)(2008-8#1)
obtained a complete##2##3##(1990-6#1)(2008-7#1)
obtained a detection limit of##2##5##(2008-10#2)
obtained a##32##2##(1990-6#1)(1990-7#1)(1991-5#1)(1994-11#1)(1994-6#2)(1997-7#1)(2007-11#6)(2007-12#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-6#1)
obtained about##4##2##(1992-5#1)(1994-5#1)(2008-1#1)(2008-10#1)
obtained above##2##2##(2008-10#2)
obtained according to the##3##4##(1995-3#1)(2008-10#2)
obtained according to##4##3##(1995-3#1)(2008-10#2)(2011-2#1)
obtained across##2##2##(2008-2#1)(2008-3#1)
obtained after a##3##3##(2008-10#2)(2008-8#1)
obtained after analyzing##2##3##(2008-10#2)
obtained after digestion##3##3##(2008-10#3)
obtained after##50##2##(1990-2#2)(1990-6#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2012-1#2)(2012-2#1)
obtained agree##3##2##(2008-10#3)
obtained allowed to##2##3##(2008-10#2)
obtained along with##2##3##(1990-8#1)(2008-2#1)
obtained among the##2##3##(1996-12#1)(2008-10#1)
obtained an##7##2##(1995-3#1)(2007-11#2)(2008-2#1)(2008-3#2)(2012-3#1)
obtained analytically##2##2##(2007-12#1)(2008-10#1)
obtained and analyzed##3##3##(2007-1#1)(2008-10#1)(2008-3#1)
obtained and characterized##2##3##(2008-10#2)
obtained and compared for the##2##5##(2008-10#2)
obtained and compared##3##3##(2008-10#3)
obtained and discussed##2##3##(2008-10#2)
obtained and it##2##3##(2008-10#1)(2012-3#1)
obtained and studied##2##3##(2007-11#1)(2007-12#1)
obtained and the calculated standard rate constant (k(s)) is##2##9##(2008-10#2)
obtained and the##14##3##(1997-5#1)(2008-10#9)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
obtained and used for##2##4##(2008-4#1)(2011-1#1)
obtained and used to calculate the##2##6##(2008-2#1)(2008-3#1)
obtained and used##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
obtained and##51##2##(1992-6#1)(1994-11#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#21)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
obtained are compared with##4##4##(1997-8#1)(2008-10#1)(2008-3#2)
obtained are compared##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)
obtained are discussed##3##3##(2008-10#2)(2009-9#1)
obtained are in good agreement with the certified values##2##9##(2008-10#2)
obtained are in good agreement with the##3##7##(2008-10#2)(2008-2#1)
obtained are in good agreement with##4##6##(2008-10#3)(2008-2#1)
obtained are in##6##3##(2008-10#5)(2008-2#1)
obtained are reported##2##3##(2008-10#2)
obtained are##28##2##(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-9#1)
obtained as a function of##2##5##(2007-12#1)(2008-10#1)
obtained as a result of the##2##6##(2007-12#1)(2008-6#1)
obtained as a result of##4##5##(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
obtained as a##9##3##(1991-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)
obtained as the##3##3##(2008-10#2)(2008-3#1)
obtained as##25##2##(1990-12#1)(1991-11#1)(1991-5#1)(1994-11#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
obtained at 0##6##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
obtained at 1##2##3##(2007-11#1)(2008-2#1)
obtained at 12##2##3##(2007-11#1)(2012-2#1)
obtained at 25 degrees C##2##5##(1990-7#1)(2008-6#1)
obtained at 30##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
obtained at 70##2##3##(2008-10#1)(2012-2#1)
obtained at a sampling rate of##2##6##(2008-10#2)
obtained at a wavelength of##2##5##(2008-3#2)
obtained at a##21##3##(1993-3#1)(1994-3#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-3#6)(2008-6#1)(2009-11#1)
obtained at different##2##3##(1992-8#1)(2008-10#1)
obtained at low##3##3##(1992-8#1)(2007-11#1)(2008-10#1)
obtained at pH 4##2##4##(2008-12#1)(2009-7#1)
obtained at pH##3##3##(1995-5#1)(2008-12#1)(2009-7#1)
obtained at the signal##2##4##(2008-10#2)
obtained at the##21##3##(1991-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-3#3)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
obtained at##119##2##(1990-7#2)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-6#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#6)(2007-12#7)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#5)(2008-6#6)(2008-7#2)(2009-11#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)
obtained because##2##2##(2007-12#1)(2008-3#1)
obtained before and after##2##4##(2013-1#2)
obtained before##5##2##(1995-2#1)(2008-11#1)(2009-10#1)(2013-1#2)
obtained between the##16##3##(1990-2#1)(1993-2#1)(2008-10#12)(2008-2#1)(2008-3#1)
obtained between##29##2##(1990-2#1)(1993-2#2)(1995-2#1)(2008-10#21)(2008-2#2)(2008-3#1)(2012-1#1)
obtained beyond##2##2##(1995-6#1)(2011-2#1)
obtained biosensor##2##2##(2008-10#2)
obtained both from##2##3##(2008-10#2)
obtained both##7##2##(1991-2#1)(1994-12#1)(2008-10#4)(2008-7#1)
obtained but##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
obtained by Fourier##3##3##(2008-10#2)(2008-2#1)
obtained by HPLC and##2##4##(1992-3#1)(2008-10#1)
obtained by HPLC##6##3##(1992-3#1)(2008-10#5)
obtained by ICP-AES and##2##4##(2008-10#2)
obtained by ICP-AES##6##3##(2008-10#6)
obtained by PCR##2##3##(1993-9#1)(2008-9#1)
obtained by Soxhlet##2##3##(2008-10#2)
obtained by X-ray fluorescence##2##4##(2008-10#1)(2013-8#1)
obtained by X-ray##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
obtained by a reference method##3##5##(2008-10#3)
obtained by a##36##3##(1991-2#1)(1993-12#1)(1995-9#1)(1996-8#1)(2008-10#19)(2008-2#3)(2008-3#4)(2008-5#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
obtained by acid##2##3##(2008-10#1)(2008-5#1)
obtained by adding##2##3##(2008-10#1)(2011-2#1)
obtained by all##2##3##(2008-10#2)
obtained by an##11##3##(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
obtained by analyzing##2##3##(2008-10#1)(2010-11#1)
obtained by application of##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
obtained by applying the##3##4##(2008-10#3)
obtained by applying##7##3##(2008-10#6)(2008-5#1)
obtained by atomic absorption spectrometry##2##5##(2008-10#2)
obtained by atomic absorption##4##4##(2008-10#4)
obtained by atomic##6##3##(2007-12#1)(2008-10#5)
obtained by both methods were compared##2##6##(1996-5#1)(2008-10#1)
obtained by both methods##4##4##(1996-5#1)(2008-10#3)
obtained by both##11##3##(1996-5#1)(2008-10#9)(2011-2#1)
obtained by collagenase##2##3##(1991-5#1)(1994-6#1)
obtained by combining##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
obtained by comparing the##2##4##(2008-10#2)
obtained by comparison of##2##4##(2007-11#1)(2008-3#1)
obtained by continuous addition of a reagent##2##7##(2008-10#2)
obtained by conventional##9##3##(1995-4#1)(2008-10#5)(2008-3#1)(2008-5#1)(2012-3#1)
obtained by detecting##2##3##(2008-2#1)(2010-8#1)
obtained by detection of##2##4##(2007-12#1)(2008-3#1)
obtained by difference##2##3##(2008-10#1)(2008-2#1)
obtained by differential##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
obtained by digestion of##2##4##(1992-6#1)(2008-10#1)
obtained by direct##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
obtained by either##2##3##(2008-10#2)
obtained by electropolymerization of##2##4##(2008-10#2)
obtained by fitting##3##3##(2008-2#1)(2008-8#1)(2009-11#1)
obtained by gas chromatography##3##4##(2008-10#3)
obtained by gas##4##3##(2008-10#3)(2012-1#1)
obtained by graphite furnace atomic absorption spectrometry##2##7##(2008-10#2)
obtained by homologous recombination##2##4##(1991-6#1)(2008-10#1)
obtained by hydrodistillation##2##3##(2012-2#1)(2012-3#1)
obtained by in vitro##2##4##(1993-11#1)(2011-1#1)
obtained by in##3##3##(1993-11#2)(2011-1#1)
obtained by increasing the##2##4##(2008-10#1)(2008-5#1)
obtained by inductively coupled plasma##3##5##(2008-10#3)
obtained by infection with##2##4##(1990-5#1)(2008-7#1)
obtained by integration of the##2##5##(2008-3#2)
obtained by manual##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
obtained by means of the##2##5##(2008-10#1)(2008-3#1)
obtained by means of##16##4##(1993-3#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-3#5)
obtained by measuring the##2##4##(2008-10#1)(2008-5#1)
obtained by measuring##4##3##(2008-10#3)(2008-5#1)
obtained by mechanical##2##3##(1993-9#1)(2008-6#1)
obtained by mixing##2##3##(1990-8#1)(2008-10#1)
obtained by modulation of the##2##5##(2008-2#1)(2008-3#1)
obtained by optimization of##2##4##(2007-12#1)(2008-10#1)
obtained by other methods##2##4##(2008-10#2)
obtained by other##8##3##(1991-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)
obtained by our##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
obtained by oxidation of##2##4##(2008-10#2)
obtained by oxidation##3##3##(1995-2#1)(2008-10#2)
obtained by reaction between##2##4##(2008-10#2)
obtained by reaction of##2##4##(1996-2#1)(2007-11#1)
obtained by reaction##4##3##(1996-2#1)(2007-11#1)(2008-10#2)
obtained by reactive blending of##2##5##(2008-10#2)
obtained by rigorous##2##3##(1990-9#1)(2008-3#1)
obtained by several groups##2##4##(2008-4#1)(2009-3#1)
obtained by several##3##3##(2008-4#1)(2008-5#1)(2009-3#1)
obtained by spectrophotometry##2##3##(2008-10#1)(2008-5#1)
obtained by standard##2##3##(2008-10#1)(2012-2#1)
obtained by stimulated##2##3##(2008-2#1)(2008-3#1)
obtained by studying##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
obtained by subtracting##2##3##(2008-8#2)
obtained by supercritical carbon dioxide##2##5##(2008-10#2)
obtained by the FIA##2##4##(2008-10#2)
obtained by the HPLC##2##4##(2008-10#2)
obtained by the application of##3##5##(2008-10#3)
obtained by the developed##3##4##(2008-10#3)
obtained by the direct##2##4##(2008-10#1)(2011-1#1)
obtained by the measurement##2##4##(2008-10#1)(2008-3#1)
obtained by the present method##3##5##(1995-3#1)(2008-10#2)
obtained by the present##5##4##(1995-3#1)(2008-10#4)
obtained by the proposed method##10##5##(2008-10#10)
obtained by the proposed##16##4##(1990-8#1)(2008-10#15)
obtained by the reference##4##4##(2008-10#4)
obtained by the standard addition method##2##6##(2008-10#2)
obtained by the standard##4##4##(2008-10#4)
obtained by the two methods##4##5##(1996-5#1)(2007-7#1)(2008-10#2)
obtained by the two##6##4##(1996-5#1)(2007-7#1)(2008-10#4)
obtained by the use of##4##5##(1997-3#1)(2008-11#1)(2008-3#2)
obtained by the##141##3##(1990-8#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#106)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
obtained by thermal cracking of waste polymers##2##7##(2008-10#2)
obtained by thermal##4##3##(2008-10#4)
obtained by these two resins##2##5##(2008-10#2)
obtained by these##3##3##(2008-10#2)(2008-3#1)
obtained by this method agreed##3##5##(2008-10#3)
obtained by this method are##2##5##(1992-4#1)(2008-10#1)
obtained by this method were in##3##6##(2008-10#2)(2008-5#1)
obtained by this method were##6##5##(2008-10#5)(2008-5#1)
obtained by this method##13##4##(1990-2#1)(1992-4#1)(2008-10#10)(2008-5#1)
obtained by this procedure##2##4##(2008-10#2)
obtained by this##23##3##(1990-2#1)(1992-4#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
obtained by total##2##3##(1995-3#1)(2008-10#1)
obtained by transmission##2##3##(2008-3#1)(2009-9#1)
obtained by treatment##2##3##(1990-9#1)(1995-11#1)
obtained by two##4##3##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
obtained by use of a##9##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)
obtained by use of an##2##5##(2007-11#1)(2007-12#1)
obtained by use of the##4##5##(2008-2#1)(2008-3#3)
obtained by use of two##2##5##(2007-11#1)(2008-3#1)
obtained by use of##30##4##(2007-11#3)(2007-12#5)(2008-2#4)(2008-3#18)
obtained by using a##10##4##(2008-10#8)(2011-1#1)(2013-1#1)
obtained by using the##14##4##(1994-9#1)(1995-12#1)(2008-10#9)(2010-4#1)(2010-7#1)(2012-1#1)
obtained by using##47##3##(1992-8#1)(1994-9#1)(1995-12#1)(2008-1#1)(2008-10#33)(2008-8#4)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#1)
obtained by##795##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#4)(1990-9#4)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#3)(1996-5#3)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-10#1)(2007-11#17)(2007-12#19)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#409)(2008-11#7)(2008-12#2)(2008-2#33)(2008-3#67)(2008-4#7)(2008-5#21)(2008-6#6)(2008-7#8)(2008-8#14)(2008-9#6)(2009-1#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#6)(2013-7#2)(2013-8#5)
obtained can be used##3##4##(2008-10#1)(2008-2#1)(2009-8#1)
obtained can be##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2009-8#1)
obtained can##7##2##(2008-10#2)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
obtained compare well##2##3##(2008-10#2)
obtained compared to##2##3##(2008-10#1)(2008-8#1)
obtained compared with##3##3##(2008-10#3)
obtained compared##7##2##(2008-10#6)(2008-8#1)
obtained could##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
obtained data##10##2##(1990-5#1)(1993-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#3)(2011-1#1)
obtained demonstrated that##3##3##(1996-12#1)(1997-7#1)(2008-5#1)
obtained directly by##2##3##(1993-3#1)(2008-8#1)
obtained directly from##2##3##(1996-2#1)(2008-3#1)
obtained directly##6##2##(1993-3#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
obtained do not##2##3##(2008-10#1)(2008-5#1)
obtained due to the##2##4##(2008-10#1)(2011-1#1)
obtained due to##3##3##(2008-10#2)(2011-1#1)
obtained during rainy##2##3##(2012-2#2)
obtained during the##7##3##(1990-7#1)(1997-3#1)(2007-11#1)(2008-2#1)(2011-1#1)(2013-1#2)
obtained during two##3##3##(2008-3#2)(2008-5#1)
obtained during##30##2##(1990-7#1)(1991-8#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#3)
obtained either##3##2##(1990-5#1)(1997-5#1)(2013-1#1)
obtained employing##3##2##(2008-10#3)
obtained even##3##2##(1995-2#1)(1997-4#1)(2008-7#1)
obtained evidence##4##2##(1990-5#1)(1991-2#1)(2008-10#1)(2012-3#1)
obtained experimental##3##2##(1997-2#1)(2008-2#1)(2011-2#1)
obtained experimentally##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-4#1)
obtained following##6##2##(1993-11#1)(2007-11#2)(2008-10#1)(2013-1#1)(2013-7#1)
obtained for As##2##3##(2008-10#2)
obtained for Cu and##2##4##(2008-10#2)
obtained for Cu##3##3##(2008-10#3)
obtained for a##18##3##(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-2#1)(2008-3#3)
obtained for all elements##3##4##(2008-10#1)(2011-2#2)
obtained for all the compounds##2##5##(2008-10#1)(2008-7#1)
obtained for all the##7##4##(2008-10#6)(2008-7#1)
obtained for all##15##3##(1992-10#1)(2008-10#11)(2008-7#1)(2011-2#2)
obtained for an##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2010-3#1)
obtained for bismuth##2##3##(2008-10#2)
obtained for both the##2##4##(2008-10#1)(2008-3#1)
obtained for both##11##3##(2008-10#8)(2008-2#1)(2008-3#1)(2012-12#1)
obtained for commercial##3##3##(2008-10#3)
obtained for determination of##2##4##(2008-10#2)
obtained for different amounts of cadmium##2##6##(2008-10#2)
obtained for different##5##3##(2008-10#4)(2008-3#1)
obtained for each sample##2##4##(2008-10#1)(2008-12#1)
obtained for each##16##3##(1996-1#1)(2008-10#9)(2008-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
obtained for five##2##3##(2008-10#2)
obtained for low##2##3##(2008-10#1)(2008-7#1)
obtained for most##3##3##(2008-10#3)
obtained for nine##3##3##(2008-10#3)
obtained for several##2##3##(2008-10#1)(2008-3#1)
obtained for simultaneous##2##3##(2008-10#2)
obtained for the analysis of##2##5##(2008-10#1)(2008-12#1)
obtained for the determination of##10##5##(2008-10#10)
obtained for the enzyme from##2##5##(1992-12#1)(1994-11#1)
obtained for the enzyme##3##4##(1992-12#1)(1993-8#1)(1994-11#1)
obtained for the first time##3##5##(2007-12#1)(2008-10#1)(2013-1#1)
obtained for the membrane##2##4##(2008-10#2)
obtained for the same##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
obtained for the##86##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-11#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#53)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
obtained for these##5##3##(2008-10#5)
obtained for this##6##3##(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
obtained for total##2##3##(2008-10#2)
obtained for untreated##3##3##(1995-8#2)(2008-5#1)
obtained for vanadium##2##3##(2008-10#2)
obtained for young##2##3##(1995-2#1)(2010-3#1)
obtained for##373##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#241)(2008-11#6)(2008-12#4)(2008-2#12)(2008-3#26)(2008-4#1)(2008-5#4)(2008-7#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)
obtained four##2##2##(2008-10#1)(2008-9#1)
obtained free##2##2##(2008-10#2)
obtained from 0##6##3##(2008-10#6)
obtained from 10##6##3##(2006-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)
obtained from 12##2##3##(2008-5#1)(2010-4#1)
obtained from 46##2##3##(1990-2#1)(1997-3#1)
obtained from 49##2##3##(2008-1#1)(2008-10#1)
obtained from 55##2##3##(1995-12#1)(2008-1#1)
obtained from a Nd##2##4##(2008-2#2)
obtained from a commercial##2##4##(2008-10#2)
obtained from a human##2##4##(1994-11#1)(1994-8#1)
obtained from a previous##2##4##(1991-2#2)
obtained from a single##5##4##(1994-8#1)(2007-11#1)(2008-10#2)(2008-3#1)
obtained from a synthetic phage display##2##6##(2008-10#2)
obtained from a total##2##4##(1994-12#1)(2008-10#1)
obtained from a##66##3##(1990-12#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1996-12#2)(1997-7#1)(2007-11#7)(2007-12#1)(2008-1#2)(2008-10#16)(2008-12#3)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
obtained from all##2##3##(1995-5#1)(2012-12#1)
obtained from an##13##3##(1992-12#1)(1993-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)
obtained from both methods##2##4##(2008-10#2)
obtained from both##10##3##(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
obtained from bovine##2##3##(2008-11#1)(2013-1#1)
obtained from commercial##2##3##(2008-10#1)(2013-7#1)
obtained from conventional##2##3##(2008-10#1)(2008-3#1)
obtained from different places##2##4##(2008-10#2)
obtained from different##8##3##(1996-11#1)(2008-10#5)(2008-11#1)(2008-5#1)
obtained from diseased leaves##2##4##(2008-10#2)
obtained from diseased##4##3##(2008-10#4)
obtained from dye##2##3##(1992-6#1)(2008-3#1)
obtained from each##2##3##(2008-5#1)(2009-6#1)
obtained from experiments##3##3##(2008-10#2)(2008-2#1)
obtained from healthy##2##3##(2008-10#2)
obtained from human##4##3##(1990-12#1)(1990-8#1)(1996-10#1)(2011-3#1)
obtained from in vivo##3##4##(2008-10#2)(2008-11#1)
obtained from in##4##3##(2008-10#3)(2008-11#1)
obtained from linear##2##3##(2008-10#1)(2011-1#1)
obtained from measurements in##2##4##(2008-10#1)(2008-2#1)
obtained from measurements##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
obtained from multiple sources including##2##5##(2008-8#1)(2009-11#1)
obtained from multiple sources##3##4##(2008-8#1)(2009-11#1)(2011-2#1)
obtained from multiple##4##3##(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)
obtained from normal##3##3##(1997-1#1)(1997-7#1)(2008-2#1)
obtained from numerical##2##3##(2007-11#1)(2008-3#1)
obtained from other hosts##2##4##(2008-10#2)
obtained from other##8##3##(2008-10#3)(2008-4#2)(2008-5#2)(2008-7#1)
obtained from our##2##3##(1996-4#1)(2008-8#1)
obtained from patients who##2##4##(1993-9#1)(2009-11#1)
obtained from patients##5##3##(1993-9#1)(1995-12#1)(2008-7#1)(2009-11#1)(2013-8#1)
obtained from plant##2##3##(2008-10#2)
obtained from rabbits##2##3##(1991-2#1)(1995-11#1)
obtained from rat##2##3##(1993-12#1)(2008-2#1)
obtained from samples##2##3##(2008-10#2)
obtained from soil samples fortified at##2##6##(2008-10#2)
obtained from soil##3##3##(2008-10#3)
obtained from soils##2##3##(2008-10#2)
obtained from spectral##2##3##(2007-11#1)(2008-2#1)
obtained from standard##2##3##(2008-11#1)(2008-9#1)
obtained from such##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
obtained from the Spanish market##2##5##(2008-10#2)
obtained from the absorption##2##4##(2008-2#1)(2008-3#1)
obtained from the analysis of##2##5##(2008-10#2)
obtained from the experimental##2##4##(2008-10#2)
obtained from the first##2##4##(1990-5#1)(2007-8#1)
obtained from the in##2##4##(2008-11#1)(2008-5#1)
obtained from the reaction of##2##5##(2008-10#1)(2013-1#1)
obtained from the reaction##3##4##(1990-5#1)(2008-10#1)(2013-1#1)
obtained from the regression##3##4##(2007-11#1)(2012-7#1)(2013-8#1)
obtained from the same##3##4##(1992-3#1)(2008-3#2)
obtained from the##148##3##(1990-5#3)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#43)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#12)(2008-5#4)(2008-6#4)(2008-7#1)(2008-9#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#3)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#3)
obtained from their##2##3##(2009-12#1)(2010-8#1)
obtained from these##8##3##(1993-11#1)(1997-2#1)(2008-10#2)(2008-4#2)(2013-1#1)(2013-8#1)
obtained from this study show that##2##6##(2010-8#1)(2011-1#1)
obtained from this study##3##4##(2008-10#1)(2010-8#1)(2011-1#1)
obtained from this##12##3##(1994-2#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2010-8#1)(2011-1#1)(2013-7#1)
obtained from three##4##3##(1990-12#1)(1990-8#1)(2008-5#1)(2012-2#1)
obtained from total##2##3##(1995-3#1)(2008-10#1)
obtained from two##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
obtained from using the##2##4##(2008-10#2)
obtained from using##3##3##(2008-10#2)(2008-3#1)
obtained from various##3##3##(1992-3#1)(2007-7#1)(2008-10#1)
obtained from##707##2##(1990-12#5)(1990-2#3)(1990-5#3)(1990-8#6)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#23)(2007-12#14)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#8)(2008-10#220)(2008-11#23)(2008-12#12)(2008-2#36)(2008-3#41)(2008-4#10)(2008-5#17)(2008-6#13)(2008-7#16)(2008-8#5)(2008-9#9)(2009-11#2)(2009-12#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#3)(2012-7#2)(2013-1#16)(2013-7#4)(2013-8#8)
obtained further##3##2##(2008-10#2)(2008-2#1)
obtained have been##2##3##(1996-11#1)(2008-10#1)
obtained have##4##2##(1993-8#1)(1996-11#1)(2008-10#2)
obtained here##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
obtained highly##2##2##(2008-10#1)(2011-2#1)
obtained if the##3##3##(2008-10#2)(2008-3#1)
obtained if##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
obtained immediately##2##2##(2008-12#1)(2013-1#1)
obtained in 0##3##3##(2008-10#3)
obtained in 20##4##3##(1990-6#1)(1996-5#1)(2008-9#2)
obtained in a classical##2##4##(2008-11#2)
obtained in a few##2##4##(1996-5#1)(2008-4#1)
obtained in a group of##2##5##(2013-1#2)
obtained in a laboratory##2##4##(2008-3#1)(2008-6#1)
obtained in a##33##3##(1990-11#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2013-1#2)
obtained in all cases##4##4##(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)
obtained in all##7##3##(1993-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)
obtained in an##2##3##(2008-10#1)(2011-2#1)
obtained in aqueous solution##2##4##(1990-5#1)(2008-10#1)
obtained in both##5##3##(2008-10#5)
obtained in excellent##2##3##(2008-5#1)(2011-1#1)
obtained in experiments##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
obtained in good yields##3##4##(2007-11#1)(2008-5#1)(2013-7#1)
obtained in good##4##3##(2007-11#2)(2008-5#1)(2013-7#1)
obtained in less than##2##4##(2008-10#1)(2011-1#1)
obtained in normal subjects##2##4##(1994-3#1)(2012-3#1)
obtained in only 0##2##4##(2008-10#2)
obtained in other##2##3##(2008-12#1)(2008-8#1)
obtained in our##3##3##(1993-8#1)(1994-2#1)(2008-3#1)
obtained in preoperative##2##3##(2008-7#1)(2011-2#1)
obtained in several##3##3##(1990-5#1)(2007-12#1)(2008-10#1)
obtained in terms of##2##4##(1991-6#1)(2008-2#1)
obtained in the absence of##3##5##(2008-10#2)(2013-1#1)
obtained in the analysis of##5##5##(2008-10#5)
obtained in the concentration range##9##5##(1996-5#1)(2008-10#7)(2010-5#1)
obtained in the concentration##10##4##(1996-5#1)(2008-10#8)(2010-5#1)
obtained in the determination of##4##5##(2008-10#4)
obtained in the laboratory##2##4##(2007-5#1)(2008-2#1)
obtained in the presence of##4##5##(1992-9#1)(1997-2#1)(2008-10#2)
obtained in the range 0##2##5##(2008-10#2)
obtained in the range of##5##5##(1990-8#1)(2008-10#3)(2008-12#1)
obtained in the range##11##4##(1990-8#1)(2008-10#9)(2008-12#1)
obtained in the same conditions##2##5##(2008-10#2)
obtained in the same##3##4##(2008-10#3)
obtained in the##106##3##(1990-8#1)(1991-6#1)(1992-9#2)(1993-12#1)(1993-6#1)(1995-12#1)(1996-5#3)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#56)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
obtained in these studies##2##4##(2008-5#1)(2013-8#1)
obtained in these##4##3##(2007-11#1)(2008-5#1)(2009-5#1)(2013-8#1)
obtained in this study##8##4##(1993-6#1)(2006-6#1)(2008-10#3)(2008-11#1)(2009-12#1)(2011-2#1)
obtained in this system##2##4##(2007-11#1)(2008-11#1)
obtained in this work##4##4##(2008-10#4)
obtained in this##25##3##(1990-3#1)(1992-2#1)(1993-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#2)
obtained in vitro with##2##4##(1995-2#1)(2008-5#1)
obtained in vitro##4##3##(1995-2#1)(1996-12#1)(2008-3#1)(2008-5#1)
obtained in vivo##4##3##(1990-8#1)(1993-9#1)(2007-12#1)(2008-5#1)
obtained in water##2##3##(1992-12#1)(2008-10#1)
obtained in##379##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#3)(1991-12#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#5)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-6#1)(2007-11#8)(2007-12#10)(2007-5#1)(2007-8#6)(2008-1#1)(2008-10#126)(2008-11#19)(2008-12#4)(2008-2#14)(2008-3#13)(2008-4#2)(2008-5#25)(2008-6#5)(2008-7#10)(2008-8#3)(2008-9#5)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#6)
obtained indicate that the##5##4##(2008-10#3)(2008-5#1)(2012-2#1)
obtained indicate that##12##3##(1991-9#1)(1992-8#1)(2007-11#1)(2008-10#6)(2008-5#2)(2012-2#1)
obtained indicate##16##2##(1991-9#1)(1992-8#1)(1995-9#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2012-2#1)
obtained indicated##5##2##(1991-5#1)(2008-10#4)
obtained indicating that##2##3##(1996-5#1)(2008-10#1)
obtained is in##2##3##(2008-3#1)(2008-6#1)
obtained is##12##2##(1992-9#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-12#1)
obtained more than##2##3##(2007-12#1)(2008-10#1)
obtained more##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
obtained numerically##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
obtained of##2##2##(1996-9#1)(2008-10#1)
obtained on a##4##3##(1993-9#1)(2008-10#2)(2008-5#1)
obtained on all##3##3##(2007-10#1)(2008-9#1)(2012-2#1)
obtained on days##3##3##(1990-11#1)(1995-12#2)
obtained on the##11##3##(1995-3#1)(2007-10#1)(2008-10#5)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
obtained on##51##2##(1990-11#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-10#3)(2007-12#1)(2008-10#16)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
obtained only by##3##3##(1994-12#1)(2008-8#1)(2009-3#1)
obtained only if##2##3##(2008-10#2)
obtained only in##3##3##(1995-2#1)(1997-7#1)(2011-2#1)
obtained only##15##2##(1991-6#2)(1992-9#1)(1994-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)
obtained over a##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
obtained over the concentration##2##4##(2008-10#2)
obtained over the range##5##4##(2008-10#5)
obtained over the##12##3##(2008-10#11)(2008-3#1)
obtained over##22##2##(2007-11#1)(2007-12#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-4#1)
obtained peak##2##2##(2008-10#1)(2008-2#1)
obtained per##4##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
obtained previously for##2##3##(1992-3#1)(1995-2#1)
obtained previously with##2##3##(1992-9#1)(1993-11#1)
obtained previously##7##2##(1992-3#1)(1992-9#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-3#2)
obtained prior to##2##3##(2008-5#1)(2011-2#1)
obtained proved##2##2##(2008-10#2)
obtained provided that##2##3##(1990-7#1)(2008-10#1)
obtained provided##3##2##(1990-7#1)(2008-10#2)
obtained ranged from##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
obtained respectively##3##2##(1993-8#1)(1996-12#1)(1997-3#1)
obtained results and##3##3##(1997-4#1)(2008-10#2)
obtained results of##2##3##(2008-10#1)(2011-1#1)
obtained results was##2##3##(2008-10#2)
obtained results were in##2##4##(2008-10#1)(2008-3#1)
obtained results were##13##3##(2008-10#9)(2008-12#2)(2008-3#1)(2008-7#1)
obtained results with##2##3##(2008-10#1)(2011-1#1)
obtained results##64##2##(1990-9#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-12#3)(2008-3#2)(2008-5#4)(2008-7#1)(2009-10#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
obtained revealed that##2##3##(2008-10#1)(2008-12#1)
obtained revealed##4##2##(2008-10#3)(2008-12#1)
obtained show that there##2##4##(2008-10#1)(2012-2#1)
obtained show that##10##3##(1990-8#1)(1991-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2012-2#1)
obtained show the##2##3##(2008-5#1)(2013-1#1)
obtained show##14##2##(1990-8#1)(1991-12#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-5#2)(2012-2#1)(2013-1#1)
obtained showed better##2##3##(2008-10#2)
obtained showed that the##2##4##(2008-5#1)(2013-7#1)
obtained showed that##5##3##(1993-3#1)(2008-10#2)(2008-5#1)(2013-7#1)
obtained showed##10##2##(1993-3#1)(2008-10#7)(2008-5#1)(2013-7#1)
obtained simultaneously from##2##3##(1991-12#1)(1996-2#1)
obtained simultaneously##6##2##(1991-12#1)(1996-2#1)(2008-2#2)(2008-3#1)(2008-9#1)
obtained solution##3##2##(2007-11#1)(2008-10#2)
obtained suggest##5##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-5#1)
obtained that##14##2##(1990-11#1)(1992-11#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2011-1#1)
obtained the##13##2##(1992-11#1)(1993-8#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-9#2)(2012-1#1)
obtained three##3##2##(2008-11#1)(2008-8#1)(2009-3#1)
obtained through a##11##3##(1990-9#1)(1994-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)
obtained through the##12##3##(1990-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2013-1#2)
obtained through this##2##3##(2008-7#1)(2011-10#1)
obtained through##51##2##(1990-10#1)(1990-8#1)(1990-9#1)(1992-4#1)(1992-9#1)(1994-12#1)(1995-12#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#5)(2009-3#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
obtained to date##3##3##(1991-2#1)(1993-8#1)(2008-7#1)
obtained to describe the##2##4##(2007-11#2)
obtained to determine##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
obtained to the##2##3##(2008-10#1)(2010-5#1)
obtained to##22##2##(1991-2#1)(1992-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
obtained together with##2##3##(2008-10#2)
obtained two##2##2##(1995-6#1)(1997-7#1)
obtained under the optimized##2##4##(2008-10#2)
obtained under the same experimental##2##5##(2008-10#1)(2008-3#1)
obtained under the same##3##4##(2008-10#2)(2008-3#1)
obtained under the##10##3##(2008-10#8)(2008-3#2)
obtained under##24##2##(2007-11#2)(2008-10#13)(2008-2#1)(2008-3#3)(2008-6#1)(2009-6#1)(2009-9#2)(2011-2#1)
obtained up to##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
obtained upon sonication were##2##4##(2008-10#2)
obtained upon##4##2##(2008-10#3)(2009-6#1)
obtained using Mg2+##2##3##(1995-6#2)
obtained using a##25##3##(1990-8#2)(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#16)(2008-2#1)(2008-5#2)(2009-10#1)
obtained using an##4##3##(1992-3#1)(2008-10#1)(2010-11#1)(2012-2#1)
obtained using atomic absorption spectrometry##3##5##(2008-10#3)
obtained using chemical##2##3##(2008-10#2)
obtained using only##2##3##(2008-10#2)
obtained using solid-phase##2##3##(2008-10#1)(2013-8#1)
obtained using the standard##2##4##(2008-10#2)
obtained using the##38##3##(1990-8#1)(1997-4#1)(2006-6#1)(2008-10#25)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
obtained using##156##2##(1990-5#1)(1990-8#3)(1992-3#1)(1992-6#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#91)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
obtained values of##2##3##(2008-10#1)(2008-7#1)
obtained values##3##2##(2008-10#2)(2008-7#1)
obtained via##4##2##(2008-10#3)(2008-6#1)
obtained was of##2##3##(2007-11#1)(2008-10#1)
obtained was##23##2##(1990-8#1)(1991-5#1)(1992-12#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-5#1)
obtained were 0##3##3##(1995-6#1)(2008-10#2)
obtained were compared with the##5##5##(2008-10#3)(2008-5#1)(2012-3#1)
obtained were compared with##8##4##(2008-10#6)(2008-5#1)(2012-3#1)
obtained were compared##11##3##(2008-10#7)(2008-4#1)(2008-5#1)(2010-4#1)(2012-3#1)
obtained were in good agreement with the certified values##2##9##(2008-10#2)
obtained were in##6##3##(2008-10#6)
obtained were used to##3##4##(2007-11#1)(2008-10#1)(2010-5#1)
obtained were used##4##3##(2007-11#2)(2008-10#1)(2010-5#1)
obtained were##67##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1995-6#1)(2007-11#3)(2008-10#41)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2010-4#1)(2010-5#3)(2010-6#1)(2012-3#1)(2013-7#2)
obtained when a##6##3##(2007-11#2)(2008-10#1)(2008-3#2)(2008-4#1)
obtained when the##25##3##(1995-5#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#2)(2013-7#1)
obtained when using the##2##4##(2008-10#1)(2008-12#1)
obtained when using##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
obtained when##61##2##(1991-2#1)(1995-5#1)(1995-6#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#6)(2011-2#1)(2013-7#1)(2013-8#1)
obtained which##5##2##(1992-5#1)(2008-10#2)(2008-9#1)(2012-12#1)
obtained with 0##2##3##(2007-12#1)(2008-10#1)
obtained with 1##2##3##(1993-8#1)(2011-2#1)
obtained with a commercial##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
obtained with a commercially available##2##5##(2008-10#1)(2008-2#1)
obtained with a resolution of##2##5##(2008-2#2)
obtained with a simple##2##4##(2008-2#1)(2008-5#1)
obtained with a##87##3##(1991-4#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1997-8#1)(2007-11#3)(2007-12#11)(2008-10#27)(2008-11#4)(2008-2#11)(2008-3#16)(2008-5#3)(2008-6#1)(2008-7#2)(2009-9#1)(2011-2#1)
obtained with an##11##3##(1993-5#1)(1996-5#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#2)
obtained with and without##2##4##(2008-10#1)(2012-2#1)
obtained with as##2##3##(2007-11#1)(2013-8#1)
obtained with both methods##2##4##(1990-12#1)(1990-8#1)
obtained with both##8##3##(1990-12#1)(1990-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2013-1#1)
obtained with classical##2##3##(2007-12#1)(2008-10#1)
obtained with conventional##6##3##(1996-8#1)(2007-12#1)(2008-10#3)(2008-3#1)
obtained with detection##2##3##(2008-10#2)
obtained with different##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
obtained with either##2##3##(1990-11#1)(2012-2#1)
obtained with high##2##3##(2008-11#1)(2012-2#1)
obtained with individual##2##3##(2008-10#1)(2013-1#1)
obtained with natural##2##3##(2008-10#2)
obtained with no##2##3##(1996-5#1)(2008-10#1)
obtained with other methods##2##4##(2008-11#1)(2008-2#1)
obtained with other##6##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
obtained with probes##2##3##(1996-12#1)(2008-10#1)
obtained with respect to##2##4##(2008-10#1)(2012-7#1)
obtained with strain##3##3##(2008-10#2)(2008-3#1)
obtained with the QA-810 V##2##5##(2008-10#2)
obtained with the classical##2##4##(2008-10#2)
obtained with the conventional##4##4##(1995-3#1)(2007-12#1)(2008-10#2)
obtained with the different##2##4##(1990-10#1)(2012-1#1)
obtained with the new##3##4##(2008-2#2)(2008-3#1)
obtained with the same##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
obtained with the single##2##4##(2008-8#1)(2011-2#1)
obtained with the two##5##4##(2008-10#3)(2008-5#2)
obtained with the use of##5##5##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
obtained with the##110##3##(1990-10#1)(1990-12#1)(1992-5#1)(1995-3#1)(1995-8#1)(1997-3#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#56)(2008-11#6)(2008-2#12)(2008-3#11)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#1)
obtained with these two##2##4##(2008-10#1)(2008-3#1)
obtained with these##6##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
obtained with this method##4##4##(1997-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
obtained with this system##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
obtained with this technique##4##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
obtained with this##22##3##(1990-3#1)(1996-5#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)
obtained with those##2##3##(2008-10#2)
obtained with three##2##3##(2008-10#1)(2008-2#1)
obtained with traditional##2##3##(2008-3#1)(2009-5#1)
obtained with two##2##3##(1992-6#1)(2008-5#1)
obtained with use of##2##4##(2008-10#1)(2008-2#1)
obtained with##455##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#4)(1991-12#1)(1991-4#1)(1991-6#3)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#6)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-10#3)(2007-11#12)(2007-12#25)(2007-8#4)(2008-10#172)(2008-11#22)(2008-12#2)(2008-2#37)(2008-3#54)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#1)(2009-3#2)(2009-5#2)(2009-9#2)(2010-12#1)(2010-3#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#2)
obtained within a##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
obtained within the##2##3##(1991-2#1)(2007-12#1)
obtained within##14##2##(1991-2#1)(1992-12#1)(1994-9#1)(2007-12#2)(2008-10#7)(2008-4#2)
obtained without any##2##3##(2007-12#1)(2008-6#1)
obtained without the##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
obtained without##13##2##(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-3#1)
obtained##4833##1##(1990-10#4)(1990-11#10)(1990-12#13)(1990-2#11)(1990-3#5)(1990-5#17)(1990-6#8)(1990-7#11)(1990-8#26)(1990-9#6)(1991-1#1)(1991-11#2)(1991-12#15)(1991-2#16)(1991-3#3)(1991-4#1)(1991-5#10)(1991-6#13)(1991-8#8)(1991-9#10)(1992-10#3)(1992-11#7)(1992-12#15)(1992-2#5)(1992-3#19)(1992-4#2)(1992-5#8)(1992-6#12)(1992-8#17)(1992-9#12)(1993-1#1)(1993-11#15)(1993-12#9)(1993-2#8)(1993-3#12)(1993-5#1)(1993-6#11)(1993-8#15)(1993-9#7)(1994-1#2)(1994-11#14)(1994-12#13)(1994-2#4)(1994-3#14)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#10)(1994-9#8)(1995-1#1)(1995-11#13)(1995-12#23)(1995-2#17)(1995-3#13)(1995-4#2)(1995-5#10)(1995-6#14)(1995-8#7)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#13)(1996-2#12)(1996-3#3)(1996-4#1)(1996-5#27)(1996-6#3)(1996-7#1)(1996-8#6)(1996-9#5)(1997-1#2)(1997-2#12)(1997-3#12)(1997-4#15)(1997-5#5)(1997-6#7)(1997-7#20)(1997-8#13)(2006-12#3)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#20)(2007-11#144)(2007-12#154)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#20)(2008-1#21)(2008-10#1999)(2008-11#124)(2008-12#48)(2008-2#238)(2008-3#365)(2008-4#45)(2008-5#151)(2008-6#59)(2008-7#78)(2008-8#58)(2008-9#48)(2009-1#1)(2009-10#3)(2009-11#7)(2009-12#7)(2009-3#13)(2009-4#5)(2009-5#6)(2009-6#6)(2009-7#9)(2009-8#6)(2009-9#7)(2010-10#1)(2010-11#6)(2010-12#9)(2010-2#1)(2010-3#9)(2010-4#19)(2010-5#17)(2010-6#7)(2010-7#5)(2010-8#19)(2010-9#5)(2011-1#39)(2011-10#1)(2011-2#80)(2011-3#5)(2012-1#16)(2012-12#18)(2012-2#43)(2012-3#23)(2012-4#1)(2012-5#1)(2012-7#4)(2012-8#2)(2013-1#71)(2013-7#16)(2013-8#38)
obtaining a fellowship##2##3##(2011-2#2)
obtaining a full-length##2##3##(2008-10#1)(2008-9#1)
obtaining a##35##2##(1993-3#2)(1994-12#1)(1995-12#2)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2011-2#3)(2013-8#1)
obtaining accurate##4##2##(2008-10#2)(2010-7#1)(2013-1#1)
obtaining adequate##2##2##(2008-10#1)(2008-9#1)
obtaining an##10##2##(1992-2#1)(1993-3#1)(2008-10#2)(2008-12#1)(2008-7#3)(2011-2#1)(2012-5#1)
obtaining and##2##2##(1995-3#1)(2012-3#1)
obtaining better##3##2##(1995-2#1)(2008-6#1)(2009-6#1)
obtaining blood##2##2##(1990-12#1)(1990-8#1)
obtaining fresh##2##2##(2008-10#2)
obtaining high-performance##2##2##(2008-3#2)
obtaining information##3##2##(1990-2#1)(2008-10#1)(2010-10#1)
obtaining large numbers of##3##4##(2008-4#3)
obtaining more##2##2##(2008-10#1)(2008-3#1)
obtaining new##2##2##(2008-10#1)(2011-3#1)
obtaining of##2##2##(2007-8#1)(2008-10#1)
obtaining positive##3##2##(1992-12#1)(2010-6#2)
obtaining quantitative##2##2##(2008-3#1)(2008-4#1)
obtaining real-time##2##2##(2008-11#1)(2008-3#1)
obtaining reproducible##2##2##(2008-9#2)
obtaining stable##2##2##(2008-2#1)(2012-2#1)
obtaining sufficient##2##2##(2008-10#1)(2008-9#1)
obtaining the analytical##2##3##(2008-10#2)
obtaining the diagnosis##2##3##(2012-2#1)(2013-8#1)
obtaining the necessary##2##3##(1996-12#1)(2011-2#1)
obtaining the##29##2##(1994-12#1)(1996-12#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#7)(2008-4#2)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
obtaining useful##3##2##(1990-12#1)(2008-10#1)(2008-12#1)
obtaining##220##1##(1990-12#3)(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#3)(1994-11#2)(1994-12#3)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#3)(2008-12#3)(2008-2#14)(2008-3#21)(2008-4#13)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#3)(2013-8#2)
obtains##10##1##(1996-3#1)(1997-3#3)(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#1)(2011-1#1)
obtenus##2##1##(2008-5#1)(2013-1#1)
obturation##4##1##(1991-3#1)(2008-2#1)(2011-1#1)(2013-1#1)
obtuse##2##1##(2008-3#1)(2013-1#1)
obtusifolia##6##1##(2008-10#6)
obtusifoliol##4##1##(1992-3#4)
obviate the need for##5##4##(1991-11#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)
obviate the##7##2##(1991-11#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2011-2#1)
obviate##9##1##(1991-11#1)(1991-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
obviated##3##1##(2007-10#1)(2008-4#1)(2008-8#1)
obviates the need for##5##4##(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)
obviates the need to##3##4##(1996-11#1)(1997-4#1)(2008-9#1)
obviates the need##8##3##(1996-1#1)(1996-11#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
obviates the use of##2##4##(2007-4#1)(2008-4#1)
obviates the##10##2##(1996-1#1)(1996-11#1)(1997-4#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
obviates##11##1##(1990-2#1)(1996-1#1)(1996-11#1)(1997-4#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
obviating the need for##3##4##(1991-5#1)(2008-5#1)(2013-1#1)
obviating the##4##2##(1991-5#1)(1993-12#1)(2008-5#1)(2013-1#1)
obvious bands##2##2##(2008-4#1)(2008-8#1)
obvious cause for##2##3##(1991-8#1)(2007-10#1)
obvious change##2##2##(2008-11#1)(2013-8#1)
obvious changes in##2##3##(2008-9#2)
obvious changes##4##2##(2008-10#1)(2008-9#3)
obvious clinical##2##2##(2008-7#1)(2013-1#1)
obvious correlation##2##2##(2008-10#1)(2008-3#1)
obvious difference in##2##3##(1995-3#1)(2008-9#1)
obvious difference##7##2##(1995-3#1)(2008-11#1)(2008-8#1)(2008-9#2)(2012-2#2)
obvious differences##3##2##(1995-5#1)(2008-11#1)(2008-7#1)
obvious ethnic##2##2##(2008-5#1)(2008-8#1)
obvious external##2##2##(2008-7#1)(2008-9#1)
obvious in##3##2##(1990-7#1)(1995-8#1)(2008-7#1)
obvious symptoms##2##2##(2008-10#2)
obvious that##6##2##(1994-12#1)(2007-12#1)(2008-5#2)(2010-12#1)(2013-7#1)
obvious when##2##2##(2008-10#1)(2008-11#1)
obvious##126##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#2)(2008-10#19)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#10)(2009-1#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
obviously higher##2##2##(2008-5#1)(2013-1#1)
obviously inhibited##2##2##(1994-12#1)(2010-1#1)
obviously weaker##2##2##(2008-11#1)(2008-9#1)
obviously##53##1##(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-4#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#9)(2009-12#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
occasion of the##3##3##(1994-3#1)(1997-2#1)(1997-3#1)
occasion of##11##2##(1990-8#1)(1992-5#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
occasion to##2##2##(1995-1#1)(2008-5#1)
occasion##28##1##(1990-8#2)(1991-6#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2011-1#1)(2013-1#2)
occasional##41##1##(1990-12#2)(1992-11#1)(1993-1#1)(1993-11#2)(1994-3#2)(1994-6#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#4)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#2)
occasionally and##2##2##(1994-5#1)(2008-9#1)
occasionally cause##2##2##(1994-9#1)(2011-2#1)
occasionally in##3##2##(1996-5#2)(2008-10#1)
occasionally observed in the##2##4##(1995-12#1)(1996-5#1)
occasionally observed##4##2##(1995-12#1)(1996-5#1)(2008-10#1)(2008-2#1)
occasionally surgical##2##2##(2013-1#2)
occasionally the##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
occasionally with##2##2##(2007-7#1)(2011-2#1)
occasionally##85##1##(1991-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#3)(1997-2#1)(1997-3#2)(2007-12#1)(2007-7#2)(2008-10#12)(2008-11#4)(2008-2#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#5)(2010-8#1)(2010-9#1)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
occasions during##2##2##(2007-10#1)(2007-12#1)
occasions from##2##2##(2008-10#1)(2011-1#1)
occasions in##2##2##(1993-12#1)(2008-12#1)
occasions the testis was##2##4##(2011-2#2)
occasions with##3##2##(1993-1#1)(1997-4#1)(2006-6#1)
occasions##36##1##(1990-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-5#2)(1997-4#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#2)
occidentale)##4##1##(1992-2#1)(2008-10#1)(2012-2#2)
occidentalis and##4##2##(2008-10#2)(2008-8#2)
occidentalis##24##1##(1995-11#1)(2008-10#14)(2008-5#3)(2008-8#5)(2011-2#1)
occidentalis) was##2##2##(2008-10#2)
occidentalis)##3##1##(2008-10#2)(2009-8#1)
occipital and parietal##2##3##(2007-10#1)(2008-7#1)
occipital and##4##2##(1991-12#1)(2007-10#1)(2007-8#1)(2008-7#1)
occipital bone##3##2##(2007-7#1)(2008-7#1)(2011-2#1)
occipital condyle##5##2##(2008-7#1)(2013-1#4)
occipital condyles##3##2##(2013-1#3)
occipital cortex##4##2##(1994-3#1)(1995-12#1)(1997-2#1)(2008-7#1)
occipital craniotomy##2##2##(2008-7#1)(2011-2#1)
occipital lobe##4##2##(1996-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
occipital lobes##2##2##(1990-8#1)(2008-7#1)
occipital##53##1##(1990-8#1)(1991-12#2)(1992-2#1)(1992-8#2)(1993-12#1)(1994-3#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#2)(1997-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#16)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#3)(2013-1#7)(2013-8#1)
occipitocervical fusion##3##2##(2008-12#1)(2012-3#2)
occipitocervical##5##1##(2008-12#1)(2012-3#4)
occiput to C2##3##3##(2012-3#3)
occlude##6##1##(1997-3#1)(2006-12#1)(2008-6#1)(2008-7#2)(2010-5#1)
occluded CVCs##2##2##(2008-7#2)
occluded and##2##2##(1995-12#1)(2013-1#1)
occluded by a##2##3##(2007-8#1)(2008-2#1)
occluded with wax##2##3##(2008-10#2)
occluded with##4##2##(2006-12#1)(2008-10#2)(2008-4#1)
occluded##40##1##(1990-12#1)(1990-3#2)(1991-3#2)(1991-6#1)(1995-12#1)(1995-2#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-8#2)(2006-12#1)(2007-8#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#4)
occluder##4##1##(1996-6#1)(1997-8#1)(2009-10#1)(2013-1#1)
occluding the##3##2##(2006-12#1)(2007-7#1)(2007-8#1)
occluding##11##1##(1991-12#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2009-11#2)(2010-2#1)(2011-1#1)
occlusal scheme##2##2##(2009-8#1)(2013-1#1)
occlusal splint##2##2##(2010-6#2)
occlusal splints##2##2##(2010-6#2)
occlusal##21##1##(1993-1#1)(2007-12#1)(2008-7#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-6#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
occlusion and the##5##3##(1996-6#1)(2008-11#1)(2010-9#1)(2011-2#2)
occlusion and##16##2##(1990-8#1)(1991-5#1)(1992-6#1)(1992-9#1)(1996-6#1)(2007-10#1)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#5)(2013-1#2)
occlusion are##2##2##(2008-7#1)(2008-9#1)
occlusion by##5##2##(2007-10#2)(2008-10#1)(2009-1#1)(2009-2#1)
occlusion due to##3##3##(1990-3#1)(1993-9#1)(2007-10#1)
occlusion following the##2##3##(2007-10#1)(2013-1#1)
occlusion following##3##2##(2007-10#1)(2008-7#1)(2013-1#1)
occlusion has been##2##3##(1991-11#1)(2008-11#1)
occlusion in the##3##3##(2011-1#1)(2011-2#1)(2013-7#1)
occlusion in##15##2##(1990-5#1)(1995-12#2)(1997-3#5)(2008-4#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
occlusion is a##2##3##(2008-10#1)(2008-8#1)
occlusion is##6##2##(1990-6#1)(1991-12#1)(1994-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
occlusion of a##5##3##(1997-6#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-7#1)
occlusion of the common carotid artery##2##6##(2008-7#1)(2009-12#1)
occlusion of the internal carotid artery##2##6##(2008-7#2)
occlusion of the left atrial appendage##2##6##(2007-8#1)(2010-12#1)
occlusion of the left##6##4##(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-3#1)
occlusion of the lumen##2##4##(2008-3#1)(2010-4#1)
occlusion of the middle cerebral artery##4##6##(2007-10#3)(2008-4#1)
occlusion of the middle##5##4##(2007-10#3)(2008-12#1)(2008-4#1)
occlusion of the subclavian artery##2##5##(2008-7#2)
occlusion of the vessel##2##4##(1991-8#1)(2011-1#1)
occlusion of the##43##3##(1991-8#1)(1993-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#2)(2007-10#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#9)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
occlusion of##61##2##(1991-8#1)(1993-3#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-10#4)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#12)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#3)
occlusion rate##2##2##(1997-3#1)(2011-2#1)
occlusion was##2##2##(1991-3#1)(1997-6#1)
occlusion were##3##2##(1991-12#1)(2010-4#1)(2013-1#1)
occlusion with the##2##3##(1997-3#1)(2013-1#1)
occlusion with##4##2##(1997-3#1)(2008-11#1)(2009-7#1)(2013-1#1)
occlusion without##3##2##(1997-8#1)(2010-6#2)
occlusion##247##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-11#1)(1995-12#8)(1996-12#1)(1996-2#2)(1996-6#3)(1996-9#2)(1997-2#2)(1997-3#10)(1997-6#3)(1997-8#8)(2006-10#1)(2006-12#2)(2007-10#27)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#8)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#22)(2008-8#5)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-9#5)(2011-1#7)(2011-2#15)(2011-3#2)(2012-3#3)(2013-1#17)(2013-7#3)(2013-8#4)
occlusion)##3##1##(2007-7#1)(2008-7#2)
occlusions and##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
occlusions as a##2##3##(2008-7#1)(2010-4#1)
occlusions as##3##2##(2008-7#1)(2010-4#1)(2011-1#1)
occlusions in##3##2##(1994-11#1)(2007-8#1)(2011-2#1)
occlusions of the##2##3##(2008-12#1)(2011-2#1)
occlusions of##4##2##(2008-12#1)(2011-2#3)
occlusions were##2##2##(1997-8#1)(2011-2#1)
occlusions with##2##2##(2008-12#1)(2011-2#1)
occlusions##37##1##(1991-3#3)(1994-11#2)(1994-12#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#7)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-2#1)
occlusive disease##3##2##(1996-8#1)(2008-11#1)(2008-7#1)
occlusive lesions##2##2##(2007-10#2)
occlusive phase##2##2##(1991-6#1)(1997-8#1)
occlusive vascular disease##4##3##(1992-9#4)
occlusive vascular##6##2##(1992-9#4)(1995-2#1)(2007-10#1)
occlusive##28##1##(1991-2#3)(1991-3#1)(1991-6#1)(1992-9#4)(1995-2#1)(1996-8#2)(1997-3#1)(1997-8#1)(2007-10#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
occlusivity##3##1##(2008-5#3)
occlusoproximal composites in premolars##2##4##(2009-2#2)
occult blood test##4##3##(1993-8#4)
occult blood##15##2##(1990-8#1)(1991-3#1)(1993-6#1)(1993-8#6)(1994-2#1)(1997-8#1)(2009-1#1)(2009-12#1)(2010-8#1)(2012-12#1)
occult fecal blood##4##3##(1991-6#2)(1993-3#2)
occult papillary thyroid carcinoma##2##4##(1990-6#2)
occult papillary##3##2##(1990-6#3)
occult sciences##2##2##(2008-11#2)
occult##53##1##(1990-6#5)(1990-8#2)(1991-2#1)(1991-3#1)(1991-6#5)(1992-2#1)(1993-3#2)(1993-6#1)(1993-8#6)(1994-2#1)(1995-11#2)(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2009-1#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
occultation data##2##2##(2008-2#1)(2008-3#1)
occultation experiments##2##2##(2008-2#2)
occultation##10##1##(2008-2#6)(2008-3#4)
occulters##2##1##(2008-3#2)
occupancy also##2##2##(1991-12#1)(1995-2#1)
occupancy at##3##2##(2008-8#1)(2010-11#2)
occupancy of the##2##3##(1995-5#2)
occupancy of##6##2##(1993-8#1)(1995-2#1)(1995-5#2)(2008-2#1)(2012-2#1)
occupancy rates##2##2##(1992-12#1)(1996-3#1)
occupancy surveys##2##2##(2008-8#2)
occupancy##40##1##(1991-12#1)(1992-12#1)(1993-8#2)(1995-2#3)(1995-5#3)(1996-3#1)(2008-11#2)(2008-2#3)(2008-8#13)(2008-9#6)(2010-11#2)(2010-8#1)(2011-1#1)(2012-2#1)
occupant survivability##2##2##(1996-12#2)
occupant##6##1##(1991-12#1)(1996-12#4)(2013-1#1)
occupants of##2##2##(1991-12#1)(1992-2#1)
occupants##9##1##(1991-12#2)(1992-2#1)(1996-12#2)(2008-9#2)(2009-9#1)(2010-5#1)
occupation and##3##2##(1991-12#1)(1992-8#1)(2008-12#1)
occupation of##2##2##(2008-8#1)(2011-2#1)
occupation the##2##2##(1990-6#2)
occupation was##2##2##(1995-6#1)(2012-12#1)
occupation##29##1##(1990-6#6)(1990-8#1)(1991-12#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)
occupational and environmental intoxication##2##4##(2009-12#2)
occupational and environmental##6##3##(1991-12#1)(2008-10#1)(2009-12#3)(2010-1#1)
occupational and##13##2##(1991-12#2)(1996-6#1)(2008-10#3)(2008-12#1)(2009-12#3)(2010-1#1)(2012-2#1)(2013-7#1)
occupational asthma##5##2##(1990-3#1)(1997-1#1)(2008-10#3)
occupational discourses##2##2##(2010-9#2)
occupational diseases in##2##3##(1990-3#1)(2010-4#1)
occupational diseases##4##2##(1990-3#1)(2009-12#2)(2010-4#1)
occupational exposure in##2##3##(2009-12#1)(2012-2#1)
occupational exposure to solvents##2##4##(1990-2#1)(1990-8#1)
occupational exposure to##10##3##(1990-2#1)(1990-8#1)(1991-11#1)(1996-2#1)(1997-5#1)(2008-10#2)(2008-9#1)(2013-1#2)
occupational exposure##21##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1994-12#1)(1996-2#1)(1997-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
occupational exposures##3##2##(2007-6#1)(2008-12#1)(2013-1#1)
occupational hazards##2##2##(1992-3#1)(2013-1#1)
occupational health and##3##3##(2008-12#1)(2009-11#1)(2012-2#1)
occupational health care##3##3##(1991-6#1)(1995-6#2)
occupational health service##4##3##(1995-2#3)(2009-12#1)
occupational health services##3##3##(1990-6#1)(1991-3#1)(2012-12#1)
occupational health##32##2##(1990-6#1)(1991-3#3)(1991-6#1)(1995-2#3)(1995-6#2)(1996-3#1)(2008-11#3)(2008-12#3)(2008-7#1)(2009-11#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
occupational history##3##2##(1992-11#2)(1992-5#1)
occupational hygiene##2##2##(2008-10#1)(2009-4#1)
occupational injuries and##2##3##(1993-12#1)(2008-11#1)
occupational injuries##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
occupational injury and##3##3##(1993-12#1)(2008-11#2)
occupational injury##5##2##(1993-12#1)(1994-3#2)(2008-11#2)
occupational medicine##5##2##(1990-12#1)(1991-2#1)(1994-6#1)(1995-6#1)(2011-2#1)
occupational medicine]##3##2##(1990-3#2)(1997-8#1)
occupational noise##2##2##(2011-2#2)
occupational or##2##2##(1996-9#1)(2007-12#1)
occupational rhinitis##2##2##(2012-3#2)
occupational risk of##2##3##(2012-12#1)(2013-1#1)
occupational risk##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
occupational safety and health##4##4##(1993-12#1)(1993-2#1)(1993-3#1)(2008-9#1)
occupational safety and##5##3##(1993-12#1)(1993-2#1)(1993-3#1)(2008-8#1)(2008-9#1)
occupational settings##2##2##(2010-3#1)(2012-3#1)
occupational status##4##2##(1995-3#2)(2010-1#1)(2013-1#1)
occupational stress and##2##3##(2009-5#1)(2013-1#1)
occupational stress increases##2##3##(2009-5#2)
occupational stress##8##2##(2009-5#3)(2010-12#3)(2012-2#1)(2013-1#1)
occupational therapist##5##2##(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
occupational therapists##8##2##(1996-2#1)(2008-11#2)(2008-4#2)(2012-2#1)(2013-8#2)
occupational therapy and occupational science##2##5##(2010-9#2)
occupational therapy services##8##3##(2013-7#7)(2013-8#1)
occupational therapy##30##2##(2007-10#1)(2008-11#2)(2008-12#1)(2010-3#1)(2010-9#7)(2012-1#8)(2013-7#8)(2013-8#2)
occupational##232##1##(1990-12#1)(1990-2#2)(1990-3#6)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#4)(1991-6#2)(1992-11#2)(1992-3#1)(1992-5#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#15)(2008-12#8)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#12)(2009-3#1)(2009-4#2)(2009-5#4)(2010-1#2)(2010-11#2)(2010-12#8)(2010-3#4)(2010-4#1)(2010-9#13)(2011-1#1)(2011-2#11)(2012-1#9)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#10)(2013-8#10)
occupationally exposed to##3##3##(1991-12#2)(2013-1#1)
occupationally exposed##6##2##(1991-12#3)(2008-12#1)(2013-1#1)(2013-8#1)
occupationally##10##1##(1991-12#3)(1995-5#1)(2008-10#2)(2008-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
occupationally-relevant doses of TCE##2##4##(2008-10#2)
occupations and##2##2##(1991-12#1)(1993-3#1)
occupations##16##1##(1991-1#2)(1991-12#1)(1991-4#1)(1993-1#1)(1993-3#2)(1994-3#2)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#1)(2011-2#1)(2012-1#1)
occupied by the cells##2##4##(2008-11#2)
occupied by the##8##3##(1994-12#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-2#2)
occupied by##25##2##(1990-7#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-11#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-1#2)
occupied the##4##2##(1992-11#1)(2008-10#1)(2008-7#1)(2009-3#1)
occupied##46##1##(1990-7#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-8#1)(1996-2#2)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-1#2)(2013-1#1)
occupies a##4##2##(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
occupies the##4##2##(1992-3#1)(2007-12#1)(2008-2#1)(2008-9#1)
occupies##13##1##(1992-3#1)(1994-12#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
occupy a single##2##3##(2006-4#1)(2008-9#1)
occupy a##6##2##(1994-2#1)(1997-6#1)(2006-10#1)(2006-4#1)(2008-9#1)(2009-5#1)
occupy the##6##2##(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)
occupy##27##1##(1991-8#1)(1993-11#1)(1994-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#2)
occupying a##2##2##(2006-4#1)(2008-11#1)
occupying the##5##2##(1990-11#1)(1992-3#1)(1993-11#1)(2011-2#1)(2013-1#1)
occupying##18##1##(1990-11#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1996-4#1)(1997-7#1)(2006-4#1)(2008-11#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#4)
occur after##17##2##(1990-7#1)(1991-3#1)(1991-9#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-8#1)(2013-8#2)
occur among##5##2##(1994-3#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-6#1)
occur and the##2##3##(1992-6#1)(2008-8#1)
occur and##13##2##(1991-12#1)(1992-6#1)(1995-2#1)(1996-4#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#1)
occur anywhere in the body##2##5##(2011-2#1)(2013-8#1)
occur anywhere##3##2##(2007-5#1)(2011-2#1)(2013-8#1)
occur as a consequence of a##2##6##(2006-10#1)(2011-2#1)
occur as a consequence of##4##5##(2006-10#1)(2008-11#1)(2011-2#2)
occur as a result of##7##5##(1991-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2013-1#1)
occur as a##15##3##(1991-9#1)(1995-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
occur as the##3##3##(1994-2#1)(2007-12#1)(2008-10#1)
occur as##34##2##(1991-9#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-12#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
occur at a##5##3##(1992-5#1)(1995-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
occur at an early stage##2##5##(1992-12#1)(2012-2#1)
occur at an##3##3##(1992-12#1)(2007-11#1)(2012-2#1)
occur at any##3##3##(2007-2#1)(2009-5#1)(2011-2#1)
occur at different##4##3##(1994-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
occur at the##9##3##(1991-2#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)
occur at two##2##3##(1990-5#1)(2009-9#1)
occur at##41##2##(1990-5#1)(1991-2#1)(1992-12#1)(1992-5#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
occur because of the##2##4##(2008-10#1)(2008-2#1)
occur because of##5##3##(1995-11#1)(2008-10#1)(2008-2#2)(2011-2#1)
occur because##7##2##(1995-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-10#1)(2011-2#1)
occur between the##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
occur between##12##2##(1991-5#1)(1993-11#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
occur beyond the##2##3##(2008-2#1)(2012-2#1)
occur both##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
occur but##2##2##(1991-6#1)(2008-7#1)
occur by##11##2##(1992-8#1)(1993-9#1)(1994-2#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#2)(2012-12#2)
occur commonly in the##2##4##(2008-9#1)(2012-3#1)
occur commonly in##3##3##(2008-9#1)(2010-1#1)(2012-3#1)
occur due to##7##3##(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2011-1#1)
occur during a##2##3##(1997-8#1)(2008-7#1)
occur during or after##2##4##(2007-10#1)(2010-8#1)
occur during pregnancy##2##3##(2008-4#1)(2013-1#1)
occur during the##15##3##(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)(2013-1#2)
occur during##42##2##(1993-9#1)(1994-11#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
occur early##2##2##(2008-2#1)(2011-2#1)
occur either as a##2##4##(1996-11#1)(2008-9#1)
occur either##4##2##(1996-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
occur even##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
occur exclusively in##2##3##(2008-10#1)(2008-9#1)
occur following##8##2##(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
occur for the most##2##4##(1997-8#1)(2007-12#1)
occur for the##3##3##(1997-8#1)(2007-12#1)(2008-2#1)
occur for##10##2##(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-7#1)(2010-11#1)(2010-7#1)(2013-8#1)
occur frequently##4##2##(1991-12#1)(2008-10#2)(2011-1#1)
occur from the##2##3##(2007-12#1)(2012-2#1)
occur from##6##2##(1991-12#1)(2007-12#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-2#1)
occur if the##3##3##(2008-4#1)(2008-8#2)
occur if##6##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)
occur in a##12##3##(1991-3#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
occur in about##2##3##(1990-6#1)(2008-2#1)
occur in all##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
occur in any##4##3##(1995-2#1)(2008-12#1)(2008-7#1)(2013-1#1)
occur in approximately##2##3##(1995-5#1)(2008-1#1)
occur in as little as##2##5##(1993-11#1)(2008-11#1)
occur in as##3##3##(1993-11#1)(2008-11#1)(2009-5#1)
occur in cells##2##3##(1997-4#1)(1997-7#1)
occur in childhood##2##3##(1990-6#1)(2008-7#1)
occur in children##3##3##(2007-12#1)(2008-6#1)(2008-7#1)
occur in combination with##2##4##(1992-6#1)(2013-8#1)
occur in different##2##3##(2008-8#1)(2011-1#1)
occur in early##2##3##(2008-7#1)(2010-12#1)
occur in four##2##3##(2008-6#1)(2012-3#1)
occur in guinea-pig##2##3##(1995-12#1)(2008-2#1)
occur in isolation##4##3##(2010-10#1)(2011-2#1)(2013-1#2)
occur in less than##2##4##(1996-11#1)(2011-2#1)
occur in many##2##3##(1994-12#1)(2008-8#1)
occur in other##2##3##(2007-7#1)(2011-1#1)
occur in patients with##4##4##(1994-8#1)(1997-3#1)(2007-10#1)(2007-7#1)
occur in patients##9##3##(1990-9#1)(1991-11#1)(1994-8#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2013-1#1)
occur in relation to##2##4##(2008-7#1)(2013-1#1)
occur in response to##4##4##(1993-2#1)(2008-4#1)(2008-7#1)(2009-10#1)
occur in sleep##2##3##(2008-9#2)
occur in some##2##3##(1990-11#1)(2008-3#1)
occur in the absence of##6##5##(1990-8#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-4#1)
occur in the early##2##4##(2011-1#1)(2012-1#1)
occur in the##65##3##(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-6#1)(2006-10#2)(2007-12#2)(2008-10#9)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#3)
occur in these##4##3##(1994-5#1)(2008-6#1)(2008-7#1)(2013-7#1)
occur in this##3##3##(1992-6#1)(1995-6#1)(2010-11#1)
occur in three##2##3##(2007-12#2)
occur in vivo##2##3##(1994-3#1)(1994-5#1)
occur in##248##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#5)(1995-6#4)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#19)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#3)
occur independent of##2##3##(1995-6#1)(2008-10#1)
occur later in##2##3##(2007-10#1)(2008-2#1)
occur more frequently in##2##4##(2007-12#1)(2008-1#1)
occur more frequently##3##3##(1990-6#1)(2007-12#1)(2008-1#1)
occur more##5##2##(1990-6#1)(2007-12#2)(2008-1#1)(2012-1#1)
occur most commonly in##2##4##(2008-8#1)(2011-1#1)
occur most commonly##3##3##(1991-2#1)(2008-8#1)(2011-1#1)
occur most##5##2##(1991-2#1)(1996-6#1)(2008-3#1)(2008-8#1)(2011-1#1)
occur not only in##3##4##(1994-11#1)(1996-5#1)(2008-11#1)
occur not##5##2##(1994-11#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-5#1)
occur on a##2##3##(2008-1#1)(2008-10#1)
occur on the##6##3##(1997-5#1)(2008-10#2)(2008-5#2)(2009-4#1)
occur on##12##2##(1996-6#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-5#2)(2009-4#2)
occur only at##3##3##(1996-12#1)(2008-1#1)(2008-4#1)
occur only##8##2##(1996-11#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)
occur outside##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
occur over##4##2##(1990-7#1)(2008-11#1)(2008-3#1)(2008-8#1)
occur predominantly##2##2##(1994-8#1)(2008-5#1)
occur primarily in the##2##4##(1997-8#1)(2011-2#1)
occur primarily##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
occur resulting in##2##3##(2008-10#1)(2013-1#1)
occur secondary to##3##3##(1994-2#1)(2008-1#1)(2011-2#1)
occur simultaneously##3##2##(2008-6#1)(2008-7#1)(2008-9#1)
occur spontaneously##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
occur sporadically##4##2##(2008-1#2)(2008-8#1)(2012-3#1)
occur that##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
occur through a##2##3##(1993-11#1)(1995-6#1)
occur through the##3##3##(1993-9#1)(1994-8#1)(2008-10#1)
occur through##11##2##(1990-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-6#1)(2008-10#3)(2012-2#1)(2013-1#1)
occur throughout the##4##3##(2008-10#3)(2008-8#1)
occur throughout##5##2##(2007-12#1)(2008-10#3)(2008-8#1)
occur to##6##2##(1994-2#1)(2007-8#1)(2008-11#1)(2009-10#2)(2011-3#1)
occur together##2##2##(1991-12#1)(2008-10#1)
occur under##6##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-7#1)
occur upon##2##2##(1992-6#2)
occur via a##2##3##(1997-7#1)(2013-7#1)
occur via##9##2##(1990-5#1)(1990-7#1)(1994-3#1)(1994-9#1)(1997-7#1)(2008-11#1)(2013-1#2)(2013-7#1)
occur when a##3##3##(2008-9#1)(2010-8#1)(2012-12#1)
occur when one of the##2##5##(2008-3#1)(2008-5#1)
occur when the##6##3##(1994-3#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
occur when##21##2##(1990-9#1)(1991-6#1)(1994-3#1)(1995-3#2)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-8#1)(2012-12#1)(2012-3#1)
occur while##3##2##(2009-5#1)(2012-2#1)(2013-8#1)
occur with##25##2##(1990-11#2)(1991-8#1)(1992-3#1)(1993-2#1)(1993-6#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-3#2)
occur within the##5##3##(1993-12#1)(1996-12#1)(2009-12#1)(2010-8#1)(2012-12#1)
occur within##13##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-8#1)(2012-12#2)(2013-1#2)
occur without##4##2##(1992-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
occur##829##1##(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#4)(1991-9#5)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#7)(1994-3#9)(1994-5#4)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#4)(1995-3#6)(1995-5#6)(1995-6#7)(1995-8#3)(1996-1#1)(1996-11#4)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#6)(1996-5#5)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#8)(2006-10#5)(2007-10#6)(2007-11#7)(2007-12#29)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#11)(2008-1#12)(2008-10#96)(2008-11#22)(2008-12#4)(2008-2#16)(2008-3#27)(2008-4#10)(2008-5#23)(2008-6#6)(2008-7#43)(2008-8#40)(2008-9#28)(2009-1#1)(2009-10#9)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#5)(2010-12#2)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#9)(2011-2#39)(2011-3#1)(2012-1#4)(2012-12#17)(2012-2#13)(2012-3#10)(2013-1#25)(2013-7#5)(2013-8#12)
occur)##2##1##(2008-10#1)(2008-3#1)
occured##5##1##(1996-9#1)(2007-11#1)(2008-7#1)(2010-5#1)(2011-1#1)
occurence##2##1##(2007-8#1)(2013-1#1)
occuring##4##1##(2007-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
occurred 1##3##2##(2007-8#2)(2011-2#1)
occurred after a##2##3##(1991-2#1)(2008-7#1)
occurred after surgery##2##3##(2008-7#1)(2012-12#1)
occurred after the initial##2##4##(2011-2#1)(2013-8#1)
occurred after the##6##3##(1991-6#1)(2007-7#1)(2008-10#1)(2011-2#2)(2013-8#1)
occurred after##27##2##(1991-2#1)(1991-6#1)(1993-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-9#1)(1997-8#2)(2007-7#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
occurred almost##2##2##(2008-11#1)(2008-4#1)
occurred among##9##2##(1991-12#3)(1991-8#1)(2007-8#1)(2008-10#2)(2013-1#2)
occurred and##4##2##(1991-1#1)(1991-6#1)(1994-3#1)(2008-10#1)
occurred approximately##2##2##(2012-2#1)(2013-7#1)
occurred around##3##2##(2008-10#2)(2010-5#1)
occurred as a result of the##4##6##(1992-3#1)(2008-3#1)(2008-4#1)(2010-11#1)
occurred as a##6##3##(1992-3#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
occurred as of##2##3##(1992-9#1)(2008-12#1)
occurred as the##4##3##(1997-8#1)(2008-10#2)(2008-2#1)
occurred as##17##2##(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
occurred at 0##2##3##(2008-10#2)
occurred at 30 degrees C##2##5##(2008-10#2)
occurred at a rate##2##4##(1991-9#1)(2008-10#1)
occurred at a significantly higher##2##5##(2008-10#1)(2008-7#1)
occurred at a##15##3##(1991-9#1)(1992-11#1)(1995-11#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2013-1#2)
occurred at high##2##3##(2010-8#1)(2012-2#1)
occurred at pH 3##3##4##(2008-6#2)(2010-5#1)
occurred at pH##5##3##(1992-12#1)(2008-6#2)(2010-5#1)(2013-1#1)
occurred at temperatures ranging from 5 to##2##7##(2008-10#2)
occurred at temperatures ranging from##3##5##(2008-10#3)
occurred at temperatures##4##3##(1995-6#1)(2008-10#3)
occurred at the site of application in##4##7##(2008-9#4)
occurred at the site of application##5##6##(2008-9#5)
occurred at the##25##3##(1990-3#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#6)(2009-7#1)(2013-1#1)
occurred at##89##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#7)(2009-11#2)(2009-7#1)(2009-8#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)
occurred because of##2##3##(2011-2#2)
occurred because##3##2##(1994-11#1)(2011-2#2)
occurred before##8##2##(1991-6#1)(2007-12#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-1#1)
occurred between 12##2##3##(1997-3#1)(2008-10#1)
occurred between the##3##3##(2008-10#3)
occurred between these##2##3##(2008-10#2)
occurred between##23##2##(1990-3#1)(1994-11#1)(1996-12#1)(1997-3#3)(1997-6#1)(2008-10#12)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
occurred by the##2##3##(1994-3#1)(2008-10#1)
occurred by##9##2##(1994-3#1)(2008-10#3)(2008-9#1)(2010-5#3)(2011-2#1)
occurred despite##2##2##(1990-5#1)(1994-8#1)
occurred due to##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
occurred during a##2##3##(1995-5#1)(2011-1#1)
occurred during the course of##2##5##(1991-12#1)(2008-6#1)
occurred during the first##2##4##(2008-5#1)(2008-9#1)
occurred during the##18##3##(1991-12#1)(1995-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-9#2)(2009-5#1)(2011-2#1)(2013-8#1)
occurred during##38##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-9#2)(2009-5#2)(2010-10#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-8#1)
occurred earlier and##3##3##(1991-9#1)(1994-11#1)(1996-12#1)
occurred earlier##7##2##(1990-2#1)(1991-9#1)(1994-11#1)(1996-12#1)(2008-10#2)(2010-6#1)
occurred even though##3##3##(1994-11#1)(1997-2#1)(2008-10#1)
occurred even when the##2##4##(2008-10#1)(2008-6#1)
occurred even##8##2##(1994-11#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-12#1)
occurred exclusively##4##2##(1993-11#1)(1993-8#1)(2008-10#2)
occurred following##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
occurred for##8##2##(1990-2#1)(1992-3#1)(1993-8#1)(1994-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)
occurred frequently##4##2##(1996-6#1)(2008-10#2)(2011-2#1)
occurred from the##2##3##(2008-10#2)
occurred from##5##2##(1991-3#1)(1994-3#1)(2008-10#3)
occurred in 12 mg/kg males##2##5##(2008-9#2)
occurred in 12 mg/kg##3##4##(2008-9#3)
occurred in 12##5##3##(1997-8#1)(2008-6#1)(2008-9#3)
occurred in 14##2##3##(1990-5#1)(2008-9#1)
occurred in 24##2##3##(2008-8#1)(2011-2#1)
occurred in 3##3##3##(1992-8#1)(2007-8#1)(2013-8#1)
occurred in 37%##2##3##(2008-7#1)(2011-2#1)
occurred in 4 patients##2##4##(1997-3#1)(1997-8#1)
occurred in 42##2##3##(2008-8#1)(2013-8#1)
occurred in 7##2##3##(1992-5#1)(2007-8#1)
occurred in African##2##3##(2007-10#1)(2010-3#1)
occurred in a young##2##4##(2008-6#1)(2011-1#1)
occurred in a##23##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-8#1)(1993-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
occurred in all three##2##4##(1996-6#1)(2008-12#1)
occurred in all##13##3##(1991-8#1)(1995-8#1)(1996-6#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)
occurred in an##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
occurred in association with a##2##5##(1991-12#1)(1992-9#1)
occurred in association with##3##4##(1991-12#1)(1992-9#1)(2008-5#1)
occurred in both##3##3##(2008-3#1)(2008-7#1)(2010-8#1)
occurred in different##3##3##(1994-5#1)(2007-11#1)(2008-10#1)
occurred in late##2##3##(2008-12#1)(2008-8#1)
occurred in less than##2##4##(1997-4#1)(2013-1#1)
occurred in many##3##3##(1990-2#1)(2008-10#1)(2012-12#1)
occurred in nine##2##3##(2008-1#1)(2008-4#1)
occurred in one##2##3##(2007-11#1)(2008-7#1)
occurred in only two##2##4##(1996-9#1)(2008-10#1)
occurred in only##3##3##(1996-9#1)(2008-10#1)(2009-8#1)
occurred in patients##2##3##(2008-3#1)(2011-2#1)
occurred in resistant##3##3##(1994-8#1)(2008-10#2)
occurred in response to##4##4##(1990-10#1)(2008-10#2)(2008-4#1)
occurred in seven##2##3##(1995-5#1)(2008-11#1)
occurred in snap bean##2##4##(2008-10#2)
occurred in some##2##3##(2008-8#1)(2008-9#1)
occurred in the 4 to##2##5##(1991-3#1)(2010-5#1)
occurred in the presence of##3##5##(1990-12#1)(1990-5#1)(1992-3#1)
occurred in the previous one year##2##6##(2011-2#2)
occurred in the same##2##4##(1990-11#1)(1991-2#1)
occurred in the##83##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-6#1)(1997-4#2)(1997-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#19)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#4)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-7#1)
occurred in these##2##3##(1991-2#1)(2007-6#1)
occurred in this series##2##4##(1992-2#1)(2009-3#1)
occurred in this##4##3##(1992-2#1)(2008-10#1)(2008-7#1)(2009-3#1)
occurred in three##3##3##(2009-7#1)(2012-2#1)(2013-8#1)
occurred in two patients##2##4##(1996-9#1)(2011-2#1)
occurred in two##8##3##(1990-10#1)(1993-12#1)(1996-9#1)(2008-10#1)(2008-9#1)(2011-2#3)
occurred in##322##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#3)(1993-2#3)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-7#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#4)(1996-1#4)(1996-11#4)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#2)(1997-8#3)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-6#2)(2007-7#5)(2007-8#4)(2008-1#5)(2008-10#58)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#13)(2008-9#23)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#5)(2011-2#14)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#6)
occurred later##2##2##(2008-10#1)(2008-11#1)
occurred mainly##3##2##(1992-5#1)(2007-8#1)(2008-10#1)
occurred more commonly in##2##4##(2007-7#2)
occurred more frequently in##2##4##(2007-10#1)(2011-2#1)
occurred more frequently##3##3##(2007-10#1)(2008-6#1)(2011-2#1)
occurred more rapidly##2##3##(2008-10#1)(2008-9#1)
occurred more than##2##3##(2008-12#1)(2009-8#1)
occurred more##9##2##(2007-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
occurred much earlier than##2##4##(2008-7#1)(2011-2#1)
occurred near##3##2##(1996-11#1)(1997-7#1)(2012-2#1)
occurred on the##7##3##(1995-11#2)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
occurred on##20##2##(1990-11#1)(1991-5#1)(1993-12#1)(1995-11#2)(1996-5#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
occurred only at##2##3##(2008-10#1)(2008-9#1)
occurred only in the##3##4##(1995-11#1)(2008-9#2)
occurred only in##10##3##(1990-12#1)(1991-8#1)(1995-11#1)(2007-8#1)(2008-10#3)(2008-9#2)(2013-1#1)
occurred only when##2##3##(1990-7#1)(2008-10#1)
occurred only##18##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1994-5#1)(1995-11#1)(2007-8#1)(2008-10#6)(2008-9#3)(2010-5#1)(2013-1#1)
occurred over the last##2##4##(2007-9#1)(2011-2#1)
occurred over the##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
occurred over##6##2##(2007-9#1)(2008-10#3)(2011-2#1)(2013-8#1)
occurred predominantly in##3##3##(1991-2#1)(2008-1#1)(2013-1#1)
occurred primarily in##2##3##(2008-9#2)
occurred primarily##3##2##(2008-10#1)(2008-9#2)
occurred rapidly##3##2##(1994-3#1)(1995-8#1)(2010-11#1)
occurred regularly##2##2##(2008-10#1)(2008-9#1)
occurred relatively early in##2##4##(1993-6#1)(1996-5#1)
occurred relatively##3##2##(1993-6#1)(1996-5#1)(2008-10#1)
occurred significantly##2##2##(1997-3#1)(2007-8#1)
occurred specifically##2##2##(1995-6#1)(2008-9#1)
occurred spontaneously##2##2##(1995-2#1)(1996-1#1)
occurred three##2##2##(1992-6#1)(2013-1#1)
occurred through the##2##3##(1996-5#1)(2008-10#1)
occurred through##5##2##(1993-3#1)(1996-5#1)(2008-10#2)(2008-8#1)
occurred to##4##2##(1994-3#1)(1995-8#1)(1996-5#1)(2009-10#1)
occurred under the##2##3##(2008-10#1)(2012-12#1)
occurred under##3##2##(2008-10#2)(2012-12#1)
occurred upon##2##2##(1992-1#1)(2008-7#1)
occurred via##3##2##(1992-3#1)(1995-8#1)(2008-7#1)
occurred was##2##2##(2009-7#1)(2012-12#1)
occurred when the##9##3##(1991-12#1)(1992-10#1)(1993-10#1)(2008-10#4)(2010-11#2)
occurred when##29##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-8#1)(1993-10#1)(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#12)(2008-3#1)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-3#1)
occurred while##2##2##(1994-2#1)(2013-8#1)
occurred with a significantly increased incidence in##2##7##(2008-9#2)
occurred with a##3##3##(2008-10#1)(2008-9#2)
occurred with the##4##3##(1994-12#1)(2008-10#1)(2008-12#1)(2009-7#1)
occurred with##30##2##(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-9#3)(2009-5#2)(2009-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
occurred within 0##2##3##(1990-2#2)
occurred within 24##2##3##(2008-10#2)
occurred within the first##2##4##(1992-1#1)(2009-12#1)
occurred within the##6##3##(1992-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-12#1)
occurred within two months after##2##5##(2008-8#2)
occurred within##31##2##(1990-2#2)(1990-6#1)(1992-1#1)(1992-11#1)(1993-3#1)(1994-8#2)(1995-9#1)(2007-7#1)(2008-10#13)(2008-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2012-2#1)(2012-3#1)
occurred without any##2##3##(1994-6#1)(2008-6#1)
occurred without##10##2##(1991-5#1)(1992-8#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-8#1)
occurred##1006##1##(1990-10#4)(1990-11#4)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#10)(1991-2#5)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#5)(1991-8#7)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#7)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#10)(1994-12#3)(1994-2#4)(1994-3#15)(1994-5#5)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#2)(1995-11#11)(1995-12#1)(1995-2#8)(1995-3#2)(1995-5#4)(1995-6#11)(1995-8#9)(1995-9#1)(1996-1#5)(1996-11#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#5)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#11)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#6)(2006-10#1)(2006-8#1)(2007-10#8)(2007-11#9)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#14)(2007-8#12)(2007-9#1)(2008-1#8)(2008-10#242)(2008-11#24)(2008-12#12)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#14)(2008-6#13)(2008-7#32)(2008-8#22)(2008-9#52)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#9)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#12)(2010-6#1)(2010-8#3)(2011-1#8)(2011-2#41)(2011-3#3)(2012-12#15)(2012-2#11)(2012-3#8)(2013-1#30)(2013-7#2)(2013-8#13)
occurrence among##6##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
occurrence and levels##2##3##(2008-10#2)
occurrence and spread of##2##4##(2008-10#1)(2008-12#1)
occurrence and the##6##3##(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)
occurrence and##38##2##(1990-11#1)(1990-8#1)(1992-9#1)(1996-11#1)(1997-4#1)(2007-7#1)(2008-10#11)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
occurrence as##2##2##(1993-11#1)(2007-8#1)
occurrence by##2##2##(1997-4#1)(2008-10#1)
occurrence during##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
occurrence in the##5##3##(2008-10#2)(2008-6#1)(2009-10#1)(2012-12#1)
occurrence in##33##2##(1990-6#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
occurrence is important for##2##4##(1991-3#1)(2009-10#1)
occurrence is##6##2##(1991-3#1)(2007-11#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)
occurrence of P##2##3##(2008-10#2)
occurrence of a second##2##4##(1990-8#1)(2012-2#1)
occurrence of a##12##3##(1990-8#1)(1993-11#1)(1993-9#1)(1994-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#4)
occurrence of adenomatous polyps##2##4##(1997-8#2)
occurrence of aggressive behaviours##2##4##(2011-2#2)
occurrence of an##4##3##(1994-6#1)(1997-3#1)(2008-10#1)(2008-8#1)
occurrence of both##3##3##(2008-10#2)(2008-4#1)
occurrence of cardiovascular##2##3##(2008-11#1)(2011-1#1)
occurrence of different##2##3##(1990-6#1)(1997-4#1)
occurrence of each##2##3##(2008-10#1)(2013-1#1)
occurrence of empty##2##3##(2008-10#2)
occurrence of hexaploid loach Misgurnus anguillicaudatus##2##6##(2010-8#2)
occurrence of major##2##3##(2008-9#1)(2010-12#1)
occurrence of malignant##2##3##(1993-9#1)(2010-1#1)
occurrence of more than one##2##5##(2008-10#2)
occurrence of more##3##3##(2008-10#2)(2013-8#1)
occurrence of multiple##2##3##(2011-2#1)(2012-2#1)
occurrence of oospores##2##3##(2008-10#2)
occurrence of other##3##3##(1996-9#1)(2008-7#1)(2012-3#1)
occurrence of pain##3##3##(2008-7#1)(2010-12#2)
occurrence of several##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
occurrence of subsequent##2##3##(2011-2#1)(2012-3#1)
occurrence of such##4##3##(1991-12#1)(1994-9#1)(2008-2#1)(2008-9#1)
occurrence of symptoms##2##3##(1995-8#1)(2011-2#1)
occurrence of the sexual stage of this fungus##2##8##(2008-10#2)
occurrence of the sexual stage of##3##6##(2008-10#3)
occurrence of the##21##3##(1991-11#1)(1996-12#1)(1997-4#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)
occurrence of these##2##3##(1992-5#1)(2007-7#1)
occurrence of this##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)
occurrence of two##3##3##(1992-6#1)(2008-8#1)(2013-1#1)
occurrence of urinary##2##3##(2008-10#1)(2012-12#1)
occurrence of ventricular##2##3##(1995-12#1)(2012-3#1)
occurrence of##335##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-6#3)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#3)(1996-6#2)(1996-7#2)(1996-9#1)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#5)(2007-12#8)(2007-7#6)(2007-8#4)(2008-1#3)(2008-10#55)(2008-11#15)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#7)(2008-7#24)(2008-8#14)(2008-9#8)(2009-1#1)(2009-10#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#18)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#11)(2013-7#3)(2013-8#9)
occurrence on the##2##3##(2007-12#1)(2012-1#1)
occurrence rates of##2##3##(2007-8#1)(2012-3#1)
occurrence time and##2##3##(2011-2#2)
occurrence with a##2##3##(2010-3#1)(2013-1#1)
occurrence with##6##2##(1992-9#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
occurrence##497##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-9#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#7)(1997-6#3)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#7)(2007-11#1)(2007-12#9)(2007-2#1)(2007-5#3)(2007-7#8)(2007-8#7)(2008-1#6)(2008-10#81)(2008-11#21)(2008-12#8)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#10)(2008-7#29)(2008-8#18)(2008-9#10)(2009-1#2)(2009-10#5)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#8)(2011-1#5)(2011-2#35)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#11)(2012-3#8)(2013-1#16)(2013-7#4)(2013-8#13)
occurrences in##3##2##(1992-2#1)(1997-6#1)(2013-8#1)
occurrences of##9##2##(1990-11#1)(1997-4#1)(1997-5#1)(2007-12#3)(2008-11#1)(2008-3#1)(2012-3#1)
occurrences##29##1##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-12#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
occurring after a##2##3##(2008-7#1)(2012-2#1)
occurring after initial##2##3##(2008-10#1)(2008-7#1)
occurring after##18##2##(1994-5#1)(1995-12#1)(1996-12#1)(2006-6#1)(2007-8#2)(2008-10#2)(2008-7#2)(2010-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
occurring among##2##2##(1992-9#1)(2009-5#1)
occurring and##3##2##(1997-3#1)(2008-10#2)
occurring as a result of##2##5##(2007-12#1)(2009-11#1)
occurring as an##2##3##(2007-7#1)(2008-10#1)
occurring as##7##2##(2007-12#1)(2007-7#1)(2008-10#2)(2009-11#1)(2010-12#1)(2013-8#1)
occurring at a##5##3##(1994-2#1)(1997-3#1)(2008-10#1)(2010-3#2)
occurring at the##11##3##(1990-7#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)
occurring at##29##2##(1990-7#1)(1991-3#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-12#1)(2009-4#1)(2010-3#2)(2011-2#1)(2012-2#1)
occurring before the##2##3##(1991-4#1)(2008-8#1)
occurring before##3##2##(1991-4#1)(2008-8#1)(2009-3#1)
occurring between##4##2##(1992-6#1)(1995-11#1)(2008-12#1)(2011-2#1)
occurring disease##2##2##(2008-10#1)(2011-2#1)
occurring during a##2##3##(2008-10#1)(2008-11#1)
occurring during the course of##2##5##(2009-11#1)(2013-7#1)
occurring during the##8##3##(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-7#1)
occurring during##25##2##(1994-2#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-7#1)
occurring from##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
occurring in 0##2##3##(2010-6#1)(2012-2#1)
occurring in a##9##3##(1990-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#2)
occurring in an##2##3##(2009-9#1)(2011-2#1)
occurring in both##3##3##(2008-10#2)(2008-4#1)
occurring in different##2##3##(1991-12#1)(2008-10#1)
occurring in early childhood##2##4##(2007-7#1)(2011-2#1)
occurring in patients with##3##4##(2007-10#1)(2007-11#1)(2011-2#1)
occurring in several##2##3##(1992-9#1)(2006-10#1)
occurring in the course of##2##5##(2008-7#1)(2010-12#1)
occurring in the same##2##4##(2008-11#1)(2008-7#1)
occurring in the##41##3##(1991-9#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
occurring in these##2##3##(2008-1#1)(2008-7#1)
occurring in##138##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#22)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#3)(2013-7#1)(2013-8#3)
occurring mainly in##2##3##(1997-8#1)(2013-8#1)
occurring on a##3##3##(1995-5#1)(2008-10#1)(2008-9#1)
occurring on the##3##3##(1990-12#1)(2008-10#2)
occurring on##15##2##(1990-12#1)(1995-5#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-9#1)(2010-3#1)
occurring only in##2##3##(2006-10#1)(2008-6#1)
occurring over##4##2##(1996-4#1)(2007-7#1)(2008-7#1)(2008-9#1)
occurring populations of##2##3##(2008-10#2)
occurring populations##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
occurring throughout##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
occurring variants##2##2##(2008-10#1)(2012-2#1)
occurring when##2##2##(2008-3#1)(2011-2#1)
occurring with the##2##3##(2008-11#1)(2009-11#1)
occurring with##4##2##(2008-1#1)(2008-11#1)(2009-11#1)(2010-12#1)
occurring within 2##2##3##(1990-11#1)(1990-5#1)
occurring within the##5##3##(1994-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)
occurring within##14##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#2)
occurring##454##1##(1990-11#4)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-7#2)(1997-8#2)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#87)(2008-11#19)(2008-12#6)(2008-2#6)(2008-3#9)(2008-4#16)(2008-5#15)(2008-6#6)(2008-7#20)(2008-8#14)(2008-9#10)(2009-1#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#5)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#1)(2012-12#8)(2012-2#12)(2012-3#10)(2012-6#1)(2013-1#3)(2013-7#3)(2013-8#6)
occurs across##2##2##(1993-8#1)(1994-5#1)
occurs after exposure to##2##4##(2007-12#1)(2008-8#1)
occurs after the##2##3##(2010-1#1)(2010-6#1)
occurs after##17##2##(1992-6#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#2)(2011-1#1)
occurs along##3##2##(2007-12#1)(2008-12#1)(2008-3#1)
occurs and the##2##3##(1995-2#1)(2008-10#1)
occurs and##5##2##(1995-2#1)(1996-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
occurs as a result of##3##5##(1992-6#1)(2007-8#1)(2008-6#1)
occurs as a##6##3##(1991-9#1)(1992-6#1)(1992-9#1)(2007-8#1)(2008-6#2)
occurs as the##3##3##(2007-12#1)(2008-7#1)(2009-8#1)
occurs as##17##2##(1990-5#1)(1991-9#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-7#2)(2009-2#1)(2009-8#1)
occurs at a rate##2##4##(1993-8#1)(2009-5#1)
occurs at a##9##3##(1993-2#1)(1993-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#1)
occurs at its##2##3##(1991-12#1)(2008-6#1)
occurs at the level of the##2##6##(1994-5#1)(2010-7#1)
occurs at the level of##4##5##(1994-11#1)(1994-5#1)(2008-9#1)(2010-7#1)
occurs at the##20##3##(1990-10#1)(1990-5#1)(1991-12#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-3#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
occurs at##59##2##(1990-10#1)(1990-11#3)(1990-5#1)(1991-12#2)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#2)(1994-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-12#4)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
occurs because##3##2##(2008-2#1)(2008-8#1)(2012-3#1)
occurs before##2##2##(1990-7#1)(2009-6#1)
occurs below##3##2##(1995-11#1)(2008-2#1)(2008-8#1)
occurs between the##5##3##(1994-5#2)(1995-5#1)(2008-10#1)(2008-3#1)
occurs between two##2##3##(1992-9#1)(2008-6#1)
occurs between##14##2##(1992-9#1)(1994-5#2)(1995-5#1)(1997-6#2)(2008-10#3)(2008-3#2)(2008-6#1)(2010-5#1)(2011-1#1)
occurs by a##2##3##(1990-2#1)(1995-8#1)
occurs by##12##2##(1990-2#1)(1991-5#1)(1993-8#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-8#1)(2008-10#3)(2008-4#1)
occurs commonly in##2##3##(2008-8#1)(2009-9#1)
occurs continuously##2##2##(2008-9#1)(2011-2#1)
occurs due to the##2##4##(2013-1#1)(2013-8#1)
occurs during liver##2##3##(1994-6#1)(1997-7#1)
occurs during the##7##3##(1990-11#1)(1994-8#2)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
occurs during##21##2##(1990-11#1)(1990-12#1)(1991-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#3)(2012-3#1)
occurs early##2##2##(1996-3#1)(2008-2#1)
occurs even##2##2##(1994-8#1)(2012-3#1)
occurs following##3##2##(1991-9#2)(2008-7#1)
occurs for the##3##3##(1992-8#1)(2007-11#1)(2008-2#1)
occurs for##9##2##(1992-8#1)(1996-12#1)(2007-11#2)(2008-11#1)(2008-2#3)(2008-3#1)
occurs frequently in##3##3##(1994-11#1)(2008-3#1)(2010-10#1)
occurs frequently##7##2##(1991-12#1)(1994-11#1)(1997-3#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)
occurs from an##2##3##(1995-5#1)(1997-1#1)
occurs from##4##2##(1995-5#1)(1997-1#1)(2008-10#1)(2009-7#1)
occurs if##2##2##(2007-11#1)(2008-3#1)
occurs in 1 in##2##4##(2012-3#1)(2013-1#1)
occurs in a##17##3##(1993-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-11#1)(2009-8#1)(2012-12#1)(2013-8#1)
occurs in about##2##3##(2008-1#1)(2008-7#1)
occurs in approximately##2##3##(1991-2#1)(2008-7#1)
occurs in both##2##3##(2008-7#1)(2009-6#1)
occurs in elderly##2##3##(1993-5#1)(2008-7#1)
occurs in individuals##3##3##(2006-10#1)(2007-12#1)(2008-8#1)
occurs in less than##2##4##(2007-12#1)(2012-3#1)
occurs in many##3##3##(2007-2#2)(2008-4#1)
occurs in most##2##3##(2007-11#1)(2008-6#1)
occurs in patients with##3##4##(1997-7#1)(2008-1#1)(2008-6#1)
occurs in some patients##2##4##(1994-11#1)(2007-9#1)
occurs in some##5##3##(1994-11#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-10#1)
occurs in the##52##3##(1990-5#1)(1991-12#2)(1992-8#2)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
occurs in these##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
occurs in this##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
occurs in two##2##3##(1995-5#1)(2008-10#1)
occurs in vivo##3##3##(1992-12#1)(1994-6#1)(1995-3#1)
occurs in##189##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#5)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-10#2)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#2)(2007-9#1)(2008-1#5)(2008-10#28)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#13)(2008-8#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#1)
occurs independently of##3##3##(2008-9#1)(2009-9#1)(2012-2#1)
occurs inside##2##2##(2008-8#2)
occurs intracellularly##2##2##(1995-12#1)(2013-1#1)
occurs mainly in##2##3##(1995-12#1)(2011-1#1)
occurs mainly through##2##3##(2008-4#1)(2011-2#1)
occurs mainly##7##2##(1991-5#1)(1992-12#1)(1995-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
occurs more frequently##2##3##(2008-3#1)(2011-2#1)
occurs more often##2##3##(2007-11#1)(2012-7#1)
occurs more##4##2##(2007-11#1)(2008-3#1)(2011-2#1)(2012-7#1)
occurs most commonly in##2##4##(1993-6#1)(2009-3#1)
occurs most frequently##2##3##(2007-12#1)(2013-1#1)
occurs most##5##2##(1993-6#1)(2006-10#1)(2007-12#1)(2009-3#1)(2013-1#1)
occurs naturally##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
occurs normally in##2##3##(1993-6#1)(2008-9#1)
occurs on##10##2##(1991-9#1)(1995-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2010-6#1)(2012-2#1)
occurs only during##2##3##(1990-12#1)(1994-8#1)
occurs only for angles##2##4##(2008-3#2)
occurs only in##5##3##(1990-6#1)(2008-5#1)(2008-6#1)(2008-7#2)
occurs only##14##2##(1990-12#1)(1990-6#1)(1994-8#1)(1994-9#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2012-2#1)
occurs over a##2##3##(1990-2#1)(1992-9#1)
occurs over##5##2##(1990-2#1)(1992-9#1)(2007-5#1)(2008-10#1)(2008-3#1)
occurs owing to##2##3##(2007-12#2)
occurs predominantly in the##2##4##(2009-6#1)(2013-7#1)
occurs predominantly##3##2##(2009-5#1)(2009-6#1)(2013-7#1)
occurs primarily in the##2##4##(1992-10#1)(2008-11#1)
occurs primarily in##4##3##(1992-10#1)(2008-11#2)(2012-12#1)
occurs primarily##8##2##(1991-12#1)(1992-10#1)(1994-12#1)(2008-11#3)(2008-4#1)(2012-12#1)
occurs prior to##2##3##(2008-10#1)(2008-9#1)
occurs rapidly##2##2##(2008-10#1)(2008-4#1)
occurs rarely##2##2##(1991-2#1)(2007-8#1)
occurs shortly after the##2##4##(2010-12#1)(2011-1#1)
occurs shortly after##3##3##(1995-2#1)(2010-12#1)(2011-1#1)
occurs simultaneously with##2##3##(1995-5#1)(2012-7#1)
occurs sporadically##2##2##(2008-10#1)(2008-7#1)
occurs through a##4##3##(1994-8#1)(1995-6#1)(2008-6#1)(2011-1#1)
occurs through the##5##3##(1993-11#1)(1995-6#1)(2008-10#2)(2011-2#1)
occurs through##17##2##(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-6#3)(2007-12#1)(2008-10#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
occurs to##6##2##(1992-3#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#1)
occurs under##4##2##(1991-2#1)(1996-5#1)(2012-12#1)(2013-8#1)
occurs via a##3##3##(1992-11#1)(1995-8#1)(1996-2#1)
occurs via an##2##3##(1993-11#1)(1995-2#1)
occurs via##10##2##(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1993-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(2010-12#1)
occurs when a##2##3##(2008-4#1)(2011-2#1)
occurs when proliferation ceases while cells##2##6##(2008-11#2)
occurs when the##7##3##(1991-3#1)(1991-9#1)(2007-11#2)(2008-10#1)(2010-8#1)(2013-8#1)
occurs when##26##2##(1990-5#1)(1991-3#2)(1991-9#1)(1992-1#1)(1993-11#1)(1995-8#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
occurs with the##2##3##(1997-7#1)(2009-11#1)
occurs with##15##2##(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)
occurs within a##2##3##(2008-8#1)(2009-5#1)
occurs within the##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
occurs within##9##2##(1992-6#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)
occurs without##6##2##(1990-6#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-8#1)(2012-12#1)
occurs##711##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-5#5)(1990-6#2)(1990-7#4)(1990-9#1)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#3)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#4)(1992-3#3)(1992-5#1)(1992-6#5)(1992-8#5)(1992-9#5)(1993-11#5)(1993-12#4)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-11#10)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#7)(1994-6#5)(1994-8#9)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#5)(1995-5#6)(1995-6#11)(1995-8#5)(1996-11#1)(1996-12#2)(1996-2#8)(1996-3#3)(1996-5#11)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#6)(2006-10#3)(2007-10#2)(2007-11#15)(2007-12#24)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#9)(2008-10#95)(2008-11#22)(2008-12#7)(2008-2#15)(2008-3#24)(2008-4#20)(2008-5#12)(2008-6#14)(2008-7#32)(2008-8#20)(2008-9#9)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#9)(2012-3#11)(2012-7#2)(2013-1#19)(2013-7#5)(2013-8#7)
ocean and atmospheric##2##3##(2008-3#2)
ocean and##5##2##(2008-2#2)(2008-3#3)
ocean bio-optical##2##2##(2008-2#1)(2008-3#1)
ocean color and##4##3##(2008-2#1)(2008-3#3)
ocean color sensors##3##3##(2008-2#3)
ocean color##29##2##(2008-2#12)(2008-3#17)
ocean currents##3##2##(1996-4#2)(2013-1#1)
ocean floor##2##2##(1991-8#1)(2008-8#1)
ocean optics##2##2##(2008-3#2)
ocean water types##2##3##(2008-3#2)
ocean water##12##2##(2008-2#5)(2008-3#7)
ocean##103##1##(1990-8#3)(1991-8#1)(1994-1#1)(1996-4#5)(2008-10#5)(2008-2#33)(2008-3#46)(2008-8#2)(2008-9#4)(2012-2#2)(2013-1#1)
ocean-bottom##2##1##(2008-3#2)
ocean-color##5##1##(2008-2#3)(2008-3#2)
oceanic chlorophyll##2##2##(2008-2#2)
oceanic front##3##2##(2010-8#3)
oceanic islands##3##2##(1996-4#1)(2008-8#2)
oceanic water##3##2##(2008-2#3)
oceanic waters##6##2##(2008-2#1)(2008-3#5)
oceanic##35##1##(1996-4#1)(2008-10#1)(2008-2#15)(2008-3#10)(2008-8#2)(2010-8#4)(2011-2#2)
oceanographic cruises##2##2##(2008-5#2)
oceanographic lidar##3##2##(2008-2#3)
oceanographic##8##1##(2008-2#3)(2008-5#2)(2008-8#1)(2010-5#1)(2010-8#1)
oceans##9##1##(2008-10#2)(2008-2#1)(2008-3#2)(2012-2#3)(2013-8#1)
ocellata##7##1##(2010-8#6)(2010-9#1)
ocellatus##7##1##(1996-2#1)(2008-5#4)(2010-3#2)
ocelli##3##1##(2008-9#3)
oceurrence of##2##2##(2013-8#2)
ochnaflavone##5##1##(1994-11#4)(2008-11#1)
ochracea in##2##2##(2008-10#2)
ochracea was##2##2##(2008-10#2)
ochracea##11##1##(2008-10#11)
ochratoxin A (OTA)##3##3##(2008-10#3)
ochratoxin A##9##2##(1993-3#2)(1995-11#1)(2008-10#6)
ochratoxin##10##1##(1993-3#2)(1995-11#1)(1997-3#1)(2008-10#6)
ochre##12##1##(1995-8#1)(2008-10#6)(2008-5#2)(2008-9#3)
octadecane##2##1##(2008-10#2)
octadecenedioic acid##5##2##(2008-5#5)
octadecyl and diol##2##3##(1997-2#2)
octadecyl silica membrane disks modified with##4##6##(2008-10#4)
octadecyl silica membrane disks modified##9##5##(2008-10#9)
octadecyl silica##12##2##(2008-10#12)
octadecyl##20##1##(1990-8#1)(1997-2#2)(1997-7#1)(2008-10#16)
octadecyl-bonded silica membrane##2##3##(2008-10#2)
octadecyl-bonded silica##3##2##(2008-10#3)
octadecyl-treated porous glasses##2##3##(1990-8#2)
octadecyl-treated##3##1##(1990-8#3)
octadecylamine##2##1##(2008-10#2)
octadecylsilica##4##1##(1990-8#1)(2008-10#3)
octadecylsilyl##2##1##(1991-5#1)(2008-4#1)
octahedra##6##1##(1996-2#2)(1997-7#1)(2008-10#3)
octahedral coordination##3##2##(1996-2#1)(1997-7#1)(2008-10#1)
octahedral geometry##5##2##(1996-2#2)(1997-7#1)(2008-10#1)(2008-5#1)
octahedral low-spin diadducts##2##3##(1997-7#2)
octahedral##13##1##(1996-2#4)(1997-7#4)(2008-10#3)(2008-5#1)(2011-2#1)
octahedron##3##1##(1996-2#2)(1997-7#1)
octahydro-1##3##1##(2008-10#3)
octamer motif##3##2##(1994-9#3)
octamer##13##1##(1991-10#2)(1992-3#1)(1992-6#1)(1992-8#2)(1994-9#4)(2008-8#3)
octameric##6##1##(1991-10#2)(1992-3#1)(1992-8#2)(1995-2#1)
octan-1-ol##3##1##(2008-10#3)
octane##5##1##(1990-5#2)(2007-11#1)(2008-10#1)(2008-3#1)
octanoic##2##1##(2008-10#1)(2008-5#1)
octanol##11##1##(1991-5#7)(2008-10#4)
octanol-water distribution##2##2##(2008-10#2)
octanol-water##3##1##(2008-10#2)(2008-5#1)
octanol/water partition coefficient##2##3##(2008-10#1)(2008-5#1)
octanol/water partition##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
octanol/water##4##1##(1991-5#1)(1996-2#1)(2008-10#1)(2008-5#1)
octapeptide and##2##2##(1992-5#1)(2008-4#1)
octapeptide##12##1##(1990-7#1)(1991-1#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-8#3)(2008-4#1)
octapeptides##2##1##(1995-12#1)(2008-9#1)
octaurelia##2##1##(2008-12#2)
octave of the##2##3##(2007-11#1)(2007-12#1)
octave##5##1##(2007-11#2)(2007-12#2)(2007-7#1)
octocorals and sponges##3##3##(2008-5#3)
octocorals##4##1##(2008-5#4)
octogenarians##3##1##(1995-3#1)(1997-7#1)(2011-2#1)
octopamine and##2##2##(1994-2#1)(2008-7#1)
octopamine##8##1##(1991-5#1)(1994-2#3)(2008-7#4)
octopirox in##2##2##(2008-5#2)
octopole collision cell ICP-MS##4##4##(2008-10#4)
octopole collision cell##6##3##(2008-10#6)
octopole reaction##2##2##(2008-10#2)
octopole##8##1##(2008-10#8)
octopus##2##1##(2008-10#1)(2008-7#1)
octreotide for##2##2##(1991-8#1)(1995-8#1)
octreotide in##2##2##(1991-11#1)(1991-8#1)
octreotide##11##1##(1991-11#1)(1991-8#3)(1995-8#2)(1997-4#4)(2007-5#1)
octy##2##1##(2008-10#2)
octyl beta-D-glucoside##2##2##(2008-4#2)
octyl dimethyl PABA##3##3##(2008-5#3)
octyl dimethyl##4##2##(2008-5#4)
octyl ether (NPOE)##5##3##(2008-10#5)
octyl ether (o-NPOE)##2##3##(2008-10#2)
octyl ether##14##2##(2008-10#14)
octyl glucoside##4##2##(1990-2#1)(1992-12#2)(1994-11#1)
octyl methoxy##2##2##(2008-5#2)
octyl methoxycinnamate and octyl salicylate##2##5##(2008-5#2)
octyl methoxycinnamate and##3##3##(2008-5#3)
octyl methoxycinnamate##9##2##(2008-5#9)
octyl salicylate##5##2##(2008-5#5)
octyl##42##1##(1990-2#1)(1992-12#2)(1994-11#1)(1994-5#1)(2008-10#15)(2008-4#2)(2008-5#20)
octylamine##2##1##(2008-10#1)(2013-1#1)
octylmethoxycinnamate##2##1##(2008-5#2)
octylphenol##4##1##(2008-10#3)(2008-11#1)
octylphenoxypolyethoxyethanol##2##1##(2008-10#2)
octylphenyl-N-N- diisobutylcarbamoylmethylphosphine oxide##2##3##(2008-10#2)
ocular bioavailability##3##2##(1991-11#1)(2011-3#2)
ocular defects##2##2##(1997-3#1)(2013-8#1)
ocular disease##2##2##(2011-1#1)(2012-12#1)
ocular diseases##3##2##(2008-8#1)(2010-10#2)
ocular dominance columns in##3##4##(2008-11#3)
ocular dominance columns##4##3##(2008-11#4)
ocular dominance plasticity in adult##2##5##(1994-8#2)
ocular dominance plasticity##5##3##(1994-8#2)(2012-2#3)
ocular dominance shift##2##3##(1994-8#1)(2012-2#1)
ocular dominance##15##2##(1994-8#5)(2008-11#5)(2012-2#5)
ocular infection##3##2##(2012-2#1)(2012-3#2)
ocular inflammation##2##2##(2010-1#1)(2011-2#1)
ocular manifestations##4##2##(2007-10#3)(2008-7#1)
ocular melanoma##4##2##(1994-2#1)(2010-9#3)
ocular melatonin##2##2##(1995-12#2)
ocular prosthesis##2##2##(2013-8#2)
ocular symptoms were##2##3##(2006-10#1)(2007-10#1)
ocular symptoms##4##2##(2006-10#2)(2007-10#1)(2008-3#1)
ocular trauma##5##2##(1991-11#2)(2011-1#3)
ocular wave-front aberration##2##3##(2007-12#2)
ocular##107##1##(1990-3#1)(1990-7#1)(1991-11#3)(1991-2#2)(1991-6#1)(1993-9#1)(1994-2#1)(1994-8#5)(1994-9#1)(1995-12#2)(1997-2#1)(1997-3#2)(2006-10#2)(2007-10#5)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-3#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#9)(2011-2#4)(2011-3#5)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#6)
oculocutaneous albinism##2##2##(1997-4#2)
oculomotor##4##1##(1996-3#1)(2008-6#1)(2011-2#2)
oculopalpebral signs##2##2##(2013-1#2)
od##2##1##(1992-9#1)(2013-1#1)
odd##4##1##(1992-6#1)(2007-11#1)(2008-10#1)(2011-2#1)
odd-periodic correlation##3##2##(2008-2#1)(2008-3#2)
odd-periodic##6##1##(2008-2#4)(2008-3#2)
oddball##2##1##(2009-2#1)(2013-8#1)
odds for##4##2##(1995-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
odds of CP##2##3##(2011-2#2)
odds of a positive discography##3##5##(2012-12#3)
odds of a##5##3##(2010-7#2)(2012-12#3)
odds of being##3##3##(2010-6#1)(2011-1#1)(2013-1#1)
odds of##26##2##(2007-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#8)
odds ratio (OR) for##3##4##(2008-6#1)(2009-9#1)(2012-3#1)
odds ratio (OR)##8##3##(2007-10#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
odds ratio 1##4##3##(2008-8#1)(2011-1#1)(2011-2#2)
odds ratio 2##2##3##(2007-10#2)
odds ratio for##7##3##(1991-11#1)(1995-8#1)(1997-8#1)(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#1)
odds ratio of##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#2)(2012-3#2)
odds ratio##45##2##(1990-8#1)(1991-11#2)(1991-8#2)(1994-2#1)(1994-9#2)(1995-8#1)(1997-8#1)(2007-10#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-3#4)(2013-1#3)
odds ratios (OR)##2##3##(2011-2#1)(2013-1#1)
odds ratios for##3##3##(1990-9#2)(2008-11#1)
odds ratios##15##2##(1990-9#2)(1993-9#2)(1995-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
odds reduction##2##2##(1994-7#1)(1997-7#1)
odds with the##3##3##(1995-11#1)(1995-8#1)(1996-5#1)
odds with##4##2##(1995-11#1)(1995-8#1)(1996-5#1)(2009-4#1)
odds##104##1##(1990-8#1)(1990-9#2)(1991-11#2)(1991-8#2)(1993-5#1)(1993-9#2)(1994-2#1)(1994-7#2)(1994-9#2)(1995-11#2)(1995-2#1)(1995-8#2)(1996-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#6)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#4)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#5)(2011-2#13)(2012-12#5)(2012-3#7)(2013-1#14)
odontogenic cyst##5##2##(2007-12#1)(2013-1#4)
odontogenic cysts##3##2##(2013-1#3)
odontogenic keratocyst##9##2##(1997-3#1)(2007-12#8)
odontogenic keratocysts##2##2##(2007-12#1)(2013-1#1)
odontogenic tumor##6##2##(2007-12#3)(2013-1#3)
odontogenic tumors##4##2##(2007-12#2)(2013-1#2)
odontogenic##36##1##(1997-3#1)(2007-12#18)(2012-2#1)(2013-1#16)
odontoiatric##2##1##(1990-12#1)(1990-9#1)
odontoid##4##1##(2011-2#3)(2013-1#1)
odontology##4##1##(1993-2#1)(2008-10#2)(2008-12#1)
odontoma##5##1##(2007-12#1)(2013-1#4)
odontomas in##2##2##(2013-1#2)
odontomas##3##1##(2013-1#3)
odontostomatologic##2##1##(1990-3#2)
odor chemicals##6##2##(2008-10#6)
odor compounds##2##2##(2007-12#2)
odor generator##2##2##(2008-4#2)
odor of##4##2##(1994-8#1)(2008-5#2)(2009-8#1)
odor signature chemicals##2##3##(2008-10#2)
odor signature##3##2##(2008-10#3)
odor##40##1##(1990-8#1)(1994-8#1)(2007-12#2)(2008-10#12)(2008-4#7)(2008-5#10)(2008-8#1)(2009-8#5)(2012-2#1)
odor-binding##2##1##(2008-5#2)
odorant binding proteins##3##3##(2013-8#3)
odorant binding##4##2##(2008-10#1)(2013-8#3)
odorant##8##1##(1991-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#3)
odorants##4##1##(1991-2#2)(2012-2#1)(2013-1#1)
odoratus##2##1##(2008-5#2)
odorless##2##1##(2008-5#2)
odorous##5##1##(1994-8#1)(2008-12#1)(2008-5#3)
odors##19##1##(1990-11#1)(1993-3#1)(1994-8#1)(2007-12#1)(2008-10#4)(2008-4#6)(2008-5#2)(2009-6#1)(2013-1#2)
odour detection##3##2##(2008-7#3)
odour evaluation##4##2##(2008-5#4)
odour perception##8##2##(2008-7#8)
odour production##2##2##(1997-4#1)(2008-5#1)
odour##40##1##(1990-5#3)(1991-2#1)(1993-3#1)(1997-4#3)(2007-12#1)(2008-10#8)(2008-5#11)(2008-7#11)(2009-12#1)
odours and##2##2##(2008-10#1)(2010-4#1)
odours##8##1##(2008-10#4)(2008-5#3)(2010-4#1)
odynophagia##2##1##(1997-8#1)(2008-5#1)
oedema and##4##2##(1991-6#1)(1994-6#1)(2008-7#1)(2011-2#1)
oedema in##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
oedema induced by carrageenan and histamine##2##6##(2013-7#2)
oedema of the##2##3##(2011-1#1)(2011-3#1)
oedema was##3##2##(1996-6#3)
oedema with##2##2##(2011-2#1)(2013-7#1)
oedema##46##1##(1991-11#1)(1991-6#1)(1994-6#1)(1994-7#1)(1995-11#1)(1996-6#5)(2007-10#1)(2007-11#1)(2008-5#3)(2008-7#5)(2010-7#3)(2011-1#5)(2011-2#10)(2011-3#1)(2012-8#1)(2013-1#2)(2013-7#3)(2013-8#1)
oedematous##3##1##(2011-1#1)(2012-2#2)
oerstedii and B##3##3##(2008-5#3)
oerstedii##6##1##(2007-12#3)(2008-5#3)
oesophageal and gastric events##2##4##(2008-11#2)
oesophageal and gastric##3##3##(2008-11#3)
oesophageal cancer and##2##3##(1990-9#1)(2011-2#1)
oesophageal cancer##7##2##(1990-9#2)(1993-6#1)(2008-1#2)(2011-2#2)
oesophageal or gastric##2##3##(2008-11#2)
oesophageal smooth muscle##2##3##(1995-12#2)
oesophageal sphincter##4##2##(1994-2#1)(2011-1#1)(2012-3#2)
oesophageal varices##6##2##(1991-5#1)(2009-8#3)(2013-1#2)
oesophageal##41##1##(1990-9#2)(1991-5#1)(1993-2#1)(1993-6#2)(1994-2#2)(1995-12#4)(1996-3#2)(2007-11#1)(2008-1#3)(2008-11#9)(2008-7#1)(2009-8#3)(2010-11#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#2)
oesophagectomy and##2##2##(2011-2#2)
oesophagectomy##5##1##(2007-8#2)(2009-4#1)(2011-2#2)
oesophagitis##11##1##(1993-12#1)(1994-2#1)(1996-3#1)(1996-6#5)(2008-11#2)(2009-8#1)
oesophagocutaneous##2##1##(2008-7#2)
oesophagus##21##1##(1990-12#1)(1990-6#1)(1990-9#1)(1993-6#1)(1996-8#2)(2007-8#2)(2008-1#3)(2008-11#1)(2009-4#3)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
oestradiol##6##1##(1994-6#1)(2011-2#4)(2012-2#1)
oestrogen receptor##2##2##(2007-10#1)(2008-2#1)
oestrogen receptors##2##2##(1990-11#1)(2008-4#1)
oestrogen target##2##2##(1994-6#1)(2008-4#1)
oestrogen##20##1##(1990-11#2)(1991-5#1)(1992-8#3)(1994-6#2)(2007-10#1)(2008-2#1)(2008-4#7)(2009-6#1)(2011-2#1)(2013-8#1)
oestrogens have been##2##3##(1996-11#1)(2008-4#1)
oestrogens in##2##2##(2008-4#2)
oestrogens##9##1##(1990-9#1)(1994-2#1)(1994-6#1)(1996-11#1)(2008-4#5)
oestrone-3-glucuronide##2##1##(1995-12#2)
oestrus##2##1##(1994-7#2)
of $1##2##2##(1994-2#1)(1994-9#1)
of $100##3##2##(1993-3#1)(1994-2#1)(1997-1#1)
of $5##2##2##(1994-3#1)(2008-11#1)
of $500##2##2##(1993-1#1)(1994-9#1)
of %##5##2##(2008-5#5)
of &gt##77##2##(1992-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-5#2)(2007-11#5)(2007-12#5)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#4)(2009-3#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
of &lt##78##2##(1993-8#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-5#3)(1997-7#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-2#9)(2008-3#10)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
of &quot##187##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-8#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#3)(1997-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#5)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#10)(2008-9#2)(2009-10#2)(2009-11#1)(2009-7#2)(2009-8#2)(2010-1#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#4)(2013-8#4)
of 'Aichi Asahi'##2##3##(2008-10#2)
of 'Canthatch'##2##2##(2008-10#2)
of 'Oketsu'##2##2##(2008-10#2)
of 'beating heart' without CPB (off-pump##2##6##(2008-10#2)
of 'benifuuki' green tea##2##4##(2008-11#2)
of 'out of date'##2##4##(2008-1#2)
of 'replenishing##3##2##(2013-8#3)
of 'treating different diseases by the same method'##2##8##(2013-8#2)
of 'treating different diseases by the same##3##7##(2013-8#3)
of (+)-CQ##2##2##(2008-10#2)
of (-) diet##4##3##(1997-4#4)
of (-)##5##2##(1991-1#1)(1997-4#4)
of (-)-dictyostatin##3##2##(2008-8#3)
of (-)-epicatechin in##2##3##(2008-10#2)
of (-)-epicatechin##3##2##(2008-10#3)
of (0##2##2##(1996-5#1)(2008-9#1)
of (1##9##2##(1991-8#3)(1995-2#1)(2007-12#1)(2008-10#4)
of (1) and (2)##2##4##(2008-5#2)
of (1) and##4##3##(1990-11#1)(2006-4#1)(2008-5#2)
of (1)##7##2##(1990-11#1)(1993-3#1)(1997-3#1)(2006-4#1)(2008-5#2)(2012-12#1)
of (187)Os in molybdenite by##2##5##(2008-10#2)
of (2##4##2##(2008-10#1)(2008-12#1)(2008-3#2)
of (2+1) -dimensional##2##3##(2007-12#2)
of (234)Th##2##2##(2008-10#2)
of (3##2##2##(1992-11#1)(1995-2#1)
of (5##3##2##(2008-10#2)(2008-2#1)
of (58##2##2##(2008-10#2)
of (7##3##2##(1992-10#1)(2008-10#1)(2008-3#1)
of (R##2##2##(1996-2#2)
of (R)-1##2##2##(2008-10#2)
of (R)-levocetirizine##3##2##(2010-4#3)
of (a)##2##2##(2011-1#1)(2012-12#1)
of (dT)n##3##2##(1995-5#3)
of (i)##5##2##(1990-7#1)(2008-10#2)(2008-5#1)(2008-7#1)
of (rGGCGAGCC)2##2##2##(1993-11#2)
of +##2##2##(1990-12#1)(2008-10#1)
of +/- 1##2##3##(2008-10#1)(2008-3#1)
of +/-0##10##2##(2007-11#1)(2008-10#7)(2008-3#2)
of +/-1##4##2##(2008-10#2)(2008-3#2)
of +/-10%##2##2##(2008-10#2)
of +/-2##4##2##(2007-11#1)(2008-10#3)
of +0##7##2##(1995-12#1)(2008-10#6)
of +5##2##2##(2007-12#1)(2011-2#1)
of -##3##2##(1995-3#1)(2008-10#1)(2009-12#1)
of -0##31##2##(1992-6#1)(1992-7#2)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#22)(2008-3#1)(2008-7#2)
of -1##6##2##(1996-2#1)(2008-10#3)(2012-7#1)(2012-9#1)
of -12##2##2##(2008-10#1)(2012-2#1)
of -23##2##2##(2008-10#1)(2008-3#1)
of -3 dB##2##3##(2008-3#1)(2009-5#1)
of -3##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
of -300##3##2##(2008-10#2)(2008-3#1)
of -40 mV##2##3##(1995-12#1)(2008-8#1)
of -40##3##2##(1995-12#1)(2007-12#1)(2008-8#1)
of -5##2##2##(1991-8#1)(2008-10#1)
of -6##2##2##(2008-10#1)(2008-3#1)
of -7##4##2##(1991-8#1)(2008-10#3)
of -8##2##2##(2007-11#1)(2008-10#1)
of 0 to 10##2##4##(2008-5#1)(2008-7#1)
of 0 to 5##2##4##(2008-10#1)(2008-3#1)
of 0 to##12##3##(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2013-1#1)
of 0##1260##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-11#6)(1992-12#2)(1992-3#7)(1992-5#1)(1992-6#2)(1992-8#8)(1992-9#3)(1993-12#3)(1993-2#7)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#1)(1995-11#5)(1995-12#5)(1995-2#8)(1995-3#6)(1995-5#2)(1995-6#3)(1995-8#4)(1996-12#4)(1996-2#1)(1996-5#4)(1996-7#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-7#2)(1997-8#3)(2006-4#1)(2007-1#1)(2007-11#26)(2007-12#38)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#661)(2008-11#37)(2008-12#10)(2008-2#45)(2008-3#76)(2008-5#18)(2008-6#15)(2008-7#14)(2008-8#14)(2008-9#11)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#16)(2011-2#22)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#26)(2013-7#8)(2013-8#8)
of 0-1##2##2##(2008-10#1)(2013-1#1)
of 0-10##5##2##(2008-10#2)(2008-7#1)(2013-1#2)
of 0-2##3##2##(2008-10#2)(2013-1#1)
of 0-4##2##2##(1991-3#1)(2008-10#1)
of 0-5##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
of 1 GHz##2##3##(2008-3#1)(2011-1#1)
of 1 M##4##3##(1997-2#1)(2008-10#3)
of 1 W##7##3##(2007-11#2)(2007-12#3)(2008-3#2)
of 1 alpha##3##3##(1992-12#3)
of 1 and 0##2##4##(2008-10#2)
of 1 and 2##3##4##(1997-7#1)(2008-12#1)(2010-5#1)
of 1 and the##2##4##(2008-10#2)
of 1 and##10##3##(1997-7#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2010-5#1)
of 1 cm##4##3##(2007-12#1)(2007-8#1)(2009-2#1)(2013-1#1)
of 1 equiv of##2##4##(1992-6#1)(1996-2#1)
of 1 g##2##3##(2008-11#1)(2008-12#1)
of 1 have been##2##4##(1997-7#2)
of 1 in##6##3##(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-5#1)
of 1 m##3##3##(2008-10#1)(2008-3#2)
of 1 mM##5##3##(1992-12#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-11#1)
of 1 mW##3##3##(2007-12#1)(2008-3#2)
of 1 mg##4##3##(1992-5#1)(1996-5#1)(2008-5#1)(2011-2#1)
of 1 microM##8##3##(1990-12#1)(1990-5#1)(1991-12#1)(1995-11#2)(1997-7#2)(2009-12#1)
of 1 microm##4##3##(2007-11#1)(2008-3#3)
of 1 min##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
of 1 ml min(-1)##3##4##(2008-10#3)
of 1 ml of##2##4##(2008-10#2)
of 1 ml##6##3##(2008-10#5)(2013-1#1)
of 1 ml/min##3##3##(2008-10#1)(2010-3#1)(2012-2#1)
of 1 mm##4##3##(1994-2#1)(2008-1#1)(2008-3#1)(2008-9#1)
of 1 mol l(-1)##3##4##(2008-10#3)
of 1 mol of##2##4##(1994-11#1)(1994-5#1)
of 1 mol##6##3##(1994-11#1)(1994-5#1)(2008-10#4)
of 1 month##2##3##(1990-6#1)(2008-9#1)
of 1 ms##2##3##(2008-3#2)
of 1 muM for##2##4##(2008-10#2)
of 1 muM##5##3##(2008-10#4)(2008-11#1)
of 1 mug l(-1)##3##4##(2008-10#3)
of 1 mug##5##3##(2008-10#5)
of 1 nM##3##3##(1995-11#1)(1995-12#1)(2008-11#1)
of 1 ng/ml##2##3##(1992-8#1)(1996-5#1)
of 1 nm##3##3##(2008-3#2)(2009-7#1)
of 1 or##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
of 1 to 4##2##4##(2008-10#1)(2008-6#1)
of 1 to##8##3##(1992-10#1)(1992-8#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
of 1 week##2##3##(2008-10#1)(2008-7#1)
of 1 with##3##3##(1996-2#2)(2008-10#1)
of 1 x 10(-3)##2##4##(2008-2#2)
of 1 x 10(-4)##2##4##(1992-8#1)(2008-3#1)
of 1 x 10(7)##2##4##(2008-10#1)(2008-2#1)
of 1 x##12##3##(1992-8#2)(1994-5#1)(2008-10#3)(2008-2#3)(2008-3#3)
of 1 year##6##3##(1995-2#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-2#2)
of 1##994##2##(1990-11#6)(1990-12#4)(1990-2#6)(1990-5#3)(1990-6#4)(1990-7#6)(1990-8#3)(1990-9#5)(1991-12#2)(1991-3#1)(1991-5#8)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#9)(1992-3#5)(1992-5#2)(1992-6#9)(1992-8#6)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#6)(1994-6#3)(1994-8#1)(1995-11#6)(1995-12#4)(1995-2#5)(1995-3#12)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#4)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#15)(1996-6#6)(1996-7#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#4)(1997-9#1)(2007-10#5)(2007-11#29)(2007-12#37)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#375)(2008-11#24)(2008-12#8)(2008-2#37)(2008-3#65)(2008-4#5)(2008-5#18)(2008-6#7)(2008-7#9)(2008-8#5)(2008-9#13)(2009-1#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#11)(2012-1#3)(2012-12#7)(2012-2#14)(2012-3#7)(2013-1#18)(2013-7#3)(2013-8#4)
of 1% and##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
of 1% at##2##3##(2008-10#1)(2008-11#1)
of 1% in the##3##4##(1994-11#1)(2008-10#2)
of 1%##22##2##(1992-2#1)(1993-11#1)(1994-11#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-3#1)
of 1-##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
of 1-10##3##2##(1994-12#1)(1996-2#1)(2008-10#1)
of 1-2##2##2##(2008-11#2)
of 1-20##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
of 1-3 x##2##3##(1990-5#1)(1994-6#1)
of 1-4##6##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2013-1#2)
of 1-5##6##2##(1990-2#2)(2007-11#1)(2008-10#2)(2008-3#1)
of 1-8##2##2##(2008-10#2)
of 1-NAA##3##2##(2008-10#3)
of 1-[G'(1)]##2##2##(1996-5#2)
of 1-decylalcohol##2##2##(2008-10#2)
of 1-dopa##2##2##(2008-7#2)
of 1-fluoro-2##3##2##(1995-6#1)(2008-10#2)
of 1-microm##2##2##(2008-2#1)(2008-3#1)
of 1-naphthaleneacetic acid##2##3##(2008-10#2)
of 1-naphthol and##2##3##(1992-8#1)(2008-11#1)
of 1-nitroso-2-naphthol##2##2##(2008-10#2)
of 1-pyrrolidine##2##2##(2008-10#2)
of 1-year##2##2##(2010-5#1)(2012-12#1)
of 1/1##2##2##(1996-2#1)(2008-10#1)
of 1/8##2##2##(1991-12#1)(2008-3#1)
of 10 Hz##4##3##(2008-3#3)(2008-9#1)
of 10 J##2##3##(2007-12#1)(2008-2#1)
of 10 amino##2##3##(1995-8#1)(2008-8#1)
of 10 and 20##2##4##(2008-5#1)(2008-9#1)
of 10 and##11##3##(1994-9#1)(1995-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-12#1)
of 10 cases##2##3##(2008-1#1)(2008-6#1)
of 10 cm##3##3##(2008-10#2)(2008-3#1)
of 10 days##6##3##(1990-6#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
of 10 degrees C##2##4##(2008-10#2)
of 10 degrees##7##3##(2008-10#2)(2008-2#1)(2008-3#4)
of 10 different##4##3##(1990-7#1)(1993-8#1)(2008-10#1)(2008-7#1)
of 10 m##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
of 10 mM phosphate##2##4##(2008-10#2)
of 10 mM##7##3##(1995-11#1)(1997-2#1)(2008-10#3)(2008-11#2)
of 10 mV##3##3##(2008-10#3)
of 10 male and 10 female Tg##5##7##(2008-9#5)
of 10 male and 10 female p53 haploinsufficient mice were exposed to drinking water containing 0##2##16##(2008-9#2)
of 10 male and 10 female p53 haploinsufficient mice were##3##10##(2008-9#3)
of 10 male and 10 female##15##6##(2008-9#15)
of 10 male##16##3##(2008-9#15)(2009-7#1)
of 10 mg##3##3##(1991-6#1)(2008-10#2)
of 10 mg/kg##4##3##(1993-3#1)(1994-6#1)(2007-7#1)(2013-1#1)
of 10 microg of##2##4##(2007-10#1)(2008-10#1)
of 10 microg##3##3##(2007-10#1)(2008-10#2)
of 10 micrograms##3##3##(1990-2#1)(1993-6#1)(1996-2#1)
of 10 min##7##3##(1994-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)
of 10 mm##3##3##(2007-11#1)(2008-10#1)(2010-10#1)
of 10 months##4##3##(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
of 10 muM##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
of 10 nM##6##3##(1992-6#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
of 10 ng##2##3##(2008-10#2)
of 10 nm and##2##4##(2007-12#1)(2008-7#1)
of 10 nm filaments##2##4##(2008-8#2)
of 10 nm##5##3##(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)
of 10 pM and##2##4##(1990-5#1)(1993-11#1)
of 10 patients treated with##2##5##(2007-11#1)(2008-7#1)
of 10 patients who##2##4##(2007-5#1)(2008-1#1)
of 10 patients with##4##4##(1996-2#1)(1996-9#1)(2006-10#1)(2007-10#1)
of 10 patients##10##3##(1996-2#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)
of 10 pg##2##3##(2008-10#2)
of 10 samples##2##3##(2008-10#2)
of 10 strains##2##3##(2008-10#1)(2008-6#1)
of 10 to 15%##2##4##(1991-5#1)(1994-12#1)
of 10 to##6##3##(1991-5#1)(1993-9#1)(1994-12#1)(2008-10#3)
of 10 was##2##3##(2008-10#2)
of 10 weeks##2##3##(1995-3#1)(2010-3#1)
of 10 years##3##3##(1996-5#1)(1997-2#1)(2007-7#1)
of 10 μm##2##3##(2009-12#1)(2011-2#1)
of 10##353##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(2006-10#2)(2007-10#3)(2007-11#9)(2007-12#9)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#95)(2008-11#11)(2008-12#4)(2008-2#9)(2008-3#24)(2008-4#1)(2008-5#9)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#23)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-9#3)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#2)
of 10% NaOCl##2##3##(2008-12#2)
of 10% and##2##3##(2008-10#1)(2008-2#1)
of 10% calf serum##3##4##(1990-2#1)(1991-5#1)(2008-11#1)
of 10% of##3##3##(1995-1#1)(2008-3#1)(2008-9#1)
of 10% or##2##3##(1997-7#1)(2012-3#1)
of 10%##29##2##(1990-2#1)(1991-5#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-7#1)(2007-11#2)(2007-3#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of 10(-10)##2##2##(1993-6#1)(2008-10#1)
of 10(-12)##2##2##(2007-11#1)(2008-10#1)
of 10(-3) M##4##3##(2008-10#4)
of 10(-3)##6##2##(2008-10#5)(2008-2#1)
of 10(-4) M##2##3##(2008-10#2)
of 10(-4)##6##2##(2008-10#3)(2008-3#3)
of 10(-5) M##4##3##(1992-11#1)(1997-4#1)(2008-10#2)
of 10(-5)##6##2##(1992-11#1)(1997-4#1)(2008-10#2)(2008-2#1)(2011-2#1)
of 10(-6) M##4##3##(1991-9#1)(1993-12#1)(1994-3#1)(1997-4#1)
of 10(-6)##5##2##(1991-9#1)(1993-12#1)(1994-3#1)(1997-4#1)(2008-10#1)
of 10(-7)##2##2##(1993-9#1)(2008-2#1)
of 10(-9) M##3##3##(1990-11#1)(1994-3#1)(2008-10#1)
of 10(-9)##9##2##(1990-11#1)(1994-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#2)
of 10(12)##2##2##(2007-12#1)(2008-3#1)
of 10(2)##4##2##(1995-2#1)(2008-10#2)(2009-6#1)
of 10(3)##2##2##(2007-12#1)(2008-3#1)
of 10(4) to##2##3##(1995-2#1)(2008-10#1)
of 10(4)##6##2##(1995-2#1)(1996-7#1)(2007-11#1)(2008-10#3)
of 10(6)##5##2##(1990-8#1)(1996-5#1)(1997-4#1)(2008-11#2)
of 10(7)##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
of 10(8)##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
of 10(9)##4##2##(1997-1#1)(2008-10#2)(2008-9#1)
of 10-##3##2##(1996-12#2)(2007-11#1)
of 10-100##4##2##(1994-8#1)(2008-10#2)(2008-3#1)
of 10-15##3##2##(1996-11#1)(2007-12#1)(2013-8#1)
of 10-30%##2##2##(2007-7#1)(2012-2#1)
of 10-40##2##2##(1994-2#1)(2008-9#1)
of 10-50##2##2##(2008-3#1)(2008-6#1)
of 10-60##2##2##(2008-10#1)(2008-3#1)
of 10-Gbit/s##2##2##(2007-12#2)
of 100 +/-##2##3##(1995-6#1)(2008-10#1)
of 100 000##3##3##(2008-1#1)(2008-5#1)(2008-7#1)
of 100 Hz##5##3##(2008-2#1)(2008-3#3)(2010-1#1)
of 100 MHz##2##3##(2007-11#1)(2007-12#1)
of 100 U##2##3##(1995-11#1)(2008-11#1)
of 100 and 200 mg/kg##3##5##(2008-10#1)(2012-2#2)
of 100 and 200##4##4##(1997-6#1)(2008-10#1)(2012-2#2)
of 100 and##9##3##(1995-2#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-2#1)(2012-2#2)
of 100 cases]##2##3##(1990-2#1)(2009-5#1)
of 100 in##2##3##(1992-2#1)(2008-3#1)
of 100 kDa##2##3##(1990-5#1)(2008-10#1)
of 100 m##4##3##(1996-4#2)(2008-10#1)(2008-2#1)
of 100 mg##2##3##(1996-5#1)(2007-7#1)
of 100 mg/kg females##3##4##(2008-9#3)
of 100 mg/kg##6##3##(1992-2#1)(2008-9#4)(2011-2#1)
of 100 microM##3##3##(1992-3#1)(1995-12#2)
of 100 ml##7##3##(2008-10#7)
of 100 ms##3##3##(2007-11#1)(2008-3#2)
of 100 mug l(-1)##2##4##(2008-10#2)
of 100 nM##4##3##(1994-5#1)(1997-4#1)(2008-11#1)(2009-11#1)
of 100 ng ml(-1)##4##4##(2008-10#4)
of 100 nm##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
of 100 patients##4##3##(1990-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
of 100 ps##4##3##(1992-6#1)(2007-12#1)(2008-3#2)
of 100 to##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)
of 100##164##2##(1990-2#1)(1990-5#1)(1990-6#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#48)(2008-11#6)(2008-12#3)(2008-2#7)(2008-3#16)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#6)(2009-11#3)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2013-1#2)
of 100% and##3##3##(1997-3#1)(2007-7#1)(2008-6#1)
of 100% in##3##3##(2008-10#1)(2011-2#2)
of 100%##26##2##(1995-6#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
of 100-fold##2##2##(2008-10#1)(2008-11#1)
of 100-fs##2##2##(2007-12#2)
of 1000 and##2##3##(2008-10#2)
of 1000 holograms##2##3##(2008-2#2)
of 1000 mg/kg##5##3##(1995-3#4)(2013-1#1)
of 1000 patients##2##3##(1994-2#1)(2008-9#1)
of 1000##22##2##(1994-2#1)(1994-6#1)(1995-3#4)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2013-1#1)
of 100mugl(-1)##2##2##(2008-10#2)
of 101 patients##4##3##(1992-5#1)(1993-9#1)(2008-7#1)(2012-3#1)
of 101##18##2##(1992-5#1)(1993-9#2)(1994-12#1)(1996-7#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
of 1013##2##2##(1997-8#1)(2013-8#1)
of 102 children##3##3##(2006-10#1)(2008-9#1)(2013-1#1)
of 102 patients##4##3##(2007-11#2)(2007-8#1)(2008-8#1)
of 102##14##2##(1990-6#1)(1993-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#2)
of 103##7##2##(1995-11#1)(1996-1#1)(2008-10#3)(2008-9#1)(2011-1#1)
of 104##9##2##(1994-2#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-3#1)(2011-2#1)(2013-7#1)
of 105##13##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-10#1)(2012-3#1)(2013-1#2)
of 1059##2##2##(1995-2#1)(2008-10#1)
of 106 patients##2##3##(1997-8#1)(2007-8#1)
of 106##6##2##(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)
of 1064##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
of 1064-nm##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of 107##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
of 108 epidemics of##2##4##(2008-10#2)
of 108##10##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-8#2)(2013-1#1)
of 109##6##2##(1992-6#1)(2007-11#1)(2008-10#1)(2010-5#1)(2011-2#2)
of 10mgl(-1)##2##2##(2008-10#2)
of 10min##5##2##(2008-10#5)
of 10nM##2##2##(2008-10#2)
of 10s##3##2##(2008-10#3)
of 10x##2##2##(2007-11#1)(2008-10#1)
of 11 QIs##2##3##(2012-3#2)
of 11 and##5##3##(1995-6#1)(1996-5#1)(2008-10#3)
of 11 carbamate pesticide residues in Glycyrrhizae radix et rhizoma and its extracts##2##13##(2011-1#2)
of 11 carbamate##4##3##(2011-1#4)
of 11 cases##2##3##(1991-6#1)(2011-2#1)
of 11 nm##2##3##(2007-11#1)(2008-2#1)
of 11 patients##3##3##(1992-10#1)(1996-9#1)(2007-11#1)
of 11##110##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#5)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
of 11%##2##2##(1993-8#1)(2007-12#1)
of 11)##2##2##(1996-10#1)(1996-3#1)
of 110 HIV##2##3##(2007-7#2)
of 110 MHz##2##3##(2007-12#2)
of 110 and##2##3##(1995-12#1)(2007-12#1)
of 110 kDa##2##3##(1995-6#1)(2009-2#1)
of 110 patients##2##3##(2007-7#1)(2011-3#1)
of 110##20##2##(1991-6#1)(1995-12#1)(1995-6#1)(2007-11#1)(2007-12#3)(2007-7#4)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-3#1)(2013-1#1)
of 1100##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
of 111 cases##2##3##(1993-5#1)(2007-10#1)
of 111 patients##2##3##(1990-2#1)(2013-1#1)
of 111##10##2##(1990-2#1)(1993-5#2)(2007-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#2)
of 1116##3##2##(2007-8#3)
of 112##9##2##(1996-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2012-2#1)(2013-1#1)
of 113##2##2##(1993-12#1)(2008-10#1)
of 114##11##2##(1991-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
of 115 patients with##2##4##(1992-8#1)(1996-1#1)
of 115##7##2##(1990-11#1)(1991-1#1)(1991-4#1)(1992-8#1)(1996-1#1)(2007-12#1)(2010-3#1)
of 116##4##2##(1990-12#1)(2008-10#1)(2008-6#2)
of 117##8##2##(1995-12#1)(1995-6#2)(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2012-3#1)
of 118##7##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-2#1)
of 118) were##2##3##(2007-7#2)
of 119 patients with##2##4##(1997-8#1)(2011-1#1)
of 119##10##2##(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
of 11β-HSD1##4##2##(2013-1#4)
of 12 amino##2##3##(1991-12#1)(2008-10#1)
of 12 and##2##3##(1990-2#1)(2008-10#1)
of 12 cases##2##3##(2007-7#1)(2012-1#1)
of 12 h##3##3##(2008-10#3)
of 12 mg/kg females##3##4##(2008-9#3)
of 12 mg/kg##6##3##(2008-9#6)
of 12 months##7##3##(1993-9#1)(1995-6#2)(2007-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
of 12 mug##3##3##(2008-10#2)(2008-11#1)
of 12 patients who had##2##5##(1997-7#1)(2013-1#1)
of 12 patients who##3##4##(1997-7#1)(2007-8#1)(2013-1#1)
of 12 patients with##2##4##(1991-5#1)(2013-1#1)
of 12 patients##11##3##(1991-12#1)(1991-5#1)(1997-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#2)
of 12 samples##2##3##(2008-10#2)
of 12 selected##2##3##(1992-1#1)(2008-10#1)
of 12 volunteers##2##3##(2008-11#1)(2012-2#1)
of 12 weeks##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
of 12 years##3##3##(2008-1#1)(2008-9#1)(2010-6#1)
of 12##148##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-6#2)(1996-7#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#38)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#9)(2009-12#2)(2009-2#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
of 12%##5##2##(1997-8#1)(2007-11#1)(2010-3#2)(2011-1#1)
of 12-O-tetradecanoylphorbol-13-acetate (TPA)##3##3##(1992-8#1)(1993-9#1)(1997-1#1)
of 12-O-tetradecanoylphorbol-13-acetate##7##2##(1992-8#4)(1993-9#1)(1994-12#1)(1997-1#1)
of 12-h day##2##3##(2011-2#2)
of 12-h##3##2##(2011-2#3)
of 120 and##2##3##(2008-2#1)(2008-3#1)
of 120 samples##2##3##(2008-10#2)
of 120##40##2##(1990-10#1)(1990-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-2#3)(2008-3#5)(2008-5#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
of 1200##4##2##(1991-5#1)(1997-2#1)(2008-10#2)
of 121##4##2##(1992-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
of 122 patients##3##3##(2008-1#1)(2008-8#1)(2012-3#1)
of 122##7##2##(1991-11#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-3#1)
of 122)##3##2##(2007-7#2)(2008-10#1)
of 123 patients##2##3##(2010-3#1)(2013-8#1)
of 123##8##2##(1993-12#1)(1996-11#1)(2008-10#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
of 123-I MIBG imaging##3##4##(2012-2#3)
of 124##5##2##(1997-8#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-3#1)
of 125##10##2##(1991-12#1)(1993-12#1)(1995-1#1)(2007-11#2)(2008-10#2)(2008-3#2)(2011-2#1)
of 125I-IGF-II##7##2##(1990-5#7)
of 125I-[Y39]exendin-4##2##2##(1994-8#2)
of 125I-bFGF##2##2##(1991-12#2)
of 125I-calmodulin##4##2##(1991-12#4)
of 125I-labeled##4##2##(1990-5#1)(1991-9#1)(1992-3#1)(1995-2#1)
of 125IUdR incorporation##2##3##(1993-11#2)
of 126##8##2##(1990-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
of 127 amino acids##2##4##(1990-5#1)(1991-9#1)
of 127##9##2##(1990-11#1)(1990-5#2)(1991-9#1)(1993-11#1)(1995-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
of 128 patients##2##3##(2008-8#1)(2013-1#1)
of 128##11##2##(1993-6#1)(1995-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
of 129##3##2##(1995-11#1)(2008-11#1)(2013-1#1)
of 1294##2##2##(2008-1#1)(2008-9#1)
of 12h##2##2##(2013-1#1)(2013-7#1)
of 13 +/-##2##3##(1994-8#1)(1995-2#1)
of 13 and##4##3##(1995-8#1)(2007-8#1)(2008-9#1)(2011-1#1)
of 13 exons##2##3##(1991-5#1)(1996-10#1)
of 13 other##2##3##(1996-5#1)(2008-10#1)
of 13 patients with##3##4##(1991-11#1)(1994-10#1)(2007-11#1)
of 13 patients##4##3##(1990-2#1)(1991-11#1)(1994-10#1)(2007-11#1)
of 13 studies##3##3##(1993-1#1)(1994-2#1)(2011-2#1)
of 13##65##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
of 13%##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
of 130 cases of##2##4##(2008-11#1)(2013-1#1)
of 130##15##2##(1992-12#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
of 130/80 mm Hg##2##4##(2008-1#1)(2013-8#1)
of 1300##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of 131##3##2##(1990-8#1)(2008-10#1)(2013-1#1)
of 131I-MIBG##3##2##(1990-10#3)
of 132##3##2##(2007-2#1)(2008-10#1)(2008-9#1)
of 133##10##2##(1995-3#1)(1995-6#2)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
of 134##4##2##(1990-10#1)(1996-12#1)(2007-11#1)(2012-2#1)
of 135##14##2##(1991-8#1)(1993-11#1)(1993-2#1)(1996-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2013-1#1)
of 136##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
of 138##3##2##(1993-12#1)(2007-8#1)(2008-8#1)
of 139##5##2##(1994-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
of 13C##2##2##(1992-12#1)(2012-3#1)
of 13C-labeled##3##2##(1993-3#3)
of 14 days##5##3##(1990-12#1)(1990-9#1)(2008-10#2)(2012-2#1)
of 14 different##2##3##(1997-6#1)(2008-10#1)
of 14 patients##4##3##(1990-2#1)(1991-5#1)(2008-10#1)(2013-1#1)
of 14 species of##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
of 14 species##5##3##(2007-12#1)(2008-10#2)(2008-8#2)
of 14##85##2##(1990-12#2)(1990-2#1)(1990-9#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#5)(2009-3#1)(2009-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#2)
of 14%##2##2##(1993-12#1)(2010-2#1)
of 14-18 carbons##2##3##(1990-5#1)(1993-8#1)
of 14-3-3 protein##2##3##(2008-11#2)
of 14-3-3##4##2##(2008-11#3)(2010-12#1)
of 140##8##2##(1991-6#1)(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
of 1400##2##2##(2008-10#1)(2008-3#1)
of 141##3##2##(1990-8#1)(2008-7#1)(2011-2#1)
of 142##4##2##(1996-6#1)(2007-7#1)(2008-10#1)(2013-7#1)
of 143##5##2##(1990-11#1)(1990-12#1)(2008-10#2)(2012-3#1)
of 144##3##2##(1997-8#1)(2008-11#1)(2008-7#1)
of 145##2##2##(1990-6#1)(2008-7#1)
of 146##5##2##(1995-5#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
of 147##2##2##(1997-7#1)(2013-1#1)
of 148##4##2##(1992-2#1)(1994-8#1)(1997-2#1)(2008-10#1)
of 149##9##2##(1990-5#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2013-1#1)
of 14C-5HT##4##2##(1995-11#4)
of 14F7##2##2##(2012-3#2)
of 15 STR##2##3##(2008-12#2)
of 15 and 60 min##2##5##(2008-9#2)
of 15 and 60##3##4##(1991-8#1)(2008-9#2)
of 15 and##5##3##(1990-7#1)(1991-8#1)(2008-10#1)(2008-9#2)
of 15 different##2##3##(1997-4#1)(2008-10#1)
of 15 km##2##3##(2007-12#1)(2008-3#1)
of 15 male and 15 female##20##6##(2008-8#3)(2008-9#17)
of 15 mg/kg##2##3##(1992-3#1)(2008-7#1)
of 15 min##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
of 15 organic phosphonate esters##2##5##(2008-10#2)
of 15 studies##2##3##(1990-6#1)(2013-8#1)
of 15 to##3##3##(2008-10#3)
of 15 years of##2##4##(2007-8#1)(2008-3#1)
of 15 years##7##3##(1990-8#1)(1992-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
of 15##151##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#33)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#23)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#4)
of 15% of the maximum##2##5##(2007-12#1)(2011-1#1)
of 15% of##4##3##(2007-12#1)(2011-1#2)(2012-2#1)
of 15%##11##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
of 15)##2##2##(1996-3#1)(2008-10#1)
of 15-20##2##2##(2007-10#1)(2008-6#1)
of 15-30##3##2##(1994-8#1)(1995-8#1)(2008-10#1)
of 15-LO##2##2##(2008-5#2)
of 150 cases##2##3##(1990-12#1)(1996-3#1)
of 150 nM##2##3##(1994-9#2)
of 150 patients##3##3##(1990-8#1)(2009-11#1)(2010-6#1)
of 150##38##2##(1990-12#2)(1990-8#1)(1991-6#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#3)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#2)(2010-12#1)(2010-6#1)(2012-2#1)
of 150-200##2##2##(1990-2#1)(1993-6#1)
of 1500##6##2##(1994-3#1)(2008-10#3)(2008-2#1)(2013-1#1)
of 151##2##2##(2008-11#1)(2008-9#1)
of 152##4##2##(2008-10#2)(2008-8#1)(2009-5#1)
of 153##7##2##(1990-5#1)(1993-8#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
of 154##8##2##(1992-10#1)(2007-11#3)(2007-12#1)(2008-10#2)(2012-3#1)
of 1540##4##2##(2007-11#2)(2007-12#2)
of 155##5##2##(1994-3#1)(2008-10#2)(2008-3#1)(2013-7#1)
of 156 individuals##2##3##(2007-10#1)(2008-11#1)
of 156 patients##2##3##(2010-12#1)(2011-2#1)
of 156##10##2##(1994-12#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
of 157##2##2##(2007-12#1)(2008-3#1)
of 158##7##2##(1991-8#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
of 159##6##2##(1990-2#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
of 15C5##2##2##(2008-10#2)
of 15N-labeled##3##2##(1995-2#1)(1995-5#1)(2008-4#1)
of 16 alpha-OHE1##2##3##(1995-9#2)
of 16 cases##2##3##(1990-5#1)(2008-11#1)
of 16 different##3##3##(1995-6#1)(1996-5#1)(2008-10#1)
of 16 months##4##3##(1996-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
of 16 patients##6##3##(1994-7#1)(1996-6#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
of 16 studies##5##3##(2008-2#1)(2009-6#4)
of 16 years##5##3##(1991-6#1)(1995-6#1)(1997-8#1)(2008-10#1)(2011-2#1)
of 16##105##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#2)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-6#6)(2010-4#1)(2010-5#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
of 16%##2##2##(2008-2#1)(2008-3#1)
of 16-week Kouk-Sun-Do##2##3##(2010-4#2)
of 160##12##2##(1991-12#1)(1992-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-9#1)(2010-4#1)
of 161##6##2##(1994-12#1)(1997-7#1)(2008-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
of 163##6##2##(1995-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-8#1)
of 164##3##2##(1995-11#1)(2008-7#1)(2013-1#1)
of 165##10##2##(1990-12#2)(1996-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-11#1)(2012-12#1)
of 166##2##2##(2008-10#1)(2008-3#1)
of 168##4##2##(1995-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
of 169##2##2##(2008-12#1)(2008-8#1)
of 16C5 and##3##3##(2008-10#3)
of 16C5##7##2##(2008-10#7)
of 16S rDNA and##2##4##(2008-10#2)
of 16S rDNA##6##3##(2008-10#4)(2008-5#1)(2013-7#1)
of 16S rRNA gene##5##4##(2008-10#1)(2008-12#1)(2011-2#2)(2012-2#1)
of 16S rRNA##10##3##(1992-6#1)(1993-11#1)(2008-10#3)(2008-12#1)(2011-2#3)(2012-2#1)
of 16S##19##2##(1992-6#2)(1993-11#1)(2008-10#9)(2008-12#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-7#1)
of 17 beta-(N-alkyl/arylformamido)- and 17##2##5##(1995-3#2)
of 17 beta-estradiol##6##3##(1993-9#3)(1995-11#1)(1996-5#1)(2008-11#1)
of 17 elements##2##3##(2008-10#2)
of 17 patients##6##3##(1994-1#1)(1997-4#1)(2008-9#1)(2010-4#1)(2013-1#2)
of 17 to##2##3##(2012-2#1)(2013-1#1)
of 17##69##2##(1990-10#1)(1990-2#1)(1990-7#2)(1991-3#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#3)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#4)(2008-6#3)(2008-9#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#5)
of 17%##3##2##(2008-3#1)(2010-4#1)(2013-1#1)
of 17)##2##2##(1992-1#1)(1996-3#1)
of 170 fs##2##3##(2007-12#1)(2008-3#1)
of 170##8##2##(1993-3#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
of 171 patients##2##3##(1994-6#1)(2006-10#1)
of 171##5##2##(1994-6#1)(1995-8#1)(2006-10#1)(2008-7#1)(2013-1#1)
of 173##3##2##(1990-5#1)(1991-8#1)(2008-12#1)
of 174##4##2##(1992-11#1)(2007-11#1)(2008-1#1)(2008-10#1)
of 175##7##2##(1990-8#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-3#1)(2013-1#1)
of 177##3##2##(1990-11#1)(1993-2#1)(2010-12#1)
of 179##5##2##(1992-9#1)(1995-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
of 17E8##4##2##(1995-2#4)
of 18 +/-##2##3##(2007-12#1)(2008-2#1)
of 18 and##2##3##(2008-10#1)(2012-2#1)
of 18 cases##2##3##(1993-6#1)(2009-8#1)
of 18 months##4##3##(1991-11#1)(1991-8#1)(1994-6#1)(2008-10#1)
of 18 patients##6##3##(1990-2#1)(1990-6#1)(1990-8#1)(1992-6#1)(2008-10#1)(2012-3#1)
of 18 to##2##3##(2008-10#1)(2008-5#1)
of 18 years##3##3##(2009-12#1)(2011-2#1)(2012-3#1)
of 18##96##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-7#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-12#3)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#3)
of 18%##6##2##(1991-11#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-7#2)
of 18-crown-6##4##2##(2008-10#4)
of 18-month-old##2##2##(1994-5#1)(2010-6#1)
of 180 degrees##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
of 180##11##2##(1990-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#2)
of 180s##2##2##(2008-10#2)
of 181##3##2##(1992-8#1)(2008-3#1)(2011-2#1)
of 182##6##2##(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#1)(2013-8#1)
of 183##4##2##(1990-6#2)(2007-12#1)(2011-2#1)
of 186##5##2##(1996-10#1)(2007-7#2)(2008-10#1)(2010-1#1)
of 187 patients##2##3##(1990-6#1)(2011-2#1)
of 187##4##2##(1990-6#1)(2008-12#1)(2011-2#1)(2012-2#1)
of 188##4##2##(1992-2#1)(1993-9#1)(1994-12#2)
of 189##4##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
of 18S##2##2##(2008-10#1)(2010-3#1)
of 19 HCMV-induced TGr##2##4##(1997-3#2)
of 19 months##2##3##(1994-6#1)(1996-3#1)
of 19 patients with##3##4##(1992-5#1)(2008-9#1)(2011-2#1)
of 19 patients##10##3##(1992-5#1)(1995-12#1)(1996-6#1)(2008-9#1)(2009-3#1)(2011-2#3)(2012-3#2)
of 19##68##2##(1990-5#1)(1991-11#1)(1991-6#2)(1992-5#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
of 19%##2##2##(2007-7#1)(2010-2#1)
of 190##5##2##(1990-12#1)(1990-2#1)(1997-8#1)(2008-2#1)(2010-11#1)
of 1900##3##2##(1990-11#1)(2008-10#2)
of 191##2##2##(2008-1#1)(2008-3#1)
of 1918-1919##2##2##(2009-7#2)
of 192##2##2##(1997-8#1)(2008-10#1)
of 193-nm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of 194##2##2##(2008-5#1)(2012-12#1)
of 195##4##2##(1992-12#1)(1997-3#1)(2008-10#1)(2008-11#1)
of 1950##2##2##(2007-12#1)(2008-10#1)
of 196##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
of 197##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
of 198##3##2##(1991-12#1)(2007-11#1)(2007-7#1)
of 1980##2##2##(1991-1#1)(1994-2#1)
of 1982##4##2##(1993-12#1)(1994-3#1)(1995-3#1)(1997-1#1)
of 1985##2##2##(1991-1#1)(1993-1#1)
of 1986##4##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)
of 1987##4##2##(1993-1#1)(1993-2#1)(1994-1#1)(1996-3#1)
of 1988##5##2##(1991-2#1)(1994-2#1)(1997-4#1)(2008-10#2)
of 1989##8##2##(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-1#1)(1997-2#1)
of 199##3##2##(1994-12#1)(2007-10#1)(2011-2#1)
of 1990 (Public Law 101-508)##2##5##(1991-12#2)
of 1990##14##2##(1991-12#2)(1992-1#2)(1993-1#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-3#2)(2009-11#1)
of 1991##10##2##(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-3#1)(1995-11#1)(1996-12#1)(1997-1#1)
of 1992##11##2##(1990-12#1)(1992-8#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(2008-2#3)
of 1993 (Public Law 103-66)##2##5##(1994-3#2)
of 1993##12##2##(1994-3#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-2#1)
of 1994##12##2##(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-6#2)(2008-10#3)(2008-3#1)
of 1995 and##3##3##(2007-2#1)(2008-10#2)
of 1996##6##2##(1996-11#1)(1997-3#1)(2007-5#2)(2007-6#2)
of 1997##15##2##(1997-4#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2011-1#1)
of 1998 and##2##3##(2008-10#2)
of 1998##13##2##(1992-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#4)
of 1999 and##2##3##(2007-6#2)
of 1999##10##2##(2007-6#2)(2008-10#3)(2008-11#2)(2008-5#3)
of 19C6 for##2##3##(2008-10#2)
of 19C6##6##2##(2008-10#6)
of 1D##2##2##(1995-2#1)(2008-9#1)
of 1H##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2009-7#1)
of 1M##2##2##(2008-10#2)
of 1a##5##2##(1992-12#1)(1996-5#2)(2008-10#1)(2009-9#1)
of 1alpha##2##2##(1997-1#1)(2008-4#1)
of 1day##2##2##(2013-1#2)
of 1h##2##2##(2008-10#1)(2013-1#1)
of 1ml of##2##3##(2008-10#2)
of 1ml##4##2##(2008-10#4)
of 1x10(-5)##3##2##(2008-10#3)
of 1x10(-6)##3##2##(2008-10#3)
of 1x10(-7)##3##2##(2008-10#3)
of 2 M##2##3##(2008-10#2)
of 2 and 4##2##4##(2008-11#1)(2008-5#1)
of 2 and##10##3##(1997-7#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
of 2 cases of##2##4##(1992-8#1)(1997-3#1)
of 2 cases##5##3##(1992-8#1)(1995-3#1)(1997-3#1)(2006-10#1)(2013-1#1)
of 2 cases]##2##3##(1992-5#1)(1993-6#1)
of 2 cm##4##3##(1990-9#1)(1991-12#1)(2007-12#1)(2008-3#1)
of 2 g##2##3##(2008-10#1)(2011-2#1)
of 2 h##3##3##(2008-10#2)(2011-2#1)
of 2 kHz##2##3##(2008-3#1)(2010-9#1)
of 2 mM##3##3##(1992-6#1)(1993-8#1)(1994-6#1)
of 2 mg cm(-2)##2##4##(2008-5#2)
of 2 mg##5##3##(1991-5#1)(1995-5#1)(2008-10#1)(2008-5#2)
of 2 microM##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
of 2 ml##4##3##(2007-11#1)(2008-10#3)
of 2 mol l(-1)##3##4##(2008-10#3)
of 2 nm##2##3##(1994-2#1)(2008-3#1)
of 2 or##2##3##(2008-7#1)(2010-12#1)
of 2 parts in##2##4##(2008-2#1)(2008-3#1)
of 2 parts##3##3##(2008-2#1)(2008-3#1)(2010-11#1)
of 2 to 3##3##4##(2008-10#2)(2008-8#1)
of 2 to##8##3##(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)
of 2 was##2##3##(2008-10#1)(2013-1#1)
of 2 weeks##5##3##(1991-2#1)(1992-10#1)(2007-10#1)(2007-7#1)(2011-2#1)
of 2 x 2##2##4##(1995-2#1)(2008-2#1)
of 2 x##9##3##(1992-5#1)(1995-2#1)(2008-10#2)(2008-2#2)(2008-3#3)
of 2 years##8##3##(1997-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
of 2##628##2##(1990-2#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-3#6)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#6)(1994-6#3)(1994-8#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#8)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#3)(1997-7#3)(2006-10#2)(2007-10#4)(2007-11#13)(2007-12#27)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#271)(2008-11#9)(2008-12#13)(2008-2#13)(2008-3#45)(2008-4#3)(2008-5#11)(2008-6#5)(2008-7#11)(2008-8#7)(2008-9#5)(2009-12#1)(2009-3#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#11)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
of 2%##15##2##(1993-1#2)(1993-9#1)(1995-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#1)
of 2'##2##2##(1990-9#1)(1994-11#1)
of 2'-deoxycytidylyl-(3'-5')-thymidine##2##2##(1992-8#2)
of 2'-hydroxy-4-R-chalcones##2##2##(2008-10#2)
of 2(2+) to##2##3##(1996-2#2)
of 2- and##2##3##(1992-9#1)(1995-9#1)
of 2-##3##2##(1992-12#1)(1992-9#1)(1995-9#1)
of 2-(1-carboxy-1-hydroxyethyl)-3##2##2##(1993-8#2)
of 2-3 nm##2##3##(2007-11#1)(2008-2#1)
of 2-3##11##2##(1992-1#1)(1994-11#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)
of 2-4##2##2##(1995-12#1)(2007-11#1)
of 2-5##2##2##(2008-2#1)(2008-3#1)
of 2-5%##2##2##(1991-2#1)(2008-10#1)
of 2-5A##2##2##(1990-2#2)
of 2-6##2##2##(1995-11#1)(2008-3#1)
of 2-8##2##2##(1990-7#1)(2007-11#1)
of 2-[2-(2##4##2##(2011-1#4)
of 2-acetyl-1-pyrroline in aroma rice##2##5##(2011-1#2)
of 2-acetyl-1-pyrroline in##3##3##(2011-1#3)
of 2-acetyl-1-pyrroline##4##2##(2011-1#4)
of 2-amino-5##2##2##(2008-10#2)
of 2-butoxyethanol from##2##3##(2008-10#2)
of 2-cephems and 3-cephems##2##4##(2008-11#2)
of 2-ethoxyethanol in##2##3##(2008-5#2)
of 2-ethoxyethanol##4##2##(2008-5#4)
of 2-ethylhexyl-p-methoxycinnamate##2##2##(2008-10#2)
of 2-mercaptobenzothiazole##2##2##(2008-10#1)(2012-12#1)
of 2-mercaptoethanol to the##2##4##(1990-8#1)(1994-8#1)
of 2-mercaptoethanol##7##2##(1990-8#1)(1994-8#2)(1996-5#1)(2008-10#3)
of 2-mercaptopyridine##2##2##(2008-10#2)
of 2-methyl-4-amino-5-hydroxymethylpyrimidine##2##2##(1990-2#2)
of 2-methyltaurine##2##2##(1996-5#2)
of 2-nonanol##2##2##(2007-12#2)
of 2-phenylethynyladenosine (PEAdo) derivatives##2##4##(2008-4#2)
of 2-propanol##6##2##(2008-10#6)
of 2-propanol-water binary mixtures##2##4##(2008-10#2)
of 2-week##3##2##(1996-11#1)(2012-2#1)(2013-1#1)
of 2-week-old##2##2##(1996-5#1)(2008-10#1)
of 20 +/-##2##3##(1993-8#1)(1995-12#1)
of 20 and##7##3##(2008-10#5)(2008-3#1)(2012-2#1)
of 20 cases##2##3##(1994-9#1)(2011-1#1)
of 20 different##2##3##(2008-10#2)
of 20 genes##2##3##(1996-2#1)(2008-10#1)
of 20 healthy##2##3##(2008-5#1)(2008-7#1)
of 20 m##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of 20 mg##3##3##(1990-2#1)(1991-8#1)(2008-10#1)
of 20 microM##3##3##(1994-8#2)(1995-2#1)
of 20 microm and##2##4##(2008-3#2)
of 20 microm##4##3##(2007-12#1)(2008-3#3)
of 20 min##4##3##(1992-6#1)(1996-2#1)(2008-3#2)
of 20 muM##3##3##(2008-10#2)(2008-11#1)
of 20 mug##3##3##(2008-10#3)
of 20 ng##3##3##(2008-10#3)
of 20 nm##2##3##(2008-3#1)(2008-5#1)
of 20 patients treated with##2##5##(1990-6#1)(2008-11#1)
of 20 patients##12##3##(1990-6#1)(1990-8#1)(1994-12#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
of 20 samples h(-1)##2##4##(2008-10#2)
of 20 samples per##3##4##(2008-10#3)
of 20 samples##5##3##(2008-10#5)
of 20 to 40##2##4##(2007-11#1)(2008-1#1)
of 20 to##7##3##(1997-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
of 20 years##5##3##(1995-11#1)(1997-3#1)(1997-8#1)(2008-7#2)
of 20##193##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#3)(1997-8#2)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#62)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#19)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#4)
of 20% and##2##3##(2008-10#1)(2011-2#1)
of 20% of the##2##4##(1994-3#1)(2008-11#1)
of 20%##14##2##(1990-9#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
of 20-##2##2##(1996-12#1)(2008-3#1)
of 20-25##2##2##(2008-3#1)(2008-6#1)
of 20-30##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
of 20-3000 ng ml(-1)##2##4##(2008-10#2)
of 20-40##2##2##(2007-11#1)(2008-6#1)
of 20-50##2##2##(1994-6#1)(1994-8#1)
of 200 MHz##2##3##(2007-12#1)(2008-3#1)
of 200 and##4##3##(1992-11#1)(2008-10#1)(2010-3#2)
of 200 fs##2##3##(2007-12#1)(2008-10#1)
of 200 mW##4##3##(2007-12#2)(2008-3#2)
of 200 mg l(-1)##2##4##(2008-10#2)
of 200 mg##3##3##(2008-10#2)(2008-5#1)
of 200 mg/kg##2##3##(1995-3#1)(2008-9#1)
of 200 mm##2##3##(1990-2#1)(2008-3#1)
of 200 ms##2##3##(2008-3#1)(2010-9#1)
of 200 muM##3##3##(2008-10#3)
of 200 patients with##2##4##(2007-11#1)(2008-1#1)
of 200 patients##3##3##(2007-11#1)(2007-8#1)(2008-1#1)
of 200##72##2##(1990-2#2)(1990-5#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
of 200-400##3##2##(2008-11#1)(2008-5#2)
of 2000 parts in 10(6)##2##5##(2008-3#2)
of 2000##14##2##(1993-2#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#2)(2010-8#1)
of 2000-2006##2##2##(2010-8#1)(2011-2#1)
of 2001##3##2##(2007-6#2)(2008-8#1)
of 2002##6##2##(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#1)
of 2003##5##2##(2008-11#2)(2008-5#1)(2012-3#1)(2013-8#1)
of 2004##8##2##(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
of 2005##2##2##(2010-10#1)(2010-8#1)
of 2006##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
of 2007##3##2##(1991-12#1)(2011-2#1)(2012-2#1)
of 2008##5##2##(2011-1#1)(2011-2#3)(2012-2#1)
of 2009##7##2##(2011-2#3)(2011-9#2)(2012-12#1)(2012-2#1)
of 201##2##2##(1995-5#1)(2010-1#1)
of 2010##5##2##(2008-1#1)(2011-1#1)(2011-2#2)(2012-3#1)
of 2011##2##2##(2009-6#1)(2012-3#1)
of 2012##2##2##(2013-1#1)(2013-8#1)
of 202 amino acid residues##2##5##(1991-2#1)(1992-8#1)
of 202##6##2##(1990-7#1)(1991-2#1)(1992-8#1)(1994-11#1)(1997-3#1)(2008-10#1)
of 203##3##2##(1997-2#1)(2008-8#1)(2009-5#1)
of 204##2##2##(1994-12#1)(1997-7#1)
of 206##4##2##(2007-8#1)(2008-5#2)(2011-2#1)
of 207##2##2##(1990-3#1)(2009-7#1)
of 208##5##2##(1992-6#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#1)
of 21 cases##2##3##(1990-3#1)(1992-11#1)
of 21 days##3##3##(1994-3#1)(2008-5#1)(2010-4#1)
of 21 months##2##3##(1990-12#1)(2007-7#1)
of 21 patients##8##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
of 21##56##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-3#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
of 21%##3##2##(2007-12#2)(2008-2#1)
of 21-##2##2##(1995-5#1)(2008-1#1)
of 210##10##2##(1992-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-5#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
of 2100##2##2##(2007-12#1)(2008-11#1)
of 210Po and 210Pb##3##4##(1994-9#3)
of 212##5##2##(1994-3#1)(1996-3#1)(1997-4#1)(1997-7#1)(2009-10#1)
of 214##3##2##(1993-11#1)(2008-10#1)(2013-8#1)
of 215##2##2##(1995-3#1)(2008-9#1)
of 216##2##2##(2008-10#1)(2008-9#1)
of 218##2##2##(1993-12#1)(2010-6#1)
of 219##2##2##(2008-10#1)(2013-1#1)
of 22 metallic elements##2##4##(2008-10#2)
of 22 patients##3##3##(1993-9#1)(2006-12#1)(2012-3#1)
of 22 species of##2##4##(2008-7#1)(2013-7#1)
of 22##57##2##(1990-11#1)(1990-3#1)(1990-7#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-11#5)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
of 22%##4##2##(1991-2#1)(2008-3#1)(2008-7#1)(2012-8#1)
of 22-26##2##2##(1990-12#1)(1990-8#1)
of 220 amino acids##2##4##(1997-2#1)(2008-8#1)
of 220 patients##2##3##(2012-3#1)(2013-8#1)
of 220##9##2##(1991-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-8#2)
of 221##2##2##(1996-6#1)(2011-2#1)
of 223##5##2##(1994-3#1)(1997-2#1)(2008-12#1)(2010-3#1)(2013-1#1)
of 224##2##2##(1994-1#1)(2008-5#1)
of 225##6##2##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-1#1)
of 226##2##2##(2008-10#1)(2012-2#1)
of 227##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
of 228##4##2##(1993-2#1)(2007-7#1)(2008-10#1)(2012-3#1)
of 22q11##3##2##(1997-3#2)(2012-12#1)
of 23 and##3##3##(1994-1#1)(2008-10#2)
of 23 patients##2##3##(2007-8#1)(2013-1#1)
of 23##47##2##(1990-10#1)(1990-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
of 23%##2##2##(1997-4#1)(2010-2#1)
of 23-kDa##3##2##(1993-6#1)(1996-10#2)
of 230 nm##2##3##(2007-11#1)(2008-10#1)
of 230##8##2##(1990-12#1)(1990-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
of 232##2##2##(1991-9#1)(1995-5#1)
of 233##2##2##(1997-3#1)(2013-1#1)
of 234##5##2##(1994-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
of 235##4##2##(1990-2#1)(2008-3#1)(2009-11#1)(2010-12#1)
of 236##6##2##(1996-5#1)(1997-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
of 237##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
of 238##5##2##(1990-6#1)(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#1)
of 239##3##2##(1995-8#1)(2007-5#1)(2008-10#1)
of 23S rRNA##2##3##(1992-6#2)
of 23S##3##2##(1992-6#2)(1995-8#1)
of 24 and##2##3##(2008-10#2)
of 24 consecutive patients##2##4##(1997-8#1)(2008-9#1)
of 24 dansylamino acids##2##4##(1994-9#2)
of 24 degrees##2##3##(2008-10#1)(2008-9#1)
of 24 h##9##3##(1997-2#1)(2008-10#2)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#2)
of 24 kDa##2##3##(2008-10#2)
of 24 months##4##3##(2008-10#1)(2008-6#1)(2012-12#2)
of 24 patients treated##2##4##(1990-6#1)(2008-7#1)
of 24 patients##5##3##(1990-6#1)(1994-12#1)(2008-7#1)(2009-1#1)(2011-2#1)
of 24 samples per hour##2##5##(2008-10#2)
of 24 samples##3##3##(2008-10#3)
of 24##84##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-6#1)(1995-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
of 24%##3##2##(2007-11#1)(2008-4#1)(2010-3#1)
of 24-h##2##2##(1995-11#1)(2008-10#1)
of 24-hour##2##2##(1996-1#1)(1997-8#1)
of 240##10##2##(1994-7#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
of 242##2##2##(2008-10#1)(2013-1#1)
of 243##3##2##(1990-11#1)(2008-10#1)(2013-1#1)
of 244##4##2##(1991-12#1)(1992-11#1)(2008-10#1)(2008-7#1)
of 245##2##2##(2008-10#1)(2009-7#1)
of 246##4##2##(1995-12#1)(2007-7#1)(2008-5#1)(2008-7#1)
of 247##2##2##(1991-5#1)(2010-8#1)
of 248##3##2##(2007-7#1)(2008-10#2)
of 2490##2##2##(1993-11#1)(2011-2#1)
of 25 (OH)##2##3##(2012-3#1)(2013-1#1)
of 25 and##4##3##(2008-10#3)(2010-1#1)
of 25 cases##4##3##(2007-7#1)(2008-1#1)(2010-11#1)(2010-9#1)
of 25 mg/kg males##2##4##(2008-9#2)
of 25 nm and##2##4##(2008-3#2)
of 25 nm##3##3##(2008-3#3)
of 25 of##2##3##(1994-9#1)(2013-1#1)
of 25 patients who##3##4##(1990-9#1)(1991-6#1)(1994-2#1)
of 25 patients##5##3##(1990-9#1)(1991-6#1)(1994-2#1)(2007-11#1)(2012-3#1)
of 25 samples##2##3##(2008-10#2)
of 25 to##2##3##(2008-10#1)(2008-6#1)
of 25##96##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
of 25%##7##2##(1992-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)
of 25-30##2##2##(2008-11#1)(2012-2#1)
of 25-300##2##2##(2008-10#2)
of 250 and##2##3##(2007-12#1)(2008-11#1)
of 250 mg/kg##2##3##(1992-9#1)(2008-5#1)
of 250 parts##2##3##(2007-12#1)(2008-3#1)
of 250 to##2##3##(1994-3#1)(2013-8#1)
of 250##35##2##(1992-5#2)(1992-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(2007-11#3)(2007-12#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2011-2#1)(2012-5#1)(2013-8#1)
of 253##2##2##(1990-8#1)(2008-6#1)
of 255 +/-##2##3##(1993-8#1)(2011-2#1)
of 255##5##2##(1990-9#1)(1993-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
of 258##6##2##(1992-5#1)(1996-2#1)(1997-2#1)(2008-7#1)(2010-5#1)(2011-1#1)
of 25S rRNA##2##3##(2008-10#1)(2008-8#1)
of 26 in##2##3##(1990-12#1)(2011-2#1)
of 26 patients treated##3##4##(2006-10#1)(2007-11#1)(2008-6#1)
of 26 patients with##2##4##(1990-2#1)(2007-11#1)
of 26 patients##6##3##(1990-2#1)(2006-10#1)(2007-11#2)(2008-6#1)(2010-3#1)
of 26##52##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-3#3)(1996-3#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#7)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of 26%##3##2##(1994-6#1)(2007-12#1)(2008-2#1)
of 26)##2##2##(1990-5#2)
of 260##10##2##(1990-8#1)(1991-5#1)(1996-2#1)(2008-10#3)(2008-7#1)(2011-1#2)(2012-2#1)
of 261##3##2##(1992-9#1)(2008-7#1)(2012-2#1)
of 262##2##2##(2008-3#1)(2013-7#1)
of 264##2##2##(1993-6#1)(2008-10#1)
of 2641##2##2##(1993-5#1)(1997-4#1)
of 266 nm##2##3##(1994-5#1)(2012-2#1)
of 268##3##2##(1997-6#1)(2006-10#1)(2013-8#1)
of 269##2##2##(2007-5#1)(2011-1#1)
of 27 kDa and##2##4##(1990-5#1)(2008-10#1)
of 27 kDa##3##3##(1990-5#1)(1996-5#1)(2008-10#1)
of 27 of##2##3##(2008-7#1)(2013-1#1)
of 27 patients##2##3##(2008-6#1)(2013-1#1)
of 27##46##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-5#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
of 27%##2##2##(2008-6#1)(2011-2#1)
of 270##5##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
of 272##3##2##(1990-11#1)(2008-10#1)(2008-9#1)
of 275##2##2##(1992-8#1)(1994-3#1)
of 277##2##2##(1990-6#1)(2008-10#1)
of 28 degrees##2##3##(2008-10#1)(2008-12#1)
of 28 isolates##2##3##(2008-10#2)
of 28 kDa##2##3##(1992-6#1)(1993-2#1)
of 28 patients with##2##4##(1997-2#1)(2013-1#1)
of 28 patients##4##3##(1997-2#1)(2008-9#2)(2013-1#1)
of 28##48##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#3)
of 28%##6##2##(2008-10#2)(2008-3#3)(2008-9#1)
of 280##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
of 282##2##2##(1991-3#1)(1994-11#1)
of 283##3##2##(1993-2#1)(1995-6#1)(2011-2#1)
of 284##2##2##(2007-9#1)(2012-1#1)
of 285##5##2##(1991-12#1)(1997-2#1)(2010-12#1)(2011-1#1)(2013-1#1)
of 289##2##2##(1992-3#1)(2013-1#1)
of 29 amino acids##2##4##(1992-8#1)(1994-12#1)
of 29 amino##3##3##(1990-12#1)(1992-8#1)(1994-12#1)
of 29 cases##2##3##(1992-12#1)(1996-9#1)
of 29 patients with##2##4##(2008-7#1)(2009-9#1)
of 29 patients##6##3##(1991-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)
of 29##48##2##(1990-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-9#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
of 29)##2##2##(1990-5#2)
of 290##8##2##(1996-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2010-4#1)(2010-8#1)
of 291##3##2##(1991-8#1)(1997-4#1)(2010-4#1)
of 293 cells##5##3##(2008-11#5)
of 293##6##2##(2008-11#6)
of 295##5##2##(1993-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
of 29G11##2##2##(1995-2#2)
of 2AID##2##2##(2008-5#2)
of 2D and 3D##2##4##(2010-12#2)
of 2D##9##2##(1994-5#1)(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-12#2)(2012-12#1)
of 2M##3##2##(2008-10#3)
of 2MeS-ADP##2##2##(2008-4#2)
of 2b was##2##3##(1996-5#1)(2008-10#1)
of 2h##2##2##(2011-2#1)(2013-1#1)
of 2ml##2##2##(2008-10#2)
of 2nd##2##2##(2008-6#1)(2012-3#1)
of 2pi##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of 2x10(-5)##2##2##(2008-10#2)
of 2x10(-6)##2##2##(2008-10#2)
of 2x10(-9)##2##2##(2008-10#2)
of 3 and 5##2##4##(2008-10#1)(2013-1#1)
of 3 and##9##3##(2007-11#3)(2008-1#1)(2008-10#4)(2013-1#1)
of 3 cases##2##3##(2007-5#1)(2008-7#1)
of 3 cases]##2##3##(2008-11#1)(2011-2#1)
of 3 clinical##2##3##(1990-2#1)(2011-2#1)
of 3 h##2##3##(1997-2#1)(2008-10#1)
of 3 mg/kg##2##3##(2006-10#1)(2012-2#1)
of 3 microM##4##3##(1991-8#2)(1994-11#1)(2008-11#1)
of 3 min##3##3##(2008-10#3)
of 3 mm##4##3##(1997-8#1)(2007-11#1)(2008-3#1)(2013-1#1)
of 3 months##7##3##(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
of 3 nm##2##3##(2008-10#1)(2008-8#1)
of 3 ns##2##3##(2007-11#1)(2008-3#1)
of 3 or 5##2##4##(2008-10#1)(2013-1#1)
of 3 or##4##3##(1993-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
of 3 over##2##3##(1992-3#1)(1996-5#1)
of 3 patients##3##3##(2007-11#2)(2008-1#1)
of 3 strains in 2##2##5##(2007-11#2)
of 3 strains in##3##4##(2007-11#3)
of 3 to 5##3##4##(2007-12#1)(2008-4#1)(2010-1#1)
of 3 to##8##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-1#1)(2012-12#2)(2013-1#1)
of 3 weeks##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
of 3 x 10(6)##2##4##(1990-12#1)(2008-10#1)
of 3 x##9##3##(1990-12#1)(1994-11#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)
of 3 years##12##3##(1993-8#1)(1994-9#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-6#1)(2012-2#1)
of 3 years'##2##3##(2007-7#1)(2008-9#1)
of 3##410##2##(1990-11#3)(1990-12#4)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#1)(1993-1#5)(1993-11#1)(1993-12#1)(1993-8#3)(1994-1#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#19)(2007-12#15)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#160)(2008-11#5)(2008-12#5)(2008-2#7)(2008-3#18)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2012-6#2)(2013-1#13)(2013-8#6)
of 3%##9##2##(1993-1#1)(2008-10#5)(2010-4#1)(2011-1#1)(2012-3#1)
of 3'##5##2##(1994-11#1)(1997-4#1)(2008-4#2)(2008-8#1)
of 3'-azido-3'-deoxythymidine##2##2##(1992-9#2)
of 3'-end##2##2##(1994-12#1)(2008-10#1)
of 3'-untranslated##2##2##(1995-12#1)(1997-4#1)
of 3)##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
of 3-##2##2##(2008-5#1)(2008-9#1)
of 3-4##3##2##(1994-12#1)(2007-11#1)(2008-2#1)
of 3-4%##3##2##(1990-6#1)(1996-12#1)(2008-10#1)
of 3-5##5##2##(1995-12#1)(1995-6#1)(2008-2#1)(2008-3#1)(2012-3#1)
of 3-8##2##2##(2008-2#1)(2013-8#1)
of 3-D##6##2##(2007-11#2)(2008-3#4)
of 3-methyl-2-benzothiazolinone hydrazone (MBTH)##2##4##(2008-10#2)
of 3-methyl-2-benzothiazolinone hydrazone with##3##4##(2008-10#3)
of 3-methyl-2-benzothiazolinone hydrazone##5##3##(2008-10#5)
of 3-methylcholanthrene##3##2##(1991-12#1)(2008-11#2)
of 30 +/-##2##3##(1995-2#1)(2008-1#1)
of 30 FNABs##2##3##(2011-1#2)
of 30 and##5##3##(1991-8#1)(1992-8#1)(2008-10#3)
of 30 cases##4##3##(1991-12#1)(2007-8#1)(2008-10#1)(2009-7#1)
of 30 cm##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
of 30 degrees##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
of 30 h(-1)##4##3##(2008-10#4)
of 30 healthy subjects##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
of 30 healthy##5##3##(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
of 30 in##2##3##(1993-9#1)(2009-10#1)
of 30 kDa##3##3##(1995-6#1)(2008-6#1)(2013-1#1)
of 30 mV per decade##2##5##(2008-10#2)
of 30 mg/kg##2##3##(1992-9#1)(1996-2#1)
of 30 min and##2##4##(1991-5#1)(2008-10#1)
of 30 min##8##3##(1991-5#1)(1993-1#1)(1994-8#1)(2008-10#4)(2008-7#1)
of 30 months##4##3##(1993-9#1)(1997-8#1)(2008-9#1)(2009-3#1)
of 30 or more on the##2##6##(1992-1#2)
of 30 patients with##4##4##(1991-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
of 30 patients##10##3##(1990-8#1)(1991-12#1)(1991-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
of 30 s##2##3##(1996-5#1)(2008-10#1)
of 30 samples per h##2##5##(2008-10#2)
of 30 samples per##3##4##(2008-10#3)
of 30 samples##5##3##(2008-10#4)(2010-4#1)
of 30 to 40%##2##4##(2008-11#1)(2008-7#1)
of 30 to##5##3##(1991-9#1)(2008-10#1)(2008-11#2)(2008-7#1)
of 30 years##5##3##(1997-3#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-7#1)
of 30##156##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#4)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-9#2)(1994-1#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-8#4)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#40)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
of 30% to##2##3##(2008-7#1)(2010-12#1)
of 30%##14##2##(1996-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-8#1)
of 30-##3##2##(1993-11#1)(1995-3#1)(1996-12#1)
of 30-40##4##2##(1992-5#1)(2008-10#1)(2008-3#1)(2010-4#1)
of 300 mg##3##3##(1990-12#1)(1990-9#1)(1991-11#1)
of 300 ms##2##3##(1995-12#1)(1997-2#1)
of 300 patients##3##3##(1993-6#2)(2008-11#1)
of 300##39##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-6#2)(1994-12#1)(1995-12#3)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-1#1)
of 3000##4##2##(1990-8#1)(1995-2#1)(2008-9#1)(2013-1#1)
of 303##2##2##(2008-5#1)(2010-12#1)
of 304##6##2##(1992-6#1)(1992-9#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)
of 305##2##2##(2007-2#1)(2008-12#1)
of 307##4##2##(1992-6#1)(2008-10#1)(2008-5#2)
of 308 patients##2##3##(2007-8#1)(2008-4#1)
of 308##3##2##(2007-8#1)(2008-4#1)(2012-12#1)
of 30h(-1)##2##2##(2008-10#2)
of 31 patients with##3##4##(1990-3#1)(2007-11#2)
of 31 patients##4##3##(1990-3#1)(2007-11#3)
of 31##28##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#2)
of 311##5##2##(1993-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)
of 312##4##2##(2008-10#2)(2010-4#1)(2011-2#1)
of 317##4##2##(1991-2#1)(1991-7#1)(2012-2#2)
of 318##2##2##(2008-7#1)(2013-1#1)
of 319##3##2##(1992-9#1)(2011-1#1)(2011-2#1)
of 32 degrees C##2##4##(2008-10#1)(2008-5#1)
of 32 healthy##2##3##(2007-12#1)(2008-5#1)
of 32 months##2##3##(2008-1#1)(2011-2#1)
of 32 patients who underwent##2##5##(1996-3#2)
of 32 patients with##2##4##(1995-2#1)(2008-11#1)
of 32 patients##5##3##(1993-5#1)(1995-2#1)(1996-3#2)(2008-11#1)
of 32 years##2##3##(2008-7#1)(2013-1#1)
of 32##47##2##(1991-5#1)(1991-6#1)(1993-11#1)(1993-5#1)(1995-2#1)(1996-3#2)(1996-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
of 320##3##2##(1991-3#1)(2008-2#2)
of 322##2##2##(1995-6#1)(2008-12#1)
of 323##3##2##(1994-6#1)(2007-7#2)
of 327##2##2##(1992-12#1)(2011-2#1)
of 32P##3##2##(1995-12#1)(1995-6#1)(1997-1#1)
of 32P-labeled##2##2##(1990-11#1)(1992-9#1)
of 32PO4(3-)##2##2##(1996-2#2)
of 33 cases##2##3##(2008-10#1)(2008-12#1)
of 33 patients##4##3##(1991-9#1)(2008-7#1)(2010-3#1)(2012-12#1)
of 33##36##2##(1991-8#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
of 33%##3##2##(1995-12#1)(2007-11#2)
of 330##4##2##(1991-11#2)(2008-10#1)(2010-3#1)
of 331 patients##2##3##(1990-2#1)(1990-9#1)
of 331##3##2##(1990-2#1)(1990-9#1)(1997-2#1)
of 333##5##2##(1992-6#1)(1994-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
of 334##4##2##(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
of 3342##2##2##(1990-11#2)
of 335##2##2##(1996-12#1)(2008-11#1)
of 336##2##2##(1993-12#1)(2010-1#1)
of 339##3##2##(1991-2#1)(2008-10#1)(2009-5#1)
of 34 patients##2##3##(1995-4#1)(2011-2#1)
of 34##38##2##(1990-5#1)(1992-8#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
of 34%##3##2##(2007-12#1)(2008-2#1)(2011-2#1)
of 340##6##2##(1990-8#1)(1993-9#1)(1995-6#1)(1995-8#1)(2008-3#1)(2011-2#1)
of 342##2##2##(1994-11#1)(2011-2#1)
of 347##2##2##(1993-12#1)(1997-6#1)
of 35 amino acid##2##4##(1997-4#1)(2008-6#1)
of 35 amino##3##3##(1991-12#1)(1997-4#1)(2008-6#1)
of 35 and##4##3##(1995-6#1)(2008-10#2)(2012-2#1)
of 35 degrees##4##3##(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
of 35 patients##5##3##(1990-9#1)(1991-3#1)(2007-11#1)(2008-9#1)(2011-2#1)
of 35##47##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1993-1#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-10#13)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
of 35%##5##2##(1995-12#1)(2007-11#2)(2007-12#1)(2008-11#1)
of 350 cases##4##3##(1990-12#1)(1991-8#1)(2010-7#2)
of 350 kb##3##3##(1996-10#2)(1996-12#1)
of 350##21##2##(1990-12#2)(1991-8#1)(1996-10#2)(1996-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-9#4)(2010-7#3)(2013-1#1)
of 351##2##2##(1996-6#1)(2008-2#1)
of 354##2##2##(1991-12#1)(1991-9#1)
of 355##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
of 357 patients##2##3##(2008-7#2)
of 357##4##2##(1995-6#1)(2008-1#1)(2008-7#2)
of 358##2##2##(1990-11#1)(2008-12#1)
of 359 amino##2##3##(1991-5#1)(1992-3#1)
of 36 patients##4##3##(1995-10#1)(1997-6#1)(2008-7#1)(2011-2#1)
of 36##50##2##(1990-12#1)(1991-11#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#1)(1997-6#1)(2007-11#4)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)
of 36%##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
of 360 patients##2##3##(1990-9#1)(2008-7#1)
of 360##11##2##(1990-9#1)(1993-8#1)(1996-2#1)(2008-10#6)(2008-12#1)(2008-7#1)
of 362##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
of 363##2##2##(1991-11#1)(1994-11#1)
of 368##2##2##(2008-5#1)(2008-6#1)
of 37 degrees C##3##4##(2008-10#2)(2008-11#1)
of 37 degrees##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
of 37##31##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1993-12#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#4)(2008-6#2)(2008-7#1)(2009-11#1)(2010-6#1)(2012-3#3)(2013-8#1)
of 37%##4##2##(1992-2#1)(2007-11#1)(2008-10#2)
of 370##2##2##(2007-11#1)(2008-3#1)
of 372##4##2##(1992-8#1)(2008-10#1)(2010-8#1)(2013-8#1)
of 373##2##2##(2008-3#2)
of 375 amino##2##3##(1995-8#1)(1997-7#1)
of 375##3##2##(1992-3#1)(1995-8#1)(1997-7#1)
of 38 kDa##2##3##(1993-11#1)(2008-10#1)
of 38 loci##2##3##(2008-8#2)
of 38##37##2##(1990-12#1)(1991-12#1)(1993-1#1)(1993-11#1)(1994-1#4)(1994-11#1)(1994-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
of 38%##2##2##(1991-4#1)(1991-6#1)
of 382##2##2##(1996-6#1)(2008-7#1)
of 384##2##2##(2009-8#1)(2012-12#1)
of 386##4##2##(1994-8#1)(1997-2#1)(2008-10#2)
of 389##2##2##(2008-3#1)(2008-5#1)
of 39 and##2##3##(1995-8#1)(2008-10#1)
of 39 kDa##2##3##(2008-5#2)
of 39##26##2##(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#2)(1994-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
of 390##2##2##(2008-10#2)
of 391##2##2##(1996-12#1)(1997-8#1)
of 393##4##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-8#1)
of 399##2##2##(2008-5#2)
of 3D data sets##2##4##(2008-9#2)
of 3D data##3##3##(2007-12#1)(2008-9#2)
of 3D interaction position##2##4##(2010-3#2)
of 3D##21##2##(1995-11#1)(2007-11#2)(2007-12#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-10#1)(2010-3#4)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
of 3H-thymidine incorporation##4##3##(1991-4#2)(1991-6#1)(1995-3#1)
of 3H-thymidine##6##2##(1991-4#2)(1991-6#1)(1995-3#2)(2008-7#1)
of 3LL##2##2##(1991-6#2)
of 3T3-L1 cells##2##3##(2008-3#2)
of 3T3-L1##5##2##(1993-8#1)(2008-3#4)
of 3a##2##2##(1996-5#1)(1997-7#1)
of 3alphaOHT##2##2##(2008-10#2)
of 3beta-HSD deficiency##3##3##(2008-4#3)
of 4 M##4##3##(2008-10#4)
of 4 and##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
of 4 cases##3##3##(1990-6#1)(2007-5#1)(2013-1#1)
of 4 cm##2##3##(1993-9#1)(2011-2#1)
of 4 degrees C##2##4##(1996-12#1)(2007-12#1)
of 4 degrees##4##3##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#1)
of 4 different##2##3##(1991-3#1)(1996-2#1)
of 4 h##3##3##(1996-2#1)(2008-10#2)
of 4 hamsters with tumors) or estradiol plus RU 39##2##10##(1992-5#2)
of 4 mg##2##3##(2008-11#1)(2009-4#1)
of 4 months##5##3##(1995-12#1)(2007-11#1)(2008-10#2)(2008-7#1)
of 4 ms at##2##4##(1996-5#1)(2008-2#1)
of 4 mug l(-1)##2##4##(2008-10#2)
of 4 mug##3##3##(2008-10#3)
of 4 or##2##3##(1996-11#1)(1997-2#1)
of 4 patients##3##3##(1997-7#1)(2007-11#1)(2008-7#1)
of 4 to 5##2##4##(2008-10#1)(2012-12#1)
of 4 to 6 weeks##2##5##(2007-7#1)(2008-10#1)
of 4 to##9##3##(1996-5#1)(1997-7#1)(2007-7#1)(2008-10#3)(2012-12#2)(2013-1#1)
of 4 was##2##3##(1992-3#1)(2008-10#1)
of 4 weeks##3##3##(2008-10#3)
of 4 with##3##3##(1996-2#1)(1996-5#2)
of 4 x##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
of 4 years duration##2##4##(1994-12#1)(2009-3#1)
of 4 years##6##3##(1991-2#1)(1994-12#1)(1996-8#1)(2009-3#1)(2009-8#1)(2012-2#1)
of 4##294##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#5)(1992-9#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#4)(1996-8#1)(1997-2#3)(1997-4#3)(1997-5#1)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#99)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#9)(2010-6#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#4)
of 4%##5##2##(2007-7#1)(2008-10#3)(2008-3#1)
of 4'-chemistry##3##2##(1991-3#3)
of 4-(2-pyridylazo)resorcinol (PAR)##3##3##(2008-10#3)
of 4-4-20##2##2##(1992-6#2)
of 4-6##5##2##(1995-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2013-1#1)
of 4-NP##3##2##(2008-10#3)
of 4-amino-2##3##2##(1994-5#3)
of 4-aminophenol##5##2##(2008-10#5)
of 4-epi-doxorubicin##2##2##(1990-2#2)
of 4-hydroxynonenal##2##2##(1990-5#1)(1996-12#1)
of 4-nitrophenol##4##2##(2008-10#4)
of 4-substituted##2##2##(1992-11#1)(2008-12#1)
of 4-week-old##2##2##(1995-12#1)(2008-10#1)
of 40 and##2##3##(1994-6#1)(2013-1#1)
of 40 cases##4##3##(2008-10#2)(2008-12#1)(2009-4#1)
of 40 h(-1)##3##3##(2008-10#3)
of 40 kDa##2##3##(1993-1#1)(1993-8#1)
of 40 mg##6##3##(1991-6#1)(1995-12#1)(1995-5#1)(2007-7#1)(2010-12#1)(2011-2#1)
of 40 months##2##3##(1990-12#1)(1990-9#1)
of 40 mul s(-1)##2##4##(2008-10#2)
of 40 patients with##2##4##(1990-2#1)(2013-1#1)
of 40 patients##6##3##(1990-2#1)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
of 40 samples per hour##3##5##(2008-10#3)
of 40 samples##4##3##(2008-10#4)
of 40 to##2##3##(2010-12#1)(2012-3#1)
of 40 years##5##3##(2008-10#1)(2008-5#2)(2008-9#1)(2013-1#1)
of 40##121##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#4)(2013-1#8)(2013-8#1)
of 40% of##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
of 40%##9##2##(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-4#1)(2011-2#1)
of 40)##3##2##(1994-7#1)(2008-10#1)(2011-2#1)
of 40-50##3##2##(1990-5#1)(1997-4#1)(2008-3#1)
of 40-year old persons in##2##5##(1994-11#2)
of 400 and 800##2##4##(2008-10#1)(2008-9#1)
of 400 and##4##3##(2008-10#3)(2008-9#1)
of 400 mg##2##3##(1994-6#1)(2008-10#1)
of 400 nm##2##3##(2007-12#1)(2008-10#1)
of 400##28##2##(1992-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#3)(2010-8#1)(2013-1#2)
of 4000##2##2##(1994-9#1)(2007-11#1)
of 401(k)##4##2##(2011-2#4)
of 408##2##2##(1993-2#1)(2012-2#1)
of 40h(-1)##3##2##(2008-10#3)
of 41 patients with##3##4##(1990-12#1)(1990-6#1)(1996-11#1)
of 41##30##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1993-9#1)(1994-12#1)(1996-11#1)(1996-2#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-5#3)(2008-9#1)(2009-2#1)(2010-3#1)(2011-1#2)(2012-3#2)(2013-1#3)
of 410##2##2##(1996-11#1)(2008-10#1)
of 411##2##2##(2008-10#1)(2010-7#1)
of 414##2##2##(2013-1#2)
of 415##2##2##(2008-10#1)(2008-3#1)
of 42 years##3##3##(1992-5#1)(2007-8#2)
of 42##38##2##(1990-12#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#5)(2013-1#2)
of 42%##5##2##(1991-8#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
of 420##4##2##(1996-2#1)(1997-2#1)(2008-3#2)
of 421##3##2##(1991-8#1)(2011-1#1)(2013-1#1)
of 426##3##2##(2007-12#1)(2008-8#1)(2009-7#1)
of 429##2##2##(1992-3#1)(2012-12#1)
of 43 kDa##2##3##(1991-12#1)(2010-12#1)
of 43 patients with##2##4##(2007-10#1)(2008-7#1)
of 43 years##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
of 43##31##2##(1990-5#1)(1991-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
of 434##2##2##(1995-8#1)(2008-3#1)
of 44 +/-##2##3##(2007-7#1)(2008-3#1)
of 44 and##2##3##(2008-10#2)
of 44 patients##2##3##(1990-2#1)(2008-12#1)
of 44##20##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-8#2)(1992-6#1)(1995-12#1)(1995-3#1)(1997-6#1)(2007-7#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
of 44% and##2##3##(1990-11#1)(2008-5#1)
of 44%##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
of 440##2##2##(2008-10#1)(2008-11#1)
of 449##3##2##(1994-11#1)(2011-1#1)(2013-7#1)
of 45 and##2##3##(1997-2#1)(2009-11#1)
of 45 cases##2##3##(2008-10#1)(2008-7#1)
of 45 degrees C##2##4##(2008-10#1)(2008-6#1)
of 45 degrees##4##3##(2008-10#1)(2008-2#2)(2008-6#1)
of 45 patients who##2##4##(1992-5#1)(1996-3#1)
of 45 patients##4##3##(1992-5#1)(1996-3#1)(2007-7#1)(2008-1#1)
of 45 samples per##2##4##(2008-10#2)
of 45 samples##3##3##(2008-10#2)(2008-12#1)
of 45##56##2##(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-5#1)(1993-10#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#2)
of 45%##2##2##(2008-11#1)(2013-1#1)
of 450##5##2##(1990-5#1)(1991-2#1)(1997-2#1)(2008-10#1)(2008-2#1)
of 453##3##2##(1994-12#1)(2007-12#1)(2008-3#1)
of 454##2##2##(2007-7#1)(2008-9#1)
of 45Ca by##2##3##(1990-2#1)(1993-3#1)
of 45Ca##4##2##(1990-2#1)(1993-3#2)(1995-3#1)
of 45Ca2+ was##2##3##(1997-2#2)
of 45Ca2+##4##2##(1990-12#1)(1997-2#3)
of 46 patients##8##3##(1990-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
of 46##34##2##(1990-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
of 46%##3##2##(1990-2#1)(1994-11#1)(2008-4#1)
of 460##4##2##(2008-10#3)(2008-3#1)
of 467##2##2##(2008-7#2)
of 469 amino##2##3##(1993-12#1)(1997-4#1)
of 469##5##2##(1990-3#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-10#1)
of 47 patients##2##3##(1993-9#1)(2007-11#1)
of 47##21##2##(1990-11#1)(1991-12#1)(1993-9#1)(1995-3#2)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-4#1)(2008-6#1)(2009-12#1)(2009-2#1)(2010-4#1)
of 47%##3##2##(1996-5#1)(1997-6#1)(2010-4#1)
of 470##2##2##(1993-2#1)(2013-7#1)
of 474##3##2##(1997-4#1)(2008-9#1)(2013-1#1)
of 48 cases##2##3##(2007-7#1)(2008-10#1)
of 48 h##2##3##(2011-1#1)(2013-1#1)
of 48 hours##2##3##(1992-5#1)(2008-1#1)
of 48 months##4##3##(1992-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
of 48 patients##2##3##(2008-6#1)(2011-2#1)
of 48##31##2##(1991-2#1)(1992-12#2)(1992-2#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
of 48%##3##2##(1991-6#1)(2008-2#1)(2012-3#1)
of 48)##2##2##(2008-12#2)
of 480##6##2##(1991-4#1)(2007-11#2)(2008-10#1)(2008-5#1)(2011-2#1)
of 481##2##2##(1991-2#1)(2013-8#1)
of 488##2##2##(2008-12#1)(2008-2#1)
of 49##13##2##(1995-1#1)(1995-2#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2012-2#1)(2013-7#1)
of 49%##3##2##(2008-12#1)(2008-2#1)(2009-5#1)
of 490##3##2##(2008-10#2)(2008-5#1)
of 493##2##2##(1996-6#1)(1996-9#1)
of 497##2##2##(2008-10#1)(2008-7#1)
of 4q32→q35##2##2##(2012-3#2)
of 5 alpha##2##3##(2008-2#2)
of 5 and 10##2##4##(1995-2#1)(2008-10#1)
of 5 and##10##3##(1991-3#1)(1991-8#1)(1995-2#1)(2007-12#2)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
of 5 cases]##3##3##(1990-6#1)(1990-9#1)(2011-2#1)
of 5 cm##3##3##(1995-3#1)(2007-8#1)(2008-7#1)
of 5 containing an##2##4##(1996-5#2)
of 5 degrees##5##3##(2008-10#2)(2008-3#2)(2009-8#1)
of 5 kHz##2##3##(2007-12#1)(2008-3#1)
of 5 m##2##3##(2008-3#2)
of 5 mM##7##3##(1990-7#1)(1992-11#1)(1992-3#1)(1994-9#1)(1997-1#1)(1997-2#1)(2008-10#1)
of 5 mg##3##3##(2008-10#2)(2011-2#1)
of 5 mg/kg##3##3##(1992-3#1)(1994-6#1)(2011-1#1)
of 5 microM##5##3##(1991-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-5#1)
of 5 min##8##3##(1992-11#1)(1997-2#1)(2008-10#5)(2008-2#1)
of 5 mm##2##3##(2007-12#1)(2009-4#1)
of 5 months##5##3##(1991-2#2)(2007-7#1)(2008-10#2)
of 5 mug l(-1)##2##4##(2008-10#2)
of 5 mum##2##3##(2008-3#1)(2010-3#1)
of 5 nM##2##3##(1994-6#1)(1997-4#1)
of 5 nm##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
of 5 or##2##3##(2008-10#1)(2008-3#1)
of 5 patients##2##3##(1990-10#1)(2008-1#1)
of 5 percent##2##3##(1992-2#1)(1994-12#1)
of 5 to 20##2##4##(2008-10#1)(2008-5#1)
of 5 to##5##3##(1990-7#1)(2008-10#2)(2008-2#1)(2008-5#1)
of 5 with##3##3##(1996-5#3)
of 5 x 10(-5)##2##4##(1994-5#1)(2007-12#1)
of 5 x 10(-6)##2##4##(1994-5#1)(2008-3#1)
of 5 x##13##3##(1994-5#2)(1996-12#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-7#1)
of 5 years##12##3##(1992-6#1)(1993-9#2)(1997-2#1)(1997-3#1)(2006-12#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
of 5##370##2##(1990-10#2)(1990-11#5)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-8#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#11)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2006-12#1)(2007-11#9)(2007-12#8)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#116)(2008-11#3)(2008-12#5)(2008-2#7)(2008-3#25)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#2)(2009-1#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#5)
of 5% to##2##3##(2008-8#1)(2010-1#1)
of 5%##23##2##(1992-5#1)(1993-8#1)(1993-9#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
of 5'##7##2##(1990-12#1)(1995-2#1)(1996-9#1)(2008-8#2)(2008-9#2)
of 5'-amino-2'##2##2##(2008-4#2)
of 5'-flanking region of human##2##5##(1994-6#2)
of 5'-flanking region##3##3##(1991-7#1)(1994-6#2)
of 5'-flanking##4##2##(1991-7#1)(1994-2#1)(1994-6#2)
of 5'AMP##2##2##(2008-4#2)
of 5-10##9##2##(1992-6#1)(1992-9#1)(1996-4#1)(1996-9#1)(2008-10#2)(2008-3#1)(2010-2#1)(2013-8#1)
of 5-10%##2##2##(2007-5#1)(2008-3#1)
of 5-15##2##2##(2007-8#1)(2008-2#1)
of 5-15%##2##2##(2008-10#1)(2013-1#1)
of 5-2-1-AN##2##2##(2010-8#2)
of 5-200##2##2##(1994-9#1)(2007-12#1)
of 5-6##2##2##(1993-8#1)(2008-2#1)
of 5-8##2##2##(1993-12#1)(2007-11#1)
of 5-FU##7##2##(1991-3#1)(1993-8#2)(1994-7#2)(2008-11#1)(2010-12#1)
of 5-HIAA and##2##3##(2008-3#2)
of 5-HIAA in the##2##4##(1995-12#1)(2008-10#1)
of 5-HIAA in##3##3##(1995-11#1)(1995-12#1)(2008-10#1)
of 5-HIAA##6##2##(1992-1#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-3#2)
of 5-HT and NE in##2##5##(2008-3#2)
of 5-HT and##5##3##(1994-2#1)(1995-12#1)(2008-3#2)(2008-7#1)
of 5-HT fibers##2##3##(1996-12#2)
of 5-HT in the##2##4##(1995-12#1)(2008-6#1)
of 5-HT in##4##3##(1990-5#1)(1995-12#1)(2008-6#1)(2012-12#1)
of 5-HT neurons in the##2##5##(1995-5#1)(1997-6#1)
of 5-HT transporter##2##3##(2008-7#2)
of 5-HT##38##2##(1990-5#2)(1991-2#2)(1992-8#1)(1993-12#3)(1993-3#2)(1993-9#2)(1994-2#2)(1995-12#2)(1995-5#1)(1996-12#3)(1997-6#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2012-12#1)
of 5-HT1A receptor##2##3##(1993-3#1)(1995-12#1)
of 5-HT1A##6##2##(1990-5#1)(1991-2#1)(1993-3#1)(1994-2#1)(1995-12#2)
of 5-HT1B binding sites##2##4##(1995-12#2)
of 5-HT1B receptor##2##3##(1995-12#2)
of 5-HT1B receptors##3##3##(1995-12#3)
of 5-HT1B##8##2##(1995-12#8)
of 5-HT1D and##2##3##(1994-2#1)(1995-12#1)
of 5-HT2 receptors##3##3##(1991-2#1)(1995-12#1)(1995-3#1)
of 5-HT2##4##2##(1990-5#1)(1991-2#1)(1995-12#1)(1995-3#1)
of 5-HT4##2##2##(1996-12#2)
of 5-VOT is##4##3##(2008-10#4)
of 5-VOT##5##2##(2008-10#5)
of 5-alpha-reductase##2##2##(1990-11#1)(2008-5#1)
of 5-aminolevulinic acid##2##3##(1992-8#1)(1992-9#1)
of 5-aminosalicylate##2##2##(1997-3#1)(2012-12#1)
of 5-androstene-3 beta##2##3##(1990-11#2)
of 5-azacitidine##2##2##(2011-2#2)
of 5-fluorouracil on##3##3##(1990-2#1)(1992-8#2)
of 5-fluorouracil##11##2##(1990-2#1)(1990-8#2)(1991-4#1)(1992-2#2)(1992-8#2)(1994-7#1)(2008-7#1)(2013-7#1)
of 5-fluorouridine##2##2##(1993-8#2)
of 5-fs pulses##2##3##(2007-11#2)
of 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone##2##2##(1992-9#2)
of 5-hydroxytryptamine##4##2##(1994-6#1)(1995-12#1)(1995-3#1)(2012-3#1)
of 5-hydroxytryptophan##2##2##(1995-12#1)(1995-3#1)
of 5-methyltetrahydrofolate##4##2##(1994-6#4)
of 5-methylthioninhydrin##2##2##(2012-2#2)
of 5-sulfosalicylic acid (SSA)##2##4##(2008-10#2)
of 50 GHz##2##3##(2007-11#2)
of 50 and 100##2##4##(2008-5#1)(2008-9#1)
of 50 and 60 kDa##2##5##(2008-10#2)
of 50 and##8##3##(1995-6#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)
of 50 is##2##3##(2008-10#1)(2008-5#1)
of 50 mV##2##3##(2008-10#2)
of 50 mg##7##3##(1990-11#1)(1991-11#1)(1994-8#1)(2008-10#3)(2008-11#1)
of 50 microM##2##3##(1996-5#1)(2010-3#1)
of 50 microg l(-1)##2##4##(2008-10#2)
of 50 mm##3##3##(2007-8#1)(2008-12#1)(2013-8#1)
of 50 mug l(-1) of##2##5##(2008-10#2)
of 50 mug l(-1)##3##4##(2008-10#3)
of 50 ng/ml##2##3##(1996-5#1)(2008-10#1)
of 50 nm##2##3##(2007-12#1)(2008-10#1)
of 50 patients##4##3##(1990-3#1)(2007-7#1)(2008-5#1)(2012-12#1)
of 50 ppm##3##3##(2008-11#1)(2008-5#2)
of 50 times##2##3##(2008-10#2)
of 50 to##4##3##(1990-3#1)(2008-10#1)(2008-2#1)(2008-6#1)
of 50 years##5##3##(1994-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)
of 50##137##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-8#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#3)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#4)(2007-8#3)(2008-10#45)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
of 50% and##3##3##(1993-12#1)(1994-5#1)(1995-11#1)
of 50% in##2##3##(1994-6#1)(2008-7#1)
of 50% were##2##3##(2008-3#1)(2013-1#1)
of 50%##20##2##(1990-6#1)(1993-12#1)(1994-5#2)(1994-6#2)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of 50-100##3##2##(2008-10#2)(2008-5#1)
of 50-1000##3##2##(2008-10#3)
of 50-150##2##2##(1993-12#1)(2010-6#1)
of 50-60##3##2##(2008-10#2)(2013-8#1)
of 50-mum##2##2##(2008-10#1)(2008-2#1)
of 500 and##2##3##(1995-8#1)(2008-10#1)
of 500 mg##5##3##(2008-10#3)(2008-3#1)(2011-2#1)
of 500 nM##4##3##(1991-5#1)(1991-9#2)(1996-2#1)
of 500 nm##2##3##(2008-10#1)(2008-2#1)
of 500 patients##2##3##(1991-3#1)(1995-10#1)
of 500##40##2##(1990-3#1)(1991-3#1)(1991-5#1)(1991-9#2)(1993-11#1)(1993-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#2)(2007-12#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#6)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
of 5000##5##2##(1991-12#1)(1995-3#1)(2008-11#2)(2008-7#1)
of 500ml##2##2##(2008-10#2)
of 501##2##2##(1995-8#1)(2008-10#1)
of 503##2##2##(1990-11#1)(2009-1#1)
of 504##2##2##(2008-2#1)(2010-2#1)
of 509 disc excisions in 476##2##6##(2008-7#2)
of 509##3##2##(2008-10#1)(2008-7#2)
of 50mM##2##2##(2008-10#2)
of 51 patients##2##3##(2007-11#1)(2012-3#1)
of 51##21##2##(1990-9#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#4)(2012-3#1)
of 512 x##2##3##(2007-12#1)(2008-3#1)
of 512##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
of 514##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
of 515##2##2##(1990-12#1)(2007-8#1)
of 516##4##2##(1993-1#1)(2007-8#1)(2008-12#1)(2011-2#1)
of 52 cases##2##3##(1995-6#1)(2011-2#1)
of 52 patients##6##3##(1997-5#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)
of 52 samples##2##3##(2008-10#2)
of 52##31##2##(1990-12#1)(1991-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-7#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)(2013-1#1)
of 52%##2##2##(1996-10#1)(2007-12#1)
of 520##2##2##(2007-7#1)(2008-12#1)
of 525##2##2##(2008-10#1)(2011-2#1)
of 528##2##2##(2008-11#1)(2012-3#1)
of 53 patients who had##2##5##(1994-3#1)(2011-2#1)
of 53 patients##4##3##(1993-5#1)(1994-3#1)(2011-2#2)
of 53##20##2##(1991-8#1)(1993-2#2)(1993-5#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-5#1)(1997-8#3)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#3)(2012-2#1)(2013-1#1)
of 53%##5##2##(1993-9#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-12#1)
of 530##4##2##(1994-12#1)(2007-12#2)(2008-10#1)
of 532-nm##2##2##(2007-12#1)(2008-3#1)
of 539##2##2##(1994-11#1)(2007-2#1)
of 54 and##2##3##(2008-10#1)(2008-11#1)
of 54 patients##2##3##(2008-5#1)(2013-1#1)
of 54##15##2##(1993-2#1)(1994-3#1)(1996-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#1)
of 54%##4##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)
of 540##5##2##(1997-5#2)(2007-12#1)(2008-10#1)(2009-5#1)
of 543##2##2##(1997-7#1)(2008-10#1)
of 55 +/-##2##3##(2008-10#1)(2009-9#1)
of 55 years##2##3##(1991-11#1)(1992-12#1)
of 55##26##2##(1990-11#2)(1991-11#1)(1992-12#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-10#2)(2008-10#7)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-4#1)(2012-2#1)
of 55% of##2##3##(2007-11#1)(2007-12#1)
of 55%##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of 550##2##2##(1992-1#1)(2008-9#1)
of 56 patients##2##3##(1996-7#1)(1997-8#1)
of 56##24##2##(1990-11#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-12#2)(2008-6#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
of 560##3##2##(1994-12#1)(2007-12#1)(2011-2#1)
of 561##2##2##(1994-11#1)(2008-12#1)
of 57##22##2##(1990-2#1)(1990-5#1)(1991-2#1)(1993-2#1)(1993-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
of 57%##2##2##(2008-10#1)(2012-3#1)
of 58 isolates of##2##4##(2008-10#1)(2008-12#1)
of 58##18##2##(1990-2#1)(1990-8#1)(1991-11#1)(1994-7#1)(1995-3#1)(1996-12#1)(2008-10#5)(2008-12#2)(2011-1#2)(2012-3#1)(2013-1#2)
of 58%##2##2##(2008-10#1)(2008-2#1)
of 580##2##2##(2008-10#2)
of 586##2##2##(2012-3#2)
of 589##3##2##(1997-4#1)(2007-11#1)(2011-2#1)
of 59 months##2##3##(2008-6#1)(2008-9#1)
of 59##24##2##(1990-5#1)(1990-6#1)(1991-6#1)(1993-9#2)(1996-12#1)(2007-7#1)(2008-10#7)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#3)(2013-7#1)
of 595##2##2##(1993-12#1)(2008-10#1)
of 59Fe##2##2##(1992-6#2)
of 5FU##2##2##(1992-2#2)
of 5HT##4##2##(1995-11#1)(1996-7#2)(2008-6#1)
of 5alphaR##3##2##(2008-5#3)
of 5mgl(-1)##2##2##(2008-10#2)
of 5mul##2##2##(2008-10#2)
of 5x10(-6)##2##2##(2008-10#2)
of 5x10(-7)##2##2##(2008-10#2)
of 6 +/-##2##3##(1991-8#1)(2013-7#1)
of 6 M##3##3##(2008-10#3)
of 6 and 12 mg/kg males and females were significantly##2##10##(2008-9#2)
of 6 and 12 mg/kg males and females were##3##9##(2008-9#3)
of 6 and 12 mg/kg males and females##4##8##(2008-9#4)
of 6 and 12 mg/kg males and##5##7##(2008-9#5)
of 6 and 12 mg/kg##6##5##(2008-9#6)
of 6 and 8##2##4##(1991-3#1)(2008-10#1)
of 6 and##13##3##(1990-6#1)(1991-3#1)(2008-10#3)(2008-3#2)(2008-9#6)
of 6 cases##2##3##(1990-6#2)
of 6 cases]##2##3##(1994-9#1)(2007-8#1)
of 6 microM##2##3##(1993-8#1)(1994-5#1)
of 6 min##2##3##(1994-3#1)(1997-7#1)
of 6 mm##2##3##(2008-10#1)(2008-9#1)
of 6 months##5##3##(1992-10#1)(2008-10#3)(2013-8#1)
of 6 nm##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
of 6 or##2##3##(2007-8#1)(2008-10#1)
of 6 patients with##2##4##(1994-7#1)(1997-3#1)
of 6 patients##5##3##(1992-3#1)(1994-7#1)(1996-12#1)(1997-3#1)(2008-10#1)
of 6 to##2##3##(2011-1#1)(2012-3#1)
of 6 weeks##5##3##(2008-11#2)(2008-6#1)(2008-7#1)(2013-1#1)
of 6 x##3##3##(1993-8#1)(2008-3#2)
of 6 years##2##3##(1997-3#1)(2009-4#1)
of 6##213##2##(1990-11#1)(1990-12#1)(1990-6#4)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(2007-11#10)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#61)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#9)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
of 6%##3##2##(2008-10#2)(2012-1#1)
of 6-APA##4##2##(2008-12#4)
of 6-MP##5##2##(1992-9#2)(2008-10#3)
of 6-OHDA##2##2##(1993-12#1)(1995-5#1)
of 6-hydroxydopamine##6##2##(1992-10#1)(1993-3#1)(1995-12#1)(1995-5#2)(2008-7#1)
of 6-keto PGF1 alpha##2##4##(1991-5#1)(1994-9#1)
of 6-keto-PGF1 alpha##2##3##(1994-5#1)(1995-11#1)
of 6-mercaptopurine (6-MP)##2##3##(1992-9#1)(2008-10#1)
of 6-mercaptopurine on##2##3##(1992-9#1)(2008-10#1)
of 6-mercaptopurine##6##2##(1992-9#2)(2008-10#4)
of 6-substituted##2##2##(1992-9#1)(1995-3#1)
of 6-week##2##2##(2007-12#1)(2011-2#1)
of 6-week-old##2##2##(1994-5#1)(2008-10#1)
of 60 Gy##4##3##(1991-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
of 60 bp##2##3##(1990-12#1)(1993-6#1)
of 60 cases##2##3##(1992-8#1)(2008-7#1)
of 60 h(-1) were achieved##2##5##(2008-10#2)
of 60 h(-1)##6##3##(2008-10#6)
of 60 kDa##3##3##(1990-7#1)(1997-2#2)
of 60 mW##3##3##(2007-11#2)(2007-12#1)
of 60 min##3##3##(1994-5#1)(2008-6#1)(2010-2#1)
of 60 ml##2##3##(2008-10#2)
of 60 patients##3##3##(2012-2#2)(2013-1#1)
of 60 s##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
of 60 samples##2##3##(2008-10#2)
of 60##89##2##(1990-12#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#3)(2013-1#1)
of 60% of the##2##4##(2008-10#1)(2008-7#1)
of 60% of##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
of 60% to##2##3##(2008-10#1)(2008-4#1)
of 60%##12##2##(1997-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#1)
of 60-70%##2##2##(2010-3#2)
of 600 and##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of 600##16##2##(1991-6#1)(1992-3#1)(1992-5#1)(1994-12#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-3#1)
of 601##2##2##(1990-5#1)(2009-7#1)
of 604##2##2##(1995-3#1)(2012-3#1)
of 605##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
of 61 consecutive patients##2##4##(2007-11#1)(2011-2#1)
of 61##11##2##(1990-8#1)(1992-3#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)
of 61%##2##2##(2007-5#1)(2008-11#1)
of 62 patients with##2##4##(2007-11#1)(2013-1#1)
of 62##20##2##(1991-11#1)(1991-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
of 62%##3##2##(2007-2#1)(2008-3#1)(2008-5#1)
of 624##2##2##(2013-1#1)(2013-8#1)
of 627##2##2##(1996-8#1)(2010-10#1)
of 63 and##2##3##(2007-11#1)(2007-12#1)
of 63##19##2##(1994-1#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of 63%##2##2##(2010-8#1)(2012-12#1)
of 630##2##2##(1996-12#1)(2008-3#1)
of 633##4##2##(2008-3#4)
of 64 and##3##3##(1990-12#1)(1991-8#1)(2008-8#1)
of 64 patients##2##3##(1993-1#1)(2011-2#1)
of 64##21##2##(1990-12#1)(1990-2#1)(1991-8#2)(1993-1#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#2)
of 65 cases##2##3##(2007-7#1)(2011-2#1)
of 65 degrees##2##3##(2008-6#1)(2013-8#1)
of 65 patients##3##3##(1990-3#1)(1993-2#1)(2008-1#1)
of 65##28##2##(1990-3#1)(1990-8#2)(1991-3#1)(1993-2#2)(1993-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-8#1)
of 65%##5##2##(2008-10#2)(2008-6#1)(2010-7#1)(2011-2#1)
of 650##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)
of 66##12##2##(1990-11#1)(1994-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#2)
of 66%##2##2##(2007-8#1)(2011-2#1)
of 660##2##2##(2008-8#1)(2012-2#1)
of 67 cases##2##3##(1990-9#2)
of 67##15##2##(1990-9#2)(1991-3#1)(1991-9#1)(1993-11#1)(1996-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
of 67%##3##2##(2007-11#1)(2008-7#1)(2009-4#1)
of 670##2##2##(1996-2#1)(2007-11#1)
of 68 kDa##3##3##(1994-5#2)(1995-12#1)
of 68 patients##4##3##(1990-2#1)(1991-8#1)(2007-11#1)(2008-3#1)
of 68##20##2##(1990-2#2)(1991-8#1)(1991-9#1)(1994-5#2)(1994-8#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of 68%##2##2##(2008-10#1)(2010-7#1)
of 680##2##2##(1990-12#1)(1995-6#1)
of 69 patients##4##3##(1994-2#1)(1996-8#1)(2008-7#1)(2011-1#1)
of 69##18##2##(1991-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1996-8#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)
of 696-nm##2##2##(2008-3#2)
of 6ml##2##2##(2008-10#2)
of 6th##3##2##(1997-3#1)(2011-2#2)
of 7 alpha-methyl-19-nortestosterone##2##3##(1990-11#2)
of 7 and##5##3##(1995-12#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
of 7 cases##2##3##(2007-11#1)(2008-12#1)
of 7 cases]##2##3##(1990-3#1)(1995-3#1)
of 7 days##5##3##(1990-2#1)(1992-3#1)(2008-12#2)(2008-8#1)
of 7 months##2##3##(1995-3#1)(2008-6#1)
of 7 of##3##3##(1995-2#1)(2008-10#1)(2009-3#1)
of 7 patients##9##3##(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2010-12#2)(2011-2#1)
of 7 to 10##3##4##(1991-11#1)(1994-2#1)(2008-4#1)
of 7 to##5##3##(1991-11#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-4#1)
of 7 was##2##3##(1994-5#1)(2008-10#1)
of 7##164##2##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1994-2#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#43)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
of 7% for##2##3##(2008-10#1)(2008-2#1)
of 7%##8##2##(1990-12#1)(1993-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)
of 7-12##2##2##(2008-3#2)
of 7-8##3##2##(1994-3#2)(2008-3#1)
of 7-9##2##2##(1995-2#1)(2008-3#1)
of 70 samples##2##3##(2008-10#1)(2009-4#1)
of 70##25##2##(1990-2#1)(1990-6#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-4#1)
of 70% at##2##3##(2008-3#1)(2008-7#1)
of 70% or##2##3##(1991-11#1)(1993-12#1)
of 70%##7##2##(1991-11#1)(1993-12#2)(2008-10#2)(2008-3#1)(2008-7#1)
of 700 mg/L##2##3##(2008-9#2)
of 700##7##2##(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#2)(2013-1#1)
of 71##12##2##(1990-11#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#2)(2013-7#1)
of 71%##2##2##(2008-3#1)(2010-8#1)
of 710##2##2##(1991-9#1)(2008-10#1)
of 72 cases##3##3##(1991-2#1)(1994-7#1)(2010-11#1)
of 72 h##2##3##(2007-12#1)(2013-1#1)
of 72 kDa##2##3##(1993-3#1)(1995-6#1)
of 72##21##2##(1991-2#1)(1993-3#1)(1994-1#1)(1994-7#1)(1995-6#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#2)
of 720##2##2##(2008-10#2)
of 727##2##2##(2012-3#1)(2013-1#1)
of 73##8##2##(1990-5#1)(1991-11#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
of 73%##3##2##(1993-5#1)(2011-2#1)(2012-1#1)
of 732##2##2##(1991-12#1)(2008-10#1)
of 74##9##2##(1993-5#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-8#1)
of 740 mW of blue light##2##6##(2007-12#2)
of 740##3##2##(2007-12#2)(2008-8#1)
of 75 Gy##2##3##(2008-6#2)
of 75 and 150##2##4##(2008-10#1)(2011-2#1)
of 75 kDa##2##3##(1992-8#1)(2008-11#1)
of 75 mg aspirin##2##4##(1991-11#2)
of 75##32##2##(1991-11#3)(1991-2#1)(1992-8#1)(1994-2#1)(1994-9#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#4)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of 75%##4##2##(2008-10#1)(2008-9#1)(2012-1#1)(2012-12#1)
of 750##2##2##(1992-1#1)(2008-3#1)
of 76 amino acids##2##4##(1997-2#1)(2008-11#1)
of 76 patients##3##3##(1990-8#1)(1991-8#1)(2011-2#1)
of 76##13##2##(1990-6#1)(1990-8#1)(1991-8#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)(2013-1#1)
of 76%##2##2##(2008-10#1)(2013-1#1)
of 769##2##2##(1993-2#1)(2012-12#1)
of 77 amino##2##3##(1994-11#1)(1996-10#1)
of 77##13##2##(1990-3#1)(1993-9#1)(1994-11#1)(1995-9#1)(1996-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-6#1)(2011-1#1)(2013-8#1)
of 77%##2##2##(1990-9#1)(2008-3#1)
of 78 patients##3##3##(1991-3#1)(2008-1#1)(2008-3#1)
of 78 residues##2##3##(1995-2#1)(1995-6#1)
of 78##15##2##(1991-12#1)(1991-3#1)(1995-2#1)(1995-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#2)(2009-7#1)(2010-8#1)(2013-1#1)
of 78%##6##2##(1990-12#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
of 78-GHz optical time-division multiplexed pulses##2##6##(2007-11#2)
of 780##3##2##(1991-8#1)(2008-2#1)(2008-3#1)
of 79##10##2##(1991-12#1)(1992-2#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#2)(2013-1#1)
of 79% and##2##3##(1991-6#1)(1994-2#1)
of 79%##3##2##(1991-6#1)(1992-10#1)(1994-2#1)
of 7MENT##2##2##(1990-11#2)
of 8 degrees##3##3##(2008-3#3)
of 8 hamsters with tumors)##2##5##(1992-5#2)
of 8 healthy volunteers##2##4##(2008-5#1)(2008-7#1)
of 8 mg/kg##3##3##(1991-6#1)(1996-2#1)(2008-7#1)
of 8 months##7##3##(1994-3#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-1#1)
of 8 patients##2##3##(2011-2#2)
of 8 to##4##3##(1991-12#1)(2008-10#2)(2010-1#1)
of 8 weeks##3##3##(2007-7#1)(2008-10#2)
of 8 with##4##3##(1995-3#2)(1996-5#1)(2007-11#1)
of 8 x##2##3##(2008-10#1)(2008-3#1)
of 8 years##5##3##(1990-2#1)(1991-11#1)(2007-7#1)(2009-3#1)(2009-7#1)
of 8##157##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#4)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#1)(2006-10#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#4)(2008-1#2)(2008-10#39)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
of 8% and##3##3##(2008-2#2)(2010-2#1)
of 8%##6##2##(1993-11#1)(2008-2#2)(2008-3#2)(2010-2#1)
of 8)##2##2##(1990-12#1)(2008-6#1)
of 8-OH-DPAT##7##2##(1990-5#3)(1991-2#2)(1993-3#1)(1994-2#1)
of 8-OHdG##2##2##(1994-6#2)
of 8-hydroxy-2'-deoxyguanosine (8-OHdG)##2##3##(1994-6#1)(2008-4#1)
of 8-hydroxy-2'-deoxyguanosine##3##2##(1994-6#2)(2008-4#1)
of 8-oxo-7##2##2##(2008-10#2)
of 8-oxoGua and 8-oxodGuo in##2##5##(2008-10#2)
of 8-oxoGua##3##2##(2008-10#3)
of 80 V/cm##2##3##(1996-12#2)
of 80 kDa##2##3##(1992-6#1)(1995-8#1)
of 80 persons##2##3##(2007-8#1)(2008-7#1)
of 80##49##2##(1990-12#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#2)(1996-12#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#12)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
of 80% of##2##3##(2007-8#1)(2008-6#1)
of 80%##9##2##(1994-5#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-7#1)
of 80-100##3##2##(1990-5#1)(1993-8#1)(1994-2#1)
of 800##9##2##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-7#1)
of 8000##2##2##(2008-10#1)(2008-3#1)
of 804##2##2##(1997-6#1)(2008-10#1)
of 81##16##2##(1991-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2013-1#1)
of 82##20##2##(1992-3#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-6#2)(1996-12#2)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)
of 82%##4##2##(1995-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
of 83##8##2##(1991-6#1)(2008-10#4)(2008-2#1)(2011-1#1)(2011-2#1)
of 83%##6##2##(1990-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(2007-12#1)(2008-10#1)
of 84 patients##2##3##(1994-3#1)(2008-5#1)
of 84##16##2##(1990-11#1)(1993-2#1)(1994-3#1)(1994-7#1)(2008-10#3)(2008-5#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
of 84%##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
of 85##17##2##(1991-1#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-2#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
of 85%##5##2##(1990-2#1)(1990-6#1)(1993-3#1)(2008-10#1)(2008-8#1)
of 86##10##2##(1991-11#1)(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2013-1#1)
of 86% and##2##3##(2008-6#2)
of 86%##5##2##(1995-4#1)(2008-3#1)(2008-6#3)
of 87##14##2##(1991-12#1)(1991-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-7#1)
of 88 patients##2##3##(1991-8#1)(1996-6#1)
of 88##9##2##(1990-7#1)(1991-8#1)(1996-2#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2010-1#1)
of 88%##6##2##(1992-3#2)(1993-11#1)(1993-8#1)(2008-6#1)(2013-1#1)
of 89##6##2##(2007-8#1)(2008-10#2)(2010-10#1)(2011-1#1)(2013-8#1)
of 89% compared##2##3##(1990-9#1)(2007-8#1)
of 89%##5##2##(1990-9#1)(1993-8#1)(2007-8#1)(2008-11#1)(2012-12#1)
of 8x10(-9) to##2##3##(2008-10#2)
of 9 and##4##3##(2008-10#2)(2010-2#1)(2013-1#1)
of 9 cases##2##3##(2007-7#1)(2011-1#1)
of 9 months##3##3##(2009-10#1)(2010-3#1)(2010-8#1)
of 9##83##2##(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-7#2)(2007-9#1)(2008-10#20)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#3)
of 9%##2##2##(2008-10#1)(2008-2#1)
of 9-fluorenone-2-carboxylic acid##2##3##(2013-1#2)
of 90 and##3##3##(1996-12#1)(2008-10#2)
of 90 degrees##6##3##(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)
of 90 h(-1) was##2##4##(2008-10#2)
of 90 h(-1)##5##3##(2008-10#5)
of 90 to##2##3##(2008-10#1)(2008-7#1)
of 90##49##2##(1990-7#1)(1990-8#1)(1992-10#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2011-2#1)(2012-1#3)(2012-3#2)
of 90%##14##2##(1990-2#1)(1991-8#1)(1993-2#2)(1993-8#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
of 900##3##2##(1991-6#1)(1994-6#1)(2008-10#1)
of 91##10##2##(1990-9#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-8#1)(2012-3#2)
of 917##2##2##(1993-11#1)(2011-2#1)
of 92##9##2##(1992-9#1)(1994-8#1)(1997-8#1)(2008-10#3)(2008-9#1)(2012-2#1)(2013-1#1)
of 92% and##2##3##(1996-2#1)(2012-2#1)
of 92%##3##2##(1992-3#1)(1996-2#1)(2012-2#1)
of 921##2##2##(2009-7#1)(2013-8#1)
of 93##10##2##(1992-5#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#3)(2013-8#1)
of 93-100%##2##2##(2008-1#1)(2008-10#1)
of 930##2##2##(1990-5#1)(2007-12#1)
of 94##17##2##(1990-5#1)(1993-6#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#1)
of 95 amino##2##3##(1990-2#1)(1994-2#1)
of 95##15##2##(1990-2#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-2#1)(2011-2#1)(2013-1#1)
of 95% of the##2##4##(2008-10#1)(2010-8#1)
of 95%##16##2##(1997-4#1)(1997-8#1)(2008-10#8)(2008-3#3)(2010-8#1)(2013-1#2)
of 950##3##2##(1995-12#1)(1995-4#1)(2008-10#1)
of 951##3##2##(1992-10#1)(2009-7#1)(2010-4#1)
of 96 ppm##2##3##(2008-10#2)
of 96##25##2##(1990-9#1)(1991-12#1)(1993-12#1)(1993-2#1)(1995-8#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
of 96%##2##2##(2008-3#1)(2013-1#1)
of 97##20##2##(1996-6#1)(2007-10#2)(2008-10#6)(2008-12#1)(2008-5#3)(2008-7#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#2)
of 98 patients##4##3##(1990-3#1)(1995-5#1)(2007-8#1)(2011-2#1)
of 98##18##2##(1990-3#1)(1991-8#1)(1994-6#1)(1995-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
of 98% and##2##3##(1990-6#1)(2011-2#1)
of 98%##9##2##(1990-6#1)(1996-9#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
of 980##2##2##(1990-11#1)(2008-3#1)
of 99 patients##4##3##(2007-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
of 99##24##2##(1991-9#1)(1992-6#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of 99%##4##2##(1990-9#1)(2008-10#1)(2008-3#1)(2009-10#1)
of 9F2CA have been##2##4##(2013-1#2)
of ?0##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
of ?f?##2##2##(2008-3#2)
of A and B##2##4##(2008-12#1)(2011-2#1)
of A and##3##3##(1991-5#1)(2008-12#1)(2011-2#1)
of A beta##11##3##(1994-11#4)(1994-8#3)(1996-2#2)(1996-5#2)
of A##163##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1991-9#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#4)(1994-3#2)(1994-8#3)(1995-3#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#5)(1997-8#1)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#72)(2008-12#3)(2008-3#2)(2008-5#8)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#3)
of A(2A)R antagonists##2##3##(2008-4#2)
of A(2A)R##3##2##(2008-4#3)
of A(549)##2##2##(2008-9#2)
of A-kinase##2##2##(1995-11#2)
of A-type lamins##2##3##(2011-2#2)
of A/H3N2##2##2##(2009-5#1)(2011-2#1)
of A/J##2##2##(2011-2#1)(2012-1#1)
of A1##7##2##(1990-5#1)(1992-9#1)(1996-5#1)(2008-10#3)(2008-11#1)
of A10 dopamine cells##2##4##(1994-2#1)(1995-12#1)
of A10##3##2##(1994-2#1)(1995-12#2)
of A103C and A103C-MB##2##4##(1993-11#2)
of A1PCTS##2##2##(1990-11#2)
of A2 and##3##3##(1996-2#2)(2008-10#1)
of A2##4##2##(1996-2#2)(2008-10#2)
of A20##3##2##(1992-7#3)
of A23187##2##2##(1992-6#1)(1994-3#1)
of A431 cells##2##3##(1990-11#1)(1992-7#1)
of A506##3##2##(2008-10#3)
of A511##2##2##(2012-2#2)
of A549 specific##2##3##(2008-11#2)
of A549##3##2##(2008-11#3)
of A9##2##2##(1995-12#1)(2008-9#1)
of AA and DA##3##4##(2008-10#3)
of AA and##4##3##(1993-3#1)(2008-10#3)
of AA in##7##3##(1992-12#2)(2008-10#5)
of AA was##4##3##(1995-5#1)(2008-10#3)
of AA##32##2##(1992-12#3)(1993-3#2)(1993-8#1)(1995-5#2)(1997-2#1)(2008-10#19)(2008-12#2)(2008-3#2)
of AAA##2##2##(2010-12#1)(2013-1#1)
of AANAT##2##2##(2008-5#2)
of AAPCC##2##2##(1993-3#2)
of ABA biosynthesis##2##3##(2008-8#1)(2009-6#1)
of ABA in##2##3##(2008-10#1)(2009-6#1)
of ABA##8##2##(2008-10#1)(2008-8#4)(2009-6#3)
of ABO##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
of ABTS##3##2##(2008-10#3)
of ACA##3##2##(2011-2#3)
of ACC##6##2##(1991-11#1)(1991-6#1)(1993-6#1)(2008-10#2)(2013-1#1)
of ACE inhibitors##4##3##(1990-2#1)(1994-7#1)(2008-7#2)
of ACE##9##2##(1990-2#2)(1993-12#1)(1994-7#1)(1997-5#1)(2008-3#1)(2008-7#3)
of ACL reconstruction##2##3##(2012-2#1)(2013-1#1)
of ACL##4##2##(1997-8#1)(2007-11#1)(2012-2#1)(2013-1#1)
of ACLSV##4##2##(2008-10#4)
of ACP##3##2##(1991-11#2)(2013-8#1)
of ACPD in the##2##4##(1995-12#2)
of ACPD##3##2##(1995-12#3)
of ACS and ACO enzymes##2##5##(2011-2#2)
of ACS and##3##3##(2008-3#1)(2011-2#2)
of ACS at##2##3##(2008-3#1)(2011-2#1)
of ACS##10##2##(2008-10#1)(2008-3#4)(2008-4#1)(2008-6#1)(2011-2#3)
of ACT##4##2##(2007-2#3)(2011-2#1)
of ACT-toxin##2##2##(2008-10#2)
of ACTH and corticosterone##2##4##(1996-12#2)
of ACTH and##3##3##(1996-12#2)(2011-2#1)
of ACTH##7##2##(1993-5#1)(1995-12#2)(1996-12#2)(2011-1#1)(2011-2#1)
of ACh##3##2##(1993-3#1)(2011-1#2)
of AChE molecular forms##2##4##(1990-5#2)
of AChE##4##2##(1990-5#2)(1995-12#1)(2008-10#1)
of AChR clusters##2##3##(2009-8#2)
of AChR##4##2##(1997-5#1)(2009-8#2)(2012-2#1)
of AD is##3##3##(2008-7#2)(2012-2#1)
of AD patients##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
of AD##32##2##(1992-12#1)(1993-12#1)(1994-11#1)(1995-12#2)(1995-8#1)(1997-2#2)(2008-5#2)(2008-7#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-2#1)(2011-1#2)(2012-2#6)(2013-1#1)
of ADAM22##3##2##(2008-9#3)
of ADAM29##2##2##(2008-8#2)
of ADAMTS13 in##2##3##(2009-7#2)
of ADAMTS13##3##2##(2009-7#3)
of ADBI##4##2##(2008-10#4)
of ADC##2##2##(2009-11#1)(2011-1#1)
of ADDTP##2##2##(2008-10#2)
of ADE of the pharmacy##3##5##(2011-1#3)
of ADE##6##2##(2008-10#2)(2008-8#1)(2011-1#3)
of ADH##3##2##(1997-8#1)(2007-8#1)(2008-8#1)
of ADH-I was##2##3##(2008-11#2)
of ADH-I##5##2##(2008-11#5)
of ADHD and##2##3##(2008-2#1)(2011-2#1)
of ADHD in##3##3##(2008-2#1)(2013-7#2)
of ADHD##18##2##(2008-2#9)(2008-9#1)(2009-9#1)(2011-2#2)(2013-7#3)(2013-8#2)
of ADHF##3##2##(2008-3#3)
of ADK##4##2##(2009-8#4)
of ADP and ATP##2##4##(2013-1#2)
of ADP and##6##3##(1990-7#1)(2006-6#2)(2008-5#1)(2013-1#2)
of ADP##16##2##(1990-7#1)(1991-12#1)(1991-9#2)(1994-8#2)(1995-2#1)(2006-6#3)(2008-4#3)(2008-5#1)(2013-1#2)
of ADPKD##2##2##(2013-1#2)
of ADPssS##2##2##(2008-4#2)
of ADR and##2##3##(1990-2#1)(1994-7#1)
of ADR cases##2##3##(2011-2#2)
of ADR##11##2##(1990-2#2)(1993-12#1)(1994-7#2)(1997-7#1)(2011-2#5)
of ADR/AE following##2##3##(2011-2#2)
of ADR/AE##10##2##(2011-2#10)
of ADRs caused by##2##4##(2011-2#2)
of ADRs##8##2##(1993-1#1)(2008-3#2)(2011-2#5)
of ADSCs in##2##3##(2012-12#2)
of ADSCs##4##2##(2012-12#2)(2012-3#2)
of ADT procedure##2##3##(2012-2#2)
of ADT##4##2##(2008-7#1)(2012-2#3)
of AE6F4 antibody on 14-3-3##2##5##(2008-11#2)
of AE6F4 antibody##3##3##(2008-11#3)
of AEDs##2##2##(2008-8#1)(2013-1#1)
of AF and##2##3##(2007-8#1)(2011-2#1)
of AF is##2##3##(2010-12#1)(2012-12#1)
of AF tissue##2##3##(2012-2#2)
of AF##15##2##(1997-2#1)(2007-8#1)(2008-6#2)(2010-12#3)(2011-2#1)(2012-12#5)(2012-2#2)
of AFB##2##2##(2007-8#2)
of AFB(1) aerosol##2##3##(2008-10#2)
of AFB(1) in##2##3##(2010-5#2)
of AFB(1)##6##2##(2008-10#4)(2010-5#2)
of AFB1##4##2##(2008-10#4)
of AFLP data##2##3##(2008-10#2)
of AFLP markers##2##3##(2008-10#2)
of AFLP##8##2##(2008-10#8)
of AFM##3##2##(2008-10#2)(2008-4#1)
of AFP mRNA##3##3##(2008-10#3)
of AFP##6##2##(2008-10#5)(2008-8#1)
of AFP-27##2##2##(2008-11#2)
of AG(9 kDa)##2##3##(1995-11#2)
of AG-1##4##2##(2008-10#4)
of AG-12##4##2##(2008-10#4)
of AG-13##6##2##(2008-10#6)
of AG-2##6##2##(2008-10#6)
of AG-4##2##2##(2008-10#2)
of AG-G##2##2##(2008-10#2)
of AG-MIN##2##2##(2008-10#2)
of AGE##2##2##(2008-1#1)(2012-12#1)
of AGE-beta 2M##2##3##(1994-6#2)
of AGR##2##2##(2008-10#2)
of AGT##4##2##(1993-11#1)(1995-12#2)(1995-5#1)
of AH##2##2##(1993-8#1)(2009-7#1)
of AH109A invasion##3##3##(2008-11#3)
of AH109A##18##2##(2008-11#18)
of AHAs##2##2##(2008-5#2)
of AHL-inactivating##2##2##(2008-9#2)
of AHLV were##3##3##(2011-1#3)
of AHO##3##2##(2010-6#2)(2011-1#1)
of AI##9##2##(2007-12#1)(2007-6#2)(2008-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
of AI-2 can##2##3##(2008-9#1)(2009-6#1)
of AI-2##3##2##(2008-9#1)(2009-6#2)
of AID##5##2##(2011-2#5)
of AIDS and##6##3##(1992-2#1)(1993-6#1)(1993-9#1)(2008-9#1)(2009-4#1)(2010-1#1)
of AIDS cases##2##3##(1991-6#1)(1993-6#1)
of AIDS in##4##3##(1993-3#1)(1994-6#1)(1997-6#2)
of AIDS incidence data##2##4##(1994-9#2)
of AIDS incidence##3##3##(1992-9#1)(1994-9#2)
of AIDS patients##2##3##(1992-3#1)(2008-5#1)
of AIDS volunteers is##2##4##(1993-12#1)(1994-3#1)
of AIDS volunteers##3##3##(1993-12#1)(1994-3#2)
of AIDS##72##2##(1990-12#1)(1990-3#3)(1990-6#1)(1990-9#2)(1991-12#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-9#5)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#9)(2007-7#1)(2008-10#1)(2008-5#3)(2008-9#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-3#2)
of AIDS-related##3##2##(1997-6#1)(2009-6#1)(2010-8#1)
of AIDS/HIV##2##2##(1995-1#2)
of AII##5##2##(1991-5#1)(1994-12#2)(1997-2#2)
of AIII##2##2##(1994-2#2)
of AIP##3##2##(1990-2#2)(2013-1#1)
of AIT-082##3##2##(2008-5#3)
of AKBR below 0##2##4##(2007-8#2)
of AKBR##4##2##(2007-8#4)
of AKT##3##2##(2008-10#2)(2013-1#1)
of AL##2##2##(2008-10#1)(2010-4#1)
of ALA##3##2##(1992-9#2)(2008-1#1)
of ALA-induced porphyrins##2##3##(1992-9#2)
of ALCL##2##2##(1997-3#1)(2013-1#1)
of ALL##4##2##(2010-11#1)(2011-2#3)
of ALM in situ##2##4##(2010-6#2)
of ALM##4##2##(2010-6#4)
of ALP##2##2##(2008-10#1)(2008-11#1)
of ALR##2##2##(1997-7#1)(2008-8#1)
of ALT##2##2##(2008-10#1)(2010-11#1)
of AM was##2##3##(1994-6#1)(2011-2#1)
of AM##8##2##(1994-6#3)(2008-10#1)(2008-11#1)(2011-2#3)
of AMD##5##2##(2010-2#2)(2011-2#3)
of AMD3100##4##2##(2008-7#4)
of AMF##2##2##(2008-8#2)
of AMG 517##3##3##(2010-2#3)
of AMI##4##2##(1992-3#1)(2008-10#1)(2008-3#2)
of AML and##2##3##(2007-10#1)(2010-4#1)
of AML##7##2##(1992-10#1)(2007-10#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
of AML1/ETO fusion gene in##2##5##(2008-10#2)
of AMP##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
of AMPA receptor subunit##2##4##(1993-12#1)(2008-7#1)
of AMPA receptors##2##3##(1995-12#1)(1996-2#1)
of AMPA##5##2##(1993-12#1)(1995-12#1)(1996-2#1)(2008-7#1)(2008-8#1)
of AMV##2##2##(2008-10#2)
of ANA##2##2##(1991-2#2)
of ANG II##4##3##(1991-5#1)(1994-11#1)(1994-8#2)
of ANG##6##2##(1991-5#2)(1994-11#1)(1994-8#3)
of ANN##6##2##(2008-10#5)(2010-8#1)
of ANNs for##2##3##(2008-10#2)
of ANNs##4##2##(2008-10#4)
of ANP and BNP##3##4##(1991-5#2)(2009-5#1)
of ANP##7##2##(1990-12#3)(1991-5#2)(2009-5#2)
of ANS dysfunction##2##3##(2011-1#2)
of ANS##6##2##(1991-9#1)(2008-4#2)(2011-1#2)(2013-8#1)
of AO##2##2##(2008-2#1)(2012-2#1)
of AOD##2##2##(2008-2#1)(2012-12#1)
of AOM##4##2##(1992-3#1)(1993-11#2)(2011-2#1)
of AOX protein##3##3##(1994-6#1)(2008-9#2)
of AOX##5##2##(1994-6#1)(2008-9#3)(2009-8#1)
of AP##12##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#2)(2013-1#6)
of AP-1 and##2##3##(1994-11#1)(2008-9#1)
of AP-1 complexes##2##3##(1995-12#1)(1996-2#1)
of AP-1##10##2##(1992-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-2#3)(2008-11#1)(2008-9#2)
of APC##4##2##(1993-11#2)(2011-2#1)(2013-1#1)
of APCs##2##2##(2008-11#1)(2012-3#1)
of APP and APLP2 mRNA##2##5##(1996-12#2)
of APP and APLP2##3##4##(1996-12#3)
of APP in##2##3##(1992-12#1)(1995-12#1)
of APP processing##3##3##(1992-12#1)(1996-12#1)(2008-5#1)
of APP##25##2##(1992-12#6)(1992-6#2)(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#7)(2008-11#2)(2008-5#1)
of APPI##3##2##(1991-11#3)
of APS##7##2##(2008-10#4)(2009-8#2)(2013-8#1)
of APS1 and APS2##2##4##(2008-7#2)
of AQP1##2##2##(2007-12#1)(2008-7#1)
of AQP2##2##2##(2012-12#2)
of AQP7##2##2##(2008-5#2)
of AR and##2##3##(2011-2#1)(2012-12#1)
of AR mRNA##2##3##(1995-12#2)
of AR root##2##3##(2008-10#2)
of AR##16##2##(1990-11#2)(1995-12#4)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of AR-mediated cardiac hypertrophy##3##4##(2010-12#3)
of ARDS##4##2##(1991-9#2)(1993-2#1)(2009-5#1)
of ARF##6##2##(2008-1#1)(2008-4#5)
of ARF18##5##2##(2008-10#5)
of ARIS##4##2##(1992-8#4)
of ARM and##3##3##(1994-8#3)
of ARM in##3##3##(2011-2#3)
of ARM##12##2##(1994-8#3)(2011-2#9)
of ARMD and##2##3##(2011-2#2)
of ARMD is##3##3##(2011-2#3)
of ARMD##8##2##(2011-2#8)
of ARP1##2##2##(2008-9#2)
of ARS##3##2##(2008-10#3)
of ART in##2##3##(1992-2#1)(2011-2#1)
of ART##5##2##(1992-2#1)(2008-6#1)(2011-2#1)(2012-12#2)
of ARTEMISIA ANNUA##2##3##(2007-1#2)
of AS were##2##3##(1994-6#1)(2008-10#1)
of AS##13##2##(1994-6#3)(2007-7#5)(2008-10#2)(2011-2#1)(2013-8#2)
of ASA and##3##3##(2008-10#3)
of ASA##5##2##(2008-10#5)
of ASCs in##2##3##(2012-4#2)
of ASCs##3##2##(1997-1#1)(2012-4#2)
of ASD as##2##3##(2011-2#1)(2012-3#1)
of ASD##11##2##(2008-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#5)
of ASGT##2##2##(2008-5#2)
of ASP##2##2##(2013-1#2)
of ASPD##5##2##(1994-2#5)
of ASPs##3##2##(2013-1#3)
of ASTP##2##2##(1993-6#2)
of ASY##3##2##(2008-8#1)(2008-9#2)
of AT##4##2##(1992-3#1)(1993-6#1)(1993-8#1)(2008-4#1)
of AT-rich DNA##2##3##(2008-10#1)(2008-12#1)
of ATG##2##2##(2008-7#1)(2008-8#1)
of ATP and ADP with rubisco activase##3##7##(1991-9#3)
of ATP and the##2##4##(1993-6#1)(2008-4#1)
of ATP and##12##3##(1991-9#3)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-4#4)
of ATP by##2##3##(2008-4#1)(2008-7#1)
of ATP hydrolysis##6##3##(1992-6#1)(1996-6#1)(2013-1#4)
of ATP in##2##3##(1990-7#1)(1994-2#1)
of ATP induced##2##3##(1993-8#1)(1994-2#1)
of ATP is##2##3##(2008-4#1)(2009-4#1)
of ATP on##2##3##(1993-6#1)(2008-4#1)
of ATP or##2##3##(1993-8#1)(1995-3#1)
of ATP receptors##3##3##(2008-4#3)
of ATP release##2##3##(2008-4#2)
of ATP sulfurylase##2##3##(2008-7#2)
of ATP synthase##2##3##(2008-8#2)
of ATP to##4##3##(1990-7#1)(1991-9#1)(1992-12#1)(2008-4#1)
of ATP with##2##3##(1995-2#1)(2008-10#1)
of ATP##101##2##(1990-7#5)(1991-12#2)(1991-5#2)(1991-9#7)(1992-12#3)(1992-6#2)(1993-11#1)(1993-6#8)(1993-8#4)(1994-2#3)(1994-3#2)(1995-11#1)(1995-2#5)(1995-3#2)(1995-8#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-11#4)(2008-4#23)(2008-5#2)(2008-7#3)(2008-8#5)(2009-3#1)(2009-4#1)(2011-2#1)(2013-1#5)
of ATP-hydrolysis##2##2##(1994-12#2)
of ATP-sensitive K+ channels##2##4##(1997-1#1)(1997-7#1)
of ATP-sensitive##5##2##(1994-6#1)(1997-1#1)(1997-7#1)(2008-8#1)(2010-11#1)
of ATPase activity##2##3##(1995-2#1)(2008-7#1)
of ATPase##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
of ATPgammaS##2##2##(1996-2#2)
of AUPHA##2##2##(1991-1#1)(1995-1#1)
of AVF at the##2##4##(2008-1#2)
of AVF##4##2##(2007-7#2)(2008-1#2)
of AVM##4##2##(1996-6#1)(2008-7#1)(2012-3#2)
of AVMs##5##2##(2008-7#4)(2008-9#1)
of AVN##4##2##(2006-10#1)(2007-8#3)
of AVP##2##2##(1990-5#1)(1995-12#1)
of AW##2##2##(2008-2#2)
of AWR##3##2##(2008-10#3)
of AX3##2##2##(1992-12#2)
of AZT in##2##3##(1993-3#1)(2008-10#1)
of AZT##5##2##(1990-8#1)(1993-3#1)(1995-6#1)(2008-10#2)
of Abeta##2##2##(2008-10#1)(2008-7#1)
of Abl kinase activity##2##4##(2011-2#1)(2012-12#1)
of Abl##10##2##(1994-10#1)(2011-2#1)(2012-12#8)
of Aboriginal##4##2##(2008-12#4)
of AcNPV##4##2##(1997-4#4)
of Achilles tendon##3##3##(2010-3#3)
of Acidothermus cellulolyticus##2##3##(2008-6#1)(2011-2#1)
of Acidovorax avenae subsp##2##4##(2008-10#2)
of Acinetobacter sp##3##3##(1997-6#3)
of Acinetobacter##5##2##(1997-6#3)(2007-7#1)(2012-2#1)
of Acorus macrospadiceus (Yamamoto) F##2##5##(2013-1#2)
of Acro-LDL uptake##2##3##(2013-1#2)
of Acro-LDL##5##2##(2013-1#5)
of Actinobacillus##3##2##(1996-12#3)
of Action and##2##3##(2008-10#1)(2008-11#1)
of Action##7##2##(2008-10#1)(2008-11#4)(2009-11#1)(2010-10#1)
of Acute Coronary Syndrome##2##4##(2008-10#1)(2008-3#1)
of Acute Coronary##3##3##(2008-10#1)(2008-3#2)
of Acute##9##2##(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
of Ad##2##2##(1997-4#1)(2008-11#1)
of Ad-HGF##4##2##(2008-9#4)
of Adair##2##2##(1990-8#2)
of Adaptive##2##2##(2010-7#1)(2013-8#1)
of Adderall XR##2##3##(2008-11#2)
of Adherence##2##2##(2011-1#2)
of AdoMetDC##2##2##(1992-8#2)
of Adolescent##9##2##(2009-7#1)(2010-7#2)(2010-9#2)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
of Adult##5##2##(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#2)
of Advanced Nursing##6##3##(2008-11#5)(2008-12#1)
of Advanced##11##2##(1990-11#1)(1994-7#1)(2008-11#5)(2008-12#1)(2008-6#1)(2010-8#1)(2012-12#1)
of Adverse##2##2##(1992-2#1)(2012-2#1)
of Aedes aegypti##5##3##(2007-10#3)(2008-5#2)
of Aedes##6##2##(2007-10#3)(2007-7#1)(2008-5#2)
of Aegle marmelos in##2##4##(2012-2#2)
of Aegle marmelos##6##3##(2012-2#6)
of Aeromonas##4##2##(2007-10#1)(2007-7#2)(2008-10#1)
of Aerosols##2##2##(2008-2#1)(2008-3#1)
of Aflatoxin##4##2##(2008-10#2)(2013-1#2)
of Africa##5##2##(1994-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-5#1)
of African American adolescents'##2##4##(2012-12#2)
of African American and##3##4##(2008-12#1)(2008-4#1)(2012-3#1)
of African American men##5##4##(2008-4#1)(2009-5#4)
of African American women during the breast cancer treatment phase##3##10##(2008-4#3)
of African American##21##3##(2008-12#2)(2008-4#6)(2009-12#1)(2009-5#4)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)
of African Americans and##2##4##(2008-4#1)(2013-1#1)
of African Americans##4##3##(2008-4#1)(2008-8#1)(2010-10#1)(2013-1#1)
of African catfish GnRH##3##4##(1992-8#3)
of African histoplasmosis##2##3##(2008-5#2)
of African origin##2##3##(2008-8#1)(2012-12#1)
of African##37##2##(1992-8#3)(1996-6#1)(2008-10#1)(2008-12#3)(2008-4#7)(2008-5#2)(2008-8#2)(2009-12#1)(2009-5#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#1)
of African-American hair##2##3##(2008-5#2)
of African-American##4##2##(2007-2#1)(2008-4#1)(2008-5#2)
of African-Americans##2##2##(1994-1#1)(1997-3#1)
of Ag (I)##2##3##(2008-10#2)
of Ag##13##2##(2007-12#2)(2008-10#7)(2008-3#1)(2011-2#1)(2013-1#2)
of Ag(+) and Zn(2+)##2##4##(2008-10#2)
of Ag(+) and##3##3##(2008-10#3)
of Ag(+)##8##2##(2008-10#7)(2010-11#1)
of Ag(I)##9##2##(2008-10#9)
of AgOAc solution##2##3##(1996-2#2)
of AgOAc##3##2##(1996-2#3)
of Agaricus##2##2##(1997-1#1)(2008-10#1)
of Age##3##2##(1995-11#1)(2008-2#1)(2009-7#1)
of Age-Related Macular Degeneration##2##4##(2011-2#2)
of Aging##2##2##(2008-5#1)(2009-10#1)
of Aglaia foveolata##2##3##(2008-8#2)
of Agricultural##2##2##(2010-10#1)(2011-3#1)
of Agriculture##12##2##(1996-3#1)(1997-4#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-8#1)(2010-4#1)(2012-2#2)
of Agrobacterium tumefaciens##2##3##(1990-5#1)(2008-10#1)
of Agrobacterium##5##2##(1990-5#1)(2008-10#2)(2008-6#1)(2008-9#1)
of Akt##7##2##(2009-5#3)(2009-9#1)(2010-1#2)(2013-1#1)
of Al from##2##3##(2008-10#2)
of Al in a tungsten coil##2##6##(2008-10#2)
of Al in the##2##4##(1996-12#2)
of Al in##11##3##(1996-12#2)(2008-10#9)
of Al is##2##3##(2008-10#1)(2008-2#1)
of Al##41##2##(1996-12#5)(2008-10#32)(2008-2#1)(2008-3#2)(2009-8#1)
of Al(2)O(3)##2##2##(2007-12#1)(2008-10#1)
of Al(III) and Fe(III)##5##4##(2008-10#5)
of Al(III) and##7##3##(2008-10#7)
of Al(III) in##2##3##(2008-10#2)
of Al(III)##12##2##(2008-10#12)
of Al-citrate in##2##3##(2008-10#2)
of Al-citrate##6##2##(2008-10#6)
of AlCl(3)##2##2##(2009-2#1)(2013-1#1)
of AlCl3##2##2##(1993-3#1)(2008-10#1)
of Ala for##2##3##(1992-4#2)
of Alabama at##2##3##(1992-12#1)(2009-8#1)
of Alabama##5##2##(1992-12#1)(2008-12#2)(2009-8#1)(2010-4#1)
of Alberta##11##2##(1992-12#1)(1995-12#2)(1995-3#2)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
of Alcohol##4##2##(2008-6#1)(2010-11#1)(2012-2#1)(2013-8#1)
of Alfalfa mosaic virus in##3##5##(2008-10#3)
of Alfalfa mosaic virus##6##4##(2008-10#6)
of Alfalfa##7##2##(2008-10#7)
of Alfuzosin##2##2##(2010-5#2)
of Alkyl##2##2##(2009-5#1)(2009-8#1)
of Allied Health##2##3##(1996-2#1)(2011-1#1)
of Allium spp##2##3##(2008-10#2)
of Allium##5##2##(2008-10#5)
of Almond##2##2##(2008-10#2)
of Alocasia indica##4##3##(2010-5#1)(2011-1#3)
of Alternaria alternata##11##3##(2008-10#11)
of Alternaria citri was##2##4##(2008-10#2)
of Alternaria citri##4##3##(2008-10#4)
of Alternaria panax##2##3##(2008-10#2)
of Alternaria spp##6##3##(2008-10#6)
of Alternaria##28##2##(2008-10#27)(2008-5#1)
of Alternative##2##2##(2008-10#1)(2008-3#1)
of Alu##2##2##(1991-5#1)(1995-3#1)
of Alzheimer disease and##2##4##(1990-3#1)(2008-4#1)
of Alzheimer disease##7##3##(1990-3#3)(1994-8#1)(2008-4#1)(2010-6#1)(2011-2#1)
of Alzheimer##11##2##(1990-3#3)(1991-9#1)(1992-12#1)(1993-8#1)(1994-8#2)(2008-4#1)(2010-6#1)(2011-2#1)
of Alzheimer's dementia##2##3##(1990-11#1)(1996-11#1)
of Alzheimer's disease (AD)##11##4##(1991-1#1)(1991-11#1)(1993-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-5#3)(2008-7#2)
of Alzheimer's disease amyloid##3##4##(1990-7#1)(1997-2#2)
of Alzheimer's disease in##2##4##(2008-6#1)(2008-7#1)
of Alzheimer's disease##45##3##(1990-7#1)(1991-1#1)(1991-11#1)(1992-12#2)(1992-6#1)(1992-8#4)(1993-12#1)(1994-11#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-2#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#3)
of Alzheimer's##57##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-12#4)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-2#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2009-12#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#3)
of Am(III)##2##2##(2008-10#2)
of AmB is##2##3##(1997-2#2)
of AmB##6##2##(1997-2#6)
of Amberlite XAD-2 resin loaded with##2##6##(2008-10#2)
of Amberlite XAD-2 resin##3##4##(2008-10#3)
of Amberlite XAD-2##4##3##(2008-10#4)
of Amberlite##7##2##(2008-10#7)
of Amd##2##2##(2008-7#2)
of America##15##2##(1992-3#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2009-12#1)(2010-3#1)(2012-12#1)
of America's##2##2##(1995-12#1)(1996-12#1)
of American Medical##2##3##(1990-4#1)(2012-3#1)
of American children##2##3##(1995-3#1)(2012-12#1)
of American health care##4##4##(1993-2#1)(1996-2#1)(1997-3#1)(2012-3#1)
of American health##5##3##(1993-2#2)(1996-2#1)(1997-3#1)(2012-3#1)
of American##21##2##(1990-2#1)(1990-4#1)(1990-5#1)(1993-2#2)(1994-1#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#2)
of American-English##2##2##(2013-8#2)
of Americans##6##2##(1996-5#1)(1997-5#1)(2007-6#1)(2010-8#1)(2011-1#2)
of Amerindian##2##2##(1991-12#1)(2008-12#1)
of Amino Acids##2##3##(1996-5#1)(2009-3#1)
of Amino##3##2##(1996-5#1)(2008-12#1)(2009-3#1)
of Amorpha fruticosa LINNE##3##4##(2008-11#3)
of Amphiprion##2##2##(2010-8#2)
of An##7##2##(2007-12#1)(2008-8#2)(2012-12#4)
of AnFBV##2##2##(2008-10#2)
of Analysed Samples##2##3##(2008-10#2)
of Analysis##2##2##(2008-10#1)(2008-2#1)
of Analytical Chemistry##2##3##(2008-10#1)(2010-11#1)
of Anaplasma phagocytophilum##2##3##(2008-12#1)(2008-9#1)
of Anaplasma##3##2##(2008-12#2)(2008-9#1)
of Anastrepha suspensa (Diptera##2##4##(2007-12#1)(2011-2#1)
of Andreas##2##2##(2009-7#2)
of Anemia##2##2##(2008-1#2)
of Angelica##2##2##(2012-3#1)(2013-1#1)
of Angelman's##2##2##(1990-9#2)
of Animal##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
of Anisogramma anomala##4##3##(2008-10#4)
of Ankara##3##2##(2008-12#3)
of Annex II##2##3##(2008-11#2)
of Annexin32##3##2##(2008-9#3)
of Annona coriacea##2##3##(2013-7#2)
of Anopheles gambiae##2##3##(2008-8#2)
of Anopheles##7##2##(2008-8#2)(2010-1#3)(2012-12#2)
of Antidepressant##2##2##(2009-12#1)(2013-1#1)
of Antioquia##4##2##(2012-12#4)
of Antwerp##2##2##(2008-10#2)
of Ap4A##3##2##(1997-7#2)(2009-2#1)
of Aphanomyces cochlioides##3##3##(2008-10#3)
of Aphanomyces euteiches from##2##4##(2008-10#2)
of Aphanomyces euteiches##7##3##(2008-10#7)
of Aphanomyces##11##2##(2008-10#11)
of Apis mellifera L##2##4##(2008-6#2)
of Apis mellifera##4##3##(2008-6#2)(2008-7#1)(2011-2#1)
of Aplysia##3##2##(1990-7#1)(1993-12#1)(1994-8#1)
of Apo B##4##3##(1990-8#1)(1994-3#3)
of ApoAI##2##2##(1993-12#2)
of Appeals for the Fourth##3##5##(1995-6#2)(1997-6#1)
of Appeals for the##8##4##(1995-6#4)(1996-12#3)(1997-6#1)
of Appeals##19##2##(1995-12#4)(1995-6#4)(1996-12#3)(1996-5#3)(1997-5#4)(1997-6#1)
of Apple Fruit##2##3##(2008-10#2)
of Apple chlorotic leaf spot virus##4##6##(2008-10#4)
of Apple stem pitting virus##2##5##(2008-10#2)
of Apple##14##2##(2008-10#14)
of Applied##10##2##(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2013-1#1)
of Appressoria##3##2##(2008-10#3)
of April##4##2##(1995-11#1)(1995-2#1)(2008-10#1)(2012-3#1)
of Ar##2##2##(2007-12#1)(2008-10#1)
of ArCl##2##2##(2008-10#2)
of ArF-excimer laser light##2##4##(2008-3#2)
of Arabidopsis plants##2##3##(2008-10#2)
of Arabidopsis thaliana roots##2##4##(2008-10#1)(2012-1#1)
of Arabidopsis thaliana to Bacterial Wilt Caused by Ralstonia solanacearum##2##10##(2008-10#2)
of Arabidopsis thaliana was##2##4##(1997-2#1)(2008-9#1)
of Arabidopsis thaliana##17##3##(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-9#2)(2009-10#2)(2011-1#1)(2012-1#1)(2012-3#1)
of Arabidopsis##38##2##(1996-10#2)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-4#1)(2008-7#2)(2008-9#4)(2009-10#6)(2009-6#2)(2009-8#3)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
of Arc##3##2##(2007-11#2)(2013-1#1)
of Areca catechu L##2##4##(2008-5#2)
of Arg 303##3##3##(1995-5#3)
of Arg 44 with Leu##2##5##(1992-6#2)
of Arg 44##3##3##(1992-6#3)
of Arg##9##2##(1992-6#3)(1993-3#1)(1995-3#1)(1995-5#3)(2008-11#1)
of Argentina##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
of Argyreia speciosa##4##3##(2010-3#4)
of Arizona##5##2##(1990-8#1)(1992-2#1)(1997-5#1)(2008-10#1)(2008-2#1)
of Arom-IR neurones were##2##4##(1994-2#2)
of Arslantepe##2##2##(2012-9#2)
of Artemia franciscana##2##3##(2013-1#2)
of Artemia##6##2##(1994-8#1)(2008-5#2)(2008-9#1)(2013-1#2)
of Arthrobacter##2##2##(1995-3#1)(2008-10#1)
of Artichoke##2##2##(2008-10#1)(2011-2#1)
of Artificial##2##2##(2008-10#1)(2010-8#1)
of As and Sb##3##4##(2008-10#3)
of As and Se##5##4##(2008-10#5)
of As and##9##3##(2008-10#9)
of As at##4##3##(2008-10#4)
of As in##2##3##(2008-10#2)
of As species##2##3##(2008-10#2)
of As was##4##3##(2008-10#4)
of As##50##2##(2008-10#46)(2010-5#1)(2013-1#3)
of As(III) and As(V) in##6##5##(2008-10#6)
of As(III) and As(V)##11##4##(2008-10#11)
of As(III) in##6##3##(2008-10#6)
of As(III) is##2##3##(2008-10#2)
of As(III) to As(V)##2##4##(2008-10#2)
of As(III) was##2##3##(2008-10#2)
of As(III)##39##2##(2008-10#38)(2010-5#1)
of As(V)##6##2##(2008-10#5)(2010-5#1)
of As51##2##2##(2010-8#2)
of AsA##4##2##(2008-10#3)(2008-11#1)
of AsH(3)##2##2##(2008-10#2)
of Ascochyta##3##2##(2008-10#3)
of Ascospores in##3##3##(2008-10#3)
of Ascospores of Anisogramma anomala##2##5##(2008-10#2)
of Ascospores of##5##3##(2008-10#5)
of Ascospores##10##2##(2008-10#10)
of Asia and the South Pacific##2##6##(2008-1#2)
of Asia and the##3##4##(2008-1#2)(2012-12#1)
of Asia and##4##3##(2008-1#2)(2008-9#1)(2012-12#1)
of Asia##10##2##(1991-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
of Asian##11##2##(1991-9#1)(2007-12#2)(2008-7#2)(2009-10#1)(2010-8#2)(2011-1#2)(2013-7#1)
of Asians##4##2##(1990-6#1)(2007-12#1)(2010-6#1)(2010-8#1)
of Asn##2##2##(1990-8#1)(1991-9#1)
of Asp##2##2##(1990-11#1)(1992-9#1)
of Asp102##3##2##(1992-3#3)
of Asp222##2##2##(1992-6#2)
of Asparagus racemosus##5##3##(2008-10#1)(2010-5#3)(2013-1#1)
of Asparagus##7##2##(1990-11#1)(2008-10#2)(2010-5#3)(2013-1#1)
of Aspergillus awamori##2##3##(2008-6#2)
of Aspergillus flavus and##2##4##(2008-10#2)
of Aspergillus flavus##6##3##(2008-10#5)(2008-12#1)
of Aspergillus nidulans##4##3##(1997-4#1)(1997-7#1)(1997-8#1)(2009-8#1)
of Aspergillus niger##6##3##(1997-2#2)(2008-7#3)(2008-9#1)
of Aspergillus species##3##3##(1997-2#1)(2008-1#1)(2011-2#1)
of Aspergillus spp##2##3##(2008-11#1)(2008-5#1)
of Aspergillus##30##2##(1993-12#1)(1994-3#1)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
of Assessment##2##2##(2008-11#1)(2012-2#1)
of Asthma##2##2##(2007-6#1)(2012-3#1)
of Asturias]##2##2##(1993-3#1)(1995-5#1)
of Asymptomatic##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
of AtTMPK##3##2##(2009-8#3)
of Atherosclerosis##2##2##(2008-11#1)(2008-7#1)
of Atlantic cod Gadus morhua##2##5##(2010-8#2)
of Atlantic salmon##2##3##(2008-7#2)
of Atlantic##6##2##(2008-6#2)(2008-7#2)(2010-8#2)
of Atmospheric##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of Atomic Orbitals##2##3##(2007-11#2)
of Atta##2##2##(2008-8#2)
of Attention##3##2##(2007-11#1)(2008-11#1)(2010-8#1)
of Atteva##3##2##(2013-8#3)
of Au and the##2##4##(2008-10#1)(2011-1#1)
of Au nanoparticle##2##3##(2008-7#1)(2011-1#1)
of Au nanoparticles##3##3##(2008-10#2)(2010-12#1)
of Au##26##2##(1992-11#1)(2007-11#3)(2008-10#12)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)
of Au(III)##7##2##(2008-10#7)
of August##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
of Augustine's##2##2##(2008-12#2)
of Aureobasidium pullulans##2##3##(2007-11#1)(2008-10#1)
of Aurora kinases##2##3##(2013-1#2)
of Aurora##3##2##(2013-1#3)
of Australia and##3##3##(1994-12#1)(1994-9#1)(2009-12#1)
of Australia##10##2##(1992-2#1)(1994-12#1)(1994-9#1)(2007-2#2)(2008-10#1)(2009-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
of Australian centenarians##2##3##(2012-12#2)
of Australian##13##2##(1997-5#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
of Autism##2##2##(2008-11#1)(2010-7#1)
of Autographa californica nuclear polyhedrosis virus (AcNPV)##2##7##(1994-11#1)(2008-8#1)
of Autographa californica##4##3##(1993-12#1)(1994-11#1)(1997-4#1)(2008-8#1)
of Avena sativa##2##3##(2008-10#1)(2008-9#1)
of Avena##3##2##(2008-10#2)(2008-9#1)
of Avirulence##4##2##(2008-10#4)
of Avr##2##2##(2008-10#2)
of Avr-Hattan 3##2##3##(2008-10#2)
of AvrPto##2##2##(2009-8#2)
of AxeA##2##2##(2011-1#2)
of Azadirachta indica##4##3##(2007-7#1)(2008-12#2)(2010-3#1)
of Azorubin##2##2##(2008-10#2)
of Azotobacter##2##2##(1992-3#1)(2008-11#1)
of B and T lymphocytes##2##5##(1994-3#1)(2007-10#1)
of B and##4##3##(1992-12#1)(1994-3#1)(2007-10#1)(2008-5#1)
of B cell##11##3##(2008-11#2)(2008-4#8)(2008-7#1)
of B cells and##3##4##(1990-12#1)(2008-4#1)(2008-5#1)
of B cells##14##3##(1990-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-9#1)(2008-11#3)(2008-4#4)(2008-5#1)(2013-1#1)
of B chromosomes##3##3##(2008-12#2)(2008-5#1)
of B coli##2##3##(2007-12#2)
of B lymphocytes##2##3##(2008-1#1)(2008-4#1)
of B##175##2##(1990-11#2)(1990-12#2)(1990-4#1)(1991-5#1)(1992-12#1)(1992-3#3)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-2#3)(1997-4#1)(1997-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#75)(2008-11#6)(2008-12#6)(2008-3#1)(2008-4#13)(2008-5#9)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-6#2)(2011-1#1)(2011-2#16)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#2)(2013-8#1)
of B(2)##2##2##(2008-10#2)
of B(A)P##5##2##(1993-8#5)
of B-CLL##2##2##(1991-4#1)(1995-2#1)
of B-GOx##5##2##(2008-10#5)
of B-cell##4##2##(1997-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
of B-cells##2##2##(2007-8#2)
of B1##2##2##(2008-11#1)(2012-5#1)
of B12 deficiency##3##3##(2012-2#3)
of B12##4##2##(2008-8#1)(2012-2#3)
of B16 2F2##3##3##(2008-11#3)
of B16##5##2##(1993-5#1)(2008-11#4)
of B18C6##2##2##(2008-10#2)
of B2 containing##2##3##(1991-2#2)
of B2##4##2##(1991-2#2)(1992-3#1)(2008-12#1)
of B5##2##2##(1997-8#2)
of B6 mice and SAM##2##5##(1994-5#2)
of BA##7##2##(2008-10#4)(2008-7#3)
of BABA##3##2##(2008-10#2)(2009-6#1)
of BABO##2##2##(2008-9#2)
of BAC DNA##2##3##(2008-4#2)
of BAC clones##2##3##(2008-8#1)(2012-3#1)
of BAC transgenic mice in neuroscience research##2##7##(2008-4#2)
of BAC transgenic mice##3##4##(2008-4#3)
of BAC##8##2##(2008-2#1)(2008-4#5)(2008-8#1)(2012-3#1)
of BAK##2##2##(1992-11#2)
of BALB/c mice##2##3##(2012-1#2)
of BALB/c##3##2##(2012-1#2)(2013-1#1)
of BAP2##3##2##(1995-11#3)
of BAT##3##2##(2011-2#1)(2013-1#2)
of BB##3##2##(1990-12#1)(2007-7#2)
of BBMV##3##2##(1992-6#2)(2008-10#1)
of BBSV from China##2##4##(2008-10#2)
of BBSV##4##2##(2008-10#4)
of BBWV##2##2##(2008-10#2)
of BC##7##2##(1993-3#2)(2007-5#1)(2008-10#1)(2008-6#3)
of BC-1 RNA##2##3##(1992-11#2)
of BCAs##2##2##(2008-10#2)
of BCF##2##2##(2008-12#2)
of BCG##6##2##(1995-12#1)(2008-10#1)(2011-2#3)(2013-8#1)
of BCL2##3##2##(2008-9#1)(2009-8#2)
of BCVA##2##2##(2011-2#2)
of BD##2##2##(2007-12#1)(2008-11#1)
of BDNF and##2##3##(1997-2#1)(2011-2#1)
of BDNF mRNA##6##3##(1996-12#1)(1997-2#3)(2012-1#2)
of BDNF##22##2##(1995-5#1)(1996-12#1)(1997-2#5)(1997-6#1)(2009-3#4)(2009-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
of BDV##2##2##(1990-11#2)
of BE##3##2##(2008-10#1)(2010-12#2)
of BEFV##2##2##(2008-10#2)
of BFP and##2##3##(1991-8#2)
of BFP##3##2##(1991-8#3)
of BGQ60##2##2##(1995-6#2)
of BGYMV##2##2##(2008-10#2)
of BH4##3##2##(1993-8#2)(1994-11#1)
of BHK cells##4##3##(1992-9#2)(2008-11#2)
of BHK##6##2##(1992-9#3)(2008-11#3)
of BHK-21##2##2##(2008-11#1)(2008-8#1)
of BHT##3##2##(1994-5#1)(1995-3#1)(2013-8#1)
of BI##3##2##(2007-12#3)
of BIM expression by##2##4##(2008-8#2)
of BIM expression##5##3##(2008-8#5)
of BIM##9##2##(2008-11#2)(2008-8#7)
of BK(-/-)##2##2##(2009-2#2)
of BL##2##2##(1993-9#1)(2007-7#1)
of BLM##2##2##(1990-12#2)
of BLPC##2##2##(2010-4#2)
of BM aspirates##2##3##(2008-11#2)
of BM##5##2##(2008-11#2)(2009-5#1)(2013-1#2)
of BMD##4##2##(2008-8#1)(2011-2#3)
of BMI##5##2##(1994-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
of BML in##2##3##(1996-11#1)(2012-3#1)
of BML##5##2##(1996-11#1)(2012-3#4)
of BMP-2/4##3##2##(2011-2#3)
of BMP-7##3##2##(2011-2#3)
of BMPR-II##2##2##(2011-2#2)
of BMPs##4##2##(2011-2#3)(2012-12#1)
of BMT##2##2##(2007-4#2)
of BMV##2##2##(2008-10#2)
of BNP##7##2##(1990-12#1)(1991-2#1)(1991-5#1)(2008-3#3)(2008-7#1)
of BNR hyphae##2##3##(2008-10#2)
of BNR##6##2##(2008-10#5)(2008-12#1)
of BNYVV##2##2##(2008-10#2)
of BOC##3##2##(2013-1#3)
of BP##10##2##(1991-3#1)(1994-8#3)(2008-10#1)(2008-11#4)(2009-4#1)
of BPA in##3##3##(2008-10#1)(2009-8#1)(2010-9#1)
of BPA##7##2##(2008-10#4)(2009-8#1)(2010-9#2)
of BPD##3##2##(2009-8#2)(2011-1#1)
of BPMV##5##2##(1992-8#2)(2008-10#3)
of BR##4##2##(1993-11#2)(2007-12#1)(2009-8#1)
of BRAF##2##2##(2008-8#1)(2009-4#1)
of BRAF(V600E)##3##2##(2008-8#2)(2009-4#1)
of BRCA1##2##2##(2008-10#1)(2011-2#1)
of BRD7##3##2##(2008-9#3)
of BRS##2##2##(2008-1#2)
of BSA was##2##3##(1991-5#1)(1993-11#1)
of BSA##11##2##(1991-5#1)(1993-11#1)(1995-12#1)(1995-6#1)(2008-10#6)(2008-3#1)
of BSE##5##2##(1991-3#1)(2007-10#2)(2008-11#1)(2011-2#1)
of BSM##3##2##(1994-9#2)(2008-10#1)
of BT##4##2##(1992-11#2)(2007-7#1)(2008-2#1)
of BTAH##3##2##(2013-1#3)
of BTEX##6##2##(2008-10#6)
of BTH##3##2##(2008-10#3)
of BTI-Tn-5B1-4 cells##2##3##(1997-4#2)
of BTV##3##2##(1997-4#2)(2011-2#1)
of BYDV##9##2##(2008-10#9)
of BYDV-RMV##3##2##(2008-10#3)
of BYSV##2##2##(2008-10#2)
of Ba and##2##3##(2008-10#1)(2010-8#1)
of Ba##5##2##(2008-10#3)(2010-8#2)
of Ba(IO(3))(2)##2##2##(2008-10#2)
of Ba2+##2##2##(1995-11#2)
of BaP 7##4##3##(1992-2#4)
of BaP##6##2##(1992-2#4)(2011-1#2)
of Bacillus and Paenibacillus spp##2##5##(2008-10#2)
of Bacillus and##3##3##(2008-10#3)
of Bacillus cereus strain##2##4##(2011-2#2)
of Bacillus cereus##9##3##(1992-3#1)(2008-10#2)(2011-1#1)(2011-2#5)
of Bacillus sphaericus##2##3##(2008-6#2)
of Bacillus spp##3##3##(2008-10#3)
of Bacillus stearothermophilus##3##3##(1993-11#1)(1995-2#1)(2008-7#1)
of Bacillus subtilis and##2##4##(1995-3#1)(1996-6#1)
of Bacillus subtilis##8##3##(1993-6#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-6#1)(1997-4#2)(2008-10#1)
of Bacillus thuringiensis##3##3##(1993-12#1)(1995-6#1)(2008-9#1)
of Bacillus##45##2##(1992-11#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#2)(2008-10#11)(2008-3#2)(2008-6#3)(2008-7#1)(2008-9#1)(2010-1#2)(2011-1#1)(2011-2#8)
of Bacteria##41##2##(2008-10#2)(2011-2#39)
of Bacterial Antagonists##2##3##(2008-10#2)
of Bacterial Blight##2##3##(2008-10#2)
of Bacterial##11##2##(1994-12#1)(2008-10#8)(2011-2#2)
of Bacteroides##2##2##(1997-2#1)(2008-7#1)
of Bactrocera papayae##2##3##(2011-2#2)
of Bactrocera##5##2##(2011-2#5)
of Bad##2##2##(2008-10#2)
of Bahia in the##2##4##(2009-10#2)
of Bahia##9##2##(1991-9#1)(2008-10#1)(2008-8#3)(2009-10#4)
of Balb/c##2##2##(2007-10#1)(2008-11#1)
of Baltic##2##2##(2008-10#2)
of Banana##4##2##(2008-10#4)
of Bangladesh##5##2##(2008-10#4)(2011-2#1)
of Barcelona##3##2##(1993-3#1)(1997-5#1)(2008-10#1)
of Barley Yellow Dwarf##2##4##(2008-10#2)
of Barley yellow dwarf virus##5##5##(2008-10#5)
of Barley yellow dwarf##6##4##(2008-10#6)
of Barley##13##2##(2008-10#13)
of Barrett's##2##2##(1996-8#1)(2013-1#1)
of Bartonella bacilliformis##2##3##(1995-8#2)
of Basal##2##2##(2008-10#1)(2013-1#1)
of Basel##2##2##(1996-6#1)(2008-1#1)
of Basic##2##2##(2008-12#1)(2008-5#1)
of Batesian mimicry##2##3##(2012-3#2)
of Bax and Caspase-3##2##4##(2013-8#2)
of Bax and##3##3##(2008-5#1)(2013-8#2)
of Bax##5##2##(2008-5#1)(2009-4#1)(2013-1#1)(2013-8#2)
of Baxter Colleague infusion pumps##2##5##(2011-2#2)
of Baxter's##2##2##(1993-3#1)(1994-1#1)
of Bayesian##7##2##(1994-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-8#1)
of BcEST##2##2##(2011-1#2)
of BcOS1p##2##2##(2008-10#2)
of Bcl-2 and Bax in##2##5##(2008-9#1)(2010-8#1)
of Bcl-2 and Bax##4##4##(2008-9#2)(2010-8#1)(2013-7#1)
of Bcl-2 and##5##3##(2008-9#2)(2010-8#1)(2012-12#1)(2013-7#1)
of Bcl-2 family proteins##3##4##(2011-2#1)(2013-7#1)(2013-8#1)
of Bcl-2 family##4##3##(2009-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
of Bcl-2##19##2##(2008-11#4)(2008-9#3)(2009-12#1)(2009-4#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#3)(2013-8#2)
of Bcl-xL##3##2##(2008-11#3)
of Be(+2)##3##2##(2008-10#3)
of Be(II)##3##2##(2008-10#3)
of Bean common mosaic necrosis virus##3##6##(2008-10#3)
of Bean common mosaic##4##4##(2008-10#4)
of Bean golden##2##3##(2008-10#2)
of Bean pod mottle##3##4##(2008-10#3)
of Bean##9##2##(2008-10#9)
of Beer's Law##2##3##(2008-10#1)(2008-2#1)
of Beer's##3##2##(2008-10#2)(2008-2#1)
of Beet black scorch##2##4##(2008-10#2)
of Beet##6##2##(2008-10#6)
of Beijing##5##2##(2008-10#1)(2008-9#1)(2011-1#1)(2013-8#2)
of Belgian##2##2##(1994-12#1)(2008-3#1)
of Bell##2##2##(2008-10#2)
of Bemisia tabaci Gennadius##2##4##(2008-12#2)
of Bemisia tabaci##5##3##(2008-10#2)(2008-12#2)(2011-2#1)
of Benzimidazole##2##2##(2008-10#1)(2012-2#1)
of Bergen##3##2##(1992-6#2)(1993-3#1)
of Berry's four-cell typology##2##4##(2008-8#2)
of Bessel beams##3##3##(2008-2#1)(2009-6#2)
of Bhutan##2##2##(2008-10#2)
of Bi##12##2##(1991-11#1)(2007-11#1)(2008-10#10)
of Bi(III)##2##2##(2008-10#2)
of BiP##4##2##(1994-11#1)(1995-2#1)(2008-11#1)(2008-7#1)
of Bifidobacterium##5##2##(2008-11#3)(2008-5#1)(2011-1#1)
of Billing's##2##2##(2008-10#2)
of Billroth##2##2##(1991-6#1)(2013-1#1)
of Billroth's##2##2##(2013-1#2)
of Binucleate Rhizoctonia##2##3##(2008-10#2)
of Biochemistry##3##2##(1997-7#1)(2011-2#2)
of Biocontrol##3##2##(2008-10#3)
of Biolog##2##2##(2008-10#2)
of Biological Control##2##3##(2008-10#2)
of Biological##8##2##(1990-12#1)(2007-10#1)(2008-10#3)(2008-4#1)(2010-2#1)(2011-4#1)
of Biomphalaria glabrata##2##3##(1993-6#1)(2008-12#1)
of Biomphalaria##3##2##(1993-6#2)(2008-12#1)
of Biotinylated##2##2##(2008-11#1)(2010-2#1)
of Bipolaris sorokiniana##5##3##(2008-10#5)
of Bipolaris##7##2##(2008-10#7)
of Bis(melaminium) terephthalate dihydrate##3##4##(2013-1#3)
of Black##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
of Blk##2##2##(1995-6#2)
of Blood##5##2##(1994-9#1)(1995-6#1)(1997-5#1)(2009-11#1)(2011-2#1)
of Blumeria graminis f##2##4##(2008-10#2)
of BmNPV gp64 promoter##2##4##(2008-11#2)
of BmNPV##4##2##(2008-11#4)
of BoHV-1##2##2##(2011-2#2)
of BoNT in##2##3##(2011-2#2)
of BoNT##5##2##(2008-5#1)(2011-2#4)
of Body Mass Index##2##4##(2008-12#1)(2012-2#1)
of Bombyx mori nucleopolyhedrovirus##3##4##(2008-11#3)
of Bombyx mori##7##3##(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#2)
of Bone Marrow##2##3##(2008-6#1)(2008-9#1)
of Bone##5##2##(1994-12#1)(2006-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
of Bonghan##3##2##(2010-7#3)
of Bordetella pertussis##2##3##(2007-12#1)(2008-7#1)
of Borrelia burgdorferi infection##2##4##(2011-2#2)
of Borrelia burgdorferi##12##3##(1990-2#1)(1992-3#1)(1995-5#1)(2008-9#4)(2010-6#1)(2011-2#4)
of Borrelia##15##2##(1990-2#1)(1992-3#1)(1995-5#1)(2008-9#4)(2010-6#1)(2011-2#4)(2012-2#3)
of Bortezomib##2##2##(2010-8#2)
of Boswellia serrata##3##3##(2013-1#3)
of Both##2##2##(2008-11#1)(2013-7#1)
of Bothrops jararaca##2##3##(1995-5#1)(2008-7#1)
of Bothrops##4##2##(1995-5#1)(2008-5#2)(2008-7#1)
of Botryosphaeria dothidea##8##3##(2008-10#8)
of Botryosphaeria##12##2##(2008-10#12)
of Botryotinia fuckeliana##2##3##(2008-10#2)
of Botryotinia##3##2##(2008-10#3)
of Botrytis cinerea and##2##4##(2008-10#1)(2008-5#1)
of Botrytis cinerea conidia##2##4##(2008-10#2)
of Botrytis cinerea in##2##4##(2008-10#2)
of Botrytis cinerea on##8##4##(2008-10#8)
of Botrytis cinerea was##2##4##(2008-10#2)
of Botrytis cinerea##36##3##(2008-10#35)(2008-5#1)
of Botrytis spp##3##3##(2008-10#3)
of Botrytis##41##2##(2008-10#40)(2008-5#1)
of Botswana##2##2##(1993-11#1)(2013-1#1)
of Bowen's disease##3##3##(2007-8#1)(2010-6#2)
of Bp-1 protein##2##3##(1992-11#2)
of Br polymorphism##3##3##(2006-6#3)
of Br(-)##2##2##(2008-10#2)
of Bragg fibers##2##3##(2007-12#2)
of Bragg gratings##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of Bragg##12##2##(2007-11#3)(2007-12#5)(2008-3#4)
of Brain##3##2##(1996-3#1)(1997-3#1)(2012-3#1)
of Brassica juncea##3##3##(1991-12#2)(2011-1#1)
of Brassica napus##3##3##(2008-10#2)(2012-3#1)
of Brassica oleracea##2##3##(2008-10#1)(2012-3#1)
of Brassica spp##2##3##(2008-10#2)
of Brassica##11##2##(1991-12#2)(2008-10#6)(2011-1#1)(2012-3#2)
of Brazil##17##2##(1991-12#1)(1993-6#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#2)(2009-7#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
of Brazilian##8##2##(1992-5#1)(1993-6#1)(2008-10#4)(2009-10#1)(2012-12#1)
of BrdU##4##2##(1993-11#1)(2007-12#1)(2008-9#2)
of Breast##3##2##(1995-4#2)(2012-12#1)
of Bremia lactucae on##2##4##(2008-10#2)
of Bremia lactucae##9##3##(2008-10#9)
of Brenneria##2##2##(2008-10#2)
of Brilliant##2##2##(2008-10#2)
of Brillouin##2##2##(2007-11#1)(2007-12#1)
of British Columbia##8##3##(1992-12#1)(1993-3#2)(1997-8#1)(2008-10#1)(2008-12#1)(2009-3#1)(2013-8#1)
of British##15##2##(1992-12#1)(1993-3#2)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-3#1)(2011-1#4)(2013-8#1)
of Brn-3a##2##2##(1995-6#1)(1996-12#1)
of Brown##3##2##(2008-10#2)(2008-7#1)
of Brucella abortus##2##3##(2008-9#2)
of Brucella canis in##2##4##(2011-2#1)(2012-2#1)
of Brucella##5##2##(2008-9#2)(2011-2#2)(2012-2#1)
of Bs##4##2##(2008-12#1)(2008-5#3)
of Bt##2##2##(2008-5#1)(2011-2#1)
of BuChE##2##2##(1992-12#2)
of Buccal##2##2##(2007-9#1)(2010-5#1)
of Buenos Aires##4##3##(2008-5#1)(2009-10#2)(2009-7#1)
of Buerger disease##2##3##(1997-8#2)
of Buerger's disease##3##3##(1996-8#1)(1997-8#1)(2008-10#1)
of Burkholderia cepacia##2##3##(2007-12#1)(2008-10#1)
of Burkholderia##3##2##(2007-12#1)(2007-7#1)(2008-10#1)
of Burkitt's lymphoma##5##3##(1996-8#1)(2008-1#3)(2008-9#1)
of ByT-FAS##2##2##(2008-10#2)
of C and##4##3##(1992-6#2)(2008-6#1)(2012-1#1)
of C levels##2##3##(2008-9#2)
of C##245##2##(1990-2#1)(1990-3#1)(1990-5#2)(1992-6#3)(1993-9#2)(1994-7#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-4#1)(2007-11#3)(2007-12#5)(2007-6#2)(2007-7#3)(2008-10#125)(2008-12#2)(2008-3#2)(2008-5#12)(2008-6#8)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2009-2#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#7)(2012-1#2)(2012-3#5)(2012-6#7)(2013-1#11)(2013-7#5)(2013-8#2)
of C(17)##2##2##(1990-7#2)
of C(60) molecules##2##3##(2008-5#2)
of C(60)##7##2##(2008-10#2)(2008-2#3)(2008-5#2)
of C-ADR compared with##2##4##(2012-12#2)
of C-ADR##4##2##(2012-12#4)
of C-C bond##2##3##(2009-9#1)(2010-7#1)
of C-RFa##2##2##(2008-6#2)
of C-reactive protein (CRP) in##2##5##(2007-10#1)(2007-8#1)
of C-reactive protein (CRP)##4##4##(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
of C-reactive protein##6##3##(1992-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
of C-type natriuretic peptide##3##4##(1990-7#1)(1993-11#1)(1994-11#1)
of C-type##4##2##(1990-7#1)(1993-11#1)(1994-11#1)(1996-2#1)
of C/EBP##3##2##(1990-5#1)(2008-5#1)(2012-2#1)
of C/H##2##2##(2008-10#2)
of C1 inhibitor##2##3##(2013-1#2)
of C10-C16##2##2##(2008-6#2)
of C16##2##2##(2008-8#2)
of C18##2##2##(1990-12#1)(2008-10#1)
of C1YVV isolates of strain##2##5##(2008-10#2)
of C1YVV isolates##3##3##(2008-10#3)
of C2 content##2##3##(2007-12#2)
of C2##7##2##(2007-12#3)(2008-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
of C24##3##2##(2012-3#3)
of C2C12##2##2##(2008-11#1)(2008-4#1)
of C3 were##2##3##(2008-10#2)
of C3##10##2##(1991-2#1)(1993-6#2)(2008-10#7)
of C4##3##2##(2008-4#1)(2013-1#1)(2013-8#1)
of C57BL/6##2##2##(1992-9#1)(1995-2#1)
of C5a##3##2##(2008-10#3)
of C6##3##2##(1992-6#1)(1997-8#1)(2007-11#1)
of C60##2##2##(2007-11#1)(2008-10#1)
of C7##2##2##(2011-2#1)(2012-1#1)
of C9-1S on##2##3##(2008-10#2)
of C9-1S##4##2##(2008-10#4)
of CA cells##2##3##(1995-11#1)(2008-7#1)
of CA group was##2##4##(2011-1#2)
of CA##10##2##(1994-5#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#2)
of CA1 pyramidal##2##3##(1995-8#1)(1997-2#1)
of CA1##4##2##(1995-8#1)(1997-2#1)(2008-11#1)(2009-12#1)
of CA125##2##2##(1992-9#2)
of CAA##2##2##(2008-10#2)
of CACY##2##2##(1994-5#2)
of CAD##8##2##(2008-10#2)(2008-7#2)(2011-2#1)(2012-2#2)(2012-3#1)
of CAF##2##2##(1994-7#1)(1995-4#1)
of CAI##2##2##(2013-1#2)
of CAK##2##2##(1997-1#2)
of CAL-IR##3##2##(1996-5#3)
of CALUX results##2##3##(2008-10#2)
of CALUX##4##2##(2008-10#4)
of CAM##2##2##(2008-10#2)
of CAN##4##2##(2012-2#4)
of CAP102 protein##2##3##(1991-5#2)
of CAPD patients##6##3##(2007-12#2)(2007-7#2)(2008-10#2)
of CAPD training##2##3##(2007-12#2)
of CAPD##9##2##(2007-12#5)(2007-7#2)(2008-10#2)
of CAS##8##2##(2006-12#4)(2011-2#3)(2012-12#1)
of CAT activity##2##3##(1991-11#1)(1995-2#1)
of CAT##10##2##(1990-8#2)(1991-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#4)
of CArG##2##2##(1994-11#2)
of CB agonists##3##3##(2009-12#3)
of CB##4##2##(2008-10#1)(2009-12#3)
of CBB bacteria##2##3##(2008-10#2)
of CBF##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
of CBF-B##3##2##(2012-2#3)
of CBS in##3##3##(2011-2#2)(2013-8#1)
of CBS##7##2##(1993-8#3)(2011-2#2)(2013-8#2)
of CBZ and CBZ-E##2##4##(2008-10#2)
of CBZ##4##2##(2008-10#4)
of CBs##2##2##(2008-10#2)
of CC##8##2##(2008-11#5)(2011-1#1)(2012-12#1)(2013-8#1)
of CC-1065 and the duocarmycins##2##5##(2007-11#2)
of CC-516##5##2##(2008-5#5)
of CCA##3##2##(2008-7#1)(2009-12#1)(2010-1#1)
of CCBs##2##2##(2008-11#2)
of CCD##6##2##(2007-11#1)(2008-3#2)(2011-1#2)(2013-1#1)
of CCK##6##2##(1990-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#2)
of CCK-58##3##2##(1991-8#3)
of CCK-8##5##2##(1994-2#4)(1995-11#1)
of CCMV RNA3##2##3##(2008-10#2)
of CCMV##3##2##(2008-10#3)
of CCOP performance##2##3##(1992-12#2)
of CCSVI##6##2##(2012-3#6)
of CCTA##2##2##(2008-12#2)
of CCl4 to the trichloromethyl radical##2##6##(1993-3#2)
of CCl4##5##2##(1993-3#3)(1994-5#1)(2008-10#1)
of CD spectra##3##3##(1992-5#1)(2008-4#2)
of CD##16##2##(1990-8#1)(1992-5#1)(1994-5#2)(1995-5#2)(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#1)(2012-2#2)(2013-8#1)
of CD-ROM##6##2##(1991-12#2)(1991-3#3)(1995-3#1)
of CD-causing R##2##3##(2008-10#2)
of CD10##2##2##(2010-12#1)(2011-2#1)
of CD11a/CD18##2##2##(1996-12#2)
of CD11b and##2##3##(1994-6#1)(1996-2#1)
of CD11b##3##2##(1994-6#2)(1996-2#1)
of CD14##3##2##(2008-10#2)(2008-4#1)
of CD1a+##2##2##(1996-12#2)
of CD20##2##2##(2008-7#1)(2009-8#1)
of CD25+CD4+ T cells##2##4##(2011-2#2)
of CD25+CD4+ regulatory T cells##2##5##(2011-2#2)
of CD25+CD4+##4##2##(2011-2#4)
of CD3##2##2##(1991-6#1)(1993-9#1)
of CD3+##2##2##(2007-8#1)(2013-8#1)
of CD34(+) cells##4##3##(2008-8#2)(2008-9#2)
of CD34(+)##6##2##(2008-8#2)(2008-9#4)
of CD34+ cells##2##3##(2011-2#2)
of CD34+##4##2##(2008-7#1)(2008-9#1)(2011-2#2)
of CD36##3##2##(1991-2#2)(2010-2#1)
of CD38##4##2##(1994-11#3)(2008-9#1)
of CD39 and##2##3##(2008-4#2)
of CD39##6##2##(2008-4#6)
of CD4##9##2##(1993-3#1)(1995-2#1)(1995-3#2)(2006-10#1)(2008-4#2)(2008-8#1)(2012-2#1)
of CD4(+) T cells##2##4##(2008-11#1)(2010-1#1)
of CD4(+) or CD8(+)##2##4##(2008-10#1)(2008-5#1)
of CD4(+)##10##2##(2008-10#4)(2008-11#3)(2008-5#2)(2010-1#1)
of CD4+ T cells##2##4##(1994-12#1)(1995-2#1)
of CD4+ T##3##3##(1994-12#1)(1995-2#1)(2008-11#1)
of CD4+##7##2##(1994-12#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-8#1)
of CD40##2##2##(2008-10#1)(2008-9#1)
of CD41##2##2##(2006-6#2)
of CD44##3##2##(1994-10#1)(2008-4#1)(2009-4#1)
of CD44s##3##2##(1994-10#1)(2008-4#2)
of CD45##2##2##(1993-11#1)(2011-2#1)
of CD45(-) CD105(+) cells among##2##5##(2008-11#2)
of CD45RA+CD4+ cells##2##3##(1995-12#2)
of CD5(+)B cells##2##3##(2011-2#2)
of CD69+##2##2##(2007-8#2)
of CD8##4##2##(1996-11#1)(1997-9#1)(2007-11#1)(2008-10#1)
of CD8+ T##2##3##(2013-8#2)
of CD8+##5##2##(2008-11#2)(2013-8#3)
of CD86 expression##2##3##(2008-10#2)
of CD86##3##2##(2008-10#2)(2008-11#1)
of CD9##2##2##(2009-8#2)
of CDC25##2##2##(1994-12#1)(1994-8#1)
of CDD/ ANP-(99-126)##2##3##(1995-11#2)
of CDD/ANP-(99-126)##2##2##(1995-11#2)
of CDDP##4##2##(1990-6#1)(2013-1#3)
of CDDP-DNA adducts##2##3##(2013-1#2)
of CDI##3##2##(2010-8#3)
of CDKN2A gene##2##3##(2008-12#2)
of CDKN2A##4##2##(1997-7#1)(2008-12#2)(2008-7#1)
of CDKs##2##2##(1997-6#1)(2012-12#1)
of CDP##3##2##(1993-12#3)
of CE for##2##3##(2008-10#2)
of CE with##3##3##(1994-9#1)(2008-10#2)
of CE##10##2##(1994-9#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-7#1)
of CEA in##2##3##(1994-2#1)(2008-10#1)
of CEA##6##2##(1994-2#1)(2008-10#1)(2008-11#4)
of CEC and CEP##3##4##(2010-1#3)
of CEF##3##2##(1991-5#3)
of CENP-B box##2##3##(2008-7#2)
of CER3##2##2##(2008-10#2)
of CETP##3##2##(1995-5#3)
of CEUS has##2##3##(2010-12#2)
of CEUS in##2##3##(2010-12#2)
of CEUS##6##2##(2010-12#6)
of CEVd##2##2##(2008-10#2)
of CEf##2##2##(2008-5#2)
of CEs##5##2##(2008-5#5)
of CF was##2##3##(2012-3#1)(2013-1#1)
of CF##8##2##(1994-2#1)(1997-1#1)(2008-10#1)(2009-8#1)(2012-3#3)(2013-1#1)
of CFCs##6##2##(1992-3#1)(1996-1#5)
of CFD##2##2##(2008-11#1)(2010-3#1)
of CFS patients##2##3##(2010-1#2)
of CFS##5##2##(2010-1#5)
of CFTR##5##2##(1990-8#1)(2011-3#2)(2012-12#2)
of CFU##5##2##(2008-10#3)(2013-7#2)
of CGG##2##2##(2008-4#1)(2009-5#1)
of CGRP in the##5##4##(1990-7#1)(1992-6#3)(1992-9#1)
of CGRP in##7##3##(1990-7#1)(1992-6#5)(1992-9#1)
of CGRP is##2##3##(1992-6#2)
of CGRP##28##2##(1990-7#1)(1992-6#20)(1992-9#1)(1993-3#1)(1997-3#1)(1997-4#4)
of CH##3##2##(2007-12#1)(2008-10#2)
of CH(4)##4##2##(2008-3#3)(2010-7#1)
of CHA0##4##2##(2008-10#4)
of CHCHD1##2##2##(2013-8#2)
of CHCs##2##2##(2011-2#1)(2012-3#1)
of CHD##7##2##(1990-3#1)(2007-10#2)(2008-3#2)(2012-2#2)
of CHF##2##2##(2011-1#2)
of CHI##2##2##(2013-1#1)(2013-8#1)
of CHIK##2##2##(2011-1#2)
of CHINs##2##2##(1997-1#2)
of CHM##2##2##(2008-10#2)
of CHO cell##4##3##(1992-12#1)(1993-9#1)(2008-11#1)(2011-2#1)
of CHO cells and##2##4##(2008-11#1)(2011-2#1)
of CHO cells in##3##4##(2008-11#2)(2008-7#1)
of CHO cells##18##3##(1995-2#1)(1997-1#1)(2008-11#12)(2008-4#1)(2008-7#2)(2011-2#1)
of CHO##26##2##(1992-12#1)(1993-9#1)(1995-2#1)(1997-1#1)(2008-11#15)(2008-4#1)(2008-7#2)(2011-2#2)(2013-8#2)
of CHO-K1 cells##4##3##(1996-5#1)(1997-1#1)(2008-11#2)
of CHO-K1##5##2##(1996-5#1)(1997-1#1)(2008-11#3)
of CHT##2##2##(2008-10#2)
of CHX against##2##3##(2011-3#2)
of CHX##4##2##(2011-3#4)
of CI##7##2##(1992-6#1)(1996-2#1)(2007-10#2)(2008-8#2)(2010-10#1)
of CIA##2##2##(1990-6#1)(2008-11#1)
of CIITA G-944C gene polymorphism in##2##6##(2011-1#2)
of CIITA G-944C gene##3##4##(2011-1#3)
of CIITA G-944C##5##3##(2011-1#5)
of CIN##10##2##(1991-2#2)(1992-10#2)(1994-1#2)(1994-12#1)(1994-2#2)(2008-4#1)
of CINV in patients with##2##5##(2008-7#2)
of CINV##4##2##(2008-7#4)
of CK specific cDNA##2##4##(2008-11#2)
of CK##9##2##(1990-11#1)(1991-9#1)(1992-11#1)(1993-6#1)(2008-11#2)(2011-3#3)
of CK-II##2##2##(1993-2#2)
of CK-MM3##2##2##(1991-2#2)
of CKD##4##2##(2009-1#2)(2012-2#1)(2013-1#1)
of CL development##2##3##(2008-9#2)
of CL intensity##3##3##(2008-10#3)
of CL##14##2##(1991-2#1)(2007-7#2)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#2)
of CL-emission##2##2##(2008-10#2)
of CLA##3##2##(1993-8#1)(2008-5#2)
of CLL cells##2##3##(1995-2#2)
of CLL##5##2##(1995-2#3)(2008-9#2)
of CLP##2##2##(2012-3#2)
of CMC##3##2##(1993-6#1)(2008-10#2)
of CMF##4##2##(1992-12#1)(2008-11#1)(2009-1#2)
of CMI##3##2##(2007-2#1)(2008-3#1)(2011-2#1)
of CML##9##2##(1997-3#2)(2010-4#3)(2011-2#2)(2012-12#2)
of CMLV##2##2##(2008-10#2)
of CMM##2##2##(2007-10#1)(2012-3#1)
of CMP-Neu5Ac##2##2##(1992-11#2)
of CMS##3##2##(1995-2#2)(2011-2#1)
of CMT##2##2##(2009-10#1)(2011-2#1)
of CMT1A##2##2##(1997-3#2)
of CMT4C in##2##3##(2013-1#2)
of CMT4C##3##2##(2013-1#3)
of CMV and##3##3##(2008-10#3)
of CMV in##2##3##(2008-10#1)(2010-12#1)
of CMV isolates##3##3##(2008-10#3)
of CMV was##2##3##(2008-10#2)
of CMV##23##2##(2007-12#1)(2008-10#17)(2008-8#1)(2010-12#4)
of CN##2##2##(2008-10#1)(2011-2#1)
of CN(-)##4##2##(2008-10#4)
of CNE-2L2 cell##2##3##(2008-8#2)
of CNG channels in the##2##5##(2009-10#2)
of CNG channels in##4##4##(2009-10#4)
of CNL patients##2##3##(2008-7#2)
of CNL##3##2##(2008-7#3)
of CNP##2##2##(1990-7#1)(2011-2#1)
of CNS diseases##2##3##(1994-9#1)(2012-2#1)
of CNS disorders##2##3##(2008-5#1)(2008-7#1)
of CNS##17##2##(1990-7#1)(1994-5#1)(1994-9#1)(1995-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#7)(2012-1#1)(2012-2#1)(2013-1#1)
of CNTF##5##2##(1990-5#3)(1996-2#1)(2008-5#1)
of CNTs##2##2##(2008-7#1)(2010-4#1)
of CO exposure##2##3##(1990-5#2)
of CO##23##2##(1990-3#1)(1990-5#3)(1990-8#1)(1992-3#1)(1995-2#2)(1995-3#1)(1997-2#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-8#1)(2009-5#1)(2010-12#1)
of CO(2) and O(2)##2##4##(2007-12#1)(2008-2#1)
of CO(2) and##3##3##(2007-12#1)(2008-2#2)
of CO(2) in##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of CO(2) laser##4##3##(2008-2#3)(2008-3#1)
of CO(2) on##2##3##(2008-10#2)
of CO(2) were##2##3##(2007-11#1)(2008-3#1)
of CO(2)##32##2##(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#13)(2008-3#5)(2008-7#1)(2008-9#1)
of CO(3)(2-)##2##2##(2008-10#2)
of CO2 and HCO3-##2##4##(1993-6#2)
of CO2 and##5##3##(1993-6#2)(1995-8#1)(1996-12#1)(2008-11#1)
of CO2 laser##5##3##(1994-12#1)(1995-2#1)(2008-2#2)(2008-3#1)
of CO2##16##2##(1993-6#3)(1994-12#1)(1995-2#1)(1995-8#1)(1996-12#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#4)
of CO2-laser##3##2##(2008-3#3)
of CO39##2##2##(2008-10#2)
of CO3s##2##2##(2008-6#2)
of COD##4##2##(2008-10#3)(2013-1#1)
of COL1A2##2##2##(1992-8#2)
of CONH##2##2##(1992-8#1)(1997-2#1)
of COOP##2##2##(2008-7#1)(2010-8#1)
of COP##2##2##(2008-2#1)(2010-9#1)
of COPD##9##2##(2008-1#1)(2010-5#3)(2011-2#3)(2013-8#2)
of COS##3##2##(2008-2#1)(2011-1#2)
of COUP-TF in##2##3##(1992-11#2)
of COUP-TF##3##2##(1992-11#2)(1996-5#1)
of COX##3##2##(2007-4#1)(2010-2#1)(2012-2#1)
of COX-1##2##2##(2010-2#2)
of COX-2##6##2##(2008-11#1)(2010-12#1)(2011-2#2)(2013-8#2)
of CP compared with full term##2##6##(2011-2#2)
of CP were##2##3##(2008-10#1)(2011-2#1)
of CP##18##2##(1990-12#1)(2008-10#5)(2008-12#1)(2008-7#2)(2011-2#7)(2012-2#1)(2012-3#1)
of CPA##2##2##(1993-9#1)(2012-3#1)
of CPB##3##2##(2007-8#2)(2008-10#1)
of CPC in##2##3##(2008-10#2)
of CPC##4##2##(2008-10#4)
of CPE##2##2##(1994-2#1)(2008-10#1)
of CPIB##3##2##(1990-2#1)(1991-4#2)
of CPL##2##2##(2008-10#1)(2010-12#1)
of CPMV##2##2##(1995-2#2)
of CPP##2##2##(2008-12#1)(2008-7#1)
of CPPs##4##2##(2009-8#2)(2011-3#2)
of CPT##4##2##(1994-2#1)(1994-8#1)(1995-5#1)(2007-11#1)
of CQI are##2##3##(1993-3#2)
of CQI##8##2##(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-2#1)
of CR or BER on the repeated cocaine-induced##2##8##(2008-10#2)
of CR or##3##3##(2008-10#3)
of CR##13##2##(1994-5#2)(2007-10#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-10#3)
of CR-EAE##2##2##(2013-7#2)
of CRB##2##2##(2010-3#2)
of CRC##9##2##(2008-10#3)(2008-7#1)(2009-12#1)(2010-12#3)(2012-2#1)
of CRD##5##2##(2008-2#5)
of CREB at##2##3##(2008-11#2)
of CREB##7##2##(1996-12#2)(2008-11#5)
of CRF##8##2##(1997-4#2)(2007-7#3)(2008-1#3)
of CRH and##2##3##(2008-4#2)
of CRH##6##2##(1990-12#1)(2008-11#2)(2008-4#3)
of CRMP2##3##2##(2013-1#3)
of CRP and##2##3##(2007-10#1)(2008-7#1)
of CRP##10##2##(2007-10#4)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
of CRS##2##2##(2011-2#1)(2013-8#1)
of CS to##4##3##(1997-2#1)(2008-10#1)(2013-1#2)
of CS was##2##3##(2008-10#1)(2013-1#1)
of CS##28##2##(1995-2#1)(1997-2#1)(2008-10#3)(2010-8#2)(2011-2#2)(2013-1#19)
of CSCs##4##2##(2011-2#3)(2012-12#1)
of CSD and##2##3##(2008-10#2)
of CSD##4##2##(2007-10#1)(2008-10#3)
of CSD-symptomatic trees##3##3##(2008-10#3)
of CSE##3##2##(2012-2#1)(2013-8#2)
of CSF flow##2##3##(1993-8#1)(2008-7#1)
of CSF leak##3##3##(2011-2#1)(2012-3#2)
of CSF##16##2##(1993-1#1)(1993-8#1)(1994-9#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#4)(2009-6#1)(2011-2#2)(2012-3#2)(2013-7#1)
of CSI##2##2##(2008-8#2)
of CSN3##2##2##(2008-12#2)
of CSOM##2##2##(2008-9#2)
of CSS##2##2##(2008-10#1)(2008-3#1)
of CT and MR##2##4##(1997-8#1)(2008-1#1)
of CT and##5##3##(1992-12#1)(1992-6#1)(1997-8#1)(2008-1#1)(2013-1#1)
of CT findings##4##3##(1990-3#1)(1997-8#1)(2008-1#1)(2012-2#1)
of CT imaging##2##3##(2007-8#1)(2012-2#1)
of CT in##3##3##(2008-1#1)(2008-12#1)(2013-7#1)
of CT or##2##3##(1995-3#1)(2008-7#1)
of CT scan##2##3##(2008-7#1)(2009-7#1)
of CT scans##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of CT systems##2##3##(2008-7#1)(2012-2#1)
of CT##47##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-6#2)(1994-2#1)(1995-3#4)(1997-8#4)(2007-11#2)(2007-8#2)(2008-1#4)(2008-12#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#2)(2009-7#1)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#4)(2013-7#1)
of CTA##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
of CTAB and##3##3##(2008-10#2)(2008-11#1)
of CTAB##6##2##(2008-10#3)(2008-11#3)
of CTC##3##2##(2008-1#1)(2008-10#1)(2010-8#1)
of CTEPH in##2##3##(2010-6#2)
of CTEPH##10##2##(2010-10#1)(2010-6#9)
of CTL activity##2##3##(1995-3#2)
of CTL##4##2##(1995-3#2)(2008-4#1)(2008-8#1)
of CTLA-4 and##2##3##(2007-5#1)(2011-2#1)
of CTLs##5##2##(1994-5#1)(2008-11#4)
of CTMA##3##2##(2008-10#3)
of CTP##6##2##(1991-11#2)(1992-11#1)(1992-6#1)(1997-2#2)
of CTS##3##2##(2008-9#2)(2010-8#1)
of CTV incidence at the##3##5##(2008-10#3)
of CTV incidence##4##3##(2008-10#4)
of CTV##10##2##(2008-10#10)
of CTV-positive trees##2##3##(2008-10#2)
of CV##5##2##(2008-10#4)(2008-12#1)
of CVD and##2##3##(2008-1#1)(2010-12#1)
of CVD in##2##3##(2008-3#1)(2012-12#1)
of CVD risk##2##3##(2013-1#2)
of CVD##19##2##(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#3)(2011-1#4)(2012-12#1)(2012-2#2)(2013-1#2)
of CVI##5##2##(2011-2#3)(2011-3#2)
of CWD##2##2##(2008-10#2)
of CWI signaling##3##3##(2012-1#3)
of CWP##5##2##(2008-10#5)
of CYDV##2##2##(2008-10#2)
of CYP##2##2##(2008-8#1)(2011-2#1)
of CYP1A##5##2##(1996-12#2)(2008-10#3)
of CYP1A1##10##2##(1992-8#1)(1994-6#4)(1995-11#2)(2008-10#1)(2008-11#2)
of CYP1A2##2##2##(1994-8#1)(2008-8#1)
of CYP1B1 protein##2##3##(1995-11#2)
of CYP1B1##3##2##(1995-11#3)
of CYP2A6##2##2##(2008-8#2)
of CYP2C11 decreased##2##3##(2008-8#2)
of CYP2D6##7##2##(1993-6#2)(2008-10#4)(2008-11#1)
of CYP2E1 in##3##3##(1990-11#1)(2008-8#2)
of CYP2E1 protein##2##3##(1990-11#1)(2008-8#1)
of CYP2E1##8##2##(1990-11#2)(2008-8#6)
of CYP3A and P-glycoprotein on the absorption of buagafuran in##2##10##(2011-3#2)
of CYP3A##4##2##(2011-2#1)(2011-3#2)(2013-1#1)
of CYP3A23##2##2##(2008-8#2)
of CYP3A4##8##2##(1994-5#1)(2008-10#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-3#1)
of CYP450##3##2##(2011-1#3)
of CYP51A1 was##2##3##(2008-10#2)
of CYP51A1##3##2##(2008-10#3)
of CYSDV##3##2##(2008-10#3)
of CYVD strains##2##3##(2008-10#2)
of CYVD##3##2##(2008-10#3)
of CZ and FZ##2##4##(1993-6#2)
of Ca and Mg##2##4##(2008-10#2)
of Ca##17##2##(1991-5#1)(2008-10#11)(2008-3#1)(2009-6#2)(2011-2#1)(2012-2#1)
of Ca(2+) and Mg(2+)##4##4##(2008-10#3)(2008-11#1)
of Ca(2+) and##6##3##(2008-10#4)(2008-11#1)(2008-4#1)
of Ca(2+) from##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)
of Ca(2+) in##2##3##(2007-11#1)(2008-4#1)
of Ca(2+) with##2##3##(2008-10#2)
of Ca(2+)##28##2##(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#3)(2008-4#6)(2008-8#4)(2008-9#1)(2009-6#1)(2012-2#1)
of Ca(2+)-ATPase##4##2##(1992-11#1)(1992-5#1)(1995-11#1)(2008-8#1)
of Ca(2+)-binding proteins##2##3##(1991-6#1)(1992-6#1)
of Ca(2+)-dependent##5##2##(1992-6#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-7#1)
of Ca(v)beta subunits in the##2##5##(2008-8#2)
of Ca++##2##2##(1991-9#1)(1993-11#1)
of Ca2+ and##9##3##(1993-8#1)(1994-11#5)(1995-5#1)(1995-6#1)(1996-2#1)
of Ca2+ bound##2##3##(1995-8#1)(2009-7#1)
of Ca2+ channels##2##3##(1992-9#1)(1994-6#1)
of Ca2+ currents##2##3##(1992-8#1)(1996-2#1)
of Ca2+ entry##2##3##(1992-6#1)(1997-2#1)
of Ca2+ from##2##3##(1991-12#1)(1995-11#1)
of Ca2+ in##2##3##(1991-12#1)(1995-11#1)
of Ca2+ influx and##2##4##(1990-12#2)
of Ca2+ influx by##2##4##(1991-1#1)(1992-8#1)
of Ca2+ influx##10##3##(1990-12#5)(1991-1#2)(1992-8#1)(1994-8#1)(1996-5#1)
of Ca2+ release##4##3##(1995-6#4)
of Ca2+##74##2##(1990-10#1)(1990-12#5)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#2)(1991-12#3)(1991-8#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-8#3)(1994-11#6)(1994-12#1)(1994-2#1)(1994-6#5)(1994-8#1)(1995-11#5)(1995-2#1)(1995-5#2)(1995-6#8)(1995-8#1)(1996-2#4)(1996-5#1)(1997-2#1)(1997-7#1)(2008-8#4)(2009-3#1)(2009-7#1)(2010-11#1)(2013-1#1)
of Ca2+/calmodulin-dependent protein kinase II##2##5##(1993-6#2)
of Ca2+/calmodulin-dependent##3##2##(1990-5#1)(1993-6#2)
of CaCO(3) and##2##3##(2008-10#2)
of CaCO3##3##2##(2008-6#3)
of CaCl2##4##2##(1990-7#1)(1991-2#1)(1992-5#1)(1995-3#1)
of CaD*##3##2##(1994-5#3)
of CaF(2)##2##2##(2008-10#1)(2008-3#1)
of CaM and##2##3##(2008-8#1)(2011-3#1)
of CaM in##3##3##(1994-3#1)(2008-8#2)
of CaM kinase II for calmodulin##2##6##(1993-6#2)
of CaM kinase II##4##4##(1993-6#4)
of CaM##15##2##(1993-6#4)(1994-3#1)(1996-12#1)(2008-8#7)(2011-3#2)
of CaMK II##3##3##(1995-8#3)
of CaMKII##2##2##(2009-7#1)(2012-2#1)
of CaMV 35S promoter##3##4##(2008-8#1)(2008-9#2)
of CaMV 35S##4##3##(2008-8#1)(2008-9#3)
of CaMV##5##2##(2008-10#1)(2008-8#1)(2008-9#3)
of CaMV35S##3##2##(2008-9#3)
of CaN##2##2##(2011-3#2)
of CaO##3##2##(2013-1#3)
of CaSR mRNA##5##3##(2008-11#5)
of CaSR##6##2##(2008-11#6)
of Caco-2 cells##6##3##(1994-6#3)(2007-12#1)(2008-11#2)
of Caco-2##7##2##(1994-6#3)(2007-12#1)(2008-11#3)
of Cadaba trifoliata##2##3##(2010-3#2)
of Caenorhabditis elegans##6##3##(1995-9#1)(2007-11#1)(2008-3#1)(2008-7#2)(2013-1#1)
of Caesarean##3##2##(1991-9#2)(1996-11#1)
of CagA##2##2##(2011-2#1)(2012-12#1)
of Cajal (ICC)##2##3##(2009-12#2)
of Cajal##4##2##(2008-6#1)(2009-12#2)(2012-12#1)
of Calcium##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
of California and##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
of California##34##2##(1991-1#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-2#2)(1997-1#1)(1997-5#1)(2008-10#12)(2008-3#1)(2008-5#4)(2008-8#1)(2009-2#3)(2010-10#1)(2011-2#1)(2012-3#1)
of Calla lily chlorotic spot virus##2##6##(2008-10#2)
of Callinectes sapidus##2##3##(2007-12#2)
of Calotropis gigantea##3##3##(2008-12#3)
of Calycotome Villosa Subsp##2##4##(2007-11#2)
of Campylobacter fetus##5##3##(2011-1#5)
of Campylobacter jejuni##3##3##(1990-3#1)(1993-9#1)(2010-12#1)
of Campylobacter##16##2##(1990-3#1)(1993-9#2)(2008-10#6)(2010-12#1)(2011-1#6)
of Canada##20##2##(1991-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-8#1)(2013-8#1)
of Canada's##8##2##(2007-12#2)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#3)
of Canadian Populations of the Sapstain Fungus##2##7##(2008-10#2)
of Canadian and##2##3##(1996-9#1)(2007-12#1)
of Canadian health care##3##4##(1995-1#1)(1995-3#1)(1997-2#1)
of Canadian public health nutritionists##2##5##(1993-1#1)(1993-2#1)
of Canadian##27##2##(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
of Cancer##21##2##(1992-12#1)(1994-12#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#9)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)
of Candida albicans to##2##4##(2008-5#1)(2013-1#1)
of Candida albicans##13##3##(1990-5#1)(1991-12#2)(1997-4#1)(2007-12#1)(2008-5#6)(2013-1#2)
of Candida antarctica lipase B##2##5##(2011-2#1)(2013-1#1)
of Candida infections##2##3##(2008-5#1)(2012-3#1)
of Candida oleophila##2##3##(2008-10#2)
of Candida saitoana##2##3##(2008-10#2)
of Candida sake (CPA-1)##2##4##(2008-10#2)
of Candida sake##4##3##(2008-10#4)
of Candida species##3##3##(2008-5#2)(2008-7#1)
of Candida spp##3##3##(2008-5#2)(2011-2#1)
of Candida##40##2##(1990-5#1)(1991-12#2)(1997-4#1)(2007-12#1)(2008-10#8)(2008-5#17)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
of Candidatus##2##2##(2011-2#2)
of Cannabis##2##2##(1997-6#2)
of Canola##2##2##(2008-10#2)
of Canton##2##2##(1996-11#2)
of Capsicum##3##2##(1993-11#1)(2008-10#2)
of Captopril in pharmaceutical formulation and reconstituted serum##2##8##(2008-10#2)
of Captopril in##4##3##(2008-10#4)
of Captopril##7##2##(2008-10#7)
of Carbohydrate##2##2##(2013-1#2)
of Carbon Monoxide##2##3##(2008-2#1)(2008-8#1)
of Carbon##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
of Cardiac Troponin I in##2##5##(2008-12#2)
of Cardiac##7##2##(2008-12#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
of Cardiology##14##2##(2008-10#5)(2008-3#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-1#1)
of Cardiorespiratory##2##2##(1997-3#1)(2009-3#1)
of Cardiovascular Surgery##2##3##(2007-8#1)(2008-4#1)
of Cardiovascular##5##2##(2007-8#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
of Care and##2##3##(1996-12#1)(2010-12#1)
of Care##9##2##(1994-3#1)(1996-1#1)(1996-12#3)(1997-1#1)(2010-12#1)(2010-7#1)(2012-3#1)
of Cas and NEDD9##2##4##(2012-12#2)
of Case Mix Groups##2##4##(1991-12#1)(1993-12#1)
of Case##3##2##(1991-12#1)(1993-12#1)(2013-8#1)
of Castell de Barberà (Vallès-Penedès Basin##2##6##(2011-2#2)
of Castleman's disease##2##3##(1992-5#2)
of Catalonia]##2##2##(1992-5#1)(1997-3#1)
of Catalyser-21(TM)##2##2##(2008-11#2)
of Caucasian##2##2##(2008-5#2)
of Cauliflower##2##2##(2008-10#2)
of Cav-1##2##2##(2012-3#2)
of Cavernous##3##2##(2012-3#1)(2013-1#2)
of Caño Negro##2##3##(2008-5#2)
of Cb##2##2##(1994-12#1)(1995-12#1)
of Cd after##2##3##(1995-3#2)
of Cd and Hg##4##4##(1990-5#4)
of Cd and Pb in##3##5##(2008-10#3)
of Cd and Pb##8##4##(2008-10#8)
of Cd and Zn##5##4##(2008-10#5)
of Cd and##18##3##(1990-5#4)(2008-10#14)
of Cd exposure##2##3##(1997-4#2)
of Cd from##2##3##(1995-3#2)
of Cd in biological samples##2##5##(2008-10#2)
of Cd in the##4##4##(1990-5#1)(1995-3#2)(2008-10#1)
of Cd in##14##3##(1990-5#1)(1995-3#3)(1997-4#1)(2008-10#8)(2008-12#1)
of Cd was##2##3##(2008-10#2)
of Cd##78##2##(1990-5#5)(1995-3#8)(1997-4#9)(2008-10#51)(2008-11#3)(2008-12#1)(2008-7#1)
of Cd(2+) and##2##3##(2008-10#2)
of Cd(2+) in##2##3##(2008-10#2)
of Cd(2+) ions##2##3##(2008-10#2)
of Cd(2+)##10##2##(2008-10#10)
of Cd(II) and In(III)##2##4##(2008-10#2)
of Cd(II) and Pb(II)##3##4##(2008-10#3)
of Cd(II) and##6##3##(2008-10#6)
of Cd(II)##24##2##(1995-5#1)(2008-10#23)
of Cd(II)-8-hydroxyquinoline-5-sulphonic acid complex##2##4##(2008-10#2)
of Cd2+##3##2##(1991-12#2)(1991-9#1)
of CdHL##2##2##(2008-10#2)
of CdS and PbS##2##4##(2008-10#2)
of CdS##8##2##(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#2)
of CdSe##6##2##(2007-11#1)(2008-10#5)
of CdTe##3##2##(2008-2#2)(2013-8#1)
of Cdc7##3##2##(2012-3#3)
of Ce##6##2##(2008-10#3)(2008-3#2)(2010-4#1)
of Ce(3+) and Eu(3+)##2##4##(2008-10#2)
of Ce(3+)##4##2##(2007-11#1)(2008-10#2)(2010-4#1)
of Ce(III)##3##2##(2008-10#3)
of Ce(III)-EDTA complex##2##3##(2008-10#2)
of Ce(IV)##4##2##(2008-10#4)
of Ce3+##2##2##(2013-8#2)
of CeA for##3##3##(2008-10#3)
of CeA##4##2##(2008-10#4)
of Cell##3##2##(2008-11#1)(2009-9#1)(2013-8#1)
of Cellular##2##2##(2008-10#1)(2013-8#1)
of Cellulytic##2##2##(2008-10#2)
of Central Mexico##2##3##(2008-10#2)
of Central Nervous System##2##4##(2011-2#1)(2012-3#1)
of Central##8##2##(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
of Cephalosporium gramineum##2##3##(2008-10#2)
of Cephalosporium##3##2##(2008-10#2)(2008-6#1)
of Ceratocystis fimbriata##4##3##(2008-10#4)
of Ceratocystis resinifera##3##3##(2008-10#3)
of Ceratocystis##7##2##(2008-10#7)
of Cercospora Leaf##2##3##(2008-10#1)(2012-3#1)
of Cercospora sorghi from##2##4##(2008-10#2)
of Cercospora sorghi##3##3##(2008-10#3)
of Cercospora zeae-maydis##2##3##(2008-10#2)
of Cercospora##12##2##(2008-10#11)(2012-3#1)
of Cervical##3##2##(2012-3#1)(2013-8#2)
of ChMV##2##2##(2008-10#2)
of Chagas disease##2##3##(2008-8#1)(2012-12#1)
of Chagas' disease##2##3##(1993-6#2)
of Chagas'##3##2##(1993-6#2)(1996-3#1)
of Change##6##2##(2008-12#2)(2008-4#2)(2008-6#1)(2009-12#1)
of Chaotic Systems##2##3##(1996-12#1)(1996-9#1)
of Charcot-Marie-Tooth disease##2##3##(2012-3#1)(2013-1#1)
of Charles Bonnet##2##3##(2011-2#1)(2013-8#1)
of Charles##4##2##(1994-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
of CheY##2##2##(1993-11#2)
of Chemical##23##2##(2008-5#1)(2011-2#22)
of Chemistry##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
of Chenopodium##3##2##(2007-2#1)(2008-11#1)(2008-8#1)
of Chernobyl##4##2##(1991-11#1)(1995-11#1)(2010-4#1)(2011-1#1)
of Chest##2##2##(2008-3#1)(2011-2#1)
of Chevassu)##2##2##(2007-5#2)
of Chicago##3##2##(1990-11#1)(2008-5#1)(2013-1#1)
of Chikungunya fever##3##3##(2013-8#3)
of Chikungunya was##2##3##(2013-8#2)
of Chikungunya##5##2##(2013-8#5)
of Child Oncology and##2##4##(2008-9#2)
of Child and Adolescent Psychiatry##2##5##(2006-10#1)(2008-4#1)
of Child##12##2##(1991-3#1)(1992-8#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-4#1)(2008-9#4)(2010-3#1)(2013-1#1)
of Children's Health##3##3##(1992-3#1)(1994-3#2)
of Children's##4##2##(1992-3#1)(1994-3#2)(2011-2#1)
of Chile##6##2##(2012-2#1)(2013-1#4)(2013-8#1)
of Chilean##2##2##(2013-1#2)
of China were##2##3##(2008-10#1)(2008-9#1)
of China##30##2##(1995-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#6)(2011-2#3)(2012-3#3)(2013-8#1)
of Chinese and##2##3##(2008-10#1)(2013-8#1)
of Chinese cabbage##3##3##(2008-8#3)
of Chinese hamster ovary (CHO) cells##5##6##(2008-10#1)(2008-11#2)(2008-7#2)
of Chinese hamster ovary (CHO)##6##5##(2008-10#1)(2008-11#3)(2008-7#2)
of Chinese hamster ovary cells##5##5##(2008-11#4)(2008-7#1)
of Chinese hamster ovary##13##4##(2008-10#1)(2008-11#9)(2008-7#3)
of Chinese hamster##14##3##(1997-7#1)(2008-10#1)(2008-11#9)(2008-7#3)
of Chinese herb##2##3##(2012-3#1)(2013-1#1)
of Chinese herbal medicine##3##4##(2008-10#1)(2013-8#2)
of Chinese herbal##6##3##(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
of Chinese medicine##2##3##(2011-2#1)(2012-3#1)
of Chinese##54##2##(1993-9#1)(1994-12#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#7)(2008-11#10)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-5#2)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
of Chitinase##2##2##(2008-10#2)
of Chlamydia infection##2##3##(2008-12#1)(2010-12#1)
of Chlamydia psittaci##3##3##(1990-5#1)(1993-2#2)
of Chlamydia trachomatis and##2##4##(2007-7#2)
of Chlamydia trachomatis##9##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-9#1)(2007-7#2)(2008-12#1)(2008-9#1)(2013-1#1)
of Chlamydia##16##2##(1990-2#1)(1990-5#2)(1990-6#1)(1991-9#1)(1993-2#2)(2007-7#2)(2008-12#2)(2008-5#2)(2008-9#1)(2010-12#1)(2013-1#1)
of Chlamydomonas reinhardtii##2##3##(1993-11#1)(1995-8#1)
of Chlorella vulgaris##3##3##(2008-10#1)(2013-1#2)
of Chloroplast##2##2##(2009-5#1)(2012-3#1)
of ChromID ESBL agar##2##4##(2010-6#2)
of Chromium##2##2##(2008-10#1)(2013-1#1)
of Chronic##3##2##(2008-1#2)(2013-7#1)
of Chuuk##2##2##(2013-8#2)
of Cichorium endivia##2##3##(2013-1#2)
of Cincinnati##4##2##(1993-1#1)(1994-12#1)(2008-5#1)(2012-3#1)
of Cistanche species##3##3##(2011-2#3)
of Cistanche##4##2##(2011-2#4)
of Citrobacter freundii##3##3##(1993-11#1)(1994-9#2)
of Citrus Tristeza Virus##2##4##(2008-10#2)
of Citrus limetta##2##3##(2012-3#2)
of Citrus tristeza virus (CTV)##2##5##(2008-10#2)
of Citrus tristeza virus##5##4##(2008-10#5)
of Citrus##14##2##(2008-10#12)(2012-3#2)
of Ciwujia##2##2##(2011-2#2)
of Cl and##2##3##(2008-10#1)(2008-3#1)
of Cl##4##2##(1996-9#1)(2008-10#2)(2008-3#1)
of Cl(-)##7##2##(2008-10#5)(2009-8#1)(2012-7#1)
of Cl-##3##2##(1990-2#1)(1990-8#1)(2008-8#1)
of ClO(3)(-)-ClO(2)(-)##2##2##(2008-10#2)
of Cladosporium tenuissimum##2##3##(2008-10#2)
of Cladosporium##3##2##(2008-10#3)
of Clark##3##2##(1991-7#1)(2008-11#1)(2008-8#1)
of Class Analogy##2##3##(2008-10#2)
of Class II##2##3##(2008-11#1)(2013-1#1)
of Class Pi##2##3##(1990-2#2)
of Class##7##2##(1990-2#2)(1995-6#1)(2008-10#2)(2008-11#1)(2013-1#1)
of Clavibacter michiganensis subsp##4##4##(2008-10#4)
of Clavibacter michiganensis##5##3##(2008-10#5)
of Claviceps##2##2##(2008-10#2)
of Cleome##2##2##(2010-2#1)(2013-8#1)
of Clinical Chemistry##4##3##(1994-12#3)(2008-10#1)
of Clinical Oncology##7##3##(2008-5#1)(2008-7#3)(2010-11#1)(2011-2#1)(2013-1#1)
of Clinical Performance##2##3##(1996-12#1)(2010-7#1)
of Clinical##38##2##(1991-3#2)(1991-5#1)(1994-12#8)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#3)
of Clostridium botulinum##4##3##(1992-3#2)(1997-4#1)(2011-2#1)
of Clostridium difficile##2##3##(2007-12#1)(2011-2#1)
of Clostridium perfringens##3##3##(2010-6#1)(2011-2#2)
of Clostridium##14##2##(1991-8#2)(1992-3#2)(1997-4#1)(2007-12#2)(2008-5#1)(2010-6#1)(2011-2#4)(2013-1#1)
of CmPGIP##2##2##(2008-10#2)
of CnH##2##2##(1993-6#2)
of Cnidium monnieri fruits in different regions of China##2##9##(2008-10#2)
of Co##11##2##(2008-10#11)
of Co(2+) and Cu(2+)##2##4##(2008-10#2)
of Co(2+)##8##2##(2007-11#1)(2008-10#6)(2008-3#1)
of Co(II) and Zn(II)##4##4##(2008-10#4)
of Co(II) and##6##3##(2008-10#6)
of Co(II) determination##2##3##(2008-10#2)
of Co(II) was##2##3##(2008-10#2)
of Co(II) with##4##3##(2008-10#4)
of Co(II)##27##2##(2008-10#25)(2008-5#2)
of Co(III)##3##2##(2008-10#3)
of Co(en)(3)(3+)##3##2##(1997-7#3)
of CoA##2##2##(1990-11#1)(1995-2#1)
of CoHCF##2##2##(2008-10#2)
of CoNS##5##2##(2011-2#5)
of CoPc-modified##2##2##(2008-10#2)
of CoQ10 in##2##3##(1993-3#2)
of CoQ10##7##2##(1991-5#1)(1993-3#4)(2013-1#2)
of Cochliomyia hominivorax (Coquerel)##2##4##(2008-6#2)
of Cochlospermum##2##2##(2008-12#2)
of Coleus##2##2##(2008-11#1)(2008-5#1)
of Colletotrichum acutatum and##2##4##(2008-10#2)
of Colletotrichum acutatum on Symptomless Strawberry Leaves##2##7##(2008-10#2)
of Colletotrichum acutatum on##5##4##(2008-10#5)
of Colletotrichum acutatum were##2##4##(2008-10#2)
of Colletotrichum acutatum##15##3##(2008-10#15)
of Colletotrichum gloeosporioides##7##3##(2008-10#7)
of Colletotrichum graminicola##2##3##(2008-10#2)
of Colletotrichum lindemuthianum##4##3##(2008-10#4)
of Colletotrichum spp##6##3##(2008-10#6)
of Colletotrichum##40##2##(2008-10#40)
of Colombia##9##2##(2008-5#1)(2012-12#4)(2013-7#4)
of Colombia]##2##2##(2008-5#1)(2013-7#1)
of Colombian##5##2##(2011-2#3)(2012-12#1)(2013-1#1)
of Colonization##2##2##(2008-10#2)
of Combination##2##2##(2009-6#1)(2013-1#1)
of Combined##2##2##(2008-2#1)(2010-8#1)
of Commerce##4##2##(1994-7#1)(1996-12#1)(1997-2#1)(2008-11#1)
of Common Blight Bacteria (Xanthomonas campestris pv##2##7##(2008-10#2)
of Common##5##2##(1995-12#2)(2008-10#3)
of Community##3##2##(1995-3#1)(1995-6#1)(2009-12#1)
of Complex##2##2##(2008-10#2)
of Compound 1 in##2##4##(1990-7#2)
of Compound 1##3##3##(1990-7#3)
of Compound##4##2##(1990-7#3)(2008-10#1)
of Computerized##2##2##(2010-8#1)(2011-1#1)
of Con A##2##3##(2008-10#2)
of Con##3##2##(2008-10#2)(2008-7#1)
of Congenital##2##2##(2007-11#1)(2010-9#1)
of Conidia of##2##3##(2008-10#2)
of Connecticut##2##2##(1996-9#1)(1997-3#1)
of Continuous##3##2##(2007-8#1)(2009-9#1)(2012-3#1)
of Continuum##2##2##(1996-9#1)(2012-1#1)
of Control##2##2##(1994-2#1)(2009-10#1)
of Control)##3##2##(1994-2#3)
of Copenhagen##4##2##(1995-3#1)(1996-9#1)(2008-11#1)(2011-2#1)
of Corn##3##2##(2008-10#3)
of Cornelia de Lange syndrome##2##5##(2007-7#1)(2013-1#1)
of Corynebacterium glutamicum##4##3##(1994-6#1)(2008-7#3)
of Corynebacterium species##2##3##(2008-5#2)
of Corynebacterium##7##2##(1994-6#1)(2008-5#3)(2008-7#3)
of Cosmetic##3##2##(2007-12#1)(2008-5#2)
of Costa Rica##6##3##(2008-5#6)
of Costa Rican##2##3##(2008-5#2)
of Costa##10##2##(2008-5#10)
of Cotesia##2##2##(2008-8#1)(2010-4#1)
of Cotton##3##2##(2008-10#3)
of Cougarblight##2##2##(2008-10#2)
of Coxiella burnetii##2##3##(1995-12#1)(2007-12#1)
of CpG islands associated with##2##5##(1995-12#1)(1996-10#1)
of CpG islands##3##3##(1995-12#2)(1996-10#1)
of CpG##8##2##(1993-2#1)(1993-6#1)(1995-12#2)(1996-10#1)(2008-4#3)
of Cr##18##2##(1993-8#1)(2007-11#1)(2008-10#14)(2008-2#1)(2009-12#1)
of Cr(2)O(3) for the standard##2##5##(2008-10#2)
of Cr(2)O(3)##4##2##(2008-10#4)
of Cr(2+)##4##2##(2007-11#3)(2007-12#1)
of Cr(3+)##4##2##(2008-10#4)
of Cr(4+)##5##2##(2007-11#2)(2008-3#3)
of Cr(III) and Cr(VI) in river and reservoir water##2##9##(2008-10#2)
of Cr(III) and Cr(VI) in water samples##2##7##(2008-10#2)
of Cr(III) and Cr(VI) in water##3##6##(2008-10#3)
of Cr(III) and Cr(VI) in##7##5##(2008-10#7)
of Cr(III) and Cr(VI)##13##4##(2008-10#13)
of Cr(III) and##14##3##(2008-10#14)
of Cr(III) ions##5##3##(2008-10#5)
of Cr(III) to Cr(VI)##4##4##(2008-10#4)
of Cr(III) with##3##3##(2008-10#3)
of Cr(III)##41##2##(2008-10#41)
of Cr(III)TTHA##2##2##(2008-10#2)
of Cr(VI) and Cr(III)##4##4##(2008-10#4)
of Cr(VI) and Pb(II)##3##4##(2008-10#3)
of Cr(VI) and##8##3##(2008-10#8)
of Cr(VI) concentrations##2##3##(2008-10#2)
of Cr(VI) in the##2##4##(2008-10#2)
of Cr(VI) in##9##3##(2008-10#9)
of Cr(VI) on##2##3##(2008-10#2)
of Cr(VI) was##5##3##(2008-10#5)
of Cr(VI) with##4##3##(2008-10#4)
of Cr(VI)##49##2##(2008-10#46)(2011-2#2)(2013-1#1)
of Cr1##2##2##(2008-10#2)
of Cr2##4##2##(2008-10#4)
of CrEL##2##2##(2008-10#2)
of Crataeva nurvala##2##3##(2010-3#2)
of Cremophor EL##3##3##(2008-10#1)(2008-3#2)
of Creutzfeldt-Jakob disease##2##3##(1996-8#1)(2008-5#1)
of Creutzfeldt-Jakob##4##2##(1996-3#1)(1996-8#1)(2008-5#1)(2010-8#1)
of Crinipellis perniciosa##2##3##(2008-10#2)
of Critical Care##2##3##(2011-2#1)(2013-1#1)
of Crk and##2##3##(2012-12#2)
of Crk signaling##2##3##(2012-12#2)
of Crk##9##2##(2012-12#9)
of Croatia##6##2##(2008-10#1)(2011-2#3)(2013-1#2)
of Croatian scientists##2##3##(2013-1#2)
of Croatian##6##2##(2011-1#1)(2011-2#1)(2013-1#4)
of Crohn disease##3##3##(1993-2#1)(1997-8#2)
of Crohn's disease and##4##4##(1990-3#1)(1992-5#1)(2007-12#1)(2010-12#1)
of Crohn's disease in the##2##5##(1991-11#1)(2010-12#1)
of Crohn's disease in##3##4##(1991-11#1)(2010-12#2)
of Crohn's disease##20##3##(1990-3#2)(1991-11#1)(1992-5#1)(1994-6#2)(1997-5#1)(2007-12#1)(2008-10#1)(2010-12#8)(2012-2#1)(2013-1#1)(2013-8#1)
of Crohn's##22##2##(1990-3#2)(1991-11#1)(1992-5#1)(1994-6#2)(1997-5#1)(2007-12#1)(2008-10#2)(2010-12#9)(2012-2#1)(2013-1#1)(2013-8#1)
of Cronartium ribicola##5##3##(2008-10#5)
of Cronbach's##2##2##(2009-12#2)
of Cry2Ab##2##2##(2011-2#2)
of CryIA(b)##2##2##(2008-10#2)
of Cryphonectria parasitica##3##3##(2008-10#3)
of Cryphonectria##4##2##(2008-10#4)
of Cryptococcus neoformans var##5##4##(2008-5#5)
of Cryptococcus neoformans##11##3##(2007-10#1)(2007-7#1)(2008-5#8)(2009-2#1)
of Cryptococcus##16##2##(2007-10#2)(2007-7#1)(2008-10#2)(2008-5#10)(2009-2#1)
of Cryptosporidium in##2##3##(2013-1#2)
of Cryptosporidium##6##2##(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#3)
of CsA##9##2##(1990-12#2)(1991-9#1)(1994-8#1)(1997-2#1)(2007-7#2)(2008-6#2)
of CsLiB(6)O(10)##2##2##(2007-11#2)
of Cu and Mn##3##4##(2008-10#3)
of Cu and Pb##2##4##(2008-10#2)
of Cu and Zn##3##4##(2008-10#3)
of Cu and##13##3##(1995-3#1)(2008-10#11)(2008-12#1)
of Cu in##4##3##(1995-3#1)(2008-10#3)
of Cu on##3##3##(2008-10#2)(2008-12#1)
of Cu##67##2##(1995-3#4)(1995-6#2)(1997-4#1)(1997-8#4)(2007-11#1)(2007-12#1)(2008-10#47)(2008-11#2)(2008-12#2)(2008-5#1)(2012-2#2)
of Cu(2+) in##2##3##(2008-10#1)(2008-12#1)
of Cu(2+) ion##2##3##(2008-10#2)
of Cu(2+) ions##2##3##(2008-10#2)
of Cu(2+) with a##2##4##(2008-10#2)
of Cu(2+) with##5##3##(2008-10#5)
of Cu(2+)##22##2##(2008-10#20)(2008-12#2)
of Cu(II) and Ni(II)##3##4##(2008-10#3)
of Cu(II) and Zn(II)##2##4##(2008-10#2)
of Cu(II) and##11##3##(2008-10#9)(2008-5#1)(2013-1#1)
of Cu(II) by##3##3##(2008-10#3)
of Cu(II) from##3##3##(2008-10#3)
of Cu(II) in##8##3##(2008-10#8)
of Cu(II) ions##2##3##(2008-10#2)
of Cu(II) was##2##3##(2008-10#2)
of Cu(II) with##10##3##(2008-10#10)
of Cu(II)##61##2##(1990-8#1)(2008-10#58)(2008-5#1)(2013-1#1)
of Cu(II)/tetraglycine##2##2##(2008-10#2)
of Cu(II)L(2)##2##2##(2008-10#2)
of Cu-adenine##2##2##(2008-10#2)
of CuLCV-AZ and##2##3##(2008-10#2)
of CuSO(4) induced S2MtEGFP##2##4##(2008-11#2)
of CuSO(4)##4##2##(2008-10#1)(2008-11#3)
of CuSO₄##3##2##(2010-11#3)
of Cuba##5##2##(2008-5#3)(2013-1#2)
of Cucumber mosaic virus (CMV)##3##5##(2008-10#3)
of Cucumber mosaic virus##7##4##(2008-10#7)
of Culex quinquefasciatus##2##3##(2007-12#2)
of Cullin-5 E3 ubiquitin ligases##2##5##(2013-1#2)
of Current##4##2##(1997-3#2)(2008-9#2)
of Cushing's Syndrome (CS)##2##4##(2011-2#1)(2013-1#1)
of Cushing's syndrome##7##3##(1990-11#1)(1990-3#1)(1991-10#1)(1992-10#1)(1997-7#1)(2011-2#2)
of Cushing's##14##2##(1990-11#1)(1990-3#3)(1991-10#1)(1992-10#1)(1997-7#1)(2011-2#6)(2013-1#1)
of Cx43##4##2##(2008-11#2)(2008-6#1)(2008-8#1)
of Cydia pomonella##2##3##(2011-2#2)
of CymMV-K2##3##2##(1997-2#3)
of Cys##4##2##(1990-12#1)(1993-11#1)(2008-10#1)(2012-2#1)
of Cys/Sec replacement##2##3##(2012-2#2)
of CytPTKs##5##2##(1995-11#5)
of Cytoplasmic##2##2##(2008-10#1)(2013-8#1)
of D antigen##3##3##(1994-12#3)
of D##67##2##(1990-8#3)(1991-8#1)(1993-12#4)(1994-12#3)(1994-7#1)(1995-3#2)(1995-8#1)(2007-12#1)(2008-10#27)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#5)
of D-Ala-D-Ala##2##2##(1995-2#2)
of D-alanine into##3##3##(1995-6#3)
of D-alanine##5##2##(1991-12#1)(1995-6#4)
of D-amphetamine##6##2##(1993-12#1)(1993-6#5)
of D-dimer##4##2##(2010-3#1)(2011-2#3)
of D-glucosaminic acid##2##3##(2011-2#2)
of D-glucosaminic##3##2##(2011-2#3)
of D-positive fetal##2##3##(1994-6#2)
of D1 dopamine receptors##2##4##(1994-2#2)
of D1##3##2##(1994-2#2)(1994-3#1)
of D1R- and##2##3##(2013-8#2)
of D2##2##2##(1993-9#1)(1995-3#1)
of D29 cells##2##3##(2008-11#2)
of D4T##5##2##(1991-3#2)(2008-7#3)
of DA in##2##3##(1996-12#1)(2008-10#1)
of DA##22##2##(1992-7#3)(1995-3#1)(1996-12#9)(1997-2#2)(2008-10#3)(2008-5#1)(2008-6#2)(2013-1#1)
of DA-9601##3##2##(2008-11#3)
of DAB2IP##2##2##(2013-1#2)
of DAG##3##2##(1991-12#1)(1992-12#1)(1992-9#1)
of DAPG##2##2##(2008-10#2)
of DAPI##3##2##(1992-3#2)(2008-2#1)
of DAPI-stained##2##2##(2008-10#1)(2008-2#1)
of DAST##3##2##(2007-12#3)
of DAT##2##2##(1996-12#1)(2008-6#1)
of DB exercise##2##3##(2012-2#2)
of DBA##3##2##(2013-1#3)
of DBB neurons##2##3##(1995-12#2)
of DBP##3##2##(1990-3#3)
of DBS##2##2##(2008-1#1)(2009-8#1)
of DBTC##2##2##(2008-10#2)
of DC##11##2##(2008-10#3)(2008-11#4)(2008-4#1)(2008-9#1)(2012-2#2)
of DC-SIGNR in##2##3##(2013-7#2)
of DC-SIGNR##4##2##(2013-7#4)
of DC-based##2##2##(2008-5#1)(2012-2#1)
of DCE-MRI##2##2##(2008-8#2)
of DCPC system##2##3##(2013-8#2)
of DCs##6##2##(2008-11#2)(2010-5#2)(2011-2#1)(2012-2#1)
of DD##4##2##(2008-10#1)(2008-9#2)(2011-2#1)
of DDH##10##2##(2007-11#2)(2007-8#7)(2008-10#1)
of DDP##2##2##(1990-6#1)(1992-2#1)
of DDSP##3##2##(2008-3#1)(2011-1#2)
of DEET through##2##3##(2008-5#2)
of DEET##5##2##(1991-9#1)(2008-5#4)
of DEJ##4##2##(2008-5#3)(2010-10#1)
of DEP##3##2##(2008-10#3)
of DES##3##2##(2008-10#3)
of DETA##3##2##(2008-10#3)
of DG##3##2##(1993-8#1)(1994-3#1)(2011-1#1)
of DGPS##2##2##(2009-10#2)
of DHA##4##2##(2012-1#2)(2013-1#2)
of DHAA##2##2##(1997-2#2)
of DHEA to##2##3##(1994-6#2)
of DHEA##4##2##(1994-6#3)(2007-11#1)
of DHEAS##4##2##(1994-5#4)
of DHN1 expression and subcellular distribution in A##2##8##(2008-9#2)
of DHP##2##2##(1991-2#2)
of DHZS##2##2##(2008-10#2)
of DI RNAs##3##3##(2008-10#3)
of DI##4##2##(2007-10#1)(2008-10#3)
of DIDS##2##2##(1990-2#1)(1992-12#1)
of DIV##3##2##(2008-10#2)(2011-2#1)
of DKT##4##2##(2011-2#4)
of DKTP##2##2##(2008-10#2)
of DL-PAPG##2##2##(2008-8#2)
of DLA-EIAV and EIAV L##2##5##(2008-9#2)
of DLA-EIAV and##3##3##(2008-9#3)
of DLA-EIAV##5##2##(2008-9#5)
of DLIF##3##2##(1991-8#3)
of DM##10##2##(1991-8#1)(1995-3#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#4)
of DMA##8##2##(2008-10#8)
of DMAA##2##2##(1993-3#2)
of DMD gene##2##3##(1990-7#2)
of DMD##3##2##(1990-7#2)(1995-12#1)
of DME##6##2##(2008-1#2)(2011-7#4)
of DMF##4##2##(2008-10#4)
of DMI##3##2##(2008-10#3)
of DMSA##2##2##(1992-12#1)(1995-3#1)
of DMSO##5##2##(2008-10#5)
of DMSP##2##2##(2008-10#2)
of DMT##2##2##(2008-10#2)
of DN##2##2##(2008-1#2)
of DNA DSB##2##3##(1995-2#1)(2010-2#1)
of DNA Damage##2##3##(2009-5#1)(2011-2#1)
of DNA adduct formation##3##4##(1993-8#2)(1995-9#1)
of DNA adducts##4##3##(1993-8#1)(1994-2#1)(1994-8#1)(2008-10#1)
of DNA alkylation##2##3##(1992-11#2)
of DNA alterations##3##3##(2008-7#3)
of DNA amplification##2##3##(2008-5#1)(2013-8#1)
of DNA and RNA##7##4##(1991-4#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-9#3)
of DNA and proteins##4##4##(1991-6#2)(2008-7#2)
of DNA and the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
of DNA and##23##3##(1991-4#1)(1991-6#2)(1994-3#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-4#6)(2008-7#2)(2008-9#3)(2011-2#1)
of DNA are##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)
of DNA as##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
of DNA at the##3##4##(1994-3#1)(1995-6#1)(2008-10#1)
of DNA at##5##3##(1994-3#1)(1995-6#1)(1997-7#1)(2008-10#2)
of DNA bands##3##3##(2008-10#3)
of DNA base##2##3##(1997-6#1)(2009-6#1)
of DNA binding##6##3##(1991-5#1)(1995-2#1)(1995-8#1)(2008-4#1)(2008-7#1)(2008-9#1)
of DNA biosynthesis##3##3##(1990-2#2)(1991-4#1)
of DNA by##5##3##(1991-12#1)(1995-2#1)(2008-2#1)(2008-9#1)(2012-2#1)
of DNA content and DNA strand breaks##2##7##(2008-9#2)
of DNA content and##8##4##(1992-9#1)(2008-12#1)(2008-9#6)
of DNA content##15##3##(1992-9#1)(1997-7#1)(2008-12#1)(2008-9#12)
of DNA damage by##2##4##(1997-4#1)(2008-7#1)
of DNA damage in##12##4##(1994-5#1)(1997-4#5)(2008-11#1)(2008-4#1)(2009-5#2)(2010-2#2)
of DNA damage induced in##2##5##(1992-3#1)(1997-4#1)
of DNA damage that##2##4##(1996-12#1)(2011-2#1)
of DNA damage##36##3##(1992-3#3)(1994-5#2)(1994-8#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#8)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-5#4)(2010-2#2)(2011-2#1)(2012-12#1)(2013-1#1)
of DNA double-strand breaks##4##4##(1995-2#1)(1997-7#1)(2008-9#1)(2011-2#1)
of DNA double-strand##5##3##(1995-2#1)(1997-7#2)(2008-9#1)(2011-2#1)
of DNA during##2##3##(1994-10#1)(1995-5#1)
of DNA extracted from##3##4##(2008-10#2)(2008-12#1)
of DNA extraction##5##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#2)
of DNA fingerprints##2##3##(2008-5#2)
of DNA following##2##3##(1994-12#1)(2008-10#1)
of DNA for##3##3##(1996-6#1)(2008-1#1)(2011-1#1)
of DNA fragmentation by##2##4##(2008-1#2)
of DNA fragmentation##7##3##(1992-3#1)(1995-12#1)(1996-12#1)(2008-1#2)(2008-10#1)(2008-9#1)
of DNA fragments in##3##4##(1994-2#1)(2008-10#1)(2008-8#1)
of DNA fragments of##3##4##(1994-6#1)(2011-1#2)
of DNA fragments##14##3##(1993-2#1)(1994-2#1)(1994-6#1)(1995-2#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#2)
of DNA from a##2##4##(2008-4#1)(2008-6#1)
of DNA from##14##3##(1993-6#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2013-1#1)
of DNA hybridisation##2##3##(2008-10#2)
of DNA hybridization##6##3##(2008-10#5)(2008-4#1)
of DNA in the##2##4##(1992-3#1)(2008-7#1)
of DNA in##11##3##(1991-5#2)(1992-3#1)(1993-6#1)(1993-9#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
of DNA into the##2##4##(1995-5#1)(2008-11#1)
of DNA into##6##3##(1993-9#1)(1995-5#1)(2008-11#2)(2008-2#2)
of DNA is##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
of DNA markers##3##3##(1996-10#1)(2008-10#2)
of DNA methylation##6##3##(1995-12#1)(2007-11#1)(2008-8#1)(2009-4#1)(2013-8#2)
of DNA microarrays##6##3##(2008-4#4)(2008-7#1)(2012-3#1)
of DNA molecules##3##3##(2008-10#2)(2008-8#1)
of DNA mutations##2##3##(2008-12#1)(2008-4#1)
of DNA nanotechnology##3##3##(2008-4#2)(2008-7#1)
of DNA of##4##3##(2008-10#4)
of DNA on##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
of DNA or##2##3##(2008-10#1)(2008-7#1)
of DNA oxidative damage##2##4##(2008-10#2)
of DNA ploidy##2##3##(2008-9#2)
of DNA polymerase##2##3##(1990-7#1)(1995-4#1)
of DNA polymerases##2##3##(1992-6#2)
of DNA polymorphism##2##3##(2008-10#2)
of DNA probes##2##3##(2008-10#1)(2008-4#1)
of DNA repair##11##3##(1993-11#1)(1993-8#2)(2008-11#5)(2008-7#1)(2010-8#1)(2011-2#1)
of DNA replication at##2##4##(1990-11#1)(2009-8#1)
of DNA replication in##2##4##(2012-2#2)
of DNA replication##16##3##(1990-11#3)(1994-11#1)(1994-12#1)(1994-3#1)(1997-3#1)(2008-4#1)(2008-7#1)(2009-2#3)(2009-8#1)(2010-3#1)(2012-2#2)
of DNA sequence##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
of DNA sequences that##2##4##(1995-8#1)(2008-10#1)
of DNA sequences##11##3##(1990-3#1)(1990-5#1)(1995-8#1)(2008-10#4)(2008-4#1)(2013-8#3)
of DNA single-strand breaks##4##4##(1993-3#1)(1994-8#2)(1997-4#1)
of DNA strand breaks##3##4##(1991-12#1)(1997-4#1)(2008-9#1)
of DNA strand##6##3##(1991-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-9#1)
of DNA structure##3##3##(1992-11#1)(1994-3#1)(2008-4#1)
of DNA synthesis and##7##4##(1990-2#1)(1992-11#1)(1997-4#3)(2008-4#1)(2008-7#1)
of DNA synthesis by##3##4##(1991-12#1)(1992-3#1)(1997-7#1)
of DNA synthesis in hepatocytes##2##5##(1993-3#2)
of DNA synthesis##27##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-3#2)(1994-11#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#1)(2008-3#1)(2008-4#2)(2008-7#3)(2009-3#1)
of DNA through##2##3##(1996-6#1)(2008-4#1)
of DNA to detect##2##4##(1994-10#2)
of DNA to##4##3##(1994-10#2)(1994-3#1)(2011-2#1)
of DNA topoisomerase II##2##4##(1995-6#1)(2008-11#1)
of DNA using##3##3##(2008-10#3)
of DNA vaccines##2##3##(2008-5#1)(2013-1#1)
of DNA was##3##3##(1991-12#1)(1995-5#1)(2008-10#1)
of DNA were##3##3##(2008-10#2)(2008-9#1)
of DNA with the##2##4##(1990-5#1)(1995-3#1)
of DNA with##4##3##(1990-5#1)(1995-3#1)(1996-12#1)(2008-10#1)
of DNA##522##2##(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#5)(1990-7#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#4)(1991-8#1)(1992-11#4)(1992-3#10)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#8)(1993-9#3)(1994-10#4)(1994-11#2)(1994-12#8)(1994-2#3)(1994-3#7)(1994-5#7)(1994-6#2)(1994-8#6)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#2)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#5)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#17)(1997-6#3)(1997-7#7)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#93)(2008-11#21)(2008-12#8)(2008-2#15)(2008-3#3)(2008-4#36)(2008-5#8)(2008-6#2)(2008-7#30)(2008-8#8)(2008-9#30)(2009-1#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#7)
of DNA-A and DNA-B##2##4##(2008-10#2)
of DNA-A##3##2##(2008-10#3)
of DNA-binding proteins in##2##4##(1997-4#1)(2008-2#1)
of DNA-binding proteins##5##3##(1994-12#1)(1997-4#1)(2008-2#3)
of DNA-binding##7##2##(1990-11#1)(1994-12#1)(1997-4#1)(2008-2#3)(2008-9#1)
of DNA-dependent##3##2##(1991-9#1)(1995-2#1)(2013-1#1)
of DNA-protein##2##2##(1990-5#1)(2008-9#1)
of DNAs##3##2##(1995-2#1)(1997-5#1)(2008-10#1)
of DNB##2##2##(2008-3#2)
of DNR orders##3##3##(1992-12#1)(1992-3#2)
of DNase I##2##3##(1992-4#1)(1995-5#1)
of DO##3##2##(1994-3#1)(2008-10#2)
of DOC##2##2##(1992-9#1)(2008-4#1)
of DOE's##2##2##(2008-3#2)
of DOM-bound##3##2##(2008-11#3)
of DON##4##2##(2008-10#4)
of DOPA##4##2##(2008-5#1)(2009-9#2)(2010-2#1)
of DOPT was##2##3##(1997-2#2)
of DOT##2##2##(1996-3#2)
of DOX##5##2##(2009-11#5)
of DP##2##2##(1993-8#1)(2009-10#1)
of DPE##3##2##(2013-1#3)
of DPH##4##2##(1990-2#1)(1991-5#1)(1995-8#1)(2008-9#1)
of DPKSH##3##2##(2008-10#3)
of DPM##5##2##(2008-5#1)(2008-7#4)
of DPP-IV##3##2##(2012-2#2)(2012-3#1)
of DPPC was##2##3##(2008-8#2)
of DPPC##5##2##(1992-6#2)(2008-8#3)
of DPPH radical##2##3##(2008-10#2)
of DR and##2##3##(2008-1#1)(2008-7#1)
of DR##12##2##(1991-2#1)(2008-1#5)(2008-10#1)(2008-7#1)(2010-8#2)(2011-2#2)
of DR-ILD##3##2##(2011-2#3)
of DRG neurons##3##3##(1993-12#1)(1996-12#1)(1996-5#1)
of DRG refinement##2##3##(1992-2#2)
of DRG##9##2##(1992-2#2)(1993-12#1)(1994-12#2)(1995-8#1)(1996-12#1)(1996-5#1)(2013-1#1)
of DRGs on##2##3##(1992-12#1)(1992-3#1)
of DRGs##5##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#1)
of DS salt##8##3##(2008-5#8)
of DS##16##2##(1996-2#1)(2008-5#8)(2011-2#1)(2012-12#2)(2012-2#4)
of DSB repair and##2##4##(2013-1#2)
of DSB repair##3##3##(2011-2#1)(2013-1#2)
of DSB##7##2##(1995-2#4)(2011-2#1)(2013-1#2)
of DSBs##2##2##(1995-8#2)
of DSKNPH##5##2##(2008-10#5)
of DSP##5##2##(1997-4#1)(2008-1#3)(2010-6#1)
of DSRCT of the kidney##2##5##(2008-10#2)
of DT-diaphorase##3##2##(1995-8#3)
of DTBTA-Eu(3+)-labeled##2##2##(2008-10#2)
of DTC television##2##3##(2008-12#2)
of DTP##4##2##(1995-5#1)(2010-4#3)
of DTPA and BHT##4##4##(2008-5#4)
of DTSP##2##2##(2013-8#2)
of DVT##3##2##(1993-5#1)(2007-2#1)(2007-8#1)
of DWI##2##2##(2007-10#2)
of DXR##2##2##(1994-12#2)
of DZ##2##2##(2008-2#2)
of Dahlgren cells##3##3##(2008-7#3)
of Daily Living##8##3##(2008-7#5)(2011-2#2)(2012-2#1)
of Danish##3##2##(1990-6#1)(1995-3#1)(1997-3#1)
of Dantu District##2##3##(2012-3#2)
of Daphnia##2##2##(2008-5#1)(2008-9#1)
of Data##3##2##(1991-8#1)(1996-8#1)(2010-8#1)
of Date Palm (Phoenix##2##4##(2008-10#1)(2013-1#1)
of Date##3##2##(2008-10#2)(2013-1#1)
of Daucus glaber Forssk##2##4##(2008-11#2)
of Dc##2##2##(1996-4#2)
of Dead Sea##2##3##(2008-5#2)
of Deaf##2##2##(2011-2#2)
of December##2##2##(2007-8#1)(2012-12#1)
of Dechloromonas sp##2##3##(2013-8#2)
of Defense##6##2##(1995-6#1)(1996-12#1)(1996-5#2)(2008-10#2)
of Degenerate Primers for##2##4##(2008-10#2)
of Delaware##2##2##(2010-5#1)(2010-8#1)
of Delhi##6##2##(1994-9#3)(2007-7#2)(2008-7#1)
of Delta##2##2##(2008-10#2)
of DeltaA'-plants##2##2##(2008-10#2)
of Denmark##2##2##(1991-2#1)(1996-9#1)
of Dental Medicine##2##3##(2013-1#2)
of Dental##4##2##(2008-11#1)(2013-1#3)
of Depression##2##2##(2010-8#1)(2012-12#1)
of Dermatology##2##2##(2008-5#1)(2008-6#1)
of Desulfovibrio##3##2##(1990-8#2)(1994-5#1)
of DiYMV were##2##3##(2008-10#2)
of Diabetes in##2##3##(1995-11#1)(2009-5#1)
of Diabetes##3##2##(1995-11#1)(2009-5#1)(2010-8#1)
of Diabetic##3##2##(1995-9#1)(2007-7#1)(2013-1#1)
of Diadema antillarum##3##3##(2008-5#1)(2011-2#2)
of Diagnostic Accuracy##2##3##(2008-12#2)
of Diagnostic##10##2##(1991-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#3)(2011-1#1)
of Diaporthe phaseolorum and Phomopsis longicolla from##2##7##(2008-10#2)
of Diaporthe phaseolorum and Phomopsis longicolla##3##6##(2008-10#3)
of Diaporthe phaseolorum##4##3##(2008-10#4)
of Dictyostelium discoideum##4##3##(1991-9#1)(1993-6#1)(1995-6#1)(1997-3#1)
of Didymella rabiei##5##3##(2008-10#5)
of Didymella##6##2##(2008-10#6)
of Diesel##2##2##(2008-3#2)
of Diet in Renal Disease##3##5##(1994-3#1)(2011-2#1)(2013-1#1)
of Dietary##2##2##(2008-1#1)(2012-2#1)
of Different Genotypes of##2##4##(2008-10#2)
of Different##3##2##(2008-10#2)(2009-1#1)
of Differentially Expressed##2##3##(2008-10#1)(2010-8#1)
of Direct Fluorescent Antibody##2##4##(2007-7#2)
of Direct##3##2##(2007-7#2)(2008-2#1)
of Disease##3##2##(2008-10#2)(2013-8#1)
of Distinct##2##2##(2008-10#2)
of Ditylenchus##2##2##(1994-12#1)(2008-10#1)
of Diversity in##2##3##(2008-10#2)
of Diversity##5##2##(2008-10#5)
of DnaC##3##2##(1991-12#3)
of Dnl4##2##2##(1997-7#2)
of Docetaxel in##2##3##(2008-6#2)
of Doehlert designs##2##3##(2008-10#2)
of Doehlert##4##2##(2008-10#4)
of Doppler sonography##2##3##(1995-6#1)(2012-3#1)
of Doppler##9##2##(1990-5#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-2#2)(2011-1#1)(2012-3#2)
of Dothistroma needle blight##3##4##(2008-10#3)
of Dothistroma##4##2##(2008-10#4)
of Double##2##2##(2008-10#1)(2013-8#1)
of Double-Stranded##2##2##(2008-10#2)
of Douglas##2##2##(1994-9#1)(2007-7#1)
of Douglas-fir##2##2##(2008-10#2)
of Down's syndrome and##2##4##(1992-2#1)(1996-12#1)
of Down's syndrome##7##3##(1992-2#1)(1996-12#4)(1996-3#1)(2008-7#1)
of Down's##8##2##(1992-2#1)(1993-11#1)(1996-12#4)(1996-3#1)(2008-7#1)
of Dpp##2##2##(2012-12#2)
of Dr##10##2##(1992-11#1)(1993-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-3#1)
of Drosophila and##2##3##(1990-3#2)
of Drosophila hydei##2##3##(1993-12#2)
of Drosophila larvae##2##3##(2008-8#1)(2008-9#1)
of Drosophila melanogaster##19##3##(1990-12#1)(1991-6#1)(1993-6#1)(1995-6#1)(1996-2#2)(1997-8#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#3)(2010-1#1)
of Drosophila##53##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-5#2)(1991-6#1)(1993-12#3)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#4)(1995-8#1)(1996-2#3)(1996-6#1)(1997-7#2)(1997-8#3)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#3)(2008-9#8)(2010-1#1)(2012-12#1)(2012-3#2)
of Drug##3##2##(1991-1#2)(2010-11#1)
of Drugs##2##2##(1996-10#1)(2008-11#1)
of Dry##2##2##(1992-3#1)(2006-10#1)
of Dsk2p##2##2##(2009-7#2)
of DuP 532##2##3##(1991-5#2)
of DuP##3##2##(1991-5#2)(1991-9#1)
of Duck HBV##4##3##(2009-7#4)
of Duke's##2##2##(2012-12#1)(2012-2#1)
of Dupuytren's disease##3##3##(2008-9#3)
of Dural##2##2##(1996-9#1)(2012-3#1)
of Dutch##7##2##(1990-6#1)(2007-6#2)(2008-10#2)(2008-5#1)(2011-2#1)
of E rhusiopathiae##2##3##(2007-12#2)
of E##128##2##(1990-11#1)(1990-5#4)(1990-8#1)(1991-12#3)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#3)(1994-9#3)(1995-12#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-11#2)(2007-12#2)(2007-7#2)(2008-10#38)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
of E- and##2##3##(1995-11#1)(2007-11#1)
of E-cadherin##6##2##(1991-12#2)(2010-8#1)(2013-1#3)
of E-selectin##2##2##(1992-12#1)(1993-8#1)
of E/K42##2##2##(1993-11#2)
of E1##2##2##(1994-8#1)(2008-11#1)
of E1B-19K##2##2##(2008-11#2)
of E2 C16 alpha-hydroxylation##2##4##(1995-9#2)
of E2##12##2##(1995-12#2)(1995-9#4)(1997-6#2)(2008-10#2)(2008-11#1)(2008-9#1)
of E2F1/DP1 complex##2##3##(2012-2#2)
of E2F4 expression##3##3##(2011-2#3)
of E2F4##5##2##(2011-2#5)
of E3##2##2##(2008-4#1)(2009-10#1)
of E8##2##2##(1997-4#2)
of EA##10##2##(1995-12#2)(1995-2#1)(2008-10#1)(2008-5#2)(2011-2#2)(2012-3#2)
of EAE##5##2##(2007-11#3)(2011-2#2)
of EAP##2##2##(1995-6#2)
of EAS##2##2##(2008-3#1)(2008-8#1)
of EAT##2##2##(1992-3#1)(2009-1#1)
of EB##3##2##(2008-10#3)
of EBL##2##2##(2008-12#2)
of EBM and HTA##4##4##(2012-12#4)
of EBV##6##2##(1993-8#1)(1994-8#1)(2008-2#1)(2008-5#2)(2008-9#1)
of EC##7##2##(1990-12#1)(1994-2#3)(2008-10#1)(2012-12#1)(2012-3#1)
of ECAO##2##2##(1995-5#2)
of ECDs##3##2##(2010-1#3)
of ECG##6##2##(1995-8#2)(2008-1#1)(2010-8#3)
of ECH in##2##3##(2008-10#2)
of ECH##4##2##(2008-10#4)
of ECL##2##2##(2008-10#2)
of ECM in##3##3##(2009-10#2)(2013-8#1)
of ECM proteins and##2##4##(2012-1#2)
of ECM proteins##3##3##(2012-1#3)
of ECM##14##2##(1994-5#1)(1994-9#1)(2009-10#2)(2011-2#1)(2012-1#3)(2012-2#2)(2013-8#4)
of ECP##4##2##(1996-12#4)
of ECT##3##2##(2008-12#1)(2010-7#1)(2011-1#1)
of ECs##2##2##(2008-11#1)(2012-12#1)
of ED##13##2##(1996-12#1)(2007-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#3)
of EDF on megakaryocytic differentiation##2##5##(1991-12#2)
of EDO##2##2##(1997-8#2)
of EDRF##2##2##(1990-12#1)(1991-9#1)
of EDRF1##5##2##(2008-8#4)(2008-9#1)
of EDTA and##3##3##(2008-10#3)
of EDTA in##2##3##(2008-10#2)
of EDTA to##2##3##(1993-3#1)(2008-4#1)
of EDTA with##2##3##(2008-10#2)
of EDTA##22##2##(1990-5#1)(1993-3#1)(1994-3#1)(1995-6#4)(2008-10#14)(2008-4#1)
of EE and##2##3##(2013-1#1)(2013-8#1)
of EE##4##2##(2009-11#1)(2013-1#1)(2013-8#2)
of EEG##7##2##(1990-3#1)(1994-3#1)(2008-6#1)(2008-7#1)(2010-8#2)(2012-12#1)
of EF##2##2##(1993-9#1)(2013-1#1)
of EF-1 beta##2##3##(1993-11#2)
of EF-3##4##2##(1996-2#4)
of EG##2##2##(2008-10#2)
of EGCG was##2##3##(2008-11#2)
of EGCG##5##2##(2008-11#5)
of EGCG3''Me##3##2##(2008-11#3)
of EGF on glucose and sodium##2##6##(1994-6#2)
of EGF on##5##3##(1994-6#4)(2008-6#1)
of EGF##12##2##(1991-12#1)(1993-3#1)(1993-6#1)(1994-6#5)(2008-6#3)(2010-5#1)
of EGFR in##2##3##(2010-8#1)(2013-1#1)
of EGFR##8##2##(1993-3#1)(2008-11#1)(2010-8#2)(2012-1#2)(2012-2#1)(2013-1#1)
of EGTA to##2##3##(1991-9#1)(1994-6#1)
of EGTA##10##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-9#1)(1994-6#4)(1995-8#1)
of EH##2##2##(2008-9#1)(2011-2#1)
of EHMC##2##2##(2008-10#2)
of EHR##2##2##(2010-8#2)
of EI and##2##3##(2008-6#1)(2013-1#1)
of EIB##2##2##(2010-1#2)
of EIN##2##2##(2011-2#2)
of ELBW teenagers##3##3##(2008-11#3)
of ELISA and##2##3##(1991-12#1)(2008-11#1)
of ELISA##7##2##(1991-1#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-9#1)
of EMD 51921##2##3##(1994-12#2)
of EMD##3##2##(1994-12#2)(2006-8#1)
of EMF##3##2##(2008-12#2)(2011-2#1)
of EMG##4##2##(2010-8#1)(2012-12#3)
of EMLA##4##2##(1993-1#3)(2009-5#1)
of EMR produced by##3##4##(2008-12#3)
of EMR##7##2##(2008-12#5)(2008-4#1)(2012-3#1)
of EMS##2##2##(1996-3#1)(2008-9#1)
of ENOX2##4##2##(2009-9#4)
of ENT##3##2##(1990-5#1)(2008-8#1)(2013-8#1)
of ENX in##2##3##(2010-4#2)
of ENX##3##2##(2010-4#3)
of ENs##3##2##(2007-10#3)
of EOC##2##2##(2010-7#2)
of EP##4##2##(1993-12#1)(2008-10#3)
of EP-IPV##3##2##(1995-5#3)
of EPA##2##2##(1991-2#1)(2012-1#1)
of EPCs##3##2##(2012-12#3)
of EPO in the##2##4##(2007-7#1)(2008-11#1)
of EPO in##3##3##(2007-7#1)(2008-11#2)
of EPO##13##2##(2007-7#3)(2008-1#1)(2008-11#7)(2008-4#1)(2008-8#1)
of EPS I##3##3##(2008-10#3)
of EPS in##2##3##(2011-2#2)
of EPS##12##2##(2007-12#1)(2008-10#3)(2011-2#8)
of EPTB##5##2##(2013-8#5)
of ER and PR##3##4##(1997-7#1)(2013-8#2)
of ER and##5##3##(1991-12#1)(1993-9#1)(1997-7#1)(2013-8#2)
of ER##13##2##(1991-12#1)(1993-9#1)(1994-9#1)(1995-4#1)(1997-7#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
of ERCP in##2##3##(1991-9#1)(2013-1#1)
of ERCP##3##2##(1991-9#1)(2013-1#2)
of ERK activation##2##3##(2013-8#2)
of ERK in##2##3##(2008-4#1)(2010-12#1)
of ERK phosphorylation##2##3##(2008-4#2)
of ERK##15##2##(2008-10#1)(2008-4#5)(2008-9#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#5)
of ERK1-4##2##2##(2010-10#2)
of ERP##3##2##(2008-11#1)(2008-8#2)
of ERalpha mRNA##2##3##(2008-12#2)
of ERalpha##4##2##(2008-12#3)(2008-4#1)
of ERα##3##2##(2011-2#3)
of ES cell##5##3##(2008-11#3)(2008-9#1)(2012-2#1)
of ES cells into##2##4##(2008-9#2)
of ES cells##6##3##(2008-11#2)(2008-8#2)(2008-9#2)
of ES##18##2##(2008-11#5)(2008-8#2)(2008-9#4)(2010-8#1)(2012-2#1)(2013-1#5)
of ESA##3##2##(2008-11#2)(2008-3#1)
of ESAs##2##2##(2010-11#2)
of ESBL##2##2##(2010-6#1)(2012-2#1)
of ESM##3##2##(2008-2#1)(2008-6#2)
of ESRD in##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
of ESRD patients with ascites##2##5##(2007-12#2)
of ESRD patients##5##3##(1996-2#1)(2007-12#2)(2007-7#1)(2008-1#1)
of ESRD were##2##3##(2007-7#1)(2008-4#1)
of ESRD##20##2##(1991-3#1)(1996-2#1)(2007-12#2)(2007-7#9)(2008-1#4)(2008-4#3)
of EST##2##2##(2008-11#1)(2008-7#1)
of ESTs and##2##3##(2008-4#1)(2010-10#1)
of ESTs##3##2##(2008-4#1)(2010-10#1)(2010-4#1)
of ESWL##2##2##(1994-5#1)(2007-7#1)
of ET in##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
of ET##12##2##(2008-10#4)(2008-7#4)(2012-3#3)(2013-1#1)
of ET-1 and##3##3##(1994-11#1)(2008-4#2)
of ET-1##13##2##(1993-3#5)(1994-11#2)(1994-8#4)(2008-4#2)
of ETAAS##3##2##(2008-10#3)
of ETB1 and ETB2 receptors##2##5##(1994-11#2)
of ETOH##2##2##(1990-5#2)
of ETT stabilisation##2##3##(2007-11#2)
of EU##3##2##(2008-10#1)(2008-11#2)
of EUS in##2##3##(2008-2#2)
of EUS##3##2##(2008-2#2)(2013-1#1)
of EUSES##5##2##(2008-11#5)
of EUV##2##2##(2008-3#2)
of EV71 RdRp (3D(pol))##2##4##(2011-1#2)
of EV71##5##2##(2008-12#1)(2008-8#1)(2011-1#3)
of EVAR##2##2##(2010-12#2)
of Ea153N on##2##3##(2008-10#2)
of Ea153N##3##2##(2008-10#3)
of Early##7##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
of Earth##2##2##(2008-3#1)(2012-1#1)
of Earth's##2##2##(1995-3#1)(2008-12#1)
of East Asia##2##3##(2008-8#1)(2010-3#1)
of East Asian##2##3##(2008-5#1)(2010-8#1)
of East Coast##2##3##(2010-1#2)
of East##9##2##(1997-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-1#2)(2010-3#1)(2010-8#1)
of Eastern##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
of Echinacea angustifolia##2##3##(2006-11#2)
of Echinococcus multilocularis DNA##2##4##(1996-12#2)
of Echinococcus##3##2##(1996-12#2)(2011-2#1)
of EcoRI##3##2##(1990-7#2)(1991-9#1)
of Economic##2##2##(1997-2#1)(2009-10#1)
of Edinburgh##3##2##(1997-8#1)(2008-10#1)(2010-12#1)
of Edmonton##3##2##(1994-1#2)(2008-10#1)
of Education##7##2##(1991-12#4)(1992-3#1)(2008-11#1)(2008-6#1)
of Egr-1##2##2##(1994-11#1)(2012-2#1)
of Egypt##4##2##(2010-4#1)(2011-2#1)(2013-1#2)
of Egyptian nursing home residents towards staying in a nursing home##2##11##(2010-10#2)
of Egyptian##3##2##(2008-10#1)(2010-10#2)
of Eh252 or 10##2##4##(2008-10#2)
of Eh252##4##2##(2008-10#4)
of Ehlers-Danlos syndrome##2##3##(2013-8#2)
of El##2##2##(2008-10#1)(2012-12#1)
of Electronic Health Records##2##4##(2010-8#2)
of Electronic Health##3##3##(2010-8#3)
of Elymus##2##2##(2008-5#2)
of Embelia ribes##2##3##(2012-2#2)
of Embelia##4##2##(2012-2#4)
of Emergency##2##2##(2008-3#1)(2009-4#1)
of Empathy and##2##3##(2008-11#1)(2013-1#1)
of Emperor##2##2##(2007-10#1)(2008-11#1)
of Energy##7##2##(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#2)
of England##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
of English##4##2##(2008-11#1)(2008-4#1)(2009-5#1)(2013-8#1)
of Enrolled##2##2##(2007-10#1)(2008-12#1)
of Entamoeba histolytica##2##3##(1991-7#1)(2009-10#1)
of Enterobacter cloacae##4##3##(1992-6#2)(2008-9#1)(2011-2#1)
of Enterobacteriaceae##3##2##(1997-5#1)(2008-5#1)(2010-4#1)
of Enterovirus##3##2##(2008-8#2)(2012-2#1)
of Entry##2##2##(2008-10#1)(2009-5#1)
of Environmental Factors##2##3##(2008-10#2)
of Environmental Health##3##3##(2008-1#1)(2008-9#2)
of Environmental##12##2##(1991-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-9#2)
of Epinephelus coioides##2##3##(2008-12#2)
of Epistylis##3##2##(2008-9#3)
of Epo##3##2##(2008-11#3)
of Epstein-Barr Virus##2##3##(1993-9#1)(2008-4#1)
of Epstein-Barr virus (EBV)##2##4##(1992-12#1)(1994-8#1)
of Epstein-Barr virus type 1##2##5##(2008-12#2)
of Epstein-Barr virus##6##3##(1992-12#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-12#2)
of Epstein-Barr##9##2##(1992-12#1)(1993-9#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-12#2)(2008-4#1)(2010-6#1)
of Equisetum arvense##3##3##(2008-12#3)
of Er##5##2##(1990-5#2)(1991-9#1)(2008-2#1)(2008-3#1)
of Er(3+)##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of ErbB-2 protein and##2##4##(1994-7#2)
of ErbB-2 protein##3##3##(1994-7#3)
of ErbB-2##4##2##(1994-7#4)
of Ergotamine Tartrate##2##3##(2008-10#2)
of Erwinia amylovora on##2##4##(2008-10#2)
of Erwinia amylovora was##3##4##(2008-10#3)
of Erwinia amylovora with##2##4##(2008-10#2)
of Erwinia amylovora##14##3##(2008-10#14)
of Erwinia##18##2##(1990-5#1)(1991-9#1)(1993-8#1)(2008-10#15)
of Erysiphe necator in##2##4##(2008-10#2)
of Erythrophleum africanum##2##3##(2008-12#2)
of Escherichia coli K-12##5##4##(1991-11#1)(1996-12#2)(2008-10#1)(2008-7#1)
of Escherichia coli K12##3##4##(1990-5#1)(2008-7#2)
of Escherichia coli and##2##4##(1994-8#1)(1997-4#1)
of Escherichia coli aspartate aminotransferase##2##5##(1992-6#2)
of Escherichia coli aspartate##4##4##(1992-6#2)(1995-6#2)
of Escherichia coli is##6##4##(1990-8#2)(1991-12#1)(1992-12#1)(1994-12#1)(1995-2#1)
of Escherichia coli strains##2##4##(1993-9#1)(2008-7#1)
of Escherichia coli sulfite reductase##2##5##(1990-5#1)(1993-8#1)
of Escherichia coli to##4##4##(1990-5#1)(1994-6#1)(1997-3#1)(2010-8#1)
of Escherichia coli was determined##2##5##(1991-9#1)(2008-10#1)
of Escherichia coli was##5##4##(1991-5#1)(1991-9#1)(1995-8#1)(2008-10#1)(2008-8#1)
of Escherichia coli were##3##4##(1994-12#1)(1995-11#1)(1996-12#1)
of Escherichia coli##95##3##(1990-11#7)(1990-5#5)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-12#2)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#2)(1996-12#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#9)(2008-8#2)(2009-6#1)(2010-8#2)(2011-1#3)(2012-3#1)
of Escherichia coliform (E##2##4##(2008-10#2)
of Escherichia coliform##3##3##(2008-10#3)
of Escherichia##99##2##(1990-11#7)(1990-5#5)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-12#2)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#2)(1996-12#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-7#9)(2008-8#2)(2009-6#1)(2010-8#2)(2011-1#3)(2012-3#1)
of Espeletia grandiflora (Asteraceae)##2##4##(2013-7#2)
of Essential Oil##2##3##(2007-1#1)(2010-5#1)
of Essential##3##2##(2007-1#1)(2008-3#1)(2010-5#1)
of EtOH on##2##3##(1996-5#1)(2008-8#1)
of EtOH##8##2##(1996-5#1)(2008-10#2)(2008-8#5)
of Ethanolic Extract of##3##4##(2008-10#2)(2011-1#1)
of Ethiopia##2##2##(2008-8#1)(2011-2#1)
of Ethylene Production##2##3##(2008-10#2)
of Eu##4##2##(2008-10#4)
of Eu(3+) to Eu(2+)##2##4##(2007-12#2)
of Eu(3+)##7##2##(2007-11#1)(2007-12#5)(2008-10#1)
of Eu(III)##4##2##(2008-10#4)
of Eucalyptus##6##2##(2008-10#2)(2008-5#2)(2009-12#1)(2010-3#1)
of Eucosma notanthes Meyrick##2##4##(2008-10#2)
of Eugenia##3##2##(2008-10#1)(2010-2#2)
of Eulaema helvola Moure##2##4##(2008-6#2)
of Euphorbia##7##2##(2011-1#5)(2013-1#2)
of Europe and North America##3##5##(2008-10#1)(2009-5#1)(2012-2#1)
of Europe and##6##3##(1997-6#1)(2007-2#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
of Europe##10##2##(1994-2#1)(1997-6#1)(2007-2#1)(2008-10#1)(2009-5#1)(2011-2#2)(2012-2#2)(2013-8#1)
of European American##2##3##(2008-12#1)(2011-2#1)
of European and##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
of European species##2##3##(2008-8#2)
of European##26##2##(1991-4#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-7#1)
of Eutypa dieback##3##3##(2008-10#3)
of Eutypa lata and Eutypella vitis in##2##7##(2008-10#2)
of Eutypa##10##2##(2008-10#10)
of Evaluation of##2##3##(1997-3#1)(2012-12#1)
of Everyday##2##2##(2008-12#1)(2012-3#1)
of Ewing's sarcoma in##2##4##(2008-6#2)
of Ewing's sarcoma##3##3##(2008-6#3)
of Experimental##4##2##(1991-6#1)(2009-8#2)(2012-2#1)
of Expresso##4##2##(2008-7#4)
of Expt##2##2##(1992-12#1)(1993-6#1)
of Extracellular##2##2##(2008-10#1)(2013-8#1)
of F##112##2##(1997-6#1)(1997-7#1)(2008-10#101)(2008-12#3)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
of F(-)##3##2##(2008-10#3)
of F(0) was##2##3##(2008-8#2)
of F(0)##5##2##(2008-8#5)
of F(1)##5##2##(2008-10#4)(2008-9#1)
of F(2)##3##2##(2008-10#3)
of F(3) families##2##3##(2008-10#2)
of F(3)##3##2##(2008-10#3)
of F-actin##14##2##(1991-5#1)(1993-8#4)(1994-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-10#1)(2012-2#1)
of F1##7##2##(1992-6#2)(2008-11#3)(2011-2#2)
of F1-ATPase##2##2##(1990-2#2)
of F113##2##2##(2008-10#2)
of F18 FDG PET/CT in##2##5##(2012-12#2)
of F344 rats##3##3##(1992-3#1)(1992-9#1)(2008-7#1)
of F3TdR##3##2##(1994-8#3)
of F9 cells##2##3##(1992-9#2)
of FA##9##2##(2008-10#2)(2008-4#2)(2008-5#1)(2013-1#2)(2013-8#2)
of FAD##5##2##(1992-1#1)(1996-8#2)(2010-2#2)
of FAE##2##2##(2011-1#1)(2013-1#1)
of FAs##4##2##(2008-10#3)(2013-1#1)
of FB##3##2##(1995-3#1)(2012-2#2)
of FB(1)##3##2##(2008-10#3)
of FBA/NE-ISG was##2##3##(2011-3#2)
of FBA/NE-ISG##3##2##(2011-3#3)
of FBS##7##2##(1992-11#1)(1994-2#1)(2007-11#3)(2008-11#2)
of FCC##2##2##(1991-1#1)(1991-12#1)
of FDH##2##2##(2008-7#1)(2011-2#1)
of FDP##4##2##(2008-10#4)
of FEP Teflon##2##3##(2010-4#2)
of FF##6##2##(2008-12#4)(2013-8#2)
of FFA in##2##3##(2008-10#1)(2008-6#1)
of FFA##3##2##(2008-10#2)(2008-6#1)
of FFS##2##2##(1993-12#1)(1997-2#1)
of FGD cases##2##3##(2011-1#2)
of FGF receptor##2##3##(1997-1#1)(1997-7#1)
of FGF##3##2##(1997-1#1)(1997-7#1)(2012-12#1)
of FGF-2##5##2##(1997-4#3)(2008-11#2)
of FGFR mutations##2##3##(2007-12#2)
of FGFR##5##2##(1997-1#1)(2007-12#3)(2013-1#1)
of FGT removal##3##3##(2007-10#3)
of FHB and GER##3##4##(2008-10#3)
of FHB resistance##2##3##(2008-10#2)
of FHB##10##2##(2008-10#8)(2011-10#2)
of FHL3##2##2##(2012-3#2)
of FIA systems##2##3##(2008-10#2)
of FIA##12##2##(2008-10#12)
of FITC-labeled##2##2##(2008-10#2)
of FIX protein##3##3##(1995-2#3)
of FK506##2##2##(1990-9#1)(1993-11#1)
of FL##3##2##(2010-11#3)
of FLHCC##3##2##(2010-3#3)
of FLIP##4##2##(2009-9#3)(2011-2#1)
of FLLs##2##2##(2010-12#2)
of FLT3 gene##2##3##(2011-2#2)
of FM patients##2##3##(2009-11#1)(2010-12#1)
of FMD virus##2##3##(2009-2#2)
of FMD##4##2##(2009-2#3)(2011-2#1)
of FMH##2##2##(1994-6#1)(2011-2#1)
of FMOC##2##2##(2008-10#2)
of FMR1##3##2##(2009-5#2)(2012-1#1)
of FMRFamide##4##2##(1991-1#1)(1991-2#3)
of FMS##2##2##(2011-2#2)
of FN##9##2##(1994-11#3)(1994-9#1)(2008-7#3)(2012-2#2)
of FNAB##4##2##(2008-10#2)(2008-6#1)(2011-1#1)
of FNAC##2##2##(1990-6#1)(2013-8#1)
of FP-IX##3##2##(1994-8#3)
of FPs##3##2##(2008-10#1)(2008-6#2)
of FRE##4##2##(2008-10#4)
of FRET##2##2##(2008-9#1)(2009-8#1)
of FRM2##2##2##(1996-3#2)
of FS##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
of FSA##2##2##(1995-12#1)(2012-1#1)
of FSGS##2##2##(2008-1#2)
of FSH##8##2##(1993-11#3)(1995-11#2)(2011-2#2)(2012-12#1)
of FT##2##2##(1994-7#1)(2013-1#1)
of FT-IR##2##2##(2008-10#2)
of FTD##8##2##(2008-4#1)(2008-6#1)(2008-9#6)
of FTIR##2##2##(2007-12#1)(2008-10#1)
of FU##2##2##(1992-8#1)(1995-3#1)
of FZ##4##2##(2006-4#2)(2008-10#2)
of Fabry-Perot etalons##2##3##(2008-3#2)
of Fabry-Perot##4##2##(2008-2#1)(2008-3#3)
of Facial##2##2##(2010-1#1)(2012-12#1)
of Fallot##6##2##(1997-3#2)(2007-8#1)(2009-10#1)(2012-3#2)
of Family and Community##2##4##(1993-5#1)(1994-2#1)
of Family and##3##3##(1993-5#1)(1994-2#1)(2013-1#1)
of Family##14##2##(1991-1#1)(1992-1#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-7#1)(1996-8#1)(1997-8#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
of Fas expression##2##3##(2010-3#2)
of Fas##4##2##(2008-8#2)(2010-3#2)
of Fas/FasL##2##2##(2008-9#1)(2010-3#1)
of Fasciola eggs##2##3##(1996-12#2)
of Fasciola##5##2##(1996-12#3)(2009-8#1)(2012-2#1)
of Fatty Acids##2##3##(2008-10#1)(2009-8#1)
of Fatty##4##2##(2008-10#2)(2009-8#1)(2010-3#1)
of Fc receptor-mediated phagocytosis in##2##5##(1993-6#1)(1994-6#1)
of Fc##5##2##(1993-6#1)(1994-6#2)(1995-3#1)(2008-4#1)
of Fc-fusion##2##2##(2012-2#2)
of Fcgamma##2##2##(2008-10#1)(2008-8#1)
of Fe and Ni##3##4##(2008-10#3)
of Fe and##7##3##(2008-10#6)(2013-8#1)
of Fe in##2##3##(2008-10#2)
of Fe##29##2##(1995-3#1)(1996-2#2)(2008-10#22)(2008-12#1)(2010-11#2)(2013-8#1)
of Fe(3+) in##3##3##(2008-10#3)
of Fe(3+) using##2##3##(2008-10#2)
of Fe(3+)##10##2##(2008-10#9)(2010-11#1)
of Fe(II) and Fe(III) with##2##5##(2008-10#2)
of Fe(II) and Fe(III)##10##4##(2008-10#10)
of Fe(II) and total-Fe##2##4##(2008-10#2)
of Fe(II) and##12##3##(2008-10#12)
of Fe(II) to##2##3##(2008-10#2)
of Fe(II) uptake##3##3##(1996-2#3)
of Fe(II) with##2##3##(2008-10#2)
of Fe(II)##37##2##(1996-2#5)(2008-10#31)(2008-5#1)
of Fe(III) and Fe(II)##7##4##(2008-10#7)
of Fe(III) and##10##3##(2008-10#10)
of Fe(III) in##5##3##(2008-10#5)
of Fe(III) to Fe(II)##3##4##(1995-6#1)(2008-10#2)
of Fe(III)##36##2##(1995-6#1)(1997-7#1)(2008-10#34)
of Fe-SOD and Mn-SOD##2##4##(1990-11#2)
of FeNO##2##2##(2012-1#2)
of FeS at##2##3##(1995-6#2)
of FeS##4##2##(1995-6#3)(2008-10#1)
of FeSO(4)##3##2##(2008-11#2)(2008-7#1)
of February##2##2##(2010-3#1)(2013-7#1)
of Federal##7##2##(1994-1#2)(1995-12#1)(1996-1#1)(1996-3#3)
of Fiber##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of Ficus bengalensis Linn##2##4##(2011-1#2)
of Ficus##4##2##(2008-10#1)(2008-5#1)(2011-1#2)
of Fiji##2##2##(2008-1#2)
of Finnish##2##2##(1996-3#1)(2011-1#1)
of Finnmark##2##2##(1993-11#1)(1993-6#1)
of Fis##2##2##(2008-7#2)
of Fischer 344 rats##2##4##(1992-12#1)(2008-3#1)
of Fischer carbene complexes with conjugated enediynes##2##7##(2009-10#2)
of Fischer##4##2##(1992-12#1)(2008-3#1)(2009-10#2)
of Fitness for Practice##2##4##(2008-11#2)
of Flame x##2##3##(2008-10#2)
of Flavescence dorée phytoplasma##2##4##(2008-10#2)
of Flavobacterium##2##2##(1993-11#1)(2008-9#1)
of Florence##7##2##(1991-5#1)(1991-6#2)(1992-2#1)(1994-9#1)(2008-5#1)(2011-2#1)
of Florida##5##2##(1991-3#1)(1992-1#2)(2008-10#2)
of Flow##2##2##(2008-10#2)
of Fo-B2##4##2##(2008-10#4)
of Fo47##4##2##(2008-10#4)
of Forensic Medicine##4##3##(1995-3#2)(1997-8#2)
of Forensic##7##2##(1995-3#2)(1995-6#1)(1997-8#2)(2008-12#1)(2011-2#1)
of Fos##4##2##(1993-12#2)(1996-12#2)
of Fos-LI##3##2##(1994-2#3)
of Fos-ir neurons##2##3##(1993-12#2)
of Fos-like immunoreactivity##2##3##(1993-12#1)(1997-2#1)
of Fos-like##4##2##(1993-12#1)(1997-2#3)
of Fot1##2##2##(2008-10#2)
of Four##3##2##(2008-10#2)(2012-12#1)
of Fourier transform infrared spectrometry##2##5##(2008-10#2)
of Fourier transform##3##3##(2008-10#2)(2008-3#1)
of Fourier##10##2##(1993-3#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#2)(2012-1#1)
of Framesearch##2##2##(2008-9#2)
of France##6##2##(1992-2#1)(2008-10#4)(2010-1#1)
of Frank##2##2##(1996-3#1)(2008-8#1)
of Frankliniella fusca##2##3##(2008-10#2)
of Free##2##2##(1996-2#1)(2009-9#1)
of French##5##2##(1996-11#1)(1997-5#1)(2008-10#2)(2011-2#1)
of Fresnel##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
of Freund's##2##2##(1996-12#1)(1997-2#1)
of Friend virus##2##3##(1994-8#2)
of Friend##3##2##(1993-8#1)(1994-8#2)
of Functional##4##2##(2007-11#2)(2011-2#2)
of Functioning##6##2##(1991-2#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
of Fungal##4##2##(2008-10#4)
of Fungi##3##2##(2008-10#2)(2010-6#1)
of Fungicides##2##2##(2008-10#2)
of Fusarium Wilt in##2##4##(2008-10#2)
of Fusarium Wilt of Chickpea##2##5##(2008-10#2)
of Fusarium Wilt of Tomato by Nonpathogenic Fusarium##3##8##(2008-10#3)
of Fusarium Wilt of##7##4##(2008-10#7)
of Fusarium Wilt##10##3##(2008-10#10)
of Fusarium crown and root rot of##3##7##(2008-10#3)
of Fusarium culmorum##3##3##(2008-10#3)
of Fusarium graminearum##5##3##(2008-10#5)
of Fusarium head blight (FHB)##3##5##(2008-10#3)
of Fusarium head blight of wheat##2##6##(2008-10#2)
of Fusarium head blight##7##4##(2008-10#7)
of Fusarium moniliforme##2##3##(2008-10#2)
of Fusarium oxysporum and##2##4##(2008-10#2)
of Fusarium oxysporum f##34##4##(2008-10#34)
of Fusarium oxysporum in##2##4##(1997-4#1)(2008-10#1)
of Fusarium oxysporum##47##3##(1997-4#1)(2008-10#46)
of Fusarium solani f##6##4##(2008-10#6)
of Fusarium solani##7##3##(2008-10#6)(2008-7#1)
of Fusarium spp##10##3##(1997-6#1)(2008-10#9)
of Fusarium verticillioides in##2##4##(2008-10#1)(2008-12#1)
of Fusarium verticillioides##3##3##(2008-10#2)(2008-12#1)
of Fusarium were##3##3##(2008-10#3)
of Fusarium wilt epidemics##4##4##(2008-10#4)
of Fusarium wilt in##2##4##(2008-10#2)
of Fusarium wilt of chickpea##2##5##(2008-10#2)
of Fusarium wilt of flax##3##5##(2008-10#3)
of Fusarium wilt of##8##4##(2008-10#8)
of Fusarium wilt was##2##4##(2008-10#2)
of Fusarium wilt##24##3##(2008-10#24)
of Fusarium##139##2##(1997-4#1)(1997-6#3)(2008-10#131)(2008-12#1)(2008-5#2)(2008-7#1)
of G alpha subunits##2##4##(1995-6#2)
of G alpha##4##3##(1991-2#1)(1993-3#1)(1995-6#2)
of G and K##2##4##(1996-4#2)
of G protein and cGMP on phytochrome-mediated amaranthin##2##8##(2008-4#2)
of G protein##5##3##(1995-11#1)(2008-4#2)(2008-9#2)
of G protein-coupled receptors##3##4##(1991-9#1)(1994-12#1)(2008-4#1)
of G proteins in##6##4##(1991-9#2)(1993-3#1)(1994-6#1)(2008-7#1)(2008-9#1)
of G proteins##9##3##(1991-9#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
of G##84##2##(1991-2#1)(1991-9#3)(1993-3#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-6#3)(1996-4#2)(1997-7#1)(2008-10#42)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of G(o alpha)##2##3##(1992-9#2)
of G(o)alpha GDP##2##3##(2008-9#2)
of G(o)alpha##5##2##(2008-9#5)
of G-CSF##4##2##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
of G-LDL##2##2##(1991-5#2)
of G-actin##6##2##(1992-4#5)(2011-2#1)
of G-protein coupled receptors##3##4##(1992-12#1)(1997-1#1)(2008-11#1)
of G-protein coupled##4##3##(1992-12#1)(1996-2#1)(1997-1#1)(2008-11#1)
of G-protein##6##2##(1992-12#1)(1992-3#1)(1996-2#1)(1997-1#1)(2008-11#1)(2012-2#1)
of G-protein-coupled receptors##2##3##(1996-2#1)(2008-4#1)
of G-proteins##3##2##(1991-5#1)(1993-3#1)(2008-8#1)
of G1 cyclins##2##3##(2008-7#1)(2012-12#1)
of G1##6##2##(1991-5#1)(1991-9#1)(1994-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
of G3OH can bind##2##4##(1990-9#2)
of G4##2##2##(1991-7#2)
of G418##5##2##(1995-2#1)(2008-11#4)
of G6PD deficiency in##2##4##(2007-12#1)(2013-8#1)
of G6PD deficiency##3##3##(1991-2#1)(2007-12#1)(2013-8#1)
of GA##2##2##(1992-11#1)(2008-9#1)
of GA12##2##2##(1994-8#2)
of GABA rho 1 receptors##2##5##(1995-5#2)
of GABA##14##2##(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-5#3)(2008-11#1)(2008-7#2)(2008-8#1)
of GABA(A) receptors##2##3##(2008-8#2)
of GABA(A)##3##2##(2008-8#2)(2011-2#1)
of GABA- and##2##3##(1994-2#2)
of GABAA receptors##3##3##(1995-12#2)(1997-2#1)
of GABAA##4##2##(1995-11#1)(1995-12#2)(1997-2#1)
of GABAB receptors##2##3##(1993-12#1)(2013-8#1)
of GABAergic transmission in##2##4##(1990-5#1)(1993-12#1)
of GABAergic##5##2##(1990-5#1)(1993-12#2)(2009-8#1)(2011-2#1)
of GAD activity##2##3##(1996-5#2)
of GAD67##2##2##(1996-12#2)
of GAI##3##2##(2008-6#3)
of GAP##7##2##(1991-5#2)(1992-8#1)(2013-1#4)
of GAP-43 mRNA in##2##4##(1995-12#2)
of GAP-43##10##2##(1994-2#2)(1995-12#2)(1995-5#2)(2008-7#1)(2008-9#3)
of GAP1##2##2##(1990-5#2)
of GAPDH##5##2##(1990-7#1)(1994-5#3)(2009-10#1)
of GB stones##2##3##(2013-8#2)
of GB##4##2##(2008-10#1)(2013-8#3)
of GBM cells##2##3##(2011-2#2)
of GBM##4##2##(2011-2#3)(2012-2#1)
of GBP for immobilizing the antibody on the sensor chip##2##10##(2008-10#2)
of GBP##4##2##(1992-6#2)(2008-10#2)
of GC neurons##3##3##(2008-11#3)
of GC##11##2##(1991-9#1)(1997-1#1)(2008-10#5)(2008-11#3)(2009-8#1)
of GC-MS##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
of GC-rich##2##2##(1997-6#1)(2012-3#1)
of GC7##3##2##(1997-1#3)
of GCC in##2##3##(2009-9#2)
of GCC##3##2##(2009-9#3)
of GCG in##2##3##(2013-1#2)
of GCP##2##2##(1991-3#2)
of GCY##3##2##(1990-5#3)
of GCs on##2##3##(2008-11#1)(2008-7#1)
of GCs##6##2##(2008-11#3)(2008-7#3)
of GD and##2##3##(2013-8#2)
of GD##4##2##(2013-8#4)
of GDH##3##2##(1993-9#1)(2008-4#1)(2008-8#1)
of GDM was##2##3##(2011-2#2)
of GDM##11##2##(2008-1#4)(2009-3#4)(2011-2#3)
of GDP##8##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-11#1)(1995-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
of GDP/GTP exchange##2##3##(1995-6#1)(2008-9#1)
of GDP/GTP##3##2##(1995-2#1)(1995-6#1)(2008-9#1)
of GE##2##2##(1990-2#2)
of GEPR##2##2##(1996-12#2)
of GFAP mRNA##2##3##(1995-12#1)(1997-3#1)
of GFAP##4##2##(1995-12#2)(1997-2#1)(1997-3#1)
of GFAP+ astrocytes##3##3##(1996-5#3)
of GFAP-positive##2##2##(2007-10#1)(2008-7#1)
of GFLV RNA-2 in##2##4##(2008-10#2)
of GFLV##3##2##(2008-10#3)
of GFP as a##2##4##(1996-6#1)(2008-4#1)
of GFP fluorescence##2##3##(2008-11#1)(2008-9#1)
of GFP##19##2##(1996-6#3)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2011-3#1)
of GGT##2##2##(1995-12#2)
of GH and IGF-I##4##4##(2010-5#2)(2012-3#2)
of GH and##6##3##(2008-1#1)(2010-5#2)(2012-1#1)(2012-3#2)
of GH in##3##3##(1993-3#1)(1997-8#1)(2008-1#1)
of GH replacement in the GH-deficient adult##2##7##(1997-8#2)
of GH replacement##4##3##(1996-11#1)(1997-8#2)(2008-4#1)
of GH secretion##2##3##(1997-2#1)(2007-7#1)
of GH##32##2##(1991-12#1)(1993-3#1)(1993-6#2)(1994-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#3)(2007-7#1)(2008-1#4)(2008-3#1)(2008-4#3)(2010-2#1)(2010-5#4)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)
of GHD##2##2##(2012-3#2)
of GHR##5##2##(2008-9#2)(2010-5#2)(2012-1#1)
of GHR1##3##2##(1995-8#2)(2010-5#1)
of GI and GII norovirus##2##5##(2013-8#2)
of GI events##2##3##(2008-11#2)
of GI##8##2##(2008-11#3)(2011-2#2)(2012-12#1)(2013-8#2)
of GIP##4##2##(1995-11#1)(1997-4#3)
of GIP(1-42)##2##2##(1997-4#2)
of GIS##2##2##(2007-5#1)(2008-8#1)
of GIS-derived and meteorological predictors##2##5##(2009-7#2)
of GIST##5##2##(2008-6#2)(2012-12#1)(2012-3#2)
of GLA in##2##3##(2008-7#2)
of GLA##3##2##(1997-2#1)(2008-7#2)
of GLC7##2##2##(1995-6#2)
of GLG6##2##2##(1990-12#2)
of GLP-1##3##2##(1995-8#1)(1996-2#1)(2010-11#1)
of GLS##2##2##(2008-10#2)
of GLUT##2##2##(1994-2#2)
of GLUT-2##2##2##(1993-6#2)
of GLUT1##2##2##(1991-9#1)(1993-6#1)
of GLUT4##3##2##(1994-8#2)(2008-11#1)
of GLY and AMPA were##2##5##(2011-1#2)
of GLY and AMPA##4##4##(2011-1#4)
of GM##2##2##(2009-7#1)(2011-2#1)
of GM-CSF versus placebo or##2##5##(2008-7#2)
of GM-CSF##7##2##(1991-8#1)(1992-3#1)(2008-7#3)(2008-8#2)
of GM1 ganglioside##2##3##(1993-3#1)(2012-3#1)
of GM1##6##2##(1993-3#2)(1995-12#1)(2012-3#3)
of GM3##2##2##(1990-8#2)
of GMP-140##3##2##(1991-12#2)(1992-3#1)
of GN##3##2##(1997-8#1)(2008-1#2)
of GNPs##2##2##(1991-1#2)
of GO##6##2##(2008-7#4)(2012-2#2)
of GOX in##2##3##(2008-10#2)
of GOx##2##2##(2008-10#2)
of GP##2##2##(2008-10#1)(2013-1#1)
of GPI##3##2##(1990-8#1)(1995-2#2)
of GPI-anchored##2##2##(2008-11#2)
of GPIIb##2##2##(1991-8#2)
of GPIIb/IIIa##2##2##(1997-7#1)(2008-5#1)
of GPNMB##3##2##(2009-4#3)
of GPS 5##2##3##(2008-10#2)
of GPs##6##2##(2007-2#5)(2008-7#1)
of GR##3##2##(2008-11#1)(2011-2#2)
of GRNX were##2##3##(2011-2#2)
of GRP##2##2##(1992-6#1)(2008-9#1)
of GRV##3##2##(2008-10#3)
of GSG1##2##2##(1995-9#2)
of GSH depletion##2##3##(2008-7#2)
of GSH in##5##3##(2008-10#4)(2008-7#1)
of GSH##22##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-2#1)(2008-10#10)(2008-7#5)(2013-1#1)
of GSM##3##2##(2008-9#1)(2009-6#2)
of GST P##2##3##(1990-2#2)
of GST mu##2##3##(1997-7#2)
of GST##9##2##(1990-2#2)(1994-2#1)(1995-6#1)(1997-7#3)(2008-12#1)(2013-7#1)
of GST-P##2##2##(1992-3#1)(1992-6#1)
of GST-P-positive lesions##2##3##(2008-4#2)
of GTH-II##5##2##(1994-8#2)(2008-5#3)
of GTN##2##2##(1995-11#1)(2009-5#1)
of GTP and##5##3##(1991-12#1)(1991-5#2)(1996-5#1)(1997-1#1)
of GTP gamma S##4##4##(1991-2#1)(1992-11#1)(1993-8#1)(1995-8#1)
of GTP to##3##3##(1991-2#1)(1995-2#1)(1995-6#1)
of GTP##22##2##(1990-7#1)(1991-12#2)(1991-2#2)(1991-5#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-4#1)(2008-6#2)
of GTP-binding proteins##3##3##(1991-9#1)(1994-12#1)(1994-9#1)
of GTP-binding##4##2##(1991-9#1)(1994-12#1)(1994-9#1)(2008-7#1)
of GTPCH mRNA##5##3##(1993-8#5)
of GTPCH##6##2##(1993-8#6)
of GUS activity of##2##4##(2008-8#2)
of GUS activity##4##3##(1996-12#1)(2008-8#2)(2008-9#1)
of GUS##7##2##(1996-12#1)(2008-10#1)(2008-8#2)(2008-9#3)
of GVA##2##2##(2008-10#2)
of GVHD##3##2##(2009-10#3)
of GYKI 52466##2##3##(1994-6#1)(1995-12#1)
of Ga(3+)##3##2##(2008-10#3)
of GaAs##5##2##(1996-9#1)(2007-12#1)(2008-3#2)(2008-7#1)
of Gadd45-β##6##2##(2011-2#6)
of Gag##2##2##(1997-3#1)(2011-3#1)
of Gal4##2##2##(1995-6#1)(2008-10#1)
of GalC+ oligodendrocytes expressed##3##4##(1996-5#3)
of GalC+ oligodendrocytes##5##3##(1996-5#5)
of GalNAc##2##2##(1992-10#1)(1992-8#1)
of Galen##7##2##(1996-3#2)(1996-6#4)(1996-9#1)
of Galpha subunits##3##3##(2008-7#2)(2009-7#1)
of Gandalf##3##2##(1995-8#3)
of Ganoderma lucidum##2##3##(1997-2#2)
of Garcinia cambogia in##2##4##(2012-2#2)
of Garcinia cambogia##3##3##(2012-2#3)
of Gardenia##3##2##(2013-1#2)(2013-8#1)
of Gastroenterology##4##2##(1995-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
of Gastrointestinal##6##2##(2008-6#1)(2008-7#2)(2010-12#3)
of Gaucher disease in##2##4##(2008-10#2)
of Gaussian beams##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of Gaussian blur##2##3##(2008-3#2)
of Gaussian##15##2##(2007-12#1)(2008-2#6)(2008-3#7)(2013-1#1)
of GbCLH##2##2##(2008-11#2)
of Gcr1p##2##2##(1996-3#2)
of Gd and##2##3##(1997-8#1)(2008-10#1)
of Gd##5##2##(1997-8#3)(2007-12#1)(2008-10#1)
of Gd-BOPTA##2##2##(2008-7#2)
of Gd-DTPA##2##2##(1990-2#1)(2008-10#1)
of Gdańsk##3##2##(2008-11#3)
of Gdn##3##2##(1993-6#3)
of Ge##5##2##(2008-10#4)(2008-3#1)
of Ge-doped silica##2##3##(2007-12#2)
of GeXP were##2##3##(2013-8#2)
of GeXP##3##2##(2013-8#3)
of Gender##2##2##(2011-2#1)(2012-3#1)
of Gene##5##2##(2008-10#1)(2008-5#4)
of General##8##2##(1991-12#1)(1994-6#2)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)
of Genes##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)
of Genetic##7##2##(1990-12#1)(1995-9#1)(2007-1#1)(2008-10#4)
of Geneva##2##2##(1990-11#1)(1996-11#1)
of Genoa syndrome##2##3##(2011-1#2)
of Genomic##4##2##(2008-2#2)(2008-6#1)(2011-2#1)
of Georgia##2##2##(1990-11#1)(1996-9#1)
of German##5##2##(1990-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
of Germany and##2##3##(1992-1#1)(2013-1#1)
of Germany##12##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#3)(1994-3#1)(1995-1#1)(1996-5#1)(2008-11#2)(2013-1#1)
of Gerumano##2##2##(2012-12#2)
of Gestalt##2##2##(2010-6#2)
of GhTub1 in##2##3##(2008-9#2)
of GhTub1##3##2##(2008-9#3)
of Ghana##2##2##(1997-4#1)(2013-1#1)
of Gi2 alpha##2##3##(1994-9#2)
of Giardia duodenalis in dairy and beef cattle##2##8##(2012-3#2)
of Giardia##4##2##(2008-8#1)(2012-12#1)(2012-3#2)
of Gibberella zeae##7##3##(2008-10#7)
of Giemsa-stained##2##2##(1991-11#1)(2012-2#1)
of Gilbertiodendron##2##2##(2008-8#2)
of Ginkgo biloba##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
of Glasses##2##2##(2008-3#2)
of Glioblastoma##2##2##(2012-3#1)(2013-1#1)
of Glomerella##2##2##(2008-10#2)
of Glu 177##2##3##(1992-3#2)
of Glu##7##2##(1992-12#1)(1992-3#2)(1992-6#1)(1994-8#1)(1995-5#1)(2008-10#1)
of Glu-98 was##3##3##(1995-6#3)
of Glu-98##5##2##(1995-6#5)
of GluR-B##2##2##(1993-12#2)
of GluR1##2##2##(2008-7#2)
of Glucolevel##3##2##(2008-10#3)
of Gly##2##2##(1990-5#1)(1991-3#1)
of GnRH##8##2##(1993-3#1)(1994-8#1)(1995-11#3)(1996-2#2)(2008-5#1)
of Go Local##2##3##(2010-5#2)
of God means##2##3##(2013-1#2)
of God##7##2##(2008-4#1)(2009-10#1)(2013-1#5)
of Goiás##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
of Golgi##3##2##(1993-9#1)(2008-8#1)(2009-10#1)
of Gore-Tex##3##2##(2007-7#3)
of Gorgan##2##2##(2008-12#2)
of Gosse et al##2##4##(2008-3#2)
of Governmental##5##2##(1996-3#4)(2008-10#1)
of Gpp(NH)p-sensitive high affinity binding of##2##6##(2008-3#2)
of Gpp(NH)p-sensitive high affinity##3##4##(2008-3#3)
of Gq alpha##2##3##(1995-2#2)
of Grade I##3##3##(2008-9#1)(2011-2#1)(2012-12#1)
of Grade##4##2##(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)
of Gram##3##2##(2010-12#1)(2010-6#2)
of Gram-negative bacilli##3##3##(2010-4#1)(2012-2#2)
of Gram-negative bacteria##4##3##(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
of Gram-negative bacterial##2##3##(1995-2#1)(2013-1#1)
of Gram-negative##11##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-1#2)(2013-8#1)
of Gram-positive organisms##2##3##(2008-6#1)(2008-9#1)
of Gram-positive##5##2##(2008-5#1)(2008-6#2)(2008-9#1)(2010-4#1)
of Granada##3##2##(2008-5#3)
of Grape Berries##2##3##(2008-10#2)
of Grape##6##2##(2008-10#6)
of Grapevine fanleaf virus##4##4##(2008-10#4)
of Grapevine leafroll-associated virus-5##2##4##(2008-10#2)
of Grapevine leafroll-associated##3##3##(2008-10#3)
of Grapevine##13##2##(2008-10#13)
of Gratings with Arbitrary Line Orientation##2##6##(2008-3#2)
of Gray's##2##2##(2008-8#1)(2010-1#1)
of Great Britain and##2##4##(2009-4#1)(2012-2#1)
of Great##3##2##(1995-2#1)(2009-4#1)(2012-2#1)
of Greater##4##2##(1993-9#2)(1994-1#1)(1995-12#1)
of Greek##6##2##(2008-11#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#2)
of Green S##2##3##(1993-8#2)
of Green##10##2##(1993-8#2)(2008-10#6)(2008-6#1)(2009-11#1)
of Gremmeniella abietina##4##3##(2008-10#4)
of GroE##2##2##(1992-3#2)
of GroEL14##2##2##(1994-5#2)
of Grob test mixture and##2##5##(2011-1#2)
of Groundnut rosette assistor virus##2##5##(2008-10#2)
of Groundnut rosette##3##3##(2008-10#3)
of Group A##2##3##(2007-8#1)(2012-2#1)
of Group II##2##3##(2008-10#1)(2013-1#1)
of Group##7##2##(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
of Grynfeltt's quadrilateral##2##3##(1993-9#2)
of Gs alpha##3##3##(1994-2#1)(1994-9#1)(1995-6#1)
of Gs##4##2##(1992-3#1)(1994-2#1)(1994-9#1)(1995-6#1)
of Guam##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
of Guatemala##2##2##(2008-8#2)
of Guillain-Barré syndrome##5##3##(1991-11#1)(2008-7#1)(2012-2#1)(2012-3#2)
of Guinea pig##2##3##(2013-1#2)
of Guinea yam (Dioscorea rotundata##2##5##(2008-5#2)
of Guinea yam##3##3##(2008-5#3)
of Guinea##7##2##(2008-5#3)(2011-1#1)(2011-2#1)(2013-1#2)
of Gurung community##2##3##(2008-7#2)
of Gurung##3##2##(2008-7#3)
of Gus mRNA##2##3##(1993-8#2)
of Gus##3##2##(1993-8#2)(1996-5#1)
of Gynaecology and Obstetrics##2##4##(2007-4#1)(2011-1#1)
of Gynaecology##3##2##(1991-9#1)(2007-4#1)(2011-1#1)
of Gynecology and Obstetrics##3##4##(1994-5#1)(1995-3#1)(2011-2#1)
of H current##6##3##(2008-2#6)
of H x V =##2##5##(2008-3#2)
of H##107##2##(1990-2#1)(1990-5#1)(1991-8#2)(1993-12#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-1#6)(1997-3#2)(1997-6#3)(1997-7#1)(2008-1#6)(2008-10#36)(2008-11#2)(2008-12#4)(2008-2#6)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#1)(2012-8#1)
of H(2)##4##2##(2007-12#2)(2008-2#1)(2009-9#1)
of H(2)O##2##2##(2008-2#1)(2008-3#1)
of H(2)O(2) and##6##3##(2008-10#5)(2013-1#1)
of H(2)O(2) in the##3##4##(2008-10#3)
of H(2)O(2) in##9##3##(2008-10#9)
of H(2)O(2) with##2##3##(2008-10#2)
of H(2)O(2)##43##2##(2008-10#40)(2008-5#1)(2010-4#1)(2013-1#1)
of H(2)S##3##2##(2008-10#2)(2011-1#1)
of H(2)SO(4) and##4##3##(2008-10#3)(2008-3#1)
of H(2)SO(4)##6##2##(2008-10#5)(2008-3#1)
of H+##8##2##(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#3)(1997-8#1)(2013-8#1)
of H-7##2##2##(1990-2#2)
of H-H##2##2##(2010-4#2)
of H-Y##2##2##(1997-3#1)(2008-10#1)
of H-point##2##2##(2008-10#2)
of H1(0)##3##2##(1993-6#3)
of H2##2##2##(2008-2#1)(2010-5#1)
of H2-antagonist##2##2##(1990-5#1)(1991-5#1)
of H2O##3##2##(2008-2#1)(2008-3#2)
of H2O2 and##2##3##(1995-2#1)(2013-8#1)
of H2O2##11##2##(1991-9#2)(1993-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-6#1)(2013-8#1)
of H7 subtype##2##3##(2013-8#2)
of H9 cells##2##3##(1994-11#1)(1997-1#1)
of H9N2##2##2##(2010-4#2)
of HA and FA##3##4##(2008-10#3)
of HA and##8##3##(1993-12#1)(2008-10#4)(2009-7#1)(2011-2#1)(2013-8#1)
of HA in##2##3##(2008-10#1)(2013-8#1)
of HA on##2##3##(2010-8#1)(2013-8#1)
of HA was obtained##2##4##(2008-5#2)
of HA was##4##3##(2008-5#2)(2013-8#2)
of HA were##2##3##(2008-10#1)(2013-8#1)
of HA##34##2##(1990-5#1)(1993-12#1)(2008-10#12)(2008-5#3)(2009-7#2)(2010-10#1)(2010-8#1)(2011-2#3)(2013-8#10)
of HAART on##3##3##(2007-1#1)(2013-8#2)
of HAART##9##2##(2007-1#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-8#5)
of HAC##2##2##(2008-11#2)
of HAG1##2##2##(2008-8#2)
of HAM/TSP##2##2##(2012-12#2)
of HAP##2##2##(1994-8#1)(2008-7#1)
of HAV##2##2##(2007-12#1)(2009-5#1)
of HAc-NaAc##2##2##(2008-10#2)
of HB-EGF mRNA##3##3##(1997-1#3)
of HB-EGF##6##2##(1993-11#1)(1997-1#4)(2013-8#1)
of HBD-2##3##2##(2011-3#3)
of HBV DNA##4##3##(1990-8#1)(1997-4#2)(2013-1#1)
of HBV and##5##3##(1995-5#1)(2007-7#1)(2009-8#1)(2011-1#1)(2013-8#1)
of HBV expression##2##3##(2012-12#2)
of HBV in##2##3##(2008-4#1)(2009-3#1)
of HBV infection##3##3##(1995-2#1)(1997-4#1)(2007-12#1)
of HBV reactivation##2##3##(1991-3#1)(2009-12#1)
of HBV recurrence##2##3##(2013-8#2)
of HBV transmission##2##3##(2008-7#1)(2012-1#1)
of HBV##36##2##(1990-8#1)(1991-3#1)(1995-2#3)(1995-5#1)(1997-4#4)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-8#2)(2011-1#4)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#4)
of HBV-DNA##2##2##(2011-1#2)
of HBV-infected##2##2##(1991-11#1)(2007-12#1)
of HBc##2##2##(2008-8#2)
of HBs##3##2##(1994-5#1)(2011-2#1)(2013-1#1)
of HBsAg was##2##3##(2008-10#1)(2008-12#1)
of HBsAg##9##2##(1995-2#2)(1996-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#2)
of HBx##4##2##(2012-12#4)
of HC and##2##3##(2008-10#1)(2011-1#1)
of HC##5##2##(1991-12#1)(2008-10#2)(2011-1#1)(2011-3#1)
of HC-Pro##2##2##(2008-10#2)
of HCA##2##2##(2009-8#2)
of HCC and##2##3##(2006-10#1)(2008-11#1)
of HCC in patients with HCV##2##6##(2006-10#2)
of HCC in patients with##3##5##(2006-10#2)(2008-7#1)
of HCC in patients##5##4##(2006-10#2)(2008-11#2)(2008-7#1)
of HCC in##6##3##(2006-10#2)(2008-11#3)(2008-7#1)
of HCC is##3##3##(2006-10#1)(2013-1#1)(2013-7#1)
of HCC##21##2##(1991-11#2)(1993-2#1)(2006-10#4)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
of HCD##2##2##(2008-10#2)
of HCHO in##2##3##(2008-10#2)
of HCHs and DDTs##3##4##(2008-7#3)
of HCMV##4##2##(1997-3#3)(2008-9#1)
of HCO(3)(-)##2##2##(2008-10#2)
of HCV RNA##3##3##(1994-8#1)(2008-11#1)(2008-4#1)
of HCV infection in##4##4##(2007-7#2)(2009-8#1)(2012-2#1)
of HCV infection##9##3##(2007-7#5)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of HCV is##2##3##(2008-1#1)(2013-1#1)
of HCV##29##2##(1994-8#1)(2007-7#7)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#3)
of HCc##2##2##(2008-8#2)
of HCl and##5##3##(2008-10#4)(2008-2#1)
of HCl was added##2##4##(2008-10#1)(2010-2#1)
of HCl##19##2##(1997-1#1)(2008-10#16)(2008-2#1)(2010-2#1)
of HD and place##2##4##(2007-8#2)
of HD and##3##3##(2007-8#2)(2008-10#1)
of HD was##2##3##(2007-8#1)(2008-10#1)
of HD##14##2##(1993-9#1)(2007-12#1)(2007-8#4)(2008-1#5)(2008-10#3)
of HDAC inhibitors##3##3##(2010-6#1)(2012-12#1)(2013-1#1)
of HDAC##4##2##(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
of HDC##2##2##(1997-1#2)
of HDL##10##2##(1994-8#1)(1995-5#1)(2008-3#1)(2008-4#1)(2008-6#4)(2011-2#1)(2012-2#1)
of HDR##2##2##(2009-2#2)
of HEC##3##2##(1994-2#2)(1995-12#1)
of HEG##3##2##(2008-10#3)
of HEK293##2##2##(2008-4#1)(2008-8#1)
of HEL##3##2##(1994-8#1)(2008-11#2)
of HEL117##2##2##(1995-6#2)
of HER-2/neu##3##2##(1997-7#2)(2009-7#1)
of HER2##2##2##(2008-11#1)(2009-9#1)
of HERG##2##2##(2008-8#2)
of HES##2##2##(2007-7#1)(2012-1#1)
of HF and##2##3##(2008-10#2)
of HF##10##2##(2007-11#1)(2008-10#6)(2008-4#1)(2013-8#2)
of HFA134a##4##2##(1996-1#3)(1996-2#1)
of HFK cells##2##3##(2008-11#2)
of HFMD##2##2##(2013-8#2)
of HFpEF##2##2##(2011-2#2)
of HG##4##2##(2008-10#2)(2008-7#2)
of HGF and EGF on##3##5##(1991-12#3)
of HGF and##4##3##(1991-12#3)(2008-11#1)
of HGF in##2##3##(1992-12#1)(2008-9#1)
of HGF was##4##3##(1992-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
of HGF##21##2##(1991-12#4)(1992-12#2)(1993-3#1)(2008-1#1)(2008-11#9)(2008-8#1)(2008-9#2)(2011-2#1)
of HGP##2##2##(1994-8#2)
of HH therapy##3##3##(2007-10#3)
of HHBIM-NTf2##2##2##(2011-1#2)
of HHE##2##2##(2011-1#2)
of HI 6 in##2##4##(1997-7#2)
of HI 6##5##3##(1997-7#5)
of HI##8##2##(1997-3#1)(1997-7#5)(2008-1#2)
of HIA##3##2##(2013-1#3)
of HIC1##2##2##(2009-8#2)
of HIF-1##3##2##(2009-4#1)(2010-7#2)
of HIT##6##2##(2010-3#1)(2013-1#5)
of HIV LTR-CAT##2##3##(1993-8#2)
of HIV among##2##3##(1991-1#1)(2009-4#1)
of HIV and##5##3##(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#2)
of HIV care##2##3##(2010-8#1)(2013-1#1)
of HIV disease##4##3##(1995-6#1)(2009-5#1)(2011-2#2)
of HIV expression##2##3##(2008-4#2)
of HIV in##5##3##(1995-3#1)(1996-11#1)(2008-1#1)(2009-4#1)(2013-1#1)
of HIV infected and##2##4##(1995-12#2)
of HIV infected##5##3##(1993-8#1)(1995-12#2)(2007-7#1)(2010-9#1)
of HIV infection among##6##4##(2007-7#2)(2011-2#4)
of HIV infection and##3##4##(1996-11#1)(2008-8#1)(2010-3#1)
of HIV infection by##2##4##(1996-8#1)(2013-8#1)
of HIV infection in the##2##5##(1996-11#1)(2008-8#1)
of HIV infection in##6##4##(1990-3#1)(1991-3#1)(1993-11#1)(1996-11#1)(2007-7#1)(2008-8#1)
of HIV infection on##2##4##(1992-9#1)(2013-8#1)
of HIV infection##39##3##(1990-3#1)(1991-3#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#2)(1995-6#1)(1996-11#3)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-7#4)(2008-5#2)(2008-7#1)(2008-8#2)(2010-3#1)(2011-1#2)(2011-2#6)(2013-8#3)
of HIV infections##6##3##(1993-3#1)(1996-9#1)(1997-3#2)(1997-6#1)(2007-7#1)
of HIV latency##2##3##(2012-12#2)
of HIV or##2##3##(1995-6#1)(2012-12#1)
of HIV patients##2##3##(2012-12#1)(2013-1#1)
of HIV positive##2##3##(2008-5#1)(2013-1#1)
of HIV prevalence##2##3##(1992-9#1)(2011-2#1)
of HIV prevention community planning##3##5##(1997-2#3)
of HIV prevention##6##3##(1996-5#1)(1997-2#3)(2007-7#1)(2011-2#1)
of HIV risk##2##3##(1997-3#1)(2009-8#1)
of HIV seropositivity##3##3##(1991-1#1)(2007-7#2)
of HIV status##4##3##(1997-5#1)(2008-10#1)(2010-4#1)(2012-12#1)
of HIV strains##2##3##(2007-12#1)(2011-2#1)
of HIV test##2##3##(1997-5#1)(2011-1#1)
of HIV transmission and##2##4##(2011-2#1)(2012-12#1)
of HIV transmission from##2##4##(1996-5#1)(2012-12#1)
of HIV transmission##10##3##(1993-1#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-12#3)
of HIV treatment##4##3##(2008-10#2)(2008-6#1)(2010-11#1)
of HIV with##2##3##(2006-10#1)(2011-1#1)
of HIV##191##2##(1990-3#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#4)(1993-6#1)(1993-8#4)(1994-11#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#6)(1996-11#6)(1996-3#1)(1996-5#7)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#5)(1997-5#6)(1997-6#4)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#15)(2008-1#3)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#5)(2009-5#3)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#13)(2011-3#4)(2012-12#10)(2012-2#7)(2013-1#4)(2013-8#6)
of HIV-1 Infection##3##3##(2008-2#3)
of HIV-1 PR##2##3##(1991-9#1)(2011-3#1)
of HIV-1 Rev##2##3##(1993-8#2)
of HIV-1 and HIV-2##2##4##(1990-5#1)(1990-8#1)
of HIV-1 and##3##3##(1990-5#1)(1990-8#1)(2008-2#1)
of HIV-1 by##2##3##(2011-3#2)
of HIV-1 can##2##3##(1993-3#1)(2008-12#1)
of HIV-1 env##2##3##(1994-8#1)(2013-8#1)
of HIV-1 in##4##3##(1991-9#1)(1992-12#1)(1992-9#2)
of HIV-1 infected##2##3##(1990-2#1)(2011-2#1)
of HIV-1 infection##8##3##(1991-1#1)(1995-9#3)(1996-11#1)(2008-11#1)(2008-2#2)
of HIV-1 integrase##2##3##(1992-6#1)(2011-3#1)
of HIV-1 on##2##3##(2008-11#2)
of HIV-1 p24CA##2##3##(1997-3#2)
of HIV-1 production##2##3##(1994-11#2)
of HIV-1 protease complexed with##2##5##(1992-11#1)(1992-8#1)
of HIV-1 protease##6##3##(1991-12#2)(1991-9#2)(1992-11#1)(1992-8#1)
of HIV-1 replication##2##3##(1994-6#1)(2013-1#1)
of HIV-1 reverse transcriptase##3##4##(1992-3#1)(1993-3#1)(2011-3#1)
of HIV-1##95##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-9#5)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#4)(1993-3#3)(1993-8#2)(1994-11#3)(1994-2#2)(1994-5#1)(1994-6#5)(1994-8#1)(1995-9#3)(1996-11#1)(1996-5#1)(1997-3#5)(2007-7#1)(2008-11#4)(2008-12#2)(2008-2#10)(2008-5#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#3)(2011-3#12)(2013-1#3)(2013-7#1)(2013-8#2)
of HIV-1-associated##2##2##(2008-2#2)
of HIV-1-based lentiviral vector##2##4##(2008-2#2)
of HIV-1-based lentiviral##3##3##(2008-2#3)
of HIV-1-infected##2##2##(1994-6#1)(2008-12#1)
of HIV-infected patients with##2##4##(1997-8#1)(2011-2#1)
of HIV-infected patients##6##3##(1996-2#1)(1997-8#1)(2008-3#2)(2008-9#1)(2011-2#1)
of HIV-infected persons##2##3##(1990-3#1)(1997-6#1)
of HIV-infected##14##2##(1990-3#1)(1993-3#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-2#2)(2008-3#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)
of HIV-infection is##2##3##(1990-6#1)(1992-8#1)
of HIV-infection##3##2##(1990-6#1)(1992-2#1)(1992-8#1)
of HIV-positive##7##2##(1990-3#2)(1993-6#1)(2007-2#1)(2008-1#1)(2009-8#1)(2010-12#1)
of HIV-related##5##2##(1992-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2013-1#1)
of HIV/AIDS among##3##3##(2010-8#2)(2012-12#1)
of HIV/AIDS and##4##3##(1995-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
of HIV/AIDS in##2##3##(2008-1#1)(2010-8#1)
of HIV/AIDS patients##3##3##(1995-6#1)(2007-7#1)(2008-1#1)
of HIV/AIDS##33##2##(1992-12#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-6#1)(2007-7#3)(2008-1#4)(2008-10#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-8#7)(2011-1#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
of HIVmn##2##2##(1991-9#2)
of HL-60 cells##8##3##(1993-8#3)(1994-11#1)(1994-6#1)(2008-11#1)(2008-8#2)
of HL-60##10##2##(1991-9#1)(1993-8#3)(1994-11#1)(1994-6#1)(2008-11#2)(2008-8#2)
of HL60##2##2##(1993-8#1)(2012-12#1)
of HLA antibodies##2##3##(2008-9#2)
of HLA class I and##3##5##(2008-4#1)(2011-2#1)(2012-12#1)
of HLA class I heavy chain expression##2##7##(1997-9#2)
of HLA class I heavy##4##5##(1997-9#4)
of HLA class I##10##4##(1994-5#1)(1997-9#6)(2008-4#1)(2011-2#1)(2012-12#1)
of HLA class II genes##2##5##(1997-8#2)
of HLA class##12##3##(1994-5#1)(1997-8#2)(1997-9#6)(2008-4#1)(2011-2#1)(2012-12#1)
of HLA##26##2##(1994-5#1)(1997-8#4)(1997-9#7)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#4)(2011-2#4)(2012-12#2)
of HLA-B27##4##2##(2008-9#1)(2012-12#3)
of HLA-B5##2##2##(1997-8#2)
of HLA-DR##3##2##(1990-6#1)(1991-2#1)(2008-8#1)
of HLH##8##2##(2011-2#7)(2012-3#1)
of HM##3##2##(2008-10#1)(2008-9#2)
of HMA##2##2##(1994-8#1)(2008-10#1)
of HMC-1##3##2##(2011-2#3)
of HMF was##2##3##(1996-2#2)
of HMF##3##2##(1996-2#2)(2008-10#1)
of HMG 2##3##3##(1990-3#3)
of HMG proteins##3##3##(1990-3#2)(2008-8#1)
of HMG##9##2##(1990-3#8)(2008-8#1)
of HMG-CoA##3##2##(1990-8#2)(1993-6#1)
of HMG2 mRNA in the cells##2##6##(1995-2#2)
of HMGA2##2##2##(2012-12#2)
of HMO##4##2##(1993-12#1)(1997-2#1)(2008-11#2)
of HMOs##8##2##(1991-3#3)(1994-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
of HMPAO##4##2##(1995-5#4)
of HMQ##4##2##(2008-10#4)
of HMV-1 cells##3##3##(2008-11#3)
of HMW protein##2##3##(1990-12#2)
of HMW##3##2##(1990-12#2)(2008-10#1)
of HN protein##2##3##(2008-9#2)
of HN##7##2##(2008-7#3)(2008-9#4)
of HNE and LNAC##2##4##(1996-12#2)
of HNE##3##2##(1996-12#3)
of HNO(3) and##3##3##(2008-10#3)
of HNO(3)##11##2##(2008-10#11)
of HO in##2##3##(2007-11#1)(2012-2#1)
of HO##9##2##(1995-2#1)(2007-11#3)(2008-10#1)(2008-4#1)(2012-2#3)
of HO-1##8##2##(1995-2#1)(2008-4#2)(2011-2#5)
of HOCl##3##2##(1992-5#3)
of HORs##2##2##(2008-7#2)
of HP-beta-CD##2##2##(2008-10#2)
of HPA axis function##2##4##(2013-1#2)
of HPA axis##3##3##(2013-1#3)
of HPLC for##2##3##(1991-5#1)(2008-10#1)
of HPLC to the##2##4##(1990-8#1)(1991-5#1)
of HPLC##20##2##(1990-11#1)(1990-8#2)(1991-5#3)(2008-10#14)
of HPLC-separated##2##2##(1990-8#2)
of HPRG with##2##3##(1997-2#2)
of HPRG##10##2##(1995-2#5)(1997-2#5)
of HPSE##2##2##(2013-8#2)
of HPTLC##2##2##(2008-10#2)
of HPV 6b E7##2##4##(2011-1#2)
of HPV 6b##3##3##(2011-1#3)
of HPV infection in##2##4##(1991-2#2)
of HPV infection##6##3##(1991-2#4)(2011-3#1)(2013-1#1)
of HPV##20##2##(1991-2#4)(1992-10#1)(1993-9#1)(2008-8#3)(2011-1#3)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#3)
of HPV-16 infection##3##3##(2011-3#3)
of HPV-16##6##2##(1992-2#1)(1995-2#2)(2011-3#3)
of HPV-related##2##2##(1994-1#1)(2008-11#1)
of HPg##3##2##(1993-8#3)
of HPlg##2##2##(1993-8#2)
of HQ##2##2##(1992-3#1)(2008-10#1)
of HR##6##2##(2008-10#2)(2012-2#4)
of HR-HPV##2##2##(2011-1#2)
of HRP##13##2##(2008-10#13)
of HRP-SjAb##4##2##(2008-10#4)
of HRT##2##2##(2010-12#1)(2013-8#1)
of HRV##4##2##(2012-2#1)(2013-8#3)
of HRV-positive##2##2##(2013-8#2)
of HS##12##2##(2008-10#6)(2008-9#1)(2011-2#5)
of HS-metal##2##2##(2008-10#2)
of HSA and ACN##2##4##(1994-9#2)
of HSA##7##2##(1994-9#3)(1997-6#2)(2008-10#2)
of HSCs##2##2##(2008-4#1)(2009-12#1)
of HSF##8##2##(1990-11#1)(1994-8#1)(1995-11#4)(2010-2#2)
of HSP##5##2##(1994-11#4)(1996-9#1)
of HSP28##3##2##(1994-8#3)
of HSP70 and##3##3##(1993-8#1)(1994-8#1)(2008-9#1)
of HSP70 in##2##3##(1995-11#1)(2008-10#1)
of HSP70 mRNA##3##3##(1994-8#1)(1995-11#2)
of HSP70 synthesis##2##3##(1995-11#2)
of HSP70##14##2##(1993-8#1)(1994-8#2)(1995-11#6)(2008-10#3)(2008-9#1)(2010-5#1)
of HSP72##3##2##(1991-9#1)(1995-5#2)
of HSPs##2##2##(2008-12#1)(2008-7#1)
of HSR##2##2##(2010-2#2)
of HSSB##3##2##(1994-8#3)
of HSV##7##2##(1996-6#1)(2008-11#2)(2008-9#4)
of HSV-1##3##2##(1994-11#1)(2007-12#1)(2008-4#1)
of HTC##2##2##(1997-4#1)(2008-8#1)
of HTLV-1 infection##2##3##(1990-3#1)(2012-12#1)
of HTLV-1##3##2##(1990-3#1)(2011-2#1)(2012-12#1)
of HTLV-I##4##2##(1991-12#1)(1994-11#1)(1994-6#1)(2008-8#1)
of HTN##4##2##(2010-4#4)
of HUH7-ins##2##2##(2010-11#2)
of HUVEC##6##2##(2008-11#2)(2008-8#1)(2008-9#2)(2010-3#1)
of Haemophilus influenzae type b##3##5##(1990-12#1)(2007-11#1)(2009-5#1)
of Haemophilus influenzae##7##3##(1990-12#1)(2007-11#1)(2007-7#1)(2009-5#4)
of Haemophilus paragallinarum and##2##4##(1997-6#1)(2008-5#1)
of Haemophilus paragallinarum##6##3##(1997-3#2)(1997-6#2)(2008-5#2)
of Haemophilus##15##2##(1990-12#2)(1997-3#2)(1997-6#2)(2007-11#1)(2007-7#2)(2008-5#2)(2009-5#4)
of Haglund's syndrome##2##3##(2008-8#2)
of Haglund's##3##2##(2008-8#3)
of Halobacterium halobium##2##3##(1990-11#1)(1990-5#1)
of Han##3##2##(2008-8#1)(2008-9#1)(2011-1#1)
of Hansen's disease##2##3##(2007-7#2)
of Hansenula##2##2##(1993-12#1)(1995-9#1)
of Havana##2##2##(2007-10#1)(2008-5#1)
of Hawaii##5##2##(2007-10#1)(2008-1#1)(2008-10#3)
of Hb Phe-37 beta##2##4##(1992-3#2)
of Hb concentration##2##3##(1990-8#1)(1997-2#1)
of Hb heme Fe(III)/Fe(II) redox couple##2##6##(2008-10#2)
of Hb in##3##3##(1994-12#1)(2008-10#2)
of Hb##20##2##(1990-7#1)(1990-8#2)(1992-11#2)(1992-3#2)(1994-12#1)(1997-2#1)(2008-10#8)(2008-12#1)(2008-7#2)
of HbA1c and##2##3##(2011-2#1)(2012-4#1)
of HbA1c##9##2##(1994-6#1)(2011-2#4)(2012-4#1)(2012-5#3)
of HbF##3##2##(1990-8#1)(2009-3#1)(2009-4#1)
of Hct in##2##3##(2011-3#2)
of Hct##9##2##(2011-3#9)
of He-Ne laser light##3##4##(2008-3#3)
of He-Ne laser##4##3##(1996-5#1)(2008-3#3)
of HeLa cell##2##3##(1993-6#1)(2008-8#1)
of HeLa cells##11##3##(1992-3#2)(1997-1#1)(2008-11#1)(2008-8#6)(2009-4#1)
of HeLa##15##2##(1992-11#1)(1992-3#2)(1993-6#1)(1993-8#1)(1997-1#1)(2008-11#1)(2008-8#7)(2009-4#1)
of Head##3##2##(1990-9#1)(2008-10#1)(2009-4#1)
of Health Administration##3##3##(1992-1#1)(1994-2#1)(1996-1#1)
of Health Care##3##3##(2010-3#1)(2011-2#1)(2012-12#1)
of Health Outcomes##2##3##(1994-1#1)(2012-12#1)
of Health Sciences##7##3##(1994-3#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#2)
of Health Services Management at the##2##6##(1991-2#1)(1996-1#1)
of Health Services Research##4##4##(2012-2#4)
of Health Services##7##3##(1991-2#1)(1994-12#1)(1996-1#1)(2012-2#4)
of Health and Human Services##11##5##(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(2008-7#1)(2012-2#1)
of Health and Human##12##4##(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-7#1)(2012-2#1)
of Health and##28##3##(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
of Health has proposed##2##4##(2008-1#1)(2010-8#1)
of Health has##4##3##(1997-1#1)(1997-2#1)(2008-1#1)(2010-8#1)
of Health in##6##3##(1994-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
of Health of##4##3##(1997-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
of Health recommended##2##3##(2010-12#1)(2012-3#1)
of Health##178##2##(1990-12#1)(1990-2#1)(1991-12#3)(1991-2#5)(1991-3#1)(1992-1#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#2)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#4)(2006-10#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#9)(2008-10#5)(2008-11#15)(2008-12#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#13)
of Health's##6##2##(1995-2#1)(2008-11#1)(2010-10#1)(2012-12#3)
of Healthcare##8##2##(1991-1#1)(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(2008-11#1)
of Healthy People 2000##2##4##(1996-12#1)(1996-2#1)
of Healthy People##3##3##(1996-12#1)(1996-2#1)(2011-1#1)
of Heart Rate##2##3##(2010-5#1)(2011-1#1)
of Heart##3##2##(2010-5#1)(2011-1#1)(2011-2#1)
of Heat##2##2##(2008-11#1)(2008-12#1)
of Hel-N1##2##2##(1994-12#2)
of Hela cells##2##3##(2008-10#1)(2011-1#1)
of Helichrysum##2##2##(2008-11#2)
of Helicobacter pylori infection in##2##5##(1992-5#1)(2011-2#1)
of Helicobacter pylori infection with##2##5##(2008-5#1)(2013-8#1)
of Helicobacter pylori infection##6##4##(1992-5#1)(1997-1#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of Helicobacter pylori isolates##2##4##(2007-7#2)
of Helicobacter pylori##23##3##(1992-5#2)(1996-12#2)(1997-1#1)(1997-7#1)(1997-8#2)(2007-7#2)(2008-12#3)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Helicobacter##24##2##(1990-2#1)(1992-5#2)(1996-12#2)(1997-1#1)(1997-7#1)(1997-8#2)(2007-7#2)(2008-12#3)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Helicoverpa armigera##3##3##(2008-12#2)(2011-2#1)
of Helicoverpa##4##2##(2008-12#2)(2011-2#2)
of Heliosperma##3##2##(2010-6#3)
of Helmholtz##2##2##(2008-2#1)(2008-3#1)
of Helminthosporium solani##2##3##(2008-10#2)
of Hematology and##2##3##(2008-11#1)(2008-9#1)
of Hematology##7##2##(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-11#2)
of HepG2 cells with dexamethasone##2##5##(1990-5#2)
of HepG2##3##2##(1990-5#2)(1992-3#1)
of Hepatitis B##4##3##(2008-10#2)(2008-11#1)(2009-7#1)
of Hepatitis G virus##2##4##(2008-10#2)
of Hepatitis##7##2##(2008-1#1)(2008-10#4)(2008-11#1)(2009-7#1)
of Hering##2##2##(2006-10#1)(2008-11#1)
of Hermite-Gaussian modes##2##3##(2008-3#2)
of Herpesvirus##2##2##(1991-6#1)(2009-5#1)
of Hes1##2##2##(2010-3#2)
of Hessian fly##4##3##(2011-2#4)
of Heterobasidion annosum in##3##4##(2008-10#3)
of Heterobasidion annosum##4##3##(2008-10#4)
of Heterodera glycines##7##3##(2008-10#7)
of Heterodera schachtii##3##3##(2008-10#3)
of Heterodera##10##2##(2008-10#10)
of Hexapoda and##2##3##(2007-12#2)
of Hf##5##2##(2008-10#5)
of Hg in##7##3##(2008-10#7)
of Hg species##2##3##(2008-10#2)
of Hg##17##2##(2008-10#16)(2008-7#1)
of Hg(2+)##8##2##(2008-10#8)
of Hg(I)##2##2##(2008-10#2)
of Hg(II) in pharmaceutical preparations##2##5##(2008-10#2)
of Hg(II) in the##2##4##(2008-10#2)
of Hg(II) in##9##3##(2008-10#9)
of Hg(II) ions by##2##4##(2008-10#2)
of Hg(II) ions##3##3##(2008-10#3)
of Hg(II) is##3##3##(2008-10#3)
of Hg(II) was##2##3##(2008-10#2)
of Hg(II) with##2##3##(2008-10#2)
of Hg(II)##26##2##(2008-10#26)
of Hg(II)-SCN##2##2##(2008-10#2)
of Hg2+##7##2##(1992-11#5)(1993-12#2)
of HiPIP##2##2##(1993-11#2)
of Hib vaccine##2##3##(2008-1#2)
of Hib##5##2##(2007-12#1)(2008-1#3)(2009-5#1)
of High##6##2##(1990-11#1)(2008-3#2)(2008-7#2)(2013-8#1)
of High-Fivetrade mark cells##2##4##(2008-11#2)
of Higher Education Institutions##2##4##(2008-11#2)
of Highly##3##2##(2009-11#1)(2011-1#1)(2013-1#1)
of Hira##4##2##(2008-7#4)
of Hirschsprung's disease##2##3##(1994-12#1)(1995-12#1)
of His##3##2##(1990-2#1)(1991-3#1)(1995-5#1)
of Hispanic##4##2##(2008-9#1)(2010-8#2)(2012-12#1)
of Hispanics##2##2##(2011-2#2)
of Histoplasma capsulatum##3##3##(2007-7#1)(2008-5#2)
of Hitachi##2##2##(1990-8#1)(2008-10#1)
of Hodgkin##2##2##(2008-7#1)(2013-1#1)
of Hodgkin's disease##3##3##(1993-9#1)(2007-7#1)(2009-7#1)
of Hodgkin's lymphoma##3##3##(2008-10#1)(2008-4#2)
of Hodgkin's##7##2##(1990-9#1)(1993-9#1)(2007-7#1)(2008-10#1)(2008-4#2)(2009-7#1)
of Hoechst 33342##3##3##(2008-11#2)(2008-9#1)
of Hoechst##5##2##(2008-11#2)(2008-9#3)
of Holographic##2##2##(2008-2#2)
of Homo sapiens##2##3##(2008-10#1)(2010-3#1)
of Hong Kong##2##3##(1994-3#1)(2010-10#1)
of Hordaland##2##2##(1994-11#1)(1996-9#1)
of Hospital##4##2##(1994-2#1)(2007-7#1)(2008-8#1)(2013-8#1)
of Host Plants##2##3##(2008-10#2)
of Host##13##2##(2008-10#13)
of Hox genes##2##3##(1993-12#1)(2008-1#1)
of Hox##5##2##(1993-12#1)(2008-1#1)(2008-9#1)(2012-2#2)
of Hsp70 in##2##3##(1991-9#2)
of Hsp70##5##2##(1991-9#5)
of Hsp70s##2##2##(2009-5#2)
of Hsp90##2##2##(1997-4#1)(2010-4#1)
of Human Bone Marrow Mesenchymal Stem Cells##2##7##(2008-11#2)
of Human Bone Marrow Mesenchymal Stem##3##6##(2008-11#3)
of Human Rights##3##3##(1995-6#2)(2008-9#1)
of Human##22##2##(1994-12#1)(1995-6#2)(1996-4#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-9#2)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2012-3#1)
of Humic Cambisol-DOM##2##3##(2008-11#2)
of Hunan##2##2##(2008-9#2)
of Huntington's disease##2##3##(1995-12#1)(2008-5#1)
of Hv-p68 in##2##3##(2008-10#2)
of Hv-p68##4##2##(2008-10#4)
of Hx##2##2##(1994-8#1)(2008-10#1)
of Hyderabad##2##2##(2007-7#1)(2008-12#1)
of Hydrogen cyanide gas##2##4##(2008-10#2)
of Hydrogen##3##2##(2008-10#2)(2008-5#1)
of Hymenolepis##2##2##(2011-2#1)(2012-2#1)
of Hypertension in##2##3##(2008-1#1)(2008-11#1)
of Hypertension##3##2##(2008-1#1)(2008-11#1)(2012-2#1)
of Hyphantria cunea##2##3##(2008-11#2)
of I and II##2##4##(2008-10#2)
of I and##3##3##(1990-2#1)(2008-10#2)
of I with##2##3##(1997-7#1)(2008-10#1)
of I##33##2##(1990-2#1)(1990-6#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#13)(2008-11#4)(2008-6#2)(2011-2#4)(2013-1#1)(2013-8#1)
of I(-)##4##2##(2008-10#4)
of I(Kv11##2##2##(2008-8#2)
of I-A k##4##3##(1990-12#4)
of I/R injury##3##3##(2010-8#3)
of I/R##4##2##(2010-8#4)
of I184Y##2##2##(1992-1#2)
of I2-imidazoline receptors##3##3##(1996-5#3)
of IA##3##2##(2011-2#3)
of IAA in##2##3##(2008-10#2)
of IAA##9##2##(2008-10#5)(2008-12#1)(2008-7#1)(2008-9#2)
of IAD##2##2##(2013-8#2)
of IAPP##3##2##(1992-6#1)(1994-8#2)
of IBD##6##2##(2008-9#1)(2009-12#4)(2011-2#1)
of IBS##4##2##(2010-6#2)(2013-1#2)
of IBV##8##2##(1997-6#5)(2008-5#3)
of IC##2##2##(2008-10#2)
of ICA##5##2##(1994-12#2)(2008-7#2)(2012-3#1)
of ICAM-1##4##2##(2008-10#1)(2010-1#3)
of ICD-10##3##2##(1997-8#1)(2012-12#2)
of ICD-9##2##2##(1991-12#1)(2012-12#1)
of ICH##3##2##(2007-10#3)
of ICI 182##2##3##(2007-10#1)(2013-1#1)
of ICP gradients##2##3##(2008-7#2)
of ICP##5##2##(2008-10#1)(2008-12#1)(2008-7#3)
of ICP-AES##4##2##(2008-10#4)
of ICP-MS and ICP-OES##2##4##(2008-10#2)
of ICP-MS##6##2##(2008-10#6)
of ICSS##6##2##(1991-2#4)(1996-2#2)
of ICU##2##2##(1996-2#1)(2008-8#1)
of ID##2##2##(2008-10#1)(2008-12#1)
of IDA##2##2##(2008-10#2)
of IDDM##4##2##(1990-11#1)(1994-12#1)(1996-12#1)(2007-5#1)
of IDHR##4##2##(2008-10#4)
of IDO##3##2##(2008-11#3)
of IE##3##2##(2011-2#3)
of IECs##2##2##(2008-11#2)
of IF in##2##3##(1990-11#2)
of IF##3##2##(1990-11#2)(2008-8#1)
of IFN##10##2##(1992-2#1)(1993-2#1)(1995-12#1)(2008-4#2)(2008-5#1)(2009-8#3)(2013-7#1)
of IFN-alpha##3##2##(1993-2#2)(2009-5#1)
of IFN-beta##4##2##(1995-12#1)(2008-11#3)
of IFN-gamma by##2##3##(1996-12#1)(2008-7#1)
of IFN-gamma with##2##3##(1996-12#1)(2008-7#1)
of IFN-gamma##17##2##(1993-9#1)(1994-9#2)(1996-12#3)(2008-11#5)(2008-4#2)(2008-7#3)(2008-8#1)
of IFN-γ##3##2##(2011-2#2)(2012-1#1)
of IFNgamma##3##2##(2008-10#2)(2008-9#1)
of IGEs##3##2##(2008-8#3)
of IGF##5##2##(1994-6#1)(1996-5#1)(2008-11#1)(2008-4#1)(2010-8#1)
of IGF-1##6##2##(1992-12#1)(1994-11#2)(2008-9#2)(2012-2#1)
of IGF-I and##3##3##(1996-2#1)(2008-11#2)
of IGF-I##22##2##(1991-5#1)(1992-3#1)(1993-6#1)(1994-2#1)(1996-2#4)(1997-7#1)(2008-11#6)(2008-6#1)(2010-5#3)(2011-1#1)(2012-3#1)(2013-1#1)
of IGF-II##4##2##(1990-5#1)(2008-6#2)(2013-1#1)
of IGF-IR##5##2##(2008-8#5)
of IGFBP-4##2##2##(1992-4#1)(2011-1#1)
of IGS##2##2##(2008-10#2)
of IH901##3##2##(2008-11#3)
of IHD##7##2##(2008-3#7)
of IHPM##2##2##(2010-12#2)
of II##2##2##(2008-10#1)(2011-2#1)
of III##3##2##(1993-1#1)(2008-10#1)(2013-1#1)
of III-V##2##2##(1996-9#1)(2011-2#1)
of IImtl##2##2##(1991-10#2)
of IL-1 and##2##3##(1994-3#2)
of IL-1 beta precursor##2##4##(1995-2#2)
of IL-1 beta##13##3##(1993-3#1)(1993-8#1)(1994-11#3)(1995-2#5)(1996-12#3)
of IL-1 in##2##3##(1990-12#2)
of IL-1##21##2##(1990-12#4)(1993-3#1)(1993-8#2)(1994-11#3)(1994-3#2)(1995-2#5)(1996-12#3)(2008-5#1)
of IL-10 and##2##3##(2011-1#1)(2011-3#1)
of IL-10 have been reported##2##5##(1996-12#1)(2012-12#1)
of IL-10 in the##3##4##(1996-12#1)(2008-11#1)(2011-1#1)
of IL-10 in##4##3##(1996-12#2)(2008-11#1)(2011-1#1)
of IL-10##18##2##(1994-8#1)(1996-12#4)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#4)(2011-2#1)(2011-3#2)(2012-12#3)
of IL-12 and##2##3##(2008-11#1)(2011-2#1)
of IL-12 to##2##3##(2008-11#2)
of IL-12##17##2##(2008-11#6)(2008-4#2)(2008-8#7)(2011-2#2)
of IL-17 and##2##3##(2012-2#2)
of IL-17##3##2##(2007-11#1)(2012-2#2)
of IL-1beta##2##2##(2008-6#1)(2013-8#1)
of IL-1ra##2##2##(1992-3#1)(2008-5#1)
of IL-2 and IL-4##2##4##(2008-11#2)
of IL-2 and##4##3##(1990-2#1)(1994-12#1)(2008-11#2)
of IL-2 gene##2##3##(1992-8#1)(1994-11#1)
of IL-2 production##2##3##(1990-2#1)(1991-12#1)
of IL-2##23##2##(1990-12#3)(1990-2#4)(1991-12#1)(1991-2#2)(1992-12#1)(1992-8#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#2)(2008-11#3)(2008-7#1)
of IL-4##12##2##(1992-8#2)(1996-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-12#3)(2009-5#1)(2010-12#2)
of IL-5##4##2##(1995-6#2)(2008-1#1)(2008-4#1)
of IL-6 and the TNF-alpha##2##5##(2011-1#2)
of IL-6 and##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#2)
of IL-6 production##2##3##(2008-10#2)
of IL-6##18##2##(1990-5#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1997-7#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#2)(2013-1#2)
of IL-6-receptor##2##2##(1990-5#2)
of IL-6sR and sTNF-Rs##2##4##(2008-4#2)
of IL-6sR##4##2##(2008-4#4)
of IL-7 gene##2##3##(1995-2#2)
of IL-7##4##2##(1995-2#2)(2008-11#2)
of IL-8##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
of IL-9##3##2##(2008-4#3)
of IL28B polymorphisms##2##3##(2012-12#2)
of IL28B##3##2##(2012-12#2)(2012-2#1)
of IMCT##2##2##(2010-2#2)
of IMD##3##2##(2007-12#3)
of IMID##6##2##(2011-2#6)
of IMP dehydrogenase##2##3##(1990-10#1)(1993-8#1)
of IMRT##3##2##(2008-2#1)(2011-2#1)(2012-1#1)
of IMS##5##2##(2008-10#4)(2010-9#1)
of IMT##3##2##(2012-3#3)
of IN##2##2##(2011-3#1)(2013-1#1)
of INF alpha##3##3##(1997-5#3)
of INF1##2##2##(2008-10#2)
of INH##5##2##(2008-10#3)(2008-7#2)
of IOP##3##2##(2011-2#3)
of IORT##2##2##(2011-2#2)
of IP##3##2##(2008-7#3)
of IP3 to##3##3##(1993-8#3)
of IP3##11##2##(1990-12#1)(1991-12#1)(1992-9#1)(1993-3#1)(1993-8#6)(1995-11#1)
of IP5##4##2##(1992-11#4)
of IPA in##3##3##(2011-2#3)
of IPA##4##2##(2011-2#3)(2013-1#1)
of IPC##3##2##(2010-1#1)(2013-7#2)
of IPFY##2##2##(2012-2#2)
of IPMC##2##2##(2010-4#2)
of IPS4334##2##2##(2011-2#2)
of IPTG##2##2##(1993-8#1)(1993-9#1)
of IQ##2##2##(1997-7#1)(2008-10#1)
of IR in##2##3##(2010-4#1)(2012-2#1)
of IR receptors on the##2##5##(2007-12#2)
of IR receptors##4##3##(2007-12#4)
of IR##17##2##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
of IR-beta-endorphin##2##2##(1994-9#2)
of IRB members and chairs##3##5##(2009-4#3)
of IRB##5##2##(2009-4#5)
of IRBs##2##2##(2009-4#2)
of IRF-8##3##2##(2013-1#3)
of IRS##2##2##(1996-2#1)(2008-3#1)
of IRS-1 and IRS-2##2##4##(2008-6#2)
of IRS-1 in vitro##3##4##(1995-8#3)
of IRS-1 in##6##3##(1995-8#6)
of IRS-1##12##2##(1992-10#2)(1994-11#2)(1995-8#6)(2008-6#2)
of IRS-I##8##2##(1997-1#8)
of IS##4##2##(1993-12#1)(1995-8#1)(1996-1#1)(2012-3#1)
of IS4 into the tnpA gene of##2##7##(1990-11#2)
of ISAV##2##2##(2009-6#2)
of ISDN in##2##3##(2008-10#2)
of ISDN##3##2##(2008-10#3)
of ISEs based on##2##4##(2008-10#2)
of ISEs##4##2##(2008-10#4)
of ISFETs##2##2##(2008-10#2)
of ISGs##2##2##(2010-10#2)
of ISIS##4##2##(2008-10#4)
of ISL3##2##2##(1995-8#2)
of ISO##2##2##(2010-9#1)(2011-2#1)
of ISR by Bacillus spp##2##5##(2008-10#2)
of ISR by##3##3##(2008-10#3)
of ISR##5##2##(2008-10#5)
of ITCZ##3##2##(2008-1#3)
of ITO-TEOS-BSA-ChOx/HRP##2##2##(2008-10#2)
of ITP##2##2##(2006-6#2)
of ITS##2##2##(2008-10#1)(2008-11#1)
of IUC##2##2##(2013-1#2)
of IUGR##2##2##(1995-8#1)(2011-2#1)
of IV cyclophosphamide##2##3##(2006-10#2)
of IV drug##2##3##(1997-6#1)(2007-7#1)
of IV##9##2##(1992-9#1)(1997-6#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-2#1)
of IVCP##2##2##(2007-7#2)
of IVF##3##2##(1990-10#1)(1990-2#1)(1991-11#1)
of IVH##6##2##(2007-10#1)(2008-7#1)(2011-2#4)
of Id-1##4##2##(2008-8#4)
of Id1##2##2##(2013-1#2)
of Idiopathic##2##2##(2008-7#2)
of Ig##4##2##(1990-12#2)(2008-10#1)(2008-11#1)
of IgA in##2##3##(1990-12#1)(1993-2#1)
of IgA nephropathy##2##3##(2007-7#1)(2008-1#1)
of IgA##11##2##(1990-12#1)(1991-2#2)(1993-2#1)(1994-2#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2013-8#1)
of IgD##2##2##(1993-8#1)(1993-9#1)
of IgE##5##2##(2008-10#1)(2008-4#1)(2010-5#2)(2013-1#1)
of IgG antibodies##3##3##(1990-2#1)(1991-11#1)(1995-2#1)
of IgG or##2##3##(1990-2#1)(2008-10#1)
of IgG##24##2##(1990-12#3)(1990-2#2)(1991-11#2)(1991-5#2)(1995-12#1)(1995-2#3)(2008-10#6)(2008-11#2)(2008-7#1)(2010-3#1)(2011-1#1)
of IgG1 and##2##3##(1993-6#1)(1997-8#1)
of IgM and IgG##2##4##(1994-9#1)(2007-7#1)
of IgM and##3##3##(1994-9#1)(2007-10#1)(2007-7#1)
of IgM##7##2##(1990-12#2)(1993-12#1)(1994-2#1)(1994-9#1)(2007-10#1)(2007-7#1)
of Igf2##2##2##(1996-10#2)
of Igs##2##2##(2007-10#2)
of Ilha do Mel##2##4##(2008-5#2)
of Ilizarov##2##2##(1997-5#1)(2013-1#1)
of Illinois##3##2##(1992-12#1)(1992-9#1)(1995-3#1)
of Imatinib and its main metabolite##2##6##(2008-10#2)
of Imatinib##5##2##(2008-10#5)
of In Vitro##2##3##(2007-12#1)(2008-10#1)
of In(III)##3##2##(2008-10#3)
of InAs quantum dots##2##4##(2007-11#2)
of InAs##3##2##(2007-11#3)
of InBr(-)(4)##2##2##(2008-10#2)
of InGaAs##3##2##(2008-3#1)(2009-11#2)
of InGaAsP/InP##2##2##(2007-12#1)(2008-3#1)
of Income and##2##3##(1992-2#1)(2013-1#1)
of India##17##2##(1994-3#1)(1996-4#2)(2007-2#1)(2007-7#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
of Indian##3##2##(1994-7#1)(2012-2#1)(2013-8#1)
of Individuals with##2##3##(2009-3#1)(2010-4#1)
of Individuals##3##2##(2009-3#1)(2010-4#1)(2012-12#1)
of Infected##3##2##(2008-10#2)(2012-2#1)
of Infection and Colonization of##2##5##(2008-10#2)
of Infection by##2##3##(2008-10#2)
of Infection##9##2##(2008-10#7)(2010-6#2)
of Infirmary##2##2##(2008-10#2)
of Information##2##2##(1995-2#1)(2013-1#1)
of Inh##2##2##(2008-10#2)
of Inner Mongolia##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
of Innovation##2##2##(1994-1#1)(2010-10#1)
of InsP3 and##2##3##(1991-12#1)(1994-6#1)
of InsP3##3##2##(1991-12#1)(1994-11#1)(1994-6#1)
of Inspector##4##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-2#1)
of Institute##2##2##(2008-10#1)(2012-2#1)
of Institutional Review Boards (IRBs)##2##5##(2009-4#1)(2009-6#1)
of Institutional Review##3##3##(1997-8#1)(2009-4#1)(2009-6#1)
of Insulin via##2##3##(2011-1#1)(2011-2#1)
of Insulin##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
of Integrated##2##2##(2008-1#1)(2008-12#1)
of Interceed (TC7)##2##3##(1992-1#2)
of Interest##3##2##(2009-3#1)(2010-8#1)(2011-1#1)
of Internal Medicine##8##3##(1994-3#1)(1995-11#1)(1996-11#1)(1997-6#1)(2008-7#1)(2008-8#1)(2013-1#2)
of Internal##12##2##(1991-2#1)(1994-3#1)(1995-11#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#2)
of Internet use##2##3##(2007-12#1)(2009-5#1)
of Internet##4##2##(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#1)
of Intracranial##2##2##(1995-11#1)(1996-6#1)
of Inula helenium L##2##4##(2008-10#1)(2008-5#1)
of Inula viscosa##4##3##(2008-10#4)
of Inula##6##2##(2008-10#5)(2008-5#1)
of Ioannina##3##2##(2008-10#3)
of Iowa##3##2##(1994-2#2)(1997-3#1)
of Ip1 to the##2##4##(1995-5#2)
of Ip1 to##3##3##(1995-5#3)
of Ir##2##2##(2007-12#1)(2008-10#1)
of Iran is##2##3##(2008-12#1)(2012-2#1)
of Iran using##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
of Iran##26##2##(2007-2#1)(2008-10#2)(2008-12#15)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
of Iran)##3##2##(2008-12#3)
of Iranian patients##2##3##(2008-12#1)(2010-11#1)
of Iranian##7##2##(2008-12#5)(2010-11#1)(2012-12#1)
of Iraqi##2##2##(1992-6#1)(2011-2#1)
of Iron##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
of Isfahan##3##2##(2008-12#2)(2010-8#1)
of Isolates of##4##3##(2008-10#4)
of Isolates##8##2##(2008-10#8)
of Isospora##2##2##(1996-12#2)
of Israel##2##2##(2008-10#2)
of Israeli travelers##2##3##(2011-2#2)
of Israeli##3##2##(2008-10#1)(2011-2#2)
of Italian##6##2##(1991-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
of Italy##9##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-9#1)(1993-2#1)(2008-10#2)(2008-7#1)(2013-8#1)
of Itch##3##2##(2012-2#3)
of Items##2##2##(2009-5#1)(2011-1#1)
of Its##4##2##(2008-10#4)
of Ixodes##2##2##(2007-12#1)(2013-1#1)
of J##4##2##(2008-5#3)(2008-8#1)
of J-aggregates##3##2##(2008-7#2)(2010-4#1)
of J/ psi##2##3##(1992-8#1)(1994-2#1)
of J774 cells##2##3##(1990-7#2)
of J774##4##2##(1990-7#2)(1990-8#1)(1995-3#1)
of JE##3##2##(1994-9#3)
of JH synthesis in##2##4##(2008-7#2)
of JH synthesis##5##3##(2008-7#5)
of JH##12##2##(2008-7#6)(2012-2#6)
of JNK1 and Raf1##2##4##(2012-12#2)
of JQ1##2##2##(2012-12#2)
of JYG-MMTV##2##2##(1994-12#2)
of Jalisco##2##2##(2008-5#1)(2011-2#1)
of January##4##2##(1994-1#1)(2007-8#1)(2008-5#1)(2008-7#1)
of Japan from##2##3##(1994-7#1)(2008-10#1)
of Japan##11##2##(1994-7#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#2)(2012-2#1)
of Japanese cedar pollinosis in##2##5##(2012-12#2)
of Japanese cedar pollinosis##3##4##(2012-12#3)
of Japanese cedar##4##3##(2012-12#4)
of Japanese flounder##2##3##(2009-7#2)
of Japanese native horses##2##4##(2013-1#2)
of Japanese style acupuncture##2##4##(2008-10#2)
of Japanese##31##2##(1995-12#1)(1997-3#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#3)
of Jehovah's Witnesses##2##3##(1996-9#2)
of Jehovah's##3##2##(1996-9#2)(2008-11#1)
of Jerusalem##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
of Jixian county##2##3##(2011-1#2)
of Jixian##3##2##(2011-1#3)
of John##2##2##(1990-6#1)(2009-11#1)
of Joint##2##2##(2008-2#1)(2008-5#1)
of July##4##2##(1991-3#1)(1996-12#1)(2008-10#1)(2008-5#1)
of June##5##2##(1992-3#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-10#1)
of Jurkat##5##2##(1992-12#1)(1993-6#1)(1994-6#2)(2012-1#1)
of Justice##5##2##(1991-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(2008-9#1)
of K and##3##3##(1996-4#1)(2008-12#1)(2008-3#1)
of K repeated measures##2##4##(1992-6#1)(1997-3#1)
of K##16##2##(1992-6#1)(1994-9#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-7#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#3)(2011-2#1)(2013-7#1)
of K(+) channels##3##3##(2008-4#1)(2008-8#2)
of K(+)##7##2##(2008-10#3)(2008-4#1)(2008-8#2)(2009-12#1)
of K(ATP) channels##3##3##(1997-7#3)
of K(ATP)##4##2##(1997-7#3)(2008-8#1)
of K(f)##3##2##(2008-10#3)
of K(v)2##4##2##(2008-8#4)
of K+ and##2##3##(1992-11#1)(2008-11#1)
of K+ channels##3##3##(1994-12#1)(2007-10#1)(2008-8#1)
of K+##17##2##(1990-7#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-6#2)(1993-11#1)(1994-12#1)(1994-3#2)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)
of K252a##4##2##(1990-12#2)(1994-11#1)(2008-11#1)
of K562 cells##3##3##(2008-11#2)(2008-9#1)
of K562##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
of KAP##2##2##(1996-5#2)
of KATP channel##2##3##(1995-5#1)(2008-8#1)
of KB##5##2##(1991-10#1)(1991-12#3)(1992-3#1)
of KBD##2##2##(2011-2#2)
of KBr##2##2##(1996-2#1)(2008-10#1)
of KC##2##2##(1994-9#2)
of KC/gro protein##3##3##(1993-11#3)
of KC70 in##2##3##(2010-5#2)
of KC70##3##2##(2010-5#3)
of KChIP2b##3##2##(2008-8#3)
of KCl in##2##3##(2008-10#2)
of KCl##8##2##(1990-5#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-12#2)
of KD##3##2##(2012-2#3)
of KDR in##2##3##(1992-9#1)(1994-11#1)
of KF cells##2##3##(1993-9#2)
of KF##4##2##(1993-9#4)
of KF19514##4##2##(1997-7#4)
of KK and MH cells##3##5##(1993-9#3)
of KK##5##2##(1993-9#3)(2008-10#2)
of KLC1##3##2##(2010-11#3)
of KLH##4##2##(2008-10#4)
of KOH##2##2##(2008-10#2)
of KPF(6)##2##2##(2008-10#2)
of KS##5##2##(1992-2#1)(2008-6#2)(2012-3#2)
of KSA##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
of KSD##2##2##(2010-4#2)
of KT##4##2##(2013-1#4)
of KTP crystals##2##3##(2008-3#2)
of KTP##4##2##(2008-10#1)(2008-3#3)
of KTiOPO(4)##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
of KTiOPO4 crystals##2##3##(2008-3#2)
of KU812 cells treated with both 450 ng ml(-1) IgE and 1##2##12##(2008-11#2)
of KU812 cells treated with##3##5##(2008-11#3)
of KU812 cells##7##3##(1990-5#1)(2008-11#6)
of Kaposi's sarcoma (KS)##3##4##(1990-9#1)(1991-12#1)(1991-8#1)
of Karachi##2##2##(2013-7#2)
of Karnal##2##2##(2008-10#2)
of Kashmir##2##2##(2008-5#2)
of Kathmandu##3##2##(2008-11#2)(2012-3#1)
of Kawasaki disease with##2##4##(2012-2#1)(2013-1#1)
of Kawasaki disease##4##3##(2008-11#1)(2012-2#2)(2013-1#1)
of Kazakhstan##2##2##(2008-10#1)(2013-1#1)
of Kefir##2##2##(2008-11#2)
of Kerr##2##2##(2007-11#1)(2007-12#1)
of Khon Kaen##2##3##(2011-2#2)
of Ki##4##2##(1991-5#1)(1992-8#2)(2012-2#1)
of Ki-energy##2##2##(2008-10#2)
of Kikuchi's disease##2##3##(2011-2#2)
of King##2##2##(2008-11#1)(2010-11#1)
of Kir2##5##2##(2008-8#3)(2013-7#2)
of Kir4##3##2##(2008-8#3)
of Kirschner wire##3##3##(2007-8#2)(2011-2#1)
of Klebsiella##2##2##(2008-8#1)(2013-8#1)
of Km*1##2##2##(1997-8#2)
of Kohonen neural networks##2##4##(2008-10#2)
of Korea##3##2##(2012-2#2)(2013-8#1)
of Korean ginseng##4##3##(1997-2#3)(2012-3#1)
of Korean##7##2##(1997-2#4)(2008-8#1)(2009-12#1)(2012-3#1)
of Kosrae##2##2##(2013-8#2)
of Krukenberg tumour##2##3##(2012-2#2)
of Ku##2##2##(1996-2#1)(2013-1#1)
of Kupffer cells##2##3##(1995-3#1)(1997-4#1)
of Kupffer##4##2##(1993-6#1)(1994-6#1)(1995-3#1)(1997-4#1)
of L##55##2##(1990-7#1)(1991-10#1)(1994-11#1)(1995-8#1)(1996-12#4)(1997-6#1)(2007-12#1)(2008-10#17)(2008-5#5)(2008-6#5)(2008-7#2)(2008-9#1)(2009-12#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#2)
of L-163##2##2##(1995-12#2)
of L-680##2##2##(1993-8#2)
of L-689##3##2##(1991-12#3)
of L-Arm##2##2##(2007-11#2)
of L-DOPA##2##2##(1995-3#2)
of L-NAME##5##2##(1995-12#1)(1995-5#2)(1996-5#1)(1997-7#1)
of L-PHP##3##2##(2013-7#3)
of L-TGF-beta 1##2##3##(1990-2#2)
of L-ZGP##2##2##(1995-6#2)
of L-acetylcarnitine in##2##3##(1990-3#1)(2008-7#1)
of L-acetylcarnitine##3##2##(1990-3#2)(2008-7#1)
of L-arginine or total amino acids##2##6##(1990-12#2)
of L-arginine or##3##3##(1990-12#3)
of L-arginine to##3##3##(1991-12#1)(1995-11#1)(2008-10#1)
of L-arginine##19##2##(1990-12#6)(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-11#2)(1995-12#2)(1997-2#2)(1997-7#1)(2008-10#1)(2009-2#1)
of L-ascorbic acid for##2##4##(2013-1#2)
of L-ascorbic acid##5##3##(1993-12#1)(2008-11#1)(2013-1#3)
of L-ascorbic##6##2##(1993-12#1)(2008-11#1)(2013-1#4)
of L-carnitine##6##2##(1991-12#2)(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
of L-chain##2##2##(1995-2#2)
of L-deprenyl##6##2##(1994-6#5)(2008-7#1)
of L-dopa##5##2##(1990-8#1)(2008-10#4)
of L-glutamate##2##2##(1996-5#1)(2008-7#1)
of L-histidine##8##2##(1995-8#3)(2008-11#5)
of L-lactic acid##5##3##(2008-6#4)(2008-7#1)
of L-leucine##7##2##(1990-2#1)(2008-11#6)
of L-pABA##2##2##(1990-8#2)
of L-proline##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
of L-selectin positive##2##3##(2008-10#2)
of L-selectin##7##2##(1992-12#3)(1996-2#1)(2008-10#3)
of L-type##3##2##(1997-2#3)
of L-tyrosine##2##2##(2008-10#2)
of L1 in##2##3##(1995-2#1)(1996-12#1)
of L1##7##2##(1991-11#1)(1995-2#3)(1996-12#2)(2008-11#1)
of L16C5 and##2##3##(2008-10#2)
of L16C5##4##2##(2008-10#4)
of L3##4##2##(1991-11#2)(1991-2#1)(2008-10#1)
of L3-L4##2##2##(2007-11#1)(2011-2#1)
of L6##3##2##(1992-6#1)(2008-11#1)(2010-10#1)
of L8057##3##2##(1991-12#3)
of L929 cells##2##3##(1990-12#1)(2008-5#1)
of L929##3##2##(1990-12#1)(2008-11#1)(2008-5#1)
of LA##5##2##(1992-5#1)(2008-5#4)
of LAB##4##2##(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)
of LADA##2##2##(2008-3#2)
of LAIV and TIV##2##4##(2011-2#2)
of LAIV##3##2##(2011-2#3)
of LANs##2##2##(1994-12#1)(2008-7#1)
of LAS##3##2##(2008-10#3)
of LATEBLIGHT##2##2##(2008-10#2)
of LBP##2##2##(2010-3#1)(2012-12#1)
of LBVV##3##2##(2008-10#3)
of LC##3##2##(1995-12#1)(2008-10#2)
of LC-MS##2##2##(2010-4#2)
of LCAT##3##2##(1993-6#2)(1993-8#1)
of LChD##2##2##(2008-10#2)
of LD muscle##2##3##(2010-4#2)
of LD##5##2##(2008-12#2)(2008-7#1)(2010-4#2)
of LDH was##3##3##(2008-11#3)
of LDH##10##2##(1992-11#2)(1993-12#1)(1994-2#1)(2008-11#5)(2011-2#1)
of LDL and##4##3##(1992-5#1)(1994-9#1)(2008-10#2)
of LDL by##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
of LDL oxidation##2##3##(1995-12#1)(1996-11#1)
of LDL particle##2##3##(2011-1#2)
of LDL receptor##4##3##(1990-2#1)(1990-7#3)
of LDL to oxidation##3##4##(1991-12#1)(1995-12#1)(1996-3#1)
of LDL to oxidative modification##2##5##(1995-12#2)
of LDL to##7##3##(1991-12#1)(1991-5#1)(1995-12#3)(1995-5#1)(1996-3#1)
of LDL with##4##3##(1994-8#1)(2008-3#1)(2009-8#1)(2013-1#1)
of LDL##53##2##(1990-11#2)(1990-2#1)(1990-7#3)(1991-12#3)(1991-2#1)(1991-5#2)(1992-5#2)(1994-3#1)(1994-8#1)(1994-9#5)(1995-12#6)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(2008-10#4)(2008-3#3)(2008-6#1)(2008-9#1)(2009-8#6)(2011-1#2)(2013-1#2)
of LDL-R##2##2##(2008-8#2)
of LDL-cholesterol##3##2##(1990-12#1)(1993-12#1)(2008-1#1)
of LDR in##2##3##(2008-7#2)
of LDR##5##2##(2008-7#3)(2013-1#2)
of LEAP##2##2##(1996-3#2)
of LED##2##2##(2008-3#2)
of LEDGF/p75-IN##2##2##(2013-1#2)
of LEH##4##2##(1994-11#3)(1994-12#1)
of LFLX##2##2##(2008-10#2)
of LH beta mRNA levels##2##5##(1997-2#2)
of LH beta mRNA##10##4##(1997-2#10)
of LH beta##11##3##(1997-2#11)
of LH receptor mRNA##2##4##(2008-5#2)
of LH##20##2##(1995-2#2)(1995-3#2)(1997-2#12)(2008-5#2)(2010-3#1)(2013-8#1)
of LH-RH##2##2##(1993-1#2)
of LHR mRNA##4##3##(2008-8#4)
of LHRH agonists##2##3##(2008-4#2)
of LHRH analogues##2##3##(2008-4#2)
of LHRH##5##2##(2008-4#5)
of LIF to##2##3##(2008-11#2)
of LIF##13##2##(1995-2#2)(1997-7#3)(2008-10#1)(2008-11#4)(2008-3#2)(2009-3#1)
of LIGO##2##2##(2008-3#2)
of LII for##2##3##(2008-2#2)
of LII##4##2##(2008-2#4)
of LIR was##3##3##(2008-9#3)
of LL##2##2##(2007-7#1)(2012-1#1)
of LLC-PK(1) cells##2##3##(2008-7#2)
of LLC-PK1A cells##2##3##(1992-5#2)
of LLD##2##2##(2008-11#2)
of LM##2##2##(1992-5#2)
of LMM##3##2##(2011-2#3)
of LMP2##3##2##(2012-2#3)
of LMWH##4##2##(2007-10#1)(2008-1#3)
of LNA##3##2##(2008-4#3)
of LNK##3##2##(2012-2#3)
of LOMM##2##2##(2008-3#2)
of LOOH##2##2##(2008-10#1)(2008-11#1)
of LOV##3##2##(2011-1#3)
of LP##5##2##(2007-7#2)(2008-10#1)(2008-12#2)
of LP2179##3##2##(2010-10#3)
of LPA signaling##2##3##(2010-3#2)
of LPA##4##2##(2010-3#4)
of LPG##2##2##(2008-10#2)
of LPL in##2##3##(1992-12#1)(2008-11#1)
of LPL##5##2##(1992-12#1)(1992-3#3)(2008-11#1)
of LPS##8##2##(1992-3#1)(1993-11#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2012-1#1)
of LRI##2##2##(1994-2#2)
of LS##4##2##(2008-1#1)(2008-10#1)(2012-3#2)
of LS-11##3##2##(2008-10#3)
of LSCs##2##2##(2011-2#2)
of LSD##2##2##(1997-7#2)
of LSI##2##2##(2010-11#2)
of LT##4##2##(1990-9#1)(1994-2#3)
of LTB4##2##2##(1991-8#2)
of LTC##4##2##(1992-12#1)(1996-2#1)(1997-3#1)(2009-4#1)
of LTP in##3##3##(1996-2#2)(2008-7#1)
of LTP was##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
of LTP##19##2##(1993-12#1)(1995-12#3)(1995-2#2)(1996-2#2)(1997-2#4)(2008-7#6)(2012-3#1)
of LTs##2##2##(1994-8#2)
of LV##7##2##(2008-10#2)(2011-2#5)
of LVH##3##2##(2009-1#2)(2010-8#1)
of LVNC##3##2##(2010-4#3)
of LW##2##2##(1992-12#2)
of LXA4 and LXB4##2##4##(1991-5#2)
of LXA4##3##2##(1991-5#3)
of LY 294002##3##3##(2008-4#3)
of LY##5##2##(2008-10#2)(2008-4#3)
of La##5##2##(1992-11#2)(1996-2#1)(2007-10#1)(2009-7#1)
of La(3+)##2##2##(2008-10#1)(2008-9#1)
of La(III)##4##2##(2008-10#4)
of La3+##2##2##(1996-2#1)(1997-2#1)
of Lactobacilli##3##2##(2008-12#3)
of Lactobacillus acidophilus##2##3##(2008-5#2)
of Lactobacillus strains##2##3##(2008-12#1)(2012-2#1)
of Lactobacillus##11##2##(1994-12#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2012-2#2)(2013-1#1)
of Lactococcus lactis##2##3##(2008-6#2)
of Lactococcus##3##2##(2008-6#2)(2008-7#1)
of Lagenaria breviflora##4##3##(2013-7#4)
of Lake Nasser##2##3##(2008-10#2)
of Lake##3##2##(1996-6#1)(2008-10#2)
of Landsat imagery##2##3##(2007-5#2)
of Langerhans in##2##3##(1994-8#1)(2008-1#1)
of Langerhans##12##2##(1994-8#1)(1995-8#2)(1997-4#1)(2007-10#1)(2008-1#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2012-3#1)
of Langmuir##2##2##(2008-10#2)
of Las##3##2##(2008-5#1)(2011-2#2)
of Late##2##2##(2008-10#1)(2011-2#1)
of Latent##2##2##(2008-10#2)
of Lathyrus##2##2##(1993-8#1)(2008-5#1)
of Latin America##4##3##(2008-5#1)(2011-2#2)(2013-1#1)
of Latin American##2##3##(1993-6#1)(2008-12#1)
of Latin##8##2##(1993-1#1)(1993-6#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#2)(2013-1#1)
of Latino youth##2##3##(2012-2#1)(2013-1#1)
of Latino##4##2##(1997-5#2)(2012-2#1)(2013-1#1)
of Latinos##2##2##(2011-2#1)(2013-1#1)
of Layered Learning##2##3##(1995-2#2)
of LeCAS expression##2##3##(2008-10#2)
of LeCAS##3##2##(2008-10#3)
of Lead##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
of Leaf##3##2##(2008-10#3)
of Leaves of Alocasia indica##2##5##(2010-5#1)(2011-1#1)
of Leaves of##3##3##(2010-3#1)(2010-5#1)(2011-1#1)
of Leaves##4##2##(2008-10#1)(2010-3#1)(2010-5#1)(2011-1#1)
of Legionella pneumophila by##2##4##(1990-9#1)(2008-12#1)
of Legionella pneumophila##3##3##(1990-9#1)(2008-12#2)
of Leipzig##3##2##(2008-11#1)(2008-7#2)
of Leishmania chagasi##2##3##(2007-12#1)(2010-12#1)
of Leishmania spp##2##3##(2012-2#2)
of Leishmania##11##2##(2007-12#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-2#4)(2013-1#1)
of Lemon verbena##6##3##(2008-12#6)
of Leptosphaeria maculans##4##3##(2008-10#4)
of Leptospira biflexa##2##3##(2007-7#1)(2008-9#1)
of Leptospira##5##2##(2007-7#1)(2008-9#4)
of Lettuce Drop##2##3##(2008-10#2)
of Lettuce big-vein virus##2##4##(2008-10#2)
of Lettuce##7##2##(2008-10#7)
of Leu 55 Gln mutation in##2##6##(2008-2#2)
of Leu##3##2##(1995-3#1)(2008-2#2)
of Lewis lung carcinoma##2##4##(1991-6#1)(2008-11#1)
of Lewis##7##2##(1991-6#1)(1992-8#1)(1993-12#1)(1994-8#1)(1996-5#2)(2008-11#1)
of Lewisite I##2##3##(2008-11#2)
of Lewy bodies in##2##4##(2008-7#2)
of Lewy bodies##3##3##(2008-7#3)
of Leydig cell cytoplasm##2##4##(1992-12#2)
of Leydig cell##3##3##(1992-12#3)
of Leydig##4##2##(1992-12#3)(1996-5#1)
of Li##3##2##(2008-10#2)(2012-3#1)
of Li(+)##3##2##(2008-10#2)(2008-2#1)
of Li+##2##2##(1990-7#1)(1992-8#1)
of LiCF(3)SO(3) and gamma-LiAlO(2) in composite##2##6##(2008-10#2)
of LiCF(3)SO(3)##3##2##(2008-10#3)
of LiCl##2##2##(1993-6#1)(1995-12#1)
of LiF##2##2##(2007-12#1)(2008-2#1)
of LiMn2O4##2##2##(2013-8#2)
of LiNPh(2) to##2##3##(2008-11#2)
of LiNbO(3)##2##2##(2007-11#2)
of Life##27##2##(1993-3#1)(1994-12#1)(1994-3#3)(1995-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-4#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#5)
of Light##8##2##(1996-12#1)(1996-2#2)(2008-10#5)
of Lilium##4##2##(1995-6#1)(2008-8#2)(2009-12#1)
of Lima##2##2##(2008-3#1)(2008-5#1)
of Lineweaver-Burk##2##2##(2008-10#1)(2010-11#1)
of Listeria monocytogenes to##2##4##(2008-7#1)(2008-9#1)
of Listeria monocytogenes##9##3##(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of Listeria##11##2##(1994-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
of Literature##3##2##(2008-1#1)(2009-8#1)(2012-3#1)
of Little cherry virus##2##4##(2008-10#2)
of Liver##2##2##(1995-4#1)(2009-8#1)
of Lmo2##2##2##(2008-9#2)
of London##7##2##(1990-9#1)(1996-8#2)(1997-8#1)(2007-12#1)(2008-10#1)(2009-10#1)
of Long-Term##2##2##(2010-12#1)(2011-2#1)
of Love waves##2##3##(2008-10#2)
of Lowry##3##2##(2008-10#2)(2008-12#1)
of Lp(a)##3##2##(1993-2#1)(1995-6#1)(2008-6#1)
of Lu(2)O(3)##2##2##(2010-4#2)
of Luminal##3##2##(2010-12#3)
of Lung Cancer##2##3##(2010-8#1)(2013-8#1)
of Lung##3##2##(2010-8#1)(2011-3#1)(2013-8#1)
of Lutzomyia##3##2##(2007-12#3)
of LuxS##2##2##(2009-6#2)
of Ly-49+##2##2##(1995-2#2)
of Lygus hesperus##2##3##(2011-2#2)
of Lyme borreliosis##3##3##(1991-11#1)(1994-6#1)(2008-10#1)
of Lyme disease in##2##4##(1997-3#1)(2008-11#1)
of Lyme disease##11##3##(1992-3#1)(1997-3#9)(2008-11#1)
of Lyme##16##2##(1991-11#1)(1992-3#1)(1994-6#1)(1997-3#9)(2008-10#2)(2008-11#1)(2011-2#1)
of Lynch##2##2##(2011-2#1)(2012-3#1)
of Lys 164 by##2##4##(1992-8#2)
of Lys##4##2##(1992-8#2)(2008-4#1)(2011-2#1)
of Lys199##2##2##(1992-9#2)
of Lysholm##2##2##(2013-1#2)
of Lysiphlebus testaceipes##2##3##(2008-6#1)(2013-8#1)
of M##145##2##(1990-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-11#2)(1994-12#1)(1995-2#3)(1997-3#2)(2007-12#4)(2007-8#1)(2008-10#76)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#6)(2008-6#5)(2008-7#6)(2008-9#4)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#7)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
of M(2) approximately##3##3##(2007-11#1)(2008-3#2)
of M(r) =##2##3##(1992-9#1)(1994-2#1)
of M(r)##5##2##(1992-12#1)(1992-9#1)(1993-9#1)(1994-2#1)(2010-4#1)
of M-CSF##3##2##(1990-5#1)(1991-5#1)(1994-6#1)
of M1 and M2##2##4##(1992-10#1)(1996-5#1)
of M1##3##2##(1992-10#1)(1996-5#1)(2013-1#1)
of M2##2##2##(1990-2#1)(2008-3#1)
of M344##2##2##(2010-6#2)
of M79##3##2##(2008-8#3)
of MA and##2##3##(1994-2#1)(2008-2#1)
of MA##3##2##(1990-8#1)(1994-2#1)(2008-2#1)
of MAC disease##2##3##(2007-12#2)
of MAE extracts##2##3##(2008-10#2)
of MAO-B##3##2##(1992-11#3)
of MAP kinase##5##3##(1992-8#2)(1993-8#2)(1995-8#1)
of MAP##9##2##(1992-8#2)(1993-8#2)(1995-8#1)(1997-6#1)(2008-10#1)(2009-7#1)(2013-7#1)
of MAPK activation##2##3##(2008-10#1)(2008-11#1)
of MAPK signaling##2##3##(2008-11#1)(2010-12#1)
of MAPK##12##2##(2008-10#1)(2008-11#3)(2008-4#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
of MAPKK##2##2##(1995-2#2)
of MAPKs##6##2##(1995-6#2)(2008-9#2)(2009-6#1)(2009-8#1)
of MAT-1##2##2##(2008-10#2)
of MAb##4##2##(1994-5#1)(2008-11#3)
of MB and NMB on##2##5##(2008-10#2)
of MB and##3##3##(2008-10#3)
of MB##10##2##(2008-10#10)
of MB-ODNs##2##2##(2008-4#2)
of MBCK I##2##3##(1993-6#2)
of MBL##2##2##(2012-3#2)
of MBP##5##2##(1992-9#2)(1993-3#1)(1993-6#1)(2012-3#1)
of MC##7##2##(1993-11#1)(1995-2#2)(2011-1#1)(2011-2#1)(2012-12#2)
of MC-540##2##2##(1992-6#2)
of MCA##3##2##(1995-6#1)(1996-6#1)(2008-10#1)
of MCAO##2##2##(1997-2#1)(2007-10#1)
of MCC##7##2##(2011-2#2)(2013-1#3)(2013-8#2)
of MCD##2##2##(2008-1#2)
of MCE##2##2##(2011-2#2)
of MCF-7 cells##6##3##(1993-1#1)(1993-9#1)(2008-11#4)
of MCF-7##9##2##(1993-1#1)(1993-9#1)(1994-11#1)(2008-11#6)
of MCI in PD##2##4##(2008-6#2)
of MCI##6##2##(2008-5#1)(2008-6#2)(2013-1#1)(2013-8#2)
of MCL##2##2##(2009-1#1)(2009-8#1)
of MCO##2##2##(2012-2#2)
of MCP##4##2##(2008-10#2)(2008-3#2)
of MCs##4##2##(2008-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
of MD##2##2##(1996-5#1)(2008-10#1)
of MDA in##2##3##(2007-12#1)(2008-12#1)
of MDA##8##2##(1996-2#3)(2007-12#3)(2008-12#2)
of MDA-MB-231 cells##2##3##(1993-9#1)(2013-1#1)
of MDC##2##2##(1990-8#1)(2010-3#1)
of MDCK4##2##2##(1992-5#2)
of MDCT##4##2##(2008-7#2)(2011-2#1)(2012-2#1)
of MDD##5##2##(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
of MDL##2##2##(1996-2#2)
of MDM2 inhibitors##2##3##(2013-1#2)
of MDM2##7##2##(1994-12#1)(2011-2#1)(2013-1#5)
of MDR TB##2##3##(2011-2#2)
of MDR##9##2##(1990-2#1)(2008-11#4)(2010-2#1)(2010-4#1)(2011-2#2)
of MDR-TB##4##2##(2007-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
of MDR-associated##2##2##(2008-11#2)
of MDR1 expression##2##3##(2007-10#2)
of MDR1##9##2##(1995-11#5)(2007-10#3)(2008-11#1)
of MDS##3##2##(2008-11#1)(2009-8#1)(2012-12#1)
of MDSS2N##2##2##(2008-11#2)
of MDV##2##2##(2007-6#2)
of MDX##2##2##(1992-12#2)
of ME49##2##2##(1992-8#2)
of MEDLINE and##3##3##(1994-3#1)(2013-1#2)
of MEDLINE##6##2##(1991-1#1)(1992-12#1)(1994-3#1)(1995-1#1)(2013-1#2)
of MEFs##3##2##(2008-2#2)(2010-3#1)
of MEL##6##2##(1993-6#1)(2010-8#5)
of MEP##2##2##(2008-11#1)(2008-7#1)
of MES##3##2##(2007-8#3)
of MFH##2##2##(2008-6#2)
of MG##10##2##(1997-6#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2012-12#1)(2012-2#1)
of MGMT##3##2##(1992-3#3)
of MHC class I molecules on##2##6##(2008-8#2)
of MHC class I molecules##4##5##(2008-11#1)(2008-8#3)
of MHC class I##8##4##(1995-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-8#4)
of MHC class##11##3##(1993-6#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#5)
of MHC##14##2##(1993-6#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-8#6)
of MHO##2##2##(2013-1#2)
of MI##6##2##(2007-8#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#2)
of MICA/B and ULBP2##2##4##(2013-1#2)
of MIPS##3##2##(2012-3#3)
of MK-447##5##2##(1991-8#5)
of MK-801##4##2##(1990-5#3)(1991-2#1)
of MKL-4##3##2##(1994-12#3)
of MLA##2##2##(1996-9#2)
of MLC kinase##2##3##(1992-9#2)
of MLC##5##2##(1992-9#4)(2010-11#1)
of MLC20##5##2##(1994-11#5)
of MLC601##2##2##(2013-1#2)
of MLCK##3##2##(1991-2#1)(1992-6#2)
of MLD##2##2##(1997-3#1)(2008-10#1)
of MLT##2##2##(2013-7#2)
of MM##3##2##(1990-12#1)(2010-12#2)
of MM-related bone disease##2##4##(2008-7#2)
of MMA##2##2##(2008-10#1)(2010-8#1)
of MMD##2##2##(2008-10#1)(2013-1#1)
of MMP##3##2##(1997-4#2)(2008-5#1)
of MMP-1##4##2##(2008-4#1)(2008-5#2)(2012-3#1)
of MMP-2 and##3##3##(2008-9#1)(2009-3#1)(2013-7#1)
of MMP-2##7##2##(1992-9#2)(2008-9#2)(2009-3#1)(2013-7#1)(2013-8#1)
of MMPs##4##2##(2008-11#2)(2008-4#2)
of MMTV##2##2##(1994-11#1)(1994-7#1)
of MNU##2##2##(1994-5#2)
of MO##2##2##(2008-3#1)(2013-8#1)
of MOEE##4##2##(2008-10#4)
of MORs##2##2##(2009-7#2)
of MP activity##2##3##(1991-8#2)
of MP affinity to RNA##2##5##(1997-3#2)
of MP##6##2##(1991-8#4)(1997-3#2)
of MPA##5##2##(1993-1#4)(2008-10#1)
of MPD##5##2##(2008-10#1)(2012-2#4)
of MPI##3##2##(1995-2#2)(2013-1#1)
of MPO##4##2##(1992-10#3)(2008-12#1)
of MPTP##5##2##(1990-7#2)(1992-11#1)(2008-7#2)
of MPs##2##2##(2007-11#1)(2008-7#1)
of MR imaging in##2##4##(2012-12#1)(2012-2#1)
of MR imaging##3##3##(1997-8#1)(2012-12#1)(2012-2#1)
of MR##13##2##(1990-10#2)(1990-11#2)(1992-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#2)
of MRA##3##2##(1997-8#1)(2008-7#2)
of MRD##4##2##(2011-2#4)
of MRI and##2##3##(2007-11#1)(2012-3#1)
of MRI in the diagnosis of##2##6##(2008-1#1)(2011-2#1)
of MRI in the diagnosis##3##5##(1996-11#1)(2008-1#1)(2011-2#1)
of MRI in the##4##4##(1996-11#1)(2008-1#1)(2010-12#1)(2011-2#1)
of MRI in##9##3##(1994-2#1)(1996-11#1)(1996-8#1)(2008-1#2)(2010-12#2)(2011-2#1)(2012-12#1)
of MRI##27##2##(1992-3#1)(1994-2#1)(1995-1#1)(1996-11#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-1#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
of MRL(+/+) mice##2##3##(2008-10#2)
of MRP##2##2##(2008-11#2)
of MRSA##6##2##(1996-11#3)(2010-8#2)(2012-2#1)
of MS and##4##3##(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
of MS patients##4##3##(1995-12#1)(2010-12#2)(2012-3#1)
of MS score##3##3##(2011-1#3)
of MS score/MS components aggregation was##2##6##(2011-1#2)
of MS were##2##3##(2011-1#1)(2013-1#1)
of MS##35##2##(1995-12#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-7#5)(2010-11#1)(2010-12#5)(2011-1#9)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#2)
of MSAFP##3##2##(1996-12#1)(2011-2#2)
of MSC##6##2##(2008-5#4)(2011-1#1)(2013-8#1)
of MSCs for##4##3##(2008-11#1)(2009-10#1)(2012-12#2)
of MSCs##8##2##(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#4)(2012-7#1)
of MSOPD##2##2##(2008-10#2)
of MSP##3##2##(2008-8#3)
of MSV resistance##2##3##(2008-10#2)
of MT in the##2##4##(1995-3#1)(2008-10#1)
of MT in##6##3##(1995-3#1)(2008-10#3)(2008-11#2)
of MT##26##2##(1992-6#1)(1995-3#3)(1996-12#4)(2008-10#10)(2008-11#7)(2013-7#1)
of MTBE##4##2##(2008-12#3)(2009-8#1)
of MTBI##3##2##(1997-2#3)
of MTC##3##2##(2008-7#3)
of MTU##2##2##(2008-10#2)
of MTX treatment##2##3##(1992-8#2)
of MTX uptake##2##3##(1992-8#2)
of MTX##8##2##(1992-8#6)(1995-2#1)(2006-10#1)
of MTs##7##2##(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-7#3)
of MUAP##2##2##(1993-9#2)
of MVA##3##2##(1995-12#2)(2013-8#1)
of MVC##2##2##(1993-12#2)
of MVP1-4##4##2##(2008-10#4)
of MVT##2##2##(2011-2#2)
of MW##2##2##(2008-1#1)(2013-8#1)
of MY##3##2##(2008-10#3)
of MYCN amplification##2##3##(2011-2#2)
of MYCN amplified##2##3##(2011-2#2)
of MYCN##6##2##(2011-2#6)
of MaYMFV##2##2##(2008-10#2)
of Macroptilium##2##2##(2008-10#2)
of Madopar##2##2##(2008-7#2)
of Madrid honeys##2##3##(2011-2#2)
of Madrid##7##2##(2008-10#2)(2008-11#2)(2011-2#3)
of MafA##2##2##(2012-2#2)
of Magnaporthe grisea##11##3##(2008-10#11)
of Magnaporthe oryzae in##2##4##(2008-10#1)(2012-2#1)
of Magnaporthe oryzae##7##3##(2008-10#6)(2012-2#1)
of Magnaporthe##18##2##(2008-10#17)(2012-2#1)
of Maharashtra##2##2##(2009-10#1)(2013-8#1)
of Maine's##2##2##(1991-1#1)(2008-5#1)
of Maize Streak Virus##2##4##(2008-10#2)
of Maize streak virus##2##4##(2008-10#2)
of Maize##10##2##(2008-10#10)
of Major##2##2##(2008-10#1)(2008-6#1)
of Majuro##2##2##(2008-1#2)
of Malaria##3##2##(2007-2#1)(2012-2#2)
of Malassezia spp##2##3##(2008-5#2)
of Malassezia##3##2##(2008-5#2)(2010-6#1)
of Malathion##4##2##(2008-10#2)(2008-11#2)
of Malaysia##4##2##(2008-12#2)(2011-1#2)
of Malaysian##6##2##(2008-10#1)(2008-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
of Malignant##2##2##(2012-3#1)(2013-1#1)
of Mammalian##4##2##(1994-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
of Management Scheme on Control of Imported Falciparum##2##8##(2012-3#2)
of Manchester##4##2##(2008-11#1)(2008-7#3)
of Mancozeb and##2##3##(2008-10#2)
of Mancozeb##4##2##(2008-10#4)
of Manduca sexta##2##3##(1995-6#1)(2007-12#1)
of Mango##2##2##(2008-10#2)
of Mansonia##2##2##(2008-12#1)(2008-5#1)
of Mao-to##3##2##(2010-7#3)
of March##2##2##(1996-6#1)(2012-2#1)
of Marek's disease virus serotype##2##5##(2008-5#2)
of Marek's disease##3##3##(2007-6#1)(2008-5#2)
of Marfan syndrome##4##3##(2012-1#1)(2013-1#3)
of Marine##2##2##(2007-5#1)(2007-8#1)
of Markov##2##2##(1995-12#1)(2008-7#1)
of Martin##2##2##(2008-3#1)(2012-3#1)
of Massachusetts adults identified as##2##5##(2008-12#2)
of Massachusetts##8##2##(1993-3#1)(1995-1#1)(1996-1#1)(1997-2#2)(2008-11#1)(2008-12#2)
of Maternal##4##2##(1996-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
of Matlab##2##2##(2008-6#1)(2013-8#1)
of Mato Grosso##3##3##(1991-12#1)(2010-8#1)(2013-7#1)
of Matrigel##2##2##(2008-11#2)
of Maximal##4##2##(2008-5#1)(2008-7#3)
of Maxwell's equations##2##3##(2007-12#1)(2008-2#1)
of Maxwell's##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of May to##2##3##(2007-7#1)(2008-10#1)
of May##4##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
of Mb##2##2##(2008-10#2)
of Mb-PAM films##3##3##(2008-10#3)
of Mdm2SNP309##2##2##(2011-2#2)
of MeBr##3##2##(1995-3#3)
of MeHg##2##2##(2008-10#2)
of Meckel's diverticulum##3##3##(1990-6#2)(2009-8#1)
of Meckel's##4##2##(1990-6#2)(1991-5#1)(2009-8#1)
of Medicago truncatula##2##3##(2008-10#1)(2008-7#1)
of Medicago##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)
of Medicaid and##2##3##(1992-2#2)
of Medicaid eligibility##3##3##(1992-2#2)(1994-2#1)
of Medicaid expenditure growth##2##4##(1996-1#2)
of Medicaid expenditures##2##3##(1995-1#1)(1995-2#1)
of Medicaid managed care##2##4##(1995-12#1)(1996-12#1)
of Medicaid recipients##2##3##(1994-2#1)(1994-3#1)
of Medicaid##26##2##(1992-1#2)(1992-2#6)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#3)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#3)(1996-12#1)(1997-2#1)(2013-1#1)
of Medical Microbiology##2##3##(2007-12#1)(2007-7#1)
of Medical Oncology##2##3##(1991-3#1)(1991-6#1)
of Medical Psychology##2##3##(2013-1#2)
of Medical Research##3##3##(1996-4#1)(2008-7#1)(2012-2#1)
of Medical Sciences##13##3##(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
of Medical electrical equipment##2##4##(2012-3#2)
of Medical##43##2##(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#1)(1996-11#2)(1996-4#1)(1997-1#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#2)
of Medicare and Medicaid##5##4##(1991-2#1)(1991-3#1)(1992-12#1)(1996-2#1)(1996-3#1)
of Medicare and##6##3##(1991-2#1)(1991-3#1)(1992-12#1)(1996-12#1)(1996-2#1)(1996-3#1)
of Medicare beneficiaries have private supplementary##2##6##(1991-2#1)(1996-3#1)
of Medicare beneficiaries##6##3##(1991-2#1)(1993-1#1)(1994-3#1)(1995-12#2)(1996-3#1)
of Medicare data##2##3##(1992-11#1)(1997-3#1)
of Medicare discharges##2##3##(1993-1#1)(1993-12#1)
of Medicare home health##2##4##(1994-2#1)(1995-3#1)
of Medicare payment##2##3##(1991-12#1)(1994-12#1)
of Medicare##41##2##(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#3)(1996-12#2)(1996-2#1)(1996-3#3)(1997-2#2)(1997-3#1)(2008-7#1)(2012-3#1)
of Medicare's RBRVS##3##3##(1994-12#3)
of Medicare's##6##2##(1994-12#3)(1994-2#1)(1996-3#1)(1997-3#1)
of Medicare-covered##3##2##(1994-2#1)(1995-3#1)(1997-1#1)
of Medicinal##2##2##(2008-5#1)(2010-3#1)
of Medicine and Health Sciences##2##5##(2008-1#2)
of Medicine and##5##3##(1996-9#1)(1997-2#1)(2008-1#2)(2012-3#1)
of Medicine in##4##3##(1993-11#1)(2006-12#1)(2007-11#1)(2010-1#1)
of Medicine of the University of##3##6##(1994-2#1)(2008-10#1)(2009-7#1)
of Medicine of the##5##4##(1991-12#1)(1994-2#1)(2008-10#1)(2009-7#1)(2010-4#1)
of Medicine of##9##3##(1991-12#1)(1992-1#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-7#1)(2010-4#1)(2012-3#2)
of Medicine was##2##3##(1996-3#1)(2013-1#1)
of Medicine##75##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#4)(1992-2#1)(1993-11#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-12#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#8)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#3)(2009-12#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#5)(2013-1#2)
of Medicine's##5##2##(1993-3#1)(1995-11#1)(1996-1#1)(2008-1#1)(2013-1#1)
of Medicines##2##2##(1997-1#1)(2008-11#1)
of Mediterranean fruit fly##2##4##(2008-11#1)(2008-3#1)
of Mediterranean##4##2##(2008-11#1)(2008-3#1)(2011-2#2)
of Megapitaria squalida##2##3##(2008-5#2)
of Meharry Medical College##2##4##(2012-3#2)
of Melampsora##2##2##(2008-10#2)
of Meldola's blue##2##3##(2008-10#2)
of Melipona subnitida Ducke##2##4##(2008-6#2)
of Meloidogyne chitwoodi and M##2##5##(2008-10#2)
of Meloidogyne##5##2##(2008-10#5)
of MenACWY-CRM in##2##3##(2013-1#2)
of Mental Disorders##13##3##(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#6)(2013-1#1)
of Mental Health Problems##2##4##(2010-12#1)(2013-1#1)
of Mental Health##6##3##(1995-1#1)(1995-2#1)(1997-5#1)(2010-12#1)(2013-1#2)
of Mental##20##2##(1995-1#1)(1995-2#1)(1997-5#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#7)(2013-1#3)
of Mentha piperita L##2##4##(2008-10#1)(2013-1#1)
of Mentha pulegium L##2##4##(2008-10#2)
of Mentha##7##2##(2008-10#3)(2013-1#4)
of Merkel cell##2##3##(1993-3#1)(2013-1#1)
of Met##2##2##(1990-8#1)(2008-10#1)
of MetS##4##2##(2010-10#2)(2013-8#2)
of Metabolic##2##2##(2008-11#1)(2013-1#1)
of Metarhizium anisopliae (Metsch##2##4##(2008-6#2)
of Metarhizium anisopliae chlamydospores in tick eggs##2##7##(2010-10#2)
of Metarhizium anisopliae##6##3##(2008-6#4)(2010-10#2)
of Mexican American##2##3##(2007-12#1)(2010-2#1)
of Mexican##9##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
of Mexico##13##2##(2008-10#4)(2008-3#1)(2008-5#4)(2011-2#1)(2012-3#1)(2013-7#2)
of Mexico]##4##2##(2008-5#4)
of Meynert##4##2##(1995-5#2)(1997-2#1)(2008-9#1)
of Mg##3##2##(2008-10#3)
of Mg(2+) and K(+)##2##4##(2008-10#1)(2008-9#1)
of Mg(2+) and##4##3##(2008-10#2)(2008-9#2)
of Mg(2+) and/or vitamin D(2) into pure DPPC liposomes##2##9##(2008-10#2)
of Mg(2+) in##3##3##(2008-10#1)(2013-1#2)
of Mg(2+) with##3##3##(2008-10#3)
of Mg(2+)##23##2##(2008-10#16)(2008-8#2)(2008-9#3)(2013-1#2)
of Mg(CH3COO)2##2##2##(1995-3#2)
of Mg2+##11##2##(1990-5#1)(1991-9#1)(1992-3#3)(1993-6#2)(1995-3#1)(1995-5#2)(2008-4#1)
of MgADP and##2##3##(1993-11#2)
of MgADP##4##2##(1992-3#2)(1993-11#2)
of MgAl2O4##2##2##(2013-8#2)
of MgAl2O4/Ce##2##2##(2013-8#2)
of MgCl2##3##2##(1990-7#2)(1991-5#1)
of MgO##2##2##(2007-11#1)(2008-2#1)
of MgSO(4)##2##2##(2008-10#1)(2008-7#1)
of MhNPR1##2##2##(2011-10#2)
of Mhc genes##2##3##(2008-8#2)
of Mhc##3##2##(2008-8#3)
of MiLV##2##2##(2008-10#2)
of Mibelli##2##2##(2007-7#2)
of Michel##2##2##(2012-3#1)(2013-1#1)
of Michigan##11##2##(1991-1#1)(1991-3#1)(1994-1#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-7#1)(2008-11#1)
of MicroRNAs##2##2##(2010-1#1)(2011-1#1)
of Microbiology of##2##3##(2010-1#1)(2010-12#1)
of Micrococcus luteus##2##3##(2008-10#1)(2008-12#1)
of Micronesia##10##2##(2008-1#2)(2008-10#3)(2013-8#5)
of Microsatellite##2##2##(2008-10#1)(2013-8#1)
of Microsomacanthus##2##2##(2011-2#2)
of Microsphaeropsis sp##5##3##(2008-10#5)
of Microsphaeropsis##6##2##(2008-10#6)
of Middle Age##2##3##(2008-10#2)
of Middle##4##2##(2008-10#3)(2008-12#1)
of Mie scattering##4##3##(2008-2#2)(2008-3#2)
of Mie theory##6##3##(2007-11#1)(2008-2#4)(2008-3#1)
of Mie##11##2##(2007-11#1)(2008-2#7)(2008-3#3)
of Milan##4##2##(1991-12#1)(1993-6#1)(2008-10#1)(2011-2#1)
of Milsana##4##2##(2008-10#4)
of Minas Gerais##6##3##(2008-5#1)(2008-6#3)(2010-10#1)(2012-3#1)
of Minnesota Employee Group Insurance Program##2##6##(1994-3#1)(1997-3#1)
of Mississippi Medical Center##2##4##(2009-3#2)
of Mississippi##5##2##(2008-8#1)(2009-3#3)(2010-9#1)
of Mitochondrial DNA##2##3##(2008-6#2)
of Mitochondrial##3##2##(2008-5#1)(2008-6#2)
of Mn##12##2##(2008-10#12)
of Mn(II)##8##2##(2008-10#8)
of Mn2+##5##2##(1992-5#4)(1995-6#1)
of MnP##3##2##(2008-7#3)
of MnSOD mRNA by irradiation##2##5##(1995-6#2)
of MnSOD mRNA##3##3##(1995-6#3)
of MnSOD##8##2##(1994-6#1)(1995-6#5)(2008-5#1)(2012-2#1)
of Mo and Bi in steels##2##6##(2008-10#2)
of Mo in the##2##4##(2008-10#2)
of Mo in##3##3##(2008-10#3)
of Mo##11##2##(2008-10#11)
of Mo(VI) and##2##3##(2008-10#2)
of Mo(VI) with##2##3##(2008-10#2)
of Mo(VI)##7##2##(2008-10#7)
of Mo/Si##3##2##(2008-2#1)(2008-3#2)
of Mo17##2##2##(2008-10#2)
of MoAb##2##2##(1993-1#1)(2008-11#1)
of Modena##4##2##(1990-3#1)(2008-10#2)(2008-11#1)
of Molecular Ecology##3##3##(2013-1#3)
of Molecular##9##2##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#3)
of Monastir##2##2##(2007-8#2)
of Monilinia fructicola##5##3##(2008-10#5)
of Monilinia vaccinii-corymbosi##2##3##(2008-10#2)
of Monilinia##9##2##(2008-10#9)
of Monte Carlo simulation##3##4##(2008-3#2)(2013-8#1)
of Monte Carlo simulations##2##4##(2008-2#1)(2008-3#1)
of Monte Carlo##7##3##(2008-2#1)(2008-3#3)(2008-7#1)(2010-9#1)(2013-8#1)
of Monte-Carlo##2##2##(2008-10#2)
of Monterrey##2##2##(2011-1#2)
of Moraxella sp##3##3##(1997-6#3)
of Moraxella##4##2##(1997-6#3)(2013-8#1)
of Moringa oleifera Lam##3##4##(2008-10#3)
of Moringa oleifera##5##3##(2008-10#5)
of Mortality##2##2##(2008-7#1)(2012-1#1)
of Morton's##2##2##(2007-11#2)
of Motor oils##2##3##(2008-10#2)
of Motor##4##2##(2008-10#3)(2011-8#1)
of Mouse##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
of Moutan Cortex##4##3##(2008-10#4)
of Mr##12##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-10#2)(1991-5#1)(1991-9#2)(1997-9#1)(2008-11#1)
of Mre11##3##2##(2011-2#3)
of Msx1##3##2##(2012-12#3)
of Mt##7##2##(2007-2#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
of Mtx##3##2##(2008-10#2)(2011-2#1)
of Mucor circinelloides##2##3##(2008-8#2)
of Muir-Torre##2##2##(1991-6#1)(2010-8#1)
of Mulberry##2##2##(2008-10#2)
of MultiHance for##2##3##(2008-7#2)
of MultiHance##4##2##(2008-7#4)
of Multiple##2##2##(2008-2#1)(2009-2#1)
of Muscat grapes##2##3##(2008-10#2)
of Mustela##2##2##(2008-6#2)
of MxA mRNA##3##3##(2008-7#3)
of My##3##2##(2008-12#1)(2010-7#2)
of Myc##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
of Mycelium of##2##3##(2008-10#2)
of Mycobacterium marinum##2##3##(2008-9#2)
of Mycobacterium tuberculosis (M##2##4##(2008-10#1)(2008-5#1)
of Mycobacterium tuberculosis and Mycobacterium bovis##2##6##(2012-3#2)
of Mycobacterium tuberculosis##22##3##(1990-9#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#6)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of Mycobacterium##29##2##(1990-9#1)(1991-8#1)(1993-11#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#8)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
of Mycoplasma meleagridis##2##3##(2008-5#2)
of Mycoplasma##10##2##(1992-5#1)(1994-12#1)(1997-3#1)(2008-1#1)(2008-5#2)(2010-6#1)(2010-9#1)(2011-2#1)(2013-8#1)
of Mycosphaerella citri##3##3##(2008-10#3)
of Mycosphaerella fijiensis##2##3##(2008-10#2)
of Mycosphaerella graminicola were##2##4##(2008-10#2)
of Mycosphaerella graminicola##19##3##(2008-10#18)(2011-10#1)
of Mycosphaerella spp##3##3##(2008-10#3)
of Mycosphaerella##31##2##(2008-10#30)(2011-10#1)
of Myf5##2##2##(1996-2#2)
of Myo-D1##7##2##(1993-2#6)(1994-12#1)
of MyoD1##4##2##(1992-8#4)
of Mytilus##2##2##(1995-8#1)(2010-5#1)
of Myxobacter Sp##2##3##(2009-3#2)
of Mérida##2##2##(2007-10#1)(2008-10#1)
of Müller##2##2##(2008-7#2)
of N =##2##3##(2008-10#1)(2009-4#1)
of N and##4##3##(2008-10#3)(2012-5#1)
of N per##2##3##(2008-10#2)
of N sampling units##2##4##(2008-10#2)
of N##71##2##(1992-1#1)(2007-12#3)(2008-10#39)(2008-12#6)(2008-2#2)(2008-3#3)(2008-5#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2012-5#1)(2012-8#1)(2012-9#1)
of N(2)##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)
of N(6)##2##2##(2012-2#2)
of N(G)-nitro-L-arginine##2##2##(1995-12#1)(1997-7#1)
of N)##2##2##(2008-10#2)
of N-CDAD##5##2##(2007-12#5)
of N-acetyl##2##2##(1992-11#1)(1994-8#1)
of N-acetyl-D-glucosamine##3##2##(1992-6#1)(1997-3#1)(2008-10#1)
of N-acetyl-d-glucosamine and d-glucosamine##2##4##(2008-10#2)
of N-acetylated##3##2##(1993-5#1)(1994-3#1)(2008-4#1)
of N-acetylcysteine and##3##3##(1991-9#2)(2008-11#1)
of N-acetylcysteine in clinical toxicology##2##5##(1991-9#2)
of N-acetylcysteine##11##2##(1991-11#1)(1991-9#8)(2008-10#1)(2008-11#1)
of N-glycan##2##2##(1995-2#1)(2008-11#1)
of N-glycosylation of##2##3##(2013-1#2)
of N-glycosylation##4##2##(1993-6#1)(2013-1#3)
of N-level##2##2##(2008-2#2)
of N-linked glycosylation##3##3##(1992-12#1)(1995-2#1)(2008-4#1)
of N-linked oligosaccharide##3##3##(1992-12#1)(1994-5#1)(2008-7#1)
of N-linked##10##2##(1992-12#2)(1994-5#2)(1995-2#1)(2008-11#1)(2008-4#2)(2008-7#2)
of N-methyl-D-aspartate (NMDA)##5##3##(1995-5#1)(1996-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
of N-methyl-D-aspartate##8##2##(1995-12#2)(1995-5#1)(1996-2#1)(2008-8#1)(2009-8#1)(2012-2#2)
of N-myc##2##2##(1991-4#2)
of N-nitrosodiethanolamine (NDELA) in##2##4##(2008-5#2)
of N-nitrosodiethanolamine##3##2##(2008-5#3)
of N-phenylanthranilic acid in the two-phase systems##2##7##(2008-10#2)
of N-phenylanthranilic acid in the##3##5##(2008-10#3)
of N-phenylanthranilic acid in##4##4##(2008-10#4)
of N-terminal##5##2##(1992-9#2)(1996-12#1)(1997-6#1)(2008-8#1)
of N-terminus##2##2##(1990-12#1)(2008-8#1)
of N-type calcium channels##2##4##(1993-9#1)(2008-8#1)
of N-type##3##2##(1993-9#1)(2008-8#2)
of N1##4##2##(1990-6#1)(1991-8#1)(1995-5#1)(2008-8#1)
of N2 and##3##3##(1990-6#1)(1991-8#1)(2008-10#1)
of N2##5##2##(1990-6#1)(1991-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
of N2O##3##2##(1992-8#1)(1993-1#1)(2008-3#1)
of N3##2##2##(1990-6#1)(1991-8#1)
of N3UDP##2##2##(1993-11#2)
of NA and##3##3##(2008-10#2)(2008-7#1)
of NA##7##2##(2008-10#2)(2008-7#1)(2008-8#3)(2013-8#1)
of NAA and##2##3##(2008-10#2)
of NAA were##2##3##(2007-10#1)(2008-10#1)
of NAA##8##2##(2007-10#2)(2008-10#4)(2008-12#1)(2008-8#1)
of NACP##5##2##(1997-2#5)
of NAD(+) and NADH in normal and cancer tissues##2##9##(2008-10#2)
of NAD(+) and NADH in##3##5##(2008-10#3)
of NAD(P)H##3##2##(1996-2#2)(2008-10#1)
of NAD+##9##2##(1990-10#4)(1990-11#1)(1992-3#1)(1994-11#2)(2008-10#1)
of NADH and##5##3##(1990-10#1)(1990-8#1)(2008-10#3)
of NADH at##2##3##(2008-10#1)(2010-5#1)
of NADH dehydrogenase##3##3##(1990-5#1)(1995-3#2)
of NADH in##2##3##(2008-10#1)(2008-6#1)
of NADH is##3##3##(2008-10#2)(2010-5#1)
of NADH oxidation##3##3##(1990-5#1)(2008-10#1)(2008-6#1)
of NADH##31##2##(1990-10#1)(1990-5#2)(1990-7#1)(1990-8#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-3#2)(1995-5#1)(2008-10#16)(2008-6#2)(2010-5#2)
of NADPH oxidase##14##3##(1990-5#1)(1991-12#2)(1991-5#1)(1993-6#1)(1993-8#3)(1994-6#1)(2008-10#1)(2008-4#1)(2009-12#2)(2013-8#1)
of NADPH##28##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#4)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#5)(1994-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-12#2)(2009-9#1)(2010-12#1)(2013-8#1)
of NADPH-cytochrome P-450 reductase##2##4##(1993-6#2)
of NADPH-cytochrome P450##2##3##(1991-5#1)(1994-8#1)
of NADPH-cytochrome##5##2##(1991-5#1)(1993-6#2)(1994-8#1)(2008-8#1)
of NADPH-dependent cytosolic##3##3##(1991-5#3)
of NADPH-diaphorase##2##2##(1992-12#1)(1995-12#1)
of NADPH-diaphorase-positive perikarya##2##3##(1992-12#2)
of NADPH-diaphorase-positive##3##2##(1992-12#3)
of NAL in##3##3##(2008-10#3)
of NAL##4##2##(2008-10#4)
of NANC##3##2##(1996-5#1)(1997-4#2)
of NAS##2##2##(2009-10#2)
of NAT##4##2##(1994-2#2)(1995-3#1)(2011-2#1)
of NBCCS##2##2##(1997-3#1)(2007-4#1)
of NBD##3##2##(1994-2#2)(2012-3#1)
of NBF1##4##2##(2008-8#4)
of NBL##5##2##(2011-2#5)
of NBS with##2##3##(2008-10#2)
of NBS##5##2##(2008-10#5)
of NCAH##2##2##(2008-1#2)
of NCAM expression##2##3##(1995-5#2)
of NCD##2##2##(2012-12#1)(2013-8#1)
of NCDC##3##2##(1991-12#3)
of NCDs##3##2##(2013-8#3)
of NCKX##3##2##(2008-8#3)
of NCL##3##2##(2009-5#3)
of NCX-4016##3##2##(2008-5#3)
of NDELA##2##2##(2008-5#2)
of NDPK##2##2##(1996-2#2)
of NDV##2##2##(2008-9#2)
of NE##12##2##(1991-11#4)(1994-6#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)
of NEP1##2##2##(2008-10#2)
of NETs##3##2##(2011-2#3)
of NF##3##2##(1991-3#2)(1996-3#1)
of NF-B##3##2##(2010-10#3)
of NF-E2 p45##2##3##(1994-8#2)
of NF-E2##3##2##(1994-8#2)(2008-9#1)
of NF-L##5##2##(2008-8#5)
of NF-M and##3##3##(1997-2#1)(2008-8#2)
of NF-kappa B activation##3##4##(1992-12#1)(1993-3#1)(2008-10#1)
of NF-kappa B##5##3##(1992-12#2)(1993-3#1)(2008-10#1)(2008-11#1)
of NF-kappa##6##2##(1991-7#1)(1992-12#2)(1993-3#1)(2008-10#1)(2008-11#1)
of NF-kappaB activation##2##3##(2008-11#2)
of NF-kappaB in##2##3##(2008-11#1)(2010-3#1)
of NF-kappaB##9##2##(2008-11#4)(2010-3#4)(2010-6#1)
of NF-κB##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
of NF1-GRD##4##2##(1992-8#4)
of NFκB##5##2##(2010-11#1)(2011-2#4)
of NG-monomethyl-L-arginine##5##2##(1992-3#1)(1994-6#1)(1995-12#3)
of NG2(+) cells##3##3##(2008-7#3)
of NGAL##3##2##(2010-5#3)
of NGF and BDNF##2##4##(1994-8#1)(1996-12#1)
of NGF and##3##3##(1991-12#1)(1994-8#1)(1996-12#1)
of NGF in##4##3##(1996-2#1)(2010-8#3)
of NGF##13##2##(1991-12#1)(1993-12#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#1)(2010-8#3)
of NGFI-A mRNA##2##3##(1996-12#2)
of NGFI-B mRNA in##3##4##(1996-12#3)
of NGFI-B mRNA##7##3##(1996-12#7)
of NGFI-B##10##2##(1991-5#1)(1996-12#9)
of NGOs##4##2##(2007-2#3)(2013-1#1)
of NH and##2##3##(2008-2#2)
of NH(3) and CO(2) were##2##5##(2008-3#2)
of NH(3) and CO(2)##5##4##(2008-3#5)
of NH(3) and##6##3##(2008-3#5)(2012-2#1)
of NH(3) gas##3##3##(2008-10#3)
of NH(3) with##2##3##(1997-7#1)(2008-2#1)
of NH(3)##11##2##(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#5)(2012-2#1)
of NH(4)(+)##4##2##(2008-10#4)
of NH(4)H(2)PO(4)##2##2##(2008-10#2)
of NH4Cl##2##2##(1994-6#1)(2008-11#1)
of NHL##3##2##(2007-10#1)(2012-3#1)(2013-1#1)
of NIDDM##3##2##(2008-5#3)
of NIH 3T3 cells##5##4##(1991-12#1)(1993-11#1)(1995-2#3)
of NIH 3T3##6##3##(1991-12#1)(1992-7#1)(1993-11#1)(1995-2#3)
of NIH##7##2##(1990-5#1)(1991-12#1)(1992-7#1)(1993-11#1)(1995-2#3)
of NIR##5##2##(2008-10#4)(2011-1#1)
of NK cells in##2##4##(2008-10#1)(2011-2#1)
of NK cells to##2##4##(2008-8#2)
of NK cells##9##3##(2008-10#4)(2008-8#3)(2011-2#1)(2013-1#1)
of NK##13##2##(1991-1#1)(2008-10#4)(2008-8#4)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of NK-2 receptor##2##3##(1993-3#2)
of NK433##2##2##(1996-2#2)
of NKG2D##3##2##(2011-2#1)(2013-1#2)
of NL-3 K##3##3##(2008-10#3)
of NMDA and##3##3##(1995-12#1)(1995-5#1)(1997-2#1)
of NMDA receptor##5##3##(1993-12#2)(1997-7#1)(2012-12#2)
of NMDA receptors in##2##4##(1990-5#1)(1991-1#1)
of NMDA receptors##8##3##(1990-5#1)(1990-7#1)(1991-1#1)(1996-2#1)(1997-2#1)(2008-7#1)(2009-8#2)
of NMDA##23##2##(1990-5#1)(1990-7#1)(1991-1#1)(1992-8#1)(1993-12#2)(1995-12#1)(1995-5#3)(1996-2#1)(1996-5#1)(1997-2#3)(1997-7#2)(2008-7#1)(2008-8#1)(2009-8#2)(2012-12#2)
of NMDAR1##4##2##(1994-8#1)(1997-2#3)
of NMDAR2B mRNA##2##3##(1996-2#2)
of NMDS##4##2##(1995-5#4)
of NMF##3##2##(2008-10#3)
of NMR spectra##2##3##(1995-3#1)(2008-10#1)
of NMR##3##2##(1995-3#1)(2008-10#1)(2012-2#1)
of NNK by##3##3##(1990-6#2)(1993-11#1)
of NNK##7##2##(1990-6#2)(1992-9#2)(1993-11#3)
of NNN##2##2##(2011-1#2)
of NO and##4##3##(1995-2#1)(2008-10#1)(2008-8#2)
of NO at##2##3##(2008-10#1)(2010-6#1)
of NO from##2##3##(1992-3#1)(2008-10#1)
of NO in the##2##4##(2008-10#1)(2008-2#1)
of NO in##13##3##(1992-5#2)(1993-8#1)(2008-10#3)(2008-2#4)(2008-3#1)(2008-6#1)(2010-12#1)
of NO is##2##3##(1996-2#1)(2008-10#1)
of NO on##2##3##(1995-11#1)(1997-7#1)
of NO production##7##3##(1991-9#1)(1992-5#1)(2006-10#1)(2008-7#3)(2012-2#1)
of NO synthase##9##3##(1991-3#1)(1992-12#2)(1995-11#2)(1997-2#1)(1997-7#1)(2008-3#1)(2008-7#1)
of NO to##2##3##(2008-2#1)(2008-7#1)
of NO##91##2##(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#3)(1992-8#1)(1993-6#1)(1993-8#3)(1994-6#2)(1995-11#3)(1995-2#1)(1995-5#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#6)(2006-10#1)(2008-10#22)(2008-2#9)(2008-3#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)
of NO(2) in the air##2##5##(2008-10#2)
of NO(2) in##3##3##(2008-10#3)
of NO(2)##7##2##(2008-10#4)(2008-11#1)(2008-2#2)
of NO(2)(-)##2##2##(2008-10#2)
of NO2##4##2##(1992-9#1)(1996-12#3)
of NOC##3##2##(2011-1#2)(2013-1#1)
of NOL7##4##2##(2013-1#4)
of NOM##5##2##(2008-10#1)(2008-11#4)
of NOR-1##3##2##(1994-12#1)(1995-12#2)
of NOS that##2##3##(1992-3#1)(2008-5#1)
of NOS##9##2##(1992-3#2)(1994-6#1)(1995-12#3)(2008-5#2)(2011-1#1)
of NP test##2##3##(2010-1#2)
of NP##4##2##(2008-10#2)(2010-1#2)
of NP-III under aerobic conditions##2##5##(1991-2#2)
of NP-III##3##2##(1991-2#3)
of NPC##6##2##(1990-8#2)(1992-6#1)(2008-9#1)(2011-2#2)
of NPH-MCKD complex##2##3##(2007-7#2)
of NPIK##3##2##(1997-8#3)
of NPS##2##2##(2008-7#2)
of NPSLE is##2##3##(2012-3#2)
of NPY and##2##3##(1997-2#1)(1997-4#1)
of NPY##6##2##(1995-3#1)(1997-2#1)(1997-4#4)
of NPY-IR/NADPH-d-negative neurons##2##3##(1997-2#2)
of NPs##2##2##(2012-12#1)(2012-6#1)
of NRK cells##2##3##(1991-12#1)(1991-8#1)
of NRK##4##2##(1991-12#3)(1991-8#1)
of NRT##5##2##(2008-6#1)(2008-9#1)(2012-3#3)
of NS##4##2##(2008-10#4)
of NS0 cells##2##3##(2008-11#2)
of NSAID##2##2##(1991-8#1)(2006-10#1)
of NSAIDs##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)
of NSCLC##5##2##(2008-4#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
of NSCLCs##2##2##(2008-4#2)
of NSCs##5##2##(2008-11#2)(2008-4#1)(2009-10#2)
of NSW##2##2##(1990-2#1)(2011-2#1)
of NSs##2##2##(2008-10#2)
of NT and##2##3##(1996-2#1)(2008-7#1)
of NT##5##2##(1996-2#2)(2008-5#1)(2008-7#1)(2008-9#1)
of NTG##3##2##(1991-9#3)
of NTO and ANTA in##2##5##(2008-11#2)
of NTO and ANTA##3##4##(2008-11#3)
of NXIIts##3##2##(2008-8#3)
of NYT##2##2##(2008-10#2)
of Na and##3##3##(1991-9#1)(2008-10#1)(2008-9#1)
of Na##8##2##(1991-9#1)(1992-8#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-3#1)(2013-8#1)
of Na(+) and##2##3##(2008-10#1)(2008-6#1)
of Na(+)##12##2##(2008-10#7)(2008-6#2)(2008-8#1)(2012-7#1)(2013-1#1)
of Na(+)/K(+)-ATPase##4##2##(2007-12#1)(2008-7#1)(2009-12#2)
of Na(2)O##2##2##(2007-12#1)(2008-10#1)
of Na(v)1##2##2##(2008-8#2)
of Na+ and M2+##2##4##(1991-8#2)
of Na+ channel##2##3##(2008-7#2)
of Na+##11##2##(1990-11#1)(1990-2#1)(1991-8#2)(1992-3#1)(1992-6#1)(1993-3#1)(1995-12#1)(2008-7#2)(2008-8#1)
of Na+/H+ exchange##2##3##(1992-10#1)(1995-8#1)
of Na+/H+##3##2##(1992-10#1)(1993-3#1)(1995-8#1)
of Na+/K(+)-ATPase##7##2##(1990-11#1)(1990-2#1)(1990-5#2)(1994-6#1)(1995-6#2)
of Na-K ATPase##2##3##(1995-8#2)
of Na-butyrate##2##2##(2008-11#2)
of NaB##2##2##(1992-3#2)
of NaBH(4)##2##2##(2008-10#2)
of NaBH(4)/KPF(6)##2##2##(2008-10#2)
of NaCl on the##2##4##(1997-2#1)(2008-10#1)
of NaCl on##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
of NaCl were##3##3##(1997-2#1)(2008-10#2)
of NaCl##28##2##(1990-5#1)(1991-12#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-5#1)(1997-2#5)(2008-10#10)(2008-11#4)(2011-2#1)(2012-7#1)
of NaF on##2##3##(1990-8#1)(1993-3#1)
of NaF##6##2##(1990-8#2)(1993-3#1)(2008-10#2)(2013-1#1)
of NaH##2##2##(1996-5#1)(2007-11#1)
of NaOH##2##2##(2008-10#2)
of Nafion##6##2##(2008-10#6)
of Naja naja atra##2##4##(1997-7#2)
of Nanta##3##2##(2012-12#3)
of Narcissus##2##2##(1990-7#1)(2008-2#1)
of Nariño##2##2##(2012-12#2)
of National Health##2##3##(1991-1#1)(2010-8#1)
of National##11##2##(1991-1#1)(1991-2#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#2)
of Native Hawaiian well-being##2##4##(2008-1#2)
of Native Hawaiian##3##3##(2008-1#3)
of Native##6##2##(2008-1#4)(2011-2#1)(2013-7#1)
of Natural##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
of Navarre##6##2##(2013-1#6)
of NbS2##2##2##(1992-5#2)
of Nck##2##2##(1997-4#2)
of Nd##18##2##(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#10)
of Ne##2##2##(1996-5#1)(2007-12#1)
of Negative##4##2##(1996-7#2)(2010-10#1)(2010-3#1)
of Nei's coefficient of##2##4##(2008-10#2)
of Nei's##3##2##(2008-10#3)
of Neisseria gonorrhoeae##5##3##(1993-9#2)(2007-7#1)(2007-8#2)
of Neisseria meningitidis##8##3##(1993-12#2)(2007-12#3)(2008-12#1)(2011-1#1)(2013-1#1)
of Neisseria##14##2##(1993-12#3)(1993-9#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-12#1)(2011-1#1)(2013-1#1)
of Neotibilis##3##2##(2008-6#3)
of Nep1##6##2##(2008-10#6)
of Nepal##10##2##(2008-10#1)(2008-7#4)(2010-4#1)(2012-3#4)
of Nepalese##2##2##(2012-3#2)
of Nervoheel N##2##3##(2008-10#2)
of Neu5Ac##3##2##(1992-11#1)(2012-2#2)
of Neu5Gc alpha 2--&gt##2##4##(1994-11#2)
of NeuroD##2##2##(2010-11#2)
of Neuroimaging##2##2##(2009-12#1)(2010-5#1)
of Neurological Surgeons##3##3##(2012-3#2)(2013-1#1)
of Neurological##6##2##(2008-7#2)(2011-2#1)(2012-3#2)(2013-1#1)
of Neurology at##2##3##(1997-8#1)(2010-5#1)
of Neurology##5##2##(1997-8#1)(2007-8#1)(2009-11#1)(2010-1#1)(2010-5#1)
of Neuropsychology##2##2##(2007-6#1)(2009-10#1)
of Neurospora crassa##5##3##(1992-3#2)(1997-4#2)(2012-3#1)
of Neurosurgery##3##2##(1995-11#1)(2013-8#2)
of NeutrAvidin-tagged liposomal nanovesicles as##2##5##(2008-10#2)
of NeutrAvidin-tagged liposomes##3##3##(2008-10#3)
of NeutrAvidin-tagged##5##2##(2008-10#5)
of New South Wales##4##4##(1990-2#2)(1996-1#1)(2008-2#1)
of New World##2##3##(2008-11#1)(2012-2#1)
of New York##8##3##(1991-12#1)(1992-1#1)(1994-12#2)(2008-10#2)(2008-8#1)(2013-1#1)
of New Zealand##7##3##(2007-12#1)(2008-12#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-1#1)
of New##32##2##(1990-2#2)(1991-12#1)(1991-7#1)(1992-1#1)(1993-1#2)(1994-11#1)(1994-12#2)(1996-1#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
of Newcastle disease virus##2##4##(2007-6#1)(2008-5#1)
of Newcastle disease viruses##2##4##(1997-3#1)(2007-6#1)
of Newcastle disease##7##3##(1997-3#1)(2007-6#2)(2008-5#4)
of NeyTumorin##2##2##(1997-4#2)
of Nf-1##3##2##(1991-12#3)
of Ngn3##3##2##(2010-11#3)
of Ni and##3##3##(2008-10#3)
of Ni in##4##3##(2008-10#4)
of Ni##16##2##(2008-10#16)
of Ni(2+)##3##2##(2008-10#3)
of Ni(II) and##4##3##(2008-10#4)
of Ni(II)##9##2##(1993-8#1)(2008-10#8)
of Ni3S2 alone##2##3##(1994-5#2)
of Ni3S2##4##2##(1994-5#4)
of NiHCF##2##2##(2008-10#2)
of NiS in##2##3##(2008-10#2)
of NiS##7##2##(2008-10#7)
of NiTMpyP##4##2##(2008-10#4)
of NiV##3##2##(2008-12#3)
of Nicaragua##2##2##(2012-12#2)
of Nicotiana benthamiana##2##3##(2008-10#2)
of Nicotiana obtusifolia##2##3##(2008-10#2)
of Nicotiana tabacum##2##3##(2008-10#1)(2008-7#1)
of Nicotiana##11##2##(2008-10#9)(2008-11#1)(2008-7#1)
of Nicoya##5##2##(2008-5#3)(2013-7#2)
of NifA central domain##5##4##(2008-9#5)
of NifA##12##2##(2008-4#1)(2008-9#11)
of Nigella sativa##4##3##(1992-3#1)(2008-12#2)(2009-7#1)
of Nigeria##7##2##(2007-7#2)(2008-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
of Nile blue A##2##4##(2008-10#2)
of Nile##3##2##(2008-10#3)
of Nippostrongylus brasiliensis and Heligmosomoides polygyrus##2##6##(2008-4#2)
of Nitric Oxide##2##3##(2008-8#1)(2010-6#1)
of NleA##2##2##(2011-2#2)
of Nocardia##2##2##(1994-8#1)(2007-7#1)
of Nod##2##2##(1994-8#1)(2011-2#1)
of Nonpathogenic##2##2##(2008-10#2)
of North America and##2##4##(2008-10#1)(2008-5#1)
of North America##7##3##(2008-10#3)(2008-5#2)(2008-8#1)(2009-2#1)
of North American birds##2##4##(2008-9#2)
of North American##6##3##(1991-12#1)(2008-10#1)(2008-9#2)(2009-2#1)(2010-10#1)
of North Carolina##3##3##(1995-12#1)(2011-2#2)
of North##21##2##(1991-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-2#2)(2010-10#1)(2011-2#2)
of Northern blot##2##3##(2008-7#1)(2008-8#1)
of Northern##7##2##(1991-12#1)(1995-3#1)(1997-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#1)
of Norway and##3##3##(1990-6#1)(1995-5#1)(1995-6#1)
of Norway##7##2##(1990-6#1)(1991-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1997-6#1)
of Norway's##3##2##(1990-6#1)(1991-6#1)(1993-3#1)
of Norwegian##8##2##(1990-9#1)(1991-11#1)(1991-6#1)(1991-9#1)(1993-2#1)(1995-5#1)(1995-6#2)
of Norwegians##2##2##(1991-2#1)(1996-11#1)
of Notch signaling in##3##4##(2007-12#2)(2010-3#1)
of Notch##7##2##(2007-12#3)(2010-3#4)
of Novel##4##2##(2008-10#2)(2008-12#1)(2011-1#1)
of November##6##2##(1991-3#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
of Noxa##5##2##(2010-3#2)(2012-12#3)
of NuMA##4##2##(2010-5#4)
of Nuc##3##2##(1992-8#3)
of Nuclear Magnetic Resonance##2##4##(1992-3#1)(2011-2#1)
of Nuclear Medicine##3##3##(2008-10#1)(2012-2#2)
of Nuclear##11##2##(1992-3#1)(1996-9#1)(2008-10#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
of Nun##2##2##(1995-3#2)
of Nunavut##2##2##(2008-11#1)(2013-8#1)
of Nurse Education##2##3##(2008-11#1)(2008-12#1)
of Nursing Practice##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
of Nursing##41##2##(1992-2#1)(1995-2#1)(2007-10#2)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#8)(2010-3#5)(2012-2#2)(2012-3#6)(2013-8#1)
of Nutrient##2##2##(2008-10#1)(2013-1#1)
of Nutrition##2##2##(1995-1#1)(2008-10#1)
of O##20##2##(1991-12#1)(2008-10#10)(2008-12#1)(2008-5#2)(2008-8#2)(2009-10#1)(2010-4#1)(2010-8#1)(2013-8#1)
of O(2) and N(2)##2##4##(2008-3#2)
of O(2) and##4##3##(2008-10#1)(2008-3#3)
of O(2)##9##2##(1996-2#1)(2008-10#3)(2008-3#5)
of O(3) on##3##3##(2008-3#1)(2008-5#2)
of O(3)##6##2##(2008-3#1)(2008-5#5)
of O-DMA##3##2##(2012-2#3)
of O-GlcNAc##4##2##(2008-11#1)(2008-4#3)
of O-acetate##2##2##(1994-9#2)
of O-glycosylated oligosaccharide##2##3##(1992-12#2)
of O2##11##2##(1991-3#1)(1994-11#1)(1995-6#3)(1997-2#1)(2007-11#1)(2008-10#3)(2008-3#1)
of O2-##2##2##(1991-2#1)(1994-8#1)
of O6-alkylguanine-DNA alkyltransferase##2##3##(1993-11#1)(2008-5#1)
of OA##6##2##(1992-3#1)(1993-6#1)(1994-3#1)(2007-11#2)(2013-1#1)
of OAA##2##2##(2008-10#2)
of OAB##2##2##(2008-12#2)
of OAV##3##2##(1997-3#3)
of OB##2##2##(2008-2#1)(2012-2#1)
of OC##3##2##(1994-5#1)(2008-10#1)(2008-6#1)
of OCD in children##2##4##(2008-11#1)(2008-6#1)
of OCD##7##2##(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#2)(2013-1#1)
of OCE##3##2##(2011-2#3)
of OCT in##2##3##(2011-7#2)
of OCT##9##2##(2007-11#1)(2008-2#1)(2010-12#2)(2011-7#5)
of OCT4A##2##2##(2013-1#2)
of ODA##3##2##(1995-12#1)(2008-10#1)(2010-5#1)
of ODC activity##3##3##(1995-8#1)(2008-10#2)
of ODC##5##2##(1992-9#1)(1995-8#1)(2008-10#3)
of ODNs##4##2##(1994-12#3)(2008-10#1)
of OECs##2##2##(2008-7#2)
of OFL##3##2##(2008-10#3)
of OH 182##3##3##(2008-10#3)
of OH A##2##3##(2008-2#2)
of OH radical concentration in combustion environments##2##7##(2008-2#2)
of OH radicals##2##3##(2008-11#2)
of OH##23##2##(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#9)(2008-3#5)
of OL1 with the##2##4##(1992-4#2)
of OM##3##2##(2008-12#1)(2009-11#1)(2013-8#1)
of OMC##2##2##(2008-5#2)
of OMP##2##2##(2008-12#1)(2013-1#1)
of OP pesticides##4##3##(2013-1#4)
of OP poisoning##6##3##(2013-1#6)
of OP##19##2##(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#16)
of OPC##2##2##(2008-5#1)(2008-7#1)
of OPCs in##2##3##(2008-7#1)(2012-4#1)
of OPCs##4##2##(2008-7#3)(2012-4#1)
of OPG##3##2##(2008-12#1)(2013-8#2)
of OPN in the islets##2##5##(2010-11#2)
of OPN##7##2##(2010-11#7)
of OPV##2##2##(1995-5#2)
of OPs##2##2##(2008-10#2)
of ORF##5##2##(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
of ORF7##3##2##(2008-10#3)
of ORFs##3##2##(1995-12#1)(1997-4#1)(2008-7#1)
of ORNs##2##2##(2007-12#2)
of OSC##2##2##(1992-8#1)(2008-5#1)
of OSCC##4##2##(2010-12#2)(2013-1#2)
of OSCE##2##2##(1994-2#2)
of OSR##2##2##(2008-10#2)
of OTA##5##2##(2008-10#3)(2011-2#2)
of OVA and##2##3##(2008-11#2)
of OYDV##2##2##(2008-10#2)
of Obesity##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
of Obstetrics and Gynecology##6##4##(1990-10#2)(1991-3#2)(1994-5#1)(1996-9#1)
of Obstetrics and##8##3##(1990-10#2)(1991-3#2)(1994-5#1)(1996-1#1)(1996-9#1)(2008-3#1)
of Obstetrics##10##2##(1990-10#2)(1991-3#2)(1991-6#1)(1994-5#1)(1996-1#1)(1996-9#1)(2008-3#1)(2013-1#1)
of Occupational##2##2##(1990-12#1)(1995-2#1)
of Ocimum basilicum as##2##4##(2010-5#2)
of Ocimum basilicum##3##3##(2008-5#1)(2010-5#2)
of Ocimum##4##2##(2008-5#1)(2010-5#3)
of October##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
of Odontotremataceae##2##2##(2010-10#2)
of Ohio##2##2##(2008-10#2)
of Oil##2##2##(2008-10#1)(2010-3#1)
of Okazaki fragment synthesis##2##4##(1992-3#2)
of Old world##2##3##(2008-1#2)
of Old##6##2##(1995-11#1)(2008-1#2)(2008-12#1)(2013-1#2)
of OmniGen-AF on blood neutrophil gene expression##2##7##(2013-1#2)
of OmpR mutants##2##3##(1995-8#2)
of OmpR##5##2##(1995-8#5)
of OmpU##2##2##(2008-8#2)
of Oncology##5##2##(1991-12#1)(1993-3#2)(1994-7#1)(1995-5#1)
of Ontario hospitals##3##3##(1993-3#1)(1994-1#1)(1994-2#1)
of Ontario##9##2##(1993-1#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-3#2)(2007-12#2)
of Ontogenic##2##2##(2008-10#1)(2008-11#1)
of Op18##2##2##(1991-9#2)
of Ophiosphaerella agrostis##2##3##(2008-10#2)
of Ophiostoma##2##2##(2008-10#2)
of Ophthalmology##2##2##(2010-10#1)(2011-2#1)
of Optical##2##2##(2008-2#2)
of Oregon##4##2##(1993-12#1)(2008-10#3)
of Origin##3##2##(2008-10#3)
of Orissa##2##2##(2012-1#2)
of Orobanche##3##2##(2008-10#2)(2011-2#1)
of Orthopaedics and Traumatology##5##4##(2007-11#1)(2007-8#1)(2009-4#1)(2013-1#2)
of Orthopaedics##7##2##(2007-11#3)(2007-8#1)(2009-4#1)(2013-1#2)
of Orthopedic oncology##2##3##(2010-3#2)
of Orthopedic##4##2##(2007-11#1)(2007-8#1)(2010-3#2)
of Orthopedics and Traumatology of the##2##6##(2007-11#2)
of Orthopedics and Traumatology##4##4##(2007-11#3)(2007-8#1)
of Orthopedics##5##2##(2007-11#3)(2007-8#1)(2012-3#1)
of Orthosiphon##2##2##(2008-10#2)
of Oryza sativa L##2##4##(2008-9#2)
of Oryza sativa##4##3##(2008-10#1)(2008-9#2)(2009-10#1)
of Oryza##6##2##(2008-10#1)(2008-8#1)(2008-9#2)(2009-10#2)
of Osgrp- 2##2##3##(2008-9#2)
of Oslo##7##2##(1990-9#1)(1992-6#2)(1994-2#1)(1994-6#1)(1995-2#1)(1996-6#1)
of Otolaryngology##2##2##(2011-2#1)(2013-1#1)
of Otostegia persica Boiss##2##4##(2008-12#2)
of Ouagadougou##2##2##(2008-12#1)(2009-10#1)
of OxyContin##2##2##(2008-3#2)
of P and N##2##4##(1997-3#1)(2010-2#1)
of P in##2##3##(1993-11#1)(2008-10#1)
of P##378##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-11#8)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-2#3)(2007-7#1)(2008-10#285)(2008-12#1)(2008-2#1)(2008-5#10)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#3)(2009-5#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#12)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#1)
of P(+III)##5##2##(2008-10#5)
of P(V)##3##2##(2008-10#3)
of P-450##2##2##(1990-7#1)(2008-8#1)
of P-450(11 beta)##3##3##(1990-5#3)
of P-450arom##2##2##(1995-8#2)
of P-glycoprotein and##3##3##(1995-11#1)(2008-11#2)
of P-glycoprotein##13##2##(1992-12#1)(1995-11#4)(1997-4#1)(2008-10#2)(2008-11#3)(2008-8#1)(2011-2#1)
of P-gp##4##2##(2007-2#2)(2011-3#2)
of P-selectin (CD62P)##2##3##(2008-4#1)(2008-9#1)
of P-selectin##7##2##(1997-7#1)(2006-6#1)(2008-4#1)(2008-9#2)(2011-2#2)
of P/D##2##2##(2008-2#2)
of P1##5##2##(1992-6#2)(1994-11#1)(1994-6#1)(2008-9#1)
of P2 receptors is##3##4##(2008-4#3)
of P2 receptors##6##3##(2008-4#6)
of P2##13##2##(1990-2#1)(1990-7#1)(1995-8#1)(2008-4#9)(2008-5#1)
of P29 and##2##3##(2008-10#2)
of P29##3##2##(2008-10#3)
of P2O##2##2##(2008-6#2)
of P2X receptor channel function##2##5##(2008-4#2)
of P2X##4##2##(2008-4#4)
of P2Y receptors in the##3##5##(2008-4#3)
of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis##2##15##(2008-4#2)
of P2Y receptors##6##3##(2008-4#6)
of P2Y##11##2##(2008-4#11)
of P2Y(1)##4##2##(2008-4#4)
of P2Y(2)##3##2##(2008-4#3)
of P2Y2 receptors##2##3##(2008-4#2)
of P450 4A##2##3##(1995-3#2)
of P450##9##2##(1990-5#1)(1993-8#1)(1994-8#1)(1995-3#2)(2008-7#2)(2009-9#2)
of P450c17##2##2##(2008-4#2)
of P450cam##3##2##(1992-11#1)(1994-6#2)
of P50##2##2##(1994-12#1)(2011-1#1)
of P89##2##2##(2008-10#2)
of PA and##2##3##(2007-12#1)(2008-11#1)
of PA##6##2##(2007-12#1)(2008-10#3)(2008-11#1)(2013-1#1)
of PA-BJ##3##2##(1995-5#3)
of PAA##3##2##(2008-10#3)
of PACAP##2##2##(1995-11#2)
of PACAP38##2##2##(1990-7#2)
of PACE##2##2##(1992-1#1)(2008-7#1)
of PACS##4##2##(1996-2#2)(1997-8#1)(2012-2#1)
of PAD##4##2##(2008-10#1)(2008-8#3)
of PADPRP##4##2##(1991-12#4)
of PAF to platelets##2##4##(2008-3#2)
of PAF##7##2##(1991-12#1)(1991-5#2)(2008-3#4)
of PAH##10##2##(2008-10#6)(2008-11#3)(2010-10#1)
of PAHs from##4##3##(2008-10#4)
of PAHs in##9##3##(2008-10#7)(2008-11#1)(2010-5#1)
of PAHs was##2##3##(2008-10#2)
of PAHs##24##2##(2008-10#21)(2008-11#1)(2010-5#2)
of PAI##5##2##(1995-2#5)
of PAI-1##3##2##(1993-12#1)(2011-2#1)(2013-1#1)
of PAM##8##2##(1994-11#3)(1996-3#1)(2008-7#1)(2008-9#1)(2012-12#2)
of PAN-treated##2##2##(2009-6#2)
of PAP in##3##3##(2008-10#1)(2008-12#2)
of PAP##5##2##(1990-9#1)(2008-10#1)(2008-12#3)
of PAR and##2##3##(2008-3#1)(2008-7#1)
of PAR during the##2##4##(2008-10#2)
of PAR##15##2##(2008-10#8)(2008-3#5)(2008-7#2)
of PARAFAC##2##2##(2008-10#2)
of PARP##2##2##(2008-12#1)(2010-6#1)
of PAV in##2##3##(2008-10#2)
of PAV##3##2##(2008-10#3)
of PBDEs##4##2##(2008-10#4)
of PBL##3##2##(2008-11#1)(2012-2#2)
of PBLs##2##2##(2008-11#1)(2012-2#1)
of PBMC##2##2##(1992-12#1)(2010-12#1)
of PBMCs##2##2##(2008-10#1)(2008-4#1)
of PBN gustatory neurons##2##4##(2009-10#2)
of PBS was##2##3##(2008-8#2)
of PBS##8##2##(2008-10#1)(2008-8#7)
of PC and##4##3##(1990-11#1)(1995-2#1)(2008-4#1)(2013-1#1)
of PC exposure##2##3##(2012-3#2)
of PC was##2##3##(1992-9#1)(2008-4#1)
of PC##18##2##(1990-11#3)(1990-6#4)(1992-9#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-4#2)(2008-7#1)(2012-3#2)(2013-1#1)
of PC12 cells##10##3##(1992-9#1)(2008-10#3)(2008-11#6)
of PC12##11##2##(1992-9#1)(2008-10#3)(2008-11#7)
of PCA##2##2##(2011-1#2)
of PCBs in##2##3##(2008-10#2)
of PCC4 cells##3##3##(1993-9#3)
of PCD in##2##3##(2009-10#2)
of PCD##4##2##(2009-10#4)
of PCDD/F##2##2##(2008-10#2)
of PCDDs##3##2##(2008-10#3)
of PCDDs/PCDFs and dioxin-like PCBs in food##2##7##(2008-10#2)
of PCE##2##2##(2008-10#1)(2009-2#1)
of PCF##2##2##(2007-11#2)
of PCFV##4##2##(2008-10#4)
of PCL##2##2##(2010-4#2)
of PCOS in##2##3##(2008-3#1)(2013-1#1)
of PCOS##6##2##(2008-3#3)(2008-4#2)(2013-1#1)
of PCP in##2##3##(2008-10#2)
of PCP##5##2##(2008-10#4)(2009-3#1)
of PCR primers##2##3##(2008-10#2)
of PCR products for##3##4##(1997-4#1)(2008-4#2)
of PCR products##9##3##(1992-8#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-2#3)(2008-4#2)
of PCR using##2##3##(1996-12#1)(1997-4#1)
of PCR##38##2##(1990-3#1)(1992-8#1)(1993-12#2)(1993-6#1)(1996-12#2)(1997-4#3)(1997-7#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#4)(2008-4#3)(2008-9#3)(2009-5#1)(2011-1#1)(2013-8#2)
of PCR-amplified##4##2##(1997-4#1)(2008-10#3)
of PCS##4##2##(2013-1#4)
of PCT##3##2##(1992-9#1)(2008-11#1)(2012-12#1)
of PCV-2 DNA##3##3##(2012-3#3)
of PCVAD##3##2##(2012-3#2)(2013-1#1)
of PCs in##2##3##(1994-2#1)(2008-10#1)
of PCs##6##2##(1994-2#1)(2008-10#4)(2008-11#1)
of PD and##3##3##(2008-6#1)(2008-7#2)
of PD dementia##2##3##(2008-7#2)
of PD in##2##3##(2008-10#1)(2008-12#1)
of PD patients##3##3##(2008-7#3)
of PD phytoplasma##2##3##(2008-10#2)
of PD therapy##4##3##(2011-2#4)
of PD##54##2##(1990-6#2)(1995-5#1)(1997-2#1)(2007-12#3)(2008-10#4)(2008-12#2)(2008-6#1)(2008-7#27)(2008-8#1)(2009-10#2)(2010-8#1)(2011-2#8)(2012-12#1)
of PD-L1 on##2##3##(2010-8#1)(2012-3#1)
of PD-L1##4##2##(2010-8#1)(2012-3#3)
of PDA##4##2##(2007-7#1)(2008-10#1)(2008-12#1)(2012-12#1)
of PDE IV inhibitors##2##4##(2008-5#2)
of PDF##4##2##(2008-9#1)(2011-1#3)
of PDG##2##2##(2011-1#2)
of PDGF##5##2##(1993-8#1)(1995-11#3)(1997-6#1)
of PDGF-betaRWT##2##2##(1997-7#2)
of PDMCs##2##2##(2008-9#2)
of PDMS##2##2##(2008-10#1)(2009-2#1)
of PDT using##2##3##(1992-8#1)(2008-5#1)
of PDT##9##2##(1990-11#1)(1992-8#1)(1992-9#1)(2008-5#2)(2008-8#1)(2009-4#2)(2012-3#1)
of PE mRNA##2##3##(1991-1#2)
of PE##11##2##(1991-1#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-2#2)
of PEDOT##3##2##(2009-11#2)(2013-1#1)
of PEF##2##2##(1996-3#1)(2007-2#1)
of PEG from##2##3##(2008-10#2)
of PEG into##3##3##(2008-10#3)
of PEG##10##2##(2008-10#8)(2008-12#1)(2011-2#1)
of PEI##5##2##(1996-5#1)(2008-10#3)(2008-11#1)
of PEO##3##2##(2008-10#3)
of PET and##2##3##(2012-12#1)(2012-2#1)
of PET radiopharmaceuticals##3##3##(2013-1#3)
of PET##11##2##(1995-2#1)(2008-10#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)
of PET/CT##3##2##(2009-2#1)(2009-9#1)(2012-2#1)
of PF-68##2##2##(2011-2#2)
of PFBBr##4##2##(2008-10#4)
of PFC##3##2##(1995-12#1)(1996-5#1)(2013-8#1)
of PFK-M##2##2##(1990-12#2)
of PFTs##2##2##(2008-8#2)
of PG isozymes##2##3##(2008-10#2)
of PG##15##2##(1990-2#2)(1994-9#1)(2008-10#4)(2008-11#3)(2008-8#4)(2013-8#1)
of PGC-1alpha##2##2##(2008-1#2)
of PGCs##6##2##(2008-11#6)
of PGE(2) and TXB(2)##2##4##(2008-10#2)
of PGE1##4##2##(1993-12#1)(1994-2#3)
of PGE2 at##4##3##(1997-2#4)
of PGE2 synthesis##2##3##(1990-2#2)
of PGE2##7##2##(1990-2#2)(1997-1#1)(1997-2#4)
of PGEs and gold##2##4##(2008-10#2)
of PGF2alpha but not that of LIF##2##7##(1997-7#2)
of PGM##2##2##(2008-10#2)
of PGMs##2##2##(2008-10#2)
of PGN##2##2##(2009-8#2)
of PGs##3##2##(2008-11#1)(2008-7#2)
of PGx##2##2##(2008-10#1)(2010-8#1)
of PH##3##2##(2010-10#1)(2010-6#2)
of PHB##2##2##(2008-6#1)(2008-7#1)
of PHC##3##2##(2008-1#2)(2011-2#1)
of PHR1##2##2##(1996-3#2)
of PHS 70 in##2##4##(2012-3#2)
of PHS##4##2##(1993-8#1)(2012-3#3)
of PHV##4##2##(2008-10#1)(2008-5#3)
of PI 3-kinase##3##3##(1994-11#3)
of PI 88788##2##3##(2008-10#2)
of PI##8##2##(1990-5#1)(1993-6#1)(1994-11#3)(2008-10#2)(2013-1#1)
of PI-PLC##2##2##(1995-8#2)
of PI3-kinase##2##2##(1996-2#1)(2008-8#1)
of PI3K activity##2##3##(2011-1#2)
of PI3K in##2##3##(2010-9#1)(2012-2#1)
of PI3K##10##2##(1996-2#4)(2010-9#2)(2011-1#2)(2012-1#1)(2012-2#1)
of PIA##2##2##(1994-3#1)(1997-3#1)
of PIBs produced##2##3##(2008-11#2)
of PIBs##3##2##(2008-11#3)
of PICH##4##2##(2007-10#4)
of PIH##4##2##(1994-3#3)(2012-2#1)
of PIN proteins##2##3##(2009-10#2)
of PIN##3##2##(2009-10#3)
of PIP(2)##2##2##(2008-8#2)
of PIP2##4##2##(1993-6#1)(2008-8#3)
of PIP3##2##2##(1993-8#2)
of PKA is##2##3##(1990-12#1)(2008-8#1)
of PKA##14##2##(1990-12#1)(1993-3#1)(1994-8#5)(2008-10#1)(2008-11#1)(2008-8#2)(2009-2#2)(2012-2#1)
of PKC activity##3##3##(1992-11#1)(1997-2#1)(2008-10#1)
of PKC alpha##6##3##(1994-5#1)(1995-11#5)
of PKC and##2##3##(1992-6#1)(1995-6#1)
of PKC by##4##3##(1992-9#1)(1993-6#1)(1996-12#1)(1997-1#1)
of PKC epsilon##2##3##(1995-2#2)
of PKC in the##3##4##(1994-6#2)(1997-1#1)
of PKC in##9##3##(1992-9#1)(1994-6#2)(1995-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-4#2)
of PKC isoforms##4##3##(1994-6#1)(1996-5#1)(1996-9#2)
of PKC may##2##3##(1992-6#1)(1993-9#1)
of PKC to##3##3##(1992-9#1)(1993-12#1)(1993-8#1)
of PKC was##3##3##(2008-11#1)(2008-8#2)
of PKC##73##2##(1990-5#1)(1991-2#2)(1992-11#1)(1992-12#2)(1992-6#6)(1992-8#2)(1992-9#8)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#8)(1995-2#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-8#2)(2008-9#1)
of PKC-alpha##6##2##(1994-6#1)(1995-11#2)(1996-5#2)(2008-8#1)
of PKCalpha was##2##3##(2008-9#2)
of PKCalpha##4##2##(2008-9#4)
of PKMζ##4##2##(2012-3#4)
of PKRs##2##2##(2008-7#2)
of PL##10##2##(1993-11#1)(1997-4#4)(2008-10#4)(2008-7#1)
of PLA2##10##2##(1990-7#2)(1991-5#1)(1993-11#1)(1993-9#2)(1994-6#2)(2013-7#2)
of PLA2-L##2##2##(1990-7#2)
of PLC##3##2##(2008-4#1)(2009-3#1)(2010-11#1)
of PLC-gamma##4##2##(1992-7#2)(1993-3#1)(1997-7#1)
of PLD activity##3##3##(1991-2#1)(1995-8#2)
of PLD##7##2##(1991-2#2)(1995-8#5)
of PLDMV##2##2##(2008-10#2)
of PLDMV-C##3##2##(2008-10#3)
of PLGA##2##2##(2009-11#1)(2009-7#1)
of PLL##2##2##(1991-5#1)(2008-10#1)
of PLP##3##2##(1997-7#1)(2009-6#2)
of PLRV##2##2##(2008-10#2)
of PLS and##2##3##(2008-10#2)
of PLS regression##2##3##(2008-10#2)
of PLS##7##2##(2008-10#6)(2013-8#1)
of PLs##2##2##(2012-6#2)
of PM##10##2##(1993-11#1)(2008-1#1)(2008-10#4)(2008-7#2)(2013-7#2)
of PMA or##2##3##(1994-3#1)(1997-2#1)
of PMA##7##2##(1994-3#1)(1994-8#3)(1995-11#1)(1997-1#1)(1997-2#1)
of PMCs##2##2##(2013-1#2)
of PME##2##2##(1991-9#1)(2008-8#1)
of PMMA##2##2##(2007-12#1)(2008-3#1)
of PMMV-k##2##2##(1997-6#2)
of PMN##5##2##(1991-2#2)(1991-8#1)(1993-6#1)(2008-10#1)
of PMNs##5##2##(1991-9#2)(1993-6#2)(2009-10#1)
of PMSF##2##2##(1991-2#1)(1996-2#1)
of PMSG##2##2##(2008-5#1)(2008-8#1)
of PMT##2##2##(2013-8#2)
of PMWS-affected##2##2##(2012-3#2)
of PN##3##2##(2008-7#2)(2013-1#1)
of PN-2/APP in##2##3##(1992-12#2)
of PN-2/APP##3##2##(1992-12#3)
of PNAs##2##2##(2008-4#2)
of PNBCE##2##2##(1994-12#2)
of PNET in a##2##4##(2008-7#2)
of PNH##2##2##(1996-8#1)(2008-9#1)
of PNRSV##2##2##(2008-10#2)
of PNZIP promoter##2##3##(2008-9#2)
of PNZIP##3##2##(2008-9#3)
of PO in##2##3##(2008-10#1)(2011-10#1)
of PO##3##2##(1993-8#1)(2008-10#1)(2011-10#1)
of POEMS syndrome##2##3##(1992-12#1)(2009-7#1)
of POMC##4##2##(1993-5#4)
of POPC##2##2##(1992-6#1)(1997-2#1)
of POPs##2##2##(2008-10#1)(2008-7#1)
of POX in##2##3##(1997-4#1)(2008-10#1)
of POX##3##2##(1997-4#2)(2008-10#1)
of PP##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
of PP1##3##2##(1995-6#1)(2012-12#2)
of PPA##3##2##(1990-7#2)(1990-9#1)
of PPAR gamma 2##2##4##(1994-12#2)
of PPAR gamma##3##3##(1994-12#3)
of PPAR##5##2##(1994-12#3)(2008-1#2)
of PPARgamma##3##2##(2008-11#1)(2008-3#2)
of PPD##2##2##(2007-2#1)(2010-5#1)
of PPG and its derivatives##2##5##(2008-9#2)
of PPG-1025##2##2##(2008-10#2)
of PPH##4##2##(1997-5#3)(2011-2#1)
of PPI hydrolysis##2##3##(1996-5#1)(2008-8#1)
of PPI##6##2##(1996-5#1)(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#1)
of PPP##3##2##(1997-7#3)
of PPR##3##2##(1995-12#1)(2011-2#2)
of PPS##3##2##(1992-1#1)(1992-2#2)
of PPV HC-Pro##3##3##(2008-10#3)
of PPV##7##2##(2008-10#7)
of PPV-M##2##2##(2008-10#2)
of PPa in##2##3##(2008-8#2)
of PPa##3##2##(2008-8#3)
of PQ##5##2##(1995-8#1)(2008-10#4)
of PQC##2##2##(2008-10#2)
of PR proteins##2##3##(2008-10#2)
of PR##9##2##(1993-9#1)(2008-10#5)(2013-1#1)(2013-8#2)
of PRL and##3##3##(2008-6#2)(2011-2#1)
of PRL expression in##2##4##(1994-3#2)
of PRL secretion##2##3##(1990-7#1)(2008-7#1)
of PRL was##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
of PRL##16##2##(1990-7#1)(1994-3#3)(2008-10#1)(2008-6#2)(2008-7#6)(2011-2#3)
of PRL-R mRNA##2##3##(2011-2#2)
of PRL-R##5##2##(2011-2#5)
of PRN##3##2##(1997-6#3)
of PRO##4##2##(1991-1#1)(1991-3#1)(2008-10#2)
of PROM##3##2##(2012-3#3)
of PRSV##2##2##(2008-10#2)
of PRms in##2##3##(2008-10#2)
of PRms##3##2##(2008-10#3)
of PS##4##2##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)
of PSA in##3##3##(2008-4#1)(2010-12#2)
of PSA promoter##2##3##(2008-9#2)
of PSA##15##2##(1990-9#1)(2008-4#3)(2008-9#2)(2009-5#1)(2010-12#5)(2011-2#1)(2012-12#1)(2013-1#1)
of PSD values of##2##4##(2010-8#2)
of PSD-95 clusters##3##3##(2012-3#3)
of PSD-95##4##2##(2012-3#4)
of PSII##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-7#1)
of PSP toxins##2##3##(1994-12#2)
of PSP##6##2##(1992-8#2)(1994-12#2)(2012-12#2)
of PSS##2##2##(2007-10#1)(2010-1#1)
of PST##3##2##(1990-12#3)
of PSTI##3##2##(1990-12#3)
of PT##2##2##(1993-12#1)(1995-5#1)
of PT-mediated##2##2##(1993-12#2)
of PT-responsive##2##2##(1993-12#2)
of PTB##2##2##(2008-1#2)
of PTCA##3##2##(1992-9#2)(2006-8#1)
of PTDM##4##2##(2008-1#4)
of PTE##2##2##(2008-1#1)(2008-10#1)
of PTFE##3##2##(1990-9#1)(2008-10#2)
of PTH##12##2##(1990-2#1)(1991-12#2)(1993-12#1)(1994-11#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-8#2)(2011-1#1)(2013-8#1)
of PTH(1-84)##3##2##(1994-6#3)
of PTHrP in##2##3##(1993-3#2)
of PTHrP##7##2##(1993-3#4)(1994-7#2)(2013-7#1)
of PTM##2##2##(2009-5#1)(2009-6#1)
of PTOiTr##2##2##(2007-11#1)(2007-8#1)
of PTP synthase##3##3##(1997-8#3)
of PTP##5##2##(1994-6#2)(1997-8#3)
of PTPase activity##2##3##(1993-3#1)(2008-8#1)
of PTPase##4##2##(1993-3#1)(2008-8#3)
of PTPepsilon##2##2##(2009-6#2)
of PTSD and depression##2##4##(2008-8#1)(2013-1#1)
of PTSD and##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of PTSD##10##2##(1991-2#1)(2008-10#2)(2008-6#3)(2008-8#1)(2009-11#1)(2010-10#1)(2013-1#1)
of PUFA##2##2##(1995-8#1)(2008-5#1)
of PUFAs##6##2##(2008-10#3)(2010-6#2)(2013-1#1)
of PUV in##2##3##(2008-1#2)
of PUV##3##2##(2008-1#3)
of PV##7##2##(1996-5#1)(2008-10#1)(2010-7#1)(2011-2#4)
of PVA and##2##3##(2008-10#1)(2008-5#1)
of PVA in##2##3##(2008-10#2)
of PVA##9##2##(2008-10#7)(2008-5#2)
of PVC and##3##3##(1996-8#1)(2008-10#2)
of PVC##8##2##(1996-8#1)(2007-7#1)(2008-10#6)
of PVMV##2##2##(2008-10#2)
of PVV##3##2##(2008-10#3)
of PVY##7##2##(2008-10#7)
of PZFX##3##2##(2011-2#3)
of Pacific hake Merluccius productus##2##5##(2010-8#2)
of Pacific##8##2##(2008-1#4)(2008-10#2)(2010-8#2)
of Pacificans##2##2##(2008-1#2)
of Padua##2##2##(1990-2#1)(2013-8#1)
of Paediatrics##4##2##(2008-11#2)(2009-5#1)(2012-12#1)
of Paget's disease##4##3##(1990-6#1)(1991-11#2)(2007-11#1)
of Paget's##5##2##(1990-6#1)(1991-11#2)(2007-11#2)
of Pain##3##2##(2008-10#1)(2013-1#2)
of Pairs##2##2##(2008-10#1)(2012-3#1)
of Pakistan and##2##3##(2012-2#2)
of Pakistan##3##2##(2012-2#3)
of Palau##14##2##(2008-1#12)(2013-8#2)
of Palauan##2##2##(2008-1#2)
of Panama##3##2##(2008-5#2)(2010-4#1)
of Panicum##2##2##(1996-10#1)(2008-10#1)
of Pantoea agglomerans on##2##4##(2008-10#2)
of Pantoea agglomerans##6##3##(2008-10#6)
of Pantoea ananatis##2##3##(2008-10#2)
of Pantoea##9##2##(2008-10#9)
of Pantopoda##3##2##(2007-12#3)
of Pap smears##2##3##(1990-12#2)
of Pap##3##2##(1990-12#2)(2011-2#1)
of Papaya leaf distortion mosaic virus##2##6##(2008-10#2)
of Papaya ringspot virus##3##4##(2008-10#3)
of Papaya##5##2##(2008-10#5)
of Papio papio##2##3##(1991-12#2)
of Paracoccidioides brasiliensis##2##3##(2008-5#2)
of Parathyroid##2##2##(2008-8#1)(2011-1#1)
of Paris##7##2##(2007-4#1)(2008-11#1)(2010-1#1)(2012-3#2)(2013-1#2)
of Parkinson syndrome in North America is##2##7##(2008-7#2)
of Parkinson##4##2##(1995-2#1)(2008-7#2)(2012-12#1)
of Parkinson's disease (PD)##6##4##(2008-10#1)(2008-7#5)
of Parkinson's disease and##6##4##(1991-5#2)(1995-3#1)(1997-2#1)(2008-7#2)
of Parkinson's disease in##3##4##(2008-7#3)
of Parkinson's disease##47##3##(1991-5#2)(1992-3#1)(1993-9#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#2)(1997-2#2)(2008-10#2)(2008-12#1)(2008-7#24)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
of Parkinson's##49##2##(1991-5#2)(1992-3#1)(1993-9#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#2)(1997-2#2)(2008-10#2)(2008-12#1)(2008-7#25)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-7#1)
of Parkinsonism##2##2##(2008-7#2)
of Partial Resistance to##2##4##(2008-10#2)
of Partial Resistance##3##3##(2008-10#3)
of Partial##4##2##(2008-10#3)(2008-11#1)
of Particles##2##2##(2008-2#1)(2012-1#1)
of Passiflora edulis Sims##2##4##(2010-5#2)
of Pathogenic##2##2##(2008-10#2)
of Pathogenicity and##2##3##(2008-10#2)
of Pathologists##2##2##(1994-12#1)(1994-8#1)
of Pathology##6##2##(1991-9#1)(1994-12#1)(2008-5#1)(2012-1#1)(2013-8#2)
of Pathotypes##2##2##(2008-10#2)
of Patient Focused##5##3##(1993-12#1)(1994-2#4)
of Patient##9##2##(1992-1#1)(1993-12#1)(1994-2#4)(1995-12#1)(2008-1#1)(2013-8#1)
of Patients with##5##3##(1995-11#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
of Patients##8##2##(1995-11#1)(2007-7#1)(2009-10#1)(2010-4#1)(2010-8#2)(2012-3#1)(2013-8#1)
of Pb and Cd##2##4##(2008-10#2)
of Pb and##6##3##(2008-10#6)
of Pb in##4##3##(2008-1#1)(2008-10#3)
of Pb##29##2##(1995-3#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-7#1)
of Pb(2+) and Cd(2+)##4##4##(2008-10#4)
of Pb(2+) ions##4##3##(2008-10#4)
of Pb(2+)##14##2##(2008-10#14)
of Pb(II) and Tl(I)##2##4##(2008-10#2)
of Pb(II) and##3##3##(2008-10#3)
of Pb(II) at##3##3##(2008-10#3)
of Pb(II) with##2##3##(2008-10#2)
of Pb(II)##14##2##(2008-10#14)
of Pb2+ on##2##3##(1995-11#2)
of PbO##2##2##(2013-8#2)
of PcMV##7##2##(2008-10#7)
of Pd##9##2##(2008-10#8)(2008-11#1)
of Pd(II) and Pt(IV)##2##4##(2008-10#2)
of Pd(II) with##3##3##(2008-10#3)
of Pd(II)##13##2##(2008-10#13)
of Pd(II)TMPyP##3##2##(2008-10#3)
of Pd6 clusters was##2##4##(2008-10#2)
of Pdx##2##2##(1994-5#2)
of Pea##2##2##(2008-10#2)
of Peach##3##2##(2008-10#3)
of Peanut chlorotic fan-spot virus##2##5##(2008-10#2)
of Peanut##5##2##(2008-10#5)
of Pear and Apple##2##4##(2008-10#2)
of Pear##3##2##(2008-10#3)
of Pediatric Oncology and##4##4##(2008-9#3)(2011-2#1)
of Pediatric##11##2##(2008-10#4)(2008-2#1)(2008-9#3)(2011-2#2)(2013-1#1)
of Pediatrics##9##2##(1991-6#1)(1996-6#1)(2008-11#1)(2008-9#2)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
of Peg-Interferon##3##2##(2013-1#3)
of Penicillium digitatum##2##3##(2008-10#2)
of Penicillium oxalicum##3##3##(2008-10#3)
of Penicillium spp##2##3##(2008-10#2)
of Penicillium##11##2##(2008-10#10)(2011-2#1)
of Pennisetum##2##2##(2008-10#2)
of Pennsylvania and##2##3##(1996-12#1)(1997-5#1)
of Pennsylvania##7##2##(1990-11#1)(1993-2#1)(1996-12#1)(1997-5#1)(2008-2#1)(2008-5#1)(2012-12#1)
of PepGMV##3##2##(2008-10#3)
of PepGMV-Ser##2##2##(2008-10#2)
of PepMoV through the stem##2##5##(2008-10#2)
of PepMoV##3##2##(2008-10#3)
of Pepino mosaic virus##2##4##(2008-10#2)
of Pepper mild mottle virus##2##5##(2008-10#2)
of Pepper##4##2##(2008-10#4)
of Peptide##2##2##(1996-5#1)(2012-12#1)
of Perceived##2##2##(2008-11#1)(2013-8#1)
of Perna##2##2##(2008-10#2)
of Peronospora tabacina with##2##4##(2008-10#2)
of Peronospora tabacina##6##3##(2008-10#6)
of Peronospora##7##2##(2008-10#7)
of Persian version##2##3##(2012-12#1)(2013-8#1)
of Persian##3##2##(2008-12#1)(2012-12#1)(2013-8#1)
of Personality##3##2##(2009-8#1)(2012-3#2)
of Perthes disease##2##3##(2007-11#2)
of Peru##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
of Peruvian##2##2##(2008-10#2)
of Petiveria alliacea##2##3##(2008-5#2)
of Petroselinum crispum##3##3##(2008-12#3)
of Petunia##2##2##(1992-8#1)(2008-10#1)
of Peyer's patch##2##3##(2008-10#1)(2008-11#1)
of Peyronie's disease##3##3##(2007-9#2)(2008-1#1)
of PfODCase##2##2##(2013-7#2)
of PfTrx-2##5##2##(2012-2#5)
of PgR and##2##3##(2008-12#2)
of Ph+ ALL##2##3##(2011-1#1)(2012-12#1)
of PhTX-343 and spermine##2##4##(1990-7#2)
of PhTX-343 and##3##3##(1990-7#3)
of Phaeosphaeria nodorum##5##3##(2008-10#5)
of Phanerochaete chrysosporium##2##3##(2008-6#1)(2008-7#1)
of Pharmacy##6##2##(1991-3#1)(2008-5#1)(2010-11#1)(2010-3#2)(2011-1#1)
of Phase##2##2##(1996-12#1)(1996-9#1)
of Phaseolus vulgaris##5##3##(2008-10#2)(2008-11#1)(2008-12#2)
of Phaseolus##7##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)
of Phaulopsis fascisepala##2##3##(2008-10#2)
of Phe##3##2##(1992-4#1)(2008-9#2)
of Phellinus##4##2##(2008-8#4)
of Phialophora gregata##2##3##(2008-10#2)
of Philadelphia positive##2##3##(2007-11#2)
of Philadelphia##3##2##(2007-11#2)(2010-11#1)
of Philip##2##2##(2008-10#1)(2008-11#1)
of Phlebotominae sand flies##2##4##(2008-12#2)
of Phlebovirus##2##2##(2013-8#2)
of Phomopsis amygdali##2##3##(2008-10#2)
of Phomopsis leaf blight##3##4##(2008-10#3)
of Phomopsis##6##2##(2008-10#6)
of Photobacterium##2##2##(2008-11#1)(2009-5#1)
of Photodynamic Therapy for##2##4##(2008-5#2)
of Photofrin II##2##3##(1993-8#2)
of Phyllophaga##2##2##(2011-2#2)
of Physical Activity##2##3##(2012-2#1)(2012-3#1)
of Physical##5##2##(2008-12#1)(2012-1#2)(2012-2#1)(2012-3#1)
of Physician##2##2##(2009-2#2)
of PhysioDirect##2##2##(2011-2#2)
of Phytolacca##2##2##(1990-11#1)(2008-10#1)
of Phytophthora capsici in Michigan##3##5##(2008-10#3)
of Phytophthora capsici in##6##4##(2008-10#6)
of Phytophthora capsici##12##3##(2008-10#12)
of Phytophthora cinnamomi in##2##4##(2008-10#2)
of Phytophthora cinnamomi##4##3##(2008-10#4)
of Phytophthora infestans Sporangia##2##4##(2008-10#2)
of Phytophthora infestans from the##2##5##(2008-10#2)
of Phytophthora infestans from##4##4##(2008-10#4)
of Phytophthora infestans in the Toluca Valley##2##7##(2008-10#2)
of Phytophthora infestans in the Toluca##3##6##(2008-10#3)
of Phytophthora infestans in the United States and Canada##2##9##(2008-10#2)
of Phytophthora infestans in the United States##4##7##(2008-10#4)
of Phytophthora infestans in the##7##5##(2008-10#7)
of Phytophthora infestans in##12##4##(2008-10#12)
of Phytophthora infestans on##4##4##(2008-10#4)
of Phytophthora infestans sensu lato##2##5##(2008-10#2)
of Phytophthora infestans to##3##4##(2008-10#3)
of Phytophthora infestans were##2##4##(2008-10#2)
of Phytophthora infestans##55##3##(2008-10#54)(2008-8#1)
of Phytophthora is##2##3##(2008-10#2)
of Phytophthora nicotianae##6##3##(2008-10#6)
of Phytophthora parasitica in##3##4##(2008-10#3)
of Phytophthora parasitica var##2##4##(2008-10#2)
of Phytophthora parasitica##9##3##(2008-10#9)
of Phytophthora ramorum from##2##4##(2008-10#2)
of Phytophthora ramorum in##3##4##(2008-10#3)
of Phytophthora ramorum##13##3##(2008-10#13)
of Phytophthora spp##7##3##(2008-10#7)
of Phytophthora##126##2##(2008-10#125)(2008-8#1)
of Pi-ta##4##2##(2008-10#4)
of Pichia anomala##2##3##(2008-10#2)
of Pichia etchellsii##2##3##(1997-4#2)
of Pichia guilermondii and Bacillus mycoides##2##6##(2008-10#2)
of Pichia guilermondii##3##3##(2008-10#3)
of Pichia##8##2##(1997-4#2)(2008-10#5)(2008-7#1)
of Picroliv##2##2##(2008-8#2)
of Pierce's Disease##3##3##(2008-10#3)
of Pierce's disease (PD)##2##4##(2008-10#2)
of Pierce's##5##2##(2008-10#5)
of Pieris rapae crucivora##2##4##(2008-5#1)(2008-6#1)
of Pimelodus##3##2##(2008-12#3)
of Pineapple##2##2##(2008-10#2)
of Pinus taeda##3##3##(2008-7#3)
of Pinus##9##2##(2008-10#4)(2008-7#3)(2011-10#1)(2013-8#1)
of Pipizini##2##2##(2008-8#2)
of Pittsburgh##5##2##(2008-1#1)(2008-5#2)(2009-5#1)(2013-8#1)
of Pka1##3##2##(1994-12#3)
of Plant##17##2##(2008-10#6)(2009-8#1)(2011-2#5)(2012-1#5)
of Plantago palmata##2##3##(2008-10#2)
of Plasma##2##2##(2008-1#1)(2008-11#1)
of Plasmodiophora brassicae##3##3##(2008-10#3)
of Plasmodium falciparum malaria##3##4##(1991-2#1)(2008-8#1)(2012-2#1)
of Plasmodium falciparum##18##3##(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of Plasmodium knowlesi##2##3##(1990-2#1)(2012-12#1)
of Plasmodium vivax##2##3##(2011-2#1)(2012-12#1)
of Plasmodium##25##2##(1990-2#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)
of Plasmopara halstedii##2##3##(2008-10#2)
of Plasmopara viticola##2##3##(2008-10#2)
of Plasmopara##4##2##(2008-10#4)
of Plum pox virus (PPV)##3##5##(2008-10#3)
of Plum pox virus##6##4##(2008-10#6)
of PmTLP##6##2##(2008-10#6)
of Pneumocystis carinii##2##3##(1990-11#1)(1993-2#1)
of Pneumocystis##3##2##(1990-11#1)(1991-12#1)(1993-2#1)
of Po-210##4##2##(2008-7#4)
of Podosphaera macularis##2##3##(2008-10#2)
of Podosphaera##4##2##(2008-10#4)
of Poland##4##2##(2008-10#1)(2008-12#3)
of Polish Pediatric Leukemia/Lymphoma Study Group##3##6##(2011-2#3)
of Polish Pediatric##4##3##(2011-2#4)
of Polish intelligentsia##2##3##(2008-12#2)
of Polish specialists##2##3##(2007-8#2)
of Polish##13##2##(2007-8#5)(2008-12#3)(2011-2#4)(2013-1#1)
of Pollution in the##3##4##(2008-3#3)
of Poly(ethylene##2##2##(2008-10#1)(2008-8#1)
of Polygonum##3##2##(2009-5#1)(2012-3#2)
of Polymorphisms in##2##3##(2011-2#1)(2013-8#1)
of Polystoechotes punctatus##2##3##(2007-12#2)
of Ponceau##3##2##(2008-10#3)
of Population##4##2##(2008-10#1)(2010-11#1)(2012-12#1)(2013-8#1)
of Populations of##3##3##(2008-10#2)(2008-6#1)
of Populations##4##2##(2008-10#3)(2008-6#1)
of Populus spp##2##3##(2008-10#2)
of Populus##3##2##(2008-10#3)
of Porphyromonas gingivalis and Bacteroides forsythus in chronic periodontitis##2##9##(2008-12#2)
of Porphyromonas gingivalis##4##3##(2008-12#2)(2008-9#1)(2013-1#1)
of Porphyromonas##5##2##(2008-12#2)(2008-9#2)(2013-1#1)
of Porto##3##2##(2009-7#1)(2012-3#1)(2013-8#1)
of Portugal##2##2##(2008-10#2)
of Posterior##2##2##(2008-1#1)(2012-3#1)
of Potassium##2##2##(2008-10#1)(2008-2#1)
of Potato virus V##2##4##(2008-10#2)
of Potato virus X##2##4##(2008-10#2)
of Potato virus Y##3##4##(2008-10#3)
of Potato virus##8##3##(2008-10#8)
of Potato##16##2##(2008-10#15)(2011-2#1)
of PrEP##3##2##(2012-2#2)(2013-1#1)
of Practice##2##2##(2012-1#1)(2012-3#1)
of Pratylenchus penetrans##2##3##(2008-10#2)
of Pratylenchus##4##2##(2008-10#4)
of Prc-MIH##3##2##(2008-6#3)
of President Clinton's##2##3##(1995-6#1)(2008-7#1)
of President Reagan's colon cancer episode##2##6##(1991-3#2)
of President##4##2##(1991-3#2)(1995-6#1)(2008-7#1)
of Prevalence##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
of Prevention##2##2##(1997-5#1)(2010-6#1)
of Preventive##2##2##(2007-12#1)(2013-1#1)
of Primary and Secondary##2##4##(2008-10#1)(2008-11#1)
of Primary##10##2##(1991-9#2)(1994-6#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-6#1)(2009-9#1)
of Primatone RL##4##3##(2008-7#4)
of Principal##2##2##(2008-10#1)(2008-5#1)
of Pro 66##2##3##(1992-6#2)
of Pro##4##2##(1991-9#1)(1992-6#2)(1994-3#1)
of Pro-Pro-[3H]benzylamide##2##2##(1992-3#2)
of Production##3##2##(2008-10#2)(2011-2#1)
of Prof##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)
of Professor##7##2##(1992-5#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
of Programmed##2##2##(2012-3#2)
of Project##2##2##(2008-1#1)(2008-12#1)
of Prospero##2##2##(2008-7#2)
of Protein Kinase##2##3##(2008-11#1)(2008-3#1)
of Protein##6##2##(1996-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
of Proteus syndrome##2##3##(2007-7#2)
of Prune dwarf virus##2##4##(2008-10#2)
of Prune##5##2##(2008-10#5)
of Prunus necrotic ringspot virus (PNRSV)##2##6##(2008-10#2)
of Prunus necrotic ringspot virus##3##5##(2008-10#3)
of Prunus##6##2##(2008-10#6)
of Prussian-Blue##2##2##(2008-10#2)
of Pseudomonas aeruginosa was##2##4##(1992-11#1)(2008-10#1)
of Pseudomonas aeruginosa##15##3##(1992-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-10#1)(2012-2#4)(2012-3#1)(2013-1#1)
of Pseudomonas fluorescens B5##5##4##(2008-10#5)
of Pseudomonas fluorescens##13##3##(2008-10#13)
of Pseudomonas putida 06909-rif/nal##8##4##(2008-10#8)
of Pseudomonas putida##13##3##(1994-12#1)(1994-6#1)(1995-8#1)(1997-2#1)(2008-10#8)(2012-2#1)
of Pseudomonas spp##3##3##(2008-10#2)(2011-1#1)
of Pseudomonas syringae pv##8##4##(2008-10#8)
of Pseudomonas syringae pvs##2##4##(2008-10#2)
of Pseudomonas syringae##16##3##(2008-10#16)
of Pseudomonas##69##2##(1990-11#1)(1992-11#1)(1994-12#3)(1994-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#44)(2008-12#1)(2008-6#2)(2008-7#2)(2009-2#1)(2010-10#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
of Pseudothecia##2##2##(2008-10#2)
of Psidium guajava##2##3##(2013-1#2)
of Psoriasis##3##2##(2007-7#3)
of Psychiatric##5##2##(2008-12#1)(2009-6#1)(2011-4#1)(2012-2#1)(2013-8#1)
of Psychiatry and##2##3##(2008-7#1)(2011-3#1)
of Psychiatry##7##2##(1996-12#1)(2008-12#1)(2008-7#1)(2011-3#1)(2011-4#3)
of Pt and##2##3##(2008-10#2)
of Pt##8##2##(2008-10#6)(2008-11#2)
of PtdIns 3-kinase##3##3##(1992-12#3)
of PtdSer##2##2##(1992-9#2)
of Pten in##2##3##(2011-2#2)
of Pten##3##2##(2011-2#3)
of Pterocarya fraxinifolia##2##3##(2011-1#2)
of Ptiliidae##3##2##(2007-12#3)
of Ptinella tenella##2##3##(2007-12#2)
of Ptr##2##2##(2008-10#2)
of Pu##7##2##(2008-10#7)
of PubMed##2##2##(2009-9#1)(2012-2#1)
of Public Health and##3##4##(1996-1#1)(2008-1#1)(2011-2#1)
of Public Health identified##2##4##(1996-1#1)(2008-10#1)
of Public Health of##2##4##(2008-12#1)(2012-3#1)
of Public Health##39##3##(1990-3#1)(1991-2#2)(1995-11#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-6#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-1#15)(2011-2#1)(2012-3#1)
of Public##43##2##(1990-3#1)(1991-2#2)(1991-3#1)(1993-12#1)(1995-11#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-6#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#15)(2011-2#1)(2012-3#1)
of Puccinia allii##2##3##(2008-10#2)
of Puccinia coronata##3##3##(2008-10#3)
of Puccinia graminis f##2##4##(2008-10#2)
of Puccinia graminis##3##3##(2008-10#3)
of Puccinia recondita f##2##4##(2008-10#2)
of Puccinia striiformis##2##3##(2008-10#2)
of Puccinia triticina from##3##4##(2008-10#3)
of Puccinia triticina##11##3##(2008-10#11)
of Puccinia##25##2##(2008-10#25)
of Puerto Rico##2##3##(2006-10#1)(2007-5#1)
of Puerto##6##2##(1994-2#1)(2006-10#1)(2007-5#1)(2012-12#3)
of PurR##3##2##(2008-8#3)
of Purkinje cells in##3##4##(1996-2#1)(1997-8#1)(2012-2#1)
of Purkinje cells##4##3##(1996-2#1)(1996-5#1)(1997-8#1)(2012-2#1)
of Purkinje neurons##2##3##(1995-8#2)
of Purkinje##7##2##(1995-8#2)(1996-2#1)(1996-5#1)(1997-8#1)(2012-2#2)
of PvSR2##2##2##(2008-9#2)
of Pyr and D-Pyr##2##4##(1994-12#2)
of Pyr-ms##2##2##(2008-10#2)
of Pyrenopeziza brassicae##2##3##(2008-10#2)
of Pyrenophora tritici-repentis##5##3##(2008-10#5)
of Pyrenophora##6##2##(2008-10#6)
of Pyricularia grisea from##2##4##(2008-10#2)
of Pyricularia grisea##5##3##(2008-10#5)
of Pyricularia##6##2##(2008-10#6)
of Pythium oligandrum##3##3##(2008-10#3)
of Pythium spp##8##3##(2008-10#8)
of Pythium ultimum var##3##4##(2008-10#3)
of Pythium ultimum##4##3##(2008-10#4)
of Pythium##24##2##(2008-10#24)
of Q -switched##2##3##(2007-11#2)
of Q fever##2##3##(2007-12#2)
of Q were##2##3##(2008-10#2)
of Q##14##2##(2007-11#3)(2007-12#3)(2008-10#6)(2012-5#1)(2012-6#1)
of Q-switched mode locking##2##4##(2007-11#2)
of Q8r1-96##2##2##(2008-10#2)
of QA##3##2##(1992-6#1)(1994-2#1)(2007-7#1)
of QAS##2##2##(2008-10#2)
of QC##2##2##(2009-12#2)
of QCM##2##2##(2008-10#2)
of QDs##2##2##(2009-11#2)
of QRS##2##2##(2008-10#1)(2012-3#1)
of QSAR##2##2##(2008-10#1)(2012-3#1)
of QTL for##2##3##(2008-10#1)(2012-3#1)
of QTL##9##2##(2008-10#5)(2009-5#2)(2012-3#2)
of QTLs for##2##3##(2008-9#1)(2009-10#1)
of QTLs##6##2##(2008-10#1)(2008-9#2)(2009-10#1)(2011-1#2)
of Qc to##2##3##(1993-8#2)
of Qc##3##2##(1993-8#3)
of Qi deficiency##2##3##(2013-1#1)(2013-8#1)
of Qi##3##2##(2012-3#1)(2013-1#1)(2013-8#1)
of QoL##7##2##(2008-10#3)(2008-3#1)(2013-1#3)
of Quality##2##2##(1997-1#1)(1997-2#1)
of Quantitative Trait Loci##2##4##(2008-10#2)
of Quantitative##3##2##(2008-10#3)
of Quebec##10##2##(1992-1#2)(1996-1#2)(1997-2#1)(2007-12#3)(2009-10#1)(2011-2#1)
of Queensland##4##2##(2010-10#1)(2010-8#1)(2012-12#1)(2013-8#1)
of Quercus##4##2##(2008-10#1)(2009-12#1)(2009-6#1)(2012-6#1)
of Québec##2##2##(1996-3#1)(2008-10#1)
of R alleles##2##3##(2008-10#2)
of R genes##3##3##(2008-10#3)
of R##101##2##(1991-8#4)(1992-11#1)(1994-12#1)(1995-12#1)(2008-10#73)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-2#3)(2009-6#1)(2010-1#1)(2011-1#2)(2012-2#3)(2013-7#2)
of R(1)##2##2##(2008-10#2)
of R(2)##2##2##(2008-3#1)(2011-1#1)
of R-(+)-pulegone##2##2##(1990-12#1)(1991-5#1)
of R-PIA (3##2##3##(1997-2#2)
of R-baclofen##3##2##(2008-10#3)
of R-strand##2##2##(2008-7#2)
of R1##4##2##(1990-12#1)(1993-11#2)(2008-10#1)
of R2##3##2##(1993-11#3)
of R22L##2##2##(2008-8#2)
of R338W##5##2##(1995-8#5)
of RA and##3##3##(2008-11#2)(2008-7#1)
of RA into##2##3##(2008-5#2)
of RA##27##2##(1990-6#2)(1996-5#2)(2008-11#4)(2008-5#5)(2008-7#2)(2008-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#3)
of RAM1##2##2##(1993-9#2)
of RANKL##2##2##(2008-11#2)
of RANTES/CCL5##2##2##(2012-1#2)
of RAPB##2##2##(2008-9#2)
of RAPD and##3##3##(2008-10#2)(2008-5#1)
of RAPD markers##5##3##(1995-6#1)(2008-10#1)(2008-5#3)
of RAPD##12##2##(1995-6#1)(2008-10#7)(2008-5#4)
of RATEC##2##2##(2008-11#2)
of RB protein##6##3##(1993-8#5)(1997-7#1)
of RB##12##2##(1993-8#5)(1997-7#1)(2008-10#4)(2013-1#2)
of RBC##5##2##(2008-10#1)(2008-12#3)(2010-8#1)
of RBCs##9##2##(1994-12#1)(1994-3#1)(1994-6#2)(2008-8#2)(2009-11#3)
of RBM3##3##2##(1997-7#3)
of RBV##3##2##(2013-1#3)
of RC##2##2##(2008-12#1)(2008-8#1)
of RC-160##4##2##(1995-2#4)
of RCC##13##2##(2007-4#1)(2008-1#3)(2008-8#3)(2011-2#1)(2012-3#3)(2013-1#2)
of RCK7##2##2##(2008-11#2)
of RCNSNS(*)##2##2##(1996-2#2)
of RCT##2##2##(2011-2#2)
of RCTs##3##2##(1993-12#1)(1996-8#1)(2007-7#1)
of RDV##4##2##(2008-10#4)
of RDX##11##2##(2008-10#7)(2008-7#4)
of RE##4##2##(2008-8#4)
of REE##5##2##(2008-10#4)(2012-2#1)
of REEs in##2##3##(2008-10#2)
of REEs##6##2##(2008-10#6)
of REM##2##2##(2008-7#1)(2012-3#1)
of RER##2##2##(1992-6#1)(2008-4#1)
of REV were##2##3##(2008-5#1)(2013-8#1)
of REV##3##2##(2008-5#1)(2013-8#2)
of REp##2##2##(2008-5#2)
of RF power##3##3##(1992-3#3)
of RF##9##2##(1992-3#5)(2008-10#1)(2010-6#1)(2011-2#2)
of RFA##4##2##(2008-9#1)(2012-2#3)
of RFID##2##2##(2008-12#2)
of RFLP markers##3##3##(2008-10#1)(2008-5#2)
of RGAs were##2##3##(2008-10#2)
of RGAs##3##2##(2008-10#3)
of RGCs##2##2##(2009-12#2)
of RGP##3##2##(1995-2#3)
of RH##6##2##(2008-10#5)(2008-6#1)
of RH10##2##2##(1992-11#2)
of RHD##3##2##(2012-2#3)
of RICM images##2##3##(2008-2#2)
of RJ##2##2##(2008-10#2)
of RJA and##2##3##(2013-1#2)
of RJA##6##2##(2013-1#6)
of RLA/Verh rats as compared to##2##6##(1994-2#2)
of RLS##4##2##(1997-4#1)(2012-12#3)
of RNA 1 and##2##4##(2008-10#2)
of RNA 2##2##3##(2008-10#2)
of RNA and DNA##6##4##(1992-3#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
of RNA and protein##2##4##(1992-8#1)(1994-8#1)
of RNA and proteins##2##4##(1991-8#1)(1992-8#1)
of RNA and##11##3##(1991-8#1)(1992-3#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
of RNA by##4##3##(2008-2#2)(2008-4#2)
of RNA editing in##3##4##(2010-9#1)(2012-2#2)
of RNA editing##5##3##(1992-11#1)(1997-2#1)(2010-9#1)(2012-2#2)
of RNA from##3##3##(1994-9#1)(2008-7#1)(2008-9#1)
of RNA in##2##3##(1997-6#1)(2009-3#1)
of RNA interference##3##3##(2008-2#2)(2010-5#1)
of RNA isolated from##2##4##(2008-10#1)(2008-7#1)
of RNA polymerase II##3##4##(1994-3#2)(2012-2#1)
of RNA polymerase##11##3##(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#2)
of RNA samples##2##3##(2008-4#1)(2008-5#1)
of RNA secondary structure##2##4##(1991-9#1)(1994-8#1)
of RNA secondary##3##3##(1991-9#1)(1994-8#1)(2011-3#1)
of RNA sequences##3##3##(2008-2#1)(2008-4#1)(2008-7#1)
of RNA silencing##2##3##(2011-1#1)(2011-2#1)
of RNA structure##2##3##(2008-4#1)(2008-7#1)
of RNA synthesis##4##3##(1995-2#2)(1996-2#1)(2008-9#1)
of RNA transcripts##2##3##(2008-4#2)
of RNA viruses##2##3##(2008-10#1)(2013-8#1)
of RNA with##3##3##(1997-2#1)(2008-2#1)(2008-4#1)
of RNA##119##2##(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-8#4)(1994-9#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-6#4)(2007-12#1)(2008-10#11)(2008-2#7)(2008-4#16)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#10)(2009-3#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
of RNA-binding proteins##2##3##(2007-12#1)(2012-12#1)
of RNA-dependent RNA polymerases##3##4##(2008-10#3)
of RNA-dependent RNA##4##3##(2008-10#4)
of RNA-protein complexes##2##3##(2008-2#2)
of RNA-protein##4##2##(2008-2#4)
of RNA1##3##2##(2008-10#3)
of RNA2##3##2##(1992-8#3)
of RNAi##4##2##(2008-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
of RNAs##8##2##(1992-12#1)(1992-9#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
of RNase##4##2##(1990-7#1)(1992-11#1)(1995-6#1)(2009-2#1)
of RO 11-2933##2##3##(1990-2#2)
of RO##3##2##(1990-2#2)(2008-12#1)
of ROE##2##2##(2008-5#2)
of ROH##2##2##(2008-10#2)
of ROI quantification##2##3##(2010-2#2)
of ROI##3##2##(2010-2#3)
of ROP1##2##2##(2009-10#2)
of ROR gamma##2##3##(1994-12#2)
of ROR##3##2##(1994-12#3)
of ROS and##2##3##(2008-11#1)(2011-2#1)
of ROS by##3##3##(1994-5#2)(2008-5#1)
of ROS in##2##3##(2011-2#1)(2013-8#1)
of ROS production was##3##4##(1994-5#1)(2008-4#2)
of ROS production##5##3##(1994-5#1)(2008-4#2)(2009-3#1)(2010-12#1)
of ROS##28##2##(1994-11#1)(1994-5#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
of RP genes##3##3##(2009-8#3)
of RP##5##2##(2009-8#3)(2011-2#2)
of RP-HPLC and##2##3##(1996-5#1)(2011-1#1)
of RPGRIP1##2##2##(2012-12#2)
of RPGRIP1α(1)##5##2##(2012-12#5)
of RPMI 1788 cells##3##4##(1990-12#3)
of RPMI 1788##4##3##(1990-12#4)
of RPP##3##2##(2007-12#3)
of RPs in##2##3##(2008-7#2)
of RPs##5##2##(2008-7#5)
of RQA##2##2##(2008-11#2)
of RS extract##7##3##(2008-11#7)
of RSA##2##2##(2010-10#2)
of RSB##2##2##(2013-1#2)
of RSV##2##2##(1995-6#2)
of RT MCE##2##3##(2010-8#2)
of RT##3##2##(2008-11#1)(2010-8#2)
of RT-PCR##5##2##(2008-10#3)(2008-9#1)(2011-1#1)
of RTA##2##2##(1992-3#1)(2008-3#1)
of RTP##2##2##(2008-10#2)
of RU##2##2##(1992-5#1)(2008-7#1)
of RU486##3##2##(1996-5#2)(2008-9#1)
of RWA##2##2##(2008-9#2)
of RXRα##3##2##(2012-12#3)
of Rab##5##2##(1995-8#1)(2011-2#4)
of Rabphilin-3A##2##2##(1994-9#2)
of Rac1 activity##2##3##(1996-2#1)(2012-7#1)
of Rac2##2##2##(1997-7#2)
of Race##2##2##(2008-10#2)
of Race-Specific##3##2##(2008-10#3)
of Radiation Oncology and##2##4##(2008-10#2)
of Radiation Oncology##4##3##(1994-3#1)(2008-10#3)
of Radiation##5##2##(1994-3#1)(2008-10#3)(2013-1#1)
of Radiologic Technologists##2##3##(1996-3#2)
of Radiology Management##6##3##(1991-2#1)(1994-12#1)(1995-1#1)(1995-2#2)(1996-1#1)
of Radiology##16##2##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-1#1)(2010-12#2)(2012-2#6)
of Radiotherapy##2##2##(1990-10#1)(2008-10#1)
of Raf1 and JNK1##2##4##(2012-12#2)
of Raf55-132##2##2##(1995-5#2)
of Ragusa##2##2##(1991-2#2)
of Ralstonia solanacearum Biovar 2##2##5##(2008-10#2)
of Ralstonia solanacearum Race 3##2##5##(2008-10#2)
of Ralstonia solanacearum Race##3##4##(2008-10#3)
of Ralstonia solanacearum in##2##4##(2008-10#2)
of Ralstonia solanacearum##16##3##(2008-10#16)
of Ramadan##5##2##(1992-2#1)(2008-4#3)(2009-7#1)
of Raman scattering to##3##4##(2008-3#3)
of Raman scattering##11##3##(2007-12#2)(2008-2#1)(2008-3#8)
of Raman signals##2##3##(2008-3#2)
of Raman spectroscopy to##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
of Raman spectroscopy##6##3##(2008-10#2)(2008-3#1)(2008-4#1)(2013-8#2)
of Raman tweezers##2##3##(2009-12#2)
of Raman##40##2##(2007-11#6)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#15)(2008-4#1)(2009-12#2)(2011-1#1)(2013-8#5)
of Ran##4##2##(1995-2#2)(2011-2#1)(2012-12#1)
of Random Amplified Polymorphic DNA Markers Linked to##2##8##(2008-10#2)
of Random##3##2##(1996-12#1)(2008-10#2)
of Ranvier##2##2##(2008-7#1)(2008-8#1)
of Ras proteins is##2##4##(1994-8#1)(2008-5#1)
of Ras proteins##3##3##(1994-8#1)(2008-5#1)(2013-7#1)
of Ras##22##2##(1993-11#1)(1994-12#1)(1994-8#5)(1995-2#2)(1996-2#3)(1997-7#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-7#2)
of RasGRP1##3##2##(2013-8#3)
of Rat##3##2##(2008-11#2)(2009-8#1)
of Rauvolfia tetraphylla L##2##4##(2008-12#2)
of Rayleigh scattering##4##3##(2007-12#1)(2008-2#3)
of Rayleigh##6##2##(2007-11#2)(2007-12#1)(2008-2#3)
of Rb##6##2##(1995-2#2)(2007-12#2)(2008-10#1)(2008-8#1)
of Reactive##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
of Reference##4##2##(2008-10#3)(2011-2#1)
of Regulatory Fit##2##3##(2009-5#1)(2009-6#1)
of Rehabilitation##2##2##(2007-8#1)(2009-8#1)
of Relative##3##2##(2008-10#3)
of Remember/Know##2##2##(2009-8#2)
of Renal##4##2##(2008-1#2)(2011-2#1)(2013-1#1)
of RepK##4##2##(1997-6#4)
of Republic of##2##3##(2008-1#1)(2008-10#1)
of Research##2##2##(2009-4#2)
of Resistance to Sterol Demethylation##2##5##(2008-10#2)
of Resistance to##17##3##(2008-10#17)
of Resistance##20##2##(2008-10#19)(2010-1#1)
of Resource Intensity Weights##2##4##(1991-12#1)(1995-1#1)
of Resource##3##2##(1991-12#1)(1994-12#1)(1995-1#1)
of Respiratory##2##2##(1997-4#1)(2011-2#1)
of Retzius##2##2##(1997-3#2)
of Revista##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
of Rh##7##2##(1992-9#1)(1994-12#1)(1996-3#2)(2008-10#2)(2012-2#1)
of Rheumatology at Hospital for Special Surgery##3##7##(2008-8#3)
of Rheumatology criteria##2##3##(1997-8#1)(2006-10#1)
of Rheumatology##8##2##(1997-8#1)(2006-10#2)(2007-8#1)(2008-8#3)(2011-2#1)
of Rhexocercosporidium##3##2##(2008-10#3)
of Rhizobium##3##2##(1994-8#1)(2011-2#2)
of Rhizoctonia blight##2##3##(2008-10#2)
of Rhizoctonia solani Anastomosis Group##3##5##(2008-10#3)
of Rhizoctonia solani Anastomosis##4##4##(2008-10#4)
of Rhizoctonia solani anastomosis group##3##5##(2008-10#3)
of Rhizoctonia solani and##2##4##(2008-10#2)
of Rhizoctonia solani in##2##4##(2008-10#2)
of Rhizoctonia solani##24##3##(2008-10#24)
of Rhizoctonia spp##5##3##(2008-10#3)(2008-12#2)
of Rhizoctonia##36##2##(2008-10#34)(2008-12#2)
of Rhizopus head rot##3##4##(2008-10#3)
of Rhizopus##9##2##(2008-10#3)(2008-6#6)
of Rho GTPases##2##3##(2011-2#1)(2012-7#1)
of Rho##4##2##(2008-7#1)(2011-2#1)(2012-7#1)(2013-1#1)
of Rho(D) antigen##2##3##(1994-12#2)
of Rho123##3##2##(2008-10#3)
of Rhodamine 6G##4##3##(2007-11#1)(2008-3#3)
of Rhodamine##6##2##(2007-11#1)(2008-10#1)(2008-3#4)
of Rhode Island##2##3##(1991-3#1)(1992-2#1)
of Rhodobacter sphaeroides##6##3##(1993-11#1)(2008-10#1)(2008-8#2)(2010-2#2)
of Rhynchosporium secalis from##2##4##(2008-10#2)
of Rhynchosporium secalis in##2##4##(2008-10#2)
of Rhynchosporium secalis##4##3##(2008-10#4)
of Rhythmic##2##2##(2010-9#1)(2012-12#1)
of Riberalta##2##2##(2012-12#2)
of Rice Blast##2##3##(2008-10#2)
of Rice##6##2##(2008-10#5)(2013-8#1)
of Ricinus communis##2##3##(1993-11#1)(2008-11#1)
of Rickettsia slovaca##2##3##(1995-12#1)(2009-2#1)
of Rickettsia##4##2##(1995-12#1)(2008-5#1)(2008-7#1)(2009-2#1)
of Riedel's thyroiditis##3##3##(2008-12#3)
of Rio Frio##2##3##(2008-5#2)
of Rio Grande do Sul##3##5##(1993-6#2)(2013-7#1)
of Rio de Janeiro##6##4##(1991-6#1)(2008-6#3)(2009-7#1)(2012-3#1)
of Rio de##7##3##(1991-6#2)(2008-6#3)(2009-7#1)(2012-3#1)
of Rio##13##2##(1991-6#2)(1993-6#2)(2008-10#1)(2008-5#2)(2008-6#3)(2009-7#1)(2012-3#1)(2013-7#1)
of Rizaben for##2##3##(2008-5#2)
of Ro 40-8757 to##2##4##(1993-9#2)
of Ro##3##2##(1993-9#2)(1994-6#1)
of Robert##3##2##(2008-3#1)(2008-5#1)(2009-7#1)
of Robertsonian##2##2##(2010-3#2)
of Roman age##2##3##(2008-10#2)
of Roman high-avoidance##2##3##(1994-2#2)
of Roman##6##2##(1994-2#2)(2008-10#4)
of Rome##6##2##(1990-8#2)(1992-9#1)(2011-7#1)(2013-1#2)
of Rooibos tea##2##3##(1994-2#2)
of Root and##2##3##(2008-10#2)
of Root##3##2##(2008-10#3)
of Rosellinia necatrix##2##3##(2008-10#2)
of Rotavirus##2##2##(2008-5#1)(2011-2#1)
of Rotylenchulus reniformis##2##3##(2008-10#2)
of Ru##4##2##(2008-10#4)
of Ru(III)##2##2##(2008-10#2)
of Ru(bpy)(3)(2+)##11##2##(2008-10#11)
of Ru-bipy##2##2##(2008-12#2)
of Rubia cordifolia in##2##4##(2012-2#2)
of Rubia cordifolia##5##3##(2012-2#5)
of Rubia##6##2##(2012-2#6)
of Rubisco##3##2##(1993-11#1)(2008-8#2)
of Rumination and##2##3##(2008-8#1)(2010-10#1)
of Russia##2##2##(2011-2#1)(2013-1#1)
of Russian##2##2##(2008-9#1)(2013-8#1)
of S and R captopril using##2##6##(2008-10#2)
of S and##3##3##(2008-10#2)(2008-2#1)
of S strain##2##3##(2008-10#2)
of S##190##2##(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#1)(1991-5#1)(1992-2#1)(1992-6#3)(1993-9#1)(1994-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#5)(1996-6#5)(1996-8#1)(1997-3#7)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-10#69)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#9)(2008-7#5)(2008-8#12)(2008-9#5)(2009-2#2)(2009-6#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#8)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
of S(rs)##2##2##(2008-2#2)
of S-1##7##2##(1991-5#5)(1994-8#1)(1995-2#1)
of S-1(A2)##3##2##(1992-4#3)
of S-adenosylhomocysteine hydrolase##2##3##(1994-8#1)(2011-2#1)
of S-adenosylmethionine on##2##3##(2009-8#1)(2013-1#1)
of S-adenosylmethionine##5##2##(1991-12#1)(1992-8#1)(1993-6#1)(2009-8#1)(2013-1#1)
of S1##5##2##(1992-3#1)(1994-5#1)(1997-3#1)(1997-9#1)(2008-12#1)
of S100##3##2##(1993-12#1)(2013-8#2)
of S100A8##3##2##(2013-8#3)
of S1NPV##3##2##(1997-4#3)
of S9##5##2##(1992-2#1)(1992-8#1)(1996-2#1)(1997-4#1)(2008-9#1)
of SA signaling##2##3##(2009-6#2)
of SA##13##2##(1993-6#1)(2008-10#8)(2008-12#1)(2009-6#2)(2011-2#1)
of SAA##2##2##(2009-10#2)
of SAGE##2##2##(2008-1#2)
of SAH in##2##3##(1995-5#1)(2009-7#1)
of SAH##8##2##(1995-5#3)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#2)
of SAILS##2##2##(2008-3#2)
of SAM##2##2##(2008-10#1)(2008-7#1)
of SAMs##2##2##(2008-10#2)
of SAP##2##2##(2008-5#1)(2013-1#1)
of SAR##5##2##(1991-1#1)(1995-6#1)(2008-10#3)
of SARS##2##2##(2007-11#1)(2010-2#1)
of SB obstruction##2##3##(1997-8#2)
of SBA levels##2##3##(2013-1#2)
of SC lipids##2##3##(2008-5#2)
of SC##5##2##(2008-10#1)(2008-5#4)
of SC115##5##2##(1990-11#5)
of SCAR##4##2##(2008-10#1)(2008-5#1)(2009-10#2)
of SCAVMs##3##2##(1995-11#2)(1997-6#1)
of SCD in young##2##4##(2012-3#2)
of SCE##3##2##(1990-6#1)(2008-11#2)
of SCEs##2##2##(1990-6#1)(2008-4#1)
of SCFAs in##2##3##(2012-1#2)
of SCFAs##3##2##(2012-1#3)
of SCH##2##2##(2012-3#2)
of SCI##2##2##(2008-8#1)(2009-12#1)
of SCMV##3##2##(2008-10#2)(2008-9#1)
of SCN(-)##2##2##(2008-10#2)
of SCN1A##2##2##(2012-12#2)
of SCSs##2##2##(2008-10#1)(2008-11#1)
of SCr##2##2##(2008-1#2)
of SD##3##2##(2008-10#1)(2008-9#1)(2009-2#1)
of SDHD##2##2##(2010-5#2)
of SDME##2##2##(2008-10#2)
of SDS was##3##3##(1990-11#1)(2012-2#2)
of SDS##17##2##(1990-11#1)(1991-5#1)(1992-12#1)(2008-10#7)(2008-5#2)(2012-2#5)
of SDS-degrading##2##2##(2012-2#2)
of SDS/OP micellar medium##2##4##(2008-10#2)
of SDZ ASM 981##3##4##(2007-11#3)
of SE##4##2##(2008-10#1)(2008-2#2)(2009-8#1)
of SE5-OH##2##2##(2010-1#2)
of SEAP##3##2##(2008-11#3)
of SEM##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
of SEP##2##2##(2008-10#1)(2009-3#1)
of SERS activity##2##3##(2007-12#2)
of SERS##9##2##(2007-12#3)(2008-10#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-8#2)
of SERS-active##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
of SES##2##2##(2010-11#1)(2012-12#1)
of SFE##3##2##(2008-10#3)
of SFN in sarcoidosis##2##4##(2013-1#2)
of SFO##3##2##(1992-5#2)(1994-2#1)
of SFPI##3##2##(2011-3#3)
of SFV##2##2##(2008-1#1)(2008-11#1)
of SGLT1 mRNA##2##3##(1991-12#2)
of SGP##2##2##(2013-1#2)
of SH2 profiling##2##3##(2012-12#2)
of SHG##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
of SHI##2##2##(2008-7#2)
of SHIP2-SH2##2##2##(2012-2#2)
of SHLI with western##2##4##(2011-2#2)
of SHLI with##3##3##(2011-2#3)
of SHLI##8##2##(2011-2#8)
of SHR##2##2##(1997-6#2)
of SI##2##2##(1995-12#1)(2008-7#1)
of SIA for##2##3##(2008-10#2)
of SIB##3##2##(2009-10#3)
of SIDS##11##2##(1991-11#1)(1992-11#5)(1992-4#1)(1993-12#1)(2008-1#1)(2013-1#2)
of SIJ dysfunction##3##3##(2010-1#3)
of SIL##2##2##(2012-12#2)
of SIN-1##3##2##(1995-11#1)(1997-4#2)
of SIP##5##2##(1993-6#2)(2011-2#3)
of SIT##7##2##(2011-2#6)(2012-12#1)
of SIV##2##2##(1994-12#1)(1995-2#1)
of SIV-PR##2##2##(1991-9#2)
of SIV-infected##2##2##(1995-2#2)
of SIVs##3##2##(2013-1#1)(2013-8#2)
of SIVsmmPBj1##2##2##(1995-2#2)
of SK&amp##3##2##(1991-8#3)
of SL-selectin##2##2##(1992-12#2)
of SLC6A4 gene##2##3##(2012-1#2)
of SLCO1B1##2##2##(2011-2#2)
of SLE in##3##3##(2006-10#3)
of SLE patients##6##3##(2006-10#2)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)
of SLE##20##2##(2006-10#6)(2008-1#4)(2008-10#2)(2010-12#2)(2010-5#1)(2011-2#4)(2013-1#1)
of SLI and##2##3##(2009-8#1)(2012-3#1)
of SLI##6##2##(2008-11#1)(2009-8#1)(2012-3#4)
of SLIT##4##2##(2008-8#1)(2011-2#3)
of SLTs##2##2##(2012-3#2)
of SMARCAL1##2##2##(2011-2#2)
of SMBG in T2DM##3##4##(2009-11#3)
of SMBG in##4##3##(2009-11#4)
of SMBG##7##2##(2008-8#2)(2009-11#5)
of SMC##3##2##(1994-11#1)(2008-10#1)(2009-11#1)
of SMV HC-Pro##2##3##(2008-10#2)
of SMV##11##2##(2008-10#11)
of SN##3##2##(2010-8#3)
of SNAP-25##4##2##(1995-2#3)(1995-6#1)
of SNAZOXS##2##2##(2008-10#2)
of SNB##2##2##(2008-10#2)
of SNP##3##2##(1995-11#1)(2008-7#1)(2011-2#1)
of SNPs in##2##3##(2008-9#1)(2013-1#1)
of SNPs##8##2##(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
of SO(2)##8##2##(2008-10#3)(2008-11#2)(2008-3#3)
of SO(4)(2-)##2##2##(2008-10#2)
of SO3(2-)##2##2##(1994-11#2)
of SOD and CAT##2##4##(1994-6#2)
of SOD and##3##3##(1994-6#2)(1997-4#1)
of SOD##12##2##(1990-3#1)(1994-6#2)(1997-4#2)(1997-8#2)(2008-10#2)(2008-5#1)(2011-3#2)
of SOM##2##2##(2013-8#2)
of SOP##2##2##(2008-7#2)
of SP##3##2##(1997-3#2)(2008-10#1)
of SP-B and SP-C##2##4##(2007-11#2)
of SP-B##4##2##(2007-11#4)
of SP1##3##2##(1995-8#1)(2010-4#2)
of SPA##4##2##(1994-12#2)(2008-4#2)
of SPARC##3##2##(2008-1#3)
of SPB##2##2##(2012-12#2)
of SPC##4##2##(1995-2#3)(2008-10#1)
of SPE##4##2##(2008-10#3)(2013-1#1)
of SPECT in##2##3##(1994-1#2)
of SPECT##4##2##(1994-1#2)(1996-7#1)(2012-1#1)
of SPFMV##4##2##(2008-10#4)
of SPIOs##3##2##(2013-1#3)
of SPME with##2##3##(2008-10#2)
of SPME##10##2##(2008-10#8)(2009-8#2)
of SPR##2##2##(2008-10#1)(2008-3#1)
of SPS##3##2##(2008-12#2)(2011-2#1)
of SPs and the##2##4##(2013-1#2)
of SR 48692##2##3##(1997-2#2)
of SR alpha##3##3##(1995-6#3)
of SR##13##2##(1992-3#1)(1995-6#4)(1997-2#2)(1997-7#1)(2008-3#1)(2008-8#3)(2013-8#1)
of SR141716A##2##2##(1996-2#2)
of SREs##3##2##(2008-7#3)
of SRIF mRNA##2##3##(1997-2#2)
of SRIF##3##2##(1997-2#3)
of SRM##3##2##(2008-10#3)
of SS##6##2##(2007-11#1)(2009-11#2)(2010-5#2)(2011-2#1)
of SS-like immunoreactivity##2##3##(1996-5#2)
of SSAT expression##2##3##(1995-2#2)
of SSAT##6##2##(1992-10#2)(1995-2#4)
of SSB##2##2##(1997-2#1)(2011-2#1)
of SSCP##3##2##(1992-8#1)(2008-12#1)(2008-4#1)
of SSE1##2##2##(1993-9#2)
of SSI rates##2##3##(2010-12#2)
of SSR incidence##2##3##(2008-10#2)
of SSR##9##2##(2008-10#5)(2008-5#2)(2010-7#2)
of SSRI treatment##2##3##(2011-1#2)
of SSRI##5##2##(2008-3#1)(2008-6#1)(2011-1#3)
of SSRs##2##2##(2008-7#1)(2011-2#1)
of SSTIs is##2##3##(2009-4#2)
of SSTIs##5##2##(2009-4#5)
of ST segment and R wave changes in##2##8##(1996-6#2)
of ST##5##2##(1996-6#3)(2008-12#1)(2012-3#1)
of ST3##2##2##(2008-4#2)
of STA##3##2##(1995-6#1)(2008-10#2)
of STAT1##2##2##(2011-2#2)
of STATs##3##2##(1996-2#1)(2012-3#2)
of STD##2##2##(1990-6#1)(2007-7#1)
of STDs##2##2##(1990-3#1)(2011-1#1)
of STE7##2##2##(1997-4#2)
of STI##2##2##(2008-12#1)(2011-2#1)
of STL-3##4##2##(2008-11#4)
of STLCV##3##2##(2008-10#3)
of STPP in##2##3##(2008-10#2)
of STS##3##2##(2008-6#2)(2013-8#1)
of SU-8##3##2##(2007-12#1)(2008-10#2)
of SUI##2##2##(2008-3#1)(2011-1#1)
of SUMER##4##2##(2008-2#1)(2008-3#3)
of SUV##2##2##(1992-3#1)(2008-10#1)
of SV##2##2##(1991-12#2)
of SV2##4##2##(1993-12#4)
of SV40##4##2##(1994-6#1)(2008-11#2)(2008-4#1)
of SVPC##2##2##(2010-11#2)
of SW catalytic##2##3##(2008-10#2)
of SWIs##2##2##(2007-8#2)
of SWNTs in##2##3##(2008-7#2)
of SWNTs##9##2##(2008-7#7)(2009-11#2)
of SYSV##3##2##(2008-10#3)
of Saccharomyces cerevisiae by##2##4##(1995-6#1)(1997-6#1)
of Saccharomyces cerevisiae chromosome VII##8##5##(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#5)
of Saccharomyces cerevisiae chromosome XIV##2##5##(1996-3#2)
of Saccharomyces cerevisiae chromosome##14##4##(1994-9#2)(1995-12#1)(1995-9#1)(1996-3#3)(1996-6#1)(1997-3#6)
of Saccharomyces cerevisiae is##2##4##(1996-3#1)(1996-6#1)
of Saccharomyces cerevisiae that##3##4##(1993-12#1)(1995-2#1)(1997-6#1)
of Saccharomyces cerevisiae was##3##4##(1995-9#1)(1996-6#1)(1997-3#1)
of Saccharomyces cerevisiae##60##3##(1990-2#1)(1990-5#3)(1991-9#1)(1992-3#1)(1993-12#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-6#6)(1995-8#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#8)(1996-6#3)(1997-1#1)(1997-3#9)(1997-4#3)(1997-6#2)(1997-7#1)(2008-10#2)(2008-6#1)(2008-7#3)(2009-12#1)
of Saccharomyces##65##2##(1990-2#1)(1990-5#3)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-6#6)(1995-8#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#8)(1996-6#3)(1997-1#1)(1997-3#9)(1997-4#3)(1997-6#2)(1997-7#2)(2008-10#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-8#1)(2011-1#1)
of Salmonella SBP##2##3##(2009-8#2)
of Salmonella enterica serovar Typhimurium##2##5##(2008-11#2)
of Salmonella enterica##3##3##(2007-7#1)(2008-11#2)
of Salmonella enteritidis##6##3##(1990-6#1)(1991-11#1)(1993-2#1)(1995-9#2)(2008-10#1)
of Salmonella in##2##3##(2008-9#1)(2013-8#1)
of Salmonella typhi##4##3##(1990-12#1)(2007-7#2)(2008-8#1)
of Salmonella typhimurium##3##3##(1990-11#2)(2009-5#1)
of Salmonella##30##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#3)(1991-11#1)(1993-2#1)(1995-5#1)(1995-9#2)(2007-7#4)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#2)(2011-2#1)(2013-8#4)
of Salvador##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
of Salvador's##2##2##(2009-10#2)
of Salvia##2##2##(2008-11#1)(2012-3#1)
of Sample##2##2##(2008-10#1)(2010-2#1)
of San##2##2##(2013-7#2)
of Sanandaj city##2##3##(2008-12#2)
of Sanandaj##3##2##(2008-12#3)
of Santa##3##2##(1995-12#1)(2008-5#1)(2011-2#1)
of Santiago##6##2##(1997-6#1)(2007-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
of Sao##4##2##(1993-8#3)(2012-3#1)
of Sarcandra##2##2##(2008-10#2)
of Sasang typology##3##3##(2012-12#3)
of Sasang##4##2##(2012-12#4)
of Saskatchewan##3##2##(1995-12#1)(2008-10#1)(2008-12#1)
of Saudi Arabia (KSA)##4##4##(2008-1#1)(2008-4#1)(2013-1#1)(2013-8#1)
of Saudi Arabia were##3##4##(2008-1#2)(2008-10#1)
of Saudi Arabia##15##3##(2008-1#9)(2008-10#1)(2008-4#2)(2010-11#1)(2013-1#1)(2013-8#1)
of Saudi##16##2##(2008-1#9)(2008-10#1)(2008-4#2)(2008-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
of Sb in##2##3##(2008-10#2)
of Sb##5##2##(2008-10#5)
of Sb(III) and Bi(III)##4##4##(2008-10#4)
of Sb(III) and Sb(V)##5##4##(2008-10#5)
of Sb(III) and##9##3##(2008-10#9)
of Sb(III) in##5##3##(2008-10#5)
of Sb(III)##18##2##(2008-10#18)
of Sb(V) to Sb(III)##3##4##(2008-10#3)
of Sb(V)##6##2##(2008-10#6)
of ScYLV##2##2##(2008-10#2)
of Scedosporium##2##2##(2008-5#2)
of Sceloporus##2##2##(2010-3#2)
of Schaffer##2##2##(1991-12#1)(2008-7#1)
of Scheuermann's disease##2##3##(2007-11#2)
of Schiff base##2##3##(2008-10#2)
of Schiff##3##2##(2008-10#2)(2010-8#1)
of Schistosoma japonicum in##2##4##(2011-2#1)(2012-3#1)
of Schistosoma japonicum##7##3##(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#3)
of Schistosoma mansoni##6##3##(1993-2#2)(1993-6#1)(1996-8#1)(1997-6#2)
of Schistosoma##18##2##(1992-2#1)(1993-2#2)(1993-6#1)(1996-12#1)(1996-8#1)(1997-6#2)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#6)
of Schizosaccharomyces pombe##6##3##(1996-7#1)(1997-2#1)(1997-4#1)(2008-2#1)(2012-3#2)
of Schwann##2##2##(1990-8#1)(2009-11#1)
of Schönlein-Henoch purpura##2##3##(1997-8#2)
of Schönlein-Henoch##3##2##(1997-8#3)
of Science and##2##3##(2008-7#1)(2013-1#1)
of Science##6##2##(1994-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
of Scientific##3##2##(2006-12#1)(2007-11#1)(2012-2#1)
of Scleranthus annuus##2##3##(2008-10#2)
of Sclerotia##2##2##(2008-10#2)
of Sclerotinia homoeocarpa##5##3##(2008-10#5)
of Sclerotinia minor and S##3##5##(2008-10#3)
of Sclerotinia minor##5##3##(2008-10#5)
of Sclerotinia sclerotiorum from##2##4##(2008-10#2)
of Sclerotinia sclerotiorum in##3##4##(2008-10#3)
of Sclerotinia sclerotiorum to##2##4##(2008-10#2)
of Sclerotinia sclerotiorum##12##3##(2008-10#12)
of Sclerotinia stem rot##3##4##(2008-10#3)
of Sclerotinia##26##2##(2008-10#26)
of Sclerotium rolfsii##6##3##(2008-10#5)(2008-8#1)
of Scotland##3##2##(1991-3#1)(1991-6#1)(1997-8#1)
of Se (IV)##2##3##(2008-10#2)
of Se compounds##3##3##(2008-10#3)
of Se in##4##3##(2008-10#4)
of Se##27##2##(2008-10#23)(2012-2#4)
of Se(IV) and Se(VI) were##2##5##(2008-10#2)
of Se(IV) and Se(VI)##4##4##(2008-10#4)
of Se(IV) and##5##3##(2008-10#5)
of Se(IV) in##4##3##(2008-10#4)
of Se(IV) on##3##3##(2008-10#3)
of Se(IV)##25##2##(2008-10#25)
of Se(VI) to Se(IV)##5##4##(2008-10#5)
of Se(VI)##10##2##(2008-10#10)
of Se-GSH-Px##2##2##(1991-12#2)
of SeaWiFS##5##2##(2008-3#5)
of Sec16##2##2##(2012-2#2)
of SecY##2##2##(1991-5#2)
of Seedborne##2##2##(2008-10#2)
of Seedling##2##2##(2008-10#2)
of Selangor##3##2##(2008-10#2)(2011-1#1)
of Selective##2##2##(2008-10#1)(2009-9#1)
of Sendai##2##2##(2008-3#1)(2008-9#1)
of Senecio vulgaris##2##3##(2008-10#2)
of Sepia officinalis##3##3##(2008-7#3)
of Sepia##4##2##(2008-7#4)
of September##5##2##(1990-6#1)(1992-5#1)(1995-5#1)(1997-2#1)(2008-12#1)
of Septoria passerinii##2##3##(2008-10#2)
of Septoria tritici##5##3##(2008-10#5)
of Septoria##9##2##(2008-10#9)
of Ser##4##2##(1991-3#1)(1992-8#1)(1994-11#1)(2008-2#1)
of Ser(727) in STAT1##2##4##(2011-2#2)
of Ser-132##4##2##(1992-3#4)
of Serratia marcescens Strains##2##4##(2008-10#2)
of Serratia marcescens##3##3##(1996-12#1)(2008-10#2)
of Sertoli cells##2##3##(2009-10#2)
of Serum Response Factor##2##4##(1994-6#2)
of Serum##4##2##(1994-6#2)(2013-1#1)(2013-8#1)
of Set7/9 in##2##3##(2010-11#2)
of Setosphaeria turcica##3##3##(2008-10#3)
of Sexual##2##2##(2008-10#1)(2012-1#1)
of Sf-9 cells##2##3##(2008-11#1)(2008-7#1)
of Sf9##3##2##(1997-4#1)(2008-11#1)(2008-4#1)
of Sharka disease##2##3##(2008-10#2)
of Sharka##3##2##(2008-10#3)
of Shc##5##2##(1995-8#1)(1997-7#3)(2012-2#1)
of Shen deficiency##3##3##(2013-8#3)
of Sherry##2##2##(2008-10#2)
of Shigella##4##2##(2008-10#1)(2008-9#2)(2013-1#1)
of Shpol'skii solvent##2##3##(2008-10#2)
of Shuanghuanglian injection##2##3##(2011-2#2)
of Si increased##3##3##(2008-10#3)
of Si on##2##3##(2008-10#2)
of Si##15##2##(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#1)(2012-2#1)(2013-8#1)
of Si-sol##2##2##(2008-10#2)
of SiO(2) and##2##3##(2008-10#1)(2008-3#1)
of SiO(2)##8##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)
of SiO2##3##2##(1992-8#1)(2008-10#1)(2008-2#1)
of SiOEP##2##2##(2008-10#2)
of SiR-HP##2##2##(1993-8#2)
of Siberian##2##2##(2008-5#1)(2010-8#1)
of Sida cordifolia##3##3##(2010-5#3)
of Sig-1R##3##2##(2011-2#3)
of SilicoSec##4##2##(2008-12#4)
of Silicon##2##2##(1996-9#1)(2008-10#1)
of Silver dicyano complex##2##4##(2008-10#2)
of Single##3##2##(2008-10#1)(2010-2#1)(2012-1#1)
of Sir##3##2##(2007-10#2)(2008-10#1)
of Sjögren's syndrome##4##3##(2008-7#3)(2011-2#1)
of Skull Base##3##3##(2006-12#1)(2011-2#1)(2012-3#1)
of Slt-IA##3##2##(1992-3#3)
of Smad2 conditional gene targeting##2##5##(2008-9#2)
of Smad2##4##2##(2008-9#4)
of Smoking##2##2##(2010-4#1)(2013-1#1)
of Sn##5##2##(2008-10#5)
of Sn(IV)##3##2##(2008-10#3)
of SnO(2)##2##2##(2008-10#2)
of Snail##2##2##(2011-1#2)
of Snails and##3##3##(2011-1#3)
of Snails##6##2##(2011-1#6)
of Social Security##3##3##(1995-2#1)(2011-2#2)
of Social##10##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-3#1)(2011-2#3)(2013-1#1)
of Sodium##3##2##(1996-2#1)(2008-12#1)(2010-12#1)
of Soil##4##2##(2008-10#4)
of Solanum##5##2##(1992-12#2)(2008-10#2)(2008-11#1)
of Sorghum bicolor by Colletotrichum sublineolum##2##6##(2008-10#2)
of Sorghum##3##2##(1990-5#1)(2008-10#2)
of Sorubim lima##3##3##(2008-7#3)
of South Africa##12##3##(1997-7#1)(2010-11#3)(2010-3#2)(2011-1#3)(2011-2#1)(2013-8#2)
of South African##5##3##(2008-10#1)(2011-1#2)(2013-1#2)
of South America##6##3##(1991-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
of South Australia##2##3##(2008-10#1)(2008-12#1)
of South Carolina##3##3##(1991-2#1)(1991-8#2)
of South Jutland##2##3##(1991-9#2)
of South##40##2##(1991-11#1)(1991-2#1)(1991-8#2)(1991-9#2)(1996-1#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#1)(2009-5#1)(2010-11#3)(2010-3#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#3)
of Southern California##2##3##(1992-12#1)(1996-4#1)
of Southern blotting##2##3##(2008-1#1)(2008-4#1)
of Southern##10##2##(1992-12#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2013-8#1)
of Soxhlet##2##2##(2008-10#2)
of Soybean dwarf virus##2##4##(2008-10#2)
of Soybean mosaic virus (SMV)##2##5##(2008-10#2)
of Soybean mosaic virus##3##4##(2008-10#3)
of Soybean##8##2##(2008-10#8)
of SpA in##2##3##(1994-6#2)
of Spain and##2##3##(2008-10#2)
of Spain were##2##3##(1996-12#1)(2008-10#1)
of Spain##16##2##(1990-8#1)(1996-12#2)(2007-8#1)(2008-10#8)(2008-8#2)(2009-10#2)
of Spain)##4##2##(2008-10#2)(2008-5#2)
of Spanish honeys##2##3##(2008-10#2)
of Spanish##12##2##(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)
of Special##8##2##(2008-11#8)
of Species##2##2##(2010-5#1)(2012-2#1)
of Specific##5##2##(2008-10#2)(2008-12#1)(2012-1#1)(2012-2#1)
of Speech##2##2##(2011-1#1)(2012-3#1)
of Spodoptera frugiperda cells##3##4##(1992-8#1)(1994-11#1)(1997-4#1)
of Spodoptera frugiperda##6##3##(1992-8#1)(1993-6#1)(1994-11#1)(1997-4#1)(2008-11#1)(2008-7#1)
of Spodoptera litura nuclear polyhedrosis virus##2##6##(1997-4#2)
of Spodoptera##8##2##(1992-8#1)(1993-6#1)(1994-11#1)(1997-4#3)(2008-11#1)(2008-7#1)
of Spontaneous##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)
of Sport and Exercise##2##4##(2008-12#1)(2010-6#1)
of Sports Medicine##2##3##(1996-6#1)(2012-3#1)
of Sports##5##2##(1993-3#1)(1996-6#1)(2008-5#1)(2012-3#2)
of Spr3##2##2##(2009-10#2)
of Sprague-Dawley##2##2##(1993-12#1)(2008-7#1)
of Sr##3##2##(2007-11#1)(2008-10#2)
of SrSRI##2##2##(2009-8#2)
of Src and##2##3##(1995-6#1)(2012-12#1)
of Src##14##2##(1995-6#5)(2009-7#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
of St##5##2##(1991-2#1)(1991-3#2)(2008-10#1)(2011-2#1)
of St-A1c##2##2##(1990-8#2)
of Stage##3##2##(1997-7#1)(2013-1#1)(2013-8#1)
of Stagonospora nodorum##4##3##(2008-10#4)
of Stagonospora##5##2##(2008-10#5)
of Stammering Research##2##3##(2008-4#2)
of Standard##2##2##(2008-10#1)(2008-3#1)
of Staphylococcus aureus in##3##4##(2008-5#1)(2012-1#1)(2012-3#1)
of Staphylococcus aureus##17##3##(1990-7#1)(1991-9#1)(1992-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-12#3)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of Staphylococcus epidermidis##2##3##(1991-3#1)(1993-9#1)
of Staphylococcus##22##2##(1990-7#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-7#1)(2008-12#3)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
of State health care reform##2##5##(1996-1#2)
of State health##3##3##(1996-1#3)
of State##9##2##(1995-1#1)(1995-12#2)(1996-1#3)(1996-4#1)(1997-2#1)(2010-3#1)
of States##3##2##(1992-1#1)(1996-9#1)(1997-2#1)
of Statistical##2##2##(2008-6#1)(2013-8#1)
of Stem##2##2##(2008-10#1)(2008-11#1)
of Stewart's Disease of Corn##2##5##(2008-10#2)
of Stimulated##2##2##(1996-9#1)(2008-3#1)
of Stokes##5##2##(1996-4#1)(2007-12#2)(2008-2#1)(2008-3#1)
of Stratospheric##2##2##(2008-3#2)
of Strawberry##4##2##(2008-10#4)
of Streptococcus pneumoniae##6##3##(1994-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-7#1)(2013-8#1)
of Streptococcus pyogenes in##2##4##(2007-8#1)(2008-9#1)
of Streptococcus pyogenes##5##3##(1996-12#2)(2007-8#1)(2008-9#2)
of Streptococcus suis type 2##2##5##(1991-8#2)
of Streptococcus##16##2##(1991-8#2)(1994-11#1)(1996-12#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Streptomyces ansochromogenes##6##3##(2008-8#4)(2008-9#2)
of Streptomyces coelicolor##3##3##(1990-5#1)(2008-8#2)
of Streptomyces scabies##2##3##(2008-10#2)
of Streptomyces sp##3##3##(2008-10#1)(2008-6#2)
of Streptomyces##23##2##(1990-5#1)(1992-3#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#8)(2008-9#2)(2009-6#1)(2012-3#2)
of Stress##4##2##(2007-2#1)(2008-1#1)(2008-6#1)(2011-2#1)
of Striga asiatica##3##3##(2008-10#2)(2009-8#1)
of Striga spp##2##3##(2008-10#2)
of Striga##7##2##(2008-10#6)(2009-8#1)
of Stroke##3##2##(2007-10#2)(2008-8#1)
of Studies##2##2##(2008-12#1)(2012-12#1)
of Stx##2##2##(2011-1#1)(2013-1#1)
of Subjective##2##2##(2009-8#1)(2012-3#1)
of Subpopulations of##2##3##(2008-10#1)(2008-11#1)
of Substance##2##2##(2008-5#1)(2010-10#1)
of Sucre##2##2##(2008-12#1)(2011-2#1)
of Sudan##3##2##(1996-12#2)(2007-10#1)
of Sudarshan Kriya Yoga##2##4##(2012-2#2)
of Sudden##3##2##(2007-10#1)(2008-10#2)
of Suez##2##2##(2013-1#2)
of Sugar Beet##2##3##(2008-10#2)
of Sugarcane##2##2##(2008-10#2)
of Suicide##3##2##(1992-1#1)(2012-2#1)(2013-8#1)
of Sun##2##2##(2008-2#1)(2008-3#1)
of Surface##2##2##(1996-9#1)(2008-2#1)
of Surgery and##3##3##(1991-9#1)(1992-5#1)(2009-7#1)
of Surgery at##3##3##(1992-3#1)(2012-3#2)
of Surgery in##2##3##(1992-6#1)(2009-4#1)
of Surgery##12##2##(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1995-12#1)(1995-4#1)(2009-4#1)(2009-7#1)(2012-3#3)
of Surgical##3##2##(1995-4#1)(2011-2#1)(2012-1#1)
of Susceptible and Resistant##2##4##(2008-10#2)
of Sweden##3##2##(2009-6#1)(2011-2#2)
of Swedish##2##2##(2008-12#1)(2008-7#1)
of Sweet##2##2##(2008-10#2)
of Sweetpotato feathery mottle virus##2##5##(2008-10#2)
of Swiss 3T3 cells##2##4##(1993-9#1)(1994-3#1)
of Swiss##7##2##(1993-9#1)(1994-3#1)(2008-10#2)(2008-12#1)(2010-1#1)(2012-3#1)
of Syk##2##2##(1995-6#1)(2009-6#1)
of Symmetrical##2##2##(1996-2#1)(2008-2#1)
of Synechococcus sp##2##3##(1992-3#2)
of Synechocystis sp##8##3##(1995-12#1)(1995-8#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#2)
of Synechocystis##9##2##(1995-12#2)(1995-8#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#2)
of SyrM##2##2##(2008-8#2)
of System##2##2##(1995-12#1)(2008-2#1)
of Systematic##6##2##(1993-12#1)(2008-3#1)(2011-2#1)(2013-1#3)
of São Paulo##8##3##(1996-12#1)(2008-10#4)(2011-2#1)(2013-7#1)(2013-8#1)
of São Paulo)##2##3##(2008-12#1)(2011-2#1)
of São##10##2##(1996-12#1)(2008-10#4)(2008-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
of T and B cells##2##5##(1997-8#1)(2008-4#1)
of T cell large granular lymphocyte##2##6##(2009-8#2)
of T cell proliferative responses##2##5##(2008-7#2)
of T cell receptor##2##4##(2008-11#1)(2008-4#1)
of T cell subpopulations##4##4##(2008-4#4)
of T cell##21##3##(1994-9#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-11#3)(2008-4#9)(2008-7#2)(2009-8#2)(2012-2#1)
of T cells and##3##4##(2008-10#1)(2009-6#1)(2011-2#1)
of T cells is##3##4##(1995-5#1)(2008-4#2)
of T cells that##4##4##(2008-4#2)(2010-11#1)(2012-2#1)
of T cells to##3##4##(1992-6#1)(2008-5#1)(2013-1#1)
of T cells with##2##4##(2008-9#1)(2012-2#1)
of T cells##34##3##(1991-2#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-12#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#9)(2008-5#2)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
of T helper##3##3##(1994-5#1)(1994-8#1)(1995-5#1)
of T lymphocyte##2##3##(1991-12#1)(1995-3#1)
of T lymphocytes and macrophages in##2##6##(1997-8#2)
of T lymphocytes and##4##4##(1993-3#1)(1994-3#1)(1997-8#2)
of T lymphocytes##8##3##(1992-2#1)(1993-3#1)(1994-3#2)(1997-8#2)(2008-9#1)(2013-1#1)
of T##169##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#4)(1996-12#1)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#3)(2008-10#53)(2008-11#6)(2008-12#8)(2008-4#19)(2008-5#5)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
of T(1)##2##2##(2008-10#1)(2010-8#1)
of T(2)##3##2##(2010-8#2)(2012-2#1)
of T(382)##2##2##(2008-10#2)
of T(4)##3##2##(2008-10#1)(2009-12#2)
of T- and##4##3##(1990-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
of T-CD4 T cells##6##4##(2012-12#6)
of T-LGL leukemia##2##3##(2009-8#2)
of T-cell epitopes##2##3##(1991-12#1)(2008-12#1)
of T-cell lymphoma##3##3##(1991-12#2)(2011-2#1)
of T-cell##18##2##(1991-12#3)(1992-12#1)(1994-8#1)(1995-2#2)(1997-3#1)(1997-6#2)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
of T-cells in##2##3##(2008-10#1)(2011-2#1)
of T-cells##6##2##(2006-10#1)(2008-10#3)(2008-11#1)(2011-2#1)
of T-lymphocytes##4##2##(1992-8#1)(1996-12#2)(2010-2#1)
of T-matrix##2##2##(2008-2#1)(2008-3#1)
of T-type##3##2##(2008-8#3)
of T1 and T2##2##4##(1991-12#2)
of T1 and##5##3##(1991-12#2)(1991-6#1)(2008-10#2)
of T1##12##2##(1990-6#1)(1991-12#3)(1991-4#1)(1991-6#1)(1997-2#2)(2008-10#2)(2011-2#1)(2012-12#1)
of T1D##5##2##(2007-5#3)(2010-5#1)(2013-8#1)
of T1DM##3##2##(2008-1#1)(2010-11#1)(2011-1#1)
of T2##3##2##(1990-6#1)(1993-5#1)(2011-2#1)
of T22##4##2##(2008-10#4)
of T3 in##2##3##(2008-10#2)
of T3##12##2##(1990-6#1)(1993-8#2)(1994-11#3)(1996-5#2)(1997-2#1)(2008-10#3)
of T4 lysozyme##2##3##(1997-2#2)
of T4##9##2##(1990-6#2)(1993-2#1)(1995-2#1)(1995-6#1)(1997-2#2)(1997-7#1)(2008-6#1)
of T7 RNA polymerase##5##4##(1991-12#2)(1991-5#1)(1997-4#2)
of T7##9##2##(1991-12#2)(1991-5#2)(1994-5#1)(1997-4#4)
of TA##7##2##(1997-8#7)
of TAM##5##2##(1994-7#1)(1997-7#2)(2008-10#2)
of TAP##2##2##(1991-8#2)
of TASK-2##2##2##(2013-8#2)
of TAT##3##2##(1991-3#2)(2010-3#1)
of TB IRIS##3##3##(2010-5#3)
of TB and##3##3##(2009-4#1)(2010-5#1)(2013-1#1)
of TB cases##2##3##(2013-1#2)
of TB in children##3##4##(2011-2#1)(2013-7#2)
of TB in##5##3##(2007-2#1)(2008-1#1)(2011-2#1)(2013-7#2)
of TB infection##3##3##(2007-2#2)(2010-11#1)
of TB##26##2##(1996-11#1)(2006-10#1)(2007-2#3)(2008-1#3)(2008-8#1)(2009-4#1)(2010-11#1)(2010-5#6)(2011-2#1)(2013-1#4)(2013-7#4)
of TBARS##4##2##(1994-6#1)(1994-9#1)(1995-3#1)(2008-10#1)
of TBAs is##2##3##(1994-3#2)
of TBAs##3##2##(1994-3#2)(2011-1#1)
of TBE in##3##3##(1996-11#2)(2008-8#1)
of TBE infections##2##3##(1996-11#2)
of TBE##9##2##(1996-11#6)(2007-2#1)(2008-8#2)
of TBI and##2##3##(2008-6#1)(2013-1#1)
of TBI patients##5##3##(2008-10#1)(2008-9#3)(2010-9#1)
of TBI##13##2##(2007-4#3)(2008-10#2)(2008-6#2)(2008-9#4)(2010-9#1)(2013-1#1)
of TBL##2##2##(1992-2#2)
of TBP##8##2##(1993-8#2)(1993-9#2)(2008-1#4)
of TBTO##5##2##(2008-10#5)
of TBZ##2##2##(2011-10#2)
of TC##6##2##(1992-3#1)(2008-1#1)(2008-10#1)(2009-5#2)(2011-2#1)
of TCA in##2##3##(2008-10#2)
of TCA overdose##2##3##(2010-1#2)
of TCA##5##2##(2008-10#2)(2010-1#3)
of TCC was##2##3##(2008-4#1)(2012-3#1)
of TCD##3##2##(2012-1#3)
of TCD-defined vasospasm##2##3##(2007-10#2)
of TCDD and related HAHs##2##5##(2008-10#2)
of TCDD on##4##3##(1995-3#1)(2008-10#3)
of TCDD##17##2##(1992-12#1)(1994-5#3)(1995-3#6)(2008-10#5)(2008-11#2)
of TCE##10##2##(2008-10#6)(2008-7#2)(2010-4#1)(2012-12#1)
of TCI-R##2##2##(2009-9#2)
of TCMTB##6##2##(2008-10#6)
of TCP##7##2##(1992-6#4)(2008-10#2)(2009-8#1)
of TCPP with##3##3##(2008-10#3)
of TCPP##9##2##(2008-10#9)
of TCR##4##2##(2008-11#1)(2008-4#1)(2009-8#2)
of TCRgammadelta(+) IELs##2##3##(2008-11#2)
of TCS##4##2##(2008-10#3)(2008-5#1)
of TD##2##2##(2007-7#1)(2010-12#1)
of TDCPP##2##2##(2013-1#2)
of TE##6##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-3#1)
of TE-6##2##2##(1992-9#2)
of TEA##4##2##(2008-10#2)(2008-3#2)
of TEMPO##2##2##(2008-8#2)
of TEP##2##2##(2008-10#2)
of TER##5##2##(2008-10#5)
of TEWL##3##2##(2008-5#3)
of TF##2##2##(1994-9#1)(2008-7#1)
of TFAR19##3##2##(2008-9#3)
of TFIIB##2##2##(1995-2#2)
of TFs##5##2##(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
of TG in rats##2##4##(2011-2#2)
of TG##6##2##(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#2)
of TGF alpha##2##3##(1997-1#1)(1997-4#1)
of TGF beta##5##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-8#1)(1995-12#1)
of TGF##8##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-8#1)(1995-12#1)(1997-1#2)(1997-4#1)
of TGF-alpha##4##2##(1992-9#3)(1993-9#1)
of TGF-beta 1 on##2##4##(1990-5#2)
of TGF-beta 1##7##3##(1990-5#4)(1990-8#1)(1992-3#1)(1994-11#1)
of TGF-beta##18##2##(1990-12#1)(1990-5#4)(1990-8#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-2#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#1)
of TGF-beta1##2##2##(2008-11#1)(2011-2#1)
of TH mRNA##2##3##(1992-12#1)(1996-12#1)
of TH##9##2##(1992-12#1)(1995-5#2)(1996-12#2)(2008-10#2)(2008-11#1)(2013-1#1)
of THA##2##2##(1990-7#1)(2007-8#1)
of THBA##2##2##(2008-10#2)
of THP-1 cells##3##3##(1993-6#1)(2008-11#1)(2010-6#1)
of THP-1##6##2##(1993-6#1)(2008-11#1)(2010-6#2)(2012-2#1)(2013-1#1)
of THz##2##2##(2007-12#1)(2011-1#1)
of TI##6##2##(1991-12#2)(1992-8#1)(2008-10#3)
of TIEG2-MAO B##2##3##(2009-12#2)
of TIMP-1##2##2##(2008-5#1)(2008-9#1)
of TIMP-2##2##2##(1992-2#2)
of TKA##4##2##(2007-8#2)(2013-1#2)
of TKI##2##2##(2010-4#1)(2012-1#1)
of TL1 and TL2 averaged##2##5##(2008-10#2)
of TLC##2##2##(1996-2#2)
of TLI (+)##2##3##(2013-1#2)
of TLR4 and##2##3##(2008-10#1)(2013-8#1)
of TLR4##5##2##(2008-10#1)(2008-3#1)(2013-8#3)
of TLS##5##2##(2008-7#5)
of TM##2##2##(2007-2#1)(2012-2#1)
of TM-β##2##2##(2010-12#2)
of TMA##4##2##(2008-10#4)
of TMG##3##2##(2008-10#3)
of TMJ##3##2##(1990-10#1)(2011-2#2)
of TMLR##3##2##(2007-8#3)
of TMSG-1 was##2##3##(2008-9#2)
of TMSG-1##5##2##(2008-9#5)
of TMV##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
of TMV-B##3##2##(2008-8#3)
of TNF in##2##3##(1990-12#1)(1992-3#1)
of TNF##20##2##(1990-12#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#5)(1994-5#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
of TNF-alpha and##2##3##(1996-12#1)(2007-8#1)
of TNF-alpha production##2##3##(1992-12#1)(1995-12#1)
of TNF-alpha##18##2##(1992-12#3)(1992-8#1)(1995-12#3)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-9#1)(2013-1#5)
of TNF-α antagonists in aphthous ulceration##3##6##(2012-1#3)
of TNF-α antagonists in##4##4##(2012-1#4)
of TNF-α##9##2##(2012-1#5)(2012-12#1)(2012-2#1)(2013-1#2)
of TNFalpha##3##2##(2008-5#2)(2008-6#1)
of TNNT3##3##2##(2008-7#3)
of TNP-470##4##2##(1994-12#4)
of TNT and##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
of TNT in##3##3##(2008-10#2)(2008-11#1)
of TNT vapor##2##3##(2008-3#2)
of TNT##26##2##(1995-6#5)(1997-5#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#3)(2009-3#1)
of TP##3##2##(2008-12#2)(2012-2#1)
of TP2##2##2##(1991-9#2)
of TP53##3##2##(2008-4#1)(2008-6#1)(2013-1#1)
of TPA in##2##3##(2007-12#2)
of TPA##10##2##(1991-2#1)(1992-8#1)(1992-9#3)(1995-12#1)(2007-12#3)(2008-8#1)
of TPF##2##2##(2008-10#1)(2008-3#1)
of TPH##2##2##(2008-6#2)
of TPMT##3##2##(2013-1#3)
of TPO cDNA##2##3##(2008-8#2)
of TPO##5##2##(2008-8#5)
of TPP##4##2##(2008-10#1)(2009-8#3)
of TQM as##2##3##(1992-2#1)(1995-3#1)
of TQM in##2##3##(1992-2#2)
of TQM##16##2##(1992-2#5)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-3#3)(2008-12#2)
of TRAMP##2##2##(2008-4#1)(2013-1#1)
of TRAb##2##2##(2012-3#2)
of TRH was##2##3##(1992-8#1)(2008-10#1)
of TRH##8##2##(1991-6#1)(1992-8#2)(1994-6#2)(1995-5#1)(2008-10#1)(2013-7#1)
of TRP##3##2##(1996-12#1)(1996-7#1)(2008-7#1)
of TRPV1##4##2##(2008-7#2)(2008-8#1)(2009-12#1)
of TRPV3##2##2##(2013-1#2)
of TRPV4##2##2##(2011-2#2)
of TS##2##2##(2008-10#1)(2008-7#1)
of TS/pH##2##2##(2008-11#2)
of TSAH##2##2##(2008-7#2)
of TSH and##2##3##(1991-5#1)(1993-3#1)
of TSH receptor##2##3##(1991-5#1)(2012-3#1)
of TSH secretion##2##3##(1995-5#2)
of TSH##10##2##(1991-5#2)(1992-12#1)(1993-3#1)(1995-5#3)(1996-5#1)(2012-12#1)(2012-3#1)
of TSHr##2##2##(1994-11#2)
of TSP and##2##3##(2007-3#1)(2008-10#1)
of TSP in##2##3##(1993-9#1)(2008-10#1)
of TSP with##2##3##(1991-2#1)(1993-6#1)
of TSP##10##2##(1991-11#1)(1991-2#1)(1993-6#1)(1993-9#3)(2007-3#1)(2008-10#2)(2013-8#1)
of TSPO binding##2##3##(2012-2#2)
of TSPO##11##2##(2012-2#11)
of TSWV and INSV##3##4##(2008-10#3)
of TSWV and##4##3##(2008-10#4)
of TSWV from##2##3##(2008-10#2)
of TSWV in the##2##4##(2008-10#2)
of TSWV inoculum##2##3##(2008-10#2)
of TSWV##23##2##(2008-10#23)
of TSWV-infected##2##2##(2008-10#2)
of TT##3##2##(2007-7#1)(2008-10#1)(2012-12#1)
of TTCTOHA##2##2##(2008-10#2)
of TTM##6##2##(2007-12#3)(2013-1#3)
of TWIST##2##2##(1991-8#2)
of TX-100##2##2##(2008-10#2)
of TYLCV##11##2##(2008-10#11)
of TYLCV-Sr##2##2##(2008-10#2)
of TYMV##3##2##(1997-3#1)(2008-10#2)
of Ta(2)O(5)##2##2##(2008-3#2)
of Tachypleus amebocyte lysate##2##4##(2008-10#2)
of Taiwan##4##2##(2008-10#1)(2008-7#1)(2009-5#1)(2010-8#1)
of Takayasu arteritis (TA)##3##4##(1997-8#3)
of Takayasu arteritis##12##3##(1997-8#12)
of Takayasu##13##2##(1997-8#13)
of Takayasu's arteritis##4##3##(1997-8#3)(2011-1#1)
of Takotsubo cardiomyopathy##3##3##(2010-5#1)(2010-7#1)(2013-1#1)
of Talipexole##3##2##(2007-10#3)
of Tamsulosin##2##2##(2008-10#2)
of Tan Spot of Wheat##2##5##(2008-10#2)
of Tanichthys albonubes##4##3##(2010-5#4)
of Tanzania##2##2##(1994-11#1)(2008-10#1)
of Tapesia##2##2##(2008-10#2)
of Taphrina deformans##3##3##(2008-10#3)
of Taq DNA polymerase##3##4##(1997-6#1)(1997-8#1)(2008-5#1)
of Tartrazine##4##2##(2008-10#4)
of Tat##2##2##(2009-8#1)(2012-12#1)
of TauD##2##2##(2012-12#2)
of Taxus##2##2##(2012-7#2)
of TbCSV-[Y35]##3##2##(2008-10#3)
of TcPO2##2##2##(2013-1#2)
of Technical Requirements for Registration of##2##6##(2008-10#2)
of Technology##7##2##(1993-12#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-12#1)
of Teflon##3##2##(1990-3#1)(2008-10#2)
of Tegaderm##2##2##(2008-9#2)
of Tehran##3##2##(2008-12#1)(2008-3#2)
of Temperature and Inoculum Density of Fusarium oxysporum f##2##9##(2008-10#2)
of Temperature and Wetness Duration on##2##6##(2008-10#2)
of Temperature and##7##3##(2008-10#6)(2008-3#1)
of Temperature##9##2##(2008-10#8)(2008-3#1)
of Tenckhoff##2##2##(2008-1#2)
of Tessier##2##2##(2008-10#2)
of Tetrahymena##3##2##(1990-7#2)(2012-12#1)
of Tetramune##2##2##(1995-5#2)
of Texas##6##2##(1990-11#2)(1996-5#1)(2007-12#1)(2011-2#2)
of Tf##5##2##(1990-8#1)(2010-11#3)(2013-7#1)
of Tg##2##2##(1991-6#1)(2008-8#1)
of Th##6##2##(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#2)
of Th1-type##3##2##(2008-11#3)
of Th2 cytokines##2##3##(1996-12#1)(2011-2#1)
of Th2##4##2##(1996-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
of Th2-type cytokine producing##2##4##(2008-11#2)
of Th2-type cytokine##3##3##(2008-11#3)
of Th2-type##5##2##(2008-11#5)
of Thai basil oils and their##2##6##(2008-5#2)
of Thal##3##2##(2008-3#3)
of Thalassia##4##2##(2008-5#4)
of Thatcher wheat##2##3##(2008-10#2)
of Thatcher##5##2##(2008-10#5)
of The American Phytopathological Society##2##5##(2008-10#2)
of The##9##2##(1995-3#1)(2008-10#3)(2009-9#1)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
of Their##5##2##(2007-2#1)(2008-1#1)(2008-10#1)(2013-1#2)
of Therapeutic##3##2##(1996-9#1)(2008-10#1)(2012-12#1)
of Therapy##2##2##(2008-12#1)(2010-8#1)
of Thermal##2##2##(1996-12#1)(2008-2#1)
of Thermobia domestica (Packard)##2##4##(2008-12#2)
of Thessaloniki##2##2##(2008-3#1)(2011-2#1)
of Thielaviopsis basicola##4##3##(2008-10#4)
of Thinopyrum ponticum##2##3##(2008-10#2)
of Thinopyrum##6##2##(2008-10#5)(2008-5#1)
of Thr##3##2##(1991-3#1)(1993-3#1)(2006-12#1)
of Thr246##3##2##(1993-11#3)
of Three##7##2##(2008-10#6)(2013-1#1)
of Three-Dimensional##2##2##(2008-3#1)(2010-8#1)
of Thurgau##2##2##(1996-11#2)
of Thymus kotschyanus var##2##4##(2008-11#2)
of Thymus##5##2##(2008-11#2)(2008-12#3)
of ThzID1-M3##2##2##(2008-10#2)
of Ti##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
of Ti-6Al-4V alloy##2##3##(2012-2#2)
of Ti-6Al-4V##5##2##(2009-7#3)(2012-2#2)
of TiO _ 2##3##4##(2008-5#3)
of TiO(2) nanoparticles in PEDOT##2##5##(2009-11#2)
of TiO(2) nanoparticles##3##3##(2009-11#3)
of TiO(2)##17##2##(2008-10#7)(2008-2#1)(2008-3#4)(2008-5#1)(2009-11#4)
of TiO2##3##2##(1994-3#1)(2007-12#1)(2008-10#1)
of Tid1##2##2##(2011-2#2)
of Tilletia controversa and T##2##5##(2008-10#2)
of Tilletia indica##4##3##(2008-10#4)
of Tilletia##8##2##(2008-10#8)
of Time##3##2##(2007-12#1)(2009-3#2)
of Tiron##2##2##(2008-10#2)
of Title X##2##3##(1991-1#2)
of Tl##3##2##(2008-10#3)
of Tl(I)##2##2##(2008-10#2)
of Tl(III) in##2##3##(2008-10#2)
of Tm##3##2##(1995-5#1)(2008-2#2)
of Tn4001##2##2##(1993-12#2)
of Tn5##2##2##(1990-5#1)(1995-8#1)
of TnC##2##2##(1995-5#1)(1995-6#1)
of TnT##4##2##(1995-6#1)(2007-8#2)(2008-7#1)
of ToCV##3##2##(2008-10#3)
of ToM##3##2##(2008-12#2)(2013-1#1)
of Tobacco mild green mosaic virus##2##6##(2008-10#2)
of Tobacco##5##2##(2008-10#5)
of Toki's morphological criteria for the diagnosis of##2##8##(2013-1#2)
of Toll-like receptor##2##3##(2012-1#1)(2013-1#1)
of Tomato Spotted Wilt Virus##2##5##(2008-10#2)
of Tomato Spotted Wilt##3##4##(2008-10#3)
of Tomato by##4##3##(2008-10#4)
of Tomato leaf curl##4##4##(2008-10#4)
of Tomato spotted wilt virus (TSWV)##5##6##(2008-10#5)
of Tomato spotted wilt virus by##2##6##(2008-10#2)
of Tomato spotted wilt virus##10##5##(2008-10#10)
of Tomato spotted wilt##11##4##(2008-10#11)
of Tomato yellow leaf curl virus (TYLCV)##2##7##(2008-10#2)
of Tomato yellow leaf curl virus##6##6##(2008-10#6)
of Tomato##42##2##(2008-10#41)(2011-2#1)
of Tongan##2##2##(2008-1#2)
of Toremifene upon the##2##4##(1991-3#2)
of Toremifene##4##2##(1991-3#4)
of Toronto##8##2##(1991-1#1)(1991-12#1)(1991-2#2)(1996-12#1)(2007-5#1)(2008-11#1)(2008-3#1)
of Total##3##2##(2008-12#1)(2009-10#1)(2009-4#1)
of Toxicology##6##2##(2008-10#4)(2011-2#1)(2012-1#1)
of Toxocara##2##2##(2008-8#1)(2013-1#1)
of Toxoplasma gondii##6##3##(1992-8#2)(1996-3#1)(2007-7#1)(2012-2#2)
of Toxoplasma##7##2##(1992-8#2)(1996-3#1)(2007-7#2)(2012-2#2)
of TrPs##2##2##(2010-9#2)
of Trace##2##2##(2008-3#1)(2009-8#1)
of Traditional Uighur Medicine##2##4##(2009-5#2)
of Traditional##3##2##(2009-5#2)(2011-1#1)
of Transmissible##2##2##(1997-5#1)(2008-10#1)
of Transplantation##2##2##(2008-4#1)(2010-8#1)
of Traumatic##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of Treatment##4##2##(1991-8#1)(2008-10#1)(2009-9#1)(2010-6#1)
of Treg##4##2##(2008-4#1)(2013-8#3)
of Trends##2##2##(2008-3#1)(2008-4#1)
of Treponema denticola##2##3##(2008-9#2)
of Triatoma##2##2##(2007-12#1)(2008-8#1)
of Trichoderma and their##2##4##(2008-10#2)
of Trichoderma atroviride##2##3##(2008-10#2)
of Trichoderma harzianum##7##3##(2008-10#7)
of Trichoderma longibrachiatum##2##3##(2008-10#2)
of Trichoderma reesei##4##3##(1991-9#2)(1993-8#1)(2008-10#1)
of Trichoderma spp##6##3##(2008-10#6)
of Trichoderma stromaticum##2##3##(2008-10#2)
of Trichoderma virens##2##3##(2008-10#2)
of Trichoderma##33##2##(1991-9#2)(1993-8#1)(2008-10#29)(2013-8#1)
of Trichomonas##2##2##(2007-6#1)(2012-2#1)
of Trichophyton simii in a##2##5##(2008-5#2)
of Trichophyton spp##3##3##(2011-2#3)
of Trichophyton##7##2##(2008-5#4)(2011-2#3)
of Trichosporon##2##2##(2008-10#1)(2009-4#1)
of Trimeresurus##2##2##(1993-3#1)(2008-6#1)
of Trinidad##2##2##(2007-5#2)
of Tris##2##2##(1992-9#1)(2008-10#1)
of Triticum##2##2##(2008-10#1)(2008-8#1)
of Triton X-100 and##4##4##(1990-2#1)(2008-10#3)
of Triton X-100##7##3##(1990-2#1)(2008-10#5)(2008-4#1)
of Triton##9##2##(1990-2#1)(2008-10#7)(2008-4#1)
of Trolox C##3##3##(2008-11#3)
of Trolox##6##2##(2008-10#3)(2008-11#3)
of Tromsø##7##2##(1992-5#1)(1993-3#2)(1993-6#2)(1995-5#1)(1996-9#1)
of Tropical##2##2##(2007-10#1)(2007-2#1)
of Trp residues##3##3##(1990-2#1)(1990-5#1)(1995-2#1)
of Trp##8##2##(1990-2#1)(1990-5#1)(1994-5#1)(1995-2#1)(2008-10#3)(2008-4#1)
of Trypanosoma cruzi##3##3##(1992-9#2)(2012-12#1)
of Trypanosoma##5##2##(1992-9#2)(1994-12#1)(2012-12#1)(2013-1#1)
of Tsx##4##2##(1990-11#4)
of Tuberculosis##4##2##(2009-5#1)(2011-2#3)
of Tumor Necrosis Factor##2##4##(2012-3#1)(2013-1#1)
of Tumor##6##2##(1994-7#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
of Tunisia##2##2##(2007-8#2)
of Tunisian safflower##2##3##(2008-12#2)
of Tunisian##3##2##(2008-12#2)(2009-1#1)
of Turkey and the##2##4##(2008-12#2)
of Turkey##13##2##(1996-12#1)(1997-3#2)(1997-5#1)(2008-10#2)(2008-12#6)(2009-8#1)
of Turkish##7##2##(1991-12#2)(1992-5#1)(2008-12#1)(2010-10#1)(2010-7#1)(2011-1#1)
of Turnip##2##2##(2008-10#2)
of Tween 80##4##3##(2008-10#4)
of Tween##5##2##(2008-10#4)(2008-7#1)
of Two Distinct##2##3##(2008-10#2)
of Two New##4##3##(1997-7#1)(2008-10#1)(2008-6#1)(2013-8#1)
of Two Thrips Species##2##4##(2008-10#2)
of Two##25##2##(1997-7#2)(2007-12#1)(2008-10#14)(2008-4#1)(2008-6#1)(2009-11#1)(2011-2#2)(2013-1#1)(2013-8#2)
of Two-Dimensional##2##2##(1996-9#1)(2008-3#1)
of Type 1 diabetes##3##4##(1994-12#2)(2010-10#1)
of Type 2 Diabetes##2##4##(1994-12#1)(2009-3#1)
of Type 2##5##3##(1994-12#1)(2007-7#2)(2008-3#1)(2009-3#1)
of Type I##2##3##(1994-2#1)(2008-8#1)
of Type II alcoholics##3##4##(1994-2#3)
of Type II##5##3##(1994-2#3)(1994-9#1)(2012-3#1)
of Type##17##2##(1994-12#3)(1994-2#5)(1994-7#1)(1994-9#1)(2007-7#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-10#1)(2012-3#1)
of Typhula spp##2##3##(2008-10#2)
of Tyr##5##2##(1991-5#1)(1994-5#2)(1995-5#1)(2008-10#1)
of Tyr83##2##2##(1990-5#2)
of U isotope ratios##2##4##(2008-10#2)
of U isotope##3##3##(2008-10#3)
of U##43##2##(1993-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#3)(1997-2#1)(2008-1#1)(2008-10#22)(2008-12#2)(2008-5#2)(2009-7#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of U(VI) and Th(IV) from##2##5##(2008-10#2)
of U(VI) and Th(IV)##4##4##(2008-10#4)
of U(VI)##19##2##(2008-10#19)
of U(VI)-TBP complex##2##3##(2008-10#2)
of U(VI)-TBP##4##2##(2008-10#4)
of U-50##2##2##(1997-2#2)
of U-CLIP##2##2##(2007-7#2)
of U1-A##2##2##(1991-6#2)
of U2##3##2##(1993-8#1)(1995-6#2)
of U937##3##2##(1990-2#1)(1992-12#1)(2008-10#1)
of UA##7##2##(1994-8#1)(2008-10#6)
of UC##5##2##(2008-9#1)(2011-2#2)(2012-2#2)
of UCP2 and UCP3##2##4##(2008-1#2)
of UCP2##3##2##(2008-1#3)
of UCS##4##2##(2008-11#2)(2011-2#2)
of UDCA##3##2##(2008-8#3)
of UDPglucuronosyltransferase##2##2##(1991-5#2)
of UFH##3##2##(2008-1#1)(2013-8#2)
of UHR-OCT##2##2##(2011-7#2)
of UI##4##2##(2011-1#4)
of UK##5##2##(1996-1#1)(1997-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
of UM programs##2##3##(1992-1#2)
of UO(2)(2+)##2##2##(2008-10#2)
of UOS##2##2##(2012-3#2)
of UOx with##2##3##(2008-10#2)
of UOx##4##2##(2008-10#4)
of UPLC##2##2##(2008-10#2)
of UR##2##2##(2011-1#2)
of URM faculty##2##3##(2012-3#2)
of US##12##2##(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#2)(2010-12#4)(2010-5#1)(2012-2#1)
of US-1 and US-8 isolates##2##5##(2008-10#2)
of US-1##3##2##(2008-10#3)
of US-11##3##2##(2008-10#3)
of US-8 isolates##3##3##(2008-10#3)
of US-8##8##2##(2008-10#8)
of USC atrophy##2##3##(2010-12#2)
of USV##2##2##(2008-4#2)
of UTI##6##2##(1994-3#1)(2007-10#1)(2008-7#2)(2009-5#1)(2010-8#1)
of UTII in patients##2##4##(2008-7#2)
of UTII##3##2##(2008-7#3)
of UTIs caused by##2##4##(2011-2#2)
of UV absorption##2##3##(1994-9#1)(2008-10#1)
of UV exposure##2##3##(2008-5#1)(2011-2#1)
of UV irradiation##3##3##(2008-10#3)
of UV light##5##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-5#2)
of UV photobleaching of poled##2##5##(2008-2#2)
of UV photobleaching##3##3##(2008-2#3)
of UV radiation##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#2)
of UV##38##2##(1993-3#1)(1994-9#1)(2007-11#3)(2007-12#2)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#7)(2011-2#4)
of UV-B##2##2##(1991-6#1)(2011-2#1)
of UV-Vis spectra##2##3##(2008-10#2)
of UV-Vis##6##2##(2008-10#6)
of UV-absorbing##2##2##(2008-10#1)(2008-5#1)
of UV-induced##3##2##(2008-10#2)(2008-2#1)
of UV-vis spectra##2##3##(2008-10#1)(2009-3#1)
of UV-vis##6##2##(2008-10#5)(2009-3#1)
of UVA protection##4##3##(2008-5#4)
of UVA##6##2##(2008-10#1)(2008-5#5)
of UVA-filter##2##2##(2008-5#2)
of UVB radiation##3##3##(2008-11#3)
of UVB##5##2##(2008-11#3)(2008-5#2)
of UVR##2##2##(2011-2#2)
of Ubx##2##2##(2012-2#2)
of Uf##7##2##(1991-8#7)
of Uganda##3##2##(2008-10#2)(2008-8#1)
of Ukraine##2##2##(2010-4#1)(2011-1#1)
of Ulocladium atrum##2##3##(2008-10#2)
of Uncinula necator on##2##4##(2008-10#2)
of Uncinula necator##4##3##(2008-10#4)
of United##2##2##(2008-5#1)(2008-7#1)
of University##3##2##(1991-1#2)(2011-1#1)
of Upper##2##2##(2006-10#1)(2008-10#1)
of Ureaplasma urealyticum in##2##4##(2008-12#1)(2013-1#1)
of Urmia##2##2##(2008-12#2)
of Uromyces appendiculatus##2##3##(2008-10#2)
of Urtica dioica on##2##4##(2008-12#2)
of Ustilago hordei##2##3##(2008-10#2)
of Ustilago nuda##2##3##(2008-10#2)
of Ustilago##9##2##(1996-6#1)(2008-10#8)
of V##82##2##(1990-9#1)(1994-11#1)(1994-12#2)(1997-8#2)(2008-10#59)(2008-12#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#2)(2011-1#3)(2012-3#2)
of V(D)J##2##2##(1997-7#1)(2008-7#1)
of V(H) and V(L)##2##4##(2008-10#1)(2008-11#1)
of V(IV) and Co(II)##2##4##(2008-10#2)
of V(IV) and V(V)##2##4##(2008-10#2)
of V(IV) and##4##3##(2008-10#4)
of V(IV)##7##2##(2008-10#7)
of V(V) and##6##3##(2008-10#6)
of V(V) by##2##3##(2008-10#2)
of V(V) in##3##3##(2008-10#3)
of V(V)##14##2##(2008-10#14)
of V(c) was##2##3##(2008-10#2)
of V(c)##6##2##(2008-10#6)
of V(v)##3##2##(2008-10#3)
of V-ATPase activity##3##3##(1995-6#2)(2008-9#1)
of V1##2##2##(2008-11#2)
of VA and c9##2##4##(2012-2#2)
of VA##3##2##(2011-2#1)(2012-2#2)
of VAD##2##2##(2010-6#1)(2012-3#1)
of VADs##2##2##(2011-2#1)(2012-3#1)
of VAP##2##2##(1995-5#1)(2010-7#1)
of VAT##2##2##(2008-5#1)(2008-7#1)
of VATS##4##2##(2010-8#4)
of VB##3##2##(2008-12#3)
of VB(2)##4##2##(2008-10#4)
of VC is##2##3##(2009-1#2)
of VC##5##2##(2008-10#1)(2009-1#4)
of VCG1A##4##2##(2008-10#4)
of VCG4##2##2##(2008-10#2)
of VCSEL's##2##2##(2007-12#1)(2008-3#1)
of VCT##4##2##(2013-1#4)
of VCZ##2##2##(2008-10#2)
of VDCC beta 3 mRNA was##2##6##(1997-4#2)
of VDCC beta 3##3##4##(1997-4#3)
of VDR##2##2##(1995-2#2)
of VE-cadherin##2##2##(2011-1#2)
of VEGF and##5##3##(2008-1#1)(2008-3#1)(2008-9#1)(2012-1#2)
of VEGF expression in##3##4##(2008-9#1)(2010-12#1)(2012-1#1)
of VEGF expression##6##3##(2008-9#1)(2009-8#3)(2010-12#1)(2012-1#1)
of VEGF in##2##3##(2008-1#1)(2008-9#1)
of VEGF##18##2##(2007-8#1)(2008-1#2)(2008-3#1)(2008-9#4)(2009-8#4)(2010-12#1)(2012-1#3)(2013-8#2)
of VFAs##4##2##(2008-10#2)(2008-5#2)
of VGAM##2##2##(1996-3#2)
of VHFs##2##2##(2013-8#2)
of VHL protein##2##3##(2011-1#2)
of VHL##4##2##(2011-1#4)
of VIP is##2##3##(1995-5#2)
of VIP##9##2##(1990-5#1)(1995-11#1)(1995-5#3)(2012-3#4)
of VLDL##6##2##(1991-12#5)(1993-6#1)
of VMA##2##2##(2008-10#2)
of VME##2##2##(2008-10#2)
of VNS##2##2##(2008-7#2)
of VO(2+)##4##2##(2008-10#4)
of VOCs in##3##3##(2008-10#3)
of VOCs##5##2##(2008-10#4)(2008-11#1)
of VP##2##2##(2007-10#1)(2008-5#1)
of VP1##2##2##(1994-8#1)(2011-1#1)
of VPA##4##2##(1996-5#1)(2011-1#1)(2011-2#2)
of VR##3##2##(1992-3#1)(2009-11#2)
of VRE in Canada##2##4##(2007-12#2)
of VRE##5##2##(2007-12#5)
of VSM##2##2##(1993-8#2)
of VSMC##6##2##(1990-12#1)(1994-9#2)(2008-5#1)(2008-9#2)
of VTE##5##2##(2007-10#2)(2012-3#3)
of VV##2##2##(2013-1#2)
of VWA##2##2##(2008-12#2)
of Valencia##3##2##(2008-10#3)
of VanX##3##2##(1995-2#3)
of Vancouver Island##2##3##(2008-10#2)
of Vancouver##3##2##(2008-10#2)(2011-2#1)
of Vargula luciferase secretion##2##4##(1995-2#2)
of Vascular##3##2##(2007-7#1)(2008-4#1)(2012-3#1)
of Vasonat##2##2##(2011-1#2)
of Vater##2##2##(1990-9#1)(2011-2#1)
of Vaud##4##2##(1990-6#1)(1991-6#1)(1993-9#2)
of Vcyto##3##2##(1991-11#3)
of Vegetative Compatibility##2##3##(2008-10#2)
of Venezuela##6##2##(2008-10#2)(2008-5#3)(2013-7#1)
of Venezuelan spirituous beverages##2##4##(2008-10#2)
of Venezuelan##4##2##(2008-10#3)(2009-10#1)
of Ventolin##2##2##(1994-12#2)
of Venturia inaequalis and##2##4##(2008-10#2)
of Venturia inaequalis##16##3##(2008-10#16)
of Venturia nashicola##3##3##(2008-10#3)
of Venturia##20##2##(2008-10#20)
of Venus##7##2##(1991-5#1)(1991-8#1)(1992-7#1)(2008-11#1)(2008-3#2)(2009-8#1)
of Vero and##2##3##(2008-11#2)
of Vero cell growth##2##4##(2008-11#1)(2008-9#1)
of Vero cells in##2##4##(2008-11#2)
of Vero cells##5##3##(2008-11#3)(2008-9#2)
of Vero##10##2##(2008-11#7)(2008-9#3)
of Verticillium dahliae in##2##4##(2008-10#2)
of Verticillium dahliae##11##3##(2008-10#9)(2008-12#2)
of Verticillium fungicola##2##3##(2008-10#2)
of Verticillium spp##3##3##(2008-10#3)
of Verticillium wilt##6##3##(2008-10#6)
of Verticillium##28##2##(2008-10#25)(2008-12#2)(2008-5#1)
of Vesalius##2##2##(2009-7#1)(2012-2#1)
of Veterans Affairs##9##3##(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(2009-11#1)(2011-2#1)(2013-1#1)
of Veterinary Medicine##2##3##(2013-8#2)
of Veterinary Science##3##3##(1997-8#2)(2013-8#1)
of Veterinary##7##2##(1996-12#1)(1997-8#3)(2013-8#3)
of Vf##2##2##(2008-10#2)
of Vg##3##2##(2008-10#3)
of Viable##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
of Vibrio cholerae 01##2##4##(2007-10#1)(2012-3#1)
of Vibrio cholerae##11##3##(1990-5#1)(1993-9#1)(2007-10#1)(2007-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2012-3#2)
of Vibrio##16##2##(1990-5#1)(1991-9#1)(1993-9#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-8#2)(2008-9#2)(2009-8#1)(2012-2#1)(2012-3#2)
of Vicia faba##5##3##(2008-12#2)(2008-8#3)
of Victoria blue##2##3##(2008-10#1)(2008-11#1)
of Victoria##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
of Vincent van##2##3##(1996-3#2)
of Virginia##2##2##(1995-6#1)(2009-9#1)
of Virginia's##2##2##(1997-2#1)(1997-6#1)
of Virulence in##4##3##(2008-10#4)
of Virulence##6##2##(2008-10#6)
of Viruses##2##2##(2008-10#1)(2012-3#1)
of Vis-NIR##2##2##(2010-4#2)
of Vit##2##2##(2013-1#2)
of Vitamin A##2##3##(2008-9#1)(2011-1#1)
of Vitamin C##2##3##(2008-10#1)(2008-5#1)
of Vitamin D in##2##4##(2008-1#1)(2013-1#1)
of Vitamin D##3##3##(2008-1#1)(2013-1#2)
of Vitamin##17##2##(2007-7#1)(2008-1#2)(2008-10#7)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#2)(2013-1#2)
of Vitis vinifera and##2##4##(2008-10#2)
of Vitis vinifera##5##3##(2008-10#5)
of Vitis##7##2##(2008-10#7)
of Vmax##3##2##(1990-3#1)(1995-8#1)(1996-7#1)
of Volunteer##2##2##(1992-1#1)(1996-12#1)
of Voriconazole##2##2##(2012-12#2)
of Vpr and Vpx##3##4##(1997-3#3)
of W (VI)##4##3##(2008-10#4)
of W##9##2##(2007-11#1)(2007-12#1)(2008-10#7)
of W(VI)##4##2##(2008-10#4)
of W370dsRNA##2##2##(2008-10#2)
of WB and PS showed##2##5##(1993-11#2)
of WB##3##2##(1993-11#3)
of WCS358##2##2##(2008-10#2)
of WD leading to different##2##5##(2008-10#2)
of WD##3##2##(2008-10#3)
of WDNM1 and ferritin heavy chain##2##6##(1997-6#2)
of WDNM1##3##2##(1997-6#3)
of WDR neurons##2##3##(1997-2#2)
of WEP##2##2##(2008-11#2)
of WHO##9##2##(1990-12#1)(1993-11#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-10#1)
of WICE##3##2##(1994-7#3)
of WKY##3##2##(1993-12#1)(1997-6#1)(2008-2#1)
of WM##3##2##(2008-3#1)(2010-7#2)
of WNV##2##2##(2007-12#2)
of WO(3)##2##2##(2008-3#1)(2009-11#1)
of WRN in##2##3##(2010-2#2)
of WRN##3##2##(2010-2#3)
of WSMV##11##2##(2008-10#11)
of WSMoV##6##2##(2008-10#6)
of WSN virus##2##3##(1990-5#2)
of WT##5##2##(1995-6#2)(2008-10#1)(2008-9#1)(2013-8#1)
of WT1##4##2##(1991-10#2)(2011-2#2)
of WTEs##2##2##(2012-2#2)
of WTORS##2##2##(2013-1#2)
of WW domain##2##3##(2008-11#2)
of WW##3##2##(2008-11#3)
of WWP##2##2##(2008-10#2)
of Wake Forest University##2##4##(1992-1#1)(2008-11#1)
of Wales##4##2##(1996-1#1)(1996-7#1)(2008-11#1)(2012-6#1)
of Wallerian degeneration##2##3##(2008-7#2)
of Warsaw##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
of Washington##11##2##(1995-12#2)(1996-1#1)(1997-6#1)(2008-10#4)(2008-5#2)(2012-12#1)
of Waste##3##2##(2008-10#1)(2013-1#2)
of Water in##2##3##(2008-10#1)(2008-2#1)
of Water##9##2##(2008-10#5)(2008-12#1)(2008-2#2)(2009-10#1)
of Watermelon silver mottle virus (WSMoV) was##2##7##(2008-10#2)
of Watermelon silver mottle virus##4##5##(2008-10#4)
of Watermelon##5##2##(2008-10#5)
of Web##3##2##(1996-12#1)(2007-2#1)(2008-7#1)
of Wegener's granulomatosis##4##3##(2008-1#1)(2010-11#3)
of West Bengal##5##3##(2010-10#1)(2010-4#2)(2011-1#1)(2012-2#1)
of West Nile##2##3##(2007-12#1)(2013-8#1)
of West Virginia##3##3##(1995-1#3)
of West##14##2##(1995-1#3)(1995-2#1)(2007-12#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Western Rajasthan##2##3##(2013-7#2)
of Western blotting##5##3##(2008-8#2)(2008-9#3)
of Western##21##2##(1992-1#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
of Wheat##14##2##(2008-10#14)
of Whipple's disease##2##3##(2008-7#1)(2009-5#1)
of Whipple's##3##2##(1994-3#1)(2008-7#1)(2009-5#1)
of White adolescents'##3##3##(2009-7#3)
of White##4##2##(2009-7#4)
of Wide##2##2##(1994-7#1)(1997-3#1)
of Williams and Beuren syndrome##2##5##(2008-10#2)
of Wilms' tumor##2##3##(2008-10#2)
of Winter Wheat##4##3##(2008-10#4)
of Winter##6##2##(2008-10#6)
of Wistar rats##4##3##(1993-12#1)(1996-3#1)(2008-10#1)(2011-2#1)
of Wistar##7##2##(1993-12#2)(1995-8#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
of Wnt signaling##2##3##(2007-12#2)
of Wnt##5##2##(2007-12#4)(2012-12#1)
of Wolbachia##5##2##(2008-8#3)(2008-9#2)
of Women##3##2##(1995-6#1)(2011-1#1)(2011-2#1)
of Women's Health##2##3##(2008-12#1)(2011-2#1)
of Women's##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
of Work##4##2##(1993-2#3)(2010-5#1)
of World Health Organization##2##4##(2008-2#1)(2010-8#1)
of World Health##3##3##(1995-3#1)(2008-2#1)(2010-8#1)
of World Journal of Gastrointestinal Surgery##2##6##(2010-12#2)
of World Journal of##4##4##(2010-12#4)
of World War II##7##4##(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#4)
of World War##8##3##(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#4)
of World##16##2##(1995-3#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-12#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
of Wuyujing-7##2##2##(2009-10#2)
of X chromosomes##5##3##(2007-11#1)(2007-12#3)(2008-12#1)
of X rays##2##3##(2008-3#1)(2013-1#1)
of X##90##2##(1990-3#1)(1990-7#1)(1993-6#3)(1994-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#72)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#2)(2013-1#1)
of X-linked gene##2##3##(2007-12#1)(2008-11#1)
of X-linked##3##2##(2007-12#1)(2008-11#2)
of X-ray crystallography##4##3##(1997-4#1)(2008-4#3)
of X-ray diffraction and##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
of X-ray diffraction##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)
of X-ray scattering##2##3##(2008-2#1)(2008-4#1)
of X-ray##20##2##(1997-4#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#5)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
of X-rays##2##2##(2007-11#1)(2013-8#1)
of XBP1 in##4##3##(2011-2#4)
of XBP1##6##2##(2011-2#6)
of XC DFB lasers##2##4##(2008-3#2)
of XDR-TB##4##2##(2008-10#1)(2010-5#3)
of XGP##2##2##(2008-1#1)(2013-1#1)
of Xa4##2##2##(2008-10#2)
of Xanthomonas albilineans##5##3##(2008-10#5)
of Xanthomonas axonopodis pv##11##4##(2008-10#11)
of Xanthomonas campestris pv##17##4##(2008-10#17)
of Xanthomonas campestris##18##3##(2008-10#17)(2012-2#1)
of Xanthomonas oryzae pv##12##4##(2008-10#11)(2008-9#1)
of Xanthomonas strains##2##3##(2008-10#2)
of Xanthomonas translucens pv##2##4##(2008-10#2)
of Xanthomonas translucens##4##3##(2008-10#4)
of Xanthomonas##60##2##(2008-10#57)(2008-8#1)(2008-9#1)(2012-2#1)
of XcTcmJ##3##2##(2010-10#3)
of Xenopus laevis##11##3##(1990-12#1)(1993-5#5)(1993-6#1)(1995-12#2)(1997-2#1)(2011-2#1)
of Xenopus oocytes##5##3##(1990-7#2)(1991-12#3)
of Xenopus##22##2##(1990-12#1)(1990-7#2)(1991-12#3)(1993-3#1)(1993-5#5)(1993-6#1)(1995-12#2)(1995-2#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-8#2)(2011-2#1)
of Xiphinema index##2##3##(2008-10#2)
of Xiphinema##3##2##(2008-10#3)
of Xmsx-1##4##2##(2008-6#4)
of Xmsx-2B in##2##3##(2008-6#2)
of Xmsx-2B##6##2##(2008-6#6)
of XylS##2##2##(2011-1#2)
of Xylella fastidiosa Strains##2##4##(2008-10#2)
of Xylella fastidiosa from Citrus##2##5##(2008-10#2)
of Xylella fastidiosa from##3##4##(2008-10#3)
of Xylella fastidiosa in##4##4##(2008-10#4)
of Xylella fastidiosa##18##3##(2008-10#18)
of Y chromosome##4##3##(1992-11#1)(2008-8#1)(2008-9#2)
of Y was##3##3##(2008-10#3)
of Y with respect to##2##5##(2008-10#2)
of Y##20##2##(1992-11#1)(1993-9#1)(1997-4#4)(2007-7#1)(2008-1#1)(2008-10#6)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)
of Y-CPApK##3##2##(2008-10#3)
of YAC clones##4##3##(1996-12#2)(2008-5#2)
of YAC insert##2##3##(1997-2#1)(2008-5#1)
of YAC##10##2##(1995-6#1)(1996-10#1)(1996-12#2)(1997-2#1)(2008-4#2)(2008-5#3)
of YAG##4##2##(2013-8#4)
of YH439##5##2##(2008-11#5)
of YKE2##2##2##(1994-12#2)
of YPA(4)##2##2##(2008-10#2)
of YRRM sequences##2##3##(1993-12#2)
of YY1##2##2##(2008-11#1)(2008-7#1)
of Yb##2##2##(1997-8#1)(2008-3#1)
of Yb(3+) ions in##2##4##(2007-11#1)(2008-2#1)
of Yb(3+)##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
of Yersinia enterocolitica##3##3##(1992-5#1)(1997-4#1)(2013-8#1)
of Yersinia##7##2##(1990-6#1)(1992-5#1)(1996-12#2)(1997-4#1)(2012-2#1)(2013-8#1)
of Yl##2##2##(1995-2#2)
of Young's modulus##3##3##(2009-4#1)(2009-5#1)(2009-7#1)
of Young's##5##2##(2008-3#1)(2009-4#1)(2009-5#1)(2009-7#2)
of Youth##3##2##(2009-8#1)(2009-9#1)(2011-2#1)
of Yunnan##4##2##(2008-9#2)(2011-1#2)
of Z##3##2##(2008-3#1)(2011-2#2)
of Z-D-Phe-L-PheGly##4##2##(1992-3#4)
of ZAPM##2##2##(2008-7#2)
of ZBP-89##2##2##(2010-8#2)
of ZCFIA##2##2##(2008-10#2)
of ZDV and##2##3##(2008-7#2)
of ZGMMV##2##2##(2008-10#2)
of ZYMV##4##2##(2008-10#4)
of Zea mays L##2##4##(2008-12#1)(2008-5#1)
of Zea mays##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)
of Zernike polynomials##2##3##(2008-3#2)
of Zernike##4##2##(2008-2#1)(2008-3#3)
of Zinc##2##2##(1997-7#1)(2008-5#1)
of Zingel asper##2##3##(2010-8#2)
of Ziram and##4##3##(2008-10#4)
of Ziram##7##2##(2008-10#7)
of Zn and##4##3##(1993-12#1)(1997-4#2)(2010-2#1)
of Zn by between 15 and 25%##2##7##(2008-10#2)
of Zn in##5##3##(2008-10#1)(2010-2#1)(2012-2#2)(2013-8#1)
of Zn##29##2##(1993-12#3)(1997-4#3)(2008-10#7)(2008-12#1)(2008-5#1)(2010-11#1)(2010-2#7)(2012-2#5)(2013-8#1)
of Zn(2+) in##2##3##(2008-10#2)
of Zn(2+)##9##2##(2008-10#9)
of Zn(II) in##2##3##(2008-10#2)
of Zn(II)##8##2##(2008-10#8)
of Zn(ii)-NA##2##2##(2010-11#2)
of Zn2+##5##2##(1992-11#2)(1997-4#3)
of ZnPc##2##2##(1994-12#2)
of ZnS##2##2##(2008-3#2)
of ZnSO(4)##2##2##(2008-10#2)
of Zr##8##2##(2008-10#8)
of Zr(IV) and Hf(IV) in##2##5##(2008-10#2)
of Zr(IV) and Hf(IV)##5##4##(2008-10#5)
of Zucchini yellow mosaic virus##4##5##(2008-10#4)
of Zymomonas mobilis##5##3##(2008-6#2)(2008-7#3)
of [(18)F]-fluorodeoxyglucose incorporation##5##3##(2008-11#5)
of [(18)F]-fluorodeoxyglucose##6##2##(2008-11#6)
of [(3)H]5-HT##2##2##(2008-7#2)
of [1-14C]-palmitic acid into##2##4##(1990-11#2)
of [1-14C]pyruvate##2##2##(1991-3#1)(1991-5#1)
of [111In-DTPA-D-Phe1]-octreotide scintigraphy##2##3##(1997-8#2)
of [125I]D-Trp6-LH-RH and##2##3##(1993-1#2)
of [125I]ET-1 by A10VSMC##2##4##(1995-11#2)
of [125I]ET-1 by##3##3##(1995-11#3)
of [125I]ET-1##5##2##(1995-11#5)
of [125I]thyroxine in the##2##4##(1993-12#2)
of [125I]thyroxine##5##2##(1991-5#2)(1993-12#3)
of [2]rotaxane##2##2##(2007-11#2)
of [32P]##2##2##(1991-12#1)(1992-9#1)
of [3H]##4##2##(1991-9#1)(1992-11#1)(1993-12#1)(1994-8#1)
of [3H]-thymidine into DNA##3##4##(1991-12#1)(1993-6#1)(1997-7#1)
of [3H]-thymidine##4##2##(1991-12#1)(1993-6#1)(1997-7#1)(2008-9#1)
of [3H]5-HT release##2##3##(1995-12#2)
of [3H]5-HT##5##2##(1994-2#1)(1995-12#4)
of [3H]ACPC##2##2##(1995-11#2)
of [3H]D-aspartate transport##4##3##(1995-11#4)
of [3H]D-aspartate##5##2##(1995-11#5)
of [3H]DA##2##2##(1991-1#1)(1996-5#1)
of [3H]Ins1##2##2##(1993-6#2)
of [3H]MK-801 was increased##3##4##(1997-2#3)
of [3H]MK-801##4##2##(1997-2#4)
of [3H]PtdInsP2##2##2##(1993-6#2)
of [3H]glycerol into##2##3##(1994-5#2)
of [3H]inositol##2##2##(1997-1#2)
of [3H]leucine##2##2##(1993-12#1)(1994-8#1)
of [3H]paroxetine binding##2##3##(1996-5#2)
of [3H]paroxetine##3##2##(1996-5#3)
of [3H]prazosin##3##2##(1991-6#3)
of [3H]thymidine incorporation##2##3##(1992-3#1)(1994-3#1)
of [3H]thymidine##10##2##(1991-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-2#3)(1996-5#1)(1997-1#1)(2008-4#1)
of [4##5##2##(1996-5#5)
of [Ca(2+)]##2##2##(2008-8#1)(2008-9#1)
of [Ca(2+)](i)##4##2##(2008-9#3)(2012-2#1)
of [Ca++]i##2##2##(1991-5#2)
of [Ca2+]i##14##2##(1990-12#2)(1990-7#1)(1991-12#1)(1991-5#1)(1992-6#2)(1994-6#3)(2008-5#1)(2011-3#3)
of [Formula##6##2##(2008-10#1)(2008-11#1)(2008-8#3)(2013-1#1)
of [I] and the reagent blank##2##6##(2008-10#2)
of [I]##3##2##(2008-10#3)
of [Leu]- and [Met]enkephalin##2##4##(1991-3#2)
of [gamma-32P]ATP##2##2##(1992-6#1)(1993-11#1)
of [rho(w)(lambda(NIR))](N) are##2##3##(2008-3#2)
of [rho(w)(lambda(NIR))](N)##3##2##(2008-3#3)
of a &quot##37##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)
of a 0##14##3##(1996-8#1)(2008-10#11)(2008-3#2)
of a 1##30##3##(1990-2#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-9#1)(1997-3#2)(2007-11#1)(2007-12#2)(2008-10#12)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
of a 10##8##3##(1993-2#1)(1997-3#2)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
of a 10-mum##2##3##(2007-11#1)(2008-2#1)
of a 100##3##3##(1991-5#1)(2008-10#1)(2010-5#1)
of a 13##2##3##(1991-3#1)(2011-2#1)
of a 14##2##3##(1996-3#1)(2011-2#1)
of a 15##2##3##(1994-9#1)(2010-8#1)
of a 15-year-old##2##3##(2010-3#1)(2012-2#1)
of a 150##2##3##(2008-10#2)
of a 160-GHz##2##3##(2007-11#2)
of a 17##3##3##(1997-3#2)(2007-10#1)
of a 1D##2##3##(2009-11#2)
of a 2##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
of a 20 kDa##2##4##(1992-8#1)(2011-2#1)
of a 20##5##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
of a 20-year-old##3##3##(2008-6#2)(2010-6#1)
of a 21##2##3##(1996-3#1)(2007-12#1)
of a 21-year-old##3##3##(1991-8#1)(2009-7#1)(2013-1#1)
of a 23##2##3##(1997-3#2)
of a 23-year-old##2##3##(1990-6#1)(2013-8#1)
of a 24-year-old##3##3##(2007-7#1)(2010-9#1)(2012-2#1)
of a 25-year-old##2##3##(2007-8#1)(2008-12#1)
of a 256 x 256 pixel##2##6##(2008-3#2)
of a 26-year-old##2##3##(1994-12#1)(2010-6#1)
of a 266-nm##2##3##(2007-12#2)
of a 27##2##3##(1990-7#1)(1996-8#1)
of a 27-year-old##2##3##(2008-12#1)(2013-1#1)
of a 29-year-old male##2##4##(2008-12#1)(2013-1#1)
of a 3##8##3##(1992-3#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-3#1)
of a 30-year-old man who had##2##6##(1990-8#1)(2008-11#1)
of a 30-year-old man##3##4##(1990-8#1)(2008-11#2)
of a 30-year-old##4##3##(1990-8#1)(2008-11#2)(2013-8#1)
of a 300##2##3##(2008-12#1)(2011-1#1)
of a 32##2##3##(1990-8#1)(2007-8#1)
of a 32-year-old##4##3##(2008-7#1)(2010-6#1)(2013-1#2)
of a 34-year-old##2##3##(1996-5#1)(2006-10#1)
of a 3D##2##3##(2008-7#1)(2012-2#1)
of a 4##3##3##(1995-2#1)(2007-12#1)(2008-3#1)
of a 4-month##2##3##(1993-1#1)(2013-7#1)
of a 4-year##4##3##(1992-6#1)(1993-12#1)(1994-12#1)(2008-10#1)
of a 40##5##3##(1992-11#1)(1994-11#1)(1996-6#2)(2008-10#1)
of a 45-year-old##5##3##(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of a 48-year-old##4##3##(2008-6#1)(2010-5#1)(2012-12#1)(2013-1#1)
of a 5##5##3##(1992-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
of a 5-mm##2##3##(2006-6#1)(2007-12#1)
of a 5-year-old child##2##4##(2008-10#1)(2013-1#1)
of a 5-year-old##5##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
of a 53-year-old##2##3##(1992-6#1)(2006-10#1)
of a 54##2##3##(1997-3#1)(2008-5#1)
of a 57-year-old man with##3##5##(1997-8#1)(2011-2#2)
of a 57-year-old##4##3##(1997-8#1)(2011-2#2)(2013-7#1)
of a 58-year-old##3##3##(2009-9#1)(2011-2#1)(2013-1#1)
of a 6##5##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
of a 60 kDa##2##4##(1996-12#2)
of a 60##3##3##(1996-12#2)(2011-2#1)
of a 63-year-old##2##3##(2007-5#1)(2012-12#1)
of a 65-year-old woman##2##4##(2008-11#1)(2012-3#1)
of a 65-year-old##4##3##(1992-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
of a 73-year-old man##2##4##(2013-1#2)
of a 946-nm Nd##2##4##(2008-2#2)
of a 96-well microtiter plate##2##5##(1997-7#1)(2008-9#1)
of a 96-well##3##3##(1997-7#1)(2008-11#1)(2008-9#1)
of a B##2##3##(2008-9#1)(2012-2#1)
of a C##2##3##(2008-10#2)
of a C-N##2##3##(1997-7#2)
of a C5-C6##2##3##(2011-2#2)
of a CCD##3##3##(2008-2#1)(2008-3#2)
of a CD-R##2##3##(2008-10#1)(2008-3#1)
of a CO(2) Laser##2##4##(2008-2#2)
of a CO(2) laser##3##4##(2008-2#1)(2008-3#2)
of a CO(2)##6##3##(2008-2#3)(2008-3#3)
of a CT scan##2##4##(1990-12#1)(1995-11#1)
of a Ca2+ channel##2##4##(1995-11#1)(1997-7#1)
of a Case##3##3##(1994-7#1)(1996-6#1)(2011-1#1)
of a Chinese##5##3##(1991-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
of a CpG##2##3##(1991-6#1)(2008-10#1)
of a Cr##2##3##(2008-2#2)
of a Cr(2+)##2##3##(2007-11#1)(2007-12#1)
of a Cr(4+)##2##3##(2007-11#2)
of a DNA fragment##2##4##(1993-6#1)(1993-8#1)
of a DNA##13##3##(1990-5#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-9#1)(2013-7#1)
of a DNA-binding protein##2##4##(1990-11#1)(1993-11#1)
of a DNR order##6##4##(1992-12#3)(1992-3#3)
of a Diploma in##2##4##(2008-11#1)(2013-1#1)
of a Doppler signal##2##4##(1991-12#1)(2008-2#1)
of a Fabry-Perot etalon##2##4##(2008-2#2)
of a Fabry-Perot interferometer to##2##5##(2008-3#2)
of a Fabry-Perot##11##3##(2007-12#1)(2008-2#5)(2008-3#5)
of a Fourier##4##3##(2008-2#2)(2008-3#2)
of a Fourier-transform infrared##2##4##(2008-2#1)(2008-3#1)
of a Fourier-transform##5##3##(2008-2#2)(2008-3#3)
of a G##4##3##(1994-3#1)(1995-6#1)(2008-4#1)(2009-5#1)
of a GIST##2##3##(2009-7#1)(2012-12#1)
of a GPU##2##3##(2012-2#2)
of a Gaussian beam##6##4##(2007-11#2)(2007-12#1)(2008-3#3)
of a Gaussian##12##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#6)(2008-6#1)
of a Gene##4##3##(2008-10#4)
of a Gene-for-Gene Coevolution System##2##5##(2008-10#2)
of a GnRH##2##3##(2008-5#2)
of a H+ electrochemical potential##2##5##(1997-8#2)
of a He-Ne laser##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a Health Goals##2##4##(1991-2#2)
of a Japanese##2##3##(1990-7#1)(2008-5#1)
of a KTP##2##3##(2008-2#2)
of a KrF##2##3##(2007-11#1)(2008-2#1)
of a Lewis acid##2##4##(1993-11#1)(1996-5#1)
of a MADS##2##3##(1997-2#1)(2008-8#1)
of a Mach-Zehnder interferometer##2##4##(2007-11#1)(2010-4#1)
of a Member of the##2##5##(2008-10#2)
of a Michelson interferometer##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of a Monte Carlo##4##4##(2008-2#1)(2008-3#3)
of a National##2##3##(2008-1#1)(2008-5#1)
of a Nd##21##3##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#7)
of a New##7##3##(1996-5#1)(1997-7#1)(2008-10#4)(2008-11#1)
of a North American##2##4##(1993-12#1)(2008-10#1)
of a Novel##6##3##(1996-2#1)(1997-7#1)(2008-10#3)(2010-8#1)
of a P##2##3##(2008-10#1)(2008-7#1)
of a PACS##2##3##(2008-7#2)
of a PCR##3##3##(2008-10#3)
of a PCR-based##2##3##(1995-11#1)(2008-10#1)
of a PD##2##3##(2007-12#1)(2008-10#1)
of a Patient##2##3##(1995-3#1)(2008-6#1)
of a Phase##2##3##(2008-6#1)(2010-8#1)
of a Poisson##2##3##(2008-3#2)
of a Q-switched laser##2##4##(2008-2#2)
of a Q-switched##5##3##(2008-2#3)(2008-3#2)
of a Raman lidar measurement of middle and upper tropospheric water vapor##2##12##(2008-3#2)
of a Raman##3##3##(2008-10#1)(2008-3#2)
of a Rhodamine 6G##2##4##(2008-2#2)
of a Sagnac interferometer##2##4##(2007-12#1)(2008-2#1)
of a Schmidt telescope##2##4##(2008-3#2)
of a Schmidt##3##3##(2008-3#3)
of a Shack-Hartmann wave-front sensor##3##5##(2008-3#3)
of a Shack-Hartmann##4##3##(2008-3#4)
of a Small##5##3##(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
of a Streptococcus##2##3##(1995-8#1)(1997-7#1)
of a T##3##3##(2007-5#1)(2008-10#1)(2008-11#1)
of a TV##2##3##(1996-8#1)(2008-3#1)
of a Ti##7##3##(2007-11#2)(2007-12#3)(2008-3#2)
of a U##4##3##(1991-2#1)(1992-1#1)(2008-10#1)(2008-2#1)
of a UV##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
of a V-shaped##2##3##(2007-12#1)(2009-12#1)
of a Viral##2##3##(2008-10#2)
of a Web##2##3##(2008-11#1)(2008-4#1)
of a Web-based##5##3##(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
of a Worldwide Collection of Puccinia triticina from Durum Wheat##2##10##(2008-10#2)
of a Y-maze avoidance learning task##2##6##(1993-5#2)
of a Zn(II)##2##3##(2008-10#2)
of a and b(b)##2##4##(2008-2#1)(2008-3#1)
of a and##3##3##(2008-2#2)(2008-3#1)
of a baby##4##3##(1992-2#1)(1996-2#1)(2007-7#1)(2008-11#1)
of a bacterial##6##3##(1990-11#1)(1997-2#1)(2008-5#1)(2008-8#2)(2009-7#1)
of a bacterium##2##3##(2008-8#2)
of a band##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
of a bare##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-5#1)
of a barrier##2##3##(1990-6#1)(2008-10#1)
of a base##2##3##(1995-6#1)(2008-7#1)
of a baseline##2##3##(1991-5#1)(2008-10#1)
of a basic##6##3##(1996-7#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2011-2#1)
of a basilar artery##2##4##(2011-2#2)
of a batch##4##3##(2008-10#1)(2008-11#1)(2008-7#2)
of a beam##8##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
of a behavioral##3##3##(1997-1#1)(2008-9#1)(2011-2#1)
of a benign##3##3##(2007-8#1)(2008-12#1)(2013-1#1)
of a benomyl-resistant##2##3##(1997-2#2)
of a bent##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
of a benzodiazepine##4##3##(1991-12#1)(1992-7#1)(1994-2#1)(1996-9#1)
of a better##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
of a biaxial##2##3##(2008-3#2)
of a bicomponent cloud##2##4##(2008-2#2)
of a bidirectional##2##3##(2007-11#1)(2009-3#1)
of a bimodal distribution##2##4##(2008-3#1)(2009-7#1)
of a bimodal##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
of a binary solvent mixture##2##5##(2008-10#1)(2008-7#1)
of a binary##8##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)
of a biocontrol##2##3##(2008-10#2)
of a biological##5##3##(1990-11#1)(2008-2#1)(2008-4#1)(2008-9#2)
of a biologically##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
of a biomimetic##2##3##(2008-10#1)(2010-5#1)
of a bioprocess##2##3##(2012-2#1)(2013-1#1)
of a biopsy##2##3##(2011-2#1)(2013-1#1)
of a biosensor##6##3##(2008-10#6)
of a bioterrorist attack##2##4##(2007-12#2)
of a biotinylated##2##3##(1992-6#1)(2008-10#1)
of a bird##2##3##(1996-8#2)
of a birefringent##5##3##(2008-3#5)
of a blind##3##3##(1991-9#2)(2007-8#1)
of a blood pressure##2##4##(2008-12#1)(2012-3#1)
of a blood##3##3##(1991-7#1)(2008-12#1)(2012-3#1)
of a blue##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
of a bone##4##3##(2008-11#2)(2008-6#1)(2013-1#1)
of a bovine##3##3##(1991-2#1)(1995-12#1)(1996-6#1)
of a brain##3##3##(1991-11#1)(2011-2#1)(2011-3#1)
of a branched##2##3##(1993-12#1)(2008-1#1)
of a breast##5##3##(1993-11#1)(1994-12#1)(1994-9#1)(2012-12#1)(2013-1#1)
of a brief##4##3##(2007-12#1)(2008-11#1)(2010-9#1)(2013-1#1)
of a bright##2##3##(1991-5#1)(2007-11#1)
of a broad range of##2##5##(2008-5#2)
of a broad##7##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-4#1)
of a broad-area semiconductor laser##2##5##(2008-2#1)(2008-3#1)
of a broadband light source##2##5##(2007-11#1)(2008-3#1)
of a broadband##4##3##(2007-11#3)(2008-3#1)
of a broader##5##3##(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#2)
of a broadly##2##3##(1991-9#1)(2008-2#1)
of a broken##2##3##(2008-11#1)(2013-7#1)
of a built-in##2##3##(1996-5#1)(2007-12#1)
of a bulk##2##3##(2007-11#1)(2008-3#1)
of a burnout workshop##2##4##(1996-2#2)
of a butterfly scale microstructure##2##5##(2008-2#2)
of a butterfly##3##3##(2008-2#2)(2013-1#1)
of a cDNA clone encoding##2##5##(1992-3#1)(1994-8#1)
of a cDNA clone##4##4##(1990-12#1)(1990-2#1)(1992-3#1)(1994-8#1)
of a cDNA coding for##2##5##(1995-2#1)(1996-2#1)
of a cDNA encoding a##5##5##(1992-8#1)(1994-12#2)(1997-1#1)(2008-8#1)
of a cDNA encoding human##2##5##(1994-12#1)(2008-8#1)
of a cDNA encoding the##5##5##(1992-11#1)(1993-3#2)(1994-12#1)(2008-5#1)
of a cDNA encoding##15##4##(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-12#4)(1997-1#1)(2008-5#1)(2008-8#2)
of a cDNA for##4##4##(1990-11#1)(1993-11#1)(1994-11#1)(1995-6#1)
of a cDNA##32##3##(1990-11#1)(1990-12#1)(1990-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#4)(1994-12#5)(1994-8#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-1#1)(2008-5#2)(2008-6#1)(2008-8#2)
of a calcium##3##3##(2008-10#2)(2008-3#1)
of a calibration##4##3##(2008-10#3)(2008-9#1)
of a cancer##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
of a candidate##2##3##(1992-12#1)(2010-9#1)
of a capillary electrophoresis method for the##3##7##(1994-12#1)(2008-10#2)
of a capillary##12##3##(1994-12#1)(1994-9#1)(1997-2#2)(2008-10#7)(2008-2#1)
of a carbohydrate-restricted diet##4##4##(2008-3#4)
of a carbon paste electrode modified##2##6##(2008-10#2)
of a carbon paste electrode##4##5##(2008-10#4)
of a carbon##10##3##(1994-8#1)(2008-10#7)(2008-3#2)
of a carbonyl##2##3##(1995-3#1)(2009-5#1)
of a cardiac##4##3##(2007-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
of a cardiovascular##2##3##(2008-4#1)(2013-8#1)
of a care##2##3##(1990-2#1)(2008-11#1)
of a careful##2##3##(1991-6#1)(1993-11#1)
of a carotenoid##3##3##(2009-9#1)(2010-2#2)
of a carrier##5##3##(1990-7#1)(2008-10#2)(2008-11#1)(2009-5#1)
of a case and literature review##2##6##(2011-1#1)(2012-3#1)
of a case and review of the literature##5##8##(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2013-1#1)
of a case and review of the literature]##2##8##(1990-6#1)(1997-3#1)
of a case and review of the##7##7##(1990-6#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2013-1#1)
of a case and review of##10##6##(1990-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-9#1)(2013-1#1)
of a case and##12##4##(1990-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of a case of##12##4##(1990-3#1)(1991-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
of a case report##2##4##(1994-11#1)(2010-8#1)
of a case study##3##4##(1996-1#1)(2008-11#1)(2012-2#1)
of a case##53##3##(1990-3#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-3#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of a case]##4##3##(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)
of a catalytic combustion sensor##2##5##(2008-10#2)
of a catalytic##4##3##(2008-10#3)(2010-6#1)
of a catheter##3##3##(2008-7#1)(2009-9#1)(2012-12#1)
of a cationic surfactant##6##4##(2008-10#6)
of a cationic##8##3##(1990-7#1)(2008-10#6)(2009-12#1)
of a causal relationship between##2##5##(1990-6#1)(2010-2#1)
of a causal##4##3##(1990-6#1)(1997-3#1)(2009-9#1)(2010-2#1)
of a cavity##3##3##(1996-5#1)(2008-2#2)
of a cell adhesion##2##4##(2008-11#1)(2008-5#1)
of a cell wall##2##4##(2008-10#2)
of a cell##20##3##(1993-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)
of a cellular##4##3##(1990-12#1)(2008-11#2)(2011-2#1)
of a cellulose binding domain##2##5##(2008-7#2)
of a cemented##3##3##(2008-2#1)(2008-6#1)(2009-7#1)
of a central venous catheter##4##5##(2007-7#1)(2008-7#2)(2011-2#1)
of a central##5##3##(1993-5#1)(2007-7#1)(2008-7#2)(2011-2#1)
of a cerebral##8##3##(1992-2#1)(1994-8#1)(1997-5#4)(2008-7#1)(2008-9#1)
of a certain##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
of a certified##3##3##(2008-10#3)
of a cervical##5##3##(1996-6#1)(2007-11#1)(2008-9#1)(2010-8#1)(2013-1#1)
of a chain##3##3##(1994-11#1)(1997-7#1)(2009-11#1)
of a change in##4##4##(1991-2#1)(1996-2#1)(1996-8#1)(2007-11#1)
of a change##6##3##(1991-2#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-9#1)(2013-7#1)
of a characteristic##3##3##(1996-4#1)(2008-10#1)(2008-3#1)
of a charge##2##3##(1995-11#1)(2008-7#1)
of a charged##2##3##(2008-7#1)(2009-6#1)
of a chelating resin##2##4##(2008-10#2)
of a chemical##5##3##(1992-9#1)(2008-10#3)(2008-11#1)
of a chemically##3##3##(1990-7#1)(2007-12#1)(2008-11#1)
of a chest##2##3##(2007-7#1)(2008-3#1)
of a child with##7##4##(1992-6#1)(2009-5#3)(2010-7#1)(2011-1#1)(2012-12#1)
of a child##20##3##(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#2)(2007-8#1)(2008-11#1)(2008-9#1)(2009-5#5)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
of a child's##4##3##(1992-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
of a chimeric gene composed of the##2##7##(1994-5#2)
of a chimeric##5##3##(1990-8#1)(1994-3#1)(1994-5#2)(2008-11#1)
of a chirped##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
of a cholinergic##3##3##(1994-8#1)(2013-1#2)
of a chromatographic##3##3##(2008-10#2)(2013-1#1)
of a chromosomal##2##3##(1996-12#1)(2008-2#1)
of a chronic disease##2##4##(1993-11#1)(1994-5#1)
of a chronic##5##3##(1993-11#1)(1994-5#1)(1996-3#1)(2008-7#1)(2009-8#1)
of a circular aperture##2##4##(2008-3#2)
of a circular##3##3##(2008-10#1)(2008-3#2)
of a city##2##3##(2008-10#1)(2008-11#1)
of a class of##3##4##(1996-3#1)(2007-12#1)(2008-10#1)
of a class##5##3##(1996-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)
of a classic##3##3##(2007-12#2)(2008-3#1)
of a classical##7##3##(1991-12#1)(1993-12#1)(1995-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
of a classification system##2##4##(2010-12#1)(2012-1#1)
of a clean##3##3##(1997-1#1)(2008-3#1)(2008-7#1)
of a clear##3##3##(1991-9#1)(2010-1#1)(2012-3#1)
of a cleaved optical fiber##2##5##(2007-12#1)(2008-3#1)
of a clinical case##3##4##(1990-5#1)(1993-5#1)(2007-12#1)
of a clinical case]##4##4##(1990-3#1)(1993-5#1)(1993-6#2)
of a clinical trial##7##4##(1992-9#1)(1996-6#2)(1997-4#1)(2010-6#1)(2010-8#1)(2012-2#1)
of a clinical##28##3##(1990-3#2)(1990-5#3)(1992-9#1)(1993-5#2)(1993-6#2)(1995-2#2)(1996-1#1)(1996-6#2)(1997-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of a clinically##2##3##(2009-12#1)(2011-2#1)
of a clone##3##3##(1994-11#1)(1996-3#1)(2008-9#1)
of a cloned##5##3##(1990-11#1)(1997-2#2)(2008-11#1)(2008-8#1)
of a closed##2##3##(2007-12#1)(2008-10#1)
of a closterovirus associated with##3##5##(2008-10#3)
of a cluster of##2##4##(2008-9#1)(2009-2#1)
of a coated##2##3##(2008-10#1)(2008-3#1)
of a cochlear implant##5##4##(2008-9#4)(2012-2#1)
of a cocktail of##2##4##(2007-11#1)(2008-10#1)
of a cognitive##3##3##(2007-8#1)(2008-4#2)
of a coherent##9##3##(1993-2#1)(2007-11#3)(2008-2#2)(2008-3#3)
of a cohort of##4##4##(1990-9#1)(1995-9#1)(2010-1#1)(2010-4#1)
of a cold##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
of a collaborative##5##3##(1992-1#1)(1994-12#1)(1995-11#1)(2008-11#1)(2008-12#1)
of a collection of##4##4##(2007-11#1)(2008-10#3)
of a combination of##17##4##(1991-8#1)(1993-9#1)(1994-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)
of a combination##18##3##(1991-8#1)(1993-9#1)(1994-8#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)
of a combined##8##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2013-2#1)
of a commercial##16##3##(1994-8#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-5#1)(2009-12#1)(2013-8#1)
of a commercially available##7##4##(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)
of a common single-mode fiber##2##5##(2008-3#2)
of a common##19##3##(1990-8#1)(1991-12#1)(1992-2#1)(1993-9#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
of a commonly used##2##4##(2008-10#2)
of a commonly##3##3##(2008-10#3)
of a community engagement##2##4##(2012-2#2)
of a community##8##3##(1991-2#1)(1996-11#1)(1997-3#1)(2008-9#1)(2010-10#1)(2012-2#3)
of a community-based##5##3##(1992-1#1)(1994-1#1)(2008-11#1)(2008-3#1)(2012-12#1)
of a compact##15##3##(2007-11#3)(2008-10#6)(2008-2#2)(2008-3#4)
of a comparable##2##3##(1997-2#1)(2008-3#1)
of a comparative##2##3##(1990-9#1)(2008-10#1)
of a comparison of the##3##5##(2008-2#1)(2008-3#2)
of a comparison##4##3##(2008-2#1)(2008-3#2)(2012-2#1)
of a compensator##2##3##(2008-3#2)
of a competitive##4##3##(1991-3#1)(1994-9#1)(2008-10#1)(2012-3#1)
of a complementary##4##3##(1993-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
of a complete denture##2##4##(2013-1#2)
of a complete##16##3##(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#3)
of a complex network##2##4##(2012-2#2)
of a complex of##5##4##(1991-2#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#1)
of a complex spectral##2##4##(2007-12#1)(2011-1#1)
of a complex with##3##4##(1990-2#1)(2008-10#2)
of a complex##44##3##(1990-11#1)(1990-2#1)(1991-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-5#2)(2007-12#4)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
of a complex-coupled##2##3##(2008-3#2)
of a complicated##3##3##(1994-11#1)(2010-12#1)(2013-8#1)
of a composite resin##3##4##(2008-12#3)
of a composite##11##3##(2007-12#1)(2008-10#2)(2008-12#3)(2008-2#2)(2009-11#1)(2009-6#1)(2010-2#1)
of a compound##11##3##(1991-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2010-11#1)(2011-2#1)
of a comprehensive approach##2##4##(2008-3#1)(2011-2#1)
of a comprehensive screening program##2##5##(1996-2#1)(2008-10#1)
of a comprehensive##19##3##(1991-2#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#3)(2010-12#1)(2010-5#1)(2011-2#1)
of a computer search of##2##5##(1995-8#1)(2008-8#1)
of a computer##7##3##(1993-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)
of a computerized##5##3##(1996-3#1)(1997-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
of a concept##3##3##(1994-3#2)(2008-11#1)
of a conditional##2##3##(1997-3#1)(2008-8#1)
of a conditioned place preference (CPP)##2##6##(1993-6#1)(1994-2#1)
of a conference##10##3##(1992-12#1)(1992-3#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-8#1)
of a confirmatory##2##3##(2011-2#1)(2012-2#1)
of a confocal microscope##3##4##(2007-12#1)(2008-3#2)
of a confocal##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of a congenital splenic cyst##3##5##(1997-8#3)
of a congenital##6##3##(1997-8#3)(2007-8#1)(2010-3#1)(2012-3#1)
of a conidial suspension##2##4##(2008-10#2)
of a consensus##5##3##(1990-11#1)(1991-2#1)(1993-2#1)(1994-8#1)(2008-10#1)
of a conserved##6##3##(1994-2#1)(1995-2#1)(1996-5#1)(2008-10#1)(2009-8#1)(2010-10#1)
of a considerable##2##3##(2008-10#1)(2010-10#1)
of a consistent##4##3##(1993-3#1)(2008-9#1)(2013-1#2)
of a conspecific##3##3##(1994-8#1)(2008-9#1)(2009-6#1)
of a constant##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
of a consumer##2##3##(1996-2#1)(2008-11#1)
of a contact##3##3##(2008-10#1)(2008-3#1)(2009-1#1)
of a continuous scanning procedure and##2##6##(2011-1#2)
of a continuous##16##3##(1992-9#1)(1994-3#1)(1994-5#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2011-1#2)(2013-1#1)
of a continuous-wave laser##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a continuous-wave##12##3##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2011-1#1)
of a continuously##4##3##(2008-2#1)(2008-3#1)(2010-11#1)(2012-2#1)
of a continuum of##2##4##(2008-10#1)(2008-12#1)
of a continuum##3##3##(1994-9#1)(2008-10#1)(2008-12#1)
of a control group##3##4##(1990-6#1)(1991-3#1)(1993-2#1)
of a control##10##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-3#1)(1993-2#1)(2007-6#1)(2008-10#2)(2008-9#1)(2009-2#1)
of a controlled##3##3##(2010-12#1)(2011-2#2)
of a conventional##22##3##(1990-12#1)(1994-5#1)(1994-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#3)(2010-8#1)(2013-8#1)
of a coordinated##2##3##(1992-1#1)(2008-12#1)
of a copper-vapor laser##2##4##(2007-12#2)
of a core of##2##4##(1990-3#1)(2007-6#1)
of a core##6##3##(1990-3#1)(1996-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)
of a coronary artery##2##4##(2008-4#1)(2010-5#1)
of a coronary stent##2##4##(2008-7#1)(2011-2#1)
of a coronary##5##3##(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#1)
of a correct##6##3##(1991-3#1)(1991-5#1)(1991-6#1)(2007-11#1)(2008-3#1)(2013-1#1)
of a correction factor##2##4##(1995-12#1)(2008-10#1)
of a correction##3##3##(1995-12#1)(1997-4#1)(2008-10#1)
of a corresponding##4##3##(1993-12#1)(1995-9#1)(2008-10#1)(2008-3#1)
of a cosmetic formulation##2##4##(2008-5#2)
of a cosmetic product##2##4##(2008-5#2)
of a cosmetic##6##3##(2008-5#5)(2013-7#1)
of a cost function##2##4##(2008-2#2)
of a cost-effective##3##3##(1994-2#1)(2007-12#1)(2008-10#1)
of a counterpropagating##3##3##(2007-12#1)(2008-2#2)
of a coupling##2##3##(2008-3#1)(2008-4#1)
of a covariance##2##3##(2008-10#1)(2008-3#1)
of a cover crop##2##4##(2008-10#2)
of a creatine##2##3##(2008-5#2)
of a crime##2##3##(2007-1#1)(2008-10#1)
of a crisis##2##3##(1994-2#1)(2009-6#1)
of a critical pathway##3##4##(2008-3#3)
of a critical review of##2##5##(2008-11#1)(2008-7#1)
of a critical##8##3##(1990-12#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-11#1)
of a crop##2##3##(2008-10#1)(2008-11#1)
of a cross between##4##4##(2008-10#3)(2008-9#1)
of a cross of##2##4##(2008-10#2)
of a cross##6##3##(2008-10#5)(2008-9#1)
of a cross-sectional##5##3##(1994-11#2)(2010-3#1)(2011-1#1)(2011-2#1)
of a crosslinked##2##3##(2008-10#1)(2010-6#1)
of a crown##2##3##(2008-10#1)(2009-8#1)
of a crude##2##3##(2008-10#2)
of a crystal##2##3##(2007-11#1)(2008-2#1)
of a current##2##3##(1992-6#1)(2008-12#1)
of a curve##2##3##(2008-10#1)(2009-6#1)
of a customizable##2##3##(2013-1#2)
of a cutaneous##4##3##(1990-8#1)(2008-9#1)(2010-6#1)(2013-8#1)
of a cuticular##2##3##(1994-12#2)
of a cw laser##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of a cw##12##3##(2007-12#4)(2008-2#4)(2008-3#4)
of a cyclic##2##3##(1992-4#1)(1995-9#1)
of a cylinder with an elliptical cross section##2##8##(2008-2#2)
of a cylindrical##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of a cysteine##2##3##(1992-9#1)(1997-6#1)
of a cytoskeletal##3##3##(1990-8#1)(1995-12#2)
of a cytosolic##2##3##(1992-3#2)
of a daily##2##3##(1991-6#1)(2007-7#1)
of a dark##2##3##(2008-7#1)(2008-8#1)
of a data collection##2##4##(1993-3#1)(1995-2#1)
of a database##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
of a dc component##2##4##(2008-2#1)(2008-3#1)
of a decade##3##3##(1992-3#2)(2007-12#1)
of a decline in##2##4##(1995-9#1)(2008-9#1)
of a decrease in the##2##5##(2008-12#1)(2008-5#1)
of a decrease in##4##4##(2008-12#1)(2008-5#2)(2011-2#1)
of a decreased##2##3##(2008-5#1)(2012-3#1)
of a dedicated##6##3##(1993-3#1)(1994-1#2)(2008-10#1)(2008-11#1)(2008-3#1)
of a deep##2##3##(2011-2#1)(2013-1#1)
of a defective##3##3##(1992-6#1)(1995-8#1)(2007-8#1)
of a defined##3##3##(1991-1#1)(1995-6#1)(2008-10#1)
of a deformable mirror##4##4##(2008-2#2)(2008-3#2)
of a deformed##2##3##(2008-3#1)(2008-7#1)
of a degree##2##3##(1992-1#1)(2008-10#1)
of a delay##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
of a delayed##4##3##(1992-11#1)(1993-3#1)(2008-7#1)(2009-3#1)
of a deletion##2##3##(1993-11#1)(1997-3#1)
of a dental##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
of a design##2##3##(1992-12#1)(1994-2#1)
of a detailed##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
of a detection system based on##2##6##(2008-10#1)(2008-3#1)
of a detector##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2012-1#1)
of a developmental##2##3##(2008-3#1)(2009-3#1)
of a diagnosis##2##3##(2008-10#1)(2008-11#1)
of a diagnostic approach##2##4##(1994-6#1)(1996-12#1)
of a diagnostic##5##3##(1994-6#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)
of a dielectric##6##3##(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#2)
of a diet containing##2##4##(2008-11#1)(2011-1#1)
of a diet##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
of a dietary##2##3##(2008-5#1)(2011-2#1)
of a difference##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
of a different##11##3##(1990-7#1)(1992-2#1)(1993-9#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)
of a differential##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
of a diffraction##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of a diffractive lens##2##4##(2007-12#1)(2008-3#1)
of a diffractive optical filter##2##5##(2008-3#2)
of a diffractive optical##4##4##(2008-3#4)
of a diffractive##8##3##(2007-12#1)(2008-3#7)
of a diffuse##4##3##(2008-3#4)
of a digital optical computing system##2##6##(2008-3#2)
of a digital##11##3##(1993-2#1)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#5)(2010-8#1)
of a dilute##2##3##(1993-12#1)(2008-10#1)
of a diluted##2##3##(2008-10#1)(2008-3#1)
of a diode laser##10##4##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
of a diode##11##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)
of a diode-laser sensor to monitor water vapor in high-pressure combustion gases##2##12##(2008-2#2)
of a diode-laser##4##3##(2008-2#3)(2008-3#1)
of a diode-pumped Nd##7##4##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
of a diode-pumped monolithic##2##4##(2007-12#2)
of a diode-pumped##19##3##(2007-11#1)(2007-12#9)(2008-2#3)(2008-3#6)
of a dipole##2##3##(2007-12#1)(2008-3#1)
of a direct##6##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
of a disaster##2##3##(2008-2#1)(2012-2#1)
of a discrete##3##3##(1993-8#1)(2008-3#2)
of a disease to##2##4##(1993-12#1)(2011-2#1)
of a disease##11##3##(1993-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2011-2#1)
of a dispersion of##2##4##(1997-2#1)(2008-3#1)
of a dispersion##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
of a dispersion-managed##3##3##(2007-11#1)(2007-12#2)
of a disposable##5##3##(2008-10#5)
of a dissolved oxygen##2##4##(2008-10#2)
of a distal##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
of a distinct##6##3##(1990-12#1)(1991-12#1)(1992-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
of a distributed-feedback##3##3##(2007-11#1)(2008-3#2)
of a diverse group of##2##5##(2008-10#1)(2008-4#1)
of a diverse range of##4##5##(2008-11#1)(2011-2#2)(2012-2#1)
of a diverse##13##3##(1990-11#1)(1997-2#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
of a divine##2##3##(2013-1#2)
of a documentation##2##3##(1997-2#2)
of a domain##2##3##(1992-3#1)(2008-7#1)
of a dominant##3##3##(2007-6#1)(2008-4#1)(2008-7#1)
of a donor##2##3##(1994-1#1)(2008-4#1)
of a double##10##3##(1992-12#1)(1992-2#1)(1992-3#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)
of a double-blind randomized##2##4##(1991-3#1)(1994-6#1)
of a double-pass##2##3##(2008-2#2)
of a doubly##2##3##(2007-12#1)(2008-3#1)
of a downstream##2##3##(2008-1#1)(2011-2#1)
of a drug##19##3##(1990-3#1)(1992-9#2)(1993-12#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#2)(2009-9#1)(2010-8#1)(2012-3#1)
of a dry##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
of a dual##6##3##(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)
of a dye##3##3##(2008-2#1)(2008-3#1)(2009-6#1)
of a dynamic##9##3##(2007-11#1)(2008-10#4)(2008-3#1)(2009-8#1)(2011-2#1)(2012-12#1)
of a fabry-perot interferometer##2##4##(2008-3#2)
of a factor of##3##4##(2008-2#2)(2008-3#1)
of a factor##5##3##(1992-2#1)(1996-2#1)(2008-2#2)(2008-3#1)
of a false##3##3##(2007-10#1)(2007-8#1)(2011-2#1)
of a family of##10##4##(1992-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-8#2)(2008-10#1)(2008-9#1)(2011-2#2)
of a family with##2##4##(1992-8#1)(1997-8#1)
of a family##19##3##(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#2)(2009-2#1)(2011-2#3)
of a fast##8##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2009-12#1)
of a feeding##3##3##(1994-12#1)(2008-11#1)(2008-4#1)
of a female patient##6##4##(1992-12#1)(2008-1#1)(2010-7#1)(2012-12#2)(2012-3#1)
of a female##15##3##(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
of a femoral##2##3##(2009-4#2)
of a femtosecond Ti##2##4##(2007-12#1)(2008-3#1)
of a femtosecond pulse##3##4##(2007-11#2)(2008-3#1)
of a femtosecond##9##3##(2007-11#3)(2007-12#4)(2008-3#2)
of a fetal##4##3##(1990-5#1)(1994-8#1)(1996-12#1)(2008-10#1)
of a few centimeters##2##4##(2008-3#2)
of a few hundred##2##4##(2008-3#1)(2009-5#1)
of a few micrometers##2##4##(2007-12#1)(2008-3#1)
of a few nanometers##2##4##(2008-10#1)(2008-3#1)
of a few percent to##2##5##(1992-6#1)(2008-3#1)
of a few percent##4##4##(1992-6#1)(2008-3#3)
of a few tens of##3##5##(2008-3#2)(2012-1#1)
of a few to##3##4##(1996-4#2)(2009-11#1)
of a few wavelengths##2##4##(2008-3#2)
of a few##54##3##(1990-8#1)(1992-3#1)(1992-6#1)(1996-4#2)(1997-6#1)(2007-11#2)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#22)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
of a few-cycle##2##3##(2007-12#2)
of a fiber Bragg grating##2##5##(2007-11#1)(2008-2#1)
of a fiber grating##2##4##(2007-12#2)
of a fiber laser cavity##2##5##(2008-2#1)(2008-3#1)
of a fiber optical parametric amplifier##3##6##(2007-11#3)
of a fiber ring##2##4##(2008-2#1)(2008-3#1)
of a fiber##25##3##(1991-9#1)(2007-11#5)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#8)
of a fiber-optic probe##2##4##(2008-10#1)(2008-3#1)
of a fiber-optic##8##3##(2008-10#1)(2008-2#2)(2008-3#5)
of a field of##3##4##(2008-9#1)(2009-8#1)(2012-12#1)
of a field##8##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-8#1)(2012-12#1)
of a film on an isotropic substrate##2##7##(2008-3#2)
of a film on an##3##5##(2008-3#3)
of a film##6##3##(2008-2#2)(2008-3#4)
of a filter##2##3##(1995-3#1)(2008-2#1)
of a finite##7##3##(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)
of a fire##2##3##(1995-6#1)(1996-12#1)
of a firing##2##3##(2008-11#1)(2008-2#1)
of a first##3##3##(1996-5#1)(2008-11#1)(2011-2#1)
of a fish##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
of a fixed##7##3##(1991-2#1)(1991-6#1)(1994-9#1)(2008-11#1)(2008-3#2)(2012-12#1)
of a fixed-price##2##3##(1995-2#2)
of a flame##4##3##(2008-10#3)(2008-2#1)
of a flash-lamp-pumped##2##3##(2008-2#2)
of a flat sheet membrane desolvator##2##6##(2008-10#2)
of a flat##7##3##(1991-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
of a flexible##2##3##(1992-1#1)(2007-11#1)
of a flexor##2##3##(2008-9#2)
of a flow cytometer##5##4##(2008-9#5)
of a flow cytometric##2##4##(1994-6#1)(2011-2#1)
of a flow injection (FI)##2##5##(2008-10#2)
of a flow injection analysis (FIA) system##2##7##(2008-10#2)
of a flow injection analysis##3##5##(2008-10#3)
of a flow injection system for the##2##7##(2008-10#2)
of a flow injection##8##4##(2008-10#8)
of a flow##22##3##(1994-6#1)(2008-10#13)(2008-9#6)(2011-1#1)(2011-2#1)
of a flow-through type redox electrode detector##2##7##(2008-10#2)
of a flow-through##5##3##(2008-10#5)
of a fluid##3##3##(1991-9#1)(2008-2#1)(2011-2#1)
of a fluorescence##4##3##(2008-10#1)(2008-3#2)(2008-9#1)
of a fluorescent##8##3##(1992-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-4#1)
of a fluorometric-enzymatic method##2##4##(2008-10#2)
of a focal##3##3##(2008-2#1)(2008-3#2)
of a focused beam##2##4##(2008-2#1)(2008-3#1)
of a focused##10##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2011-1#1)
of a focusing##2##3##(2008-3#2)
of a follow-up of##2##4##(1991-6#1)(1993-6#1)
of a follow-up##5##3##(1990-3#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-6#1)
of a food##3##3##(1990-6#1)(2008-5#1)(2012-2#1)
of a foreign body##3##4##(2011-2#2)(2013-1#1)
of a foreign gene##2##4##(2008-10#1)(2008-11#1)
of a foreign##6##3##(2008-10#1)(2008-11#2)(2011-2#2)(2013-1#1)
of a former##2##3##(2008-11#2)
of a formulation##2##3##(2008-5#2)
of a founder effect##2##4##(2008-10#2)
of a four-level##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a fourth leader exon##2##5##(1990-11#2)
of a fourth##6##3##(1990-11#3)(1993-3#3)
of a fraction of the##2##5##(2008-10#1)(2008-3#1)
of a fraction of##3##4##(1992-5#1)(2008-10#1)(2008-3#1)
of a fracture##2##3##(2008-9#1)(2013-1#1)
of a fragment of##4##4##(1992-12#1)(1996-3#1)(2008-12#1)(2013-8#1)
of a fragrance##2##3##(2008-5#2)
of a framework for##2##4##(1995-2#1)(1995-5#1)
of a framework##4##3##(1995-2#1)(1995-5#1)(2008-10#1)(2012-12#1)
of a free radical##2##4##(1994-6#1)(2007-11#1)
of a free##5##3##(1993-12#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-4#1)
of a free-space optical##3##4##(2008-2#1)(2008-3#2)
of a freely propagating##2##4##(2007-11#1)(2007-12#1)
of a freely##3##3##(2007-11#1)(2007-12#1)(2010-5#1)
of a frequency-doubled##2##3##(2007-12#1)(2008-2#1)
of a frequency-modulated continuous-wave##3##4##(2008-3#3)
of a frequency-modulated##4##3##(2008-2#1)(2008-3#3)
of a full length##2##4##(1991-5#1)(1994-6#1)
of a full##10##3##(1991-5#1)(1994-6#1)(2008-10#2)(2008-3#2)(2008-5#2)(2009-11#1)(2013-8#1)
of a full-length cDNA encoding##3##5##(1991-2#1)(1994-12#2)
of a full-length cDNA##5##4##(1991-2#1)(1991-9#1)(1994-12#2)(1996-3#1)
of a full-length##9##3##(1991-2#1)(1991-9#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-9#1)
of a fully##8##3##(1993-1#1)(1993-11#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
of a function##2##3##(2007-11#2)
of a functional mobility assessment tool##2##6##(1993-12#2)
of a functional##25##3##(1991-6#1)(1992-8#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-3#1)(1995-11#2)(1995-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-10#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of a fundamental##7##3##(2007-12#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)
of a fungal##4##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-9#1)
of a fused-silica##3##3##(1997-2#1)(2007-11#1)(2007-12#1)
of a fusion protein##4##4##(1991-5#1)(1992-12#1)(1994-11#1)(2008-8#1)
of a fusion##5##3##(1991-5#1)(1992-12#1)(1994-11#1)(2008-8#1)(2012-3#1)
of a future##2##3##(2008-3#1)(2008-8#1)
of a fuzzy associative memory##3##5##(2007-12#3)
of a gap##2##3##(2007-11#1)(2008-11#1)
of a gas-diffusion##2##3##(2008-10#2)
of a gas-filled##2##3##(2007-11#2)
of a gaussian beam near the critical angle##3##8##(2008-3#3)
of a gaussian beam##6##4##(2008-2#3)(2008-3#3)
of a gene encoding##5##4##(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-6#1)
of a gene product##2##4##(1995-2#1)(2008-4#1)
of a gene that encodes##2##5##(1993-2#1)(2008-10#1)
of a gene##32##3##(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-2#3)(1996-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
of a general practice##2##4##(1993-12#1)(1997-5#1)
of a general##22##3##(1993-12#1)(1994-3#1)(1995-1#1)(1996-7#1)(1997-5#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-7#2)(2012-2#1)
of a generalized self-filtering unstable resonator (GSFUR)##2##7##(2008-2#1)(2008-3#1)
of a generalized##8##3##(2007-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-7#1)
of a genetic correlation between the##2##6##(1991-1#1)(2008-8#1)
of a genetic##13##3##(1991-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-8#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of a genomic##3##3##(1991-9#1)(1994-12#1)(2009-5#1)
of a geometrical##3##3##(2007-11#1)(2007-12#1)(2009-4#1)
of a geriatric assessment unit in##2##6##(1990-5#1)(1992-2#1)
of a geriatric##3##3##(1990-5#1)(1992-2#1)(2013-8#1)
of a giant##9##3##(2007-8#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#4)
of a given gene##3##4##(1997-9#1)(2008-8#1)(2011-2#1)
of a given protein##3##4##(2008-1#1)(2008-4#1)(2009-12#1)
of a given species##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
of a given##45##3##(1990-8#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1995-11#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-8#2)
of a glass capillary tube and##2##6##(2007-12#1)(2008-3#1)
of a glass electrode##2##4##(2008-10#2)
of a glass tube packed with##2##6##(2008-10#2)
of a glass tube##3##4##(2008-10#3)
of a glass##14##3##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#2)
of a glassy carbon electrode##7##5##(1990-12#1)(2008-10#6)
of a glial##2##3##(2008-11#1)(2012-1#1)
of a global##5##3##(2008-11#1)(2008-7#2)(2008-9#1)(2011-1#1)
of a glucose analogue inhibitor##2##5##(2010-2#2)
of a glucose##4##3##(2008-10#2)(2010-2#2)
of a good##8##3##(1992-2#1)(1992-3#1)(1996-2#1)(2008-11#2)(2008-7#1)(2010-10#1)(2013-1#1)
of a gradient-index##2##3##(2008-3#2)
of a graduate##2##3##(1991-12#1)(1993-12#1)
of a graft##2##3##(2010-3#1)(2011-3#1)
of a granulomatous##2##3##(2011-2#1)(2013-1#1)
of a grass pollen allergic patient##2##6##(2012-2#2)
of a grass##3##3##(2008-8#1)(2012-2#2)
of a grating##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
of a grazing-incidence##3##3##(2008-3#3)
of a great##3##3##(1994-1#1)(2008-10#1)(2012-3#1)
of a greater number of##2##5##(1993-12#1)(2007-8#1)
of a greater##6##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
of a green##5##3##(1995-9#1)(2008-10#3)(2008-3#1)
of a group of##16##4##(1990-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-1#1)(2012-3#1)
of a group##24##3##(1990-6#1)(1993-2#1)(1994-12#1)(1994-3#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of a growing number of##2##5##(1995-12#1)(2007-12#1)
of a growing##5##3##(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#2)
of a growth factor##2##4##(1990-7#2)
of a growth inhibitory##2##4##(1996-2#1)(2008-6#1)
of a growth##7##3##(1990-11#1)(1990-7#2)(1996-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
of a guidewire##4##3##(1997-6#1)(2010-12#3)
of a hand-held##3##3##(2008-10#2)(2008-11#1)
of a head##4##3##(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#1)
of a health care organization##2##5##(1995-1#1)(1997-1#1)
of a health care##7##4##(1991-1#1)(1994-12#1)(1995-1#2)(1997-1#1)(2008-12#1)(2013-1#1)
of a health center]##2##4##(1995-5#1)(1996-11#1)
of a health system##2##4##(2011-1#1)(2012-12#1)
of a health##19##3##(1990-12#1)(1991-1#1)(1993-3#2)(1994-12#2)(1995-1#3)(1995-12#1)(1995-5#1)(1996-11#1)(1997-1#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of a healthy volunteer##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
of a healthy##12##3##(1995-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-1#2)(2011-2#1)(2013-8#1)
of a heart##4##3##(1993-3#1)(1994-11#1)(2008-3#2)
of a heavy##3##3##(1996-12#1)(2008-10#2)
of a hemodialysis##2##3##(1996-2#1)(1996-3#1)
of a hepatic##2##3##(2008-3#1)(2008-9#1)
of a heptapeptide substrate##2##4##(1993-11#2)
of a herbal medicine##2##4##(2008-10#1)(2010-2#1)
of a hereditary##2##3##(1991-5#1)(2011-2#1)
of a heterodyne##2##3##(2007-11#1)(2008-3#1)
of a heterogeneous group of##2##5##(2008-5#1)(2012-3#1)
of a heterogeneous##6##3##(1995-12#1)(2008-5#1)(2008-8#2)(2009-3#1)(2012-3#1)
of a heterologous##2##3##(1997-3#1)(2008-5#1)
of a heterozygous##2##3##(2008-10#1)(2008-4#1)
of a heuristic##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
of a hexagonal##2##3##(2008-3#2)
of a hexamer##2##3##(1993-11#1)(1997-2#1)
of a high concentration of##2##5##(2008-10#1)(2009-12#1)
of a high concentration##3##4##(2008-10#1)(2008-7#1)(2009-12#1)
of a high density of##2##5##(2010-5#1)(2012-3#1)
of a high performance liquid chromatography##3##6##(2008-10#1)(2008-5#2)
of a high performance##4##4##(2008-10#1)(2008-5#2)(2011-2#1)
of a high proportion##2##4##(1991-6#1)(1992-3#1)
of a high throughput##2##4##(2008-10#2)
of a high##35##3##(1990-11#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-6#1)(2008-10#9)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of a high-affinity##2##3##(1993-6#1)(1995-5#1)
of a high-finesse##2##3##(2007-11#1)(2008-3#1)
of a high-power##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of a high-precision##2##3##(2007-11#1)(2008-10#1)
of a high-resolution##3##3##(2008-3#3)
of a high-risk##3##3##(1996-3#2)(2013-1#1)
of a high-speed##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
of a high-temperature##2##3##(2008-2#1)(2008-3#1)
of a high-throughput grazing-incidence flat-field spectrometer##2##6##(2008-3#2)
of a high-throughput##3##3##(2008-3#2)(2011-3#1)
of a higher order##2##4##(1990-11#1)(2008-2#1)
of a higher proportion of##2##5##(2008-11#1)(2011-1#1)
of a higher##10##3##(1990-11#1)(1991-5#1)(2008-10#3)(2008-11#3)(2008-2#1)(2011-1#1)
of a higher-order##6##3##(1993-11#1)(2007-11#3)(2007-12#1)(2008-2#1)
of a highly conserved microsatellite locus##2##6##(2010-8#2)
of a highly conserved##5##4##(1991-12#1)(2008-10#2)(2010-8#2)
of a highly reflecting##2##4##(2007-11#1)(2008-3#1)
of a highly sensitive##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
of a highly stable##2##4##(2007-11#1)(2008-3#1)
of a highly##31##3##(1991-12#1)(1992-3#1)(1993-9#1)(1995-2#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#2)(2013-1#1)
of a hip##2##3##(1993-11#1)(2009-3#1)
of a historical##2##3##(2008-3#1)(2011-2#1)
of a hollow##6##3##(1993-6#1)(1995-10#1)(2008-10#2)(2008-3#2)
of a hologram##2##3##(2007-11#1)(2008-3#1)
of a holographic grating##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of a holographic##9##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
of a home care##2##4##(1991-12#1)(1997-4#1)
of a home##7##3##(1991-12#1)(1993-11#1)(1994-12#1)(1996-5#1)(1997-4#1)(2006-5#1)(2007-12#1)
of a home-built##2##3##(2008-10#1)(2008-11#1)
of a homogeneous##4##3##(2008-10#3)(2008-3#1)
of a homologous series of##3##5##(1990-7#2)(1992-11#1)
of a homologous##4##3##(1990-7#2)(1992-11#1)(1996-9#1)
of a hospital merger##2##4##(1992-2#1)(1997-2#1)
of a hospital to##2##4##(1991-2#1)(1991-3#1)
of a hospital##14##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#3)(1992-2#1)(1992-9#1)(1993-12#1)(1994-1#1)(1996-1#1)(1997-2#1)(2007-12#1)(2009-5#1)
of a hospital-based##5##3##(1990-8#1)(1994-1#3)(1996-1#1)
of a host##8##3##(1991-2#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-8#2)
of a huge##4##3##(1997-8#1)(2008-7#1)(2011-1#2)
of a human alpha-1##2##4##(1992-8#1)(1995-2#1)
of a human cDNA##3##4##(1991-6#1)(1993-9#1)(1994-8#1)
of a human gene##2##4##(1995-12#1)(1995-8#1)
of a human prostatic##2##4##(1990-12#1)(1991-2#1)
of a human single-chain##2##4##(2008-8#1)(2009-2#1)
of a human##49##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#2)(2012-2#1)(2013-1#1)
of a hyaluronic acid preparation##3##5##(2013-1#3)
of a hyaluronic acid##4##4##(2008-5#1)(2013-1#3)
of a hybrid artificial liver##3##5##(2008-11#3)
of a hybrid##17##3##(1991-9#2)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#6)
of a hybridoma cell line##3##5##(1994-5#1)(2008-11#2)
of a hydrogel##2##3##(2008-5#1)(2010-12#1)
of a hydrogen bond##3##4##(1990-8#1)(1995-2#1)(2008-10#1)
of a hydrogen##4##3##(1990-8#1)(1991-3#1)(1995-2#1)(2008-10#1)
of a hydrophilic##2##3##(1995-2#2)
of a hydrophobic##2##3##(2008-10#1)(2008-11#1)
of a hypervascular##3##3##(2008-1#3)
of a hypomorphic rudimentary##2##4##(2008-9#2)
of a hypothetical##2##3##(2008-7#1)(2008-8#1)
of a jet##2##3##(2008-11#1)(2013-1#1)
of a joint transform correlator##2##5##(2008-3#2)
of a joint##8##3##(1994-3#2)(2007-12#1)(2008-2#1)(2008-3#3)(2013-1#1)
of a key##3##3##(1990-5#1)(1993-12#1)(2009-3#1)
of a kidney##2##3##(1990-2#1)(2011-2#1)
of a kinetically##3##3##(1991-9#1)(2007-12#1)(2008-10#1)
of a knee##3##3##(2013-1#3)
of a known##12##3##(1991-5#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-9#1)(2010-2#1)(2010-7#2)(2013-1#1)
of a l-lysine biosensor##2##4##(2008-10#2)
of a laboratory##7##3##(1996-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
of a lacZ##2##3##(1992-5#1)(1994-12#1)
of a lacZ-marked##2##3##(2009-12#2)
of a lack of##5##4##(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-1#1)
of a laminar##2##3##(1993-12#1)(2008-2#1)
of a large amount of##5##5##(2008-10#3)(2008-6#1)(2012-12#1)
of a large and##2##4##(2007-11#1)(2008-11#1)
of a large group of##2##5##(2008-10#1)(2011-2#1)
of a large nonspherical particle by##2##6##(2008-3#2)
of a large number of genes##2##6##(1996-12#1)(1996-6#1)
of a large number of new##2##6##(1994-3#1)(1997-3#1)
of a large number of samples##2##6##(1997-4#1)(2008-10#1)
of a large number of##31##5##(1990-12#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)
of a large##104##3##(1990-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#2)(1995-11#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#4)(2008-10#24)(2008-11#6)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#2)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of a large-scale##3##3##(2008-3#1)(2008-7#1)(2010-5#1)
of a larger complex##2##4##(1990-8#1)(1996-5#1)
of a larger##16##3##(1990-8#1)(1992-1#1)(1993-9#1)(1995-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-7#1)(2012-1#1)(2013-8#1)
of a laser beam##5##4##(2008-2#2)(2008-3#3)
of a laser diode to single-mode##2##6##(2008-3#2)
of a laser diode to##4##5##(2008-2#2)(2008-3#2)
of a laser diode with##2##5##(2008-3#2)
of a laser diode##14##4##(2007-12#3)(2008-2#4)(2008-3#7)
of a laser is##2##4##(2007-12#1)(2008-2#1)
of a laser##38##3##(1993-2#1)(2007-11#4)(2007-12#5)(2008-2#10)(2008-3#17)(2008-4#1)
of a laser-diode##2##3##(2007-12#1)(2008-3#1)
of a laser-pumped##2##3##(2008-2#1)(2008-3#1)
of a latent##4##3##(1995-6#1)(2009-11#1)(2010-12#1)(2012-12#1)
of a lateral shearing##2##4##(2008-2#1)(2008-3#1)
of a lawsuit filed by##2##5##(1995-12#2)
of a layer of##3##4##(2008-10#1)(2008-3#2)
of a layer##4##3##(2008-10#1)(2008-3#3)
of a layered##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
of a leaf##4##3##(2008-10#4)
of a learning##4##3##(1995-11#1)(2008-11#2)(2008-2#1)
of a least-squares method##2##4##(2008-3#2)
of a left##4##3##(1991-6#1)(2008-10#2)(2008-7#1)
of a lens and##3##4##(2007-12#1)(2008-2#2)
of a lens##14##3##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#5)
of a lesion##4##3##(2008-10#1)(2008-4#1)(2010-3#1)(2013-1#1)
of a less##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
of a level##2##3##(1991-6#1)(2011-2#1)
of a library##2##3##(1990-11#1)(2009-10#1)
of a lidar##3##3##(2008-2#1)(2008-3#2)
of a life course approach for##2##6##(2008-12#2)
of a life-threatening##2##3##(1991-8#1)(2008-11#1)
of a lifespan##2##3##(2008-11#1)(2010-3#1)
of a ligand##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
of a light beam can##2##5##(2008-3#2)
of a light beam##4##4##(2008-3#4)
of a light pulse##2##4##(2007-11#2)
of a light source##2##4##(2008-2#1)(2008-3#1)
of a light##11##3##(2007-11#2)(2008-2#2)(2008-3#7)
of a light-sheet##2##3##(2011-1#2)
of a limited number of##5##5##(1995-2#1)(2008-7#2)(2011-1#1)(2011-2#1)
of a limited##14##3##(1991-1#1)(1992-6#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#3)
of a limiting##2##3##(1994-11#1)(2008-8#1)
of a line##5##3##(1996-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
of a linear combination of##2##5##(2008-3#1)(2010-2#1)
of a linear correlation##2##4##(2008-2#1)(2008-3#1)
of a linear##14##3##(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#2)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
of a linearly##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a link##2##3##(1993-12#1)(2008-1#1)
of a lipid##3##3##(1994-5#1)(2008-10#1)(2010-5#1)
of a lipomatous##2##3##(2008-6#1)(2009-1#1)
of a liquid##13##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2009-6#2)
of a liquid's##2##3##(2008-3#2)
of a liquid-crystal display##3##4##(2008-3#2)(2010-9#1)
of a liquid-crystal spatial light modulator##3##6##(2007-11#1)(2008-3#2)
of a liquid-crystal##12##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#5)(2010-9#1)
of a literature review##2##4##(2008-11#1)(2011-1#1)
of a lithium##2##3##(1996-5#1)(2008-10#1)
of a live##2##3##(2008-3#1)(2008-7#1)
of a living##2##3##(2010-12#1)(2011-2#1)
of a local recurrence##2##4##(2008-6#2)
of a local##10##3##(1993-6#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#2)(2013-1#1)
of a localized##4##3##(2007-11#1)(2007-12#2)(2012-12#1)
of a locally##2##3##(1997-8#1)(2007-8#1)
of a locus##2##3##(1990-5#1)(1996-5#1)
of a logistic##2##3##(2008-10#2)
of a long journey##2##4##(2007-2#1)(2012-2#1)
of a long period grating##2##5##(2008-10#2)
of a long##16##3##(1991-5#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of a long-baseline Fabry-Perot cavity by##2##6##(2008-3#2)
of a long-period##2##3##(2007-11#1)(2008-3#1)
of a long-term care##2##4##(1995-3#1)(1997-3#1)
of a longer##2##3##(2008-5#1)(2012-2#1)
of a longitudinal##4##3##(1995-2#1)(1996-9#1)(2007-12#1)(2010-5#1)
of a low dose of##5##5##(1994-7#1)(1995-11#1)(2008-3#1)(2008-6#2)
of a low level of##3##5##(2008-11#1)(2008-3#2)
of a low molecular weight##3##5##(1992-9#1)(1995-5#1)(2008-10#1)
of a low temperature##2##4##(2008-10#2)
of a low##26##3##(1992-10#1)(1992-9#1)(1993-9#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-8#1)(2007-5#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2010-4#1)
of a low-carbohydrate##2##3##(2008-3#2)
of a low-cost##7##3##(1996-3#1)(2008-10#4)(2008-3#2)
of a low-fat##2##3##(1995-9#1)(1997-1#1)
of a low-finesse##2##3##(2008-3#2)
of a low-order tunable##2##4##(2008-2#1)(2008-3#1)
of a low-order##3##3##(2008-2#2)(2008-3#1)
of a lower##7##3##(1991-2#1)(1995-6#1)(2008-10#2)(2008-6#1)(2012-2#1)(2013-1#1)
of a lumbar##2##3##(2012-2#2)
of a lung nodule##3##4##(2010-9#3)
of a lung##4##3##(2007-12#1)(2010-9#3)
of a machine orientation##2##4##(1993-2#2)
of a magnet##2##3##(1990-12#2)
of a magnetic field##2##4##(2007-12#1)(2008-2#1)
of a magnetic##4##3##(1993-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
of a magneto-optical disk##2##4##(2008-2#1)(2008-3#1)
of a maize##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
of a major hemorrhage##2##4##(2012-1#2)
of a major##21##3##(1991-9#1)(1992-1#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-3#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-5#1)(2012-1#2)(2012-2#1)(2013-1#1)
of a majority of##3##4##(1994-2#1)(2008-6#1)(2008-7#1)
of a male patient##2##4##(2008-2#1)(2010-3#1)
of a male##6##3##(2008-1#1)(2008-2#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
of a malignant##5##3##(1991-9#1)(1995-4#1)(1996-6#1)(2008-1#1)(2009-5#1)
of a mammalian##4##3##(1993-11#1)(1994-12#1)(1997-7#2)
of a man##6##3##(1995-12#1)(1997-3#1)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#1)
of a managed care##3##4##(1994-2#1)(1996-1#1)(2006-10#1)
of a mandatory##2##3##(1994-1#1)(2008-10#1)
of a mandibular first molar with##2##6##(2012-12#2)
of a mandibular##4##3##(1997-5#1)(2012-12#2)(2012-2#1)
of a manual##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
of a mapping population##2##4##(2008-10#1)(2008-5#1)
of a mass disaster##4##4##(1995-11#4)
of a mass##7##3##(1995-11#4)(2008-10#1)(2008-5#1)(2012-2#1)
of a material##4##3##(2008-2#2)(2009-12#1)(2010-7#1)
of a mathematical model##5##4##(1991-2#1)(1995-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
of a mature##4##3##(2011-3#2)(2012-3#1)(2013-1#1)
of a maxillary##5##3##(1990-3#1)(2013-1#4)
of a maximum##2##3##(2011-2#1)(2013-8#1)
of a means##2##3##(1996-12#1)(2008-10#1)
of a measure of##2##4##(1997-3#1)(2008-8#1)
of a measure##3##3##(1997-3#1)(2008-8#1)(2009-11#1)
of a mechanical##3##3##(2008-10#1)(2008-3#2)
of a mechanically##2##3##(1994-6#1)(2008-3#1)
of a mechanism##2##3##(1992-5#1)(2008-7#1)
of a medical##11##3##(1991-2#1)(1993-1#1)(1994-12#1)(1997-2#1)(2007-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#3)
of a medium##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of a member of the family##8##6##(2011-2#8)
of a member of the genus##8##6##(2011-2#8)
of a member of the##20##5##(2008-11#1)(2011-2#19)
of a member of##21##4##(2008-11#1)(2010-10#1)(2011-2#19)
of a member##22##3##(2008-11#1)(2010-10#1)(2011-2#20)
of a membrane oxygenator##2##4##(2007-8#2)
of a membrane##5##3##(1995-6#1)(2007-8#2)(2008-10#1)(2008-7#1)
of a meningioma##2##3##(2008-7#2)
of a mental health##4##4##(2008-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
of a mercury electrode##2##4##(1990-5#1)(2008-10#1)
of a mercury##3##3##(1990-5#1)(2008-10#2)
of a meta-analysis of the##2##5##(1995-2#1)(1997-7#1)
of a meta-analysis of##3##4##(1995-2#1)(1997-7#1)(2008-9#1)
of a metabolic pathway##2##4##(1990-12#1)(1994-9#1)
of a metabolic##5##3##(1990-12#1)(1994-9#1)(2008-10#2)(2008-11#1)
of a metabotropic glutamate receptor##4##5##(1991-2#2)(1995-12#1)(1997-2#1)
of a metal##11##3##(1996-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)
of a metal-oxide-semiconductor field-effect##2##4##(2009-5#2)
of a metallic film##2##4##(2008-3#2)
of a metallic##6##3##(2008-3#4)(2008-7#1)(2012-2#1)
of a metapopulation##3##3##(2008-8#2)(2008-9#1)
of a methanol##2##3##(2007-11#1)(2011-1#1)
of a method for the determination of##3##7##(2008-10#3)
of a method for the##4##5##(2008-10#4)
of a method for##6##4##(2008-10#6)
of a method of##4##4##(1997-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
of a method to##3##4##(1997-7#1)(2008-11#1)(2011-1#1)
of a method##17##3##(1997-2#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
of a methodology to##2##4##(1990-3#1)(2007-6#1)
of a methodology##3##3##(1990-3#1)(2007-6#1)(2008-10#1)
of a methylene group to##2##5##(2008-10#2)
of a methylene group##3##4##(2008-10#3)
of a micro-optic##2##3##(2008-3#2)
of a microbial##2##3##(1993-6#1)(2008-10#1)
of a microelectromechanical mirror##2##4##(2007-11#2)
of a microlens array##3##4##(2007-11#2)(2008-3#1)
of a microlens##5##3##(2007-11#2)(2008-3#3)
of a micropump##2##3##(2008-10#2)
of a microscope##4##3##(2008-3#1)(2008-5#1)(2008-9#2)
of a microscopic object##3##4##(2008-3#3)
of a microscopic##5##3##(2008-2#1)(2008-3#3)(2012-2#1)
of a microsomal retinol dehydrogenase##2##5##(1995-5#2)
of a microsphere##2##3##(2007-12#1)(2008-9#1)
of a microwave##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
of a mid-infrared##2##3##(2008-3#2)
of a mild##4##3##(1997-8#1)(2008-1#1)(2008-2#1)(2009-2#1)
of a miniature##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
of a miniaturized##2##3##(2010-5#2)
of a minicolumn##2##3##(2008-10#2)
of a minimal tiling path##2##5##(2012-3#2)
of a minimal##4##3##(1995-2#1)(2009-5#1)(2012-3#2)
of a minimum amount of##2##5##(1997-8#1)(2008-4#1)
of a minimum of##2##4##(2008-10#1)(2013-8#1)
of a minimum##7##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
of a minor##3##3##(1992-3#1)(1992-5#1)(2008-4#1)
of a mirror##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of a misdiagnosed Brodie's abscess##2##5##(2012-2#2)
of a mitochondrial##2##3##(1994-8#1)(1996-10#1)
of a mixed##10##3##(1994-12#1)(1995-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2013-8#1)
of a mixture containing##5##4##(2008-10#4)(2008-3#1)
of a mixture of##24##4##(1990-12#1)(1990-8#1)(1990-9#1)(1992-10#1)(1995-2#1)(2007-12#1)(2008-10#16)(2008-8#1)(2013-1#1)
of a mixture##32##3##(1990-12#1)(1990-8#1)(1990-9#1)(1992-10#1)(1995-2#1)(2007-12#1)(2008-10#23)(2008-3#1)(2008-8#1)(2013-1#1)
of a mobile##2##3##(1992-5#1)(2008-7#1)
of a mock##2##3##(2008-8#1)(2010-7#1)
of a mode##2##3##(2007-12#1)(2008-2#1)
of a mode-locked Cr##4##4##(2007-12#4)
of a mode-locked Nd##2##4##(2008-2#2)
of a mode-locked laser##2##4##(2007-11#1)(2008-3#1)
of a mode-locked##12##3##(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#2)
of a model for##7##4##(1996-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
of a model liquid crystal##2##5##(2008-10#2)
of a model of##4##4##(1996-1#1)(2007-12#1)(2008-3#1)(2013-8#1)
of a model substrate##2##4##(2008-10#1)(2008-4#1)
of a model##41##3##(1990-11#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-8#1)
of a moderately##2##3##(2008-3#2)
of a modern##6##3##(1994-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
of a modified##22##3##(1990-8#1)(1995-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2011-2#2)
of a modular##3##3##(2008-3#1)(2011-2#2)
of a modulated##2##3##(2007-12#1)(2008-3#1)
of a molecular##8##3##(1993-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
of a molecule##3##3##(1991-5#1)(2008-10#1)(2008-2#1)
of a monochromatic##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of a monoclonal antibody to##3##5##(1992-6#1)(1995-2#1)(2008-4#1)
of a monoclonal antibody##7##4##(1992-6#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-3#1)
of a monoclonal##10##3##(1992-5#1)(1992-6#1)(1994-8#1)(1995-2#2)(2008-11#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
of a monolayer of##2##4##(2008-5#1)(2009-3#1)
of a monolayer##3##3##(2008-5#1)(2009-3#1)(2010-4#1)
of a monolayered epithelium##2##4##(2007-12#1)(2008-7#1)
of a monolithically integrated##2##4##(2007-11#2)
of a monomer##2##3##(2008-11#1)(2009-10#1)
of a monomeric##3##3##(1992-6#1)(1993-11#1)(1997-6#1)
of a more complex##2##4##(1996-11#1)(2010-12#1)
of a more fundamental##2##4##(2008-3#1)(2009-4#1)
of a more##22##3##(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#3)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#3)
of a mouse cDNA##2##4##(1993-8#1)(1997-7#1)
of a mouse##12##3##(1993-8#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
of a moving##6##3##(2007-12#2)(2008-10#1)(2009-8#2)(2011-2#1)
of a multi-frequency laser##2##4##(2008-10#2)
of a multi-site##2##3##(1995-3#1)(2009-5#1)
of a multicenter series of##3##5##(1990-12#2)(1991-8#1)
of a multicentre##2##3##(1990-3#1)(2007-12#1)
of a multichannel##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)
of a multicore fiber##2##4##(2007-11#2)
of a multidimensional##4##3##(1992-12#1)(1997-1#1)(2007-7#1)(2008-2#1)
of a multidisciplinary approach##5##4##(1991-2#1)(2009-10#1)(2013-1#3)
of a multidisciplinary pain##2##4##(1994-1#1)(2013-1#1)
of a multidisciplinary program to quit##2##6##(2013-8#2)
of a multidisciplinary##18##3##(1991-2#1)(1994-1#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-12#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
of a multigene family##4##4##(1991-6#1)(1993-6#1)(1994-11#1)(1996-12#1)
of a multigene##5##3##(1991-6#1)(1993-6#1)(1994-11#1)(1996-12#2)
of a multilayer##8##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)
of a multilevel##3##3##(2008-3#2)(2012-12#1)
of a multimode laser##2##4##(1992-11#1)(2008-3#1)
of a multimode##5##3##(1992-11#1)(2007-11#1)(2008-2#1)(2008-3#2)
of a multiple##4##3##(2008-4#2)(2008-5#2)
of a multiple-component##2##3##(1995-6#1)(2008-8#1)
of a multisensor##2##3##(2008-10#2)
of a multistep##2##3##(2008-10#1)(2011-2#1)
of a multitude of##2##4##(2008-1#1)(2008-7#1)
of a multivariate calibration model##2##5##(2008-10#2)
of a multivariate calibration##3##4##(2008-10#3)
of a multivariate##4##3##(2008-10#4)
of a multiwavelength##2##3##(2008-3#2)
of a murine hybridoma##4##4##(2008-11#3)(2008-7#1)
of a murine##17##3##(1991-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-9#1)
of a muscular##2##3##(1993-3#1)(2007-12#1)
of a mutant##6##3##(1993-11#1)(1995-8#1)(1995-9#1)(2008-11#1)(2008-4#1)(2008-8#1)
of a mutated##2##3##(1993-6#1)(1996-5#1)
of a mutation in the##2##5##(1991-12#1)(2010-4#1)
of a mutation in##3##4##(1991-12#1)(2010-4#1)(2013-1#1)
of a mutation##6##3##(1991-12#1)(1994-8#1)(1997-7#1)(2010-4#2)(2013-1#1)
of a nanotube##2##3##(2008-7#2)
of a narrow##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of a narrow-band##2##3##(2007-12#1)(2008-2#1)
of a nasopharyngeal##2##3##(2008-12#1)(2011-2#1)
of a national health##2##4##(1994-12#1)(1994-2#1)
of a national##14##3##(1992-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
of a nationwide##2##3##(1992-12#1)(1995-1#1)
of a native##2##3##(2008-10#1)(2011-2#1)
of a natural disaster on##2##5##(1991-2#2)
of a natural##14##3##(1990-2#1)(1991-2#2)(1997-3#2)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-5#1)
of a naturally occurring##4##4##(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#1)
of a near-field##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of a near-infrared##5##3##(2008-10#3)(2008-3#2)
of a nearly##5##3##(1995-3#1)(2008-2#1)(2008-3#2)(2011-3#1)
of a negative##7##3##(1992-5#1)(1993-8#1)(2007-11#2)(2008-10#1)(2009-11#1)(2009-8#1)
of a neighboring##2##3##(2007-11#1)(2012-3#1)
of a neodymium-doped##2##3##(2008-2#1)(2008-3#1)
of a nested polymerase chain reaction##2##6##(1992-9#1)(2012-3#1)
of a nested##5##3##(1992-9#1)(1994-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
of a network of##3##4##(2008-1#1)(2008-5#1)(2011-2#1)
of a network##5##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
of a neural network##2##4##(2008-10#1)(2008-3#1)
of a neural##5##3##(1993-6#1)(2008-10#1)(2008-3#3)
of a neuroendocrine##2##3##(1997-7#1)(2008-12#1)
of a neuropeptide##2##3##(1990-7#1)(1994-11#1)
of a neutral##7##3##(1994-8#1)(2007-12#1)(2008-10#3)(2008-9#1)(2013-1#1)
of a new and##4##4##(2007-12#1)(2008-10#1)(2009-8#1)(2010-4#1)
of a new approach##3##4##(1992-1#1)(2008-5#1)(2008-6#1)
of a new calibration##2##4##(2007-12#1)(2008-10#1)
of a new class of##7##5##(1991-3#1)(1996-7#1)(2008-11#1)(2008-5#1)(2009-9#1)(2013-1#2)
of a new desensitizing dentifrice containing 8##2##7##(2011-2#2)
of a new discipline##2##4##(2010-1#1)(2013-1#1)
of a new era in##2##5##(2008-11#1)(2009-5#1)
of a new era##4##4##(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
of a new extraction##2##4##(2008-10#2)
of a new family of##2##5##(2008-3#1)(2012-2#1)
of a new gene##2##4##(2008-8#2)
of a new group of##2##5##(2007-11#1)(2008-10#1)
of a new lignin peroxidase##2##5##(1990-12#2)
of a new material##2##4##(2008-10#1)(2008-2#1)
of a new method##3##4##(2007-11#1)(2008-10#1)(2009-2#1)
of a new model of##2##5##(1995-3#1)(2010-4#1)
of a new soya biopeptide##2##5##(2008-5#2)
of a new species##3##4##(2008-10#1)(2008-5#1)(2010-9#1)
of a new trial##3##4##(1996-6#3)
of a new type of##12##5##(1992-6#1)(1994-1#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
of a new type##15##4##(1992-6#1)(1994-1#1)(2008-10#6)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
of a new##212##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-1#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#49)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#9)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#4)(2013-8#1)
of a newborn##4##3##(2008-10#2)(2012-12#2)
of a newly developed##3##4##(1997-7#1)(2007-7#1)(2008-11#1)
of a newly identified##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
of a newly synthesized##2##4##(2008-10#1)(2009-9#1)
of a newly##12##3##(1994-12#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)
of a nickel##2##3##(2008-10#2)
of a nitric oxide##2##4##(1996-5#1)(2011-2#1)
of a nitrogen##3##3##(2008-10#3)
of a non##2##3##(2008-10#1)(2012-2#1)
of a non-ionic surfactant##2##4##(1994-9#1)(2008-10#1)
of a non-ionic##3##3##(1994-9#1)(1997-7#1)(2008-10#1)
of a non-specific##2##3##(1997-8#1)(2008-5#1)
of a nonfunctional##2##3##(1997-8#1)(2012-2#1)
of a noninvasive##5##3##(2008-11#1)(2008-2#2)(2008-9#1)(2009-11#1)
of a nonlinear mode in a cylindrical##2##7##(2007-12#2)
of a nonlinear##13##3##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#4)
of a normal##10##3##(1991-5#1)(1995-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
of a novel anti-perspirant roll-on formulation##2##6##(2008-5#2)
of a novel antiatheromatous agent##2##5##(1990-7#2)
of a novel cDNA##2##4##(1995-6#1)(2008-4#1)
of a novel class of##4##5##(1990-12#1)(1991-2#1)(2007-12#1)(2009-3#1)
of a novel functional##2##4##(1994-12#1)(2008-10#1)
of a novel gene##2##4##(1995-8#1)(1996-10#1)
of a novel human##3##4##(1993-11#1)(1996-2#1)(1997-8#1)
of a novel mechanism##3##4##(1992-12#1)(2010-11#1)(2012-2#1)
of a novel member of##2##5##(1994-12#1)(2008-9#1)
of a novel method##2##4##(2008-10#1)(2012-2#1)
of a novel type of##2##5##(2007-12#1)(2008-3#1)
of a novel type##3##4##(1990-5#1)(2007-12#1)(2008-3#1)
of a novel##126##3##(1990-12#1)(1990-5#4)(1990-7#4)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-11#2)(1993-2#1)(1994-1#1)(1994-12#4)(1994-6#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-4#1)(1997-7#4)(1997-8#2)(2007-11#4)(2007-12#6)(2007-8#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
of a nuclear##4##3##(1990-8#1)(1994-11#1)(2008-3#1)(2008-9#1)
of a nucleotide##3##3##(1997-2#1)(2008-4#1)(2013-8#1)
of a null lens##2##4##(2008-3#2)
of a null##3##3##(1996-4#1)(2008-3#2)
of a number of different##2##5##(2008-10#1)(2008-11#1)
of a number of genes##3##5##(1992-8#1)(1996-12#1)(2010-8#1)
of a number of important##4##5##(1997-3#1)(2008-10#1)(2008-8#1)(2010-8#1)
of a number of key##2##5##(1993-12#1)(2008-10#1)
of a number of new##2##5##(2008-10#1)(2008-4#1)
of a number of possible##3##5##(2008-10#1)(2008-3#1)(2008-9#1)
of a number of##93##4##(1990-11#1)(1990-8#2)(1991-12#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#7)(2009-2#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
of a numerical model##2##4##(2007-11#1)(2008-3#1)
of a numerical##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
of a nurse practitioner##2##4##(2007-11#1)(2008-1#1)
of a nurse##4##3##(2007-11#1)(2008-1#2)(2008-11#1)
of a nursing##6##3##(1992-2#1)(1994-3#1)(2008-11#1)(2008-7#2)(2012-3#1)
of a one-dimensional##5##3##(2008-2#1)(2008-3#4)
of a pH##5##3##(1993-8#1)(1995-2#1)(2008-10#3)
of a painful swelling##2##4##(2007-6#1)(2008-7#1)
of a painful##3##3##(2007-6#1)(2008-7#1)(2008-9#1)
of a pair of##12##4##(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#2)(2008-8#2)
of a panel of##4##4##(1993-9#1)(1995-3#1)(2008-11#1)(2010-9#1)
of a paper##2##3##(2008-10#1)(2012-2#1)
of a parabolic##2##3##(2008-3#2)
of a parasite##3##3##(1991-2#1)(2008-8#1)(2008-9#1)
of a parasitoid##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
of a parathyroid adenoma##2##4##(2012-1#2)
of a paraxial focus##2##4##(2008-2#2)
of a parent##3##3##(1991-12#1)(1991-2#1)(2008-11#1)
of a partial##4##3##(1992-8#1)(1992-9#1)(1996-5#1)(2008-7#1)
of a partially##4##3##(1991-12#1)(1995-3#1)(2007-11#1)(2008-3#1)
of a particle in##2##4##(2008-2#2)
of a particle##7##3##(2008-10#1)(2008-2#3)(2008-3#2)(2009-6#1)
of a particular Al species##2##5##(2008-10#2)
of a particular disease##2##4##(1997-8#1)(2012-2#1)
of a particular##31##3##(1990-7#1)(1992-1#1)(1993-12#1)(1993-6#1)(1995-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
of a partnership##4##3##(1992-3#1)(1996-3#1)(2008-12#2)
of a passive##2##3##(2007-12#1)(2008-3#1)
of a passively##2##3##(2007-11#1)(2008-2#1)
of a patent ductus arteriosus##2##5##(1997-8#1)(2007-9#1)
of a patent foramen ovale##2##5##(2007-10#1)(2007-8#1)
of a patent##5##3##(1997-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)
of a pathogen##9##3##(2008-10#7)(2008-8#1)(2008-9#1)
of a pathogenic##2##3##(2008-10#2)
of a pathological##2##3##(1990-6#1)(2007-11#1)
of a pathology##2##3##(1996-6#1)(2011-2#1)
of a patient classification system##2##5##(1994-3#1)(1995-2#1)
of a patient from##2##4##(2007-12#1)(2013-1#1)
of a patient of##2##4##(2008-7#1)(2013-1#1)
of a patient to##2##4##(1990-6#1)(2012-12#1)
of a patient who had##2##5##(1993-8#1)(1995-3#1)
of a patient who##8##4##(1993-8#2)(1995-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
of a patient with AIDS##2##5##(2007-12#1)(2009-2#1)
of a patient with a##3##5##(2008-12#1)(2008-6#1)(2008-7#1)
of a patient with acute##2##5##(1994-12#1)(2008-5#1)
of a patient with an##2##5##(2013-1#2)
of a patient with cervicogenic headache##2##6##(2008-12#2)
of a patient with myasthenia gravis##2##6##(2012-2#1)(2012-3#1)
of a patient with##40##4##(1990-8#1)(1991-11#1)(1994-12#1)(1994-3#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#5)
of a patient##79##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#1)(1993-2#1)(1993-6#3)(1993-8#2)(1994-12#2)(1994-3#2)(1995-2#2)(1995-3#2)(1995-9#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#1)
of a patient's##9##3##(1991-12#1)(1993-12#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#2)(2012-1#1)
of a pattern##2##3##(1991-3#1)(2010-6#1)
of a peak##2##3##(1991-12#1)(2008-3#1)
of a pediatric##2##3##(2007-12#1)(2011-2#1)
of a pelvic##3##3##(1991-2#1)(2008-12#1)(2008-6#1)
of a penetrating##2##3##(2007-10#1)(2013-1#1)
of a pepper isolate of potato virus##2##7##(2008-10#2)
of a peptide##14##3##(1991-9#1)(1992-5#1)(1994-11#2)(1994-8#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-6#1)(2012-2#1)
of a percutaneous##2##3##(2008-10#1)(2012-3#1)
of a perfect##2##3##(1990-5#1)(2008-2#1)
of a perfectly matched layer##2##5##(2008-3#1)(2013-7#1)
of a performance##2##3##(2007-11#1)(2013-1#1)
of a periodic##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
of a periodically##4##3##(2007-12#3)(2008-10#1)
of a permanent##4##3##(2007-7#2)(2010-1#1)(2011-2#1)
of a persistent##3##3##(1991-12#1)(2010-4#1)(2010-8#1)
of a persistently##2##3##(1992-9#1)(1997-8#1)
of a person who##2##4##(2007-11#1)(2008-2#1)
of a person##7##3##(1991-12#1)(1993-6#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
of a person's##2##3##(2008-10#1)(2013-8#1)
of a personal##6##3##(1990-2#1)(1993-6#2)(1995-2#1)(2008-11#1)(2008-3#1)
of a pharmacodynamic effect##2##4##(2008-5#2)
of a phase II study##3##5##(1993-6#1)(1994-2#1)(1995-10#1)
of a phase mask##2##4##(2008-2#2)
of a phase##11##3##(1993-6#1)(1994-2#1)(1995-10#1)(2008-2#4)(2008-3#3)(2009-11#1)
of a phase-conjugate##2##3##(2007-12#1)(2008-2#1)
of a phenyl##2##3##(1995-3#1)(2008-4#1)
of a phenylalanine##2##3##(1992-9#1)(1994-5#1)
of a photoactive##2##3##(2007-12#1)(2008-10#1)
of a photodiode##2##3##(2008-10#1)(2008-3#1)
of a photomultiplier##2##3##(2007-11#1)(2008-10#1)
of a photon##2##3##(2008-10#1)(2008-3#1)
of a photonic bandgap##2##4##(2007-12#2)
of a photonic##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
of a photopolymer##2##3##(2008-3#2)
of a photorefractive##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a phylogenetic tree##3##4##(1991-5#1)(2008-8#1)(2009-10#1)
of a physical##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
of a physically##2##3##(2008-3#1)(2009-12#1)
of a physician##2##3##(1993-12#1)(1996-2#1)
of a physician's##2##3##(1994-1#1)(1997-2#1)
of a picosecond##4##3##(2007-11#1)(2007-12#3)
of a piezoelectric transducer##2##4##(2007-12#1)(2008-3#1)
of a piezoelectric##9##3##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#2)
of a pilot study##3##4##(2008-11#1)(2010-9#1)(2012-1#1)
of a pilot##9##3##(1993-1#1)(1994-1#1)(1994-11#1)(1994-3#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-9#1)(2012-1#1)
of a pineal##2##3##(2008-7#2)
of a pinhole##2##3##(2007-12#1)(2008-3#1)
of a pixelated##3##3##(2007-11#2)(2008-3#1)
of a placebo##4##3##(1992-5#1)(1993-3#1)(2008-5#1)(2012-2#1)
of a plan##2##3##(1992-1#1)(2008-11#1)
of a planar##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
of a plane##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of a plant##9##3##(1993-2#1)(1995-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)
of a plasma sample was##2##5##(1990-8#2)
of a plasma##7##3##(1990-5#1)(1990-8#2)(2007-12#2)(2008-3#1)(2008-4#1)
of a plastic##3##3##(2008-2#1)(2008-3#1)(2009-3#1)
of a plate##3##3##(2008-3#2)(2013-1#1)
of a platinum##2##3##(2008-10#2)
of a point##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
of a point-source integrating-cavity absorption meter##2##6##(2008-3#2)
of a pointlike##2##3##(2008-3#2)
of a polar##2##3##(1995-2#1)(2009-10#1)
of a polarimetric##2##3##(2007-11#1)(2008-2#1)
of a polarization##4##3##(2007-11#1)(2008-3#3)
of a polarization-maintaining##2##3##(2007-11#2)
of a polarized##2##3##(1994-9#1)(2008-3#1)
of a polyclonal##3##3##(1992-8#1)(2008-10#2)
of a polymer##6##3##(1996-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
of a polymerase chain##4##4##(1996-12#1)(2008-10#2)(2012-2#1)
of a polyp##2##3##(1993-3#1)(2012-12#1)
of a polypeptide##2##3##(1991-2#1)(2010-7#1)
of a polypill##2##3##(2011-1#2)
of a polystyrene##2##3##(2008-3#2)
of a pool of##3##4##(1993-6#1)(2008-11#1)(2010-2#1)
of a poor##6##3##(1993-11#2)(2007-2#1)(2007-6#1)(2008-3#1)(2010-12#1)
of a population is##2##4##(2009-2#1)(2012-2#1)
of a population of##5##4##(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
of a population sample of##2##5##(1990-8#1)(1992-2#1)
of a population##23##3##(1990-8#1)(1992-2#1)(1995-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#4)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
of a population's##2##3##(1997-7#1)(2011-1#1)
of a portable##6##3##(1997-4#1)(2008-10#3)(2008-2#1)(2009-10#1)
of a portfolio##2##3##(2008-12#2)
of a portion of the##2##5##(2008-10#2)
of a positive and a negative##2##6##(1990-3#1)(2009-2#1)
of a positive##21##3##(1990-3#1)(1990-6#1)(1991-2#1)(1992-5#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(2007-12#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)
of a positively##2##3##(1992-8#1)(2008-11#1)
of a possible##15##3##(1990-6#1)(1993-2#1)(1993-3#2)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#2)
of a posterior##9##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-12#2)
of a potato##2##3##(2008-12#1)(2009-6#1)
of a potent##2##3##(1992-8#1)(1994-12#1)
of a potential##17##3##(1992-2#1)(1993-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#2)
of a potentially##2##3##(2008-12#1)(2008-9#1)
of a potentiometric sensor##2##4##(2008-10#2)
of a potentiometric##5##3##(2008-10#5)
of a potyvirus##2##3##(2008-10#1)(2008-9#1)
of a power plant##2##4##(2008-10#1)(2010-8#1)
of a power##5##3##(1992-9#1)(2008-10#1)(2008-6#1)(2010-3#1)(2010-8#1)
of a power-recycled##2##3##(2008-2#1)(2008-3#1)
of a practical##8##3##(2008-10#1)(2008-2#2)(2008-3#4)(2012-3#1)
of a practice##2##3##(2007-7#1)(2008-11#1)
of a pre-registration##2##3##(2008-11#2)
of a predator##3##3##(2008-4#1)(2009-8#1)(2012-3#1)
of a pregnancy##4##3##(2007-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of a pregnant##3##3##(1997-4#1)(1997-7#1)(2008-10#1)
of a premorbid diagnosis of ADHD##2##6##(2013-8#2)
of a preoperative##2##3##(2007-11#1)(2012-3#1)
of a pressure##2##3##(2009-10#1)(2011-1#1)
of a presumptive##3##3##(1993-8#1)(1993-9#1)(2008-10#1)
of a preterm infant##2##4##(1994-3#2)
of a previous study##4##4##(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)
of a previous##11##3##(1996-3#1)(2006-10#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#2)
of a previously derived##3##4##(2007-12#2)(2008-3#1)
of a previously described##3##4##(1994-8#1)(2008-11#1)(2008-2#1)
of a previously healthy##2##4##(2007-12#1)(2009-3#1)
of a previously published##2##4##(1992-11#1)(2008-11#1)
of a previously reported##2##4##(2008-10#1)(2012-12#1)
of a previously unknown##2##4##(1995-2#1)(2012-12#1)
of a previously##25##3##(1991-5#1)(1992-11#1)(1992-3#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-7#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#2)
of a primarily##2##3##(2006-10#1)(2008-2#1)
of a primary care##3##4##(1994-3#1)(1996-11#1)(2008-11#1)
of a primary##14##3##(1994-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#3)
of a prior##3##3##(2010-6#2)(2012-3#1)
of a priori##3##3##(2008-2#1)(2008-3#2)
of a prism##2##3##(2008-3#2)
of a private##3##3##(1991-12#1)(1993-2#1)(1995-6#1)
of a probability##2##3##(2008-3#1)(2011-2#1)
of a probe##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
of a problem##3##3##(2008-9#1)(2012-2#1)(2013-8#1)
of a procedure for##3##4##(1997-3#1)(2008-10#1)(2008-5#1)
of a procedure##5##3##(1997-3#1)(2008-10#3)(2008-5#1)
of a process##7##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-6#2)(2013-8#1)
of a processed pseudogene##2##4##(1991-6#1)(1997-4#1)
of a processing##3##3##(2008-2#1)(2008-3#2)
of a product##6##3##(2008-10#2)(2008-5#3)(2008-7#1)
of a professional##3##3##(1991-6#1)(1993-3#1)(1996-2#1)
of a progeny##2##3##(2008-10#2)
of a program for##2##4##(1995-3#1)(2008-12#1)
of a program of preventive activities##2##6##(1993-11#1)(1993-3#1)
of a program of##4##4##(1993-11#1)(1993-3#1)(1996-6#1)(2008-3#1)
of a program##12##3##(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)
of a progressive##2##3##(2008-10#1)(2012-2#1)
of a project##4##3##(1991-12#1)(1995-12#1)(2008-10#1)(2009-10#1)
of a promoter##2##3##(1990-12#1)(1993-12#1)
of a properly##2##3##(1996-3#1)(2007-11#1)
of a proposed##3##3##(1997-7#1)(1997-8#1)(2008-3#1)
of a prospective payment##2##4##(1994-3#2)
of a prospective randomized##2##4##(1993-9#1)(2008-7#1)
of a prospective##7##3##(1993-9#1)(1994-3#2)(1997-3#1)(2008-7#1)(2008-8#1)(2009-5#1)
of a prostatic##2##3##(1991-2#1)(1992-2#1)
of a protected##2##3##(2013-7#2)
of a protective##2##3##(2008-10#1)(2011-1#1)
of a protein in##2##4##(2008-11#1)(2008-4#1)
of a protein inhibitor##2##4##(1993-3#1)(1994-6#1)
of a protein is coupled##2##5##(1993-11#1)(2008-9#1)
of a protein is##3##4##(1993-11#1)(2008-4#1)(2008-9#1)
of a protein substrate##2##4##(1995-2#1)(2008-4#1)
of a protein that##2##4##(1995-12#1)(2008-8#1)
of a protein##43##3##(1991-2#1)(1991-5#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-8#2)(1997-2#3)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-4#9)(2008-8#1)(2008-9#3)(2013-8#1)
of a protein-free diet or food restriction on the immune system##2##11##(1993-12#2)
of a protein-free##3##3##(1993-12#2)(2008-11#1)
of a protocol for##2##4##(2007-8#1)(2008-11#1)
of a protocol##4##3##(1997-1#1)(2007-11#1)(2007-8#1)(2008-11#1)
of a proton##4##3##(1991-8#1)(1992-10#1)(1992-6#1)(2008-10#1)
of a prototype sensor is##2##5##(2008-2#1)(2008-3#1)
of a prototype##10##3##(1991-9#1)(1994-5#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-3#1)
of a psychiatric##3##3##(1996-8#1)(2008-4#1)(2012-12#1)
of a public good##3##4##(1993-2#1)(2008-10#1)(2012-3#1)
of a public health##3##4##(1991-3#1)(1997-2#1)(2011-2#1)
of a public##9##3##(1991-3#1)(1993-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
of a publicly##2##3##(1992-2#1)(2008-5#1)
of a pulmonary##2##3##(1993-3#1)(2007-6#1)
of a pulp##2##3##(2008-10#1)(2008-3#1)
of a pulse##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
of a pulsed Nd##2##4##(2008-2#1)(2008-3#1)
of a pulsed coherent##2##4##(2008-2#1)(2008-3#1)
of a pulsed laser##2##4##(2007-12#1)(2008-3#1)
of a pulsed##14##3##(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#9)
of a pump beam##2##4##(2007-11#2)
of a pump##6##3##(2007-11#4)(2007-12#2)
of a pure##3##3##(2008-2#1)(2008-6#1)(2012-1#1)
of a purely##2##3##(2007-11#1)(2007-12#1)
of a purified##5##3##(1991-5#1)(1995-2#1)(1995-5#1)(2008-4#1)(2011-2#1)
of a purine##2##3##(1992-4#1)(2008-3#1)
of a putative##9##3##(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-4#2)(2008-1#1)(2009-11#1)
of a quadrat##2##3##(2008-10#1)(2008-8#1)
of a qualitative##5##3##(1996-1#1)(2008-11#1)(2009-5#1)(2011-2#2)
of a quality improvement##2##4##(1995-6#1)(2013-1#1)
of a quality##6##3##(1992-1#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
of a quantitative trait##4##4##(2008-8#2)(2012-3#2)
of a quantitative##11##3##(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)
of a quarter-wave plate##2##4##(2008-2#1)(2008-3#1)
of a quartz crystal##3##4##(2008-10#2)(2009-5#1)
of a questionnaire##9##3##(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(2007-7#1)(2008-9#2)(2010-1#1)(2013-1#1)
of a quick##2##3##(2008-10#1)(2008-5#1)
of a radical##2##3##(1992-3#1)(1992-6#1)
of a radiology##3##3##(1993-12#1)(1994-2#1)(2007-4#1)
of a random sample of##3##5##(1991-3#1)(1997-4#1)(2008-7#1)
of a random##9##3##(1991-3#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-11#1)
of a randomised controlled##2##4##(2010-5#1)(2011-1#1)
of a randomised##3##3##(2008-8#1)(2010-5#1)(2011-1#1)
of a randomized trial##2##4##(1994-8#1)(1995-12#1)
of a randomized##5##3##(1994-8#1)(1995-12#1)(1995-9#1)(2008-3#1)(2009-12#1)
of a randomly##3##3##(2007-11#1)(2008-3#1)(2012-12#1)
of a range of##20##4##(1994-1#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-5#3)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
of a rapid and##3##4##(1992-6#1)(2007-2#1)(2008-4#1)
of a rapid##9##3##(1992-6#1)(1992-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-3#1)
of a rapidly##4##3##(1994-2#1)(2008-12#1)(2008-3#2)
of a rare case##3##4##(2008-11#1)(2010-5#1)(2013-1#1)
of a rare##17##3##(1990-9#1)(1994-12#1)(1995-11#1)(1996-3#1)(1997-3#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of a rat airway##2##4##(1993-8#2)
of a rat##11##3##(1991-5#1)(1991-9#1)(1993-8#2)(1994-6#1)(1995-6#1)(1997-7#1)(2008-11#3)(2008-9#1)
of a rational##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
of a reactive##3##3##(1990-10#1)(2006-12#1)(2013-1#1)
of a reagent##3##3##(2008-10#3)
of a real##4##3##(2008-10#3)(2009-12#1)
of a real-time##4##3##(2008-3#1)(2011-1#1)(2011-2#2)
of a recent case of##2##5##(1990-9#1)(2007-12#1)
of a recent##16##3##(1990-9#2)(1991-12#1)(1992-3#1)(1992-5#1)(1995-1#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)
of a recently developed##2##4##(1995-11#1)(2008-3#1)
of a recently discovered##3##4##(1990-3#2)(1995-12#1)
of a recently introduced##2##4##(2008-10#1)(2008-2#1)
of a recently proposed method for estimating creatinine clearance##2##9##(2008-7#2)
of a recently##11##3##(1990-3#2)(1991-9#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)
of a receptor##3##3##(1992-12#1)(1994-5#1)(1995-6#1)
of a recombinant CHO cell line in##2##7##(2008-11#2)
of a recombinant CHO cell line##3##6##(2008-11#3)
of a recombinant form of##2##5##(2008-6#1)(2009-3#1)
of a recombinant glycoprotein##2##4##(2008-7#1)(2011-2#1)
of a recombinant human##2##4##(1994-6#1)(2008-11#1)
of a recombinant therapeutic##2##4##(2008-11#1)(2011-2#1)
of a recombinant##25##3##(1994-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#10)(2008-4#1)(2008-6#2)(2008-7#3)(2009-3#1)(2010-4#1)(2011-2#2)
of a rectal##2##3##(1994-3#1)(2009-12#1)
of a rectangular##2##3##(2008-2#2)
of a recurrent##3##3##(2008-2#1)(2008-9#1)(2009-3#1)
of a recurring##2##3##(1997-4#2)
of a red##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#2)
of a red-region fluorescent##2##4##(2008-10#2)
of a redox##2##3##(2008-10#2)
of a reduced##5##3##(1990-7#1)(2008-1#1)(2009-5#1)(2009-9#1)(2012-12#1)
of a reducing agent##3##4##(2008-10#3)
of a reducing##4##3##(2008-10#3)(2013-1#1)
of a reduction in##3##4##(1990-5#1)(2008-10#1)(2008-9#1)
of a reduction##4##3##(1990-5#1)(2007-11#1)(2008-10#1)(2008-9#1)
of a reference##6##3##(2008-3#4)(2008-4#1)(2008-9#1)
of a reflection grating##2##4##(2007-12#1)(2008-3#1)
of a reflection##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
of a reflective##2##3##(2008-2#1)(2012-12#1)
of a reflector##2##3##(2008-3#2)
of a refractive-index##2##3##(2008-2#1)(2008-3#1)
of a region of##2##4##(1990-2#1)(1997-2#1)
of a region##7##3##(1990-2#1)(1991-5#1)(1994-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
of a regional##4##3##(1993-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
of a registered##2##3##(1995-3#1)(2007-10#1)
of a regular array of##2##5##(2007-12#1)(2008-3#1)
of a regular##6##3##(2007-12#1)(2008-3#3)(2008-5#1)(2008-6#1)
of a regulatory gene##2##4##(2008-8#2)
of a regulatory##4##3##(1994-11#1)(2008-8#2)(2011-2#1)
of a rehabilitation program##2##4##(2007-11#1)(2008-4#1)
of a related##2##3##(1992-9#1)(2008-8#1)
of a relationship between##2##4##(2008-7#1)(2011-2#1)
of a relative##2##3##(2011-2#1)(2013-8#1)
of a relatively high##2##4##(1992-6#1)(2008-12#1)
of a relatively small##2##4##(2008-10#1)(2009-5#1)
of a relatively##9##3##(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
of a reliable##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
of a reminder##2##3##(2013-1#2)
of a renal##3##3##(1992-6#1)(2007-7#1)(2008-12#1)
of a repeat##2##3##(2008-12#2)
of a repeating##2##3##(1992-12#1)(2008-7#1)
of a repetitive##2##3##(2007-12#1)(2008-11#1)
of a replication##3##3##(2008-3#2)(2012-2#1)
of a reporter gene under the control of##2##8##(1994-12#1)(1995-8#1)
of a reporter gene##7##4##(1993-3#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-8#1)(2010-10#1)
of a reporter##8##3##(1993-3#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-8#1)(2010-10#1)
of a representative sample of##2##5##(1994-6#1)(2008-5#1)
of a representative##6##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
of a reproducible pulsed flow##2##5##(2008-10#2)
of a reproducible##3##3##(2008-10#2)(2008-3#1)
of a research project##2##4##(1991-9#1)(2013-1#1)
of a research##8##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#2)
of a residue##3##3##(1991-9#1)(1992-6#1)(1993-11#1)
of a resistant cultivar##3##4##(2008-10#3)
of a resistant##4##3##(2008-10#4)
of a resource##2##3##(2008-12#1)(2008-8#1)
of a resource-based##2##3##(1991-12#1)(1994-1#1)
of a respiratory##2##3##(1996-3#1)(2006-10#1)
of a response##3##3##(1996-5#1)(2008-6#1)(2010-12#1)
of a restriction##2##3##(2008-10#1)(2008-4#1)
of a restructured##2##3##(1994-3#1)(1996-3#1)
of a retained##2##3##(2008-12#1)(2012-3#1)
of a retinal##2##3##(1996-5#1)(2010-1#1)
of a retrospective##3##3##(1992-12#1)(2007-10#1)(2009-5#1)
of a reverse##2##3##(2008-10#1)(2008-8#1)
of a reversible immunosensor with##2##5##(2008-7#2)
of a reversible##4##3##(2008-11#1)(2008-7#2)(2011-2#1)
of a review##2##3##(1993-1#1)(2008-10#1)
of a ribosomal##2##3##(2007-11#1)(2008-10#1)
of a rice##8##3##(1996-12#1)(1997-2#1)(2008-8#2)(2008-9#3)(2009-10#1)
of a right##5##3##(1997-6#1)(2007-8#2)(2008-8#1)(2009-6#1)
of a rigid##2##3##(2008-8#1)(2012-2#1)
of a rigorous##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of a risk##2##3##(2008-4#1)(2011-2#1)
of a robotic##2##3##(2008-10#1)(2010-7#1)
of a robust##4##3##(1992-9#1)(2008-10#2)(2009-9#1)
of a role for##3##4##(1993-11#1)(2007-12#1)(2008-4#1)
of a role of##3##4##(1993-9#1)(1995-12#1)(2008-10#1)
of a role##6##3##(1993-11#1)(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
of a room-temperature##2##3##(2007-11#1)(2008-2#1)
of a rotating##6##3##(2007-11#1)(2008-10#3)(2008-2#2)
of a rotationally symmetric##2##4##(2007-12#1)(2008-3#1)
of a rough surface##5##4##(2007-12#1)(2008-3#4)
of a rough##6##3##(2007-12#1)(2008-3#5)
of a routine##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
of a rovibrational##2##3##(2007-12#2)
of a rural town]##2##4##(1993-5#2)
of a sample containing##2##4##(2008-10#2)
of a sample of##5##4##(1995-5#1)(1997-6#1)(2008-10#1)(2008-12#1)(2011-1#1)
of a sample solution##2##4##(2008-1#1)(2008-10#1)
of a sample##29##3##(1995-5#1)(1997-6#1)(2007-11#3)(2008-1#2)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#5)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
of a sampling##6##3##(2008-10#6)
of a saphenous vein##2##4##(2007-8#2)
of a sarcoma##2##3##(1991-11#1)(2008-6#1)
of a satisfactory##2##3##(2006-10#1)(2008-10#1)
of a saturable absorber subject to##2##6##(2008-2#1)(2008-3#1)
of a saturable absorber##3##4##(2008-2#1)(2008-3#2)
of a saturable##5##3##(1990-8#1)(2007-11#1)(2008-2#1)(2008-3#2)
of a scale of##2##4##(1994-3#1)(2011-1#1)
of a scale##6##3##(1994-3#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
of a scalp##2##3##(2010-6#1)(2013-8#1)
of a scanning##8##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#3)
of a scattering##3##3##(2008-2#1)(2008-3#2)
of a school##4##3##(1993-1#1)(1996-10#1)(2008-2#1)(2012-2#1)
of a school-based##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
of a screen##2##3##(2008-3#2)
of a screening tool##2##4##(1992-12#1)(2010-9#1)
of a screening##7##3##(1991-6#1)(1992-12#1)(1995-12#1)(2008-10#1)(2010-9#2)(2011-3#1)
of a seamless##2##3##(1996-3#1)(2008-11#1)
of a search for##2##4##(1992-5#1)(2012-3#1)
of a search##4##3##(1992-5#1)(2007-12#1)(2008-12#1)(2012-3#1)
of a season##2##3##(1996-6#1)(2008-10#1)
of a second transition##2##4##(1992-10#1)(2007-12#1)
of a second##30##3##(1990-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-8#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of a second-order nonlinear##2##4##(2007-11#1)(2008-2#1)
of a second-order##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
of a secondary##3##3##(1993-8#1)(1996-5#1)(2008-9#1)
of a secreted##4##3##(1997-4#1)(2008-11#3)
of a section of##2##4##(1992-12#1)(2008-3#1)
of a sedation protocol in##2##5##(2007-11#2)
of a seed##3##3##(2008-10#1)(2008-8#2)
of a segment of the##3##5##(1996-6#1)(2008-4#1)(2012-12#1)
of a segment of##4##4##(1996-6#1)(1997-3#1)(2008-4#1)(2012-12#1)
of a segmented##2##3##(2007-11#1)(2008-2#1)
of a selectable marker##2##4##(1994-12#1)(2008-2#1)
of a selected##8##3##(1991-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)
of a selection of##3##4##(2008-10#1)(2008-11#2)
of a selection##5##3##(2008-10#2)(2008-11#2)(2008-8#1)
of a selective##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
of a self##2##3##(2008-10#1)(2008-11#1)
of a self-activating##2##3##(2008-11#2)
of a self-assembled monolayer (SAM) of##2##6##(2008-10#2)
of a self-frequency-doubling##2##3##(2007-11#1)(2008-3#1)
of a self-regulating##2##3##(1995-6#1)(2008-1#1)
of a semi-infinite##2##3##(2008-2#1)(2008-3#1)
of a semiconductor laser##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
of a semiconductor##7##3##(2007-11#4)(2007-12#2)(2008-2#1)
of a sensitive and##2##4##(1992-3#1)(2008-10#1)
of a sensitive##8##3##(1990-2#2)(1992-3#1)(2008-10#4)(2010-6#1)
of a sensitivity##2##3##(2008-3#1)(2011-1#1)
of a sensor##2##3##(2008-2#1)(2008-4#1)
of a separate##2##3##(1993-12#1)(2008-10#1)
of a separated file##2##4##(2008-7#2)
of a separated##4##3##(2008-10#1)(2008-2#1)(2008-7#2)
of a sequence##5##3##(1992-8#1)(1996-12#1)(2008-3#2)(2008-9#1)
of a sequential injection##3##4##(2008-10#3)
of a sequential##7##3##(2007-12#1)(2008-10#5)(2008-4#1)
of a series of individual##2##5##(2008-10#2)
of a series of##51##4##(1990-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#3)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
of a serine proteinase##2##4##(1992-11#1)(1995-5#1)
of a serine##3##3##(1992-11#1)(1995-3#1)(1995-5#1)
of a serine/threonine##2##3##(1992-12#1)(1996-2#1)
of a serious##2##3##(1991-1#1)(2008-10#1)
of a serum-free##3##3##(2008-11#3)
of a service##3##3##(1993-3#1)(1994-12#1)(1997-3#1)
of a set of##33##4##(1990-5#1)(1992-12#1)(1993-9#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2013-1#1)
of a severe strain##2##4##(2008-10#2)
of a severe##6##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-1#1)
of a severely##3##3##(1990-7#1)(2008-7#1)(2009-8#1)
of a severity##4##3##(1992-3#2)(2009-4#2)
of a sexual##2##3##(2013-1#1)(2013-8#1)
of a sexually reproducing##2##4##(2008-10#1)(2009-2#1)
of a sexually##3##3##(1992-3#1)(2008-10#1)(2009-2#1)
of a shampoo##3##3##(2008-10#1)(2008-5#2)
of a shaped##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a shared vision##2##4##(1993-12#1)(1995-2#1)
of a shared##5##3##(1993-12#1)(1995-2#1)(2008-11#1)(2009-5#1)(2011-1#1)
of a sharp##3##3##(1992-1#1)(1995-3#1)(2007-12#1)
of a shearing interferometer concept for at-wavelength##2##7##(2008-3#2)
of a short pulse##4##4##(2007-11#1)(2008-2#3)
of a short##14##3##(1991-8#1)(1993-2#1)(1994-3#1)(1995-2#1)(2007-11#3)(2008-10#1)(2008-2#4)(2008-3#1)(2008-7#1)
of a shortage of##2##4##(1997-6#1)(2008-11#1)
of a side##2##3##(1990-9#1)(1993-11#1)
of a signal##10##3##(1991-10#1)(1993-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)
of a significant amount of##2##5##(1997-2#1)(2011-2#1)
of a significant difference in the##3##6##(1994-2#1)(1996-7#1)(2013-1#1)
of a significant difference##4##4##(1994-2#1)(1996-7#1)(2008-10#1)(2013-1#1)
of a significant##15##3##(1990-2#1)(1990-5#1)(1992-8#1)(1994-2#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2009-7#1)(2011-2#1)(2013-1#1)
of a silicon wafer##2##4##(2007-12#1)(2008-3#1)
of a silicon##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2012-2#1)
of a silicone##2##3##(2008-5#1)(2013-1#1)
of a similar##15##3##(1990-6#2)(1991-9#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-3#1)
of a simple and##2##4##(2008-10#1)(2008-2#1)
of a simple model##3##4##(1990-8#1)(2008-3#1)(2009-10#1)
of a simple##38##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1992-6#1)(1994-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#12)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
of a simulated##5##3##(2007-12#1)(2008-12#1)(2008-3#3)
of a simulation study##3##4##(1996-3#1)(1997-3#2)
of a simulation##5##3##(1996-3#1)(1997-3#2)(2008-10#1)(2008-3#1)
of a simultaneous##2##3##(1992-2#1)(1996-2#1)
of a single and##2##4##(1997-7#1)(2007-12#1)
of a single base##2##4##(1993-3#1)(2007-10#1)
of a single cell##6##4##(1990-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
of a single channel##3##4##(2008-10#1)(2011-3#2)
of a single copy of the##2##6##(1997-2#2)
of a single dose of##3##5##(1990-6#1)(1993-9#1)(2012-3#1)
of a single gene##6##4##(1993-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#2)
of a single host##2##4##(2008-10#2)
of a single mutant##2##4##(2008-8#1)(2013-8#1)
of a single or##3##4##(2008-2#1)(2008-4#1)(2009-5#1)
of a single pH##2##4##(1994-7#1)(2008-10#1)
of a single protein##3##4##(1993-11#1)(2008-4#2)
of a single resistance gene##2##5##(2008-10#2)
of a single step##2##4##(2008-3#1)(2013-1#1)
of a single##184##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-7#2)(2008-10#34)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#17)(2008-4#11)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
of a single-chain antibody##2##4##(2008-8#2)
of a single-chain##3##3##(1992-12#1)(2008-8#2)
of a single-copy gene##2##4##(1993-3#1)(2008-8#1)
of a single-layer##2##3##(2008-2#1)(2009-10#1)
of a single-mode fiber##3##4##(2008-2#3)
of a single-mode##12##3##(2007-11#4)(2007-12#2)(2008-2#6)
of a single-pass##2##3##(2008-2#1)(2008-3#1)
of a site##2##3##(1991-2#1)(1994-3#1)
of a six##2##3##(2008-10#1)(2008-7#1)
of a skin##2##3##(2008-5#1)(2012-3#1)
of a slab##4##3##(2007-12#1)(2008-3#3)
of a slightly##2##3##(2008-2#1)(2013-1#1)
of a small amount of##6##5##(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)
of a small amount##7##4##(1993-8#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)
of a small fraction of##2##5##(1997-6#1)(2007-12#1)
of a small group of##2##5##(2008-8#1)(2013-1#1)
of a small heat##2##4##(1997-2#1)(2013-1#1)
of a small inclination##2##4##(2008-3#2)
of a small number of##4##5##(1990-5#1)(1995-5#1)(1997-6#1)(1997-7#1)
of a small percentage of##2##5##(1992-12#1)(2008-4#1)
of a small##48##3##(1990-5#2)(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-5#3)(1997-2#1)(1997-6#2)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-10#1)(2010-4#1)(2013-1#2)
of a smaller species##2##4##(2008-9#2)
of a smaller##3##3##(2008-9#2)(2010-11#1)
of a smooth##2##3##(1992-9#1)(2008-11#1)
of a snake##2##3##(1992-12#2)
of a so-called##3##3##(1995-6#1)(2007-8#1)(2008-10#1)
of a social##4##3##(2008-11#1)(2008-9#2)(2009-6#1)
of a society##2##3##(1994-9#1)(2008-1#1)
of a sodium##3##3##(1990-6#1)(2008-10#1)(2012-2#1)
of a soft tissue sarcoma##2##5##(2008-6#1)(2009-3#1)
of a soft##6##3##(1992-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)
of a soil to##2##4##(2008-10#2)
of a soil##7##3##(2008-10#6)(2008-9#1)
of a solar-pumped Nd##2##4##(2008-3#2)
of a solar-pumped##4##3##(2007-12#1)(2008-3#3)
of a solid phase extraction (SPE)##2##6##(2008-10#2)
of a solid##12##3##(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#1)(2012-2#2)
of a solid-phase extraction##2##4##(1997-2#1)(2008-10#1)
of a solid-phase microextraction##2##4##(1997-2#1)(2008-10#1)
of a solid-phase##4##3##(1997-2#2)(2008-10#2)
of a solid-state##4##3##(1992-1#1)(2008-2#2)(2008-3#1)
of a solitary##3##3##(2007-8#1)(2011-1#1)(2012-12#1)
of a soluble solid sample##2##5##(2008-10#2)
of a soluble##8##3##(1990-10#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#1)
of a solution containing##5##4##(2008-10#4)(2008-3#1)
of a solution of##3##4##(2008-10#3)
of a solution##12##3##(1991-9#1)(2008-10#8)(2008-11#1)(2008-3#2)
of a sounding rocket and##2##5##(2008-3#2)
of a source##4##3##(2008-10#1)(2008-2#3)
of a spacer device must be such that##2##8##(1996-2#2)
of a spatial##11##3##(1993-3#1)(1993-6#1)(1994-3#2)(1994-8#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)
of a spatially multiplexed##2##4##(2008-2#2)
of a spatially##7##3##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)
of a special##7##3##(1990-8#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
of a specialised##2##3##(1995-9#1)(2007-12#1)
of a specialist##4##3##(1994-12#1)(2007-11#1)(2010-10#1)(2013-8#1)
of a specialized##2##3##(2007-12#1)(2013-8#1)
of a species##5##3##(2008-10#1)(2008-8#3)(2009-9#1)
of a species'##2##3##(2008-8#1)(2013-1#1)
of a specific DNA##2##4##(1995-8#1)(2008-10#1)
of a specific##53##3##(1991-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#2)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
of a specimen##2##3##(2009-7#1)(2012-2#1)
of a speckle##2##3##(2007-12#2)
of a spectral##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
of a spectrally##2##3##(2008-3#2)
of a spectrofluorimeter##2##3##(2008-10#1)(2008-4#1)
of a spectrometer##3##3##(2008-2#2)(2008-3#1)
of a spectrometric##2##3##(2008-10#1)(2008-2#1)
of a spectrophotometer##2##3##(2008-10#1)(2008-3#1)
of a spectrophotometric method##2##4##(2008-10#2)
of a spectrophotometric##3##3##(2008-10#3)
of a spectrum of##2##4##(2008-10#1)(2012-2#1)
of a spectrum##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
of a spherical bioparticle under substrate inhibition##2##7##(2008-7#2)
of a spherical wave##2##4##(2008-3#2)
of a spherical##14##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#9)(2008-7#2)
of a spider monkey (Ateles)##2##5##(2011-2#2)
of a spike##2##3##(2008-1#1)(2008-10#1)
of a spiked##2##3##(1996-5#1)(2008-9#1)
of a spin##2##3##(1990-12#1)(2008-7#1)
of a spinal##5##3##(2008-7#4)(2013-1#1)
of a splicing##2##3##(1991-9#1)(1993-12#1)
of a spontaneous##3##3##(2007-8#1)(2011-2#2)
of a sports##2##3##(1993-3#1)(2007-11#1)
of a square-wave##2##3##(2007-12#1)(2008-3#1)
of a stable##19##3##(1992-12#1)(1993-8#1)(1996-5#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#4)(2008-2#2)(2008-4#1)(2010-12#1)(2010-7#1)(2013-1#1)
of a standard and##2##4##(2008-10#1)(2008-5#1)
of a standard reference##2##4##(2008-10#2)
of a standard##35##3##(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1994-12#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)
of a standardized##8##3##(1993-2#1)(2008-11#2)(2008-5#2)(2010-1#1)(2013-1#1)(2013-8#1)
of a standing surface plasmon by rapid ionization in a semiconductor##2##11##(2007-12#2)
of a standing##3##3##(2007-12#2)(2008-2#1)
of a state##2##3##(1996-2#1)(2011-2#1)
of a statewide##4##3##(1995-1#1)(1995-12#1)(1996-1#1)(2008-9#1)
of a static##3##3##(2007-12#2)(2008-3#1)
of a statistical##4##3##(1992-2#1)(2007-12#1)(2008-10#2)
of a stellar interferometer##2##4##(2007-11#2)
of a stem##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
of a step##3##3##(1995-12#1)(2008-3#2)
of a step-index##2##3##(2007-12#1)(2008-3#1)
of a sterile##2##3##(2008-10#1)(2012-2#1)
of a stochastic##2##3##(2008-2#2)
of a stoichiometric##2##3##(2008-11#1)(2008-7#1)
of a stop codon##2##4##(1995-2#1)(2008-4#1)
of a straightforward##2##3##(2008-3#1)(2008-4#1)
of a strain of##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
of a strain##6##3##(1993-9#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
of a strategic##2##3##(1992-2#1)(1993-3#1)
of a strategy for##3##4##(1996-3#1)(2008-8#1)(2013-8#1)
of a strategy##6##3##(1996-3#1)(2008-1#2)(2008-7#1)(2008-8#1)(2013-8#1)
of a stratified##3##3##(2008-2#3)
of a strong##12##3##(1995-12#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
of a strongly focused##2##4##(2007-11#2)
of a structural##3##3##(1992-3#1)(1997-2#1)(2008-2#1)
of a structurally related##2##4##(1993-11#1)(1994-8#1)
of a structure##2##3##(1990-3#1)(2008-7#1)
of a structured##5##3##(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#2)
of a student##3##3##(2008-12#1)(2010-3#1)(2010-9#1)
of a study conducted##2##4##(2008-2#1)(2009-10#1)
of a study in##2##4##(1997-4#1)(2008-5#1)
of a study of##10##4##(1992-1#1)(1992-5#1)(1993-9#1)(1995-12#1)(1996-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-10#1)
of a study which##2##4##(1996-1#1)(1997-3#1)
of a study##33##3##(1992-1#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-2#4)(2008-5#4)(2008-6#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-9#1)
of a subgroup of##2##4##(1993-1#1)(1997-5#1)
of a subject##3##3##(1991-3#1)(1992-9#1)(2008-4#1)
of a submerged object##3##4##(2008-3#3)
of a submerged##4##3##(1994-3#1)(2008-3#3)
of a subpopulation of##2##4##(2008-7#1)(2011-2#1)
of a subsample of##2##4##(2008-4#1)(2012-3#1)
of a subsequent##2##3##(1992-3#1)(1993-9#1)
of a subset of##7##4##(1993-9#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)
of a subset##8##3##(1993-9#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)
of a substitution##2##3##(1996-2#1)(2008-10#1)
of a subunit##2##3##(1992-8#1)(1995-2#1)
of a successful marketing plan##2##5##(1991-3#1)(1993-3#1)
of a successful##14##3##(1991-2#1)(1991-3#1)(1993-2#1)(1993-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-4#1)(2013-7#1)
of a suicide attempt##2##4##(2009-3#1)(2010-7#1)
of a suitable laser model##2##5##(2008-2#1)(2008-3#1)
of a suitable laser##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
of a suitable##18##3##(1993-8#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
of a suite of##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
of a supercontinuum##2##3##(2007-12#2)
of a superficial##2##3##(2008-2#1)(2013-8#1)
of a superior##3##3##(1993-12#1)(2009-3#1)(2012-3#1)
of a support tool for complex decision-making##2##7##(2011-2#2)
of a suppressor##2##3##(2008-10#2)
of a surface##8##3##(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#1)(2010-7#1)
of a surfactant##3##3##(1992-5#1)(2008-10#2)
of a surgical technique##2##4##(2008-7#2)
of a survey##17##3##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#2)(1996-12#1)(1997-3#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-11#1)(2011-1#1)
of a survival##3##3##(1996-12#1)(2008-10#1)(2008-6#1)
of a susceptibility locus for##2##5##(1996-2#1)(1997-5#1)
of a susceptibility locus##4##4##(1996-2#1)(1997-5#3)
of a susceptible cultivar##2##4##(2008-10#2)
of a susceptible##7##3##(2008-10#6)(2011-2#1)
of a suspension culture##2##4##(2008-11#1)(2008-2#1)
of a suspension##3##3##(2008-11#1)(2008-12#1)(2008-2#1)
of a sustainable##2##3##(1995-12#1)(2008-10#1)
of a symmetrical##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of a symptomatic##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
of a syndrome##3##3##(1997-5#1)(2009-6#1)(2012-3#1)
of a synthetic##9##3##(1990-11#1)(1992-7#1)(2007-11#1)(2008-10#4)(2009-4#1)(2011-2#1)
of a system composed##2##4##(2008-7#1)(2012-2#1)
of a system##11##3##(1993-3#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-9#1)(2012-2#1)
of a systematic literature##2##4##(2008-11#1)(2013-1#1)
of a systematic##11##3##(1992-2#1)(1994-10#1)(1996-2#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
of a systemic##4##3##(1990-6#1)(2007-7#1)(2009-10#1)(2013-8#1)
of a talon cusp##2##4##(2012-2#2)
of a tandem##2##3##(2008-3#1)(2008-7#1)
of a tapered fiber##2##4##(2007-11#2)
of a tapered##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
of a target##11##3##(2007-11#1)(2007-12#1)(2008-11#4)(2008-3#3)(2008-7#1)(2009-11#1)
of a targeted##2##3##(1996-2#1)(2007-11#1)
of a task##2##3##(1993-12#1)(1993-6#1)
of a teaching##4##3##(1990-2#1)(1996-1#1)(2008-10#1)(2008-12#1)
of a team##3##3##(1996-2#1)(1997-4#1)(2008-2#1)
of a technical advisory panel##2##5##(1992-3#1)(1993-12#1)
of a technique##3##3##(1992-12#1)(2008-10#2)
of a telescope##2##3##(2007-11#1)(2008-2#1)
of a temperature-sensitive##2##3##(1993-9#1)(1995-8#1)
of a template##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
of a temporal##4##3##(2006-6#1)(2007-12#2)(2011-2#1)
of a ternary##3##3##(1994-5#1)(2008-10#2)
of a test compound##3##4##(2008-1#1)(2008-10#1)(2008-4#1)
of a test object##2##4##(2008-2#1)(2008-3#1)
of a test sample##3##4##(2007-11#1)(2008-11#1)(2008-4#1)
of a test##15##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2012-2#1)(2013-1#1)
of a tetrasaccharide##2##3##(1990-9#1)(1992-12#1)
of a theophylline-selective electrode##2##4##(2008-10#2)
of a theoretical framework##2##4##(2009-6#1)(2012-3#1)
of a theoretical##6##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-3#1)
of a therapeutic##4##3##(1991-9#1)(2008-1#1)(2008-11#1)(2008-9#1)
of a thermodynamic##2##3##(1990-8#1)(2008-10#1)
of a thick##3##3##(2007-11#1)(2008-3#2)
of a thin film##2##4##(2008-10#2)
of a thin lens##2##4##(2008-3#2)
of a thin##15##3##(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2013-8#1)
of a thin-film##2##3##(2008-3#1)(2010-4#1)
of a third##6##3##(1993-10#1)(1997-7#1)(2008-3#1)(2010-6#1)(2011-1#1)(2013-1#1)
of a thoracic##3##3##(2011-2#2)(2013-1#1)
of a thorough##2##3##(2008-7#2)
of a thoroughgoing##2##3##(2008-6#1)(2010-2#1)
of a three year##2##4##(2007-7#1)(2008-11#1)
of a three##4##3##(1990-9#1)(1994-6#1)(2007-7#1)(2008-11#1)
of a three-dimensional object with##2##5##(2008-2#1)(2008-3#1)
of a three-dimensional object##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of a three-dimensional tissue construct from##2##6##(2013-1#2)
of a three-dimensional##22##3##(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2009-4#1)(2011-2#3)(2013-1#2)
of a three-species##2##3##(2008-8#2)
of a three-state##2##3##(1993-8#1)(2008-3#1)
of a three-step##2##3##(2008-2#1)(2013-1#1)
of a threshold for##2##4##(1990-8#1)(2009-5#1)
of a threshold##4##3##(1990-8#1)(2008-10#1)(2009-5#1)(2010-1#1)
of a thrombus##2##3##(2008-7#1)(2008-8#1)
of a tight##4##3##(1993-11#1)(1995-12#1)(1995-2#1)(2013-8#1)
of a tilted##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
of a time##3##3##(2009-9#2)(2011-1#1)
of a tissue##2##3##(2008-10#1)(2013-1#1)
of a tissuelike##2##3##(2008-3#2)
of a tool##2##3##(2009-2#2)
of a tooth##2##3##(2010-10#1)(2013-1#1)
of a total of##16##4##(1991-12#1)(1992-9#1)(1993-2#1)(1995-4#1)(1996-8#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
of a total##24##3##(1991-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of a trace##2##3##(2008-10#1)(2008-3#1)
of a trade-off##2##3##(2008-9#1)(2010-10#1)
of a training program for##2##5##(1991-12#1)(2008-7#1)
of a training##5##3##(1991-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)
of a trait##2##3##(2008-8#1)(2012-3#1)
of a transcription factor##3##4##(1995-2#1)(2008-11#2)
of a transformation##2##3##(1996-6#1)(2008-11#1)
of a transfusion##2##3##(1994-9#1)(1995-6#1)
of a transgene##3##3##(1990-12#1)(1995-2#1)(2008-4#1)
of a transgenic##2##3##(2008-10#2)
of a transient##4##3##(1995-8#1)(1996-5#1)(2007-11#1)(2011-2#1)
of a transition##3##3##(1991-9#1)(1997-4#1)(2009-1#1)
of a transparent##5##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)
of a transported##2##3##(1994-11#2)
of a transverse##2##3##(2007-12#1)(2008-3#1)
of a traumatic##4##3##(1994-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
of a travel##2##3##(2011-2#2)
of a treatment##2##3##(1996-5#2)
of a tree##3##3##(2008-10#3)
of a trial##6##3##(1996-6#2)(1997-4#1)(2008-10#1)(2008-3#2)
of a tropical##2##3##(2008-5#1)(2013-8#1)
of a true##3##3##(2008-11#1)(2008-4#1)(2010-6#1)
of a truncated##2##3##(1991-12#1)(2007-12#1)
of a tumor suppressor gene##2##5##(1994-12#1)(1994-6#1)
of a tumor with##2##4##(1991-4#1)(1994-12#1)
of a tumor##11##3##(1991-4#2)(1994-12#2)(1994-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2013-8#1)
of a tumour##4##3##(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
of a tunable##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
of a tungsten##3##3##(2007-12#1)(2008-10#2)
of a turbid medium##2##4##(2008-2#1)(2008-3#1)
of a turbid##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of a twin##2##3##(1990-6#1)(2011-2#1)
of a two##2##3##(2008-10#1)(2008-7#1)
of a two-dimensional array of vertical-cavity surface-emitting lasers##2##8##(2008-3#2)
of a two-dimensional periodic##2##4##(2008-3#1)(2008-7#1)
of a two-dimensional##13##3##(1991-9#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#6)(2008-7#1)
of a two-layer##4##3##(2007-12#1)(2008-2#2)(2010-2#1)
of a two-part article##4##4##(1992-12#1)(1993-2#1)(1994-3#1)(2007-2#1)
of a two-part##5##3##(1992-12#1)(1993-2#1)(1994-3#1)(2007-2#1)(2007-5#1)
of a two-stage##2##3##(2008-10#1)(2008-3#1)
of a two-step process##3##4##(1994-2#1)(2007-12#1)(2009-4#1)
of a two-step##7##3##(1990-2#1)(1994-2#1)(2007-12#1)(2008-3#2)(2008-9#1)(2009-4#1)
of a type I##3##4##(1991-12#1)(2008-2#2)
of a type##9##3##(1991-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2011-2#2)
of a typical soft ice cream##2##6##(2011-2#2)
of a typical##15##3##(1993-9#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#2)
of a tyrosinase##2##3##(2008-10#2)
of a tyrosine##2##3##(1995-2#1)(2008-4#1)
of a uniform##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
of a uniformly##3##3##(2008-2#1)(2008-3#2)
of a unilateral##2##3##(2008-7#1)(2011-1#1)
of a unique##11##3##(1995-11#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of a unit##2##3##(2008-10#1)(2011-2#1)
of a universal##2##3##(2008-4#1)(2008-7#1)
of a university hospital##3##4##(1996-12#1)(2009-1#1)(2010-8#1)
of a university##7##3##(1995-11#1)(1996-12#1)(1997-1#1)(2008-1#1)(2009-1#1)(2010-1#1)(2010-8#1)
of a urachal##2##3##(2008-10#1)(2008-6#1)
of a urinary##2##3##(1990-12#1)(1993-6#1)
of a urine##5##3##(2006-10#1)(2007-10#1)(2007-12#1)(2012-12#1)(2013-1#1)
of a useful##2##3##(1996-3#1)(2011-2#1)
of a utilization management##2##4##(1995-1#1)(1996-1#1)
of a vaccination policy##2##4##(2007-6#2)
of a vaccine against##2##4##(1997-7#1)(2008-7#1)
of a vaccine for##2##4##(1994-8#1)(1995-2#1)
of a vaccine##7##3##(1994-8#1)(1995-2#1)(1997-7#2)(2008-7#1)(2011-2#1)(2013-1#1)
of a validated##2##3##(2010-11#1)(2010-5#1)
of a variable##2##3##(2007-12#1)(2008-8#1)
of a variety of compounds##2##5##(2008-10#2)
of a variety of different##2##5##(2008-10#1)(2013-1#1)
of a variety of genes##3##5##(1993-3#1)(1995-12#1)(2008-10#1)
of a variety of kidney##2##5##(2008-1#1)(2008-7#1)
of a variety of##50##4##(1991-9#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
of a vascular##4##3##(1990-12#1)(2008-12#1)(2008-7#1)(2009-1#1)
of a vasoconstrictor to a local anesthetic may##2##8##(1993-1#2)
of a vasodilator##2##3##(1991-3#1)(1997-7#1)
of a vector with##2##4##(1994-12#1)(2010-7#1)
of a vector##6##3##(1994-12#1)(1997-3#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-7#1)
of a versatile##2##3##(2008-10#1)(2008-3#1)
of a vertical##3##3##(2008-3#3)
of a very different nature##2##5##(1996-12#1)(2008-11#1)
of a very high##2##4##(1997-7#1)(2008-3#1)
of a very##14##3##(1990-11#1)(1993-12#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#1)
of a vestibular schwannoma##2##4##(2011-2#2)
of a vibrational##2##3##(2007-11#1)(2013-1#1)
of a viral##4##3##(1995-5#1)(2008-9#2)(2010-5#1)
of a virtual##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
of a virulent##2##3##(2008-10#1)(2008-9#1)
of a virus##7##3##(1997-1#1)(2007-6#1)(2008-10#3)(2008-5#1)(2012-12#1)
of a visible##4##3##(2007-12#2)(2008-10#2)
of a visual##5##3##(1990-12#1)(1991-2#1)(1995-5#1)(1996-2#1)(2008-1#1)
of a volatile##2##3##(2008-10#1)(2012-3#1)
of a voltammetric sensor##2##4##(2008-10#2)
of a volume##4##3##(2008-2#1)(2008-3#3)
of a voluminous##2##3##(1993-9#1)(2007-8#1)
of a voluntary##2##3##(1996-12#1)(2009-11#1)
of a wastewater treatment plant (WWTP)##2##6##(2008-10#2)
of a water droplet##2##4##(2008-10#1)(2008-2#1)
of a water##8##3##(1991-2#1)(2008-10#5)(2008-2#1)(2009-9#1)
of a water-soluble polymer##2##4##(2008-10#1)(2008-7#1)
of a water-soluble##5##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
of a wave front##5##4##(2007-12#1)(2008-3#4)
of a wave##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
of a waveguide##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of a wavelength##2##3##(2008-2#1)(2008-3#1)
of a weak##6##3##(1992-8#1)(2007-10#1)(2008-10#2)(2008-3#1)(2010-12#1)
of a weakly##2##3##(2008-10#2)
of a well##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
of a well-defined##5##3##(1997-3#1)(2008-10#3)(2012-2#1)
of a wheat##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
of a white##2##3##(1994-12#1)(2008-3#1)
of a white-light continuum##2##4##(2007-12#2)
of a whole##4##3##(1997-5#1)(2008-10#2)(2008-11#1)
of a wide range of##16##5##(1995-3#1)(1996-3#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
of a wide spectrum##2##4##(1992-5#1)(2008-9#1)
of a wide variety of##13##5##(1990-5#1)(1996-11#1)(1996-3#1)(1997-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-12#1)
of a wide##35##3##(1990-5#1)(1991-3#1)(1992-5#1)(1995-3#1)(1996-11#1)(1996-3#2)(1997-2#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
of a widely##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
of a wider##5##3##(1996-11#1)(2008-10#1)(2008-12#1)(2009-5#1)(2013-8#1)
of a wild-type##2##3##(2008-10#1)(2013-1#1)
of a wire grid polarizer##2##5##(2008-3#2)
of a woman who##3##4##(1992-2#1)(1997-3#1)(2007-6#1)
of a woman with##2##4##(1993-11#1)(2008-4#1)
of a woman##8##3##(1991-3#1)(1991-6#1)(1992-2#1)(1993-11#1)(1997-3#1)(2007-6#1)(2008-4#1)(2012-2#1)
of a woman's##2##3##(2008-11#1)(2008-2#1)
of a work##2##3##(1993-1#1)(1996-3#1)
of a workshop on##2##4##(1994-2#1)(2007-12#1)
of a workshop##4##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-6#1)
of a worse prognosis##2##4##(1990-8#1)(2011-2#1)
of a year##2##3##(2008-9#1)(2013-8#1)
of a yeast##8##3##(1990-5#1)(1991-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)
of a young male##4##4##(2006-10#1)(2007-8#1)(2008-11#1)(2012-2#1)
of a young man with##2##5##(2009-3#1)(2012-3#1)
of a young man##5##4##(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
of a young woman with##3##5##(2006-10#1)(2010-12#1)(2011-2#1)
of a young woman##5##4##(2006-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
of a young##22##3##(1996-2#2)(1996-8#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
of a zinc##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
of a zone##2##3##(2008-2#1)(2008-5#1)
of a##11465##2##(1990-10#8)(1990-11#36)(1990-12#49)(1990-2#20)(1990-3#21)(1990-4#2)(1990-5#37)(1990-6#28)(1990-7#37)(1990-8#44)(1990-9#15)(1991-1#9)(1991-10#4)(1991-11#15)(1991-12#57)(1991-2#64)(1991-3#24)(1991-4#2)(1991-5#32)(1991-6#40)(1991-7#2)(1991-8#17)(1991-9#48)(1992-1#23)(1992-10#10)(1992-11#12)(1992-12#41)(1992-2#31)(1992-3#61)(1992-4#5)(1992-5#27)(1992-6#36)(1992-7#3)(1992-8#32)(1992-9#31)(1993-1#21)(1993-10#1)(1993-11#61)(1993-12#69)(1993-2#50)(1993-3#49)(1993-5#16)(1993-6#49)(1993-8#31)(1993-9#34)(1994-1#28)(1994-10#1)(1994-11#42)(1994-12#85)(1994-2#45)(1994-3#56)(1994-5#24)(1994-6#25)(1994-7#8)(1994-8#60)(1994-9#23)(1995-1#23)(1995-10#2)(1995-11#33)(1995-12#52)(1995-2#87)(1995-3#50)(1995-4#4)(1995-5#38)(1995-6#51)(1995-8#32)(1995-9#23)(1996-1#19)(1996-10#5)(1996-11#14)(1996-12#46)(1996-2#65)(1996-3#52)(1996-4#7)(1996-5#41)(1996-6#32)(1996-7#8)(1996-8#15)(1996-9#15)(1997-1#19)(1997-2#75)(1997-3#77)(1997-4#46)(1997-5#19)(1997-6#24)(1997-7#70)(1997-8#39)(1997-9#1)(2006-10#19)(2006-12#3)(2006-5#1)(2006-6#2)(2007-1#2)(2007-10#33)(2007-11#402)(2007-12#527)(2007-2#13)(2007-4#4)(2007-5#11)(2007-6#13)(2007-7#39)(2007-8#76)(2007-9#5)(2008-1#67)(2008-10#1688)(2008-11#390)(2008-12#128)(2008-2#630)(2008-3#1273)(2008-4#184)(2008-5#223)(2008-6#108)(2008-7#334)(2008-8#181)(2008-9#220)(2009-1#10)(2009-10#39)(2009-11#37)(2009-12#30)(2009-2#27)(2009-3#34)(2009-4#19)(2009-5#51)(2009-6#27)(2009-7#35)(2009-8#47)(2009-9#26)(2010-1#18)(2010-10#30)(2010-11#20)(2010-12#55)(2010-2#30)(2010-3#25)(2010-4#35)(2010-5#48)(2010-6#31)(2010-7#19)(2010-8#55)(2010-9#21)(2011-1#107)(2011-2#344)(2011-3#12)(2011-6#1)(2011-7#1)(2012-1#28)(2012-12#115)(2012-2#167)(2012-3#138)(2012-7#2)(2012-8#1)(2013-1#284)(2013-2#1)(2013-7#24)(2013-8#110)
of aPS##3##2##(2008-7#3)
of aSKa##3##2##(1993-9#3)
of abandoned##2##2##(2008-9#1)(2011-2#1)
of abandoning##2##2##(1991-3#1)(2007-2#1)
of abatacept##4##2##(2012-1#1)(2012-3#3)
of abdomen##2##2##(2008-7#1)(2012-2#1)
of abdominal aorta##2##3##(2012-12#1)(2012-2#1)
of abdominal aortic aneurysm##3##4##(1992-5#2)(2010-12#1)
of abdominal aortic aneurysms##2##4##(1993-5#1)(2010-12#1)
of abdominal aortic##6##3##(1992-5#3)(1993-5#1)(2010-12#2)
of abdominal compartment syndrome##2##4##(2008-10#2)
of abdominal pain and##2##4##(1991-2#1)(2008-10#1)
of abdominal pain was##2##4##(1991-2#1)(2013-1#1)
of abdominal pain##12##3##(1991-2#2)(1997-5#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)(2012-12#1)(2013-1#1)
of abdominal spiracles##2##3##(2007-12#1)(2008-5#1)
of abdominal tergites##2##3##(2007-12#2)
of abdominal wall##2##3##(2011-2#2)
of abdominal##51##2##(1991-2#3)(1991-3#2)(1992-2#1)(1992-5#3)(1993-5#1)(1993-9#1)(1995-3#1)(1996-2#1)(1997-5#2)(1997-7#1)(2007-12#4)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of abduction and##4##3##(2007-11#3)(2011-2#1)
of abduction##5##2##(2007-11#3)(2008-8#1)(2011-2#1)
of aberrant##8##2##(1991-12#1)(1992-9#1)(1995-9#1)(1996-12#1)(2008-11#1)(2008-3#1)(2009-5#2)
of aberration##4##2##(2008-3#4)
of aberrations##6##2##(2008-3#6)
of ability to pay##2##4##(1992-2#1)(1994-2#1)
of ability to##9##3##(1990-2#1)(1992-2#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)
of ability##10##2##(1990-2#1)(1992-2#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-12#1)(2011-2#1)
of abiotic##4##2##(2008-10#1)(2008-8#1)(2009-10#1)(2013-8#1)
of abl##2##2##(2012-12#2)
of ablation##5##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)
of abnormal cardiac function##2##4##(2011-2#2)
of abnormal cells##3##3##(2008-1#1)(2008-10#1)(2012-3#1)
of abnormal endometrial##2##3##(1994-9#2)
of abnormal joint torque coupling##2##5##(2010-7#2)
of abnormal micro-lesions##5##3##(2012-2#5)
of abnormal results##3##3##(2007-11#1)(2007-2#1)(2013-1#1)
of abnormal ventricular septal motion in##2##6##(2012-2#2)
of abnormal##56##2##(1990-12#1)(1990-8#4)(1990-9#2)(1991-12#1)(1991-2#1)(1992-12#1)(1994-3#1)(1994-9#2)(1995-5#1)(1996-11#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-7#2)(2010-8#4)(2011-2#4)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
of abnormalities and##2##3##(2012-2#2)
of abnormalities in the##2##4##(2008-4#1)(2008-9#1)
of abnormalities in##5##3##(1990-2#1)(1997-8#1)(2008-4#1)(2008-9#1)(2011-1#1)
of abnormalities of##4##3##(1993-9#1)(2007-10#1)(2008-6#1)(2011-2#1)
of abnormalities##14##2##(1990-2#1)(1993-9#1)(1997-8#1)(2007-10#2)(2008-4#2)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#3)
of abnormality##2##2##(1991-12#1)(2008-12#1)
of aborted##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
of abortion and##2##3##(1990-8#1)(2008-11#1)
of abortion##13##2##(1990-8#1)(1991-6#1)(1993-2#1)(1994-2#4)(2008-11#2)(2008-9#1)(2012-3#2)(2013-8#1)
of abortions##6##2##(1991-3#2)(1994-2#3)(2008-11#1)
of abortive##2##2##(1991-9#1)(1997-4#1)
of about 0##15##3##(1992-6#1)(1995-6#1)(1996-12#1)(2008-10#9)(2008-8#2)(2009-5#1)
of about 1##12##3##(1990-12#1)(1990-2#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
of about 10##6##3##(1990-11#1)(2008-10#5)
of about 10%##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
of about 10(7)##2##3##(2008-10#2)
of about 100##5##3##(1991-5#1)(1997-3#1)(2007-12#1)(2008-10#2)
of about 12##2##3##(2008-7#1)(2010-12#1)
of about 14##2##3##(1990-2#1)(2008-8#1)
of about 15##3##3##(1990-8#1)(1993-11#1)(2008-11#1)
of about 18##2##3##(1990-2#1)(2008-8#1)
of about 2##7##3##(1995-5#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-5#2)
of about 20##5##3##(1990-7#1)(1995-4#1)(2008-1#1)(2008-10#1)(2008-8#1)
of about 24##2##3##(1992-8#1)(2008-10#1)
of about 25% in##2##4##(1993-11#1)(2008-7#1)
of about 25%##3##3##(1993-11#1)(1993-8#1)(2008-7#1)
of about 3##3##3##(1993-6#1)(2008-10#2)
of about 30 kDa##2##4##(1990-5#1)(1994-11#1)
of about 30##5##3##(1990-5#1)(1994-11#1)(1996-12#1)(2008-10#2)
of about 32##2##3##(1997-6#1)(2013-8#1)
of about 35##3##3##(1991-5#1)(1993-3#1)(2012-12#1)
of about 4 x##2##4##(2008-10#1)(2008-11#1)
of about 4##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
of about 40##2##3##(2008-1#1)(2008-10#1)
of about 40% of##2##4##(1996-6#1)(2011-3#1)
of about 40%##3##3##(1996-6#1)(2008-12#1)(2011-3#1)
of about 50##4##3##(2008-10#3)(2009-5#1)
of about 60 samples##2##4##(2008-10#2)
of about 60##3##3##(1997-7#1)(2008-10#2)
of about 70##3##3##(1994-11#1)(2008-6#1)(2008-8#1)
of about 70%##2##3##(1991-12#1)(2008-12#1)
of about a##3##3##(1995-11#1)(2008-11#1)(2010-12#1)
of about two##2##3##(2008-10#1)(2010-4#1)
of about##193##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#2)(1997-2#3)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#66)(2008-11#8)(2008-12#3)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
of above##3##2##(1990-5#1)(2008-10#2)
of absence of##3##3##(1997-3#1)(2012-2#1)(2013-1#1)
of absence seizures in##2##4##(1992-3#1)(2009-9#1)
of absence seizures##3##3##(1992-3#1)(2009-9#2)
of absence##7##2##(1992-3#1)(1992-4#1)(1997-3#1)(2009-9#2)(2012-2#1)(2013-1#1)
of absolute##19##2##(1994-12#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#7)(2008-9#1)(2009-4#1)(2010-8#1)
of absorbance at##3##3##(2008-10#3)
of absorbance measurements##2##3##(2008-10#2)
of absorbance versus sample loading flow rate##2##7##(2008-10#2)
of absorbance versus##3##3##(2008-10#3)
of absorbance##17##2##(2008-10#14)(2008-12#1)(2008-3#1)(2010-7#1)
of absorbances##3##2##(1990-12#1)(2008-10#2)
of absorbed pump power##3##4##(2007-12#1)(2008-2#2)
of absorbed##10##2##(2007-12#1)(2008-2#5)(2008-3#1)(2012-1#2)(2012-12#1)
of absorber concentrations in##2##4##(2007-12#2)
of absorber##3##2##(2007-12#2)(2008-3#1)
of absorbers##3##2##(2008-3#3)
of absorbing and scattering##2##4##(2008-2#2)
of absorbing particles##2##3##(2007-11#1)(2007-12#1)
of absorbing species##2##3##(2008-3#2)
of absorbing##13##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#5)(2011-2#1)
of absorption and backscattering coefficients##2##5##(2008-2#2)
of absorption and scattering coefficients##2##5##(2008-3#2)
of absorption and scattering##5##4##(2008-3#5)
of absorption and##15##3##(1993-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#7)
of absorption coefficients##2##3##(2008-2#1)(2008-3#1)
of absorption of the##2##4##(2008-11#1)(2008-3#1)
of absorption of##5##3##(2008-11#1)(2008-3#3)(2008-5#1)
of absorption spectra##3##3##(2008-10#2)(2008-3#1)
of absorption##46##2##(1993-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#8)(2008-3#19)(2008-5#2)(2008-9#1)
of absorptive##3##2##(2008-10#1)(2008-3#2)
of absorptivity##2##2##(2008-10#1)(2008-2#1)
of abstinence##3##2##(1995-11#1)(2009-5#1)(2013-8#1)
of abstract##2##2##(2007-12#1)(2010-4#1)
of abundance##3##2##(1992-12#1)(2008-7#1)(2012-12#1)
of abundant##6##2##(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#2)(2012-12#1)
of abuse (C2 (1##2##4##(2010-3#2)
of abuse##27##2##(1991-1#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-10#5)(2008-3#1)(2009-7#1)(2010-12#1)(2010-3#2)(2012-1#1)(2012-12#4)(2012-3#2)(2013-8#3)
of abused women##2##3##(2010-3#2)
of abused##3##2##(2010-3#2)(2010-4#1)
of academia##2##2##(2008-1#1)(2012-3#1)
of academic advising##2##3##(2010-3#2)
of academic health centers##2##4##(1996-1#1)(1997-2#1)
of academic health##3##3##(1996-1#1)(1997-2#2)
of academic##20##2##(1993-1#1)(1994-3#1)(1996-1#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#2)(2011-2#2)(2012-2#1)
of acamprosate in##2##3##(2008-2#2)
of acamprosate##4##2##(2008-2#4)
of acarbose##2##2##(1994-12#2)
of accelerated##7##2##(1995-9#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#3)
of accelerating slip##2##3##(1996-4#2)
of accelerating##3##2##(1990-6#1)(1996-4#2)
of acceleration##4##2##(1994-9#1)(1996-4#1)(2008-10#1)(2013-1#1)
of acceptability##4##2##(1994-2#1)(2008-6#1)(2009-11#1)(2010-8#1)
of acceptable##6##2##(1991-12#1)(1992-3#1)(2008-3#2)(2008-7#1)(2008-8#1)
of acceptance and##2##3##(2007-11#1)(2008-3#1)
of acceptance of the disease##2##5##(1993-11#2)
of acceptance of##4##3##(1992-11#1)(1993-11#2)(1994-2#1)
of acceptance##12##2##(1990-10#1)(1992-11#1)(1993-11#2)(1994-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-1#1)(2012-2#1)
of accepted##3##2##(2006-6#1)(2008-5#1)(2008-6#1)
of accepting##3##2##(1993-11#1)(2008-7#1)(2008-8#1)
of acceptor##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
of access and##2##3##(1995-12#1)(2008-4#1)
of access for##2##3##(2008-11#1)(2011-2#1)
of access site complications##2##4##(2011-2#2)
of access site##3##3##(2011-2#3)
of access to care##3##4##(1995-12#1)(1997-4#1)(2013-8#1)
of access to health care##2##5##(2008-11#1)(2009-5#1)
of access to health##4##4##(2008-11#1)(2009-5#1)(2012-12#2)
of access to services##2##4##(1994-12#1)(1997-5#1)
of access to##20##3##(1992-3#1)(1993-12#2)(1994-12#1)(1995-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#2)(2010-10#1)(2010-8#1)(2012-12#2)(2013-8#1)
of access##36##2##(1992-3#2)(1993-12#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1996-1#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#2)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#1)
of accessing##4##2##(1997-3#1)(2009-6#1)(2011-1#1)(2012-12#1)
of accessions##3##2##(2008-10#3)
of accessory gland secretion##2##4##(2007-12#2)
of accessory##5##2##(2007-12#3)(2008-7#2)
of accidental pleurotomy##3##3##(2007-8#3)
of accidental##9##2##(1991-8#1)(1995-3#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
of accidents and##3##3##(1990-6#1)(2010-5#1)(2011-2#1)
of accidents##6##2##(1990-6#2)(1995-8#1)(2007-10#1)(2010-5#1)(2011-2#1)
of accommodation##3##2##(1990-3#2)(2012-12#1)
of accountability for##2##3##(2008-6#1)(2008-7#1)
of accountability##4##2##(1993-12#1)(2008-6#2)(2008-7#1)
of accreditation to the##2##4##(1996-12#2)
of accreditation to##3##3##(1996-12#3)
of accreditation##5##2##(1992-1#1)(1996-12#4)
of acculturation##8##2##(2007-12#2)(2008-8#3)(2010-8#1)(2012-2#2)
of accumulated##8##2##(1991-12#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
of accumulation of##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
of accumulation was##2##3##(2008-11#1)(2008-12#1)
of accumulation##9##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
of accuracy and precision##3##4##(2008-10#2)(2008-3#1)
of accuracy and##5##3##(1990-2#1)(2008-10#3)(2008-3#1)
of accuracy in##4##3##(1994-7#1)(2008-12#1)(2008-2#1)(2008-3#1)
of accuracy of##6##3##(1993-5#1)(1995-6#2)(2008-10#2)(2009-5#1)
of accuracy that##2##3##(2008-3#2)
of accuracy##39##2##(1990-2#1)(1993-5#1)(1994-7#1)(1995-6#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#8)(2008-9#1)(2009-5#2)(2010-4#1)(2012-2#1)(2013-1#1)
of accurate and##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
of accurate control##2##3##(2008-10#2)
of accurate diagnosis and##2##4##(2007-7#1)(2008-8#1)
of accurate information##2##3##(1996-3#1)(2007-2#1)
of accurate##15##2##(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
of accurately measuring##3##3##(1993-1#1)(2007-12#1)(2013-1#1)
of accurately##7##2##(1993-1#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2013-1#1)
of acellular##2##2##(1997-8#1)(2008-5#1)
of acesulfame potassium in##2##4##(2008-9#2)
of acesulfame potassium##3##3##(2008-9#3)
of acetabular##4##2##(2008-11#1)(2008-8#3)
of acetaldehyde##6##2##(1994-5#2)(2007-12#2)(2008-2#1)(2011-2#1)
of acetamide##2##2##(2008-6#2)
of acetaminophen##13##2##(1991-9#2)(2007-10#1)(2008-10#7)(2008-11#1)(2008-3#1)(2013-8#1)
of acetate buffer##3##3##(2008-10#3)
of acetate##16##2##(1997-2#1)(2008-10#9)(2008-6#2)(2008-7#2)(2011-1#1)(2013-8#1)
of acetazolamide and##2##3##(2008-10#2)
of acetic acid was##3##4##(1991-5#2)(2008-6#1)
of acetic acid with##2##4##(2008-10#2)
of acetic acid##20##3##(1991-5#2)(1994-8#1)(2008-10#6)(2008-6#10)(2012-2#1)
of acetic##24##2##(1991-5#2)(1994-8#1)(2007-11#1)(2008-10#8)(2008-3#1)(2008-6#10)(2012-2#1)
of acetoin##3##2##(2008-6#2)(2013-1#1)
of acetone and##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
of acetone fluorescence##2##3##(2008-2#2)
of acetone was##3##3##(2008-10#1)(2008-2#1)(2009-12#1)
of acetone##17##2##(2008-10#7)(2008-2#8)(2008-9#1)(2009-12#1)
of acetonitrile and##5##3##(2008-10#3)(2011-1#1)(2012-12#1)
of acetonitrile##13##2##(1994-9#1)(2008-10#10)(2011-1#1)(2012-12#1)
of acetonitrile-water##3##2##(2008-10#3)
of acetyl CoA##6##3##(1993-11#6)
of acetyl##11##2##(1993-11#6)(1995-6#1)(2008-10#1)(2008-8#1)(2013-1#2)
of acetyl-L-carnitine##8##2##(1990-3#1)(1990-7#1)(1992-7#4)(1997-2#2)
of acetylated H3 and H4##2##5##(2011-2#2)
of acetylation##2##2##(2008-10#2)
of acetylcholine (ACh)##2##3##(2008-8#1)(2009-8#1)
of acetylcholine and##3##3##(2008-8#1)(2013-1#2)
of acetylcholine in##5##3##(1994-8#4)(2008-10#1)
of acetylcholine release##2##3##(1992-3#1)(2013-8#1)
of acetylcholine##25##2##(1992-3#2)(1993-12#1)(1993-9#1)(1994-8#4)(1995-11#1)(1995-12#1)(2008-10#5)(2008-8#3)(2009-8#2)(2013-1#4)(2013-8#1)
of acetylcholinesterase##5##2##(1990-5#2)(1992-8#1)(1994-8#1)(2008-10#1)
of acetylene##4##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
of acetylsalicylic acid##6##3##(2008-10#6)
of achalasia##3##2##(2011-1#3)
of achievement##5##2##(1994-1#1)(2008-12#2)(2009-12#1)(2013-1#1)
of achieving a balance between##2##5##(1997-5#1)(2008-11#1)
of achieving a target weight##2##5##(2013-1#2)
of achieving a##11##3##(1990-6#1)(1994-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-4#1)(2013-1#2)
of achieving high##2##3##(2008-10#1)(2008-3#1)
of achieving the##3##3##(1990-11#1)(2008-7#1)(2013-1#1)
of achieving this##3##3##(2007-7#1)(2008-2#1)(2010-10#1)
of achieving universal access to##2##5##(2009-7#2)
of achieving##33##2##(1990-11#1)(1990-2#1)(1990-6#1)(1994-3#1)(1996-3#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#3)
of achondrogenesis type II##3##4##(2010-4#3)
of achromatic and##2##3##(2007-11#1)(2008-3#1)
of acid and##3##3##(2008-10#2)(2008-5#1)
of acid concentration was##2##4##(2008-10#1)(2013-1#1)
of acid concentration##3##3##(2008-10#2)(2013-1#1)
of acid dissociation constants based on##2##6##(2008-10#2)
of acid dissociation constants##4##4##(2008-10#4)
of acid invertase##6##3##(2008-9#6)
of acid phosphatase##3##3##(1995-3#1)(2008-11#1)(2008-7#1)
of acid rain##2##3##(2008-10#2)
of acid##57##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-6#1)(1993-10#1)(1993-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-4#2)(2008-10#31)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#6)(2010-3#1)(2012-2#2)(2013-1#2)
of acid-base indicators##2##3##(2008-10#2)
of acid-base##4##2##(2008-10#4)
of acidic and##2##3##(1994-9#1)(2008-10#1)
of acidic##16##2##(1992-6#1)(1994-3#1)(1994-5#2)(1994-9#1)(1997-7#1)(2008-10#7)(2008-5#1)(2008-8#2)
of acidified##5##2##(1990-12#1)(2008-10#3)(2012-12#1)
of acidity constants of some##2##5##(2008-10#2)
of acidity constants of##4##4##(2008-10#4)
of acidity constants##6##3##(2008-10#6)
of acidity##12##2##(2008-10#11)(2008-5#1)
of acids and bases##2##4##(2008-10#2)
of acids##9##2##(2008-10#8)(2008-5#1)
of acinar cells and##3##4##(1995-11#3)
of acinar cells##4##3##(1995-11#4)
of acivicin##2##2##(2008-7#2)
of acne vulgaris##10##3##(1997-8#1)(2007-7#2)(2008-5#2)(2010-8#5)
of acne##16##2##(1997-8#1)(2007-7#2)(2008-5#6)(2009-2#1)(2010-8#5)(2012-12#1)
of acoustic energy##2##3##(1993-5#1)(2009-5#1)
of acoustic neuroma##2##3##(2008-7#1)(2011-2#1)
of acoustic wave##2##3##(2008-10#1)(2009-3#1)
of acoustic##13##2##(1993-5#1)(1993-9#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-5#2)(2011-2#1)
of acousto-optic (AO)##2##3##(2008-2#2)
of acousto-optic devices##2##3##(2007-12#1)(2008-10#1)
of acousto-optic tunable filters##2##4##(2008-10#2)
of acousto-optic##8##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)
of acquired immunodeficiency syndrome (AIDS)##5##5##(1991-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2011-3#1)
of acquired immunodeficiency syndrome##6##4##(1991-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-12#1)(2011-3#1)
of acquired immunodeficiency##7##3##(1991-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-12#1)(2011-2#1)(2011-3#1)
of acquired resistance##2##3##(2010-5#2)
of acquired##22##2##(1991-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-2#2)
of acquiring new##2##3##(1997-3#1)(2007-2#1)
of acquiring##12##2##(1994-1#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
of acquisition of##3##3##(1994-8#1)(2007-7#1)(2008-10#1)
of acquisition##9##2##(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#3)(2008-5#2)(2011-1#1)
of acridine orange##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
of acrivastine in##4##3##(2008-10#4)
of acrivastine##5##2##(2008-10#5)
of acromegaly##2##2##(2008-5#1)(2011-2#1)
of acroporid##3##2##(2007-5#3)
of acrosome##5##2##(2008-7#2)(2012-2#1)(2013-1#2)
of acrylamide##3##2##(2008-10#2)(2008-2#1)
of acrylic acid##3##3##(2008-5#1)(2008-6#1)(2009-9#1)
of acrylic##8##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2013-1#1)
of actigraphy##2##2##(2008-6#1)(2012-12#1)
of actin and myosin##4##4##(1990-5#1)(1991-5#1)(1992-2#1)(1992-9#1)
of actin and##5##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-9#1)(2008-11#1)
of actin cytoskeleton##2##3##(1997-7#1)(2008-9#1)
of actin dynamics in##2##4##(2008-11#1)(2012-2#1)
of actin dynamics##3##3##(2008-11#1)(2012-2#2)
of actin filament bundles at the##2##6##(2012-2#2)
of actin filament bundles##3##4##(2012-2#3)
of actin filament##5##3##(1994-6#1)(1996-12#1)(2012-2#3)
of actin filaments and##2##4##(1993-8#1)(2007-12#1)
of actin filaments##12##3##(1993-8#1)(1993-9#1)(1994-6#1)(2007-12#1)(2008-1#4)(2008-7#1)(2009-9#2)(2012-2#1)
of actin in##3##3##(1993-3#1)(1995-2#1)(1996-12#1)
of actin polymerization##2##3##(1996-5#1)(1997-6#1)
of actin##53##2##(1990-5#1)(1991-5#4)(1992-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#6)(2008-11#5)(2008-4#1)(2008-7#2)(2008-9#2)(2009-9#2)(2010-2#1)(2011-2#1)(2012-2#9)
of actin-binding proteins##3##3##(2008-1#2)(2011-2#1)
of actin-binding##4##2##(1993-8#1)(2008-1#2)(2011-2#1)
of actinic keratosis##2##3##(1990-6#1)(2010-8#1)
of actinic##4##2##(1990-6#1)(2008-5#1)(2010-8#2)
of actinides and##3##3##(2008-10#3)
of actinomycetes##4##2##(2008-10#3)(2010-12#1)
of actinomycin D##4##3##(1991-5#1)(1992-8#1)(1997-2#1)(2008-11#1)
of action and the##4##4##(1991-12#1)(1991-2#1)(1995-8#1)(2008-7#1)
of action and##23##3##(1991-12#1)(1991-2#2)(1993-12#1)(1993-2#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)
of action as##3##3##(2011-2#3)
of action by##3##3##(1991-1#1)(2008-10#1)(2012-2#1)
of action for the##3##4##(1993-3#1)(2008-11#1)(2008-7#1)
of action for##14##3##(1993-3#2)(1994-1#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#2)(2010-9#1)
of action in##4##3##(1992-12#1)(1996-2#1)(2010-10#1)(2012-12#1)
of action include##2##3##(2008-10#1)(2008-5#1)
of action is unknown##2##4##(1990-12#1)(2009-12#1)
of action is##5##3##(1990-12#1)(1994-6#1)(2008-6#1)(2009-12#1)(2010-10#1)
of action of the drugs##2##5##(1997-1#1)(2011-1#1)
of action of the##18##4##(1992-9#1)(1994-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-8#1)
of action of these##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
of action of this##2##4##(1996-3#1)(1997-2#1)
of action of##89##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-7#1)(2013-8#2)
of action on##2##3##(1990-12#1)(2011-3#1)
of action potential##3##3##(1993-12#1)(2008-4#1)(2013-8#1)
of action potentials in the##2##5##(1992-12#1)(2009-12#1)
of action potentials##8##3##(1992-12#1)(1997-6#1)(2008-11#2)(2008-4#1)(2009-12#2)(2009-8#1)
of action studies##2##3##(2011-2#2)
of action than the##3##4##(1991-5#1)(2008-7#2)
of action than##4##3##(1991-5#1)(1994-6#1)(2008-7#2)
of action that##4##3##(1993-1#1)(2008-10#1)(2008-11#1)(2010-3#1)
of action##274##2##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-5#3)(1994-6#2)(1994-8#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#1)(2007-11#4)(2007-8#1)(2008-1#4)(2008-10#36)(2008-11#18)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#13)(2008-6#6)(2008-7#20)(2008-8#5)(2008-9#3)(2009-12#4)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
of action&quot##2##2##(1991-3#1)(2008-7#1)
of actions and##3##3##(1991-1#1)(2008-11#1)(2008-8#1)
of actions##11##2##(1991-1#1)(1993-2#1)(1996-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
of activated B cells (NF-κB)##2##5##(2012-3#1)(2013-1#1)
of activated B cells##5##4##(1991-3#2)(1995-6#1)(2012-3#1)(2013-1#1)
of activated T cells##2##4##(2009-6#1)(2010-5#1)
of activated carbon##3##3##(2008-6#3)
of activated cells##2##3##(2008-10#1)(2008-4#1)
of activated charcoal##2##3##(2008-10#2)
of activated esters to##2##4##(2008-4#2)
of activated human##2##3##(1995-12#1)(2008-7#1)
of activated macrophages##3##3##(1993-12#1)(1994-5#2)
of activated platelets##2##3##(1991-12#1)(1997-7#1)
of activated##45##2##(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-6#4)(1997-7#2)(2008-10#7)(2008-4#3)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
of activating##9##2##(1990-2#1)(1992-8#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
of activation and##4##3##(1991-6#1)(1992-11#1)(2008-6#1)(2008-8#1)
of activation by##3##3##(1990-5#1)(1990-7#1)(1995-6#1)
of activation can##2##3##(2008-4#1)(2012-2#1)
of activation in##2##3##(1995-11#1)(2013-8#1)
of activation of the##5##4##(1991-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(2008-10#1)
of activation of##11##3##(1990-12#1)(1991-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-2#1)(2008-10#1)(2010-10#1)
of activation was##3##3##(1992-9#1)(1995-8#1)(2009-6#1)
of activation within##3##3##(2008-11#3)
of activation##47##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-2#2)(2006-6#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#3)(2010-10#1)(2010-11#1)(2012-2#3)(2013-8#1)
of activator protein-1##2##3##(1994-6#2)
of activator##3##2##(1994-6#2)(2008-8#1)
of active TrPs##2##3##(2010-9#2)
of active and##4##3##(2008-12#1)(2008-7#1)(2009-8#1)(2012-2#1)
of active enzyme##2##3##(1992-11#1)(1993-8#1)
of active genes in##3##4##(1996-10#2)(1996-2#1)
of active growth##2##3##(1994-6#1)(2008-7#1)
of active ingredient##4##3##(2008-5#4)
of active ingredients in##3##4##(2008-10#2)(2010-9#1)
of active ingredients'##2##3##(2008-5#2)
of active molecules##2##3##(2008-10#1)(2010-12#1)
of active nanostructures##2##3##(2010-12#2)
of active oxygen radicals##3##4##(1996-2#3)
of active recombinant##2##3##(2008-11#2)
of active site residues##2##4##(1992-11#1)(1995-2#1)
of active sites##2##3##(2008-10#1)(2008-4#1)
of active substances##2##3##(2008-10#1)(2011-1#1)
of active##117##2##(1990-9#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-10#2)(1996-2#4)(1996-5#2)(1997-1#1)(1997-7#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#4)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
of actively growing##2##3##(1994-5#1)(2008-10#1)
of actively##7##2##(1993-1#1)(1993-12#1)(1994-5#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of actives##2##2##(2008-5#2)
of activin A##3##3##(1992-6#1)(1995-8#2)
of activin A-##2##3##(1994-9#2)
of activin on##2##3##(1990-11#2)
of activin##12##2##(1990-11#3)(1992-6#2)(1992-8#1)(1993-8#1)(1994-9#3)(1995-8#2)
of activin-A##2##2##(1994-11#2)
of activities and##2##3##(2011-1#1)(2012-12#1)
of activities in##2##3##(1990-11#1)(2007-11#1)
of activities of the##2##4##(1996-2#1)(2012-12#1)
of activities of##6##3##(1994-11#1)(1996-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
of activities that##2##3##(2008-12#1)(2013-7#1)
of activities##29##2##(1990-11#2)(1991-1#1)(1993-12#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
of activity against##3##3##(2008-5#1)(2010-3#1)(2010-5#1)
of activity and the##2##4##(2007-6#1)(2008-7#1)
of activity and##9##3##(1995-3#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-3#1)
of activity as##2##3##(1990-10#1)(1992-12#1)
of activity at##2##3##(1996-4#1)(2013-1#1)
of activity between##2##3##(1996-1#1)(2008-10#1)
of activity by##2##3##(1992-3#1)(1995-8#1)
of activity coefficients##2##3##(2008-10#1)(2008-5#1)
of activity from##2##3##(1997-1#1)(2008-10#1)
of activity in the##4##4##(1991-12#1)(1993-3#1)(2008-11#1)(2008-4#1)
of activity in##10##3##(1991-12#1)(1991-2#1)(1993-3#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)
of activity of the##6##4##(1990-11#1)(1993-8#1)(1994-2#2)(2008-5#1)(2008-7#1)
of activity of##16##3##(1990-11#1)(1993-8#1)(1994-2#2)(1995-11#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2013-1#3)
of activity on the##2##4##(1995-12#1)(2008-9#1)
of activity on##5##3##(1992-9#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
of activity that##2##3##(1995-2#1)(2009-8#1)
of activity##114##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#6)
of activity)##3##2##(2008-10#2)(2008-7#1)
of activity-dependent##2##2##(1996-2#1)(1997-7#1)
of actual##17##2##(1991-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-5#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
of acu-moxibustion##2##2##(2012-3#2)
of acupuncture and##4##3##(2008-10#1)(2012-3#2)(2013-1#1)
of acupuncture in##2##3##(1995-12#1)(2007-10#1)
of acupuncture practice in##2##4##(2008-10#2)
of acupuncture skills##2##3##(2012-3#2)
of acupuncture treatment##2##3##(2010-7#1)(2013-1#1)
of acupuncture##36##2##(1993-3#1)(1993-7#1)(1995-12#4)(1997-6#1)(2007-10#1)(2008-10#12)(2010-7#2)(2012-3#11)(2013-1#3)
of acute EtOH administration##2##4##(2008-10#2)
of acute PE##2##3##(2011-2#2)
of acute PID##2##3##(2007-7#2)
of acute Q fever##2##4##(2007-12#2)
of acute ST##2##3##(2008-3#1)(2010-5#1)
of acute abdomen##7##3##(1993-5#1)(2007-7#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
of acute and chronic##8##4##(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)
of acute and##13##3##(1994-11#1)(1995-12#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#2)
of acute aortic dissection##2##4##(2011-2#1)(2013-1#1)
of acute appendicitis in children##2##5##(2013-1#2)
of acute appendicitis##5##3##(1993-6#1)(2009-7#1)(2011-2#1)(2013-1#2)
of acute arterial thrombosis##2##4##(2006-6#1)(2011-2#1)
of acute back pain##2##4##(1993-6#1)(2007-11#1)
of acute bacterial meningitis##2##4##(1996-3#1)(2010-12#1)
of acute bacterial pneumonia in##2##5##(1991-3#2)
of acute bacterial##5##3##(1991-3#2)(1996-3#1)(2008-10#1)(2010-12#1)
of acute carbon monoxide poisoning##2##5##(1990-5#1)(1991-9#1)
of acute care##6##3##(1992-3#1)(1994-3#2)(1996-1#1)(2007-12#2)
of acute cholecystitis##2##3##(1990-9#1)(2008-5#1)
of acute colonic diverticulitis##2##4##(2009-8#2)
of acute compartment syndrome##2##4##(2009-1#1)(2009-3#1)
of acute complications##3##3##(1994-6#2)(2013-7#1)
of acute coronary syndrome and##3##5##(2008-3#2)(2011-2#1)
of acute coronary syndrome##7##4##(2008-3#6)(2011-2#1)
of acute coronary syndromes##10##4##(2008-3#9)(2009-10#1)
of acute coronary##18##3##(2008-3#15)(2008-7#1)(2009-10#1)(2011-2#1)
of acute diarrhoea##3##3##(2007-7#2)(2009-5#1)
of acute exacerbation##2##3##(2008-1#1)(2010-2#1)
of acute exacerbations##2##3##(2011-2#2)
of acute gastroenteritis##2##3##(1996-6#1)(2011-2#1)
of acute hepatitis##5##3##(1995-3#1)(1996-3#1)(2007-12#1)(2008-7#1)(2010-8#1)
of acute infection##4##3##(2007-8#1)(2008-2#1)(2008-4#1)(2009-4#1)
of acute inflammatory##2##3##(2008-7#1)(2008-8#1)
of acute intestinal##2##3##(1990-3#1)(1993-5#1)
of acute ischaemic stroke##2##4##(1992-2#2)
of acute ischaemic##3##3##(1992-2#2)(2011-2#1)
of acute ischemic stroke##3##4##(2007-10#2)(2009-11#1)
of acute ischemic##4##3##(2007-10#3)(2009-11#1)
of acute leukemia##2##3##(2008-9#1)(2013-1#1)
of acute medical##2##3##(1991-6#1)(2010-12#1)
of acute myelogenous leukemia##2##4##(1997-4#1)(2010-4#1)
of acute myeloid leukemia (AML)##2##5##(2011-2#1)(2012-12#1)
of acute myeloid leukemia##4##4##(1990-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
of acute myocardial infarct##2##4##(1990-9#1)(1991-6#1)
of acute myocardial infarction (AMI)##3##5##(2008-10#1)(2008-3#1)(2009-6#1)
of acute myocardial infarction and##3##5##(2008-3#1)(2011-1#1)(2012-2#1)
of acute myocardial infarction in##3##5##(1991-9#1)(2009-4#1)(2010-11#1)
of acute myocardial infarction##20##4##(1990-12#1)(1990-9#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
of acute myocardial##23##3##(1990-12#1)(1990-9#2)(1991-6#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
of acute onset##4##3##(2006-10#1)(2007-5#1)(2008-1#1)(2013-1#1)
of acute or##3##3##(1990-6#1)(1991-3#1)(1992-9#1)
of acute pain##4##3##(2013-1#4)
of acute pancreatitis is##2##4##(2013-1#2)
of acute pancreatitis##12##3##(1990-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#6)(2013-8#2)
of acute pulmonary##2##3##(2010-6#1)(2011-2#1)
of acute pyelonephritis##2##3##(2007-7#1)(2008-10#1)
of acute rejection##6##3##(1991-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
of acute renal failure (ARF)##4##5##(2008-1#2)(2008-4#2)
of acute renal failure in##3##5##(2008-1#2)(2008-4#1)
of acute renal failure##12##4##(2008-1#4)(2008-4#6)(2008-8#2)
of acute respiratory##7##3##(1993-5#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-12#3)
of acute spinal##2##3##(1992-6#1)(2012-12#1)
of acute stress##4##3##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of acute stroke treatment##2##4##(2007-10#2)
of acute stroke##14##3##(1995-5#1)(2007-10#7)(2007-9#1)(2008-7#1)(2008-8#1)(2009-11#2)(2013-8#1)
of acute toxicity of##2##4##(2008-12#1)(2013-1#1)
of acute toxicity##3##3##(2008-12#2)(2013-1#1)
of acute viral hepatitis##4##4##(2007-12#1)(2007-7#2)(2010-4#1)
of acute##362##2##(1990-12#1)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-5#3)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#3)(1994-9#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-6#2)(2007-10#10)(2007-11#3)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#12)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#11)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#24)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#4)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#25)(2012-1#2)(2012-12#9)(2012-2#6)(2012-3#2)(2013-1#28)(2013-7#1)(2013-8#8)
of acutely and chronically##2##4##(1990-3#1)(1992-8#1)
of acutely##6##2##(1990-3#1)(1991-2#2)(1992-8#1)(1992-9#1)(2007-10#1)
of acyclovir##6##2##(1991-12#1)(1994-3#1)(1995-2#1)(1995-6#2)(2007-7#1)
of acyl##3##2##(1992-6#1)(1997-2#1)(2008-8#1)
of acyl-chain length##2##3##(1992-6#2)
of acylation##3##2##(1990-8#3)
of acylglycerols##3##2##(2009-8#3)
of adaptation to##10##3##(1992-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
of adaptation##20##2##(1991-4#1)(1992-11#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#6)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
of adapted##6##2##(1994-8#1)(2008-10#1)(2008-11#1)(2013-8#3)
of adapter##2##2##(2008-2#1)(2008-6#1)
of adapting##2##2##(2008-2#1)(2009-8#1)
of adaptive and##2##3##(2008-2#1)(2008-7#1)
of adaptive deme formation in phytophagous##2##6##(2008-9#2)
of adaptive deme formation##3##4##(2008-9#3)
of adaptive evolution##2##3##(2008-8#2)
of adaptive mutations##2##3##(2008-9#2)
of adaptive optics##6##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#2)
of adaptive radiation in##2##4##(2008-8#2)
of adaptive radiation##3##3##(2008-8#3)
of adaptive##43##2##(1990-8#1)(1996-1#1)(1996-12#2)(1996-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#2)(2008-8#10)(2008-9#5)(2009-3#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#3)(2013-1#2)(2013-8#2)
of adaptive-optics##2##2##(2008-2#1)(2008-3#1)
of adaptively##2##2##(2008-10#1)(2008-8#1)
of adaptivity##3##2##(2008-3#3)
of adaptors##2##2##(2008-2#1)(2012-12#1)
of add-on devices##2##3##(1996-2#1)(1997-1#1)
of add-on##3##2##(1996-2#1)(1997-1#1)(2009-10#1)
of added##21##2##(1990-11#3)(1990-12#1)(1990-9#1)(1991-5#1)(1991-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-10#7)(2008-11#1)(2009-8#1)
of addicted##2##2##(2011-1#2)
of addiction and##2##3##(2013-1#1)(2013-8#1)
of addiction##8##2##(1991-1#1)(2008-12#1)(2008-4#2)(2013-1#2)(2013-8#2)
of addictions##2##2##(2009-10#1)(2013-8#1)
of adding a##4##3##(1991-1#1)(1997-3#2)(2008-10#1)
of adding##16##2##(1991-1#1)(1997-3#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
of addition of##4##3##(2008-10#3)(2008-11#1)
of addition##7##2##(1992-11#1)(1994-11#1)(2008-10#3)(2008-11#2)
of additional curing)##2##3##(2008-10#2)
of additional factors##2##3##(1997-2#1)(2008-11#1)
of additional significant##2##3##(2007-11#1)(2011-2#1)
of additional##70##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-2#2)(1991-6#1)(1992-2#2)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#3)(2011-2#4)(2013-1#2)(2013-7#1)
of additive effects##2##3##(2007-11#1)(2008-9#1)
of additive##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
of additives in##2##3##(2008-10#1)(2012-3#1)
of additives##9##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-11#2)(2012-3#2)
of additivity##2##2##(1995-11#1)(2008-10#1)
of addressing##6##2##(1995-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
of adduct levels##2##3##(2008-12#2)
of adduct##7##2##(1994-5#1)(2008-10#4)(2008-12#2)
of adducts##3##2##(2008-10#2)(2008-12#1)
of adefovir-resistant##3##2##(2013-1#3)
of adenine nucleotides##6##3##(1991-8#1)(1992-6#2)(2008-7#3)
of adenine##13##2##(1991-8#1)(1992-6#2)(1995-6#1)(2008-10#4)(2008-11#2)(2008-7#3)
of adenocarcinoma##7##2##(1991-3#1)(1991-4#1)(2008-1#3)(2008-10#1)(2011-2#1)
of adenocarcinomas##2##2##(1992-9#1)(1994-9#1)
of adenoma##2##2##(2010-12#1)(2013-8#1)
of adenomas##5##2##(1992-5#1)(1992-6#1)(2009-12#1)(2012-3#1)(2013-8#1)
of adenomatoid odontogenic##2##3##(2013-1#2)
of adenomatous polyps##5##3##(1997-8#3)(2008-1#1)(2009-12#1)
of adenomatous##7##2##(1997-8#3)(2006-12#1)(2008-1#1)(2008-4#1)(2009-12#1)
of adenoregulin##3##2##(1993-3#3)
of adenosine 3'##2##3##(1990-12#1)(1994-9#1)
of adenosine A1 receptors##4##4##(1995-12#1)(1997-1#3)
of adenosine A1##5##3##(1993-6#1)(1995-12#1)(1997-1#3)
of adenosine and##2##3##(1993-12#2)
of adenosine deaminase##3##3##(1991-3#1)(1991-5#1)(2010-9#1)
of adenosine in the##2##4##(2008-4#2)
of adenosine in##4##3##(1996-2#1)(2008-4#2)(2008-7#1)
of adenosine influx##2##3##(1994-8#2)
of adenosine kinase##2##3##(1997-7#2)
of adenosine on##3##3##(1996-5#1)(2008-4#2)
of adenosine receptors##3##3##(1993-6#1)(2008-4#1)(2008-7#1)
of adenosine triphosphate (ATP)##2##4##(1991-9#1)(2007-10#1)
of adenosine triphosphate##4##3##(1991-9#1)(2007-10#1)(2009-12#1)(2009-8#1)
of adenosine##62##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-6#2)(1994-11#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-2#6)(1996-5#3)(1997-1#3)(1997-7#3)(1997-8#1)(2007-10#1)(2008-4#12)(2008-7#4)(2009-12#1)(2009-8#1)(2010-9#2)
of adenosine-containing products##2##3##(2008-5#2)
of adenoviral##5##2##(2008-11#5)
of adenovirus##8##2##(1994-8#1)(1997-8#1)(2008-11#3)(2010-1#1)(2011-2#1)(2012-3#1)
of adenylate cyclase and##2##4##(1994-8#1)(2008-4#1)
of adenylate cyclase in Dictyostelium discoideum##2##6##(1991-2#2)
of adenylate cyclase in##3##4##(1991-2#2)(1995-3#1)
of adenylate cyclase##11##3##(1990-7#1)(1990-8#1)(1991-2#3)(1992-6#1)(1993-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-4#1)
of adenylate kinase##3##3##(1992-3#1)(2008-4#2)
of adenylate##14##2##(1990-7#1)(1990-8#1)(1991-2#3)(1992-3#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-4#3)
of adenylyl cyclase##8##3##(1990-12#1)(1991-9#1)(1995-11#2)(1995-12#2)(1997-1#1)(1997-2#1)
of adequacy##2##2##(1993-1#1)(2011-2#1)
of adequate dialysis##3##3##(1996-2#1)(2007-12#1)(2008-1#1)
of adequate treatment##2##3##(1994-5#1)(2011-2#1)
of adequate##31##2##(1993-1#1)(1993-2#1)(1994-5#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
of adherence of##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
of adherence to##4##3##(1994-3#2)(2008-10#1)(2009-7#1)
of adherence with antihypertensive drugs##2##5##(2008-3#2)
of adherence with##3##3##(2008-3#3)
of adherence##18##2##(1992-12#1)(1994-3#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#2)
of adherent and suspension cells##2##5##(2008-1#1)(2008-2#1)
of adherent and##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
of adherent cells##6##3##(2008-10#1)(2008-11#1)(2008-2#2)(2010-10#1)(2010-6#1)
of adherent##10##2##(1991-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2010-10#1)(2010-6#1)
of adhering##4##2##(2008-11#1)(2009-5#1)(2009-7#2)
of adhesion formation##3##3##(1991-1#1)(1992-1#1)(1992-2#1)
of adhesion molecules##5##3##(1995-5#1)(2006-6#1)(2008-1#1)(2008-5#1)(2012-2#1)
of adhesion##17##2##(1991-1#1)(1992-1#2)(1992-2#1)(1995-5#1)(1997-7#1)(2006-6#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2012-2#1)
of adhesions##3##2##(1994-12#1)(1996-1#1)(2007-9#1)
of adhesive resin cement##2##4##(2008-8#2)
of adhesive##7##2##(2008-11#1)(2008-12#3)(2008-8#2)(2009-6#1)
of adipic acid##2##3##(2008-10#2)
of adipocyte differentiation##2##3##(1994-12#1)(2008-3#1)
of adipocyte##4##2##(1992-9#1)(1994-12#1)(2008-3#1)(2011-2#1)
of adipocytes##8##2##(1990-4#1)(1991-12#1)(1994-6#2)(2006-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
of adipogenesis##2##2##(1994-12#1)(2008-11#1)
of adipogenic genes##2##3##(2010-4#1)(2012-2#1)
of adipogenic##3##2##(2008-4#1)(2010-4#1)(2012-2#1)
of adiponectin and##2##3##(2011-1#1)(2013-1#1)
of adiponectin gene and##2##4##(2011-1#2)
of adiponectin gene##4##3##(2011-1#3)(2011-2#1)
of adiponectin##7##2##(2011-1#5)(2011-2#1)(2013-1#1)
of adipose and##2##3##(2007-12#1)(2010-6#1)
of adipose cells##2##3##(1990-11#1)(2008-10#1)
of adipose tissue in##2##4##(2008-1#1)(2008-11#1)
of adipose tissue##11##3##(1990-9#1)(2008-1#1)(2008-11#4)(2008-3#2)(2009-2#1)(2011-2#1)(2012-2#1)
of adipose##15##2##(1990-11#1)(1990-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#2)(2009-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
of adipose-derived stem cells##3##4##(2009-11#1)(2012-2#1)(2012-4#1)
of adiposity##6##2##(2012-2#6)
of adjacent chromosomal##2##3##(1991-9#1)(1993-12#1)
of adjacent segment disease##3##4##(2012-12#2)(2012-3#1)
of adjacent##27##2##(1991-9#1)(1993-12#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#3)(2012-3#1)(2013-1#1)
of adjudin##3##2##(2012-2#3)
of adjunctive##6##2##(2008-4#1)(2008-6#1)(2011-2#2)(2013-1#2)
of adjusting the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
of adjusting##7##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)
of adjustment##5##2##(1997-7#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-2#1)
of adjustments to the number of##2##6##(2008-9#2)
of adjuvant chemotherapy##5##3##(2007-5#1)(2007-8#1)(2008-6#2)(2011-1#1)
of adjuvant hormonal therapy##2##4##(2013-1#2)
of adjuvant radiation therapy##2##4##(1994-8#1)(2008-6#1)
of adjuvant radiotherapy##2##3##(1990-10#1)(1992-12#1)
of adjuvant systemic therapy##2##4##(1995-4#2)
of adjuvant therapy of breast cancer##2##6##(1993-11#1)(1993-2#1)
of adjuvant therapy##6##3##(1992-11#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(2012-3#1)
of adjuvant##30##2##(1990-10#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-9#2)(1994-8#1)(1995-4#2)(1995-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#5)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
of adjuvants##5##2##(1995-5#4)(2012-2#1)
of administered##2##2##(1992-3#1)(2008-10#1)
of administering##8##2##(1994-9#1)(1995-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#2)(2013-8#1)
of administration and##2##3##(1993-11#1)(2008-4#1)
of administration are##3##3##(1993-11#1)(2008-8#1)(2010-10#1)
of administration of the##4##4##(1992-9#1)(1997-5#1)(2007-9#1)(2008-5#1)
of administration of##16##3##(1992-12#1)(1992-9#1)(1995-3#4)(1997-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-7#2)(2011-2#1)(2013-1#1)
of administration##43##2##(1991-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-5#2)(1995-3#5)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-10#1)(2010-6#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of administrative influence on a public health##2##7##(2011-1#2)
of administrative##15##2##(1993-2#1)(1996-12#1)(2011-1#2)(2013-1#1)(2013-8#10)
of admission to the##3##4##(1992-3#1)(1994-1#1)(2007-10#1)
of admission##16##2##(1990-9#1)(1991-12#2)(1991-8#1)(1992-3#1)(1992-6#1)(1994-1#1)(2006-8#2)(2007-10#2)(2007-12#1)(2009-12#1)(2013-1#3)
of admissions and##2##3##(1992-3#1)(1996-3#1)
of admissions##6##2##(1992-3#1)(1993-12#1)(1996-3#2)(1997-4#1)(2008-1#1)
of adolescent cannabis##2##3##(2009-7#1)(2013-8#1)
of adolescent girls##6##3##(2008-1#1)(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
of adolescent motherhood##2##3##(1995-1#1)(2013-8#1)
of adolescent mothers##3##3##(1995-1#1)(2013-1#2)
of adolescent##48##2##(1991-1#1)(1992-3#1)(1994-2#1)(1995-1#2)(2008-1#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2009-7#7)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#8)(2013-8#3)
of adolescents aged##2##3##(1997-6#1)(2009-7#1)
of adolescents and adults##2##4##(1993-1#1)(2008-11#1)
of adolescents and young##2##4##(2008-11#1)(2008-12#1)
of adolescents and##5##3##(1993-1#1)(2008-11#2)(2008-12#1)(2010-1#1)
of adolescents in##4##3##(1993-3#1)(1997-3#1)(1997-8#1)(2008-9#1)
of adolescents who were##2##4##(2009-7#1)(2012-2#1)
of adolescents who##4##3##(2009-7#1)(2012-2#2)(2013-1#1)
of adolescents with##6##3##(1993-3#1)(2008-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2012-3#1)
of adolescents##35##2##(1990-6#1)(1990-9#1)(1992-3#1)(1993-1#1)(1993-3#2)(1996-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-7#4)(2010-1#2)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
of adolescents'##3##2##(2009-7#1)(2010-4#1)(2010-5#1)
of adopting##3##2##(1994-1#1)(1994-2#1)(2008-9#1)
of adoption of the three practices##2##6##(2010-11#2)
of adoption of##3##3##(2010-11#3)
of adoption##4##2##(2009-8#1)(2010-11#3)
of adoptive##4##2##(2009-11#1)(2009-2#1)(2011-2#2)
of adrenal##17##2##(1990-11#1)(1990-12#2)(1991-6#1)(1991-8#1)(1993-3#2)(1996-5#1)(2007-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
of adrenaline##3##2##(1995-3#1)(1996-5#1)(2008-5#1)
of adrenergic##4##2##(1992-8#1)(1994-6#1)(2007-10#1)(2008-2#1)
of adrenocorticotropic hormone (ACTH)##2##4##(1995-11#1)(2011-1#1)
of adrenocorticotropic hormone##4##3##(1990-2#1)(1993-5#1)(1995-11#1)(2011-1#1)
of adrenomedullin (AM) in##2##4##(1994-6#1)(1995-12#1)
of adrenomedullin (AM)##3##3##(1994-11#1)(1994-6#1)(1995-12#1)
of adriamycin (ADR)##2##3##(1994-7#1)(2008-10#1)
of adriamycin##10##2##(1993-6#1)(1994-7#1)(2008-10#4)(2008-6#2)(2010-3#2)
of adriblastina##4##2##(2008-10#4)
of adsorbates##2##2##(2007-12#1)(2008-2#1)
of adsorbed dyes##2##3##(2007-12#1)(2013-1#1)
of adsorbed##10##2##(1994-6#1)(2007-12#2)(2008-10#6)(2013-1#1)
of adsorbent##7##2##(2008-10#6)(2010-5#1)
of adsorption for##2##3##(2008-10#2)
of adsorption of##5##3##(2008-10#4)(2008-6#1)
of adsorption was##2##3##(2008-10#1)(2010-5#1)
of adsorption##17##2##(2008-10#10)(2008-2#3)(2008-6#2)(2010-5#1)(2013-8#1)
of adsorptive##3##2##(2008-10#3)
of adult T-cell##2##3##(1991-11#1)(2012-12#1)
of adult and##2##3##(2008-5#2)
of adult animals##2##3##(1995-12#1)(1997-6#1)
of adult at##2##3##(1997-2#2)
of adult cochlear implant##2##4##(2008-9#2)
of adult day care##3##4##(1992-1#2)(1992-3#1)
of adult development##2##3##(2007-12#2)
of adult disease##4##3##(2008-10#1)(2013-1#3)
of adult education##2##3##(1992-2#1)(2008-12#1)
of adult female##2##3##(1994-9#1)(2007-12#1)
of adult females##2##3##(2008-8#1)(2008-9#1)
of adult fish##4##3##(2008-7#3)(2009-7#1)
of adult health##3##3##(2011-1#1)(2012-2#2)
of adult male rats##2##4##(1993-12#1)(1994-8#1)
of adult male##3##3##(1993-12#1)(1994-8#1)(2009-9#1)
of adult males##2##3##(1991-12#1)(2007-12#1)
of adult mice fed##2##4##(1994-11#1)(2012-2#1)
of adult mice##3##3##(1994-11#1)(2008-9#1)(2012-2#1)
of adult neurogenesis##2##3##(1996-5#2)
of adult onset##2##3##(2008-1#2)
of adult patients with##5##4##(1991-2#1)(2008-1#1)(2008-6#1)(2010-3#1)(2013-1#1)
of adult patients##10##3##(1991-2#1)(2008-1#3)(2008-6#1)(2010-3#1)(2013-1#4)
of adult rat hepatocytes##3##4##(1993-8#2)(1995-8#1)
of adult rat##4##3##(1993-8#2)(1995-8#1)(2008-11#1)
of adult rats##6##3##(1991-5#1)(1992-11#1)(1994-2#2)(1995-12#1)(1997-1#1)
of adult type-II cells##3##4##(1994-3#3)
of adult wheat plants##2##4##(2008-10#2)
of adult women##3##3##(2008-4#1)(2013-1#2)
of adult##159##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#4)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(2007-10#1)(2007-12#5)(2007-5#1)(2007-8#4)(2008-1#5)(2008-10#11)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#8)(2009-3#1)(2009-7#3)(2009-9#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#1)
of adult)##4##2##(1997-2#4)
of adult-plant##2##2##(2008-10#2)
of adulthood##3##2##(2008-2#2)(2011-2#1)
of adults and##3##3##(2007-2#1)(2008-1#1)(2008-8#1)
of adults experiencing chronic nonmalignant pain##2##6##(2010-3#2)
of adults in the##2##4##(2008-12#1)(2008-3#1)
of adults in##4##3##(2008-12#2)(2008-3#1)(2010-5#1)
of adults with chronic##2##4##(2008-8#1)(2010-3#1)
of adults with##8##3##(1993-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-3#1)(2013-8#1)
of adults##33##2##(1992-4#1)(1993-2#1)(1993-9#3)(1994-8#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2013-8#1)
of advance directives##3##3##(1992-12#1)(1993-2#1)(2010-8#1)
of advance##4##2##(1992-12#1)(1993-2#1)(2008-7#1)(2010-8#1)
of advanced age##2##3##(1994-2#1)(1997-3#1)
of advanced breast##2##3##(1992-5#1)(1994-12#1)
of advanced cancer##3##3##(1992-6#1)(2008-2#2)
of advanced gastric##2##3##(1991-4#1)(2012-2#1)
of advanced glycation end products##3##5##(2008-1#2)(2012-2#1)
of advanced imaging##2##3##(2008-8#1)(2013-1#1)
of advanced lithographic tools##2##4##(2008-3#2)
of advanced##61##2##(1990-12#4)(1990-6#1)(1991-4#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-8#2)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#2)(2009-4#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
of advancement##3##2##(1995-12#1)(2008-12#1)(2011-3#1)
of advances in the##2##4##(2008-4#1)(2011-2#1)
of advances in##4##3##(2006-7#1)(2008-4#1)(2009-12#1)(2011-2#1)
of advances##5##2##(1997-4#1)(2006-7#1)(2008-4#1)(2009-12#1)(2011-2#1)
of advantage##2##2##(2008-2#1)(2012-2#1)
of advantages over traditional##2##4##(1993-3#1)(2008-9#1)
of advantages over##8##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
of advantages##15##2##(1993-3#1)(2007-11#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-3#1)
of adventitial##2##2##(1997-8#2)
of adventitious##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
of adverse drug reactions by##2##5##(1995-2#1)(1997-8#1)
of adverse drug reactions##13##4##(1995-2#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#4)(2010-6#1)(2011-2#1)(2013-8#1)
of adverse drug##15##3##(1995-2#1)(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-5#4)(2010-6#1)(2011-2#2)(2013-8#1)
of adverse effects from##2##4##(2007-12#1)(2013-1#1)
of adverse effects of##3##4##(2008-5#1)(2010-2#1)(2011-1#1)
of adverse effects on##2##4##(2007-11#1)(2008-2#1)
of adverse effects##17##3##(1991-11#1)(1991-5#1)(1992-11#1)(1996-12#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
of adverse events and##4##4##(1992-1#2)(2011-2#1)(2013-1#1)
of adverse events in the##2##5##(2008-7#2)
of adverse events in##4##4##(2008-11#1)(2008-7#2)(2009-12#1)
of adverse events##20##3##(1992-1#2)(1994-6#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of adverse health effects##2##4##(2008-10#1)(2008-11#1)
of adverse health##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
of adverse oesophageal##2##3##(2008-11#2)
of adverse outcomes##2##3##(1995-2#1)(2012-2#1)
of adverse reaction##2##3##(2013-1#1)(2013-8#1)
of adverse reactions to##2##4##(1990-3#1)(2008-11#1)
of adverse reactions##9##3##(1990-3#1)(1991-9#1)(1996-3#1)(1996-8#1)(1997-7#2)(2008-10#1)(2008-11#1)(2013-1#1)
of adverse##84##2##(1990-3#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#2)(1994-6#1)(1995-2#2)(1996-12#1)(1996-3#1)(1996-8#2)(1997-5#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#8)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#4)(2009-1#1)(2009-12#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#2)
of advice##6##2##(1995-1#1)(2007-12#2)(2011-1#1)(2012-3#2)
of advocacy##4##2##(1997-5#1)(2009-12#3)
of aequorin##2##2##(1990-8#2)
of aeration##2##2##(2010-11#2)
of aerial##4##2##(2007-5#1)(2008-10#1)(2012-2#2)
of aerobic bacteria isolated from##2##5##(1991-3#1)(2013-8#1)
of aerobic bacteria##5##3##(1991-3#1)(2008-1#1)(2008-10#1)(2011-1#1)(2013-8#1)
of aerobic endospore-forming bacteria##3##4##(2008-10#3)
of aerobic exercise on##2##4##(2010-12#1)(2013-1#1)
of aerobic exercise##4##3##(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
of aerobic metabolism##2##3##(1993-9#1)(2008-11#1)
of aerobic spore-forming bacteria##2##4##(2011-2#2)
of aerobic training on##2##4##(2013-1#2)
of aerobic##24##2##(1991-3#1)(1993-9#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
of aerosol and cloud##3##4##(2008-2#2)(2008-3#1)
of aerosol and##4##3##(2008-2#3)(2008-3#1)
of aerosol containment##2##3##(2008-9#2)
of aerosol delivery##2##3##(1995-3#1)(2012-1#1)
of aerosol extinction and##2##4##(2008-3#2)
of aerosol extinction##3##3##(2008-3#3)
of aerosol particles##2##3##(1996-2#1)(2008-3#1)
of aerosol size distributions##2##4##(2008-3#2)
of aerosol spectral##2##3##(2008-3#2)
of aerosol to##2##3##(1996-2#1)(1996-3#1)
of aerosol##52##2##(1991-1#2)(1992-3#2)(1995-3#2)(1996-2#2)(1996-3#4)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#22)(2008-9#2)(2010-3#1)(2012-1#1)
of aerosol-soot mixtures##2##3##(2008-3#2)
of aerosolized##7##2##(1992-2#1)(1993-2#1)(1995-3#2)(1996-3#1)(2008-10#2)
of aerosols and##2##3##(2008-2#1)(2008-9#1)
of aerosols from##2##3##(2008-3#2)
of aerosols in the##2##4##(1992-3#1)(2008-2#1)
of aerosols in##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
of aerosols##15##2##(1992-3#1)(1997-1#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-9#1)(2012-2#1)
of aerospace##2##2##(2008-3#1)(2008-9#1)
of aesculin and##3##3##(2008-10#3)
of affect##2##2##(2008-6#1)(2013-8#1)
of affected doves##3##3##(2008-5#3)
of affected individuals##2##3##(1995-12#1)(2007-8#1)
of affected males##2##3##(2008-1#1)(2012-3#1)
of affected patients##2##3##(1993-3#1)(2007-7#1)
of affected relatives of##3##4##(1992-9#3)
of affected relatives##4##3##(1992-9#4)
of affected status##3##3##(1997-5#3)
of affected##34##2##(1992-2#1)(1992-9#5)(1993-3#1)(1995-12#1)(1997-2#1)(1997-5#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#1)(2010-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
of affection##2##2##(1997-5#1)(2007-2#1)
of affective disorders##3##3##(1991-11#1)(1996-12#1)(2008-6#1)
of affective interpersonal bonds##2##4##(2008-1#2)
of affective##14##2##(1991-11#1)(1993-6#1)(1996-12#1)(2007-7#1)(2008-1#4)(2008-11#2)(2008-2#1)(2008-6#1)(2010-6#1)(2013-1#1)
of afferent inputs##2##3##(2007-12#2)
of afferent##6##2##(1993-12#1)(1996-12#1)(1996-2#1)(2007-12#2)(2007-8#1)
of affinity chromatography##3##3##(1991-5#1)(1994-11#1)(1995-11#1)
of affinity##15##2##(1990-12#1)(1991-5#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#1)
of affluence##2##2##(2008-1#1)(2011-1#1)
of aflatoxin B1##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
of aflatoxin M1##4##3##(2008-12#2)(2013-1#2)
of aflatoxin contamination in##2##4##(2008-10#2)
of aflatoxin contamination##3##3##(2008-10#3)
of aflatoxin in the feed##2##5##(1997-6#2)
of aflatoxin on##3##3##(1997-6#1)(2008-12#1)(2012-3#1)
of aflatoxin##25##2##(1991-11#1)(1992-9#1)(1997-6#3)(2008-10#8)(2008-12#8)(2010-5#1)(2012-3#1)(2013-1#2)
of aflatoxins in##2##3##(1992-11#2)
of aflatoxins##8##2##(1992-11#3)(2008-10#3)(2010-4#2)
of agar##6##2##(2008-10#2)(2008-7#2)(2012-2#2)
of agaro-oligosaccharides##2##2##(2008-10#2)
of age (mean##3##3##(2007-11#2)(2009-7#1)
of age (n =##2##4##(2007-12#1)(2010-6#1)
of age and gender on##2##5##(2008-3#1)(2010-4#1)
of age and gender##3##4##(2008-3#2)(2010-4#1)
of age and older##2##4##(2011-2#1)(2013-8#1)
of age and sex on##2##5##(2008-7#1)(2013-7#1)
of age and sex##4##4##(1997-6#1)(2008-7#2)(2013-7#1)
of age and##38##3##(1991-12#1)(1994-9#1)(1996-5#1)(1997-6#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
of age as a##2##4##(2008-12#1)(2008-4#1)
of age as##3##3##(2008-12#1)(2008-4#1)(2008-7#1)
of age at first##2##4##(1995-12#1)(2009-5#1)
of age at implantation##2##4##(2008-9#1)(2010-10#1)
of age at##12##3##(1995-12#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-10#2)(2011-1#1)(2012-2#1)
of age for##4##3##(1993-2#1)(2008-7#1)(2013-1#2)
of age group##4##3##(1997-3#1)(2012-2#1)(2012-3#2)
of age in##15##3##(1990-11#1)(1990-3#2)(1995-4#1)(1997-8#1)(2007-6#2)(2008-7#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)
of age is##5##3##(1990-6#1)(1991-6#1)(1995-8#2)(2008-10#1)
of age matched controls##2##4##(1996-5#1)(1997-5#1)
of age of##4##3##(1994-8#2)(1997-5#1)(2008-5#1)
of age on the##4##4##(1990-3#1)(2008-3#1)(2008-7#1)(2008-9#1)
of age on##16##3##(1990-3#3)(1995-8#1)(1996-5#1)(2008-1#2)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#2)(2011-2#1)
of age or##10##3##(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-10#2)
of age related##3##3##(2007-7#1)(2009-12#1)(2011-2#1)
of age the##4##3##(1991-6#1)(1991-8#1)(1994-11#1)(1997-5#1)
of age to##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
of age was##6##3##(1991-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
of age were##8##3##(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(2008-10#2)(2012-1#1)(2012-12#1)
of age when##2##3##(2010-1#1)(2012-1#1)
of age who##5##3##(1993-1#1)(2006-5#1)(2008-3#1)(2011-2#2)
of age with##7##3##(1994-6#1)(2007-11#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
of age##440##2##(1990-11#2)(1990-2#1)(1990-3#8)(1990-6#1)(1990-9#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#3)(1991-6#7)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#9)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#6)(1996-9#1)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#8)(1997-8#2)(2006-10#1)(2006-5#4)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#9)(2008-1#6)(2008-10#17)(2008-11#9)(2008-12#11)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#7)(2008-6#6)(2008-7#29)(2008-8#7)(2008-9#15)(2009-10#4)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#7)(2010-11#3)(2010-12#1)(2010-3#4)(2010-4#7)(2010-5#2)(2010-6#3)(2010-9#2)(2011-1#11)(2011-2#39)(2012-1#4)(2012-12#8)(2012-2#10)(2012-3#8)(2013-1#20)(2013-7#4)(2013-8#8)
of age) were used##2##4##(2008-12#1)(2010-2#1)
of age)##13##2##(1992-2#1)(1996-5#3)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-10#1)(2010-2#2)(2012-12#1)
of age-appropriate##2##2##(1992-1#1)(2009-11#1)
of age-dependent##2##2##(1991-12#1)(2010-8#1)
of age-matched controls##3##3##(1991-12#1)(2011-2#1)(2013-8#1)
of age-matched##8##2##(1990-11#1)(1991-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of age-related changes in the##2##5##(2008-5#1)(2008-7#1)
of age-related changes in##4##4##(1995-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
of age-related macular degeneration##3##4##(2010-8#1)(2011-2#2)
of age-related variation in##2##4##(2008-8#2)
of age-related##21##2##(1994-6#2)(1995-8#1)(1996-5#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#2)
of age-specific##3##2##(1991-2#1)(1991-6#1)(2008-10#1)
of age]##2##2##(2012-3#2)
of aged Medicare##2##3##(1993-12#1)(1997-1#1)
of aged mice##3##3##(2008-3#2)(2012-2#1)
of aged rats##5##3##(1990-7#1)(1993-12#1)(1994-6#1)(1997-2#1)(2012-1#1)
of aged##19##2##(1990-5#1)(1990-7#1)(1993-12#2)(1994-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-3#3)(2010-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of ageing and##4##3##(1995-3#1)(2008-10#2)(2008-7#1)
of ageing on##2##3##(2008-5#1)(2012-2#1)
of ageing##13##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#3)(2012-2#1)
of agencies##5##2##(1995-3#2)(1996-12#1)(1997-3#1)(2008-6#1)
of agency##4##2##(1995-6#1)(1997-3#1)(2008-11#1)(2008-2#1)
of agent##2##2##(2011-2#2)
of agents active in the presynaptic dopaminergic system on the##2##10##(1996-2#2)
of agents including##3##3##(2006-10#1)(2008-3#1)(2008-8#1)
of agents of human granulocytic anaplasmosis and monocytic erlychiosis##2##9##(2013-1#2)
of agents of human granulocytic anaplasmosis and monocytic##3##8##(2013-1#3)
of agents of##4##3##(2013-1#4)
of agents that##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
of agents to##2##3##(2008-2#1)(2008-4#1)
of agents with##3##3##(2008-5#1)(2009-8#2)
of agents##32##2##(1995-6#1)(1996-2#2)(1997-1#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#2)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#5)
of ages##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
of agglomerates##5##2##(2008-3#4)(2008-5#1)
of aggrecan mRNA##3##3##(2008-11#3)
of aggrecan##7##2##(1992-1#3)(2008-11#4)
of aggregate##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
of aggregated aerosols##2##3##(2008-3#2)
of aggregated virus##2##3##(2011-2#2)
of aggregated##8##2##(1993-11#1)(1994-8#1)(2008-3#2)(2011-2#2)(2012-2#1)(2013-7#1)
of aggregates##6##2##(1993-11#1)(1994-2#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#1)
of aggregation and##4##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
of aggregation of##9##3##(1994-5#2)(2008-10#6)(2012-12#1)
of aggregation##32##2##(1990-5#1)(1992-9#1)(1994-5#2)(1997-2#1)(2006-6#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2010-11#1)(2012-12#1)
of aggression and##2##3##(2008-10#1)(2011-2#1)
of aggression in##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)
of aggression##14##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-9#1)(2011-2#1)(2012-3#2)
of aggressive behaviour##3##3##(1993-2#2)(1994-12#1)
of aggressive interactions on##2##4##(2008-8#2)
of aggressive melanoma cells##2##4##(2009-3#2)
of aggressive tumor##2##3##(2009-3#1)(2010-8#1)
of aggressive##22##2##(1993-2#2)(1994-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#2)(2009-10#1)(2009-3#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#4)(2013-1#1)
of aggressiveness of##2##3##(2008-10#1)(2008-2#1)
of aggressiveness on##2##3##(2008-10#2)
of aggressiveness##9##2##(2008-10#8)(2008-2#1)
of aging and acetyl-L-carnitine on the##2##6##(1990-7#1)(1994-6#1)
of aging and cancer##2##4##(1994-5#1)(2008-1#1)
of aging and the##2##4##(1996-1#1)(2010-8#1)
of aging and##13##3##(1990-7#2)(1992-12#1)(1992-8#1)(1993-12#1)(1994-5#2)(1994-6#1)(1996-1#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-8#1)
of aging in the##3##4##(1994-6#1)(2008-7#1)(2009-7#1)
of aging in##9##3##(1994-6#1)(2008-7#3)(2008-9#2)(2009-7#1)(2012-2#1)(2013-8#1)
of aging is##5##3##(2008-9#3)(2009-12#1)(2013-8#1)
of aging mice##2##3##(1993-12#2)
of aging of##2##3##(2009-12#1)(2009-5#1)
of aging on the##3##4##(2008-7#2)(2013-7#1)
of aging on##6##3##(1994-6#1)(2008-7#4)(2013-7#1)
of aging rat##2##3##(1994-6#2)
of aging than##2##3##(2008-3#1)(2008-9#1)
of aging##72##2##(1990-3#2)(1990-7#2)(1991-12#2)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#4)(1994-5#3)(1994-6#8)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#10)(2008-9#9)(2009-12#3)(2009-5#3)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#3)
of agitation##3##2##(2008-7#1)(2009-6#1)(2010-11#1)
of agonist##5##2##(1992-2#1)(1997-7#1)(2008-3#1)(2008-4#2)
of agonists and##2##3##(2008-5#2)
of agonists##11##2##(1990-5#2)(1992-11#1)(1993-3#1)(1994-5#2)(1996-2#1)(2008-5#2)(2008-9#1)(2012-2#1)
of agreeableness##2##2##(2008-5#1)(2009-7#1)
of agreement between the##4##4##(2008-5#1)(2011-2#3)
of agreement between##8##3##(1993-12#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#4)
of agreement on##2##3##(1993-12#1)(1995-1#1)
of agreement##24##2##(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(2007-5#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-1#2)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#4)
of agricultural chemicals##2##3##(2008-10#1)(2008-12#1)
of agricultural##19##2##(1995-3#1)(2008-10#8)(2008-11#3)(2008-12#2)(2009-11#1)(2011-2#2)(2013-1#2)
of agriculture##4##2##(2008-11#2)(2008-7#1)(2012-12#1)
of agrochemicals##2##2##(2008-10#1)(2010-7#1)
of agrocin 84##2##3##(2008-10#2)
of agroinoculation##2##2##(2008-10#2)
of agronomic##2##2##(2008-10#1)(2012-3#1)
of air bubbles##2##3##(2008-10#1)(2013-1#1)
of air dispersion##2##3##(2007-11#2)
of air drying##3##3##(2008-10#3)
of air holes##4##3##(2007-11#4)
of air particulate matter is##2##5##(2008-10#2)
of air pollutants##4##3##(2008-10#1)(2008-11#1)(2008-2#2)
of air pollution in##3##4##(1992-9#1)(2008-11#2)
of air pollution on##3##4##(1997-1#1)(2008-11#1)(2010-6#1)
of air pollution##8##3##(1992-9#2)(1997-1#2)(2008-11#3)(2010-6#1)
of air samples##2##3##(2008-10#1)(2010-4#1)
of air temperature##2##3##(2008-6#1)(2008-7#1)
of air to##2##3##(2008-10#1)(2008-3#1)
of air with##2##3##(2008-3#1)(2008-7#1)
of air##78##2##(1991-3#3)(1992-9#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#2)(2007-11#7)(2007-12#5)(2007-2#1)(2008-1#2)(2008-10#17)(2008-11#6)(2008-2#7)(2008-3#8)(2008-6#3)(2008-7#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
of air-leaks and##2##3##(2007-8#2)
of airborne and##2##3##(2008-3#2)
of airborne lidar##5##3##(2008-2#5)
of airborne particles##2##3##(2008-3#2)
of airborne particulate matter##3##4##(2008-10#2)(2009-7#1)
of airborne##32##2##(1994-3#1)(2008-10#16)(2008-11#1)(2008-2#7)(2008-3#5)(2009-7#1)(2012-7#1)
of aircraft##5##2##(1996-12#2)(2008-3#2)(2009-7#1)
of airflow##2##2##(2008-10#1)(2011-2#1)
of airway and##2##3##(1992-3#1)(1997-2#1)
of airway epithelial cells##2##4##(1991-5#1)(2010-5#1)
of airway inflammation##3##3##(2009-1#1)(2010-5#1)(2012-1#1)
of airway management##2##3##(2008-2#2)
of airway obstruction##2##3##(2007-12#1)(2008-11#1)
of airway retention##4##3##(1995-12#4)
of airway sensitization potential of##2##5##(2008-10#2)
of airway##28##2##(1991-5#1)(1992-3#1)(1995-12#4)(1996-12#1)(1997-1#3)(1997-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-1#1)(2010-1#1)(2010-5#4)(2010-7#1)(2011-2#1)(2012-1#1)
of airways##4##2##(1995-12#1)(1995-2#1)(2008-7#2)
of akinesia##2##2##(2008-7#2)
of alachlor##2##2##(1993-12#1)(2008-10#1)
of alanine aminotransferase (ALT)##2##4##(2009-8#1)(2012-3#1)
of alanine aminotransferase##3##3##(2008-12#1)(2009-8#1)(2012-3#1)
of alanine##12##2##(1990-2#1)(1992-8#1)(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
of alate##2##2##(2008-10#2)
of albedo##2##2##(2008-2#2)
of albicidin##5##2##(2008-10#5)
of albinism in##2##3##(2008-6#2)
of albinism##3##2##(2008-6#3)
of albino##2##2##(2008-11#1)(2010-11#1)
of albumin and IgG1##2##4##(2008-10#2)
of albumin and##7##3##(1992-12#1)(2008-10#5)(2011-2#1)
of albumin in##2##3##(2008-10#1)(2008-7#1)
of albumin secretion##3##3##(2008-11#3)
of albumin was##2##3##(2008-10#1)(2011-1#1)
of albumin##39##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-4#1)(1995-2#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#6)(2011-1#1)(2011-2#2)(2013-1#2)
of albumin-globulin ratio##2##3##(2012-2#2)
of albuminuria##4##2##(2008-10#1)(2012-1#2)(2012-2#1)
of alcian blue##2##3##(2008-10#2)
of alcohol abuse##6##3##(1990-2#1)(1993-8#1)(1997-2#2)(2009-2#1)(2009-7#1)
of alcohol and nicotine##2##4##(2009-6#2)
of alcohol and##7##3##(1994-2#2)(2008-7#1)(2009-5#1)(2009-6#2)(2011-1#1)
of alcohol consumption##5##3##(1992-9#1)(1995-11#2)(2009-7#1)(2011-2#1)
of alcohol dehydrogenase##6##3##(1990-5#1)(1992-11#1)(1994-9#1)(2008-11#1)(2008-5#1)(2010-5#1)
of alcohol dependence##9##3##(1991-12#3)(1994-2#2)(2008-2#2)(2009-10#2)
of alcohol drinking##3##3##(1990-2#1)(2011-2#1)(2013-8#1)
of alcohol on##3##3##(1991-11#1)(1994-11#2)
of alcohol use disorders in humans##2##6##(2012-3#2)
of alcohol use disorders##3##4##(2012-3#3)
of alcohol use##9##3##(2008-11#3)(2008-12#1)(2012-12#1)(2012-3#3)(2013-8#1)
of alcohol withdrawal##2##3##(2008-2#1)(2012-2#1)
of alcohol##92##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-12#3)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-2#9)(1994-5#1)(1994-9#2)(1995-11#3)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#3)(1997-8#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
of alcoholic beverages##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
of alcoholic##14##2##(1990-5#1)(1993-9#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-9#1)(2009-7#4)(2013-1#1)
of alcoholics##9##2##(1993-11#1)(1994-2#4)(1995-11#1)(1997-5#2)(2008-6#1)
of alcoholism##14##2##(1991-1#1)(1993-2#1)(1994-2#7)(1994-5#1)(1994-6#1)(1995-11#3)
of alcohols and##3##3##(2007-11#1)(2008-10#2)
of alcohols##14##2##(1990-12#1)(1990-5#2)(1992-6#2)(2007-11#2)(2008-10#4)(2008-4#1)(2009-8#1)(2010-12#1)
of aldehyde 5##2##3##(2008-6#2)
of aldehyde dehydrogenase##2##3##(1995-2#1)(2010-12#1)
of aldehyde##5##2##(1995-2#1)(1995-3#1)(2008-6#2)(2010-12#1)
of aldehydes and ketones##2##4##(1996-5#1)(2008-10#1)
of aldehydes and##3##3##(1996-5#1)(2008-10#1)(2010-12#1)
of aldehydes##10##2##(1994-12#1)(1996-5#1)(2008-10#5)(2010-12#2)(2012-3#1)
of aldose reductase gene expression##2##5##(1992-8#2)
of aldose reductase##5##3##(1992-8#3)(1996-2#2)
of aldosterone##3##2##(1990-11#1)(1992-12#1)(1994-7#1)
of alendronate sodium in##2##4##(2008-10#2)
of alendronate sodium##6##3##(2008-10#6)
of alendronate##9##2##(2008-10#8)(2008-11#1)
of alerting##2##2##(1995-6#1)(2008-4#1)
of alexithymia##3##2##(2008-11#2)(2008-9#1)
of alfalfa##5##2##(2008-10#4)(2008-11#1)
of algD##2##2##(2008-7#2)
of algae##5##2##(2007-5#2)(2008-10#2)(2008-3#1)
of algal##3##2##(2008-10#3)
of alginate##5##2##(2008-10#2)(2008-7#3)
of alginate/poly-L##2##2##(2008-11#2)
of algorithms and##2##3##(2008-3#1)(2008-9#1)
of algorithms##4##2##(2008-2#1)(2008-3#1)(2008-9#2)
of alien##2##2##(2008-5#1)(2008-8#1)
of aligned carbon nanotubes##2##4##(2008-10#1)(2008-7#1)
of aligned##10##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#6)
of alignment##7##2##(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#3)
of alignments##2##2##(2008-9#1)(2011-3#1)
of aliphatic alcohols##4##3##(1990-5#1)(2008-10#3)
of aliphatic amines in water##2##5##(2008-10#2)
of aliphatic amines in##5##4##(2008-10#5)
of aliphatic amines##9##3##(2008-10#9)
of aliphatic##20##2##(1990-5#1)(1992-3#2)(1994-8#1)(2008-10#14)(2008-11#2)
of aliquots##2##2##(2008-10#2)
of alizarin red S##2##4##(2008-10#1)(2013-7#1)
of alizarin##3##2##(2008-10#2)(2013-7#1)
of alkali and alkaline earth metal ions##2##7##(2008-10#2)
of alkali and alkaline earth metal##3##6##(2008-10#3)
of alkali and alkaline##4##4##(2008-10#4)
of alkali metal picrates with##3##5##(2008-10#3)
of alkali metal##6##3##(2008-10#4)(2008-2#1)(2012-2#1)
of alkali##16##2##(2008-10#14)(2008-2#1)(2012-2#1)
of alkali-labile##2##2##(1993-11#1)(2008-4#1)
of alkaline aluminate solutions with##2##5##(2008-10#2)
of alkaline phosphatase activity##4##4##(1994-12#1)(2008-10#2)(2008-5#1)
of alkaline phosphatase and##2##4##(2008-10#1)(2008-7#1)
of alkaline phosphatase##17##3##(1991-10#3)(1994-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
of alkaline##29##2##(1991-10#3)(1992-11#1)(1994-12#1)(1997-4#1)(2008-10#14)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-4#1)(2013-1#1)
of alkaloid salts##2##3##(2008-10#2)
of alkaloid##5##2##(1994-12#1)(2008-10#2)(2011-3#2)
of alkaloids##4##2##(2007-11#1)(2008-10#3)
of alkyl sulfatase was##2##4##(2012-2#2)
of alkyl sulfatase##3##3##(2012-2#3)
of alkyl##13##2##(1995-11#1)(1995-3#2)(2007-11#1)(2008-10#2)(2009-5#2)(2009-8#1)(2012-2#3)(2013-8#1)
of alkylating##4##2##(2008-10#2)(2008-11#1)(2010-11#1)
of alkylation##2##2##(1994-5#1)(2007-11#1)
of alkylphenolic non-ionic surfactants##2##4##(2008-10#2)
of alkylphenolic##3##2##(2008-10#2)(2008-11#1)
of alkynyl halides##2##3##(2009-11#2)
of all 3##3##3##(1991-5#1)(2008-5#1)(2008-8#1)
of all ages to##2##4##(2008-7#1)(2012-3#1)
of all ages##12##3##(1992-3#1)(1993-1#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
of all animals##2##3##(1991-12#1)(2011-1#1)
of all assays##2##3##(2008-10#2)
of all available data##2##4##(2010-11#1)(2011-2#1)
of all available##7##3##(2007-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
of all brain##2##3##(1993-8#1)(2012-2#1)
of all breast##2##3##(1995-12#1)(2012-2#1)
of all cancers##4##3##(1990-2#2)(1994-2#1)(1997-3#1)
of all captured##2##3##(2011-2#2)
of all cases in the##2##5##(2008-4#1)(2013-1#1)
of all cases of##7##4##(1990-12#1)(1990-9#1)(2008-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
of all cases were##2##4##(2008-7#1)(2012-3#1)
of all cases##16##3##(1990-12#1)(1990-9#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
of all cells##4##3##(1991-9#1)(1994-11#1)(2008-8#1)(2012-12#1)
of all childhood##2##3##(2010-3#1)(2011-2#1)
of all children in##2##4##(1991-8#1)(1994-9#1)
of all children##5##3##(1991-8#1)(1994-9#1)(2007-11#1)(2008-3#1)(2010-3#1)
of all circulating##2##3##(2008-4#1)(2013-8#1)
of all combinations##2##3##(2007-8#1)(2008-10#1)
of all compounds##3##3##(2008-10#2)(2010-6#1)
of all courses)##2##3##(1992-10#2)
of all deaths##4##3##(1992-6#2)(2008-11#1)(2011-2#1)
of all defined##2##3##(2012-2#2)
of all degrees of##2##4##(1994-7#1)(2008-2#1)
of all demented PD patients)##2##5##(2008-7#2)
of all dendritic##2##3##(2008-9#1)(2012-2#1)
of all different##2##3##(2007-11#1)(2008-12#1)
of all dosed groups of##3##5##(2008-9#3)
of all elements##2##3##(2007-12#1)(2008-7#1)
of all examined hips##2##4##(2007-11#2)
of all examined##3##3##(2007-11#2)(2011-1#1)
of all extracts##2##3##(2008-5#2)
of all five##4##3##(2008-10#2)(2009-12#1)(2013-8#1)
of all flow##2##3##(2008-10#1)(2008-4#1)
of all forms of##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
of all four##10##3##(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-10#3)(2012-3#2)
of all fungal##2##3##(1997-3#1)(2008-10#1)
of all ganglion neurons##2##4##(2008-7#2)
of all hospital##2##3##(1994-12#1)(2012-2#1)
of all human cancers##2##4##(2009-9#1)(2013-1#1)
of all human##3##3##(2009-9#1)(2013-1#2)
of all individuals##2##3##(2008-10#1)(2008-6#1)
of all influenza##2##3##(1992-6#2)
of all injuries##2##3##(1990-6#1)(2007-8#1)
of all isolates##4##3##(2008-10#4)
of all kinds of##4##4##(1990-2#1)(2008-1#1)(2008-5#1)(2012-2#1)
of all kinds##6##3##(1990-2#1)(1992-2#1)(1993-12#1)(2008-1#1)(2008-5#1)(2012-2#1)
of all known##6##3##(1990-11#1)(1994-11#1)(1997-9#2)(2008-10#1)(2011-2#1)
of all large acrocentric autosomes##2##5##(1993-12#2)
of all large##3##3##(1993-12#2)(2012-3#1)
of all lesions##2##3##(1994-1#1)(2008-10#1)
of all lung##2##3##(2009-1#1)(2011-3#1)
of all major##5##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
of all malignant##2##3##(2008-6#1)(2011-2#1)
of all materials##2##3##(2010-3#1)(2013-1#1)
of all men and women##2##5##(1994-11#1)(2008-10#1)
of all men##3##3##(1994-11#1)(2008-1#1)(2008-10#1)
of all metabolites##2##3##(1993-11#1)(2009-5#1)
of all methods##2##3##(2008-10#1)(2008-6#1)
of all newly##2##3##(2008-10#1)(2012-2#1)
of all of the##5##4##(1990-8#1)(1994-6#1)(2008-5#1)(2010-9#1)(2011-2#1)
of all of these##3##4##(1992-8#1)(1993-8#1)(2011-2#1)
of all of##9##3##(1990-8#1)(1992-8#1)(1993-8#1)(1994-6#1)(1997-3#1)(2008-5#1)(2010-9#1)(2011-2#2)
of all oral cancer##2##4##(2010-12#1)(2013-1#1)
of all other##12##3##(1995-2#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)
of all our##2##3##(1995-2#1)(2008-5#1)
of all outpatient##2##3##(1995-1#1)(1996-1#1)
of all ovarian##2##3##(1990-2#1)(2007-8#1)
of all pairs##2##3##(2008-10#1)(2009-11#1)
of all participants##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
of all pathogenic##2##3##(2008-10#2)
of all patients had##2##4##(1992-11#2)
of all patients with##8##4##(1991-8#1)(1992-12#1)(1995-5#1)(1997-4#1)(1997-5#1)(2007-10#1)(2011-1#1)(2013-8#1)
of all patients##31##3##(1991-3#1)(1991-8#1)(1992-11#2)(1992-12#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#1)
of all phases##2##3##(2008-10#1)(2012-3#1)
of all pixels##2##3##(2007-10#1)(2013-8#1)
of all possible##8##3##(2007-12#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-7#1)(2010-2#1)
of all pregnant women##2##4##(1990-6#1)(1991-11#1)
of all primary malignant##2##4##(2008-10#1)(2010-3#1)
of all primary##4##3##(1992-11#1)(2007-10#1)(2008-10#1)(2010-3#1)
of all radiation##3##3##(1994-12#1)(1995-1#1)(2008-7#1)
of all relevant##6##3##(1993-12#1)(2007-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
of all samples##4##3##(1991-11#1)(2008-10#1)(2008-12#1)(2008-4#1)
of all six##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
of all sizes##2##3##(1996-4#1)(2008-2#1)
of all species##2##3##(2008-10#1)(2008-2#1)
of all stages of##2##4##(2008-10#1)(2010-6#1)
of all strains were##2##4##(2008-10#2)
of all strains##3##3##(2008-10#2)(2008-9#1)
of all studies##2##3##(1994-2#1)(2011-2#1)
of all taxa##2##3##(2008-10#1)(2009-4#1)
of all test##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
of all the analytes##2##4##(2008-10#2)
of all the elements##2##4##(2007-8#1)(2008-10#1)
of all the lambs##2##4##(1994-7#2)
of all the studied##2##4##(2008-10#1)(2012-1#1)
of all the three##3##4##(1992-8#1)(2008-7#1)(2008-8#1)
of all the##83##3##(1991-12#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-7#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of all these aspects##2##4##(2008-10#2)
of all these metal ions##2##5##(2008-10#2)
of all these##16##3##(1991-3#1)(1994-3#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
of all three species##2##4##(1990-5#1)(2012-8#1)
of all three substrates##2##4##(1994-5#1)(2008-11#1)
of all three##30##3##(1990-2#2)(1990-5#2)(1992-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-8#1)
of all treatments##3##3##(2008-10#1)(2008-12#1)(2010-4#1)
of all tumors##2##3##(1990-2#1)(2008-4#1)
of all types of##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
of all types##8##3##(1994-12#1)(2006-12#1)(2007-12#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
of all units##2##3##(1992-6#1)(2008-4#1)
of all variables##2##3##(2008-10#1)(2008-3#1)
of all women##3##3##(1990-6#1)(2008-4#1)(2011-2#1)
of all##799##2##(1990-11#3)(1990-12#3)(1990-2#7)(1990-3#3)(1990-5#4)(1990-6#4)(1990-8#4)(1990-9#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#9)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#3)(1993-6#1)(1993-8#5)(1994-1#2)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#3)(1994-8#2)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#7)(1995-5#2)(1995-6#3)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#3)(1997-5#2)(1997-6#2)(1997-9#2)(2006-10#3)(2006-12#1)(2007-10#6)(2007-11#14)(2007-12#18)(2007-4#3)(2007-5#1)(2007-7#7)(2007-8#10)(2008-1#19)(2008-10#123)(2008-11#22)(2008-12#13)(2008-2#7)(2008-3#15)(2008-4#16)(2008-5#22)(2008-6#11)(2008-7#26)(2008-8#21)(2008-9#24)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#8)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#8)(2011-2#48)(2011-3#4)(2011-9#1)(2012-1#4)(2012-12#3)(2012-2#24)(2012-3#11)(2012-8#1)(2013-1#23)(2013-7#4)(2013-8#12)
of all-cause mortality##3##3##(2008-7#3)
of all-cause##5##2##(2008-7#3)(2009-10#1)(2013-1#1)
of all-optical switching##2##3##(2007-12#1)(2008-3#1)
of all-optical##7##2##(2007-11#1)(2007-12#2)(2008-3#3)(2012-2#1)
of all-trans retinoic acid (RA)##2##5##(1996-5#1)(2008-5#1)
of all-trans retinoic acid##4##4##(1996-5#1)(2008-5#2)(2008-8#1)
of all-trans-retinoic acid##3##3##(1994-6#1)(1996-5#2)
of alleged##2##2##(2008-12#1)(2011-2#1)
of allele frequencies was##2##4##(2008-10#1)(2013-1#1)
of allele frequencies##3##3##(2008-10#2)(2013-1#1)
of allele##7##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
of allele-specific##2##2##(1996-6#1)(2011-2#1)
of alleles at##2##3##(2008-10#2)
of alleles for##2##3##(2008-10#1)(2009-10#1)
of alleles in##2##3##(2008-10#1)(2012-3#1)
of alleles per locus ranged from##2##6##(2008-5#1)(2013-8#1)
of alleles per locus##4##4##(2008-10#1)(2008-5#1)(2013-8#2)
of alleles with##3##3##(1992-3#1)(1997-5#1)(2012-12#1)
of alleles##23##2##(1992-3#1)(1994-12#1)(1997-5#2)(2008-10#9)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
of allelic##5##2##(1994-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
of allergen##5##2##(2008-10#2)(2008-8#2)(2010-5#1)
of allergen-specific IgE##4##3##(1990-12#1)(2008-10#3)
of allergen-specific##6##2##(1990-12#1)(2008-10#4)(2009-5#1)
of allergenic##2##2##(1996-5#1)(2007-2#1)
of allergens##2##2##(2012-2#1)(2013-8#1)
of allergic antibody to##2##4##(2008-10#2)
of allergic contact dermatitis##2##4##(2008-5#2)
of allergic disease##2##3##(2010-6#1)(2011-1#1)
of allergic diseases##5##3##(1992-3#1)(1994-6#1)(2008-3#1)(2011-2#1)(2012-12#1)
of allergic rhinitis (AR)##2##4##(2008-7#1)(2013-8#1)
of allergic rhinitis in##2##4##(2013-1#1)(2013-8#1)
of allergic rhinitis##11##3##(2007-11#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
of allergic subjects##2##3##(2008-11#1)(2010-5#1)
of allergic##29##2##(1990-3#1)(1992-3#1)(1994-6#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
of allergy sufferers##2##3##(1994-2#2)
of allergy##5##2##(1994-2#2)(2008-10#1)(2008-11#1)(2012-12#1)
of alliance activities##2##3##(2013-1#2)
of allied health##2##3##(1996-2#2)
of alloantibodies##2##2##(1994-3#1)(2011-2#1)
of allochthonous inputs on##2##4##(2008-9#2)
of allochthonous inputs##3##3##(2008-9#3)
of allodynia##5##2##(1996-6#1)(2008-9#2)(2011-2#2)
of allogeneic hematopoietic##2##3##(2008-11#1)(2010-11#1)
of allogeneic##9##2##(1996-9#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
of allograft##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
of allografts##2##2##(2008-8#2)
of alloplasmic wheat##2##3##(2008-8#2)
of allopurinol in the##2##4##(2008-10#2)
of allopurinol##4##2##(2008-10#4)
of allosteric interaction##2##3##(1995-11#2)
of allosteric##7##2##(1990-8#2)(1991-10#1)(1995-11#2)(1997-2#1)(2008-3#1)
of allotetraploid##2##2##(2008-9#2)
of allotetraploids##2##2##(2013-1#2)
of allowing##3##2##(1992-3#1)(2008-10#1)(2013-8#1)
of alloy samples##3##3##(2008-10#3)
of alloy##4##2##(2008-10#3)(2013-1#1)
of alloys##2##2##(2008-10#1)(2008-7#1)
of allyl glycosides##2##3##(1992-12#2)
of allyl##3##2##(1992-12#2)(1996-5#1)
of allylic alcohols##2##3##(2007-11#1)(2008-8#1)
of almond and peach##2##4##(2008-10#2)
of almond##3##2##(2008-10#3)
of almost all ions##2##4##(2008-10#2)
of almost all##4##3##(2008-10#4)
of almost##16##2##(1993-6#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
of almost-periodic vertical-grating-assisted codirectional##2##4##(2008-3#2)
of alopecia areata##2##3##(2007-7#2)
of alopecia##4##2##(2007-7#2)(2008-10#1)(2013-8#1)
of alpha 1##2##3##(1994-12#1)(1994-6#1)
of alpha 1-adrenoceptor##2##3##(1995-11#2)
of alpha 7##3##3##(1996-12#3)
of alpha Amy3##3##3##(1994-11#3)
of alpha B-crystallin mRNA in##3##5##(1991-12#3)
of alpha B-crystallin##5##3##(1991-12#5)
of alpha and beta subunits##3##5##(1991-10#1)(1992-9#1)(1994-8#1)
of alpha and beta##4##4##(1991-10#1)(1992-9#1)(1994-8#1)(2008-8#1)
of alpha and##8##3##(1991-10#1)(1992-9#1)(1994-8#1)(1995-6#2)(2008-3#1)(2008-8#2)
of alpha beta dimers##2##4##(1990-8#1)(1994-8#1)
of alpha beta##3##3##(1990-8#1)(1994-8#2)
of alpha phase##3##3##(2009-7#3)
of alpha##63##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#5)(1991-6#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#4)(1995-11#4)(1995-5#2)(1995-6#4)(1995-8#1)(1996-12#3)(1996-5#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-7#3)(2010-7#1)(2011-3#2)
of alpha(1B)-AR mRNA##2##3##(2008-4#2)
of alpha(1B)-AR##4##2##(2008-4#4)
of alpha- and beta- myosin heavy chain genes in##2##9##(1992-3#2)
of alpha- and beta- myosin heavy chain##3##7##(1992-3#3)
of alpha- and beta-naphthol##2##4##(2008-10#2)
of alpha- and beta-subunits##2##4##(1991-3#2)
of alpha- and##13##3##(1990-2#1)(1990-9#1)(1991-3#2)(1992-3#3)(1992-6#1)(1996-2#1)(1997-4#1)(2008-10#3)
of alpha-##16##2##(1990-2#1)(1990-9#1)(1991-3#2)(1992-3#3)(1992-6#1)(1996-2#1)(1997-4#1)(2008-10#6)
of alpha-1##2##2##(1997-4#1)(2008-4#1)
of alpha-AT##2##2##(1992-3#2)
of alpha-CD##5##2##(2008-10#4)(2008-6#1)
of alpha-GP##3##2##(2008-10#3)
of alpha-Gs##2##2##(1994-6#1)(1997-1#1)
of alpha-KGDH##2##2##(1995-5#2)
of alpha-MSH and##3##3##(1993-5#2)(1995-2#1)
of alpha-MSH##12##2##(1993-5#9)(1995-2#1)(2008-1#1)(2008-6#1)
of alpha-actinin to actin##3##4##(1993-8#3)
of alpha-actinin##6##2##(1993-8#4)(1993-9#2)
of alpha-amino##3##2##(1996-5#1)(2007-11#1)(2009-8#1)
of alpha-amylase gene fromS##2##4##(2008-8#2)
of alpha-amylase gene##4##3##(2008-8#4)
of alpha-amylase##9##2##(1991-5#3)(2008-10#1)(2008-8#5)
of alpha-bungarotoxin##3##2##(1996-12#3)
of alpha-crystallin##2##2##(1992-12#2)
of alpha-cyclodextrin##2##2##(1997-2#1)(2008-10#1)
of alpha-fetoprotein##2##2##(1990-2#1)(2008-10#1)
of alpha-helical##2##2##(2008-8#1)(2009-2#1)
of alpha-helices##2##2##(1994-6#1)(2008-10#1)
of alpha-helix##3##2##(1995-12#1)(1995-2#1)(2008-8#1)
of alpha-hydroxy acids in##2##4##(2008-5#2)
of alpha-hydroxy##4##2##(1992-12#1)(2008-5#3)
of alpha-hydroxyacids##2##2##(2007-11#1)(2008-5#1)
of alpha-interferon##3##2##(1992-2#1)(1996-6#1)(2011-1#1)
of alpha-ketoglutarate##5##2##(1995-5#1)(2007-8#3)(2008-8#1)
of alpha-lactalbumin##3##2##(2008-7#3)
of alpha-lytic protease##2##3##(1993-11#1)(1995-3#1)
of alpha-maltose and##3##3##(1995-11#3)
of alpha-maltose##6##2##(1995-11#6)
of alpha-melanocyte-stimulating hormone##5##3##(1993-5#4)(1996-2#1)
of alpha-naphtholphthalein in polyIBM##2##4##(2008-10#2)
of alpha-naphtholphthalein in##3##3##(2008-10#3)
of alpha-particles##3##2##(2008-10#1)(2008-7#2)
of alpha-pinene gas##2##3##(2008-3#2)
of alpha-pinene##4##2##(2008-3#2)(2010-5#2)
of alpha-tocopherol##12##2##(1990-8#3)(1991-12#1)(1992-9#1)(1995-2#1)(1996-2#2)(2008-10#1)(2009-8#3)
of alpha-toxin##2##2##(2010-6#2)
of alpha-trinositol##3##2##(1995-12#3)
of alpha1-adrenoceptor##2##2##(1995-12#2)
of alpha2-adrenoceptors##2##2##(1995-12#1)(1997-7#1)
of alteplase##3##2##(1991-6#1)(1997-8#1)(2007-11#1)
of alteration of consciousness##3##4##(2013-8#3)
of alteration of##4##3##(2008-5#1)(2013-8#3)
of alteration##5##2##(2008-11#1)(2008-5#1)(2013-8#3)
of alterations found##2##3##(2008-11#1)(2011-2#1)
of alterations in the##2##4##(1991-4#1)(2009-5#1)
of alterations in##6##3##(1991-4#1)(1992-1#1)(1993-12#1)(2008-10#1)(2008-11#1)(2009-5#1)
of alterations##12##2##(1991-2#1)(1991-4#1)(1992-1#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2009-7#1)(2011-2#1)
of altered##17##2##(1991-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
of altering the##2##3##(1990-5#1)(1991-1#1)
of altering##4##2##(1990-5#1)(1991-1#1)(1996-2#1)(2008-12#1)
of alternant PAHs##2##3##(2008-10#2)
of alternaria##2##2##(2008-10#2)
of alternate##7##2##(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#1)(1997-1#1)(2008-3#1)(2008-8#1)
of alternating layers of##2##4##(2008-10#2)
of alternating##16##2##(1996-2#2)(1997-7#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-8#1)
of alternative biological##2##3##(2008-10#1)(2010-4#1)
of alternative food##2##3##(2008-8#2)
of alternative fumigants##2##3##(2008-10#2)
of alternative medicine##6##3##(1994-9#1)(1997-6#4)(2008-10#1)
of alternative methods for##2##4##(1992-12#1)(2010-3#1)
of alternative methods##7##3##(1992-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-3#1)
of alternative models##2##3##(1996-6#1)(2008-9#1)
of alternative routes for##2##4##(1992-12#1)(2008-10#1)
of alternative splicing of##2##4##(1991-12#1)(2008-7#1)
of alternative splicing##4##3##(1991-12#1)(1994-12#1)(2008-4#1)(2008-7#1)
of alternative techniques##2##3##(1997-7#1)(2013-7#1)
of alternative##67##2##(1990-8#1)(1991-12#1)(1992-12#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-9#1)(1996-1#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-6#5)(1997-7#2)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
of alternatively spliced##4##3##(1990-12#1)(1990-7#1)(1994-11#1)(2008-11#1)
of alternatives to##2##3##(2008-10#1)(2013-1#1)
of alternatives##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
of altitude range##2##3##(2008-2#2)
of altitude##6##2##(1990-8#1)(1992-2#1)(2008-2#2)(2008-3#1)(2013-7#1)
of altruism##7##2##(1995-3#1)(2008-10#1)(2008-8#4)(2008-9#1)
of altruistic##2##2##(2008-8#1)(2010-12#1)
of alumina aggregates##2##3##(2008-3#2)
of alumina##3##2##(2008-10#1)(2008-3#2)
of aluminium and lead##2##4##(2008-10#2)
of aluminium and manganese in human scalp hair##2##8##(2008-10#2)
of aluminium and##4##3##(2008-10#4)
of aluminium as##2##3##(2008-10#2)
of aluminium chloride with##3##4##(2008-10#3)
of aluminium in the##2##4##(1995-6#1)(2008-10#1)
of aluminium in##6##3##(1990-3#1)(1995-6#2)(2008-10#3)
of aluminium ion##2##3##(2008-10#2)
of aluminium on##2##3##(2008-10#2)
of aluminium##35##2##(1990-3#1)(1995-6#2)(1996-12#1)(2008-10#29)(2008-3#1)(2008-7#1)
of aluminon##2##2##(2008-10#2)
of aluminum (0##2##3##(1992-11#2)
of aluminum alloys##2##3##(2008-10#2)
of aluminum by electrothermal##2##4##(2008-10#2)
of aluminum by##4##3##(2008-10#4)
of aluminum exposure##2##3##(1992-11#2)
of aluminum in natural waters with rubeanic acid##2##8##(2008-10#2)
of aluminum in##8##3##(2008-10#8)
of aluminum ions to##2##4##(1994-11#2)
of aluminum tetrasulfophthalocyanines##5##3##(2012-3#5)
of aluminum##44##2##(1991-2#1)(1992-11#5)(1992-12#4)(1994-11#2)(2007-5#2)(2007-8#1)(2008-10#23)(2010-4#1)(2012-3#5)
of alveolar bone##3##3##(2011-2#2)(2012-12#1)
of alveolar macrophages##5##3##(1990-5#2)(1992-8#2)(1995-12#1)
of alveolar type of##2##4##(2010-11#2)
of alveolar type##3##3##(1995-8#1)(2010-11#2)
of alveolar##20##2##(1990-5#2)(1992-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-12#1)(2009-4#2)(2010-11#2)(2010-7#1)(2011-2#4)(2012-12#1)
of amalgam##3##2##(1990-10#1)(1990-9#1)(1992-11#1)
of amantadine for##2##3##(2011-10#1)(2011-2#1)
of amantadine##4##2##(1997-2#1)(2011-10#1)(2011-2#2)
of amaranth grain##4##3##(2008-11#4)
of ambient air##2##3##(2007-12#1)(2008-3#1)
of ambient##8##2##(1992-9#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
of ambiguity##2##2##(2008-2#2)
of ambiguous##3##2##(2008-10#2)(2011-3#1)
of amblyopia in##2##3##(2008-7#1)(2012-12#1)
of amblyopia##5##2##(2008-7#1)(2012-12#2)(2013-1#1)(2013-7#1)
of ambroxol hydrochloride##4##3##(2008-10#2)(2010-5#2)
of ambroxol##6##2##(2008-10#4)(2010-5#2)
of ambulatory care##2##3##(1991-3#2)
of ambulatory##7##2##(1991-1#1)(1991-3#2)(1995-2#1)(1996-3#1)(2010-1#1)(2013-8#1)
of amendment##2##2##(2008-10#2)
of amendments##2##2##(2008-10#2)
of american##2##2##(2013-1#1)(2013-8#1)
of amide linkages on acidity##2##5##(2008-10#2)
of amide linkages##3##3##(2008-10#3)
of amide proton##2##3##(1992-4#1)(2008-4#1)
of amide##5##2##(1992-4#1)(2008-10#3)(2008-4#1)
of amides and aryl chlorides##2##5##(2010-8#2)
of amifostine##2##2##(2008-7#2)
of amikacin##2##2##(1990-6#1)(2008-10#1)
of amiloride##8##2##(1991-5#2)(1992-5#1)(1994-8#1)(2008-10#2)(2008-4#2)
of amine accumulation in##2##4##(2010-11#2)
of amine##6##2##(1994-11#1)(2008-10#2)(2010-11#2)(2010-4#1)
of amines and##2##3##(2008-10#2)
of amines##10##2##(1995-3#2)(2008-10#8)
of amino acid and organic acid##2##6##(2008-10#2)
of amino acid derivatives by##2##5##(1994-9#1)(2008-10#1)
of amino acid derivatives##4##4##(1994-9#1)(1997-3#1)(2008-10#1)(2008-7#1)
of amino acid residues in the##2##6##(1994-5#1)(1995-5#1)
of amino acid residues##5##4##(1992-5#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-5#1)
of amino acid sequence##5##4##(1990-5#1)(1990-7#1)(1992-7#1)(1993-3#2)
of amino acid sequences of the##2##6##(2008-10#2)
of amino acid sequences of##6##5##(1994-11#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-8#1)
of amino acid sequences##8##4##(1994-11#2)(1994-12#1)(1997-8#2)(2008-10#2)(2008-8#1)
of amino acid side chains##2##5##(1990-12#1)(1995-5#1)
of amino acid##45##3##(1990-12#4)(1990-5#1)(1990-7#1)(1990-8#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1997-3#1)(1997-8#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-1#1)(2013-8#1)
of amino acids and peptides##2##5##(2008-10#2)
of amino acids and##7##4##(1990-2#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-2#2)
of amino acids from##2##4##(1995-12#1)(2008-10#1)
of amino acids in##5##4##(1993-3#1)(2008-10#3)(2008-11#1)
of amino acids on the##2##5##(1997-3#1)(2008-10#1)
of amino acids on##3##4##(1997-3#1)(2008-10#1)(2011-2#1)
of amino acids was##3##4##(1997-3#1)(2008-10#2)
of amino acids were##2##4##(1990-7#1)(1997-3#1)
of amino acids##69##3##(1990-12#2)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-9#2)(1993-3#2)(1993-8#2)(1994-5#1)(1994-6#2)(1995-12#2)(1997-3#4)(1997-6#1)(1997-7#1)(2008-10#22)(2008-11#4)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of amino and organic acids##2##5##(2008-4#2)
of amino and##3##3##(1996-12#1)(2008-4#2)
of amino compounds in xylem##2##5##(2012-8#2)
of amino compounds in##3##4##(2012-8#3)
of amino groups in##2##4##(1993-11#1)(2008-10#1)
of amino groups##3##3##(1993-11#1)(2008-10#2)
of amino##129##2##(1990-12#6)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-11#2)(1993-3#5)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1997-3#5)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#31)(2008-11#6)(2008-2#2)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2010-1#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-8#3)(2013-1#1)(2013-8#2)
of aminoacylation##5##2##(1997-3#3)(2008-4#1)(2012-2#1)
of aminoalkylindole##2##2##(1991-1#2)
of aminoglycoside##2##2##(2008-9#1)(2013-8#1)
of aminoglycosides##2##2##(1995-2#1)(2009-8#1)
of aminomethylbenzoic acid and aminophylline##3##5##(2008-10#3)
of aminomethylbenzoic acid in##2##4##(2008-10#2)
of aminomethylbenzoic acid##5##3##(2008-10#5)
of aminophylline##2##2##(2007-8#1)(2008-10#1)
of amiodarone##4##2##(1990-5#1)(1993-6#1)(1994-8#1)(2008-11#1)
of amitraz##2##2##(2008-10#2)
of amitrole in##2##3##(2008-10#2)
of amitrole with##2##3##(2008-10#2)
of amitrole##6##2##(2008-10#6)
of amlodipine besylate##4##3##(2008-10#4)
of amlodipine##7##2##(2007-10#1)(2008-10#4)(2008-3#1)(2012-12#1)
of ammodytin L##2##3##(1995-8#2)
of ammonia and##5##3##(2007-12#1)(2008-10#3)(2008-11#1)
of ammonia based on##2##4##(2008-10#2)
of ammonia in beers##2##4##(2008-10#2)
of ammonia in natural water##2##5##(2008-10#2)
of ammonia in##6##3##(2008-10#6)
of ammonia to##3##3##(2008-10#3)
of ammonia was##3##3##(2008-11#3)
of ammonia##51##2##(1992-11#2)(1994-5#1)(1995-3#2)(2007-12#2)(2008-10#27)(2008-11#8)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)
of ammonium acetate##2##3##(2008-10#2)
of ammonium and nitrate##5##4##(2008-10#5)
of ammonium and##8##3##(2008-10#7)(2008-9#1)
of ammonium assimilation##2##3##(1997-1#2)
of ammonium in Kjeldahl digests##2##5##(2008-10#2)
of ammonium in##4##3##(2008-10#4)
of ammonium ion##3##3##(2008-10#2)(2008-11#1)
of ammonium molybdate##4##3##(2008-10#4)
of ammonium sulfate precipitation and##2##5##(1991-9#1)(2008-8#1)
of ammonium sulfate##4##3##(1991-5#1)(1991-9#1)(1995-6#1)(2008-8#1)
of ammonium upon##2##3##(2008-7#2)
of ammonium##47##2##(1990-12#1)(1991-5#1)(1991-9#1)(1995-6#1)(1997-1#2)(1997-3#1)(2008-10#31)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-2#1)
of amniocenteses tests##2##3##(2012-3#2)
of amniocenteses##3##2##(2012-3#3)
of amniote##2##2##(2010-3#2)
of amniotes##2##2##(1996-5#1)(1997-3#1)
of amniotic fluid##5##3##(1990-9#1)(1992-12#1)(1995-8#1)(2012-12#1)(2012-2#1)
of amorphous##4##2##(2008-10#2)(2008-3#1)(2010-7#1)
of amosite fibers##2##3##(1991-12#2)
of amount##2##2##(2008-10#2)
of amoxicillin and cloxacillin##2##4##(2011-1#2)
of amoxicillin and##3##3##(1994-11#1)(2011-1#2)
of amoxycillin and clavulanic acid##2##5##(2008-10#2)
of amperometric##12##2##(2008-10#12)
of amperometry##2##2##(2008-10#2)
of amphetamine and##3##3##(1993-6#1)(1994-2#1)(2008-10#1)
of amphetamine in rat's blood and brain##2##7##(2008-10#2)
of amphetamine##11##2##(1993-6#2)(1994-2#1)(2008-10#5)(2013-1#3)
of amphetamine-induced##2##2##(1993-6#1)(1994-2#1)
of amphibians##5##2##(1996-5#1)(1997-3#3)(2013-1#1)
of amphipathic##2##2##(1990-5#1)(1995-11#1)
of amphiphile##3##2##(1992-5#3)
of amphiphilic##2##2##(2008-10#1)(2008-5#1)
of amphotericin B##5##3##(1992-6#1)(1997-1#1)(2008-5#1)(2011-2#2)
of amphotericin##8##2##(1992-6#3)(1997-1#1)(2008-5#1)(2011-2#3)
of ampicillin in##2##3##(2008-10#2)
of ampicillin resistance##2##3##(1990-6#2)
of ampicillin##9##2##(1990-6#2)(2008-10#5)(2009-12#1)(2011-2#1)
of amplicon##2##2##(2008-4#2)
of amplicons##5##2##(1995-12#1)(2008-10#3)(2008-4#1)
of amplification and expression##2##4##(1992-9#1)(2008-2#1)
of amplification and##3##3##(1992-9#1)(2008-2#1)(2008-4#1)
of amplification of the##2##4##(2007-11#1)(2008-10#1)
of amplification of##3##3##(1991-4#1)(2007-11#1)(2008-10#1)
of amplification##12##2##(1990-6#1)(1991-4#1)(1992-9#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)
of amplified femtosecond pulses##2##4##(2007-11#2)
of amplified femtosecond##3##3##(2007-11#2)(2007-12#1)
of amplified fragment length##2##4##(2008-10#2)
of amplified genes##3##3##(2008-11#3)
of amplified spontaneous emission##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
of amplified##22##2##(2007-11#3)(2007-12#4)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2011-2#1)
of amplifier##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2011-1#1)
of amplifying##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
of amplitude and phase##2##4##(2007-11#2)
of amplitude noise##2##3##(2007-11#1)(2007-12#1)
of amplitude##11##2##(1991-12#1)(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#3)
of amputation##2##2##(2007-11#1)(2008-6#1)
of amygdala activation##4##3##(2008-7#4)
of amygdala##5##2##(1990-5#1)(2008-7#4)
of amygdaloid##2##2##(1994-2#1)(2008-10#1)
of amylase activity##3##3##(2008-10#3)
of amylase##7##2##(1990-12#1)(1991-8#1)(2008-10#5)
of amylin##3##2##(1991-12#2)(2008-9#1)
of amyloid beta protein##2##4##(1992-6#1)(1994-11#1)
of amyloid beta##4##3##(1992-6#1)(1994-11#2)(1996-5#1)
of amyloid beta-protein precursor##2##4##(1994-9#2)
of amyloid beta-protein##3##3##(1994-9#3)
of amyloid deposits##2##3##(1994-6#1)(1994-8#1)
of amyloid peptides from##2##4##(1994-11#1)(2008-4#1)
of amyloid precursor protein##5##4##(1992-12#1)(1993-3#1)(1995-12#1)(2008-11#1)(2012-3#1)
of amyloid##30##2##(1991-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-12#1)(1996-5#1)(2008-11#3)(2008-4#2)(2008-5#2)(2010-11#1)(2012-1#1)(2012-3#1)(2013-7#1)
of amyloidosis##5##2##(2007-7#2)(2008-7#1)(2011-2#2)
of amyotrophic lateral sclerosis##4##4##(2008-4#1)(2009-9#1)(2012-3#1)(2013-1#1)
of amyotrophic##5##2##(2008-4#1)(2009-9#1)(2012-3#1)(2013-1#2)
of an &quot##5##3##(1990-9#1)(2008-10#1)(2009-1#1)(2009-4#1)(2013-7#1)
of an 8-year-old##3##3##(2007-5#1)(2010-5#1)(2012-3#1)
of an 800-nm##2##3##(2007-11#1)(2007-12#1)
of an AO system##6##4##(2008-3#6)
of an ARF##2##3##(1993-6#2)
of an ASP##2##3##(2013-1#2)
of an African##2##3##(1991-5#1)(1994-3#1)
of an Arabidopsis##4##3##(1997-2#1)(2007-12#1)(2008-8#1)(2009-6#1)
of an Australian##2##3##(1996-1#1)(2008-11#1)
of an E##2##3##(1997-4#1)(2008-10#1)
of an HPLC##3##3##(2008-10#2)(2008-4#1)
of an ICP-MS##2##3##(2008-10#2)
of an IR##3##3##(2007-12#2)(2008-3#1)
of an IgG##2##3##(1990-12#1)(1994-2#1)
of an Iranian##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
of an Italian##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
of an LDL particle##2##4##(1996-8#1)(2008-5#1)
of an N-terminal##4##3##(1991-10#1)(1992-6#1)(1994-5#1)(1995-6#1)
of an OCD##3##3##(2013-1#3)
of an OH group##2##4##(2007-12#2)
of an RNA##4##3##(1992-3#1)(1995-8#1)(1997-6#1)(2008-4#1)
of an SPR sensor chip##2##5##(2008-10#2)
of an UV beam##2##4##(2008-2#1)(2008-3#1)
of an UV##4##3##(2008-2#2)(2008-3#2)
of an abdominal aortic aneurysm##3##5##(2010-7#1)(2011-2#2)
of an abdominal##4##3##(1994-2#1)(2010-7#1)(2011-2#2)
of an aberrant##2##3##(2008-6#1)(2010-7#1)
of an abnormal shadow##2##4##(2008-1#2)
of an abnormal##5##3##(1993-11#1)(1994-1#1)(2008-1#3)
of an abnormally##2##3##(2008-2#1)(2013-1#1)
of an abrupt##2##3##(1992-6#1)(2008-8#1)
of an absorber##3##3##(2008-2#2)(2008-3#1)
of an absorbing##4##3##(2008-3#3)(2013-1#1)
of an absorption##2##3##(2007-11#1)(2007-12#1)
of an abstract##2##3##(2008-12#1)(2010-4#1)
of an abundant##2##3##(1996-11#1)(2008-7#1)
of an accurate##5##3##(1990-6#1)(1991-11#1)(1995-11#1)(2008-3#1)(2013-8#1)
of an achromatic##2##3##(2007-12#1)(2008-2#1)
of an acid##2##3##(2008-10#1)(2011-2#1)
of an acidic##4##3##(1994-5#1)(1994-6#1)(2010-10#1)(2011-2#1)
of an acousto-optic##2##3##(2007-12#1)(2008-10#1)
of an activated##2##3##(1997-3#1)(2008-9#1)
of an activator##2##3##(1992-8#1)(1994-5#1)
of an active immunotoxin##2##4##(1997-4#2)
of an active##22##3##(1990-5#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-6#2)(1997-4#2)(2007-11#3)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#2)
of an actively tilted##2##4##(2008-2#2)
of an actual##3##3##(1991-12#1)(2008-2#1)(2008-6#1)
of an acute ischemic##2##4##(2007-10#1)(2011-2#1)
of an acute##7##3##(1994-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
of an adapted##2##3##(1995-2#1)(2007-12#1)
of an adaptive optics system##2##5##(2007-12#1)(2008-3#1)
of an adaptive##9##3##(1997-4#1)(2007-11#2)(2007-12#1)(2008-3#3)(2008-6#1)(2009-6#1)
of an additional##7##3##(1990-5#1)(1993-3#1)(1997-3#1)(2008-10#3)(2008-3#1)
of an adenosine##3##3##(1990-12#1)(1993-6#1)(2008-9#1)
of an adenovirus##2##3##(1992-9#1)(2010-1#1)
of an adequate##7##3##(1991-12#1)(1997-4#1)(2008-10#2)(2008-3#2)(2010-12#1)
of an adhesive##2##3##(2008-12#1)(2010-4#1)
of an admixture of##3##4##(1997-8#1)(2010-6#1)(2011-2#1)
of an adolescent##3##3##(1992-3#1)(2008-11#1)(2012-2#1)
of an adult with##3##4##(2012-2#1)(2013-1#2)
of an adult##13##3##(1992-8#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of an advanced##3##3##(1995-8#1)(1996-2#1)(2008-2#1)
of an aerosol##4##3##(1992-3#1)(1996-3#1)(2008-2#1)(2008-3#1)
of an affected##2##3##(2008-7#1)(2008-9#1)
of an agent##3##3##(2008-10#1)(2008-5#1)(2009-11#1)
of an aggressive##7##3##(1990-3#1)(1991-1#1)(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
of an aging##3##3##(1994-2#1)(2007-12#1)(2009-5#1)
of an agricultural##2##3##(2007-7#1)(2008-12#1)
of an air##4##3##(2008-10#2)(2008-11#1)(2009-10#1)
of an alcohol##2##3##(1990-11#1)(2007-12#1)
of an algorithm##5##3##(2008-2#1)(2008-3#3)(2008-4#1)
of an alkaline##2##3##(2008-10#1)(2008-8#1)
of an alkyl##2##3##(2008-10#2)
of an all-optical##3##3##(2008-2#1)(2008-3#2)
of an alpha##2##3##(1994-8#1)(1995-5#1)
of an alpha-helical##2##3##(1991-12#1)(1994-12#1)
of an alpha-helix##3##3##(1992-6#1)(1995-12#1)(2008-9#1)
of an alternate action is##2##5##(2013-1#2)
of an alternate##3##3##(1993-12#1)(2013-1#2)
of an alternative##10##3##(1993-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
of an amine##2##3##(2008-10#1)(2010-2#1)
of an amino acid residue##2##5##(1992-8#1)(1993-11#1)
of an amino acid##3##4##(1992-8#1)(1993-11#1)(2010-12#1)
of an amino##4##3##(1992-8#1)(1993-11#1)(2008-10#1)(2010-12#1)
of an amorphous##2##3##(2008-10#2)
of an amperometric biosensor##2##4##(2008-10#2)
of an amperometric glucose biosensor based on##2##7##(2008-10#2)
of an amperometric glucose##3##4##(2008-10#3)
of an amperometric##6##3##(2008-10#5)(2010-5#1)
of an amplified##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of an analog##2##3##(2007-11#1)(2008-2#1)
of an analysis of##3##4##(1997-5#1)(2008-10#1)(2008-3#1)
of an analysis##4##3##(1997-5#1)(2008-10#2)(2008-3#1)
of an analyte##6##3##(1996-5#1)(2008-10#5)
of an analytical method to##2##5##(1996-12#1)(2008-10#1)
of an analytical method##4##4##(1996-12#1)(2008-10#3)
of an analytical procedure##3##4##(2008-10#3)
of an analytical##13##3##(1996-12#1)(2007-11#2)(2008-10#9)(2008-2#1)
of an anatomical##2##3##(1991-6#1)(2008-10#1)
of an ancestral##2##3##(2007-12#1)(2009-8#1)
of an androgen##3##3##(1990-11#2)(2008-4#1)
of an aneurysm##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
of an angiomyolipoma##3##3##(1992-2#1)(2010-6#2)
of an angiotensin##3##3##(1995-12#2)(2013-1#1)
of an animal##2##3##(2008-8#1)(2008-9#1)
of an anionic##4##3##(1994-5#1)(2008-10#3)
of an annual##2##3##(2008-8#1)(2008-9#1)
of an antagonist##3##3##(1994-5#1)(2008-10#2)
of an anterior##8##3##(1992-9#2)(1996-3#2)(2007-8#1)(2008-7#1)(2009-3#1)(2012-2#1)
of an anti-inflammatory##2##3##(1990-6#1)(2009-6#1)
of an antibacterial##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
of an antibody##7##3##(1991-1#1)(1992-9#1)(1993-8#1)(1994-9#1)(2008-10#1)(2008-4#1)(2010-6#1)
of an antifungal##2##3##(1997-4#1)(2008-10#1)
of an antihypertensive##2##3##(2008-10#1)(2008-8#1)
of an antimicrobial##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
of an antineoplastic##2##3##(1990-10#1)(2007-11#1)
of an aortic##4##3##(1994-6#1)(2011-2#2)(2013-1#1)
of an apparent molecular##2##4##(1992-6#1)(1994-11#1)
of an apparent##4##3##(1992-6#1)(1994-11#1)(2008-1#1)(2008-11#1)
of an apparently healthy##2##4##(2011-2#1)(2013-1#1)
of an apparently##4##3##(1992-8#1)(1993-11#1)(2011-2#1)(2013-1#1)
of an application##2##3##(1994-9#1)(2013-1#1)
of an applied electric field##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
of an applied##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#2)
of an approach to##2##4##(2007-12#1)(2008-10#1)
of an approach##5##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
of an appropriate##11##3##(1990-9#1)(1991-9#1)(1995-2#1)(1996-4#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2009-11#1)
of an approximately##2##3##(1992-12#1)(1995-11#1)
of an aqueous sample##2##4##(2008-10#2)
of an aqueous solution of##3##5##(2007-11#1)(2008-10#2)
of an aqueous solution##4##4##(2007-11#2)(2008-10#2)
of an aqueous##8##3##(2007-11#2)(2008-10#4)(2008-7#2)
of an arbitrary input##2##4##(2007-12#1)(2008-3#1)
of an arbitrary##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
of an arc that might be either a 22 degrees##2##10##(2008-2#2)
of an arc##3##3##(2008-2#3)
of an argon##2##3##(2008-2#2)
of an array of##9##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#5)
of an artemisinin-type compound##2##4##(2008-10#2)
of an artery##3##3##(2008-9#2)(2009-1#1)
of an article##9##3##(2008-11#6)(2008-7#1)(2012-2#1)(2012-3#1)
of an artificial culture matrix##2##5##(2011-2#2)
of an artificial neural network##2##5##(2008-1#1)(2008-10#1)
of an artificial##7##3##(2008-1#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-4#1)(2011-2#2)
of an aspartate##2##3##(1991-12#1)(1995-8#1)
of an assessment of##2##4##(1995-6#1)(2008-4#1)
of an assessment##4##3##(1995-6#1)(2008-11#1)(2008-4#1)(2013-8#1)
of an association between##7##4##(1995-12#1)(1997-4#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-5#1)(2011-1#1)
of an association##9##3##(1990-3#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-3#1)
of an associative##2##3##(2008-1#1)(2008-11#1)
of an asymmetric##7##3##(1992-3#1)(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
of an asymptomatic##6##3##(1992-12#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2012-12#1)
of an atmospheric-pressure##2##3##(2008-2#1)(2008-3#1)
of an atom##4##3##(1991-9#1)(2006-4#2)(2007-12#1)
of an atomic absorption##2##4##(2008-10#2)
of an atomic##4##3##(2008-10#3)(2010-4#1)
of an atomic-force microscope (AFM)##2##5##(2007-12#1)(2008-2#1)
of an atrial septal defect##2##5##(2007-8#2)
of an atrial septal##3##4##(1994-11#1)(2007-8#2)
of an attenuated##2##3##(1992-3#1)(2008-3#1)
of an automated sample##2##4##(2008-10#2)
of an automated solid-phase##2##4##(2008-10#1)(2012-2#1)
of an automated##11##3##(1990-2#1)(1993-8#1)(2008-10#6)(2008-4#1)(2010-8#1)(2012-2#1)
of an automatic##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
of an autosomal##2##3##(1990-9#1)(2008-7#1)
of an auxiliary##2##3##(1995-3#1)(2007-11#1)
of an average##3##3##(1995-11#1)(2007-12#1)(2008-3#1)
of an avian##2##3##(2008-8#1)(2013-8#1)
of an axicon##2##3##(2007-11#1)(2008-2#1)
of an earlier study##2##4##(1993-12#1)(2008-2#1)
of an earlier##8##3##(1993-12#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
of an early postnatal hypoxia on the##2##7##(1993-12#2)
of an early stage##2##4##(2007-10#1)(2007-9#1)
of an early##10##3##(1990-6#1)(1993-12#3)(2007-10#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-8#1)
of an easily##2##3##(2008-11#1)(2012-3#1)
of an educational intervention##3##4##(2008-8#2)(2012-1#1)
of an educational##7##3##(1997-7#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-1#1)
of an effective##11##3##(1996-12#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
of an efficient and##5##4##(1994-3#2)(1996-12#1)(2008-11#1)(2008-3#1)
of an efficient##13##3##(1993-9#1)(1994-3#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2013-1#1)
of an eight-week##2##3##(1990-2#1)(2011-1#1)
of an elderly male##2##4##(2010-5#1)(2010-7#1)
of an elderly##10##3##(1994-12#1)(2008-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
of an electric field##4##4##(1996-12#1)(2007-11#1)(2008-11#1)(2008-3#1)
of an electric##5##3##(1996-12#1)(2007-11#1)(2008-11#2)(2008-3#1)
of an electrical##5##3##(1994-5#1)(2007-12#2)(2008-3#1)(2012-1#1)
of an electrically##3##3##(2007-12#1)(2008-3#2)
of an electrochemical##4##3##(2008-10#4)
of an electrode##5##3##(2007-11#1)(2008-10#4)
of an electron##4##3##(2007-12#1)(2008-10#3)
of an electronic##8##3##(1991-8#1)(1993-10#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
of an electroosmotic##2##3##(1996-5#1)(2008-10#1)
of an element by##2##4##(2006-4#1)(2008-10#1)
of an elevated blood pressure in the acute phase of a cerebral infarction is##2##14##(1997-5#2)
of an elliptic retarder##2##4##(2008-3#2)
of an elliptic##3##3##(2008-3#3)
of an emergency##6##3##(1992-1#1)(1996-1#1)(1997-2#1)(2008-3#2)(2010-1#1)
of an emerging##2##3##(2008-3#1)(2008-5#1)
of an encrypted##2##3##(2008-3#2)
of an end-stage renal disease##2##5##(2007-7#1)(2013-1#1)
of an end-to-end##2##3##(1991-9#1)(2008-3#1)
of an endogenous EAA##2##4##(1994-11#2)
of an endogenous RNA transcript with##2##6##(1992-8#2)
of an endogenous##10##3##(1990-5#1)(1991-2#1)(1992-8#3)(1994-11#2)(1994-5#1)(1996-12#1)(2010-8#1)
of an enormous##2##3##(2008-10#1)(2013-1#1)
of an entire##2##3##(2007-8#1)(2008-10#1)
of an entirely new##2##4##(2008-3#2)
of an enzyme##11##3##(1990-5#1)(1990-8#1)(1991-5#2)(1992-3#1)(2008-10#4)(2008-4#1)(2009-5#1)
of an enzyme-linked immunosorbent assay (ELISA) for##2##7##(2008-10#1)(2011-2#1)
of an enzyme-linked immunosorbent assay (ELISA)##4##6##(2008-10#2)(2010-4#1)(2011-2#1)
of an enzyme-linked immunosorbent assay##5##5##(2008-10#2)(2010-4#1)(2011-2#2)
of an epidemic of##2##4##(1996-11#1)(2007-7#1)
of an epidemic##5##3##(1996-11#1)(1997-3#1)(2007-7#1)(2008-10#2)
of an epidemiological##2##3##(2008-7#1)(2011-2#1)
of an epidural catheter##2##4##(1993-10#1)(2011-2#1)
of an equilibrium##3##3##(1992-6#1)(2008-10#1)(2009-5#1)
of an equipment##2##3##(2008-10#2)
of an equivalent amount of##2##5##(1992-6#1)(2008-10#1)
of an equivalent##4##3##(1992-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
of an erbium-doped fiber amplifier##2##5##(2007-11#1)(2008-3#1)
of an erbium-doped fiber##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of an error##2##3##(2008-2#1)(2008-3#1)
of an erythrocyte##2##3##(1990-2#1)(2008-3#1)
of an escalating##2##3##(1992-8#1)(2008-5#1)
of an esophagus##2##3##(2008-10#1)(2012-3#1)
of an essential fatty acid##2##5##(1992-3#2)
of an essential##5##3##(1992-3#2)(1995-6#1)(2008-8#1)(2010-10#1)
of an established##2##3##(2009-10#1)(2009-11#1)
of an evidence-based##3##3##(2008-8#1)(2013-1#2)
of an evolutionary##2##3##(1997-4#1)(2009-10#1)
of an evolving##2##3##(2008-8#1)(2010-5#1)
of an exact##4##3##(2008-2#1)(2008-3#2)(2012-3#1)
of an excess of the##2##5##(1992-8#1)(2008-10#1)
of an excess of##8##4##(1991-12#1)(1992-8#1)(1995-6#1)(2008-10#4)(2008-12#1)
of an exclusively##2##3##(2008-3#1)(2011-2#1)
of an existing##2##3##(1994-12#1)(2008-2#1)
of an exogenous##6##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
of an expanded##2##3##(2008-9#1)(2010-12#1)
of an expanding##4##3##(2007-12#1)(2008-10#3)
of an experimental##9##3##(1992-8#1)(1997-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
of an experimentally##2##3##(2008-4#1)(2012-2#1)
of an expression##2##3##(1992-10#1)(1994-11#1)
of an extended cavity##2##4##(2007-11#1)(2007-12#1)
of an extended##9##3##(1991-2#1)(1992-4#1)(1993-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-5#1)
of an extensive##7##3##(1992-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-5#1)(2008-10#1)(2013-7#1)
of an external cavity diode laser##2##6##(2008-2#1)(2008-3#1)
of an external cavity##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of an external magnetic field##2##5##(2008-3#1)(2008-7#1)
of an external##13##3##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-7#2)(2010-5#1)(2013-1#1)
of an external-cavity laser##2##4##(2007-11#1)(2008-3#1)
of an external-cavity##8##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#2)
of an extra##3##3##(1990-12#1)(1997-2#1)(2008-10#1)
of an extract of##4##4##(1992-5#1)(1992-8#1)(2008-10#2)
of an extract##5##3##(1992-5#1)(1992-8#1)(1993-2#1)(2008-10#2)
of an extraction##4##3##(2008-10#4)
of an extradural##2##3##(2008-7#2)
of an extreme-ultraviolet transmission grating spectrometer with##2##7##(2008-3#2)
of an extreme-ultraviolet##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
of an iatrogenic##2##3##(1991-6#1)(2008-12#1)
of an identical##2##3##(2007-12#1)(2008-7#1)
of an illuminated##2##3##(2008-2#2)
of an image to##2##4##(2008-6#1)(2012-1#1)
of an image##16##3##(1994-8#1)(2007-12#2)(2008-2#2)(2008-3#4)(2008-6#2)(2008-9#3)(2012-1#1)(2013-7#1)
of an imaging##7##3##(2007-12#3)(2008-2#1)(2008-3#3)
of an immediate##2##3##(1990-5#1)(1991-2#1)
of an immobilised##3##3##(2008-10#3)
of an immobilized##2##3##(1990-5#1)(2008-10#1)
of an immunohistochemical##2##3##(1997-7#1)(2012-3#1)
of an immunosuppressive##2##3##(1990-5#1)(1990-9#1)
of an impacted##2##3##(2007-12#1)(2010-12#1)
of an imperfect##2##3##(1995-8#1)(1996-8#1)
of an implantable##2##3##(2007-7#1)(2011-1#1)
of an important##10##3##(1994-12#1)(1994-8#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-7#1)(2010-4#1)(2013-1#2)
of an improved##3##3##(1996-12#1)(2008-10#2)
of an improvement##2##3##(1995-12#1)(2013-1#1)
of an in vitro system to##2##6##(1996-2#1)(2013-8#1)
of an in vitro##11##4##(1990-12#1)(1996-2#1)(2008-11#2)(2008-5#2)(2011-2#1)(2013-1#3)(2013-8#1)
of an in##14##3##(1990-12#1)(1996-2#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
of an in-frame##2##3##(1990-7#1)(1997-4#1)
of an inactivated##2##3##(2008-5#2)
of an inactive##2##3##(1991-6#1)(2012-3#1)
of an incident light beam##2##5##(2008-3#2)
of an incident##6##3##(2008-2#1)(2008-3#5)
of an inclusion##4##3##(2008-10#1)(2008-3#3)
of an incoherent optical##2##4##(2007-11#1)(2008-3#1)
of an incoherent##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
of an incoherently##2##3##(2008-3#2)
of an incomplete##2##3##(2008-9#1)(2012-12#1)
of an increase in the##4##5##(1991-12#1)(1997-1#1)(2008-9#1)(2011-1#1)
of an increase in##8##4##(1990-2#1)(1991-12#1)(1996-9#1)(1997-1#2)(2007-8#1)(2008-9#1)(2011-1#1)
of an increase##10##3##(1990-2#1)(1991-12#1)(1996-9#1)(1997-1#2)(2007-12#1)(2007-8#1)(2008-9#1)(2010-11#1)(2011-1#1)
of an increased##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
of an increasing##3##3##(1997-4#1)(2011-2#2)
of an increasingly##3##3##(1996-1#1)(2007-9#1)(2010-3#1)
of an independent##6##3##(1993-12#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-11#1)
of an indirect##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
of an individual with##4##4##(1994-12#1)(2011-1#3)
of an individual##28##3##(1990-9#2)(1993-3#1)(1994-12#1)(1995-6#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2010-11#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of an individual's##8##3##(1995-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
of an inducible##2##3##(1992-3#1)(2008-2#1)
of an industrial##2##3##(1995-3#1)(2007-11#1)
of an inexpensive##2##3##(2008-10#2)
of an infant with##2##4##(2012-2#1)(2012-3#1)
of an infant##8##3##(1991-2#1)(1993-12#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
of an infected urachal cyst in a##2##7##(2008-10#2)
of an infected urachal cyst##3##5##(2008-10#3)
of an infected##6##3##(1990-6#1)(2008-10#3)(2011-3#2)
of an infection of##2##4##(2008-11#1)(2010-12#1)
of an infection##5##3##(2008-11#2)(2010-12#1)(2010-5#1)(2011-2#1)
of an infectious molecular clone of##2##6##(1991-9#2)
of an infectious##7##3##(1990-12#1)(1991-9#2)(2008-10#3)(2008-8#1)
of an infinite##2##3##(2007-11#1)(2008-11#1)
of an inflammatory##3##3##(1994-11#1)(1996-3#1)(2008-4#1)
of an influenza##3##3##(1996-6#1)(2008-11#2)
of an infrared##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of an inherent safety approach##2##5##(2009-10#2)
of an inherent##3##3##(2008-11#1)(2009-10#2)
of an inhibitor of##2##4##(2008-10#1)(2011-2#1)
of an inhibitory##3##3##(1991-2#1)(1993-12#1)(2009-10#1)
of an initial##8##3##(1993-6#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)
of an initially##2##3##(2007-12#1)(2008-8#1)
of an initiative##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
of an initiator##2##3##(1994-11#1)(2008-10#1)
of an injectable##2##3##(2008-9#1)(2009-7#1)
of an injection##2##3##(2008-10#1)(2011-2#1)
of an inner##4##3##(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)
of an innovative education##2##4##(2008-12#1)(2008-6#1)
of an innovative##10##3##(1994-2#1)(2008-10#1)(2008-12#3)(2008-5#2)(2008-6#1)(2012-12#1)(2013-1#1)
of an inorganic##3##3##(2008-10#2)(2010-6#1)
of an input##3##3##(2007-11#1)(2007-12#2)
of an insoluble##2##3##(2010-5#1)(2011-2#1)
of an instrument##6##3##(1997-1#2)(2008-3#2)(2009-12#1)(2012-2#1)
of an insufficient##2##3##(1990-3#1)(2008-10#1)
of an insulin##3##3##(1992-6#1)(1996-3#1)(2008-12#1)
of an intact##2##3##(1995-11#1)(2009-8#1)
of an integral##5##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)
of an integrated approach to##2##5##(2008-10#1)(2008-11#1)
of an integrated approach##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
of an integrated management##3##4##(2008-10#3)
of an integrated optical##2##4##(2008-3#1)(2011-1#1)
of an integrated##31##3##(1992-2#1)(1992-3#2)(1995-2#1)(1996-3#1)(2006-9#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-1#3)(2013-8#1)
of an integration##2##3##(2008-10#1)(2008-3#1)
of an intense##4##3##(2007-11#1)(2007-12#2)(2008-5#1)
of an intensely##2##3##(2007-11#1)(2008-10#1)
of an intensive##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
of an interaction##2##3##(2009-7#1)(2011-2#1)
of an interactive##2##3##(2008-12#1)(2012-2#1)
of an intercalibration between the##2##5##(2008-3#2)
of an interdisciplinary approach in##2##5##(1997-8#1)(2008-4#1)
of an interdisciplinary##4##3##(1997-8#1)(2008-3#1)(2008-4#1)(2011-2#1)
of an interference##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of an interferogram##2##3##(2008-2#1)(2008-3#1)
of an interfood interval##2##4##(2008-5#2)
of an intermediate##8##3##(1992-3#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)
of an internal##5##3##(1993-8#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)
of an international##8##3##(1993-1#2)(1994-2#1)(1995-12#1)(1995-9#1)(2008-10#2)(2010-5#1)
of an intervention to##2##4##(2010-4#1)(2012-3#1)
of an intervention##6##3##(1991-2#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
of an intracavity##11##3##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#3)
of an intracranial##4##3##(1992-6#1)(1995-5#1)(2008-7#2)
of an intramolecular##2##3##(1992-12#1)(2009-9#1)
of an introduced##3##3##(2008-10#2)(2012-3#1)
of an intron##5##3##(1991-9#4)(1994-11#1)
of an inverse##5##3##(1994-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
of an inversion algorithm##2##4##(2008-3#2)
of an inverted##2##3##(2008-11#1)(2008-2#1)
of an investigation##5##3##(1993-5#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-6#1)
of an ion associate##2##4##(2008-10#2)
of an ion mobility spectrometer##2##5##(2008-10#2)
of an ion##8##3##(2008-10#7)(2008-8#1)
of an ion-selective##2##3##(2008-10#2)
of an ionic##2##3##(1990-11#1)(2009-12#1)
of an irreversible##3##3##(1994-11#2)(2008-4#1)
of an ischemic##2##3##(2007-8#1)(2008-3#1)
of an isolate of##2##4##(2008-10#1)(2008-5#1)
of an isolate##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
of an isolated##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
of an iterative##4##3##(1992-9#1)(2008-2#1)(2008-3#2)
of an mRNA##3##3##(1992-11#1)(2011-2#1)(2012-3#1)
of an object can##2##4##(2007-11#1)(2008-3#1)
of an object from##2##4##(2008-3#2)
of an object recognition##2##4##(2008-6#2)
of an object##18##3##(1996-2#2)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#9)(2008-6#2)(2012-2#1)
of an objective##2##3##(2008-11#1)(2008-3#1)
of an observation##3##3##(1996-4#1)(2012-12#1)(2012-3#1)
of an observer##2##3##(2007-4#1)(2008-2#1)
of an off-axis##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
of an oil spill##2##4##(2008-10#1)(2008-11#1)
of an oil##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-2#1)
of an old##4##3##(1994-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
of an older##2##3##(2008-3#1)(2012-2#1)
of an oligonucleotide##4##3##(1995-2#1)(2008-4#3)
of an on-line preconcentration system for##3##6##(2008-10#3)
of an on-line preconcentration##4##4##(2008-10#4)
of an on-line##10##3##(1997-2#1)(2008-10#9)
of an ongoing##7##3##(1996-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-3#1)
of an open reading frame (ORF)##3##6##(1993-12#1)(1996-8#1)(2008-10#1)
of an open reading frame##4##5##(1993-12#1)(1996-8#1)(2008-10#2)
of an open##10##3##(1990-12#1)(1991-8#1)(1993-12#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
of an operation##3##3##(1993-9#1)(2012-12#1)(2013-1#1)
of an optical beam##2##4##(2007-11#1)(2008-3#1)
of an optical biosensor##3##4##(2008-10#3)
of an optical disk data storage system##2##7##(2008-2#1)(2008-3#1)
of an optical disk##3##4##(2008-2#2)(2008-3#1)
of an optical fiber##9##4##(2007-11#4)(2007-12#2)(2008-10#1)(2008-3#2)
of an optical frequency##2##4##(2007-12#2)
of an optical isolator by use of a nonreciprocal phase shift##2##11##(2008-3#2)
of an optical isolator##3##4##(2008-3#3)
of an optical parametric oscillator##2##5##(2007-11#1)(2007-12#1)
of an optical pickup##2##4##(2007-12#1)(2008-3#1)
of an optical pulse##2##4##(2007-11#1)(2008-3#1)
of an optical system##5##4##(2007-12#1)(2008-3#4)
of an optical vortex##2##4##(2007-11#1)(2009-5#1)
of an optical waveguide##2##4##(2007-11#1)(2008-3#1)
of an optical##75##3##(1992-11#1)(2007-11#13)(2007-12#12)(2008-10#7)(2008-2#5)(2008-3#35)(2009-5#1)(2011-1#1)
of an optically addressed##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of an optically thick##2##4##(2008-3#2)
of an optically##16##3##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#5)
of an optimal##6##3##(2007-7#1)(2008-2#2)(2008-7#1)(2011-3#1)(2013-8#1)
of an optimized##3##3##(2008-10#1)(2008-3#2)
of an optimum##2##3##(2010-3#1)(2013-1#1)
of an oral##3##3##(1991-2#1)(1992-11#1)(2008-11#1)
of an organ##3##3##(1990-3#1)(1993-2#1)(2011-2#1)
of an organic modifier##2##4##(2008-10#2)
of an organic reducing reagent##2##5##(2008-10#2)
of an organic##8##3##(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)
of an organically modified##2##4##(2008-10#2)
of an organism##3##3##(1995-8#1)(2008-10#2)
of an organization##3##3##(1991-12#1)(1994-1#1)(1995-12#1)
of an organization's##2##3##(1993-3#1)(2010-8#1)
of an original##3##3##(1992-6#1)(2007-12#1)(2008-3#1)
of an otherwise##2##3##(1994-9#1)(1997-3#1)
of an outbreak##3##3##(1996-2#1)(2007-12#1)(2008-12#1)
of an outer##3##3##(1997-3#1)(2008-10#1)(2012-12#1)
of an overall##3##3##(1992-2#1)(1996-3#1)(2011-2#1)
of an oxidative stress##2##4##(2008-10#1)(2010-12#1)
of an oxidative##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
of an oxidizing##2##3##(1991-9#1)(1996-5#1)
of an ultrafast##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of an ultrashort laser pulse##2##5##(2007-11#1)(2007-12#1)
of an ultrashort optical pulse##2##5##(2007-11#2)
of an ultrashort optical##3##4##(2007-11#2)(2008-3#1)
of an ultrashort pulse in##2##5##(2007-11#1)(2007-12#1)
of an ultrashort pulse##3##4##(2007-11#1)(2007-12#2)
of an ultrashort##9##3##(2007-11#4)(2007-12#4)(2008-3#1)
of an ultrasonic##2##3##(2008-10#2)
of an ultrasound##2##3##(2007-12#1)(2012-2#1)
of an unambiguous patient identification##2##5##(2011-2#2)
of an uncemented##2##3##(2009-4#1)(2012-12#1)
of an underlying##5##3##(1994-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)
of an understanding regarding##2##4##(2008-4#1)(2013-1#1)
of an understanding##3##3##(1994-11#1)(2008-4#1)(2013-1#1)
of an unfamiliar group##2##4##(2010-2#2)
of an unfamiliar##3##3##(2008-4#1)(2010-2#2)
of an unfavorable##3##3##(1993-11#1)(2012-3#1)(2013-1#1)
of an unknown##7##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)
of an unstable resonator with a stable core##2##8##(2008-3#2)
of an unstable resonator##4##4##(2008-3#4)
of an unstable ring resonator with 90-deg beam rotation for a##2##11##(2008-3#2)
of an unstable##10##3##(2007-12#1)(2008-10#1)(2008-3#6)(2011-2#1)(2013-1#1)
of an ununited##2##3##(1991-3#1)(2008-9#1)
of an unusual##7##3##(1990-9#1)(1993-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
of an upcoming##2##3##(2008-7#1)(2009-8#1)
of an upper##4##3##(2007-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
of an urban##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
of an##2447##2##(1990-10#3)(1990-11#7)(1990-12#12)(1990-2#7)(1990-3#7)(1990-4#1)(1990-5#11)(1990-6#5)(1990-7#6)(1990-8#4)(1990-9#10)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#12)(1991-2#10)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#5)(1991-7#1)(1991-8#5)(1991-9#12)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#7)(1992-3#18)(1992-4#1)(1992-5#3)(1992-6#12)(1992-8#14)(1992-9#7)(1993-1#5)(1993-10#2)(1993-11#9)(1993-12#18)(1993-2#5)(1993-3#6)(1993-5#2)(1993-6#5)(1993-8#10)(1993-9#4)(1994-1#2)(1994-11#17)(1994-12#10)(1994-2#15)(1994-3#8)(1994-5#13)(1994-6#6)(1994-7#1)(1994-8#9)(1994-9#6)(1995-11#8)(1995-12#10)(1995-2#11)(1995-3#4)(1995-5#8)(1995-6#12)(1995-8#7)(1995-9#3)(1996-1#6)(1996-10#2)(1996-11#3)(1996-12#16)(1996-2#10)(1996-3#10)(1996-4#3)(1996-5#11)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#13)(1997-3#13)(1997-4#14)(1997-5#3)(1997-6#7)(1997-7#7)(1997-8#5)(2006-10#1)(2006-4#4)(2006-9#1)(2007-10#6)(2007-11#95)(2007-12#116)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#15)(2007-8#22)(2007-9#3)(2008-1#12)(2008-10#387)(2008-11#71)(2008-12#32)(2008-2#116)(2008-3#274)(2008-4#36)(2008-5#53)(2008-6#31)(2008-7#58)(2008-8#45)(2008-9#33)(2009-1#3)(2009-10#15)(2009-11#8)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#7)(2009-5#9)(2009-6#10)(2009-7#5)(2009-8#6)(2009-9#6)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#8)(2010-2#5)(2010-3#8)(2010-4#9)(2010-5#14)(2010-6#9)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#21)(2011-10#2)(2011-2#71)(2011-3#5)(2012-1#7)(2012-12#30)(2012-2#30)(2012-3#38)(2013-1#71)(2013-7#3)(2013-8#20)
of anabolic##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
of anaemia in##3##3##(2008-1#1)(2009-10#2)
of anaemia##6##2##(1993-8#1)(2008-1#1)(2008-11#1)(2009-10#3)
of anaerobes##2##2##(2007-7#2)
of anaerobic bacteria##2##3##(2011-1#2)
of anaerobic digesters##2##3##(2008-7#2)
of anaerobic##9##2##(1990-8#1)(1997-4#1)(2008-2#1)(2008-7#2)(2011-1#2)(2012-3#1)(2013-1#1)
of anaesthesia##9##2##(1994-3#1)(1996-6#1)(2010-7#2)(2011-2#4)(2012-2#1)
of anaesthetic##4##2##(1991-6#1)(2008-8#1)(2010-7#1)(2011-1#1)
of anal canal##2##3##(2013-1#2)
of anal##5##2##(2011-1#1)(2011-2#2)(2013-1#2)
of analgesia during##2##3##(1990-8#1)(2012-3#1)
of analgesia##6##2##(1990-8#1)(2007-7#1)(2012-2#1)(2012-3#3)
of analgesic and##2##3##(1993-12#1)(2008-12#1)
of analgesic effects##3##3##(1991-1#1)(2008-10#1)(2012-1#1)
of analgesic##7##2##(1991-1#1)(1993-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-12#1)(2012-1#1)
of analgesics and##2##3##(1992-5#1)(2008-11#1)
of analgesics##5##2##(1992-5#1)(1993-9#1)(2008-11#1)(2010-11#1)(2012-3#1)
of analog##3##2##(1994-8#1)(2008-3#1)(2009-2#1)
of analogous##5##2##(1990-8#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-8#1)
of analogs##6##2##(1990-5#1)(1994-8#1)(1995-3#2)(2008-4#1)(2008-6#1)
of analogue##2##2##(1992-3#1)(2008-7#1)
of analogues of##2##3##(1994-8#1)(2008-4#1)
of analysers##2##2##(2008-10#2)
of analyses of##3##3##(1994-9#1)(2008-10#2)
of analyses##11##2##(1993-12#1)(1994-9#1)(2008-10#5)(2008-4#1)(2008-9#2)(2009-8#1)
of analysing the##4##3##(2008-10#3)(2008-11#1)
of analysing##7##2##(2008-10#4)(2008-11#2)(2008-12#1)
of analysis and##7##3##(1994-12#1)(2008-10#5)(2012-7#1)
of analysis are##2##3##(1994-9#1)(2008-10#1)
of analysis for##3##3##(2008-10#2)(2008-9#1)
of analysis in##2##3##(2008-10#1)(2011-2#1)
of analysis is##8##3##(2008-10#4)(2008-9#3)(2011-2#1)
of analysis of the##5##4##(1995-6#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
of analysis of variance##2##4##(2008-10#1)(2008-7#1)
of analysis of##17##3##(1993-2#1)(1995-6#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
of analysis that##3##3##(2008-2#1)(2008-9#1)(2012-12#1)
of analysis was##3##3##(2008-10#3)
of analysis were##3##3##(1997-5#1)(2008-10#1)(2010-5#1)
of analysis##91##2##(1990-2#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-10#43)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#7)(2009-5#1)(2010-5#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#3)
of analyte concentrations##3##3##(2008-10#3)
of analyte extraction from##2##4##(2008-10#2)
of analyte extraction##3##3##(2008-10#3)
of analyte ions in##2##4##(2008-10#2)
of analyte ions##4##3##(2008-10#4)
of analyte molecules##2##3##(2008-10#2)
of analyte##33##2##(2007-11#1)(2008-10#30)(2008-4#1)(2008-7#1)
of analytes and##4##3##(1996-5#1)(2008-10#3)
of analytes in the##4##4##(2008-10#3)(2011-1#1)
of analytes in##9##3##(2008-10#6)(2008-3#1)(2008-4#1)(2011-1#1)
of analytes is##3##3##(2008-10#3)
of analytes were##3##3##(2008-10#3)
of analytes##42##2##(1990-8#1)(1996-5#1)(2008-10#35)(2008-3#1)(2008-4#1)(2009-11#1)(2010-5#1)(2011-1#1)
of analytic##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
of analytical and##8##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
of analytical chemistry##4##3##(2008-10#1)(2008-11#1)(2010-7#2)
of analytical information##2##3##(1992-2#1)(2008-10#1)
of analytical laboratories##2##3##(2008-10#1)(2009-11#1)
of analytical methodology##2##3##(2008-10#2)
of analytical methods for##4##4##(1994-3#1)(2008-10#3)
of analytical methods##6##3##(1994-3#1)(2008-10#5)
of analytical procedures##3##3##(1992-3#1)(2008-10#2)
of analytical results##3##3##(2008-10#3)
of analytical separation##3##3##(2008-10#3)
of analytical signals in##2##4##(2007-11#1)(2008-10#1)
of analytical signals##4##3##(2007-11#1)(2008-10#3)
of analytical steps##2##3##(2008-10#2)
of analytical techniques and instruments##2##5##(2008-10#2)
of analytical techniques##5##3##(2007-12#1)(2008-10#4)
of analytical##79##2##(1992-2#1)(1992-3#1)(1994-3#1)(1995-3#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#56)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-8#1)
of analyzed##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
of analyzing the##4##3##(1990-6#1)(1993-2#1)(1993-6#1)(2008-3#1)
of analyzing##12##2##(1990-6#1)(1993-2#1)(1993-6#1)(1995-1#1)(2008-10#4)(2008-3#2)(2009-10#1)(2013-1#1)
of anamorph##3##2##(2008-10#3)
of anaphylaxis##7##2##(1992-6#1)(2010-6#1)(2012-3#1)(2013-1#3)(2013-8#1)
of anaplastic transformation##2##3##(2008-12#2)
of anaplastic##6##2##(2008-12#4)(2011-2#1)(2013-1#1)
of anastomoses##3##2##(1990-3#1)(2007-8#1)(2012-2#1)
of anastomosis group##2##3##(2008-10#2)
of anastomosis##5##2##(1992-9#1)(2008-10#3)(2008-7#1)
of anatomic##6##2##(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-2#1)
of anatomical and##2##3##(2011-2#1)(2013-1#1)
of anatomical##10##2##(1994-3#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
of anatomically reduced##2##3##(2013-1#2)
of anatomically##6##2##(1994-3#1)(2009-6#1)(2013-1#4)
of anatomy and##2##3##(2011-2#1)(2013-1#1)
of anatomy##5##2##(2007-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of ancestral##8##2##(1997-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-2#1)
of anchorage-dependent cells##4##3##(2008-11#4)
of anchorage-dependent##7##2##(2008-1#1)(2008-11#6)
of anchored##2##2##(1993-12#1)(2011-2#1)
of ancient ceramic##2##3##(2008-10#2)
of ancient##15##2##(1991-5#1)(2007-12#1)(2008-10#9)(2008-3#1)(2010-10#1)(2012-2#1)(2013-8#1)
of ancillary services##3##3##(1996-1#2)(2013-7#1)
of ancillary##7##2##(1996-1#2)(2007-8#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-7#1)
of and risk factors for##4##5##(2009-2#1)(2009-8#1)(2012-12#1)(2012-3#1)
of and the##5##3##(1996-2#1)(1996-9#1)(2007-12#1)(2009-9#1)(2011-2#1)
of and##50##2##(1991-2#1)(1991-3#2)(1992-2#1)(1992-9#1)(1993-6#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-9#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#6)(2013-1#4)(2013-8#1)
of androgen receptor expression in##2##5##(1991-5#1)(2008-4#1)
of androgen receptor expression##3##4##(1991-5#2)(2008-4#1)
of androgen receptor##7##3##(1990-11#1)(1991-5#3)(1991-9#1)(1995-12#1)(2008-4#1)
of androgen##16##2##(1990-11#2)(1991-5#3)(1991-9#1)(1993-8#1)(1995-12#2)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)
of androgens in##2##3##(1994-8#1)(2012-3#1)
of androgens to##3##3##(1990-11#1)(1990-9#1)(2011-1#1)
of androgens##11##2##(1990-11#1)(1990-9#1)(1994-8#1)(1996-5#1)(2008-4#2)(2008-5#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
of androids##2##2##(2008-11#2)
of androstenone##4##2##(2008-5#4)
of anecdotal##2##2##(2008-11#1)(2008-8#1)
of anemia in patients with##2##5##(2008-1#1)(2008-7#1)
of anemia in##6##3##(2008-1#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
of anemia was##2##3##(2011-2#2)
of anemia##23##2##(1996-2#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#4)
of anergy##3##2##(2008-11#2)(2008-4#1)
of anesthesia and##3##3##(2008-6#1)(2010-5#1)(2012-3#1)
of anesthesia in arthroscopies of the knee##2##7##(2007-11#2)
of anesthesia in##4##3##(2007-11#2)(2010-8#2)
of anesthesia##27##2##(1990-9#1)(1993-1#1)(1997-3#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#5)
of anesthesia-induced modest hypothermia##2##4##(2008-9#2)
of anesthetic##8##2##(1993-1#1)(2007-8#1)(2010-8#2)(2011-2#1)(2012-3#3)
of anesthetics##5##2##(1990-2#1)(1995-12#3)(2010-8#1)
of anesthetized##5##2##(1992-3#2)(1994-11#1)(1997-2#1)(2012-3#1)
of aneuploidy##3##2##(1991-6#1)(2007-11#1)(2012-3#1)
of aneurysm##7##2##(2007-10#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of aneurysmal bone##2##3##(2012-12#1)(2013-1#1)
of aneurysmal##4##2##(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
of aneurysms of the##2##4##(1990-6#1)(2010-7#1)
of aneurysms##7##2##(1990-6#1)(2008-7#1)(2010-7#1)(2012-2#2)(2013-8#2)
of angina and##3##3##(1992-4#1)(2006-10#1)(2008-10#1)
of angina pectoris##5##3##(1990-8#1)(1992-4#1)(2007-8#1)(2010-8#1)(2013-1#1)
of angina##13##2##(1990-8#1)(1992-4#2)(1994-11#1)(1996-3#1)(2006-10#1)(2007-8#3)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
of angiodysplasias##2##2##(1992-5#1)(2013-1#1)
of angiogenesis in##3##3##(1990-4#1)(2010-11#1)(2012-1#1)
of angiogenesis inhibitors##2##3##(1994-12#1)(1997-1#1)
of angiogenesis is##3##3##(2008-1#1)(2010-9#1)(2013-8#1)
of angiogenesis##17##2##(1990-4#1)(1991-12#1)(1994-12#1)(1997-1#1)(2008-1#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of angiogenic factors##3##3##(2010-9#1)(2012-12#1)(2012-3#1)
of angiogenic inhibitors##3##3##(2008-1#3)
of angiogenic##8##2##(2008-1#3)(2009-8#1)(2010-9#2)(2012-12#1)(2012-3#1)
of angiographic##6##2##(1991-2#1)(1997-3#2)(2011-1#1)(2012-3#2)
of angiography##2##2##(2007-10#2)
of angioplasty##2##2##(2008-1#1)(2011-2#1)
of angiosperm plant orders##2##4##(2008-10#2)
of angiosperms##2##2##(2008-10#1)(2009-8#1)
of angiotensin I##2##3##(1990-12#1)(1994-8#1)
of angiotensin II analogues##2##4##(1991-5#2)
of angiotensin II and##2##4##(1997-7#2)
of angiotensin II in##2##4##(1992-9#1)(1994-8#1)
of angiotensin II receptor subtypes in##2##6##(1990-11#1)(1996-5#1)
of angiotensin II##14##3##(1990-11#1)(1991-5#3)(1992-3#1)(1992-9#3)(1994-8#3)(1996-5#1)(1997-7#2)
of angiotensin III##2##3##(1993-6#1)(1994-2#1)
of angiotensin converting enzyme##5##4##(1990-5#3)(1995-12#1)(2008-1#1)
of angiotensin receptor##2##3##(1991-9#1)(2008-8#1)
of angiotensin##27##2##(1990-11#1)(1990-12#1)(1990-5#3)(1991-12#1)(1991-5#3)(1991-9#2)(1992-3#1)(1992-9#3)(1993-6#1)(1994-2#1)(1994-8#4)(1995-12#1)(1996-5#1)(1997-7#2)(2008-1#1)(2008-8#1)
of angiotensins##4##2##(1997-7#4)
of angle##3##2##(2008-3#3)
of angles and##2##3##(2007-12#1)(2008-3#1)
of angles##5##2##(2007-12#1)(2008-3#3)(2008-8#1)
of angry##3##2##(2008-11#2)(2009-4#1)
of angular leaf spot and##2##5##(2008-10#2)
of angular leaf spot##3##4##(2008-10#3)
of angular##14##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2012-2#1)(2013-1#2)
of anhydrous##3##2##(2008-7#1)(2010-3#1)(2011-1#1)
of aniline in##2##3##(2008-10#2)
of aniline##6##2##(2008-10#6)
of animal and human##2##4##(2008-2#1)(2009-7#1)
of animal and plant cells##2##5##(2008-11#1)(2009-8#1)
of animal and plant##4##4##(1997-4#1)(2008-11#1)(2009-8#1)(2011-2#1)
of animal and##7##3##(1997-4#1)(2008-11#1)(2008-2#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
of animal behavior##2##3##(2008-11#2)
of animal cell culture##4##4##(2008-11#4)
of animal cell##9##3##(2008-11#6)(2008-4#1)(2008-8#1)(2009-8#1)
of animal cells##7##3##(1994-6#1)(2008-10#1)(2008-11#3)(2008-8#1)(2013-1#1)
of animal data##2##3##(2008-10#1)(2012-3#1)
of animal exposure##2##3##(2008-4#2)
of animal feed##2##3##(2008-10#1)(2010-4#1)
of animal feeds##2##3##(2008-10#2)
of animal models for##2##4##(1990-9#1)(1997-7#1)
of animal models of infection for the evaluation of##2##9##(2008-7#2)
of animal models of##4##4##(1992-9#1)(2008-4#1)(2008-7#2)
of animal models##12##3##(1990-9#1)(1992-9#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
of animal origin and##2##4##(2008-10#1)(2011-1#1)
of animal origin##9##3##(2008-10#1)(2008-11#3)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
of animal protein##8##3##(1993-11#1)(2010-4#1)(2011-2#1)(2013-7#5)
of animal##99##2##(1990-9#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#2)(1994-7#1)(1995-2#1)(1997-4#1)(1997-7#5)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#20)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-7#1)(2009-8#3)(2010-4#4)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#2)
of animal-derived raw materials##2##4##(2008-11#2)
of animal-derived##4##2##(2008-11#4)
of animals and plants##2##4##(2008-10#1)(2008-8#1)
of animals and##7##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-5#1)(2011-1#1)
of animals from##2##3##(1993-5#1)(2013-1#1)
of animals in##5##3##(1992-12#1)(1992-3#1)(1996-12#1)(2007-3#1)(2008-10#1)
of animals is##3##3##(1990-12#1)(2007-6#1)(2008-5#1)
of animals received##2##3##(1993-6#1)(2009-12#1)
of animals to##3##3##(1991-2#1)(2008-8#2)
of animals under##2##3##(2008-12#1)(2013-1#1)
of animals was##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of animals were##7##3##(1991-12#1)(1991-2#2)(1995-12#1)(2006-6#1)(2008-11#1)(2008-12#1)
of animals with##2##3##(1994-11#1)(1994-3#1)
of animals##64##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-6#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)
of anion binding##2##3##(1990-5#1)(1990-8#1)
of anion##6##2##(1990-5#1)(1990-8#1)(2008-10#3)(2011-2#1)
of anion-exchange##4##2##(1991-5#1)(1994-8#1)(2008-10#2)
of anionic additive##2##3##(2008-10#2)
of anionic and##4##3##(1990-8#1)(2008-10#3)
of anionic surfactants##7##3##(2008-10#5)(2008-5#2)
of anionic##29##2##(1990-12#1)(1990-5#2)(1990-8#2)(2008-10#18)(2008-12#2)(2008-5#2)(2008-7#1)(2009-8#1)
of anions and cations##4##4##(2008-10#4)
of anions and##5##3##(2008-10#5)
of anions in##2##3##(2008-10#2)
of anions which##2##3##(1990-8#1)(2008-10#1)
of anions##31##2##(1990-8#4)(1994-5#1)(1995-5#1)(2008-10#25)
of anisette samples##2##3##(2008-10#2)
of anisotropic diffraction##2##3##(2007-11#2)
of anisotropic##19##2##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#8)(2009-7#1)(2010-4#2)
of anisotropy##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of ankle fracture##2##3##(2009-1#2)
of ankle fractures##2##3##(2009-1#1)(2013-1#1)
of ankle sprain##2##3##(2011-2#1)(2013-1#1)
of ankle##14##2##(2007-11#1)(2009-1#3)(2009-7#1)(2011-2#7)(2013-1#2)
of ankylosing spondylitis##3##3##(1990-6#1)(2008-7#1)(2012-3#1)
of ankylosing##5##2##(1990-6#1)(1991-8#1)(2008-7#1)(2012-3#1)(2013-8#1)
of annexin 3##2##3##(1992-12#2)
of annexin V in human platelets##2##6##(1994-6#2)
of annexin V##5##3##(1994-6#3)(2006-6#1)(2008-11#1)
of annexin##7##2##(1992-12#2)(1994-6#3)(2006-6#1)(2008-11#1)
of annexins I##2##3##(1992-12#1)(1993-8#1)
of annexins in human platelets##2##5##(1992-12#2)
of annexins##4##2##(1992-12#3)(1993-8#1)
of annual clovers##2##3##(2011-2#2)
of annual##11##2##(2007-2#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#5)
of annular collagen##2##3##(2008-8#2)
of annular##4##2##(2008-8#3)(2009-10#1)
of annuloplasty##2##2##(2007-8#2)
of anodic##2##2##(2008-10#2)
of anomalies of##2##3##(1996-3#1)(1997-4#1)
of anomalies##5##2##(1996-3#1)(1997-4#1)(2008-10#1)(2010-6#1)(2011-1#1)
of anomalous##6##2##(2006-4#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)
of anorectic agents##2##3##(1997-5#1)(2008-4#1)
of anorectic##3##2##(1997-5#1)(2008-4#2)
of anorexia and##2##3##(2007-7#1)(2013-1#1)
of anorexia nervosa (AN)##2##4##(1991-11#1)(2007-7#1)
of anorexia nervosa##5##3##(1991-11#1)(1996-8#1)(2007-7#3)
of anorexia##9##2##(1991-11#1)(1992-11#1)(1996-8#1)(2007-7#5)(2013-1#1)
of another group##2##3##(1990-2#1)(2008-10#1)
of another person##2##3##(2008-11#1)(2008-9#1)
of another##38##2##(1990-2#1)(1991-2#1)(1991-6#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
of anoxia##3##2##(1990-7#1)(1996-9#2)
of anoxic##2##2##(1990-7#1)(1997-2#1)
of anserine bursitis##2##3##(2006-10#2)
of ant##2##2##(2008-6#1)(2012-2#1)
of antagonism between##2##3##(2008-10#2)
of antagonism##3##2##(2008-10#3)
of antagonist##2##2##(1997-2#1)(2008-10#1)
of antagonistic##6##2##(2007-12#1)(2008-10#4)(2008-8#1)
of antagonists##3##2##(1992-11#1)(1997-7#1)(2008-10#1)
of antenatal care and##2##4##(2008-11#1)(2008-7#1)
of antenatal care##5##3##(1991-3#1)(1991-6#1)(2008-11#2)(2008-7#1)
of antenatal##9##2##(1991-3#1)(1991-6#1)(1996-8#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-1#1)(2012-3#1)
of antenatally diagnosed##3##3##(2008-10#3)
of antenna##2##2##(2007-12#2)
of antennae##2##2##(2007-12#1)(2008-7#1)
of antennal sensilla##2##3##(2007-12#2)
of antennal##3##2##(2007-12#2)(2008-9#1)
of anterior and##2##3##(1990-7#1)(2011-2#1)
of anterior communicating artery##2##4##(2008-7#2)
of anterior pituitary##4##3##(1990-8#1)(1994-6#1)(1996-2#1)(2010-2#1)
of anterior tibial##2##3##(1991-8#1)(2008-12#1)
of anterior##28##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2010-2#1)(2011-2#3)(2012-12#2)(2013-1#3)
of anthazoline and naphazoline##2##4##(2008-10#2)
of anthelmintic##2##2##(1997-7#2)
of anthesis##3##2##(2008-10#3)
of anthocyanins##6##2##(2008-10#1)(2008-4#5)
of anthracene##3##2##(2008-10#3)
of anthracnose lesions##3##3##(1997-6#2)(2008-10#1)
of anthracnose##14##2##(1997-6#2)(2008-10#12)
of anthracycline##2##2##(1993-6#1)(2013-7#1)
of anthrax in##2##3##(1990-9#1)(1992-12#1)
of anthrax infection##2##3##(2012-2#2)
of anthrax##10##2##(1990-9#2)(1992-12#1)(2007-12#1)(2009-10#1)(2011-2#1)(2012-2#4)
of anthropogenic##6##2##(2008-10#2)(2008-11#2)(2010-8#1)(2013-1#1)
of anthropometric##2##2##(2011-2#2)
of anthurium##4##2##(2008-10#4)
of anti-CJC-specific IgG##2##3##(2008-7#2)
of anti-D##2##2##(1994-3#1)(2010-11#1)
of anti-HCV##9##2##(2007-7#4)(2008-1#2)(2008-12#1)(2009-4#1)(2013-1#1)
of anti-HIV natural compounds##2##4##(2011-3#2)
of anti-HIV##5##2##(2011-2#1)(2011-3#4)
of anti-HIV-1 drugs##3##3##(2011-2#2)(2011-3#1)
of anti-HIV-1##4##2##(1992-8#1)(2011-2#2)(2011-3#1)
of anti-Hu##2##2##(1991-11#1)(1996-11#1)
of anti-IgG##2##2##(2008-10#2)
of anti-JO1##2##2##(2006-10#2)
of anti-K4##2##2##(1994-9#2)
of anti-Leishmania antibodies##2##3##(1996-12#1)(2012-2#1)
of anti-TNF therapies##2##3##(2011-2#2)
of anti-TNF##3##2##(2011-2#3)
of anti-TNF-alpha##3##2##(2008-10#1)(2010-12#2)
of anti-VEGF##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
of anti-ageing##2##2##(2008-5#2)
of anti-apoptotic##2##2##(2008-11#1)(2010-6#1)
of anti-cancer##3##2##(2008-11#2)(2013-1#1)
of anti-fibrotic##2##2##(2013-8#2)
of anti-ganglioside##2##2##(1994-2#1)(2008-7#1)
of anti-heart antibodies in##2##4##(2008-7#2)
of anti-inflammatory drugs##2##3##(2008-11#2)
of anti-inflammatory##9##2##(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2012-2#2)
of anti-nuclear antibodies##2##3##(1993-3#1)(2008-10#1)
of anti-nuclear##3##2##(1993-3#1)(2008-10#2)
of anti-oxidant##3##2##(2008-7#1)(2009-5#1)(2012-2#1)
of anti-oxidants##3##2##(2008-11#1)(2008-5#2)
of anti-p185HER2 immunoliposomes##3##3##(1995-2#3)
of anti-peptide antisera##2##3##(1990-5#1)(2008-4#1)
of anti-rat HDC antibody with guinea-pig DDC##2##7##(1990-12#2)
of anti-streptokinase antibodies##2##3##(1993-9#2)
of antibacterial activity of##2##4##(2007-11#1)(2008-8#1)
of antibacterial activity##4##3##(2007-11#2)(2008-8#1)(2012-3#1)
of antibacterial agents##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2010-2#1)
of antibacterial##16##2##(1992-6#1)(1997-3#1)(1997-5#1)(2007-11#3)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
of antibiotic and##2##3##(2008-9#1)(2010-10#1)
of antibiotic prophylaxis in##2##4##(1992-6#1)(2008-7#1)
of antibiotic prophylaxis##3##3##(1992-6#2)(2008-7#1)
of antibiotic resistance##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
of antibiotic therapy##8##3##(1990-5#1)(1990-6#1)(1993-11#1)(2007-8#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#1)
of antibiotic treatment and##2##4##(1996-3#1)(1997-3#1)
of antibiotic treatment##6##3##(1995-9#1)(1996-3#1)(1997-3#1)(2008-10#1)(2009-5#1)(2013-8#1)
of antibiotic use##4##3##(1996-11#2)(2008-7#1)(2013-1#1)
of antibiotic##42##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-6#2)(1993-11#1)(1995-3#2)(1995-9#1)(1996-11#3)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of antibiotic-associated diarrhea##2##3##(1996-3#1)(2007-12#1)
of antibiotics and##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
of antibiotics are##2##3##(2011-2#1)(2013-1#1)
of antibiotics for##3##3##(2007-11#1)(2008-1#1)(2013-8#1)
of antibiotics in cement in addition to the intravenous prophylaxis##2##10##(2011-2#2)
of antibiotics in##8##3##(1996-3#1)(2008-10#1)(2010-6#1)(2011-2#3)(2012-1#1)(2013-8#1)
of antibiotics##48##2##(1991-3#1)(1995-2#1)(1996-11#2)(1996-3#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#4)(2008-1#2)(2008-10#6)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
of antibodies against cytochrome c##2##5##(1993-3#2)
of antibodies against small##2##4##(2008-11#1)(2011-2#1)
of antibodies against the##3##4##(1995-12#1)(2011-2#1)(2013-1#1)
of antibodies against##18##3##(1992-2#1)(1993-3#3)(1995-12#1)(1995-2#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#3)(2012-3#1)(2013-1#1)
of antibodies and##2##3##(1995-2#1)(2008-10#1)
of antibodies can be##2##4##(2008-4#1)(2011-2#1)
of antibodies for##2##3##(2008-4#1)(2008-9#1)
of antibodies or##3##3##(2008-3#1)(2008-4#1)(2008-6#1)
of antibodies that can##2##4##(2008-10#1)(2012-12#1)
of antibodies that recognize##5##4##(2008-1#1)(2008-2#1)(2008-4#3)
of antibodies that##9##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#4)(2012-12#1)
of antibodies to the##2##4##(1991-5#1)(1995-12#1)
of antibodies to##18##3##(1990-12#2)(1990-6#1)(1991-11#2)(1991-3#2)(1991-5#1)(1992-6#1)(1992-8#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-12#1)(2013-1#1)
of antibodies were##2##3##(1990-12#1)(2008-10#1)
of antibodies with##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
of antibodies##81##2##(1990-12#5)(1990-6#1)(1991-11#2)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-3#4)(1993-8#1)(1994-7#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
of antibody against##3##3##(1990-5#1)(1992-2#1)(1993-11#1)
of antibody avidity and##2##4##(1995-5#2)
of antibody for##2##3##(2008-11#1)(2008-9#1)
of antibody in##2##3##(1996-5#1)(2008-11#1)
of antibody production in##2##4##(2008-11#2)
of antibody production was not##2##5##(2008-11#2)
of antibody production##13##3##(2008-10#1)(2008-11#12)
of antibody response##3##3##(1994-5#1)(2008-10#1)(2013-1#1)
of antibody secretion##2##3##(2008-11#1)(2008-4#1)
of antibody to##3##3##(1991-3#1)(1996-12#1)(1997-2#1)
of antibody##58##2##(1990-5#1)(1991-3#2)(1992-2#1)(1993-11#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-12#2)(1996-5#1)(1997-2#2)(2006-6#1)(2008-10#13)(2008-11#16)(2008-12#1)(2008-4#3)(2008-5#1)(2008-9#4)(2011-2#1)(2013-1#1)
of antibody-antigen binding##2##3##(2008-10#2)
of antibody-antigen##4##2##(1994-2#1)(2008-10#2)(2008-7#1)
of antibody-producing cells##2##3##(2008-4#2)
of antibody-producing##3##2##(2008-4#3)
of anticancer agents##2##3##(1995-5#1)(2008-11#1)
of anticancer drug##2##3##(2008-11#1)(2008-8#1)
of anticancer drugs##2##3##(2008-10#1)(2009-12#1)
of anticancer treatment##2##3##(2008-7#1)(2010-11#1)
of anticancer##14##2##(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#2)(2010-11#1)(2010-5#1)(2012-3#2)
of anticardiolipin antibodies##2##3##(2006-10#1)(2008-7#1)
of anticardiolipin antibody##2##3##(2011-2#2)
of anticardiolipin##4##2##(2006-10#1)(2008-7#1)(2011-2#2)
of anticholinergic##2##2##(1990-3#1)(2008-5#1)
of anticipation##2##2##(1997-5#1)(2008-2#1)
of anticoagulants in acute##3##4##(1993-12#2)(2012-12#1)
of anticoagulants in##4##3##(1993-12#2)(2012-12#2)
of anticoagulants##8##2##(1990-12#1)(1993-12#2)(2012-12#5)
of anticoagulation in##2##3##(1992-1#1)(1995-11#1)
of anticoagulation##5##2##(1990-12#1)(1992-1#1)(1995-11#1)(1997-3#1)(2008-5#1)
of anticonvulsant##4##2##(1990-5#1)(1992-3#1)(2008-5#1)(2010-4#1)
of anticonvulsants##2##2##(1995-12#1)(2008-11#1)
of antidepressant drugs##3##3##(1990-5#1)(2008-10#1)(2012-2#1)
of antidepressant##7##2##(1990-5#1)(1995-12#1)(1996-7#1)(2008-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
of antidepressants##8##2##(1996-7#1)(2008-11#2)(2008-6#2)(2010-5#1)(2012-2#1)(2012-3#1)
of antidiuretic hormone##2##3##(1994-8#1)(2008-1#1)
of antiendomysial##2##2##(2008-10#2)
of antiepileptic##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
of antiestrogen##2##2##(2008-11#2)
of antiestrogens##6##2##(1992-5#1)(2008-10#2)(2008-11#3)
of antifouling agent##3##3##(2008-10#3)
of antifouling##4##2##(2008-10#3)(2008-11#1)
of antifreeze##2##2##(1990-12#1)(2008-10#1)
of antifungal activity of##2##4##(2008-10#1)(2008-5#1)
of antifungal activity##4##3##(2008-10#1)(2008-5#1)(2010-5#2)
of antifungal agents##3##3##(2007-11#1)(2009-3#1)(2011-2#1)
of antifungal compounds##2##3##(2008-10#2)
of antifungal therapy##3##3##(2008-12#1)(2009-3#1)(2011-2#1)
of antifungal##19##2##(2007-11#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-5#2)(2011-2#3)
of antigen in the##2##4##(2008-10#2)
of antigen in##4##3##(2008-10#4)
of antigen presentation by##2##4##(1995-5#1)(2008-11#1)
of antigen presenting cells##3##4##(1993-3#1)(1994-11#1)(1996-12#1)
of antigen to##2##3##(1994-11#1)(2008-4#1)
of antigen##34##2##(1990-12#1)(1993-3#2)(1994-11#3)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#5)(2008-11#9)(2008-4#1)(2008-9#2)(2012-12#1)(2012-2#2)
of antigen-presenting cells##2##3##(1991-8#1)(2008-11#1)
of antigen-specific T cells##4##4##(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
of antigen-specific human B##2##4##(2008-11#2)
of antigen-specific##12##2##(2008-10#1)(2008-11#5)(2008-4#2)(2012-12#2)(2012-2#1)(2013-8#1)
of antigenic peptides##2##3##(1991-2#1)(1995-11#1)
of antigenic variation##2##3##(1994-8#1)(2008-5#1)
of antigenic##12##2##(1991-2#2)(1992-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-5#2)(2008-8#1)(2010-6#1)(2012-2#1)
of antigens and##2##3##(1990-12#2)
of antigens in##3##3##(1993-2#1)(1997-3#1)(2008-9#1)
of antigens that##2##3##(2008-4#2)
of antigens##18##2##(1990-12#3)(1993-2#1)(1994-2#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-9#2)(2011-2#1)
of antihistamines##3##2##(2010-5#3)
of antihypertensive drugs##2##3##(1992-11#1)(1996-6#1)
of antihypertensive medicines##2##3##(2010-5#2)
of antihypertensive therapy for patients of elderly and senile age in the hospital##2##13##(2011-1#2)
of antihypertensive therapy##8##3##(1990-8#1)(1992-8#2)(2010-1#2)(2011-1#2)(2013-8#1)
of antihypertensive treatment##3##3##(1997-8#1)(2008-10#1)(2011-1#1)
of antihypertensive##18##2##(1990-8#1)(1992-11#1)(1992-8#2)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2010-1#2)(2010-5#2)(2011-1#4)(2012-12#1)(2013-8#1)
of antimalarial##3##2##(1991-8#1)(2008-10#2)
of antimicrobial actives##2##3##(2008-5#2)
of antimicrobial activity##3##3##(1994-11#1)(1994-5#1)(2008-10#1)
of antimicrobial agents have been##2##5##(2008-7#1)(2013-1#1)
of antimicrobial agents##14##3##(1990-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#5)(2011-2#2)(2013-1#3)
of antimicrobial compounds##2##3##(2008-11#1)(2009-6#1)
of antimicrobial resistance in bacteria##4##5##(2010-4#3)(2013-8#1)
of antimicrobial resistance surveillance##2##4##(2007-7#1)(2009-5#1)
of antimicrobial resistance##10##3##(1996-11#1)(1997-3#1)(2007-7#2)(2009-5#1)(2010-4#3)(2013-1#1)(2013-8#1)
of antimicrobial therapy is##2##4##(2009-4#1)(2011-2#1)
of antimicrobial therapy##8##3##(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#3)(2013-8#2)
of antimicrobial##55##2##(1990-6#1)(1990-9#1)(1991-3#1)(1994-11#1)(1994-5#1)(1996-11#1)(1997-3#1)(2007-12#1)(2007-7#5)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#7)(2009-4#1)(2009-5#1)(2009-6#2)(2010-4#3)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#3)
of antimicrobially impregnated catheters##3##4##(2007-7#3)
of antimicrobially impregnated##4##3##(2007-7#4)
of antimicrobials##5##2##(1990-6#1)(2007-7#1)(2008-7#1)(2010-4#2)
of antimony and bismuth##2##4##(2008-10#2)
of antimony and##3##3##(2008-10#3)
of antimony by##5##3##(2008-10#5)
of antimony in##13##3##(2008-10#13)
of antimony##26##2##(2008-10#26)
of antimony(III) and antimony(V)##3##4##(2008-10#3)
of antimony(III) in##3##3##(2008-10#3)
of antimony(III)##7##2##(2008-10#7)
of antineoplastic##2##2##(1990-2#1)(2007-11#1)
of antinuclear antibodies (ANA)##2##4##(2008-10#2)
of antinuclear antibodies##3##3##(1991-2#1)(2008-10#2)
of antinuclear##4##2##(1991-2#1)(2006-10#1)(2008-10#2)
of antioxidant activity##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
of antioxidant and##2##3##(2008-12#1)(2009-8#1)
of antioxidant defense##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
of antioxidant enzyme##2##3##(1991-12#1)(2011-2#1)
of antioxidant enzymes in##2##4##(1990-3#1)(1996-9#1)
of antioxidant enzymes##7##3##(1990-3#1)(1994-6#1)(1996-9#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
of antioxidant vitamins##2##3##(1992-9#2)
of antioxidant##35##2##(1990-3#1)(1991-12#2)(1991-9#1)(1992-9#2)(1994-6#1)(1996-9#1)(2006-10#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-7#2)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#4)(2013-8#1)
of antioxidants and##3##3##(1996-9#1)(2011-1#1)(2011-2#1)
of antioxidants for##3##3##(2008-11#2)(2008-5#1)
of antioxidants in##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
of antioxidants##25##2##(1991-9#1)(1992-9#1)(1994-6#1)(1996-9#1)(2008-10#4)(2008-11#2)(2008-5#3)(2008-7#1)(2009-6#1)(2009-8#2)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
of antioxidative##2##2##(1991-12#1)(2008-12#1)
of antiperspirant##2##2##(2008-5#2)
of antiperspirants##3##2##(2008-5#3)
of antiphospholipid antibodies (aPL) in##2##5##(2007-10#1)(2008-7#1)
of antiphospholipid##3##2##(2007-10#1)(2008-7#1)(2012-3#1)
of antiplatelet agents##2##3##(2008-8#1)(2011-2#1)
of antiplatelet therapies##3##3##(2006-7#1)(2009-5#1)(2012-3#1)
of antiplatelet therapy##5##3##(2008-3#2)(2011-2#3)
of antiplatelet##14##2##(1991-11#1)(2006-7#1)(2007-8#1)(2008-3#3)(2008-8#2)(2009-5#1)(2011-2#4)(2012-3#1)
of antipsychotic drugs##2##3##(1992-6#1)(2008-11#1)
of antipsychotic##5##2##(1992-6#1)(2008-11#1)(2008-4#1)(2008-6#2)
of antipsychotics##3##2##(2008-6#1)(2011-2#2)
of antiretroviral drug##3##3##(2008-11#2)(2009-7#1)
of antiretroviral therapy (ART)##2##4##(2011-2#1)(2012-12#1)
of antiretroviral therapy in##3##4##(2009-4#1)(2009-7#1)(2010-8#1)
of antiretroviral therapy##8##3##(2006-10#1)(2008-2#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of antiretroviral##14##2##(1990-8#1)(1992-6#1)(2006-10#1)(2008-11#2)(2008-2#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of antiretrovirals##2##2##(2007-7#1)(2013-8#1)
of antisense RNA##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
of antisense oligonucleotide##4##3##(2008-11#4)
of antisense##14##2##(1991-9#2)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#1)(2009-10#1)
of antisera##2##2##(2008-10#2)
of antisocial behavior##4##3##(2008-11#2)(2010-4#1)(2012-12#1)
of antisocial personality##2##3##(1994-2#2)
of antisocial##7##2##(1994-2#2)(2008-11#2)(2009-5#1)(2010-4#1)(2012-12#1)
of antithrombotic##2##2##(2008-9#1)(2013-1#1)
of antithyroid##3##2##(2008-10#2)(2008-6#1)
of antitrust liability##2##3##(1993-1#2)
of antitrust##6##2##(1992-12#1)(1993-1#3)(1996-3#1)(1997-3#1)
of antitrypsin##2##2##(1993-2#2)
of antitubercular##2##2##(2008-10#1)(2008-7#1)
of antituberculous##3##2##(1996-3#1)(2007-8#1)(2009-8#1)
of antitumor##8##2##(1991-8#1)(1994-5#1)(1997-4#1)(2008-5#2)(2010-11#1)(2011-1#1)(2012-3#1)
of antiviral##7##2##(2008-11#1)(2008-4#1)(2011-2#2)(2011-3#1)(2013-1#2)
of ants##4##2##(2008-10#2)(2008-6#2)
of anuran##2##2##(1996-5#1)(2013-7#1)
of anurans and##2##3##(1996-5#1)(2008-7#1)
of anurans##3##2##(1996-5#1)(2008-5#1)(2008-7#1)
of anxiety and affective lability during##2##6##(2008-6#2)
of anxiety and depression##3##4##(1995-12#1)(2007-6#1)(2008-11#1)
of anxiety and##9##3##(1995-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-10#2)(2009-7#1)
of anxiety disorders##7##3##(1991-2#2)(2008-6#1)(2008-7#1)(2009-6#1)(2013-8#2)
of anxiety in##5##3##(1994-3#2)(1995-2#1)(2010-12#1)(2012-2#1)
of anxiety symptoms##4##3##(2012-2#4)
of anxiety to##2##3##(2008-4#1)(2013-1#1)
of anxiety##47##2##(1991-2#2)(1993-3#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(2007-6#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#3)(2009-9#3)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#3)
of anxiolytic drugs##3##3##(1990-11#1)(1993-3#1)(2008-7#1)
of anxious##2##2##(2009-12#1)(2009-6#1)
of any additional##2##3##(2008-10#1)(2011-2#1)
of any analysis##2##3##(2008-7#1)(2011-1#1)
of any animal protein##2##4##(2008-11#1)(2013-7#1)
of any antibiotic##3##3##(2007-11#2)(2008-9#1)
of any apparent##2##3##(1996-12#1)(2008-5#1)
of any biological##3##3##(2008-1#1)(2008-4#2)
of any clinical##2##3##(2013-7#1)(2013-8#1)
of any combination of##2##4##(1990-7#1)(2013-1#1)
of any combination##3##3##(1990-7#1)(2008-10#1)(2013-1#1)
of any drug##2##3##(1990-3#1)(1995-12#1)
of any effect##2##3##(1991-3#1)(1993-11#1)
of any effort##2##3##(1993-3#1)(1997-3#1)
of any genetic##2##3##(2008-7#1)(2013-1#1)
of any given##4##3##(1994-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
of any group##2##3##(2007-8#1)(2011-1#1)
of any health##3##3##(1991-12#1)(2008-12#1)(2012-12#1)
of any healthcare##2##3##(1995-2#1)(1996-2#1)
of any identity##2##3##(2008-4#2)
of any of the##13##4##(1990-7#1)(1992-5#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-3#1)
of any of these##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
of any of##17##3##(1990-7#1)(1992-5#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
of any one##7##3##(1991-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-2#1)
of any order##2##3##(2007-11#1)(2010-3#1)
of any organic##2##3##(2008-10#1)(2008-6#1)
of any other##9##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-7#1)(2013-8#1)
of any pair of##2##4##(2008-3#1)(2008-9#1)
of any particular##4##3##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
of any possible##2##3##(2008-3#1)(2012-1#1)
of any similar##2##3##(2007-11#1)(2012-12#1)
of any single##2##3##(2007-8#1)(2012-3#1)
of any state of##3##4##(2007-11#2)(2007-12#1)
of any type##2##3##(2010-4#1)(2012-1#1)
of any unusual##2##3##(1995-3#1)(2008-12#1)
of any##255##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2006-10#3)(2006-12#1)(2007-11#10)(2007-12#8)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#34)(2008-11#7)(2008-12#4)(2008-2#7)(2008-3#12)(2008-4#8)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#8)(2009-10#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#5)
of aorta##9##2##(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#3)(2013-1#1)(2013-8#2)
of aortic aneurysm##2##3##(1991-8#1)(2009-10#1)
of aortic arch aneurysm##2##4##(2007-8#1)(2008-8#1)
of aortic arch aneurysms##2##4##(2011-2#2)
of aortic arch##5##3##(2007-8#2)(2008-8#1)(2011-2#2)
of aortic dissection##2##3##(1991-2#1)(2012-1#1)
of aortic endothelial##2##3##(1993-6#2)
of aortic valve##4##3##(1996-9#1)(2007-7#1)(2008-8#1)(2012-2#1)
of aortic##32##2##(1991-2#1)(1991-8#1)(1993-6#2)(1996-9#1)(1997-8#2)(2007-7#1)(2007-8#3)(2008-12#2)(2008-3#1)(2008-8#2)(2009-10#2)(2010-12#1)(2011-2#5)(2012-1#1)(2012-2#5)(2013-1#1)(2013-3#1)
of aorto-iliac##2##2##(1997-8#1)(2011-2#1)
of aortoarteritis##2##2##(2008-12#1)(2012-12#1)
of apatite##3##2##(2013-1#3)
of aperture size##3##3##(2008-2#2)(2008-3#1)
of aperture##5##2##(2008-2#4)(2008-3#1)
of aphasia and##2##3##(2007-8#1)(2012-3#1)
of aphasia##5##2##(2007-10#1)(2007-8#1)(2012-3#3)
of aphid##7##2##(1996-12#1)(2008-10#5)(2008-6#1)
of aphids##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
of apical dendrites##2##3##(1993-12#1)(2007-8#1)
of apical##10##2##(1993-12#1)(2007-8#2)(2008-10#2)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
of apitherapy##2##2##(2008-10#2)
of aplasia of the lacrimal and salivary glands##2##8##(2011-1#2)
of aplasia of the##3##4##(2011-1#3)
of aplasia##4##2##(2010-8#1)(2011-1#3)
of apo B and##2##4##(1994-11#1)(1995-8#1)
of apo B##7##3##(1990-11#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-8#1)
of apo B-48##2##3##(1990-8#2)
of apo##13##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-8#1)(2012-2#1)
of apo(a)##4##2##(1992-3#1)(1993-2#1)(1995-6#1)(1996-8#1)
of apoA-I##3##2##(1991-12#2)(2008-6#1)
of apoB##4##2##(1992-3#2)(1994-8#1)(2008-6#1)
of apoE mRNA##2##3##(1995-6#2)
of apoE##5##2##(1995-6#3)(1996-2#1)(1996-6#1)
of apodization on the retrieval of geophysical parameters from##2##9##(2008-2#2)
of apodization##4##2##(2008-2#3)(2008-3#1)
of apolipoprotein B (apo B)##2##5##(1993-9#1)(1997-8#1)
of apolipoprotein B##7##3##(1990-11#1)(1992-12#1)(1993-9#3)(1995-2#1)(1997-8#1)
of apolipoprotein E##4##3##(2008-10#1)(2008-4#2)(2008-7#1)
of apolipoprotein##16##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-9#3)(1995-2#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2013-8#1)
of apolipoprotein(a)##2##2##(1992-9#1)(1993-3#1)
of apomorphine in plasma##2##4##(1996-5#2)
of apomorphine##9##2##(1992-11#3)(1995-2#1)(1996-5#3)(1997-2#2)
of apoptosis and necrosis##5##4##(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
of apoptosis and proliferation##5##4##(1994-10#2)(2008-6#1)(2012-1#2)
of apoptosis and the##2##4##(1994-10#1)(2013-1#1)
of apoptosis and##22##3##(1991-12#1)(1994-10#3)(1995-12#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-1#3)(2013-1#2)
of apoptosis as##2##3##(2006-10#1)(2008-7#1)
of apoptosis by##3##3##(1992-9#1)(2008-8#1)(2009-3#1)
of apoptosis did not##2##4##(2008-10#1)(2013-8#1)
of apoptosis in human##2##4##(1994-6#1)(2010-6#1)
of apoptosis in the##7##4##(1992-3#1)(1995-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
of apoptosis in##23##3##(1992-3#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)(2013-1#2)
of apoptosis induction##4##3##(2007-8#1)(2008-11#1)(2008-12#2)
of apoptosis is##3##3##(1992-9#1)(2008-1#1)(2012-2#1)
of apoptosis of##4##3##(1995-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
of apoptosis was observed##2##4##(1992-3#1)(1994-10#1)
of apoptosis was##3##3##(1992-3#1)(1994-10#1)(2012-2#1)
of apoptosis with##3##3##(2008-8#2)(2013-8#1)
of apoptosis##132##2##(1991-12#1)(1992-3#2)(1992-9#2)(1993-8#3)(1993-9#2)(1994-10#7)(1994-11#1)(1994-6#2)(1995-12#2)(1995-2#2)(1996-12#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#15)(2008-12#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#13)(2008-9#10)(2009-12#3)(2009-3#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#4)(2012-12#4)(2012-2#3)(2013-1#7)(2013-8#3)
of apoptotic bodies##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
of apoptotic cell death##8##4##(1994-10#1)(1995-2#1)(1995-6#1)(1995-8#2)(2008-11#1)(2008-4#1)(2011-2#1)
of apoptotic cell##9##3##(1994-10#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(2008-11#1)(2008-4#1)(2011-2#1)
of apoptotic cells##11##3##(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
of apoptotic##33##2##(1992-9#1)(1994-10#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#1)
of apothecia by##2##3##(2008-10#2)
of apothecia of##2##3##(2008-10#2)
of apothecia##17##2##(2008-10#17)
of apothecial development##2##3##(2008-10#2)
of apothecial##3##2##(2008-10#3)
of apothecium development##2##3##(2008-10#2)
of apothecium##4##2##(2008-10#4)
of apparatus##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
of apparent molecular weight##3##4##(1990-11#1)(1991-2#1)(1991-5#1)
of apparent molecular##4##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)
of apparent##25##2##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1994-3#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-2#1)(2011-2#1)
of apparently##6##2##(1990-12#1)(1990-5#1)(1993-12#1)(2007-6#1)(2010-6#1)(2013-8#1)
of appearance and##3##3##(1991-12#1)(1992-12#1)(2009-11#1)
of appearance of##6##3##(1993-12#1)(1993-8#1)(1994-8#1)(1997-4#1)(2009-8#1)(2010-12#1)
of appearance##14##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-8#1)(1997-4#1)(2007-12#4)(2008-11#1)(2009-11#1)(2009-8#1)(2010-12#1)
of appearing##2##2##(2008-10#1)(2011-7#1)
of appendages##2##2##(2007-12#2)
of appendectomy##3##2##(2008-10#2)(2012-12#1)
of appendiceal Crohn's disease##3##4##(2011-2#3)
of appendiceal masses##2##3##(2008-12#2)
of appendiceal##6##2##(1990-3#1)(2008-12#2)(2011-2#3)
of appendicitis##8##2##(1991-12#1)(2011-2#3)(2013-1#4)
of appetite##2##2##(2008-7#1)(2011-2#1)
of apple and##4##3##(2008-10#4)
of apple in##5##3##(2008-10#5)
of apple leaves##2##3##(2008-10#2)
of apple replant disease in##2##5##(2008-10#2)
of apple replant disease##5##4##(2008-10#5)
of apple scab on##2##4##(2008-10#2)
of apple scab##7##3##(2008-10#7)
of apple seedlings grown in##3##5##(2008-10#3)
of apple seedlings##4##3##(2008-10#4)
of apple stem grooving capillovirus##2##5##(2008-10#2)
of apple was##2##3##(2008-10#2)
of apple##56##2##(1990-9#2)(1997-2#1)(2008-10#53)
of apples (Malus##2##3##(2008-10#1)(2011-2#1)
of apples##8##2##(2008-10#6)(2008-3#1)(2011-2#1)
of applicability##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
of applicants##3##2##(1995-5#1)(1997-3#1)(2012-3#1)
of application and##2##3##(2008-10#2)
of application in the##2##4##(2008-2#1)(2008-9#1)
of application in##15##3##(2008-10#1)(2008-2#1)(2008-9#13)
of application of the##3##4##(2008-3#2)(2008-7#1)
of application of##11##3##(1995-5#1)(2008-10#4)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#1)
of application to##2##3##(1996-3#1)(2008-5#1)
of application was##2##3##(2008-10#1)(2008-9#1)
of application##83##2##(1991-3#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#3)(2008-9#41)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
of application-specific##3##2##(2008-10#1)(2008-2#2)
of applications and##2##3##(2008-11#1)(2008-3#1)
of applications for##3##3##(1993-6#1)(2008-11#1)(2008-3#1)
of applications in##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
of applications include##2##3##(1990-8#1)(2008-11#1)
of applications of the##2##4##(1997-4#1)(2012-2#1)
of applications of##9##3##(1997-4#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#2)
of applications that##2##3##(2008-10#1)(2008-3#1)
of applications##55##2##(1990-8#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-12#2)(2011-1#1)(2012-2#5)(2013-1#3)
of applied current##3##3##(2008-10#2)(2009-12#1)
of applied potential##2##3##(2008-10#2)
of applied voltage##2##3##(2008-10#2)
of applied##18##2##(2007-11#1)(2008-1#1)(2008-10#8)(2008-5#1)(2009-12#2)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
of applying the##7##3##(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
of applying##24##2##(1996-8#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
of appointments##2##2##(1990-9#1)(2013-8#1)
of appressoria produced##2##3##(2008-10#2)
of appressoria was##2##3##(2008-10#2)
of appressoria##11##2##(2008-10#11)
of appressorium formation by the##2##5##(2008-10#2)
of appressorium formation by##3##4##(2008-10#3)
of appressorium formation##4##3##(2008-10#4)
of approach to##2##3##(1996-12#1)(2013-1#1)
of approach##7##2##(1990-3#1)(1995-11#1)(1996-12#1)(2007-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
of approaches have been proposed##2##5##(2008-10#1)(2012-3#1)
of approaches have been##5##4##(2008-10#2)(2008-11#1)(2010-8#1)(2012-3#1)
of approaches to##4##3##(2008-10#1)(2008-9#1)(2010-11#1)(2010-7#1)
of approaches##19##2##(1991-3#1)(1993-1#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-7#1)(2010-8#1)(2012-3#3)
of approaching##2##2##(2011-2#1)(2012-2#1)
of appropriate standards##3##3##(2008-2#1)(2008-4#1)(2008-6#1)
of appropriate therapy##2##3##(2013-1#1)(2013-8#1)
of appropriate treatment##3##3##(2006-10#2)(2007-8#1)
of appropriate##73##2##(1990-10#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
of appropriateness##3##2##(2008-1#1)(2013-1#2)
of approved##3##2##(1992-3#1)(1997-5#1)(2008-4#1)
of approx##13##2##(1991-6#1)(1993-12#2)(1993-6#1)(1997-7#2)(2007-12#1)(2008-5#1)(2008-6#4)(2011-2#1)
of approximately 0##16##3##(1990-12#1)(1995-6#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#3)
of approximately 1 microM##2##4##(1990-5#1)(1990-8#1)
of approximately 1##18##3##(1990-5#1)(1990-8#1)(1991-11#1)(1992-5#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-3#7)(2008-5#1)(2008-8#1)(2011-2#1)
of approximately 10 nm##2##4##(2008-3#1)(2009-5#1)
of approximately 10##11##3##(1990-3#1)(1991-2#1)(1991-8#1)(1997-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2012-3#1)
of approximately 10%##2##3##(2008-2#1)(2009-9#1)
of approximately 10(3)##2##3##(2008-10#1)(2008-3#1)
of approximately 100##5##3##(1996-10#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
of approximately 12##3##3##(2008-3#2)(2008-5#1)
of approximately 13##3##3##(1995-2#1)(2008-7#1)(2008-9#1)
of approximately 130##2##3##(1995-6#1)(2007-12#1)
of approximately 15##6##3##(2008-10#2)(2008-2#1)(2008-3#3)
of approximately 17##2##3##(1995-12#1)(2007-10#1)
of approximately 18##4##3##(2008-10#3)(2008-9#1)
of approximately 2##11##3##(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)
of approximately 20##9##3##(1991-1#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#2)(2012-1#1)
of approximately 200##7##3##(1991-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
of approximately 210##2##3##(1995-2#1)(2008-4#1)
of approximately 225##2##3##(2008-2#1)(2008-3#1)
of approximately 23##2##3##(2008-10#1)(2008-11#1)
of approximately 25##3##3##(1995-11#1)(1995-5#1)(1997-5#1)
of approximately 25%##2##3##(2008-2#1)(2008-3#1)
of approximately 250##3##3##(1995-3#1)(2007-2#1)(2008-3#1)
of approximately 28##2##3##(1994-12#1)(2008-10#1)
of approximately 3##4##3##(1992-6#1)(1994-5#1)(2008-11#1)(2008-3#1)
of approximately 30##6##3##(1991-8#1)(1992-12#1)(1997-5#1)(2008-2#2)(2008-3#1)
of approximately 300##4##3##(1991-3#1)(2008-10#1)(2008-2#1)(2009-12#1)
of approximately 330##2##3##(2008-10#1)(2008-3#1)
of approximately 35##2##3##(1995-2#1)(2008-10#1)
of approximately 37##2##3##(1991-9#1)(2008-2#1)
of approximately 4##9##3##(1990-5#1)(1992-8#1)(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-2#1)
of approximately 4-5##2##3##(2007-12#1)(2008-3#1)
of approximately 40##6##3##(1992-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)
of approximately 45 kDa##2##4##(1992-3#1)(1993-3#1)
of approximately 45##3##3##(1992-3#1)(1993-3#1)(2008-3#1)
of approximately 490##3##3##(2008-8#3)
of approximately 5 x##2##4##(2008-11#1)(2008-3#1)
of approximately 5##14##3##(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#5)(2013-8#1)
of approximately 50##7##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)
of approximately 50%##3##3##(1993-11#1)(1995-11#1)(2008-3#1)
of approximately 6##8##3##(1990-12#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
of approximately 60##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
of approximately 7##8##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#2)
of approximately 7%##2##3##(2008-10#1)(2011-2#1)
of approximately 70##3##3##(1993-3#1)(2008-10#2)
of approximately 8##6##3##(1991-2#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-9#2)
of approximately 80##2##3##(1992-9#1)(2008-11#1)
of approximately 80%##3##3##(2008-10#2)(2008-3#1)
of approximately 90##3##3##(2008-10#2)(2008-3#1)
of approximately one##2##3##(2008-8#2)
of approximately two##5##3##(1991-6#1)(1995-5#1)(1997-5#1)(2008-5#1)(2013-1#1)
of approximately##325##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#5)(1993-3#4)(1993-6#5)(1993-8#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#9)(1995-3#2)(1995-5#2)(1995-6#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-5#5)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#13)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#47)(2008-11#14)(2008-12#2)(2008-2#28)(2008-3#65)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#12)(2009-12#1)(2009-5#4)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
of approximation##2##2##(2008-2#1)(2008-3#1)
of aprepitant for the treatment of hot flashes##2##8##(2008-7#2)
of aprotinin##5##2##(1990-3#1)(1996-9#1)(2006-10#1)(2007-8#2)
of aptamers##5##2##(2008-4#1)(2010-5#2)(2010-7#2)
of apyrase##3##2##(1994-11#1)(2008-4#2)
of aquaporins##2##2##(2007-12#1)(2013-1#1)
of aquatic humic solutes##2##4##(2008-10#2)
of aquatic humic substances##3##4##(2008-10#3)
of aquatic humic##8##3##(2008-10#8)
of aquatic humic-type organic constituents by##2##6##(2008-10#2)
of aquatic humic-type##3##3##(2008-10#3)
of aquatic plant communities##2##4##(2008-5#2)
of aquatic plant##3##3##(2008-10#1)(2008-5#2)
of aquatic##19##2##(1992-5#1)(2008-10#12)(2008-5#2)(2009-3#1)(2013-1#1)(2013-7#2)
of aqueous and##4##3##(2008-10#2)(2010-3#2)
of aqueous extract of##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
of aqueous extracts of##2##4##(1992-2#1)(1992-8#1)
of aqueous phase##8##3##(2008-10#8)
of aqueous sample solution##2##4##(2008-10#2)
of aqueous sample##5##3##(2008-10#5)
of aqueous samples##3##3##(2008-10#2)(2012-1#1)
of aqueous solution##5##3##(2008-10#5)
of aqueous solutions of various##2##5##(2008-10#2)
of aqueous solutions of##5##4##(2008-10#5)
of aqueous solutions##10##3##(2007-5#1)(2008-10#8)(2008-5#1)
of aqueous standards##4##3##(2008-10#4)
of aqueous two-phase extraction##2##4##(2008-6#2)
of aqueous##72##2##(1990-7#1)(1992-2#1)(1992-8#1)(1995-3#1)(2007-5#1)(2008-10#47)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-5#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of ara-C##4##2##(1990-2#1)(1992-5#3)
of arachidonate release from##3##4##(2008-11#3)
of arachidonate release##4##3##(1994-11#1)(2008-11#3)
of arachidonic acid (AA)##3##4##(1991-2#1)(1992-12#1)(2010-9#1)
of arachidonic acid and##3##4##(1993-8#1)(1996-2#1)(2013-1#1)
of arachidonic acid to##2##4##(1991-8#1)(1992-8#1)
of arachidonic acid##23##3##(1991-12#1)(1991-2#1)(1991-8#3)(1992-12#2)(1992-8#1)(1993-8#2)(1994-2#1)(1994-5#2)(1995-12#1)(1996-2#1)(1997-1#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
of arachidonic and##2##3##(1994-5#1)(1996-7#1)
of arachidonic##26##2##(1991-12#1)(1991-2#1)(1991-8#4)(1992-12#2)(1992-8#1)(1993-8#2)(1994-2#1)(1994-5#3)(1995-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
of arbitrary shape##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of arbitrary topology##2##3##(2008-6#2)
of arbitrary##20##2##(1992-9#1)(2007-11#6)(2007-12#1)(2008-2#3)(2008-3#4)(2008-6#4)(2009-7#1)
of arbuscular mycorrhizal fungus (Glomus veruciforme) on##2##7##(2008-12#2)
of arbuscular mycorrhizal##3##3##(2008-12#2)(2013-8#1)
of arch##2##2##(2011-2#2)
of archaebacteria##2##2##(1990-2#1)(1995-8#1)
of archaeological bones for reconstruction of paleodiet##2##7##(2008-10#2)
of archaeological##6##2##(2008-10#5)(2012-9#1)
of architectural##2##2##(1991-12#1)(2009-12#1)
of archival##5##2##(1992-1#1)(1994-11#1)(2008-10#1)(2010-3#1)(2012-12#1)
of area and temperature##2##4##(2008-9#2)
of area and##3##3##(2008-12#1)(2008-9#2)
of area estimates##4##3##(1997-3#4)
of area##21##2##(1992-11#1)(1996-5#4)(1997-3#5)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#4)(2013-1#1)
of areas as##2##3##(1991-12#1)(2008-11#1)
of areas for improvement##2##4##(1996-2#1)(2010-12#1)
of areas of##2##3##(1992-10#1)(2011-2#1)
of areas##10##2##(1991-12#1)(1992-10#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
of arginase##2##2##(1992-5#1)(2013-8#1)
of arginine at##2##3##(1990-11#1)(1995-12#1)
of arginine to##2##3##(2008-10#1)(2009-4#1)
of arginine vasopressin##3##3##(2007-9#1)(2008-4#1)(2010-1#1)
of arginine##18##2##(1990-11#1)(1992-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-7#2)(2010-1#1)(2013-7#1)
of arginine-128 to alanine##2##4##(1995-5#2)
of arginine-vasopressin##4##2##(1995-12#4)
of argon##5##2##(2008-10#1)(2008-3#1)(2013-1#2)(2013-8#1)
of aristolochic##2##2##(2008-10#2)
of arm##2##2##(1990-11#1)(2013-8#1)
of aroma compounds in##2##4##(2008-10#2)
of aroma compounds##6##3##(2008-10#6)
of aroma rice##2##3##(2011-1#2)
of aroma##11##2##(2008-10#7)(2008-5#1)(2011-1#2)(2012-2#1)
of aromatase activity##2##3##(1991-5#1)(1994-2#1)
of aromatase mRNA in##4##4##(1993-8#4)
of aromatase##10##2##(1991-5#2)(1993-8#5)(1994-2#1)(2008-4#1)(2009-7#1)
of aromatherapy##3##2##(2008-10#3)
of aromatic amines in##2##4##(2008-10#2)
of aromatic amines##5##3##(1990-8#2)(2008-10#3)
of aromatic amino acids##2##4##(2008-10#2)
of aromatic and##3##3##(1992-6#1)(1995-3#1)(2011-2#1)
of aromatic compounds##5##3##(2008-10#2)(2008-11#2)(2011-1#1)
of aromatic rings##2##3##(2008-10#1)(2010-11#1)
of aromatic##32##2##(1990-8#3)(1992-6#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#1)(2007-11#1)(2008-10#14)(2008-11#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of aromatics##2##2##(2008-10#2)
of around +/-2%##2##3##(2008-10#2)
of around 40##2##3##(2008-7#1)(2008-8#1)
of around##18##2##(1990-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
of around-the-clock##2##2##(2008-11#1)(2013-1#1)
of arousal##2##2##(1993-5#1)(2008-7#1)
of array element##2##3##(2008-2#1)(2008-3#1)
of array##3##2##(2008-2#2)(2008-3#1)
of arrays##5##2##(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)
of arrestin##4##2##(1992-5#4)
of arrhenotokous populations##2##3##(2008-10#2)
of arrhythmia##2##2##(1991-6#1)(2013-8#1)
of arrhythmias##7##2##(1995-11#1)(1996-2#1)(2010-12#1)(2010-3#1)(2011-1#2)(2013-7#1)
of arrhythmogenic##3##2##(1996-3#1)(2008-12#1)(2012-2#1)
of arrival##3##2##(2008-2#1)(2010-3#1)(2011-1#1)
of arsenate and##3##3##(2008-10#2)(2008-11#1)
of arsenate##6##2##(2008-10#5)(2008-11#1)
of arsenic (As) in##2##4##(2008-10#2)
of arsenic (As)##4##3##(2008-10#3)(2013-1#1)
of arsenic acid##2##3##(2008-10#2)
of arsenic and antimony in##2##5##(2008-10#2)
of arsenic and selenium##3##4##(2008-10#3)
of arsenic and##8##3##(1995-11#1)(2008-10#7)
of arsenic by##6##3##(2008-10#6)
of arsenic compounds from lichens##2##5##(2008-10#2)
of arsenic compounds in##5##4##(2008-10#5)
of arsenic compounds##7##3##(2008-10#7)
of arsenic in a##2##4##(1995-11#1)(2008-10#1)
of arsenic in aqueous samples##2##5##(2008-10#2)
of arsenic in environmental samples##3##5##(2008-10#3)
of arsenic in environmental##5##4##(2008-10#5)
of arsenic in ground water##2##5##(2008-10#2)
of arsenic in groundwater##2##4##(2008-10#2)
of arsenic in the##2##4##(1995-11#1)(2008-10#1)
of arsenic in##35##3##(1995-11#2)(2008-10#32)(2013-1#1)
of arsenic species in water samples##2##6##(2008-10#2)
of arsenic species in##7##4##(2008-10#6)(2010-5#1)
of arsenic species##12##3##(2008-10#11)(2010-5#1)
of arsenic was##2##3##(2008-10#2)
of arsenic were##3##3##(1995-11#1)(2008-10#2)
of arsenic##130##2##(1995-11#10)(2008-10#110)(2008-8#1)(2010-1#1)(2010-5#4)(2011-2#1)(2013-1#3)
of arsenic(III) and arsenic(V) by##2##5##(2008-10#2)
of arsenic(III) and arsenic(V)##4##4##(2008-10#4)
of arsenic(III) and##5##3##(2008-10#4)(2010-5#1)
of arsenic(V) in##2##3##(2008-10#2)
of arsenite and arsenate##2##4##(2008-10#2)
of arsenite##10##2##(1994-11#1)(2008-10#9)
of arsenobetaine##3##2##(2008-10#3)
of arsine##2##2##(2008-10#1)(2009-6#1)
of art##19##2##(1993-2#1)(1995-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#1)
of artemether##2##2##(1994-8#2)
of artemisinin and##2##3##(1997-4#1)(2008-10#1)
of artemisinin##7##2##(1995-3#2)(1997-4#1)(2007-1#1)(2008-10#3)
of arterial and venous##2##4##(1990-3#1)(2009-7#1)
of arterial and##4##3##(1990-3#1)(2008-4#2)(2009-7#1)
of arterial baroreflex##2##3##(1991-10#1)(2009-9#1)
of arterial blood pressure##6##4##(1990-8#1)(1991-3#1)(1997-8#1)(2008-7#1)(2009-5#1)(2012-3#1)
of arterial hypertension in##3##4##(2011-1#1)(2011-2#2)
of arterial hypertension##13##3##(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)
of arterial pressure##2##3##(2008-1#1)(2009-1#1)
of arterial thrombosis and##2##4##(1993-9#1)(2011-2#1)
of arterial thrombosis##4##3##(1990-9#1)(1992-3#1)(1993-9#1)(2011-2#1)
of arterial wall##2##3##(2008-11#1)(2011-1#1)
of arterial##53##2##(1990-11#1)(1990-3#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of arteries##2##2##(2007-12#1)(2013-7#1)
of arteriosclerotic##2##2##(1991-3#1)(1997-3#1)
of arteriovenous angiodysplasias##2##3##(2012-1#2)
of arteriovenous fistula##3##3##(2007-7#2)(2008-1#1)
of arteriovenous fistulae##2##3##(1996-9#1)(2007-7#1)
of arteriovenous malformation (AVM)##2##4##(2008-7#2)
of arteriovenous malformation##4##3##(2008-7#4)
of arteriovenous malformations (AVMs)##2##4##(2008-7#2)
of arteriovenous malformations##7##3##(2008-7#6)(2008-9#1)
of arteriovenous##20##2##(1991-11#1)(1991-5#1)(1996-9#1)(2007-7#3)(2008-1#1)(2008-7#10)(2008-9#1)(2012-1#2)
of arthritic##2##2##(2008-11#1)(2013-1#1)
of arthritis and##2##3##(2008-7#1)(2011-2#1)
of arthritis that##2##3##(2008-11#1)(2008-7#1)
of arthritis##12##2##(1990-6#1)(1991-8#1)(2006-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2011-2#1)(2012-1#1)
of arthrodesis##2##2##(2008-8#1)(2012-3#1)
of arthrogryposis##2##2##(2008-10#1)(2009-5#1)
of arthropod##6##2##(2007-12#2)(2008-9#2)(2009-2#1)(2011-2#1)
of arthropods and##2##3##(2008-9#1)(2011-2#1)
of arthropods##7##2##(1997-7#1)(2007-12#2)(2008-7#1)(2008-9#1)(2011-2#2)
of arthroscopic techniques##2##3##(2007-11#1)(2008-8#1)
of arthroscopic treatment of##2##4##(2007-11#2)
of arthroscopic##7##2##(2007-11#4)(2008-8#2)(2013-1#1)
of arthroscopy in##4##3##(1990-3#1)(2007-11#2)(2013-1#1)
of arthroscopy##6##2##(1990-3#1)(2007-11#2)(2008-9#2)(2013-1#1)
of articles dealing with##2##4##(1996-3#1)(2007-11#1)
of articles discussing##3##3##(2008-9#3)
of articles on##2##3##(1991-11#1)(2011-1#1)
of articles##20##2##(1991-11#1)(1991-6#1)(1992-4#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-9#4)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of articular cartilage##4##3##(1997-3#1)(2008-9#1)(2009-12#1)(2012-3#1)
of articular surface##2##3##(2011-2#2)
of articular surfaces##2##3##(2007-11#1)(2012-3#1)
of articular##14##2##(1991-11#1)(1997-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-3#4)(2013-1#1)
of articulated##2##2##(2007-12#1)(2012-2#1)
of articulating##3##2##(2008-1#1)(2008-12#1)(2011-2#1)
of articulation##3##2##(2007-12#1)(2008-9#1)(2009-11#1)
of artifacts##2##2##(2008-10#1)(2009-6#1)
of artificial heart##2##3##(1991-3#1)(2010-8#1)
of artificial intelligence##2##3##(2007-11#1)(2008-10#1)
of artificial neural network##5##4##(2008-10#5)
of artificial neural networks##9##4##(2008-10#8)(2009-3#1)
of artificial neural##14##3##(2008-10#13)(2009-3#1)
of artificial pancreas##2##3##(2009-11#2)
of artificial surfaces##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
of artificial##47##2##(1991-3#1)(1991-9#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#2)(2009-3#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#3)
of artificially inoculated##3##3##(2008-10#2)(2010-4#1)
of artificially##6##2##(1993-12#1)(2008-10#3)(2008-5#1)(2010-4#1)
of aryl##5##2##(1992-6#1)(1996-5#1)(2008-12#1)(2008-6#1)(2010-5#1)
of arylamine##3##2##(1991-5#1)(1993-11#1)(1993-3#1)
of aryldiamines##3##2##(2008-10#3)
of arylsulfatase A##3##3##(1991-12#1)(1997-3#2)
of as great as##3##4##(2008-3#3)
of as little as##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
of as long as##2##4##(2008-2#1)(2008-3#1)
of as many as##6##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
of as many##8##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2012-2#1)
of as much as 1##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
of as much as 10%##2##5##(2007-11#1)(2007-12#1)
of as much as 18##2##5##(2007-11#1)(2008-3#1)
of as much as 20##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
of as much as 3##2##5##(2007-11#1)(2008-3#1)
of as much as 6##2##5##(2008-2#1)(2008-3#1)
of as much as 8##2##5##(2007-12#1)(2008-3#1)
of as much as##44##4##(2007-11#15)(2007-12#14)(2008-2#2)(2008-3#12)(2012-2#1)
of as##72##2##(1995-5#1)(1997-7#1)(2007-11#17)(2007-12#15)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#18)(2008-5#1)(2008-9#2)(2010-4#2)(2010-8#1)(2012-2#3)(2013-1#1)
of asbestos exposure was##2##4##(1991-12#1)(1992-11#1)
of asbestos exposure##6##3##(1991-12#3)(1992-11#1)(2010-12#1)(2010-5#1)
of asbestos fibers##7##3##(1990-12#1)(1991-12#6)
of asbestos in##3##3##(1991-12#2)(1992-11#1)
of asbestos##27##2##(1990-12#1)(1991-12#18)(1992-1#1)(1992-11#2)(1995-2#1)(2010-12#1)(2010-5#1)(2013-8#2)
of asbestos-induced pleural fibrosis##2##4##(1991-12#2)
of asbestos-induced##3##2##(1991-12#3)
of asbestos-related pleural##2##3##(1991-12#2)
of asbestos-related##3##2##(1991-12#2)(1995-2#1)
of asbestosis##4##2##(1991-12#4)
of ascending##3##2##(1991-6#1)(2007-8#1)(2008-11#1)
of ascent##3##2##(1992-2#2)(2011-2#1)
of ascertainment##2##2##(1997-5#1)(2007-6#1)
of asci##5##2##(1997-3#1)(2008-10#4)
of ascites##8##2##(1991-12#1)(1997-6#1)(1997-7#1)(2007-12#1)(2011-2#1)(2013-1#3)
of ascitic fluid##2##3##(1992-2#1)(2008-10#1)
of ascitic##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
of ascocarps on foliage##2##4##(2008-10#2)
of ascocarps##3##2##(2008-10#3)
of ascomycetes##2##2##(2008-10#2)
of ascorbate and##2##3##(1992-11#1)(2008-10#1)
of ascorbate##16##2##(1990-9#2)(1992-11#1)(1993-8#2)(1995-2#1)(2008-10#7)(2008-11#1)(2009-9#1)(2013-1#1)
of ascorbic acid (AA) and##2##5##(2008-10#2)
of ascorbic acid (AA) in##2##5##(2008-10#2)
of ascorbic acid (AA)##7##4##(2008-10#7)
of ascorbic acid (AsA)##3##4##(2008-10#2)(2008-11#1)
of ascorbic acid and uric acid##3##6##(2008-10#3)
of ascorbic acid and##7##4##(2008-10#6)(2008-5#1)
of ascorbic acid at##2##4##(2008-10#2)
of ascorbic acid concentration##2##4##(2008-10#2)
of ascorbic acid in Vitamin C tablets##2##7##(2008-10#2)
of ascorbic acid in##13##4##(1992-12#1)(1997-4#1)(2008-10#11)
of ascorbic acid on the BZ oscillating chemical system##2##9##(2008-10#2)
of ascorbic acid on the##3##5##(2008-10#3)
of ascorbic acid using##4##4##(2008-10#4)
of ascorbic acid was##6##4##(2008-10#6)
of ascorbic acid with##3##4##(2008-10#3)
of ascorbic acid##99##3##(1992-12#1)(1993-12#1)(1997-4#1)(2007-4#1)(2008-10#84)(2008-11#2)(2008-5#3)(2008-7#1)(2011-1#2)(2011-2#2)(2012-2#1)
of ascorbic##101##2##(1992-12#1)(1993-12#1)(1997-4#1)(2007-4#1)(2008-10#85)(2008-11#3)(2008-5#3)(2008-7#1)(2011-1#2)(2011-2#2)(2012-2#1)
of ascospore germination##3##3##(2008-10#2)(2008-8#1)
of ascospore release##6##3##(2008-10#6)
of ascospore##13##2##(2008-10#12)(2008-8#1)
of ascospores by##2##3##(2008-10#2)
of ascospores in the##3##4##(2008-10#3)
of ascospores in##5##3##(2008-10#4)(2008-8#1)
of ascospores of##4##3##(2008-10#4)
of ascospores was##3##3##(2008-10#3)
of ascospores were##4##3##(2008-10#4)
of ascospores##38##2##(1993-3#1)(2008-10#35)(2008-8#2)
of aseptic loosening##2##3##(2009-4#1)(2013-1#1)
of asexual##4##2##(2008-10#3)(2010-3#1)
of ash##2##2##(2008-10#2)
of asialoglycoprotein receptor##2##3##(1993-11#2)
of asian##2##2##(2008-10#1)(2013-1#1)
of asparagine and glutamine##2##4##(2008-11#2)
of asparagine##5##2##(1991-9#1)(1993-6#1)(1997-3#1)(2008-11#2)
of asparagine-linked glycoproteins##2##3##(1992-10#2)
of aspartame in##2##3##(2008-8#2)
of aspartame##4##2##(2008-8#4)
of aspartase##2##2##(1991-5#1)(1992-11#1)
of aspartate aminotransferase##4##3##(1990-7#1)(1993-2#1)(1997-5#1)(2008-12#1)
of aspartate formation##2##3##(1991-3#2)
of aspartate##12##2##(1990-11#1)(1990-7#1)(1991-3#4)(1992-6#1)(1993-2#1)(1995-6#2)(1997-5#1)(2008-12#1)
of aspartic acid##2##3##(1990-10#1)(1990-12#1)
of aspartic##4##2##(1990-10#1)(1990-12#1)(1995-3#1)(2008-4#1)
of aspects of##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
of aspects##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)
of aspergillosis##4##2##(1997-3#3)(2008-10#1)
of aspheres##2##2##(2008-3#2)
of aspirated##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
of aspiration##5##2##(1990-6#1)(1993-10#3)(2010-3#1)
of aspirin and##4##3##(2006-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
of aspirin in##2##3##(1990-3#1)(1991-11#1)
of aspirin resistance##2##3##(2008-3#1)(2013-8#1)
of aspirin##21##2##(1990-3#1)(1990-5#1)(1991-11#3)(1992-5#1)(1993-2#1)(1997-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-2#1)(2013-8#2)
of assay##7##2##(1997-4#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-6#1)
of assays are##2##3##(2008-1#1)(2008-4#1)
of assays in##2##3##(2008-10#1)(2008-4#1)
of assays##9##2##(1995-8#2)(2008-1#2)(2008-10#2)(2008-4#3)
of assembling##2##2##(2008-7#1)(2008-8#1)
of assembly##6##2##(1991-5#1)(1995-2#2)(1997-2#1)(2009-11#1)(2011-3#1)
of assessing renal##2##3##(2008-1#1)(2013-8#1)
of assessing the##9##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
of assessing##30##2##(1990-8#1)(1993-6#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of assessment and##3##3##(2008-11#1)(2010-7#1)(2012-2#1)
of assessment are##3##3##(1994-2#1)(2008-11#2)
of assessment of##5##3##(1995-5#1)(2007-11#1)(2008-9#1)(2009-11#1)(2011-2#1)
of assessment##31##2##(1991-12#1)(1992-3#1)(1994-2#3)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#10)(2008-9#4)(2009-11#1)(2009-12#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
of assets##2##2##(2012-12#2)
of assigning##3##2##(1992-2#1)(1995-6#1)(2008-4#1)
of assignment##2##2##(2008-12#1)(2008-2#1)
of assistance##3##2##(1995-1#1)(2009-3#1)(2009-7#1)
of assisted living in##2##4##(2008-12#2)
of assisted living##4##3##(2008-12#4)
of assisted reproductive technologies##2##4##(2008-11#1)(2011-1#1)
of assisted reproductive##3##3##(2007-2#1)(2008-11#1)(2011-1#1)
of assisted suicide##4##3##(2010-12#4)
of assisted##16##2##(1991-11#1)(1991-3#1)(1996-9#1)(2007-2#1)(2008-11#1)(2008-12#4)(2009-10#1)(2010-12#4)(2010-5#1)(2011-1#1)
of associated##15##2##(1992-6#1)(1995-10#1)(1996-3#1)(1997-8#1)(2007-7#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of association between the##2##4##(1995-2#1)(2013-8#1)
of association between##10##3##(1990-6#1)(1995-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of association constants##2##3##(2008-10#2)
of association of these##2##4##(1996-2#1)(2008-10#1)
of association of##6##3##(1995-2#1)(1995-6#1)(1996-2#1)(2007-2#1)(2008-10#2)
of association with##2##3##(2012-3#1)(2013-1#1)
of association##36##2##(1990-6#1)(1993-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-7#1)(2007-2#1)(2008-10#16)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
of associations between##2##3##(2008-10#1)(2012-1#1)
of associations##9##2##(2008-10#2)(2008-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of assuming##2##2##(1996-2#1)(2009-2#1)
of assumptions##3##2##(1994-3#1)(2008-7#1)(2010-8#1)
of astaxanthin##4##2##(2008-10#3)(2013-8#1)
of astemizole##3##2##(2008-10#3)
of asthma and rhinitis in South##2##6##(2012-3#2)
of asthma and##7##3##(1996-1#1)(1997-1#1)(2007-6#1)(2011-1#1)(2012-3#3)
of asthma are##2##3##(2007-11#1)(2011-1#1)
of asthma control and##2##4##(2008-3#2)
of asthma control##5##3##(2008-3#3)(2010-9#1)(2012-1#1)
of asthma in adults##3##4##(1990-9#1)(2008-12#2)
of asthma in##9##3##(1990-9#1)(1991-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2010-6#1)
of asthma is##3##3##(2008-3#1)(2010-5#1)(2013-1#1)
of asthma patients##2##3##(2012-12#1)(2013-1#1)
of asthma severity##2##3##(2010-5#2)
of asthma##76##2##(1990-9#1)(1991-6#1)(1992-2#4)(1992-3#2)(1993-1#2)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-2#1)(2007-6#3)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#7)(2008-7#6)(2010-2#1)(2010-5#10)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#7)(2013-1#2)
of asthmatic patients##2##3##(1990-9#1)(2008-3#1)
of asthmatic##5##2##(1990-9#1)(1992-3#2)(2007-6#1)(2008-3#1)
of asthmatics##2##2##(1992-2#1)(2008-7#1)
of astigmatism##2##2##(2008-3#2)
of astringinin##2##2##(2013-1#2)
of astrocyte##4##2##(1990-7#1)(2008-11#1)(2008-7#1)(2009-5#1)
of astrocytes and##2##3##(2009-3#1)(2013-7#1)
of astrocytes in##2##3##(1997-3#1)(2009-3#1)
of astrocytes is##2##3##(2008-11#1)(2008-12#1)
of astrocytes was##2##3##(2008-11#1)(2009-3#1)
of astrocytes##18##2##(1994-2#1)(1997-3#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#5)(2009-3#5)(2013-7#1)
of astrocytic##6##2##(2008-4#1)(2008-7#4)(2012-2#1)
of astrogliosis##2##2##(2009-8#2)
of asylum##2##2##(1993-6#1)(2009-7#1)
of asymmetric##12##2##(1990-8#1)(1993-8#2)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-2#2)
of asymmetry##4##2##(1994-8#1)(2008-3#3)
of asymptomatic bacteriuria##2##3##(2007-12#1)(2008-12#1)
of asymptomatic plants##2##3##(2008-10#2)
of asymptomatic##25##2##(1990-3#3)(1994-6#1)(1996-6#1)(1996-9#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2011-2#2)(2012-2#3)(2012-3#3)(2013-8#1)
of asynchrony##2##2##(1996-2#1)(2008-10#1)
of at least 1##3##4##(1995-2#1)(2007-7#1)(2008-10#1)
of at least 15##3##4##(1994-3#1)(1994-7#1)(2008-11#1)
of at least 20##2##4##(2008-6#1)(2012-2#1)
of at least 3##2##4##(2008-3#2)
of at least 300##2##4##(1990-9#1)(2008-9#1)
of at least 4##4##4##(1990-12#1)(1997-3#1)(2008-3#1)(2012-12#1)
of at least 5##2##4##(2008-8#1)(2011-2#1)
of at least 6 months##2##5##(1990-12#1)(1991-2#1)
of at least 6##4##4##(1990-12#1)(1991-2#1)(2007-11#1)(2008-11#1)
of at least 70##2##4##(1994-2#1)(2008-10#1)
of at least five##3##4##(2008-10#1)(2009-9#1)(2010-8#1)
of at least four##3##4##(1993-9#1)(1994-6#1)(1995-6#1)
of at least nine##2##4##(1993-8#1)(2008-10#1)
of at least one##12##4##(1995-12#1)(1996-10#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
of at least six##2##4##(2008-10#1)(2008-5#1)
of at least some##3##4##(1990-6#1)(2008-7#1)(2008-8#1)
of at least three different##2##5##(1995-2#1)(2007-5#1)
of at least three##8##4##(1990-8#1)(1995-2#1)(2007-5#1)(2008-10#3)(2010-6#1)(2012-3#1)
of at least two##11##4##(1990-8#2)(1992-12#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)
of at least##101##3##(1990-11#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#2)(1992-12#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-5#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#17)(2008-11#6)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
of at##104##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#2)(1992-12#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-5#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#18)(2008-11#7)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
of ataxia##2##2##(2008-6#1)(2008-7#1)
of atenolol##3##2##(1995-6#1)(2008-10#2)
of atherogenesis##2##2##(2008-10#1)(2008-5#1)
of atherogenic lipids##2##3##(2008-9#2)
of atherogenic##5##2##(1995-5#1)(2008-1#1)(2008-9#2)(2013-1#1)
of atheromatous##2##2##(1992-6#1)(2012-3#1)
of atherosclerosis and cardiovascular##2##4##(2008-6#1)(2008-7#1)
of atherosclerosis and##14##3##(1990-2#1)(1995-8#1)(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
of atherosclerosis in##4##3##(2008-1#2)(2008-3#2)
of atherosclerosis##65##2##(1990-2#1)(1991-12#1)(1991-6#1)(1991-9#2)(1993-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-8#3)(2007-8#3)(2008-1#6)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#3)(2010-5#2)(2010-9#2)(2011-2#3)(2012-2#3)(2012-3#4)(2013-7#1)
of atherosclerotic changes##2##3##(2011-2#2)
of atherosclerotic disease##4##3##(1991-6#1)(1996-2#1)(2008-7#1)(2008-8#1)
of atherosclerotic lesions in##4##4##(2008-3#1)(2008-7#3)
of atherosclerotic lesions##8##3##(1996-3#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-8#1)(2010-9#1)
of atherosclerotic plaque##3##3##(2010-9#3)
of atherosclerotic plaques##3##3##(1991-3#1)(1991-9#1)(2007-11#1)
of atherosclerotic##23##2##(1991-3#1)(1991-6#1)(1991-9#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#1)(2010-8#1)(2010-9#4)(2011-2#2)(2012-2#1)
of atherothrombosis##2##2##(2008-3#1)(2011-2#1)
of atherothrombotic##2##2##(2011-2#2)
of athletes##5##2##(1993-3#2)(2008-5#1)(2010-1#1)(2013-1#1)
of athletic##5##2##(1994-2#1)(1994-3#1)(2008-5#1)(2010-1#1)(2010-7#1)
of atmospheric SO(2)##2##3##(2008-3#2)
of atmospheric aerosol##4##3##(2008-10#2)(2008-3#2)
of atmospheric aerosols at##2##4##(2008-2#1)(2008-3#1)
of atmospheric aerosols##3##3##(2008-2#2)(2008-3#1)
of atmospheric backscatter##2##3##(2008-3#2)
of atmospheric particulate##2##3##(2008-10#1)(2008-3#1)
of atmospheric profiles##2##3##(2008-2#1)(2008-3#1)
of atmospheric scattering##2##3##(2008-3#2)
of atmospheric temperature##2##3##(2008-3#2)
of atmospheric turbulence and reflective speckle##2##6##(2008-3#2)
of atmospheric turbulence##8##3##(2007-12#1)(2008-2#1)(2008-3#6)
of atmospheric water vapor##2##4##(2008-3#2)
of atmospheric##64##2##(1995-3#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-2#12)(2008-3#37)(2013-8#2)
of atomic absorption spectrometry##4##4##(2008-10#4)
of atomic arsenic##2##3##(2008-2#2)
of atomic force microscopy (AFM)##2##5##(2008-10#1)(2008-7#1)
of atomic force microscopy##4##4##(2008-10#1)(2008-2#2)(2008-7#1)
of atomic nitrogen##3##3##(2008-2#3)
of atomic orbitals##2##3##(2007-11#2)
of atomic##25##2##(2007-11#3)(2008-10#5)(2008-12#1)(2008-2#10)(2008-3#4)(2008-7#1)(2011-1#1)
of atomization##4##2##(2008-10#3)(2008-2#1)
of atoms in the##2##4##(1990-12#1)(1997-2#1)
of atoms in##3##3##(1990-12#1)(1997-2#1)(2007-11#1)
of atoms##8##2##(1990-12#1)(1992-8#1)(1997-2#1)(2007-11#1)(2008-7#2)(2009-12#1)(2009-7#1)
of atopic dermatitis##11##3##(1991-2#4)(1992-9#2)(2007-11#1)(2011-1#2)(2012-2#2)
of atopic##14##2##(1991-2#6)(1992-9#2)(2007-11#1)(2008-10#1)(2011-1#2)(2012-2#2)
of atopy was##2##3##(2007-7#2)
of atopy##9##2##(2007-7#5)(2009-10#1)(2009-2#1)(2012-3#1)(2013-8#1)
of atorvastatin##3##2##(2008-5#2)(2011-2#1)
of atranorin##2##2##(2008-5#2)
of atrazine and simazine in##2##5##(2008-10#2)
of atrazine and simazine##3##4##(2008-10#3)
of atrazine and##5##3##(2008-10#4)(2013-1#1)
of atrazine at##2##3##(2008-10#2)
of atrazine in##6##3##(2008-10#6)
of atrazine using##2##3##(2008-10#2)
of atrazine##30##2##(2008-10#27)(2013-1#3)
of atretic follicles##2##3##(2008-11#1)(2008-8#1)
of atrial fibrillation after##2##4##(1994-3#1)(2013-8#1)
of atrial fibrillation and##3##4##(2008-8#1)(2010-6#1)(2011-2#1)
of atrial fibrillation in##3##4##(2007-8#1)(2012-3#1)(2013-8#1)
of atrial fibrillation##17##3##(1994-3#1)(2007-10#1)(2007-8#5)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
of atrial septal defect##2##4##(2007-8#1)(2008-11#1)
of atrial septal defects##3##4##(1997-8#2)(2012-1#1)
of atrial septal##5##3##(1997-8#2)(2007-8#1)(2008-11#1)(2012-1#1)
of atrial##31##2##(1992-3#1)(1994-3#1)(1996-2#2)(1997-8#2)(2007-10#1)(2007-8#8)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#2)
of atrioventricular##2##2##(1992-6#1)(2007-8#1)
of atrophic##3##2##(2008-5#1)(2013-1#1)(2013-8#1)
of atropine and##4##3##(1993-9#1)(2008-10#2)(2008-12#1)
of atropine##9##2##(1990-9#1)(1993-9#1)(1996-12#1)(1997-4#2)(2008-10#2)(2008-12#1)(2012-12#1)
of attached##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
of attaching##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
of attachment and##3##3##(2007-12#1)(2008-11#1)(2010-8#1)
of attachment of##2##3##(1990-8#1)(2012-1#1)
of attachment##11##2##(1990-8#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-7#2)(2010-8#1)(2012-1#2)
of attack##4##2##(1991-3#1)(2007-10#1)(2008-12#1)(2008-8#1)
of attacks##3##2##(1994-11#2)(2011-2#1)
of attaining##2##2##(2008-11#1)(2010-12#1)
of attempted##2##2##(2008-10#1)(2011-2#1)
of attempting to##2##3##(1991-12#1)(2007-8#1)
of attempts to##2##3##(1990-8#1)(2008-9#1)
of attempts##5##2##(1990-8#1)(2008-1#1)(2008-9#1)(2013-1#2)
of attendance##4##2##(1992-2#1)(2009-7#2)(2010-2#1)
of attendees##3##2##(1991-3#1)(2008-5#1)(2009-5#1)
of attention and##3##3##(2008-4#1)(2008-7#1)(2009-2#1)
of attention deficit hyperactivity disorder (ADHD)##2##6##(2008-6#1)(2009-9#1)
of attention deficit hyperactivity disorder##3##5##(2008-6#1)(2009-9#1)(2013-8#1)
of attention deficit/hyperactivity disorder##2##4##(1997-8#2)
of attention in the##2##4##(2007-8#1)(2013-8#1)
of attention in##5##3##(1997-2#1)(2007-8#1)(2008-12#1)(2010-9#1)(2013-8#1)
of attention to##2##3##(2008-12#1)(2009-10#1)
of attention##47##2##(1991-3#1)(1992-2#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
of attention-deficit/hyperactivity disorder##5##3##(2008-2#4)(2010-9#1)
of attentional##5##2##(1995-5#1)(2008-11#1)(2009-2#1)(2012-3#1)(2013-8#1)
of attenuated total reflectance##2##4##(2008-10#2)
of attenuated total reflection##2##4##(2007-12#1)(2008-10#1)
of attenuated total##7##3##(2007-12#1)(2008-10#5)(2008-5#1)
of attenuated##10##2##(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-9#1)
of attenuation##4##2##(1992-9#1)(2007-11#1)(2008-11#1)(2008-3#1)
of attitude##2##2##(1992-3#1)(2009-11#1)
of attitudes##3##2##(1994-3#1)(1995-12#1)(2010-12#1)
of attorney##3##2##(1992-1#1)(1994-1#1)(1997-1#1)
of attracting##2##2##(1992-12#1)(2013-1#1)
of attraction##4##2##(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
of attractive male##2##3##(2008-8#2)
of attractive##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#2)
of attractiveness##2##2##(2007-12#2)
of attributes##2##2##(2008-10#1)(2008-8#1)
of attributing##2##2##(1990-3#1)(2012-2#1)
of atypical antipsychotic agents##2##4##(2008-4#1)(2008-8#1)
of atypical antipsychotics##4##3##(2008-8#3)(2012-3#1)
of atypical##18##2##(1991-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
of audio-visual##2##2##(2011-1#1)(2012-2#1)
of audit##5##2##(1996-11#3)(2007-11#2)
of auditory performance##3##3##(2008-9#2)(2012-2#1)
of auditory rehabilitation##2##3##(2008-9#2)
of auditory##27##2##(1995-12#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#9)(2009-2#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
of auricles##2##2##(2011-1#2)
of auricular acupuncture##3##3##(2008-11#1)(2010-6#2)
of authentic##11##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1994-9#1)(1995-12#1)(2008-10#4)(2008-12#1)
of authentication##2##2##(2008-11#2)
of authorities##3##2##(2008-12#1)(2011-2#1)(2013-7#1)
of authors##2##2##(2008-11#1)(2008-7#1)
of autism and##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
of autism in##3##3##(2012-12#2)(2012-2#1)
of autism spectrum disorders##4##4##(2008-11#1)(2010-12#1)(2012-1#1)(2012-2#1)
of autism##19##2##(1997-8#1)(2007-8#1)(2008-11#3)(2010-12#1)(2010-7#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)
of autistic features##2##3##(2008-11#2)
of autistic##4##2##(1997-8#1)(2008-11#2)(2008-3#1)
of auto-antibodies##2##2##(2008-1#1)(2008-7#1)
of autoantibodies against erythrocytes and platelets##2##6##(1991-4#2)
of autoantibodies against##4##3##(1991-4#2)(1995-3#1)(1996-11#1)
of autoantibodies in##2##3##(2011-2#1)(2013-1#1)
of autoantibodies##9##2##(1991-4#2)(1995-3#1)(1996-11#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of autobiographical memory construction##2##4##(2008-2#2)
of autobiographical memory impairment according to disease severity##2##8##(2009-2#2)
of autobiographical memory in##2##4##(2009-2#2)
of autobiographical memory##10##3##(2008-2#5)(2009-2#4)(2010-8#1)
of autobiographical##11##2##(2008-2#6)(2009-2#4)(2010-8#1)
of autocatalytic##2##2##(1993-6#1)(2008-10#1)
of autochthonous##3##2##(2008-10#2)(2010-4#1)
of autocorrelation##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)
of autocrine and paracrine##2##4##(1995-8#1)(2006-10#1)
of autocrine##5##2##(1990-5#1)(1994-9#1)(1995-8#1)(2006-10#1)(2008-11#1)
of autodeposition##2##2##(2008-10#2)
of autoencoders##2##2##(2010-8#2)
of autofluorescence from malignant and normal##2##6##(2008-3#2)
of autogamy##3##2##(2008-12#3)
of autogenic##2##2##(2007-8#1)(2012-12#1)
of autogenous##2##2##(2009-10#1)(2011-3#1)
of autograft and allograft fixation in##2##6##(2009-3#2)
of autograft##3##2##(2009-3#2)(2010-3#1)
of autoimmune and##2##3##(2007-11#1)(2012-3#1)
of autoimmune disease in##2##4##(1993-3#1)(1996-11#1)
of autoimmune disease##6##3##(1993-3#1)(1996-11#2)(2008-10#3)
of autoimmune diseases such as##2##5##(2007-5#1)(2011-2#1)
of autoimmune diseases##9##3##(1992-5#1)(2007-5#1)(2008-10#3)(2008-4#2)(2011-2#2)
of autoimmune hepatitis##6##3##(1996-11#3)(2006-10#1)(2008-10#1)(2011-1#1)
of autoimmune##36##2##(1990-9#1)(1992-5#1)(1993-3#2)(1994-12#1)(1996-11#5)(1997-8#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-4#2)(2008-5#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
of autoimmunity in##2##3##(2008-10#1)(2008-9#1)
of autoimmunity##15##2##(2007-5#2)(2008-10#6)(2008-8#1)(2008-9#1)(2010-5#2)(2011-2#2)(2013-1#1)
of autoinhibited##2##2##(2012-12#2)
of autologous bone marrow##3##4##(2006-10#1)(2011-2#1)(2012-1#1)
of autologous##18##2##(1990-2#1)(1994-9#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-3#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)
of automated dissolution##2##3##(2008-10#2)
of automated test procedures##2##4##(2008-10#2)
of automated test##3##3##(2008-10#3)
of automated##21##2##(1992-12#1)(1995-11#1)(1996-12#2)(1997-2#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
of automatic##4##2##(1990-8#1)(2008-3#1)(2010-5#1)(2013-8#1)
of automating##2##2##(2008-10#1)(2008-9#1)
of automation##8##2##(2007-12#1)(2008-10#5)(2008-4#1)(2012-12#1)
of automotive##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
of autonomic dysfunction##4##3##(1994-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
of autonomic neuropathy##2##3##(2008-6#1)(2009-12#1)
of autonomic system##2##3##(2008-12#2)
of autonomic##16##2##(1994-3#1)(1996-6#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
of autonomous agents##2##3##(2008-5#1)(2012-2#1)
of autonomous##4##2##(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
of autonomy and##5##3##(1992-1#1)(1994-3#1)(2008-11#1)(2008-9#1)(2009-7#1)
of autonomy##9##2##(1992-1#1)(1994-3#1)(1995-9#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2013-1#1)
of autophagic##4##2##(1990-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
of autophagy##5##2##(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of autoreactive T cells##2##4##(1996-11#1)(2007-5#1)
of autoreactive T##3##3##(1996-11#1)(2007-5#2)
of autoreactive##4##2##(1996-11#1)(2007-5#2)(2011-2#1)
of autoregulation##2##2##(2007-10#1)(2008-7#1)
of autosomal dominant##2##3##(1996-2#1)(2010-6#1)
of autosomal recessive##2##3##(1996-8#1)(2012-3#1)
of autosomal##4##2##(1996-2#1)(1996-8#1)(2010-6#1)(2012-3#1)
of autosomes##2##2##(2007-11#1)(2007-12#1)
of auxiliary##2##2##(1995-3#1)(2008-10#1)
of auxin signaling##2##3##(2009-8#1)(2011-1#1)
of auxin##11##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#3)(2011-1#1)
of auxins##2##2##(2008-10#1)(2008-12#1)
of availability of##4##3##(1993-6#1)(2008-10#1)(2008-2#1)(2010-8#1)
of availability##7##2##(1993-12#1)(1993-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#2)
of available data to##2##4##(2008-5#1)(2009-8#1)
of available data##8##3##(1990-8#1)(1990-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)
of available research##3##3##(2007-10#1)(2008-12#1)(2008-9#1)
of available resources##2##3##(2008-1#1)(2008-11#1)
of available treatments##2##3##(2008-11#1)(2012-3#1)
of available##45##2##(1990-8#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-2#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)
of avascular necrosis##3##3##(2007-11#2)(2007-8#1)
of average and##2##3##(2008-11#1)(2011-2#1)
of average flow velocity##2##4##(2011-2#2)
of average molecular mass M(a) = 0##2##7##(2008-5#2)
of average power##10##3##(2007-11#4)(2007-12#4)(2008-2#1)(2008-3#1)
of average pump power##2##4##(2007-11#1)(2007-12#1)
of average weight##2##3##(1995-12#1)(2008-11#1)
of average##39##2##(1995-1#1)(1995-12#1)(2007-11#9)(2007-12#7)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#2)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
of averaging##3##2##(2008-2#2)(2008-3#1)
of avian influenza##4##3##(2007-6#2)(2011-2#1)(2013-8#1)
of avian reovirus##3##3##(1997-6#2)(2007-6#1)
of avian##23##2##(1991-8#1)(1994-8#1)(1997-3#4)(1997-6#3)(2007-6#5)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#2)(2013-8#1)
of aviation##2##2##(2008-10#1)(2012-3#1)
of avidin##6##2##(1993-6#4)(2008-10#1)(2008-12#1)
of avirulence in the##2##4##(2008-10#2)
of avirulence or virulence##2##4##(2008-10#2)
of avirulence##11##2##(2008-10#11)
of avirulent##2##2##(2008-10#1)(2008-9#1)
of avocado fruit with Cg-M-142##2##5##(2008-10#2)
of avocado##5##2##(2007-11#1)(2008-10#4)
of avoiding##6##2##(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
of awake##3##2##(1995-12#2)(1997-2#1)
of awareness and##4##3##(2007-2#1)(2009-4#1)(2010-12#1)(2011-1#1)
of awareness of the##2##4##(2008-10#1)(2012-12#1)
of awareness of##7##3##(1995-8#1)(1996-1#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
of awareness##18##2##(1994-1#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of axial CT##2##3##(1996-6#1)(2007-11#1)
of axial and##2##3##(2008-3#2)
of axial rotation##2##3##(2007-8#2)
of axial strain##2##3##(2007-12#2)
of axial stress##2##3##(2008-2#1)(2008-7#1)
of axial##16##2##(1994-12#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)
of axillary bacteria##2##3##(2008-5#2)
of axillary malodour##2##3##(2008-5#2)
of axillary node##2##3##(2008-10#2)
of axillary##15##2##(1991-8#1)(2008-10#2)(2008-5#11)(2012-3#1)
of axon terminals with##3##4##(1997-2#3)
of axon terminals##4##3##(1997-2#4)
of axonal##6##2##(1995-12#1)(1996-5#1)(1997-3#1)(2008-7#2)(2011-7#1)
of axons##10##2##(1993-12#1)(1995-12#1)(1996-2#2)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#3)
of ayahuasca##3##2##(2008-7#2)(2013-8#1)
of azacyclonol##2##2##(1992-8#2)
of azaspiracid##2##2##(2008-7#2)
of azathioprine##3##2##(2007-7#1)(2008-10#2)
of azide##4##2##(1993-11#3)(1996-5#1)
of azidothymidine##2##2##(2008-10#2)
of azimuthal##4##2##(2008-1#1)(2008-2#3)
of azithromycin##3##2##(2008-10#3)
of azo dyes##2##3##(2008-10#1)(2011-1#1)
of azo##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
of azobenzene liquid-crystal##2##3##(1995-6#1)(2007-11#1)
of azobenzene##6##2##(1995-6#2)(2007-11#2)(2007-12#1)(2008-10#1)
of b##5##2##(2008-10#3)(2010-11#1)(2011-2#1)
of b(5)##5##2##(2008-7#5)
of b(rw)##2##2##(2008-2#2)
of b-lactamase##2##2##(2007-8#2)
of bFGF and##4##3##(1994-11#2)(1995-12#1)(2008-11#1)
of bFGF gene##2##3##(1995-12#1)(2008-5#1)
of bFGF in the##3##4##(1990-5#1)(1992-3#1)(1995-12#1)
of bFGF in##4##3##(1990-5#1)(1992-3#1)(1995-12#1)(2013-8#1)
of bFGF##22##2##(1990-5#2)(1991-2#1)(1992-3#2)(1994-11#3)(1995-12#9)(2008-11#3)(2008-5#1)(2013-8#1)
of bZIP60##4##2##(2012-2#4)
of babies born##2##3##(2008-1#1)(2012-2#1)
of babies##5##2##(2008-1#1)(2008-11#1)(2010-6#1)(2011-1#1)(2012-2#1)
of baboon##2##2##(1993-6#1)(1994-12#1)
of baccalaureate##3##2##(1991-1#2)(1994-2#1)
of back pain syndrome##2##4##(2007-11#2)
of back pain##5##3##(1997-2#1)(2007-11#3)(2008-12#1)
of back##7##2##(1997-2#1)(1997-6#1)(2007-11#3)(2008-10#1)(2008-12#1)
of backbone##2##2##(1993-11#1)(2008-8#1)
of backcrossing##2##2##(2008-10#1)(2008-5#1)
of background noise##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of background signals##3##3##(2008-3#3)
of background##29##2##(1993-5#1)(1996-2#1)(2008-10#9)(2008-2#5)(2008-3#10)(2008-4#1)(2010-3#1)(2012-12#1)
of backscatter from two##2##4##(2008-3#2)
of backscatter##5##2##(2008-2#1)(2008-3#4)
of backscattered light##4##3##(2007-11#1)(2008-3#3)
of backscattered##5##2##(2007-11#1)(2008-3#4)
of backscattering by##2##3##(2008-3#2)
of backscattering##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
of backward##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
of baclofen produced##2##3##(1990-5#1)(1993-12#1)
of baclofen##6##2##(1990-5#2)(1993-12#3)(2008-10#1)
of bacteraemia##3##2##(1995-3#1)(2008-5#1)(2013-8#1)
of bacteremia##7##2##(1990-2#1)(2007-12#1)(2007-7#2)(2010-6#1)(2013-1#2)
of bacteria and fungi##2##4##(2006-6#1)(2008-5#1)
of bacteria and##8##3##(2006-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
of bacteria are##2##3##(2008-9#1)(2011-1#1)
of bacteria but##2##3##(2007-7#1)(2008-10#1)
of bacteria by##2##3##(2008-9#1)(2011-2#1)
of bacteria in the##2##4##(2008-10#1)(2011-2#1)
of bacteria in##9##3##(2008-10#6)(2008-9#1)(2010-12#1)(2011-2#1)
of bacteria is##2##3##(2008-9#1)(2011-2#1)
of bacteria on##3##3##(2008-10#2)(2008-8#1)
of bacteria pathogenic on potato##2##5##(2008-10#2)
of bacteria to the##2##4##(2006-6#1)(2008-7#1)
of bacteria to##5##3##(1997-4#1)(2006-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
of bacteria using##2##3##(2008-10#1)(2008-12#1)
of bacteria which##2##3##(2008-10#1)(2013-7#1)
of bacteria with##3##3##(2009-4#1)(2011-2#1)(2013-1#1)
of bacteria within the##2##4##(1996-6#1)(2013-8#1)
of bacteria##94##2##(1990-5#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-6#2)(2007-12#1)(2007-7#2)(2008-10#35)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#7)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
of bacterial DNA##2##3##(1995-6#1)(2008-10#1)
of bacterial adenylate kinases##2##4##(1992-3#2)
of bacterial aggregates##2##3##(2008-10#2)
of bacterial and yeast##3##4##(2007-7#1)(2008-10#1)(2012-2#1)
of bacterial and##6##3##(1994-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
of bacterial antagonists##2##3##(2008-10#2)
of bacterial artificial chromosome (BAC)##3##5##(2007-6#1)(2008-8#1)(2009-10#1)
of bacterial artificial##4##3##(2007-6#1)(2008-4#1)(2008-8#1)(2009-10#1)
of bacterial bioreporters##2##3##(2011-2#2)
of bacterial blight of onion##3##5##(2008-10#3)
of bacterial blight of rice##2##5##(2008-10#2)
of bacterial blight of##6##4##(2008-10#6)
of bacterial blight##8##3##(2008-10#7)(2008-8#1)
of bacterial cells##7##3##(2008-10#5)(2008-3#1)(2008-9#1)
of bacterial cellulose##2##3##(2008-6#2)
of bacterial endocarditis##3##3##(2007-7#2)(2007-8#1)
of bacterial endotoxin##2##3##(1990-12#1)(1996-12#1)
of bacterial fatty##2##3##(2008-10#2)
of bacterial growth by##2##4##(2007-10#1)(2008-5#1)
of bacterial growth inhibition##2##4##(2008-5#2)
of bacterial growth##7##3##(1994-6#1)(1997-8#1)(2007-10#1)(2008-5#3)(2009-6#1)
of bacterial infection##5##3##(1990-12#1)(1990-8#1)(1992-2#1)(2006-5#1)(2013-1#1)
of bacterial infections in##3##4##(2012-3#2)(2013-1#1)
of bacterial infections##6##3##(1996-12#1)(2008-12#1)(2012-3#3)(2013-1#1)
of bacterial leaf##3##3##(2008-10#3)
of bacterial lipopolysaccharide##2##3##(1995-12#1)(2012-1#1)
of bacterial meningitis in##3##4##(1992-11#1)(2007-5#1)(2008-11#1)
of bacterial meningitis##7##3##(1992-11#1)(1996-3#1)(2007-5#1)(2008-11#1)(2009-3#2)(2010-12#1)
of bacterial origin##2##3##(1997-2#1)(2008-5#1)
of bacterial pathogens##4##3##(2008-4#1)(2008-7#1)(2008-9#2)
of bacterial resistance to##2##4##(1991-2#1)(1997-3#1)
of bacterial resistance##6##3##(1991-2#1)(1997-3#2)(2008-7#1)(2009-5#1)(2013-1#1)
of bacterial species##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
of bacterial speck##3##3##(2008-10#3)
of bacterial spot of##2##4##(2008-10#2)
of bacterial spot on##2##4##(2008-10#2)
of bacterial spot##4##3##(2008-10#4)
of bacterial strains##2##3##(2010-2#1)(2013-8#1)
of bacterial vaginosis##3##3##(2007-12#2)(2008-10#1)
of bacterial wilt##2##3##(2008-10#2)
of bacterial##171##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-10#44)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#11)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#4)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#5)(2012-1#3)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
of bacterially produced##2##3##(2008-10#1)(2008-4#1)
of bacteriemia is##2##3##(2010-12#2)
of bacteriemia##3##2##(2010-12#3)
of bacteriophage P22##2##3##(2008-4#1)(2009-5#1)
of bacteriophage lambda##2##3##(1993-9#1)(1995-2#1)
of bacteriophage phi X174##2##4##(1991-5#2)
of bacteriophage##15##2##(1991-5#2)(1993-11#1)(1993-9#1)(1995-2#2)(1996-2#1)(1997-4#1)(2008-4#1)(2008-8#3)(2009-5#1)(2012-2#2)
of bacteriopheophytin##2##2##(2008-9#2)
of bacteriorhodopsin in##2##3##(1990-11#1)(1990-5#1)
of bacteriorhodopsin##11##2##(1990-11#2)(1990-5#1)(1991-12#2)(1994-5#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-2#1)
of bacterivorous##2##2##(2008-10#1)(2008-8#1)
of baculovirus##3##2##(1991-2#1)(1997-4#1)(2008-2#1)
of bad##4##2##(1992-5#1)(1997-4#1)(2007-11#1)(2008-7#1)
of baicalein##2##2##(2008-10#2)
of baker's yeast##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of baker's##4##2##(1990-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
of balance and##4##3##(1997-8#1)(2008-1#1)(2010-11#1)(2013-1#1)
of balance##15##2##(1994-12#2)(1996-7#2)(1997-8#1)(2008-1#1)(2008-11#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
of balanced##7##2##(2008-11#3)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
of balancing##3##2##(2008-2#1)(2010-5#1)(2013-1#1)
of ball##4##2##(2008-6#1)(2008-7#1)(2013-1#2)
of ballistic##2##2##(2007-11#1)(2008-2#1)
of balloon angioplasty##2##3##(1991-3#1)(2012-3#1)
of balloon##3##2##(1991-3#1)(2008-7#1)(2012-3#1)
of balloon-occluded retrograde transvenous obliteration##2##5##(2013-1#2)
of bambaragroundnut seeds##4##3##(2010-2#4)
of banana and##2##3##(2008-10#2)
of banana##10##2##(2008-10#10)
of bananas##2##2##(2008-10#2)
of band 3##2##3##(1993-11#2)
of band patterns##2##3##(2008-12#2)
of band##10##2##(1991-9#1)(1993-11#2)(2007-12#1)(2008-12#2)(2013-1#1)(2013-8#3)
of bandpass filters##2##3##(2007-12#1)(2008-10#1)
of bandpass##5##2##(2007-12#1)(2008-10#1)(2008-3#3)
of bands in##2##3##(2007-10#1)(2007-12#1)
of bands##10##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)
of bandwidth W##2##3##(2008-2#1)(2008-3#1)
of bandwidth##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
of bar presses##2##3##(1993-5#2)
of barbiturates##4##2##(1991-1#1)(2008-10#1)(2008-6#2)
of bare##7##2##(1997-4#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-11#1)
of bariatric surgery##2##3##(1993-5#2)
of bariatric##3##2##(1993-5#2)(2012-12#1)
of barium iodate##2##3##(2008-10#2)
of barium##7##2##(2008-10#4)(2010-8#2)(2011-2#1)
of barley (Hordeum vulgare L##2##5##(1995-6#1)(2008-10#1)
of barley (Hordeum##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
of barley alpha-amylase##2##3##(2008-8#2)
of barley and##2##3##(2008-10#2)
of barley covered smut##2##4##(2008-10#2)
of barley in##7##3##(2008-10#7)
of barley##42##2##(1992-8#1)(1992-9#1)(1994-6#1)(1995-6#2)(2008-10#32)(2008-5#1)(2008-8#4)
of baroreflex##2##2##(2008-1#1)(2010-5#1)
of barrier agents##2##3##(1991-1#2)
of barrier cells##2##3##(2008-7#2)
of barrier function##4##3##(2008-5#3)(2010-10#1)
of barrier products in the prevention and treatment##2##8##(2013-8#2)
of barrier##12##2##(1991-1#2)(1995-12#1)(2008-5#4)(2008-7#2)(2010-10#1)(2013-8#2)
of barriers in ion-implanted##2##4##(2008-3#2)
of barriers to##5##3##(1993-12#1)(1994-1#1)(2008-11#1)(2008-7#1)(2011-1#1)
of barriers##10##2##(1993-12#1)(1994-1#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-1#1)
of basal cell carcinoma##3##4##(1997-3#1)(2013-1#1)(2013-8#1)
of basal cell##4##3##(1990-9#1)(1997-3#1)(2013-1#1)(2013-8#1)
of basal forebrain cholinergic neurons##2##5##(1996-5#2)
of basal forebrain##3##3##(1996-5#2)(2009-3#1)
of basal keratinocytes##2##3##(2008-5#1)(2013-1#1)
of basal##20##2##(1990-9#1)(1991-7#1)(1993-6#1)(1995-5#1)(1996-5#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
of base line##2##3##(2008-10#2)
of base pairing##2##3##(1992-8#1)(2008-7#1)
of base time##4##3##(2008-8#4)
of base##14##2##(1990-11#1)(1992-8#1)(1993-11#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#4)(2012-2#1)
of baseline##17##2##(1995-5#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
of basement membrane##4##3##(1993-12#1)(1997-4#1)(2008-11#2)
of bases##5##2##(1991-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-10#1)
of basic FGF##2##3##(1991-2#2)
of basic alloys##2##3##(2013-1#2)
of basic fibroblast growth factor (bFGF)##2##6##(1992-3#1)(2008-11#1)
of basic fibroblast growth factor##8##5##(1991-2#2)(1992-3#2)(1992-9#1)(1994-6#1)(1995-12#1)(2008-11#1)
of basic images##2##3##(2008-3#2)
of basic laparoscopic skills##2##4##(2010-3#2)
of basic needs##2##3##(1992-3#2)
of basic research##6##3##(1991-12#1)(1992-12#1)(2008-5#3)(2012-2#1)
of basic##64##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#4)(1992-12#1)(1992-3#4)(1992-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
of basidiomycetes associated with wood decay##2##6##(2008-10#2)
of basolateral membranes##2##3##(1993-3#2)
of basolateral##5##2##(1993-3#2)(1993-6#1)(2008-11#1)(2008-8#1)
of basonuclin protein##2##3##(2008-9#2)
of basonuclin##4##2##(2008-9#4)
of basophilic##2##2##(2008-11#1)(2008-3#1)
of basophils##2##2##(2008-11#2)
of bat##3##2##(2009-8#1)(2013-1#2)
of batch culture##3##3##(1994-8#1)(2008-11#2)
of batch cultures##4##3##(1994-5#1)(2008-11#3)
of batch##15##2##(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-6#2)(2010-8#1)(2011-2#1)
of bats##7##2##(1994-11#2)(2009-8#1)(2013-1#4)
of battered women in##2##4##(2009-5#1)(2010-3#1)
of battered##5##2##(1995-5#3)(2009-5#1)(2010-3#1)
of batteries##2##2##(2008-10#1)(2008-7#1)
of bcl-2 and bag-1##3##4##(2008-11#3)
of bcl-2 expression on##2##4##(2008-11#1)(2008-7#1)
of bcl-2 expression##3##3##(2008-11#2)(2008-7#1)
of bcl-2 in##2##3##(2008-11#2)
of bcl-2 over-expression##2##3##(2008-11#2)
of bcl-2##20##2##(1993-3#1)(1993-9#2)(1994-10#3)(2008-10#1)(2008-11#12)(2008-7#1)
of bead##2##2##(2008-10#1)(2012-2#1)
of beads##9##2##(1997-2#3)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
of beam misalignment##2##3##(2008-3#2)
of beam propagation##3##3##(2008-2#1)(2008-3#2)
of beam##29##2##(1994-8#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#17)(2012-1#1)
of beam-shape coefficients##3##3##(2008-2#1)(2008-3#2)
of beam-splitter##2##2##(2008-3#2)
of beams##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
of bean samples##2##3##(2008-10#2)
of bean##13##2##(1992-8#1)(2008-10#12)
of beat frequencies##3##3##(2008-3#3)
of beat##4##2##(2007-12#1)(2008-3#3)
of beauty##2##2##(2008-5#1)(2010-8#1)
of beclomethasone dipropionate##2##3##(1990-9#1)(2008-10#1)
of beclomethasone##3##2##(1990-9#2)(2008-10#1)
of becoming##6##2##(1996-2#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)
of bed use in##2##4##(1995-2#2)
of bed##5##2##(1990-12#1)(1993-11#1)(1995-2#2)(2010-4#1)
of beds##5##2##(1991-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(1997-4#1)
of bee##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
of beef patties##3##3##(2010-4#3)
of beef quality##2##3##(2010-4#2)
of beef##13##2##(2008-10#1)(2010-4#10)(2013-1#2)
of beer with##2##3##(2008-10#2)
of beer##11##2##(1991-5#1)(2008-10#9)(2012-2#1)
of beers##3##2##(2008-10#3)
of beet necrotic yellow vein virus##2##6##(2008-10#2)
of beet##4##2##(2008-10#4)
of beetles##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
of begomovirus##4##2##(2008-10#4)
of begomoviruses in clarified plant extracts##2##6##(2008-10#2)
of begomoviruses##6##2##(2008-10#6)
of behavior and##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
of behavior are##2##3##(1990-8#1)(2008-8#1)
of behavior change##3##3##(1993-12#1)(1994-12#1)(2013-1#1)
of behavior generation##2##3##(2008-11#2)
of behavior that##2##3##(2007-11#1)(2008-4#1)
of behavior therapy##2##3##(2013-1#2)
of behavior##37##2##(1990-12#1)(1990-8#1)(1992-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#6)(2008-4#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#4)(2013-8#1)
of behavioral change##2##3##(1991-3#1)(2008-11#1)
of behavioral deficits##2##3##(1991-2#1)(1993-12#1)
of behavioral health care##2##4##(1995-1#2)
of behavioral health##3##3##(1991-3#1)(1995-1#2)
of behavioral supersensitivity##2##3##(1993-12#2)
of behavioral tasks##2##3##(1993-5#1)(1997-2#1)
of behavioral##42##2##(1991-1#1)(1991-2#1)(1991-3#2)(1993-12#3)(1993-5#1)(1994-3#1)(1995-1#2)(1995-5#1)(1996-12#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-7#1)(2013-8#2)
of behaviors##6##2##(1992-11#2)(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#1)
of behaviour##6##2##(1990-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-5#1)(2007-2#1)
of behavioural changes##2##3##(1990-3#1)(2007-7#1)
of behavioural deficits##2##3##(1991-2#1)(1997-2#1)
of behavioural##13##2##(1990-3#1)(1991-2#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#2)
of being a##14##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
of being able to##2##4##(2008-7#1)(2010-8#1)
of being an##2##3##(2008-10#1)(2011-2#1)
of being assisted##2##3##(2009-6#1)(2011-1#1)
of being highly##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
of being in##3##3##(1996-7#1)(2008-11#1)(2010-10#1)
of being infected##2##3##(2007-6#1)(2008-8#1)
of being overweight##3##3##(2007-12#1)(2010-7#1)(2013-1#1)
of being##92##2##(1990-6#1)(1991-3#1)(1991-6#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-12#4)(2007-6#2)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#5)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
of beliefs##3##2##(1994-2#1)(1996-12#1)(2007-6#1)
of bell##2##2##(2008-10#2)
of belonging##3##2##(2010-4#2)(2012-12#1)
of below 1##2##3##(2008-10#1)(2008-6#1)
of below##4##2##(1993-12#1)(2008-10#2)(2008-6#1)
of belt##2##2##(1993-3#1)(2008-7#1)
of benchmark##2##2##(2008-5#1)(2013-1#1)
of benchmarking##3##2##(1994-12#1)(1995-3#1)(1996-3#1)
of bending of##2##3##(1991-7#1)(1996-12#1)
of bending##7##2##(1991-7#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-3#3)
of bends##3##2##(2009-11#3)
of beneficence##4##2##(1991-2#1)(1992-3#1)(1995-9#1)(2008-1#1)
of beneficial##6##2##(1996-9#1)(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
of beneficiaries##4##2##(1994-12#1)(1997-2#1)(1997-3#2)
of benefit to##3##3##(1992-3#2)(2007-2#1)
of benefit##13##2##(1991-3#1)(1992-11#1)(1992-3#2)(1997-1#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-6#1)(2012-2#1)
of benefits and##3##3##(1992-3#1)(2008-8#1)(2013-1#1)
of benefits for the##2##4##(1995-12#1)(2010-8#1)
of benefits##13##2##(1990-2#1)(1991-3#1)(1992-3#1)(1995-12#1)(1996-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#2)
of benfluorex##3##2##(1995-11#3)
of benign and malignant liver##2##5##(2008-11#1)(2008-7#1)
of benign and malignant##9##4##(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#3)
of benign and##10##3##(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#3)
of benign##35##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-4#1)(1994-11#1)(1994-5#1)(1994-9#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)
of bent##6##2##(1997-6#1)(2008-3#4)(2009-11#1)
of benthic organisms##2##3##(2008-5#2)
of benthic##9##2##(2007-5#1)(2008-5#6)(2008-9#1)(2012-1#1)
of benzene and other gases##2##5##(2008-2#2)
of benzene and##4##3##(2008-10#1)(2008-2#3)
of benzene in##2##3##(1993-11#1)(2008-10#1)
of benzene##20##2##(1990-8#1)(1993-11#1)(2007-11#1)(2008-10#11)(2008-2#3)(2008-3#2)(2010-11#1)
of benzenoid hydrocarbons##2##3##(2007-11#2)
of benzidine##2##2##(2008-10#2)
of benzimidazole##2##2##(2008-10#2)
of benziodarone##3##2##(1990-11#3)
of benzo(a)pyrene##4##2##(1993-8#1)(2008-11#1)(2008-4#1)(2010-5#1)
of benzo-18-crown-6 (B18C6)##2##3##(2008-10#2)
of benzo[a]fluoranthene##2##2##(1990-7#2)
of benzo[a]pyrene##11##2##(1992-2#1)(1994-6#2)(1994-8#1)(2008-10#6)(2011-1#1)
of benzodiazepine binding##2##3##(1995-11#1)(1995-12#1)
of benzodiazepine receptor##2##3##(1992-3#1)(1995-12#1)
of benzodiazepine receptors by##2##4##(1996-2#2)
of benzodiazepine receptors##5##3##(1993-12#1)(1996-2#4)
of benzodiazepine##13##2##(1991-12#1)(1992-3#1)(1993-12#1)(1995-11#2)(1995-12#2)(1996-2#4)(1996-9#1)(2008-10#1)
of benzodiazepine-like##2##2##(1991-12#2)
of benzodiazepines in the treatment of anxiety##2##7##(2009-9#2)
of benzodiazepines##8##2##(1991-1#1)(1994-2#1)(1995-12#1)(1996-9#2)(2008-10#1)(2009-9#2)
of benzoic acid##3##3##(2008-10#3)
of benzoic acids##2##3##(2008-10#2)
of benzoic##6##2##(1990-8#1)(2008-10#5)
of benzophenone##2##2##(2008-10#1)(2010-4#1)
of benzophenone-3##3##2##(2008-3#2)(2008-5#1)
of benzotriazole##2##2##(2013-1#2)
of benzoyl peroxide##4##3##(2008-10#4)
of benzoyl##6##2##(2008-10#6)
of benzoylurea insecticides##2##3##(2008-10#2)
of benzyl alcohol##2##3##(2008-10#2)
of benzyl##4##2##(2008-10#3)(2010-2#1)
of benzylpenicillin##2##2##(1992-12#1)(2011-1#1)
of berbamine##2##2##(1995-11#2)
of berberine##2##2##(2008-10#1)(2013-1#1)
of bereavement programs##3##3##(2007-11#3)
of bereavement##5##2##(2007-11#3)(2008-12#1)(2013-1#1)
of bermudagrass##4##2##(2008-10#4)
of berries##4##2##(2008-10#3)(2008-6#1)
of berry##5##2##(2008-10#5)
of beryllium from##3##3##(2008-10#3)
of beryllium in##3##3##(2008-10#3)
of beryllium using##2##3##(2008-10#2)
of beryllium##15##2##(2007-11#1)(2008-10#14)
of best practice##2##3##(2008-11#1)(2010-10#1)
of best##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#2)(2013-1#1)
of beta AP1-40##2##3##(1995-12#2)
of beta APP in##2##4##(1992-12#1)(1992-9#1)
of beta APP##7##3##(1991-10#1)(1992-12#4)(1992-8#1)(1992-9#1)
of beta P##2##3##(1991-9#2)
of beta and##3##3##(1994-11#1)(1995-5#1)(2008-10#1)
of beta cells##2##3##(1994-8#1)(2008-11#1)
of beta##47##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-10#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#4)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2013-8#1)
of beta(2a)##4##2##(2008-8#4)
of beta(nuc)##2##2##(2009-8#2)
of beta- and gamma-CD##2##4##(1996-5#2)
of beta- and gamma-peptides##2##4##(2006-12#2)
of beta- and##4##3##(1996-5#2)(2006-12#2)
of beta-##5##2##(1994-5#1)(1996-5#2)(2006-12#2)
of beta-1##12##2##(1997-6#1)(2008-10#11)
of beta-APP##3##2##(1993-8#3)
of beta-CD and##3##3##(2008-10#1)(2008-11#2)
of beta-CD##15##2##(1994-3#2)(2008-10#9)(2008-11#2)(2008-6#1)(2011-1#1)
of beta-actin mRNA was##2##4##(1995-12#1)(2008-8#1)
of beta-actin mRNA##3##3##(1995-12#2)(2008-8#1)
of beta-actin##4##2##(1995-12#3)(2008-8#1)
of beta-adrenergic##5##2##(1994-6#1)(1995-2#1)(1997-6#1)(2008-3#2)
of beta-adrenoceptors##3##2##(1995-11#1)(1997-2#1)(2008-9#1)
of beta-amylase##2##2##(2008-9#2)
of beta-amyloid precursor protein##7##4##(1992-12#1)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#1)
of beta-amyloid protein precursor##2##4##(1992-6#2)
of beta-amyloid protein##6##3##(1992-6#2)(2008-7#2)(2008-8#2)
of beta-amyloid##18##2##(1991-10#1)(1992-12#2)(1992-6#3)(1992-8#2)(1993-8#2)(1994-5#2)(1995-5#2)(2008-7#2)(2008-8#2)
of beta-blocker##3##2##(2008-10#1)(2008-3#2)
of beta-blockers##4##2##(1995-6#2)(2008-10#1)(2008-3#1)
of beta-carotene##5##2##(1992-9#1)(2008-10#1)(2008-7#1)(2009-6#2)
of beta-casein gene##2##3##(2008-8#2)
of beta-catenin##3##2##(1994-11#1)(2008-11#1)(2009-8#1)
of beta-cell function and insulin sensitivity##3##6##(1994-12#3)
of beta-cell function##5##3##(1994-12#4)(2009-3#1)
of beta-cell##9##2##(1993-5#1)(1994-12#5)(2009-3#3)
of beta-cells##4##2##(1996-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
of beta-core##2##2##(1996-12#2)
of beta-cyclodextrin (beta-CD)##3##3##(2008-10#3)
of beta-cyclodextrin and its##2##4##(2008-10#1)(2008-11#1)
of beta-cyclodextrin and##3##3##(2008-10#2)(2008-11#1)
of beta-cyclodextrin##10##2##(1996-5#1)(2008-10#7)(2008-11#1)(2008-6#1)
of beta-endorphin in##3##3##(1990-12#2)(1993-5#1)
of beta-endorphin##9##2##(1990-12#3)(1991-5#2)(1993-5#1)(1994-2#1)(1994-9#2)
of beta-galactosidase (beta##2##3##(1991-5#1)(1997-4#1)
of beta-galactosidase and##2##3##(1993-8#1)(1994-12#1)
of beta-galactosidase by recombinant##2##4##(1997-8#2)
of beta-galactosidase by##3##3##(1997-8#2)(2008-11#1)
of beta-galactosidase##18##2##(1990-5#3)(1991-5#1)(1992-12#3)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-8#2)(2008-11#2)(2008-7#1)(2008-8#1)
of beta-globin##2##2##(1993-3#1)(2008-11#1)
of beta-glucuronidase##3##2##(1996-12#1)(2008-4#1)(2008-9#1)
of beta-keratins##2##2##(2011-2#2)
of beta-l##2##2##(2008-11#2)
of beta-lactam antibiotics##4##3##(1990-11#1)(1994-8#1)(1995-3#1)(2010-6#1)
of beta-lactam##6##2##(1990-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-7#1)(2010-6#1)
of beta-lactamase##2##2##(1997-3#1)(2010-6#1)
of beta-lactamases was##2##3##(2008-12#2)
of beta-lactamases##3##2##(2008-12#3)
of beta-lactoglobulin##4##2##(1995-5#2)(1997-2#1)(2008-11#1)
of beta-mercaptoethanol##2##2##(1991-2#1)(2008-10#1)
of beta-sheet##2##2##(1996-2#1)(2008-10#1)
of beta-thalassemia##3##2##(1993-3#3)
of beta-thromboglobulin##2##2##(1990-12#1)(2010-3#1)
of beta-tubulin##2##2##(1995-5#2)
of beta-turn##2##2##(1995-12#1)(2008-9#1)
of beta2-M in the##3##4##(2007-7#3)
of beta2-M##4##2##(2007-7#4)
of beta2m##4##2##(1997-9#4)
of beta3 integrin##3##3##(2009-9#3)
of betaAP##3##2##(2008-7#3)
of betablockers##3##2##(2008-10#2)(2012-3#1)
of betagamma-crystallin##2##2##(2009-7#2)
of betahistine##2##2##(2008-2#2)
of betel nut use among##2##5##(2008-1#2)
of betel nut##3##3##(2008-1#3)
of better than 0##5##4##(1992-7#1)(2008-10#3)(2008-3#1)
of better than 1##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
of better than 50##2##4##(2007-11#1)(2008-3#1)
of better than##27##3##(1992-7#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-2#5)(2008-3#9)(2012-3#1)
of better##43##2##(1992-1#1)(1992-7#1)(1994-2#1)(1996-3#1)(1996-4#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-10#8)(2008-2#5)(2008-3#9)(2008-5#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
of betulinic acid##2##3##(2008-10#2)
of between 1##2##3##(1992-11#1)(1994-8#1)
of between and on row##2##5##(2008-12#2)
of between##19##2##(1991-11#1)(1992-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)
of bevacizumab##4##2##(2008-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
of bi-##2##2##(1994-5#1)(2013-1#1)
of bi-CoPc##2##2##(2008-10#2)
of bias and##2##3##(1995-2#1)(2009-11#1)
of bias caused by##2##4##(1994-11#1)(2008-8#1)
of bias errors##2##3##(2008-10#2)
of bias in the##3##4##(1996-3#1)(2008-10#2)
of bias##21##2##(1992-6#1)(1992-9#1)(1994-11#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
of biased##4##2##(1996-6#1)(2008-7#1)(2009-9#1)(2012-2#1)
of biases##2##2##(2008-12#1)(2009-5#1)
of biaxial##2##2##(2007-11#1)(2008-3#1)
of bibliographic instruction##2##3##(1995-3#2)
of bicarbonate##3##2##(1990-11#1)(1994-3#1)(1995-2#1)
of biceps##2##2##(2008-9#1)(2010-8#1)
of bicuculline##7##2##(1993-12#2)(1993-3#1)(1996-5#3)(2008-7#1)
of bicycle##2##2##(1992-4#1)(2007-3#1)
of bidirectional##6##2##(1994-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)
of bifunctional chelators##2##3##(2012-3#2)
of bifunctional##3##2##(2012-3#3)
of big ET##2##3##(1990-2#2)
of big ET-1(1-39)##2##3##(1990-12#2)
of big##7##2##(1990-12#2)(1990-2#2)(1994-12#1)(2006-7#1)(2010-8#1)
of bilateral breast##2##3##(1994-12#1)(2007-5#1)
of bilateral retinal vasculitis##2##4##(2011-1#2)
of bilateral simultaneous##2##3##(2008-7#1)(2012-2#1)
of bilateral##41##2##(1990-5#1)(1994-12#1)(1994-3#1)(1997-6#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
of bilayer##4##2##(1992-5#1)(1993-8#1)(2008-10#1)(2008-8#1)
of bilayers##5##2##(1992-5#3)(2008-10#1)(2008-7#1)
of bile acids in##3##4##(1992-9#1)(1993-2#1)(2008-4#1)
of bile acids into##2##4##(1992-3#2)
of bile acids##9##3##(1992-3#2)(1992-9#1)(1993-2#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
of bile duct##4##3##(1995-11#1)(2008-2#1)(2010-12#2)
of bile flow##2##3##(1996-12#1)(2008-5#1)
of bile##26##2##(1990-8#1)(1991-3#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1994-12#1)(1995-11#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-12#2)(2012-2#2)(2013-1#1)
of biliary atresia##2##3##(2013-1#2)
of biliary##12##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of bilingual##2##2##(2010-8#1)(2011-2#1)
of bilirubin from##2##3##(1992-3#2)
of bilirubin toxicity##2##3##(1993-12#2)
of bilirubin were##2##3##(2008-10#1)(2008-5#1)
of bilirubin with##2##3##(2008-10#1)(2008-5#1)
of bilirubin##22##2##(1992-3#5)(1992-4#3)(1993-12#3)(2008-10#6)(2008-11#1)(2008-5#4)
of biliverdin to BSA##2##4##(2008-10#2)
of binary and ternary mixtures##4##5##(2008-10#4)
of binary and ternary##7##4##(1994-3#1)(2008-10#6)
of binary data##2##3##(2007-12#1)(2008-10#1)
of binary mixtures of##6##4##(2008-10#6)
of binary mixtures##9##3##(2008-10#9)
of binary##33##2##(1990-7#1)(1993-9#1)(1994-3#1)(2006-4#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#5)(2013-8#1)
of binary-phase##4##2##(2007-12#3)(2008-3#1)
of binding and interaction##2##4##(1992-6#2)
of binding and##4##3##(1990-8#1)(1992-6#2)(2008-10#1)
of binding events in##2##4##(2008-4#1)(2009-2#1)
of binding is##2##3##(2007-11#1)(2008-10#1)
of binding may##2##3##(1995-11#1)(1995-3#1)
of binding of the##3##4##(1991-12#1)(1994-11#1)(2009-2#1)
of binding of##9##3##(1990-11#2)(1991-12#1)(1993-1#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(2009-2#1)
of binding parameters##5##3##(2008-10#5)
of binding sites for##4##4##(1990-8#1)(1991-5#1)(1993-9#1)(2008-4#1)
of binding sites in##2##4##(1994-3#1)(2008-10#1)
of binding sites with a##3##5##(1990-2#1)(1990-8#1)(1993-12#1)
of binding sites##20##3##(1990-12#1)(1990-2#1)(1990-8#2)(1991-5#1)(1992-3#2)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)
of binding to the##4##4##(1990-5#1)(1992-3#1)(2008-6#1)(2011-1#1)
of binding to##12##3##(1990-5#1)(1991-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-6#1)(2011-1#1)
of binding was##2##3##(1993-8#1)(1996-5#1)
of binding with##2##3##(1990-6#1)(1994-3#1)
of binding##94##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-12#2)(1991-5#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#5)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-10#15)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#2)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-7#1)
of binge eating in##2##4##(2007-7#2)
of binge eating##5##3##(2007-7#3)(2008-4#2)
of binge##6##2##(2007-7#3)(2008-4#2)(2011-2#1)
of bingeing##2##2##(2007-7#1)(2008-4#1)
of binocular##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
of binucleate Rhizoctonia spp##5##4##(2008-10#5)
of binucleate Rhizoctonia##9##3##(2008-10#8)(2008-12#1)
of bio-molecules##2##2##(2008-10#1)(2009-12#1)
of bioaccumulation##3##2##(2008-11#1)(2008-12#2)
of bioactivation and covalent binding of##2##6##(1995-6#2)
of bioactive amines in##2##4##(2008-10#2)
of bioactive and##2##3##(2010-12#1)(2012-12#1)
of bioactive compounds from##2##4##(2008-10#2)
of bioactive compounds##4##3##(2008-10#3)(2011-1#1)
of bioactive glass##2##3##(2007-12#1)(2009-7#1)
of bioactive##22##2##(1992-8#1)(1995-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#3)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#2)
of bioactivity##2##2##(2008-5#2)
of bioadditives##2##2##(2013-1#2)
of bioanalytical applications##2##3##(2008-10#1)(2010-11#1)
of bioanalytical##4##2##(2008-10#2)(2010-11#2)
of bioartificial liver##2##3##(2008-11#1)(2010-12#1)
of bioavailable##2##2##(1990-11#1)(2008-5#1)
of biocatalysis##3##2##(2008-7#1)(2011-1#2)
of biocatalyst##3##2##(1991-5#1)(2008-7#1)(2011-2#1)
of biocatalysts##2##2##(2008-10#1)(2013-1#1)
of biochemical and##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
of biochemical markers of##2##4##(1994-2#1)(2007-11#1)
of biochemical parameters##3##3##(1993-11#1)(1994-7#1)(2012-2#1)
of biochemical pathways##3##3##(1997-6#1)(2008-7#1)(2008-9#1)
of biochemical reactions##2##3##(2008-4#1)(2008-5#1)
of biochemical##35##2##(1990-5#1)(1990-8#1)(1993-11#1)(1994-2#1)(1994-7#1)(1995-3#1)(1996-12#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-10#1)(2012-2#2)(2012-3#1)
of biochemistry##2##2##(1994-12#2)
of biochips##2##2##(2008-7#1)(2009-12#1)
of biocide action##2##3##(2008-7#2)
of biocides in the##2##4##(2008-3#2)
of biocides##4##2##(2008-3#4)
of biocompatible##2##2##(2008-7#1)(2011-2#1)
of biocontrol agents for fire blight##2##6##(2008-10#2)
of biocontrol agents##3##3##(2008-10#3)
of biocontrol in##2##3##(2008-10#2)
of biocontrol of##3##3##(2008-10#3)
of biocontrol pseudomonads##2##3##(2008-10#2)
of biocontrol strains##2##3##(2008-10#2)
of biocontrol yeasts##2##3##(2008-10#2)
of biocontrol##19##2##(2008-10#19)
of biodegradability##2##2##(2007-11#2)
of biodegradable##6##2##(1993-1#1)(2008-6#2)(2010-10#2)(2013-1#1)
of biodiversity and##2##3##(2009-8#1)(2013-7#1)
of biodiversity##4##2##(2008-8#1)(2008-9#1)(2009-8#1)(2013-7#1)
of bioequivalence##3##2##(1992-9#1)(2008-8#1)(2012-3#1)
of biofilm culture##2##3##(2008-9#2)
of biofilm formation##5##3##(2008-9#2)(2011-2#1)(2013-8#2)
of biofilm##15##2##(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2011-2#1)(2013-8#4)
of biofilms in##2##3##(2008-5#1)(2011-2#1)
of biofilms##7##2##(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-7#1)
of biogenic amine##2##3##(2008-10#1)(2008-7#1)
of biogenic amine-related enzymes##3##4##(1991-5#3)
of biogenic amines in##2##4##(2008-10#1)(2008-7#1)
of biogenic amines with##2##4##(1991-5#1)(2008-10#1)
of biogenic amines##8##3##(1991-5#2)(2008-10#4)(2008-4#1)(2008-7#1)
of biogenic##13##2##(1991-5#5)(2008-10#5)(2008-4#1)(2008-7#2)
of bioinformatics and##2##3##(2007-12#1)(2008-7#1)
of bioinformatics applications##2##3##(2008-7#2)
of bioinformatics##10##2##(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-9#1)(2010-11#1)(2013-8#1)
of biologic##12##2##(1991-3#1)(1997-1#1)(2007-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of biological activities##6##3##(1990-4#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)
of biological activity of##4##4##(2008-12#2)(2008-7#1)(2011-3#1)
of biological activity##9##3##(1990-12#1)(1990-5#1)(1995-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-3#1)
of biological and##7##3##(1991-6#1)(2008-10#4)(2008-12#1)(2010-11#1)
of biological applications##2##3##(2008-11#2)
of biological control by##2##4##(2008-10#2)
of biological control in##2##4##(2008-10#2)
of biological control of##3##4##(2008-10#3)
of biological control##19##3##(2008-10#17)(2008-6#2)
of biological effects##3##3##(1995-12#1)(1995-8#1)(2012-3#1)
of biological functions##2##3##(1994-6#1)(2012-2#1)
of biological importance##2##3##(1991-5#1)(2008-9#1)
of biological macromolecules##3##3##(1997-6#1)(2008-10#2)
of biological markers##3##3##(1991-11#1)(2007-10#1)(2008-7#1)
of biological materials##4##3##(2008-10#3)(2008-9#1)
of biological membranes in##2##4##(2008-10#2)
of biological membranes##4##3##(1994-12#1)(1994-5#1)(2008-10#2)
of biological molecules##3##3##(2008-10#2)(2008-4#1)
of biological organization##2##3##(2008-1#1)(2008-8#1)
of biological origin##3##3##(2008-10#2)(2011-2#1)
of biological processes##10##3##(1991-5#1)(1995-11#1)(1996-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
of biological products##2##3##(2008-11#1)(2012-2#1)
of biological properties##3##3##(1997-6#1)(2012-12#1)(2012-3#1)
of biological responses##2##3##(2008-10#1)(2008-4#1)
of biological sample##2##3##(2008-3#1)(2009-12#1)
of biological samples using##2##4##(2008-4#1)(2009-12#1)
of biological samples##18##3##(1991-5#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#3)(2008-7#1)(2009-12#2)(2010-5#1)(2011-1#1)
of biological significance##3##3##(1991-12#1)(2008-9#1)(2009-12#1)
of biological species##2##3##(2008-10#1)(2010-2#1)
of biological specimens##2##3##(2008-9#1)(2010-5#1)
of biological systems##7##3##(2008-10#1)(2008-9#1)(2009-12#1)(2009-5#1)(2012-2#2)(2013-1#1)
of biological tissue##8##3##(2007-11#1)(2007-12#3)(2008-3#4)
of biological tissues and##2##4##(2008-3#1)(2008-9#1)
of biological tissues by##2##4##(2008-3#2)
of biological tissues##7##3##(2007-12#1)(2008-3#4)(2008-9#1)(2011-1#1)
of biological treatment##2##3##(1992-5#1)(2012-3#1)
of biological weapons##2##3##(1990-2#2)
of biological##214##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#3)(1991-6#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#49)(2008-11#9)(2008-12#3)(2008-3#16)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#12)(2009-12#5)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
of biologically active peptides##2##4##(1996-5#1)(2007-11#1)
of biologically active recombinant##2##4##(1990-8#1)(2010-5#1)
of biologically active##18##3##(1990-8#1)(1992-5#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-5#1)(1996-5#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)
of biologically derived##2##3##(2008-10#2)
of biologically##25##2##(1990-8#1)(1992-5#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-4#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#2)(2010-2#1)(2010-5#2)(2011-1#1)
of biologicals##3##2##(2008-11#1)(2008-8#1)(2010-11#1)
of biologics##2##2##(2008-6#1)(2010-10#1)
of biologists##2##2##(2008-8#1)(2012-12#1)
of biology##14##2##(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
of bioluminescence##2##2##(2007-12#1)(2008-10#1)
of bioluminescent bacteria##3##3##(1990-7#2)(2007-12#1)
of bioluminescent##4##2##(1990-7#2)(2007-12#1)(2008-10#1)
of biomarker studies##2##3##(2010-5#2)
of biomarker##6##2##(2008-11#1)(2008-7#1)(2010-5#4)
of biomarkers for##2##3##(2011-2#2)
of biomarkers in early##2##4##(2008-8#2)
of biomarkers in##4##3##(2008-8#3)(2010-5#1)
of biomarkers##11##2##(1997-4#1)(2007-10#1)(2008-10#1)(2008-8#4)(2010-5#1)(2011-2#2)(2013-1#1)
of biomass and ligninolytic enzymes by Pleurotus ostreatus##2##8##(2008-5#2)
of biomass and##4##3##(2008-5#3)(2008-7#1)
of biomass burning##2##3##(2008-11#1)(2008-3#1)
of biomass in the##2##4##(2008-7#1)(2008-9#1)
of biomass production##2##3##(2008-10#1)(2008-8#1)
of biomass##21##2##(2007-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
of biomaterials##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
of biomechanical##3##2##(2008-11#1)(2008-5#2)
of biomedical applications##3##3##(2009-12#1)(2010-12#1)(2010-5#1)
of biomedical devices##2##3##(2008-8#2)
of biomedical research##4##3##(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)
of biomedical##18##2##(1990-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)
of biomimetic##2##2##(2008-5#1)(2009-9#1)
of biomolecular##4##2##(2007-11#2)(2008-9#1)(2012-8#1)
of biomolecule##2##2##(2008-7#1)(2009-12#1)
of biomolecules and##3##3##(1997-6#1)(2008-5#1)(2010-7#1)
of biomolecules with##3##3##(1997-6#2)(2007-11#1)
of biomolecules##16##2##(1997-6#3)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-2#1)(2010-7#2)(2012-2#1)(2013-1#1)
of bionanocapsules##2##2##(2013-1#2)
of biopharmaceuticals in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of biopharmaceuticals##7##2##(2008-10#2)(2008-11#3)(2011-2#1)(2012-2#1)
of biopolymer##3##2##(2008-10#2)(2012-2#1)
of biopolymers##6##2##(1995-2#1)(1996-5#2)(2008-10#3)
of bioprocess##2##2##(2008-11#1)(2013-1#1)
of biopsies##5##2##(1990-11#1)(1991-2#1)(1996-12#1)(2008-1#1)(2013-8#1)
of biopsy specimens revealed##2##4##(1991-11#1)(2011-2#1)
of biopsy##10##2##(1991-11#1)(2007-12#1)(2008-1#3)(2011-2#1)(2012-2#1)(2013-7#3)
of bioreactors##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
of biorecognition##2##2##(2008-10#2)
of biosensing##2##2##(2008-10#1)(2009-5#1)
of biosensor##8##2##(1995-11#1)(2008-10#7)
of biosensors are##2##3##(2008-10#1)(2009-11#1)
of biosensors based on##2##4##(2008-10#2)
of biosensors for##2##3##(2008-10#2)
of biosensors##15##2##(2008-10#13)(2009-11#1)(2010-5#1)
of biosorbent##2##2##(2008-12#2)
of biosorption##2##2##(2008-10#2)
of biosurfactant##3##2##(2008-6#3)
of biosynthetic##4##2##(1993-1#1)(1993-12#1)(2008-7#1)(2009-5#1)
of biotechnological##2##2##(2008-11#2)
of biotechnology##8##2##(1990-2#1)(1990-7#1)(1994-12#1)(2008-11#4)(2008-7#1)
of biotherapeutic##2##2##(2008-10#2)
of biotherapeutics in clinical##2##4##(2008-10#2)
of biotherapeutics##5##2##(2008-10#5)
of biotic and abiotic##3##4##(2008-6#1)(2010-10#2)
of biotic##4##2##(2008-11#1)(2008-6#1)(2010-10#2)
of biotin to##3##3##(1995-11#1)(2008-10#2)
of biotin transport##4##3##(1992-6#4)
of biotin##14##2##(1990-12#1)(1992-6#7)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(2008-10#2)
of biotinylated ligands##2##3##(2008-10#2)
of biotinylated##10##2##(1994-5#1)(1996-5#2)(2008-1#1)(2008-10#5)(2008-11#1)
of biotransformation##3##2##(1994-6#1)(2008-10#2)
of biotrophic##3##2##(2008-10#2)(2009-6#1)
of bipolar affective##2##3##(1996-7#1)(2013-7#1)
of bipolar disorder##5##3##(2008-8#1)(2010-6#1)(2010-7#3)
of bipolar prosthesis##2##3##(2007-8#2)
of bipolar##14##2##(1992-12#1)(1996-7#1)(1997-5#2)(2007-8#2)(2008-8#1)(2010-6#1)(2010-7#3)(2011-1#2)(2013-7#1)
of bipolarity##2##2##(2009-10#2)
of biporous##2##2##(2008-10#2)
of birch##5##2##(2008-11#3)(2012-5#2)
of bird##4##2##(2008-6#1)(2010-1#1)(2010-9#1)(2013-8#1)
of birds and##2##3##(2008-5#1)(2010-3#1)
of birds##23##2##(1991-6#1)(1994-3#1)(1997-3#1)(1997-4#1)(1997-6#4)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#3)(2009-2#1)(2010-3#1)(2010-5#1)(2012-3#2)
of birefringence and##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of birefringence correlation length##2##4##(2007-11#2)
of birefringence in##2##3##(2007-11#2)
of birefringence on##2##3##(2008-3#2)
of birefringence##21##2##(2007-11#7)(2007-12#2)(2008-2#3)(2008-3#9)
of birefringent##2##2##(2007-12#1)(2008-3#1)
of birth and##6##3##(1990-9#2)(1992-8#1)(2012-3#1)(2013-1#2)
of birth control in##2##4##(1994-3#1)(1996-8#1)
of birth control##5##3##(1994-3#1)(1994-9#1)(1996-8#2)(2008-7#1)
of birth defects##3##3##(2010-1#1)(2012-12#2)
of birth##32##2##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-8#2)(1997-7#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
of births##6##2##(1990-12#1)(1990-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
of bis(2##2##2##(2008-10#2)
of bismuth in biological##2##4##(2008-10#2)
of bismuth in water samples##2##5##(2008-10#2)
of bismuth in water##3##4##(2008-10#3)
of bismuth in##12##3##(2008-10#12)
of bismuth was investigated##2##4##(2008-10#2)
of bismuth##33##2##(2007-11#1)(2008-10#31)(2009-11#1)
of bismuth(III)##4##2##(2008-10#4)
of bisphenol A (BPA) in##2##5##(2008-10#1)(2009-8#1)
of bisphenol A and##2##4##(2008-10#1)(2010-5#1)
of bisphenol A##8##3##(2008-10#4)(2009-8#2)(2010-12#1)(2010-5#1)
of bisphenol S in paper by##2##6##(2013-1#2)
of bisphenol S in##3##4##(2013-1#3)
of bisphenol S##4##3##(2013-1#4)
of bisphenol##13##2##(2008-10#4)(2008-4#1)(2009-8#2)(2010-12#1)(2010-5#1)(2013-1#4)
of bisphosphonate therapy on##2##4##(2007-11#2)
of bisphosphonate therapy##3##3##(2007-11#2)(2008-7#1)
of bisphosphonate##5##2##(1993-11#1)(2007-11#2)(2008-11#1)(2008-7#1)
of bisphosphonates for the management of##2##6##(2008-7#2)
of bisphosphonates in the prevention##2##5##(1993-11#2)
of bisphosphonates in##3##3##(1993-11#2)(2010-4#1)
of bisphosphonates##8##2##(1993-11#2)(2007-11#1)(2008-7#3)(2010-3#1)(2010-4#1)
of bistable##2##2##(2008-3#1)(2008-7#1)
of bivalent##3##2##(1990-7#1)(2008-10#1)(2013-1#1)
of bivariate##2##2##(1997-4#1)(2009-4#1)
of black carbon##3##3##(2008-3#3)
of black fathers##3##3##(2010-3#3)
of black patients##2##3##(1993-9#1)(1995-12#1)
of black porgy in##2##4##(2008-7#2)
of black tea##6##3##(2008-10#1)(2009-8#5)
of black tooth stains##2##4##(2013-1#2)
of black##30##2##(1993-9#1)(1995-12#1)(2008-10#8)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-8#5)(2009-9#1)(2010-3#3)(2012-3#1)(2013-1#3)
of bladder and##2##3##(1997-7#1)(2011-2#1)
of bladder cancer##6##3##(1991-8#1)(2007-10#1)(2009-4#1)(2011-2#1)(2013-8#2)
of bladder exstrophy in##2##4##(2008-10#2)
of bladder exstrophy##5##3##(2008-10#5)
of bladder mucosa##2##3##(2008-10#2)
of bladder preservation##2##3##(2008-10#1)(2008-11#1)
of bladder##41##2##(1991-11#1)(1991-8#1)(1992-11#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-7#3)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#7)(2013-8#2)
of blank##6##2##(2008-10#6)
of blast##5##2##(2008-10#5)
of blastocysts derived in##2##4##(2008-11#2)
of blastocysts was##2##3##(1996-8#1)(2008-9#1)
of blastocysts##5##2##(1996-8#1)(2008-11#3)(2008-9#1)
of bleeding and##3##3##(2007-7#1)(2007-8#1)(2012-2#1)
of bleeding from##2##3##(1991-6#1)(2010-8#1)
of bleeding in the##2##4##(1996-11#1)(2008-7#1)
of bleeding was not##2##4##(2008-1#1)(2008-7#1)
of bleeding##32##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-8#2)(1996-11#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-3#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-1#3)
of bleeds##2##2##(2009-3#2)
of blind##5##2##(1990-11#1)(2008-3#1)(2009-11#1)(2012-3#2)
of blinded##2##2##(2011-2#1)(2012-2#1)
of blister##3##2##(2008-10#2)(2008-11#1)
of block##5##2##(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
of blocking##5##2##(1990-2#1)(2007-12#1)(2008-7#1)(2010-4#1)(2012-12#1)
of blocks##3##2##(2008-4#1)(2008-9#1)(2012-3#1)
of blood absorption##3##3##(2007-11#3)
of blood alcohol concentration in##2##5##(2011-2#1)(2013-1#1)
of blood and blood products##2##5##(2007-9#1)(2008-12#1)
of blood and blood##3##4##(1993-11#1)(2007-9#1)(2008-12#1)
of blood and plasma##3##4##(2008-10#1)(2008-2#2)
of blood and##18##3##(1991-1#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
of blood banks##2##3##(1995-6#1)(2011-2#1)
of blood cells##3##3##(2008-10#1)(2009-11#1)(2010-8#1)
of blood coagulation##7##3##(1991-9#1)(1992-12#1)(1995-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
of blood collection##2##3##(2008-10#1)(2010-6#1)
of blood cultures were##2##4##(2011-2#2)
of blood cultures##5##3##(2007-12#1)(2010-12#1)(2010-6#1)(2011-2#2)
of blood donors##4##3##(1990-6#1)(1996-1#1)(2008-11#1)(2008-12#1)
of blood flow and##2##4##(1995-12#1)(2013-8#1)
of blood flow##12##3##(1995-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#2)(2010-3#1)(2011-1#1)(2013-1#3)(2013-8#1)
of blood from##2##3##(2008-10#1)(2008-4#1)
of blood glucose concentration##2##4##(2007-11#2)
of blood glucose control##2##4##(1990-8#1)(1991-2#1)
of blood glucose level##2##4##(2010-4#1)(2012-2#1)
of blood glucose levels##2##4##(2010-11#2)
of blood glucose##17##3##(1990-8#1)(1991-12#1)(1991-2#2)(1993-12#1)(2007-11#2)(2008-8#2)(2009-11#2)(2010-11#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
of blood group##4##3##(1992-12#2)(1993-1#1)(1993-12#1)
of blood in##3##3##(1991-3#1)(2008-1#1)(2008-3#1)
of blood levels##2##3##(1992-9#1)(1993-3#1)
of blood lipids##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
of blood loss##3##3##(1993-1#1)(1994-3#1)(1994-9#1)
of blood parameters##2##3##(2008-12#2)
of blood pressure (BP) and heart rate (HR)##2##8##(2008-11#2)
of blood pressure and##6##4##(1990-8#1)(1994-6#1)(2008-1#1)(2008-8#1)(2012-12#1)(2012-3#1)
of blood pressure control##2##4##(2008-3#1)(2008-7#1)
of blood pressure in##3##4##(1997-8#1)(2008-10#1)(2010-7#1)
of blood pressure is##2##4##(1993-11#1)(2008-5#1)
of blood pressure##31##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-8#1)(2007-10#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
of blood samples##3##3##(1990-8#1)(1992-3#1)(2008-7#1)
of blood serum##3##3##(2008-7#1)(2013-1#2)
of blood sugar##2##3##(2008-1#1)(2008-4#1)
of blood supply##2##3##(2009-3#1)(2012-1#1)
of blood to##2##3##(1992-9#1)(1996-9#1)
of blood transfusion##4##3##(2007-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
of blood transfusions##2##3##(2007-7#1)(2008-1#1)
of blood units##2##3##(2007-7#2)
of blood urea##2##3##(2008-10#1)(2012-2#1)
of blood vessels and##3##4##(2008-1#1)(2008-12#1)(2010-5#1)
of blood vessels is##3##4##(1993-9#1)(1994-9#1)(2010-1#1)
of blood vessels##16##3##(1993-9#1)(1994-9#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
of blood volume and##2##4##(2008-7#1)(2010-7#1)
of blood volume##3##3##(2006-10#1)(2008-7#1)(2010-7#1)
of blood##245##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#5)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-9#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-1#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#3)(2007-10#2)(2007-11#6)(2007-12#2)(2007-7#8)(2007-8#1)(2007-9#3)(2008-1#13)(2008-10#16)(2008-11#7)(2008-12#8)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#4)(2009-11#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#6)(2010-8#2)(2011-1#4)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#13)(2013-8#4)
of blood-borne##3##2##(2007-3#1)(2008-1#1)(2008-10#1)
of blood-brain barrier##2##3##(1997-2#1)(2008-4#1)
of bloom and##2##3##(2008-10#2)
of bloom##7##2##(2008-10#7)
of blossom blight##2##3##(2008-10#2)
of blossom##5##2##(2008-10#5)
of blossoms by##2##3##(2008-10#2)
of blossoms colonized by##2##4##(2008-10#2)
of blossoms##13##2##(2008-10#13)
of blue light##3##3##(2007-11#1)(2007-12#2)
of blue##14##2##(1991-11#1)(1994-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#2)(2010-1#1)(2010-8#1)
of blueberry##4##2##(2008-10#4)
of bluegill##2##2##(2008-10#1)(2010-8#1)
of bluetongue virus##2##3##(2010-4#2)
of bluetongue##3##2##(2008-8#1)(2010-4#2)
of blunt renal##2##3##(1990-9#2)
of blunt thoracic trauma##2##4##(2012-2#1)(2013-1#1)
of blunt##6##2##(1990-9#2)(1991-6#1)(2012-2#2)(2013-1#1)
of blurred##2##2##(2007-12#1)(2013-8#1)
of blushing##3##2##(2010-4#3)
of bmDCs##2##2##(2008-10#2)
of board##3##2##(1991-12#1)(1992-3#1)(1994-2#1)
of boards##2##2##(1992-3#1)(1996-1#1)
of bodies##5##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
of bodily pain##2##3##(2007-11#2)
of bodily##5##2##(1997-6#1)(2007-11#2)(2009-10#1)(2012-12#1)
of body and##2##3##(1996-5#1)(2012-2#1)
of body awareness##2##3##(2009-1#2)
of body composition and##2##4##(2011-2#1)(2012-2#1)
of body composition##5##3##(1990-5#1)(2007-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
of body condition##2##3##(1996-8#1)(2008-9#1)
of body dissatisfaction (BD)##2##4##(2007-12#2)
of body dissatisfaction in##2##4##(2007-12#2)
of body dissatisfaction##9##3##(2007-12#8)(2013-8#1)
of body fat distribution##3##4##(1990-9#1)(2008-3#1)(2010-6#1)
of body fat##10##3##(1990-9#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-6#1)
of body image concerns##2##4##(2007-12#2)
of body image##16##3##(2007-12#14)(2009-5#1)(2010-11#1)
of body mass index (BMI)##2##5##(2007-12#1)(2008-7#1)
of body mass index##4##4##(2007-12#1)(2008-7#1)(2008-9#1)(2009-2#1)
of body mass##7##3##(1995-2#2)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)
of body of##2##3##(2010-5#1)(2012-12#1)
of body size evolution in##2##5##(2012-3#2)
of body size on##2##4##(2008-8#1)(2008-9#1)
of body size##7##3##(2007-12#2)(2008-8#1)(2008-9#1)(2012-3#2)(2013-7#1)
of body surface##3##3##(1990-6#1)(2009-3#1)(2011-3#1)
of body temperature on##2##4##(2008-7#1)(2013-7#1)
of body temperature##5##3##(1992-2#1)(2007-8#1)(2008-7#1)(2013-7#2)
of body weight and##5##4##(1992-10#1)(2007-12#2)(2009-4#1)(2011-3#1)
of body weight##18##3##(1990-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1995-3#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-5#1)(2009-4#2)(2009-7#1)(2011-2#1)(2011-3#2)(2013-1#2)
of body##112##2##(1990-5#1)(1990-6#1)(1990-9#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-1#1)(1995-2#3)(1995-3#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#33)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#3)(2013-8#2)
of bohemine##2##2##(2008-11#2)
of bolesatine##2##2##(1995-11#2)
of bolus##2##2##(2007-9#1)(2008-7#1)
of bombarded microspores##2##3##(2008-5#2)
of bombesin##2##2##(1994-3#2)
of bombolitin III##2##3##(1994-5#2)
of bond##5##2##(1996-2#1)(2007-11#3)(2008-8#1)
of bonded glucose##2##3##(2008-10#2)
of bonded##4##2##(1990-8#1)(2008-10#3)
of bonding##2##2##(2008-10#1)(2008-5#1)
of bonds##2##2##(1994-5#1)(2008-1#1)
of bone and cartilage##2##4##(1990-11#1)(2013-7#1)
of bone and##8##3##(1990-11#1)(1991-5#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-3#1)(2013-7#1)
of bone cell##2##3##(2008-7#1)(2009-7#1)
of bone densitometry##2##3##(1997-6#2)
of bone density and##3##4##(1991-11#1)(2007-8#1)(2012-2#1)
of bone density##7##3##(1991-11#3)(1994-12#1)(2007-8#1)(2012-2#2)
of bone destruction##2##3##(1992-3#1)(2012-12#1)
of bone diameter##2##3##(2013-1#2)
of bone disease##2##3##(2008-4#2)
of bone formation and##3##4##(2008-11#1)(2008-7#1)(2010-9#1)
of bone formation##9##3##(1991-5#1)(1993-11#2)(1994-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-9#1)
of bone fractures##2##3##(2007-11#1)(2007-7#1)
of bone fragments##3##3##(2007-8#1)(2013-1#2)
of bone from##2##3##(1991-5#1)(1992-12#1)
of bone graft##2##3##(2007-12#1)(2013-1#1)
of bone grafting products##3##4##(2008-8#3)
of bone grafting##4##3##(2008-6#1)(2008-8#3)
of bone grafts##3##3##(2009-4#3)
of bone in the##5##4##(1990-12#2)(2007-12#1)(2008-7#1)(2011-1#1)
of bone in##9##3##(1990-12#2)(1990-6#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)
of bone involvement##2##3##(2008-4#1)(2010-6#1)
of bone lesions##2##3##(2008-6#2)
of bone loss##7##3##(1991-11#1)(1993-11#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#2)
of bone marrow aspirates##3##4##(2008-10#3)
of bone marrow derived##2##4##(2008-10#1)(2008-9#1)
of bone marrow stromal##2##4##(2008-11#1)(2011-1#1)
of bone marrow##15##3##(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)
of bone mass may##2##4##(1993-11#2)
of bone mass##8##3##(1991-11#1)(1993-11#6)(2011-2#1)
of bone matrix##2##3##(2008-11#1)(2008-4#1)
of bone metabolism##2##3##(1992-6#1)(2007-8#1)
of bone metastases to the##4##5##(2007-11#4)
of bone metastases to##6##4##(2007-11#6)
of bone metastases##25##3##(1991-8#2)(2007-11#19)(2008-1#1)(2008-7#2)(2011-2#1)
of bone metastasis##4##3##(1994-12#2)(2010-10#1)(2011-2#1)
of bone mineral density##5##4##(1996-8#2)(2011-2#2)(2012-12#1)
of bone mineral mass##2##4##(2008-4#2)
of bone mineral##10##3##(1990-11#1)(1994-9#1)(1996-8#2)(2008-4#2)(2011-2#3)(2012-12#1)
of bone morphogenetic proteins##3##4##(1991-5#1)(2011-2#1)(2012-12#1)
of bone morphogenetic##5##3##(1991-5#1)(2011-2#3)(2012-12#1)
of bone pain##3##3##(1991-11#1)(2008-10#1)(2008-7#1)
of bone remodeling##2##3##(1993-11#1)(2007-8#1)
of bone resorbing factors on##2##5##(1993-12#2)
of bone resorption##8##3##(1992-3#1)(1993-11#2)(1995-2#1)(2007-11#1)(2008-10#1)(2013-1#2)
of bone scintigraphy in##2##4##(2007-11#1)(2008-7#1)
of bone scintigraphy##3##3##(2007-11#1)(2008-1#1)(2008-7#1)
of bone stock##2##3##(2007-11#2)
of bone tissue##7##3##(2007-11#2)(2007-8#4)(2008-5#1)
of bone tumours##2##3##(2007-8#1)(2008-6#1)
of bone tunnel##2##3##(2013-1#2)
of bone turnover##7##3##(1990-2#1)(1993-11#2)(1997-6#1)(2008-7#2)(2011-2#1)
of bone union##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
of bone##256##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#9)(1991-5#4)(1991-8#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#16)(1993-12#2)(1994-12#3)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-3#2)(1996-8#2)(1997-1#1)(1997-6#6)(2006-10#3)(2007-11#30)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#16)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#10)(2008-7#12)(2008-8#8)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-7#6)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#5)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#20)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#15)(2013-7#1)
of bone's##2##2##(2013-1#2)
of bone-anchored hearing aid##2##4##(2008-9#1)(2011-2#1)
of bones##9##2##(2007-11#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)
of bony##4##2##(1996-6#1)(2007-11#1)(2009-3#1)(2010-3#1)
of border cell and root tip exudates on##2##8##(2008-10#2)
of border cells##3##3##(2008-10#3)
of border##5##2##(2008-10#5)
of borderline statistical significance##3##4##(2008-11#2)(2008-4#1)
of borderline##7##2##(1990-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2011-1#1)
of boreal##2##2##(2008-9#2)
of boredom##2##2##(2008-1#2)
of boric acid as a##2##5##(2008-10#2)
of boron as boric acid in eye lotions##2##8##(2008-10#2)
of boron in water samples##2##5##(2008-10#2)
of boron in##10##3##(2008-10#10)
of boron neutron capture therapy##2##5##(1994-3#1)(1995-2#1)
of boron per##3##3##(1995-2#3)
of boron with##2##3##(2008-10#2)
of boron##34##2##(1990-3#1)(1994-3#1)(1995-2#5)(2007-11#1)(2008-10#24)(2008-5#1)(2012-2#1)
of boron)##2##2##(2008-10#2)
of boron-modified##2##2##(2008-5#2)
of borrelial##3##2##(2008-9#1)(2012-2#2)
of bortezomib##6##2##(2009-4#1)(2010-4#2)(2011-2#3)
of bosentan##3##2##(2009-10#2)(2010-10#1)
of botanicals##2##2##(2008-5#1)(2009-6#1)
of both 1##2##3##(1993-11#1)(2008-10#1)
of both 2##2##3##(1990-3#1)(2008-10#1)
of both 25 (OH) and 1##2##6##(2012-3#2)
of both HA and##2##4##(2008-10#1)(2009-7#1)
of both IgG and##2##4##(1994-2#1)(2008-7#1)
of both a##4##3##(2007-12#1)(2008-3#2)(2008-7#1)
of both active##3##3##(2008-10#2)(2013-8#1)
of both adrenal glands##2##4##(2013-1#2)
of both ages##2##3##(2013-7#2)
of both analytes in##5##4##(2008-10#5)
of both analytes##12##3##(2008-10#12)
of both anions##3##3##(2008-10#3)
of both anterior cerebral arteries##2##5##(2008-7#2)
of both approaches##3##3##(2008-10#2)(2011-2#1)
of both beneficial and harmful##2##5##(2008-10#1)(2013-8#1)
of both beneficial and##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
of both beta##3##3##(1991-5#1)(1993-12#2)
of both biocontrol##2##3##(2008-10#2)
of both cell lines##3##4##(1994-8#1)(1997-1#1)(2008-11#1)
of both cell types##2##4##(1997-4#1)(2008-11#1)
of both cell##5##3##(1994-8#1)(1997-1#1)(1997-4#1)(2008-11#2)
of both cells##2##3##(1993-8#1)(2008-9#1)
of both common carotid arteries##2##5##(2011-1#1)(2011-2#1)
of both common##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
of both composites##3##3##(2008-10#3)
of both compounds##5##3##(1992-2#1)(1992-8#1)(2008-10#3)
of both conditions##2##3##(2007-10#1)(2011-1#1)
of both cultivars##3##3##(2008-10#3)
of both diseases##3##3##(2008-10#1)(2013-8#2)
of both drugs##7##3##(1993-6#1)(1997-4#1)(2008-10#2)(2008-5#3)
of both enzymes##4##3##(1993-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
of both factors##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
of both female and male##2##5##(1990-3#1)(1994-2#1)
of both forms of##4##4##(1992-8#1)(2008-10#1)(2009-9#1)(2011-2#1)
of both free and##5##4##(1990-12#1)(1991-2#1)(2008-10#1)(2008-7#2)
of both fungi##3##3##(2008-10#3)
of both gene pools##3##4##(2008-10#3)
of both genes##4##3##(1991-6#1)(2008-10#2)(2012-2#1)
of both genetic and environmental##2##5##(2008-12#1)(2012-2#1)
of both genetic##4##3##(2008-12#1)(2008-3#1)(2010-10#1)(2012-2#1)
of both genotypes##2##3##(2008-10#2)
of both groups of##2##4##(2009-8#1)(2011-2#1)
of both groups was##2##4##(2007-11#1)(2013-7#1)
of both groups were##2##4##(2007-8#1)(2008-5#1)
of both groups##10##3##(1990-2#1)(2007-11#2)(2007-8#2)(2008-5#2)(2009-8#1)(2011-2#1)(2013-7#1)
of both hands and##3##4##(2007-7#1)(2010-6#1)(2012-3#1)
of both hands##4##3##(1996-8#1)(2007-7#1)(2010-6#1)(2012-3#1)
of both host##2##3##(2008-10#1)(2008-8#1)
of both human and##2##4##(2008-9#1)(2012-12#1)
of both imaging##2##3##(2008-3#1)(2012-2#1)
of both in##3##3##(1993-8#1)(2008-4#1)(2008-5#1)
of both insulin and##2##4##(2008-7#1)(2010-6#1)
of both insulin##3##3##(2008-1#1)(2008-7#1)(2010-6#1)
of both is a##2##4##(2012-12#2)
of both is##3##3##(2012-12#2)(2012-3#1)
of both its##2##3##(2008-8#1)(2011-1#1)
of both lesions##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
of both ligands##2##3##(1993-3#1)(1995-5#1)
of both light##2##3##(1993-9#1)(2008-2#1)
of both limbs##2##3##(2013-1#1)(2013-8#1)
of both lipid##2##3##(1991-9#1)(2012-3#1)
of both liver and##2##4##(1990-11#1)(1990-5#1)
of both liver##3##3##(1990-11#1)(1990-5#2)
of both local and##2##4##(2008-3#1)(2009-2#1)
of both local##3##3##(2008-3#1)(2008-6#1)(2009-2#1)
of both low and##2##4##(2008-10#1)(2008-7#1)
of both lower##2##3##(2012-12#1)(2012-2#1)
of both lungs##4##3##(2007-8#1)(2008-1#2)(2011-2#1)
of both mass spectrometry##2##4##(1997-2#1)(2008-7#1)
of both metals in##2##4##(2008-10#2)
of both metals##5##3##(2008-10#5)
of both methanol and##2##4##(2008-10#1)(2010-12#1)
of both methods in##2##4##(1993-8#1)(2008-10#1)
of both methods##14##3##(1993-8#1)(2007-8#1)(2008-10#7)(2008-3#2)(2011-2#1)(2012-3#2)
of both microvascular and##2##4##(2008-5#1)(2013-1#1)
of both models##2##3##(2008-10#1)(2008-7#1)
of both normal and##3##4##(1990-12#1)(1997-1#1)(2008-10#1)
of both normal##4##3##(1990-12#1)(1997-1#1)(2008-10#1)(2010-4#1)
of both of these##3##4##(2008-8#2)(2012-12#1)
of both of##5##3##(1992-3#1)(2008-8#2)(2012-12#1)(2013-1#1)
of both organic and##3##4##(2008-10#3)
of both organisms##2##3##(2008-10#1)(2012-2#1)
of both parental species##2##4##(2008-10#1)(2008-8#1)
of both parental##3##3##(2008-10#1)(2008-8#2)
of both pathogens##3##3##(2008-10#3)
of both patients and##2##4##(2009-12#1)(2009-5#1)
of both patients##5##3##(1991-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-1#1)
of both peaks##4##3##(1995-6#1)(2008-10#2)(2008-3#1)
of both platinum and palladium##2##5##(2008-10#2)
of both platinum##3##3##(2008-10#2)(2010-11#1)
of both polarized##2##3##(2007-11#1)(2008-2#1)
of both populations##2##3##(2008-8#1)(2013-8#1)
of both position and##2##4##(2007-12#1)(2013-1#1)
of both positive and negative##4##5##(1993-12#1)(1995-8#1)(2008-2#2)
of both procedures##2##3##(2008-1#1)(2008-10#1)
of both products of##2##4##(1991-3#1)(1993-12#1)
of both products##4##3##(1990-7#1)(1991-3#1)(1993-12#1)(2008-8#1)
of both protein##2##3##(1993-12#1)(1994-11#1)
of both proteins were##2##4##(1997-2#1)(2009-10#1)
of both proteins##5##3##(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#1)(2009-10#1)
of both rapidly##2##3##(1995-6#1)(2008-10#1)
of both risk##2##3##(2006-10#1)(2007-10#1)
of both sample##2##3##(2008-10#2)
of both scientific##2##3##(2008-10#1)(2012-2#1)
of both sexes between##2##4##(2006-10#1)(2011-1#1)
of both sexes##29##3##(1990-10#1)(1990-11#2)(1992-6#1)(1993-8#2)(1995-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-3#1)
of both size and##2##4##(1993-9#1)(2008-10#1)
of both skin##2##3##(2008-8#1)(2008-9#1)
of both sodium and##2##4##(1994-6#1)(2008-6#1)
of both solid and##2##4##(2008-2#1)(2013-1#1)
of both species in##4##4##(2008-10#2)(2008-8#1)(2012-8#1)
of both species were##4##4##(1991-8#1)(2008-10#2)(2010-8#1)
of both species##19##3##(1991-8#1)(1992-3#1)(1994-11#1)(2008-10#8)(2008-5#2)(2008-7#1)(2008-8#2)(2010-8#2)(2012-8#1)
of both strains and##2##4##(2008-10#1)(2008-11#1)
of both strains##7##3##(1994-3#1)(2008-10#4)(2008-11#1)(2013-1#1)
of both strands of##2##4##(1994-12#1)(1996-6#1)
of both studies##2##3##(2008-9#1)(2009-9#1)
of both subjective and##2##4##(2008-5#1)(2013-1#1)
of both substances##2##3##(2008-10#2)
of both subunits##3##3##(1996-2#2)(2008-7#1)
of both synthetic##2##3##(1990-5#1)(2008-10#1)
of both techniques##5##3##(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
of both temperature and##3##4##(1994-5#1)(2008-10#2)
of both the enzymes##2##4##(2008-10#1)(2011-1#1)
of both the gas##2##4##(2008-7#1)(2011-2#1)
of both the number of##3##5##(1997-7#1)(2008-10#1)(2008-3#1)
of both the protein##2##4##(2008-4#1)(2010-1#1)
of both the##127##3##(1990-11#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#4)(1992-9#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
of both their##2##3##(1990-2#1)(2008-10#1)
of both these##2##3##(1997-6#1)(2008-5#1)
of both type##2##3##(2008-10#1)(2013-1#1)
of both types of##8##4##(1994-8#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
of both virulence and##2##4##(2008-10#2)
of both viruses in##3##4##(2008-10#3)
of both viruses##9##3##(1995-12#1)(2008-10#8)
of both young and old##2##5##(1994-6#2)
of both##1100##2##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#8)(1990-7#2)(1990-8#5)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#4)(1992-1#2)(1992-11#5)(1992-12#6)(1992-2#3)(1992-3#8)(1992-5#3)(1992-6#8)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#15)(1993-2#1)(1993-3#4)(1993-6#8)(1993-8#7)(1993-9#4)(1994-11#7)(1994-12#4)(1994-2#7)(1994-3#5)(1994-5#6)(1994-6#7)(1994-7#1)(1994-8#8)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#6)(1995-6#11)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#7)(1996-3#3)(1996-5#2)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#8)(1997-6#3)(1997-7#5)(1997-8#1)(1997-9#1)(2006-10#4)(2006-12#1)(2006-6#3)(2007-10#4)(2007-11#14)(2007-12#19)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#10)(2008-1#12)(2008-10#244)(2008-11#33)(2008-12#14)(2008-2#25)(2008-3#52)(2008-4#17)(2008-5#31)(2008-6#9)(2008-7#46)(2008-8#24)(2008-9#16)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#4)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#6)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#7)(2011-1#17)(2011-2#30)(2011-7#1)(2012-1#3)(2012-12#15)(2012-2#17)(2012-3#16)(2012-7#1)(2012-8#1)(2013-1#25)(2013-7#5)(2013-8#13)
of botrocetin##2##2##(1993-3#1)(1994-11#1)
of botryoid rhabdomyosarcoma with cartilaginous differentiation in the urinary bladder of##2##11##(2007-7#2)
of botryoid rhabdomyosarcoma##3##3##(2007-7#3)
of botulinum neurotoxin##4##3##(1994-11#3)(2011-2#1)
of botulinum toxin type A##3##5##(2008-10#2)(2008-8#1)
of botulinum toxin##7##3##(2008-10#2)(2008-8#2)(2009-3#1)(2012-3#2)
of botulinum##14##2##(1990-5#1)(1994-11#3)(2008-10#2)(2008-8#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
of botulism in##3##3##(1991-3#1)(2007-12#2)
of bound GDP##2##3##(1994-11#2)
of bound states##3##3##(2007-11#1)(2007-12#2)
of bound versus free##2##4##(2008-9#1)(2010-11#1)
of bound water##2##3##(1991-11#1)(2008-5#1)
of bound##25##2##(1990-12#1)(1991-11#1)(1992-6#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)
of boundaries##2##2##(2008-3#1)(2012-12#1)
of boundary##3##2##(1991-3#1)(2008-11#2)
of bovine TB##2##3##(2010-4#2)
of bovine adrenal##2##3##(1992-6#1)(2009-9#1)
of bovine adrenocortical##2##3##(1993-11#2)
of bovine and##2##3##(1993-11#1)(1994-8#1)
of bovine blastocysts##2##3##(2008-11#2)
of bovine brain##6##3##(1992-11#2)(1993-8#1)(1994-5#1)(1997-2#1)(2013-7#1)
of bovine cardiac##2##3##(1991-12#2)
of bovine gamma##2##3##(1992-8#1)(1993-6#1)
of bovine heart##3##3##(1990-5#1)(1992-6#1)(1995-2#1)
of bovine hemoglobin##4##3##(1990-8#1)(1995-3#3)
of bovine herpesvirus 1##2##4##(2011-2#2)
of bovine liver glutamate dehydrogenase##2##5##(1990-7#2)
of bovine liver##3##3##(1990-7#2)(2008-10#1)
of bovine neutrophil homogenates##2##4##(1992-6#1)(1993-8#1)
of bovine plasma fibronectin##2##4##(1990-7#2)
of bovine seminal plasma##2##4##(1990-5#1)(1994-3#1)
of bovine seminal##3##3##(1990-5#2)(1994-3#1)
of bovine serum albumin (BSA)##2##5##(2008-10#2)
of bovine serum albumin##14##4##(1991-5#1)(1993-11#1)(1993-8#1)(1995-12#4)(1995-5#1)(1997-2#1)(2008-10#3)(2008-9#1)(2013-1#1)
of bovine serum##17##3##(1991-5#1)(1992-9#2)(1993-11#1)(1993-8#1)(1995-12#4)(1995-5#1)(1997-2#1)(2008-10#3)(2008-9#1)(2012-6#1)(2013-1#1)
of bovine spongiform encephalopathy (BSE)##3##5##(2010-4#1)(2011-2#2)
of bovine spongiform encephalopathy##6##4##(1990-9#1)(2010-4#2)(2011-2#3)
of bovine tissue##2##3##(1990-8#1)(1991-12#1)
of bovine trypsin##3##3##(1990-12#2)(1996-12#1)
of bovine##109##2##(1990-11#1)(1990-12#3)(1990-5#3)(1990-7#4)(1990-8#5)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#5)(1993-2#1)(1993-6#1)(1993-8#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#3)(1995-9#1)(1996-11#1)(1996-12#3)(1997-1#1)(1997-2#3)(1997-5#1)(2007-8#1)(2008-10#5)(2008-11#9)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-4#4)(2011-1#2)(2011-2#5)(2012-12#1)(2012-6#1)(2013-1#1)(2013-7#1)
of bowel gas##2##3##(2008-10#2)
of bowel##6##2##(1994-2#1)(1996-6#1)(2008-10#2)(2010-12#1)(2012-2#1)
of boys and##2##3##(2007-12#1)(2008-10#1)
of boys##6##2##(1996-11#2)(2007-12#1)(2008-10#1)(2013-7#1)(2013-8#1)
of brachial plexus##4##3##(2008-7#2)(2008-9#2)
of bracket##2##2##(2009-7#1)(2010-3#1)
of bradykinin and##2##3##(1990-7#1)(1996-7#1)
of bradykinin##8##2##(1990-7#2)(1991-12#1)(1996-7#4)(1997-2#1)
of brain PD##3##3##(2009-4#3)
of brain abscess##2##3##(2010-11#2)
of brain activity##3##3##(2008-11#1)(2008-4#1)(2009-8#1)
of brain and spinal cord##3##5##(1993-12#1)(2008-5#1)(2010-12#1)
of brain and##6##3##(1993-12#1)(1994-11#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-2#1)
of brain cell death##2##4##(2007-10#1)(2012-2#1)
of brain cells from##2##4##(1992-11#1)(2008-11#1)
of brain death##3##3##(1991-9#1)(2007-11#2)
of brain function##6##3##(1992-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
of brain functions##2##3##(2007-8#1)(2008-8#1)
of brain information##2##3##(2008-11#1)(2008-7#1)
of brain injury##6##3##(1992-3#1)(1996-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2011-7#1)
of brain ischemia##2##3##(2007-10#1)(2007-8#1)
of brain lesions##2##3##(2008-7#2)
of brain natriuretic peptide##2##4##(1991-2#1)(1991-5#1)
of brain regions##8##3##(1995-12#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-12#1)(2012-1#1)(2013-8#1)
of brain research##2##3##(2010-9#2)
of brain response to##2##4##(2009-9#1)(2012-12#1)
of brain size##4##3##(1996-7#1)(2012-3#3)
of brain stimulation reward##2##4##(1992-12#1)(1994-3#1)
of brain stimulation##3##3##(1992-12#1)(1994-3#1)(2008-1#1)
of brain systems##2##3##(1995-5#1)(2008-4#1)
of brain tissue##6##3##(1990-10#1)(2008-6#1)(2008-9#1)(2009-7#2)(2011-1#1)
of brain tissues##2##3##(2008-10#1)(2008-7#1)
of brain tumor in##2##4##(2009-11#1)(2012-12#1)
of brain tumor##3##3##(2009-11#1)(2009-3#1)(2012-12#1)
of brain tumors and##2##4##(2008-11#1)(2008-7#1)
of brain tumors##10##3##(1992-9#1)(1993-6#1)(1995-2#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#2)
of brain tumours##4##3##(2008-7#2)(2009-4#2)
of brain##162##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#1)(2007-10#5)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#11)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#16)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#3)(2010-12#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#2)
of brain-derived neurotrophic factor (BDNF)##2##5##(1997-2#1)(2013-1#1)
of brain-derived neurotrophic factor##5##4##(1997-2#1)(1997-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
of brain-initiated normal and pathological behaviors##2##6##(2009-5#2)
of brain-sparing flow##3##3##(2011-2#3)
of brains##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
of brainstem##6##2##(1991-5#1)(1994-2#1)(1996-5#2)(2008-12#1)(2011-2#1)
of branch points##2##3##(2007-12#1)(2008-3#1)
of branch##4##2##(2007-12#1)(2008-3#2)(2008-4#1)
of branched##4##2##(1992-12#1)(2008-4#2)(2013-7#1)
of branched-chain amino acids##2##4##(1993-12#1)(1994-5#1)
of branched-chain##3##2##(1993-12#1)(1994-5#1)(2008-6#1)
of branches##4##2##(2008-10#1)(2008-12#3)
of branching##3##2##(1995-3#1)(2008-11#1)(2008-6#1)
of branchiosaurids and amphibamids##2##4##(2010-6#2)
of branchiosaurids##3##2##(2010-6#3)
of brassinosteroid##2##2##(2008-9#1)(2009-8#1)
of brazzein##3##2##(2008-9#3)
of bread wheat##3##3##(2008-10#2)(2008-5#1)
of bread##4##2##(1990-8#1)(2008-10#2)(2008-5#1)
of breakfast has##2##3##(2012-1#2)
of breakfast##3##2##(2012-1#3)
of breaking##3##2##(2007-11#1)(2008-9#1)(2009-11#1)
of breast and endometrial cancer##2##5##(2008-10#1)(2011-2#1)
of breast and gastrointestinal tract##2##5##(1991-12#1)(2008-1#1)
of breast and##8##3##(1990-6#1)(1991-12#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
of breast cancer and##9##4##(1990-11#1)(1992-10#1)(1993-11#1)(1994-12#1)(1995-4#1)(2007-11#1)(2009-4#1)(2013-1#1)(2013-8#1)
of breast cancer are##2##4##(1996-11#1)(2012-3#1)
of breast cancer associated with##2##5##(1994-2#1)(2008-10#1)
of breast cancer cells in the brain##2##7##(2012-2#2)
of breast cancer cells##4##4##(2009-2#1)(2012-2#2)(2013-8#1)
of breast cancer in Nepal##4##5##(2010-8#4)
of breast cancer in##12##4##(1991-4#1)(1992-8#1)(1993-1#1)(1997-7#1)(2007-2#1)(2007-5#1)(2008-3#1)(2010-8#4)(2011-2#1)
of breast cancer is still##2##5##(1994-12#1)(2007-5#1)
of breast cancer is##3##4##(1993-8#1)(1994-12#1)(2007-5#1)
of breast cancer patients and##2##5##(1992-2#1)(1994-3#1)
of breast cancer patients##11##4##(1991-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-2#1)
of breast cancer screening##4##4##(1994-3#1)(1995-4#1)(1997-1#1)(2013-1#1)
of breast cancer was##3##4##(1993-1#1)(1995-4#1)(2012-3#1)
of breast cancer were##2##4##(1995-4#1)(1996-3#1)
of breast cancer which##3##4##(1990-11#1)(2012-3#1)(2013-7#1)
of breast cancer##133##3##(1990-11#3)(1990-12#3)(1990-8#1)(1991-12#4)(1991-2#1)(1991-4#1)(1992-10#1)(1992-2#3)(1992-5#1)(1992-8#2)(1993-1#4)(1993-11#7)(1993-2#1)(1993-8#3)(1993-9#3)(1994-12#2)(1994-2#4)(1994-3#2)(1994-7#1)(1994-9#2)(1995-11#1)(1995-4#6)(1996-11#2)(1996-3#2)(1997-1#2)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-5#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#6)(2008-7#2)(2009-1#1)(2009-2#2)(2009-4#4)(2009-5#3)(2009-7#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#7)(2013-1#3)(2013-7#3)(2013-8#4)
of breast cancer]##3##3##(1992-2#1)(1996-3#1)(1997-3#1)
of breast cancers##7##3##(1992-8#1)(1993-11#2)(1994-12#1)(1997-3#1)(1997-7#1)(2007-8#1)
of breast carcinoma##7##3##(1992-8#1)(1994-12#4)(2007-10#1)(2013-8#1)
of breast carcinomas##2##3##(1997-7#1)(2007-10#1)
of breast feeding in##2##4##(1990-2#2)
of breast feeding##4##3##(1990-2#3)(2008-1#1)
of breast lesions##2##3##(2012-2#2)
of breast reconstruction##2##3##(1990-9#1)(2013-1#1)
of breast tissue##3##3##(1990-2#1)(2008-3#2)
of breast tumors##2##3##(1995-4#1)(2008-3#1)
of breast##208##2##(1990-11#4)(1990-12#3)(1990-2#5)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#7)(1991-2#1)(1991-4#1)(1992-10#1)(1992-2#4)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#4)(1993-11#10)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#4)(1993-9#3)(1994-12#7)(1994-2#4)(1994-3#2)(1994-5#2)(1994-7#2)(1994-9#2)(1995-11#1)(1995-4#8)(1995-6#1)(1996-11#2)(1996-3#3)(1996-9#1)(1997-1#2)(1997-3#4)(1997-7#3)(2007-10#4)(2007-11#5)(2007-2#1)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#7)(2008-4#7)(2008-7#5)(2009-1#1)(2009-2#2)(2009-4#4)(2009-5#3)(2009-7#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#7)(2013-1#7)(2013-7#3)(2013-8#6)
of breastfeeding##16##2##(1990-12#1)(1991-8#1)(1993-6#1)(2007-10#1)(2007-2#2)(2009-4#2)(2010-5#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
of breath##13##2##(2007-12#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#3)(2010-10#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
of breathing##2##2##(1991-12#1)(2007-6#1)
of breathlessness##2##2##(2007-6#1)(2010-10#1)
of breeders##2##2##(2008-8#2)
of breeding##6##2##(2008-10#3)(2008-8#3)
of brefeldin A##4##3##(1990-7#2)(1997-7#2)
of brewer##2##2##(2008-2#1)(2011-2#1)
of bridge##2##2##(1995-6#1)(2009-10#1)
of bridging##3##2##(1997-7#1)(2008-3#1)(2011-2#1)
of brief##8##2##(1996-12#1)(1997-2#1)(2008-11#1)(2008-4#3)(2008-5#1)(2010-1#1)
of bright##4##2##(1991-5#1)(2007-11#2)(2013-1#1)
of brimonidine##2##2##(1995-12#2)
of brine shrimp##2##3##(2008-9#1)(2010-2#1)
of brine##3##2##(2008-10#1)(2008-9#1)(2010-2#1)
of broad##8##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2011-2#1)
of broadband and##2##3##(2007-11#1)(2007-12#1)
of broadband frequency-modulated##2##3##(2007-11#2)
of broadband laser pulses##2##4##(2007-11#2)
of broadband##19##2##(2007-11#10)(2007-12#2)(2008-2#2)(2008-3#4)(2011-1#1)
of broadening##3##2##(1991-12#1)(1995-1#1)(2008-2#1)
of broccoli##5##2##(2008-10#5)
of broiler chicks##3##3##(2008-12#2)(2010-4#1)
of broiler##6##2##(1997-6#1)(2007-6#1)(2008-12#2)(2010-4#1)(2012-1#1)
of broilers##4##2##(1997-3#2)(1997-6#1)(2010-4#1)
of bromate##8##2##(2008-10#6)(2010-5#2)
of bromazepam##4##2##(1990-8#1)(2008-10#3)
of bromelain##3##2##(1990-5#1)(2013-1#2)
of bromhexine##2##2##(2008-10#1)(2009-7#1)
of bromide in seawater##6##4##(2008-10#6)
of bromide in##8##3##(2008-10#8)
of bromide ion in##3##4##(2008-10#3)
of bromide ion##4##3##(2008-10#4)
of bromide ions##4##3##(2008-10#4)
of bromide##24##2##(2008-10#24)
of bromides##2##2##(2008-10#1)(2011-1#1)
of bromine##2##2##(2008-10#2)
of bromoalcohols##2##2##(2008-10#2)
of bromocriptine on##3##3##(1991-1#1)(2008-7#1)(2011-1#1)
of bromophenols##2##2##(2008-10#2)
of bromopropylate##2##2##(2008-10#2)
of bronchial arteries in##2##4##(1992-9#1)(2010-8#1)
of bronchial arteries##4##3##(1992-9#1)(2010-8#3)
of bronchial asthma##7##3##(1991-11#1)(1996-7#3)(2008-1#1)(2008-4#1)(2008-7#1)
of bronchial##22##2##(1990-8#1)(1991-11#1)(1992-2#1)(1992-9#2)(1995-12#1)(1996-3#1)(1996-7#4)(2008-1#3)(2008-4#1)(2008-7#1)(2010-8#4)(2012-3#1)(2013-8#1)
of bronchiectasis##3##2##(1991-3#1)(2007-8#1)(2011-3#1)
of bronchiolitis##4##2##(2010-5#1)(2013-1#3)
of bronchoalveolar lavage fluid##2##4##(1991-12#1)(2008-1#1)
of bronchoalveolar lavage##3##3##(1991-12#1)(2007-8#1)(2008-1#1)
of bronchogenic carcinoma##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
of bronchogenic##4##2##(2007-7#1)(2007-8#1)(2011-2#1)(2011-3#1)
of bronchopleural fistula##2##3##(2007-8#1)(2012-2#1)
of bronchopleural##4##2##(2007-8#2)(2012-2#2)
of bronchospasm##3##2##(1992-5#1)(1996-12#1)(2010-7#1)
of brood##3##2##(2008-6#1)(2008-9#1)(2012-12#1)
of brooms on##2##3##(2008-10#2)
of brooms##4##2##(2008-10#4)
of brown hare##2##3##(2013-1#2)
of brown rot in##2##4##(2008-10#2)
of brown rot of##3##4##(2008-10#3)
of brown rot##10##3##(2008-10#10)
of brown stem rot of soybean##2##6##(2008-10#2)
of brown stem rot was##3##5##(2008-10#3)
of brown stem rot##10##4##(2008-10#10)
of brown##29##2##(2007-7#1)(2008-10#23)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#2)
of brucellosis##4##2##(1990-9#1)(2007-7#1)(2012-2#2)
of brush border membrane vesicles with antiserum##2##7##(1990-11#2)
of brush border membrane vesicles##3##5##(1990-11#3)
of brush border membrane##4##4##(1990-11#3)(2007-7#1)
of brush##6##2##(1990-11#3)(1997-8#1)(2007-7#1)(2011-2#1)
of buagafuran in##5##3##(2011-3#5)
of buagafuran was##3##3##(2011-3#3)
of buagafuran##8##2##(2011-3#8)
of bubbles in##3##3##(2008-2#1)(2008-7#1)(2009-11#1)
of bubbles##6##2##(2008-2#3)(2008-7#1)(2009-11#2)
of budding yeast##3##3##(1995-12#1)(1995-2#1)(2008-9#1)
of budding##4##2##(1995-12#1)(1995-2#1)(2008-9#1)(2009-12#1)
of buffer solution##2##3##(2008-10#2)
of buffer solutions##2##3##(2008-10#1)(2008-5#1)
of buffer##14##2##(1994-9#1)(2008-10#11)(2008-5#1)(2008-6#1)
of buffered##2##2##(2008-10#2)
of buffers##4##2##(2008-10#3)(2008-4#1)
of building a##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
of building an##2##3##(1996-3#1)(2008-10#1)
of building##12##2##(1991-3#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
of bulgy##3##2##(2012-12#3)
of bulimia##2##2##(1993-12#1)(2007-7#1)
of bulk and##2##3##(2007-11#1)(2008-3#1)
of bulk drug##2##3##(2008-10#2)
of bulk liquids##4##3##(2008-11#4)
of bulk material##2##3##(2007-11#1)(2008-2#1)
of bulk water##2##3##(2008-5#2)
of bulk##17##2##(1993-8#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)
of bulky##2##2##(1991-5#1)(2008-10#1)
of bullfrog##4##2##(1997-7#4)
of bullous pemphigoid##2##3##(2007-7#2)
of bullous##3##2##(2007-7#2)(2008-12#1)
of bullying##6##2##(2008-11#5)(2009-7#1)
of bundled##2##2##(2009-7#1)(2009-9#1)
of bundles of##2##3##(1994-8#1)(2008-7#1)
of bundles##4##2##(1994-8#1)(2008-10#2)(2008-7#1)
of bupivacaine##3##2##(2007-11#1)(2008-7#1)(2012-12#1)
of buprenorphine##12##2##(1991-1#5)(1995-12#1)(2008-11#5)(2008-6#1)
of bupropion##2##2##(1991-1#1)(2008-6#1)
of burden##3##2##(2011-2#1)(2013-8#2)
of bureaucracy##3##2##(1993-2#1)(2008-1#1)(2013-1#1)
of buried##3##2##(1997-2#2)(2008-4#1)
of burning##2##2##(2013-1#2)
of burnout and##3##3##(2010-2#1)(2011-2#2)
of burnout##20##2##(1992-1#1)(1995-1#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#2)(2010-2#1)(2010-7#1)(2010-9#2)(2011-2#8)
of bursts##2##2##(1994-3#1)(1997-7#1)
of business##7##2##(1992-1#1)(1992-11#2)(1994-2#1)(1995-6#1)(2007-9#1)(2013-1#1)
of butane##3##2##(2008-10#1)(2011-2#2)
of butterfly##2##2##(2008-2#1)(2012-2#1)
of butyl##3##2##(1990-5#1)(2008-5#1)(2013-1#1)
of butyrate##3##2##(2008-11#3)
of butyric acid##3##3##(2008-11#2)(2008-6#1)
of butyric##5##2##(1993-8#1)(2008-11#2)(2008-6#2)
of butyrylcholinesterase##2##2##(1994-6#1)(2012-2#1)
of buying##3##2##(1994-1#1)(1996-3#1)(2012-2#1)
of by##2##2##(1992-6#1)(1994-6#1)
of bystander##5##2##(2008-7#5)
of c##3##2##(2010-8#2)(2013-8#1)
of c-Abl##3##2##(1994-10#1)(1995-8#2)
of c-FLIP##3##2##(2012-2#3)
of c-FLIP(L)##2##2##(2012-2#2)
of c-Jun and##2##3##(1995-2#1)(2010-3#1)
of c-Jun##5##2##(1995-2#2)(1996-12#1)(2010-3#2)
of c-KIT##2##2##(2013-1#2)
of c-Kit mutations##2##3##(2008-6#1)(2010-4#1)
of c-MYC##2##2##(1993-11#1)(1993-8#1)
of c-Myc in##2##3##(2013-1#2)
of c-Myc##7##2##(1994-9#2)(2008-11#1)(2013-1#4)
of c-erbB-2##2##2##(1993-1#1)(1994-7#1)
of c-fos and junB##5##4##(1994-8#5)
of c-fos and##7##3##(1992-9#1)(1994-8#5)(2008-9#1)
of c-fos##19##2##(1990-12#1)(1990-5#2)(1992-9#1)(1993-6#1)(1994-11#3)(1994-8#5)(1995-12#1)(1996-12#2)(1996-5#1)(1997-2#1)(2008-9#1)
of c-jun AS##2##3##(2008-11#2)
of c-jun and##2##3##(1991-12#1)(1994-8#1)
of c-jun gene##2##3##(1995-8#1)(2008-11#1)
of c-jun mRNA was##2##4##(1991-9#1)(1995-8#1)
of c-jun##10##2##(1991-12#1)(1991-9#2)(1994-8#1)(1995-8#3)(2008-11#3)
of c-kit and PDGFR##2##4##(2011-2#2)
of c-kit##3##2##(2008-11#1)(2011-2#2)
of c-myb##2##2##(1990-6#2)
of c-myc and##3##3##(1992-8#1)(2007-5#1)(2008-8#1)
of c-myc gene expression##2##4##(2008-11#1)(2008-8#1)
of c-myc gene##4##3##(1992-9#1)(2008-11#1)(2008-8#2)
of c-myc mRNA##2##3##(1993-11#1)(1997-7#1)
of c-myc##23##2##(1991-4#1)(1991-9#2)(1992-2#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1997-7#1)(2007-5#1)(2008-11#5)(2008-8#3)
of c-type cytochromes##2##3##(1994-8#2)
of cADPR##2##2##(1994-11#1)(1995-3#1)
of cAMP formation##4##3##(1992-4#1)(1995-12#1)(1995-6#2)
of cAMP in##2##3##(1997-2#1)(2010-1#1)
of cAMP may##2##3##(1994-8#1)(1994-9#1)
of cAMP on##4##3##(1994-11#1)(1995-6#1)(1996-5#1)(2010-11#1)
of cAMP pathway##3##3##(2008-11#3)
of cAMP was##2##3##(1993-3#1)(1997-2#1)
of cAMP##31##2##(1992-4#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#3)(1996-5#1)(1997-2#7)(2008-10#1)(2008-11#4)(2008-8#2)(2009-2#1)(2010-1#1)(2010-11#1)
of cAMP-dependent phosphorylation##2##3##(1994-8#1)(1995-3#1)
of cAMP-dependent protein kinase##7##4##(1990-2#1)(1994-12#1)(1995-2#3)(2008-10#1)(2008-12#1)
of cAMP-dependent##9##2##(1990-2#1)(1994-12#1)(1994-8#1)(1995-2#3)(1995-3#1)(2008-10#1)(2008-12#1)
of cDNA and genomic##3##4##(1991-9#1)(1996-12#1)(2008-9#1)
of cDNA and##5##3##(1990-12#1)(1991-9#1)(1996-12#1)(2008-1#1)(2008-9#1)
of cDNA clones##11##3##(1991-6#1)(1993-11#1)(1995-8#2)(1996-10#1)(1996-2#2)(1996-8#1)(1997-2#3)
of cDNA encoding##4##3##(1990-5#1)(1993-2#1)(1994-8#1)(1996-10#1)
of cDNA for##2##3##(1990-12#1)(1996-12#1)
of cDNA from##3##3##(1990-11#1)(1995-12#1)(2008-7#1)
of cDNA libraries##2##3##(1997-6#1)(2008-11#1)
of cDNA##45##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-2#2)(1996-8#1)(1997-2#3)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2010-5#2)
of cDNAs encoding##6##3##(1991-12#1)(1991-6#1)(1992-12#1)(1994-12#1)(2008-2#2)
of cDNAs for##2##3##(1992-8#1)(2008-11#1)
of cDNAs##13##2##(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-12#1)(2008-11#1)(2008-2#2)(2008-6#1)
of cER gene##2##3##(1992-9#2)
of cFIX cDNA##2##3##(2008-9#2)
of cGMP##4##2##(1995-2#2)(1995-8#1)(2008-7#1)
of cGMP-binding##2##2##(1995-8#2)
of cLBP##2##2##(2013-1#2)
of cTR##3##2##(1991-6#3)
of cTnI##3##2##(2008-10#1)(2010-12#2)
of ca##26##2##(1992-8#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-6#1)(2008-10#12)(2009-3#2)(2009-9#2)(2010-10#1)
of ca(2+)##2##2##(2008-8#2)
of cabbage##5##2##(1997-8#1)(2008-10#3)(2013-8#1)
of cabin##5##2##(1996-12#4)(2007-2#1)
of cacao##2##2##(2008-10#2)
of cachexia##4##2##(2008-10#2)(2008-5#2)
of cadaver organs##2##3##(1994-1#1)(1995-12#1)
of cadaver##3##2##(1991-9#1)(1994-1#1)(1995-12#1)
of cadaveric donors##3##3##(2008-10#1)(2011-2#2)
of cadaveric##6##2##(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#3)
of cadavers##2##2##(2007-7#1)(2008-4#1)
of cadmium (Cd)##2##3##(1995-3#1)(2008-11#1)
of cadmium (II) and lead (II)##2##6##(2008-10#2)
of cadmium (II)##3##3##(2008-10#3)
of cadmium and copper##3##4##(2008-10#3)
of cadmium and lead in biological##2##6##(2008-10#2)
of cadmium and lead in table salt samples##3##8##(2008-10#3)
of cadmium and lead in table salt##4##7##(2008-10#4)
of cadmium and lead in##10##5##(2008-10#10)
of cadmium and lead with##2##5##(2008-10#2)
of cadmium and lead##17##4##(2008-10#17)
of cadmium and zinc##4##4##(1994-6#1)(2008-10#3)
of cadmium and##28##3##(1991-9#1)(1994-6#1)(1995-3#1)(2008-10#24)(2008-11#1)
of cadmium at##2##3##(2008-10#2)
of cadmium chloride##2##3##(1990-5#1)(2008-7#1)
of cadmium from##2##3##(2008-10#2)
of cadmium in sewage sludge by differential pulse anodic stripping voltammetry##2##11##(2008-10#2)
of cadmium in the##2##4##(1993-12#1)(2008-10#1)
of cadmium in urine by##2##5##(2008-10#2)
of cadmium in urine specimens by graphite furnace atomic absorption spectrometry##2##11##(2008-10#2)
of cadmium in urine##4##4##(2008-10#4)
of cadmium in water##3##4##(2008-10#3)
of cadmium in##24##3##(1993-12#1)(2008-10#23)
of cadmium on##2##3##(2008-10#1)(2008-7#1)
of cadmium sulphide##2##3##(1996-7#2)
of cadmium was##2##3##(2008-10#2)
of cadmium##104##2##(1990-5#1)(1991-9#1)(1993-12#1)(1994-6#1)(1995-3#2)(1996-7#4)(1997-4#1)(2008-10#86)(2008-11#3)(2008-7#2)(2011-2#1)(2013-1#1)
of cadmium(II) and##4##3##(1991-5#1)(2008-10#3)
of cadmium(II)##9##2##(1991-5#1)(2008-10#8)
of caffeic acid and##2##4##(2012-1#1)(2013-1#1)
of caffeic acid in##3##4##(2008-11#2)(2009-12#1)
of caffeic acid##7##3##(2008-10#1)(2008-11#2)(2009-12#1)(2012-1#1)(2013-1#2)
of caffeine and nicotine in people with schizophrenia##2##8##(2009-7#2)
of caffeine and nicotine##3##4##(2009-7#3)
of caffeine and##4##3##(2008-10#1)(2009-7#3)
of caffeine in##2##3##(2008-10#2)
of caffeine on Ca2+ fluxes and##2##6##(1995-11#2)
of caffeine on##5##3##(1995-11#5)
of caffeine##25##2##(1990-2#1)(1991-1#1)(1995-11#5)(1996-11#1)(2008-10#10)(2008-5#4)(2009-7#3)
of cagA##3##2##(1997-8#2)(2012-12#1)
of caged neurotransmitters##2##3##(2008-4#2)
of caged##5##2##(1995-2#1)(1995-3#1)(2008-4#3)
of calanolide A (1)##2##4##(1992-8#2)
of calbindin-D28k##2##2##(1993-12#1)(1994-2#1)
of calcaneal intraosseous##2##3##(2010-3#2)
of calcaneal##5##2##(2007-11#1)(2007-8#1)(2010-3#3)
of calcaneocuboid##2##2##(2009-10#1)(2012-2#1)
of calcaneus##3##2##(2007-8#3)
of calcification##3##2##(2007-11#1)(2012-12#1)(2013-1#1)
of calcified tissues##2##3##(2008-3#2)
of calcified##5##2##(2008-3#4)(2013-1#1)
of calcifying##2##2##(1991-4#1)(2012-12#1)
of calcineurin##3##2##(1991-9#1)(2008-1#1)(2008-9#1)
of calcitonin gene##2##3##(1990-2#1)(1992-9#1)
of calcitonin gene-related peptide in the rat##2##7##(1992-6#2)
of calcitonin gene-related peptide in the##5##6##(1992-6#4)(1993-3#1)
of calcitonin gene-related peptide in##8##5##(1991-1#1)(1992-6#6)(1993-3#1)
of calcitonin gene-related peptide##10##4##(1991-1#1)(1992-6#8)(1993-3#1)
of calcitonin##17##2##(1990-2#3)(1990-9#1)(1991-1#1)(1992-6#9)(1992-9#1)(1993-11#1)(1993-3#1)
of calcitriol##5##2##(2008-1#4)(2011-1#1)
of calcium and cadmium##2##4##(2008-10#2)
of calcium and magnesium in##4##5##(2008-10#4)
of calcium and magnesium ions##2##5##(2008-10#2)
of calcium and magnesium##10##4##(2008-10#10)
of calcium and##24##3##(1990-8#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1997-8#1)(2008-10#15)(2008-7#1)(2013-1#1)
of calcium antagonists (verapamil##2##4##(1994-9#1)(2008-7#1)
of calcium antagonists##10##3##(1990-2#1)(1990-6#1)(1991-8#2)(1992-2#1)(1994-9#4)(2008-7#1)
of calcium carbonate##4##3##(2008-10#3)(2012-12#1)
of calcium channel blockers##4##4##(2008-10#1)(2008-11#3)
of calcium channel##7##3##(1993-12#1)(1993-5#1)(2008-10#1)(2008-11#3)(2012-12#1)
of calcium concentration in##2##4##(2008-10#1)(2013-8#1)
of calcium concentrations##3##3##(1993-6#1)(2008-8#1)(2009-8#1)
of calcium entry##2##3##(1990-3#1)(2008-4#1)
of calcium from##2##3##(1991-8#1)(2008-4#1)
of calcium homeostasis##2##3##(1995-3#1)(2008-7#1)
of calcium in the##4##4##(1991-2#1)(1993-11#1)(2008-10#1)(2012-3#1)
of calcium in##11##3##(1991-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(2008-10#5)(2008-8#1)(2012-3#1)
of calcium influx and##2##4##(1993-11#1)(2010-5#1)
of calcium ions in##2##4##(1995-8#1)(1997-7#1)
of calcium ions##6##3##(1995-11#2)(1995-8#2)(1997-7#1)(2008-10#1)
of calcium is##2##3##(1997-8#2)
of calcium oxalate##7##3##(1991-12#1)(1992-9#3)(1993-3#1)(2008-10#2)
of calcium oxide##2##3##(2013-1#2)
of calcium phosphate##6##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-1#2)
of calcium removal##2##3##(2008-8#2)
of calcium signaling##2##3##(2008-8#1)(2009-12#1)
of calcium to##4##3##(1992-3#1)(1994-3#1)(1995-2#1)(2011-2#1)
of calcium was##2##3##(2008-10#1)(2008-5#1)
of calcium with##3##3##(1997-7#1)(2008-10#2)
of calcium##174##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#6)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#5)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-11#4)(1995-2#3)(1995-3#3)(1995-8#3)(1996-9#1)(1997-5#1)(1997-7#2)(1997-8#3)(2007-12#1)(2008-1#3)(2008-10#54)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#3)(2008-7#4)(2008-8#7)(2008-9#2)(2009-12#1)(2009-8#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
of calcium-based##2##2##(2012-12#2)
of calcium-dependent##5##2##(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#1)(2008-7#1)
of calcium-induced##2##2##(1990-8#1)(1992-12#1)
of calcium/calmodulin-dependent protein kinase II##3##5##(1995-2#2)(1996-2#1)
of calcium/calmodulin-dependent##4##2##(1995-2#2)(1996-12#1)(1996-2#1)
of calculating the##4##3##(1990-12#1)(2008-3#2)(2013-8#1)
of calculating##5##2##(1990-12#1)(2008-3#2)(2008-4#1)(2013-8#1)
of calculation##2##2##(2008-10#1)(2008-11#1)
of calculations##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of caldesmon##4##2##(1994-5#4)
of calendar instruments##2##3##(2010-1#2)
of calendar##3##2##(2010-1#3)
of calf thymus DNA##2##4##(2008-10#1)(2008-8#1)
of calf thymus##4##3##(1990-8#1)(1995-6#1)(2008-10#1)(2008-8#1)
of calf##7##2##(1990-8#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)
of calibrated polystyrene##2##3##(2008-2#1)(2008-3#1)
of calibrated##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
of calibration and validation##2##4##(2008-10#2)
of calibration and##3##3##(2008-10#2)(2008-2#1)
of calibration curve##2##3##(2008-10#2)
of calibration curves##3##3##(2008-10#2)(2010-11#1)
of calibration samples##2##3##(2008-10#2)
of calibration##28##2##(2008-1#1)(2008-10#15)(2008-2#2)(2008-3#5)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
of call##3##2##(2010-2#1)(2010-3#2)
of callose##2##2##(2008-10#2)
of callus and##2##3##(2008-12#2)
of callus##4##2##(2008-10#1)(2008-12#3)
of calmodulin and##5##3##(1990-12#1)(1992-12#1)(1994-12#1)(1995-11#1)(2008-8#1)
of calmodulin gene##2##3##(1991-9#1)(2008-10#1)
of calmodulin in##2##3##(1994-3#1)(2008-8#1)
of calmodulin with##2##3##(1991-12#1)(1994-12#1)
of calmodulin##19##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#3)(2008-10#1)(2008-8#3)
of caloric restriction##5##3##(1994-5#2)(2008-10#1)(2008-7#2)
of caloric##6##2##(1991-5#1)(1994-5#2)(2008-10#1)(2008-7#2)
of calories##4##2##(1990-8#1)(2008-3#1)(2012-12#2)
of calorimetry##2##2##(2011-1#2)
of calpain I##3##3##(1992-6#3)
of calpain inhibitors##2##3##(1992-12#1)(2008-11#1)
of calpain##11##2##(1990-2#3)(1992-12#3)(1992-6#3)(1992-9#1)(2008-11#1)
of calpains##2##2##(1995-11#1)(2010-11#1)
of calponin##3##2##(1993-6#3)
of calreticulin##3##2##(1994-11#3)
of calsequestrin##2##2##(1990-2#2)
of calves##6##2##(1996-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
of camera##4##2##(2008-2#1)(2008-9#1)(2010-11#1)(2010-3#1)
of camphor##2##2##(2007-10#1)(2010-5#1)
of campylobacteriosis##3##2##(2008-10#1)(2008-7#2)
of canadian##2##2##(2008-10#1)(2008-11#1)
of cancellous bone##2##3##(2009-7#2)
of cancellous##3##2##(2009-7#2)(2010-3#1)
of cancer and##12##3##(1992-9#1)(1993-1#1)(1994-5#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
of cancer as##3##3##(1994-2#1)(2008-9#1)(2013-7#1)
of cancer at##3##3##(1990-2#1)(2010-7#1)(2012-6#1)
of cancer biology##3##3##(1992-2#1)(2008-11#1)(2009-5#1)
of cancer care to##2##4##(2012-3#2)
of cancer care##6##3##(2008-11#1)(2012-3#4)(2013-1#1)
of cancer cases##3##3##(1995-12#1)(2007-5#1)(2011-3#1)
of cancer cell lines##3##4##(2008-11#1)(2008-8#1)(2009-4#1)
of cancer cell metabolism##2##4##(2010-12#2)
of cancer cell##12##3##(1995-3#1)(2008-11#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-12#3)(2013-8#1)
of cancer cells and of##2##5##(2008-11#1)(2013-8#1)
of cancer cells and##5##4##(1991-6#1)(2008-11#1)(2008-9#1)(2013-8#2)
of cancer cells from##3##4##(1992-9#1)(1993-6#1)(2008-1#1)
of cancer cells is##3##4##(2009-3#1)(2011-2#1)(2013-1#1)
of cancer cells to##6##4##(1991-2#1)(1993-9#1)(2008-1#1)(2008-11#2)(2009-7#1)
of cancer cells##36##3##(1991-2#1)(1991-6#2)(1992-9#2)(1993-6#1)(1993-9#1)(2008-1#2)(2008-11#8)(2008-7#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#3)
of cancer control programs##2##4##(2011-3#2)
of cancer control##5##3##(1997-1#3)(2011-3#2)
of cancer deaths in##3##4##(2008-7#1)(2009-12#1)(2013-1#1)
of cancer deaths##4##3##(1997-1#1)(2008-7#1)(2009-12#1)(2013-1#1)
of cancer diagnosis##2##3##(2008-11#1)(2013-1#1)
of cancer during##3##3##(1994-9#1)(2013-1#2)
of cancer in the##2##4##(1990-6#1)(2013-1#1)
of cancer in##12##3##(1990-6#1)(1993-3#1)(1994-2#1)(2008-1#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#2)(2012-6#1)(2013-1#1)
of cancer is##6##3##(1990-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
of cancer metastases##2##3##(2007-11#2)
of cancer metastasis##3##3##(2008-1#2)(2011-1#1)
of cancer mortality and##2##4##(2012-3#1)(2013-1#1)
of cancer mortality##6##3##(1990-8#1)(1994-2#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#1)
of cancer of the##9##4##(1990-3#1)(1990-9#1)(1992-10#1)(1996-6#1)(1996-9#1)(2009-11#1)(2010-12#2)(2013-1#1)
of cancer of##10##3##(1990-3#1)(1990-9#1)(1991-12#1)(1992-10#1)(1996-6#1)(1996-9#1)(2009-11#1)(2010-12#2)(2013-1#1)
of cancer pain in##2##4##(1997-3#1)(2008-7#1)
of cancer pain##8##3##(1997-3#3)(2008-7#2)(2012-2#3)
of cancer patients##11##3##(1990-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-1#2)(2011-3#1)
of cancer prevention##4##3##(1997-1#1)(2008-9#1)(2013-1#2)
of cancer risk##2##3##(1995-9#1)(2008-7#1)
of cancer survivors##4##3##(2008-7#2)(2008-8#1)(2011-2#1)
of cancer survivorship##3##3##(2008-7#2)(2012-3#1)
of cancer therapy##2##3##(2008-7#1)(2011-2#1)
of cancer treatment##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#2)
of cancer was##3##3##(2008-5#1)(2012-12#2)
of cancer were##2##3##(1992-9#1)(2008-5#1)
of cancer with##3##3##(1990-8#1)(2007-11#1)(2012-6#1)
of cancer##327##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#4)(1992-10#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#5)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-11#2)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#8)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#4)(2008-11#26)(2008-12#1)(2008-4#4)(2008-5#8)(2008-7#30)(2008-8#6)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#7)(2011-2#14)(2011-3#7)(2012-12#14)(2012-2#7)(2012-3#10)(2012-6#3)(2012-8#1)(2013-1#20)(2013-7#2)(2013-8#8)
of cancer-associated##2##2##(2008-7#1)(2010-12#1)
of cancer-causing##2##2##(2011-2#1)(2011-3#1)
of cancer-related##9##2##(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
of cancer]##2##2##(1993-3#1)(1994-9#1)
of cancers are##2##3##(2008-7#1)(2011-3#1)
of cancers in##3##3##(1994-12#1)(1995-11#1)(2012-12#1)
of cancers##27##2##(1991-6#1)(1992-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
of candidate genes for##3##4##(1994-8#1)(2007-10#1)(2009-5#1)
of candidate genes##12##3##(1994-8#1)(1997-8#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-3#1)
of candidate##19##2##(1994-8#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#2)
of candidates##2##2##(2008-7#1)(2011-3#1)
of candidiasis##7##2##(1997-3#1)(2008-5#6)
of candour##2##2##(2013-8#2)
of canine leukocytes##2##3##(2008-10#2)
of canine mammary##2##3##(2013-8#2)
of canine rabies##2##3##(2011-2#2)
of canine##21##2##(1991-8#1)(1992-2#1)(1993-3#1)(1994-11#2)(1995-2#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
of canker##2##2##(2008-10#2)
of cankers was##2##3##(2008-10#2)
of cankers##3##2##(2008-10#3)
of cannabinoid binding sites##2##4##(1996-2#2)
of cannabinoid##5##2##(1996-2#2)(2008-7#2)(2009-12#1)
of cannabinoids##2##2##(1997-8#1)(2008-11#1)
of cannabis##12##2##(2008-12#3)(2009-7#3)(2012-12#2)(2013-1#1)(2013-8#3)
of cannulae##2##2##(2010-8#2)
of canola##5##2##(2008-10#5)
of canonical##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
of canopy closure##3##3##(2008-10#3)
of canopy##7##2##(2008-10#5)(2008-12#2)
of cantaloupe fruit##2##3##(2008-10#2)
of cantaloupe##11##2##(2008-10#11)
of canthaxanthin##2##2##(1992-8#2)
of cantilever##2##2##(2008-3#1)(2010-7#1)
of capability##3##2##(1990-2#1)(1997-3#1)(2013-1#1)
of capacitation##3##2##(2011-1#1)(2012-3#2)
of capacity and##3##3##(2008-7#1)(2010-8#2)
of capacity##7##2##(1992-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#2)
of capillaries##6##2##(1990-11#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-12#1)
of capillary electrophoresis (CE)##3##4##(2008-10#2)(2010-7#1)
of capillary electrophoresis is##2##4##(2008-10#2)
of capillary electrophoresis to##4##4##(2008-10#4)
of capillary electrophoresis##15##3##(1996-5#2)(2008-10#10)(2008-2#1)(2008-5#1)(2010-7#1)
of capillary waves in##2##4##(2008-3#2)
of capillary waves##3##3##(2008-3#3)
of capillary zone electrophoresis##3##4##(2008-10#3)
of capillary##32##2##(1994-9#1)(1996-5#2)(1996-9#1)(2008-10#21)(2008-2#1)(2008-3#3)(2008-5#2)(2010-7#1)
of capital for##2##3##(1993-1#1)(1994-2#1)
of capital##11##2##(1990-4#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(2013-1#1)(2013-8#1)
of capitalism and##2##3##(1991-6#1)(2013-1#1)
of capitation##3##2##(1991-2#1)(1997-1#2)
of capped RNA##2##3##(2011-2#2)
of capsaicin on the##2##4##(1992-6#1)(1993-11#1)
of capsaicin on##5##3##(1992-6#1)(1993-11#2)(2008-11#1)(2009-9#1)
of capsaicin##14##2##(1990-7#1)(1992-6#4)(1993-11#2)(1997-4#2)(2008-11#3)(2008-7#1)(2009-9#1)
of capsular##2##2##(1990-6#1)(2011-2#1)
of capsule endoscopy##2##3##(2010-12#1)(2011-2#1)
of captive##3##2##(1997-6#1)(2007-12#1)(2009-4#1)
of captopril##11##2##(1990-11#1)(1990-12#1)(1992-5#1)(1993-2#1)(2008-10#5)(2008-7#2)
of captured##2##2##(2008-10#1)(2008-5#1)
of capturing##5##2##(2007-5#2)(2010-9#1)(2011-7#1)(2012-2#1)
of carbachol and##3##3##(1994-8#1)(1995-12#1)(1996-12#1)
of carbachol into the##2##4##(1994-8#1)(1996-5#1)
of carbachol##15##2##(1990-5#1)(1990-7#2)(1994-8#6)(1995-12#1)(1996-12#3)(1996-5#1)(1997-1#1)
of carbamates##4##2##(2008-10#4)
of carbamazepine##5##2##(2008-10#2)(2011-2#3)
of carbamoyl##2##2##(1995-3#1)(1995-6#1)
of carbaryl##9##2##(1992-2#1)(2008-10#8)
of carbofuran##5##2##(2008-10#5)
of carbohydrate and##2##3##(2012-1#1)(2012-3#1)
of carbohydrate metabolism##2##3##(2008-10#2)
of carbohydrate##15##2##(1993-1#1)(1994-5#1)(1995-8#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
of carbohydrates to##2##3##(1993-1#1)(1995-5#1)
of carbohydrates##9##2##(1993-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(2008-10#2)(2012-1#1)
of carbon and##4##3##(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
of carbon atoms##6##3##(1990-7#1)(2007-11#1)(2008-10#3)(2008-7#1)
of carbon dioxide in gaseous samples##2##6##(2008-10#2)
of carbon dioxide in##3##4##(2008-10#3)
of carbon dioxide##19##3##(1992-1#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-3#1)(2013-8#1)
of carbon electrodes##2##3##(2008-10#1)(2013-1#1)
of carbon fibers for##2##4##(2008-10#2)
of carbon in##5##3##(2008-10#4)(2008-3#1)
of carbon monoxide##5##3##(1991-12#1)(1996-2#1)(2008-2#3)
of carbon nanotube##2##3##(2007-11#1)(2013-8#1)
of carbon nanotubes (CNTs)##2##4##(2008-7#1)(2010-4#1)
of carbon nanotubes and##2##4##(2008-10#2)
of carbon nanotubes by##2##4##(2008-7#2)
of carbon nanotubes in##3##4##(2008-10#1)(2008-7#1)(2010-2#1)
of carbon nanotubes was##2##4##(2009-11#1)(2011-2#1)
of carbon nanotubes##20##3##(2007-11#1)(2008-10#6)(2008-7#5)(2009-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
of carbon paste electrode modified with##2##6##(2008-10#2)
of carbon paste electrode##3##4##(2008-10#3)
of carbon sources##2##3##(2008-5#1)(2011-2#1)
of carbon tetrachloride##6##3##(1995-3#6)
of carbon##100##2##(1990-7#1)(1991-12#1)(1992-1#1)(1995-3#7)(1995-6#1)(1996-12#1)(1996-2#1)(2007-11#4)(2007-12#2)(2008-10#35)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#1)(2009-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of carbonaceous##4##2##(2007-12#1)(2008-10#3)
of carbonate in##3##3##(2008-10#3)
of carbonate##9##2##(2008-10#9)
of carbonic anhydrase##4##3##(1991-5#3)(2009-3#1)
of carbonyl compounds##4##3##(2008-10#4)
of carbonyl##7##2##(1996-5#1)(2008-10#4)(2008-3#1)(2009-8#1)
of carboxyl groups##2##3##(2008-10#2)
of carboxylate##2##2##(1993-6#1)(2008-10#1)
of carboxylic acid groups##2##4##(2010-4#1)(2012-2#1)
of carboxylic acids and##2##4##(1995-5#1)(1997-2#1)
of carboxylic##7##2##(1995-5#1)(1997-2#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-2#1)
of carboxymethyl cellulose##2##3##(2008-10#1)(2008-5#1)
of carboxypeptidase M##2##3##(1995-6#2)
of carboxypeptidase##3##2##(1995-6#2)(1995-8#1)
of carcinoembryonic antigen (CEA)##4##4##(1991-4#1)(1992-11#1)(2008-10#1)(2008-11#1)
of carcinoembryonic antigen##5##3##(1991-4#1)(1992-11#1)(2008-10#2)(2008-11#1)
of carcinogenesis##7##2##(1990-8#1)(2008-12#1)(2008-2#1)(2008-7#3)(2009-3#1)
of carcinogenic##16##2##(1991-12#2)(1992-6#1)(1992-8#2)(1997-7#1)(2008-8#1)(2008-9#5)(2009-6#1)(2013-1#2)(2013-8#1)
of carcinogens##2##2##(1991-12#1)(2012-1#1)
of carcinoid##3##2##(2010-2#1)(2011-2#2)
of carcinoma cells##4##3##(1992-8#1)(2008-11#3)
of carcinoma in##2##3##(1991-9#1)(1992-6#1)
of carcinoma of the##4##4##(1990-6#1)(1990-8#1)(1991-3#1)(2008-3#1)
of carcinoma was##2##3##(1990-11#1)(1993-8#1)
of carcinoma##18##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-8#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-2#1)
of carcinomas##4##2##(1994-12#2)(2012-3#1)(2013-8#1)
of carcinomatous##2##2##(1991-6#1)(2011-2#1)
of cardiac L-type##2##3##(1994-6#1)(1994-9#1)
of cardiac amyloidosis##4##3##(2010-8#4)
of cardiac and##2##3##(1995-2#1)(2007-8#1)
of cardiac arrest##3##3##(1996-11#1)(2010-8#1)(2012-12#1)
of cardiac arrhythmias##2##3##(1990-9#1)(2009-4#1)
of cardiac care in##2##4##(2008-3#2)
of cardiac complications##2##3##(2008-11#1)(2009-5#1)
of cardiac computed tomography##3##4##(2008-12#2)(2013-2#1)
of cardiac contractility##3##3##(2008-9#2)(2010-4#1)
of cardiac dysfunction##3##3##(2010-8#1)(2011-2#2)
of cardiac failure##2##3##(2008-10#1)(2008-5#1)
of cardiac function##5##3##(1991-9#1)(1992-6#1)(2008-7#1)(2010-6#1)(2012-2#1)
of cardiac health##2##3##(2009-7#1)(2010-8#1)
of cardiac herniation##2##3##(2007-8#2)
of cardiac hypertrophy##5##3##(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#1)
of cardiac hystiocyte##2##3##(2011-1#2)
of cardiac imaging##4##3##(2009-4#3)(2012-2#1)
of cardiac involvement##3##3##(2008-8#1)(2010-4#1)(2011-2#1)
of cardiac muscle##2##3##(2008-10#1)(2011-1#1)
of cardiac myocytes##2##3##(1996-2#1)(2008-11#1)
of cardiac output##2##3##(1991-3#1)(2012-3#1)
of cardiac remodelling##2##3##(2012-3#2)
of cardiac rhythm##2##3##(1996-2#1)(2011-1#1)
of cardiac surgery##5##3##(2007-8#1)(2008-5#1)(2010-8#1)(2013-1#2)
of cardiac surgical##2##3##(2006-10#2)
of cardiac troponin I (cTnI)##2##5##(2008-10#1)(2010-12#1)
of cardiac troponin I##3##4##(2008-10#2)(2010-12#1)
of cardiac troponin##4##3##(2008-10#2)(2008-6#1)(2010-12#1)
of cardiac##121##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#2)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-4#4)(2009-5#3)(2009-7#1)(2010-12#2)(2010-4#3)(2010-6#4)(2010-7#1)(2010-8#11)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#3)(2013-2#1)(2013-7#2)(2013-8#1)
of cardio-vascular##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
of cardiogenic shock##2##3##(2010-5#1)(2013-8#1)
of cardiogenic##3##2##(1991-11#1)(2010-5#1)(2013-8#1)
of cardiologists##2##2##(2011-2#1)(2013-7#1)
of cardiology##2##2##(2007-7#1)(2009-6#1)
of cardiometabolic risk##2##3##(2011-1#1)(2011-2#1)
of cardiomyocyte##2##2##(2008-11#1)(2011-1#1)
of cardiomyocytes##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
of cardiomyopathy##6##2##(1996-8#1)(2008-11#2)(2010-4#1)(2010-6#1)(2013-8#1)
of cardioplegic solution##3##3##(2007-9#3)
of cardioplegic##4##2##(2007-9#3)(2008-7#1)
of cardioprotection##2##2##(2010-12#1)(2013-8#1)
of cardiopulmonary bypass (CPB)##3##4##(2007-8#2)(2008-10#1)
of cardiopulmonary bypass##9##3##(2006-10#1)(2007-8#3)(2008-10#1)(2010-8#2)(2011-2#1)(2013-1#1)
of cardiopulmonary##10##2##(1994-9#1)(2006-10#1)(2007-8#3)(2008-10#1)(2010-8#2)(2011-2#1)(2013-1#1)
of cardiorespiratory fitness##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
of cardiorespiratory physical therapy##2##4##(1993-12#2)
of cardiorespiratory##8##2##(1993-12#3)(1997-3#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
of cardiovascular and##3##3##(1991-8#1)(2011-1#1)(2012-1#1)
of cardiovascular autonomic neuropathy##2##4##(1990-9#1)(2012-2#1)
of cardiovascular autonomic##3##3##(1990-9#2)(2012-2#1)
of cardiovascular disease (CVD) and##2##5##(2008-3#1)(2012-2#1)
of cardiovascular disease (CVD)##8##4##(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
of cardiovascular disease and##4##4##(2007-8#1)(2008-3#1)(2011-1#1)(2013-7#1)
of cardiovascular disease guided by total##2##6##(2013-1#2)
of cardiovascular disease in##5##4##(1993-12#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
of cardiovascular disease##51##3##(1992-8#1)(1993-11#1)(1993-12#1)(1996-11#1)(1996-6#3)(1997-8#2)(2007-8#1)(2008-1#4)(2008-10#1)(2008-3#4)(2008-4#1)(2008-7#4)(2009-11#1)(2009-4#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-3#1)(2013-7#1)(2013-8#1)
of cardiovascular diseases in the##2##5##(2008-11#1)(2008-7#1)
of cardiovascular diseases in##5##4##(1991-6#2)(2008-11#1)(2008-7#1)(2009-10#1)
of cardiovascular diseases##18##3##(1990-2#2)(1991-6#2)(1993-11#1)(1995-2#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-8#1)
of cardiovascular episodes and##2##4##(2008-7#2)
of cardiovascular episodes##4##3##(2008-7#4)
of cardiovascular events##7##3##(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-1#1)(2012-3#2)
of cardiovascular imaging##4##3##(2007-8#1)(2009-10#1)(2009-4#2)
of cardiovascular pharmacology##2##3##(2008-5#2)
of cardiovascular protective therapies##4##4##(2008-3#3)(2012-3#1)
of cardiovascular risk factors and##2##5##(2008-2#1)(2009-9#1)
of cardiovascular risk factors##8##4##(2008-2#1)(2008-3#1)(2008-7#3)(2009-9#1)(2013-3#1)(2013-8#1)
of cardiovascular risk##15##3##(1992-8#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-12#1)(2009-9#1)(2010-9#1)(2013-1#1)(2013-3#1)(2013-8#3)
of cardiovascular surgery##2##3##(2010-8#2)
of cardiovascular##141##2##(1990-2#2)(1990-5#1)(1990-9#2)(1991-6#2)(1991-8#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-2#2)(1996-11#1)(1996-6#3)(1997-8#2)(2006-10#1)(2007-8#3)(2008-1#5)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#2)(2008-7#13)(2008-8#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#4)(2009-9#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#5)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#5)(2013-3#2)(2013-7#2)(2013-8#5)
of care across a##2##4##(1994-12#1)(1996-2#1)
of care across##4##3##(1994-12#1)(1996-2#1)(2010-12#1)(2012-3#1)
of care among##3##3##(1995-12#1)(2011-1#1)(2012-3#1)
of care and a##2##4##(2007-10#1)(2008-3#1)
of care and the##2##4##(2008-1#1)(2012-12#1)
of care and to##2##4##(1992-12#1)(1994-3#1)
of care and##33##3##(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-3#3)(1995-12#1)(1996-12#1)(1996-2#4)(1996-3#4)(1997-8#1)(2007-10#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2012-12#1)(2012-3#2)(2013-8#1)
of care are##5##3##(1994-3#1)(1997-3#1)(2010-12#2)(2011-1#1)
of care as well as##2##5##(1991-1#1)(1995-12#1)
of care as##5##3##(1991-1#1)(1994-3#1)(1995-12#1)(2008-11#1)(2010-12#1)
of care at##2##3##(1993-3#1)(1997-2#1)
of care by##2##3##(1997-2#1)(2013-1#1)
of care coordination##2##3##(1993-3#1)(1995-3#1)
of care delivery##2##3##(1997-3#1)(2008-2#1)
of care destined to##3##4##(2008-2#3)
of care for patients with##2##5##(2008-3#1)(2008-6#1)
of care for patients##3##4##(2008-3#2)(2008-6#1)
of care for the##5##4##(1991-12#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-8#1)
of care for##27##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-12#2)(1996-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#2)(2008-8#1)(2009-12#1)(2009-5#1)(2012-3#2)(2013-1#1)
of care given to##2##4##(1996-12#1)(2011-1#1)
of care has##2##3##(1991-1#1)(1993-3#1)
of care in teaching nursing homes##2##6##(1996-2#2)
of care in the##7##4##(1991-11#1)(1997-2#1)(1997-3#1)(2008-11#2)(2013-1#2)
of care in their##2##4##(2008-1#1)(2008-3#1)
of care in##34##3##(1991-11#1)(1991-3#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-2#4)(1997-1#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#3)(2013-1#3)
of care is##4##3##(1993-1#1)(1996-12#1)(1996-3#1)(1997-3#1)
of care of patients##3##4##(2008-1#1)(2008-3#2)
of care of the##2##4##(1991-12#1)(2012-3#1)
of care of##12##3##(1990-10#1)(1990-11#2)(1990-6#1)(1991-12#1)(1991-6#1)(1995-5#1)(2008-1#1)(2008-3#2)(2010-5#1)(2012-3#1)
of care provided by##2##4##(1992-1#1)(2012-3#1)
of care provided to##4##4##(1992-1#1)(1996-2#1)(2007-9#1)(2008-3#1)
of care provided##9##3##(1992-1#2)(1993-2#1)(1996-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#1)
of care related to##3##4##(1995-2#1)(2008-3#2)
of care that are##2##4##(1994-12#1)(2008-7#1)
of care that##3##3##(1994-12#1)(1995-12#1)(2008-7#1)
of care to##6##3##(1994-2#1)(1996-1#1)(2007-12#1)(2008-11#1)(2010-10#1)(2011-1#1)
of care used to deliver##2##5##(2009-10#2)
of care used##3##3##(1991-1#1)(2009-10#2)
of care were##2##3##(1994-12#1)(2009-3#1)
of care with##5##3##(1991-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)
of care##410##2##(1990-10#1)(1990-11#3)(1990-6#2)(1991-1#7)(1991-11#2)(1991-12#13)(1991-2#1)(1991-3#5)(1991-6#1)(1992-1#6)(1992-12#2)(1992-2#3)(1992-3#6)(1992-4#2)(1993-1#6)(1993-12#8)(1993-2#4)(1993-3#8)(1993-6#1)(1994-1#2)(1994-12#9)(1994-2#6)(1994-3#16)(1995-1#2)(1995-12#9)(1995-2#4)(1995-3#8)(1995-5#1)(1995-9#1)(1996-1#11)(1996-12#8)(1996-2#20)(1996-3#12)(1996-9#1)(1997-1#8)(1997-2#14)(1997-3#16)(1997-4#1)(1997-8#3)(2006-10#1)(2007-10#4)(2007-11#1)(2007-12#6)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#9)(2008-10#4)(2008-11#16)(2008-12#3)(2008-2#6)(2008-3#15)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#2)(2010-10#2)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#17)(2013-1#16)(2013-8#10)
of care&quot##4##2##(1995-3#1)(2010-3#1)(2012-12#1)(2012-3#1)
of career##4##2##(1991-6#1)(1995-12#1)(2008-1#1)(2012-2#1)
of careful##7##2##(1992-6#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
of carefully##3##2##(2008-3#1)(2008-5#1)(2013-1#1)
of caregiver##2##2##(2009-5#1)(2012-2#1)
of caregivers and##6##3##(1990-3#1)(1996-1#1)(2008-6#2)(2009-5#2)
of caregivers##15##2##(1990-3#1)(1991-12#1)(1993-11#1)(1994-1#1)(1996-1#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-5#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
of caregiving##5##2##(1991-12#1)(1996-1#1)(2008-6#1)(2008-7#2)
of cargo##2##2##(2008-7#1)(2009-8#1)
of caries and periodontal disease##2##5##(1990-3#2)
of caries##3##2##(1990-3#2)(1991-6#1)
of caring for##7##3##(1993-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-9#1)(2011-1#1)
of caring##18##2##(1993-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-1#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2011-1#1)(2012-3#2)(2013-8#1)
of carminic acid##6##3##(2008-10#6)
of carotenogenesis##2##2##(2010-10#2)
of carotenoid biosynthesis##2##3##(1995-2#1)(2009-10#1)
of carotenoid pigment##2##3##(2007-11#1)(2008-8#1)
of carotenoid##6##2##(1995-2#1)(2007-11#1)(2008-8#3)(2009-10#1)
of carotenoids is##3##3##(1992-8#1)(2010-2#2)
of carotenoids##10##2##(1992-8#3)(2010-2#7)
of carotid artery stenosis##2##4##(2008-7#1)(2011-2#1)
of carotid artery##12##3##(2007-10#3)(2008-11#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)
of carotid endarterectomy##2##3##(2008-7#1)(2009-7#1)
of carotid intima-media##2##3##(2008-11#1)(2012-3#1)
of carotid##28##2##(1990-5#1)(1992-6#2)(1996-8#1)(2007-10#4)(2008-11#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-7#2)(2010-10#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#3)
of carp hemoglobin##2##3##(1990-8#2)
of carp##6##2##(1990-8#2)(2008-10#3)(2008-12#1)
of carpal tunnel syndrome (CTS)##2##5##(2008-9#1)(2010-8#1)
of carpal tunnel syndrome##8##4##(1994-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-8#2)
of carpal tunnel##9##3##(1994-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#3)(2010-8#2)
of carpal##11##2##(1994-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#3)(2010-8#2)(2012-1#1)(2013-1#1)
of carpogenic germination##2##3##(2008-10#2)
of carrier fringes in##2##4##(2008-2#1)(2008-3#1)
of carrier fringes##3##3##(2008-2#2)(2008-3#1)
of carrier solution##3##3##(2008-10#3)
of carrier##14##2##(1994-5#1)(1995-5#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
of carriers of##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
of carriers##7##2##(1991-3#1)(1992-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
of carrot##3##2##(2008-10#2)(2008-9#1)
of carrying out a##2##4##(1990-9#1)(2008-10#1)
of carrying out##4##3##(1990-9#1)(2008-10#1)(2008-2#1)(2008-7#1)
of carrying the##3##3##(2008-2#1)(2011-1#2)
of carrying##10##2##(1990-9#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#2)
of carthamin at##3##3##(2008-11#3)
of carthamin##4##2##(2008-11#4)
of cartilage and bone##2##4##(1991-5#1)(2007-11#1)
of cartilage##13##2##(1990-11#1)(1990-3#1)(1991-5#1)(1993-2#3)(2007-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)
of carvacrol on##2##3##(2008-11#2)
of carvacrol##7##2##(2008-11#7)
of carvedilol##7##2##(1992-5#1)(1995-12#1)(2008-10#3)(2011-1#2)
of cascaded long-period fiber gratings##2##5##(2007-11#2)
of cascaded##10##2##(2007-11#4)(2008-2#1)(2008-3#5)
of cascading##2##2##(2007-12#1)(2008-8#1)
of case management in##5##4##(1992-3#1)(1996-1#4)
of case management##13##3##(1992-3#2)(1993-12#1)(1995-12#1)(1996-1#6)(1996-2#1)(1997-3#1)(2008-1#1)
of case mix and##3##4##(1992-12#2)(1995-2#1)
of case mix##8##3##(1991-12#1)(1992-12#2)(1992-2#1)(1995-2#4)
of case reports##4##3##(1991-12#1)(2011-2#1)(2013-1#2)
of case studies##4##3##(2008-11#3)(2012-1#1)
of case##38##2##(1991-12#4)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#4)(1996-1#6)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#3)
of case-mix##2##2##(1993-1#1)(1993-2#1)
of casein kinase I##3##4##(1993-6#1)(1994-11#2)
of casein kinase II##2##4##(1990-12#1)(1994-11#1)
of casein kinase##6##3##(1990-12#1)(1993-6#1)(1994-11#3)(2008-4#1)
of casein##8##2##(1990-12#1)(1993-11#1)(1993-6#1)(1994-11#3)(2007-11#1)(2008-4#1)
of caseins##6##2##(2008-10#1)(2013-8#5)
of cases among##3##3##(1991-11#1)(1991-9#1)(2013-8#1)
of cases and controls##7##4##(1990-8#1)(1992-9#1)(1996-12#1)(2008-10#1)(2011-2#3)
of cases and hemodynamic##2##4##(2007-8#1)(2012-2#1)
of cases and##20##3##(1990-8#1)(1992-9#2)(1994-3#1)(1995-6#1)(1996-12#1)(2007-8#2)(2008-10#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
of cases are due to##4##5##(1995-12#1)(2008-11#1)(2010-2#1)(2013-1#1)
of cases are##9##3##(1995-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2010-3#1)(2013-1#1)
of cases as##2##3##(1995-2#1)(2007-2#1)
of cases at the##2##4##(1990-9#1)(2013-8#1)
of cases at##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
of cases but##2##3##(2008-5#1)(2011-2#1)
of cases by##2##3##(2008-9#1)(2011-2#1)
of cases classified as##2##4##(2011-2#2)
of cases decreased##2##3##(2007-8#2)
of cases had##2##3##(1990-6#1)(2011-2#1)
of cases have been reported##2##5##(2008-4#1)(2013-1#1)
of cases have been##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
of cases have##4##3##(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
of cases in patients##2##4##(2008-12#1)(2012-3#1)
of cases in the##3##4##(1994-9#1)(1997-6#1)(2010-3#1)
of cases in which##2##4##(2008-9#1)(2013-1#1)
of cases in##10##3##(1993-9#1)(1994-9#2)(1995-12#1)(1997-6#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
of cases of##33##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#4)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of cases reported##3##3##(1990-6#1)(1994-9#1)(2008-4#1)
of cases respectively##2##3##(2007-7#1)(2012-3#1)
of cases seen in##2##4##(2007-2#1)(2010-12#1)
of cases that had a##2##5##(2011-1#2)
of cases that##4##3##(1993-12#1)(2008-6#1)(2011-1#2)
of cases the##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
of cases were##5##3##(1992-12#1)(1994-3#1)(2010-12#2)(2011-2#1)
of cases which##2##3##(1994-11#1)(2008-3#1)
of cases with##13##3##(1990-12#1)(1990-8#1)(1991-2#1)(1994-7#1)(1995-2#1)(1995-4#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
of cases within##2##3##(1993-1#1)(2008-7#1)
of cases##289##2##(1990-10#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#5)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#6)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-9#3)(1994-11#1)(1994-3#2)(1994-7#1)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#8)(2007-8#17)(2008-1#6)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#14)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#2)(2009-8#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#5)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#8)(2011-2#29)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#7)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#8)
of cases)##5##2##(2007-11#1)(2009-8#1)(2011-2#3)
of cashew nut shell oil##3##5##(1992-2#3)
of cashew nut##4##3##(1992-2#4)
of caspase activation##3##3##(2008-11#3)
of caspase##4##2##(2008-11#3)(2011-2#1)
of caspase-3##12##2##(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
of caspases##2##2##(2008-11#1)(2008-4#1)
of cassava##5##2##(2008-10#4)(2008-6#1)
of castrated##2##2##(1991-5#1)(2010-4#1)
of castration-resistant prostate cancer##2##4##(2011-2#1)(2013-1#1)
of castration-resistant##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
of cat##6##2##(1991-10#1)(1991-4#1)(2007-8#1)(2008-9#2)(2011-2#1)
of cat-86##3##2##(1991-9#3)
of catabolism##2##2##(2008-5#1)(2008-8#1)
of catalase activity##2##3##(1990-12#1)(2008-7#1)
of catalase##11##2##(1990-12#2)(1990-3#1)(1991-12#1)(1991-9#1)(2008-10#4)(2008-7#2)
of catalepsy##4##2##(1990-7#1)(1995-3#1)(2013-1#2)
of catalysis on the##2##4##(2008-10#2)
of catalysis##6##2##(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-4#1)
of catalyst##2##2##(2007-11#1)(2008-10#1)
of catalysts##2##2##(2008-10#2)
of catalytic activity##5##3##(1990-5#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-6#1)
of catalytic antibodies##2##3##(1994-8#1)(1995-2#1)
of catalytic converters##2##3##(2008-10#2)
of catalytic##27##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#11)(2008-4#1)(2008-7#2)(2009-9#1)(2011-1#1)
of catalytically##2##2##(1994-5#1)(2010-12#1)
of cataplexy##2##2##(1991-5#1)(1996-7#1)
of cataract##2##2##(2008-11#1)(2010-8#1)
of catastrophic##3##2##(1997-5#1)(2008-12#1)(2013-1#1)
of catechin##4##2##(2008-10#4)
of catechin-rich beverages##2##3##(2009-5#2)
of catechins##10##2##(2008-10#7)(2009-11#2)(2009-5#1)
of catechol##9##2##(1995-5#1)(1995-8#1)(2008-10#7)
of catecholamine##6##2##(1997-2#1)(2008-10#3)(2013-1#2)
of catecholaminergic##5##2##(1995-12#1)(1997-2#2)(2008-10#2)
of catecholamines in the##2##4##(1997-2#2)
of catecholamines in##6##3##(1997-2#2)(2008-10#4)
of catecholamines##10##2##(1993-3#1)(1997-2#2)(2008-10#7)
of categorization##2##2##(2008-5#1)(2012-2#1)
of cathepsin B##2##3##(1995-6#1)(2009-8#1)
of cathepsin D activity in##2##5##(2008-7#2)
of cathepsin D activity##4##4##(2008-7#4)
of cathepsin D in##3##4##(2008-7#3)
of cathepsin D was determined in##2##6##(2008-7#2)
of cathepsin D##13##3##(1994-5#2)(1995-8#1)(2008-7#10)
of cathepsin E mRNA##2##4##(1992-9#2)
of cathepsin E##5##3##(1991-2#1)(1992-9#3)(1993-11#1)
of cathepsin G and##2##4##(1992-5#1)(1994-5#1)
of cathepsin G##3##3##(1992-5#1)(1994-5#2)
of cathepsin##27##2##(1991-2#1)(1992-5#1)(1992-9#4)(1993-11#1)(1994-5#4)(1995-2#1)(1995-6#2)(1995-8#1)(2008-7#11)(2009-8#1)
of cathepsins B and D##3##5##(1995-6#2)(1997-1#1)
of catheter##9##2##(1991-3#1)(1994-6#1)(2007-10#1)(2007-7#2)(2008-7#1)(2011-2#2)(2013-1#1)
of catheters##3##2##(2007-7#1)(2008-5#1)(2011-2#1)
of cathodic electrolyte on the performance of electrochemical hydride generation##2##10##(2008-10#2)
of cathodic##3##2##(2008-10#3)
of cation##7##2##(2008-10#5)(2009-8#1)(2010-3#1)
of cationic amino acid transporter##2##5##(2012-2#2)
of cationic arsenic##4##3##(2008-10#4)
of cationic polyelectrolytes##4##3##(2008-10#4)
of cationic species##3##3##(2008-10#2)(2009-9#1)
of cationic surfactant##3##3##(2008-10#3)
of cationic surfactants##3##3##(2008-10#3)
of cationic##41##2##(1992-6#1)(1995-2#2)(1996-12#2)(2007-11#2)(2008-10#23)(2008-11#2)(2008-5#5)(2008-9#1)(2009-9#1)(2012-2#2)
of cations and anions##4##4##(2008-10#4)
of cations and##5##3##(2008-10#5)
of cations with##3##3##(2008-10#3)
of cations##25##2##(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#20)(2008-6#2)
of cats##3##2##(1990-9#1)(2008-8#1)(2012-3#1)
of cattle herds##2##3##(2011-2#2)
of cattle infected with##2##4##(2012-3#2)
of cattle liver##2##3##(2008-10#2)
of cattle##19##2##(1990-9#1)(1991-8#1)(1996-12#2)(1996-8#1)(2007-2#1)(2008-10#4)(2010-4#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
of caudal##2##2##(2008-5#1)(2010-8#1)
of cauliflower##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
of causal##5##2##(2008-11#2)(2010-2#1)(2011-1#1)(2011-2#1)
of causality##4##2##(2007-12#1)(2008-1#1)(2012-1#1)(2012-2#1)
of causation##2##2##(2008-7#1)(2013-1#1)
of causative##2##2##(2008-12#1)(2011-1#1)
of causes including##2##3##(2008-11#1)(2008-6#1)
of causes of death##3##4##(1990-9#1)(2008-8#1)(2012-12#1)
of causes of##4##3##(1990-9#1)(2007-7#1)(2008-8#1)(2012-12#1)
of causes##10##2##(1990-9#1)(1991-12#1)(1991-6#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
of causing##16##2##(1993-9#2)(1994-11#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2012-12#1)(2013-8#1)
of caveolin##4##2##(1995-2#2)(1995-6#2)
of caveolin-1##2##2##(2010-1#2)
of caveolin-3##2##2##(2008-7#2)
of cavernous##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
of cavitation##4##2##(2008-10#1)(2008-12#2)(2013-8#1)
of cavities among adolescents in public and private schools in João Pessoa##2##12##(2008-9#2)
of cavities##6##2##(2008-3#2)(2008-9#4)
of cavity length##2##3##(2007-11#1)(2008-3#1)
of cavity ringdown spectroscopy##3##4##(2008-3#3)
of cavity ringdown##4##3##(2008-2#1)(2008-3#3)
of cavity wounds##2##3##(1991-8#1)(1996-7#1)
of cavity##14##2##(1991-8#1)(1996-7#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#6)(2009-2#1)
of cdc25##2##2##(1990-2#1)(1994-12#1)
of cecal volvulus##2##3##(2012-3#2)
of cecropin CMIV##2##3##(2008-8#2)
of cecropin##5##2##(1994-5#3)(2008-8#2)
of cefadroxil monohydrate##2##3##(2008-10#2)
of cefadroxil##8##2##(2008-10#8)
of cefazolin sodium##3##3##(2008-10#3)
of cefazolin##4##2##(2008-10#4)
of cefixime was##2##3##(2008-10#2)
of cefixime##5##2##(2008-10#5)
of cefminox in##3##3##(2008-10#3)
of cefminox##5##2##(2008-10#5)
of ceftazidime##2##2##(2008-10#2)
of ceftibuten##2##2##(1994-8#2)
of celecoxib in##2##3##(2008-10#2)
of celecoxib##4##2##(2008-10#3)(2008-11#1)
of celiac disease##4##3##(2008-10#1)(2008-12#2)(2011-2#1)
of celiac##5##2##(2008-10#1)(2008-12#2)(2011-2#1)(2013-1#1)
of cell adhesion molecules##2##4##(1996-2#1)(2009-8#1)
of cell adhesion on##2##4##(2008-11#2)
of cell adhesion to##2##4##(1990-5#1)(2008-4#1)
of cell adhesion##9##3##(1990-5#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-4#2)(2009-8#1)(2010-4#1)
of cell and##3##3##(2008-11#1)(2008-9#2)
of cell attachment##2##3##(1995-6#2)
of cell biology and##2##4##(2008-10#1)(2008-7#1)
of cell biology##4##3##(1994-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
of cell bodies##2##3##(1992-12#1)(1997-3#1)
of cell concentration##3##3##(2008-11#2)(2008-7#1)
of cell culture##9##3##(1993-12#1)(1997-7#1)(2008-11#6)(2008-8#1)
of cell cultures##5##3##(2008-11#5)
of cell cycle analyses##2##4##(2008-11#1)(2008-9#1)
of cell cycle analysis##3##4##(2008-11#2)(2008-9#1)
of cell cycle arrest##3##4##(2008-11#1)(2009-3#1)(2012-12#1)
of cell cycle phases##2##4##(2008-11#2)
of cell cycle progression and##2##5##(1991-9#1)(2008-11#1)
of cell cycle progression##6##4##(1991-9#1)(1995-9#1)(1997-7#1)(2008-11#1)(2012-3#2)
of cell cycle regulation##2##4##(2009-8#1)(2012-12#1)
of cell cycle regulators##3##4##(2012-2#1)(2013-1#2)
of cell cycle##37##3##(1991-9#1)(1992-9#1)(1993-3#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-11#9)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-8#1)(2010-2#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)
of cell damage##2##3##(1992-9#1)(2012-12#1)
of cell death and##2##4##(2007-10#1)(2008-5#1)
of cell death by##2##4##(2008-11#1)(2008-8#1)
of cell death during##2##4##(2008-10#1)(2008-11#1)
of cell death in the##4##5##(1996-12#1)(2008-11#1)(2008-4#1)(2009-8#1)
of cell death##39##3##(1992-3#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-3#1)
of cell density##2##3##(2008-4#1)(2008-6#1)
of cell differentiation##3##3##(1992-8#1)(1992-9#1)(1995-8#1)
of cell division and##2##4##(1990-5#1)(1997-4#1)
of cell division in##2##4##(2008-1#1)(2008-11#1)
of cell division##13##3##(1990-5#1)(1993-8#1)(1997-4#1)(2008-1#1)(2008-11#3)(2008-9#3)(2009-5#2)(2012-12#1)
of cell expansion##2##3##(2009-8#2)
of cell extracts##2##3##(1994-5#1)(2008-10#1)
of cell fusion##2##3##(2008-11#1)(2008-8#1)
of cell growth and differentiation##2##5##(2008-11#1)(2008-8#1)
of cell growth and##11##4##(1990-2#1)(1993-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
of cell growth at##2##4##(2008-11#2)
of cell growth by##4##4##(1992-9#1)(1994-2#1)(1995-2#1)(2008-11#1)
of cell growth in a##2##5##(2008-7#2)
of cell growth in##6##4##(1990-8#1)(2008-11#3)(2008-7#2)
of cell growth##43##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(1997-7#1)(2007-2#1)(2008-1#2)(2008-11#16)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of cell inventory##2##3##(2008-7#2)
of cell killing##2##3##(1993-8#1)(2008-9#1)
of cell kinetics##2##3##(1993-11#1)(2008-10#1)
of cell line cross-contamination##2##4##(2008-11#2)
of cell lines for##2##4##(2008-11#2)
of cell lines##15##3##(1991-6#1)(1992-8#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-7#1)(2008-9#1)
of cell membrane##4##3##(1994-5#1)(2008-8#1)(2011-3#1)(2012-1#1)
of cell membranes##6##3##(1991-5#1)(2008-10#1)(2008-11#1)(2009-7#1)(2013-7#2)
of cell metabolism##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
of cell migration##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)
of cell morphology##3##3##(2008-11#3)
of cell nuclei##3##3##(2009-10#1)(2010-8#2)
of cell numbers##2##3##(2008-7#2)
of cell physiology##3##3##(2008-11#2)(2010-10#1)
of cell polarity##5##3##(1990-5#1)(2008-9#2)(2009-10#1)(2009-5#1)
of cell populations in the gastric##2##6##(2012-1#2)
of cell populations##4##3##(2008-11#1)(2008-9#1)(2012-1#2)
of cell proliferation and cell fate##2##6##(2008-4#1)(2009-5#1)
of cell proliferation and cell##3##5##(2008-4#1)(2008-9#1)(2009-5#1)
of cell proliferation and##7##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)
of cell proliferation by##3##4##(1995-2#1)(2008-6#1)(2008-9#1)
of cell proliferation in##2##4##(1995-12#1)(2008-4#1)
of cell proliferation of MCF-7 cells##2##6##(2008-11#2)
of cell proliferation of##3##4##(1997-1#1)(2008-11#2)
of cell proliferation##33##3##(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#2)(1994-5#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-11#4)(2008-4#6)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2012-12#1)
of cell properties##2##3##(2008-11#1)(2008-5#1)
of cell shape##5##3##(1994-8#1)(2008-11#2)(2008-2#1)(2011-2#1)
of cell signaling##2##3##(1991-9#1)(2008-10#1)
of cell sizes##2##3##(2008-10#2)
of cell specific##2##3##(1995-3#1)(2008-11#1)
of cell stress##2##3##(2008-10#1)(2008-7#1)
of cell subsets##2##3##(1994-8#1)(2008-4#1)
of cell surface molecules##2##4##(2008-11#1)(2008-9#1)
of cell surface proteins##2##4##(1992-3#1)(2008-1#1)
of cell surface receptors##4##4##(1993-3#1)(1997-4#1)(2009-9#1)(2012-12#1)
of cell surface##20##3##(1992-3#1)(1993-3#1)(1994-5#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
of cell survival##2##3##(2008-10#1)(2012-2#1)
of cell suspensions##2##3##(1990-12#1)(2008-4#1)
of cell therapy##3##3##(1994-6#3)
of cell turnover##2##3##(1995-6#1)(2008-7#1)
of cell type specific factors##2##5##(2008-11#1)(2009-8#1)
of cell type##4##3##(1994-11#1)(1994-8#1)(2008-11#1)(2009-8#1)
of cell types##14##3##(1992-3#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#2)(2010-3#1)(2012-3#1)
of cell viability in##3##4##(2008-11#3)
of cell viability was##2##4##(1997-4#1)(2008-11#1)
of cell viability##11##3##(1997-4#4)(2008-11#6)(2008-9#1)
of cell wall extracts##3##4##(2008-5#3)
of cell wall##10##3##(2008-10#5)(2008-5#3)(2008-9#1)(2009-12#1)
of cell walls##8##3##(2008-10#8)
of cell##464##2##(1990-12#2)(1990-2#1)(1990-5#5)(1990-8#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-8#2)(1992-9#6)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#4)(1994-8#5)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#4)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#7)(1997-7#3)(1997-8#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-1#10)(2008-10#38)(2008-11#101)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#25)(2008-5#10)(2008-6#4)(2008-7#24)(2008-8#13)(2008-9#37)(2009-1#1)(2009-10#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#6)(2012-12#11)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#1)
of cell-adhesion molecules that##2##4##(2008-7#1)(2013-1#1)
of cell-associated##3##2##(1993-6#1)(1997-4#1)(2008-11#1)
of cell-based therapies##2##3##(2008-10#1)(2008-9#1)
of cell-based##7##2##(2008-10#4)(2008-7#1)(2008-9#1)(2009-6#1)
of cell-binding##2##2##(1993-8#1)(1994-11#1)
of cell-cell##6##2##(2008-7#1)(2009-12#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
of cell-cycle##2##2##(2008-11#1)(2012-3#1)
of cell-free##8##2##(1991-8#1)(1994-8#1)(2008-11#1)(2008-4#2)(2010-11#1)(2011-2#1)(2013-1#1)
of cell-mediated immunity##3##3##(2008-5#1)(2009-12#2)
of cell-mediated##4##2##(1994-11#1)(2008-5#1)(2009-12#2)
of cell-penetrating peptides##3##3##(2009-8#1)(2010-10#1)(2011-3#1)
of cell-surface molecules##2##3##(2008-4#2)
of cell-surface thrombomodulin##2##3##(1990-5#2)
of cell-surface##10##2##(1990-5#2)(1992-9#1)(1996-12#1)(2008-1#1)(2008-4#3)(2009-6#2)
of cell-to-cell##2##2##(2008-10#1)(2008-4#1)
of cellobiose##2##2##(1997-4#1)(2013-1#1)
of cells and cell##2##4##(2008-11#1)(2008-12#1)
of cells and tissues##4##4##(1994-8#1)(2008-7#1)(2009-3#1)(2012-2#1)
of cells and##22##3##(1992-11#1)(1993-8#1)(1994-8#1)(2007-6#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-3#1)(2010-10#1)(2010-2#1)(2012-2#2)(2012-3#1)
of cells are##5##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
of cells as##2##3##(1994-2#1)(2008-11#1)
of cells at##2##3##(2007-12#1)(2012-1#1)
of cells by##6##3##(1990-11#1)(1992-12#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
of cells can be##2##4##(2008-4#1)(2008-9#1)
of cells close to##2##4##(2008-10#1)(2009-12#1)
of cells containing##2##3##(1995-5#1)(2012-12#1)
of cells cultured on##2##4##(2008-5#2)
of cells cultured##3##3##(1994-3#1)(2008-5#2)
of cells expressing the##2##4##(1992-8#1)(2008-11#1)
of cells expressing##6##3##(1992-8#2)(1995-2#2)(2008-11#1)(2008-4#1)
of cells for##8##3##(1994-6#1)(2008-10#1)(2008-11#3)(2008-9#2)(2013-1#1)
of cells from different##2##4##(1995-11#1)(2012-3#1)
of cells from the##2##4##(2007-12#1)(2008-11#1)
of cells from##12##3##(1995-11#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-6#1)(2012-3#1)
of cells grown in##4##4##(2008-11#3)(2008-9#1)
of cells in G1##2##4##(1997-7#1)(2008-9#1)
of cells in metaphase##2##4##(2008-2#1)(2008-9#1)
of cells in peripheral blood##2##5##(1992-2#1)(1995-2#1)
of cells in response to##2##5##(2008-4#1)(2010-10#1)
of cells in the S##4##5##(1994-3#1)(2008-11#2)(2008-9#1)
of cells in the fraction were##2##6##(2008-11#2)
of cells in the##14##4##(1991-2#1)(1991-5#1)(1994-3#1)(1996-5#1)(1997-1#1)(2008-11#6)(2008-7#1)(2008-9#2)
of cells in vitro##3##4##(2008-11#2)(2008-4#1)
of cells in##38##3##(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-11#12)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#5)(2010-10#1)(2012-2#1)
of cells infected with##2##4##(1993-6#1)(2008-7#1)
of cells into the##3##4##(2008-1#1)(2008-7#1)(2008-8#1)
of cells into##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)
of cells involved in##2##4##(1993-1#1)(2013-1#1)
of cells known##2##3##(2008-12#1)(2010-6#1)
of cells may##2##3##(2007-12#1)(2008-11#1)
of cells of interest##2##4##(2008-9#2)
of cells of the##2##4##(1997-8#1)(2008-10#1)
of cells of##10##3##(1992-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#2)
of cells on##6##3##(1995-9#2)(2008-10#1)(2008-11#3)
of cells or##2##3##(2008-5#1)(2008-9#1)
of cells prelabelled with (2-palmitoyl 9##2##6##(1990-12#2)
of cells present in##3##4##(1996-5#1)(2008-4#1)(2008-9#1)
of cells present##4##3##(1996-5#1)(2008-4#1)(2008-9#2)
of cells resistant to##2##4##(1993-8#1)(1997-4#1)
of cells stimulated with##2##4##(1990-7#1)(1995-11#1)
of cells subjected to##2##4##(2008-7#1)(2009-12#1)
of cells that were##3##4##(1992-3#1)(1994-8#1)(2007-12#1)
of cells that##11##3##(1992-3#1)(1992-8#1)(1992-9#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-9#1)(2011-1#1)
of cells through##3##3##(1995-2#1)(2008-11#2)
of cells to a##2##4##(2008-7#1)(2008-9#1)
of cells to the inhibition of ubiquitin-proteasome pathway##2##8##(2008-9#2)
of cells to the##5##4##(1997-4#1)(2008-4#1)(2008-5#1)(2008-9#2)
of cells to##24##3##(1992-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-3#1)
of cells treated with##3##4##(1997-1#1)(2012-2#1)(2013-8#1)
of cells treated##4##3##(1992-3#1)(1997-1#1)(2012-2#1)(2013-8#1)
of cells was found to##2##5##(1992-12#1)(2008-11#1)
of cells was##5##3##(1992-12#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)
of cells were##4##3##(1992-8#2)(2008-7#2)
of cells which##4##3##(1990-3#1)(1992-8#1)(1997-4#1)(2008-5#1)
of cells with the##5##4##(1991-12#1)(1995-11#1)(2008-11#1)(2008-5#1)(2008-9#1)
of cells with##40##3##(1990-2#1)(1991-12#2)(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#2)(2008-1#3)(2008-11#9)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2011-2#2)(2012-1#4)(2012-3#1)
of cells within##2##3##(2008-2#1)(2012-1#1)
of cells##381##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#7)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-11#3)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#3)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#4)(1997-2#1)(1997-3#5)(1997-4#5)(1997-7#1)(1997-8#1)(2007-12#11)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#17)(2008-11#60)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#26)(2008-5#11)(2008-6#4)(2008-7#20)(2008-8#6)(2008-9#36)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#5)(2012-1#7)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#4)(2013-8#2)
of cellular DNA##5##3##(1992-11#1)(2008-11#1)(2008-9#3)
of cellular activation##2##3##(1995-11#1)(2008-9#1)
of cellular activities##2##3##(2008-7#1)(2011-2#1)
of cellular aging in##2##4##(2010-2#1)(2011-2#1)
of cellular aging##3##3##(2008-7#1)(2010-2#1)(2011-2#1)
of cellular and viral##2##4##(2008-11#1)(2010-1#1)
of cellular and##6##3##(2008-11#2)(2008-2#1)(2008-4#1)(2010-1#1)(2012-2#1)
of cellular behavior##2##3##(2009-3#1)(2010-9#1)
of cellular components##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
of cellular differentiation##4##3##(2008-11#2)(2008-7#1)(2008-9#1)
of cellular function can##2##4##(2008-7#1)(2008-8#1)
of cellular function##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
of cellular functions##4##3##(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#1)
of cellular fura-2##4##3##(1992-5#4)
of cellular glutathione##2##3##(1992-11#1)(2008-7#1)
of cellular growth##2##3##(1994-3#1)(2007-10#1)
of cellular immune##4##3##(1990-12#1)(1994-3#1)(2008-4#2)
of cellular metabolism##3##3##(2008-11#3)
of cellular morphology##2##3##(1992-2#1)(1996-2#1)
of cellular physiology##3##3##(1994-11#1)(2008-7#1)(2009-8#1)
of cellular processes##11##3##(1994-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
of cellular proliferation in##3##4##(1991-5#1)(1994-9#1)(2008-1#1)
of cellular proliferation##4##3##(1991-5#1)(1994-9#1)(1996-2#1)(2008-1#1)
of cellular protein##4##3##(1990-5#1)(1993-8#1)(2008-11#1)(2010-12#1)
of cellular proteins##13##3##(1991-5#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-5#1)(1996-8#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-9#1)
of cellular responses##2##3##(1997-4#1)(2008-5#1)
of cellular senescence##3##3##(2008-7#2)(2012-3#1)
of cellular signal transduction pathways by leptin##2##7##(2012-3#2)
of cellular signal transduction##4##4##(1992-12#1)(2011-3#1)(2012-3#2)
of cellular therapies##2##3##(2013-1#2)
of cellular therapy products##2##4##(2013-1#2)
of cellular uptake of##2##4##(1991-12#1)(1993-3#1)
of cellular##194##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1991-12#2)(1991-4#3)(1991-5#4)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#4)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#21)(2008-2#3)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#3)(2008-9#10)(2009-10#2)(2009-2#4)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-9#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#1)
of cellulase##3##2##(2008-10#2)(2011-2#1)
of cellulases##2##2##(1990-5#1)(2011-2#1)
of cellulite intensity##2##3##(2008-5#2)
of cellulite is##3##3##(2008-5#3)
of cellulite##12##2##(2008-5#12)
of cellulolytic and##2##3##(2008-10#2)
of cellulolytic##3##2##(2008-10#2)(2008-6#1)
of cellulose and##3##3##(2008-10#3)
of cellulose to ethanol##2##4##(2008-6#2)
of cellulose##21##2##(1994-3#2)(2008-10#8)(2008-11#1)(2008-6#5)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
of cement materials of variable##2##5##(2008-10#2)
of cement##5##2##(2006-4#1)(2008-10#3)(2008-6#1)
of cemented##4##2##(2008-3#2)(2009-4#1)(2013-1#1)
of cementless metal-backed##2##3##(2008-5#2)
of census##3##2##(2008-8#2)(2013-8#1)
of centenarians##3##2##(2008-7#3)
of center##2##2##(2008-10#1)(2013-1#1)
of centers##2##2##(1997-2#1)(2012-2#1)
of central Chile##2##3##(1997-6#1)(2009-2#1)
of central European##2##3##(2009-7#2)
of central and##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
of central importance##2##3##(2007-6#1)(2008-4#1)
of central interest##2##3##(1990-2#1)(2008-8#1)
of central metabolic##2##3##(2008-11#1)(2010-7#1)
of central nervous system (CNS) involvement##2##6##(2007-10#1)(2012-2#1)
of central nervous system (CNS)##5##5##(1993-6#1)(1997-4#1)(2007-10#1)(2011-2#1)(2012-2#1)
of central nervous system##14##4##(1993-12#1)(1993-6#1)(1997-4#1)(2007-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-2#2)(2013-1#1)
of central nervous##15##3##(1993-12#1)(1993-6#1)(1997-4#1)(2007-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-2#2)(2013-1#2)
of central retinal##2##3##(2011-2#2)
of central venous catheter##2##4##(2008-7#2)
of central venous catheters##2##4##(1990-3#1)(2008-7#1)
of central venous##8##3##(1990-3#1)(1993-5#1)(2007-7#1)(2008-7#4)(2011-3#1)
of central##79##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#2)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
of centralized##7##2##(1995-12#2)(1996-1#1)(1997-8#1)(2008-10#3)
of centre##2##2##(1995-11#1)(1996-6#1)
of centres##3##2##(1993-12#1)(2012-12#1)(2013-1#1)
of centrifugal##2##2##(1996-12#1)(2009-12#1)
of centrin##2##2##(2008-9#2)
of centrin-1##2##2##(2008-9#2)
of centuries##2##2##(1994-12#1)(2010-3#1)
of cephalopod##2##2##(2008-7#2)
of cephalosporin antibiotics##2##3##(2008-10#2)
of cephalosporin##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
of cephalosporin-resistant##2##2##(2007-12#1)(2011-2#1)
of cephalosporins##4##2##(1990-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
of ceramic TCP or ZnTCP##2##5##(2008-5#2)
of ceramic##7##2##(2008-10#2)(2008-5#4)(2008-8#1)
of ceramide##7##2##(1994-10#1)(1995-12#1)(1995-2#1)(2008-5#3)(2008-8#1)
of ceramides##3##2##(2008-5#3)
of cercospora##3##2##(2008-10#3)
of cereal##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
of cereals##5##2##(2008-10#4)(2012-2#1)
of cerebellar##14##2##(1991-12#1)(1992-12#1)(1992-6#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-8#2)(2008-7#2)(2009-8#2)
of cerebral AVM##2##3##(2008-9#1)(2012-3#1)
of cerebral AVMs##3##3##(2008-7#2)(2008-9#1)
of cerebral air embolism##2##4##(2008-7#2)
of cerebral and##4##3##(1991-11#1)(1991-3#1)(2007-10#1)(2009-9#1)
of cerebral aneurysms##3##3##(2008-7#2)(2013-1#1)
of cerebral arteriovenous malformation##2##4##(2008-7#2)
of cerebral arteriovenous malformations (AVMs)##4##5##(2008-7#3)(2008-9#1)
of cerebral arteriovenous malformations##8##4##(1997-6#1)(2008-7#4)(2008-9#3)
of cerebral arteriovenous##10##3##(1997-6#1)(2008-7#6)(2008-9#3)
of cerebral blood flow##3##4##(1996-6#1)(2007-10#1)(2008-7#1)
of cerebral blood##6##3##(1996-6#1)(2007-10#2)(2008-7#2)(2011-1#1)
of cerebral cortex##2##3##(1996-5#1)(2008-10#1)
of cerebral infarction and##2##4##(2008-7#1)(2010-11#1)
of cerebral infarction##6##3##(1990-3#1)(1997-5#1)(2007-10#1)(2008-7#2)(2010-11#1)
of cerebral ischemia##4##3##(2008-8#1)(2009-12#2)(2011-2#1)
of cerebral microbleeds##2##3##(2008-8#2)
of cerebral oxygen##2##3##(1990-5#1)(2008-7#1)
of cerebral palsy##6##3##(1995-6#4)(1995-8#1)(2011-2#1)
of cerebral venous thrombosis##3##4##(2007-10#3)
of cerebral venous##4##3##(2007-10#4)
of cerebral##101##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-3#1)(1992-2#2)(1992-6#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-6#4)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-10#8)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#20)(2008-8#8)(2008-9#9)(2009-1#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#5)
of cerebro-spinal fluid##2##3##(2007-8#2)
of cerebroside##3##2##(1993-8#2)(2008-10#1)
of cerebrospinal fluid (CSF)##6##4##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(2008-7#1)(2011-2#1)
of cerebrospinal fluid in##2##4##(1993-10#1)(2008-7#1)
of cerebrospinal fluid##15##3##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1995-3#1)(1997-3#1)(2006-12#2)(2008-7#3)(2011-2#2)(2012-1#1)
of cerebrospinal##16##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1995-3#1)(1997-3#1)(2006-12#3)(2008-7#3)(2011-2#2)(2012-1#1)
of cerebrovascular disease##2##3##(2008-10#1)(2008-8#1)
of cerebrovascular disorders##2##3##(2007-10#2)
of cerebrovascular##13##2##(1996-5#1)(2007-10#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
of ceria##2##2##(2008-7#1)(2010-4#1)
of cerium##6##2##(2008-10#6)
of cerium(IV)##2##2##(2008-10#2)
of certain brain regions##2##4##(2008-2#1)(2012-1#1)
of certain cancers##2##3##(2008-2#1)(2011-1#1)
of certain compounds##2##3##(2008-10#1)(2008-8#1)
of certain drugs##2##3##(1992-8#1)(2008-11#1)
of certain dyes##2##3##(2008-5#1)(2008-9#1)
of certain genes##2##3##(1992-3#1)(1992-6#1)
of certain human##3##3##(2008-4#1)(2009-5#1)(2009-8#1)
of certain procedures##2##3##(1992-3#1)(2008-7#1)
of certain subunits##2##3##(2009-9#2)
of certain types of##4##4##(1992-9#1)(1994-12#1)(2008-10#1)(2008-6#1)
of certain##123##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#9)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#3)(2009-2#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
of certainty##3##2##(1995-3#1)(2008-6#1)(2009-8#1)
of certification##4##2##(1993-12#2)(2008-10#1)(2012-12#1)
of certified reference materials and##8##5##(2008-10#8)
of certified reference materials of##2##5##(2008-10#2)
of certified reference materials##17##4##(2008-10#17)
of certified reference##24##3##(2008-10#24)
of certified seeds##3##3##(2008-12#3)
of certified values##3##3##(2008-10#3)
of certified##35##2##(2008-10#30)(2008-12#4)(2010-11#1)
of cerulenin##2##2##(1995-6#1)(2009-8#1)
of ceruloplasmin##6##2##(1992-12#1)(1995-3#1)(2008-10#1)(2012-2#2)(2013-1#1)
of cervical cancer##15##3##(1992-10#2)(1995-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
of cervical carcinoma in##2##4##(1994-5#1)(2010-8#1)
of cervical carcinoma##5##3##(1990-10#2)(1994-5#1)(2007-4#1)(2010-8#1)
of cervical cytology##2##3##(1994-1#1)(2008-7#1)
of cervical disc##2##3##(2008-7#1)(2011-2#1)
of cervical intraepithelial neoplasia and##2##5##(1991-2#1)(2011-1#1)
of cervical intraepithelial neoplasia##11##4##(1991-2#2)(1994-12#2)(1994-2#2)(2011-1#3)(2012-3#1)(2013-1#1)
of cervical involvement##4##3##(1994-9#1)(2006-10#3)
of cervical pain and stiffness##2##5##(2006-10#2)
of cervical pain and##3##4##(2006-10#2)(2008-12#1)
of cervical spine##5##3##(2007-11#3)(2009-4#1)(2013-1#1)
of cervical spondylitis##3##3##(2006-10#3)
of cervical##84##2##(1990-10#2)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#3)(1992-10#2)(1992-2#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-3#1)(2006-10#8)(2007-10#1)(2007-11#5)(2007-4#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-12#4)(2008-2#1)(2008-7#3)(2008-8#1)(2009-4#2)(2010-12#1)(2010-8#2)(2011-1#7)(2011-2#4)(2011-3#1)(2012-12#3)(2012-3#4)(2013-1#6)(2013-7#1)
of cervicofacial##2##2##(2007-12#1)(2012-2#1)
of cervix##6##2##(2012-12#1)(2013-1#5)
of cesarean section##2##3##(1991-6#1)(2011-2#1)
of cesium ion##2##3##(2008-10#2)
of cesium##5##2##(2007-12#1)(2008-10#4)
of cessation##2##2##(2010-8#1)(2011-2#1)
of cestode##2##2##(2008-12#2)
of ceterizine hydrochloride##2##3##(2008-10#2)
of cetirizine##6##2##(2010-4#6)
of cetuximab##3##2##(2008-5#1)(2011-2#2)
of cetyl alcohol##2##3##(2008-5#2)
of cetylpyridinium chloride##6##3##(2008-10#6)
of cetylpyridinium##8##2##(2008-10#8)
of cetyltriethylammonium bromide##3##3##(2008-11#3)
of cetyltrimethylammonium bromide (CTAB)##4##4##(2008-10#4)
of cetyltrimethylammonium bromide##6##3##(2008-10#6)
of cetyltrimethylammonium##7##2##(2008-10#7)
of chain##2##2##(1997-6#1)(2008-10#1)
of chains##2##2##(1996-2#1)(2008-3#1)
of chalcogenide##2##2##(2008-10#1)(2008-3#1)
of challenges to the##2##4##(2010-6#1)(2012-12#1)
of challenges##9##2##(1997-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
of challenging##2##2##(2008-10#1)(2010-5#1)
of change and##3##3##(1990-4#1)(1991-1#1)(2008-11#1)
of change for##2##3##(1992-12#1)(1996-1#1)
of change in the##4##4##(1990-10#1)(1992-12#1)(2007-12#1)(2007-5#1)
of change in##29##3##(1990-10#1)(1990-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#4)(2013-1#1)(2013-8#1)
of change of##8##3##(1990-2#1)(1992-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)
of change##84##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#2)(1993-12#1)(1993-5#1)(1994-1#2)(1994-8#1)(1995-12#3)(1995-3#2)(1996-1#3)(1996-2#1)(1996-3#1)(1997-1#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#5)(2010-5#1)(2011-1#3)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
of change&quot##2##2##(2008-3#1)(2008-4#1)
of changes in a##4##4##(1992-8#1)(1993-11#1)(2007-11#1)(2008-9#1)
of changes in population##2##4##(2008-12#1)(2008-8#1)
of changes in the##18##4##(1992-12#1)(1994-2#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
of changes in##76##3##(1991-1#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
of changes of##2##3##(2008-5#1)(2011-1#1)
of changes on##2##3##(1995-12#1)(2012-2#1)
of changes that##2##3##(2008-3#1)(2011-2#1)
of changes to the##3##4##(2008-5#1)(2011-1#1)(2013-1#1)
of changes to##5##3##(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
of changes##100##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#7)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)
of changing the##6##3##(1992-6#1)(1994-2#1)(1996-2#1)(2008-3#2)(2012-1#1)
of changing##24##2##(1990-8#1)(1991-5#1)(1992-6#1)(1994-2#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
of channel activity##4##3##(1995-5#1)(2008-8#3)
of channel gating##2##3##(1997-2#1)(2008-8#1)
of channel inactivation##2##3##(1991-9#1)(2008-8#1)
of channel opening##2##3##(2008-4#1)(2010-12#1)
of channel##17##2##(1991-9#1)(1993-3#1)(1995-5#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#8)(2010-12#1)
of channels and##3##3##(2008-8#1)(2008-9#2)
of channels##14##2##(1994-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#4)
of chaos in##3##3##(2007-11#2)(2008-11#1)
of chaos##7##2##(1995-12#1)(1996-2#1)(2007-11#2)(2008-11#2)(2008-9#1)
of chaotic oscillations in##3##4##(2007-12#3)
of chaotic oscillations##4##3##(2007-12#4)
of chaotic##9##2##(2007-10#1)(2007-11#1)(2007-12#5)(2008-11#1)(2009-5#1)
of character##2##2##(2008-8#2)
of characterising##2##2##(2008-10#1)(2011-3#1)
of characteristic##14##2##(1992-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)
of characteristics including##2##3##(2008-7#1)(2011-2#1)
of characteristics##9##2##(1992-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-2#1)
of characterization of##2##3##(2008-10#1)(2012-1#1)
of characterization##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-1#1)
of characterized##2##2##(1994-12#1)(2011-1#1)
of characterizing##7##2##(1992-12#1)(1996-12#1)(2008-10#1)(2008-3#3)(2008-7#1)
of characters##5##2##(2008-5#2)(2008-8#2)(2010-6#1)
of charge##10##2##(1990-12#1)(1991-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2011-1#1)
of charge-transfer##3##2##(1992-1#1)(2008-10#2)
of charged amino##2##3##(1995-2#1)(1995-6#1)
of charged residues##3##3##(1990-11#1)(1997-9#1)(2011-1#1)
of charged##19##2##(1990-11#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-2#2)(1997-9#1)(2008-10#3)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
of charges##7##2##(1990-12#1)(1991-3#1)(1992-12#1)(1995-12#1)(2008-10#3)
of charity care##6##3##(1992-3#2)(1996-2#3)(2008-11#1)
of charity##8##2##(1992-3#3)(1996-2#4)(2008-11#1)
of checking the##2##3##(2007-8#1)(2013-1#1)
of checking##3##2##(1994-7#1)(2007-8#1)(2013-1#1)
of cheese##3##2##(2008-10#3)
of cheeses##2##2##(2012-2#2)
of chelate##2##2##(2008-10#2)
of chelating agent##2##3##(2008-10#2)
of chelating agents##2##3##(1994-5#1)(1995-3#1)
of chelating resin##2##3##(2008-10#2)
of chelating##10##2##(1994-5#1)(1995-3#1)(2008-10#8)
of chelation##3##2##(2008-10#3)
of chelerythrine and sanguinarine in##2##5##(2008-10#2)
of chelerythrine and sanguinarine##3##4##(2008-10#3)
of chemical analysis and##2##4##(2008-10#2)
of chemical analysis##4##3##(2008-10#3)(2010-5#1)
of chemical and biological##3##4##(2006-12#1)(2007-11#1)(2008-10#1)
of chemical and physical##3##4##(2008-3#1)(2008-7#1)(2010-5#1)
of chemical and##11##3##(2006-12#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-7#1)(2010-5#1)
of chemical aversion therapy##2##4##(1991-12#2)
of chemical aversion##5##3##(1991-12#5)
of chemical components##2##3##(2011-3#1)(2012-3#1)
of chemical composition gratings in fluorine-germanium-doped silica fibers##3##8##(2007-11#3)
of chemical composition gratings in##4##5##(2007-11#4)
of chemical composition gratings##5##4##(2007-11#5)
of chemical composition of##3##4##(2012-3#1)(2013-1#2)
of chemical composition##10##3##(2007-11#5)(2008-10#1)(2012-3#1)(2013-1#3)
of chemical compounds##3##3##(1995-11#1)(1997-4#1)(2008-12#1)
of chemical control and##2##4##(2008-10#2)
of chemical control##3##3##(2008-10#3)
of chemical data##2##3##(2008-10#1)(2008-5#1)
of chemical modification of##3##4##(1990-7#1)(1990-8#1)(1995-2#1)
of chemical modification##7##3##(1990-7#1)(1990-8#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-4#1)
of chemical modifier##2##3##(2008-10#2)
of chemical modifiers##3##3##(2008-10#3)
of chemical oxygen demand values##2##5##(2008-10#2)
of chemical oxygen demand##4##4##(2008-10#4)
of chemical reagents##2##3##(2008-10#1)(2008-5#1)
of chemical shift##2##3##(1995-2#1)(2008-9#1)
of chemical shifts##4##3##(1992-8#1)(1994-8#1)(2008-9#1)(2012-2#1)
of chemical species##2##3##(2008-10#1)(2008-3#1)
of chemical synthesis##2##3##(2008-10#1)(2009-5#1)
of chemical vapor plumes##3##4##(2008-2#1)(2008-3#2)
of chemical##126##2##(1990-7#1)(1990-8#2)(1991-12#5)(1991-9#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1996-4#1)(1997-4#2)(2006-12#1)(2007-11#6)(2007-12#1)(2007-7#1)(2008-10#43)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-5#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
of chemically induced##4##3##(1990-6#1)(1992-5#1)(1995-11#1)(1997-4#1)
of chemically modified##4##3##(2008-10#4)
of chemically##24##2##(1990-6#1)(1991-2#1)(1992-5#1)(1993-11#2)(1994-2#1)(1995-11#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-9#2)
of chemicals and contaminated environmental samples##2##6##(2008-11#2)
of chemicals and##3##3##(2008-11#2)(2008-5#1)
of chemicals in the##2##4##(2008-11#1)(2011-2#1)
of chemicals in##6##3##(1997-4#1)(2008-10#3)(2008-11#1)(2011-2#1)
of chemicals to##3##3##(2007-5#1)(2008-11#1)(2012-1#1)
of chemicals##30##2##(1994-11#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-11#11)(2008-5#2)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of chemiluminescence and##2##3##(2008-10#2)
of chemiluminescence##6##2##(2008-10#6)
of chemiluminescent##2##2##(2008-10#1)(2010-11#1)
of chemisorption##2##2##(2008-10#2)
of chemistry##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)
of chemokines##7##2##(2008-10#1)(2008-2#1)(2009-12#1)(2012-1#3)(2013-1#1)
of chemometrics##7##2##(2008-10#6)(2010-5#1)
of chemosensory##2##2##(1995-3#1)(2007-12#1)
of chemotactic##3##2##(1994-6#1)(2009-12#1)(2010-5#1)
of chemotaxis assays##2##3##(2009-12#2)
of chemotaxis##10##2##(1990-12#1)(1993-6#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-12#2)
of chemotherapeutic agents##5##3##(1990-2#1)(1997-7#1)(2008-11#1)(2012-2#2)
of chemotherapeutic##8##2##(1990-2#1)(1992-2#1)(1992-8#1)(1997-7#2)(2008-11#1)(2012-2#2)
of chemotherapy and##12##3##(1991-8#2)(2006-6#1)(2008-6#1)(2008-7#4)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
of chemotherapy for##5##3##(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
of chemotherapy had##2##3##(1990-6#1)(2010-3#1)
of chemotherapy in breast cancer##2##5##(2007-5#1)(2008-7#1)
of chemotherapy in the##3##4##(1990-6#1)(1997-5#1)(2010-3#1)
of chemotherapy in##10##3##(1990-6#1)(1994-8#1)(1997-5#1)(2007-5#1)(2008-6#2)(2008-7#2)(2010-3#1)(2012-1#1)
of chemotherapy with##2##3##(1995-10#1)(2013-1#1)
of chemotherapy##73##2##(1990-6#2)(1990-9#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#2)(1994-8#1)(1995-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#7)(2008-7#12)(2010-3#6)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#7)(2013-7#1)
of chemotherapy-associated anemia##2##3##(2008-7#2)
of chemotherapy-induced emesis##4##3##(2008-7#4)
of chemotherapy-induced febrile neutropenia##2##4##(2008-7#2)
of chemotherapy-induced nausea and vomiting##3##5##(2010-12#2)(2010-9#1)
of chemotherapy-induced##14##2##(2008-11#1)(2008-7#9)(2010-11#1)(2010-12#2)(2010-9#1)
of chenodeoxycholic acid##2##3##(1990-8#1)(2008-10#1)
of chest pain centers##3##4##(2008-3#3)
of chest pain patients in the##3##6##(2008-3#2)(2012-2#1)
of chest pain##14##3##(1997-2#1)(2008-10#1)(2008-3#7)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#2)
of chest wall##11##3##(1992-6#1)(2006-10#2)(2007-12#1)(2007-8#4)(2012-2#3)
of chest##34##2##(1991-2#1)(1992-6#1)(1995-2#1)(1997-2#1)(2006-10#3)(2007-12#1)(2007-8#4)(2008-10#1)(2008-3#7)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#6)
of chestnut blight##2##3##(2008-10#2)
of chewing lice##2##3##(2011-2#2)
of chewing##4##2##(2009-4#1)(2010-12#1)(2011-2#2)
of chi((2))##2##2##(2007-11#2)
of chi((3))##2##2##(2007-11#2)
of chiasmata##2##2##(2008-5#2)
of chiasmate chromosome arms in female meiosis than in male meiosis##2##11##(2008-5#2)
of chick##4##2##(1993-6#1)(1996-2#2)(1997-4#1)
of chicken PTH-(1-88)##2##3##(1991-3#2)
of chicken and##2##3##(1993-12#1)(2010-3#1)
of chicken brain##2##3##(1993-6#2)
of chicken breast tissue##2##4##(2008-2#2)
of chicken embryos##2##3##(1992-3#1)(2008-8#1)
of chicken heart apocytochrome c##2##5##(2008-8#2)
of chicken liver##2##3##(1990-11#1)(1990-5#1)
of chicken##39##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#2)(1992-11#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-11#1)(1997-3#1)(1997-6#1)(1997-9#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-8#4)(2010-3#2)(2010-4#1)(2013-8#1)
of chickens with##2##3##(1997-6#1)(2008-5#1)
of chickens##7##2##(1997-6#1)(2007-6#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)
of chickpea (Cicer##2##3##(2008-10#2)
of chickpea##8##2##(2008-10#8)
of chickpeas##2##2##(2008-10#2)
of chicks with##2##3##(1991-3#1)(1997-3#1)
of chicks##9##2##(1990-3#1)(1991-3#2)(1997-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#2)
of chief##2##2##(1993-3#1)(1995-8#1)
of chikungunya virus##2##3##(2011-1#2)
of chikungunya##5##2##(2011-1#4)(2013-8#1)
of child abuse##8##3##(1992-1#1)(1995-5#1)(1996-2#1)(2007-12#3)(2009-9#2)
of child and adolescent##2##4##(2008-9#1)(2011-2#1)
of child and##4##3##(1994-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
of child care and protection##2##5##(1995-5#2)
of child development and##2##4##(1996-9#1)(2011-1#1)
of child development##5##3##(1995-1#1)(1996-9#1)(2010-12#1)(2011-1#2)
of child health##3##3##(1994-6#1)(2009-7#1)(2012-3#1)
of child sexual##2##3##(1992-1#1)(1995-5#1)
of child well-being##3##3##(2008-11#1)(2008-2#1)(2010-3#1)
of child##47##2##(1992-1#2)(1993-12#3)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#6)(1996-2#3)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
of childbearing age in##2##4##(1991-1#1)(2010-4#1)
of childbearing age##5##3##(1991-1#1)(1992-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
of childbearing##9##2##(1990-2#1)(1991-1#1)(1992-12#1)(2009-10#1)(2010-4#1)(2013-1#3)(2013-8#1)
of childbirth##7##2##(1995-1#1)(2007-2#5)(2010-6#1)
of childhood acute lymphoblastic##2##4##(2010-11#1)(2011-2#1)
of childhood and##7##3##(1990-12#1)(1993-1#1)(1995-5#1)(2007-7#1)(2008-10#1)(2010-3#1)(2010-4#1)
of childhood asthma##2##3##(2008-11#2)
of childhood community adversity on young adult##2##7##(2010-7#2)
of childhood community adversity##4##4##(2010-7#4)
of childhood community contexts##2##4##(2010-7#2)
of childhood community##6##3##(2010-7#6)
of childhood obesity##5##3##(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
of childhood that##2##3##(1997-8#1)(2011-2#1)
of childhood##53##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#2)(1993-1#1)(1994-2#2)(1995-3#1)(1995-5#3)(1997-8#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#6)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
of children aged##6##3##(1990-12#2)(2007-7#1)(2010-11#1)(2010-6#1)(2013-1#1)
of children and adolescents with##4##5##(2008-11#1)(2010-5#1)(2011-2#2)
of children and adolescents##15##4##(1991-2#1)(1993-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#2)(2011-2#3)(2013-1#3)
of children and their families##3##5##(1994-1#1)(2008-11#1)(2010-12#1)
of children and their##4##4##(1994-1#1)(1995-12#1)(2008-11#1)(2010-12#1)
of children and##30##3##(1991-2#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-1#1)(1995-12#1)(1997-6#1)(2007-3#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#3)(2011-2#3)(2013-1#3)
of children are##3##3##(1997-2#1)(2008-11#1)(2011-1#1)
of children at risk for##2##5##(1996-12#1)(2009-7#1)
of children at risk##4##4##(1991-12#1)(1996-12#1)(2008-12#1)(2009-7#1)
of children born##3##3##(1992-5#1)(2011-1#1)(2013-1#1)
of children from##3##3##(1990-6#1)(1996-12#1)(2013-1#1)
of children hospitalized in##2##4##(1992-2#1)(2009-5#1)
of children in a##4##4##(2011-2#2)(2012-3#1)(2013-8#1)
of children in the##3##4##(2008-9#1)(2012-12#1)(2013-7#1)
of children in##17##3##(1992-3#1)(1993-12#1)(1997-1#1)(1997-4#3)(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
of children is##2##3##(1991-12#1)(1994-8#1)
of children presenting to the##2##5##(2008-1#1)(2008-11#1)
of children presenting##3##3##(2008-1#1)(2008-11#2)
of children receiving##2##3##(1996-1#1)(2007-11#1)
of children treated with##2##4##(2007-11#1)(2011-2#1)
of children treated##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
of children undergoing##2##3##(2009-4#1)(2010-7#1)
of children was##3##3##(2011-1#2)(2013-8#1)
of children who are technology dependent##2##6##(1992-1#2)
of children who are##4##4##(1992-1#2)(1992-3#1)(2009-9#1)
of children who have##2##4##(1991-1#1)(2008-11#1)
of children who receive##2##4##(1994-6#1)(2010-4#1)
of children who received##2##4##(2008-11#1)(2008-6#1)
of children who were##2##4##(1995-1#1)(1995-12#1)
of children who##19##3##(1991-1#1)(1992-1#2)(1992-3#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-11#2)(2008-2#2)(2008-6#1)(2008-9#1)(2009-9#2)(2010-4#1)(2011-1#1)
of children with ADHD##3##4##(1996-6#1)(2008-11#1)(2011-2#1)
of children with AIDS##3##4##(2012-3#3)
of children with a##3##4##(1993-1#1)(2008-9#1)(2010-10#1)
of children with cerebral palsy##2##5##(2009-4#1)(2011-2#1)
of children with chronic illness##2##5##(1993-1#1)(1997-2#1)
of children with chronic illnesses##2##5##(1991-8#1)(1995-12#1)
of children with chronic##7##4##(1991-8#1)(1993-1#3)(1995-12#1)(1997-2#1)(2011-2#1)
of children with cochlear implants##5##5##(2008-9#5)
of children with complex##2##4##(2008-11#1)(2012-2#1)
of children with developmental##2##4##(1993-1#1)(2012-2#1)
of children with diabetes##6##4##(1994-6#1)(1995-2#3)(1995-3#1)(2009-10#1)
of children with disabilities##4##4##(1994-1#2)(1995-1#1)(1996-1#1)
of children with learning difficulties##2##5##(2008-11#2)
of children with learning disabilities##2##5##(2011-1#2)
of children with learning##4##4##(2008-11#2)(2011-1#2)
of children with liver disease##2##5##(1996-1#2)
of children with mental##2##4##(1991-8#1)(1993-3#1)
of children with severe disabilities##2##5##(1993-3#1)(1996-1#1)
of children with severe##5##4##(1993-3#3)(1996-1#1)(2009-3#1)
of children with##106##3##(1990-12#1)(1990-8#1)(1991-8#2)(1992-11#1)(1992-2#2)(1993-1#6)(1993-3#6)(1994-1#2)(1994-3#1)(1994-6#2)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#2)(1996-1#4)(1996-11#1)(1996-6#2)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#6)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#6)(2011-2#8)(2011-5#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)
of children within##2##3##(2010-12#1)(2010-8#1)
of children##291##2##(1990-12#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-8#2)(1992-1#3)(1992-11#1)(1992-2#4)(1992-3#3)(1992-4#2)(1992-5#2)(1993-1#9)(1993-12#2)(1993-3#6)(1994-1#3)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#1)(1995-1#5)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-4#5)(1997-6#1)(2006-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#22)(2008-12#4)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#15)(2009-10#4)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#14)(2011-2#21)(2011-5#1)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#11)(2013-7#3)(2013-8#2)
of children's artwork to evaluate the effectiveness of a hospital preparation program##2##12##(1992-1#2)
of children's mental health##2##4##(1993-1#1)(2010-12#1)
of children's reactive control##2##4##(2011-2#2)
of children's##24##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-1#2)(1992-3#2)(1993-1#2)(1995-1#1)(2008-11#3)(2008-2#3)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
of chili powder##2##3##(2008-10#2)
of chill accumulation##2##3##(2012-4#1)(2012-8#1)
of chill-hours##2##2##(2008-10#2)
of chilling##3##2##(2008-10#1)(2012-4#1)(2012-8#1)
of chimeras##2##2##(2008-4#2)
of chimeric and##2##3##(2008-10#1)(2008-11#1)
of chimeric genes##3##3##(1990-11#1)(2008-4#1)(2008-6#1)
of chimeric##14##2##(1990-11#1)(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2013-7#1)
of chiral discrimination##2##3##(2008-10#2)
of chiral induction##2##3##(2009-10#1)(2010-12#1)
of chiral##20##2##(1992-11#1)(1994-8#3)(1995-3#2)(2007-11#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-4#1)(2012-3#1)
of chirality##2##2##(1995-3#1)(2009-12#1)
of chiropractic and##2##3##(1990-6#1)(2007-11#1)
of chirped pulses##2##3##(2007-11#1)(2008-2#1)
of chirped##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
of chitin in the##2##4##(2008-10#2)
of chitin##10##2##(2008-10#9)(2011-2#1)
of chitinase##3##2##(2008-10#3)
of chitinases##2##2##(2008-10#2)
of chitobiase enzyme##2##3##(1992-10#2)
of chitobiase gene expression##2##4##(1992-10#2)
of chitobiase##4##2##(1992-10#4)
of chitosan as##2##3##(2008-5#1)(2012-2#1)
of chitosan was##2##3##(2008-10#2)
of chitosan##12##2##(2008-10#6)(2008-5#5)(2012-2#1)
of chitosan/pGM-CSF complexes##2##3##(2012-2#2)
of chlamydia##3##2##(1990-5#1)(2012-1#1)(2012-3#1)
of chlamydial##3##2##(1990-2#2)(2009-8#1)
of chlamydospores##6##2##(2008-10#3)(2010-10#2)(2010-3#1)
of chlorambucil##2##2##(1995-3#1)(2008-11#1)
of chloramphenicol##9##2##(1991-2#1)(1995-6#1)(2008-10#7)
of chloranilic acid##2##3##(2008-10#2)
of chlorate##4##2##(2008-10#4)
of chlordiazepoxide on##3##3##(1992-7#2)(1993-12#1)
of chlordiazepoxide##5##2##(1992-7#3)(1993-12#2)
of chloride and##2##3##(2008-10#2)
of chloride channel##2##3##(1994-6#1)(2011-3#1)
of chloride in drinking and ground water##2##7##(2008-10#2)
of chloride in##8##3##(2008-10#8)
of chloride ion in aqueous samples##2##6##(2008-10#2)
of chloride ion in##3##4##(2008-10#3)
of chloride ion##6##3##(2008-10#5)(2013-8#1)
of chloride reactant##2##3##(2008-10#2)
of chloride with##2##3##(1994-5#1)(2008-10#1)
of chloride##42##2##(1991-9#1)(1994-5#3)(1994-6#1)(1995-11#1)(2008-10#33)(2011-3#1)(2013-1#1)(2013-8#1)
of chlorides and##2##3##(2008-10#2)
of chlorides##3##2##(2008-10#3)
of chlorinated biphenyls (CBs)##2##4##(2008-10#2)
of chlorinated##8##2##(1992-5#1)(2008-10#5)(2008-2#1)(2011-1#1)
of chlorine and##2##3##(2008-9#1)(2009-8#1)
of chlorine dioxide in##3##4##(2008-10#3)
of chlorine##11##2##(1995-6#1)(2008-10#8)(2008-9#1)(2009-8#1)
of chlorite in drinking##2##4##(2008-10#2)
of chlorite##5##2##(2008-10#4)(2009-2#1)
of chloro-organic product formation##2##4##(2009-8#2)
of chloro-organic##3##2##(2009-8#3)
of chloroacetic acids (mono-##2##4##(2008-10#2)
of chloroacetic acids##3##3##(2008-10#3)
of chloroaluminum (III) tetrasulphonated naphthalocyanine##2##5##(2008-10#2)
of chlorobenzenes##2##2##(2008-10#2)
of chlorofluorocarbon (CFC) propellants##2##4##(1992-3#2)
of chlorofluorocarbon (CFC)##3##3##(1992-3#2)(1996-1#1)
of chloroform and##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
of chloroform##7##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-9#1)
of chlorogenic acid##8##3##(2008-10#4)(2008-11#4)
of chloroguaiacol##2##2##(2008-10#2)
of chloroperoxidase##2##2##(1994-5#1)(1994-6#1)
of chlorophenols##3##2##(2008-10#2)(2012-1#1)
of chlorophenoxyacid herbicides##4##3##(2008-10#4)
of chlorophyll a##5##3##(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
of chlorophyll concentration and depth##2##5##(2008-3#2)
of chlorophyll concentration##3##3##(2008-3#3)
of chlorophyll##18##2##(1992-8#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#9)(2008-8#2)(2009-10#1)
of chlorophylls a and b##3##5##(2008-10#3)
of chlorophylls and pheopigments##2##4##(2008-10#2)
of chlorophylls##5##2##(2008-10#5)
of chloroplast DNA##2##3##(1997-2#1)(2008-5#1)
of chloroplast and mitochondrial##2##4##(2008-7#2)
of chloroplast##9##2##(1995-2#1)(1997-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)
of chloroplasts##3##2##(1997-6#1)(2008-10#1)(2009-8#1)
of chloroquine##12##2##(1993-8#2)(1994-3#2)(1996-8#1)(2008-10#6)(2009-4#1)
of chlorosis##3##2##(2008-10#3)
of chlorotic##3##2##(2008-10#3)
of chlorotriazines##2##2##(2008-10#2)
of chlorovinylarsines##2##2##(2008-11#2)
of chlorpromazine hydrochloride##3##3##(2008-10#3)
of chlorpromazine##7##2##(2008-10#6)(2012-2#1)
of chlortetracycline##5##2##(2008-10#5)
of choanoflagellate##2##2##(2010-2#2)
of choice and##6##3##(1992-9#1)(1995-1#2)(1995-2#1)(1996-11#1)(2011-2#1)
of choice are##2##3##(2007-8#1)(2008-11#1)
of choice for many##2##4##(1991-5#1)(2010-10#1)
of choice for patients with##3##5##(2007-7#1)(2009-12#1)(2010-10#1)
of choice for symptomatic##3##4##(2008-10#1)(2008-8#1)(2009-3#1)
of choice for the##7##4##(1996-2#1)(1997-2#1)(1997-4#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)
of choice for##51##3##(1991-10#1)(1991-5#1)(1991-9#1)(1992-11#2)(1994-12#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-6#3)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
of choice has##2##3##(2008-10#1)(2011-2#1)
of choice in the##8##4##(1990-2#1)(2007-11#3)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
of choice in treating##2##4##(2010-8#1)(2011-2#1)
of choice in##35##3##(1990-2#1)(1990-9#1)(1991-6#1)(1992-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-9#1)(2007-11#6)(2007-7#1)(2007-8#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
of choice is##5##3##(1990-2#1)(1992-9#1)(1994-5#1)(1996-9#1)(2013-1#1)
of choice of##2##3##(1992-3#1)(1993-6#1)
of choice to assist##2##4##(2011-7#1)(2012-12#1)
of choice was##2##3##(2008-7#1)(2009-3#1)
of choice were##2##3##(2008-6#1)(2008-8#1)
of choice when##3##3##(1990-2#1)(1997-2#1)(2012-12#1)
of choice##168##2##(1990-2#3)(1990-3#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-9#7)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#8)(2007-7#3)(2007-8#10)(2008-1#4)(2008-10#7)(2008-11#5)(2008-2#3)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-6#5)(2010-8#3)(2011-2#11)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
of choices##3##2##(1993-3#1)(1994-9#1)(2008-11#1)
of cholangiocarcinoma##4##2##(2008-2#1)(2009-9#2)(2013-8#1)
of cholecystokinin (CCK)##3##3##(1990-12#1)(1996-2#1)(2008-7#1)
of cholecystokinin and dopamine##2##4##(1993-12#2)
of cholecystokinin and##4##3##(1993-12#2)(1995-12#1)(1997-1#1)
of cholecystokinin##10##2##(1990-12#1)(1993-12#2)(1995-12#3)(1996-2#1)(1997-1#1)(2008-7#2)
of choledocholithiasis in##2##3##(2008-5#1)(2009-9#1)
of choledocholithiasis##5##2##(1994-3#1)(1997-8#1)(2008-5#2)(2009-9#1)
of cholelithiasis##4##2##(1991-3#1)(1993-9#1)(2013-1#1)(2013-8#1)
of cholera in##2##3##(1992-5#1)(2007-2#1)
of cholera to##2##3##(2007-2#2)
of cholera toxin##2##3##(1993-9#1)(1997-3#1)
of cholera##15##2##(1992-5#2)(1992-6#1)(1993-3#2)(1993-9#1)(1997-3#1)(2007-2#5)(2008-10#2)(2008-8#1)
of cholestanol##4##2##(1992-6#4)
of cholestatic jaundice##2##3##(1992-9#1)(2013-1#1)
of cholestatic##7##2##(1992-6#1)(1992-9#1)(1996-3#1)(2008-8#3)(2013-1#1)
of cholesteatoma##2##2##(2011-2#1)(2013-1#1)
of cholesterol accumulation##2##3##(1992-6#1)(2013-1#1)
of cholesterol and##6##3##(1990-8#1)(1991-4#1)(1992-6#1)(2008-10#2)(2012-2#1)
of cholesterol content in##2##4##(2013-8#2)
of cholesterol esterification##2##3##(1990-8#1)(1994-8#1)
of cholesterol for##2##3##(1993-6#1)(1995-5#1)
of cholesterol from##2##3##(1994-8#2)
of cholesterol in egg yolk##2##5##(2008-10#2)
of cholesterol in solution##2##4##(2008-10#2)
of cholesterol in##7##3##(1995-12#1)(2008-10#5)(2013-1#1)
of cholesterol into##2##3##(1992-6#1)(1994-8#1)
of cholesterol lowering##2##3##(1991-8#2)
of cholesterol metabolism##3##3##(1993-3#1)(1993-6#1)(2013-1#1)
of cholesterol on##4##3##(1990-2#1)(1992-6#2)(1997-5#1)
of cholesterol synthesis##2##3##(1991-5#1)(1991-6#1)
of cholesterol to##3##3##(1990-3#1)(1992-6#1)(1994-8#1)
of cholesterol transport##2##3##(1996-2#1)(2006-12#1)
of cholesterol with##2##3##(2008-10#2)
of cholesterol##81##2##(1990-12#1)(1990-2#5)(1990-3#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-6#8)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#2)(2006-12#1)(2008-10#16)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#2)
of cholesterol-lowering##5##2##(1991-6#2)(2008-4#1)(2008-6#1)(2011-1#1)
of cholesteryl ester transfer protein##3##5##(1995-5#1)(2008-12#2)
of cholesteryl ester##4##3##(1992-3#1)(1995-5#1)(2008-12#2)
of cholesteryl esters##2##3##(1992-3#1)(1996-5#1)
of cholesteryl##6##2##(1992-3#2)(1995-5#1)(1996-5#1)(2008-12#2)
of cholic##2##2##(2008-10#2)
of choline acetyltransferase (ChAT)##2##4##(1993-3#1)(2009-11#1)
of choline acetyltransferase##4##3##(1993-3#1)(1996-2#1)(2008-10#1)(2009-11#1)
of choline and##2##3##(1990-12#1)(1995-3#1)
of choline to females##2##4##(1995-6#2)
of choline##14##2##(1990-11#1)(1990-12#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#1)(2008-10#3)(2009-11#1)
of cholinergic nerve##2##3##(2008-5#1)(2008-8#1)
of cholinergic neurons##2##3##(1997-2#1)(2008-5#1)
of cholinergic transmission##4##3##(2008-8#3)(2013-8#1)
of cholinergic##20##2##(1990-7#1)(1991-7#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-5#3)(2008-8#4)(2013-1#1)(2013-8#2)
of cholinesterase inhibitors##3##3##(1991-12#1)(1994-6#1)(2008-10#1)
of cholinesterase##5##2##(1991-12#1)(1994-6#1)(2008-10#1)(2010-9#1)(2011-1#1)
of cholinomimetics##2##2##(1991-12#1)(1994-6#1)
of chondroblastic osteosarcoma##2##3##(2013-1#2)
of chondrocyte##2##2##(1992-1#1)(2008-7#1)
of chondrocytes in##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
of chondrocytes##8##2##(2008-11#4)(2008-7#1)(2008-9#1)(2011-2#2)
of chondrogenic##2##2##(2008-11#2)
of choosing##3##2##(1993-3#1)(1995-6#1)(2008-2#1)
of chorea##4##2##(2008-7#1)(2011-10#3)
of chosen##2##2##(1997-6#1)(2013-8#1)
of chromaffin cells##3##3##(1992-6#1)(1993-12#2)
of chromate##2##2##(2008-10#2)
of chromatic##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
of chromatin condensation##2##3##(1991-9#1)(2008-7#1)
of chromatin structure##4##3##(1996-2#1)(2008-2#2)(2010-2#1)
of chromatin##19##2##(1990-11#1)(1991-9#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#2)(2011-2#1)(2011-9#1)(2012-2#1)
of chromatographic analysis##2##3##(2008-10#2)
of chromatographic methods##2##3##(2008-10#2)
of chromatographic resolution##2##3##(2008-10#2)
of chromatographic##14##2##(1993-8#1)(2007-12#1)(2008-10#12)
of chromatography##4##2##(1991-5#1)(1997-2#1)(2008-10#1)(2010-7#1)
of chromatophores in##2##3##(2008-5#2)
of chromatophores##5##2##(2008-5#5)
of chromium (III) converted to chromium (VI)##2##7##(2008-10#2)
of chromium (III)##5##3##(2008-10#5)
of chromium (VI) with##3##4##(2008-10#3)
of chromium (VI)##6##3##(2008-10#6)
of chromium and##4##3##(2008-10#3)(2008-12#1)
of chromium by##2##3##(2008-10#2)
of chromium determination##2##3##(2008-10#2)
of chromium in drinking water samples by##2##7##(2008-10#2)
of chromium in gallium##2##4##(2008-10#2)
of chromium in mineral waters and salinas##2##7##(2008-10#2)
of chromium in##20##3##(2008-10#20)
of chromium is##4##3##(2008-10#4)
of chromium species##3##3##(2008-10#3)
of chromium used for hologram formation##2##6##(2008-2#2)
of chromium using##2##3##(2008-10#2)
of chromium##78##2##(1996-12#1)(2007-11#1)(2008-10#69)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)
of chromium(III) in##2##3##(2008-10#2)
of chromium(III)##6##2##(2008-10#6)
of chromium(V) in the##2##4##(2008-10#2)
of chromium(V)##4##2##(2008-10#4)
of chromium(VI) and##4##3##(2008-10#4)
of chromium(VI) by##4##3##(2008-10#4)
of chromium(VI) in##9##3##(2008-10#9)
of chromium(VI) ion##2##3##(2008-10#2)
of chromium(VI) with iron(II)##2##4##(2008-10#2)
of chromium(VI) with##4##3##(2008-10#4)
of chromium(VI)##31##2##(2008-10#31)
of chromogenic##4##2##(1990-8#1)(1992-12#1)(2008-10#1)(2012-3#1)
of chromogranin A##4##3##(1993-8#2)(1994-11#1)(2010-11#1)
of chromogranin##5##2##(1992-12#1)(1993-8#2)(1994-11#1)(2010-11#1)
of chromophore##7##2##(1993-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
of chromophores##3##2##(1997-7#1)(2007-12#1)(2008-5#1)
of chromosomal DNA##2##3##(1997-3#1)(2007-11#1)
of chromosomal aberrations##2##3##(2008-11#1)(2012-12#1)
of chromosomal damage##2##3##(1992-8#1)(2012-2#1)
of chromosomal integration of transgenes in microinjected##2##7##(1993-6#2)
of chromosomal integration of##3##4##(1993-6#2)(1997-4#1)
of chromosomal integration##4##3##(1993-6#2)(1994-2#1)(1997-4#1)
of chromosomal rearrangements on gene flow##2##6##(2012-3#2)
of chromosomal rearrangements##3##3##(2009-2#1)(2012-3#2)
of chromosomal##30##2##(1990-8#1)(1992-8#1)(1993-6#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
of chromosome 1##5##3##(1996-10#1)(2007-11#1)(2008-10#2)(2012-3#1)
of chromosome 11##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
of chromosome 13##3##3##(2008-9#1)(2013-1#2)
of chromosome 16##2##3##(1994-11#1)(1997-5#1)
of chromosome 2##2##3##(1990-12#1)(1997-8#1)
of chromosome 22##2##3##(1997-5#1)(2012-12#1)
of chromosome 3##5##3##(1997-2#1)(2008-7#2)(2009-10#2)
of chromosome 3H##2##3##(2008-10#2)
of chromosome 4##3##3##(2007-12#1)(2009-10#1)(2012-3#1)
of chromosome 5##7##3##(1996-10#1)(1997-5#2)(1997-6#1)(1997-8#2)(2012-12#1)
of chromosome 5q##2##3##(1997-5#1)(2012-12#1)
of chromosome 6##5##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
of chromosome 9##3##3##(1994-6#1)(2007-11#1)(2008-7#1)
of chromosome II##3##3##(1995-11#1)(1996-6#1)(2012-3#1)
of chromosome V##2##3##(1995-6#1)(1996-6#1)
of chromosome VI were##2##4##(1997-6#2)
of chromosome VIII##3##3##(1995-6#3)
of chromosome X##3##3##(1995-6#1)(1996-6#1)(2007-7#1)
of chromosome XIII##2##3##(1995-9#1)(2008-8#1)
of chromosome breakage##3##3##(1997-3#1)(2012-3#2)
of chromosome microdissection and microcloning##3##5##(2008-7#3)
of chromosome##132##2##(1990-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-6#1)(1995-11#1)(1995-6#14)(1995-9#4)(1996-10#2)(1996-2#1)(1996-3#4)(1996-6#7)(1996-8#2)(1997-2#2)(1997-3#3)(1997-5#6)(1997-6#3)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#3)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#3)(2010-1#1)(2010-3#4)(2012-12#4)(2012-3#6)(2013-1#3)(2013-8#1)
of chromosomes and##2##3##(2007-11#1)(2008-9#1)
of chromosomes in the##2##4##(2008-12#1)(2013-1#1)
of chromosomes in##4##3##(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
of chromosomes##34##2##(1990-5#1)(1991-4#1)(1992-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-12#1)(2010-3#1)(2011-2#1)(2012-3#3)(2013-1#2)
of chromotropic acid##2##3##(2008-10#2)
of chronic HCV infection##2##4##(2009-4#1)(2013-1#1)
of chronic HCV##4##3##(2009-3#1)(2009-4#1)(2013-1#2)
of chronic TRZ##2##3##(1996-12#2)
of chronic active##2##3##(1991-6#1)(2008-9#1)
of chronic and##4##3##(1990-6#1)(1991-11#1)(2009-12#1)(2012-3#1)
of chronic angina pectoris##2##4##(2008-12#2)
of chronic benign pain syndrome##2##5##(1997-1#2)
of chronic bronchitis and##2##4##(1996-8#1)(2008-7#1)
of chronic bronchitis in elderly patients##2##6##(1990-2#2)
of chronic bronchitis##7##3##(1990-2#2)(1996-11#1)(1996-8#1)(1997-4#1)(2008-7#2)
of chronic cerebral hypoperfusion##2##4##(2008-7#1)(2009-6#1)
of chronic cerebral##3##3##(2008-7#2)(2009-6#1)
of chronic cerebrospinal venous insufficiency##4##5##(2012-3#3)(2013-1#1)
of chronic cocaine##2##3##(1991-1#2)
of chronic conditions##6##3##(1992-12#1)(1997-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of chronic congestive heart failure##2##5##(2008-7#2)
of chronic dialysis##2##3##(2007-7#1)(2008-1#1)
of chronic disease##10##3##(1995-3#1)(2006-10#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
of chronic diseases and##4##4##(1992-5#1)(1996-6#1)(2008-10#1)(2008-12#1)
of chronic diseases in##2##4##(1991-3#1)(2012-2#1)
of chronic diseases##13##3##(1991-3#1)(1992-5#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-2#2)(2010-8#1)(2012-2#2)(2013-7#1)(2013-8#1)
of chronic fatigue syndrome##2##4##(2009-10#1)(2010-1#1)
of chronic fatigue##4##3##(2008-10#2)(2009-10#1)(2010-1#1)
of chronic granulomatous disease##4##4##(1992-5#1)(1993-11#1)(2013-1#2)
of chronic headache##2##3##(1996-2#1)(2008-9#1)
of chronic heart failure##6##4##(2008-3#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-3#1)
of chronic heart##7##3##(1992-6#1)(2008-3#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-3#1)
of chronic hepatitis B virus (HBV) infection##2##7##(2008-10#1)(2009-8#1)
of chronic hepatitis B##9##4##(1993-2#1)(2007-12#1)(2008-10#1)(2009-8#4)(2011-2#1)(2013-8#1)
of chronic hepatitis C##4##4##(2007-12#1)(2009-5#1)(2012-12#1)(2013-7#1)
of chronic hepatitis due to##2##5##(1995-10#1)(2013-1#1)
of chronic hepatitis##17##3##(1991-8#1)(1993-2#1)(1995-10#1)(2007-12#2)(2008-10#1)(2009-5#1)(2009-8#5)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
of chronic hypertension##2##3##(2008-4#2)
of chronic hypoxia##2##3##(1996-12#1)(2010-4#1)
of chronic illness##4##3##(1991-8#1)(1997-1#1)(2013-1#2)
of chronic infection##2##3##(2006-10#1)(2008-7#1)
of chronic inflammation and##2##4##(2012-2#2)
of chronic inflammation##6##3##(1992-6#1)(2008-9#2)(2012-2#2)(2013-1#1)
of chronic inflammatory bowel##2##4##(1994-2#1)(1996-2#1)
of chronic inflammatory##6##3##(1994-2#1)(1996-2#1)(2008-4#2)(2008-5#1)(2013-1#1)
of chronic kidney disease##7##4##(2008-8#1)(2009-1#2)(2010-10#1)(2011-2#2)(2012-2#1)
of chronic liver disease##6##4##(2007-7#1)(2008-1#2)(2009-8#2)(2010-12#1)
of chronic lung disease##3##4##(1992-2#1)(1994-6#1)(2006-10#1)
of chronic lymphocytic leukemia (CLL)##3##5##(2009-12#1)(2009-2#1)(2011-2#1)
of chronic lymphocytic##4##3##(2008-7#1)(2009-12#1)(2009-2#1)(2011-2#1)
of chronic myeloid leukemia cells##2##5##(1990-2#1)(2012-12#1)
of chronic myeloid leukemia##5##4##(1990-2#1)(2010-11#2)(2011-2#1)(2012-12#1)
of chronic obstructive lung##2##4##(1995-2#1)(2008-1#1)
of chronic obstructive pulmonary disease (COPD)##6##6##(1991-4#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
of chronic obstructive pulmonary disease##11##5##(1991-4#1)(2007-12#1)(2008-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
of chronic obstructive##14##3##(1991-4#2)(1995-2#1)(2007-12#1)(2008-1#2)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
of chronic or##2##3##(2008-1#1)(2010-3#1)
of chronic osteomyelitis##3##3##(2007-7#2)(2010-6#1)
of chronic pain syndrome##2##4##(2008-4#2)
of chronic pain##7##3##(2008-4#5)(2010-12#1)(2012-3#1)
of chronic pancreatitis##3##3##(1991-8#1)(2009-7#1)(2011-2#1)
of chronic patients##2##3##(2011-1#1)(2012-12#1)
of chronic pelvic pain##2##4##(1991-2#1)(2008-8#1)
of chronic periodontitis patients and healthy subjects##2##7##(2008-12#2)
of chronic periodontitis patients and##3##5##(2008-12#3)
of chronic periodontitis##5##3##(2008-12#5)
of chronic polyarthritis##2##3##(1990-6#1)(1993-6#1)
of chronic renal disease##3##4##(1994-3#1)(2008-1#1)(2011-2#1)
of chronic renal failure##7##4##(1990-2#1)(2007-7#2)(2008-1#2)(2011-1#1)(2011-2#1)
of chronic renal insufficiency##2##4##(2011-2#2)
of chronic renal##13##3##(1990-2#1)(1994-3#1)(2007-7#2)(2008-1#4)(2011-1#1)(2011-2#4)
of chronic resistive airway loading on##2##6##(2013-1#2)
of chronic respiratory##2##3##(2007-2#1)(2010-8#1)
of chronic rhinosinusitis##4##3##(2011-2#1)(2012-1#3)
of chronic suppurative##2##3##(1997-1#1)(2008-9#1)
of chronic thromboembolic pulmonary hypertension (CTEPH)##2##6##(2010-6#2)
of chronic total occlusions##2##4##(2008-12#2)
of chronic total##3##3##(2008-12#3)
of chronic treatment with the##2##5##(1993-3#1)(2010-6#1)
of chronic treatment with##5##4##(1992-3#1)(1993-3#1)(1995-12#1)(2010-6#1)(2013-1#1)
of chronic use##2##3##(1991-1#1)(2013-1#1)
of chronic versus acute EtOH##2##5##(2008-10#2)
of chronic viral infections##2##4##(2008-8#1)(2010-5#1)
of chronic viral##3##3##(2007-12#1)(2008-8#1)(2010-5#1)
of chronic##333##2##(1990-2#4)(1990-6#3)(1990-9#1)(1991-1#7)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1994-11#1)(1994-2#4)(1994-3#1)(1994-6#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#7)(1997-2#2)(1997-4#3)(1997-6#1)(2006-10#5)(2007-10#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#6)(2008-1#12)(2008-10#8)(2008-11#4)(2008-12#11)(2008-3#2)(2008-4#11)(2008-5#4)(2008-6#2)(2008-7#16)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-8#3)(2011-1#4)(2011-2#27)(2012-1#3)(2012-12#7)(2012-2#8)(2012-3#10)(2013-1#26)(2013-7#4)(2013-8#4)
of chronically ill patients##4##4##(1996-12#1)(1997-1#2)(2012-3#1)
of chronically ill##6##3##(1990-10#1)(1996-12#1)(1997-1#2)(2012-3#2)
of chronically stressed##2##3##(2008-11#1)(2008-7#1)
of chronically##12##2##(1990-10#1)(1994-5#1)(1996-12#1)(1997-1#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#2)
of chrysotile asbestos##2##3##(1991-12#2)
of chrysotile##3##2##(1991-12#3)
of chsA gene##2##3##(2008-9#2)
of chyle##2##2##(2007-8#1)(2008-10#1)
of chylomicrons##4##2##(1995-2#1)(2008-10#3)
of chymosin##2##2##(2008-7#2)
of chymotrypsin##3##2##(1995-2#1)(1995-5#2)
of cicada Cercopis vulnerata##2##4##(2007-12#2)
of ciclesonide##2##2##(2008-8#2)
of cigarette smoke on##3##4##(1991-9#1)(2008-5#2)
of cigarette smoke##4##3##(1991-9#1)(1992-9#1)(2008-5#2)
of cigarette smoking on##5##4##(1992-9#1)(1996-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
of cigarette smoking##8##3##(1991-12#1)(1992-9#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
of cigarette##15##2##(1991-12#1)(1991-9#1)(1992-9#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#2)(2013-1#1)(2013-8#2)
of cigarettes smoked##2##3##(2013-1#2)
of cigarettes##8##2##(1991-9#2)(1993-2#1)(1994-6#1)(1997-4#1)(2009-7#1)(2013-1#2)
of ciliary##2##2##(1996-2#1)(2008-7#1)
of cimetidine and ranitidine##2##4##(2008-11#2)
of cimetidine##6##2##(1991-5#1)(2008-11#5)
of cine computed tomographic##2##4##(2013-1#2)
of cinnamic acid##2##3##(2008-10#1)(2013-1#1)
of cinnamic##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
of cinnamon##2##2##(2010-11#1)(2013-1#1)
of ciprofloxacin in human urine and serum samples##2##8##(2008-10#2)
of ciprofloxacin in##5##3##(2007-8#1)(2008-10#4)
of ciprofloxacin was##3##3##(2007-7#2)(2008-10#1)
of ciprofloxacin##12##2##(2007-7#2)(2007-8#1)(2008-10#8)(2008-7#1)
of circadian rhythm##2##3##(1991-12#1)(1997-2#1)
of circadian rhythms##2##3##(1995-12#1)(2008-8#1)
of circadian##12##2##(1991-12#1)(1991-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)
of circuit librarianship##2##3##(1995-1#2)
of circuit##4##2##(1995-1#4)
of circular dichroism and##2##4##(1990-5#1)(1994-5#1)
of circular dichroism in##2##4##(1992-8#1)(2006-4#1)
of circular dichroism##5##3##(1990-5#1)(1992-8#2)(1994-5#1)(2006-4#1)
of circular##17##2##(1990-11#1)(1990-5#1)(1992-8#2)(1994-5#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-8#1)
of circularly polarized##3##3##(2007-11#2)(2008-2#1)
of circulating cells##2##3##(2009-2#1)(2010-8#1)
of circulating immune complexes##2##4##(1990-12#1)(1997-8#1)
of circulating immune##3##3##(1990-12#1)(1997-8#1)(2011-1#1)
of circulating influenza##2##3##(2012-12#1)(2013-8#1)
of circulating platelets##2##3##(2008-4#1)(2008-9#1)
of circulating serum##2##3##(1991-2#1)(2008-7#1)
of circulating##49##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#2)(1994-8#1)(1995-11#1)(1995-9#1)(1996-12#2)(1997-8#2)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
of circulation##3##2##(2008-10#2)(2010-5#1)
of circumferential##2##2##(2008-10#1)(2009-3#1)
of circumnutation##3##2##(2009-6#3)
of circumstances##3##2##(1992-3#1)(2009-5#1)(2009-8#1)
of cirrhosis and portal hypertension##2##5##(2006-10#2)
of cirrhosis and##4##3##(1997-7#1)(2006-10#2)(2013-8#1)
of cirrhosis##15##2##(1991-3#2)(1996-11#1)(1997-7#2)(2006-10#4)(2008-9#1)(2009-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
of cirrus and##3##3##(2008-2#1)(2008-3#2)
of cirrus clouds##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of cirrus##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
of cis##4##2##(2010-2#4)
of cis- and##2##3##(1992-8#1)(2012-2#1)
of cis-acting##4##2##(1992-6#1)(1993-3#1)(2008-7#2)
of cis-platin and carboplatin##2##4##(2008-10#2)
of cis-platin##4##2##(2008-10#4)
of cisapride##5##2##(1990-5#4)(1994-2#1)
of cisatracurium in##2##3##(2008-10#2)
of cisatracurium##6##2##(2008-10#6)
of cisplatin and etoposide##3##4##(1992-10#1)(1993-9#1)(2013-1#1)
of cisplatin and##6##3##(1991-2#1)(1992-10#1)(1993-8#1)(1993-9#1)(2010-11#1)(2013-1#1)
of cisplatin in##2##3##(1993-8#1)(2008-6#1)
of cisplatin treated##2##3##(1991-9#2)
of cisplatin##19##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-5#1)(1993-5#1)(1993-8#3)(1993-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-11#2)(2013-1#2)
of cisplatin-induced##3##2##(1990-12#2)(1990-6#1)
of citations##6##2##(1996-2#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
of cited##2##2##(2008-10#2)
of cities##3##2##(1990-11#3)
of citrate##11##2##(1992-11#1)(1992-9#3)(1997-2#1)(1997-4#1)(2008-10#3)(2008-7#2)
of citric acid production by##2##5##(2008-7#2)
of citric acid production##3##4##(2008-7#3)
of citric acid was##2##4##(2008-10#2)
of citric acid##12##3##(2008-10#7)(2008-7#3)(2012-2#2)
of citric and##2##3##(1997-4#1)(2008-10#1)
of citric##14##2##(1997-4#1)(2008-10#8)(2008-7#3)(2012-2#2)
of citrinin##4##2##(1993-12#4)
of citrus fruit##5##3##(2008-10#5)
of citrus in##3##3##(2008-10#3)
of citrus samples##3##3##(2008-10#3)
of citrus tristeza virus (CTV)##2##5##(2008-10#2)
of citrus tristeza virus incidence##3##5##(2008-10#3)
of citrus tristeza virus##7##4##(2008-10#7)
of citrus variegated chlorosis##3##4##(2008-10#3)
of citrus##45##2##(2008-10#40)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
of civil registration##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
of civil##5##2##(1991-12#1)(1994-3#1)(2008-11#1)(2011-2#1)(2012-12#1)
of civilization##3##2##(1991-6#1)(1995-5#1)(2008-9#1)
of cladding modes excited by##2##5##(2007-12#2)
of cladding modes##3##3##(2007-12#3)
of cladograms##3##2##(2010-3#3)
of claims data##2##3##(1991-1#1)(1993-12#1)
of claims##9##2##(1990-2#1)(1991-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#4)
of clamping##2##2##(1992-9#1)(2008-7#1)
of clandestine tablets##2##3##(2008-10#2)
of clarified##2##2##(1997-3#1)(2008-10#1)
of clarifying the##3##3##(1994-11#2)(2008-11#1)
of clarithromycin in human plasma##2##5##(2008-10#2)
of clarithromycin in##3##3##(2008-10#3)
of clarithromycin##7##2##(2007-12#2)(2008-10#5)
of class 1##2##3##(1995-2#1)(2008-11#1)
of class I MHC##3##4##(1990-5#1)(1994-5#1)(2008-4#1)
of class I##5##3##(1990-5#1)(1994-5#1)(1995-12#1)(1997-9#1)(2008-4#1)
of class IC atrial flutter##2##5##(2012-3#2)
of class III##2##3##(2007-12#1)(2008-5#1)
of class analogy (SIMCA)##4##4##(2008-10#3)(2013-8#1)
of class analogy##6##3##(2008-10#5)(2013-8#1)
of class##24##2##(1990-5#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-9#1)(2006-4#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#2)(2012-3#2)(2013-8#1)
of classes of##2##3##(2008-10#1)(2008-5#1)
of classes##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
of classic##9##2##(1990-6#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
of classical and##2##3##(2008-2#1)(2008-5#1)
of classical##16##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#3)(2012-3#1)(2013-1#1)
of classification##14##2##(1990-3#1)(1992-8#1)(1993-1#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-7#1)(2011-2#2)(2013-8#1)
of classifications##3##2##(1996-1#1)(2007-11#1)(2008-6#1)
of classifier##2##2##(2008-11#2)
of classifying##3##2##(2008-10#1)(2008-3#2)
of classroom climate##2##3##(2008-12#2)
of classroom##7##2##(2008-12#7)
of clathrin-coated##2##2##(1995-6#1)(2008-1#1)
of clavulanic acid##2##3##(2007-7#1)(2011-2#1)
of clay##2##2##(2008-10#2)
of clean##2##2##(2007-7#1)(2008-1#1)
of cleansing##4##2##(2007-12#2)(2008-5#2)
of clear##5##2##(1990-11#1)(2008-10#2)(2008-2#1)(2010-10#1)
of clearance##3##2##(1993-6#1)(1996-2#1)(2011-3#1)
of cleavage##3##2##(1991-3#1)(1993-6#1)(1993-8#1)
of cleaved##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
of cleft##2##2##(2009-8#1)(2011-2#1)
of clenbuterol by capillary electrophoresis##2##5##(2008-10#2)
of clenbuterol##8##2##(2008-10#6)(2010-12#1)(2010-6#1)
of client groups and##2##4##(2013-8#2)
of client##4##2##(1993-1#1)(2010-4#1)(2013-8#2)
of clients and##2##3##(1994-12#1)(1995-3#1)
of clients##14##2##(1991-1#1)(1993-1#3)(1994-12#2)(1994-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-3#1)
of climate change on##2##4##(2008-11#2)
of climate change##13##3##(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2012-12#2)(2012-8#1)(2013-8#1)
of climate##17##2##(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#2)(2012-12#2)(2012-8#1)(2013-8#1)
of climatic and##2##3##(2011-2#2)
of clindamycin##5##2##(2007-11#4)(2007-2#1)
of clinic##2##2##(1996-2#1)(1996-3#1)
of clinical and experimental##2##4##(2008-10#1)(2011-1#1)
of clinical and radiological##6##4##(2007-11#1)(2007-8#3)(2008-6#1)(2012-3#1)
of clinical and##26##3##(1990-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(2007-11#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of clinical application of nursing diagnosis##2##6##(1990-2#2)
of clinical applications##3##3##(2008-11#2)(2009-4#1)
of clinical assessment##2##3##(2008-1#1)(2008-12#1)
of clinical backgrounds##2##3##(2008-11#2)
of clinical biochemistry on##3##4##(1994-12#3)
of clinical biochemistry##4##3##(1994-12#4)
of clinical biochemists##3##3##(1994-12#3)
of clinical care##3##3##(1995-2#1)(2008-12#1)(2008-7#1)
of clinical chemistry and##2##4##(1994-12#1)(2012-1#1)
of clinical competence##2##3##(1994-2#1)(2008-11#1)
of clinical data##4##3##(1997-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
of clinical decision-making##10##3##(2007-10#1)(2008-11#9)
of clinical development##2##3##(2008-8#2)
of clinical diagnosis##4##3##(2007-5#1)(2008-10#2)(2009-7#1)
of clinical effectiveness##2##3##(1993-12#1)(2012-12#1)
of clinical efficacy##2##3##(2008-5#1)(2013-8#1)
of clinical endpoints##2##3##(2008-8#1)(2013-1#1)
of clinical evidence##3##3##(2011-2#1)(2012-2#2)
of clinical examination##2##3##(1990-12#1)(1995-2#1)
of clinical experience##5##3##(1990-3#1)(1993-12#1)(2012-3#2)(2013-1#1)
of clinical factors##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
of clinical features##4##3##(1996-12#1)(2008-7#2)(2013-1#1)
of clinical findings##2##3##(1993-12#1)(2011-1#1)
of clinical guidelines##3##3##(1996-1#1)(2008-3#2)
of clinical implications##2##3##(2007-12#1)(2010-4#1)
of clinical information##4##3##(1991-12#1)(1992-12#1)(1995-9#1)(1997-1#1)
of clinical isolates of##2##4##(2008-5#1)(2010-12#1)
of clinical isolates##3##3##(2008-5#2)(2010-12#1)
of clinical laboratory technologist##2##4##(1994-12#2)
of clinical laboratory##5##3##(1994-12#5)
of clinical manifestations and##2##4##(2008-1#1)(2013-1#1)
of clinical manifestations##7##3##(2006-10#2)(2008-1#2)(2009-2#1)(2013-1#2)
of clinical mastitis in##2##4##(1993-2#1)(1996-8#1)
of clinical mastitis##4##3##(1992-2#1)(1993-2#1)(1996-8#2)
of clinical medicine##4##3##(1993-11#1)(1997-3#1)(2011-3#2)
of clinical nursing care##2##4##(2011-1#2)
of clinical nursing##3##3##(2008-11#1)(2011-1#2)
of clinical or##2##3##(2008-7#1)(2008-9#1)
of clinical outcome in##2##4##(2010-11#1)(2013-1#1)
of clinical outcome##11##3##(1992-10#1)(1997-1#2)(2007-12#1)(2008-7#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
of clinical outcomes##4##3##(1996-1#1)(1997-1#1)(2009-6#1)(2009-7#1)
of clinical placements##4##3##(1995-3#1)(2008-11#1)(2008-12#2)
of clinical practice and##2##4##(1997-1#1)(2007-11#1)
of clinical practice guidelines##2##4##(1993-12#1)(1996-2#1)
of clinical practice##19##3##(1993-12#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-8#1)
of clinical presentation##2##3##(2007-4#1)(2008-3#1)
of clinical preventive services##2##4##(1996-2#1)(2008-1#1)
of clinical reasoning##2##3##(2008-11#1)(2008-12#1)
of clinical research##5##3##(1995-5#1)(1997-3#1)(2009-10#1)(2009-3#1)(2010-11#1)
of clinical response##3##3##(2008-5#1)(2008-6#1)(2008-9#1)
of clinical samples##3##3##(2008-10#1)(2008-5#2)
of clinical significance##6##3##(1997-7#2)(2008-10#1)(2008-11#1)(2013-1#2)
of clinical signs of##3##4##(1995-2#1)(2007-11#1)(2010-8#1)
of clinical signs##9##3##(1990-3#2)(1992-5#1)(1995-2#1)(1997-8#1)(2007-11#1)(2008-5#1)(2010-8#2)
of clinical skills##2##3##(1992-6#2)
of clinical stage##2##3##(1996-9#2)
of clinical studies are##2##4##(2013-1#1)(2013-8#1)
of clinical studies##8##3##(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
of clinical subgroups##2##3##(1995-12#1)(2008-12#1)
of clinical supervision##3##3##(1996-7#1)(2008-11#1)(2008-4#1)
of clinical symptoms##5##3##(1990-9#1)(1992-3#1)(1997-3#1)(2007-8#1)(2013-1#1)
of clinical trial##2##3##(2008-3#1)(2013-1#1)
of clinical trials is##2##4##(2008-3#1)(2013-7#1)
of clinical trials of##3##4##(1995-5#1)(2008-8#2)
of clinical trials##29##3##(1992-2#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-6#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
of clinical utility##2##3##(1997-3#1)(2009-4#1)
of clinical value##2##3##(2007-11#1)(2010-3#1)
of clinical##386##2##(1990-12#1)(1990-2#3)(1990-3#5)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#2)(1992-6#2)(1992-9#4)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-12#14)(1994-2#2)(1994-3#3)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#3)(2007-11#7)(2007-12#3)(2007-4#1)(2007-5#3)(2007-8#5)(2008-1#6)(2008-10#13)(2008-11#30)(2008-12#10)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-3#3)(2010-4#3)(2010-5#2)(2010-8#11)(2011-1#7)(2011-2#13)(2011-3#2)(2012-1#4)(2012-12#12)(2012-2#9)(2012-3#11)(2013-1#20)(2013-7#2)(2013-8#11)
of clinically important##3##3##(1994-12#1)(1997-7#1)(2008-10#1)
of clinically relevant##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
of clinically significant##3##3##(1994-11#1)(1994-3#1)(2008-3#1)
of clinically useful##2##3##(2007-11#1)(2008-5#1)
of clinically##25##2##(1990-6#1)(1991-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-8#1)(2013-8#1)
of clinicians and##2##3##(1992-3#1)(2010-10#1)
of clinicians to##2##3##(2007-7#1)(2008-11#1)
of clinicians##9##2##(1990-3#1)(1992-3#1)(2007-7#1)(2008-11#2)(2009-7#1)(2010-10#1)(2011-1#1)(2012-12#1)
of clock##2##2##(2008-2#1)(2008-3#1)
of clofibrate##4##2##(1992-11#4)
of clonal lineages##2##3##(2008-10#2)
of clonal##11##2##(1994-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#2)(2010-2#1)(2011-2#1)
of clonality##3##2##(2008-10#2)(2012-2#1)
of clonazepam##2##2##(1991-12#2)
of clone##4##2##(1997-7#1)(1997-8#1)(2008-7#1)(2008-9#1)
of clone-D##2##2##(1992-9#2)
of cloned DNA##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
of cloned##18##2##(1990-5#2)(1991-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1997-4#2)(2007-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#2)(2011-1#1)(2013-8#1)
of clones##5##2##(1993-11#1)(1993-12#1)(1994-12#2)(2008-5#1)
of clonidine##4##2##(1992-8#1)(1993-12#1)(1997-4#2)
of cloning##7##2##(1993-11#1)(1994-12#2)(1995-2#1)(1997-2#2)(2008-11#1)
of clopidogrel bisulphate##3##3##(2008-10#3)
of clopidogrel in##3##3##(2008-3#1)(2011-2#2)
of clopidogrel##7##2##(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#2)
of close contact##2##3##(2011-2#2)
of close relationships##2##3##(2012-2#2)
of close to##2##3##(1994-12#1)(2008-5#1)
of close##15##2##(1990-11#1)(1990-2#1)(1991-8#1)(1992-9#1)(1994-12#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-2#2)
of close-proximity fluorophores##2##3##(2009-5#2)
of closed circular DNA##2##4##(1995-2#1)(1995-3#1)
of closed##12##2##(1994-11#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2012-12#1)(2012-2#1)(2013-1#2)
of closed-loop##3##2##(2009-11#1)(2009-9#2)
of closely related species##4##4##(1995-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
of closely related##11##3##(1990-12#1)(1994-9#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-7#1)
of closely spaced##2##3##(2007-11#1)(2008-4#1)
of closely##16##2##(1990-12#1)(1991-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#1)(2013-7#1)
of closing##3##2##(1993-12#1)(2008-1#1)(2013-8#1)
of closure##2##2##(2006-12#1)(2011-1#1)
of clothing and bedding##2##4##(1990-2#2)
of clothing##3##2##(1990-2#2)(2011-2#1)
of clotting##2##2##(1997-3#1)(1997-4#1)
of cloud##10##2##(2007-11#1)(2008-2#5)(2008-3#3)(2013-1#1)
of clouds and aerosols##6##4##(2008-3#6)
of clouds and##8##3##(2008-10#1)(2008-2#1)(2008-3#6)
of clouds##11##2##(2008-10#1)(2008-2#1)(2008-3#9)
of clover##4##2##(2008-10#4)
of clozapine in##2##3##(1996-5#1)(1996-7#1)
of clozapine##5##2##(1996-5#1)(1996-7#1)(2008-12#3)
of cluster##11##2##(1992-2#1)(1993-8#1)(2008-10#5)(2008-8#1)(2009-11#1)(2010-11#1)(2012-3#1)
of clustering of##3##3##(1990-11#1)(2008-12#1)(2008-3#1)
of clustering##6##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
of clusters of##5##3##(1995-6#1)(2008-10#2)(2009-2#1)(2011-2#1)
of clusters##10##2##(1995-2#1)(1995-6#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-10#2)(2011-2#1)(2013-1#1)
of cms-T##3##2##(2008-10#3)
of co-existing##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
of co-infection##2##2##(2011-2#2)
of co-occurrence##2##2##(2008-2#1)(2011-2#1)
of co-stimulatory molecules##3##3##(2007-11#1)(2008-10#2)
of coagulase-negative staphylococci##3##3##(2008-7#1)(2010-4#2)
of coagulase-negative##4##2##(2007-12#1)(2008-7#1)(2010-4#2)
of coagulation and fibrinolysis##3##4##(2008-7#1)(2010-3#2)
of coagulation and##4##3##(2006-12#1)(2008-7#1)(2010-3#2)
of coagulation factor##2##3##(1995-12#1)(2008-8#1)
of coagulation is##2##3##(1991-9#1)(2013-1#1)
of coagulation##11##2##(1991-9#1)(1995-12#1)(2006-12#1)(2007-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2010-3#2)(2013-1#1)
of coagulopathy##3##2##(1990-2#1)(2008-7#2)
of coal fly ash and##2##5##(2008-10#2)
of coal samples##3##3##(2008-10#3)
of coal##10##2##(2008-10#7)(2008-6#3)
of coarctation of aorta##2##4##(2007-8#1)(2011-2#1)
of coarctation of the aorta##3##5##(2007-8#2)(2012-1#1)
of coarctation of##5##3##(2007-8#3)(2011-2#1)(2012-1#1)
of coarse##3##2##(2008-11#1)(2010-6#1)(2012-3#1)
of coastal and##3##3##(2008-2#2)(2008-3#1)
of coastal##7##2##(2007-5#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-1#1)
of coat protein##4##3##(1997-3#2)(2008-10#1)(2008-8#1)
of coat##5##2##(1990-9#1)(1997-3#2)(2008-10#1)(2008-8#1)
of coated and uncoated parallel-slab multireflection beam splitters##2##8##(2008-3#2)
of coated##10##2##(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)
of coating##8##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#1)
of coatings are##2##3##(2008-10#1)(2008-2#1)
of coatings on##3##3##(2008-10#3)
of coatings##8##2##(2008-10#6)(2008-2#1)(2008-3#1)
of cobalamin##4##2##(1992-9#1)(2008-3#1)(2011-1#1)(2013-1#1)
of cobalt after##2##3##(2008-10#2)
of cobalt and nickel##3##4##(2008-10#3)
of cobalt and##6##3##(2008-10#6)
of cobalt by##2##3##(2008-10#2)
of cobalt hexacyanoferrate##2##3##(2008-10#2)
of cobalt in the presence of##2##6##(2008-10#2)
of cobalt in##16##3##(2008-10#16)
of cobalt with nitroso-R-salt##2##4##(2008-10#2)
of cobalt with##4##3##(2008-10#4)
of cobalt##68##2##(1997-3#1)(2008-10#64)(2008-12#2)(2008-7#1)
of cobalt(II) and##4##3##(2008-10#4)
of cobalt(II) with##2##3##(2008-10#2)
of cobalt(II)##20##2##(1996-2#2)(2008-10#18)
of cocaethylene##5##2##(1996-12#5)
of cocaine addiction##3##3##(1991-1#1)(2008-11#1)(2008-6#1)
of cocaine by##3##3##(1990-7#1)(1991-1#1)(2008-10#1)
of cocaine in##2##3##(1993-6#1)(2013-8#1)
of cocaine on##2##3##(1993-12#1)(2011-2#1)
of cocaine was##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
of cocaine with##2##3##(1991-1#2)
of cocaine##47##2##(1990-7#2)(1991-1#16)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1992-11#1)(1993-12#4)(1993-6#2)(1996-5#1)(2008-10#5)(2008-11#1)(2008-6#1)(2010-11#2)(2011-2#2)(2013-8#4)
of coccidioidomycosis##2##2##(2007-2#1)(2008-5#1)
of cochlear implant electrode arrays##2##5##(2008-9#2)
of cochlear implant use##2##4##(2008-9#2)
of cochlear implant##16##3##(2008-9#15)(2012-2#1)
of cochlear implantation in##7##4##(2008-9#4)(2012-2#3)
of cochlear implantation##13##3##(2008-9#8)(2012-2#5)
of cochlear implants##8##3##(2008-9#8)
of cochlear##43##2##(1996-2#1)(2008-4#1)(2008-9#35)(2012-2#6)
of cochleostomy##2##2##(2008-9#2)
of coconut palm##2##3##(2008-10#2)
of coconut##3##2##(2008-10#3)
of cocultivation##2##2##(2008-10#2)
of coda Q-1 and##2##4##(1996-4#2)
of coding and##2##3##(1997-3#1)(2008-7#1)
of coding##7##2##(1994-12#1)(1997-3#1)(1997-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
of codlemone##2##2##(2011-2#2)
of codon##4##2##(1991-12#1)(1992-2#1)(1993-11#1)(1994-11#1)
of codons##4##2##(1995-12#1)(1997-8#2)(2008-7#1)
of coefficients##2##2##(1996-3#1)(2010-1#1)
of coeliac disease and##2##4##(1991-11#1)(1992-12#1)
of coeliac disease##3##3##(1991-11#2)(1992-12#1)
of coeliac##5##2##(1991-11#2)(1991-12#2)(1992-12#1)
of coenzyme##5##2##(1993-3#1)(1994-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
of coercion##3##2##(2008-11#1)(2011-2#2)
of coevolution between##2##3##(2008-10#1)(2008-9#1)
of coevolution##3##2##(2008-10#2)(2008-9#1)
of coexistence##3##2##(2008-8#1)(2010-5#1)(2010-8#1)
of coexistent##5##2##(1993-1#1)(1993-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
of coexisting ions were##2##4##(2008-10#2)
of coexisting##7##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
of cofactor##2##2##(1993-11#1)(1993-8#1)
of cofactors##2##2##(1991-9#1)(2008-2#1)
of coffee##9##2##(1990-6#1)(2008-10#5)(2008-11#1)(2008-5#2)
of cognition in##2##3##(2008-4#1)(2009-8#1)
of cognition##12##2##(1991-5#1)(1996-11#1)(2007-10#1)(2008-12#2)(2008-4#1)(2009-12#1)(2009-7#2)(2009-8#3)
of cognitive abilities##3##3##(1993-12#1)(2008-9#1)(2009-8#1)
of cognitive deficits##3##3##(2008-4#1)(2008-7#2)
of cognitive function in##2##4##(1995-8#1)(2008-7#1)
of cognitive function##8##3##(1993-11#1)(1993-5#1)(1995-11#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
of cognitive functioning##6##3##(1990-3#2)(1996-1#1)(2010-12#1)(2012-12#2)
of cognitive impairment##7##3##(2008-2#2)(2008-6#2)(2012-12#2)(2013-8#1)
of cognitive performance##3##3##(1995-11#1)(2008-12#1)(2013-1#1)
of cognitive processes##2##3##(2009-2#1)(2013-7#1)
of cognitive##60##2##(1990-3#2)(1991-6#1)(1993-11#2)(1993-12#1)(1993-5#1)(1995-1#1)(1995-11#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-5#1)(2007-8#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#3)(2008-7#6)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of cognitive-behavioral therapy##2##3##(2009-11#1)(2012-2#1)
of cognitive-behavioral##4##2##(1995-12#1)(2009-11#1)(2012-2#1)(2013-1#1)
of coherence##9##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#4)(2012-3#1)
of coherent Doppler lidar##3##4##(2008-2#1)(2008-3#2)
of coherent lidar performance##2##4##(2008-3#2)
of coherent optical##4##3##(1992-11#1)(2007-11#1)(2008-3#2)
of coherent##26##2##(1992-11#1)(1992-8#1)(2007-11#9)(2007-12#6)(2008-2#1)(2008-3#8)
of cohorts##2##2##(2008-10#2)
of coinfected##2##2##(2008-10#1)(2008-7#1)
of colchicine##5##2##(1990-2#1)(1992-9#2)(1995-2#1)(2007-7#1)
of cold and##2##3##(1993-8#1)(2012-3#1)
of cold atoms##3##3##(2007-11#2)(2008-2#1)
of cold pain##2##3##(2008-8#2)
of cold storage##2##3##(2008-10#1)(2011-2#1)
of cold##19##2##(1991-12#1)(1993-8#1)(1994-12#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#4)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of colds##2##2##(2008-7#2)
of colicin##2##2##(1994-2#1)(1995-5#1)
of colipase##3##2##(1990-2#1)(1992-12#2)
of colitic mice##2##3##(2011-3#2)
of colitis##6##2##(1991-8#1)(1992-6#2)(1994-2#1)(2011-3#1)(2012-2#1)
of collaboration and##2##3##(1996-12#1)(2008-11#1)
of collaboration between##4##3##(1991-2#1)(1993-3#1)(1996-12#1)(2008-12#1)
of collaboration##17##2##(1991-2#1)(1993-3#1)(1995-2#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2010-3#1)(2013-1#2)(2013-8#1)
of collaborative##2##2##(1996-4#1)(2008-1#1)
of collagen alpha 1##2##4##(1994-12#2)
of collagen and##3##3##(1990-2#1)(2008-5#1)(2009-9#1)
of collagen fibers##2##3##(2012-1#1)(2012-3#1)
of collagen fibrils##3##3##(2008-5#1)(2008-7#2)
of collagen gel##3##3##(1994-11#2)(1994-8#1)
of collagen synthesis##5##3##(1992-9#1)(2008-5#2)(2008-9#2)
of collagen##45##2##(1990-2#1)(1992-8#1)(1992-9#2)(1994-11#2)(1994-12#2)(1994-8#3)(1995-12#1)(1996-5#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#9)(2008-7#4)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
of collagenase and##3##3##(1992-2#1)(1997-8#1)(2008-11#1)
of collagenase##8##2##(1992-2#2)(1992-5#1)(1996-11#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
of collagenous spherulosis##3##3##(2007-5#3)
of collagenous##6##2##(1992-9#1)(2007-5#3)(2009-8#1)(2010-12#1)
of collagens##5##2##(1991-5#1)(1992-9#3)(2008-5#1)
of collapse##2##2##(2008-1#1)(2008-9#1)
of collared##2##2##(1995-12#1)(2011-2#1)
of collateral##4##2##(2007-10#1)(2007-8#1)(2012-3#1)(2013-8#1)
of colleagues##3##2##(1990-6#1)(1994-12#1)(1995-3#1)
of collecting ducts and ureters of##3##6##(1997-6#3)
of collecting ducts and ureters##5##5##(1997-6#5)
of collecting the##2##3##(1996-3#1)(2012-2#1)
of collecting##13##2##(1996-3#1)(1997-1#1)(1997-6#5)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
of collection##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
of collective action##3##3##(1994-2#1)(2008-10#1)(2012-2#1)
of collective##7##2##(1994-2#1)(2008-10#2)(2009-8#1)(2010-8#1)(2012-2#2)
of college graduates##2##3##(1995-2#1)(1997-2#1)
of college students##6##3##(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#3)
of college##12##2##(1992-1#1)(1995-2#1)(1997-2#1)(2007-12#2)(2008-5#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-8#3)
of colleters##2##2##(2008-5#2)
of colletotrichum species from##2##4##(2008-10#2)
of colletotrichum##4##2##(2008-10#4)
of collimated##2##2##(2008-3#2)
of colloid cysts##2##3##(2008-7#2)
of colloid##3##2##(1991-11#1)(2008-7#2)
of colloidal PbSe nanocrystals##4##4##(2013-8#4)
of colloidal PbSe##5##3##(2013-8#5)
of colloidal and##2##3##(1992-5#1)(2008-10#1)
of colloidal##16##2##(1990-6#1)(1992-5#1)(2007-11#2)(2008-10#2)(2008-3#3)(2008-7#1)(2013-1#1)(2013-8#5)
of colloids##2##2##(2008-10#1)(2008-3#1)
of colocalization##2##2##(1997-2#1)(2008-4#1)
of colon CSCs##2##3##(2011-2#2)
of colon cancer in##2##4##(1997-4#1)(2006-8#1)
of colon cancer##18##3##(1993-11#1)(1993-12#1)(1993-9#1)(1995-9#2)(1997-4#1)(2006-8#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2011-2#2)(2013-8#1)
of colon carcinoma##4##3##(2006-8#3)(2008-4#1)
of colon lamina propria dendritic cells from mice with colitis##2##10##(2008-11#2)
of colon tumors in##2##4##(1993-11#2)
of colon tumors##3##3##(1993-11#3)
of colon##34##2##(1992-8#1)(1993-11#5)(1993-12#1)(1993-9#1)(1995-9#2)(1997-4#1)(2006-8#4)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2011-2#5)(2013-8#1)
of coloniality##3##2##(2008-9#3)
of colonic tuberculosis##2##3##(2007-12#2)
of colonic##13##2##(1990-6#1)(1992-9#1)(1993-9#1)(1995-3#1)(2007-12#2)(2008-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
of colonies##11##2##(1993-8#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#5)(2008-5#1)(2010-2#1)
of colonization and##2##3##(2008-10#2)
of colonization of tomato##2##4##(2008-10#2)
of colonization of##5##3##(2008-10#4)(2013-1#1)
of colonization##23##2##(1996-4#1)(2008-10#15)(2008-11#1)(2008-8#3)(2013-1#2)(2013-8#1)
of colonizing##2##2##(2008-7#1)(2008-8#1)
of colonoscopy##2##2##(1990-6#1)(1995-10#1)
of colony form##2##3##(2008-9#1)(2009-8#1)
of colony formation##4##3##(1990-12#1)(1992-9#1)(2008-11#1)(2012-12#1)
of colony forming units##2##4##(2008-10#1)(2008-5#1)
of colony forming##3##3##(1992-11#1)(2008-10#1)(2008-5#1)
of colony##18##2##(1990-12#1)(1992-11#1)(1992-9#1)(1993-9#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-2#1)(2009-8#1)(2012-12#1)
of colony-forming##2##2##(2012-12#1)(2013-7#1)
of color and##2##3##(1994-12#1)(1996-5#1)
of color##20##2##(1990-12#1)(1993-3#1)(1994-12#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-6#1)(2009-5#1)(2009-7#3)(2012-2#1)
of colorectal adenomas and carcinomas##2##5##(1990-11#2)
of colorectal anastomosis##2##3##(1990-3#1)(1992-9#1)
of colorectal cancer (CRC)##3##4##(2008-4#1)(2010-12#1)(2010-6#1)
of colorectal cancer following##3##4##(1993-12#2)(1993-9#1)
of colorectal cancer in##3##4##(1993-9#2)(2011-2#1)
of colorectal cancer patients##3##4##(1990-6#1)(1997-8#2)
of colorectal cancer was##3##4##(1993-9#2)(1994-2#1)
of colorectal cancer##35##3##(1990-2#1)(1990-6#1)(1991-11#1)(1993-12#2)(1993-3#1)(1993-9#7)(1994-2#2)(1995-5#1)(1995-9#1)(1997-8#5)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)
of colorectal carcinoma##4##3##(1993-12#2)(1995-12#1)(2012-12#1)
of colorectal liver metastases##3##4##(2012-3#2)(2013-1#1)
of colorectal polyps in patients##2##5##(2007-4#1)(2008-11#1)
of colorectal polyps##3##3##(2007-4#1)(2008-11#2)
of colorectal tumors##2##3##(1993-8#1)(2008-10#1)
of colorectal##62##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-8#1)(1993-9#8)(1994-2#3)(1995-12#1)(1995-5#1)(1995-9#1)(1997-8#5)(2007-4#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
of colored##3##2##(2008-10#2)(2008-3#1)
of colour##11##2##(1990-12#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-5#4)(2011-1#1)(2011-2#1)
of coloured##3##2##(1990-5#1)(2008-10#2)
of colours##4##2##(1995-6#1)(2008-10#2)(2013-8#1)
of colposcopy##4##2##(1992-10#2)(1992-3#2)
of column ozone##3##3##(2008-2#3)
of column##6##2##(2008-10#2)(2008-2#3)(2008-3#1)
of columnar##4##2##(1991-2#2)(2008-3#1)(2012-3#1)
of columns##4##2##(2008-10#1)(2008-4#1)(2009-5#1)(2013-1#1)
of coma and##2##3##(2008-11#1)(2008-3#1)
of coma in##2##3##(1990-9#1)(2008-2#1)
of coma##13##2##(1990-9#3)(1991-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#4)
of combination chemotherapy##3##3##(1993-2#1)(1993-8#1)(2007-7#1)
of combination of##5##3##(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of combination regimens##2##3##(1994-2#1)(2008-6#1)
of combination therapy in##3##4##(2008-2#1)(2010-10#2)
of combination therapy with##3##4##(1993-9#1)(2008-7#1)(2011-2#1)
of combination therapy##10##3##(1993-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#4)(2010-4#1)(2011-2#1)
of combination vaccines##2##3##(1995-5#2)
of combination##27##2##(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-5#3)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-10#4)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
of combinations of##7##3##(1994-5#1)(2007-12#1)(2008-7#1)(2010-4#1)(2011-2#2)(2013-1#1)
of combinations##9##2##(1994-5#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#2)(2013-1#1)
of combinatorial chemistry##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
of combinatorial##5##2##(1997-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-8#1)
of combined open fractures of##2##5##(2008-9#2)
of combined species densities##2##4##(2008-8#2)
of combined##40##2##(1990-2#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-8#1)(1993-9#1)(1997-3#1)(2007-11#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-8#2)(2008-9#4)(2009-4#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
of combining the##9##3##(1995-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2010-11#1)
of combining##21##2##(1994-2#1)(1995-9#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2012-1#1)(2013-1#1)
of combustible##2##2##(2008-10#2)
of combustion gases##2##3##(1996-12#2)
of combustion products##2##3##(1996-12#2)
of combustion##6##2##(1996-12#6)
of comedones##2##2##(2008-5#2)
of comet##2##2##(1995-6#1)(1997-4#1)
of comfort in##2##3##(1996-9#1)(2010-6#1)
of comfort##4##2##(1996-9#1)(2008-4#1)(2009-3#1)(2010-6#1)
of coming##2##2##(2010-3#1)(2011-2#1)
of comma bacillus##2##3##(2013-1#2)
of commercial samples##2##3##(2008-10#2)
of commercial tea##2##3##(2008-10#1)(2012-2#1)
of commercial##44##2##(1995-8#1)(1997-3#1)(2007-5#1)(2008-10#27)(2008-3#1)(2008-5#3)(2008-6#2)(2010-11#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-1#2)
of commercially available instruments##2##4##(2008-4#1)(2008-9#1)
of commercially available##24##3##(1993-3#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-9#4)(2013-1#1)
of commercially##29##2##(1993-3#1)(2007-11#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-9#4)(2012-2#1)(2013-1#2)
of commitment##4##2##(1992-1#1)(2008-11#1)(2008-7#1)(2009-7#1)
of common SNPs##2##3##(2012-3#2)
of common and##2##3##(2007-12#1)(2011-2#1)
of common human##2##3##(2009-3#1)(2012-3#1)
of common lambsquarters##3##3##(2008-12#3)
of common renal##2##3##(2008-1#1)(2012-2#1)
of common scab##2##3##(2008-10#2)
of common standards##2##3##(2008-7#1)(2013-8#1)
of common variants##2##3##(2010-2#1)(2012-3#1)
of common weeds in##2##4##(2008-12#2)
of common weeds##3##3##(2008-12#2)(2013-8#1)
of common##96##2##(1991-11#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#1)(2013-8#5)
of commonly used drugs##2##4##(2006-10#1)(2013-1#1)
of commonly used##11##3##(1997-2#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-1#1)
of commonly##15##2##(1993-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
of communal##2##2##(2008-11#1)(2008-9#1)
of communicable diseases##2##3##(1996-6#1)(2007-7#1)
of communicating with people##2##4##(2008-11#1)(2013-8#1)
of communicating##4##2##(2008-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
of communication (p##2##3##(2008-9#1)(2010-4#1)
of communication as##2##3##(2008-9#1)(2013-8#1)
of communication between##5##3##(1994-2#1)(2008-2#1)(2012-12#1)(2013-1#2)
of communication with##2##3##(2007-9#1)(2013-1#1)
of communication##37##2##(1992-2#1)(1992-3#3)(1994-2#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-9#5)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#3)
of communications##2##2##(2008-12#1)(2008-3#1)
of communities and##2##3##(1997-3#1)(2013-7#1)
of communities##7##2##(1995-2#1)(1997-3#1)(2008-10#1)(2008-8#3)(2013-7#1)
of community and##2##3##(1995-3#1)(2010-4#1)
of community based##2##3##(2008-12#2)
of community benefit##7##3##(1993-1#1)(1995-2#2)(1997-1#4)
of community care##2##3##(1995-2#1)(2010-10#1)
of community engagement##2##3##(2012-2#2)
of community health information networks##2##5##(1996-1#2)
of community health##9##3##(1996-1#2)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2011-2#3)
of community involvement in health##3##5##(2010-3#3)
of community involvement##4##3##(2010-3#3)(2010-8#1)
of community nurses##2##3##(2011-1#1)(2012-12#1)
of community pharmacists##2##3##(2011-1#1)(2013-1#1)
of community residents in##3##4##(1995-3#3)
of community resources##3##3##(1996-3#1)(2008-1#1)(2008-6#1)
of community##73##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-1#2)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#4)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#6)(1997-2#1)(1997-3#2)(2007-12#2)(2008-1#4)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-10#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#3)
of community-acquired pneumonia in the##2##5##(1992-5#1)(2008-3#1)
of community-acquired pneumonia in##4##4##(1992-5#1)(2007-12#1)(2008-3#1)(2010-5#1)
of community-acquired pneumonia##5##3##(1992-5#1)(2007-12#2)(2008-3#1)(2010-5#1)
of community-acquired##8##2##(1992-12#1)(1992-5#2)(2007-12#2)(2008-3#1)(2010-5#1)(2011-2#1)
of community-associated methicillin-resistant Staphylococcus aureus in##2##6##(2008-11#2)
of community-associated methicillin-resistant Staphylococcus aureus##4##5##(2008-10#1)(2008-11#2)(2012-2#1)
of community-based education##3##3##(2010-3#3)
of community-based##9##2##(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-3#3)(2013-1#1)
of comorbid conditions##3##3##(2007-8#1)(2010-6#1)(2013-8#1)
of comorbid##10##2##(1997-5#3)(2007-5#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-6#1)(2013-8#1)
of comorbidities##5##2##(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2013-8#1)
of comorbidity##5##2##(1993-12#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-6#1)
of compact antibodies##2##3##(2009-2#2)
of compact##13##2##(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)(2009-2#2)(2009-7#1)(2011-2#1)
of companies that##2##3##(2008-11#2)
of companies##6##2##(1992-3#2)(2008-10#1)(2008-11#2)(2008-4#1)
of comparable quality to##2##4##(1994-3#1)(2012-12#1)
of comparable size to##2##4##(1992-10#1)(2008-10#1)
of comparable size##5##3##(1992-10#1)(2008-10#3)(2008-3#1)
of comparable##17##2##(1992-10#1)(1994-3#1)(1995-12#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-9#1)(2012-12#1)
of comparative##16##2##(1995-5#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-3#2)(2011-1#1)(2011-2#1)
of comparatively##2##2##(2008-10#1)(2008-5#1)
of comparing the##4##3##(1994-12#1)(1994-3#1)(2008-10#1)(2008-3#1)
of comparing##8##2##(1994-12#1)(1994-3#1)(1994-6#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
of comparison##11##2##(1991-12#1)(1993-2#1)(1994-1#1)(1994-9#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-9#1)
of comparisons of##2##3##(1995-2#1)(2009-6#1)
of comparisons##3##2##(1995-2#1)(2009-6#1)(2012-1#1)
of compartmental##3##2##(2008-11#1)(2008-5#2)
of compassion##3##2##(2007-10#2)(2008-1#1)
of compatibilities##2##2##(2008-10#1)(2012-3#1)
of compatible##3##2##(2008-10#1)(2008-2#1)(2012-7#1)
of compensated##2##2##(2008-9#1)(2010-8#1)
of compensating##4##2##(1996-12#1)(2007-12#1)(2008-10#2)
of compensation for##2##3##(1994-2#1)(2009-6#1)
of compensation##14##2##(1991-2#2)(1992-3#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-6#1)(2012-2#1)(2013-1#1)
of compensatory homeostasis##2##3##(2012-2#2)
of compensatory interactions##2##3##(1994-8#2)
of compensatory##8##2##(1991-1#1)(1994-8#2)(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
of competence in##2##3##(1992-2#1)(2007-12#1)
of competence##12##2##(1990-11#1)(1991-6#1)(1992-2#1)(1993-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-8#1)(2009-11#1)
of competencies##3##2##(2008-1#1)(2008-12#1)(2012-3#1)
of competency assessment##2##3##(1995-3#1)(2008-11#1)
of competency##4##2##(1994-1#1)(1995-3#1)(2008-11#1)(2010-3#1)
of competent##5##2##(2008-11#2)(2008-12#2)(2012-3#1)
of competing species at a single trophic level##2##8##(2008-9#2)
of competing species##5##3##(2008-8#3)(2008-9#2)
of competing##17##2##(1990-12#1)(1991-4#1)(1991-5#1)(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#1)
of competition among##2##3##(1997-1#1)(2008-8#1)
of competition and##2##3##(2008-8#1)(2009-7#1)
of competition are##2##3##(2008-11#1)(2008-9#1)
of competition between##6##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)
of competition in##3##3##(1995-2#1)(1997-1#1)(2008-8#1)
of competition is##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
of competition##36##2##(1992-3#1)(1993-2#1)(1995-1#2)(1995-2#1)(1997-1#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#12)(2008-9#7)(2009-7#1)
of competitive ELISA##2##3##(1990-12#1)(1995-12#1)
of competitive exclusion##3##3##(2008-8#2)(2009-8#1)
of competitive##16##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-2#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-8#1)(2010-2#1)(2012-2#1)
of competitor##2##2##(2008-10#1)(2008-8#1)
of competitors##8##2##(1995-1#1)(2008-8#4)(2008-9#2)(2009-10#1)
of complaints from##2##3##(1992-11#1)(1994-6#1)
of complaints##6##2##(1990-3#1)(1992-11#2)(1994-6#1)(1996-2#2)
of complement##9##2##(1990-8#1)(1992-12#1)(1993-3#2)(1994-11#1)(1994-2#2)(1997-6#1)(2009-6#1)
of complementarity##3##2##(1994-5#1)(1997-7#1)(2008-4#1)
of complementary sequences##2##3##(2008-10#1)(2012-2#1)
of complementary##11##2##(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
of complete genome sequences##2##4##(2008-4#2)
of complete genome##3##3##(2008-4#2)(2008-9#1)
of complete remission##2##3##(1991-5#1)(2012-12#1)
of complete##42##2##(1991-2#1)(1991-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
of completed suicide##2##3##(2009-7#1)(2011-2#1)
of completed##4##2##(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
of completely##7##2##(1993-5#1)(1993-9#1)(1994-2#1)(2008-11#2)(2008-2#1)(2008-5#1)
of completeness of##2##3##(2008-10#1)(2010-8#1)
of completing a##2##3##(2008-11#1)(2008-2#1)
of completing##4##2##(1991-8#1)(2008-11#1)(2008-2#1)(2012-12#1)
of complex biological##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
of complex carbohydrates in##2##4##(1995-2#1)(2008-5#1)
of complex carbohydrates##3##3##(1995-2#1)(1997-2#1)(2008-5#1)
of complex defects##2##3##(2011-2#2)
of complex diseases##2##3##(2008-2#1)(2009-4#1)
of complex disorders##2##3##(2008-7#1)(2010-5#1)
of complex formation equilibria##2##4##(2008-10#2)
of complex formation of##2##4##(2008-10#2)
of complex formation##7##3##(2008-10#6)(2008-4#1)
of complex functions##2##3##(2007-12#1)(2008-3#1)
of complex metabolic##2##3##(1991-5#1)(2011-2#1)
of complex microbial communities##2##4##(2011-2#2)
of complex molecules##2##3##(1992-4#1)(2008-8#1)
of complex or##2##3##(2008-10#1)(2009-12#1)
of complex pathotypes##2##3##(2008-10#2)
of complex samples##4##3##(2008-10#4)
of complex species##4##3##(2008-10#4)
of complex therapy##2##3##(2007-11#1)(2011-1#1)
of complex training##2##3##(2009-1#2)
of complex traits##5##3##(1994-9#2)(2010-7#1)(2012-3#2)
of complex treatment##2##3##(1992-12#1)(2007-11#1)
of complex##147##2##(1990-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-2#1)(1995-5#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#7)(2007-12#3)(2008-1#2)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#1)
of complexation of##2##3##(2008-10#2)
of complexation##6##2##(2008-10#6)
of complexed##2##2##(2008-10#2)
of complexes between##2##3##(2008-10#2)
of complexes formed by##2##4##(2008-10#2)
of complexes formed##4##3##(1995-8#1)(2008-10#3)
of complexes of##3##3##(2007-12#2)(2008-10#1)
of complexes were studied##2##4##(2012-2#2)
of complexes were##3##3##(2008-10#1)(2012-2#2)
of complexes with##2##3##(2008-10#2)
of complexes##31##2##(1990-2#1)(1992-2#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#1)(2007-12#2)(2008-10#15)(2008-7#2)(2011-2#2)(2012-2#3)
of complexing agent##3##3##(2008-10#3)
of complexing agent)##2##3##(2008-10#2)
of complexing##8##2##(2008-10#6)(2008-5#1)(2008-8#1)
of complexity is##3##3##(2008-3#1)(2009-5#1)(2012-12#1)
of complexity of##2##3##(2008-1#1)(2008-10#1)
of complexity##13##2##(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
of compliance with the##3##4##(1992-3#1)(2007-12#1)(2008-3#1)
of compliance with##6##3##(1991-8#1)(1992-3#1)(1994-5#1)(2007-12#1)(2008-3#1)(2012-12#1)
of compliance##13##2##(1991-8#1)(1992-3#1)(1993-3#1)(1994-5#1)(1997-3#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
of complicated##13##2##(1993-12#1)(2007-12#2)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)
of complication##7##2##(1990-5#1)(1996-8#1)(2007-8#1)(2009-8#1)(2011-1#1)(2013-1#2)
of complications and mortality##2##4##(2011-2#1)(2013-1#1)
of complications and##8##3##(2007-8#1)(2011-2#2)(2011-3#1)(2013-1#4)
of complications associated with##2##4##(2007-10#1)(2010-7#1)
of complications in patients with##2##5##(2007-8#1)(2008-3#1)
of complications in patients##3##4##(2007-8#1)(2008-3#1)(2010-12#1)
of complications in the##2##4##(1991-9#1)(1992-12#1)
of complications in##11##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-12#1)(1995-12#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)
of complications is low##2##4##(1994-9#1)(2008-9#1)
of complications is##3##3##(1994-9#1)(2008-9#1)(2013-1#1)
of complications such as##5##4##(1996-9#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-3#1)
of complications that##2##3##(2008-7#1)(2013-1#1)
of complications was compared##2##4##(2007-7#1)(2008-9#1)
of complications was##9##3##(1990-3#1)(1991-8#1)(1992-12#2)(2007-7#1)(2008-1#1)(2008-9#1)(2010-3#1)(2012-1#1)
of complications were##2##3##(2009-8#1)(2013-1#1)
of complications##88##2##(1990-11#1)(1990-3#3)(1990-9#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-12#2)(1996-11#1)(1996-6#2)(1996-9#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#15)
of component##6##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)
of components in the##2##4##(2008-10#2)
of components in##3##3##(2008-10#3)
of components of the##3##4##(2007-12#1)(2008-10#2)
of components of##5##3##(2007-12#1)(2008-10#4)
of components##27##2##(1990-8#1)(1994-6#1)(1997-3#1)(2007-12#2)(2008-10#13)(2008-2#2)(2008-4#3)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
of composite tissue##2##3##(2008-9#2)
of composite##23##2##(1990-5#2)(1991-6#1)(1995-2#1)(2007-11#2)(2008-10#5)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)
of composites##2##2##(1990-5#1)(2013-1#1)
of composition and##2##3##(2010-4#1)(2012-2#1)
of composition##8##2##(1992-12#1)(2007-12#1)(2008-10#4)(2010-4#1)(2012-2#1)
of compost##5##2##(1995-11#1)(2008-10#3)(2008-11#1)
of compost-amended##2##2##(2008-10#2)
of compost-mediated induced resistance##2##4##(2008-10#2)
of compound 1##2##3##(2007-11#1)(2012-2#1)
of compound action##2##3##(2008-4#1)(2008-8#1)
of compound##25##2##(1991-12#1)(1994-6#1)(1995-3#3)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#4)(2013-1#1)
of compounds and##2##3##(2008-10#1)(2010-5#1)
of compounds are##4##3##(2008-10#4)
of compounds as##2##3##(1993-8#1)(1994-8#1)
of compounds for##4##3##(1990-8#1)(1991-1#1)(2008-10#2)
of compounds in##6##3##(1990-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)
of compounds is##2##3##(2008-10#1)(2008-6#1)
of compounds of##3##3##(1996-12#1)(1997-3#1)(2008-10#1)
of compounds that inhibit##2##4##(2008-10#2)
of compounds that##12##3##(1995-12#1)(1997-4#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#2)
of compounds was##2##3##(2008-10#2)
of compounds were##3##3##(1992-8#1)(2009-4#1)(2012-2#1)
of compounds which##2##3##(2008-10#2)
of compounds with##7##3##(2007-12#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-3#1)(2012-8#1)
of compounds##90##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-11#2)(1992-8#1)(1993-8#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(2007-12#1)(2008-10#33)(2008-11#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-8#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-8#1)
of comprehension##4##2##(1997-3#2)(2009-4#1)(2010-7#1)
of comprehensive care##3##3##(1994-2#1)(2007-5#1)(2008-11#1)
of comprehensive##20##2##(1992-1#3)(1994-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#2)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
of compression##12##2##(1994-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2013-8#2)
of compressive##2##2##(2008-7#1)(2011-3#1)
of compromised##4##2##(2007-12#1)(2008-1#1)(2008-9#2)
of compulsory##3##2##(1994-1#2)(1994-2#1)
of computation##5##2##(2008-2#1)(2008-3#4)
of computational methods##2##3##(2008-7#1)(2010-12#1)
of computational##8##2##(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#1)
of computed tomography (CT)##3##4##(2007-7#1)(2008-9#1)(2011-2#1)
of computed tomography and magnetic resonance imaging##2##7##(1990-12#1)(1997-8#1)
of computed tomography and##4##4##(1990-12#1)(1997-8#1)(2011-1#1)(2011-2#1)
of computed tomography in##2##4##(2008-12#1)(2012-2#1)
of computed tomography##16##3##(1990-12#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)
of computed##21##2##(1990-12#1)(1990-3#1)(1994-8#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of computer simulation##6##3##(2007-11#1)(2008-3#2)(2008-4#2)(2010-8#1)
of computer simulations##4##3##(2008-3#4)
of computer software##4##3##(2008-7#1)(2008-9#2)(2012-2#1)
of computer technology##2##3##(2006-10#1)(2008-12#1)
of computer vision##2##3##(2012-3#2)
of computer##33##2##(1990-9#1)(1993-1#1)(1996-1#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#7)(2008-4#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
of computer-based##5##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
of computer-generated holograms##2##3##(2008-2#1)(2008-3#1)
of computer-generated##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
of computerized##14##2##(1995-3#1)(1996-8#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#2)
of computers in##3##3##(2006-10#1)(2008-5#1)(2009-9#1)
of computers##8##2##(1991-4#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2012-2#1)
of computing the##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2011-3#1)
of computing##11##2##(1995-9#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2011-3#1)
of concanavalin A (Con A)##3##5##(1994-11#1)(2008-10#2)
of concanavalin##4##2##(1994-11#1)(2008-10#3)
of concealed##3##2##(2008-10#3)
of concealing##2##2##(2007-8#1)(2008-3#1)
of concentrate##2##2##(2010-2#1)(2010-4#1)
of concentrated HCl##3##3##(2008-10#3)
of concentrated HNO(3)##2##3##(2008-10#2)
of concentrated and##2##3##(2008-11#1)(2008-5#1)
of concentrated hydrochloric acid##2##4##(2008-10#2)
of concentrated##19##2##(1990-8#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-7#1)
of concentration and a detection limit of##2##7##(2008-10#2)
of concentration and##8##3##(1992-11#1)(2008-10#5)(2008-2#1)(2010-5#1)
of concentration is##2##3##(1994-11#1)(2008-6#1)
of concentration of##15##3##(1992-11#1)(2008-10#6)(2012-3#1)(2013-1#6)(2013-8#1)
of concentration was##3##3##(2008-10#3)
of concentration##51##2##(1991-8#1)(1992-11#2)(1992-8#1)(1994-11#1)(1996-8#1)(2008-10#24)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#6)(2013-8#2)
of concentrations and##2##3##(2008-10#1)(2010-5#1)
of concentrations of##8##3##(1996-12#1)(2008-10#4)(2008-12#2)(2008-7#1)
of concentrations##24##2##(1992-6#2)(1994-11#1)(1995-6#1)(1996-12#1)(2008-10#14)(2008-12#2)(2008-5#1)(2008-7#1)(2010-5#1)
of concentric##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2012-1#1)
of concentrically##2##2##(2008-10#1)(2012-1#1)
of concept##12##2##(1996-6#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
of conception##2##2##(1993-2#1)(2012-12#1)
of concepts and##3##3##(1992-12#1)(1996-3#1)(2010-12#1)
of concepts##11##2##(1992-12#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#1)
of conceptual and##2##3##(2009-8#1)(2010-10#1)
of conceptual##5##2##(1996-3#1)(2009-2#1)(2009-8#1)(2010-10#1)(2012-12#1)
of concern for##2##3##(2008-9#1)(2013-8#1)
of concern in the##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
of concern in##9##3##(1993-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-3#1)
of concern is##2##3##(2007-12#1)(2011-2#1)
of concern to the##2##4##(2008-10#1)(2008-11#1)
of concern to##6##3##(1992-1#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
of concern##32##2##(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1997-1#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of concerns that##2##3##(1993-3#1)(2013-1#1)
of concerns##6##2##(1991-3#1)(1993-3#1)(2007-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
of concerted##2##2##(1997-2#1)(2008-8#1)
of concise##2##2##(2008-3#1)(2011-3#1)
of conclusions about##2##3##(2008-10#1)(2009-12#1)
of conclusions is##2##3##(1996-3#1)(2008-8#1)
of conclusions##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2009-12#1)
of conclusive##2##2##(2008-6#2)
of concomitant##16##2##(1990-9#1)(1992-8#1)(1993-11#1)(1993-9#1)(1997-4#1)(2007-7#1)(2008-10#4)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
of concomitants##2##2##(2008-10#2)
of concordance##2##2##(1997-3#1)(2008-9#1)
of concordant##3##2##(2009-8#1)(2011-2#2)
of concrete##5##2##(2007-12#3)(2008-11#1)(2013-1#1)
of concurrency##2##2##(2011-2#2)
of concurrent sexual partnerships##2##4##(2011-2#2)
of concurrent visual##2##3##(1993-12#1)(2013-8#1)
of concurrent##21##2##(1990-6#1)(1992-5#1)(1993-12#1)(1994-2#1)(1997-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
of concussion##2##2##(2010-1#1)(2013-1#1)
of condensation##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of condensed chromatin##2##3##(2008-1#1)(2008-7#1)
of condensed##5##2##(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)
of condition##2##2##(1991-12#1)(1993-2#1)
of condition-dependent##3##2##(2008-8#2)(2013-1#1)
of conditional stability constants of##2##5##(2008-10#2)
of conditional stability constants##4##4##(2008-10#4)
of conditional##10##2##(1991-1#1)(1992-10#1)(2008-10#6)(2008-11#1)(2012-3#1)
of conditionally##2##2##(1995-11#1)(2008-11#1)
of conditioned fear##2##3##(1997-7#2)
of conditioned medium##4##3##(1990-11#1)(2008-11#3)
of conditioned suppression##2##3##(1993-5#1)(2008-4#1)
of conditioned##9##2##(1990-11#1)(1993-5#1)(1997-7#2)(2008-11#3)(2008-4#1)(2009-9#1)
of conditions and##2##3##(2008-2#1)(2008-9#1)
of conditions for##3##3##(2008-10#2)(2008-6#1)
of conditions such##2##3##(2010-12#1)(2013-8#1)
of conditions##39##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1994-9#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-2#1)(2013-1#2)(2013-8#1)
of condom use##3##3##(2008-1#1)(2011-1#1)(2012-12#1)
of condom##6##2##(2008-1#1)(2008-10#1)(2009-5#2)(2011-1#1)(2012-12#1)
of condoms##10##2##(1990-6#2)(1993-2#1)(1996-12#1)(2009-5#1)(2011-1#1)(2011-2#4)
of conduct##2##2##(1994-2#1)(2012-2#1)
of conductance##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
of conducting a##2##3##(2010-8#1)(2012-2#1)
of conducting and##2##3##(2008-7#1)(2010-5#1)
of conducting polymer##2##3##(2008-10#2)
of conducting polymers##2##3##(1990-8#1)(2008-10#1)
of conducting##20##2##(1990-8#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-10#5)(2008-7#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
of conduction block##2##3##(2010-8#1)(2013-1#1)
of conduction##6##2##(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#3)
of conductive##4##2##(2008-10#1)(2009-11#2)(2009-12#1)
of condyloma##3##2##(2012-3#3)
of confabulation##5##2##(1996-11#1)(2008-4#4)
of confectionery sunflower##2##3##(2008-10#2)
of conference##2##2##(2008-8#1)(2012-2#1)
of conferences##2##2##(2008-12#1)(2008-5#1)
of confidence intervals for##2##4##(1994-9#1)(2008-10#1)
of confidence intervals##5##3##(1994-9#2)(1995-5#1)(2008-10#2)
of confidence##25##2##(1990-7#1)(1994-9#2)(1995-5#1)(1996-2#1)(2008-10#15)(2008-12#1)(2008-3#2)(2008-9#1)(2009-7#1)
of confidentiality##8##2##(1990-2#1)(1993-12#1)(1994-7#1)(1995-12#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-8#1)
of configuration at C-2##2##4##(1996-5#2)
of configuration at##4##3##(1996-5#3)(2008-4#1)
of configuration##6##2##(1996-5#3)(2007-12#1)(2008-4#1)(2009-12#1)
of confirmatory##2##2##(2009-3#1)(2013-1#1)
of confirmed##4##2##(1990-11#1)(1991-11#1)(2007-2#1)(2008-1#1)
of conflict and##3##3##(2008-8#1)(2009-10#1)(2010-1#1)
of conflict between##4##3##(1991-2#1)(1993-12#1)(2007-8#1)(2008-8#1)
of conflict##9##2##(1991-2#1)(1993-12#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-8#2)(2009-10#1)(2010-1#1)
of confluent##2##2##(1991-5#1)(2008-10#1)
of confocal and conventional##3##4##(2008-3#3)
of confocal microscopy and optical##2##5##(2007-11#1)(2007-12#1)
of confocal microscopy and the##2##5##(2008-9#2)
of confocal microscopy and##4##4##(2007-11#1)(2007-12#1)(2008-9#2)
of confocal microscopy##9##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#5)
of confocal##18##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-9#5)
of conformal radiotherapy##2##3##(2008-6#2)
of conformal##3##2##(2007-11#1)(2008-6#2)
of conformation of##2##3##(1990-5#1)(2008-10#1)
of conformation##3##2##(1990-5#1)(1995-2#1)(2008-10#1)
of conformational changes##3##3##(1990-5#1)(1990-7#1)(1991-9#1)
of conformational states##2##3##(1997-2#2)
of conformational##12##2##(1990-5#1)(1990-7#1)(1991-9#2)(1992-3#2)(1997-2#2)(2008-5#1)(2009-2#1)(2009-9#1)(2012-2#1)
of conformations##2##2##(2008-3#1)(2008-8#1)
of confounding factors##5##3##(1996-12#1)(2008-6#1)(2008-7#2)(2011-2#1)
of confounding##10##2##(1990-6#1)(1991-8#1)(1992-9#1)(1996-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)
of confusion##3##2##(1991-12#1)(1997-6#1)(2010-10#1)
of congenital adrenal hyperplasia (CAH)##3##5##(2008-4#3)
of congenital adrenal hyperplasia##6##4##(2008-4#6)
of congenital anomalies##5##3##(1997-3#2)(2008-11#1)(2008-9#1)(2012-12#1)
of congenital chest wall deformities##3##5##(2012-2#3)
of congenital diaphragmatic hernia##2##4##(2011-1#1)(2012-3#1)
of congenital hearing loss##2##4##(2008-4#1)(2012-2#1)
of congenital heart disease##7##4##(1993-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
of congenital heart##10##3##(1993-12#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
of congenital hip##2##3##(1994-9#1)(2007-11#1)
of congenital hydronephrosis##2##3##(2008-10#1)(2008-4#1)
of congenital hypothyroidism##5##3##(2008-1#2)(2008-4#1)(2011-1#1)(2013-1#1)
of congenital malformations##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
of congenital toxoplasmosis##5##3##(1990-3#1)(1990-9#4)
of congenital##77##2##(1990-3#1)(1990-9#7)(1991-8#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-9#1)(1997-3#2)(1997-8#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#9)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#5)(2013-8#1)
of congenitally##2##2##(1990-11#1)(2008-9#1)
of congestive heart failure in##2##5##(2008-11#1)(2010-8#1)
of congestive heart failure##7##4##(1992-6#1)(2008-11#1)(2008-3#1)(2010-8#2)(2012-3#2)
of congestive##8##2##(1992-6#1)(1996-3#1)(2008-11#1)(2008-3#1)(2010-8#2)(2012-3#2)
of conglutinin##2##2##(1992-9#2)
of conidia and hyphae##3##4##(2008-3#2)(2008-5#1)
of conidia and##12##3##(2008-10#7)(2008-3#2)(2008-5#1)(2010-3#1)(2011-1#1)
of conidia from##6##3##(2008-10#6)
of conidia germinated##2##3##(2008-10#2)
of conidia in##3##3##(2008-10#3)
of conidia of##4##3##(2008-10#4)
of conidia on##3##3##(2008-10#3)
of conidia or##2##3##(2008-10#2)
of conidia produced in PV plus##2##6##(2008-10#2)
of conidia produced##3##3##(2008-10#3)
of conidia was##2##3##(2008-10#1)(2008-5#1)
of conidia##68##2##(2008-10#61)(2008-3#2)(2008-5#2)(2008-6#1)(2010-3#1)(2011-1#1)
of conidial germination##2##3##(2008-10#2)
of conidial##4##2##(2008-10#4)
of conifer##2##2##(2008-10#1)(2008-7#1)
of conifers##2##2##(2008-10#1)(2010-10#1)
of coniine for##2##3##(1996-12#2)
of coniine##3##2##(1996-12#3)
of coniine-induced teratogenesis##2##3##(1996-12#2)
of conjugal violence##2##3##(2008-2#2)
of conjugal##3##2##(1997-5#1)(2008-2#2)
of conjugate##4##2##(2006-6#1)(2007-11#1)(2008-3#1)(2008-8#1)
of conjugated dienes##4##3##(1992-3#2)(2009-8#2)
of conjugated polymers##2##3##(2007-12#1)(2009-11#1)
of conjugated##17##2##(1990-12#1)(1992-3#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-11#2)(2009-8#2)(2010-2#2)(2012-2#1)
of conjugates##2##2##(2008-4#2)
of conjugation##5##2##(1990-11#1)(2007-11#2)(2008-11#1)(2008-4#1)
of conjunctival##2##2##(1995-11#2)
of connected##3##2##(2007-11#1)(2008-6#1)(2009-9#1)
of connecting##2##2##(2010-3#1)(2012-12#1)
of connection data##2##3##(1995-5#2)
of connections between##5##3##(1994-8#2)(1995-5#2)(2009-8#1)
of connections##6##2##(1994-8#2)(1995-5#2)(1997-3#1)(2009-8#1)
of connective tissue disease##2##4##(1997-4#1)(2006-10#1)
of connective tissue growth factor##2##5##(2012-1#1)(2013-8#1)
of connective tissue##16##3##(1997-4#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-4#1)(2010-8#1)(2012-1#2)(2013-1#3)(2013-8#1)
of connective##17##2##(1997-4#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-4#1)(2010-8#1)(2012-1#2)(2013-1#4)(2013-8#1)
of connectivity##2##2##(1994-3#1)(2007-12#1)
of conscientious##2##2##(2011-2#2)
of conscientiousness##2##2##(2011-2#1)(2012-1#1)
of conscious and##2##3##(1995-9#1)(2010-4#1)
of conscious rats##2##3##(1991-12#1)(1995-12#1)
of conscious##11##2##(1991-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-6#1)(2007-10#1)(2008-11#1)(2010-4#1)(2012-12#1)(2012-3#1)
of consciousness and##6##3##(1997-3#1)(2008-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
of consciousness is##3##3##(2008-11#3)
of consciousness##27##2##(1992-6#2)(1997-3#1)(2007-8#1)(2008-1#1)(2008-11#7)(2008-7#1)(2010-12#1)(2010-6#2)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-8#3)
of consecutive cases##2##3##(2007-8#1)(2010-3#1)
of consecutive patients##3##3##(2008-8#1)(2009-3#1)(2013-1#1)
of consecutive##17##2##(1991-8#1)(1994-12#1)(1994-2#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#2)(2010-3#1)(2011-2#1)(2013-1#1)
of consensus over##2##3##(1997-7#1)(2010-10#1)
of consensus##12##2##(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
of consent to##2##3##(1992-3#2)
of consent##4##2##(1992-3#2)(1993-2#1)(2008-8#1)
of consequence##2##2##(2008-7#1)(2013-1#1)
of conservation between##2##3##(1991-12#1)(2008-4#1)
of conservation of##4##3##(1990-2#1)(1993-12#1)(2008-2#1)(2008-3#1)
of conservation##12##2##(1990-2#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
of conservative and surgical##2##4##(1997-6#1)(2007-8#1)
of conservative and##3##3##(1997-6#1)(2007-11#1)(2007-8#1)
of conservative surgery##3##3##(1990-12#1)(1990-2#1)(1995-9#1)
of conservative treatment of##2##4##(1993-8#1)(2007-11#1)
of conservative treatment##8##3##(1993-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2013-1#2)
of conservative##21##2##(1990-12#1)(1990-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-4#1)(1995-9#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#2)
of conserved##14##2##(1990-11#1)(1993-12#1)(1993-2#1)(1995-5#2)(2007-12#1)(2008-1#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
of considerable importance##5##3##(2007-11#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)
of considerable interest##5##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
of considerable##20##2##(2007-11#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
of considerations for the##2##4##(1995-9#1)(2008-7#1)
of considering##17##2##(1993-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#3)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#2)
of consistency lots##3##3##(1995-5#3)
of consistency##6##2##(1995-5#3)(2008-5#1)(2008-7#1)(2010-4#1)
of consistent##3##2##(1990-8#1)(2010-9#1)(2012-3#1)
of consolidation##4##2##(2007-8#1)(2008-10#3)
of conspecific sperm precedence##2##4##(2008-8#2)
of conspecific##6##2##(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)
of constant##18##2##(1990-11#4)(1996-3#1)(1997-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#2)
of constipation##3##2##(2008-10#1)(2008-7#2)
of constituent##2##2##(2008-2#1)(2008-7#1)
of constituents##4##2##(2008-10#1)(2008-2#1)(2010-10#1)(2013-1#1)
of constitutional##3##2##(2008-4#1)(2013-1#2)
of constitutive and##3##3##(1994-8#1)(1995-9#1)(2008-8#1)
of constitutive##11##2##(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
of constitutively##3##2##(2008-1#1)(2013-1#2)
of constrained##4##2##(2008-10#1)(2008-9#1)(2012-1#1)(2012-2#1)
of constraints on##3##3##(1994-3#1)(2008-8#1)(2008-9#1)
of constraints##8##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)
of constructed##2##2##(2008-6#1)(2013-1#1)
of constructing an##2##3##(2008-11#1)(2011-2#1)
of constructing##4##2##(1996-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
of construction and##2##3##(2008-10#1)(2008-3#1)
of constructive##4##2##(1997-1#1)(2007-11#1)(2008-3#2)
of consultation in##2##3##(2008-10#1)(2013-1#1)
of consultation##6##2##(1991-6#1)(1993-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
of consultations in##2##3##(1990-9#1)(1991-3#1)
of consultations##3##2##(1990-9#1)(1991-3#1)(1997-6#1)
of consulting##2##2##(1995-5#1)(2008-6#1)
of consumed##3##2##(2008-10#2)(2010-8#1)
of consumer complaints##2##3##(1993-3#1)(1997-3#1)
of consumer empowerment and involvement##2##5##(1997-3#2)
of consumer individuals over the landscape of patches##2##8##(2008-9#2)
of consumer information##2##3##(1997-3#2)
of consumer surveys##3##3##(1996-2#1)(1996-3#2)
of consumer##27##2##(1991-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#2)(1997-3#6)(2008-5#1)(2008-9#4)(2010-10#2)(2011-1#2)
of consumer/survivor##2##2##(1997-3#2)
of consumers and the##3##4##(2008-7#1)(2010-7#1)(2011-2#1)
of consumers and##4##3##(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)
of consumers##14##2##(1996-3#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
of consumption of##2##3##(1990-6#1)(1992-10#1)
of consumption##5##2##(1990-6#1)(1992-10#1)(1994-2#1)(2008-7#1)(2011-2#1)
of contact and##3##3##(2008-10#1)(2009-4#1)(2010-10#1)
of contact between the##3##4##(1994-5#1)(2008-11#1)(2012-2#1)
of contact between##6##3##(1994-5#2)(2008-11#1)(2010-12#2)(2012-2#1)
of contact surface between##2##4##(2009-4#1)(2013-1#1)
of contact with##5##3##(1992-5#1)(1995-2#1)(2007-2#1)(2008-11#1)(2011-2#1)
of contact##36##2##(1991-2#1)(1992-5#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-2#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#8)(2008-11#3)(2009-11#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of contacts##5##2##(1992-12#1)(1994-6#3)(1995-11#1)
of contagion and##2##3##(2008-10#1)(2013-8#1)
of containing##3##2##(1995-12#1)(2008-8#1)(2009-7#1)
of containment##4##2##(2008-4#1)(2011-2#2)(2013-1#1)
of contaminant elements##2##3##(2008-10#2)
of contaminant##6##2##(2008-10#4)(2008-6#1)(2008-7#1)
of contaminants##10##2##(1997-4#1)(2008-10#2)(2008-11#3)(2008-9#2)(2011-2#1)(2013-1#1)
of contaminated soil##3##3##(2008-10#2)(2011-1#1)
of contaminated##13##2##(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-3#1)
of contaminating##7##2##(1993-8#1)(1995-6#1)(1997-3#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
of contamination and##3##3##(2008-1#1)(2008-10#2)
of contamination by##2##3##(2011-2#1)(2012-2#1)
of contamination##26##2##(1994-3#1)(1997-4#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#2)
of contemporary dance##2##3##(2008-2#2)
of contemporary##17##2##(1994-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-12#1)
of content of##2##3##(1994-2#1)(2013-1#1)
of content##8##2##(1991-8#1)(1994-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
of contents##4##2##(1992-12#1)(1995-3#1)(2008-12#1)(2009-4#1)
of context##4##2##(2007-10#1)(2009-7#1)(2009-9#1)(2011-1#1)
of contexts##3##2##(1991-1#1)(1991-12#1)(2013-8#1)
of contextual##4##2##(2008-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
of contiguous##6##2##(1995-6#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)
of continental##2##2##(2010-8#1)(2011-2#1)
of contingent##2##2##(2009-9#2)
of continued##4##2##(1992-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
of continuing education##5##3##(1996-3#2)(1997-5#1)(2008-11#1)(2013-1#1)
of continuing##12##2##(1993-8#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-5#1)(2008-10#1)(2008-11#2)(2013-1#2)
of continuity and##3##3##(1990-5#1)(1993-1#1)(2012-3#1)
of continuity of care##3##4##(1991-12#1)(1993-1#1)(2013-8#1)
of continuity##8##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-1#2)(2012-3#1)(2013-8#1)
of continuous ambulatory peritoneal dialysis patients##2##6##(2007-12#2)
of continuous ambulatory peritoneal dialysis##3##5##(2007-12#3)
of continuous and##2##3##(1997-4#1)(2008-10#1)
of continuous flow##4##3##(2008-10#3)(2010-6#1)
of continuous improvement##2##3##(1994-1#1)(1994-2#1)
of continuous quality improvement in##2##5##(1993-2#1)(1994-2#1)
of continuous quality improvement##9##4##(1992-12#1)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)
of continuous subcutaneous insulin infusion##2##5##(2008-7#1)(2009-11#1)
of continuous##70##2##(1991-3#1)(1992-12#1)(1993-11#1)(1993-2#3)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1995-12#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-4#1)
of continuous-flow##2##2##(1997-3#1)(2010-6#1)
of continuous-relief diffractive structures##2##4##(2007-12#2)
of continuous-wave##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of continuously##4##2##(1995-2#1)(1995-6#1)(2007-11#1)(2008-2#1)
of contour objects##3##3##(2008-3#3)
of contour##5##2##(2008-3#4)(2009-4#1)
of contraception##5##2##(1993-2#2)(1994-7#1)(1996-8#1)(2013-1#1)
of contraceptive method##2##3##(1996-11#1)(2013-1#1)
of contraceptive methods##2##3##(1994-8#1)(1996-11#1)
of contraceptive use##3##3##(2012-12#3)
of contraceptive##9##2##(1994-8#1)(1994-9#1)(1996-11#2)(2008-10#1)(2012-12#3)(2013-1#1)
of contract learning##2##3##(2008-11#2)
of contract##5##2##(1992-1#1)(1994-1#1)(1997-5#1)(2008-11#2)
of contractile proteins##3##3##(2009-9#2)(2010-8#1)
of contractile##6##2##(1995-12#1)(1996-9#1)(2008-11#1)(2009-9#2)(2010-8#1)
of contracting AIDS##2##3##(1992-12#1)(1995-12#1)
of contracting##8##2##(1992-12#1)(1992-2#1)(1995-12#1)(2007-2#2)(2010-8#1)(2011-2#1)(2012-12#1)
of contraction induced by##2##4##(1992-9#1)(1997-7#1)
of contraction##7##2##(1992-9#1)(1993-3#1)(1995-12#1)(1997-7#3)(2012-7#1)
of contractions##3##2##(1997-7#1)(2009-2#1)(2013-8#1)
of contracture##3##2##(2008-8#1)(2008-9#2)
of contraindications##2##2##(2008-1#1)(2008-11#1)
of contralateral breast##2##3##(1990-12#1)(2007-10#1)
of contralateral##11##2##(1990-12#1)(1990-8#2)(1994-2#1)(1995-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
of contrast agent##2##3##(2007-10#2)
of contrast agents##5##3##(2008-2#1)(2008-7#3)(2010-9#1)
of contrast enhancement##4##3##(2008-7#1)(2012-2#2)(2013-1#1)
of contrast material##4##3##(2007-10#2)(2008-12#1)(2008-7#1)
of contrast media##2##3##(1992-3#1)(2008-12#1)
of contrast medium##4##3##(1990-3#1)(1992-12#1)(1996-9#1)(2011-2#1)
of contrast##31##2##(1990-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-9#1)(2007-10#4)(2008-10#3)(2008-12#2)(2008-2#2)(2008-7#6)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of contrast-enhanced MR mammography##3##4##(1997-8#3)
of contrast-enhanced US in##2##4##(2008-7#1)(2012-2#1)
of contrast-enhanced US##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
of contrast-enhanced##10##2##(1997-8#4)(2008-7#2)(2010-12#2)(2012-2#2)
of contrasts##2##2##(2012-1#2)
of contributing##2##2##(1996-12#1)(2008-10#1)
of contributions to the##2##4##(2008-3#2)
of contributions##5##2##(1992-6#1)(2007-12#1)(2008-3#3)
of control and##12##3##(1993-8#1)(1995-9#1)(1996-2#2)(1997-7#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)
of control animals##2##3##(1994-6#1)(1995-11#1)
of control cells##6##3##(1997-4#1)(2008-11#5)
of control coefficients to##2##4##(1990-7#2)
of control for##4##3##(2008-10#3)(2009-7#1)
of control group##7##3##(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of control groups##4##3##(1992-11#1)(1997-5#1)(2008-9#2)
of control in##4##3##(1992-3#1)(2007-2#1)(2008-10#1)(2010-4#1)
of control levels##2##3##(1994-9#1)(1996-5#1)
of control measures##4##3##(2008-8#1)(2011-2#2)(2013-1#1)
of control methods##2##3##(1991-9#1)(2008-10#1)
of control of##5##3##(1994-11#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
of control or##3##3##(1995-3#1)(2007-12#1)(2007-3#1)
of control receptors prepared without iodoacetamide##2##6##(1994-6#2)
of control strategies##3##3##(2008-10#2)(2008-11#1)
of control subjects##7##3##(1992-3#1)(1995-12#1)(1996-7#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-6#1)
of control tissue##2##3##(2008-11#1)(2011-1#1)
of control values##4##3##(1990-5#1)(1994-3#1)(1994-8#1)(1997-2#1)
of control##161##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#4)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-1#3)(1996-2#4)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2008-1#3)(2008-10#17)(2008-11#17)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#3)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
of control)##4##2##(1993-8#1)(1994-12#1)(1996-12#1)(2008-11#1)
of controlled clinical trials##2##4##(2006-10#1)(2008-2#1)
of controlled studies##2##3##(1997-3#1)(2012-1#1)
of controlled##16##2##(1991-10#1)(1992-1#1)(1994-11#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-1#1)
of controlling the##6##3##(1991-12#1)(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#1)
of controlling##16##2##(1990-11#1)(1991-12#1)(1994-11#1)(1994-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-1#2)(2012-2#2)
of controls in##2##3##(1990-8#1)(1991-12#1)
of controls##30##2##(1990-11#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-2#2)(1994-3#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2011-2#1)(2012-3#2)(2013-1#1)
of controls)##2##2##(1993-9#1)(2008-6#1)
of controversy##9##2##(1990-5#1)(1993-11#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)(2013-1#1)
of convenient##2##2##(2008-12#1)(2010-8#1)
of conventional and##2##3##(2007-2#1)(2012-2#1)
of conventional electronic##2##3##(2008-3#2)
of conventional emission##2##3##(2008-10#2)
of conventional glass##2##3##(2010-3#1)(2013-1#1)
of conventional methods##4##3##(2008-3#1)(2008-5#1)(2010-12#1)(2010-6#1)
of conventional optical##2##3##(2007-12#2)
of conventional radiography##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of conventional risk##2##3##(2010-9#1)(2012-3#1)
of conventional##97##2##(1990-11#1)(1992-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#4)(2007-12#10)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#5)(2008-3#11)(2008-5#2)(2008-6#7)(2008-7#6)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
of convergence to the##2##4##(2008-7#1)(2008-8#1)
of convergence##8##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)
of convergent evolution##4##3##(2008-9#1)(2009-6#1)(2011-2#2)
of convergent##7##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#2)
of converging laser beams propagating in##2##6##(2008-3#2)
of conversion of Se(VI)##2##4##(2008-10#2)
of conversion of##4##3##(1990-10#1)(2008-10#3)
of conversion##14##2##(1990-10#1)(1992-11#1)(1996-11#1)(2007-12#1)(2008-10#4)(2008-6#2)(2008-7#2)(2013-1#2)
of converting##8##2##(1992-12#1)(1994-11#1)(1996-1#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-1#1)
of convex##2##2##(2008-3#1)(2009-9#1)
of convincing##2##2##(1991-3#1)(1994-1#1)
of convulsions##3##2##(1992-11#1)(1993-12#2)
of cooked##6##2##(2008-10#2)(2010-2#1)(2010-4#3)
of cooking time##2##3##(2010-2#2)
of cooling##5##2##(2007-10#2)(2008-3#2)(2008-5#1)
of cooperation##16##2##(1992-1#1)(1995-1#1)(2008-8#8)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
of cooperative free##2##3##(1990-8#2)
of cooperative interactions##3##3##(1997-2#2)(2008-10#1)
of cooperative##17##2##(1990-8#2)(1991-2#1)(1994-6#1)(1995-1#1)(1997-2#3)(1997-6#1)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2012-3#1)
of cooperativity##8##2##(1990-8#6)(1993-11#1)(1997-2#1)
of cooperators##2##2##(2012-3#2)
of coordinate expression##2##3##(1997-7#2)
of coordinate##4##2##(1991-2#1)(1997-7#2)(2008-2#1)
of coordinated##3##2##(1994-8#1)(2009-6#1)(2012-2#1)
of copies of the##2##4##(1990-5#1)(2012-12#1)
of copies##3##2##(1990-5#1)(1991-2#1)(2012-12#1)
of coping in##2##3##(1990-10#1)(2011-2#1)
of coping skills training##2##4##(2013-1#2)
of coping strategies##4##3##(1994-12#2)(2008-1#1)(2011-1#1)
of coping##17##2##(1990-10#4)(1994-12#2)(1997-8#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
of copolymers##3##2##(2009-10#1)(2010-2#1)(2013-1#1)
of copper (Cu) and##2##4##(2010-5#1)(2013-8#1)
of copper (Cu)##4##3##(1995-3#1)(1997-4#1)(2010-5#1)(2013-8#1)
of copper and iron in##4##5##(2008-10#4)
of copper and iron##11##4##(2008-10#11)
of copper and lead##4##4##(2007-5#1)(2008-10#3)
of copper and mercury ions##3##5##(2008-10#3)
of copper and zinc##3##4##(2008-10#3)
of copper and##30##3##(2007-5#1)(2008-10#29)
of copper are##2##3##(1992-12#1)(2008-10#1)
of copper at##5##3##(2008-10#5)
of copper by##9##3##(2008-10#9)
of copper deficiency##2##3##(2012-2#2)
of copper determination in##2##4##(2008-10#2)
of copper from##2##3##(2008-10#2)
of copper in alloys##2##4##(2008-10#2)
of copper in natural##3##4##(2008-10#3)
of copper in the presence of##3##6##(2008-10#2)(2010-5#1)
of copper in the##9##4##(1995-6#1)(2008-10#5)(2008-9#2)(2010-5#1)
of copper in water samples##5##5##(2008-10#5)
of copper in##38##3##(1995-6#1)(2008-10#34)(2008-9#2)(2010-5#1)
of copper ions##4##3##(2008-10#4)
of copper is##4##3##(2008-10#4)
of copper metabolism##2##3##(1992-12#1)(2008-12#1)
of copper on##3##3##(2008-10#2)(2008-12#1)
of copper oxide##2##3##(2008-10#1)(2008-2#1)
of copper was##5##3##(2008-10#5)
of copper were##2##3##(2008-10#2)
of copper with##4##3##(2008-10#4)
of copper##193##2##(1990-8#2)(1992-12#2)(1995-3#2)(1995-6#1)(1997-4#2)(2007-12#1)(2007-5#1)(2008-10#165)(2008-12#4)(2008-2#2)(2008-9#4)(2010-5#2)(2012-2#4)(2013-8#1)
of copper(II) and##8##3##(2008-10#8)
of copper(II) at##2##3##(2008-10#2)
of copper(II) based on its catalytic##2##6##(2008-10#2)
of copper(II) based on its##3##5##(2008-10#3)
of copper(II) based on##4##4##(2008-10#4)
of copper(II) by##6##3##(2008-10#6)
of copper(II) in##7##3##(2008-10#7)
of copper(II) ions##5##3##(2008-10#5)
of copper(II) with##4##3##(2008-10#4)
of copper(II)##62##2##(2008-10#62)
of copper-resistant##2##2##(2008-10#2)
of copulation##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
of copy number##2##3##(2008-9#1)(2012-3#1)
of coral reef##3##3##(2007-5#2)(2013-1#1)
of coral##9##2##(1992-7#1)(2007-5#4)(2008-3#1)(2012-2#2)(2013-1#1)
of coral-reef fishes##2##3##(2010-8#2)
of corals##4##2##(2007-5#1)(2008-5#2)(2012-2#1)
of cord blood cells##2##4##(2008-11#2)
of cord blood##5##3##(2008-11#5)
of core values##2##3##(1995-12#2)
of core##13##2##(1993-1#1)(1994-12#2)(1994-3#1)(1995-12#2)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)
of corn (Zea mays)##2##4##(2008-10#2)
of corn fiber##3##3##(2008-6#3)
of corn from##2##3##(2008-10#2)
of corn stover##2##3##(2011-2#1)(2013-1#1)
of corn##24##2##(1997-4#1)(2008-10#15)(2008-6#3)(2011-2#2)(2012-12#1)(2013-1#2)
of cornea##2##2##(2011-3#1)(2012-3#1)
of corneal haze##3##3##(2008-3#3)
of corneal surface##2##3##(2011-1#2)
of corneal##15##2##(2007-7#1)(2008-3#3)(2008-7#2)(2009-4#1)(2010-10#1)(2011-1#3)(2011-2#3)(2013-1#1)
of corneocytes##8##2##(2008-5#8)
of corona radiata infarcts##2##4##(2007-10#2)
of coronary arteries##4##3##(1991-12#1)(2007-8#1)(2012-3#2)
of coronary artery bypass grafting (CABG)##2##6##(2007-8#1)(2010-8#1)
of coronary artery bypass grafting##3##5##(2007-8#2)(2010-8#1)
of coronary artery bypass##4##4##(1994-2#1)(2007-8#2)(2010-8#1)
of coronary artery disease (CAD)##5##5##(1991-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
of coronary artery disease in##2##5##(1996-3#1)(2008-3#1)
of coronary artery disease##27##4##(1990-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-3#4)(2008-7#1)(2009-10#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
of coronary artery stenosis##3##4##(1994-11#1)(2011-2#2)
of coronary artery##45##3##(1990-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-11#1)(1994-2#1)(1996-3#1)(1997-8#1)(2007-8#5)(2008-11#3)(2008-12#4)(2008-3#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
of coronary disease##2##3##(1996-8#1)(2011-2#1)
of coronary events and##2##4##(1990-5#1)(1992-6#1)
of coronary heart disease (CHD)##3##5##(2007-10#1)(2008-3#1)(2012-2#1)
of coronary heart disease in##4##5##(1995-11#1)(1996-3#1)(1996-8#2)
of coronary heart disease is##3##5##(1991-2#1)(1991-6#1)(2008-4#1)
of coronary heart disease##18##4##(1991-2#1)(1991-6#1)(1991-8#1)(1995-11#1)(1996-3#2)(1996-8#2)(2007-10#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-8#1)(2010-6#1)(2012-2#1)
of coronary heart##21##3##(1991-2#1)(1991-6#1)(1991-8#1)(1995-11#1)(1996-3#3)(1996-8#2)(2007-10#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
of coronary interventionism##2##3##(2008-10#2)
of coronary lesion##2##3##(2008-11#1)(2009-7#1)
of coronary mortality and##2##4##(1992-8#1)(2009-9#1)
of coronary spasm##2##3##(2007-8#1)(2008-7#1)
of coronary##109##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-12#2)(1996-3#4)(1996-8#3)(1996-9#1)(1997-8#1)(2007-10#1)(2007-8#10)(2008-10#4)(2008-11#6)(2008-12#8)(2008-3#6)(2008-4#5)(2008-7#4)(2008-8#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
of corpora allata##2##3##(1995-11#1)(2008-7#1)
of corpora lutea##3##3##(1992-3#2)(1996-12#1)
of corpora##6##2##(1992-3#2)(1995-11#1)(1996-12#1)(2008-7#2)
of corporate##5##2##(1991-1#1)(1991-3#2)(1993-2#1)(2008-12#1)
of corpus##5##2##(1995-11#1)(2008-10#1)(2008-7#2)(2009-5#1)
of corpuscularism##2##2##(2008-12#2)
of correct answers##4##3##(1993-12#2)(2008-12#1)(2013-8#1)
of correct classification for##2##4##(2008-10#2)
of correct classification##3##3##(2008-10#3)
of correct diagnosis##2##3##(1990-9#1)(2010-5#1)
of correct responses##3##3##(1991-2#1)(1993-3#1)(2013-8#1)
of correct##27##2##(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#2)(1993-12#2)(1993-3#1)(1995-2#1)(1996-7#1)(2008-10#5)(2008-12#2)(2008-9#5)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#2)
of corrected##3##2##(1992-6#1)(2008-2#1)(2012-12#1)
of correcting##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of correction##7##2##(2008-10#1)(2008-7#2)(2010-11#1)(2012-1#1)(2012-12#1)(2013-8#1)
of correctly identified##2##3##(2008-10#1)(2013-1#1)
of correctly##4##2##(1992-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
of correlated photons##3##3##(2007-12#2)(2008-2#1)
of correlated##11##2##(1996-6#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
of correlation and##2##3##(2008-5#1)(2013-8#1)
of correlation between the##2##4##(2008-3#1)(2010-6#1)
of correlation between##10##3##(1991-12#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
of correlation coefficient##4##3##(2008-10#4)
of correlation functions##2##3##(2007-12#1)(2009-2#1)
of correlation of##2##3##(2008-3#1)(2008-7#1)
of correlation with##3##3##(1994-8#1)(1996-7#1)(2013-8#1)
of correlation##37##2##(1991-12#1)(1994-8#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2009-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
of correlations between##2##3##(2008-10#1)(2008-9#1)
of correlations##7##2##(1992-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
of corresponding##10##2##(1994-6#1)(1995-11#1)(1996-12#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
of corrosion beneath##2##3##(2007-12#2)
of corrosion##4##2##(2007-12#3)(2008-3#1)
of cortex##7##2##(1990-11#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
of cortexin##2##2##(2010-4#2)
of cortical activation##3##3##(1994-3#1)(2012-12#2)
of cortical and hippocampal 5-HT1A##2##5##(1994-2#2)
of cortical and subcortical##2##4##(2008-11#2)
of cortical and##4##3##(1994-2#2)(2008-11#2)
of cortical bone##5##3##(1993-11#1)(1995-6#2)(2009-7#1)(2013-1#1)
of cortical cell walls##2##4##(2008-10#2)
of cortical cells##4##3##(1990-8#1)(2008-10#2)(2008-11#1)
of cortical neuron##2##3##(1990-8#1)(1996-5#1)
of cortical processing##3##3##(1994-8#2)(2008-11#1)
of cortical##50##2##(1990-8#2)(1993-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-8#3)(1995-3#1)(1995-6#2)(1996-5#2)(1996-7#1)(2007-10#2)(2008-10#5)(2008-11#12)(2008-7#4)(2009-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
of corticosteroid therapy##2##3##(2006-10#1)(2012-3#1)
of corticosteroid##5##2##(1997-7#1)(2006-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
of corticosteroids##11##2##(1992-3#1)(1997-5#2)(1997-8#1)(2006-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
of corticosterone to##2##3##(1990-11#1)(2008-7#1)
of corticosterone was##2##3##(1994-6#1)(2013-1#1)
of corticosterone were##2##3##(1994-6#1)(1997-2#1)
of corticosterone##19##2##(1990-11#3)(1994-6#3)(1995-3#1)(1996-2#2)(1997-2#2)(2008-10#1)(2008-7#4)(2008-8#1)(2012-1#1)(2013-1#1)
of corticotropin releasing##2##3##(1991-12#1)(1992-12#1)
of corticotropin##3##2##(1991-12#1)(1992-12#1)(1995-11#1)
of corticotropin-releasing hormone##2##3##(1990-12#1)(1990-5#1)
of corticotropin-releasing##3##2##(1990-12#1)(1990-5#1)(2008-4#1)
of cortisol or##2##3##(1990-5#1)(1995-11#1)
of cortisol##11##2##(1990-12#1)(1990-5#1)(1991-6#1)(1995-11#3)(2008-1#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
of cos-1 cells##2##3##(1995-5#2)
of cosmetic and##2##3##(2008-10#1)(2008-5#1)
of cosmetic products##12##3##(2008-5#12)
of cosmetic surgery##4##3##(2007-12#3)(2010-8#1)
of cosmetic##27##2##(1991-6#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-5#20)(2010-8#1)
of cosmetics have been##3##4##(2008-5#3)
of cosmetics##14##2##(2008-5#14)
of cospeciation##2##2##(1995-3#2)
of cost and##7##3##(1992-11#1)(1993-3#1)(1994-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
of cost containment on##2##4##(1991-3#1)(1992-1#1)
of cost containment##6##3##(1991-3#2)(1992-1#2)(1992-3#1)(1995-3#1)
of cost savings##2##3##(1991-1#1)(1996-1#1)
of cost##29##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#3)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-3#2)(1995-3#2)(1996-1#1)(2007-4#1)(2008-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
of cost-effective##4##2##(1994-12#1)(1994-2#1)(2008-11#1)(2009-8#1)
of cost-effectiveness##6##2##(1992-1#1)(1997-8#1)(2008-2#1)(2008-7#2)(2009-8#1)
of costimulatory molecules on##2##4##(2008-11#2)
of costimulatory molecules##4##3##(2007-12#1)(2008-10#1)(2008-11#2)
of costs and benefits of##2##5##(2008-12#1)(2009-4#1)
of costs and##6##3##(1992-5#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)
of costs##14##2##(1991-1#1)(1992-5#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)
of cotrimoxazole and trimethoprim##2##4##(2008-11#2)
of cotrimoxazole##7##2##(2007-12#1)(2008-11#6)
of cotton fibers##2##3##(2008-2#1)(2008-9#1)
of cotton leafworm Spodoptera littoralis##2##5##(2008-12#2)
of cotton wilt disease##2##4##(2008-12#2)
of cotton##20##2##(2008-10#11)(2008-12#5)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
of cottonball##2##2##(2008-10#2)
of cottonseed##3##2##(2008-10#3)
of cotyledon##5##2##(2008-8#1)(2008-9#4)
of cotyledons##3##2##(2008-10#2)(2009-8#1)
of cough##4##2##(1990-6#2)(1996-12#1)(2008-1#1)
of coughing##3##2##(1991-11#1)(1993-6#1)(2008-12#1)
of coumarin##5##2##(1992-8#1)(2008-10#2)(2008-11#2)
of coumarins##2##2##(1990-6#1)(2008-10#1)
of coumestrol to##3##3##(1995-11#3)
of coumestrol##4##2##(1995-11#4)
of counseling##4##2##(2008-3#1)(2008-6#2)(2012-3#1)
of counter ion##2##3##(2008-10#1)(2008-5#1)
of counter##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
of counterion species##2##3##(1997-2#2)
of counterpropagating##2##2##(2007-11#2)
of countries##6##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
of country##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
of couple therapy##2##3##(2012-2#2)
of couple##3##2##(2012-2#3)
of coupled cells##2##3##(1996-8#1)(2009-8#1)
of coupled oscillators##2##3##(2009-8#1)(2012-2#1)
of coupled resonators##2##3##(2007-11#1)(2007-12#1)
of coupled##17##2##(1996-8#2)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#2)(2012-2#3)(2013-1#2)(2013-8#1)
of couples who##2##3##(2012-2#2)
of couples##4##2##(2012-2#4)
of coupling between##5##3##(1994-12#1)(1995-11#1)(1997-2#1)(2007-11#1)(2011-1#1)
of coupling##19##2##(1994-12#1)(1995-11#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
of course and##2##3##(2008-12#1)(2013-1#1)
of course##16##2##(1994-1#3)(1996-3#1)(1997-4#1)(2008-12#3)(2008-5#1)(2008-8#1)(2009-10#2)(2011-1#1)(2013-1#3)
of courses##5##2##(1990-12#1)(1994-12#1)(1996-1#1)(2008-11#1)(2011-2#1)
of courtship##2##2##(2008-6#1)(2008-8#1)
of covalent attachment##2##3##(1994-5#1)(2010-12#1)
of covalent binding of##2##4##(2008-10#1)(2008-3#1)
of covalent binding##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
of covalent modifications##2##3##(1992-11#1)(1994-5#1)
of covalent##14##2##(1992-11#1)(1994-5#3)(1995-12#1)(1995-6#4)(2008-10#3)(2008-3#1)(2010-12#1)
of covalently bound fatty acids##2##5##(1993-6#1)(2008-5#1)
of covalently bound##4##3##(1993-6#1)(1995-11#1)(1995-6#1)(2008-5#1)
of covalently closed##3##3##(1995-3#1)(2008-10#1)(2010-2#1)
of covalently##12##2##(1992-8#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-2#1)
of covariance##12##2##(1990-3#1)(1992-9#1)(1996-7#1)(1997-7#1)(2008-10#1)(2009-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of covariates that##2##3##(1994-2#1)(1995-2#1)
of covariates##8##2##(1994-2#2)(1995-2#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
of covariation##2##2##(2008-10#2)
of cover crop##2##3##(2008-10#2)
of coverage##3##2##(1995-1#1)(1996-12#1)(2012-2#1)
of cow milk##4##3##(2008-10#4)
of cow##5##2##(2008-10#4)(2008-7#1)
of cow's milk##3##3##(2007-8#1)(2009-2#1)(2010-6#1)
of cowpea##3##2##(1995-2#1)(2008-10#1)(2008-12#1)
of cows##3##2##(1992-12#1)(2008-12#1)(2013-1#1)
of coxsackievirus B1##2##3##(2013-8#2)
of coxsackievirus##3##2##(1991-5#1)(2013-8#2)
of cpe-positive C##3##3##(2011-2#3)
of crack##7##2##(2008-1#2)(2008-10#2)(2008-8#1)(2009-7#1)(2012-2#1)
of cranberry##6##2##(2008-10#4)(2011-1#1)(2012-12#1)
of cranial nerve##2##3##(1996-12#1)(2008-7#1)
of cranial nerves##2##3##(1993-9#1)(1996-12#1)
of cranial##11##2##(1993-9#1)(1994-9#1)(1996-12#2)(1996-8#2)(2007-10#1)(2007-12#1)(2008-7#1)(2011-2#2)
of craniofacial deformities##2##3##(2007-12#1)(2011-2#1)
of craniofacial##7##2##(2007-12#4)(2008-8#1)(2010-6#1)(2011-2#1)
of craniopharyngioma##3##2##(1995-5#1)(2008-7#1)(2011-2#1)
of craniosynostosis##3##2##(2007-12#2)(2011-1#1)
of cream##3##2##(2008-5#3)
of creamide##2##2##(2013-1#2)
of creams##4##2##(2008-5#4)
of creatine and##4##3##(1990-8#1)(2008-10#3)
of creatine kinase##5##3##(1991-2#1)(1992-3#1)(1993-3#1)(1995-8#2)
of creatine phosphokinase B##4##4##(1990-11#4)
of creatine phosphokinase##5##3##(1990-11#4)(2006-10#1)
of creatine supplementation##2##3##(2008-5#2)
of creatine##22##2##(1990-11#5)(1990-8#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-8#2)(2006-10#1)(2008-10#3)(2008-5#4)(2008-7#1)(2013-1#1)
of creating a##2##3##(1995-3#1)(2010-4#1)
of creating an##2##3##(2008-1#1)(2010-8#1)
of creating##14##2##(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-7#1)(2010-4#1)(2010-8#1)(2012-2#1)
of creatinine and##3##3##(2008-10#1)(2011-2#2)
of creatinine in urine##4##4##(1992-11#2)(2008-10#2)
of creatinine in##5##3##(1991-12#1)(1992-11#2)(2008-10#2)
of creatinine was##3##3##(1992-11#1)(2008-4#1)(2011-2#1)
of creatinine##26##2##(1991-12#2)(1992-11#4)(1995-3#1)(2008-1#3)(2008-10#8)(2008-4#2)(2011-2#5)(2013-1#1)
of creation of##4##3##(1991-8#1)(2007-8#1)(2008-1#1)(2008-2#1)
of creation##5##2##(1991-8#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-9#1)
of creative##3##2##(1993-2#1)(2007-8#1)(2012-3#1)
of creativity##2##2##(1995-1#2)
of credit##2##2##(1991-9#1)(2007-7#1)
of creep##2##2##(1996-4#1)(2009-4#1)
of creeping bentgrass (Agrostis stolonifera)##2##5##(2008-10#2)
of creeping bentgrass##6##3##(2008-10#6)
of creeping##7##2##(2008-10#7)
of crime##8##2##(1990-3#1)(1991-1#1)(1992-2#1)(2008-10#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
of crimes##2##2##(1991-6#1)(2008-10#1)
of criminal##3##2##(1992-1#1)(2008-10#1)(2009-7#1)
of crises##4##2##(1996-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
of crisis##5##2##(1993-12#1)(1993-3#1)(2008-12#1)(2009-6#1)(2013-1#1)
of criteria and##2##3##(2008-7#1)(2011-1#1)
of criteria for##6##3##(1993-12#1)(1993-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
of criteria##13##2##(1993-12#1)(1993-2#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
of critical care nursing practice##2##5##(2007-11#2)
of critical care##6##3##(1996-2#2)(1997-1#1)(2007-11#2)(2007-12#1)
of critical importance##6##3##(1990-6#1)(1991-1#1)(1995-8#1)(2008-10#1)(2009-3#1)(2013-8#1)
of critical paths##3##3##(1993-3#1)(1995-12#2)
of critical pathways##5##3##(1995-12#1)(1996-12#1)(2008-3#3)
of critical thinking##7##3##(2008-11#6)(2008-12#1)
of critical##53##2##(1990-11#1)(1990-6#1)(1991-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#5)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#10)(2008-12#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of critically ill children##2##4##(1995-12#1)(2012-2#1)
of critically ill patients##3##4##(2007-11#1)(2010-5#1)(2010-8#1)
of critically ill##5##3##(1995-12#1)(2007-11#1)(2010-5#1)(2010-8#1)(2012-2#1)
of critically##7##2##(1995-12#1)(2007-11#1)(2008-12#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-2#1)
of criticism##4##2##(1990-11#1)(2008-11#2)(2009-11#1)
of cromakalim##2##2##(1992-9#1)(1996-9#1)
of crop plants##3##3##(2008-10#2)(2008-11#1)
of crop protection##3##3##(2008-10#3)
of crop yield##2##3##(2008-10#1)(2008-12#1)
of crop##19##2##(2008-10#11)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
of crops##7##2##(2008-10#5)(2008-6#1)(2013-8#1)
of cross protection##2##3##(2008-10#2)
of cross talk##3##3##(2008-2#1)(2008-3#2)
of cross##12##2##(1995-5#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#1)(2013-8#1)
of cross-cultural##4##2##(1991-12#1)(2007-8#1)(2008-1#1)(2013-8#1)
of cross-flow filtration##2##3##(2008-10#2)
of cross-flow##3##2##(1992-5#1)(2008-10#2)
of cross-linked##6##2##(1992-2#1)(1996-12#1)(2008-10#1)(2008-5#2)(2008-6#1)
of cross-linking molecular weights##2##4##(2008-5#2)
of cross-linking##6##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-5#2)(2010-4#1)
of cross-phase modulation##2##3##(2007-12#2)
of cross-protection##5##2##(1997-3#2)(2008-8#3)
of cross-reactive##2##2##(2008-11#1)(2011-2#1)
of cross-resistance##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
of cross-sectional##3##2##(2008-1#1)(2008-10#1)(2009-4#1)
of cross-species##2##2##(2008-11#1)(2008-5#1)
of cross-talk##3##2##(1995-5#1)(1997-1#1)(2008-3#1)
of crossed##2##2##(2008-10#1)(2008-3#1)
of crosses between resistant##2##4##(2008-10#2)
of crosses between##5##3##(1995-8#1)(2008-10#4)
of crosses##10##2##(1995-8#1)(2008-10#8)(2012-3#1)
of crossing##2##2##(1995-6#1)(2008-10#1)
of crosslinking##2##2##(1991-2#1)(2009-7#1)
of crosslinks##2##2##(1993-3#2)
of croup##5##2##(1990-8#3)(2007-12#1)(2008-11#1)
of crown and root rot disease of tomato##2##8##(2008-10#2)
of crown and root rot##3##5##(2008-10#3)
of crown ether##2##3##(2008-10#2)
of crown ethers##3##3##(2008-10#3)
of crown gall of tomato##2##5##(2008-10#2)
of crown gall##3##3##(2008-10#3)
of crown rust resistance in##3##5##(2008-10#3)
of crown rust resistance##4##4##(2008-10#4)
of crown rust##5##3##(2008-10#5)
of crown##21##2##(2008-10#18)(2011-2#1)(2013-1#1)(2013-7#1)
of crucial importance in##3##4##(2008-10#2)(2008-9#1)
of crucial importance to##2##4##(2007-10#1)(2010-5#1)
of crucial importance##8##3##(2007-10#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-5#2)
of cruciferous##2##2##(2008-10#2)
of crucifers##2##2##(2008-10#2)
of crude glycerol in##2##4##(2013-1#2)
of crude glycerol##3##3##(2013-1#3)
of crude oil##3##3##(2008-10#2)(2008-3#1)
of crude protein##2##3##(1997-4#1)(2008-4#1)
of crude##16##2##(1996-12#2)(1997-4#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#3)
of cry1Ab gene in transgenic rice##2##6##(2008-9#2)
of cryIVB##2##2##(1993-12#2)
of cryopreserved composite##3##3##(2008-9#3)
of cryopreserved##5##2##(1996-3#1)(2008-11#1)(2008-9#3)
of cryptic##5##2##(1997-4#1)(2008-10#1)(2009-6#1)(2010-4#1)(2012-3#1)
of cryptococcal meningitis in##3##4##(1991-2#1)(2011-2#2)
of cryptococcal meningitis##5##3##(1991-2#1)(2007-7#1)(2007-8#1)(2011-2#2)
of cryptococcosis in##2##3##(2008-5#2)
of cryptogenic stroke##2##3##(2007-10#1)(2008-7#1)
of cryptogenic##3##2##(2007-10#1)(2008-7#1)(2009-10#1)
of cryptolepis sanguinolenta##3##3##(2011-2#3)
of crystal violet solution##3##4##(2008-10#3)
of crystal violet##5##3##(2008-10#5)
of crystal##9##2##(1995-6#1)(2007-11#1)(2008-10#5)(2008-3#1)(2013-1#1)
of crystalline##7##2##(1992-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#3)
of crystallization##6##2##(2008-3#2)(2008-4#4)
of crystallographic data##2##3##(1994-6#1)(2011-3#1)
of crystals##3##2##(1995-6#2)(2008-3#1)
of ctDNA##2##2##(2008-10#2)
of cubic##5##2##(1991-5#1)(2007-11#2)(2008-3#2)
of cucumber (Cucumis sativus)##2##4##(2008-10#2)
of cucumber leaves##2##3##(2008-10#2)
of cucumber mosaic cucumovirus##2##4##(2008-10#2)
of cucumber mosaic virus (CMV)##3##5##(1997-6#1)(2008-10#2)
of cucumber mosaic virus##6##4##(1997-6#2)(2008-10#4)
of cucumber mosaic##8##3##(1997-6#2)(2008-10#6)
of cucumber##27##2##(1997-6#2)(2008-10#25)
of cucurbit-infecting##2##2##(2008-10#2)
of cucurbits##6##2##(2008-10#5)(2013-8#1)
of culinary practice##2##3##(2012-2#2)
of culinary##3##2##(1994-3#1)(2012-2#2)
of cultivar and##2##3##(2008-10#2)
of cultivar##9##2##(2008-10#9)
of cultivars with##2##3##(2008-10#2)
of cultivars##9##2##(2008-10#8)(2012-4#1)
of cultivated##6##2##(2008-10#3)(2008-12#1)(2009-10#1)(2013-1#1)
of cultivating##4##2##(1994-11#1)(2008-11#1)(2011-2#2)
of cultivation and##2##3##(2008-11#1)(2010-7#1)
of cultivation for##2##3##(2008-4#1)(2012-3#1)
of cultivation##14##2##(2008-10#1)(2008-11#6)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
of culturable bacteria##5##3##(2008-10#4)(2012-3#1)
of culturable##7##2##(2008-10#5)(2008-7#1)(2012-3#1)
of cultural diversity in##2##4##(2008-11#2)
of cultural diversity##3##3##(1997-2#1)(2008-11#2)
of cultural heritage##2##3##(2008-10#2)
of cultural practices##3##3##(2008-10#2)(2009-7#1)
of cultural##19##2##(1991-12#3)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)
of culturally appropriate##2##3##(2008-6#1)(2010-9#1)
of culturally##6##2##(1997-2#1)(2008-1#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-3#1)
of culture and##2##3##(2008-11#1)(2011-2#1)
of culture conditions for##2##4##(2008-11#2)
of culture conditions##5##3##(2008-11#3)(2008-9#1)(2009-3#1)
of culture in##4##3##(1993-6#1)(2008-5#1)(2008-9#1)(2009-7#1)
of culture media##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
of culture medium##4##3##(1995-2#1)(1996-12#1)(1997-4#1)(2008-11#1)
of culture with##2##3##(1990-12#1)(2008-11#1)
of culture##65##2##(1990-12#2)(1991-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#22)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#3)(2011-2#1)(2013-1#1)
of culture-negative endocarditis##2##3##(1993-2#1)(1996-11#1)
of culture-negative##4##2##(1993-12#1)(1993-2#1)(1996-11#1)(2011-2#1)
of cultured cells of##2##4##(2008-10#1)(2008-9#1)
of cultured cells were##2##4##(2008-11#1)(2008-6#1)
of cultured cells with##2##4##(1994-11#1)(2008-9#1)
of cultured cells##18##3##(1992-12#1)(1994-11#4)(1994-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
of cultured hippocampal neurons##3##4##(1996-12#1)(1997-7#2)
of cultured human##4##3##(1990-2#1)(1993-6#1)(1994-3#1)(2008-11#1)
of cultured mouse##3##3##(1990-11#1)(1990-7#2)
of cultured neurons##2##3##(1992-12#1)(1995-5#1)
of cultured rat##2##3##(1993-3#1)(1993-6#1)
of cultured##54##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-5#1)(1992-12#2)(1992-6#1)(1993-3#1)(1993-6#3)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-7#2)(2008-1#2)(2008-10#3)(2008-11#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-2#2)(2012-2#1)(2013-7#1)
of cultures##10##2##(1997-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
of culturing##4##2##(1992-8#1)(2008-11#2)(2012-1#1)
of cumulative##7##2##(1992-9#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-10#1)
of cumulus cells##4##3##(2008-9#1)(2013-1#3)
of cupric ion##2##3##(1995-6#1)(2008-10#1)
of cupric##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
of curcumin on##4##3##(2008-11#2)(2011-2#1)(2012-3#1)
of curcumin##12##2##(2008-11#4)(2010-3#1)(2011-2#3)(2012-3#2)(2013-1#2)
of cure##6##2##(1990-8#1)(1997-3#1)(1997-6#1)(2008-12#1)(2010-8#1)(2011-2#1)
of curing##2##2##(2008-10#1)(2008-12#1)
of current and##4##3##(1994-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
of current interest##3##3##(1997-2#1)(2008-5#1)(2008-7#1)
of current issues##3##3##(1993-2#1)(1994-1#1)(1996-1#1)
of current knowledge of##2##4##(2008-7#1)(2012-12#1)
of current knowledge##6##3##(1996-3#1)(2008-7#1)(2009-4#2)(2012-12#1)(2012-2#1)
of current literature##2##3##(1994-1#1)(2007-8#1)
of current methodology##2##3##(2008-2#1)(2008-6#1)
of current methods##3##3##(2008-11#1)(2008-12#1)(2008-2#1)
of current practice##2##3##(2008-7#1)(2008-8#1)
of current research##3##3##(1996-11#1)(2008-11#1)(2008-3#1)
of current scientific##2##3##(2008-2#1)(2011-2#1)
of current through##2##3##(2008-9#2)
of current##118##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of currently available##7##3##(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
of currently used##3##3##(2007-4#1)(2008-5#1)(2008-9#1)
of currently##12##2##(1997-3#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
of curricular##2##2##(1996-2#1)(2009-8#1)
of curriculum and##2##3##(2011-2#1)(2013-1#1)
of curriculum##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
of curvature and##2##3##(2008-3#1)(2009-6#1)
of curvature of the##5##4##(2008-2#1)(2008-3#4)
of curvature of##8##3##(2007-11#1)(2008-2#2)(2008-3#5)
of curvature##23##2##(1990-12#1)(1992-3#2)(2007-11#1)(2008-2#3)(2008-3#12)(2008-7#2)(2008-9#1)(2009-6#1)
of curve fitting##2##3##(2008-2#1)(2008-4#1)
of curves were##2##3##(2008-3#1)(2013-8#1)
of custom##4##2##(1993-9#1)(1996-3#1)(2007-11#1)(2008-3#1)
of customer satisfaction##3##3##(1994-3#1)(1995-3#1)(2008-10#1)
of customer##5##2##(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-10#1)
of customers'##2##2##(1992-1#1)(1993-12#1)
of cut##3##2##(2008-10#1)(2008-9#2)
of cut-flower roses##2##3##(2008-10#2)
of cutaneous haemangiomas in chickens##2##5##(2008-5#2)
of cutaneous leishmaniasis (CL)##2##4##(2007-7#2)
of cutaneous leishmaniasis##6##3##(2007-7#4)(2012-12#2)
of cutaneous melanoma##2##3##(2007-12#1)(2010-6#1)
of cutaneous melanomas##2##3##(2009-4#2)
of cutaneous metastases##2##3##(2010-6#1)(2013-8#1)
of cutaneous metastasis##2##3##(2007-7#1)(2010-11#1)
of cutaneous##51##2##(1990-7#1)(1992-6#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-6#1)(2007-12#3)(2007-2#1)(2007-7#8)(2008-10#1)(2008-11#1)(2008-5#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-11#1)(2010-6#5)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
of cuticle and##2##3##(2007-12#1)(2008-10#1)
of cuticle##8##2##(2007-12#3)(2008-10#3)(2008-5#1)(2009-8#1)
of cuticular caps##2##3##(2007-12#2)
of cuticular hydrocarbons that##2##4##(2008-9#1)(2013-8#1)
of cuticular hydrocarbons##4##3##(2008-9#1)(2012-3#2)(2013-8#1)
of cuticular##8##2##(1994-12#1)(2007-12#3)(2008-9#1)(2012-3#2)(2013-8#1)
of cuts in##2##3##(2008-11#1)(2013-8#1)
of cuts##3##2##(2008-11#1)(2009-4#1)(2013-8#1)
of cutting##2##2##(1996-2#1)(2008-5#1)
of cv##15##2##(2008-10#15)
of cvs##6##2##(2008-10#6)
of cw output power##2##4##(2007-12#1)(2008-2#1)
of cw##11##2##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#1)
of cyanide ion##2##3##(2008-10#2)
of cyanide using##2##3##(2008-10#2)
of cyanide##19##2##(2008-10#19)
of cyanine##2##2##(2007-11#1)(2008-7#1)
of cyanobacteria##3##2##(1996-12#1)(2008-10#1)(2013-7#1)
of cyanobacterial##3##2##(2008-11#1)(2008-2#1)(2010-5#1)
of cyanthiwigin U to##2##4##(2009-12#2)
of cyanthiwigin##3##2##(2009-12#3)
of cyclamate##3##2##(2008-10#3)
of cyclamen##2##2##(2008-10#2)
of cyclandelate##3##2##(1994-8#3)
of cycle##2##2##(2008-10#2)
of cycles##6##2##(1991-8#2)(1992-2#1)(2007-12#1)(2008-11#1)(2009-4#1)
of cyclic AMP accumulation##2##4##(1993-3#1)(1996-12#1)
of cyclic AMP production##2##4##(1995-11#2)
of cyclic AMP##14##3##(1991-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-2#2)(1994-6#2)(1995-11#2)(1996-12#1)(1997-2#1)(2008-10#1)
of cyclic AMP-dependent protein kinase##2##5##(1990-12#1)(1993-8#1)
of cyclic GMP##3##3##(1992-12#1)(1992-3#1)(1994-11#1)
of cyclic strain##4##3##(1993-3#2)(1994-11#2)
of cyclic succession##2##3##(2008-9#2)
of cyclic tertiary amines##2##4##(1991-9#2)
of cyclic voltammetric##3##3##(2008-10#3)
of cyclic##46##2##(1990-12#1)(1991-9#5)(1992-12#1)(1992-3#2)(1993-11#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#2)(1994-6#2)(1995-11#2)(1996-12#1)(1997-2#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#2)(2012-7#1)
of cyclin A##6##3##(1993-6#3)(1994-11#1)(1994-6#2)
of cyclin D1##3##3##(2008-4#1)(2010-1#2)
of cyclin D2##5##3##(1997-8#5)
of cyclin##23##2##(1993-6#3)(1994-11#3)(1994-6#3)(1994-8#1)(1995-5#2)(1997-4#1)(1997-7#1)(1997-8#5)(2008-4#1)(2008-9#1)(2010-1#2)
of cyclin-dependent##3##2##(1997-7#1)(2010-6#1)(2012-2#1)
of cycling cells##2##3##(2008-11#2)
of cycling##4##2##(2008-11#2)(2009-4#1)(2013-8#1)
of cyclins D1##2##3##(1997-6#2)
of cyclins##6##2##(1997-6#4)(2008-4#1)(2008-5#1)
of cycloaddition##2##2##(1996-5#2)
of cyclodextrins##5##2##(2008-10#5)
of cycloheximide##8##2##(1991-12#1)(1992-8#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-3#1)
of cyclohexyl moieties##2##3##(1995-11#2)
of cyclohexylamine##2##2##(2008-10#2)
of cyclooxygenase##7##2##(1993-8#1)(1994-9#3)(2006-10#1)(2008-11#2)
of cyclooxygenase-2##4##2##(1997-1#2)(2008-10#2)
of cyclophosphamide##8##2##(1993-9#1)(1994-7#1)(2006-10#1)(2007-7#2)(2008-10#2)(2009-4#1)
of cyclopropane derivatives##2##3##(2008-10#2)
of cyclosporiasis##2##2##(2007-12#2)
of cyclosporin##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
of cyclosporine A##6##3##(1995-12#2)(2008-10#3)(2011-3#1)
of cyclosporine##8##2##(1995-12#3)(2008-10#4)(2011-3#1)
of cylindrical multicellular aggregate (cylindroid)##2##5##(2008-11#2)
of cylindrical##13##2##(1992-12#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-3#5)(2011-2#1)
of cymbidium mosaic##3##3##(1997-2#2)(2008-10#1)
of cypermethrin and deltamethrin##3##4##(2008-10#3)
of cypermethrin##5##2##(2008-10#3)(2008-12#2)
of cyst##7##2##(1994-7#1)(1996-3#2)(1997-8#1)(2008-12#1)(2008-7#1)(2013-1#1)
of cystadenocarcinoma##2##2##(1990-6#2)
of cystathionine##5##2##(1995-12#4)(1995-2#1)
of cystatin C##2##3##(2010-4#1)(2010-8#1)
of cystatin##3##2##(1990-2#1)(2010-4#1)(2010-8#1)
of cysteine and cystine##2##4##(1991-5#2)
of cysteine and##8##3##(1991-5#2)(2008-10#5)(2009-8#1)
of cysteine in human serum##2##5##(2008-10#2)
of cysteine in human##3##4##(2008-10#3)
of cysteine in##5##3##(1993-11#1)(2008-10#4)
of cysteine on##3##3##(2008-10#3)
of cysteine residues of##2##4##(1991-9#1)(1993-6#1)
of cysteine residues##4##3##(1991-9#1)(1992-12#1)(1993-6#1)(1993-9#1)
of cysteine to##2##3##(2008-10#1)(2009-11#1)
of cysteine##62##2##(1991-12#1)(1991-5#5)(1991-9#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-4#2)(2008-7#1)(2009-11#2)(2009-8#1)(2009-9#1)(2012-3#1)
of cysteinyl leukotrienes##2##3##(1993-9#1)(1994-12#1)
of cysteinyl##3##2##(1993-9#2)(1994-12#1)
of cystic fibrosis (CF)##2##4##(1990-3#1)(2013-1#1)
of cystic fibrosis patients##2##4##(1990-4#1)(2012-12#1)
of cystic fibrosis##15##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-8#1)(1994-5#1)(1997-1#1)(1997-8#1)(2007-6#1)(2009-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
of cystic fibrosis]##2##3##(1990-3#1)(1994-2#1)
of cystic##23##2##(1990-3#2)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-9#1)(1997-1#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-12#1)(2009-3#1)(2009-5#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
of cysticercosis##2##2##(1991-8#2)
of cystine and##2##3##(1991-5#1)(2007-7#1)
of cystine##12##2##(1990-5#2)(1991-5#2)(1991-9#1)(2007-7#2)(2008-10#2)(2008-11#3)
of cystinuria##3##2##(2007-7#3)
of cystitis##3##2##(1991-6#1)(1993-2#1)(2009-1#1)
of cystosarcoma##3##2##(2008-10#1)(2011-3#2)
of cysts##9##2##(1992-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
of cytarabine##2##2##(1990-2#1)(2008-5#1)
of cytidine##2##2##(1990-7#1)(1994-5#1)
of cytisine after oral##2##4##(2011-1#2)
of cytisine after single##2##4##(2011-1#2)
of cytisine after##4##3##(2011-1#4)
of cytisine in##2##3##(2011-1#2)
of cytisine on some brain and hepatic biochemical parameters in spontaneously hypertensive rats##2##13##(2011-1#2)
of cytisine##9##2##(2011-1#9)
of cytochrome P-450 and##2##4##(1990-11#1)(1990-5#1)
of cytochrome P-450 in##2##4##(1990-7#1)(1992-3#1)
of cytochrome P-450##13##3##(1990-11#1)(1990-5#1)(1990-7#4)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-8#1)(2008-5#1)(2008-8#1)
of cytochrome P-450cam##2##3##(1994-5#2)
of cytochrome P450 3A4##2##4##(2008-10#1)(2008-3#1)
of cytochrome P450##9##3##(1992-11#1)(1992-8#1)(1993-11#2)(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#2)
of cytochrome P450cam##3##3##(1994-6#3)
of cytochrome b(5)##4##3##(2011-2#4)
of cytochrome b558##2##3##(1993-8#2)
of cytochrome b559##2##3##(1996-4#2)
of cytochrome c and##2##4##(1994-8#1)(2008-10#1)
of cytochrome c oxidase subunit##2##5##(2008-10#1)(2010-4#1)
of cytochrome c oxidase##8##4##(1990-12#1)(1991-6#2)(1997-7#3)(2008-10#1)(2010-4#1)
of cytochrome c##21##3##(1990-12#1)(1991-6#2)(1994-8#2)(1995-2#4)(1995-5#1)(1997-2#1)(1997-7#3)(2008-10#3)(2008-6#1)(2009-9#1)(2010-4#1)(2011-2#1)
of cytochrome oxidase activity##2##4##(1990-3#1)(2008-7#1)
of cytochrome oxidase##6##3##(1990-3#1)(1990-5#1)(1993-2#1)(1995-6#2)(2008-7#1)
of cytochrome##75##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#4)(1990-7#4)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#2)(1992-3#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-8#2)(1994-5#4)(1994-6#4)(1994-8#2)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-4#2)(1997-2#3)(1997-7#3)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#5)
of cytogenetic##6##2##(1993-9#1)(1996-2#1)(2008-4#1)(2008-9#1)(2010-3#1)(2013-8#1)
of cytoglobin##4##2##(2010-11#4)
of cytokine genes##2##3##(2008-4#1)(2008-9#1)
of cytokine levels##2##3##(2008-6#2)
of cytokine networks##2##3##(1997-2#2)
of cytokine production##5##3##(1991-2#1)(1992-2#1)(1996-12#1)(2008-4#2)
of cytokine receptors##2##3##(1996-2#1)(2008-9#1)
of cytokine##31##2##(1991-2#1)(1992-2#2)(1994-8#1)(1994-9#1)(1996-12#3)(1996-2#2)(1997-2#2)(2008-10#1)(2008-4#6)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#3)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
of cytokines and##11##3##(1993-11#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-11#3)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
of cytokines in##4##3##(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)
of cytokines to##3##3##(1996-12#1)(1996-2#1)(2008-11#1)
of cytokines##34##2##(1992-2#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-1#5)(2011-2#1)(2012-2#1)(2013-1#1)
of cytokinesis##5##2##(2008-11#2)(2009-10#2)(2013-1#1)
of cytological##3##2##(1992-10#1)(2009-10#1)(2011-10#1)
of cytolytic T##3##3##(1991-9#2)(2008-4#1)
of cytolytic##5##2##(1991-9#2)(1993-3#1)(1993-9#1)(2008-4#1)
of cytomegalovirus and##2##3##(1990-9#1)(2008-1#1)
of cytomegalovirus infection##2##3##(2008-1#1)(2011-2#1)
of cytomegalovirus##8##2##(1990-9#1)(1991-8#1)(2007-12#2)(2008-1#2)(2010-12#1)(2011-2#1)
of cytometry##3##2##(2008-9#3)
of cytoplasm and##2##3##(2008-10#1)(2010-8#1)
of cytoplasm##4##2##(2008-10#3)(2010-8#1)
of cytoplasmic RNA##2##3##(1990-7#1)(2008-2#1)
of cytoplasmic and##3##3##(1993-2#1)(2008-11#1)(2008-8#1)
of cytoplasmic calcium##2##3##(1991-5#1)(1991-9#1)
of cytoplasmic lipid droplets##2##4##(2007-12#2)
of cytoplasmic##27##2##(1990-2#1)(1990-7#1)(1991-11#4)(1991-5#1)(1991-9#1)(1992-10#1)(1992-6#3)(1993-2#1)(1994-11#1)(1997-7#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)
of cytosine and cytosine derivatives##2##5##(1992-8#2)
of cytosine##5##2##(1992-8#3)(1997-2#2)
of cytoskeletal##7##2##(1993-6#1)(1994-8#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-8#1)
of cytoskeleton##3##2##(1993-6#2)(1997-3#1)
of cytosol and membrane##2##4##(1991-2#1)(1993-8#1)
of cytosol##4##2##(1990-5#1)(1991-2#1)(1993-8#1)(1996-2#1)
of cytosolic Ca2+##7##3##(1990-7#1)(1991-5#1)(1995-11#1)(1996-2#3)(2008-8#1)
of cytosolic calcium##2##3##(1990-2#1)(1993-12#1)
of cytosolic free##3##3##(1990-7#1)(1993-12#1)(1995-5#1)
of cytosolic phospholipase A2##4##4##(1994-11#2)(1995-11#2)
of cytosolic proteins##2##3##(1992-12#2)
of cytosolic##34##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-5#4)(1992-12#2)(1993-12#2)(1993-8#2)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#3)(1995-5#1)(1995-6#1)(1996-2#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)
of cytostatic##4##2##(1990-9#1)(1991-8#2)(1994-8#1)
of cytotoxic T cells##2##4##(1991-9#1)(2008-10#1)
of cytotoxic T##3##3##(1991-9#1)(1995-3#1)(2008-10#1)
of cytotoxic activity##2##3##(1990-12#1)(2008-4#1)
of cytotoxic agents##2##3##(2008-7#1)(2009-9#1)
of cytotoxic chemotherapeutic agents##2##4##(2008-5#1)(2013-1#1)
of cytotoxic chemotherapy##4##3##(1997-5#1)(2008-6#2)(2012-1#1)
of cytotoxic drugs##5##3##(1990-9#1)(1991-8#1)(2007-5#1)(2009-12#1)(2013-1#1)
of cytotoxic##25##2##(1990-12#1)(1990-9#1)(1991-8#1)(1991-9#1)(1993-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2009-9#1)(2012-1#1)(2013-1#3)
of cytotoxicity against##2##3##(1994-3#1)(2008-4#1)
of cytotoxicity in##2##3##(1995-8#1)(2008-11#1)
of cytotoxicity of##4##3##(2008-11#2)(2009-12#2)
of cytotoxicity##17##2##(1992-11#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#1)(2009-12#2)(2009-7#1)(2011-1#1)(2013-1#1)
of cytotrophoblasts with##3##3##(1994-9#3)
of cytotrophoblasts##6##2##(1994-9#6)
of d##5##2##(1993-12#1)(1996-2#1)(2008-10#3)
of d(CH2)5Tyr(Me)vasopressin##2##2##(1995-12#2)
of d- and##3##3##(2008-10#2)(2010-5#1)
of d-gluconic-delta-lactone acid##2##3##(2008-10#2)
of d-glucosamine##2##2##(2008-10#2)
of d-lactic acid##2##3##(2008-10#2)
of d-malate and l-malate##3##4##(2008-10#3)
of d-penicillamine##2##2##(2008-10#2)
of d-sorbitol##2##2##(2008-5#2)
of d-tagatose and d-sorbitol##3##4##(2008-5#3)
of d-tagatose to##2##3##(2008-5#2)
of d-tagatose##7##2##(2008-5#7)
of dAMP##2##2##(2008-8#2)
of dQTL##3##2##(2008-10#3)
of dRecQ5##3##2##(2011-1#3)
of dSMAD2##2##2##(2008-9#2)
of dahlia##2##2##(2008-10#1)(2008-12#1)
of daidzein##7##2##(2008-10#4)(2010-1#2)(2012-2#1)
of daily and##3##3##(2008-10#1)(2008-11#2)
of daily life##5##3##(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)
of daily living and##6##4##(1991-12#1)(1995-2#1)(1995-3#1)(2007-11#1)(2011-2#1)(2013-1#1)
of daily living##25##3##(1991-12#1)(1992-12#1)(1993-3#1)(1995-2#2)(1995-3#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-7#4)(2009-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
of daily pain##2##3##(2008-7#2)
of daily smoking##2##3##(1991-11#1)(1991-6#1)
of daily##64##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-2#2)(1995-3#1)(1997-2#1)(2007-10#2)(2007-11#2)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#8)(2008-9#1)(2009-3#1)(2009-7#2)(2009-9#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
of dairy food consumption on body weight##2##7##(2012-2#2)
of dairy products##3##3##(2008-10#1)(2012-2#2)
of dairy##11##2##(1996-12#1)(1996-8#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#4)(2013-1#2)
of damage control principles##2##4##(2008-9#1)(2011-2#1)
of damage in##2##3##(2008-3#1)(2011-2#1)
of damage to##5##3##(1990-3#1)(1992-8#1)(2007-11#1)(2008-1#1)(2008-10#1)
of damage was##3##3##(1994-5#2)(2008-10#1)
of damage were##2##3##(1994-5#1)(2007-12#1)
of damage##31##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-8#1)(1994-5#3)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
of damaged DNA##2##3##(1993-3#1)(1995-3#1)
of damaged and##3##3##(1995-2#2)(2007-10#1)
of damaged plants##3##3##(2008-8#3)
of damaged##13##2##(1993-3#1)(1995-2#2)(1995-3#1)(2007-10#1)(2008-5#1)(2008-8#3)(2011-2#2)(2012-2#1)(2012-3#1)
of damages##2##2##(2008-2#1)(2013-1#1)
of damaging agents##2##3##(2008-7#2)
of damaging##4##2##(2008-7#2)(2011-2#2)
of damping-off caused by Pythium##2##5##(2008-10#2)
of damping-off##6##2##(2008-10#6)
of dandruff##4##2##(2008-5#4)
of danger##5##2##(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#2)
of dansyl chloride##2##3##(2008-10#2)
of dansyl fluorescence##3##3##(1992-3#1)(2008-10#2)
of dansyl##7##2##(1992-3#1)(1994-5#1)(1994-9#1)(2008-10#4)
of darbepoetin alfa##2##3##(2008-7#2)
of dark green##2##3##(2013-8#2)
of dark##7##2##(1991-12#1)(2007-8#1)(2008-10#2)(2008-9#1)(2013-8#2)
of data analysis##8##3##(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-7#1)
of data and##8##3##(1995-12#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-9#1)
of data are##6##3##(1994-2#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-7#1)(2010-8#1)
of data available##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
of data by##4##3##(2008-10#3)(2009-10#1)
of data can##3##3##(1995-8#1)(2008-7#1)(2012-1#1)
of data collection in##2##4##(2008-11#1)(2009-10#1)
of data collection##12##3##(1992-1#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-11#1)(1997-3#1)(2008-11#3)(2008-7#1)(2009-10#1)(2010-12#1)
of data describing the##2##4##(2010-10#1)(2011-2#1)
of data for a##2##4##(2008-2#1)(2008-3#1)
of data for##9##3##(1992-3#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
of data found##2##3##(1990-9#1)(2008-10#1)
of data from a##3##4##(1991-8#1)(2008-3#1)(2010-11#1)
of data from an##2##4##(1994-11#1)(2008-3#1)
of data from the##7##4##(1994-2#1)(1994-6#2)(1995-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of data from##32##3##(1990-9#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-6#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of data has been##2##4##(1995-12#1)(2009-3#1)
of data has##6##3##(1995-12#1)(2008-7#1)(2009-3#2)(2011-3#1)(2012-2#1)
of data have also##2##4##(2008-1#2)
of data have##4##3##(1992-8#1)(2008-1#2)(2012-3#1)
of data in a##2##4##(2008-2#1)(2008-7#1)
of data in##10##3##(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
of data indicates that the##2##5##(2008-10#1)(2008-7#1)
of data into a##2##4##(1992-12#1)(2008-3#1)
of data into##3##3##(1992-12#1)(1997-3#1)(2008-3#1)
of data is##4##3##(1995-5#1)(2008-10#1)(2008-5#1)(2009-9#1)
of data management##3##3##(1996-3#1)(2008-7#1)(2012-12#1)
of data mining##3##3##(2008-9#2)(2010-8#1)
of data obtained from##2##4##(1994-5#1)(2011-2#1)
of data obtained##5##3##(1994-5#1)(1996-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
of data of##2##3##(2008-1#1)(2012-12#1)
of data on the##6##4##(1993-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#1)
of data on##19##3##(1993-9#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#3)
of data points##5##3##(2008-2#1)(2008-3#2)(2009-11#1)(2013-8#1)
of data preparation##2##3##(1994-2#1)(2009-8#1)
of data regarding##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
of data sets##5##3##(2007-10#1)(2008-10#2)(2008-8#1)(2010-7#1)
of data standards##2##3##(2008-7#1)(2010-8#1)
of data systems##2##3##(1992-12#1)(1996-2#1)
of data that##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
of data to##3##3##(1997-2#1)(2008-2#1)(2008-3#1)
of data was used to##2##5##(2008-11#1)(2011-1#1)
of data was##5##3##(1991-2#1)(2008-11#1)(2011-1#1)(2013-1#2)
of data with##2##3##(2008-10#2)
of data##306##2##(1990-12#1)(1990-3#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#2)(1994-7#1)(1995-12#8)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-4#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#8)(2008-10#37)(2008-11#18)(2008-12#1)(2008-2#9)(2008-3#23)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#19)(2008-8#5)(2008-9#11)(2009-10#3)(2009-11#3)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#4)(2011-1#3)(2011-2#10)(2011-3#3)(2011-8#1)(2012-1#1)(2012-12#12)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#2)
of database##7##2##(1992-3#1)(2008-11#1)(2008-3#1)(2008-4#4)
of databases##6##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)
of date of##2##3##(1990-9#1)(2008-10#1)
of date##6##2##(1990-9#1)(2008-1#1)(2008-10#3)(2011-2#1)
of date' foods##2##3##(2008-1#2)
of date'##5##2##(2008-1#5)
of dating##2##2##(2009-7#1)(2009-9#1)
of daughter cells##2##3##(1995-9#1)(2010-10#1)
of daughter##3##2##(1995-9#1)(2008-10#1)(2010-10#1)
of daunomycin is##2##3##(1994-12#1)(2008-10#1)
of daunomycin##6##2##(1990-2#2)(1994-12#1)(2008-10#2)(2008-7#1)
of daunorubicin in##2##3##(1997-4#2)
of daunorubicin##4##2##(1994-5#1)(1997-4#3)
of day care##2##3##(1994-3#1)(2010-3#1)
of day##25##2##(1990-5#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-3#1)(1996-5#1)(2007-11#1)(2007-12#6)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#2)(2010-3#1)(2010-7#1)(2012-5#1)
of day-to-day##2##2##(2007-4#1)(2009-6#1)
of daylight and noise current on cloud and aerosol observations by##2##11##(2008-3#2)
of daylight and##3##3##(2008-3#3)
of daylight##4##2##(2008-2#1)(2008-3#3)
of days of##2##3##(2008-10#1)(2011-1#1)
of days with##2##3##(2008-10#1)(2012-12#1)
of days##22##2##(1990-5#1)(1995-5#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-12#1)(2011-1#2)(2012-12#2)(2012-2#1)
of daytime##2##2##(1997-5#1)(2008-3#1)
of db/db##2##2##(2012-3#2)
of dc##2##2##(2007-12#1)(2008-3#1)
of ddGuo##2##2##(1990-10#2)
of de Broglie##2##3##(2008-5#2)
of de novo purine synthesis##2##5##(1993-12#2)
of de novo##10##3##(1993-12#2)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-6#1)
of de##14##2##(1993-12#2)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2013-8#1)
of deactivation of##2##3##(1990-6#1)(2008-6#1)
of deactivation##4##2##(1990-6#1)(1997-2#1)(2008-6#1)(2008-8#1)
of dead cells##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
of dead space##2##3##(1991-12#1)(2008-9#1)
of dead spot##2##3##(2008-10#2)
of dead##19##2##(1991-12#2)(1997-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)
of deaf##2##2##(2011-2#2)
of deafness##7##2##(2008-9#6)(2013-1#1)
of dealing with the problem##2##5##(1992-1#1)(1994-6#1)
of dealing with the##3##4##(1992-1#1)(1994-6#1)(1995-3#1)
of dealing with##9##3##(1992-1#1)(1992-2#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-1#1)(2013-1#1)
of death among##3##3##(2008-1#1)(2008-4#1)(2013-1#1)
of death and disability##5##4##(1995-11#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
of death and##13##3##(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
of death are##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
of death by##3##3##(1996-2#1)(2008-8#1)(2008-9#1)
of death during the##2##4##(2008-7#1)(2013-1#1)
of death for##2##3##(1991-3#1)(2012-12#1)
of death from cardiovascular##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
of death from##7##3##(1995-12#1)(2007-12#1)(2008-11#2)(2008-7#1)(2011-1#1)(2011-2#1)
of death in Western countries##2##5##(2012-2#1)(2012-3#1)
of death in Western##4##4##(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of death in patients with##4##5##(1993-9#1)(1996-11#1)(2010-3#1)(2011-2#1)
of death in patients##5##4##(1993-9#1)(1996-11#1)(2010-3#1)(2011-2#2)
of death in the##7##4##(1992-8#1)(2008-10#3)(2008-7#1)(2010-10#1)(2011-3#1)
of death in##38##3##(1991-3#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-10#2)(2010-3#2)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of death of##8##3##(1990-5#1)(1990-6#1)(1991-12#1)(1992-4#1)(2008-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
of death was##12##3##(1991-12#1)(1991-2#1)(1994-11#1)(1995-11#2)(1995-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
of death were##10##3##(1991-12#1)(2008-1#2)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
of death##168##2##(1990-11#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#1)(1992-4#2)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#4)(1997-1#1)(1997-3#3)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#15)(2011-3#3)(2012-1#1)(2012-12#12)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#12)
of deaths and##3##3##(1997-7#1)(2007-2#1)(2010-8#1)
of deaths due to##3##4##(1992-6#1)(2008-9#1)(2012-2#1)
of deaths from##5##3##(1997-7#2)(2011-1#2)(2011-2#1)
of deaths in the##2##4##(2008-9#1)(2012-2#1)
of deaths in##7##3##(1991-3#1)(1991-9#1)(1997-2#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-2#1)
of deaths##32##2##(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#2)(1997-2#1)(1997-3#1)(1997-7#3)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)
of debate in##4##3##(1995-3#1)(2008-11#1)(2008-7#1)(2013-8#1)
of debate##12##2##(1990-8#1)(1995-3#1)(1997-5#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-11#1)(2013-8#1)
of debris flow##3##3##(2008-2#2)(2008-3#1)
of debris##10##2##(2008-10#5)(2008-2#2)(2008-3#1)(2008-9#1)(2012-3#1)
of debrisoquine 4-hydroxylase isozymes##2##4##(1992-11#2)
of debrisoquine##3##2##(1992-11#2)(2008-10#1)
of debt##3##2##(1990-2#1)(1992-5#1)(1994-2#1)
of decanethiol##8##2##(2008-10#8)
of decanol to##2##3##(2008-10#2)
of decanol##3##2##(2008-10#3)
of decapeptide 9##2##3##(1995-3#2)
of decapods##2##2##(2007-12#2)
of decay rates##2##3##(2008-3#2)
of decay transients##2##3##(2008-3#2)
of decay##6##2##(1991-2#1)(2008-10#1)(2008-3#4)
of decentralization of##2##3##(1993-6#1)(2012-12#1)
of decentralization##6##2##(1993-6#2)(2008-7#2)(2012-12#2)
of deceptive##3##2##(2008-9#3)
of decidualization##3##2##(1994-9#1)(1997-6#2)
of deciduous##2##2##(2012-9#1)(2013-8#1)
of decision making##5##3##(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)
of decision thresholds##6##3##(1997-3#6)
of decision##17##2##(1995-2#1)(1996-2#1)(1997-3#6)(2007-8#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#2)(2010-8#1)(2013-1#1)
of decision-making##4##2##(1995-5#1)(2008-11#1)(2008-9#1)(2010-11#1)
of decisions##2##2##(1994-3#1)(2008-7#1)
of decline in##2##3##(1993-3#1)(2010-12#1)
of decline##5##2##(1993-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)
of declines in##2##3##(2008-8#1)(2011-1#1)
of declining##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
of decomposition##2##2##(2008-10#1)(2008-11#1)
of decorin##3##2##(2007-8#1)(2012-1#1)(2012-2#1)
of decrease in##3##3##(1994-11#1)(1994-3#1)(1995-9#1)
of decrease##9##2##(1994-11#1)(1994-3#2)(1995-9#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
of decreased##17##2##(1991-11#1)(1991-12#1)(1991-7#1)(1995-2#1)(1996-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
of decreasing the##3##3##(1990-8#1)(1993-12#1)(2011-2#1)
of decreasing##14##2##(1990-8#1)(1993-12#1)(1993-9#2)(1995-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#2)(2013-8#1)
of dedicated##2##2##(2009-8#1)(2011-1#1)
of deep brain stimulation##2##4##(2008-1#1)(2009-9#1)
of deep breathing##4##3##(2012-2#4)
of deep endometriosis##3##3##(1994-9#2)(2010-12#1)
of deep mycoses##2##3##(2008-5#2)
of deep venous thrombosis##3##4##(1990-6#1)(2008-7#1)(2008-8#1)
of deep venous##4##3##(1990-6#1)(2007-8#1)(2008-7#1)(2008-8#1)
of deep##34##2##(1990-6#1)(1991-9#1)(1993-12#2)(1994-9#2)(1995-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#1)
of deep-sea multicellular organisms##2##4##(2008-11#2)
of deep-sea##4##2##(2008-11#2)(2011-2#1)(2012-2#1)
of defatted##3##2##(2008-10#2)(2008-6#1)
of default##2##2##(2008-2#2)
of defeated##2##2##(2008-10#2)
of defect in##2##3##(2007-11#1)(2007-12#1)
of defect##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
of defective RNAs##2##3##(2008-10#2)
of defective interfering##3##3##(1994-8#2)(2008-10#1)
of defective##13##2##(1990-12#1)(1991-11#1)(1994-8#2)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
of defects in the##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
of defects in##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
of defects of the##2##4##(1991-5#1)(2012-2#1)
of defects##20##2##(1991-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
of defending##2##2##(1996-8#1)(2008-10#1)
of defense against##6##3##(1993-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-7#1)
of defense compounds##2##3##(2008-10#2)
of defense genes##2##3##(2008-10#2)
of defense mechanisms##3##3##(1991-9#1)(2008-10#2)
of defense response##3##3##(2008-10#3)
of defense responses##2##3##(2008-10#1)(2008-9#1)
of defense##27##2##(1991-9#1)(1993-12#1)(2007-12#1)(2007-2#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#1)
of defense-related##5##2##(2008-10#4)(2009-8#1)
of defensive##2##2##(1993-12#1)(2007-12#1)
of deficiencies in##2##3##(1993-9#1)(2012-1#1)
of deficiencies##6##2##(1993-9#1)(2007-11#1)(2007-12#1)(2008-9#1)(2012-1#1)(2012-3#1)
of deficiency##2##2##(1994-3#1)(2008-10#1)
of deficient##2##2##(1997-7#1)(2009-10#1)
of deficits in##3##3##(2007-10#1)(2009-7#1)(2013-8#1)
of deficits##4##2##(1992-3#1)(2007-10#1)(2009-7#1)(2013-8#1)
of defined mixtures of two different polyamines##2##7##(2008-12#2)
of defined populations##2##3##(1995-12#1)(1996-3#1)
of defined size##2##3##(1990-2#1)(2008-11#1)
of defined##15##2##(1990-2#1)(1992-6#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
of defining##4##2##(1995-2#1)(1995-9#1)(2008-2#1)(2013-1#1)
of definitive##3##2##(1991-3#1)(2008-7#1)(2012-12#1)
of deflection##2##2##(2008-10#1)(2008-2#1)
of defocus##3##2##(2008-2#1)(2008-3#2)
of defocused##2##2##(2008-2#1)(2008-3#1)
of defoliation##2##2##(2008-10#2)
of deformation##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
of deformations##2##2##(2008-2#1)(2008-3#1)
of deformities##2##2##(2007-7#1)(2009-5#1)
of degenerate##7##2##(1990-11#1)(1992-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
of degenerated##2##2##(2008-5#1)(2012-3#1)
of degeneration##4##2##(1993-6#1)(2009-4#1)(2010-3#1)(2011-2#1)
of degenerative changes in synaptic terminals and axons##2##8##(1997-3#2)
of degenerative changes in the##2##5##(2007-8#2)
of degenerative changes in##5##4##(1997-3#2)(2007-11#1)(2007-8#2)
of degenerative changes##9##3##(1997-3#4)(2007-11#1)(2007-8#4)
of degenerative disc disease##4##4##(2008-11#1)(2011-2#1)(2012-3#2)
of degenerative hepatic##2##3##(2008-10#2)
of degenerative##25##2##(1991-11#1)(1996-6#1)(1997-3#4)(2007-11#2)(2007-8#5)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
of degradation of##9##3##(1990-5#1)(1992-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
of degradation##23##2##(1990-5#1)(1991-9#1)(1992-12#1)(1994-5#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of degraded areas##2##3##(2013-7#2)
of degraded##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-7#2)
of degree hours##2##3##(2008-10#2)
of degree of##5##3##(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
of degree##7##2##(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-3#1)
of degree-days##2##2##(2008-10#2)
of dehydration##3##2##(2007-12#1)(2012-1#1)(2012-12#1)
of dehydroascorbate##2##2##(2009-9#2)
of dehydroascorbic acid##2##3##(2008-10#2)
of delay time on laser-induced breakdown spectroscopy##2##7##(2013-8#2)
of delay##7##2##(1991-8#1)(1995-2#1)(1996-3#1)(2008-3#1)(2013-8#3)
of delayed alternation##2##3##(1994-8#2)
of delayed implant##2##3##(2013-1#2)
of delayed##27##2##(1994-8#2)(1995-5#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#3)(2009-10#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#2)
of delaying##2##2##(2008-7#1)(2013-8#1)
of delays in##2##3##(1991-6#1)(2011-2#1)
of deleterious mutations##4##3##(1997-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
of deleterious##7##2##(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2013-1#1)
of deletion mutants by##2##4##(1990-12#1)(1993-2#1)
of deletion mutants##6##3##(1990-12#1)(1993-2#1)(1994-8#1)(1997-7#1)(2008-7#1)(2012-2#1)
of deletion##14##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
of deletions and##3##3##(1993-2#1)(2008-4#2)
of deletions##5##2##(1993-2#1)(1993-3#1)(2008-4#2)(2008-9#1)
of deliberate self-persuasion##3##3##(2008-5#3)
of deliberate##6##2##(1993-12#1)(2008-5#3)(2009-3#1)(2010-3#1)
of delinquency##3##2##(1994-2#1)(2009-7#1)(2012-12#1)
of delinquent or depressed##2##4##(2009-7#2)
of delinquent##5##2##(1990-12#2)(2009-7#2)(2009-8#1)
of delipidated LH/hCG##2##3##(1995-8#2)
of delipidated##5##2##(1993-11#1)(1995-8#4)
of delirium in##3##3##(2010-10#1)(2012-12#1)(2013-1#1)
of delirium##11##2##(2008-7#3)(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#4)
of deliveries##2##2##(1993-3#1)(2011-1#1)
of delivering##6##2##(1995-1#1)(1995-3#1)(2007-4#1)(2008-5#1)(2010-4#1)(2012-2#1)
of delivery and##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
of delivery of##3##3##(1995-11#1)(2008-5#1)(2010-2#1)
of delivery##36##2##(1992-11#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-11#1)(1997-1#2)(1997-2#1)(2007-11#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
of delta C/CL##3##3##(1990-7#3)
of delta and##2##3##(2008-8#2)
of delta##15##2##(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-9#1)(1992-5#2)(1993-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-8#2)
of deltaT##3##2##(2008-3#3)
of deltamethrin on##2##3##(2008-10#2)
of deltamethrin##6##2##(2008-10#5)(2013-1#1)
of delusional depression##3##3##(2008-6#3)
of delusional##4##2##(2008-4#1)(2008-6#3)
of delusions##2##2##(2008-2#1)(2012-1#1)
of demand for services##2##4##(1992-2#1)(1995-2#1)
of demand for##3##3##(1992-2#1)(1995-2#1)(2008-12#1)
of demand##4##2##(1992-2#1)(1995-2#1)(2008-12#1)(2013-8#1)
of dematiaceous fungi##4##3##(2008-5#4)
of demented PD patients##2##4##(2008-7#2)
of demented##5##2##(2008-7#5)
of dementia and regional brain syndromes in##2##7##(2008-7#2)
of dementia and##3##3##(2008-7#3)
of dementia in##5##3##(1995-12#1)(2008-7#3)(2009-12#1)
of dementia on##2##3##(2008-1#1)(2008-7#1)
of dementia patients##3##3##(2008-6#2)(2013-1#1)
of dementia was similar##2##4##(1991-9#1)(2008-7#1)
of dementia##51##2##(1990-11#1)(1991-11#1)(1991-8#1)(1991-9#3)(1995-12#1)(1996-11#4)(1996-2#1)(1996-9#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#18)(2009-12#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
of dementia-specific##2##2##(1993-2#2)
of demethylation##2##2##(2008-10#1)(2008-9#1)
of demographic and##4##3##(1995-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
of demographic##13##2##(1990-11#1)(1995-6#1)(1996-3#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of demography##2##2##(2010-8#2)
of demonstrating##2##2##(1993-2#1)(2008-10#1)
of demyelination##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
of denaturation##2##2##(1997-3#1)(2008-10#1)
of denatured##3##2##(2008-10#3)
of dendrimers##2##2##(1996-5#2)
of dendrites##3##2##(1994-2#2)(2008-10#1)
of dendritic cell##2##3##(2008-11#1)(2008-4#1)
of dendritic cells (DC)##2##4##(2008-10#1)(2008-11#1)
of dendritic cells and##2##4##(2008-9#1)(2012-1#1)
of dendritic cells##10##3##(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#3)(2011-2#1)(2012-1#1)
of dendritic spines##5##3##(1995-8#1)(1996-6#1)(2008-11#1)(2012-2#2)
of dendritic trees##2##3##(2012-2#2)
of dendritic##29##2##(1994-2#1)(1995-8#1)(1996-6#2)(2007-11#1)(2008-10#2)(2008-11#4)(2008-4#5)(2008-9#3)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#6)(2013-7#1)
of denervated##2##2##(1997-3#1)(2007-8#1)
of dengue haemorrhagic fever##2##4##(1992-6#1)(2007-2#1)
of dengue in##2##3##(2007-10#1)(2011-1#1)
of dengue virus##3##3##(1992-6#1)(2011-2#1)(2013-8#1)
of dengue##20##2##(1992-6#2)(2007-10#2)(2007-2#2)(2008-5#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
of denosumab##2##2##(2008-7#1)(2013-7#1)
of dense##10##2##(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
of densely packed##2##3##(2008-7#1)(2011-1#1)
of densely##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
of densitometric##3##2##(2007-11#2)(2007-8#1)
of density dependence##5##3##(2008-8#4)(2008-9#1)
of density##11##2##(2006-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#5)(2008-9#1)
of density-dependent##2##2##(2008-7#1)(2011-2#1)
of density-independent mortality##2##3##(2008-8#2)
of dental alterations##2##3##(2008-12#2)
of dental amalgam fillings##4##4##(1993-8#4)
of dental anomalies##2##3##(2008-12#2)
of dental caries and##2##4##(1991-6#1)(2010-3#1)
of dental caries##9##3##(1991-6#1)(2008-7#3)(2010-3#1)(2011-1#1)(2013-7#1)(2013-8#2)
of dental education##3##3##(1993-1#1)(2008-8#1)(2013-1#1)
of dental hygiene students##2##4##(2009-5#2)
of dental implants##7##3##(2007-12#2)(2009-7#1)(2011-7#1)(2012-12#1)(2013-1#2)
of dental patients##2##3##(2008-1#1)(2008-5#1)
of dental services##2##3##(1994-3#1)(1996-3#1)
of dental treatment##2##3##(2008-1#1)(2011-1#1)
of dental##63##2##(1990-12#1)(1991-6#1)(1993-1#3)(1993-12#1)(1993-8#4)(1994-3#1)(1995-9#1)(1996-3#2)(2007-12#2)(2008-1#5)(2008-10#1)(2008-12#4)(2008-5#2)(2008-7#4)(2008-8#4)(2009-5#2)(2009-7#2)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#4)(2011-7#1)(2012-12#2)(2013-1#6)(2013-7#1)(2013-8#3)
of dentigerous cysts##4##3##(2010-3#1)(2011-1#1)(2013-1#2)
of dentin hypersensitivity##4##3##(2011-2#4)
of dentin##8##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#4)(2013-1#1)
of dentinal##2##2##(2008-7#1)(2013-1#1)
of dentistry##9##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1995-6#1)(2012-2#1)(2013-8#1)
of dentists and consumers##2##4##(2008-12#2)
of dentists and dental patients##2##5##(1994-12#1)(2008-12#1)
of dentists and##5##3##(1994-12#1)(2008-1#1)(2008-12#3)
of dentists##10##2##(1994-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#4)(2010-9#1)(2013-1#1)
of denture##4##2##(2013-1#4)
of deoxy Hb##2##3##(1992-3#2)
of deoxyhypusine##3##2##(1994-3#1)(1997-1#2)
of deoxyribonucleoside##3##2##(2008-4#3)
of deoxyribose##2##2##(1995-6#1)(2008-10#1)
of dependence and##2##3##(2008-6#1)(2012-12#1)
of dependence of##2##3##(2008-1#1)(2012-6#1)
of dependence##7##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-6#1)
of dependency of##2##3##(2008-3#1)(2012-12#1)
of dependency##4##2##(1997-4#1)(2008-3#1)(2008-6#1)(2012-12#1)
of dependent##7##2##(1994-3#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-5#1)(2012-12#1)
of deployment##4##2##(2007-8#1)(2008-10#3)
of depolarization##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of depolarization-induced##2##2##(1991-2#1)(1996-5#1)
of deposited##3##2##(2008-10#2)(2008-3#1)
of deposition##10##2##(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)
of deprenyl##4##2##(1994-6#2)(2009-12#2)
of depressed##5##2##(1991-2#1)(1993-2#1)(2008-7#3)
of depression after##2##3##(2007-10#1)(2009-5#1)
of depression among##3##3##(2008-12#1)(2009-10#1)(2011-2#1)
of depression and anxiety were##2##5##(2007-6#1)(2010-8#1)
of depression and anxiety##4##4##(2007-6#1)(2008-11#1)(2009-5#1)(2010-8#1)
of depression and hostility##2##4##(2008-4#2)
of depression and the##3##4##(1990-3#1)(2011-2#2)
of depression and##19##3##(1990-3#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-4#2)(2009-5#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
of depression in Parkinson's disease##2##5##(2008-6#1)(2008-7#1)
of depression in mothers of children with CP##2##8##(2011-2#2)
of depression in mothers##3##4##(2011-2#3)
of depression in##9##3##(2008-4#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#3)(2012-3#1)
of depression may##2##3##(2007-10#1)(2010-12#1)
of depression model rats##2##4##(2013-1#2)
of depression on##2##3##(2008-1#2)
of depression or##2##3##(2008-12#1)(2010-7#1)
of depression were##2##3##(1991-1#1)(2008-12#1)
of depression with and without dementia in##2##7##(2008-7#2)
of depression##103##2##(1990-3#1)(1991-1#1)(1992-1#1)(1994-2#1)(1995-5#1)(1996-7#5)(1997-7#2)(2007-10#5)(2007-12#4)(2007-6#1)(2008-1#3)(2008-11#1)(2008-12#5)(2008-2#2)(2008-4#9)(2008-6#9)(2008-7#8)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-4#4)(2010-7#3)(2010-8#1)(2011-2#9)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#2)
of depressive and##2##3##(2008-7#1)(2009-10#1)
of depressive patients##3##3##(1995-5#1)(2008-7#1)(2013-8#1)
of depressive symptoms and##5##4##(2009-11#1)(2009-5#2)(2010-10#1)(2013-1#1)
of depressive symptoms in##4##4##(2013-1#1)(2013-8#3)
of depressive symptoms was found##2##5##(2010-10#1)(2013-1#1)
of depressive symptoms was##3##4##(2010-10#1)(2013-1#1)(2013-8#1)
of depressive symptoms##22##3##(1994-2#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-5#6)(2010-10#3)(2011-1#1)(2013-1#4)(2013-8#4)
of depressive##35##2##(1994-2#1)(1995-5#1)(1996-7#1)(2007-12#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#6)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#8)
of deprivation##2##2##(1991-1#1)(1991-6#1)
of deprotonation##2##2##(1990-5#1)(2008-10#1)
of depth of##2##3##(2008-3#1)(2011-1#1)
of depth profiles of##2##4##(2008-2#2)
of depth##9##2##(2007-12#2)(2008-2#2)(2008-3#2)(2010-11#1)(2011-1#1)(2011-2#1)
of derivation##2##2##(2008-11#1)(2011-2#1)
of derivative spectrophotometry##3##3##(2008-10#3)
of derivative##6##2##(2008-10#5)(2010-3#1)
of derivatives of##3##3##(1995-3#1)(1995-8#1)(1997-7#1)
of derivatives##6##2##(1995-3#1)(1995-8#1)(1997-7#1)(2008-10#2)(2012-3#1)
of derivatized##2##2##(2008-10#2)
of derived##6##2##(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#2)
of deriving##2##2##(2008-11#1)(2008-3#1)
of dermal##6##2##(1993-3#1)(1996-6#1)(2007-9#1)(2008-9#3)
of dermaseptin b and##2##4##(1994-5#2)
of dermaseptin b##3##3##(1994-5#3)
of dermatitis##4##2##(1990-3#1)(1991-11#1)(2008-5#1)(2011-1#1)
of dermatofibrosarcoma##2##2##(1992-2#2)
of dermatologic##3##2##(2007-7#1)(2008-5#1)(2010-8#1)
of dermatology##3##2##(2008-5#1)(2009-10#1)(2012-3#1)
of dermatomyositis##3##2##(1994-7#1)(2006-10#2)
of dermatophytes##2##2##(2007-7#1)(2008-5#1)
of dermatoses##4##2##(2007-8#1)(2011-2#3)
of desacetyl-alpha-MSH##2##2##(2008-6#2)
of desaturation##3##2##(1990-11#1)(1993-1#2)
of descending aorta##3##3##(2012-2#1)(2012-3#2)
of descending necrotizing mediastinitis##2##4##(2007-8#1)(2008-12#1)
of descending thoracic##2##3##(2007-8#2)
of descending##7##2##(2007-8#3)(2008-12#1)(2012-2#1)(2012-3#2)
of described##2##2##(2008-10#1)(2008-5#1)
of describing##2##2##(1996-4#1)(2010-9#1)
of descriptive##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
of descriptors##2##2##(1992-6#1)(2009-3#1)
of desensitization##3##2##(1992-3#1)(1997-2#1)(2011-2#1)
of desferrioxamine##4##2##(1993-2#1)(2008-10#2)(2008-12#1)
of design of##2##3##(1990-8#1)(2007-11#1)
of design##5##2##(1990-8#1)(2007-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
of designated##2##2##(2008-11#2)
of designing a##2##3##(2010-8#1)(2012-2#1)
of designing an##2##3##(2008-2#1)(2010-8#1)
of designing different##2##3##(1994-12#1)(2008-2#1)
of designing the##2##3##(2008-2#1)(2010-11#1)
of designing##19##2##(1990-5#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#2)(2009-10#1)(2010-11#1)(2010-8#2)(2012-12#1)(2012-2#3)
of designs##2##2##(2008-10#1)(2010-7#1)
of desirable##5##2##(1995-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
of desire##3##2##(2007-7#2)(2008-8#1)
of desired##7##2##(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)
of desmetryne##2##2##(2008-10#2)
of desmoid##4##2##(1997-8#2)(2007-5#1)(2009-12#1)
of desmoids##3##2##(1997-8#3)
of desmoplastic mesothelioma##2##3##(2012-2#2)
of desmoplastic##4##2##(1991-2#1)(2008-7#1)(2012-2#2)
of desorption of##2##3##(2008-10#1)(2010-4#1)
of desorption##3##2##(2008-10#2)(2010-4#1)
of desquamation##5##2##(2008-5#5)
of destruction##3##2##(1997-5#1)(2007-11#1)(2011-2#1)
of destructive##2##2##(2006-10#1)(2012-12#1)
of detached##3##2##(2008-10#3)
of detail##7##2##(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2011-2#1)
of detailed##9##2##(1994-2#1)(1996-3#1)(2008-11#2)(2008-2#1)(2009-6#1)(2011-3#1)(2013-1#2)
of details##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
of detainees in police custody##2##5##(2010-1#2)
of detainees##3##2##(2010-1#3)
of detectability##2##2##(2008-10#1)(2008-5#1)
of detectable populations##4##3##(2008-10#4)
of detectable##18##2##(1990-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#6)(2012-3#1)
of detected##8##2##(1992-10#1)(1996-12#1)(2010-2#1)(2011-1#1)(2012-3#4)
of detecting a##3##3##(1997-7#1)(2008-3#1)(2008-9#1)
of detecting and##2##3##(2008-10#1)(2008-3#1)
of detecting multiple##2##3##(2008-10#2)
of detecting the##3##3##(2008-10#1)(2008-2#2)
of detecting##44##2##(1990-12#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-12#1)(1997-7#2)(2007-10#1)(2007-12#1)(2008-10#13)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
of detection (1##2##3##(2008-10#2)
of detection (3sigma) for##2##4##(2008-10#2)
of detection (3sigma)##12##3##(2008-10#12)
of detection (LD)##2##3##(2008-10#2)
of detection (LOD) and quantitation (LOQ)##2##6##(2008-10#2)
of detection (LOD) and##8##4##(2008-10#8)
of detection (LOD) for##9##4##(2008-10#8)(2010-5#1)
of detection (LOD) ranged from##2##5##(2008-10#2)
of detection (LOD) ranged##3##4##(2008-10#3)
of detection (LOD) were##2##4##(2008-10#2)
of detection (LOD)##51##3##(2008-10#49)(2010-5#1)(2012-1#1)
of detection (LODs) ranged from 0##3##6##(1996-5#1)(2008-10#2)
of detection (LODs) were##2##4##(2008-10#2)
of detection (LODs)##7##3##(1996-5#1)(2008-10#6)
of detection (S/N=3)##4##3##(2008-10#4)
of detection achieved##4##3##(2008-10#4)
of detection and quantification of##3##5##(2008-10#3)
of detection and quantification##6##4##(2008-10#5)(2009-7#1)
of detection and quantitation were##3##5##(2008-10#3)
of detection and quantitation##4##4##(2008-10#4)
of detection and##30##3##(1997-2#1)(2008-10#24)(2008-2#1)(2009-7#1)(2010-3#2)(2012-2#1)
of detection as 1##2##4##(2008-10#2)
of detection at the##4##4##(2008-10#4)
of detection at##6##3##(2008-10#5)(2008-3#1)
of detection between##3##3##(2008-10#3)
of detection by##3##3##(1993-8#1)(2008-10#2)
of detection corresponding to##2##4##(2008-10#2)
of detection for a##2##4##(2008-10#2)
of detection for each type of##2##6##(2008-10#2)
of detection for the##4##4##(2008-10#3)(2010-11#1)
of detection for##42##3##(1990-8#2)(1995-2#1)(2008-10#37)(2008-2#1)(2010-11#1)
of detection in##10##3##(1993-8#1)(2008-10#8)(2012-8#1)
of detection is##20##3##(2008-10#18)(2011-1#1)(2013-1#1)
of detection obtained##4##3##(2008-10#3)(2008-2#1)
of detection of 0##12##4##(2008-10#12)
of detection of a##2##4##(2007-12#1)(2011-2#1)
of detection of the method##6##5##(2008-10#5)(2011-1#1)
of detection of the##18##4##(2008-10#17)(2011-1#1)
of detection of##76##3##(2007-12#1)(2008-1#2)(2008-10#64)(2008-3#1)(2008-5#1)(2009-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
of detection than the other##2##5##(2008-10#1)(2008-2#1)
of detection than##3##3##(2008-10#2)(2008-2#1)
of detection values##3##3##(2008-10#2)(2011-2#1)
of detection was##45##3##(1991-5#1)(1997-2#1)(1997-6#1)(2008-10#40)(2010-5#2)
of detection were##24##3##(2008-10#20)(2008-2#1)(2009-6#1)(2011-1#1)(2013-1#1)
of detection with##2##3##(2008-10#2)
of detection##476##2##(1990-8#2)(1991-5#1)(1993-8#2)(1995-2#1)(1996-5#2)(1996-8#1)(1997-2#3)(1997-6#1)(2007-12#1)(2008-1#4)(2008-10#407)(2008-2#5)(2008-3#5)(2008-5#4)(2008-7#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-8#1)(2013-1#4)
of detection)##4##2##(2008-10#3)(2013-8#1)
of detections (LODs)##2##3##(2008-10#2)
of detections##5##2##(2008-10#5)
of detector A##2##3##(2008-2#1)(2008-3#1)
of detector##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
of detectors in##2##3##(2008-2#1)(2008-3#1)
of detectors##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
of detergent##2##2##(1991-10#1)(1992-12#1)
of detergents##6##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-7#1)(2008-4#1)(2008-5#1)
of deterioration##2##2##(2008-10#2)
of determinants##3##2##(1990-12#1)(1992-3#1)(2013-1#1)
of determination (R##3##3##(2008-10#3)
of determination (r(2))##2##3##(2008-10#2)
of determination by the proposed method##2##6##(2008-10#2)
of determination for##8##3##(2008-10#7)(2008-11#1)
of determination is##2##3##(2008-10#2)
of determination of the##2##4##(2008-10#2)
of determination of##15##3##(1997-7#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-8#2)(2011-1#1)
of determination were##2##3##(2008-10#2)
of determination##54##2##(1990-6#1)(1997-7#1)(2008-10#42)(2008-11#1)(2008-12#2)(2008-5#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-1#1)
of determined##2##2##(1994-5#1)(2008-10#1)
of determining an##2##3##(1992-12#1)(2011-2#1)
of determining the##18##3##(1992-12#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)
of determining which##2##3##(2008-11#1)(2008-9#1)
of determining##44##2##(1992-12#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
of deterministic##2##2##(1994-8#1)(2008-8#1)
of detrimental##2##2##(1996-6#1)(2011-1#1)
of deuterated##2##2##(2008-2#1)(2008-5#1)
of deuterium##9##2##(1991-3#1)(1992-4#1)(1992-6#2)(2008-10#2)(2008-3#1)(2008-4#1)(2009-11#1)
of developed countries##3##3##(2009-3#1)(2012-2#1)(2013-1#1)
of developed##8##2##(1996-9#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-3#1)(2012-2#2)(2013-1#1)
of developing a new##2##4##(1990-12#1)(1996-5#1)
of developing a##10##3##(1990-12#1)(1991-3#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)(2011-8#1)(2013-1#1)
of developing an##4##3##(1993-9#1)(2009-7#2)(2012-2#1)
of developing and##4##3##(1993-3#1)(2008-11#1)(2008-4#1)(2009-11#1)
of developing endometrial##2##3##(2008-10#1)(2011-2#1)
of developing management##2##3##(1990-4#1)(1994-2#1)
of developing mild cognitive impairment##2##5##(2009-10#2)
of developing new##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
of developing such##2##3##(2008-4#1)(2009-6#1)
of developing the disease##3##4##(1992-9#2)(1996-6#1)
of developing the disorder##2##4##(1997-5#1)(2008-4#1)
of developing the##8##3##(1990-11#1)(1992-9#2)(1996-6#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-4#1)
of developing##124##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-9#1)(1996-5#2)(1996-6#1)(1997-5#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#7)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#7)(2011-8#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#1)
of development and##9##3##(1991-1#1)(1992-12#1)(1995-9#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-3#1)
of development in##3##3##(1993-2#1)(2008-10#1)(2008-7#1)
of development is##3##3##(1992-2#1)(2008-4#1)(2012-1#1)
of development of both the##2##5##(2008-10#2)
of development of##17##3##(1996-8#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-9#1)(2012-3#5)(2013-8#1)
of development##94##2##(1990-11#1)(1990-5#1)(1991-1#2)(1991-7#1)(1992-12#3)(1992-2#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#6)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#1)
of developmental biology##3##3##(2008-9#1)(2009-3#1)(2012-2#1)
of developmental disability##2##3##(2008-11#1)(2008-3#1)
of developmental dislocation of the hip##3##6##(2007-11#1)(2007-8#2)
of developmental dislocation##5##3##(2007-11#2)(2007-8#3)
of developmental dysplasia of the hip (DDH)##2##7##(2007-11#1)(2007-8#1)
of developmental dysplasia of the hip##7##6##(2007-11#1)(2007-8#6)
of developmental dysplasia of##8##4##(2007-11#1)(2007-8#6)(2013-7#1)
of developmental events##4##3##(1995-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
of developmental hip dislocation##4##4##(2007-11#1)(2007-8#2)(2009-4#1)
of developmental sequences##2##3##(2008-9#2)
of developmental stages##2##3##(1996-10#1)(2008-11#1)
of developmental thresholds##2##3##(2008-8#2)
of developmental##59##2##(1994-1#2)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#2)(2007-11#4)(2007-12#1)(2007-8#13)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-3#1)(2009-4#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
of developmentally appropriate##2##3##(2008-9#1)(2010-5#1)
of developmentally##4##2##(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
of developments in##3##3##(1992-1#1)(2008-12#1)(2010-1#1)
of developments##4##2##(1992-1#1)(2008-10#1)(2008-12#1)(2010-1#1)
of deviations of the##2##4##(2008-2#1)(2008-3#1)
of deviations##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of device and##2##3##(2011-1#1)(2013-8#1)
of device##14##2##(2007-11#2)(2008-10#2)(2008-11#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
of devices in##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
of devices that##2##3##(2008-7#1)(2012-2#1)
of devices##17##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-11#4)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)
of dew##2##2##(2008-10#2)
of dexamethasone on##3##3##(1994-3#1)(1996-5#1)(2010-12#1)
of dexamethasone was##2##3##(1993-5#1)(2008-5#1)
of dexamethasone##19##2##(1992-11#2)(1993-3#1)(1993-5#1)(1994-10#1)(1994-3#3)(1996-5#2)(2008-11#4)(2008-5#1)(2009-11#2)(2009-4#1)(2010-12#1)
of dexmedetomidine and ketamine infusions##2##5##(2011-2#2)
of dexmedetomidine and ketamine##3##4##(2011-2#3)
of dexmedetomidine##4##2##(2011-2#4)
of dexrazoxane##3##2##(2008-11#3)
of diS-C3(3)##2##2##(1994-12#2)
of diabetes and its##4##4##(2008-1#2)(2010-9#2)
of diabetes and other##3##4##(2008-1#2)(2013-8#1)
of diabetes and the##2##4##(2008-1#2)
of diabetes and##20##3##(1994-6#1)(1995-2#1)(2008-1#8)(2008-3#1)(2008-7#1)(2010-10#2)(2010-9#2)(2012-3#1)(2012-5#1)(2013-8#2)
of diabetes care##5##3##(2008-7#4)(2010-12#1)
of diabetes has been##2##4##(2008-1#2)
of diabetes has##4##3##(1990-11#1)(2008-1#2)(2010-8#1)
of diabetes in the##2##4##(2008-7#1)(2013-8#1)
of diabetes in##11##3##(1994-12#1)(2008-1#2)(2008-11#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-8#1)
of diabetes is##8##3##(2008-1#2)(2008-10#1)(2008-4#1)(2009-11#1)(2010-4#1)(2010-8#1)(2012-2#1)
of diabetes mellitus (DM)##2##4##(2007-7#1)(2008-1#1)
of diabetes mellitus and##4##4##(2007-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
of diabetes mellitus in##3##4##(2008-1#1)(2008-7#1)(2011-2#1)
of diabetes mellitus type##2##4##(2011-2#1)(2012-2#1)
of diabetes mellitus##34##3##(1994-6#1)(1996-11#1)(1996-2#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#3)(2008-8#1)(2010-11#3)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2013-1#3)
of diabetes on the##5##4##(1993-9#1)(2008-1#1)(2008-11#1)(2011-2#2)
of diabetes on##10##3##(1993-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
of diabetes treatment##2##3##(2008-10#1)(2009-11#1)
of diabetes was##2##3##(2008-7#1)(2012-12#1)
of diabetes were##2##3##(2007-7#1)(2013-1#1)
of diabetes##161##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-11#1)(1993-2#2)(1993-9#1)(1994-12#4)(1994-6#3)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#4)(2008-1#27)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#15)(2008-8#4)(2009-11#5)(2009-5#1)(2010-10#7)(2010-11#3)(2010-12#2)(2010-4#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2012-5#2)(2013-1#7)(2013-7#3)(2013-8#5)
of diabetic and##2##3##(2008-7#1)(2011-2#1)
of diabetic complications##9##3##(1991-5#1)(1996-2#1)(2008-1#3)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#1)
of diabetic dyslipidemic pigs##2##4##(2008-4#2)
of diabetic foot##4##3##(2007-11#1)(2010-10#1)(2011-1#1)(2011-2#1)
of diabetic macular edema##2##4##(2011-7#2)
of diabetic nephropathy##8##3##(1997-8#2)(2007-12#1)(2007-7#1)(2008-1#2)(2013-1#2)
of diabetic neuropathy##6##3##(2008-1#4)(2012-2#1)(2013-1#1)
of diabetic patients and##2##4##(1990-11#1)(2012-3#1)
of diabetic patients##14##3##(1990-11#1)(1993-11#1)(1995-5#1)(1996-12#1)(2007-10#3)(2008-1#2)(2008-7#1)(2011-1#1)(2012-2#2)(2012-3#1)
of diabetic peripheral neuropathy##2##4##(2007-7#1)(2008-7#1)
of diabetic peripheral##3##3##(2007-7#1)(2008-7#1)(2008-9#1)
of diabetic rats##2##3##(2011-2#1)(2012-1#1)
of diabetic retinopathy##4##3##(1995-9#1)(2008-1#1)(2010-8#1)(2011-2#1)
of diabetic vascular complication##2##4##(2008-1#2)
of diabetic vascular##4##3##(2008-1#4)
of diabetic##84##2##(1990-11#1)(1990-5#1)(1991-5#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-8#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#21)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#2)(2011-7#2)(2012-1#2)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#1)
of diabetics##5##2##(1990-11#3)(1996-9#1)(2012-2#1)
of diacetyl##2##2##(2008-6#2)
of diacylglycerol and##3##3##(1991-3#1)(1994-8#1)(2008-11#1)
of diacylglycerol in##2##3##(1990-12#1)(1991-12#1)
of diacylglycerol##15##2##(1990-12#2)(1990-5#2)(1991-12#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-5#4)(1994-8#1)(1997-2#1)(2008-11#1)
of diagnosed##2##2##(2008-5#1)(2012-12#1)
of diagnoses and##2##3##(1994-9#1)(2012-12#1)
of diagnoses were##2##3##(1997-5#1)(2010-12#1)
of diagnoses##9##2##(1992-8#1)(1994-9#1)(1997-5#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
of diagnosing##5##2##(1993-2#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-2#1)
of diagnosis and management##2##4##(2008-1#1)(2011-2#1)
of diagnosis and therapy##3##4##(1993-6#1)(1993-9#1)(2007-12#1)
of diagnosis and treatment##5##4##(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
of diagnosis and##23##3##(1990-3#1)(1991-11#1)(1992-5#1)(1993-1#1)(1993-6#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-7#1)(2013-8#2)
of diagnosis in##5##3##(1994-2#1)(1996-8#1)(2007-8#1)(2008-7#1)(2009-4#1)
of diagnosis of##7##3##(1992-8#1)(1996-11#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
of diagnosis was##2##3##(2007-8#1)(2008-6#1)
of diagnosis were##2##3##(1996-7#1)(2011-2#1)
of diagnosis##79##2##(1990-10#2)(1990-3#1)(1990-6#1)(1991-11#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#4)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#4)(2010-3#1)(2011-1#2)(2011-2#6)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of diagnosis-related groups##4##3##(1991-12#1)(1991-3#1)(1994-12#2)
of diagnosis-related##5##2##(1991-12#1)(1991-3#1)(1992-2#1)(1994-12#2)
of diagnostic - therapeutic proceedings in back pain##2##8##(2007-11#2)
of diagnostic accuracy##4##3##(1995-11#1)(2008-12#1)(2013-1#2)
of diagnostic and therapeutic##3##4##(1996-3#1)(2008-1#1)(2013-7#1)
of diagnostic and##7##3##(1990-3#1)(1994-11#1)(1996-3#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-7#1)
of diagnostic assays##2##3##(2008-10#2)
of diagnostic categories##2##3##(1994-2#1)(1997-1#1)
of diagnostic criteria##3##3##(1995-11#1)(2011-2#2)
of diagnostic imaging##6##3##(1994-1#2)(2007-11#2)(2007-4#1)(2012-2#1)
of diagnostic laparoscopy##2##3##(1994-3#1)(2007-7#1)
of diagnostic methods in##2##4##(1994-9#1)(2007-11#1)
of diagnostic methods##4##3##(1990-9#1)(1994-9#1)(2007-11#1)(2008-10#1)
of diagnostic procedures##2##3##(1996-3#1)(1997-3#1)
of diagnostic techniques##2##3##(1997-3#1)(2010-8#1)
of diagnostic tests##3##3##(1993-3#1)(2011-2#1)(2012-3#1)
of diagnostic uncertainty##3##3##(2007-11#1)(2008-12#2)
of diagnostic##69##2##(1990-3#3)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-3#1)(1996-3#2)(1997-1#1)(1997-3#2)(2007-11#6)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
of diagnostically##2##2##(2008-5#2)
of diagnostics and##2##3##(1996-6#1)(2013-8#1)
of dialysate##5##2##(2007-7#1)(2008-1#3)(2011-2#1)
of dialyser##3##2##(2008-1#3)
of dialysis and##2##3##(2007-7#1)(2011-2#1)
of dialysis in##2##3##(2007-12#1)(2008-12#1)
of dialysis patients##4##3##(2007-8#1)(2008-1#2)(2008-10#1)
of dialysis therapy##2##3##(2008-7#1)(2011-2#1)
of dialysis treatment##2##3##(2007-10#1)(2008-4#1)
of dialysis##34##2##(1990-12#1)(1993-6#1)(1995-12#1)(2007-10#1)(2007-12#1)(2007-7#7)(2007-8#1)(2008-1#9)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#3)
of diameter##6##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#2)
of diameters##2##2##(2008-2#1)(2011-2#1)
of diamine oxidase##4##3##(1992-11#2)(1992-8#2)
of diamines##2##2##(1992-11#1)(2008-10#1)
of diamondback moth##3##3##(2011-2#3)
of diapause##3##2##(2008-8#3)
of diaphragm##3##2##(2008-7#1)(2010-5#1)(2012-3#1)
of diarrhea and##2##3##(1990-2#1)(2012-1#1)
of diarrhea##10##2##(1990-2#1)(1991-3#1)(1991-8#2)(1992-12#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-1#1)
of diarrhoea and##2##3##(1995-10#1)(2007-7#1)
of diarrhoea##4##2##(1995-10#1)(2007-7#2)(2010-12#1)
of diastolic blood pressure##3##4##(1990-3#1)(2008-7#1)(2011-1#1)
of diastolic function##2##3##(2006-10#1)(2013-1#1)
of diastolic##7##2##(1990-3#1)(1990-8#1)(2006-10#1)(2008-7#1)(2011-1#1)(2013-1#2)
of diazacrown##2##2##(2008-10#2)
of diazepam and prazepam in##2##5##(2008-10#2)
of diazepam and##4##3##(1990-8#1)(1993-5#1)(2008-10#2)
of diazepam in##2##3##(1991-12#2)
of diazepam##9##2##(1990-8#1)(1991-12#2)(1993-12#1)(1993-5#1)(2008-10#2)(2008-6#2)
of diazepam-insensitive##2##2##(1992-3#1)(1995-11#1)
of diazinon##3##2##(2008-10#3)
of dibenzo-18-crown-6##4##2##(2008-10#4)
of dibutyryl##3##2##(1993-8#1)(1995-8#1)(1997-7#1)
of dicarboxylic##2##2##(2008-4#2)
of dichlobenil and its metabolites##2##5##(2008-10#2)
of dichloroacetic acid in##3##4##(2008-10#1)(2008-9#2)
of dichloroacetic acid##5##3##(2008-10#2)(2008-9#3)
of dichloromethane and##2##3##(2008-10#2)
of dichloromethane##4##2##(1996-2#1)(2008-10#3)
of dichlorvos##8##2##(2008-10#8)
of dichroic##2##2##(2008-3#2)
of dichromate-induced##2##2##(2008-10#2)
of dichromated gelatin##4##3##(2008-2#1)(2008-3#3)
of dichromated-gelatin##2##2##(2008-2#1)(2008-3#1)
of diclofenac in pharmaceutical preparations by diffuse reflectance##2##8##(2008-10#2)
of diclofenac in pharmaceutical preparations##3##5##(2008-10#3)
of diclofenac in the presence of##2##6##(2008-10#2)
of diclofenac in##6##3##(2008-10#6)
of diclofenac sodium##2##3##(1991-3#1)(2010-8#1)
of diclofenac##9##2##(1991-3#1)(2008-10#7)(2010-8#1)
of dicyclohexylcarbodiimide in##2##3##(2008-9#2)
of dicyclohexylcarbodiimide##6##2##(2008-9#6)
of dielectric coatings##2##3##(2007-12#1)(2008-3#1)
of dielectric objects##2##3##(2008-3#2)
of dielectric##17##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#9)(2008-5#1)(2013-8#1)
of diesel exhaust particles##3##4##(2008-10#3)
of diesel##7##2##(2008-10#5)(2008-11#2)
of diet and obesity##2##4##(2008-10#1)(2012-2#1)
of diet and##10##3##(1990-8#1)(1992-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-2#3)(2013-1#1)
of diet in##2##3##(1990-8#1)(2012-2#1)
of diet on##4##3##(1996-12#1)(2008-12#1)(2008-2#1)(2009-4#1)
of diet##28##2##(1990-8#4)(1992-10#1)(1992-8#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#6)(2013-1#1)
of diet-induced##2##2##(2009-12#1)(2012-2#1)
of dietary and##2##3##(1992-9#1)(2008-7#1)
of dietary boron##2##3##(1990-3#2)
of dietary fat##4##3##(1990-7#1)(1994-2#1)(2008-4#1)(2010-4#1)
of dietary fiber##5##3##(1993-11#3)(2010-8#1)(2012-2#1)
of dietary fibre##3##3##(1993-9#3)
of dietary gluten##3##3##(2007-5#3)
of dietary habits##2##3##(1993-9#1)(2012-12#1)
of dietary intake##2##3##(1991-2#1)(2009-5#1)
of dietary isoflavones##2##3##(1993-12#2)
of dietary phospholipid##2##3##(2008-7#2)
of dietary phytoestrogens##3##3##(2008-10#3)
of dietary protein restriction##2##4##(1994-3#2)
of dietary protein##5##3##(1994-3#2)(2008-5#3)
of dietary proteins and##2##4##(2012-1#1)(2012-2#1)
of dietary proteins##3##3##(2012-1#2)(2012-2#1)
of dietary restriction on serum antioxidant##2##6##(2008-7#2)
of dietary restriction##4##3##(1991-12#1)(2008-7#3)
of dietary supplementation##2##3##(1991-6#1)(2013-1#1)
of dietary supplements##4##3##(2008-5#3)(2010-3#1)
of dietary##95##2##(1990-3#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-11#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-9#4)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(1997-4#3)(1997-8#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#7)(2008-7#7)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#13)(2013-1#3)(2013-8#1)
of dietetic practice and##2##4##(1992-2#1)(1994-2#1)
of dietetic##4##2##(1992-2#2)(1993-5#1)(1994-2#1)
of dietetics##4##2##(1992-2#3)(1994-2#1)
of diethyl##2##2##(1990-8#1)(2008-10#1)
of diethylenetriamine##3##2##(2008-10#3)
of diethylstilbestrol##2##2##(2008-10#2)
of dietitians##2##2##(1993-12#1)(1994-2#1)
of diets##6##2##(2008-10#1)(2008-12#5)
of diferric transferrin##2##3##(1994-3#2)
of difference between##2##3##(1992-11#1)(1994-7#1)
of difference##5##2##(1992-11#1)(1994-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
of differences between the##2##4##(2007-10#1)(2010-1#1)
of differences between##10##3##(1997-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-1#1)(2012-12#1)
of differences in the##5##4##(1995-11#1)(2008-1#1)(2008-10#2)(2008-7#1)
of differences in their##2##4##(2008-10#1)(2010-8#1)
of differences in##27##3##(1991-11#1)(1993-3#1)(1995-11#1)(1996-3#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
of differences##47##2##(1991-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-2#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
of different acid##2##3##(2008-10#1)(2013-1#1)
of different age##5##3##(1990-2#1)(2008-7#1)(2011-2#1)(2013-1#2)
of different ages##10##3##(1991-9#1)(1995-6#1)(1997-6#1)(1997-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)
of different amounts of##2##4##(1997-7#1)(2008-10#1)
of different analytical methods##2##4##(2008-10#2)
of different analytical##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
of different and##3##3##(2008-4#2)(2013-7#1)
of different areas of##2##4##(2008-10#1)(2008-12#1)
of different aspects of the##2##5##(1996-2#1)(2008-10#1)
of different aspects of##3##4##(1996-2#1)(2008-10#1)(2008-3#1)
of different atomic species##2##4##(2008-2#1)(2008-7#1)
of different biological##2##3##(2007-5#1)(2008-5#1)
of different biomarkers##2##3##(2013-1#1)(2013-8#1)
of different body##3##3##(2008-12#2)(2010-12#1)
of different buffer media##2##4##(2008-10#2)
of different calibration##2##3##(2008-10#2)
of different cancers##2##3##(1997-2#1)(2008-8#1)
of different cell lines##2##4##(2008-11#2)
of different cell types##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
of different cell##7##3##(2008-11#3)(2008-2#1)(2008-7#1)(2009-4#1)(2009-8#1)
of different cells##2##3##(2008-11#1)(2013-8#1)
of different chemical forms##2##4##(2008-10#2)
of different chemical##3##3##(2008-10#3)
of different chromophore##2##3##(2008-2#2)
of different classes of##2##4##(2008-10#2)
of different classes##3##3##(2008-10#3)
of different clinical##4##3##(2008-7#2)(2012-12#1)(2012-3#1)
of different combinations of##3##4##(2008-10#1)(2008-11#1)(2012-4#1)
of different commercial##2##3##(2008-10#2)
of different concentrations of##7##4##(1993-12#1)(1997-8#1)(2008-12#2)(2008-6#1)(2012-2#1)(2012-3#1)
of different concentrations##9##3##(1993-12#1)(1997-8#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
of different control##2##3##(1997-3#1)(2008-10#1)
of different culture##2##3##(1996-12#1)(2008-11#1)
of different cytokines##2##3##(2006-6#1)(2008-10#1)
of different days of meat spoilage##2##6##(2008-10#2)
of different densities##2##3##(2008-3#1)(2008-9#1)
of different diseases##4##3##(1990-6#1)(2008-10#2)(2012-12#1)
of different drugs##2##3##(1997-7#1)(2013-8#1)
of different empirical models##2##4##(2008-12#2)
of different empirical##3##3##(2008-12#3)
of different etiologies##2##3##(1991-8#1)(2013-7#1)
of different experimental##4##3##(1990-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
of different factors##4##3##(2008-10#4)
of different families##2##3##(2008-10#2)
of different flow##2##3##(2008-10#2)
of different focus of attention##2##5##(2013-1#2)
of different food##2##3##(2008-10#2)
of different forms of##5##4##(1993-2#1)(1996-3#1)(2008-2#1)(2008-3#1)(2013-1#1)
of different forms##7##3##(1993-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
of different frequencies##4##3##(1996-12#3)(2008-8#1)
of different generations##2##3##(2007-11#1)(2008-8#1)
of different groups##2##3##(2008-6#1)(2012-1#1)
of different growing media on the growth and development of Dahlia (Dahlia pinnata)##2##13##(2008-12#2)
of different growth##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
of different hospitals##2##3##(1994-2#1)(2010-8#1)
of different host plants##2##4##(2008-9#1)(2011-2#1)
of different host##3##3##(2008-9#2)(2011-2#1)
of different immunosuppressive drugs##2##4##(2008-9#2)
of different immunosuppressive##3##3##(2008-1#1)(2008-9#2)
of different intensities##3##3##(1996-2#1)(2008-2#1)(2008-8#1)
of different isoforms of##2##4##(1993-8#1)(1995-11#1)
of different kinds of##7##4##(1991-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
of different kinds##8##3##(1991-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)
of different length##2##3##(1990-2#1)(1996-6#1)
of different lengths of##2##4##(2008-3#1)(2011-1#1)
of different lengths##3##3##(2008-3#1)(2009-2#1)(2011-1#1)
of different levels of feed added black seed (Nigella sativa L##2##11##(2008-12#2)
of different levels of##5##4##(2008-12#3)(2010-8#1)(2011-1#1)
of different levels##6##3##(2008-12#3)(2010-8#2)(2011-1#1)
of different light-curing units on##2##5##(2008-12#2)
of different lipid##5##3##(2007-7#1)(2008-10#1)(2008-11#2)(2009-8#1)
of different load application devices on fracture resistance##2##8##(2013-1#2)
of different mammalian##2##3##(1993-9#1)(2013-1#1)
of different mating##2##3##(2008-10#2)
of different matrix##2##3##(2008-10#2)
of different metal ions##2##4##(2008-10#1)(2008-7#1)
of different methods for##3##4##(2007-6#1)(2009-8#1)(2012-2#1)
of different methods of##2##4##(2008-5#1)(2012-3#1)
of different methods##7##3##(2007-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
of different models of##2##4##(1996-1#1)(1997-2#1)
of different modes##2##3##(2008-3#2)
of different molecular descriptors##2##4##(2008-10#2)
of different molecular weight##2##4##(1990-12#1)(2008-10#1)
of different molecular##9##3##(1990-12#1)(1992-9#1)(2008-10#5)(2011-2#1)(2013-8#1)
of different objects##2##3##(1996-2#1)(2007-12#1)
of different organs##2##3##(2008-1#1)(2012-3#1)
of different origin including##2##4##(2008-10#2)
of different origin##10##3##(1991-9#1)(2008-10#5)(2008-11#2)(2009-2#1)(2011-2#1)
of different origins##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
of different parameters on##2##4##(2008-10#2)
of different parameters such as##2##5##(2008-10#2)
of different parameters##12##3##(1997-2#1)(2008-10#9)(2008-3#1)(2012-1#1)
of different parts of the##2##5##(2008-10#1)(2008-7#1)
of different parts of##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
of different percentages of##3##4##(2008-10#3)
of different phases##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
of different plant spacing on the production of cauliflower##2##9##(2008-12#2)
of different polarity##4##3##(2008-10#4)
of different possible##2##3##(1995-5#1)(2013-8#1)
of different probiotic strains##2##4##(2012-1#1)(2013-8#1)
of different processing##2##3##(1995-5#1)(2008-5#1)
of different products##2##3##(2008-10#1)(2008-12#1)
of different properties##2##3##(2008-3#1)(2012-2#1)
of different protein##2##3##(2008-1#1)(2008-4#1)
of different proteins##2##3##(1997-4#1)(2008-10#1)
of different protocols##2##3##(2008-4#1)(2013-8#1)
of different psychiatric##2##3##(1996-7#1)(2009-9#1)
of different rates##2##3##(2008-10#1)(2008-7#1)
of different regions of the##2##5##(1995-3#1)(2012-3#1)
of different regions of##3##4##(1993-12#1)(1995-3#1)(2012-3#1)
of different regions##4##3##(1993-12#1)(1995-3#1)(2011-1#1)(2012-3#1)
of different sample##3##3##(2008-10#3)
of different samples##3##3##(2007-11#1)(2008-10#1)(2011-3#1)
of different scales##2##3##(2008-10#1)(2008-9#1)
of different sets of##4##4##(1992-12#1)(1996-2#1)(2008-2#1)(2008-9#1)
of different signaling pathways##3##4##(2008-8#2)(2008-9#1)
of different sites of##2##4##(1997-2#1)(2006-4#1)
of different size##2##3##(2012-12#1)(2013-7#1)
of different sized##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of different sizes and##5##4##(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
of different sizes##23##3##(1990-2#1)(1996-4#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#4)(2011-2#1)(2012-2#3)
of different skill levels##2##4##(2011-2#2)
of different skill##3##3##(1997-2#1)(2011-2#2)
of different solutions##2##3##(2008-10#1)(2008-3#1)
of different spatial frequencies##2##4##(2007-11#1)(2008-3#1)
of different spatial##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of different species and##3##4##(2008-10#2)(2008-8#1)
of different species in##2##4##(2007-12#1)(2008-10#1)
of different species of##3##4##(1994-9#1)(2008-7#1)(2008-8#1)
of different species##11##3##(1994-9#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2013-7#1)
of different stages of##2##4##(2008-7#1)(2011-2#1)
of different strains of the##2##5##(2008-10#1)(2010-12#1)
of different strains of##5##4##(1992-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
of different strains##6##3##(1992-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
of different strategies##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
of different structural##2##3##(1995-5#1)(1997-4#1)
of different studies##2##3##(2008-10#1)(2008-9#1)
of different substrates##2##3##(1991-5#1)(2010-3#1)
of different surface##3##3##(1994-5#1)(2008-10#1)(2008-12#1)
of different techniques##5##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
of different tissue##2##3##(2008-8#1)(2009-9#1)
of different treatments##2##3##(1997-4#1)(2008-6#1)
of different type##2##3##(2008-10#2)
of different types of##27##4##(1992-1#1)(1992-8#1)(1994-1#1)(1997-4#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
of different types##41##3##(1992-1#1)(1992-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(1997-4#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)
of different values##2##3##(1992-3#1)(2009-7#1)
of different variables##4##3##(2008-10#4)
of different varieties of##2##4##(1991-8#1)(2008-10#1)
of different varieties##3##3##(1991-8#1)(2008-10#2)
of different wavelengths##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of different##862##2##(1990-12#2)(1990-2#5)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#2)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#4)(1997-9#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#9)(2007-12#12)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#11)(2008-10#243)(2008-11#29)(2008-12#35)(2008-2#27)(2008-3#39)(2008-4#8)(2008-5#17)(2008-6#11)(2008-7#28)(2008-8#29)(2008-9#20)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#11)(2011-2#29)(2011-3#2)(2011-4#1)(2012-1#6)(2012-12#9)(2012-2#20)(2012-3#14)(2012-4#1)(2012-6#1)(2012-8#2)(2012-9#1)(2013-1#36)(2013-7#8)(2013-8#15)
of differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
of differential absorption##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of differential diagnosis##9##3##(1992-6#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
of differential equations##3##3##(2008-2#1)(2010-11#1)(2013-8#1)
of differential expression##4##3##(2008-7#3)(2012-3#1)
of differential pulse##2##3##(2008-10#1)(2010-2#1)
of differential scanning calorimetry and##2##5##(1990-2#1)(2008-10#1)
of differential staining##3##3##(1997-8#1)(2008-9#2)
of differential##51##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-10#9)(2008-12#2)(2008-2#5)(2008-3#4)(2008-7#6)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
of differentially expressed genes##4##4##(2008-2#1)(2008-7#1)(2010-4#1)(2011-1#1)
of differentially expressed##8##3##(2008-2#1)(2008-7#2)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#1)
of differentially##10##2##(2008-10#2)(2008-2#1)(2008-7#2)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#1)
of differentiated cells##2##3##(2008-11#1)(2008-7#1)
of differentiated neurons##2##3##(2007-12#1)(2013-1#1)
of differentiated##12##2##(1992-3#1)(1995-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#3)
of differentiating##11##2##(2007-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#1)
of differentiation and##6##3##(1993-3#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-1#1)
of differentiation as##2##3##(1992-9#1)(2008-6#1)
of differentiation factors##2##3##(2008-11#1)(2011-2#1)
of differentiation in##2##3##(1993-12#1)(2008-11#1)
of differentiation of the##2##4##(1992-3#1)(1997-6#1)
of differentiation of##5##3##(1992-3#1)(1993-3#1)(1997-6#1)(2008-10#1)(2008-4#1)
of differentiation##44##2##(1990-5#1)(1991-2#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1997-6#1)(2008-10#3)(2008-11#9)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-3#1)(2011-2#4)(2013-1#1)(2013-7#1)
of differing size##2##3##(2008-8#1)(2009-12#1)
of differing##16##2##(1990-12#1)(1990-7#1)(1991-12#1)(1993-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-12#1)(2010-1#1)(2010-8#1)
of difficult##5##2##(1993-1#1)(2007-12#1)(2008-6#1)(2011-2#1)(2013-8#1)
of difficult-to-control asthma##2##3##(2009-6#2)
of difficulties in##4##3##(2007-11#1)(2008-7#3)
of difficulties##7##2##(1994-3#1)(2007-11#1)(2007-4#1)(2008-7#3)(2008-8#1)
of difficulty in identifying those##2##5##(2008-10#1)(2008-3#1)
of difficulty in##6##3##(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-7#1)
of difficulty of##2##3##(1992-3#1)(2008-11#1)
of difficulty##12##2##(1992-3#1)(1993-5#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-7#1)
of diffracted beam spots##2##4##(2008-3#2)
of diffracted##5##2##(2007-11#1)(2008-3#4)
of diffraction and##2##3##(2008-2#1)(2008-3#1)
of diffraction efficiency##4##3##(2008-2#3)(2008-3#1)
of diffraction gratings##3##3##(2008-3#3)
of diffraction tomography##3##3##(2007-11#1)(2008-2#2)
of diffraction##28##2##(2006-4#1)(2007-11#5)(2007-12#3)(2008-2#10)(2008-3#8)(2009-5#1)
of diffraction-free beams##2##3##(2008-3#2)
of diffraction-limited##2##2##(2007-12#1)(2008-3#1)
of diffractive and micro-optical##2##4##(2008-3#2)
of diffractive beam-shaping elements in##3##5##(2008-3#3)
of diffractive elements with##2##4##(2007-11#1)(2008-3#1)
of diffractive elements##7##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
of diffractive lenses##2##3##(2008-3#2)
of diffractive optical elements (DOE's)##3##5##(2008-3#3)
of diffractive optical elements for##3##5##(2007-12#1)(2008-2#2)
of diffractive optical elements with##2##5##(2008-2#1)(2008-3#1)
of diffractive optical elements##15##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#10)
of diffractive optical##18##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#12)
of diffractive optics##2##3##(2008-3#2)
of diffractive phase elements (DPE's)##2##5##(2007-12#1)(2008-2#1)
of diffractive phase elements for##2##5##(2007-11#1)(2008-3#1)
of diffractive phase elements##7##4##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
of diffractive##47##2##(2007-11#6)(2007-12#4)(2008-2#8)(2008-3#29)
of diffuse malignant mesothelioma##6##4##(1991-12#6)
of diffuse marine reflectance##3##4##(2008-3#3)
of diffuse media##2##3##(2007-11#2)
of diffuse objects##2##3##(2008-3#2)
of diffuse scattering##2##3##(2008-3#2)
of diffuse##38##2##(1990-8#1)(1991-12#6)(1993-9#1)(1994-6#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
of diffusely reflected##2##3##(2008-3#2)
of diffusible##3##2##(2008-10#3)
of diffusion in##3##3##(1990-6#1)(1993-11#1)(2008-9#1)
of diffusion of##3##3##(1993-3#1)(2008-5#1)(2010-3#1)
of diffusion theory##3##3##(2007-11#1)(2008-3#2)
of diffusion##26##2##(1990-6#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#3)(2009-7#1)(2010-10#1)(2010-3#1)(2013-8#1)
of diffusive##6##2##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
of digested P-450C21##2##3##(1993-11#2)
of digested sample##3##3##(2008-10#3)
of digested##8##2##(1993-11#2)(2008-10#6)
of digester##2##2##(2008-7#2)
of digestion##6##2##(2008-10#5)(2012-1#1)
of digestive##7##2##(1990-6#1)(1991-11#2)(1991-3#1)(1993-11#1)(2007-12#1)(2013-1#1)
of digital holography##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
of digital microscopic##2##3##(2008-3#1)(2008-9#1)
of digital microscopy##2##3##(2008-3#1)(2008-9#1)
of digital radiography##2##3##(2008-7#1)(2009-9#1)
of digital speckle photography##3##4##(2008-3#3)
of digital##38##2##(1992-9#1)(1994-7#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#18)(2008-4#1)(2008-7#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2013-1#1)
of digitized##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
of dignity##4##2##(1990-6#1)(1991-8#1)(2012-3#2)
of digoxin##3##2##(1995-11#1)(2009-10#2)
of digoxin-equivalent##2##2##(1991-8#2)
of dihydroberberine derivatives##2##3##(2008-11#2)
of dihydroergotoxine##2##2##(1990-6#2)
of dihydroetorphine##4##2##(1995-11#4)
of dihydrofolate reductase##4##3##(1992-6#2)(1992-8#1)(2007-11#1)
of diisopropylcarbodiimide##3##2##(2008-9#3)
of dilated cardiomyopathy in##2##4##(2008-7#1)(2013-8#1)
of dilated cardiomyopathy##4##3##(2008-7#1)(2012-2#2)(2013-8#1)
of dilated##5##2##(1990-6#1)(2008-7#1)(2012-2#2)(2013-8#1)
of dilemma theory##2##3##(2008-8#2)
of diltiazem##7##2##(1990-8#2)(1992-8#4)(2008-7#1)
of dilute##8##2##(2007-12#1)(2008-10#4)(2008-3#3)
of diluted##4##2##(2008-10#4)
of dilution of##2##3##(1992-3#1)(2008-10#1)
of dilution##8##2##(1992-3#1)(2008-10#4)(2008-11#1)(2008-6#2)
of dimensional approaches##2##3##(2008-8#2)
of dimensional##6##2##(1990-9#1)(2008-2#2)(2008-8#2)(2009-2#1)
of dimensionality##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
of dimensions of##2##3##(1996-2#1)(2008-7#1)
of dimensions##5##2##(1996-2#1)(2008-2#1)(2008-7#1)(2012-2#2)
of dimer##4##2##(1990-7#1)(1997-2#1)(2008-10#1)(2008-8#1)
of dimer-tetramer assembly##4##3##(1990-8#3)(1997-2#1)
of dimeric##5##2##(1994-6#1)(1995-6#1)(1996-2#2)(2008-10#1)
of dimers##6##2##(1993-11#1)(1997-2#3)(2008-11#1)(2008-9#1)
of dimethicone and cyclotetrasiloxane##3##4##(2008-5#3)
of dimethyl sulfate##2##3##(2008-10#2)
of dimethyl sulfoxide and##2##4##(2008-10#1)(2009-5#1)
of dimethyl##9##2##(1996-5#1)(2008-10#4)(2008-7#1)(2009-5#1)(2011-2#2)
of dimethylarsinate (DMA)##2##3##(2008-10#2)
of dimethylformamide (DMF)##5##3##(2008-10#5)
of dimethylformamide##6##2##(2008-10#6)
of dimethylsulfoniopropionate##2##2##(2008-10#2)
of dimethylsulfoxide##3##2##(1993-8#1)(2008-10#2)
of dimethyltin chloride##5##3##(2008-10#5)
of diminished##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
of diminishing resources##2##3##(1993-12#1)(1996-12#1)
of diminishing##3##2##(1993-12#1)(1996-12#1)(2012-2#1)
of dinucleotide occurrences##2##3##(1997-6#2)
of dinucleotide##4##2##(1997-6#3)(2008-4#1)
of diode lasers##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of diode-pumped##2##2##(2007-11#2)
of diolein##2##2##(1990-8#1)(1992-6#1)
of dioleoylphosphatidylcholine##2##2##(1990-2#1)(1992-6#1)
of dioxin in##2##3##(2008-10#2)
of dioxin##7##2##(1991-11#1)(2008-10#4)(2008-7#2)
of dioxin-like compounds##2##3##(2008-10#2)
of dioxin-like##4##2##(2008-10#4)
of dioxins and##2##3##(2008-10#2)
of dioxins in##6##3##(2008-10#6)
of dioxins##16##2##(2008-10#12)(2008-11#1)(2008-7#3)
of dioxygen##4##2##(2008-10#4)
of dip##2##2##(1994-11#1)(2008-3#1)
of dipalmitoylphosphatidylcholine (DPPC)##2##3##(1991-5#1)(1992-3#1)
of dipalmitoylphosphatidylcholine##3##2##(1991-5#1)(1992-3#1)(1994-12#1)
of dipeptides and##2##3##(1990-11#1)(1990-8#1)
of dipeptides##5##2##(1990-11#1)(1990-8#1)(1995-6#3)
of diphenhydramine##5##2##(2008-10#5)
of diphtheria##4##2##(1995-3#2)(1995-5#1)(2007-11#1)
of diploid##5##2##(1990-3#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-2#1)
of dipole##3##2##(2007-11#1)(2008-3#2)
of dipstick tests##2##3##(2007-2#2)
of dipyridamole##5##2##(1992-5#2)(2008-10#3)
of direct and indirect##2##4##(2008-10#1)(2008-9#1)
of direct and scattered solar radiation##2##6##(2008-3#2)
of direct and##8##3##(2008-10#3)(2008-2#1)(2008-3#3)(2008-9#1)
of direct current##3##3##(2008-7#1)(2013-8#2)
of direct detection##4##3##(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
of direct determination of##3##4##(2008-10#2)(2008-3#1)
of direct gene transfer##4##4##(1991-9#1)(1994-5#2)(1996-5#1)
of direct numerical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of direct patient care##2##4##(2007-10#1)(2008-11#1)
of direct##74##2##(1990-5#1)(1990-6#2)(1990-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#8)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
of direct-acting##2##2##(1991-9#1)(2009-5#1)
of direct-detection Doppler lidar##2##4##(2008-3#2)
of direct-to-consumer (DTC)##2##3##(1996-1#1)(2008-12#1)
of directed##3##2##(2011-2#1)(2012-2#2)
of directing##3##2##(1991-9#1)(1992-3#1)(2013-1#1)
of direction of##2##3##(1994-8#1)(2009-6#1)
of direction##3##2##(1994-8#1)(2008-8#1)(2009-6#1)
of directional effects##2##3##(2008-3#2)
of directional##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
of directions##3##2##(1997-3#1)(2009-7#1)(2011-2#1)
of directly observed##2##3##(2010-4#1)(2013-8#1)
of directly##15##2##(1995-8#2)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-8#2)
of directors##8##2##(1992-2#1)(1993-1#2)(1994-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-9#1)
of dirithromycin##3##2##(2008-10#3)
of disabilities##3##2##(2007-7#2)(2010-7#1)
of disability among##3##3##(1995-2#1)(2007-10#1)(2010-12#1)
of disability and##2##3##(1995-12#1)(2011-2#1)
of disability in##3##3##(1990-3#1)(1997-5#1)(2013-1#1)
of disability##32##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-2#1)(1994-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#4)(1997-5#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
of disabled##6##2##(1991-1#1)(1991-12#1)(1992-3#1)(1994-1#2)(2008-8#1)
of disagreement##3##2##(2011-2#1)(2012-1#1)(2013-1#1)
of disaster##4##2##(1992-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
of disasters##3##2##(2010-8#2)(2013-1#1)
of disc##6##2##(2007-11#2)(2008-10#1)(2012-12#1)(2012-3#2)
of discharge (P &lt##2##4##(2007-10#2)
of discharge and##2##3##(1990-11#1)(2008-11#1)
of discharge from##2##3##(2008-11#1)(2008-3#1)
of discharge##14##2##(1990-11#1)(1994-2#1)(2007-10#2)(2007-12#1)(2008-11#3)(2008-3#2)(2009-11#1)(2011-1#1)(2012-12#2)
of discharged##3##2##(1995-2#1)(2008-11#1)(2012-12#1)
of discharges##4##2##(1990-12#2)(1992-12#1)(1992-2#1)
of disciplines##4##2##(2008-12#1)(2009-11#1)(2011-2#1)(2013-8#1)
of disclosure##8##2##(1991-3#1)(1995-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2009-4#1)(2011-1#1)
of discolored##7##2##(2008-10#3)(2009-8#1)(2011-2#3)
of discontinuation##3##2##(1991-12#2)(1991-2#1)
of discontinuity sources and##2##4##(2008-3#2)
of discontinuity sources##3##3##(2008-3#3)
of discontinuous objects##3##3##(2008-3#3)
of discontinuous##8##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#4)(2010-4#1)
of discourse##5##2##(2008-12#1)(2012-3#2)(2013-1#2)
of discovery##5##2##(1995-12#1)(1997-3#1)(2011-3#1)(2012-2#2)
of discrete wavelet##2##3##(2007-11#1)(2008-10#1)
of discrete##26##2##(1991-1#1)(1994-2#1)(2006-4#1)(2007-11#5)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-6#1)(2013-8#1)
of discretionary##2##2##(1994-3#1)(2008-11#1)
of discriminant analysis##3##3##(2008-10#3)
of discriminant##6##2##(1991-2#1)(1992-11#1)(1995-6#1)(2008-10#3)
of discriminating among##2##3##(2008-9#1)(2012-1#1)
of discriminating between##2##3##(1994-5#1)(2008-10#1)
of discriminating##5##2##(1994-5#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-1#1)
of discrimination and##3##3##(1992-10#1)(2008-11#1)(2009-3#1)
of discrimination of##2##3##(2008-2#1)(2008-9#1)
of discrimination##11##2##(1992-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)
of discussion and##2##3##(1996-1#1)(2008-11#1)
of discussion in the##2##4##(1996-12#1)(2008-10#1)
of discussion on##2##3##(1996-2#1)(2008-8#1)
of discussion##15##2##(1996-1#1)(1996-12#1)(1996-2#1)(2006-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2012-12#1)
of disease across##2##3##(2008-10#2)
of disease activity##4##3##(1997-8#2)(2006-10#1)(2008-7#1)
of disease and for##2##4##(1992-12#1)(2013-7#1)
of disease and the##3##4##(2008-1#1)(2008-10#2)
of disease and##22##3##(1992-12#1)(1993-11#1)(1995-5#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-1#2)(2013-7#2)
of disease as##3##3##(1991-8#1)(1997-6#1)(2008-10#1)
of disease at##5##3##(1990-12#1)(1993-11#2)(2008-6#1)(2009-1#1)
of disease between##2##3##(2008-10#2)
of disease caused by the##2##5##(2008-10#2)
of disease caused by##3##4##(2008-10#2)(2011-2#1)
of disease control##11##3##(2008-10#11)
of disease could##2##3##(2008-10#1)(2008-3#1)
of disease development##7##3##(2008-10#7)
of disease during##4##3##(1991-2#1)(1994-8#1)(2008-10#1)(2010-3#1)
of disease extension##2##3##(1992-9#1)(2008-1#1)
of disease for##6##3##(2008-10#2)(2008-7#1)(2012-12#3)
of disease from##5##3##(2008-10#2)(2010-3#1)(2012-12#1)(2013-1#1)
of disease gradients##2##3##(2008-10#2)
of disease in##17##3##(1991-4#1)(1997-8#1)(2007-1#1)(2008-10#8)(2008-12#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-3#1)
of disease incidence and severity##2##5##(2008-10#2)
of disease incidence and##4##4##(2008-10#4)
of disease incidence data##5##4##(2008-10#5)
of disease incidence was##2##4##(2008-10#2)
of disease incidence##22##3##(1994-9#1)(1997-3#1)(2008-10#20)
of disease increase##5##3##(2008-10#4)(2008-7#1)
of disease intensity##4##3##(2008-10#4)
of disease is##5##3##(2008-10#3)(2012-1#1)(2013-1#1)
of disease management##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
of disease occurrence##2##3##(2008-10#1)(2012-2#1)
of disease on##3##3##(2007-2#1)(2008-10#2)
of disease onset##3##3##(1997-5#1)(2008-10#2)
of disease outbreaks##2##3##(1996-12#1)(2008-10#1)
of disease pathophysiology##2##3##(2006-10#1)(2012-12#1)
of disease processes##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2010-2#1)
of disease progress##6##3##(2008-10#6)
of disease progression##11##3##(1991-6#1)(2008-10#3)(2008-7#2)(2009-6#1)(2010-10#1)(2011-7#1)(2012-12#1)(2013-8#1)
of disease recurrence##7##3##(2008-6#1)(2012-2#2)(2013-1#3)(2013-8#1)
of disease reduction##4##3##(2008-10#4)
of disease resistance in##2##4##(2008-10#2)
of disease resistance##5##3##(2008-10#5)
of disease resulting from##2##4##(1991-12#1)(2008-10#1)
of disease risk##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
of disease severity at##2##4##(2008-10#2)
of disease severity in##3##4##(2008-10#2)(2008-9#1)
of disease severity##25##3##(2008-10#16)(2008-11#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#2)(2012-2#1)(2013-8#1)
of disease spread##3##3##(2008-10#3)
of disease suppression##5##3##(2008-10#5)
of disease symptoms and##2##4##(2008-5#1)(2008-7#1)
of disease symptoms##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
of disease that##2##3##(2008-10#1)(2010-4#1)
of disease was found##2##4##(2008-7#1)(2011-2#1)
of disease was##15##3##(1992-12#1)(1995-3#2)(1996-7#1)(2008-10#6)(2008-7#1)(2011-2#4)
of disease were observed##2##4##(1992-2#1)(2008-10#1)
of disease were##6##3##(1990-2#1)(1992-2#1)(1992-8#1)(2008-10#3)
of disease with a##2##4##(1990-2#1)(2009-12#1)
of disease with##4##3##(1990-2#1)(2008-10#1)(2009-12#1)(2010-3#1)
of disease##447##2##(1990-10#1)(1990-12#2)(1990-2#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-6#2)(1991-8#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-3#3)(1995-5#2)(1996-12#3)(1996-2#1)(1996-7#1)(1997-3#6)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#195)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#12)(2008-7#16)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#19)(2011-7#2)(2012-1#2)(2012-12#12)(2012-2#11)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#6)
of disease&quot##3##2##(1997-6#1)(2008-10#1)(2013-1#1)
of disease)##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of disease-causing##2##2##(2008-4#1)(2012-3#1)
of disease-free##2##2##(2008-10#1)(2010-3#1)
of disease-induced root growth##2##4##(2008-10#2)
of disease-induced root production##2##4##(2008-10#2)
of disease-induced root##4##3##(2008-10#4)
of disease-induced##5##2##(2008-10#5)
of disease-suppressive##2##2##(2008-10#2)
of diseased individuals##2##3##(2008-10#2)
of diseased plants in##2##4##(2008-10#2)
of diseased plants##8##3##(2008-10#8)
of diseased spikelets##4##3##(2008-10#4)
of diseased##30##2##(2008-10#30)
of diseases and##5##3##(1991-11#1)(1991-6#2)(1994-6#1)(2007-8#1)
of diseases caused by##4##4##(1994-9#1)(1995-2#1)(2008-10#1)(2008-5#1)
of diseases diagnosed##2##3##(1994-2#2)
of diseases in humans##3##4##(2011-1#1)(2011-2#1)(2012-3#1)
of diseases in##7##3##(1995-8#1)(1997-3#1)(2006-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of diseases including##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
of diseases of the##3##4##(1992-9#1)(2007-8#1)(2011-2#1)
of diseases should be##2##4##(2008-5#1)(2011-1#1)
of diseases that affect the##2##5##(2009-10#1)(2010-9#1)
of diseases that##5##3##(2009-10#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#1)
of diseases##74##2##(1990-6#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-9#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#9)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#2)
of diseases]##3##2##(1990-3#2)(2008-7#1)
of disfluency##8##2##(2008-2#8)
of disgust##3##2##(2010-7#1)(2012-2#2)
of disinfection by-products##2##3##(2008-9#2)
of disinfection##4##2##(2008-9#2)(2012-2#1)(2013-8#1)
of disinhibition##3##2##(2010-3#3)
of disintegrated##2##2##(2008-10#1)(2008-7#1)
of disk tilt##5##3##(2008-2#5)
of disk##8##2##(2008-12#1)(2008-2#6)(2008-8#1)
of disks##2##2##(2008-11#1)(2008-8#1)
of dislocation##5##2##(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
of disorder##2##2##(1990-5#1)(2010-8#1)
of disordered##2##2##(2007-12#1)(2012-2#1)
of disorders characterized by##2##4##(2008-7#1)(2010-10#1)
of disorders diagnosable##2##3##(1991-11#2)
of disorders in##2##3##(2007-10#1)(2011-2#1)
of disorders of the##2##4##(1990-12#1)(2011-7#1)
of disorders of##3##3##(1990-12#1)(1990-6#1)(2011-7#1)
of disorders##19##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#2)(1997-2#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2010-10#1)(2011-2#1)(2011-7#1)(2012-2#2)
of disparities in##2##3##(2008-11#1)(2013-1#1)
of disparities##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
of dispensing##2##2##(2010-3#1)(2013-8#1)
of dispersal ability##2##3##(2008-9#2)
of dispersal and##5##3##(2008-8#3)(2008-9#1)(2013-7#1)
of dispersal of##2##3##(2008-10#2)
of dispersal that##2##3##(2008-10#1)(2008-8#1)
of dispersal##30##2##(2008-10#10)(2008-8#11)(2008-9#6)(2013-1#2)(2013-7#1)
of dispersed##7##2##(1992-9#1)(2008-10#4)(2008-4#1)(2008-7#1)
of dispersing##2##2##(2008-12#1)(2011-2#1)
of dispersion in##2##3##(2007-11#1)(2008-10#1)
of dispersion is##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of dispersion management##3##3##(2007-11#1)(2007-12#2)
of dispersion of the##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
of dispersion of##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
of dispersion on##2##3##(2008-2#2)
of dispersion##26##2##(2007-11#6)(2007-12#4)(2008-10#10)(2008-2#5)(2008-3#1)
of dispersion-managed solitons##6##3##(2007-11#1)(2007-12#5)
of dispersion-managed##9##2##(2007-11#2)(2007-12#7)
of dispersive##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
of displaced persons##3##3##(1994-9#2)(2008-7#1)
of displaced##10##2##(1991-9#1)(1994-9#2)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#3)
of displacement curves of##2##4##(1993-1#2)
of displacement##9##2##(1993-1#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)
of displaying##2##2##(2008-3#1)(2009-8#1)
of disposable##4##2##(1994-2#1)(2007-7#1)(2008-10#2)
of disruption of##2##3##(2008-7#1)(2009-2#1)
of disruption##4##2##(1995-8#1)(2008-7#1)(2008-8#1)(2009-2#1)
of disruptions##2##2##(1993-9#1)(2011-2#1)
of disruptive passenger behaviour##2##4##(2007-2#2)
of disruptive selection##2##3##(2008-8#2)
of disruptive##4##2##(2007-2#2)(2008-8#2)
of dissatisfaction with##2##3##(1996-3#1)(2008-11#1)
of dissatisfaction##3##2##(1996-3#1)(2008-11#1)(2010-4#1)
of dissecting##2##2##(2008-10#1)(2013-1#1)
of disseminated cryptococcosis##2##3##(2008-5#2)
of disseminated superficial##3##3##(2007-7#3)
of disseminated tumor cells##2##4##(2008-9#1)(2010-3#1)
of disseminated##12##2##(1993-9#1)(1997-3#1)(2007-7#3)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
of dissemination##4##2##(2008-10#1)(2008-11#1)(2010-10#1)(2013-1#1)
of dissimilarity##2##2##(1995-5#1)(2009-2#1)
of dissipative##2##2##(2010-7#1)(2012-2#1)
of dissociated##5##2##(1990-8#1)(2008-10#3)(2009-9#1)
of dissociation constants##2##3##(1991-9#1)(2008-10#1)
of dissociation of##2##3##(1997-2#1)(2008-10#1)
of dissociation##8##2##(1991-9#1)(1995-11#1)(1997-2#1)(2008-10#4)(2008-2#1)
of dissolution medium##2##3##(2008-10#1)(2010-3#1)
of dissolution tests##2##3##(2008-10#2)
of dissolution##10##2##(2008-10#7)(2010-3#2)(2012-2#1)
of dissolved and##2##3##(2008-10#1)(2008-3#1)
of dissolved humic##2##3##(2008-10#2)
of dissolved hydrogen##3##3##(2008-11#1)(2008-7#2)
of dissolved organic matter##4##4##(2008-10#3)(2008-2#1)
of dissolved organic##8##3##(2008-10#7)(2008-2#1)
of dissolved oxygen (DO)##2##4##(2008-10#1)(2008-11#1)
of dissolved oxygen and##2##4##(2008-10#1)(2008-7#1)
of dissolved oxygen in##3##4##(2008-10#3)
of dissolved oxygen##10##3##(2008-10#8)(2008-11#1)(2008-7#1)
of dissolved reactive phosphorus (DRP) and##2##6##(2008-10#2)
of dissolved reactive##3##3##(2008-10#3)
of dissolved##48##2##(2008-10#38)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#3)(2011-2#1)(2013-1#1)
of distal aortic##2##3##(2007-8#2)
of distal lung##2##3##(2008-9#2)
of distal radial##3##3##(2007-8#1)(2013-8#2)
of distal##32##2##(1991-12#1)(1993-1#1)(1994-5#1)(1996-9#2)(1997-1#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-12#1)(2008-7#2)(2008-9#4)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
of distally##2##2##(1997-3#1)(2007-7#1)
of distamycin##2##2##(1995-3#2)
of distance between##2##3##(2008-8#1)(2010-11#1)
of distance##15##2##(1991-8#1)(1995-6#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)
of distant metastases##5##3##(1991-8#1)(2008-6#2)(2010-3#1)(2011-2#1)
of distant##9##2##(1991-8#1)(1993-12#1)(1993-9#1)(1995-11#1)(2008-6#2)(2009-11#1)(2010-3#1)(2011-2#1)
of distantly related##2##3##(1991-5#1)(2008-4#1)
of distilled drinks##2##3##(2008-10#2)
of distilled water and##2##4##(2008-10#1)(2012-3#1)
of distilled water##10##3##(2008-10#4)(2008-6#1)(2010-3#4)(2012-3#1)
of distilled##14##2##(2008-10#6)(2008-6#2)(2010-3#4)(2012-3#2)
of distinct primary##2##3##(2008-10#1)(2011-2#1)
of distinct##31##2##(1990-8#1)(1991-9#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of distinguishing these##2##3##(2008-11#1)(2012-2#1)
of distinguishing##7##2##(1991-12#1)(2008-11#2)(2008-2#1)(2008-6#1)(2010-10#1)(2012-2#1)
of distorted##4##2##(1997-7#1)(2008-10#1)(2008-3#2)
of distortion in##2##3##(2008-2#1)(2008-3#1)
of distortion##4##2##(2008-2#3)(2008-3#1)
of distortion-invariant##2##2##(2008-2#1)(2008-3#1)
of distracters##4##2##(2009-2#4)
of distraction osteogenesis##8##3##(2007-12#4)(2007-8#3)(2009-3#1)
of distraction##15##2##(2007-12#6)(2007-8#3)(2009-3#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of distress##7##2##(1995-12#1)(1995-2#1)(2008-2#1)(2012-1#1)(2013-8#3)
of distributed##6##2##(2007-12#1)(2008-3#2)(2008-8#1)(2010-8#1)(2012-2#1)
of distribution in##2##3##(1993-6#1)(1994-6#1)
of distribution of##5##3##(1995-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
of distribution##26##2##(1990-12#1)(1991-12#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#11)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
of distributions##2##2##(2008-10#1)(2008-3#1)
of district##3##2##(1997-5#1)(2009-7#1)(2013-8#1)
of disturbance and##2##3##(2008-9#2)
of disturbance on##2##3##(2008-9#2)
of disturbance##8##2##(2008-2#1)(2008-8#2)(2008-9#5)
of disturbances of##2##3##(2007-11#1)(2013-8#1)
of disturbances##4##2##(1997-2#1)(2007-11#1)(2008-8#1)(2013-8#1)
of disturbed eating attitudes##3##4##(2007-7#3)
of disturbed##10##2##(1994-2#1)(2007-7#3)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
of disulfide bonding##2##3##(2012-1#2)
of disulfide bonds##2##3##(1995-5#1)(2008-10#1)
of disulfide##6##2##(1992-12#1)(1995-5#1)(2008-10#2)(2012-1#2)
of disulfides on##2##3##(2008-10#2)
of disulfides##3##2##(2008-10#2)(2010-10#1)
of dithiocarbamate##3##2##(2008-10#3)
of dithiothreitol##2##2##(1992-3#2)
of diuretics in##3##3##(2008-10#3)
of diuretics##9##2##(1992-11#1)(1994-12#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-10#1)
of diurnal##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
of diuron##2##2##(2008-10#2)
of divalent cation##3##3##(1990-2#3)
of divalent cations on the##2##5##(1994-5#2)
of divalent cations##6##3##(1994-5#2)(1994-6#1)(1995-2#1)(1995-5#1)(2008-10#1)
of divalent metal cations##2##4##(2008-10#2)
of divalent metal##4##3##(1995-2#1)(2008-10#3)
of divalent polyamines##2##3##(1991-8#2)
of divalent transition metal beta-diketonates##2##5##(2008-10#2)
of divalent transition metals##2##4##(2008-10#2)
of divalent transition##4##3##(2008-10#4)
of divalent##23##2##(1990-2#3)(1991-8#2)(1994-5#2)(1994-6#1)(1995-2#2)(1995-5#1)(2006-6#1)(2008-10#10)(2010-11#1)
of divergence between##2##3##(2008-8#1)(2013-1#1)
of divergence##6##2##(2008-10#1)(2008-8#2)(2009-2#1)(2010-6#1)(2013-1#1)
of divergent##5##2##(1990-5#1)(1995-2#1)(1997-9#1)(2008-6#1)(2012-2#1)
of diverse functions##2##3##(1993-5#1)(1996-5#1)
of diverse ions and##2##4##(2008-10#2)
of diverse ions on the determination of##2##7##(2008-10#2)
of diverse ions on the##4##5##(2008-10#4)
of diverse ions##6##3##(2008-10#6)
of diverse##35##2##(1990-5#1)(1993-5#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of diversification in##2##3##(2008-10#1)(2010-3#1)
of diversification##4##2##(1997-4#1)(2008-10#1)(2010-3#1)(2012-3#1)
of diversity among##2##3##(2008-10#1)(2013-1#1)
of diversity and##4##3##(2008-10#1)(2011-1#1)(2012-3#2)
of diversity for aggressiveness##2##4##(2008-10#2)
of diversity in this##2##4##(2008-10#2)
of diversity in##3##3##(2008-10#2)(2008-11#1)
of diversity that##2##3##(2012-12#1)(2013-1#1)
of diversity within the##2##4##(2008-10#1)(2009-2#1)
of diversity within##4##3##(2008-10#3)(2009-2#1)
of diversity##39##2##(1994-12#1)(1995-12#1)(1996-6#2)(2008-10#22)(2008-11#1)(2008-7#1)(2008-8#2)(2009-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
of diverticular disease is##2##4##(2010-8#2)
of diverticular disease##4##3##(2010-8#4)
of diverticular hemorrhage##2##3##(2010-8#2)
of diverticular##7##2##(2010-8#7)
of diverticulitis##3##2##(2010-8#3)
of dividing cells##3##3##(1995-2#1)(2008-9#1)(2009-8#1)
of dividing##5##2##(1995-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-12#1)
of division of labor##2##4##(1995-1#1)(2008-8#1)
of division of##3##3##(1995-1#1)(2008-8#1)(2009-5#1)
of division##6##2##(1995-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-5#1)
of divorce##3##2##(2011-2#3)
of dizocilpine maleate##2##3##(1996-12#2)
of dobutamine##4##2##(1994-11#1)(1996-2#1)(2007-7#1)(2009-4#1)
of docetaxel##5##2##(2008-10#2)(2008-6#3)
of docked granules##3##3##(1997-7#3)
of docking##3##2##(1997-7#1)(2008-11#1)(2012-2#1)
of doctor##2##2##(1992-6#1)(1993-11#1)
of doctors and##3##3##(2008-12#1)(2008-8#1)(2012-12#1)
of doctors in##2##3##(2008-10#1)(2013-1#1)
of doctors##22##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#3)(1993-2#2)(1993-6#1)(1995-5#2)(1997-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
of documentation and##2##3##(1997-2#1)(2010-8#1)
of documentation##4##2##(1997-2#1)(2007-4#1)(2008-2#1)(2010-8#1)
of documented##8##2##(1990-3#1)(1995-12#1)(1997-3#1)(2007-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
of documenting##2##2##(1994-3#1)(2013-1#1)
of documents##3##2##(1996-3#1)(2008-2#1)(2009-10#1)
of dodecyl sulfate##4##3##(1990-11#1)(2008-10#3)
of dodecyl##6##2##(1990-11#1)(2008-10#5)
of dog bites##2##3##(2013-8#2)
of dog##6##2##(1990-6#1)(1991-6#2)(2008-9#1)(2013-8#2)
of dogs##12##2##(1991-6#1)(1992-5#1)(1993-2#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-1#1)(2012-3#2)
of doing so##3##3##(1993-11#1)(2013-1#2)
of doing##13##2##(1990-2#1)(1991-3#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-11#1)(2012-2#2)(2013-1#2)
of doll therapy##4##3##(2013-8#4)
of dollar spot by##3##4##(2008-10#3)
of dollar spot resistance in##2##5##(2008-10#2)
of dollar spot##10##3##(2008-10#10)
of dollars##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
of domain II-less Aux/IAA##2##4##(2009-8#2)
of domain##11##2##(1997-4#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#2)(2009-8#2)(2011-2#1)(2012-2#1)
of domains##4##2##(2009-5#1)(2011-2#2)(2012-2#1)
of domestic animals##2##3##(2007-12#1)(2008-8#1)
of domestic homicide##3##3##(2011-2#3)
of domestic violence##3##3##(1995-12#1)(2012-12#1)(2013-1#1)
of domestic##20##2##(1995-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of dominance##5##2##(2008-10#5)
of dominant negative##2##3##(1991-9#1)(2010-11#1)
of dominant##11##2##(1990-5#1)(1991-9#1)(1992-1#1)(1994-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-7#1)
of domino##2##2##(2009-10#2)
of domperidone from wastewater##2##4##(2008-10#2)
of domperidone in##2##3##(2008-10#2)
of domperidone##10##2##(2008-10#4)(2011-2#6)
of donated##3##2##(1992-1#1)(1992-3#1)(1994-2#1)
of donation##3##2##(1991-7#1)(2008-12#1)(2008-4#1)
of donations##2##2##(1991-12#1)(1991-2#1)
of donor and acceptor##3##4##(1996-12#1)(2008-10#2)
of donor and recipient cells##2##5##(2008-4#2)
of donor and##5##3##(1996-12#1)(2008-10#2)(2008-4#2)
of donor cells##4##3##(2008-11#1)(2008-9#3)
of donor site##3##3##(2012-3#1)(2013-1#2)
of donor specific##2##3##(1990-11#1)(2011-2#1)
of donor##40##2##(1990-11#1)(1990-8#1)(1991-5#1)(1994-2#1)(1994-3#2)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#3)(2008-8#1)(2008-9#6)(2009-3#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)
of donors##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
of dopamine (DA)##9##3##(1992-7#1)(1995-3#1)(1996-12#2)(1997-2#1)(2008-10#4)
of dopamine D2 receptor##2##4##(1995-12#1)(1996-5#1)
of dopamine D2 receptors##3##4##(1995-12#3)
of dopamine D2##5##3##(1995-12#4)(1996-5#1)
of dopamine and ascorbic acid##2##5##(2008-10#2)
of dopamine and its##3##4##(1997-3#1)(2008-10#1)(2008-7#1)
of dopamine and serotonin##2##4##(1997-7#1)(2008-9#1)
of dopamine and##12##3##(1990-8#1)(1991-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-7#1)(2008-9#1)
of dopamine at##3##3##(2008-10#3)
of dopamine by##2##3##(2008-10#2)
of dopamine hydrochloride##2##3##(2008-10#2)
of dopamine in the presence of ascorbic acid##2##8##(2008-10#2)
of dopamine in the##5##4##(2008-10#4)(2008-7#1)
of dopamine in##13##3##(1990-8#1)(1994-3#1)(2007-8#1)(2008-10#9)(2008-7#1)
of dopamine is obtained##2##4##(2008-10#2)
of dopamine is##3##3##(2008-10#3)
of dopamine neurons in##2##4##(1992-11#1)(1995-3#1)
of dopamine neurons##3##3##(1992-11#1)(1995-3#1)(2008-7#1)
of dopamine on the##3##4##(1993-5#1)(2008-10#2)
of dopamine on##4##3##(1993-5#1)(2008-10#3)
of dopamine receptors##3##3##(1992-11#2)(1995-2#1)
of dopamine sensing##4##3##(2008-10#4)
of dopamine to##2##3##(1993-8#1)(1995-8#1)
of dopamine##99##2##(1990-7#1)(1990-8#3)(1991-1#2)(1991-5#1)(1992-10#1)(1992-11#4)(1992-3#1)(1992-7#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#4)(2007-8#1)(2008-10#41)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#5)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
of dopaminergic axons##2##3##(1995-5#2)
of dopaminergic neurons in the##2##5##(1997-3#1)(2008-7#1)
of dopaminergic neurons in##3##4##(1996-5#1)(1997-3#1)(2008-7#1)
of dopaminergic neurons##6##3##(1990-7#1)(1996-5#3)(1997-3#1)(2008-7#1)
of dopaminergic transmissions##2##3##(1994-3#2)
of dopaminergic##24##2##(1990-7#1)(1993-1#1)(1993-5#1)(1994-3#2)(1995-2#1)(1995-5#2)(1996-2#1)(1996-5#4)(1997-3#1)(2008-5#1)(2008-7#4)(2009-11#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
of dopants##3##2##(2007-11#1)(2007-12#2)
of doped##2##2##(1991-9#1)(2008-7#1)
of doping##6##2##(1993-3#2)(2008-10#1)(2009-7#1)(2010-11#2)
of dormancy##2##2##(2012-8#2)
of dormant##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
of dorsal horn group II##2##5##(1997-3#2)
of dorsal horn##3##3##(1993-12#1)(1997-3#2)
of dorsal lips##3##3##(2011-2#3)
of dorsal root ganglion##3##4##(2008-5#1)(2013-1#2)
of dorsal root##5##3##(1996-5#1)(2008-5#1)(2008-7#1)(2013-1#2)
of dorsal##18##2##(1993-12#1)(1993-5#1)(1996-5#2)(1997-3#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#3)(2012-12#1)(2013-1#2)
of dose on average##2##4##(2007-11#2)
of dose optimization points##2##4##(2009-2#2)
of dose##18##2##(1991-12#1)(1992-3#1)(1995-9#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#2)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
of dose-response##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
of dose/response##2##2##(1993-8#1)(2008-10#1)
of dosed groups##8##3##(2008-9#8)
of dosed males and females was similar to that of the vehicle control groups##4##14##(2008-9#4)
of dosed males and females was similar to that of the##5##11##(2008-9#5)
of dosed males and females##6##5##(2008-9#6)
of dosed males##7##3##(2008-9#7)
of dosed##16##2##(2008-9#16)
of doses##5##2##(1992-3#1)(1992-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
of dosing##4##2##(1992-8#1)(1997-7#1)(2008-10#1)(2008-11#1)
of dots##4##2##(1995-3#1)(2008-10#2)(2008-7#1)
of double negative##2##3##(2008-10#1)(2008-5#1)
of double##19##2##(1990-8#1)(1992-5#1)(1993-8#2)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
of double- and##2##3##(1991-5#1)(1993-3#1)
of double-balloon##2##2##(2010-12#1)(2012-2#1)
of double-coated optical fibers to minimize long-term hydrostatic-pressure-induced microbending losses##2##10##(2007-11#2)
of double-stranded (ds) RNA##2##4##(2008-10#2)
of double-stranded (ds)##3##3##(2008-10#2)(2008-2#1)
of double-stranded DNA##13##3##(1994-12#2)(1995-3#1)(2008-10#5)(2008-2#1)(2008-9#1)(2010-5#3)
of double-stranded RNA (dsRNA)##2##4##(2008-10#1)(2008-2#1)
of double-stranded RNA##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
of double-stranded cDNA##2##3##(2008-2#2)
of double-stranded##24##2##(1990-11#1)(1994-12#2)(1995-3#1)(2008-10#8)(2008-2#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#3)
of double-walled##2##2##(2008-7#2)
of doubly##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
of downstream##5##2##(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2013-7#1)
of downward##2##2##(1997-5#1)(2008-3#1)
of downy mildew of##2##4##(2008-10#2)
of downy mildew##10##3##(2008-10#10)
of doxazosin##2##2##(1993-2#1)(1995-12#1)
of doxorubicin and Victoria Blue BO##2##6##(2008-11#2)
of doxorubicin and##6##3##(1990-10#1)(1991-8#1)(2008-11#2)(2009-11#1)(2013-1#1)
of doxorubicin at##2##3##(2008-11#1)(2013-1#1)
of doxorubicin##25##2##(1990-10#2)(1990-2#1)(1991-8#1)(2008-10#4)(2008-11#7)(2009-11#1)(2011-2#3)(2012-1#3)(2013-1#3)
of doxorubicin-induced##2##2##(2011-2#2)
of doxycycline hydrochloride and chlortetracycline hydrochloride##2##6##(2008-10#2)
of doxycycline hydrochloride##4##3##(2008-10#4)
of doxycycline or chlortetracycline in pharmaceutical formulations##2##7##(2008-10#2)
of doxycycline or##3##3##(2007-11#1)(2008-10#2)
of doxycycline##9##2##(2007-11#1)(2008-10#7)(2011-2#1)
of drainage##2##2##(1990-8#1)(1993-9#1)
of drastically##2##2##(2008-10#1)(2008-2#1)
of dreams##2##2##(2008-12#2)
of drebrin E##3##3##(2012-2#3)
of dressing##2##2##(2007-7#1)(2008-10#1)
of dried leaves of##2##4##(2008-10#1)(2012-2#1)
of dried##7##2##(1991-8#1)(1994-6#1)(2008-10#3)(2010-11#1)(2012-2#1)
of drift algae##2##3##(2007-5#2)
of drift##4##2##(2007-5#2)(2008-10#1)(2008-2#1)
of drinking water##8##3##(1992-2#1)(1992-5#1)(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#2)
of drinking##15##2##(1990-2#1)(1991-12#1)(1992-2#1)(1992-5#1)(1994-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-7#2)(2013-1#1)(2013-8#2)
of drinks##2##2##(2008-2#1)(2009-7#1)
of driver##2##2##(2008-2#1)(2008-7#1)
of drop##4##2##(2008-10#3)(2008-3#1)
of drop-based analytical measurements##2##4##(2008-10#2)
of droplet size##2##3##(2008-3#1)(2008-5#1)
of droplet##9##2##(1995-3#2)(2008-2#1)(2008-3#5)(2008-5#1)
of droplets and##3##3##(2007-5#1)(2008-3#1)(2008-9#1)
of droplets##9##2##(2007-12#1)(2007-5#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)
of dropped fruit##2##3##(2008-10#2)
of drops##3##2##(2008-10#2)(2008-2#1)
of drought and##2##3##(2012-6#1)(2012-9#1)
of drought stress##2##3##(2008-12#1)(2011-2#1)
of drought##5##2##(2008-12#1)(2011-2#1)(2012-6#1)(2012-9#2)
of drug absorption##2##3##(1994-2#1)(2008-10#1)
of drug abuse treatment##2##4##(1991-1#1)(2008-6#1)
of drug abuse##5##3##(1991-1#2)(2008-1#1)(2008-6#1)(2009-7#1)
of drug addiction##3##3##(2008-12#1)(2008-4#1)(2012-3#1)
of drug administration##6##3##(1994-6#1)(1994-9#1)(2007-7#1)(2008-11#1)(2008-8#1)(2013-1#1)
of drug and##5##3##(1994-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
of drug concentrations in the##2##5##(1992-9#1)(2008-8#1)
of drug concentrations##6##3##(1991-8#1)(1992-9#1)(1995-2#2)(2008-8#1)(2011-3#1)
of drug delivery##7##3##(1996-2#1)(1997-1#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
of drug development for##2##4##(1991-3#1)(2008-10#1)
of drug development##6##3##(1991-3#1)(2007-7#1)(2008-10#2)(2008-8#1)(2013-1#1)
of drug discovery##2##3##(1997-4#1)(2008-10#1)
of drug epidemics##2##3##(2013-8#2)
of drug exposure##4##3##(1996-12#1)(1997-4#1)(2008-10#1)(2012-2#1)
of drug from##2##3##(1996-1#1)(2010-5#1)
of drug in##5##3##(1996-2#1)(2008-10#3)(2010-5#1)
of drug influx##2##3##(1990-2#1)(2008-4#1)
of drug level##2##3##(2010-11#1)(2013-1#1)
of drug resistance and##3##4##(1992-2#1)(2007-11#1)(2009-8#1)
of drug resistance genes##2##4##(1994-5#1)(2008-11#1)
of drug resistance in vitro and in##2##7##(1994-5#1)(2008-11#1)
of drug resistance in##5##4##(1994-5#1)(1997-6#1)(2008-11#1)(2008-6#1)(2012-3#1)
of drug resistance##22##3##(1990-2#1)(1992-2#2)(1994-5#2)(1997-6#2)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-8#2)(2009-8#1)(2012-3#1)
of drug resistant##3##3##(2008-11#1)(2010-7#1)(2011-2#1)
of drug safety##2##3##(2008-11#2)
of drug target##2##3##(2007-11#1)(2008-11#1)
of drug therapy##4##3##(2007-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
of drug to##4##3##(1996-2#1)(1997-1#1)(2009-8#1)(2011-1#1)
of drug tolerance##2##3##(1990-8#1)(2011-2#1)
of drug transport##2##3##(1990-2#1)(2008-7#1)
of drug treatment##5##3##(1990-11#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-9#1)
of drug use and##2##4##(1991-1#1)(2008-11#1)
of drug use##11##3##(1991-1#1)(2008-1#1)(2008-11#2)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#3)
of drug##206##2##(1990-11#1)(1990-2#3)(1990-8#1)(1991-1#6)(1991-3#1)(1991-8#1)(1992-10#2)(1992-2#3)(1992-3#4)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#4)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#3)(2007-1#1)(2007-11#2)(2007-7#4)(2008-1#2)(2008-10#18)(2008-11#21)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#2)(2009-11#2)(2009-12#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#5)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#5)(2013-8#8)
of drug-drug interactions##3##3##(2007-11#1)(2008-5#1)(2011-1#1)
of drug-eluting stents in##2##4##(2008-11#1)(2008-12#1)
of drug-eluting stents##8##3##(2008-11#5)(2008-12#1)(2009-12#1)(2011-2#1)
of drug-eluting##9##2##(2008-11#5)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)
of drug-induced liver disease##3##4##(2006-10#2)(2008-8#1)
of drug-induced liver##6##3##(2006-10#2)(2008-8#4)
of drug-induced##16##2##(1991-1#1)(1995-5#1)(2006-10#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#4)(2010-8#1)(2011-2#1)
of drug-related##3##2##(2008-8#2)(2011-2#1)
of drug-resistant bacteria##2##3##(2012-2#2)
of drug-resistant##6##2##(1991-4#1)(2008-10#1)(2011-3#1)(2012-2#2)(2013-1#1)
of drug-treated##4##2##(1992-12#2)(2008-11#1)(2008-4#1)
of drugs and##18##3##(1992-3#1)(1993-3#1)(1995-8#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)
of drugs are##3##3##(1995-8#1)(1997-6#1)(2008-8#1)
of drugs at the β(2)-adrenergic receptor##2##6##(2012-2#2)
of drugs at##3##3##(2008-10#1)(2012-2#2)
of drugs by##3##3##(1992-3#1)(1996-3#1)(2008-10#1)
of drugs can##3##3##(1993-3#1)(1995-1#1)(2008-8#1)
of drugs commonly used in##2##5##(2006-10#1)(2008-2#1)
of drugs for##6##3##(1991-6#1)(2006-10#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
of drugs from##2##3##(1992-5#1)(2008-10#1)
of drugs have##3##3##(2008-8#1)(2009-12#1)(2011-2#1)
of drugs in patients##2##4##(1991-3#1)(2008-8#1)
of drugs in rat model of##2##6##(2008-8#2)
of drugs in the##3##4##(1996-6#1)(2008-10#1)(2008-8#1)
of drugs in##16##3##(1990-8#1)(1991-3#1)(1994-11#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-5#1)(2008-8#5)(2009-12#1)(2013-8#1)
of drugs may##2##3##(1990-11#1)(1997-2#1)
of drugs of abuse##2##4##(1991-1#1)(2008-10#1)
of drugs of##5##3##(1991-1#2)(1996-5#1)(2008-10#2)
of drugs on##4##3##(1992-9#1)(1993-12#1)(2010-9#1)(2011-2#1)
of drugs or##2##3##(1997-6#1)(2008-4#1)
of drugs prescribed##2##3##(2008-11#1)(2010-5#1)
of drugs should be##2##4##(1996-6#1)(2012-3#1)
of drugs that##3##3##(1997-6#1)(2008-8#1)(2011-1#1)
of drugs to##5##3##(1992-5#1)(1995-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
of drugs used in the treatment of##2##7##(1997-1#1)(2011-2#1)
of drugs used##5##3##(1990-6#1)(1997-1#1)(2008-8#2)(2011-2#1)
of drugs were##3##3##(1996-5#2)(2011-3#1)
of drugs which##2##3##(2008-11#1)(2009-12#1)
of drugs with##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of drugs##162##2##(1990-11#1)(1990-2#3)(1990-6#1)(1990-8#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-6#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-2#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-8#2)(1996-3#3)(1996-5#4)(1996-6#5)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(2006-10#2)(2006-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#20)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#15)(2008-9#1)(2009-12#5)(2009-7#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#5)(2011-3#3)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
of drugs]##3##2##(1991-6#1)(1992-2#1)(1996-9#1)
of dry and##2##3##(2008-10#1)(2008-5#1)
of dry mass##2##3##(2008-10#1)(2008-12#1)
of dry matter production before and after heading##2##8##(2008-9#2)
of dry matter##6##3##(1997-4#2)(2008-10#2)(2008-9#2)
of dry mouth##3##3##(2006-10#2)(2008-3#1)
of dry soil##2##3##(2008-10#2)
of dry##41##2##(1991-5#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#2)(2006-10#4)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-9#3)(2010-4#2)(2012-3#1)
of drying oils##2##3##(2008-10#2)
of drying temperature##2##3##(2011-2#2)
of drying##5##2##(2008-10#2)(2008-6#1)(2011-2#2)
of dsDNA##7##2##(2008-10#6)(2008-2#1)
of dsRNA##8##2##(2008-10#5)(2008-9#1)(2010-2#1)(2013-1#1)
of dual##11##2##(1990-12#1)(1992-5#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
of dual-wavelength##2##2##(2007-11#1)(2008-10#1)
of dually##2##2##(2008-5#1)(2009-9#1)
of duck##2##2##(1997-7#1)(2006-10#1)
of ducklings##2##2##(2006-10#1)(2008-9#1)
of ductal invasive carcinoma##2##4##(1997-7#2)
of ductal##3##2##(1995-4#1)(1997-7#2)
of due##2##2##(1992-3#1)(1993-12#1)
of duloxetine##6##2##(2008-10#2)(2008-3#3)(2011-2#1)
of dung beetles##2##3##(2008-5#1)(2013-7#1)
of duodenal##3##2##(1992-11#1)(2009-12#1)(2011-2#1)
of duodenum##2##2##(2008-10#1)(2008-12#1)
of duplex DNA##2##3##(1995-3#1)(1995-5#1)
of duplex scanning##2##3##(2012-3#2)
of duplex##5##2##(1995-3#1)(1995-5#1)(2012-3#3)
of duplexes##2##2##(1995-5#1)(2008-4#1)
of duplicate##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-8#1)
of duplicated genes##3##3##(1990-12#1)(1993-3#1)(2007-11#1)
of duplicated##4##2##(1990-12#1)(1993-3#1)(2007-11#1)(2008-10#1)
of duplication of##2##3##(2007-11#1)(2011-2#1)
of duplications and##2##3##(1997-3#1)(2008-7#1)
of durability of##4##3##(2007-11#1)(2008-10#2)(2010-3#1)
of durability##7##2##(2007-11#1)(2008-10#5)(2010-3#1)
of dural arteriovenous malformations of the cranium##2##7##(2008-7#2)
of dural arteriovenous##6##3##(1996-9#3)(2008-7#2)(2013-8#1)
of dural sinus thrombosis##2##4##(2008-7#2)
of dural##10##2##(1996-9#3)(1997-3#1)(2008-7#4)(2011-2#1)(2013-8#1)
of duration of##7##3##(1990-11#1)(1992-9#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2011-3#1)
of duration##12##2##(1990-11#1)(1992-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
of durum wheat##4##3##(2008-10#3)(2013-8#1)
of durum##5##2##(2008-10#4)(2013-8#1)
of dust##7##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2013-8#2)
of duty##3##2##(1994-2#1)(1997-3#1)(2009-6#1)
of dwarf mistletoe##2##3##(2008-10#2)
of dwarf##3##2##(2008-10#2)(2008-9#1)
of dyad##3##2##(1990-11#1)(2010-4#1)(2010-5#1)
of dye and##2##3##(1994-12#1)(2011-1#1)
of dye molecules##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
of dye##23##2##(1992-3#1)(1992-6#1)(1994-12#1)(2007-11#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#1)
of dye-doped##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of dye-induced##2##2##(2008-10#2)
of dyed##2##2##(1990-2#1)(2008-3#1)
of dyes##8##2##(2007-11#1)(2008-10#5)(2008-3#1)(2008-4#1)
of dying well##2##3##(2010-8#2)
of dying##19##2##(1990-10#2)(1993-6#1)(1994-9#1)(1996-1#1)(1997-7#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-8#2)(2012-12#2)(2013-1#1)
of dynamic changes in##2##4##(2008-11#1)(2008-3#1)
of dynamic extraction##2##3##(2008-10#2)
of dynamic high-pressure micro-fluidization##2##4##(2013-8#2)
of dynamic measurements##2##3##(2007-11#1)(2008-3#1)
of dynamic##40##2##(1992-3#1)(2007-11#5)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#9)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#2)
of dynamical##2##2##(2008-3#1)(2010-8#1)
of dynamics##4##2##(2008-3#1)(2008-8#2)(2011-1#1)
of dyschondroplastic##2##2##(1991-9#1)(1997-3#1)
of dysfunction##5##2##(2007-8#1)(2008-12#2)(2010-9#2)
of dysfunctional##3##2##(1994-12#1)(2008-7#1)(2009-9#1)
of dysfunctioning##2##2##(2007-8#1)(2013-1#1)
of dysfunctions##2##2##(1990-2#1)(2010-9#1)
of dysgnathic subjects##2##3##(1990-6#2)
of dyslexia##4##2##(2008-11#2)(2008-12#1)(2012-2#1)
of dyslexic##3##2##(2008-11#1)(2010-2#2)
of dyslexics##2##2##(2008-11#2)
of dyslipidemia##5##2##(2008-1#2)(2008-7#1)(2010-12#1)(2011-2#1)
of dyspepsia##2##2##(1995-10#2)
of dysphagia in patients with##3##5##(1993-6#1)(2007-8#1)(2011-2#1)
of dysphagia in the dog##2##5##(1993-2#1)(2011-1#1)
of dysphagia in##6##3##(1993-2#2)(1993-6#1)(2007-8#1)(2011-1#1)(2011-2#1)
of dysphagia##17##2##(1992-9#1)(1993-2#3)(1993-6#2)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-8#1)
of dysplasia and epidermoid cancer of cervix##2##7##(2013-1#2)
of dysplasia and##4##3##(1993-8#1)(2007-11#1)(2013-1#2)
of dysplasia were found##2##4##(2007-11#2)
of dysplasia##10##2##(1990-6#1)(1993-8#3)(2007-11#4)(2013-1#2)
of dysplastic lesions##3##3##(1993-8#3)
of dysplastic##5##2##(1993-8#3)(2007-11#1)(2013-1#1)
of dyspnea and##3##3##(2008-1#1)(2008-10#1)(2010-1#1)
of dyspnea in##2##3##(2008-8#1)(2012-3#1)
of dyspnea was##2##3##(1990-12#1)(2008-10#1)
of dyspnea##15##2##(1990-12#2)(2008-1#2)(2008-10#7)(2008-3#1)(2008-8#1)(2010-1#1)(2012-3#1)
of dyspnoea##4##2##(2008-8#1)(2010-10#2)(2013-8#1)
of dysprosium from##2##3##(2008-10#2)
of dysprosium##5##2##(2008-10#5)
of dystonia##2##2##(2008-7#2)
of dystrophin##9##2##(1991-12#4)(1993-3#2)(1994-8#1)(1995-12#1)(2011-2#1)
of dysuria##3##2##(2007-7#1)(2008-10#2)
of e##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
of e(r)##7##2##(2008-9#7)
of e-mail##2##2##(2012-3#2)
of e37a##2##2##(2008-8#2)
of eEF-2##2##2##(1992-8#2)
of eIF-2 alpha-subunit phosphorylation in reticulocyte##2##6##(1994-5#2)
of eIF-2 alpha-subunit##3##3##(1994-5#3)
of eIF-2 beta##2##3##(1994-6#2)
of eIF-2##10##2##(1991-12#4)(1994-5#4)(1994-6#2)
of eIF2α##3##2##(2012-2#3)
of eIF4E in##2##3##(1997-7#2)
of eIF4E##4##2##(1997-7#3)(2010-8#1)
of each amino acid##2##4##(1994-9#1)(2008-10#1)
of each approach##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
of each area##3##3##(1991-12#1)(2008-3#1)(2011-2#1)
of each assay##2##3##(2008-10#1)(2008-4#1)
of each call type##2##4##(2009-9#1)(2010-2#1)
of each cannula##2##3##(2010-8#2)
of each cell##3##3##(1995-12#2)(2008-11#1)
of each characteristic##2##3##(2008-5#2)
of each chromosome##4##3##(1997-2#1)(2008-5#1)(2008-9#1)(2010-3#1)
of each client##2##3##(2007-6#1)(2012-3#1)
of each component are##2##4##(2008-10#1)(2008-5#1)
of each component##11##3##(1996-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2013-8#1)
of each compound##5##3##(2008-10#5)
of each country##3##3##(1994-1#1)(2011-2#1)(2013-1#1)
of each cycle##2##3##(2008-11#1)(2013-1#1)
of each dialysis session##2##4##(2008-1#2)
of each domain##2##3##(1991-12#1)(2012-2#1)
of each element##5##3##(2008-10#4)(2013-8#1)
of each enzyme##3##3##(2008-10#2)(2008-4#1)
of each event##3##3##(2008-10#1)(2011-2#2)
of each experiment##4##3##(1994-3#2)(2008-10#2)
of each extract##2##3##(2008-10#1)(2008-5#1)
of each factor##4##3##(1997-4#1)(2008-5#2)(2013-1#1)
of each food group##2##4##(2008-1#1)(2011-2#1)
of each genotype##2##3##(1995-5#1)(2011-1#1)
of each group and##2##4##(1991-12#1)(2008-10#1)
of each group##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
of each guest residue##2##4##(1993-11#2)
of each having##2##3##(1997-7#1)(2008-4#1)
of each individual##13##3##(1990-3#1)(1995-9#1)(1996-12#2)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-12#1)(2013-7#1)
of each instrument##3##3##(2007-11#1)(2013-1#2)
of each isolate##6##3##(2008-10#4)(2008-12#1)(2011-2#1)
of each layer as well as the##2##7##(2008-3#2)
of each layer##4##3##(2008-3#4)
of each measurement##2##3##(2008-10#1)(2008-3#1)
of each member of the##2##5##(1993-6#1)(2007-12#1)
of each metal##5##3##(2008-10#4)(2008-5#1)
of each method are##3##4##(2008-11#1)(2008-3#1)(2008-4#1)
of each method##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
of each mirror##2##3##(2007-11#1)(2008-3#1)
of each mutant enzyme##2##4##(1992-6#1)(1994-5#1)
of each mutant##3##3##(1992-6#2)(1994-5#1)
of each neuron##2##3##(2008-11#1)(2010-11#1)
of each of four##4##4##(1992-9#1)(2008-10#3)
of each of its##2##4##(1990-3#1)(2008-10#1)
of each of the four##5##5##(1994-11#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
of each of the methods##2##5##(2008-10#2)
of each of the three##4##5##(1992-1#1)(2008-7#1)(2008-8#1)(2011-1#1)
of each of the two##3##5##(1994-5#1)(2008-2#1)(2011-2#1)
of each of the##38##4##(1990-5#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#3)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#2)
of each of them##3##4##(1991-12#1)(2008-11#1)(2012-3#1)
of each of these groups##2##5##(2008-11#1)(2010-2#1)
of each of these##20##4##(1990-5#1)(1993-12#1)(1993-8#2)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-2#1)
of each of three##2##4##(1993-12#1)(2008-10#1)
of each of##75##3##(1990-3#1)(1990-5#2)(1991-12#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#5)(2009-11#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
of each one of the##2##5##(1990-5#1)(2008-10#1)
of each one##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
of each order##2##3##(2007-12#1)(2008-3#1)
of each other and##3##4##(2008-10#1)(2008-8#2)
of each other##14##3##(1991-11#1)(1993-8#1)(1994-12#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#2)(2012-2#1)
of each pair##2##3##(1994-5#2)
of each pathogen##2##3##(2008-10#1)(2013-8#1)
of each patient##6##3##(1995-2#1)(2007-12#1)(2008-5#1)(2011-3#1)(2013-1#2)
of each patient's##2##3##(2010-4#1)(2012-3#1)
of each peptide was##2##4##(2008-8#2)
of each peptide##3##3##(1996-12#1)(2008-8#2)
of each pixel##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of each plot##2##3##(2008-10#1)(2008-6#1)
of each primer set##2##4##(2008-10#2)
of each protein##7##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
of each sample was##2##4##(2008-10#2)
of each sample##8##3##(2008-10#8)
of each sex##3##3##(2008-9#1)(2013-1#2)
of each signal##2##3##(2007-9#1)(2010-8#1)
of each single compound##2##4##(2008-10#1)(2008-5#1)
of each solution##2##3##(2007-11#1)(2008-10#1)
of each species in##2##4##(2008-10#1)(2013-1#1)
of each species##10##3##(2008-10#4)(2008-12#1)(2008-5#3)(2008-8#1)(2013-1#1)
of each strain##3##3##(1996-5#1)(2008-10#2)
of each surgical##2##3##(2007-11#1)(2010-8#1)
of each technique are##2##4##(2008-10#2)
of each technique##4##3##(2008-10#3)(2010-7#1)
of each transporter##2##3##(2008-7#2)
of each treatment##5##3##(1994-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)
of each type of##4##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
of each type##7##3##(1993-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)
of each variable##2##3##(1992-1#1)(2013-1#1)
of each virus##4##3##(2008-10#4)
of each vitamin##3##3##(2008-10#1)(2008-5#2)
of each was##2##3##(2008-10#1)(2008-5#1)
of each##635##2##(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#5)(1990-8#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#3)(1992-2#2)(1992-3#2)(1992-6#3)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#5)(1994-6#1)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#3)(1995-9#1)(1996-10#1)(1996-12#8)(1996-2#3)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#13)(2007-12#19)(2007-2#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#162)(2008-11#16)(2008-12#9)(2008-2#14)(2008-3#41)(2008-4#8)(2008-5#30)(2008-6#6)(2008-7#17)(2008-8#17)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#4)(2010-3#5)(2010-4#3)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#9)(2011-2#21)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#15)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#6)
of ear##4##2##(2008-10#2)(2008-9#2)
of earlier findings##2##3##(1992-12#1)(1994-11#1)
of earlier studies##4##3##(1996-12#1)(1996-7#1)(2008-2#1)(2008-5#1)
of earlier##21##2##(1991-6#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#2)(1996-12#1)(1996-7#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#3)
of early Late Triassic age##2##5##(1990-8#2)
of early abortion of the##2##5##(2008-10#2)
of early abortion of##3##4##(2008-10#3)
of early and late complications##2##5##(2007-11#1)(2011-2#1)
of early and late##3##4##(2007-11#1)(2008-12#1)(2011-2#1)
of early and##6##3##(1991-3#1)(2007-11#1)(2008-12#1)(2011-2#2)(2012-2#1)
of early arterial##2##3##(2008-7#1)(2008-8#1)
of early breast cancer##5##4##(1992-2#1)(1993-11#1)(1993-9#1)(2010-7#1)(2013-1#1)
of early child development in##2##5##(2008-11#1)(2010-12#1)
of early child development##3##4##(2008-11#1)(2010-12#2)
of early colorectal cancer##2##4##(2011-1#1)(2011-2#1)
of early detection##3##3##(1990-8#1)(1991-3#1)(2008-4#1)
of early development##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
of early diagnosis and treatment##2##5##(2013-1#2)
of early diagnosis and##3##4##(2013-1#2)(2013-7#1)
of early diagnosis##6##3##(1990-6#1)(2008-11#1)(2013-1#3)(2013-7#1)
of early embryogenesis##2##3##(2008-11#1)(2012-12#1)
of early flowering##2##3##(1997-8#1)(2008-10#1)
of early gastric##3##3##(2009-3#1)(2009-8#1)(2013-8#1)
of early gene##2##3##(1991-5#1)(1993-9#1)
of early infantile##2##3##(1990-9#1)(2011-1#1)
of early intervention and the##2##5##(2008-11#1)(2008-9#1)
of early intervention##8##3##(1991-12#2)(1992-12#1)(1994-1#1)(1995-1#1)(1997-2#1)(2008-11#1)(2008-9#1)
of early leaf spot##2##4##(2008-10#2)
of early onset##5##3##(1996-2#1)(2008-12#1)(2009-7#1)(2011-2#2)
of early postoperative##4##3##(1991-5#1)(2007-8#1)(2012-3#1)(2013-1#1)
of early pregnancy##3##3##(1995-8#2)(2011-1#1)
of early rehabilitation##2##3##(2007-8#1)(2012-1#1)
of early response##2##3##(2010-12#1)(2010-3#1)
of early stage##3##3##(1997-7#1)(2010-8#1)(2011-2#1)
of early stages##2##3##(2010-12#1)(2010-8#1)
of early surgical##2##3##(2007-11#1)(2010-3#1)
of early treatment##3##3##(1996-11#1)(2008-9#2)
of early##197##2##(1990-2#1)(1990-6#1)(1990-8#4)(1990-9#3)(1991-12#4)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-9#2)(1994-1#1)(1994-2#1)(1995-1#1)(1995-11#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#9)(2008-8#3)(2008-9#5)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#21)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#3)
of early-onset##4##2##(1995-8#1)(2006-10#1)(2008-3#1)(2012-3#1)
of early-stage##2##2##(1995-8#1)(2012-1#1)
of ears##2##2##(2008-8#1)(2008-9#1)
of earth##2##2##(1996-4#1)(1997-6#1)
of earthquake##10##2##(1996-4#9)(2013-1#1)
of earthquakes at##2##3##(1996-4#2)
of earthquakes in##2##3##(1996-4#2)
of earthquakes##10##2##(1996-4#10)
of ease of##2##3##(2008-10#2)
of ease##3##2##(2008-10#2)(2009-5#1)
of easily##4##2##(2008-10#3)(2008-3#1)
of eastern equine encephalitis##2##4##(1992-8#2)
of eastern filbert blight##3##4##(2008-10#3)
of eastern##12##2##(1992-8#2)(2008-10#6)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
of easy##3##2##(1994-1#1)(2008-7#1)(2012-2#1)
of eating and##2##3##(1993-12#1)(2008-9#1)
of eating disorder##2##3##(2012-2#2)
of eating disorders##8##3##(1997-7#1)(2007-7#3)(2010-11#3)(2012-2#1)
of eating##24##2##(1993-12#3)(1993-3#1)(1993-6#1)(1997-7#2)(2007-12#2)(2007-7#3)(2008-11#1)(2008-9#1)(2010-11#4)(2012-12#1)(2012-2#4)(2013-1#1)
of eberconazole##2##2##(2008-5#2)
of eccrine sweat##2##3##(2008-5#2)
of ecdysone##3##2##(2008-5#3)
of ecdysteroid secretion by##2##4##(1995-11#2)
of ecdysteroid secretion##3##3##(1995-11#3)
of ecdysteroid##5##2##(1995-11#3)(2007-12#1)(2008-9#1)
of ecdysteroids in##2##3##(2008-9#2)
of ecdysteroids##4##2##(2008-9#3)(2012-2#1)
of echicetin##3##2##(1994-11#3)
of echinococcosis##4##2##(2012-3#4)
of echinoderm larvae##3##3##(2011-2#3)
of echinoderm larval abundance##2##4##(2011-2#2)
of echinoderm larval##3##3##(2011-2#3)
of echinoderm##6##2##(2011-2#6)
of echocardiography##7##2##(1992-5#1)(1997-3#1)(2006-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
of ecological communities##2##3##(2008-8#1)(2008-9#1)
of ecological constraints##5##3##(2008-8#5)
of ecological specialization##2##3##(2008-8#2)
of ecological##22##2##(2008-10#2)(2008-11#2)(2008-8#11)(2008-9#4)(2011-1#1)(2012-2#2)
of ecology##2##2##(2008-8#2)
of economic activity##2##3##(2011-2#2)
of economic analysis##2##3##(1996-1#1)(1997-2#1)
of economic and##2##3##(2008-3#1)(2009-10#1)
of economic credentialing##2##3##(1991-12#2)
of economic importance##2##3##(2008-12#1)(2011-2#1)
of economic##25##2##(1991-12#4)(1991-6#1)(1992-5#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-1#2)(2011-2#3)(2013-1#2)
of economical##2##2##(2008-1#1)(2008-7#1)
of economically##2##2##(2008-10#2)
of economies##3##2##(1994-3#1)(1996-1#1)(2008-11#1)
of economy##2##2##(1991-3#1)(2012-3#1)
of ecosystem##2##2##(2008-9#2)
of ecto-nucleoside triphosphate diphosphohydrolases##2##4##(2008-4#2)
of ecto-nucleoside triphosphate##4##3##(2008-4#4)
of ectodermal##4##2##(2007-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
of ectopic pregnancies##2##3##(1990-8#1)(1992-4#1)
of ectopic pregnancy##4##3##(1994-3#1)(1997-2#1)(2011-2#1)(2012-12#1)
of ectopic pregnancy]##2##3##(1997-2#1)(2013-8#1)
of ectopic##18##2##(1990-8#1)(1992-4#1)(1994-3#1)(1997-2#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
of edema##6##2##(1992-6#1)(1992-9#2)(2008-10#1)(2008-12#1)(2011-2#1)
of edentulous patients##2##3##(2010-5#1)(2011-7#1)
of edentulous##5##2##(2009-4#1)(2010-5#1)(2011-7#1)(2013-1#2)
of edge##5##2##(2007-11#1)(2008-3#2)(2008-6#1)(2010-8#1)
of edges in##2##3##(2008-2#1)(2011-2#1)
of edges##3##2##(2008-2#1)(2009-3#1)(2011-2#1)
of edible oil##2##3##(2008-10#2)
of edible##10##2##(2008-10#6)(2008-12#1)(2009-4#1)(2010-7#1)(2013-1#1)
of editing##2##2##(2008-7#1)(2010-9#1)
of educated##2##2##(1992-4#1)(1993-12#1)
of educating##2##2##(2009-3#1)(2013-7#1)
of education and experience on##2##5##(1995-3#1)(2007-10#1)
of education and the##3##4##(1991-2#1)(1993-3#1)(2013-1#1)
of education and##14##3##(1991-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(2007-10#1)(2008-1#2)(2008-11#2)(2008-12#1)(2010-8#1)(2013-1#1)
of education has##2##3##(2008-11#1)(2008-12#1)
of education in managed care##2##5##(1997-3#2)
of education in##5##3##(1997-3#2)(2008-11#2)(2011-2#1)
of education on##3##3##(1990-3#1)(1991-1#1)(2008-11#1)
of education was##2##3##(2008-7#1)(2009-11#1)
of education##60##2##(1990-3#1)(1991-1#2)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-1#2)(1997-3#2)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-11#9)(2008-12#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
of educational preparation##2##3##(2008-1#1)(2008-9#1)
of educational processes##2##3##(1992-2#1)(2008-12#1)
of educational strategies##3##3##(2007-6#3)
of educational##22##2##(1992-2#1)(2007-6#3)(2008-1#2)(2008-11#5)(2008-12#5)(2008-9#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
of efavirenz##5##2##(2008-5#5)
of effect in##2##3##(1993-3#1)(2013-8#1)
of effect of##10##3##(1990-12#1)(1991-3#1)(1991-6#1)(1996-11#1)(2008-11#2)(2008-8#2)(2010-10#1)(2011-2#1)
of effect##27##2##(1990-12#1)(1990-3#2)(1991-1#3)(1991-3#1)(1991-6#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-11#1)(2008-11#3)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of effecting##2##2##(2008-5#1)(2008-7#1)
of effective and ineffective##2##4##(2013-1#2)
of effective and##3##3##(2008-10#1)(2013-1#2)
of effective treatment and##2##4##(1995-9#1)(2012-1#1)
of effective treatment##5##3##(1995-9#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
of effective##68##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-10#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
of effectively##3##2##(1995-6#1)(2008-5#2)
of effectiveness assessment##2##3##(1994-12#2)
of effectiveness of the##2##4##(2007-7#1)(2009-6#1)
of effectiveness of##7##3##(1992-5#1)(1996-11#1)(2007-7#1)(2008-10#2)(2009-6#1)(2013-1#1)
of effectiveness##14##2##(1991-2#1)(1992-5#1)(1994-12#2)(1996-11#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
of effector mechanisms##2##3##(2008-10#2)
of effector##7##2##(1990-12#2)(2008-10#2)(2008-4#1)(2009-8#1)(2010-5#1)
of effectors##2##2##(1990-8#1)(1997-7#1)
of effects are##2##3##(1991-1#1)(2008-4#1)
of effects in##2##3##(1994-6#1)(2008-11#1)
of effects of##9##3##(1991-12#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
of effects on##7##3##(1993-12#1)(2007-12#1)(2008-11#2)(2008-4#1)(2012-2#1)(2013-1#1)
of effects was##2##3##(2009-1#1)(2010-4#1)
of effects##34##2##(1991-1#1)(1991-12#1)(1993-12#1)(1994-6#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of efferent##2##2##(1995-3#1)(1997-3#1)
of efficacy and safety of##2##5##(2008-7#1)(2011-1#1)
of efficacy and safety##5##4##(1990-9#1)(2008-7#1)(2008-8#2)(2011-1#1)
of efficacy and##10##3##(1990-6#1)(1990-9#1)(1992-2#1)(1996-12#1)(1996-3#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)
of efficacy at##2##3##(2008-5#1)(2012-2#1)
of efficacy of##4##3##(1997-8#1)(2007-7#1)(2011-2#2)
of efficacy##35##2##(1990-6#1)(1990-9#2)(1992-2#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#1)
of efficiency and##2##3##(1997-1#1)(2008-12#1)
of efficiency over##2##3##(2008-10#2)
of efficiency##12##2##(1995-12#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-8#1)
of efficient and##5##3##(1997-2#1)(2008-2#2)(2010-4#1)(2011-2#1)
of efficient sampling##3##3##(2008-10#2)(2013-7#1)
of efficient##24##2##(1990-2#1)(1992-12#1)(1994-5#1)(1997-2#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
of efficiently##4##2##(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
of effluent##5##2##(2008-10#3)(2008-12#1)(2008-7#1)
of effort##7##2##(1994-2#1)(1995-1#1)(2007-9#1)(2008-12#1)(2008-8#2)(2013-8#1)
of efforts to##7##3##(1991-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2008-11#1)(2010-4#1)
of efforts##12##2##(1991-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#1)
of egg contents and##2##4##(1991-11#1)(2008-8#1)
of egg drop syndrome virus##2##5##(2008-8#2)
of egg laying##2##3##(2009-5#2)
of egg production##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
of egg size##3##3##(1991-5#2)(2010-8#1)
of egg##28##2##(1990-2#1)(1991-11#1)(1991-5#2)(1992-8#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#2)(2010-8#2)(2013-1#2)
of eggplant##2##2##(2008-10#2)
of eggs in##4##3##(1996-12#2)(2008-10#1)(2008-9#1)
of eggs laid##2##3##(2008-3#1)(2013-7#1)
of eggs of##2##3##(2007-10#1)(2008-10#1)
of eggs##23##2##(1993-6#1)(1996-12#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-8#3)(2012-12#2)(2013-1#1)(2013-7#1)
of eicosanoids##2##2##(2008-1#1)(2008-4#1)
of eicosapentaenoic##3##2##(1991-2#1)(2008-11#1)(2011-2#1)
of eigenmodes##2##2##(1992-8#1)(2008-2#1)
of eight HBV DNA integrated cases##2##6##(2008-4#2)
of eight animals were protected better than 80% by##2##9##(1995-5#2)
of eight animals were protected better than##3##7##(1995-5#3)
of eight cases##2##3##(2008-5#1)(2009-4#1)
of eight critical##2##3##(1993-12#1)(1995-1#1)
of eight of##2##3##(2008-10#1)(2008-5#1)
of eight patients with##5##4##(1990-12#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
of eight patients##7##3##(1990-12#1)(2008-7#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
of eight species##2##3##(2008-12#1)(2013-7#1)
of eight triazines##2##3##(2008-10#2)
of eight##92##2##(1990-12#1)(1990-5#2)(1991-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-5#2)(1995-1#1)(1995-5#4)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#3)(2008-10#34)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#3)(2010-8#1)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
of eighteen##3##2##(1996-5#1)(1997-3#1)(2012-3#1)
of either (1)##2##3##(2008-9#1)(2013-7#1)
of either 1##2##3##(1995-11#1)(2008-10#1)
of either a##4##3##(1991-9#1)(1993-12#1)(2008-2#2)
of either agent##2##3##(1990-11#1)(2009-6#1)
of either high or low##2##5##(2008-3#1)(2008-9#1)
of either high##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
of either mating type##2##4##(2008-10#2)
of either of the##4##4##(1991-12#1)(1992-6#1)(1997-7#1)(2008-7#1)
of either of##5##3##(1991-12#1)(1992-6#1)(1996-2#1)(1997-7#1)(2008-7#1)
of either one##2##3##(2008-1#1)(2008-5#1)
of either sex##2##3##(2007-12#1)(2010-7#1)
of either species##5##3##(1997-4#1)(2008-10#4)
of either the##23##3##(1990-11#2)(1992-11#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2012-1#1)
of either type of##2##4##(1990-12#1)(1995-11#1)
of either type##3##3##(1990-12#1)(1995-11#1)(2008-10#1)
of either##211##2##(1990-11#5)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-11#2)(1991-12#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#35)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of ejaculation##2##2##(1991-6#1)(2008-10#1)
of elastase activity##2##3##(2008-5#1)(2008-7#1)
of elastase##8##2##(1991-12#1)(1992-12#2)(2008-5#4)(2008-7#1)
of elastic and##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
of elastic recoil##2##3##(1991-12#1)(2013-1#1)
of elastic##10##2##(1991-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-10#1)(2012-2#1)(2013-1#1)
of elasticity and##2##3##(2009-4#2)
of elasticity modulus##3##3##(2008-10#3)
of elasticity##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#2)
of elastin##10##2##(1990-7#1)(1990-8#1)(1994-6#1)(2008-5#4)(2008-7#2)(2009-7#1)
of elastofibroma##3##2##(1991-6#1)(2009-4#2)
of elastomeric##2##2##(2008-12#1)(2010-3#1)
of elbow##9##2##(2007-8#2)(2008-9#4)(2011-2#3)
of elder##3##2##(1991-1#1)(1995-3#1)(1996-1#1)
of elderly and##3##3##(2007-12#1)(2011-1#2)
of elderly men##3##3##(2008-3#1)(2011-2#2)
of elderly patients with cancer##2##5##(2008-7#2)
of elderly patients with##4##4##(2008-7#4)
of elderly patients##14##3##(1990-5#1)(1991-1#1)(1991-11#1)(1994-3#2)(2008-7#7)(2008-8#1)(2011-2#1)
of elderly people##4##3##(1992-1#1)(1994-3#1)(2008-7#1)(2012-3#1)
of elderly residents##2##3##(2008-11#1)(2010-10#1)
of elderly subjects##3##3##(1993-1#1)(1994-5#1)(2008-3#1)
of elderly##51##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-3#2)(1993-1#2)(1993-12#1)(1994-1#2)(1994-3#3)(1994-5#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#12)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#6)(2012-3#2)(2013-1#1)
of election##2##2##(1990-3#1)(2008-10#1)
of elective surgery for##2##4##(2010-8#2)
of elective surgery##3##3##(1992-5#1)(2010-8#2)
of elective##4##2##(1992-5#1)(2007-10#1)(2010-8#2)
of electric field##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
of electric##9##2##(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
of electrical activity##6##3##(1994-3#1)(1996-2#3)(2009-5#1)(2010-6#1)
of electrical and##2##3##(1994-3#1)(1997-6#1)
of electrical injury##4##3##(1994-5#4)
of electrical stimulation of the##2##5##(1996-2#1)(2008-9#1)
of electrical stimulation##8##3##(1992-11#1)(1994-2#1)(1996-2#1)(2008-1#1)(2008-8#1)(2008-9#2)(2009-10#1)
of electrical stunning##2##3##(1990-9#1)(2011-1#1)
of electrical##26##2##(1990-9#1)(1992-11#1)(1994-2#1)(1994-3#2)(1994-5#4)(1996-2#4)(1997-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#1)
of electrically evoked##3##3##(1995-12#2)(2008-9#1)
of electrically stimulated##2##3##(1995-3#1)(2009-9#1)
of electrically##11##2##(1990-12#1)(1995-12#2)(1995-3#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-9#1)(2010-7#1)
of electro-optic (EO)##2##3##(2007-11#1)(2008-3#1)
of electro-optic coefficients##2##3##(2008-3#2)
of electro-optic modulators##2##3##(2007-11#1)(2007-12#1)
of electro-optic##13##2##(2007-11#3)(2007-12#6)(2008-3#3)(2013-8#1)
of electroactive##4##2##(2008-10#3)(2008-4#1)
of electroacupuncture combined##2##3##(2013-1#1)(2013-8#1)
of electroacupuncture##5##2##(2012-3#3)(2013-1#1)(2013-8#1)
of electrocardiogram##2##2##(2009-11#1)(2010-8#1)
of electrocardiographic##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
of electrocatalytic##3##2##(2010-4#1)(2010-6#2)
of electrochemical biosensors##2##3##(2008-10#1)(2008-7#1)
of electrochemical hydride generation##4##4##(2008-10#4)
of electrochemical sensors##2##3##(2008-10#2)
of electrochemical techniques##2##3##(2008-10#2)
of electrochemical##23##2##(2008-10#22)(2008-7#1)
of electrochemically##3##2##(2008-10#3)
of electrochemiluminescent##2##2##(2008-10#2)
of electrochemistry##3##2##(2008-10#2)(2009-9#1)
of electroconvulsive therapy##2##3##(2008-7#1)(2012-12#1)
of electroconvulsive##3##2##(1993-11#1)(2008-7#1)(2012-12#1)
of electrode is##2##3##(2008-10#2)
of electrode polishing##2##3##(2008-10#2)
of electrode potential##2##3##(2008-10#2)
of electrode surface##2##3##(2008-10#2)
of electrode was##2##3##(2008-10#2)
of electrode##18##2##(2008-10#15)(2008-9#1)(2009-7#1)(2010-7#1)
of electrodes##14##2##(2007-9#1)(2008-10#8)(2008-11#2)(2008-9#1)(2010-2#1)(2010-7#1)
of electrodialysis##2##2##(2008-10#2)
of electrogenerated##3##2##(2008-10#3)
of electroinactive##2##2##(2008-10#2)
of electrolyte leakage##2##3##(2008-10#2)
of electrolyte solution##3##3##(2008-10#3)
of electrolyte##14##2##(2008-10#13)(2010-4#1)
of electrolytes and##2##3##(2008-10#1)(2008-7#1)
of electrolytes on the retention behavior of some benzenesulfonates in electrochemically modulated liquid chromatography##2##14##(2008-10#2)
of electrolytes##17##2##(1993-2#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
of electrolytic##2##2##(2008-10#1)(2008-2#1)
of electromagnetic fields##2##3##(2008-10#1)(2008-2#1)
of electromagnetic radiation##2##3##(2008-3#2)
of electromagnetic scattering by##2##4##(2008-2#1)(2008-3#1)
of electromagnetic theory##2##3##(2008-3#2)
of electromagnetic waves##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
of electromagnetic##23##2##(1992-3#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#8)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of electromechanical##3##2##(1996-9#1)(2009-9#1)(2013-7#1)
of electron beam##2##3##(1995-9#1)(2009-7#1)
of electron beams##2##3##(2008-3#1)(2012-1#1)
of electron microscopy and##3##4##(1990-8#1)(2008-5#1)(2008-9#1)
of electron microscopy##6##3##(1990-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
of electron temperature##2##3##(2008-2#1)(2008-3#1)
of electron transfer between##2##4##(1995-5#1)(2008-10#1)
of electron transfer from##2##4##(1997-7#1)(2008-10#1)
of electron transfer##7##3##(1992-6#1)(1995-2#2)(1995-5#1)(1997-7#1)(2008-10#2)
of electron transport##5##3##(1990-5#1)(1994-11#1)(1995-3#1)(1996-4#1)(2012-2#1)
of electron##35##2##(1990-5#1)(1990-8#1)(1992-6#1)(1994-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
of electron-beam##2##2##(2008-2#1)(2008-3#1)
of electron-dense##3##2##(1992-2#1)(2008-10#2)
of electronic devices##3##3##(2008-7#3)
of electronic health##2##3##(2010-8#2)
of electronic medical##3##3##(2006-10#1)(2010-8#1)(2011-2#1)
of electronic##27##2##(1995-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#4)(2009-10#1)(2010-1#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)
of electrons and##4##3##(2007-11#1)(2009-11#1)(2009-6#1)(2012-2#1)
of electrons transferred##3##3##(2008-10#3)
of electrons##16##2##(1991-5#1)(1994-9#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)
of electroosmotic flow##2##3##(2008-10#1)(2009-12#1)
of electroosmotic##4##2##(2008-10#3)(2009-12#1)
of electropherograms##2##2##(2008-10#1)(2008-12#1)
of electrophilic##4##2##(1991-9#1)(1996-5#1)(2008-4#1)(2010-12#1)
of electrophoretic##3##2##(2008-10#2)(2008-3#1)
of electrophysiologic##2##2##(1990-3#1)(2009-5#1)
of electroporation##2##2##(2008-11#2)
of electrospinning for TE applications##3##5##(2010-10#3)
of electrospinning for##4##3##(2010-10#4)
of electrospray ionization##2##3##(2010-6#1)(2010-7#1)
of electrospray##5##2##(2008-10#3)(2010-6#1)(2010-7#1)
of electrospun##3##2##(2009-12#1)(2009-7#2)
of electrostatic and##2##3##(1990-2#1)(1993-11#1)
of electrostatic interactions in##3##4##(1996-5#1)(1997-2#1)(2008-4#1)
of electrostatic interactions##5##3##(1996-5#1)(1997-2#1)(2008-10#1)(2008-4#2)
of electrostatic##14##2##(1990-2#1)(1993-11#1)(1994-8#1)(1996-5#1)(1997-2#2)(2008-10#1)(2008-3#1)(2008-4#3)(2009-5#1)(2012-2#1)(2013-8#1)
of electrosurgery##2##2##(1996-1#1)(2012-3#1)
of element##4##2##(2007-5#1)(2008-10#2)(2013-8#1)
of elemental analysis##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
of elemental composition of##2##4##(2008-10#2)
of elemental composition##3##3##(2008-10#3)
of elemental concentrations##2##3##(2008-10#2)
of elemental##15##2##(2008-10#13)(2008-4#1)(2010-3#1)
of elementary##3##2##(1995-2#1)(2008-3#1)(2011-2#1)
of elements in##8##3##(1995-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)
of elements of##4##3##(1990-11#1)(2008-2#1)(2010-8#1)(2013-1#1)
of elements were##2##3##(1994-3#1)(2008-10#1)
of elements##32##2##(1990-11#1)(1990-5#1)(1991-6#1)(1994-3#1)(1995-5#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
of elevated blood pressure##2##4##(2008-5#2)
of elevated blood##5##3##(1997-4#2)(2008-5#2)(2009-11#1)
of elevated concentrations of##2##4##(2008-11#1)(2008-7#1)
of elevated levels of##3##4##(1994-2#1)(1995-2#1)(2008-11#1)
of elevated##33##2##(1991-12#3)(1992-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-4#4)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
of eleven##8##2##(1996-5#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-1#1)
of elicited##2##2##(2008-10#1)(2011-10#1)
of elicitin production##2##3##(2008-10#2)
of eliciting##2##2##(1992-12#1)(2008-11#1)
of eligibility##2##2##(2007-10#1)(2011-1#1)
of eliminating malaria##2##3##(2012-12#1)(2012-3#1)
of eliminating##5##2##(1992-6#1)(2008-3#2)(2012-12#1)(2012-3#1)
of elimination of##2##3##(1996-1#1)(2008-7#1)
of elimination##4##2##(1996-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
of elite and##2##3##(2008-9#1)(2011-2#1)
of elite##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
of ellagic acid on platelet##2##5##(2011-2#2)
of ellagic acid on##3##4##(2008-5#1)(2011-2#2)
of ellagic acid##9##3##(1994-6#2)(2008-10#2)(2008-5#2)(2011-2#3)
of ellipsometric##2##2##(2008-10#1)(2008-3#1)
of elliptic##2##2##(2007-12#1)(2008-3#1)
of elliptical halos##2##3##(2008-3#2)
of elliptically polarized light##2##4##(2007-11#1)(2008-3#1)
of ellipticity##3##2##(1990-5#1)(2007-11#1)(2007-12#1)
of elongated particles##2##3##(1991-12#2)
of elongated##6##2##(1991-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
of elongating##3##2##(2009-10#1)(2012-2#2)
of elongation factor 3##2##4##(1996-2#2)
of elongation factor##3##3##(1992-8#1)(1996-2#2)
of elongation##6##2##(1992-8#1)(1994-11#1)(1996-2#2)(2008-10#1)(2008-3#1)
of eluate##3##2##(1990-2#1)(2008-10#2)
of eluent and##3##3##(2008-10#3)
of eluent##16##2##(2008-10#16)
of elution##11##2##(1990-8#1)(1991-2#1)(1994-9#1)(1995-6#1)(2008-10#7)
of embarrassment##2##2##(1996-5#1)(2013-8#1)
of embolic##3##2##(2008-7#1)(2010-5#1)(2010-6#1)
of embolism##3##2##(2007-10#1)(2009-3#1)(2012-12#1)
of embolization of##2##3##(2008-7#2)
of embolization##3##2##(1997-8#1)(2008-7#2)
of embryo transfer##2##3##(1996-5#1)(1996-8#1)
of embryo##6##2##(1992-5#1)(1996-5#1)(1996-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
of embryogenesis and##3##3##(1992-9#1)(2007-12#1)(2009-12#1)
of embryogenesis##11##2##(1992-9#1)(1994-12#1)(2007-12#4)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
of embryology##2##2##(2008-11#1)(2009-9#1)
of embryonal##2##2##(1993-9#1)(2011-1#1)
of embryonated##2##2##(2008-5#1)(2008-9#1)
of embryonic acid tolerance and##2##5##(2012-3#2)
of embryonic and##3##3##(2009-3#1)(2012-2#1)(2013-1#1)
of embryonic brain development##3##4##(2007-12#3)
of embryonic development##11##3##(2007-12#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2012-3#1)(2013-7#1)
of embryonic stem cell##2##4##(2008-9#1)(2010-7#1)
of embryonic stem cells##5##4##(2008-11#3)(2008-9#2)
of embryonic stem##8##3##(2008-11#4)(2008-9#3)(2010-7#1)
of embryonic##44##2##(1990-5#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(2007-12#7)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#5)(2009-3#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
of embryos##24##2##(1991-3#1)(1992-12#1)(1992-3#2)(1992-9#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
of emergence and##4##3##(2007-12#2)(2008-12#1)(2010-4#1)
of emergence of##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
of emergence##17##2##(2007-12#4)(2008-10#1)(2008-12#3)(2008-6#2)(2008-8#1)(2010-4#1)(2011-2#4)(2012-12#1)
of emergencies##2##2##(1996-8#1)(2007-7#1)
of emergency department##2##3##(1996-2#1)(2008-11#1)
of emergency medical##2##3##(2008-3#1)(2010-8#1)
of emergency nurses##2##3##(2008-11#2)
of emergency obstetric##2##3##(2010-11#1)(2011-1#1)
of emergency room##2##3##(2008-10#1)(2011-2#1)
of emergency surgery##2##3##(1991-6#1)(2008-7#1)
of emergency##28##2##(1991-6#2)(1992-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2009-4#2)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)
of emergent iono-neuronal dynamics##3##4##(2009-5#3)
of emergent##8##2##(2008-1#1)(2008-5#1)(2009-5#3)(2009-9#1)(2012-12#1)(2013-8#1)
of emerging and##2##3##(2008-10#1)(2011-1#1)
of emerging diseases##2##3##(2010-4#1)(2011-1#1)
of emerging pathogens##2##3##(2011-2#1)(2013-8#1)
of emerging##22##2##(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#3)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of emesis and##2##3##(1991-2#1)(2013-1#1)
of emetine##2##2##(1995-3#2)
of emigration##2##2##(1993-6#1)(2008-8#1)
of emission from##2##3##(2008-2#2)
of emission lines##2##3##(2008-10#1)(2008-3#1)
of emission##10##2##(1992-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)
of emissions##5##2##(2008-10#4)(2008-3#1)
of emitted##2##2##(1994-8#1)(2008-11#1)
of emollients##2##2##(2008-5#2)
of emotion and##2##3##(2008-4#1)(2011-2#1)
of emotion##11##2##(1995-1#1)(2008-11#5)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#2)
of emotional distress##2##3##(1992-3#1)(1995-6#1)
of emotional exhaustion##2##3##(2008-11#1)(2010-7#1)
of emotional facial expressions##2##4##(2008-1#1)(2008-6#1)
of emotional##27##2##(1992-3#1)(1995-1#1)(1995-6#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#8)(2008-4#1)(2008-6#4)(2009-10#1)(2009-11#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
of emotions and##2##3##(1994-2#1)(2008-5#1)
of emotions in##2##3##(1997-2#1)(2008-1#1)
of emotions##6##2##(1994-2#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-5#2)
of empathy##2##2##(1996-1#1)(2011-2#1)
of emphysema##4##2##(1991-12#3)(2008-5#1)
of emphysematous pyelonephritis##2##3##(2007-10#1)(2008-8#1)
of empirical data##2##3##(1996-3#1)(2010-6#1)
of empirical findings##2##3##(2008-11#1)(2013-8#1)
of empirical work##2##3##(2008-11#1)(2008-8#1)
of empirical##9##2##(1994-12#1)(1996-3#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
of empirically##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
of employee##6##2##(1994-3#2)(1995-1#1)(1995-6#1)(2008-12#1)(2012-12#1)
of employees##11##2##(1994-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
of employees'##3##2##(1997-3#1)(2009-10#1)(2010-6#1)
of employer-sponsored health insurance##2##4##(2008-11#2)
of employing a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
of employing the##2##3##(2008-10#2)
of employing##17##2##(1991-2#1)(1993-3#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-8#1)(2012-12#1)
of employment as##2##3##(1991-12#1)(2008-10#1)
of employment##6##2##(1991-12#1)(1994-1#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#1)
of empty##3##2##(2008-10#2)(2013-7#1)
of emulsifier##2##2##(2008-10#2)
of emulsion##3##2##(2008-5#3)
of emulsions##2##2##(2008-5#2)
of enamel and dentin##2##4##(1991-2#1)(2012-12#1)
of enamel and##3##3##(1991-2#1)(2008-7#1)(2012-12#1)
of enamel##12##2##(1991-2#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
of enantiomeric mixtures##2##3##(1994-9#1)(2008-10#1)
of enantiomeric##5##2##(1994-9#1)(1995-6#1)(2008-10#3)
of enantiomerically pure##4##3##(2006-12#1)(2008-7#1)(2009-12#1)(2009-9#1)
of enantiomers of##3##3##(2008-10#3)
of enantiomers##6##2##(1994-9#1)(2008-10#5)
of enantioselective##2##2##(2008-10#2)
of encapsulated##4##2##(2007-11#2)(2008-11#1)(2008-5#1)
of encapsulating peritoneal sclerosis##3##4##(2011-2#3)
of encapsulation##2##2##(2008-10#1)(2008-5#1)
of encephalitis##4##2##(2008-2#1)(2008-7#1)(2011-2#2)
of encoded##4##2##(1995-3#1)(1997-4#2)(2011-2#1)
of encoding##8##2##(1995-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2013-8#1)
of encounter##3##2##(1997-2#1)(2008-8#1)(2008-9#1)
of encountering##3##2##(2008-1#1)(2008-3#1)(2010-10#1)
of encounters with##2##3##(2008-11#1)(2008-8#1)
of encounters##4##2##(2008-11#1)(2008-8#3)
of encouraging##2##2##(1993-11#1)(2010-5#1)
of encrypted digital holograms##2##4##(2007-11#2)
of end stage renal disease (ESRD)##2##6##(1991-3#1)(2012-2#1)
of end stage renal disease##4##5##(1991-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
of end stage##5##3##(1991-3#1)(2008-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
of end users##2##3##(1992-12#1)(2009-6#1)
of end##9##2##(1991-3#1)(1992-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-4#1)(2012-2#1)(2013-1#1)
of end-stage renal disease (ESRD)##5##5##(2006-10#1)(2007-7#2)(2008-1#1)(2008-8#1)
of end-stage renal disease##11##4##(2006-10#1)(2007-12#2)(2007-7#3)(2008-1#4)(2008-8#1)
of end-stage renal##14##3##(2006-10#1)(2007-12#2)(2007-7#3)(2008-1#7)(2008-8#1)
of end-stage##24##2##(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#3)(2008-1#7)(2008-8#1)(2010-6#2)(2011-2#1)(2011-3#2)(2013-1#3)
of endangered##3##2##(2008-9#1)(2013-7#2)
of endemic##2##2##(1991-8#1)(1996-6#1)
of endemicity##2##2##(2007-12#1)(2012-12#1)
of endo-PG##2##2##(2008-10#2)
of endobiliary stent##2##3##(2008-12#2)
of endobronchial##6##2##(1992-8#3)(2008-7#1)(2010-8#1)(2013-7#1)
of endocardial##2##2##(2007-8#1)(2010-6#1)
of endocarditis##6##2##(1997-5#1)(2007-12#3)(2011-2#2)
of endocrine and neuroendocrine##2##4##(2008-5#1)(2008-8#1)
of endocrine and##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
of endocrine impairment##2##3##(1991-2#1)(2012-3#1)
of endocrine##14##2##(1990-11#1)(1991-2#2)(1992-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of endocrinology##2##2##(2007-8#1)(2011-2#1)
of endocytosis##2##2##(1990-11#1)(2013-8#1)
of endodontic##2##2##(2008-7#1)(2009-8#1)
of endogenous DNA damage##2##4##(2010-2#2)
of endogenous ROS in##2##4##(2008-11#2)
of endogenous ROS##4##3##(2008-11#3)(2009-8#1)
of endogenous ammonia##2##3##(1992-11#1)(2008-10#1)
of endogenous and exogenous##3##4##(1992-5#1)(2008-10#1)(2011-2#1)
of endogenous antioxidant##2##3##(2008-7#1)(2009-12#1)
of endogenous antioxidants##2##3##(1991-2#1)(1993-2#1)
of endogenous cellular##2##3##(1992-3#1)(2008-8#1)
of endogenous compounds##3##3##(1990-12#1)(2008-8#1)(2011-2#1)
of endogenous genes##3##3##(2008-9#3)
of endogenous ligands##3##3##(1994-2#1)(2008-3#1)(2009-7#1)
of endogenous mouse apoB-48##2##4##(1992-11#2)
of endogenous opioid peptides##2##4##(1994-9#1)(2008-3#1)
of endogenous opioid##5##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#2)
of endogenous substrates##6##3##(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(2008-5#1)
of endogenous urinary##2##3##(1993-9#1)(2008-10#1)
of endogenous##108##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#4)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#2)(1995-6#1)(1996-12#5)(1996-2#1)(1997-1#3)(1997-7#5)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-2#2)(2011-2#3)(2012-3#1)
of endogenously formed##2##3##(1992-8#1)(1997-4#1)
of endogenously released##2##3##(1992-6#1)(2008-4#1)
of endogenously##5##2##(1992-6#1)(1992-8#1)(1997-4#1)(2008-4#1)(2013-8#1)
of endometrial cancer##4##3##(1991-12#1)(1994-9#2)(2008-10#1)
of endometrial cancer]##3##3##(1996-6#1)(2011-1#1)(2013-1#1)
of endometrial carcinoma##6##3##(1994-9#2)(1995-3#1)(2011-2#2)(2012-1#1)
of endometrial epithelium##3##3##(1994-9#3)
of endometrial##35##2##(1991-12#1)(1992-2#1)(1994-12#1)(1994-9#14)(1995-3#3)(1996-2#1)(1996-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)
of endometriosis in##2##3##(2010-12#1)(2011-1#1)
of endometriosis is##3##3##(1992-2#2)(1994-9#1)
of endometriosis##15##2##(1992-2#2)(1993-2#1)(1994-3#1)(1994-9#6)(1995-12#1)(1995-2#1)(2010-12#2)(2011-1#1)
of endometritis##4##2##(2012-3#4)
of endometrium##2##2##(1994-9#1)(2011-2#1)
of endomyocardial##2##2##(2007-8#2)
of endonuclease III##2##3##(1995-2#2)
of endonuclease##3##2##(1995-2#2)(2008-8#1)
of endopeptidases##2##2##(2008-11#1)(2008-4#1)
of endophthalmitis##3##2##(1991-11#3)
of endopolygalacturonase##2##2##(2008-10#2)
of endoprostheses##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
of endoreduplication##2##2##(2008-5#1)(2008-7#1)
of endos(00003)/+##2##2##(2012-3#2)
of endoscopic and##2##3##(1991-3#1)(2008-10#1)
of endoscopic procedures##3##3##(2010-8#2)(2012-12#1)
of endoscopic third ventriculostomy##2##4##(2008-2#1)(2011-2#1)
of endoscopic##28##2##(1990-6#1)(1991-3#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-8#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#4)
of endoscopy##2##2##(1997-8#1)(2012-2#1)
of endosepsis in##2##3##(2008-10#2)
of endosepsis##3##2##(2008-10#3)
of endosperm##2##2##(1995-6#1)(2008-5#1)
of endosulfan##2##2##(2008-12#2)
of endothelial KATP##2##3##(2008-5#2)
of endothelial and##2##3##(2008-10#1)(2010-11#1)
of endothelial cell functions##2##4##(2010-9#2)
of endothelial cell##5##3##(1991-9#1)(2009-11#1)(2010-9#2)(2012-3#1)
of endothelial cells and##3##4##(2008-8#1)(2011-2#1)(2012-12#1)
of endothelial cells in##4##4##(1991-12#1)(2008-6#1)(2010-11#1)(2012-1#1)
of endothelial cells to monocytes##2##5##(1995-12#2)
of endothelial cells to##6##4##(1993-3#1)(1995-12#2)(2008-11#1)(2010-1#1)(2011-2#1)
of endothelial cells with##2##4##(1991-9#1)(2010-9#1)
of endothelial cells##31##3##(1990-12#1)(1991-12#2)(1991-9#4)(1993-3#3)(1993-6#1)(1995-12#2)(1996-12#1)(2008-1#2)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)
of endothelial dysfunction##4##3##(2008-1#2)(2008-3#1)(2010-10#1)
of endothelial##52##2##(1990-12#1)(1991-12#2)(1991-9#5)(1993-3#3)(1993-6#2)(1995-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)
of endothelin##22##2##(1990-2#4)(1990-8#1)(1992-12#2)(1992-3#1)(1993-3#1)(1994-11#6)(1995-12#2)(1997-4#1)(2008-1#4)
of endothelin-1 in##2##3##(1991-8#1)(1993-3#1)
of endothelin-1 on##5##3##(1992-3#4)(1995-12#1)
of endothelin-1##18##2##(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#6)(1993-3#1)(1994-6#1)(1995-12#2)(2008-1#1)
of endothelium##3##2##(1991-9#1)(1995-12#1)(1997-7#1)
of endothelium-derived relaxing factor##2##4##(1990-12#1)(1991-9#1)
of endothelium-derived relaxing##3##3##(1990-12#1)(1991-9#1)(1993-3#1)
of endothelium-derived##4##2##(1990-12#1)(1991-6#1)(1991-9#1)(1993-3#1)
of endotoxemia##3##2##(1995-12#2)(2008-12#1)
of endotoxin##5##2##(1994-7#4)(1996-9#1)
of endovascular and##2##3##(2008-7#1)(2011-3#1)
of endovascular treatment##2##3##(1996-6#1)(1997-6#1)
of endovascular##14##2##(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-3#1)(2012-1#1)(2012-2#2)
of endurance exercise##2##3##(2012-3#2)
of energetic materials##2##3##(2008-2#1)(2008-3#1)
of energetic##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
of energy and##9##3##(1994-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
of energy as##6##3##(1996-12#2)(2008-1#2)(2008-4#2)
of energy coding##3##3##(2008-11#3)
of energy conservation##2##3##(2008-2#1)(2012-2#1)
of energy delivered by##2##4##(2008-10#1)(2013-1#1)
of energy delivered##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
of energy expenditure in##2##4##(2008-2#1)(2008-4#1)
of energy expenditure##3##3##(2008-2#1)(2008-4#2)
of energy from the##2##4##(2007-12#2)
of energy from##4##3##(2007-12#3)(2008-3#1)
of energy homeostasis##5##3##(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)
of energy in a##2##4##(2007-12#2)
of energy in##4##3##(1994-5#1)(2007-12#2)(2008-10#1)
of energy intake as##2##4##(1997-8#2)
of energy intake##3##3##(1997-8#2)(2009-8#1)
of energy metabolism##4##3##(1994-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
of energy of the##2##4##(2008-10#1)(2008-11#1)
of energy reserves##2##3##(2008-7#1)(2013-1#1)
of energy to##3##3##(2008-3#2)(2010-6#1)
of energy transfer from##3##4##(1993-11#1)(1995-5#1)(2012-2#1)
of energy transfer##8##3##(1993-11#2)(1995-5#1)(2008-10#3)(2008-7#1)(2012-2#1)
of energy##113##2##(1993-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-6#1)(1997-8#2)(2007-11#3)(2007-12#6)(2008-1#4)(2008-10#11)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-2#2)(2009-8#2)(2010-3#2)(2010-6#2)(2011-2#1)(2012-1#2)(2012-2#5)(2013-1#9)(2013-8#1)
of engagement##2##2##(2008-12#1)(2009-7#1)
of engaging##2##2##(2009-5#1)(2010-9#1)
of engine##3##2##(2008-10#1)(2008-3#2)
of engineered##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-12#1)
of engineering surfaces##2##3##(2008-3#2)
of engineering##5##2##(1990-11#1)(2008-10#1)(2008-3#2)(2008-8#1)
of engrafted cells##2##3##(2012-12#1)(2013-1#1)
of engraftment##2##2##(2010-11#1)(2013-1#1)
of engrailed expression##2##3##(2007-12#2)
of engrailed##4##2##(1993-2#1)(2007-12#3)
of enhanced backscattering##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
of enhanced##29##2##(1991-10#1)(1991-12#1)(1993-1#1)(1994-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#2)
of enhancement of the##2##4##(1991-5#1)(2007-11#1)
of enhancement of##3##3##(1991-5#1)(2007-11#1)(2007-12#1)
of enhancement##6##2##(1991-5#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
of enhancer##2##2##(1990-11#1)(1991-11#1)
of enhancing the##5##3##(1995-5#1)(2007-11#1)(2007-5#1)(2008-10#2)
of enhancing##10##2##(1995-5#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
of enkephalin##2##2##(1996-12#1)(1997-2#1)
of enlarged similarity##2##3##(1996-6#2)
of enlarged##5##2##(1996-6#2)(2008-10#2)(2009-10#1)
of enlargement##2##2##(2011-2#1)(2012-12#1)
of enoxaparin in patients##2##4##(2008-3#2)
of enoxaparin in##3##3##(2008-3#3)
of enoxaparin##7##2##(2007-10#2)(2007-7#1)(2008-10#1)(2008-3#3)
of enriched (137)Ba##2##3##(2010-8#2)
of enriched##4##2##(2008-10#2)(2010-8#2)
of enrichment factor##2##3##(2008-10#2)
of enrichment##8##2##(1993-11#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
of enrofloxacin against Riemerella anatipestifer##2##5##(2008-5#2)
of enrolled##4##2##(2007-10#2)(2008-7#1)(2010-8#1)
of enrollment##4##2##(1991-1#1)(1991-12#2)(1991-3#1)
of ensuring##4##2##(1991-3#1)(1992-2#1)(2011-1#1)(2012-3#1)
of entactin##3##2##(1995-6#3)
of enteral##2##2##(1993-12#1)(2013-1#1)
of enteric##6##2##(1994-12#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
of entering the##2##3##(1990-3#1)(2011-1#1)
of enterocyte##3##2##(1992-2#1)(1995-2#1)(1996-5#1)
of enterosorption in##2##3##(2011-1#2)
of enterotoxin##2##2##(1990-12#1)(1993-9#1)
of enterovirus 71##3##3##(2008-12#2)(2013-8#1)
of enterovirus##5##2##(2008-12#2)(2011-1#2)(2013-8#1)
of enthalpy and##2##3##(1990-8#1)(2008-10#1)
of enthalpy##3##2##(1990-8#1)(1995-2#1)(2008-10#1)
of enthusiasm##2##2##(2008-2#1)(2011-1#1)
of entire tissue##2##3##(2010-8#1)(2012-2#1)
of entire##8##2##(1992-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-2#1)
of entities##2##2##(1995-5#1)(2011-1#1)
of entomology##3##2##(2010-1#3)
of entomopathogenic##3##2##(2008-5#1)(2008-8#2)
of entrance##2##2##(1994-12#1)(2008-2#1)
of entrapment by estoppel##2##4##(1994-3#2)
of entrepreneurs##2##2##(1996-2#2)
of entropy##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
of entry into the##2##4##(1992-5#1)(2008-11#1)
of entry into##3##3##(1991-2#1)(1992-5#1)(2008-11#1)
of entry of##2##3##(2008-5#1)(2008-7#1)
of entry##15##2##(1991-2#1)(1992-5#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
of enuresis##3##2##(2007-7#2)(2013-8#1)
of env mRNAs##2##3##(1994-8#2)
of envelope##2##2##(2008-3#1)(2013-8#1)
of enveloped##2##2##(1994-6#1)(1995-2#1)
of environment on##2##3##(2008-10#1)(2010-1#1)
of environment##5##2##(2008-10#2)(2008-5#1)(2010-1#1)(2010-6#1)
of environmental analysis##2##3##(2008-10#2)
of environmental and genetic factors##2##5##(2008-9#1)(2009-8#1)
of environmental and genetic##3##4##(2008-9#1)(2009-8#1)(2010-4#1)
of environmental and industrial exposure to heavy metals##2##8##(2008-10#2)
of environmental and occupational##2##4##(2009-12#1)(2012-1#1)
of environmental and##12##3##(2008-10#4)(2008-2#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2012-1#1)
of environmental conditions and##2##4##(1997-6#1)(2008-10#1)
of environmental conditions##6##3##(1997-6#1)(2008-10#4)(2008-5#1)
of environmental data##2##3##(2008-10#1)(2008-8#1)
of environmental factors and##2##4##(2008-8#1)(2011-1#1)
of environmental factors##7##3##(1997-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
of environmental health services##2##4##(1997-2#2)
of environmental health##4##3##(1997-2#2)(2008-1#2)
of environmental noise##6##3##(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)
of environmental pollutants##7##3##(2008-10#6)(2008-7#1)
of environmental pollution##2##3##(2008-10#2)
of environmental problems##2##3##(2008-10#1)(2008-11#1)
of environmental samples##4##3##(2008-10#3)(2012-12#1)
of environmental sounds in##2##4##(2008-9#2)
of environmental stewardship and##2##4##(2009-8#2)
of environmental stresses##2##3##(1994-11#1)(2009-8#1)
of environmental stressors##3##3##(2009-8#1)(2010-4#1)(2012-2#1)
of environmental tobacco smoke##2##4##(1996-3#2)
of environmental variables##2##3##(2008-11#1)(2008-5#1)
of environmental variation##2##3##(2008-8#1)(2012-3#1)
of environmental##127##2##(1991-1#1)(1991-12#1)(1993-1#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-11#2)(1996-1#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#15)(2008-9#6)(2009-12#2)(2009-8#7)(2009-9#1)(2010-4#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
of environmentally realistic##2##3##(2008-11#1)(2008-5#1)
of environmentally##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)
of environments that##2##3##(2008-8#1)(2008-9#1)
of environments##8##2##(2007-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#1)
of enzymatic activities will##2##4##(1991-5#2)
of enzymatic activities##5##3##(1991-5#3)(2008-7#2)
of enzymatic activity##7##3##(1991-5#2)(1993-6#1)(1996-12#2)(2008-11#1)(2008-7#1)
of enzymatic and non-enzymatic antioxidants##2##5##(2008-5#2)
of enzymatic and non-enzymatic##3##4##(2008-10#1)(2008-5#2)
of enzymatic and##4##3##(2008-10#2)(2008-5#2)
of enzymatic hydrolysis of##4##4##(2008-5#2)(2008-7#2)
of enzymatic hydrolysis##7##3##(2008-10#1)(2008-5#2)(2008-7#2)(2013-1#2)
of enzymatic oxidation##2##3##(2008-10#2)
of enzymatic reactions##3##3##(1990-3#1)(1990-5#1)(2008-4#1)
of enzymatic##40##2##(1990-3#1)(1990-5#1)(1991-5#5)(1993-6#1)(1994-12#1)(1996-12#2)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-9#1)(2013-1#3)
of enzymatically active##3##3##(1992-12#1)(2008-4#2)
of enzymatically generated##3##3##(2008-10#3)
of enzymatically##9##2##(1992-12#1)(1992-8#1)(1993-6#1)(2008-10#4)(2008-4#2)
of enzyme activities##4##3##(1991-5#2)(2008-5#1)(2008-7#1)
of enzyme activity by##3##4##(1992-3#1)(2008-4#1)(2011-1#1)
of enzyme activity##19##3##(1990-5#2)(1991-5#2)(1992-3#1)(1992-6#1)(1995-6#2)(1997-2#1)(1997-6#2)(2008-4#3)(2008-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
of enzyme and##4##3##(1992-3#1)(1993-11#1)(1994-5#1)(1995-2#1)
of enzyme inhibitors##3##3##(1992-9#1)(1997-4#2)
of enzyme kinetic##2##3##(2008-10#1)(2011-1#1)
of enzyme molecules##2##3##(2011-2#1)(2012-2#1)
of enzyme reaction##2##3##(1995-11#1)(2008-10#1)
of enzyme subunit##3##3##(1990-10#1)(1990-7#2)
of enzyme##81##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#4)(1991-5#5)(1992-11#1)(1992-3#4)(1992-6#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#2)(1996-12#1)(1997-2#2)(1997-4#2)(1997-6#2)(2007-7#1)(2008-10#16)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
of enzyme-catalyzed reaction##2##3##(2008-10#2)
of enzyme-catalyzed##3##2##(2008-10#2)(2008-7#1)
of enzyme-linked##2##2##(1991-9#1)(1997-6#1)
of enzyme-substrate##2##2##(1994-5#1)(1996-12#1)
of enzymes by##2##3##(1994-2#1)(1997-7#1)
of enzymes in##5##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
of enzymes involved in##2##4##(1994-6#1)(2008-11#1)
of enzymes of##2##3##(1996-12#1)(2012-2#1)
of enzymes such as##2##4##(2008-2#1)(2009-8#1)
of enzymes that are##3##4##(1990-8#1)(1993-6#2)
of enzymes that##8##3##(1990-8#1)(1993-6#2)(2008-1#1)(2008-4#2)(2009-10#1)(2012-2#1)
of enzymes##51##2##(1990-8#1)(1991-5#3)(1992-11#1)(1992-9#1)(1993-6#2)(1994-2#1)(1994-6#2)(1995-3#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
of eosinophil##5##2##(1992-12#1)(1994-11#1)(1995-6#1)(1996-12#1)(2012-3#1)
of eosinophil-specific genes##3##3##(2012-3#3)
of eosinophilia##2##2##(2008-7#1)(2010-5#1)
of eosinophilic##5##2##(1990-11#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
of eosinophils and##2##3##(2010-6#1)(2012-3#1)
of eosinophils in the pathogenesis of asthma##2##7##(2012-3#2)
of eosinophils in the##3##4##(2008-1#1)(2012-3#2)
of eosinophils in##5##3##(1992-3#1)(2008-1#1)(2012-3#3)
of eosinophils##14##2##(1992-11#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)(2012-3#4)(2013-1#1)
of eperisone-HCl##2##2##(1996-2#2)
of ephedrine derivatives##2##3##(2008-10#2)
of ephedrine in ephedra callus##2##5##(2008-10#2)
of ephedrine in##3##3##(2008-10#3)
of ephedrine##9##2##(1994-9#1)(1995-2#2)(2008-10#6)
of epicatechin##5##2##(2008-10#4)(2012-3#1)
of epichlorohydrin in##2##3##(2008-10#2)
of epichlorohydrin##3##2##(2008-10#3)
of epicuticular##2##2##(2007-12#1)(2008-10#1)
of epidemic onset##3##3##(2008-10#3)
of epidemic progress##2##3##(2008-10#2)
of epidemic##14##2##(1992-9#1)(2007-2#3)(2008-10#6)(2009-9#1)(2010-10#1)(2010-4#1)(2012-2#1)
of epidemics in##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
of epidemics##13##2##(1990-6#1)(1995-5#1)(2008-10#8)(2012-2#1)(2013-1#2)
of epidemiologic studies##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
of epidemiologic##5##2##(1992-3#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
of epidemiological##11##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-12#3)
of epidemiology in the##2##4##(1994-3#1)(2008-11#1)
of epidemiology##6##2##(1993-11#1)(1994-2#1)(1994-3#2)(2008-11#1)(2012-3#1)
of epidermal and cortical##2##4##(2008-10#1)(2008-12#1)
of epidermal and##3##3##(2008-10#2)(2008-12#1)
of epidermal cell##3##3##(2008-10#2)(2013-8#1)
of epidermal cells##4##3##(2008-10#2)(2008-7#2)
of epidermal glands in neotenic reproductives of##2##7##(2007-12#2)
of epidermal growth factor (EGF)##3##5##(1994-6#1)(1995-11#1)(2013-7#1)
of epidermal growth factor on##2##5##(1992-3#1)(1994-8#1)
of epidermal growth factor receptor (EGFR)##3##6##(1992-8#1)(2008-5#1)(2012-3#1)
of epidermal growth factor receptor and##2##6##(1992-8#1)(2011-2#1)
of epidermal growth factor receptor##6##5##(1992-8#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
of epidermal growth factor##12##4##(1990-7#1)(1992-3#1)(1992-8#2)(1994-6#1)(1994-8#1)(1995-11#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
of epidermal hyperkeratosis##2##3##(2008-9#2)
of epidermal hyperplasia##4##3##(2008-9#4)
of epidermal##42##2##(1990-11#1)(1990-7#1)(1992-3#1)(1992-8#4)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-5#4)(2008-7#2)(2008-9#6)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
of epidermoid##2##2##(1995-9#1)(2013-1#1)
of epidural##4##2##(1992-11#1)(1996-3#1)(2009-5#1)(2011-2#1)
of epigenetic changes##2##3##(2009-4#2)
of epigenetic marks##3##3##(2009-12#1)(2012-2#2)
of epigenetic##13##2##(2007-11#2)(2008-11#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#3)(2011-1#1)(2011-9#1)(2012-2#2)
of epigenetically silenced##2##3##(2007-11#2)
of epilepsy in##2##3##(2008-11#1)(2008-2#1)
of epilepsy patients and##2##4##(2009-9#1)(2010-8#1)
of epilepsy patients##4##3##(2008-7#1)(2009-9#1)(2010-8#2)
of epilepsy##21##2##(1990-3#1)(1991-11#1)(1992-5#2)(1992-9#1)(1994-2#2)(1996-3#1)(1997-8#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-8#2)(2011-1#1)
of epileptic crisis##2##3##(2007-8#1)(2008-6#1)
of epileptic seizures##2##3##(2008-5#1)(2010-8#1)
of epileptic##8##2##(1990-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-8#2)
of epinephrine in##4##3##(1990-5#1)(2008-10#3)
of epinephrine with##2##3##(1990-5#1)(2008-10#1)
of epinephrine##17##2##(1990-5#2)(1990-8#1)(2008-10#13)(2008-3#1)
of epiphyseal##2##2##(2012-1#1)(2012-12#1)
of epiphytes##3##2##(2008-5#3)
of epiphytic##2##2##(2008-10#1)(2008-5#1)
of epiphytotics##2##2##(2008-10#2)
of epirubicin in##3##3##(1990-10#2)(1993-2#1)
of epirubicin##7##2##(1990-10#3)(1991-6#2)(1993-2#1)(2010-3#1)
of episodes of##2##3##(1990-8#1)(2007-7#1)
of episodes##3##2##(1990-8#1)(2007-7#1)(2008-6#1)
of episodic wakefulness##2##3##(2007-6#2)
of episodic##6##2##(2007-6#2)(2008-1#1)(2008-2#1)(2008-9#2)
of epistasis##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
of epistaxis##2##2##(2008-11#1)(2012-12#1)
of epithelial and##3##3##(2007-5#1)(2012-1#1)(2012-3#1)
of epithelial cells##10##3##(1991-11#1)(1991-8#1)(1993-11#1)(1995-11#1)(1995-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-1#1)
of epithelial origin##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
of epithelial ovarian##3##3##(1994-12#1)(2009-5#1)(2011-1#1)
of epithelial proliferation##2##3##(1993-3#1)(1994-3#1)
of epithelial tissues##3##3##(2010-9#3)
of epithelial##45##2##(1991-11#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
of epithelial-myoepithelial carcinoma##2##3##(1991-6#2)
of epitheloid##2##2##(2008-5#1)(2009-5#1)
of epitope##2##2##(1992-12#1)(2008-11#1)
of epoetin alfa##8##3##(2008-7#8)
of epoxides##2##2##(1990-2#1)(2012-12#1)
of epoxy##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
of eprosartan##4##2##(2008-10#4)
of epsilon##5##2##(1993-11#1)(1994-11#1)(1997-8#1)(2008-4#1)(2009-7#1)
of epsilon-aminocaproic acid##2##3##(1993-8#1)(1997-2#1)
of equal amounts of##2##4##(2008-10#1)(2010-12#1)
of equal importance##2##3##(1995-2#1)(2008-8#1)
of equal##21##2##(1992-9#1)(1994-2#1)(1995-2#2)(1996-1#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#2)(2008-9#2)(2010-12#1)
of equally##3##2##(1990-8#1)(2008-3#1)(2008-9#1)
of equations##11##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2013-8#2)
of equidistant##2##2##(2007-11#1)(2007-12#1)
of equilibrated##2##2##(2008-10#1)(2008-5#1)
of equilibration##2##2##(2008-10#1)(2008-4#1)
of equilibria##6##2##(2008-10#5)(2008-9#1)
of equilibrium between the##3##4##(1995-3#1)(2008-10#2)
of equilibrium concentrations of##2##4##(2008-10#2)
of equilibrium constants##3##3##(1997-2#1)(2008-10#2)
of equilibrium##20##2##(1994-12#1)(1994-6#1)(1995-3#1)(1997-2#1)(2008-10#12)(2009-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
of equine##5##2##(1996-5#1)(2009-7#1)(2012-1#1)(2012-3#2)
of equipment suitable for##2##4##(1996-3#2)
of equipment was##2##3##(1997-3#1)(2007-10#1)
of equipment##14##2##(1990-2#1)(1994-12#1)(1996-3#2)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
of equity in##2##3##(1990-12#1)(1994-2#1)
of equity##3##2##(1990-12#1)(1992-3#1)(1994-2#1)
of equivalence##5##2##(2008-10#3)(2008-3#2)
of equivalent##17##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
of eradicating##4##2##(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)
of eradication therapy##2##3##(1996-11#1)(2013-1#1)
of eradication##3##2##(1996-11#1)(2008-5#1)(2013-1#1)
of erbium ions##2##3##(2008-10#1)(2008-2#1)
of erbium-doped fiber##2##3##(2007-11#1)(2008-2#1)
of erbium-doped##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
of erectile dysfunction##2##3##(1990-6#1)(2011-2#1)
of erectile##3##2##(1990-6#2)(2011-2#1)
of eretmodine cichlids##2##3##(1996-6#2)
of ergonomic problems##2##3##(2008-11#2)
of ergosterol##2##2##(1992-11#1)(1997-2#1)
of ergot##5##2##(1996-2#1)(2008-10#3)(2008-7#1)
of erosion##3##2##(2011-2#2)(2013-1#1)
of erroneous##2##2##(2008-3#2)
of error analysis##2##3##(2008-3#2)
of error are##2##3##(2008-3#2)
of error in##8##3##(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2009-9#1)
of error propagation##2##3##(2008-3#2)
of error##31##2##(2007-11#1)(2008-10#8)(2008-12#1)(2008-2#4)(2008-3#13)(2008-6#1)(2009-8#1)(2009-9#1)(2011-1#1)
of errors in the##4##4##(1995-8#1)(2007-7#1)(2008-3#1)(2013-8#1)
of errors in##7##3##(1995-8#1)(1996-2#1)(2007-7#1)(2008-3#3)(2013-8#1)
of errors on the##2##4##(2008-2#2)
of errors##27##2##(1995-8#1)(1996-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
of erythema and##2##3##(2008-5#1)(2013-8#1)
of erythema nodosum leprosum##3##4##(2008-5#1)(2012-12#2)
of erythema##6##2##(2008-5#3)(2012-12#2)(2013-8#1)
of erythroblast##2##2##(2008-10#1)(2008-9#1)
of erythroblastic##3##2##(2013-1#3)
of erythrocyte scramblase##2##3##(2008-8#2)
of erythrocyte##13##2##(1990-2#1)(1992-11#1)(1993-6#1)(1995-8#3)(1997-8#1)(2008-8#5)(2013-8#1)
of erythrocytes##10##2##(1990-11#1)(1990-2#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
of erythroid cells##3##3##(1994-8#1)(2008-10#1)(2008-9#1)
of erythroid differentiation factor##2##4##(1991-12#2)
of erythroid differentiation##5##3##(1990-11#1)(1991-12#2)(1993-8#2)
of erythroid precursors##2##3##(2007-10#1)(2008-9#1)
of erythroid##15##2##(1990-11#1)(1991-12#2)(1993-8#2)(1994-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#4)(2012-12#1)
of erythromycin##4##2##(2007-12#2)(2008-7#2)
of erythropoiesis##2##2##(1993-12#1)(2013-1#1)
of erythropoietin in##2##3##(1990-9#1)(2007-7#1)
of erythropoietin##5##2##(1990-9#1)(1995-1#1)(2007-7#1)(2008-11#2)
of esca##3##2##(2008-10#3)
of escalating##2##2##(1993-9#1)(1995-2#1)
of escalation events##2##3##(2009-10#2)
of escape##5##2##(1996-12#2)(2007-12#1)(2008-10#1)(2008-12#1)
of escitalopram and##2##3##(2012-3#2)
of escitalopram##4##2##(2012-3#4)
of esculetin from the seeds of Euphorbia lathyris L##3##9##(2011-1#3)
of esomeprazole##3##2##(2011-2#2)(2013-1#1)
of esophageal cancer in##2##4##(2013-1#1)(2013-7#1)
of esophageal cancer##9##3##(2010-12#1)(2010-6#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of esophageal carcinoma##3##3##(1992-8#1)(1993-8#1)(2012-12#1)
of esophageal motility##3##3##(2013-8#3)
of esophageal stents##2##3##(2013-1#2)
of esophageal##25##2##(1990-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1997-8#1)(2008-5#1)(2010-12#2)(2010-6#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#5)
of essential amino acids##2##4##(2010-4#2)
of essential and##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
of essential fatty##2##3##(1990-3#1)(2012-1#1)
of essential genes in##2##4##(2008-10#1)(2012-2#1)
of essential genes##3##3##(2008-10#1)(2012-2#2)
of essential hypertension##6##3##(1990-2#1)(1992-8#1)(1993-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
of essential oil##9##3##(2008-5#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#4)(2013-1#1)
of essential oils##9##3##(2008-10#3)(2008-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
of essential tremor (ET)##2##4##(2008-7#1)(2013-1#1)
of essential tremor##3##3##(2008-7#2)(2013-1#1)
of essential##57##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-4#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#1)
of essentially##4##2##(2007-11#1)(2007-12#1)(2008-8#1)(2009-9#1)
of established##9##2##(1993-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#2)(2013-8#1)
of establishing a##7##3##(1991-11#1)(1992-6#1)(1995-3#1)(2007-6#1)(2008-6#1)(2008-8#1)(2013-8#1)
of establishing new##2##3##(2008-12#1)(2008-8#1)
of establishing the diagnosis##2##4##(1995-3#1)(2013-1#1)
of establishing the##3##3##(1995-3#1)(2008-12#1)(2013-1#1)
of establishing##22##2##(1990-3#1)(1991-11#1)(1992-6#1)(1993-6#1)(1995-3#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#4)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of establishment of##2##3##(2008-10#1)(2011-2#1)
of establishment##4##2##(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)
of establishments##2##2##(1996-1#1)(2008-6#1)
of ester synthesis##2##3##(2011-1#2)
of ester##7##2##(1995-2#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#3)
of esters##2##2##(1995-6#1)(2011-1#1)
of estimated##6##2##(1991-7#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
of estimates of##2##3##(2008-10#1)(2008-6#1)
of estimates##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
of estimating the frequency of recombination in##2##7##(2008-10#2)
of estimating the##11##3##(1992-5#1)(1995-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)
of estimating##16##2##(1992-5#1)(1994-1#1)(1995-6#1)(1995-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-8#1)
of estimation##4##2##(1997-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
of estimators##3##2##(1997-7#1)(2008-2#1)(2012-3#1)
of estradiol (E2)##2##3##(1993-1#1)(1995-12#1)
of estradiol and##2##3##(2012-3#1)(2013-1#1)
of estradiol##10##2##(1993-1#1)(1993-5#1)(1994-8#1)(1995-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
of estradiol-17 beta##2##3##(1992-9#1)(1994-3#1)
of estriol##2##2##(2008-10#2)
of estrogen action##2##3##(2008-4#2)
of estrogen and progesterone receptors##2##5##(1993-9#1)(2013-8#1)
of estrogen and progesterone##5##4##(1993-9#1)(2007-10#2)(2008-7#1)(2013-8#1)
of estrogen and##7##3##(1993-9#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
of estrogen in central##2##4##(2007-10#2)
of estrogen in##7##3##(1995-9#1)(2007-10#2)(2008-10#1)(2008-7#2)(2010-6#1)
of estrogen on##7##3##(1997-6#1)(2008-11#3)(2008-6#1)(2008-7#2)
of estrogen receptor (ER)##2##4##(1993-1#1)(1995-2#1)
of estrogen receptor alpha##2##4##(2008-12#2)
of estrogen receptor##18##3##(1992-10#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1995-2#2)(2008-11#4)(2008-12#2)(2008-4#1)(2010-5#1)(2013-1#1)
of estrogen receptors##4##3##(2007-10#1)(2008-11#3)
of estrogen##65##2##(1992-10#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-9#1)(1995-2#2)(1995-9#1)(1997-6#2)(1997-7#1)(2007-10#7)(2008-10#1)(2008-11#13)(2008-12#3)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#5)(2010-5#1)(2010-6#1)(2011-1#2)(2013-1#4)(2013-8#2)
of estrogen-induced##3##2##(1992-5#2)(2008-11#1)
of estrogen-responsive genes##2##3##(1995-2#1)(2008-4#1)
of estrogenic##3##2##(1994-8#1)(2008-10#2)
of estrogenicity##3##2##(2008-10#3)
of estrogens and##2##3##(1995-12#1)(2008-11#1)
of estrogens in the##3##4##(1996-5#1)(2008-12#1)(2012-2#1)
of estrogens in##7##3##(1995-12#1)(1996-5#1)(2008-10#2)(2008-12#2)(2012-2#1)
of estrogens on##2##3##(1997-7#1)(2008-4#1)
of estrogens##18##2##(1995-12#2)(1996-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of estrone##2##2##(1995-8#1)(2008-10#1)
of estrus##7##2##(1996-12#1)(2008-12#2)(2013-1#4)
of etching##4##2##(2008-2#3)(2013-1#1)
of ethane##2##2##(2007-11#1)(2008-11#1)
of ethanol absorption##3##3##(2008-11#3)
of ethanol and##10##3##(1991-5#1)(2008-10#6)(2008-2#1)(2008-5#1)(2012-2#1)
of ethanol consumption##2##3##(1996-2#1)(2011-2#1)
of ethanol extract of Plectranthus amboinicus##5##6##(2012-2#5)
of ethanol from starch##2##4##(2008-6#2)
of ethanol from##5##3##(2008-10#1)(2008-6#3)(2011-2#1)
of ethanol in the organic phase##2##6##(2008-10#2)
of ethanol in the##6##4##(1993-12#1)(1997-2#1)(2008-10#2)(2009-10#1)(2011-2#1)
of ethanol in##15##3##(1990-5#1)(1993-12#1)(1997-2#1)(2008-10#8)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#1)
of ethanol on##5##3##(1992-6#1)(1992-7#1)(1994-9#1)(2008-7#1)(2009-7#1)
of ethanol was##3##3##(1991-5#1)(2008-10#1)(2011-1#1)
of ethanol with##4##3##(1992-6#1)(1993-8#1)(2008-10#2)
of ethanol##97##2##(1990-12#2)(1990-5#1)(1991-1#1)(1991-5#2)(1992-6#3)(1992-7#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#2)(1996-2#2)(1997-2#2)(1997-7#2)(2008-10#30)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-2#6)(2013-1#2)
of ethanol's##4##2##(1997-2#3)(2009-7#1)
of ethanol-induced motor impairment##4##4##(1997-2#4)
of ethanol-induced motor incoordination##3##4##(1997-2#3)
of ethanol-induced motor##7##3##(1997-2#7)
of ethanol-induced##8##2##(1994-7#1)(1997-2#7)
of ethanolic extract of##5##4##(2008-10#2)(2008-12#2)(2012-2#1)
of ethanolic extract##7##3##(2008-10#3)(2008-12#2)(2011-1#1)(2012-2#1)
of ethical issues##2##3##(2008-11#1)(2009-4#1)
of ethical principles##3##3##(1994-12#1)(2008-1#1)(2008-7#1)
of ethical##13##2##(1991-3#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#1)
of ethics and##2##3##(1991-3#1)(2008-9#1)
of ethics##9##2##(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#2)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
of ethidium bromide##2##3##(1990-2#1)(2008-10#1)
of ethidium##5##2##(1990-2#1)(1995-2#1)(2007-11#2)(2008-10#1)
of ethinylestradiol##2##2##(2008-10#2)
of ethirimol##2##2##(2008-10#2)
of ethnic identity##2##3##(2009-7#1)(2012-12#1)
of ethnic minorities##2##3##(2008-8#1)(2009-5#1)
of ethnic skin types##2##4##(2008-5#1)(2010-8#1)
of ethnic##9##2##(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-8#3)(2012-12#1)
of ethnicity##3##2##(2009-7#1)(2010-1#1)(2010-2#1)
of ethyl acetate##5##3##(2008-10#4)(2012-2#1)
of ethyl alcohol##4##3##(1990-5#1)(2008-10#2)(2008-3#1)
of ethyl##24##2##(1990-5#1)(1993-1#2)(1994-2#1)(1996-5#1)(2007-11#3)(2008-10#8)(2008-3#1)(2008-4#1)(2009-12#2)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
of ethylarsine dichloride##2##3##(2008-11#2)
of ethylbenzene##2##2##(1992-11#2)
of ethylene glycol##2##3##(1992-6#1)(2008-10#1)
of ethylene production##3##3##(2008-10#3)
of ethylene##16##2##(1992-6#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2009-6#1)(2012-12#1)
of ethylenediaminetetraacetate##2##2##(1990-8#1)(2008-10#1)
of etiologic##3##2##(1992-8#1)(1995-5#1)(2008-11#1)
of etiologies##2##2##(2008-3#1)(2010-6#1)
of etiology and##2##3##(1991-2#1)(2007-10#1)
of etiology##7##2##(1991-2#1)(1991-6#1)(2007-10#1)(2007-8#1)(2009-4#1)(2010-7#1)(2013-1#1)
of etodolac##4##2##(2008-10#4)
of etoposide##2##2##(1997-4#1)(2008-5#1)
of eu- and##2##3##(2008-5#1)(2008-7#1)
of eucalyptus wood residue##2##4##(2009-3#2)
of eucalyptus##5##2##(2008-10#1)(2008-5#1)(2009-3#2)(2011-2#1)
of eugenol##2##2##(2009-12#1)(2012-3#1)
of eukaryotes and##2##3##(2008-7#1)(2010-8#1)
of eukaryotes are##2##3##(2009-6#2)
of eukaryotes##9##2##(1995-8#2)(1997-7#1)(2008-11#1)(2008-7#2)(2009-6#2)(2010-8#1)
of eukaryotic DNA topoisomerase I##2##5##(1995-5#2)
of eukaryotic cells is a##2##5##(2008-11#1)(2008-4#1)
of eukaryotic cells##10##3##(1991-12#1)(1993-8#1)(1994-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-6#1)(2009-8#1)(2013-8#1)
of eukaryotic genes##2##3##(1996-3#1)(2012-12#1)
of eukaryotic mRNA##2##3##(2008-10#1)(2008-11#1)
of eukaryotic nucleus##2##3##(2008-8#2)
of eukaryotic##39##2##(1990-7#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
of europium (III)##5##3##(2008-10#5)
of europium##12##2##(2008-10#12)
of europium(III)##4##2##(2008-10#4)
of euthanasia##4##2##(1991-8#1)(2008-4#1)(2009-7#1)(2012-12#1)
of eutypa##2##2##(2008-10#2)
of evaluable cases##2##3##(1991-12#1)(1997-2#1)
of evaluating and##3##3##(2007-11#1)(2008-6#1)(2008-9#1)
of evaluating the##11##3##(1990-8#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
of evaluating##22##2##(1990-8#1)(1991-12#1)(1992-3#1)(1994-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#1)
of evaluation of the##2##4##(2007-8#1)(2008-2#1)
of evaluation of##4##3##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
of evaluation or##2##3##(1997-6#1)(2008-4#1)
of evaluation##24##2##(1991-12#1)(1992-1#1)(1992-5#1)(1993-11#1)(1996-3#2)(1997-6#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
of evanescent fields##2##3##(2008-2#1)(2008-3#1)
of evanescent##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of even order##2##3##(2008-8#1)(2013-1#1)
of even the##3##3##(1997-1#1)(2008-3#1)(2008-7#1)
of even##18##2##(1991-3#1)(1992-3#1)(1992-9#1)(1993-9#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
of event##11##2##(1992-9#1)(1993-3#1)(1997-3#1)(1997-4#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)
of events and##2##3##(2008-11#1)(2009-9#1)
of events during##2##3##(1995-2#1)(2012-3#1)
of events in##3##3##(1992-11#1)(2008-4#1)(2009-9#1)
of events leading to the##4##5##(1991-5#1)(1992-3#1)(1993-8#1)(1996-9#1)
of events leading to##5##4##(1991-5#1)(1992-3#1)(1993-8#1)(1996-9#1)(2008-12#1)
of events leading up to##2##5##(1990-9#1)(2010-3#1)
of events leading##7##3##(1990-9#1)(1991-5#1)(1992-3#1)(1993-8#1)(1996-9#1)(2008-12#1)(2010-3#1)
of events that##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
of events was##2##3##(2008-10#1)(2013-8#1)
of events##49##2##(1990-9#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#2)(1995-2#1)(1996-9#1)(1997-1#1)(1997-4#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-6#2)(2009-9#2)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of eventual##4##2##(2008-6#1)(2008-7#1)(2011-2#2)
of eventually##2##2##(1990-2#1)(2008-11#1)
of every day##2##3##(1997-5#1)(2009-10#1)
of every##26##2##(1991-6#1)(1993-11#2)(1993-8#1)(1994-2#1)(1995-12#3)(1996-8#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-10#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
of everyday life##4##3##(2007-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
of everyday##7##2##(1996-8#1)(2007-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
of evidence and##2##3##(2008-7#1)(2012-2#1)
of evidence as##3##3##(1997-8#1)(2008-11#1)(2008-8#1)
of evidence based medicine##3##4##(2007-7#1)(2010-9#1)(2011-2#1)
of evidence based practice##3##4##(2008-11#3)
of evidence based##7##3##(2007-7#1)(2008-11#3)(2008-7#1)(2010-9#1)(2011-2#1)
of evidence for a##2##4##(1991-12#1)(1993-8#1)
of evidence for##6##3##(1991-12#1)(1993-8#1)(1994-3#1)(2010-10#1)(2011-1#1)(2012-12#1)
of evidence in the##2##4##(1993-12#1)(2010-12#1)
of evidence in##3##3##(1993-12#1)(2007-12#1)(2010-12#1)
of evidence indicate that##8##4##(1990-11#1)(1996-6#1)(2008-7#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
of evidence is also##2##4##(2008-10#1)(2011-2#1)
of evidence is##6##3##(2008-10#1)(2011-2#1)(2012-12#3)(2013-1#1)
of evidence obtained##2##3##(2009-3#1)(2012-2#1)
of evidence on##4##3##(1997-8#1)(2008-11#1)(2012-2#1)(2012-3#1)
of evidence shows that the##2##5##(2006-10#1)(2008-9#1)
of evidence suggesting that##2##4##(2008-10#1)(2008-12#1)
of evidence support the hypothesis that##2##6##(2008-7#1)(2012-1#1)
of evidence supporting##2##3##(2008-8#1)(2009-6#1)
of evidence that##5##3##(1993-11#1)(1997-7#1)(2008-3#2)(2009-2#1)
of evidence##110##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-6#2)(1997-7#1)(1997-8#4)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-2#2)(2009-3#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#13)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
of evidence-based guidelines##2##3##(2008-10#1)(2010-12#1)
of evidence-based medications##2##3##(2008-3#2)
of evidence-based medicine##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
of evidence-based policies##3##3##(2008-11#3)
of evidence-based practice##4##3##(2008-11#2)(2008-12#1)(2008-3#1)
of evidence-based##24##2##(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#5)(2008-8#1)(2009-3#2)(2010-10#2)(2010-11#2)(2010-12#1)(2012-3#1)
of evidentiary pluralism##2##3##(2009-8#2)
of evoked synaptic potentials##2##4##(1991-12#2)
of evoked##8##2##(1990-5#1)(1991-1#1)(1991-12#2)(1992-7#1)(1996-2#1)(1996-5#1)(2009-6#1)
of evolution and##6##3##(1990-3#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)
of evolution is##3##3##(1995-11#1)(1997-6#2)
of evolution of the##2##4##(2007-12#1)(2008-8#1)
of evolution of##5##3##(2007-12#1)(2008-8#3)(2008-9#1)
of evolution##38##2##(1990-3#1)(1991-3#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-6#1)(1997-6#3)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#10)(2008-9#3)(2009-5#2)(2009-8#2)(2010-3#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
of evolutionarily##3##2##(1994-6#1)(2008-11#1)(2008-8#1)
of evolutionary biology##3##3##(2008-7#1)(2008-8#1)(2009-6#1)
of evolutionary change##3##3##(2008-8#1)(2010-4#1)(2012-3#1)
of evolutionary divergence##2##3##(2010-6#1)(2013-1#1)
of evolutionary games##2##3##(2013-8#2)
of evolutionary strategies##2##3##(1997-6#2)
of evolutionary##28##2##(1992-8#1)(1997-6#4)(2007-12#3)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
of evolved gas##4##3##(2008-10#4)
of evolved##5##2##(2008-10#4)(2012-3#1)
of evolving##3##2##(1997-6#1)(2008-8#1)(2011-1#1)
of ewes##2##2##(2010-2#2)
of ex vivo##2##3##(2008-4#1)(2008-5#1)
of exacerbating##2##2##(2008-8#1)(2010-6#1)
of exacerbation##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
of exacerbations and##2##3##(2008-7#1)(2011-2#1)
of exacerbations##6##2##(2008-5#1)(2008-7#1)(2011-2#4)
of exact##5##2##(2008-2#1)(2008-3#3)(2013-1#1)
of examination and##2##3##(1997-8#1)(2012-3#1)
of examination##5##2##(1991-12#2)(1997-8#1)(2007-11#1)(2012-3#1)
of examinations##5##2##(1991-7#1)(1992-5#1)(2007-11#2)(2013-1#1)
of examined##5##2##(1991-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
of examining##9##2##(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#1)
of examples of##4##3##(1994-12#1)(1995-2#1)(2008-1#1)(2012-3#1)
of examples##10##2##(1991-5#1)(1994-12#1)(1995-2#1)(1996-6#1)(2008-1#2)(2008-6#1)(2009-11#1)(2012-2#1)(2012-3#1)
of excellence##7##2##(1992-1#1)(1992-12#1)(1992-3#1)(1995-3#1)(1996-12#1)(2008-5#1)(2013-1#1)
of excellent##6##2##(1993-3#1)(2008-10#2)(2008-4#1)(2010-6#1)(2010-8#1)
of excess allele sharing##2##4##(1997-5#2)
of excess demand are##2##4##(1995-2#1)(2008-11#1)
of excess demand##3##3##(1995-2#2)(2008-11#1)
of excess of##6##3##(1991-6#1)(1994-12#1)(2008-10#4)
of excess unlabeled ET-1##2##4##(1995-11#2)
of excess unlabeled##3##3##(1995-11#3)
of excess weight##3##3##(2009-10#1)(2010-4#1)(2013-1#1)
of excess##44##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#2)(1994-11#2)(1994-12#1)(1995-11#3)(1995-2#2)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of excessive mastocytes##2##3##(1991-11#2)
of excessive##14##2##(1991-11#2)(1992-5#1)(1994-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)
of exchange and##2##3##(1990-11#1)(2008-3#1)
of exchange of##3##3##(1990-11#1)(2008-10#1)(2008-7#1)
of exchange##10##2##(1990-11#2)(1990-8#1)(1993-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)
of exchangeable aluminum##2##3##(2008-10#2)
of excimer lasers in##2##4##(2008-3#2)
of excimer lasers##3##3##(2008-3#3)
of excipients##3##2##(2012-2#3)
of excised##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
of excision##3##2##(1994-9#1)(2008-9#1)(2010-9#1)
of excitability in##2##3##(1991-2#1)(2011-2#1)
of excitability##4##2##(1991-2#1)(1993-12#1)(2008-4#1)(2011-2#1)
of excitable##2##2##(2009-9#1)(2012-3#1)
of excitation and emission##7##4##(2008-10#6)(2008-3#1)
of excitation and##8##3##(2008-10#6)(2008-3#2)
of excitation in##2##3##(2013-1#2)
of excitation##18##2##(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#3)(2010-5#1)(2013-1#2)
of excitatory amino##2##3##(1990-11#1)(1992-12#1)
of excitatory neurotransmission##2##3##(1994-11#1)(1997-4#1)
of excitatory transmission##2##3##(1997-4#1)(2012-2#1)
of excitatory##10##2##(1990-11#1)(1992-12#1)(1993-12#1)(1994-11#1)(1997-2#2)(1997-4#2)(2008-11#1)(2012-2#1)
of excited-state##2##2##(2007-1#1)(2008-3#1)
of exciting##2##2##(2008-3#1)(2011-1#1)
of exclusion##4##2##(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#1)
of exclusive breastfeeding##3##3##(2010-5#1)(2010-6#1)(2011-2#1)
of exclusive##5##2##(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)
of excretion##3##2##(1994-7#1)(2008-10#1)(2008-6#1)
of executive directors##2##3##(1993-1#1)(1994-12#1)
of executive function##4##3##(1995-11#2)(2013-8#2)
of executive functions##2##3##(2007-11#1)(2013-1#1)
of executive##14##2##(1993-1#1)(1994-12#1)(1995-11#2)(1995-12#1)(2007-11#1)(2007-8#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#4)
of executives##2##2##(1994-12#2)
of exenatide##4##2##(2012-3#4)
of exercise and##5##3##(1995-2#1)(1995-3#1)(1996-11#1)(2008-3#1)(2012-2#1)
of exercise as##2##3##(1993-11#1)(2010-1#1)
of exercise in##2##3##(1993-11#1)(2013-8#1)
of exercise on##2##3##(2008-7#1)(2008-8#1)
of exercise programs for OA##2##5##(2013-1#2)
of exercise programs##4##3##(2013-1#4)
of exercise training on##2##4##(2011-2#1)(2012-3#1)
of exercise training##8##3##(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#3)
of exercise##57##2##(1990-3#1)(1993-11#3)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(2007-6#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#2)
of exercise-induced anaphylaxis##2##3##(1991-11#1)(2010-1#1)
of exercise-induced asthma##2##3##(1995-6#1)(2010-5#1)
of exercise-induced##8##2##(1991-11#2)(1995-6#1)(2008-5#2)(2010-1#1)(2010-5#1)(2010-6#1)
of exertional##2##2##(2008-1#1)(2011-2#1)
of exhaled nitric oxide##2##4##(2010-5#1)(2012-1#1)
of exhaled##3##2##(2008-10#1)(2010-5#1)(2012-1#1)
of exhibiting##4##2##(2007-11#1)(2008-2#1)(2009-9#1)(2012-2#1)
of existence of##4##3##(1994-9#1)(2008-2#1)(2008-5#1)(2013-8#1)
of existence##5##2##(1994-9#1)(2007-8#1)(2008-2#1)(2008-5#1)(2013-8#1)
of existing methods##3##3##(2007-11#1)(2008-10#1)(2009-9#1)
of existing##43##2##(1991-8#1)(1992-3#1)(1994-3#1)(1994-8#1)(1997-3#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)
of exit-site##2##2##(2007-12#1)(2011-2#1)
of exocrine pancreas##2##3##(2012-12#2)
of exocrine pancreatic##2##3##(1992-11#1)(2008-8#1)
of exocrine##4##2##(1992-11#1)(2008-8#1)(2012-12#2)
of exocytosis in##2##3##(1990-8#1)(2008-8#1)
of exocytosis##6##2##(1990-8#1)(1992-6#2)(1993-11#1)(2008-8#1)(2012-2#1)
of exogenous double-stranded RNA##2##4##(2008-9#2)
of exogenous genes##3##3##(1996-5#1)(2012-3#2)
of exogenous growth factors##2##4##(2008-11#2)
of exogenous melatonin##2##3##(2008-12#1)(2008-3#1)
of exogenous##56##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-12#2)(2012-3#3)(2013-7#1)(2013-8#1)
of exogenously added##3##3##(1990-11#2)(1992-9#1)
of exogenously supplied##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
of exogenously##8##2##(1990-11#2)(1992-9#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
of exoglc1 was##2##3##(2008-10#2)
of exoglycosidases##3##2##(1993-12#1)(2009-8#2)
of exon 1##2##3##(1990-11#1)(2008-9#1)
of exon 11##2##3##(1990-8#1)(1991-12#1)
of exon 9##2##3##(1995-12#1)(1997-7#1)
of exon##16##2##(1990-11#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#1)(1993-11#1)(1993-6#1)(1995-12#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-7#1)(2008-9#1)
of exons##9##2##(1990-8#1)(1991-5#1)(1991-6#1)(1993-11#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#1)(2008-9#1)
of exotic species##3##3##(2010-3#3)
of exotic##8##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#3)(2012-2#1)
of expanded##4##2##(2007-10#1)(2008-10#1)(2008-4#1)(2011-2#1)
of expander-implant##2##2##(2013-1#2)
of expanding##7##2##(1996-1#1)(2008-10#1)(2008-9#1)(2012-3#2)(2013-1#2)
of expansion of##2##3##(2008-10#1)(2012-3#1)
of expansion##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of expectant management##2##3##(2008-10#1)(2013-8#1)
of expectation##2##2##(2007-11#1)(2012-1#1)
of expectations and##2##3##(2008-9#1)(2013-1#1)
of expectations##4##2##(1995-1#1)(1996-3#1)(2008-9#1)(2013-1#1)
of expected##7##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-1#1)
of expenditure##3##2##(1991-2#1)(2008-9#2)
of expenditures on##2##3##(1990-11#1)(1997-1#1)
of expenditures##8##2##(1990-11#1)(1991-12#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#1)
of expense##2##2##(2008-12#2)
of expensive##4##2##(1992-12#1)(1993-11#1)(2008-10#1)(2010-4#1)
of experience and##3##3##(1994-3#1)(2007-12#1)(2008-1#1)
of experience in##7##3##(1991-9#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-12#1)
of experience with##2##3##(1995-3#1)(2007-8#1)
of experience##30##2##(1991-9#1)(1993-12#2)(1993-6#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#1)
of experienced##6##2##(1990-10#1)(1991-6#1)(2008-11#1)(2010-12#1)(2012-2#2)
of experiences##4##2##(2007-4#1)(2008-11#1)(2012-2#1)(2012-3#1)
of experiencing##2##2##(2013-1#1)(2013-8#1)
of experiential learning in##2##4##(1995-1#2)
of experiential learning##4##3##(1995-1#3)(2008-11#1)
of experiential##7##2##(1995-1#3)(1996-1#2)(2008-11#2)
of experiment##8##2##(1992-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-8#1)
of experimental and##7##3##(1994-2#1)(1994-7#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-12#1)
of experimental animals##6##3##(1992-9#1)(1994-5#1)(2008-4#1)(2010-7#1)(2012-1#1)(2013-1#1)
of experimental approaches##2##3##(1995-6#1)(2008-8#1)
of experimental conditions##10##3##(2008-10#5)(2008-4#1)(2008-7#2)(2009-11#1)(2011-1#1)
of experimental data and##2##4##(2007-11#1)(2008-4#1)
of experimental data##17##3##(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2013-8#1)
of experimental design and##2##4##(2008-10#1)(2008-8#1)
of experimental design##3##3##(2008-10#2)(2008-8#1)
of experimental designs##3##3##(1994-11#1)(2008-7#1)(2012-12#1)
of experimental diets##2##3##(2010-2#2)
of experimental error##3##3##(1990-7#1)(1990-8#1)(2008-10#1)
of experimental errors##2##3##(2008-2#1)(2008-3#1)
of experimental factors##2##3##(2008-10#1)(2011-2#1)
of experimental investigations##2##3##(2008-10#1)(2008-3#1)
of experimental parameters##9##3##(1997-2#1)(2008-10#7)(2011-1#1)
of experimental procedures##2##3##(1996-12#1)(2008-9#1)
of experimental research##2##3##(2008-11#1)(2008-3#1)
of experimental results and##2##4##(2007-12#1)(2008-3#1)
of experimental results##7##3##(1995-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
of experimental studies##2##3##(2008-3#1)(2008-7#1)
of experimental techniques##2##3##(2008-6#1)(2008-7#1)
of experimental variables##2##3##(2008-10#2)
of experimental##130##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-12#1)(1997-2#2)(1997-3#1)(2007-11#4)(2007-12#3)(2008-10#29)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
of experimentally induced##4##3##(2007-12#1)(2007-6#1)(2009-11#1)(2012-3#1)
of experimentally measured##2##3##(2008-10#1)(2008-11#1)
of experimentally##14##2##(1995-12#1)(1995-5#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-7#2)(2012-3#1)(2013-1#1)
of experimentation##2##2##(2008-10#1)(2008-7#1)
of experiments carried out##2##4##(2008-5#1)(2008-6#1)
of experiments on##4##3##(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
of experiments was carried out##2##5##(1993-8#1)(2008-6#1)
of experiments was##5##3##(1993-8#1)(1994-3#1)(1997-4#1)(2008-6#1)(2008-8#1)
of experiments were##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
of experiments##54##2##(1990-12#1)(1992-6#2)(1993-3#2)(1993-8#2)(1994-12#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-4#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-8#1)
of expert##7##2##(1992-10#1)(1992-3#1)(1993-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
of expertise##7##2##(1990-11#1)(1992-1#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)
of experts in##2##3##(2007-2#1)(2011-10#1)
of experts##6##2##(1991-3#1)(2007-2#1)(2008-3#1)(2011-10#2)(2013-1#1)
of expirated##2##2##(2010-5#2)
of expired air condensate in children with recurrent bronchitis##2##9##(2011-1#2)
of expired##4##2##(2008-1#2)(2011-1#2)
of explanations##2##2##(2009-10#1)(2011-1#1)
of explanatory variables##2##3##(2008-4#1)(2010-1#1)
of explanatory##4##2##(1997-8#1)(2008-4#1)(2008-7#1)(2010-1#1)
of explantation##3##2##(2008-10#1)(2008-9#2)
of explants##3##2##(1990-3#1)(2008-12#1)(2008-8#1)
of explicit##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
of exploitation##3##2##(1995-5#3)
of exploiting##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
of exploration of the##2##4##(1992-8#1)(1993-12#1)
of exploration##6##2##(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#1)(2009-2#1)
of exploratory##2##2##(1993-6#1)(2008-10#1)
of exploring##5##2##(2007-12#1)(2008-1#1)(2008-8#2)(2009-5#1)
of explosion##3##2##(1992-9#1)(2009-10#2)
of explosive compounds##2##3##(2008-10#2)
of explosive##7##2##(2008-10#6)(2009-10#1)
of explosives and##2##3##(2008-10#2)
of explosives in##2##3##(2008-10#2)
of explosives using##2##3##(2008-10#2)
of explosives##20##2##(2008-10#19)(2008-3#1)
of exponential growth##4##3##(2008-11#1)(2008-7#2)(2009-12#1)
of exponential##5##2##(2008-11#2)(2008-7#2)(2009-12#1)
of exposed groups was similar to that of control groups##2##10##(2008-9#2)
of exposed individuals##3##3##(1991-12#2)(1995-3#1)
of exposed males and females##5##5##(2008-9#5)
of exposed males##7##3##(2008-9#7)
of exposed##14##2##(1991-12#2)(1995-3#1)(2008-9#9)(2010-12#1)(2011-2#1)
of exposure and covariate##2##4##(1992-6#2)
of exposure and the##2##4##(2008-10#1)(2008-2#1)
of exposure and##13##3##(1990-5#1)(1992-6#2)(1995-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
of exposure at the##2##4##(2008-5#1)(2013-1#1)
of exposure at##4##3##(1997-4#1)(2008-12#1)(2008-5#1)(2013-1#1)
of exposure compared to##2##4##(2008-5#1)(2011-2#1)
of exposure compared##3##3##(1995-3#1)(2008-5#1)(2011-2#1)
of exposure in##2##3##(1991-12#1)(2008-7#1)
of exposure of the##3##4##(2007-12#1)(2008-11#1)(2008-8#1)
of exposure of##4##3##(1996-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
of exposure on##2##3##(2008-10#1)(2012-4#1)
of exposure time##2##3##(2007-12#1)(2008-10#1)
of exposure to a##2##4##(2008-11#1)(2012-12#1)
of exposure to aflatoxins##2##4##(1991-11#2)
of exposure to asbestos##2##4##(1991-12#2)
of exposure to the##6##4##(1992-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
of exposure to violence##2##4##(2008-11#1)(2009-9#1)
of exposure to##58##3##(1991-11#2)(1991-12#2)(1992-11#2)(1992-3#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#2)(2009-7#3)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
of exposure##141##2##(1990-5#1)(1991-11#2)(1991-12#4)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#2)(1993-1#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#6)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-12#5)(2007-2#3)(2007-8#1)(2008-10#20)(2008-11#5)(2008-12#5)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#1)(2009-12#3)(2009-7#4)(2009-9#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#1)
of exposures and##2##3##(2009-9#1)(2011-1#1)
of exposures##5##2##(1991-12#1)(1996-12#1)(2008-10#1)(2009-9#1)(2011-1#1)
of expressed enzyme##2##3##(1990-12#1)(1995-5#1)
of expressed genes##3##3##(1996-10#1)(2008-2#1)(2008-4#1)
of expressed sequence tags (ESTs)##4##5##(1995-8#1)(1997-6#1)(2010-4#1)(2013-8#1)
of expressed sequence tags##8##4##(1995-8#1)(1997-6#1)(2008-7#1)(2010-4#4)(2013-8#1)
of expressed##18##2##(1990-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of expressing a##2##3##(2008-1#1)(2008-8#1)
of expressing##10##2##(1992-3#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-8#1)(2013-1#1)
of expression and##4##3##(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)
of expression are##2##3##(1994-8#1)(2013-8#1)
of expression data##2##3##(2008-4#1)(2008-7#1)
of expression during##2##3##(1991-9#1)(1995-2#1)
of expression for##2##3##(2008-10#1)(2011-1#1)
of expression in##7##3##(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1997-1#1)(1997-6#1)(1997-7#1)
of expression of cell##2##4##(2008-10#1)(2012-1#1)
of expression of the reporter gene##2##6##(2008-11#1)(2011-1#1)
of expression of the##23##4##(1992-3#1)(1993-3#1)(1993-9#2)(1994-11#1)(1995-12#1)(1995-8#2)(1996-5#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)
of expression of##49##3##(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#2)(1995-8#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-4#2)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
of expression profiles##3##3##(2008-7#2)(2008-9#1)
of expression vectors##3##3##(1991-6#1)(1993-2#1)(1994-12#1)
of expression was##2##3##(1997-4#1)(2008-9#1)
of expression##110##2##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-8#3)(1995-9#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-4#4)(1997-6#1)(1997-7#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#8)(2008-2#1)(2008-4#6)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-8#1)
of expressive##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
of extant##5##2##(2007-12#1)(2008-1#1)(2008-4#1)(2012-2#1)(2012-3#1)
of extended colostrum feeding on##2##5##(2012-2#2)
of extended extinction##2##3##(2008-5#2)
of extended spectrum##2##3##(2007-7#1)(2012-2#1)
of extended##17##2##(1990-6#1)(1990-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2010-11#1)(2012-2#3)(2013-1#1)
of extended-MDR##2##2##(2008-11#2)
of extended-release##2##2##(2010-4#1)(2011-1#1)
of extending the##2##3##(2008-11#1)(2008-3#1)
of extending##5##2##(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
of extension##5##2##(1993-5#1)(1995-12#1)(1997-2#2)(2008-11#1)
of extensions##2##2##(1990-12#1)(2013-1#1)
of extensive##27##2##(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1997-3#1)(2006-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
of extensor muscle afferents##2##4##(1997-2#2)
of extensor muscle##3##3##(1997-2#3)
of extensor##6##2##(1995-8#1)(1997-2#3)(2010-3#1)(2012-2#1)
of exterior##2##2##(1993-2#2)
of external ATP##2##3##(2008-4#2)
of external Ca2+##7##3##(1990-7#1)(1992-11#1)(1992-12#2)(1993-12#2)(1993-3#1)
of external and internal##5##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
of external electric field##2##4##(2007-12#1)(2008-9#1)
of external fixation##2##3##(2008-8#2)
of external male##2##3##(2008-2#1)(2012-3#1)
of external##69##2##(1990-5#1)(1990-7#1)(1991-11#1)(1992-11#2)(1992-12#2)(1993-12#2)(1993-3#2)(1994-2#1)(1996-6#2)(1996-8#1)(1997-7#1)(2007-11#5)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of extinction and##2##3##(2008-2#1)(2008-3#1)
of extinction error##2##3##(2008-3#2)
of extinction of##2##3##(2008-9#1)(2009-8#1)
of extinction##18##2##(1991-5#1)(2008-2#1)(2008-3#6)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2013-8#1)
of extra pulmonary##2##3##(2011-2#2)
of extra##7##2##(1996-4#1)(2008-10#2)(2008-2#1)(2009-12#1)(2011-2#2)
of extra- and##2##3##(2008-11#1)(2008-7#1)
of extra-adrenal##2##2##(1990-6#1)(2008-4#1)
of extra-articular##2##2##(2008-9#1)(2009-1#1)
of extra-hepatic##2##2##(1992-9#1)(2008-10#1)
of extracellular ATP##4##3##(1991-9#1)(2008-4#3)
of extracellular Ca++##2##3##(1991-9#1)(1993-8#1)
of extracellular Ca2+##7##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-3#1)(1994-6#1)(1996-12#1)(2008-8#1)
of extracellular K+##2##3##(1994-2#1)(1997-1#1)
of extracellular adenosine##3##3##(2008-4#3)
of extracellular calcium##9##3##(1990-12#1)(1990-5#1)(1990-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)
of extracellular matrix (ECM)##3##4##(2009-10#1)(2009-12#1)(2013-8#1)
of extracellular matrix and##2##4##(2008-9#1)(2009-8#1)
of extracellular matrix genes##2##4##(1990-5#1)(1992-8#1)
of extracellular matrix proteins##2##4##(1994-12#1)(2008-9#1)
of extracellular matrix##12##3##(1990-5#1)(1992-8#1)(1994-12#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
of extracellular nucleotides##4##3##(2008-4#3)(2013-8#1)
of extracellular purines##2##3##(2013-8#2)
of extracellular signal-regulated kinase 1/2##2##5##(2008-10#1)(2010-12#1)
of extracellular signal-regulated kinase##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
of extracellular signal-regulated##4##3##(2008-10#1)(2010-12#1)(2011-2#2)
of extracellular signals##4##3##(1994-11#1)(1995-2#1)(2009-8#2)
of extracellular##98##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#8)(2008-11#4)(2008-4#14)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#3)(2010-12#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-8#4)
of extracellularly##2##2##(1997-7#1)(2008-4#1)
of extrachromosomal##3##2##(2007-12#2)(2008-10#1)
of extracorporeal circulation##4##3##(2010-8#4)
of extracorporeal##7##2##(1997-6#1)(2007-8#1)(2008-11#1)(2010-8#4)
of extracranial carotid artery##2##4##(1992-5#1)(2008-7#1)
of extracranial##7##2##(1992-5#1)(2007-10#1)(2008-7#3)(2012-3#2)
of extract from##3##3##(1996-12#1)(2008-10#2)
of extract of Apocynum venetum##2##5##(2011-3#2)
of extract of##3##3##(1994-2#1)(2011-3#2)
of extract were added to##2##5##(2008-10#1)(2008-12#1)
of extract##11##2##(1992-6#1)(1994-2#1)(1996-12#1)(2008-10#3)(2008-12#3)(2011-3#2)
of extractable arsenic in##2##4##(2008-10#2)
of extractable##7##2##(2008-10#5)(2008-11#1)(2008-12#1)
of extractant##2##2##(2008-10#2)
of extractants##3##2##(2008-10#3)
of extracted##9##2##(1991-3#1)(2007-8#1)(2008-10#6)(2008-3#1)
of extracting##4##2##(2008-10#3)(2008-2#1)
of extraction and##4##3##(2008-10#4)
of extraction are##2##3##(2008-10#2)
of extraction conditions##2##3##(2008-10#1)(2008-6#1)
of extraction of##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
of extraction was##2##3##(2008-10#2)
of extraction##45##2##(2008-10#37)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of extractions##2##2##(2008-2#1)(2010-3#1)
of extracts from##7##3##(1990-12#1)(1993-3#1)(2008-10#3)(2012-1#1)(2012-3#1)
of extracts of##3##3##(1993-6#1)(1997-6#1)(2008-10#1)
of extracts##19##2##(1990-12#1)(1993-3#1)(1993-6#1)(1997-6#1)(2007-2#1)(2008-10#11)(2010-2#1)(2012-1#1)(2012-3#1)
of extradural anterior clinoidectomy via the trans-SOF approach##2##8##(2011-2#2)
of extraintestinal##4##2##(1997-3#1)(2010-12#1)(2013-8#2)
of extraneous##2##2##(2008-10#1)(2008-2#1)
of extraordinary##3##2##(2008-3#1)(2009-6#1)(2010-3#1)
of extrapolation##2##2##(1991-8#1)(1995-11#1)
of extrapulmonary##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
of extrathoracic##2##2##(2008-11#1)(2008-7#1)
of extreme importance##2##3##(2011-1#1)(2011-2#1)
of extreme outgroups##2##3##(2008-11#2)
of extreme##19##2##(1990-6#1)(1991-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
of extreme-ultraviolet optics##2##3##(2008-3#2)
of extreme-ultraviolet##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
of extremely low frequency electromagnetic fields##2##6##(2008-12#1)(2011-2#1)
of extremely low##4##3##(1991-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
of extremely short##2##3##(2008-2#2)
of extremely##13##2##(1991-6#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
of extremities##3##2##(2006-10#1)(2007-7#1)(2011-1#1)
of extrinsic phospholipid##3##3##(2008-9#3)
of extrinsic##11##2##(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#4)(2010-12#1)(2010-3#1)(2011-2#1)
of exudative##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
of eye gaze##2##3##(2007-4#1)(2012-12#1)
of eye##20##2##(1990-11#1)(1990-3#1)(1990-9#1)(1993-11#1)(2007-4#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-8#1)
of eyes##6##2##(1992-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
of eyespot##3##2##(2008-10#2)(2008-9#1)
of eyestalk posture##3##3##(2008-5#3)
of ezetimibe and low-dose simvastatin##2##5##(2011-2#2)
of ezetimibe##4##2##(2011-2#2)(2012-2#2)
of f##2##2##(2008-10#1)(2013-1#1)
of fMRI##2##2##(2008-11#2)
of fabricating a##2##3##(2008-3#1)(2013-1#1)
of fabricating##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
of fabrication errors and##2##4##(2008-3#2)
of fabrication errors##4##3##(2008-2#2)(2008-3#2)
of fabrication##12##2##(2008-10#2)(2008-2#3)(2008-3#7)
of fac-Re(CO)(3)(dpknph)Cl##12##2##(2008-10#12)
of face and volar forearm##2##5##(2008-5#2)
of face and##4##3##(1991-11#1)(2008-5#2)(2008-7#1)
of face representation in the cingulate##2##6##(1996-5#2)
of face##12##2##(1991-11#1)(1996-5#2)(2008-11#2)(2008-5#3)(2008-7#1)(2009-10#1)(2009-7#1)(2012-1#1)
of faces and objects##2##4##(2007-8#1)(2009-10#1)
of faces and##4##3##(2007-8#1)(2009-10#1)(2009-8#1)(2012-1#1)
of faces##13##2##(1991-11#1)(1995-6#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-10#3)(2009-8#1)(2012-1#1)(2013-8#1)
of facial cellulitis##2##3##(2013-1#2)
of facial components##3##3##(1995-6#3)
of facial expression##2##3##(2008-11#2)
of facial expressions##5##3##(2008-11#4)(2009-8#1)
of facial features##3##3##(2007-8#1)(2012-12#1)(2012-2#1)
of facial motion##2##3##(2007-8#2)
of facial nerve##2##3##(2008-9#1)(2013-8#1)
of facial skin##2##3##(1997-2#1)(2007-12#1)
of facial wrinkles##2##3##(2008-5#2)
of facial##42##2##(1993-1#1)(1995-6#4)(1997-2#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-11#6)(2008-12#1)(2008-5#5)(2008-6#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
of facilitating##7##2##(1991-1#1)(2008-12#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
of facilitative glucose transporter##2##4##(1993-6#2)
of facilitators##2##2##(2010-10#2)
of facilities##7##2##(1992-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(2007-12#1)(2010-8#1)(2011-1#1)
of facility##5##2##(1992-2#3)(1994-1#1)(2008-2#1)
of factor 2##2##3##(1995-2#2)
of factor H##2##3##(2009-6#2)
of factor IX##2##3##(1995-2#1)(2008-9#1)
of factor VIII##2##3##(2011-2#2)
of factor VIIa##2##3##(1995-6#2)
of factor Va with##2##4##(1993-11#1)(1994-5#1)
of factor Va##4##3##(1993-11#2)(1994-5#2)
of factor XI by##2##4##(1991-9#2)
of factor XIII##5##3##(1995-12#1)(2008-11#4)
of factor b##2##3##(1993-12#2)
of factor##29##2##(1991-9#2)(1993-11#2)(1993-12#2)(1994-5#2)(1995-12#1)(1995-2#3)(1995-6#2)(2008-10#2)(2008-11#5)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#2)(2013-8#1)
of factorial##3##2##(2008-10#2)(2008-5#1)
of factors affecting##2##3##(2008-2#1)(2013-8#1)
of factors and##3##3##(2008-10#2)(2013-1#1)
of factors associated with##6##4##(1996-3#1)(2007-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
of factors by##2##3##(1991-2#1)(2008-4#1)
of factors in##2##3##(1995-3#1)(2008-10#1)
of factors including##5##3##(2008-1#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
of factors influencing##5##3##(1994-3#1)(1997-1#1)(2007-5#1)(2008-7#1)(2009-5#1)
of factors must be##2##4##(2008-7#1)(2009-8#1)
of factors required for##2##4##(1995-3#1)(2011-1#1)
of factors required##3##3##(1992-9#1)(1995-3#1)(2011-1#1)
of factors such as##2##4##(1993-12#1)(2008-10#1)
of factors that influence the##3##5##(1993-11#1)(1995-9#1)(2008-9#1)
of factors that influence##4##4##(1993-11#1)(1995-12#1)(1995-9#1)(2008-9#1)
of factors that##14##3##(1992-12#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-2#1)
of factors which##3##3##(1994-8#1)(1997-2#1)(2008-11#1)
of factors##91##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#21)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#2)
of faculty##9##2##(1993-2#1)(1996-1#1)(2008-11#3)(2008-12#2)(2010-3#1)(2013-1#1)
of fading##2##2##(2008-2#1)(2008-5#1)
of faecal##2##2##(1993-8#1)(2007-6#1)
of failed##3##2##(2008-8#1)(2010-5#1)(2010-7#1)
of failing##4##2##(2007-8#1)(2008-1#1)(2008-7#1)(2012-2#1)
of failure and##3##3##(2008-11#1)(2009-4#1)(2011-2#1)
of failure as##2##3##(2008-9#1)(2009-7#1)
of failure of##7##3##(1993-10#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
of failure to##3##3##(1996-12#1)(2008-1#1)(2010-3#1)
of failure was##2##3##(1991-2#1)(2008-12#1)
of failure##33##2##(1991-2#1)(1993-10#1)(1994-12#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-3#2)(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#1)
of failures##4##2##(1990-11#1)(1993-12#1)(1994-3#1)(2011-2#1)
of fairly##2##2##(2008-5#1)(2011-2#1)
of fairness##4##2##(1992-2#1)(1992-3#1)(1994-3#1)(2009-6#1)
of faith development##2##3##(2008-12#1)(2011-1#1)
of faith##5##2##(2008-12#2)(2009-11#1)(2009-5#1)(2011-1#1)
of falciparum malaria##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
of fall##4##2##(1991-9#1)(2008-10#1)(2010-11#1)(2010-3#1)
of falling##3##2##(2008-2#1)(2008-4#1)(2010-11#1)
of falls and##2##3##(2007-11#1)(2008-7#1)
of falls in##5##3##(1994-12#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-3#1)
of falls##16##2##(1993-11#1)(1994-12#1)(1997-6#1)(2007-11#7)(2007-2#1)(2008-3#1)(2008-7#2)(2010-3#2)
of false negative results##2##4##(1997-2#1)(2008-10#1)
of false negatives##2##3##(1994-11#1)(1996-9#1)
of false positive##2##3##(1997-2#1)(2008-8#1)
of false positives and##3##4##(2008-10#2)(2008-7#1)
of false positives##5##3##(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
of false##19##2##(1990-3#1)(1994-11#1)(1996-9#1)(1997-2#2)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#2)(2011-2#1)
of false-negative##2##2##(1992-8#1)(1996-9#1)
of false-negatives##5##2##(2010-10#1)(2012-12#4)
of false-positive and false-negative results##2##5##(1997-4#1)(2008-4#1)
of false-positive##5##2##(1997-4#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
of false-positives and##2##3##(2008-7#1)(2010-10#1)
of false-positives##3##2##(2008-7#1)(2010-10#1)(2012-12#1)
of familial coaggregation##2##3##(1997-5#2)
of familial moyamoya disease##2##4##(2007-10#2)
of familial parkinsonism##2##3##(2008-7#2)
of familial##31##2##(1991-3#1)(1991-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1995-6#1)(1995-8#1)(1997-5#3)(2007-10#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#4)(2009-12#1)(2010-4#1)(2010-7#1)(2012-1#2)(2012-3#1)
of familiar melodies##2##3##(2008-9#2)
of familiar##6##2##(2007-12#1)(2008-1#2)(2008-9#2)(2009-12#1)
of familiarity##6##2##(2007-10#1)(2007-12#1)(2008-4#1)(2008-8#2)(2011-2#1)
of families in##3##3##(1991-3#2)(2011-2#1)
of families of ncRNAs##2##4##(2008-4#2)
of families with multiple affected members##2##6##(1996-2#1)(1997-5#1)
of families with##7##3##(1992-1#1)(1995-5#1)(1996-2#1)(1997-5#3)(2011-1#1)
of families##21##2##(1991-3#2)(1992-1#1)(1993-2#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-2#2)(1997-5#3)(2007-5#1)(2008-1#1)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
of family and peer##2##4##(2007-2#1)(2013-1#1)
of family and##4##3##(1992-12#1)(2007-2#1)(2010-8#1)(2013-1#1)
of family connectedness##3##3##(2010-10#3)
of family dinners##5##3##(2013-1#5)
of family functioning##5##3##(1996-1#2)(2011-1#1)(2013-1#2)
of family life##2##3##(2011-2#1)(2013-1#1)
of family medicine##3##3##(1997-4#1)(2007-10#1)(2008-12#1)
of family members of##2##4##(2008-11#1)(2011-2#1)
of family members##7##3##(1997-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)
of family planning clinics##2##4##(1991-1#1)(1994-8#1)
of family planning from##2##4##(1991-1#1)(1992-4#1)
of family planning##7##3##(1991-1#3)(1992-4#1)(1994-8#3)
of family practice##2##3##(1992-1#1)(1995-8#1)
of family support##2##3##(1995-1#1)(2008-7#1)
of family##87##2##(1991-1#4)(1991-12#1)(1991-3#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-8#3)(1995-1#2)(1995-3#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#3)(2008-9#2)(2009-10#2)(2009-11#3)(2009-12#1)(2009-9#1)(2010-10#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#11)(2013-8#2)
of family-centered care##2##3##(1993-12#1)(1994-3#1)
of family-centered pediatric care##2##4##(2010-9#2)
of family-centered##7##2##(1991-12#2)(1993-12#1)(1994-3#2)(2010-9#2)
of famotidine were##2##3##(2008-10#2)
of famotidine##5##2##(2008-10#4)(2012-2#1)
of far-field scattering##2##3##(2007-11#1)(2008-2#1)
of far-field##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
of farm##9##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-4#1)(2013-1#2)
of farmers##2##2##(1995-8#1)(1996-3#1)
of farming##3##2##(2008-12#2)(2010-5#1)
of farms##2##2##(2008-10#1)(2010-1#1)
of farnesyl diphosphate##2##3##(1995-2#2)
of fascia##4##2##(1991-2#1)(2009-9#2)(2013-1#1)
of fascial##5##2##(1991-2#2)(1992-1#1)(2008-9#1)(2009-9#1)
of fasciitis##3##2##(2006-10#3)
of fasciolosis##2##2##(2008-12#2)
of fast analysis##2##3##(2008-10#1)(2010-9#1)
of fast and##2##3##(2008-10#1)(2012-2#1)
of fast##20##2##(1995-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-3#3)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#2)
of fast-reaction##2##2##(1995-5#1)(2008-10#1)
of fast-twitch##2##2##(1996-2#2)
of fasting and refeeding on##2##5##(2008-7#2)
of fasting##15##2##(1991-7#2)(1992-6#2)(1992-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2012-2#1)(2012-3#3)
of fat and##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
of fat grafting##3##3##(2013-1#3)
of fat in the##2##4##(2008-6#1)(2012-2#1)
of fat injection##3##3##(2011-2#1)(2013-1#2)
of fat mass##3##3##(2008-3#2)(2008-4#1)
of fat necrosis##4##3##(2007-10#1)(2013-1#3)
of fat tissue and##2##4##(2011-1#1)(2012-3#1)
of fat tissue##4##3##(2011-1#2)(2012-1#1)(2012-3#1)
of fat##43##2##(1993-9#1)(1995-2#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#8)
of fatal and##3##3##(2007-2#2)(2011-2#1)
of fatal##13##2##(1991-11#1)(1992-9#1)(1995-11#1)(1996-6#1)(2007-2#2)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#3)
of fathers##3##2##(1997-3#1)(2010-3#2)
of fatigue and low-grade##2##4##(2007-8#1)(2012-3#1)
of fatigue##13##2##(1992-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#4)(2009-7#1)(2010-8#2)(2012-3#1)(2013-1#1)
of fatty acid and##2##4##(1995-6#1)(2012-3#1)
of fatty acid metabolism##3##4##(2008-1#1)(2012-2#2)
of fatty acid methyl esters##3##5##(2008-10#3)
of fatty acid synthesis##3##4##(1992-4#1)(1992-8#1)(1995-6#1)
of fatty acid##23##3##(1991-2#1)(1992-4#3)(1992-6#1)(1992-8#2)(1993-3#1)(1995-6#2)(1996-6#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#2)(2012-3#1)
of fatty acids and##2##4##(1994-8#1)(2013-1#1)
of fatty acids from##4##4##(2008-10#2)(2008-6#1)(2009-8#1)
of fatty acids in##3##4##(1995-6#1)(2012-2#1)(2012-3#1)
of fatty acids##26##3##(1990-12#1)(1990-8#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-6#2)(1996-7#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2009-8#2)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
of fatty change in hepatocytes of##2##6##(2008-9#2)
of fatty liver deposition##2##4##(2012-2#2)
of fatty tissue##2##3##(1993-3#1)(2008-1#1)
of fatty##58##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-4#3)(1992-6#1)(1992-8#3)(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#4)(1996-6#1)(1996-7#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#2)(2010-12#1)(2010-4#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#1)
of fault##2##2##(1996-4#2)
of faults and the##2##4##(1996-4#2)
of faults##6##2##(1996-4#6)
of faulty##2##2##(2007-7#1)(2012-2#1)
of favorable##2##2##(1993-11#1)(1997-1#1)
of fear and##2##3##(1990-12#1)(2009-8#1)
of fear of##2##3##(1996-6#2)
of fear##11##2##(1990-12#1)(1996-6#2)(2007-4#1)(2007-8#1)(2008-11#2)(2009-8#1)(2010-2#1)(2010-9#1)(2013-8#1)
of fearful##3##2##(2007-4#2)(2008-11#1)
of feasibility##2##2##(2008-10#1)(2010-5#1)
of feather##7##2##(1997-6#1)(2008-5#1)(2008-6#4)(2008-9#1)
of feature##2##2##(2013-8#2)
of features and##2##3##(2008-6#1)(2011-2#1)
of features in##2##3##(2008-6#1)(2009-9#1)
of features of##2##3##(2008-3#2)
of features##18##2##(1994-2#2)(1995-2#1)(1996-4#1)(1997-7#1)(2008-3#4)(2008-6#3)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
of febrile neutropenia##4##3##(2008-11#2)(2008-7#2)
of febrile##11##2##(1993-7#1)(1993-8#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-7#2)(2012-3#1)
of fecal##7##2##(1990-12#1)(1995-5#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
of feces and##2##3##(2007-10#1)(2008-10#1)
of feces in a loop of sigmoid colon##2##8##(2008-12#2)
of feces##5##2##(2007-10#1)(2008-10#2)(2008-12#2)
of fed-batch culture##2##3##(2008-6#1)(2008-7#1)
of fed-batch##5##2##(2008-11#1)(2008-6#2)(2008-7#2)
of federal and state##3##4##(1996-1#2)(2008-10#1)
of federal health##2##3##(1994-12#1)(1996-12#1)
of federal##13##2##(1990-10#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(2007-4#1)(2008-10#1)(2010-4#1)(2011-9#1)
of fee##2##2##(1992-2#1)(2013-1#1)
of fee-for-service##2##2##(1996-2#1)(1997-2#1)
of feed in##2##3##(2008-10#1)(2008-5#1)
of feed rate on##2##4##(2008-11#2)
of feed##19##2##(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-5#2)(2010-4#2)(2011-1#1)(2013-1#1)
of feed-forward##2##2##(2008-10#1)(2008-4#1)
of feedback and##2##3##(1991-3#1)(2009-10#1)
of feedback##13##2##(1991-3#1)(1996-12#1)(2007-10#2)(2007-11#2)(2009-10#3)(2011-2#1)(2013-8#3)
of feeder cells##5##3##(1993-9#4)(2008-9#1)
of feeding and##3##3##(2008-8#2)(2011-2#1)
of feeding behavior in##2##4##(1993-6#1)(2008-11#1)
of feeding difficulties and##2##4##(2010-9#2)
of feeding difficulties##3##3##(2010-9#3)
of feeding fermented fish##2##4##(2010-2#2)
of feeding frequency on non-carcass components and wholesale cuts##2##9##(2008-12#2)
of feeding frequency##3##3##(2008-12#3)
of feeding in##3##3##(1993-12#1)(2008-12#2)
of feeding non-fibrous carbohydrate##2##4##(2012-2#2)
of feeding##43##2##(1993-12#1)(1993-6#2)(1994-2#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#6)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-9#3)(2011-2#2)(2012-12#1)(2012-2#3)
of feelings##2##2##(1991-3#1)(2008-11#1)
of feline immunodeficiency virus##2##4##(1997-3#2)
of feline##6##2##(1997-3#2)(2008-11#3)(2013-8#1)
of female and male##4##4##(1990-3#1)(2008-12#1)(2008-5#1)(2010-4#1)
of female breast##2##3##(1990-12#1)(1992-2#1)
of female carriers##2##3##(2007-7#1)(2011-2#1)
of female genital##2##3##(1995-9#1)(1996-12#1)
of female managers##2##3##(2012-3#2)
of female migration to##2##4##(2011-2#2)
of female patients with##2##4##(2007-9#1)(2013-8#1)
of female patients##3##3##(2007-11#1)(2007-9#1)(2013-8#1)
of female preferences##2##3##(2008-8#1)(2009-9#1)
of female rats##6##3##(1990-11#1)(1993-6#1)(1995-3#1)(1995-8#2)(2013-1#1)
of female sex##2##3##(2008-7#1)(2010-8#1)
of female sexual##2##3##(1993-9#1)(2009-10#1)
of female urinary incontinence##2##4##(1994-5#2)
of female##96##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-6#3)(1992-12#1)(1992-2#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-5#2)(1995-12#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#6)(2008-5#5)(2008-7#2)(2008-8#6)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
of female-search##3##2##(2008-5#1)(2008-6#2)
of female-searching males##2##3##(2008-6#2)
of female-searching##3##2##(2008-6#3)
of females and##3##3##(2008-7#1)(2008-9#1)(2013-8#1)
of females in the##2##4##(2008-9#2)
of females with##2##3##(1991-5#1)(2012-2#1)
of females##37##2##(1990-6#1)(1991-5#1)(1994-6#3)(1995-8#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#11)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
of feminine##2##2##(2009-10#2)
of femoral artery##2##3##(2008-1#1)(2008-7#1)
of femoral bone##3##3##(2007-11#3)
of femoral head necrosis##2##4##(1992-11#1)(1994-7#1)
of femoral head##3##3##(1992-11#1)(1994-7#1)(2007-11#1)
of femoral neck fractures##3##4##(1991-9#2)(2007-8#1)
of femoral neck##5##3##(1991-9#2)(2007-11#1)(2007-8#1)(2011-2#1)
of femoral nerve palsy secondary to##2##6##(2009-3#2)
of femoral##20##2##(1991-9#2)(1992-11#1)(1994-7#1)(2007-11#6)(2007-8#1)(2008-1#1)(2008-7#2)(2009-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
of femtosecond laser pulses##5##4##(2007-11#3)(2007-12#1)(2008-2#1)
of femtosecond optical##2##3##(2007-11#1)(2008-3#1)
of femtosecond pulse##2##3##(2007-11#1)(2007-12#1)
of femtosecond pulses by use of a##2##7##(2007-11#2)
of femtosecond pulses by##3##4##(2007-11#3)
of femtosecond pulses from a Ti##2##6##(2007-12#2)
of femtosecond pulses in a##2##5##(2007-11#1)(2007-12#1)
of femtosecond pulses in##4##4##(2007-11#1)(2007-12#3)
of femtosecond pulses##18##3##(2007-11#8)(2007-12#10)
of femtosecond##36##2##(2007-11#17)(2007-12#17)(2008-2#1)(2008-3#1)
of femur##7##2##(1991-11#1)(2007-11#5)(2008-7#1)
of fenspiride##2##2##(1995-12#2)
of ferbam in##2##3##(2008-10#2)
of ferbam##6##2##(2008-10#6)
of fermentation and##2##3##(2008-7#2)
of fermentation##9##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2012-3#1)
of fermented##4##2##(2010-2#2)(2010-4#1)(2011-1#1)
of fermenting##2##2##(2008-10#1)(2012-3#1)
of fern##3##2##(2008-5#2)(2008-8#1)
of ferric##5##2##(1990-8#2)(2008-10#2)(2008-11#1)
of ferriprotoporphyrin IX##2##3##(1993-8#2)
of ferritin heavy chain mRNA##2##5##(1997-6#2)
of ferritin in##5##3##(1993-11#1)(2008-10#2)(2012-1#2)
of ferritin##17##2##(1990-5#3)(1993-11#1)(1996-5#1)(1997-6#2)(2008-10#4)(2012-1#4)(2013-8#2)
of ferroelectric##2##2##(2008-2#2)
of ferromagnetic##4##2##(1992-11#1)(2008-7#2)(2009-11#1)
of ferrous ion##2##3##(2008-11#1)(2013-1#1)
of ferrous##9##2##(1990-12#1)(1992-8#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-11#1)(2013-1#1)
of fertile##3##2##(1996-10#1)(1996-12#2)
of fertility##6##2##(1996-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)
of fertilization in##2##3##(1994-9#1)(2011-1#1)
of fertilization##5##2##(1994-9#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
of fertilized eggs##4##3##(1997-2#1)(2008-11#1)(2008-12#1)(2010-8#1)
of fertilized##5##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)
of fertilizer##2##2##(1996-12#1)(2008-12#1)
of ferulic acid by##2##4##(1994-5#1)(2008-10#1)
of ferulic acid##11##3##(1994-5#5)(2008-10#5)(2008-5#1)
of fetal alcohol syndrome (fas)##2##5##(2008-11#2)
of fetal alcohol##3##3##(2008-11#3)
of fetal and##2##3##(2008-7#2)
of fetal growth##3##3##(1994-3#1)(2007-5#1)(2011-1#1)
of fetal hemoglobin##4##3##(1992-3#2)(1996-12#1)(2009-9#1)
of fetal liver##2##3##(2008-10#1)(2008-9#1)
of fetal loss##3##3##(2006-10#1)(2011-1#2)
of fetal red blood cells##2##5##(2008-9#1)(2011-2#1)
of fetal##65##2##(1990-11#2)(1990-6#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-12#1)(1995-8#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-9#1)(2010-11#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
of fetuses with##3##3##(1990-2#1)(1993-12#1)(2012-12#1)
of fetuses##4##2##(1990-2#1)(1993-12#1)(1996-12#1)(2012-12#1)
of fever and##3##3##(1994-11#1)(2008-7#1)(2012-12#1)
of fever in children##2##4##(2007-2#1)(2008-11#1)
of fever in##7##3##(1994-3#3)(2007-2#1)(2008-11#1)(2008-7#2)
of fever##30##2##(1994-11#1)(1994-12#1)(1994-3#3)(1997-4#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of feverfew##2##2##(2008-10#2)
of few##9##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
of few-tillering##2##2##(2008-9#2)
of fewer##6##2##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#1)
of fiber Bragg grating##2##4##(2007-11#1)(2008-3#1)
of fiber Bragg gratings##10##4##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
of fiber Bragg##12##3##(2007-11#5)(2007-12#1)(2008-2#1)(2008-3#4)(2013-8#1)
of fiber bragg##2##3##(2008-3#2)
of fiber distributed-feedback lasers##2##4##(2008-3#2)
of fiber distributed-feedback##4##3##(2008-3#4)
of fiber grating##2##3##(2008-3#2)
of fiber gratings with##2##4##(2007-12#1)(2008-3#1)
of fiber gratings##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of fiber lasers##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of fiber optic##2##3##(2008-10#1)(2008-3#1)
of fiber tilt and position##2##5##(2008-2#2)
of fiber tilt##3##3##(2008-2#3)
of fiber##56##2##(1991-12#1)(2007-11#7)(2007-12#10)(2008-10#3)(2008-2#9)(2008-3#20)(2008-9#1)(2009-12#1)(2009-7#1)(2010-4#2)(2013-8#1)
of fiber-optic##6##2##(2007-11#1)(2008-3#5)
of fibers##9##2##(1991-1#1)(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
of fibre##5##2##(2008-10#1)(2009-7#2)(2010-4#2)
of fibres##2##2##(1996-5#1)(2009-7#1)
of fibril##3##2##(1991-11#1)(2007-8#1)(2011-2#1)
of fibrillar##5##2##(1994-5#1)(2008-1#1)(2008-5#2)(2008-8#1)
of fibrils##5##2##(1993-2#1)(1994-5#1)(2008-5#1)(2008-7#2)
of fibrin polymerization##2##3##(1994-9#1)(1995-3#1)
of fibrin##6##2##(1992-3#1)(1994-9#1)(1995-3#1)(1997-2#1)(2010-6#1)(2011-2#1)
of fibrinogen concentration##2##3##(2008-10#1)(2012-3#1)
of fibrinogen molecules##2##3##(1992-8#1)(1994-6#1)
of fibrinogen##17##2##(1990-5#1)(1992-8#1)(1993-8#3)(1994-5#2)(1994-6#1)(1995-2#3)(1996-2#1)(2006-6#1)(2008-10#3)(2012-3#1)
of fibrinolysis##2##2##(1994-9#1)(1995-8#1)
of fibrinolytic activity##2##3##(1990-5#1)(2010-3#1)
of fibrinolytic##3##2##(1990-5#1)(2007-5#1)(2010-3#1)
of fibro-osseous lesions##3##3##(2007-12#2)(2013-7#1)
of fibroblast and keratinocyte##2##4##(2008-9#1)(2012-3#1)
of fibroblast growth factor receptor##2##5##(2007-12#1)(2008-3#1)
of fibroblast growth##5##3##(1997-1#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
of fibroblast##9##2##(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
of fibroblasts with##2##3##(1994-5#1)(1995-3#1)
of fibroblasts##6##2##(1994-5#1)(1995-3#2)(2008-5#1)(2011-2#1)(2012-3#1)
of fibromatosis cells in##2##4##(2008-6#2)
of fibromatosis##3##2##(2008-6#3)
of fibromyalgia##4##2##(2006-10#1)(2009-11#1)(2013-1#2)
of fibronectin (FN)##2##3##(1994-11#1)(2010-4#1)
of fibronectin matrix assembly##2##4##(2008-1#2)
of fibronectin matrix##3##3##(2008-1#3)
of fibronectin##16##2##(1990-7#2)(1992-3#1)(1993-8#1)(1994-11#1)(1995-5#2)(2007-11#1)(2008-1#4)(2008-11#1)(2010-11#1)(2010-4#1)(2012-2#1)
of fibrosis##2##2##(1997-3#1)(2006-10#1)
of fibrotic##4##2##(2008-1#2)(2008-5#1)(2010-11#1)
of fibrous tissue##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
of fibrous tremolite##2##3##(1991-12#2)
of fibrous##11##2##(1991-12#2)(2006-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
of field and##7##3##(2008-10#3)(2008-12#2)(2008-3#1)(2012-2#1)
of field data##3##3##(2008-10#2)(2008-8#1)
of field experiments##4##3##(2008-10#1)(2008-12#2)(2008-2#1)
of field incidence##2##3##(2008-10#2)
of field populations of##5##4##(2008-10#5)
of field populations##6##3##(2008-10#6)
of field soil##2##3##(2008-10#2)
of field testing##2##3##(2008-10#1)(2008-12#1)
of field##70##2##(1993-12#1)(1994-3#1)(1995-12#2)(1996-1#1)(2007-10#1)(2007-11#1)(2008-10#36)(2008-12#5)(2008-2#1)(2008-3#11)(2008-8#1)(2010-9#1)(2011-2#2)(2011-8#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-7#1)
of field-collected##2##2##(2008-10#1)(2011-2#1)
of field-grown##4##2##(2008-10#4)
of fields in##3##3##(2008-10#1)(2008-3#2)
of fields that is sprayed##2##5##(2008-10#2)
of fields##10##2##(1990-11#1)(1990-7#1)(2008-10#3)(2008-3#2)(2010-1#1)(2011-8#1)(2012-1#1)
of fifteen beta-agonists##2##3##(2011-1#2)
of fifteen isolates identified as##2##5##(2008-10#2)
of fifteen##9##2##(1994-2#1)(1997-3#1)(2008-10#2)(2009-8#1)(2011-1#2)(2012-2#1)(2013-8#1)
of fifth instar##2##3##(2007-12#1)(2010-11#1)
of fifty##3##2##(1996-3#1)(2007-4#1)(2008-5#1)
of fig##2##2##(2008-10#2)
of fights##2##2##(2008-9#2)
of filament##4##2##(1993-8#1)(1995-2#1)(2008-8#1)(2009-10#1)
of filamentous actin (F-actin)##2##4##(1994-8#1)(1997-6#1)
of filamentous actin##4##3##(1994-8#1)(1997-6#1)(2008-9#1)(2011-2#1)
of filamentous fungi##6##3##(1991-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
of filamentous material##2##3##(2008-10#2)
of filamentous phage##2##3##(1993-8#1)(1994-12#1)
of filamentous##18##2##(1991-5#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
of filaments##2##2##(2008-7#1)(2012-1#1)
of filarial##4##2##(1994-11#2)(2007-7#1)(2008-4#1)
of filgrastim##3##2##(2008-7#3)
of filling##2##2##(1993-1#1)(2013-1#1)
of film thickness##2##3##(2008-10#2)
of film##12##2##(1993-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2012-3#1)
of films of##2##3##(2008-10#1)(2008-3#1)
of films##8##2##(2008-10#1)(2008-12#3)(2008-2#2)(2008-3#2)
of filopodia##2##2##(2008-7#1)(2012-7#1)
of filter paper##3##3##(2008-10#2)(2008-5#1)
of filter radiometers##2##3##(2008-2#2)
of filter##17##2##(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
of filters##4##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
of fimbrial##2##2##(1996-6#1)(2008-10#1)
of final##12##2##(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#3)(2008-9#1)(2010-4#1)(2012-2#1)
of financial and##3##3##(1995-12#1)(1997-3#1)(2007-2#1)
of financial resources and##2##4##(2010-3#1)(2011-2#1)
of financial resources##3##3##(1991-3#1)(2010-3#1)(2011-2#1)
of financial##16##2##(1991-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#2)(1997-3#1)(2007-2#1)(2008-11#4)(2008-7#1)(2010-3#1)(2011-2#1)
of financing##4##2##(1992-1#1)(1994-2#1)(1996-3#1)(2008-11#1)
of finasteride##10##2##(1994-11#4)(1995-9#1)(2008-5#2)(2011-2#2)(2012-3#1)
of finding the##2##3##(2008-3#1)(2011-2#1)
of finding##14##2##(1992-6#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#2)(2013-1#1)
of findings are##3##3##(1990-3#1)(1992-12#1)(1995-3#1)
of findings by##3##3##(1990-2#1)(1996-2#1)(2011-2#1)
of findings is##2##3##(2007-7#1)(2011-2#1)
of findings of##2##3##(2008-1#1)(2008-11#1)
of findings##18##2##(1990-2#1)(1990-3#1)(1990-6#1)(1992-12#1)(1992-3#1)(1995-3#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#3)
of fine needle aspiration cytology in##3##6##(1990-6#1)(2008-7#1)(2013-8#1)
of fine needle aspiration cytology##4##5##(1990-6#1)(2008-7#1)(2013-8#2)
of fine needle aspiration##5##4##(1990-6#1)(1991-3#1)(2008-7#1)(2013-8#2)
of fine needle##8##3##(1990-6#1)(1991-3#1)(1994-7#2)(1997-2#1)(2008-7#1)(2013-8#2)
of fine##16##2##(1990-6#1)(1991-3#1)(1994-7#2)(1997-2#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#2)
of fine-needle aspiration##2##3##(2008-6#1)(2011-1#1)
of fine-needle##3##2##(2008-6#1)(2008-9#1)(2011-1#1)
of finger##6##2##(2008-1#2)(2013-1#1)(2013-8#3)
of fingerprint##2##2##(2008-2#1)(2011-2#1)
of fingerprinting##2##2##(2008-10#2)
of fingers in##2##3##(2013-8#2)
of fingers##4##2##(1990-11#1)(2011-1#1)(2013-8#2)
of finished##4##2##(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
of finishing##6##2##(2008-12#2)(2012-2#3)(2012-7#1)
of finite extent##3##3##(2007-12#2)(2008-3#1)
of finite length##3##3##(1996-4#1)(2008-3#2)
of finite##17##2##(1992-3#1)(1996-4#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#8)(2011-2#1)(2013-1#1)
of finite-length##2##2##(2008-10#1)(2008-2#1)
of fire blight by##2##4##(2008-10#2)
of fire blight##19##3##(2008-10#19)
of fire##25##2##(1994-12#1)(1996-12#3)(2008-10#20)(2008-2#1)
of firefly luciferase##2##3##(1991-9#1)(2008-10#1)
of firing##2##2##(2008-8#1)(2009-10#1)
of first and second##2##4##(1992-11#1)(2007-11#1)
of first and##3##3##(1992-11#1)(2007-11#1)(2007-8#1)
of first choice##3##3##(1991-6#1)(1993-9#1)(2008-7#1)
of first order##2##3##(2008-10#1)(2008-6#1)
of first time users##3##4##(1996-9#3)
of first year##3##3##(2008-12#1)(2013-1#1)(2013-8#1)
of first##51##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-9#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#4)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
of first- and second-order comparator##2##5##(2008-5#2)
of first- and##3##3##(2008-5#2)(2012-12#1)
of first-degree relatives##2##3##(1995-9#1)(2013-8#1)
of first-episode##2##2##(2008-6#1)(2011-1#1)
of first-line##3##2##(1996-11#1)(1997-2#1)(2010-12#1)
of first-order##4##2##(1992-3#1)(2007-11#1)(2008-3#2)
of first-year##2##2##(2010-10#1)(2012-3#1)
of fiscal and##2##3##(1991-12#1)(1995-3#1)
of fiscal##4##2##(1991-12#1)(1995-3#1)(1996-12#1)(1997-2#1)
of fish and##3##3##(2008-7#2)(2010-8#1)
of fish feces##2##3##(2008-10#2)
of fish feed##2##3##(2008-10#2)
of fish freshness##5##3##(2008-10#5)
of fish in the water##2##5##(2008-2#2)
of fish in the##3##4##(2008-2#2)(2008-5#1)
of fish spoilage##2##3##(2008-10#2)
of fish were##2##3##(2013-7#2)
of fish##63##2##(1991-9#1)(1992-8#2)(1993-5#1)(1994-9#1)(1997-4#1)(2008-10#16)(2008-11#4)(2008-12#4)(2008-2#2)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#2)(2010-8#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#6)
of fishes in the##2##4##(2013-1#2)
of fishes##6##2##(2008-5#1)(2010-8#2)(2012-2#1)(2013-1#2)
of fission yeast##2##3##(1994-12#1)(2008-2#1)
of fission##4##2##(1994-12#1)(2008-10#1)(2008-2#1)(2009-6#1)
of fit##8##2##(1995-9#1)(2008-10#1)(2009-10#6)
of fitness##8##2##(2008-3#2)(2008-8#3)(2008-9#2)(2013-1#1)
of fitting##7##2##(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)
of five and##2##3##(1995-1#1)(2007-11#1)
of five bivalents##2##3##(2008-5#2)
of five cases##6##3##(1991-8#1)(2008-10#1)(2008-7#1)(2009-12#2)(2012-12#1)
of five different variables##3##4##(2008-10#3)
of five different##7##3##(1991-1#1)(1992-3#1)(2008-10#4)(2008-9#1)
of five exons##3##3##(1991-6#1)(1993-6#1)(1997-7#1)
of five male and five female rats were##2##8##(2008-9#1)(2013-1#1)
of five male and five female##7##6##(2008-9#6)(2013-1#1)
of five members of##2##4##(1993-12#1)(2009-10#1)
of five minutes##3##3##(2008-1#2)(2010-8#1)
of five of##2##3##(1994-8#1)(2008-10#1)
of five out of##2##4##(1994-2#1)(2008-10#1)
of five patients with##2##4##(1997-5#1)(2008-6#1)
of five patients##3##3##(1991-9#1)(1997-5#1)(2008-6#1)
of five species in##2##4##(1996-5#1)(2008-10#1)
of five species of##3##4##(2007-12#1)(2008-10#1)(2010-8#1)
of five species##6##3##(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-8#1)
of five synthetic sweeteners##2##4##(2011-1#2)
of five synthetic##3##3##(2008-6#1)(2011-1#2)
of five teacher actions to encourage children's##2##7##(2008-4#2)
of five##198##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-1#4)(2008-10#52)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#11)(2008-6#6)(2008-7#5)(2008-8#1)(2008-9#9)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
of fixation of##2##3##(2008-10#1)(2012-2#1)
of fixation##17##2##(1991-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#3)(2009-8#1)(2012-2#1)(2012-3#2)(2013-1#3)
of fixed and##2##3##(2008-11#1)(2012-1#1)
of fixed cells##2##3##(2008-9#2)
of fixed nitrogen##2##3##(2008-4#1)(2008-9#1)
of fixed##14##2##(1990-5#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-3#1)(2011-2#1)(2012-1#2)
of flabby##2##2##(2013-1#2)
of flag leaves##2##3##(2008-12#1)(2008-9#1)
of flag shoots as primary inoculum##2##6##(2008-10#2)
of flag##5##2##(2008-10#2)(2008-12#2)(2008-9#1)
of flagella##2##2##(2008-8#1)(2011-2#1)
of flame##2##2##(2008-10#2)
of flanking regions##2##3##(1995-2#1)(1997-4#1)
of flanking##5##2##(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#2)
of flap elevation##2##3##(2009-8#1)(2012-2#1)
of flap##4##2##(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
of flaps and grafts in modern hypospadiology##2##7##(2009-5#2)
of flaps and grafts##3##4##(2009-5#3)
of flaps##5##2##(2009-5#3)(2011-2#2)
of flasks##2##2##(2008-10#1)(2008-7#1)
of flat##5##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-3#2)
of flatness distortion##2##3##(2008-2#2)
of flatness##3##2##(2008-2#2)(2008-3#1)
of flattened Gaussian beams##4##4##(2007-11#1)(2008-3#3)
of flattened##5##2##(1997-2#1)(2007-11#1)(2008-3#3)
of flattening##3##2##(1990-3#1)(2008-3#2)
of flavonoid compounds##2##3##(2007-11#1)(2008-5#1)
of flavonoid##10##2##(1993-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
of flavonoids from##2##3##(2010-9#1)(2012-3#1)
of flavonoids has##2##3##(2008-10#1)(2008-5#1)
of flavonoids in the##3##4##(2008-5#2)(2009-10#1)
of flavonoids in##9##3##(2008-10#5)(2008-5#2)(2009-10#2)
of flavonoids##30##2##(2007-11#1)(2008-10#9)(2008-11#5)(2008-5#7)(2009-10#4)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
of flaxseed flour##3##3##(2010-4#3)
of fleroxacin##3##2##(2008-10#3)
of flexibility##2##2##(1997-3#1)(2008-10#1)
of flexible##12##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#5)(2011-2#1)(2012-2#1)(2012-3#1)
of flexicurity##2##2##(2012-2#2)
of flexion of the##2##4##(2008-9#1)(2009-1#1)
of flexion##7##2##(2007-8#3)(2008-9#1)(2009-1#1)(2012-3#1)(2013-1#1)
of flexor digitorum##2##3##(2009-5#1)(2010-5#1)
of flexor##6##2##(1993-12#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-5#1)
of flies##4##2##(1995-6#1)(2007-12#1)(2008-9#2)
of flight##21##2##(2007-12#4)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#3)(2013-1#1)
of float glass##2##3##(2008-2#1)(2008-3#1)
of floaters##2##2##(2008-10#1)(2008-8#1)
of floating##2##2##(2011-1#1)(2012-3#1)
of flooding##3##2##(2012-5#2)(2013-8#1)
of floor##2##2##(1996-12#1)(1997-2#1)
of floral integration##5##3##(2009-8#5)
of floral tissues##2##3##(2009-8#1)(2011-10#1)
of floral traits##3##3##(2008-8#2)(2009-8#1)
of floral##15##2##(1997-2#1)(1997-8#1)(2008-8#4)(2008-9#1)(2009-8#7)(2011-10#1)
of florid##3##2##(2008-1#1)(2008-11#1)(2012-2#1)
of flow analysis##2##3##(2008-10#2)
of flow and image cytometry##2##5##(2008-9#2)
of flow and##3##3##(2008-9#2)(2013-1#1)
of flow cytometer##2##3##(2007-8#1)(2008-9#1)
of flow cytometers##5##3##(2008-9#4)(2012-2#1)
of flow cytometric DNA##2##4##(1993-1#1)(2008-6#1)
of flow cytometric##3##3##(1993-1#1)(2008-4#1)(2008-6#1)
of flow cytometry and##2##4##(2008-7#1)(2008-9#1)
of flow cytometry data##2##4##(2008-8#1)(2008-9#1)
of flow cytometry for##2##4##(2008-9#2)
of flow cytometry in##4##4##(2008-1#1)(2008-9#3)
of flow cytometry##25##3##(1993-1#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#19)
of flow direction##2##3##(2007-11#1)(2012-3#1)
of flow injection (FI)##2##4##(2008-10#2)
of flow injection analysis (FIA)##4##5##(2008-10#4)
of flow injection analysis##8##4##(2008-10#8)
of flow injection##14##3##(2008-10#14)
of flow profiles##2##3##(2007-7#1)(2012-2#1)
of flow rate and##4##4##(2008-10#3)(2010-4#1)
of flow rate##10##3##(1997-2#1)(2008-10#7)(2008-7#1)(2010-4#1)
of flow rates of##4##4##(1996-2#1)(2008-10#3)
of flow rates##7##3##(1996-12#1)(1996-2#1)(2008-10#4)(2010-4#1)
of flow techniques##3##3##(2008-10#3)
of flow velocity and##2##4##(2007-11#1)(2008-2#1)
of flow velocity##5##3##(2007-11#3)(2008-2#1)(2008-7#1)
of flow##97##2##(1993-1#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#34)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#26)(2010-4#2)(2012-2#2)(2012-3#1)(2013-1#1)
of flow-injection analysis##2##3##(2008-10#2)
of flow-injection##3##2##(2008-10#3)
of flow-through##2##2##(2008-10#1)(2013-1#1)
of flow-volume##2##2##(1996-3#1)(2010-8#1)
of flower and##3##3##(2008-10#3)
of flower development##2##3##(1997-8#1)(2008-8#1)
of flower extracts##2##3##(2008-10#2)
of flower infection and##2##4##(2008-10#2)
of flower infection##4##3##(2008-10#4)
of flower##24##2##(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-8#4)
of flowering plants##3##3##(2008-9#1)(2010-5#2)
of flowering##8##2##(2008-12#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#2)
of flowers and##2##3##(2008-9#1)(2009-5#1)
of flowers per##2##3##(2008-12#1)(2009-5#1)
of flowers with##4##3##(2008-10#4)
of flowers##15##2##(2007-12#1)(2008-10#7)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#2)(2011-2#1)
of flowing##6##2##(1993-12#1)(2008-10#4)(2008-3#1)
of flows##2##2##(2008-11#1)(2008-3#1)
of floxuridine##2##2##(1992-10#2)
of fluconazole##2##2##(2007-2#1)(2008-5#1)
of fluctuating##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
of fluctuations##4##2##(1996-4#1)(2007-11#1)(2008-3#1)(2008-8#1)
of fluence-limiting defects##2##3##(2008-3#2)
of fluency##3##2##(2008-2#1)(2013-1#2)
of flufenamic##2##2##(2008-10#2)
of fluid dynamics##2##3##(1991-9#1)(2008-3#1)
of fluid flow##2##3##(2008-7#2)
of fluid transport systems##2##4##(1990-8#2)
of fluid##22##2##(1990-8#2)(1991-9#1)(1993-12#1)(1994-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2009-10#1)(2010-6#1)(2011-2#2)(2013-7#1)
of fluids and##3##3##(1996-4#1)(2007-7#1)(2013-1#1)
of fluids##9##2##(1992-11#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#1)
of flunarizine##3##2##(1990-3#1)(2008-10#2)
of fluo-3##2##2##(1990-2#1)(1991-5#1)
of fluorescein isothiocyanate##2##3##(2008-10#2)
of fluorescein##11##2##(1995-5#1)(2008-10#3)(2008-12#5)(2008-3#1)(2008-9#1)
of fluorescence and##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
of fluorescence changes##2##3##(1994-5#2)
of fluorescence correlation spectroscopy##2##4##(1997-6#2)
of fluorescence detection##2##3##(2008-10#1)(2008-3#1)
of fluorescence endoscopic##2##3##(2008-2#2)
of fluorescence enhancement##2##3##(1991-3#1)(2008-10#1)
of fluorescence from##2##3##(2008-1#1)(2009-11#1)
of fluorescence in situ hybridization##2##5##(2008-4#1)(2008-9#1)
of fluorescence in##3##3##(1994-12#1)(2008-4#1)(2008-9#1)
of fluorescence intensity##6##3##(1995-5#1)(2008-10#3)(2008-3#2)
of fluorescence is##4##3##(2008-10#4)
of fluorescence microscopy##3##3##(1994-5#1)(2008-11#1)(2008-9#1)
of fluorescence of the##2##4##(1990-2#1)(2008-10#1)
of fluorescence of##6##3##(1990-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
of fluorescence resonance energy transfer##2##5##(1995-6#1)(2010-2#1)
of fluorescence signal##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
of fluorescence signals##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
of fluorescence that##2##3##(2008-10#1)(2008-2#1)
of fluorescence through##2##3##(2007-11#1)(2009-11#1)
of fluorescence was##3##3##(2008-10#2)(2008-3#1)
of fluorescence##97##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#1)(1994-12#2)(1994-5#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#1)(2008-9#9)(2009-11#2)(2009-5#1)(2010-12#2)(2010-2#1)
of fluorescence-labeled##2##2##(2008-4#1)(2008-7#1)
of fluorescent Pseudomonas spp##2##4##(2008-10#2)
of fluorescent cells and##2##4##(2007-10#1)(2008-11#1)
of fluorescent cells##3##3##(2007-10#1)(2008-11#1)(2008-4#1)
of fluorescent dyes##4##3##(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)
of fluorescent microspheres##2##3##(2007-11#1)(2008-3#1)
of fluorescent molecules##2##3##(2008-10#1)(2008-3#1)
of fluorescent probes in tissue-like##2##5##(2010-12#2)
of fluorescent probes in##3##4##(2008-9#1)(2010-12#2)
of fluorescent probes##7##3##(2007-11#1)(2008-9#4)(2010-12#2)
of fluorescent proteins##3##3##(2008-9#2)(2009-4#1)
of fluorescent pseudomonads##3##3##(2008-10#3)
of fluorescent##45##2##(1991-5#1)(1992-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#8)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#3)(2010-4#1)(2012-3#1)
of fluorescently labeled##3##3##(2008-10#1)(2008-4#2)
of fluorescently##7##2##(2008-10#1)(2008-2#2)(2008-4#3)(2008-9#1)
of fluorescing corals##2##3##(2008-3#2)
of fluoride and##2##3##(2008-10#1)(2008-12#1)
of fluoride in##9##3##(1996-2#1)(2008-10#6)(2012-1#1)(2013-1#1)
of fluoride ion##7##3##(2008-10#7)
of fluoride ions##4##3##(2008-10#4)
of fluoride on##3##3##(2008-10#2)(2013-1#1)
of fluoride with##3##3##(2008-10#3)
of fluoride##47##2##(1991-11#1)(1993-11#1)(1996-2#1)(2007-12#1)(2008-10#29)(2008-12#3)(2008-2#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#7)
of fluorinated##2##2##(1991-9#1)(2009-9#1)
of fluorine##4##2##(1991-6#1)(2008-10#3)
of fluorochromes##2##2##(2008-9#2)
of fluorophore concentration##2##3##(2008-3#2)
of fluorophore##5##2##(1991-9#1)(2008-10#1)(2008-12#1)(2008-3#2)
of fluorophores##12##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)
of fluoroquinolone##2##2##(2008-10#1)(2012-3#1)
of fluoroquinolones in##2##3##(2008-10#2)
of fluoroquinolones##3##2##(2008-10#3)
of fluorosis##2##2##(1991-11#2)
of fluorouracil##4##2##(1991-3#2)(1992-8#1)(1995-10#1)
of fluoxetine and its##3##4##(1997-6#1)(2008-10#2)
of fluoxetine and norfluoxetine##2##4##(2008-10#2)
of fluoxetine and##7##3##(1997-6#2)(2008-10#4)(2013-1#1)
of fluoxetine in##4##3##(1996-3#1)(2008-10#3)
of fluoxetine##16##2##(1996-3#1)(1997-6#3)(2008-10#10)(2008-4#1)(2013-1#1)
of fluphenazine##3##2##(2008-10#3)
of flupirtine##3##2##(1995-12#3)
of flurbiprofen##6##2##(2008-10#2)(2011-2#2)(2011-3#2)
of flux##6##2##(1990-11#1)(1991-3#1)(1993-2#1)(2008-2#1)(2009-11#1)(2013-1#1)
of fluxes##2##2##(2008-10#1)(2008-7#1)
of fly ash samples##2##4##(2008-10#2)
of fly ash##8##3##(2008-10#6)(2008-3#2)
of fly##11##2##(2008-10#6)(2008-12#1)(2008-3#2)(2009-5#1)(2010-10#1)
of foam and emulsion bilayers##2##5##(1992-5#2)
of foam bilayers##3##3##(1992-5#3)
of foam##10##2##(1990-8#1)(1992-5#5)(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)
of focal adhesions##2##3##(2008-7#1)(2010-4#1)
of focal liver lesions##8##4##(2008-7#2)(2010-12#6)
of focal positions##2##3##(2008-3#2)
of focal segmental##2##3##(2007-7#2)
of focal##34##2##(1991-2#2)(1995-12#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#3)(2008-9#3)(2009-10#1)(2010-12#6)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
of focal-plane##2##2##(2008-2#2)
of focally##2##2##(2008-5#1)(2010-12#1)
of foci##8##2##(1992-3#2)(2007-11#1)(2007-12#1)(2008-10#4)
of focus group##4##3##(1997-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
of focus of##3##3##(2008-3#3)
of focus wave modes##2##4##(2007-11#2)
of focus##22##2##(1994-1#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
of focused ultrasound##2##3##(2008-10#2)
of focused##11##2##(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#2)
of focusing##2##2##(2007-10#1)(2008-2#1)
of foetal haemoglobin##2##3##(2009-3#2)
of foetal ovarian##2##3##(2008-11#2)
of foetal weight##2##3##(1995-6#1)(2009-7#1)
of foetal##8##2##(1991-9#2)(1995-6#1)(2008-11#2)(2009-3#2)(2009-7#1)
of folate deficiency##3##3##(1993-6#1)(2008-7#2)
of folate in##2##3##(1994-6#2)
of folate supplementation##2##3##(1992-9#1)(2008-7#1)
of folate##18##2##(1992-10#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#2)(1995-2#2)(2007-10#1)(2008-7#4)(2009-12#1)(2009-3#1)(2011-2#2)(2013-8#1)
of folates##2##2##(2011-2#1)(2012-2#1)
of folded##2##2##(2009-7#1)(2013-1#1)
of folding (delta##2##3##(1992-5#2)
of folding and##2##3##(2008-1#1)(2008-10#1)
of folding##14##2##(1990-7#1)(1992-5#4)(1993-11#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
of foliar disease##2##3##(2008-10#2)
of foliar diseases##3##3##(2008-10#3)
of foliar##13##2##(2008-10#12)(2008-8#1)
of folic acid in##2##4##(1992-9#1)(2008-7#1)
of folic acid##7##3##(1992-9#1)(2008-7#1)(2010-5#3)(2012-1#2)
of folic##8##2##(1992-9#1)(2008-7#1)(2010-5#4)(2012-1#2)
of folinic acid (FA)##2##4##(1992-2#1)(1992-8#1)
of folinic acid##4##3##(1992-2#1)(1992-8#1)(2008-10#2)
of follicle stimulating hormone (FSH)##3##5##(1990-11#1)(1993-11#1)(2011-2#1)
of follicle##5##2##(1990-11#1)(1993-11#1)(2008-7#2)(2011-2#1)
of follicles##2##2##(2008-8#1)(2012-3#1)
of follicular atresia##4##3##(2008-7#3)(2008-8#1)
of follicular##9##2##(1990-9#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)
of follow up was##2##4##(2007-8#1)(2010-3#1)
of follow up##12##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#5)
of follow-up and##3##3##(2008-7#2)(2011-1#1)
of follow-up in##4##3##(1991-3#1)(1995-11#1)(2007-8#1)(2013-1#1)
of follow-up was##7##3##(1991-11#1)(1993-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of follow-up##67##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1997-2#1)(1997-4#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#2)
of following##7##2##(1992-11#1)(1992-12#1)(1993-11#1)(2008-10#1)(2008-9#1)(2013-1#2)
of followup##2##2##(2012-3#1)(2013-1#1)
of food additives##2##3##(2008-11#2)
of food and feeds##2##4##(1993-3#1)(2010-7#1)
of food and medicine##2##4##(1996-11#2)
of food and##13##3##(1991-2#1)(1993-12#2)(1993-3#1)(1996-11#2)(2008-10#2)(2008-5#1)(2009-8#1)(2010-7#1)(2012-2#2)
of food available##2##3##(2008-5#1)(2008-9#1)
of food but##2##3##(1993-6#1)(2009-5#1)
of food consumed##6##3##(1997-4#3)(2008-9#1)(2010-8#1)(2013-1#1)
of food consumption##5##3##(1993-3#1)(1994-6#1)(2008-4#1)(2008-5#1)(2008-7#1)
of food in##3##3##(2009-5#2)(2013-1#1)
of food intake and##3##4##(1997-3#1)(2008-2#1)(2008-3#1)
of food intake##11##3##(1996-2#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)
of food items##3##3##(2008-5#1)(2009-5#2)
of food on##2##3##(1997-1#1)(2008-11#1)
of food packaging##3##3##(1994-3#2)(2010-7#1)
of food products##8##3##(1997-4#1)(2008-10#2)(2010-7#3)(2011-2#1)(2013-1#1)
of food ration and##2##4##(2010-8#2)
of food ration##3##3##(2010-8#3)
of food resources##3##3##(2008-8#3)
of food restriction##2##3##(1990-3#2)
of food safety##2##3##(2007-12#1)(2008-10#1)
of food samples##3##3##(2008-10#3)
of food service##2##3##(1995-1#1)(1996-1#1)
of food spoilage##2##3##(2011-2#2)
of food types##2##3##(2008-11#1)(2008-8#1)
of food web##2##3##(2008-8#1)(2008-9#1)
of food##149##2##(1990-3#2)(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#1)(1992-5#1)(1993-12#2)(1993-3#2)(1993-6#5)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#6)(1997-6#1)(2007-12#2)(2008-1#4)(2008-10#12)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#9)(2009-3#1)(2009-4#1)(2009-5#8)(2009-8#1)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#5)(2011-1#6)(2011-2#4)(2012-1#3)(2012-2#8)(2013-1#3)
of foodborne disease is##2##4##(2007-12#2)
of foodborne disease##5##3##(2007-12#5)
of foodborne illness##3##3##(2007-12#2)(2011-2#1)
of foodborne##12##2##(2007-12#9)(2011-2#2)(2012-2#1)
of foods and beverages##2##4##(2008-10#1)(2012-12#1)
of foods and##4##3##(1997-4#1)(2008-10#1)(2011-2#1)(2012-12#1)
of foods at##2##3##(2007-12#1)(2012-2#1)
of foods##21##2##(1993-6#1)(1994-3#2)(1995-2#1)(1997-2#1)(1997-4#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
of foodstuffs##3##2##(1997-4#1)(2008-10#1)(2011-2#1)
of foot and hand massage##2##5##(2010-7#2)
of foot and##6##3##(2007-8#1)(2008-8#1)(2010-3#1)(2010-7#2)(2011-2#1)
of foot ulcer##2##3##(2007-7#1)(2008-8#1)
of foot##19##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#2)(2009-10#1)(2010-10#2)(2010-3#2)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
of foot-and-mouth disease##2##3##(1994-8#1)(2009-2#1)
of for-profit##2##2##(1991-12#1)(1996-1#1)
of foragers##3##2##(2008-8#1)(2008-9#2)
of foraging in##2##3##(2008-8#2)
of foraging##11##2##(2008-8#6)(2008-9#4)(2011-2#1)
of force fields##2##3##(2008-11#1)(2010-2#1)
of force##14##2##(1991-12#1)(1992-8#1)(1995-5#2)(1995-6#2)(1996-9#1)(2007-12#1)(2008-1#1)(2008-11#2)(2010-2#1)(2012-12#1)(2012-2#1)
of forced##2##2##(2007-12#1)(2008-11#1)
of forces##7##2##(1995-5#1)(2007-12#3)(2008-5#1)(2009-10#1)(2010-4#1)
of foreign DNA##4##3##(2008-1#1)(2008-11#1)(2008-2#2)
of foreign body##3##3##(2010-4#1)(2012-12#1)(2013-1#1)
of foreign gene##3##3##(2008-8#1)(2008-9#2)
of foreign genes in##3##4##(1995-5#1)(1997-4#1)(2008-4#1)
of foreign genes##9##3##(1995-5#1)(1997-4#2)(1997-8#1)(2008-11#2)(2008-4#1)(2008-8#2)
of foreign ions and##2##4##(2008-10#2)
of foreign ions on the##2##5##(2008-10#2)
of foreign ions on##3##4##(2008-10#3)
of foreign ions##14##3##(2008-10#14)
of foreign proteins in##2##4##(1994-12#1)(1995-5#1)
of foreign proteins##3##3##(1994-12#1)(1995-5#1)(1997-4#1)
of foreign##47##2##(1993-3#1)(1994-12#1)(1995-5#2)(1997-4#4)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-2#2)(2008-4#1)(2008-8#4)(2008-9#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of forelimb response##2##3##(1997-6#2)
of forelimb##3##2##(1997-6#2)(2012-2#1)
of forensic##15##2##(1996-5#1)(2008-10#1)(2008-12#6)(2010-4#1)(2010-7#1)(2011-2#5)
of forest pathology##2##3##(2008-10#2)
of forest trees##2##3##(2008-12#1)(2010-4#1)
of forest##16##2##(1995-3#2)(2008-10#7)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)
of forestry##2##2##(2008-10#1)(2008-8#1)
of forests##3##2##(2008-10#3)
of form and##2##3##(2010-6#1)(2010-8#1)
of form##3##2##(2009-5#1)(2010-6#1)(2010-8#1)
of formal training##2##3##(1996-4#1)(2008-11#1)
of formal##11##2##(1994-12#1)(1996-4#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#1)
of formaldehyde in air##4##4##(2008-10#4)
of formaldehyde in anaerobic##2##4##(2008-7#2)
of formaldehyde in shiitake mushroom##2##5##(2008-10#2)
of formaldehyde in the##5##4##(2008-10#3)(2008-3#1)(2008-7#1)
of formaldehyde in##18##3##(2008-10#14)(2008-3#1)(2008-7#3)
of formaldehyde##32##2##(1995-11#1)(2008-10#23)(2008-3#2)(2008-7#6)
of formalin##3##2##(1995-12#1)(2012-3#2)
of formalin-fixed##5##2##(1997-3#1)(1997-7#1)(2008-11#1)(2008-7#1)(2012-12#1)
of formally incorporating##2##3##(1996-6#2)
of formally##3##2##(1996-6#2)(2008-11#1)
of formate##3##2##(1990-12#1)(1992-10#1)(2008-7#1)
of formation constants of complexes##3##5##(2008-10#3)
of formation constants of##4##4##(2008-10#4)
of formation constants##5##3##(2008-10#5)
of formation of the##4##4##(1991-5#1)(1993-9#1)(2008-10#1)(2008-7#1)
of formation of##8##3##(1991-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(2008-10#2)(2008-7#1)
of formation##21##2##(1991-5#1)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)
of formed##2##2##(2008-10#1)(2008-3#1)
of former##4##2##(1996-3#1)(2007-11#1)(2008-1#1)(2008-8#1)
of forming an##2##3##(1992-8#1)(2008-11#1)
of forming##16##2##(1992-8#2)(1993-11#1)(1994-8#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#1)
of forms##5##2##(1991-3#1)(1997-3#1)(2008-6#1)(2009-2#1)(2013-1#1)
of formula##2##2##(1997-7#1)(2008-10#1)
of formulas##2##2##(2008-2#1)(2012-1#1)
of formulating##2##2##(2008-10#1)(2011-2#1)
of formulation##9##2##(2008-10#4)(2008-3#1)(2008-5#3)(2010-5#1)
of formulations containing##2##3##(2008-5#1)(2010-5#1)
of formulations##8##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2010-5#1)(2010-8#1)
of forskolin##8##2##(1993-3#1)(1996-5#1)(1997-7#2)(2008-11#1)(2009-12#3)
of fortified medium##2##3##(2008-11#2)
of forward head posture##2##4##(2010-9#2)
of forward##8##2##(1992-6#1)(2007-11#2)(2007-12#1)(2008-9#1)(2009-11#1)(2010-9#2)
of forward-scattered##4##2##(2007-11#1)(2008-2#3)
of fos-lacZ##2##2##(1996-5#2)
of fosfomycin##2##2##(2008-10#2)
of fossil##5##2##(2008-10#2)(2008-8#1)(2010-6#1)(2013-8#1)
of fossilized##2##2##(1995-3#2)
of fouling##4##2##(2008-10#1)(2008-11#2)(2010-8#1)
of founder##3##2##(1996-6#1)(2009-6#1)(2010-8#1)
of four and##3##3##(1997-3#1)(2006-10#1)(2008-12#1)
of four anti-dandruff agents##3##4##(2008-5#3)
of four birth cohorts##2##4##(2008-7#2)
of four carcinogens##2##3##(2008-7#1)(2011-1#1)
of four cases##8##3##(1990-12#1)(1991-12#2)(1996-12#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-2#1)
of four different##12##3##(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
of four exons##4##3##(1993-2#1)(1993-6#1)(1994-12#2)
of four experimental##2##3##(1996-2#1)(2008-4#1)
of four groups##4##3##(1992-1#1)(2008-12#1)(2011-2#2)
of four identical##2##3##(2007-11#1)(2008-3#1)
of four impurities for a stavudine synthesis control##2##8##(2008-10#2)
of four isolates of##2##4##(2008-10#2)
of four isolates##3##3##(2008-10#3)
of four key##3##3##(1997-3#1)(2008-11#2)
of four kinds of##2##4##(2008-10#1)(2013-8#1)
of four known##2##3##(1995-8#1)(2010-3#1)
of four main##2##3##(2008-9#1)(2012-3#1)
of four major##7##3##(1997-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
of four mammalian cell lines##2##5##(2008-11#2)
of four models##2##3##(1995-3#1)(2008-11#1)
of four months##4##3##(1993-2#1)(1997-5#1)(2007-8#1)(2011-2#1)
of four novel##3##3##(1991-5#1)(2007-7#1)(2008-10#1)
of four of these##2##4##(2008-11#1)(2008-3#1)
of four of##6##3##(1994-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
of four other##2##3##(1991-2#1)(2013-1#1)
of four pairs of##2##4##(2008-10#1)(2008-12#1)
of four patients with##4##4##(2008-12#2)(2009-8#1)(2013-8#1)
of four patients##10##3##(1991-11#1)(1993-5#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
of four restriction##3##3##(1992-11#1)(1997-5#1)(2008-10#1)
of four species of##5##4##(2007-12#1)(2008-10#1)(2008-5#2)(2010-8#1)
of four studies##2##3##(2007-12#1)(2011-2#1)
of four to five##2##4##(1995-3#1)(2008-10#1)
of four treatments##2##3##(2008-12#1)(2012-9#1)
of four types of##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
of four variable##2##3##(1991-9#1)(1995-2#1)
of four variables##2##3##(2008-10#1)(2011-2#1)
of four vignettes##2##3##(1993-12#1)(2007-12#1)
of four volunteers##2##3##(2008-10#2)
of four weeks##4##3##(1990-6#1)(1991-6#2)(2007-7#1)
of four years##3##3##(1995-6#1)(2008-1#1)(2011-1#1)
of four##309##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#83)(2008-11#10)(2008-12#14)(2008-2#4)(2008-3#10)(2008-4#6)(2008-5#18)(2008-7#5)(2008-8#4)(2008-9#7)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#4)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#11)(2012-1#2)(2012-2#6)(2012-3#3)(2012-9#1)(2013-1#4)(2013-7#2)(2013-8#3)
of four-channel##2##2##(2007-12#1)(2008-2#1)
of four-wave mixing in##2##4##(2007-11#1)(2007-12#1)
of four-wave mixing##8##3##(2007-11#4)(2007-12#2)(2008-3#2)
of fourier-transform##2##2##(2008-3#2)
of fourteen##3##2##(1991-5#1)(2008-1#2)
of fourth-order##2##2##(2007-11#1)(2008-3#1)
of fox##2##2##(1994-8#1)(1996-12#1)
of foxes##2##2##(1995-3#1)(1996-12#1)
of fractal##5##2##(2008-2#1)(2008-3#3)(2011-2#1)
of fraction##4##2##(1992-12#2)(2008-11#2)
of fractional correlation##2##3##(2008-2#1)(2008-3#1)
of fractional##7##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
of fractionated doses of##2##4##(1993-9#1)(2008-12#1)
of fractions with##2##3##(1993-8#1)(2008-4#1)
of fractions##7##2##(1990-5#1)(1993-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2011-2#1)
of fracture and##4##3##(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
of fracture line##2##3##(2011-2#1)(2013-1#1)
of fracture risk##2##3##(1993-11#2)
of fracture##31##2##(1991-6#1)(1993-11#2)(1996-4#1)(2007-11#1)(2007-8#6)(2008-11#4)(2008-5#1)(2008-8#3)(2009-11#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)
of fractured##4##2##(2007-11#4)
of fractures and cardiovascular disease##2##5##(1993-11#2)
of fractures and##3##3##(1993-11#2)(2011-2#1)
of fractures in##4##3##(1993-11#1)(1995-11#1)(2007-11#1)(2008-11#1)
of fractures of the##3##4##(2007-8#1)(2008-9#1)(2009-3#1)
of fractures or##2##3##(2007-8#1)(2008-7#1)
of fractures##28##2##(1991-11#1)(1991-8#1)(1993-11#3)(1995-11#1)(1996-4#1)(2007-11#2)(2007-8#8)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#2)(2011-2#1)(2012-2#1)
of fragile X syndrome##3##4##(2007-2#1)(2008-4#2)
of fragile sites in cancer development##2##6##(2011-2#2)
of fragile sites##4##3##(1997-5#2)(2011-2#2)
of fragile##9##2##(1997-5#2)(2007-2#1)(2008-4#2)(2008-5#1)(2011-2#3)
of fragility fractures##2##3##(2008-4#1)(2008-8#1)
of fragility##3##2##(2008-4#1)(2008-8#1)(2012-12#1)
of fragment##7##2##(1993-11#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-7#1)
of fragmentation##5##2##(1992-3#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
of fragmented##8##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-4#1)(2012-3#1)
of fragments of##4##3##(2008-10#2)(2009-7#1)(2013-1#1)
of fragments##11##2##(1991-12#1)(1993-2#1)(2008-10#3)(2008-2#1)(2009-7#1)(2013-1#1)(2013-7#3)
of fragrance materials##2##3##(2008-5#2)
of fragrance##5##2##(2008-5#5)
of frames of##2##3##(2008-2#2)
of frames##3##2##(2008-2#2)(2012-3#1)
of framework##2##2##(2008-11#1)(2008-7#1)
of fraud##3##2##(1994-2#1)(2007-9#1)(2009-11#1)
of free 2##2##3##(2008-10#2)
of free NO and of##2##5##(2008-10#2)
of free Os##2##3##(2008-10#2)
of free TNT##3##3##(2008-10#3)
of free amino acids##3##4##(2008-5#2)(2008-6#1)
of free amino##4##3##(2008-5#3)(2008-6#1)
of free and conjugated##2##4##(1993-2#1)(2008-10#1)
of free and immobilized##2##4##(2008-6#1)(2008-7#1)
of free and sulphate##3##4##(1997-7#3)
of free and total##3##4##(2008-10#2)(2008-5#1)
of free and##15##3##(1990-7#1)(1991-12#1)(1993-2#1)(1997-7#3)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)
of free available##2##3##(2008-10#2)
of free calcium##2##3##(1997-4#1)(2008-10#1)
of free catecholamines in human urine##2##6##(1990-8#2)
of free chlorine##3##3##(2008-10#3)
of free fatty acids and##2##5##(2008-10#1)(2008-5#1)
of free fatty acids from##4##5##(1990-8#1)(1992-12#1)(1994-8#1)(2008-10#1)
of free fatty acids released from##2##6##(1990-8#2)
of free fatty acids##11##4##(1990-8#3)(1992-12#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-6#1)
of free fatty##12##3##(1990-8#3)(1992-12#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)
of free glucose##2##3##(2008-10#1)(2008-11#1)
of free moisture##3##3##(1997-6#1)(2008-10#2)
of free radical activity##2##4##(1990-3#2)
of free radical scavengers##6##4##(1991-9#3)(2008-5#3)
of free radical##15##3##(1990-12#1)(1990-3#2)(1991-9#3)(1996-2#1)(2008-10#2)(2008-5#4)(2008-7#1)(2011-1#1)
of free radicals and##4##4##(2008-10#1)(2008-5#2)(2013-8#1)
of free radicals by##3##4##(1994-6#1)(2008-10#1)(2008-7#1)
of free radicals that##2##4##(2007-8#1)(2009-8#1)
of free radicals##21##3##(1991-12#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#2)(2009-8#1)(2013-8#2)
of free sugars##2##3##(2008-10#2)
of free will and responsibility##2##5##(2010-12#2)
of free zinc ions##2##4##(2013-7#2)
of free##178##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-7#2)(1990-8#6)(1991-12#4)(1991-2#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#5)(2007-12#4)(2007-8#1)(2008-10#55)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#15)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#5)
of free-living##7##2##(1997-6#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-2#1)
of free-space and guided-wave optical interconnections##2##6##(2008-3#2)
of free-space and guided-wave optical##3##5##(2008-2#1)(2008-3#2)
of free-space optical##3##3##(2008-2#2)(2008-3#1)
of free-space optics##2##3##(2008-2#1)(2008-3#1)
of free-space##12##2##(2008-2#6)(2008-3#6)
of freedom in##2##3##(2007-11#1)(2011-2#1)
of freedom of a##2##4##(2008-2#1)(2008-7#1)
of freedom of the##2##4##(2008-3#1)(2008-6#1)
of freedom of##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
of freedom##30##2##(1990-8#1)(1992-6#2)(1992-8#1)(1994-9#1)(1995-3#1)(1997-3#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
of freely moving rats##3##4##(1995-12#1)(1997-2#1)(2008-4#1)
of freely moving##4##3##(1990-7#1)(1995-12#1)(1997-2#1)(2008-4#1)
of freely##7##2##(1990-7#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
of freestanding##3##2##(1991-1#1)(2008-11#1)(2008-3#1)
of freeze-dried cells##2##3##(2008-10#2)
of freeze-dried##6##2##(2008-10#4)(2008-6#1)(2012-12#1)
of freezing temperatures##2##3##(2008-10#2)
of freezing##3##2##(2008-10#2)(2008-8#1)
of frequencies##6##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
of frequency and##2##3##(2007-11#1)(2007-12#1)
of frequency of##3##3##(1994-5#1)(2008-6#1)(2011-2#1)
of frequency##21##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-8#1)(1994-5#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-3#3)(2008-6#1)(2010-4#1)(2011-2#1)
of frequency-domain##2##2##(2008-3#2)
of frequency-doubled##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of frequency-resolved optical gating##3##4##(2007-12#2)(2008-3#1)
of frequency-selective components##2##3##(2008-3#2)
of frequent cannabis use##2##4##(2009-7#2)
of frequent##8##2##(2007-8#1)(2009-7#3)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
of frequently used##2##3##(1996-3#1)(1997-6#1)
of frequently##3##2##(1996-3#1)(1997-6#1)(2008-9#1)
of fresh and##3##3##(2008-10#1)(2010-4#1)(2012-5#1)
of fresh cells##2##3##(1994-6#2)
of fresh fish and##2##4##(2008-1#2)
of fresh fish##3##3##(1990-8#1)(2008-1#2)
of fresh ginseng##2##3##(2012-3#2)
of fresh meat##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
of fresh water##3##3##(2008-5#1)(2008-6#2)
of fresh##49##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#5)(2012-5#1)(2012-7#1)(2013-8#1)
of freshly isolated##2##3##(1997-1#1)(2008-11#1)
of freshly##5##2##(1990-12#1)(1997-1#1)(2008-11#1)(2008-5#2)
of freshwater fish##3##3##(2008-11#1)(2013-7#2)
of freshwater##13##2##(1991-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#2)(2013-7#2)
of friction##4##2##(1996-4#1)(2008-5#1)(2010-4#1)(2012-2#1)
of friends and##3##3##(2009-7#3)
of friends##8##2##(2009-7#7)(2010-5#1)
of fringe patterns##5##3##(2008-2#2)(2008-3#3)
of fringe##15##2##(2007-12#1)(2008-2#5)(2008-3#9)
of fringes##3##2##(2008-3#3)
of frog olfactory bulb##2##4##(1996-5#2)
of frog##6##2##(1993-2#1)(1993-8#1)(1996-5#2)(2013-1#2)
of from##10##2##(2008-2#7)(2008-3#2)(2008-7#1)
of front##2##2##(1996-1#1)(2008-11#1)
of front-line##3##2##(2009-3#2)(2010-1#1)
of frontal cortical##3##3##(1992-11#1)(1995-12#2)
of frontal part##2##3##(2008-5#2)
of frontal sinus##2##3##(2013-1#2)
of frontal##17##2##(1992-11#1)(1995-12#2)(1995-2#1)(1996-6#1)(1997-8#1)(2007-11#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-8#2)(2013-1#3)
of frontotemporal##2##2##(2008-9#1)(2013-1#1)
of frozen section##3##3##(1995-4#1)(2007-8#2)
of frozen##10##2##(1994-9#1)(1995-12#1)(1995-4#1)(2007-11#1)(2007-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-8#1)
of frozen-thawed##4##2##(1996-8#3)(2012-3#1)
of fructose##10##2##(1990-7#3)(1996-2#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#3)
of fructose-1##2##2##(2008-9#1)(2010-12#1)
of fruit and vegetable##3##4##(1992-10#1)(2011-1#1)(2011-2#1)
of fruit and##5##3##(1992-10#1)(1997-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
of fruit bats##2##3##(2007-5#2)
of fruit brown rot##3##4##(2008-10#3)
of fruit flies was##2##4##(2013-8#2)
of fruit flies##4##3##(2013-8#4)
of fruit rot##4##3##(2008-10#4)
of fruit##50##2##(1992-10#1)(1997-1#1)(2007-5#2)(2008-10#34)(2008-12#1)(2008-5#2)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#4)
of fruiting bodies##2##3##(2008-10#2)
of fruits and vegetables##11##4##(2011-1#3)(2012-2#6)(2013-1#1)(2013-8#1)
of fruits##20##2##(1994-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2010-3#1)(2010-8#1)(2011-1#3)(2012-2#6)(2013-1#1)(2013-8#1)
of frying fats##2##3##(2008-10#2)
of ftz##2##2##(1993-9#2)
of fucose##3##2##(1990-8#1)(1992-8#1)(2008-11#1)
of fucosylated##2##2##(2008-11#1)(2008-5#1)
of fuel ethanol##2##3##(2008-10#1)(2008-6#1)
of fuel##3##2##(2008-10#1)(2008-6#1)(2010-12#1)
of full length##2##3##(2008-11#2)
of full##15##2##(1991-1#1)(1995-1#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
of full-length cDNA clones of##2##5##(2008-10#2)
of full-length cDNA##7##3##(1997-2#4)(2008-10#2)(2008-8#1)
of full-length##18##2##(1993-6#1)(1995-2#3)(1995-6#1)(1997-2#4)(1997-4#1)(2008-1#1)(2008-10#4)(2008-8#1)(2008-9#2)
of full-scale##2##2##(1996-12#1)(2008-6#1)
of full-thickness slice##2##3##(1996-2#2)
of full-thickness##4##2##(1996-2#2)(2011-2#1)(2013-8#1)
of full-time##2##2##(1992-2#1)(1995-3#1)
of fullerene##2##2##(2008-10#2)
of fullerenes##3##2##(2008-2#1)(2008-8#2)
of fully three-dimensional##3##3##(2008-3#3)
of fully##19##2##(1990-11#1)(1990-7#1)(1992-6#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#6)(2008-7#1)(2012-2#1)
of fulminant##5##2##(2011-2#2)(2013-1#3)
of fulvic and humic acids##3##5##(2008-10#3)
of fulvic##5##2##(2008-10#5)
of fumaric##2##2##(2008-6#2)
of fumigants##2##2##(2008-10#2)
of fumonisin##6##2##(2008-10#5)(2013-1#1)
of fumonisins##2##2##(1995-3#1)(2008-10#1)
of fun##2##2##(2009-10#1)(2010-4#1)
of function and quality of life##3##6##(2009-12#1)(2011-2#1)(2013-8#1)
of function and quality of##4##5##(2009-12#2)(2011-2#1)(2013-8#1)
of function and##10##3##(1994-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#2)(2011-2#2)(2013-8#2)
of function in##5##3##(1997-4#1)(1997-8#1)(2008-11#1)(2008-9#2)
of function is##2##3##(2008-2#1)(2009-8#1)
of function of the##5##4##(1991-2#1)(1996-5#1)(2007-8#1)(2011-2#1)(2011-3#1)
of function of##9##3##(1991-2#1)(1996-5#1)(2007-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
of function with##2##3##(1990-11#1)(2008-9#1)
of function words##2##3##(2008-2#2)
of function##68##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#4)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#8)(2009-12#3)(2009-5#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2013-8#3)
of function&quot##2##2##(1995-9#1)(2009-5#1)
of function'##2##2##(2008-11#2)
of functional MRI##2##3##(2009-9#2)
of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model##2##17##(2008-4#2)
of functional analysis##2##3##(1996-3#1)(2008-7#1)
of functional and##3##3##(1996-7#1)(2008-11#1)(2012-2#1)
of functional cells##2##3##(2013-1#2)
of functional domains##4##3##(1990-5#1)(1997-3#1)(2010-2#2)
of functional genomics##5##3##(2008-5#2)(2008-7#2)(2009-10#1)
of functional glutamate transporters in the developing##2##7##(2008-7#2)
of functional groups##8##3##(1992-11#1)(1992-6#1)(1994-9#1)(2008-10#4)(2008-9#1)
of functional human##4##3##(1992-12#2)(2012-2#2)
of functional imaging##2##3##(2008-2#1)(2008-9#1)
of functional impairment##2##3##(1996-6#1)(2013-1#1)
of functional importance##3##3##(2008-9#1)(2010-5#1)(2012-3#1)
of functional interactions between##2##4##(1993-6#1)(2008-4#1)
of functional interfaces##3##3##(2008-7#3)
of functional life##2##3##(2008-7#2)
of functional neuroimaging##2##3##(2008-11#1)(2009-9#1)
of functional organization##2##3##(2007-8#1)(2008-11#1)
of functional recovery##2##3##(2008-8#1)(2013-1#1)
of functional regions##2##3##(1992-12#1)(2008-11#1)
of functional state of##3##4##(2011-1#2)(2013-1#1)
of functional stem cells##2##4##(2010-10#1)(2012-2#1)
of functional viral##2##3##(2008-10#1)(2008-9#1)
of functional##142##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#17)(2008-8#4)(2008-9#8)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
of functionality##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
of functionalized nano-HgS##2##3##(2008-10#2)
of functionalized##11##2##(2008-10#9)(2008-12#1)(2010-5#1)
of functionally##13##2##(1990-5#2)(1993-12#1)(1993-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
of functioning and##3##3##(1991-6#1)(2007-10#1)(2011-2#1)
of functioning##18##2##(1990-11#1)(1991-6#1)(1993-2#1)(1996-2#1)(1997-6#1)(1997-8#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#2)(2012-12#1)
of functions and##2##3##(2008-11#1)(2012-2#1)
of functions##12##2##(1992-1#1)(1995-9#1)(1997-6#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#2)
of fund##3##2##(1994-3#1)(1995-1#1)(1995-3#1)
of fundamental and##3##3##(1995-12#1)(2008-3#2)
of fundamental importance in providing##2##5##(2007-11#1)(2008-10#1)
of fundamental importance in##4##4##(1990-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
of fundamental importance to many##2##5##(2008-7#1)(2010-7#1)
of fundamental importance to##4##4##(2008-10#1)(2008-7#1)(2010-7#1)(2012-1#1)
of fundamental importance##10##3##(1990-2#1)(2007-11#1)(2008-10#2)(2008-7#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)
of fundamental interest##2##3##(2008-3#1)(2008-8#1)
of fundamental##36##2##(1990-2#1)(1991-5#1)(1994-1#1)(1995-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
of funding and##2##3##(1993-2#1)(2011-2#1)
of funding for##5##3##(1993-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
of funding from##4##3##(1992-1#1)(1995-3#1)(1997-1#1)(1997-3#1)
of funding##29##2##(1991-1#1)(1992-1#1)(1993-2#2)(1993-3#2)(1994-2#2)(1995-12#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)
of funds##5##2##(1991-2#1)(1992-3#1)(1993-12#1)(1997-2#1)(2007-7#1)
of fungal DNA##3##3##(2008-10#2)(2011-2#1)
of fungal biomass##3##3##(2008-10#3)
of fungal colonization##5##3##(2008-10#4)(2008-12#1)
of fungal contamination##2##3##(2008-12#2)
of fungal development##3##3##(2008-10#1)(2009-8#1)(2010-10#1)
of fungal diversity##2##3##(2008-10#1)(2010-6#1)
of fungal growth in##2##4##(2008-10#2)
of fungal growth##5##3##(2008-10#5)
of fungal hyphae##2##3##(2008-10#2)
of fungal infection##2##3##(2008-10#1)(2008-5#1)
of fungal infections##6##3##(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
of fungal isolates##2##3##(2008-10#1)(2008-12#1)
of fungal laccase##2##3##(2008-10#2)
of fungal pathogens##4##3##(2008-5#1)(2009-6#3)
of fungal spore adhesion##2##4##(2008-10#2)
of fungal##80##2##(1991-5#2)(1993-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#41)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2013-1#1)
of fungemia##3##2##(2008-5#3)
of fungi and##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#2)
of fungi in##2##3##(2008-10#2)
of fungi on##2##3##(2008-10#1)(2008-5#1)
of fungi##25##2##(1997-2#1)(2008-10#10)(2008-3#3)(2008-5#4)(2008-9#1)(2009-8#3)(2010-10#1)(2011-1#1)(2011-2#1)
of fungicidal protection##2##3##(2008-10#2)
of fungicide resistance##4##3##(2008-10#4)
of fungicide to##2##3##(1996-8#1)(2008-10#1)
of fungicide##18##2##(1996-8#1)(2008-10#16)(2008-7#1)
of fungicide-resistant##2##2##(2008-10#2)
of fungicides in##3##3##(2008-10#3)
of fungicides##17##2##(2008-10#17)
of fungus##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
of fura-2##6##2##(1991-12#1)(1991-5#1)(1992-5#3)(2013-1#1)
of furfural##3##2##(2011-1#1)(2013-1#2)
of furin##6##2##(1991-9#2)(1992-12#3)(2010-12#1)
of furosemide##12##2##(1991-8#1)(1992-8#2)(1993-2#1)(1994-8#1)(1997-4#1)(2008-10#3)(2012-2#3)
of further research##2##3##(2008-10#1)(2008-7#1)
of further##24##2##(1990-12#1)(1991-3#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
of fusarium head blight##3##4##(2008-10#3)
of fusarium wilt of##4##4##(2008-10#4)
of fusarium wilt##5##3##(2008-10#5)
of fusarium##13##2##(2008-10#12)(2008-7#1)
of fused C2-C3 was##2##4##(2013-1#2)
of fused silica and##2##4##(2008-3#2)
of fused silica##8##3##(2007-11#3)(2007-12#3)(2008-3#2)
of fused##13##2##(1993-12#1)(2007-11#3)(2007-12#3)(2008-3#3)(2013-1#3)
of fusiform##2##2##(2007-10#1)(2008-10#1)
of fusion of##2##3##(1995-6#2)
of fusion proteins on##2##4##(1994-12#1)(2008-4#1)
of fusion proteins##6##3##(1994-12#1)(1995-2#1)(1996-6#1)(2008-1#2)(2008-4#1)
of fusion##21##2##(1991-7#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-6#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
of future cardiovascular##2##3##(2008-11#1)(2009-12#1)
of future cases of##2##4##(2008-1#1)(2010-6#1)
of future clinical##2##3##(2012-1#1)(2013-1#1)
of future development of##2##4##(2011-7#1)(2013-7#1)
of future development##3##3##(2008-10#1)(2011-7#1)(2013-7#1)
of future health##2##3##(1996-2#1)(2010-2#1)
of future research in##2##4##(2010-8#1)(2013-1#1)
of future research##5##3##(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
of future systems##2##3##(2009-5#1)(2012-2#1)
of future##61##2##(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
of fuzzy logic##2##3##(2011-2#2)
of fuzzy##4##2##(2007-12#1)(2011-2#3)
of fuzzy-logic##3##2##(2008-2#2)(2008-3#1)
of g-KGM##2##2##(2011-2#2)
of g-SA##2##2##(2011-2#2)
of gabapentin (100 mg/kg)##2##4##(2011-2#2)
of gabapentin##4##2##(2011-2#2)(2011-3#2)
of gadolinium##3##2##(1997-8#1)(2008-10#1)(2012-3#1)
of gag##3##2##(1991-12#1)(1994-12#1)(2007-7#1)
of gain and##2##3##(2008-3#2)
of gain##8##2##(2007-11#2)(2007-12#3)(2008-3#3)
of gains##3##2##(2009-10#1)(2009-11#1)(2012-3#1)
of gait##10##2##(1994-12#1)(2010-3#2)(2013-1#6)(2013-7#1)
of galactosamine##4##2##(1994-6#1)(2008-10#3)
of galactose##4##2##(1990-5#1)(1991-6#1)(1994-5#1)(2008-5#1)
of galactose-6-sulphate sulphatase activity##2##4##(1990-2#2)
of galactose-6-sulphate sulphatase##3##3##(1990-2#3)
of galanin##5##2##(1993-3#1)(1994-8#3)(1996-12#1)
of gallbladder cancer##4##3##(2010-12#3)(2013-1#1)
of gallbladder##10##2##(1990-12#1)(1991-8#1)(1992-9#1)(2008-11#1)(2008-12#1)(2010-12#3)(2012-3#1)(2013-1#1)
of gallium (III)##3##3##(2008-10#3)
of gallium and##2##3##(2008-10#2)
of gallium by##3##3##(2008-10#3)
of gallium was##2##3##(2008-10#2)
of gallium##17##2##(1990-3#1)(1993-11#1)(2007-12#1)(2008-10#14)
of gallium(III) with 2-methyl-8-quinolinol##2##4##(2008-10#2)
of gallium(III) with HMO(4)Q##2##4##(2008-10#2)
of gallium(III) with##4##3##(2008-10#4)
of gallium(III)##6##2##(2008-10#6)
of gallstone##4##2##(1990-9#1)(2008-12#2)(2013-1#1)
of galvanic##3##2##(2008-10#2)(2012-3#1)
of gambling##3##2##(2012-12#3)
of game##3##2##(2013-1#1)(2013-7#2)
of gametes with##2##3##(2008-7#1)(2009-12#1)
of gametes##3##2##(2008-7#1)(2008-8#1)(2009-12#1)
of gametic disequilibrium##3##3##(2008-10#3)
of gametic##5##2##(2008-10#3)(2009-2#1)(2010-5#1)
of gamma H2AX##2##3##(2009-5#2)
of gamma interferon##2##3##(2010-4#2)
of gamma radiation##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
of gamma##18##2##(1990-12#1)(1992-8#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#2)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)
of gamma-LGLA on##2##3##(1993-5#2)
of gamma-aminobutyric acid (GABA) in##2##5##(1990-5#1)(1996-7#1)
of gamma-aminobutyric acid (GABA)##5##4##(1990-5#1)(1996-7#1)(2008-8#2)(2008-9#1)
of gamma-aminobutyric acid##10##3##(1990-5#2)(1995-11#1)(1995-12#1)(1996-5#1)(1996-7#2)(2008-8#2)(2008-9#1)
of gamma-globulin##2##2##(2008-10#2)
of gamma-glutamyltransferase##3##2##(1990-9#2)(1995-11#1)
of gamma-irradiation##2##2##(1996-2#1)(2008-10#1)
of gamma/delta T##2##3##(1993-8#2)
of gamma2-MSH##2##2##(1995-12#2)
of gammadelta T-LGL leukemia were##2##5##(2009-8#2)
of gang##2##2##(2009-5#2)
of ganglion##5##2##(1992-3#1)(1996-5#3)(1997-3#1)
of ganglioside##5##2##(1992-9#2)(1993-5#1)(1994-3#1)(1996-5#1)
of gangliosides and galactolipids in##2##5##(1996-5#2)
of gangliosides and galactolipids##3##4##(1996-5#3)
of gangliosides on the##2##4##(1990-11#2)
of gangliosides##9##2##(1990-11#3)(1991-2#1)(1993-11#1)(1993-3#1)(1996-5#3)
of gap junction##3##3##(2008-7#3)
of gap junctions##6##3##(1994-3#1)(2008-6#1)(2008-7#2)(2010-9#1)(2012-2#1)
of gap##11##2##(1994-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#5)(2010-9#1)(2012-2#1)
of garcinia cambogia##2##3##(2008-5#1)(2012-2#1)
of garenoxacin in##4##3##(2008-10#4)
of garenoxacin##7##2##(2008-10#5)(2011-2#2)
of garlic oil on##3##4##(2008-9#2)(2012-2#1)
of garlic##5##2##(2007-7#1)(2008-9#3)(2012-2#1)
of gas chromatographic##3##3##(2008-10#3)
of gas chromatography (GC)##2##4##(2008-10#2)
of gas chromatography##4##3##(2008-10#4)
of gas concentrations##3##3##(1996-12#1)(2008-3#2)
of gas diffusion##2##3##(1992-5#1)(2008-10#1)
of gas exchange##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
of gas from a##2##4##(2007-12#1)(2012-2#1)
of gas gangrene##3##3##(2007-7#1)(2013-1#2)
of gas leaks##2##3##(2008-10#1)(2008-3#1)
of gas phase##4##3##(1996-2#1)(2008-10#2)(2008-11#1)
of gas plumes##2##3##(2008-3#2)
of gas##49##2##(1992-5#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#2)
of gas-phase##2##2##(2008-3#2)
of gaseous pollutants##2##3##(2008-10#1)(2008-3#1)
of gaseous##8##2##(2008-10#7)(2008-3#1)
of gases##9##2##(1993-11#1)(1997-1#1)(2008-10#3)(2008-3#2)(2012-2#2)
of gasoline##2##2##(1992-3#1)(2008-10#1)
of gastric acid secretion##3##4##(1992-6#1)(1993-12#1)(1997-1#1)
of gastric adenocarcinoma##2##3##(2008-1#1)(2008-9#1)
of gastric and duodenal ulcers##2##5##(1995-2#1)(2006-10#1)
of gastric and##3##3##(1992-5#1)(1995-2#1)(2006-10#1)
of gastric cancer cell##2##4##(2008-11#2)
of gastric cancer in##4##4##(2008-1#1)(2008-12#3)
of gastric cancer##17##3##(1992-12#1)(1992-9#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-12#6)(2011-2#4)
of gastric carcinoma##6##3##(1992-9#1)(1994-12#1)(2010-12#1)(2011-2#3)
of gastric emptying##8##3##(1994-3#1)(1997-4#1)(2012-2#1)(2013-1#5)
of gastric function##3##3##(1992-6#3)
of gastric juice##2##3##(2008-10#2)
of gastric mucosal##2##3##(2012-3#1)(2013-8#1)
of gastric neuroendocrine##2##3##(1997-1#2)
of gastric tube##3##3##(1991-11#1)(2010-7#2)
of gastric ulcer##2##3##(2008-5#1)(2011-2#1)
of gastric wall##2##3##(1992-9#2)
of gastric##77##2##(1991-11#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#6)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-1#5)(1997-4#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#9)(2008-5#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-7#2)(2011-2#9)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#1)
of gastrin mRNA##2##3##(1990-7#1)(1992-8#1)
of gastrin on cytosolic free Ca2+##2##6##(1992-3#2)
of gastrin on##4##3##(1992-3#2)(1994-8#2)
of gastrin##8##2##(1990-7#1)(1992-3#2)(1992-8#1)(1994-8#2)(1997-1#1)(2011-2#1)
of gastritis##6##2##(1997-1#3)(2008-1#1)(2008-5#1)(2010-12#1)
of gastroduodenal##4##2##(1990-5#1)(1992-5#1)(2008-12#1)(2011-1#1)
of gastroenteritis##4##2##(1990-6#1)(1996-2#1)(2009-3#1)(2012-12#1)
of gastroenterologists##2##2##(1992-4#1)(2008-12#1)
of gastroenterology##2##2##(1990-2#1)(2013-1#1)
of gastroenteropancreatic neuroendocrine tumors]##2##4##(2010-9#2)
of gastroenteropancreatic neuroendocrine##4##3##(2010-9#2)(2011-2#2)
of gastroesophageal reflux disease##4##4##(2008-3#1)(2013-1#2)(2013-8#1)
of gastroesophageal reflux##9##3##(1992-11#1)(1992-3#2)(2008-3#1)(2013-1#3)(2013-8#2)
of gastroesophageal##10##2##(1992-11#1)(1992-3#2)(2008-11#1)(2008-3#1)(2013-1#3)(2013-8#2)
of gastrointestinal (GI)##2##3##(1991-2#1)(2011-2#1)
of gastrointestinal bleeding in##2##4##(1995-9#1)(2012-3#1)
of gastrointestinal bleeding##5##3##(1995-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
of gastrointestinal cancer in##2##4##(1990-9#2)
of gastrointestinal cancer##3##3##(1990-9#2)(1995-8#1)
of gastrointestinal disorders##4##3##(1990-8#1)(1991-3#1)(2007-2#1)(2008-11#1)
of gastrointestinal nematodes in##2##4##(1996-11#1)(1996-12#1)
of gastrointestinal nematodes##3##3##(1996-11#1)(1996-12#2)
of gastrointestinal parasites of stray dogs impounded by the Society for the Prevention of Cruelty to Animals (SPCA)##2##18##(2011-1#2)
of gastrointestinal stromal##2##3##(2008-10#1)(2013-1#1)
of gastrointestinal tract##3##3##(1991-12#1)(1992-8#1)(2008-11#1)
of gastrointestinal tumors##2##3##(1990-6#1)(2011-1#1)
of gastrointestinal##44##2##(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-8#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1997-3#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
of gastroparesis##4##2##(2008-1#1)(2012-2#3)
of gastrovascular##3##2##(2010-2#3)
of gating##8##2##(1993-3#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#3)
of gays and lesbians##2##4##(2008-12#2)
of gaze##3##2##(2008-11#1)(2010-10#1)(2011-2#1)
of gcm##2##2##(2008-7#2)
of gdh##2##2##(1993-9#2)
of gel beads##3##3##(2008-7#3)
of gel electrophoresis and##2##4##(2008-11#1)(2008-4#1)
of gel electrophoresis##3##3##(2008-11#1)(2008-4#2)
of gel filtration##3##3##(2008-10#1)(2008-8#2)
of gel##21##2##(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)
of gelatinases##3##2##(1992-9#1)(1997-3#2)
of gellan gum##2##3##(2010-3#2)
of gellike material##2##3##(2008-11#2)
of gellike##3##2##(2008-11#3)
of gels##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
of gemcitabine##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
of geminate recombination##2##3##(1990-8#2)
of geminivirus##3##2##(2008-10#2)(2008-8#1)
of geminiviruses in##2##3##(2008-10#2)
of gender and age##4##4##(2007-10#1)(2007-12#1)(2008-9#1)(2013-1#1)
of gender and its##2##4##(2009-10#2)
of gender and##13##3##(1990-9#1)(1993-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-7#2)(2013-1#1)
of gender differences in##4##4##(2008-12#2)(2008-4#1)(2008-7#1)
of gender differences##6##3##(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
of gender identity##2##3##(2008-12#1)(2011-2#1)
of gender on the association of adiposity with cardiovascular reactivity##2##10##(2012-2#2)
of gender or age##2##4##(2008-3#2)
of gender##41##2##(1990-9#2)(1993-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)
of gender-specific##2##2##(2008-11#1)(2010-6#1)
of gendered##2##2##(2007-7#1)(2011-2#1)
of gene 32##2##3##(1997-3#2)
of gene action##2##3##(2008-10#1)(2009-10#1)
of gene activation##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
of gene activity in##2##4##(1995-2#1)(2010-5#1)
of gene amplification##5##3##(1991-6#2)(1994-12#1)(1996-12#1)(2008-11#1)
of gene and##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
of gene disruption##3##3##(2008-8#3)
of gene diversity was distributed among##2##6##(2008-10#2)
of gene diversity was distributed within##3##6##(2008-10#3)
of gene diversity was distributed##5##5##(2008-10#5)
of gene diversity##8##3##(2008-10#7)(2012-5#1)
of gene encoding##2##3##(1997-3#1)(2008-5#1)
of gene essentiality##2##3##(2012-2#2)
of gene expression and regulation##2##5##(2008-9#1)(2012-12#1)
of gene expression and##7##4##(1995-2#1)(2008-4#2)(2008-9#2)(2009-8#1)(2012-12#1)
of gene expression at##3##4##(2008-11#1)(2008-4#2)
of gene expression by##5##4##(1994-8#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-4#1)
of gene expression for##3##4##(2008-10#1)(2008-7#2)
of gene expression in the##3##5##(2008-7#1)(2012-2#1)(2013-7#1)
of gene expression in##21##4##(1991-12#1)(1993-12#1)(1995-2#2)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#4)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
of gene expression is##3##4##(2008-7#3)
of gene expression of##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
of gene expression profiles##2##4##(2011-2#1)(2012-2#1)
of gene expression to##2##4##(2007-11#1)(2010-1#1)
of gene expression was##2##4##(2008-11#1)(2012-2#1)
of gene expression##112##3##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-2#5)(1995-6#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#1)(2007-11#2)(2007-12#3)(2008-1#4)(2008-10#7)(2008-11#8)(2008-2#1)(2008-4#7)(2008-5#1)(2008-7#20)(2008-8#2)(2008-9#8)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
of gene families##3##3##(2008-7#1)(2009-6#1)(2011-2#1)
of gene flow among##2##4##(2008-10#1)(2011-2#1)
of gene flow between##3##4##(2008-10#2)(2013-1#1)
of gene flow##12##3##(2008-10#6)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#2)(2013-1#1)
of gene fragments##3##3##(1990-5#1)(2008-4#2)
of gene function and##2##4##(2008-2#1)(2008-7#1)
of gene function##8##3##(1991-5#1)(1997-8#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-5#1)
of gene functions##2##3##(2007-6#1)(2012-3#1)
of gene fusions##2##3##(1991-6#1)(2008-9#1)
of gene in##2##3##(2008-2#1)(2008-8#1)
of gene interaction##2##3##(2008-10#1)(2011-3#1)
of gene interactions##2##3##(2008-7#1)(2010-10#1)
of gene models##2##3##(2009-10#2)
of gene mutations##3##3##(2008-4#1)(2008-8#1)(2010-4#1)
of gene products##3##3##(1995-9#1)(2008-4#1)(2008-9#1)
of gene regulation##5##3##(2008-7#2)(2012-3#1)(2013-8#2)
of gene regulatory##2##3##(2008-8#1)(2010-4#1)
of gene technology##3##3##(1991-11#2)(1997-4#1)
of gene therapy for##3##4##(2007-11#1)(2008-8#1)(2008-9#1)
of gene therapy##14##3##(1994-5#1)(1995-6#2)(2007-11#2)(2008-11#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-10#1)(2013-8#1)
of gene transcription and##2##4##(1994-11#1)(1996-3#1)
of gene transcription##4##3##(1990-11#1)(1994-11#1)(1996-3#1)(2012-12#1)
of gene transfer and expression##3##5##(2008-11#1)(2008-9#2)
of gene transfer and##5##4##(1994-5#1)(2008-11#2)(2008-9#2)
of gene transfer##11##3##(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#3)
of gene##279##2##(1990-11#2)(1990-5#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#5)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#6)(1995-6#4)(1995-9#1)(1996-12#4)(1996-3#1)(1997-3#5)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#2)(2007-11#4)(2007-12#4)(2007-6#1)(2008-1#5)(2008-10#33)(2008-11#13)(2008-2#5)(2008-4#18)(2008-5#4)(2008-6#1)(2008-7#31)(2008-8#13)(2008-9#19)(2009-10#5)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#4)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#5)
of gene(s) in##2##3##(1997-8#1)(2008-7#1)
of gene(s)##3##2##(1997-8#1)(2008-7#1)(2009-12#1)
of gene-gene interactions##2##3##(2008-4#2)
of gene-gene##3##2##(2008-4#2)(2011-2#1)
of gene-modified##2##2##(1994-5#1)(2012-10#1)
of genealogy##2##2##(1990-3#1)(1995-5#1)
of genera##2##2##(2008-8#1)(2013-1#1)
of general and##5##3##(1990-12#1)(1990-6#1)(1997-3#1)(2007-12#1)(2010-8#1)
of general anesthesia##3##3##(1990-11#2)(2012-12#1)
of general cognitive##3##3##(2010-1#2)(2010-5#1)
of general complications##2##3##(2007-11#2)
of general health##7##3##(1992-3#2)(1993-12#1)(2008-11#1)(2008-12#1)(2010-1#1)(2013-1#1)
of general interest##2##3##(2008-11#1)(2010-11#1)
of general manager##2##3##(1990-12#2)
of general practice##3##3##(1990-3#1)(1997-4#1)(2007-2#1)
of general practitioners in the##2##5##(1997-4#1)(2008-11#1)
of general practitioners in##4##4##(1994-3#1)(1997-4#1)(2008-11#1)(2008-3#1)
of general practitioners##9##3##(1991-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-3#1)
of general validity##2##3##(2007-11#1)(2008-11#1)
of general##92##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-8#1)(2009-9#1)(2010-1#4)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
of generalized anxiety disorder##2##4##(2013-1#2)
of generalized##16##2##(1992-3#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-6#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
of generated##7##2##(1997-2#1)(2007-11#1)(2008-10#3)(2008-7#1)(2011-1#1)
of generating a##2##3##(2007-12#1)(2009-9#1)
of generating##28##2##(1990-12#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-2#1)
of generation of##2##3##(1996-12#1)(2008-10#1)
of generation##3##2##(1996-12#1)(2008-10#2)
of generator##2##2##(1997-6#1)(2008-10#1)
of generic medicines##4##3##(2011-1#4)
of generic##14##2##(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-4#1)(2011-1#5)(2011-3#1)
of genes active in##2##4##(1996-2#1)(1997-8#1)
of genes and gene##2##4##(1996-12#1)(2008-7#1)
of genes and##8##3##(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
of genes are##3##3##(1997-7#1)(2008-9#1)(2009-8#1)
of genes associated with##4##4##(2008-10#2)(2010-11#1)(2013-1#1)
of genes belonging to the##2##5##(1995-6#1)(2011-1#1)
of genes by##2##3##(1991-7#1)(2008-7#1)
of genes cloned##2##3##(1991-9#1)(1993-9#1)
of genes coding for##2##4##(1997-8#1)(2012-2#1)
of genes coding##3##3##(1997-8#1)(2008-12#1)(2012-2#1)
of genes controlling##2##3##(2008-10#1)(2008-7#1)
of genes encoding glycolytic enzymes##2##5##(1996-3#2)
of genes encoding##14##3##(1990-5#1)(1994-11#1)(1996-12#2)(1996-3#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2012-2#1)(2012-3#1)
of genes expressed##2##3##(2008-10#1)(2008-7#1)
of genes for resistance to##3##5##(2008-10#3)
of genes for##7##3##(1996-12#2)(2008-10#4)(2013-7#1)
of genes from##2##3##(1993-9#1)(2008-7#1)
of genes have##2##3##(2008-10#1)(2008-4#1)
of genes implicated in prostate carcinogenesis##2##6##(2008-6#2)
of genes implicated in##3##4##(2008-4#1)(2008-6#2)
of genes in a##2##4##(1995-2#1)(2011-2#1)
of genes in parallel##2##4##(2008-7#2)
of genes in the##4##4##(1995-8#2)(2008-6#1)(2008-7#1)
of genes in various##2##4##(2008-10#1)(2011-3#1)
of genes in##18##3##(1990-5#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2011-2#1)(2011-3#1)(2012-3#1)
of genes including##2##3##(2008-10#1)(2013-1#1)
of genes involved in the##2##5##(2008-7#1)(2013-1#1)
of genes involved in##12##4##(1990-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
of genes involved##13##3##(1990-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
of genes is##3##3##(2007-11#1)(2008-4#1)(2008-7#1)
of genes of##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
of genes regulating##2##3##(2008-1#1)(2013-1#1)
of genes related to##6##4##(1991-9#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-5#1)
of genes responsible for##2##4##(2011-1#1)(2011-10#1)
of genes that are##3##4##(1993-9#1)(2008-4#1)(2011-1#1)
of genes that encode##3##4##(1992-8#1)(2008-4#1)(2012-3#1)
of genes that influence##2##4##(2007-10#1)(2008-10#1)
of genes that##19##3##(1992-8#1)(1993-9#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#3)
of genes to##3##3##(2008-4#1)(2008-7#1)(2010-11#1)
of genes under##2##3##(2008-10#1)(2008-7#1)
of genes were##2##3##(2010-4#1)(2013-8#1)
of genes whose##3##3##(1991-12#1)(1992-12#1)(2008-4#1)
of genes with##4##3##(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)
of genes##220##2##(1990-5#3)(1991-12#1)(1991-7#2)(1991-9#3)(1992-12#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#4)(1996-12#7)(1996-2#2)(1996-3#3)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#2)(2007-10#1)(2007-11#1)(2008-1#5)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#3)(2008-4#13)(2008-5#3)(2008-6#3)(2008-7#34)(2008-8#7)(2008-9#8)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#6)(2013-7#2)(2013-8#2)
of genetic algorithms##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
of genetic alterations##2##3##(2008-11#1)(2011-2#1)
of genetic and acquired##2##4##(2010-10#1)(2013-8#1)
of genetic and epigenetic changes##2##5##(1992-3#1)(2011-2#1)
of genetic and phenotypic##2##4##(2008-10#1)(2010-12#1)
of genetic and physical##2##4##(1996-10#1)(2009-10#1)
of genetic and##17##3##(1990-6#1)(1992-3#1)(1996-10#1)(1997-5#1)(2008-10#5)(2008-4#1)(2009-10#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
of genetic association##3##3##(1997-5#1)(2012-3#2)
of genetic changes##2##3##(1993-8#1)(2007-10#1)
of genetic control of##2##4##(1993-2#1)(2008-10#1)
of genetic correlations##2##3##(2008-8#2)
of genetic counseling and##2##4##(2008-1#1)(2008-3#1)
of genetic counseling##3##3##(2008-1#2)(2008-3#1)
of genetic differentiation among##5##4##(2008-10#5)
of genetic differentiation were##3##4##(2008-10#3)
of genetic differentiation##16##3##(2008-10#14)(2012-3#1)(2012-5#1)
of genetic disease##3##3##(1994-2#1)(2007-7#1)(2008-11#1)
of genetic disorders##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
of genetic diversity and##4##4##(2008-10#4)
of genetic diversity in the##2##5##(1997-3#1)(2012-3#1)
of genetic diversity in##3##4##(1997-3#1)(2008-5#1)(2012-3#1)
of genetic diversity may##2##4##(2008-10#1)(2013-1#1)
of genetic diversity##22##3##(1997-3#1)(2008-10#13)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#2)
of genetic engineering##2##3##(2008-8#1)(2011-2#1)
of genetic epidemiology##3##3##(2008-7#2)(2011-2#1)
of genetic events##2##3##(1993-2#1)(1994-12#1)
of genetic factors##7##3##(1990-12#1)(1994-2#1)(1997-5#1)(1997-8#1)(2009-4#1)(2009-5#1)(2013-8#1)
of genetic information##7##3##(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#1)
of genetic instability##2##3##(2012-2#1)(2013-1#1)
of genetic isolation##2##3##(2008-5#1)(2008-9#1)
of genetic material##2##3##(2008-10#1)(2008-7#1)
of genetic origin##2##3##(1990-2#1)(2013-1#1)
of genetic polymorphism in##2##4##(1996-6#1)(2012-3#1)
of genetic polymorphism##6##3##(1996-6#1)(2006-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
of genetic profiles for##2##4##(2008-11#1)(2010-7#1)
of genetic recombination##2##3##(2008-10#2)
of genetic regulatory networks##2##4##(2008-7#2)
of genetic regulatory##3##3##(2008-11#1)(2008-7#2)
of genetic resistance##2##3##(2008-10#2)
of genetic risk##2##3##(2008-7#2)
of genetic structure##3##3##(2008-10#2)(2008-8#1)
of genetic susceptibility##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
of genetic testing in##3##4##(2009-7#1)(2010-7#1)(2011-2#1)
of genetic testing##8##3##(1991-11#1)(1995-9#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-3#1)
of genetic tests##3##3##(2008-10#2)(2011-3#1)
of genetic tools##2##3##(2008-8#1)(2011-1#1)
of genetic variability##8##3##(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)
of genetic variation among##2##4##(2008-10#2)
of genetic variation in##3##4##(2008-10#2)(2009-9#1)
of genetic variation##20##3##(1996-6#2)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-4#1)(2012-2#1)
of genetic##234##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#4)(1994-9#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-6#4)(1996-8#1)(1997-3#3)(1997-5#4)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-7#2)(2008-1#3)(2008-10#63)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#18)(2008-8#14)(2008-9#12)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#11)(2011-3#2)(2012-1#2)(2012-2#6)(2012-3#8)(2012-5#1)(2013-1#7)(2013-8#2)
of genetically and##2##3##(2008-10#1)(2013-1#1)
of genetically engineered herpes simplex viruses##2##6##(1995-2#2)
of genetically engineered##4##3##(1995-2#2)(2008-11#1)(2011-1#1)
of genetically modified mice##2##4##(2008-4#1)(2012-3#1)
of genetically modified##4##3##(1997-3#1)(2007-10#1)(2008-4#1)(2012-3#1)
of genetically##20##2##(1991-8#1)(1995-2#2)(1996-12#1)(1997-3#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of genetics and##2##3##(2010-1#1)(2012-12#1)
of genetics research##2##3##(2009-6#2)
of genetics##8##2##(1996-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#2)(2010-1#1)(2012-12#1)
of geniculate##2##2##(1997-7#1)(2011-2#1)
of genistein on##3##3##(1993-3#1)(1997-7#1)(2010-10#1)
of genistein##15##2##(1992-12#1)(1992-8#2)(1993-3#1)(1997-7#3)(2008-11#1)(2010-10#1)(2010-3#2)(2012-2#4)
of genital herpes##8##3##(2007-12#2)(2008-10#6)
of genital pathology##2##3##(1991-11#1)(1996-12#1)
of genital##25##2##(1991-11#1)(1992-2#1)(1994-2#1)(1996-1#1)(1996-12#3)(2007-12#3)(2008-10#7)(2008-4#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
of genitourinary##5##2##(1995-12#1)(1997-8#1)(2008-10#1)(2013-8#2)
of genome sequences##3##3##(2008-7#1)(2009-5#1)(2013-8#1)
of genome size##2##3##(1997-2#1)(2008-8#1)
of genome structure##2##3##(1996-10#1)(2008-4#1)
of genome##24##2##(1992-8#1)(1993-12#1)(1996-10#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-5#2)(2010-3#4)(2011-2#1)(2013-1#1)(2013-8#1)
of genome-wide##5##2##(2008-7#1)(2011-2#3)(2012-3#1)
of genomes##6##2##(1997-2#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-5#1)(2012-3#1)
of genomic DNA and##4##4##(1992-3#1)(1993-12#1)(1997-7#1)(2008-4#1)
of genomic DNA from##5##4##(1993-2#1)(1996-6#1)(2008-10#1)(2008-2#1)(2010-2#1)
of genomic DNA of##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
of genomic DNA##41##3##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-8#2)(1993-12#2)(1993-2#3)(1993-6#1)(1993-9#1)(1995-5#1)(1996-10#1)(1996-6#1)(1997-6#3)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#6)(2008-7#1)(2008-9#1)(2010-2#1)(2012-2#1)
of genomic and##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of genomic clones##3##3##(1990-8#1)(1991-6#1)(2008-10#1)
of genomic data##4##3##(2008-7#1)(2010-3#1)(2011-2#1)(2011-3#1)
of genomic instability##2##3##(2010-2#1)(2013-1#1)
of genomic regions##2##3##(2008-10#1)(2008-7#1)
of genomic research##3##3##(2008-7#2)(2012-2#1)
of genomic sequence##4##3##(1993-2#1)(2008-11#1)(2010-7#1)(2012-2#1)
of genomic sequences##2##3##(2008-9#1)(2009-10#1)
of genomic structure and##2##4##(2010-3#2)
of genomic tools##2##3##(2008-11#1)(2010-10#1)
of genomic##91##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-8#2)(1993-12#2)(1993-2#4)(1993-6#1)(1993-9#1)(1995-5#1)(1996-10#1)(1996-6#1)(1997-6#3)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-2#2)(2008-4#8)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-2#2)(2010-3#5)(2010-5#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)
of genomics and##2##3##(2008-10#1)(2008-11#1)
of genomics##9##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
of genotype calls##2##3##(2009-8#2)
of genotype on##2##3##(2008-10#1)(2011-1#1)
of genotype resistance and##2##4##(2008-10#2)
of genotype resistance##4##3##(2008-10#4)
of genotype##15##2##(2008-10#8)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-12#1)
of genotypes from##2##3##(2008-10#2)
of genotypes of##2##3##(2008-10#1)(2009-12#1)
of genotypes or##2##3##(2008-10#1)(2011-1#1)
of genotypes that##2##3##(2008-10#2)
of genotypes with##2##3##(2008-10#1)(2008-9#1)
of genotypes within##2##3##(2008-10#2)
of genotypes##24##2##(1995-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-12#1)
of genotypic diversity##8##3##(2008-10#8)
of genotypic##13##2##(2008-10#11)(2008-9#1)(2011-2#1)
of genotyping##3##2##(2008-4#2)(2009-8#1)
of gentamicin 2##2##3##(2010-3#2)
of gentamicin##6##2##(2008-10#2)(2010-3#4)
of gentamycin##7##2##(2007-12#1)(2008-10#5)(2013-8#1)
of genuine##7##2##(1994-3#2)(1997-3#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)
of genus##5##2##(1997-4#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of geochemical##3##2##(1996-4#1)(2007-5#2)
of geographic isolation##2##3##(2008-1#1)(2010-8#1)
of geographic variation in##2##4##(2008-8#1)(2010-8#1)
of geographic variation##3##3##(2008-8#1)(2010-8#2)
of geographic##13##2##(1994-6#1)(2008-1#1)(2008-10#4)(2008-8#2)(2010-8#3)(2011-2#1)(2013-8#1)
of geographical location##2##3##(1993-2#1)(2008-10#1)
of geographical##7##2##(1993-2#1)(2008-10#1)(2008-8#2)(2010-11#1)(2011-2#2)
of geological samples##3##3##(2008-10#3)
of geological##6##2##(1996-4#1)(2008-10#4)(2008-12#1)
of geometric and##2##3##(2008-3#2)
of geometric isomers of carotenoids##3##5##(2010-2#3)
of geometric##11##2##(1996-4#1)(2008-3#5)(2010-2#3)(2010-8#1)(2013-1#1)
of geometrical optics##3##3##(2008-2#1)(2008-3#2)
of geometrical parameters of transpedicular##2##5##(2007-11#2)
of geometrical##10##2##(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#4)(2009-3#1)(2009-7#1)
of geophysical parameters from##3##4##(2008-2#2)(2008-3#1)
of geraniol##3##2##(2007-11#2)(2008-5#1)
of geriatric patients##2##3##(1990-11#1)(2013-8#1)
of geriatric##6##2##(1990-11#1)(1991-1#1)(1991-11#1)(1992-1#1)(2008-4#1)(2013-8#1)
of geriatrics##2##2##(1994-2#1)(2008-7#1)
of germ cell development##4##4##(2009-10#1)(2009-3#1)(2012-2#2)
of germ cell##9##3##(1994-7#1)(2008-12#2)(2008-6#1)(2009-10#1)(2009-3#1)(2012-2#3)
of germ cells##4##3##(1990-9#1)(2008-7#1)(2009-10#1)(2013-8#1)
of germ line p53 mutations##2##5##(1990-12#1)(1994-12#1)
of germ line##3##3##(1990-12#1)(1994-12#1)(2008-11#1)
of germ tubes##6##3##(2008-10#6)
of germ##23##2##(1990-12#1)(1990-9#1)(1994-12#1)(1994-7#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-3#1)(2012-2#3)(2013-8#1)
of germanium by##3##3##(2008-10#3)
of germanium in botanical samples##2##5##(2008-10#2)
of germanium in##3##3##(2008-10#3)
of germanium##7##2##(2008-10#7)
of germinal##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
of germinated conidia##4##3##(2008-10#4)
of germinated##8##2##(2008-10#6)(2008-5#2)
of germinating seeds##2##3##(2008-10#1)(2008-7#1)
of germinating##8##2##(1990-5#2)(2008-10#3)(2008-12#1)(2008-7#1)(2009-10#1)
of germination and##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
of germination in##2##3##(2008-10#2)
of germination of sclerotia##2##4##(2008-10#2)
of germination of##5##3##(2008-10#3)(2008-12#1)(2008-5#1)
of germination was##2##3##(2008-10#2)
of germination##23##2##(2008-10#13)(2008-12#6)(2008-5#1)(2011-2#3)
of germination)##2##2##(2008-12#1)(2008-9#1)
of germline##3##2##(1996-12#1)(2008-9#1)(2011-2#1)
of germplasm##2##2##(2008-12#1)(2008-9#1)
of gestation and##4##3##(1993-12#2)(2007-11#1)(2008-5#1)
of gestation in##2##3##(1992-5#1)(2008-11#1)
of gestation is##2##3##(2008-11#1)(2011-1#1)
of gestation to##2##3##(1990-5#1)(1995-8#1)
of gestation with##3##3##(2007-7#1)(2013-1#2)
of gestation##46##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-12#6)(1993-6#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2010-2#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
of gestation)##2##2##(1993-6#1)(1996-5#1)
of gestational age and##2##4##(2008-11#1)(2011-1#1)
of gestational age##3##3##(2008-11#2)(2011-1#1)
of gestational diabetes mellitus##2##4##(1992-12#1)(2008-1#1)
of gestational diabetes##5##3##(1992-12#1)(1996-11#2)(2008-1#1)(2013-1#1)
of gestational stress on##2##4##(2008-11#2)
of gestational stress##4##3##(2008-11#4)
of gestational##14##2##(1992-12#1)(1996-11#2)(2008-1#1)(2008-11#6)(2008-7#1)(2011-1#1)(2013-1#2)
of gestodene##3##2##(2011-3#3)
of getting##6##2##(1991-1#1)(1993-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-4#1)
of ghrelin in##2##3##(2011-1#1)(2011-2#1)
of ghrelin##14##2##(2008-3#5)(2011-1#2)(2011-2#5)(2012-3#1)(2013-8#1)
of giant cell reparative##2##4##(2006-12#2)
of giant cell##5##3##(2006-12#3)(2008-6#1)(2009-3#1)
of giant intracranial##2##3##(2008-7#1)(2008-9#1)
of giant##28##2##(1991-6#2)(1997-8#1)(2006-12#4)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
of gifts##2##2##(1997-4#1)(2008-12#1)
of gigahertz##2##2##(2007-12#2)
of gilthead sea bream##3##4##(2009-5#1)(2010-8#2)
of ginger##2##2##(2008-10#1)(2008-11#1)
of gingival##4##2##(2008-5#1)(2012-3#1)(2013-1#2)
of gingivitis##2##2##(1990-10#1)(2012-12#1)
of ginseng leaves##2##3##(2008-10#2)
of ginseng##10##2##(2008-10#7)(2008-11#1)(2012-3#2)
of ginsenoside##2##2##(2012-3#1)(2013-1#1)
of girls##7##2##(1990-2#1)(1995-6#1)(1996-11#1)(2008-10#2)(2009-10#1)(2009-5#1)
of given##4##2##(2008-10#2)(2008-3#2)
of giving birth##2##3##(2009-10#1)(2010-12#1)
of giving##5##2##(1994-3#1)(1995-2#1)(2009-10#1)(2010-12#1)(2012-3#1)
of glaA gene##2##3##(2008-9#2)
of glaA##3##2##(2008-8#1)(2008-9#2)
of glands in##2##3##(1997-1#1)(2007-12#1)
of glands##4##2##(1995-11#1)(1997-1#1)(2007-12#2)
of glandular##5##2##(1997-6#1)(2008-5#1)(2011-2#2)(2012-1#1)
of glass and##3##3##(2008-10#2)(2008-4#1)
of glass beads##2##3##(2008-10#1)(2008-5#1)
of glass electrodes##3##3##(2008-10#3)
of glass fibers##4##3##(2008-3#2)(2009-7#2)
of glass samples##2##3##(2008-10#2)
of glass with##2##3##(2007-11#2)
of glass##38##2##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#23)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#2)(2010-3#1)
of glass-ionomer##2##2##(2009-7#1)(2013-1#1)
of glasses for##3##3##(2008-3#3)
of glasses##9##2##(1995-3#2)(2008-10#2)(2008-2#1)(2008-3#4)
of glassy carbon##3##3##(2008-10#3)
of glassy##5##2##(1995-3#1)(2008-10#4)
of glaucoma##7##2##(1990-11#1)(2007-11#1)(2008-7#1)(2009-9#1)(2011-2#2)(2011-7#1)
of glia are##2##3##(2008-7#2)
of glia##9##2##(2008-7#9)
of glial cell##2##3##(2008-7#1)(2008-8#1)
of glial cells in##2##4##(2008-11#1)(2008-7#1)
of glial cells##6##3##(2008-11#1)(2008-5#1)(2008-7#3)(2013-8#1)
of glial fibrillary acidic protein (GFAP)##2##6##(1994-6#1)(1997-3#1)
of glial##15##2##(1994-6#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#1)(2013-8#1)
of glibenclamide##3##2##(1992-3#1)(1996-9#1)(2008-8#1)
of gliclazide##5##2##(2011-1#5)
of glimepiride##2##2##(1994-8#1)(2011-1#1)
of glimepride decreased significantly##2##4##(2011-1#2)
of glimepride##9##2##(2011-1#9)
of glioblastoma cells##2##3##(2008-7#1)(2013-1#1)
of glioblastoma in##2##3##(2011-2#2)
of glioblastoma multiforme##6##3##(1995-9#1)(2008-12#1)(2008-7#1)(2011-2#2)(2011-3#1)
of glioblastoma##14##2##(1995-9#1)(2008-12#1)(2008-7#3)(2011-2#5)(2011-3#2)(2012-3#1)(2013-1#1)
of glioma##4##2##(1993-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
of glistening##2##2##(2008-2#2)
of global and##3##3##(1996-5#1)(2009-8#1)(2013-3#1)
of global budgeting##2##3##(1993-1#1)(1994-2#1)
of global budgets##2##3##(1994-1#2)
of global climate change##2##4##(2008-10#1)(2008-11#1)
of global health##5##3##(2008-10#1)(2008-7#1)(2011-1#3)
of global postural reeducation in the treatment of temporomandibular disorder##2##10##(2013-1#2)
of global warming##3##3##(1992-3#1)(2008-12#1)(2008-8#1)
of global##57##2##(1990-6#1)(1990-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-1#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#3)(1996-9#1)(2006-10#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#4)(2013-3#1)(2013-8#1)
of global/local feature analysis##2##4##(1996-5#2)
of globalization##2##2##(2009-8#1)(2013-1#1)
of globin##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
of globular proteins##3##3##(1992-5#1)(2008-7#1)(2011-2#1)
of globular##4##2##(1992-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
of globule##2##2##(1997-4#1)(2008-10#1)
of globuli cells##2##3##(2007-12#2)
of glomerular disease in##3##4##(2007-7#2)(2008-1#1)
of glomerular disease##5##3##(2007-7#2)(2008-1#3)
of glomerular diseases in##2##4##(2008-1#2)
of glomerular diseases##4##3##(2008-1#3)(2012-2#1)
of glomerular lesions##2##3##(1993-2#2)
of glomerular##16##2##(1993-2#2)(1996-6#2)(2007-7#2)(2008-1#8)(2011-2#1)(2012-2#1)
of glomerulonephritis in##6##3##(2007-7#2)(2008-1#4)
of glomerulonephritis##11##2##(1996-6#1)(2007-7#4)(2008-1#5)(2011-2#1)
of gloves##5##2##(1996-11#1)(2009-5#1)(2012-2#3)
of glucagon at##2##3##(1994-8#1)(1996-2#1)
of glucagon secretion in##2##4##(1994-11#1)(2010-11#1)
of glucagon secretion##7##3##(1994-11#2)(2010-11#5)
of glucagon##16##2##(1990-8#1)(1991-12#1)(1992-9#1)(1994-11#2)(1994-8#1)(1995-6#2)(1996-2#2)(2010-11#5)(2012-2#1)
of glucagon-induced##2##2##(1994-8#1)(1996-2#1)
of glucocorticoid and##2##3##(1993-8#1)(2008-4#1)
of glucocorticoid receptor##3##3##(1990-11#1)(1993-12#1)(1996-12#1)
of glucocorticoid receptors##2##3##(1991-12#1)(2009-6#1)
of glucocorticoid##10##2##(1990-11#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-4#1)(2009-6#1)
of glucocorticoid-induced##3##2##(2008-6#1)(2012-12#2)
of glucocorticoids and##3##3##(1994-5#1)(1994-9#1)(2012-1#1)
of glucocorticoids in the treatment of##2##6##(2008-11#1)(2012-12#1)
of glucocorticoids in##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
of glucocorticoids on##2##3##(2008-7#1)(2008-9#1)
of glucocorticoids##14##2##(1994-5#1)(1994-9#3)(1996-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2012-1#1)(2012-12#1)
of glucokinase##6##2##(1990-7#6)
of gluconeogenesis in##2##3##(1991-3#1)(1994-8#1)
of gluconeogenesis##4##2##(1991-3#2)(1994-8#1)(1995-8#1)
of gluconic acid and sorbitol##2##5##(2008-6#2)
of gluconic acid##5##3##(2008-10#3)(2008-6#2)
of glucose and ethanol##4##4##(2008-10#4)
of glucose and fructose##2##4##(2008-6#2)
of glucose and glutamine metabolism in hybridoma##2##7##(2008-11#2)
of glucose and glutamine metabolism##3##5##(2008-11#3)
of glucose and glutamine##7##4##(1994-5#1)(2008-11#6)
of glucose and urea##3##4##(2008-11#1)(2008-3#2)
of glucose and##36##3##(1990-7#1)(1991-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-10#9)(2008-11#7)(2008-3#2)(2008-6#3)(2008-7#3)(2009-3#2)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
of glucose by the##2##4##(2008-10#2)
of glucose by##5##3##(1992-6#1)(2008-10#3)(2008-5#1)
of glucose concentration##5##3##(1992-12#2)(2007-11#1)(2008-10#1)(2009-8#1)
of glucose control##3##3##(1990-6#1)(2008-1#1)(2012-5#1)
of glucose for##2##3##(1995-8#1)(2008-10#1)
of glucose from##5##3##(1990-11#1)(1991-9#1)(1994-6#1)(1997-7#1)(2009-10#1)
of glucose homeostasis##9##3##(1991-7#1)(2007-5#1)(2008-1#3)(2008-4#3)(2011-2#1)
of glucose in the range##2##5##(2008-10#2)
of glucose in the##9##4##(1991-10#1)(1994-8#1)(2007-8#1)(2008-10#6)
of glucose in##23##3##(1991-10#1)(1994-8#1)(1995-8#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-3#1)(2010-5#1)
of glucose into##2##3##(1990-11#1)(1997-7#1)
of glucose metabolism in##3##4##(1993-11#1)(2008-7#1)(2013-8#1)
of glucose metabolism##7##3##(1991-12#1)(1993-11#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
of glucose on##4##3##(1992-9#1)(1994-8#1)(2008-7#1)(2010-11#1)
of glucose oxidase (GOx)##2##4##(2008-10#2)
of glucose oxidase and##2##4##(2008-10#2)
of glucose oxidase##11##3##(2008-10#11)
of glucose sensors##2##3##(2009-11#2)
of glucose starvation##2##3##(2008-11#2)
of glucose to##7##3##(1991-7#1)(1995-8#4)(2008-10#2)
of glucose tolerance##3##3##(1995-11#1)(2008-1#1)(2008-7#1)
of glucose transport in##2##4##(1994-12#1)(2008-7#1)
of glucose transport##7##3##(1992-11#2)(1994-11#2)(1994-12#1)(1994-6#1)(2008-7#1)
of glucose transporter##3##3##(1993-8#1)(2008-11#2)
of glucose transporters##4##3##(1990-11#1)(1993-6#1)(1994-12#1)(2008-7#1)
of glucose uptake by##2##4##(1991-7#1)(2008-10#1)
of glucose uptake##3##3##(1991-7#1)(2008-10#1)(2008-11#1)
of glucose utilization in##3##4##(1990-11#1)(1994-8#2)
of glucose utilization##4##3##(1990-11#1)(1994-8#3)
of glucose was##8##3##(1990-11#1)(1994-6#1)(2008-10#5)(2008-6#1)
of glucose with##3##3##(1994-12#1)(2008-10#2)
of glucose##233##2##(1990-11#7)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#4)(1991-9#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#4)(1994-5#2)(1994-6#3)(1994-8#7)(1995-11#1)(1995-8#10)(1996-2#1)(1997-6#2)(1997-7#2)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#67)(2008-11#21)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#13)(2008-7#13)(2009-10#2)(2009-11#2)(2009-3#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#3)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#3)(2013-8#1)
of glucose-6-phosphatase##4##2##(1994-11#2)(1997-7#2)
of glucose-6-phosphate dehydrogenase and##2##4##(1991-5#1)(2008-11#1)
of glucose-6-phosphate dehydrogenase##5##3##(1991-5#2)(1995-6#1)(2007-12#1)(2008-11#1)
of glucose-6-phosphate##7##2##(1991-5#2)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
of glucose-stimulated insulin##2##3##(2008-11#1)(2010-11#1)
of glucose-stimulated##3##2##(2008-11#2)(2010-11#1)
of glucosinolate##2##2##(2008-10#2)
of glucuronidation##3##2##(2008-11#3)
of glutamate and##4##3##(1995-12#1)(2008-7#3)
of glutamate decarboxylase##2##3##(1996-5#2)
of glutamate dehydrogenase##3##3##(1995-11#1)(2008-4#2)
of glutamate from the##2##4##(1993-12#1)(2008-7#1)
of glutamate in the##2##4##(1992-11#1)(1994-2#1)
of glutamate in##5##3##(1992-11#1)(1994-2#1)(2008-11#1)(2008-4#1)(2012-12#1)
of glutamate on##2##3##(1995-12#1)(2008-11#1)
of glutamate receptor##6##3##(1990-8#1)(1993-9#2)(1994-11#1)(1995-5#1)(2008-7#1)
of glutamate receptors##7##3##(1994-8#1)(1995-5#1)(1997-2#1)(1997-6#1)(2012-12#2)(2012-2#1)
of glutamate##49##2##(1990-8#1)(1992-11#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#3)(1995-11#2)(1995-12#2)(1995-5#3)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#8)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#3)(2012-2#1)
of glutamatergic##5##2##(1991-5#1)(2008-7#2)(2009-8#1)(2011-1#1)
of glutamic acid by##2##4##(2008-10#2)
of glutamic acid on the oscillating##2##6##(2008-10#2)
of glutamic acid##10##3##(1991-5#1)(1996-12#1)(2008-10#6)(2011-2#1)(2013-8#1)
of glutamic##11##2##(1991-5#1)(1996-12#1)(2008-10#6)(2008-11#1)(2011-2#1)(2013-8#1)
of glutaminase##2##2##(2008-11#2)
of glutamine and serine##2##4##(2008-11#2)
of glutamine and##3##3##(2008-11#3)
of glutamine in##5##3##(1993-9#3)(1995-3#1)(2008-11#1)
of glutamine synthetase in##2##4##(1992-12#1)(1996-12#1)
of glutamine synthetase##6##3##(1992-12#1)(1996-12#4)(1997-1#1)
of glutamine##29##2##(1992-12#1)(1993-8#2)(1993-9#3)(1995-3#1)(1996-12#4)(1997-1#1)(2008-11#16)(2013-8#1)
of glutaraldehyde##7##2##(1993-8#1)(2008-10#5)(2008-7#1)
of glutathione (GSH) and##3##4##(1991-9#1)(1994-2#1)(2008-10#1)
of glutathione (GSH)##6##3##(1990-2#1)(1991-9#1)(1994-2#1)(2008-10#2)(2008-7#1)
of glutathione S-transferase##6##3##(1992-3#1)(1992-6#1)(1995-6#1)(1997-7#1)(2008-12#1)(2013-1#1)
of glutathione S-transferases##2##3##(1990-2#1)(2006-10#1)
of glutathione and glutathione disulfide in human plasma and tobacco leaves##2##11##(2008-10#2)
of glutathione and##6##3##(1991-12#1)(2008-10#2)(2008-5#2)(2012-2#1)
of glutathione in##4##3##(1992-8#1)(2008-10#2)(2008-5#1)
of glutathione on##2##3##(2008-11#1)(2012-2#1)
of glutathione peroxidase##7##3##(1991-12#2)(1991-9#1)(1993-8#2)(1994-6#2)
of glutathione reductase##3##3##(1992-1#2)(2011-2#1)
of glutathione##55##2##(1990-2#3)(1991-12#3)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
of glutathione-S-transferase##2##2##(1995-2#1)(2013-7#1)
of glutathionylcobalamin (GSCbl)##2##3##(2008-10#2)
of glutinous##3##2##(2008-10#3)
of glycaemic control in##2##4##(1992-9#1)(1995-2#1)
of glycaemic control##4##3##(1992-9#3)(1995-2#1)
of glycated albumin##2##3##(1993-6#1)(2009-11#1)
of glycated##6##2##(1991-5#1)(1993-6#3)(2009-11#1)(2011-2#1)
of glycemia##2##2##(2008-1#1)(2011-1#1)
of glycemic control##2##3##(2008-3#2)
of glycemic##6##2##(2008-10#1)(2008-3#2)(2009-11#2)(2012-5#1)
of glyceraldehyde-3-phosphate##2##2##(1990-7#1)(1994-5#1)
of glycerin##2##2##(2008-5#2)
of glycerol or##2##3##(2008-10#1)(2008-7#1)
of glycerol##12##2##(1990-5#1)(1991-8#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
of glyceroplasmalopsychosine##2##2##(2009-10#2)
of glyceryl trinitrate##3##3##(2007-10#1)(2007-8#2)
of glyceryl##4##2##(2007-10#1)(2007-8#2)(2013-1#1)
of glycine and GABA##2##4##(1997-2#2)
of glycine and##5##3##(1994-6#1)(1997-2#3)(2008-10#1)
of glycine by alanine at##2##5##(2008-10#2)
of glycine##15##2##(1990-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#3)(2008-10#5)(2011-1#1)
of glycinebetaine##2##2##(1997-4#1)(2008-4#1)
of glycoconjugates##4##2##(1995-2#1)(2008-4#1)(2010-11#1)(2011-2#1)
of glycogen and##2##3##(1994-3#1)(2008-7#1)
of glycogen synthase##2##3##(1996-2#1)(2012-2#1)
of glycogen##13##2##(1990-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-7#1)(2012-2#4)(2013-1#1)
of glycolate##2##2##(1997-7#1)(2008-8#1)
of glycolic acid##3##3##(2007-7#1)(2008-5#2)
of glycolic##4##2##(2007-7#1)(2008-5#3)
of glycolysis and##2##3##(2010-12#1)(2010-7#1)
of glycolysis##6##2##(1995-11#1)(1997-6#2)(2008-11#1)(2010-12#1)(2010-7#1)
of glycolytic##7##2##(1990-11#1)(1996-6#3)(2008-11#1)(2008-6#1)(2010-12#1)
of glyconanoparticles##2##2##(2008-8#2)
of glycopeptides##2##2##(1990-7#1)(2010-11#1)
of glycophorin##2##2##(1992-6#1)(1993-12#1)
of glycoprotein##5##2##(1996-2#1)(2008-1#1)(2008-3#3)
of glycoproteins containing##2##3##(1990-12#1)(2008-4#1)
of glycoproteins with##2##3##(2008-1#1)(2008-7#1)
of glycoproteins##14##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-11#1)(1994-9#1)(1997-7#1)(2008-1#4)(2008-11#1)(2008-4#2)(2008-7#1)
of glycosaminoglycans##2##2##(2008-5#1)(2008-9#1)
of glycosyl hydrolase family##2##4##(1995-6#1)(2013-1#1)
of glycosylated##6##2##(1990-12#1)(1991-2#1)(1992-12#2)(2008-8#1)(2010-11#1)
of glycosylation in##2##3##(1992-12#1)(1995-2#1)
of glycosylation##12##2##(1992-12#1)(1992-6#1)(1993-1#1)(1994-11#1)(1995-2#2)(2008-11#5)(2011-2#1)
of glyoxalase I##2##3##(1991-12#1)(1991-5#1)
of glyphosate was##2##3##(2008-10#1)(2010-1#1)
of glyphosate##7##2##(2008-10#2)(2010-1#3)(2011-1#2)
of goals and##3##3##(1991-12#1)(1996-12#1)(2008-2#1)
of goat and sheep##2##4##(2008-12#1)(2010-4#1)
of goat##10##2##(1995-6#1)(2008-10#1)(2008-12#1)(2010-4#6)(2013-1#1)
of goblet cells##2##3##(1994-11#1)(2008-5#1)
of goblet##3##2##(1994-11#2)(2008-5#1)
of gold at##2##3##(1994-5#2)
of gold by##3##3##(2007-12#1)(2008-10#2)
of gold in##2##3##(2007-12#1)(2008-10#1)
of gold nanoparticles##2##3##(2008-10#1)(2008-11#1)
of gold particles##2##3##(2007-12#1)(2008-9#1)
of gold sodium thiomalate in##2##5##(1994-5#1)(1995-3#1)
of gold sodium thiomalate##3##4##(1994-5#2)(1995-3#1)
of gold were studied##2##4##(1994-5#1)(2008-10#1)
of gold##47##2##(1991-9#1)(1994-10#1)(1994-5#7)(1995-3#1)(2007-12#4)(2008-10#20)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#4)
of goldfilled##2##2##(2008-10#2)
of goldfish##2##2##(1994-11#1)(2011-2#1)
of gonadal##7##2##(2007-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
of gonococcal##3##2##(1993-12#1)(1995-12#1)(2007-8#1)
of gonorrhoea##2##2##(1990-3#2)
of good and##3##3##(1996-5#1)(2007-11#1)(2010-10#1)
of good genes##2##3##(2008-8#1)(2013-1#1)
of good nutrition##2##3##(2012-12#1)(2012-3#1)
of good quality and##2##4##(2008-10#2)
of good quality##7##3##(2008-10#2)(2008-11#2)(2008-7#2)(2010-4#1)
of good##41##2##(1990-12#1)(1993-1#1)(1994-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#2)(2010-10#2)(2010-4#1)(2012-1#1)(2012-12#2)(2012-3#5)(2013-1#1)
of goods and##2##3##(1991-2#1)(2008-11#1)
of goods##4##2##(1991-2#1)(2008-10#2)(2008-11#1)
of gossypol was##2##3##(2008-8#2)
of gossypol were##2##3##(1990-11#2)
of gossypol##6##2##(1990-11#4)(2008-8#2)
of gout##9##2##(1990-11#1)(1991-8#1)(2006-10#6)(2011-2#1)
of governance##3##2##(1996-1#2)(2013-7#1)
of government in##3##3##(1996-12#1)(1996-3#1)(2012-2#1)
of government is##2##3##(2007-12#1)(2008-6#1)
of government##24##2##(1991-2#1)(1992-1#2)(1992-2#1)(1994-1#1)(1994-2#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-7#1)(2007-12#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-7#1)
of gp120##5##2##(1995-2#1)(2008-12#3)(2013-1#1)
of gp41##2##2##(2011-3#1)(2013-8#1)
of grade 1##3##3##(1994-2#1)(2011-2#1)(2013-8#1)
of grade 2##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
of grade 4 neutropenia##2##4##(2008-6#1)(2008-7#1)
of grade IIIC##2##3##(2013-8#2)
of grade IV##3##3##(2007-10#1)(2008-12#2)
of grade##21##2##(1991-5#1)(1994-2#1)(2007-10#1)(2008-12#4)(2008-6#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#9)
of graded##2##2##(2008-10#1)(2008-3#1)
of graded-index##2##2##(2008-2#1)(2008-3#1)
of gradient##3##2##(1997-4#1)(2008-3#1)(2010-2#1)
of gradient-enriched##2##2##(1997-3#2)
of gradient-index lenses with##2##4##(2008-3#2)
of gradient-index##3##2##(2008-3#3)
of gradual##2##2##(2008-11#1)(2010-8#1)
of gradually##2##2##(2012-2#1)(2013-1#1)
of graduate medical education##4##4##(1991-8#2)(2007-4#1)(2008-11#1)
of graduate##11##2##(1991-1#1)(1991-8#3)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(2007-4#1)(2008-11#1)(2011-1#1)
of graduates##7##2##(1991-2#1)(1991-8#1)(1996-1#1)(1996-3#1)(2012-3#3)
of graft function##2##3##(1991-9#1)(1994-5#1)
of graft loss##2##3##(2008-8#1)(2013-1#1)
of graft##17##2##(1991-9#1)(1994-5#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-8#1)(2013-1#2)
of graft-versus-host disease##2##3##(1997-8#1)(2009-10#1)
of grafted##4##2##(2008-10#1)(2008-3#1)(2009-5#1)(2013-1#1)
of grafting##2##2##(2007-8#1)(2008-3#1)
of grafts in the##2##4##(1990-5#1)(1991-2#1)
of grafts in##3##3##(1990-5#1)(1991-2#1)(2011-3#1)
of grafts##6##2##(1990-5#1)(1991-2#1)(2007-8#1)(2008-1#2)(2011-3#1)
of grain##11##2##(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#2)(2013-1#1)
of grains##3##2##(1990-12#1)(2008-12#1)(2010-1#1)
of gram positive##2##3##(2007-7#1)(2008-12#1)
of gram##4##2##(1991-2#1)(2007-7#2)(2008-12#1)
of gram-negative bacteria##2##3##(2007-7#1)(2008-2#1)
of gram-negative##5##2##(2007-7#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-3#1)
of granisetron##3##2##(2010-12#2)(2010-7#1)
of granite##2##2##(2008-1#1)(2008-10#1)
of granular sludge##2##3##(2013-1#2)
of granular##7##2##(1995-3#1)(2008-10#2)(2008-7#1)(2013-1#3)
of granulated##2##2##(2008-11#1)(2010-1#1)
of granule cells in##2##4##(1994-8#1)(2008-6#1)
of granule##4##2##(1994-8#2)(2008-6#2)
of granules##3##2##(1990-5#1)(2010-11#1)(2013-1#1)
of granulocyte colony-stimulating factor in##2##5##(2008-11#2)
of granulocyte colony-stimulating factor##4##4##(1994-12#1)(2008-11#2)(2013-1#1)
of granulocytes and##2##3##(2006-7#1)(2011-2#1)
of granulocytes##3##2##(2006-7#1)(2011-2#1)(2013-1#1)
of granulocytic anaplasmosis##2##3##(2008-12#1)(2013-1#1)
of granulomas##2##2##(1990-5#1)(1992-5#1)
of granulomatous##4##2##(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
of granulosa cells##2##3##(1995-12#1)(2008-12#1)
of granulosa##3##2##(1995-12#2)(2008-12#1)
of grape black rot##3##4##(2008-10#3)
of grape##12##2##(2008-10#12)
of grapefruit##3##2##(2008-10#2)(2008-8#1)
of grapes##7##2##(2008-10#6)(2013-1#1)
of grapevine downy mildew##2##4##(2008-10#2)
of grapevine leaves by##2##4##(2008-10#2)
of grapevine##11##2##(2008-10#11)
of grapevines##2##2##(2008-10#2)
of graphene##3##2##(2012-2#3)
of graphical##2##2##(1994-3#1)(2012-2#1)
of graphics##2##2##(2008-6#1)(2011-1#1)
of graphite##3##2##(2008-10#2)(2012-2#1)
of grass shrimp##2##3##(2010-4#2)
of grass##4##2##(2008-10#1)(2008-7#1)(2010-4#2)
of grasses and##3##3##(2008-10#1)(2008-8#2)
of grasses##4##2##(2008-10#2)(2008-8#2)
of grasshoppers##4##2##(2013-7#4)
of grating couplers##2##3##(2008-2#2)
of grating##17##2##(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#4)(2013-8#3)
of grating-assisted##4##2##(2007-12#2)(2008-3#2)
of gratings written##2##3##(2007-12#2)
of gratings##10##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)
of gratitude##2##2##(2008-12#2)
of gravity##8##2##(1997-5#2)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
of gray leaf spot of maize##2##6##(2008-10#2)
of gray leaf spot of perennial ryegrass turf##2##8##(2008-10#2)
of gray leaf spot of##5##5##(2008-10#5)
of gray leaf spot##7##4##(2008-10#7)
of gray mold disease##2##4##(1997-4#1)(2008-10#1)
of gray mold##4##3##(1997-4#1)(2008-10#3)
of gray##14##2##(1991-5#1)(1997-4#1)(2008-10#10)(2008-3#2)
of grazing on chemical soil properties and vegetation cover##2##9##(2008-12#2)
of grazing##6##2##(1996-12#2)(2008-12#2)(2010-2#1)(2013-7#1)
of great concern##4##3##(1994-1#1)(2008-10#2)(2010-8#1)
of great importance for the##2##5##(2006-10#1)(2011-2#1)
of great importance for##7##4##(1991-2#1)(1992-12#1)(2006-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
of great importance in##7##4##(1991-9#1)(1997-1#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#2)
of great importance to##2##4##(2008-9#1)(2009-1#1)
of great importance##27##3##(1990-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)
of great interest for##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
of great interest in the##2##5##(2008-10#2)
of great interest in##3##4##(2008-10#2)(2009-5#1)
of great interest##19##3##(1992-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of great practical importance##2##4##(2008-8#1)(2010-7#1)
of great practical##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)
of great significance##2##3##(2007-12#1)(2008-10#1)
of great value##6##3##(1991-6#1)(1992-8#1)(1996-11#1)(2009-8#1)(2010-8#1)(2013-8#1)
of great##88##2##(1990-11#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
of greater relevance##2##3##(2008-10#2)
of greater than 100##2##4##(1995-6#1)(2008-3#1)
of greater than 200##2##4##(1991-8#1)(2008-3#1)
of greater than 80%##2##4##(1995-6#1)(2008-3#1)
of greater than 90%##2##4##(2007-11#1)(2008-3#1)
of greater than##22##3##(1991-8#1)(1994-12#1)(1995-6#2)(1997-4#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#7)(2011-2#1)(2012-2#1)(2012-3#1)
of greater thickness##2##3##(2008-10#1)(2008-3#1)
of greater##53##2##(1990-2#1)(1991-12#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-4#2)(2007-11#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
of greatest##5##2##(1995-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-7#1)
of greatly##2##2##(1991-12#1)(1994-8#1)
of green and black tea##2##5##(2009-8#2)
of green and##3##3##(2008-10#1)(2009-8#2)
of green fluorescent protein (GFP)##2##5##(2008-1#1)(2008-7#1)
of green fluorescent protein##8##4##(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#4)
of green mold##2##3##(2008-10#2)
of green tea extract##2##4##(2009-11#2)
of green tea##7##3##(2008-10#1)(2008-11#1)(2009-11#3)(2009-5#1)(2009-8#1)
of green##37##2##(1993-8#1)(1994-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#3)(2009-5#1)(2009-8#3)(2010-6#1)(2011-2#2)
of green-yellow colour##2##3##(2011-2#2)
of greenhouse##5##2##(2008-10#3)(2008-12#1)(2012-2#1)
of greenhouse-grown##3##2##(2008-10#3)
of grey cast iron##4##4##(2008-10#4)
of grey matter##2##3##(1995-8#1)(2012-1#1)
of grey##6##2##(1995-8#1)(2008-10#4)(2012-1#1)
of grief and##3##3##(1990-10#2)(1993-3#1)
of grief##8##2##(1990-10#3)(1993-3#2)(1993-6#1)(2008-12#1)(2013-7#1)
of grinding##4##2##(2008-10#1)(2008-3#3)
of grip force control##3##4##(2013-1#3)
of grip##6##2##(2008-9#3)(2013-1#3)
of grooves##2##2##(2008-3#2)
of gross national product##2##4##(1991-12#1)(1992-3#1)
of gross saponins of Tribulus terrestris##2##6##(2011-3#2)
of gross##18##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-3#2)
of ground squirrel##2##3##(2008-8#2)
of ground squirrels##2##3##(1995-12#2)
of ground##15##2##(1995-12#2)(1997-5#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#2)(2012-12#1)(2013-1#1)
of ground-based##3##2##(2008-3#2)(2013-8#1)
of ground-state##2##2##(2008-2#1)(2008-3#1)
of groundnut rosette disease##2##4##(2008-10#2)
of groundnut rosette##3##3##(2008-10#3)
of groundnut##8##2##(2008-10#8)
of groundwater##4##2##(1996-4#1)(2008-10#1)(2013-1#2)
of group 1 were##2##4##(2008-10#1)(2008-9#1)
of group 1##6##3##(1991-3#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-5#1)
of group 2##4##3##(1991-3#1)(2008-10#2)(2008-9#1)
of group A Streptococcus##2##4##(2007-8#1)(2009-9#1)
of group A##6##3##(1993-12#1)(2007-12#1)(2007-8#2)(2009-9#1)(2012-2#1)
of group B Streptococcus type III oligosaccharides##2##7##(1995-6#2)
of group B##3##3##(1995-6#2)(2012-2#1)
of group C##2##3##(2010-7#1)(2012-2#1)
of group I isolates##2##4##(2008-10#2)
of group I metabotropic##3##4##(1996-12#2)(2009-3#1)
of group I##8##3##(1995-12#1)(1995-6#1)(1996-12#2)(2007-8#1)(2008-10#2)(2009-3#1)
of group II isolates##2##4##(2008-10#2)
of group II##6##3##(2007-8#1)(2008-10#5)
of group III##4##3##(2008-10#3)(2008-8#1)
of group differences##4##3##(1992-6#3)(1997-3#1)
of group medical##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
of group size##2##3##(2008-8#2)
of group##70##2##(1991-3#3)(1992-6#3)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-9#2)(1995-12#1)(1995-6#3)(1996-12#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#3)(2008-10#15)(2008-11#4)(2008-2#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
of group-delay ripples##2##3##(2007-11#2)
of group-delay##3##2##(2007-11#2)(2008-3#1)
of group-velocity##3##2##(2007-11#1)(2008-3#2)
of grouping##2##2##(1995-2#1)(2008-4#1)
of groups A##2##3##(2007-8#1)(2008-10#1)
of groups I and II##4##5##(2008-10#4)
of groups I##5##3##(2008-10#5)
of groups in##2##3##(1994-9#1)(2009-1#1)
of groups of##5##3##(1990-3#1)(1995-2#1)(2008-10#2)(2009-4#1)
of groups##31##2##(1990-3#1)(1991-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1997-7#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#3)(2009-4#1)(2010-4#2)(2012-2#1)
of growing concern##2##3##(2007-12#1)(2008-8#1)
of growing importance##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
of growing##22##2##(1991-12#1)(1992-11#1)(1992-3#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-3#1)
of growth and development##3##4##(2008-11#1)(2010-8#1)(2011-1#1)
of growth and differentiation of##4##5##(1990-12#1)(1993-9#1)(1997-2#1)(2008-11#1)
of growth and##28##3##(1990-12#1)(1992-5#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2013-1#2)(2013-8#1)
of growth arrest##5##3##(1995-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2009-5#1)
of growth by##3##3##(1994-8#1)(1995-2#1)(2008-8#1)
of growth during##2##3##(2008-7#1)(2009-8#1)
of growth factor##5##3##(1990-12#2)(1992-9#1)(2008-12#1)(2012-1#1)
of growth factors and cytokines##2##5##(1994-3#1)(1994-9#1)
of growth factors and##4##4##(1992-8#1)(1994-3#1)(1994-5#1)(1994-9#1)
of growth factors in##3##4##(1990-12#1)(1993-8#1)(2007-12#1)
of growth factors##24##3##(1990-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1996-12#1)(2007-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-10#1)(2013-8#2)
of growth hormone (GH)##3##4##(2010-5#1)(2013-1#1)(2013-7#1)
of growth hormone and prolactin##2##5##(1993-2#2)
of growth hormone in##4##4##(2012-3#1)(2013-1#1)(2013-7#2)
of growth hormone receptor (GHR)##2##5##(2008-9#1)(2010-5#1)
of growth hormone receptor##4##4##(1993-2#1)(2008-9#2)(2010-5#1)
of growth hormone replacement##2##4##(1993-2#1)(1997-8#1)
of growth hormone##18##3##(1990-12#1)(1993-2#4)(1997-8#2)(2008-9#2)(2009-2#1)(2010-5#2)(2012-3#1)(2013-1#2)(2013-7#3)
of growth hormone-releasing factor##2##4##(1990-2#1)(1991-9#1)
of growth in##4##3##(1992-2#1)(1993-9#1)(2008-10#1)(2013-7#1)
of growth of##13##3##(1990-7#2)(1994-10#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
of growth or##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
of growth rate and##2##4##(1994-3#1)(2010-8#1)
of growth rate##6##3##(1994-3#1)(2007-11#2)(2008-11#1)(2010-8#1)(2012-2#1)
of growth rates##3##3##(2008-10#1)(2008-8#2)
of growth temperature##2##3##(2011-2#2)
of growth under##2##3##(1993-9#1)(2008-10#1)
of growth was##2##3##(2008-5#1)(2008-8#1)
of growth were##6##3##(1992-5#1)(2008-11#3)(2010-8#1)(2013-7#1)
of growth##192##2##(1990-12#6)(1990-2#1)(1990-6#1)(1990-7#3)(1991-1#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#4)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#5)(1994-9#1)(1995-11#3)(1995-2#4)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#4)(2008-1#1)(2008-10#14)(2008-11#13)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#6)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#2)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#6)(2013-8#4)
of growth-arrest genes##2##3##(1992-12#2)
of guanethidine##2##2##(1995-12#1)(1997-4#1)
of guanidine hydrochloride with the##2##5##(1993-3#2)
of guanidine hydrochloride with##4##4##(1993-3#3)(1993-6#1)
of guanidine hydrochloride##10##3##(1992-6#2)(1993-3#4)(1993-6#1)(1995-5#3)
of guanidine x HCl##2##4##(2008-4#2)
of guanidine##13##2##(1992-6#3)(1993-3#4)(1993-6#1)(1995-5#3)(2008-4#2)
of guanine and##2##3##(1994-8#1)(2008-11#1)
of guanine bases##2##3##(1990-5#2)
of guanine in the presence of##2##6##(2008-10#2)
of guanine in##3##3##(2008-10#3)
of guanine nucleotides with the##3##5##(1991-5#1)(1995-5#2)
of guanine nucleotides##5##3##(1991-5#1)(1992-11#1)(1993-6#1)(1995-5#2)
of guanine##20##2##(1990-5#2)(1991-5#1)(1992-11#1)(1993-6#1)(1994-8#3)(1995-5#2)(2008-10#9)(2008-11#1)
of guanosine triphosphate##2##3##(1991-9#1)(2009-12#1)
of guanosine##8##2##(1991-9#1)(1995-8#1)(2008-4#3)(2009-12#3)
of guanylyl cyclase##2##3##(1995-2#1)(2008-4#1)
of guest##3##2##(2008-10#1)(2010-12#2)
of guidance and##2##3##(2008-11#1)(2008-12#1)
of guidance##4##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)
of guide##2##2##(2011-2#2)
of guided modes##2##3##(2007-11#1)(2007-12#1)
of guided##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2012-3#2)(2013-1#1)
of guided-mode resonance filters##2##4##(2008-3#2)
of guided-wave##3##2##(2007-12#1)(2008-2#2)
of guideline development##2##3##(2008-7#1)(2008-8#1)
of guidelines##11##2##(1992-2#1)(1994-1#1)(1994-3#2)(1996-3#2)(1996-4#1)(2008-1#1)(2008-9#1)(2009-4#1)(2013-1#1)
of guiding##5##2##(2007-12#1)(2008-11#2)(2008-9#1)(2011-2#1)
of guilt##2##2##(1992-2#1)(2012-12#1)
of guinea pig ileum##2##4##(1991-5#1)(1995-12#1)
of guinea pig spermatozoa##2##4##(2008-8#2)
of guinea pig##13##3##(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-12#1)(2008-8#3)(2013-1#1)
of guinea pigs##3##3##(1994-8#1)(1995-12#1)(2011-1#1)
of guinea##16##2##(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#2)(2008-8#3)(2011-1#1)(2013-1#1)
of guinea-pig##5##2##(1990-5#1)(1997-4#1)(1997-7#1)(2008-2#1)(2009-12#1)
of gummy##2##2##(2008-10#1)(2012-3#1)
of gun##2##2##(1995-2#1)(2011-2#1)
of guppies from##2##3##(2008-8#1)(2012-3#1)
of gustatory##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
of gut##4##2##(1990-12#1)(2007-12#1)(2011-1#1)(2011-2#1)
of gutta-percha##2##2##(1991-3#1)(2009-8#1)
of gynecologic malignancy##2##3##(1991-3#1)(2013-8#1)
of gynecologic##6##2##(1991-3#1)(1992-3#1)(1993-3#1)(2007-8#1)(2012-3#1)(2013-8#1)
of gynecological##2##2##(2010-11#1)(2011-1#1)
of gypsum application on##2##4##(2008-12#2)
of gypsum##4##2##(2008-12#4)
of gypsy##2##2##(2008-9#2)
of h-TR beta 1##3##4##(1991-2#1)(1993-8#2)
of hASCs##3##2##(2012-5#1)(2012-6#2)
of hBD-2 mRNA##2##3##(2008-11#2)
of hBM-MSCs##2##2##(2009-12#2)
of hCG##3##2##(1990-5#1)(1993-6#1)(1996-12#1)
of hCaT1##2##2##(2008-11#2)
of hESC##6##2##(2008-11#2)(2008-9#4)
of hEp##3##2##(1993-12#2)(1993-6#1)
of hFGF-10##2##2##(2011-3#2)
of hFIX protein##3##3##(2008-8#2)(2008-9#1)
of hFIX##8##2##(2008-8#5)(2008-9#3)
of hFSH-beta##2##2##(1990-4#2)
of hIAPP##2##2##(1994-8#2)
of hIK1##3##2##(2008-8#3)
of hIL-6 and##2##3##(2008-8#2)
of hIL-6##9##2##(1992-8#2)(2008-11#4)(2008-8#3)
of hIL-6R (V106-P322)##3##3##(2008-8#3)
of hIL-6R with##2##3##(2008-8#2)
of hIL-6R##5##2##(2008-8#5)
of hMSCs in the presence of FGF-2##2##7##(2008-11#2)
of hMSCs##8##2##(2008-11#5)(2010-8#3)
of hMss4##2##2##(1995-8#2)
of hSIM2##2##2##(1996-6#2)
of hTERT transcription##2##3##(2008-11#2)
of hTERT##4##2##(2008-11#4)
of hTERT-immortalized cells##2##3##(2008-11#2)
of hTGF alpha##5##3##(1995-2#5)
of hTR##2##2##(1991-6#2)
of habitat change##2##3##(2008-8#2)
of habitat in the##2##4##(2008-8#1)(2008-9#1)
of habitat patches##5##3##(2008-8#3)(2008-9#2)
of habitat saturation##2##3##(2008-8#2)
of habitat selection##2##3##(2008-8#2)
of habitat structure##2##3##(2008-8#1)(2013-7#1)
of habitat##28##2##(2008-5#1)(2008-8#20)(2008-9#5)(2010-8#1)(2013-7#1)
of habitats##4##2##(2007-10#1)(2008-8#1)(2010-3#1)(2012-2#1)
of habituation to##3##3##(1994-3#1)(2008-11#1)(2009-8#1)
of habituation##5##2##(1994-3#1)(1997-2#1)(2007-8#1)(2008-11#1)(2009-8#1)
of haematoma##2##2##(2008-7#1)(2008-8#1)
of haemoglobin##7##2##(1990-3#1)(1994-8#1)(2010-5#1)(2011-1#2)(2013-1#2)
of haemolysis##4##2##(1994-8#1)(2008-10#1)(2009-10#1)(2009-4#1)
of haemolytic##2##2##(1997-2#1)(2011-2#1)
of haemopoietic cells##2##3##(1991-5#1)(2008-11#1)
of haemoptysis##2##2##(2008-4#1)(2010-2#1)
of haemorrhage##5##2##(1992-6#1)(1996-6#2)(1996-9#1)(2008-7#1)
of haemorrhagic enteritis##2##3##(2011-2#2)
of hagfishes##2##2##(2012-2#2)
of hair and##2##3##(2008-10#1)(2008-5#1)
of hair care products##2##4##(2008-5#2)
of hair cells##2##3##(1993-9#1)(2013-1#1)
of hair in##3##3##(2008-5#2)(2009-7#1)
of hair loss##5##3##(2008-5#4)(2010-6#1)
of hair samples##2##3##(2008-5#1)(2013-1#1)
of hair shampoo##6##3##(2008-5#6)
of hair was##2##3##(2012-3#2)
of hair##54##2##(1990-8#2)(1993-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#32)(2008-7#2)(2008-9#2)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)
of hairless##2##2##(1992-8#1)(1994-6#1)
of hairpin##3##2##(1991-5#1)(1993-12#1)(2011-1#1)
of hairs##5##2##(2008-5#2)(2011-2#2)(2013-8#1)
of half##5##2##(1990-6#1)(2008-10#3)(2013-8#1)
of halide##4##2##(1994-5#1)(2008-10#3)
of halides##2##2##(2008-10#2)
of hallucinogenic plants in plant mixtures##2##6##(2008-12#2)
of hallux valgus deformity with primary medial collateral ligamentous insufficiency##2##10##(2012-2#2)
of hallux valgus deformity##3##4##(2012-2#3)
of hallux valgus##4##3##(2009-10#1)(2012-2#3)
of halo nevi##3##3##(2011-2#3)
of halo##5##2##(2008-2#1)(2011-2#3)(2012-2#1)
of haloacetic acids##2##3##(2008-10#1)(2008-9#1)
of haloacetic##3##2##(2008-10#2)(2008-9#1)
of halogenated##10##2##(1993-12#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-9#1)
of halogenoalkyl##2##2##(2008-4#2)
of haloperidol on##2##3##(1997-7#2)
of haloperidol##9##2##(1992-5#2)(1996-12#1)(1996-7#1)(1997-7#3)(2008-10#1)(2008-6#1)
of halos##2##2##(2008-2#2)
of halothane##4##2##(1990-2#1)(1991-2#1)(1995-3#2)
of hamster##3##2##(1990-8#1)(1994-8#1)(2008-11#1)
of hamstring##2##2##(2008-11#1)(2012-2#1)
of hand and##3##3##(1994-9#1)(2011-2#1)(2012-2#1)
of hand containment/massage##2##3##(2008-10#2)
of hand hygiene guidelines and protocols##2##6##(2011-2#2)
of hand hygiene##4##3##(2008-12#1)(2011-2#2)(2012-3#1)
of hand##28##2##(1991-6#1)(1992-3#1)(1994-9#1)(1995-12#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#4)(2008-5#1)(2008-9#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of handedness##3##2##(1994-8#1)(1997-8#1)(2007-12#1)
of handling and fixation processes on##2##6##(2008-3#2)
of handling and##3##3##(2008-3#2)(2008-9#1)
of handling##13##2##(1992-11#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-9#1)(2010-5#1)
of hands##3##2##(1994-11#2)(2009-5#1)
of hantavirus##4##2##(1991-11#1)(2008-10#3)
of haploid##4##2##(1991-12#1)(1994-11#1)(2008-10#2)
of haplotype##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
of haplotypes##2##2##(2008-10#2)
of haplotypic##2##2##(2008-10#1)(2008-9#1)
of hapten and bovine serum albumin##2##6##(2008-11#2)
of hapten##5##2##(2008-11#5)
of harboring##2##2##(2008-10#1)(2012-2#1)
of hard and soft tissue##2##5##(2007-12#1)(2008-2#1)
of hard and soft##4##4##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
of hard boundaries and an##2##5##(2008-8#2)
of hard##21##2##(1991-2#1)(1993-1#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
of hardware and software##2##4##(1996-12#1)(2012-12#1)
of hardware and##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
of hares##3##2##(2013-1#3)
of harm reduction##2##3##(1997-5#1)(2008-7#1)
of harmane##2##2##(2008-10#2)
of harmful effects##2##3##(2008-11#1)(2008-7#1)
of harmful##5##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)
of harpin##3##2##(2008-10#1)(2008-8#2)
of harsh##2##2##(2008-9#1)(2009-7#1)
of harvested##2##2##(2008-10#2)
of harvesting##2##2##(2007-8#1)(2008-12#1)
of hatching##3##2##(2008-5#1)(2008-8#1)(2013-1#1)
of haustoria##2##2##(2008-10#2)
of haustorial##2##2##(2008-10#2)
of having a baby with congenital anomalies##2##7##(2008-11#2)
of having a mentor during their first practice placement##2##9##(2008-11#2)
of having a usual source of##2##6##(1995-12#1)(2008-10#1)
of having a##23##3##(1990-9#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#3)(2012-3#1)
of having an##4##3##(2008-11#1)(2008-2#1)(2012-1#1)(2013-1#1)
of having at least one##2##5##(2012-12#1)(2013-1#1)
of having more than one##2##5##(1992-9#1)(1997-2#1)
of having the##3##3##(1992-5#1)(2008-7#1)(2012-2#1)
of having##57##2##(1990-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-2#2)(2007-12#1)(2007-7#3)(2007-9#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
of hay fever##2##3##(1992-3#2)
of hazardous chemicals##3##3##(2008-2#1)(2008-9#1)(2010-7#1)
of hazardous materials##2##3##(2008-10#1)(2009-10#1)
of hazardous##12##2##(1996-5#1)(2008-10#4)(2008-2#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)
of hazards and risks##2##4##(2008-9#2)
of hazards##4##2##(1995-5#1)(2008-11#1)(2008-9#2)
of hazmat##2##2##(2009-10#2)
of hcp##2##2##(1990-12#1)(1995-3#1)
of he##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
of head and neck cancer patients##3##6##(2008-5#3)
of head and neck cancer##11##5##(1992-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#4)(2013-1#2)
of head and neck cancers##3##5##(1992-10#1)(2008-5#1)(2010-4#1)
of head and neck tumors##2##5##(2009-11#1)(2011-2#1)
of head and neck##29##4##(1990-12#1)(1992-10#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#3)
of head and##30##3##(1990-12#1)(1992-10#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#3)
of head blight##2##3##(2008-10#2)
of head concussions##2##3##(2010-1#2)
of head injury##3##3##(2010-8#1)(2012-3#1)(2013-1#1)
of head movement##2##3##(1990-5#1)(2008-9#1)
of head trauma##2##3##(2008-7#1)(2013-7#1)
of head##48##2##(1990-12#1)(1990-5#1)(1992-10#2)(1992-6#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
of head-down tilt##2##3##(1993-1#2)
of head-mounted##2##2##(2008-3#2)
of headache##10##2##(1994-6#1)(1994-9#1)(1996-9#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2013-1#1)
of headaches##4##2##(2008-4#3)(2008-6#1)
of headspace volume##2##3##(2008-10#2)
of headspace##6##2##(2008-10#5)(2011-2#1)
of healing##5##2##(1997-3#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
of health administration education##3##4##(1991-12#1)(1993-2#1)(1996-3#1)
of health administration##8##3##(1991-12#1)(1993-2#5)(1996-1#1)(1996-3#1)
of health and disease##5##4##(1992-5#1)(1993-11#1)(2010-10#1)(2012-2#2)
of health and healing##2##4##(2008-1#1)(2008-12#1)
of health and safety in##3##5##(1995-3#3)
of health and social services##2##5##(1994-1#1)(2008-1#1)
of health and social##4##4##(1992-3#1)(1994-1#1)(2008-1#1)(2011-1#1)
of health and well-being##2##4##(2008-7#1)(2011-2#1)
of health and##29##3##(1990-3#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-2#1)(1995-3#3)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-12#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
of health are##2##3##(2008-1#1)(2008-12#1)
of health benefits##2##3##(1996-5#1)(2008-7#1)
of health care and##3##4##(1993-1#1)(1993-12#1)(1995-2#1)
of health care are##2##4##(1991-3#1)(1992-3#1)
of health care costs##7##4##(1992-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-3#1)(2009-4#1)
of health care delivery and financing##2##6##(1993-2#1)(1996-3#1)
of health care delivery systems##2##5##(1994-12#1)(1995-12#1)
of health care delivery##11##4##(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-3#2)(2008-1#2)
of health care expenditure##2##4##(2013-7#2)
of health care expenditures in##2##5##(1992-1#1)(1997-1#1)
of health care expenditures##4##4##(1992-1#1)(1993-3#1)(1995-3#1)(1997-1#1)
of health care facilities in the##2##6##(1997-2#1)(2007-12#1)
of health care facilities##3##4##(1997-2#1)(2007-12#1)(2012-1#1)
of health care for##3##4##(1991-3#1)(1994-3#2)
of health care in the United States##2##7##(1995-3#1)(2007-12#1)
of health care in the##6##5##(1995-3#1)(2007-12#1)(2008-1#3)(2013-1#1)
of health care in##13##4##(1992-1#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-1#3)(2013-1#1)
of health care information##4##4##(1992-12#1)(1993-1#1)(1996-2#1)(2008-11#1)
of health care is##4##4##(1992-1#1)(1992-3#1)(1996-2#1)(2008-11#1)
of health care management##2##4##(1995-3#1)(1996-2#1)
of health care managers##2##4##(1995-12#1)(1995-2#1)
of health care networks##3##4##(1996-2#3)
of health care organizations##5##4##(1991-3#1)(1992-2#1)(1994-2#1)(1996-2#1)(1997-2#1)
of health care professionals##8##4##(1991-3#1)(1994-1#2)(1994-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-4#1)
of health care providers##12##4##(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(2008-11#2)
of health care quality##6##4##(1994-1#2)(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)
of health care reform##19##4##(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-1#2)(1996-3#2)(1997-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
of health care resources and##2##5##(1996-12#1)(2008-7#1)
of health care resources##8##4##(1996-12#1)(2008-1#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
of health care services in##2##5##(1995-1#1)(1995-2#1)
of health care services provided##2##5##(1994-12#1)(1995-12#1)
of health care services##26##4##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-1#1)(2008-2#1)(2010-3#1)
of health care spending##4##4##(1993-3#1)(1994-1#1)(1995-2#1)(2008-7#1)
of health care system##2##4##(1995-2#1)(2009-4#1)
of health care to##4##4##(1994-3#2)(1995-12#1)(1997-3#1)
of health care will##2##4##(1994-12#1)(2008-7#1)
of health care within the##3##5##(1991-6#1)(2008-1#1)(2008-7#1)
of health care workers##4##4##(2008-11#1)(2010-11#2)(2010-3#1)
of health care##256##3##(1990-11#1)(1990-2#1)(1991-12#3)(1991-2#4)(1991-3#4)(1991-6#1)(1992-1#3)(1992-12#3)(1992-2#4)(1992-3#5)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#12)(1993-2#6)(1993-3#5)(1993-6#2)(1994-1#11)(1994-11#1)(1994-12#11)(1994-2#13)(1994-3#13)(1994-6#1)(1995-1#5)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#7)(1995-8#1)(1996-1#5)(1996-12#3)(1996-2#11)(1996-3#11)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#1)(1997-8#1)(2007-12#3)(2007-6#1)(2008-1#9)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#8)(2008-8#1)(2009-4#2)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#1)
of health centers and##2##4##(1996-9#1)(2008-10#1)
of health centers##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
of health consumers##2##3##(2008-1#1)(2008-11#1)
of health data##2##3##(1995-2#1)(2008-7#1)
of health disparities##4##3##(2010-2#1)(2011-1#2)(2013-1#1)
of health economic##2##3##(2013-8#2)
of health education##6##3##(1996-2#1)(1997-6#1)(2008-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
of health expenditures##2##3##(1991-2#1)(1995-3#1)
of health in##3##3##(1993-1#1)(1993-2#1)(2008-1#1)
of health information systems##3##4##(2012-12#3)
of health information##11##3##(1990-12#1)(1995-12#1)(1995-3#1)(2009-5#1)(2012-12#5)(2012-3#1)(2013-7#1)
of health insurance coverage##4##4##(1991-2#1)(1993-3#1)(2011-1#1)(2012-1#1)
of health insurance for##2##4##(1992-3#1)(2011-2#1)
of health insurance##12##3##(1991-2#1)(1992-3#2)(1993-3#1)(2008-11#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
of health literacy##4##3##(2009-8#2)(2013-7#2)
of health maintenance organization##2##4##(1996-2#1)(1996-3#1)
of health maintenance##4##3##(1991-3#1)(1994-2#1)(1996-2#1)(1996-3#1)
of health management##3##3##(1994-12#1)(2012-12#2)
of health of##2##3##(1992-3#1)(2011-2#1)
of health personnel were##2##4##(1990-6#1)(1996-9#1)
of health plan##2##3##(1995-2#1)(1997-3#1)
of health plans##3##3##(1996-12#1)(1997-3#1)(2013-8#1)
of health policy in##2##4##(1992-1#1)(2008-7#1)
of health policy##4##3##(1992-1#1)(1994-12#1)(1994-2#1)(2008-7#1)
of health problems##3##3##(1992-3#1)(1997-1#1)(2008-10#1)
of health professionals in##2##4##(1993-12#1)(2013-1#1)
of health professionals to##3##4##(1995-3#1)(2008-11#1)(2008-12#1)
of health professionals##13##3##(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-11#4)(2008-12#1)(2010-3#1)(2013-1#2)
of health promotion in##2##4##(2008-11#1)(2013-8#1)
of health promotion##6##3##(1993-11#1)(2008-11#2)(2009-6#1)(2011-1#1)(2013-8#1)
of health providers and health insurance underwriters##2##7##(1996-12#1)(1997-2#1)
of health providers##3##3##(1996-12#1)(1997-2#1)(2011-2#1)
of health psychology##2##3##(2013-1#2)
of health reform##5##3##(1994-1#1)(1994-3#1)(1996-1#1)(1996-3#2)
of health research##3##3##(2009-6#2)(2013-7#1)
of health risk##2##3##(1995-11#1)(1996-8#1)
of health risks##2##3##(2009-10#1)(2009-12#1)
of health service delivery##2##4##(1997-2#1)(2010-3#1)
of health service##6##3##(1991-2#1)(1993-2#1)(1997-2#1)(2008-7#1)(2008-8#1)(2010-3#1)
of health services administration##3##4##(1994-2#1)(1996-1#1)(1997-3#1)
of health services and##2##4##(1996-2#1)(2011-1#1)
of health services##39##3##(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#6)(1994-12#1)(1994-2#4)(1994-3#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-12#1)
of health sites##2##3##(1996-12#2)
of health spending##4##3##(1991-2#1)(1992-12#1)(1996-2#1)(1997-3#1)
of health staff##2##3##(2007-11#1)(2008-10#1)
of health status and##3##4##(1996-2#1)(1997-1#1)(2010-3#1)
of health status##11##3##(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-1#2)(2008-6#1)(2008-7#1)(2010-3#1)
of health system##4##3##(1995-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
of health systems##7##3##(1991-3#1)(1994-3#2)(1996-12#1)(2012-12#2)(2013-8#1)
of health technology##3##3##(2009-3#2)(2011-2#1)
of health workers in##2##4##(1990-11#1)(2010-8#1)
of health workers##4##3##(1990-11#2)(2010-8#1)(2013-1#1)
of health##579##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1991-12#4)(1991-2#10)(1991-3#8)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#11)(1992-5#2)(1992-9#1)(1993-1#5)(1993-11#5)(1993-12#16)(1993-2#15)(1993-3#7)(1993-6#10)(1994-1#13)(1994-11#1)(1994-12#16)(1994-2#20)(1994-3#19)(1994-6#1)(1994-9#1)(1995-1#6)(1995-11#2)(1995-12#11)(1995-2#10)(1995-3#15)(1995-8#1)(1996-1#10)(1996-12#9)(1996-2#18)(1996-3#15)(1996-5#2)(1996-8#2)(1996-9#4)(1997-1#8)(1997-2#9)(1997-3#12)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#20)(2008-10#10)(2008-11#23)(2008-12#9)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#19)(2008-8#6)(2009-10#3)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#5)(2009-8#2)(2010-10#5)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#6)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#17)(2011-2#17)(2012-1#3)(2012-12#17)(2012-2#2)(2012-3#9)(2013-1#16)(2013-7#8)(2013-8#6)
of health-related##3##2##(1997-3#1)(2008-1#1)(2010-11#1)
of health-relevant##2##2##(2008-4#1)(2008-8#1)
of health-risk behaviors##2##3##(2010-5#1)(2010-7#1)
of healthcare facilities##3##3##(1996-12#1)(1996-3#1)(2009-8#1)
of healthcare in##2##3##(2008-10#1)(2013-1#1)
of healthcare organizations##2##3##(1994-12#1)(1995-2#1)
of healthcare practitioners on##2##4##(2008-9#2)
of healthcare professionals##2##3##(1991-1#1)(2008-11#1)
of healthcare providers to##2##4##(1997-7#1)(2007-12#1)
of healthcare quality##2##3##(2013-1#2)
of healthcare reform##3##3##(1993-12#2)(1995-1#1)
of healthcare resources##2##3##(2012-2#2)
of healthcare services##5##3##(1994-3#1)(2008-1#1)(2008-9#1)(2012-2#1)(2013-8#1)
of healthcare systems##3##3##(2009-3#1)(2010-3#1)(2012-2#1)
of healthcare workers in##3##4##(2012-12#1)(2013-1#2)
of healthcare workers##5##3##(2012-1#1)(2012-12#1)(2013-1#3)
of healthcare##63##2##(1991-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#11)(2013-8#2)
of healthy and diseased##2##4##(2008-10#2)
of healthy and##6##3##(2008-10#3)(2008-11#2)(2008-5#1)
of healthy children##4##3##(1995-2#2)(1996-1#1)(2008-12#1)
of healthy controls and##2##4##(1991-12#1)(1992-9#1)
of healthy controls##7##3##(1990-2#1)(1991-12#1)(1992-9#2)(1993-8#1)(2009-8#1)(2013-8#1)
of healthy host##2##3##(2008-10#2)
of healthy individuals##9##3##(2008-10#2)(2008-7#2)(2009-10#1)(2010-2#1)(2011-2#2)(2012-12#1)
of healthy lifestyle##2##3##(2008-12#1)(2013-1#1)
of healthy subjects and##2##4##(2008-12#1)(2010-12#1)
of healthy subjects##8##3##(1994-1#1)(1995-11#1)(2008-12#1)(2009-12#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
of healthy##81##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-10#20)(2008-11#7)(2008-12#4)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
of hearing and##2##3##(1990-12#1)(2011-2#1)
of hearing impairment##2##3##(2013-1#2)
of hearing loss##5##3##(1996-6#1)(2008-4#1)(2008-9#2)(2011-2#1)
of hearing##28##2##(1990-12#3)(1994-9#2)(1996-6#1)(2008-4#2)(2008-9#4)(2010-4#1)(2011-2#10)(2012-2#1)(2013-1#4)
of hearing-impaired##2##2##(1995-1#1)(2013-1#1)
of heart and##6##3##(1995-11#1)(2007-8#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#1)
of heart attack##4##3##(2008-3#2)(2010-12#1)(2013-7#1)
of heart disease and##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
of heart disease##10##3##(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-1#1)
of heart failure (HF)##2##4##(2011-2#1)(2013-8#1)
of heart failure and##4##4##(1990-3#1)(2008-1#1)(2008-3#1)(2012-3#1)
of heart failure in the##2##5##(1994-6#1)(2010-8#1)
of heart failure in##3##4##(1994-6#1)(2008-3#1)(2010-8#1)
of heart failure with##2##4##(2012-3#1)(2013-1#1)
of heart failure##43##3##(1990-3#2)(1992-6#1)(1994-6#1)(1994-7#2)(1996-6#2)(1996-9#1)(2007-8#1)(2008-1#1)(2008-3#6)(2008-5#2)(2008-7#4)(2009-10#3)(2010-6#4)(2010-8#3)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
of heart failure]##3##3##(1992-9#1)(1994-7#1)(1996-6#1)
of heart function##2##3##(1995-12#1)(2013-1#1)
of heart rate variability##2##4##(2010-5#1)(2011-2#1)
of heart rate##4##3##(2008-6#1)(2010-5#2)(2011-2#1)
of heart##91##2##(1990-3#2)(1991-8#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-7#3)(1995-11#2)(1995-12#1)(1996-6#3)(1996-9#1)(1997-7#1)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#3)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-6#4)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
of heat and##3##3##(1992-2#2)(1996-12#1)
of heat flow in##2##4##(2008-3#2)
of heat on##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
of heat shock genes##2##4##(1990-11#1)(1994-8#1)
of heat shock protein (HSP)##3##5##(1994-11#1)(2008-7#1)(2013-1#1)
of heat shock protein 70##2##5##(1994-11#1)(2012-1#1)
of heat shock protein with a molecular weight of 90 kDa##2##11##(2012-1#2)
of heat shock protein##13##4##(1994-11#3)(1994-8#3)(1995-5#1)(2008-7#1)(2012-1#4)(2013-1#1)
of heat shock proteins in##3##5##(1994-11#3)
of heat shock proteins##4##4##(1994-11#4)
of heat shock##29##3##(1990-11#1)(1994-11#10)(1994-8#8)(1995-11#1)(1995-5#1)(2008-7#2)(2010-2#1)(2012-1#4)(2013-1#1)
of heat stress##7##3##(1994-11#1)(2008-12#3)(2010-7#1)(2012-2#2)
of heat transfer##2##3##(2008-10#2)
of heat treatment##3##3##(1992-8#1)(2008-7#1)(2013-8#1)
of heat wave on##2##4##(2011-1#2)
of heat wave##3##3##(2011-1#3)
of heat##76##2##(1990-10#1)(1990-11#1)(1990-12#1)(1992-2#2)(1992-3#4)(1992-8#1)(1993-6#1)(1994-11#11)(1994-5#1)(1994-8#9)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#5)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#4)(2012-2#3)(2013-1#3)(2013-8#3)
of heat-shock##3##2##(1993-6#1)(1994-11#1)(2008-7#1)
of heat-treated##2##2##(1995-6#1)(1997-7#1)
of heating and##3##3##(1990-9#1)(2008-10#2)
of heating in##3##3##(1990-2#1)(1994-5#1)(2008-10#1)
of heating temperature and##2##4##(2013-1#2)
of heating##13##2##(1990-2#2)(1990-9#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-2#1)(2013-1#2)
of heavy and##2##3##(1994-2#1)(2008-4#1)
of heavy metal ions from aqueous##2##6##(2008-10#2)
of heavy metal ions from##3##5##(1994-6#1)(2008-10#2)
of heavy metal ions in##2##5##(2008-10#2)
of heavy metal ions onto the##2##6##(2008-10#2)
of heavy metal ions onto##3##5##(2008-10#3)
of heavy metal ions##18##4##(1994-6#1)(2008-10#17)
of heavy metal##27##3##(1993-12#1)(1994-6#1)(2008-10#22)(2013-1#2)(2013-8#1)
of heavy metals by##2##4##(1995-3#1)(2008-10#1)
of heavy metals from##2##4##(2008-10#2)
of heavy metals in different tissues of##2##7##(2008-12#2)
of heavy metals in different##3##5##(2008-11#1)(2008-12#2)
of heavy metals in the##3##5##(1995-3#1)(2008-10#1)(2011-2#1)
of heavy metals in##15##4##(1995-3#1)(2008-10#8)(2008-11#1)(2008-12#2)(2010-11#1)(2011-2#1)(2013-8#1)
of heavy metals on##2##4##(2008-10#1)(2008-5#1)
of heavy metals with##2##4##(2008-10#1)(2008-11#1)
of heavy metals##38##3##(1994-6#1)(1995-3#2)(2008-10#23)(2008-11#2)(2008-12#3)(2008-5#3)(2010-11#1)(2011-2#1)(2013-8#2)
of heavy##73##2##(1993-12#1)(1994-2#1)(1994-6#2)(1995-3#2)(1997-1#1)(1997-9#1)(2008-10#46)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#1)(2010-11#1)(2011-2#3)(2013-1#2)(2013-8#3)
of hedgehog##2##2##(1993-2#2)
of hegemonic##2##2##(2008-10#1)(2009-5#1)
of heifers to discriminate between##2##5##(2010-2#2)
of height##2##2##(2008-8#1)(2011-2#1)
of helical##3##2##(2007-11#1)(2008-11#1)(2008-6#1)
of helices##3##2##(1991-6#1)(1994-6#1)(1994-8#1)
of helix##4##2##(1990-11#1)(1992-8#1)(1993-11#1)(2008-9#1)
of helminth parasites##2##3##(2011-1#2)
of helminth##4##2##(1997-7#1)(2007-12#1)(2011-1#2)
of helminthes##2##2##(2011-2#2)
of help for##2##3##(1992-5#1)(2008-4#1)
of help##5##2##(1990-9#1)(1992-5#1)(1996-3#1)(2008-10#1)(2008-4#1)
of helper virus##2##3##(1990-5#1)(2008-10#1)
of helper##6##2##(1990-5#1)(1992-3#1)(1997-3#1)(2008-10#2)(2008-4#1)
of helping##5##2##(1991-12#1)(1993-1#1)(2008-12#1)(2008-8#1)(2010-4#1)
of hematocrit##2##2##(2008-3#1)(2013-1#1)
of hematogenous##2##2##(2007-8#1)(2008-10#1)
of hematologic##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
of hematological malignancies##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
of hematological##4##2##(2007-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
of hematology##2##2##(2008-10#1)(2011-2#1)
of hematoma and##2##3##(1990-5#2)
of hematoma##3##2##(1990-5#2)(2007-10#1)
of hematopoiesis##2##2##(2008-10#1)(2008-8#1)
of hematopoietic cells##6##3##(1996-2#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-9#1)
of hematopoietic progenitor cells##2##4##(2008-11#2)
of hematopoietic progenitors##4##3##(2008-11#2)(2010-8#1)(2011-2#1)
of hematopoietic stem cell##2##4##(2009-10#1)(2012-12#1)
of hematopoietic stem cells from##2##5##(2008-10#1)(2008-9#1)
of hematopoietic stem cells##6##4##(2008-10#3)(2008-9#3)
of hematopoietic stem##8##3##(2008-10#3)(2008-9#3)(2009-10#1)(2012-12#1)
of hematopoietic##27##2##(1993-8#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#7)(2008-7#1)(2008-9#7)(2009-10#1)(2010-8#2)(2011-2#1)(2012-12#1)
of hematoporphyrin##2##2##(2008-8#1)(2008-9#1)
of hematuria##4##2##(1993-2#1)(1996-12#1)(2006-10#1)(2007-7#1)
of heme and##2##3##(2008-9#2)
of heme oxygenase##2##3##(2008-4#2)
of heme polymerase##2##3##(1993-8#2)
of heme site cooperativity##2##4##(1997-2#2)
of heme##20##2##(1990-8#1)(1992-3#1)(1992-4#1)(1993-8#3)(1994-5#2)(1994-8#2)(1997-2#2)(2007-11#1)(2008-10#1)(2008-4#2)(2008-9#3)(2010-12#1)
of heme-protein##2##2##(2008-10#2)
of hemerythrin##3##2##(1991-10#1)(1992-8#2)
of hemi-fusion in##2##3##(1991-5#2)
of hemiballismus##2##2##(2008-7#2)
of hemicellulose hydrolysate##2##3##(2008-6#2)
of hemin##15##2##(1991-9#2)(1994-5#7)(2008-10#5)(2008-8#1)
of hemiparetic##2##2##(1994-1#1)(2007-11#1)
of hemispherical##2##2##(2008-10#1)(2008-2#1)
of hemocytes##6##2##(2008-5#4)(2008-7#1)(2010-4#1)
of hemodialysis (HD)##2##3##(2008-1#1)(2011-2#1)
of hemodialysis facilities##2##3##(1991-12#2)
of hemodialysis patients##2##3##(2007-7#2)
of hemodialysis treatment##2##3##(2008-4#1)(2011-2#1)
of hemodialysis##17##2##(1991-12#2)(2007-7#3)(2008-1#7)(2008-4#1)(2011-2#2)(2013-1#2)
of hemodynamic and##2##3##(1993-9#1)(2012-12#1)
of hemodynamic factors in##2##4##(2007-7#1)(2009-1#1)
of hemodynamic##13##2##(1990-8#1)(1991-9#1)(1993-9#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-1#1)(2009-3#1)(2012-12#1)(2012-3#1)
of hemoglobin (Hb)##4##3##(1994-12#1)(2008-10#2)(2008-7#1)
of hemoglobin A0##2##3##(1990-8#2)
of hemoglobin A1c##2##3##(2012-5#2)
of hemoglobin and##2##3##(1990-8#1)(2008-1#1)
of hemoglobin have been##2##4##(1990-8#1)(1997-2#1)
of hemoglobin in##7##3##(1990-8#1)(1994-12#1)(2008-10#3)(2008-9#1)(2011-1#1)
of hemoglobin level##2##3##(2008-7#1)(2013-1#1)
of hemoglobin oxygenation##2##3##(1990-8#1)(2008-3#1)
of hemoglobin using##2##3##(2008-10#2)
of hemoglobin was##2##3##(1994-12#1)(2008-10#1)
of hemoglobin with##2##3##(1990-8#2)
of hemoglobin##56##2##(1990-7#1)(1990-8#14)(1990-9#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-9#1)(1995-5#1)(1997-2#4)(2008-1#2)(2008-10#11)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-5#2)(2013-1#1)(2013-8#2)
of hemolymph##2##2##(1997-8#2)
of hemolysis##7##2##(1992-6#1)(1994-12#1)(1994-9#1)(2008-4#1)(2008-7#1)(2013-1#2)
of hemolytic disease of the##2##5##(1992-12#1)(2010-11#1)
of hemopoietic cells##2##3##(1993-3#1)(1997-2#1)
of hemopoietic##3##2##(1993-3#1)(1994-5#1)(1997-2#1)
of hemorrhage##3##2##(2008-7#1)(2009-8#1)(2012-3#1)
of hemorrhagic fever with renal syndrome##3##6##(2013-1#3)
of hemorrhagic stroke##2##3##(2008-8#1)(2012-12#1)
of hemorrhagic##10##2##(1991-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#4)
of hemostasis##8##2##(1994-9#1)(2008-10#2)(2008-9#1)(2012-2#1)(2013-1#3)
of hen egg white lysozyme##2##5##(1994-8#1)(1997-2#1)
of hen##3##2##(1994-8#1)(1996-12#1)(1997-2#1)
of heparan sulfate in##2##4##(1995-12#2)
of heparan##4##2##(1992-9#1)(1995-12#2)(1996-8#1)
of heparin binding##2##3##(1992-10#1)(1997-4#1)
of heparin in##3##3##(1992-10#2)(2008-10#1)
of heparin or##2##3##(1990-12#1)(1993-6#1)
of heparin therapy##2##3##(1997-2#1)(2008-10#1)
of heparin to##3##3##(1992-10#1)(1995-2#1)(2008-11#1)
of heparin##38##2##(1990-12#1)(1992-10#4)(1992-5#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-2#1)(2007-7#2)(2007-9#2)(2008-10#8)(2008-11#3)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
of heparin-induced extracorporeal lipoprotein apheresis##2##5##(2011-2#2)
of heparin-induced##3##2##(2011-2#2)(2013-1#1)
of heparinized##2##2##(1990-8#1)(2011-2#1)
of hepatic and extra-hepatic##2##4##(1992-11#1)(2008-1#1)
of hepatic and##3##3##(1992-11#1)(2008-1#1)(2008-10#1)
of hepatic cells##2##3##(1993-6#1)(2010-11#1)
of hepatic damage##3##3##(1992-12#1)(1995-3#1)(2008-9#1)
of hepatic glucagon##2##3##(1994-11#2)
of hepatic glucose production##4##4##(1991-7#1)(1993-8#2)(2008-1#1)
of hepatic glucose##5##3##(1991-7#2)(1993-8#2)(2008-1#1)
of hepatic lipase##2##3##(1994-8#2)
of hepatic metastases##2##3##(1992-11#1)(2008-7#1)
of hepatic##67##2##(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1993-12#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-8#4)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#2)(2011-2#3)(2012-2#3)(2013-1#4)
of hepatitis A has##2##4##(2007-12#2)
of hepatitis A in##2##4##(2007-12#2)
of hepatitis A virus##3##4##(2008-7#1)(2012-12#2)
of hepatitis A##11##3##(2007-12#6)(2007-2#1)(2008-7#1)(2011-1#1)(2012-12#2)
of hepatitis B and C##2##5##(1997-7#1)(2013-7#1)
of hepatitis B and##3##4##(1997-7#1)(2009-7#1)(2013-7#1)
of hepatitis B in##3##4##(2007-12#2)(2010-11#1)
of hepatitis B surface antigen##2##5##(1996-11#1)(1997-4#1)
of hepatitis B surface##3##4##(1996-11#1)(1997-4#1)(2008-8#1)
of hepatitis B vaccine among##3##5##(2008-9#3)
of hepatitis B vaccine##5##4##(1990-6#1)(1995-3#1)(2008-9#3)
of hepatitis B virus (HBV)##7##5##(1990-8#1)(1997-4#2)(2007-12#1)(2008-4#1)(2008-8#1)(2009-8#1)
of hepatitis B virus DNA##2##5##(1990-8#1)(2006-10#1)
of hepatitis B virus in##2##5##(1993-2#1)(2009-3#1)
of hepatitis B virus surface antigen Pre-S1##2##7##(2008-8#2)
of hepatitis B virus surface antigen##3##6##(2008-8#3)
of hepatitis B virus##30##4##(1990-8#2)(1993-2#1)(1994-8#2)(1996-2#1)(1996-3#2)(1997-4#2)(1997-5#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2009-3#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
of hepatitis B##50##3##(1990-6#1)(1990-8#2)(1993-2#1)(1994-8#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#4)(1997-4#3)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-7#2)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-3#2)(2009-7#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
of hepatitis C in##3##4##(2007-7#1)(2008-1#1)(2010-11#1)
of hepatitis C on##2##4##(2006-10#1)(2008-1#1)
of hepatitis C virus (HCV) infection##3##6##(2006-10#1)(2012-2#1)(2013-1#1)
of hepatitis C virus (HCV)##10##5##(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
of hepatitis C virus in##2##5##(2007-7#1)(2008-10#1)
of hepatitis C virus##27##4##(1991-11#1)(1991-2#3)(1994-7#1)(1994-8#1)(1996-2#1)(1996-3#1)(2006-10#3)(2007-7#3)(2008-1#1)(2008-10#4)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
of hepatitis C##39##3##(1991-11#1)(1991-2#3)(1992-5#1)(1994-7#1)(1994-8#1)(1996-2#1)(1996-3#1)(2006-10#4)(2007-7#5)(2008-1#5)(2008-10#4)(2008-6#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
of hepatitis##111##2##(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#3)(1992-5#1)(1993-2#1)(1994-11#1)(1994-7#1)(1994-8#3)(1995-3#1)(1996-11#1)(1996-2#2)(1996-3#7)(1997-4#3)(1997-5#1)(1997-7#1)(2006-10#6)(2007-12#9)(2007-2#2)(2007-7#9)(2008-1#5)(2008-10#5)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#4)(2013-1#3)(2013-7#2)
of hepatoblastoma##3##2##(2011-1#3)
of hepatocarcinoma##2##2##(2010-1#1)(2013-1#1)
of hepatocellular carcinoma (HCC)##5##4##(2006-10#1)(2008-10#1)(2010-12#1)(2013-1#1)(2013-7#1)
of hepatocellular carcinoma in a##3##5##(1993-2#1)(2011-2#1)(2013-8#1)
of hepatocellular carcinoma##20##3##(1993-2#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#5)
of hepatocellular##22##2##(1993-2#2)(1994-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
of hepatocyte cytoplasmic vacuolization in##2##5##(2008-9#2)
of hepatocyte cytoplasmic vacuolization were increased in males##2##8##(2008-9#2)
of hepatocyte cytoplasmic vacuolization##4##4##(2008-9#4)
of hepatocyte growth factor##6##4##(1992-12#1)(2008-1#1)(2008-11#3)(2013-1#1)
of hepatocyte##20##2##(1992-12#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-11#5)(2008-7#1)(2008-9#9)(2013-1#1)
of hepatocytes and##3##3##(1993-3#1)(2008-11#2)
of hepatocytes from##3##3##(1991-12#1)(1994-11#1)(1996-5#1)
of hepatocytes in##2##3##(1994-8#1)(2008-11#1)
of hepatocytes with the##2##4##(1992-3#1)(1996-2#1)
of hepatocytes with##3##3##(1992-3#1)(1996-2#1)(2008-10#1)
of hepatocytes##26##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#3)(1994-8#2)(1996-2#1)(1996-5#2)(1997-4#2)(2008-10#1)(2008-11#7)(2008-6#1)(2012-2#1)(2013-1#1)
of hepatoma cell invasion##2##4##(2008-11#2)
of hepatoma cells##7##3##(1991-5#1)(2008-11#6)
of hepatoma##11##2##(1991-5#1)(2008-11#8)(2008-2#1)(2013-8#1)
of hepatorenal##2##2##(1992-8#1)(1996-6#1)
of hepatotoxicity##4##2##(1995-3#2)(1996-12#1)(2008-7#1)
of hepcidin isoforms##4##3##(2010-12#4)
of hepcidin##5##2##(2010-12#5)
of her body##2##3##(1991-3#1)(1995-3#1)
of her left##2##3##(1996-8#1)(2008-12#1)
of her right##4##3##(1991-12#1)(2008-12#1)(2008-5#1)(2010-3#1)
of her symptoms##5##3##(2006-10#1)(2008-7#2)(2013-1#1)(2013-8#1)
of her upper##2##3##(2008-5#1)(2013-1#1)
of her##45##2##(1991-12#2)(1991-3#2)(1991-6#1)(1992-9#2)(1993-2#1)(1994-7#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-3#2)(2006-10#1)(2007-7#2)(2008-1#2)(2008-12#2)(2008-5#3)(2008-7#2)(2009-3#2)(2010-12#1)(2010-3#1)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
of her-2/neu##2##2##(2008-10#1)(2008-11#1)
of herb##3##2##(2008-10#2)(2012-3#1)
of herbage##2##2##(2010-2#1)(2012-2#1)
of herbal products##3##3##(2008-10#2)(2013-1#1)
of herbal shampoos##2##3##(2008-5#2)
of herbal##12##2##(2008-10#3)(2008-5#2)(2009-12#2)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
of herbicide##2##2##(2008-10#1)(2008-11#1)
of herbicides##6##2##(1996-3#2)(2008-10#4)
of herbivore##2##2##(2008-8#1)(2008-9#1)
of herbivore-induced##2##2##(1990-11#1)(2008-9#1)
of herbivores##4##2##(2008-8#2)(2008-9#2)
of herbivorous insects##2##3##(2008-8#2)
of herbivorous##3##2##(2008-8#3)
of herbivory##7##2##(2008-8#4)(2008-9#3)
of herds with##2##3##(1992-5#1)(2012-1#1)
of hereditary breast##2##3##(1995-12#1)(2011-2#1)
of hereditary cancer##2##3##(2011-2#2)
of hereditary hemorrhagic telangiectasia##2##4##(2008-1#1)(2010-6#1)
of hereditary##23##2##(1990-3#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-7#3)(2007-7#1)(2008-1#3)(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#1)
of heritability##4##2##(1997-7#1)(2008-10#1)(2009-4#1)(2012-3#1)
of hermaphrodites##4##2##(2007-12#2)(2008-5#1)(2008-9#1)
of hermaphroditism in animals##2##4##(2008-8#2)
of hermaphroditism##3##2##(2008-8#3)
of hernia is##2##3##(1990-5#1)(2008-12#1)
of hernia##7##2##(1990-5#1)(2008-12#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
of herniated##2##2##(1990-5#1)(1990-9#1)
of herniation##8##2##(1995-11#1)(2006-7#1)(2007-8#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
of heroin##4##2##(1991-12#1)(1996-11#1)(1996-5#1)(2008-11#1)
of herpes simplex virus DNA polymerase##2##6##(1995-2#2)
of herpes simplex virus type 1##2##6##(2007-12#2)
of herpes simplex virus##5##4##(1995-2#2)(2007-12#2)(2009-4#1)
of herpes simplex##9##3##(1994-11#1)(1995-2#2)(1996-6#1)(2007-12#2)(2007-2#1)(2009-4#2)
of herpes zoster##2##3##(2007-7#1)(2008-7#1)
of herpes##12##2##(1994-11#1)(1995-2#2)(1996-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-4#2)
of herpesvirus##4##2##(1991-2#1)(1997-6#1)(2008-5#1)(2012-3#1)
of heterochromatic##3##2##(2009-3#3)
of heterochromatin##3##2##(2008-12#3)
of heterocyclic amines##2##3##(1997-2#1)(2008-10#1)
of heterocyclic##8##2##(1995-2#2)(1995-3#1)(1997-2#1)(2007-11#2)(2008-10#1)(2009-12#1)
of heterodyne##6##2##(2007-11#2)(2008-2#2)(2008-3#2)
of heterogeneity of the##3##4##(2008-10#2)(2008-8#1)
of heterogeneity of##5##3##(1994-2#1)(2008-10#3)(2008-8#1)
of heterogeneity##17##2##(1994-2#1)(1994-8#1)(1996-3#1)(2008-10#10)(2008-12#2)(2008-8#1)(2008-9#1)
of heterogeneous bead behavior##2##4##(2008-7#2)
of heterogeneous##17##2##(1990-12#1)(1995-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2012-2#3)
of heterogenous##2##2##(2008-7#1)(2010-8#1)
of heterologous genes##5##3##(1991-9#1)(1994-12#2)(1997-4#1)(2008-5#1)
of heterologous protein##2##3##(2008-11#1)(2008-7#1)
of heterologous proteins##3##3##(1997-4#2)(2008-7#1)
of heterologous##17##2##(1990-12#1)(1991-9#1)(1994-12#2)(1994-6#1)(1995-5#2)(1996-12#1)(1997-4#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)
of heterologously expressed##2##3##(2008-4#2)
of heterophils##2##2##(2007-6#1)(2008-5#1)
of heteroplasmy##4##2##(2012-3#2)(2013-8#2)
of heterosexual##2##2##(2009-5#1)(2012-2#1)
of heterosis in rice##4##4##(2008-4#2)(2008-8#2)
of heterosis##6##2##(2008-4#3)(2008-8#2)(2009-10#1)
of heterotopic ossification##5##3##(1994-8#2)(2007-11#1)(2012-12#2)
of heterotopic pancreas##2##3##(1997-8#1)(2013-7#1)
of heterotopic##8##2##(1994-8#2)(1997-8#1)(2007-11#2)(2012-12#2)(2013-7#1)
of heterotrimeric G proteins##3##4##(1995-6#1)(1995-8#1)(2008-7#1)
of heterotrophic##5##2##(2009-4#1)(2013-1#2)(2013-7#2)
of heterozygosity loss##2##3##(1994-12#1)(1997-5#1)
of heterozygosity##16##2##(1993-11#1)(1994-12#2)(1994-6#1)(1995-12#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#2)(2011-1#1)(2012-3#2)
of heterozygotes##5##2##(1995-2#1)(1996-6#1)(2008-10#2)(2008-6#1)
of heterozygous##4##2##(1995-2#1)(2009-5#1)(2013-1#2)
of heuristic algorithms##2##3##(2010-2#2)
of heuristic##3##2##(2007-8#1)(2010-2#2)
of hexacyanoferrate(III)##3##2##(2008-10#3)
of hexagonal array illumination##2##4##(2007-11#2)
of hexagonal ice##2##3##(2007-12#2)
of hexagonal##9##2##(1991-5#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
of hexahydro-1##2##2##(2008-10#2)
of hexamethyldisiloxane##2##2##(2008-10#1)(2008-3#1)
of hexane##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
of hexaploid##4##2##(2008-10#1)(2008-5#1)(2010-8#2)
of hexapod##2##2##(2007-12#2)
of hexavalent chromium##9##3##(2008-10#5)(2008-12#2)(2011-2#1)(2013-1#1)
of hexavalent##10##2##(2008-10#6)(2008-12#2)(2011-2#1)(2013-1#1)
of hexokinase##3##2##(1993-11#1)(1994-8#1)(2008-10#1)
of hexosaminidase##2##2##(1992-3#2)
of hexose##2##2##(2010-2#1)(2012-1#1)
of hfNSCs in##2##3##(2009-10#2)
of hiatal##2##2##(2011-2#2)
of hidden##7##2##(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-6#1)(2012-3#1)
of hierarchical structures##2##3##(2012-2#2)
of hierarchical##10##2##(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-10#1)(2012-1#1)(2012-2#2)
of hierarchically composed##2##3##(1996-5#2)
of hierarchically##3##2##(1996-5#2)(2008-11#1)
of hierarchy##2##2##(1993-2#1)(1995-9#1)
of high affinity##13##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-6#2)(1995-12#2)(2008-11#1)(2008-7#1)(2008-8#1)
of high amounts of##2##4##(1991-5#1)(1994-11#1)
of high and low affinity binding sites##2##7##(1990-5#2)
of high and low##7##4##(1990-5#2)(1995-3#1)(2007-11#1)(2008-10#1)(2009-12#1)(2011-2#1)
of high and##10##3##(1990-5#2)(1995-3#1)(2007-11#2)(2008-10#2)(2008-8#1)(2009-12#1)(2011-2#1)
of high blood pressure##4##4##(1992-6#1)(1993-2#1)(1994-6#1)(2011-2#1)
of high cell density##2##4##(2008-11#2)
of high cell##3##3##(2008-11#3)
of high concentration of##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
of high concentration##5##3##(1995-3#1)(2008-10#2)(2008-5#1)(2011-1#1)
of high concentrations of copper##2##5##(2007-5#1)(2008-10#1)
of high concentrations of glucose##2##5##(2008-11#1)(2008-4#1)
of high concentrations of##13##4##(1990-11#1)(1990-12#2)(1994-9#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)
of high cost##2##3##(2008-10#1)(2008-11#1)
of high degree##2##3##(2011-1#2)
of high density lipoprotein (HDL)##2##5##(2012-2#2)
of high density lipoprotein##3##4##(2010-5#1)(2012-2#2)
of high density##11##3##(1990-5#1)(1991-10#1)(1993-2#1)(2008-10#2)(2008-3#1)(2009-12#1)(2010-5#1)(2012-2#2)(2013-1#1)
of high dose##3##3##(1996-8#1)(2008-11#1)(2008-5#1)
of high doses of##4##4##(1992-9#1)(1995-2#1)(1997-3#1)(2008-10#1)
of high doses##6##3##(1992-9#1)(1995-2#2)(1997-3#1)(2008-10#1)(2010-8#1)
of high frequency ventilation##2##4##(1994-6#2)
of high frequency##4##3##(1994-6#2)(2007-12#1)(2011-2#1)
of high gain##2##3##(2007-12#1)(2008-2#1)
of high glucose##3##3##(1992-6#1)(2011-2#1)(2012-5#1)
of high grade##4##3##(1992-1#2)(2008-6#1)(2013-8#1)
of high level##3##3##(2008-11#1)(2010-5#1)(2012-3#1)
of high levels of##12##4##(1990-8#1)(1992-9#1)(1996-1#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)
of high molecular weight##11##4##(1990-12#2)(1991-9#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-5#2)(2010-11#2)
of high or##2##3##(2008-10#1)(2008-7#1)
of high performance liquid chromatography (HPLC)##3##6##(2008-10#3)
of high performance##4##3##(2008-10#3)(2008-7#1)
of high power##2##3##(1994-2#1)(2011-1#1)
of high priority##2##3##(2008-10#1)(2012-3#1)
of high purity arsenic through##2##5##(2008-10#2)
of high purity##8##3##(2008-10#6)(2008-11#1)(2008-6#1)
of high quality##13##3##(1993-12#1)(1994-3#1)(1995-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
of high relative humidity##3##4##(2008-10#3)
of high relative##4##3##(1991-2#1)(2008-10#3)
of high resolution mass spectrometry##2##5##(2008-10#1)(2008-11#1)
of high resolution##5##3##(1993-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-6#1)
of high risk and complicated pregnancies##2##6##(2011-1#2)
of high risk and##3##4##(2007-5#1)(2011-1#2)
of high risk##7##3##(1994-3#1)(1995-1#1)(2007-5#1)(2008-10#1)(2009-5#1)(2011-1#2)
of high sensitivity##5##3##(2008-10#3)(2008-3#1)(2011-2#1)
of high socioeconomic status##2##4##(1990-2#1)(2013-8#1)
of high spatial resolution##2##4##(2008-3#1)(2012-1#1)
of high spectral##2##3##(2007-12#1)(2008-2#1)
of high temperature on##2##4##(2008-10#1)(2008-7#1)
of high temperature##4##3##(2008-10#3)(2008-7#1)
of high##311##2##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#5)(1990-8#1)(1991-10#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1996-1#1)(1996-12#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#8)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#67)(2008-11#17)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#11)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2010-11#3)(2010-2#1)(2010-4#2)(2010-5#5)(2010-6#3)(2010-8#3)(2011-1#7)(2011-2#7)(2011-3#2)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#3)
of high- and##3##3##(1990-11#1)(2007-11#1)(2008-8#1)
of high-##4##2##(1990-11#1)(2007-11#1)(2008-8#1)(2012-2#1)
of high-affinity binding sites##2##4##(1993-9#1)(1996-2#1)
of high-affinity##5##2##(1990-7#1)(1993-9#1)(1996-2#1)(1996-5#1)(2009-7#1)
of high-average-power##2##2##(2007-12#1)(2008-3#1)
of high-density lipoprotein##3##3##(2008-6#2)(2011-2#1)
of high-density##4##2##(2008-3#1)(2008-6#2)(2011-2#1)
of high-dose##8##2##(1990-12#1)(1992-8#1)(1993-9#1)(1996-6#1)(2008-7#2)(2011-2#1)(2012-2#1)
of high-efficiency##3##2##(2008-1#1)(2008-2#1)(2013-8#1)
of high-energy pulses by##2##4##(2007-11#2)
of high-energy##14##2##(1993-5#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-11#1)(2011-2#1)
of high-fidelity##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
of high-flow priapism in##2##4##(2008-10#2)
of high-frequency##5##2##(1992-9#1)(1994-6#1)(2007-12#2)(2010-8#1)
of high-grade dysplasia in##2##4##(1996-8#1)(2009-4#1)
of high-grade dysplasia##3##3##(1996-8#1)(2009-4#2)
of high-grade glioma##2##3##(2011-2#1)(2013-1#1)
of high-grade##12##2##(1996-8#1)(2007-10#1)(2008-10#2)(2009-4#2)(2011-2#2)(2013-1#2)(2013-8#2)
of high-intensity laser##2##3##(2007-11#1)(2008-2#1)
of high-intensity##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2011-2#1)
of high-level##2##2##(2008-10#1)(2008-11#1)
of high-molecular-weight genomic DNA##2##4##(2008-4#1)(2010-2#1)
of high-molecular-weight polycyclic aromatic##2##4##(2011-1#2)
of high-molecular-weight##4##2##(2008-4#1)(2010-2#1)(2011-1#2)
of high-numerical-aperture##2##2##(2007-12#1)(2008-3#1)
of high-order rainbows##2##3##(2008-2#2)
of high-order##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
of high-performance capillary##3##3##(1996-12#2)(2008-10#1)
of high-performance liquid chromatographic##2##4##(1990-8#1)(1997-2#1)
of high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
of high-performance liquid chromatography in##2##5##(1990-8#2)
of high-performance liquid chromatography to the study of biogenic amine-related enzymes##2##11##(1991-5#2)
of high-performance liquid chromatography##8##4##(1990-8#2)(1991-5#2)(1997-2#1)(2008-10#3)
of high-performance liquid##11##3##(1990-8#3)(1991-5#2)(1997-2#2)(2008-10#4)
of high-performance##19##2##(1990-8#3)(1991-5#3)(1996-12#2)(1997-2#2)(2008-10#6)(2008-7#1)(2010-10#1)(2010-12#1)
of high-permittivity##2##2##(2008-3#2)
of high-power##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
of high-pressure##2##2##(2007-11#1)(2008-3#1)
of high-purity##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
of high-quality research##2##3##(1993-12#1)(2008-11#1)
of high-quality##19##2##(1992-2#2)(1993-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-9#1)(2012-1#1)
of high-repetition-rate##2##2##(2007-12#2)
of high-resolution##11##2##(1991-6#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-9#1)(2011-2#1)
of high-risk infants##3##3##(2008-11#3)
of high-risk patients##2##3##(2006-10#1)(2008-3#1)
of high-risk##18##2##(1993-3#2)(1995-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#3)(2008-3#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
of high-school##2##2##(2010-5#1)(2011-2#1)
of high-sensitivity##2##2##(2007-12#1)(2008-9#1)
of high-speed##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
of high-temperature##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
of high-throughput screening##2##3##(2008-10#2)
of high-throughput##11##2##(2008-10#2)(2008-11#1)(2008-7#3)(2009-4#2)(2009-8#1)(2012-3#2)
of higher concentrations##3##3##(1990-12#1)(2008-10#1)(2009-9#1)
of higher education for##2##4##(2008-12#2)
of higher levels of##5##4##(1993-11#1)(2008-11#2)(2008-8#1)(2009-11#1)
of higher organisms##2##3##(2008-11#1)(2009-12#1)
of higher plant##3##3##(1994-12#1)(1995-2#1)(2008-11#1)
of higher plants##3##3##(1995-8#2)(1996-12#1)
of higher##71##2##(1990-12#1)(1992-12#2)(1993-11#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#3)(2012-5#2)(2013-1#2)(2013-7#1)(2013-8#1)
of higher-order modes##2##3##(2007-12#1)(2008-3#1)
of higher-order##15##2##(1994-8#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-2#3)(2008-3#4)(2012-2#1)
of highest##8##2##(1990-11#1)(1990-9#1)(2008-10#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
of highly absorbing black appliqués##2##5##(2008-3#2)
of highly active antiretroviral therapy (HAART) has##2##7##(2008-3#2)
of highly active antiretroviral therapy (HAART)##5##6##(2008-3#2)(2009-5#1)(2009-7#1)(2011-2#1)
of highly active##7##3##(2008-1#1)(2008-10#1)(2008-3#2)(2009-5#1)(2009-7#1)(2011-2#1)
of highly birefringent##3##3##(2007-12#1)(2008-2#2)
of highly conserved##3##3##(1995-6#1)(2010-7#1)(2013-1#1)
of highly differentiated##2##3##(2008-11#1)(2013-1#1)
of highly effective##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
of highly efficient##10##3##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)
of highly functionalised##2##3##(2007-11#1)(2009-10#1)
of highly heterogeneous##2##3##(2008-10#1)(2008-6#1)
of highly nonlinear##3##3##(2007-11#3)
of highly ordered##3##3##(2008-12#1)(2009-11#1)(2010-4#1)
of highly resistant##2##3##(2008-10#1)(2013-1#1)
of highly scattering media##3##4##(2008-2#1)(2008-3#2)
of highly scattering##4##3##(2008-2#2)(2008-3#2)
of highly sensitive##6##3##(1991-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-4#1)(2010-7#1)
of highly##117##2##(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#11)(2007-12#10)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#4)(2013-7#2)
of hilar##2##2##(2011-2#1)(2012-2#1)
of hind leg##3##3##(1997-2#1)(2007-12#2)
of hind##5##2##(1997-2#1)(2007-12#2)(2010-12#1)(2010-3#1)
of hindfoot##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
of hip and##2##3##(2008-11#1)(2012-2#1)
of hip arthroplasty##2##3##(2012-2#1)(2013-1#1)
of hip dysplasia##2##3##(2007-11#1)(2007-8#1)
of hip fracture##3##3##(1990-9#1)(1993-11#1)(2008-7#1)
of hip fractures##4##3##(1993-11#4)
of hip joint##5##3##(2007-11#3)(2007-8#1)(2009-4#1)
of hip##31##2##(1990-9#1)(1993-11#6)(1995-9#1)(2007-11#7)(2007-8#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-7#3)
of hippocampal 5-HT1A##2##3##(1994-2#2)
of hippocampal CA1##2##3##(2008-11#1)(2009-12#1)
of hippocampal and cortical##2##4##(1996-5#2)
of hippocampal function##2##3##(2007-8#2)
of hippocampal neurons in vivo##2##5##(2009-12#2)
of hippocampal neurons##5##3##(2008-8#1)(2009-12#3)(2012-3#1)
of hippocampal slices##3##3##(1995-2#1)(1996-5#1)(2008-4#1)
of hippocampal synaptic plasticity##3##4##(1993-12#1)(2008-7#1)(2009-8#1)
of hippocampal##34##2##(1991-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#3)(1996-9#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#4)(2009-3#1)(2009-8#2)(2012-2#1)(2012-3#1)(2013-8#1)
of hippocampus##5##2##(1990-11#1)(1994-2#1)(1996-5#1)(2008-12#2)
of hirsutism##2##2##(2008-1#1)(2008-3#1)
of hirulog-1##2##2##(1990-7#2)
of his death##2##3##(2009-10#1)(2009-7#1)
of his family##2##3##(2011-2#2)
of his head##2##3##(2011-2#1)(2013-8#1)
of his life and##2##4##(2007-8#1)(2008-11#1)
of his life##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
of his lower##2##3##(2008-7#1)(2011-2#1)
of his neurological##2##3##(2008-7#1)(2011-2#1)
of his symptoms##3##3##(2010-1#1)(2011-2#1)(2012-2#1)
of his work##3##3##(2007-5#1)(2008-12#1)(2009-2#1)
of his##90##2##(1990-8#1)(1990-9#1)(1991-6#1)(1992-5#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-6#1)(1996-9#2)(1997-5#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#1)(2009-7#2)(2010-1#4)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#10)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
of his/her##8##2##(1992-1#1)(1992-12#1)(1993-1#1)(2007-6#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
of histamine in##2##3##(1995-12#1)(2008-10#1)
of histamine on##3##3##(1995-12#1)(1996-5#1)(2008-12#1)
of histamine were##2##3##(1990-7#1)(1996-5#1)
of histamine##18##2##(1990-7#1)(1991-12#1)(1991-5#1)(1994-6#1)(1995-12#2)(1996-5#2)(1997-1#1)(2008-10#4)(2008-12#3)(2011-2#1)(2012-2#1)
of histamine-induced##2##2##(1994-8#1)(2008-5#1)
of histidine ammonia-lyase##2##3##(1994-5#1)(1994-6#1)
of histidine and its metabolites##2##5##(2008-10#2)
of histidine and##3##3##(1990-12#1)(2008-10#2)
of histidine are##2##3##(1990-5#1)(2008-10#1)
of histidine in##2##3##(1995-3#1)(2008-10#1)
of histidine residues and sulfhydryl groups in the function of the##2##11##(1992-6#2)
of histidine residues and sulfhydryl groups in the##3##8##(1992-6#3)
of histidine residues##5##3##(1992-6#3)(1992-8#2)
of histidine##23##2##(1990-12#1)(1990-5#1)(1992-6#3)(1992-8#2)(1994-11#1)(1994-5#2)(1994-6#1)(1995-3#1)(1997-1#1)(2008-10#7)(2008-8#1)(2012-2#1)(2013-8#1)
of histiocytic necrotizing lymphadenitis (Kikuchi's disease)##2##6##(1991-3#1)(1991-9#1)
of histiocytic##3##2##(1991-3#1)(1991-9#1)(2012-12#1)
of histologic verification##2##3##(1991-2#2)
of histologic##6##2##(1991-2#2)(1994-12#1)(2009-3#1)(2011-2#1)(2012-12#1)
of histological##13##2##(1991-6#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#2)(2013-8#1)
of histologically proven##2##3##(1997-8#1)(2008-7#1)
of histologically##7##2##(1993-9#1)(1994-1#2)(1997-8#1)(2008-2#1)(2008-7#1)(2010-3#1)
of histone H2AX##3##3##(2008-9#2)(2009-5#1)
of histone H3##4##3##(1992-8#1)(1997-2#1)(2008-9#1)(2013-1#1)
of histone deacetylase##3##3##(2010-6#1)(2011-2#1)(2012-2#1)
of histone deacetylation##2##3##(2008-7#1)(2013-8#1)
of histone gene##2##3##(1990-5#1)(2008-7#1)
of histone modifications##2##3##(2009-8#1)(2011-2#1)
of histone##23##2##(1990-5#2)(1992-8#1)(1994-9#1)(1997-2#1)(2008-10#2)(2008-7#3)(2008-9#3)(2009-5#2)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
of histones##5##2##(1990-2#1)(1992-8#1)(1995-2#2)(2013-1#1)
of histopathological##3##2##(2007-7#1)(2012-3#2)
of histopathology##2##2##(2007-7#1)(2008-10#1)
of historic##6##2##(2008-10#2)(2008-2#3)(2013-1#1)
of historical##10##2##(1996-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
of history and##2##3##(2011-1#1)(2012-3#1)
of history##11##2##(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
of hit compounds##2##3##(2013-1#2)
of hnRNP##2##2##(2008-8#2)
of holes of##2##3##(2006-4#1)(2008-3#1)
of holes##5##2##(2006-4#1)(2007-11#1)(2008-3#3)
of holistic care##5##3##(2008-11#4)(2008-4#1)
of holistic##9##2##(2008-11#5)(2008-12#1)(2008-4#1)(2009-11#1)(2009-8#1)
of hollow waveguides##2##3##(2008-3#2)
of hollow##6##2##(2007-11#1)(2008-11#1)(2008-3#2)(2009-9#1)(2013-1#1)
of hologram formation in dichromated gelatin##2##6##(2008-2#2)
of hologram formation##5##3##(2008-2#5)
of hologram##8##2##(2007-11#2)(2008-2#5)(2008-3#1)
of holograms of##2##3##(2007-11#1)(2007-12#1)
of holograms##10##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#5)
of holographic gratings##2##3##(2007-12#1)(2008-3#1)
of holographic optical elements##3##4##(2008-2#2)(2008-3#1)
of holographic##13##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#5)
of holography##4##2##(2008-2#2)(2008-3#2)
of homatropine methylbromide##2##3##(2008-10#2)
of home birth##2##3##(2007-2#2)
of home care##11##3##(1991-3#3)(1992-2#1)(1992-3#1)(1995-2#2)(1997-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
of home health care##7##4##(1993-1#1)(1995-3#4)(1996-12#1)(1997-2#1)
of home health services##4##4##(1995-3#4)
of home health##14##3##(1993-1#1)(1994-2#1)(1995-3#10)(1996-12#1)(1997-2#1)
of home##44##2##(1991-1#1)(1991-2#1)(1991-3#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#3)(1995-3#10)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
of home-based##4##2##(1995-12#2)(2007-12#1)(2008-10#1)
of home-made##3##2##(1991-9#2)(2008-10#1)
of homeless##2##2##(2008-4#1)(2012-3#1)
of homeopathic##3##2##(1994-2#1)(2008-10#2)
of homeopathy##6##2##(1994-2#2)(1997-6#2)(2008-10#2)
of homeostasis system##2##3##(2013-1#2)
of homeostasis##6##2##(1993-6#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
of homes##3##2##(1992-3#1)(1995-2#2)
of homo- and##2##3##(1992-12#1)(2008-10#1)
of homocysteine in plasma##2##4##(1992-9#2)
of homocysteine##18##2##(1992-9#3)(2008-10#6)(2008-3#6)(2008-8#1)(2010-5#1)(2011-2#1)
of homoeopathy##2##2##(1997-6#2)
of homogeneity in##2##3##(2011-2#1)(2012-3#1)
of homogeneity of##2##3##(2008-10#1)(2008-3#1)
of homogeneity##9##2##(1992-6#1)(1997-4#1)(1997-5#3)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
of homogeneous and##3##3##(2007-12#2)(2010-12#1)
of homogeneous##12##2##(1992-10#1)(1994-5#1)(1996-4#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-12#1)
of homologated##2##2##(2006-12#2)
of homologous blood##5##3##(1990-2#1)(1992-3#1)(1996-9#2)(2007-9#1)
of homologous recombination##2##3##(1994-8#1)(2008-11#1)
of homologous sequences##2##3##(1993-2#1)(2008-7#1)
of homologous##24##2##(1990-2#1)(1992-3#1)(1992-6#2)(1993-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1996-9#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-8#1)
of homologues##2##2##(1997-7#1)(2006-12#1)
of homology between##3##3##(1990-7#1)(1993-2#1)(2008-10#1)
of homology in##2##3##(1994-11#1)(2008-4#1)
of homology is##2##3##(1993-2#1)(2008-7#1)
of homology to other##2##4##(1992-8#1)(1993-6#1)
of homology to##6##3##(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-6#1)
of homology with##5##3##(1990-2#1)(1993-11#1)(1993-3#1)(1996-12#1)(2008-9#1)
of homology##29##2##(1990-2#1)(1990-7#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#2)(1994-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2012-2#1)
of homophobia in##2##3##(2008-12#2)
of homophobia##3##2##(2008-12#3)
of homosexual and bisexual men##2##5##(2013-7#2)
of homosexual##4##2##(2008-5#1)(2011-2#1)(2013-7#2)
of homozygotes##2##2##(1995-2#1)(1997-8#1)
of homozygous##5##2##(1997-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
of honesty##2##2##(1996-12#1)(2010-10#1)
of honey and##2##3##(2008-10#2)
of honey with##3##3##(2008-10#2)(2011-2#1)
of honey##8##2##(2008-10#5)(2008-7#1)(2011-2#2)
of honeybee behaviour##2##3##(2008-7#2)
of honeybee##3##2##(2008-10#1)(2008-7#2)
of honeybees##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
of honokiol and magnolol in##3##5##(2008-10#3)
of honokiol and magnolol##4##4##(2008-10#4)
of hop powdery mildew##3##4##(2008-10#3)
of hop stunt viroid##2##4##(2008-10#2)
of hop##5##2##(2008-10#5)
of hope and expectancy##2##4##(2008-11#2)
of hope and##3##3##(2008-11#2)(2012-3#1)
of hope##8##2##(1997-5#1)(2007-7#1)(2008-11#2)(2008-4#1)(2010-10#2)(2012-3#1)
of horizontal gene transfer##2##4##(1994-8#2)
of horizontal transmission##2##3##(2012-3#2)
of horizontal##11##2##(1993-12#1)(1994-8#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-6#1)(2012-3#2)
of horizontally##2##2##(1994-7#1)(2011-1#1)
of hormesis in##4##3##(2008-7#4)
of hormesis##9##2##(2008-7#9)
of hormetic##2##2##(2008-7#2)
of hormonal treatment##2##3##(2008-10#1)(2008-6#1)
of hormonal##13##2##(1990-6#1)(1991-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#2)
of hormone and receptor molecules##2##5##(2008-1#2)
of hormone and##4##3##(1995-11#1)(2008-1#2)(2009-10#1)
of hormone receptors##2##3##(1992-11#1)(2008-9#1)
of hormone replacement therapy (HRT)##3##5##(2008-5#1)(2010-12#1)(2013-8#1)
of hormone replacement therapy in##2##5##(1993-11#1)(2012-3#1)
of hormone replacement therapy##10##4##(1993-11#1)(1994-9#1)(1996-11#1)(1997-5#2)(2008-5#2)(2010-12#1)(2012-3#1)(2013-8#1)
of hormone therapy##3##3##(2007-10#1)(2008-11#2)
of hormone##32##2##(1990-11#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-5#2)(1997-7#2)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of hormone-dependent cancers##2##3##(2008-10#1)(2008-2#1)
of hormone-dependent##3##2##(1993-1#1)(2008-10#1)(2008-2#1)
of hormone-related##3##2##(1990-6#1)(1995-9#1)(2009-8#1)
of hormones and##6##3##(1993-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-7#1)
of hormones in##2##3##(2008-8#1)(2010-5#1)
of hormones##17##2##(1990-8#1)(1993-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-8#1)(2010-5#1)(2011-2#1)(2013-7#2)
of horse chestnut##2##3##(2008-5#2)
of horse heart##3##3##(1990-8#1)(1994-5#2)
of horse##12##2##(1990-8#2)(1994-5#2)(1995-3#1)(2008-10#1)(2008-5#2)(2012-1#1)(2012-12#3)
of horseradish peroxidase (HRP) and##2##5##(2008-10#2)
of horseradish peroxidase (HRP)##7##4##(2008-10#7)
of horseradish peroxidase##13##3##(1994-5#1)(1994-6#1)(1997-2#1)(2008-10#10)
of horseradish##14##2##(1994-5#1)(1994-6#1)(1997-2#1)(2008-10#10)(2008-4#1)
of horses##2##2##(2012-3#1)(2013-1#1)
of hospice##4##2##(1990-10#1)(1994-12#1)(1995-12#1)(2010-2#1)
of hospital admission##2##3##(2008-3#1)(2012-12#1)
of hospital admissions##2##3##(1992-5#1)(2007-10#1)
of hospital and##6##3##(1991-12#1)(1995-3#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
of hospital beds##2##3##(1990-6#1)(1997-6#1)
of hospital care and##2##4##(1994-2#1)(2008-8#1)
of hospital care##9##3##(1991-3#4)(1992-3#1)(1994-2#2)(1994-3#1)(2008-8#1)
of hospital effluents##2##3##(2013-1#2)
of hospital employees##2##3##(1992-3#1)(2008-12#1)
of hospital governing boards##2##4##(1991-1#1)(1991-12#1)
of hospital information systems##2##4##(1993-12#1)(1994-3#1)
of hospital information##3##3##(1993-12#1)(1994-3#1)(2012-3#1)
of hospital medical##2##3##(1994-1#1)(1996-3#1)
of hospital outpatient##2##3##(1991-2#1)(1992-12#1)
of hospital security##3##3##(1991-12#1)(1993-2#1)(1996-12#1)
of hospital services in##2##4##(1991-2#1)(1993-2#1)
of hospital services##4##3##(1991-1#1)(1991-2#1)(1993-2#1)(1993-6#1)
of hospital stay##23##3##(1991-12#3)(1992-12#1)(1992-2#1)(1994-5#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#2)(2011-2#3)(2013-1#4)(2013-8#1)
of hospital technologists##2##3##(1992-1#2)
of hospital##112##2##(1990-11#1)(1990-6#2)(1991-1#2)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#6)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-1#6)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#2)
of hospital-acquired##2##2##(2008-10#1)(2013-1#1)
of hospital-based##3##2##(1991-1#1)(1991-3#1)(1996-1#1)
of hospitalisation and##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
of hospitalisation##6##2##(1994-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
of hospitalists##2##2##(2008-3#2)
of hospitalization and high##2##4##(2008-11#1)(2011-2#1)
of hospitalization and##10##3##(1992-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)
of hospitalization for##2##3##(1995-12#1)(2008-11#1)
of hospitalization of patients##2##4##(1992-3#1)(2011-1#1)
of hospitalization were##2##3##(1993-12#1)(2013-1#1)
of hospitalization##47##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#3)(1996-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#3)(2011-2#4)(2013-1#8)
of hospitalizations and##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
of hospitalizations for##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
of hospitalizations##7##2##(1995-1#1)(1995-12#1)(2008-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
of hospitalized children##5##3##(1991-1#2)(1991-2#1)(2013-1#2)
of hospitalized intubated patients##2##4##(2010-10#2)
of hospitalized##13##2##(1990-6#1)(1991-1#2)(1991-2#1)(1993-12#1)(1994-12#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#2)(2013-1#2)
of hospitals are##3##3##(1993-3#1)(1995-1#1)(1997-1#1)
of hospitals in Isfahan##2##4##(2010-8#2)
of hospitals in##4##3##(1993-12#1)(1994-2#1)(2010-8#2)
of hospitals serving##2##3##(1991-6#1)(1992-2#1)
of hospitals to##3##3##(1992-2#1)(1996-3#1)(2008-11#1)
of hospitals with##2##3##(2008-8#1)(2011-2#1)
of hospitals##40##2##(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#3)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#2)(2011-2#1)
of hospitals'##2##2##(1994-2#1)(1995-2#1)
of host DNA##2##3##(2008-10#2)
of host and parasite##2##4##(2008-8#2)
of host and pathogen##3##4##(2008-10#2)(2008-9#1)
of host and##5##3##(2008-10#2)(2008-8#2)(2008-9#1)
of host cell##2##3##(2008-10#2)
of host cells##2##3##(2008-10#1)(2008-9#1)
of host cytoplasm##2##3##(2008-10#2)
of host defense##2##3##(2008-10#2)
of host diversity on##4##4##(2008-10#4)
of host diversity##6##3##(2008-10#6)
of host functions##2##3##(2008-9#1)(2013-1#1)
of host genotype in##2##4##(2008-10#2)
of host genotype##4##3##(2008-10#4)
of host genotypes on##2##4##(2008-10#2)
of host genotypes##4##3##(2008-10#4)
of host phenology##2##3##(2008-10#2)
of host plant infection by##2##5##(2008-10#2)
of host plant##5##3##(2008-10#5)
of host plants in##2##4##(2008-5#1)(2009-8#1)
of host plants with##2##4##(2008-10#2)
of host plants##15##3##(2007-12#2)(2008-10#10)(2008-5#1)(2009-8#1)(2010-10#1)
of host range##2##3##(2008-10#1)(2008-11#1)
of host resistance and##3##4##(2008-10#2)(2008-8#1)
of host resistance##13##3##(2008-10#9)(2008-8#3)(2009-10#1)
of host specialization##3##3##(2008-10#2)(2008-9#1)
of host species##7##3##(2008-10#5)(2008-5#1)(2008-8#1)
of host tissue##3##3##(2008-10#3)
of host tissues##2##3##(2008-10#1)(2013-1#1)
of host traits##2##3##(2008-8#1)(2012-3#1)
of host##132##2##(1991-9#1)(1995-9#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#92)(2008-11#3)(2008-5#2)(2008-8#10)(2008-9#7)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
of host-diversity effects##3##3##(2008-10#3)
of host-guest complexation##2##3##(2008-10#1)(2010-12#1)
of host-guest##3##2##(2008-10#1)(2010-12#2)
of host-parasite associations##2##3##(2008-8#1)(2012-3#1)
of host-parasite##5##2##(2008-10#1)(2008-8#3)(2012-3#1)
of host-pathogen interactions has##2##4##(2008-9#1)(2013-1#1)
of host-pathogen interactions##6##3##(2008-10#1)(2008-9#2)(2010-12#1)(2013-1#2)
of host-specific virulence in##2##4##(2008-10#2)
of host-specific##4##2##(2008-10#3)(2009-8#1)
of hosts and##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
of hosts##12##2##(1996-12#1)(2008-1#1)(2008-10#3)(2008-9#2)(2009-5#1)(2011-2#2)(2013-1#2)
of hot flashes in men##2##5##(2008-7#2)
of hot flashes in##3##4##(2008-7#3)
of hot flashes##7##3##(2008-7#6)(2009-5#1)
of hot spots##2##3##(2008-3#1)(2011-2#1)
of hot##11##2##(1992-6#1)(2007-2#1)(2008-3#1)(2008-7#6)(2009-5#1)(2011-2#1)
of hot-carrier luminescence from##2##4##(2007-12#2)
of hourly##2##2##(2008-11#1)(2008-3#1)
of hours of continuous##2##4##(2008-10#2)
of hours work##2##3##(1990-3#1)(1991-6#1)
of hours##12##2##(1990-3#2)(1991-6#1)(1995-9#1)(1997-5#2)(2007-11#1)(2008-10#5)
of house dust##2##3##(1995-6#1)(2012-12#1)
of house##4##2##(1995-3#1)(1995-6#1)(2007-11#1)(2012-12#1)
of household labor##2##3##(2011-2#2)
of household##8##2##(1993-6#1)(2008-1#1)(2008-12#1)(2011-2#4)(2013-1#1)
of households with##2##3##(2007-11#1)(2011-2#1)
of households##5##2##(1991-12#1)(2007-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
of how and##2##3##(2008-4#1)(2008-9#1)
of how health##2##3##(1994-12#1)(1997-3#1)
of how one##2##3##(1996-3#1)(2011-2#1)
of how stress##2##3##(2009-8#1)(2012-2#1)
of how the##28##3##(1990-9#1)(1992-10#1)(1993-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-10#1)(2011-3#1)(2012-3#1)(2013-1#2)
of how these##13##3##(1991-9#1)(1995-9#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
of how they##3##3##(1995-1#1)(2008-11#1)(2008-9#1)
of how this##5##3##(1997-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
of how to develop##2##4##(1993-2#1)(2007-4#1)
of how to go about##2##5##(2008-11#1)(2008-9#1)
of how to manage##2##4##(1995-12#2)
of how to##24##3##(1993-2#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-3#1)(2012-2#2)(2012-3#1)
of how well the##2##4##(1990-11#1)(2008-5#1)
of how##171##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#3)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#12)(2008-11#17)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#17)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)
of hrp##2##2##(2008-10#2)
of hsCRP##2##2##(2011-2#2)
of hsp##4##2##(2008-5#4)
of hsp27##5##2##(1991-2#3)(2008-5#2)
of hsp70 in##3##3##(1994-11#3)
of hsp70 proteins##2##3##(1994-11#2)
of hsp70##12##2##(1994-11#11)(2012-12#1)
of huge##4##2##(2008-11#1)(2008-7#2)(2013-7#1)
of hugin##3##2##(2008-9#3)
of hull and hull-less soybean flour##2##6##(2012-2#2)
of hull##4##2##(2008-8#2)(2012-2#2)
of human 15-lipoxygenase##2##3##(1995-5#2)
of human B cell##2##4##(2008-11#1)(2008-8#1)
of human B##5##3##(1990-12#1)(1991-9#1)(1992-8#1)(2008-11#1)(2008-8#1)
of human Cu##7##3##(1997-2#5)(1997-8#2)
of human Cu/Zn superoxide dismutase (SOD1)##2##6##(1994-6#1)(1996-5#1)
of human Cu/Zn superoxide dismutase##3##5##(1994-6#2)(1996-5#1)
of human DNA##6##3##(1991-9#1)(1994-12#1)(1996-6#1)(1997-7#1)(2008-12#1)(2008-5#1)
of human DPSCs##2##3##(2012-12#2)
of human ES cells##2##4##(2008-9#2)
of human IgG##2##3##(1996-12#1)(2008-10#1)
of human NK cells##2##4##(2008-4#1)(2008-8#1)
of human NK##3##3##(2008-4#2)(2008-8#1)
of human P-glycoprotein##2##3##(2013-1#2)
of human RAD52 confers##2##4##(1995-6#2)
of human SOD1##2##3##(1994-6#2)
of human Schwann cells##2##4##(1995-2#2)
of human T cell##7##4##(1995-12#2)(2008-11#3)(2008-4#1)(2012-12#1)
of human T cells##3##4##(1991-2#1)(2008-11#1)(2008-4#1)
of human T##13##3##(1991-2#1)(1994-12#2)(1995-12#2)(2008-11#4)(2008-4#3)(2012-12#1)
of human T-cell leukemia virus##2##5##(1991-12#1)(2012-12#1)
of human T-lymphocytes##3##3##(1992-9#1)(2008-11#2)
of human adenovirus##5##3##(2013-8#5)
of human aging##3##3##(2008-11#1)(2009-8#2)
of human alpha##2##3##(1991-12#1)(1994-6#1)
of human and animal##6##4##(1994-6#1)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)
of human and mouse##3##4##(1997-7#1)(2008-4#1)(2013-1#1)
of human and murine##7##4##(1990-12#1)(1992-2#2)(1993-2#1)(1993-8#1)(1994-11#1)(2013-1#1)
of human and rat##2##4##(1990-2#1)(1993-8#1)
of human and##30##3##(1990-12#1)(1990-2#1)(1991-9#1)(1992-2#2)(1993-2#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-6#2)(1995-12#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#3)
of human angiogenin##3##3##(1994-9#3)
of human antibody in CHO cells##2##6##(2008-11#2)
of human atherosclerosis##2##3##(1997-8#1)(2010-9#1)
of human being##2##3##(2010-8#1)(2013-1#1)
of human beings##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
of human beta 1 thyroid hormone receptor##2##7##(1993-8#2)
of human beta-endorphin##2##3##(1990-5#2)
of human blood##10##3##(1990-7#2)(1990-8#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
of human body##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
of human bone marrow mesenchymal stem cells (MSCs)##2##8##(2008-11#2)
of human bone marrow mesenchymal stem cells##4##7##(2008-11#3)(2012-1#1)
of human bone marrow mesenchymal##5##5##(2008-11#3)(2012-1#2)
of human bone marrow##7##4##(2008-11#3)(2008-9#1)(2009-4#1)(2012-1#2)
of human bone##9##3##(1991-5#1)(1994-6#1)(2008-11#3)(2008-9#1)(2009-4#1)(2012-1#2)
of human brain##9##3##(1991-5#1)(1992-8#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
of human breast cancer and##2##5##(1993-1#1)(1994-2#1)
of human breast cancer cells##2##5##(1994-8#1)(2012-3#1)
of human breast cancer##11##4##(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(2008-11#2)(2009-9#1)(2012-3#2)
of human breast##15##3##(1993-1#1)(1993-11#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-10#1)(2008-11#2)(2008-3#1)(2009-9#1)(2011-2#1)(2012-3#2)
of human cancer cells and##2##5##(2008-11#1)(2008-4#1)
of human cancer cells##3##4##(2008-11#2)(2008-4#1)
of human cancer##10##3##(1990-11#2)(1997-4#1)(2007-10#1)(2008-11#4)(2008-4#1)(2008-7#1)
of human cancers##10##3##(1997-7#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2012-12#2)(2013-1#3)
of human cell lines##2##4##(2008-11#2)
of human cell##5##3##(1995-8#1)(1996-2#1)(2008-11#2)(2009-3#1)
of human cells to##2##4##(1993-3#1)(1996-12#1)
of human cells##8##3##(1993-3#1)(1995-6#1)(1996-12#1)(1997-3#2)(1997-7#1)(2008-11#1)(2012-12#1)
of human cerebellum and##2##4##(1991-12#1)(1993-9#1)
of human chondrocytes##2##3##(2008-11#2)
of human chorionic gonadotropin (hCG)##2##5##(1992-8#1)(1994-8#1)
of human chorionic gonadotropin##5##4##(1992-8#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-4#1)
of human chromosome 7##2##4##(1996-6#2)
of human chromosome##5##3##(1996-2#1)(1996-6#2)(1997-8#1)(2008-7#1)
of human chromosomes##2##3##(2007-11#2)
of human colon cancer##2##4##(1994-8#1)(1997-4#1)
of human colon##4##3##(1994-8#1)(1997-4#1)(2008-11#1)(2008-3#1)
of human copper##2##3##(2008-12#1)(2010-11#1)
of human cytomegalovirus (HCMV)##3##4##(1993-8#1)(1996-12#1)(1997-3#1)
of human cytomegalovirus##5##3##(1993-8#2)(1996-12#1)(1997-3#1)(1997-4#1)
of human cytosolic purine 5'-nucleotidase##2##5##(1994-11#2)
of human development and##2##4##(1993-12#1)(2009-3#1)
of human development##3##3##(1993-12#2)(2009-3#1)
of human dihydrolipoamide dehydrogenase##2##4##(1995-6#2)
of human disease##17##3##(1994-5#1)(2008-11#1)(2008-4#8)(2008-7#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2012-12#1)
of human diseased##2##3##(2010-8#1)(2013-1#1)
of human diseases##3##3##(1993-3#1)(2009-8#1)(2011-2#1)
of human disorders##2##3##(2008-4#1)(2011-2#1)
of human embryonic stem cells##5##5##(2008-11#2)(2008-9#2)(2012-3#1)
of human embryonic stem##7##4##(2008-11#2)(2008-8#1)(2008-9#3)(2012-3#1)
of human endometrial stromal cells##2##5##(1994-9#2)
of human endometrial##4##3##(1994-9#3)(2013-1#1)
of human endometrium##4##3##(1994-9#3)(2010-12#1)
of human endothelial cells##3##4##(1994-8#1)(1994-9#1)(1997-7#1)
of human enterovirus 71##2##4##(2013-8#2)
of human epidermal##3##3##(1992-2#1)(2008-1#1)(2009-9#1)
of human erythrocyte membranes##2##4##(2008-8#1)(2009-8#1)
of human erythrocyte##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
of human erythrocytes##5##3##(1991-5#3)(1995-6#2)
of human esophageal##2##3##(1992-8#1)(2012-2#1)
of human exposure to##2##4##(1992-3#1)(2008-8#1)
of human exposure##3##3##(1992-3#1)(2008-8#1)(2013-1#1)
of human eye##2##3##(2008-2#1)(2008-3#1)
of human factor IX mutant##2##5##(2008-9#2)
of human factor##3##3##(1995-6#1)(2008-9#2)
of human fetal##9##3##(1992-5#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-9#2)(2009-10#2)(2012-12#1)
of human fibrin##2##3##(1992-5#1)(1994-3#1)
of human fibroblast##3##3##(1997-4#1)(2008-12#1)(2008-5#1)
of human fibroblasts##4##3##(1990-5#1)(1994-3#1)(1995-2#1)(2013-1#1)
of human fibrosarcoma##2##3##(2008-11#1)(2011-2#1)
of human foetal liver Zn-metallothioneins##2##5##(2008-10#2)
of human genes##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
of human granulocytic anaplasmosis##4##4##(2008-9#1)(2013-1#3)
of human growth hormone##2##4##(1997-2#1)(2008-8#1)
of human growth##3##3##(1997-2#1)(2008-8#1)(2009-7#1)
of human hair and##2##4##(2008-10#2)
of human hair##9##3##(2008-10#2)(2008-5#7)
of human health##4##3##(1991-2#1)(2007-12#1)(2008-1#1)(2011-2#1)
of human hematopoietic progenitor##2##4##(2008-11#2)
of human hematopoietic##6##3##(2008-11#6)
of human hemoglobin##2##3##(1990-8#2)
of human hepatocellular##2##3##(2011-2#2)
of human hepatoma##4##3##(1995-2#1)(2008-11#1)(2008-8#2)
of human immune##3##3##(1995-5#1)(2008-11#1)(2013-1#1)
of human immunodeficiency virus (HIV) infection##3##6##(1990-3#1)(1996-9#1)(2008-2#1)
of human immunodeficiency virus (HIV)##4##5##(1990-3#1)(1996-9#1)(2008-2#1)(2010-2#1)
of human immunodeficiency virus type 1 (HIV-1)##2##7##(1994-8#1)(2008-2#1)
of human immunodeficiency virus type 1##7##6##(1992-6#1)(1994-8#2)(1997-3#1)(2008-1#1)(2008-11#1)(2008-2#1)
of human immunodeficiency virus##25##4##(1990-2#1)(1990-3#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-8#3)(1995-2#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-2#1)(2013-1#3)
of human immunodeficiency virus-1##2##4##(1992-8#1)(2008-11#1)
of human immunodeficiency viruses##2##4##(1990-5#1)(2008-9#1)
of human immunodeficiency##30##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-8#3)(1995-2#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2013-1#3)
of human individuals to##2##4##(1994-3#1)(1995-3#1)
of human influenza##6##3##(1994-8#3)(2008-9#1)(2009-5#2)
of human interleukin-6 (hIL-6)##2##4##(1992-8#1)(2008-8#1)
of human interleukin-6##4##3##(1992-8#2)(2008-8#2)
of human intestinal##4##3##(1990-2#1)(1995-12#1)(2008-4#1)(2011-2#1)
of human language##5##3##(1997-8#1)(2010-5#2)(2012-12#2)
of human leukocyte##4##3##(1993-11#1)(1997-4#1)(2008-5#1)(2010-6#1)
of human life##3##3##(2008-5#1)(2008-9#1)(2010-8#1)
of human liver UDP-glucuronosyltransferase cDNA##2##5##(2008-11#2)
of human liver##8##3##(1990-5#1)(1991-12#1)(1993-8#1)(1994-8#1)(2008-11#3)(2008-9#1)
of human lung cancer##2##4##(1990-5#1)(2008-8#1)
of human lung##4##3##(1990-5#1)(1996-2#1)(2008-8#1)(2008-9#1)
of human lymphocyte##2##3##(1991-5#1)(1992-6#1)
of human lymphocytes##4##3##(1997-4#1)(2008-4#1)(2011-2#1)(2012-2#1)
of human malaria##4##3##(1991-2#1)(2010-12#1)(2011-1#1)(2012-2#1)
of human malignancies##4##3##(1993-9#1)(1994-10#1)(2008-11#1)(2011-2#1)
of human malignant tumor cells##2##5##(1993-9#2)
of human malignant##4##3##(1993-9#2)(1995-2#1)(2008-4#1)
of human melanocytes##2##3##(1993-5#1)(1995-2#1)
of human melanoma##5##3##(1994-6#1)(2008-10#1)(2008-11#2)(2008-8#1)
of human mesenchymal stem cells##4##5##(2008-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
of human mitochondrial tRNA(Leu(UUR))##2##4##(2008-8#2)
of human monoclonal antibody##4##4##(2008-11#4)
of human monoclonal##7##3##(2008-11#6)(2010-12#1)
of human myometrium##2##3##(1993-12#1)(1994-8#1)
of human natural killer##5##4##(1990-12#3)(1994-5#1)(2008-4#1)
of human nebulin##2##3##(2008-6#2)
of human neutrophils##3##3##(1992-12#1)(1993-6#1)(2008-1#1)
of human obesity##3##3##(2006-8#1)(2008-3#1)(2009-2#1)
of human occupation##2##3##(2008-8#1)(2010-5#1)
of human or mouse##2##4##(2008-4#2)
of human or##3##3##(2008-11#1)(2008-4#2)
of human origin##2##3##(2008-8#1)(2009-2#1)
of human osteoblast-like osteosarcoma cell##2##5##(1992-8#2)
of human osteoblast-like##4##3##(1992-8#2)(2008-11#1)(2012-2#1)
of human osteoblasts##2##3##(1993-3#1)(2008-11#1)
of human ovarian##3##3##(1993-8#1)(1993-9#2)
of human pancreatic##3##3##(1994-11#1)(2010-11#2)
of human papilloma virus##2##4##(1991-2#1)(2007-8#1)
of human papillomavirus (HPV) infection##3##5##(1992-2#1)(1992-3#1)(2011-2#1)
of human papillomavirus type 16##3##5##(1990-5#2)(1995-2#1)
of human papillomavirus##11##3##(1990-5#2)(1992-2#1)(1992-3#1)(1995-2#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of human parathyroid##3##3##(1991-6#2)(2008-11#1)
of human peripheral blood lymphocytes (PBL)##2##6##(1995-12#1)(2008-11#1)
of human peripheral blood lymphocytes##5##5##(1995-12#2)(2008-11#2)(2008-9#1)
of human peripheral blood mononuclear cells (PBMC)##2##7##(1992-12#1)(2008-11#1)
of human peripheral blood mononuclear cells##3##6##(1992-12#1)(2008-11#1)(2008-9#1)
of human peripheral blood##12##4##(1992-12#1)(1992-3#1)(1994-11#1)(1995-12#2)(2008-11#3)(2008-4#1)(2008-9#3)
of human perturbations##2##3##(2008-10#2)
of human placenta##5##3##(1990-2#1)(1992-8#2)(1993-11#1)(1994-11#1)
of human placental##4##3##(1990-12#1)(1991-2#1)(1991-5#1)(1994-3#1)
of human plasma##8##3##(1990-12#1)(1990-8#1)(1991-8#1)(1993-12#1)(1994-3#1)(1995-5#1)(2008-10#2)
of human plasminogen##4##3##(1990-12#1)(1993-8#2)(2008-4#1)
of human platelets##3##3##(1990-5#1)(1992-8#1)(1997-7#1)
of human pluripotent stem cells##2##5##(2009-3#2)
of human polymorphonuclear##2##3##(1993-6#1)(1993-8#1)
of human populations##2##3##(1997-4#1)(2012-3#1)
of human preadipocytes to##2##4##(2008-5#2)
of human preadipocytes##3##3##(2008-5#3)
of human presence##2##3##(2008-11#1)(2008-8#1)
of human prevalence of S##2##5##(2008-8#2)
of human prostate cancer##2##4##(2008-4#1)(2011-2#1)
of human protein C##2##4##(1995-2#2)
of human recombinant##9##3##(1991-3#1)(1992-8#4)(1994-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
of human resources##5##3##(1993-2#1)(1994-1#1)(2008-10#1)(2008-11#1)(2010-8#1)
of human retinal##2##3##(1993-3#1)(2007-11#1)
of human retroviral replication##2##4##(1995-2#2)
of human retroviral##3##3##(1995-2#3)
of human rhinovirus##2##3##(2013-8#2)
of human rights##3##3##(1991-3#1)(1995-11#2)
of human salivary##3##3##(1990-12#1)(1994-12#1)(2011-2#1)
of human serum albumin (HSA)##4##5##(2008-10#4)
of human serum albumin##5##4##(2008-10#5)
of human serum and urine##2##5##(2008-10#2)
of human serum##9##3##(1992-12#1)(1994-3#1)(2008-10#7)
of human sex##2##3##(2008-4#2)
of human skeletal muscle##5##4##(1990-11#2)(1995-2#1)(2008-11#1)(2008-6#1)
of human skin fibroblasts and##2##5##(1993-12#1)(2008-5#1)
of human skin fibroblasts##4##4##(1993-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
of human skin in vivo##4##5##(2008-3#1)(2008-5#3)
of human skin##21##3##(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#1)(2012-3#1)
of human spaceflight##2##3##(2012-3#2)
of human sperm protamines##3##4##(1990-7#2)(1994-6#1)
of human sperm##4##3##(1990-7#2)(1994-6#1)(2011-1#1)
of human subjects##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
of human telomerase##4##3##(2008-11#3)(2008-9#1)
of human thyrotropin receptor possess thyroid stimulating activities##2##8##(1991-12#1)(1991-9#1)
of human thyrotropin receptor##3##4##(1991-12#2)(1991-9#1)
of human tissue plasminogen activator##2##5##(1991-9#2)
of human tissue##5##3##(1990-8#1)(1991-9#2)(1996-11#1)(2009-4#1)
of human tissues##5##3##(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
of human topoisomerase II beta in##2##6##(1995-6#2)
of human transforming growth factor##3##5##(1990-8#1)(2008-8#2)
of human tumor antigens recognized by##2##6##(2008-4#2)
of human tumor antigens##3##4##(2008-4#3)
of human tumor##8##3##(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#1)(2013-7#1)
of human tumors##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
of human type I##2##4##(1995-3#1)(2008-5#1)
of human umbilical vein endothelial cells (HUVEC)##2##7##(1994-8#1)(2008-9#1)
of human umbilical vein endothelial cells##6##6##(1991-5#1)(1994-8#1)(1994-9#2)(2008-10#1)(2008-9#1)
of human umbilical##8##3##(1991-5#1)(1994-8#1)(1994-9#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
of human urinary##2##3##(1990-12#1)(2010-12#1)
of human urine and##2##4##(2008-10#2)
of human vascular endothelial growth##2##5##(1997-7#1)(2008-8#1)
of human vascular##3##3##(1994-9#1)(1997-7#1)(2008-8#1)
of human viral##2##3##(1994-12#1)(2010-11#1)
of human volunteers##2##3##(2008-5#2)
of human##1084##2##(1990-10#1)(1990-11#5)(1990-12#15)(1990-2#10)(1990-3#3)(1990-5#13)(1990-7#7)(1990-8#8)(1991-12#11)(1991-2#9)(1991-3#4)(1991-5#9)(1991-6#6)(1991-7#1)(1991-8#2)(1991-9#9)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#4)(1992-8#21)(1992-9#5)(1993-1#1)(1993-11#10)(1993-12#7)(1993-2#3)(1993-3#7)(1993-5#2)(1993-6#5)(1993-8#17)(1993-9#11)(1994-1#1)(1994-10#3)(1994-11#15)(1994-12#13)(1994-2#2)(1994-3#8)(1994-5#7)(1994-6#16)(1994-8#23)(1994-9#16)(1995-11#4)(1995-12#13)(1995-2#21)(1995-3#11)(1995-5#7)(1995-6#14)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#13)(1997-3#4)(1997-4#10)(1997-6#3)(1997-7#11)(1997-8#6)(1997-9#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#39)(2008-11#91)(2008-12#10)(2008-2#9)(2008-3#16)(2008-4#53)(2008-5#42)(2008-6#8)(2008-7#22)(2008-8#41)(2008-9#41)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#4)(2009-7#13)(2009-8#7)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#24)(2011-3#1)(2012-1#5)(2012-12#13)(2012-2#15)(2012-3#13)(2012-7#1)(2013-1#31)(2013-7#3)(2013-8#13)
of humanangiopoietin-1##2##2##(2008-8#2)
of humans and animals##4##4##(1991-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
of humans and mice##2##4##(2008-10#1)(2012-2#1)
of humans and other##2##4##(1991-8#1)(2011-2#1)
of humans and##10##3##(1991-8#2)(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#3)(2012-2#1)
of humans to##5##3##(1992-3#1)(1993-3#1)(1994-5#1)(2008-7#1)(2011-2#1)
of humans with##3##3##(1994-3#1)(2008-5#1)(2012-2#1)
of humans##28##2##(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-5#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#4)(2012-2#4)(2013-7#1)
of humeral##2##2##(2007-11#1)(2012-2#1)
of humerus in##2##3##(2010-11#1)(2012-2#1)
of humerus##3##2##(2007-11#1)(2010-11#1)(2012-2#1)
of humic acid##7##3##(2008-10#6)(2013-8#1)
of humic acids (HA)##3##4##(2008-10#3)
of humic acids##9##3##(2008-10#9)
of humic and fulvic##2##4##(2008-10#1)(2008-3#1)
of humic compounds present in the##2##6##(2008-10#2)
of humic compounds##4##3##(2008-10#4)
of humic substances (HS)##2##4##(2008-10#2)
of humic substances were##2##4##(1992-5#1)(2008-10#1)
of humic substances##11##3##(1992-5#4)(2008-10#7)
of humic##38##2##(1992-5#4)(2008-10#32)(2008-3#1)(2013-8#1)
of humidity on the##2##4##(2008-10#2)
of humidity on##3##3##(2008-10#3)
of humidity were##2##3##(2008-10#2)
of humidity##9##2##(2008-10#6)(2008-2#1)(2008-3#1)(2012-2#1)
of hummingbird##2##2##(2008-8#1)(2008-9#1)
of humor for##2##3##(2008-10#2)
of humor##3##2##(2008-10#2)(2008-12#1)
of humoral and cellular##2##4##(1997-3#1)(2008-4#1)
of humoral immune response##2##4##(1997-8#1)(2012-2#1)
of humoral immune##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
of humoral immunity##4##3##(1993-12#1)(1995-12#1)(1997-6#1)(2011-1#1)
of humoral##12##2##(1993-12#2)(1993-3#1)(1994-8#1)(1995-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
of hundreds of##11##3##(1991-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-5#1)(2013-8#1)
of hundreds##12##2##(1991-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-5#1)(2013-8#1)
of husbandry parameters on the##3##5##(2008-11#3)
of hyaline##2##2##(1991-8#1)(2013-8#1)
of hyaluronan in##2##3##(1993-6#1)(2011-1#1)
of hyaluronan##10##2##(1993-6#2)(2008-10#2)(2011-1#6)
of hyaluronic acid##6##3##(2008-10#2)(2010-10#1)(2012-2#1)(2013-1#2)
of hybrid and parental##2##4##(2008-12#2)
of hybrid and##4##3##(2008-12#2)(2008-3#1)(2008-8#1)
of hybrid imaging##2##3##(2008-6#1)(2012-2#1)
of hybrid##24##2##(1991-5#1)(1994-12#1)(1995-5#2)(1995-8#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-3#1)(2012-2#2)(2012-3#1)
of hybridization and##2##3##(2008-8#1)(2012-3#1)
of hybridization between the##2##4##(2008-10#1)(2012-3#1)
of hybridization between##3##3##(2008-10#1)(2010-3#1)(2012-3#1)
of hybridization in##2##3##(2008-8#1)(2012-3#1)
of hybridization##12##2##(1996-12#1)(2008-10#2)(2008-8#2)(2008-9#2)(2010-3#1)(2012-3#4)
of hybridoma cells##8##3##(1994-5#1)(2008-11#7)
of hybridoma culture##2##3##(1990-12#1)(2008-11#1)
of hybridoma##17##2##(1990-12#1)(1994-5#3)(1997-4#1)(2008-11#12)
of hybridomas##3##2##(2008-11#3)
of hybrids##8##2##(1996-6#1)(2008-10#5)(2008-9#2)
of hydatid cyst of the##2##5##(1991-5#1)(2008-12#1)
of hydatid cyst of##3##4##(1991-5#1)(2007-7#1)(2008-12#1)
of hydatid cyst##6##3##(1991-5#1)(2007-7#2)(2008-12#2)(2010-11#1)
of hydatid disease##2##3##(2008-7#1)(2013-1#1)
of hydatid##10##2##(1991-5#1)(1991-8#1)(2007-7#2)(2008-12#3)(2008-7#1)(2010-11#1)(2013-1#1)
of hydatidosis##2##2##(2010-12#1)(2011-2#1)
of hydration of the##3##4##(1995-5#1)(1997-7#1)(2008-5#1)
of hydration of##4##3##(1995-11#1)(1995-5#1)(1997-7#1)(2008-5#1)
of hydration##11##2##(1991-11#1)(1995-11#1)(1995-5#1)(1997-7#1)(2008-10#2)(2008-5#3)(2008-7#1)(2010-2#1)
of hydraulic##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
of hydrazine and phenylhydrazine in##2##5##(2008-10#2)
of hydrazine and phenylhydrazine##4##4##(2008-10#4)
of hydrazine and##7##3##(2008-10#7)
of hydrazine at##3##3##(2008-10#3)
of hydrazine by##2##3##(2008-10#2)
of hydrazine in##7##3##(2008-10#6)(2010-5#1)
of hydrazine with##3##3##(2008-10#2)(2013-1#1)
of hydrazine##33##2##(1996-5#1)(2008-10#28)(2008-11#1)(2010-5#2)(2013-1#1)
of hydride##4##2##(1994-11#1)(1997-7#1)(2008-10#2)
of hydrocarbon##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
of hydrocarbons and##2##3##(1992-3#1)(1992-5#1)
of hydrocarbons by##2##3##(2008-10#1)(2011-1#1)
of hydrocarbons from##3##3##(2008-10#2)(2008-6#1)
of hydrocarbons in##2##3##(2008-10#1)(2008-11#1)
of hydrocarbons##16##2##(1992-3#2)(1992-5#1)(2008-10#9)(2008-11#1)(2008-6#2)(2011-1#1)
of hydrocephalus##4##2##(2008-7#3)(2011-2#1)
of hydrochloric acid##6##3##(2008-10#6)
of hydrochloric##8##2##(2008-10#8)
of hydrochlorothiazide and indapamide on##2##5##(2011-2#2)
of hydrochlorothiazide in##3##3##(2008-10#2)(2011-3#1)
of hydrochlorothiazide with##2##3##(2008-10#1)(2011-2#1)
of hydrochlorothiazide##10##2##(2008-10#5)(2011-2#3)(2011-3#2)
of hydrocortisone##2##2##(2011-3#1)(2012-3#1)
of hydrofluoric acid##4##3##(2008-10#3)(2013-1#1)
of hydrofluoric##5##2##(2008-10#4)(2013-1#1)
of hydrogel##3##2##(2008-10#1)(2008-5#1)(2009-12#1)
of hydrogels##5##2##(2008-5#1)(2008-8#2)(2009-9#1)(2010-10#1)
of hydrogen bond##2##3##(2008-8#1)(2012-3#1)
of hydrogen bonding with##2##4##(1993-11#1)(2010-4#1)
of hydrogen bonding##5##3##(1991-1#1)(1993-11#1)(2008-10#1)(2009-12#1)(2010-4#1)
of hydrogen bonds##2##3##(2008-10#2)
of hydrogen desorption via the##2##5##(2008-10#2)
of hydrogen desorption##3##3##(2008-10#3)
of hydrogen gas on the plasma##2##6##(2008-10#2)
of hydrogen gas##4##3##(1997-7#1)(2008-10#3)
of hydrogen ion##4##3##(1993-12#1)(2008-10#3)
of hydrogen ions##4##3##(2008-10#4)
of hydrogen peroxide (H(2)O(2))##3##4##(2008-10#3)
of hydrogen peroxide (H2O2)##2##4##(1995-3#1)(2008-4#1)
of hydrogen peroxide and##9##4##(2008-10#9)
of hydrogen peroxide at##3##4##(2008-10#3)
of hydrogen peroxide by##2##4##(2008-10#2)
of hydrogen peroxide in rainwater##4##5##(2008-10#4)
of hydrogen peroxide in snow##2##5##(2008-10#2)
of hydrogen peroxide in the##4##5##(2008-10#4)
of hydrogen peroxide in##15##4##(2008-10#15)
of hydrogen peroxide using##2##4##(2008-10#2)
of hydrogen peroxide with##4##4##(1991-9#1)(1996-2#1)(2008-10#2)
of hydrogen peroxide##80##3##(1991-5#1)(1991-9#3)(1992-11#3)(1995-3#1)(1996-2#1)(2008-10#67)(2008-4#2)(2008-5#1)(2012-8#1)
of hydrogen sulfide##4##3##(2008-10#2)(2011-1#1)(2013-8#1)
of hydrogen was##2##3##(2008-10#2)
of hydrogen##134##2##(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#3)(1992-12#1)(1993-11#1)(1993-12#1)(1995-3#1)(1996-2#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#95)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#2)(2011-1#1)(2012-3#1)(2012-8#1)(2013-8#1)
of hydrogen-bonding##2##2##(1993-11#1)(2008-10#1)
of hydrogen-loaded##2##2##(2007-12#2)
of hydrogenase##2##2##(1990-11#1)(1992-3#1)
of hydrolase##2##2##(1992-6#1)(2008-7#1)
of hydrolysis of##8##3##(1990-11#1)(1990-5#1)(1992-11#1)(1992-7#1)(1994-11#1)(1994-5#1)(2008-11#1)(2009-2#1)
of hydrolysis were##2##3##(2008-10#1)(2008-5#1)
of hydrolysis##20##2##(1990-11#1)(1990-5#1)(1992-11#1)(1992-7#1)(1994-11#1)(1994-5#2)(1996-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
of hydrolytic enzymes that##2##4##(1992-3#1)(2012-2#1)
of hydrolytic##3##2##(1992-3#1)(2010-9#1)(2012-2#1)
of hydrolyzed##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
of hydronephrosis##3##2##(2008-10#2)(2008-4#1)
of hydroperoxides##4##2##(1990-5#2)(1995-2#1)(2009-7#1)
of hydrophilic compounds##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
of hydrophilic##15##2##(1990-8#1)(1994-2#1)(1994-6#1)(1995-6#2)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)
of hydrophobic interaction##3##3##(2008-10#2)(2013-1#1)
of hydrophobic residues##3##3##(1992-6#1)(1994-5#1)(1995-3#1)
of hydrophobic##18##2##(1992-12#1)(1992-6#2)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#2)(2008-10#5)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
of hydrophobicity and##2##3##(1991-5#1)(1996-8#1)
of hydrophobicity of##2##3##(1993-3#1)(2008-7#1)
of hydrophobicity##7##2##(1991-5#1)(1993-3#1)(1996-8#1)(2008-5#2)(2008-7#1)(2011-1#1)
of hydroquinone in##6##3##(2008-10#6)
of hydroquinone##18##2##(2008-10#15)(2008-5#1)(2008-6#1)(2011-1#1)
of hydrostatic pressure and temperature##2##5##(2008-2#1)(2008-3#1)
of hydrostatic pressure##4##3##(2008-2#1)(2008-3#3)
of hydroxide##4##2##(2008-10#4)
of hydroxyapatite##5##2##(2008-12#1)(2008-5#1)(2009-7#3)
of hydroxychloroquine##2##2##(2012-12#1)(2013-1#1)
of hydroxyl groups##2##3##(2008-10#2)
of hydroxyl radical in##2##4##(1996-2#1)(2008-10#1)
of hydroxyl radical with##2##4##(2008-9#2)
of hydroxyl radical##6##3##(1996-2#1)(2008-10#3)(2008-9#2)
of hydroxyl radicals (##2##4##(1991-9#1)(1995-12#1)
of hydroxyl radicals##7##3##(1990-12#1)(1991-9#1)(1995-12#1)(2008-10#3)(2008-4#1)
of hydroxyl##21##2##(1990-12#1)(1991-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-9#2)
of hydroxylamine hydrochloride##2##3##(2008-10#2)
of hydroxylamine##3##2##(1994-11#1)(2008-10#2)
of hydroxyproline##2##2##(1992-8#1)(1995-2#1)
of hydroxypropylmethylcellulose and ethyl cellulose##2##5##(2010-5#2)
of hydroxyurea##4##2##(1990-2#2)(1994-11#2)
of hydrozoans##3##2##(2010-2#3)
of hygiene and##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
of hygiene##7##2##(2009-4#4)(2011-1#1)(2012-12#1)(2013-1#1)
of hygroscopic##3##2##(1994-12#1)(2008-5#1)(2013-1#1)
of hypaphorine##2##2##(2008-10#2)
of hyperactivity and##2##3##(1996-6#1)(2008-2#1)
of hyperactivity##4##2##(1996-6#1)(2008-2#1)(2011-2#1)(2013-7#1)
of hyperacute##3##2##(2011-2#2)(2011-3#1)
of hyperandrogenism##3##2##(2008-4#3)
of hyperbaric##2##2##(2008-8#1)(2012-12#1)
of hyperbilirubinemia in##3##3##(2008-11#2)(2008-7#1)
of hypercalcaemia##2##2##(1997-3#1)(2011-1#1)
of hypercalcemia##2##2##(1991-12#1)(2008-1#1)
of hypercholesterolaemia##2##2##(2008-8#1)(2013-8#1)
of hypercholesterolemia in##2##3##(1991-6#1)(2008-1#1)
of hypercholesterolemia##6##2##(1991-6#2)(2008-1#1)(2008-5#1)(2008-8#2)
of hypercholesterolemia]##2##2##(1991-3#1)(1996-2#1)
of hyperfine##2##2##(1991-9#1)(1993-8#1)
of hyperglycaemia##2##2##(1996-12#1)(2008-1#1)
of hyperglycemia##7##2##(1991-7#1)(1994-6#1)(2008-1#2)(2008-11#1)(2010-10#1)(2010-11#1)
of hyperglycemic##2##2##(1994-2#1)(2010-11#1)
of hyperhomocysteinemia with##2##3##(2008-3#2)
of hyperhomocysteinemia##11##2##(2007-10#2)(2008-3#9)
of hypericin##4##2##(2008-8#1)(2009-3#2)(2013-8#1)
of hyperinsulinemia##3##2##(1990-7#1)(2008-3#1)(2011-2#1)
of hyperkinetic##3##2##(1990-9#1)(1991-8#1)(2006-10#1)
of hyperlipidemia##6##2##(1992-11#1)(1995-11#2)(2008-4#1)(2008-9#1)(2010-8#1)
of hyperosmotic##2##2##(2008-11#2)
of hyperpigmentation##2##2##(2008-5#2)
of hyperplasia##3##2##(1994-9#1)(2006-6#1)(2011-2#1)
of hyperpolarization-activated##2##2##(2012-2#2)
of hyperprolactinemia##3##2##(2008-7#1)(2011-1#2)
of hypersensitive##2##2##(1992-9#1)(2008-10#1)
of hypersensitivity reactions##2##3##(2008-8#2)
of hypersensitivity##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
of hypertension after##2##3##(1991-11#1)(2008-1#1)
of hypertension and its##2##4##(2008-11#1)(2010-4#1)
of hypertension and##14##3##(1990-2#2)(1994-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-2#1)(2010-4#1)(2011-2#1)
of hypertension as an##2##4##(2008-8#1)(2012-2#1)
of hypertension as##4##3##(2007-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
of hypertension in an urban##2##5##(2008-11#2)
of hypertension in different##2##4##(2008-1#1)(2008-11#1)
of hypertension in patients with##2##5##(2008-1#1)(2010-4#1)
of hypertension in patients##3##4##(1993-8#1)(2008-1#1)(2010-4#1)
of hypertension in the elderly]##3##5##(1992-6#2)(1993-3#1)
of hypertension in the##8##4##(1992-6#3)(1992-9#1)(1993-3#1)(1997-5#1)(2008-7#1)(2009-9#1)
of hypertension in this##2##4##(2008-1#1)(2011-1#1)
of hypertension in utero##2##4##(1993-2#1)(2009-8#1)
of hypertension in##34##3##(1992-6#4)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-5#1)(1997-6#1)(2008-1#7)(2008-11#7)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
of hypertension is##2##3##(2008-11#2)
of hypertension on##4##3##(1990-2#1)(2008-1#1)(2008-7#1)(2010-4#1)
of hypertension was investigated##2##4##(1990-11#1)(1997-6#1)
of hypertension was##8##3##(1990-11#1)(1994-12#1)(1997-6#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
of hypertension##139##2##(1990-11#2)(1990-2#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-6#4)(1992-8#6)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-6#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#4)(1997-8#2)(2007-7#2)(2007-8#2)(2008-1#19)(2008-10#1)(2008-11#21)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#9)(2008-8#3)(2009-1#3)(2009-3#1)(2009-8#1)(2009-9#3)(2010-2#1)(2010-4#8)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#5)
of hypertensive patients##6##3##(1991-3#1)(1992-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
of hypertensive rats##2##3##(1990-7#1)(1997-2#1)
of hypertensive##19##2##(1990-7#2)(1991-3#1)(1992-8#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
of hyperthyroid rats##2##3##(1990-8#2)
of hyperthyroidism##4##2##(2007-5#2)(2007-8#2)
of hypertonic saline##6##3##(1993-12#4)(2008-5#1)(2008-9#1)
of hypertonic##9##2##(1992-8#1)(1993-12#4)(1995-9#1)(2008-5#1)(2008-9#1)(2011-1#1)
of hypertriglyceridemia##5##2##(1991-8#1)(2012-12#1)(2013-1#3)
of hypertriglyceridemic patients##2##3##(1991-8#1)(1994-3#1)
of hypertrophic cardiomyopathy##2##3##(1997-7#1)(2008-4#1)
of hypertrophic scarring in##2##4##(1991-2#2)
of hypertrophic##10##2##(1991-2#2)(1992-8#1)(1992-9#1)(1997-7#1)(2007-5#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
of hyphae in##2##3##(2007-7#1)(2008-5#1)
of hyphae of##2##3##(2008-10#2)
of hyphae##14##2##(2007-7#1)(2008-10#8)(2008-5#1)(2010-10#1)(2010-2#1)(2011-1#2)
of hyphal growth##2##3##(2008-10#2)
of hyphal##7##2##(2008-10#7)
of hypnosis##4##2##(2009-9#4)
of hypo- and##2##3##(1991-8#1)(2008-4#1)
of hypo-##3##2##(1991-8#2)(2008-4#1)
of hypobaric hypoxia##2##3##(1996-12#2)
of hypocalcemia and hypophosphatemia in malignancy##2##6##(1991-8#2)
of hypocalcemia##4##2##(1991-8#2)(2011-2#2)
of hypochlorite and##2##3##(2008-10#2)
of hypochlorite##8##2##(2007-7#1)(2008-10#7)
of hypocrellin##2##2##(2008-8#2)
of hypoglycaemia during##2##3##(1991-8#1)(2011-1#1)
of hypoglycaemia##8##2##(1991-8#4)(1995-9#1)(2011-1#3)
of hypoglycemia during##2##3##(2009-4#1)(2010-2#1)
of hypoglycemia##12##2##(1990-5#1)(1990-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-5#1)(2009-4#3)(2010-2#1)(2011-1#1)
of hypogonadal##2##2##(2008-1#1)(2008-3#1)
of hyponatremia and##2##3##(2009-11#1)(2011-2#1)
of hyponatremia##4##2##(1990-9#1)(1996-7#1)(2009-11#1)(2011-2#1)
of hypoparathyroidism##2##2##(2013-8#2)
of hypopituitarism##2##2##(2008-7#1)(2013-1#1)
of hypospadia##2##2##(2013-1#2)
of hypospadias surgery##2##3##(2008-10#1)(2009-5#1)
of hypospadias##12##2##(2008-10#3)(2009-5#9)
of hypospadiology##2##2##(2009-5#2)
of hypotension in##2##3##(2008-1#1)(2011-2#1)
of hypotension##5##2##(2008-1#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-3#1)
of hypotensive episodes in##2##4##(1991-9#1)(2008-1#1)
of hypotensive episodes##5##3##(1991-9#1)(2007-7#1)(2008-1#3)
of hypothalamic##10##2##(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-4#1)
of hypothalamic-pituitary function##2##3##(1991-2#1)(2008-4#1)
of hypothermia##10##2##(1993-12#1)(1995-3#1)(1996-12#1)(2007-10#2)(2008-8#3)(2008-9#1)(2010-9#1)
of hypothermic##3##2##(1995-12#1)(2007-8#1)(2010-6#1)
of hypotheses##6##2##(1990-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
of hypothesized##4##2##(2008-12#1)(2008-8#1)(2013-1#2)
of hypothetical##5##2##(1993-12#1)(1997-3#1)(2008-10#2)(2011-1#1)
of hypothyroid##2##2##(2007-8#1)(2008-4#1)
of hypothyroidism in##2##3##(2008-4#1)(2011-1#1)
of hypothyroidism##9##2##(1996-5#1)(1996-8#1)(2008-4#2)(2008-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
of hypovirulence##6##2##(2008-10#4)(2008-9#2)
of hypovirulent isolate##2##3##(2008-10#2)
of hypovirulent##3##2##(2008-10#3)
of hypoxanthine##2##2##(1994-8#1)(2011-1#1)
of hypoxemia##5##2##(1991-9#1)(2008-1#1)(2010-8#1)(2012-2#2)
of hypoxia and##2##3##(1990-7#1)(2008-4#1)
of hypoxia on##3##3##(1990-7#1)(1994-5#1)(2013-1#1)
of hypoxia##15##2##(1990-7#3)(1992-9#1)(1993-6#1)(1994-2#2)(1994-5#1)(1996-12#1)(2008-1#1)(2008-4#1)(2010-4#1)(2013-1#3)
of hypoxic##4##2##(1993-6#1)(2010-8#2)(2013-1#1)
of hysterectomy and##2##3##(1995-12#1)(2010-12#1)
of hysterectomy##7##2##(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#2)(2010-12#1)(2012-3#1)
of hysteroscopic##3##2##(1992-1#1)(1996-2#2)
of i##13##2##(1992-3#1)(1993-8#1)(1995-12#1)(1995-5#2)(1996-2#1)(1997-4#2)(2007-7#1)(2008-1#2)(2008-4#1)(2008-7#1)
of iNOS and##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
of iNOS gene##2##3##(2011-2#2)
of iNOS mRNA##2##3##(1993-8#1)(1995-12#1)
of iNOS##12##2##(1993-8#1)(1995-12#1)(1996-12#3)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)
of iatrogenic complications##4##3##(1993-10#1)(1996-3#2)(2007-9#1)
of iatrogenic##16##2##(1993-10#1)(1996-3#4)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-2#1)
of ibandronic acid on##3##4##(2011-2#2)(2013-8#1)
of ibandronic acid##4##3##(2011-2#3)(2013-8#1)
of ibogaine##3##2##(1997-2#3)
of ibotenic acid##2##3##(1993-3#1)(1993-6#1)
of ibuprofen in pharmaceutical preparations##2##5##(2008-10#2)
of ibuprofen in##5##3##(2008-10#5)
of ibuprofen##11##2##(1991-3#1)(2008-10#6)(2010-5#1)(2012-12#3)
of ice crystals##4##3##(2007-11#2)(2008-3#2)
of ice##11##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#6)
of ice-like water##2##3##(2008-5#2)
of ice-like##3##2##(2008-5#3)
of iconic##2##2##(2010-5#2)
of icosahedral##2##2##(1995-2#1)(2008-10#1)
of ideal values##2##3##(2008-2#1)(2009-10#1)
of ideal##7##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#1)
of ideas##11##2##(1991-1#1)(1995-5#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
of identical and##2##3##(2008-10#1)(2008-8#1)
of identical sequence##2##3##(1995-8#1)(1997-7#1)
of identical spheres##2##3##(2008-2#2)
of identical##18##2##(1990-4#1)(1991-12#1)(1993-12#1)(1995-8#1)(1996-3#1)(1997-7#1)(1997-9#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#1)
of identification and##5##3##(2008-10#3)(2009-10#1)(2009-8#1)
of identification rate##2##3##(2013-8#2)
of identification##17##2##(1992-6#1)(1993-6#1)(1994-9#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
of identified barriers##2##3##(2008-11#1)(2011-1#1)
of identified neurons##2##3##(1997-3#1)(2007-12#1)
of identified proteins in##2##4##(2008-9#1)(2010-2#1)
of identified##12##2##(1990-7#1)(1997-3#1)(1997-6#1)(2007-12#3)(2008-11#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
of identifying genes##2##3##(2008-4#1)(2008-9#1)
of identifying the##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
of identifying##24##2##(1994-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of identity development##3##3##(2012-12#3)
of identity##16##2##(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1994-12#1)(1996-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#5)
of idiopathic pulmonary arterial hypertension##2##5##(2008-10#1)(2010-10#1)
of idiopathic pulmonary arterial##3##4##(2008-10#2)(2010-10#1)
of idiopathic scoliosis##6##3##(2007-11#3)(2007-8#2)(2012-2#1)
of idiopathic##20##2##(1990-9#1)(1992-2#1)(1997-8#2)(2006-12#1)(2007-11#3)(2007-8#2)(2008-10#4)(2008-12#1)(2008-7#1)(2010-10#2)(2012-2#1)(2013-1#1)
of idiosyncratic##2##2##(1990-3#1)(2008-10#1)
of ifenprodil##2##2##(1996-2#2)
of ifosfamide and##2##3##(2008-6#2)
of ifosfamide##9##2##(2008-6#9)
of ignorance##2##2##(2009-10#1)(2010-4#1)
of ileal##5##2##(1990-3#2)(1991-9#1)(1992-8#2)
of ileum##5##2##(2008-10#2)(2008-12#3)
of iliofemoral vein thrombosis##2##4##(1997-8#2)
of illegal##2##2##(2008-10#1)(2013-1#1)
of illicit drugs##3##3##(1996-4#1)(2008-10#1)(2013-8#1)
of illicit##8##2##(1991-12#1)(1996-4#1)(2008-10#5)(2013-8#1)
of illness and death##2##4##(1993-12#1)(2010-12#1)
of illness and##9##3##(1993-12#3)(1994-2#1)(1996-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
of illness in##3##3##(1993-12#1)(2007-11#1)(2007-2#1)
of illness is##2##3##(1993-2#1)(1995-5#1)
of illness##52##2##(1991-9#1)(1992-3#1)(1993-1#3)(1993-12#5)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#2)(2007-1#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of illnesses##5##2##(1991-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
of illumination and reflection##2##4##(2008-2#1)(2008-3#1)
of illumination and##3##3##(2008-2#1)(2008-3#2)
of illumination by##3##3##(2008-2#2)(2008-3#1)
of illumination##15##2##(2008-2#5)(2008-3#7)(2008-9#3)
of illusory contours##2##3##(2008-9#2)
of illusory##4##2##(2007-12#1)(2008-9#3)
of illustration##7##2##(2008-10#2)(2008-11#1)(2010-8#4)
of iloprost##6##2##(2008-7#3)(2011-2#3)
of image analysis##2##3##(2008-1#1)(2008-2#1)
of image data##3##3##(2008-9#3)
of image formation##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
of image processing##6##3##(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#2)
of image quality##3##3##(1997-8#1)(2008-2#1)(2008-3#1)
of image reconstruction in##2##4##(2007-11#1)(2008-3#1)
of image reconstruction##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
of image##48##2##(1991-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#4)(2008-1#1)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#7)(2009-4#1)(2010-8#1)(2011-1#2)
of image-guided surgery##3##3##(2009-12#2)(2012-2#1)
of imagery)##2##2##(2013-8#2)
of images and##3##3##(2007-12#1)(2008-6#2)
of images in##3##3##(1991-2#1)(2008-3#2)
of images of the##2##4##(2008-10#1)(2008-2#1)
of images of##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
of images##35##2##(1991-2#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#12)(2008-5#2)(2008-6#2)(2008-7#1)(2010-9#1)(2012-2#2)(2013-1#2)
of imagination and##2##3##(1992-3#1)(2011-2#1)
of imagination##3##2##(1992-3#1)(2008-5#1)(2011-2#1)
of imaging and##4##3##(1997-6#1)(2008-3#2)(2009-11#1)
of imaging biological samples##2##4##(2008-2#1)(2008-4#1)
of imaging characteristics of##2##4##(2007-10#1)(2012-2#1)
of imaging fiber bundles##2##4##(2008-3#2)
of imaging in##6##3##(2007-11#1)(2007-5#1)(2008-9#1)(2009-4#2)(2010-5#1)
of imaging methods##2##3##(2008-12#1)(2012-2#1)
of imaging systems##2##3##(2007-12#1)(2012-2#1)
of imaging the##3##3##(2007-11#2)(2012-2#1)
of imaging##68##2##(1994-1#1)(1995-12#1)(1997-6#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#3)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#9)(2013-8#1)
of imatinib##5##2##(2009-4#1)(2011-2#2)(2012-12#2)
of imazalil##2##2##(2008-10#2)
of imidazole derivatives##3##3##(2008-10#3)
of imidazole##10##2##(1994-5#4)(2008-10#6)
of imipramine##6##2##(1990-5#4)(1994-2#1)(2008-10#1)
of immature##19##2##(1990-11#1)(1994-10#1)(1995-5#1)(1996-2#1)(1997-9#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-7#1)
of immediate and##2##3##(1997-4#1)(2012-7#1)
of immediate early genes##5##4##(1993-6#1)(1994-12#2)(1994-8#1)(1995-11#1)
of immediate early##6##3##(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)
of immediate hypersensitivity##2##3##(2008-10#1)(2013-1#1)
of immediate##24##2##(1990-3#1)(1990-5#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#4)
of immediate-early genes##4##3##(1994-9#1)(1996-12#1)(1997-3#1)(2008-7#1)
of immediately loaded##3##3##(2011-7#1)(2013-1#2)
of immigrant##4##2##(1992-5#1)(2008-8#2)(2011-2#1)
of immigrants from##2##3##(1996-6#1)(1997-8#1)
of immigrants##6##2##(1992-1#1)(1993-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-9#1)
of immigration##3##2##(1992-8#1)(2008-10#1)(2013-8#1)
of immobilisation##2##2##(2008-10#2)
of immobilised##2##2##(2008-10#2)
of immobilization##9##2##(1995-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2013-7#1)
of immobilized DNA##2##3##(2008-10#2)
of immobilized human plasminogen##2##4##(1993-8#2)
of immobilized human##3##3##(1993-8#3)
of immobilized nanometer TiO(2) for##2##5##(2008-10#2)
of immobilized protein##2##3##(2008-10#1)(2009-2#1)
of immobilized##36##2##(1990-12#1)(1992-11#2)(1993-8#3)(1994-11#2)(1994-5#1)(1995-3#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-11#1)
of immortalised##2##2##(2008-11#2)
of immortalized##2##2##(2008-11#2)
of immune cell##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
of immune cells in##2##4##(2008-9#1)(2012-3#1)
of immune cells to##2##4##(2008-3#1)(2011-2#1)
of immune cells##11##3##(1991-2#1)(1992-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)
of immune complex##3##3##(1996-5#1)(1997-8#1)(2008-1#1)
of immune complexes##3##3##(1991-2#1)(2008-10#1)(2010-5#1)
of immune defense##2##3##(2008-8#2)
of immune function##6##3##(1991-1#1)(1995-12#1)(2008-10#2)(2008-4#1)(2008-9#1)
of immune functions##2##3##(1993-12#1)(1994-11#1)
of immune privilege in the##2##5##(2010-1#2)
of immune privilege##4##3##(2010-1#4)
of immune response##6##3##(1992-9#1)(1994-6#1)(1997-8#1)(2009-3#1)(2012-12#1)(2013-8#1)
of immune responses to##2##4##(2008-10#1)(2011-2#1)
of immune responses##5##3##(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
of immune system##3##3##(2009-1#1)(2013-1#1)(2013-7#1)
of immune tolerance##2##3##(2012-3#1)(2013-1#1)
of immune##77##2##(1991-1#1)(1991-2#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-8#2)(2006-10#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#4)(2010-12#1)(2010-3#2)(2010-5#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#2)
of immune-mediated inflammatory diseases (IMID)##2##5##(2011-2#2)
of immune-mediated inflammatory diseases##6##4##(2011-2#6)
of immune-mediated inflammatory##7##3##(2008-10#1)(2011-2#6)
of immunity##6##2##(1993-3#1)(2007-11#1)(2008-7#2)(2008-9#1)(2012-3#1)
of immunization with##3##3##(1995-5#1)(2008-12#1)(2011-2#1)
of immunization##11##2##(1995-5#2)(1996-12#2)(2008-10#4)(2008-12#1)(2009-5#1)(2011-2#1)
of immunizations##4##2##(1995-5#2)(1996-12#2)
of immunized animals##2##3##(1995-2#1)(2011-2#1)
of immunized##3##2##(1995-2#1)(2008-4#1)(2011-2#1)
of immunizing##3##2##(1996-1#1)(1996-12#2)
of immunoassays##3##2##(2008-12#1)(2008-4#1)(2011-1#1)
of immunocomplex##2##2##(1990-8#1)(2008-10#1)
of immunocompromised patients##2##3##(2011-2#1)(2013-1#1)
of immunocompromised##3##2##(2011-2#2)(2013-1#1)
of immunodeficiency##5##2##(1991-5#1)(1995-2#1)(1996-11#1)(2008-10#1)(2012-12#1)
of immunodepression##3##2##(1991-5#3)
of immunofluorescence##2##2##(2007-7#2)
of immunogenic##4##2##(1990-12#1)(1992-9#2)(2011-1#1)
of immunogenicity##8##2##(1990-12#1)(1995-5#2)(2008-10#4)(2013-8#1)
of immunoglobulin G with affinity for##2##6##(1993-8#2)
of immunoglobulin G##4##3##(1993-8#2)(2008-1#1)(2008-7#1)
of immunoglobulin light chain amyloidosis##2##5##(2010-4#2)
of immunoglobulin##20##2##(1992-2#1)(1992-6#1)(1993-8#2)(1993-9#1)(1994-3#2)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-7#1)(2009-2#1)(2010-4#2)
of immunoglobulins and##3##3##(1995-12#1)(2008-11#1)(2008-5#1)
of immunoglobulins##7##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
of immunohistochemical staining##2##3##(1994-7#1)(1996-12#1)
of immunohistochemical##6##2##(1994-7#1)(1996-12#1)(1997-8#1)(2008-5#1)(2008-8#1)(2013-1#1)
of immunohistochemistry and##2##3##(2008-6#1)(2009-8#1)
of immunohistochemistry in##2##3##(2008-12#1)(2010-8#1)
of immunohistochemistry##10##2##(1991-8#1)(1993-12#1)(1997-3#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#2)
of immunologic##3##2##(1995-5#2)(1997-8#1)
of immunological and##2##3##(1996-2#1)(1997-7#1)
of immunological##17##2##(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#4)(2007-5#1)(2013-1#1)(2013-8#1)
of immunologically##2##2##(2008-4#1)(2012-3#1)
of immunomodulatory##3##2##(1991-5#1)(2008-10#1)(2008-11#1)
of immunopositive cells##2##3##(1993-12#1)(2008-6#1)
of immunopositive##3##2##(1993-12#1)(2008-6#2)
of immunoreactive##13##2##(1990-5#1)(1990-7#2)(1991-5#1)(1993-11#1)(1993-5#1)(1994-12#1)(1995-11#1)(1997-2#2)(2007-12#2)(2008-6#1)
of immunoreactivity of##2##3##(1990-5#1)(1993-11#1)
of immunoreactivity##7##2##(1990-2#1)(1990-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-2#1)
of immunostaining##3##2##(1995-12#2)(1997-3#1)
of immunosuppressants##2##2##(2010-10#1)(2010-12#1)
of immunosuppression and##2##3##(2007-8#1)(2011-2#1)
of immunosuppression on the##2##4##(2008-5#2)
of immunosuppression##15##2##(1991-3#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-4#1)(2008-5#3)(2011-2#1)(2013-1#1)
of immunosuppressive agents##2##3##(1994-5#1)(2007-11#1)
of immunosuppressive drugs##6##3##(2008-1#2)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)
of immunosuppressive medications##2##3##(2006-10#1)(2010-6#1)
of immunosuppressive therapy##4##3##(1994-5#1)(2008-3#1)(2011-2#2)
of immunosuppressive treatment##2##3##(1991-11#1)(2012-3#1)
of immunosuppressive##18##2##(1991-11#1)(1994-5#2)(2006-10#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-9#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-3#1)
of immunotherapy##4##2##(1991-6#1)(1992-11#1)(1994-12#1)(2008-11#1)
of immunotoxic##2##2##(2008-10#2)
of immunotoxicity##8##2##(2008-10#8)
of immunotoxicology##2##2##(2008-10#2)
of impact and##2##3##(2008-2#1)(2008-8#1)
of impact are##2##3##(2008-2#2)
of impact of##2##3##(2011-1#1)(2012-2#1)
of impact on##2##3##(2012-2#1)(2013-1#1)
of impact##22##2##(1995-3#1)(1997-5#8)(2007-5#1)(2008-2#4)(2008-7#1)(2008-8#2)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
of impacted teeth in children##2##5##(2007-12#2)
of impacted teeth##4##3##(1990-2#1)(2007-12#3)
of impacted##8##2##(1990-2#1)(1991-3#1)(2007-12#3)(2010-12#1)(2013-1#2)
of impacts##6##2##(1995-6#1)(1997-5#2)(2007-7#1)(2008-10#1)(2013-1#1)
of impaired glucose tolerance##4##4##(1995-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
of impaired glucose##6##3##(1995-12#1)(2007-5#1)(2008-1#1)(2008-7#2)(2012-3#1)
of impaired##16##2##(1991-7#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-5#2)(1995-12#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-7#3)(2012-1#1)(2012-3#1)(2013-1#1)
of impairment and##2##3##(1991-1#1)(1991-12#1)
of impairment##13##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1995-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
of impairments and##2##3##(2007-7#1)(2008-12#1)
of impedance##3##2##(2008-7#1)(2009-1#1)(2011-1#1)
of impending##4##2##(1995-1#1)(2008-8#1)(2011-1#2)
of imperfect##3##2##(2008-3#2)(2012-3#1)
of impetigo##2##2##(1997-5#1)(2008-5#1)
of impingement##2##2##(2011-2#2)
of implant users##2##3##(2008-9#2)
of implant##11##2##(2007-8#1)(2008-11#1)(2008-9#5)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
of implantable devices##3##3##(2009-11#3)
of implantable medical##3##3##(2008-5#1)(2012-3#2)
of implantable##13##2##(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#4)(2010-8#1)(2012-3#2)
of implantation of rat##2##4##(2012-1#2)
of implantation of##4##3##(2008-12#1)(2012-1#3)
of implantation sites##2##3##(1996-12#1)(2008-9#1)
of implantation##19##2##(1994-9#2)(1996-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#4)(2010-10#1)(2010-6#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)
of implanted children##2##3##(2008-9#2)
of implanted##11##2##(1992-3#1)(1994-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2012-3#1)
of implantees##2##2##(2008-9#2)
of implants in##3##3##(2008-11#1)(2010-5#1)(2013-1#1)
of implants##14##2##(1996-3#1)(2007-11#5)(2007-12#1)(2008-11#1)(2009-4#1)(2010-5#1)(2011-2#2)(2013-1#2)
of implementation and##3##3##(1995-3#1)(2007-12#1)(2008-2#1)
of implementation of the##2##4##(2008-1#1)(2008-2#1)
of implementation of##7##3##(1995-3#1)(2008-1#1)(2008-2#1)(2009-11#1)(2013-1#3)
of implementation##21##2##(1992-2#1)(1993-3#3)(1995-3#2)(1996-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#3)
of implementing a##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)
of implementing the##9##3##(1991-12#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)
of implementing##27##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
of implicit##4##2##(2007-12#1)(2008-2#1)(2008-5#1)(2009-12#1)
of import##3##2##(1995-2#1)(2008-1#1)(2008-8#1)
of importance for the##8##4##(1991-9#1)(1992-12#1)(1994-11#1)(1994-3#1)(1996-5#2)(1997-7#1)(2010-3#1)
of importance for##16##3##(1991-9#1)(1992-12#2)(1994-11#1)(1994-3#1)(1995-5#1)(1996-5#2)(1997-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)
of importance from##2##3##(1994-1#1)(2008-10#1)
of importance in the##7##4##(1990-11#1)(1990-12#1)(1992-9#1)(1997-8#1)(2007-11#1)(2008-5#1)(2010-12#1)
of importance in##16##3##(1990-11#1)(1990-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1994-12#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-12#1)(2011-2#1)
of importance since##2##3##(1994-8#1)(2008-3#1)
of importance to forensic##2##4##(1995-6#2)
of importance to##5##3##(1992-9#1)(1995-6#2)(2008-10#1)(2012-3#1)
of importance##53##2##(1990-11#1)(1990-12#3)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#1)
of important crops##2##3##(2008-10#2)
of important structural##2##3##(2008-7#1)(2008-9#1)
of important##42##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-5#1)(1997-3#2)(2007-11#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-2#2)
of imported falciparum malaria cases of Nantong City##2##8##(2012-3#2)
of imported falciparum malaria##3##4##(2012-3#3)
of imported infections##2##3##(2007-2#2)
of imported##9##2##(2007-2#3)(2011-1#1)(2011-2#1)(2012-3#3)(2013-8#1)
of imprinted genes##2##3##(1996-10#1)(2008-7#1)
of imprinted##4##2##(1996-10#1)(2008-10#1)(2008-7#2)
of improper##6##2##(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
of improved access and##2##4##(1995-1#2)
of improved##30##2##(1993-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1997-8#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-4#1)
of improvement in the##2##4##(1996-9#1)(2008-10#1)
of improvement in##11##3##(1995-3#1)(1996-2#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-1#1)
of improvement of##4##3##(1995-2#1)(2007-8#2)(2011-2#1)
of improvement was##4##3##(2007-8#1)(2008-10#2)(2008-9#1)
of improvement##29##2##(1991-3#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
of improvements in##5##3##(1997-3#1)(2008-11#2)(2008-5#1)(2010-10#1)
of improvements##7##2##(1994-12#1)(1997-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-10#1)
of improving optical poling efficiency##2##5##(2007-11#2)
of improving patient##2##3##(2010-3#1)(2010-8#1)
of improving the##12##3##(1990-2#1)(1992-11#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)
of improving##34##2##(1990-2#2)(1992-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-11#2)(2007-4#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of impulses and##2##3##(1992-5#1)(2007-11#1)
of impulsive##4##2##(2008-3#1)(2010-6#2)(2013-1#1)
of impulsivity##6##2##(2008-6#1)(2010-6#2)(2013-7#3)
of impurities in##2##3##(2008-10#2)
of impurities##10##2##(2008-10#6)(2008-11#1)(2008-7#1)(2013-8#2)
of impurity##3##2##(2008-7#2)(2013-8#1)
of in situ hybridization##3##4##(1995-2#1)(1997-2#1)(2010-1#1)
of in situ measurements##2##4##(2008-2#1)(2008-3#1)
of in situ##30##3##(1990-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-2#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#2)
of in utero##3##3##(1991-1#1)(2007-11#1)(2008-8#1)
of in vitro and in vivo##3##6##(2007-7#1)(2008-5#2)
of in vitro antifungal##3##4##(2008-5#2)(2010-5#1)
of in vitro development##2##4##(1996-2#1)(2009-12#1)
of in vitro fertilization##2##4##(1991-11#1)(2013-1#1)
of in vitro studies on##2##5##(2008-11#1)(2012-2#1)
of in vitro systems##2##4##(2008-1#1)(2008-10#1)
of in vitro##46##3##(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1995-2#1)(1996-2#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#9)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#3)
of in vivo human skin##3##5##(2007-11#1)(2007-12#2)
of in vivo##38##3##(1991-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(2007-11#4)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#2)(2009-9#1)(2010-9#2)(2011-1#1)(2012-3#1)(2013-1#1)
of in##126##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-5#1)(2007-11#6)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#10)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#3)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#4)
of in-ambulance##2##2##(2010-8#2)
of in-center hemodialysis##2##3##(1996-2#1)(2010-5#1)
of in-flight##2##2##(1991-2#1)(2008-2#1)
of in-home##2##2##(1991-2#1)(1995-3#1)
of in-hospital##4##2##(2008-3#1)(2011-2#1)(2013-1#2)
of in-house##3##2##(2008-10#3)
of in-line fiber-optic##2##3##(2008-2#2)
of in-line##3##2##(2007-12#1)(2008-2#2)
of in-patient##2##2##(1991-9#1)(2011-2#1)
of in-phase##4##2##(1997-8#2)(2007-12#1)(2009-3#1)
of in-plane and out-of-plane##2##4##(2008-3#2)
of in-plane##5##2##(2007-11#1)(2008-3#3)(2009-7#1)
of in-stent##4##2##(2008-12#1)(2009-5#1)(2011-2#2)
of in-vitro##3##2##(1990-12#1)(1991-3#1)(2008-10#1)
of in-water##2##2##(2008-2#2)
of inactivated vaccine##2##3##(1991-3#1)(1996-12#1)
of inactivated##6##2##(1991-3#1)(1992-9#1)(1994-5#1)(1996-12#1)(1997-6#1)(2009-5#1)
of inactivation and##2##3##(1990-5#1)(1995-12#1)
of inactivation of RDPR##2##4##(1993-11#2)
of inactivation of##3##3##(1993-11#2)(2008-8#1)
of inactivation##12##2##(1990-5#2)(1993-11#5)(1995-12#1)(1995-6#1)(2008-8#3)
of inactive##4##2##(1992-9#1)(1996-5#1)(2008-2#1)(2008-8#1)
of inadequacy##2##2##(1993-3#1)(2013-1#1)
of inadequate##13##2##(1991-2#1)(1992-9#1)(1993-3#2)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-10#1)(2012-2#1)(2013-1#2)
of inaperisone hydrochloride (inaperisone)##2##4##(1992-3#2)
of inaperisone##4##2##(1992-3#4)
of inappropriate antidiuretic hormone##2##4##(2009-8#1)(2011-2#1)
of inappropriate##6##2##(1990-3#1)(1996-1#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-12#1)
of inattention##2##2##(2008-2#1)(2008-8#1)
of inborn errors##2##3##(2008-4#2)
of inbred lines##3##3##(2008-5#3)
of inbred##5##2##(1994-8#1)(2008-5#3)(2008-8#1)
of inbreds##2##2##(2008-10#2)
of inbreeding and##2##3##(2009-5#1)(2012-3#1)
of inbreeding depression##3##3##(2008-8#2)(2008-9#1)
of inbreeding##12##2##(2008-12#1)(2008-8#2)(2008-9#4)(2009-5#2)(2012-3#3)
of incarcerated women##2##3##(1996-7#1)(2009-11#1)
of incarcerated##5##2##(1996-7#1)(2008-11#1)(2009-11#2)(2011-1#1)
of incarceration of##3##3##(2008-12#2)(2009-11#1)
of incentives##3##2##(1993-3#1)(1996-12#1)(2012-3#1)
of incest in Palau##2##4##(2008-1#2)
of incest in##3##3##(2008-1#3)
of incest##6##2##(1996-5#1)(2008-1#5)
of incidence and severity##2##4##(2008-10#2)
of incidence and##13##3##(1991-6#1)(1992-12#1)(2008-10#2)(2008-2#2)(2008-3#6)(2008-8#1)
of incidence is##3##3##(1991-3#1)(2007-12#1)(2008-3#1)
of incidence of the##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
of incidence of##16##3##(1990-11#1)(1990-12#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#4)
of incidence on##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of incidence with the##2##4##(2008-3#2)
of incidence with##3##3##(2008-3#3)
of incidence##83##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-12#2)(1995-5#2)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#13)(2008-2#16)(2008-3#32)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)
of incident beam##3##3##(2008-2#2)(2008-3#1)
of incident cases##2##3##(1992-8#2)
of incident light##6##3##(2007-12#2)(2008-3#4)
of incident##21##2##(1992-8#2)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#9)(2008-7#1)(2010-12#1)
of incidental##4##2##(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
of incidents##5##2##(2007-2#3)(2011-2#1)(2012-12#1)
of incipient##4##2##(2007-12#1)(2008-1#1)(2008-9#1)(2013-8#1)
of incisional##4##2##(2007-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
of included##3##2##(2008-10#1)(2011-2#2)
of including a##2##3##(1992-2#1)(2008-8#1)
of including##10##2##(1992-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#2)(2010-3#1)(2013-1#1)
of inclusion bodies in##2##4##(2008-10#1)(2009-3#1)
of inclusion complexes##2##3##(2008-10#2)
of inclusion##9##2##(1994-9#1)(1996-3#1)(1996-5#1)(2008-10#3)(2009-3#1)(2012-3#2)
of inclusions##4##2##(2008-10#3)(2008-3#1)
of incoherent bright and dark##2##5##(2007-12#2)
of incoherent##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
of income to##2##3##(2008-8#1)(2013-1#1)
of income##12##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-5#1)(2008-12#1)(2008-8#2)(2010-2#2)(2012-12#1)(2013-1#2)
of incoming##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
of incompatibility##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
of incompetence##2##2##(1995-5#1)(2011-1#1)
of incomplete resistance##4##3##(2008-10#4)
of incomplete##10##2##(1990-9#1)(1996-12#3)(2006-12#1)(2008-10#4)(2008-8#1)
of incompletely occluded aneurysms##2##4##(2013-1#2)
of incompletely occluded##3##3##(2013-1#3)
of incompletely##4##2##(1994-8#1)(2013-1#3)
of incongruence##2##2##(2007-8#2)
of incorporated##4##2##(1991-12#1)(1994-12#1)(2008-10#2)
of incorporating an##2##3##(2008-10#1)(2010-4#1)
of incorporating the##4##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
of incorporating##7##2##(1994-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-4#1)(2011-2#1)
of incorporation##5##2##(1991-12#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-4#1)
of incorrect##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
of incoupling##2##2##(2008-3#2)
of increase in mortality rate##2##5##(2008-9#2)
of increase in##10##3##(1990-7#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-2#1)
of increase is##2##3##(2008-10#1)(2008-7#1)
of increase of##4##3##(2008-10#2)(2008-8#2)
of increase##24##2##(1990-7#2)(1992-6#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#2)(2012-2#1)
of increased awareness and##2##4##(1994-1#1)(2007-7#1)
of increased intracranial pressure##4##4##(1992-11#1)(2008-1#1)(2008-12#1)(2008-7#1)
of increased metabolic##2##3##(2008-11#1)(2010-12#1)
of increased mortality##2##3##(1994-7#1)(1997-6#1)
of increased numbers of##2##4##(1996-4#1)(1997-4#1)
of increased##85##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-5#1)(1992-6#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-4#1)(1997-3#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
of increases in##3##3##(1994-8#1)(2008-10#1)(2013-8#1)
of increases##4##2##(1994-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
of increasing access to##2##4##(2011-1#1)(2011-2#1)
of increasing age##2##3##(1996-5#1)(2008-7#1)
of increasing complexity##2##3##(2008-11#1)(2012-2#1)
of increasing concern##3##3##(1996-3#1)(2009-5#1)(2012-12#1)
of increasing dietary##2##3##(2013-1#2)
of increasing incidence##2##3##(1992-9#1)(2013-8#1)
of increasing interest##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
of increasing the response##2##4##(1991-1#1)(2008-6#1)
of increasing the##19##3##(1990-2#1)(1990-7#1)(1991-1#1)(1991-2#1)(1995-12#1)(1997-2#1)(2007-11#3)(2008-10#3)(2008-2#2)(2008-6#1)(2008-8#2)(2009-4#1)(2010-3#1)
of increasing##79##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
of increasingly##6##2##(1992-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)
of incremental##2##2##(2010-12#1)(2011-2#1)
of increments##2##2##(1992-12#1)(1993-9#1)
of incubation and##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
of incubation at##2##3##(1991-2#1)(2008-10#1)
of incubation in##2##3##(1990-12#1)(1997-4#1)
of incubation of##3##3##(1990-5#1)(1997-2#1)(2008-11#1)
of incubation temperature##3##3##(2008-10#1)(2011-2#2)
of incubation time##7##3##(1992-12#1)(2008-10#2)(2008-12#1)(2008-5#3)
of incubation with##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
of incubation##53##2##(1990-12#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-12#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
of indentation##2##2##(2008-10#1)(2009-7#1)
of independence and##2##3##(1991-2#1)(1996-2#1)
of independence##9##2##(1991-2#1)(1993-6#1)(1995-12#1)(1996-2#2)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)
of independent genetic##2##3##(2008-10#1)(2012-3#1)
of independent studies##2##3##(1996-6#1)(2008-2#1)
of independent walking##2##3##(1993-12#2)
of independent##30##2##(1993-12#2)(1993-9#1)(1994-2#1)(1994-3#1)(1996-6#2)(1997-2#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
of indeterminate##3##2##(1994-6#1)(2008-1#1)(2010-12#1)
of index modulation##2##3##(2008-3#2)
of index##15##2##(1992-9#2)(1996-3#4)(2007-11#3)(2007-12#1)(2008-3#4)(2008-8#1)
of indication##2##2##(2010-8#1)(2013-1#1)
of indications for##3##3##(2007-11#2)(2008-7#1)
of indications##9##2##(1990-9#1)(1996-3#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-7#1)(2008-8#1)
of indicator information##2##3##(1997-1#2)
of indicator##9##2##(1990-12#1)(1991-2#1)(1997-1#3)(2008-10#2)(2008-9#1)(2012-2#1)
of indicators of##4##3##(1996-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
of indicators##19##2##(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-12#1)(2007-4#1)(2008-11#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#4)(2013-1#1)
of indices##5##2##(1995-2#1)(1995-6#1)(2008-11#1)(2008-8#1)(2011-1#1)
of indigenous##14##2##(2008-10#6)(2008-11#2)(2008-12#1)(2009-6#1)(2010-1#1)(2011-1#1)(2013-1#2)
of indigent patients##2##3##(2008-11#1)(2008-12#1)
of indigent##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
of indigo carmine##2##3##(2008-10#2)
of indirect##10##2##(1994-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-1#1)
of indium in high purity antimony by electrothermal atomic absorption##2##10##(2008-10#2)
of indium in##4##3##(2008-10#4)
of indium tin oxide (ITO)##2##5##(2007-12#1)(2008-2#1)
of indium tin oxide##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of indium tin##4##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
of indium##13##2##(1995-3#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#1)
of individual amino acid##2##4##(1993-8#1)(1997-4#1)
of individual amino##3##3##(1993-8#1)(1995-5#1)(1997-4#1)
of individual and##4##3##(1995-1#1)(2008-10#1)(2008-9#1)(2009-11#1)
of individual cells##10##3##(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2009-9#1)(2011-1#1)
of individual chemical##2##3##(1995-6#1)(2008-10#1)
of individual components##2##3##(2008-10#2)
of individual compounds##2##3##(2008-10#2)
of individual defect nanoclusters##2##4##(2007-12#2)
of individual defect##3##3##(2007-12#3)
of individual differences in##3##4##(2008-11#1)(2008-5#1)(2012-1#1)
of individual enzymes##2##3##(1996-5#1)(2010-3#1)
of individual genes##2##3##(2008-11#1)(2008-7#1)
of individual isolates##2##3##(2008-10#1)(2011-2#1)
of individual members##2##3##(1997-7#1)(2008-4#1)
of individual molecules##2##3##(2008-7#2)
of individual negotiator##2##3##(1992-2#2)
of individual patients may be##2##5##(1991-3#1)(1997-5#1)
of individual patients with##2##4##(1996-7#1)(2010-12#1)
of individual patients##6##3##(1991-3#1)(1996-7#1)(1997-5#1)(2008-11#1)(2008-2#1)(2010-12#1)
of individual plants##3##3##(2008-10#3)
of individual pulses##2##3##(2007-12#2)
of individual species##5##3##(1995-8#1)(2008-10#1)(2008-6#1)(2009-8#1)(2012-3#1)
of individual volunteers##2##3##(1993-12#1)(1994-3#1)
of individual##205##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#8)(2007-8#1)(2008-1#4)(2008-10#46)(2008-11#12)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
of individualized##2##2##(1995-5#1)(2007-10#1)
of individually##2##2##(1992-4#1)(2007-11#1)
of individuals and##10##3##(1993-3#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-8#1)
of individuals are##3##3##(1997-4#1)(2008-9#1)(2009-11#1)
of individuals at risk##2##4##(1997-5#1)(2011-2#1)
of individuals at##4##3##(1997-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
of individuals for##2##3##(1995-3#1)(2007-1#1)
of individuals from##3##3##(1994-1#1)(1996-12#1)(2008-12#1)
of individuals in##4##3##(1991-2#1)(1994-12#1)(2008-9#1)(2011-2#1)
of individuals of##4##3##(2008-10#1)(2013-7#3)
of individuals receiving##3##3##(1996-3#1)(2011-2#1)(2013-7#1)
of individuals that##3##3##(2007-7#1)(2008-8#2)
of individuals to##2##3##(1996-12#1)(1996-3#1)
of individuals who##5##3##(1995-3#1)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
of individuals with Down syndrome##3##5##(2010-4#3)
of individuals with FXS##2##4##(2010-4#2)
of individuals with early##2##4##(2011-1#1)(2012-3#1)
of individuals with schizophrenia or other psychotic illnesses##4##8##(2011-2#4)
of individuals with similar##2##4##(2008-10#1)(2010-4#1)
of individuals with##41##3##(1992-1#1)(1994-12#2)(1994-2#2)(1994-5#1)(1997-1#1)(1997-3#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#3)(2010-10#1)(2010-4#6)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
of individuals within##2##3##(2008-10#1)(2008-8#1)
of individuals worldwide##3##3##(2007-2#1)(2008-8#1)(2013-1#1)
of individuals would##2##3##(1991-2#1)(2013-7#1)
of individuals##144##2##(1990-3#1)(1991-2#2)(1992-1#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-2#1)(1995-3#3)(1996-12#2)(1996-3#2)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#16)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#7)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#1)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#7)(2013-8#4)
of individuals'##2##2##(2008-9#1)(2009-12#1)
of indole-3-acetic##2##2##(2008-10#2)
of indomethacin in##2##3##(1992-8#1)(2008-10#1)
of indomethacin on##2##3##(1990-11#1)(1994-8#1)
of indomethacin##13##2##(1990-11#1)(1990-2#1)(1992-8#1)(1994-8#2)(2008-10#5)(2011-1#1)(2012-2#1)(2013-7#1)
of indoor air##3##3##(1994-9#1)(2008-10#1)(2010-5#1)
of indoor and outdoor##2##4##(2008-10#1)(2010-5#1)
of indoor pollution##2##3##(2008-10#2)
of indoor##8##2##(1994-9#2)(2008-10#4)(2010-5#2)
of induced abortion##2##3##(1991-6#2)
of induced abortions##3##3##(2013-1#3)
of induced resistance is##2##4##(2008-10#2)
of induced resistance##7##3##(2008-10#7)
of induced systemic resistance##3##4##(2008-10#3)
of induced##35##2##(1991-3#2)(1991-6#2)(1994-2#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#3)(2013-1#3)
of inducer##6##2##(1995-2#1)(1995-8#1)(1996-6#1)(2008-6#1)(2008-7#1)(2012-2#1)
of inducible NO-synthase in##2##4##(1995-12#2)
of inducible NO-synthase##3##3##(1995-12#3)
of inducible nitric oxide synthase##6##5##(1995-12#1)(1996-12#2)(2008-5#1)(2009-9#1)(2010-12#1)
of inducible nitric oxide##7##4##(1995-12#1)(1996-12#2)(2008-5#1)(2009-9#1)(2010-12#1)(2013-1#1)
of inducible##17##2##(1994-11#1)(1994-8#2)(1995-12#4)(1996-12#3)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
of inducing a##4##3##(1990-9#1)(2008-10#2)(2008-8#1)
of inducing the##2##3##(2007-8#1)(2008-7#1)
of inducing##19##2##(1990-9#1)(1991-12#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
of induction chemotherapy##2##3##(1990-6#1)(2008-10#1)
of induction of##7##3##(1994-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
of induction##23##2##(1990-5#1)(1990-6#1)(1993-8#1)(1994-8#1)(1995-2#2)(1997-7#1)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#2)(2011-2#2)(2013-8#2)
of inductive##4##2##(1994-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
of inductively coupled plasma atomic##2##5##(2008-10#2)
of inductively coupled plasma mass spectrometry##2##6##(2008-10#2)
of inductively coupled plasma##7##4##(2007-12#1)(2008-10#5)(2013-8#1)
of industrial applications##2##3##(2008-9#1)(2009-8#1)
of industrial fermentation##2##3##(2012-3#2)
of industrial hygiene and##2##4##(2012-12#2)
of industrial products##2##3##(2011-2#1)(2012-3#1)
of industrial##27##2##(1991-4#1)(1994-3#1)(1996-1#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#3)(2013-8#1)
of industrialized countries##2##3##(1994-2#1)(2010-2#1)
of industrialized##4##2##(1994-2#1)(2008-10#1)(2010-2#1)(2012-2#1)
of industries##3##2##(2008-10#1)(2008-12#1)(2012-1#1)
of industry##6##2##(1994-12#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-8#1)
of indwelling##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
of ineffective##3##2##(1996-3#1)(2008-7#1)(2011-2#1)
of inefficiency##2##2##(2010-8#1)(2013-8#1)
of inelastic##4##2##(2008-2#2)(2008-3#1)(2009-4#1)
of inequality##2##2##(2011-2#2)
of inert##2##2##(2008-10#2)
of inertial confinement fusion##3##4##(1991-9#1)(2008-3#2)
of inertial##4##2##(1991-9#1)(2008-3#2)(2010-8#1)
of inexpensive##4##2##(1991-9#1)(1994-9#1)(2008-10#1)(2011-1#1)
of infancy##12##2##(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2009-12#1)(2010-6#1)(2011-2#1)(2013-8#2)
of infant health##3##3##(1993-3#1)(1994-3#2)
of infant massage##2##3##(2008-10#2)
of infant mortality##2##3##(1997-6#1)(2012-3#1)
of infant##16##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-3#2)(1995-3#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#2)(2013-1#1)
of infantile##4##2##(1994-8#1)(1996-6#1)(2008-7#1)(2012-12#1)
of infants and children with##2##5##(1991-12#1)(1995-6#1)
of infants and children##4##4##(1991-12#1)(1995-6#1)(2006-10#1)(2008-11#1)
of infants and young children##3##5##(2010-5#2)(2013-1#1)
of infants and##9##3##(1991-12#2)(1992-12#1)(1995-6#1)(2006-10#1)(2008-11#1)(2010-5#2)(2013-1#1)
of infants born at##2##4##(2009-5#1)(2012-2#1)
of infants born##3##3##(2007-12#1)(2009-5#1)(2012-2#1)
of infants was##2##3##(2010-4#1)(2011-1#1)
of infants with##3##3##(1994-6#2)(1995-6#1)
of infants##30##2##(1990-2#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-6#4)(1995-6#2)(1997-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2009-5#2)(2010-4#2)(2010-5#2)(2011-1#3)(2012-2#1)(2013-1#1)
of infarct##2##2##(1996-9#1)(2007-10#1)
of infarction##5##2##(1990-5#1)(1990-9#1)(1993-11#2)(2008-7#1)
of infected and susceptible roots over time##3##7##(2008-10#3)
of infected and##7##3##(1991-6#1)(1994-9#1)(2008-10#4)(2008-9#1)
of infected cell##2##3##(2008-11#1)(2008-9#1)
of infected cells in##2##4##(2007-10#1)(2009-7#1)
of infected cells##14##3##(1990-7#1)(1997-3#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#3)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
of infected fruit in##3##4##(2008-10#3)
of infected fruit##6##3##(2008-10#6)
of infected individuals##3##3##(1992-12#1)(2007-12#1)(2012-12#1)
of infected leaf##2##3##(2008-10#2)
of infected leaves##4##3##(2008-10#4)
of infected mice##3##3##(1996-12#1)(2008-4#1)(2012-2#1)
of infected plant##3##3##(2008-10#3)
of infected plants in##3##4##(2008-10#3)
of infected plants##11##3##(2008-10#11)
of infected pollen##2##3##(2008-10#2)
of infected potato##4##3##(2008-10#4)
of infected tissue##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
of infected##114##2##(1990-7#1)(1991-6#1)(1992-12#1)(1994-9#2)(1996-11#1)(1996-12#2)(1997-3#2)(1997-4#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#63)(2008-11#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#1)(2009-7#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
of infecting##7##2##(1991-11#1)(1995-2#1)(2008-10#4)(2011-3#1)
of infection (MOI)##4##3##(2008-11#4)
of infection after##2##3##(2008-6#1)(2011-2#1)
of infection and clinical##3##4##(1991-8#1)(2007-12#1)(2010-8#1)
of infection and for##2##4##(2011-1#1)(2012-12#1)
of infection and precancerous lesions##3##5##(2011-3#3)
of infection and the##3##4##(2008-10#1)(2009-5#1)(2012-12#1)
of infection and##36##3##(1991-8#1)(1994-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#5)(2012-2#2)
of infection are##2##3##(2007-7#1)(2013-1#1)
of infection at##2##3##(2008-5#1)(2009-8#1)
of infection by the##2##4##(1990-9#1)(2007-2#1)
of infection by##16##3##(1990-9#1)(2007-2#2)(2008-10#10)(2009-8#1)(2012-12#1)(2013-1#1)
of infection caused by##3##4##(2007-12#1)(2008-10#1)(2010-10#1)
of infection courts##2##3##(2008-10#2)
of infection decreases##2##3##(1994-6#1)(2011-1#1)
of infection for##8##3##(2008-10#3)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)
of infection hyphae from##2##4##(2008-10#1)(2012-2#1)
of infection in a##3##4##(1992-6#2)(1996-8#1)
of infection in both##2##4##(2008-10#2)
of infection in the##6##4##(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
of infection in##38##3##(1992-6#2)(1994-6#1)(1994-9#1)(1996-8#1)(2007-12#4)(2007-7#1)(2008-10#13)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#2)
of infection is the##3##4##(1991-3#1)(2007-12#1)(2008-10#1)
of infection is##7##3##(1991-3#1)(2007-12#2)(2008-10#3)(2012-2#1)
of infection of the##3##4##(1994-11#1)(1997-3#1)(2009-6#1)
of infection of##11##3##(1994-11#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-6#1)(2011-1#1)
of infection on##2##3##(2008-7#1)(2010-5#1)
of infection or##5##3##(1991-2#1)(2008-10#1)(2011-2#2)(2013-1#1)
of infection through##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
of infection type##2##3##(2008-10#2)
of infection was##8##3##(1990-8#1)(2008-10#3)(2008-12#1)(2009-6#1)(2012-12#2)
of infection were##10##3##(2007-12#1)(2008-10#5)(2008-7#2)(2012-12#2)
of infection with an##2##4##(2008-11#1)(2011-2#1)
of infection with human immunodeficiency virus##2##6##(1991-2#1)(2009-12#1)
of infection with##12##3##(1991-2#1)(1992-11#1)(1996-6#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2011-2#2)
of infection##293##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-6#2)(1992-9#2)(1994-11#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#12)(2007-2#6)(2007-6#1)(2007-7#7)(2008-1#2)(2008-10#93)(2008-11#12)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-8#2)(2010-10#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#16)(2011-3#4)(2012-12#16)(2012-2#5)(2012-3#7)(2013-1#11)(2013-8#3)
of infection)##3##2##(2007-11#1)(2011-3#2)
of infections and##2##3##(1990-6#1)(1995-3#1)
of infections at##2##3##(2008-10#2)
of infections caused by##2##4##(2008-10#1)(2013-8#1)
of infections in##4##3##(1992-6#1)(2007-11#1)(2008-10#1)(2008-5#1)
of infections is##2##3##(2009-2#1)(2011-2#1)
of infections of##3##3##(1991-8#1)(2010-12#2)
of infections with##2##3##(1996-11#1)(2007-7#1)
of infections##37##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-8#1)(1992-11#1)(1992-6#2)(1994-11#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#3)(2010-12#2)(2011-2#2)(2012-3#1)(2013-8#1)
of infectious agents##3##3##(1991-11#1)(1997-6#1)(2008-8#1)
of infectious bronchitis virus (IBV)##6##5##(1997-3#1)(1997-6#2)(2008-5#3)
of infectious bronchitis virus in##2##5##(1997-6#1)(2008-5#1)
of infectious bronchitis virus##13##4##(1996-11#1)(1997-3#2)(1997-6#4)(2008-5#6)
of infectious complications##3##3##(1991-12#1)(2007-7#1)(2011-2#1)
of infectious coryza##2##3##(1997-3#1)(2008-5#1)
of infectious disease##2##3##(1991-3#1)(2007-12#1)
of infectious diseases and##3##4##(2008-7#1)(2012-3#1)(2013-8#1)
of infectious diseases##22##3##(1990-6#1)(1994-6#2)(1995-9#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
of infectious organisms can be##2##5##(2008-9#1)(2012-3#1)
of infectious salmon anaemia virus (ISAV)##2##6##(2009-6#2)
of infectious sources##2##3##(2012-3#2)
of infectious virus##2##3##(2012-2#2)
of infectious##77##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1994-6#2)(1995-9#1)(1996-11#2)(1997-3#4)(1997-6#5)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#8)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#3)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-8#2)
of infective endocarditis##4##3##(2006-6#1)(2007-7#1)(2011-2#1)(2013-8#1)
of infective insects##2##3##(2008-10#2)
of infective##12##2##(1991-11#1)(2006-6#1)(2007-7#1)(2008-10#4)(2009-5#1)(2011-2#3)(2013-8#1)
of infectivity##4##2##(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)
of inference##2##2##(2008-7#1)(2008-8#1)
of inferior competitors##2##3##(2008-8#2)
of inferior pancreaticoduodenal artery##2##4##(2008-7#2)
of inferior vena cava##2##4##(2008-7#2)
of inferior##10##2##(2008-2#3)(2008-7#4)(2008-8#2)(2008-9#1)
of inferring##2##2##(1995-3#1)(2008-10#1)
of infertile##6##2##(1996-12#1)(2007-10#1)(2008-12#4)
of infertility##7##2##(1991-11#1)(1991-12#1)(1991-3#1)(1994-12#1)(1996-12#1)(2008-3#1)(2011-1#1)
of infestation for##2##3##(2011-2#2)
of infestation##8##2##(1996-12#1)(2008-10#3)(2008-12#1)(2011-2#2)(2012-12#1)
of infested##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
of infiltrating##4##2##(1991-2#1)(1992-8#1)(1993-9#1)(2008-5#1)
of infiltration##3##2##(1994-9#1)(1995-4#1)(2012-12#1)
of infinite##3##2##(1997-7#1)(2008-11#1)(2008-3#1)
of infirmary##4##2##(2008-10#4)
of inflammation and immune##2##4##(1991-12#1)(1994-11#1)
of inflammation and##9##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of inflammation in the##2##4##(2012-2#2)
of inflammation in##5##3##(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#2)
of inflammation##47##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1993-2#3)(1994-11#2)(1997-1#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
of inflammatory and infectious##2##4##(2013-1#1)(2013-8#1)
of inflammatory and##7##3##(1994-9#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of inflammatory bowel disease##7##4##(1991-8#1)(2008-11#1)(2008-4#1)(2010-12#3)(2013-8#1)
of inflammatory bowel diseases##2##4##(1996-2#2)
of inflammatory bowel##10##3##(1991-8#1)(1996-2#2)(1997-3#1)(2008-11#1)(2008-4#1)(2010-12#3)(2013-8#1)
of inflammatory cell##2##3##(1991-5#1)(2010-6#1)
of inflammatory cells in the##2##5##(1997-8#1)(2008-3#1)
of inflammatory cells##7##3##(1992-2#1)(1992-5#1)(1997-8#1)(2008-10#1)(2008-3#2)(2009-10#1)
of inflammatory conditions##5##3##(2007-12#1)(2008-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
of inflammatory cytokines##4##3##(2007-11#3)(2008-10#1)
of inflammatory diseases of##2##4##(1995-12#1)(2012-3#1)
of inflammatory diseases##8##3##(1995-12#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
of inflammatory joint diseases##2##4##(2010-5#2)
of inflammatory markers##2##3##(2008-3#1)(2008-5#1)
of inflammatory mediators and##2##4##(2008-12#1)(2013-1#1)
of inflammatory mediators##8##3##(2008-1#1)(2008-12#1)(2008-7#3)(2009-11#1)(2011-2#1)(2013-1#1)
of inflammatory myositis##2##3##(2006-10#2)
of inflammatory responses##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
of inflammatory##92##2##(1990-6#1)(1991-5#1)(1991-8#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-3#2)(1997-8#1)(2006-10#2)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#8)(2009-1#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-5#3)(2010-6#3)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
of infliximab therapy##3##3##(2010-12#2)(2012-3#1)
of infliximab##5##2##(2010-12#3)(2012-3#2)
of inflorescence architecture##2##3##(1996-2#2)
of inflorescence##3##2##(1996-2#2)(2009-5#1)
of inflow##3##2##(1997-3#1)(2008-7#1)(2009-7#1)
of influence of##8##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
of influence##22##2##(1990-12#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of influences##2##2##(1997-1#1)(2008-6#1)
of influencing##4##2##(1994-2#1)(1995-3#1)(2010-10#1)(2012-2#1)
of influential##4##2##(2008-10#4)
of influenza A virus##5##4##(1992-9#1)(2011-2#3)(2013-8#1)
of influenza A viruses##5##4##(1992-9#2)(1996-6#1)(2013-1#1)(2013-8#1)
of influenza A##13##3##(1992-6#1)(1992-9#3)(1996-6#1)(2008-9#1)(2011-2#4)(2013-1#1)(2013-8#2)
of influenza A(H1N1)##2##3##(1994-9#1)(2011-2#1)
of influenza A(H3N2) viruses##2##4##(2013-8#2)
of influenza A(H3N2)##4##3##(1994-9#1)(2013-8#3)
of influenza B##2##3##(2011-2#2)
of influenza in##3##3##(1996-6#1)(2009-5#1)(2012-3#1)
of influenza vaccination##3##3##(2007-12#1)(2009-12#1)(2011-2#1)
of influenza virus##6##3##(1990-5#2)(2008-5#1)(2012-3#1)(2013-8#2)
of influenza viruses in humans##2##5##(2011-2#2)
of influenza viruses in##4##4##(2011-2#2)(2013-1#1)(2013-8#1)
of influenza viruses##5##3##(2011-2#2)(2013-1#2)(2013-8#1)
of influenza##55##2##(1990-5#2)(1991-3#1)(1991-8#2)(1992-6#1)(1992-9#3)(1994-9#2)(1996-6#3)(1997-7#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-4#1)(2011-2#16)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#8)
of informal##3##2##(1992-1#1)(2009-5#1)(2013-1#1)
of informants##2##2##(1994-1#1)(2011-2#1)
of information about the##3##4##(1996-2#1)(2011-2#2)
of information about##11##3##(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
of information and communication##2##4##(1996-4#1)(2012-12#1)
of information and##12##3##(1990-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1996-11#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
of information are##4##3##(1991-5#1)(1995-12#1)(2008-12#1)(2011-2#1)
of information available to##2##4##(1997-3#1)(2008-11#1)
of information available##3##3##(1995-3#1)(1997-3#1)(2008-11#1)
of information between##6##3##(1992-11#1)(1992-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-5#1)
of information can be##2##4##(2008-3#1)(2010-5#1)
of information concerning##6##3##(1991-2#3)(2008-6#1)(2010-3#1)(2013-8#1)
of information contained##2##3##(1992-3#1)(2008-7#1)
of information for##4##3##(1997-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
of information from##7##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#2)
of information in consumer##2##4##(1997-3#2)
of information in the literature##2##5##(1992-2#1)(2008-1#1)
of information in the##4##4##(1992-2#1)(2008-1#1)(2008-4#1)(2013-1#1)
of information in##13##3##(1992-2#2)(1993-2#1)(1993-6#1)(1995-1#1)(1995-2#1)(1997-3#2)(2008-1#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
of information is##6##3##(1993-3#1)(1994-3#1)(2008-10#2)(2008-7#1)(2012-1#1)
of information needed##3##3##(1997-1#1)(2008-4#1)(2008-6#1)
of information on the##7##4##(2007-12#2)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#2)
of information on##16##3##(1991-11#1)(1994-3#1)(1997-3#2)(2007-12#2)(2008-10#1)(2008-3#2)(2009-5#1)(2010-11#1)(2012-12#1)(2012-2#4)
of information processing##2##3##(1993-5#1)(2012-12#1)
of information provided by the##2##5##(1992-12#1)(2008-10#1)
of information provided by##4##4##(1992-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
of information resources##2##3##(2008-11#1)(2008-7#1)
of information systems (IS)##2##4##(1993-12#1)(1996-1#1)
of information systems##5##3##(1993-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)
of information technologies##2##3##(2010-8#1)(2013-1#1)
of information technology in##3##4##(1993-2#1)(2008-10#2)
of information technology##8##3##(1993-2#2)(1996-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
of information that can be##2##5##(2008-12#1)(2008-4#1)
of information that##8##3##(1992-9#1)(1995-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-12#1)
of information to##5##3##(1990-2#1)(1991-3#1)(2007-12#1)(2010-11#1)(2011-10#1)
of information used##2##3##(1994-2#1)(1997-3#1)
of information was##3##3##(1997-1#1)(2008-10#1)(2011-1#1)
of information##216##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#3)(1995-1#2)(1995-12#6)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#5)(1996-4#1)(1997-1#2)(1997-3#11)(1997-6#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-1#4)(2008-10#9)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#6)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#3)
of information)##2##2##(2008-7#1)(2012-2#1)
of informational##3##2##(1992-12#1)(1997-3#1)(2008-4#1)
of informed consent for##2##4##(1997-6#1)(2012-1#1)
of informed consent##11##3##(1993-2#3)(1996-11#1)(1997-6#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-1#2)
of informed##12##2##(1993-2#3)(1996-11#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-1#2)
of infrared (IR)##2##3##(2007-12#1)(2008-3#1)
of infrared and##2##3##(1997-7#1)(2007-12#1)
of infrared femtosecond laser pulses##3##5##(2007-12#3)
of infrared spectra##2##3##(2007-12#1)(2008-10#1)
of infrared spectroscopy##2##3##(2008-10#2)
of infrared##23##2##(1997-7#1)(2007-11#1)(2007-12#6)(2008-10#5)(2008-2#1)(2008-3#8)(2013-8#1)
of infrastructure##2##2##(2007-7#1)(2008-11#1)
of infusion of##2##3##(2008-7#1)(2010-7#1)
of infusion##7##2##(1995-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#1)
of ingestion##5##2##(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#2)
of ingredients##5##2##(2008-5#5)
of ingroup##2##2##(2008-11#1)(2012-3#1)
of inguinal hernia in children##2##5##(2008-12#2)
of inguinal hernia##5##3##(2008-12#3)(2011-2#1)(2012-12#1)
of inguinal##8##2##(1990-6#1)(1993-9#1)(1996-9#1)(2008-12#3)(2011-2#1)(2012-12#1)
of inhalation flow rate on the##2##6##(1997-2#2)
of inhalation flow rate##4##4##(1994-2#1)(1997-2#3)
of inhalation##9##2##(1994-2#1)(1994-5#1)(1997-2#5)(2008-10#2)
of inhaled cocaine##2##3##(2013-8#2)
of inhaled corticosteroids##4##3##(2007-11#2)(2011-2#1)(2013-8#1)
of inhaled insulin##2##3##(2008-8#2)
of inhaled particles##2##3##(1992-3#1)(1997-1#1)
of inhaled##24##2##(1991-12#1)(1992-3#1)(1993-8#3)(1994-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#3)(2007-11#3)(2008-10#1)(2008-12#1)(2008-8#2)(2010-5#1)(2011-2#1)(2013-8#3)
of inherent optical##2##3##(2008-2#1)(2008-3#1)
of inherent##9##2##(1991-2#1)(1994-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#1)
of inherently##3##2##(2008-10#2)(2008-2#1)
of inheritance##18##2##(1994-8#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
of inherited arrhythmias in##2##4##(2009-5#2)
of inherited arrhythmias##3##3##(2009-5#3)
of inherited##15##2##(1990-5#1)(1991-11#1)(1991-9#1)(1997-7#1)(2007-7#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#3)(2010-12#1)(2011-1#1)
of inheriting##2##2##(1997-3#1)(2008-8#1)
of inhibin subunits##2##3##(2008-8#2)
of inhibited##3##2##(1995-6#1)(1997-7#1)(2009-10#1)
of inhibiting the##2##3##(2008-10#1)(2008-11#1)
of inhibiting##12##2##(1992-12#1)(1994-11#1)(1994-12#1)(1995-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-2#1)(2012-2#1)(2012-3#1)
of inhibition by##2##3##(1992-6#1)(1992-8#1)
of inhibition from##2##3##(2008-1#1)(2010-7#1)
of inhibition in##4##3##(1992-3#1)(2008-12#1)(2008-7#2)
of inhibition of both##2##4##(1991-8#1)(2008-4#1)
of inhibition of the##3##4##(1992-6#1)(1995-11#1)(2008-10#1)
of inhibition of ubiquitin-proteasome pathway on human##2##7##(2008-9#2)
of inhibition of##26##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)
of inhibition on##2##3##(1995-6#1)(2008-11#1)
of inhibition was##2##3##(2010-1#1)(2010-3#1)
of inhibition##54##2##(1990-11#2)(1990-12#2)(1991-1#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of inhibitor and##3##3##(1992-12#1)(1993-8#1)(1994-8#1)
of inhibitor binding##2##3##(1994-8#1)(2012-12#1)
of inhibitor##12##2##(1992-12#2)(1992-9#1)(1993-8#1)(1994-8#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-3#1)(2012-12#2)
of inhibitors from##3##3##(2008-10#1)(2011-1#2)
of inhibitors of the##2##4##(1993-8#1)(2008-7#1)
of inhibitors of##5##3##(1991-5#1)(1993-11#1)(1993-8#1)(2008-7#1)(2009-8#1)
of inhibitors##19##2##(1990-5#1)(1991-5#1)(1993-11#1)(1993-8#1)(2008-10#1)(2008-4#3)(2008-7#2)(2009-8#1)(2011-1#2)(2011-3#1)(2012-12#2)(2013-1#3)
of inhibitory postsynaptic##2##3##(1995-2#1)(2011-2#1)
of inhibitory##16##2##(1993-9#1)(1994-8#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#3)
of inhomogeneities##3##2##(1996-4#1)(2008-3#2)
of inhomogeneity of##2##3##(2008-2#1)(2013-7#1)
of inhomogeneous##7##2##(1996-4#1)(2008-2#1)(2008-3#5)
of initial conditions##2##3##(2008-10#1)(2013-8#1)
of initial diagnosis##3##3##(2007-11#2)(2008-11#1)
of initial disturbances##2##3##(2008-2#2)
of initial dose in##2##4##(1994-12#1)(2010-6#1)
of initial epidemic conditions##2##4##(2008-10#2)
of initial inocula##2##3##(2008-10#2)
of initial inoculum##2##3##(2008-10#2)
of initial##52##2##(1992-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of initially##3##2##(1993-12#2)(2008-10#1)
of initiating##9##2##(2008-10#1)(2008-12#1)(2008-8#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
of initiation and##3##3##(1994-8#1)(2009-4#1)(2009-6#1)
of initiation of##2##3##(1997-7#1)(2011-1#1)
of initiation##11##2##(1993-11#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-7#1)(2008-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2011-1#1)(2013-8#1)
of initiatives##2##2##(1995-1#1)(2013-1#1)
of initiator##2##2##(2008-10#1)(2009-10#1)
of injected##6##2##(1991-5#1)(1993-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
of injecting the##2##3##(1995-2#1)(2010-8#1)
of injecting##7##2##(1993-12#1)(1995-2#2)(2007-7#1)(2010-8#2)(2013-8#1)
of injection drug##2##3##(2007-4#2)
of injection of##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
of injection##23##2##(1992-6#1)(1993-1#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-4#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#2)(2013-1#1)(2013-8#1)
of injections in##2##3##(1996-3#1)(1997-5#1)
of injections##5##2##(1994-8#1)(1996-3#1)(1997-5#1)(2011-2#1)(2013-8#1)
of injured cells##2##3##(2008-10#2)
of injured peripheral nerves##2##4##(2008-7#1)(2011-2#1)
of injured##11##2##(1990-9#1)(1992-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
of injuries and##3##3##(1996-6#1)(2010-8#1)(2012-2#1)
of injuries associated with electrical events##2##6##(1994-5#2)
of injuries during##2##3##(1990-6#1)(2007-8#1)
of injuries##15##2##(1990-6#1)(1991-12#1)(1992-6#2)(1994-5#2)(1996-6#1)(1997-2#1)(2007-11#1)(2007-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of injuries]##2##2##(1990-6#1)(1992-2#1)
of injury and##4##3##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
of injury in##7##3##(1992-6#1)(1995-11#1)(1997-6#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of injury that##3##3##(1992-4#1)(1992-6#1)(2013-1#1)
of injury to##4##3##(2007-8#2)(2008-5#1)(2013-1#1)
of injury was##5##3##(1992-6#2)(2008-12#2)(2012-2#1)
of injury were##2##3##(2008-9#1)(2013-1#1)
of injury##63##2##(1990-6#1)(1992-4#1)(1992-6#6)(1992-9#1)(1993-2#1)(1995-11#2)(1995-3#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#2)(2009-3#1)(2010-1#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#2)
of inks##2##2##(2008-10#2)
of innate immune responses##2##4##(2008-4#1)(2013-8#1)
of innate immune##4##3##(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
of innate immunity##4##3##(2008-10#1)(2008-9#1)(2009-3#1)(2009-6#1)
of innate##10##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
of inner##5##2##(1990-11#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
of innervation##3##2##(1992-6#1)(1994-12#1)(1996-6#1)
of innovation in##2##3##(2009-7#1)(2010-5#1)
of innovation##8##2##(1991-1#1)(1994-12#1)(1995-1#1)(2007-12#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)
of innovations##5##2##(2008-11#1)(2010-10#2)(2013-8#2)
of innovative##7##2##(1991-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#2)(2013-1#1)
of inocula##2##2##(2008-10#2)
of inoculated leaves##4##3##(2008-10#4)
of inoculated plants##4##3##(2008-10#4)
of inoculated##15##2##(2008-10#14)(2008-12#1)
of inoculation##22##2##(1992-2#1)(2008-10#19)(2008-11#1)(2008-5#1)
of inoculum and##4##3##(2008-10#4)
of inoculum density##5##3##(2008-10#5)
of inoculum for##8##3##(2008-10#8)
of inoculum in##4##3##(2008-10#4)
of inoculum of##2##3##(2008-10#2)
of inoculum sources##2##3##(2008-10#2)
of inoculum was##3##3##(2008-10#3)
of inoculum##57##2##(2008-10#56)(2008-11#1)
of inorganic As(III)##2##3##(2008-10#2)
of inorganic and alkylmercury##2##4##(2008-10#2)
of inorganic and methyl mercury in##2##6##(2008-10#2)
of inorganic and organic mercury##2##5##(2008-10#2)
of inorganic and organic##7##4##(2008-10#6)(2011-2#1)
of inorganic and##11##3##(2008-10#10)(2011-2#1)
of inorganic anions##2##3##(2008-10#2)
of inorganic arsenic in##3##4##(2008-10#3)
of inorganic arsenic species in##2##5##(2008-10#2)
of inorganic arsenic species##4##4##(2008-10#4)
of inorganic arsenic using##2##4##(2008-10#2)
of inorganic arsenic##17##3##(1995-11#1)(2008-10#16)
of inorganic cations##3##3##(2008-10#3)
of inorganic ions##3##3##(2008-10#3)
of inorganic mercury##5##3##(1993-12#1)(2008-10#4)
of inorganic nickel compounds in##2##5##(2008-10#2)
of inorganic oxyanions of As##2##5##(2008-10#2)
of inorganic phosphate (Pi)##2##4##(1993-12#1)(2010-8#1)
of inorganic phosphate##5##3##(1992-12#1)(1993-12#2)(2008-10#1)(2010-8#1)
of inorganic salts##5##3##(1991-9#1)(1994-5#1)(2008-10#2)(2008-11#1)
of inorganic selenium##3##3##(2008-10#3)
of inorganic selenium(IV)##3##3##(2008-10#3)
of inorganic species##2##3##(2008-10#1)(2008-7#1)
of inorganic##96##2##(1991-9#1)(1992-12#1)(1993-12#3)(1993-3#2)(1994-5#1)(1995-11#2)(1995-3#2)(1997-6#1)(2008-10#72)(2008-11#2)(2008-6#2)(2008-7#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
of inosine##7##2##(2008-10#7)
of inositol 1##13##3##(1990-8#1)(1991-12#2)(1992-11#2)(1992-5#1)(1993-6#1)(1993-8#2)(1995-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
of inositol phosphates was##2##4##(1990-12#1)(1993-6#1)
of inositol phosphates##10##3##(1990-12#1)(1990-8#2)(1991-5#1)(1992-11#1)(1993-6#4)(2008-4#1)
of inositol trisphosphate##7##3##(1990-8#3)(1991-12#1)(1993-3#2)(1993-6#1)
of inositol##39##2##(1990-12#1)(1990-7#2)(1990-8#7)(1991-12#3)(1991-5#1)(1992-11#3)(1992-5#1)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#6)(1993-8#3)(1995-11#1)(1997-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
of inpatient care##3##3##(1992-1#1)(1992-2#1)(1993-12#1)
of inpatient diabetes##2##3##(2009-11#2)
of inpatient hospital##2##3##(1992-2#1)(1994-3#1)
of inpatient psychiatric treatment##2##4##(1991-2#1)(1992-2#1)
of inpatient psychiatric##3##3##(1991-2#2)(1992-2#1)
of inpatient treatment##2##3##(1993-2#1)(1995-11#1)
of inpatient##19##2##(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#3)(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(2008-6#1)(2009-11#3)
of inpatients with##2##3##(2008-11#1)(2013-8#1)
of inpatients##4##2##(1995-2#1)(2007-7#1)(2008-11#1)(2013-8#1)
of input and##2##3##(2008-2#1)(2008-9#1)
of input data##2##3##(2008-2#1)(2008-6#1)
of input images##2##3##(2007-12#1)(2008-3#1)
of input noise##2##3##(2008-2#2)
of input##26##2##(1991-3#1)(1996-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#6)(2008-3#5)(2008-6#1)(2008-9#1)(2012-3#1)
of inputs can be##2##4##(2007-8#1)(2008-3#1)
of inputs##7##2##(1994-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2013-8#1)
of inquiry##5##2##(1996-2#1)(2008-12#2)(2008-8#2)
of insanity##2##2##(2009-10#1)(2011-1#1)
of insect cell cultures##2##4##(2008-2#2)
of insect cell##4##3##(2008-11#2)(2008-2#2)
of insect cells and##2##4##(2008-11#1)(2008-2#1)
of insect cells with##2##4##(2008-11#1)(2008-2#1)
of insect cells##8##3##(1993-6#1)(1994-10#1)(2008-11#4)(2008-2#2)
of insect herbivores##2##3##(2011-2#1)(2013-7#1)
of insect pheromones##2##3##(2008-10#2)
of insect vectors of##2##4##(2007-7#1)(2008-10#1)
of insect##41##2##(1993-6#1)(1994-10#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#1)(2008-8#3)(2008-9#2)(2010-4#1)(2011-2#4)(2013-7#1)
of insect-plant##2##2##(2008-1#1)(2009-6#1)
of insecticide##5##2##(1997-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
of insecticides##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-12#1)
of insects and##3##3##(1995-11#1)(2007-12#2)
of insects in##3##3##(2007-12#2)(2010-6#1)
of insects is##2##3##(2007-12#1)(2012-3#1)
of insects##19##2##(1995-11#1)(2007-12#6)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-6#1)(2012-3#1)
of insensitivity in##2##3##(2008-10#2)
of insensitivity##4##2##(2008-10#4)
of insert##2##2##(1993-11#1)(2008-3#1)
of insertion and##2##3##(2008-10#1)(2010-7#1)
of insertion loss##3##3##(2007-11#1)(2008-3#2)
of insertion of##3##3##(1991-10#1)(2007-8#1)(2010-7#1)
of insertion##17##2##(1991-10#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-12#1)(2010-7#6)(2012-2#1)
of insight and##2##3##(2008-7#1)(2013-8#1)
of insight##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
of insoluble exopolysaccharide##2##3##(2008-6#2)
of insoluble##13##2##(1991-11#1)(1993-8#1)(1994-11#2)(1994-3#1)(2008-10#2)(2008-4#1)(2008-6#3)(2011-2#2)
of insolubles in##2##3##(2008-10#2)
of insomnia##7##2##(1994-6#1)(2007-2#1)(2008-5#3)(2008-7#1)(2013-1#1)
of inspection##2##2##(2007-12#1)(2008-10#1)
of inspiration##4##2##(1996-2#1)(2007-12#1)(2008-12#1)(2012-3#1)
of inspiratory##2##2##(1995-3#1)(2013-7#1)
of instability##6##2##(1995-2#1)(1996-4#1)(2007-11#1)(2008-5#1)(2009-1#1)(2012-3#1)
of installing##3##2##(2008-7#1)(2009-12#2)
of instant##2##2##(2008-1#1)(2008-11#1)
of instantaneous##2##2##(2008-10#1)(2013-1#1)
of institutional##10##2##(1991-1#2)(1991-2#1)(1991-6#1)(1993-1#1)(1996-12#1)(1997-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
of institutionalization##3##2##(1992-12#1)(2008-7#1)(2009-9#1)
of institutionalized##3##2##(1991-6#1)(1994-12#1)(1997-3#1)
of institutions##9##2##(1993-12#2)(1993-2#1)(1995-12#1)(1995-5#1)(2008-12#1)(2008-6#1)(2009-4#1)(2012-12#1)
of instruction##11##2##(1992-12#1)(1993-12#2)(1993-3#1)(1994-6#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
of instructions##2##2##(2008-11#1)(2008-8#1)
of instrument##7##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-9#1)
of instrumental and##7##3##(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)
of instrumental##17##2##(2008-10#8)(2008-3#3)(2008-4#2)(2008-5#2)(2008-8#1)(2012-12#1)
of instrumentation##3##2##(2008-10#2)(2010-11#1)
of instruments and##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
of instruments used##2##3##(2008-5#1)(2013-8#1)
of instruments##9##2##(1996-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-8#1)
of insufficient##5##2##(1997-8#1)(2010-5#1)(2010-7#1)(2011-2#2)
of insulin +##2##3##(1991-12#1)(1993-6#1)
of insulin action##4##3##(1993-8#1)(1994-8#1)(1996-2#1)(2009-12#1)
of insulin and IGF-1 receptors##2##5##(1994-11#2)
of insulin and IGF-1##4##4##(1994-11#3)(2008-9#1)
of insulin and glucagon##2##4##(1994-11#1)(2008-3#1)
of insulin and##11##3##(1994-11#4)(1994-6#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-11#1)
of insulin by##2##3##(1990-11#1)(2008-8#1)
of insulin exocytosis##2##3##(2010-11#2)
of insulin granule##2##3##(2010-11#2)
of insulin in the##3##4##(1990-11#1)(2008-3#1)(2011-1#1)
of insulin in##8##3##(1990-11#1)(2008-1#1)(2008-3#2)(2010-11#1)(2011-1#3)
of insulin on the##3##4##(1991-7#1)(1995-6#1)(1996-2#1)
of insulin on##5##3##(1991-7#1)(1995-6#1)(1996-2#1)(2009-10#1)(2010-11#1)
of insulin pump therapy in##2##5##(2008-1#2)
of insulin pump therapy##3##4##(2008-1#3)
of insulin pump##4##3##(2008-1#3)(2008-7#1)
of insulin receptor##7##3##(1992-10#1)(1994-11#1)(1994-12#1)(1997-1#1)(2008-3#1)(2010-11#1)(2013-1#1)
of insulin receptors##2##3##(1994-6#1)(2008-1#1)
of insulin release##3##3##(1990-12#2)(2010-11#1)
of insulin resistance (HOMA-IR)##2##4##(2008-3#1)(2011-1#1)
of insulin resistance and diabetes##2##5##(2008-3#1)(2012-2#1)
of insulin resistance and type 2 diabetes##2##7##(2010-12#1)(2011-1#1)
of insulin resistance and##10##4##(1990-2#1)(2008-1#1)(2008-3#2)(2010-12#2)(2011-1#2)(2012-2#2)
of insulin resistance in##5##4##(2008-1#2)(2008-3#2)(2012-5#1)
of insulin resistance##45##3##(1990-2#1)(2008-1#8)(2008-3#13)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#3)(2011-1#8)(2012-2#2)(2012-5#2)(2013-1#3)(2013-7#1)
of insulin secretion and##3##4##(2009-12#1)(2010-10#1)(2011-1#1)
of insulin secretion by##2##4##(1997-4#1)(2008-4#1)
of insulin secretion in##2##4##(1995-8#1)(2013-1#1)
of insulin secretion##19##3##(1990-12#1)(1994-11#1)(1995-8#1)(1996-5#3)(1997-4#4)(2008-11#1)(2008-4#2)(2009-12#1)(2010-10#1)(2010-11#2)(2011-1#1)(2013-1#1)
of insulin sensitivity##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
of insulin stimulation##2##3##(2008-11#1)(2008-6#1)
of insulin therapy##7##3##(1993-12#4)(2009-11#1)(2011-1#2)
of insulin to##3##3##(2008-3#2)(2009-11#1)
of insulin was##2##3##(2008-9#1)(2013-8#1)
of insulin##211##2##(1990-11#4)(1990-12#6)(1990-2#1)(1990-7#1)(1991-12#4)(1991-2#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-12#4)(1993-6#3)(1993-8#1)(1994-11#8)(1994-12#1)(1994-6#2)(1994-8#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#4)(1997-1#1)(1997-4#4)(2007-10#2)(2007-7#1)(2008-1#18)(2008-10#1)(2008-11#7)(2008-3#24)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-9#2)(2010-10#5)(2010-11#18)(2010-12#3)(2011-1#20)(2011-2#2)(2012-2#4)(2012-4#1)(2012-5#2)(2013-1#6)(2013-7#2)(2013-8#2)
of insulin)##2##2##(1990-8#1)(1997-2#1)
of insulin-dependent diabetes mellitus##2##4##(2007-5#1)(2010-11#1)
of insulin-dependent diabetes##3##3##(1994-12#1)(2007-5#1)(2010-11#1)
of insulin-like growth factor 1##2##5##(2008-9#2)
of insulin-like growth factor##5##4##(1992-3#1)(2008-4#1)(2008-6#1)(2008-9#2)
of insulin-like growth##7##3##(1992-3#1)(1994-6#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-5#1)
of insulin-like##9##2##(1992-3#1)(1993-9#1)(1994-6#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-4#1)(2010-5#1)
of insulin-responsive glucose transporter (GLUT4)##2##5##(1994-11#2)
of insulin-stimulated##2##2##(1992-6#1)(1994-11#1)
of insulinoma##4##2##(1997-5#1)(2007-5#1)(2008-2#1)(2009-4#1)
of insults##3##2##(2008-11#1)(2008-9#2)
of insurance benefits##2##3##(1996-5#1)(1997-5#1)
of insurance contract##3##3##(1992-1#3)
of insurance##14##2##(1991-3#1)(1992-1#5)(1993-2#1)(1995-1#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-5#1)(2009-11#1)
of insurers##2##2##(1992-3#1)(2008-10#1)
of intact BAC DNA for##2##5##(2008-4#2)
of intact cells##2##3##(1994-8#1)(1996-6#1)
of intact chromogranin A##2##4##(1993-8#2)
of intact type VI collagen microfibrils##2##6##(1993-3#2)
of intact##44##2##(1990-12#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-8#3)(1994-9#1)(1995-5#3)(1996-12#3)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#2)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)
of intake of##3##3##(1990-8#1)(2008-1#1)(2012-1#1)
of intake##8##2##(1990-10#1)(1990-8#1)(1991-12#1)(1993-11#1)(2008-1#1)(2009-4#2)(2012-1#1)
of integral imaging##2##3##(2007-11#2)
of integral membrane proteins##3##4##(1990-5#1)(2008-4#2)
of integral##10##2##(1990-5#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-7#1)(2012-1#1)
of integrated delivery systems##3##4##(1996-1#1)(1996-2#1)(1996-3#1)
of integrated delivery##4##3##(1996-1#1)(1996-2#1)(1996-3#1)(2010-8#1)
of integrated health care delivery##2##5##(1996-1#1)(2008-1#1)
of integrated health care##4##4##(1994-1#1)(1995-12#1)(1996-1#1)(2008-1#1)
of integrated optical##4##3##(2007-11#1)(2008-3#3)
of integrated pest management strategies##2##5##(2008-9#1)(2011-2#1)
of integrated pest management##4##4##(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
of integrated systems##2##3##(1992-12#1)(1997-3#1)
of integrated vector management##2##4##(2008-8#2)
of integrated##42##2##(1992-12#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-1#2)(1996-2#1)(1996-3#4)(1997-3#2)(1997-7#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-3#2)
of integrating##12##2##(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
of integration and##2##3##(2008-10#1)(2008-2#1)
of integration##13##2##(1991-9#1)(1995-2#1)(1997-3#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)
of integrative approaches to couple therapy##2##6##(2012-2#2)
of integrative##4##2##(1997-6#1)(2012-2#3)
of integrin clusters in##2##4##(2010-10#2)
of integrin clusters##4##3##(2010-10#4)
of integrin##12##2##(1995-6#1)(1996-2#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-10#5)(2010-6#1)(2010-7#1)
of integrins##2##2##(2009-1#1)(2012-2#1)
of integrity of##3##3##(2008-10#2)(2008-4#1)
of integrity##6##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#2)
of inteins##2##2##(2013-1#2)
of intellectual property rights##3##4##(2012-3#3)
of intellectual property##4##3##(1994-3#1)(2012-3#3)
of intellectual##10##2##(1993-3#1)(1994-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-4#2)(2012-3#3)
of intense debate##2##3##(2010-12#1)(2010-3#1)
of intense femtosecond##2##3##(2007-12#2)
of intense investigation##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
of intense research##4##3##(2008-5#1)(2008-9#1)(2010-7#1)(2010-9#1)
of intense ultrabroadband optical pulses##2##5##(2007-12#2)
of intense##38##2##(1992-2#1)(1992-3#1)(1993-12#1)(2006-10#2)(2006-4#3)(2007-11#1)(2007-12#10)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)
of intensely##4##2##(1990-11#1)(1997-2#1)(1997-3#1)(2008-3#1)
of intensified IFADIC##2##3##(2008-6#2)
of intensified##3##2##(1991-3#1)(2008-6#2)
of intensities of##2##3##(1994-12#1)(2008-10#1)
of intensity and pleasantness##3##4##(2012-12#3)
of intensity and##4##3##(2008-3#1)(2012-12#3)
of intensity fluctuations##2##3##(2007-11#1)(2008-3#1)
of intensity noise in##2##4##(2007-12#1)(2008-3#1)
of intensity of##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
of intensity##37##2##(1992-9#1)(1995-12#2)(1995-5#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#12)(2008-9#1)(2011-2#1)(2012-12#5)(2013-8#1)
of intensity-modulated laser diodes##2##4##(2008-3#2)
of intensive care therapy##2##4##(1996-9#2)
of intensive care unit##2##4##(2009-11#1)(2013-1#1)
of intensive care##10##3##(1990-11#1)(1990-2#1)(1995-1#1)(1996-9#3)(2007-11#1)(2009-11#1)(2009-4#1)(2013-1#1)
of intensive research##3##3##(1990-6#1)(2007-5#1)(2012-2#1)
of intensive treatment##2##3##(1993-9#1)(2012-2#1)
of intensive##36##2##(1990-11#1)(1990-2#1)(1990-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1996-9#3)(2007-11#2)(2007-5#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-9#2)(2009-11#1)(2009-4#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
of intent##3##2##(1996-3#1)(2008-4#1)(2008-5#1)
of intentional##4##2##(2008-11#1)(2009-10#1)(2009-12#1)(2010-2#1)
of intentions##2##2##(1997-3#1)(2010-2#1)
of inter##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
of inter- and##2##3##(1992-3#1)(2008-9#1)
of interacting phenotypes##4##3##(2008-8#4)
of interacting species##2##3##(1997-2#1)(2013-8#1)
of interacting with the##3##4##(1994-11#1)(1995-5#1)(2013-1#1)
of interacting with##4##3##(1994-11#1)(1995-5#1)(2008-11#1)(2013-1#1)
of interacting##18##2##(1994-11#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
of interaction among##2##3##(2008-11#1)(2010-6#1)
of interaction and##2##3##(2009-12#1)(2012-3#1)
of interaction between the##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
of interaction between##12##3##(1990-11#1)(1990-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)
of interaction of##7##3##(1993-6#1)(1994-8#1)(2008-10#3)(2008-7#1)(2009-8#1)
of interaction with##4##3##(1990-4#1)(2008-11#1)(2008-7#1)(2008-9#1)
of interaction##47##2##(1990-11#1)(1990-2#2)(1990-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)
of interactions between the##4##4##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
of interactions between##16##3##(1992-6#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of interactions that##2##3##(2008-9#1)(2009-7#1)
of interactions with other##3##4##(2007-8#1)(2013-1#2)
of interactions with##9##3##(1993-1#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2013-1#2)
of interactions##39##2##(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of interactive##2##2##(2008-7#1)(2012-3#1)
of intercellular communication##2##3##(2008-7#1)(2013-8#1)
of intercellular signaling##2##3##(2007-12#1)(2008-4#1)
of intercellular spaces##2##3##(2008-10#1)(2008-7#1)
of intercellular##11##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-1#1)(2013-8#1)
of interchangeability##2##2##(1990-2#1)(2013-1#1)
of interconnected regions##2##3##(2008-4#1)(2008-6#1)
of interconnected##3##2##(2008-4#1)(2008-6#1)(2012-2#1)
of intercostal##2##2##(2007-8#2)
of interdigitated##2##2##(2007-12#1)(2008-10#1)
of interdisciplinary##2##2##(2008-8#1)(2013-1#1)
of interest analysis##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
of interest and##16##3##(1992-3#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2012-3#1)
of interest are discussed##2##4##(2008-11#1)(2013-8#1)
of interest are##12##3##(1991-5#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#2)(2013-8#1)
of interest as##4##3##(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
of interest because##11##3##(1990-8#1)(2010-5#1)(2011-2#9)
of interest can be##5##4##(1996-6#2)(2008-4#1)(2008-7#1)(2012-2#1)
of interest for an##2##4##(2008-2#1)(2008-3#1)
of interest for further##2##4##(1991-5#1)(1997-5#1)
of interest for many##2##4##(2008-3#1)(2009-10#1)
of interest for the##4##4##(2008-10#1)(2008-9#1)(2009-12#1)(2013-8#1)
of interest for##23##3##(1991-5#1)(1992-9#1)(1993-9#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)(2013-8#1)
of interest from##3##3##(1995-1#1)(2008-2#1)(2008-4#1)
of interest has##2##3##(1994-2#1)(2008-10#1)
of interest in the##10##4##(1992-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2013-1#1)
of interest in##29##3##(1991-6#1)(1992-9#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#3)
of interest into##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
of interest is expressed as a##3##6##(2008-2#2)(2008-9#1)
of interest is the##3##4##(2008-10#1)(2008-9#2)
of interest is##23##3##(1994-11#1)(1994-2#2)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-7#1)(2008-9#3)(2012-2#2)
of interest on##4##3##(1995-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
of interest such as##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
of interest to determine whether##2##5##(1992-3#1)(2008-4#1)
of interest to the history and culture of health##2##9##(2009-10#2)
of interest to the##5##4##(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)
of interest to##33##3##(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
of interest was##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
of interest were##4##3##(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
of interest with##2##3##(1994-8#1)(2008-10#1)
of interest##373##2##(1990-2#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-6#4)(1997-3#1)(1997-4#5)(1997-5#2)(1997-7#2)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#39)(2008-11#21)(2008-12#4)(2008-2#19)(2008-3#24)(2008-4#27)(2008-5#4)(2008-6#3)(2008-7#16)(2008-8#7)(2008-9#26)(2009-10#5)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#5)(2010-6#1)(2010-8#2)(2011-1#37)(2011-2#17)(2011-3#4)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#8)(2013-8#3)
of interested##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
of interesting##2##2##(1997-4#1)(2008-10#1)
of interests and##2##3##(2009-10#1)(2010-2#1)
of interests##6##2##(1992-1#1)(1996-11#2)(2008-12#1)(2009-10#1)(2010-2#1)
of interface##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#2)
of interfaces##2##2##(1992-6#1)(2008-10#1)
of interfacial##7##2##(1990-8#1)(2008-10#1)(2008-3#3)(2012-1#1)(2012-2#1)
of interference between##3##3##(2007-11#1)(2008-3#1)(2009-5#1)
of interference by##2##3##(2008-10#1)(2008-2#1)
of interference effects##2##3##(2008-1#1)(2008-3#1)
of interference fringes##4##3##(2008-3#4)
of interference from##4##3##(2007-12#1)(2008-10#2)(2010-6#1)
of interference of##2##3##(1990-12#1)(2008-6#1)
of interference##30##2##(1990-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#8)(2008-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
of interferences from##3##3##(2008-10#3)
of interferences in##2##3##(2008-10#2)
of interferences was##3##3##(2008-10#3)
of interferences##23##2##(2008-10#23)
of interferent##2##2##(2008-10#2)
of interferents##5##2##(2008-10#5)
of interfering ions on##2##4##(2008-10#2)
of interfering ions were##2##4##(2008-10#2)
of interfering ions##13##3##(2008-10#13)
of interfering species##3##3##(2008-10#1)(2008-2#2)
of interfering substances##2##3##(2008-10#2)
of interfering##27##2##(1997-2#2)(2008-10#22)(2008-2#2)(2013-1#1)
of interferogram##3##2##(2008-3#1)(2013-8#2)
of interferograms##4##2##(2008-2#1)(2008-3#3)
of interferometric##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
of interferon (IFN)##2##3##(1993-2#1)(2013-7#1)
of interferon (IFN)-gamma##3##3##(1994-8#1)(1996-12#1)(2008-11#1)
of interferon alpha##3##3##(1997-3#1)(1997-5#1)(2009-10#1)
of interferon therapy##2##3##(2006-10#1)(2009-3#1)
of interferon##20##2##(1991-8#1)(1993-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-3#2)(2013-1#1)(2013-7#1)
of interferon-alpha##3##2##(1993-2#1)(1997-5#1)(2007-11#1)
of interferon-beta##9##2##(1994-6#1)(2008-11#8)
of interferon-gamma (IFN-gamma)##4##3##(1993-12#1)(1994-6#1)(2008-11#1)(2008-7#1)
of interferon-gamma (IFNgamma) in##2##4##(2008-10#2)
of interferon-gamma##8##2##(1993-12#1)(1993-6#1)(1994-6#2)(2008-10#2)(2008-11#1)(2008-7#1)
of interlaboratory##2##2##(2008-10#2)
of interleukin (IL)-1beta##2##3##(2008-12#1)(2008-6#1)
of interleukin 2##2##3##(1990-6#1)(2008-4#1)
of interleukin 6##2##3##(1995-2#1)(2008-4#1)
of interleukin 7 (IL-7)##2##4##(2008-11#2)
of interleukin 7##4##3##(2008-11#3)(2008-4#1)
of interleukin##18##2##(1990-11#1)(1990-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
of interleukin-1 (IL-1)##2##3##(1991-8#1)(1995-6#1)
of interleukin-1##9##2##(1990-10#2)(1990-12#1)(1991-8#1)(1992-3#1)(1994-6#2)(1995-6#1)(2012-2#1)
of interleukin-2##5##2##(1990-5#1)(1993-6#2)(1994-6#1)(2012-2#1)
of interleukin-4 (IL-4)##2##3##(1992-5#1)(2009-12#1)
of interleukin-6 (IL-6)##3##3##(1994-6#1)(2008-11#1)(2012-3#1)
of interleukin-6##6##2##(1992-8#1)(1994-6#1)(1995-12#1)(2008-11#1)(2009-4#1)(2012-3#1)
of interleukin-8##2##2##(1993-6#1)(2009-3#1)
of intermediate grade##2##3##(1990-3#1)(2008-5#1)
of intermediate##25##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1994-6#1)(1994-8#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
of intermediates of##2##3##(1990-5#1)(1992-6#1)
of intermediates##12##2##(1990-5#2)(1990-8#1)(1991-6#1)(1992-6#1)(1994-6#1)(1997-2#1)(2008-10#3)(2009-2#1)(2011-1#1)
of intermittent fever##2##3##(2011-2#1)(2012-2#1)
of intermittent##12##2##(1993-9#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#3)(2012-2#1)
of intermolecular##4##2##(1993-8#1)(1995-8#1)(2008-10#2)
of internal and external##2##4##(2008-1#1)(2009-10#1)
of internal carotid artery##2##4##(2008-3#1)(2013-1#1)
of internal carotid##3##3##(1996-9#1)(2008-3#1)(2013-1#1)
of internal consistency##2##3##(2008-3#1)(2009-12#1)
of internal fields in##2##4##(2008-2#2)
of internal marketing to the##2##5##(2008-12#2)
of internal organs##2##3##(2010-7#1)(2012-3#1)
of internal standard##5##3##(2008-10#5)
of internal standards##2##3##(2008-10#2)
of internal transcribed spacer (ITS)##2##5##(2008-10#2)
of internal transcribed##3##3##(2008-10#3)
of internal##74##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#3)
of internalization of##3##3##(2007-12#2)(2008-5#1)
of internalized##2##2##(1994-8#1)(2011-1#1)
of internally##5##2##(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
of international importance##2##3##(1997-8#1)(2013-7#1)
of international##20##2##(1991-8#1)(1992-10#1)(1993-12#1)(1993-2#2)(1997-8#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
of interneurons##3##2##(1990-5#1)(1997-3#2)
of interobserver variability##3##3##(1991-12#1)(2008-3#1)(2009-11#1)
of interpartner conflict##2##3##(2009-9#2)
of interpersonal power##3##3##(2008-9#3)
of interpersonal##12##2##(2007-1#1)(2007-11#1)(2008-11#1)(2008-9#4)(2009-9#1)(2012-12#1)(2012-3#3)
of interphase##3##2##(1990-3#1)(1997-3#1)(2008-4#1)
of interpolation##2##2##(2007-10#1)(2008-8#1)
of interpretation of##3##3##(1994-12#1)(2008-11#1)(2010-2#1)
of interpretation##7##2##(1991-12#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-2#1)
of interpreting the##3##3##(2008-10#1)(2009-12#1)(2009-6#1)
of interpreting##8##2##(1992-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-6#1)
of interprofessional collaboration##2##3##(2008-12#1)(2013-1#1)
of interprofessional##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
of interrelation##2##2##(2008-3#1)(2011-1#1)
of interrogation##2##2##(2011-2#2)
of interruption of##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
of intersex##3##2##(2008-10#3)
of intersexual##2##2##(2008-8#1)(2008-9#1)
of interspecies##3##2##(1991-9#1)(1993-8#1)(2013-1#1)
of interspecific competition##5##3##(2007-7#1)(2008-8#3)(2012-2#1)
of interspecific hybridization was##2##4##(2008-9#2)
of interspecific hybridization##5##3##(2008-10#1)(2008-9#4)
of interspecific##15##2##(2007-7#1)(2008-10#2)(2008-6#1)(2008-8#3)(2008-9#7)(2012-2#1)
of interstitial lung disease in##2##5##(2008-8#1)(2011-2#1)
of interstitial lung disease##3##4##(2008-8#1)(2011-2#1)(2012-12#1)
of interstitial lung##4##3##(1991-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
of interstitial##11##2##(1991-12#1)(1991-8#1)(1992-1#1)(1996-12#2)(2007-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)
of interstrand##2##2##(1992-3#1)(1992-6#1)
of intertrochanteric nonunion##2##3##(2009-3#2)
of intertrochanteric##3##2##(2007-8#1)(2009-3#2)
of interval##3##2##(1995-1#1)(1996-11#1)(1997-7#1)
of intervening##2##2##(1990-3#1)(1994-2#1)
of intervention and##5##3##(1991-6#1)(2007-12#1)(2007-6#1)(2008-7#1)(2011-2#1)
of intervention for##2##3##(2009-5#1)(2009-9#1)
of intervention in##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
of intervention##41##2##(1991-12#1)(1991-6#1)(1992-5#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-2#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#4)
of interventional radiology##2##3##(2012-2#2)
of interventional##8##2##(1991-3#1)(1994-3#1)(1995-11#1)(1997-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
of interventions are##2##3##(2008-11#1)(2011-2#1)
of interventions for##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
of interventions to reduce##2##4##(2008-10#1)(2012-1#1)
of interventions to##6##3##(2008-10#1)(2010-8#1)(2011-2#3)(2012-1#1)
of interventions##28##2##(1990-6#1)(1993-3#1)(1994-9#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
of intervertebral disc##2##3##(2007-11#2)
of intervertebral discs##2##3##(2007-11#1)(2007-8#1)
of intervertebral##4##2##(2007-11#3)(2007-8#1)
of interview data##2##3##(2013-1#2)
of interview##3##2##(2011-8#1)(2013-1#2)
of interviews with##3##3##(1994-2#1)(1996-3#1)(2012-3#1)
of interviews##5##2##(1991-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(2012-3#1)
of intestinal and##3##3##(1990-2#1)(1994-11#1)(2013-8#1)
of intestinal bacteria##3##3##(2008-11#2)(2008-8#1)
of intestinal calcium##2##3##(1992-12#1)(1996-5#1)
of intestinal inflammation##2##3##(2008-10#2)
of intestinal obstruction##7##3##(1990-5#1)(2008-12#3)(2009-8#1)(2013-1#2)
of intestinal occlusion##3##3##(1990-3#1)(1990-5#1)(1990-6#1)
of intestinal parasites##4##3##(1996-12#1)(1997-3#1)(2009-10#1)(2012-3#1)
of intestinal parasitic##2##3##(2007-12#1)(2012-3#1)
of intestinal parasitosis among##2##4##(2012-3#2)
of intestinal protozoa##3##3##(2009-10#3)
of intestinal##75##2##(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-6#2)(1992-12#2)(1992-5#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-12#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#5)(2008-4#1)(2008-8#2)(2009-1#1)(2009-10#4)(2009-2#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
of intestine##3##2##(1993-2#1)(2008-5#1)(2012-3#1)
of intestines##2##2##(1993-9#1)(2013-1#1)
of intimal##4##2##(1995-12#1)(1996-2#1)(1997-8#1)(2006-6#1)
of intimate partner violence (IPV)##2##5##(2008-12#1)(2009-5#1)
of intimate partner violence##6##4##(2008-12#2)(2009-5#2)(2012-12#2)
of intolerance##2##2##(1990-3#1)(2010-12#1)
of intonation##4##2##(2010-10#3)(2013-8#1)
of intoxication##3##2##(1996-5#1)(2008-10#1)(2010-1#1)
of intra##3##2##(2007-11#1)(2007-8#1)(2012-2#1)
of intra- and intermolecular hydrogen bonding##2##6##(2008-10#2)
of intra- and intermolecular##3##4##(2007-11#1)(2008-10#2)
of intra- and##6##3##(1992-3#1)(2007-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
of intra-abdominal##3##2##(1996-8#1)(2011-2#1)(2013-8#1)
of intra-arterial calcium##2##3##(1997-5#1)(2007-5#1)
of intra-arterial##5##2##(1997-3#1)(1997-5#1)(2007-10#1)(2007-5#1)(2007-9#1)
of intra-articular##3##2##(2012-2#1)(2013-1#2)
of intra-operative##5##2##(2007-8#2)(2008-9#1)(2010-8#1)(2013-1#1)
of intraaortic balloon##2##3##(2008-3#1)(2010-8#1)
of intraaortic##3##2##(2008-3#1)(2008-8#1)(2010-8#1)
of intracavity##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
of intracellular Ca(2+) concentration in##2##5##(2008-11#1)(2008-4#1)
of intracellular Ca(2+)##5##3##(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#2)
of intracellular Ca2+##12##3##(1990-12#1)(1990-2#1)(1991-6#2)(1992-12#1)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#1)(1996-2#1)(2008-9#1)
of intracellular MIF in##4##4##(2009-6#4)
of intracellular MIF##5##3##(2009-6#5)
of intracellular ROS##2##3##(2008-11#2)
of intracellular amino##2##3##(1990-12#2)
of intracellular cAMP##2##3##(1990-12#1)(2008-11#1)
of intracellular calcium and##2##4##(1993-5#1)(1994-2#1)
of intracellular calcium##11##3##(1990-8#2)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-4#1)(2008-8#2)(2008-9#1)
of intracellular flux analysis##2##4##(2008-7#2)
of intracellular flux##4##3##(2008-7#4)
of intracellular free##3##3##(1993-11#1)(1994-6#1)(2008-9#1)
of intracellular ions##2##3##(1991-11#1)(2008-4#1)
of intracellular lactate dehydrogenase (LDH)##2##5##(2008-11#2)
of intracellular organelles##3##3##(2008-1#1)(2008-7#1)(2008-9#1)
of intracellular pH##4##3##(1990-2#1)(1992-12#1)(2008-9#1)(2010-8#1)
of intracellular proteins##2##3##(2008-11#1)(2008-8#1)
of intracellular reactive oxygen species (ROS)##2##6##(2008-9#1)(2009-8#1)
of intracellular signaling pathways##3##4##(2008-11#1)(2008-7#1)(2009-12#1)
of intracellular signaling##7##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#1)
of intracellular##133##2##(1990-12#4)(1990-2#4)(1990-5#2)(1990-8#4)(1991-11#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#5)(1994-8#3)(1995-11#1)(1995-2#2)(1995-8#3)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-7#1)(2008-1#2)(2008-10#4)(2008-11#16)(2008-4#5)(2008-5#3)(2008-7#12)(2008-8#5)(2008-9#10)(2009-12#1)(2009-6#6)(2009-8#3)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#1)
of intracellularly##2##2##(1993-12#1)(1994-2#1)
of intracerebral hemorrhage##4##3##(2007-10#2)(2007-9#1)(2012-3#1)
of intracerebral##9##2##(1993-12#1)(2007-10#2)(2007-9#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
of intracerebroventricular##2##2##(1992-3#1)(1997-4#1)
of intrachromosomal##3##2##(1990-5#1)(1996-2#1)(2012-3#1)
of intracochlear trauma##2##3##(2012-2#2)
of intracoronary##3##2##(1994-11#1)(2007-8#1)(2012-1#1)
of intracranial aneurysm##3##3##(1995-5#1)(2007-10#1)(2011-2#1)
of intracranial aneurysms##5##3##(1997-3#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#1)
of intracranial atherosclerosis##2##3##(2008-12#1)(2008-8#1)
of intracranial haemorrhage##3##3##(1992-6#1)(2008-7#1)(2011-2#1)
of intracranial##33##2##(1991-12#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-8#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-6#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#1)(2009-7#1)(2009-9#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of intractable nausea and vomiting##3##5##(2013-8#3)
of intractable##7##2##(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#3)
of intracystic##2##2##(1992-2#1)(1994-7#1)
of intradural spinal##2##3##(2011-2#1)(2012-3#1)
of intradural##4##2##(2009-5#1)(2011-2#1)(2012-3#2)
of intraguild predation and stage structure##2##6##(2008-8#2)
of intrahepatic##2##2##(1990-3#1)(2010-12#1)
of intralacustrine##2##2##(1996-6#1)(2010-8#1)
of intralesional##2##2##(2007-7#2)
of intraluminal##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
of intramedullary##5##2##(2007-11#3)(2012-2#1)(2012-3#1)
of intramembranous##2##2##(1992-6#1)(2011-2#1)
of intramolecular##6##2##(1992-11#1)(1993-11#1)(1994-11#1)(1996-12#1)(1996-2#1)(2008-10#1)
of intramuscular fat##2##3##(2010-4#2)
of intramuscular injection of##2##4##(1990-6#1)(2013-7#1)
of intramuscular##8##2##(1990-6#1)(2008-8#1)(2010-2#1)(2010-4#3)(2010-5#1)(2013-7#1)
of intranasal##2##2##(2007-10#1)(2009-11#1)
of intranuclear##3##2##(2007-12#1)(2010-3#2)
of intraocular##5##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
of intraoperative##16##2##(1990-3#1)(1990-6#1)(1992-2#1)(1992-6#1)(1994-3#2)(2007-8#4)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of intraoral##4##2##(1993-1#1)(2007-12#1)(2007-8#1)(2012-3#1)
of intraperitoneal administration of##2##4##(1995-12#1)(2012-1#1)
of intraperitoneal##6##2##(1995-12#2)(2008-1#1)(2008-10#1)(2010-11#1)(2012-1#1)
of intraspecific variation##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
of intraspecific##8##2##(1995-11#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-2#1)(2012-2#1)
of intratesticular##2##2##(2008-4#1)(2011-5#1)
of intrathoracic##5##2##(1993-5#1)(2007-11#1)(2007-8#2)(2012-2#1)
of intrauterine contraceptive device##2##4##(2007-7#1)(2013-1#1)
of intrauterine devices##2##3##(1993-12#2)
of intrauterine##10##2##(1991-2#1)(1992-4#1)(1993-12#2)(1996-5#2)(2007-7#1)(2010-8#1)(2013-1#2)
of intravascular catheters##2##3##(1991-8#1)(1994-5#1)
of intravascular##9##2##(1991-8#1)(1993-2#1)(1994-5#1)(1996-6#1)(2007-8#1)(2008-11#1)(2008-6#1)(2012-3#2)
of intravenous (IV)##2##3##(2012-12#1)(2012-2#1)
of intravenous digital subtraction angiography##2##5##(1993-8#2)
of intravenous drug use##2##4##(1996-11#1)(2007-12#1)
of intravenous iron saccharate##2##4##(2007-7#2)
of intravenous tissue plasminogen activator##2##5##(2007-9#1)(2008-8#1)
of intravenous##38##2##(1991-12#1)(1991-9#1)(1993-1#1)(1993-6#1)(1993-8#2)(1995-8#1)(1996-11#2)(1997-2#2)(1997-7#1)(2007-10#3)(2007-12#2)(2007-7#2)(2007-9#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
of intravenously##3##2##(1991-9#1)(1993-11#1)(2010-8#1)
of intraventricular hemorrhage and post hemorrhagic hydrocephalus##2##7##(2011-2#2)
of intraventricular##4##2##(2007-10#1)(2008-7#1)(2011-2#2)
of intravesical chemotherapy##2##3##(2008-1#1)(2011-2#1)
of intravesical##4##2##(1991-11#1)(2007-9#1)(2008-1#1)(2011-2#1)
of intravitreal Ranibizumab##2##3##(2013-1#2)
of intravitreal##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
of intrinsic linear birefringence##2##4##(2008-2#2)
of intrinsic lung disease##3##4##(2006-10#3)
of intrinsic skin aging##2##4##(2008-5#2)
of intrinsic skin##3##3##(2008-5#3)
of intrinsic##30##2##(1990-5#1)(1992-12#1)(1992-6#1)(1995-5#2)(1996-6#1)(1997-3#1)(2006-10#3)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
of introduced##8##2##(2007-7#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
of introducing a##2##3##(2008-11#1)(2008-3#1)
of introducing laparoscopically assisted vaginal hysterectomy##2##6##(1996-2#2)
of introducing the##2##3##(2008-10#1)(2008-11#1)
of introducing##17##2##(1996-2#2)(1997-4#1)(2008-10#1)(2008-11#3)(2008-3#4)(2008-7#1)(2008-8#2)(2010-4#1)(2013-1#1)(2013-8#1)
of introduction of the##2##4##(1991-9#1)(2008-10#1)
of introduction of##3##3##(1991-9#1)(2008-10#1)(2011-2#1)
of introduction##9##2##(1991-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#2)
of introgression##3##2##(2008-8#1)(2009-2#2)
of intron##4##2##(1991-1#1)(1995-8#1)(2008-8#1)(2011-1#1)
of introns in the##2##4##(1992-3#1)(1995-8#1)
of introns##4##2##(1992-3#1)(1995-8#1)(2008-7#1)(2009-10#1)
of introspection##2##2##(1993-2#1)(2012-3#1)
of inulin##3##2##(1992-1#1)(2008-10#1)(2011-1#1)
of inulinase##2##2##(2008-6#1)(2011-1#1)
of invading##2##2##(1990-2#1)(2008-10#1)
of invariant##2##2##(1995-11#1)(2008-4#1)
of invasion of##2##3##(1995-12#1)(2013-8#1)
of invasion##13##2##(1990-9#1)(1994-9#2)(1995-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-8#1)
of invasive BC##2##3##(1992-8#1)(2013-8#1)
of invasive aspergillosis##4##3##(2008-7#2)(2009-3#2)
of invasive bladder cancer##4##4##(1993-9#2)(2013-8#2)
of invasive breast##2##3##(2013-1#2)
of invasive carcinoma##2##3##(1990-6#1)(1994-2#1)
of invasive cervical resorption##2##4##(2013-1#2)
of invasive cervical##3##3##(1992-8#1)(2013-1#2)
of invasive disease in##2##4##(2009-5#1)(2011-1#1)
of invasive disease##3##3##(2008-11#1)(2009-5#1)(2011-1#1)
of invasive ductal##2##3##(1995-4#1)(2012-12#1)
of invasive fungal infections in patients with##2##7##(2008-7#1)(2012-2#1)
of invasive fungal infections##4##4##(2008-7#1)(2011-2#2)(2012-2#1)
of invasive infections##2##3##(1996-12#1)(1997-2#1)
of invasive meningococcal disease##3##4##(2007-12#1)(2008-11#2)
of invasive meningococcal##4##3##(2007-12#1)(2008-11#2)(2010-10#1)
of invasive procedures##4##3##(1996-2#1)(2007-4#1)(2013-1#2)
of invasive##61##2##(1990-6#1)(1992-8#2)(1993-9#2)(1994-2#2)(1995-4#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#2)(2008-7#3)(2009-11#1)(2009-3#2)(2009-5#3)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#3)
of invasiveness##2##2##(1990-6#1)(2008-8#1)
of inverse##5##2##(1996-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)
of inversion##4##2##(1996-2#1)(2008-3#2)(2013-1#1)
of inversions##3##2##(2008-4#1)(2013-1#2)
of invertase##6##2##(2008-10#2)(2008-12#1)(2008-7#3)
of invertebrate##2##2##(2009-4#1)(2009-6#1)
of invertebrates##5##2##(1990-5#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-6#1)
of inverted##3##2##(1997-2#1)(2008-3#1)(2013-1#1)
of inverting the##2##3##(2008-3#2)
of inverting##3##2##(2008-3#2)(2010-11#1)
of investigated##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
of investigating the##3##3##(1991-2#1)(2008-8#1)(2013-8#1)
of investigating their##2##3##(1994-8#1)(2012-3#1)
of investigating##11##2##(1991-2#1)(1994-8#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-2#2)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
of investigation and##2##3##(1992-12#1)(1993-11#1)
of investigation in the##3##4##(1992-1#1)(2009-6#1)(2010-2#1)
of investigation in##5##3##(1991-3#1)(1992-1#1)(2008-3#1)(2009-6#1)(2010-2#1)
of investigation of##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
of investigation##27##2##(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#3)
of investigations##11##2##(1992-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2012-12#1)
of investigators##4##2##(1994-3#1)(2007-7#1)(2008-1#1)(2010-6#1)
of investment##2##2##(1996-1#1)(2008-5#1)
of inveterate##2##2##(2007-11#2)
of involved##7##2##(1993-3#1)(1993-9#1)(2007-8#3)(2008-10#1)(2010-3#1)
of involvement in##4##3##(1990-8#1)(2007-11#1)(2009-7#1)(2013-7#1)
of involvement of the##4##4##(1997-8#2)(2006-10#1)(2013-1#1)
of involvement of##8##3##(1995-2#1)(1995-4#1)(1997-8#2)(2006-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
of involvement was##2##3##(2011-2#1)(2012-2#1)
of involvement##24##2##(1990-12#1)(1990-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1997-3#1)(1997-8#3)(2006-10#1)(2007-11#1)(2008-7#1)(2009-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of involving service users##2##4##(2008-12#2)
of involving##6##2##(1997-7#1)(2008-12#3)(2011-2#2)
of inward current##2##3##(1992-12#1)(2008-8#1)
of inward##3##2##(1992-12#1)(1996-5#1)(2008-8#1)
of iodate and sulphate in##3##5##(2008-10#3)
of iodate and##6##3##(2008-10#6)
of iodate in##3##3##(2008-10#3)
of iodate##13##2##(2008-10#13)
of iodide by##3##3##(2008-10#3)
of iodide in##5##3##(2008-10#5)
of iodide ion##4##3##(2008-10#4)
of iodide on##2##3##(2008-10#2)
of iodide oxidation##2##3##(2008-10#2)
of iodide was##2##3##(2008-10#2)
of iodide##27##2##(1996-2#1)(2008-10#26)
of iodinated##3##2##(2008-10#2)(2012-12#1)
of iodine and bromine with two new macrocycle diamides##2##9##(2008-10#2)
of iodine in##2##3##(2008-10#1)(2012-3#1)
of iodine supplementation##2##3##(2012-3#2)
of iodine using##2##3##(2008-10#2)
of iodine##23##2##(1997-8#1)(2007-11#3)(2008-10#13)(2008-3#1)(2008-4#1)(2012-3#3)(2013-1#1)
of ion associates of##3##4##(2008-10#3)
of ion associates##6##3##(2008-10#6)
of ion association of##2##4##(2008-10#2)
of ion association##5##3##(2008-10#5)
of ion channel##6##3##(1992-6#2)(1995-8#2)(2008-8#1)(2012-3#1)
of ion channels in##2##4##(2008-8#1)(2009-12#1)
of ion channels##10##3##(2008-4#1)(2008-8#7)(2008-9#1)(2009-12#1)
of ion chromatography##2##3##(2008-10#2)
of ion exchange equilibrium constants##3##5##(2008-10#3)
of ion exchange##5##3##(2008-10#5)
of ion mobility spectrometry##3##4##(2008-10#3)
of ion pairing##2##3##(2008-11#1)(2008-5#1)
of ion pairs##4##3##(2008-10#4)
of ion selective electrodes##3##4##(2008-10#2)(2008-6#1)
of ion##61##2##(1992-6#2)(1994-12#1)(1995-8#2)(2007-12#1)(2008-10#36)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#9)(2008-9#1)(2009-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
of ion-exchange chromatography##2##3##(1990-12#1)(2008-10#1)
of ion-exchange##5##2##(1990-12#1)(1991-12#1)(2008-10#2)(2013-1#1)
of ion-exchanger##2##2##(2008-10#2)
of ion-pair flow injection with piezoelectric detection##2##7##(2008-10#2)
of ion-pair##4##2##(2008-10#4)
of ion-selective electrode##2##3##(2008-10#2)
of ion-selective electrodes (ISEs)##3##4##(2008-10#3)
of ion-selective electrodes##6##3##(2008-10#6)
of ion-selective##8##2##(2008-10#8)
of ionene##2##2##(2008-10#2)
of ionic liquid##2##3##(2008-10#1)(2013-1#1)
of ionic liquids##2##3##(2010-7#1)(2012-1#1)
of ionic species##2##3##(2008-10#2)
of ionic strength and##2##4##(2008-10#2)
of ionic strength##6##3##(2008-10#6)
of ionic##21##2##(1990-7#1)(1995-12#1)(1995-5#1)(2007-5#1)(2008-10#12)(2008-5#1)(2010-7#1)(2012-1#1)(2013-1#2)
of ionizing radiation and##3##4##(1990-7#1)(2008-11#1)(2008-7#1)
of ionizing radiation are##2##4##(2008-7#1)(2013-1#1)
of ionizing radiation##14##3##(1990-7#1)(1997-8#1)(2008-11#1)(2008-7#4)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#4)
of ionizing##18##2##(1990-7#1)(1997-8#1)(2008-11#2)(2008-7#5)(2008-8#1)(2009-10#1)(2011-1#2)(2013-1#5)
of ionophore##4##2##(2008-10#4)
of ionotropic##4##2##(1995-11#2)(2008-7#2)
of ions and##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2010-5#1)
of ions in the##3##4##(2008-10#3)
of ions in##4##3##(2008-10#4)
of ions##26##2##(1990-7#1)(2008-10#15)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#2)
of iprodione##4##2##(2008-10#4)
of ipsilateral recurrence##2##3##(1990-12#1)(1991-11#1)
of ipsilateral##4##2##(1990-12#1)(1991-11#1)(1992-8#1)(2008-8#1)
of iran##4##2##(2012-2#2)(2013-1#2)
of iridium oxide##2##3##(2008-10#2)
of iridium##10##2##(2008-10#10)
of iridophores in##3##3##(2008-5#3)
of irinotecan##3##2##(2008-8#3)
of iris##2##2##(2008-10#1)(2008-8#1)
of iron (II)##3##3##(2008-10#2)(2009-9#1)
of iron (III)##6##3##(2008-10#5)(2013-8#1)
of iron and copper##2##4##(2008-10#2)
of iron and manganese##2##4##(2008-10#2)
of iron and nickel##3##4##(2008-10#3)
of iron and ruthenium##2##4##(2008-10#2)
of iron and zinc in the human hair with##2##9##(2008-10#2)
of iron and zinc in##3##5##(2008-10#3)
of iron and zinc##5##4##(2008-10#5)
of iron and##30##3##(1995-3#2)(1996-2#1)(2008-10#23)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of iron as##4##3##(2008-10#4)
of iron by##4##3##(2008-10#4)
of iron containing##2##3##(2008-11#2)
of iron content in##2##4##(2008-10#2)
of iron depletion##2##3##(2009-8#2)
of iron enrichment##2##3##(1996-5#2)
of iron for##2##3##(1996-5#1)(2008-10#1)
of iron from##5##3##(2008-10#4)(2008-5#1)
of iron in milk##2##4##(2008-10#2)
of iron in natural##2##4##(2008-10#2)
of iron in tap and##2##5##(2008-10#2)
of iron in the##9##4##(1993-2#1)(1996-5#2)(2008-10#5)(2013-8#1)
of iron in water samples##3##5##(2008-10#3)
of iron in##33##3##(1993-2#1)(1996-5#2)(2008-10#27)(2012-12#1)(2012-2#1)(2013-8#1)
of iron is##2##3##(1992-8#1)(2008-10#1)
of iron metabolism##4##3##(1992-5#1)(1993-11#1)(2008-10#1)(2013-8#1)
of iron mobilization from##2##4##(1992-6#2)
of iron on##2##3##(2008-10#2)
of iron or##2##3##(1997-5#1)(2008-10#1)
of iron oxide##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
of iron reduction##2##3##(1992-6#1)(2009-8#1)
of iron to##2##3##(2008-10#2)
of iron uptake##2##3##(1995-11#2)
of iron was##2##3##(2008-10#2)
of iron##175##2##(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#2)(1993-2#2)(1993-8#1)(1995-11#2)(1995-3#3)(1995-6#1)(1996-2#3)(1996-5#6)(1997-5#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#107)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#6)
of iron(II) and##4##3##(2008-10#3)(2008-5#1)
of iron(II) tris-(1##3##3##(2008-10#3)
of iron(II)##11##2##(2008-10#10)(2008-5#1)
of iron(III) and copper(II) and of iron(III) and palladium(II)##3##9##(2008-10#3)
of iron(III) and iron(II) in##2##5##(2008-10#2)
of iron(III) and iron(II)##3##4##(2008-10#3)
of iron(III) and titanium(IV)##3##4##(2008-10#3)
of iron(III) and total iron by sequential injection analysis##2##9##(2008-10#2)
of iron(III) and total iron##3##5##(2008-10#3)
of iron(III) and vanadium(V) using 8-quinolinol derivatives##2##7##(2008-10#2)
of iron(III) and##17##3##(2008-10#17)
of iron(III)##36##2##(2008-10#36)
of iron)##2##2##(2008-10#2)
of iron-anthracycline complexes with##2##4##(1993-6#2)
of iron-deficiency anaemia##3##3##(1994-6#1)(2009-10#2)
of iron-deficiency##4##2##(1994-6#1)(1996-10#1)(2009-10#2)
of iron-sulfur##2##2##(1993-11#1)(2008-11#1)
of irradiance##4##2##(2008-3#4)
of irradiated##11##2##(1993-9#1)(1995-2#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
of irradiation##12##2##(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#2)(2011-2#1)
of irrational beliefs##3##3##(2010-5#3)
of irrationality##3##2##(2010-5#3)
of irregular##6##2##(2008-10#2)(2010-10#1)(2011-1#2)(2013-1#1)
of irrelevant##4##2##(1995-5#2)(2009-8#1)(2013-8#1)
of irresponsible##2##2##(1996-2#1)(1997-6#1)
of irreversible##6##2##(1990-7#1)(1996-7#1)(2008-3#1)(2008-6#1)(2010-12#1)(2012-2#1)
of irrigation water##3##3##(2008-10#2)(2008-12#1)
of irrigation##7##2##(2008-10#5)(2008-12#2)
of irritable bowel syndrome##4##4##(1997-6#2)(2010-6#1)(2013-1#1)
of irritable bowel##5##3##(1997-6#2)(2010-6#1)(2013-1#2)
of irritation##4##2##(2008-10#1)(2008-5#3)
of is##2##2##(1992-1#1)(2011-2#1)
of isatin##2##2##(2008-11#1)(2011-1#1)
of ischaemia##2##2##(2008-7#1)(2013-8#1)
of ischaemia-reperfusion##2##2##(2007-9#1)(2012-2#1)
of ischaemic postconditioning##2##3##(2013-7#2)
of ischaemic stroke##4##3##(2008-8#4)
of ischaemic##11##2##(1990-8#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-8#4)(2012-2#1)(2013-7#2)
of ischemia##13##2##(1991-9#1)(1994-2#1)(1994-3#1)(1995-12#3)(1996-9#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)
of ischemia)##2##2##(2008-3#1)(2009-12#1)
of ischemic brain##2##3##(1994-2#1)(2007-10#1)
of ischemic colitis##3##3##(1990-6#1)(2013-1#2)
of ischemic heart disease (IHD)##3##5##(2008-3#2)(2012-3#1)
of ischemic heart disease and##3##5##(1997-8#1)(2008-10#1)(2008-8#1)
of ischemic heart disease##20##4##(1994-3#1)(1997-8#2)(2007-10#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-12#2)(2010-6#2)(2010-8#2)(2011-2#2)(2012-3#2)
of ischemic heart disease]##2##4##(1995-11#1)(2012-3#1)
of ischemic heart##23##3##(1994-3#1)(1995-11#1)(1997-8#2)(2007-10#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-12#2)(2010-6#2)(2010-8#2)(2011-2#2)(2012-3#3)(2013-1#1)
of ischemic postconditioning##2##3##(2013-1#1)(2013-7#1)
of ischemic preconditioning##4##3##(1996-9#2)(2010-12#1)(2013-7#1)
of ischemic stroke in young adults##2##6##(2011-1#1)(2012-3#1)
of ischemic stroke in##5##4##(2011-1#4)(2012-3#1)
of ischemic stroke patients##2##4##(2007-10#1)(2008-3#1)
of ischemic stroke##24##3##(2007-10#8)(2008-12#2)(2008-3#1)(2010-4#1)(2011-1#9)(2011-2#1)(2012-3#1)(2013-1#1)
of ischemic##75##2##(1990-6#1)(1991-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-9#3)(1997-2#1)(1997-8#2)(2007-10#12)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-7#1)(2008-8#3)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#9)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#2)
of island##3##2##(1996-6#1)(2008-8#1)(2011-2#1)
of islet amyloid##2##3##(1992-6#1)(1994-8#1)
of islet cell##2##3##(1997-5#1)(2008-1#1)
of islet##8##2##(1990-12#1)(1992-6#1)(1994-8#1)(1997-5#1)(2007-5#1)(2008-1#1)(2010-11#2)
of islets from##2##3##(2010-11#2)
of islets isolated from##3##4##(2010-11#3)
of islets##14##2##(1995-11#1)(1995-8#1)(2008-4#1)(2010-11#11)
of isochromatics##2##2##(2008-2#1)(2008-3#1)
of isoclinics##2##2##(2008-3#2)
of isoflavone##2##2##(2008-10#2)
of isoflavones##3##2##(2010-3#2)(2011-2#1)
of isoforms and##2##3##(1993-3#1)(2008-7#1)
of isoforms of##2##3##(1994-8#1)(1995-11#1)
of isoforms##7##2##(1993-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-7#1)
of isofraxidin and fumaric acid in##2##6##(2008-10#2)
of isolate EN-4##2##3##(2008-10#2)
of isolate##13##2##(2008-10#11)(2008-9#1)(2011-2#1)
of isolated cells##2##3##(2008-11#2)
of isolated coronary##2##3##(2007-8#1)(2012-3#1)
of isolated guinea pig##2##4##(1995-3#1)(1997-7#1)
of isolated outer##2##3##(1990-5#1)(2009-9#1)
of isolated pancreatic##2##3##(2010-1#1)(2013-1#1)
of isolated rat liver##2##4##(1994-6#1)(2013-1#1)
of isolated rat##3##3##(1994-6#1)(2010-12#1)(2013-1#1)
of isolated##60##2##(1990-12#2)(1990-2#1)(1990-5#3)(1991-12#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
of isolates and a##2##4##(2008-10#1)(2008-5#1)
of isolates as##2##3##(2008-10#2)
of isolates at##2##3##(2008-10#1)(2011-1#1)
of isolates belonging to group I##2##6##(2008-10#2)
of isolates belonging to##4##4##(2008-10#4)
of isolates from each##3##4##(2008-10#3)
of isolates from the##2##4##(2008-10#2)
of isolates from##16##3##(2008-10#15)(2008-12#1)
of isolates in the##3##4##(2008-10#3)
of isolates in##9##3##(1990-6#1)(1991-8#2)(2008-10#6)
of isolates of the pathogen##2##5##(2008-10#2)
of isolates of the##6##4##(2008-10#5)(2013-8#1)
of isolates of this##2##4##(2008-10#1)(2008-9#1)
of isolates of##18##3##(1997-3#2)(2008-10#12)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
of isolates sampled from##2##4##(2008-10#2)
of isolates that##2##3##(2008-10#2)
of isolates to artichoke and cotton##2##6##(2008-10#2)
of isolates to##4##3##(2008-10#3)(2011-1#1)
of isolates were HSV-1##2##4##(2007-12#2)
of isolates were identified##2##4##(2008-10#2)
of isolates were##9##3##(2007-12#2)(2008-10#6)(2008-5#1)
of isolates within##2##3##(2008-10#2)
of isolates##113##2##(1990-6#1)(1991-8#2)(1997-3#2)(2007-12#2)(2008-10#91)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of isolating##4##2##(1994-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
of isolation and purification##2##4##(2008-10#2)
of isolation and##3##3##(2008-10#3)
of isolation by distance##2##4##(2009-2#1)(2011-2#1)
of isolation of##8##3##(2008-1#1)(2008-10#3)(2008-12#1)(2009-12#1)(2010-4#1)(2012-2#1)
of isolation were##2##3##(2007-7#1)(2008-9#1)
of isolation##22##2##(1993-12#1)(1994-8#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
of isomeric##9##2##(1991-9#1)(1992-12#2)(1996-2#1)(1996-5#1)(2008-10#4)
of isomers##2##2##(1994-5#1)(2008-11#1)
of isometric quadriceps muscle strengthening exercise##2##6##(2011-2#2)
of isometric##4##2##(2007-8#1)(2008-10#1)(2011-2#2)
of isoniazid in##2##3##(1997-7#1)(2008-10#1)
of isoniazid tablets##2##3##(2008-10#2)
of isoniazid##12##2##(1991-11#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-7#1)
of isoprenoid compounds such as##2##5##(1994-11#2)
of isoprenoid compounds##3##3##(1994-11#3)
of isoprenoid##5##2##(1994-11#3)(2008-5#1)(2012-2#1)
of isoproterenol##4##2##(2008-10#3)(2011-2#1)
of isoproturon##5##2##(2008-10#5)
of isosorbide dinitrate##2##3##(1996-9#1)(2008-10#1)
of isothermal##2##2##(1997-2#1)(2008-3#1)
of isotonic##2##2##(1992-6#1)(1995-3#1)
of isotope##5##2##(1991-3#1)(1992-3#1)(2008-10#1)(2008-4#1)(2012-1#1)
of isotopic##3##2##(2008-10#3)
of isotopically enriched##2##3##(2008-4#1)(2012-3#1)
of isotopically##4##2##(1993-11#1)(2008-11#1)(2008-4#1)(2012-3#1)
of isotopomer models is##2##4##(2008-7#2)
of isotopomer##3##2##(2008-7#3)
of isotropic and##2##3##(2008-2#1)(2008-3#1)
of isotropic scattering##2##3##(2007-12#1)(2008-2#1)
of isotropic##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
of isozyme I##2##3##(1991-2#2)
of isozyme##3##2##(1991-2#3)
of isozymes I and II##2##5##(1991-2#2)
of isozymes##5##2##(1991-2#2)(1994-12#1)(2008-10#2)
of issues and##3##3##(1995-3#1)(2008-1#1)(2010-4#1)
of issues related to##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
of issues that##4##3##(1991-3#1)(2008-11#1)(2008-12#1)(2008-4#1)
of issues##22##2##(1991-3#1)(1992-11#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2010-4#1)(2010-6#1)(2013-1#2)
of it##25##2##(1990-11#1)(1991-5#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-3#2)(1996-6#1)(2007-12#3)(2008-10#6)(2008-11#2)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)
of it's##2##2##(2007-11#1)(2008-12#1)
of itch##2##2##(2008-5#1)(2010-8#1)
of itching##5##2##(1996-11#4)(2007-7#1)
of item##7##2##(2008-12#1)(2008-4#1)(2012-2#5)
of item-writing##2##2##(2008-12#2)
of items with##2##3##(2010-11#1)(2010-2#1)
of items##13##2##(1990-3#1)(1993-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
of iterative##4##2##(2008-3#3)(2008-5#1)
of itraconazole##2##2##(2008-1#1)(2008-5#1)
of its 1-(2-pyridylazo)-2-naphthol##2##3##(2008-10#2)
of its DNA##2##3##(2008-11#1)(2011-2#1)
of its ability to##9##4##(1992-9#1)(1993-6#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
of its active site##2##4##(1992-3#1)(1992-6#1)
of its active##3##3##(1992-3#1)(1992-6#1)(2008-5#1)
of its activity##5##3##(1991-5#1)(1995-6#1)(2008-5#1)(2010-2#1)(2010-6#1)
of its anatomical##2##3##(1994-5#1)(2008-10#1)
of its applicability##2##3##(2008-2#1)(2012-3#1)
of its application##2##3##(2008-2#1)(2010-5#1)
of its associated##2##3##(2011-2#1)(2012-12#1)
of its behavior##2##3##(2008-8#1)(2009-5#1)
of its binding##3##3##(1990-2#1)(1993-8#1)(1995-2#1)
of its biological##3##3##(1990-2#1)(2008-5#1)(2008-7#1)
of its cell##2##3##(1990-8#1)(2008-11#1)
of its clinical##9##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-8#1)
of its complementary##2##3##(1991-5#1)(2008-8#1)
of its complicated##2##3##(2011-2#1)(2012-2#1)
of its component##2##3##(1997-1#1)(2008-3#1)
of its components##5##3##(1990-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-12#1)
of its concentration##4##3##(2008-10#4)
of its constituent##2##3##(1990-7#1)(1992-11#1)
of its critical surface tension##2##5##(2008-5#2)
of its critical##3##3##(2008-10#1)(2008-5#2)
of its derivative##2##3##(2008-10#2)
of its derivatives##3##3##(2007-11#1)(2008-10#2)
of its development##3##3##(1992-1#1)(2006-6#1)(2008-12#1)
of its diffraction pattern##2##4##(2008-3#2)
of its distribution and##2##4##(2008-10#2)
of its effect on##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
of its effectiveness in##2##4##(1993-1#1)(2008-11#1)
of its effects on##2##4##(2008-12#1)(2012-12#1)
of its effects##3##3##(1995-12#1)(2008-12#1)(2012-12#1)
of its efficacy and##2##4##(2008-4#1)(2008-8#1)
of its electrochemical##2##3##(2008-10#2)
of its ethyl xanthate complex onto naphthalene##2##7##(2008-10#2)
of its expression##5##3##(1990-11#1)(1991-11#1)(1996-5#1)(2008-8#2)
of its fast##2##3##(2008-3#1)(2008-7#1)
of its first##2##3##(1990-11#1)(2007-7#1)
of its formation##2##3##(2008-10#1)(2011-2#1)
of its function##5##3##(1992-9#1)(1993-6#1)(1995-2#1)(1996-5#1)(2009-8#1)
of its gene##3##3##(1991-7#1)(1994-8#1)(2007-6#1)
of its genome##4##3##(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
of its geographic##2##3##(2007-1#1)(2008-10#1)
of its high##12##3##(1991-2#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#2)
of its host plant##2##4##(2009-8#2)
of its host##5##3##(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#1)
of its hydrolysis##2##3##(2008-10#2)
of its implementation##3##3##(1992-12#1)(2011-1#1)(2013-1#1)
of its initial value##2##4##(1993-6#1)(2008-4#1)
of its initial##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
of its interaction with##4##4##(1994-8#1)(1995-2#1)(2010-4#1)(2012-8#1)
of its interaction##5##3##(1994-8#1)(1995-2#1)(2008-8#1)(2010-4#1)(2012-8#1)
of its involvement in the##2##5##(2008-5#1)(2010-12#1)
of its involvement##3##3##(1996-2#1)(2008-5#1)(2010-12#1)
of its isolated##3##3##(1993-8#1)(2011-2#2)
of its kind in the##2##5##(2007-8#1)(2012-2#1)
of its kind in##4##4##(1996-3#1)(2007-8#1)(2008-8#1)(2012-2#1)
of its kind##9##3##(1996-3#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)
of its length##3##3##(1990-5#1)(2007-12#1)(2013-1#1)
of its life##2##3##(2009-7#1)(2009-8#1)
of its long arm##2##4##(1997-4#1)(2008-12#1)
of its mRNA##4##3##(1991-5#1)(1994-11#1)(1995-2#1)(2008-9#1)
of its major##3##3##(2008-11#1)(2011-3#1)(2012-2#1)
of its manufacture##2##3##(2008-10#1)(2008-3#1)
of its many##2##3##(1992-3#1)(2008-5#1)
of its mechanism##2##3##(2008-11#1)(2013-8#1)
of its members##4##3##(1992-2#1)(1996-1#1)(1996-3#1)(2011-2#1)
of its more##2##3##(1991-6#1)(1992-2#1)
of its native##2##3##(1995-2#1)(2011-2#1)
of its negative##3##3##(1994-9#1)(2007-12#1)(2013-7#1)
of its occurrence##2##3##(2011-2#2)
of its original##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
of its own##6##3##(1991-5#2)(1994-12#1)(1995-2#1)(2008-10#1)(2011-1#1)
of its oxidation##3##3##(2008-10#2)(2011-1#1)
of its parameters##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
of its parents are##2##4##(2008-10#1)(2008-12#1)
of its pattern##2##3##(2008-1#1)(2010-12#1)
of its possible##3##3##(1991-3#1)(1994-6#1)(2006-10#1)
of its potential to##2##4##(2008-10#1)(2012-2#1)
of its potential##10##3##(1996-2#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
of its prevalence##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
of its problems##2##3##(1993-11#1)(1994-9#1)
of its product##2##3##(1990-11#1)(2011-2#1)
of its properties##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)
of its protein##2##3##(1992-6#1)(1995-8#1)
of its rarity##4##3##(2008-12#1)(2010-11#1)(2010-7#1)(2012-3#1)
of its reaction with##2##4##(1996-5#1)(2008-10#1)
of its receptors##2##3##(2008-8#2)
of its resistance##2##3##(1997-4#1)(2008-10#1)
of its role in##5##4##(1991-12#1)(1994-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
of its role##6##3##(1991-12#1)(1994-10#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
of its side chain##2##4##(1993-11#1)(2007-12#1)
of its side effects##2##4##(2008-7#1)(2013-1#1)
of its side##4##3##(1993-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
of its significant##2##3##(2010-7#1)(2011-2#1)
of its specific##5##3##(1991-2#1)(1996-3#1)(2008-10#2)(2013-7#1)
of its speed and##2##4##(1990-5#1)(2008-4#1)
of its structural##3##3##(1993-8#1)(2008-7#1)(2009-12#1)
of its structure##5##3##(1990-7#1)(1994-3#1)(1997-7#2)(2012-2#1)
of its sulfhydryl##2##3##(1992-8#1)(2008-9#1)
of its surface##3##3##(1995-2#1)(2007-12#1)(2011-1#1)
of its synthesis##2##3##(1992-12#1)(1995-3#1)
of its target##2##3##(1994-3#1)(2012-12#1)
of its technical##2##3##(1990-9#1)(2009-5#1)
of its total##2##3##(2008-10#2)
of its use as a##2##5##(2008-11#1)(2008-2#1)
of its use in##3##4##(2008-1#1)(2008-8#1)(2013-8#1)
of its use##12##3##(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
of its vector##3##3##(2008-10#2)(2008-8#1)
of its volatile##2##3##(2007-12#1)(2008-10#1)
of its weight##2##3##(1993-3#1)(2008-9#1)
of its##769##2##(1990-11#7)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#11)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#7)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#6)(1992-5#1)(1992-6#6)(1992-8#3)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#4)(1993-3#2)(1993-6#4)(1993-8#5)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#5)(1994-3#5)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#5)(1995-2#13)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#2)(1996-1#3)(1996-12#4)(1996-2#5)(1996-3#5)(1996-5#5)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#8)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-6#3)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#115)(2008-11#28)(2008-12#15)(2008-2#14)(2008-3#31)(2008-4#12)(2008-5#29)(2008-6#6)(2008-7#16)(2008-8#24)(2008-9#18)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#6)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#8)(2011-2#39)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#18)(2012-3#12)(2012-8#1)(2013-1#22)(2013-7#4)(2013-8#14)
of itself##5##2##(1995-2#2)(2008-1#1)(2008-3#1)(2011-2#1)
of ixodid##2##2##(2011-1#2)
of jasmonic acid##2##3##(2008-10#1)(2009-8#1)
of jaundice##4##2##(1990-8#1)(1991-5#1)(1995-3#1)(2007-7#1)
of jejunal##6##2##(1990-5#1)(1990-9#1)(1991-12#2)(1994-6#1)(2013-1#1)
of jelly##2##2##(1992-8#1)(2008-8#1)
of jet lag##2##3##(1997-6#2)
of jet##3##2##(1997-6#2)(2008-11#1)
of job and##2##3##(1997-2#1)(2012-2#1)
of job burnout##2##3##(2008-9#1)(2010-12#1)
of job functions##2##3##(1993-12#2)
of job insecurity##2##3##(2009-10#2)
of job satisfaction##4##3##(1993-2#1)(1994-5#1)(2008-11#1)(2008-7#1)
of job strain##3##3##(2008-10#3)
of job##22##2##(1991-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-9#1)(2010-12#1)(2012-2#1)
of job-related##2##2##(2008-12#1)(2010-10#1)
of job-sharing at administrative levels##2##5##(1992-12#2)
of jobs##3##2##(2009-9#3)
of jogging on mental well-being and seasonal mood##2##8##(1991-8#2)
of jogging##4##2##(1991-8#4)
of joint application of##2##4##(2008-5#2)
of joint attention##2##3##(2008-11#1)(2010-10#1)
of joint pain##2##3##(1997-3#1)(2006-10#1)
of joint ventures##4##3##(1993-1#1)(2008-11#3)
of joint##32##2##(1990-6#1)(1992-2#1)(1992-8#1)(1993-1#2)(1995-2#2)(1996-6#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
of joints and##2##3##(1992-5#1)(2007-11#1)
of joints##6##2##(1992-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-3#1)(2011-2#1)
of journal##2##2##(2007-10#1)(2008-12#1)
of judgment and##3##3##(1993-2#1)(2008-6#2)
of judgment##4##2##(1993-2#1)(2008-11#1)(2008-6#2)
of jump##2##2##(1995-2#1)(2009-1#1)
of jun##3##2##(1991-12#2)(1991-2#1)
of junD was##2##3##(1996-12#2)
of junD##3##2##(1996-12#3)
of junior doctors##2##3##(1990-3#1)(2010-12#1)
of junior##4##2##(1990-3#1)(2009-5#1)(2010-12#2)
of just one##5##3##(1993-11#1)(1995-2#1)(2008-7#1)(2010-7#1)(2010-8#1)
of just##12##2##(1992-6#1)(1993-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
of justice##4##2##(1996-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
of juvenile hormone##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
of juvenile lemon sharks Negaprion brevirostris##2##6##(2010-8#2)
of juvenile rainbow trout##2##4##(2010-8#2)
of juvenile walleye pollock Theragra chalcogramma##2##6##(2010-8#2)
of juvenile##31##2##(1992-6#2)(1994-8#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-8#7)(2011-2#1)(2013-1#3)(2013-7#1)
of juveniles##5##2##(2008-10#3)(2008-9#2)
of k##4##2##(1995-2#2)(2008-3#1)(2009-9#1)
of kDNA##2##2##(2010-2#2)
of kainate##2##2##(1994-2#1)(1995-11#1)
of kala-azar##2##2##(1996-8#1)(2008-7#1)
of kanamycin resistance##3##3##(2008-10#3)
of kanamycin##4##2##(2008-10#3)(2008-7#1)
of kappa##4##2##(1992-8#1)(1993-12#2)(2008-3#1)
of kappa-carrageenan##2##2##(2008-6#1)(2008-7#1)
of karyotype##2##2##(2008-11#1)(2008-12#1)
of kcat##2##2##(1990-7#2)
of keloid##2##2##(2007-7#2)
of kenkey##6##2##(1997-4#6)
of keratin##10##2##(1991-12#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
of keratinized##2##2##(1990-3#2)
of keratinocyte differentiation##4##3##(1994-3#1)(2008-11#1)(2008-5#2)
of keratinocyte##7##2##(1992-2#1)(1994-3#2)(2008-11#1)(2008-5#2)(2013-8#1)
of keratinocytes##7##2##(2008-4#2)(2008-5#4)(2012-8#1)
of keratosis##2##2##(2011-2#2)
of kernel density clustering for##2##5##(2008-7#2)
of kernel##7##2##(2008-10#4)(2008-3#1)(2008-7#2)
of kernels infected##2##3##(2008-10#2)
of kernels##6##2##(2008-10#4)(2008-3#2)
of kerosene##3##2##(2008-10#1)(2008-11#2)
of ketamine in##3##3##(2011-2#2)(2012-2#1)
of ketamine##9##2##(2009-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
of ketoconazole##4##2##(2007-7#1)(2008-11#2)(2011-2#1)
of ketone##2##2##(2008-5#2)
of ketones##3##2##(2007-11#1)(2008-12#1)(2010-7#1)
of ketoprofen##3##2##(2008-10#2)(2012-3#1)
of ketorolac was##2##3##(2008-10#2)
of ketorolac##5##2##(2008-10#5)
of key articles were searched##5##5##(2012-12#5)
of key articles##8##3##(2012-12#8)
of key components##2##3##(1996-2#1)(2008-5#1)
of key elements##2##3##(2008-10#1)(2012-3#1)
of key enzymes##2##3##(2008-10#1)(2008-11#1)
of key importance##3##3##(1994-8#2)(2008-3#1)
of key molecules##2##3##(2008-1#1)(2008-5#1)
of key phospholipid synthesis##2##4##(2011-2#2)
of key regulatory##3##3##(2008-2#1)(2008-4#1)(2009-3#1)
of key stakeholders##2##3##(1991-1#1)(1991-3#1)
of key structural##2##3##(2009-12#1)(2012-2#1)
of key##82##2##(1991-1#1)(1991-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-12#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#10)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
of kidney biopsy##2##3##(1996-6#1)(2008-1#1)
of kidney damage##2##3##(1990-2#1)(1992-3#1)
of kidney disease##5##3##(2007-7#1)(2008-1#2)(2008-7#1)(2013-1#1)
of kidney in##3##3##(1997-8#1)(2008-12#2)
of kidney stones##2##3##(2008-12#1)(2013-8#1)
of kidney transplant##3##3##(1994-5#1)(2008-5#1)(2013-1#1)
of kidney##41##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-5#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-1#5)(2008-10#1)(2008-12#5)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#2)
of kidneys##6##2##(1997-8#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-3#1)
of killing##3##2##(1993-12#1)(1995-2#1)(2008-11#1)
of kilometers##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
of kin selection##2##3##(2008-8#1)(2010-4#1)
of kin##3##2##(1993-6#1)(2008-8#1)(2010-4#1)
of kinase##5##2##(1992-12#1)(1992-9#1)(1993-8#1)(2008-5#1)(2012-12#1)
of kindergarten##3##2##(1997-3#1)(2008-11#1)(2012-12#1)
of kindling##2##2##(1994-2#1)(1997-2#1)
of kinematic focusing was##2##4##(2008-10#2)
of kinematic focusing##3##3##(2008-10#3)
of kinematic##5##2##(1993-3#1)(1996-4#1)(2008-10#3)
of kinetic and##2##3##(1990-8#1)(2008-8#1)
of kinetic parameters##3##3##(1992-8#1)(1995-12#1)(2008-7#1)
of kinetic##12##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-8#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
of kinetically-hindered##2##2##(2008-10#2)
of knee OA##2##3##(1992-3#2)
of knee and ankle##2##4##(2009-4#1)(2012-2#1)
of knee evaluation##2##3##(2013-1#2)
of knee prostheses##2##3##(2007-8#2)
of knee surgery##2##3##(2007-8#2)
of knee##16##2##(1992-3#2)(1995-3#1)(2007-11#1)(2007-8#4)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
of knees##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
of knowing##5##2##(1993-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-12#1)
of knowledge about the##6##4##(1996-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)
of knowledge about##12##3##(1992-6#1)(1994-2#1)(1996-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
of knowledge and skills##2##4##(2009-6#1)(2011-2#1)
of knowledge and##18##3##(1990-6#1)(1991-9#1)(1995-2#2)(1995-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
of knowledge from the##2##4##(1994-6#1)(2008-11#1)
of knowledge in the##3##4##(2011-2#1)(2013-1#2)
of knowledge in##6##3##(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#2)
of knowledge is##2##3##(1991-9#1)(2009-8#1)
of knowledge of the##2##4##(2008-10#1)(2008-8#1)
of knowledge of##8##3##(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-3#1)
of knowledge on the##4##4##(1990-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
of knowledge on##8##3##(1990-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
of knowledge regarding the##3##4##(2007-11#1)(2008-12#1)(2012-3#1)
of knowledge regarding##5##3##(2007-11#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of knowledge that##2##3##(2012-1#1)(2013-8#1)
of knowledge with different##2##4##(2011-1#2)
of knowledge##109##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#13)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
of known amounts of##2##4##(2008-10#2)
of known and##2##3##(2011-2#1)(2012-3#1)
of known bacterial##2##3##(2008-7#2)
of known composition##2##3##(2008-10#1)(2008-3#1)
of known concentration##2##3##(2008-10#2)
of known genes##3##3##(1994-12#1)(1995-5#1)(2010-3#1)
of known or##3##3##(1994-9#1)(2008-1#1)(2008-10#1)
of known structure##2##3##(1992-12#1)(2008-4#1)
of known three-dimensional##2##3##(1992-1#1)(2008-7#1)
of known##84##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#4)(2008-1#2)(2008-10#18)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)
of kojic acid##2##3##(2008-5#2)
of kolkata##2##2##(2009-10#2)
of komaroviquinone##2##2##(2009-5#2)
of kringle 1 + 2 + 3##3##7##(1990-5#3)
of kringle 1##4##3##(1990-5#4)
of kringle##5##2##(1990-5#4)(2008-8#1)
of kynurenic acid##2##3##(1992-3#2)
of kyphotic##2##2##(2007-11#1)(2012-2#1)
of l-2-HGA##3##2##(2008-10#3)
of l-2-hydroxyglutaric acid##2##3##(2008-10#2)
of l-2-hydroxyglutaric##3##2##(2008-10#3)
of l-ascorbic acid in##3##4##(2008-10#3)
of l-ascorbic acid##14##3##(2008-10#14)
of l-carnitine##4##2##(2008-10#4)
of l-carnosine##2##2##(2011-1#2)
of l-cysteine and glutathione##3##4##(2008-10#3)
of l-cysteine and##7##3##(2008-10#7)
of l-cysteine##18##2##(2008-10#18)
of l-cystine##2##2##(2008-10#2)
of l-dT##2##2##(2008-4#2)
of l-glutamate##5##2##(2008-10#5)
of l-histidine##3##2##(2008-10#3)
of l-malic acid with alkaline metals##2##6##(2008-10#2)
of l-phenylalanine##3##2##(2008-10#3)
of l-tyrosine##4##2##(2008-10#4)
of lab##3##2##(1994-8#1)(2008-1#1)(2010-8#1)
of label##6##2##(1990-12#1)(1992-12#1)(1992-9#1)(2008-7#2)(2008-8#1)
of labeled polypeptides##2##3##(1994-11#2)
of labeled##25##2##(1990-12#1)(1992-8#1)(1994-11#2)(1994-8#2)(1995-12#1)(1997-1#7)(1997-3#1)(2008-10#2)(2008-4#4)(2009-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
of labeling was##3##3##(1994-5#1)(1994-8#1)(1997-2#1)
of labeling##8##2##(1990-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-7#1)(2009-9#1)(2013-1#1)
of labelled cells##2##3##(1992-10#1)(1994-12#1)
of labelled##9##2##(1990-12#3)(1991-9#1)(1992-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(2008-7#1)
of labelling in the##2##4##(1992-10#1)(1993-9#1)
of labelling##4##2##(1990-8#1)(1992-10#2)(1993-9#1)
of labels##3##2##(1992-3#1)(1994-3#1)(2008-10#1)
of labia##2##2##(2007-10#1)(2008-10#1)
of labile Cu(2+) in fresh waters##2##6##(2008-10#2)
of labile##8##2##(2007-12#1)(2008-10#5)(2008-4#1)(2013-7#1)
of labor in the##2##4##(2008-12#1)(2008-9#1)
of labor in##5##3##(2008-12#1)(2008-8#3)(2008-9#1)
of labor##22##2##(1991-6#3)(1994-2#2)(1994-9#1)(1995-1#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-8#6)(2008-9#1)(2011-2#1)(2013-1#3)
of laboratories##8##2##(1993-6#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)
of laboratory animals and to##3##5##(2008-10#1)(2008-4#2)
of laboratory animals##5##3##(2008-10#2)(2008-4#3)
of laboratory automation and other resources##2##6##(2008-10#2)
of laboratory automation and##3##4##(2008-10#3)
of laboratory diagnosis##2##3##(2008-7#1)(2012-3#1)
of laboratory experiments##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
of laboratory investigations##2##3##(2008-11#1)(2008-7#1)
of laboratory medicine##4##3##(1994-12#4)
of laboratory or##2##3##(1994-12#1)(2011-2#1)
of laboratory services##2##3##(1993-2#1)(1994-3#1)
of laboratory strains##2##3##(2012-3#2)
of laboratory studies##2##3##(2008-9#1)(2010-8#1)
of laboratory testing##3##3##(1994-12#1)(2008-10#1)(2013-1#1)
of laboratory tests##5##3##(1991-2#1)(1994-12#1)(1996-9#1)(1997-3#1)(2008-7#1)
of laboratory##65##2##(1990-9#1)(1991-2#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#8)(1994-3#1)(1994-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(2007-7#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#3)
of labour in##3##3##(2007-7#1)(2008-10#1)(2009-7#1)
of labour##10##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of lacZ expression##2##3##(1995-6#1)(1997-8#1)
of lacZ##9##2##(1990-5#1)(1993-12#2)(1995-6#1)(1997-4#3)(1997-8#1)(2009-12#1)
of laccase and 0##2##4##(2008-5#2)
of laccase##4##2##(2008-10#2)(2008-5#2)
of lack of##4##3##(1995-11#1)(1997-6#1)(2009-12#1)(2011-2#1)
of lacking##4##2##(2008-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
of lactate accumulation##2##3##(2008-10#1)(2008-11#1)
of lactate and##3##3##(1994-9#1)(2008-11#1)(2012-3#1)
of lactate dehydrogenase (LDH) into the##2##6##(1995-11#1)(1995-3#1)
of lactate dehydrogenase (LDH)##4##4##(1994-11#1)(1995-11#1)(1995-3#1)(2013-1#1)
of lactate dehydrogenase##11##3##(1990-5#1)(1992-11#1)(1993-12#1)(1994-11#1)(1995-11#3)(1995-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
of lactate in whole##2##4##(2008-10#2)
of lactate production from##2##4##(1990-11#1)(1991-5#1)
of lactate production##4##3##(1990-11#1)(1991-5#3)
of lactate##29##2##(1990-11#1)(1990-5#1)(1991-5#3)(1992-11#1)(1993-12#1)(1994-11#2)(1994-9#2)(1995-11#3)(1995-3#1)(2008-10#5)(2008-11#4)(2008-7#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
of lactating goats##2##3##(1992-3#1)(2010-2#1)
of lactating##4##2##(1992-3#1)(1994-6#1)(2008-8#1)(2010-2#1)
of lactation in pinnipeds##2##4##(2008-9#2)
of lactation in##3##3##(1992-5#1)(2008-9#2)
of lactation##10##2##(1992-5#2)(1996-8#1)(1997-6#1)(2007-2#1)(2008-9#3)(2010-2#1)(2012-2#1)
of lactic acid bacteria##6##4##(2008-11#5)(2012-2#1)
of lactic acid by##2##4##(2008-6#2)
of lactic acid from cheese whey##2##6##(2008-6#2)
of lactic acid produced##2##4##(2008-6#2)
of lactic acid to##3##4##(2008-6#1)(2012-2#2)
of lactic acid##28##3##(2008-10#5)(2008-11#5)(2008-6#13)(2008-7#1)(2012-2#3)(2013-1#1)
of lactic and##2##3##(2008-5#2)
of lactic dehydrogenase##2##3##(1990-5#2)
of lactic##33##2##(1990-5#2)(2008-10#5)(2008-11#5)(2008-5#2)(2008-6#14)(2008-7#1)(2012-2#3)(2013-1#1)
of lactobacilli##2##2##(1994-6#1)(2012-2#1)
of lactobacillus##2##2##(2008-12#1)(2012-2#1)
of lactose and##2##3##(2008-10#1)(2008-11#1)
of lactose##3##2##(2008-10#2)(2008-11#1)
of lacunar infarct in patients without hypertension##2##7##(2007-10#2)
of lacunar infarcts##3##3##(2007-10#3)
of lacunar##5##2##(2007-10#5)
of lacustrine##3##2##(2008-5#3)
of lag##5##2##(2008-11#1)(2011-2#4)
of lake##2##2##(2012-3#1)(2013-8#1)
of lamb##2##2##(1997-4#1)(2010-4#1)
of lambda =##2##3##(2007-12#1)(2008-3#1)
of lambda DNA##2##3##(1994-11#2)
of lambda phage##2##3##(1994-12#1)(1995-8#1)
of lambda plasmid##3##3##(1994-11#3)
of lambda##13##2##(1992-2#1)(1992-6#1)(1994-11#5)(1994-12#1)(1995-8#1)(1996-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
of lambda-DNA##3##2##(2008-8#3)
of lambda-cyhalothrin in tea and soil were##2##7##(2011-1#2)
of lambda-cyhalothrin residue##2##3##(2011-1#2)
of lambda-cyhalothrin##4##2##(2011-1#4)
of lambdaN gene expression##2##4##(2008-8#1)(2008-9#1)
of lambdaN gene##10##3##(2008-8#8)(2008-9#2)
of lambdaN##11##2##(2008-8#9)(2008-9#2)
of lambs##4##2##(1994-7#1)(1996-12#1)(2008-10#1)(2008-12#1)
of lamellae in the##2##4##(2008-7#2)
of lamellae##5##2##(2008-7#5)
of lamellar##2##2##(1990-5#1)(1995-8#1)
of lamellulae between##3##3##(2010-10#3)
of lameness and##2##3##(1994-9#1)(1997-3#1)
of lameness##3##2##(1994-9#1)(1997-3#2)
of lamin A##2##3##(1990-11#2)
of lamin##3##2##(1990-11#2)(2011-2#1)
of lamina propria##2##3##(2008-11#1)(2011-2#1)
of lamina##3##2##(1997-3#1)(2008-11#1)(2011-2#1)
of laminar##3##2##(1991-11#1)(1993-12#1)(2010-9#1)
of laminin 332##3##3##(2013-8#3)
of laminin##7##2##(1991-2#1)(1992-5#1)(1995-5#1)(1997-4#1)(2013-8#3)
of laminin-5##2##2##(2008-11#1)(2008-5#1)
of laminitis##2##2##(1997-5#2)
of lamins A and C##4##5##(1992-12#4)
of lamivudine##3##2##(2007-12#1)(2009-8#2)
of land and##3##3##(2008-3#3)
of land plants and##2##4##(2010-6#1)(2012-2#1)
of land plants##5##3##(2009-6#2)(2010-6#1)(2012-2#1)(2013-1#1)
of land##13##2##(2008-10#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-6#2)(2010-6#1)(2012-2#1)(2013-1#1)
of landmarks##4##2##(1993-2#1)(2010-8#1)(2012-12#2)
of landscape structure##2##3##(2008-8#1)(2013-1#1)
of landscape##4##2##(2008-3#1)(2008-8#1)(2013-1#2)
of language and##5##3##(2008-1#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
of language##24##2##(1994-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-5#1)(2011-1#3)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#2)
of lanosterol 14##2##3##(1991-5#1)(1992-3#1)
of lanosterol##3##2##(1991-5#1)(1992-3#2)
of lansoprazole in daily practice##2##5##(2008-11#2)
of lansoprazole##4##2##(2008-11#4)
of lanthanide ions##2##3##(2008-10#1)(2012-12#1)
of lanthanide##7##2##(2008-10#5)(2012-12#2)
of lanthanides in##2##3##(2008-10#2)
of lanthanides##13##2##(2008-10#13)
of lanthanoids(III)##3##2##(2008-10#3)
of lanthanum##7##2##(1992-11#1)(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#1)
of laparoscopic and##2##3##(2010-12#1)(2011-1#1)
of laparoscopic cholecystectomy##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
of laparoscopic hysterectomy##2##3##(2010-3#1)(2013-1#1)
of laparoscopic surgery##4##3##(1993-12#1)(2013-1#3)
of laparoscopic techniques##2##3##(2008-10#1)(2011-2#1)
of laparoscopic##30##2##(1990-6#1)(1991-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#2)(2008-10#3)(2008-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#5)
of laparoscopically assisted vaginal hysterectomy and##2##6##(1994-2#1)(2011-2#1)
of laparoscopically assisted vaginal hysterectomy##4##5##(1993-12#1)(1994-2#2)(2011-2#1)
of laparoscopy for##3##3##(2010-8#2)(2011-2#1)
of laparoscopy##12##2##(1993-3#2)(1996-1#1)(1996-3#2)(2010-8#2)(2011-2#5)
of laparotomy##2##2##(1990-2#1)(1996-1#1)
of large DNA##2##3##(2008-11#1)(2008-2#1)
of large RNAs##2##3##(2008-4#2)
of large amount of##3##4##(2008-10#3)
of large amounts of##13##4##(1992-12#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)
of large and giant##2##4##(2011-2#1)(2013-7#1)
of large and small##4##4##(1995-12#1)(1997-8#1)(2008-7#1)(2010-11#1)
of large and##9##3##(1995-12#1)(1995-6#1)(1997-8#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#1)(2013-7#1)
of large areas##2##3##(2008-10#1)(2008-3#1)
of large arteries##2##3##(2008-7#1)(2010-4#1)
of large blood vessels##2##4##(2011-2#2)
of large bowel cancer##3##4##(1991-6#3)
of large bowel##5##3##(1991-6#4)(2012-3#1)
of large cell##2##3##(2008-11#1)(2009-8#1)
of large ensembles of##2##4##(2009-8#2)
of large events##2##3##(1996-4#2)
of large excess of##2##4##(2008-10#2)
of large insert##2##3##(2008-4#2)
of large molecules##2##3##(2008-5#1)(2010-12#1)
of large numbers of samples##2##5##(2008-10#1)(2008-9#1)
of large numbers of##13##4##(1996-12#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
of large optical##2##3##(2007-11#1)(2008-3#1)
of large particles##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of large populations##2##3##(1994-3#1)(1996-12#1)
of large proteins##3##3##(1994-8#1)(2008-1#1)(2008-4#1)
of large quantities of protein##2##5##(2008-11#2)
of large quantities of##8##4##(1991-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-11#3)(2008-7#1)
of large sample##3##3##(1995-9#1)(2008-10#1)(2012-2#1)
of large scale##3##3##(2008-11#1)(2008-6#1)(2011-2#1)
of large sets of##2##4##(2008-11#1)(2008-7#1)
of large size##2##3##(2007-8#1)(2008-4#1)
of large vessels##2##3##(1997-8#1)(2010-9#1)
of large volumes of##2##4##(2008-10#1)(2009-7#1)
of large volumes##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
of large##215##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#2)(1996-4#4)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#2)(2007-11#3)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#11)(2008-12#1)(2008-2#6)(2008-3#18)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#15)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
of large-bowel##2##2##(1993-9#2)
of large-mode holey and conventional fibers##2##6##(2007-12#2)
of large-scale##17##2##(1990-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#2)(2008-7#2)(2012-2#2)(2013-1#4)
of larger particles##2##3##(1995-3#1)(2008-2#1)
of larger size##2##3##(2008-10#1)(2012-3#1)
of larger##19##2##(1994-12#1)(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
of larvae##20##2##(2008-12#2)(2008-6#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#5)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of larval Japanese##3##3##(2008-6#1)(2010-8#2)
of larval and##2##3##(2010-8#1)(2012-12#1)
of larval development##2##3##(2008-6#1)(2008-7#1)
of larval inhibition##2##3##(1996-12#2)
of larval##27##2##(1996-12#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2010-11#1)(2010-8#6)(2011-2#1)(2012-12#1)(2012-3#1)
of laryngeal carcinoma##3##3##(1997-8#2)(2011-2#1)
of laryngeal lesion##2##3##(1990-6#1)(2012-3#1)
of laryngeal##21##2##(1990-6#2)(1990-8#1)(1991-12#1)(1992-9#1)(1995-9#1)(1997-8#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
of laryngectomy##2##2##(2012-2#2)
of laryngomalacia##2##2##(2013-8#2)
of larynx was##2##3##(2010-7#2)
of larynx##5##2##(2010-7#4)(2013-1#1)
of laser ablation##3##3##(2008-10#3)
of laser activation##2##3##(2012-3#2)
of laser beam##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of laser beams in##2##4##(2008-3#2)
of laser beams##9##3##(2007-11#2)(2008-2#4)(2008-3#3)
of laser diodes##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of laser energy##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
of laser irradiation at##2##4##(2008-10#1)(2008-2#1)
of laser irradiation##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
of laser light##8##3##(1994-3#1)(2007-8#2)(2008-2#1)(2008-3#4)
of laser parameters and staining on##2##6##(2011-1#2)
of laser parameters##3##3##(2008-3#1)(2011-1#2)
of laser power##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of laser pulses##6##3##(2007-11#2)(2008-10#1)(2008-2#3)
of laser radiation##4##3##(2008-2#3)(2013-1#1)
of laser system##2##3##(2008-3#1)(2010-1#1)
of laser therapy##2##3##(2007-8#1)(2008-10#1)
of laser##108##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-3#1)(2007-11#9)(2007-12#6)(2007-8#6)(2008-10#12)(2008-12#1)(2008-2#26)(2008-3#32)(2010-1#1)(2010-8#1)(2011-1#3)(2012-3#2)(2013-1#1)(2013-8#1)
of laser-assisted##2##2##(2008-10#1)(2012-3#1)
of laser-excited##2##2##(1994-2#1)(2008-2#1)
of laser-heated##2##2##(2008-2#1)(2008-3#1)
of laser-induced breakdown in##3##4##(2008-2#1)(2008-3#2)
of laser-induced breakdown##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of laser-induced fluorescence##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of laser-induced potentials##3##3##(2012-1#3)
of laser-induced##21##2##(1991-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#7)(2011-2#1)(2012-1#3)
of laser-optical##2##2##(2008-2#2)
of lasers by##2##3##(2008-3#2)
of lasers in dentistry##2##4##(1993-3#2)
of lasers in##3##3##(1993-3#2)(2008-3#1)
of lasers##12##2##(1993-12#1)(1993-3#3)(2008-1#1)(2008-3#6)(2008-9#1)
of lasing##4##2##(2007-12#2)(2008-3#2)
of last decade##2##3##(2008-10#1)(2011-2#1)
of last##7##2##(1992-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
of last-names##2##2##(2012-12#2)
of late blight##8##3##(2008-10#7)(2008-8#1)
of late complications##2##3##(2011-2#2)
of late effects##2##3##(2010-11#2)
of late gene##2##3##(1997-3#2)
of late presentation for HIV care in Northern Greece during the##2##11##(2013-1#2)
of late##45##2##(1992-10#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-11#3)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
of late-arising##3##2##(2008-9#3)
of late-life proactivity##2##3##(2007-12#2)
of latency##2##2##(1997-3#1)(2008-8#1)
of latent infection and##2##4##(2008-10#2)
of latent infection were##2##4##(2008-10#2)
of latent infection##15##3##(2008-10#15)
of latent infections##2##3##(2008-10#2)
of latent period##2##3##(2008-10#2)
of latent##35##2##(1991-3#1)(1992-5#1)(1993-9#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#23)(2008-5#1)(2008-8#1)(2012-2#2)(2012-3#1)
of latent-period##2##2##(2008-10#2)
of later##8##2##(1991-12#1)(1995-1#1)(2007-8#1)(2008-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
of later-stage##3##2##(2011-2#3)
of lateral and##4##3##(2007-12#1)(2008-9#1)(2009-11#1)(2010-8#1)
of lateral curvature##2##3##(2007-11#1)(2008-11#1)
of lateral margin compromise##2##4##(2013-8#2)
of lateral##37##2##(1991-2#1)(1993-3#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of laterality##5##2##(1994-8#3)(2007-12#2)
of lateralization and##2##3##(1992-11#2)
of lateralization##4##2##(1992-11#2)(1994-8#2)
of latex particles##5##3##(1990-12#2)(2008-10#2)(2010-6#1)
of latex spheres##2##3##(2007-11#1)(2008-3#1)
of latex##12##2##(1990-12#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-6#1)
of lathosterol##3##2##(1992-6#3)
of launching##7##2##(2008-2#1)(2010-12#6)
of lauric acid##2##3##(1994-3#1)(1995-3#1)
of law##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
of lawsuits##2##2##(1992-2#1)(2008-11#1)
of laxatives##2##2##(1991-8#2)
of layer##6##2##(1997-2#1)(1997-3#1)(2008-3#2)(2012-2#1)(2013-1#1)
of layered niobate##2##3##(2008-10#2)
of layered##4##2##(2008-10#3)(2009-7#1)
of layers in##3##3##(2007-11#1)(2008-3#2)
of layers of##6##3##(2007-12#1)(2008-12#4)(2008-3#1)
of layers##20##2##(1990-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#9)
of leaching##3##2##(2008-10#2)(2008-11#1)
of lead (II) and mercury (II)##2##6##(2008-10#2)
of lead (Pb) on##2##4##(1995-3#1)(2008-10#1)
of lead (Pb)##4##3##(1995-3#1)(2008-10#3)
of lead and cadmium in##2##5##(2008-10#2)
of lead and cadmium##3##4##(2008-10#3)
of lead and copper##4##4##(2008-10#4)
of lead and mercury in##2##5##(2008-10#2)
of lead and tin##3##4##(2008-10#3)
of lead and##17##3##(2008-1#1)(2008-10#16)
of lead as##2##3##(1992-3#1)(2008-10#1)
of lead at##3##3##(1995-3#2)(2008-1#1)
of lead by##7##3##(1992-3#1)(2008-10#5)(2013-8#1)
of lead concentration##2##3##(2008-10#2)
of lead exposure##3##3##(1995-11#1)(1997-4#2)
of lead from##4##3##(1992-3#1)(2008-10#1)(2011-2#2)
of lead in blood##2##4##(2008-10#2)
of lead in dialysis concentrates##2##5##(2008-10#2)
of lead in human saliva##3##5##(2008-10#3)
of lead in man and the environment in##2##8##(1992-3#2)
of lead in saliva##2##4##(2008-10#2)
of lead in the presence of##2##6##(2008-10#2)
of lead in the##5##4##(1997-4#1)(2008-10#4)
of lead in water samples##3##5##(2008-10#3)
of lead in water##4##4##(2008-10#4)
of lead in wine samples##2##5##(2008-10#2)
of lead in##56##3##(1992-12#1)(1992-3#2)(1997-4#1)(2008-10#52)
of lead ions##2##3##(2008-10#2)
of lead is##2##3##(2008-10#2)
of lead nitrate##2##3##(1995-6#1)(2008-11#1)
of lead onto the##2##4##(2008-10#2)
of lead oxide##2##3##(2007-12#1)(2008-10#1)
of lead salts##2##3##(2008-10#2)
of lead using##3##3##(2008-10#3)
of lead was##4##3##(1992-3#1)(2008-10#2)(2011-2#1)
of lead were##5##3##(2008-10#4)(2011-1#1)
of lead with##6##3##(2008-10#6)
of lead##179##2##(1992-12#1)(1992-3#6)(1993-9#1)(1995-11#3)(1995-3#7)(1995-6#1)(1997-4#9)(2007-12#1)(2008-1#2)(2008-10#136)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#1)
of lead(II) from##3##3##(2008-10#3)
of lead(II) in##3##3##(2008-10#3)
of lead(II) were##2##3##(2008-10#2)
of lead(II) with##4##3##(2008-10#4)
of lead(II)##25##2##(2008-10#25)
of lead-acid batteries##2##3##(2008-10#2)
of leader##3##2##(1991-9#1)(1993-1#1)(2008-8#1)
of leaders##5##2##(1993-3#1)(1995-12#1)(1995-2#2)(1996-3#1)
of leaders'##2##2##(2009-5#2)
of leadership and##2##3##(1995-1#1)(1997-3#1)
of leadership in##4##3##(1993-12#1)(1996-3#3)
of leadership is##2##3##(1991-2#1)(2008-1#1)
of leadership##19##2##(1991-2#1)(1991-3#1)(1992-2#3)(1992-5#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-3#4)(1997-3#1)(2008-1#2)(2008-6#1)(2010-3#1)
of leading##5##2##(1994-3#1)(2008-1#1)(2008-3#1)(2010-3#1)(2011-1#1)
of leaf and flower blight##2##5##(2008-10#2)
of leaf area##4##3##(2008-10#4)
of leaf blast##3##3##(2008-10#3)
of leaf blight##4##3##(2008-10#4)
of leaf blotch##2##3##(2008-10#2)
of leaf colonization##3##3##(2008-10#3)
of leaf hairs##2##3##(2008-10#2)
of leaf infection##2##3##(2008-10#2)
of leaf nitrogen##2##3##(2008-10#1)(2012-5#1)
of leaf rust resistance gene##2##5##(2008-10#2)
of leaf rust resistance genes##3##5##(2008-10#3)
of leaf rust resistance##7##4##(2008-10#7)
of leaf rust##9##3##(2008-10#9)
of leaf samples##2##3##(2008-10#1)(2008-12#1)
of leaf scald disease##2##4##(2008-10#2)
of leaf spot##6##3##(2008-10#6)
of leaf spots##2##3##(2008-10#2)
of leaf tissue##2##3##(2008-10#2)
of leaf wetness and temperature##2##5##(2008-10#2)
of leaf wetness and##3##4##(2008-10#3)
of leaf wetness was##3##4##(2008-10#3)
of leaf wetness##12##3##(2008-10#12)
of leaf##88##2##(2008-10#75)(2008-11#1)(2008-12#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-10#1)(2012-5#2)
of leaflets with##2##3##(2008-10#2)
of leaflets##7##2##(2008-10#7)
of leakage current##3##3##(2012-3#3)
of leakage##5##2##(2007-11#2)(2012-3#3)
of lean##6##2##(1995-3#1)(2008-3#1)(2012-2#3)(2013-8#1)
of learned##4##2##(1996-7#1)(2008-4#1)(2008-8#2)
of learner-centered development##2##3##(1992-12#2)
of learners in the##2##4##(2008-11#1)(2012-1#1)
of learners##5##2##(2008-11#3)(2012-1#1)(2013-1#1)
of learning activities##2##3##(2008-12#1)(2010-8#1)
of learning and memory in##2##5##(2008-9#1)(2009-8#1)
of learning and memory##12##4##(1996-5#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)
of learning and##16##3##(1996-5#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-1#1)
of learning contracts##3##3##(2008-11#3)
of learning disability##2##3##(2008-11#2)
of learning in##5##3##(1994-3#1)(2007-7#1)(2008-11#2)(2013-1#1)
of learning new##2##3##(1994-2#1)(2008-9#1)
of learning resources##3##3##(2008-11#3)
of learning to##2##3##(2012-3#1)(2013-1#1)
of learning##72##2##(1991-2#1)(1992-11#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#24)(2008-12#5)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-8#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
of least squares##2##3##(2008-10#1)(2008-2#1)
of least##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
of leather##2##2##(2008-10#2)
of leaves and fruits##3##4##(2008-12#3)
of leaves and roots##4##4##(2008-10#3)(2009-10#1)
of leaves and##10##3##(2008-10#5)(2008-12#4)(2009-10#1)
of leaves from##2##3##(2008-10#2)
of leaves of##6##3##(2008-10#3)(2011-1#1)(2011-3#1)(2012-2#1)
of leaves were##2##3##(2008-12#1)(2012-2#1)
of leaves with##3##3##(2008-10#3)
of leaves##45##2##(2008-10#32)(2008-12#6)(2008-5#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-9#1)
of leaving##3##2##(1993-8#1)(2008-3#1)(2009-12#1)
of lectin##2##2##(1991-9#1)(2008-10#1)
of lecturer##2##2##(2008-11#2)
of lectures##5##2##(1993-11#1)(1994-12#1)(1994-9#1)(2010-11#1)(2012-2#1)
of leek rust##2##3##(2008-10#2)
of leek##5##2##(2008-10#5)
of left and right##3##4##(2007-8#1)(2010-12#2)
of left anterior descending##2##4##(2008-11#1)(2013-1#1)
of left anterior fascicle block##2##5##(2008-7#2)
of left anterior##4##3##(2008-11#1)(2008-7#2)(2013-1#1)
of left cardiac##2##3##(1993-3#1)(2008-9#1)
of left coronary artery##2##4##(2007-8#1)(2013-8#1)
of left coronary##3##3##(1994-11#1)(2007-8#1)(2013-8#1)
of left heart##2##3##(2007-8#1)(2011-2#1)
of left main coronary##2##4##(2008-3#1)(2013-8#1)
of left renal##2##3##(2008-11#1)(2010-11#1)
of left ventricle in##3##4##(2007-7#1)(2007-8#1)(2013-1#1)
of left ventricle##8##3##(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#3)(2011-1#1)(2013-1#1)
of left ventricular (LV)##2##4##(2011-2#1)(2012-12#1)
of left ventricular dysfunction##2##4##(2008-3#1)(2009-1#1)
of left ventricular function##2##4##(2007-9#1)(2012-2#1)
of left ventricular hypertrophy##2##4##(2009-1#1)(2011-2#1)
of left ventricular outflow tract##2##5##(2011-1#1)(2012-2#1)
of left ventricular systolic function##2##5##(2008-11#1)(2009-4#1)
of left ventricular systolic##3##4##(2008-11#1)(2009-4#1)(2010-11#1)
of left ventricular##26##3##(1997-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2009-1#3)(2009-4#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)
of left##77##2##(1993-3#1)(1994-11#1)(1997-3#2)(1997-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#11)(2008-8#2)(2008-9#4)(2009-1#3)(2009-4#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
of leg and back pain disorders##2##6##(2008-12#2)
of leg motoneurons in##2##4##(2007-12#2)
of leg##12##2##(1993-12#1)(1995-2#1)(2007-12#4)(2007-8#1)(2008-12#2)(2008-6#1)(2009-1#1)(2013-8#1)
of legal##8##2##(1991-2#1)(1994-6#1)(1996-11#2)(1996-4#1)(1997-1#1)(2008-7#1)(2010-2#1)
of legged locomotion that are##2##5##(2007-12#2)
of legged locomotion##3##3##(2007-12#3)
of legged##4##2##(2007-12#4)
of legislation##3##2##(1991-3#1)(1994-1#1)(2008-6#1)
of legs##5##2##(1995-2#2)(2008-12#1)(2008-5#1)(2009-10#1)
of legume##2##2##(2008-10#2)
of leguminous cover crop pollens##2##5##(2008-6#2)
of leiomyoma of the##3##4##(1992-6#1)(2012-2#1)(2013-7#1)
of leiomyosarcoma of the##2##4##(2008-5#2)
of leiomyosarcoma of##3##3##(2008-5#2)(2008-7#1)
of leiomyosarcoma##5##2##(2008-5#2)(2008-6#2)(2008-7#1)
of leishmania##3##2##(2007-7#1)(2009-5#1)(2012-2#1)
of leishmaniasis##6##2##(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)
of lemon##2##2##(2008-10#1)(2013-1#1)
of length of##5##3##(1993-12#1)(2007-10#1)(2008-10#2)(2012-3#1)
of length##10##2##(1993-12#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-9#1)(2012-3#1)
of lens aberrations##2##3##(2007-12#1)(2008-3#1)
of lens##13##2##(2007-12#2)(2008-2#1)(2008-3#6)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
of lenses##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
of lensing##3##2##(2008-2#2)(2008-3#1)
of lentiviral vectors##2##3##(2008-2#1)(2008-4#1)
of leprosy cases##4##3##(1995-9#2)(2009-5#2)
of leprosy in##2##3##(2007-7#1)(2009-7#1)
of leprosy patients##3##3##(2007-7#1)(2009-5#1)(2012-12#1)
of leprosy##22##2##(1990-5#1)(1995-6#1)(1995-9#3)(2007-7#7)(2008-8#1)(2009-5#7)(2009-7#1)(2012-12#1)
of leptin in##2##3##(2008-4#1)(2008-9#1)
of leptin##8##2##(2008-10#1)(2008-4#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
of leptospirosis in##3##3##(1991-8#1)(2007-7#2)
of leptospirosis##5##2##(1991-8#1)(2007-7#2)(2008-9#2)
of lesbian and gay parents##2##5##(2012-2#2)
of lesbian and gay##3##4##(1992-1#1)(2012-2#2)
of lesbian and##4##3##(1992-1#1)(2008-12#1)(2012-2#2)
of lesbian##6##2##(1992-1#1)(2008-12#2)(2009-7#1)(2012-2#2)
of lesion area##2##3##(2008-10#2)
of lesion density##3##3##(2008-10#3)
of lesion expansion##3##3##(2008-10#3)
of lesion of##2##3##(2008-8#1)(2013-1#1)
of lesion##19##2##(1996-9#2)(2007-10#3)(2008-10#9)(2008-6#1)(2008-8#2)(2012-2#1)(2013-1#1)
of lesions and##6##3##(1994-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#1)
of lesions caused by##4##4##(2008-10#3)(2012-3#1)
of lesions in the##3##4##(1992-10#1)(2008-11#1)(2010-8#1)
of lesions that##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
of lesions##59##2##(1991-2#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-6#1)(1994-1#1)(1994-11#2)(1994-3#2)(1994-6#1)(1996-12#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of less extensive##2##3##(2008-6#1)(2008-7#1)
of less importance##2##3##(2007-10#1)(2008-7#1)
of less invasive surgical##2##4##(2008-8#1)(2011-2#1)
of less than 0##14##4##(1995-1#1)(2008-10#6)(2008-2#2)(2008-3#5)
of less than 1 nm##2##5##(2008-3#2)
of less than 1##12##4##(2007-12#1)(2008-10#4)(2008-3#6)(2011-2#1)
of less than 1%##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
of less than 10 ps##2##5##(2007-12#1)(2008-3#1)
of less than 10##7##4##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
of less than 10%##3##4##(1996-12#1)(2008-10#1)(2010-5#1)
of less than 100##4##4##(2008-10#1)(2008-3#2)(2011-2#1)
of less than 2 cm##2##5##(1990-9#1)(1997-4#1)
of less than 2##9##4##(1990-9#1)(1997-4#1)(2008-10#3)(2008-3#3)(2013-1#1)
of less than 2%##5##4##(2008-10#2)(2008-3#2)(2012-1#1)
of less than 20##3##4##(1994-3#1)(2008-2#1)(2008-3#1)
of less than 200##2##4##(2008-10#1)(2008-9#1)
of less than 3##2##4##(2008-10#1)(2008-2#1)
of less than 30##2##4##(1997-2#1)(2008-10#1)
of less than 30%##2##4##(2008-5#2)
of less than 300##3##4##(2007-11#1)(2008-3#2)
of less than 4##2##4##(2008-10#1)(2008-2#1)
of less than 40##2##4##(2008-8#1)(2013-1#1)
of less than 5##2##4##(1995-5#1)(2008-10#1)
of less than 5% for both migration##2##7##(2008-10#2)
of less than 5% for##3##5##(2008-10#3)
of less than 6##3##4##(1992-6#1)(1994-7#1)(2008-10#1)
of less than 7##3##4##(2007-11#1)(2008-4#1)(2008-6#1)
of less than 70##2##4##(2008-1#2)
of less than approximately##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
of less than##129##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-6#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#5)(2008-10#32)(2008-11#3)(2008-2#9)(2008-3#34)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)
of less##150##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#5)(2008-10#34)(2008-11#5)(2008-2#10)(2008-3#36)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
of less-thans##2##2##(2008-10#2)
of lesser mealworm##3##3##(2011-2#3)
of lesser##4##2##(2011-2#3)(2013-1#1)
of let-60 ras##2##3##(1990-11#2)
of let-7##3##2##(2008-7#1)(2012-12#2)
of lethal##5##2##(1995-12#3)(2008-11#1)(2012-3#1)
of lethality##2##2##(1996-12#2)
of lethargy##2##2##(2008-7#2)
of letters##7##2##(1990-8#1)(2007-12#1)(2008-11#1)(2009-2#4)
of lettuce and##2##3##(2008-10#1)(2008-5#1)
of lettuce downy mildew##3##4##(2008-10#3)
of lettuce drop##4##3##(2008-10#4)
of lettuce##16##2##(2008-10#15)(2008-5#1)
of leucine##11##2##(1990-8#1)(1992-5#1)(1992-6#2)(1992-8#1)(1994-11#1)(1995-11#2)(1995-6#1)(2008-11#2)
of leucocytes##2##2##(1994-11#1)(2008-5#1)
of leucovorin and##2##3##(1991-4#1)(2008-10#1)
of leukaemia cases##2##3##(1997-8#2)
of leukaemia##6##2##(1992-5#1)(1993-2#1)(1997-8#2)(2009-3#1)(2013-1#1)
of leukemia cell##3##3##(2008-9#1)(2011-1#1)(2012-3#1)
of leukemia cells##2##3##(2011-2#2)
of leukemia was##2##3##(2008-11#1)(2008-4#1)
of leukemia##20##2##(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-3#1)
of leukemic patients##2##3##(2007-2#1)(2008-9#1)
of leukemic##5##2##(2007-2#1)(2008-11#1)(2008-9#1)(2010-6#2)
of leukoaraiosis##4##2##(2007-10#4)
of leukocyte##5##2##(1990-12#1)(1991-5#1)(1996-2#1)(2008-3#1)(2008-9#1)
of leukocyte-platelet aggregates##2##3##(2008-9#2)
of leukocytes and##2##3##(2008-10#1)(2008-5#1)
of leukocytes to endothelium##2##4##(1992-12#1)(1995-2#1)
of leukocytes to##3##3##(1992-12#1)(1995-2#1)(2008-3#1)
of leukocytes##16##2##(1991-8#2)(1992-12#1)(1993-6#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2010-8#1)
of leukotriene##3##2##(1991-5#1)(2008-1#1)(2008-11#1)
of leukotrienes##2##2##(1994-8#1)(2008-1#1)
of levamisole##2##2##(2008-1#2)
of level observed with cognate beta2m)##2##6##(1997-9#2)
of level of##2##3##(1990-10#1)(2008-10#1)
of level##5##2##(1990-10#1)(1997-9#2)(2008-10#1)(2008-6#1)
of levels of##4##3##(1995-5#1)(2008-10#1)(2008-4#1)(2012-3#1)
of levels##7##2##(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2012-3#1)
of levodopa in the##2##4##(2008-7#2)
of levodopa in##3##3##(2008-7#3)
of levodopa##12##2##(2008-10#2)(2008-7#10)
of levodropropizine in##2##3##(1991-2#2)
of levofloxacin in##4##3##(2008-10#4)
of levofloxacin##8##2##(2008-10#5)(2008-7#1)(2011-1#1)(2011-2#1)
of levonorgestrel##4##2##(2008-10#4)
of lexical##5##2##(1991-2#3)(2008-2#1)(2013-8#1)
of liability##5##2##(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-3#1)
of liberated##3##2##(1990-8#1)(2008-3#1)(2010-3#1)
of libraries##4##2##(1995-2#1)(1996-3#1)(1997-2#1)(1997-4#1)
of library##3##2##(1995-2#1)(1995-3#1)(2012-2#1)
of lichen planus##3##3##(1990-5#1)(1991-2#1)(2009-6#1)
of lichen##5##2##(1990-5#1)(1991-2#1)(2009-6#1)(2011-2#1)(2012-1#1)
of lichens##2##2##(2008-10#1)(2010-6#1)
of licking##3##2##(1990-7#1)(2013-7#2)
of lidar return signals for##2##5##(2008-2#2)
of lidar return signals##3##4##(2008-2#3)
of lidar signals##3##3##(2008-2#1)(2008-3#2)
of lidar systems##2##3##(2008-2#1)(2008-3#1)
of lidar##20##2##(2008-2#11)(2008-3#9)
of lidocaine##12##2##(1990-9#4)(1993-12#2)(2007-10#1)(2008-10#1)(2008-9#4)
of life (QOL)##11##3##(1994-12#1)(1995-4#1)(2008-6#1)(2008-7#3)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)
of life (QoL)##8##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of life after##7##3##(1995-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#2)
of life among patients##2##4##(2009-12#1)(2011-2#1)
of life among##5##3##(2008-7#1)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)
of life and death##4##4##(1993-11#2)(2007-2#1)(2011-9#1)
of life and health##3##4##(1991-12#1)(2009-5#1)(2012-2#1)
of life and the##5##4##(1990-3#1)(1996-9#1)(2008-1#1)(2012-12#1)(2013-8#1)
of life and##57##3##(1990-3#1)(1991-12#1)(1992-1#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-6#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#7)(2011-9#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
of life by##3##3##(2007-11#1)(2007-7#1)(2008-5#1)
of life decisions##4##3##(2012-12#4)
of life due to##2##4##(2007-7#1)(2012-3#1)
of life during##4##3##(1990-2#2)(2008-9#2)
of life for patients##4##4##(2007-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
of life for##22##3##(1994-5#1)(1995-1#2)(1995-12#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
of life has##2##3##(2008-7#1)(2010-11#1)
of life history##5##3##(2008-8#4)(2010-8#1)
of life in elderly##3##4##(1996-7#1)(2007-12#1)(2008-7#1)
of life in long-term##2##4##(1993-3#1)(2007-1#1)
of life in the##9##4##(1993-6#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#2)(2012-2#1)
of life in##58##3##(1990-2#1)(1991-6#2)(1992-11#1)(1993-3#1)(1993-6#1)(1996-7#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#7)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
of life is##7##3##(1995-1#1)(1996-11#1)(2007-7#1)(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
of life of the##9##4##(1993-11#1)(2007-11#3)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
of life of##36##3##(1990-10#1)(1990-12#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-3#1)(1996-2#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-4#4)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
of life quality##3##3##(2007-11#2)(2008-1#1)
of life span##5##3##(1994-5#1)(1994-6#1)(1995-6#1)(2008-9#1)(2010-8#1)
of life table##2##3##(1995-3#2)
of life to##2##3##(1993-12#1)(2011-2#1)
of life using##2##3##(2010-3#1)(2013-1#1)
of life was assessed##2##4##(2007-1#1)(2010-5#1)
of life was##10##3##(1990-12#1)(1992-10#1)(1995-6#1)(2007-1#1)(2007-11#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)
of life when##2##3##(2008-7#1)(2010-12#1)
of life with##7##3##(1995-3#1)(2007-11#1)(2007-5#1)(2008-10#2)(2009-6#1)(2011-1#1)
of life##579##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#4)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-6#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#2)(1995-6#4)(1995-8#3)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#4)(1996-9#1)(1997-1#3)(1997-3#4)(1997-5#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-1#3)(2007-10#1)(2007-11#28)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#9)(2007-9#1)(2008-1#10)(2008-10#20)(2008-11#6)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#10)(2008-5#7)(2008-6#10)(2008-7#59)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#7)(2009-12#6)(2009-3#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#7)(2010-12#9)(2010-3#5)(2010-4#2)(2010-5#6)(2010-6#3)(2010-8#7)(2010-9#2)(2011-1#14)(2011-2#51)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#4)(2012-12#17)(2012-2#12)(2012-3#14)(2013-1#30)(2013-7#4)(2013-8#15)
of life'##3##2##(1995-3#1)(1996-2#1)(2010-10#1)
of life)##5##2##(1995-8#1)(2007-11#1)(2008-1#1)(2010-11#1)(2010-5#1)
of life-history variation##2##3##(2008-8#2)
of life-history##10##2##(2008-8#8)(2008-9#1)(2010-8#1)
of life-long learning##2##3##(2008-11#2)
of life-long neurogenesis in the decapod crustacean brain##2##8##(2007-12#2)
of life-long##5##2##(2007-12#2)(2007-7#1)(2008-11#2)
of life-sustaining treatment##2##3##(1991-2#1)(2010-4#1)
of life-threatening##7##2##(1994-6#1)(2008-11#1)(2008-7#2)(2010-11#1)(2011-2#2)
of lifestyle behaviors##2##3##(2013-8#2)
of lifestyle diseases##2##3##(2008-1#2)
of lifestyle##13##2##(1993-2#1)(2008-1#4)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
of lifetime reproductive success##2##4##(2008-9#2)
of lifetime sex partners##2##4##(2008-12#2)
of lifetime##6##2##(2008-12#2)(2008-9#3)(2009-5#1)
of ligaments##2##2##(2008-5#1)(2009-4#1)
of ligand and##2##3##(2008-10#1)(2008-3#1)
of ligand binding to##3##4##(1990-5#1)(1992-9#1)(1993-8#1)
of ligand binding##10##3##(1990-5#1)(1990-8#2)(1992-9#1)(1993-8#2)(1995-11#1)(1995-2#2)(2008-4#1)
of ligand structure##2##3##(2008-10#2)
of ligand##37##2##(1990-5#1)(1990-8#3)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#3)(2008-1#1)(2008-10#12)(2008-3#1)(2008-4#4)(2008-7#1)(2012-2#1)(2013-7#1)
of ligand-macromolecule interactions##2##3##(1997-2#2)
of ligands and##2##3##(2008-4#1)(2008-5#1)
of ligands for##2##3##(1994-6#1)(2008-10#1)
of ligands in##2##3##(2008-10#1)(2009-3#1)
of ligands##25##2##(1990-5#1)(1992-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#8)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
of ligated##3##2##(1997-2#1)(2008-4#1)(2008-9#1)
of light absorption##3##3##(2008-2#2)(2008-3#1)
of light and heavy##2##4##(1993-8#1)(2008-10#1)
of light and##18##3##(1992-2#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-9#1)(2009-8#2)
of light at##6##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
of light beams##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
of light by a##2##4##(2008-2#1)(2008-3#1)
of light by##12##3##(2008-10#1)(2008-2#3)(2008-3#8)
of light chain##2##3##(2008-11#1)(2013-8#1)
of light chains##3##3##(1993-9#2)(2011-2#1)
of light delivery##2##3##(2008-7#2)
of light during##3##3##(1991-2#1)(2008-2#2)
of light exposure and##2##4##(1990-10#1)(2008-5#1)
of light exposure##5##3##(1990-10#1)(1990-11#1)(1995-12#1)(2008-5#2)
of light for##4##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
of light from the##2##4##(2007-12#1)(2008-2#1)
of light from##11##3##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#2)(2008-9#1)
of light has##2##3##(2008-3#2)
of light in a##2##4##(2007-12#1)(2008-2#1)
of light in the##6##4##(1990-5#1)(2008-2#2)(2008-3#3)
of light in##13##3##(1990-5#1)(2007-12#1)(2008-2#6)(2008-3#3)(2012-2#1)(2013-7#1)
of light intensity##5##3##(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
of light into##2##3##(2008-2#1)(2008-3#1)
of light is##3##3##(1997-6#1)(2007-12#1)(2008-3#1)
of light leaf spot##3##4##(2008-10#3)
of light microscopy##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
of light on##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
of light over##2##3##(2007-11#1)(2007-12#1)
of light pillars##3##3##(2008-2#3)
of light propagating in##2##4##(2008-2#1)(2008-3#1)
of light propagation##4##3##(2007-11#1)(2008-3#3)
of light scattered by##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
of light scattered from a##3##5##(2008-3#3)
of light scattered from##8##4##(2007-12#1)(2008-2#1)(2008-3#6)
of light scattered##16##3##(1990-8#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#9)
of light scattering by##7##4##(2007-11#1)(2008-2#4)(2008-3#2)
of light scattering from##6##4##(2008-2#3)(2008-3#3)
of light scattering##28##3##(2007-11#2)(2008-10#2)(2008-2#10)(2008-3#13)(2008-9#1)
of light that##3##3##(2008-3#3)
of light through a##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
of light through the##2##4##(2008-3#2)
of light through##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#5)(2008-7#1)
of light to##2##3##(2008-2#1)(2008-4#1)
of light transmitted##3##3##(2008-2#1)(2008-3#2)
of light waves##2##3##(2007-11#1)(2007-12#1)
of light with##4##3##(2007-12#1)(2008-3#2)(2008-7#1)
of light within the##2##4##(2008-3#2)
of light##295##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-3#3)(1993-8#2)(1993-9#2)(1994-5#1)(1994-8#1)(1995-12#2)(1997-6#1)(2007-11#21)(2007-12#20)(2008-1#2)(2008-10#33)(2008-11#4)(2008-2#53)(2008-3#95)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#10)(2009-11#1)(2009-7#1)(2009-8#4)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of light-absorbing##2##2##(2008-10#1)(2008-3#1)
of light-beam propagation in##2##4##(2007-12#1)(2008-3#1)
of light-beam##3##2##(2007-12#1)(2008-3#2)
of light-dark##2##2##(1991-12#1)(2008-5#1)
of light-emitting diodes##3##3##(2007-11#1)(2008-3#2)
of light-induced reflectivity##3##3##(2007-11#3)
of light-induced##7##2##(1994-2#2)(2007-11#3)(2008-2#1)(2008-3#1)
of light-scattering##2##2##(2007-11#1)(2008-3#1)
of lighting##2##2##(2008-3#1)(2008-6#1)
of lignified##2##2##(2008-10#1)(2008-5#1)
of lignin and##2##3##(2008-10#1)(2013-8#1)
of lignin monomers##2##3##(2008-11#2)
of lignin peroxidase##2##3##(2008-6#2)
of lignin##14##2##(2008-10#4)(2008-11#2)(2008-6#3)(2009-8#2)(2009-9#1)(2011-1#1)(2013-8#1)
of lignocellulose##2##2##(2008-7#1)(2011-1#1)
of lignocellulosic biomass##3##3##(2008-6#3)
of lignocellulosic##4##2##(2008-6#3)(2011-1#1)
of likely##3##2##(1996-3#1)(1997-6#1)(1997-7#1)
of limb##15##2##(1991-11#1)(1992-11#1)(1992-9#1)(1994-11#2)(1994-8#1)(2007-11#1)(2007-12#1)(2009-3#1)(2010-11#1)(2010-5#1)(2011-2#2)(2011-3#2)
of limbic##3##2##(2008-5#1)(2008-6#1)(2008-7#1)
of limbs##5##2##(1990-9#1)(2007-11#1)(2008-9#1)(2010-12#1)(2012-12#1)
of limit of detection##2##4##(2008-10#2)
of limit##3##2##(1995-5#1)(2008-10#2)
of limitation##3##2##(1996-5#1)(2007-10#1)(2008-10#1)
of limitations##6##2##(1996-5#2)(2008-11#2)(2008-3#1)(2011-2#1)
of limited resection##2##3##(1994-12#2)
of limited resources##6##3##(1990-2#1)(1997-2#1)(2007-4#1)(2008-7#1)(2009-6#1)(2012-12#1)
of limited surgery##2##3##(1990-12#1)(1992-8#1)
of limited use##3##3##(2008-10#2)(2008-7#1)
of limited value because##2##4##(1995-3#1)(2008-5#1)
of limited value in##2##4##(1995-12#1)(2008-7#1)
of limited value##5##3##(1995-12#1)(1995-3#1)(1995-6#1)(2008-5#1)(2008-7#1)
of limited##37##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-8#1)(1993-1#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#2)(2007-4#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of limiting the##4##3##(2008-1#1)(2008-3#1)(2008-8#1)(2012-3#1)
of limiting##11##2##(1997-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
of limits of detection##2##4##(2008-10#2)
of limits##3##2##(2008-10#2)(2011-1#1)
of limonene##3##2##(2008-5#3)
of lin-12##2##2##(1994-12#2)
of line 30-4##2##3##(2008-10#2)
of line##8##2##(1995-5#1)(2008-10#4)(2008-3#1)(2009-12#1)(2013-8#1)
of lineage##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
of lineage-specific##2##2##(2008-9#1)(2011-2#1)
of lineages##2##2##(2008-10#1)(2008-9#1)
of linear alkylbenzene sulfonates##3##4##(2008-10#3)
of linear and circular##3##4##(1994-8#1)(2007-12#2)
of linear and##5##3##(1994-8#1)(2007-12#2)(2008-3#1)(2008-8#1)
of linear equality constraints##2##4##(2008-2#2)
of linear equations##3##3##(2008-3#2)(2008-7#1)
of linear models and##2##4##(2008-3#1)(2009-9#1)
of linear models##3##3##(1992-6#1)(2008-3#1)(2009-9#1)
of linear polarization##2##3##(2008-3#2)
of linear programming##2##3##(2008-2#1)(2008-7#1)
of linear range##2##3##(2008-10#2)
of linear regression##6##3##(2008-10#4)(2011-1#1)(2012-3#1)
of linear response##3##3##(2008-10#3)
of linear##70##2##(1990-5#1)(1991-12#1)(1992-6#1)(1994-8#1)(1996-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#13)(2008-7#6)(2008-8#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-6#2)(2011-1#4)(2012-3#1)(2013-1#1)(2013-7#1)
of linearity of##2##3##(2008-10#2)
of linearity##16##2##(1996-2#1)(2008-10#12)(2009-8#1)(2010-3#1)(2012-2#1)
of linearly polarized light##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
of linearly polarized##5##3##(2007-11#3)(2008-2#1)(2008-3#1)
of linearly##9##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#3)(2009-12#1)
of lines in the##2##4##(2008-2#1)(2008-3#1)
of lines##8##2##(2008-2#3)(2008-3#3)(2008-5#1)(2010-4#1)
of linewidth##2##2##(2007-11#1)(2007-12#1)
of linezolid in the presence of##3##6##(2008-10#3)
of linezolid in##4##3##(2007-7#1)(2008-10#3)
of linezolid##6##2##(2007-12#1)(2007-7#1)(2008-10#4)
of linguistic and##2##3##(2010-5#1)(2013-8#1)
of linguistic##3##2##(1993-9#1)(2010-5#1)(2013-8#1)
of link nurses##2##3##(2008-11#2)
of linkage between##2##3##(1997-5#2)
of linkage disequilibrium##4##3##(2008-10#2)(2010-5#1)(2012-3#1)
of linkage to##2##3##(1992-10#1)(1997-5#1)
of linkage##16##2##(1990-8#4)(1992-10#1)(1994-12#1)(1997-5#3)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2012-3#2)
of linkages##3##2##(1997-2#1)(2007-12#1)(2008-12#1)
of linked##4##2##(1991-3#1)(2007-11#1)(2008-10#2)
of linker##4##2##(1991-12#1)(1994-9#1)(1997-4#1)(2008-7#1)
of linkers##2##2##(2008-4#2)
of linking##3##2##(1990-9#1)(2008-10#1)(2009-7#1)
of links##2##2##(2008-2#1)(2012-12#1)
of linoleic acid monoepoxides##2##4##(1992-8#2)
of linoleic acid##9##3##(1990-12#1)(1992-8#3)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#1)
of linoleic##11##2##(1990-12#1)(1992-8#3)(1994-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#2)
of lipase activity##7##3##(1991-5#1)(2008-10#1)(2010-10#5)
of lipase##9##2##(1991-5#1)(1992-11#1)(1992-12#1)(2008-10#1)(2010-10#5)
of lipases##5##2##(1995-3#1)(2008-7#1)(2008-8#3)
of lipid A##3##3##(1990-5#2)(2011-2#1)
of lipid and lipoprotein##2##4##(2008-6#1)(2009-7#1)
of lipid and##4##3##(1993-11#1)(2008-3#1)(2008-6#1)(2009-7#1)
of lipid bilayers##2##3##(1992-6#2)
of lipid components##2##3##(1992-12#1)(1997-6#1)
of lipid composition on the relaxivity of##2##7##(1990-2#2)
of lipid droplets##3##3##(2007-12#2)(2009-3#1)
of lipid homeostasis##2##3##(2008-2#1)(2008-3#1)
of lipid hydroperoxides##6##3##(1992-11#2)(1995-2#2)(2008-5#1)(2013-1#1)
of lipid lowering drugs##2##4##(2008-11#2)
of lipid lowering##3##3##(2008-11#2)(2008-4#1)
of lipid metabolism in##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
of lipid metabolism##10##3##(1992-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#5)
of lipid peroxidation by##3##4##(1993-2#1)(1995-6#2)
of lipid peroxidation##21##3##(1991-12#1)(1991-5#1)(1992-3#2)(1993-2#3)(1995-12#2)(1995-3#1)(1995-6#2)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-8#1)(2013-1#1)
of lipid peroxides in##3##4##(1990-5#2)(2013-1#1)
of lipid peroxides##5##3##(1990-5#2)(2008-5#2)(2013-1#1)
of lipid rafts##3##3##(2008-11#2)(2011-2#1)
of lipid##94##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-7#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#3)(1993-11#1)(1993-2#3)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#9)
of lipid-lowering##2##2##(2013-1#2)
of lipids and proteins##3##4##(2008-7#1)(2008-8#1)(2009-8#1)
of lipids and##11##3##(1990-8#1)(1991-11#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)
of lipids with##3##3##(1995-2#1)(2009-2#1)(2012-12#1)
of lipids##33##2##(1990-2#1)(1990-8#1)(1991-11#1)(1994-12#1)(1995-2#2)(1995-8#1)(1996-8#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
of lipoamide dehydrogenase deficiency##2##4##(1996-12#2)
of lipoamide dehydrogenase##5##3##(1992-1#1)(1996-12#4)
of lipofuscin in the##2##4##(1995-3#1)(2011-2#1)
of lipofuscin in##3##3##(1995-3#2)(2011-2#1)
of lipofuscin##5##2##(1994-6#1)(1995-3#3)(2011-2#1)
of lipogenesis and##2##3##(1994-6#1)(2012-2#1)
of lipogenesis##3##2##(1994-6#1)(2010-4#1)(2012-2#1)
of lipoid##2##2##(2008-5#1)(2011-2#1)
of lipolysis##2##2##(1996-2#1)(2008-3#1)
of lipoma##5##2##(1990-12#1)(1990-3#1)(2008-6#1)(2012-1#1)(2013-1#1)
of lipoperoxidation##3##2##(2008-10#2)(2008-11#1)
of lipophilic##10##2##(1992-6#1)(2008-10#5)(2008-5#4)
of lipopolysaccharide (LPS)##5##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
of lipopolysaccharide##14##2##(1991-2#1)(1995-12#2)(1996-12#5)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-12#1)
of lipopolysaccharide-induced prostaglandin H synthase-2##2##5##(1993-3#2)
of lipoprotein (a)##3##3##(1991-12#1)(2008-4#1)(2011-2#1)
of lipoprotein lipase (LPL)##2##4##(2008-11#1)(2008-7#1)
of lipoprotein lipase##6##3##(1991-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
of lipoprotein metabolism in##2##4##(2008-6#2)
of lipoprotein##15##2##(1990-8#2)(1991-12#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of lipoprotein(a)##2##2##(1993-2#1)(1995-2#1)
of lipoproteins##6##2##(1993-9#1)(1994-3#1)(1995-5#1)(1995-8#1)(2012-2#1)(2013-1#1)
of liposomal##7##2##(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#2)(2008-5#1)(2008-8#1)
of liposome##2##2##(2008-10#2)
of liposomes and##4##3##(1997-1#2)(2008-10#1)(2008-8#1)
of liposomes##19##2##(1990-11#1)(1990-2#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-1#2)(2008-10#8)(2008-5#1)(2008-8#2)
of lipoxins##2##2##(1991-5#2)
of lipoxygenase##7##2##(1992-12#2)(1992-3#1)(1994-9#1)(2008-11#2)(2011-10#1)
of lipstick##4##2##(2008-5#4)
of liquefied##3##2##(2008-6#1)(2009-10#1)(2013-1#1)
of liquid L-dopa/carbidopa in##2##4##(2008-7#2)
of liquid L-dopa/carbidopa##3##3##(2008-7#3)
of liquid and##2##3##(2008-10#1)(2008-3#1)
of liquid chromatography with##2##4##(2008-10#1)(2010-4#1)
of liquid crystal##2##3##(2007-12#1)(2008-10#1)
of liquid crystals##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
of liquid fraction##2##3##(2008-3#1)(2008-6#1)
of liquid nitrogen##3##3##(1995-11#1)(2007-12#1)(2008-8#1)
of liquid water##5##3##(2008-2#1)(2008-3#4)
of liquid##57##2##(1990-7#1)(1992-5#2)(1995-11#1)(1995-3#1)(1996-3#1)(2006-4#1)(2007-11#4)(2007-12#3)(2008-10#16)(2008-2#3)(2008-3#11)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of liquid-crystal panels##2##3##(2008-2#1)(2008-3#1)
of liquid-crystal televisions##2##3##(2008-2#2)
of liquid-crystal##8##2##(2008-2#4)(2008-3#3)(2012-2#1)
of liquid-liquid extraction##2##3##(2008-10#2)
of liquid-phase##2##2##(2007-12#1)(2010-7#1)
of liquids##8##2##(1994-2#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)
of list length##3##3##(1993-3#1)(2008-6#2)
of list##4##2##(1993-3#1)(2008-6#2)(2008-9#1)
of listening to##3##3##(2013-1#3)
of listening##4##2##(2012-2#1)(2013-1#3)
of listeriolysin O by##3##4##(1996-12#3)
of listeriolysin O##5##3##(1996-12#5)
of literature and##4##3##(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
of literature data##2##3##(2008-10#1)(2009-5#1)
of literature is##3##3##(2007-12#1)(2010-11#1)(2010-8#1)
of literature on the##4##4##(1992-8#1)(2008-8#1)(2012-12#1)(2012-2#1)
of literature on##8##3##(1992-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
of literature suggests##2##3##(2008-11#1)(2008-5#1)
of literature##75##2##(1990-10#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#1)
of lithiasis##4##2##(1990-5#1)(1991-3#1)(1997-8#1)(2008-10#1)
of lithium and##2##3##(2007-11#1)(2008-10#1)
of lithium in the##2##4##(1994-8#2)
of lithium in##3##3##(1994-8#2)(2008-10#1)
of lithium ions##2##3##(2008-10#2)
of lithium niobate##2##3##(2007-11#1)(2008-3#1)
of lithium traces##2##3##(2008-10#2)
of lithium##27##2##(1992-2#1)(1994-8#2)(1996-12#1)(1996-5#2)(2007-11#2)(2008-10#15)(2008-2#2)(2008-3#1)(2009-8#1)
of lithographically##2##2##(2008-2#1)(2008-7#1)
of lithotripter##2##2##(2008-11#2)
of little value##2##3##(1991-2#1)(2008-5#1)
of little##9##2##(1991-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of live adults##2##3##(2011-2#2)
of live attenuated##2##3##(2008-11#1)(2010-8#1)
of live biological##2##3##(2007-11#1)(2008-3#1)
of live cardiomyocytes##2##3##(2008-3#1)(2011-1#1)
of live cells##6##3##(2008-11#2)(2008-9#2)(2009-6#1)(2011-1#1)
of live weight##2##3##(2010-4#2)
of live##41##2##(1991-3#2)(1994-2#1)(1995-5#1)(1995-6#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#3)(2010-4#2)(2010-8#3)(2011-1#3)(2011-2#2)(2013-1#1)
of liver and kidney##2##4##(1990-12#1)(2008-9#1)
of liver and##7##3##(1990-12#1)(1990-2#1)(1995-9#1)(1997-4#3)(2008-9#1)
of liver cell##3##3##(2006-10#1)(2008-11#1)(2009-8#1)
of liver cells##2##3##(1994-12#1)(2009-8#1)
of liver damage##2##3##(2009-8#2)
of liver disease##7##3##(2007-7#1)(2008-1#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of liver fibrosis and##2##4##(2013-1#1)(2013-8#1)
of liver fibrosis##5##3##(2013-1#3)(2013-8#2)
of liver fluke infection##2##4##(2008-12#2)
of liver from##2##3##(1994-2#1)(1997-8#1)
of liver function tests##2##4##(1992-2#1)(2007-7#1)
of liver function##7##3##(1992-12#2)(1992-2#1)(1992-5#1)(1995-11#1)(2007-7#1)(2013-8#1)
of liver functions##3##3##(1996-12#1)(2008-11#2)
of liver in##3##3##(2010-11#1)(2012-3#1)(2013-8#1)
of liver metastases##7##3##(1995-4#1)(2008-7#4)(2010-12#2)
of liver or##2##3##(1993-8#1)(1995-11#1)
of liver regeneration##3##3##(2008-8#3)
of liver specific functions##2##4##(2008-11#2)
of liver tumors##2##3##(1990-6#1)(2008-10#1)
of liver##113##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-11#3)(1995-2#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-7#2)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#7)(2010-11#2)(2010-12#5)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#6)
of liver-specific##3##2##(1990-11#1)(2008-11#1)(2008-7#1)
of livestock production##2##3##(2011-2#2)
of livestock##9##2##(1990-3#1)(1997-7#1)(2010-1#1)(2011-2#6)
of living animals##3##3##(2008-10#1)(2008-9#1)(2009-2#1)
of living cells and##4##4##(2007-11#1)(2008-1#1)(2008-11#1)(2009-7#1)
of living cells is##2##4##(2008-3#1)(2008-7#1)
of living cells##15##3##(1992-5#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2009-7#1)
of living donor kidney transplantation##2##5##(2011-2#2)
of living donor##5##3##(2011-2#4)(2013-8#1)
of living donors##2##3##(2008-12#1)(2011-2#1)
of living donors]##2##3##(2011-2#2)
of living has##2##3##(2007-11#1)(2008-11#1)
of living in a disrupted situation as partner to a##2##10##(2009-5#2)
of living in a##3##4##(1992-3#1)(2009-5#2)
of living in##4##3##(1992-3#1)(1993-1#1)(2009-5#2)
of living organisms##4##3##(1992-11#1)(2009-5#1)(2009-8#1)(2010-11#1)
of living systems##2##3##(2008-1#1)(2012-2#1)
of living with##4##3##(2008-12#1)(2008-2#1)(2010-10#1)(2013-1#1)
of living##71##2##(1991-12#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-11#1)(1994-11#1)(1994-9#1)(2007-11#3)(2007-12#3)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of living-donor kidney transplantation]##4##4##(2011-2#4)
of living-donor kidney##5##3##(2011-2#5)
of lizards##5##2##(1991-5#1)(2008-7#1)(2010-3#2)(2011-2#1)
of lm mice##2##3##(2008-10#2)
of load##4##2##(2010-3#1)(2012-2#1)(2013-1#2)
of load-bearing bone##2##3##(2009-7#2)
of loaded##3##2##(2008-10#3)
of loading and##2##3##(2008-10#2)
of loading##6##2##(2007-8#1)(2008-1#1)(2008-10#3)(2009-7#1)
of lobar##2##2##(2008-2#1)(2012-2#1)
of lobule VII##3##3##(1994-2#3)
of local adaptation##2##3##(2012-7#2)
of local and systemic##3##4##(1991-8#1)(1995-5#1)(2011-2#1)
of local and##11##3##(1991-8#1)(1995-5#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-12#2)(2008-8#2)(2011-2#1)(2013-8#1)
of local anesthetic##3##3##(1995-3#1)(2012-3#1)(2013-1#1)
of local anesthetics##2##3##(1993-1#1)(2009-3#1)
of local control##2##3##(1991-4#1)(1992-10#1)
of local environmental##2##3##(2008-10#1)(2010-6#1)
of local government##2##3##(2007-7#1)(2013-1#1)
of local habitats##2##3##(2008-8#2)
of local or##3##3##(1990-6#2)(2007-8#1)
of local origin##2##3##(2008-10#2)
of local populations##2##3##(2008-10#1)(2010-1#1)
of local recurrence and##2##4##(2008-11#1)(2010-3#1)
of local recurrence or##3##4##(1993-11#1)(2007-12#1)(2008-6#1)
of local recurrence##12##3##(1993-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2010-3#2)(2011-1#1)(2011-2#1)(2013-1#1)
of local recurrences##2##3##(1991-9#1)(2008-6#1)
of local relapses##2##3##(1990-3#2)
of local therapy##2##3##(2008-6#1)(2011-2#1)
of local trauma##2##3##(2007-2#1)(2007-5#1)
of local##167##2##(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-11#2)(1993-6#1)(1995-3#1)(1995-5#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-6#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#14)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#6)(2008-7#5)(2008-8#12)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#6)(2012-3#5)(2012-7#2)(2013-1#8)(2013-8#2)
of local-regional##2##2##(1991-4#1)(1992-12#1)
of localization of##2##3##(2008-10#1)(2010-8#1)
of localization##5##2##(1991-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-8#1)
of localized folate##2##3##(1992-9#2)
of localized##19##2##(1990-12#1)(1991-9#1)(1992-9#2)(1995-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
of localizing##2##2##(2007-12#1)(2009-8#1)
of locally advanced breast cancer with##2##6##(1991-8#1)(1994-2#1)
of locally advanced breast cancer##6##5##(1991-8#3)(1993-11#1)(1994-2#1)(2007-5#1)
of locally advanced head and neck cancer##2##7##(1990-6#1)(1993-9#1)
of locally advanced head and neck##3##6##(1990-6#1)(1993-9#1)(1995-9#1)
of locally advanced##17##3##(1990-12#1)(1990-6#2)(1991-8#3)(1992-3#2)(1993-11#1)(1993-9#1)(1994-2#1)(1995-8#1)(1995-9#1)(1997-7#1)(2007-5#1)(2008-10#1)(2009-5#1)
of locally##27##2##(1990-12#1)(1990-6#2)(1991-8#3)(1992-3#2)(1993-11#1)(1993-9#1)(1994-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2013-1#1)
of location shift##2##3##(1996-3#2)
of location theory##2##3##(1996-1#2)
of location##10##2##(1996-1#3)(1996-3#2)(1996-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
of locations##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
of loci##6##2##(1994-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
of loco-regional##4##2##(1990-12#1)(1990-3#1)(1992-6#1)(2008-6#1)
of locomotion##3##2##(1993-3#1)(2007-8#1)(2008-9#1)
of locomotor activity##3##3##(1997-2#1)(2008-5#1)(2013-1#1)
of locomotor##11##2##(1992-12#1)(1993-3#1)(1994-3#1)(1997-2#2)(2007-11#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
of locoregional##3##2##(1993-11#1)(1996-10#1)(2012-2#1)
of locus of control and social support##2##7##(1996-2#2)
of locus##3##2##(1996-2#2)(2008-10#1)
of lodgepole pine##2##3##(2013-1#2)
of log 5##2##3##(2008-10#1)(2008-5#1)
of log##6##2##(1991-9#2)(1992-3#1)(1995-3#1)(2008-10#1)(2008-5#1)
of logistic regression##4##3##(2007-8#1)(2008-11#1)(2009-5#1)(2013-8#1)
of logistic##5##2##(1992-9#1)(2007-8#1)(2008-11#1)(2009-5#1)(2013-8#1)
of logistical problems##2##3##(1993-2#1)(2008-11#1)
of lola##2##2##(2012-12#2)
of long acting##2##3##(1993-2#1)(2008-1#1)
of long bone##4##3##(2007-11#2)(2010-6#1)(2013-1#1)
of long bones##6##3##(2007-11#2)(2007-2#1)(2007-8#1)(2008-7#1)(2009-1#1)
of long chain acyl-ACP##2##4##(1995-6#2)
of long chain fatty##2##4##(1993-8#1)(2008-10#1)
of long chain##6##3##(1993-8#1)(1995-6#3)(2008-10#1)(2009-6#1)
of long duration##4##3##(1991-2#1)(2007-7#1)(2008-7#1)(2013-1#1)
of long standing##3##3##(1997-1#1)(2008-4#1)(2012-2#1)
of long term##15##3##(1991-12#1)(1994-12#1)(1994-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
of long##72##2##(1991-12#2)(1991-2#1)(1991-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#3)(1996-6#2)(1997-1#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#6)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#6)
of long-acting##4##2##(1996-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
of long-chain fatty acids##3##4##(1990-5#1)(2008-4#1)(2008-5#1)
of long-chain##6##2##(1990-5#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
of long-distance##4##2##(2007-12#1)(2008-10#3)
of long-lived##5##2##(1994-5#1)(1995-12#1)(2008-3#1)(2012-2#1)(2012-5#1)
of long-period fiber gratings in B/Ge codoped fiber##2##8##(2007-12#2)
of long-period fiber gratings##5##4##(2007-12#3)(2008-3#2)
of long-period gratings##2##3##(2007-11#2)
of long-period##9##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-3#2)
of long-range##2##2##(2008-4#1)(2008-9#1)
of long-standing##4##2##(1990-12#1)(1992-9#1)(2007-10#1)(2012-2#1)
of long-term administration of##4##4##(1991-12#1)(1995-3#1)(2008-10#1)(2009-8#1)
of long-term care##16##3##(1992-3#4)(1993-12#1)(1994-2#1)(1995-3#4)(1996-2#1)(2008-1#1)(2008-2#1)(2012-1#1)(2012-12#2)
of long-term complications##2##3##(1993-9#1)(2008-7#1)
of long-term depression##2##3##(1997-7#1)(2012-2#1)
of long-term management##2##3##(1996-7#1)(2011-2#1)
of long-term memory##3##3##(1992-11#1)(2007-8#1)(2013-1#1)
of long-term monitoring##2##3##(2008-3#1)(2008-9#1)
of long-term outcome##2##3##(1992-12#1)(2008-11#1)
of long-term outcomes##2##3##(2008-9#1)(2009-8#1)
of long-term potentiation (LTP) in the##2##6##(1990-5#1)(2008-7#1)
of long-term potentiation (LTP) in##3##5##(1990-5#1)(1996-5#1)(2008-7#1)
of long-term potentiation (LTP) was##2##5##(1995-12#2)
of long-term potentiation (LTP)##6##4##(1990-5#1)(1995-12#3)(1996-5#1)(2008-7#1)
of long-term potentiation in the##4##5##(1990-5#1)(1995-12#2)(2008-7#1)
of long-term potentiation##12##3##(1990-5#3)(1991-12#1)(1995-12#5)(1996-5#1)(2008-7#2)
of long-term survival##2##3##(2007-12#1)(2011-3#1)
of long-term treatment##3##3##(1995-12#1)(2010-6#1)(2013-1#1)
of long-term##108##2##(1990-3#1)(1990-5#3)(1991-12#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#6)(1995-3#5)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-7#2)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
of long-term-care##2##2##(1996-12#1)(2008-5#1)
of longer duration##5##3##(1996-5#1)(2008-11#1)(2008-5#2)(2008-7#1)
of longer pulse duration##2##4##(2009-8#2)
of longer##20##2##(1992-3#1)(1993-12#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#2)(2010-11#1)(2012-3#1)
of longevity##3##2##(1992-11#1)(2008-7#1)(2012-2#1)
of longitudinal##9##2##(1992-3#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-8#1)(2011-1#2)
of lonidamine##2##2##(1991-2#1)(1993-11#1)
of looking##2##2##(1994-2#1)(2008-4#1)
of loop##6##2##(1992-3#1)(1992-4#1)(2008-8#1)(2011-2#2)(2013-1#1)
of loose##2##2##(2008-5#1)(2008-8#1)
of loosely##2##2##(2008-10#1)(2012-3#1)
of lopinavir and ritonavir in human##2##6##(2011-3#2)
of lorazepam##4##2##(2008-10#4)
of losartan##4##2##(1995-11#1)(2011-2#3)
of losing the##2##3##(1992-5#1)(1994-1#1)
of losing##7##2##(1992-5#1)(1994-1#1)(1995-12#1)(1996-11#1)(2007-12#1)(2008-10#1)(2009-9#1)
of loss and##2##3##(2007-11#1)(2008-12#1)
of loss in##2##3##(2008-3#1)(2008-8#1)
of loss of consciousness##2##4##(1992-6#1)(2008-11#1)
of loss of##12##3##(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
of loss##24##2##(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
of losses in##2##3##(2008-10#1)(2008-3#1)
of losses##4##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of lost##6##2##(1991-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)
of lovastatin##3##2##(1992-11#1)(2008-7#2)
of low LDL-C with##2##4##(2012-6#2)
of low LDL-C##3##3##(2012-6#3)
of low LET radiation##8##4##(2008-7#8)
of low SES##2##3##(2011-1#2)
of low abundance##2##3##(1997-2#1)(2008-4#1)
of low amounts of##3##4##(2008-10#2)(2010-5#1)
of low and high##4##4##(1995-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
of low and##5##3##(1994-11#1)(1995-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
of low back pain (LBP)##2##5##(2010-12#1)(2010-9#1)
of low back pain in##3##5##(2009-4#2)(2010-10#1)
of low back pain##14##4##(1993-6#1)(2007-11#1)(2007-8#2)(2008-12#2)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#2)(2012-12#1)
of low back##15##3##(1993-6#1)(2007-11#1)(2007-8#2)(2008-12#3)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#2)(2012-12#1)
of low birth weight##5##4##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(2008-11#1)
of low concentration of##2##4##(2010-5#1)(2011-1#1)
of low concentration##4##3##(2008-10#2)(2010-5#1)(2011-1#1)
of low concentrations of##6##4##(1992-7#1)(2008-10#3)(2008-3#1)(2008-7#1)
of low concentrations##8##3##(1992-7#1)(2008-10#5)(2008-3#1)(2008-7#1)
of low contrast detectability##2##4##(2012-1#2)
of low contrast##5##3##(2012-1#5)
of low density lipoprotein (LDL) receptors##2##6##(1990-11#1)(1995-8#1)
of low density lipoprotein (LDL)##5##5##(1990-11#1)(1991-5#1)(1992-5#1)(1994-9#1)(1995-8#1)
of low density lipoprotein##6##4##(1990-11#1)(1991-5#1)(1992-5#1)(1994-9#1)(1995-8#1)(2008-8#1)
of low density lipoproteins (LDL)##3##5##(1991-5#1)(1993-6#1)(1993-8#1)
of low density lipoproteins by##2##5##(1991-11#1)(1991-5#1)
of low density lipoproteins##7##4##(1991-11#2)(1991-5#2)(1993-6#1)(1993-8#1)(1994-3#1)
of low density##15##3##(1990-11#1)(1991-11#3)(1991-5#3)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-8#1)(2008-8#1)(2008-9#1)
of low dose exposures##2##4##(2008-7#2)
of low dose##7##3##(2007-11#1)(2008-11#1)(2008-7#3)(2011-1#1)(2012-2#1)
of low doses of ionizing##2##5##(2011-1#1)(2013-1#1)
of low doses of##8##4##(1990-5#1)(1993-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#2)
of low fertility##2##3##(2008-10#1)(2009-10#1)
of low folate levels##2##4##(2008-7#2)
of low grade##2##3##(2009-8#1)(2012-2#1)
of low income families##2##4##(1991-3#1)(1997-4#1)
of low income##5##3##(1991-3#1)(1994-12#1)(1995-12#1)(1997-4#1)(2008-9#1)
of low ionic strength##4##4##(1993-3#1)(1994-5#1)(2010-12#1)(2011-2#1)
of low level vancomycin resistance in##2##6##(2007-7#2)
of low level##5##3##(1995-3#1)(2007-7#2)(2008-10#1)(2008-11#1)
of low levels of##11##4##(2008-10#7)(2008-11#1)(2008-5#1)(2011-2#2)
of low levels##12##3##(2008-10#8)(2008-11#1)(2008-5#1)(2011-2#2)
of low micromolar concentrations of##2##5##(1994-2#1)(1995-11#1)
of low molecular mass##2##4##(1993-6#1)(2008-10#1)
of low molecular weight heparin##3##5##(1995-5#1)(2007-7#1)(2008-7#1)
of low molecular weight organic acids in soil solution##2##9##(2008-10#2)
of low molecular weight##16##4##(1990-7#1)(1995-2#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-7#2)(2009-9#1)(2010-11#1)(2011-2#1)
of low molecular##18##3##(1990-7#1)(1993-6#1)(1995-2#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-7#2)(2009-9#1)(2010-11#1)(2011-2#1)
of low pH##4##3##(1990-5#1)(1994-8#3)
of low power##3##3##(2011-2#1)(2012-3#2)
of low redox potential##3##4##(2008-10#3)
of low solubility##2##3##(1997-1#1)(2008-10#1)
of low spatial##2##3##(2007-12#1)(2008-3#1)
of low temperature##7##3##(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-4#1)(2013-1#1)
of low viscosity##3##3##(2008-8#2)(2009-7#1)
of low vision among schoolchildren in Kibaha##2##7##(2010-8#2)
of low vision among##4##4##(2010-8#4)
of low vision##8##3##(2010-8#7)(2011-2#1)
of low vitamin B12##2##4##(1990-3#1)(2010-1#1)
of low vitamin D##2##4##(2012-2#1)(2013-7#1)
of low vitamin##4##3##(1990-3#1)(2010-1#1)(2012-2#1)(2013-7#1)
of low##284##2##(1990-11#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1991-11#5)(1991-12#2)(1991-3#1)(1991-5#3)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#59)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#19)(2008-8#7)(2008-9#4)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-5#2)(2010-8#9)(2010-9#2)(2011-1#8)(2011-2#11)(2012-1#5)(2012-12#2)(2012-2#5)(2012-3#3)(2012-4#1)(2012-6#5)(2013-1#8)(2013-7#2)(2013-8#2)
of low- and##2##3##(1993-3#1)(2007-12#1)
of low-LET radiation##4##3##(2008-7#4)
of low-abundance##2##2##(2008-4#1)(2012-1#1)
of low-carbohydrate##3##2##(2008-3#2)(2008-5#1)
of low-coherence gating##2##3##(2007-12#2)
of low-coherence##11##2##(2007-11#2)(2007-12#2)(2008-3#7)
of low-cost##7##2##(1996-12#1)(2007-11#2)(2008-3#3)(2010-9#1)
of low-density lipoprotein (LDL)##3##4##(1995-12#1)(1996-3#1)(2008-3#1)
of low-density lipoprotein##5##3##(1990-7#1)(1995-12#1)(1996-3#1)(2008-3#1)(2011-2#1)
of low-density##7##2##(1990-7#1)(1995-12#2)(1996-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
of low-dose##9##2##(1993-12#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-4#1)
of low-dose-rate##2##2##(2008-7#2)
of low-energy##4##2##(1993-8#1)(1994-5#1)(2007-11#1)(2008-8#1)
of low-frequency fluctuations##2##3##(2007-12#2)
of low-frequency##8##2##(1992-9#1)(2007-12#3)(2008-2#2)(2008-3#2)
of low-grade##4##2##(1990-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
of low-income##5##2##(2010-6#2)(2013-1#3)
of low-intensity##2##2##(2010-4#1)(2012-2#1)
of low-level##2##2##(2007-2#1)(2011-1#1)
of low-loss##3##2##(2008-2#1)(2008-3#2)
of low-molecular-weight##4##2##(1992-11#1)(1995-6#1)(2008-10#1)(2008-3#1)
of low-power##2##2##(2007-12#1)(2008-2#1)
of low-spin##2##2##(1997-7#1)(2008-9#1)
of low-temperature##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
of low-threshold##5##2##(1993-9#3)(2007-11#1)(2008-2#1)
of lower affinity##2##3##(1995-2#1)(2008-7#1)
of lower esophageal sphincter##2##4##(1992-9#1)(2013-8#1)
of lower extremity##4##3##(1996-3#1)(2008-8#1)(2009-3#1)(2012-2#1)
of lower jaw##2##3##(1993-12#1)(2013-1#1)
of lower limb##5##3##(2007-11#2)(2008-7#1)(2011-1#1)(2012-2#1)
of lower pole##2##3##(2007-10#1)(2008-10#1)
of lower reproductive tract##2##4##(1996-12#1)(2011-1#1)
of lower respiratory tract infection##2##5##(2008-7#1)(2010-10#1)
of lower respiratory tract##4##4##(2008-7#1)(2010-10#1)(2010-5#1)(2012-12#1)
of lower respiratory##5##3##(1994-2#1)(2008-7#1)(2010-10#1)(2010-5#1)(2012-12#1)
of lower than##2##3##(1996-2#1)(2008-10#1)
of lower urinary tract##4##4##(2011-2#1)(2012-12#1)(2013-8#2)
of lower urinary##5##3##(2007-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
of lower##70##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-7#1)(2007-10#2)(2007-11#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
of lowering blood pressure##2##4##(1992-8#1)(2007-10#1)
of lowering##6##2##(1992-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
of lowest-order##2##2##(2007-11#1)(2008-3#1)
of luciferase##10##2##(1990-7#2)(1997-4#1)(2008-10#2)(2008-11#3)(2008-9#2)
of lucigenin##5##2##(2008-10#5)
of lumbar and##2##3##(2007-11#2)
of lumbar disc disease##2##4##(2007-8#1)(2008-12#1)
of lumbar disc##4##3##(2007-8#1)(2008-12#2)(2013-8#1)
of lumbar discopathy##3##3##(2007-8#3)
of lumbar disk##2##3##(1997-2#1)(2009-3#1)
of lumbar spine##6##3##(2008-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
of lumbar##26##2##(1993-1#1)(1997-2#1)(2007-11#2)(2007-8#4)(2008-11#1)(2008-12#2)(2008-8#2)(2009-3#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
of lumbo-sacral##2##2##(2007-11#1)(2008-12#1)
of lumbosacral##2##2##(2008-12#1)(2009-11#1)
of luminal##3##2##(2008-10#1)(2008-8#1)(2009-12#1)
of luminance##2##2##(1996-2#1)(2008-2#1)
of luminescence##3##2##(2008-10#2)(2008-7#1)
of luminescent##4##2##(2007-11#1)(2008-10#3)
of luminol and##2##3##(2008-10#2)
of luminol with hydrogen peroxide catalyzed by##3##7##(2008-10#3)
of luminol with hydrogen peroxide in##2##6##(2008-10#2)
of luminol with hydrogen peroxide##6##5##(2008-10#6)
of luminol with##11##3##(1991-5#1)(2008-10#10)
of luminol##23##2##(1991-5#3)(2008-10#20)
of luminol-hydrogen##2##2##(2008-10#2)
of lunar##2##2##(2008-3#1)(2013-8#1)
of lung adenocarcinoma##4##3##(2008-9#3)(2013-8#1)
of lung and##2##3##(2009-9#1)(2011-3#1)
of lung cancer and mesothelioma##2##5##(1991-12#1)(2010-5#1)
of lung cancer and##4##4##(1991-12#1)(1992-6#1)(1996-9#1)(2010-5#1)
of lung cancer in##6##4##(1991-2#1)(1991-4#1)(1996-7#1)(2008-12#1)(2008-7#2)
of lung cancer is##2##4##(2007-8#1)(2008-11#1)
of lung cancer patients##4##4##(1996-9#2)(2008-11#1)(2010-8#1)
of lung cancer##41##3##(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1995-9#1)(1996-7#1)(1996-9#5)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#1)(2009-7#1)(2010-5#3)(2010-8#3)(2011-1#1)(2011-3#2)(2012-1#1)(2013-1#1)(2013-8#1)
of lung cancer]##2##3##(2008-11#1)(2012-2#1)
of lung carcinoma##3##3##(1994-12#1)(2008-1#1)(2008-9#1)
of lung cavities##2##3##(2010-8#2)
of lung disease##4##3##(1992-9#1)(2008-10#1)(2008-9#1)(2012-3#1)
of lung function##3##3##(1991-2#1)(1991-4#1)(1992-6#1)
of lung injury##3##3##(1991-9#1)(2011-2#2)
of lung involvement##3##3##(1991-2#1)(1997-3#1)(2007-12#1)
of lung metastases##3##3##(1990-2#1)(1992-6#1)(1994-12#1)
of lung parenchyma##2##3##(2011-2#1)(2013-7#1)
of lung tissue in patients with##2##6##(1991-12#1)(2013-1#1)
of lung tissue##3##3##(1991-12#1)(2013-1#2)
of lung transplantation##5##3##(1993-2#1)(1996-6#1)(2011-3#3)
of lung##110##2##(1990-2#1)(1991-12#3)(1991-2#3)(1991-4#2)(1991-9#1)(1992-3#2)(1992-6#3)(1992-9#4)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-9#1)(1996-6#1)(1996-7#1)(1996-9#5)(1997-2#2)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-11#1)(2009-7#1)(2009-9#2)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#5)(2011-3#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
of lungs##4##2##(2007-12#1)(2012-3#1)(2013-1#2)
of lupane triterpenes on##3##4##(2008-11#3)
of lupane triterpenes##4##3##(2008-11#4)
of lupin##2##2##(2008-10#2)
of lupus erythematosus##3##3##(2007-7#2)(2013-1#1)
of lupus nephritis##8##3##(2006-10#1)(2007-7#1)(2008-1#4)(2008-10#1)(2013-1#1)
of lupus##15##2##(2006-10#2)(2007-7#3)(2008-1#4)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of luteal##2##2##(1992-9#1)(2008-5#1)
of luteinizing hormone##3##3##(1995-2#2)(2012-12#1)
of luteinizing hormone-releasing hormone##3##4##(1993-1#2)(1995-12#1)
of luteinizing##6##2##(1993-1#2)(1995-12#1)(1995-2#2)(2012-12#1)
of lying##2##2##(2010-10#1)(2013-1#1)
of lymph node metastasis in##2##5##(2011-2#2)
of lymph node metastasis##5##4##(2009-12#1)(2011-2#3)(2013-1#1)
of lymph node##9##3##(1990-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-2#3)(2013-1#1)(2013-7#1)
of lymph nodes and##2##4##(1992-2#1)(2010-8#1)
of lymph nodes##5##3##(1992-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
of lymph##16##2##(1990-9#1)(1992-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-8#2)(2011-2#4)(2013-1#2)(2013-7#1)
of lymphadenectomy##4##2##(1990-3#1)(2007-8#3)
of lymphadenopathy in##2##3##(2011-1#2)
of lymphadenopathy##6##2##(1997-8#1)(2007-12#1)(2011-1#4)
of lymphatic##6##2##(1990-8#1)(1997-7#1)(2008-11#1)(2011-2#2)(2012-3#1)
of lymphoblasts with##2##3##(1997-6#2)
of lymphoblasts##3##2##(1997-6#3)
of lymphocele##2##2##(2008-1#2)
of lymphocyte activation or##2##4##(2008-4#1)(2008-9#1)
of lymphocyte function##2##3##(2008-5#1)(2012-12#1)
of lymphocyte##14##2##(1990-12#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
of lymphocytes and##4##3##(1992-12#1)(1992-9#1)(2008-12#1)(2011-2#1)
of lymphocytes in the elderly##2##5##(1995-8#2)
of lymphocytes in##4##3##(1991-5#1)(1995-8#2)(2008-11#1)
of lymphocytes##33##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-9#1)(1995-8#5)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#6)(2008-7#2)(2010-8#1)(2011-2#2)(2012-12#1)
of lymphoid cells##4##3##(2007-8#1)(2008-4#2)(2008-5#1)
of lymphoid follicles##2##3##(2009-4#1)(2009-8#1)
of lymphoid tissues##4##3##(2008-10#4)
of lymphoid##15##2##(1991-9#1)(2007-8#1)(2008-10#4)(2008-4#4)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#2)
of lymphoma##6##2##(1990-11#1)(1992-12#1)(2009-1#2)(2011-2#1)(2012-1#1)
of lymphoproliferative disorders##3##3##(1992-2#1)(1992-8#1)(2008-5#1)
of lyophilized cells##2##3##(2008-10#2)
of lyophilized##3##2##(2008-10#2)(2008-7#1)
of lysed##2##2##(2008-11#2)
of lysergic acid diethylamide (LSD)##2##5##(1997-7#1)(2008-10#1)
of lysine and##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
of lysine residues##4##3##(1992-6#1)(1995-2#1)(1995-6#1)(1997-2#1)
of lysine##19##2##(1991-5#1)(1991-8#2)(1992-6#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-2#2)
of lysinoalanine was##2##3##(1992-6#2)
of lysis##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
of lysophosphatidic acid##3##3##(1991-2#2)(1994-12#1)
of lysophosphatidylcholine in intact##2##4##(1990-2#2)
of lysophosphatidylcholine##3##2##(1990-2#2)(2008-8#1)
of lysosomal storage disease##2##4##(2007-7#1)(2010-8#1)
of lysosomal##11##2##(1990-5#1)(1991-7#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-6#2)(2006-6#1)(2007-7#2)(2010-8#1)
of lysozyme and##3##3##(2008-7#2)(2011-2#1)
of lysozyme from##2##3##(2008-10#2)
of lysozyme##12##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2011-2#2)
of lytic##4##2##(1994-5#1)(2008-10#2)(2013-1#1)
of m values##2##3##(1997-2#2)
of m##6##2##(1994-5#1)(1997-2#2)(2008-2#1)(2013-8#2)
of m-aminophenol##2##2##(2008-10#2)
of m-axis sapphire##2##3##(2008-3#2)
of m-nisoldipine##2##2##(2011-3#2)
of m7Gua##3##2##(1994-5#3)
of mAMSA and CPT##2##4##(1994-8#2)
of mAb##2##2##(2008-11#2)
of mAbs##3##2##(1993-8#1)(1996-12#1)(2008-11#1)
of mES cells##2##3##(2008-11#2)
of mGlu##2##2##(1995-12#1)(2008-7#1)
of mGluR5##2##2##(1992-11#1)(1996-12#1)
of mGluRs in##2##3##(1995-12#2)
of mMOR##3##2##(1995-6#3)
of mPGES-1 in the##3##4##(2012-2#3)
of mPGES-1 in##4##3##(2012-2#4)
of mPGES-1##5##2##(2012-2#5)
of mRNA accumulation##2##3##(1990-12#1)(2009-8#1)
of mRNA and##6##3##(1990-5#1)(1990-7#1)(1993-6#1)(1994-11#1)(1995-6#1)(2009-12#1)
of mRNA by##3##3##(1992-10#1)(2008-2#1)(2008-9#1)
of mRNA expression of##2##4##(1990-12#1)(1996-2#1)
of mRNA expression##3##3##(1990-12#1)(1996-2#1)(2008-4#1)
of mRNA for the##2##4##(1995-8#1)(2008-4#1)
of mRNA for##9##3##(1995-12#2)(1995-2#1)(1995-8#1)(1997-2#1)(2007-8#2)(2008-4#2)
of mRNA from rat liver##2##5##(1993-6#1)(1995-2#1)
of mRNA from##5##3##(1991-2#1)(1993-6#1)(1993-9#1)(1995-2#1)(2008-7#1)
of mRNA in the##2##4##(1990-7#1)(2008-7#1)
of mRNA in##5##3##(1990-7#1)(1991-5#1)(2008-7#1)(2013-1#2)
of mRNA level##2##3##(2008-4#1)(2009-8#1)
of mRNA of the##2##4##(1995-12#1)(1997-8#1)
of mRNA of##3##3##(1995-12#1)(1997-8#1)(2008-8#1)
of mRNA transcripts##2##3##(1990-7#1)(2009-10#1)
of mRNA were##2##3##(1995-11#1)(2008-12#1)
of mRNA##76##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#4)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-8#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#7)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
of mRNAs encoding the##3##4##(1994-2#1)(1995-2#1)(2008-7#1)
of mRNAs encoding##7##3##(1994-2#1)(1995-2#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)
of mRNAs for##5##3##(1995-2#1)(1996-12#1)(2008-8#3)
of mRNAs from##3##3##(1996-12#1)(2008-10#1)(2012-2#1)
of mRNAs##27##2##(1992-8#1)(1994-2#1)(1995-2#2)(1996-12#3)(1997-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
of mSERT gene expression##2##4##(1996-12#2)
of mSERT##3##2##(1996-12#3)
of mTERT##2##2##(2008-11#2)
of mTOR signaling##2##3##(2010-3#1)(2011-2#1)
of mTOR##8##2##(2009-7#2)(2010-3#1)(2011-2#3)(2013-1#2)
of macaques##5##2##(1992-11#1)(1994-2#1)(1997-3#2)(2008-4#1)
of macerated##2##2##(1995-9#1)(2008-10#1)
of machine vision##3##3##(2007-11#2)(2008-3#1)
of machine##4##2##(2007-11#2)(2008-3#1)(2008-7#1)
of machines##2##2##(1995-1#1)(2009-6#1)
of macro##3##2##(1991-2#1)(2008-10#2)
of macro- and##2##3##(2008-10#1)(2008-12#1)
of macrocycle##4##2##(2008-10#4)
of macrocycles##2##2##(2008-10#2)
of macrokinetic##3##2##(2008-7#3)
of macrolide##2##2##(2007-12#1)(2008-10#1)
of macromolecular structures##2##3##(1990-8#1)(2008-4#1)
of macromolecular##6##2##(1990-8#1)(1991-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#1)
of macromolecule##3##2##(2008-1#1)(2008-4#1)(2010-10#1)
of macromolecules and##2##3##(2008-4#1)(2012-3#1)
of macromolecules##13##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-7#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
of macronutrients##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
of macroparasites##2##2##(2008-9#2)
of macrophage progenitors##2##3##(1990-5#1)(1991-6#1)
of macrophage##8##2##(1990-5#1)(1991-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)
of macrophages and##6##3##(1991-5#1)(1995-6#1)(2008-10#3)(2012-1#1)
of macrophages in##2##3##(2008-11#1)(2011-1#1)
of macrophages with##2##3##(1995-2#1)(2008-4#1)
of macrophages##27##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-6#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-6#1)(2011-1#1)(2012-1#1)(2013-1#3)
of macroporous##2##2##(2008-11#2)
of macroscopic haematuria##2##3##(1995-5#2)
of macroscopic objects##2##3##(2007-12#1)(2008-7#1)
of macroscopic##11##2##(1994-3#1)(1995-5#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
of macroscopically##2##2##(2008-3#1)(2013-1#1)
of macrosomia##3##2##(1996-11#1)(2008-1#2)
of macular carotenoid pigments##2##4##(2007-11#2)
of macular degeneration##5##3##(2011-2#5)
of macular##12##2##(2007-11#3)(2011-2#7)(2013-1#2)
of made up women##2##4##(2008-5#2)
of made up##3##3##(2008-5#3)
of madness##2##2##(2009-10#1)(2009-7#1)
of magnesium and##4##3##(1994-5#1)(2007-11#1)(2008-10#2)
of magnesium in different types of##2##6##(2008-10#2)
of magnesium in##7##3##(2008-10#7)
of magnesium ions on the##2##5##(1994-5#1)(2008-10#1)
of magnesium ions on##3##4##(1994-5#1)(2008-10#2)
of magnesium ions##4##3##(1994-5#1)(2008-10#2)(2008-4#1)
of magnesium were##2##3##(2008-10#2)
of magnesium##37##2##(1991-6#1)(1994-5#3)(1995-12#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#22)(2008-4#1)(2008-6#2)(2008-7#2)(2010-12#1)
of magnetic beads##5##3##(2007-12#2)(2008-10#2)(2010-11#1)
of magnetic field on##3##4##(2008-10#1)(2008-8#1)(2012-1#1)
of magnetic field##6##3##(2007-11#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-1#1)
of magnetic fields##2##3##(2008-2#1)(2008-8#1)
of magnetic resonance (MR)##2##4##(2007-7#1)(2011-2#1)
of magnetic resonance images##2##4##(1996-7#1)(2010-8#1)
of magnetic resonance imaging and##5##5##(2007-10#1)(2007-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
of magnetic resonance imaging in the##2##6##(2008-8#1)(2010-12#1)
of magnetic resonance imaging##12##4##(2007-10#1)(2007-11#1)(2007-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#2)(2012-2#1)(2012-3#1)
of magnetic resonance##25##3##(1992-3#1)(1993-11#2)(1993-5#1)(1994-8#1)(1996-11#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
of magnetic##45##2##(1992-3#1)(1993-11#2)(1993-5#1)(1994-8#1)(1996-11#1)(1996-7#1)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
of magnetically##2##2##(2009-11#1)(2009-6#1)
of magneto-optic##3##2##(2008-3#3)
of magneto-optical##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of magnitude and a##2##4##(2008-10#2)
of magnitude and the##4##4##(2008-10#3)(2008-3#1)
of magnitude and##12##3##(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#2)(2012-2#1)(2013-8#1)
of magnitude as##7##3##(1991-2#1)(1992-6#2)(2007-11#3)(2008-11#1)
of magnitude compared##2##3##(2008-2#1)(2013-8#1)
of magnitude for##5##3##(1991-5#1)(1995-5#1)(2007-12#2)(2008-10#1)
of magnitude from##5##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
of magnitude greater than that of##2##6##(1995-6#1)(2007-12#1)
of magnitude greater than that##3##5##(1995-6#1)(2007-12#1)(2008-3#1)
of magnitude greater than##4##4##(1995-6#1)(2007-12#1)(2008-3#2)
of magnitude greater##6##3##(1995-2#1)(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
of magnitude higher than that of the##3##7##(2007-12#1)(2008-10#1)(2008-7#1)
of magnitude higher than that of##4##6##(1992-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
of magnitude higher than that##5##5##(1992-8#1)(2007-12#1)(2008-10#2)(2008-7#1)
of magnitude higher than those##4##5##(1990-7#1)(1991-5#1)(2008-10#1)(2012-2#1)
of magnitude higher than##11##4##(1990-7#1)(1991-5#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#1)(2012-2#1)
of magnitude higher##13##3##(1990-7#1)(1991-5#1)(1992-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-7#1)(2008-8#1)(2012-2#1)
of magnitude in the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of magnitude in##6##3##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)
of magnitude larger than the##3##5##(2007-11#1)(2008-2#1)(2011-1#1)
of magnitude larger than##13##4##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)
of magnitude less favorable over the##2##6##(1997-2#2)
of magnitude less than the##2##5##(2008-11#1)(2008-2#1)
of magnitude less than##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
of magnitude less##6##3##(1997-2#2)(2008-11#1)(2008-2#1)(2008-3#2)
of magnitude lower than that of##2##6##(1990-11#1)(2007-11#1)
of magnitude lower than the frequency of##2##7##(1995-8#2)
of magnitude lower than the##3##5##(1995-8#2)(2008-10#1)
of magnitude lower than##9##4##(1990-11#1)(1995-8#2)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
of magnitude lower##11##3##(1990-11#1)(1990-8#1)(1995-8#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
of magnitude more sensitive to##2##5##(2008-2#1)(2008-8#1)
of magnitude more sensitive##3##4##(2008-11#1)(2008-2#1)(2008-8#1)
of magnitude more##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
of magnitude of##7##3##(1993-3#1)(2008-10#3)(2008-3#3)
of magnitude over##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of magnitude relative to##4##4##(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#1)
of magnitude than that##2##4##(2008-10#1)(2008-2#1)
of magnitude than##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of magnitude was##2##3##(2007-11#1)(2008-10#1)
of magnitude when##3##3##(2008-10#3)
of magnitude within##2##3##(2007-11#1)(2008-10#1)
of magnitude##208##2##(1990-11#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#3)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-4#1)(1997-2#2)(1997-4#1)(2007-11#15)(2007-12#16)(2008-10#64)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#31)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2012-2#4)(2012-3#1)(2013-8#3)
of magnolol##2##2##(2011-2#2)
of main and##2##3##(2008-10#1)(2011-1#1)
of main##12##2##(1994-2#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#2)
of mainly##5##2##(1996-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-8#1)
of maintained##2##2##(2008-10#1)(2009-8#1)
of maintaining a##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
of maintaining##13##2##(1992-3#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
of maintenance and repair##2##4##(2008-7#2)
of maintenance intravenous##2##3##(2008-1#2)
of maintenance##16##2##(1991-2#1)(1996-2#1)(1996-6#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
of maize (Zea mays##2##4##(2008-5#1)(2012-2#1)
of maize (Zea##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
of maize amylose##2##3##(2013-8#2)
of maize genotypes##2##3##(2008-10#2)
of maize in##2##3##(2008-10#1)(2012-2#1)
of maize streak virus (MSV)##2##5##(2008-10#2)
of maize streak##3##3##(2008-10#3)
of maize with##3##3##(2008-10#2)(2008-5#1)
of maize##60##2##(1991-10#1)(1994-8#1)(2008-10#37)(2008-12#6)(2008-5#3)(2008-8#3)(2008-9#4)(2012-2#2)(2013-8#3)
of major adverse cardiac events##2##5##(2008-11#1)(2010-12#1)
of major and minor elements of##2##6##(2008-10#2)
of major and minor##3##4##(1990-9#1)(2008-10#2)
of major complications##3##3##(2008-9#1)(2010-3#1)(2011-2#1)
of major components of##2##4##(2011-3#2)
of major components##4##3##(2011-3#2)(2012-2#1)(2013-8#1)
of major concern##2##3##(2008-10#1)(2008-7#1)
of major depression##3##3##(1996-7#2)(2008-7#1)
of major depressive##4##3##(2010-6#2)(2011-2#1)(2013-8#1)
of major genes##2##3##(2008-10#2)
of major histocompatibility complex class II##2##6##(1993-6#1)(2008-10#1)
of major histocompatibility complex class##3##5##(1993-6#1)(2008-10#1)(2013-1#1)
of major histocompatibility##5##3##(1993-6#2)(1995-12#1)(2008-10#1)(2013-1#1)
of major importance for the##2##5##(1991-2#1)(2008-11#1)
of major importance for##3##4##(1991-2#1)(1991-6#1)(2008-11#1)
of major importance in##4##4##(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
of major importance##13##3##(1991-2#1)(1991-6#1)(1997-6#1)(2008-1#1)(2008-11#2)(2008-5#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)
of major interest##2##3##(1996-12#1)(2008-7#1)
of major resistance genes##2##4##(2008-10#2)
of major vascular##2##3##(2007-10#1)(2008-1#1)
of major##111##2##(1990-6#2)(1990-9#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#22)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#3)
of making a##2##3##(1993-12#1)(2012-12#1)
of making the##3##3##(2008-8#2)(2011-2#1)
of making##17##2##(1993-12#1)(1994-2#1)(1995-3#1)(2007-11#3)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#2)
of malaria and##2##3##(2009-6#1)(2011-2#1)
of malaria cases##5##3##(2008-8#2)(2011-2#1)(2012-12#2)
of malaria control##4##3##(1997-4#1)(2008-8#1)(2012-3#2)
of malaria diagnosis##4##3##(2007-2#1)(2012-12#3)
of malaria epidemic situation after malaria basically eliminated in Wujin District##2##11##(2012-3#2)
of malaria epidemic##3##3##(2012-3#3)
of malaria from##2##3##(1991-5#1)(2007-2#1)
of malaria in the##4##4##(2011-1#1)(2012-12#2)(2012-3#1)
of malaria in##15##3##(1990-3#1)(1991-5#1)(2007-2#3)(2011-1#1)(2011-2#1)(2012-12#6)(2012-3#2)
of malaria on##2##3##(2008-8#1)(2011-2#1)
of malaria parasites##2##3##(1994-11#1)(2007-7#1)
of malaria transmission##3##3##(2008-8#3)
of malaria##66##2##(1990-12#1)(1990-3#1)(1991-5#3)(1993-8#3)(1994-11#1)(1997-4#1)(2007-2#9)(2007-7#3)(2008-10#1)(2008-8#10)(2009-6#1)(2011-1#1)(2011-2#6)(2012-12#15)(2012-2#1)(2012-3#9)
of malaria]##2##2##(1997-2#1)(2012-12#1)
of malarial##3##2##(1996-11#1)(2012-3#1)(2013-1#1)
of malate dehydrogenase##2##3##(1993-11#1)(2008-10#1)
of malate##3##2##(1991-3#1)(1993-11#1)(2008-10#1)
of malathion##2##2##(2008-10#1)(2013-1#1)
of male Filipino seafarers##3##4##(2011-2#3)
of male adults##2##3##(1991-5#1)(1996-11#1)
of male and female##10##4##(1990-12#1)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#2)(2012-2#1)(2012-3#1)
of male breast cancer##4##4##(1990-2#1)(1997-7#2)(2011-2#1)
of male factor infertility##2##4##(2007-10#1)(2008-1#1)
of male fitness##2##3##(2008-9#2)
of male gender##2##3##(2007-10#1)(2011-2#1)
of male infertility##4##3##(2008-12#1)(2009-10#1)(2009-5#1)(2011-1#1)
of male killing##2##3##(2008-8#2)
of male lambs##2##3##(2008-12#1)(2010-2#1)
of male rat sexual behavior##2##5##(1991-2#2)
of male rat##3##3##(1991-2#2)(1993-8#1)
of male rats##8##3##(1991-10#1)(1992-12#1)(1992-3#1)(1994-8#1)(1995-2#1)(2008-11#2)(2010-5#1)
of male sex pheromone##2##4##(2007-12#2)
of male sex##3##3##(2007-12#2)(2008-12#1)
of male sexual##6##3##(1994-2#1)(1995-12#1)(2009-5#1)(2009-9#1)(2012-3#2)
of male##120##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#3)(1993-9#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-11#2)(1996-6#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#6)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#9)(2008-9#9)(2009-10#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#10)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#2)
of male-male##2##2##(2008-5#1)(2008-8#1)
of maleic hydrazide##4##3##(2008-10#4)
of males and females##6##4##(1996-8#1)(2008-5#1)(2008-8#1)(2008-9#3)
of males and##14##3##(1994-6#3)(1996-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#4)(2012-12#1)(2013-7#1)
of males##59##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-6#1)(1993-8#1)(1994-6#4)(1995-6#1)(1996-6#1)(1996-8#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-6#2)(2008-8#7)(2008-9#16)(2009-9#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of malformations##3##2##(1990-8#1)(2008-10#1)(2012-3#1)
of malformed##2##2##(1996-12#1)(2008-3#1)
of malic acid##2##3##(2008-10#2)
of malic##3##2##(2008-10#3)
of malignancies##8##2##(1990-6#1)(1994-5#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
of malignancy and##4##3##(1993-8#1)(1997-6#1)(2008-10#1)(2013-1#1)
of malignancy by##2##3##(1990-3#1)(1994-12#1)
of malignancy in##5##3##(1990-10#1)(1990-2#1)(1997-2#1)(2010-11#1)(2013-8#1)
of malignancy was##2##3##(1990-2#1)(1990-3#1)
of malignancy##47##2##(1990-10#1)(1990-2#5)(1990-3#2)(1990-6#2)(1991-2#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#2)(1995-6#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of malignant and##3##3##(1991-4#1)(1995-12#1)(2010-11#1)
of malignant bone##2##3##(2008-6#1)(2011-2#1)
of malignant cells and##2##4##(2010-1#1)(2011-1#1)
of malignant cells to##2##4##(2008-11#1)(2011-2#1)
of malignant cells##9##3##(1990-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-1#2)(2011-1#1)(2011-2#1)
of malignant change in##2##4##(1990-10#1)(2008-7#1)
of malignant degeneration##2##3##(1990-11#1)(2011-2#1)
of malignant disease##4##3##(1991-4#1)(1992-2#1)(1996-11#1)(2013-1#1)
of malignant gastric outlet obstruction##3##5##(2012-2#3)
of malignant gliomas##2##3##(1993-9#1)(2008-12#1)
of malignant lesions##3##3##(2012-3#1)(2013-8#2)
of malignant lymphoma##2##3##(2008-10#1)(2009-8#1)
of malignant melanoma in##2##4##(2011-2#2)
of malignant melanoma##7##3##(2007-10#1)(2007-5#2)(2011-2#4)
of malignant mesothelioma in##2##4##(1991-12#1)(2008-8#1)
of malignant mesothelioma is##2##4##(2007-8#1)(2010-12#1)
of malignant mesothelioma##8##3##(1991-12#2)(1991-2#1)(2007-8#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
of malignant neoplasms##2##3##(1993-9#1)(2013-8#1)
of malignant plasma##2##3##(2012-12#2)
of malignant pleural mesothelioma##8##4##(1992-12#2)(1995-2#1)(1997-5#1)(2007-8#3)(2011-2#1)
of malignant pleural##9##3##(1991-6#1)(1992-12#2)(1995-2#1)(1997-5#1)(2007-8#3)(2011-2#1)
of malignant process##2##3##(2007-11#1)(2013-1#1)
of malignant transformation in##2##4##(2006-10#1)(2008-7#1)
of malignant transformation##12##3##(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-12#2)(2013-1#2)
of malignant tumors##5##3##(1996-9#1)(2008-4#1)(2010-1#1)(2011-2#2)
of malignant tumors]##2##3##(1993-2#1)(2013-1#1)
of malignant tumour##3##3##(2008-6#1)(2008-9#2)
of malignant##128##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#2)(1993-2#1)(1993-6#2)(1993-9#3)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-9#1)(1997-3#1)(1997-5#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#3)(2010-1#4)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
of malnourished##2##2##(1992-9#1)(2013-1#1)
of malnutrition and its##2##4##(2011-1#1)(2012-2#1)
of malnutrition and##5##3##(2007-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
of malnutrition in##2##3##(1991-3#1)(2012-12#1)
of malnutrition##12##2##(1991-3#1)(2007-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)
of malonaldehyde##3##2##(1990-8#2)(1992-8#1)
of malonates##2##2##(2008-11#2)
of malondialdehyde (MDA)##2##3##(2008-12#1)(2008-7#1)
of malondialdehyde##6##2##(1993-2#1)(1994-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
of malonyl-CoA in the##2##4##(1995-6#2)
of malonyl-CoA##4##2##(1995-6#4)
of malpractice##6##2##(1990-9#1)(1995-1#1)(1995-12#2)(1997-2#1)(2007-4#1)
of malt##2##2##(2008-6#1)(2009-5#1)
of maltodextrin##3##2##(2007-11#2)(2008-10#1)
of maltol##4##2##(2008-10#4)
of maltose##3##2##(1992-12#1)(1994-12#2)
of maltotriose##3##2##(1990-12#2)(1992-12#1)
of maltreatment##2##2##(2009-8#1)(2012-3#1)
of mammal##2##2##(1997-2#1)(2008-5#1)
of mammalian PKC##2##3##(1993-11#2)
of mammalian cell culture##2##4##(2008-11#2)
of mammalian cell cultures##3##4##(2008-11#3)
of mammalian cell##7##3##(2008-11#5)(2008-2#2)
of mammalian cells and##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
of mammalian cells by##3##4##(2008-11#1)(2010-10#1)(2011-2#1)
of mammalian cells to##3##4##(1994-11#1)(1994-8#1)(2009-2#1)
of mammalian cells using##2##4##(2008-11#1)(2011-1#1)
of mammalian cells##32##3##(1991-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#12)(2008-2#3)(2008-4#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#2)
of mammalian central##2##3##(1990-5#1)(1990-7#1)
of mammalian development##3##3##(1990-11#1)(1996-12#1)(1996-5#1)
of mammalian sperm##2##3##(1993-6#1)(2008-9#1)
of mammalian##89##2##(1990-11#1)(1990-5#2)(1990-7#2)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#3)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-1#2)(2008-10#2)(2008-11#22)(2008-2#6)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-9#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)
of mammals and##5##3##(1997-4#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)
of mammals##14##2##(1990-5#1)(1994-5#1)(1997-4#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-5#1)(2010-3#2)(2010-5#1)(2011-2#1)(2013-1#2)
of mammary adenocarcinoma##2##3##(1992-2#1)(2012-1#1)
of mammary gland##3##3##(1997-6#1)(2008-9#1)(2013-1#1)
of mammary preneoplasia##2##3##(1995-9#2)
of mammary tumors##4##3##(1992-9#3)(1995-9#1)
of mammary##21##2##(1991-11#1)(1992-2#1)(1992-9#5)(1993-11#2)(1994-5#2)(1995-9#3)(1997-6#2)(1997-7#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
of mammography##5##2##(1990-12#1)(1991-8#1)(1995-8#1)(2007-4#1)(2010-8#1)
of man and##2##3##(1991-6#2)
of man made mounds were##2##5##(2008-12#2)
of man##5##2##(1991-6#2)(1995-2#1)(2008-12#2)
of man-made##4##2##(1991-6#1)(2007-12#1)(2008-11#1)(2008-8#1)
of managed care and##5##4##(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(2008-11#1)
of managed care in##4##4##(1994-3#1)(1997-1#1)(1997-2#1)(2008-6#1)
of managed care on##4##4##(1992-3#1)(1994-3#1)(1997-1#1)(2006-10#1)
of managed care options available to Medicare##2##7##(1991-3#1)(1995-12#1)
of managed care options##3##4##(1991-3#1)(1995-12#1)(1997-3#1)
of managed care organizations (MCOs)##3##5##(1994-1#1)(1996-2#1)(1997-2#1)
of managed care organizations##4##4##(1994-1#1)(1996-1#1)(1996-2#1)(1997-2#1)
of managed care plans##9##4##(1994-1#2)(1994-3#1)(1995-12#3)(1996-12#2)(1997-2#1)
of managed care programs##3##4##(1995-12#1)(1995-2#1)(2008-11#1)
of managed care##55##3##(1991-3#2)(1992-2#1)(1992-3#2)(1993-12#1)(1994-1#3)(1994-12#1)(1994-3#5)(1995-1#1)(1995-12#5)(1995-2#2)(1996-1#4)(1996-12#5)(1996-2#2)(1996-3#3)(1997-1#4)(1997-2#6)(1997-3#3)(2006-10#1)(2008-11#3)(2008-6#1)
of managed competition in##2##4##(1994-3#1)(1997-2#1)
of managed competition##6##3##(1994-3#4)(1995-12#1)(1997-2#1)
of managed##68##2##(1991-3#3)(1992-2#1)(1992-3#2)(1993-12#2)(1994-1#3)(1994-12#1)(1994-3#9)(1995-1#2)(1995-12#6)(1995-2#2)(1996-1#5)(1996-12#5)(1996-2#2)(1996-3#3)(1997-1#4)(1997-2#7)(1997-3#3)(2006-10#1)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)(2012-9#1)
of management development##4##3##(1994-1#2)(1996-3#2)
of management of##11##3##(1993-1#1)(1994-9#2)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#4)(2013-1#1)
of management practices to##2##4##(2008-10#1)(2013-7#1)
of management practices##3##3##(1993-1#1)(2008-10#1)(2013-7#1)
of management that##2##3##(1992-12#1)(1993-3#1)
of management training for##2##4##(1991-2#1)(1993-1#1)
of management##54##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-1#2)(1992-12#1)(1993-1#3)(1993-3#1)(1994-1#4)(1994-3#1)(1994-9#2)(1996-1#2)(1996-3#4)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#2)(2010-6#2)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of managerial##2##2##(1994-1#1)(2009-8#1)
of managers about the##2##4##(2012-3#2)
of managers and##2##3##(2006-5#1)(2012-3#1)
of managers##9##2##(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-5#1)(2008-1#1)(2012-3#3)
of managing and##2##3##(1994-2#1)(2012-3#1)
of managing##13##2##(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
of mandatory##3##2##(1994-12#1)(1997-3#1)(2009-11#1)
of mandibular##3##2##(2007-10#1)(2007-12#2)
of manganese (II)##4##3##(2008-10#4)
of manganese and##6##3##(2008-10#5)(2013-1#1)
of manganese in urine##2##4##(2008-10#2)
of manganese in##13##3##(2008-10#13)
of manganese ions##2##3##(1990-2#1)(2008-10#1)
of manganese oxide##3##3##(2008-10#3)
of manganese peroxidase were obtained in##2##6##(2008-5#2)
of manganese peroxidase##4##3##(2008-5#2)(2008-7#2)
of manganese was##2##3##(2008-10#2)
of manganese##53##2##(1990-2#1)(2008-10#46)(2008-5#2)(2008-7#2)(2013-1#2)
of manganese(II) chloride##2##3##(2011-1#2)
of manganese(II) ions##2##3##(2008-10#2)
of manganese(II) was##3##3##(2008-10#3)
of manganese(II)##16##2##(2008-10#14)(2011-1#2)
of manganese(IV)##4##2##(2008-10#4)
of mango##4##2##(2008-10#4)
of mangrove##2##2##(2008-5#2)
of mania and##2##3##(1995-5#1)(2009-8#1)
of mania##3##2##(1995-5#1)(1996-7#1)(2009-8#1)
of manic##3##2##(1994-8#1)(2012-3#1)(2013-8#1)
of manifest##3##2##(1993-11#1)(1994-12#1)(1994-6#1)
of manipulation##9##2##(1993-1#1)(1995-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
of manipulations##4##2##(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)
of manipulative therapy##2##3##(2008-12#2)
of mannanase activity were##2##4##(2008-6#2)
of mannanase##3##2##(2008-6#3)
of mannitol has##2##3##(2008-10#2)
of mannitol was##2##3##(2008-10#1)(2011-2#1)
of mannitol##11##2##(1995-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#2)(2011-2#1)(2012-7#1)
of mantle cell lymphoma##2##4##(2008-7#1)(2009-1#1)
of mantle cell##3##3##(2008-7#1)(2009-1#1)(2012-2#1)
of manual therapy##2##3##(2008-12#1)(2012-2#1)
of manual##11##2##(1991-3#1)(1993-12#2)(2008-11#2)(2008-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
of manufactory##2##2##(2008-10#2)
of manufactured##2##2##(2008-10#1)(2013-1#1)
of manufacturing##6##2##(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)
of manuka##2##2##(2012-1#1)(2012-3#1)
of many aspects of##3##4##(1993-12#1)(2008-5#1)(2012-12#1)
of many cancers##2##3##(2008-7#1)(2012-2#1)
of many cell types##5##4##(1992-8#1)(1993-6#1)(2008-1#1)(2008-11#2)
of many cellular##4##3##(1993-6#1)(2008-5#1)(2009-4#1)(2009-5#1)
of many clinical##2##3##(2008-9#1)(2010-3#1)
of many common##3##3##(1990-8#1)(1991-9#1)(2008-10#1)
of many congenital anomalies##2##4##(2008-11#2)
of many different##2##3##(2011-2#1)(2011-3#1)
of many diseases##8##3##(1991-11#1)(2008-10#2)(2008-5#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
of many drugs and##2##4##(1992-8#1)(1994-8#1)
of many drugs##4##3##(1992-8#1)(1994-8#1)(2006-10#1)(2008-8#1)
of many eating##2##3##(1993-12#1)(2008-4#1)
of many economically important plants##2##5##(2008-10#2)
of many factors##2##3##(2008-5#1)(2011-2#1)
of many foods##2##3##(2008-10#1)(2012-2#1)
of many forms of##2##4##(1990-9#1)(2008-8#1)
of many genes##5##3##(1997-2#1)(1997-4#1)(2008-9#1)(2010-4#1)(2012-3#1)
of many health care organizations##2##5##(1994-12#1)(1996-1#1)
of many human diseases##2##4##(2006-10#1)(2009-8#1)
of many human##6##3##(2006-10#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
of many models##2##3##(2008-2#1)(2008-8#1)
of many molecular##2##3##(2008-2#1)(2010-12#1)
of many more##2##3##(2008-5#1)(2013-8#1)
of many of the##9##4##(1991-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-8#1)(2013-8#1)
of many of these##5##4##(1994-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
of many of##16##3##(1991-7#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
of many other##3##3##(2008-10#2)(2010-4#1)
of many publications##2##3##(1992-3#1)(2007-6#1)
of many researchers##2##3##(2008-10#1)(2013-1#1)
of many small##2##3##(1992-11#1)(2007-12#1)
of many species##4##3##(2007-12#1)(2009-9#1)(2013-1#1)(2013-7#1)
of many studies##2##3##(2008-7#1)(2013-7#1)
of many such##3##3##(1991-12#1)(2008-7#1)(2008-9#1)
of many tissue types##2##4##(1993-6#1)(2008-11#1)
of many vertebrates##2##3##(1993-6#1)(2008-9#1)
of many##247##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-5#2)(1992-8#2)(1993-12#2)(1993-6#5)(1994-11#1)(1994-12#3)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#3)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#3)(2007-11#1)(2007-12#8)(2007-6#1)(2008-1#2)(2008-10#39)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#10)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#12)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2011-3#3)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#7)(2013-7#4)(2013-8#4)
of map##4##2##(1993-9#1)(1996-2#1)(1997-8#1)(2007-12#1)
of mapping##5##2##(1995-8#1)(2007-11#1)(2008-2#1)(2008-8#2)
of marble industry effluent on##2##5##(2008-12#2)
of marbling##2##2##(2010-4#2)
of mares##2##2##(1994-7#1)(2012-2#1)
of marginal##4##2##(2007-12#1)(2008-10#1)(2011-3#1)(2013-1#1)
of marijuana##5##2##(1996-5#1)(2009-7#1)(2012-1#1)(2013-8#2)
of marijuana-only##2##2##(2013-8#2)
of marine algae from##2##4##(2008-11#2)
of marine constituents in coastal waters##2##6##(2008-2#2)
of marine constituents in##3##4##(2008-2#3)
of marine constituents##4##3##(2008-2#3)(2008-3#1)
of marine invertebrates##2##3##(1996-2#1)(2008-9#1)
of marine mammals##2##3##(2008-10#2)
of marine microorganisms##2##3##(2008-9#1)(2011-1#1)
of marine natural products ma'edamines A##2##6##(2013-1#2)
of marine natural products##3##4##(2009-2#1)(2013-1#2)
of marine phytoplankton##2##3##(2008-3#2)
of marine sediments##3##3##(2008-10#2)(2011-2#1)
of marine##39##2##(1994-2#1)(1996-2#1)(2007-5#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#4)
of marital##2##2##(2007-8#1)(2011-2#1)
of maritime##2##2##(2008-3#1)(2011-2#1)
of marked##9##2##(1991-1#1)(1997-6#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-8#2)
of marker##5##2##(2008-1#1)(2008-10#3)(2008-8#1)
of marker-assisted selection##2##3##(2008-10#1)(2008-5#1)
of markers in##3##3##(2008-10#2)(2008-5#1)
of markers of##3##3##(1990-3#1)(2012-2#1)(2013-8#1)
of markers was##2##3##(2008-10#1)(2008-9#1)
of markers##16##2##(1990-3#1)(1993-9#1)(1997-5#2)(2007-10#2)(2008-10#4)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of market entry##2##3##(1991-3#1)(2008-11#1)
of market##8##2##(1991-3#1)(1994-2#3)(1996-3#1)(1997-2#1)(2008-11#1)(2009-9#1)
of market-oriented##2##2##(1994-1#1)(1995-2#1)
of marketed formulation##2##3##(2010-5#1)(2012-2#1)
of marketed##5##2##(2008-10#1)(2009-12#1)(2010-3#1)(2010-5#1)(2012-2#1)
of marketing##4##2##(1993-12#1)(1997-1#1)(2008-11#1)(2008-12#1)
of marking##4##2##(2007-8#1)(2008-11#1)(2010-8#1)(2013-7#1)
of marks##3##2##(2008-9#2)(2013-8#1)
of marriage##3##2##(2008-11#2)(2009-11#1)
of married##2##2##(1994-6#1)(1996-9#1)
of marrow##2##2##(1993-2#1)(2008-6#1)
of masculinity##2##2##(2008-11#1)(2009-5#1)
of mask##4##2##(1997-3#1)(2008-2#2)(2012-2#1)
of masking##4##2##(2008-10#3)(2012-2#1)
of maspin##3##2##(1995-6#3)
of mass production##4##3##(2008-10#1)(2008-12#1)(2008-2#2)
of mass screening##2##3##(1994-11#1)(1995-4#1)
of mass spectra##2##3##(2008-10#1)(2011-2#1)
of mass spectrometry to##2##4##(2008-7#1)(2010-7#1)
of mass spectrometry##4##3##(2008-10#1)(2008-7#1)(2010-7#1)(2013-8#1)
of mass transfer##2##3##(2008-10#1)(2008-6#1)
of mass##44##2##(1990-7#1)(1991-3#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-4#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2013-1#3)(2013-8#2)
of massage therapy##2##3##(2008-11#1)(2010-6#1)
of massage##7##2##(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2010-6#1)(2011-2#1)
of massive ascites##2##3##(2007-12#2)
of massive##15##2##(1990-3#1)(1992-5#2)(1996-3#1)(2007-10#1)(2007-12#4)(2007-5#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
of mast cells##11##3##(1992-3#1)(1995-12#2)(2008-4#3)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)
of mast seeding##2##3##(2008-8#2)
of mast##16##2##(1992-3#1)(1995-12#2)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#2)(2011-2#1)
of mast-cell##2##2##(1996-8#1)(2009-6#1)
of mastectomy##3##2##(1994-2#1)(2012-3#2)
of masticatory##3##2##(1990-6#1)(1996-2#1)(2013-1#1)
of mastocytes##3##2##(1991-11#3)
of mastoid##2##2##(2008-6#1)(2008-9#1)
of matched##3##2##(1991-7#1)(1997-8#1)(2013-1#1)
of matching##5##2##(1993-9#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-3#1)
of mate recognition##4##3##(2008-8#2)(2008-9#2)
of mate##7##2##(2007-12#2)(2008-8#3)(2008-9#2)
of material and##2##3##(1995-2#1)(2008-3#1)
of material deposited in the##2##5##(1994-2#1)(1995-12#1)
of material flow systems##3##4##(1997-6#1)(2008-11#2)
of material from##3##3##(1994-2#1)(2008-3#2)
of material in##2##3##(2008-8#1)(2010-2#1)
of material removal##2##3##(2008-3#2)
of material##41##2##(1990-5#1)(1992-2#1)(1994-2#2)(1995-12#1)(1995-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#2)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of materials that##2##3##(2008-3#1)(2010-4#1)
of materials used in##2##4##(2008-10#2)
of materials used##3##3##(2008-10#2)(2013-1#1)
of materials with##3##3##(2008-3#3)
of materials##37##2##(1990-8#1)(1991-3#1)(1992-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#9)(2008-5#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of maternal acculturation##2##3##(2009-7#2)
of maternal and##4##3##(1995-2#1)(2008-9#1)(2009-7#1)(2013-8#1)
of maternal behavior##2##3##(1990-12#1)(2011-2#1)
of maternal diabetes##2##3##(1996-11#2)
of maternal health##3##3##(1994-3#1)(2012-2#1)(2013-1#1)
of maternal mRNAs##2##3##(1993-6#1)(2007-12#1)
of maternal mortality##2##3##(1994-3#1)(2012-12#1)
of maternal serum##2##3##(1990-9#1)(1992-9#1)
of maternal##45##2##(1990-12#1)(1990-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#3)(1995-2#1)(1996-11#2)(1996-2#1)(1997-7#1)(2006-10#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#5)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of maternally inherited##2##3##(1993-1#1)(2008-9#1)
of maternally##3##2##(1993-1#1)(1997-3#1)(2008-9#1)
of maternity##3##2##(2007-12#1)(2012-3#2)
of mates for##2##3##(2008-8#1)(2008-9#1)
of mates##6##2##(2008-8#4)(2008-9#2)
of mathematical and##2##3##(2008-12#1)(2009-5#1)
of mathematical##7##2##(2008-11#3)(2008-12#2)(2008-8#1)(2009-5#1)
of mathematically##2##2##(2008-3#2)
of mathematics##3##2##(2008-12#1)(2012-1#1)(2013-8#1)
of mating and##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
of mating between relatives##2##4##(2012-3#2)
of mating partners##2##3##(2008-8#2)
of mating type genes##2##4##(2008-10#2)
of mating type##5##3##(2008-10#5)
of mating types##5##3##(2008-10#5)
of mating##28##2##(1991-5#1)(2008-10#12)(2008-2#1)(2008-5#2)(2008-8#5)(2008-9#3)(2009-6#1)(2012-3#3)
of mating-type##2##2##(2008-10#1)(2012-3#1)
of matings##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
of matric water##2##3##(2008-7#2)
of matrices##8##2##(2008-10#4)(2008-11#3)(2009-4#1)
of matrine in rat plasma##2##5##(2008-10#2)
of matrine in##3##3##(2008-10#3)
of matrine##5##2##(2008-10#5)
of matrix can be##2##4##(2008-10#1)(2013-8#1)
of matrix can##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
of matrix effects##5##3##(2008-10#5)
of matrix elements##8##3##(2008-10#6)(2008-2#2)
of matrix interferences##2##3##(2008-10#2)
of matrix metalloproteinase##4##3##(1997-2#1)(2008-9#1)(2013-1#2)
of matrix metalloproteinase-2##3##3##(2013-1#1)(2013-7#2)
of matrix metalloproteinases and their inhibitors##2##6##(2008-1#1)(2008-9#1)
of matrix metalloproteinases##7##3##(1997-4#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#2)
of matrix##58##2##(1992-2#1)(1994-5#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#27)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#3)(2009-5#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of matter##6##2##(1997-6#1)(2007-12#1)(2008-10#2)(2012-2#2)
of maturation of##4##3##(2008-10#3)(2008-5#1)
of maturation##11##2##(1994-9#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-5#2)(2010-11#1)(2012-2#1)(2013-1#1)
of mature 17 kDa##2##4##(1990-12#2)
of mature adipocytes##2##3##(2008-11#1)(2010-6#1)
of mature mitochondrial aspartate aminotransferase##2##5##(1994-6#2)
of mature pollen##2##3##(2009-10#1)(2009-12#1)
of mature pseudothecia##2##3##(2008-10#2)
of mature teratoma##2##3##(2008-7#2)
of mature##55##2##(1990-11#1)(1990-12#3)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
of matured##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
of maturity of##2##3##(2008-10#1)(2008-7#1)
of maturity##8##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-8#1)
of maxillary sensilla styloconica##2##4##(2008-8#2)
of maxillary sinus##2##3##(2008-5#1)(2011-2#1)
of maxillary##15##2##(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#3)(2011-7#1)(2013-1#5)
of maxillofacial infections##3##3##(2007-12#3)
of maxillofacial##6##2##(2007-12#4)(2012-12#2)
of maxillomandibular fixation##2##3##(2007-12#1)(2013-1#1)
of maxima##5##2##(1995-5#1)(2008-3#1)(2008-9#3)
of maximal force##2##3##(1996-5#1)(2011-1#1)
of maximal##9##2##(1990-2#1)(1995-11#1)(1996-5#1)(2008-5#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)
of maximizing the##2##3##(2008-2#1)(2009-10#1)
of maximizing##3##2##(2008-2#1)(2008-8#1)(2009-10#1)
of maximum likelihood##2##3##(2008-3#1)(2008-9#1)
of maximum oxygen uptake##2##4##(2013-8#2)
of maximum temperature##2##3##(2008-10#1)(2011-1#1)
of maximum##45##2##(1992-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-8#2)
of mdx##2##2##(1995-12#2)
of meals##4##2##(1994-6#1)(2008-4#2)(2013-1#1)
of mealybug wilt of pineapple##2##5##(2008-10#2)
of mealybug##3##2##(2008-10#3)
of mean age##3##3##(1994-3#1)(2008-7#1)(2010-12#1)
of mean arterial##2##3##(1992-3#1)(1995-12#1)
of mean force##2##3##(1997-8#1)(2008-10#1)
of mean normal##2##3##(1990-2#1)(1990-8#1)
of mean values##2##3##(2008-2#1)(2008-5#1)
of mean volumes##2##3##(2012-12#2)
of mean##33##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-8#1)(2008-10#8)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-5#1)(2013-1#1)
of meaning and##2##3##(2008-12#1)(2008-7#1)
of meaning##4##2##(1995-1#1)(2008-12#1)(2008-7#1)(2012-3#1)
of meaningful##3##2##(1991-1#1)(2008-12#1)(2008-8#1)
of means of##2##3##(1994-12#1)(2008-11#1)
of means##5##2##(1992-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
of measles and##2##3##(2012-12#2)
of measles##8##2##(1995-3#2)(1995-5#2)(2009-5#1)(2012-12#3)
of measles-specific##2##2##(2008-12#2)
of measurable##3##2##(1991-2#1)(2007-12#1)(2008-2#1)
of measure##2##2##(2008-9#1)(2013-8#1)
of measured and##2##3##(2008-3#2)
of measured##12##2##(1990-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#4)(2011-1#1)(2012-1#1)(2013-1#1)
of measurement and##7##3##(1992-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
of measurement data##3##3##(2008-11#2)(2008-2#1)
of measurement error and temporal variability##2##6##(1992-9#2)
of measurement error in##2##4##(1997-4#1)(2008-3#1)
of measurement error##7##3##(1992-9#2)(1997-4#1)(2008-3#3)(2008-7#1)
of measurement for##2##3##(1990-9#1)(2008-10#1)
of measurement in##2##3##(2008-7#1)(2013-1#1)
of measurement of the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of measurement of##9##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2013-8#1)
of measurement sensitivity##2##3##(2008-3#2)
of measurement##67##2##(1990-9#1)(1992-5#1)(1992-9#2)(1993-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#19)(2008-4#2)(2008-5#1)(2008-7#4)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#5)(2013-8#1)
of measurements and##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
of measurements at##2##3##(2008-10#1)(2012-2#1)
of measurements from##2##3##(2008-3#2)
of measurements in##4##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-8#1)
of measurements made##2##3##(2008-9#2)
of measurements of##9##3##(2007-12#2)(2008-2#2)(2008-3#4)(2008-5#1)
of measurements taken##3##3##(1995-12#1)(2008-2#1)(2012-1#1)
of measurements was##4##3##(1994-1#1)(2008-10#2)(2011-2#1)
of measurements were##2##3##(2008-10#1)(2011-2#1)
of measurements with a##2##4##(2008-2#2)
of measurements##57##2##(1994-1#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#1)(2008-2#7)(2008-3#10)(2008-5#2)(2008-8#1)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
of measures are##2##3##(2008-12#1)(2012-12#1)
of measures##8##2##(1992-1#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
of measuring productivity##3##3##(1991-12#2)(1992-3#1)
of measuring the##11##3##(1997-3#1)(1997-7#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)
of measuring##59##2##(1990-2#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#9)(2008-3#13)(2008-4#3)(2008-7#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
of meat and bone meal##2##5##(2008-10#2)
of meat and##5##3##(2008-10#4)(2010-4#1)
of meat from##2##3##(2010-4#2)
of meat products##3##3##(2008-10#3)
of meat##24##2##(2008-10#11)(2009-4#1)(2010-2#2)(2010-4#9)(2013-1#1)
of mebendazole##3##2##(2008-10#3)
of mechanical and##3##3##(2008-2#1)(2009-12#1)(2012-2#1)
of mechanical complications##2##3##(2007-11#1)(2013-8#1)
of mechanical efficacy of##2##4##(2007-11#2)
of mechanical forces##2##3##(2009-8#1)(2013-8#1)
of mechanical loading##3##3##(1994-6#1)(2009-8#1)(2010-9#1)
of mechanical properties##3##3##(2008-3#1)(2012-2#1)(2013-8#1)
of mechanical ventilation##2##3##(2010-6#1)(2012-12#1)
of mechanical##49##2##(1994-6#1)(1997-8#1)(2007-10#3)(2007-11#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#3)
of mechanically##8##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2010-12#1)
of mechanism-based##2##2##(2007-11#1)(2008-3#1)
of mechanisms by which##2##4##(2008-6#1)(2008-9#1)
of mechanisms involved in##3##4##(1997-3#1)(2008-9#1)(2009-12#1)
of mechanisms of##2##3##(2008-10#1)(2012-2#1)
of mechanisms such as##2##4##(2007-5#1)(2009-11#1)
of mechanisms that##2##3##(1990-2#1)(2012-12#1)
of mechanisms##26##2##(1990-2#1)(1990-8#2)(1997-3#1)(1997-5#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
of mechanistic##3##2##(2009-8#1)(2010-6#1)(2013-1#1)
of mechanotherapy##3##2##(2008-12#3)
of mechanotransduction##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
of medaka##2##2##(2009-7#2)
of media and regulatory##2##4##(2008-11#2)
of media and##3##3##(2008-11#3)
of media for##3##3##(1995-12#1)(2007-11#1)(2008-12#1)
of media##25##2##(1992-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#1)
of medial septal##2##3##(1992-8#1)(1996-12#1)
of medial##13##2##(1992-5#1)(1992-8#1)(1996-12#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#2)
of median##4##2##(1992-5#2)(2007-8#1)(2013-8#1)
of mediastinal##7##2##(1991-8#1)(1997-8#1)(2007-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
of mediastinitis##2##2##(2007-8#1)(2013-1#1)
of mediating##6##2##(1992-9#1)(2008-10#3)(2010-1#1)(2010-8#1)
of mediator##2##2##(1991-8#1)(2008-10#1)
of mediators of##2##3##(2010-3#1)(2012-3#1)
of mediators##4##2##(1992-2#1)(2008-7#1)(2010-3#1)(2012-3#1)
of medical and mental health records##5##6##(1991-12#3)(1992-3#2)
of medical and nursing##2##4##(1991-12#1)(1996-6#1)
of medical and surgical care##2##5##(1993-12#1)(2008-11#1)
of medical and surgical##6##4##(1993-12#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-6#1)
of medical and##24##3##(1991-12#4)(1991-6#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-12#2)(1996-6#1)(1997-1#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
of medical care are##2##4##(2010-3#1)(2011-2#1)
of medical care in the##2##5##(1994-11#1)(1997-1#1)
of medical care##18##3##(1991-12#2)(1991-2#1)(1992-2#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#3)
of medical consultations in##2##4##(1990-12#1)(1993-6#1)
of medical costs and##2##4##(2010-5#1)(2010-8#1)
of medical costs##3##3##(1994-12#1)(2010-5#1)(2010-8#1)
of medical device##3##3##(2009-11#1)(2011-1#1)(2011-2#1)
of medical devices##4##3##(2008-11#2)(2008-3#1)(2010-6#1)
of medical disorders##2##3##(2012-12#1)(2012-2#1)
of medical education and##2##4##(2008-11#1)(2010-11#1)
of medical education##8##3##(1992-6#2)(1994-12#1)(2008-11#3)(2010-11#2)
of medical emergencies in India##2##5##(1995-12#1)(2009-4#1)
of medical emergencies in##3##4##(1995-12#1)(2009-4#1)(2010-9#1)
of medical emergencies##5##3##(1995-12#1)(2008-1#2)(2009-4#1)(2010-9#1)
of medical entomology and##2##4##(2010-1#2)
of medical entomology in##3##4##(2010-1#3)
of medical entomology##9##3##(2010-1#9)
of medical equipment##2##3##(2008-11#1)(2010-8#1)
of medical ethics##2##3##(2007-11#1)(2011-2#1)
of medical factors##2##3##(1997-5#1)(2008-11#1)
of medical graduates##4##3##(1992-1#1)(1994-12#2)(2009-10#1)
of medical imaging##3##3##(1996-1#1)(2007-5#1)(2009-10#1)
of medical knowledge##2##3##(1991-11#1)(2011-2#1)
of medical malpractice##2##3##(1997-1#1)(2012-3#1)
of medical management##2##3##(1992-9#1)(2010-8#1)
of medical necessity##2##3##(2011-2#2)
of medical personnel##2##3##(1992-3#1)(1994-6#1)
of medical practice##4##3##(1991-12#1)(1993-3#1)(1997-3#1)(2013-7#1)
of medical problems##2##3##(2012-12#1)(2012-3#1)
of medical procedures and##2##4##(1992-2#1)(1996-3#1)
of medical procedures##5##3##(1992-2#1)(1995-12#1)(1996-3#1)(2008-4#1)(2011-2#1)
of medical professionals##2##3##(1995-6#1)(1996-9#1)
of medical records and##4##4##(1994-3#2)(2013-1#1)(2013-8#1)
of medical records##9##3##(1992-5#1)(1994-3#2)(2010-4#1)(2013-1#3)(2013-8#2)
of medical resources and##2##4##(1994-3#1)(1996-2#1)
of medical resources##4##3##(1992-2#1)(1994-3#1)(1996-2#1)(2010-8#1)
of medical school##2##3##(1991-3#1)(2012-3#1)
of medical schools##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
of medical sciences##2##3##(2007-7#1)(2008-12#1)
of medical screening##2##3##(1995-12#1)(2008-9#1)
of medical services##9##3##(1993-3#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#1)
of medical specialists in##3##4##(1991-12#1)(1995-12#1)(2008-7#1)
of medical specialists##4##3##(1991-12#1)(1995-12#1)(2008-7#2)
of medical staff credentialing##4##4##(1993-1#1)(1993-12#3)
of medical staff##11##3##(1991-2#1)(1992-1#1)(1993-1#1)(1993-12#5)(1994-1#1)(2007-8#1)(2008-12#1)
of medical students##6##3##(1992-6#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
of medical technology##2##3##(1992-1#1)(2010-8#1)
of medical therapy##3##3##(2007-11#1)(2009-9#1)(2010-8#1)
of medical training##2##3##(1995-9#1)(2012-2#1)
of medical treatment##3##3##(1997-5#1)(2007-6#1)(2011-2#1)
of medical##265##2##(1990-12#1)(1991-11#1)(1991-12#10)(1991-2#4)(1991-3#1)(1991-6#3)(1992-1#4)(1992-12#1)(1992-2#4)(1992-3#5)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#2)(1993-12#8)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#5)(1994-6#2)(1994-9#1)(1995-1#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#4)(1996-9#1)(1997-1#5)(1997-3#2)(1997-4#1)(1997-5#3)(1997-8#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#11)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#11)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#8)(2010-9#1)(2011-1#2)(2011-2#19)(2012-12#3)(2012-2#2)(2012-3#12)(2013-1#10)(2013-7#3)(2013-8#7)
of medically##2##2##(2008-10#1)(2008-7#1)
of medication administration##2##3##(2008-2#1)(2011-1#1)
of medication errors and##4##4##(2010-8#1)(2011-1#3)
of medication errors##6##3##(2010-8#1)(2011-1#5)
of medication in##2##3##(2008-6#1)(2011-1#1)
of medication##32##2##(1992-3#1)(1994-7#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#8)(2011-2#1)(2012-12#4)(2012-3#1)
of medications##10##2##(1995-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#4)(2011-2#1)
of medicinal plants##6##3##(2008-10#1)(2008-11#2)(2009-10#1)(2010-6#1)(2012-2#1)
of medicinal##9##2##(2008-10#1)(2008-11#3)(2009-10#1)(2010-6#1)(2012-2#1)(2012-3#2)
of medicine and##3##3##(1991-6#1)(1992-3#1)(2010-1#1)
of medicine are##3##3##(1997-5#1)(2013-1#2)
of medicine in##8##3##(1994-5#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-12#1)
of medicine##65##2##(1990-2#1)(1991-1#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#2)
of medicine]##3##2##(1995-3#1)(1996-3#1)(2013-1#1)
of medicines in##4##3##(2008-1#1)(2008-11#2)(2011-2#1)
of medicines##17##2##(1992-2#1)(1996-11#1)(2008-1#1)(2008-11#5)(2008-8#2)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#3)
of medigap##4##2##(1991-2#1)(1992-2#2)(1997-3#1)
of medium and large##2##4##(2008-5#1)(2009-12#1)
of medium and##3##3##(2008-11#1)(2008-5#1)(2009-12#1)
of medium was##2##3##(2008-11#1)(2011-1#1)
of medium##29##2##(1990-7#1)(1992-6#1)(1993-12#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#12)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2009-12#1)(2011-1#1)
of medium-sized##2##2##(1996-8#1)(2013-7#1)
of medullary##3##2##(1996-5#1)(2008-7#1)(2008-8#1)
of medulloblastoma##3##2##(1993-9#1)(2008-7#1)(2009-1#1)
of meeting##5##2##(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
of meetings##2##2##(2008-7#1)(2010-8#1)
of mefenacet##4##2##(2008-10#4)
of mefenamic acid##4##3##(2012-2#4)
of mefenamic##5##2##(2012-2#5)
of mefenoxam sensitivity was##2##4##(2008-10#2)
of mefenoxam##3##2##(2008-10#3)
of mefloquine for malaria prophylaxis##2##5##(2011-2#2)
of mefloquine##4##2##(1996-8#1)(2011-2#3)
of megacolon##2##2##(1993-6#1)(1994-12#1)
of megsin##2##2##(2008-7#2)
of meiosis and##2##3##(2010-3#1)(2012-2#1)
of meiosis##4##2##(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
of meiosis-specific##3##2##(1995-8#1)(2011-2#1)(2012-3#1)
of meiotic maturation##2##3##(1992-11#1)(1994-8#1)
of meiotic prophase##2##3##(2007-12#2)
of meiotic telomeres##2##3##(2011-2#2)
of meiotic##9##2##(1992-11#1)(1994-8#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)
of melanin##4##2##(1996-9#1)(2008-5#2)(2008-9#1)
of melanin-concentrating hormone##3##3##(1993-5#3)
of melanocortins##2##2##(1993-5#2)
of melanocyte##2##2##(2008-5#1)(2008-9#1)
of melanocytes##5##2##(1997-7#1)(2008-5#2)(2008-8#1)(2011-2#1)
of melanogenesis##4##2##(1993-5#1)(1994-12#1)(2008-5#1)(2013-1#1)
of melanoma cells to##3##4##(2009-4#2)(2012-3#1)
of melanoma cells##8##3##(1990-5#1)(2007-10#1)(2008-8#2)(2009-4#2)(2012-3#2)
of melanoma##25##2##(1990-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(2007-10#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2010-8#1)(2011-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
of melanophores##2##2##(1992-3#1)(2008-5#1)
of melanosomes##2##2##(2008-1#1)(2008-8#1)
of melanotrope cells##3##3##(1993-5#3)
of melanotrope##5##2##(1993-5#5)
of melanotropic peptides##2##3##(1993-5#2)
of melanotropic##3##2##(1993-5#2)(1995-2#1)
of melatonin and its derivatives##2##5##(2008-10#2)
of melatonin and its##3##4##(2008-10#3)
of melatonin and##6##3##(1991-12#1)(1994-5#1)(2008-10#3)(2011-2#1)
of melatonin at##3##3##(1992-3#1)(1995-3#1)(2008-3#1)
of melatonin by##2##3##(1994-5#1)(2008-10#1)
of melatonin in the##3##4##(1991-12#1)(1995-11#1)(2008-11#1)
of melatonin in##8##3##(1991-12#1)(1995-11#2)(1996-2#1)(2008-10#1)(2008-11#2)(2009-12#1)
of melatonin is##2##3##(1994-5#1)(2013-7#1)
of melatonin on##4##3##(1990-5#1)(1991-12#1)(1996-2#1)(2010-12#1)
of melatonin receptors##2##3##(1995-12#1)(2013-7#1)
of melatonin##34##2##(1990-5#1)(1991-12#3)(1992-3#1)(1994-5#3)(1995-11#2)(1995-12#1)(1995-3#2)(1996-2#3)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#2)(2013-7#3)
of melittin##7##2##(1992-6#4)(2008-10#3)
of melon##5##2##(2008-10#5)
of melphalan##2##2##(2011-3#2)
of melting##2##2##(2008-10#1)(2008-4#1)
of member satisfaction##2##3##(1996-3#2)
of member##3##2##(1996-2#1)(1996-3#2)
of members and chairs##2##4##(2009-4#2)
of members and##3##3##(1996-3#1)(2009-4#2)
of members of the Association for##2##6##(1994-3#2)
of members of the family##2##5##(2008-10#1)(2008-6#1)
of members of the##9##4##(1994-3#2)(1996-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
of members of##10##3##(1994-3#2)(1996-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
of members##20##2##(1994-3#3)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
of membrane adsorption##2##3##(2008-7#1)(2010-5#1)
of membrane and##2##3##(1993-8#1)(2008-10#1)
of membrane cholesterol##3##3##(1991-5#1)(2008-8#1)(2011-1#1)
of membrane components##3##3##(1992-11#1)(2009-10#1)(2011-1#1)
of membrane composition and##2##4##(2008-10#2)
of membrane composition##4##3##(2008-10#4)
of membrane damage##2##3##(2009-6#2)
of membrane fatty##3##3##(2011-1#2)(2011-2#1)
of membrane fluidity##2##3##(1991-5#1)(1996-12#1)
of membrane lipid biophysical properties##2##5##(2008-9#2)
of membrane lipid biophysical##3##4##(2008-9#3)
of membrane lipid##4##3##(2008-9#4)
of membrane lipids##5##3##(1991-5#1)(2008-8#2)(2009-6#1)(2013-1#1)
of membrane potential##6##3##(1990-8#1)(1992-3#1)(1997-1#1)(2008-10#1)(2008-9#2)
of membrane protein##8##3##(1990-2#2)(1990-5#3)(2008-10#1)(2008-7#1)(2011-1#1)
of membrane proteins and##2##4##(2008-8#2)
of membrane proteins into the##2##5##(1992-12#1)(2012-1#1)
of membrane proteins##19##3##(1990-5#2)(1992-11#1)(1992-12#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#3)(2011-1#2)(2011-2#1)(2012-1#1)
of membrane surfaces##2##3##(2008-6#2)
of membrane with##2##3##(1992-6#1)(2008-5#1)
of membrane##120##2##(1990-12#2)(1990-2#2)(1990-5#5)(1990-7#2)(1990-8#1)(1991-5#6)(1992-11#3)(1992-12#2)(1992-3#2)(1992-6#3)(1993-11#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#11)(2008-9#8)(2009-10#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#8)(2011-2#4)(2012-1#1)(2013-1#1)
of membrane-associated (NiFe) and (NiFeSe) hydrogenases of Desulfovibrio vulgaris##2##9##(1990-8#2)
of membrane-associated##4##2##(1990-8#2)(1993-8#1)(1994-3#1)
of membrane-bound##5##2##(1991-5#2)(1996-8#1)(2006-12#1)(2008-4#1)
of membranes and##2##3##(2007-12#1)(2008-10#1)
of membranes of##2##3##(1990-12#1)(1997-6#1)
of membranes with##2##3##(1993-6#1)(2013-1#1)
of membranes##20##2##(1990-11#1)(1990-12#2)(1991-9#1)(1992-7#1)(1992-8#1)(1993-6#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#2)
of membranoproliferative##2##2##(2007-7#2)
of membranous##6##2##(2007-7#1)(2008-1#1)(2008-5#1)(2010-6#2)(2011-2#1)
of memories##2##2##(2008-4#1)(2010-8#1)
of memory and attention##2##4##(1991-5#1)(1991-6#1)
of memory and##4##3##(1991-5#1)(1991-6#1)(2008-7#1)(2012-1#1)
of memory dysfunction##2##3##(1993-12#2)
of memory formation##2##3##(1993-12#1)(1994-3#1)
of memory impairment##2##3##(1994-6#1)(2009-10#1)
of memory in##3##3##(1992-10#1)(2007-8#1)(2008-6#1)
of memory##43##2##(1991-5#1)(1991-6#1)(1992-10#1)(1993-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1996-2#1)(2007-8#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#3)(2010-8#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
of men aged##2##3##(1993-9#1)(2008-7#1)
of men and women in##2##5##(2007-7#1)(2010-12#1)
of men and women##10##4##(1994-11#1)(1995-12#1)(1996-6#1)(2007-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-8#1)
of men and##15##3##(1994-11#1)(1995-12#1)(1996-6#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2013-8#1)
of men in the##2##4##(2008-1#1)(2011-2#1)
of men in##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
of men undergoing##2##3##(2010-10#2)
of men who have sex with men##3##7##(2009-5#1)(2011-1#2)
of men who##4##3##(2009-5#1)(2010-10#1)(2011-1#2)
of men##42##2##(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-8#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#4)(2009-9#1)(2010-10#4)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2013-8#2)
of menarche was##2##3##(2013-1#2)
of menarche##3##2##(2013-1#3)
of meningeal hemangiopericytoma##2##3##(2008-6#2)
of meningeal melanocytoma##2##3##(2008-7#1)(2012-2#1)
of meningeal##6##2##(2008-6#2)(2008-7#2)(2009-11#1)(2012-2#1)
of meningioma##3##2##(2010-11#2)(2011-2#1)
of meningitis caused by##3##4##(1992-11#1)(2007-12#1)(2009-11#1)
of meningitis in##3##3##(1993-12#1)(2008-7#1)(2013-7#1)
of meningitis##16##2##(1992-11#1)(1993-12#2)(2007-12#1)(2008-12#1)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
of meningococcal disease in##2##4##(2007-2#1)(2013-8#1)
of meningococcal disease##4##3##(1991-8#1)(2007-12#1)(2007-2#1)(2013-8#1)
of meningococcal##7##2##(1990-12#1)(1991-8#2)(2007-12#1)(2007-2#1)(2010-10#1)(2013-8#1)
of meniscal##2##2##(1993-11#2)
of menopausal symptoms##2##3##(2008-4#1)(2011-1#1)
of menopausal##4##2##(1991-12#1)(2008-4#1)(2010-6#1)(2011-1#1)
of menopause##4##2##(1993-11#1)(1994-12#1)(2013-8#2)
of menorrhagia##2##2##(1991-11#1)(2008-8#1)
of menstruation##3##2##(2008-11#1)(2008-4#2)
of mental and behavioral##2##4##(1996-12#1)(1997-1#1)
of mental and##4##3##(1993-12#1)(1996-12#1)(1997-1#1)(2008-12#1)
of mental disorders##9##3##(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-8#2)
of mental health and##7##4##(1996-12#1)(1997-2#1)(2007-2#1)(2009-10#1)(2011-2#1)(2013-8#2)
of mental health care##2##4##(1994-1#1)(1995-1#1)
of mental health issues in##2##5##(2008-12#2)
of mental health nurses in##2##5##(2010-5#1)(2011-1#1)
of mental health nursing##4##4##(2008-11#2)(2008-12#1)(2009-6#1)
of mental health problems##2##4##(2012-12#1)(2013-1#1)
of mental health professionals##5##4##(1994-1#3)(2008-11#1)(2008-2#1)
of mental health services in##2##5##(2008-11#1)(2008-2#1)
of mental health services##11##4##(1994-1#2)(1996-12#1)(1996-3#3)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#2)
of mental health workers##2##4##(2008-2#2)
of mental health##56##3##(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(1994-1#7)(1995-1#3)(1996-12#2)(1996-3#3)(1997-2#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-11#5)(2008-12#3)(2008-2#5)(2009-10#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
of mental illness and the##2##5##(2009-7#1)(2012-3#1)
of mental illness and##3##4##(2009-7#1)(2011-2#1)(2012-3#1)
of mental illness in##2##4##(1993-5#1)(2013-7#1)
of mental illness##14##3##(1993-5#1)(2008-12#4)(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
of mental illnesses##3##3##(2009-5#1)(2011-1#1)(2012-2#1)
of mental impairment##5##3##(1990-3#5)
of mental processes##2##3##(1992-9#1)(2013-8#1)
of mental retardation##4##3##(1992-5#1)(1995-2#1)(2009-5#1)(2012-1#1)
of mental##113##2##(1990-3#5)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#7)(1995-1#3)(1995-11#1)(1995-2#1)(1996-12#3)(1996-3#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-11#6)(2008-12#8)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#8)
of mentally ill##5##3##(1990-2#1)(1992-3#1)(1996-9#1)(2008-2#1)(2009-7#1)
of mentally##6##2##(1990-2#1)(1992-3#1)(1994-7#1)(1996-9#1)(2008-2#1)(2009-7#1)
of menthofuran (II)##2##3##(1990-12#2)
of menthol cigarette##2##3##(2011-1#2)
of menthol##4##2##(1994-6#2)(2011-1#2)
of meperidine##2##2##(2011-2#2)
of mequitazine and the IS##2##5##(2008-10#2)
of mequitazine##4##2##(2008-10#4)
of merchant##2##2##(1991-12#1)(2008-11#1)
of mercuric chloride##2##3##(2008-7#2)
of mercuric##3##2##(2008-3#1)(2008-7#2)
of mercury and##4##3##(1995-3#1)(2008-10#3)
of mercury by##4##3##(2008-10#4)
of mercury film##2##3##(2008-10#2)
of mercury from coal##3##4##(2008-6#3)
of mercury from##12##3##(1995-6#3)(2008-10#6)(2008-6#3)
of mercury in agroindustrial samples by##2##6##(2008-10#2)
of mercury in the##3##4##(2008-10#2)(2013-1#1)
of mercury in##21##3##(1995-6#2)(2008-10#18)(2013-1#1)
of mercury ions##2##3##(2008-10#2)
of mercury species##5##3##(2008-10#5)
of mercury vapour##3##3##(1995-6#1)(2008-10#2)
of mercury with##3##3##(2008-10#3)
of mercury##88##2##(1992-11#1)(1993-6#1)(1995-3#1)(1995-6#7)(2008-10#73)(2008-6#3)(2013-1#2)
of mercury(II) and lead(II) in##2##5##(2008-10#2)
of mercury(II) and lead(II)##3##4##(2008-10#3)
of mercury(II) and##4##3##(2008-10#4)
of mercury(II) by##5##3##(2008-10#5)
of mercury(II) in##2##3##(2008-10#2)
of mercury(II) ions##2##3##(2008-10#2)
of mercury(II) with##2##3##(2008-10#2)
of mercury(II)##24##2##(2008-10#24)
of mercy##2##2##(1993-5#1)(2008-6#1)
of mergers on health maintenance organization##2##6##(1997-1#2)
of mergers##3##2##(1997-1#3)
of merit and##3##3##(2008-10#3)
of merit for##4##3##(2007-12#2)(2008-10#1)(2011-2#1)
of merit such as limit of detection##2##7##(2008-10#2)
of merit##48##2##(1996-3#1)(2007-11#4)(2007-12#5)(2008-10#29)(2008-2#2)(2008-3#6)(2011-2#1)
of merits in##2##3##(2008-10#2)
of merits##4##2##(2008-10#4)
of mesalazine##2##2##(2010-11#2)
of mesangial cells##3##3##(1993-8#1)(1995-11#1)(2011-2#1)
of mesangial##5##2##(1993-8#1)(1995-11#1)(1996-6#1)(2007-7#1)(2011-2#1)
of mesenchymal cells##2##3##(2008-11#1)(2012-12#1)
of mesenchymal origin##4##3##(2007-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
of mesenchymal stem cells (MSCs)##2##5##(2008-5#1)(2010-8#1)
of mesenchymal stem cells from##3##5##(2008-9#2)(2012-2#1)
of mesenchymal stem cells in##2##5##(2012-1#1)(2012-12#1)
of mesenchymal stem cells##16##4##(2008-5#1)(2008-9#3)(2010-12#1)(2010-8#1)(2012-1#6)(2012-12#2)(2012-2#1)(2012-7#1)
of mesenchymal stem##17##3##(2008-11#1)(2008-5#1)(2008-9#3)(2010-12#1)(2010-8#1)(2012-1#6)(2012-12#2)(2012-2#1)(2012-7#1)
of mesenchymal##27##2##(1994-5#1)(2007-8#1)(2008-11#4)(2008-5#1)(2008-9#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#6)(2012-12#4)(2012-2#1)(2012-7#1)
of mesenteric##4##2##(1990-6#1)(1992-6#1)(2007-7#1)(2008-10#1)
of mesh##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
of mesna from##2##3##(2008-10#2)
of mesna##6##2##(2008-10#6)
of meso- and##2##3##(2008-7#1)(2013-1#1)
of mesodermal##2##2##(2012-7#1)(2013-1#1)
of mesolimbic dopamine##2##3##(1993-12#1)(1993-6#1)
of mesolimbic##3##2##(1991-1#1)(1993-12#1)(1993-6#1)
of mesoporous##2##2##(2008-10#1)(2010-4#1)
of mesothelial cells##3##3##(2013-1#3)
of mesothelioma##7##2##(1991-12#6)(1997-5#1)
of messages##3##2##(2007-12#1)(2009-6#1)(2010-11#1)
of messenger RNA (mRNA)##2##4##(1994-8#1)(2008-4#1)
of messenger RNA##4##3##(1990-7#1)(1994-8#1)(2008-1#1)(2008-4#1)
of messenger##7##2##(1990-7#1)(1992-9#1)(1994-8#1)(2008-1#1)(2008-4#2)(2010-9#1)
of meta-analysis and the##2##4##(1996-6#1)(2010-11#1)
of meta-analysis and##3##3##(1992-2#1)(1996-6#1)(2010-11#1)
of meta-analysis##9##2##(1992-2#1)(1996-6#3)(1996-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-11#1)
of metabolic activity##2##3##(1991-5#1)(2007-8#1)
of metabolic and hormonal##2##4##(1994-12#1)(2013-7#1)
of metabolic and physiologic##2##4##(2008-5#1)(2012-1#1)
of metabolic and##9##3##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
of metabolic compartmentation##2##3##(2012-2#2)
of metabolic complications in renal transplant recipients is##2##8##(2008-3#2)
of metabolic control analysis##2##4##(1990-7#2)
of metabolic control##3##3##(1990-7#2)(2012-4#1)
of metabolic disorders##4##3##(1997-4#1)(2008-3#1)(2008-4#1)(2010-8#1)
of metabolic fluxes##2##3##(2008-11#1)(2013-1#1)
of metabolic functions##2##3##(2008-10#2)
of metabolic origin##2##3##(2007-8#1)(2011-2#1)
of metabolic pathways##7##3##(2008-11#1)(2008-3#1)(2008-7#3)(2009-8#1)(2010-7#1)
of metabolic reactions##2##3##(2008-7#2)
of metabolic syndrome (MS)##3##4##(2008-3#2)(2011-1#1)
of metabolic syndrome and##3##4##(2008-3#1)(2013-1#2)
of metabolic syndrome in overweight##2##5##(2012-12#2)
of metabolic syndrome in##6##4##(2008-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
of metabolic syndrome##34##3##(2008-1#1)(2008-11#1)(2008-3#17)(2008-7#1)(2010-10#1)(2011-1#2)(2012-12#4)(2012-2#2)(2013-1#5)
of metabolic##94##2##(1990-7#3)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-12#1)(1997-4#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#22)(2008-4#1)(2008-5#1)(2008-7#10)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-4#1)(2012-5#1)(2013-1#8)(2013-7#1)
of metabolically##5##2##(1992-9#1)(1994-2#1)(2008-11#1)(2008-4#2)
of metabolism##15##2##(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2013-8#1)
of metabolites and##2##3##(2008-12#1)(2013-8#1)
of metabolites by##2##3##(1993-8#1)(2010-5#1)
of metabolites in##3##3##(2008-10#2)(2010-5#1)
of metabolites of##2##3##(1991-12#1)(1996-5#1)
of metabolites##22##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-8#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-5#3)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#1)
of metabotropic glutamate##2##3##(1995-12#1)(1996-5#1)
of metabotropic##3##2##(1992-12#1)(1995-12#1)(1996-5#1)
of metacentric chromosomes##2##3##(2008-12#2)
of metacentric##3##2##(2008-12#2)(2010-3#1)
of metal Pd##2##3##(2008-10#2)
of metal atoms##2##3##(1996-2#1)(2006-4#1)
of metal cations##4##3##(1995-2#1)(2008-10#3)
of metal complexes##2##3##(2008-10#2)
of metal concentration##2##3##(2008-10#1)(2008-5#1)
of metal concentrations##2##3##(2008-10#1)(2008-2#1)
of metal content##3##3##(2008-10#2)(2010-11#1)
of metal distributions in##2##4##(2010-11#2)
of metal ion solution##2##4##(2008-10#2)
of metal ion##15##3##(1994-11#1)(2008-10#13)(2010-11#1)
of metal ions Cu(II) and##2##5##(2008-10#2)
of metal ions and##5##4##(2008-10#5)
of metal ions by##3##4##(2008-10#3)
of metal ions from##4##4##(2008-10#4)
of metal ions in the##3##5##(2008-10#3)
of metal ions in##13##4##(1997-7#1)(2008-10#12)
of metal ions is##2##4##(2008-10#2)
of metal ions to the##2##5##(2008-1#1)(2008-10#1)
of metal ions to##3##4##(2008-1#1)(2008-10#2)
of metal ions using##4##4##(2008-10#4)
of metal ions was##2##4##(2008-10#2)
of metal ions were##4##4##(2008-10#4)
of metal ions with##3##4##(2008-10#3)
of metal ions##81##3##(1994-6#1)(1997-7#1)(2008-1#2)(2008-10#76)(2008-7#1)
of metal species##2##3##(2008-10#2)
of metal to##2##3##(2008-10#1)(2008-11#1)
of metal uptake##2##3##(2008-10#1)(2008-6#1)
of metal##173##2##(1994-11#1)(1994-6#1)(1995-2#1)(1996-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#134)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-11#8)(2010-5#2)(2013-8#2)
of metal-based##2##2##(2010-5#1)(2012-3#1)
of metal-binding##2##2##(2008-10#1)(2010-11#1)
of metal-containing##2##2##(2010-11#2)
of metal-stripe subwavelength period gratings##2##5##(2008-3#2)
of metallic impurities in##2##4##(2008-10#1)(2008-3#1)
of metallic ions##2##3##(2008-10#2)
of metallic nanoparticles##2##3##(2008-10#1)(2008-7#1)
of metallic particles##2##3##(2007-12#1)(2008-6#1)
of metallic silver##2##3##(2008-10#1)(2011-2#1)
of metallic##22##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
of metalloproteases##3##2##(2006-6#1)(2008-4#1)(2008-7#1)
of metalloproteinase##8##2##(1990-8#2)(1992-6#2)(2008-5#1)(2008-9#1)(2010-1#1)(2012-1#1)
of metalloproteinases and##2##3##(1992-6#1)(2007-11#1)
of metalloproteinases##8##2##(1992-6#1)(1992-9#2)(1994-5#1)(1994-9#1)(2007-11#1)(2008-4#1)(2013-1#1)
of metalloproteins##6##2##(1990-5#1)(1995-5#1)(2008-10#1)(2010-11#3)
of metallothionein (MT)##3##3##(2008-10#3)
of metallothionein by##4##3##(1991-5#4)
of metallothionein in##2##3##(2008-10#2)
of metallothionein isoforms##3##3##(2008-10#3)
of metallothionein proteins##2##3##(2008-10#2)
of metallothionein##24##2##(1990-5#3)(1991-5#4)(1992-6#1)(1993-12#1)(2008-10#14)(2008-11#1)
of metallothioneins (MTs)##2##3##(2008-10#2)
of metallothioneins by##2##3##(2008-10#2)
of metallothioneins##9##2##(1990-5#1)(2008-10#8)
of metals and anions##2##4##(2008-10#2)
of metals and##5##3##(2008-10#5)
of metals at##2##3##(2008-10#2)
of metals from sediment##2##4##(2008-10#2)
of metals from##7##3##(2008-10#7)
of metals in lubricating##2##4##(2008-10#2)
of metals in solution##2##4##(2008-10#2)
of metals in the##2##4##(2008-10#2)
of metals in used lubricating oils##2##6##(2008-10#2)
of metals in##22##3##(2008-10#19)(2010-11#2)(2011-2#1)
of metals on##2##3##(1994-6#1)(2008-5#1)
of metals was##2##3##(2008-10#2)
of metals with##3##3##(2007-12#1)(2008-10#2)
of metals##64##2##(1994-6#1)(2007-12#1)(2008-10#52)(2008-12#1)(2008-3#1)(2008-5#1)(2010-11#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
of metaphase chromosomes##3##3##(1990-3#1)(2008-5#1)(2008-9#1)
of metaphase##5##2##(1990-3#1)(1997-3#1)(2008-5#2)(2008-9#1)
of metaphorical##2##2##(2012-2#2)
of metapopulations##4##2##(2008-8#4)
of metastable##2##2##(1992-8#1)(1997-7#1)
of metastases and##2##3##(1994-12#1)(2011-1#1)
of metastases at##3##3##(2007-8#1)(2009-10#1)(2010-3#1)
of metastases to the##2##4##(2007-11#1)(2009-10#1)
of metastases to##4##3##(1990-8#1)(2007-11#2)(2009-10#1)
of metastases##24##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-11#1)(1994-12#1)(2007-10#1)(2007-11#5)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#1)(2009-10#2)(2010-3#3)(2011-1#1)
of metastasis to lung##2##4##(2008-8#2)
of metastasis##16##2##(1990-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-8#2)(2009-3#1)(2010-3#2)(2012-3#2)
of metastatic bone disease##2##4##(2012-3#2)
of metastatic bone##5##3##(2007-11#3)(2012-3#2)
of metastatic disease and##2##4##(2008-7#1)(2010-9#1)
of metastatic disease to the##2##5##(1990-12#1)(2008-1#1)
of metastatic disease##9##3##(1990-12#1)(2007-11#1)(2008-1#2)(2008-6#1)(2008-7#2)(2010-9#1)(2012-2#1)
of metastatic gestational choriocarcinoma##2##4##(2007-10#2)
of metastatic hepatocellular carcinoma after treatment with thymostimulin##2##8##(1990-2#2)
of metastatic renal cell carcinoma##3##5##(1990-2#1)(1994-12#1)(2011-1#1)
of metastatic spread to##2##4##(1994-12#1)(2007-6#1)
of metastatic spread##6##3##(1991-2#1)(1994-12#1)(2007-6#1)(2008-1#1)(2008-6#1)(2009-9#1)
of metastatic tumor##2##3##(2007-11#1)(2007-12#1)
of metastatic tumors##5##3##(2007-11#3)(2008-1#1)(2011-1#1)
of metastatic##61##2##(1990-12#1)(1990-2#5)(1991-2#1)(1991-7#1)(1992-10#2)(1992-2#1)(1992-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1996-11#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#3)(2009-3#1)(2009-9#1)(2010-3#3)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)
of metatarsal##2##2##(2009-6#1)(2010-3#1)
of metatarsus adductus##2##3##(2012-2#2)
of meteorological##2##2##(2008-10#1)(2008-2#1)
of metered dose inhalers##3##4##(1992-2#2)(1993-2#1)
of metered dose##4##3##(1992-2#2)(1992-3#1)(1993-2#1)
of metformin hydrochloride in##2##4##(2010-5#2)
of metformin hydrochloride using##2##4##(2011-1#1)(2012-2#1)
of metformin hydrochloride##7##3##(2010-5#3)(2011-1#2)(2012-2#1)(2013-1#1)
of metformin in##6##3##(1995-8#2)(2008-10#1)(2008-3#2)(2012-3#1)
of metformin is##2##3##(1994-8#1)(2012-3#1)
of metformin##27##2##(1994-8#3)(1995-8#2)(2008-1#2)(2008-10#2)(2008-3#3)(2010-5#3)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)
of methacrylate##2##2##(2007-11#1)(2008-5#1)
of methadone base in##2##4##(2010-5#2)
of methadone base##3##3##(2010-5#3)
of methadone in##2##3##(2008-7#1)(2010-5#1)
of methadone##5##2##(2008-7#1)(2010-5#4)
of methamidophos##3##2##(2008-10#3)
of methamphetamine and prescription drug use##2##6##(2013-1#2)
of methamphetamine##11##2##(1990-8#2)(1991-1#3)(1995-3#1)(1996-7#1)(2008-10#1)(2013-1#2)(2013-8#1)
of methane and##2##3##(2008-10#1)(2008-3#1)
of methane in a##2##4##(2008-3#1)(2008-6#1)
of methane in##3##3##(2008-3#1)(2008-6#1)(2013-1#1)
of methane monooxygenase##2##3##(1991-12#2)
of methane##27##2##(1991-12#2)(2007-12#4)(2008-10#5)(2008-2#5)(2008-3#7)(2008-6#3)(2013-1#1)
of methane-air##2##2##(2008-3#2)
of methanol and ethanol##2##4##(2008-10#2)
of methanol and##6##3##(2008-10#5)(2011-1#1)
of methanol extract of Aegle marmelos##3##6##(2012-2#3)
of methanol extract of##4##4##(2012-2#3)(2012-3#1)
of methanol in##4##3##(1996-5#2)(2008-10#2)
of methanol to##2##3##(2007-11#1)(2008-7#1)
of methanol was##2##3##(1996-5#1)(2008-10#1)
of methanol##50##2##(1995-3#1)(1996-5#5)(2007-11#1)(2008-10#29)(2008-2#3)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#1)
of methanol-water##5##2##(2008-10#4)(2011-2#1)
of methanol/water##2##2##(2008-10#1)(2008-5#1)
of methaqualone##4##2##(2008-10#4)
of methemoglobin##2##2##(1990-8#1)(2010-4#1)
of methicillin-resistant Staphylococcus aureus (MRSA)##4##5##(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
of methicillin-resistant Staphylococcus aureus in##2##5##(2007-12#1)(2008-10#1)
of methicillin-resistant Staphylococcus aureus##11##4##(2007-12#5)(2007-7#1)(2008-10#2)(2009-5#1)(2010-6#1)(2011-2#1)
of methionine##7##2##(1992-6#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-1#1)
of method and##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
of method##16##2##(1995-9#1)(1996-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-3#2)
of methodological problems##2##3##(1992-11#1)(2008-6#1)
of methodological##8##2##(1992-1#1)(1992-11#1)(1992-3#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-6#1)(2012-3#1)
of methodologies for##2##3##(2008-10#1)(2013-1#1)
of methodologies to determine##2##4##(2008-10#1)(2013-8#1)
of methodologies##6##2##(1992-9#1)(1995-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
of methodology##6##2##(1990-3#1)(1991-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
of methods and##2##3##(2008-10#1)(2013-1#1)
of methods exist##2##3##(2008-4#1)(2009-7#1)
of methods for the determination of##2##6##(2008-10#1)(2008-11#1)
of methods for the##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
of methods for##14##3##(1995-2#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2010-5#1)
of methods in##2##3##(2006-4#1)(2008-10#1)
of methods is##2##3##(2008-10#1)(2013-1#1)
of methods of##2##3##(2008-7#1)(2013-1#1)
of methods that##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
of methods to##7##3##(1993-3#1)(1995-1#1)(2008-10#1)(2008-9#2)(2010-2#1)(2012-3#1)
of methods##56##2##(1993-3#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-11#1)(2006-4#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#6)(2008-5#3)(2008-7#4)(2008-9#6)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
of methotrexate (MTX)##2##3##(1990-8#1)(1992-8#1)
of methotrexate (Mtx)##3##3##(2008-10#2)(2011-2#1)
of methotrexate and##4##3##(1990-12#1)(1993-12#1)(1995-8#1)(2010-3#1)
of methotrexate in##2##3##(1990-8#1)(1992-12#1)
of methotrexate##25##2##(1990-12#1)(1990-8#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-8#3)(2006-10#2)(2007-10#1)(2008-10#4)(2008-11#4)(2010-3#2)(2011-2#1)(2012-2#1)
of methoxy##2##2##(2008-10#1)(2008-11#1)
of methyl 3-O-beta-D-glucopyranosyl-beta-D-glucopyranoside (methyl beta-D-laminarabioside)##2##5##(1992-12#2)
of methyl acrylate##2##3##(2008-10#1)(2010-8#1)
of methyl bromide##3##3##(2008-10#3)
of methyl ester##2##3##(2008-10#2)
of methyl esters##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
of methyl linoleate in micelles##2##5##(1995-2#2)
of methyl methacrylate##2##3##(2008-3#2)
of methyl orange##4##3##(2008-10#3)(2009-11#1)
of methyl tert-butyl ether##2##4##(2008-12#2)
of methyl yellow##2##3##(2008-10#2)
of methyl##42##2##(1992-12#4)(1994-5#1)(1995-11#1)(1995-2#2)(1996-5#2)(1997-6#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
of methyl-β-cyclodextrin##4##2##(2011-2#4)
of methylamine##3##2##(2008-10#2)(2008-11#1)
of methylamphetamine and related compounds##2##5##(2008-10#2)
of methylamphetamine##3##2##(2008-10#3)
of methylated##3##2##(1991-8#1)(1995-5#1)(2009-12#1)
of methylation of##3##3##(1997-4#1)(2008-7#2)
of methylation##14##2##(1990-5#1)(1992-12#1)(1992-9#1)(1994-5#1)(1997-4#3)(2008-10#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#1)(2013-1#1)
of methyldopa and dopamine##3##4##(2008-10#3)
of methyldopa##5##2##(2008-10#5)
of methylene blue (MB) with##2##5##(2008-10#2)
of methylene blue (MB)##8##4##(2008-10#8)
of methylene blue and##2##4##(2008-10#2)
of methylene blue##15##3##(2008-10#12)(2008-9#1)(2012-2#1)(2013-1#1)
of methylene chloride##2##3##(2008-10#1)(2008-2#1)
of methylene##19##2##(2008-10#15)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
of methylenebis(phosphonate)##2##2##(2008-4#2)
of methylglyoxal##3##2##(2008-11#3)
of methylmercury and inorganic mercury##2##5##(2008-10#2)
of methylmercury##5##2##(2008-10#5)
of methylphenidate hydrochloride##2##3##(1995-11#2)
of methylphenidate##7##2##(1995-11#4)(2008-9#1)(2012-2#2)
of methylprednisolone##2##2##(1996-11#1)(2007-7#1)
of methylxanthine-containing beverages##2##3##(1990-6#2)
of metoclopramide##16##2##(2008-10#12)(2008-7#1)(2012-12#3)
of metoprolol##2##2##(1997-7#1)(2008-10#1)
of metrology##2##2##(2008-3#1)(2013-8#1)
of metronidazole in##2##3##(2008-10#1)(2011-2#1)
of metronidazole##16##2##(1997-4#2)(1997-7#1)(2008-10#9)(2011-2#4)
of metropolitan##2##2##(1994-3#1)(2011-2#1)
of miR-218##2##2##(2011-2#2)
of miR-541 in##2##3##(2013-1#2)
of miR-541##3##2##(2013-1#3)
of miRNA##5##2##(2008-11#1)(2010-11#1)(2011-2#3)
of miRNAs in##3##3##(2008-1#1)(2010-11#1)(2011-2#1)
of miRNAs##13##2##(2008-1#1)(2008-11#3)(2008-7#1)(2009-5#1)(2010-11#2)(2011-1#1)(2011-2#3)(2013-1#1)
of mice and rats##2##4##(1993-3#1)(2008-10#1)
of mice and##4##3##(1993-3#1)(1995-12#1)(2008-10#1)(2010-11#1)
of mice at##2##3##(1995-12#1)(1996-2#1)
of mice bearing##4##3##(1992-3#2)(1992-5#1)(1992-9#1)
of mice exposed to##2##4##(1994-6#1)(2008-9#1)
of mice in##2##3##(1995-5#1)(2008-11#1)
of mice intoxicated with bromobenzene##2##5##(1992-3#2)
of mice that##2##3##(1993-12#1)(2011-2#1)
of mice treated with##2##4##(1996-12#1)(2013-8#1)
of mice was##3##3##(1990-12#1)(1992-8#1)(2008-9#1)
of mice were##5##3##(1991-12#1)(1994-3#1)(2008-10#1)(2008-9#2)
of mice with a##2##4##(1995-12#1)(2011-2#1)
of mice with##15##3##(1993-9#1)(1995-12#1)(1995-5#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)
of mice##91##2##(1990-12#2)(1991-12#4)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#4)(1995-2#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-2#3)(1997-8#2)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#7)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
of micellar##6##2##(1994-9#1)(2008-10#5)
of micelles of##2##3##(1990-5#1)(1994-9#1)
of miconazole nitrate##2##3##(2010-5#2)
of miconazole##5##2##(1997-2#1)(2010-5#4)
of micro##6##2##(2008-10#5)(2012-3#1)
of micro- and##2##3##(2007-12#1)(2008-7#1)
of micro-optical elements##2##3##(2008-3#2)
of micro-optical objects##2##3##(2008-3#2)
of micro-optical##5##2##(2008-3#5)
of micro-optics##3##2##(2008-3#3)
of micro-organisms##2##2##(2008-2#1)(2008-3#1)
of microRNA expression##2##3##(2010-4#2)
of microRNA##4##2##(2010-4#3)(2010-7#1)
of microRNA-218##2##2##(2011-2#2)
of microRNAs (miRNAs)##2##3##(2008-10#1)(2011-2#1)
of microRNAs##5##2##(2008-10#1)(2010-3#1)(2010-7#2)(2011-2#1)
of microarray analysis##2##3##(2008-11#1)(2009-10#1)
of microarray data##5##3##(2008-4#1)(2008-7#3)(2010-3#1)
of microarray experiments##3##3##(2008-4#1)(2008-7#1)(2009-10#1)
of microarray technology##2##3##(2008-7#2)
of microarray##21##2##(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#10)(2009-10#3)(2010-1#1)(2010-3#1)(2012-3#1)
of microarrays for##3##3##(2007-12#1)(2008-7#1)(2010-4#1)
of microarrays##12##2##(2007-12#1)(2008-10#3)(2008-7#7)(2010-4#1)
of microbes##7##2##(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#2)
of microbial activity##2##3##(2008-10#2)
of microbial communities##4##3##(2008-10#3)(2012-3#1)
of microbial contamination of##2##4##(2012-2#1)(2013-8#1)
of microbial contamination##5##3##(1997-4#2)(2008-5#1)(2012-2#1)(2013-8#1)
of microbial extracellular glycolipids##2##4##(2008-11#2)
of microbial growth##2##3##(2011-2#1)(2013-1#1)
of microbial pathogens##4##3##(2008-10#2)(2008-4#2)
of microbial viability##3##3##(2008-9#2)(2013-8#1)
of microbial##49##2##(1990-9#1)(1992-11#1)(1997-4#4)(2007-10#1)(2008-10#11)(2008-11#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
of microbially##2##2##(2008-10#2)
of microbiological##2##2##(1994-3#1)(2007-7#1)
of microbiology and##4##3##(1992-12#1)(2007-12#1)(2008-10#2)
of microbiology##9##2##(1992-12#1)(2007-12#2)(2008-10#2)(2008-9#2)(2010-12#1)(2013-1#1)
of microbodies##3##2##(2008-10#3)
of microcapsule##2##2##(2008-11#2)
of microcarrier##3##2##(2008-11#3)
of microcephaly##2##2##(1997-3#2)
of microchannel formation##2##3##(2008-3#2)
of microchannel structure##2##3##(2008-10#2)
of microchannel##6##2##(2008-10#3)(2008-3#3)
of microchip CE##2##3##(2008-10#2)
of microchip##3##2##(2008-10#3)
of microcirculation and##2##3##(2008-5#1)(2010-1#1)
of microcracks##3##2##(2008-7#1)(2009-7#2)
of microcrystalline cellulose##2##3##(2008-6#1)(2013-1#1)
of microcrystalline##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
of microcrystals##2##2##(2008-10#2)
of microcystin-LR in surface water##2##5##(2008-10#2)
of microcystins##5##2##(2008-10#4)(2010-5#1)
of microdialysis##5##2##(2008-10#1)(2008-8#4)
of microdroplets##3##2##(2008-2#3)
of microelectromechanical##2##2##(2007-12#1)(2008-3#1)
of microelements##2##2##(2008-10#2)
of microemulsions##2##2##(2008-10#1)(2012-2#1)
of microencapsulated##2##2##(2010-5#1)(2011-2#1)
of microfibrillar-associated protein 4##2##4##(2012-2#2)
of microfilament##2##2##(1993-8#1)(2009-10#1)
of microfilaments in##2##3##(1990-8#2)
of microfluidic##7##2##(2008-10#5)(2008-3#2)
of microglia in denervated neuropil##3##5##(1997-3#3)
of microglia in##6##3##(1997-3#3)(2008-6#1)(2008-7#2)
of microglial activation##2##3##(1996-12#1)(2008-7#1)
of microglial##5##2##(1996-12#1)(2008-4#2)(2008-7#2)
of microgravity on##2##3##(2008-4#1)(2008-8#1)
of microlenses with##2##3##(2007-12#1)(2008-3#1)
of microlenses##5##2##(2007-12#1)(2008-3#4)
of micromachined##2##2##(2007-11#1)(2008-3#1)
of micromechanical tunneling##2##3##(2008-3#2)
of micromechanical##3##2##(2008-3#3)
of micrometer-sized polymer##2##3##(2008-10#1)(2008-3#1)
of micrometer-sized##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
of micrometers##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
of micromolar##2##2##(2008-10#1)(2008-11#1)
of micron sized##2##3##(2008-10#2)
of micron##3##2##(2008-10#3)
of micronucleated erythrocytes in male and female##2##7##(2008-9#2)
of micronucleated erythrocytes in##4##4##(2008-8#1)(2008-9#3)
of micronucleated erythrocytes##8##3##(2008-8#1)(2008-9#7)
of micronucleated##11##2##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#8)
of micronuclei##3##2##(1993-8#1)(1996-2#1)(2008-9#1)
of micronutrients in##2##3##(2008-10#1)(2013-8#1)
of micronutrients##6##2##(2008-10#2)(2010-6#1)(2013-8#3)
of microorganism##3##2##(2006-6#1)(2008-10#1)(2010-8#1)
of microorganisms at##2##3##(2008-5#1)(2012-3#1)
of microorganisms have been##2##4##(1997-7#1)(2011-1#1)
of microorganisms in##5##3##(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
of microorganisms to##2##3##(2008-7#1)(2012-1#1)
of microorganisms were isolated from the##2##6##(2007-7#1)(2008-5#1)
of microorganisms##43##2##(1991-9#1)(1994-11#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#10)(2008-6#1)(2008-7#2)(2008-9#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
of microprism-type##3##2##(2008-2#2)(2008-3#1)
of microprisms##2##2##(2008-3#2)
of micropropagated cranberry plants##2##4##(2008-10#2)
of micropropagated##4##2##(2008-10#3)(2009-8#1)
of microsatellite markers in##2##4##(1994-6#1)(2008-5#1)
of microsatellite markers##4##3##(1994-6#1)(2008-10#1)(2008-5#2)
of microsatellite primers##2##3##(2008-10#1)(2008-5#1)
of microsatellite##9##2##(1994-6#1)(2008-10#2)(2008-5#3)(2008-9#1)(2010-7#1)(2013-8#1)
of microsatellites##7##2##(1994-11#1)(1994-3#1)(1997-6#1)(2008-10#2)(2010-7#1)(2012-3#1)
of microscale##2##2##(2008-3#1)(2010-2#1)
of microsclerotia of V##2##4##(2008-10#2)
of microsclerotia##9##2##(2008-10#9)
of microscope##2##2##(2011-2#2)
of microscopic haematuria##2##3##(1991-3#2)
of microscopic objects##3##3##(2008-3#3)
of microscopic##15##2##(1991-3#2)(1992-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-5#1)(2008-8#1)(2011-2#1)
of microscopy##7##2##(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#1)
of microsomal##9##2##(1992-11#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2012-2#1)
of microsomes##2##2##(1994-6#1)(1995-6#1)
of microspheres was##2##3##(2010-5#1)(2013-1#1)
of microspheres##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
of microsporidia##2##2##(2007-7#1)(2009-5#1)
of microstructure##3##2##(2007-12#1)(2008-3#1)(2013-1#1)
of microstructures##2##2##(2008-3#2)
of microsurgery##3##2##(2009-5#1)(2011-2#2)
of microsurgical##2##2##(2009-5#1)(2011-2#1)
of microteaching##5##2##(2008-11#5)
of microtubule assembly##2##3##(1991-5#1)(2008-11#1)
of microtubule##7##2##(1991-5#2)(2008-11#1)(2009-10#2)(2009-8#1)(2012-2#1)
of microtubule-associated##2##2##(1993-8#1)(2009-10#1)
of microtubules in the##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
of microtubules##14##2##(1994-5#1)(1995-2#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-7#1)(2012-2#1)
of microvascular decompression##2##3##(2012-3#1)(2013-1#1)
of microvascular##5##2##(2008-1#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
of microvessels##2##2##(1994-12#1)(2011-1#1)
of microvilli##4##2##(2008-12#2)(2008-6#1)(2009-8#1)
of microwave digestion##4##3##(2008-10#4)
of microwave energy##2##3##(2008-10#2)
of microwave radiation##2##3##(2007-12#1)(2008-10#1)
of microwave##16##2##(2007-11#1)(2007-12#1)(2008-10#10)(2008-12#2)(2008-3#1)(2013-8#1)
of microwave-assisted extraction##4##3##(2008-10#4)
of microwave-assisted##5##2##(2008-10#5)
of microwaves##3##2##(2008-10#3)
of mid##2##2##(2008-5#1)(2011-2#1)
of mid-IR##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of mid-infrared##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
of midazolam##9##2##(1990-8#1)(1994-2#1)(1997-2#4)(2011-2#1)(2012-2#2)
of midbrain##2##2##(1995-12#1)(2007-10#1)
of middle age##3##3##(2008-4#1)(2011-2#2)
of middle ear effusion and serum##2##6##(2008-10#2)
of middle ear##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
of middle##15##2##(1994-1#2)(1995-2#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#2)(2012-12#2)(2013-1#1)
of middle-aged##2##2##(2008-7#2)
of midecamycin producing strain##2##4##(2008-8#2)
of midface##2##2##(2007-12#1)(2012-12#1)
of midfacial##2##2##(2007-12#1)(2011-2#1)
of midgut##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
of midline neuropils in##2##4##(2007-12#2)
of midline##6##2##(2007-12#2)(2008-7#2)(2011-2#1)(2012-12#1)
of midsagittal##2##2##(1995-5#2)
of midwifery##2##2##(1996-12#1)(2008-12#1)
of midwives and##2##3##(2009-10#1)(2010-12#1)
of midwives##4##2##(1990-6#1)(2008-12#1)(2009-10#1)(2010-12#1)
of migraine attacks##2##3##(2008-9#2)
of migraine pathophysiology##2##3##(2008-9#2)
of migraine##24##2##(1994-11#1)(1996-9#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-9#13)(2009-9#1)(2010-2#5)
of migrant##3##2##(1997-8#1)(2008-12#1)(2008-8#1)
of migrants##10##2##(1992-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2010-8#1)(2013-1#2)
of migrating##4##2##(2008-8#1)(2010-6#1)(2011-1#1)(2012-3#1)
of migration in##2##3##(1992-6#1)(2008-9#1)
of migration of##4##3##(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)
of migration rate in##2##4##(2008-8#2)
of migration rate##4##3##(2008-8#4)
of migration times and peak areas##2##6##(2008-10#2)
of migration times and##4##4##(2008-10#4)
of migration times##6##3##(2008-10#6)
of migration##32##2##(1990-12#1)(1992-6#1)(1993-6#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-6#1)(2008-8#8)(2008-9#1)(2010-8#2)(2011-2#3)(2013-1#2)
of migratory birds##2##3##(1995-3#1)(1997-4#1)
of migratory##9##2##(1995-3#2)(1997-4#1)(2008-8#1)(2009-9#1)(2010-8#2)(2011-2#2)
of mild and moderate##2##4##(1996-9#1)(1997-8#1)
of mild cognitive impairment##5##4##(2008-2#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-8#1)
of mild to moderate##2##4##(2008-7#1)(2008-8#1)
of mild to##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
of mild##33##2##(1990-2#1)(1992-6#1)(1993-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-2#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#3)
of mildewed##2##2##(2008-10#2)
of military orthopaedics##2##3##(2007-8#2)
of military service##7##3##(2011-2#1)(2013-1#6)
of military##10##2##(1996-12#1)(2007-8#2)(2011-2#1)(2013-1#6)
of milk and##2##3##(2008-10#1)(2012-2#1)
of milk replacers##2##3##(2010-2#2)
of milk##19##2##(2008-10#9)(2008-11#1)(2008-12#1)(2010-2#2)(2011-2#1)(2012-2#3)(2013-1#2)
of milligram amounts of##2##4##(1992-12#1)(2008-11#1)
of milligrams##3##2##(2008-10#2)(2008-11#1)
of millimeter##2##2##(2008-3#1)(2013-7#1)
of millimeters per second##2##4##(2007-12#2)
of millimeters##4##2##(2007-12#3)(2008-3#1)
of millions of people##2##4##(2008-2#1)(2013-8#1)
of millions of##7##3##(1991-2#1)(1993-6#1)(2007-6#1)(2008-10#2)(2008-2#1)(2013-8#1)
of millions##8##2##(1991-2#1)(1993-6#1)(2007-6#1)(2008-10#3)(2008-2#1)(2013-8#1)
of milnacipran and olanzapine##2##4##(2008-6#2)
of milnacipran##3##2##(2008-6#3)
of mimicking##3##2##(1995-2#1)(2009-11#1)(2012-2#1)
of mimicry evolution##2##3##(2012-3#2)
of mimicry##3##2##(2012-3#3)
of mimosine##4##2##(2008-10#4)
of mind and##3##3##(2008-11#2)(2013-1#1)
of mind##13##2##(1994-2#1)(2008-11#3)(2008-12#2)(2010-12#1)(2012-1#2)(2013-1#3)(2013-8#1)
of mindfulness##2##2##(2012-2#1)(2013-1#1)
of mindfulness-based##3##2##(2013-1#3)
of mineral acids##2##3##(2008-10#2)
of mineral feed additives based on##2##6##(2008-10#2)
of mineral##20##2##(1991-12#1)(2008-10#9)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#2)(2012-3#1)
of mineralization##5##2##(2008-10#3)(2008-12#1)(2012-6#1)
of minerals##4##2##(1997-4#1)(2008-10#1)(2008-5#2)
of mini-white##2##2##(2012-3#2)
of miniature##4##2##(1992-12#1)(1996-2#1)(2008-10#2)
of miniaturization##2##2##(2008-10#1)(2010-6#1)
of miniaturized##2##2##(2008-10#2)
of minimal change##2##3##(2007-7#1)(2008-1#1)
of minimal##15##2##(1995-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of minimally invasive surgery in the##2##6##(2007-8#1)(2008-7#1)
of minimally invasive surgery##6##4##(2007-8#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
of minimally invasive surgical techniques##2##5##(2007-9#1)(2008-8#1)
of minimally invasive techniques##2##4##(2007-8#1)(2008-11#1)
of minimally invasive##18##3##(2007-8#4)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-2#2)(2012-12#3)(2012-3#2)
of minimizing##6##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
of minimum##5##2##(2007-12#1)(2008-2#2)(2009-6#1)(2013-1#1)
of mining##3##2##(2008-12#2)(2013-1#1)
of mink##2##2##(1990-12#2)
of minocycline##3##2##(1997-8#1)(2008-7#1)(2010-5#1)
of minor effect##2##3##(2008-10#2)
of minor groove##3##3##(1996-3#1)(2008-4#2)
of minor importance##2##3##(2008-10#1)(2008-11#1)
of minor salivary##3##3##(1990-6#1)(2013-1#2)
of minor veins##2##3##(2008-10#2)
of minor##33##2##(1990-6#1)(1992-6#2)(1993-12#2)(1994-8#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-4#2)(2009-3#2)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
of minorities##4##2##(1991-8#1)(1994-12#1)(1997-2#1)(2013-1#1)
of minority health care##2##4##(1997-2#2)
of minority##7##2##(1994-12#1)(1997-2#3)(2011-2#2)(2012-3#1)
of minors##5##2##(1991-8#1)(1994-2#2)(1996-1#1)(2008-10#1)
of minute##5##2##(1990-8#1)(1997-6#1)(2007-12#1)(2008-11#1)(2012-3#1)
of minutes##5##2##(1990-2#1)(1993-12#1)(1994-11#1)(2007-11#1)(2008-3#1)
of mirror##9##2##(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2011-1#1)
of mirrors##6##2##(2007-11#1)(2007-9#1)(2008-3#4)
of misalignment##10##2##(2008-3#10)
of misalignments##2##2##(2008-2#1)(2008-3#1)
of misbehaviour##4##2##(2012-12#4)
of misclassification##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
of misidentification##2##2##(2008-10#1)(2008-11#1)
of misleading##3##2##(2008-11#2)(2012-2#1)
of mismatch##2##2##(1995-12#1)(2013-1#1)
of mismatched grating pairs##2##4##(2008-2#2)
of mismatched##5##2##(1993-11#1)(2008-2#2)(2010-11#2)
of mismatches##3##2##(1995-12#3)
of misoprostol##4##2##(1995-8#4)
of missed##3##2##(1995-8#1)(1996-12#1)(2008-8#1)
of missing data for##2##4##(2007-10#1)(2012-2#1)
of missing data##9##3##(1994-9#1)(1995-12#1)(2007-10#2)(2012-12#3)(2012-2#2)
of missing##17##2##(1993-8#1)(1994-9#1)(1995-12#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-3#1)(2009-9#1)(2012-12#3)(2012-2#2)(2013-1#2)
of mission##4##2##(1993-12#1)(1994-1#2)(1995-12#1)
of mites##2##2##(2008-8#1)(2011-2#1)
of mitochondria and##3##3##(2007-12#1)(2008-12#1)(2013-1#1)
of mitochondria from##4##3##(1992-11#1)(1994-5#1)(2008-1#1)(2008-10#1)
of mitochondria in##4##3##(1994-12#1)(2008-1#1)(2008-7#2)
of mitochondria with##2##3##(1994-8#1)(1996-2#1)
of mitochondria##24##2##(1992-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1996-2#2)(1997-2#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#1)(2009-6#1)(2013-1#2)(2013-8#1)
of mitochondrial DNA (mtDNA)##2##4##(2009-11#1)(2009-8#1)
of mitochondrial DNA in##2##4##(1995-12#1)(2008-8#1)
of mitochondrial DNA##14##3##(1995-12#1)(1996-9#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-8#1)(2013-8#1)
of mitochondrial and##2##3##(2008-6#1)(2010-3#1)
of mitochondrial aspartate aminotransferase##2##4##(1994-6#2)
of mitochondrial cristae##2##3##(2008-12#2)
of mitochondrial dysfunction##3##3##(2007-8#2)(2008-1#1)
of mitochondrial function##5##3##(1994-5#1)(1997-1#1)(2008-7#2)(2013-1#1)
of mitochondrial matrix##2##3##(1990-2#2)
of mitochondrial membrane potential##7##4##(1993-11#2)(2008-1#1)(2008-10#1)(2008-9#2)(2011-2#1)
of mitochondrial membrane##8##3##(1993-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
of mitochondrial permeability transition##3##4##(2008-11#2)(2010-12#1)
of mitochondrial respiration##3##3##(1990-5#2)(2008-7#1)
of mitochondrial translation##2##3##(1995-6#1)(2008-7#1)
of mitochondrial##73##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1991-2#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(2007-10#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
of mitogen-activated protein kinase in##2##5##(1992-8#1)(1993-8#1)
of mitogen-activated protein kinase##5##4##(1992-8#1)(1993-8#1)(1994-8#1)(1995-6#1)(2012-3#1)
of mitomycin C (MMC)##2##4##(1997-7#1)(2008-11#1)
of mitomycin C##6##3##(1990-2#1)(1992-3#1)(1997-7#2)(2008-11#1)(2008-4#1)
of mitosis and##2##3##(2008-9#1)(2009-3#1)
of mitosis##8##2##(1992-6#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)
of mitotic and##2##3##(1990-8#1)(2010-3#1)
of mitotic cells##3##3##(2008-4#1)(2008-9#2)
of mitotic chromosomes##4##3##(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
of mitotic##17##2##(1990-8#1)(1993-12#1)(1994-8#1)(1995-9#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#3)(2010-3#1)
of mitoxantrone##5##2##(1991-12#1)(1991-6#2)(2012-3#2)
of mitral cells##3##3##(2012-2#2)(2013-1#1)
of mitral valve##2##3##(1990-9#1)(2011-2#1)
of mitral##5##2##(1990-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
of mivacurium in##2##3##(2008-10#2)
of mixed infections##2##3##(2008-10#2)
of mixed monolayers##3##3##(1990-2#2)(2008-10#1)
of mixed##48##2##(1990-2#3)(1991-11#1)(1993-9#1)(1996-5#1)(2007-11#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
of mixed-chain phosphatidylcholines##3##3##(1990-7#3)
of mixes##3##2##(2008-10#2)(2011-2#1)
of mixing the##3##3##(2007-12#1)(2008-10#2)
of mixing##13##2##(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-6#2)(2008-7#2)(2008-8#2)(2010-8#1)
of mixture design on##2##4##(2008-10#2)
of mixture##9##2##(2008-10#5)(2008-12#1)(2008-6#2)(2009-4#1)
of mixtures in##3##3##(2008-10#3)
of mixtures of three##2##4##(2008-10#2)
of mixtures of##17##3##(1990-12#1)(1992-5#1)(1993-8#1)(2008-10#10)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)
of mixtures were##2##3##(2008-10#1)(2013-8#1)
of mixtures with##2##3##(2008-10#2)
of mixtures##33##2##(1990-12#1)(1992-5#1)(1993-8#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-8#1)
of mobile phase and##2##4##(2008-10#1)(2011-1#1)
of mobile phase variables##4##4##(2008-10#4)
of mobile phase##16##3##(2008-10#13)(2008-5#1)(2011-1#1)(2013-1#1)
of mobile##32##2##(1992-5#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of mobility##8##2##(1993-12#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#1)
of mobilizations##2##2##(2012-2#2)
of modal##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
of modalities##2##2##(2008-5#1)(2008-9#1)
of modality usage##2##3##(1995-12#2)
of mode##9##2##(2007-11#2)(2007-12#3)(2008-3#3)(2013-1#1)
of mode-locked laser##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of mode-locked lasers##5##3##(2007-11#3)(2007-12#2)
of mode-locked##8##2##(2007-11#4)(2007-12#3)(2008-2#1)
of model membranes##2##3##(1994-12#1)(2009-7#1)
of model misspecification##2##3##(1992-9#1)(1997-3#1)
of model parameters##5##3##(1997-8#1)(2008-7#1)(2009-4#1)(2013-1#1)(2013-8#1)
of model systems##2##3##(2008-4#1)(2008-6#1)
of model##46##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#3)
of modeled##3##2##(2008-10#1)(2008-3#2)
of modeling and##2##3##(2008-7#1)(2012-3#1)
of modeling##15##2##(1990-2#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
of modelling##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
of models for##4##3##(1991-12#1)(1994-5#1)(2009-9#1)(2011-2#1)
of models of##5##3##(1993-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)
of models used##2##3##(2008-10#1)(2012-2#1)
of models##30##2##(1990-5#1)(1991-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2009-9#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
of moderate atmospheric refractive-index turbulence##2##5##(2008-3#2)
of moderate or severe##2##4##(1990-3#1)(2010-11#1)
of moderate or##4##3##(1990-3#1)(2010-11#2)(2012-1#1)
of moderate to severe##3##4##(2007-7#1)(2008-7#1)(2012-3#1)
of moderate##17##2##(1990-12#1)(1990-3#1)(1991-5#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2010-11#2)(2012-1#1)(2012-3#1)
of moderate-size##2##2##(1996-4#2)
of moderate-to-severe##2##2##(1990-3#1)(2010-5#1)
of moderately##4##2##(2008-10#3)(2011-2#1)
of modern biology##3##3##(2008-2#2)(2008-4#1)
of modern human##2##3##(2011-2#2)
of modern humans##3##3##(1995-11#1)(2008-8#1)(2011-2#1)
of modern technology##2##3##(2008-10#1)(2008-4#1)
of modern##50##2##(1990-12#1)(1990-6#2)(1991-11#1)(1991-12#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
of modernity##2##2##(2008-7#1)(2008-9#1)
of modes##9##2##(2007-11#2)(2007-12#1)(2008-3#3)(2011-2#2)(2012-1#1)
of modest##3##2##(1997-5#1)(2008-9#1)(2012-3#1)
of modifiable##2##2##(1990-7#1)(2011-2#1)
of modification of the##2##4##(1992-5#1)(2008-11#1)
of modification##5##2##(1990-5#1)(1992-5#1)(1995-3#1)(2008-10#1)(2008-11#1)
of modifications##2##2##(2008-6#1)(2011-2#1)
of modified &quot##2##3##(2011-2#2)
of modified electrodes##3##3##(2008-10#3)
of modified nucleotides##2##3##(2008-4#1)(2008-8#1)
of modified proteins##2##3##(2008-10#1)(2009-5#1)
of modified test##2##3##(2011-2#2)
of modified##47##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-8#2)(1995-3#1)(1995-5#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-8#2)(2008-9#1)(2009-5#2)(2010-8#1)(2011-2#7)(2012-2#1)(2013-1#3)(2013-8#1)
of modifier and##2##3##(2008-10#2)
of modifier##6##2##(2008-10#6)
of modifiers##3##2##(2008-10#2)(2012-3#1)
of modifying##4##2##(2008-4#2)(2012-12#1)(2013-8#1)
of modular##3##2##(2008-11#1)(2009-9#1)(2011-1#1)
of modulated##4##2##(1995-8#1)(2007-11#1)(2008-3#2)
of modulating##2##2##(1996-2#1)(2011-2#1)
of modulation and##2##3##(2008-3#1)(2013-1#1)
of modulation frequency##2##3##(2008-10#1)(2008-3#1)
of modulation of##4##3##(1994-3#1)(2007-11#1)(2011-2#2)
of modulation##15##2##(1994-3#1)(1994-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#2)(2013-1#1)
of modulational instability##2##3##(2007-11#1)(2007-12#1)
of module##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
of moiré fringes in##2##4##(2008-3#2)
of moiré##3##2##(2008-2#1)(2008-3#2)
of moist##2##2##(2008-10#2)
of moisture in##4##3##(2008-10#3)(2008-5#1)
of moisture occurrence##2##3##(2008-10#2)
of moisture on##2##3##(2008-10#2)
of moisture periods##2##3##(2008-10#2)
of moisture##17##2##(1996-2#1)(2008-10#13)(2008-5#1)(2008-6#1)(2012-2#1)
of molar##3##2##(1992-5#1)(2008-10#2)
of molds##2##2##(2008-3#1)(2008-7#1)
of molecular MRI##2##3##(2010-9#2)
of molecular and genetic##2##4##(2007-12#1)(2012-3#1)
of molecular and##9##3##(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)
of molecular biological##2##3##(2008-11#1)(2008-9#1)
of molecular biology in veterinary parasitology##2##6##(1997-7#2)
of molecular biology in##4##4##(1997-3#1)(1997-7#2)(2011-2#1)
of molecular biology to##2##4##(1995-9#1)(1997-7#1)
of molecular biology##17##3##(1991-11#1)(1994-3#1)(1995-9#1)(1997-3#1)(1997-7#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#3)(2012-12#1)
of molecular chaperones and##2##4##(2008-1#1)(2008-7#1)
of molecular chaperones##7##3##(1994-11#2)(2008-1#1)(2008-4#1)(2008-7#3)
of molecular data##2##3##(2008-10#2)
of molecular descriptors##3##3##(2007-11#2)(2008-10#1)
of molecular diagnostic##2##3##(2011-1#1)(2013-1#1)
of molecular dynamics simulations##4##4##(1992-6#1)(1993-11#1)(1995-3#1)(2009-5#1)
of molecular dynamics##6##3##(1992-6#1)(1993-11#1)(1993-8#1)(1995-3#1)(2008-7#1)(2009-5#1)
of molecular evolution##7##3##(1994-8#1)(1997-6#3)(2008-11#1)(2010-4#1)(2013-1#1)
of molecular genetic techniques to##2##5##(1997-4#1)(2008-9#1)
of molecular genetic##5##3##(1997-4#1)(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)
of molecular imaging##3##3##(2008-2#2)(2011-1#1)
of molecular interactions##2##3##(2008-9#1)(2010-10#1)
of molecular marker##2##3##(2008-10#1)(2011-2#1)
of molecular markers for##3##4##(1997-8#1)(2008-10#2)
of molecular markers in##2##4##(2008-5#1)(2011-2#1)
of molecular markers##14##3##(1997-7#1)(1997-8#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
of molecular mass##2##3##(1990-5#1)(1990-7#1)
of molecular mechanisms of##2##4##(2009-6#1)(2012-2#1)
of molecular mechanisms##3##3##(2009-6#1)(2012-2#2)
of molecular medicine##3##3##(1991-11#1)(2008-5#1)(2009-11#1)
of molecular orientation##2##3##(2008-10#1)(2008-2#1)
of molecular oxygen##3##3##(1994-11#1)(2008-10#1)(2008-3#1)
of molecular pathways##3##3##(2008-7#1)(2009-5#1)(2010-10#1)
of molecular recognition##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
of molecular scattering##2##3##(2008-2#1)(2008-3#1)
of molecular self-assembly##2##3##(2013-8#2)
of molecular size##2##3##(2007-11#1)(2008-10#1)
of molecular species##3##3##(1997-2#1)(2008-11#1)(2008-3#1)
of molecular techniques##2##3##(2011-2#1)(2012-2#1)
of molecular tools##2##3##(2010-10#1)(2011-1#1)
of molecular variance (AMOVA) revealed##2##5##(2008-10#2)
of molecular variance (AMOVA)##3##4##(2008-10#2)(2008-12#1)
of molecular variance revealed that##3##5##(2008-10#3)
of molecular variance##17##3##(2008-10#14)(2008-12#1)(2011-2#2)
of molecular variation##2##3##(2008-10#2)
of molecular weight##8##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
of molecular weights##4##3##(1997-6#2)(2008-10#1)(2009-10#1)
of molecular##221##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1992-10#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#6)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#49)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#5)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#5)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#15)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
of molecularly imprinted##2##3##(2008-10#2)
of molecule##2##2##(2008-10#1)(2013-8#1)
of molecules between##2##3##(2008-1#1)(2011-2#1)
of molecules in the##2##4##(2008-3#1)(2008-5#1)
of molecules in##5##3##(1997-6#1)(2007-12#1)(2008-3#2)(2008-5#1)
of molecules of##5##3##(1993-8#1)(1995-8#1)(2008-11#1)(2009-6#1)(2010-6#1)
of molecules or##2##3##(2008-7#1)(2010-7#1)
of molecules such as##2##4##(2007-5#1)(2009-9#1)
of molecules that##3##3##(2008-5#1)(2008-7#1)(2010-11#1)
of molecules with##3##3##(1995-2#1)(2008-10#2)
of molecules##47##2##(1990-4#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)
of mollusks##3##2##(2011-2#3)
of molybdate##6##2##(1990-11#2)(1992-3#1)(2008-10#3)
of molybdenum and tungsten##2##4##(2008-10#2)
of molybdenum and##5##3##(2008-10#5)
of molybdenum by##2##3##(2008-10#2)
of molybdenum determination was##2##4##(2008-10#2)
of molybdenum in seawater##2##4##(2008-10#2)
of molybdenum in##12##3##(2008-10#12)
of molybdenum was##2##3##(2008-10#2)
of molybdenum with##3##3##(2008-10#3)
of molybdenum##38##2##(2008-10#38)
of molybdenum(VI)##6##2##(2008-10#6)
of molybdenyl##2##2##(2008-10#2)
of molybdophosphate##2##2##(2008-10#2)
of momentum##2##2##(1992-7#1)(2013-1#1)
of money##2##2##(2008-7#1)(2013-8#1)
of monitoring and##3##3##(1993-2#1)(1997-2#1)(2008-10#1)
of monitoring by##2##3##(2008-10#1)(2009-7#1)
of monitoring of qualitative content of##2##6##(2013-1#2)
of monitoring of##3##3##(2008-10#1)(2013-1#2)
of monitoring the##9##3##(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
of monitoring##35##2##(1992-11#1)(1993-2#1)(1994-7#1)(1995-3#1)(1996-7#1)(1997-2#2)(2007-10#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2009-6#1)(2009-7#1)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
of monkey##3##2##(1997-2#2)(2009-5#1)
of monkeys##3##2##(1997-2#1)(2008-10#1)(2009-8#1)
of mono- and sesquiterpenes in##2##5##(2008-10#2)
of mono- and##8##3##(2008-10#6)(2009-9#1)(2010-11#1)
of mono-##11##2##(2008-10#8)(2008-11#1)(2009-9#1)(2010-11#1)
of monoamine oxidase (MAO)##2##4##(1991-12#1)(1995-11#1)
of monoamine oxidase##5##3##(1991-12#2)(1995-11#1)(1996-5#1)(2010-9#1)
of monoamine##8##2##(1991-12#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(2010-9#1)
of monoaminergic##2##2##(1995-12#1)(2008-6#1)
of monobromobenzoic acids##2##3##(2008-10#2)
of monochromator##2##2##(2008-3#2)
of monoclonal antibodies (MoAbs)##2##4##(1990-7#1)(1993-1#1)
of monoclonal antibodies (mAb)##2##4##(2008-4#1)(2011-2#1)
of monoclonal antibodies against##6##4##(1995-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)
of monoclonal antibodies and##2##4##(1991-6#1)(2008-10#1)
of monoclonal antibodies in##2##4##(1993-6#1)(2008-11#1)
of monoclonal antibodies recognizing##2##4##(1994-9#1)(2008-10#1)
of monoclonal antibodies that##3##4##(1991-5#1)(1996-12#1)(2008-4#1)
of monoclonal antibodies##42##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-1#1)(1993-6#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-4#3)(2008-8#3)(2008-9#4)(2009-8#1)(2011-2#2)
of monoclonal antibody 4-4-20##2##4##(1991-8#2)
of monoclonal antibody against##3##4##(2008-11#3)
of monoclonal antibody production##2##4##(2008-11#2)
of monoclonal antibody##20##3##(1991-5#1)(1991-8#2)(1992-6#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-11#11)(2008-8#1)
of monoclonal or##2##3##(1993-2#1)(2008-5#1)
of monoclonal##72##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#19)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#5)(2009-8#1)(2011-2#2)
of monocrotophos##2##2##(1992-11#2)
of monocular##2##2##(1994-8#2)
of monocyte and##2##3##(2011-2#1)(2012-1#1)
of monocyte##7##2##(1991-7#1)(1992-2#1)(1994-8#1)(2008-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
of monocytes and##2##3##(1997-8#1)(2008-10#1)
of monocytes##11##2##(1991-2#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-6#1)(1997-8#1)(2006-6#1)(2008-10#1)(2013-1#1)
of monocytic##2##2##(1997-7#1)(2013-1#1)
of monodisperse##3##2##(1996-2#1)(2010-5#1)(2012-2#1)
of monolayers##3##2##(1994-3#1)(1996-12#1)(2008-3#1)
of monolithic##4##2##(2008-10#2)(2008-3#1)(2009-7#1)
of monomer##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2010-2#1)
of monomeric##6##2##(2008-10#2)(2008-5#1)(2008-7#2)(2010-4#1)
of monomers##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)
of mononuclear cells from##3##4##(1992-3#1)(2008-4#1)(2008-9#1)
of mononuclear cells##9##3##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2012-1#1)
of mononuclear fraction cells from autologous bone marrow##2##8##(2012-1#2)
of mononuclear##15##2##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-10#1)(2009-11#1)(2012-1#5)
of mononucleosis syndrome##2##3##(2011-2#2)
of mononucleosis##3##2##(2007-2#1)(2011-2#2)
of monooxygenase##2##2##(1994-6#1)(2008-11#1)
of monophyletic##2##2##(2007-12#1)(2008-8#1)
of monosaccharides##2##2##(2008-10#1)(2008-6#1)
of monosomy##2##2##(1991-3#1)(2012-3#1)
of monoterpene hydrocarbons##3##3##(2008-11#3)
of monoterpenes and##2##3##(2013-1#1)(2013-8#1)
of monoterpenes##4##2##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
of monounsaturated fatty acids##2##4##(1990-2#1)(2010-4#1)
of monovalent cations##2##3##(1990-7#1)(2008-8#1)
of monovalent##6##2##(1990-7#1)(1994-5#1)(2008-10#3)(2008-8#1)
of monozygotic##5##2##(2008-7#3)(2010-8#1)(2011-1#1)
of montelukast in##2##3##(2008-1#2)
of monthly##5##2##(2007-7#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
of months##2##2##(1991-8#1)(1997-2#1)
of mood and##4##3##(1996-7#1)(2008-5#1)(2010-10#1)(2013-8#1)
of mood disorders and##2##4##(2008-7#2)
of mood disorders##10##3##(1996-7#1)(2008-4#1)(2008-7#7)(2013-8#1)
of mood##22##2##(1991-8#1)(1996-7#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2010-10#1)(2012-2#1)(2013-8#5)
of moral##9##2##(1991-2#2)(1992-3#1)(2008-11#3)(2012-2#1)(2013-8#2)
of morality##4##2##(1991-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
of morbid##5##2##(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(2013-1#1)
of morbidity after##2##3##(2012-3#1)(2013-1#1)
of morbidity among##2##3##(2008-7#1)(2009-12#1)
of morbidity and mortality in patients##2##6##(2008-3#1)(2009-8#1)
of morbidity and mortality in the##6##6##(1993-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
of morbidity and mortality in##14##5##(1993-3#1)(1993-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2011-2#1)
of morbidity and mortality worldwide##3##5##(2010-11#1)(2011-2#2)
of morbidity and mortality##40##4##(1990-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of morbidity and##44##3##(1990-8#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of morbidity in##5##3##(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
of morbidity##63##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-6#1)(1995-9#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#4)(2008-8#1)(2009-12#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
of more and more##2##4##(2008-10#1)(2009-10#1)
of more complex##3##3##(1993-11#1)(2008-6#1)(2011-2#1)
of more effective##8##3##(1993-11#1)(1993-12#1)(2007-7#1)(2008-12#1)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
of more efficient##2##3##(2008-1#1)(2008-10#1)
of more frequent##2##3##(2008-9#1)(2011-2#1)
of more general##3##3##(1993-11#1)(1995-11#1)(2008-10#1)
of more intensive##2##3##(2011-2#2)
of more potent##3##3##(1994-5#1)(2008-4#1)(2012-2#1)
of more powerful##3##3##(1996-9#1)(2008-1#1)(2008-3#1)
of more rigorous##2##3##(2008-3#1)(2010-5#1)
of more sensitive##3##3##(2009-3#1)(2011-2#2)
of more serious##2##3##(1991-3#1)(2008-2#1)
of more severe##4##3##(2007-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
of more species##2##3##(2008-10#2)
of more than 1##4##4##(1993-6#1)(1994-2#1)(1997-4#1)(2008-10#1)
of more than 10##2##4##(1995-6#1)(2007-12#1)
of more than 100 different##2##5##(2008-7#1)(2011-2#1)
of more than 100##5##4##(1996-3#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)
of more than 100%##2##4##(1994-2#1)(2007-11#1)
of more than 1000##2##4##(1995-5#1)(2007-12#1)
of more than 150##2##4##(2008-11#1)(2011-2#1)
of more than 2##4##4##(1993-9#1)(2007-12#1)(2008-10#2)
of more than 20##4##4##(2008-7#2)(2009-5#1)(2009-9#1)
of more than 200##2##4##(2007-11#1)(2008-10#1)
of more than 3##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
of more than 30##5##4##(1996-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
of more than 40##3##4##(2007-12#1)(2008-10#1)(2012-1#1)
of more than 40% in##2##5##(2008-11#1)(2008-8#1)
of more than 40%##3##4##(2008-11#1)(2008-2#1)(2008-8#1)
of more than 5##3##4##(2008-2#1)(2008-7#1)(2008-8#1)
of more than 50##3##4##(1993-2#1)(1997-3#1)(2008-10#1)
of more than 50% of##2##5##(1990-12#1)(2008-5#1)
of more than 50%##4##4##(1990-12#1)(2007-8#1)(2008-5#1)(2008-6#1)
of more than 500##2##4##(1993-2#1)(2008-8#1)
of more than 6##2##4##(2007-12#1)(2012-12#1)
of more than 600##2##4##(2007-12#2)
of more than 70##2##4##(2007-12#1)(2008-7#1)
of more than 80%##3##4##(1995-2#1)(2007-12#1)(2008-2#1)
of more than 90%##3##4##(1997-1#1)(2008-10#1)(2013-7#1)
of more than four##2##4##(1990-12#1)(2011-2#1)
of more than one##11##4##(1993-3#1)(1996-2#1)(2008-10#7)(2008-5#1)(2008-7#1)
of more than##119##3##(1990-12#3)(1990-2#2)(1990-7#1)(1992-11#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#2)(2007-11#4)(2007-12#14)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#4)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
of more virulent##2##3##(2008-9#2)
of more##214##2##(1990-12#3)(1990-2#2)(1990-7#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#35)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#15)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#3)
of more-complex##2##2##(2008-3#2)
of morin-Al(3+) complex##2##3##(2008-10#2)
of morphine (10##2##3##(1995-5#1)(1997-2#1)
of morphine and beta-endorphin##3##4##(1992-3#3)
of morphine and##5##3##(1992-3#3)(1995-6#1)(2008-10#1)
of morphine in the##2##4##(1995-12#1)(1997-2#1)
of morphine in tolerant rats##2##5##(1996-2#2)
of morphine in##9##3##(1991-1#2)(1995-12#1)(1996-2#2)(1997-2#2)(2008-10#2)
of morphine into the##2##4##(1990-7#1)(1993-12#1)
of morphine is presented##2##4##(1995-11#1)(2008-10#1)
of morphine is##3##3##(1991-1#1)(1995-11#1)(2008-10#1)
of morphine on##4##3##(1994-2#1)(1996-2#1)(2008-10#1)(2008-12#1)
of morphine sulfate##3##3##(1993-12#1)(1996-2#2)
of morphine were##3##3##(1995-11#2)(2008-12#1)
of morphine##58##2##(1990-7#1)(1991-1#6)(1992-3#3)(1993-12#6)(1994-2#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#12)(1997-2#3)(2008-10#9)(2008-11#1)(2008-12#6)(2008-7#2)(2009-4#1)
of morphogenesis##3##2##(1993-12#1)(1996-3#1)(2008-7#1)
of morphogenetic##2##2##(1994-9#1)(2009-8#1)
of morphologic and##3##3##(1993-12#1)(1996-7#1)(2008-10#1)
of morphologic##7##2##(1990-8#1)(1992-12#1)(1993-12#1)(1996-7#1)(2008-10#1)(2010-9#1)(2011-2#1)
of morphological and biochemical##2##4##(1992-11#1)(1996-5#1)
of morphological and##6##3##(1992-11#1)(1996-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
of morphological##23##2##(1992-11#1)(1992-5#3)(1996-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of morphologically distinct##2##3##(1995-2#1)(2008-10#1)
of morphologically normal##3##3##(1993-5#1)(2011-2#2)
of morphologically##11##2##(1990-12#1)(1993-5#1)(1995-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#3)
of morphology and##2##3##(2008-3#1)(2009-12#1)
of morphology##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
of morphospecies##2##2##(2008-6#2)
of morphotype##6##2##(2008-10#6)
of mortality and morbidity##4##4##(1994-11#1)(2009-10#1)(2011-2#2)
of mortality and##7##3##(1994-11#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-7#1)
of mortality at##2##3##(2008-8#1)(2012-3#1)
of mortality by##2##3##(2008-1#1)(2012-12#1)
of mortality during##2##3##(2008-10#1)(2013-1#1)
of mortality in the##2##4##(2008-1#1)(2011-2#1)
of mortality in##14##3##(1993-9#1)(1997-4#1)(2008-1#1)(2008-3#1)(2009-4#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#2)
of mortality is##4##3##(1994-11#1)(1995-8#1)(2008-10#1)(2011-2#1)
of mortality rate##3##3##(1995-3#1)(1995-8#1)(2008-8#1)
of mortality when##2##3##(2008-7#1)(2008-8#1)
of mortality##67##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-9#1)(1994-11#2)(1995-3#2)(1995-8#2)(1996-12#1)(1996-9#1)(1997-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-3#1)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
of mosaic symptoms##2##3##(2008-10#2)
of mosaic##3##2##(1991-5#1)(2008-10#2)
of mosquito##7##2##(2007-10#1)(2007-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2013-8#2)
of mosquitoes (Diptera##3##3##(2013-1#3)
of mosquitoes in##2##3##(2007-2#1)(2013-1#1)
of mosquitoes##7##2##(2007-2#1)(2008-7#1)(2010-1#1)(2013-1#4)
of moss##2##2##(2008-10#1)(2010-2#1)
of mossy fibre##2##3##(2012-2#2)
of most complex diseases##2##4##(2012-3#2)
of most interfering substances##2##4##(2008-10#2)
of most of the##16##4##(1990-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#5)(2008-4#1)(2009-7#1)(2013-1#1)
of most of these genes##2##5##(2008-8#1)(2008-9#1)
of most of these##3##4##(1997-7#1)(2008-8#1)(2008-9#1)
of most of##21##3##(1990-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-7#2)(2008-10#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
of most##100##2##(1990-11#1)(1990-12#2)(1990-2#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
of mother and child##2##4##(1994-6#1)(1994-9#1)
of mother and##4##3##(1990-12#1)(1993-6#1)(1994-6#1)(1994-9#1)
of mother##10##2##(1990-12#1)(1990-9#1)(1993-6#1)(1994-6#1)(1994-9#1)(1996-2#2)(2008-10#2)(2008-11#1)
of mother's##2##2##(1994-12#1)(2009-7#1)
of mother-to-child transmission of##7##4##(1990-9#1)(2009-4#4)(2009-7#1)(2012-2#1)
of mother-to-child transmission##10##3##(1990-9#1)(2009-4#7)(2009-7#1)(2012-2#1)
of mother-to-child##12##2##(1990-9#1)(2009-4#8)(2009-7#2)(2012-2#1)
of mothers and##3##3##(2007-5#1)(2009-11#2)
of mothers of children with##4##5##(1996-1#2)(2008-9#1)(2010-1#1)
of mothers of##5##3##(1996-1#2)(2008-2#1)(2008-9#1)(2010-1#1)
of mothers who##2##3##(1990-10#1)(1990-9#1)
of mothers with##7##3##(2007-2#1)(2009-11#1)(2011-1#4)(2012-12#1)
of mothers##25##2##(1990-10#1)(1990-9#1)(1993-3#1)(1996-1#2)(2007-2#1)(2007-5#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-11#3)(2010-1#1)(2010-10#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-3#1)
of mothers' confidence to care for children assisted with tracheostomy##2##10##(2012-2#2)
of mothers'##4##2##(2008-7#1)(2009-7#1)(2012-2#2)
of motifs##6##2##(2008-4#2)(2008-7#1)(2010-7#2)(2012-2#1)
of motile##6##2##(1994-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)
of motility##8##2##(1994-6#1)(2008-1#1)(2008-7#5)(2009-6#1)
of motion and proprioception##2##4##(2010-12#2)
of motion and##9##3##(1993-11#1)(1996-3#1)(2007-11#1)(2008-2#2)(2008-8#1)(2009-1#1)(2010-12#2)
of motion at the##2##4##(2007-11#1)(2008-7#1)
of motion blurred images##2##4##(2008-6#2)
of motion events##4##3##(2008-4#4)
of motion in##7##3##(2007-11#2)(2007-8#2)(2008-10#1)(2008-12#1)(2013-1#1)
of motion sensitivity##2##3##(2012-3#2)
of motion vision in##2##4##(1995-5#2)
of motion##93##2##(1993-11#1)(1995-5#2)(1996-3#1)(2007-11#7)(2007-12#3)(2007-8#7)(2008-10#1)(2008-11#2)(2008-12#10)(2008-2#4)(2008-3#7)(2008-4#4)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#7)(2009-1#2)(2009-7#1)(2010-12#3)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#9)
of motivation##6##2##(1993-6#2)(1996-7#2)(2013-1#2)
of motivation-related behavior##2##3##(2008-4#2)
of motivational beliefs##2##3##(2010-1#2)
of motivational readiness for physical activity##3##6##(2008-4#3)
of motivational##9##2##(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2010-1#2)(2013-1#1)
of motor complications##4##3##(2008-7#1)(2010-12#3)
of motor disability##2##3##(2008-7#2)
of motor fluctuation##2##3##(2013-1#2)
of motor function and##2##4##(1993-5#1)(1995-5#1)
of motor function##6##3##(1993-5#1)(1995-5#1)(1997-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of motor nerves##2##3##(2007-12#1)(2008-9#1)
of motor neurone diseases##2##4##(1995-12#2)
of motor neurone##4##3##(1995-12#2)(1996-5#2)
of motor neurons##2##3##(1990-5#2)
of motor units in##2##4##(1993-9#1)(1996-5#1)
of motor units##4##3##(1993-9#1)(1996-5#1)(2013-1#1)(2013-8#1)
of motor##50##2##(1990-5#2)(1992-3#1)(1993-5#1)(1993-9#1)(1995-12#3)(1995-5#1)(1996-5#3)(1997-2#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#9)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-12#3)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#5)(2013-8#3)
of moulds##2##2##(2008-5#2)
of mountain##2##2##(2013-1#1)(2013-8#1)
of mouse ES##2##3##(2008-9#1)(2012-2#1)
of mouse IgG protein##2##4##(2008-10#2)
of mouse IgG##3##3##(2008-10#3)
of mouse L cells##2##4##(1990-2#2)
of mouse N-ras##2##3##(1992-9#2)
of mouse T##2##3##(2008-4#2)
of mouse TGF-beta receptor genes##2##5##(1997-2#2)
of mouse and human##5##4##(1993-8#1)(1997-7#1)(2008-4#3)
of mouse bone marrow##2##4##(2008-11#1)(2008-9#1)
of mouse calpastatin##2##3##(2008-11#2)
of mouse chromosome##6##3##(1993-2#1)(1995-2#1)(1996-10#1)(1997-2#1)(2008-7#2)
of mouse embryonic fibroblasts##2##4##(2008-2#2)
of mouse erythroleukemia##2##3##(1992-8#1)(2008-9#1)
of mouse hepatoma Hca-F cells##2##5##(2012-3#2)
of mouse kidney##2##3##(1990-2#1)(1996-5#1)
of mouse liver##3##3##(2008-10#2)(2008-9#1)
of mouse mammary tumor virus##2##5##(1994-11#1)(1994-7#1)
of mouse mammary##3##3##(1991-12#1)(1994-11#1)(1994-7#1)
of mouse melanoma##2##3##(2008-11#2)
of mouse models##2##3##(2008-11#1)(2008-4#1)
of mouse monoclonal antibodies##2##4##(1996-5#1)(1997-6#1)
of mouse neurons##2##3##(1994-2#1)(2012-2#1)
of mouse thymic##2##3##(2008-8#2)
of mouse tissues##2##3##(1991-6#1)(2008-11#1)
of mouse##111##2##(1990-11#1)(1990-2#4)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-2#3)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#3)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#13)(2008-2#3)(2008-3#1)(2008-4#12)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#3)(2012-3#2)
of mouse-human hybridomas##2##3##(2008-11#2)
of mouse-mouse hybridoma##2##3##(1994-2#1)(1994-5#1)
of mouth##4##2##(1997-2#1)(2008-1#1)(2008-5#1)(2013-1#1)
of mouth-opening##2##2##(2008-5#2)
of movement and##4##3##(1993-2#1)(1997-3#1)(2007-11#1)(2007-8#1)
of movement in##4##3##(1996-4#1)(2007-8#3)
of movement is##2##3##(2008-8#1)(2013-8#1)
of movement of the##3##4##(1994-1#1)(2007-11#1)(2007-8#1)
of movement of##7##3##(1991-5#2)(1994-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
of movement##52##2##(1990-5#2)(1991-5#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-4#1)(1997-3#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#10)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-7#3)(2008-8#3)(2010-3#2)(2010-6#2)(2012-2#4)(2013-1#2)(2013-8#1)
of movements##4##2##(2007-12#1)(2008-7#1)(2009-2#1)(2012-3#1)
of moving objects##5##3##(2008-2#1)(2008-3#3)(2011-2#1)
of moving surfaces##2##3##(2008-3#2)
of moving##25##2##(1993-5#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#10)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
of moxibustion##2##2##(2012-3#1)(2013-1#1)
of moyamoya disease in the##2##5##(2007-10#2)
of mrf-1##2##2##(2008-6#2)
of mrr##3##2##(2008-11#3)
of mtDNA haplotypes##3##3##(2008-10#2)(2010-8#1)
of mtDNA in##3##3##(1995-11#1)(2008-8#1)(2009-11#1)
of mtDNA##14##2##(1994-11#1)(1995-11#3)(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2010-8#1)(2013-1#1)
of mtRNA(Leu(M)) was##2##3##(2008-8#2)
of mu and delta opioid receptors in##2##7##(2009-7#2)
of mu and delta##3##4##(2009-7#3)
of mu and##4##3##(2008-10#1)(2009-7#3)
of mu##6##2##(1996-2#1)(2008-10#1)(2009-7#4)
of mu(a) and mu(s)'##2##4##(2008-3#2)
of mu- and##2##3##(1995-12#1)(1996-2#1)
of mu-##3##2##(1995-12#2)(1996-2#1)
of mu-opioid receptors##3##3##(1996-2#1)(1997-2#2)
of mu-opioid##4##2##(1996-2#2)(1997-2#2)
of much debate##2##3##(2008-11#1)(2013-7#1)
of much higher##2##3##(2007-11#1)(2008-3#1)
of much less##2##3##(2009-6#2)
of much of##2##3##(1990-5#1)(1995-1#1)
of much##20##2##(1990-5#1)(1990-9#1)(1993-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2009-6#2)(2013-1#2)(2013-7#1)
of mucin##2##2##(1992-11#1)(1993-8#1)
of mucinous ovarian cystomas of intestinal##2##6##(1990-2#2)
of mucinous##4##2##(1990-2#2)(2009-5#1)(2010-12#1)
of mucins##2##2##(1992-11#1)(1994-9#1)
of mucocutaneous##2##2##(2007-12#1)(2010-6#1)
of mucormycosis##5##2##(2010-10#1)(2011-2#4)
of mucosa##3##2##(1997-1#1)(2011-1#1)(2013-8#1)
of mucosa-associated lymphoid tissue##4##4##(2009-5#1)(2009-8#3)
of mucosal##12##2##(1990-9#1)(1991-8#2)(1993-11#1)(1994-2#1)(2008-10#1)(2008-5#3)(2011-2#1)(2012-2#1)(2013-1#1)
of mucus##3##2##(1992-5#1)(1995-2#1)(1996-7#1)
of mug l(-1)##3##3##(2008-10#3)
of mug##4##2##(2008-10#4)
of mulberry anthracnose##2##3##(2008-10#2)
of mulberry##3##2##(2008-10#3)
of mulch##2##2##(2008-10#2)
of multi-component##2##2##(2008-10#2)
of multi-detector##3##2##(2008-7#1)(2011-2#2)
of multi-faceted##2##2##(1997-2#1)(2012-3#1)
of multi-resistant##2##2##(1995-8#1)(2007-2#1)
of multicellular##7##2##(1992-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-2#1)
of multichannel##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
of multicistronic expression##2##3##(2008-11#2)
of multicommutation##3##2##(2008-10#3)
of multicomponent systems##2##3##(2007-12#1)(2008-11#1)
of multicomponent##11##2##(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2013-8#2)
of multicopper oxidases##2##3##(2008-10#1)(2012-2#1)
of multidetector CT##2##3##(2008-7#1)(2010-9#1)
of multidimensional##9##2##(1995-5#1)(1997-2#1)(2008-10#2)(2008-2#2)(2010-11#1)(2012-1#1)(2012-3#1)
of multidisciplinary care##2##3##(1996-1#1)(2012-8#1)
of multidisciplinary##9##2##(1996-1#2)(2008-10#1)(2008-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#1)
of multidrug resistance in##2##4##(2007-10#1)(2008-11#1)
of multidrug resistance##6##3##(1990-2#1)(1997-4#1)(2007-10#1)(2008-11#2)(2012-3#1)
of multidrug resistant##8##3##(1996-3#1)(2008-11#2)(2008-8#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-8#1)
of multidrug##16##2##(1990-2#1)(1991-8#1)(1996-3#1)(1997-4#1)(2007-10#1)(2008-11#4)(2008-8#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of multidrug-resistant tuberculosis##2##3##(1996-3#1)(2009-4#1)
of multidrug-resistant##4##2##(1996-3#1)(2009-4#1)(2010-6#1)(2011-2#1)
of multielemental analysis in##2##4##(2008-10#2)
of multielemental analysis##3##3##(2008-10#3)
of multifactorial##2##2##(1990-3#1)(2012-2#1)
of multifocal##3##2##(1997-1#1)(2006-10#1)(2009-9#1)
of multifunctional##5##2##(2007-11#1)(2008-5#2)(2008-7#1)(2008-9#1)
of multigene metabolic engineering##2##4##(2008-11#2)
of multilayer coatings##3##3##(2008-2#2)(2010-4#1)
of multilayer##16##2##(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#6)(2010-4#1)(2010-8#1)
of multilayered##2##2##(2008-12#2)
of multilevel##5##2##(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#2)
of multilingual##2##2##(2008-7#1)(2008-9#1)
of multilocus correlation##7##3##(2008-10#7)
of multilocus structure of populations##2##5##(2008-10#2)
of multilocus##16##2##(2008-10#14)(2008-9#1)(2012-3#1)
of multimedia##2##2##(2010-7#1)(2013-8#1)
of multimodal therapy##3##3##(2010-12#1)(2010-3#2)
of multimodality##2##2##(2008-2#1)(2009-11#1)
of multimode fibers##2##3##(2008-2#1)(2008-3#1)
of multimode##11##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#5)
of multinational##2##2##(2008-5#1)(2010-3#1)
of multiorgan##3##2##(1990-6#1)(1997-3#1)(2008-12#1)
of multiparametric##2##2##(2008-1#1)(2008-4#1)
of multipass ultrashort-pulse laser amplifiers##2##5##(2008-2#2)
of multiphoton fluorescence##3##3##(2007-12#2)(2008-9#1)
of multiphoton##6##2##(2007-12#3)(2008-9#2)(2011-1#1)
of multiplanar##2##2##(2008-3#1)(2011-2#1)
of multiple analytes##3##3##(2007-11#1)(2008-3#1)(2010-5#1)
of multiple beams##2##3##(2007-12#1)(2008-2#1)
of multiple births##2##3##(1995-6#2)
of multiple burials of sclerotia##2##5##(2008-10#2)
of multiple cell##2##3##(2008-8#1)(2012-2#1)
of multiple defense##2##3##(2008-10#2)
of multiple endocrine neoplasia##2##4##(1990-3#1)(2013-1#1)
of multiple endocrine##3##3##(1990-3#1)(2009-4#1)(2013-1#1)
of multiple failure time data##2##5##(1997-4#2)
of multiple foci##2##3##(2007-11#1)(2008-10#1)
of multiple forms of##3##4##(1990-7#1)(1991-5#1)(2007-8#1)
of multiple gene##3##3##(1997-7#1)(2008-7#1)(2012-3#1)
of multiple genes##2##3##(2008-11#1)(2008-9#1)
of multiple genetic and##2##4##(2008-7#1)(2009-6#1)
of multiple genetic##4##3##(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
of multiple hydatid cysts##2##4##(2008-7#2)
of multiple infections##2##3##(1997-4#1)(2008-9#1)
of multiple isoforms##2##3##(1994-6#1)(1996-5#1)
of multiple lesions##2##3##(2011-2#1)(2013-1#1)
of multiple light##2##3##(2008-3#2)
of multiple linear regression##3##4##(2008-10#3)
of multiple measures##2##3##(2008-5#1)(2008-8#1)
of multiple myeloma by##2##4##(1991-5#1)(2008-7#1)
of multiple myeloma##9##3##(1991-12#1)(1991-5#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-12#1)(2012-12#2)
of multiple objects##3##3##(2008-3#3)
of multiple parallel synthesis##2##4##(2008-10#2)
of multiple populations##2##3##(2008-9#1)(2012-2#1)
of multiple pregnancies##2##3##(1997-2#1)(2008-11#1)
of multiple primary##2##3##(2011-2#2)
of multiple proteins##2##3##(2009-7#1)(2010-11#1)
of multiple quantitative##2##3##(2008-9#1)(2013-8#1)
of multiple rare##2##3##(2012-3#2)
of multiple reflecting surfaces##2##4##(2008-3#2)
of multiple reflection##2##3##(2007-12#1)(2008-3#1)
of multiple reversals##2##3##(1990-7#1)(2007-12#1)
of multiple rotational Raman##2##4##(2007-11#2)
of multiple scattering on##3##4##(2008-2#1)(2008-3#2)
of multiple scattering##13##3##(2007-11#1)(2008-2#4)(2008-3#7)(2013-8#1)
of multiple sclerosis (MS) patients##2##5##(2010-2#1)(2012-3#1)
of multiple sclerosis (MS)##4##4##(2010-2#1)(2012-3#3)
of multiple sclerosis##13##3##(1994-9#1)(1995-12#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#3)(2012-3#5)
of multiple sex##2##3##(1993-6#1)(2011-2#1)
of multiple signaling pathways##2##4##(2011-2#1)(2013-7#1)
of multiple species##3##3##(1995-6#1)(2008-3#1)(2009-8#1)
of multiple squamous cell papilloma of the forestomach in##2##9##(2008-9#2)
of multiple tissues##2##3##(1996-10#1)(2010-3#1)
of multiple types of##2##4##(2007-12#1)(2012-2#1)
of multiple##301##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#2)(2007-11#7)(2007-12#10)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#33)(2008-11#8)(2008-12#2)(2008-2#11)(2008-3#30)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#9)(2008-9#12)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#14)(2013-1#7)(2013-7#1)(2013-8#6)
of multiple-beam##2##2##(2008-2#1)(2008-3#1)
of multiple-scattering##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
of multiplex PCR products##3##4##(2008-10#2)(2008-9#1)
of multiplex PCR##4##3##(2008-10#3)(2008-9#1)
of multiplex##8##2##(2007-11#1)(2008-10#4)(2008-9#1)(2012-2#2)
of multiplexed##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
of multiplexing##2##2##(2007-12#1)(2008-2#1)
of multiplication and##2##3##(2008-10#2)
of multiplication##3##2##(2008-10#2)(2009-2#1)
of multiply scattered light##2##4##(2008-2#2)
of multiply scattered##4##3##(2008-2#3)(2008-3#1)
of multiply##9##2##(2008-1#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-9#1)
of multipole##2##2##(2007-11#1)(2007-12#1)
of multipotent##2##2##(2008-5#1)(2012-4#1)
of multiprofessional##2##2##(1997-8#1)(2012-3#1)
of multiresistant bacteria##2##3##(2009-5#1)(2012-1#1)
of multiresistant##4##2##(2009-5#1)(2012-1#1)(2012-3#2)
of multispecies competition##2##3##(2008-8#2)
of multispecies##3##2##(2008-8#3)
of multispectral##2##2##(2008-10#1)(2008-2#1)
of multistep##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
of multisubunit##4##2##(2008-2#2)(2008-4#1)(2010-7#1)
of multitherapy vs##2##3##(1994-6#2)
of multivariate analysis##2##3##(2008-10#2)
of multivariate calibration methods##2##4##(2008-1#2)
of multivariate calibration##3##3##(2008-1#2)(2008-10#1)
of multivariate data analysis##3##4##(2008-10#2)(2012-1#1)
of multivariate data##4##3##(2008-10#2)(2008-6#1)(2012-1#1)
of multivariate##24##2##(1992-6#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#14)(2008-3#1)(2008-6#1)(2008-8#1)(2012-1#2)
of multiwall carbon nanotubes##3##4##(2008-10#3)
of multiwalled carbon nanotubes##2##4##(2008-10#1)(2009-3#1)
of multiwavelength##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
of mummy##3##2##(2008-10#3)
of mung bean seedlings##2##4##(2008-9#2)
of mung bean##3##3##(2008-10#1)(2008-9#2)
of municipal##3##2##(1992-11#1)(1995-11#1)(1997-4#1)
of municipalities##3##2##(2008-9#2)(2012-12#1)
of mural##3##2##(1992-9#1)(2008-7#1)(2012-12#1)
of murexide##3##2##(2008-10#3)
of murine Hoxa-7##3##3##(1997-4#3)
of murine Smad5##2##3##(2008-8#2)
of murine and human##4##4##(1992-2#1)(1995-2#1)(2008-4#1)(2010-6#1)
of murine erythroid##2##3##(2008-8#2)
of murine erythroleukemia cells##2##4##(1991-2#1)(1993-6#1)
of murine erythroleukemia##3##3##(1991-2#2)(1993-6#1)
of murine hematopoietic##2##3##(1997-4#1)(2008-4#1)
of murine hybridoma##2##3##(2008-11#2)
of murine tumor##2##3##(1990-12#1)(1992-8#1)
of murine##54##2##(1990-12#2)(1991-1#1)(1991-2#2)(1992-2#1)(1992-3#2)(1992-8#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-4#5)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#4)(2008-4#5)(2008-6#1)(2008-8#7)(2008-9#2)(2010-12#1)(2010-6#1)(2013-1#1)
of muscarinic M2##4##3##(1995-12#4)
of muscarinic##9##2##(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#5)(1996-12#1)
of muscimol##2##2##(1993-12#2)
of muscle cell##2##3##(1994-12#1)(2012-2#1)
of muscle cells##2##3##(1994-3#1)(2008-10#1)
of muscle contraction##2##3##(1990-6#1)(2011-2#1)
of muscle contractions##3##3##(1994-8#2)(2008-3#1)
of muscle fiber motion##2##4##(2011-1#2)
of muscle fibers##3##3##(1995-12#1)(2008-3#1)(2011-2#1)
of muscle flap closure##2##4##(2012-2#2)
of muscle function##2##3##(2010-8#1)(2011-2#1)
of muscle pain##2##3##(1994-2#2)
of muscle tension and##2##4##(1994-2#2)
of muscle tissue##2##3##(1990-6#1)(2008-3#1)
of muscle tone##6##3##(1991-5#2)(1995-2#4)
of muscle was##2##3##(2010-4#1)(2011-2#1)
of muscle weakness##3##3##(1997-8#1)(2007-7#1)(2012-3#1)
of muscle##76##2##(1990-6#2)(1990-8#2)(1991-5#3)(1992-4#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-8#2)(1995-12#3)(1995-2#5)(1996-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#3)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
of muscles and##3##3##(1994-5#1)(2007-12#1)(2010-4#1)
of muscles##14##2##(1990-5#2)(1990-6#1)(1993-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-7#1)
of muscular dystrophy##2##3##(1997-3#1)(2008-7#1)
of muscular tissue##2##3##(2007-10#1)(2010-5#1)
of muscular##14##2##(1990-5#1)(1990-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
of musculoskeletal conditions##2##3##(2008-3#1)(2012-2#1)
of musculoskeletal discomfort##2##3##(1996-9#2)
of musculoskeletal##12##2##(1996-9#2)(2006-10#1)(2008-12#4)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
of mushroom##8##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-11#1)(2011-2#1)
of mushrooms##3##2##(1994-9#1)(2010-10#1)(2011-2#1)
of music after cochlear implantation##2##5##(2008-9#2)
of music on the##2##4##(1991-12#1)(2007-6#1)
of music on##6##3##(1991-12#2)(2007-6#2)(2008-5#1)(2008-9#1)
of music therapists##2##3##(1991-12#2)
of music therapy and other##2##5##(1993-2#2)
of music therapy##4##3##(1993-2#2)(2007-6#1)(2009-3#1)
of music##22##2##(1991-12#4)(1993-2#2)(2007-6#7)(2008-5#1)(2008-9#6)(2009-3#1)(2013-8#1)
of musical experience##2##3##(2008-11#2)
of musical instruments##2##3##(2008-9#2)
of musical##6##2##(2008-11#3)(2008-9#2)(2012-2#1)
of muskmelon##2##2##(2008-10#2)
of mussel##2##2##(2008-10#2)
of mussels##3##2##(2008-10#2)(2008-9#1)
of mutagenesis##2##2##(2011-1#1)(2013-8#1)
of mutagenic process##3##3##(2008-10#3)
of mutagenic##5##2##(1995-6#1)(2008-10#4)
of mutant alleles##3##3##(1993-3#1)(1995-9#1)(2008-10#1)
of mutant mice##5##3##(2008-10#1)(2008-8#4)
of mutant p53 in##2##4##(1991-2#1)(2009-4#1)
of mutant p53##5##3##(1990-12#1)(1991-2#1)(1991-5#1)(2009-4#2)
of mutant##38##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#1)(1993-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-8#5)(2009-10#1)(2009-3#1)(2009-4#2)(2011-2#1)(2012-3#1)
of mutants of##2##3##(1995-9#1)(2008-8#1)
of mutants was##2##3##(1995-2#1)(2008-10#1)
of mutants##15##2##(1990-7#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#1)(2012-3#1)
of mutated##9##2##(1991-11#1)(1992-6#1)(1995-5#1)(1997-7#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of mutating##2##2##(1997-7#1)(2010-5#1)
of mutation and cancer##2##4##(1991-9#2)
of mutation and##3##3##(1991-9#2)(2010-4#1)
of mutation of##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
of mutation##18##2##(1990-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2013-1#1)
of mutation-selection##2##2##(2008-1#2)
of mutations at the##3##4##(1990-7#1)(1995-9#1)(1997-3#1)
of mutations at##4##3##(1990-7#1)(1995-9#1)(1997-3#1)(2008-7#1)
of mutations in the gene for##2##6##(2008-7#2)
of mutations in the gene##4##5##(1997-3#1)(2008-4#1)(2008-7#2)
of mutations in the##6##4##(1990-8#1)(1993-11#1)(1997-3#1)(2008-4#1)(2008-7#2)
of mutations in##17##3##(1990-11#1)(1990-8#2)(1991-9#1)(1993-11#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-4#1)(2012-12#1)(2013-1#1)
of mutations that##2##3##(1990-5#1)(2008-4#1)
of mutations##39##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-9#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-3#3)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#4)(2008-7#4)(2008-9#3)(2010-3#1)(2010-4#2)(2012-12#1)(2013-1#2)
of mutual aid##2##3##(1996-3#2)
of mutual respect and##2##4##(1991-3#1)(2008-12#1)
of mutual##12##2##(1990-8#1)(1991-3#1)(1992-2#1)(1996-3#2)(1996-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
of mutualism##2##2##(2008-8#2)
of mutually##2##2##(2007-12#1)(2008-9#1)
of muzzle##2##2##(1997-6#2)
of my##9##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-7#2)
of myasthenia gravis##3##3##(2010-11#1)(2012-3#2)
of mycelia##4##2##(2008-10#3)(2012-3#1)
of mycelial growth##2##3##(2008-10#2)
of mycelial##4##2##(2008-10#4)
of mycelium in##2##3##(2008-10#2)
of mycelium##8##2##(1994-8#1)(2008-10#7)
of mycobacteria##3##2##(1991-5#1)(1997-4#1)(2011-2#1)
of mycobacterial infections##2##3##(2011-2#1)(2013-1#1)
of mycobacterial##7##2##(1997-4#1)(2008-1#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
of mycolic acids##2##3##(2008-9#2)
of mycoparasitism##2##2##(2008-10#2)
of mycoplasma contamination in cell cultures##2##6##(2008-11#2)
of mycoplasma contamination##3##3##(2008-11#3)
of mycoplasmas##4##2##(2008-11#3)(2010-9#1)
of mycoses##2##2##(2008-5#1)(2009-7#1)
of mycosis fungoides##2##3##(2010-6#2)
of mycosis##3##2##(2008-5#1)(2010-6#2)
of mycotoxin##2##2##(2008-10#2)
of mycotoxins in##2##3##(2008-10#1)(2010-7#1)
of mycotoxins##8##2##(1993-3#1)(1995-3#1)(2008-10#2)(2008-8#1)(2010-7#3)
of myelin in the##2##4##(2009-6#2)
of myelin proteins##3##3##(1992-12#3)
of myelin##9##2##(1992-12#3)(2007-11#1)(2008-7#1)(2009-6#3)(2010-12#1)
of myelinating cells##2##3##(2008-7#2)
of myelinating##3##2##(2008-7#3)
of myelination##7##2##(1996-5#4)(2008-5#2)(2008-7#1)
of myelodysplastic syndromes##2##3##(2010-1#1)(2010-11#1)
of myelodysplastic##4##2##(1990-11#1)(2008-5#1)(2010-1#1)(2010-11#1)
of myeloid cells##2##3##(2008-10#1)(2008-4#1)
of myeloid progenitor cells##2##4##(1994-5#1)(1997-7#1)
of myeloid##8##2##(1994-5#1)(1997-7#1)(2008-10#1)(2008-4#4)(2011-2#1)
of myeloma cells##2##3##(2011-2#1)(2013-1#1)
of myeloma##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
of myiasis##4##2##(2008-2#3)(2013-1#1)
of myoD##2##2##(1992-5#2)
of myoblasts##5##2##(1997-1#1)(2008-11#2)(2008-4#2)
of myocardial contractility##2##3##(2013-1#2)
of myocardial energetics in##2##4##(2010-8#2)
of myocardial gene expression in##2##5##(2009-12#1)(2010-6#1)
of myocardial infarction (MI)##2##4##(2008-10#1)(2009-5#1)
of myocardial infarction and##5##4##(1990-2#1)(1996-8#1)(2009-9#2)(2011-2#1)
of myocardial infarction##21##3##(1990-2#1)(1990-5#1)(1991-3#2)(1991-6#2)(1995-2#1)(1996-8#1)(2008-10#1)(2008-7#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-4#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
of myocardial ischemia##5##3##(1997-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
of myocardial perfusion in##2##4##(2011-2#1)(2013-8#1)
of myocardial perfusion##3##3##(2009-10#1)(2011-2#1)(2013-8#1)
of myocardial protection##2##3##(1991-3#1)(1996-9#1)
of myocardial revascularization##2##3##(1993-12#1)(2009-4#1)
of myocardial stunning##3##3##(1991-3#3)
of myocardial viability##3##3##(1992-5#1)(2009-10#1)(2012-2#1)
of myocardial##72##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-3#7)(1991-6#2)(1992-5#2)(1993-12#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-8#1)(1996-9#5)(1997-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#4)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-4#1)(2010-6#1)(2010-8#5)(2011-2#8)(2012-1#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
of myocarditis##2##2##(2010-7#1)(2012-3#1)
of myocardium##5##2##(1990-5#1)(1996-9#1)(2008-10#1)(2011-1#2)
of myoepithelial cells##2##3##(1994-12#1)(2012-3#1)
of myoepithelial##4##2##(1994-12#1)(2007-5#1)(2012-3#1)(2013-8#1)
of myofascial trigger##2##3##(2008-12#1)(2013-1#1)
of myofascial##4##2##(2008-12#2)(2009-1#1)(2013-1#1)
of myofibrils##2##2##(2008-7#1)(2010-8#1)
of myogenic factors##2##3##(1995-6#2)
of myogenic##7##2##(1995-6#2)(1995-8#4)(2008-11#1)
of myoglobin##3##2##(1992-3#1)(1993-11#1)(2008-10#1)
of myoinositol##3##2##(2008-7#1)(2008-8#2)
of myointima##2##2##(2006-6#2)
of myometrial invasion##2##3##(1994-9#1)(2011-2#1)
of myometrial##5##2##(1993-1#1)(1994-3#2)(1994-9#1)(2011-2#1)
of myopia progression##2##3##(2012-12#2)
of myopia##9##2##(2008-3#1)(2012-12#8)
of myosin light chain kinase##3##5##(1991-2#1)(1992-6#1)(1995-12#1)
of myosin subfragment 1##2##4##(1994-5#1)(1994-8#1)
of myosin##16##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-9#1)(2008-11#1)(2008-5#1)
of myositis and##2##3##(1992-11#1)(2006-10#1)
of myositis ossificans##2##3##(1992-2#2)
of myositis##6##2##(1992-11#1)(1992-2#2)(2006-10#1)(2012-2#1)(2013-1#1)
of myotonic dystrophy##2##3##(2008-7#2)
of myristic##4##2##(2008-10#4)
of myxoid and##2##3##(2008-6#1)(2010-6#1)
of myxoid##3##2##(2008-6#2)(2010-6#1)
of n =##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of n and k##2##4##(2008-3#2)
of n##21##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-7#3)(2008-9#1)(2009-12#1)(2010-7#1)
of n(2)##5##2##(2007-11#3)(2008-2#2)
of n(c)##3##2##(2008-3#3)
of n-3 PUFAs on CVD##2##5##(2013-1#2)
of n-3 PUFAs on##3##4##(2013-1#3)
of n-3 PUFAs##7##3##(2013-1#7)
of n-3 fatty acids##2##4##(2012-12#1)(2013-1#1)
of n-3##11##2##(2012-12#1)(2013-1#9)(2013-8#1)
of n-6##2##2##(2010-4#1)(2013-1#1)
of n-butylamine##2##2##(2008-10#2)
of n-hexadecane##2##2##(1994-11#2)
of n-hexane##2##2##(2008-10#1)(2008-2#1)
of n-hexanethiolate##2##2##(2007-12#2)
of nAChR##2##2##(2007-8#1)(2010-8#1)
of nNOS##2##2##(1996-12#2)
of nafion##3##2##(2008-10#3)
of naive##4##2##(1994-11#1)(1994-2#1)(1995-12#1)(2008-11#1)
of nalbuphine and fentanyl as intravenous##2##6##(1993-1#2)
of nalbuphine during##3##3##(1992-5#3)
of nalbuphine##7##2##(1992-5#5)(1993-1#2)
of naled##2##2##(2007-5#1)(2008-10#1)
of nalidixic acid##5##3##(2008-10#4)(2012-2#1)
of naloxone##2##2##(1992-5#1)(1996-2#1)
of naltrexone##3##2##(1991-1#2)(2008-2#1)
of named##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
of nano-scale##2##2##(2009-11#1)(2012-2#1)
of nanoclusters##2##2##(2008-10#2)
of nanocrystalline Ce(1-x)Ln(x)O(2-x/2-delta) (Ln = Yb##2##6##(2010-4#2)
of nanocrystalline##3##2##(2010-4#2)(2012-2#1)
of nanocrystals##2##2##(2007-11#1)(2008-10#1)
of nanogram quantities of iron(II) tris-(1##2##6##(2008-10#2)
of nanogram quantities##3##3##(2008-10#3)
of nanogram##7##2##(2008-10#7)
of nanomaterial##3##2##(2008-10#2)(2008-8#1)
of nanomaterials##6##2##(2010-12#1)(2010-7#5)
of nanometer##2##2##(2009-11#1)(2010-5#1)
of nanometers##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
of nanometric displacement##2##3##(2007-12#2)
of nanoparticle##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of nanoparticles and##2##3##(2008-7#2)
of nanoparticles##15##2##(2008-10#2)(2008-3#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#2)(2012-6#1)(2013-1#1)
of nanorose##2##2##(2011-1#2)
of nanoscale##4##2##(2007-12#1)(2010-12#1)(2010-7#2)
of nanosecond##2##2##(2007-12#1)(2008-3#1)
of nanosensors##3##2##(2008-10#3)
of nanosized##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
of nanostructured##2##2##(2008-10#1)(2009-11#1)
of nanostructures in##2##3##(2010-12#1)(2011-2#1)
of nanostructures##4##2##(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
of nanotechnology in##2##3##(2008-9#1)(2010-12#1)
of nanotechnology patent applications##2##4##(2010-12#2)
of nanotechnology##16##2##(2008-10#2)(2008-11#3)(2008-7#4)(2008-9#1)(2010-12#5)(2010-5#1)
of nanotube##3##2##(2008-10#1)(2008-7#2)
of nanotubes##5##2##(2008-10#4)(2010-2#1)
of nanowires (NWs)##2##3##(2008-7#2)
of nanowires##6##2##(2008-7#3)(2009-11#2)(2012-2#1)
of naphthalene and##2##3##(2008-11#1)(2011-2#1)
of naphthalene##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
of naphthol##2##2##(2008-10#2)
of naphthyl##2##2##(2008-10#1)(2011-2#1)
of naphthyltetrahydroisoquinoline alkaloids##2##3##(1994-12#2)
of naproxen in##2##3##(2008-10#1)(2010-5#1)
of naproxen##15##2##(2008-10#11)(2008-11#2)(2010-5#2)
of narcotic##2##2##(1991-11#1)(1996-12#1)
of narratives of illness##2##4##(1996-3#1)(2011-2#1)
of narratives##5##2##(1996-3#1)(2008-12#1)(2011-2#1)(2013-1#2)
of narrow##3##2##(2006-6#1)(2007-12#2)
of narrow-band##2##2##(2008-2#1)(2008-3#1)
of nasal cancer##3##3##(1992-10#3)
of nasal spray##2##3##(2013-1#2)
of nasal##15##2##(1991-4#1)(1992-10#3)(1993-11#2)(1993-2#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
of nasally inhaled##2##3##(2013-1#2)
of nasally##3##2##(1993-11#1)(2013-1#2)
of nascent##5##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
of nasopharyngeal carcinoma##2##3##(1991-8#1)(1993-9#1)
of nasopharyngeal##7##2##(1991-8#1)(1993-9#1)(2007-5#1)(2008-8#2)(2013-1#1)(2013-8#1)
of national and international##2##4##(1994-12#1)(1997-7#1)
of national health expenditures##2##4##(1991-2#1)(1992-3#1)
of national health##4##3##(1991-2#1)(1992-3#1)(1996-1#1)(2008-11#1)
of national standards##3##3##(1993-1#1)(1996-2#1)(2008-12#1)
of national##28##2##(1990-6#1)(1991-11#1)(1991-2#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
of nationalism##4##2##(2008-2#1)(2011-1#3)
of nations##2##2##(2012-2#1)(2013-7#1)
of native and denatured##3##4##(1990-5#1)(2008-10#2)
of native and##8##3##(1990-5#2)(1992-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
of native arteries##2##3##(2011-2#2)
of native arteriovenous fistulas in##2##5##(2007-7#2)
of native arteriovenous fistulas##3##4##(2007-7#3)
of native enzyme##5##3##(1993-8#1)(1995-6#4)
of native glucagon##2##3##(2008-8#1)(2011-2#1)
of native populations##2##3##(2008-10#2)
of native protein##3##3##(1990-7#1)(1992-8#1)(1993-11#1)
of native species##2##3##(2008-8#1)(2013-7#1)
of native zinc-containing##2##3##(1995-5#2)
of native##71##2##(1990-5#2)(1990-7#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-8#2)(1994-5#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#4)(2007-12#1)(2007-7#5)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-7#1)(2010-11#1)(2011-2#5)(2013-7#1)
of natriuretic peptide##2##3##(2009-5#2)
of natriuretic peptides##4##3##(2009-5#4)
of natriuretic##6##2##(2009-5#6)
of natural and synthetic##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
of natural and##9##3##(1990-2#1)(1992-11#1)(1992-8#1)(1994-8#1)(2008-10#2)(2008-11#2)(2012-3#1)
of natural antibodies##2##3##(1994-11#1)(1997-9#1)
of natural compounds##2##3##(1994-11#1)(2012-2#1)
of natural disasters##6##3##(2012-1#1)(2013-1#5)
of natural enemies##4##3##(2008-8#3)(2008-9#1)
of natural evolution##2##3##(1991-12#1)(1997-6#1)
of natural fluids##2##3##(2008-10#2)
of natural human##2##3##(2007-11#1)(2008-11#1)
of natural humic##2##3##(2008-10#2)
of natural increase##3##3##(2008-8#1)(2011-2#2)
of natural infections##2##3##(2008-10#1)(2008-5#1)
of natural killer (NK) cells##2##5##(2008-4#1)(2013-1#1)
of natural killer (NK)##3##4##(2008-4#1)(2008-9#1)(2013-1#1)
of natural killer cells##3##4##(1995-2#1)(1995-3#1)(1996-12#1)
of natural killer##8##3##(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-4#2)(2008-9#1)(2013-1#1)
of natural or##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
of natural organic matter (NOM)##3##5##(1992-5#1)(2008-10#1)(2008-11#1)
of natural organic matter##5##4##(1992-5#1)(2008-10#3)(2008-11#1)
of natural organic##6##3##(1992-5#1)(2008-10#4)(2008-11#1)
of natural plant##2##3##(2008-8#1)(2011-1#1)
of natural polymers##3##3##(2008-10#2)(2008-5#1)
of natural populations and##2##4##(2008-10#2)
of natural populations of##4##4##(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
of natural populations##7##3##(2008-10#3)(2008-9#2)(2012-12#1)(2012-3#1)
of natural product##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
of natural products and##2##4##(2009-10#1)(2009-2#1)
of natural products##6##3##(1997-4#1)(2008-10#1)(2009-10#1)(2009-2#1)(2010-2#2)
of natural resistance##2##3##(2008-10#2)
of natural samples##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
of natural selection in##2##4##(2010-4#1)(2012-3#1)
of natural selection on##2##4##(2008-9#2)
of natural selection##14##3##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#2)(2010-5#1)(2012-12#1)(2012-3#4)
of natural shampoos##2##3##(2008-5#2)
of natural systems##2##3##(2008-8#1)(2010-12#1)
of natural tooth##2##3##(2008-7#1)(2012-2#1)
of natural water##6##3##(2008-10#6)
of natural waters and##2##4##(2008-10#2)
of natural waters##8##3##(2008-10#5)(2008-2#1)(2008-3#2)
of natural##193##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-3#3)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-9#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#57)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#10)(2013-8#1)
of naturally infected##5##3##(2008-10#5)
of naturally occurring large presecretory proteins##2##6##(1994-11#2)
of naturally occurring##19##3##(1992-11#1)(1994-11#2)(1994-8#1)(1997-4#1)(2006-12#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
of naturally##31##2##(1992-11#1)(1994-11#2)(1994-8#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
of nature and##3##3##(2008-11#1)(2008-4#1)(2009-10#1)
of nature##18##2##(1992-3#1)(1997-6#1)(2008-11#1)(2008-12#7)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2012-2#1)
of naturopathy##2##2##(1991-2#1)(2010-3#1)
of nausea and vomiting##2##4##(1990-12#1)(2008-7#1)
of nausea##5##2##(1990-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
of navigation system##2##3##(2009-4#2)
of navigation##5##2##(2007-12#1)(2007-8#1)(2009-4#2)(2013-1#1)
of naïve T##2##3##(2008-4#1)(2010-2#1)
of naïve##3##2##(2008-4#1)(2010-2#1)(2013-8#1)
of ncRNAs##6##2##(2008-1#2)(2008-4#2)(2012-3#2)
of near##6##2##(2007-11#1)(2008-10#3)(2008-3#1)(2011-2#1)
of near-field optical##3##3##(2007-12#2)(2008-2#1)
of near-field##12##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#5)
of near-infrared (NIR)##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
of near-infrared fluorescent##2##3##(2007-11#2)
of near-infrared spectroscopy##3##3##(2007-10#1)(2008-10#2)
of near-infrared##14##2##(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-3#5)(2009-12#1)
of nearby##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)
of nearly 20##3##3##(1996-1#1)(2007-11#1)(2008-3#1)
of nearly##22##2##(1995-3#1)(1995-8#1)(1996-1#1)(1997-5#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)(2011-3#1)
of neat##2##2##(1994-3#1)(2008-5#1)
of nebivolol##2##2##(2010-2#1)(2010-3#1)
of nebulization##2##2##(1993-2#1)(1996-3#1)
of nebulized insulin was##2##4##(1996-3#2)
of nebulized insulin##3##3##(1996-3#3)
of nebulized##5##2##(1993-2#1)(1996-1#1)(1996-3#3)
of nebulizers##3##2##(1995-3#1)(1997-1#1)(2013-8#1)
of necessary##3##2##(1995-12#1)(2008-1#1)(2008-10#1)
of necessity##2##2##(2008-5#1)(2008-9#1)
of neck##10##2##(2007-11#1)(2008-7#1)(2009-4#2)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of necrosis and##5##3##(1994-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
of necrosis of the##2##4##(2008-6#1)(2011-2#1)
of necrosis of##3##3##(2008-6#2)(2011-2#1)
of necrosis##23##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-9#1)(1994-6#1)(2008-10#8)(2008-3#1)(2008-6#2)(2011-2#3)(2012-3#2)(2013-1#1)
of necrotic leaf tissue##2##4##(2008-10#2)
of necrotic lesions##4##3##(1997-6#1)(2008-10#3)
of necrotic##12##2##(1997-6#1)(2008-10#8)(2010-12#1)(2011-2#2)
of necrotizing##4##2##(2007-12#1)(2008-10#1)(2009-1#1)(2011-2#1)
of nectar on microbial antagonists##2##5##(2008-10#2)
of nectar##3##2##(2008-10#2)(2008-8#1)
of need##6##2##(1990-11#1)(1990-9#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
of needle pain##3##3##(2008-11#3)
of needle##7##2##(1993-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)
of needles##4##2##(1992-9#1)(2007-7#1)(2013-1#2)
of needlestick injuries and other##2##5##(2007-7#1)(2011-2#1)
of needs##5##2##(1990-11#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-4#1)
of negative affect##2##3##(2009-11#2)
of negative affectivity##2##3##(2010-6#2)
of negative emotions##2##3##(2008-11#1)(2010-11#1)
of negative health outcomes##2##4##(2010-10#1)(2012-1#1)
of negative phototropism##3##3##(2008-9#3)
of negative reports##2##3##(1992-8#1)(1997-5#1)
of negative##38##2##(1992-2#1)(1992-8#1)(1993-1#1)(1993-2#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#5)(2009-11#4)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
of negatively charged Al-citrate##2##4##(2008-10#2)
of negatively charged##7##3##(1992-12#1)(1995-8#1)(1996-8#1)(2008-1#1)(2008-10#3)
of negatively##8##2##(1990-5#1)(1992-12#1)(1995-8#1)(1996-8#1)(2008-1#1)(2008-10#3)
of negligence##4##2##(1991-7#1)(1992-2#1)(1995-12#1)(2008-10#1)
of negligible##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
of negotiating##2##2##(1992-3#1)(1996-3#1)
of neighborhood##8##2##(2007-10#1)(2008-11#1)(2009-7#1)(2009-9#5)
of neighboring##3##2##(2008-12#1)(2008-2#1)(2009-6#1)
of neighbors##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
of nematic##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
of nematode##3##2##(2008-10#3)
of nematode-trapping fungi was##2##4##(2008-10#2)
of nematode-trapping fungi##4##3##(2008-10#4)
of nematodes that had fed on##2##6##(2008-10#2)
of nematodes that##4##3##(2008-10#4)
of nematodes##13##2##(2008-10#12)(2008-12#1)
of neoadjuvant chemotherapy##2##3##(2010-3#1)(2011-2#1)
of neoadjuvant therapy##3##3##(2010-12#2)(2013-8#1)
of neoadjuvant##8##2##(2010-12#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#2)
of neocortical##9##2##(1992-12#2)(1994-3#1)(2007-9#1)(2008-11#4)(2010-7#1)
of neocuproine##2##2##(2008-10#2)
of neodymium##2##2##(2008-10#1)(2008-3#1)
of neointima formation##4##3##(1992-9#2)(2007-8#2)
of neoliberal##2##2##(2013-1#2)
of neomycin##2##2##(1994-11#2)
of neonatal and##2##3##(2010-12#1)(2011-2#1)
of neonatal follow-up##2##3##(2008-11#2)
of neonatal intensive care units##2##5##(1991-2#1)(2008-11#1)
of neonatal intensive care##6##4##(1991-2#1)(1994-12#1)(2008-11#4)
of neonatal mouse calvaria##2##4##(1990-11#1)(1993-8#1)
of neonatal mouse##3##3##(1990-11#1)(1993-8#1)(2008-8#1)
of neonatal rat##2##3##(1994-11#1)(1996-5#1)
of neonatal sepsis##2##3##(2008-5#1)(2009-12#1)
of neonatal septicemia##2##3##(2007-7#1)(2010-2#1)
of neonatal##47##2##(1990-11#1)(1991-2#1)(1992-10#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#8)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
of neonate##5##2##(2008-5#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
of neonates and##2##3##(1994-6#1)(2008-11#1)
of neonates##6##2##(1991-1#1)(1994-6#1)(1996-6#1)(2008-11#3)
of neoplasia in##2##3##(1992-9#1)(2008-12#1)
of neoplasia##9##2##(1990-9#2)(1992-9#1)(2008-12#1)(2008-2#1)(2010-12#1)(2011-2#1)(2013-8#2)
of neoplasm##3##2##(1992-2#1)(1993-3#1)(2007-11#1)
of neoplasmatic disease##2##3##(2007-11#2)
of neoplasmatic##3##2##(2007-11#2)(2007-8#1)
of neoplasms which##2##3##(1992-8#1)(2011-2#1)
of neoplasms##13##2##(1992-8#2)(1995-11#1)(2008-8#1)(2008-9#3)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)
of neoplastic cells##3##3##(2010-3#1)(2011-2#2)
of neoplastic diseases##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
of neoplastic transformation in vitro##4##5##(2008-7#4)
of neoplastic transformation in##6##4##(2008-7#5)(2012-12#1)
of neoplastic transformation##8##3##(1992-2#1)(2008-7#6)(2012-12#1)
of neoplastic##26##2##(1990-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(2007-11#3)(2008-11#3)(2008-4#2)(2008-7#6)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)
of neopterin##5##2##(1990-2#1)(1992-12#1)(1996-12#1)(2008-10#1)(2009-12#1)
of neostigmine##4##2##(2008-10#4)
of neosynthesized##2##2##(1990-7#1)(1996-2#1)
of neovascular##4##2##(2008-10#1)(2011-7#3)
of nephrectomy##2##2##(2007-7#1)(2011-2#1)
of nephrolithiasis##5##2##(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#1)
of nephropathy##6##2##(2008-1#4)(2008-9#2)
of nephrosis##2##2##(1996-6#1)(2009-6#1)
of nephrotic syndrome##3##3##(1992-5#1)(1996-6#2)
of nerve cell##3##3##(1994-6#2)(1996-12#1)
of nerve cells##4##3##(1995-8#1)(2008-11#1)(2008-7#2)
of nerve growth factor (NGF)##5##5##(1991-12#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-4#1)
of nerve growth factor##11##4##(1991-12#1)(1993-5#1)(1994-6#1)(1994-8#1)(1996-12#2)(1997-6#1)(2008-11#3)(2008-4#1)
of nerve injury##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
of nerve regeneration##2##3##(1993-5#1)(2011-2#1)
of nerve##36##2##(1991-12#1)(1992-3#1)(1993-5#2)(1994-6#3)(1994-8#1)(1995-8#1)(1996-12#3)(1997-6#1)(2008-11#4)(2008-12#1)(2008-4#2)(2008-7#4)(2008-9#4)(2009-5#1)(2011-2#3)(2012-2#4)
of nerves and##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
of nerves##4##2##(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
of nervous system##2##3##(1993-5#1)(2010-3#1)
of nervous##3##2##(1990-3#1)(1993-5#1)(2010-3#1)
of nested##5##2##(1994-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
of nesting##2##2##(2008-6#1)(2008-9#1)
of nests##2##2##(2007-5#1)(2008-9#1)
of net charge##3##3##(1991-10#1)(2008-4#2)
of net photosynthesis rate##2##4##(2008-10#1)(2008-12#1)
of net##14##2##(1991-10#1)(1992-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
of network##6##2##(1990-5#1)(1992-3#1)(2008-1#1)(2008-9#1)(2010-1#1)(2011-2#1)
of networks##5##2##(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)
of neural activity##3##3##(1991-2#1)(1995-5#1)(2008-4#1)
of neural and##2##3##(2008-4#1)(2008-8#1)
of neural circuits##2##3##(2008-1#1)(2008-9#1)
of neural codes##2##3##(2008-11#2)
of neural coding##3##3##(2008-1#1)(2008-11#2)
of neural development##2##3##(1995-2#1)(2010-1#1)
of neural differentiation##3##3##(1990-11#2)(2008-10#1)
of neural dynamics##2##3##(2008-11#1)(2013-8#1)
of neural network##4##3##(2008-10#3)(2010-8#1)
of neural networks##5##3##(2008-10#3)(2008-2#1)(2008-7#1)
of neural origin##2##3##(1993-12#1)(2011-2#1)
of neural precursors##2##3##(2007-12#2)
of neural responses##4##3##(2008-11#2)(2008-7#1)(2008-9#1)
of neural stem cells##8##4##(1994-11#3)(2008-10#1)(2008-11#2)(2008-4#1)(2012-1#1)
of neural stem##9##3##(1994-11#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-1#1)
of neural tissue##2##3##(1991-2#1)(2008-11#1)
of neural tube##2##3##(2010-1#1)(2012-12#1)
of neural##79##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-2#2)(1993-12#1)(1994-11#3)(1994-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#12)(2008-2#1)(2008-4#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of neurite outgrowth##3##3##(1990-8#1)(1995-6#2)
of neurite##4##2##(1990-8#1)(1995-6#2)(2008-11#1)
of neurites##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
of neuritic plaques##2##3##(1992-12#1)(1996-2#1)
of neuroactive##3##2##(1992-8#1)(1995-12#1)(2008-7#1)
of neuroanatomical connection data##3##4##(1995-5#3)
of neuroanatomical##4##2##(1995-5#3)(2008-4#1)
of neurobehavioral##3##2##(1996-12#3)
of neuroblastoma cells##2##3##(1993-3#1)(1994-10#1)
of neuroblastoma##7##2##(1990-8#1)(1993-3#1)(1994-10#1)(2011-2#4)
of neuroblasts##3##2##(2007-12#3)
of neurodegeneration##3##2##(1995-12#1)(2008-7#1)(2013-8#1)
of neurodegenerative diseases##4##3##(2008-11#2)(2008-4#1)(2008-8#1)
of neurodegenerative disorders##2##3##(1994-11#1)(2009-5#1)
of neurodegenerative##11##2##(1994-11#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#2)
of neurodevelopmental##3##2##(2008-6#1)(2011-2#1)(2012-3#1)
of neuroendocrine origin##2##3##(1997-7#1)(2008-1#1)
of neuroendocrine tumors##5##3##(1993-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
of neuroendocrine##14##2##(1991-1#1)(1993-12#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of neurofibrillary tangles##4##3##(1991-1#2)(1992-8#1)(2008-7#1)
of neurofibromatosis type 1 (NF1) gene##2##6##(1991-5#1)(1992-8#1)
of neurofibromatosis type 1##4##4##(1991-5#1)(1992-8#2)(2008-6#1)
of neurofibromatosis##10##2##(1991-5#1)(1992-8#2)(1997-3#3)(2008-6#1)(2011-2#2)(2012-3#1)
of neurofibromatosis]##2##2##(1991-3#1)(1997-3#1)
of neurofibromin##2##2##(1994-12#1)(2008-7#1)
of neurofilament proteins##2##3##(1995-12#1)(1996-12#1)
of neurofilament##5##2##(1995-12#1)(1996-12#4)
of neurofilaments in##2##3##(1991-12#1)(1995-12#1)
of neurogenesis in##3##3##(1996-5#1)(2007-12#1)(2008-7#1)
of neurogenesis##8##2##(1996-5#1)(2007-12#2)(2008-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
of neurogenic induction##2##3##(2012-1#1)(2012-7#1)
of neurogenic##6##2##(2007-12#1)(2009-2#1)(2012-1#2)(2012-7#2)
of neuroimaging##2##2##(2008-9#1)(2012-12#1)
of neuroinflammation##2##2##(2008-8#2)
of neuroinflammatory##2##2##(2012-2#1)(2013-1#1)
of neuroinvasive Borrelia##2##3##(2012-2#2)
of neuroleptic##3##2##(1992-12#1)(2012-2#1)(2012-3#1)
of neuroleptics##2##2##(1995-12#1)(1996-7#1)
of neurologic deficits##4##3##(2008-3#2)(2008-7#1)(2011-2#1)
of neurologic function##2##3##(1992-6#1)(2013-8#1)
of neurologic##11##2##(1992-12#1)(1992-6#1)(1997-3#1)(2007-10#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
of neurological and##2##3##(2007-8#1)(2011-1#1)
of neurological deficit##2##3##(1996-3#1)(2011-2#1)
of neurological deficits##3##3##(1996-9#1)(2007-8#1)(2008-7#1)
of neurological disease##4##3##(1991-8#1)(1995-12#1)(1996-11#1)(2012-3#1)
of neurological diseases##3##3##(1993-8#1)(2009-8#1)(2011-2#1)
of neurological disorders##3##3##(1997-8#1)(2008-7#1)(2008-8#1)
of neurological function##2##3##(1991-9#1)(2007-11#1)
of neurological symptoms##2##3##(2008-12#1)(2008-8#1)
of neurological##34##2##(1991-11#1)(1991-8#1)(1991-9#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
of neuromediators##4##2##(2008-10#4)
of neuromodulatory##3##2##(1995-2#1)(2008-3#1)(2008-7#1)
of neuromuscular blockade##3##3##(1993-1#1)(2010-7#1)(2012-12#1)
of neuromuscular junction##2##3##(2012-3#2)
of neuromuscular##12##2##(1993-1#1)(1993-9#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#4)
of neuron specific enolase##2##4##(1990-2#2)
of neuron##8##2##(1990-2#2)(1991-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-10#1)
of neuron-glia##2##2##(2008-7#2)
of neuron-specific enolase##3##3##(1990-6#1)(2011-2#2)
of neuron-specific##5##2##(1990-6#1)(1994-8#1)(1995-5#1)(2011-2#2)
of neuronal activity##3##3##(1991-6#1)(2008-4#1)(2009-8#1)
of neuronal cells##3##3##(1992-12#1)(1995-12#1)(2009-10#1)
of neuronal development##2##3##(1994-12#1)(2011-1#1)
of neuronal differentiation##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
of neuronal excitability##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
of neuronal function##2##3##(1997-3#1)(2008-7#1)
of neuronal functions##2##3##(2008-8#1)(2013-1#1)
of neuronal loss##3##3##(2008-7#3)
of neuronal migration##2##3##(1995-5#1)(2008-11#1)
of neuronal nicotinic acetylcholine receptors##3##5##(1995-11#3)
of neuronal populations##2##3##(2008-11#1)(2008-4#1)
of neuronal somata##3##3##(1995-12#3)
of neuronal susceptibility##2##3##(1990-7#2)
of neuronal##68##2##(1990-5#1)(1990-7#2)(1991-12#2)(1991-6#1)(1992-11#1)(1992-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#4)(1995-12#6)(1995-2#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
of neurones##5##2##(1995-12#2)(1995-8#1)(1996-5#1)(2008-11#1)
of neurons and glia is##2##5##(2007-10#1)(2008-7#1)
of neurons and glia##3##4##(1995-12#1)(2007-10#1)(2008-7#1)
of neurons and##12##3##(1993-12#2)(1995-12#1)(1996-2#2)(1997-2#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)
of neurons in the##14##4##(1990-5#1)(1991-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#1)
of neurons in##21##3##(1990-5#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2012-2#1)
of neurons that##2##3##(2007-12#1)(2008-11#1)
of neurons were##2##3##(1997-3#1)(2013-1#1)
of neurons with##3##3##(1996-12#1)(1997-3#1)(2012-2#1)
of neurons##85##2##(1990-5#2)(1991-12#1)(1991-2#3)(1992-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#3)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-4#4)(2008-5#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#7)(2012-2#2)(2013-1#2)(2013-8#1)
of neuropathic pain in the rat##2##6##(2008-4#2)
of neuropathic pain in##4##4##(2008-4#3)(2008-7#1)
of neuropathic pain##23##3##(1996-5#2)(1997-3#1)(2006-12#1)(2007-7#1)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-12#1)(2010-7#1)(2012-3#1)
of neuropathic##26##2##(1993-12#1)(1996-5#2)(1997-3#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2010-7#1)(2012-3#1)
of neuropathy and##2##3##(2012-2#2)
of neuropathy##11##2##(1993-12#1)(1996-5#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#4)
of neuropeptide Y (NPY)##2##4##(1995-3#1)(1997-2#1)
of neuropeptide Y##9##3##(1995-12#4)(1995-3#2)(1997-2#1)(1997-4#2)
of neuropeptides in##2##3##(1997-4#1)(2013-8#1)
of neuropeptides##8##2##(1994-8#1)(1997-4#1)(2007-2#2)(2008-10#1)(2008-4#1)(2009-12#1)(2013-8#1)
of neuroprotection##4##2##(1996-12#1)(2008-2#2)(2013-1#1)
of neuroprotective agents##3##3##(2007-9#1)(2008-7#2)
of neuroprotective##5##2##(2007-9#1)(2008-2#1)(2008-7#2)(2008-8#1)
of neuropsychiatric disease##2##3##(2008-4#2)
of neuropsychiatric##7##2##(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#1)
of neuropsychological functioning and decline over time in dementia##2##9##(2008-7#2)
of neuropsychological impairment##2##3##(1991-1#1)(2008-9#1)
of neuropsychological test##2##3##(1996-11#1)(2008-7#1)
of neuropsychological##9##2##(1991-1#1)(1991-2#1)(1994-5#1)(1996-11#1)(2008-11#1)(2008-7#3)(2008-9#1)
of neuroreceptor imaging##2##3##(2011-1#2)
of neuroscience##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
of neurosciences##2##2##(2008-12#1)(2009-10#1)
of neurosecretory cells which stained with##2##6##(2008-5#2)
of neurosecretory cells##3##3##(2008-5#3)
of neurosecretory##5##2##(1990-5#2)(2008-5#3)
of neurosurgery##5##2##(2007-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
of neurosurgical complications##3##3##(2012-3#3)
of neurosurgical##4##2##(2008-11#1)(2012-3#3)
of neurotensin##5##2##(1995-2#1)(1996-2#2)(1997-7#2)
of neuroticism##8##2##(2007-12#1)(2008-11#2)(2008-6#5)
of neurotoxic##2##2##(1995-3#1)(2011-9#1)
of neurotoxicity##2##2##(1991-1#1)(2008-3#1)
of neurotransmission##2##2##(2008-8#1)(2012-2#1)
of neurotransmitter release##4##3##(1995-2#1)(1996-12#1)(2008-5#1)(2008-7#1)
of neurotransmitter##8##2##(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
of neurotransmitters such as##2##4##(2008-10#1)(2012-2#1)
of neurotransmitters##5##2##(1991-12#2)(1992-11#1)(2008-10#1)(2012-2#1)
of neurotrophic factors##3##3##(2008-7#2)(2013-1#1)
of neurotrophic##5##2##(2008-11#1)(2008-7#2)(2009-3#1)(2013-1#1)
of neurotrophin##4##2##(1996-12#2)(1996-5#1)(2008-5#1)
of neurotrophins and their receptors in##2##6##(1996-12#1)(2008-5#1)
of neurotrophins and##4##3##(1996-12#1)(1996-2#1)(2008-5#1)(2008-9#1)
of neurotrophins##8##2##(1994-8#1)(1996-12#2)(1996-2#1)(2008-5#1)(2008-7#2)(2008-9#1)
of neurovascular##4##2##(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
of neutral and##2##3##(2008-10#1)(2013-1#1)
of neutral endopeptidase##2##3##(1990-5#2)
of neutral red##4##3##(1996-4#1)(2008-10#2)(2008-11#1)
of neutral##35##2##(1990-5#2)(1992-11#1)(1996-4#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#6)(2008-6#1)(2008-8#1)(2009-8#1)(2013-1#4)(2013-8#1)
of neutralization of the##2##4##(1994-3#1)(2008-10#1)
of neutralizing antibodies##3##3##(1995-2#1)(2007-10#1)(2013-1#1)
of neutralizing antibody##3##3##(1995-5#3)
of neutralizing##9##2##(1995-2#1)(1995-5#3)(2007-10#1)(2008-10#3)(2013-1#1)
of neutron##2##2##(1994-3#1)(2008-10#1)
of neutropenia##4##2##(2008-7#4)
of neutrophil collagenase##3##3##(1992-5#3)
of neutrophil elastase##4##3##(1994-5#2)(1995-2#1)(2008-5#1)
of neutrophil granules##2##3##(1990-5#2)
of neutrophil membranes##2##3##(1991-2#2)
of neutrophil##23##2##(1990-5#2)(1991-12#1)(1991-2#3)(1991-5#1)(1992-5#3)(1993-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(2008-11#5)(2008-4#1)(2008-5#1)(2010-5#1)
of neutrophils and##4##3##(1991-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
of neutrophils by##2##3##(1991-2#1)(1992-3#1)
of neutrophils##18##2##(1990-12#1)(1991-2#2)(1991-9#2)(1992-3#2)(1994-11#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2011-1#1)(2012-2#1)
of nevirapine##3##2##(2008-10#3)
of nevoid##2##2##(2007-12#1)(2007-4#1)
of new AHPs##2##3##(1994-3#2)
of new AIDS##2##3##(1991-11#1)(1993-9#1)
of new analytical##2##3##(2008-10#1)(2008-7#1)
of new and##10##3##(1994-9#1)(1995-3#1)(1996-11#1)(1997-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#1)
of new anti-HIV-1 drugs##2##4##(2011-3#2)
of new approaches##2##3##(1995-12#1)(2010-12#1)
of new areas##2##3##(1994-12#1)(2013-1#1)
of new assays##2##3##(2008-4#1)(2013-1#1)
of new cases of##4##4##(1992-2#1)(2012-2#1)(2013-1#2)
of new cases##7##3##(1992-2#1)(1997-6#2)(2008-10#1)(2012-2#1)(2013-1#2)
of new catheters##2##3##(1994-11#1)(2011-2#1)
of new cell##2##3##(2008-11#1)(2010-2#1)
of new chemical##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
of new compounds##7##3##(1991-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2012-3#1)
of new cosmetic##3##3##(2008-5#2)(2011-1#1)
of new data##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
of new developments in##2##4##(2008-10#1)(2011-1#1)
of new diethyl 1##2##4##(2012-3#2)
of new disability-pensioners##2##3##(1997-6#2)
of new drug##5##3##(2008-10#1)(2008-7#1)(2010-12#2)(2013-1#1)
of new drugs##8##3##(1993-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#2)
of new features##2##3##(2008-10#1)(2008-3#1)
of new fluorescent##4##3##(2008-10#2)(2008-4#1)(2010-2#1)
of new food##2##3##(2008-4#1)(2011-2#1)
of new functions##3##3##(2008-1#1)(2012-1#1)(2012-3#1)
of new genes##2##3##(2008-10#1)(2009-10#1)
of new genotypes##2##3##(2008-10#1)(2011-2#1)
of new infections##2##3##(2008-10#1)(2009-4#1)
of new information##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-11#1)
of new lesions##3##3##(1991-8#1)(2008-10#1)(2008-5#1)
of new materials and##2##4##(2010-10#1)(2010-7#1)
of new materials for##3##4##(2009-8#1)(2013-1#2)
of new materials##5##3##(2009-8#1)(2010-10#1)(2010-7#1)(2013-1#2)
of new members##2##3##(1993-1#1)(1997-9#1)
of new metabolic##2##3##(2008-3#1)(2010-12#1)
of new methods##4##3##(1997-1#1)(1997-8#1)(2008-10#1)(2011-1#1)
of new models##2##3##(2008-11#1)(2008-9#1)
of new molecules##3##3##(2010-11#1)(2011-3#1)(2012-12#1)
of new mouse##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
of new niches##2##3##(2008-10#1)(2012-12#1)
of new patients##2##3##(1994-2#1)(2012-3#1)
of new primary malignancies##3##4##(1991-8#3)
of new primary##4##3##(1991-8#4)
of new proteins##2##3##(1997-6#1)(2008-10#1)
of new risk factors##2##4##(2007-9#1)(2011-2#1)
of new services##2##3##(1997-3#2)
of new species##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
of new substances##2##3##(2008-10#1)(2011-3#1)
of new surgical##3##3##(1994-6#1)(2007-8#1)(2008-6#1)
of new systems##2##3##(2008-11#1)(2011-2#1)
of new tag sequences##2##4##(1997-3#2)
of new targets##2##3##(2008-11#1)(2009-12#1)
of new techniques##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
of new technologies in##2##4##(1992-2#1)(2008-11#1)
of new technologies##13##3##(1992-2#1)(1994-5#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-12#1)(2012-3#1)(2013-1#3)
of new technology##2##3##(2008-10#2)
of new therapeutic##5##3##(1996-11#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-5#1)
of new therapies##6##3##(2008-1#1)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#1)
of new treatment##5##3##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
of new types of##2##4##(2008-10#1)(2013-8#1)
of new varieties##2##3##(2008-12#1)(2008-8#1)
of new vertebral fractures##2##4##(1993-11#1)(2008-11#1)
of new words##2##3##(2008-7#1)(2011-1#1)
of new##442##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-6#2)(1990-7#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#7)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-12#2)(1995-3#3)(1995-5#3)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#9)(1997-4#1)(1997-5#2)(1997-6#6)(1997-8#2)(1997-9#1)(2006-10#1)(2007-10#3)(2007-11#9)(2007-12#7)(2007-2#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#64)(2008-11#26)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#10)(2008-5#10)(2008-6#7)(2008-7#16)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#22)(2011-3#5)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#12)(2012-4#1)(2013-1#15)(2013-7#2)(2013-8#6)
of new-onset##2##2##(2008-3#1)(2013-8#1)
of newborn calves##3##3##(1994-7#2)(2010-2#1)
of newborn cells##2##3##(2008-11#1)(2012-2#1)
of newborn infants##4##3##(1994-6#2)(1995-2#1)(2012-12#1)
of newborn mice##2##3##(1993-2#1)(2008-7#1)
of newborn##22##2##(1990-11#1)(1990-5#1)(1991-12#1)(1993-2#1)(1994-3#1)(1994-6#3)(1994-7#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-3#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
of newborns from##2##3##(2007-11#2)
of newborns##10##2##(1992-11#1)(1992-4#2)(1994-6#1)(2007-11#3)(2008-8#1)(2009-8#1)(2012-3#1)
of newer techniques##2##3##(2011-1#1)(2011-2#1)
of newer##15##2##(1991-1#3)(1994-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of newly diagnosed##5##3##(1991-2#1)(2008-1#2)(2008-11#1)(2013-1#1)
of newly eclosed##2##3##(2008-8#2)
of newly formed##3##3##(1996-5#1)(2008-10#1)(2012-1#1)
of newly hatched##2##3##(2008-12#1)(2008-5#1)
of newly registered##2##3##(2007-7#1)(2008-11#1)
of newly synthesized##8##3##(1996-2#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-4#1)
of newly##38##2##(1991-2#1)(1993-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-7#1)(2008-1#4)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
of next generation##4##3##(2008-8#1)(2011-1#1)(2012-2#2)
of ng ml(-1)##3##3##(2008-10#3)
of nia##2##2##(1993-6#2)
of nibbling and gorging dietary regimens on weight and lipid##2##10##(2008-12#2)
of nickel and##9##3##(1994-5#1)(2008-10#7)(2008-6#1)
of nickel by##2##3##(2008-10#2)
of nickel in natural waters##2##5##(2008-10#2)
of nickel in natural##4##4##(2008-10#4)
of nickel in some natural food samples##2##7##(2008-10#2)
of nickel in table salt and baking soda##2##8##(2008-10#2)
of nickel in the##3##4##(2008-10#3)
of nickel in##24##3##(2008-10#24)
of nickel ion##2##3##(2008-10#2)
of nickel with a##2##4##(2008-10#2)
of nickel within##2##3##(2008-10#2)
of nickel##63##2##(1994-5#1)(1995-3#2)(2008-10#56)(2008-3#1)(2008-6#2)(2008-7#1)
of nickel(II) in##3##3##(2008-10#3)
of nickel(II)##7##2##(2008-10#7)
of nicotinamide adenine dinucleotide phosphate##2##5##(2011-2#2)
of nicotinamide adenine dinucleotide##3##4##(2008-10#1)(2011-2#2)
of nicotinamide##4##2##(2007-7#1)(2008-10#1)(2011-2#2)
of nicotine on##7##3##(1991-1#1)(1996-2#2)(2008-3#2)(2010-8#1)(2011-1#1)
of nicotine replacement therapy##3##4##(2008-6#1)(2012-3#2)
of nicotine was##2##3##(1996-2#1)(2008-8#1)
of nicotine withdrawal##2##3##(1995-12#2)
of nicotine##32##2##(1990-7#1)(1991-1#2)(1993-8#2)(1995-12#3)(1995-5#1)(1996-2#4)(2008-10#2)(2008-3#4)(2008-6#1)(2008-8#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
of nicotinic acetylcholine receptor##2##4##(2008-8#2)
of nicotinic acetylcholine##3##3##(1995-11#1)(2008-8#2)
of nicotinic receptor##2##3##(1996-12#1)(2008-8#1)
of nicotinic##10##2##(1990-7#2)(1992-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-5#1)(2008-8#3)
of nifedipine##4##2##(1991-11#1)(1995-12#1)(1997-7#1)(2012-12#1)
of night##2##2##(1997-6#1)(2010-7#1)
of nighttime##2##2##(2007-12#1)(2009-9#1)
of nigral##2##2##(2008-7#2)
of nigrostriatal DAergic neurons##3##4##(2013-7#3)
of nigrostriatal##4##2##(1996-12#1)(2013-7#3)
of nile blue sulphate##2##4##(2008-10#2)
of nine cases##2##3##(2008-7#2)
of nine genes##2##3##(1994-8#1)(2008-7#1)
of nine isolates##2##3##(1997-8#1)(2008-10#1)
of nine selected##3##3##(2008-10#1)(2012-12#2)
of nine species of##3##4##(2008-10#1)(2008-11#1)(2013-7#1)
of nine species##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2013-7#1)
of nine##71##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#2)
of nines')##2##2##(2012-1#2)
of nineteen##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
of niobium##2##2##(2008-10#2)
of niobium(V) oxide as a##2##5##(2008-10#2)
of nisin##3##2##(2008-6#2)(2011-2#1)
of nitrate and chlorate in swimming pool water##2##8##(2008-10#2)
of nitrate and chlorate in##3##5##(2008-10#3)
of nitrate and nitrite in water and some fruit samples##3##10##(2008-10#3)
of nitrate and nitrite##6##4##(2008-10#6)
of nitrate and##14##3##(2008-10#13)(2008-11#1)
of nitrate from##2##3##(2008-10#2)
of nitrate in estuarine and coastal waters##2##7##(2008-10#2)
of nitrate in##11##3##(2008-10#11)
of nitrate ions##2##3##(2008-10#2)
of nitrate tolerance##2##3##(1991-9#2)
of nitrate##51##2##(1991-9#2)(1992-6#1)(2008-10#43)(2008-11#4)(2009-5#1)
of nitrates and##2##3##(2008-10#1)(2008-3#1)
of nitric acid and##2##4##(2008-10#2)
of nitric acid at##2##4##(2008-10#2)
of nitric acid solution##2##4##(2008-10#2)
of nitric acid##9##3##(2008-10#9)
of nitric and##2##3##(2008-10#2)
of nitric oxide (NO) and##2##5##(2008-10#2)
of nitric oxide (NO) in##3##5##(2008-10#2)(2008-8#1)
of nitric oxide (NO) synthase##2##5##(1995-11#1)(1995-12#1)
of nitric oxide (NO)##15##4##(1991-9#1)(1992-12#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-8#1)
of nitric oxide and##8##4##(1994-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
of nitric oxide in the##3##5##(1992-8#1)(1993-6#1)(1996-5#1)
of nitric oxide in##7##4##(1992-8#1)(1993-6#1)(1996-5#1)(2008-10#2)(2008-2#1)(2011-1#1)
of nitric oxide on the##2##5##(1993-3#1)(2010-12#1)
of nitric oxide on##3##4##(1993-3#2)(2010-12#1)
of nitric oxide production##2##4##(1996-5#1)(2011-1#1)
of nitric oxide synthase (NOS)##4##5##(1992-8#1)(1993-3#1)(1993-8#1)(2008-4#1)
of nitric oxide synthase##9##4##(1992-8#1)(1993-3#2)(1993-8#2)(1996-12#1)(1996-5#1)(2008-4#1)(2008-5#1)
of nitric oxide synthases##2##4##(1995-11#1)(2009-4#1)
of nitric oxide synthesis##4##4##(1992-3#1)(2013-1#3)
of nitric oxide using polymer modified electrodes##2##7##(2008-10#2)
of nitric oxide using##3##4##(2008-10#3)
of nitric oxide with##2##4##(2008-10#1)(2008-3#1)
of nitric oxide##77##3##(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#5)(1993-6#2)(1993-8#2)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#1)(1996-12#2)(1996-5#3)(1997-4#2)(1997-7#1)(2008-10#19)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2013-1#3)
of nitric##91##2##(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#5)(1993-6#2)(1993-8#2)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#1)(1996-12#2)(1996-5#3)(1997-4#2)(1997-7#1)(2008-10#32)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2013-1#3)(2013-7#1)
of nitrile##2##2##(2007-11#1)(2008-10#1)
of nitriles##2##2##(1996-2#1)(2009-6#1)
of nitrite and nitrate in##11##5##(2008-10#11)
of nitrite and nitrate using##2##5##(2008-10#2)
of nitrite and nitrate was##2##5##(2008-10#2)
of nitrite and nitrate##22##4##(2008-10#22)
of nitrite and##28##3##(2006-10#1)(2008-10#27)
of nitrite based on its##3##5##(2008-10#3)
of nitrite by##4##3##(2008-10#4)
of nitrite in the##4##4##(2008-10#4)
of nitrite in##16##3##(2008-10#16)
of nitrite ion using##3##4##(2008-10#3)
of nitrite ion##11##3##(2008-10#11)
of nitrite on the##2##4##(2008-10#2)
of nitrite using##3##3##(2008-10#3)
of nitrite was##2##3##(2008-10#2)
of nitrite##99##2##(1996-11#1)(1997-4#1)(2006-10#1)(2008-10#95)(2008-11#1)
of nitrite-nitrogen was##2##3##(2008-10#2)
of nitrite-nitrogen##3##2##(2008-10#3)
of nitrites##4##2##(2007-10#2)(2008-10#1)(2008-11#1)
of nitro##3##2##(1993-11#1)(1997-4#1)(2008-10#1)
of nitro-organic explosives##2##3##(2008-10#2)
of nitroaniline isomers##4##3##(2008-10#4)
of nitroaniline##6##2##(2008-10#6)
of nitroaromatic##6##2##(2008-10#6)
of nitrobenzene##2##2##(2008-10#1)(2008-11#1)
of nitrocompounds##3##2##(1995-8#3)
of nitrofurantoin and its toxic metabolite##2##6##(2008-10#2)
of nitrofurantoin##3##2##(2008-10#3)
of nitrofurazone##3##2##(2012-2#3)
of nitrogen PRRS##3##3##(2008-3#3)
of nitrogen and methane##2##4##(2008-2#2)
of nitrogen and phosphorus##2##4##(2008-10#1)(2013-1#1)
of nitrogen and##7##3##(2008-10#2)(2008-12#1)(2008-2#2)(2013-1#2)
of nitrogen dioxide using##2##4##(2008-10#2)
of nitrogen dioxide##7##3##(2008-10#6)(2008-11#1)
of nitrogen oxides in##3##4##(2008-10#2)(2012-2#1)
of nitrogen oxides##4##3##(2008-10#3)(2012-2#1)
of nitrogen##43##2##(1994-3#1)(2007-12#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#2)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of nitrogen-15##2##2##(1995-2#2)
of nitrous acid##2##3##(2008-10#2)
of nitrous oxide##9##3##(1991-6#2)(1992-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#2)(2009-12#1)
of nitrous##11##2##(1991-6#2)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-12#1)
of no significance##2##3##(1996-6#1)(2011-1#1)
of no##33##2##(1990-11#1)(1992-11#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
of noble metals##2##3##(2008-10#2)
of noble##4##2##(2008-10#4)
of nocardial##2##2##(2008-1#1)(2008-7#1)
of nociceptive##7##2##(1990-7#1)(1997-2#1)(2006-12#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-9#1)
of nociceptors##2##2##(1993-12#1)(1995-12#1)
of nocturnal##2##2##(2007-12#1)(2008-10#1)
of nodal metastasis##2##3##(2008-2#2)
of nodal##11##2##(1990-12#2)(2008-10#1)(2008-2#2)(2008-7#2)(2012-3#2)(2013-1#2)
of node##2##2##(2008-10#1)(2008-8#1)
of node-negative##2##2##(1992-10#1)(1995-4#1)
of nodes##9##2##(2007-11#1)(2007-9#1)(2008-10#5)(2012-2#1)(2013-1#1)
of nodular##3##2##(1993-9#1)(2008-1#1)(2008-3#1)
of nodules##2##2##(2008-11#1)(2008-7#1)
of noise and##4##3##(2008-3#2)(2008-9#1)(2013-8#1)
of noise are##2##3##(2008-2#1)(2008-3#1)
of noise in the##2##4##(1997-3#1)(2010-10#1)
of noise in##5##3##(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
of noise is##2##3##(2007-12#1)(2008-9#1)
of noise on the##4##4##(2008-3#4)
of noise on##5##3##(2008-3#4)(2011-2#1)
of noise photons##3##3##(2008-3#3)
of noise##50##2##(1997-3#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#5)(2008-3#22)(2008-4#1)(2008-9#7)(2010-10#2)(2011-1#2)(2011-2#1)(2013-8#1)
of noise-induced hearing loss##2##4##(2009-5#2)
of nominal##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
of nominally pure##2##3##(2007-11#1)(2007-12#1)
of nominally##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of non##13##2##(1990-2#1)(2007-12#1)(2007-5#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)
of non-A##2##2##(1997-2#1)(2007-7#1)
of non-CFC MDIs##2##3##(1996-1#2)
of non-Hodgkin lymphoma##3##3##(1991-6#1)(2009-10#1)(2013-7#1)
of non-Hodgkin##4##2##(1991-6#1)(2009-10#1)(2012-2#1)(2013-7#1)
of non-Hodgkin's lymphoma##4##3##(2007-10#2)(2008-12#1)(2008-7#1)
of non-Hodgkin's lymphomas##2##3##(2007-10#1)(2009-8#1)
of non-Hodgkin's##7##2##(2007-10#3)(2008-1#1)(2008-12#1)(2008-7#1)(2009-8#1)
of non-alcoholic fatty##2##3##(2013-1#2)
of non-allergic##3##2##(1996-3#2)(2011-1#1)
of non-attendance##2##2##(1992-2#2)
of non-blood contacting pneumatic ventricle assistance##2##6##(2012-3#2)
of non-cardiac##2##2##(2008-8#1)(2013-1#1)
of non-coding RNA##2##3##(2011-2#2)
of non-coding RNAs##2##3##(2008-1#2)
of non-coding##5##2##(1997-6#1)(2008-1#2)(2011-2#2)
of non-communicable diseases##11##3##(2012-12#1)(2013-8#10)
of non-covalent##3##2##(2008-10#1)(2008-9#1)(2009-11#1)
of non-enzymatic##2##2##(1993-8#1)(2013-1#1)
of non-extractable residues##3##3##(2008-11#3)
of non-fucosylated##2##2##(2008-11#2)
of non-functional##3##2##(1992-8#1)(2008-5#1)(2009-11#1)
of non-high##2##2##(1995-11#1)(2013-8#1)
of non-human##2##2##(1991-6#1)(2010-3#1)
of non-indigenous##2##2##(1991-12#1)(2008-12#1)
of non-insulin dependent diabetes mellitus (NIDDM)##2##6##(2008-11#1)(2008-5#1)
of non-insulin dependent diabetes##4##4##(1997-8#1)(2008-11#1)(2008-5#2)
of non-insulin-dependent diabetes mellitus##2##4##(1991-12#1)(2008-10#1)
of non-insulin-dependent diabetes##3##3##(1991-12#1)(1994-12#1)(2008-10#1)
of non-insulin-dependent##4##2##(1991-12#1)(1994-12#1)(1994-8#1)(2008-10#1)
of non-invasive breast cancer##2##4##(2013-1#2)
of non-invasive diagnostic##2##3##(1993-3#1)(2010-6#1)
of non-invasive imaging techniques##2##4##(2012-3#1)(2013-1#1)
of non-invasive##12##2##(1990-5#1)(1993-3#1)(1996-12#1)(1996-3#1)(2008-1#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#4)
of non-ionic detergents##2##3##(1994-9#1)(2008-10#1)
of non-ionic surfactant##3##3##(2008-10#3)
of non-ionic surfactants (NS)##2##4##(2008-10#2)
of non-ionic surfactants##5##3##(2008-10#5)
of non-ionic##11##2##(1994-9#1)(2008-10#10)
of non-linear##4##2##(1997-4#1)(2008-10#1)(2008-7#1)(2013-1#1)
of non-metallic inclusions##2##3##(2008-10#2)
of non-metallic##3##2##(2008-10#3)
of non-metastatic##3##2##(1992-6#2)(2008-10#1)
of non-modified##2##2##(1993-11#1)(2008-10#1)
of non-native##2##2##(1995-3#1)(2007-7#1)
of non-neoplastic##2##2##(2013-1#1)(2013-8#1)
of non-pharmacological##3##2##(2008-1#1)(2010-12#1)(2012-3#1)
of non-polar##2##2##(2008-10#2)
of non-polarized infrared##2##3##(2008-10#2)
of non-radioactive##3##2##(1994-2#1)(1996-12#1)(2008-1#1)
of non-random##3##2##(1995-12#1)(2009-10#1)(2012-5#1)
of non-responders##2##2##(2012-12#1)(2013-1#1)
of non-small cell lung cancer##5##5##(2007-5#1)(2007-8#1)(2008-1#2)(2013-8#1)
of non-small cell lung##7##4##(1997-5#1)(2007-5#1)(2007-8#1)(2008-1#2)(2013-1#1)(2013-8#1)
of non-small##8##2##(1997-5#1)(2007-5#1)(2007-8#1)(2008-1#2)(2013-1#2)(2013-8#1)
of non-smoking##2##2##(1991-11#2)
of non-spatial##3##2##(1993-3#1)(1993-5#1)(1995-5#1)
of non-specific##12##2##(1990-7#1)(1992-10#1)(1996-3#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-7#1)
of non-steady-state photoinduced electromotive force##2##5##(2007-12#2)
of non-steroidal anti-inflammatory drugs (NSAIDs)##2##5##(2008-12#1)(2013-1#1)
of non-steroidal anti-inflammatory drugs##4##4##(1995-5#1)(2008-12#1)(2010-2#1)(2013-1#1)
of non-targeted##2##2##(2008-7#2)
of non-telomeric DSBs##2##3##(2010-2#2)
of non-traumatic##2##2##(2012-2#1)(2013-8#1)
of non-type 1 diabetes##2##4##(2008-1#1)(2008-4#1)
of non-union##2##2##(2012-2#1)(2013-1#1)
of non-viral##2##2##(1997-4#1)(2008-5#1)
of nonabsorbing##3##2##(2008-3#3)
of nonadherence to##2##3##(2008-3#1)(2008-4#1)
of nonadherence##5##2##(1992-12#1)(1994-3#1)(2008-3#2)(2008-4#1)
of nonagenarians##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
of nonaqueous capillary electrophoresis##3##4##(2008-10#3)
of nonaqueous##4##2##(2008-10#4)
of noncanonical##2##2##(2007-11#2)
of noncoding##2##2##(1995-2#1)(2008-9#1)
of noncontact##2##2##(2008-3#1)(2010-8#1)
of noncooperative##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
of noncovalent labeling##2##3##(2007-11#2)
of noncovalent##3##2##(1992-4#1)(2007-11#2)
of nondegenerate four-wave mixing##2##4##(2007-11#1)(2007-12#1)
of nondegenerate##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of nondiffracting patterns and arrays##2##5##(2007-11#2)
of nondiffracting##3##2##(2007-11#3)
of none##2##2##(1997-4#1)(2007-4#1)
of noneconomic damages##5##3##(1991-1#2)(1992-1#3)
of noneconomic##6##2##(1991-1#3)(1992-1#3)
of nonequilibrium##2##2##(1992-8#1)(2008-3#1)
of nonexercised controls##2##3##(2008-10#2)
of nongenotoxic##2##2##(1990-8#2)
of nonhomologous DNA##3##3##(1993-2#1)(2008-10#2)
of nonhospital##3##2##(1991-12#1)(1995-3#2)
of nonhost##3##2##(2008-10#2)(2011-2#1)
of nonidentical##2##2##(1997-6#1)(2007-12#1)
of nonimaging##3##2##(2008-2#1)(2008-3#2)
of nonindigenous##2##2##(2008-10#1)(2008-8#1)
of noninoculated##2##2##(2008-10#2)
of noninvasive cardiac##2##3##(2008-12#1)(2010-8#1)
of noninvasive imaging##2##3##(2008-12#1)(2010-9#1)
of noninvasive##10##2##(1991-3#1)(1993-11#1)(2008-1#2)(2008-12#2)(2009-1#1)(2010-8#1)(2010-9#1)(2013-8#1)
of nonionic surfactant##2##3##(2008-10#2)
of nonionic##4##2##(2008-10#4)
of nonirradiated##2##2##(1995-5#1)(2011-2#1)
of nonlinear interactions##2##3##(2008-8#1)(2010-11#1)
of nonlinear optical waveguides##2##4##(2008-2#1)(2008-3#1)
of nonlinear optical##9##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)
of nonlinear techniques##2##3##(1997-2#1)(2012-2#1)
of nonlinear wave##2##3##(2007-11#1)(2008-3#1)
of nonlinear##48##2##(1996-4#2)(1997-2#1)(2007-11#9)(2007-12#9)(2008-10#1)(2008-2#6)(2008-3#8)(2008-7#4)(2008-8#1)(2009-8#2)(2010-11#1)(2012-1#1)(2012-2#2)(2013-1#1)
of nonlinearity##7##2##(1990-8#3)(1996-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
of nonmelanoma skin##2##3##(2007-12#1)(2010-8#1)
of nonmelanotic##2##2##(2007-12#2)
of nonmetastatic##3##2##(2010-3#3)
of nonnative##3##2##(1993-11#2)(2008-8#1)
of nonneoplastic##3##2##(2008-9#1)(2011-1#2)
of nonoverlapping##3##2##(2007-12#1)(2008-2#1)(2009-11#1)
of nonpalpable##2##2##(1997-8#2)
of nonparametric##3##2##(1991-12#1)(2008-10#1)(2010-12#1)
of nonparaxial##3##2##(2007-11#1)(2007-12#2)
of nonpathogenic Fusarium oxysporum##3##4##(2008-10#3)
of nonpathogenic Fusarium##4##3##(2008-10#4)
of nonpathogenic##7##2##(2008-10#7)
of nonpecuniary##2##2##(1991-1#1)(1991-2#1)
of nonpharmacological##3##2##(2009-11#1)(2013-1#1)(2013-8#1)
of nonpolar and polar surface##3##5##(1992-5#3)
of nonpolar molecules##2##3##(2010-2#2)
of nonpolar##10##2##(1990-11#1)(1990-7#1)(1992-5#4)(1995-2#1)(2008-10#1)(2010-2#2)
of nonpolyadenylated RNA##3##3##(2008-9#3)
of nonprofit organizations##2##3##(1991-12#1)(1995-2#1)
of nonprofit##8##2##(1991-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-1#1)(2008-11#2)
of nonprofits##3##2##(1994-2#1)(1995-3#2)
of nonresonant##3##2##(2007-12#1)(2008-3#2)
of nonresponders##2##2##(1990-2#1)(2008-7#1)
of nonselective##2##2##(2008-9#1)(2009-10#1)
of nonspecific binding##2##3##(2008-10#1)(2008-7#1)
of nonspecific##8##2##(1991-5#1)(1992-6#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-12#1)
of nonspherical##3##2##(2008-2#1)(2008-3#2)
of nonstationary##2##2##(2007-11#1)(2008-3#1)
of nonsteroidal anti-inflammatory drugs##2##4##(2007-4#1)(2008-7#1)
of nonsteroidal anti-inflammatory##3##3##(2007-4#1)(2008-7#1)(2008-9#1)
of nonsymmetrical##3##2##(1992-12#1)(2007-11#1)(2008-4#1)
of nontransformed##5##2##(1995-2#2)(2008-10#3)
of nontuberculous mycobacterial disease##3##4##(2007-12#3)
of nontuberculous##4##2##(2007-12#3)(2011-2#1)
of nonuniform##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of nonuniformity##2##2##(2008-2#1)(2008-3#1)
of nonunion##2##2##(2009-10#1)(2013-1#1)
of nonverbal##3##2##(1996-2#2)(2012-3#1)
of nonviable cells##2##3##(2008-4#1)(2008-9#1)
of nonviable##4##2##(2008-4#2)(2008-9#1)(2010-6#1)
of nonvital##2##2##(2009-8#2)
of nonylphenol##2##2##(2008-10#2)
of nonzero##2##2##(2008-2#1)(2008-3#1)
of noradrenaline and adrenaline##2##4##(1994-2#1)(2008-10#1)
of noradrenaline and dopamine##5##4##(1990-8#1)(2008-10#3)(2008-7#1)
of noradrenaline and##7##3##(1990-8#1)(1994-2#1)(2008-10#4)(2008-7#1)
of noradrenaline##15##2##(1990-8#1)(1991-2#1)(1992-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(2008-10#4)(2008-7#1)
of noradrenergic##4##2##(1996-5#1)(1996-7#1)(2008-6#1)(2008-7#1)
of norcantharidin##2##2##(2011-3#2)
of norepinephrine (NE)##3##3##(1993-3#1)(1996-7#1)(2008-10#1)
of norepinephrine##14##2##(1990-12#1)(1990-5#2)(1990-8#1)(1993-3#1)(1993-6#2)(1995-3#1)(1996-7#1)(2008-10#2)(2008-2#1)(2013-1#1)(2013-8#1)
of norfloxacin##3##2##(1993-2#1)(2010-5#2)
of normal B cells##2##4##(1992-12#1)(1995-2#1)
of normal aging##3##3##(1991-12#1)(2008-7#1)(2012-3#1)
of normal and abnormal##5##4##(1990-10#1)(2008-4#1)(2010-8#3)
of normal and neoplastic##2##4##(1990-7#1)(1992-3#1)
of normal and pathological##3##4##(2009-5#1)(2010-8#1)(2013-1#1)
of normal and##29##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-3#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-6#2)(1996-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#4)(2011-1#1)(2012-2#1)(2013-1#1)
of normal anterior cruciate ligament (ACL) and##2##7##(1997-8#2)
of normal atlas and##2##4##(2013-1#2)
of normal bone marrow cells##2##5##(1990-5#1)(2011-2#1)
of normal bone marrow##3##4##(1990-5#1)(2008-6#1)(2011-2#1)
of normal bone##5##3##(1990-5#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#1)
of normal breast##2##3##(1990-12#1)(2011-2#1)
of normal cell##4##3##(1994-11#1)(2008-11#2)(2008-5#1)
of normal controls##2##3##(1996-12#1)(2012-3#1)
of normal donors##2##3##(1990-12#2)
of normal human epidermal keratinocytes##3##5##(1992-2#1)(2008-4#1)(2008-5#1)
of normal human keratinocytes##4##4##(2008-4#1)(2008-5#3)
of normal human skin##3##4##(2008-4#1)(2008-5#2)
of normal human##15##3##(1991-3#1)(1992-10#1)(1992-2#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-4#3)(2008-5#6)
of normal individuals##3##3##(2008-9#1)(2011-2#2)
of normal liver##2##3##(1990-2#2)
of normal mammalian cells##2##4##(1990-5#1)(2008-11#1)
of normal mice##3##3##(1992-3#1)(1995-12#1)(1997-3#1)
of normal or##2##3##(2010-6#1)(2011-2#1)
of normal persons##2##3##(2008-3#1)(2008-9#1)
of normal platelets##3##3##(1990-5#1)(2006-6#2)
of normal rat kidney##3##4##(1991-12#2)(1991-2#1)
of normal rat liver##3##4##(1990-7#1)(1992-6#1)(1996-5#1)
of normal rat pituitary cells##2##5##(1992-6#2)
of normal rat##8##3##(1990-7#1)(1991-12#2)(1991-2#1)(1992-6#3)(1996-5#1)
of normal rats##2##3##(1990-7#1)(2013-1#1)
of normal serum##2##3##(1990-2#1)(2012-3#1)
of normal skin##2##3##(2008-5#2)
of normal sleep##2##3##(2008-7#2)
of normal subjects##5##3##(1991-12#2)(1994-12#1)(2006-6#1)(2008-2#1)
of normal tissue##4##3##(2007-12#2)(2008-2#1)(2010-8#1)
of normal tissues##6##3##(1990-12#1)(1994-2#1)(1994-5#1)(2007-4#1)(2008-6#2)
of normal##227##2##(1990-10#1)(1990-12#4)(1990-2#5)(1990-5#5)(1990-7#3)(1990-8#1)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#2)(1991-6#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#6)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-5#1)(1997-8#3)(2006-6#3)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#10)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#13)(2008-6#7)(2008-7#5)(2008-8#8)(2008-9#3)(2009-3#2)(2009-5#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#5)(2011-1#1)(2011-2#13)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#2)
of normality##4##2##(1996-3#1)(1996-7#1)(1997-7#1)(2008-10#1)
of normalization##3##2##(2008-7#2)(2010-7#1)
of normally distributed##5##3##(1995-12#1)(1995-5#1)(2008-10#2)(2008-3#1)
of normally##9##2##(1995-12#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
of normative agency##2##3##(2012-2#2)
of normativity##2##2##(2012-2#2)
of normotensive##3##2##(1994-2#1)(2008-7#1)(2012-12#1)
of normothermic##2##2##(1996-12#1)(1996-9#1)
of norovirus in##2##3##(2013-8#2)
of norovirus##3##2##(2013-8#3)
of north east##2##3##(2008-12#1)(2012-2#1)
of north##7##2##(2008-11#1)(2008-12#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of north-western Nigeria##2##3##(2010-4#2)
of northeastern##2##2##(2008-8#1)(2013-8#1)
of northern Italy##3##3##(1993-2#2)(2012-7#1)
of northern##9##2##(1990-12#1)(1993-2#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-7#1)
of northwestern##2##2##(2010-6#1)(2012-12#1)
of noscapine##4##2##(2008-11#4)
of nose##3##2##(1990-9#2)(2008-7#1)
of nosocomial and zoonotic##2##4##(2010-4#2)
of nosocomial infections in##2##4##(1990-6#1)(2008-5#1)
of nosocomial infections##3##3##(1990-6#1)(2008-5#1)(2010-4#1)
of nosocomial##12##2##(1990-6#1)(1995-6#1)(1995-9#1)(2007-12#1)(2007-7#2)(2008-5#1)(2010-4#4)(2010-8#1)
of not more than##2##4##(1990-2#1)(2008-10#1)
of not only##3##3##(1990-11#1)(2008-10#2)
of not##13##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-1#1)(2010-8#1)(2012-2#1)
of note that##2##3##(1990-12#1)(1997-6#1)
of note##4##2##(1990-12#1)(1997-6#1)(2008-12#1)(2009-4#1)
of notifiable diseases##2##3##(1997-3#2)
of novalgin##4##2##(2008-10#4)
of novel DNA##2##3##(1995-6#1)(2007-11#1)
of novel agents##2##3##(2008-7#2)
of novel and##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
of novel arylpiperazines##2##3##(1992-3#2)
of novel biological##2##3##(2009-12#1)(2010-3#1)
of novel drug##2##3##(2012-1#1)(2013-1#1)
of novel drugs##2##3##(2008-4#1)(2009-12#1)
of novel genes##6##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#2)
of novel inhibitors##2##3##(1994-2#1)(2013-1#1)
of novel optical##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
of novel synthetic##2##3##(2008-1#1)(2008-10#1)
of novel therapeutic targets##2##4##(2008-7#1)(2008-9#1)
of novel therapeutic##3##3##(2008-7#1)(2008-9#1)(2010-10#1)
of novel##150##2##(1991-1#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-4#2)(2007-11#6)(2007-12#3)(2008-1#3)(2008-10#17)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
of noxious##2##2##(2008-4#1)(2008-7#1)
of nuclear DNA content##5##4##(1991-6#1)(1992-9#1)(1994-3#1)(2008-11#1)(2008-9#1)
of nuclear DNA##11##3##(1991-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
of nuclear Overhauser effects and##2##5##(1992-4#1)(1994-5#1)
of nuclear Overhauser##3##3##(1992-4#1)(1993-8#1)(1994-5#1)
of nuclear and cytoplasmic##3##4##(2008-2#2)(2011-2#1)
of nuclear and##4##3##(1992-8#1)(2008-2#2)(2011-2#1)
of nuclear envelope##2##3##(2008-8#1)(2008-9#1)
of nuclear extracts##3##3##(1992-8#1)(2008-11#1)(2008-2#1)
of nuclear factor kappa B##4##5##(2007-8#1)(2010-10#1)(2011-1#2)
of nuclear factor##6##3##(1995-6#1)(2007-8#2)(2010-10#1)(2011-1#2)
of nuclear factor-kappaB##2##3##(2008-7#1)(2010-12#1)
of nuclear fast red##2##4##(2008-10#2)
of nuclear genes##3##3##(1991-2#1)(2008-8#1)(2011-2#1)
of nuclear lamina##5##3##(2007-12#1)(2008-8#4)
of nuclear magnetic resonance##4##4##(1990-4#1)(1992-12#1)(2008-4#1)(2010-5#1)
of nuclear matrix##6##3##(1990-5#2)(1993-8#1)(2008-8#3)
of nuclear medicine##3##3##(2010-9#1)(2012-2#2)
of nuclear membrane dynamics##2##4##(2011-2#2)
of nuclear morphology##2##3##(1997-2#1)(2009-8#1)
of nuclear proteins by##2##4##(2008-1#1)(2008-2#1)
of nuclear proteins##6##3##(1997-2#2)(2008-1#3)(2008-2#1)
of nuclear rDNA##3##3##(2008-10#2)(2008-5#1)
of nuclear receptor ligands##3##4##(2008-9#3)
of nuclear receptor##4##3##(2008-9#3)(2011-2#1)
of nuclear receptors##2##3##(2008-10#1)(2008-5#1)
of nuclear ribosomal##3##3##(2008-12#1)(2008-5#1)(2010-3#1)
of nuclear spins##3##3##(2008-7#2)(2012-2#1)
of nuclear structure##2##3##(1993-8#1)(1995-2#1)
of nuclear transcription factors##2##4##(1995-8#1)(2009-6#1)
of nuclear##119##2##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#3)(1992-9#2)(1993-8#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1997-2#3)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#14)(2008-9#9)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
of nuclear-coded subunits of##2##4##(1990-2#2)
of nuclear-encoded##2##2##(1994-8#1)(2008-1#1)
of nuclease##2##2##(1991-5#1)(1997-2#1)
of nucleated cells##2##3##(1991-2#1)(2011-2#1)
of nucleation##2##2##(1996-4#1)(2008-3#1)
of nuclei and nuclear membranes##2##5##(2008-1#2)
of nuclei and##3##3##(2008-1#2)(2008-10#1)
of nuclei of##2##3##(1991-2#1)(2008-11#1)
of nuclei with##2##3##(2008-7#2)
of nuclei##14##2##(1990-7#1)(1991-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
of nucleic acid sequences##3##4##(1996-6#1)(2008-10#1)(2008-9#1)
of nucleic acid structure##4##4##(2008-4#4)
of nucleic acid##27##3##(1992-8#1)(1996-6#2)(2008-10#6)(2008-4#7)(2008-5#1)(2008-7#1)(2008-9#3)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#3)
of nucleic acids by##3##4##(2008-10#3)
of nucleic acids in##4##4##(2008-10#3)(2008-5#1)
of nucleic acids is##2##4##(2008-4#1)(2008-9#1)
of nucleic acids to##2##4##(1994-3#1)(2010-10#1)
of nucleic acids was##2##4##(2008-10#2)
of nucleic acids##35##3##(1994-3#1)(1996-6#1)(1997-6#2)(2008-10#19)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#2)(2010-10#2)(2012-2#1)
of nucleic##64##2##(1992-8#1)(1994-3#1)(1996-6#3)(1997-6#2)(2008-10#26)(2008-2#1)(2008-4#11)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2010-10#3)(2011-2#1)(2012-2#2)(2012-3#3)
of nucleocytoplasmic transport##2##3##(2011-2#2)
of nucleocytoplasmic##3##2##(2008-9#1)(2011-2#2)
of nucleolar skeleton##3##3##(2008-8#3)
of nucleolar##6##2##(2007-12#1)(2008-8#4)(2011-2#1)
of nucleolus##4##2##(2008-12#1)(2008-8#3)
of nucleophagy##2##2##(2011-2#2)
of nucleoplasmic##2##2##(2008-8#2)
of nucleoporins##2##2##(2011-2#2)
of nucleoside 2-deoxyribosyltransferase##2##3##(1995-6#2)
of nucleoside diphosphates##2##3##(1997-7#1)(2008-7#1)
of nucleoside##9##2##(1994-8#1)(1995-6#2)(1997-7#1)(2008-4#3)(2008-7#1)(2011-2#1)
of nucleosides and bases##2##4##(2008-10#2)
of nucleosides and##3##3##(1993-12#1)(2008-10#2)
of nucleosides##7##2##(1992-3#1)(1993-12#1)(2008-10#2)(2008-4#1)(2010-4#1)(2011-1#1)
of nucleosomes at##2##3##(2008-2#2)
of nucleosomes##6##2##(1994-6#1)(2008-2#2)(2008-8#3)
of nucleotide or##2##3##(2008-4#1)(2008-9#1)
of nucleotide sequence##2##3##(2008-10#1)(2008-8#1)
of nucleotide sequences and##2##4##(1996-10#1)(2008-10#1)
of nucleotide sequences of the##2##5##(1994-8#1)(2008-6#1)
of nucleotide sequences##7##3##(1994-8#1)(1996-10#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-1#1)
of nucleotide substitution in the##2##5##(1991-2#1)(2008-6#1)
of nucleotide substitution##4##3##(1991-2#1)(2008-4#2)(2008-6#1)
of nucleotide##37##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-8#2)(1996-10#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#8)(2008-6#3)(2008-8#3)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
of nucleotides in##4##3##(1992-8#1)(2008-4#3)
of nucleotides to##2##3##(1993-11#1)(2008-11#1)
of nucleotides##21##2##(1991-7#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#4)(2008-2#2)(2008-4#6)
of nucleus basalis lesions##2##4##(1990-5#2)
of nucleus basalis##5##3##(1990-5#2)(1992-10#1)(1993-12#2)
of nucleus##9##2##(1990-5#2)(1992-10#1)(1993-12#2)(2008-8#3)(2010-9#1)
of nude mice##2##3##(2008-8#2)
of nude##3##2##(2008-8#2)(2008-9#1)
of null ellipsometry##2##3##(2008-3#2)
of null##5##2##(1996-3#1)(2008-3#2)(2008-9#1)(2009-8#1)
of nulling##2##2##(2007-11#1)(2008-3#1)
of number of trials##2##4##(2008-5#1)(2013-8#1)
of number of##14##3##(1993-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#2)(2011-2#2)(2013-7#1)(2013-8#1)
of number##16##2##(1993-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
of numbers of##2##3##(2011-2#1)(2013-7#1)
of numbers##3##2##(2010-9#1)(2011-2#1)(2013-7#1)
of numerical and structural chromosome##2##5##(2008-4#1)(2008-9#1)
of numerical and##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
of numerical experiments##2##3##(2008-3#2)
of numerical simulations##2##3##(2008-2#1)(2008-3#1)
of numerical##23##2##(1996-4#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-9#1)(2013-8#2)
of numerous##45##2##(1991-5#1)(1992-12#1)(1992-5#1)(1993-2#2)(1994-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-10#13)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)
of nurse cells##3##3##(2007-12#3)
of nurse education and##2##4##(2008-12#2)
of nurse education##8##3##(2008-11#4)(2008-12#3)(2012-3#1)
of nurse educators are##2##4##(2008-11#1)(2012-3#1)
of nurse lecturers##2##3##(2008-11#2)
of nurse##24##2##(1993-12#1)(2007-12#5)(2008-11#9)(2008-12#3)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
of nurses and##6##3##(1996-7#1)(2007-10#1)(2008-1#1)(2008-11#2)(2011-1#1)
of nurses in a##2##4##(2007-2#1)(2012-3#1)
of nurses in##7##3##(1991-2#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
of nurses that##2##3##(2008-11#1)(2011-2#1)
of nurses to##4##3##(2008-11#2)(2012-3#2)
of nurses who##4##3##(2009-5#1)(2010-11#2)(2012-3#1)
of nurses##59##2##(1990-2#1)(1991-2#2)(1992-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-7#1)(2007-10#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#5)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#3)(2010-11#4)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#5)(2013-1#2)(2013-8#2)
of nurses&quot##2##2##(1990-2#2)
of nurses' perceptions##2##3##(2010-10#1)(2013-1#1)
of nurses'##7##2##(1993-12#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2011-1#1)(2013-1#1)
of nursing activities##3##3##(1991-2#3)
of nursing administration##2##3##(1990-12#1)(2008-1#1)
of nursing advocacy##3##3##(2009-12#3)
of nursing and midwifery##3##4##(2007-10#1)(2008-11#1)(2008-12#1)
of nursing and##11##3##(2007-10#1)(2008-11#5)(2008-12#2)(2009-7#1)(2010-10#1)(2012-3#1)
of nursing as##3##3##(2008-1#2)(2008-11#1)
of nursing care and##2##4##(1991-3#1)(2007-10#1)
of nursing care in##2##4##(1990-2#1)(2012-3#1)
of nursing care of##2##4##(2008-11#1)(2012-3#1)
of nursing care##16##3##(1990-2#1)(1991-3#1)(1994-3#1)(1996-1#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2012-12#1)(2012-3#4)(2013-1#2)
of nursing diagnosis are##2##4##(1990-2#2)
of nursing diagnosis##6##3##(1990-2#4)(2010-3#2)
of nursing education##6##3##(1996-3#1)(2008-11#2)(2008-12#1)(2010-3#1)(2011-2#1)
of nursing faculty##4##3##(2008-11#3)(2012-3#1)
of nursing have##2##3##(2007-11#1)(2008-1#1)
of nursing home capital##2##4##(1992-1#2)
of nursing home care##7##4##(1991-2#1)(1993-2#1)(1995-2#1)(1996-2#1)(1997-3#1)(2009-3#1)(2012-12#1)
of nursing home residents##3##4##(1991-3#1)(1993-3#1)(1996-2#1)
of nursing home##29##3##(1990-5#2)(1991-2#1)(1991-3#3)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1995-2#2)(1996-2#3)(1997-2#1)(1997-3#2)(2008-11#2)(2009-3#1)(2010-12#1)(2012-12#1)
of nursing homes##4##3##(1991-1#1)(1997-1#1)(2008-12#1)(2012-12#1)
of nursing in##3##3##(2008-1#1)(2008-12#1)(2012-3#1)
of nursing knowledge##3##3##(2008-11#1)(2008-12#2)
of nursing leadership in##2##4##(2008-1#1)(2012-3#1)
of nursing must##2##3##(2008-11#2)
of nursing practice##7##3##(1997-7#1)(2008-11#4)(2008-12#1)(2008-4#1)
of nursing programmes##2##3##(2008-12#1)(2012-3#1)
of nursing research##4##3##(2008-12#1)(2010-9#3)
of nursing staff##3##3##(1997-6#1)(2010-10#2)
of nursing students##5##3##(2008-11#2)(2008-12#3)
of nursing to##4##3##(1990-12#1)(2008-1#1)(2008-12#2)
of nursing##180##2##(1990-12#3)(1990-2#9)(1990-5#2)(1991-1#1)(1991-11#1)(1991-2#5)(1991-3#4)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-9#1)(1995-2#2)(1996-1#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#4)(2007-11#1)(2008-1#13)(2008-11#37)(2008-12#27)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-3#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-3#4)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#10)(2013-1#4)(2013-8#1)
of nursing's##2##2##(2008-1#2)
of nursing]##2##2##(1993-8#1)(2007-3#1)
of nut##2##2##(1995-3#1)(2008-10#1)
of nutrient##16##2##(1995-3#1)(2008-10#3)(2008-11#3)(2008-7#3)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#2)
of nutrients and##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
of nutrients had##2##3##(2008-6#1)(2013-1#1)
of nutrients in##4##3##(1992-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
of nutrients on##2##3##(1997-4#1)(2012-1#1)
of nutrients to##2##3##(2008-11#1)(2008-9#1)
of nutrients##26##2##(1992-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
of nutrition and##2##3##(1996-8#2)
of nutrition care##5##3##(1994-3#4)(1997-3#1)
of nutrition for##2##3##(2007-2#1)(2008-10#1)
of nutrition in children##2##4##(2012-2#2)
of nutrition information##2##3##(1991-3#2)
of nutrition intervention##2##3##(1995-2#1)(1995-3#1)
of nutrition##23##2##(1991-3#3)(1993-1#1)(1994-3#4)(1995-2#1)(1995-3#3)(1995-6#1)(1996-8#2)(1997-3#1)(2007-2#1)(2008-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
of nutritional deficiencies##2##3##(1995-3#1)(2008-10#1)
of nutritional intake##2##3##(1991-2#1)(2008-1#1)
of nutritional interventions##2##3##(2010-6#2)
of nutritional status in##2##4##(2011-1#1)(2013-1#1)
of nutritional status##7##3##(1997-4#1)(2007-7#1)(2011-1#3)(2012-12#1)(2013-1#1)
of nutritional##25##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-3#2)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
of nutritionally##3##2##(2008-11#1)(2008-5#1)(2013-7#1)
of nutritionists##2##2##(1993-1#2)
of nymphs and adults##2##4##(2013-7#2)
of o-##2##2##(2008-10#2)
of o-catechol##2##2##(2008-10#2)
of o-phenylenediamine##2##2##(2008-10#2)
of oak##4##2##(2008-10#2)(2012-5#1)(2012-9#1)
of oat##6##2##(1990-5#1)(2008-10#3)(2008-5#1)(2008-9#1)
of oats##3##2##(1991-6#1)(2008-10#2)
of obese children##2##3##(2010-8#2)
of obese individuals##2##3##(2011-2#1)(2012-2#1)
of obese patients with##2##4##(2008-3#1)(2013-1#1)
of obese##12##2##(1995-5#1)(1996-12#2)(2007-7#1)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
of obesity among##2##3##(2008-11#1)(2012-3#1)
of obesity and##15##3##(1991-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-12#1)
of obesity has##3##3##(2010-5#1)(2010-6#1)(2011-1#1)
of obesity in the##2##4##(1993-11#1)(2009-11#1)
of obesity in##11##3##(1993-11#1)(2007-3#1)(2008-1#3)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
of obesity is##2##3##(2011-1#1)(2011-2#1)
of obesity on the psychometric##2##5##(2011-2#2)
of obesity on the##3##4##(2011-2#3)
of obesity on##5##3##(2010-3#1)(2011-2#3)(2012-3#1)
of obesity or undernutrition##2##4##(2008-7#2)
of obesity or##3##3##(2008-7#3)
of obesity was##2##3##(2007-8#1)(2008-3#1)
of obesity##84##2##(1991-6#1)(1993-11#1)(1995-5#1)(1996-12#1)(2007-3#1)(2007-8#1)(2008-1#8)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#10)(2008-4#5)(2008-5#6)(2008-7#4)(2009-11#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
of obesity]##2##2##(1990-5#1)(2007-3#1)
of object##6##2##(1993-3#1)(2007-12#1)(2008-3#2)(2009-2#1)(2011-1#1)
of objective and subjective##2##4##(1991-6#1)(2008-7#1)
of objective and##3##3##(1991-6#1)(2008-7#1)(2009-7#1)
of objective criteria##2##3##(2008-10#2)
of objective##16##2##(1991-6#1)(1996-8#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#4)
of objectively##2##2##(1994-2#1)(2008-5#1)
of objectives##5##2##(1991-2#1)(1995-3#1)(2008-9#2)(2010-9#1)
of objectivity in##2##3##(2012-2#2)
of objectivity##3##2##(2012-12#1)(2012-2#2)
of objects from##2##3##(2008-3#2)
of objects in a##2##4##(1993-6#1)(2008-3#1)
of objects in##4##3##(1993-6#1)(2007-12#1)(2008-3#2)
of objects##34##2##(1990-3#1)(1993-12#1)(1993-6#2)(1997-5#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#11)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
of obligate##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
of obliquely##4##2##(2008-2#1)(2008-3#1)(2008-5#2)
of obscure origin##2##3##(2008-7#1)(2009-8#1)
of obscure##6##2##(2006-10#1)(2008-7#2)(2009-8#1)(2012-12#1)(2012-2#1)
of observation in##2##3##(2010-1#1)(2012-12#1)
of observation##13##2##(1990-8#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)(2010-3#1)(2012-12#1)(2012-3#1)
of observation)##2##2##(2007-11#1)(2008-10#1)
of observational##2##2##(2008-11#1)(2008-12#1)
of observations in##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
of observations that##2##3##(1992-6#1)(1997-1#1)
of observations with##2##3##(2008-3#1)(2009-8#1)
of observations##17##2##(1992-6#1)(1996-8#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#2)(2012-3#1)
of observed##19##2##(1992-12#1)(1993-1#1)(1997-6#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-11#1)(2011-1#2)(2013-1#2)(2013-8#1)
of observers##2##2##(2008-11#1)(2009-8#1)
of observing and##2##3##(2008-10#1)(2008-2#1)
of observing##9##2##(1992-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-10#1)(2013-8#1)
of obsessive-compulsive disorder (OCD)##2##4##(2008-1#1)(2008-6#1)
of obsessive-compulsive disorder in##2##4##(2008-11#1)(2012-12#1)
of obsessive-compulsive disorder##6##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
of obsessive-compulsive##8##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2011-2#1)(2012-12#1)(2013-8#1)
of obstetric##5##2##(2008-2#1)(2011-1#2)(2012-2#1)(2013-1#1)
of obstetrical##3##2##(1993-12#1)(1996-2#1)(2010-11#1)
of obstructed##3##2##(1991-3#1)(1996-12#1)(2010-5#1)
of obstruction##4##2##(1997-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
of obstructive lesions##2##3##(2010-6#1)(2012-3#1)
of obstructive lung##2##3##(2008-6#2)
of obstructive sleep apnea##4##4##(2007-12#2)(2010-5#1)(2013-1#1)
of obstructive uropathy##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
of obstructive##20##2##(1991-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#2)(2010-5#1)(2010-6#2)(2011-2#2)(2012-3#1)(2013-1#1)
of obtaining a##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
of obtaining an##2##3##(2008-10#1)(2011-2#1)
of obtaining the##2##3##(2008-10#1)(2008-3#1)
of obtaining##28##2##(1990-12#1)(1991-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#2)(2010-11#1)(2010-6#1)(2011-2#1)
of obtusifoliol##3##2##(1992-3#3)
of obvious##4##2##(2008-11#1)(2008-9#1)(2010-4#1)(2013-1#1)
of occipital condyles##2##3##(2013-1#2)
of occipital##5##2##(2008-7#2)(2013-1#3)
of occluded##2##2##(2008-11#1)(2008-7#1)
of occlusal##5##2##(2009-7#1)(2010-3#1)(2010-6#2)(2011-2#1)
of occlusion##10##2##(1997-3#1)(2007-10#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#2)(2012-3#1)
of occlusive vascular disease##2##4##(1992-9#2)
of occlusive vascular##3##3##(1992-9#2)(1995-2#1)
of occlusive##4##2##(1992-9#2)(1995-2#1)(2008-5#1)
of occult blood in##2##4##(1993-6#1)(2009-1#1)
of occult papillary##2##3##(1990-6#2)
of occult##12##2##(1990-6#4)(1991-2#1)(1991-6#1)(1993-3#1)(1993-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-1#1)
of occupational asthma##3##3##(2008-10#3)
of occupational exposure##4##3##(2007-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
of occupational health##3##3##(1991-6#1)(2008-11#1)(2010-12#1)
of occupational injury and ill-health##2##5##(2008-11#2)
of occupational medicine##2##3##(1995-6#1)(2011-2#1)
of occupational stress on##4##4##(2010-12#3)(2012-2#1)
of occupational therapy##3##3##(2013-7#2)(2013-8#1)
of occupational##41##2##(1990-3#2)(1991-6#1)(1995-6#1)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#6)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
of occurrence and##2##3##(2008-12#1)(2009-10#1)
of occurrence for##2##3##(2007-5#2)
of occurrence of##12##3##(1996-4#3)(2008-10#2)(2008-11#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of occurrence##32##2##(1994-3#1)(1996-4#3)(1997-4#1)(2007-5#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2009-10#1)(2009-8#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of occurring##2##2##(2008-10#2)
of ocean color##10##3##(2008-2#4)(2008-3#6)
of ocean water##3##3##(2008-2#2)(2008-3#1)
of ocean##15##2##(1996-4#1)(2008-2#6)(2008-3#8)
of oceanic water##2##3##(2008-2#2)
of oceanic waters##3##3##(2008-3#3)
of oceanic##9##2##(1996-4#1)(2008-2#4)(2008-3#4)
of octadecenedioic acid##2##3##(2008-5#2)
of octopamine##3##2##(1994-2#3)
of octreotide##3##2##(1991-11#1)(1995-8#1)(1997-4#1)
of octyl methoxycinnamate##2##3##(2008-5#2)
of octyl##5##2##(1992-12#1)(2008-5#4)
of ocular##11##2##(1991-11#1)(1991-2#1)(1995-12#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-9#3)(2011-1#2)
of odds ratio##2##3##(1997-8#1)(2012-3#1)
of odontoblast##2##2##(2013-1#1)(2013-8#1)
of odorant##2##2##(2008-7#1)(2013-8#1)
of odorants##2##2##(1991-2#1)(2013-1#1)
of oedema##5##2##(2008-7#2)(2011-1#1)(2013-7#2)
of oesophageal varices##3##3##(2009-8#2)(2013-1#1)
of oesophageal##9##2##(1993-2#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-8#2)(2013-1#1)
of oestrogen##5##2##(1990-11#1)(2008-4#3)(2011-2#1)
of oestrogens##3##2##(1994-2#1)(1994-6#1)(2008-4#1)
of of##4##2##(1992-1#1)(1996-6#1)(2007-10#1)(2011-2#1)
of off standard pods##2##4##(2008-12#2)
of off-axis##5##2##(2008-2#1)(2008-3#4)
of offenders##5##2##(2008-11#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
of offending behavior##2##3##(2008-12#2)
of offending##6##2##(2007-9#1)(2008-12#3)(2009-7#1)(2009-8#1)
of office visits##3##3##(1995-3#1)(2010-8#2)
of official##2##2##(2008-10#1)(2011-2#1)
of offspring at##2##3##(2008-9#2)
of offspring##18##2##(2008-1#1)(2008-8#8)(2008-9#5)(2010-4#1)(2011-2#1)(2012-12#2)
of ofloxacin in##4##3##(2008-10#4)
of ofloxacin##9##2##(1990-2#1)(1996-2#1)(2008-10#7)
of oil and##2##3##(2008-10#1)(2013-1#1)
of oil for##2##3##(2008-10#1)(2009-3#1)
of oil##25##2##(2008-10#17)(2008-5#2)(2008-6#1)(2009-10#2)(2009-3#1)(2011-1#1)(2013-1#1)
of oils and solidifying agents##2##5##(2008-5#2)
of oils##8##2##(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)
of oilseed rape##4##3##(2008-10#4)
of oilseed##5##2##(2008-10#5)
of okadaic acid##4##3##(1992-8#2)(1993-8#1)(1995-5#1)
of old age##4##3##(1990-11#1)(1994-6#1)(2008-5#1)(2009-7#1)
of old and##3##3##(1995-6#1)(2008-12#1)(2011-2#1)
of old mice##2##3##(1994-5#1)(2012-2#1)
of old people##2##3##(1990-11#1)(2008-7#1)
of old people's##2##3##(2010-6#2)
of old##23##2##(1990-11#2)(1991-12#1)(1994-5#1)(1994-6#2)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-6#2)(2011-2#1)(2012-2#1)
of older adults are##3##4##(1996-1#1)(2013-1#2)
of older adults in##2##4##(2008-5#1)(2012-12#1)
of older adults##12##3##(1996-1#1)(2008-11#3)(2008-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
of older mothers##2##3##(1997-3#1)(2010-2#1)
of older patients with cancer##3##5##(2008-7#1)(2010-11#2)
of older patients with##5##4##(1992-9#1)(2008-7#1)(2010-10#1)(2010-11#2)
of older patients##6##3##(1992-9#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#2)
of older people##17##3##(1995-3#1)(2008-1#1)(2008-7#2)(2010-10#12)(2010-3#1)
of older persons in##3##4##(1997-2#1)(1997-3#1)(2010-10#1)
of older persons##5##3##(1997-2#1)(1997-3#1)(2008-3#1)(2010-10#2)
of older volunteers##2##3##(1996-3#1)(2008-3#1)
of older##64##2##(1992-9#1)(1994-11#1)(1994-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#15)(2010-11#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#5)
of oleander##2##2##(2008-10#2)
of oleic acid##6##3##(1990-7#1)(1992-12#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-7#1)
of oleic##10##2##(1990-2#2)(1990-7#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
of olfactory ensheathing cells##2##4##(2008-7#2)
of olfactory interneurons in##2##4##(1990-5#2)
of olfactory receptor neurons##2##4##(2007-12#2)
of olfactory##14##2##(1990-5#2)(1991-2#3)(1991-5#1)(2007-12#5)(2008-7#2)(2012-2#1)
of oligo(dN)##3##2##(1991-12#3)
of oligodendrocyte progenitors##2##3##(2008-7#2)
of oligodendrocyte##4##2##(2008-7#4)
of oligodendrocytes##4##2##(1991-5#1)(2008-7#3)
of oligodendroglioma##3##2##(2011-1#3)
of oligodeoxynucleotides##2##2##(2008-10#1)(2008-4#1)
of oligodeoxyribonucleotide##2##2##(1990-11#1)(1991-9#1)
of oligodeoxyribonucleotides##7##2##(1991-9#2)(2008-4#5)
of oligomer##2##2##(1990-7#1)(1993-8#1)
of oligomers##2##2##(1990-11#1)(1995-11#1)
of oligonucleotide##10##2##(1993-11#1)(1995-5#1)(2008-10#3)(2008-4#4)(2008-5#1)
of oligonucleotides and##2##3##(2008-4#1)(2011-1#1)
of oligonucleotides##14##2##(1991-12#1)(1994-11#1)(2008-10#3)(2008-4#8)(2011-1#1)
of oligopyrrole##2##2##(2008-10#2)
of oligosaccharide##5##2##(1993-11#1)(1993-3#1)(1994-9#1)(1995-5#1)(2008-12#1)
of oligosaccharides obtained by##2##4##(1990-9#2)
of oligosaccharides##13##2##(1990-9#2)(1993-11#2)(1993-8#1)(1995-5#1)(1995-6#1)(1997-4#2)(2008-10#2)(2008-4#1)(2012-2#1)
of olive oil##2##3##(2008-10#1)(2012-2#1)
of olive##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
of olmesartan medoxomil##2##3##(2008-11#2)
of omega-3 fatty acids##2##4##(1990-2#1)(1990-5#1)
of omega-6 fatty acids##2##4##(1990-5#1)(2012-1#1)
of omental cakes is##2##4##(2012-2#2)
of omental cakes##3##3##(2012-2#3)
of omentum##4##2##(2007-2#1)(2007-8#3)
of omeprazole on##2##3##(1993-11#2)
of omeprazole##4##2##(1993-11#3)(2012-2#1)
of omethoate##2##2##(2008-10#2)
of ommatidia##4##2##(2007-12#4)
of omnidirectional##2##2##(2008-3#2)
of omnivory##4##2##(2008-8#1)(2008-9#3)
of omphalocele with##2##3##(1997-3#1)(2010-8#1)
of on average##3##3##(2008-2#2)(2008-5#1)
of on pixels##2##3##(2008-3#2)
of on##9##2##(1990-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)
of on-going##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
of on-line instrumentation##2##3##(2008-10#2)
of on-line sample##3##3##(2008-10#3)
of on-line##15##2##(2008-1#1)(2008-10#13)(2010-4#1)
of on-orbit##3##2##(2008-3#3)
of once##3##2##(1997-3#1)(2008-2#1)(2010-5#1)
of onchocerciasis##3##2##(1991-12#2)(2010-8#1)
of onco-antigens in serum##2##4##(2013-1#2)
of oncofetal##2##2##(1994-9#1)(1996-12#1)
of oncogene##2##2##(1996-12#1)(2008-11#1)
of oncogenes in##4##3##(1996-7#1)(2008-11#3)
of oncogenes##10##2##(1990-8#1)(1995-2#1)(1996-7#1)(2008-11#6)(2009-4#1)
of oncogenesis##2##2##(1992-2#1)(1994-10#1)
of oncogenic##6##2##(1994-8#1)(1995-2#1)(1996-1#1)(2008-5#1)(2008-6#1)(2008-7#1)
of oncological##3##2##(1997-3#1)(2008-5#1)(2013-1#1)
of oncology in##2##3##(2008-6#1)(2008-9#1)
of oncology patients##2##3##(1996-6#1)(2007-7#1)
of oncology##9##2##(1991-8#1)(1996-6#1)(2007-5#1)(2007-7#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-1#1)(2012-3#1)
of oncolytic viruses##2##3##(2013-1#1)(2013-8#1)
of one and##4##3##(1996-6#1)(2008-10#1)(2008-6#1)(2010-11#1)
of one another##6##3##(1990-8#1)(2008-10#4)(2009-2#1)
of one aperture##2##3##(2007-11#1)(2008-3#1)
of one case]##10##3##(2012-3#1)(2013-1#5)(2013-8#4)
of one class of##2##4##(1993-12#1)(2008-10#1)
of one copy of##2##4##(2008-7#1)(2012-3#1)
of one copy##3##3##(2007-11#1)(2008-7#1)(2012-3#1)
of one electron##2##3##(2008-10#2)
of one element##2##3##(2007-12#1)(2008-10#1)
of one form of##3##4##(2008-10#2)(2009-5#1)
of one gene##3##3##(1992-6#1)(1994-8#1)(2008-10#1)
of one group##2##3##(2008-10#2)
of one hundred and##2##4##(1995-10#1)(2007-10#1)
of one kidney##2##3##(2008-10#1)(2011-1#1)
of one layer of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of one layer##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of one lung##2##3##(2008-10#1)(2011-2#1)
of one million##2##3##(2008-10#1)(2008-7#1)
of one molecule##2##3##(1995-3#1)(2008-1#1)
of one month and##2##4##(1992-11#1)(2008-10#1)
of one month##6##3##(1992-11#1)(1993-6#1)(2008-10#2)(2008-9#1)(2013-1#1)
of one of the five##2##5##(1997-7#1)(2008-3#1)
of one of the most##2##5##(1991-9#1)(1997-8#1)
of one of the two##4##5##(1992-3#1)(1997-2#1)(2008-3#1)(2012-12#1)
of one of the##53##4##(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
of one of these##8##4##(1992-10#1)(1992-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)
of one of##69##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
of one or a few##2##5##(2008-10#1)(2008-7#1)
of one or more of the##2##6##(1996-2#1)(2008-11#1)
of one or more##18##4##(1991-1#1)(1992-12#1)(1994-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)
of one or several##2##4##(2008-3#1)(2009-5#1)
of one or the other##2##5##(2008-7#1)(2009-12#1)
of one or two##6##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
of one or##34##3##(1991-1#1)(1991-8#1)(1992-12#1)(1994-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#2)(2011-2#1)(2013-1#2)
of one pair of##2##4##(2008-12#1)(2010-7#1)
of one polarization##2##3##(2008-2#1)(2008-3#1)
of one polypeptide##2##3##(1992-8#1)(1993-2#1)
of one protein##3##3##(1990-5#1)(2008-4#2)
of one proton##2##3##(1996-2#1)(2008-10#1)
of one sample##2##3##(2008-10#1)(2008-3#1)
of one side##3##3##(1993-3#1)(2007-12#1)(2008-2#1)
of one species##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
of one strand##2##3##(2008-2#1)(2008-4#1)
of one subunit##2##3##(1991-6#1)(1993-11#1)
of one such##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
of one to##3##3##(1996-2#1)(1997-4#1)(2010-5#1)
of one transverse##2##3##(2007-11#1)(2007-12#1)
of one type of##4##4##(1993-12#1)(2007-12#1)(2008-10#1)(2013-8#1)
of one type##5##3##(1993-12#1)(2007-12#1)(2008-10#2)(2013-8#1)
of one wavelength##2##3##(2008-3#2)
of one week##2##3##(1991-6#1)(1994-2#1)
of one year##15##3##(1990-12#1)(1994-6#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-5#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
of one##353##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#1)(2007-10#3)(2007-11#5)(2007-12#15)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#68)(2008-11#9)(2008-12#5)(2008-2#10)(2008-3#24)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-5#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-3#4)(2013-1#13)(2013-8#10)
of one's own##4##3##(2007-8#1)(2009-4#2)(2010-10#1)
of one's##15##2##(1994-2#2)(1994-6#1)(1996-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#3)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#1)
of one-dimensional##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of one-photon##2##2##(2008-3#2)
of onfFN##2##2##(1994-9#2)
of ongoing clinical trials##2##4##(2008-3#1)(2010-6#1)
of ongoing clinical##3##3##(2008-3#1)(2008-8#1)(2010-6#1)
of ongoing research##2##3##(1992-1#1)(2010-5#1)
of ongoing##22##2##(1992-1#1)(1993-11#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#4)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
of onion cells##2##3##(2007-11#1)(2007-12#1)
of onion yellows phytoplasma##3##4##(2008-10#3)
of onion##17##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#14)
of onium salt##4##3##(2008-10#4)
of online health##3##3##(2010-10#2)(2010-4#1)
of online resources##2##3##(1994-12#1)(2008-11#1)
of online##13##2##(1991-2#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-10#3)(2010-4#1)(2011-1#2)
of only 0##7##3##(2007-10#1)(2007-12#2)(2008-10#1)(2008-8#1)(2012-12#2)
of only 1##2##3##(2008-10#2)
of only 2##2##3##(2008-10#1)(2010-3#1)
of only 24##2##3##(1994-12#1)(2011-1#1)
of only 3##2##3##(2008-10#2)
of only 4##2##3##(2008-2#2)
of only 6##2##3##(2007-12#1)(2008-9#1)
of only a few##5##4##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
of only a single##2##4##(2008-10#1)(2008-3#1)
of only a##10##3##(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)
of only four##2##3##(1995-12#1)(2006-12#1)
of only one of##2##4##(2008-10#1)(2013-8#1)
of only one type of##2##5##(1991-9#1)(2007-12#1)
of only one##12##3##(1991-9#1)(2007-12#3)(2008-10#3)(2008-2#3)(2008-9#1)(2013-8#1)
of only the##7##3##(1990-7#1)(1991-5#1)(1994-11#1)(2008-3#3)(2010-11#1)
of only two##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
of only water##2##3##(2008-10#1)(2010-6#1)
of only##91##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-10#2)(2007-12#9)(2008-1#1)(2008-10#20)(2008-2#12)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-7#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#4)(2013-1#1)(2013-8#2)
of onset and##6##3##(1996-7#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
of onset of the##2##4##(1990-5#1)(2008-1#1)
of onset of##9##3##(1990-5#1)(1991-11#1)(1994-2#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)
of onset were##3##3##(1994-12#1)(1997-5#1)(2007-10#1)
of onset##38##2##(1990-5#1)(1991-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-7#3)(1997-5#2)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#2)(2010-10#1)(2011-2#2)(2012-12#1)(2013-7#3)
of ontogenic resistance to##2##4##(2008-10#2)
of ontogenic resistance##5##3##(2008-10#5)
of ontogenic##6##2##(2008-10#5)(2008-11#1)
of ontologies##2##2##(2008-7#2)
of ontology##2##2##(2008-7#2)
of onychomycosis##5##2##(2007-7#2)(2008-3#2)(2008-5#1)
of oocysts##4##2##(1996-12#3)(2007-12#1)
of oocyte tPA##2##3##(2008-8#2)
of oocyte##5##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#2)
of oocytes##11##2##(1995-12#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#4)
of oogenesis##2##2##(2007-12#1)(2008-9#1)
of oogonia##2##2##(2008-10#2)
of oospores in the##2##4##(2008-10#2)
of oospores in##5##3##(2008-10#5)
of oospores of##2##3##(2008-10#2)
of oospores##22##2##(2008-10#22)
of opaque microstructures in optically diffuse media##2##7##(2008-3#2)
of opaque##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
of open and##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
of open fractures##5##3##(2007-11#1)(2010-11#1)(2013-8#3)
of open pollination##2##3##(2008-10#1)(2011-2#1)
of open reading frame##2##4##(2008-10#1)(2008-8#1)
of open reading frames##2##4##(1992-3#1)(1996-6#1)
of open reading##4##3##(1992-3#1)(1996-6#1)(2008-10#1)(2008-8#1)
of open tubular##2##3##(2008-10#2)
of open##35##2##(1991-6#1)(1992-3#1)(1992-5#1)(1995-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#4)
of open-heart surgery##2##3##(1995-3#1)(1996-12#1)
of opening##2##2##(2008-10#1)(2008-12#1)
of openness##3##2##(2008-12#1)(2008-7#1)(2013-8#1)
of operable breast cancer##2##4##(1992-10#1)(1993-11#1)
of operant##2##2##(1990-7#1)(2008-4#1)
of operated##3##2##(1990-10#1)(2007-11#1)(2009-5#1)
of operating a##2##3##(1991-12#1)(2008-9#1)
of operating conditions##4##3##(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)
of operating##16##2##(1991-12#1)(1993-9#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
of operation and##10##3##(1990-2#1)(1992-9#1)(1993-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)
of operation in##4##3##(1994-9#1)(2008-11#1)(2008-2#2)
of operation is##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
of operation of the##3##4##(1990-3#1)(2008-3#1)(2011-2#1)
of operation of##5##3##(1990-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#1)
of operation##47##2##(1990-2#1)(1990-3#3)(1991-11#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-9#1)(1997-2#1)(2007-11#4)(2007-12#3)(2007-8#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#8)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
of operationally##2##2##(1991-2#1)(2008-3#1)
of operations in##2##3##(2007-8#1)(2010-8#1)
of operations##6##2##(1992-9#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-8#1)
of operative time##2##3##(2012-2#1)(2013-1#1)
of operative treatment of bone metastases to the knee##2##9##(2007-11#2)
of operative treatment of##3##4##(2007-11#3)
of operative treatment##9##3##(2007-11#9)
of operative##18##2##(1990-6#1)(1993-3#1)(2007-11#11)(2008-1#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
of ophthalmic segment##2##3##(2012-3#2)
of ophthalmic##7##2##(2008-10#1)(2011-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
of ophthalmology##3##2##(1995-9#1)(2011-7#2)
of opiate##7##2##(1991-1#3)(1991-5#2)(1995-12#1)(2007-2#1)
of opiates##3##2##(1991-1#2)(1996-5#1)
of opinion##6##2##(1990-9#1)(1991-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2013-8#1)
of opioid analgesia##2##3##(1990-7#1)(1995-5#1)
of opioid dependence##2##3##(2008-6#2)
of opioid peptides in##2##4##(1991-1#1)(1994-2#1)
of opioid peptides##5##3##(1991-1#1)(1994-2#1)(1995-6#1)(1997-2#1)(2009-7#1)
of opioid receptor agonists##2##4##(1995-12#1)(2009-7#1)
of opioid receptor##3##3##(1995-12#1)(2008-11#1)(2009-7#1)
of opioid receptors and##2##4##(2008-11#1)(2009-7#1)
of opioid receptors in the##2##5##(2008-11#2)
of opioid receptors in##4##4##(2008-11#3)(2009-7#1)
of opioid receptors##9##3##(1993-12#1)(1995-11#1)(2008-11#4)(2008-7#1)(2009-7#2)
of opioid##32##2##(1990-7#1)(1991-1#4)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-11#6)(2008-6#2)(2008-7#1)(2009-7#4)(2012-1#2)(2013-1#1)
of opioids and##2##3##(1997-5#1)(2011-2#1)
of opioids in##4##3##(2011-2#4)
of opioids##10##2##(1991-1#1)(1995-5#1)(1997-5#1)(2009-7#1)(2011-2#5)(2012-3#1)
of opium poppy##2##3##(2008-10#2)
of opportunistic infections##4##3##(1997-4#1)(2006-10#1)(2008-12#1)(2008-2#1)
of opportunistic##10##2##(1997-4#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-7#1)(2011-2#1)(2013-1#2)
of opportunities that##2##3##(1993-1#1)(2008-11#1)
of opportunities##3##2##(1993-1#1)(1993-3#1)(2008-11#1)
of opportunity for##4##3##(2008-3#1)(2010-6#1)(2010-7#1)(2013-1#1)
of opportunity##12##2##(2008-10#2)(2008-11#1)(2008-3#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-1#1)(2013-1#1)
of opposing##2##2##(2008-11#1)(2010-10#1)
of opposite sign##3##3##(1995-6#1)(2007-11#1)(2008-3#1)
of opposite##7##2##(1990-8#1)(1995-6#1)(2007-11#3)(2008-10#1)(2008-3#1)
of opsonisation##2##2##(1996-12#2)
of optic nerve##2##3##(2008-5#1)(2010-5#1)
of optic##5##2##(2008-5#1)(2008-9#1)(2010-5#1)(2011-7#1)(2012-2#1)
of optical and##2##3##(2008-3#1)(2009-7#1)
of optical anisotropy##2##3##(2007-11#1)(2008-3#1)
of optical beams by##2##4##(2007-12#2)
of optical beams##4##3##(2007-12#3)(2008-2#1)
of optical coatings##2##3##(2008-3#2)
of optical coherence tomography (OCT)##2##5##(2010-12#1)(2011-7#1)
of optical coherence tomography##8##4##(2007-11#3)(2007-12#1)(2008-3#1)(2010-12#1)(2011-7#2)
of optical coherence##10##3##(2007-11#3)(2007-12#1)(2008-3#3)(2010-12#1)(2011-7#2)
of optical communication##2##3##(2008-2#1)(2008-3#1)
of optical communications##2##3##(2007-12#1)(2008-3#1)
of optical components with##2##4##(2008-3#2)
of optical components##9##3##(2008-2#4)(2008-3#5)
of optical constants of thin##3##5##(2008-2#2)(2008-3#1)
of optical constants of##5##4##(2008-2#2)(2008-3#3)
of optical constants##8##3##(2008-2#3)(2008-3#5)
of optical correlation##2##3##(2008-2#1)(2008-3#1)
of optical correlators##2##3##(2008-3#2)
of optical damage##2##3##(2008-3#2)
of optical data links##2##4##(2008-3#2)
of optical data storage##2##4##(2007-12#1)(2008-2#1)
of optical data##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
of optical devices##7##3##(2007-11#2)(2008-2#2)(2008-3#2)(2008-9#1)
of optical disks with##2##4##(2008-2#1)(2008-3#1)
of optical disks##3##3##(2008-2#2)(2008-3#1)
of optical feedback##3##3##(2007-11#1)(2008-3#2)
of optical fiber##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
of optical fibers and##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
of optical fibers##13##3##(2007-11#5)(2008-10#1)(2008-2#2)(2008-3#5)
of optical fields##2##3##(2007-11#1)(2008-3#1)
of optical filters##5##3##(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)
of optical frequency comb##2##4##(2007-12#1)(2008-3#1)
of optical frequency##4##3##(2007-12#2)(2008-3#2)
of optical glass material##2##4##(2008-3#2)
of optical glasses##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of optical imaging##2##3##(2008-2#1)(2011-1#1)
of optical interconnections##2##3##(2008-3#2)
of optical limiting##2##3##(2007-11#1)(2007-12#1)
of optical memory##4##3##(2007-12#2)(2008-3#2)
of optical near fields##2##4##(2007-12#2)
of optical parameters in general film-substrate systems##2##7##(2008-3#2)
of optical parameters in##3##4##(2008-3#3)
of optical parameters##5##3##(1990-8#1)(2008-3#4)
of optical parametric##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of optical path##2##3##(2008-10#1)(2008-3#1)
of optical power##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of optical properties##9##3##(2007-12#1)(2008-2#3)(2008-3#5)
of optical pulse##2##3##(2007-12#2)
of optical pulses##4##3##(2007-11#1)(2008-2#3)
of optical rectification and the##2##5##(2007-12#2)
of optical rectification##3##3##(2007-11#1)(2007-12#2)
of optical sensors based on##2##5##(2008-3#2)
of optical sensors##3##3##(2008-10#1)(2008-3#2)
of optical signals##2##3##(2007-11#1)(2012-2#1)
of optical sources##2##3##(2008-2#2)
of optical space code-division##2##4##(2008-2#2)
of optical surfaces##3##3##(2008-2#1)(2008-3#2)
of optical systems##3##3##(2008-2#2)(2008-3#1)
of optical thickness##2##3##(2008-2#1)(2008-3#1)
of optical transmission##3##3##(2007-12#1)(2008-3#2)
of optical trapping##2##3##(2008-3#2)
of optical vortices in##2##4##(2007-11#1)(2007-12#1)
of optical vortices##3##3##(2007-11#1)(2007-12#2)
of optical waves##2##3##(2008-3#2)
of optical##285##2##(1990-8#1)(1991-2#1)(2007-11#32)(2007-12#39)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#57)(2008-3#124)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#2)(2012-2#2)(2013-8#1)
of optically active##7##3##(1996-5#1)(1997-7#1)(2007-12#2)(2008-3#1)(2008-7#1)(2009-10#1)
of optically pumped##3##3##(1994-2#1)(2008-3#1)(2008-7#1)
of optically thick##4##3##(2008-3#4)
of optically transparent##3##3##(2007-11#2)(2008-7#1)
of optically##29##2##(1990-8#1)(1991-5#1)(1994-2#1)(1996-5#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#11)(2008-7#3)(2009-10#1)(2011-1#1)
of optics and##2##3##(2008-2#1)(2008-3#1)
of optics in##4##3##(2007-11#1)(2008-3#3)
of optics##12##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#5)
of optimal binary##2##3##(2008-2#2)
of optimal focusing conditions##2##4##(2007-12#2)
of optimal##26##2##(1992-3#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-8#1)
of optimality##3##2##(2008-8#1)(2008-9#1)(2010-1#1)
of optimised##2##2##(2008-10#2)
of optimization##5##2##(2007-12#1)(2007-9#1)(2008-10#3)
of optimized##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
of optimizing##4##2##(1996-1#1)(2008-3#1)(2009-10#1)(2010-4#1)
of optimum##7##2##(1990-7#1)(1992-12#1)(1997-2#1)(2007-11#2)(2008-2#1)(2008-8#1)
of options and##2##3##(1992-1#1)(1994-1#1)
of options for##4##3##(1991-2#1)(2007-12#1)(2008-11#1)(2011-2#1)
of options##6##2##(1991-2#1)(1992-1#1)(1994-1#1)(2007-12#1)(2008-11#1)(2011-2#1)
of optode##2##2##(2008-10#2)
of optoelectronic devices by##2##4##(2007-12#2)
of optoelectronic devices##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
of optoelectronic##13##2##(2007-12#3)(2008-2#6)(2008-3#4)
of optokinetic##3##2##(2008-4#1)(2008-8#1)(2011-2#1)
of or the##2##3##(1995-9#1)(2007-8#1)
of or##6##2##(1991-9#1)(1995-9#1)(2007-8#1)(2008-7#1)(2009-12#1)(2013-7#1)
of oral administration of##2##4##(2008-10#1)(2008-11#1)
of oral administration##4##3##(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
of oral agents##2##3##(2010-5#1)(2010-6#1)
of oral and##5##3##(1991-12#1)(2007-11#1)(2007-7#1)(2010-10#1)(2012-3#1)
of oral anticoagulation##3##3##(1995-5#1)(1997-5#1)(2007-8#1)
of oral cancer in##2##4##(2007-2#1)(2013-1#1)
of oral cancer##4##3##(1992-9#1)(2007-2#1)(2013-1#2)
of oral care##2##3##(1997-4#1)(2012-2#1)
of oral cavity##5##3##(2009-5#1)(2010-12#1)(2011-7#1)(2013-1#2)
of oral contraceptives##7##3##(1990-6#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-9#1)(2008-11#2)
of oral corticosteroid therapy##2##4##(2008-1#1)(2008-11#1)
of oral diseases##3##3##(1991-6#1)(2008-1#2)
of oral granisetron##3##3##(2010-12#3)
of oral health##5##3##(1991-6#1)(2008-1#1)(2008-5#1)(2012-1#1)(2012-3#1)
of oral hypoglycemics##2##3##(1991-12#2)
of oral insulin##2##3##(2008-5#1)(2011-1#1)
of oral language and phonological awareness on##2##7##(2008-12#2)
of oral lesions##5##3##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
of oral lichen planus##3##4##(2008-4#2)(2013-1#1)
of oral lichen##4##3##(2008-4#3)(2013-1#1)
of oral midazolam##2##3##(2009-4#1)(2012-2#1)
of oral motor##2##3##(1993-12#2)
of oral nutritional supplements##2##4##(1995-2#2)
of oral polio vaccine##2##4##(1994-9#1)(2007-10#1)
of oral polio##3##3##(1994-9#1)(2007-10#2)
of oral presentations and##2##4##(2008-5#1)(2008-7#1)
of oral reading fluency##2##4##(2008-12#2)
of oral submucous fibrosis##3##4##(2013-1#3)
of oral tolerance##4##3##(2008-11#4)
of oral##145##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#11)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#11)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#15)(2013-8#1)
of orally administered##3##3##(1995-5#1)(2008-11#1)(2008-3#1)
of orbit##3##2##(2010-11#2)(2013-1#1)
of orbital##7##2##(2008-7#2)(2010-11#1)(2011-1#3)(2013-7#1)
of orchard##3##2##(2008-10#3)
of order##12##2##(2007-11#1)(2008-11#2)(2008-2#1)(2008-5#5)(2008-8#1)(2011-2#1)(2013-1#1)
of ordered arrays of##2##4##(2008-7#2)
of ordered##9##2##(1992-10#1)(1992-8#2)(2007-11#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-4#1)
of ordinal##5##2##(2008-10#4)(2008-9#1)
of ordinary##4##2##(1994-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
of organ donation##2##3##(2008-1#1)(2011-2#1)
of organ function##2##3##(1992-3#1)(2013-1#1)
of organ##21##2##(1990-11#1)(1992-3#1)(1994-6#1)(1994-7#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#2)
of organellar##2##2##(1995-2#1)(2012-3#1)
of organelles##13##2##(1994-8#1)(2008-11#1)(2008-4#6)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)
of organic acids in urine##2##5##(1994-9#2)
of organic acids in##4##4##(1990-8#1)(1994-9#3)
of organic acids was##2##4##(1994-9#1)(2008-10#1)
of organic acids##11##3##(1990-8#1)(1993-9#1)(1994-9#4)(2008-10#4)(2008-7#1)
of organic additives##2##3##(1994-9#1)(2008-10#1)
of organic ammonium##2##3##(2008-10#2)
of organic and inorganic##4##4##(2008-10#3)(2008-7#1)
of organic and##5##3##(2008-10#4)(2008-7#1)
of organic anions##2##3##(1992-3#1)(2008-11#1)
of organic carbon##4##3##(2008-10#4)
of organic compounds by##3##4##(2008-10#3)
of organic compounds from##3##4##(2008-10#3)
of organic compounds##17##3##(2007-11#1)(2008-10#15)(2008-7#1)
of organic contaminants in##2##4##(2008-10#2)
of organic dust##3##3##(1995-11#1)(1995-8#1)(2008-10#1)
of organic dyes##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
of organic ligands##3##3##(2008-10#3)
of organic matter##7##3##(2008-10#2)(2008-11#3)(2008-12#2)
of organic molecules##3##3##(2007-11#1)(2008-10#2)
of organic phase##2##3##(2008-10#2)
of organic phosphorus##3##3##(1995-11#1)(2008-10#2)
of organic pollutants##3##3##(2008-10#2)(2010-5#1)
of organic silicon##2##3##(2008-10#2)
of organic small molecules##3##4##(2008-10#3)
of organic solvent and##4##4##(2008-10#4)
of organic solvent##12##3##(2008-10#12)
of organic solvents in##2##4##(2008-10#2)
of organic solvents##13##3##(2008-10#9)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
of organic synthesis##2##3##(1997-4#1)(2008-10#1)
of organic thin films##3##4##(2008-3#3)
of organic##162##2##(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#5)(1995-11#3)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#3)(2007-11#2)(2007-12#1)(2008-10#96)(2008-11#9)(2008-12#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2010-5#2)(2011-2#2)(2012-2#3)(2013-1#1)
of organisational##2##2##(2007-10#1)(2008-12#1)
of organisations##3##2##(2007-2#2)(2013-1#1)
of organism##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
of organisms and##4##3##(2008-6#1)(2008-7#3)
of organisms in##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
of organisms to##7##3##(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)
of organisms##46##2##(1990-7#1)(1992-4#1)(1995-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#6)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#4)(2012-3#2)
of organization of##5##3##(2008-2#2)(2008-7#1)(2011-1#1)(2013-1#1)
of organization##17##2##(1990-5#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
of organizational and##2##3##(1992-12#1)(1994-12#1)
of organizational renewal##2##3##(1995-1#2)
of organizational##21##2##(1990-11#1)(1992-12#3)(1993-1#1)(1993-2#1)(1994-12#1)(1995-1#3)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2008-11#1)(2008-7#2)(2010-10#1)(2010-6#1)
of organizations involved##2##3##(1994-12#1)(2007-5#1)
of organizations that##2##3##(1991-3#1)(1995-3#1)
of organizations##9##2##(1991-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-2#1)(2007-5#1)(2012-3#1)
of organized##11##2##(1990-6#3)(1992-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#2)
of organochlorine pesticides##4##3##(1997-4#1)(2008-10#3)
of organochlorine##7##2##(1997-4#1)(2007-10#1)(2008-10#4)(2008-8#1)
of organogenesis##3##2##(2008-7#1)(2008-9#2)
of organomercurials##3##2##(2008-10#3)
of organometallic##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
of organophosphates##3##2##(1994-5#1)(2008-10#1)(2009-3#1)
of organophosphonate##2##2##(2008-10#2)
of organophosphorous pesticides in##3##4##(2008-10#1)(2013-1#2)
of organophosphorous pesticides##4##3##(2008-10#2)(2013-1#2)
of organophosphorous##7##2##(1994-5#1)(2008-10#2)(2010-5#2)(2013-1#2)
of organophosphorus and carbamate pesticides##2##5##(2008-10#2)
of organophosphorus pesticides in water##5##5##(2008-10#5)
of organophosphorus pesticides##11##3##(2008-10#11)
of organophosphorus##16##2##(2008-10#16)
of organotin compounds##3##3##(2008-10#3)
of organotin in##2##3##(2008-10#2)
of organotin##6##2##(2008-10#6)
of organotins##3##2##(2008-10#3)
of organs for##2##3##(1991-3#1)(2008-1#1)
of organs from##2##3##(1993-2#1)(2011-2#1)
of organs##14##2##(1991-2#1)(1991-3#2)(1993-2#2)(2006-10#1)(2008-1#1)(2008-5#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#1)
of oriLyt##4##2##(1997-3#4)
of oriental lacquer films##2##4##(2008-10#2)
of orientation and##2##3##(2008-10#1)(2008-8#1)
of orientation selectivity##2##3##(2008-11#1)(2008-8#1)
of orientation tuning##2##3##(2008-11#2)
of orientation##11##2##(1997-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#4)(2012-2#1)
of orientations##2##2##(2008-3#1)(2012-2#1)
of oriented##2##2##(2008-3#1)(2009-11#1)
of orienting##2##2##(1992-7#1)(1994-1#1)
of origin and the##2##4##(2008-10#1)(2013-7#1)
of origin and##5##3##(2008-10#2)(2010-3#1)(2012-12#1)(2013-7#1)
of origin in the##2##4##(2008-11#1)(2008-2#1)
of origin in##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#2)
of origin of primary##2##4##(1990-7#1)(2008-6#1)
of origin of the##3##4##(2008-10#2)(2012-12#1)
of origin of##15##3##(1990-7#2)(1995-2#1)(2008-10#5)(2008-6#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
of origin##62##2##(1990-7#2)(1992-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-2#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-3#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#8)(2013-7#1)
of original and##2##3##(2008-2#1)(2011-3#1)
of original##9##2##(1991-12#1)(1991-2#1)(1993-3#1)(2008-2#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-8#2)
of ornamental plants##2##3##(2008-10#2)
of ornamental##3##2##(2008-10#2)(2011-2#1)
of ornithine carbamoyl transferase##2##4##(2008-7#2)
of ornithine decarboxylase activity##2##4##(1992-9#1)(2008-10#1)
of ornithine##6##2##(1992-9#1)(2008-10#1)(2008-7#3)(2009-8#1)
of orofacial clefts##5##3##(2009-10#5)
of orofacial##10##2##(2007-2#1)(2008-5#1)(2008-6#1)(2009-10#5)(2009-2#1)(2013-1#1)
of oropharyngeal##6##2##(1996-2#3)(2007-12#1)(2008-8#2)
of orphan##3##2##(1996-5#1)(2008-7#1)(2013-1#1)
of orthodontic treatment with##2##4##(2010-3#1)(2013-1#1)
of orthodontic treatment##4##3##(2007-12#1)(2009-7#1)(2010-3#1)(2013-1#1)
of orthodontic##7##2##(2007-12#2)(2009-7#2)(2010-3#1)(2013-1#2)
of orthodontics and##2##3##(2012-3#1)(2013-1#1)
of orthodontics##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
of orthogonal films##2##3##(2009-11#2)
of orthogonal polarization##3##3##(2007-12#2)(2008-3#1)
of orthogonal##12##2##(1990-5#1)(2007-12#6)(2008-11#1)(2008-3#1)(2009-11#2)(2009-12#1)
of orthologous##2##2##(1993-12#1)(1994-6#1)
of orthopaedic##8##2##(1996-3#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-12#1)(2011-2#1)
of orthopedic surgery##5##3##(2011-2#5)
of orthopedic##10##2##(2007-11#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-2#6)
of orthophosphate and total phosphates##2##5##(2008-10#2)
of orthophosphate and total##4##4##(2008-10#4)
of orthophosphate in##4##3##(2008-10#4)
of orthophosphate##10##2##(2008-10#10)
of orthostatic##2##2##(2009-6#2)
of orthotic##5##2##(2007-11#2)(2007-8#2)(2010-3#1)
of orthotopic##2##2##(1991-11#1)(2008-5#1)
of oscillating##3##2##(2007-12#2)(2011-2#1)
of oscillation##3##2##(1994-6#1)(2008-11#1)(2008-3#1)
of oscillations##7##2##(1990-8#2)(2008-7#3)(2008-8#1)(2010-10#1)
of oscillatory##2##2##(2008-7#2)
of osmium tetroxide##2##3##(2008-10#1)(2008-7#1)
of osmium##7##2##(2008-10#6)(2008-7#1)
of osmolarity##3##2##(1991-11#1)(2008-11#2)
of osmotic##11##2##(1992-8#1)(1994-8#1)(2008-11#7)(2009-12#1)(2011-1#1)
of osmotin##2##2##(2008-10#1)(2008-8#1)
of osseous##4##2##(2008-1#1)(2009-3#1)(2010-3#1)(2013-1#1)
of osteoarthritis (OA)##2##3##(2007-11#1)(2012-1#1)
of osteoarthritis of the knee##2##5##(2011-2#1)(2013-1#1)
of osteoarthritis##12##2##(2007-11#3)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
of osteoarticular##2##2##(2007-8#1)(2008-6#1)
of osteoblast metabolism##2##3##(2008-11#2)
of osteoblast proliferation##2##3##(1991-12#1)(2008-11#1)
of osteoblast##6##2##(1991-12#2)(2008-11#3)(2008-8#1)
of osteoblastic MC3T3-E1 cells##4##4##(1991-12#2)(1997-1#2)
of osteoblastic cells##2##3##(2008-11#2)
of osteoblastic##8##2##(1990-12#1)(1991-12#2)(1997-1#2)(2008-11#2)(2008-7#1)
of osteoblasts##4##2##(1990-11#1)(1997-1#1)(2008-11#1)(2013-1#1)
of osteocalcin by##2##3##(1990-2#2)
of osteocalcin synthesis in response to##2##6##(1990-2#2)
of osteocalcin synthesis##3##3##(1990-2#3)
of osteocalcin##10##2##(1990-2#7)(1993-3#1)(2008-11#1)(2008-7#1)
of osteoclast and osteoblast##2##4##(1991-12#1)(2007-8#1)
of osteoclast differentiation##2##3##(1993-8#1)(2011-2#1)
of osteoclast##5##2##(1991-12#1)(1993-8#1)(2007-8#1)(2011-2#2)
of osteoclastic bone resorption##3##4##(1992-3#2)(1993-6#1)
of osteoclastic##5##2##(1992-3#2)(1993-6#1)(2008-11#1)(2008-5#1)
of osteoclasts##9##2##(1991-11#1)(1993-8#1)(1997-7#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
of osteogenic sarcoma of the##2##5##(1996-6#1)(2011-2#1)
of osteogenic##10##2##(1996-6#1)(2008-11#5)(2011-2#2)(2012-1#1)(2012-2#1)
of osteoid osteoma##3##3##(2007-11#1)(2008-8#2)
of osteoid##5##2##(2007-11#2)(2008-6#1)(2008-8#2)
of osteolysis##2##2##(2013-1#2)
of osteolytic##3##2##(1997-6#1)(2007-11#1)(2008-7#1)
of osteomyelitis defects##3##3##(2010-6#3)
of osteomyelitis##17##2##(2009-6#1)(2010-6#15)(2012-2#1)
of osteonecrosis and##2##3##(1994-7#2)
of osteonecrosis of the jaw##2##5##(2008-7#2)
of osteonecrosis of the##3##4##(2008-7#2)(2009-3#1)
of osteonecrosis##5##2##(1994-7#2)(2008-7#2)(2009-3#1)
of osteopenia and##2##3##(2007-8#2)
of osteopontin in##2##3##(2008-7#1)(2010-11#1)
of osteopontin##5##2##(2008-7#3)(2009-7#1)(2010-11#1)
of osteoporosis and##6##3##(1993-11#1)(1994-7#1)(1994-9#1)(1996-6#1)(2007-11#1)(2012-12#1)
of osteoporosis in the##3##4##(1996-6#1)(2008-8#1)(2010-3#1)
of osteoporosis in##11##3##(1993-11#1)(1996-6#1)(2007-11#1)(2008-7#4)(2008-8#1)(2010-3#3)
of osteoporosis is##3##3##(2007-11#1)(2008-7#1)(2010-3#1)
of osteoporosis or osteopenia##2##4##(2008-8#1)(2012-2#1)
of osteoporosis##67##2##(1990-11#1)(1991-11#3)(1993-11#12)(1994-7#1)(1994-9#1)(1996-11#1)(1996-6#3)(1997-6#4)(1997-7#1)(1997-8#1)(2007-11#6)(2007-8#5)(2008-11#1)(2008-4#3)(2008-6#2)(2008-7#5)(2008-8#5)(2010-3#10)(2012-12#1)(2012-2#1)
of osteoporotic bone##2##3##(1992-6#1)(2011-2#1)
of osteoporotic vertebral fractures##3##4##(1991-11#1)(2007-8#2)
of osteoporotic vertebral##5##3##(1991-11#1)(2007-11#1)(2007-8#3)
of osteoporotic##12##2##(1991-11#1)(1992-6#1)(2007-11#3)(2007-8#4)(2008-11#1)(2011-2#1)(2013-1#1)
of osteoprotegerin (OPG) on##2##4##(2008-12#2)
of osteoprotegerin (OPG)##4##3##(2008-12#2)(2013-1#1)(2013-8#1)
of osteoprotegerin##6##2##(2007-8#1)(2008-12#2)(2013-1#2)(2013-8#1)
of osteosarcoma in the##2##4##(2010-3#1)(2013-1#1)
of osteosarcoma in##3##3##(2010-3#2)(2013-1#1)
of osteosarcoma is##2##3##(2008-6#1)(2010-3#1)
of osteosarcoma patients##2##3##(2010-3#2)
of osteosarcoma##38##2##(1993-12#1)(2008-6#2)(2008-8#1)(2010-3#33)(2013-1#1)
of osteotomies##2##2##(1996-6#1)(2012-2#1)
of osteotomy##2##2##(2007-8#2)
of ostriches (Struthio camelus)##2##4##(1996-8#1)(2013-1#1)
of other DNA##2##3##(2008-5#1)(2008-9#1)
of other OECD countries##2##4##(1993-2#1)(1996-3#1)
of other amino##2##3##(2008-10#2)
of other animals##2##3##(2008-4#1)(2008-8#1)
of other authors##4##3##(1990-2#1)(2007-8#1)(2008-5#1)(2013-8#1)
of other bacteria was##2##4##(2008-10#2)
of other bacterial species##2##4##(1994-12#1)(2008-5#1)
of other bacterial##3##3##(1994-12#1)(2008-5#1)(2009-6#1)
of other begomoviruses##2##3##(2008-10#2)
of other cancers##3##3##(2009-12#1)(2011-2#1)(2011-3#1)
of other cations##5##3##(2008-10#5)
of other cell types##4##4##(1992-10#1)(1996-5#1)(2008-11#1)(2008-7#1)
of other cell##6##3##(1992-10#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
of other closteroviruses##3##3##(2008-10#3)
of other common##2##3##(2008-10#2)
of other components of the##2##5##(2008-3#1)(2008-8#1)
of other components##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
of other conditions##4##3##(2007-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
of other contaminants##2##3##(2008-10#2)
of other countries##3##3##(1990-6#1)(1993-6#1)(1994-2#1)
of other cytokines##3##3##(1996-2#1)(2008-4#2)
of other data##2##3##(1994-12#1)(2008-3#1)
of other diseases in##2##4##(1993-12#1)(1997-7#1)
of other diseases##8##3##(1992-6#1)(1993-12#1)(1997-3#1)(1997-7#2)(2008-7#2)(2010-8#1)
of other drugs##4##3##(1991-1#1)(2008-10#1)(2008-8#1)(2010-3#1)
of other enzymes##2##3##(1992-4#1)(2011-1#1)
of other existing##2##3##(2008-3#1)(2009-12#1)
of other factors such as##2##5##(2008-5#2)
of other factors##4##3##(1993-2#1)(2008-10#1)(2008-5#2)
of other fungi##2##3##(2008-10#2)
of other genes in##2##4##(2008-6#1)(2008-7#1)
of other genes##5##3##(1992-10#1)(2008-6#1)(2008-7#2)(2009-8#1)
of other groups of##3##4##(1995-12#1)(2008-6#1)(2011-1#1)
of other groups##4##3##(1995-12#1)(2008-6#1)(2011-1#1)(2012-3#1)
of other health##2##3##(1991-6#1)(2010-8#1)
of other inorganic##3##3##(2008-10#2)(2010-12#1)
of other ions in the##3##5##(2008-10#2)(2008-6#1)
of other ions in##4##4##(2008-10#3)(2008-6#1)
of other ions##8##3##(2008-10#7)(2008-6#1)
of other isoforms##2##3##(1992-3#1)(2010-12#1)
of other known##4##3##(1990-2#1)(1995-2#1)(1997-6#1)(2008-5#1)
of other major##2##3##(2008-3#1)(2012-2#1)
of other males##2##3##(2008-8#1)(2009-6#1)
of other mammals##3##3##(1992-11#1)(1992-12#1)(1995-6#1)
of other materials##2##3##(1990-2#1)(2007-12#1)
of other members of the##2##5##(2008-10#1)(2008-5#1)
of other metal ions##8##4##(2008-10#8)
of other metal##9##3##(2008-10#9)
of other metals##2##3##(2008-10#2)
of other microbes##2##3##(2008-10#1)(2008-5#1)
of other mutants##2##3##(1995-6#1)(2008-8#1)
of other natural##2##3##(2008-8#1)(2013-1#1)
of other neurons##2##3##(1997-3#1)(2008-11#1)
of other organisms##2##3##(1993-9#1)(1995-12#1)
of other organs##2##3##(2008-10#1)(2013-1#1)
of other people##2##3##(2008-6#1)(2009-6#1)
of other peptide##2##3##(1993-5#1)(2008-10#1)
of other plants##2##3##(2008-10#1)(2008-8#1)
of other possible##2##3##(1991-8#1)(2008-7#1)
of other potential##3##3##(2008-3#1)(2011-2#1)(2013-7#1)
of other protein##3##3##(1991-12#1)(1996-12#1)(2008-7#1)
of other proteins##7##3##(1993-11#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#2)
of other rare earths##2##4##(2008-10#2)
of other rare##3##3##(2008-10#2)(2008-2#1)
of other recombinant##2##3##(2008-11#1)(2008-4#1)
of other sites##3##3##(1991-12#1)(1992-12#1)(2010-11#1)
of other small##3##3##(1993-11#1)(1997-4#1)(2008-8#1)
of other species##9##3##(1993-6#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
of other studies##4##3##(1994-2#1)(2008-11#1)(2008-2#1)(2012-3#1)
of other subjects##2##3##(2008-10#2)
of other substances##4##3##(2008-10#4)
of other symptoms##2##3##(2009-1#1)(2013-7#1)
of other tissue##2##3##(2008-5#1)(2010-6#1)
of other tissues##2##3##(1997-8#1)(2008-6#1)
of other tumors##2##3##(2007-4#1)(2012-1#1)
of other types of##2##4##(1994-2#1)(2010-12#1)
of other types##3##3##(1994-2#1)(2008-2#1)(2010-12#1)
of other##535##2##(1990-11#4)(1990-12#2)(1990-2#6)(1990-3#4)(1990-5#2)(1990-6#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#6)(1994-2#5)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#5)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#2)(2006-10#2)(2007-10#4)(2007-11#4)(2007-12#11)(2007-4#1)(2007-8#2)(2008-1#5)(2008-10#136)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#14)(2008-5#19)(2008-6#7)(2008-7#17)(2008-8#17)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#4)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#3)(2010-8#5)(2011-1#7)(2011-2#13)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#3)(2013-7#5)(2013-8#4)
of others is##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
of others##28##2##(1990-5#1)(1991-2#1)(1991-7#1)(1993-6#1)(1994-1#1)(1995-3#1)(1996-3#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-9#2)(2011-1#1)(2013-8#1)
of otherwise##6##2##(1994-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)
of otitis media in##2##4##(1991-3#1)(2008-7#1)
of otitis media##4##3##(1991-3#2)(2008-7#1)(2008-9#1)
of otolith calcium carbonate##2##4##(2008-10#2)
of ototoxicity##3##2##(2007-7#3)
of our analysis##5##3##(1997-5#1)(2007-11#1)(2007-8#1)(2010-12#1)(2012-3#1)
of our approach is that##2##5##(2008-8#1)(2009-8#1)
of our approach is##3##4##(2007-11#1)(2008-8#1)(2009-8#1)
of our approach##11##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-8#2)(2010-8#1)(2012-2#1)
of our case study##2##4##(1991-12#1)(1991-3#1)
of our case##5##3##(1991-12#1)(1991-3#1)(2007-10#1)(2009-3#1)(2013-1#1)
of our clinical##2##3##(1997-2#1)(2013-1#1)
of our combined experience##2##4##(1991-12#1)(2008-8#1)
of our comparative##2##3##(1994-11#1)(2008-10#1)
of our current##3##3##(2008-4#1)(2013-8#2)
of our data with##2##4##(2008-10#1)(2008-12#1)
of our data##5##3##(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)
of our efforts##2##3##(2007-8#1)(2008-10#1)
of our experience##6##3##(1991-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
of our findings##9##3##(1990-6#1)(1996-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
of our first##3##3##(2008-3#1)(2008-9#1)(2012-12#1)
of our four##2##3##(2009-10#1)(2012-2#1)
of our health care system##3##5##(1997-2#1)(2008-1#1)(2008-4#1)
of our health care##4##4##(1994-1#1)(1997-2#1)(2008-1#1)(2008-4#1)
of our health##5##3##(1994-1#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-4#1)
of our hospital##3##3##(2010-9#1)(2013-1#2)
of our individual##2##3##(2008-10#1)(2011-2#1)
of our investigation##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
of our investigations##2##3##(2008-10#1)(2008-11#1)
of our knowledge about##3##4##(1997-8#1)(2008-7#1)(2010-5#1)
of our knowledge of the##2##5##(2006-12#1)(2008-4#1)
of our knowledge of##4##4##(2006-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
of our knowledge##52##3##(1991-9#1)(1994-12#1)(1995-5#1)(1997-8#1)(2006-12#1)(2007-11#4)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
of our measurements##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
of our method for the##2##5##(1991-2#1)(2008-3#1)
of our method##9##3##(1991-2#1)(2007-11#1)(2007-12#3)(2008-3#3)(2013-1#1)
of our methodology##2##3##(2008-3#2)
of our model##6##3##(1993-8#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-1#1)
of our new##2##3##(2010-12#1)(2013-1#1)
of our original##3##3##(2007-8#1)(2008-10#1)(2010-6#1)
of our own##7##3##(1993-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
of our patient##3##3##(2010-7#1)(2011-1#1)(2013-1#1)
of our patients with##3##4##(1996-3#1)(2006-10#1)(2008-8#1)
of our patients##19##3##(1990-6#1)(1991-3#1)(1992-5#1)(1996-3#1)(2006-10#2)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-5#1)(2010-8#1)(2013-1#2)(2013-8#1)
of our previous##6##3##(1992-12#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#1)
of our profession##5##3##(1993-12#1)(1994-12#1)(1995-1#1)(2008-4#1)(2012-2#1)
of our program##2##3##(1994-9#1)(2011-2#1)
of our recent work##2##4##(1994-11#1)(2007-5#1)
of our recent##5##3##(1994-11#1)(2007-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
of our research was to evaluate the##3##7##(2007-11#1)(2007-8#2)
of our research was to##6##5##(1990-5#1)(1990-6#1)(2007-11#1)(2007-8#2)(2013-1#1)
of our research##10##3##(1990-5#1)(1990-6#1)(1994-5#1)(2007-11#1)(2007-8#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
of our results##8##3##(1994-5#1)(1997-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
of our sample##2##3##(2008-11#1)(2011-2#1)
of our samples##2##3##(2008-10#1)(2008-12#1)
of our scientific##2##3##(1993-6#1)(2012-1#1)
of our screening program##2##4##(2007-11#1)(2008-10#1)
of our society##2##3##(1995-11#1)(2007-8#1)
of our structural##2##3##(1991-9#1)(2012-12#1)
of our studies##2##3##(2008-12#1)(2008-5#1)
of our study is##8##4##(2007-11#1)(2008-11#2)(2009-3#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
of our study show##3##4##(2008-1#1)(2008-11#1)(2008-3#1)
of our study showed that##2##5##(2008-7#1)(2011-2#1)
of our study was to evaluate the##5##7##(1991-3#1)(1997-8#2)(2011-2#1)(2012-3#1)
of our study was to evaluate##9##6##(1991-3#1)(1997-8#3)(2007-8#2)(2008-7#1)(2011-2#1)(2012-3#1)
of our study was to examine##2##6##(2011-1#1)(2012-3#1)
of our study was to##32##5##(1991-3#1)(1997-8#3)(2007-8#7)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#2)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
of our study was##34##4##(1990-5#1)(1991-3#1)(1997-8#3)(2007-8#8)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#2)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
of our study were##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
of our study##67##3##(1990-5#1)(1991-3#2)(1992-12#1)(1997-8#3)(2007-11#1)(2007-8#8)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-1#5)(2011-2#6)(2011-7#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#1)
of our theoretical##2##3##(2008-3#2)
of our treatment##3##3##(1990-9#1)(2007-8#1)(2009-6#1)
of our understanding of##5##4##(2007-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-3#1)
of our work##3##3##(2008-1#1)(2008-5#1)(2012-2#1)
of our##473##2##(1990-3#1)(1990-5#2)(1990-6#3)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#5)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#2)(1997-8#7)(2006-10#3)(2006-12#2)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#8)(2007-5#2)(2007-7#4)(2007-8#20)(2008-1#9)(2008-10#28)(2008-11#17)(2008-12#7)(2008-2#15)(2008-3#32)(2008-4#5)(2008-5#6)(2008-6#9)(2008-7#21)(2008-8#16)(2008-9#8)(2009-10#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#9)(2011-2#22)(2011-7#1)(2012-1#3)(2012-12#8)(2012-2#16)(2012-3#7)(2012-6#1)(2013-1#28)(2013-7#2)(2013-8#6)
of out-of-plane##2##2##(2008-2#1)(2008-3#1)
of out-patient pulmonary rehabilitation##3##4##(2011-2#3)
of out-patient##5##2##(1990-2#1)(2008-1#1)(2011-2#3)
of outbreaks of##2##3##(2008-5#1)(2010-4#1)
of outbreaks##10##2##(1997-3#1)(2008-5#1)(2009-2#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
of outcome in##2##3##(2007-10#1)(2013-1#1)
of outcome measures##8##3##(1996-1#1)(1996-3#2)(2007-11#2)(2008-11#2)(2008-12#1)
of outcome of##4##3##(1996-11#1)(2008-6#2)(2011-2#1)
of outcome with##2##3##(1992-10#1)(2007-12#1)
of outcome##39##2##(1992-10#1)(1992-9#2)(1993-1#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)
of outcomes and##2##3##(1995-12#1)(2009-2#1)
of outcomes information##2##3##(1996-1#1)(1996-2#1)
of outcomes management##2##3##(1993-3#1)(1994-11#1)
of outcomes research in##2##4##(2008-8#1)(2008-9#1)
of outcomes research##5##3##(1994-11#2)(1994-12#1)(2008-8#1)(2008-9#1)
of outcomes##17##2##(1993-3#1)(1994-11#3)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-3#1)
of outcrossing##3##2##(2008-10#2)(2008-9#1)
of outdoor aeroallergens##2##3##(2008-5#2)
of outdoor##3##2##(2008-5#3)
of outer and inner##2##4##(2008-2#1)(2008-3#1)
of outer##9##2##(1991-2#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
of outgroup##2##2##(2012-3#2)
of outgrowth##2##2##(2011-2#2)
of outlier data##3##3##(2008-10#3)
of outlier##7##2##(1993-9#1)(2008-10#5)(2009-8#1)
of outliers##4##2##(1991-12#1)(2008-10#3)
of outpatient care##2##3##(1993-12#1)(1994-3#1)
of outpatient chemotherapy##2##3##(2010-2#2)
of outpatient services##3##3##(1993-2#1)(1994-12#1)(1995-3#1)
of outpatient##24##2##(1991-3#1)(1992-1#1)(1993-12#3)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-2#2)(2010-5#1)(2012-2#1)
of outpatients##3##2##(1993-11#1)(2011-2#1)(2012-12#1)
of output power##8##3##(2007-11#2)(2007-12#2)(2008-2#3)(2011-1#1)
of output##20##2##(1992-2#1)(1993-3#1)(1994-12#1)(2007-11#2)(2007-12#4)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2011-1#1)
of outside##3##2##(1996-12#1)(1996-3#1)(2008-5#1)
of outsourcing##2##2##(2008-1#1)(2012-3#1)
of ova##3##2##(1996-12#2)(2013-1#1)
of ovarian cancer patients##2##4##(1991-4#1)(1992-9#1)
of ovarian cancer##23##3##(1990-12#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-9#5)(1994-6#1)(1994-9#1)(1996-11#1)(2008-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#4)
of ovarian carcinoma##4##3##(1991-8#1)(2010-7#1)(2013-1#2)
of ovarian tumor##2##3##(2007-12#1)(2008-4#1)
of ovarian tumors##2##3##(1990-6#1)(1994-7#1)
of ovarian##51##2##(1990-12#1)(1990-6#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-9#6)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1996-1#3)(1996-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#5)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
of ovariectomized##2##2##(1992-5#1)(1992-8#1)
of ovary##4##2##(2008-10#1)(2011-1#1)(2013-1#2)
of over 100##2##3##(1996-8#1)(2008-10#1)
of over 30##3##3##(1993-2#1)(2010-3#1)(2011-2#1)
of over 4##2##3##(1997-6#1)(2008-1#1)
of over 60##2##3##(2010-3#1)(2011-2#1)
of over 90##2##3##(2008-4#1)(2009-5#1)
of over##47##2##(1990-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-8#2)(1997-5#1)(1997-6#2)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-7#5)(2009-5#1)(2009-8#1)(2010-3#4)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#1)
of over-expression##2##2##(2008-11#2)
of over-the-counter##2##2##(2010-8#1)(2010-9#1)
of overactive bladder in##2##4##(2008-10#1)(2011-1#1)
of overactive bladder##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
of overall complications and##2##4##(2013-1#2)
of overall service quality##3##4##(1995-3#3)
of overall success##2##3##(2012-12#2)
of overall survival##3##3##(1991-4#1)(2010-3#1)(2011-2#1)
of overall##31##2##(1991-4#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#3)(1996-12#1)(1996-3#1)(1996-7#1)(1997-5#1)(2008-10#2)(2008-2#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)
of overcoming##5##2##(1995-3#1)(2008-10#1)(2008-11#2)(2013-8#1)
of overdominance##2##2##(2008-10#2)
of overexpression of##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
of overexpression##4##2##(1995-6#1)(2008-11#1)(2009-8#1)(2011-2#1)
of overhead##2##2##(2008-10#1)(2008-3#1)
of overlap between##2##3##(2007-12#1)(2008-4#1)
of overlap in##2##3##(2008-9#1)(2010-4#1)
of overlap##6##2##(1994-3#1)(2007-12#2)(2008-4#1)(2008-9#1)(2010-4#1)
of overlapping genes in bacteriophage T4##2##6##(1997-7#2)
of overlapping peaks##3##3##(2008-10#3)
of overlapping##15##2##(1992-12#1)(1993-8#1)(1995-5#1)(1997-7#2)(2008-10#6)(2008-2#1)(2008-7#2)(2011-2#1)
of overload##2##2##(1990-9#1)(2012-3#1)
of overpotential##2##2##(2008-10#2)
of overproduction##2##2##(1997-4#1)(2008-6#1)
of overt##3##2##(1990-3#1)(2009-1#1)(2011-2#1)
of overtraining##3##2##(1993-2#2)(2008-5#1)
of overweight and obesity among##3##5##(2011-1#1)(2011-2#1)(2012-12#1)
of overweight and obesity in Turkey##2##6##(2008-3#2)
of overweight and obesity in##4##5##(2008-3#2)(2012-12#1)(2012-3#1)
of overweight and obesity##13##4##(2008-3#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)
of overweight and##15##3##(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-8#1)
of overweight##24##2##(1990-9#1)(1993-9#1)(2008-10#2)(2008-3#6)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
of overwhelming##2##2##(2007-5#1)(2008-4#1)
of overwintering##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
of ovigerous females##3##3##(2013-7#3)
of ovine##5##2##(1994-8#1)(1996-12#1)(1997-3#1)(2010-12#1)(2011-1#1)
of oviposition##4##2##(2007-12#2)(2009-6#1)(2011-2#1)
of ovulation##2##2##(2008-9#1)(2011-1#1)
of ovules##2##2##(2008-5#1)(2009-12#1)
of own##3##2##(1992-6#1)(1993-12#1)(1996-6#1)
of ownership and##2##3##(1995-2#1)(2008-12#1)
of ownership of##2##3##(1993-2#1)(2008-10#1)
of ownership##6##2##(1993-2#1)(1995-2#2)(2008-10#1)(2008-12#1)(2008-7#1)
of oxalate and##2##3##(1990-12#1)(2008-10#1)
of oxalate##17##2##(1990-12#2)(1992-6#1)(2008-10#11)(2012-2#3)
of oxalic acid in urine##3##5##(1990-8#1)(2008-10#2)
of oxalic acid##7##3##(1990-8#1)(2008-10#3)(2012-2#1)(2013-1#2)
of oxaliplatin##3##2##(2008-3#2)(2008-5#1)
of oxidant##5##2##(1995-3#1)(2008-10#3)(2010-5#1)
of oxidants##3##2##(1991-9#1)(2008-1#1)(2008-10#1)
of oxidase##3##2##(1991-2#1)(2008-10#2)
of oxidation agent##2##3##(2008-10#2)
of oxidation is##2##3##(2008-10#2)
of oxidation of##8##3##(1990-5#1)(2008-10#5)(2008-12#1)(2013-1#1)
of oxidation products##2##3##(2008-10#2)
of oxidation##23##2##(1990-5#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-5#1)(2013-1#1)
of oxidative DNA damage in##2##5##(1994-6#1)(2008-10#1)
of oxidative damage of##2##4##(2008-10#1)(2008-4#1)
of oxidative damage to##2##4##(2008-1#1)(2013-8#1)
of oxidative damage##11##3##(1991-9#1)(1997-4#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2013-8#1)
of oxidative modification of##3##4##(2008-1#1)(2008-10#1)(2009-8#1)
of oxidative modification##4##3##(2008-1#2)(2008-10#1)(2009-8#1)
of oxidative phosphorylation##5##3##(1994-12#1)(2008-7#2)(2012-3#1)(2013-8#1)
of oxidative stress and##4##4##(2008-10#1)(2008-9#1)(2009-11#1)(2012-12#1)
of oxidative stress in their##2##5##(2008-11#1)(2013-8#1)
of oxidative stress in##6##4##(2008-1#1)(2008-11#2)(2009-12#1)(2010-12#1)(2013-8#1)
of oxidative stress markers##2##4##(2012-5#1)(2013-1#1)
of oxidative stress##38##3##(1991-9#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#9)(2008-7#3)(2008-9#2)(2009-11#2)(2009-12#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#2)
of oxidative##72##2##(1990-5#1)(1991-9#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-3#1)(1997-4#2)(2008-1#6)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#10)(2008-7#6)(2008-9#2)(2009-11#2)(2009-12#3)(2009-6#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#4)
of oxidatively##2##2##(1995-2#1)(2008-7#1)
of oxide##2##2##(2008-10#1)(2008-3#1)
of oxidizable##7##2##(2008-10#7)
of oxidized LDL in##2##4##(1991-2#1)(1996-2#1)
of oxidized##18##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-5#3)(1994-8#1)(1996-2#2)(2008-10#3)(2008-11#1)(2010-12#1)(2013-1#1)
of oxidizing##4##2##(1992-9#1)(2008-1#1)(2008-10#1)(2011-1#1)
of oxolinic acid##2##3##(2008-10#2)
of oxotremorine##2##2##(1993-12#2)
of oxy-##2##2##(1991-2#1)(2007-10#1)
of oxychlorine species##4##3##(2008-10#4)
of oxygen affinity##2##3##(1990-8#2)
of oxygen and##10##3##(1995-12#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-6#1)
of oxygen at##2##3##(2008-2#1)(2013-7#1)
of oxygen binding to the##2##5##(1990-8#1)(1993-8#1)
of oxygen binding to##3##4##(1990-8#2)(1993-8#1)
of oxygen consumption during##2##4##(2008-10#1)(2008-3#1)
of oxygen consumption in##2##4##(1997-1#1)(2008-7#1)
of oxygen consumption##9##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#2)
of oxygen demand##2##3##(2008-6#2)
of oxygen deprivation##2##3##(1992-3#1)(2008-10#1)
of oxygen free radicals##2##4##(1996-9#1)(2008-4#1)
of oxygen in##4##3##(1995-8#1)(2008-10#2)(2008-3#1)
of oxygen is##2##3##(2008-10#1)(2008-5#1)
of oxygen on##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
of oxygen partial pressure on##2##5##(2008-11#2)
of oxygen radicals##3##3##(1991-9#1)(1993-8#1)(1994-11#1)
of oxygen to##4##3##(1995-2#1)(2008-10#1)(2008-3#2)
of oxygen uptake and carbon dioxide production rates##2##8##(2008-11#2)
of oxygen uptake and carbon dioxide##5##6##(2008-11#5)
of oxygen uptake reserve##5##4##(2013-8#5)
of oxygen uptake##14##3##(2008-11#6)(2008-12#1)(2013-8#7)
of oxygen with##2##3##(2008-10#1)(2009-2#1)
of oxygen##123##2##(1990-5#1)(1990-8#6)(1991-2#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#28)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2010-11#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#8)
of oxygen-17##3##2##(1990-5#3)
of oxygen-derived free radicals##5##4##(2008-10#1)(2010-10#1)(2010-3#3)
of oxygen-evolving##2##2##(1996-10#1)(2008-8#1)
of oxygenated##2##2##(2008-12#1)(2011-1#1)
of oxygenation##7##2##(1990-8#1)(1995-5#1)(1995-9#1)(1997-2#1)(2008-11#1)(2008-8#1)(2012-3#1)
of oxyhemoglobin##3##2##(1990-8#1)(1995-5#1)(1997-2#1)
of oxytetracycline and metronidazole##2##4##(1996-6#2)
of oxytetracycline##3##2##(1996-6#2)(2008-10#1)
of oxytocin and##2##3##(1994-11#1)(1997-4#1)
of oxytocin##7##2##(1991-2#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-11#1)(1997-4#2)
of ozonation##2##2##(2008-10#2)
of ozone as##2##3##(2008-10#2)
of ozone in##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
of ozone on##2##3##(1992-3#1)(2008-5#1)
of ozone profiles obtained##2##4##(2008-2#1)(2008-3#1)
of ozone##33##2##(1991-5#1)(1991-9#2)(1992-3#4)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2012-2#2)(2013-8#1)
of p##11##2##(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2013-1#1)
of p-NF-kBp65 (Ser 536)##3##4##(2010-3#3)
of p-NF-kBp65##4##2##(2010-3#4)
of p-cresol##4##2##(2008-10#1)(2011-2#3)
of p-phenylenediamine##2##2##(2008-10#2)
of p-substituted N-phenylsulfonylbenzamides##2##3##(2007-11#2)
of p-toluenesulfonic acid##2##3##(2008-5#1)(2009-9#1)
of p130Cas##2##2##(2011-1#2)
of p150Glued##2##2##(1995-2#2)
of p16##2##2##(1997-7#1)(2011-2#1)
of p16INK4a##2##2##(1997-7#2)
of p185HER2-overexpressing##2##2##(1995-2#2)
of p21##4##2##(1991-12#2)(1997-7#2)
of p21ras##4##2##(1992-12#3)(1994-12#1)
of p27##2##2##(2011-2#1)(2012-12#1)
of p33CDK2##2##2##(1997-1#2)
of p34##2##2##(1994-8#2)
of p38##3##2##(2008-7#2)(2011-2#1)
of p53 and NF-B##2##4##(2010-10#2)
of p53 and##8##3##(1993-8#1)(1994-7#1)(2008-9#1)(2010-10#2)(2011-2#1)(2013-1#2)
of p53 expression##2##3##(1994-7#1)(2012-1#1)
of p53 in the##2##4##(1992-12#1)(2012-1#1)
of p53 in##8##3##(1992-12#1)(1993-9#1)(1997-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
of p53 may##2##3##(1994-12#1)(2009-5#1)
of p53 on##2##3##(1993-9#1)(2012-1#1)
of p53 or##2##3##(1994-12#1)(2010-10#1)
of p53 protein##5##3##(1992-3#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-8#1)
of p53##68##2##(1991-5#2)(1992-12#4)(1992-3#1)(1993-8#1)(1993-9#4)(1994-12#5)(1994-5#1)(1994-7#2)(1994-9#1)(1995-2#2)(1995-9#1)(1997-7#3)(2007-8#3)(2008-10#6)(2008-5#4)(2008-7#1)(2008-9#4)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#4)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of p53-mediated##2##2##(1994-12#1)(1997-7#1)
of p56lck##2##2##(1991-11#1)(1993-3#1)
of p63##2##2##(1993-8#1)(2011-2#1)
of p65##4##2##(1995-6#4)
of p72syk##6##2##(1992-6#3)(1993-11#3)
of p75##2##2##(1995-8#2)
of pAB##2##2##(1992-5#2)
of pBR322##2##2##(1990-11#1)(1990-5#1)
of pDNA##2##2##(2013-1#2)
of pH 2 and##2##4##(1990-8#2)
of pH 2##10##3##(1990-8#2)(2008-10#8)
of pH 3##3##3##(2008-10#3)
of pH 4##7##3##(1990-5#1)(1997-4#3)(2008-10#2)(2012-9#1)
of pH 5##4##3##(2008-10#4)
of pH 6##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
of pH 7##4##3##(2008-10#4)
of pH 8##3##3##(2008-10#2)(2011-1#1)
of pH and ionic strength##3##5##(1993-11#1)(2008-7#1)(2013-1#1)
of pH and of##2##4##(2008-10#2)
of pH and temperature##4##4##(1995-2#1)(2008-10#2)(2008-5#1)
of pH and the concentration of##2##6##(1996-5#1)(2008-10#1)
of pH and##24##3##(1993-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
of pH from##5##3##(1994-6#1)(2008-10#4)
of pH has##2##3##(2008-10#2)
of pH in##9##3##(2008-10#6)(2008-5#1)(2008-8#1)(2010-8#1)
of pH of the##3##4##(2008-10#3)
of pH of##6##3##(2008-10#6)
of pH on the##7##4##(2008-10#3)(2008-5#2)(2008-8#1)(2011-2#1)
of pH on##14##3##(1991-5#2)(1994-6#1)(2008-10#5)(2008-5#3)(2008-6#1)(2008-8#1)(2011-2#1)
of pH values##5##3##(1992-8#2)(2008-10#3)
of pH##180##2##(1990-5#2)(1990-7#2)(1990-8#5)(1991-5#3)(1991-9#1)(1992-8#2)(1993-11#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#3)(2008-10#123)(2008-11#1)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
of pH-metric##2##2##(2008-10#2)
of pH-sensitive##2##2##(1997-1#1)(2008-10#1)
of pHi##2##2##(1994-6#2)
of pIGFBP-4##3##2##(1991-12#3)
of pK##3##2##(1990-8#1)(1991-9#1)(2008-9#1)
of pK(a) values##2##3##(2008-10#2)
of pK(a)##4##2##(2008-10#3)(2009-9#1)
of pKa values##2##3##(1994-9#1)(2007-11#1)
of pMLZ-4##2##2##(1993-2#2)
of pOCs into##2##3##(2008-11#2)
of pOCs##4##2##(2008-11#4)
of pRB##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
of pRNA##2##2##(2010-5#2)
of pRT-9##2##2##(1994-6#2)
of pRb##2##2##(1997-7#1)(2008-6#1)
of pSK6##2##2##(1992-9#2)
of pVAX1hsp60##2##2##(2009-5#2)
of pacifier##3##2##(2007-10#2)(2009-6#1)
of packaged SFV##2##3##(2008-4#2)
of packaged##6##2##(2007-12#1)(2008-4#4)(2013-1#1)
of packed##4##2##(1993-8#1)(1994-6#1)(2008-10#1)(2013-1#1)
of paclitaxel##6##2##(1995-8#1)(1996-10#1)(2008-3#1)(2008-7#1)(2010-11#2)
of pacu##2##2##(2008-7#2)
of paediatric cochlear implant##2##4##(2008-9#1)(2011-1#1)
of paediatric cochlear implantation##3##4##(2008-9#3)
of paediatric cochlear##5##3##(2008-9#4)(2011-1#1)
of paediatric patients##2##3##(2007-9#1)(2008-7#1)
of paediatric urology##3##3##(2008-10#3)
of paediatric##27##2##(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#9)(2008-7#1)(2008-9#4)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of pages##2##2##(2008-3#1)(2012-12#1)
of paid##2##2##(1995-2#1)(2011-2#1)
of pain among##2##3##(2007-11#1)(2010-12#1)
of pain and depression##3##4##(2008-10#1)(2013-1#2)
of pain and disability##4##4##(2007-11#1)(2008-9#2)(2012-12#1)
of pain and improvement##2##4##(2007-11#1)(2008-9#1)
of pain and##28##3##(1997-3#1)(2007-11#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-7#1)(2008-9#4)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
of pain assessment##2##3##(2008-11#2)
of pain associated with##6##4##(1992-2#1)(1993-2#1)(2007-11#2)(2008-1#1)(2010-1#1)
of pain behaviour by##2##4##(2008-11#2)
of pain by the##2##4##(1990-6#1)(1994-2#1)
of pain by##3##3##(1990-6#2)(1994-2#1)
of pain can be##2##4##(1991-11#1)(2008-4#1)
of pain experienced##2##3##(2010-11#1)(2011-2#1)
of pain for##3##3##(1993-12#1)(2008-9#1)(2013-1#1)
of pain in childhood##2##4##(2008-11#2)
of pain in the##5##4##(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)
of pain in##21##3##(1991-11#2)(1994-9#1)(1997-2#1)(1997-8#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
of pain is##2##3##(2008-11#1)(2008-9#1)
of pain management##3##3##(2007-11#1)(2009-12#1)(2010-11#1)
of pain on##3##3##(1990-9#2)(1992-5#1)
of pain relief##5##3##(1990-6#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-10#1)
of pain was##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
of pain were##2##3##(1993-2#1)(2010-3#1)
of pain with##2##3##(1997-6#1)(2007-8#1)
of pain##183##2##(1990-12#2)(1990-3#1)(1990-6#3)(1990-9#2)(1991-11#3)(1991-2#1)(1991-3#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-2#2)(1994-2#2)(1994-9#1)(1995-12#1)(1995-5#1)(1996-2#4)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#25)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#7)(2008-11#14)(2008-12#7)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#12)(2009-1#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#1)
of painful diabetic neuropathy##2##4##(2008-4#2)
of painful##17##2##(1990-5#1)(1992-5#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
of painfull##2##2##(2007-11#2)
of painless##4##2##(2007-11#1)(2008-12#1)(2008-6#1)(2013-1#1)
of paint##2##2##(2007-12#1)(2012-1#1)
of painted##2##2##(2007-12#2)
of paints##2##2##(2007-12#1)(2008-10#1)
of pair-wise##2##2##(2008-12#1)(2010-8#1)
of paired##4##2##(2007-12#1)(2008-11#1)(2010-8#1)(2012-3#1)
of pairing##2##2##(2008-5#1)(2008-7#1)
of pairs of##6##3##(1996-5#1)(2008-10#2)(2008-3#1)(2010-2#1)(2011-2#1)
of pairwise##4##2##(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
of pale eggs##2##3##(2008-8#2)
of palladium and##3##3##(2008-10#2)(2008-11#1)
of palladium by##2##3##(2008-10#2)
of palladium matrix modification##2##4##(1991-12#2)
of palladium with##2##3##(2008-10#2)
of palladium##21##2##(1991-12#3)(2008-10#17)(2008-11#1)
of palladium(II) and##3##3##(2008-10#3)
of palladium(II) from##3##3##(2008-10#3)
of palladium(II) in##2##3##(2008-10#2)
of palladium(II) with##6##3##(2008-10#6)
of palladium(II)##21##2##(2008-10#21)
of palliation##3##2##(2007-10#2)(2008-12#1)
of palliative care##5##3##(2008-4#1)(2010-10#1)(2011-2#1)(2012-3#2)
of palliative medicine##2##3##(2012-3#2)
of palliative radiotherapy alone or combined with surgery##2##8##(2007-11#2)
of palliative radiotherapy##5##3##(2007-11#3)(2008-10#2)
of palliative##15##2##(1990-11#1)(1993-6#1)(2007-11#3)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#4)
of palm##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
of palmar##2##2##(2008-10#1)(2012-1#1)
of palmitate##2##2##(1994-12#1)(2008-5#1)
of palmitic acid on##3##4##(2008-5#2)(2010-12#1)
of palmitic acid##5##3##(2008-5#3)(2009-6#1)(2010-12#1)
of palmitic saturated fatty acid in##2##6##(2013-1#2)
of palmitic saturated fatty acid##4##5##(2013-1#4)
of palmitic##11##2##(1994-8#1)(2008-5#3)(2009-6#2)(2010-12#1)(2013-1#4)
of palmitoyl-CoA##2##2##(1990-5#2)
of pamidronate##2##2##(2007-11#1)(2012-12#1)
of pan masala##2##3##(1992-8#2)
of pancreas disease##2##3##(1994-7#2)
of pancreas##15##2##(1994-7#2)(2008-7#2)(2010-12#2)(2012-2#1)(2012-3#7)(2013-1#1)
of pancreatic OPN##2##3##(2010-11#2)
of pancreatic beta-cells##4##3##(1996-2#1)(2008-12#1)(2009-3#1)(2012-3#1)
of pancreatic cancer cells##2##4##(2013-1#2)
of pancreatic cancer##12##3##(1990-6#4)(1990-9#1)(1994-3#1)(2009-5#1)(2011-2#1)(2013-1#4)
of pancreatic cancer]##3##3##(1990-11#1)(1990-9#2)
of pancreatic carcinoma##2##3##(1994-6#1)(2008-1#1)
of pancreatic cells##2##3##(2008-9#1)(2010-11#1)
of pancreatic endocrine##2##3##(1992-7#1)(2011-2#1)
of pancreatic islet##5##3##(2008-2#2)(2010-11#1)(2010-12#1)(2010-9#1)
of pancreatic malignancies##2##3##(1991-3#1)(1992-2#1)
of pancreatic neoplasms##2##3##(2012-2#2)
of pancreatic pseudocysts##2##3##(1991-8#2)
of pancreatic secretion##2##3##(1992-8#1)(2008-7#1)
of pancreatic β-cells##2##3##(2010-10#1)(2010-11#1)
of pancreatic##73##2##(1990-11#1)(1990-12#2)(1990-6#4)(1990-9#3)(1991-3#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-6#2)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(2007-2#1)(2008-1#3)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-11#7)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
of pancreatitis##8##2##(1990-3#1)(2007-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
of pandemic influenza##3##3##(2010-5#1)(2011-2#2)
of pandemic spread##4##3##(2008-10#4)
of pandemic##11##2##(2008-10#4)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
of panicle and shoot blight of pistachio##2##7##(2008-10#2)
of panicle and shoot blight severity##2##6##(2008-10#2)
of panicle and shoot blight##5##5##(2008-10#5)
of panicle and##6##3##(2008-10#5)(2008-12#1)
of panicle blast##4##3##(2008-10#4)
of panicle##11##2##(2008-10#9)(2008-12#2)
of panniculitis##2##2##(2012-12#2)
of panthenol##2##2##(2008-5#2)
of papaverine##4##2##(2008-10#4)
of paper disc##2##3##(1994-11#2)
of paper is##2##3##(2008-3#1)(2013-1#1)
of paper to##2##3##(2008-3#2)
of paper##17##2##(1994-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#6)(2008-9#2)(2009-6#1)(2012-2#1)(2013-1#2)
of papers presented at the##10##5##(2008-10#8)(2008-2#1)(2010-3#1)
of papers published in the##3##5##(2008-10#1)(2008-5#2)
of papers that##2##3##(2008-2#1)(2008-5#1)
of papers##32##2##(1991-5#1)(2006-10#1)(2008-10#19)(2008-2#2)(2008-3#1)(2008-5#3)(2009-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)
of papillae and##2##3##(1991-3#1)(2008-10#1)
of papillae##5##2##(1991-3#1)(2008-10#4)
of papillary calculi##2##3##(1995-8#2)
of papillary##3##2##(1995-8#2)(2006-12#1)
of papillomas##4##2##(1992-8#1)(2008-9#1)(2013-1#2)
of papillomavirus##2##2##(1992-2#1)(2008-9#1)
of para-Cl-phenylazo-R-acid##3##2##(2008-10#3)
of para-substituted##2##2##(1994-5#1)(2008-10#1)
of paracetamol and##2##3##(2008-10#2)
of paracetamol in pharmaceutical formulations##3##5##(2008-10#3)
of paracetamol in##11##3##(2008-10#11)
of paracetamol##26##2##(2007-8#1)(2008-10#23)(2012-2#1)(2013-1#1)
of paracrine factors##2##3##(1994-9#1)(2008-9#1)
of paracrine##4##2##(1993-8#1)(1994-9#1)(2008-9#1)(2013-1#1)
of paradigms##2##2##(1995-4#1)(2013-8#1)
of paradoxical##2##2##(2008-1#1)(2013-1#1)
of paraffin-embedded##2##2##(1994-12#1)(2008-10#1)
of paraganglioma##2##2##(2011-2#1)(2012-2#1)
of parallel and concurrent architectures##2##5##(2008-2#2)
of parallel##16##2##(1993-11#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)
of parallelism##4##2##(2008-3#2)(2010-8#1)(2013-1#1)
of paralytic shellfish poisoning##2##4##(1994-12#2)
of paralytic##4##2##(1990-5#1)(1994-12#2)(1997-8#1)
of paramagnetic##3##2##(1990-5#1)(1994-5#1)(2007-11#1)
of paramecia##3##2##(1992-6#1)(2008-5#2)
of parameter values and##2##4##(1994-2#1)(2008-3#1)
of parameter values##10##3##(1994-2#1)(1997-2#1)(2008-10#2)(2008-3#2)(2008-8#2)(2008-9#1)(2010-2#1)
of parameter##14##2##(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#3)(2008-9#1)(2010-2#1)
of parameters for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of parameters in the##2##4##(1995-9#1)(2010-8#1)
of parameters of the##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
of parameters such as##3##4##(2008-1#1)(2008-3#2)
of parameters that##2##3##(2008-3#1)(2009-8#1)
of parameters##47##2##(1991-3#1)(1994-3#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#11)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
of parametric##10##2##(1997-5#1)(1997-7#1)(2007-11#5)(2007-12#3)
of paramount importance to##6##4##(1991-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2010-11#1)(2013-7#1)
of paramount importance##12##3##(1991-5#1)(1994-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
of paramount##13##2##(1991-5#1)(1994-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
of paranasal aspergilloma##2##3##(2008-5#2)
of paranasal##5##2##(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
of paraneoplastic syndromes##2##3##(2009-3#2)
of paraneoplastic##4##2##(1996-11#1)(2009-3#2)(2013-7#1)
of paraoxon##6##2##(2008-10#6)
of paraparesis##2##2##(2013-1#2)
of paraquat in human##2##4##(2008-10#2)
of paraquat in##6##3##(2008-10#6)
of paraquat##14##2##(2008-10#13)(2012-2#1)
of parasite virulence##6##3##(2008-8#6)
of parasite##19##2##(1992-9#1)(1994-11#2)(1994-12#1)(2007-7#1)(2008-8#9)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-3#1)
of parasite-mediated##2##2##(2009-2#1)(2012-3#1)
of parasitemia and##2##3##(2012-2#2)
of parasites and##3##3##(1997-7#2)(2008-9#1)
of parasites in##6##3##(1994-11#1)(1996-3#1)(1997-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
of parasites##25##2##(1992-2#1)(1994-11#1)(1996-3#1)(1997-7#6)(2008-8#4)(2008-9#2)(2010-3#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)
of parasitic diseases##3##3##(2011-2#2)(2012-12#1)
of parasitic##8##2##(2007-12#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
of parasitism in##4##3##(2008-6#1)(2008-8#3)
of parasitism##12##2##(2008-10#2)(2008-6#3)(2008-8#7)
of parasitized##3##2##(1990-2#1)(1992-6#1)(2012-12#1)
of parasitoids##2##2##(2008-9#1)(2010-2#1)
of parasitology##2##2##(2010-1#2)
of parastomal hernias##2##3##(2011-2#2)
of parasympathetic##2##2##(1992-6#1)(2008-7#1)
of parathormone##2##2##(2008-1#1)(2008-7#1)
of parathyroid adenoma##2##3##(2009-7#2)
of parathyroid adenomas##2##3##(2008-10#1)(2009-7#1)
of parathyroid hormone (1-84)##2##4##(1994-6#2)
of parathyroid hormone (PTH##2##4##(1993-12#1)(2008-8#1)
of parathyroid hormone (PTH)##5##4##(1994-11#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
of parathyroid hormone##10##3##(1993-12#1)(1994-11#1)(1994-6#2)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
of parathyroid hormone-related peptide in##2##5##(1993-3#1)(1997-6#1)
of parathyroid hormone-related##3##3##(1993-3#1)(1994-7#1)(1997-6#1)
of parathyroid##19##2##(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#2)(1994-7#1)(1997-6#1)(2008-10#2)(2008-8#1)(2009-7#4)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
of parenchyma cells##2##3##(2008-10#1)(2012-5#1)
of parenchymal##2##2##(2008-11#1)(2008-8#1)
of parent drug##2##3##(2010-11#2)
of parent involvement##2##3##(1991-3#1)(2012-2#1)
of parent##12##2##(1991-3#1)(1995-1#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-2#1)
of parent-adolescent##2##2##(2009-7#1)(2013-1#1)
of parental care in##2##4##(2008-4#1)(2008-8#1)
of parental care##4##3##(2008-4#1)(2008-8#2)(2008-9#1)
of parental investment##4##3##(2008-8#1)(2008-9#3)
of parental##27##2##(1993-3#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#6)(2009-7#1)(2010-1#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
of parenteral nutrition##2##3##(1993-5#1)(2013-1#1)
of parenteral##3##2##(1993-5#1)(2010-9#1)(2013-1#1)
of parenting##4##2##(1995-2#1)(2009-9#2)(2010-1#1)
of parents and peers##2##4##(1990-2#2)
of parents and teachers##2##4##(2011-2#1)(2012-12#1)
of parents and##8##3##(1990-2#2)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
of parents as##2##3##(1993-1#1)(2008-2#1)
of parents for##2##3##(1992-2#1)(2010-4#1)
of parents of children with##2##5##(1992-2#1)(1993-3#1)
of parents of##4##3##(1992-2#1)(1993-3#1)(1994-3#1)(2012-12#1)
of parents who##3##3##(1994-2#2)(1994-3#1)
of parents with##4##3##(2012-12#1)(2013-1#3)
of parents##38##2##(1990-2#2)(1991-12#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-3#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#3)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
of parents'##5##2##(1994-3#1)(2008-9#1)(2010-1#2)(2012-12#1)
of parents/guardians##3##2##(2008-9#1)(2010-9#2)
of parkinsonian##4##2##(1993-11#1)(2008-12#1)(2008-7#2)
of parkinsonism and##4##3##(1997-2#2)(2008-7#2)
of parkinsonism##7##2##(1997-2#2)(2008-7#5)
of parliament and##2##3##(1995-3#1)(2013-8#1)
of paroxysmal positional vertigo##3##4##(2008-4#3)
of paroxysmal##6##2##(1992-3#1)(2008-1#1)(2008-11#1)(2008-4#3)
of parsley plastocyanin##2##3##(1994-5#2)
of parsley##3##2##(1994-5#2)(1997-7#1)
of part of the##3##4##(1995-2#1)(2008-10#1)(2008-2#1)
of part of##5##3##(1992-11#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
of parthenogenetic lizards##2##3##(2010-3#2)
of parthenogenetic##3##2##(2010-3#3)
of partial bone resection procedure##2##5##(2007-11#2)
of partial coherence##2##3##(2007-9#1)(2008-3#1)
of partial hospitalization##3##3##(1991-1#2)(1992-1#1)
of partial least squares (PLS)##2##5##(2008-10#2)
of partial least squares##4##4##(2008-10#3)(2008-3#1)
of partial least-squares##2##3##(2007-11#1)(2008-3#1)
of partial resistance in##4##4##(2008-10#4)
of partial resistance to##2##4##(2008-10#2)
of partial resistance were##2##4##(2008-10#2)
of partial resistance##13##3##(2008-10#13)
of partial##62##2##(1990-2#1)(1990-5#1)(1991-1#2)(1991-5#1)(1992-1#1)(1992-11#1)(1993-5#1)(1993-6#1)(1996-2#1)(2006-12#1)(2007-11#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#2)
of partial-response##2##2##(2008-3#2)
of partially coherent anisotropic GSM beams##2##6##(2007-11#2)
of partially coherent beams##3##4##(2007-11#2)(2008-3#1)
of partially coherent fields##4##4##(2007-11#1)(2007-12#3)
of partially coherent##12##3##(2007-11#6)(2007-12#3)(2008-3#3)
of partially polarized beams##2##4##(2008-3#2)
of partially polarized light##3##4##(2007-11#1)(2008-3#2)
of partially polarized##5##3##(2007-11#1)(2008-3#4)
of partially purified##5##3##(1990-11#2)(1990-7#1)(1992-12#1)(1995-11#1)
of partially resistant##3##3##(2008-10#3)
of partially##37##2##(1990-11#2)(1990-7#1)(1990-8#1)(1992-12#2)(1995-11#1)(1995-3#2)(1996-3#1)(1997-2#1)(2007-11#7)(2007-12#4)(2008-10#5)(2008-12#1)(2008-3#8)(2008-8#1)
of participant##5##2##(2007-7#1)(2008-10#1)(2009-11#1)(2009-4#1)(2012-2#1)
of participants and##2##3##(2010-3#1)(2012-12#1)
of participants had a##2##4##(2009-3#2)
of participants had##4##3##(2008-12#1)(2009-3#2)(2012-12#1)
of participants in##2##3##(2009-6#1)(2010-3#1)
of participants reported##2##3##(2009-3#1)(2012-12#1)
of participants to##2##3##(1996-3#1)(2007-11#1)
of participants was##2##3##(2012-3#1)(2013-1#1)
of participants with##3##3##(2007-12#1)(2012-12#1)(2012-2#1)
of participants##41##2##(1995-1#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-7#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
of participating##7##2##(1995-12#2)(1997-1#1)(2009-5#1)(2012-3#2)(2013-1#1)
of participation in the##2##4##(1990-2#1)(1993-2#1)
of participation in##8##3##(1990-2#1)(1993-2#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
of participation##19##2##(1990-2#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-5#1)(2011-1#1)(2011-2#1)
of particle capture##3##3##(2008-9#3)
of particle matter##2##3##(2008-3#2)
of particle position##2##3##(2008-3#1)(2009-9#1)
of particle scattering##2##3##(1994-3#1)(2008-3#1)
of particle size and##6##4##(2008-10#2)(2008-2#2)(2008-3#1)(2009-2#1)
of particle size##18##3##(1990-8#1)(1992-3#2)(2008-10#8)(2008-2#3)(2008-3#2)(2008-5#1)(2009-2#1)
of particle sizing##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
of particle##46##2##(1990-8#1)(1992-3#3)(1993-2#1)(1994-3#1)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#15)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-9#1)(2012-2#1)(2012-3#1)
of particle-size distribution##3##3##(2007-12#1)(2008-3#2)
of particles and##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
of particles in the##3##4##(1991-12#1)(2008-10#2)
of particles in##4##3##(1991-12#1)(2008-10#2)(2008-3#1)
of particles of##2##3##(1997-3#1)(2011-2#1)
of particles that are##2##4##(1990-6#1)(2008-3#1)
of particles with##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of particles##46##2##(1990-12#2)(1990-6#1)(1991-12#1)(1992-3#1)(1993-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)
of particular clinical##2##3##(2007-11#1)(2008-6#1)
of particular concern in##4##4##(1991-4#1)(2008-10#1)(2008-3#1)(2012-3#1)
of particular concern##9##3##(1991-3#1)(1991-4#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
of particular elements##2##3##(2008-10#2)
of particular importance in the##2##5##(1993-3#1)(1994-9#1)
of particular importance in##6##4##(1992-5#1)(1993-3#1)(1994-9#1)(2007-2#1)(2008-6#1)(2013-1#1)
of particular importance##10##3##(1992-5#1)(1993-3#1)(1994-9#1)(1997-7#1)(2007-2#1)(2008-6#1)(2008-9#1)(2011-2#2)(2013-1#1)
of particular interest because##4##4##(1990-12#1)(1996-12#1)(2008-10#1)(2008-2#1)
of particular interest for##7##4##(1995-6#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)
of particular interest is##2##4##(1991-9#1)(2008-3#1)
of particular interest since the##2##5##(1992-8#1)(2008-4#1)
of particular interest since##5##4##(1991-12#1)(1992-8#1)(1997-6#1)(2008-4#1)(2011-2#1)
of particular interest to##5##4##(1993-12#2)(2008-11#1)(2008-8#1)(2008-9#1)
of particular interest##32##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-12#2)(1993-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
of particular neural##2##3##(1990-11#1)(2008-11#1)
of particular relevance for##2##4##(2007-12#1)(2012-3#1)
of particular relevance in##2##4##(2008-11#1)(2013-8#1)
of particular relevance to##2##4##(1994-8#1)(2008-1#1)
of particular relevance##6##3##(1994-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2012-3#1)(2013-8#1)
of particular species##2##3##(2008-12#1)(2010-12#1)
of particular##94##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#2)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
of particularly##2##2##(1991-4#1)(2008-7#1)
of particulate air pollution##2##4##(1997-1#1)(2012-12#1)
of particulate evidence##2##3##(2012-2#2)
of particulate matter##4##3##(2008-10#2)(2008-6#1)(2008-9#1)
of particulate##11##2##(1997-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#2)(2012-12#1)(2012-2#2)
of particulates and##2##3##(2008-3#1)(2012-2#1)
of partition coefficients##5##3##(2008-10#5)
of partition##7##2##(2008-10#5)(2008-3#1)(2011-2#1)
of partitioned##2##2##(2008-10#1)(2008-3#1)
of partitioning##2##2##(1990-5#2)
of partly##2##2##(2008-10#1)(2011-1#1)
of partnership##7##2##(1991-3#1)(1992-1#3)(1995-12#1)(2008-2#1)(2008-9#1)
of partnerships##4##2##(1994-2#1)(1995-1#1)(1997-2#1)(2012-2#1)
of parts in##2##3##(2008-3#2)
of parts per##3##3##(2008-10#1)(2008-3#2)
of parts##8##2##(2008-10#1)(2008-3#4)(2008-9#1)(2012-2#2)
of parvovirus##2##2##(1991-6#1)(2013-1#1)
of passage##4##2##(1992-11#2)(1997-3#1)(2008-12#1)
of passing##3##2##(1993-9#1)(2008-10#1)(2008-2#1)
of passive Q switching##2##4##(2008-3#2)
of passive##14##2##(1990-2#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2011-1#1)
of past research##2##3##(2007-6#1)(2012-2#1)
of past##15##2##(1990-3#1)(1993-12#1)(1995-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-2#1)(2012-9#3)(2013-1#1)
of pasture and##2##3##(2010-4#2)
of pasture##3##2##(2010-2#1)(2010-4#2)
of patch occupancy are##2##4##(2008-8#1)(2008-9#1)
of patch occupancy##5##3##(2008-8#3)(2008-9#2)
of patch##6##2##(2008-10#1)(2008-8#3)(2008-9#2)
of patches has##2##3##(2008-8#1)(2008-9#1)
of patches##12##2##(2008-10#2)(2008-8#6)(2008-9#4)
of patchy##2##2##(2008-8#1)(2008-9#1)
of patellofemoral pain syndrome##2##4##(1996-3#1)(2008-12#1)
of patent foramen ovale##2##4##(2007-8#1)(2012-2#1)
of patent##6##2##(2007-8#3)(2010-12#1)(2011-3#1)(2012-2#1)
of patented##2##2##(2010-7#1)(2012-2#1)
of patents##2##2##(2009-11#2)
of paternal care##2##3##(2008-8#2)
of paternal inheritance##2##3##(2008-8#2)
of paternal##5##2##(2008-8#4)(2008-9#1)
of paternally derived deletions##2##4##(1997-3#2)
of paternity##6##2##(2007-12#1)(2008-12#1)(2008-8#3)(2008-9#1)
of path##2##2##(2007-12#1)(2008-9#1)
of pathogen DNA in##2##4##(2008-10#2)
of pathogen DNA##7##3##(2008-10#7)
of pathogen colonization##3##3##(2008-10#2)(2009-12#1)
of pathogen growth##3##3##(2008-10#3)
of pathogen inoculum##2##3##(2008-10#2)
of pathogen virulence##2##3##(2008-10#1)(2008-9#1)
of pathogen##41##2##(2008-10#37)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)
of pathogen-derived resistance##2##3##(2008-10#2)
of pathogenesis and##4##3##(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
of pathogenesis of##2##3##(1997-8#1)(2013-1#1)
of pathogenesis##12##2##(1990-6#1)(1994-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#2)
of pathogenesis-related (PR) genes##3##4##(2008-10#3)
of pathogenesis-related (PR)##4##3##(2008-10#4)
of pathogenesis-related genes##3##3##(2008-10#1)(2011-10#2)
of pathogenesis-related##9##2##(2008-10#7)(2011-10#2)
of pathogenic Leptospira##2##3##(2008-9#2)
of pathogenic and nonpathogenic##2##4##(2008-10#2)
of pathogenic and##5##3##(2008-10#3)(2008-9#1)(2010-5#1)
of pathogenic fungi##4##3##(2008-10#3)(2009-2#1)
of pathogenic isolates from##2##4##(2008-10#2)
of pathogenic microorganisms##3##3##(1994-11#1)(1994-5#1)(2008-9#1)
of pathogenic##30##2##(1990-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(2008-10#13)(2008-9#6)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of pathogenicity and##2##3##(2007-12#1)(2008-10#1)
of pathogenicity##10##2##(2007-12#1)(2007-6#1)(2008-10#7)(2008-12#1)
of pathogens and their##2##4##(1994-3#1)(2011-2#1)
of pathogens and##5##3##(1994-3#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
of pathogens from##2##3##(2008-10#1)(2013-1#1)
of pathogens in##5##3##(1996-8#1)(2008-10#3)(2010-11#1)
of pathogens such as##2##4##(1992-2#1)(2010-11#1)
of pathogens that##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
of pathogens to##3##3##(2008-10#2)(2009-2#1)
of pathogens##41##2##(1992-2#1)(1994-3#2)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#21)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#2)(2011-2#2)(2012-2#1)(2013-1#1)
of pathologic bone##2##3##(2009-3#1)(2010-10#1)
of pathologic##16##2##(1990-6#1)(1990-8#1)(1994-8#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
of pathological changes##4##3##(1990-11#1)(1991-6#1)(2012-1#1)(2013-1#1)
of pathological fracture##6##3##(2007-11#6)
of pathological fractures in##3##4##(2007-11#3)
of pathological fractures##9##3##(2007-11#9)
of pathological gambling in##2##4##(2012-12#1)(2013-8#1)
of pathological gambling##4##3##(2008-11#1)(2012-12#2)(2013-8#1)
of pathological##37##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-6#1)(1993-3#1)(1993-6#1)(1995-5#1)(1997-3#1)(1997-4#1)(2007-11#17)(2008-11#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
of pathologies##7##2##(2006-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
of pathology##12##2##(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
of pathophysiological##2##2##(2008-2#1)(2008-5#1)
of pathophysiology and##2##3##(2013-1#2)
of pathophysiology##6##2##(1995-3#1)(2006-10#1)(2008-9#1)(2013-1#3)
of pathotypes##2##2##(2008-10#2)
of pathway##5##2##(2009-5#1)(2009-6#1)(2010-11#2)(2012-1#1)
of pathways and##2##3##(2008-7#1)(2013-8#1)
of pathways in##2##3##(2009-10#1)(2010-11#1)
of pathways of##2##3##(1990-8#1)(2010-12#1)
of pathways##16##2##(1990-8#1)(1994-11#1)(2007-7#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-8#1)
of patient advocacy##2##3##(2008-10#1)(2008-2#1)
of patient and family##2##4##(2007-11#1)(2010-2#1)
of patient and##5##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-2#1)
of patient autonomy##2##3##(1991-2#1)(1992-3#1)
of patient care##16##3##(1991-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1997-1#2)(1997-3#1)(2007-12#1)(2008-11#3)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)
of patient compliance##2##3##(1993-11#1)(1996-3#1)
of patient data##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
of patient factors##2##3##(2008-10#1)(2008-11#1)
of patient focused restructuring##2##4##(1993-12#2)
of patient focused##4##3##(1993-12#2)(1994-2#1)(1996-2#1)
of patient information and##2##4##(2011-1#1)(2012-2#1)
of patient information##6##3##(1993-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
of patient outcomes##5##3##(1993-2#1)(2008-1#1)(2010-10#1)(2013-1#2)
of patient satisfaction and##2##4##(1996-1#1)(1997-1#1)
of patient satisfaction##13##3##(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#3)(1996-3#3)(1997-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
of patient serum##2##3##(1997-4#2)
of patient status##2##3##(1997-2#1)(2013-1#1)
of patient survival##2##3##(1995-2#1)(2008-5#1)
of patient with##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
of patient##144##2##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1992-12#1)(1992-3#4)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#4)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#6)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#11)(2013-8#1)
of patient's##9##2##(1991-12#1)(1995-9#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
of patient- and##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
of patient-based##3##2##(1994-3#3)
of patient-centered care##2##3##(2012-12#1)(2013-8#1)
of patient-focused care##3##3##(1994-1#1)(1996-1#1)(1997-3#1)
of patient-reported##3##2##(1995-2#1)(2008-9#1)(2013-1#1)
of patient-specific##4##2##(2008-12#1)(2009-3#1)(2011-2#2)
of patients (average improvement##3##4##(2008-9#3)
of patients (n =##4##4##(2008-6#2)(2008-7#1)(2012-3#1)
of patients achieved##3##3##(1993-2#1)(2008-5#1)(2012-3#1)
of patients admitted to the##2##5##(2011-2#1)(2012-3#1)
of patients admitted to##5##4##(2006-8#2)(2008-7#1)(2011-2#1)(2012-3#1)
of patients admitted with##4##4##(1995-9#1)(2007-10#1)(2008-3#1)(2008-7#1)
of patients admitted##10##3##(1995-9#1)(2006-8#2)(2007-10#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-3#1)
of patients affected by##4##4##(1990-6#1)(2008-1#1)(2010-3#1)(2011-2#1)
of patients affected with##2##4##(1992-2#1)(1993-6#1)
of patients affected##6##3##(1990-6#1)(1992-2#1)(1993-6#1)(2008-1#1)(2010-3#1)(2011-2#1)
of patients after AMI##2##4##(2006-8#2)
of patients after##9##3##(1993-6#1)(2006-8#3)(2007-8#2)(2008-1#1)(2008-4#1)(2013-8#1)
of patients and controls##2##4##(1994-8#1)(2011-1#1)
of patients and physicians##2##4##(1994-2#1)(2012-1#1)
of patients and the##2##4##(2011-1#1)(2012-3#1)
of patients and volunteers##2##4##(1992-3#2)
of patients and##33##3##(1991-1#1)(1991-3#1)(1992-10#1)(1992-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#2)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
of patients and/or##2##3##(2008-11#2)
of patients are##10##3##(1993-9#1)(1995-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#1)
of patients as##4##3##(1994-10#1)(1996-12#1)(2007-7#1)(2009-5#1)
of patients at high risk of##2##6##(1993-1#1)(2008-7#1)
of patients at risk for##3##5##(1997-3#1)(2012-2#1)(2013-1#1)
of patients at risk of##3##5##(1992-12#1)(2008-8#1)(2010-5#1)
of patients at risk##7##4##(1992-12#1)(1997-3#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
of patients at##16##3##(1992-12#2)(1993-1#1)(1997-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)
of patients attending##2##3##(2008-3#2)
of patients before##5##3##(1991-2#1)(2007-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
of patients by a##3##4##(1996-12#1)(2007-11#1)(2007-8#1)
of patients by##4##3##(1996-12#1)(2007-11#1)(2007-8#1)(2013-1#1)
of patients can be##3##4##(1990-12#1)(1992-3#1)(1997-3#1)
of patients diagnosed with##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
of patients died##2##3##(2011-2#1)(2012-2#1)
of patients entering##2##3##(1994-5#1)(1996-6#1)
of patients experienced##5##3##(2008-10#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
of patients experiencing##2##3##(1994-2#1)(2008-7#1)
of patients exposed to##2##4##(1996-9#1)(1997-2#1)
of patients for whom##3##4##(1995-11#1)(1996-1#1)(2013-1#1)
of patients for##11##3##(1992-9#1)(1994-2#1)(1995-11#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#2)
of patients from##6##3##(1991-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
of patients had a successful result##2##6##(2009-3#2)
of patients had a##6##4##(1992-9#1)(2007-7#2)(2009-3#2)(2012-2#1)
of patients had at least##2##5##(1994-2#1)(2012-3#1)
of patients had steroid##2##4##(2007-8#2)
of patients had##27##3##(1990-2#1)(1992-10#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-11#2)(2008-6#1)(2009-3#2)(2010-12#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
of patients have to##2##4##(1996-2#1)(2010-12#1)
of patients have##7##3##(1990-6#1)(1996-2#1)(2007-8#2)(2008-12#1)(2010-12#1)(2012-3#1)
of patients hospitalized for##3##4##(1997-3#1)(2008-7#1)(2012-12#1)
of patients hospitalized##5##3##(1997-3#1)(2007-8#1)(2008-7#1)(2012-12#2)
of patients in a##2##4##(1994-12#1)(1995-3#1)
of patients in both groups##2##5##(1994-5#1)(2012-2#1)
of patients in the control group reported that they would make that choice##2##13##(2010-4#2)
of patients in the intervention group reported that they would choose to##2##12##(2010-4#2)
of patients in the##13##4##(1992-12#2)(2008-1#1)(2008-7#2)(2010-4#4)(2010-6#1)(2011-2#2)(2012-3#1)
of patients in whom##2##4##(2008-7#1)(2010-12#1)
of patients in##38##3##(1992-12#3)(1992-3#1)(1994-12#1)(1994-5#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#6)(2009-8#1)(2010-12#1)(2010-4#4)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
of patients irradiated due to bone metastases##3##7##(2007-11#3)
of patients is##9##3##(1992-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
of patients may##2##3##(1995-2#1)(2013-8#1)
of patients of##4##3##(1995-3#1)(2006-10#1)(2013-1#2)
of patients on hemodialysis##2##4##(2008-1#1)(2013-1#1)
of patients on maintenance hemodialysis##2##5##(2008-1#2)
of patients on##5##3##(2008-1#3)(2011-2#1)(2013-1#1)
of patients operated##4##3##(1990-9#1)(1992-6#1)(1993-11#1)(2013-8#1)
of patients over the age of##2##6##(2011-2#2)
of patients over the##3##4##(2007-8#1)(2011-2#2)
of patients over##5##3##(2007-11#1)(2007-8#1)(2011-2#3)
of patients presented##2##3##(2011-2#1)(2013-1#1)
of patients presenting with##5##4##(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#1)
of patients presenting##8##3##(1995-11#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)
of patients prior##2##3##(2009-8#1)(2011-2#1)
of patients progressing to##2##4##(2008-1#2)
of patients received##5##3##(2006-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
of patients receiving filgrastim##2##4##(2008-7#2)
of patients receiving##11##3##(1995-3#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-5#1)(2011-2#1)(2013-8#2)
of patients reported##2##3##(2008-7#1)(2010-8#1)
of patients requiring##2##3##(1995-2#1)(2011-2#1)
of patients scheduled##2##3##(2006-12#1)(2013-1#1)
of patients seeking##2##3##(2007-11#1)(2008-3#1)
of patients still##2##3##(2008-7#1)(2010-8#1)
of patients submitted to##3##4##(1993-9#1)(2008-10#1)(2013-8#1)
of patients suffering from##12##4##(1991-11#1)(1993-11#1)(1997-6#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
of patients taking##2##3##(2008-11#1)(2008-5#1)
of patients that##5##3##(1995-12#1)(2007-8#1)(2008-12#1)(2012-12#1)(2013-7#1)
of patients to be##2##4##(2010-12#1)(2011-1#1)
of patients to the##2##4##(1991-11#1)(2008-8#1)
of patients to##13##3##(1991-11#1)(1994-2#1)(1994-6#1)(2007-2#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2013-1#1)
of patients transplanted##2##3##(1991-9#1)(2010-5#1)
of patients treated at##2##4##(2008-5#1)(2008-7#1)
of patients treated by##2##4##(1992-9#1)(2008-10#1)
of patients treated for##2##4##(1993-8#1)(1994-5#1)
of patients treated with##13##4##(1990-3#1)(1990-6#1)(1995-2#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#3)(2013-1#2)
of patients treated##28##3##(1990-3#1)(1990-6#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-9#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2011-2#4)(2013-1#3)
of patients under##6##3##(1990-5#1)(1993-2#1)(1996-2#1)(1996-9#1)(2008-10#1)(2013-1#1)
of patients undergoing spinal##2##4##(2012-12#1)(2012-3#1)
of patients undergoing total hip##2##5##(2007-8#1)(2011-2#1)
of patients undergoing##17##3##(1992-3#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of patients underwent##3##3##(1990-5#1)(1992-2#1)(2008-6#1)
of patients was##12##3##(1990-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(2007-11#4)(2007-2#1)(2007-8#1)(2011-2#2)
of patients were##29##3##(1990-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#5)(2013-1#1)
of patients who are at##3##5##(1994-12#1)(2008-7#1)(2013-1#1)
of patients who are##9##4##(1994-12#1)(1995-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2013-1#2)
of patients who died##3##4##(1991-8#1)(2008-7#1)(2010-2#1)
of patients who experience##2##4##(2008-1#1)(2008-7#1)
of patients who had##7##4##(1992-3#1)(1993-11#1)(1994-3#1)(2008-9#1)(2010-7#1)(2011-2#2)
of patients who have undergone##2##5##(1990-9#1)(2010-6#1)
of patients who have##5##4##(1990-9#1)(1992-1#1)(2008-12#1)(2010-6#1)(2013-8#1)
of patients who present with##2##5##(2007-7#1)(2008-3#1)
of patients who presented##2##4##(1990-3#1)(2011-2#1)
of patients who received##2##4##(2008-7#1)(2008-9#1)
of patients who underwent##7##4##(2007-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-11#1)(2012-3#1)(2013-1#1)
of patients who were##4##4##(1991-2#1)(2007-10#2)(2008-10#1)
of patients who will##2##4##(2007-11#1)(2012-3#1)
of patients who##65##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-5#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
of patients whose##5##3##(2008-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
of patients will##6##3##(2008-5#2)(2008-6#1)(2010-5#1)(2010-8#1)(2012-2#1)
of patients with AD##2##4##(2011-1#1)(2012-2#1)
of patients with AIDS and##2##5##(1996-11#1)(2011-2#1)
of patients with AIDS##3##4##(1996-11#1)(2008-5#1)(2011-2#1)
of patients with Alzheimer's disease (AD)##2##6##(2008-7#1)(2012-2#1)
of patients with Alzheimer's disease##4##5##(1992-12#1)(2008-7#1)(2009-6#1)(2012-2#1)
of patients with CNS##2##4##(2008-7#2)
of patients with COPD##4##4##(2009-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
of patients with FTD##2##4##(2008-4#1)(2008-9#1)
of patients with Graves'##2##4##(1994-11#1)(2008-7#1)
of patients with HCV##2##4##(1994-8#1)(2012-12#1)
of patients with HD##2##4##(2008-7#1)(2011-2#1)
of patients with Parkinson##2##4##(2013-8#2)
of patients with Parkinson's disease##2##5##(1991-5#1)(2013-1#1)
of patients with RA##3##4##(2008-7#1)(2012-3#2)
of patients with SAH is##2##5##(1995-11#1)(2007-10#1)
of patients with SAH##3##4##(1995-11#1)(2007-10#1)(2008-7#1)
of patients with STS##2##4##(2008-6#2)
of patients with T1D##2##4##(2007-5#2)
of patients with a diagnosis of##2##6##(2007-10#1)(2012-2#1)
of patients with a high##2##5##(1990-3#1)(2007-11#1)
of patients with a neuromuscular disorder in this group had a successful result##2##13##(2009-3#2)
of patients with a##17##4##(1990-3#1)(1991-8#1)(1992-2#2)(1996-1#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-6#1)(2008-9#3)(2009-3#2)(2012-2#1)(2013-1#1)
of patients with abnormal##2##4##(1994-9#1)(2011-2#1)
of patients with acute chest pain##2##6##(2008-3#2)
of patients with acute coronary syndrome##2##6##(2008-3#2)
of patients with acute coronary syndromes##2##6##(2008-3#2)
of patients with acute coronary##5##5##(2008-3#4)(2013-8#1)
of patients with acute myocardial infarction##3##6##(1992-9#1)(2008-3#1)(2011-1#1)
of patients with acute##16##4##(1992-9#1)(1994-6#1)(2007-8#1)(2008-3#8)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of patients with advanced breast##3##5##(1991-6#1)(1993-12#1)(2011-2#1)
of patients with advanced##7##4##(1991-6#1)(1993-12#1)(1995-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)
of patients with asthma##4##4##(1993-1#1)(1996-2#1)(1996-7#1)(2012-2#1)
of patients with benign##3##4##(1992-5#1)(1992-9#1)(1995-3#1)
of patients with bone sarcomas##2##5##(2008-6#1)(2011-1#1)
of patients with bone##3##4##(2008-6#1)(2011-1#2)
of patients with breast cancer##3##5##(1990-8#1)(1993-1#1)(2007-11#1)
of patients with cancer is##2##5##(2007-8#1)(2008-2#1)
of patients with cancer of the stomach##5##7##(1991-2#1)(2008-7#4)
of patients with cancer of the##7##6##(1990-9#1)(1991-2#1)(1991-8#1)(2008-7#4)
of patients with cancer##16##4##(1990-9#1)(1991-2#1)(1991-8#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#8)(2012-3#1)
of patients with carcinoma##2##4##(1995-8#1)(2009-3#1)
of patients with cardiovascular##3##4##(2010-4#1)(2011-2#1)(2013-1#1)
of patients with cervical##2##4##(2007-11#1)(2007-4#1)
of patients with chest pain##3##5##(2008-3#2)(2012-2#1)
of patients with chronic heart failure##2##6##(2008-7#1)(2011-1#1)
of patients with chronic hepatitis C##2##6##(1994-8#1)(2011-2#1)
of patients with chronic pain##3##5##(2008-4#1)(2008-9#1)(2012-3#1)
of patients with chronic renal failure##2##6##(2007-7#1)(2008-1#1)
of patients with chronic##23##4##(1994-11#1)(1994-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
of patients with colorectal cancer##2##5##(2008-10#1)(2009-12#1)
of patients with colorectal##3##4##(1992-8#1)(2008-10#1)(2009-12#1)
of patients with complicated##3##4##(1991-6#1)(2008-3#1)(2012-12#1)
of patients with coronary artery disease##2##6##(1990-3#1)(2010-5#1)
of patients with coronary artery##3##5##(1990-3#1)(2008-1#1)(2010-5#1)
of patients with coronary heart disease##2##6##(1990-8#1)(2008-7#1)
of patients with coronary##7##4##(1990-3#1)(1990-8#1)(1993-3#1)(1995-3#1)(2008-1#1)(2008-7#1)(2010-5#1)
of patients with diabetes mellitus##2##5##(2008-1#1)(2013-1#1)
of patients with diabetes##6##4##(2007-10#1)(2008-1#1)(2008-8#1)(2013-1#1)(2013-8#2)
of patients with different##3##4##(1991-2#1)(1997-2#1)(2012-3#1)
of patients with end-stage renal disease##2##6##(2007-7#1)(2008-1#1)
of patients with epilepsy##2##4##(1997-8#1)(2011-2#1)
of patients with familial##2##4##(1996-5#1)(2007-10#1)
of patients with focal##2##4##(1997-8#1)(2007-8#1)
of patients with gastroenteritis##2##4##(1990-6#1)(2008-7#1)
of patients with head injuries##2##5##(1990-3#1)(1996-8#1)
of patients with idiopathic##3##4##(1991-5#1)(2013-1#2)
of patients with insulin##3##4##(1990-9#1)(2011-1#2)
of patients with ischemic stroke##3##5##(2007-10#2)(2007-9#1)
of patients with ischemic##5##4##(2006-7#1)(2007-10#2)(2007-9#1)(2008-3#1)
of patients with leukemia##2##4##(1992-3#1)(2008-1#1)
of patients with localized disease##2##5##(2010-3#2)
of patients with localized##3##4##(2010-3#2)(2011-2#1)
of patients with low##2##4##(2007-11#1)(2007-8#1)
of patients with lung##2##4##(2009-4#1)(2012-1#1)
of patients with malignant##4##4##(1990-6#1)(1995-9#1)(1997-2#1)(2008-7#1)
of patients with metastatic disease##5##5##(1990-11#1)(2007-11#1)(2008-6#1)(2010-3#2)
of patients with metastatic##7##4##(1990-11#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-6#1)(2010-3#2)
of patients with multiple myeloma##2##5##(2008-1#1)(2011-1#1)
of patients with multiple##4##4##(2008-1#1)(2009-3#1)(2011-1#2)
of patients with muscular##2##4##(2012-2#1)(2012-3#1)
of patients with normal##2##4##(2008-10#1)(2009-5#1)
of patients with osteoarthritis##2##4##(2007-11#1)(2007-8#1)
of patients with osteosarcoma##2##4##(2010-3#2)
of patients with other##2##4##(1990-3#1)(2008-1#1)
of patients with ovarian##2##4##(1994-2#1)(1996-10#1)
of patients with positive##3##4##(2007-2#1)(2012-12#1)(2012-2#1)
of patients with primary biliary cirrhosis##2##6##(1992-9#1)(1994-2#1)
of patients with primary##6##4##(1992-8#1)(1992-9#1)(1994-2#1)(1997-3#1)(2008-10#1)(2013-1#1)
of patients with pulmonary##2##4##(1992-2#1)(2008-1#1)
of patients with recurrent##2##4##(1993-2#1)(2008-1#1)
of patients with renal##3##4##(1990-12#1)(2007-7#1)(2012-3#1)
of patients with schizophrenia##2##4##(1995-5#1)(2012-3#1)
of patients with scleroderma##2##4##(1992-8#1)(2008-10#1)
of patients with severe acute##2##5##(1992-3#1)(2013-1#1)
of patients with severe sepsis##3##5##(2009-6#3)
of patients with severe##9##4##(1992-1#1)(1992-3#1)(1993-1#1)(2009-6#3)(2012-12#1)(2012-3#1)(2013-1#1)
of patients with soft tissue sarcomas##2##6##(2008-6#2)
of patients with spinal cord##2##5##(1991-6#1)(2007-8#1)
of patients with spinal##3##4##(1991-6#1)(2007-8#1)(2008-10#1)
of patients with stage##2##4##(2008-11#1)(2008-6#1)
of patients with stroke##3##4##(2007-10#2)(2013-1#1)
of patients with suspected##8##4##(1990-6#1)(1995-6#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#2)
of patients with symptomatic##3##4##(1993-2#1)(2008-8#1)(2009-8#1)
of patients with systemic##2##4##(1990-12#1)(2008-8#1)
of patients with the##3##4##(2007-10#1)(2008-5#1)(2011-1#1)
of patients with this##6##4##(2006-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#2)
of patients with type 2 diabetes##3##6##(2010-10#1)(2011-1#1)(2012-12#1)
of patients with type##5##4##(1996-11#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
of patients with unstable##2##4##(1990-12#1)(2008-3#1)
of patients with##546##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#4)(1990-6#3)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#1)(1992-8#6)(1992-9#4)(1993-1#6)(1993-12#1)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#6)(1996-2#3)(1996-3#2)(1996-5#2)(1996-7#4)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#6)(2006-10#4)(2006-7#1)(2007-10#16)(2007-11#14)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#4)(2007-7#7)(2007-8#8)(2007-9#1)(2008-1#17)(2008-10#10)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#19)(2008-4#4)(2008-5#7)(2008-6#13)(2008-7#32)(2008-8#12)(2008-9#12)(2009-1#2)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-3#7)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#22)(2011-2#28)(2011-7#1)(2012-1#3)(2012-12#12)(2012-2#18)(2012-3#26)(2012-6#1)(2013-1#38)(2013-7#1)(2013-8#8)
of patients without##4##3##(1990-3#1)(2007-10#1)(2008-10#1)(2013-8#1)
of patients##1388##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#9)(1990-5#4)(1990-6#8)(1990-8#2)(1990-9#7)(1991-1#1)(1991-11#10)(1991-12#2)(1991-2#5)(1991-3#6)(1991-5#2)(1991-6#6)(1991-8#6)(1991-9#4)(1992-1#5)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#12)(1992-3#14)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#7)(1992-9#7)(1993-1#7)(1993-11#4)(1993-12#7)(1993-2#6)(1993-3#4)(1993-6#3)(1993-8#2)(1993-9#7)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#11)(1994-3#4)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#8)(1995-12#5)(1995-2#9)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#7)(1996-12#3)(1996-2#10)(1996-3#4)(1996-5#2)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#5)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#9)(2006-10#8)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#9)(2007-10#31)(2007-11#46)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#5)(2007-7#28)(2007-8#34)(2007-9#4)(2008-1#43)(2008-10#33)(2008-11#26)(2008-12#13)(2008-2#5)(2008-3#36)(2008-4#11)(2008-5#18)(2008-6#34)(2008-7#81)(2008-8#23)(2008-9#23)(2009-1#2)(2009-11#2)(2009-12#3)(2009-3#9)(2009-4#4)(2009-5#7)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#20)(2010-2#1)(2010-3#16)(2010-4#9)(2010-5#10)(2010-6#5)(2010-7#3)(2010-8#14)(2010-9#3)(2011-1#37)(2011-2#98)(2011-3#2)(2011-7#2)(2012-1#8)(2012-12#25)(2012-2#29)(2012-3#58)(2012-6#1)(2013-1#90)(2013-7#4)(2013-8#24)
of patients' knowledge##2##3##(2008-10#1)(2008-3#1)
of patients' samples##3##3##(1994-6#3)
of patients'##27##2##(1992-5#1)(1994-6#3)(1997-2#1)(1997-5#3)(1997-8#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#1)
of patients)##2##2##(2007-8#1)(2009-12#1)
of pattern formation in##2##4##(2007-12#1)(2009-8#1)
of pattern recognition##5##3##(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#2)
of pattern##11##2##(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#2)(2009-8#1)(2010-8#1)(2012-2#2)
of patterned##2##2##(1994-2#1)(2008-3#1)
of patterning##2##2##(2008-10#2)
of patterns of##6##3##(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
of patterns##10##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
of patulin and##2##3##(2008-10#2)
of paw##2##2##(1994-8#1)(1996-5#1)
of paxillin##2##2##(1996-12#1)(2012-12#1)
of payment for outpatient##2##4##(1995-2#1)(1997-1#1)
of payment for##4##3##(1991-3#1)(1995-1#1)(1995-2#1)(1997-1#1)
of payment reform##3##3##(1993-12#1)(1994-1#1)(1997-1#1)
of payment##13##2##(1991-3#2)(1992-12#1)(1993-12#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#3)(1997-2#1)
of pazopanib and RT patients and##2##6##(2013-1#2)
of pazufloxacin mesilate##2##3##(2011-2#2)
of pea is presented##2##4##(2008-5#2)
of pea is##3##3##(2008-5#2)(2009-8#1)
of pea##14##2##(1993-8#1)(2008-10#5)(2008-5#5)(2008-8#2)(2009-8#1)
of peach fruit##3##3##(2008-10#3)
of peach rust##2##3##(2008-10#2)
of peach##15##2##(2008-10#15)
of peak area##2##3##(2008-10#2)
of peak current is##2##4##(2008-10#2)
of peak current was##2##4##(2008-10#2)
of peak current##6##3##(2008-10#6)
of peak experiences##3##3##(2013-8#3)
of peak height##3##3##(2008-10#3)
of peak potential##2##3##(2008-10#2)
of peak power##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of peak##34##2##(1993-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#18)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#2)(2013-8#5)
of peak-shaped models##2##3##(2007-12#2)
of peaks##8##2##(1990-2#1)(1994-9#1)(1996-5#1)(2008-10#3)(2008-3#1)(2012-1#1)
of peanut (Arachis hypogaea)##3##4##(2008-10#3)
of peanut and##2##3##(1996-8#1)(2009-2#1)
of peanut##7##2##(1996-8#1)(2008-10#5)(2009-2#1)
of pear and apple##6##4##(2008-10#6)
of pear##13##2##(2008-10#13)
of pearl millet##2##3##(2008-10#2)
of peat##4##2##(2008-10#3)(2008-8#1)
of peatlands##2##2##(2008-8#2)
of pecks##3##2##(2008-6#3)
of pectin##2##2##(2008-10#1)(2010-5#1)
of pectolytic enzymes##2##3##(1997-2#1)(2008-10#1)
of pectolytic##3##2##(1997-2#2)(2008-10#1)
of pectoralis minor##3##3##(2010-9#1)(2013-1#2)
of pedagogical##2##2##(2010-4#1)(2011-2#1)
of pedal edema##3##3##(2010-2#3)
of pedal##7##2##(1997-8#2)(2010-2#3)(2011-3#2)
of pediatric abdominal surgical emergencies in##2##6##(2011-2#2)
of pediatric and##2##3##(2010-3#1)(2012-2#1)
of pediatric hospitals##2##3##(1994-1#1)(2008-11#1)
of pediatric liver disease##2##4##(2006-10#2)
of pediatric liver##3##3##(1996-1#1)(2006-10#2)
of pediatric patients and##2##4##(1994-2#1)(2009-10#1)
of pediatric patients##3##3##(1994-2#1)(2009-10#1)(2012-2#1)
of pediatric population##2##3##(2011-2#1)(2012-12#1)
of pediatric renal length##2##4##(2008-10#2)
of pediatric renal##3##3##(1991-2#1)(2008-10#2)
of pediatric##63##2##(1991-2#1)(1992-12#1)(1992-5#1)(1994-1#4)(1994-2#1)(1995-12#1)(1996-1#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#3)(2008-9#4)(2009-10#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#4)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
of pediatrics##2##2##(1991-3#1)(2007-10#1)
of pedicle##2##2##(2010-8#1)(2013-8#1)
of peer group##2##3##(2009-7#1)(2009-8#1)
of peer victimization##2##3##(2008-12#1)(2008-4#1)
of peer##11##2##(1991-1#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-7#3)(2009-8#1)(2013-1#2)
of pefloxacin##2##2##(1993-2#2)
of peled##2##2##(2008-12#2)
of pellet##5##2##(2008-10#4)(2008-7#1)
of pellets##10##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#7)
of pelvic endometriosis##4##3##(1992-1#1)(1995-2#1)(2011-1#1)(2013-1#1)
of pelvic floor##2##3##(2010-12#1)(2011-2#1)
of pelvic organs##2##3##(1996-3#1)(2008-12#1)
of pelvic osteotomy##2##3##(2007-8#1)(2008-10#1)
of pelvic##27##2##(1991-1#1)(1992-1#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
of pelvic-peritoneal tuberculosis##3##3##(2008-10#3)
of pencil##2##2##(1991-9#1)(2010-9#1)
of pendimethalin residue (0##2##4##(2011-1#2)
of pendimethalin##7##2##(2008-11#1)(2011-1#6)
of penetrating##9##2##(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-1#2)
of penetration into##2##3##(2008-5#2)
of penetration of the##2##4##(2008-1#1)(2008-10#1)
of penetration of##5##3##(2008-1#1)(2008-10#3)(2008-5#1)
of penetration##15##2##(2007-4#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-5#3)(2013-1#1)
of penicillamine##2##2##(2008-10#2)
of penicillin G##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
of penicillin acylase from Escherichia coli##2##6##(1990-11#2)
of penicillin##14##2##(1990-11#2)(1992-12#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
of penile fracture##3##3##(2008-10#2)(2008-7#1)
of penile##4##2##(2008-10#3)(2008-7#1)
of penis##3##2##(2007-5#1)(2007-9#1)(2013-1#1)
of penoscrotal hypospadia##2##3##(2013-1#2)
of penoscrotal##3##2##(2008-10#1)(2013-1#2)
of pentachlorophenol in##2##3##(2008-10#2)
of pentachlorophenol##3##2##(2008-10#2)(2009-3#1)
of pentaerythritol triacrylate##3##3##(2008-9#3)
of pentamidine##6##2##(1993-2#4)(2008-10#2)
of pentane on water##2##4##(2008-3#2)
of pentane##3##2##(2008-3#3)
of pentavalent antimony##2##3##(2008-10#2)
of pentavalent##5##2##(2008-10#2)(2009-6#3)
of pentobarbitone##2##2##(1995-12#1)(2008-12#1)
of pentoxifylline##2##2##(2008-10#2)
of pentoxyverine##3##2##(2008-10#3)
of pentylenetetrazole##2##2##(1995-12#1)(2010-3#1)
of people affected##2##3##(2008-5#1)(2013-1#1)
of people are##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
of people in the##3##4##(1995-6#1)(2011-2#1)(2013-8#1)
of people in##4##3##(1995-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
of people suffering from##3##4##(1992-3#1)(2010-8#1)(2011-1#1)
of people who##9##3##(1991-8#1)(1992-3#1)(1993-2#1)(1995-1#1)(1996-12#1)(2008-11#1)(2008-7#1)(2013-1#2)
of people with AIDS and##2##5##(1995-6#2)
of people with AIDS##3##4##(1995-6#2)(1996-2#1)
of people with a##2##4##(2008-9#1)(2012-1#1)
of people with diabetes##2##4##(2011-2#1)(2012-3#1)
of people with disabilities##2##4##(1996-1#2)
of people with mental##2##4##(2011-1#1)(2012-3#1)
of people with##22##3##(1994-2#1)(1995-6#2)(1996-1#2)(1996-2#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
of people##68##2##(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-2#4)(1995-1#1)(1995-12#1)(1995-6#3)(1996-1#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-12#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
of pepF##2##2##(1994-12#2)
of pepper mild mottle virus##2##5##(1997-6#2)
of pepper plants##2##3##(2008-10#2)
of pepper##10##2##(1997-6#2)(2008-10#8)
of pepsin##4##2##(1990-2#2)(1992-12#1)(1996-5#1)
of pepsinogen secretion##2##3##(1995-8#1)(1997-1#1)
of peptic ulcer disease##2##4##(1997-1#2)
of peptic ulcer##4##3##(1997-1#2)(2011-1#2)
of peptic##5##2##(1997-1#3)(2011-1#2)
of peptidase##2##2##(1991-3#1)(2008-5#1)
of peptidases in##2##3##(2008-4#2)
of peptidases##3##2##(1992-5#1)(2008-4#2)
of peptide binding to##2##4##(2007-6#2)
of peptide hormones and##2##4##(2008-4#1)(2012-12#1)
of peptide mass##2##3##(2008-4#1)(2008-7#1)
of peptide nucleic acids##2##4##(2008-4#2)
of peptide##43##2##(1990-12#2)(1990-8#1)(1991-12#1)(1992-12#2)(1992-5#2)(1993-11#1)(1993-8#1)(1994-9#2)(1995-12#1)(1995-3#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-6#2)(2008-10#3)(2008-3#1)(2008-4#12)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
of peptidergic##2##2##(2008-7#1)(2013-8#1)
of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly##2##5##(2012-1#2)
of peptides after##2##3##(1994-5#1)(2008-4#1)
of peptides and proteins##3##4##(1995-2#1)(1997-4#1)(2008-11#1)
of peptides and##6##3##(1991-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)
of peptides derived from the##3##5##(1990-5#1)(1994-6#1)(1995-6#1)
of peptides from the##2##4##(1994-9#1)(1995-3#1)
of peptides of##2##3##(1992-12#1)(1995-12#1)
of peptides or##3##3##(1995-2#2)(2008-4#1)
of peptides produced by##3##4##(1993-8#1)(2008-4#1)(2008-9#1)
of peptides under 1 kDa in size##2##7##(2008-11#2)
of peptides##61##2##(1990-5#2)(1991-12#1)(1992-12#1)(1992-6#2)(1992-8#2)(1993-5#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#6)(1995-6#2)(1997-2#2)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#10)(2008-5#2)(2008-9#4)(2010-5#1)(2011-2#1)(2012-1#2)
of peptidic##2##2##(1992-9#2)
of per capita##3##3##(1997-3#1)(2009-4#1)(2012-2#1)
of per##5##2##(1993-12#1)(1997-3#1)(2009-4#1)(2012-2#1)(2012-3#1)
of perceived exertion (RPE)##3##4##(2013-1#1)(2013-8#2)
of perceived exertion##5##3##(2013-1#1)(2013-8#4)
of perceived friend##2##3##(2009-7#1)(2013-1#1)
of perceived norms##2##3##(2011-1#1)(2013-1#1)
of perceived quality##2##3##(1996-3#1)(2008-11#1)
of perceived support##2##3##(2010-1#1)(2010-2#1)
of perceived##34##2##(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#4)
of percent##5##2##(1993-2#1)(2008-10#3)(2008-2#1)
of percentage##5##2##(1991-2#1)(1996-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of perception and##3##3##(1994-12#1)(2007-8#1)(2012-2#1)
of perception of##2##3##(2007-6#1)(2011-2#1)
of perception##9##2##(1991-2#2)(1994-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2011-2#1)(2012-2#2)
of perceptions and##2##3##(2012-2#1)(2013-1#1)
of perceptions##6##2##(2008-11#1)(2012-2#1)(2013-1#4)
of perceptual and##2##3##(2007-8#1)(2008-11#1)
of perceptual##6##2##(1995-5#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-9#1)
of perchlorate in##6##3##(2008-10#6)
of perchlorate##15##2##(2008-10#15)
of perchloric##2##2##(1993-11#1)(2008-10#1)
of percutaneous coronary intervention (PCI)##2##5##(2008-11#1)(2013-8#1)
of percutaneous coronary intervention##4##4##(2008-11#1)(2009-12#2)(2013-8#1)
of percutaneous coronary##5##3##(2008-11#1)(2009-12#2)(2011-2#1)(2013-8#1)
of percutaneous radial artery##2##4##(1990-8#2)
of percutaneous##27##2##(1990-8#2)(1992-5#1)(1995-11#2)(1996-3#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#3)(2009-12#3)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
of perennial and##2##3##(2008-5#1)(2013-1#1)
of perennial ryegrass turf##3##4##(2008-10#3)
of perennial ryegrass##9##3##(2008-10#9)
of perennial##15##2##(2008-10#10)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
of perfect##3##2##(1997-7#1)(2007-11#1)(2008-10#1)
of perforated colonic##2##3##(1993-9#2)
of perforated##4##2##(1993-6#2)(1993-9#2)
of perforation##8##2##(1991-9#1)(1997-2#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)
of perforators##2##2##(2011-3#1)(2013-1#1)
of perforin##2##2##(1993-3#2)
of performance and##4##3##(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#1)
of performance feedback##3##3##(2007-10#3)
of performance in##4##3##(1995-12#1)(1996-12#1)(2008-4#1)(2008-9#1)
of performance indicators##2##3##(1992-12#1)(1994-2#1)
of performance measurement##2##3##(1996-2#1)(2008-4#1)
of performance measures##3##3##(1992-11#1)(1995-12#2)
of performance on##2##3##(1990-3#1)(2008-7#1)
of performance that##2##3##(2008-3#2)
of performance was##2##3##(1993-12#1)(2008-3#1)
of performance##53##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-11#2)(1992-12#2)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-12#3)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(2007-10#4)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#1)
of performing a##2##3##(2008-4#1)(2013-1#1)
of performing an##2##3##(1993-10#1)(2009-3#1)
of performing the##2##3##(1992-6#1)(2010-8#1)
of performing##25##2##(1991-3#1)(1992-6#1)(1993-10#1)(1995-1#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
of perfumes##2##2##(2008-5#2)
of perfused##3##2##(1994-6#1)(1997-2#2)
of perfusion##8##2##(1993-3#1)(1995-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-3#1)
of pergolide##3##2##(2008-7#3)
of peri-implantitis##4##2##(2007-12#1)(2013-1#3)
of periapical##2##2##(2011-2#1)(2013-1#1)
of pericardial thymic cyst##2##4##(2007-8#2)
of pericardial##6##2##(2007-8#5)(2010-5#1)
of perinatal care##2##3##(2007-2#1)(2013-1#1)
of perinatal##14##2##(1991-6#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-6#1)(1997-2#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
of perineal##2##2##(1993-6#1)(2011-2#1)
of periodate and iodate##4##4##(2008-10#4)
of periodate with 1-(3##2##4##(2008-10#2)
of periodate##11##2##(2008-10#10)(2008-8#1)
of periodic arrays##2##3##(2008-3#2)
of periodic nonlinearity##3##3##(2008-3#3)
of periodic##24##2##(1990-8#1)(2007-11#5)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
of periodically poled KTiOPO(4)##2##4##(2007-12#2)
of periodically poled lithium niobate##3##5##(2007-11#1)(2007-12#2)
of periodically poled##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
of periodically##10##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#1)
of periodontal disease##3##3##(1997-4#1)(2008-9#1)(2012-12#1)
of periodontal diseases##5##3##(2008-2#1)(2012-3#2)(2013-1#2)
of periodontal##13##2##(1995-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-12#1)(2012-3#4)(2013-1#2)
of periods of##2##3##(2008-6#1)(2008-7#1)
of periods##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
of perioperative complications##3##3##(2007-8#1)(2009-5#1)(2013-1#1)
of perioperative risk##2##3##(2009-5#1)(2011-2#1)
of perioperative##13##2##(2006-10#1)(2006-7#1)(2007-8#2)(2009-5#3)(2011-2#1)(2012-3#3)(2013-1#2)
of peripartum cardiomyopathy##2##3##(2008-11#1)(2013-8#1)
of peripheral BDZ receptors##2##4##(2008-6#2)
of peripheral arterial disease in##3##5##(2008-8#1)(2011-2#2)
of peripheral arterial disease##5##4##(1990-11#1)(2008-8#2)(2011-2#2)
of peripheral arterial##6##3##(1990-11#1)(2008-8#3)(2011-2#2)
of peripheral blood dilution##2##4##(2008-11#2)
of peripheral blood gene expression##2##5##(2008-10#2)
of peripheral blood lymphocytes##4##4##(1994-6#1)(1995-12#1)(2007-8#1)(2008-9#1)
of peripheral blood mononuclear cells##3##5##(1995-3#2)(1997-2#1)
of peripheral blood revealed##2##4##(1992-11#1)(2013-1#1)
of peripheral blood##21##3##(1992-11#1)(1994-6#1)(1995-12#1)(1995-3#2)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#3)(2011-2#1)(2013-1#1)(2013-7#1)
of peripheral nerve##8##3##(1994-5#1)(1995-12#1)(1995-5#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
of peripheral nerves##3##3##(1994-11#1)(1995-12#1)(2008-7#1)
of peripheral neuropathy and##2##4##(2007-7#1)(2008-8#1)
of peripheral neuropathy occurrence in HIV-1 infected patients##2##8##(2008-11#2)
of peripheral neuropathy occurrence in HIV-1 infected##3##7##(2008-11#3)
of peripheral neuropathy##9##3##(1996-2#1)(2007-7#1)(2008-11#4)(2008-8#2)(2012-3#1)
of peripheral pulmonary lesions##3##4##(2010-8#3)
of peripheral##87##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#2)(1993-12#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#7)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
of periportal##2##2##(1991-12#1)(2008-8#1)
of periprosthetic##2##2##(2011-2#2)
of peristaltic##2##2##(2008-10#1)(2008-7#1)
of peritoneal catheter##2##3##(2011-2#1)(2012-12#1)
of peritoneal cells to##2##4##(1991-12#1)(2008-10#1)
of peritoneal cells##3##3##(1991-12#2)(2008-10#1)
of peritoneal dialysis fluid by##2##5##(2008-5#2)
of peritoneal dialysis##11##3##(2007-12#3)(2007-7#2)(2008-10#2)(2008-5#2)(2011-2#2)
of peritoneal membrane##2##3##(2007-12#1)(2007-7#1)
of peritoneal metastases##2##3##(2008-1#2)
of peritoneal##37##2##(1991-12#4)(1993-6#2)(2007-12#7)(2007-7#4)(2008-1#4)(2008-10#3)(2008-12#1)(2008-5#2)(2010-3#1)(2011-2#7)(2012-12#1)(2012-3#1)
of peritonitis in##2##3##(2007-7#1)(2008-12#1)
of peritonitis##12##2##(1992-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2011-2#6)
of permanent and##3##3##(2008-7#1)(2010-6#1)(2011-2#1)
of permanent teeth##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
of permanent tooth germs##2##4##(2009-3#2)
of permanent##18##2##(1992-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-3#2)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
of permanganate##4##2##(2008-10#4)
of permeability##2##2##(1990-11#1)(2008-1#1)
of pernicious anemia##2##3##(2012-3#1)(2013-1#1)
of peroral##2##2##(1997-2#1)(2007-2#1)
of peroxidase activity##4##3##(1991-8#3)(2008-10#1)
of peroxidase##9##2##(1991-8#3)(1991-9#1)(2008-10#5)
of peroxidases##2##2##(2008-10#2)
of peroxide value in##2##4##(2008-10#2)
of peroxide##7##2##(1990-5#1)(1995-3#1)(2008-10#5)
of peroxisomal##6##2##(1991-12#1)(1993-8#3)(1994-6#1)(2008-1#1)
of peroxisome proliferation##2##3##(1993-9#1)(1995-3#1)
of peroxisome proliferator-activated##3##3##(2010-10#1)(2012-12#1)(2013-1#1)
of peroxisome##7##2##(1993-9#1)(1995-3#1)(1995-9#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
of peroxisomes and mitochondria##3##4##(2009-10#3)
of peroxisomes##4##2##(1993-9#1)(2009-10#3)
of peroxynitrite in##2##3##(2008-10#2)
of peroxynitrite on##2##3##(2008-10#2)
of peroxynitrite##11##2##(2008-10#11)
of perpetual##2##2##(2008-1#1)(2012-2#1)
of perphenazine in##4##3##(2008-10#4)
of perphenazine using##2##3##(2008-10#2)
of perphenazine##12##2##(2008-10#12)
of perseverative##2##2##(1994-3#1)(2012-1#1)
of persistence with##2##3##(2009-6#2)
of persistence##6##2##(1995-5#1)(2008-11#1)(2008-5#1)(2009-6#2)(2012-3#1)
of persistent TD##2##3##(2010-12#2)
of persistent infection##2##3##(1994-8#1)(2008-11#1)
of persistent left superior vena cava##2##6##(2011-2#1)(2012-2#1)
of persistent organic pollutants##2##4##(2008-10#1)(2008-7#1)
of persistent pain##4##3##(2008-7#4)
of persistent##46##2##(1990-5#1)(1992-10#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-11#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#6)(2008-8#3)(2010-12#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
of persisting##2##2##(1997-7#1)(2010-11#1)
of person##6##2##(2010-4#1)(2012-1#3)(2012-12#2)
of personal and collective##2##4##(2008-9#1)(2011-3#1)
of personal and professional values##2##5##(2008-1#1)(2011-2#1)
of personal and professional##3##4##(1994-3#1)(2008-1#1)(2011-2#1)
of personal and##8##3##(1994-3#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
of personal care products##2##4##(2008-5#2)
of personal care##3##3##(2008-5#3)
of personal cleansing##3##3##(2008-5#3)
of personal genomics##2##3##(2009-5#2)
of personal health##2##3##(1997-2#1)(2010-1#1)
of personal protective##3##3##(2008-12#1)(2009-12#1)(2010-4#1)
of personal reflection##2##3##(2008-11#1)(2008-12#1)
of personal##47##2##(1990-3#2)(1994-3#2)(1994-6#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#2)(2008-5#6)(2008-9#1)(2009-12#1)(2009-5#5)(2010-1#1)(2010-11#1)(2010-4#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)
of personality and##4##3##(1994-2#1)(2007-11#1)(2010-12#1)(2011-1#1)
of personality disorders in##4##4##(1991-1#2)(2009-10#1)(2012-12#1)
of personality traits##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
of personality vulnerability to alcoholism##2##5##(2007-8#2)
of personality##19##2##(1991-1#2)(1994-2#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
of personalized medicine and##2##4##(2010-10#2)
of personalized medicine##4##3##(2008-10#1)(2010-10#2)(2010-5#1)
of personalized##5##2##(2008-10#2)(2010-10#2)(2010-5#1)
of personnel##10##2##(1990-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(2008-10#2)(2008-12#1)(2011-1#1)
of persons living##3##3##(1994-3#1)(2008-6#2)
of persons of##2##3##(1994-2#1)(2008-10#1)
of persons suffering from##2##4##(1996-1#1)(2007-8#1)
of persons who##5##3##(2007-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of persons with burnout##2##4##(2011-2#2)
of persons with diabetes##2##4##(2008-1#1)(2011-2#1)
of persons with disabilities##2##4##(1997-2#1)(2009-6#1)
of persons with##20##3##(1992-3#1)(1993-1#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#3)(2012-3#2)
of persons##47##2##(1991-11#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-3#2)(1997-1#2)(1997-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-7#3)(2009-6#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#1)
of perspective##4##2##(1996-2#1)(2007-11#1)(2008-11#1)(2008-12#1)
of perspectives##2##2##(2008-11#1)(2013-8#1)
of persuasion##3##2##(2009-11#1)(2010-1#2)
of pertinent##3##2##(2006-10#1)(2008-11#1)(2008-2#1)
of perturbation of##2##3##(2008-10#1)(2011-2#1)
of perturbations##5##2##(2008-10#2)(2008-3#2)(2009-5#1)
of pertussis vaccine##2##3##(1993-6#1)(1995-5#1)
of pertussis vaccines##3##3##(1995-5#3)
of pertussis##6##2##(1991-1#1)(1993-6#1)(1995-5#4)
of pest##4##2##(2008-10#3)(2011-2#1)
of pesticide are##2##3##(2008-10#2)
of pesticide residues in food of plant origin in Milan##2##10##(2013-8#2)
of pesticide residues in##4##4##(2008-10#1)(2011-2#1)(2013-8#2)
of pesticide##19##2##(1995-6#1)(1996-3#1)(2007-5#1)(2008-10#11)(2011-2#3)(2013-8#2)
of pesticides and##2##3##(2008-10#1)(2008-12#1)
of pesticides in the##2##4##(2008-10#1)(2008-6#1)
of pesticides in##9##3##(1990-9#1)(2008-10#6)(2008-11#1)(2008-6#1)
of pesticides is##2##3##(2008-10#1)(2011-1#1)
of pesticides was##2##3##(2008-10#2)
of pesticides##29##2##(1990-9#1)(1991-6#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
of pests##6##2##(2008-10#6)
of pet food to##2##4##(2010-4#2)
of pet food##4##3##(2010-4#4)
of petroleum##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
of petrous bone##2##3##(2011-2#2)
of petrous##5##2##(2011-2#5)
of phage antibodies##2##3##(2008-10#1)(2008-4#1)
of phage display##2##3##(2008-4#1)(2009-6#1)
of phage lambda##2##3##(1992-4#1)(1994-12#1)
of phage therapy##5##3##(2012-2#4)(2013-1#1)
of phage##23##2##(1992-4#1)(1994-12#2)(1995-12#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-4#3)(2008-9#1)(2009-6#1)(2012-2#6)(2013-1#4)
of phagocytic##2##2##(2008-10#1)(2008-4#1)
of phagocytosis by##2##3##(1993-6#1)(2008-9#1)
of phagocytosis##10##2##(1990-12#1)(1993-6#4)(1994-6#3)(2008-6#1)(2008-9#1)
of phalloidin##2##2##(1990-5#2)
of phantom##2##2##(2008-3#1)(2011-2#1)
of pharaonis hR in##2##4##(1994-5#2)
of pharaonis hR##3##3##(1994-5#3)
of pharmaceutical and##2##3##(1990-9#1)(2008-3#1)
of pharmaceutical care##2##3##(2010-3#1)(2012-12#1)
of pharmaceutical formulations##5##3##(2008-10#5)
of pharmaceutical industry##2##3##(2008-10#1)(2012-3#1)
of pharmaceutical interest##3##3##(2008-10#3)
of pharmaceutical preparations##3##3##(2008-10#3)
of pharmaceutical product##2##3##(1997-1#1)(2011-2#1)
of pharmaceutical products##4##3##(1995-1#1)(1997-2#1)(2008-10#1)(2008-7#1)
of pharmaceutical residues in##2##4##(2008-10#2)
of pharmaceutical residues##4##3##(2008-10#4)
of pharmaceutical services at ward level in a teaching hospital##2##10##(2010-3#2)
of pharmaceutical services at ward level##3##6##(2010-3#3)
of pharmaceutical tablets##2##3##(2011-1#2)
of pharmaceutical##50##2##(1990-9#1)(1994-5#1)(1995-1#2)(1995-11#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#24)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-3#4)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of pharmaceuticals containing##2##3##(2008-10#2)
of pharmaceuticals in##3##3##(2008-10#2)(2013-1#1)
of pharmaceuticals##22##2##(1993-12#1)(1994-5#1)(1996-3#1)(2008-10#13)(2010-3#2)(2010-6#1)(2012-2#1)(2013-1#2)
of pharmacists##3##2##(2011-1#3)
of pharmacodynamic##2##2##(1992-8#1)(2010-8#1)
of pharmacoepidemiology##2##2##(2008-11#2)
of pharmacogenetic##2##2##(2008-11#1)(2008-9#1)
of pharmacogenetics##4##2##(2008-10#3)(2008-8#1)
of pharmacogenomics in##2##3##(2008-10#1)(2010-8#1)
of pharmacogenomics##8##2##(2008-10#2)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
of pharmacokinetic##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)
of pharmacologic##6##2##(1994-7#1)(2008-12#1)(2008-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of pharmacological agents##3##3##(1994-10#1)(2008-3#1)(2009-12#1)
of pharmacological and##3##3##(2007-9#1)(2008-11#1)(2009-7#1)
of pharmacological interest##2##3##(1995-6#1)(2009-8#1)
of pharmacological interventions##2##3##(1995-3#1)(2013-8#1)
of pharmacological treatment##2##3##(2011-2#1)(2013-1#1)
of pharmacological##22##2##(1994-10#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
of pharmacologically active catechins in##2##5##(2008-10#2)
of pharmacologically##3##2##(1993-8#1)(2008-10#2)
of pharmacology##4##2##(2008-11#2)(2008-12#2)
of pharmacotherapies##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
of pharmacotherapy for##2##3##(2008-2#1)(2013-1#1)
of pharmacotherapy##7##2##(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#2)
of pharmacovigilance##5##2##(2008-11#4)(2008-8#1)
of pharmacy education##2##3##(2010-3#1)(2011-1#1)
of pharmacy##6##2##(2009-12#1)(2010-3#2)(2011-1#2)(2013-1#1)
of phase I##3##3##(1995-12#1)(2008-1#1)(2011-2#1)
of phase II##5##3##(1995-12#1)(1997-8#1)(2007-7#1)(2008-5#2)
of phase and amplitude##2##4##(2007-11#1)(2008-2#1)
of phase and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of phase change##2##3##(2007-11#2)
of phase correction##2##3##(2007-12#2)
of phase errors##3##3##(2008-2#2)(2008-3#1)
of phase gratings##3##3##(2008-2#1)(2008-3#2)
of phase jump##2##3##(2008-3#2)
of phase levels of a Talbot array illuminator##2##8##(2008-3#2)
of phase levels of a##3##5##(2008-3#3)
of phase levels##6##3##(2008-2#1)(2008-3#5)
of phase matching and##2##4##(2007-12#1)(2008-3#1)
of phase matching##3##3##(2007-12#1)(2008-3#2)
of phase objects##3##3##(2008-3#3)
of phase separation##2##3##(2008-10#1)(2008-3#1)
of phase##81##2##(1991-9#1)(1995-12#2)(1997-8#1)(2007-11#13)(2007-12#7)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#33)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2011-2#1)
of phase-change##3##2##(2008-3#3)
of phase-conjugate mirrors during##2##4##(2008-2#2)
of phase-conjugate##3##2##(2008-2#2)(2008-3#1)
of phase-encoded##2##2##(2007-11#1)(2008-2#1)
of phase-locked##2##2##(2007-11#1)(2008-3#1)
of phase-matched##2##2##(2007-12#1)(2008-3#1)
of phase-modulated light##2##3##(2007-11#1)(2008-3#1)
of phase-modulated##3##2##(2007-11#2)(2008-3#1)
of phase-only##2##2##(2008-3#2)
of phase-separated##2##2##(1994-5#1)(2008-10#1)
of phase-shift##3##2##(2007-12#1)(2008-3#2)
of phase-shifted##2##2##(2008-3#2)
of phase-shifting interferometry##3##3##(2008-3#3)
of phase-shifting##8##2##(2007-11#2)(2008-3#6)
of phased-array antennas##2##3##(2007-12#1)(2008-3#1)
of phases##4##2##(1992-1#1)(2008-10#2)(2012-2#1)
of phasic##4##2##(1997-4#1)(2011-2#3)
of phenanthrene##5##2##(1994-5#2)(2008-11#3)
of phenazopyridine hydrochloride##2##3##(2008-10#2)
of phencyclidine (PCP)##2##3##(1991-1#2)
of phenethyl alcohol##3##3##(2008-5#3)
of phenobarbital and phenytoin##2##4##(2008-10#2)
of phenobarbital##6##2##(2007-8#1)(2008-10#3)(2008-6#2)
of phenol and catechol##2##4##(2008-10#2)
of phenol and chlorophenols from##2##5##(2012-1#2)
of phenol and##8##3##(2008-10#4)(2008-3#1)(2008-8#1)(2012-1#2)
of phenol in transformer##2##4##(2008-10#2)
of phenol in##5##3##(2008-10#5)
of phenol is##2##3##(2008-10#2)
of phenol##32##2##(1992-6#1)(1997-2#2)(2008-10#24)(2008-3#1)(2008-8#2)(2012-1#2)
of phenolic acids was##2##4##(2008-10#2)
of phenolic acids##3##3##(2008-10#3)
of phenolic antioxidants##3##3##(2008-10#3)
of phenolic compounds and##3##4##(2008-10#3)
of phenolic compounds as natural antioxidants##2##6##(2008-10#2)
of phenolic compounds by##2##4##(2008-10#2)
of phenolic compounds in river water##2##6##(2008-10#2)
of phenolic compounds in##5##4##(2008-10#5)
of phenolic compounds##26##3##(2008-10#21)(2008-11#1)(2011-1#1)(2011-2#1)(2012-1#2)
of phenolic##43##2##(1992-9#1)(2008-10#32)(2008-11#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#2)
of phenolics##6##2##(2008-10#3)(2011-2#1)(2012-1#1)(2012-2#1)
of phenology##2##2##(2008-10#1)(2008-5#1)
of phenols and polyphenols##3##4##(2008-10#3)
of phenols and##8##3##(1994-9#1)(2008-10#7)
of phenols by##2##3##(2008-10#2)
of phenols from##2##3##(2008-10#2)
of phenols using##2##3##(2008-10#2)
of phenols##26##2##(1994-5#2)(1994-9#2)(2008-10#22)
of phenomena##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
of phenophases##2##2##(2012-6#2)
of phenothiazine derivatives##7##3##(2008-10#7)
of phenothiazines in##2##3##(2008-10#2)
of phenothiazines##4##2##(2008-10#4)
of phenotype##6##2##(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
of phenotypes##10##2##(1994-2#1)(1995-8#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)
of phenotypic and genotypic##2##4##(2008-10#2)
of phenotypic data##2##3##(2008-8#1)(2010-2#1)
of phenotypic plasticity##3##3##(2008-8#1)(2008-9#1)(2009-6#1)
of phenotypic selection##2##3##(2008-8#2)
of phenotypic specialization##2##3##(2008-8#1)(2008-9#1)
of phenotypic variance##4##3##(2008-10#2)(2008-8#2)
of phenotypic variation##2##3##(2008-10#1)(2012-3#1)
of phenotypic##25##2##(1996-9#1)(2008-10#6)(2008-8#10)(2008-9#2)(2009-5#1)(2009-6#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of phenotypically##2##2##(1993-3#1)(2013-8#1)
of phenoxyl free##2##3##(2008-10#2)
of phenoxyl radicals##2##3##(2008-10#2)
of phenoxyl##4##2##(2008-10#4)
of phenyl##4##2##(2010-2#3)(2011-1#1)
of phenylalanine##5##2##(1990-8#1)(1993-9#1)(2008-10#3)
of phenylephrine hydrochloride##5##3##(2008-10#4)(2008-7#1)
of phenylephrine on##3##3##(1990-12#1)(1991-3#1)(2012-3#1)
of phenylephrine##14##2##(1990-12#1)(1991-3#1)(1994-3#1)(1994-6#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-7#1)(2011-2#1)(2012-3#1)
of phenylmercury##4##2##(2008-10#4)
of phenylpropanolamine and methoxamine##2##4##(2008-10#2)
of phenylurea##2##2##(2008-10#2)
of phenytoin in##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
of phenytoin on the##2##4##(2008-11#2)
of phenytoin were##3##3##(1994-2#2)(2008-11#1)
of phenytoin##18##2##(1994-2#4)(1995-12#1)(2008-10#3)(2008-11#8)(2008-7#2)
of pheochromocytoma and##2##3##(1992-2#1)(2009-1#1)
of pheochromocytoma##3##2##(1992-2#1)(2009-1#2)
of pheophytin##2##2##(2008-8#1)(2008-9#1)
of pheromone##2##2##(1990-11#1)(2009-7#1)
of phi X174##2##3##(1991-5#2)
of phi##4##2##(1991-5#2)(2008-2#1)(2008-3#1)
of phlD##6##2##(2008-10#6)
of phlD(+)##2##2##(2008-10#2)
of phlD+ pseudomonads in##2##4##(2008-10#2)
of phlebitis##2##2##(2013-1#2)
of phloem cells##3##3##(2008-10#2)(2008-11#1)
of phloem##6##2##(2008-10#4)(2008-11#2)
of phomactin A##2##3##(2008-6#2)
of phomopsis leaf blight of strawberry##2##6##(2008-10#2)
of phonological awareness and semantic intervention on word-learning##2##8##(2011-1#2)
of phonological awareness and##4##4##(2008-12#2)(2011-1#2)
of phonological awareness##5##3##(2008-12#3)(2011-1#2)
of phonological##8##2##(2008-11#1)(2008-12#3)(2008-4#1)(2011-1#2)(2012-12#1)
of phonon##2##2##(2008-2#2)
of phorbol dibutyrate##2##3##(1990-11#1)(1990-2#1)
of phorbol ester on cell growth inhibition by transforming growth factor beta 1##2##13##(1990-8#2)
of phorbol ester on##3##4##(1990-8#2)(1995-6#1)
of phorbol ester##7##3##(1990-8#2)(1992-8#1)(1992-9#1)(1995-6#1)(1995-8#1)(2008-11#1)
of phorbol esters on##2##4##(1990-12#1)(2010-12#1)
of phorbol esters##4##3##(1990-12#1)(1992-12#1)(1994-11#1)(2010-12#1)
of phorbol##16##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#2)(1992-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#2)(1995-6#1)(1995-8#1)(2008-11#1)(2010-12#1)
of phosphatase##3##2##(1995-3#3)
of phosphatases##4##2##(1990-12#1)(1992-8#1)(1995-12#1)(2008-7#1)
of phosphate and silicate using molybdenum blue##2##7##(2008-10#2)
of phosphate and silicate##3##4##(2008-10#3)
of phosphate and##8##3##(1991-8#1)(2008-10#6)(2012-12#1)
of phosphate buffer##2##3##(2008-10#2)
of phosphate esters##2##3##(1993-8#1)(1994-11#1)
of phosphate from##3##3##(1995-8#1)(2008-4#2)
of phosphate in hydroponic nutrient solutions##2##6##(2008-10#2)
of phosphate in hydroponic nutrient##3##5##(2008-10#3)
of phosphate in marine waters##2##5##(2008-10#2)
of phosphate in natural water##2##5##(2008-10#2)
of phosphate in##11##3##(1990-5#1)(2008-10#10)
of phosphate ion in##2##4##(2008-10#2)
of phosphate ion##3##3##(2008-10#3)
of phosphate to the##2##4##(2008-10#2)
of phosphate was##2##3##(1994-9#1)(2008-10#1)
of phosphate##57##2##(1990-5#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#2)(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#43)(2008-4#2)(2008-7#1)(2010-8#1)(2012-12#1)
of phosphates##3##2##(1993-6#1)(2008-10#2)
of phosphatidic acid##6##3##(1990-8#1)(1991-5#1)(1994-3#4)
of phosphatidyl inositol##2##3##(1991-11#1)(1992-12#1)
of phosphatidylcholine (PC) and phosphatidylethanolamine (PE)##2##6##(1994-12#1)(2008-8#1)
of phosphatidylcholine (PC)##5##3##(1991-5#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-8#1)
of phosphatidylcholine and phosphatidylethanolamine##2##4##(1990-2#1)(2007-11#1)
of phosphatidylcholine and##4##3##(1990-2#1)(1990-7#1)(1994-6#1)(2007-11#1)
of phosphatidylcholine bilayers##2##3##(1992-3#2)
of phosphatidylcholine in##3##3##(2008-10#3)
of phosphatidylcholine synthesis##4##3##(1995-3#4)
of phosphatidylcholine##25##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#5)(2007-11#1)(2008-10#6)(2008-8#2)
of phosphatidylcholines##2##2##(1994-12#1)(1997-2#1)
of phosphatidylethanolamine##4##2##(1990-2#1)(1990-7#1)(2012-2#2)
of phosphatidylglycerol##2##2##(2008-8#2)
of phosphatidylinositol (PI)##2##3##(1992-6#1)(1993-6#1)
of phosphatidylinositol 3-kinase (PI 3-kinase)##2##5##(1995-8#1)(2008-11#1)
of phosphatidylinositol 3-kinase##7##3##(1994-6#1)(1995-6#2)(1995-8#1)(2008-11#1)(2008-3#2)
of phosphatidylinositol 4-phosphate##2##3##(1993-8#1)(1997-8#1)
of phosphatidylinositol##26##2##(1990-8#1)(1991-8#3)(1992-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-6#3)(1995-8#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#2)(2008-11#3)(2008-3#2)(2008-4#1)(2010-11#1)(2013-1#1)
of phosphatidylserine on the##2##4##(1995-2#1)(2008-1#1)
of phosphatidylserine##8##2##(1990-5#1)(1992-9#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-8#2)
of phosphine##4##2##(2008-10#1)(2011-2#3)
of phosphite##3##2##(2008-10#3)
of phosphocreatine##2##2##(1990-11#1)(1994-8#1)
of phosphodiesterase##2##2##(1992-12#1)(2008-5#1)
of phosphodiesters##2##2##(1991-9#1)(1993-11#1)
of phosphoenolpyruvate##2##2##(1995-2#1)(1995-6#1)
of phosphofructokinase##6##2##(1990-12#1)(1994-3#1)(1995-2#1)(1997-2#3)
of phosphoinositide##7##2##(1993-11#1)(1994-9#1)(1995-8#1)(1996-2#3)(1997-1#1)
of phospholipase A(2)##4##3##(2008-11#3)(2011-2#1)
of phospholipase A2 by##2##4##(1994-11#2)
of phospholipase A2##14##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#2)(1994-11#2)(1994-5#4)(1996-2#2)(2013-8#1)
of phospholipase C and protein kinase C##2##7##(2008-11#2)
of phospholipase C and##3##4##(2008-11#3)
of phospholipase C##12##3##(1990-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2012-2#1)
of phospholipase D and##2##4##(1993-3#1)(1996-9#1)
of phospholipase D in##3##4##(1993-3#1)(1995-8#1)(2010-9#1)
of phospholipase D##8##3##(1993-3#3)(1995-8#2)(1996-9#1)(1997-2#1)(2010-9#1)
of phospholipase activity##2##3##(1995-8#2)
of phospholipase##46##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1992-5#1)(1992-9#2)(1993-3#3)(1993-6#1)(1994-11#3)(1994-5#4)(1995-2#1)(1995-8#4)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#6)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of phospholipid bilayers##2##3##(1990-2#1)(2008-11#1)
of phospholipid exchange between##2##4##(1993-11#2)
of phospholipid molecules##2##3##(1990-5#1)(2008-9#1)
of phospholipid synthesis##2##3##(1995-6#1)(2011-2#1)
of phospholipid translocation##2##3##(1994-5#1)(2011-1#1)
of phospholipid##25##2##(1990-11#1)(1990-2#2)(1990-5#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-8#3)(1994-12#1)(1994-5#2)(1995-6#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
of phospholipids and##2##3##(1990-2#1)(1993-6#1)
of phospholipids in the##2##4##(2008-10#1)(2012-12#1)
of phospholipids in##3##3##(1994-12#1)(2008-10#1)(2012-12#1)
of phospholipids on the reconstitution##2##5##(1995-8#2)
of phospholipids on the##3##4##(1995-8#3)
of phospholipids with##2##3##(1993-11#1)(1994-12#1)
of phospholipids##25##2##(1990-2#1)(1990-5#2)(1992-6#2)(1993-11#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-8#3)(2008-10#3)(2008-11#3)(2008-5#2)(2009-7#1)(2009-8#1)(2012-12#1)
of phosphonic acids##2##3##(1995-11#2)
of phosphopeptides##5##2##(1993-11#1)(1996-2#2)(2010-7#2)
of phosphoproteins##2##2##(1995-6#1)(2010-9#1)
of phosphoramidite and##2##3##(2008-4#2)
of phosphoramidites##4##2##(2008-4#4)
of phosphorescence##3##2##(2008-10#3)
of phosphoric acid##4##3##(2008-10#4)
of phosphorothioate##4##2##(1991-9#1)(1993-3#1)(1995-12#1)(2008-4#1)
of phosphorous##2##2##(2007-11#1)(2008-10#1)
of phosphorus and##2##3##(2008-12#2)
of phosphorus by##4##3##(2008-10#4)
of phosphorus in soil and sediment##3##6##(2008-10#3)
of phosphorus in##7##3##(2008-10#6)(2008-11#1)
of phosphorus is##2##3##(2008-10#2)
of phosphorus species##5##3##(2008-10#5)
of phosphorus##41##2##(2008-10#32)(2008-11#1)(2008-12#3)(2011-10#2)(2013-1#3)
of phosphorylase kinase##3##3##(1990-8#3)
of phosphorylated##13##2##(1991-12#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-8#1)(2008-10#2)(2008-7#2)(2008-9#4)
of phosphorylating and##2##3##(1991-12#1)(1994-12#1)
of phosphorylating##4##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-12#1)
of phosphorylation and##3##3##(1992-3#2)(1995-6#1)
of phosphorylation by##3##3##(1993-6#1)(1996-5#1)(1997-2#1)
of phosphorylation in##2##3##(1992-6#1)(2008-8#1)
of phosphorylation of the##4##4##(1990-5#1)(1992-11#2)(2013-1#1)
of phosphorylation of##10##3##(1990-5#1)(1991-2#1)(1992-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1995-12#1)(2011-2#1)(2013-1#1)
of phosphorylation on##2##3##(1997-2#1)(2008-11#1)
of phosphorylation##32##2##(1990-5#1)(1991-2#5)(1992-11#2)(1992-3#3)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#3)(2011-2#1)(2013-1#1)
of phosphotyrosine##3##2##(1994-11#1)(1995-11#1)(1995-6#1)
of photoacoustic##8##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-7#2)
of photoageing##2##2##(2008-5#2)
of photoaging##3##2##(1991-6#1)(2008-5#1)(2011-2#1)
of photobleaching##2##2##(2008-1#2)
of photocatalyst##2##2##(2008-10#2)
of photocatalytic##2##2##(2008-10#2)
of photochemical##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
of photochemically induced fluorescence##2##4##(2008-10#2)
of photoconductive antennas##2##3##(2008-2#2)
of photodecomposition##2##2##(1997-6#1)(2007-11#1)
of photodegradation##6##2##(1997-6#1)(2008-10#5)
of photodetectors##2##2##(2008-2#1)(2012-12#1)
of photodynamic therapy (PDT) in##2##5##(2009-4#1)(2012-3#1)
of photodynamic therapy (PDT)##4##4##(2007-8#1)(2008-5#1)(2009-4#1)(2012-3#1)
of photodynamic therapy##9##3##(1992-8#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#2)(2012-3#2)
of photodynamic##11##2##(1990-11#1)(1992-8#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#2)(2012-3#2)(2013-1#1)
of photoelastic fringe patterns##3##4##(2008-2#2)(2008-3#1)
of photoelastic fringe##4##3##(2008-2#2)(2008-3#2)
of photoelastic##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
of photographic##3##2##(2008-10#1)(2008-2#2)
of photography##2##2##(2008-2#1)(2008-8#1)
of photoinduced damage##2##3##(2007-12#2)
of photoinduced molecular polar alignment##2##5##(2007-12#2)
of photoinduced##9##2##(1995-5#1)(2007-11#3)(2007-12#5)
of photoinitiators##2##2##(2007-11#1)(2010-4#1)
of photolabeled##2##2##(1992-5#1)(1993-8#1)
of photolithography and##2##3##(2008-2#1)(2008-3#1)
of photoluminescence##3##2##(2007-11#2)(2008-10#1)
of photolysis##3##2##(1994-11#1)(2008-3#2)
of photometric quantities##2##3##(2008-3#2)
of photometric##3##2##(2008-3#3)
of photon counting##2##3##(2007-11#1)(2008-3#1)
of photon density waves##3##4##(2008-3#3)
of photon density##5##3##(2007-11#1)(2008-3#4)
of photon migration##2##3##(2007-12#2)
of photon##21##2##(1995-8#1)(2007-11#4)(2007-12#6)(2008-3#8)(2010-10#1)(2010-11#1)
of photon-echo##2##2##(2007-12#2)
of photonic crystal##3##3##(2007-11#2)(2008-3#1)
of photonic wire structure##2##4##(2007-11#2)
of photonic##14##2##(2007-11#9)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
of photonic-crystal##2##2##(2007-11#2)
of photons in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of photons inside the##2##4##(2008-3#2)
of photons with##2##3##(2008-3#2)
of photons##16##2##(2007-11#2)(2008-2#4)(2008-3#9)(2008-4#1)
of photoperiod##3##2##(2008-11#1)(2008-7#2)
of photopolymer##4##2##(2007-12#2)(2008-9#2)
of photopolymerization##2##2##(2008-2#1)(2008-3#1)
of photoprotection##2##2##(2008-5#1)(2011-2#1)
of photoreceptor outer##2##3##(2008-7#2)
of photoreceptor##8##2##(1990-11#2)(1996-2#1)(2008-7#3)(2012-12#1)(2012-3#1)
of photoreceptors##4##2##(1991-10#1)(1996-2#2)(2008-7#1)
of photorefractive holograms##2##3##(2008-2#1)(2008-3#1)
of photorefractive##9##2##(1990-4#1)(2007-12#2)(2008-2#1)(2008-3#5)
of photoresist##3##2##(2008-10#1)(2008-3#2)
of photosensitive##2##2##(2008-3#2)
of photosensitivity in##2##3##(2007-11#1)(2007-12#1)
of photosensitization##2##2##(1991-5#1)(2008-8#1)
of photosensitizer##2##2##(2009-4#1)(2012-2#1)
of photosynthesis##6##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-7#1)
of photosynthetic bacteria##2##3##(2008-8#2)
of photosynthetic electron transport to photorespiration##2##6##(2008-8#2)
of photosynthetic##8##2##(1997-4#1)(2008-10#2)(2008-8#4)(2008-9#1)
of photosynthetically active radiation##3##4##(2008-10#2)(2008-3#1)
of photosynthetically active##4##3##(2008-10#2)(2008-3#2)
of photosystem II##4##3##(1996-10#1)(1996-4#1)(1997-4#1)(2008-11#1)
of photosystem##5##2##(1996-10#1)(1996-4#1)(1997-4#1)(2008-11#1)(2008-7#1)
of photosystem-II##2##2##(1990-5#2)
of phototherapy##3##2##(1992-4#1)(1997-6#1)(2008-11#1)
of photothermal##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
of phototype##2##2##(2008-5#2)
of phthalate esters in cosmetics##2##5##(2008-5#2)
of phthalate esters##3##3##(2008-5#3)
of phthalate##6##2##(2008-10#2)(2008-5#4)
of phthalates##2##2##(2008-10#2)
of phycoerythrin##2##2##(2008-8#2)
of phycoerythrobilins on##2##3##(2008-8#2)
of phycourobilin##2##2##(2008-3#1)(2008-8#1)
of phyllodes tumour##2##3##(2011-2#2)
of phylogenetic analyses##2##3##(2008-10#1)(2008-8#1)
of phylogenetic relationships##3##3##(1996-4#1)(2008-5#1)(2008-8#1)
of phylogenetic trees##2##3##(2008-1#1)(2008-8#1)
of phylogenetic##20##2##(1991-5#1)(1996-4#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#7)(2011-1#1)(2011-2#4)(2012-12#1)
of phylogenetically##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
of phylogenies##2##2##(2010-5#1)(2012-3#1)
of phylogeny##3##2##(1994-5#2)(2010-3#1)
of physical abuse##3##3##(2010-7#1)(2011-2#1)(2012-3#1)
of physical activity and the##2##5##(2009-6#1)(2012-12#1)
of physical activity and##4##4##(2008-7#1)(2009-6#1)(2010-5#1)(2012-12#1)
of physical activity in##2##4##(2012-12#1)(2013-1#1)
of physical activity on brain health##2##6##(2013-1#2)
of physical activity on##6##4##(2007-12#1)(2012-12#1)(2013-1#4)
of physical activity##40##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#5)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#4)(2013-1#12)(2013-8#8)
of physical aggression##2##3##(2008-2#2)
of physical and biological##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
of physical and chemical##4##4##(2008-10#3)(2013-8#1)
of physical and##16##3##(1991-2#1)(1994-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
of physical barriers##2##3##(2008-10#2)
of physical evidence##2##3##(2008-10#2)
of physical examination##3##3##(1990-10#1)(2008-8#1)(2010-8#1)
of physical exercise in##2##4##(1996-9#1)(2010-12#1)
of physical exercise##7##3##(1993-6#2)(1995-6#1)(1996-9#1)(2008-3#1)(2010-12#1)(2011-1#1)
of physical medicine##2##3##(2008-12#2)
of physical parameters##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
of physical properties##2##3##(2008-5#1)(2011-2#1)
of physical restraints##3##3##(2010-10#3)
of physical therapists##2##3##(1993-12#1)(2011-2#1)
of physical therapy in##2##4##(1993-3#1)(2008-7#1)
of physical therapy students##3##4##(1995-3#2)(2011-2#1)
of physical therapy##11##3##(1991-3#1)(1993-3#1)(1995-3#2)(1996-1#1)(2008-12#2)(2008-7#2)(2010-3#1)(2011-2#1)
of physical training on##2##4##(2013-8#2)
of physical training##4##3##(2013-1#2)(2013-8#2)
of physical##149##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#9)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-11#7)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#5)(2012-3#2)(2013-1#14)(2013-8#11)
of physically##3##2##(1995-2#1)(2008-7#1)(2008-9#1)
of physician P4P##2##3##(2008-4#2)
of physician leaders##2##3##(1994-1#1)(2008-11#1)
of physician payment reform##2##4##(1994-1#2)
of physician performance##4##3##(1996-3#1)(2013-1#3)
of physician services##2##3##(1993-12#1)(1995-12#1)
of physician##33##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#5)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-4#2)(2013-1#5)
of physician-specific health care data##3##5##(1994-2#3)
of physician-specific##4##2##(1994-2#4)
of physicians and hospitals##5##4##(1992-11#1)(1992-12#1)(1993-12#1)(1994-1#1)(1997-5#1)
of physicians and nurses to##2##5##(1993-2#1)(2008-11#1)
of physicians and other##2##4##(1994-3#1)(1996-2#1)
of physicians and##17##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-11#1)
of physicians in##9##3##(1994-3#6)(1996-12#1)(2007-7#1)(2010-12#1)
of physicians to##5##3##(1994-1#2)(1994-2#1)(1995-1#1)(2008-4#1)
of physicians##65##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#4)(1994-2#2)(1994-3#7)(1995-1#3)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-3#1)(2010-1#2)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
of physicians'##9##2##(1991-2#1)(1991-3#2)(1992-12#1)(1994-1#1)(1995-12#1)(1995-2#1)(2011-1#1)(2011-2#1)
of physico-chemical##3##2##(1997-2#1)(2008-10#2)
of physicochemical parameters##2##3##(1996-5#1)(2008-10#1)
of physicochemical##4##2##(1996-5#1)(2007-11#1)(2008-10#1)(2013-1#1)
of physics##3##2##(1991-5#1)(1996-4#2)
of physiologic##5##2##(2006-10#1)(2009-9#1)(2010-7#1)(2012-3#1)(2013-1#1)
of physiological and##6##3##(1991-2#1)(1992-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
of physiological changes##2##3##(2008-8#1)(2008-9#1)
of physiological functions##4##3##(2008-5#1)(2008-7#1)(2011-2#2)
of physiological responses##2##3##(2008-10#1)(2008-6#1)
of physiological thoracic kyphosis##2##4##(2007-11#2)
of physiological##39##2##(1990-11#1)(1991-2#2)(1992-6#1)(1993-1#1)(1993-5#1)(1996-2#1)(2007-11#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-7#1)
of physiologically relevant##2##3##(1994-8#1)(2011-2#1)
of physiologically##4##2##(1990-8#1)(1994-8#1)(2008-10#1)(2011-2#1)
of physiology##7##2##(2007-8#1)(2008-1#1)(2009-11#1)(2012-2#3)(2013-8#1)
of physiotherapeutic provision for patients undergoing##2##6##(2012-12#2)
of physiotherapists and##2##3##(1996-1#1)(1996-2#1)
of physiotherapists##5##2##(1993-1#1)(1994-3#1)(1996-1#1)(1996-2#1)(2009-7#1)
of physiotherapy##12##2##(1990-6#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-2#1)(1995-3#1)(2007-8#2)(2012-1#1)(2012-12#3)
of phytase##3##2##(2010-2#3)
of phytoalexins##2##2##(2008-10#2)
of phytochemicals##4##2##(2008-7#3)(2013-1#1)
of phytochrome action##2##3##(1990-5#2)
of phytoene##3##2##(1990-7#1)(1995-2#2)
of phytoestrogens##3##2##(2008-10#2)(2012-2#1)
of phytohormones##3##2##(2008-10#3)
of phytopathogenic##3##2##(2008-10#3)
of phytophthora##2##2##(2008-10#2)
of phytoplankton blooms##2##3##(2008-3#1)(2008-8#1)
of phytoplankton##15##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#5)(2008-9#2)(2009-8#1)(2013-8#1)
of phytoplasma in the##2##4##(2008-10#2)
of phytoplasma in##6##3##(2008-10#6)
of phytoplasma##14##2##(2008-10#14)
of phytoplasmas in the##2##4##(2008-10#2)
of phytoplasmas were##2##3##(2008-10#2)
of phytoplasmas##13##2##(2008-10#13)
of pi##3##2##(2008-3#2)(2008-8#1)
of pica##2##2##(1995-11#1)(1996-11#1)
of picosecond pulses##3##3##(2008-2#2)(2008-3#1)
of picosecond##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
of picoseconds##2##2##(2008-3#2)
of picrate anions##2##3##(2008-10#2)
of picric acid##4##3##(2008-10#4)
of pieces of##2##3##(1994-3#1)(2008-2#1)
of piezoelectric immunosensors for##2##4##(2008-10#2)
of piezoelectric quartz crystal (PQC)##2##5##(2008-10#2)
of piezoelectric quartz crystal##4##4##(2008-10#4)
of piezoelectric quartz##5##3##(1990-8#1)(2008-10#4)
of piezoelectric##8##2##(1990-8#1)(2008-10#7)
of pig##11##2##(1990-12#1)(1993-3#1)(1995-6#1)(2006-6#1)(2008-12#1)(2008-3#2)(2008-5#1)(2011-1#2)(2013-1#1)
of pigeon herpes virus (PHV)##2##5##(2008-5#2)
of pigeon##4##2##(1997-6#1)(2008-5#2)(2008-6#1)
of pigeons##4##2##(1990-11#1)(2011-2#3)
of piglets from##2##3##(1996-8#1)(2013-1#1)
of pigment substitution on the electrochemical properties of Rhodobacter sphaeroides 601 reaction centers##2##13##(2008-8#2)
of pigment substitution##4##3##(2008-8#4)
of pigment##9##2##(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#4)(2013-1#1)
of pigmentation##2##2##(2008-10#1)(2008-8#1)
of pigmented and wooden surfaces##2##5##(2008-10#2)
of pigmented skin##2##3##(1997-5#1)(2011-2#1)
of pigmented surfaces##2##3##(2008-10#2)
of pigmented##9##2##(1997-5#1)(2008-10#4)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
of pigments and##2##3##(2008-10#2)
of pigments##6##2##(2008-10#4)(2008-3#1)(2008-8#1)
of pigs and the##2##4##(2011-1#2)
of pigs in##2##3##(2011-2#1)(2013-8#1)
of pigs with##2##3##(2012-2#1)(2012-3#1)
of pigs##10##2##(1991-6#1)(1996-11#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
of pilE##2##2##(1993-12#2)
of pilimiction##2##2##(2009-7#2)
of pilot##2##2##(1996-3#1)(2010-3#1)
of pindolol##6##2##(1995-6#1)(1997-5#1)(2008-10#4)
of pine##2##2##(2008-10#2)
of pineal##4##2##(1994-5#2)(2008-5#1)(2012-2#1)
of pineapple##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
of pinoresinol diglucoside##2##3##(2011-1#2)
of piperidine##2##2##(1993-8#1)(2008-11#1)
of piroxicam (PX) in##2##4##(2008-10#2)
of piroxicam##6##2##(1990-9#1)(2008-10#5)
of pistachio in California##2##4##(2008-10#2)
of pistachio in california##2##4##(2008-10#2)
of pistachio in##4##3##(2008-10#4)
of pistachio##10##2##(2008-10#10)
of pitfalls##4##2##(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
of pituitary adenomas##2##3##(1995-9#1)(2011-2#1)
of pituitary apoplexy##2##3##(2011-2#2)
of pituitary##16##2##(1992-12#1)(1993-5#2)(1994-12#1)(1994-9#1)(1995-9#1)(1996-11#1)(2009-1#1)(2009-4#1)(2011-2#5)(2012-2#1)(2013-8#1)
of pityriasis versicolor##3##3##(2007-7#1)(2008-5#2)
of pivotal##4##2##(1990-3#1)(1997-8#1)(2011-2#1)(2013-1#1)
of pixel##3##2##(2007-12#1)(2008-3#2)
of pixels in the##3##4##(2008-2#1)(2008-3#2)
of pixels that##2##3##(2007-11#1)(2008-8#1)
of pixels##8##2##(2007-11#2)(2008-2#2)(2008-3#3)(2008-8#1)
of place##7##2##(1994-3#1)(1996-1#1)(2008-11#3)(2013-1#2)
of placebo##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2010-9#1)(2013-1#1)
of placental##6##2##(1994-9#1)(1996-11#1)(1996-12#2)(2008-11#1)(2009-7#1)
of places##2##2##(2011-1#1)(2012-12#1)
of placing the##2##3##(1992-12#1)(2007-11#1)
of placing##4##2##(1992-12#1)(1993-6#1)(2007-11#1)(2013-1#1)
of plain radiography##2##3##(2010-6#1)(2011-2#1)
of plain##4##2##(2007-2#1)(2008-5#1)(2010-6#1)(2011-2#1)
of plan##3##2##(1994-2#1)(1997-3#2)
of planar waveguides##3##3##(2007-11#1)(2008-3#2)
of planar##13##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-6#1)(2012-2#1)
of plane warts##2##3##(2013-1#2)
of plane##4##2##(2008-3#2)(2013-1#2)
of planes##3##2##(2007-12#1)(2009-10#1)(2010-8#1)
of planned visits##2##3##(1992-3#2)
of planned##8##2##(1992-3#3)(1994-1#1)(2008-7#1)(2010-6#1)(2012-2#1)(2012-3#1)
of planning and##4##3##(1991-1#1)(1994-6#1)(1995-5#1)(2009-11#1)
of planning##16##2##(1991-1#1)(1991-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-11#2)(2008-2#1)(2009-10#1)(2009-11#1)
of plans##2##2##(1996-3#1)(2008-11#1)
of plant TFs##2##3##(2008-7#1)(2011-2#1)
of plant age##3##3##(2008-10#3)
of plant and animal##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
of plant and##7##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-10#1)
of plant biology##3##3##(2007-12#1)(2008-9#1)(2012-1#1)
of plant cell walls##4##4##(2008-9#1)(2009-10#1)(2013-8#2)
of plant cell##7##3##(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#3)
of plant cells by##2##4##(2008-11#1)(2009-8#1)
of plant cells##7##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#3)
of plant chromosomes##2##3##(2008-9#2)
of plant defense reactions##2##4##(2008-10#2)
of plant defense##5##3##(2008-10#4)(2008-8#1)
of plant development##5##3##(2008-10#4)(2009-8#1)
of plant disease epidemics##5##4##(2008-10#5)
of plant disease##7##3##(2008-10#7)
of plant diseases##5##3##(2008-10#5)
of plant extracts on the##2##5##(2008-12#1)(2008-5#1)
of plant extracts##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
of plant gene expression##2##4##(1995-2#1)(2008-9#1)
of plant growth regulators##2##4##(2008-10#1)(2008-12#1)
of plant growth##7##3##(2008-10#4)(2008-12#1)(2011-2#1)(2013-8#1)
of plant growth-promoting rhizobacteria##3##4##(2008-10#3)
of plant keratin intermediate##2##4##(2008-8#2)
of plant materials##2##3##(2008-10#2)
of plant or##2##3##(2008-1#1)(2008-7#1)
of plant origin##6##3##(1994-5#1)(2008-10#1)(2012-2#1)(2013-8#3)
of plant pathogen##2##3##(2008-10#2)
of plant pathogens by##2##4##(2008-10#2)
of plant pathogens##16##3##(2008-10#16)
of plant protection products##4##4##(2008-11#3)(2013-8#1)
of plant protoplasts##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
of plant responses to##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
of plant roots##4##3##(2008-10#3)(2009-8#1)
of plant samples##3##3##(2008-10#2)(2008-9#1)
of plant species##9##3##(2008-10#3)(2008-7#1)(2008-8#2)(2009-8#1)(2013-7#2)
of plant tissue##3##3##(2008-10#2)(2008-9#1)
of plant viral##2##3##(2008-9#2)
of plant viruses by##2##4##(2008-10#2)
of plant viruses##13##3##(2008-10#9)(2008-9#3)(2010-10#1)
of plant water##2##3##(2008-10#1)(2009-8#1)
of plant##217##2##(1994-5#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-4#1)(1997-8#1)(2007-12#3)(2008-1#2)(2008-10#95)(2008-11#6)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#15)(2008-9#21)(2009-10#3)(2009-6#4)(2009-8#16)(2010-10#1)(2011-1#1)(2011-10#2)(2011-2#4)(2012-1#2)(2012-2#5)(2012-3#1)(2012-6#1)(2013-7#3)(2013-8#8)
of plant-associated microbes##2##3##(2008-10#2)
of plant-derived##2##2##(2008-10#1)(2012-12#1)
of plant-herbivore##2##2##(2008-8#1)(2008-9#1)
of plant-parasitic nematodes##2##3##(2008-10#2)
of plant-pathogenic##2##2##(2008-10#2)
of plant-virus##2##2##(2008-10#2)
of plantar##3##2##(2008-7#1)(2010-3#1)(2012-2#1)
of planthoppers##2##2##(2008-10#2)
of planting##6##2##(2008-10#5)(2008-12#1)
of plants and animals##2##4##(2008-6#1)(2008-9#1)
of plants and##6##3##(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)
of plants in the##4##4##(2008-10#3)(2010-7#1)
of plants in##6##3##(2008-10#4)(2008-12#1)(2010-7#1)
of plants inoculated##2##3##(2008-10#2)
of plants of##2##3##(1996-4#1)(2008-10#1)
of plants to##11##3##(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#1)(2009-8#2)(2011-2#1)(2012-5#1)
of plants were##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
of plants with##6##3##(2008-10#5)(2008-9#1)
of plants within##2##3##(2008-10#2)
of plants##89##2##(1992-8#1)(1996-4#1)(2008-10#53)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#4)(2010-7#2)(2011-2#3)(2012-5#1)(2013-7#2)(2013-8#3)
of plaque and##2##3##(2008-7#1)(2012-3#1)
of plaque vulnerability##2##3##(2008-8#2)
of plaque##18##2##(2006-10#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-12#1)(2010-9#4)(2012-3#1)(2013-1#1)
of plaques and##2##3##(1991-1#1)(2012-2#1)
of plaques##9##2##(1990-5#1)(1991-1#1)(1991-10#1)(1992-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
of plasma and##3##3##(1994-12#1)(2008-3#1)(2013-1#1)
of plasma cells##2##3##(2008-9#2)
of plasma corticosterone##2##3##(1994-2#1)(1995-3#1)
of plasma diacyl-PC##2##3##(1994-12#2)
of plasma glucose##2##3##(1991-12#1)(1991-7#1)
of plasma homocysteine##3##3##(1991-12#1)(1992-9#1)(2008-3#1)
of plasma jet##2##3##(2013-8#2)
of plasma levels of##2##4##(1990-12#1)(1992-11#1)
of plasma levels##3##3##(1990-12#1)(1990-8#1)(1992-11#1)
of plasma membrane##14##3##(1990-11#1)(1990-5#2)(1992-12#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)
of plasma membranes##5##3##(1991-5#1)(1993-6#1)(2008-10#1)(2008-11#2)
of plasma or lipoprotein fraction##2##5##(1990-8#2)
of plasma or##3##3##(1990-8#2)(1991-12#1)
of plasma phosphatidylcholine##2##3##(1995-8#2)
of plasma platelet-activating factor##2##4##(1997-7#2)
of plasma proteins##2##3##(2010-12#1)(2011-2#1)
of plasma samples##3##3##(1993-2#1)(1993-9#1)(2008-10#1)
of plasma##116##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-8#3)(1991-12#3)(1991-3#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#4)(1994-2#3)(1994-6#2)(1994-8#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#2)(1996-11#1)(1997-7#3)(1997-8#1)(2007-10#4)(2007-11#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#8)(2008-9#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
of plasma-deposited##2##2##(2008-2#2)
of plasma-derived##2##2##(2010-11#1)(2012-12#1)
of plasmapheresis##2##2##(2013-1#1)(2013-8#1)
of plasmepsin-4##2##2##(2012-2#2)
of plasmid DNA into##2##4##(2008-2#1)(2008-4#1)
of plasmid DNA##15##3##(1997-8#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2008-8#2)(2011-2#1)
of plasmid and##2##3##(2008-11#1)(2008-2#1)
of plasmid delivery##2##3##(2008-11#1)(2012-2#1)
of plasmid##27##2##(1994-12#1)(1994-3#1)(1995-8#3)(1997-8#2)(2007-7#1)(2008-10#4)(2008-11#8)(2008-2#2)(2008-4#1)(2008-8#2)(2011-2#1)(2012-2#1)
of plasmids into##2##3##(1992-11#1)(2008-11#1)
of plasmids##9##2##(1992-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-11#1)(2011-2#1)
of plasmin##3##2##(1995-2#1)(2011-2#2)
of plasminogen activation##2##3##(1997-2#2)
of plasminogen activator inhibitor-1##3##4##(1993-12#1)(1997-1#1)(2008-4#1)
of plasminogen activator##4##3##(1993-12#1)(1994-3#1)(1997-1#1)(2008-4#1)
of plasminogen activators##2##3##(1992-6#2)
of plasminogen##14##2##(1990-12#1)(1991-6#1)(1992-6#2)(1993-12#1)(1994-3#1)(1995-6#1)(1997-1#1)(1997-2#4)(2008-4#1)(2010-3#1)
of plasmonic##2##2##(2007-11#1)(2008-7#1)
of plastic surgery##4##3##(2010-8#2)(2013-1#2)
of plastic##14##2##(1994-10#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-8#3)(2013-1#2)
of plasticity##8##2##(2008-2#1)(2008-8#6)(2009-3#1)
of plasticizer and##2##3##(2008-10#2)
of plasticizer##4##2##(2008-10#4)
of plasticizers##5##2##(2008-10#3)(2008-5#1)(2010-5#1)
of plastocyanin##2##2##(1993-11#1)(2009-10#1)
of platanus##2##2##(2013-8#2)
of plate##3##2##(2007-11#1)(2008-10#2)
of platelet activation##4##3##(1990-5#1)(1994-3#1)(1997-7#1)(2008-7#1)
of platelet aggregation and##4##4##(1990-8#1)(1991-9#1)(1992-4#1)(1997-7#1)
of platelet aggregation in##2##4##(2006-6#1)(2008-5#1)
of platelet aggregation##9##3##(1990-5#1)(1990-8#1)(1991-9#1)(1992-4#1)(1997-7#2)(2006-6#2)(2008-5#1)
of platelet alpha-granules##3##3##(1997-7#3)
of platelet cholesterol##2##3##(1992-12#1)(1997-7#1)
of platelet count##2##3##(2007-10#1)(2009-8#1)
of platelet factor##2##3##(1990-5#1)(1992-8#1)
of platelet function##2##3##(1991-12#1)(2008-11#1)
of platelet##50##2##(1990-5#3)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-4#2)(1992-8#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-7#2)(1997-7#11)(2006-6#4)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-6#1)
of platelet-activating factor##2##3##(1991-5#1)(2008-3#1)
of platelet-derived growth factor##3##4##(1990-7#1)(1995-11#1)(2008-11#1)
of platelet-derived growth##4##3##(1990-7#1)(1995-11#2)(2008-11#1)
of platelet-leukocyte##2##2##(2006-6#2)
of platelet-rich plasma##2##3##(2006-6#1)(2012-12#1)
of platelets and##3##3##(1991-12#1)(2008-11#1)(2008-4#1)
of platelets by##3##3##(1992-12#1)(2006-6#1)(2008-9#1)
of platelets in##6##3##(1990-5#1)(1991-12#1)(2006-6#1)(2008-1#1)(2008-8#2)
of platelets on##2##3##(2006-6#1)(2008-11#1)
of platelets to##4##3##(1997-7#4)
of platelets with##3##3##(1992-12#1)(1992-8#1)(1993-11#1)
of platelets##36##2##(1990-11#1)(1990-5#2)(1991-12#2)(1992-12#3)(1992-6#1)(1992-8#1)(1993-11#1)(1994-9#1)(1997-2#1)(1997-7#6)(2006-6#6)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#3)(2011-2#1)
of platform##2##2##(2008-10#1)(2012-12#1)
of plating##2##2##(1994-3#1)(2011-1#1)
of platinum and palladium##6##4##(2008-10#6)
of platinum and ruthenium##3##4##(2008-10#3)
of platinum and##12##3##(2007-7#1)(2008-10#11)
of platinum group elements##2##4##(2008-10#1)(2008-11#1)
of platinum group metals##5##4##(2008-10#5)
of platinum group##8##3##(2008-10#7)(2008-11#1)
of platinum nanoparticles##3##3##(2010-4#3)
of platinum with a##2##4##(2008-10#2)
of platinum with##3##3##(2008-10#3)
of platinum##48##2##(1993-8#1)(2007-7#1)(2008-10#39)(2008-11#2)(2009-4#1)(2010-11#1)(2010-4#3)
of platinum(II) with##4##3##(2008-10#4)
of platinum(II)##8##2##(2008-10#7)(2013-1#1)
of platinum(IV)##5##2##(2008-10#5)
of play behaviors##2##3##(1993-12#2)
of play in##4##3##(1993-12#1)(2008-9#2)(2013-8#1)
of play##13##2##(1991-3#1)(1993-12#5)(2007-11#3)(2008-12#1)(2008-9#2)(2013-8#1)
of pleomorphic##5##2##(1991-12#1)(2007-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
of pleural effusion in##2##4##(2008-7#2)
of pleural effusion##9##3##(1997-4#1)(2007-7#1)(2008-1#1)(2008-7#3)(2013-1#3)
of pleural mesothelioma##2##3##(1997-5#1)(2007-8#1)
of pleural##19##2##(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-7#3)(2010-3#1)(2013-1#3)
of ploidy##4##2##(1993-1#1)(2010-3#3)
of plots##7##2##(2008-10#4)(2008-12#1)(2008-8#2)
of plum##3##2##(2008-10#2)(2010-4#1)
of pluripotent stem cells##3##4##(2008-9#1)(2009-3#2)
of pluripotent##4##2##(2008-11#1)(2008-9#1)(2009-3#2)
of plutonium##2##2##(2008-10#2)
of pneumatic##2##2##(2008-10#2)
of pneumatosis intestinalis##3##3##(2012-2#3)
of pneumatosis##4##2##(2012-2#4)
of pneumococcal endocarditis##2##3##(1997-2#2)
of pneumococcal##11##2##(1990-9#1)(1995-3#4)(1997-2#2)(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#1)
of pneumocoeles##5##2##(2012-2#5)
of pneumoconiosis]##2##2##(2012-2#1)(2013-8#1)
of pneumonia##5##2##(1996-9#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
of pneumonic##2##2##(2008-5#2)
of pneumothorax##4##2##(1990-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
of podocyte##2##2##(2008-1#1)(2011-2#1)
of podocytes##2##2##(2008-1#2)
of podophyllotoxin##4##2##(2008-11#4)
of podoplanin##2##2##(2013-1#2)
of pods##2##2##(2008-12#2)
of poikilothermic##4##2##(2008-7#3)(2008-9#1)
of point images##2##3##(2008-3#2)
of point mutations in##2##4##(2008-10#1)(2008-7#1)
of point mutations##5##3##(1991-5#1)(1994-9#1)(2008-10#1)(2008-7#1)(2011-1#1)
of point##11##2##(1991-5#1)(1994-9#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
of pointing##3##2##(2008-2#1)(2008-3#2)
of points in##2##3##(2008-11#1)(2008-3#1)
of points of##2##3##(2008-2#1)(2008-3#1)
of points##13##2##(1997-6#1)(2007-11#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)
of poisoning##4##2##(1990-9#1)(2008-12#1)(2011-2#2)
of poisonous mushrooms##2##3##(2008-5#1)(2011-2#1)
of pokeweed antiviral protein##2##4##(2008-8#2)
of polar and nonpolar##2##4##(2008-10#1)(2013-8#1)
of polar and##4##3##(2008-10#2)(2012-3#1)(2013-8#1)
of polar surface##2##3##(1992-5#2)
of polar##13##2##(1992-5#2)(1992-6#1)(2008-10#4)(2008-3#1)(2009-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
of polarimetric##3##2##(2008-3#3)
of polarity##4##2##(1997-2#1)(2008-10#1)(2009-8#1)(2012-1#1)
of polarizability of##2##3##(2008-10#1)(2008-3#1)
of polarization and##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of polarization are##2##3##(2008-2#2)
of polarization changing and##2##4##(2008-2#2)
of polarization for##3##3##(2008-3#3)
of polarization in##2##3##(2008-2#2)
of polarization is##2##3##(2008-3#2)
of polarization mode dispersion (PMD) in spun fibers##2##8##(2007-11#2)
of polarization mode dispersion (PMD)##3##5##(2007-11#3)
of polarization mode dispersion##7##4##(2007-11#5)(2007-12#2)
of polarization of light##2##4##(2007-12#1)(2008-3#1)
of polarization of the##4##4##(2008-2#1)(2008-3#3)
of polarization of##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
of polarization##75##2##(2007-11#10)(2007-12#9)(2008-10#1)(2008-2#21)(2008-3#32)(2011-1#1)(2013-8#1)
of polarization-dependent##2##2##(2007-11#1)(2007-12#1)
of polarization-mode dispersion##2##3##(2007-11#1)(2008-3#1)
of polarization-selective##2##2##(2008-3#2)
of polarization-sensitive optical coherence tomography##4##5##(2007-11#2)(2007-12#1)(2008-3#1)
of polarization-sensitive##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
of polarized light##9##3##(2007-12#1)(2008-2#3)(2008-3#5)
of polarized##15##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#9)(2009-10#1)
of polarizers##2##2##(2007-11#1)(2008-1#1)
of polarizing##3##2##(1993-12#2)(2008-2#1)
of polarographic##2##2##(2008-10#2)
of poled polymer##2##3##(2008-2#1)(2008-3#1)
of poled##7##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
of policies and programs##2##4##(2008-11#1)(2008-9#1)
of policies and##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)
of policies for##2##3##(1995-1#1)(2007-5#1)
of policies##12##2##(1993-12#1)(1995-1#1)(1996-1#2)(2007-5#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#2)
of policy and##2##3##(2008-6#1)(2013-8#1)
of policy to##2##3##(2008-7#1)(2010-10#1)
of policy##20##2##(1990-12#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2008-7#4)(2010-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of policy-relevant##2##2##(1995-1#1)(2008-11#1)
of poliomyelitis##4##2##(1994-8#1)(1994-9#1)(1995-5#1)(2009-3#1)
of poliovirus vaccine##2##3##(2007-10#2)
of poliovirus##5##2##(1993-6#1)(1995-5#1)(2007-10#2)(2011-1#1)
of polish child orthopedics##2##4##(2007-8#2)
of polish orthopaedics##2##3##(2007-8#2)
of polish##8##2##(2007-8#8)
of polishing##3##2##(2008-10#1)(2008-2#2)
of political and financial##2##4##(1996-2#1)(1997-1#1)
of political and##5##3##(1995-2#1)(1996-2#1)(1997-1#1)(2011-2#1)(2013-1#1)
of political##12##2##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#3)(2013-1#1)
of pollen discounting and##2##4##(2008-9#2)
of pollen grains##3##3##(2008-10#2)(2013-8#1)
of pollen limitation##2##3##(2008-8#1)(2008-9#1)
of pollen transfer##2##3##(2008-8#2)
of pollen tubes##4##3##(2008-10#1)(2009-10#1)(2009-12#2)
of pollen##27##2##(1996-5#1)(2007-12#1)(2008-10#6)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#4)(2011-2#1)(2012-7#1)(2013-8#2)
of pollination##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
of pollutant##4##2##(1992-3#1)(2008-11#2)(2013-1#1)
of pollutants in a##2##4##(2008-10#2)
of pollutants in##3##3##(2008-10#3)
of pollutants##12##2##(1991-3#1)(1994-3#1)(1995-11#1)(2008-10#9)
of pollution##11##2##(1990-8#1)(2007-5#2)(2008-10#4)(2008-11#2)(2013-8#2)
of poly##4##2##(2008-10#1)(2009-10#1)(2009-11#1)(2011-2#1)
of poly(A)+##2##2##(1992-8#1)(2008-2#1)
of poly(ADP-ribose) polymerase##4##3##(1992-3#1)(1994-10#1)(2008-1#1)(2011-2#1)
of poly(ADP-ribose) synthetase in##2##4##(1993-6#2)
of poly(ADP-ribose) synthetase##3##3##(1993-6#3)
of poly(ADP-ribose)##9##2##(1992-3#1)(1993-6#3)(1994-10#1)(2008-1#3)(2011-2#1)
of poly(ADP-ribose)polymerase##2##2##(1991-12#1)(1994-10#1)
of poly(ethylene terephthalate)##3##3##(2008-10#3)
of poly(ethylene##7##2##(2008-10#5)(2009-10#1)(2010-12#1)
of poly(methyl methacrylate) (PMMA)##2##4##(2008-10#1)(2008-3#1)
of poly(sodium##2##2##(2008-10#2)
of poly(vinyl##2##2##(2008-10#2)
of poly-L-lysine##3##2##(2008-10#1)(2008-11#2)
of polyadenylated##2##2##(2010-4#2)
of polyadenylation##2##2##(1997-4#1)(2010-4#1)
of polyamine##3##2##(1992-9#1)(1997-3#1)(2013-8#1)
of polyamines and##3##3##(2008-10#2)(2008-7#1)
of polyamines##10##2##(1997-3#1)(2008-10#6)(2008-7#1)(2009-8#2)
of polyaniline fiber##2##3##(2008-10#2)
of polyaniline##9##2##(2008-10#6)(2008-7#2)(2010-4#1)
of polyanions##4##2##(2008-10#4)
of polyaromatic hydrocarbons##3##3##(2008-10#3)
of polyaromatic##4##2##(2008-10#4)
of polyarteritis nodosa##2##3##(1997-8#1)(2006-10#1)
of polyarteritis##3##2##(1990-9#1)(1997-8#1)(2006-10#1)
of polyatomic##2##2##(2008-10#2)
of polybrominated diphenyl ethers (PBDEs)##2##5##(2008-10#2)
of polybrominated diphenyl ethers##5##4##(2008-10#5)
of polybrominated##6##2##(2008-10#6)
of polycarbonate and##2##3##(2008-10#1)(2008-4#1)
of polycarbonate##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
of polychlorinated biphenyls (PCBs)##2##4##(2008-10#2)
of polychlorinated biphenyls in##2##4##(2008-10#2)
of polychlorinated biphenyls##5##3##(1996-12#1)(2008-10#4)
of polychlorinated##6##2##(1996-12#1)(2008-10#5)
of polychromatic##3##2##(2008-4#1)(2008-9#2)
of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodies##2##8##(2008-4#2)
of polyclonal and monoclonal##3##4##(2008-4#3)
of polyclonal and##4##3##(2008-4#4)
of polyclonal immunoglobulin synthesis##3##4##(2008-4#3)
of polyclonal##9##2##(2008-10#1)(2008-4#8)
of polycyclic aromatic compounds##2##4##(2008-10#2)
of polycyclic aromatic hydrocarbon##2##4##(1994-6#1)(2008-10#1)
of polycyclic aromatic hydrocarbons (PAHs) from##2##6##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) in airborne particulate matter##2##9##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) in##7##6##(2008-10#6)(2010-5#1)
of polycyclic aromatic hydrocarbons (PAHs)##13##5##(2008-10#12)(2010-5#1)
of polycyclic aromatic hydrocarbons and##3##5##(2008-10#2)(2008-11#1)
of polycyclic aromatic hydrocarbons by##3##5##(2008-10#3)
of polycyclic aromatic hydrocarbons from##2##5##(2008-10#2)
of polycyclic aromatic hydrocarbons in water samples##3##7##(2008-10#3)
of polycyclic aromatic hydrocarbons in water##4##6##(2008-10#4)
of polycyclic aromatic hydrocarbons in##8##5##(2008-10#8)
of polycyclic aromatic hydrocarbons using##2##5##(2008-10#2)
of polycyclic aromatic hydrocarbons##34##4##(2008-10#32)(2008-11#1)(2010-5#1)
of polycyclic aromatic##38##3##(1994-6#1)(2008-10#35)(2008-11#1)(2010-5#1)
of polycyclic##39##2##(1994-6#1)(2008-10#35)(2008-11#1)(2010-5#1)(2013-7#1)
of polycystic ovary syndrome (PCOS)##3##5##(2008-4#3)
of polycystic##5##2##(2008-3#1)(2008-4#4)
of polycythemia##2##2##(1990-12#1)(1993-9#1)
of polyelectrolyte##2##2##(2008-7#1)(2009-12#1)
of polyelectrolytes##2##2##(2008-10#1)(2009-11#1)
of polyester containing cyanoazobenzene units in the side chain##2##9##(2007-12#2)
of polyester##4##2##(2007-12#2)(2008-3#2)
of polyethylene glycol (PEG)##2##4##(2008-10#2)
of polyethylene glycol##6##3##(1992-11#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-3#1)
of polyethylene##10##2##(1990-4#1)(1992-11#1)(1993-11#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
of polyethyleneglycol (PEG)##2##3##(2008-10#1)(2008-12#1)
of polyethyleneglycol##3##2##(1994-11#1)(2008-10#1)(2008-12#1)
of polyethyleneimine (PEI)##2##3##(2008-10#2)
of polyethyleneimine##3##2##(2008-10#3)
of polygalacturonase##2##2##(1997-2#1)(2008-10#1)
of polygenic##2##2##(2008-7#1)(2013-1#1)
of polyhydric phenols##2##3##(2008-10#2)
of polyhydroxy phenols##2##3##(2008-10#2)
of polymer beads##2##3##(2008-7#2)
of polymer brush-modified##2##3##(2010-7#2)
of polymer film##3##3##(2008-10#3)
of polymer films##2##3##(2007-12#1)(2008-5#1)
of polymer modified electrode##2##4##(2008-10#2)
of polymer##39##2##(1996-12#1)(2007-12#3)(2008-10#15)(2008-3#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#2)(2010-5#2)(2010-7#3)(2013-1#2)
of polymer-based##2##2##(2008-10#1)(2010-10#1)
of polymer-supported##2##2##(1997-4#1)(2007-11#1)
of polymerase chain reaction (PCR)##5##5##(1990-3#1)(1991-1#1)(1995-12#1)(2008-10#1)(2008-7#1)
of polymerase chain reaction##13##4##(1990-3#1)(1991-1#1)(1992-8#1)(1995-12#1)(1996-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
of polymerase chain##14##3##(1990-3#1)(1991-1#1)(1992-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
of polymerase##15##2##(1990-3#1)(1991-1#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
of polymeric galactoglucomannans##2##3##(2013-1#2)
of polymeric resin##2##3##(2008-10#2)
of polymeric##19##2##(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#2)
of polymerization##8##2##(1990-6#1)(2008-10#3)(2008-2#1)(2013-1#3)
of polymers in##2##3##(2007-12#1)(2010-10#1)
of polymers through##2##3##(2007-11#1)(2008-9#1)
of polymers##16##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
of polymethacrylates##2##2##(2008-10#1)(2009-8#1)
of polymorphic N-acetyltransferase##2##3##(1993-3#1)(1995-9#1)
of polymorphic loci##4##3##(2008-10#3)(2008-9#1)
of polymorphic##12##2##(1993-3#1)(1995-9#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
of polymorphism than##2##3##(2008-10#1)(2008-5#1)
of polymorphism##8##2##(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2010-3#1)
of polymorphisms in the##2##4##(2008-7#1)(2010-11#1)
of polymorphisms in##3##3##(2008-7#1)(2010-11#1)(2012-1#1)
of polymorphisms##9##2##(1997-9#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
of polymorphonuclear leukocytes##2##3##(2008-12#1)(2010-1#1)
of polymorphonuclear##5##2##(1990-12#2)(1991-11#1)(2008-12#1)(2010-1#1)
of polymyalgia rheumatica##2##3##(1994-9#1)(2008-7#1)
of polymyxins on the##2##4##(2008-10#2)
of polynuclear aromatic hydrocarbons (PAHs)##2##5##(2008-10#2)
of polynuclear aromatic hydrocarbons in##2##5##(2008-10#2)
of polynuclear aromatic hydrocarbons##5##4##(1994-9#1)(2008-10#4)
of polynucleated PAM##2##3##(1993-8#2)
of polyoxometalates##3##2##(2008-10#3)
of polypeptide##6##2##(1991-10#1)(1994-11#1)(1996-2#1)(1997-6#1)(2008-4#1)(2012-1#1)
of polypeptides##8##2##(1994-11#2)(1995-12#1)(1997-4#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
of polyphenol oxidase##5##3##(2008-10#5)
of polyphenol##6##2##(2008-10#5)(2009-12#1)
of polyphenolic compounds##2##3##(1992-9#1)(2008-10#1)
of polyphenols in##4##3##(2008-10#2)(2009-12#1)(2009-3#1)
of polyphenols##10##2##(2008-10#3)(2008-7#1)(2009-12#3)(2009-3#2)(2009-8#1)
of polyphosphates in##2##3##(1994-11#1)(2008-10#1)
of polyphosphates##5##2##(1994-11#2)(1996-5#1)(2008-10#2)
of polypoid##3##2##(2008-1#1)(2009-2#1)(2013-1#1)
of polypropylene fiber liquid filtration membrane particles##2##7##(2012-3#2)
of polypropylene##3##2##(2012-3#3)
of polyps##3##2##(1996-12#1)(2008-1#1)(2010-2#1)
of polysaccharide##4##2##(2009-10#1)(2009-3#1)(2012-3#1)(2013-8#1)
of polysaccharides in##2##3##(2008-10#1)(2011-2#1)
of polysaccharides##5##2##(1996-12#1)(2008-10#1)(2008-2#1)(2011-2#2)
of polysialic##2##2##(2009-8#2)
of polyspermy##2##2##(2008-8#2)
of polystyrene beads##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of polystyrene latex spheres##3##4##(2008-3#3)
of polystyrene microspheres##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of polystyrene spheres##3##3##(2008-3#3)
of polystyrene##16##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#9)
of polysubstituted##2##2##(2009-11#1)(2009-5#1)
of polyunsaturated fatty acids (PUFAs) in##2##6##(2008-10#1)(2010-4#1)
of polyunsaturated fatty acids (PUFAs)##3##5##(2008-10#1)(2008-5#1)(2010-4#1)
of polyunsaturated fatty acids of##2##5##(1994-11#1)(2012-2#1)
of polyunsaturated fatty acids##12##4##(1990-2#1)(1991-12#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-5#2)(2010-4#1)(2012-2#2)
of polyunsaturated##14##2##(1990-2#1)(1991-12#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-5#2)(2010-4#2)(2011-1#1)(2012-2#2)
of polyurethane coated##2##3##(2013-8#2)
of polyurethane coating##3##3##(2013-8#3)
of polyurethane##6##2##(2008-11#1)(2013-8#5)
of polyvalent##2##2##(1990-7#1)(2012-12#1)
of polyvinyl alcohol##3##3##(2008-10#3)
of polyvinyl pyrrolidone##2##3##(1990-12#1)(2008-5#1)
of polyvinyl##6##2##(1990-12#1)(1996-8#1)(2008-10#3)(2008-5#1)
of pome##2##2##(2008-10#2)
of pooled##2##2##(2008-10#1)(2009-11#1)
of pools##2##2##(1995-6#1)(2008-11#1)
of poor outcome##6##3##(2008-3#1)(2011-2#1)(2012-12#3)(2012-3#1)
of poor prognosis##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
of poor quality##4##3##(1995-5#1)(1995-9#1)(1997-6#1)(2007-2#1)
of poor responders##2##3##(2010-3#1)(2011-1#1)
of poor##47##2##(1993-12#1)(1993-3#2)(1995-2#1)(1995-5#1)(1995-9#2)(1996-11#1)(1997-6#1)(2007-12#1)(2007-2#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#7)
of poorer##3##2##(1992-2#1)(2008-5#1)(2012-3#1)
of poorly differentiated##3##3##(2006-8#1)(2011-2#1)(2012-3#1)
of poorly##6##2##(1994-12#1)(2006-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of poplar##4##2##(2008-10#2)(2011-2#2)
of popliteal lymph##2##3##(2008-11#1)(2008-5#1)
of popliteal##4##2##(1991-3#2)(2008-11#1)(2008-5#1)
of popular##5##2##(1993-1#1)(1995-2#1)(2007-6#1)(2009-10#1)(2011-2#1)
of population and##2##3##(2007-8#1)(2010-4#1)
of population bottlenecks##2##3##(1995-2#2)
of population data##2##3##(2008-10#1)(2008-12#1)
of population decline##2##3##(1995-3#1)(2008-10#1)
of population differentiation##2##3##(2008-10#2)
of population dynamics##2##3##(2008-10#1)(2010-8#1)
of population fluctuations##2##3##(2008-8#2)
of population genetics##4##3##(2008-8#3)(2009-5#1)
of population growth rate##2##4##(2008-8#1)(2010-8#1)
of population growth##6##3##(1991-3#1)(1994-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
of population regulation##3##3##(2008-8#3)
of population screening##2##3##(1990-6#1)(1996-8#1)
of population size##2##3##(2008-8#1)(2008-9#1)
of population structure##6##3##(2008-10#3)(2008-9#3)
of population subdivision##2##3##(2008-10#1)(2009-2#1)
of population##76##2##(1990-6#1)(1991-3#2)(1994-7#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#16)(2008-9#10)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-2#5)(2012-12#1)(2012-2#1)
of population-based##4##2##(1991-6#1)(1993-9#1)(1995-12#1)(1997-3#1)
of population-specific##2##2##(2008-10#1)(2012-3#1)
of populations and##2##3##(2008-7#1)(2011-2#1)
of populations as##2##3##(1995-12#2)
of populations from##5##3##(2008-10#4)(2008-9#1)
of populations in##2##3##(2008-8#1)(2008-9#1)
of populations of Phytophthora##2##4##(2008-10#2)
of populations of##11##3##(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
of populations on##2##3##(2008-9#1)(2013-7#1)
of populations##51##2##(1994-3#1)(1995-12#3)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#7)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of porcine Serpulina species##2##4##(1996-11#2)
of porcine aortic##2##3##(1990-7#1)(2009-7#1)
of porcine big##3##3##(1990-12#1)(1990-2#2)
of porcine coronary artery##3##4##(1990-8#1)(2008-11#2)
of porcine coronary##4##3##(1990-8#1)(1997-8#1)(2008-11#2)
of porcine embryos##2##3##(1996-8#2)
of porcine oocytes##2##3##(2013-1#2)
of porcine pancreatic alpha-amylase##4##4##(1990-9#2)(1992-12#2)
of porcine pancreatic elastase##2##4##(1991-3#2)
of porcine pancreatic##6##3##(1990-9#2)(1991-3#2)(1992-12#2)
of porcine##56##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#2)(1991-8#1)(1992-12#4)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-11#2)(1996-12#3)(1996-8#2)(1997-8#1)(2008-11#6)(2008-5#2)(2009-4#2)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)
of pore size##3##3##(1990-8#1)(2008-2#1)(2008-5#1)
of pore##5##2##(1990-8#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
of pore-forming##3##2##(1994-2#2)(2008-8#1)
of pores##4##2##(1994-2#2)(2008-10#2)
of porins##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
of pork##4##2##(1990-8#1)(2008-10#1)(2010-2#1)(2010-4#1)
of porogens##2##2##(2008-10#2)
of porosity##2##2##(2009-7#2)
of porous silicon##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
of porous##16##2##(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
of porphyrin fluorescence##2##3##(1991-5#2)
of porphyrin to##2##3##(2008-10#2)
of porphyrin##8##2##(1991-5#2)(1996-5#1)(2008-10#4)(2008-9#1)
of porphyrins##3##2##(1991-5#1)(1992-9#1)(2008-10#1)
of port##2##2##(2007-7#2)
of portable##3##2##(1994-2#2)(2010-8#1)
of portal hypertension##3##3##(2009-9#2)(2013-1#1)
of portal infusion of##2##4##(1993-12#2)
of portal thrombosis##2##3##(1990-3#1)(1990-8#1)
of portal##10##2##(1990-3#1)(1990-8#1)(1993-12#2)(1993-9#1)(2008-2#1)(2009-9#2)(2013-1#1)(2013-8#1)
of portals##4##2##(2008-10#4)
of portfolio development##2##3##(2008-11#2)
of portfolio##4##2##(2008-11#3)(2012-12#1)
of portfolios##5##2##(2008-11#4)(2012-12#1)
of position##8##2##(1992-8#1)(1993-11#1)(1996-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-3#1)
of positional atrial##2##3##(2009-4#2)
of positional isomers##2##3##(1995-11#1)(2008-10#1)
of positional##6##2##(1995-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2009-4#2)
of positioning##3##2##(1993-12#1)(2008-3#2)
of positions and##2##3##(1994-12#1)(2007-11#1)
of positive and negative affect##2##5##(2013-8#2)
of positive and negative##8##4##(1993-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2010-4#1)(2010-9#1)(2013-8#2)
of positive cases##3##3##(1990-6#1)(2012-12#1)(2013-8#1)
of positive clones##3##3##(1990-8#1)(1994-8#1)(2008-8#1)
of positive findings##2##3##(2008-10#1)(2012-2#1)
of positive or negative correlations##2##5##(2008-9#2)
of positive results##4##3##(1990-10#1)(1997-4#1)(2011-1#1)(2011-2#1)
of positive samples##3##3##(1996-12#1)(1997-6#1)(2011-2#1)
of positive##75##2##(1990-10#1)(1990-6#1)(1990-8#2)(1992-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-7#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#3)
of positively charged amino acids##2##5##(1995-5#1)(2008-8#1)
of positively charged##5##3##(1995-5#1)(2008-10#2)(2008-8#1)(2011-1#1)
of positron emission##3##3##(1992-11#1)(1995-11#1)(2012-12#1)
of possible complications##2##3##(2008-9#1)(2013-1#1)
of possible errors##2##3##(2008-3#1)(2011-2#1)
of possible inhibitory##2##3##(1994-5#1)(2008-7#1)
of possible sources of##2##4##(1995-3#1)(2008-10#1)
of possible ways##2##3##(2008-10#1)(2008-6#1)
of possible##68##2##(1990-11#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-5#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-5#2)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of possibly##3##2##(2008-10#2)(2009-9#1)
of post transplant hypertension##3##4##(2008-1#3)
of post transplant##4##3##(2008-1#4)
of post##11##2##(1991-9#1)(1996-12#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#1)(2011-2#2)
of post-ESD ulcers##2##3##(2012-2#2)
of post-ESD##3##2##(2012-2#3)
of post-QQc cells##2##3##(2012-12#2)
of post-adolescent acne##2##3##(2008-5#2)
of post-mortem##3##2##(2008-7#1)(2009-12#1)(2009-3#1)
of post-operative##6##2##(1991-5#1)(1997-7#1)(2007-8#3)(2009-3#1)
of post-partum##2##2##(1996-12#1)(2008-7#1)
of post-prandial lipoprotein##2##3##(2008-6#2)
of post-prandial##3##2##(2008-6#3)
of post-reaction operations##2##3##(2008-10#2)
of post-surgical##3##2##(1991-1#1)(2007-8#1)(2012-12#1)
of post-transcriptional##2##2##(2009-2#2)
of post-translational modification##2##3##(2009-7#1)(2011-1#1)
of post-translational modifications##3##3##(2008-11#1)(2009-5#1)(2010-9#1)
of post-translational##8##2##(1992-12#1)(2008-11#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-9#1)(2011-1#1)
of post-translationally modified##3##3##(2009-7#1)(2010-2#1)(2011-1#1)
of post-transplant##4##2##(2007-11#2)(2008-1#1)(2012-2#1)
of post-traumatic stress disorder##3##4##(2008-6#2)(2009-6#1)
of post-traumatic stress##5##3##(2008-6#2)(2009-6#1)(2012-1#1)(2012-12#1)
of post-traumatic##7##2##(1997-3#1)(2008-6#2)(2008-7#1)(2009-6#1)(2012-1#1)(2012-12#1)
of post-treatment##5##2##(1992-9#1)(2012-1#3)(2013-1#1)
of postactivation potentiation##2##3##(2009-1#2)
of postaxial polydactyly##2##3##(2010-4#2)
of postcoital##4##2##(1993-2#4)
of postconcussive##2##2##(2008-6#1)(2013-1#1)
of posterior cingulate cortex##2##4##(1993-12#2)
of posterior circulation##2##3##(2008-7#1)(2013-8#1)
of posterior composites in##2##4##(2009-2#2)
of posterior composites##5##3##(2009-2#5)
of posterior mediastinal##2##3##(2011-2#1)(2012-3#1)
of posterior pituitary##2##3##(1997-8#2)
of posterior urethral disruption injuries##2##5##(2013-8#2)
of posterior##30##2##(1993-12#2)(1997-8#2)(2007-11#1)(2007-12#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#6)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#4)
of posteromedial tibial plateau##2##4##(2013-1#2)
of postgraduate training##2##3##(1994-12#1)(1997-6#1)
of postgraduate##6##2##(1992-1#1)(1994-12#1)(1997-6#1)(2009-7#1)(2013-1#2)
of postharvest decay##2##3##(2008-10#2)
of postharvest pathogens##2##3##(2008-10#2)
of postharvest##11##2##(2008-10#11)
of postischemic##2##2##(1991-9#1)(1993-3#1)
of postmenopausal osteoporosis by##2##4##(2012-2#2)
of postmenopausal osteoporosis##6##3##(1993-11#1)(1995-11#1)(2012-2#4)
of postmenopausal women receiving bone loss medications##2##7##(2011-1#2)
of postmenopausal women##7##3##(1994-12#1)(2008-5#2)(2008-7#1)(2011-1#3)
of postmenopausal##18##2##(1991-4#1)(1992-12#1)(1993-11#2)(1994-12#1)(1995-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)(2011-1#3)(2012-2#4)
of postmortal##2##2##(2011-2#2)
of postmortem##5##2##(1992-8#1)(1995-3#1)(1996-12#2)(2008-7#1)
of postnatal transports##2##3##(1995-5#2)
of postnatal##10##2##(1992-12#1)(1995-5#2)(1995-6#1)(1996-5#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#2)
of postoperative adjuvant##2##3##(1994-7#1)(1997-7#1)
of postoperative complications##3##3##(2007-8#1)(2011-3#1)(2012-3#1)
of postoperative death##2##3##(2007-8#1)(2010-6#1)
of postoperative infection##3##3##(1992-6#1)(2008-8#1)(2011-2#1)
of postoperative infections##3##3##(1990-11#1)(1991-5#1)(2007-12#1)
of postoperative radiotherapy##2##3##(1990-10#1)(2008-7#1)
of postoperative respiratory##2##3##(2009-5#1)(2012-3#1)
of postoperative##54##2##(1990-10#1)(1990-11#1)(1991-11#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-7#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#9)(2008-10#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)
of postpartum depression##4##3##(2007-2#1)(2013-1#3)
of postpartum fistulas##2##3##(1996-12#2)
of postpartum##10##2##(1996-12#3)(2007-2#3)(2013-1#3)(2013-8#1)
of postprandial##2##2##(1997-4#1)(2008-12#1)
of postresuscitation myocardial##2##3##(2008-3#2)
of poststroke##3##2##(2008-2#1)(2009-11#1)(2013-1#1)
of postsynaptic##5##2##(1990-9#1)(1995-12#1)(1996-6#1)(2008-11#2)
of posttranscriptional gene silencing##2##4##(2008-10#2)
of posttranscriptional##3##2##(2008-10#2)(2013-1#1)
of posttraumatic stress##2##3##(2009-11#1)(2009-9#1)
of posttraumatic##5##2##(2007-12#2)(2008-8#1)(2009-11#1)(2009-9#1)
of postural##3##2##(1990-6#1)(2008-7#2)
of posture##3##2##(2007-12#2)(2012-3#1)
of potassium bromide##2##3##(2008-10#2)
of potassium channels##6##3##(1992-6#2)(2007-10#1)(2008-8#2)(2010-12#1)
of potassium ferricyanide##4##3##(2008-10#3)(2009-9#1)
of potassium iodide##4##3##(2007-7#1)(2008-10#2)(2010-12#1)
of potassium ion in##2##4##(2008-10#2)
of potassium ion##3##3##(2008-10#3)
of potassium ions in##2##4##(1994-12#1)(2008-10#1)
of potassium ions##3##3##(1994-12#1)(2008-10#2)
of potassium phosphate buffer##2##4##(2008-10#2)
of potassium phosphate##7##3##(2007-11#1)(2008-10#5)(2008-7#1)
of potassium##56##2##(1990-12#2)(1992-6#2)(1992-9#1)(1994-12#1)(1995-11#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#32)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-12#2)
of potato (cv##2##3##(2008-10#2)
of potato and tomato##4##4##(2008-10#4)
of potato and##5##3##(2008-10#5)
of potato cultivars##4##3##(2008-10#4)
of potato cvs##2##3##(2008-10#2)
of potato cyst##2##3##(2008-10#2)
of potato in the##2##4##(2008-10#2)
of potato late blight##6##4##(2008-10#6)
of potato or tomato##2##4##(2008-10#2)
of potato or##3##3##(2008-10#3)
of potato stem rot##2##4##(2008-10#2)
of potato virus X##2##4##(1997-3#1)(2010-9#1)
of potato virus y##2##4##(2008-10#2)
of potato virus##5##3##(1997-3#1)(2008-10#3)(2010-9#1)
of potato##60##2##(1993-12#2)(1997-3#1)(2008-10#54)(2008-5#1)(2008-9#1)(2010-9#1)
of potatoes##3##2##(2008-10#2)(2008-9#1)
of potency##12##2##(1991-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1995-12#4)(2009-12#1)(2013-1#1)
of potent##9##2##(1992-8#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
of potential DNA##2##3##(2008-2#1)(2011-1#1)
of potential adverse##2##3##(2008-10#1)(2011-2#1)
of potential and##3##3##(2008-10#1)(2008-11#2)
of potential applications in##2##4##(2008-7#1)(2010-6#1)
of potential applications##4##3##(2008-7#1)(2009-10#1)(2010-6#1)(2012-12#1)
of potential candidates##3##3##(1993-2#1)(1994-1#2)
of potential exposure##2##3##(2007-2#1)(2012-3#1)
of potential importance##2##3##(2008-5#1)(2008-7#1)
of potential interest##2##3##(2008-5#2)
of potential interferences##2##3##(2008-10#2)
of potential interfering ions on the determination of##2##8##(2008-10#2)
of potential interfering ions##4##4##(2008-10#4)
of potential interfering##5##3##(2008-10#5)
of potential markers##2##3##(2008-10#1)(2010-12#1)
of potential mates##5##3##(2008-8#5)
of potential of##2##3##(2007-10#1)(2008-8#1)
of potential pathogen##3##3##(2008-10#3)
of potential pathogens##2##3##(1994-6#1)(2007-12#1)
of potential snail-borne disease transmission##2##5##(2008-8#2)
of potential sources of##2##4##(2008-10#1)(2008-12#1)
of potential target##2##3##(1995-5#1)(2008-9#1)
of potential targets for##2##4##(2011-1#1)(2011-2#1)
of potential use as an##2##5##(1993-12#1)(1996-5#1)
of potential use in the##2##5##(2008-5#1)(2008-9#1)
of potential use in##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
of potential use##6##3##(1993-12#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
of potential##151##2##(1990-12#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-6#1)(1994-8#1)(1995-5#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#39)(2008-11#7)(2008-12#3)(2008-2#3)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
of potentially confounding##2##3##(1997-4#1)(2006-10#1)
of potentially important##2##3##(2008-11#1)(2008-6#1)
of potentially lethal##2##3##(2007-10#1)(2012-2#1)
of potentially useful##2##3##(2010-1#1)(2011-1#1)
of potentially##28##2##(1993-11#1)(1994-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)
of potentials##2##2##(2008-10#2)
of potentiating##3##2##(1995-11#1)(1995-3#1)(2010-11#1)
of potentiation##3##2##(1993-6#1)(1995-12#1)(1995-3#1)
of potentiometric sensors##2##3##(2008-10#2)
of potentiometric titration##3##3##(2008-10#3)
of potentiometric titrations##2##3##(2008-10#2)
of potentiometric##14##2##(2008-10#14)
of potted apple trees##2##4##(2008-10#2)
of potted##3##2##(2008-10#3)
of potting mix##2##3##(2008-10#2)
of potting##6##2##(2008-10#6)
of potyvirus##3##2##(2008-10#3)
of potyviruses##2##2##(2008-10#2)
of poultry##3##2##(1990-8#1)(2008-5#1)(2011-2#1)
of poults##2##2##(1997-3#1)(1997-6#1)
of poverty and##3##3##(2008-11#1)(2009-8#1)(2012-12#1)
of poverty##14##2##(1992-1#1)(2008-1#2)(2008-11#8)(2009-8#2)(2012-12#1)
of powder##4##2##(1997-7#1)(2008-10#2)(2008-7#1)
of powdered##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
of powdery mildew in##2##4##(2008-10#2)
of powdery mildew on##4##4##(2008-10#4)
of powdery mildew##16##3##(2008-10#16)
of powdery##17##2##(2008-10#17)
of power and##7##3##(1993-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-9#1)(2012-3#1)
of power at a##2##4##(2007-12#2)
of power at##8##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2013-8#1)
of power from##2##3##(2007-11#1)(2008-3#1)
of power in a##2##4##(2007-12#2)
of power in##6##3##(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2010-5#1)
of power of##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
of power over##2##3##(2008-11#1)(2013-1#1)
of power##58##2##(1991-12#1)(1993-2#2)(1994-9#1)(1997-2#1)(1997-3#3)(2007-11#6)(2007-12#10)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#8)(2008-3#9)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of powerful##4##2##(1993-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
of pp185##2##2##(1992-10#2)
of pp60c-src##2##2##(1990-12#2)
of ppb##3##2##(2008-10#2)(2008-2#1)
of pph(3)##4##2##(2013-1#4)
of prC4##2##2##(1997-8#2)
of practical and##3##3##(2008-11#1)(2008-4#1)(2010-8#1)
of practical importance##4##3##(1995-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
of practical nursing skills##2##4##(2008-11#2)
of practical samples##3##3##(2008-10#3)
of practical skills##2##3##(1992-11#1)(2008-11#1)
of practical strategies##3##3##(1994-12#1)(2009-5#1)(2013-1#1)
of practical##29##2##(1992-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#2)
of practically##3##2##(2008-10#2)(2010-9#1)
of practice and##3##3##(1992-3#1)(2008-12#1)(2011-1#1)
of practice in healthcare##2##4##(2008-12#1)(2011-2#1)
of practice in the##2##4##(2007-10#1)(2012-12#1)
of practice in##7##3##(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
of practice learning##3##3##(2008-11#3)
of practice parameters##2##3##(1993-3#1)(1994-3#1)
of practice##75##2##(1990-6#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#5)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#13)(2008-12#6)(2008-4#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#3)(2012-12#3)(2012-3#3)(2013-8#1)
of practice-based teaching##3##3##(2008-11#3)
of practices##5##2##(1990-2#1)(1996-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
of practicing##5##2##(1993-12#1)(1996-1#1)(2010-11#1)(2010-5#2)
of practitioners and##2##3##(1994-12#1)(1997-4#1)
of practitioners##9##2##(1991-3#1)(1992-1#1)(1993-11#1)(1994-12#1)(1995-1#2)(1997-4#1)(2007-4#1)(2012-12#1)
of prairie##2##2##(2008-9#2)
of praseodymium##6##2##(2008-10#6)
of pre- and postoperative pulmonary rehabilitation##2##6##(2012-12#2)
of pre- and##8##3##(1991-5#1)(1993-3#1)(1995-12#1)(1996-3#1)(2008-10#1)(2012-12#2)(2012-3#1)
of pre-##9##2##(1991-5#1)(1993-3#1)(1995-12#1)(1996-3#1)(2008-10#1)(2012-12#3)(2012-3#1)
of pre-analytical##2##2##(2007-7#1)(2013-1#1)
of pre-beta-lactamase##3##2##(1992-3#3)
of pre-column##2##2##(2008-10#2)
of pre-eclampsia##3##2##(1997-3#1)(2008-4#1)(2011-2#1)
of pre-emptive##4##2##(1993-12#1)(2008-7#1)(2011-2#1)(2011-3#1)
of pre-end stage renal disease##2##5##(2008-1#2)
of pre-end stage renal##3##4##(2008-1#3)
of pre-existing β-cells##3##3##(2010-11#3)
of pre-existing##8##2##(1996-3#1)(1997-2#1)(2008-1#1)(2010-11#3)(2010-12#1)(2011-2#1)
of pre-mRNA##2##2##(1991-9#2)
of pre-operative##4##2##(1995-12#1)(1997-6#1)(2008-12#1)(2012-12#1)
of pre-pregnancy##2##2##(1990-9#1)(2011-1#1)
of pre-registration nursing##4##3##(2008-11#4)
of pre-registration##6##2##(2008-11#6)
of pre-school##2##2##(1996-1#1)(2008-9#1)
of pre-settlement##2##2##(2010-8#2)
of pre-tRNA(fMet)##2##2##(1995-6#2)
of pre-treatment##5##2##(1996-12#1)(2008-10#1)(2012-1#2)(2013-1#1)
of preactivated##2##2##(2008-10#2)
of precancer##2##2##(2008-11#1)(2011-1#1)
of precancerous lesions##4##3##(1994-5#1)(2008-2#1)(2011-2#1)(2011-3#1)
of precancerous##5##2##(1994-5#1)(2008-2#1)(2008-7#1)(2011-2#1)(2011-3#1)
of preceding crop on wireworm (Coleoptera##2##6##(2011-2#2)
of preceding##3##2##(1995-2#1)(2011-2#2)
of preceptorship##2##2##(2008-11#2)
of precious##3##2##(2008-10#3)
of precipitation and##2##3##(2008-10#1)(2008-3#1)
of precipitation##12##2##(1997-6#2)(2008-10#9)(2008-3#1)
of precise##12##2##(2007-12#1)(2008-10#2)(2008-3#4)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2012-3#1)
of precisely##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)
of precision and##2##3##(2008-11#1)(2009-11#1)
of precision##14##2##(1994-11#1)(2007-11#1)(2008-10#7)(2008-11#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)
of preclinical and clinical##2##4##(1993-11#1)(2012-3#1)
of preclinical studies##2##3##(2012-12#2)
of preclinical##10##2##(1993-11#1)(1994-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#3)(2012-3#1)
of preconcentration time##6##3##(2008-10#6)
of preconcentration##14##2##(2008-10#14)
of preconditioned##2##2##(2008-7#2)
of preconditioning##3##2##(1996-9#1)(2008-7#1)(2013-7#1)
of precordial pain##2##3##(2008-10#1)(2008-7#1)
of precursor proteins##2##3##(1991-2#1)(1994-8#1)
of precursor##7##2##(1990-5#1)(1990-7#1)(1991-2#1)(1994-8#1)(2008-11#1)(2009-6#1)(2013-8#1)
of precursors of egg envelopes##2##5##(2007-12#2)
of precursors of##3##3##(2007-12#2)(2009-8#1)
of precursors##10##2##(1991-6#1)(1991-9#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-1#1)
of predation and##2##3##(2008-9#2)
of predation on the##2##4##(2008-8#1)(2008-9#1)
of predation on##4##3##(2008-8#3)(2008-9#1)
of predation##10##2##(2008-8#6)(2008-9#4)
of predator##2##2##(2008-8#1)(2012-3#1)
of predator-prey interactions##2##3##(2008-8#1)(2008-9#1)
of predator-prey systems##2##3##(2008-8#2)
of predator-prey##4##2##(2008-8#3)(2008-9#1)
of predators and prey##2##4##(2008-8#2)
of predators in##2##3##(2008-8#2)
of predators that##2##3##(2008-8#2)
of predators##11##2##(2008-8#10)(2012-3#1)
of predictable##4##2##(1994-3#1)(2008-11#2)(2008-8#1)
of predicted##6##2##(1994-3#1)(2008-10#2)(2011-2#1)(2011-3#1)(2013-8#1)
of predicting##6##2##(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)
of prediction (RSEP)##3##3##(2008-10#3)
of prediction of##2##3##(2012-7#1)(2013-8#1)
of prediction##27##2##(1996-4#2)(2008-10#21)(2010-8#1)(2012-2#1)(2012-7#1)(2013-8#1)
of predictions made##2##3##(1994-3#1)(2008-1#1)
of predictions##8##2##(1991-5#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-7#1)
of predictive ability##2##3##(2008-10#1)(2012-3#1)
of predictive role##2##3##(2011-2#1)(2012-3#1)
of predictive validity##2##3##(1994-2#1)(2010-7#1)
of predictive##13##2##(1994-2#1)(2008-10#2)(2008-7#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
of predictors of##3##3##(1995-12#1)(2008-12#1)(2008-7#1)
of predictors##7##2##(1995-12#2)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
of predisposing factors##2##3##(2010-1#1)(2012-12#1)
of predisposing##3##2##(2010-1#1)(2012-12#2)
of predisposition##2##2##(2007-7#1)(2013-1#1)
of prednisolone##4##2##(1995-5#1)(2008-1#1)(2010-12#1)(2011-1#1)
of predominance##2##2##(1991-9#1)(2008-10#1)
of predominantly##3##2##(2008-7#1)(2009-7#1)(2012-3#1)
of preeclampsia and##3##3##(1996-11#1)(2008-11#2)
of preeclampsia##8##2##(1996-11#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
of preemergence damping-off##2##3##(2008-10#2)
of preemptive##2##2##(2011-2#1)(2012-1#1)
of preexisting conditions##2##3##(1994-2#1)(2008-7#1)
of preexisting##6##2##(1994-2#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-7#1)
of preference and performance##2##4##(2008-8#2)
of preference and##3##3##(2008-8#3)
of preference##4##2##(1995-2#1)(2008-8#3)
of preferences for##2##3##(2007-12#1)(2012-3#1)
of preferences##3##2##(2007-12#1)(2008-9#1)(2012-3#1)
of preferred##4##2##(1994-7#1)(2007-6#2)(2013-1#1)
of preformed DAPs##2##3##(2010-5#2)
of preformed antifungal##2##3##(2008-10#2)
of preformed##9##2##(1992-8#1)(1995-2#1)(2008-10#3)(2008-4#1)(2010-5#2)(2012-1#1)
of prefrontal cortex##2##3##(2007-8#1)(2009-12#1)
of prefrontal##8##2##(1995-12#2)(1996-7#1)(1997-2#1)(2007-8#1)(2008-11#2)(2009-12#1)
of pregnancies and##3##3##(2009-3#1)(2011-1#1)(2011-2#1)
of pregnancies##14##2##(1991-3#1)(1995-6#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#5)(2013-1#3)
of pregnancy and##13##3##(1995-12#2)(1995-8#1)(1996-12#1)(2007-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
of pregnancy in the##2##4##(1990-2#1)(2007-11#1)
of pregnancy in##6##3##(1990-2#1)(1990-9#1)(1991-2#1)(1995-3#1)(2007-11#1)(2012-3#1)
of pregnancy induced hypertension##2##4##(2008-4#2)
of pregnancy or##5##3##(2007-10#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-8#1)
of pregnancy outcome in##2##4##(1992-2#1)(2011-1#1)
of pregnancy outcome##3##3##(1992-2#2)(2011-1#1)
of pregnancy was##2##3##(1993-3#1)(2012-3#1)
of pregnancy were##2##3##(1995-12#2)
of pregnancy with##2##3##(2008-3#1)(2009-1#1)
of pregnancy##101##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-5#2)(1993-2#1)(1993-3#1)(1994-3#3)(1994-9#3)(1995-12#6)(1995-3#1)(1995-6#2)(1995-8#4)(1996-12#5)(1997-4#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#3)(2009-1#2)(2009-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#12)(2013-1#3)(2013-8#3)
of pregnancy-associated cancer##2##3##(2013-1#2)
of pregnancy-associated##4##2##(2008-10#1)(2013-1#3)
of pregnancy-induced hypertension##4##3##(1990-3#1)(1994-3#1)(2010-10#1)(2012-2#1)
of pregnant and lactating##3##4##(1990-11#2)(2011-2#1)
of pregnant and##4##3##(1990-11#2)(2010-6#1)(2011-2#1)
of pregnant females##3##3##(2008-7#1)(2013-7#2)
of pregnant women in##3##4##(1997-6#1)(2007-12#1)(2010-6#1)
of pregnant women##15##3##(1993-3#1)(1996-11#3)(1996-12#1)(1997-6#1)(2007-12#1)(2007-2#1)(2009-4#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
of pregnant##32##2##(1990-11#2)(1991-3#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-11#3)(1996-12#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-4#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
of pregnenolone sulfate##2##3##(1996-2#2)
of pregnenolone##4##2##(1990-11#1)(1996-2#3)
of prehaustorial resistance to##2##4##(2008-10#2)
of prehaustorial##4##2##(2008-10#4)
of prehospital##3##2##(1990-12#1)(1993-1#1)(2008-3#1)
of preimplantation genetic diagnosis##2##4##(2008-4#1)(2012-3#1)
of preliminary##9##2##(1991-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)
of prelingually##2##2##(2008-9#2)
of preload##2##2##(2011-2#2)
of premating isolation##2##3##(2008-8#1)(2008-9#1)
of premating##5##2##(2008-8#2)(2008-9#2)(2012-3#1)
of premature adrenarche##2##3##(2008-4#2)
of premature aging##2##3##(1992-9#1)(1994-5#1)
of premature infant##2##3##(1994-3#1)(1997-2#1)
of premature infants##7##3##(1990-11#1)(1994-3#1)(2007-11#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#1)
of premature infants]##2##3##(1990-11#1)(2013-1#1)
of premature newborns##3##3##(2009-5#2)(2009-9#1)
of premature ovarian failure##2##4##(1996-2#1)(2013-8#1)
of premature##28##2##(1990-11#2)(1990-9#1)(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#1)(1994-3#2)(1994-5#1)(1995-1#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-4#2)(2009-5#2)(2009-9#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
of prematurity##12##2##(1991-9#1)(1992-2#1)(1993-2#1)(1994-3#1)(2008-11#1)(2011-1#6)(2012-12#1)
of premenopausal##4##2##(1994-12#1)(1994-2#1)(2007-5#1)(2012-12#1)
of premixed##2##2##(2008-10#1)(2008-3#1)
of prenatal alcohol exposure##2##4##(2008-11#1)(2011-2#1)
of prenatal alcohol##3##3##(2008-11#2)(2011-2#1)
of prenatal care and##2##4##(1992-2#1)(1993-3#1)
of prenatal care in##2##4##(1994-3#1)(2008-10#1)
of prenatal care##17##3##(1992-2#2)(1993-3#5)(1994-3#2)(1995-12#2)(1995-2#1)(2008-1#3)(2008-10#2)
of prenatal contraceptive counseling and##2##5##(2013-1#2)
of prenatal contraceptive counseling##3##4##(2013-1#3)
of prenatal development##3##3##(2007-11#1)(2012-3#2)
of prenatal stress##2##3##(2008-2#2)
of prenatal##42##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-2#2)(1993-3#7)(1994-3#2)(1995-12#2)(1995-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-2#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
of prenatally##3##2##(2008-10#2)(2008-4#1)
of preneoplastic##2##2##(1991-6#1)(2013-7#1)
of prenyl##3##2##(2009-11#3)
of prenylated flavonoids##2##3##(2011-2#2)
of prenylated##3##2##(2008-5#1)(2011-2#2)
of prenyltransferases##2##2##(2008-8#1)(2011-2#1)
of preoperative chemotherapy##2##3##(2012-3#2)
of preoperative feeding##2##3##(2011-2#2)
of preoperative ultrasound##2##3##(1990-9#1)(1996-1#1)
of preoperative##24##2##(1990-11#1)(1990-9#1)(1993-12#1)(1993-5#1)(1995-1#1)(1996-1#1)(2007-8#1)(2008-7#1)(2008-9#2)(2010-3#2)(2011-2#3)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)
of prepaid##2##2##(1994-2#1)(1997-1#1)
of preparation and##2##3##(2008-10#1)(2008-11#1)
of preparation for##2##3##(1997-7#1)(2008-12#1)
of preparation of##2##3##(1990-5#1)(2008-10#1)
of preparation##19##2##(1990-5#1)(1991-12#1)(1994-12#2)(1994-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2010-5#1)
of preparations of##2##3##(1991-5#1)(2013-1#1)
of preparations##5##2##(1990-12#1)(1991-5#1)(1996-5#1)(2008-5#1)(2013-1#1)
of preparative quantities of##2##4##(1995-6#2)
of preparative##3##2##(1995-6#2)(2008-10#1)
of prepared##4##2##(2008-10#3)(2012-3#1)
of preparedness##2##2##(2007-12#1)(2007-2#1)
of preparing a##2##3##(2008-10#2)
of preparing##9##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-4#1)
of prepenetration##2##2##(2008-10#2)
of preprocessing##2##2##(2007-12#1)(2008-7#1)
of preschool children##2##3##(2007-11#1)(2009-9#1)
of preschool##3##2##(2007-11#1)(2009-9#1)(2011-2#1)
of prescribing##5##2##(2008-11#3)(2008-8#1)(2013-1#1)
of prescription drug##3##3##(1995-1#3)
of prescription drugs##8##3##(1995-1#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
of prescription medications is a##2##5##(2008-12#1)(2008-3#1)
of prescription##20##2##(1991-1#1)(1995-1#5)(1996-1#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of prescriptions##7##2##(1991-12#1)(1994-9#1)(2008-11#1)(2009-9#3)(2013-1#1)
of presence of##4##3##(2008-10#3)(2008-8#1)
of presence or absence of##2##5##(2008-6#1)(2011-2#1)
of presence##7##2##(2008-10#3)(2008-6#2)(2008-8#1)(2011-2#1)
of present study##5##3##(2008-12#3)(2012-2#1)(2013-1#1)
of present##13##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
of presentation and##3##3##(1991-8#1)(1995-10#1)(2008-7#1)
of presentation of##5##3##(2008-1#2)(2010-11#1)(2010-3#1)(2012-3#1)
of presentation##29##2##(1991-8#2)(1995-10#1)(1997-8#2)(2007-2#1)(2007-7#3)(2008-1#3)(2008-12#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-3#3)(2013-8#1)
of presentations##46##2##(2008-11#45)(2008-7#1)
of presenting##4##2##(1990-9#1)(1991-6#1)(2009-8#1)(2013-1#1)
of presently##2##2##(1991-2#1)(2008-8#1)
of preservatives##4##2##(2008-5#4)
of preserved##2##2##(2008-10#1)(2008-11#1)
of preserving##4##2##(1996-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
of pressure (COP)##2##3##(2010-12#1)(2010-9#1)
of pressure and temperature##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
of pressure and##7##3##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)
of pressure ulcer##2##3##(2012-3#2)
of pressure##35##2##(1991-12#1)(1991-3#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#2)
of pressurized##3##2##(1992-3#1)(2008-10#2)
of presumed##5##2##(1992-3#1)(1996-12#1)(1997-2#1)(2006-10#1)(2012-3#1)
of presynaptic function##2##3##(1995-11#1)(1997-7#1)
of presynaptic##10##2##(1992-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)
of pretectal neurons##2##3##(2008-8#2)
of preterm birth##4##3##(2007-2#2)(2011-2#2)
of preterm delivery##3##3##(1994-3#1)(1996-11#1)(2012-3#1)
of preterm infants##3##3##(1990-3#1)(1991-1#1)(2007-11#1)
of preterm labor##2##3##(2010-11#1)(2011-2#1)
of preterm neonates##4##3##(2007-11#4)
of preterm##19##2##(1990-11#1)(1990-3#1)(1991-1#1)(1993-3#1)(1994-3#1)(1996-11#1)(2007-11#6)(2007-2#2)(2010-11#1)(2011-2#3)(2012-3#1)
of pretransfusion testing##3##3##(2011-1#3)
of pretreated##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
of pretreatment and##2##3##(2011-2#1)(2013-1#1)
of pretreatment##11##2##(1990-11#1)(1992-6#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#2)
of prevailing##2##2##(1992-5#1)(2008-7#1)
of prevalence of##7##3##(1997-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-3#1)
of prevalence##9##2##(1997-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
of prevalent##4##2##(2011-1#1)(2011-2#2)(2013-1#1)
of preventable##2##2##(1994-9#1)(2011-2#1)
of preventative##2##2##(2007-6#1)(2008-10#1)
of preventing##13##2##(1992-2#1)(1992-3#1)(1993-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-1#1)
of prevention and treatment##2##4##(2007-11#1)(2013-8#1)
of prevention and##7##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-12#2)(2013-8#1)
of prevention in##2##3##(1994-9#1)(2010-4#1)
of prevention of##2##3##(2010-6#1)(2013-1#1)
of prevention programs##2##3##(1993-3#1)(1997-2#1)
of prevention##26##2##(1992-5#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#2)
of preventive activities##3##3##(1993-11#1)(1993-3#1)(1997-3#1)
of preventive and##2##3##(2007-12#1)(2012-12#1)
of preventive care##2##3##(1994-2#2)
of preventive measures##3##3##(1991-12#1)(2008-8#1)(2012-3#1)
of preventive services##5##3##(1994-2#3)(1995-12#1)(1995-2#1)
of preventive##28##2##(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#5)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-5#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
of previous blood transfusions##2##4##(1991-3#1)(2008-1#1)
of previous research##5##3##(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#2)
of previous studies##8##3##(1990-12#1)(1994-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
of previous trials##3##3##(1996-6#1)(2011-1#1)(2013-8#1)
of previous work in##2##4##(2009-2#1)(2010-8#1)
of previous work##3##3##(2008-10#1)(2009-2#1)(2010-8#1)
of previous##74##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-2#2)(1994-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
of previously described##2##3##(1993-12#1)(2009-10#1)
of previously known##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
of previously published##5##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of previously reported##2##3##(1990-11#1)(2007-11#1)
of previously unknown##2##3##(2008-10#1)(2008-7#1)
of previously unrecognised##4##3##(1994-3#1)(2008-8#3)
of previously unreported##2##3##(2010-4#1)(2013-8#1)
of previously##36##2##(1990-11#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-4#2)(2011-1#2)(2013-8#1)
of previtellogenesis##2##2##(2007-12#2)
of prey and predators##2##4##(2008-8#2)
of prey##16##2##(2008-5#6)(2008-8#6)(2008-9#1)(2010-8#3)
of price##3##2##(1993-12#1)(1995-1#1)(2008-7#1)
of pricing##3##2##(1993-1#1)(1995-1#1)(2008-12#1)
of primary As species in##2##5##(2008-10#2)
of primary B lymphocytes##2##4##(1991-2#2)
of primary B##3##3##(1991-2#2)(2008-9#1)
of primary Sjögren's syndrome##2##4##(1990-2#2)
of primary adult##2##3##(1995-8#1)(2013-1#1)
of primary afferent fibers##3##4##(1990-7#1)(1994-8#1)(2008-4#1)
of primary afferent##5##3##(1990-5#1)(1990-7#1)(1994-8#1)(2008-4#1)(2008-7#1)
of primary afferents##2##3##(1992-6#1)(1997-3#1)
of primary aliphatic short-chain monoamines##2##5##(2008-10#2)
of primary amino groups##2##4##(2008-10#1)(2008-5#1)
of primary and interfering##2##4##(2008-10#2)
of primary and recurrent##3##4##(1991-6#2)(2008-6#1)
of primary and secondary infection##7##5##(2008-10#7)
of primary and secondary prevention##3##5##(1990-12#1)(1996-12#1)(2010-2#1)
of primary and secondary##20##4##(1990-12#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)
of primary and##29##3##(1990-12#1)(1991-6#2)(1992-11#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)
of primary bone lymphoma##2##4##(2007-5#2)
of primary bone tumors##2##4##(2008-2#1)(2009-3#1)
of primary bone##5##3##(2007-5#2)(2008-2#1)(2008-6#1)(2009-3#1)
of primary breast cancer##2##4##(1991-12#1)(1991-8#1)
of primary care and##2##4##(1997-3#1)(2012-1#1)
of primary care health##2##4##(1993-6#1)(1994-9#1)
of primary care in the##2##5##(1995-3#1)(1996-9#1)
of primary care##22##3##(1991-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-9#2)(1997-3#3)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
of primary care]##4##3##(1993-10#1)(1994-6#1)(1995-6#1)(1997-5#1)
of primary cell cultures##2##4##(2008-10#1)(2008-11#1)
of primary cell##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
of primary cells##2##3##(2008-11#1)(2010-3#1)
of primary cultured##2##3##(1993-6#1)(1996-2#1)
of primary cultures of##5##4##(1994-3#1)(1995-11#1)(2008-4#1)(2010-11#2)
of primary cutaneous##5##3##(1991-6#1)(2007-7#1)(2010-8#2)(2011-1#1)
of primary endometrial##2##3##(1994-9#2)
of primary gastric##2##3##(1992-8#1)(2008-9#1)
of primary health care##10##4##(1990-9#1)(1992-11#2)(1994-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(2007-10#1)(2008-1#1)
of primary health care]##2##4##(1991-9#1)(1995-2#1)
of primary health##13##3##(1990-9#1)(1991-9#1)(1992-11#2)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(2007-10#1)(2008-1#1)(2013-1#1)
of primary human cells##2##4##(2008-11#2)
of primary human##4##3##(2008-11#3)(2013-1#1)
of primary hyperoxaluria type 1##2##5##(2007-12#1)(2009-3#1)
of primary hyperoxaluria type##4##4##(1995-12#2)(2007-12#1)(2009-3#1)
of primary hyperparathyroidism##6##3##(1990-2#1)(1995-11#1)(2008-12#2)(2011-1#1)(2012-12#1)
of primary hyperparathyroidism]##2##3##(1990-9#1)(1995-11#1)
of primary importance for##2##4##(2008-2#1)(2012-3#1)
of primary importance##4##3##(1992-3#1)(1994-11#1)(2008-2#1)(2012-3#1)
of primary infection by##2##4##(2008-10#2)
of primary infection##5##3##(1997-5#1)(2008-10#3)(2008-8#1)
of primary inoculum##13##3##(2008-10#12)(2008-12#1)
of primary intracerebral hemorrhage##2##4##(2007-10#2)
of primary liver cancer##2##4##(1991-11#1)(2013-1#1)
of primary localised cutaneous amyloidosis##2##5##(2007-7#2)
of primary malignant##2##3##(2008-6#1)(2011-2#1)
of primary mouse##2##3##(1990-7#1)(1991-2#1)
of primary open angle##2##4##(2011-2#1)(2012-2#1)
of primary particles##4##3##(2008-10#1)(2008-3#3)
of primary porcine hepatocytes##3##4##(2008-11#3)
of primary prevention of##2##4##(2010-4#1)(2013-1#1)
of primary prevention##7##3##(1995-3#1)(1996-12#1)(1996-3#1)(2007-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
of primary psychopathy##3##3##(2009-9#3)
of primary radiotherapy##2##3##(1990-10#1)(1992-3#1)
of primary rat hepatocytes##2##4##(2008-11#2)
of primary rat##3##3##(1993-3#1)(2008-11#2)
of primary resistance##2##3##(2010-5#1)(2013-1#1)
of primary retroperitoneal##4##3##(2008-6#1)(2009-5#3)
of primary school##2##3##(1993-6#1)(2009-12#1)
of primary total hip replacement##2##5##(1996-11#1)(2013-1#1)
of primary trisomics##3##3##(2009-12#3)
of primary tumor##4##3##(2007-11#1)(2008-10#1)(2013-8#2)
of primary tumour##2##3##(2007-11#1)(2012-2#1)
of primary##338##2##(1990-10#1)(1990-12#2)(1990-2#6)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#3)(1991-6#6)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#4)(1993-6#5)(1994-11#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-3#4)(1997-5#2)(1997-8#1)(2006-10#2)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#3)(2007-7#7)(2007-8#1)(2008-1#5)(2008-10#45)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#8)(2008-7#5)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#4)(2009-3#4)(2009-5#3)(2009-8#3)(2009-9#5)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#6)
of primate##3##2##(1990-8#1)(2008-9#2)
of primates##3##2##(1993-12#1)(2008-9#1)(2009-8#1)
of prime importance##4##3##(1992-12#1)(2008-10#1)(2008-9#2)
of prime##5##2##(1992-12#1)(1996-2#1)(2008-10#1)(2008-9#2)
of primer##2##2##(2008-10#1)(2008-8#1)
of primers and probe##2##4##(2008-10#2)
of primers specific for##2##4##(2007-12#1)(2008-5#1)
of primers that##3##3##(1993-12#1)(1993-6#1)(2008-10#1)
of primers were##2##3##(2008-10#1)(2011-2#1)
of primers##18##2##(1990-7#1)(1993-12#1)(1993-6#1)(1995-8#1)(2007-12#1)(2008-10#10)(2008-5#1)(2008-8#1)(2011-2#1)
of primiparas##2##2##(1996-12#1)(2011-2#1)
of primitive##4##2##(1990-10#1)(1990-5#1)(2008-5#1)(2008-6#1)
of primordial germ cells##2##4##(2008-11#1)(2010-5#1)
of primordial##4##2##(1996-2#1)(2008-11#1)(2008-9#1)(2010-5#1)
of principal component analysis (PCA)##2##5##(2008-10#1)(2011-1#1)
of principal component analysis and##2##5##(2008-10#1)(2013-8#1)
of principal component analysis##5##4##(2008-10#2)(2010-5#1)(2011-1#1)(2013-8#1)
of principal component##7##3##(2008-10#3)(2008-11#1)(2010-5#1)(2011-1#1)(2013-8#1)
of principal components##2##3##(2008-10#1)(2010-7#1)
of principal stratification to##2##4##(2009-9#2)
of principal##13##2##(2008-10#5)(2008-11#2)(2009-9#2)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
of principle for##2##3##(2008-8#1)(2010-4#1)
of principle##7##2##(1997-5#1)(2008-10#2)(2008-8#2)(2009-4#1)(2010-4#1)
of principles of##4##3##(1993-12#1)(1997-7#1)(2008-4#1)(2009-2#1)
of principles##6##2##(1993-12#1)(1994-3#1)(1997-7#1)(2008-4#1)(2008-9#1)(2009-2#1)
of print##3##2##(2009-10#1)(2009-9#1)(2013-1#1)
of printed paper surfaces##2##4##(2008-3#2)
of prion protein##3##3##(1997-5#1)(2008-11#1)(2008-5#1)
of prion##6##2##(1997-3#1)(1997-5#1)(2008-11#3)(2008-5#1)
of prior experience##2##3##(1992-12#1)(2013-1#1)
of prior##26##2##(1990-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2013-1#4)
of priority##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
of pristinamycin##2##2##(2010-2#2)
of privacy##3##2##(1995-12#1)(1996-5#1)(1997-5#1)
of private and public##2##4##(1996-1#1)(1997-3#1)
of private health insurance##3##4##(1993-3#1)(1994-3#1)(2008-7#1)
of private health##4##3##(1993-3#1)(1994-3#1)(2008-7#1)(2012-1#1)
of private insurance##2##3##(1992-2#1)(1994-1#1)
of private sector##3##3##(1994-2#1)(1995-1#1)(1996-12#1)
of private##20##2##(1992-2#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-6#1)(2008-7#4)(2009-7#1)(2010-4#1)(2011-1#1)(2012-1#1)
of prmt5 in##2##3##(2009-7#2)
of prmt5##3##2##(2009-7#3)
of pro- and anti-inflammatory cytokines##2##5##(2011-1#1)(2013-7#1)
of pro- and anti-inflammatory##3##4##(2008-10#1)(2011-1#1)(2013-7#1)
of pro- and##5##3##(2008-10#1)(2009-12#2)(2011-1#1)(2013-7#1)
of pro-##6##2##(2008-10#1)(2009-12#2)(2010-9#1)(2011-1#1)(2013-7#1)
of pro-angiogenic##2##2##(2010-9#1)(2013-1#1)
of pro-apoptotic protein Bax##2##4##(2010-6#1)(2013-1#1)
of pro-inflammatory cytokines##2##3##(2008-5#2)
of pro-inflammatory##9##2##(2008-11#1)(2008-5#4)(2008-7#1)(2009-12#1)(2012-2#2)
of pro-opiomelanocortin mRNA##2##3##(2012-1#2)
of pro-oxidants##2##2##(1991-9#2)
of proU##2##2##(1994-12#2)
of proalbumin##3##2##(1990-8#1)(1992-12#1)(1993-2#1)
of proapoptotic protein P53 and proliferation protein Ki-67##2##8##(2012-1#2)
of proapoptotic##3##2##(2008-11#1)(2012-1#2)
of probabilistic##2##2##(2010-8#1)(2012-1#1)
of probability of##3##3##(1996-6#2)(2012-3#1)
of probability##8##2##(1996-4#1)(1996-6#2)(1997-3#1)(2008-10#2)(2008-8#1)(2012-3#1)
of probable effects of##2##4##(2008-12#1)(2013-1#1)
of probable##7##2##(1992-11#1)(1994-5#1)(2008-12#1)(2008-3#1)(2012-1#2)(2013-1#1)
of probe##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#2)
of probes and##3##3##(1993-11#1)(2008-10#1)(2012-3#1)
of probes##7##2##(1993-11#1)(2008-10#2)(2008-4#1)(2008-9#2)(2012-3#1)
of probing##2##2##(1994-5#1)(2008-10#1)
of probiotic##13##2##(2008-5#1)(2009-11#1)(2009-12#1)(2010-10#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
of probiotics in health and disease##3##6##(2013-7#3)
of probiotics in##7##3##(2008-10#1)(2009-11#1)(2009-12#1)(2012-1#1)(2013-7#3)
of probiotics is##2##3##(2011-2#1)(2013-7#1)
of probiotics##18##2##(2008-10#2)(2009-11#1)(2009-12#1)(2011-2#3)(2012-1#5)(2012-2#1)(2013-7#5)
of problem behavior##3##3##(2008-12#1)(2009-9#2)
of problem behaviors were##2##4##(2008-12#2)
of problem behaviors##4##3##(1994-2#1)(2008-12#3)
of problem drinkers##2##3##(1994-2#1)(1995-5#1)
of problem drinking##2##3##(1994-2#2)
of problem##17##2##(1994-2#4)(1995-12#1)(1995-5#1)(1996-1#1)(2008-11#1)(2008-12#5)(2008-7#1)(2009-9#2)(2012-12#1)
of problem-based learning##4##3##(1995-2#1)(2008-11#1)(2008-12#1)(2012-3#1)
of problems encountered##2##3##(2008-7#1)(2012-12#1)
of problems experienced##2##3##(2007-11#1)(2010-10#1)
of problems##27##2##(1990-11#1)(1991-1#2)(1992-2#1)(1994-6#1)(1995-12#2)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
of procaine hydrochloride##8##3##(1992-5#1)(2008-10#7)
of procaine##10##2##(1992-5#1)(1993-9#2)(2008-10#7)
of procalcitonin in the##3##4##(2008-5#1)(2013-1#2)
of procalcitonin in##5##3##(2008-5#2)(2013-1#3)
of procalcitonin##8##2##(2008-5#3)(2013-1#5)
of procathepsin E to cathepsin E##2##6##(1991-2#2)
of procathepsin E##3##3##(1991-2#3)
of procathepsin L##4##3##(1995-6#4)
of procathepsin##7##2##(1991-2#3)(1995-6#4)
of procedural##3##2##(1993-2#1)(1996-2#1)(2008-12#1)
of procedure##10##2##(1996-3#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-7#1)(2013-1#1)
of procedure-related##2##2##(1996-2#1)(2008-11#1)
of procedures and##3##3##(1994-3#1)(1995-12#1)(2011-2#1)
of procedures for##5##3##(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
of procedures performed##4##3##(1995-2#1)(1995-3#1)(2011-2#1)(2013-1#1)
of procedures that##3##3##(2008-10#1)(2008-4#2)
of procedures to##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)
of procedures##28##2##(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#5)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
of proceeding##3##2##(1995-2#1)(2008-10#2)
of process or##2##3##(1995-12#1)(2013-1#1)
of process streams##2##3##(2008-6#2)
of process##18##2##(1992-12#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)(2013-8#2)
of processes of##2##3##(1996-9#1)(2008-3#1)
of processes##12##2##(1992-12#1)(1994-3#1)(1996-9#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2013-8#1)
of processing is##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
of processing of##3##3##(1990-11#1)(1994-11#1)(2009-12#1)
of processing##30##2##(1990-11#1)(1994-11#2)(1994-6#1)(1995-2#1)(1997-4#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#1)
of processors##4##2##(2008-2#1)(2008-3#2)(2010-8#1)
of procolipase##3##2##(1995-5#3)
of procurement##2##2##(1995-2#2)
of procuring##2##2##(1992-12#2)
of procyanidins##2##2##(2008-5#2)
of produced water##4##3##(2013-1#4)
of produced##9##2##(2008-10#3)(2008-11#2)(2013-1#4)
of producing a##4##3##(1994-5#1)(1994-9#1)(2008-11#1)(2008-12#1)
of producing systems##2##3##(1994-11#1)(2008-10#1)
of producing##38##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)
of product application##2##3##(2008-5#2)
of product characteristics##2##3##(2008-5#1)(2012-3#1)
of product formation##3##3##(1991-5#2)(2008-10#1)
of product inhibition##2##3##(1994-8#1)(2008-7#1)
of product quality##2##3##(2008-10#1)(2012-2#1)
of product##33##2##(1991-12#1)(1991-5#2)(1991-9#1)(1992-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(2008-10#6)(2008-11#3)(2008-5#7)(2008-7#3)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
of production and##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
of production of the##3##4##(1990-11#1)(2008-10#1)(2008-7#1)
of production of##10##3##(1990-11#1)(1993-9#1)(1994-12#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-9#1)
of production systems##2##3##(1997-4#1)(2013-8#1)
of production##32##2##(1990-11#1)(1993-9#1)(1994-12#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
of productive##2##2##(2012-2#1)(2013-1#1)
of productivity in##2##3##(2008-9#1)(2010-5#1)
of productivity##11##2##(2007-7#1)(2008-11#4)(2008-8#2)(2008-9#3)(2010-5#1)
of products and##5##3##(1991-12#1)(1992-2#1)(1996-12#1)(2008-9#1)(2012-2#1)
of products of##2##3##(2007-12#1)(2010-7#1)
of products##37##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#5)(2008-6#2)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
of professional confidence##4##3##(2008-11#2)(2008-12#2)
of professional liability##2##3##(1992-2#1)(1993-3#1)
of professional practice##3##3##(2008-11#2)(2008-12#1)
of professional relationships##2##3##(2008-7#2)
of professional##37##2##(1991-2#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#3)(2007-11#1)(2008-10#1)(2008-11#9)(2008-12#5)(2008-3#1)(2008-7#2)(2008-9#1)(2012-6#1)(2013-1#2)(2013-8#2)
of professionalism##7##2##(1993-3#1)(2008-12#1)(2008-4#1)(2012-1#2)(2013-1#2)
of professionals##10##2##(1993-2#1)(1993-6#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
of professor##2##2##(2011-2#1)(2013-8#1)
of profit##2##2##(2011-2#2)
of profound deafness##2##3##(2008-9#2)
of profound hearing loss##2##4##(2008-9#2)
of profound##6##2##(2008-9#6)
of profoundly hearing-impaired children##2##4##(2008-9#2)
of profoundly##3##2##(2008-9#3)
of progenitor cells##9##3##(1991-5#1)(2008-11#5)(2008-9#2)(2010-11#1)
of progenitor##10##2##(1991-5#1)(2008-11#6)(2008-9#2)(2010-11#1)
of progeny budded virus##2##4##(1997-3#2)
of progeny from##2##3##(2008-10#1)(2012-1#1)
of progeny of##2##3##(2008-10#2)
of progeny##12##2##(1994-11#1)(1997-3#2)(2008-10#5)(2008-8#2)(2012-1#1)(2013-8#1)
of progeria##2##2##(2007-8#2)
of progesterone receptor##3##3##(1993-11#1)(2008-11#2)
of progesterone##9##2##(1990-11#1)(1993-11#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2013-8#1)
of progestin##4##2##(1992-2#1)(2008-12#3)
of prognosis##5##2##(1990-12#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-3#1)
of prognostic factors in##2##4##(1991-11#1)(1995-8#1)
of prognostic factors##5##3##(1991-11#1)(1992-9#1)(1994-12#1)(1995-8#1)(2011-2#1)
of prognostic significance##3##3##(1990-12#1)(1996-9#1)(2007-8#1)
of prognostic value##4##3##(1990-8#1)(1996-9#1)(1997-8#1)(2011-2#1)
of prognostic##15##2##(1990-12#1)(1990-8#1)(1991-11#1)(1992-9#1)(1994-12#1)(1995-8#1)(1996-9#2)(1997-8#1)(2007-8#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
of prognostically##2##2##(1995-5#1)(2012-3#1)
of program effectiveness##2##3##(1997-2#1)(2008-4#1)
of program evaluation##4##3##(1993-12#3)(2007-11#1)
of program management##3##3##(1994-3#1)(1995-2#2)
of program##21##2##(1992-12#1)(1992-3#1)(1993-12#4)(1993-2#1)(1994-3#2)(1994-7#1)(1995-2#3)(1995-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-4#1)(2010-11#1)(2010-12#1)(2013-1#1)
of programmable##5##2##(2007-11#2)(2007-7#1)(2008-3#1)(2010-12#1)
of programmed cell death in##3##5##(1991-12#1)(2008-8#1)(2009-10#1)
of programmed cell death##11##4##(1991-12#3)(1993-9#1)(1994-9#1)(2008-10#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)
of programmed##12##2##(1991-12#3)(1993-9#1)(1994-9#1)(2008-10#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)
of programmes##2##2##(1994-6#1)(2013-7#1)
of programming##3##2##(2008-9#3)
of programs for##2##3##(1991-2#1)(1995-3#1)
of programs in##2##3##(1996-3#1)(2008-1#1)
of programs that##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
of programs##21##2##(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#2)(2012-2#1)(2012-3#1)
of progress in the##2##4##(1996-3#1)(2008-10#1)
of progress in##5##3##(1990-2#1)(1991-3#1)(1994-3#1)(1996-3#1)(2008-10#1)
of progress monitoring##3##3##(2011-2#3)
of progress##17##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-1#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-5#1)(2011-2#3)(2012-2#1)
of progression may##2##3##(2008-1#1)(2010-4#1)
of progression of the##2##4##(1990-2#1)(2012-3#1)
of progression of##11##3##(1990-2#1)(1991-8#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
of progression to##6##3##(2007-2#1)(2008-9#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
of progression##24##2##(1990-2#1)(1991-8#1)(1994-7#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of progressive##14##2##(1991-3#1)(1992-12#1)(1995-5#1)(1997-5#1)(2008-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#2)
of progressively##2##2##(1994-2#1)(2007-5#1)
of prohibited substances in##2##4##(2010-11#2)
of prohibited substances##3##3##(2010-11#2)(2010-7#1)
of prohormones##4##2##(1993-5#1)(2008-4#3)
of proinflammatory cytokine##2##3##(2008-6#1)(2009-8#1)
of proinflammatory cytokines##8##3##(2007-11#2)(2008-1#1)(2008-11#4)(2009-8#1)
of proinflammatory mediators##2##3##(1994-8#1)(2010-1#1)
of proinflammatory##14##2##(1994-8#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-6#1)(2009-8#2)(2010-1#1)(2013-7#1)
of projected##2##2##(2007-12#1)(2008-2#1)
of projection##4##2##(1991-5#1)(2008-3#2)(2008-5#1)
of projections##2##2##(2009-8#1)(2011-1#1)
of projects##10##2##(1995-6#1)(1995-8#1)(1996-10#1)(1997-8#1)(2008-10#1)(2012-2#1)(2012-3#4)
of prokaryotic and eukaryotic##2##4##(2008-10#1)(2008-11#1)
of prokaryotic##7##2##(1991-9#1)(2008-10#1)(2008-11#2)(2011-1#2)(2011-2#1)
of prolactin in##2##3##(1992-9#1)(2008-12#1)
of prolactin secretion##2##3##(1990-7#1)(1994-3#1)
of prolactin##11##2##(1990-7#1)(1991-12#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(2008-11#1)(2008-12#2)(2008-4#2)
of prolapse##3##2##(2008-12#2)(2013-1#1)
of proliferating cell nuclear antigen##2##5##(1997-6#1)(2013-1#1)
of proliferating cells##2##3##(2008-9#2)
of proliferating##7##2##(1997-6#1)(2008-11#1)(2008-7#1)(2008-9#3)(2013-1#1)
of proliferation and apoptosis##2##4##(2008-11#1)(2012-1#1)
of proliferation and##9##3##(1991-5#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)(2013-1#2)
of proliferation markers##2##3##(1997-7#1)(2011-2#1)
of proliferation of##4##3##(1991-3#1)(1992-8#1)(1994-3#1)(2013-8#1)
of proliferation##27##2##(1990-8#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-6#1)(1997-7#2)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
of proliferative##5##2##(1995-12#1)(2008-11#1)(2008-4#2)(2008-7#1)
of proline by##2##3##(1990-5#1)(2011-1#1)
of proline in##4##3##(1991-12#1)(2008-10#3)
of proline with##2##3##(1990-5#2)
of proline##12##2##(1990-5#3)(1990-9#1)(1991-12#2)(2008-10#3)(2008-5#1)(2011-1#1)(2012-7#1)
of prolonged formalin fixation##2##4##(2012-3#2)
of prolonged##20##2##(1992-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
of prolyl peptides##3##3##(1990-5#3)
of promethazine hydrochloride using##2##4##(2008-10#2)
of promethazine hydrochloride##4##3##(2008-10#4)
of promethazine-HCl##3##2##(2008-10#3)
of prominent##5##2##(2007-8#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)
of promising##6##2##(2008-11#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
of promoter activity##4##3##(1990-5#1)(1991-2#1)(1994-6#1)(1997-8#1)
of promoter and enhancer##2##4##(1992-6#1)(2008-1#1)
of promoter and##3##3##(1992-6#1)(2008-1#1)(2008-8#1)
of promoter##15##2##(1990-5#1)(1991-2#1)(1992-6#1)(1994-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2012-2#1)
of promoters##3##2##(1995-2#1)(1997-4#1)(2008-7#1)
of promoting##6##2##(1993-6#1)(2008-4#1)(2010-10#2)(2011-1#1)(2011-2#1)
of prompt##2##2##(2008-3#1)(2008-7#1)
of prone##3##2##(1992-11#1)(1992-4#1)(2012-12#1)
of proopiomelanocortin##2##2##(1993-5#2)
of propagating##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
of propagation of the##2##4##(2007-11#1)(2007-12#1)
of propagation of##8##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
of propagation through##2##3##(2007-12#2)
of propagation##16##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)
of propagule size##2##3##(2008-8#2)
of propagule##5##2##(2008-10#1)(2008-8#2)(2008-9#2)
of propagules in##3##3##(2008-10#3)
of propagules of F##2##4##(2008-10#2)
of propagules##8##2##(2008-10#7)(2008-8#1)
of propargylic##2##2##(2010-2#1)(2013-7#1)
of propellants##4##2##(1992-3#1)(1996-1#2)(2008-10#1)
of propensity##3##2##(1993-11#1)(2008-11#2)
of proper treatment##2##3##(2007-11#1)(2008-1#1)
of proper##14##2##(1990-3#1)(1993-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#4)
of properly##3##2##(1991-12#1)(1993-2#1)(1997-4#1)
of properties of##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
of properties##9##2##(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
of prophase##2##2##(2008-5#1)(2009-10#1)
of prophylactic antibiotics##4##3##(2007-12#1)(2008-7#2)(2009-5#1)
of prophylactic##21##2##(1990-6#1)(1993-3#1)(1994-2#2)(1994-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of prophylaxis and##3##3##(1992-12#1)(2013-1#2)
of prophylaxis##11##2##(1992-12#1)(1993-10#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-7#1)(2011-2#2)(2013-1#3)
of propiconazole##3##2##(2008-10#3)
of propidium iodide (PI)##2##4##(2008-9#2)
of propidium iodide##3##3##(2008-9#3)
of propidium##6##2##(1992-3#3)(2008-9#3)
of propionic acid methyl##2##4##(2008-7#2)
of propiverine and##3##3##(2008-10#3)
of propofol##3##2##(1990-3#1)(2011-2#2)
of propolis##7##2##(2008-10#3)(2008-11#4)
of proposed##11##2##(1992-9#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
of propranolol and##5##3##(1994-5#2)(2008-10#3)
of propranolol##11##2##(1994-5#2)(2008-10#5)(2008-7#1)(2009-8#3)
of propylene oxide##3##3##(2008-6#3)
of propylene##4##2##(2007-7#1)(2008-6#3)
of prosodic##3##2##(2009-10#1)(2010-9#2)
of prosody##6##2##(2008-9#1)(2010-9#5)
of prospective memory##2##3##(2008-1#1)(2013-7#1)
of prospective payment##4##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)
of prospective studies have##2##4##(1997-6#1)(2012-3#1)
of prospective##16##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1995-2#1)(1997-6#1)(2008-1#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
of prostacyclin##9##2##(1991-12#1)(1991-5#2)(1992-6#1)(1994-9#2)(1995-11#2)(2008-11#1)
of prostaglandin E2 (PGE2)##4##4##(1990-2#1)(1995-3#1)(1997-2#1)(2007-11#1)
of prostaglandin E2 in##2##4##(1990-2#1)(1997-2#1)
of prostaglandin E2 on the intensity of##2##7##(1995-12#2)
of prostaglandin E2 synthesis by##2##5##(1997-1#2)
of prostaglandin E2##12##3##(1990-2#2)(1995-12#3)(1995-3#1)(1996-2#1)(1997-1#2)(1997-2#2)(2007-11#1)
of prostaglandin H synthase##3##4##(1994-5#3)
of prostaglandin H synthase-2##3##4##(1993-3#3)
of prostaglandin H##7##3##(1993-3#3)(1994-5#4)
of prostaglandin synthesis in##2##4##(1990-12#2)
of prostaglandin synthesis##3##3##(1990-12#2)(1995-5#1)
of prostaglandin##30##2##(1990-12#3)(1990-2#2)(1990-8#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-5#4)(1995-12#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1997-1#3)(1997-2#2)(2007-11#1)(2008-7#1)
of prostaglandins (PGs)##2##3##(2008-11#1)(2008-7#1)
of prostaglandins##12##2##(1992-8#1)(1994-11#2)(1994-6#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)
of prostanoids##4##2##(1992-8#3)(1993-3#1)
of prostate cancer in##4##4##(1994-12#1)(1995-9#1)(2010-1#1)(2011-2#1)
of prostate cancer risk##3##4##(2012-12#3)
of prostate cancer##40##3##(1991-8#1)(1994-12#1)(1995-9#3)(2007-11#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-5#2)(2010-1#1)(2010-12#3)(2011-2#6)(2012-12#5)(2012-3#2)(2013-1#3)(2013-8#3)
of prostate gland##2##3##(2008-7#1)(2012-3#1)
of prostate##59##2##(1991-8#1)(1994-12#3)(1995-8#1)(1995-9#3)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-12#2)(2009-5#2)(2010-1#2)(2010-12#3)(2011-1#1)(2011-2#9)(2012-12#6)(2012-3#4)(2013-1#4)(2013-8#3)
of prostate-specific antigen in##2##4##(1996-9#1)(2007-4#1)
of prostate-specific antigen##4##3##(1996-9#1)(2007-4#1)(2008-9#2)
of prostatic cancer##4##3##(1990-9#1)(1991-2#1)(1991-7#1)(2009-5#1)
of prostatic carcinoma##3##3##(1991-2#2)(2008-4#1)
of prostatic epithelial##2##3##(1990-7#1)(2008-11#1)
of prostatic##14##2##(1990-7#1)(1990-9#1)(1991-2#5)(1991-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)
of prostatitis syndrome##2##3##(2008-10#2)
of prostatitis##3##2##(2008-10#3)
of prostheses to##2##3##(2011-2#1)(2013-1#1)
of prostheses##6##2##(2009-1#1)(2010-3#1)(2011-2#3)(2013-1#1)
of prosthesis##3##2##(1992-9#1)(2007-8#1)(2011-2#1)
of prosthetic##11##2##(1990-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2011-2#5)(2013-1#1)
of protease activity##2##3##(2011-2#2)
of protease inhibitors##3##3##(1991-2#2)(1992-6#1)
of protease##9##2##(1991-2#2)(1992-12#1)(1992-6#2)(2008-10#1)(2011-2#3)
of proteases##8##2##(1990-11#1)(1992-11#1)(1992-12#1)(1994-11#1)(1997-4#1)(2008-11#1)(2008-4#2)
of proteasome##3##2##(2008-4#1)(2012-3#1)(2013-8#1)
of protected amine-functionalised polymer beads##2##5##(2008-10#2)
of protected##8##2##(1997-4#1)(2008-10#4)(2008-4#3)
of protecting groups##4##3##(1995-11#1)(2008-6#1)(2008-7#1)(2009-9#1)
of protecting##10##2##(1991-6#1)(1992-8#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)
of protection against##7##3##(1991-9#1)(1995-12#1)(1995-5#2)(2008-10#1)(2008-7#1)(2009-12#1)
of protection and##4##3##(2007-10#1)(2007-2#1)(2009-12#1)(2011-2#1)
of protection from##3##3##(1991-2#1)(2008-11#1)(2012-12#1)
of protection in##2##3##(1994-2#1)(1995-5#1)
of protection##42##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-5#5)(1996-12#1)(1996-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
of protective antibodies##2##3##(1997-6#1)(2010-10#1)
of protective immunity##4##3##(1997-3#1)(2011-2#3)
of protective##12##2##(1992-11#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#3)
of protein 4##3##3##(1994-12#2)(2010-5#1)
of protein A in##2##4##(1990-12#2)
of protein A##9##3##(1990-12#4)(1990-8#2)(1997-4#1)(2008-10#1)(2008-11#1)
of protein C activation##2##4##(1990-5#1)(1997-2#1)
of protein C##4##3##(1990-5#1)(1997-2#1)(2008-1#1)(2008-12#1)
of protein D##7##3##(1992-3#5)(1992-8#2)
of protein G##3##3##(1995-5#1)(2008-10#2)
of protein aggregates##2##3##(1994-11#1)(2008-1#1)
of protein and to##2##4##(2008-10#1)(2013-8#1)
of protein and##10##3##(1991-5#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
of protein based on##2##4##(2008-10#2)
of protein based##3##3##(2008-10#2)(2008-5#1)
of protein biomarkers##2##3##(2008-10#1)(2010-11#1)
of protein biosynthesis##3##3##(1992-8#1)(2008-4#1)(2008-7#1)
of protein by##3##3##(1994-5#1)(2008-10#2)
of protein carbonyls##2##3##(2010-4#2)
of protein coding##2##3##(2008-4#1)(2010-7#1)
of protein complexes##4##3##(1995-6#1)(2008-7#1)(2010-10#1)(2010-9#1)
of protein concentration##4##3##(2008-1#1)(2008-10#1)(2008-4#2)
of protein crystallization##2##3##(2008-10#1)(2009-11#1)
of protein degradation##3##3##(1992-12#1)(1994-11#1)(2008-7#1)
of protein disulfide isomerase##5##4##(1990-7#1)(1993-6#2)(1995-3#1)(2013-1#1)
of protein domain evolution##2##4##(2011-2#2)
of protein domain##3##3##(2008-4#1)(2011-2#2)
of protein engineering##3##3##(1994-8#1)(2009-2#1)(2011-2#1)
of protein evolution##3##3##(1991-12#1)(2008-7#2)
of protein expression in##2##4##(1995-5#1)(2008-11#1)
of protein expression##10##3##(1995-5#1)(2008-11#4)(2008-4#3)(2008-7#1)(2010-9#1)
of protein extracts##3##3##(2008-10#2)(2008-4#1)
of protein folding and##2##4##(1991-6#1)(2008-1#1)
of protein folding##6##3##(1991-6#2)(1992-5#1)(1995-5#1)(1997-2#1)(2008-1#1)
of protein for##2##3##(1996-5#1)(1997-4#1)
of protein function##3##3##(2008-9#1)(2010-11#1)(2011-2#1)
of protein functional groups##2##4##(1997-2#1)(1997-6#1)
of protein in##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
of protein intake##4##3##(2008-5#2)(2013-1#1)(2013-8#1)
of protein interactions in living cells##2##6##(2008-4#2)
of protein interactions in##3##4##(2008-4#3)
of protein interactions##7##3##(2008-4#6)(2012-2#1)
of protein isolates##2##3##(2011-2#2)
of protein kinase A##7##4##(1990-12#1)(1992-12#2)(1993-8#1)(1996-12#1)(2008-10#1)(2012-2#1)
of protein kinase C (PKC) and##4##6##(1992-9#1)(1993-8#1)(1995-3#1)(1997-6#1)
of protein kinase C (PKC) in##4##6##(1991-2#1)(1995-11#1)(1996-5#1)(2008-4#1)
of protein kinase C (PKC)##19##5##(1991-2#1)(1992-12#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#2)
of protein kinase C activation##4##5##(1992-8#1)(1993-3#2)(2008-11#1)
of protein kinase C activity in##2##6##(1993-8#1)(1994-11#1)
of protein kinase C activity##5##5##(1990-5#1)(1990-8#1)(1993-12#1)(1993-8#1)(1994-11#1)
of protein kinase C alpha##2##5##(1994-5#1)(1995-11#1)
of protein kinase C and##6##5##(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1997-2#1)(2008-11#1)
of protein kinase C by##5##5##(1990-12#1)(1990-2#1)(1993-8#1)(1994-9#1)(2008-8#1)
of protein kinase C down-regulation##2##5##(1990-11#1)(1992-9#1)
of protein kinase C in mouse skin##2##7##(1990-11#2)
of protein kinase C in the##2##6##(1997-1#2)
of protein kinase C in##13##5##(1990-11#2)(1990-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1996-9#1)(1997-1#2)(2008-11#2)
of protein kinase C is##2##5##(1992-6#1)(1994-3#1)
of protein kinase C with##2##5##(1994-5#1)(1995-2#1)
of protein kinase C##110##4##(1990-11#4)(1990-12#3)(1990-2#3)(1990-5#5)(1990-7#2)(1990-8#4)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#3)(1992-8#4)(1992-9#9)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#7)(1994-11#3)(1994-3#1)(1994-5#7)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#8)(2008-4#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#2)
of protein kinase inhibitors##2##4##(1990-8#1)(1994-11#1)
of protein kinase##130##3##(1990-11#4)(1990-12#5)(1990-2#3)(1990-5#5)(1990-7#3)(1990-8#5)(1991-12#2)(1991-2#3)(1991-9#1)(1992-11#1)(1992-12#4)(1992-6#3)(1992-8#4)(1992-9#9)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#8)(1994-11#4)(1994-3#1)(1994-5#7)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-4#2)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
of protein kinases in the##2##5##(2008-11#1)(2012-3#1)
of protein kinases in##3##4##(1997-1#1)(2008-11#1)(2012-3#1)
of protein kinases##10##3##(1991-11#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
of protein level##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
of protein linear molecular motors##2##5##(2009-12#2)
of protein mass##2##3##(2008-7#2)
of protein molecules##2##3##(1990-11#1)(2010-10#1)
of protein on##2##3##(2008-5#1)(2008-9#1)
of protein or mRNA##2##4##(1997-4#1)(2009-9#1)
of protein per##3##3##(2008-10#2)(2010-7#1)
of protein phosphatase 2A##3##4##(1994-9#2)(1995-8#1)
of protein phosphatase##10##3##(1993-8#1)(1994-11#1)(1994-9#2)(1995-8#2)(1997-4#1)(2008-2#1)(2008-4#1)(2012-12#1)
of protein phosphatases 1 and 2A##2##6##(1992-12#2)
of protein phosphatases##4##3##(1990-12#1)(1992-12#2)(1995-11#1)
of protein phosphorylation##2##3##(1990-12#1)(1996-2#1)
of protein post-translational##2##3##(2009-6#1)(2010-12#1)
of protein secondary structure##2##4##(1991-11#1)(2008-10#1)
of protein sequence##3##3##(2008-9#2)(2009-6#1)
of protein sequences##3##3##(2008-4#1)(2009-6#1)(2013-8#1)
of protein serine/threonine##2##3##(1994-11#1)(1995-8#1)
of protein structure and##2##4##(2010-12#1)(2012-3#1)
of protein structure##5##3##(1991-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-3#1)
of protein structures by##3##4##(1994-8#2)(2008-4#1)
of protein structures##5##3##(1994-8#2)(2008-4#1)(2009-5#1)(2013-1#1)
of protein synthesis by##3##4##(1992-11#1)(1992-8#1)(1994-6#1)
of protein synthesis in##2##4##(1994-6#1)(2008-11#1)
of protein synthesis##25##3##(1990-12#1)(1991-2#1)(1992-11#2)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)
of protein tyrosine kinase (PTK)##2##5##(1994-6#1)(2008-8#1)
of protein tyrosine kinases##3##4##(1993-3#1)(1996-2#2)
of protein tyrosine phosphatase##3##4##(1993-3#1)(1994-6#1)(2008-8#1)
of protein tyrosine phosphorylation##4##4##(1993-3#1)(2012-3#3)
of protein tyrosine##12##3##(1993-3#3)(1994-6#2)(1996-2#2)(2008-8#2)(2012-3#3)
of protein unfolding##2##3##(1995-3#1)(1997-2#1)
of protein using##2##3##(2008-10#1)(2008-7#1)
of protein##473##2##(1990-11#5)(1990-12#14)(1990-2#3)(1990-5#9)(1990-7#4)(1990-8#8)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#7)(1992-3#5)(1992-5#1)(1992-6#3)(1992-8#9)(1992-9#9)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#6)(1993-6#7)(1993-8#10)(1993-9#1)(1994-11#11)(1994-12#2)(1994-3#1)(1994-5#11)(1994-6#8)(1994-8#7)(1994-9#3)(1995-11#7)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#3)(1995-8#5)(1996-12#6)(1996-2#5)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#6)(1997-6#3)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#8)(2008-10#34)(2008-11#24)(2008-12#3)(2008-2#7)(2008-4#31)(2008-5#17)(2008-6#1)(2008-7#21)(2008-8#5)(2008-9#6)(2009-11#2)(2009-12#3)(2009-2#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#2)(2010-9#4)(2011-1#3)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#5)
of protein)##2##2##(1996-2#1)(2010-11#1)
of protein-bound##5##2##(1990-3#2)(1991-12#1)(2008-5#1)(2008-7#1)
of protein-ligand##2##2##(1995-11#1)(2008-4#1)
of protein-protein and##2##3##(1992-9#1)(2008-2#1)
of protein-protein interaction networks##2##4##(2008-4#2)
of protein-protein interaction##4##3##(1993-6#1)(2008-11#1)(2008-4#2)
of protein-protein interactions##11##3##(2008-1#1)(2008-11#1)(2008-4#6)(2008-7#2)(2010-10#1)
of protein-protein##18##2##(1992-9#1)(1993-6#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#9)(2008-7#2)(2010-10#1)
of protein-tyrosine##3##2##(1992-8#3)
of proteinaceous binding media##3##4##(2008-10#3)
of proteinaceous glues##2##3##(2008-10#2)
of proteinaceous##8##2##(2007-12#1)(2008-10#6)(2008-7#1)
of proteinase inhibitors##3##3##(1992-8#1)(1996-12#2)
of proteinase##4##2##(1990-5#1)(1992-8#1)(1996-12#2)
of proteinases in##2##3##(1996-2#2)
of proteinases##8##2##(1994-5#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#2)(2008-11#1)(2012-12#1)
of proteins after##2##3##(2008-11#1)(2010-3#1)
of proteins and lipids##2##4##(1993-11#1)(2008-1#1)
of proteins and nucleic acids##2##5##(1995-2#1)(2008-6#1)
of proteins and peptides by capillary##2##6##(1996-5#1)(1997-2#1)
of proteins and peptides##4##4##(1996-5#2)(1997-2#1)(2008-10#1)
of proteins and the##2##4##(1996-5#1)(2008-6#1)
of proteins and##28##3##(1992-11#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-5#3)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
of proteins are##7##3##(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#2)(2010-12#1)(2013-1#1)
of proteins associated with##2##4##(2007-12#1)(2009-7#1)
of proteins at nanogram##2##4##(2008-10#2)
of proteins at##3##3##(2008-10#2)(2009-9#1)
of proteins based on the##2##5##(2008-10#2)
of proteins based on##3##4##(2008-10#2)(2011-3#1)
of proteins by the##2##4##(1996-12#1)(2008-10#1)
of proteins by##9##3##(1990-8#1)(1996-12#2)(1997-2#2)(2008-10#2)(2008-8#1)(2012-2#1)
of proteins can##2##3##(1993-6#1)(2008-10#1)
of proteins from the##3##4##(2008-1#1)(2008-6#2)
of proteins from whole-cell##2##4##(2008-4#2)
of proteins from##11##3##(1991-12#1)(1993-2#1)(2008-1#1)(2008-4#4)(2008-6#2)(2008-9#1)(2010-4#1)
of proteins has been##2##4##(1997-6#1)(2008-10#1)
of proteins has##5##3##(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
of proteins in cancer##2##4##(2011-2#1)(2012-12#1)
of proteins in cells##2##4##(2008-1#1)(2010-10#1)
of proteins in complex##2##4##(2008-1#1)(2008-4#1)
of proteins in the##8##4##(1992-12#1)(1994-12#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-4#1)
of proteins in##42##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-9#2)(1995-12#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-10#8)(2008-2#1)(2008-4#8)(2009-12#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)
of proteins including##2##3##(2008-11#1)(2010-12#1)
of proteins into##2##3##(1994-11#1)(2008-4#1)
of proteins involved in##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
of proteins is a##2##4##(2008-1#1)(2008-4#1)
of proteins is##9##3##(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#3)(2009-5#1)
of proteins mediating##2##3##(1994-9#1)(2010-12#1)
of proteins modified by##4##4##(2008-2#2)(2008-4#1)(2010-12#1)
of proteins of##2##3##(1991-12#1)(2011-2#1)
of proteins on##2##3##(2008-10#1)(2008-2#1)
of proteins that are##3##4##(2008-4#2)(2008-7#1)
of proteins that have##3##4##(1994-6#1)(2009-7#1)(2011-2#1)
of proteins that##15##3##(1990-11#1)(1994-6#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-1#1)
of proteins to specific##2##4##(2009-5#1)(2012-7#1)
of proteins to##4##3##(2008-11#1)(2008-7#1)(2009-5#1)(2012-7#1)
of proteins using##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
of proteins was##3##3##(2008-10#2)(2013-8#1)
of proteins were##5##3##(1990-12#1)(1994-12#1)(2008-10#3)
of proteins which are##2##4##(1991-9#1)(1994-12#1)
of proteins which##4##3##(1991-9#1)(1994-12#1)(1994-9#1)(1997-3#1)
of proteins with some heteropoly compounds##2##6##(2008-10#2)
of proteins with##13##3##(1992-6#1)(1994-6#1)(1997-2#1)(2008-10#7)(2008-2#1)(2009-9#1)(2011-2#1)
of proteins within##4##3##(2008-1#1)(2008-4#1)(2008-7#1)(2009-12#1)
of proteins##312##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-8#1)(1991-12#3)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#5)(1995-12#1)(1995-2#6)(1995-6#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#2)(2007-12#1)(2008-1#16)(2008-10#47)(2008-11#10)(2008-2#13)(2008-4#45)(2008-5#7)(2008-6#6)(2008-7#18)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#10)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-6#1)(2012-7#1)(2013-1#2)(2013-8#5)
of proteinuria and##4##3##(2008-1#2)(2011-2#1)(2012-2#1)
of proteinuria##8##2##(2007-7#1)(2008-1#3)(2008-8#2)(2011-2#1)(2012-2#1)
of proteoglycans##4##2##(1990-2#2)(2007-11#1)(2009-12#1)
of proteolipid##2##2##(2009-6#2)
of proteolysis##6##2##(1991-2#2)(1991-5#1)(1995-11#1)(2009-8#1)(2010-3#1)
of proteolytic activity##4##3##(1990-2#2)(2008-6#1)(2010-4#1)
of proteolytic enzymes##4##3##(1991-5#1)(2008-5#1)(2010-3#1)(2013-1#1)
of proteolytic##17##2##(1990-11#1)(1990-2#2)(1991-5#2)(1992-3#1)(1992-8#1)(1994-8#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
of proteomes##4##2##(2008-4#2)(2008-7#1)(2008-9#1)
of proteomic data##2##3##(2008-4#1)(2010-2#1)
of proteomic studies##3##3##(2010-12#2)(2010-2#1)
of proteomic##10##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-2#2)
of proteomics data##2##3##(2008-7#2)
of proteomics in##2##3##(2009-6#1)(2012-2#1)
of proteomics##8##2##(2008-4#1)(2008-7#4)(2009-6#1)(2010-2#1)(2012-2#1)
of proteosome-based vaccines##2##3##(1990-12#2)
of protexin##2##2##(2010-4#2)
of proto-oncogene induction##2##3##(1991-5#1)(1996-12#1)
of proto-oncogene##3##2##(1991-5#1)(1993-12#1)(1996-12#1)
of proto-oncogenes##3##2##(1992-9#1)(2008-7#1)(2011-2#1)
of protocatechuic acid##2##3##(2008-10#1)(2012-3#1)
of protocol##4##2##(2008-11#1)(2008-9#1)(2011-2#2)
of protocols for##5##3##(2008-4#4)(2008-9#1)
of protocols in##2##3##(2008-9#1)(2010-10#1)
of protocols##12##2##(2008-1#1)(2008-10#1)(2008-4#5)(2008-9#4)(2010-10#1)
of protoheme IX to##2##4##(1992-12#1)(1994-8#1)
of proton NMR##2##3##(1993-8#1)(2008-5#1)
of proton pump inhibitor##2##4##(2009-11#1)(2012-2#1)
of proton pump inhibitors##3##4##(2012-2#3)
of proton pump##5##3##(2009-11#1)(2012-2#4)
of proton##15##2##(1992-3#1)(1993-8#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-11#1)(2010-9#1)(2012-12#1)(2012-2#4)
of proton-exchanged##2##2##(2008-2#2)
of protonated##12##2##(2008-10#10)(2012-12#2)
of protonation constants##2##3##(2008-10#2)
of protonation##8##2##(1996-2#1)(1997-7#1)(2008-10#6)
of protonophores##4##2##(1996-4#4)
of protons##6##2##(1990-2#1)(1991-12#1)(2008-10#2)(2011-1#1)(2013-1#1)
of protoplasts##4##2##(2008-8#1)(2008-9#2)(2010-2#1)
of protostomes and deuterostomes##2##4##(2007-12#2)
of prototype##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
of prototypical##2##2##(2008-10#1)(2009-11#1)
of protozoa##3##2##(2008-12#1)(2009-10#1)(2012-12#1)
of protozoan##2##2##(2008-12#1)(2011-2#1)
of protruding##2##2##(1990-9#1)(2012-12#1)
of prourokinase##3##2##(2008-11#3)
of proven##6##2##(1992-8#1)(2007-7#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
of provider performance##2##3##(1995-3#1)(2013-1#1)
of provider##7##2##(1991-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-3#1)(2011-1#1)(2013-1#1)
of providers##10##2##(1992-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1996-1#1)(1996-12#1)(1997-3#2)(2011-2#1)
of providing a##6##3##(1991-11#1)(1996-3#1)(2007-12#1)(2008-2#1)(2009-7#1)(2011-1#1)
of providing an##3##3##(2008-3#1)(2009-5#1)(2013-1#1)
of providing care to##3##4##(2008-11#1)(2008-6#1)(2010-4#1)
of providing care##4##3##(2008-11#1)(2008-6#1)(2008-9#1)(2010-4#1)
of providing more##2##3##(2010-10#1)(2012-3#1)
of providing the##2##3##(1997-1#1)(2008-1#1)
of providing##62##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-5#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
of provincial##2##2##(1991-3#1)(2012-12#1)
of proviruses##2##2##(1991-5#1)(1995-8#1)
of provision##2##2##(1995-12#1)(2012-3#1)
of proximal femur fractures##2##4##(2007-11#1)(2007-8#1)
of proximal femur##4##3##(2007-11#3)(2007-8#1)
of proximal humerus fractures##3##4##(2007-8#3)
of proximal humerus##5##3##(2007-8#4)(2009-4#1)
of proximal##23##2##(1993-1#1)(1994-5#1)(1995-11#1)(1996-5#1)(2007-11#4)(2007-8#5)(2008-10#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2013-7#1)
of proximate composition##2##3##(2012-2#1)(2013-7#1)
of proximate##4##2##(2008-6#2)(2012-2#1)(2013-7#1)
of prune##4##2##(2008-10#3)(2008-7#1)
of psbP##2##2##(1996-10#2)
of pseudo cyst##2##3##(2008-5#2)
of pseudo##3##2##(2008-5#2)(2009-7#1)
of pseudo-nondiffracting beams by use of diffractive phase elements##2##9##(2008-2#2)
of pseudoaneurysm##2##2##(1991-3#1)(2008-12#1)
of pseudoarthrosis##2##2##(2009-3#2)
of pseudodipeptides##2##2##(2008-5#2)
of pseudoephedrine##4##2##(2008-10#4)
of pseudoislets##2##2##(2010-11#2)
of pseudopregnant rat##2##3##(1997-6#1)(2008-9#1)
of pseudosclerotia##9##2##(2008-10#9)
of pseudothecia and ascospores##2##4##(2008-10#2)
of pseudothecia and##4##3##(2008-10#4)
of pseudothecia on##2##3##(2008-10#2)
of pseudothecia was##3##3##(2008-10#3)
of pseudothecia##15##2##(2008-10#15)
of pseudothecial##2##2##(2008-10#2)
of pseudouridine in human urine and serum##2##7##(1990-8#2)
of pseudouridine##5##2##(1990-8#2)(1992-3#2)(1993-8#1)
of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2##2##14##(2008-10#2)
of psilocin and psilocybin##3##4##(2008-10#3)
of psilocybin in##3##3##(2008-10#3)
of psilocybin users##5##3##(2013-8#5)
of psilocybin was##2##3##(2008-10#2)
of psilocybin##13##2##(2008-10#5)(2013-8#8)
of psittacine##2##2##(2008-5#2)
of psoriasis in##3##3##(1997-8#1)(2007-11#1)(2008-6#1)
of psoriasis##16##2##(1993-11#1)(1995-5#2)(1997-8#2)(2007-11#3)(2007-7#1)(2008-5#1)(2008-6#5)(2011-1#1)
of psychiatric comorbidity##2##3##(2008-6#1)(2013-1#1)
of psychiatric diseases##2##3##(1996-12#1)(2013-1#1)
of psychiatric disorders##12##3##(1996-11#2)(1997-5#1)(2007-1#1)(2008-2#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of psychiatric hospitals##2##3##(1992-3#1)(1993-12#1)
of psychiatric morbidity##2##3##(1993-5#1)(2012-3#1)
of psychiatric occupational therapy##2##4##(2012-1#2)
of psychiatric symptoms##3##3##(2011-2#1)(2013-8#2)
of psychiatric treatment##2##3##(1993-2#1)(2010-11#1)
of psychiatric##51##2##(1991-1#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-11#3)(1996-12#1)(1997-5#1)(1997-8#1)(2007-1#1)(2008-11#1)(2008-2#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#4)
of psychiatry and##2##3##(1996-1#1)(2008-6#1)
of psychiatry##11##2##(1993-1#1)(1996-1#1)(1996-12#1)(2006-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#2)(2013-8#1)
of psychoactive drugs##5##3##(1994-2#1)(2008-1#1)(2008-6#1)(2012-3#2)
of psychoactive##7##2##(1994-2#1)(2008-1#2)(2008-6#1)(2012-3#2)(2013-1#1)
of psychoeducation##2##2##(2012-12#2)
of psychological and##2##3##(2008-1#1)(2008-4#1)
of psychological distress##3##3##(2007-12#1)(2008-3#1)(2012-1#1)
of psychological factors##2##3##(1993-12#1)(2009-2#1)
of psychological symptoms##2##3##(2008-2#1)(2008-4#1)
of psychological##19##2##(1993-12#1)(1996-1#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-10#1)(2009-2#1)(2011-2#2)(2012-1#1)(2012-2#1)
of psychology##3##2##(2008-11#1)(2011-1#2)
of psychometric##3##2##(1990-6#1)(2009-12#1)(2013-8#1)
of psychopathological##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
of psychopathology in##2##3##(2008-7#1)(2011-2#1)
of psychopathology##9##2##(1996-11#1)(2008-2#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-5#1)(2013-8#2)
of psychopharmacologic##2##2##(2008-4#2)
of psychopharmacological##2##2##(1990-3#1)(2011-1#1)
of psychophysical##2##2##(2008-9#1)(2011-2#1)
of psychosis in##2##3##(1993-1#1)(2008-7#1)
of psychosis##14##2##(1992-12#1)(1993-1#1)(1996-7#1)(1997-5#1)(2007-6#3)(2008-11#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-1#1)
of psychosocial factors##2##3##(2008-2#1)(2013-8#1)
of psychosocial intervention##2##3##(1992-3#1)(2007-12#1)
of psychosocial interventions##3##3##(1992-12#1)(2009-6#1)(2009-7#1)
of psychosocial##14##2##(1992-12#2)(1992-3#2)(1996-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
of psychosocially focused##2##3##(2010-11#2)
of psychotherapeutic interventions##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
of psychotherapeutic##7##2##(1995-6#1)(2008-6#1)(2009-10#2)(2013-1#2)(2013-8#1)
of psychotherapy##4##2##(2008-2#1)(2008-4#1)(2013-1#2)
of psychotic symptoms##3##3##(2012-1#1)(2012-12#1)(2012-2#1)
of psychotic##9##2##(1993-8#1)(1995-11#1)(2008-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)
of psychotropic drugs##2##3##(1996-9#1)(2009-3#1)
of psychotropic##4##2##(1996-9#2)(2009-3#1)(2012-3#1)
of psychrotrophic bacteria##2##3##(2011-2#2)
of pthN##2##2##(2008-10#2)
of pts##2##2##(2007-11#1)(2010-3#1)
of puberty and##2##3##(2008-2#1)(2008-4#1)
of puberty##7##2##(1991-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-6#1)(2013-8#1)
of pubic hair##3##3##(2008-4#1)(2011-2#2)
of pubis##3##2##(1995-6#1)(2008-5#2)
of public and##3##3##(1996-3#1)(2008-3#1)(2011-2#1)
of public dental care for##2##5##(2008-9#2)
of public funding##2##3##(1991-12#1)(1994-2#1)
of public goods##3##3##(2008-10#2)(2012-3#1)
of public health activities##2##4##(1992-1#1)(1996-12#1)
of public health and a##2##5##(1994-1#1)(1997-3#1)
of public health and medical care##2##6##(1995-2#2)
of public health and medicine##4##5##(1995-2#3)(2009-5#1)
of public health and##15##4##(1994-1#1)(1995-2#5)(1996-12#3)(1997-2#1)(1997-3#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
of public health importance##4##4##(1997-3#1)(2008-7#1)(2010-1#1)(2011-2#1)
of public health in an##2##5##(1996-3#1)(1997-3#1)
of public health in##3##4##(1993-6#1)(1996-3#1)(1997-3#1)
of public health is##2##4##(1996-3#1)(2013-1#1)
of public health nurses and high-priority families in northern##2##9##(2010-9#2)
of public health nurses and high-priority families in##3##8##(2010-9#3)
of public health nurses##5##4##(1995-3#1)(1996-2#1)(2010-9#3)
of public health nutritionists employed in provincial and municipal/regional departments of health in Canada##2##14##(1993-1#1)(1993-2#1)
of public health nutritionists##3##4##(1993-1#1)(1993-2#2)
of public health officials##2##4##(2012-12#2)
of public health policy##2##4##(1993-2#1)(2013-1#1)
of public health practice##4##4##(1996-2#1)(1996-3#1)(1997-3#2)
of public health surveillance##4##4##(1997-3#3)(2008-7#1)
of public health to##2##4##(1997-2#1)(2008-7#1)
of public health##104##3##(1990-11#1)(1992-1#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#2)(1995-12#10)(1995-2#5)(1995-3#1)(1995-6#1)(1996-1#7)(1996-12#5)(1996-2#6)(1996-3#8)(1997-1#1)(1997-2#5)(1997-3#12)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)
of public involvement##3##3##(1996-12#1)(2008-7#2)
of public policies##2##3##(2012-2#1)(2013-1#1)
of public policy##2##3##(1996-3#1)(2008-12#1)
of public relations##6##3##(2008-12#6)
of public sector##2##3##(1995-3#1)(2008-11#1)
of public##158##2##(1990-11#1)(1991-12#2)(1991-3#3)(1992-1#1)(1993-1#1)(1993-2#4)(1993-3#2)(1993-6#1)(1994-1#2)(1994-2#6)(1995-12#10)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#7)(1996-12#6)(1996-2#6)(1996-3#11)(1997-1#1)(1997-2#7)(1997-3#12)(2006-10#1)(2008-10#3)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#1)
of publication##15##2##(1996-12#1)(2007-8#12)(2008-3#1)(2013-1#1)
of publications has##2##3##(2008-11#1)(2013-8#1)
of publications on this##2##4##(2008-8#1)(2008-9#1)
of publications on##3##3##(2008-8#2)(2008-9#1)
of publications##15##2##(1992-2#1)(1995-2#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of publicly##2##2##(1992-2#1)(2008-4#1)
of published data##5##3##(1995-1#1)(2008-10#1)(2012-12#1)(2013-1#2)
of published literature##3##3##(2008-6#1)(2008-9#1)(2012-3#1)
of published reports##3##3##(1995-9#1)(2008-2#1)(2012-12#1)
of published studies##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
of published##43##2##(1992-1#1)(1995-1#1)(1995-3#1)(1995-9#2)(1997-1#2)(1997-4#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
of puerperal##2##2##(2009-10#1)(2012-12#1)
of pulling##2##2##(2007-12#1)(2008-12#1)
of pulmonary TB in children##2##5##(2011-2#2)
of pulmonary TB in##3##4##(2011-2#3)
of pulmonary adenomas##2##3##(1990-7#1)(2008-9#1)
of pulmonary and##4##3##(1997-1#1)(2010-3#1)(2011-1#1)(2013-1#1)
of pulmonary arterial hypertension##3##4##(2010-10#2)(2013-1#1)
of pulmonary arterial##7##3##(2008-10#2)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
of pulmonary arteries and##2##4##(2010-8#1)(2012-3#1)
of pulmonary arteries##4##3##(2008-1#2)(2010-8#1)(2012-3#1)
of pulmonary aspergillosis##2##3##(2008-1#2)
of pulmonary coccidioidomycosis##2##3##(2007-12#2)
of pulmonary disease in##2##4##(1997-3#1)(2007-12#1)
of pulmonary disease##4##3##(1997-3#1)(2007-12#1)(2007-6#1)(2011-2#1)
of pulmonary embolism (PE)##2##4##(2007-8#1)(2008-3#1)
of pulmonary embolism##8##3##(1991-11#3)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-10#1)
of pulmonary fibrosis##3##3##(2012-1#3)
of pulmonary function tests##3##4##(1991-12#1)(2007-2#1)(2008-8#1)
of pulmonary function##7##3##(1991-12#1)(1992-5#1)(2007-2#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
of pulmonary histoplasmosis##2##3##(2008-1#2)
of pulmonary hyalinizing granuloma##2##4##(2008-10#2)
of pulmonary hypertension##8##3##(2007-8#1)(2010-10#2)(2010-6#1)(2011-2#2)(2012-2#2)
of pulmonary infarction##2##3##(2007-8#2)
of pulmonary metastases in osteosarcoma##2##5##(2010-3#2)
of pulmonary metastases##5##3##(2008-8#1)(2010-3#4)
of pulmonary metastasis from##3##4##(2008-6#1)(2012-1#1)(2013-7#1)
of pulmonary metastasis##5##3##(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
of pulmonary metastatic##2##3##(2008-7#1)(2012-1#1)
of pulmonary rehabilitation##3##3##(1997-8#1)(2007-6#1)(2011-2#1)
of pulmonary thromboembolism##2##3##(2008-10#1)(2008-6#1)
of pulmonary tuberculosis in##2##4##(1995-3#1)(2011-2#1)
of pulmonary tuberculosis##6##3##(1995-2#1)(1995-3#1)(1997-3#1)(2007-7#1)(2011-2#1)(2013-7#1)
of pulmonary vessels##2##3##(2008-1#1)(2012-3#1)
of pulmonary##137##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-11#4)(1991-12#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-5#1)(1993-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-12#5)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#9)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-10#6)(2010-12#1)(2010-3#6)(2010-6#4)(2010-8#1)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#5)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#4)
of pulp##4##2##(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
of pulse energy##2##3##(2007-12#2)
of pulse propagation in##2##4##(2007-11#2)
of pulse width##2##3##(2007-12#2)
of pulse##17##2##(1993-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
of pulsed field gel electrophoresis##2##5##(2012-3#2)
of pulsed laser##2##3##(2008-10#1)(2008-2#1)
of pulsed photoacoustics##2##3##(2008-3#2)
of pulsed##21##2##(1990-6#1)(1992-3#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#4)(2012-2#2)(2012-3#2)
of pulses in the##2##4##(2007-11#1)(2007-12#1)
of pulses transmitted##2##3##(2007-12#1)(2008-3#1)
of pulses##14##2##(2007-11#1)(2007-12#8)(2008-10#2)(2008-3#3)
of pulverized##2##2##(2008-10#1)(2013-1#1)
of pumice##3##2##(2008-10#2)(2008-7#1)
of pump and##2##3##(2007-11#1)(2007-12#1)
of pump energy##2##3##(2007-11#1)(2008-3#1)
of pump power was##2##4##(2007-11#1)(2008-3#1)
of pump power##10##3##(2007-11#7)(2008-2#1)(2008-3#2)
of pump##26##2##(2007-11#13)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#6)
of pump-beam##2##2##(2008-2#1)(2008-3#1)
of pumping##3##2##(2008-2#1)(2008-3#2)
of punishment##2##2##(2008-8#2)
of pupil##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
of pupils##2##2##(2008-10#1)(2009-10#1)
of pups##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
of purR##2##2##(2008-8#1)(2008-9#1)
of purchase and##2##3##(1992-12#1)(2010-12#1)
of purchase##3##2##(1992-12#1)(2010-12#1)(2012-2#1)
of purchasing##2##2##(1992-12#1)(2008-8#1)
of pure DNA##2##3##(1990-5#1)(2008-10#1)
of pure and##5##3##(1994-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
of pure chlorophenols##3##3##(2008-10#3)
of pure curvature and twist##2##5##(2008-3#2)
of pure extraction resin##2##4##(2008-10#2)
of pure laparoscopic hepatectomy for hepatocellular carcinoma##2##7##(2013-8#2)
of pure liquid water##2##4##(2008-2#1)(2008-3#1)
of pure methyl##2##3##(2008-10#1)(2009-8#1)
of pure water##12##3##(1997-6#1)(2008-10#1)(2008-2#6)(2008-3#4)
of pure##68##2##(1990-5#1)(1991-5#1)(1992-8#1)(1994-5#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
of purification of##2##3##(1994-12#1)(2008-11#1)
of purification##9##2##(1990-5#2)(1994-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#1)
of purified MT##2##3##(2008-10#2)
of purified P2Y receptors##2##4##(2008-4#2)
of purified alpha##2##3##(1991-12#1)(1993-8#1)
of purified beta-cells to##2##4##(1990-8#2)
of purified human##3##3##(1992-8#1)(1994-8#1)(2008-4#1)
of purified protein kinase C##2##5##(1992-9#2)
of purified protein##3##3##(1992-9#2)(1997-2#1)
of purified proteins##2##3##(2008-4#1)(2009-9#1)
of purified##61##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-8#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#4)(1994-8#2)(1995-6#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-4#9)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#2)(2012-2#1)
of purifying##2##2##(2008-10#1)(2008-4#1)
of purine nucleotide##2##3##(1991-4#1)(1994-11#1)
of purine nucleotides##2##3##(1996-5#1)(2008-4#1)
of purine receptors##2##3##(2013-1#2)
of purine ribonucleosides##2##3##(2008-4#2)
of purine units##3##3##(2008-10#3)
of purine##18##2##(1991-4#1)(1994-11#1)(1995-12#1)(1996-5#2)(2008-10#4)(2008-4#3)(2008-8#1)(2008-9#2)(2010-4#1)(2013-1#2)
of purinergic signaling##4##3##(2008-4#1)(2008-5#1)(2013-8#2)
of purinergic##7##2##(1995-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2013-8#2)
of purines##3##2##(1995-12#1)(2008-8#1)(2013-8#1)
of purity of##2##3##(2008-10#2)
of purity##4##2##(2008-10#3)(2010-8#1)
of purple##2##2##(1992-3#1)(2008-10#1)
of purpose and##2##3##(2007-2#1)(2010-11#1)
of purpose##5##2##(1991-12#1)(1993-12#1)(2007-2#1)(2010-11#1)(2013-1#1)
of purposes##4##2##(1991-7#1)(1996-1#1)(2010-12#1)(2012-3#1)
of purpurogallin##3##2##(2008-10#3)
of pursuing##3##2##(1997-2#1)(2008-9#1)(2010-12#1)
of pustules##5##2##(2008-10#5)
of putative melatonin receptor antagonists##2##5##(1992-3#2)
of putative virus-resistant##2##3##(2008-10#2)
of putative##30##2##(1991-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-7#2)(2009-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of putrescine##5##2##(2008-10#2)(2011-2#2)(2012-2#1)
of pycnidia##4##2##(2008-10#4)
of pyelonephritis##3##2##(2011-2#2)(2013-1#1)
of pyloric##2##2##(1990-6#1)(1993-2#1)
of pyogenic meningitis##4##3##(2007-8#3)(2008-7#1)
of pyogenic##5##2##(2006-10#1)(2007-8#3)(2008-7#1)
of pyramidal cells##2##3##(1995-3#1)(2007-8#1)
of pyramidal neurons##2##3##(1991-2#1)(2008-11#1)
of pyramidal##6##2##(1991-2#1)(1995-3#1)(1995-8#1)(2007-10#1)(2007-8#1)(2008-11#1)
of pyrantel pamoate##2##3##(2008-10#2)
of pyrene and##2##3##(2008-10#2)
of pyrene##6##2##(1992-6#2)(2008-10#3)(2009-11#1)
of pyrexia##2##2##(1991-3#1)(2007-7#1)
of pyridine nucleotide##2##3##(1992-1#1)(1994-3#1)
of pyridine##11##2##(1990-11#1)(1992-1#1)(1994-3#1)(1996-2#2)(2007-11#1)(2008-10#4)(2013-1#1)
of pyridinium chloride##2##3##(2008-10#2)
of pyridinium##3##2##(1995-8#1)(2008-10#2)
of pyridoxal##3##2##(1995-6#1)(1996-5#1)(2013-1#1)
of pyridoxine hydrochloride##5##3##(2008-10#5)
of pyridoxine##6##2##(2008-10#5)(2013-1#1)
of pyrimidine##2##2##(1993-8#1)(2008-8#1)
of pyrocatechol##2##2##(2008-10#2)
of pyrogallol compounds##4##3##(2008-10#4)
of pyrogallol##9##2##(2008-10#9)
of pyrolysis and atomization temperatures##3##5##(2008-10#3)
of pyrolysis and atomization##4##4##(2008-10#4)
of pyrolysis##7##2##(2008-10#6)(2010-3#1)
of pyrolytic carbon##2##3##(2008-9#1)(2010-8#1)
of pyrolytic##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
of pyrrole##6##2##(1995-3#2)(2008-10#4)
of pyruvate decarboxylase##2##3##(2008-10#1)(2008-6#1)
of pyruvate in##3##3##(2008-10#3)
of pyruvate kinase from##2##4##(1990-5#2)
of pyruvate kinase##6##3##(1990-5#3)(1991-3#1)(1995-12#1)(2008-7#1)
of pyruvate##20##2##(1990-5#3)(1991-3#1)(1991-5#3)(1993-11#1)(1995-12#1)(1995-2#1)(2008-10#7)(2008-6#1)(2008-7#1)(2010-12#1)
of qi##2##2##(2008-10#2)
of quadrat size##3##3##(2008-10#3)
of quadrat##5##2##(2008-10#5)
of quadratic solitons##2##3##(2007-12#2)
of quadratic spatial solitons in periodically poled lithium niobate##2##9##(2007-12#2)
of quadratic##7##2##(2007-11#1)(2007-12#5)(2008-8#1)
of quadriceps muscle##2##3##(2013-1#2)
of quadricuspid aortic valve##4##4##(2008-11#1)(2012-3#3)
of quail##3##2##(1993-6#1)(1997-6#1)(2008-6#1)
of qualia##2##2##(2012-2#2)
of qualified nurses##2##3##(2008-11#1)(2008-12#1)
of qualified##5##2##(1992-1#1)(2008-11#2)(2008-12#1)(2012-3#1)
of qualitative content##3##3##(2009-6#1)(2013-1#2)
of qualitative research and##2##4##(1997-3#1)(2012-3#1)
of qualitative research##4##3##(1997-3#2)(2008-11#1)(2012-3#1)
of qualitative##14##2##(1992-9#1)(1994-9#1)(1997-3#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-3#2)(2013-1#2)
of quality and##4##3##(1992-2#1)(1995-12#1)(1996-12#1)(2008-7#1)
of quality assessment##2##3##(1997-1#1)(2012-12#1)
of quality assurance in##2##4##(1996-12#1)(2010-12#1)
of quality assurance##7##3##(1992-11#1)(1992-5#1)(1993-3#1)(1996-12#1)(2008-4#1)(2008-5#1)(2010-12#1)
of quality care##4##3##(1992-3#1)(1994-2#1)(1994-3#1)(1997-3#1)
of quality control and##2##4##(2008-10#1)(2011-3#1)
of quality control in##2##4##(2008-9#2)
of quality control problems##2##4##(1993-12#1)(2007-7#1)
of quality control##10##3##(1993-12#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-9#4)(2009-7#1)(2011-3#1)
of quality criteria##2##3##(1995-2#1)(2008-11#1)
of quality for##3##3##(1996-2#1)(1997-2#1)(2008-10#1)
of quality improvement##8##3##(1993-2#1)(1995-12#1)(1995-3#3)(1996-3#1)(1996-9#1)(2008-7#1)
of quality in the##2##4##(1994-12#1)(2008-10#1)
of quality in##7##3##(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)
of quality indicators##3##3##(1997-3#2)(2008-7#1)
of quality management##4##3##(1995-3#1)(1996-3#1)(1997-3#1)(2010-9#1)
of quality measurement and##2##4##(1996-2#1)(2008-7#1)
of quality measurement##4##3##(1996-2#1)(1996-3#2)(2008-7#1)
of quality of care##6##4##(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2013-1#1)
of quality of life and##2##5##(2010-3#1)(2013-1#1)
of quality of life in##4##5##(2007-1#1)(2008-7#1)(2010-11#1)(2011-2#1)
of quality of life##23##4##(1997-3#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#5)(2010-11#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
of quality of##32##3##(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#6)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
of quality should be##2##4##(1994-2#1)(1997-2#1)
of quality standards##2##3##(2008-3#1)(2011-1#1)
of quality were##2##3##(2012-12#1)(2012-3#1)
of quality##147##2##(1991-2#1)(1991-3#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#6)(1994-3#2)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#5)(1996-1#1)(1996-12#7)(1996-2#8)(1996-3#5)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#9)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#10)(2008-8#1)(2008-9#5)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-9#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#7)
of quantification (10sigma)##2##3##(2008-10#2)
of quantification (LOQ) were##2##4##(2008-10#1)(2011-1#1)
of quantification (LOQ)##8##3##(2008-10#7)(2011-1#1)
of quantification and##4##3##(2008-10#3)(2008-5#1)
of quantification for the##2##4##(2008-10#1)(2012-2#1)
of quantification for##3##3##(2008-10#2)(2012-2#1)
of quantification of##4##3##(1994-1#1)(2008-10#2)(2008-5#1)
of quantification was##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
of quantification were##6##3##(2008-10#5)(2011-3#1)
of quantification##50##2##(1994-1#1)(2008-10#38)(2008-5#4)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
of quantifying the##6##3##(2008-10#2)(2008-3#1)(2008-4#2)(2011-2#1)
of quantifying##7##2##(2008-10#3)(2008-3#1)(2008-4#2)(2011-2#1)
of quantitation (LOQ)##7##3##(1992-8#1)(1996-5#1)(2008-10#5)
of quantitation for##3##3##(2008-10#2)(2010-3#1)
of quantitation of##5##3##(1996-5#1)(2008-10#3)(2012-12#1)
of quantitation##26##2##(1992-8#1)(1996-5#3)(2008-10#18)(2010-3#2)(2012-12#1)(2013-1#1)
of quantitative analysis of##2##4##(2008-10#1)(2013-1#1)
of quantitative genetic##2##3##(2008-8#1)(2009-5#1)
of quantitative host resistance##2##4##(2008-10#2)
of quantitative phase microscopy##2##4##(2007-11#2)
of quantitative resistance##3##3##(2008-10#1)(2009-10#1)(2011-10#1)
of quantitative trait Loci for fusarium head blight resistance in##2##10##(2008-10#2)
of quantitative trait Loci for resistance to southern leaf blight##2##10##(2008-10#2)
of quantitative trait Loci for##4##5##(2008-10#4)
of quantitative trait loci (QTL)##4##5##(2008-10#3)(2012-3#1)
of quantitative trait loci##6##4##(2008-10#4)(2009-10#1)(2012-3#1)
of quantitative trait##11##3##(2008-10#8)(2009-10#1)(2012-3#2)
of quantitative##48##2##(1991-12#2)(1996-9#1)(1997-7#1)(2007-11#2)(2007-6#1)(2008-10#22)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#2)(2010-11#1)(2011-10#1)(2011-2#1)(2012-3#4)(2013-1#2)
of quantity##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
of quantized kinoforms##3##3##(2008-2#3)
of quantized##5##2##(2008-2#3)(2008-3#2)
of quantum chemical##2##3##(2011-3#1)(2013-1#1)
of quantum mechanics##2##3##(2008-5#1)(2012-2#1)
of quantum##18##2##(1992-12#1)(1993-5#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
of quantum-limited timing jitter in##2##5##(2007-11#2)
of quarantine##2##2##(2008-10#2)
of quarter-wave##2##2##(2008-2#1)(2008-3#1)
of quartz crystal microbalance (QCM)##2##5##(2008-10#2)
of quartz crystal microbalance##3##4##(2008-10#3)
of quartz crystal##5##3##(2008-10#3)(2013-8#2)
of quartz from##2##3##(2013-8#2)
of quartz##18##2##(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2010-5#1)(2013-8#5)
of quasi##2##2##(2007-12#1)(2008-8#1)
of quasi-phase-matched##2##2##(2007-11#1)(2007-12#1)
of quaternary ammonium##3##3##(2008-10#2)(2010-4#1)
of quaternary##5##2##(2008-10#3)(2008-4#1)(2010-4#1)
of quenching##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
of quercetin##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
of questionable##5##2##(1995-11#1)(2008-1#1)(2008-7#1)(2011-2#2)
of questionnaire##3##2##(1996-1#1)(2012-12#1)(2013-1#1)
of questionnaires to##3##3##(1992-5#1)(1997-4#1)(2011-1#1)
of questionnaires##4##2##(1992-5#1)(1997-4#1)(2008-9#1)(2011-1#1)
of questions for##2##3##(1993-1#1)(2008-1#1)
of questions to##2##3##(1995-2#1)(2012-3#1)
of questions##15##2##(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)(2012-3#1)
of quick##3##2##(1991-3#1)(2008-9#2)
of quickly##3##2##(2007-11#1)(2008-10#1)(2011-3#1)
of quiescent lysates##2##3##(1994-8#2)
of quiescent##10##2##(1992-8#1)(1993-12#2)(1994-8#2)(1997-3#2)(2008-10#3)
of quinapril and hydrochlorothiazide##2##4##(2010-5#2)
of quinapril##3##2##(1995-3#1)(2010-5#2)
of quinine in##2##3##(2008-10#2)
of quinine##7##2##(2008-10#7)
of quinoline and##2##3##(2008-10#1)(2008-7#1)
of quinoline##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
of quinolones##2##2##(2008-10#2)
of quinone##4##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-8#1)
of quinones##6##2##(1993-8#2)(2008-10#2)(2009-9#2)
of quinpirole##2##2##(1993-3#2)
of quite different##2##3##(2008-10#1)(2011-2#1)
of quite##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
of quorum sensing##2##3##(2010-10#1)(2013-1#1)
of quorum-quenching enzymes##2##3##(2008-9#2)
of r##4##2##(2008-10#3)(2008-2#1)
of r(2)=0##4##2##(2008-10#4)
of r(g)##2##2##(2008-10#2)
of r-HuEPO##2##2##(2008-1#2)
of r-[K4HPg]##2##2##(1993-8#2)
of rAAV##5##2##(2008-5#1)(2008-8#1)(2008-9#3)
of rCBF##4##2##(1995-5#2)(1996-5#2)
of rDNA from##2##3##(2008-10#2)
of rDNA##18##2##(2007-12#2)(2008-10#9)(2008-5#4)(2010-8#2)(2012-2#1)
of rFurin##3##2##(2008-11#3)
of rHGH##2##2##(2007-11#2)
of rHuEPO##3##2##(1995-1#3)
of rIL-2##3##2##(1990-12#2)(1991-8#1)
of rNG-hCGalpha with native hCGbeta##2##5##(1995-8#2)
of rNG-hCGalpha with##4##3##(1995-8#4)
of rNG-hCGalpha##6##2##(1995-8#6)
of rNT-3##2##2##(2008-8#2)
of rPEA##2##2##(2008-10#2)
of rPlg##4##2##(1995-6#4)
of rRNA gene##3##3##(2008-8#3)
of rRNA genes##3##3##(2008-5#1)(2008-8#2)
of rRNA##8##2##(2008-5#1)(2008-8#5)(2009-2#1)(2010-4#1)
of rTFA##2##2##(2012-2#2)
of rTNF-alpha##2##2##(1994-8#2)
of rabbit IgG##6##3##(2008-10#6)
of rabbit intestinal##2##3##(1992-6#2)
of rabbit muscle##4##3##(1992-11#1)(1992-4#1)(1994-5#1)(1997-2#1)
of rabbit reticulocyte##2##3##(1990-2#1)(1995-5#1)
of rabbit skeletal muscle##3##4##(1990-7#1)(1995-6#1)(2008-9#1)
of rabbit small##2##3##(1990-11#1)(1991-12#1)
of rabbit##48##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#3)(1991-8#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-2#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#4)(2010-4#1)
of rabbits with##6##3##(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-8#1)
of rabbits##16##2##(1990-5#1)(1991-8#2)(1993-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
of rabeprazole##2##2##(2008-10#2)
of rabies in##3##3##(2007-10#1)(2007-12#1)(2012-3#1)
of rabies virus##3##3##(1995-2#2)(2008-11#1)
of rabies##11##2##(1995-2#3)(1996-8#2)(2007-10#1)(2007-12#1)(2008-11#1)(2012-12#1)(2012-3#2)
of rac p21s is##2##4##(1993-8#2)
of rac p21s##5##3##(1993-8#5)
of rac##6##2##(1993-8#5)(1996-2#1)
of race 1 and race 2##2##6##(2008-10#2)
of race 1 isolates##2##4##(2008-10#2)
of race 1##7##3##(2008-10#7)
of race 2##3##3##(2008-10#3)
of race and ethnicity##2##4##(2010-9#1)(2011-2#1)
of race and##4##3##(2007-10#2)(2010-9#1)(2011-2#1)
of race##27##2##(2007-10#2)(2008-10#16)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#2)
of race-change mutants and##2##4##(2008-10#2)
of race-change mutants##4##3##(2008-10#4)
of race-specific##2##2##(2008-10#2)
of race/ethnicity##2##2##(2011-2#1)(2013-1#1)
of racemic##5##2##(1991-5#1)(1992-12#1)(1994-3#1)(1996-5#1)(2012-12#1)
of races 1##3##3##(2008-10#3)
of races 2 and##2##4##(2008-10#2)
of races 2##4##3##(2008-10#4)
of races 4 and##2##4##(2008-10#2)
of races in##2##3##(2008-10#2)
of races##18##2##(2008-10#18)
of rachis##4##2##(2008-10#4)
of racial and##2##3##(2008-5#1)(2008-7#1)
of racial##5##2##(2008-5#1)(2008-7#1)(2010-3#2)(2012-2#1)
of raclopride##6##2##(2008-6#6)
of radial basis function neural networks##3##6##(2008-10#2)(2008-2#1)
of radial##13##2##(1995-5#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#2)(2010-11#1)(2011-2#2)(2012-2#1)
of radiance##2##2##(2008-3#2)
of radiation and##3##3##(2008-3#1)(2008-7#1)(2010-3#1)
of radiation at##2##3##(2007-12#1)(2008-3#1)
of radiation can be##2##4##(2008-6#1)(2008-7#1)
of radiation can##4##3##(2008-6#1)(2008-7#3)
of radiation carcinogenesis##2##3##(2008-7#2)
of radiation exposure##3##3##(2008-12#1)(2008-7#1)(2012-1#1)
of radiation from##3##3##(2007-12#1)(2008-3#2)
of radiation hormesis##3##3##(2008-7#2)(2013-1#1)
of radiation in the##2##4##(2007-12#1)(2008-7#1)
of radiation in##5##3##(2007-11#1)(2007-12#2)(2008-7#1)(2013-1#1)
of radiation is##2##3##(2008-7#2)
of radiation on##3##3##(1993-9#1)(2008-3#1)(2008-7#1)
of radiation pressure##3##3##(2007-12#2)(2008-2#1)
of radiation protection for##2##4##(1993-12#1)(2008-12#1)
of radiation protection##8##3##(1993-12#1)(1994-12#1)(1996-6#2)(2008-12#2)(2008-7#1)(2012-2#1)
of radiation risk##2##3##(2008-7#2)
of radiation therapy##6##3##(1991-2#1)(1994-12#1)(1997-5#1)(2008-1#1)(2008-6#1)(2008-7#1)
of radiation through##2##3##(2008-3#2)
of radiation to##3##3##(1993-9#1)(2008-2#1)(2008-7#1)
of radiation with##2##3##(2008-7#1)(2013-1#1)
of radiation##92##2##(1990-11#1)(1991-2#1)(1993-12#1)(1993-9#2)(1994-12#2)(1996-6#5)(1997-5#1)(2007-11#1)(2007-12#7)(2007-4#1)(2008-1#1)(2008-12#5)(2008-2#4)(2008-3#10)(2008-5#2)(2008-6#3)(2008-7#30)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#6)
of radiation-induced breast##2##3##(2008-7#1)(2013-8#1)
of radiation-induced##13##2##(1992-9#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-7#4)(2011-2#2)(2013-8#1)
of radiative transfer calculations##3##4##(2008-2#2)(2008-3#1)
of radiative transfer##6##3##(2008-2#2)(2008-3#4)
of radiative##8##2##(2008-2#4)(2008-3#4)
of radical surgery##2##3##(1990-9#1)(2008-6#1)
of radical surgical##2##3##(1990-6#1)(2007-11#1)
of radical##13##2##(1990-6#1)(1990-9#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)
of radicals##2##2##(2007-11#1)(2008-11#1)
of radicular pain##2##3##(2012-2#2)
of radicular##3##2##(1997-3#1)(2012-2#2)
of radiculopathy##3##2##(2007-8#2)(2012-3#1)
of radioactive##11##2##(1990-11#1)(1990-6#1)(1991-9#1)(1992-8#1)(1994-9#2)(2008-10#3)(2008-4#1)(2012-12#1)
of radioactivity from##2##3##(1994-6#1)(1995-8#1)
of radioactivity into the##2##4##(1990-11#1)(2008-4#1)
of radioactivity##22##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-4#1)(2008-7#3)(2008-9#1)
of radiocaesium in##3##3##(1992-3#3)
of radiocaesium##4##2##(1992-3#4)
of radiofrequency ablation of##2##4##(2008-11#1)(2013-8#1)
of radiofrequency ablation##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
of radiofrequency##7##2##(2008-10#1)(2008-11#1)(2009-3#1)(2010-3#1)(2011-2#2)(2013-8#1)
of radiographic##9##2##(1991-12#2)(1997-4#1)(2006-10#1)(2008-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
of radioiodinated##5##2##(1992-10#2)(1994-8#1)(1995-6#1)(2008-4#1)
of radioisotopes and##3##3##(2007-11#1)(2008-2#2)
of radioisotopes##7##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#2)
of radiolabel##3##2##(1991-12#1)(1992-9#1)(1993-6#1)
of radiolabeled precursor##2##3##(2008-10#1)(2008-4#1)
of radiolabeled##9##2##(1993-11#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-4#4)(2009-9#1)
of radiolabelled##6##2##(1990-11#1)(1990-12#1)(1992-9#1)(1994-3#1)(2008-11#1)(2008-7#1)
of radioligand##3##2##(1994-8#1)(1995-12#1)(1996-5#1)
of radiologic##2##2##(1996-2#1)(1997-4#1)
of radiological##11##2##(1991-11#1)(1991-12#1)(1995-8#1)(2007-11#2)(2007-8#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of radiologist##2##2##(2007-4#1)(2012-2#1)
of radiologists##2##2##(1992-1#1)(2012-2#1)
of radiology and##3##3##(1995-3#2)(2009-9#1)
of radiology departments##2##3##(1993-12#1)(1994-1#1)
of radiology practices##2##3##(1993-3#2)
of radiology reports##2##3##(2012-2#2)
of radiology##26##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-3#3)(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-2#2)(2007-4#3)(2009-4#1)(2009-9#2)(2012-2#2)
of radiometric##3##2##(2008-3#3)
of radionuclides##2##2##(1993-8#1)(1995-12#1)
of radiopharmaceuticals##2##2##(1994-5#1)(2012-12#1)
of radiosurgery##4##2##(1995-12#1)(2008-7#2)(2011-2#1)
of radiotherapy and##5##3##(1995-11#1)(1995-9#1)(2008-6#1)(2008-7#1)(2013-1#1)
of radiotherapy for##3##3##(1992-10#1)(1995-9#1)(2007-11#1)
of radiotherapy in##5##3##(1994-8#1)(1995-9#1)(2007-10#1)(2008-10#1)(2010-3#1)
of radiotherapy plus##2##3##(1991-2#1)(2011-2#1)
of radiotherapy##37##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#3)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#3)(2009-1#1)(2009-5#1)(2010-3#3)(2011-2#2)(2013-1#2)
of radiotoxicity##2##2##(1991-12#2)
of radiotracers##2##2##(2007-11#1)(2008-10#1)
of radish##9##2##(2008-10#9)
of radius##3##2##(2008-4#1)(2010-11#2)
of radon##2##2##(2008-7#2)
of raft mussels##2##3##(2010-5#2)
of rain##7##2##(2008-10#5)(2008-3#1)(2013-8#1)
of rainbow trout##4##3##(1997-9#1)(2008-11#1)(2008-7#1)(2009-5#1)
of rainbow##6##2##(1997-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
of rainbows##2##2##(2008-3#2)
of raindrops##2##2##(2008-3#2)
of rainfall##2##2##(2008-10#2)
of rainwater##3##2##(2008-10#3)
of raised ICP##7##3##(1996-9#1)(2008-7#2)(2010-5#4)
of raised##12##2##(1994-3#1)(1995-12#1)(1996-9#1)(2008-7#2)(2010-5#5)(2012-3#1)(2013-1#1)
of ramadan fasting on##4##4##(2012-3#4)
of ramified##2##2##(2007-12#2)
of ramipril and##2##3##(2010-12#1)(2010-3#1)
of ramipril##3##2##(2010-12#2)(2010-3#1)
of random amplified polymorphic DNA (RAPD)##2##6##(2008-10#2)
of random amplified polymorphic DNA##4##5##(2008-10#4)
of random errors in##2##4##(2008-3#1)(2008-7#1)
of random errors##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
of random phase##2##3##(2008-3#2)
of random wave vectors##2##4##(2008-3#2)
of random##42##2##(1990-12#1)(1990-3#1)(1995-8#1)(1996-3#1)(2007-11#3)(2008-10#15)(2008-3#11)(2008-4#1)(2008-7#3)(2008-8#3)(2012-2#1)(2012-3#1)
of random-coil##2##2##(1997-2#1)(2009-2#1)
of randomised##2##2##(2010-5#1)(2012-3#1)
of randomized clinical trials##2##4##(2010-6#1)(2012-3#1)
of randomized controlled trials##4##4##(2007-10#1)(2007-7#1)(2008-11#1)(2013-1#1)
of randomized studies##2##3##(1997-3#1)(2007-8#1)
of randomized trials##4##3##(1993-12#1)(2009-9#1)(2012-1#1)(2012-3#1)
of randomized##15##2##(1993-12#1)(1994-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-6#1)(2012-1#1)(2012-3#2)(2013-1#1)
of randomly distributed soot##2##4##(2008-3#2)
of randomly oriented##4##3##(2008-2#1)(2008-3#3)
of randomly selected##2##3##(2008-10#2)
of randomly##16##2##(1995-3#1)(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)
of range of motion##2##4##(2008-9#1)(2010-12#1)
of range##5##2##(2008-10#1)(2008-2#2)(2008-9#1)(2010-12#1)
of ranitidine##5##2##(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(2008-11#1)
of rapamycin##10##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2013-1#3)
of rape##2##2##(2011-2#1)(2013-1#1)
of rapeseed oil##2##3##(2008-6#2)
of rapeseed proteins##2##3##(2008-11#2)
of rapeseed##6##2##(2008-10#1)(2008-11#2)(2008-6#3)
of rapid and##3##3##(2007-11#1)(2008-10#2)
of rapid change##3##3##(1997-3#2)(2013-1#1)
of rapid diagnostic##2##3##(2011-2#1)(2013-1#1)
of rapid evolution##2##3##(2008-7#1)(2010-8#1)
of rapid growth of##2##4##(1990-11#1)(1991-9#1)
of rapid growth##3##3##(1990-11#1)(1991-9#1)(2010-8#1)
of rapid spread##2##3##(2008-10#1)(2008-9#1)
of rapid##59##2##(1990-11#1)(1990-6#1)(1991-9#1)(1993-2#1)(1995-6#1)(1996-11#1)(1997-3#2)(2007-11#2)(2007-12#1)(2007-8#5)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-4#1)(2010-4#1)(2010-8#3)(2011-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
of rapidity##4##2##(1997-4#1)(2008-10#2)(2008-2#1)
of rapidly convergent##2##3##(2007-12#1)(2008-2#1)
of rapidly##10##2##(1990-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-7#1)(2011-2#1)
of rare alleles##4##3##(2012-3#4)
of rare earth elements##5##4##(2008-10#5)
of rare earth impurities in high purity##2##7##(2008-10#2)
of rare earth impurities##3##4##(2008-10#3)
of rare earth##11##3##(2008-10#11)
of rare earths##4##3##(2008-10#4)
of rare restriction sites##3##4##(1990-5#2)(1994-12#1)
of rare restriction##4##3##(1990-5#2)(1994-12#2)
of rare side##2##3##(1991-3#2)
of rare variants in##4##4##(2012-3#4)
of rare variants##11##3##(2012-3#11)
of rare##55##2##(1990-5#2)(1991-11#1)(1991-3#2)(1994-12#2)(2007-11#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-3#17)
of rare-earth##2##2##(2008-10#1)(2008-2#1)
of ras##2##2##(1990-11#1)(1994-12#1)
of ras-rBHK-IgG##2##2##(2008-11#2)
of rasburicase##3##2##(2008-7#3)
of rat adrenal nerve cells##2##5##(2008-11#2)
of rat and mouse##4##4##(1991-6#1)(1991-8#2)(1994-12#1)
of rat and##11##3##(1991-2#1)(1991-6#2)(1991-8#2)(1992-3#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-11#1)
of rat aorta##2##3##(1990-12#1)(1993-3#1)
of rat brain##19##3##(1990-12#1)(1990-5#3)(1990-7#2)(1991-1#1)(1991-12#2)(1991-5#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-2#1)(2008-10#2)(2011-2#1)
of rat central##2##3##(1995-12#1)(1996-5#1)
of rat duodenal##2##3##(1996-5#2)
of rat embryonic##3##3##(1994-12#1)(1997-6#1)(2012-1#1)
of rat heart##3##3##(1990-7#1)(1994-5#1)(1994-6#1)
of rat hepatic##2##3##(2008-10#1)(2013-8#1)
of rat hepatocyte##2##3##(1993-3#1)(2008-11#1)
of rat hepatocytes##7##3##(1990-5#1)(1991-9#1)(1992-3#1)(1994-8#1)(2008-1#1)(2008-11#2)
of rat hepatoma cells##2##4##(1992-3#1)(2008-11#1)
of rat hepatoma##3##3##(1992-3#1)(2008-11#2)
of rat hippocampal##3##3##(1995-12#1)(1995-6#1)(2008-7#1)
of rat hippocampus##3##3##(1995-12#1)(1997-2#1)(1997-6#1)
of rat intestinal##2##3##(1991-12#1)(1992-9#1)
of rat kidney##3##3##(1992-3#1)(1994-9#2)
of rat liver S-adenosylhomocysteinase##2##4##(1990-10#2)
of rat liver cells##3##4##(1990-12#2)(2008-8#1)
of rat liver class theta glutathione S-transferase##2##7##(1991-12#2)
of rat liver uricase##2##4##(1992-8#2)
of rat liver##30##3##(1990-10#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#4)(1992-10#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-12#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)
of rat lung##2##3##(1995-2#2)
of rat peripheral blood large granular lymphocytes (LGL)##2##8##(1990-12#2)
of rat pituitary##2##3##(1990-12#1)(1993-5#1)
of rat plasma##3##3##(1990-7#2)(1997-2#1)
of rat primary hepatocytes##2##4##(2008-11#2)
of rat primary##3##3##(1995-5#1)(2008-11#2)
of rat prolactin receptor##2##4##(1995-11#1)(2008-4#1)
of rat prolactin##4##3##(1994-11#2)(1995-11#1)(2008-4#1)
of rat renal##2##3##(1995-11#1)(2008-8#1)
of rat sensory neurons##2##4##(1990-7#1)(1995-2#1)
of rat skeletal muscle##4##4##(1991-5#1)(1993-3#1)(2008-2#1)(2008-9#1)
of rat##240##2##(1990-10#2)(1990-11#5)(1990-12#14)(1990-2#3)(1990-3#1)(1990-5#8)(1990-7#7)(1990-8#3)(1991-1#1)(1991-12#11)(1991-2#4)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#6)(1992-6#1)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#7)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#8)(1994-8#4)(1994-9#2)(1995-11#5)(1995-12#7)(1995-2#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#4)(1996-2#2)(1996-5#4)(1997-2#3)(1997-6#2)(1997-7#1)(2008-1#2)(2008-10#8)(2008-11#18)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-7#1)(2009-8#1)(2010-12#4)(2011-2#2)(2011-3#6)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
of rat's##2##2##(1995-12#1)(2008-12#1)
of rate constants##3##3##(1992-6#1)(2008-2#1)(2008-4#1)
of rate equations##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
of rate isomorphy##4##3##(2008-8#4)
of rate##17##2##(1992-6#1)(1996-4#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#1)
of rate-limiting##2##2##(2008-7#1)(2010-12#1)
of rates of##7##3##(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
of rates##10##2##(1992-5#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
of rather##2##2##(1991-6#1)(2007-11#1)
of rating##2##2##(1990-3#1)(2008-7#1)
of ratio##5##2##(2008-10#4)(2008-3#1)
of rational##4##2##(1992-9#1)(1995-5#1)(1996-3#1)(1997-3#1)
of ratios of##2##3##(2008-10#1)(2013-1#1)
of ratios##3##2##(2008-10#2)(2013-1#1)
of ratites##2##2##(2013-1#2)
of rats (n =##4##4##(1993-6#1)(1997-8#1)(2007-10#2)
of rats and mice##2##4##(2008-7#2)
of rats and##3##3##(1994-6#1)(2008-7#2)
of rats are##2##3##(2008-4#2)
of rats at##3##3##(1996-5#1)(2008-12#1)(2008-3#1)
of rats bearing##3##3##(1993-8#3)
of rats by##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
of rats exposed to##2##4##(1992-11#1)(1997-2#1)
of rats fed vitamin##2##4##(1993-12#1)(1994-5#1)
of rats fed##4##3##(1993-12#1)(1994-2#1)(1994-5#1)(2013-1#1)
of rats from##3##3##(1991-5#1)(1993-3#1)(2008-10#1)
of rats in##4##3##(1992-11#1)(1992-12#1)(1994-7#1)(2009-8#1)
of rats received##4##3##(1993-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
of rats to##5##3##(1990-7#1)(1993-12#1)(1994-6#1)(2007-10#1)(2012-2#1)
of rats treated with##6##4##(1994-5#1)(1996-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
of rats treated##7##3##(1994-5#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-5#1)(2012-2#1)
of rats was##3##3##(1991-12#2)(1993-8#1)
of rats were##6##3##(1990-5#1)(1991-12#1)(1993-8#1)(2008-5#1)(2011-1#2)
of rats with a##4##4##(1991-2#2)(1993-3#2)
of rats with##16##3##(1990-12#1)(1991-2#2)(1993-3#2)(1994-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2009-6#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of rats##143##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#4)(1991-2#2)(1991-5#1)(1992-11#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#5)(1993-6#2)(1993-8#7)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1995-12#6)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#4)(1997-6#3)(1997-7#3)(1997-8#1)(2007-10#4)(2008-10#6)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
of raw and cooked beef patties##2##6##(2010-4#2)
of raw and cooked##3##4##(2010-4#3)
of raw and##5##3##(2008-12#1)(2010-4#4)
of raw data measurements##2##4##(2008-10#2)
of raw data##4##3##(2008-10#2)(2008-2#1)(2012-12#1)
of raw material##2##3##(2011-2#2)
of raw materials used##2##4##(2008-10#2)
of raw materials##7##3##(2008-10#4)(2008-5#2)(2008-6#1)
of raw pork##6##3##(2010-2#5)(2010-4#1)
of raw##29##2##(2007-2#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-2#5)(2010-4#7)(2011-2#2)(2012-12#1)
of ray tracing and##2##4##(2008-2#1)(2008-3#1)
of ray tracing##5##3##(2008-2#3)(2008-3#2)
of ray##11##2##(2008-2#6)(2008-3#5)
of rays in##2##3##(2007-11#1)(2013-7#1)
of rays##6##2##(1995-2#1)(2007-11#1)(2008-2#2)(2008-3#1)(2013-7#1)
of re-bleeding and##3##3##(2013-1#3)
of reaching the recommended levels of HbA1c##2##7##(2011-2#2)
of reaching the##4##3##(1997-2#1)(2008-11#1)(2011-2#2)
of reaching##10##2##(1991-2#1)(1992-11#1)(1994-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-1#1)
of reacquisition##2##2##(2008-5#2)
of reaction between##4##3##(2008-10#4)
of reaction conditions on##2##4##(2008-5#1)(2008-7#1)
of reaction conditions##7##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)
of reaction norms##2##3##(2008-8#2)
of reaction of##2##3##(1994-5#1)(2008-10#1)
of reaction parameters##2##3##(2008-6#1)(2011-2#1)
of reaction products##4##3##(1992-6#1)(2008-4#3)
of reaction time##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of reaction was##3##3##(2008-10#3)
of reaction##53##2##(1990-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1994-5#2)(1994-6#1)(1995-5#1)(1996-5#1)(2007-11#3)(2008-10#19)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of reaction-diffusion equations##3##3##(2009-8#1)(2013-8#2)
of reaction-diffusion##4##2##(2008-9#1)(2009-8#1)(2013-8#2)
of reactions are##2##3##(2008-10#2)
of reactions##19##2##(1992-9#1)(1994-6#1)(1994-8#1)(1996-3#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
of reactivation##2##2##(1990-5#1)(2008-5#1)
of reactive and##2##3##(2007-12#1)(2011-2#1)
of reactive arthritis##2##3##(1990-6#2)
of reactive blue 2##2##4##(1995-12#1)(2008-4#1)
of reactive oxygen and##2##4##(2009-8#1)(2011-2#1)
of reactive oxygen species (ROS) in##3##6##(1992-12#1)(2008-5#1)(2011-2#1)
of reactive oxygen species (ROS)##18##5##(1992-12#1)(1994-11#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#2)(2009-8#2)(2010-5#1)(2011-2#4)(2013-8#1)
of reactive oxygen species and##3##5##(2008-4#1)(2011-1#1)(2013-8#1)
of reactive oxygen species by##3##5##(2008-10#1)(2009-3#1)(2010-1#1)
of reactive oxygen species in the##2##6##(2009-12#1)(2010-10#1)
of reactive oxygen species##43##4##(1990-11#1)(1991-9#1)(1992-12#2)(1993-12#1)(1994-11#1)(1994-5#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#3)
of reactive oxygen##50##3##(1990-11#1)(1991-9#1)(1992-12#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-5#2)(1995-8#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#3)
of reactive species by##2##4##(2008-10#1)(2008-11#1)
of reactive species is##2##4##(2008-10#1)(2008-11#1)
of reactive species##4##3##(2008-10#2)(2008-11#2)
of reactive##82##2##(1990-11#1)(1990-12#1)(1990-6#3)(1991-1#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-5#2)(1995-12#2)(1995-8#2)(1996-11#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-8#6)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
of reactive-ion etching##2##3##(2008-3#2)
of reactivity in##2##3##(1995-8#2)
of reactivity with##2##3##(1995-11#1)(1995-12#1)
of reactivity##7##2##(1995-11#1)(1995-12#1)(1995-8#4)(2011-2#1)
of reactor##3##2##(1994-11#1)(2008-10#1)(2008-6#1)
of readily available##6##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
of readiness to##2##3##(2008-11#1)(2012-3#1)
of readiness##4##2##(2008-11#1)(2012-3#3)
of reading##12##2##(1993-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-12#3)(2009-2#1)(2009-4#1)(2010-7#1)
of readmission or##2##3##(2011-2#1)(2013-1#1)
of readmission##3##2##(2011-2#2)(2013-1#1)
of ready-to-eat vegetable##2##3##(1997-4#2)
of ready-to-eat##3##2##(1997-4#2)(2008-1#1)
of reagent and calibrator##2##4##(2008-10#2)
of reagent and##3##3##(2008-10#3)
of reagent##24##2##(1990-12#1)(1990-2#1)(1990-7#1)(2008-10#19)(2012-2#1)(2013-8#1)
of reagents and##9##3##(2008-10#6)(2008-5#1)(2008-9#2)
of reagents to##3##3##(2008-10#2)(2008-9#1)
of reagents used##2##3##(1992-3#1)(2008-9#1)
of reagents##30##2##(1992-3#1)(1993-11#1)(2008-10#16)(2008-4#2)(2008-5#2)(2008-9#5)(2009-8#1)(2013-1#2)
of real sample analysis##3##4##(2008-10#3)
of real sample##6##3##(2008-10#6)
of real samples##14##3##(1997-2#1)(2008-10#13)
of real vapor sources##2##4##(2008-2#2)
of real water samples##2##4##(2008-10#2)
of real world##3##3##(2008-10#2)(2008-8#1)
of real##55##2##(1994-12#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-12#3)(2008-10#28)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#2)(2010-7#1)(2012-2#1)(2013-1#2)
of real-time ultrasound guidance##2##4##(2008-1#1)(2012-2#1)
of real-time##18##2##(1996-1#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
of real-world##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
of realistic##9##2##(1996-4#1)(2008-10#1)(2008-11#2)(2008-3#3)(2010-10#1)(2012-2#1)
of reality##2##2##(1995-2#1)(2008-12#1)
of realization of the##2##4##(2008-2#1)(2012-1#1)
of realizing##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
of rearing##2##2##(2007-12#2)
of reasoning##3##2##(1990-3#2)(2009-12#1)
of reasons and##2##3##(2007-11#1)(2008-12#1)
of reasons for##2##3##(2007-11#1)(2013-8#1)
of reasons##13##2##(1993-6#1)(1995-12#1)(1996-9#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-1#1)(2013-8#1)
of rebleeding##2##2##(1997-3#1)(2008-7#1)
of recA-like genes##2##3##(1995-6#2)
of recA-like##3##2##(1995-6#3)
of recalcitrant##2##2##(2013-1#2)
of recall##3##2##(1994-8#1)(2008-8#1)(2010-1#1)
of recanalization##2##2##(1990-6#1)(1991-3#1)
of receiver##2##2##(2008-2#2)
of receivers##2##2##(2008-3#2)
of receiving##3##2##(1992-12#1)(2007-7#1)(2008-8#1)
of recent University of British Columbia##2##6##(1993-3#2)
of recent advances in##2##4##(2009-5#1)(2012-12#1)
of recent advances##4##3##(1990-9#1)(2008-5#1)(2009-5#1)(2012-12#1)
of recent developments in##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
of recent findings##2##3##(2008-8#1)(2009-6#1)
of recent literature##2##3##(1996-1#1)(2009-8#1)
of recent progress in##2##4##(1994-3#1)(2009-4#1)
of recent publications##3##3##(1993-3#1)(2006-7#1)(2011-2#1)
of recent reports##2##3##(1991-4#1)(2008-3#1)
of recent research##2##3##(1991-2#1)(2011-1#1)
of recent species##2##3##(2008-9#2)
of recent studies suggest that##2##5##(1993-6#1)(1995-12#1)
of recent studies##9##3##(1993-6#1)(1995-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2009-8#1)(2011-2#2)
of recent trends in population redistribution##2##6##(2011-2#2)
of recent##86##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-11#2)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
of recently developed##2##3##(2008-11#1)(2011-2#1)
of recently##16##2##(1991-3#1)(1994-12#1)(1995-3#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#3)
of receptive field##2##3##(2008-11#1)(2008-8#1)
of receptor binding and##3##4##(1993-3#1)(1994-11#1)(2008-4#1)
of receptor binding sites##2##4##(1990-12#1)(1995-11#1)
of receptor binding##5##3##(1990-12#1)(1993-3#1)(1994-11#1)(1995-11#1)(2008-4#1)
of receptor expression##2##3##(1991-3#1)(2010-11#1)
of receptor function##3##3##(1992-3#1)(1995-11#1)(2008-5#1)
of receptor molecules##3##3##(1996-12#2)(2008-5#1)
of receptor signaling##3##3##(2008-4#1)(2012-2#2)
of receptor##38##2##(1990-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-5#2)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(2007-11#1)(2007-12#1)(2008-4#2)(2008-5#5)(2008-8#3)(2009-8#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#2)
of receptor-mediated##2##2##(1993-3#1)(1994-6#1)
of receptors expression##2##3##(2011-2#2)
of receptors for##2##3##(1993-5#1)(1994-3#1)
of receptors##26##2##(1990-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-1#1)(2011-2#2)(2013-1#1)
of recessive##2##2##(2008-10#1)(2013-1#1)
of recipient##5##2##(1997-5#1)(2008-11#3)(2010-11#1)
of reciprocal altruism##2##3##(2012-3#2)
of reciprocal##8##2##(1992-3#1)(1995-8#1)(2008-10#1)(2009-7#1)(2012-2#1)(2012-3#3)
of reciprocity##4##2##(1993-3#1)(2008-2#1)(2010-9#1)(2012-3#1)
of recognition memory##3##3##(1993-3#1)(2007-12#1)(2008-6#1)
of recognition of##2##3##(1991-11#1)(2012-3#1)
of recognition##6##2##(1991-11#1)(1993-3#1)(1997-1#1)(2007-12#1)(2008-6#1)(2012-3#1)
of recognized##2##2##(2008-10#1)(2012-12#1)
of recognizing the##4##3##(1993-12#1)(2007-10#1)(2008-10#1)(2013-1#1)
of recognizing##13##2##(1993-12#2)(1995-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#1)
of recombinant CHO##3##3##(2008-11#3)
of recombinant Chinese hamster ovary##2##5##(2008-11#2)
of recombinant DNA##2##3##(1991-9#1)(2011-2#1)
of recombinant Escherichia coli##3##4##(2008-7#2)(2013-1#1)
of recombinant IGF-I##2##3##(2008-11#1)(2008-5#1)
of recombinant adeno-associated virus##2##4##(1993-2#1)(2008-8#1)
of recombinant antibodies##2##3##(2008-10#1)(2013-8#1)
of recombinant antibody##3##3##(2008-11#3)
of recombinant baculoviruses##3##3##(2008-2#3)
of recombinant chicken##2##3##(1991-3#1)(2008-11#1)
of recombinant factor VIIa##2##4##(2007-8#2)
of recombinant hirudin##2##3##(2013-8#2)
of recombinant human coagulation factor##2##5##(2008-11#1)(2008-8#1)
of recombinant human erythropoietin##4##4##(2008-1#1)(2008-11#2)(2011-2#1)
of recombinant human glucagon was##3##5##(2008-8#3)
of recombinant human keratinocyte growth factor##2##6##(1994-11#1)(2008-7#1)
of recombinant human protein C##2##5##(2008-12#2)
of recombinant human##40##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-6#3)(1996-11#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-11#7)(2008-12#2)(2008-7#4)(2008-8#4)(2011-2#2)(2012-3#1)
of recombinant inbred (RI) lines##2##5##(2008-10#2)
of recombinant inbred lines##4##4##(2008-10#4)
of recombinant inbred##6##3##(2008-10#6)
of recombinant interleukin 2##2##4##(1990-12#1)(1995-12#1)
of recombinant mammalian cell lines##2##5##(2008-11#2)
of recombinant mammalian##3##3##(2008-11#3)
of recombinant mouse##2##3##(2008-10#1)(2008-4#1)
of recombinant plasmid##3##3##(1994-3#1)(2011-2#2)
of recombinant protein in##3##4##(2008-1#1)(2008-11#2)
of recombinant protein is##2##4##(1993-2#1)(2008-11#1)
of recombinant protein production in##2##5##(2008-11#1)(2008-7#1)
of recombinant protein##25##3##(1990-8#1)(1993-2#1)(1994-11#1)(2008-1#1)(2008-11#16)(2008-4#1)(2008-7#2)(2011-2#2)
of recombinant proteins for##4##4##(1997-4#1)(2008-11#3)
of recombinant proteins in the##2##5##(2008-11#2)
of recombinant proteins in##6##4##(2008-11#5)(2008-7#1)
of recombinant proteins produced##2##4##(2008-4#1)(2011-2#1)
of recombinant proteins using##2##4##(2008-11#1)(2008-2#1)
of recombinant proteins##32##3##(1994-11#1)(1994-5#1)(1997-3#1)(1997-4#1)(2008-11#20)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#2)
of recombinant rat##6##3##(1992-3#1)(2008-11#4)(2008-8#1)
of recombinant strain##2##3##(2013-1#2)
of recombinant tumor necrosis##2##4##(1991-12#1)(1994-8#1)
of recombinant wild-type##2##3##(1992-9#1)(1995-6#1)
of recombinant zebrafish##2##3##(2010-5#2)
of recombinant##244##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-8#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-6#5)(1996-11#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#2)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#16)(2008-11#84)(2008-12#2)(2008-2#4)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#16)(2008-8#9)(2008-9#1)(2009-7#2)(2009-8#1)(2010-5#3)(2010-6#2)(2011-2#12)(2011-3#2)(2012-3#4)(2013-1#4)(2013-8#4)
of recombinants and##2##3##(2008-10#1)(2008-2#1)
of recombinants##6##2##(1991-9#1)(1994-12#2)(1995-9#1)(2008-10#1)(2008-2#1)
of recombination and##6##3##(2008-10#4)(2009-10#1)(2013-8#1)
of recombination between##3##3##(1995-8#1)(2008-10#2)
of recombination in the##2##4##(1993-12#1)(2008-5#1)
of recombination in##5##3##(1993-12#2)(2008-10#2)(2008-5#1)
of recombination##24##2##(1993-12#2)(1994-12#1)(1995-8#1)(2008-10#13)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)(2013-8#1)
of recombined single chain insulin and##2##6##(2008-9#2)
of recombined single chain insulin##4##5##(2008-9#4)
of recommendations are##2##3##(2012-3#1)(2013-8#1)
of recommendations for##3##3##(1993-12#1)(1996-6#1)(2008-9#1)
of recommendations##13##2##(1993-12#1)(1996-6#1)(1997-3#1)(2007-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-8#1)
of recommended##5##2##(1994-12#1)(1995-1#1)(2010-4#1)(2012-2#2)
of reconstituted##6##2##(1994-8#1)(2008-8#4)(2009-8#1)
of reconstructed epidermis##3##3##(2008-5#3)
of reconstructed##8##2##(2007-12#1)(2008-3#1)(2008-5#5)(2008-9#1)
of reconstructing##7##2##(2008-3#3)(2008-4#1)(2010-10#1)(2011-3#1)(2011-7#1)
of reconstruction of the##4##4##(1990-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
of reconstruction of##6##3##(1990-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of reconstruction##22##2##(1990-3#1)(1990-9#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of reconstructions##3##2##(2007-12#1)(2011-1#2)
of reconstructive##6##2##(1993-11#1)(2007-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of recontamination##2##2##(1991-11#1)(2013-8#1)
of recordable##2##2##(2008-10#1)(2008-3#1)
of recorded signals is##2##4##(2008-3#1)(2011-1#1)
of recorded##8##2##(1997-6#1)(2008-3#5)(2011-1#1)(2012-2#1)
of recording##16##2##(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-7#1)(2011-1#1)
of records of##2##3##(2011-1#1)(2012-3#1)
of records##6##2##(1994-12#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of recovered##7##2##(1993-3#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-2#1)
of recoveries##4##2##(2008-10#4)
of recovery for##2##3##(2008-10#1)(2008-5#1)
of recovery from##6##3##(2007-12#1)(2008-6#1)(2008-8#2)(2010-3#2)
of recovery is##3##3##(1993-5#1)(2008-7#2)
of recovery of the##2##4##(2008-10#1)(2008-7#1)
of recovery of##9##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
of recovery showed##2##3##(1996-5#1)(2008-6#1)
of recovery was##5##3##(1991-2#1)(2008-10#2)(2008-12#1)(2012-3#1)
of recovery were not##2##4##(1994-8#1)(2012-3#1)
of recovery##47##2##(1991-2#2)(1993-5#1)(1994-5#1)(1994-8#1)(1995-6#2)(1996-5#2)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2010-3#3)(2010-5#1)(2012-3#3)
of recreational sports##2##3##(2012-12#2)
of recreational##5##2##(2011-2#1)(2012-12#3)(2013-1#1)
of recruiting patients##2##3##(2008-11#1)(2010-5#1)
of recruitment and##5##3##(1991-6#1)(1994-2#2)(2008-12#1)(2008-8#1)
of recruitment##9##2##(1990-2#1)(1991-6#1)(1992-1#1)(1994-2#2)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
of recruits##2##2##(2007-5#2)
of rectal cancer##7##3##(1990-9#3)(1993-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
of rectal ibuprofen was considerably lower##2##6##(2012-12#2)
of rectal mucosal prolapse and hemorrhoidal prolapse##2##7##(2013-1#2)
of rectal mucosal prolapse##5##4##(2013-1#5)
of rectal neoplasia##2##3##(2009-12#2)
of rectal polypoid lesions in dogs##2##6##(2013-1#2)
of rectal polypoid lesions in##4##5##(2013-1#4)
of rectal##28##2##(1990-3#1)(1990-5#1)(1990-9#3)(1993-8#1)(1993-9#1)(2009-11#1)(2009-12#4)(2011-2#1)(2012-12#3)(2013-1#10)(2013-8#2)
of rectangular##2##2##(2012-1#1)(2013-1#1)
of rectum##7##2##(1990-3#1)(2008-12#3)(2012-12#1)(2012-3#1)(2013-8#1)
of rectus femoris muscle##2##4##(2008-12#1)(2011-2#1)
of recurrence after surgical resection##2##5##(2010-3#1)(2013-1#1)
of recurrence after##3##3##(1993-9#1)(2010-3#1)(2013-1#1)
of recurrence and the##2##4##(2007-10#1)(2012-3#1)
of recurrence and##7##3##(2007-10#1)(2008-2#1)(2008-6#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
of recurrence of##5##3##(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)
of recurrence##50##2##(1990-8#1)(1991-4#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-9#2)(1994-2#1)(1994-8#1)(1996-11#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#2)
of recurrences for##2##3##(1994-1#1)(2008-10#1)
of recurrences of##3##3##(1996-12#1)(1997-4#1)(2008-1#1)
of recurrences##11##2##(1992-5#1)(1993-9#1)(1994-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
of recurrent disease##3##3##(1991-6#1)(1994-5#1)(2012-3#1)
of recurrent events##2##3##(1997-4#1)(2008-8#1)
of recurrent hepatitis##2##3##(2006-10#2)
of recurrent infection##3##3##(1992-11#1)(2008-8#1)(2011-2#1)
of recurrent ovarian##2##3##(2007-7#1)(2011-1#1)
of recurrent respiratory##2##3##(1997-1#1)(2008-7#1)
of recurrent vertigo##3##3##(2012-3#3)
of recurrent##76##2##(1990-2#2)(1991-6#1)(1992-11#1)(1992-5#1)(1993-1#2)(1994-5#1)(1994-7#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-10#3)(2007-12#2)(2007-7#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-12#1)(2009-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#8)(2013-1#2)(2013-8#3)
of recurring##3##2##(1991-3#1)(2007-10#1)(2011-2#1)
of recycling##5##2##(1996-12#2)(1996-3#2)(2008-10#1)
of red beds and##3##4##(2013-8#3)
of red beds##5##3##(2013-8#5)
of red blood cell##2##4##(2008-8#1)(2013-1#1)
of red blood cells##8##4##(1992-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)
of red blood##10##3##(1992-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)
of red cell##2##3##(1994-9#2)
of red light##2##3##(1990-5#2)
of red tilapia##2##3##(2008-12#2)
of red wine or resveratrol##2##5##(2011-2#2)
of red wine##9##3##(2008-10#2)(2008-7#5)(2011-2#2)
of red##54##2##(1990-5#2)(1992-11#2)(1992-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#3)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#5)
of redisplacement##3##2##(1991-9#1)(2011-2#2)
of redox mediator##2##3##(2008-10#2)
of redox##12##2##(1990-12#1)(1992-6#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)
of redox-active##2##2##(2008-10#1)(2009-10#1)
of reduced P##3##3##(1993-11#2)(2008-10#1)
of reduced glutathione (GSH) in##2##5##(2008-10#2)
of reduced glutathione (GSH)##5##4##(1991-9#1)(2008-10#2)(2008-12#1)(2013-1#1)
of reduced glutathione##7##3##(1990-12#1)(1991-9#1)(2008-10#3)(2008-12#1)(2013-1#1)
of reduced hemodynamic load##2##4##(2012-3#2)
of reduced phosphorus##2##3##(2008-10#2)
of reduced sulfur compounds (RSC)##2##5##(2008-10#2)
of reduced sulfur compounds##4##4##(2008-10#4)
of reduced##65##2##(1990-12#1)(1991-2#1)(1991-9#2)(1992-9#1)(1993-11#2)(1993-12#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
of reduced-resolution##2##2##(2008-2#1)(2008-3#1)
of reducing agents##2##3##(1991-2#1)(1992-9#1)
of reducing equivalents##3##3##(1991-2#1)(2009-4#1)(2009-9#1)
of reducing maternal mortality##2##4##(2010-12#1)(2011-1#1)
of reducing power##2##3##(2008-7#1)(2010-11#1)
of reducing the number of##2##5##(1997-2#1)(2008-9#1)
of reducing the##13##3##(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
of reducing##51##2##(1990-12#1)(1991-2#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#4)
of reductant##3##2##(1992-6#1)(1995-5#1)(2008-10#1)
of reductase##2##2##(1991-5#1)(1993-6#1)
of reduction and##2##3##(1991-9#1)(2008-10#1)
of reduction in##4##3##(1996-2#1)(2008-10#1)(2009-7#1)(2012-3#1)
of reduction of the##2##4##(2008-10#1)(2009-8#1)
of reduction of##6##3##(2008-10#4)(2008-2#1)(2009-8#1)
of reduction was##2##3##(2007-8#1)(2008-10#1)
of reduction##22##2##(1991-9#1)(1992-8#1)(1996-2#1)(2007-11#1)(2007-8#2)(2008-10#10)(2008-2#2)(2008-3#1)(2009-7#1)(2009-8#1)(2012-3#1)
of reductions in##2##3##(1996-12#1)(2008-3#1)
of reductive##5##2##(2008-10#3)(2008-11#1)(2011-1#1)
of redundancy##3##2##(2008-1#1)(2011-2#1)(2011-3#1)
of reef##6##2##(2007-5#4)(2008-8#1)(2013-7#1)
of reelin expression##2##3##(2009-8#2)
of reelin##3##2##(2009-8#3)
of reengineering##4##2##(1994-12#1)(1995-1#1)(1995-3#1)(1997-3#1)
of refeeding##2##2##(2008-3#1)(2008-7#1)
of reference compounds##2##3##(2008-10#1)(2008-5#1)
of reference for the##5##4##(1990-12#1)(1995-3#1)(2007-11#1)(2010-12#1)(2011-2#1)
of reference materials##4##3##(2008-10#4)
of reference values##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
of reference##49##2##(1990-12#1)(1990-2#1)(1992-2#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-6#1)(2009-9#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-3#3)
of references##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
of referral of##2##3##(1990-12#1)(1992-12#1)
of referral##7##2##(1990-12#1)(1991-6#1)(1992-12#1)(2008-1#1)(2008-11#1)(2011-1#1)(2012-3#1)
of referrals##5##2##(1994-2#1)(1995-8#1)(1997-8#1)(2008-12#1)(2010-4#1)
of referring##2##2##(1991-1#1)(2011-1#1)
of refined##2##2##(1994-5#1)(2008-6#1)
of reflectance and path length to scattering variations##3##8##(2008-3#3)
of reflectance and##4##3##(2008-3#4)
of reflectance at##2##3##(1991-2#1)(2007-12#1)
of reflectance data##2##3##(2008-3#2)
of reflectance##18##2##(1991-2#1)(2007-12#2)(2008-10#5)(2008-3#9)(2008-8#1)
of reflected##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
of reflection and reflective practice##3##5##(2008-11#3)
of reflection and##6##3##(2008-11#5)(2008-3#1)
of reflection as a##2##4##(2008-12#2)
of reflection as##3##3##(2008-11#1)(2008-12#2)
of reflection in##3##3##(2008-11#2)(2008-12#1)
of reflection or##2##3##(2008-11#1)(2008-3#1)
of reflection##30##2##(2007-11#1)(2007-12#1)(2008-11#15)(2008-12#4)(2008-2#3)(2008-3#5)(2013-1#1)
of reflection-type##2##2##(2007-12#1)(2008-2#1)
of reflective practice##3##3##(1997-4#1)(2008-11#1)(2012-12#1)
of reflective##14##2##(1997-4#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2012-12#1)(2013-1#1)
of reflectivity and roughness##2##4##(2008-3#2)
of reflectivity##7##2##(2007-11#3)(2008-3#4)
of reflex responses##2##3##(1993-12#1)(1995-8#1)
of reflow##2##2##(1991-9#1)(1993-3#1)
of reflux disease##2##3##(2011-2#2)
of reflux##5##2##(2008-4#3)(2011-2#2)
of refluxing ureters##2##3##(2008-10#2)
of refluxing##3##2##(2008-10#3)
of reform##5##2##(1993-12#1)(1993-3#1)(1994-12#1)(1996-2#1)(2008-3#1)
of reforms##3##2##(1993-2#1)(1997-1#1)(2008-1#1)
of refraction and size##5##4##(2008-2#3)(2008-3#2)
of refraction and##12##3##(2007-12#1)(2008-2#7)(2008-3#4)
of refraction halos##2##3##(2008-2#2)
of refraction of##11##3##(2008-2#5)(2008-3#6)
of refraction through##2##3##(2007-11#1)(2008-3#1)
of refraction##77##2##(1991-9#1)(2007-11#6)(2007-12#5)(2008-2#29)(2008-3#36)
of refractive errors##2##3##(2009-9#1)(2010-8#1)
of refractive index n(0)##2##4##(2008-3#2)
of refractive index##11##3##(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#5)
of refractive indices##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2009-5#1)
of refractive turbulence on ground-based verification of##2##7##(2008-3#2)
of refractive turbulence on##3##4##(2008-3#3)
of refractive turbulence##4##3##(2008-3#4)
of refractive##28##2##(2007-11#3)(2008-10#2)(2008-2#6)(2008-3#13)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)
of refractive-index change##2##3##(2008-3#2)
of refractive-index mismatch##2##3##(2008-2#1)(2008-3#1)
of refractive-index##6##2##(2008-2#2)(2008-3#4)
of refractoriness##4##2##(1992-8#1)(1993-12#1)(2013-1#2)
of refractory ascites by using a##2##6##(2007-12#2)
of refractory ascites##3##3##(2007-12#3)
of refractory##23##2##(1991-2#1)(1991-3#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-5#2)(2011-2#3)(2012-2#1)(2013-8#3)
of refugees and asylum-seekers who##2##5##(1995-11#2)
of refugees##3##2##(1990-6#1)(1995-11#2)
of refuse##2##2##(1991-9#1)(2008-10#1)
of refusers##2##2##(1991-6#2)
of regenerated##6##2##(1995-12#1)(2007-11#2)(2008-10#1)(2011-2#1)(2013-8#1)
of regenerating##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
of regeneration of the##2##4##(1995-12#1)(2008-10#1)
of regeneration of##5##3##(1993-2#1)(1995-12#1)(2008-10#2)(2013-8#1)
of regeneration##8##2##(1993-2#1)(1995-12#1)(2008-10#2)(2012-2#1)(2013-8#3)
of regenerative medicine##3##3##(2008-11#2)(2013-1#1)
of regimens##3##2##(1992-8#1)(1997-7#2)
of region##3##2##(1994-12#1)(2008-6#1)(2010-8#1)
of regional anaesthesia##2##3##(2006-10#2)
of regional anesthesia##3##3##(2008-8#1)(2012-2#1)(2012-3#1)
of regional brain##2##3##(2008-4#1)(2009-6#1)
of regional differences##2##3##(2009-10#1)(2011-2#1)
of regional systems##3##3##(1992-12#3)
of regional##38##2##(1990-9#2)(1992-12#4)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-3#1)(2013-8#1)
of regions of##2##3##(2009-7#1)(2011-2#1)
of regions##5##2##(1991-6#1)(2008-11#1)(2008-2#1)(2009-7#1)(2011-2#1)
of registered nurses in##2##4##(2008-11#1)(2012-3#1)
of registered nurses##4##3##(1991-2#1)(2008-11#2)(2012-3#1)
of registered##8##2##(1991-2#1)(1996-3#1)(2008-11#3)(2008-9#1)(2012-12#1)(2012-3#1)
of registration##2##2##(1993-12#1)(2008-11#1)
of regression coefficients for the##2##5##(2008-10#1)(2008-3#1)
of regression models##3##3##(1991-1#1)(1992-9#1)(2011-1#1)
of regression##10##2##(1991-1#2)(1992-9#1)(2008-10#3)(2008-3#1)(2011-1#1)(2013-8#2)
of regrowth##2##2##(1992-9#2)
of regular##19##2##(1992-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#3)(2012-12#1)(2013-8#1)
of regularization##2##2##(2008-3#1)(2008-6#1)
of regulated##4##2##(1992-12#1)(1994-9#1)(2008-10#1)(2009-7#1)
of regulating gene expression##2##4##(2007-12#1)(2008-4#1)
of regulating##7##2##(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#2)
of regulation and##2##3##(2008-7#1)(2009-4#1)
of regulation of##11##3##(1992-6#1)(1994-6#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)
of regulation##25##2##(1990-8#1)(1991-12#1)(1992-6#1)(1994-12#1)(1994-6#2)(1995-12#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2013-1#1)
of regulations##3##2##(1995-5#1)(2008-11#2)
of regulator##2##2##(1990-7#1)(2008-11#1)
of regulatory T cells##3##4##(2007-5#2)(2011-2#1)
of regulatory genes##2##3##(1994-11#1)(2008-10#1)
of regulatory networks##2##3##(2008-11#1)(2010-10#1)
of regulatory peptides##2##3##(1990-11#1)(2008-4#1)
of regulatory proteins##5##3##(2008-4#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
of regulatory##35##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-9#1)(1994-11#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#4)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of rehabilitation after##2##3##(1995-5#1)(2007-11#1)
of rehabilitation in##5##3##(2007-11#1)(2007-8#1)(2008-9#2)(2010-10#1)
of rehabilitation measures##2##3##(1991-5#1)(1995-5#1)
of rehabilitation of the##2##4##(2007-11#1)(2008-5#1)
of rehabilitation##39##2##(1991-5#1)(1993-6#1)(1995-5#5)(1996-3#1)(2006-5#1)(2007-11#7)(2007-8#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
of reimbursement##2##2##(1992-3#1)(1994-2#1)
of reindeer##2##2##(1990-8#2)
of reinforcement##6##2##(1993-6#2)(1994-3#1)(2008-5#1)(2009-7#1)(2010-10#1)
of reinforcers for##3##3##(2011-2#3)
of reinforcing##2##2##(2008-12#1)(2008-2#1)
of reinfusion drains##2##3##(2008-8#2)
of reinnervation##2##2##(2008-3#1)(2013-8#1)
of rejected##2##2##(1995-5#1)(2011-3#1)
of rejection and##2##3##(2006-10#1)(2010-3#1)
of rejection##6##2##(1990-11#1)(1997-5#1)(2006-10#1)(2009-3#1)(2010-3#1)(2010-8#1)
of relapse and##2##3##(1993-1#1)(2012-12#1)
of relapse of##2##3##(2007-7#1)(2013-1#1)
of relapse##18##2##(1990-11#1)(1991-4#1)(1992-12#1)(1993-1#1)(1997-8#2)(2007-7#1)(2008-2#1)(2008-6#2)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
of relapsed##4##2##(2008-5#2)(2010-4#2)
of relapses##4##2##(2008-1#1)(2008-4#1)(2012-3#1)(2013-8#1)
of relapsing##4##2##(1991-2#1)(1994-2#1)(2008-1#1)(2010-12#1)
of related growth##2##3##(1994-12#1)(2010-8#1)
of related species sperms##2##4##(2008-9#2)
of related##30##2##(1990-5#1)(1992-4#1)(1992-6#1)(1994-12#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
of relatedness and##2##3##(2009-10#1)(2010-4#1)
of relatedness##5##2##(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)
of relating##5##2##(1993-1#1)(1993-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
of relational##3##2##(1992-3#1)(2010-8#1)(2012-12#1)
of relations among##2##3##(2008-9#1)(2010-2#1)
of relations between the##2##4##(2010-10#1)(2010-6#1)
of relations between##4##3##(2008-10#1)(2008-7#1)(2010-10#1)(2010-6#1)
of relations##7##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)
of relationship and##2##3##(2008-11#1)(2008-6#1)
of relationship satisfaction##3##3##(2008-6#1)(2010-8#1)(2012-2#1)
of relationship##13##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#3)
of relationships among##2##3##(1992-3#1)(1997-2#1)
of relationships between##6##3##(1991-2#1)(1992-3#1)(1993-1#1)(2008-10#2)(2008-5#1)
of relationships with##3##3##(1995-2#1)(2009-7#1)(2011-1#1)
of relationships##20##2##(1991-2#1)(1992-3#2)(1993-1#2)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2011-1#1)(2013-1#2)
of relative fluorescence##2##3##(2008-10#1)(2008-3#1)
of relative humidity##5##3##(2008-10#3)(2008-2#1)(2008-5#1)
of relative potency##2##3##(1995-12#1)(2008-5#1)
of relative risk##3##3##(1992-6#1)(1994-2#1)(1997-5#1)
of relative standard deviation (R##4##5##(2008-10#4)
of relative standard deviation##7##4##(2008-1#1)(2008-10#6)
of relative value##2##3##(1991-2#1)(1992-3#1)
of relative##51##2##(1991-2#2)(1991-9#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-4#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-9#1)
of relatively high and##2##4##(1991-9#1)(2012-2#1)
of relatively high##3##3##(1990-12#1)(1991-9#1)(2012-2#1)
of relatively hydrophilic chemicals##2##4##(2008-11#2)
of relatively large##6##3##(1997-2#1)(1997-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
of relatively low##4##3##(1990-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
of relatively##26##2##(1990-12#3)(1991-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
of relatives##4##2##(2009-11#1)(2009-6#1)(2011-2#2)
of relaxation and##2##3##(2008-7#1)(2012-3#1)
of relaxation##8##2##(1991-12#2)(1991-9#1)(1997-4#1)(2008-11#1)(2008-7#1)(2012-3#1)(2012-7#1)
of relaxed selective constraint##2##4##(2011-2#2)
of relaxed##3##2##(1995-3#1)(2011-2#2)
of relaxing##2##2##(1995-3#1)(1997-4#1)
of release of##7##3##(1992-3#1)(1992-6#1)(1993-5#1)(1994-6#1)(2008-10#1)(2008-4#2)
of release##15##2##(1992-3#1)(1992-6#1)(1993-5#1)(1994-6#1)(1995-12#2)(1996-2#1)(2008-10#2)(2008-4#3)(2008-5#1)(2009-6#1)(2013-1#1)
of released alpha-tocopherol##2##3##(2009-8#2)
of released##12##2##(1992-6#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-4#3)(2009-8#3)(2011-2#2)
of releasing##4##2##(1992-9#1)(1994-6#1)(1997-4#1)(2008-8#1)
of relevance for##2##3##(2008-12#1)(2008-3#1)
of relevance in##3##3##(1990-8#1)(1991-1#1)(2007-2#1)
of relevance to the##3##4##(1992-12#1)(2011-2#1)(2013-1#1)
of relevance to##6##3##(1992-12#1)(2007-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
of relevance##14##2##(1990-8#1)(1991-1#1)(1992-12#1)(2007-11#2)(2007-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
of relevant and##2##3##(2008-10#1)(2008-7#1)
of relevant articles for##2##4##(1994-3#1)(2013-8#1)
of relevant information##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
of relevant literature##2##3##(2008-11#1)(2013-8#1)
of relevant##30##2##(1991-6#1)(1994-3#2)(1995-2#1)(1996-11#1)(2006-4#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#6)(2009-11#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-8#2)
of reliability and##2##3##(2008-1#1)(2012-2#1)
of reliability##8##2##(1993-12#1)(1995-2#1)(1997-4#1)(2008-1#1)(2009-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
of reliable##7##2##(1993-6#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-11#1)(2013-8#1)
of reliably##4##2##(1991-3#1)(2008-10#2)(2012-2#1)
of religion on##2##3##(2009-6#1)(2009-7#1)
of religion##7##2##(2008-12#2)(2009-4#1)(2009-6#1)(2009-7#3)
of religiosity##6##2##(2009-11#2)(2009-7#2)(2011-1#2)
of religious beliefs##2##3##(2012-12#2)
of religious##8##2##(1996-2#1)(2009-7#2)(2009-8#1)(2010-10#2)(2012-12#2)
of relocated##2##2##(2007-5#1)(2013-7#1)
of relocation##2##2##(2013-7#2)
of relying on##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
of remaining##6##2##(1992-9#1)(1996-12#1)(2007-2#1)(2008-7#2)(2011-2#1)
of remarkable##4##2##(2008-1#1)(2008-12#1)(2008-7#1)(2010-3#1)
of remembering##2##2##(2011-2#2)
of remifentanil for reducing##2##4##(2011-2#2)
of remifentanil on arterial oxygenation during one-lung ventilation##2##8##(2011-2#2)
of remifentanil on##3##3##(2011-2#3)
of remifentanil##7##2##(2011-2#6)(2012-12#1)
of reminder##2##2##(2012-3#2)
of remission in##2##3##(2010-12#1)(2012-3#1)
of remission##13##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-4#1)(1992-2#1)(1994-6#1)(2006-10#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-3#1)
of remodeling##3##2##(2007-8#1)(2009-11#1)(2011-1#1)
of remote sensing of##2##4##(2008-2#1)(2008-3#1)
of remote sensing##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
of remote##8##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-8#1)
of remote-sensing reflectance##2##3##(2008-3#2)
of removal of##3##3##(1993-12#1)(1994-8#1)(2008-10#1)
of removal##5##2##(1993-12#1)(1994-6#1)(1994-8#1)(2008-10#1)(2013-8#1)
of removing the##4##3##(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
of removing##9##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
of remyelination##5##2##(2008-12#2)(2008-7#3)
of renal arteries##3##3##(1993-8#1)(2008-12#1)(2008-7#1)
of renal artery stenosis##3##4##(2008-1#2)(2008-12#1)
of renal artery##4##3##(1994-9#1)(2008-1#2)(2008-12#1)
of renal cancer##3##3##(1993-9#2)(2007-11#1)
of renal cell carcinoma (RCC)##2##5##(2007-4#1)(2012-3#1)
of renal cell carcinoma in##2##5##(1990-8#2)
of renal cell carcinoma##9##4##(1990-8#2)(1995-12#1)(2007-4#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
of renal cell##13##3##(1990-8#2)(1992-8#1)(1995-12#1)(2007-4#2)(2008-1#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
of renal colic using intracutaneous injection of sterile water##2##9##(2007-10#2)
of renal disease can##2##4##(2007-7#2)
of renal disease##7##3##(2007-7#2)(2008-1#3)(2008-7#1)(2009-6#1)
of renal diseases in children##2##5##(2007-7#1)(2008-4#1)
of renal diseases##7##3##(1997-5#1)(2007-7#3)(2008-1#1)(2008-4#1)(2013-1#1)
of renal dysfunction##2##3##(2011-1#1)(2013-1#1)
of renal failure##14##3##(1995-12#1)(2006-10#1)(2007-7#1)(2008-1#4)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#4)
of renal function##14##3##(1995-11#1)(2007-7#1)(2008-1#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#2)
of renal functional##2##3##(2008-1#2)
of renal impairment##3##3##(2008-1#1)(2013-1#2)
of renal injuries##2##3##(1990-9#1)(2012-2#1)
of renal injury##2##3##(1994-5#1)(2009-6#1)
of renal insufficiency##5##3##(1990-5#1)(1990-9#1)(1993-5#1)(2007-7#2)
of renal masses##2##3##(2012-2#2)
of renal osteodystrophy##2##3##(2008-4#1)(2011-2#1)
of renal replacement therapy in##2##5##(2008-3#1)(2008-8#1)
of renal replacement therapy##5##4##(2008-1#2)(2008-3#2)(2008-8#1)
of renal scarring##2##3##(2008-4#2)
of renal stones##2##3##(2008-10#1)(2011-2#1)
of renal transplant patients##2##4##(2009-10#1)(2010-7#1)
of renal transplant##5##3##(2008-1#1)(2009-10#1)(2010-7#2)(2011-2#1)
of renal transplantation in##3##4##(2008-4#2)(2013-1#1)
of renal transplantation##11##3##(1991-11#1)(1994-5#1)(2007-7#1)(2008-1#2)(2008-4#4)(2009-10#1)(2013-1#1)
of renal tubular##3##3##(1992-3#1)(2007-7#1)(2008-4#1)
of renal tubule dilatation in##2##5##(2008-9#2)
of renal tubule##5##3##(2008-9#5)
of renal tumor##3##3##(2007-7#1)(2008-10#2)
of renal##173##2##(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-5#1)(1992-3#1)(1992-5#2)(1992-8#3)(1993-5#1)(1993-8#1)(1993-9#2)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1996-6#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#14)(2008-1#32)(2008-10#9)(2008-12#2)(2008-3#3)(2008-4#11)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#2)(2009-5#1)(2009-6#2)(2010-11#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#15)(2013-8#1)
of renal-cell##2##2##(1991-2#1)(2008-8#1)
of rendering##2##2##(1996-9#1)(2008-4#1)
of renin##6##2##(1990-5#2)(1990-8#2)(1996-5#1)(2013-1#1)
of renovascular hypertension##3##3##(1990-2#2)(2007-7#1)
of renovascular##4##2##(1990-2#2)(2007-7#2)
of reoperation with##2##3##(2012-3#2)
of reoperation##6##2##(2007-8#1)(2010-3#1)(2012-12#2)(2012-3#2)
of repair##10##2##(1994-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#1)
of repeat##10##2##(1990-3#1)(1993-11#1)(1993-6#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-1#2)
of repeatability at the##2##4##(2008-10#2)
of repeatability##5##2##(2008-10#4)(2012-12#1)
of repeated fasting/refeeding##2##3##(2012-3#2)
of repeated measurements##3##3##(1990-8#1)(2008-10#2)
of repeated measures##6##3##(1992-6#1)(1992-9#2)(1994-9#1)(1997-3#2)
of repeated sequence##2##3##(1992-6#1)(2008-8#1)
of repeated##44##2##(1990-8#1)(1991-1#1)(1992-4#1)(1992-6#3)(1992-9#2)(1993-10#1)(1993-12#1)(1993-6#2)(1994-9#1)(1995-12#2)(1995-5#1)(1997-2#1)(1997-3#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-3#2)(2013-1#3)
of repeating##3##2##(1995-11#1)(1995-2#1)(2008-9#1)
of repeats##2##2##(2008-7#1)(2011-2#1)
of reperfusion injury##4##3##(1990-3#1)(1991-9#1)(2007-8#1)(2010-3#1)
of reperfusion##15##2##(1990-3#2)(1991-9#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-9#2)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-3#1)(2013-1#1)
of repetition##4##2##(1996-4#1)(2008-3#1)(2010-4#1)(2010-7#1)
of repetitive self-injury##2##3##(2008-11#2)
of repetitive sequences##2##3##(1991-6#1)(2010-3#1)
of repetitive transcranial magnetic stimulation##2##5##(2012-1#1)(2012-2#1)
of repetitive##20##2##(1990-11#1)(1991-6#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-2#2)
of replacement therapy##2##3##(1997-1#1)(2007-7#1)
of replacement##5##2##(1990-11#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#1)
of replacing##6##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#2)(2013-1#1)
of replant##2##2##(2008-10#2)
of replicas of the Skylab 3600-line/mm concave grating with multilayer and gold coatings##2##13##(2008-2#2)
of replicas of the##3##4##(2007-11#1)(2008-2#2)
of replicas##4##2##(2007-11#1)(2008-2#2)(2008-5#1)
of replicate##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
of replicating##2##2##(1994-8#1)(1995-2#1)
of replication in##2##3##(1994-12#1)(2008-8#1)
of replication of##4##3##(1990-11#1)(1991-12#1)(1991-9#1)(1994-11#1)
of replication stress##2##3##(2011-2#1)(2012-3#1)
of replication##25##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-5#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-8#2)(2008-9#2)(2010-3#1)(2011-2#2)(2012-3#1)
of repolarization##3##2##(2009-2#1)(2009-8#1)(2010-8#1)
of reportable##3##2##(1997-3#2)(2010-11#1)
of reported cases in##2##4##(2007-12#1)(2008-6#1)
of reported cases of##2##4##(2007-12#1)(2007-7#1)
of reported cases##7##3##(1991-2#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-6#1)(2013-1#1)
of reported##26##2##(1991-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-6#1)(2010-8#1)(2012-12#1)(2013-1#4)(2013-8#2)
of reporter gene expression##3##4##(1995-2#1)(2008-11#1)(2008-8#1)
of reporter genes##2##3##(2008-10#1)(2008-8#1)
of reporter##10##2##(1994-11#1)(1995-2#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2012-2#1)
of reporting of##3##3##(1996-3#1)(2008-10#1)(2012-3#1)
of reporting##8##2##(1993-9#1)(1996-3#1)(2008-10#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of reports of##7##3##(1995-3#1)(1995-9#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
of reports on##2##3##(2008-10#1)(2008-4#1)
of reports that##4##3##(1992-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
of reports##29##2##(1992-8#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-8#1)(1996-9#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
of representative isolates##2##3##(2008-10#1)(2011-2#1)
of representative##10##2##(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
of representing##5##2##(2007-11#1)(2007-12#1)(2008-7#1)(2009-7#1)(2013-8#1)
of repressive and sanitary institutions##2##5##(2009-7#2)
of repressor and##2##3##(1991-5#1)(2012-3#1)
of repressor##4##2##(1991-12#1)(1991-5#1)(1992-4#1)(2012-3#1)
of reproducibility##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
of reproducible##2##2##(2008-10#2)
of reproducing##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
of reproduction in##4##3##(1997-7#1)(2008-5#1)(2008-8#2)
of reproduction##19##2##(1991-6#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-8#6)(2008-9#6)(2011-1#1)(2013-7#1)
of reproductive age##8##3##(1994-9#1)(2008-3#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#1)
of reproductive and##2##3##(2008-11#1)(2010-3#1)
of reproductive biology##2##3##(2009-6#1)(2013-8#1)
of reproductive effort##6##3##(2008-8#5)(2008-9#1)
of reproductive health##2##3##(2008-1#2)
of reproductive isolation##5##3##(2008-8#5)
of reproductive organs##2##3##(2008-5#1)(2008-7#1)
of reproductive output##3##3##(2008-8#3)
of reproductive skew##4##3##(2008-8#3)(2008-9#1)
of reproductive structure##2##3##(2011-2#2)
of reproductive traits##2##3##(2008-8#1)(2012-12#1)
of reproductive##59##2##(1991-1#1)(1992-2#1)(1994-9#1)(1996-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#17)(2008-9#4)(2009-12#2)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#4)(2013-1#1)(2013-8#1)
of reptiles##3##2##(2010-3#3)
of requests for##2##3##(1992-12#1)(1994-1#1)
of required##2##2##(2008-10#1)(2010-3#1)
of requirements##3##2##(1994-3#1)(2008-1#1)(2009-11#1)
of requiring##3##2##(1996-1#1)(2008-3#1)(2013-1#1)
of research aimed at##2##4##(2008-1#1)(2008-2#1)
of research and practice##5##4##(2010-10#5)
of research and##13##3##(1990-6#1)(1995-4#1)(1995-8#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-10#5)(2012-2#1)
of research are##5##3##(1997-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)
of research areas##2##3##(1993-2#1)(2009-10#1)
of research at##2##3##(2007-7#1)(2010-2#1)
of research conducted##2##3##(1993-1#1)(2009-5#1)
of research ethics##2##3##(1996-11#1)(2008-9#1)
of research evidence to##2##4##(2008-11#1)(2008-12#1)
of research evidence##3##3##(2008-11#2)(2008-12#1)
of research for the##2##4##(2008-10#1)(2010-2#1)
of research for##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
of research has been conducted##2##5##(2010-12#1)(2011-2#1)
of research has been##4##4##(2010-12#1)(2011-2#1)(2013-1#2)
of research has demonstrated##2##4##(1990-11#1)(2008-7#1)
of research has##8##3##(1990-11#1)(1997-1#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
of research in primary##2##4##(1993-2#1)(1996-9#1)
of research in the area of##2##6##(2007-11#1)(2008-11#1)
of research in the past##2##5##(2009-1#1)(2010-10#1)
of research in the##7##4##(1992-6#1)(1997-3#1)(2007-11#1)(2008-11#1)(2009-1#1)(2010-10#1)(2012-2#1)
of research in this area##3##5##(2012-12#1)(2013-1#1)(2013-8#1)
of research in this##4##4##(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
of research in##27##3##(1990-12#1)(1992-6#1)(1993-2#1)(1995-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of research into##7##3##(1993-6#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
of research investigations##2##3##(2008-10#1)(2012-12#1)
of research involving##2##3##(2008-7#1)(2010-11#1)
of research is##5##3##(1997-1#1)(2008-11#2)(2008-7#1)(2012-1#1)
of research issues##2##3##(1992-12#1)(2013-1#1)
of research on the##6##4##(1993-1#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-8#1)
of research on##8##3##(1993-1#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2013-8#1)
of research participation##2##3##(2009-4#2)
of research priorities for Australian critical care nurses##2##8##(2007-11#2)
of research priorities for critical care##2##6##(2007-11#2)
of research priorities for##4##4##(2007-11#4)
of research projects##2##3##(1997-1#1)(1997-3#1)
of research protocols##2##3##(1992-3#1)(2011-1#1)
of research results##3##3##(1992-12#1)(1993-6#1)(2011-2#1)
of research studies##2##3##(2008-3#1)(2010-12#1)
of research supervision##3##3##(2012-3#3)
of research that##14##3##(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
of research to##2##3##(2008-11#2)
of research uptake##3##3##(2010-10#3)
of research with the##2##4##(2010-12#1)(2012-2#1)
of research with##3##3##(1994-9#1)(2010-12#1)(2012-2#1)
of research within##2##3##(1997-3#1)(2008-5#1)
of research##224##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-1#6)(1997-3#4)(1997-8#1)(2007-11#6)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#8)(2008-11#17)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#5)(2009-4#8)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#11)(2010-11#5)(2010-12#6)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#13)(2012-3#4)(2013-1#10)(2013-8#4)
of researchers and##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
of researchers who##2##3##(2008-4#1)(2009-3#1)
of researchers##11##2##(1993-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-12#1)
of resectable##2##2##(1992-12#1)(2013-1#1)
of resected specimen##2##3##(2007-8#1)(2008-10#1)
of resected##4##2##(2007-8#1)(2008-10#1)(2013-1#2)
of resection of##2##3##(2007-8#1)(2011-2#1)
of resection##8##2##(1994-12#1)(2007-8#2)(2008-9#3)(2009-10#1)(2011-2#1)
of reserpine in the##2##4##(2008-10#1)(2008-12#1)
of reserpine in##4##3##(2008-10#2)(2008-12#2)
of reserpine##10##2##(2008-10#5)(2008-12#4)(2012-2#1)
of reserves##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
of residence in the##2##4##(2008-8#1)(2010-12#1)
of residence in##4##3##(2008-8#1)(2010-12#2)(2010-8#1)
of residence##16##2##(1991-1#1)(1994-3#1)(1994-6#1)(1997-2#1)(2007-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#2)
of residency##5##2##(1992-1#1)(1992-3#1)(1994-12#1)(1994-3#1)(2010-8#1)
of resident bacteria##2##3##(2008-5#2)
of resident##17##2##(1991-3#1)(1997-1#1)(2008-10#4)(2008-12#2)(2008-5#4)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-2#1)
of residential##5##2##(2009-9#1)(2010-3#2)(2012-12#1)(2013-8#1)
of residents and##3##3##(1997-1#2)(2012-3#1)
of residents in##3##3##(1992-2#1)(1994-3#1)(1996-9#1)
of residents##18##2##(1991-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-2#1)(1996-9#1)(1997-1#2)(2009-3#1)(2011-1#1)(2011-2#3)(2012-3#1)
of residual acetic acid##2##4##(2008-10#2)
of residual chlorine##2##3##(2008-10#2)
of residual hearing and##2##4##(2008-9#1)(2012-2#1)
of residual hearing##3##3##(2008-9#1)(2012-2#2)
of residual renal function##4##4##(2007-12#2)(2011-2#2)
of residual stress##4##3##(2007-11#2)(2008-2#1)(2009-7#1)
of residual yolk sac##3##4##(2008-12#3)
of residual##52##2##(1990-6#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-9#3)(1993-1#1)(1995-11#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#3)(2008-2#4)(2008-3#2)(2008-9#2)(2009-11#1)(2009-7#2)(2011-1#1)(2011-2#5)(2012-2#3)(2013-8#1)
of residuals##2##2##(1995-12#1)(2008-10#1)
of residue 161##3##3##(1995-5#3)
of residue##12##2##(1992-3#1)(1994-11#2)(1995-5#4)(1997-2#1)(2008-10#3)(2008-11#1)
of residues at positions##2##4##(1994-3#1)(1994-5#1)
of residues in##2##3##(1995-2#1)(1995-5#1)
of residues##17##2##(1990-7#1)(1992-12#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-4#2)(2008-10#3)(2012-2#1)
of resilience##2##2##(2011-1#1)(2012-1#1)
of resilin##2##2##(2007-12#2)
of resin composites##2##3##(2010-10#1)(2013-1#1)
of resin##9##2##(2008-10#5)(2008-3#1)(2009-8#1)(2010-10#1)(2013-1#1)
of resin-resin interfaces##2##3##(2008-12#2)
of resistance against##4##3##(2008-10#3)(2008-8#1)
of resistance among##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
of resistance and virulence##2##4##(2008-10#2)
of resistance and##10##3##(1995-6#1)(1997-6#1)(2008-10#7)(2013-1#1)
of resistance are##2##3##(1997-6#1)(2008-10#1)
of resistance by##2##3##(2008-10#1)(2011-2#1)
of resistance conferred by##2##4##(2008-10#2)
of resistance development##3##3##(2008-10#2)(2011-2#1)
of resistance displayed by the source plant##2##7##(2008-10#2)
of resistance elicitors##4##3##(2008-10#4)
of resistance genes##8##3##(2008-10#8)
of resistance in a##2##4##(2008-10#1)(2008-11#1)
of resistance in the##2##4##(2008-10#2)
of resistance in wheat to##2##5##(2008-10#1)(2011-2#1)
of resistance in##15##3##(1995-6#1)(2008-10#11)(2008-11#1)(2011-10#1)(2011-2#1)
of resistance into commercial##2##4##(2008-10#2)
of resistance into##3##3##(2008-10#3)
of resistance is##3##3##(2008-10#3)
of resistance loci##3##3##(2008-10#3)
of resistance of##4##3##(2008-10#2)(2010-8#1)(2012-12#1)
of resistance responses##2##3##(2008-10#1)(2009-6#1)
of resistance to Aspergillus ear rot and aflatoxin production##2##9##(2008-10#2)
of resistance to Aspergillus ear rot and aflatoxin##3##8##(2008-10#3)
of resistance to FHB##2##4##(2008-10#2)
of resistance to STB##2##4##(2008-10#2)
of resistance to Sclerotinia##2##4##(2008-10#2)
of resistance to a##2##4##(1997-5#1)(2011-2#1)
of resistance to aflatoxin production##2##5##(2008-10#2)
of resistance to alkylating agents##2##5##(2008-11#2)
of resistance to fumonisin production and accumulation in grain##2##9##(2008-10#2)
of resistance to fumonisin##3##4##(2008-10#3)
of resistance to the##3##4##(2008-10#2)(2008-12#1)
of resistance to therapy##2##4##(1995-2#1)(2012-3#1)
of resistance to this##2##4##(2008-10#1)(2008-11#1)
of resistance to##92##3##(1990-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-2#1)(1997-5#1)(2007-7#1)(2008-10#62)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
of resistance was##7##3##(2008-10#7)
of resistance were##5##3##(2008-10#4)(2013-8#1)
of resistance##246##2##(1990-6#1)(1992-8#1)(1993-12#2)(1993-8#2)(1994-8#1)(1995-2#1)(1995-6#2)(1997-5#1)(1997-6#5)(2007-2#1)(2007-7#1)(2008-10#170)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-10#1)(2011-2#13)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
of resistance-associated##2##2##(2008-11#2)
of resistant and susceptible##4##4##(2008-10#4)
of resistant and##5##3##(2008-10#5)
of resistant cultivars##8##3##(2008-10#8)
of resistant genotypes##2##3##(2008-10#2)
of resistant host##2##3##(2008-10#1)(2008-8#1)
of resistant hypertension##2##3##(2010-6#2)
of resistant isolates##5##3##(2008-10#5)
of resistant plants##2##3##(2008-10#2)
of resistant strains##3##3##(2008-1#1)(2008-10#2)
of resistant##51##2##(1996-3#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#34)(2008-8#3)(2009-12#1)(2010-11#1)(2010-6#2)(2011-2#2)(2013-1#3)
of resistin in##2##3##(2008-1#2)
of resistin##4##2##(2008-1#4)
of resistivity for antibiotics##3##4##(2010-8#3)
of resolution and##5##3##(1991-7#1)(1993-9#1)(2008-3#2)(2009-5#1)
of resolution of##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
of resolution##22##2##(1991-7#1)(1992-5#1)(1993-9#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)
of resolving##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of resonance interferometry##2##3##(2008-2#2)
of resonance##9##2##(2008-10#3)(2008-2#2)(2008-3#2)(2008-9#1)(2012-2#1)
of resonances##2##2##(1994-5#1)(2007-11#1)
of resonant##6##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)
of resonator##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
of resonator-originated and external beam shaping##2##6##(2008-2#2)
of resonators##2##2##(2007-11#1)(2008-3#1)
of resorption villi##2##3##(2011-1#2)
of resorption##3##2##(2011-1#2)(2013-1#1)
of resource allocation##2##3##(1992-3#1)(2007-4#1)
of resource availability##4##3##(2008-8#3)(2008-9#1)
of resource capture##3##3##(2008-8#1)(2008-9#2)
of resource competition##4##3##(2007-7#1)(2008-8#2)(2008-9#1)
of resource patches##2##3##(2008-9#2)
of resource sharing##2##3##(1995-2#1)(2011-2#1)
of resource supply##2##3##(2008-8#2)
of resource use##2##3##(1993-12#1)(2008-9#1)
of resource##36##2##(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-8#19)(2008-9#8)(2011-2#1)
of resources and##9##3##(1994-12#1)(1997-3#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-2#1)
of resources between##2##3##(2007-7#1)(2008-8#1)
of resources for##3##3##(2012-12#2)(2012-3#1)
of resources in the##2##4##(1990-9#1)(2013-1#1)
of resources in##3##3##(1990-9#1)(2008-8#1)(2013-1#1)
of resources to a##2##4##(1990-12#1)(1994-12#1)
of resources to##5##3##(1990-12#1)(1994-12#1)(1995-3#1)(2008-9#2)
of resources used##2##3##(1997-4#1)(2008-8#1)
of resources##54##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-3#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
of respect##2##2##(1992-3#1)(1994-1#1)
of respective##6##2##(1991-12#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
of respirable size##2##3##(1991-12#1)(1996-1#1)
of respirable##3##2##(1991-12#2)(1996-1#1)
of respiration is##2##3##(2008-7#2)
of respiration##8##2##(1990-8#1)(2008-7#4)(2009-8#1)(2011-2#1)(2012-2#1)
of respiratory disease in##2##4##(1997-1#1)(1997-6#1)
of respiratory disease##4##3##(1997-1#1)(1997-6#1)(2008-12#1)(2009-10#1)
of respiratory diseases##2##3##(1996-3#2)
of respiratory distress syndrome##3##4##(1992-2#1)(2007-11#1)(2009-6#1)
of respiratory distress##7##3##(1992-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#2)
of respiratory epithelium and##2##4##(2012-3#2)
of respiratory epithelium##3##3##(1992-3#1)(2012-3#2)
of respiratory failure##2##3##(1991-6#1)(2009-5#1)
of respiratory muscles and##2##4##(1991-6#1)(2012-3#1)
of respiratory problems##2##3##(2010-5#1)(2012-1#1)
of respiratory syncytial virus##2##4##(2010-10#1)(2010-5#1)
of respiratory tract infections##2##4##(1997-2#1)(2007-12#1)
of respiratory tract##3##3##(1992-6#1)(1997-2#1)(2007-12#1)
of respiratory##60##2##(1990-11#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-8#3)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
of respondents from##2##3##(1993-1#1)(1995-3#1)
of respondents had##2##3##(1993-1#1)(2008-12#1)
of respondents reported##3##3##(1990-6#1)(2008-12#1)(2010-8#1)
of respondents reporting##2##3##(1993-9#1)(1996-3#1)
of respondents were##3##3##(2008-9#1)(2009-10#1)(2011-2#1)
of respondents##40##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-9#1)(1995-3#1)(1996-3#1)(1997-3#1)(2007-10#3)(2007-12#1)(2007-7#1)(2008-11#2)(2008-12#4)(2008-9#1)(2009-10#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
of responders##9##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-8#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)
of responding to the##3##4##(2008-10#1)(2008-5#2)
of responding to##4##3##(2008-10#1)(2008-4#1)(2008-5#2)
of responding##15##2##(1992-10#1)(1992-11#1)(1993-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#7)
of response and##4##3##(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
of response to neoadjuvant##2##4##(1993-11#1)(2010-7#1)
of response to treatment##4##4##(2007-2#1)(2008-12#1)(2010-8#1)(2011-2#1)
of response to##24##3##(1990-12#1)(1993-11#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of response was##10##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-8#1)(1997-1#1)(2013-1#1)
of response were found##2##4##(1992-9#1)(2008-6#1)
of response were##3##3##(1992-9#1)(1993-2#1)(2008-6#1)
of response##79##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#3)(2010-3#3)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
of responses in##2##3##(1995-8#1)(2008-11#1)
of responses increased significantly from##2##5##(2008-12#2)
of responses of##2##3##(1990-2#1)(2008-10#1)
of responses that##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
of responses to the##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
of responses to##9##3##(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
of responses##34##2##(1990-2#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#7)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
of responsibilities##5##2##(1995-12#1)(2008-1#1)(2008-7#1)(2012-3#2)
of responsibility and##2##3##(2007-10#1)(2008-11#1)
of responsibility for quality of care##2##6##(1991-12#1)(1996-2#1)
of responsibility for##5##3##(1991-12#1)(1995-12#1)(1996-2#1)(2008-7#1)(2009-5#1)
of responsibility in##2##3##(1997-2#1)(2011-2#1)
of responsibility to##2##3##(1996-1#1)(2012-1#1)
of responsibility##18##2##(1991-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#3)(1997-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-1#1)
of responsiveness##4##2##(1991-1#1)(1994-9#1)(1995-12#1)(2007-6#1)
of rest##2##2##(2009-1#1)(2013-1#1)
of rest/activity##2##2##(2008-6#2)
of restenosis after##5##3##(1991-5#1)(1995-8#1)(1996-8#1)(2007-8#1)(2008-7#1)
of restenosis has##2##3##(1994-11#1)(2008-12#1)
of restenosis##18##2##(1991-5#1)(1992-4#2)(1992-9#3)(1994-11#3)(1994-9#2)(1995-8#1)(1996-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
of resting platelets##2##3##(1997-7#1)(2006-6#1)
of resting spores##2##3##(2008-10#2)
of resting##14##2##(1990-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)
of restoration##5##2##(2008-3#4)(2013-7#1)
of restorative##3##2##(2008-11#1)(2008-7#2)
of restored##2##2##(2008-2#1)(2013-1#1)
of restraint##4##2##(1991-12#1)(1997-2#2)(2008-7#1)
of restricted##4##2##(1992-6#1)(2008-3#1)(2008-9#1)(2012-3#1)
of restriction enzyme##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
of restriction fragment length polymorphism##3##5##(2008-10#1)(2008-4#1)(2008-9#1)
of restriction fragment length##4##4##(1996-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
of restriction sites##3##3##(1994-12#1)(1996-2#1)(2008-11#1)
of restriction##14##2##(1993-12#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
of restrictions##2##2##(1994-2#1)(2007-12#1)
of restrictive##3##2##(1990-9#1)(1991-12#2)
of restructuring##4##2##(1993-1#1)(1994-2#1)(1995-12#2)
of result##2##2##(2007-11#1)(2008-2#1)
of resultant##2##2##(1997-1#1)(2008-2#1)
of resulting##9##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)
of results and##2##3##(1991-8#1)(2012-2#1)
of results between##2##3##(2008-10#1)(2008-4#1)
of results can##2##3##(2008-9#1)(2013-1#1)
of results from a##4##4##(1990-9#1)(1997-5#1)(2008-2#1)(2008-5#1)
of results from different##3##4##(2008-2#2)(2008-4#1)
of results from##13##3##(1990-9#1)(1995-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
of results in the##2##4##(2008-10#1)(2008-12#1)
of results in##4##3##(2008-1#1)(2008-10#1)(2008-12#2)
of results obtained by##3##4##(2008-10#2)(2008-11#1)
of results obtained##9##3##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
of results of##3##3##(1990-2#1)(2009-4#1)(2010-12#1)
of results was##2##3##(2008-10#2)
of results with##3##3##(2008-10#2)(2008-7#1)
of results##78##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
of resuscitation##4##2##(2008-11#1)(2008-3#1)(2010-8#1)(2012-2#1)
of resveratrol on##2##3##(2009-12#1)(2012-4#1)
of resveratrol##8##2##(2008-10#5)(2009-12#2)(2012-4#1)
of retained placenta##2##3##(1996-11#2)
of retained wooden foreign bodies##2##5##(2010-5#2)
of retained##8##2##(1994-8#1)(1996-11#2)(2007-12#1)(2008-12#2)(2010-5#2)
of retardation##2##2##(1991-5#1)(2008-2#1)
of retention and elution##3##4##(2008-10#3)
of retention of##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
of retention times##2##3##(2008-10#1)(2013-1#1)
of retention##18##2##(1990-5#1)(1995-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#3)
of reticular##3##2##(1990-6#1)(1990-9#1)(2013-1#1)
of reticulate##3##2##(2008-8#2)(2010-3#1)
of reticulated platelets##4##3##(2006-6#3)(2008-9#1)
of reticulocyte##2##2##(1992-8#1)(2008-9#1)
of reticulocytes in##2##3##(2008-9#2)
of reticulocytes turning into##2##4##(2008-9#2)
of reticulocytes##6##2##(1993-2#1)(1996-2#1)(2008-9#4)
of retina##2##2##(2010-1#1)(2011-2#1)
of retinal birefringence##2##3##(2007-11#1)(2008-2#1)
of retinal ganglion cells##4##4##(1993-12#1)(2008-7#1)(2009-12#1)(2011-2#1)
of retinal neurons##3##3##(2008-8#3)
of retinal pathology##2##3##(2011-7#2)
of retinal##31##2##(1990-3#1)(1992-3#1)(1993-12#2)(1994-5#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-5#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#3)(2011-2#2)(2011-7#2)(2011-9#1)(2012-12#1)(2013-1#1)
of retinitis pigmentosa##2##3##(2012-2#2)
of retinoblastoma##5##2##(1995-2#1)(1997-7#1)(2007-5#1)(2011-1#1)(2011-2#1)
of retinoic acid (RA)##3##4##(1990-6#1)(1994-6#1)(1995-9#1)
of retinoic acid in##2##4##(1990-6#1)(2007-11#1)
of retinoic acid on##3##4##(1993-3#1)(1994-11#1)(2008-11#1)
of retinoic acid synthesis##2##4##(1993-12#1)(1996-5#1)
of retinoic acid##11##3##(1990-6#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-6#1)(1995-9#1)(1996-5#1)(2007-11#1)(2008-11#1)
of retinoic acid-induced differentiation##2##4##(1992-12#1)(1997-7#1)
of retinoic##13##2##(1990-6#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-6#1)(1995-9#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-11#1)
of retinoid X##2##3##(1993-3#1)(1995-8#1)
of retinoid##7##2##(1993-3#3)(1995-8#1)(2007-11#2)(2008-5#1)
of retinoids and cytokines##2##4##(1992-2#2)
of retinoids may be##2##4##(1994-6#1)(2008-4#1)
of retinoids##5##2##(1992-2#2)(1994-6#1)(2007-11#1)(2008-4#1)
of retinol deficiency and curcumin##2##5##(1994-8#2)
of retinol##15##2##(1994-8#2)(2008-5#11)(2009-6#2)
of retinopathy of prematurity in##2##5##(2011-1#2)
of retinopathy##4##2##(1995-9#2)(2011-1#2)
of retinula##2##2##(2007-12#2)
of retired workers##2##3##(1993-1#2)
of retraction##2##2##(1996-1#1)(2007-12#1)
of retrieval of##3##3##(1993-12#1)(2008-3#2)
of retrieved aerosol##2##3##(2008-2#1)(2008-3#1)
of retrieved##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2013-1#1)
of retrieving##2##2##(2008-2#1)(2008-3#1)
of retrocalcaneal##2##2##(2008-8#1)(2009-10#1)
of retrograde##2##2##(1995-5#1)(2007-9#1)
of retroperitoneal lesions##2##3##(2011-2#2)
of retroperitoneal##9##2##(1990-5#1)(1990-6#1)(1994-6#1)(1996-6#1)(2008-1#1)(2011-2#2)(2013-1#2)
of retroreflectors##2##2##(2008-3#2)
of retrospective study##2##3##(2008-11#1)(2012-3#1)
of retrospective##4##2##(2007-11#1)(2008-11#1)(2011-2#1)(2012-3#1)
of retroviral vector##2##3##(2008-11#2)
of retroviral##7##2##(1994-8#1)(2008-11#3)(2008-4#3)
of retroviruses##5##2##(1992-12#1)(1995-8#1)(2008-11#3)
of return to##2##3##(1992-1#1)(2011-1#1)
of return##7##2##(1992-1#1)(1992-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
of return-to-zero##2##2##(2007-12#2)
of returned##2##2##(1994-11#1)(2008-3#1)
of returning to##3##3##(1991-12#1)(2008-12#1)(2008-8#1)
of returning##6##2##(1991-12#1)(2007-11#1)(2008-12#1)(2008-8#3)
of returns from##2##3##(1993-1#1)(1994-2#1)
of returns##3##2##(1993-1#1)(1994-2#1)(2008-3#1)
of reusable##2##2##(1992-12#1)(2011-2#1)
of reuse##2##2##(1992-3#1)(1994-11#1)
of revascularization##3##2##(1990-5#1)(2007-8#2)
of revealing##2##2##(2008-3#1)(2008-9#1)
of revenue##2##2##(1991-1#1)(1996-3#1)
of reversal##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
of reverse oblique##2##3##(2013-1#2)
of reverse transcription polymerase chain reaction##2##6##(2007-10#1)(2008-10#1)
of reverse transcription##3##3##(1995-12#1)(2007-10#1)(2008-10#1)
of reverse##16##2##(1993-3#1)(1994-6#2)(1995-12#1)(1996-12#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-1#1)(2013-1#4)
of reverse-correlation##3##2##(2013-8#3)
of reversed micelles as##2##4##(2008-10#2)
of reversed micelles##4##3##(1990-5#1)(1995-3#1)(2008-10#2)
of reversed##7##2##(1990-12#1)(1990-5#3)(1995-3#1)(2008-10#2)
of reversed-phase high-performance liquid chromatography##4##5##(1996-5#2)(1997-2#1)(2008-10#1)
of reversed-phase##5##2##(1996-12#1)(1996-5#2)(1997-2#1)(2008-10#1)
of reversibility##5##2##(1992-10#1)(1992-5#1)(2008-10#3)
of reversible##5##2##(1990-7#1)(1990-9#1)(1997-2#1)(2008-10#1)(2011-1#1)
of revertants##4##2##(1995-5#1)(1995-6#2)(2008-9#1)
of review##2##2##(2007-5#1)(2008-12#1)
of reviewed##2##2##(2008-10#1)(2008-11#1)
of reviews##2##2##(2008-10#1)(2008-7#1)
of revision THA in##2##4##(2013-1#2)
of revision THA##3##3##(2013-1#3)
of revision and##2##3##(2011-1#1)(2012-12#1)
of revision##10##2##(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
of revolution that##2##3##(2008-2#1)(2008-3#1)
of revolution##3##2##(2008-2#2)(2008-3#1)
of reward and##3##3##(1994-8#1)(2008-7#1)(2013-8#1)
of reward##12##2##(1991-1#1)(1992-12#2)(1994-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2013-8#2)
of rh TNF##2##3##(1992-9#2)
of rh##3##2##(1992-9#2)(2012-3#1)
of rhAT III##2##3##(2008-7#2)
of rhBMP-2 induced periosteal cells##2##5##(2008-5#2)
of rhBMP-2##4##2##(2008-5#2)(2012-12#2)
of rhBMPs##2##2##(2008-8#2)
of rhIL-1 alpha##2##3##(1990-12#1)(1990-2#1)
of rhP2##2##2##(1995-12#2)
of rhPC##2##2##(2008-12#2)
of rhabdomyolysis##4##2##(2008-1#2)(2011-2#2)
of rhabdomyosarcoma of##2##3##(2007-10#1)(2010-11#1)
of rhabdomyosarcoma##3##2##(2007-10#1)(2008-6#1)(2010-11#1)
of rhein##5##2##(2008-10#1)(2010-3#4)
of rheological properties of##2##4##(2008-5#1)(2008-7#1)
of rheology##4##2##(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)
of rheumatic diseases##3##3##(1990-6#1)(1991-8#1)(1993-3#1)
of rheumatic fever##3##3##(1996-12#2)(2008-7#1)
of rheumatic##11##2##(1990-6#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-12#2)(2006-10#1)(2008-7#2)(2008-8#1)
of rheumatoid arthritis (RA)##2##4##(2011-2#1)(2012-3#1)
of rheumatoid arthritis and##3##4##(2006-10#1)(2009-1#1)(2013-1#1)
of rheumatoid arthritis is##3##4##(1990-6#1)(2007-11#2)
of rheumatoid arthritis##24##3##(1990-6#3)(1991-8#1)(1996-9#1)(2006-10#4)(2007-11#4)(2008-5#2)(2008-8#1)(2009-1#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of rheumatoid factor##3##3##(2008-4#1)(2011-2#2)
of rheumatoid##29##2##(1990-6#3)(1991-11#1)(1991-8#1)(1996-9#1)(2006-10#4)(2007-11#5)(2008-4#1)(2008-5#2)(2008-8#1)(2009-1#1)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of rheumatological##5##2##(1990-6#1)(2013-1#4)
of rheumatology##3##2##(1991-11#1)(2006-10#1)(2012-2#1)
of rhinogenic deafness##3##3##(2008-4#3)
of rhizoctonia##2##2##(2008-10#2)
of rhizomania in##2##3##(2008-10#2)
of rhizomania##6##2##(2008-10#6)
of rhizosphere##2##2##(2008-10#2)
of rho##8##2##(1992-3#1)(1994-11#1)(2008-10#3)(2008-3#3)
of rhodamine 6G##2##3##(2008-10#2)
of rhodamine B##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
of rhodamine##9##2##(2008-10#7)(2008-12#1)(2013-8#1)
of rhodium by##2##3##(2008-10#2)
of rhodium in different##2##4##(2008-10#2)
of rhodium in##4##3##(2008-10#4)
of rhodium##21##2##(2008-10#21)
of rhodium(III) has been##2##4##(2008-10#2)
of rhodium(III) in##3##3##(2008-10#3)
of rhodium(III)##9##2##(2008-10#9)
of rhombic##2##2##(1997-7#1)(2009-7#1)
of rhythm##2##2##(2007-8#1)(2008-10#1)
of rhythmical##2##2##(2007-8#1)(2008-8#1)
of rhythms##2##2##(2008-11#1)(2008-6#1)
of ribavirin##4##2##(1990-10#1)(2008-10#3)
of riboflavin in beer by capillary##2##6##(2008-10#2)
of riboflavin in##6##3##(2008-10#5)(2008-9#1)
of riboflavin##11##2##(1992-9#1)(2008-10#6)(2008-9#2)(2012-2#1)(2012-3#1)
of ribonuclease##3##2##(1992-4#1)(1997-2#1)(2008-7#1)
of ribonucleoprotein##2##2##(1995-2#1)(1995-6#1)
of ribonucleosides to##3##3##(2008-4#3)
of ribonucleosides##4##2##(1997-2#1)(2008-4#3)
of ribonucleotide reductase##14##3##(1990-2#4)(1991-5#3)(1992-10#2)(1992-8#1)(1993-11#2)(1994-8#2)
of ribonucleotide##15##2##(1990-2#4)(1991-5#3)(1992-10#2)(1992-8#1)(1993-11#3)(1994-8#2)
of ribosomal DNA##9##3##(2008-10#7)(2008-9#1)(2009-2#1)
of ribosomal RNA##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
of ribosomal frameshifting##3##3##(1995-9#3)
of ribosomal protein genes##2##4##(2008-11#1)(2009-8#1)
of ribosomal protein##6##3##(1993-11#1)(1995-6#1)(2008-11#2)(2008-8#1)(2009-8#1)
of ribosomal##25##2##(1993-11#1)(1993-12#1)(1995-6#1)(1995-9#3)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
of ribosomes##3##2##(2007-12#1)(2008-7#1)(2009-11#1)
of ribulose-1##2##2##(1993-12#1)(1994-8#1)
of rice (Oryza sativa L##2##5##(1992-8#1)(2008-10#1)
of rice (Oryza sativa##3##4##(1992-8#1)(2008-10#1)(2009-10#1)
of rice (Oryza##4##3##(1992-8#1)(2008-10#2)(2009-10#1)
of rice 5-enolpyruvylshikimate 3-phosphate synthase gene##2##6##(2008-9#2)
of rice and wheat##2##4##(2008-10#1)(2008-11#1)
of rice and##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#3)(2013-8#1)
of rice blast##5##3##(2008-10#5)
of rice chromosome 1##2##4##(1996-10#2)
of rice chromosome##4##3##(1996-10#3)(2009-10#1)
of rice chromosomes 4 and 7##2##6##(1997-2#2)
of rice chromosomes##5##3##(1996-12#2)(1997-2#2)(2008-8#1)
of rice dwarf##2##3##(2008-10#1)(2008-8#1)
of rice growth##2##3##(2008-10#1)(2008-9#1)
of rice panicle##2##3##(2008-10#1)(2008-12#1)
of rice paper##4##3##(2008-10#4)
of rice root##6##3##(2008-9#6)
of rice to##3##3##(2008-10#3)
of rice##103##2##(1992-8#2)(1995-6#1)(1996-10#4)(1996-12#2)(1997-2#3)(2008-10#39)(2008-11#2)(2008-12#4)(2008-5#1)(2008-8#12)(2008-9#17)(2009-10#10)(2012-2#3)(2013-1#1)(2013-8#2)
of richness##2##2##(2008-6#1)(2013-7#1)
of ricin and abrin##2##4##(1994-5#2)
of ricin and##3##3##(1990-11#1)(1994-5#2)
of ricin##4##2##(1990-11#1)(1993-11#1)(1994-5#2)
of rickets##4##2##(2008-1#3)(2011-1#1)
of rifalazil##2##2##(2008-5#2)
of rifampicin resistance##3##3##(2007-7#3)
of rifampicin##5##2##(2007-7#3)(2008-10#2)
of right ventricle##2##3##(2008-7#1)(2011-2#1)
of right ventricular##3##3##(2008-3#1)(2010-10#1)(2010-6#1)
of right##24##2##(1990-6#1)(1994-2#1)(1995-1#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-8#1)
of right-sided facial##2##3##(2011-2#2)
of right-sided##3##2##(1990-11#1)(2011-2#2)
of rigid##2##2##(2011-1#1)(2011-2#1)
of rigorous and##2##3##(1992-2#1)(2012-12#1)
of rigorous##4##2##(1992-2#1)(2008-11#1)(2009-4#1)(2012-12#1)
of rinderpest in##2##3##(1990-3#1)(2011-2#1)
of rinderpest##3##2##(1990-3#1)(2011-2#2)
of ring##7##2##(1993-1#1)(1994-11#1)(1994-5#1)(2008-10#4)
of rings##4##2##(1991-8#1)(1993-8#1)(2007-12#1)(2009-7#1)
of rise##2##2##(1994-2#1)(1994-3#1)
of rising##9##2##(1993-1#1)(1993-3#1)(1995-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-4#2)
of risk adjustment##2##3##(1995-2#1)(1995-3#1)
of risk analysis##2##3##(2008-11#1)(2009-7#1)
of risk and##4##3##(1997-3#1)(2008-6#1)(2009-4#1)(2012-12#1)
of risk assessment##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
of risk assessments##2##3##(2008-10#1)(2011-2#1)
of risk behaviors##4##3##(1995-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
of risk factor##2##3##(2007-11#1)(2011-2#1)
of risk factors and##5##4##(1993-3#1)(2010-4#1)(2010-8#1)(2011-2#2)
of risk factors for chronic disease as health status adjusters##2##10##(1993-3#2)
of risk factors for coronary heart disease##2##7##(2008-12#2)
of risk factors for##15##4##(1992-11#1)(1993-3#2)(1995-6#1)(2008-10#1)(2008-12#2)(2008-7#3)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
of risk factors on##2##4##(1992-9#1)(2009-5#1)
of risk factors which##2##4##(1993-9#1)(2008-11#1)
of risk factors##47##3##(1992-11#1)(1992-12#1)(1992-9#2)(1993-2#1)(1993-3#3)(1993-9#1)(1995-6#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#3)(2008-8#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#4)(2013-8#3)
of risk for##4##3##(1990-8#1)(1991-8#1)(1996-2#1)(2012-2#1)
of risk groups##3##3##(2011-2#3)
of risk in##2##3##(1994-2#1)(2007-8#1)
of risk management at##2##4##(1996-2#1)(2009-4#1)
of risk management##5##3##(1993-2#1)(1994-2#1)(1996-2#1)(2007-11#1)(2009-4#1)
of risk or##2##3##(1997-3#1)(2008-3#1)
of risk to##2##3##(1991-12#1)(2012-3#1)
of risk tolerance##2##3##(2011-2#2)
of risk##131##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-9#4)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#6)(2009-5#1)(2009-7#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#4)
of risk-adjusted##2##2##(1997-1#1)(2008-11#1)
of risks##9##2##(1996-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2011-2#2)(2013-1#2)
of risky sexual##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
of risky##5##2##(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
of ritodrine hydrochloride##4##3##(2008-10#4)
of ritual##2##2##(1991-8#1)(2009-10#1)
of rituximab##4##2##(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
of rivalry##2##2##(1992-3#1)(2008-11#1)
of rivanol##4##2##(2008-10#4)
of rivastigmine##3##2##(2011-2#3)
of river water and##2##4##(2008-10#2)
of river water##3##3##(2008-10#3)
of river##7##2##(2008-10#6)(2008-6#1)
of road traffic##5##3##(2008-10#1)(2008-8#1)(2010-11#3)
of road##6##2##(2008-10#1)(2008-8#1)(2010-11#3)(2013-8#1)
of roadside soils##2##3##(2008-10#2)
of roadside##4##2##(2008-10#3)(2013-1#1)
of robotic##5##2##(2007-8#2)(2008-11#1)(2013-1#1)(2013-8#1)
of robotics##3##2##(2008-10#2)(2010-7#1)
of robots##5##2##(2007-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
of robust##14##2##(1993-3#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-7#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
of rock##2##2##(2008-10#1)(2013-8#1)
of rocks##3##2##(1996-4#1)(2008-10#1)(2008-3#1)
of rocuronium in##2##3##(2011-2#1)(2012-12#1)
of rocuronium##3##2##(2011-2#2)(2012-12#1)
of rod outer segments##2##4##(1993-8#1)(2008-4#1)
of rod##5##2##(1993-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
of rodent##7##2##(1990-5#1)(1990-8#1)(2008-11#2)(2008-4#2)(2011-1#1)
of rodents##7##2##(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(2006-12#1)(2008-7#1)(2012-2#1)
of role conflict and##2##4##(1990-2#2)
of role conflict##3##3##(1990-2#3)
of role modelling##4##3##(2008-12#4)
of role##11##2##(1990-2#3)(2007-10#1)(2008-12#4)(2009-11#2)(2009-7#1)
of roles in##2##3##(1996-7#1)(2010-11#1)
of roles##9##2##(1991-3#1)(1996-7#1)(1997-3#1)(2008-1#1)(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of rolling circle plasmid pKYM##2##5##(1997-6#2)
of rolling-stock##2##2##(1991-12#2)
of roman age##2##3##(2008-10#2)
of roman##3##2##(2008-10#3)
of romantic disengagement##4##3##(2009-9#4)
of romantic##5##2##(2009-9#4)(2010-8#1)
of room temperature##2##3##(2008-10#1)(2009-6#1)
of room##4##2##(2008-10#1)(2008-6#1)(2009-6#1)(2012-12#1)
of room-temperature##3##2##(2007-11#2)(2008-10#1)
of root and##3##3##(2008-10#2)(2008-12#1)
of root bark of##2##4##(2008-10#1)(2008-12#1)
of root canal##2##3##(2008-7#1)(2013-1#1)
of root canals##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
of root colonization by##2##4##(2008-10#2)
of root colonization##3##3##(2008-10#3)
of root disease##2##3##(2008-10#2)
of root infection##3##3##(2008-10#3)
of root necrosis##2##3##(2008-10#2)
of root pathogens##2##3##(2008-10#2)
of root rot##4##3##(2008-10#4)
of root samples##2##3##(2008-10#2)
of root surface biomodification##2##4##(2013-1#2)
of root##56##2##(2008-10#38)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-5#1)(2012-3#1)(2013-1#6)
of root-knot nematodes##2##3##(2008-10#2)
of root-knot##3##2##(2008-10#3)
of roots and##2##3##(2008-10#1)(2009-10#1)
of roots from##3##3##(2008-10#3)
of roots was##2##3##(2008-10#2)
of roots##18##2##(2008-10#13)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-1#1)
of ropinirole##2##2##(2008-7#2)
of rosiglitazone##3##2##(2008-11#1)(2008-3#1)(2010-7#1)
of rosmarinic acid##2##3##(2013-1#2)
of rotating constant magnetic field##2##5##(2008-8#2)
of rotating objects with##2##4##(2008-3#2)
of rotating the##2##3##(2008-3#2)
of rotating##7##2##(2008-2#1)(2008-3#4)(2008-8#2)
of rotation of the##3##4##(2008-3#2)(2009-8#1)
of rotation of##4##3##(2008-3#2)(2009-8#1)(2012-2#1)
of rotation rate##2##3##(1997-2#1)(2008-11#1)
of rotation##22##2##(1992-10#2)(1995-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)(2009-8#1)(2012-2#3)
of rotational##10##2##(1991-5#1)(2007-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2011-2#1)(2013-8#1)
of rotator cuff##3##3##(2007-11#2)(2012-2#1)
of rotavirus infection was##2##4##(2011-2#2)
of rotavirus infections##2##3##(2009-5#2)
of rotavirus##6##2##(2008-12#1)(2008-5#1)(2009-5#2)(2011-2#2)
of rotavirus-associated diarrhea##2##3##(2007-12#2)
of rotenone##3##2##(1994-12#1)(1995-3#1)(2011-1#1)
of rough endoplasmic reticulum##4##4##(1992-6#2)(2008-7#2)
of rough microsomes##2##3##(1992-6#2)
of rough surfaces##5##3##(2008-2#1)(2008-3#4)
of rough##13##2##(1992-6#4)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#2)
of roughly 1##2##3##(2008-10#1)(2008-7#1)
of roughly##5##2##(2008-10#2)(2008-7#2)(2011-2#1)
of round##8##2##(1991-3#1)(1997-4#3)(2008-2#1)(2008-5#1)(2008-6#1)(2012-3#1)
of routine health##2##3##(2009-6#1)(2010-9#1)
of routine wrist radiography##2##4##(2008-9#2)
of routine##28##2##(1990-6#1)(1991-11#1)(1991-12#1)(1992-6#1)(1994-1#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)
of rows##2##2##(2008-10#1)(2013-8#1)
of rs12979860##2##2##(2012-12#1)(2013-1#1)
of rs2241766##2##2##(2011-1#2)
of rs266729##3##2##(2011-1#3)
of rt-PA##4##2##(1997-8#1)(2007-10#3)
of rtN236T##3##2##(2013-1#3)
of rubidate##5##2##(2008-10#5)
of rubidium in##2##3##(2008-10#2)
of rubidium##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
of rubisco##2##2##(1991-9#2)
of rudimentary##4##2##(2008-7#1)(2008-9#2)(2011-1#1)
of rules##6##2##(1990-11#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-3#1)
of ruminant##2##2##(2011-2#1)(2012-3#1)
of ruminants##4##2##(1997-7#2)(2011-1#1)(2013-1#1)
of ruminative thinking##3##3##(2008-8#1)(2012-1#2)
of running buffer##2##3##(2008-10#2)
of rupintrivir##2##2##(2008-10#2)
of rupture of pregnant uterus##2##5##(2008-7#2)
of rupture of the##3##4##(1994-7#1)(1996-1#1)(2012-2#1)
of rupture of##7##3##(1991-6#1)(1994-7#1)(1996-1#1)(2008-7#2)(2011-2#1)(2012-2#1)
of rupture##13##2##(1991-6#1)(1994-1#1)(1994-7#1)(1996-1#1)(2008-7#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of ruptured intracranial aneurysms##2##4##(2006-7#1)(2008-7#1)
of ruptured##6##2##(1997-3#1)(2006-7#1)(2008-7#2)(2010-5#2)
of rural and urban##2##4##(1994-2#1)(2010-3#1)
of rural hospitals##2##3##(1992-12#1)(1993-2#1)
of rural##22##2##(1990-12#1)(1991-1#1)(1992-12#3)(1993-12#1)(1993-2#1)(1994-2#1)(1996-1#1)(1996-3#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2013-1#1)
of rust on leaves##2##4##(2008-10#2)
of rust on##3##3##(2008-10#3)
of rust##20##2##(2008-10#20)
of rusts##2##2##(2008-10#2)
of ruthenium and##3##3##(2008-10#3)
of ruthenium oxide materials##2##4##(2010-4#2)
of ruthenium##14##2##(2008-10#11)(2010-4#2)(2010-7#1)
of ruthenium(II)##2##2##(2008-10#2)
of rutile##3##2##(2008-3#3)
of rutin and##2##3##(2008-10#1)(2008-9#1)
of rutin in##4##3##(2008-10#4)
of rutin##13##2##(2008-10#12)(2008-9#1)
of ryanodine##4##2##(1990-2#2)(1992-3#1)(2010-11#1)
of rye##6##2##(2008-10#4)(2008-5#2)
of s and##2##3##(2008-3#2)
of s##5##2##(2008-10#1)(2008-11#1)(2008-3#3)
of s(x)##2##2##(2008-3#2)
of sICAM-1 in##2##3##(1993-8#2)
of sICAM-1##3##2##(1993-8#3)
of sIL-1R I##2##3##(2008-10#2)
of sIL-1R##4##2##(1995-2#2)(2008-10#2)
of sIL-6R##2##2##(1994-2#1)(1997-7#1)
of sIgA##2##2##(2008-5#1)(2011-1#1)
of saccades##2##2##(1991-5#1)(2009-2#1)
of saccharides##2##2##(1991-7#1)(2008-4#1)
of saccharin##2##2##(1995-12#1)(2008-5#1)
of sacroiliac joints in##2##4##(2011-2#2)
of safe abortion##2##3##(2011-1#1)(2011-2#1)
of safe and##3##3##(2008-12#1)(2008-8#1)(2010-10#1)
of safe sex##2##3##(1997-6#2)
of safe##14##2##(1995-1#1)(1997-6#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
of safety and##4##3##(1992-2#1)(1995-2#1)(2008-7#1)(2008-8#1)
of safety data##4##3##(2008-11#2)(2008-8#1)(2012-3#1)
of safety##24##2##(1992-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
of saffron##3##2##(2008-10#2)(2008-12#1)
of said##2##2##(2009-11#1)(2011-1#1)
of saikosaponin c##3##3##(2008-11#3)
of salbutamol in pharmaceutical products##2##5##(2008-10#2)
of salbutamol in pharmaceutical##3##4##(2008-10#3)
of salbutamol in##5##3##(2008-10#4)(2008-11#1)
of salbutamol with 4-aminoantipyrine##2##4##(2008-10#2)
of salbutamol##19##2##(1996-1#3)(1996-12#1)(1996-2#2)(2008-10#11)(2008-11#2)
of salicylaldehyde##2##2##(2008-10#2)
of salicylate in##3##3##(2008-10#3)
of salicylate##4##2##(1993-12#1)(2008-10#3)
of salicylic acid (SA)##3##4##(2008-10#3)
of salicylic acid and its derivatives##2##6##(1993-11#2)
of salicylic acid and its##3##5##(1993-11#3)
of salicylic acid in##3##4##(2008-10#3)
of salicylic acid##16##3##(1993-11#3)(2008-10#13)
of salicylic##17##2##(1993-11#3)(2008-10#14)
of saline (0##2##3##(1997-4#1)(2011-2#1)
of saline in the##2##4##(1993-10#1)(2008-9#1)
of saline or##3##3##(1993-12#1)(1994-2#1)(2008-10#1)
of saline##21##2##(1990-7#2)(1991-12#1)(1993-10#4)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-4#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
of salinity##5##2##(2008-12#1)(2008-2#1)(2008-3#2)(2013-7#1)
of saliva##5##2##(2008-11#1)(2009-6#2)(2010-5#1)(2012-3#1)
of salivary gland tumours##3##4##(2012-2#3)
of salivary gland##5##3##(1991-11#1)(2008-8#1)(2012-2#3)
of salivary glands##4##3##(2007-12#1)(2008-8#1)(2011-2#2)
of salivary##19##2##(1990-6#1)(1991-11#1)(1991-2#1)(2007-12#2)(2008-10#1)(2008-8#2)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
of salmeterol##2##2##(1996-2#2)
of salt and##3##3##(1997-8#1)(2008-8#1)(2012-2#1)
of salt concentration##2##3##(1990-7#1)(2009-12#1)
of salt stress##3##3##(2008-11#1)(2009-8#2)
of salt tolerant rice##2##4##(2008-12#2)
of salt##22##2##(1990-7#1)(1991-9#1)(1997-8#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2012-2#1)(2013-8#1)
of saltatory##2##2##(2008-12#1)(2010-8#1)
of salts##6##2##(2008-10#4)(2009-10#1)(2009-8#1)
of salvage##3##2##(2007-5#1)(2008-1#1)(2013-1#1)
of salvianolic##2##2##(2008-10#2)
of samarium##3##2##(2008-10#3)
of same age##2##3##(2008-10#1)(2008-7#1)
of same##5##2##(1993-3#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
of sample and eluent##3##4##(2008-10#3)
of sample and reagent##4##4##(2008-10#4)
of sample and reagents##5##4##(2008-10#4)(2010-7#1)
of sample and##21##3##(2008-10#20)(2010-7#1)
of sample and/or standard solution containing##2##6##(2008-10#2)
of sample handling##2##3##(2008-10#2)
of sample is##4##3##(2008-10#4)
of sample matrix##5##3##(2008-10#5)
of sample or standard##2##4##(2008-10#2)
of sample or##3##3##(2008-10#3)
of sample preparation and##3##4##(2008-10#1)(2008-5#1)(2010-7#1)
of sample preparation methods##2##4##(2008-10#2)
of sample preparation##12##3##(1994-9#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)
of sample pretreatment##2##3##(2008-10#2)
of sample processing##2##3##(2008-10#1)(2008-11#1)
of sample size##2##3##(1994-9#1)(2012-3#1)
of sample solution and eluent##3##5##(2008-10#3)
of sample solution and##5##4##(2008-10#5)
of sample solution gave a##2##5##(2008-10#2)
of sample solution is##3##4##(2008-10#3)
of sample solution were##2##4##(2008-10#2)
of sample solution##26##3##(2008-10#25)(2013-8#1)
of sample solutions##2##3##(2008-10#2)
of sample to##3##3##(2008-10#3)
of sample treatment##2##3##(2008-10#2)
of sample types##3##3##(2008-10#2)(2008-3#1)
of sample volume##4##3##(2008-10#4)
of sample volume)##4##3##(2008-10#4)
of sample was used and the L(D) was approximately##2##9##(2008-10#2)
of sample was##4##3##(2008-10#4)
of sample with a##2##4##(2008-10#2)
of sample with##4##3##(2008-10#4)
of sample##177##2##(1994-2#1)(1994-3#1)(1994-9#3)(1995-1#1)(2007-12#2)(2008-10#143)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-3#3)(2013-1#1)(2013-8#2)
of sample)##2##2##(2008-10#2)
of sampled##2##2##(1992-1#1)(2008-10#1)
of samples and reagents##2##4##(2008-10#2)
of samples and the##3##4##(2008-10#2)(2008-7#1)
of samples and##10##3##(2008-10#8)(2008-7#2)
of samples are##3##3##(2008-10#2)(2011-2#1)
of samples by##5##3##(1996-12#1)(2008-10#3)(2008-3#1)
of samples collected in##2##4##(2011-2#2)
of samples collected##3##3##(2009-2#1)(2011-2#2)
of samples could be##2##4##(2008-10#2)
of samples for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
of samples from##6##3##(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)
of samples have##2##3##(2008-10#1)(2009-4#1)
of samples having##2##3##(2007-12#1)(2008-10#1)
of samples in a##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
of samples in##9##3##(2008-10#3)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#2)(2012-2#1)
of samples into##2##3##(2008-10#1)(2008-9#1)
of samples is##3##3##(2008-10#3)
of samples of##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
of samples that##2##3##(2008-10#2)
of samples was##7##3##(2008-10#7)
of samples were##4##3##(2008-10#3)(2008-12#1)
of samples with##14##3##(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#2)
of samples##170##2##(1991-9#1)(1992-12#1)(1992-3#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#102)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#1)(2008-7#3)(2008-9#7)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
of samples)##3##2##(2008-10#2)(2008-4#1)
of sampling design##2##3##(2008-10#1)(2013-7#1)
of sampling points##3##3##(2008-10#1)(2008-3#2)
of sampling techniques##2##3##(2008-10#2)
of sampling the##3##3##(1991-5#1)(2008-3#1)(2008-5#1)
of sampling units##5##3##(2008-10#4)(2011-2#1)
of sampling##45##2##(1991-5#1)(1992-12#1)(1994-11#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-3#5)(2008-5#2)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-7#2)
of samplings##2##2##(2008-10#2)
of sanA##2##2##(2008-9#2)
of sand flies##3##3##(2008-12#1)(2013-1#2)
of sand fly##2##3##(2008-12#1)(2012-2#1)
of sand##5##2##(2008-12#2)(2012-2#1)(2013-1#2)
of sandy soils##2##3##(2008-10#1)(2013-7#1)
of sandy##4##2##(2008-1#1)(2008-10#1)(2011-1#1)(2013-7#1)
of sanitary##2##2##(2007-6#1)(2008-8#1)
of saphenous vein graft##3##4##(2007-8#3)
of saphenous##4##2##(1996-5#1)(2007-8#3)
of saplings in the##2##4##(2008-5#1)(2008-9#1)
of saplings##5##2##(2008-5#3)(2008-9#1)(2012-9#1)
of saponins##6##2##(1997-4#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-7#1)(2013-8#1)
of sapphire##2##2##(2008-3#2)
of sapstain##3##2##(2008-10#3)
of sarafotoxin##2##2##(1992-12#1)(1994-11#1)
of sarcoidosis##8##2##(1997-5#1)(2007-6#1)(2008-1#1)(2008-4#2)(2012-12#1)(2012-3#1)(2013-7#1)
of sarcoma arising in##2##4##(2008-6#1)(2013-7#1)
of sarcoma##7##2##(2008-6#4)(2008-7#1)(2011-2#1)(2013-7#1)
of sarcomas##3##2##(2008-6#2)(2013-1#1)
of sarcomatous##2##2##(1993-6#1)(2008-6#1)
of sarcoplasmic reticulum##3##3##(1990-2#1)(1994-11#1)(1997-7#1)
of sarcoplasmic##4##2##(1990-2#1)(1994-11#1)(1997-7#1)(2010-4#1)
of satRNA##2##2##(2008-10#2)
of satRNAs##2##2##(2008-10#2)
of satellite DNA##2##3##(2008-10#1)(2010-8#1)
of satellite cells##4##3##(1993-3#1)(2008-7#1)(2009-3#2)
of satellite imagery over mountainous terrain##2##6##(2008-2#2)
of satellite images##2##3##(2008-2#2)
of satellite tobacco mosaic virus (STMV)##2##6##(2008-10#1)(2008-9#1)
of satellite tobacco mosaic virus##3##5##(2008-10#2)(2008-9#1)
of satellite##24##2##(1993-3#1)(2008-10#5)(2008-2#7)(2008-3#5)(2008-7#1)(2008-9#1)(2009-3#3)(2010-8#1)
of satisfaction with the##4##4##(1990-10#1)(1993-12#1)(2008-11#1)(2013-8#1)
of satisfaction with##7##3##(1990-10#1)(1993-12#1)(1996-3#1)(2007-6#1)(2008-11#1)(2012-2#1)(2013-8#1)
of satisfaction##12##2##(1990-10#1)(1992-1#1)(1992-2#1)(1993-12#1)(1995-12#1)(1996-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
of satisfactory##2##2##(1992-11#1)(2012-2#1)
of saturable##2##2##(1993-1#1)(2007-12#1)
of saturated fatty acids##6##4##(1990-2#2)(1992-8#2)(2008-11#1)(2008-12#1)
of saturated##13##2##(1990-2#3)(1990-7#1)(1992-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)
of saturating pump intensities minimizes the##2##6##(2008-3#2)
of saturating##5##2##(1995-11#1)(1997-2#1)(2008-3#2)(2008-8#1)
of saturation and##2##3##(1995-12#1)(2008-3#1)
of saturation in##2##3##(2008-3#1)(2010-10#1)
of saturation##19##2##(1990-8#1)(1995-12#1)(1995-3#1)(2007-12#2)(2008-2#2)(2008-3#6)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
of saudi arabia##3##3##(2008-1#3)
of sauna bathing##3##3##(2008-7#3)
of sauropsids##2##2##(2010-3#2)
of savings##2##2##(1991-1#1)(1995-2#1)
of saw##2##2##(2008-12#1)(2008-8#1)
of sawdust##2##2##(2008-9#1)(2013-1#1)
of scab on##2##3##(2008-10#2)
of scab##10##2##(2008-10#10)
of scabies##4##2##(1996-12#1)(2010-2#1)(2010-6#2)
of scaffold##2##2##(2010-9#1)(2012-2#1)
of scalar diffraction##3##3##(2008-3#3)
of scalar##5##2##(2007-12#1)(2008-3#4)
of scale##16##2##(1991-2#1)(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
of scaled##3##2##(2008-2#2)(2012-3#1)
of scales##8##2##(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#3)
of scaling##11##2##(1993-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#6)(2008-8#1)
of scalp##2##2##(1992-4#1)(2007-7#1)
of scandium(III) and yttrium(III)##3##4##(2008-10#3)
of scanning calorimetry##2##3##(1993-11#1)(1997-2#1)
of scanning electron microscopy##2##4##(2007-12#1)(2008-10#1)
of scanning electron##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
of scanning##16##2##(1993-11#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-3#6)(2008-6#1)(2008-7#2)
of scaphoid##3##2##(2007-11#2)(2008-9#1)
of scar tissue##2##3##(1997-3#1)(2013-7#1)
of scar##4##2##(1997-3#1)(2008-9#2)(2013-7#1)
of scarce##3##2##(2008-7#1)(2010-12#1)(2012-12#1)
of scarcity##2##2##(2008-12#1)(2011-2#1)
of scarring##4##2##(1991-12#1)(2008-4#2)(2013-1#1)
of scattered light is##3##4##(2008-3#3)
of scattered light were##2##4##(2007-12#1)(2008-2#1)
of scattered light##14##3##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)(2011-2#2)
of scattered radiation##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of scattered##21##2##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#10)(2011-2#2)(2013-1#1)
of scatterer##3##2##(2008-2#1)(2008-3#2)
of scatterers on the##2##4##(2008-3#2)
of scatterers##8##2##(2008-2#3)(2008-3#5)
of scattering and absorption##3##4##(2007-11#1)(2008-3#2)
of scattering and##10##3##(2007-11#1)(2008-2#3)(2008-3#6)
of scattering by##3##3##(2008-2#2)(2008-3#1)
of scattering centers in##2##4##(2008-2#1)(2008-3#1)
of scattering centers##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of scattering layers in the##2##5##(2008-3#2)
of scattering media##3##3##(2008-3#3)
of scattering on the##2##4##(2008-3#2)
of scattering on##3##3##(2008-3#3)
of scattering particles##2##3##(2007-12#1)(2008-3#1)
of scattering##55##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#10)(2008-3#36)(2008-7#1)(2010-7#1)
of scavenger##4##2##(1993-6#1)(1993-8#3)
of sceletal complications##2##3##(2007-11#2)
of scenarios##2##2##(2008-10#1)(2009-10#1)
of scene##2##2##(2008-3#1)(2012-2#1)
of schistosomal portal##2##3##(2013-8#2)
of schistosomiasis control##2##3##(2012-3#2)
of schistosomiasis in a national##3##5##(2012-3#3)
of schistosomiasis in a##4##4##(1996-8#1)(2012-3#3)
of schistosomiasis in##9##3##(1996-8#1)(2008-8#1)(2012-3#7)
of schistosomiasis japonica##2##3##(2012-3#2)
of schistosomiasis transmission in##2##4##(2012-3#2)
of schistosomiasis##25##2##(1996-12#2)(1996-8#1)(2008-8#4)(2012-3#18)
of schizophrenia and##8##3##(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2011-1#1)(2011-2#1)
of schizophrenia in##2##3##(1996-5#1)(2008-8#1)
of schizophrenia is##3##3##(1990-11#1)(1993-9#1)(2008-2#1)
of schizophrenia##47##2##(1990-11#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#2)(1996-7#2)(2007-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#2)(2010-1#2)(2011-1#8)(2011-2#4)(2012-12#2)(2012-2#1)
of schizophrenic patients##2##3##(2012-1#1)(2013-1#1)
of schizophrenic##5##2##(2007-1#2)(2008-11#1)(2012-1#1)(2013-1#1)
of scholarly##3##2##(2010-12#1)(2010-4#1)(2012-12#1)
of school children##2##3##(2008-7#1)(2012-2#1)
of school engagement##2##3##(2009-7#2)
of school readiness##2##3##(2008-11#1)(2008-12#1)
of school##24##2##(1991-6#1)(1993-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#1)(2008-9#1)(2009-7#5)(2010-1#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
of school-age##3##2##(1991-2#2)(1993-12#1)
of school-aged children##2##3##(2008-9#1)(2010-5#1)
of school-based##5##2##(1995-12#1)(2008-9#1)(2009-6#2)(2009-7#1)
of schoolchildren##2##2##(1990-3#2)
of schooling##2##2##(2011-1#1)(2013-1#1)
of schools##3##2##(1992-6#1)(2008-12#1)(2008-9#1)
of schwannoma##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
of schwannomas##2##2##(2009-3#1)(2013-1#1)
of science and##4##3##(1994-12#1)(2007-5#1)(2008-11#1)(2009-4#1)
of science##23##2##(1991-6#1)(1994-12#1)(1995-11#2)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#1)
of sciences##2##2##(1997-3#1)(1997-4#1)
of scientific and##3##3##(1995-1#1)(1997-7#1)(2010-11#1)
of scientific data##2##3##(1991-5#1)(2008-7#1)
of scientific discovery##2##3##(2012-2#2)
of scientific evidence##2##3##(2008-2#1)(2008-7#1)
of scientific information##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
of scientific interest##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
of scientific knowledge##4##3##(2009-5#1)(2010-1#1)(2011-2#2)
of scientific literature##2##3##(2008-11#1)(2013-1#1)
of scientific medicine##2##3##(1997-6#1)(2009-11#1)
of scientific publications##2##3##(1992-6#1)(2012-12#1)
of scientific##43##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1993-2#2)(1995-1#1)(1995-12#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
of scientifically##2##2##(2008-6#1)(2011-2#1)
of scientists and##2##3##(2009-11#1)(2012-12#1)
of scientists##12##2##(1990-2#1)(1993-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
of scimitar syndrome##2##3##(2007-8#2)
of scintigraphic##3##2##(2011-2#1)(2013-1#2)
of scirtids##2##2##(2008-12#2)
of sclerites and the##2##4##(2008-7#1)(2013-1#1)
of sclerites##4##2##(2008-7#2)(2013-1#2)
of scleroderma##4##2##(1992-8#1)(1993-9#1)(2006-10#1)(2008-10#1)
of sclerotia and the##2##4##(2008-10#2)
of sclerotia and##4##3##(2008-10#4)
of sclerotia in##3##3##(2008-10#3)
of sclerotia produced##2##3##(2008-10#2)
of sclerotia##30##2##(2008-10#30)
of sclerotial size##2##3##(2008-10#2)
of sclerotial##5##2##(2008-10#5)
of sclerotinia stem rot of##2##5##(2008-10#2)
of sclerotised##2##2##(2007-12#2)
of scoliosis##7##2##(2007-11#1)(2007-8#2)(2008-11#3)(2012-2#1)
of scope##4##2##(1997-1#2)(2012-12#2)
of scopolamine and its##2##4##(2008-10#2)
of scopolamine on##2##3##(1992-11#1)(1994-8#1)
of scopolamine##8##2##(1992-11#2)(1994-8#1)(2007-5#1)(2008-10#4)
of score##3##2##(2013-1#3)
of scores##4##2##(2008-10#2)(2011-1#2)
of screen-detected cancer cases##2##4##(1995-12#2)
of screen-detected##3##2##(1991-6#1)(1995-12#2)
of screen-printed##2##2##(2008-10#2)
of screening and##5##3##(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#2)
of screening for prostatic cancer##2##5##(1991-7#2)
of screening for##11##3##(1990-6#2)(1991-7#2)(1993-3#1)(1994-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
of screening mammography##2##3##(2007-4#1)(2008-10#1)
of screening methods##2##3##(2008-10#1)(2008-12#1)
of screening tests##2##3##(2008-11#2)
of screening##53##2##(1990-2#1)(1990-6#2)(1991-7#2)(1992-10#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-12#2)(1996-12#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
of screw##3##2##(2007-11#1)(2008-8#1)(2009-3#1)
of screws##2##2##(2007-11#1)(2012-12#1)
of scrutiny##2##2##(1992-12#1)(2013-1#1)
of scs1/lcb2 mutant cells##2##4##(1997-3#2)
of sea urchin sperm flagella##2##5##(1991-2#2)
of sea urchin##6##3##(1991-2#2)(1997-4#1)(2008-6#1)(2009-7#1)(2012-2#1)
of sea urchins##2##3##(1994-11#1)(1997-4#1)
of sea water##5##3##(2007-10#1)(2008-10#4)
of sea##14##2##(1991-2#2)(1994-11#1)(1997-4#2)(2007-10#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#1)
of seafarers##2##2##(2011-2#2)
of seafood##4##2##(2008-2#1)(2010-9#1)(2012-1#1)(2013-7#1)
of seagrass##2##2##(2007-5#2)
of search##5##2##(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#2)
of searching##7##2##(1994-3#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#2)
of season##2##2##(1995-11#1)(2008-5#1)
of seasonal##9##2##(2007-11#1)(2008-12#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
of seasonality##2##2##(2008-9#1)(2011-2#1)
of seatbelts##2##2##(1997-6#1)(2008-10#1)
of seawater is##2##3##(2008-3#2)
of seawater samples##3##3##(2008-10#3)
of seawater##23##2##(2008-10#14)(2008-2#3)(2008-3#6)
of sebaceous glands##2##3##(2008-5#1)(2009-2#1)
of sebaceous##5##2##(2008-5#2)(2008-8#1)(2009-2#1)(2012-3#1)
of seborrheic keratosis##2##3##(2007-8#1)(2011-2#1)
of seborrheic##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
of sebum##4##2##(2008-5#4)
of second and third##2##4##(1993-1#1)(2007-11#1)
of second and##3##3##(1993-1#1)(2007-11#1)(2011-1#1)
of second generation##3##3##(1990-2#1)(1997-3#1)(2013-1#1)
of second group##2##3##(2012-3#2)
of second harmonic##3##3##(2007-12#1)(2008-10#1)(2009-7#1)
of second messengers##3##3##(1991-3#1)(2009-8#1)(2013-1#1)
of second##27##2##(1990-2#1)(1991-3#1)(1993-1#1)(1993-3#1)(1993-8#1)(1995-11#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
of second-generation##4##2##(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
of second-harmonic generation (SHG) in##2##5##(2007-12#1)(2008-3#1)
of second-harmonic generation (SHG)##4##4##(2007-12#2)(2008-3#2)
of second-harmonic generation##12##3##(2007-11#2)(2007-12#7)(2008-3#3)
of second-harmonic##17##2##(2007-11#3)(2007-12#11)(2008-3#3)
of second-order##6##2##(1997-7#1)(2007-11#3)(2007-12#1)(2008-3#1)
of secondarily##2##2##(2008-9#1)(2010-6#1)
of secondary and tertiary##2##4##(1994-5#1)(1995-5#1)
of secondary conidia##3##3##(2008-10#3)
of secondary hyperparathyroidism##2##3##(1991-11#1)(1991-8#1)
of secondary inoculum##2##3##(2008-10#2)
of secondary prevention##3##3##(1993-3#1)(2011-3#1)(2013-1#1)
of secondary products##2##3##(2008-10#1)(2008-11#1)
of secondary school##2##3##(2008-10#1)(2013-8#1)
of secondary sporidia##2##3##(2008-10#2)
of secondary structural elements##2##4##(1993-11#1)(1995-5#1)
of secondary structure##5##3##(1990-4#1)(1990-5#1)(1995-2#1)(2008-4#1)(2011-2#1)
of secondary structures##3##3##(1990-5#1)(1991-2#1)(1995-8#1)
of secondary##90##2##(1990-12#2)(1990-4#1)(1990-5#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-5#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
of seconds at##2##3##(1994-5#1)(2008-10#1)
of seconds##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
of secreted human##2##3##(1997-2#1)(1997-4#1)
of secreted protein##2##3##(1997-4#1)(2008-10#1)
of secreted proteins##2##3##(1995-8#1)(1997-3#1)
of secreted uPA-IgG##2##3##(1997-4#2)
of secreted##16##2##(1992-9#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-4#4)(2008-10#2)(2008-11#2)(2008-4#1)(2009-6#1)
of secretion of##5##3##(1992-3#2)(2008-11#2)(2008-6#1)
of secretion##12##2##(1990-8#1)(1991-5#1)(1992-3#2)(1997-4#1)(2007-12#1)(2008-11#3)(2008-6#1)(2008-7#1)(2010-11#1)
of secretions##2##2##(1997-1#2)
of secretory cells##3##3##(1993-11#1)(2007-12#1)(2008-7#1)
of secretory granule##3##3##(2010-11#3)
of secretory proteins##3##3##(1991-5#1)(1994-2#1)(1994-8#1)
of secretory vesicles##2##3##(2008-11#2)
of secretory##20##2##(1990-12#1)(1991-5#1)(1993-11#1)(1994-2#1)(1994-8#1)(1997-6#1)(2007-12#3)(2008-11#3)(2008-5#1)(2008-7#2)(2010-11#4)(2012-1#1)
of sections##3##2##(1995-6#1)(2007-11#2)
of sectors##2##2##(1994-9#1)(2012-12#1)
of securing##3##2##(2007-8#1)(2010-7#1)(2011-1#1)
of security##5##2##(1991-3#1)(1992-12#1)(2007-12#1)(2008-2#1)(2013-1#1)
of sedation and##3##3##(2008-8#2)(2010-4#1)
of sedation##7##2##(2007-11#1)(2008-8#5)(2010-4#1)
of sedative##2##2##(2008-8#2)
of sediment samples##2##3##(2008-10#2)
of sediment##7##2##(2008-10#4)(2008-5#1)(2012-1#2)
of sedimentation of##2##3##(1990-12#1)(2008-1#1)
of sedimentation##4##2##(1990-12#1)(2008-1#1)(2008-7#2)
of sediments and##2##3##(2008-5#2)
of sediments##6##2##(2007-5#1)(2008-10#3)(2008-5#2)
of seed coat##2##3##(2013-8#2)
of seed development##2##3##(2008-12#2)
of seed dispersal##2##3##(2008-12#1)(2008-9#1)
of seed extract##3##3##(2012-2#3)
of seed infection##5##3##(2008-10#5)
of seed meal##2##3##(2008-10#2)
of seed plant##2##3##(2008-8#2)
of seed predators##3##3##(2008-5#1)(2013-1#2)
of seed##47##2##(2008-10#19)(2008-12#7)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-6#1)(2012-2#3)(2013-1#4)(2013-8#3)
of seed-transmitted endophytes##2##3##(2008-8#2)
of seed-transmitted##3##2##(2008-10#1)(2008-8#2)
of seedborne##4##2##(2008-10#4)
of seeded atomic Rb##2##4##(2008-2#2)
of seeded##3##2##(2008-2#2)(2008-3#1)
of seeding of##2##3##(2008-10#1)(2008-6#1)
of seeding##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2011-2#2)
of seedling##4##2##(2008-10#3)(2008-12#1)
of seedlings##11##2##(2008-10#10)(2008-9#1)
of seeds from##2##3##(2008-5#1)(2012-3#1)
of seeds of##6##3##(2008-10#2)(2008-12#2)(2008-8#1)(2013-7#1)
of seeds or##2##3##(2008-10#1)(2008-9#1)
of seeds##26##2##(2008-10#4)(2008-12#7)(2008-5#4)(2008-8#3)(2008-9#4)(2009-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
of seeing##3##2##(1997-3#1)(2008-3#1)(2013-7#1)
of seeking##4##2##(2008-7#1)(2010-10#1)(2011-1#1)(2012-12#1)
of segment##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
of segmental##4##2##(1995-5#1)(2008-1#1)(2012-2#1)(2012-3#1)
of segmentation##5##2##(1991-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
of segmented composite filtering##2##4##(2008-3#2)
of segmented##5##2##(2008-3#3)(2008-6#1)(2009-6#1)
of segments of the##2##4##(2008-10#1)(2008-3#1)
of segments of##3##3##(2008-10#2)(2008-3#1)
of segments##5##2##(1992-5#1)(2008-10#3)(2008-3#1)
of segregating##2##2##(2008-10#2)
of segregation##5##2##(2008-10#4)(2011-2#1)
of seismic##2##2##(1996-4#2)
of seismicity in##2##3##(1996-4#2)
of seismicity##7##2##(1996-4#7)
of seizure activity##2##3##(1990-5#1)(1997-3#1)
of seizure##8##2##(1990-5#1)(1997-3#2)(2008-8#1)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
of seizures in##2##3##(2008-11#1)(2008-8#1)
of seizures##10##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#2)(2011-1#2)(2013-1#1)
of select metals##2##3##(2008-10#2)
of select##8##2##(1996-2#1)(2008-10#3)(2008-11#1)(2009-11#1)(2010-10#1)(2013-1#1)
of selectable##2##2##(1991-6#1)(2008-10#1)
of selected PCBs##2##3##(2008-11#2)
of selected biological##3##3##(2007-8#2)(2009-7#1)
of selected clinical##2##3##(2012-3#1)(2013-1#1)
of selected findings##2##3##(1990-8#1)(1994-12#1)
of selected patients##2##3##(1990-6#1)(2008-8#1)
of selected##84##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-4#3)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#4)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#3)
of selectin##2##2##(1993-8#1)(2008-3#1)
of selecting and##2##3##(2008-7#1)(2010-8#1)
of selecting##9##2##(1995-12#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-1#1)(2010-8#1)
of selection and##7##3##(2008-1#1)(2008-4#1)(2008-8#4)(2012-3#1)
of selection bias##3##3##(1997-5#2)(2007-10#1)
of selection for resistance##3##4##(2008-10#3)
of selection for##6##3##(1997-4#1)(2008-10#3)(2008-2#1)(2008-8#1)
of selection in##2##3##(1995-2#1)(2012-3#1)
of selection of##3##3##(1990-8#1)(2008-10#1)(2011-3#1)
of selection on##6##3##(2008-8#4)(2008-9#2)
of selection##60##2##(1990-8#1)(1992-2#1)(1995-2#2)(1997-4#1)(1997-5#2)(2007-10#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#21)(2008-9#4)(2009-8#1)(2010-4#2)(2011-3#1)(2012-3#3)(2013-1#2)
of selective and nonselective media##2##5##(2008-12#2)
of selective and nonselective##3##4##(2008-10#1)(2008-12#2)
of selective axonal hypotrophy##2##4##(1996-5#2)
of selective brain cooling on the expression of##2##8##(2010-1#2)
of selective serotonin reuptake inhibitors (SSRIs)##2##6##(2008-11#1)(2008-6#1)
of selective serotonin reuptake inhibitors##5##5##(1997-8#3)(2008-11#1)(2008-6#1)
of selective serotonin reuptake##6##4##(1997-8#3)(2008-11#1)(2008-3#1)(2008-6#1)
of selective##44##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1995-11#1)(1995-12#2)(1996-5#2)(1996-6#1)(1997-8#3)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#2)(2011-1#1)(2011-2#3)(2012-2#1)
of selectively##4##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-5#1)
of selectivity and##5##3##(2008-10#4)(2008-5#1)
of selectivity coefficients of##2##4##(2008-10#2)
of selectivity coefficients##4##3##(2008-10#4)
of selectivity for##2##3##(2008-10#2)
of selectivity in##2##3##(1990-5#1)(2008-10#1)
of selectivity##21##2##(1990-5#1)(1997-1#2)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
of selenite (Se(IV))##2##3##(2008-10#2)
of selenite##11##2##(1993-12#2)(2008-10#9)
of selenium (IV) in##2##4##(2008-10#2)
of selenium (IV)##4##3##(2008-10#4)
of selenium and##2##3##(2008-10#2)
of selenium by##2##3##(2008-10#2)
of selenium in the##3##4##(2008-10#2)(2012-2#1)
of selenium in water and##2##5##(2008-10#2)
of selenium in water##3##4##(2008-10#3)
of selenium in##19##3##(1992-11#1)(2008-10#17)(2012-2#1)
of selenium is##5##3##(2008-10#5)
of selenium species##3##3##(2008-10#3)
of selenium##57##2##(1992-11#1)(2008-10#47)(2008-6#2)(2010-11#1)(2012-2#2)(2013-1#1)(2013-8#3)
of selenium(IV) and molybdenum(VI)##2##4##(2008-10#2)
of selenium(IV) and##7##3##(2008-10#7)
of selenium(IV)##13##2##(2008-10#13)
of selenium-containing##2##2##(2008-10#1)(2008-8#1)
of selenium-deficient##3##2##(1990-12#1)(1992-11#2)
of selenoamino acids in##2##4##(2008-10#2)
of selenoamino acids##3##3##(2008-10#3)
of selenoprotein mRNA##2##3##(2012-2#2)
of selenoprotein##4##2##(2012-2#4)
of selenospecies##3##2##(2008-10#3)
of self and others##2##4##(2008-11#1)(2008-12#1)
of self and##5##3##(2008-11#3)(2008-12#1)(2008-9#1)
of self monitoring##3##3##(2008-10#3)
of self##23##2##(1993-12#1)(1997-4#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-8#1)
of self-assembled monolayers (SAMs)##2##4##(2008-10#1)(2010-4#1)
of self-assembled monolayers##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
of self-assembled##7##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#2)(2010-4#1)
of self-assembly of##2##3##(2008-3#1)(2013-8#1)
of self-assembly##3##2##(2008-3#1)(2008-7#1)(2013-8#1)
of self-awareness##2##2##(2008-1#1)(2013-1#1)
of self-care##2##2##(2008-12#1)(2010-2#1)
of self-control##4##2##(2008-12#3)(2011-1#1)
of self-defense##2##2##(2008-10#2)
of self-diffraction##2##2##(2007-11#1)(2007-12#1)
of self-directed work teams##3##4##(1993-12#3)
of self-directed##4##2##(1993-12#3)(1996-2#1)
of self-efficacy##2##2##(2011-1#1)(2012-3#1)
of self-esteem##4##2##(2009-5#3)(2013-1#1)
of self-fertilization##3##2##(2008-8#1)(2008-9#2)
of self-help groups in##2##4##(1996-3#1)(2008-4#1)
of self-help groups##4##3##(1996-3#2)(2008-4#2)
of self-help##7##2##(1994-1#1)(1996-3#4)(2008-4#2)
of self-improvement##2##2##(1997-1#1)(2007-12#1)
of self-injurious behavior##2##3##(2009-10#1)(2012-2#1)
of self-management##2##2##(1993-12#1)(2012-12#1)
of self-monitoring of blood glucose (SMBG)##2##6##(2008-8#1)(2009-11#1)
of self-monitoring##4##2##(2008-11#2)(2008-8#1)(2009-11#1)
of self-organization in the##2##4##(2008-3#1)(2008-8#1)
of self-organization in##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
of self-organization##5##2##(1996-4#1)(2008-3#1)(2008-8#1)(2008-9#2)
of self-phase modulation and##2##4##(2007-11#1)(2007-12#1)
of self-phase modulation##3##3##(2007-11#2)(2007-12#1)
of self-pumped phase conjugation##2##4##(2008-2#2)
of self-pumped phase##3##3##(2008-2#3)
of self-reference##2##2##(2008-9#2)
of self-regulation##2##2##(2012-3#1)(2013-7#1)
of self-renewal and##3##3##(2009-3#1)(2013-1#2)
of self-renewal##6##2##(2008-11#1)(2009-12#1)(2009-3#1)(2013-1#3)
of self-repair##2##2##(2008-5#2)
of self-reported health status##3##4##(1992-9#1)(1995-12#1)(2008-10#1)
of self-reported health##4##3##(1992-9#1)(1993-1#1)(1995-12#1)(2008-10#1)
of self-reported##13##2##(1990-9#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
of self-serving##2##2##(2008-6#1)(2010-2#1)
of self-trapped##2##2##(2007-11#2)
of self-written waveguides##2##3##(2007-11#1)(2007-12#1)
of selfing##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
of selfishness##5##2##(2008-9#4)(2010-2#1)
of semantic and##2##3##(2008-2#1)(2009-2#1)
of semantic knowledge##3##3##(1996-7#1)(2007-8#1)(2009-2#1)
of semantic##8##2##(1996-7#2)(2007-8#1)(2008-2#1)(2009-2#3)(2012-2#1)
of semen##5##2##(2008-12#2)(2009-4#1)(2010-12#1)(2012-3#1)
of semi-structured interviews with##2##4##(2008-12#1)(2009-10#1)
of semi-structured interviews##3##3##(2008-12#1)(2009-10#1)(2009-12#1)
of semi-structured##6##2##(1995-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-12#1)(2013-1#1)
of semicarbazide and hydrazine##4##4##(2008-10#4)
of semicarbazide##6##2##(2008-10#6)
of semiconducting##2##2##(2008-10#1)(2010-12#1)
of semiconductor laser##2##3##(2007-12#2)
of semiconductor lasers##2##3##(2007-11#1)(2008-2#1)
of semiconductor##11##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-7#3)
of seminal fluid##2##3##(1997-8#1)(2011-2#1)
of seminal gamma-GTP##2##3##(1995-11#2)
of seminal##11##2##(1990-5#1)(1994-3#1)(1995-11#3)(1997-8#1)(2008-11#1)(2008-7#1)(2011-2#3)
of seminiferous tubules##2##3##(1995-6#1)(2013-8#1)
of seminiferous##3##2##(1990-9#1)(1995-6#1)(2013-8#1)
of semiselective##2##2##(2008-10#2)
of semisolid##2##2##(2008-10#1)(2008-5#1)
of semisynthetic penicillins##2##3##(2008-10#2)
of semisynthetic##4##2##(1993-8#1)(2008-10#2)(2009-12#1)
of senS##2##2##(1993-6#2)
of senescence and##2##3##(2008-8#1)(2010-2#1)
of senescence in##4##3##(1997-7#1)(2008-3#1)(2011-2#1)(2012-3#1)
of senescence##13##2##(1994-5#1)(1997-7#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-2#1)(2011-2#1)(2012-3#2)
of senescent##2##2##(1997-7#1)(2008-5#1)
of senile dementia in##2##4##(1991-9#2)
of senile dementia##3##3##(1991-9#2)(1994-5#1)
of senile plaques##3##3##(1992-12#1)(1993-3#1)(2008-7#1)
of senile##7##2##(1991-9#2)(1992-12#1)(1993-3#1)(1994-5#1)(2008-7#1)(2011-2#1)
of senior management##2##3##(1993-1#1)(1995-3#1)
of senior##13##2##(1992-3#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#2)(1995-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-7#1)
of sensation##2##2##(1990-3#1)(1990-5#1)
of sense and antisenseabp transgenic tobacco##2##6##(2008-8#2)
of sense of##2##3##(2008-7#1)(2013-1#1)
of sense##4##2##(2008-7#1)(2008-8#2)(2013-1#1)
of sensilla basiconica##2##3##(2007-12#2)
of sensilla##3##2##(2007-12#3)
of sensing molecules##2##3##(2008-10#1)(2013-8#1)
of sensing##10##2##(2008-10#4)(2008-3#2)(2008-9#1)(2009-2#1)(2010-6#1)(2013-8#1)
of sensitisation##3##2##(1990-11#1)(1996-1#1)(2008-7#1)
of sensitive and##2##3##(2008-10#1)(2008-6#1)
of sensitive detection of##2##4##(2008-10#1)(2012-2#1)
of sensitive skin##3##3##(2008-5#3)
of sensitive##12##2##(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-8#1)(2012-2#1)
of sensitivities##4##2##(1994-12#1)(2008-10#3)
of sensitivity and reproducibility##2##4##(2008-10#1)(2008-4#1)
of sensitivity and selectivity##4##4##(2008-10#4)
of sensitivity and specificity##3##4##(1993-3#1)(1996-8#1)(2011-2#1)
of sensitivity and##15##3##(1992-2#1)(1993-3#1)(1996-8#1)(1997-3#1)(2008-10#8)(2008-4#2)(2011-2#1)
of sensitivity for the##2##4##(2008-10#2)
of sensitivity for##6##3##(1996-5#1)(1996-8#1)(2008-10#4)
of sensitivity in the##2##4##(2008-3#1)(2009-9#1)
of sensitivity in##4##3##(1991-12#1)(2008-10#1)(2008-3#1)(2009-9#1)
of sensitivity of the##3##4##(1997-1#1)(2008-10#1)(2010-10#1)
of sensitivity of##7##3##(1993-9#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
of sensitivity to the##3##4##(1992-8#1)(2007-11#1)(2008-10#1)
of sensitivity to##14##3##(1990-12#2)(1990-5#1)(1992-8#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-5#1)(2013-1#1)
of sensitivity was##2##3##(2008-10#2)
of sensitivity##73##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-9#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#38)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-1#1)
of sensitization##6##2##(1993-6#1)(1993-8#1)(2008-10#3)(2009-8#1)
of sensitizing##2##2##(2008-10#1)(2008-11#1)
of sensor and##2##3##(2008-2#1)(2012-3#1)
of sensor errors##6##3##(2009-9#6)
of sensor response##2##3##(2008-10#1)(2008-7#1)
of sensor##21##2##(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#7)(2012-3#1)
of sensorimotor reflexes##2##3##(1992-12#2)
of sensors and##3##3##(2008-10#2)(2012-2#1)
of sensors are##2##3##(2008-10#2)
of sensors that##2##3##(2007-12#1)(2008-10#1)
of sensors##15##2##(2007-12#1)(2008-10#12)(2009-6#1)(2012-2#1)
of sensory and##2##3##(2007-12#1)(2008-10#1)
of sensory axons##2##3##(1995-2#1)(2013-1#1)
of sensory cells##3##3##(2007-12#2)(2011-2#1)
of sensory input##2##3##(1996-5#1)(2009-12#1)
of sensory nerves##2##3##(1992-6#2)
of sensory neurons##2##3##(1993-12#1)(2008-7#1)
of sensory processing##2##3##(2009-12#1)(2013-8#1)
of sensory stimulation##2##3##(1993-12#1)(2008-11#1)
of sensory stimuli##2##3##(2013-1#2)
of sensory##38##2##(1990-11#3)(1992-6#2)(1993-12#6)(1995-2#1)(1996-5#1)(2007-12#5)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#3)(2009-8#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
of sentence##4##2##(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of sentinel lymph node##2##4##(2011-2#1)(2013-8#1)
of sentinel node biopsy##2##4##(2007-12#1)(2010-7#1)
of sentinel node##3##3##(2007-12#1)(2010-7#1)(2010-8#1)
of sentinel##6##2##(2007-12#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
of separate##15##2##(1990-7#1)(1992-1#1)(1994-1#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)
of separated##3##2##(1996-5#1)(2008-10#2)
of separating##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
of separation and##2##3##(2008-10#2)
of separation as##2##3##(1996-5#1)(2008-10#1)
of separation of##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
of separation##20##2##(1993-1#1)(1996-5#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2013-7#1)
of sepsis in##2##3##(2007-5#1)(2011-2#1)
of sepsis management are##2##4##(2011-2#2)
of sepsis management##3##3##(2011-2#3)
of sepsis##20##2##(1991-3#2)(2007-12#1)(2007-5#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-3#1)(2013-8#1)
of septal##2##2##(1993-12#1)(2008-11#1)
of septic arthritis caused by L##2##6##(2006-10#2)
of septic arthritis##4##3##(2006-10#2)(2010-12#1)(2013-8#1)
of septic shock##7##3##(1994-8#1)(1996-3#1)(2008-1#1)(2009-8#1)(2011-2#3)
of septic##15##2##(1994-8#1)(1996-3#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-8#1)
of sequence analysis##3##3##(1995-8#1)(2008-2#1)(2008-4#1)
of sequence conservation between##2##4##(2008-7#1)(2012-3#1)
of sequence data##4##3##(1997-2#1)(2008-7#2)(2010-6#1)
of sequence divergence##3##3##(2008-10#3)
of sequence homology##3##3##(1993-3#1)(1995-8#1)(2008-10#1)
of sequence identity with##2##4##(1994-12#1)(1995-11#1)
of sequence identity##3##3##(1992-8#1)(1994-12#1)(1995-11#1)
of sequence information##2##3##(1995-8#1)(2008-4#1)
of sequence similarity to##2##4##(1992-11#1)(1994-8#1)
of sequence similarity##8##3##(1990-12#1)(1992-11#1)(1994-8#1)(2008-4#3)(2008-9#1)(2009-5#1)
of sequence variants##7##3##(2008-10#5)(2008-4#2)
of sequence##58##2##(1990-12#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-8#1)(1995-11#2)(1995-6#1)(1995-8#3)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#2)(2008-10#11)(2008-2#1)(2008-4#9)(2008-7#5)(2008-9#1)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
of sequence-specific##4##2##(1992-3#1)(1992-8#1)(2008-4#2)
of sequenced##4##2##(1997-6#1)(2008-7#2)(2009-6#1)
of sequences and##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
of sequences from##2##3##(1996-12#1)(2008-10#1)
of sequences of the##2##4##(2008-10#2)
of sequences of##5##3##(1991-2#1)(2008-10#3)(2008-7#1)
of sequences##25##2##(1991-2#1)(1994-12#1)(1996-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
of sequencing targets##2##3##(2008-10#2)
of sequencing##4##2##(1996-10#1)(2008-10#2)(2011-1#1)
of sequential injection analysis##5##4##(2008-10#5)
of sequential injection systems##2##4##(2008-10#2)
of sequential injection with##2##4##(2008-10#2)
of sequential injection##10##3##(2008-10#10)
of sequential##24##2##(1990-11#1)(1990-6#1)(1991-9#1)(1994-9#1)(1996-11#1)(2007-5#1)(2008-10#16)(2008-5#1)(2012-2#1)
of sequentially implanted children##2##4##(2012-2#2)
of sequentially##4##2##(1992-9#1)(1997-6#1)(2012-2#2)
of sequestered##2##2##(1990-5#1)(1994-8#1)
of sequestering##2##2##(2008-10#1)(2008-11#1)
of sera from##2##3##(1994-11#1)(2008-11#1)
of sera##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
of serial##12##2##(1990-5#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#2)(2009-3#1)(2010-1#1)(2013-1#2)
of sericin##3##2##(2008-11#3)
of serine and##3##3##(2008-10#2)(2008-4#1)
of serine proteases##6##3##(1991-6#1)(1995-2#1)(1995-5#1)(2008-4#2)(2008-9#1)
of serine proteinases##6##3##(1991-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(2012-3#2)
of serine##31##2##(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#3)(1994-8#1)(1995-2#1)(1995-5#1)(1997-1#2)(1997-7#1)(2008-10#5)(2008-4#3)(2008-9#1)(2012-3#2)
of serine-143##2##2##(1994-5#2)
of serine/threonine kinases##2##3##(1993-3#1)(1995-2#1)
of serine/threonine protein kinases##3##4##(1993-6#1)(1994-9#1)(1995-6#1)
of serine/threonine##6##2##(1993-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(2009-9#1)
of serious adverse##2##3##(2008-8#1)(2013-8#1)
of serious complications##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
of serious hypoglycemia##2##3##(1994-6#2)
of serious illness##2##3##(1995-3#1)(2008-11#1)
of serious side effects##4##4##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
of serious##40##2##(1992-11#1)(1992-2#2)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of serogroup##5##2##(2007-12#1)(2008-10#2)(2009-5#1)(2011-2#1)
of serogroups of Neisseria meningitidis##2##5##(2007-12#2)
of serological and##2##3##(1995-12#1)(2008-10#1)
of serological markers##2##3##(2008-12#1)(2008-5#1)
of serological tests##2##3##(1997-3#1)(2011-2#1)
of serological##7##2##(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
of serologically##2##2##(1997-6#1)(2012-2#1)
of seropositive dogs##2##3##(2011-2#2)
of seropositive##4##2##(2007-7#1)(2011-2#2)(2012-3#1)
of seropositivity was##2##3##(1996-3#1)(2007-7#1)
of seropositivity##4##2##(1991-11#2)(1996-3#1)(2007-7#1)
of serotonergic##9##2##(1992-11#1)(1992-3#1)(1993-3#1)(1996-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
of serotonin (5-HT)##5##3##(1992-1#1)(1993-12#1)(1993-3#1)(2008-6#1)(2008-8#1)
of serotonin (5-hydroxytryptamine##4##3##(1995-12#2)(1996-7#1)(2012-12#1)
of serotonin transport##2##3##(1996-12#2)
of serotonin##27##2##(1990-5#2)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#2)(1995-11#1)(1995-12#6)(1996-12#2)(1996-7#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2012-12#1)(2012-3#3)
of serotypes 1##3##3##(1996-12#2)(1997-6#1)
of serotypes##4##2##(1996-12#3)(1997-6#1)
of serous##6##2##(1992-2#1)(2008-12#1)(2012-2#4)
of serrated polyps##2##3##(2009-12#2)
of serrated##3##2##(2009-12#3)
of serum IgG##2##3##(2011-1#1)(2012-12#1)
of serum albumin in the##2##5##(2008-7#2)
of serum albumin##6##3##(1995-12#2)(2008-10#1)(2008-7#2)(2011-2#1)
of serum amylase##2##3##(1993-12#1)(2012-2#1)
of serum and##10##3##(1990-2#1)(1992-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-7#1)(2008-11#3)(2011-1#1)
of serum antibodies##2##3##(2008-10#1)(2008-4#1)
of serum antibody to##2##4##(1991-12#1)(1995-5#1)
of serum cholesterol was##2##4##(1991-6#1)(2008-10#1)
of serum cholesterol##5##3##(1991-6#2)(1992-6#1)(2008-10#1)(2013-8#1)
of serum cortisol##2##3##(2011-2#2)
of serum creatinine##2##3##(1990-12#1)(1994-12#1)
of serum ferritin##3##3##(1996-3#1)(2008-10#1)(2009-8#1)
of serum free thyroxine##2##4##(2008-6#1)(2012-3#1)
of serum from##2##3##(1995-2#1)(2008-10#1)
of serum growth factors##2##4##(1992-12#1)(1994-11#1)
of serum in the##3##4##(1991-5#1)(2008-1#1)(2008-11#1)
of serum in##6##3##(1991-5#1)(1992-3#1)(2008-1#1)(2008-11#3)
of serum lipid##2##3##(2008-9#1)(2011-2#1)
of serum magnesium##2##3##(2011-2#2)
of serum markers##2##3##(1991-12#1)(1993-2#1)
of serum proteins in##2##4##(1992-6#1)(1996-6#1)
of serum proteins##7##3##(1991-12#1)(1992-6#2)(1993-9#1)(1996-6#1)(1997-5#1)(2013-8#1)
of serum sickness##2##3##(1997-8#2)
of serum sodium concentration##2##4##(2010-1#2)
of serum total##2##3##(1995-12#1)(2012-12#1)
of serum triglycerides##2##3##(1992-6#2)
of serum was##2##3##(1995-12#1)(2008-10#1)
of serum were##2##3##(2008-7#2)
of serum##174##2##(1990-11#1)(1990-12#3)(1990-2#5)(1990-6#2)(1990-8#1)(1991-12#8)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-11#3)(1992-12#1)(1992-3#3)(1992-6#6)(1992-8#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-7#2)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#3)(1996-2#4)(1996-3#1)(1996-6#2)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#11)(2008-11#19)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-1#5)(2010-12#3)(2010-2#1)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
of serum-derived##2##2##(1990-7#1)(2008-11#1)
of serum-free media##2##3##(2008-11#2)
of serum-free produced##2##3##(2008-11#2)
of serum-free##7##2##(1992-11#1)(2008-11#5)(2012-12#1)
of service among##3##3##(1995-2#1)(2012-3#2)
of service and##4##3##(1992-3#1)(1994-3#1)(1995-3#1)(1997-1#1)
of service delivery##6##3##(1992-12#2)(1994-2#2)(1995-1#1)(2011-1#1)
of service needs##2##3##(2013-8#2)
of service providers##4##3##(1993-1#1)(1995-1#1)(2012-3#2)
of service provision##2##3##(1996-1#1)(1996-3#1)
of service quality##5##3##(1993-12#2)(1994-2#1)(1995-2#1)(1997-3#1)
of service user##2##3##(2008-12#2)
of service users and##2##4##(2008-11#1)(2009-6#1)
of service users##5##3##(2008-11#1)(2008-12#2)(2009-6#2)
of service##79##2##(1992-12#2)(1992-3#1)(1993-1#2)(1993-12#2)(1994-1#2)(1994-2#6)(1994-3#1)(1995-1#4)(1995-2#2)(1995-3#3)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#4)(1997-1#1)(1997-3#2)(2006-5#1)(2007-9#1)(2008-11#1)(2008-12#4)(2008-3#2)(2009-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#12)
of services a##2##3##(1992-3#1)(1994-1#1)
of services and##6##3##(1991-2#1)(1993-2#1)(1993-3#1)(2008-1#1)(2010-6#1)(2012-2#1)
of services by##3##3##(1994-12#1)(1996-1#1)(2007-12#1)
of services for the##2##4##(1991-3#1)(1997-2#1)
of services for##3##3##(1991-3#1)(1995-3#1)(1997-2#1)
of services is##3##3##(1991-2#1)(1992-12#1)(2008-8#1)
of services offered##2##3##(1994-2#1)(1996-12#1)
of services provided##5##3##(1992-12#1)(1992-2#1)(1995-3#2)(2013-1#1)
of services required##2##3##(1997-3#1)(2009-6#1)
of services to##5##3##(1991-3#1)(1997-8#1)(2008-11#1)(2009-6#1)(2011-1#1)
of services were##2##3##(1996-1#1)(2012-2#1)
of services##88##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#3)(1992-12#4)(1992-2#3)(1992-3#1)(1993-2#2)(1993-3#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#4)(1996-1#6)(1996-12#1)(1996-2#6)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-8#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-8#1)(2009-6#2)(2010-6#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
of serving##2##2##(1994-12#1)(1996-8#1)
of sesquiterpene##2##2##(2008-8#2)
of sesquiterpenes##2##2##(2011-10#1)(2013-8#1)
of sessile##2##2##(1992-6#1)(2008-8#1)
of setae##3##2##(2007-12#1)(2013-1#2)
of setal##2##2##(2013-1#2)
of setting##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
of settings and##2##3##(1994-2#1)(2008-11#1)
of settings##6##2##(1994-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
of settlement##4##2##(2008-10#1)(2008-9#1)(2011-2#2)
of seven EST clones##2##4##(2008-10#2)
of seven cases##3##3##(1991-2#1)(1991-6#1)(2008-7#1)
of seven compounds in##2##4##(2011-1#1)(2012-3#1)
of seven different##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
of seven exons##2##3##(1991-9#1)(1997-2#1)
of seven field trials##2##4##(2008-10#2)
of seven patients with##3##4##(1993-3#1)(1995-4#1)(2008-7#1)
of seven patients##6##3##(1993-3#1)(1995-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-12#1)
of seven populations from##2##4##(2008-10#1)(2008-8#1)
of seven populations##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of seven replicates##5##3##(2008-10#5)
of seven##91##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#3)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#36)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
of several analytes##2##3##(2008-10#2)
of several attachment##2##3##(2012-5#2)
of several cellular proteins##2##4##(1990-12#1)(1992-8#1)
of several cellular##3##3##(1990-12#1)(1992-8#1)(2008-8#1)
of several clinical##4##3##(1994-12#1)(1996-3#1)(2008-5#1)(2011-1#1)
of several common##2##3##(1991-12#1)(2008-10#1)
of several commonly used##2##4##(2008-3#1)(2008-6#1)
of several components of##2##4##(2008-10#1)(2012-3#1)
of several components##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
of several compounds##3##3##(1995-8#1)(2008-10#2)
of several different##8##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)
of several distinct##2##3##(1996-4#1)(2008-10#1)
of several enzymes##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
of several experimental##3##3##(2008-10#3)
of several factors##5##3##(1990-8#1)(1992-3#1)(2008-10#1)(2008-4#1)(2009-5#1)
of several forms##2##3##(1991-3#1)(2010-11#1)
of several genes##4##3##(1991-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
of several human##6##3##(1990-2#1)(1990-5#1)(1997-8#1)(2008-11#1)(2008-8#2)
of several hundred##8##3##(1993-12#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-3#2)
of several important factors##4##4##(2008-10#4)
of several important##6##3##(2008-10#4)(2008-11#1)(2008-7#1)
of several ions##2##3##(2008-10#2)
of several key##2##3##(1997-2#1)(2008-5#1)
of several kinds of##4##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
of several known##2##3##(2008-10#1)(2013-1#1)
of several mammalian##2##3##(2008-10#1)(2008-11#1)
of several mechanisms##2##3##(2008-10#1)(2008-8#1)
of several members of##3##4##(1992-3#1)(1997-7#1)(2008-11#1)
of several metals##2##3##(2008-10#2)
of several mixtures##3##3##(2008-10#3)
of several natural##2##3##(1995-3#1)(2008-10#1)
of several of the##3##4##(1996-2#1)(2012-2#1)(2012-3#1)
of several of these##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
of several of##9##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#2)(2012-3#2)
of several oncogenic##2##3##(1995-2#1)(2012-12#1)
of several orders of##2##4##(2008-10#1)(2008-3#1)
of several organs##3##3##(2008-10#1)(2010-10#1)(2010-11#1)
of several other##2##3##(1993-2#1)(2008-10#1)
of several parameters##2##3##(2008-10#2)
of several protein##2##3##(1994-5#1)(2008-11#1)
of several proteins##2##3##(1993-11#1)(2008-10#1)
of several recent studies##2##4##(2008-3#1)(2009-5#1)
of several recent##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)
of several species##3##3##(2008-10#2)(2009-5#1)
of several strains of##2##4##(2008-10#1)(2008-9#1)
of several substances##3##3##(2008-10#2)(2010-5#1)
of several surfactants##2##3##(1996-1#1)(2008-10#1)
of several techniques##4##3##(1992-12#1)(2008-3#1)(2008-4#1)(2009-9#1)
of several tens of##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
of several thousand##2##3##(2008-2#1)(2008-3#1)
of several trace##2##3##(2008-10#1)(2008-2#1)
of several transcription##2##3##(1996-5#1)(2011-1#1)
of several tumour suppressor genes##2##5##(2008-7#2)
of several types of##8##4##(1990-6#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)
of several variables##6##3##(1995-3#1)(2008-10#4)(2009-8#1)
of several varieties of##2##4##(2008-10#1)(2011-2#1)
of several weeks##2##3##(1993-3#1)(2008-10#1)
of several##460##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#5)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#6)(2007-12#10)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#143)(2008-11#21)(2008-12#3)(2008-2#8)(2008-3#25)(2008-4#10)(2008-5#8)(2008-6#5)(2008-7#15)(2008-8#12)(2008-9#8)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#8)(2012-5#2)(2013-1#5)(2013-8#2)
of severe and##2##3##(1996-11#1)(2012-12#1)
of severe complications##2##3##(2011-2#2)
of severe disease##2##3##(2006-6#1)(2011-2#1)
of severe head injury##2##4##(2008-7#1)(2013-8#1)
of severe headache##2##3##(1992-2#1)(2008-7#1)
of severe human##2##3##(2008-4#1)(2008-8#1)
of severe hypotension##2##3##(1990-8#1)(2013-1#1)
of severe pulmonary##3##3##(2008-10#1)(2008-11#2)
of severe respiratory distress syndrome##2##5##(1992-2#1)(1994-6#1)
of severe sepsis and##2##4##(2007-12#1)(2011-2#1)
of severe sepsis##6##3##(2007-12#4)(2011-2#1)(2012-2#1)
of severe##129##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#3)(1992-5#1)(1993-10#2)(1994-6#1)(1995-5#2)(1996-11#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#4)
of severely##3##2##(1995-1#1)(2008-10#1)(2013-1#1)
of severity of##7##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
of severity##19##2##(1992-3#1)(1994-1#1)(1994-12#2)(1994-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
of sewage sludge disposal##2##4##(1997-4#2)
of sewage sludge##10##3##(1997-4#7)(2007-12#1)(2008-11#1)(2008-12#1)
of sewage##12##2##(1997-4#7)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2013-1#1)
of sex allocation##2##3##(2008-8#1)(2008-9#1)
of sex and##7##3##(1990-2#1)(2007-11#1)(2007-7#1)(2008-5#2)(2009-9#1)(2010-2#1)
of sex chromosomal##3##3##(1990-3#1)(2013-1#2)
of sex chromosome evolution##3##4##(2010-5#3)
of sex chromosome##6##3##(2008-12#1)(2010-3#1)(2010-5#3)(2012-3#1)
of sex chromosomes and##2##4##(2010-3#2)
of sex chromosomes##9##3##(2008-12#1)(2008-7#1)(2010-3#7)
of sex differences in##4##4##(1996-5#1)(2008-4#1)(2008-8#1)(2008-9#1)
of sex education##2##3##(1990-9#1)(1993-8#1)
of sex hormones##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
of sex in##2##3##(1997-7#1)(2008-10#1)
of sex is##2##3##(1997-7#1)(2009-2#1)
of sex pheromone##3##3##(2008-10#3)
of sex steroids in##2##4##(1995-12#1)(2011-1#1)
of sex steroids on##2##4##(1993-5#1)(1997-6#1)
of sex steroids##7##3##(1990-11#1)(1993-5#1)(1995-12#1)(1997-6#1)(2009-6#1)(2009-7#1)(2011-1#1)
of sex##81##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#3)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-3#11)(2010-5#3)(2010-6#1)(2011-1#4)(2012-3#5)(2013-1#5)
of sex-determining##3##2##(2010-3#2)(2010-5#1)
of sex-linked##2##2##(2012-3#2)
of sex-specific##3##2##(2008-11#1)(2010-6#2)
of sexting##3##2##(2013-1#3)
of sexual abuse##12##3##(1992-2#1)(1996-11#2)(2009-9#4)(2010-10#3)(2010-4#1)(2012-1#1)
of sexual and reproductive health##2##5##(1996-12#1)(2012-12#1)
of sexual and##4##3##(1996-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
of sexual assault##3##3##(2008-12#2)(2009-5#1)
of sexual behavior and##2##4##(2008-4#1)(2011-2#1)
of sexual behavior##6##3##(1992-12#1)(2008-4#1)(2011-2#3)(2012-1#1)
of sexual development##2##3##(2008-5#1)(2011-2#1)
of sexual dimorphism in##3##4##(1995-6#1)(2008-8#1)(2012-3#1)
of sexual dimorphism##5##3##(1995-6#1)(2008-8#3)(2012-3#1)
of sexual dysfunction##2##3##(2008-6#1)(2012-3#1)
of sexual function##2##3##(2008-1#1)(2012-1#1)
of sexual maturity##2##3##(2008-5#1)(2013-7#1)
of sexual minority##2##3##(2008-12#2)
of sexual recombination##6##3##(2008-10#6)
of sexual reproduction in##2##4##(2010-12#1)(2012-3#1)
of sexual reproduction of##2##4##(2008-10#2)
of sexual reproduction##12##3##(2008-10#4)(2008-9#2)(2009-5#1)(2010-12#1)(2012-3#3)(2013-1#1)
of sexual risk##4##3##(2008-4#1)(2009-8#2)(2011-2#1)
of sexual selection in##2##4##(1995-2#1)(2008-8#1)
of sexual selection on males##2##5##(2008-8#2)
of sexual selection on##3##4##(2008-8#3)
of sexual selection##19##3##(1995-2#2)(2008-5#1)(2008-8#10)(2008-9#2)(2009-9#1)(2012-3#2)(2013-1#1)
of sexual signalling##3##3##(2009-9#3)
of sexual##126##2##(1990-6#1)(1990-9#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#2)(2007-5#1)(2008-1#1)(2008-10#13)(2008-12#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#17)(2008-9#10)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#8)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#10)(2013-1#4)(2013-7#2)
of sexuality##5##2##(1996-9#1)(1997-7#2)(2008-1#1)(2009-5#1)
of sexually abused children##3##4##(2008-2#2)(2010-10#1)
of sexually abused##4##3##(1990-11#1)(2008-2#2)(2010-10#1)
of sexually selected traits##3##4##(2008-9#1)(2012-3#2)
of sexually transmitted disease##2##4##(1996-12#1)(2008-4#1)
of sexually transmitted diseases##4##4##(1994-3#1)(1996-6#1)(1997-3#1)(2009-12#1)
of sexually transmitted infections##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
of sexually transmitted##12##3##(1994-3#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(2008-4#1)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
of sexually##27##2##(1990-11#1)(1993-5#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of sgcD##2##2##(2008-9#2)
of sgk##3##2##(2008-8#3)
of shadows##2##2##(2008-3#1)(2008-6#1)
of shaft##2##2##(2007-11#1)(2011-2#1)
of shallow##2##2##(2008-10#1)(2008-2#1)
of shallow-water bathymetry##2##3##(2008-2#1)(2008-3#1)
of shallow-water##3##2##(2007-5#1)(2008-2#1)(2008-3#1)
of sham##2##2##(1995-11#1)(2013-1#1)
of sham-operated##2##2##(1994-8#1)(2008-5#1)
of shame##3##2##(1997-7#1)(2008-1#2)
of shampoo##8##2##(2008-10#1)(2008-5#7)
of shampooing##2##2##(2008-10#1)(2008-5#1)
of shape##5##2##(2008-3#1)(2008-6#1)(2008-7#2)(2009-4#1)
of shapes##4##2##(2008-6#2)(2009-10#1)(2009-8#1)
of shared##9##2##(1992-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
of shareholders##2##2##(1994-1#1)(2007-3#1)
of sharing in##2##3##(1995-3#1)(2012-12#1)
of sharing##5##2##(1995-3#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-12#1)
of sharp##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
of shaving on axillary##2##4##(2008-5#2)
of shaving on##3##3##(2008-5#3)
of shaving##6##2##(2008-5#6)
of shear for##2##3##(1997-6#1)(2011-2#1)
of shear in##2##3##(2011-2#2)
of shear stress on##3##4##(1993-11#1)(2008-11#1)(2009-12#1)
of shear stress##5##3##(1993-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-1#1)
of shear##10##2##(1993-11#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-1#1)(2011-2#3)
of sheath blight##4##3##(2008-10#4)
of sheath##5##2##(2008-10#5)
of shedding of revertant virus##2##5##(1995-5#2)
of shedding##5##2##(1995-5#2)(2012-3#1)(2013-8#2)
of sheep and goats##2##4##(2008-12#1)(2011-2#1)
of sheep liver##2##3##(2008-5#2)
of sheep meat##2##3##(2010-4#1)(2013-1#1)
of sheep##17##2##(1991-8#1)(1996-12#2)(1997-5#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of shell##3##2##(2010-4#1)(2011-2#2)
of shellfish##3##2##(1997-4#2)(2013-7#1)
of shift of tumor position##2##5##(2009-11#2)
of shift work on##2##4##(2010-7#2)
of shift work##4##3##(2010-7#3)(2011-2#1)
of shift##7##2##(2007-12#1)(2009-11#2)(2010-7#3)(2011-2#1)
of shifting##3##2##(1992-2#1)(2008-3#2)
of shifts in##2##3##(2008-9#1)(2012-6#1)
of shiga toxin##3##3##(2008-8#3)
of shikonin##2##2##(1994-11#2)
of shock and##2##3##(2009-8#1)(2013-1#1)
of shock waves##2##3##(1994-5#2)
of shock##7##2##(1992-5#1)(1994-5#2)(2007-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
of shoot##3##2##(2008-10#1)(2013-1#2)
of shoots and roots##3##4##(2008-10#2)(2008-12#1)
of shoots and##4##3##(2008-10#3)(2008-12#1)
of shoots##9##2##(2008-10#7)(2008-12#2)
of shorebirds##3##2##(2013-7#3)
of short DNA fragments##2##4##(2008-10#1)(2012-3#1)
of short DNA##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
of short and long##2##4##(2008-11#1)(2012-12#1)
of short bowel syndrome##3##4##(1991-12#1)(1993-5#1)(2008-10#1)
of short bowel##4##3##(1991-12#1)(1993-5#1)(2008-10#2)
of short duration and##2##4##(2008-11#1)(2008-9#1)
of short duration##4##3##(1990-2#1)(2007-7#1)(2008-11#1)(2008-9#1)
of short oligonucleotides##2##3##(2008-10#1)(2008-4#1)
of short protein coding regions##2##5##(1996-12#2)
of short pulses##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of short stature##6##3##(1993-6#1)(2011-1#1)(2012-2#2)(2013-1#2)
of short##69##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#3)(2007-11#2)(2007-12#6)(2007-7#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-9#2)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)
of short- and##3##3##(1991-11#1)(1995-8#1)(2008-10#1)
of short-##5##2##(1991-11#1)(1995-8#1)(2007-8#1)(2007-9#1)(2008-10#1)
of short-chain fatty##2##3##(2008-5#1)(2012-1#1)
of short-chain##7##2##(1990-12#1)(1990-8#1)(1991-5#1)(1995-5#1)(1995-6#1)(2008-5#1)(2012-1#1)
of short-distance##2##2##(2008-10#1)(2011-2#1)
of short-lived##4##2##(1992-12#2)(2008-10#1)(2009-9#1)
of short-pulse##3##2##(2007-11#3)
of short-stay hospital##2##3##(1991-1#1)(1991-3#1)
of short-term and##2##3##(2008-1#1)(2012-2#1)
of short-term efficacy of##2##4##(1991-2#1)(2011-2#1)
of short-term memory##3##3##(1992-11#1)(2007-8#2)
of short-term##26##2##(1990-6#1)(1991-2#1)(1992-11#1)(1992-9#2)(1993-9#1)(1994-11#1)(1995-12#3)(1995-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-7#1)
of short-wavelength##2##2##(2007-11#1)(2008-3#1)
of shortening the##2##3##(2007-8#1)(2012-12#1)
of shortening##5##2##(1993-9#1)(2007-8#3)(2012-12#1)
of shorter##4##2##(1995-2#1)(2008-10#1)(2008-7#2)
of shortness of breath##2##4##(2008-1#1)(2013-8#1)
of shot fabric##2##3##(2008-3#2)
of shot fabrics##3##3##(2008-3#3)
of shot##7##2##(2008-2#1)(2008-3#6)
of shoulder function##3##3##(2008-9#3)
of shoulder muscles##2##3##(2012-2#2)
of shoulder##15##2##(1997-8#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-8#1)(2008-9#4)(2010-7#1)(2012-2#2)
of showing##2##2##(2008-10#1)(2013-8#1)
of shrimps##2##2##(2008-8#1)(2013-7#1)
of sialic acid on the viscosity of canine tracheal mucin##2##10##(1994-11#2)
of sialic acid##6##3##(1990-5#1)(1992-12#1)(1994-11#2)(1995-12#1)(2008-11#1)
of sialic##7##2##(1990-5#1)(1992-12#1)(1994-11#2)(1995-12#1)(2008-11#2)
of sialolithiasis##3##2##(2008-10#1)(2011-2#2)
of sibling species##2##3##(2008-10#1)(2013-7#1)
of sibling##6##2##(2008-10#5)(2013-7#1)
of siblings about##2##3##(2010-9#2)
of siblings##4##2##(2008-8#1)(2010-9#2)(2013-1#1)
of siboglinids##2##2##(2009-8#2)
of sibutramine and citalopram##3##4##(2012-3#3)
of sick leave##2##3##(1991-8#1)(2008-7#1)
of sick##3##2##(1991-8#1)(1994-6#1)(2008-7#1)
of sickle cell##5##3##(1992-6#1)(2007-7#1)(2013-1#2)(2013-8#1)
of sickle##6##2##(1992-6#1)(1992-9#1)(2007-7#1)(2013-1#2)(2013-8#1)
of sickness##2##2##(1992-1#1)(1997-6#1)
of side effects and##2##4##(1997-1#1)(2008-6#1)
of side effects of##2##4##(1991-6#1)(2007-11#1)
of side effects##18##3##(1991-6#1)(1993-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-2#3)(2013-1#2)
of side population cells##2##4##(2010-6#2)
of side##23##2##(1991-6#1)(1993-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-11#1)(2010-6#2)(2011-2#3)(2013-1#2)(2013-8#1)
of side-chain##2##2##(1992-8#1)(1994-5#1)
of side-effects##4##2##(2008-5#1)(2011-2#3)
of siderophore##2##2##(2013-1#2)
of sieve##2##2##(2008-10#1)(2008-11#1)
of sight of their optics##2##5##(2008-2#1)(2008-3#1)
of sight of##3##3##(2008-2#1)(2008-3#2)
of sight##10##2##(2007-12#1)(2008-2#3)(2008-3#5)(2008-6#1)
of sight)##2##2##(1994-8#1)(2008-3#1)
of sigma##2##2##(1995-12#1)(1996-3#1)
of sigmoid colon##3##3##(2008-12#2)(2012-12#1)
of sigmoid##6##2##(2008-12#2)(2009-1#1)(2010-12#1)(2010-8#1)(2012-12#1)
of sign-out##2##2##(2011-1#2)
of signal and idler##3##4##(2007-12#2)(2008-2#1)
of signal generation##2##3##(2008-11#1)(2009-8#1)
of signal peptides##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
of signal processing##2##3##(2007-7#1)(2008-3#1)
of signal transduction and##3##4##(1997-2#1)(2008-11#2)
of signal transduction pathways##2##4##(2008-8#1)(2008-9#1)
of signal transduction##12##3##(1993-6#1)(1994-6#1)(1995-2#1)(1997-2#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
of signal##60##2##(1990-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#5)(2008-2#5)(2008-3#9)(2008-8#1)(2008-9#2)(2009-11#3)(2009-3#1)(2009-8#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-3#1)(2012-2#2)(2012-3#3)
of signal-to-noise ratio is##2##4##(2008-3#2)
of signal-to-noise ratio##4##3##(2007-12#1)(2008-3#3)
of signal-to-noise##7##2##(2007-12#1)(2008-10#2)(2008-3#3)(2008-8#1)
of signaling cascades##2##3##(2008-7#2)
of signaling events##2##3##(2008-4#1)(2011-2#1)
of signaling molecules##3##3##(2009-12#1)(2010-11#1)(2013-8#1)
of signaling pathways##8##3##(1994-12#1)(1995-6#1)(2008-1#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-8#1)
of signaling##26##2##(1994-12#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
of signalling events##2##3##(1997-7#1)(2008-1#1)
of signalling##10##2##(1996-2#1)(1997-7#1)(2008-1#1)(2009-7#1)(2009-9#2)(2011-2#1)(2012-12#3)
of signals from##4##3##(1995-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
of signals in##2##3##(1992-3#1)(2008-2#1)
of signals##17##2##(1992-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#4)(2008-9#1)(2010-8#1)(2012-12#1)
of signature chemicals##2##3##(2008-10#2)
of signature##3##2##(2008-10#2)(2013-1#1)
of signatures##2##2##(2008-10#1)(2008-7#1)
of significance for##2##3##(1990-11#1)(2010-9#1)
of significance in##2##3##(1994-8#1)(2008-5#1)
of significance to##3##3##(1992-2#1)(1996-5#1)(2008-8#1)
of significance##15##2##(1990-11#1)(1992-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-6#1)(2010-9#1)(2013-8#1)
of significant CAD##2##3##(2012-2#2)
of significant amounts of##4##4##(1990-5#1)(1993-11#1)(1996-5#1)(2008-7#1)
of significant association##2##3##(1997-4#1)(2008-10#1)
of significant differences##4##3##(2008-12#1)(2010-1#1)(2010-8#1)(2013-1#1)
of significant importance##2##3##(1994-9#1)(2008-10#1)
of significant potential##2##3##(1995-2#1)(2010-6#1)
of significant renal##2##3##(2008-10#1)(2011-2#1)
of significant##78##2##(1990-5#2)(1991-11#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
of significantly##6##2##(1991-12#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
of signs and symptoms##6##4##(2006-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
of signs of##4##3##(1995-3#1)(2009-8#1)(2013-1#2)
of signs##12##2##(1993-2#1)(1995-3#1)(2006-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#3)
of sildenafil citrate##4##3##(2008-10#4)
of silencing##4##2##(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of silent##9##2##(1995-11#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
of silica fume produced by zircon desilication##2##7##(2008-10#2)
of silica gel and##2##4##(2008-10#2)
of silica gel##11##3##(2008-10#11)
of silica gels##2##3##(2008-10#1)(2010-4#1)
of silica glass##2##3##(2007-11#1)(2007-12#1)
of silica in##2##3##(2008-10#2)
of silica modified with##2##4##(2008-10#2)
of silica nanospheres##2##3##(2008-10#2)
of silica surface##2##3##(2008-10#2)
of silica with##2##3##(2008-10#1)(2008-3#1)
of silica##48##2##(1997-2#1)(2007-11#4)(2007-12#2)(2008-10#30)(2008-2#2)(2008-3#1)(2008-5#1)(2009-7#2)(2009-8#1)(2010-4#2)(2010-7#2)
of silica-ERT phase##4##3##(2008-10#4)
of silica-ERT##5##2##(2008-10#5)
of silicate based##2##3##(2008-10#2)
of silicate##5##2##(2008-10#5)
of silicon (Si)##4##3##(2008-10#4)
of silicon and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of silicon by##2##3##(2008-10#2)
of silicon in##5##3##(2008-10#5)
of silicon nanowires##3##3##(2008-7#1)(2010-3#2)
of silicon on##2##3##(2008-10#1)(2008-9#1)
of silicon oxide##2##3##(2008-3#1)(2008-7#1)
of silicon photodiode##3##3##(2008-2#1)(2008-3#2)
of silicon##49##2##(1992-7#1)(2007-11#3)(2007-12#2)(2008-10#19)(2008-2#4)(2008-3#11)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#1)
of silicone##7##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-6#1)(2010-10#1)
of silicosis##2##2##(2009-12#1)(2012-2#1)
of siliquae##2##2##(2013-8#2)
of silk fibroin##2##3##(2012-8#2)
of silk##11##2##(2007-12#1)(2008-7#1)(2008-9#1)(2012-2#6)(2012-8#2)
of silkworm hemolymph on the expression of##2##7##(1997-8#2)
of silkworm##3##2##(1997-8#2)(2012-2#1)
of silkwormAttacus ricini##2##3##(2008-8#2)
of silver and##4##3##(1992-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
of silver in##7##3##(2008-10#7)
of silver ions onto##4##4##(2008-10#4)
of silver ions##8##3##(2008-10#8)
of silver nanoparticles##3##3##(2008-3#1)(2011-2#2)
of silver picrate##2##3##(2008-10#2)
of silver was##3##3##(2008-10#3)
of silver were##2##3##(2008-10#2)
of silver##61##2##(1992-12#3)(1992-8#1)(2007-12#2)(2008-10#39)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2011-2#4)(2012-2#1)(2013-1#2)
of silver(I)##8##2##(2008-10#8)
of simazine##2##2##(2008-10#1)(2008-2#1)
of simian virus 40##2##4##(1997-7#1)(2008-11#1)
of simian##4##2##(1995-2#1)(1997-7#1)(2008-11#1)(2012-12#1)
of similar ages##2##3##(1996-7#1)(2008-5#1)
of similar cases##2##3##(2008-12#1)(2012-12#1)
of similar magnitude##3##3##(1992-8#1)(1997-4#1)(2008-10#1)
of similar mass##2##3##(2008-8#1)(2008-9#1)
of similar size and##2##4##(1996-3#1)(2008-10#1)
of similar size##9##3##(1993-12#1)(1994-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-2#1)
of similar structure##5##3##(2008-10#4)(2012-3#1)
of similar##74##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
of similarities##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
of similarity among##2##3##(2008-10#2)
of similarity between##3##3##(1993-2#1)(2008-10#1)(2010-5#1)
of similarity factor##2##3##(2010-3#2)
of similarity to##4##3##(1992-12#1)(1992-8#1)(1995-12#1)(2008-10#1)
of similarity##28##2##(1992-12#1)(1992-8#1)(1993-2#2)(1993-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-10#9)(2008-4#4)(2008-8#1)(2010-3#2)(2010-5#1)(2012-2#1)(2013-8#1)
of similarly##2##2##(2008-3#1)(2008-7#1)
of simple and##2##3##(2012-1#1)(2012-2#1)
of simple bromophenols in##2##4##(2008-10#2)
of simple cells##4##3##(1996-2#1)(2008-11#1)(2008-8#2)
of simple methods##2##3##(2008-2#1)(2013-1#1)
of simple sequence repeats##2##4##(1996-8#1)(2008-7#1)
of simple##71##2##(1991-9#1)(1992-12#1)(1992-9#1)(1994-11#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-5#1)(2007-5#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#7)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of simple-cell receptive##2##3##(2008-8#2)
of simpler##2##2##(1992-6#1)(2009-4#1)
of simplicity and##3##3##(2008-10#2)(2008-3#1)
of simplicity##10##2##(2008-10#7)(2008-2#1)(2008-3#2)
of simplified##3##2##(1994-3#1)(1995-6#1)(2008-7#1)
of simplifying##2##2##(2008-5#1)(2011-2#1)
of simulated and experimental##2##4##(2008-2#1)(2008-3#1)
of simulated annealing##2##3##(2008-2#1)(2008-3#1)
of simulated microgravity on nitric oxide##2##6##(2008-9#2)
of simulated microgravity on##3##4##(2008-9#3)
of simulated microgravity##4##3##(2008-9#4)
of simulated##17##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#4)(2010-2#1)(2012-5#1)
of simulating##3##2##(1994-3#1)(2008-11#1)(2008-7#1)
of simulation and##2##3##(2008-3#2)
of simulation in##2##3##(2008-10#1)(2008-11#1)
of simulation results##2##3##(2008-3#2)
of simulation##17##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
of simulation-based##3##2##(2010-8#1)(2012-2#1)(2013-8#1)
of simulations of##3##3##(2008-3#3)
of simulations with##2##3##(2008-12#1)(2008-3#1)
of simulations##12##2##(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-9#1)
of simulators##2##2##(2011-2#2)
of simultaneous degradation of##2##4##(2008-10#1)(2008-7#1)
of simultaneous determination of##3##4##(2008-10#3)
of simultaneous measurement of##2##4##(2007-11#1)(2008-3#1)
of simultaneous measurements##2##3##(2008-3#2)
of simultaneous##34##2##(1994-9#1)(1995-5#2)(1996-3#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-3#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of simultaneously##8##2##(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
of simvastatin##5##2##(1991-12#1)(1991-6#1)(2008-12#3)
of single amino acid##2##4##(1991-8#1)(2008-10#1)
of single and multiple##3##4##(2007-10#1)(2008-2#1)(2011-1#1)
of single and##9##3##(1993-3#1)(1997-2#1)(2007-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
of single cell##2##3##(2007-11#1)(2008-8#1)
of single cells and##2##4##(1995-11#1)(2008-9#1)
of single cells from##2##4##(2008-2#1)(2009-2#1)
of single cells##11##3##(1995-11#1)(2008-2#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-2#1)
of single gene##2##3##(2008-8#1)(2012-3#1)
of single mandibular molars##2##4##(2013-1#2)
of single molecules##5##3##(2007-11#2)(2008-7#3)
of single neurons##3##3##(1995-6#1)(2007-8#1)(2009-5#1)
of single nucleotide polymorphism##2##4##(2008-7#1)(2011-1#1)
of single nucleotide polymorphisms##5##4##(2007-3#1)(2008-10#2)(2008-7#1)(2009-8#1)
of single nucleotide##7##3##(2007-3#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-1#1)
of single or##2##3##(2008-9#1)(2011-1#1)
of single strand conformation polymorphism##2##5##(1992-2#1)(2008-8#1)
of single strand##3##3##(1992-2#1)(1993-12#1)(2008-8#1)
of single versus multiple##3##4##(2008-10#3)
of single##131##2##(1990-2#2)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-7#2)(2007-10#1)(2007-11#8)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#4)(2009-12#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
of single-band##3##2##(2008-3#3)
of single-base##2##2##(2008-10#1)(2008-2#1)
of single-cell suspensions of##2##4##(2008-4#1)(2008-9#1)
of single-cell##3##2##(1997-4#1)(2008-4#1)(2008-9#1)
of single-chain variable##2##3##(2008-10#2)
of single-chain##5##2##(2008-10#3)(2008-4#2)
of single-channel##2##2##(1994-12#1)(2007-12#1)
of single-copy sequences##2##3##(2008-5#1)(2008-9#1)
of single-copy##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
of single-crystal##2##2##(2008-2#2)
of single-cycle terahertz pulses##2##4##(2007-12#2)
of single-cycle##3##2##(2007-12#3)
of single-dose##3##2##(1997-5#1)(2007-12#1)(2012-12#1)
of single-electron reduction##2##3##(1995-8#2)
of single-electron##3##2##(1995-8#2)(1996-5#1)
of single-frequency##8##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
of single-layer##2##2##(2007-12#1)(2008-3#1)
of single-mode fibers##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of single-mode optical fibers##2##4##(2008-3#2)
of single-mode optical##4##3##(2008-2#1)(2008-3#3)
of single-mode output##2##3##(2008-2#1)(2008-3#1)
of single-mode##26##2##(2007-11#4)(2007-12#4)(2008-2#7)(2008-3#10)(2008-7#1)
of single-nucleotide polymorphisms##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
of single-pass##2##2##(2007-12#1)(2008-2#1)
of single-photon and two-photon##2##4##(2008-3#2)
of single-photon##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of single-pulse##2##2##(2007-12#1)(2008-3#1)
of single-scattering##2##2##(2008-3#2)
of single-shot##6##2##(2007-11#1)(2008-3#4)(2011-1#1)
of single-spore##2##2##(2008-10#2)
of single-stranded DNA##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
of single-stranded##6##2##(1992-8#1)(1994-12#1)(2008-10#3)(2008-9#1)
of single-walled carbon nanotubes (SWNTs)##2##5##(2008-7#2)
of single-walled carbon nanotubes##6##4##(2008-10#2)(2008-7#4)
of singlet oxygen and##2##4##(2008-5#1)(2008-8#1)
of singlet oxygen formation##2##4##(1992-12#2)
of singlet oxygen##13##3##(1990-11#3)(1992-12#2)(2008-10#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-4#1)
of singly protonated##2##3##(1996-7#2)
of singly resonant##2##3##(2007-11#1)(2007-12#1)
of singly##8##2##(1993-11#1)(1996-7#3)(2007-11#1)(2007-12#1)(2008-2#1)(2009-12#1)
of singular##5##2##(1990-8#1)(2007-11#1)(2008-10#1)(2009-7#1)(2013-1#1)
of sinoatrial blocks##2##3##(1996-3#2)
of sinonasal symptoms##2##3##(2011-2#2)
of sinonasal##4##2##(2008-3#1)(2011-2#2)(2012-1#1)
of sinus rhythm##5##3##(2008-7#1)(2010-12#2)(2012-3#2)
of sinus##7##2##(2007-12#1)(2008-7#1)(2010-12#2)(2012-3#2)(2013-1#1)
of sinusitis##3##2##(1993-2#1)(2008-7#1)(2012-8#1)
of sinusoidal##8##2##(1995-2#1)(1996-5#1)(2006-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
of sirolimus##2##2##(2008-11#1)(2013-1#1)
of sister chromatid##3##3##(1992-9#1)(1997-7#2)
of sister##4##2##(1992-9#1)(1997-7#2)(2009-2#1)
of site##8##2##(1991-6#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#2)
of site-directed mutagenesis##2##3##(1990-7#1)(1993-8#1)
of site-directed##4##2##(1990-7#1)(1993-8#1)(1995-2#1)(2008-11#1)
of site-specific recombinases##2##3##(2008-11#2)
of site-specific##9##2##(1990-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-4#1)
of sites for##3##3##(1991-5#1)(1991-6#1)(1992-3#1)
of sites of##2##3##(1990-11#1)(1994-12#1)
of sites##15##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2012-5#1)
of situation##4##2##(1996-1#1)(1996-9#1)(2010-4#1)(2012-12#1)
of situational##2##2##(2008-12#1)(2009-7#1)
of situations##5##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
of six and##3##3##(1996-12#1)(2008-10#2)
of six cases##2##3##(1993-3#1)(2008-9#1)
of six chicken respiratory##2##4##(2013-8#2)
of six different##2##3##(2008-6#1)(2008-7#1)
of six months##9##3##(1990-12#1)(1990-5#2)(1997-4#1)(2007-7#1)(2008-4#1)(2008-6#1)(2013-1#1)(2013-8#1)
of six patients with##2##4##(2008-7#1)(2013-1#1)
of six patients##4##3##(1991-3#1)(1996-12#1)(2008-7#1)(2013-1#1)
of six phenols and related compounds##2##6##(2008-10#2)
of six phenothiazine derivatives##2##4##(2008-10#2)
of six prisms##2##3##(2008-3#2)
of six pyrethroids##2##3##(2008-10#2)
of six samples##3##3##(2008-10#3)
of six trials##2##3##(2008-10#1)(2008-3#1)
of six vineyards##2##3##(2008-10#2)
of six weeks##2##3##(2012-3#1)(2013-7#1)
of six years##3##3##(1991-2#1)(1993-1#1)(2007-7#1)
of six##163##2##(1990-12#1)(1990-5#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#3)(1993-6#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#6)(1997-7#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#46)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
of sixteen##2##2##(1996-5#1)(1997-2#1)
of sixty-seven##2##2##(1996-3#1)(2007-10#1)
of size 1##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
of size and shape##2##4##(2008-5#1)(2010-7#1)
of size and##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-8#1)
of size distribution##2##3##(2008-3#1)(2008-9#1)
of size exclusion chromatography##3##4##(2008-10#3)
of size inequality##2##3##(2008-8#2)
of size parameters##2##3##(2007-11#1)(2008-2#1)
of size variation##2##3##(2008-8#2)
of size##38##2##(1991-11#1)(1991-9#1)(1993-2#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#8)(2008-9#1)(2009-11#1)(2010-7#1)(2011-2#4)(2013-7#1)(2013-8#1)
of size-abundance relationships among free-living animals##2##6##(2008-9#2)
of size-exclusion chromatography##2##3##(2008-10#1)(2008-4#1)
of sizzled expression##2##3##(2012-12#2)
of sizzled##3##2##(2012-12#3)
of skeletal and##2##3##(2010-7#1)(2012-3#1)
of skeletal complications and##2##4##(2007-11#1)(2008-7#1)
of skeletal complications##3##3##(2007-11#2)(2008-7#1)
of skeletal disease##2##3##(2007-11#2)
of skeletal events##2##3##(2010-4#2)
of skeletal metastases##3##3##(2007-11#2)(2008-7#1)
of skeletal muscle##21##3##(1992-5#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-2#1)(1994-6#1)(2007-11#2)(2008-1#1)(2008-5#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
of skeletal muscles##4##3##(1995-12#1)(1995-2#1)(2012-1#2)
of skeletal myoblasts##2##3##(1993-12#1)(2009-9#1)
of skeletal##61##2##(1990-11#1)(1990-5#1)(1992-5#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-10#2)(2007-11#9)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
of skew rays through metal light pipes##2##7##(2008-3#2)
of skew##6##2##(2008-3#2)(2008-8#4)
of skill acquisition##3##3##(1994-2#1)(2011-1#2)
of skill in##2##3##(1992-11#1)(2008-11#1)
of skill##6##2##(1992-11#1)(1994-2#1)(2008-11#1)(2011-1#2)(2011-2#1)
of skilled attendance##2##3##(2011-1#2)
of skilled nursing##2##3##(1992-1#1)(1992-2#1)
of skilled##6##2##(1992-1#1)(1992-2#1)(2010-1#1)(2010-12#1)(2011-1#2)
of skills of##2##3##(2011-2#1)(2012-3#1)
of skills##10##2##(1990-12#1)(1994-12#2)(1996-3#1)(2007-12#1)(2008-11#2)(2011-2#1)(2012-12#1)(2012-3#1)
of skin ageing##3##3##(2008-5#3)
of skin aging##3##3##(2008-5#2)(2009-9#1)
of skin and##4##3##(1995-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
of skin barrier##2##3##(2008-5#2)
of skin cancer is##2##4##(2011-2#2)
of skin cancer##7##3##(1991-6#1)(1994-5#1)(2007-12#3)(2011-2#2)
of skin cancers and##2##4##(2007-12#1)(2011-2#1)
of skin cancers##5##3##(2007-12#2)(2008-5#1)(2011-2#2)
of skin care##2##3##(2008-5#2)
of skin cells##2##3##(2008-4#1)(2008-5#1)
of skin color##2##3##(2008-5#2)
of skin colour##2##3##(2008-5#2)
of skin damage##2##3##(2008-5#1)(2011-2#1)
of skin dryness##3##3##(2008-5#3)
of skin fibroblast##2##3##(1990-3#1)(2008-2#1)
of skin fibroblasts##8##3##(1990-3#3)(1993-9#1)(2008-2#1)(2008-5#2)(2008-7#1)
of skin hydration in##2##4##(2008-5#2)
of skin hydration##5##3##(2008-10#1)(2008-5#3)(2010-8#1)
of skin improvement##2##3##(2008-5#2)
of skin in##4##3##(1990-2#1)(1995-11#1)(1996-12#1)(2008-5#1)
of skin irritation##2##3##(2008-10#1)(2008-5#1)
of skin is##2##3##(2008-5#2)
of skin lesions at the site of application##3##8##(2008-9#3)
of skin lesions##8##3##(1990-6#1)(2008-9#4)(2010-6#1)(2012-2#1)(2012-3#1)
of skin markers##2##3##(2013-1#2)
of skin melanoma in##2##4##(1994-12#1)(2011-2#1)
of skin metastases in##2##4##(1991-6#2)
of skin physiology##2##3##(2008-5#2)
of skin sensitization##2##3##(2008-5#2)
of skin surface##3##3##(2008-5#2)(2010-8#1)
of skin tissue##2##3##(2009-11#1)(2013-8#1)
of skin to##3##3##(2008-5#2)(2010-8#1)
of skin tone##2##3##(2008-11#2)
of skin with##3##3##(1992-8#2)(2008-5#1)
of skin##170##2##(1990-2#1)(1990-3#4)(1990-6#1)(1991-6#3)(1991-8#1)(1992-8#3)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#82)(2008-6#1)(2008-7#4)(2008-9#6)(2009-11#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-2#8)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#3)
of skull base##2##3##(2006-12#1)(2013-7#1)
of skull##7##2##(2006-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of skylight polarization##3##3##(2008-2#3)
of skylight##8##2##(2008-2#6)(2008-3#2)
of slab##2##2##(2008-3#2)
of slash and##2##3##(2008-10#1)(2010-7#1)
of slaughtered pigs##2##3##(1991-8#1)(2011-2#1)
of sleep EEG##2##3##(2009-8#1)(2010-8#1)
of sleep and##3##3##(2009-8#1)(2013-1#2)
of sleep deprivation##2##3##(2011-2#1)(2013-1#1)
of sleep disorders##2##3##(1993-2#1)(2008-11#1)
of sleep in##2##3##(2010-12#1)(2013-1#1)
of sleep loss##2##3##(1995-12#1)(2013-1#1)
of sleep onset##2##3##(1990-5#1)(1996-7#1)
of sleep stages##2##3##(2010-8#2)
of sleep##32##2##(1990-5#1)(1993-2#1)(1994-8#1)(1995-12#2)(1996-7#1)(1997-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-8#3)(2011-2#1)(2012-12#3)(2013-1#5)
of sleep-related breathing disorders##3##4##(2007-12#3)
of slice##2##2##(1995-5#1)(1997-2#1)
of sliding##5##2##(1995-3#1)(1996-4#2)(2011-2#2)
of slight##2##2##(1996-6#1)(2008-11#1)
of slightly different##2##3##(2007-11#1)(2008-2#1)
of slightly##9##2##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#1)
of slip on##2##3##(1996-4#2)
of slip##5##2##(1996-4#5)
of slipped##2##2##(2008-8#2)
of slope##3##2##(2008-10#2)(2008-3#1)
of slow##13##2##(1991-3#1)(1992-3#1)(1993-8#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-7#1)
of slowly##3##2##(1992-9#1)(2008-7#1)(2012-3#1)
of sludge##6##2##(2008-11#1)(2008-12#4)(2008-5#1)
of slurries##2##2##(2008-10#2)
of slurry##4##2##(2008-10#4)
of small (&lt##5##3##(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
of small GTP-binding proteins##4##4##(1992-3#1)(1994-6#1)(1997-1#1)(2008-6#1)
of small GTP-binding##5##3##(1992-3#1)(1993-6#1)(1994-6#1)(1997-1#1)(2008-6#1)
of small RNA##2##3##(2008-2#1)(2010-5#1)
of small RNAs##4##3##(2008-2#2)(2009-3#2)
of small amounts of##8##4##(1990-5#1)(1993-6#1)(2008-10#5)(2008-8#1)
of small amounts##9##3##(1990-5#1)(1993-6#1)(1994-2#1)(2008-10#5)(2008-8#1)
of small amplitude##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of small and medium##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
of small and##4##3##(1993-12#1)(2006-10#1)(2008-10#1)(2012-12#1)
of small animal##2##3##(1996-12#1)(2009-8#1)
of small animals##2##3##(2010-12#1)(2010-7#1)
of small bowel disorders in##2##5##(2012-2#2)
of small bowel obstruction##2##4##(2008-12#2)
of small bowel##13##3##(1991-12#1)(1995-12#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-12#3)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
of small cell carcinoma##2##4##(1992-12#1)(2009-3#1)
of small cell lung cancer##2##5##(2009-1#2)
of small cell##5##3##(1992-12#1)(1997-4#1)(2009-1#2)(2009-3#1)
of small grains##2##3##(2008-10#2)
of small intestinal##5##3##(1996-6#1)(2008-5#1)(2012-2#1)(2013-1#2)
of small intestine in##2##4##(2007-2#1)(2007-8#1)
of small intestine##5##3##(1995-12#1)(1997-3#1)(2007-2#1)(2007-8#1)(2012-2#1)
of small lymphocytes and##2##4##(1991-8#1)(1997-6#1)
of small lymphocytes with##2##4##(1997-6#2)
of small lymphocytes##4##3##(1991-8#1)(1997-6#3)
of small molecule##3##3##(2008-10#1)(2010-3#1)(2013-8#1)
of small molecules##9##3##(1990-12#1)(2007-12#1)(2008-4#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-3#1)
of small particles##2##3##(2008-2#1)(2009-5#1)
of small peptides##2##3##(1990-11#1)(2008-4#1)
of small phosphorus-containing compounds by capillary electrophoresis##2##7##(2008-10#2)
of small quantities of##3##4##(2008-10#2)(2008-5#1)
of small scatterers##3##3##(2008-3#3)
of small solutes##4##3##(1993-11#2)(2011-2#2)
of small studies##2##3##(1995-12#1)(2008-6#1)
of small tissue##2##3##(2008-10#2)
of small to##2##3##(1990-8#1)(2008-10#1)
of small vesicles##2##3##(2007-12#2)
of small##205##2##(1990-11#2)(1990-12#2)(1990-5#4)(1990-6#1)(1990-8#2)(1991-12#1)(1991-6#3)(1991-8#3)(1992-12#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-6#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-8#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#7)(2008-3#21)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#4)(2009-1#3)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#1)
of small- and##2##3##(2006-10#1)(2008-9#1)
of small-bowel##2##2##(2008-12#1)(2013-1#1)
of small-diameter##3##2##(1991-2#2)(2008-10#1)
of small-molecule##4##2##(1997-4#1)(2010-11#1)(2010-12#1)(2010-4#1)
of small-scale##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
of smaller##15##2##(1995-3#1)(1996-4#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)
of smallpox in##4##3##(1993-12#1)(1993-6#3)
of smallpox##6##2##(1993-12#1)(1993-6#4)(1994-9#1)
of smart##4##2##(2008-8#3)(2009-7#1)
of smell##6##2##(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
of smells##2##2##(2012-2#2)
of smoke##5##2##(1991-4#1)(1992-5#1)(1996-12#3)
of smoke-dried meat##2##3##(1992-5#2)
of smokers among##2##3##(1991-4#2)
of smokers in##2##3##(2008-10#1)(2013-1#1)
of smokers##14##2##(1991-4#3)(1991-9#1)(1992-9#1)(1996-9#1)(2007-12#1)(2008-10#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
of smoking among women##2##4##(1991-11#2)
of smoking among##5##3##(1991-11#3)(1991-4#1)(2009-7#1)
of smoking and the##2##4##(1995-6#1)(2011-1#1)
of smoking and##6##3##(1992-6#1)(1995-6#1)(2009-5#1)(2011-1#1)(2013-1#2)
of smoking are##2##3##(2008-7#1)(2011-2#1)
of smoking cessation##6##3##(1995-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
of smoking during pregnancy##2##4##(1995-6#1)(1997-7#1)
of smoking habits##2##3##(1990-2#1)(1996-3#1)
of smoking in##4##3##(1991-9#1)(1995-6#1)(2007-8#1)(2008-10#1)
of smoking mothers##3##3##(1991-11#2)(1991-4#1)
of smoking on##4##3##(1990-6#1)(1995-6#1)(2007-10#1)(2012-3#1)
of smoking was##3##3##(1996-3#1)(2007-7#1)(2011-2#1)
of smoking were##4##3##(1996-3#1)(2010-11#1)(2010-2#2)
of smoking##66##2##(1990-2#1)(1990-6#2)(1991-1#1)(1991-11#5)(1991-12#1)(1991-4#2)(1991-9#2)(1992-3#1)(1992-6#1)(1994-6#2)(1995-3#1)(1995-6#5)(1996-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#2)(2009-7#1)(2010-11#2)(2010-2#5)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
of smooth faults##2##3##(1996-4#2)
of smooth muscle cell proliferation##2##5##(2008-10#1)(2008-7#1)
of smooth muscle cell##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
of smooth muscle cells##11##4##(1992-9#1)(1993-8#2)(1995-11#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-1#1)
of smooth muscle myosin light chain kinase##2##7##(1991-2#1)(1992-9#1)
of smooth muscle myosin##3##4##(1991-2#1)(1991-5#1)(1992-9#1)
of smooth muscle##27##3##(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#4)(1993-6#1)(1993-8#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2012-1#1)(2012-2#1)
of smooth##32##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#4)(1993-6#1)(1993-8#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2012-1#1)(2012-2#2)
of smoothing##3##2##(1994-11#1)(2008-10#2)
of smoothness##2##2##(2008-3#1)(2011-2#1)
of snail##4##2##(1995-5#1)(2008-12#1)(2008-8#1)(2012-3#1)
of snails##4##2##(2008-12#4)
of snake##6##2##(2008-12#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-3#1)
of snakes##2##2##(1996-12#1)(2012-2#1)
of snoring and mild##2##4##(2007-12#2)
of snoring##3##2##(2007-12#2)(2011-2#1)
of snow molds##2##3##(2008-10#2)
of snow##6##2##(1993-3#2)(2008-10#2)(2008-3#2)
of so many##2##3##(1992-2#1)(2008-7#1)
of so-called &quot##3##3##(1990-6#1)(1991-2#1)(1991-3#1)
of so-called##6##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1995-5#1)(2010-1#1)
of social and##8##3##(1991-1#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
of social behavior##4##3##(2008-11#1)(2008-8#1)(2009-4#1)(2010-3#1)
of social change on health##2##5##(2008-1#2)
of social cognition and##3##4##(2008-11#1)(2012-1#1)(2013-1#1)
of social cognition##5##3##(2008-11#3)(2012-1#1)(2013-1#1)
of social cohesion##2##3##(2008-7#1)(2012-1#1)
of social determinants##2##3##(2011-1#1)(2013-1#1)
of social dominance##3##3##(2008-11#1)(2008-8#1)(2010-1#1)
of social evolution##4##3##(2008-8#1)(2012-3#3)
of social factors##2##3##(2008-2#1)(2009-7#1)
of social functioning##2##3##(1996-1#2)
of social influence##2##3##(2010-2#1)(2012-2#1)
of social interaction##5##3##(1996-11#1)(2008-11#1)(2008-4#1)(2011-2#2)
of social interactions##5##3##(2008-12#1)(2008-8#2)(2010-8#1)(2012-3#1)
of social medicine]##2##3##(1996-11#2)
of social network##3##3##(2010-1#1)(2012-2#2)
of social phobia##8##3##(2008-4#5)(2010-2#3)
of social science research##2##4##(1995-2#1)(2008-12#1)
of social selection##2##3##(2008-8#1)(2012-3#1)
of social services##2##3##(1995-3#1)(2011-1#1)
of social spending##2##3##(2013-1#2)
of social support and##3##4##(1992-3#1)(2009-7#2)
of social support from##3##4##(2009-7#3)
of social support##19##3##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#4)(1996-3#1)(2007-4#1)(2008-12#1)(2009-10#1)(2009-5#2)(2009-7#6)
of social work##2##3##(2009-12#1)(2010-10#1)
of social##158##2##(1991-1#2)(1992-1#1)(1992-2#1)(1992-3#4)(1993-6#1)(1994-2#2)(1994-3#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#4)(1996-11#4)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#13)(2008-12#7)(2008-2#2)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#4)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-2#4)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#6)(2013-1#12)
of sociality in##2##3##(2008-8#2)
of sociality##7##2##(2008-8#5)(2013-1#2)
of socially##4##2##(2007-8#1)(2009-6#1)(2009-7#1)(2012-2#1)
of societal standards##2##3##(2007-12#2)
of societal##4##2##(2007-12#2)(2009-6#1)(2011-2#1)
of society and##4##3##(1995-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
of society to##3##3##(1991-3#1)(1992-4#1)(2008-8#1)
of society##20##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1995-5#2)(2008-1#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of socio-economic and behavioural factors on childhood malnutrition in Yemen##2##10##(2010-6#2)
of socio-economic##5##2##(2007-12#2)(2010-11#1)(2010-6#2)
of sociobiology##2##2##(2010-4#2)
of socioeconomic change##3##3##(1991-12#1)(2008-12#2)
of socioeconomic##8##2##(1991-12#1)(1994-2#1)(2008-12#2)(2009-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
of sodium and potassium##4##4##(2008-10#4)
of sodium and water retention in cirrhosis##2##7##(1997-7#2)
of sodium and water##3##4##(1997-7#2)(2013-8#1)
of sodium and##7##3##(1997-7#2)(2008-10#4)(2013-8#1)
of sodium ascorbate##2##3##(1997-4#2)
of sodium azide##2##3##(1991-8#1)(2008-10#1)
of sodium bromate in##2##4##(2008-9#2)
of sodium bromate##3##3##(2008-9#3)
of sodium butyrate##2##3##(1992-3#1)(2008-11#1)
of sodium carboxymethyl cellulose##3##4##(2008-5#3)
of sodium channel##7##3##(1995-3#1)(1996-12#2)(2008-7#2)(2009-8#1)(2012-12#1)
of sodium chloride in##2##4##(2008-10#1)(2011-2#1)
of sodium chloride##10##3##(1994-5#1)(1996-3#1)(2008-10#5)(2008-12#2)(2011-2#1)
of sodium citrate##2##3##(1997-4#1)(2011-2#1)
of sodium dodecyl sulfate (SDS)##7##5##(1990-11#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-2#1)
of sodium dodecyl sulfate and##3##5##(1995-5#1)(1996-12#1)(2008-10#1)
of sodium dodecyl sulfate##11##4##(1990-11#1)(1990-5#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-5#1)(2008-10#3)(2008-2#1)
of sodium dodecyl sulphate (SDS) and##2##6##(2008-10#2)
of sodium dodecyl sulphate##3##4##(2008-10#3)
of sodium dodecyl##14##3##(1990-11#1)(1990-5#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-5#1)(2008-10#6)(2008-2#1)
of sodium dodecylsulfate (SDS)##2##4##(2008-10#2)
of sodium dodecylsulfate##3##3##(2008-10#3)
of sodium fluoride##5##3##(1990-2#1)(1995-12#1)(2008-12#1)(2010-3#1)(2013-1#1)
of sodium hydroxide##4##3##(2008-10#3)(2008-6#1)
of sodium hypochlorite solution##2##4##(2008-5#2)
of sodium hypochlorite##3##3##(2008-10#1)(2008-5#2)
of sodium impurities##3##3##(2008-10#2)(2008-3#1)
of sodium in##4##3##(2008-10#4)
of sodium ion##4##3##(2008-10#4)
of sodium ions##3##3##(1991-8#2)(1992-3#1)
of sodium lauryl##2##3##(2008-10#1)(2008-5#1)
of sodium metabisulfite in##2##4##(2008-10#2)
of sodium nitroprusside##3##3##(2007-11#1)(2007-8#1)(2013-7#1)
of sodium selenite##2##3##(1996-2#1)(2011-1#1)
of sodium sulfate##2##3##(2008-10#1)(2008-9#1)
of sodium##169##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-8#4)(1992-11#1)(1992-12#2)(1992-3#2)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#4)(1997-7#3)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#72)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-9#5)(2009-12#1)(2009-8#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
of sodium-selective electrodes##2##3##(2008-10#2)
of soft lithography##2##3##(2007-5#1)(2008-7#1)
of soft tissue and non-thrust joint manipulation##2##7##(2008-12#2)
of soft tissue and##3##4##(2008-12#2)(2008-6#1)
of soft tissue for##3##4##(2007-12#1)(2008-12#1)(2008-6#1)
of soft tissue in##2##4##(2008-3#1)(2009-4#1)
of soft tissue sarcoma in##2##5##(2008-6#1)(2008-7#1)
of soft tissue sarcoma##8##4##(2008-6#6)(2008-7#1)(2010-3#1)
of soft tissue sarcomas##4##4##(2008-6#4)
of soft tissue tumours##2##4##(2008-6#1)(2012-2#1)
of soft tissue##35##3##(1992-1#1)(1996-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#15)(2008-7#2)(2009-4#1)(2010-3#2)(2011-2#1)(2012-2#1)
of soft tissues##7##3##(2007-7#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-4#1)(2010-9#1)(2012-2#1)
of soft##60##2##(1992-1#1)(1996-11#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#16)(2008-7#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-3#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-7#1)
of soft-tissue sarcomas##2##3##(2008-6#2)
of soft-tissue##6##2##(2008-6#3)(2008-9#2)(2013-1#1)
of soft-x-ray##3##2##(2007-12#1)(2008-3#2)
of software for##2##3##(1992-9#1)(2008-10#1)
of software##7##2##(1992-2#1)(1992-9#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-2#1)
of soil and plant##2##4##(1990-9#1)(2008-11#1)
of soil and sediment##3##4##(2008-10#3)
of soil and vegetation##2##4##(2008-12#1)(2008-9#1)
of soil and##17##3##(1990-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
of soil fertility##2##3##(2008-11#1)(2010-7#1)
of soil in##4##3##(2008-10#4)
of soil microbial##2##3##(2008-10#2)
of soil moisture and##2##4##(2008-10#1)(2008-9#1)
of soil of##2##3##(2008-10#2)
of soil organic matter##3##4##(2008-10#2)(2013-8#1)
of soil organic phosphorus##3##4##(2008-10#3)
of soil organic##7##3##(2008-10#5)(2008-12#1)(2013-8#1)
of soil samples##4##3##(2008-10#2)(2008-11#2)
of soil to##2##3##(2008-10#2)
of soil were##3##3##(2008-10#3)
of soil with##5##3##(2008-10#4)(2008-12#1)
of soil##123##2##(1990-9#1)(1993-8#1)(2008-10#87)(2008-11#11)(2008-12#8)(2008-5#2)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#2)(2013-8#2)
of soil)##12##2##(2008-10#12)
of soilborne pathogens##7##3##(2008-10#7)
of soilborne plant pathogens##4##4##(2008-10#4)
of soilborne plant##5##3##(2008-10#5)
of soilborne##21##2##(2008-10#21)
of soils and sediments##2##4##(2008-10#2)
of soils and##4##3##(2008-10#4)
of soils by##2##3##(2008-10#1)(2008-12#1)
of soils in##2##3##(2008-10#2)
of soils on the man made mounds in the Harran Plain##2##11##(2008-12#2)
of soils with##3##3##(2008-10#2)(2011-1#1)
of soils##25##2##(2008-10#18)(2008-12#5)(2008-6#1)(2011-1#1)
of sol-gel and self-assembly process##2##5##(2008-10#2)
of sol-gel##6##2##(2008-10#5)(2010-7#1)
of solanaceous##2##2##(2008-10#1)(2008-6#1)
of solar UV##3##3##(2008-10#1)(2008-5#2)
of solar energy##2##3##(2008-8#1)(2008-9#1)
of solar radiation and##2##4##(2008-2#1)(2010-1#1)
of solar radiation on##2##4##(2010-1#2)
of solar radiation##10##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2010-1#3)(2011-2#1)
of solar##26##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#3)(2011-2#2)
of sole##2##2##(2008-10#1)(2011-2#1)
of solenoid##2##2##(2008-10#2)
of solid or##2##3##(1992-3#1)(2010-4#1)
of solid phase extraction##2##4##(2008-10#2)
of solid phase##6##3##(1996-12#1)(2008-10#5)
of solid samples##3##3##(2008-10#3)
of solid substrate##2##3##(1997-2#1)(2008-7#1)
of solid tumors including##2##4##(2011-1#1)(2013-1#1)
of solid tumors##9##3##(2008-11#1)(2008-7#3)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
of solid tumours##2##3##(2008-11#1)(2009-4#1)
of solid waste##2##3##(2008-12#2)
of solid wastes##2##3##(1997-4#1)(2008-10#1)
of solid##62##2##(1991-5#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-4#1)(1996-12#1)(1997-2#3)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#6)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
of solid-phase extraction (SPE)##2##4##(2008-10#2)
of solid-phase extraction##7##3##(2008-10#7)
of solid-phase microextraction##3##3##(2008-10#3)
of solid-phase##12##2##(2008-10#10)(2008-2#1)(2008-4#1)
of solid-state##5##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-4#1)
of solids##5##2##(1994-12#1)(2008-10#3)(2008-3#1)
of solitary fibrous##2##3##(2007-8#1)(2011-1#1)
of solitary wasps and bees##2##5##(2008-6#2)
of solitary##18##2##(1991-3#2)(1992-12#1)(2007-8#1)(2008-6#4)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-1#1)
of soliton##6##2##(2007-11#3)(2007-12#3)
of solitons in##2##3##(2007-11#1)(2007-12#1)
of solitons##5##2##(2007-11#2)(2007-12#3)
of solubility##8##2##(1991-12#1)(1991-2#1)(2008-10#4)(2010-3#1)(2012-2#1)
of solubilized##5##2##(1990-11#1)(1992-3#1)(2008-11#1)(2013-1#2)
of soluble and exchangeable##2##4##(2011-2#2)
of soluble and##5##3##(1996-1#1)(2008-10#1)(2008-4#1)(2011-2#2)
of soluble fulvic##2##3##(2008-10#2)
of soluble or membrane-bound##2##4##(2008-4#2)
of soluble or##3##3##(1995-2#1)(2008-4#2)
of soluble phosphates in##2##4##(2008-10#2)
of soluble protein A##2##4##(1990-12#1)(1994-12#1)
of soluble protein##3##3##(1990-12#1)(1994-12#1)(1995-3#1)
of soluble proteins from##2##4##(2008-4#2)
of soluble proteins##5##3##(2008-4#4)(2008-6#1)
of soluble##58##2##(1990-12#1)(1990-5#1)(1990-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1997-3#2)(2006-6#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#10)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
of solute diffusion##2##3##(1993-11#2)
of solute is##2##3##(2008-10#1)(2008-3#1)
of solute##7##2##(1993-11#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)
of solute-solvent##2##2##(2008-10#1)(2010-2#1)
of solutes##8##2##(1993-11#1)(2008-10#2)(2008-7#3)(2010-2#1)(2011-2#1)
of solution acidity##2##3##(2008-10#2)
of solution pH on the##2##5##(2008-10#1)(2008-5#1)
of solution pH##7##3##(1995-2#1)(2008-10#5)(2008-5#1)
of solution##30##2##(1992-8#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#20)(2008-5#1)(2010-4#1)(2011-2#2)
of solutions and the##2##4##(2008-10#2)
of solutions and##3##3##(2008-10#3)
of solutions containing##2##3##(2008-10#2)
of solutions is##2##3##(1997-5#1)(2008-2#1)
of solutions of##4##3##(1990-7#1)(1997-7#1)(2008-10#2)
of solutions with##3##3##(2008-10#3)
of solutions##27##2##(1990-7#1)(1994-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2013-8#1)
of solvated##2##2##(1992-6#1)(2012-2#1)
of solvation##8##2##(1990-8#2)(2008-10#3)(2008-4#1)(2009-9#1)(2010-7#1)
of solvent and##4##3##(2008-10#4)
of solvent composition##3##3##(2008-10#3)
of solvent on the##2##4##(2008-10#2)
of solvent##34##2##(1992-4#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#2)(2012-12#1)(2013-1#2)
of solvents##11##2##(1995-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
of solving##2##2##(2008-10#2)
of somatic alterations##2##3##(2008-9#2)
of somatic cell##2##3##(2008-7#1)(2013-1#1)
of somatic cells##3##3##(2008-5#1)(2008-9#1)(2010-7#1)
of somatic mutations##2##3##(1995-12#1)(2008-4#1)
of somatic##18##2##(1994-5#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-7#1)(2012-2#2)(2013-1#1)
of somatosensory##3##2##(1991-1#1)(2008-5#1)(2010-7#1)
of somatostatin receptors##3##3##(1997-2#2)(2012-3#1)
of somatostatin##14##2##(1995-8#1)(1996-5#1)(1997-2#4)(1997-4#4)(1997-8#2)(2008-4#1)(2012-3#1)
of somatostatinergic##2##2##(1995-2#1)(1996-5#1)
of somatotropes##3##2##(1992-6#2)(1994-9#1)
of some 3##2##3##(2008-5#1)(2013-1#1)
of some B vitamins##2##4##(1995-6#2)
of some POPs##2##3##(2008-7#2)
of some active##2##3##(2008-10#2)
of some amino acids##2##4##(2008-10#2)
of some amino##3##3##(1997-2#1)(2008-10#2)
of some analytical##2##3##(2008-10#2)
of some anions##3##3##(2008-10#3)
of some aromatic amines##5##4##(1990-8#1)(2007-11#2)(2008-10#2)
of some aromatic##9##3##(1990-8#1)(2007-11#2)(2008-10#4)(2008-5#2)
of some aspects of the##3##5##(2008-10#2)(2008-7#1)
of some bacterial##2##3##(2010-4#1)(2010-7#1)
of some basic##2##3##(2008-1#1)(2008-2#1)
of some biological##3##3##(2008-10#3)
of some biologically##3##3##(2007-11#1)(2008-12#1)(2013-8#1)
of some catechol derivatives##2##4##(2008-10#2)
of some chronic##2##3##(1996-1#1)(2007-8#1)
of some clinical##2##3##(2008-10#1)(2008-5#1)
of some components##2##3##(1994-3#1)(1996-12#1)
of some diseases##3##3##(1993-2#1)(1997-7#1)(2008-11#1)
of some elements##2##3##(2008-10#2)
of some enzymes involved in##2##5##(1990-8#1)(1991-4#1)
of some factors##2##3##(2008-10#1)(2008-4#1)
of some functional##2##3##(2008-10#1)(2008-5#1)
of some genes##2##3##(2009-8#1)(2012-3#1)
of some groups of##3##4##(2007-12#1)(2010-4#2)
of some heavy##2##3##(2008-10#2)
of some important##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
of some increase##2##3##(1990-6#1)(2008-3#1)
of some instrumental factors##2##4##(2008-10#2)
of some instrumental##3##3##(2008-10#3)
of some ions##3##3##(2008-10#3)
of some isolates##2##3##(2008-10#2)
of some matrix##2##3##(2008-10#2)
of some metal ions##5##4##(2008-10#5)
of some metal-4-(2-pyridylazo) resorcinol##2##4##(2008-10#2)
of some metals##4##3##(2008-10#4)
of some new##6##3##(2007-11#4)(2008-10#2)
of some novel##4##3##(1996-5#1)(2007-11#2)(2012-2#1)
of some of the compounds##3##5##(1993-11#1)(1994-8#1)(2008-10#1)
of some of the more common##2##6##(2008-9#1)(2012-2#1)
of some of the most##3##5##(2007-5#1)(2008-11#1)(2011-2#1)
of some of the##51##4##(1990-7#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-2#2)(1994-8#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#1)
of some of them##2##4##(2008-2#1)(2008-4#1)
of some of these##7##4##(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-9#1)(2013-8#1)
of some of##63##3##(1990-7#1)(1991-12#2)(1992-12#1)(1993-1#1)(1993-11#2)(1993-2#2)(1994-8#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
of some organic and biological molecules##2##6##(2008-10#2)
of some organic##6##3##(1990-9#1)(2008-10#5)
of some other##2##3##(2008-4#1)(2009-6#1)
of some parameters##2##3##(2008-10#1)(2012-1#1)
of some patients##2##3##(2008-12#1)(2012-3#1)
of some performance criteria##2##4##(2008-10#1)(2008-3#1)
of some pharmaceutical##2##3##(2008-10#2)
of some physiological##2##3##(2008-12#2)
of some plants##3##3##(2008-10#2)(2013-1#1)
of some proteins##2##3##(1993-11#1)(2009-9#1)
of some recently synthesized##2##4##(2008-10#2)
of some risk factors##2##4##(2007-11#1)(2008-1#1)
of some samples##2##3##(2008-10#2)
of some species##2##3##(2008-12#1)(2008-5#1)
of some specific##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
of some standard##2##3##(2008-10#1)(2008-2#1)
of some strains##2##3##(2008-10#1)(2008-9#1)
of some trace elements##2##4##(2008-10#2)
of some transition metals##2##4##(2008-10#2)
of some transition##3##3##(2008-10#3)
of some trivalent metal##2##4##(2008-10#2)
of some tumor##2##3##(2007-11#1)(2008-8#1)
of some variables##2##3##(2008-10#1)(2008-8#1)
of some well##2##3##(2008-10#1)(2009-5#1)
of some##486##2##(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#5)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#5)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#3)(1997-9#1)(2006-10#1)(2007-11#14)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#174)(2008-11#8)(2008-12#12)(2008-2#9)(2008-3#13)(2008-4#11)(2008-5#19)(2008-6#3)(2008-7#20)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#5)(2012-7#1)(2013-1#9)(2013-7#4)(2013-8#4)
of somites##4##2##(1994-12#3)(1996-5#1)
of song sparrows (Melospiza melodia)##3##5##(2008-8#1)(2008-9#2)
of song##6##2##(2008-8#3)(2008-9#3)
of sonicated##3##2##(1990-2#1)(2008-11#1)(2013-1#1)
of sonication##3##2##(2008-10#3)
of sonography in##2##3##(1991-3#1)(2013-1#1)
of sonography##3##2##(1991-3#1)(1997-8#1)(2013-1#1)
of soot in##2##3##(2008-3#2)
of soot volume fraction##4##4##(2008-2#3)(2008-3#1)
of soot##17##2##(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#9)
of sophisticated##4##2##(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
of sorbent##7##2##(2008-10#7)
of sorbic##2##2##(2011-2#2)
of sorbinil on##3##3##(1994-8#3)
of sorbitol##4##2##(2008-6#2)(2008-8#1)(2012-7#1)
of sorghum anthracnose##3##3##(2008-10#3)
of sorghum##10##2##(2008-10#7)(2008-9#3)
of sorption of##4##3##(2008-10#4)
of sorption##15##2##(2008-10#13)(2010-4#2)
of sound speed##2##3##(2008-3#2)
of sound##20##2##(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-6#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
of sounds##4##2##(2008-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
of sour orange##4##3##(2008-10#4)
of source##13##2##(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-11#1)(2009-2#1)(2011-2#1)
of source-sink dynamics##2##3##(2008-8#2)
of sources and##2##3##(1992-6#1)(2008-11#1)
of sources of##2##3##(2008-10#1)(2008-12#1)
of sources##18##2##(1992-6#2)(1993-12#1)(1993-2#1)(1995-1#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
of south##3##2##(1996-8#1)(2009-7#1)(2012-3#1)
of southern##8##2##(2008-10#4)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)
of southwestern##2##2##(2008-10#1)(2011-1#1)
of sowing date##4##3##(2008-10#4)
of sowing distances on edible pod yields and yield components of three vegetable cowpea cultivars (Vigna unguiculata L##2##18##(2008-12#2)
of sowing##8##2##(2008-10#6)(2008-12#2)
of sows##2##2##(2008-8#1)(2010-2#1)
of soy sauce##2##3##(1996-2#1)(2008-10#1)
of soy##5##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
of soybean (Glycine max L##2##5##(1997-6#1)(2008-12#1)
of soybean (Glycine max)##4##4##(1991-12#1)(2008-10#3)
of soybean (Glycine##6##3##(1991-12#1)(1997-6#1)(2008-10#3)(2008-12#1)
of soybean and palm oils##2##5##(2013-1#2)
of soybean and##3##3##(2008-10#1)(2013-1#2)
of soybean fungal diseases in##2##5##(2008-10#2)
of soybean mosaic virus##3##4##(2008-10#2)(2008-8#1)
of soybean oil ethanolysis##2##4##(2008-10#2)
of soybean rust and##2##4##(2008-10#2)
of soybean rust##8##3##(2008-10#8)
of soybean sclerotinia stem rot##2##5##(2008-10#2)
of soybean seedlings##3##3##(2008-10#2)(2008-8#1)
of soybean##51##2##(1991-12#1)(1996-12#1)(1997-6#1)(2008-10#39)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2013-1#2)
of soybeans##6##2##(2008-10#5)(2011-2#1)
of space and time##2##4##(2007-11#1)(2009-9#1)
of space and##4##3##(2007-11#1)(2008-2#2)(2009-9#1)
of space exposure on##2##4##(2008-2#2)
of space in##3##3##(2007-11#1)(2009-10#1)(2013-8#1)
of space##22##2##(1995-12#2)(2007-11#2)(2008-10#2)(2008-2#5)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-9#1)(2011-2#1)(2013-8#1)
of space-occupying##2##2##(1991-3#1)(2009-3#1)
of space-time coupling##3##3##(2007-11#2)(2008-3#1)
of space-time##6##2##(2007-11#2)(2008-2#1)(2008-3#3)
of spaceborne##3##2##(2008-3#3)
of spaceflight##2##2##(1991-2#1)(2009-7#1)
of spacing##3##2##(1990-2#1)(1995-2#1)(2009-2#1)
of sparfloxacin induced TEN##2##4##(2007-7#2)
of sparkling wines##3##3##(2008-10#3)
of sparkling##4##2##(2008-10#4)
of sparse##2##2##(2008-10#1)(2008-7#1)
of sparsity##2##2##(1995-5#1)(2008-3#1)
of spasmodic##3##2##(1991-8#1)(1996-2#2)
of spastic##2##2##(1995-6#1)(2009-11#1)
of spatial aggregation and##2##4##(2008-10#1)(2008-8#1)
of spatial aggregation##4##3##(2008-10#2)(2008-8#2)
of spatial analysis##2##3##(2008-8#2)
of spatial and temporal##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)
of spatial and##5##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)
of spatial association##2##3##(2008-10#2)
of spatial coherence and##2##4##(2007-11#2)
of spatial coherence##9##3##(2007-11#4)(2007-12#2)(2008-3#3)
of spatial correlation##2##3##(2008-10#2)
of spatial delayed alternation##2##4##(1991-2#1)(1994-8#1)
of spatial filtering##2##3##(2007-12#1)(2008-2#1)
of spatial frequencies##2##3##(2008-2#2)
of spatial heterogeneity##3##3##(2008-10#2)(2008-8#1)
of spatial hole burning##4##4##(2007-11#2)(2008-3#2)
of spatial learning##2##3##(1991-7#1)(2012-2#1)
of spatial light modulators##3##4##(2008-2#3)
of spatial memory##7##3##(1993-12#2)(1993-5#1)(1994-8#3)(2008-11#1)
of spatial organization##2##3##(1991-2#1)(1995-6#1)
of spatial patterns##3##3##(2008-10#1)(2008-8#2)
of spatial proximity##2##3##(2008-7#2)
of spatial resolution##4##3##(1995-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
of spatial scales##2##3##(2007-11#1)(2008-10#1)
of spatial solitons in##3##4##(2007-11#1)(2007-12#2)
of spatial solitons##5##3##(2007-11#2)(2007-12#3)
of spatial working memory##2##4##(1992-11#1)(1994-8#1)
of spatial##110##2##(1991-2#4)(1991-7#1)(1992-11#1)(1993-12#3)(1993-5#1)(1994-8#5)(1995-11#1)(1995-5#1)(1995-6#1)(2007-11#11)(2007-12#10)(2007-5#1)(2007-8#1)(2008-10#22)(2008-11#4)(2008-2#7)(2008-3#11)(2008-7#3)(2008-8#10)(2008-9#1)(2009-11#1)(2009-2#1)(2009-9#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
of spatially correlated extinctions##2##4##(2008-8#2)
of spatially referenced##3##3##(2008-10#3)
of spatially resolved##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
of spatially##12##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-10#1)(2013-8#1)
of spatiotemporal##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
of spawning##3##2##(2010-8#3)
of spawnings##2##2##(2010-8#2)
of speaker##2##2##(2009-10#1)(2013-8#1)
of special importance in##2##4##(2008-10#1)(2013-8#1)
of special interest for##4##4##(2007-11#1)(2011-2#3)
of special interest##12##3##(1990-9#1)(1996-3#1)(2007-11#1)(2011-1#1)(2011-2#8)
of special##40##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#9)(2013-1#1)(2013-8#1)
of specialised cells##2##3##(1993-11#2)
of specialist##11##2##(1993-12#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
of specialists##3##2##(2007-8#2)(2011-1#1)
of specialization and##3##3##(2008-8#3)
of specialization in##2##3##(1993-12#1)(1993-2#1)
of specialization##13##2##(1992-11#1)(1993-12#1)(1993-2#1)(2008-10#1)(2008-8#7)(2008-9#2)
of specialized metabolites##2##3##(2011-2#2)
of specialized services##4##3##(1993-2#2)(1996-1#1)(2008-7#1)
of specialized training##2##3##(1994-12#1)(1996-11#1)
of specialized##25##2##(1991-2#1)(1991-3#1)(1993-2#3)(1994-12#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
of specialties##2##2##(1993-6#1)(2007-4#1)
of specialty and##2##3##(1993-6#2)
of specialty##9##2##(1991-2#1)(1991-6#3)(1993-6#2)(1995-12#1)(1996-3#1)(2009-9#1)
of speciation##15##2##(1996-6#1)(2008-10#4)(2008-8#6)(2008-9#1)(2010-3#1)(2013-1#2)
of species and##3##3##(1993-2#1)(2008-5#1)(2008-8#1)
of species at##2##3##(1997-5#1)(2008-10#1)
of species diversity##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
of species from the##2##4##(2008-8#1)(2012-3#1)
of species from##6##3##(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
of species has##2##3##(2008-10#1)(2008-8#1)
of species in a##3##4##(1991-8#1)(2008-8#2)
of species in the##2##4##(2007-12#2)
of species in##11##3##(1991-8#1)(1994-3#1)(2007-12#2)(2008-10#3)(2008-8#4)
of species of##6##3##(1993-2#1)(1994-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
of species on##2##3##(2008-10#1)(2008-8#1)
of species relationships##2##3##(2008-6#1)(2013-1#1)
of species specificity##3##3##(2008-1#1)(2008-12#1)(2008-7#1)
of species that are##3##4##(2008-6#1)(2008-9#1)(2010-3#1)
of species with##5##3##(2008-10#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)
of species within##2##3##(2008-8#1)(2010-10#1)
of species##110##2##(1991-8#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#16)(2008-9#12)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#1)
of species-specific##2##2##(2008-10#2)
of specific IgE in##2##4##(1990-12#2)
of specific IgE##3##3##(1990-12#2)(2008-10#1)
of specific antibodies against##2##4##(2008-4#1)(2008-7#1)
of specific antibodies##3##3##(1997-6#1)(2008-4#1)(2008-7#1)
of specific antibody##2##3##(1995-6#1)(2008-10#1)
of specific aspects of##2##4##(1991-3#1)(2008-8#1)
of specific binding sites for##2##5##(1990-5#1)(1990-8#1)
of specific binding##3##3##(1990-2#1)(1990-5#1)(1990-8#1)
of specific biological##2##3##(2008-7#1)(2010-12#1)
of specific cell types##3##4##(1997-4#1)(2008-4#2)
of specific cell##4##3##(1997-4#1)(2008-11#1)(2008-4#2)
of specific changes##2##3##(1994-6#1)(2008-11#1)
of specific compounds##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
of specific elements##2##3##(1996-5#1)(2006-4#1)
of specific gene##6##3##(1995-11#2)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
of specific genes##8##3##(1991-12#1)(1994-3#1)(2008-4#3)(2008-7#2)(2009-5#1)
of specific genetic##2##3##(1997-4#1)(2008-7#1)
of specific growth##3##3##(2008-11#2)(2008-9#1)
of specific interaction##2##3##(1990-5#1)(2008-10#1)
of specific interactions between##2##4##(2008-3#1)(2013-1#1)
of specific markers for##2##4##(2008-9#2)
of specific molecular##2##3##(2008-11#1)(2008-4#1)
of specific molecules##2##3##(2008-1#1)(2008-3#1)
of specific parameters##2##3##(1990-3#1)(1991-5#1)
of specific peptide##2##3##(1993-11#1)(2008-4#1)
of specific primers and##2##4##(2008-10#2)
of specific primers##4##3##(2008-10#3)(2013-8#1)
of specific procedures##2##3##(1995-8#1)(2006-10#1)
of specific protein##3##3##(1991-9#1)(1994-12#1)(2008-4#1)
of specific proteins in##2##4##(1993-11#1)(2010-11#1)
of specific proteins##10##3##(1993-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2010-11#2)
of specific treatment##2##3##(1997-2#1)(2008-9#1)
of specific##263##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#5)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#4)(2008-1#6)(2008-10#28)(2008-11#14)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#22)(2008-5#1)(2008-6#4)(2008-7#15)(2008-8#5)(2008-9#11)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#3)
of specifically##7##2##(1995-11#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-11#1)
of specificity and##2##3##(1992-6#1)(2008-10#1)
of specificity##11##2##(1992-6#1)(1994-6#2)(1996-3#1)(2008-10#3)(2008-8#1)(2009-11#1)(2010-6#1)(2013-1#1)
of specified##2##2##(1995-2#1)(2008-10#1)
of specimen##2##2##(2008-4#1)(2009-7#1)
of specimens from##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
of specimens of##2##3##(2008-10#1)(2010-1#1)
of specimens using##2##3##(2008-12#1)(2012-2#1)
of specimens were##2##3##(1996-12#1)(2013-7#1)
of specimens##14##2##(1991-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
of speckle patterns##4##3##(2008-2#2)(2008-3#2)
of speckle##11##2##(2008-2#7)(2008-3#4)
of speckled##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
of speckles##3##2##(2008-2#2)(2008-3#1)
of spectra for##2##3##(1997-2#1)(2008-3#1)
of spectra##15##2##(1997-2#1)(2007-12#3)(2008-10#6)(2008-2#2)(2008-3#2)(2008-8#1)
of spectral data##6##3##(2008-10#5)(2008-11#1)
of spectral extinction##2##3##(2008-3#2)
of spectral hole burning##2##4##(2007-11#1)(2007-12#1)
of spectral image##2##3##(2007-12#2)
of spectral interference##2##3##(2007-12#1)(2008-3#1)
of spectral interferences##3##3##(2008-10#2)(2011-1#1)
of spectral lines##2##3##(2008-3#1)(2013-8#1)
of spectral##51##2##(2007-11#7)(2007-12#6)(2007-5#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#12)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-8#3)
of spectral-domain OCT##4##3##(2011-7#4)
of spectrally distinct##2##3##(2008-2#1)(2008-9#1)
of spectrally resolved##3##3##(2007-12#1)(2008-2#2)
of spectrally##6##2##(2007-12#2)(2008-2#3)(2008-9#1)
of spectrophotometric data##3##3##(2008-10#3)
of spectrophotometric method##2##3##(2008-10#2)
of spectrophotometric##7##2##(2008-10#5)(2008-3#1)(2011-1#1)
of spectroscopic##9##2##(1994-8#1)(2007-11#1)(2008-10#4)(2008-3#2)(2013-1#1)
of spectrum##3##2##(2008-3#1)(2013-8#2)
of speech and language##2##4##(2007-8#1)(2011-1#1)
of speech and##5##3##(2007-8#1)(2008-9#1)(2011-1#2)(2012-1#1)
of speech in##3##3##(2011-1#3)
of speech perception##3##3##(2008-11#1)(2008-9#1)(2009-2#1)
of speech recognition##2##3##(2007-12#1)(2008-9#1)
of speech##30##2##(1990-3#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2011-1#12)(2012-1#1)(2012-2#1)(2013-1#1)
of speech-recognition technology##2##3##(2007-12#2)
of speed and##2##3##(1991-12#1)(2008-10#1)
of speed##8##2##(1991-12#1)(2008-10#3)(2008-2#1)(2008-4#2)(2011-1#1)
of spending##2##2##(1991-2#2)
of spent cell culture medium##2##5##(1994-5#2)
of spent##4##2##(1994-5#2)(2008-10#1)(2008-11#1)
of sperm cells##3##3##(2008-12#3)
of sperm competition in##2##4##(2008-8#1)(2009-6#1)
of sperm competition##3##3##(2008-8#1)(2009-6#1)(2013-1#1)
of sperm storage##3##3##(2007-12#3)
of sperm transfer##2##3##(1995-2#1)(2007-12#1)
of sperm with##2##3##(1992-8#2)
of sperm##34##2##(1990-9#1)(1992-8#3)(1994-5#2)(1995-2#1)(1996-9#1)(1997-4#1)(2007-12#5)(2008-12#5)(2008-4#1)(2008-7#2)(2008-8#3)(2009-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
of spermatic##2##2##(2008-10#1)(2008-5#1)
of spermatid##2##2##(1991-9#1)(2012-2#1)
of spermatids##2##2##(2008-7#2)
of spermatocytes##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
of spermatodesms##4##2##(2008-7#4)
of spermatogenesis and##4##3##(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
of spermatogenesis are##2##3##(2009-10#1)(2012-2#1)
of spermatogenesis##17##2##(1992-12#1)(2008-4#1)(2008-8#1)(2009-10#4)(2010-5#1)(2011-1#1)(2012-2#7)(2013-8#1)
of spermatogenic##3##2##(2008-5#1)(2012-2#2)
of spermatozoa of the rove beetle Aleochara##2##7##(2007-12#1)(2008-7#1)
of spermatozoa of the##3##4##(2007-12#1)(2008-7#2)
of spermatozoa of##5##3##(2007-12#2)(2008-7#3)
of spermatozoa##17##2##(1991-6#1)(2007-12#2)(2008-6#1)(2008-7#7)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
of spermidine and spermine##2##4##(2008-8#1)(2009-8#1)
of spermidine/spermine N1-acetyltransferase##2##3##(1991-9#1)(1992-10#1)
of spermine##4##2##(1990-7#1)(1992-11#1)(1996-2#1)(2008-8#1)
of spermiogenesis##5##2##(2007-12#1)(2008-7#3)(2012-2#1)
of spheres deposited on a##2##5##(2008-3#2)
of spheres with##2##3##(2008-2#2)
of spheres##18##2##(2008-2#7)(2008-3#11)
of spherical aberration caused by##2##5##(2008-2#1)(2008-3#1)
of spherical aberration is##2##4##(2007-12#2)
of spherical aberration on##3##4##(2008-2#1)(2008-3#2)
of spherical aberration##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
of spherical aberrations##2##3##(2008-2#1)(2008-3#1)
of spherical and##2##3##(2008-2#1)(2008-3#1)
of spherical monodisperse magnetite particles##2##5##(1992-12#2)
of spherical particles##2##3##(2008-2#1)(2008-7#1)
of spherical##30##2##(1992-12#2)(1996-1#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#13)(2008-7#1)
of sphingomyelinase in##2##3##(1992-6#2)
of sphingomyelinase##4##2##(1992-6#2)(2008-8#1)(2009-9#1)
of sphingosine##5##2##(1994-3#2)(1995-2#1)(2009-9#2)
of spider##4##2##(2007-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
of spike##8##2##(1993-12#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#1)
of spiked samples and##3##4##(2008-10#3)
of spiked samples were found##2##5##(2008-10#2)
of spiked samples were##4##4##(2008-10#4)
of spiked samples##9##3##(2008-10#9)
of spiked tap##2##3##(2008-10#2)
of spiked water samples##4##4##(2008-10#4)
of spiked##23##2##(1997-2#1)(2008-10#21)(2011-1#1)
of spikelet##2##2##(2008-12#1)(2008-9#1)
of spikes##5##2##(2008-10#2)(2008-11#1)(2009-8#2)
of spiking##4##2##(2008-11#2)(2009-8#1)(2011-2#1)
of spilled##2##2##(2008-10#1)(2012-2#1)
of spin##7##2##(1994-5#1)(1996-2#1)(2007-11#2)(2008-8#1)(2010-7#1)(2012-2#1)
of spin-labeled##2##2##(1994-5#2)
of spinach##10##2##(1990-5#1)(1994-11#1)(1995-2#1)(2008-10#3)(2008-9#4)
of spinal anesthesia##5##3##(2012-3#5)
of spinal arteriovenous malformations##2##4##(2008-7#2)
of spinal canal##3##3##(2007-11#1)(2007-8#2)
of spinal cord compression##9##4##(1991-9#1)(1992-12#1)(2007-11#5)(2008-10#1)(2008-7#1)
of spinal cord stimulation##3##4##(1997-2#2)(2013-1#1)
of spinal cord was##2##4##(2008-5#2)
of spinal cord##23##3##(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1995-5#1)(1995-9#1)(1997-2#2)(1997-6#1)(2007-11#6)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#1)
of spinal fusion##3##3##(2008-8#2)(2012-3#1)
of spinal intramedullary##2##3##(2012-2#2)
of spinal metastases##4##3##(2007-11#3)(2008-7#1)
of spinal nerve roots##2##4##(2006-12#1)(2013-1#1)
of spinal nerve##3##3##(2006-12#2)(2013-1#1)
of spinal trauma##2##3##(2007-11#2)
of spinal##79##2##(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2006-12#2)(2007-11#21)(2007-8#4)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#4)(2009-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#4)(2012-3#7)(2013-1#3)(2013-8#1)
of spindle cell##3##3##(1990-12#1)(1991-8#1)(2008-6#1)
of spindle cells and##2##4##(2012-12#1)(2012-2#1)
of spindle##7##2##(1990-12#1)(1991-8#1)(2007-8#1)(2008-2#1)(2008-6#1)(2012-12#1)(2012-2#1)
of spine and##2##3##(2007-11#1)(2007-8#1)
of spine curve##4##3##(2007-8#4)
of spine##20##2##(1990-12#1)(2007-11#5)(2007-8#11)(2011-2#1)(2012-12#1)(2012-2#1)
of spines##3##2##(2008-11#3)
of spinfilter rotation velocity##2##4##(2008-11#2)
of spinocerebellar ataxias##3##3##(2008-6#3)
of spiral##4##2##(1997-3#1)(2007-11#1)(2007-12#1)(2012-3#1)
of spiritual##2##2##(2008-4#1)(2010-11#1)
of spirituality and religiosity##2##4##(2008-4#2)
of spirituality and##3##3##(2008-4#2)(2010-11#1)
of spirituality in nursing##3##4##(2008-4#3)
of spirituality in##6##3##(2008-12#2)(2008-4#4)
of spirituality##21##2##(2008-11#1)(2008-12#3)(2008-4#11)(2010-11#2)(2013-1#4)
of spirometric##2##2##(1990-9#1)(2010-8#1)
of spironolactone##3##2##(2008-10#3)
of spiroplasma##2##2##(2008-10#2)
of spiroplasmas##3##2##(2008-10#3)
of splash##2##2##(2008-10#2)
of splashed rain##4##3##(2008-10#4)
of spleen cells##4##3##(1996-12#1)(2007-2#1)(2008-11#1)(2008-7#1)
of spleen in##2##3##(1992-2#1)(2008-10#1)
of spleen##11##2##(1992-2#1)(1995-11#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
of splenectomy##3##2##(2012-12#1)(2012-2#1)(2012-3#1)
of splenic rupture##2##3##(1992-2#1)(2011-2#1)
of splenic##16##2##(1992-2#2)(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-7#2)(2011-1#1)(2011-2#2)(2012-3#2)
of splenocytes##6##2##(1991-1#1)(1991-12#1)(1995-12#1)(2008-10#3)
of splenomegaly##2##2##(2007-12#1)(2012-2#1)
of splicing##7##2##(1991-5#1)(1993-8#1)(2007-12#1)(2008-8#2)(2010-12#2)
of spline wavelet least square##2##5##(2008-10#2)
of spline wavelet##3##3##(2008-10#3)
of split rice spikelet##2##4##(2008-8#2)
of split##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2012-3#1)
of spoilage##4##2##(1997-4#1)(2008-10#3)
of spoken##2##2##(2008-11#1)(2008-9#1)
of spondylarthritis]##2##2##(1990-6#2)
of spondyloarthritis##2##2##(2010-12#1)(2012-12#1)
of spondylolysis##2##2##(1996-6#2)
of spontaneous Brillouin##2##3##(2007-11#1)(2008-3#1)
of spontaneous PC##2##3##(2008-7#2)
of spontaneous activity##4##3##(2008-11#1)(2013-1#1)(2013-8#2)
of spontaneous and##3##3##(1990-3#1)(2008-11#1)(2008-7#1)
of spontaneous bacterial peritonitis##2##4##(2009-8#1)(2011-2#1)
of spontaneous emission from##2##4##(2007-11#2)
of spontaneous emission in##2##4##(2007-11#1)(2008-3#1)
of spontaneous emission rates##3##4##(2007-11#3)
of spontaneous emission##10##3##(1993-5#1)(2007-11#7)(2008-3#2)
of spontaneous intraventricular haemorrhage##3##4##(2008-7#3)
of spontaneous pneumothorax##5##3##(2006-10#1)(2007-8#1)(2008-7#3)
of spontaneous revertants in##2##4##(1995-6#2)
of spontaneous speech##2##3##(2008-10#1)(2008-4#1)
of spontaneous splenic rupture##3##4##(1992-2#2)(1993-9#1)
of spontaneous##93##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-12#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2007-11#9)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#12)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
of spontaneously##5##2##(1996-5#1)(2007-12#1)(2010-3#2)(2012-12#1)
of sporadic##7##2##(2007-12#2)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#1)
of sporamin in the foam##2##5##(2008-6#2)
of sporamin##3##2##(2008-6#3)
of sporangia and zoospores in##2##5##(2008-10#2)
of sporangia and zoospores of##2##5##(2008-10#2)
of sporangia and zoospores##6##4##(2008-10#6)
of sporangia of##3##3##(2008-10#3)
of sporangia produced##3##3##(2008-10#3)
of sporangia##22##2##(2008-10#22)
of sporangiophores##2##2##(2008-10#2)
of spore deposition of##2##4##(2008-10#2)
of spore deposition##6##3##(2008-10#6)
of spore dispersal##2##3##(2008-10#2)
of spore germination and outgrowth##2##5##(2011-2#2)
of spore germination##3##3##(2011-2#3)
of spore##20##2##(2008-10#16)(2011-2#4)
of spore-forming bacteria##3##3##(2011-2#3)
of spores from a##2##4##(2008-10#2)
of spores from##5##3##(2007-5#1)(2008-10#4)
of spores in water##2##4##(2008-10#2)
of spores in##3##3##(1997-4#1)(2008-10#2)
of spores of Bacillus cereus##2##5##(2011-2#2)
of spores of##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
of spores##39##2##(1997-4#1)(2007-5#1)(2008-10#24)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#6)
of sport##4##2##(1993-3#1)(2008-10#1)(2008-6#1)(2009-5#1)
of sports and##3##3##(2009-7#1)(2013-1#2)
of sports nutrition##2##3##(2008-5#2)
of sports##9##2##(1993-3#1)(1996-6#1)(2008-5#2)(2009-7#1)(2010-11#1)(2012-6#1)(2013-1#2)
of sports-related injuries##2##3##(2013-1#2)
of sporulating lesions##3##3##(2008-10#3)
of sporulating##7##2##(2008-10#6)(2008-8#1)
of sporulation by light##2##4##(2008-10#2)
of sporulation##13##2##(1990-12#1)(1995-9#1)(2008-10#9)(2011-2#2)
of spot arrays##2##3##(2008-3#2)
of spot blotch##2##3##(2008-10#2)
of spot##5##2##(2008-10#3)(2008-3#2)
of spots##3##2##(2007-12#1)(2010-12#1)(2012-2#1)
of spotted fever##2##3##(1991-8#1)(2009-2#1)
of spray and point inoculation##2##5##(2008-10#2)
of spray##4##2##(2008-10#3)(2008-3#1)
of spread and##3##3##(2008-7#1)(2008-8#2)
of spread in##2##3##(1996-10#1)(1996-5#1)
of spread of the##3##4##(2008-10#2)(2011-2#1)
of spread of##10##3##(2007-2#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-2#1)(2011-2#1)
of spread was##2##3##(2008-10#1)(2009-2#1)
of spread##28##2##(1996-10#1)(1996-5#1)(2007-2#1)(2008-1#1)(2008-10#14)(2008-7#1)(2008-8#5)(2009-2#2)(2011-2#2)
of spreading depression##2##3##(1996-5#2)
of spreading##7##2##(1990-12#1)(1990-2#1)(1991-8#1)(1996-5#2)(2008-10#1)(2009-10#1)
of spring##5##2##(1996-12#1)(2008-10#2)(2008-12#1)(2013-1#1)
of spruce##4##2##(2008-10#2)(2013-1#2)
of spun fibers##3##3##(2007-11#3)
of sputtered##2##2##(2008-2#1)(2008-7#1)
of sputum from##2##3##(1997-1#1)(2012-2#1)
of sputum##7##2##(1991-11#1)(1997-1#1)(2007-8#2)(2008-3#1)(2012-2#1)(2013-8#1)
of squalene##4##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-5#1)
of squamous and adenosquamous##2##4##(1996-9#2)
of squamous cell carcinoma##6##4##(1991-6#1)(1993-8#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
of squamous cell papilloma of the##2##6##(2008-9#2)
of squamous cell papilloma##5##4##(2008-9#5)
of squamous cell##16##3##(1991-6#1)(1993-8#1)(1997-3#1)(2008-1#1)(2008-9#7)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of squamous##20##2##(1991-2#1)(1991-6#1)(1993-8#1)(1996-9#2)(1997-3#1)(2008-1#1)(2008-9#7)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
of squamous-cell carcinoma##3##3##(1992-10#1)(1993-9#2)
of square wave voltammetry##3##4##(2008-10#3)
of square wave##4##3##(2008-10#4)
of square##8##2##(2007-8#1)(2008-10#5)(2008-2#2)
of srebf1a##2##2##(2012-2#2)
of ssDNA##3##2##(1991-5#2)(2008-10#1)
of stabilisation##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
of stability and##2##3##(2008-10#1)(2008-8#1)
of stability constants for##3##4##(2008-10#3)
of stability constants of##7##4##(2008-10#7)
of stability constants##16##3##(2008-10#16)
of stability in##2##3##(1996-6#1)(2008-5#1)
of stability of the##2##4##(2007-8#1)(2008-11#1)
of stability of##4##3##(2007-8#1)(2008-10#1)(2008-11#2)
of stability##35##2##(1996-6#1)(1996-7#1)(2007-8#1)(2008-10#22)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)
of stabilization and##2##3##(1990-8#1)(2007-8#1)
of stabilization##6##2##(1990-8#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)
of stabilized##5##2##(1997-4#1)(2008-10#2)(2008-2#1)(2010-4#1)
of stabilizing selection##3##3##(2008-8#2)(2008-9#1)
of stabilizing##7##2##(1995-5#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-3#1)
of stable and unstable##2##4##(2007-8#1)(2008-2#1)
of stable and##7##3##(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
of stable cell lines##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
of stable disease##5##3##(2008-6#5)
of stable glycosylated##2##3##(1991-2#2)
of stable isotope##2##3##(2008-6#1)(2010-8#1)
of stable transfectants##2##3##(2008-11#1)(2008-2#1)
of stable##59##2##(1990-11#1)(1990-8#1)(1991-2#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-2#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#7)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
of stably transfected##2##3##(2008-11#1)(2008-2#1)
of stably##4##2##(2008-11#2)(2008-2#1)(2008-8#1)
of stachyose in Chinese artichoke##3##5##(2008-10#3)
of stachyose in##4##3##(2008-10#4)
of stachyose##5##2##(2008-10#5)
of stacked##3##2##(2008-10#1)(2008-2#2)
of stacking##2##2##(2007-11#1)(2008-3#1)
of staff and##2##3##(1993-2#1)(2008-11#1)
of staff development##3##3##(1994-1#2)(2008-9#1)
of staff who##4##3##(2008-11#3)(2013-8#1)
of staff##27##2##(1991-12#3)(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#1)(1995-1#2)(1997-2#1)(2007-11#2)(2007-2#1)(2008-11#5)(2008-12#2)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#2)
of staffing and##2##3##(1996-11#1)(2012-3#1)
of stage I##4##3##(1990-2#1)(2007-8#2)(2013-7#1)
of stage II##4##3##(1993-11#1)(1994-7#1)(2009-10#2)
of stage and##2##3##(2011-2#2)
of stage at diagnosis##2##4##(1990-12#1)(2012-3#1)
of stage##21##2##(1990-12#1)(1990-2#1)(1990-6#2)(1993-11#1)(1994-7#1)(1994-8#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-8#2)(2009-10#2)(2011-2#3)(2012-3#2)(2013-7#1)
of stages##3##2##(1995-1#1)(1996-5#1)(2009-2#1)
of staining with##2##3##(1994-2#2)
of staining##7##2##(1990-5#1)(1994-2#2)(1995-12#1)(2008-5#1)(2008-7#1)(2012-7#1)
of stakeholder management##2##3##(1993-3#1)(2008-1#1)
of stakeholder##4##2##(1993-3#1)(1995-1#1)(2008-1#1)(2013-1#1)
of stakeholders##6##2##(1995-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
of stalk##2##2##(2008-8#2)
of staminate##2##2##(2012-3#2)
of stance balance performance##2##4##(1994-1#2)
of stand-alone body image treatments##2##5##(2007-12#2)
of stand-alone body image##3##4##(2007-12#3)
of stand-alone##4##2##(2007-12#4)
of stand-by therapy##2##3##(1993-8#2)
of standard addition##2##3##(2008-10#2)
of standard and##2##3##(1991-5#1)(1995-5#1)
of standard drink##2##3##(2009-7#2)
of standard fiber##2##3##(2007-12#1)(2008-3#1)
of standard in vitro##2##4##(2008-4#1)(2008-5#1)
of standard optical##2##3##(2007-11#1)(2007-12#1)
of standard reference materials##7##4##(2008-10#7)
of standard reference##8##3##(2008-10#8)
of standard samples##2##3##(2008-10#2)
of standard solutions##3##3##(2008-10#3)
of standard##91##2##(1991-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-6#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#3)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
of standardised##2##2##(2008-11#1)(2008-12#1)
of standardization##8##2##(1996-12#1)(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
of standardized##15##2##(1991-11#2)(1992-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#3)
of standardizing##2##2##(2008-10#1)(2008-9#1)
of standards and##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
of standards for##3##3##(1996-9#1)(2008-9#1)(2010-4#1)
of standards##21##2##(1994-12#2)(1994-3#1)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2013-1#2)
of standards)##2##2##(1991-5#1)(2008-10#1)
of standing##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
of staphylococcal nuclease##3##3##(1992-6#2)(1997-2#1)
of staphylococcal protein A##2##4##(1990-12#1)(1994-12#1)
of staphylococcal##6##2##(1990-12#1)(1992-6#2)(1994-12#1)(1997-2#1)(2012-12#1)
of staphylococcus aureus in##2##4##(2010-12#1)(2010-8#1)
of starch##11##2##(1997-4#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
of staring##2##2##(2008-3#2)
of starting material##2##3##(2008-1#2)
of starting##9##2##(1991-9#1)(1993-8#1)(2007-7#2)(2008-1#2)(2008-10#3)
of startle##5##2##(1996-5#1)(2008-11#2)(2008-4#2)
of starvation##4##2##(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
of state and federal##2##4##(1995-2#1)(1997-3#1)
of state and##3##3##(1995-2#1)(1996-3#1)(1997-3#1)
of state##29##2##(1990-12#1)(1993-1#1)(1994-12#1)(1994-2#3)(1995-12#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-9#2)(1997-1#1)(1997-3#2)(2007-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
of states in##3##3##(1995-3#1)(1997-3#1)(2009-11#1)
of states that##2##3##(1997-2#1)(2008-12#1)
of states##14##2##(1990-10#1)(1991-9#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#4)
of static and dynamic##4##4##(1990-6#1)(1994-3#1)(2007-11#1)(2008-3#1)
of static and##6##3##(1990-6#1)(1994-3#1)(2007-11#1)(2008-3#2)(2009-1#1)
of static extraction and 5##2##5##(2008-10#2)
of static##20##2##(1990-6#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-2#1)(2011-2#1)(2012-1#1)
of statin therapy##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
of statins and##3##3##(2008-12#1)(2009-6#1)(2012-2#1)
of statins##10##2##(2008-1#1)(2008-12#1)(2009-6#3)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
of station 3##2##3##(2007-8#2)
of stationary phase##5##3##(2008-10#4)(2008-11#1)
of stationary##7##2##(2008-10#4)(2008-11#2)(2009-8#1)
of statistical analysis of the##2##5##(1990-3#1)(2008-9#1)
of statistical analysis##4##3##(1990-3#1)(1997-8#1)(2008-8#1)(2008-9#1)
of statistical and##3##3##(1993-12#1)(2007-12#1)(2008-3#1)
of statistical data##2##3##(1995-1#1)(2008-10#1)
of statistical geometry##2##3##(1997-6#2)
of statistical methods for##2##4##(1997-4#1)(2012-3#1)
of statistical methods##7##3##(1995-12#1)(1997-1#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
of statistical models for##2##4##(2008-4#1)(2010-1#1)
of statistical process control##3##4##(1995-2#1)(2008-10#1)(2008-3#1)
of statistical tests##2##3##(1997-3#2)
of statistical tools##2##3##(1993-3#1)(2008-10#1)
of statistical##51##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
of statistically##4##2##(1994-12#1)(2006-12#1)(2008-2#1)(2008-3#1)
of statistics in##2##3##(1996-3#1)(2008-10#1)
of statistics##7##2##(1992-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
of status##5##2##(2008-12#3)(2008-8#1)(2009-8#1)
of statutory##3##2##(1996-3#1)(1996-8#1)(2008-11#1)
of staurosporine##2##2##(1995-12#2)
of stavudine##2##2##(2008-5#1)(2008-7#1)
of stay (LOS)##8##3##(1991-12#1)(1993-12#3)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)
of stay among the##2##4##(1992-2#1)(2012-3#1)
of stay and##11##3##(1993-3#1)(1995-12#2)(1995-3#1)(1996-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of stay by##2##3##(1992-3#1)(1995-3#1)
of stay decreased##2##3##(1993-1#1)(2007-8#1)
of stay in hospital##4##4##(1990-6#1)(1992-5#1)(1996-1#1)(2013-1#1)
of stay in the##4##4##(1996-2#1)(2006-10#1)(2007-5#1)(2009-8#1)
of stay in##10##3##(1990-6#1)(1992-5#1)(1996-1#1)(1996-2#1)(2006-10#2)(2007-5#1)(2008-3#1)(2009-8#1)(2013-1#1)
of stay of##3##3##(1991-1#1)(1992-12#1)(2013-1#1)
of stay to##2##3##(2010-8#1)(2012-2#1)
of stay was##3##3##(1992-12#1)(2008-3#1)(2012-2#1)
of stay were##2##3##(1994-3#1)(1996-3#1)
of stay which##2##3##(1994-12#1)(2012-2#1)
of stay##99##2##(1990-6#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-5#1)(1993-1#3)(1993-12#8)(1993-2#2)(1993-3#2)(1994-12#3)(1994-3#5)(1995-1#2)(1995-12#3)(1995-3#5)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#1)(2006-10#3)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#12)(2012-3#4)(2013-1#6)(2013-8#1)
of steady state##6##3##(1996-3#1)(2008-10#2)(2008-6#1)(2008-7#2)
of steady##7##2##(1996-3#1)(1996-8#1)(2008-10#2)(2008-6#1)(2008-7#2)
of steady-state##5##2##(1990-12#1)(1994-5#1)(2007-12#2)(2008-10#1)
of steam-exploded poplar biomass##2##4##(2008-6#2)
of steatosis##2##2##(2012-2#1)(2013-1#1)
of steel##3##2##(2007-12#1)(2008-3#1)(2013-1#1)
of steers##2##2##(2012-2#2)
of stellar scintillation##3##3##(2008-2#1)(2008-3#2)
of stellar##4##2##(2008-2#1)(2008-3#3)
of stem and##4##3##(2008-10#3)(2012-12#1)
of stem canker##3##3##(2008-10#3)
of stem cell based therapy and tissue engineering in the regeneration of the##2##13##(2008-5#2)
of stem cell fate##2##4##(2008-11#1)(2009-3#1)
of stem cell research##2##4##(2010-11#1)(2012-12#1)
of stem cell transplantation##2##4##(2008-10#1)(2010-8#1)
of stem cell##23##3##(2008-10#1)(2008-11#4)(2008-5#3)(2008-6#1)(2009-12#1)(2009-3#3)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of stem cell-based##2##3##(2012-12#2)
of stem cells for##2##4##(2008-11#2)
of stem cells from##3##4##(2008-11#1)(2008-8#1)(2012-1#1)
of stem cells in##3##4##(2008-5#1)(2012-12#1)(2012-2#1)
of stem cells into##2##4##(2008-11#2)
of stem cells to the##2##5##(2008-10#1)(2008-11#1)
of stem cells to##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
of stem cells will be##2##5##(2008-11#1)(2010-12#1)
of stem cells##33##3##(2008-10#2)(2008-11#12)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#1)
of stem diameter##2##3##(2008-10#2)
of stem infection##2##3##(2008-10#2)
of stem rot##2##3##(2008-10#2)
of stem rust resistance in##3##5##(2008-10#3)
of stem rust resistance##4##4##(2008-10#4)
of stem rust##8##3##(2008-10#8)
of stem tissue##3##3##(2008-10#3)
of stem##91##2##(2008-10#32)(2008-11#16)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#3)(2009-6#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#7)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
of stems and leaves##2##4##(2008-12#1)(2008-5#1)
of stems with##7##3##(2008-10#7)
of stems##14##2##(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#1)(2013-1#1)
of stenophagy in spiders##2##4##(2012-3#2)
of stenophagy were##2##3##(2012-3#2)
of stenophagy##4##2##(2012-3#4)
of stenosis in##3##3##(2007-10#1)(2008-3#1)(2011-2#1)
of stenosis##14##2##(1993-8#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
of stent implantation##2##3##(1996-8#1)(2008-11#1)
of stent wires##2##3##(2010-12#2)
of stent##9##2##(1990-8#1)(1994-11#1)(1996-8#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-12#2)(2011-2#1)
of stents##2##2##(1994-11#1)(1994-9#1)
of step##2##2##(2008-7#1)(2012-2#1)
of steps and##2##3##(2008-6#1)(2010-3#1)
of steps##14##2##(1992-3#1)(1993-3#1)(2007-10#3)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#2)(2012-3#1)(2013-1#1)
of stepwise graded##2##3##(2008-3#2)
of stepwise##7##2##(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)
of stereodefined PS-oligos##2##3##(2008-4#2)
of stereoisomers##4##2##(2010-2#4)
of stereopsis##2##2##(1994-8#1)(2008-9#1)
of stereoregular poly(methyl methacrylate)##2##4##(2007-12#2)
of stereoselectivity##3##2##(1990-6#1)(1991-12#2)
of stereospecific##2##2##(1995-3#1)(1995-8#1)
of stereotactic##2##2##(2008-7#2)
of stereotypy##3##2##(1995-3#1)(2008-11#2)
of steric##5##2##(1991-1#1)(2007-11#1)(2008-10#2)(2012-2#1)
of sterile##15##2##(2007-10#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
of sterility##4##2##(1995-8#1)(2008-10#1)(2008-11#2)
of sterilization##7##2##(1991-3#3)(1995-1#2)(1996-3#1)(2011-1#1)
of sternal wound infection##3##4##(2012-2#3)
of sternal wound##4##3##(2007-8#1)(2012-2#3)
of sternal##5##2##(2007-8#1)(2012-2#4)
of steroid 5 alpha-reductase##4##4##(1990-11#2)(1994-11#1)(1995-9#1)
of steroid action##2##3##(2008-4#1)(2008-5#1)
of steroid hormone##2##3##(2007-4#1)(2008-4#1)
of steroid hormones on##2##4##(1994-9#1)(2012-3#1)
of steroid receptor##2##3##(1992-11#1)(1993-2#1)
of steroid##27##2##(1990-11#2)(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#1)
of steroidogenesis in##2##3##(1996-2#2)
of steroidogenesis##7##2##(1991-3#1)(1991-9#1)(1996-2#2)(2012-2#2)(2013-1#1)
of steroids and##2##3##(2007-7#1)(2012-2#1)
of steroids are##2##3##(2007-10#1)(2010-6#1)
of steroids on##2##3##(2008-7#1)(2012-2#1)
of steroids##23##2##(1990-11#1)(1990-2#1)(1992-3#1)(1995-12#1)(1996-3#1)(1996-5#1)(2006-10#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-6#1)(2012-2#3)(2013-1#1)
of sterol synthesis##2##3##(1992-3#1)(1993-6#1)
of sterol##8##2##(1990-12#1)(1991-5#2)(1992-3#2)(1993-6#1)(2007-11#2)
of sterols##4##2##(1990-11#1)(1992-3#1)(2008-10#2)
of stethoscopes used by medical students in Nigeria##2##8##(2009-6#2)
of stewardship in health policy##2##5##(2012-2#2)
of stewardship in health##3##4##(2012-2#3)
of stewardship##4##2##(2012-2#4)
of stiffness##2##2##(2007-8#1)(2009-7#1)
of stifle##2##2##(2012-3#2)
of stigma##6##2##(2008-6#1)(2009-5#2)(2011-1#2)(2012-1#1)
of stigmasterol##2##2##(1990-2#1)(2008-12#1)
of stigmata##2##2##(2007-8#1)(2008-10#1)
of still##3##2##(2008-5#1)(2011-1#1)(2012-12#1)
of stimulants##3##2##(2008-10#2)(2008-3#1)
of stimulated Brillouin scattering##3##4##(2007-11#3)
of stimulated Raman scattering (SRS) at##2##6##(2008-2#1)(2008-3#1)
of stimulated Raman scattering and##2##5##(2007-12#1)(2008-2#1)
of stimulated Raman scattering##6##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
of stimulated emission##2##3##(2007-11#2)
of stimulated scattering##2##3##(2008-3#2)
of stimulated##18##2##(1992-8#1)(1993-11#1)(1995-12#1)(2007-11#7)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
of stimulating##3##2##(1993-3#1)(1997-2#1)(2008-11#1)
of stimulation of##4##3##(1990-8#1)(1995-2#1)(2008-7#1)(2012-2#1)
of stimulation rate##2##3##(2008-9#2)
of stimulation##29##2##(1990-8#1)(1991-12#1)(1992-12#2)(1992-8#1)(1993-12#2)(1993-6#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#5)(2008-9#6)(2010-10#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
of stimulator##2##2##(2012-3#2)
of stimulatory##3##2##(1993-9#1)(1996-2#1)(2008-11#1)
of stimuli and##3##3##(1993-12#1)(2008-9#1)(2012-2#1)
of stimuli to##2##3##(1997-7#1)(2009-2#1)
of stimuli##20##2##(1992-11#1)(1993-12#3)(1993-3#1)(1997-7#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-2#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
of stimulus delivery##2##3##(1995-12#1)(2008-4#1)
of stimulus##9##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
of stimulus--reward##2##2##(1993-6#2)
of stimulus-frequency##2##2##(2009-5#2)
of stirred##2##2##(2008-10#1)(2008-11#1)
of stirring##3##2##(2008-10#3)
of stochastic##12##2##(1992-6#1)(1992-9#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-7#4)(2008-8#2)(2011-2#1)
of stocking rate on##2##4##(1996-12#2)
of stocking rate##3##3##(1996-12#3)
of stoichiometric amounts of##2##4##(1990-11#1)(1991-5#1)
of stoichiometric##5##2##(1990-11#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
of stoichiometry and##3##3##(1994-5#1)(2008-10#2)
of stolon regression##2##3##(2009-8#2)
of stolon##3##2##(2009-8#3)
of stomach cancer in##2##4##(1992-12#1)(2012-12#1)
of stomach cancer##4##3##(1990-9#1)(1992-12#1)(2012-12#2)
of stomach##11##2##(1990-9#1)(1992-12#1)(1992-9#1)(1996-12#1)(1997-7#1)(2008-7#3)(2012-12#2)(2013-1#1)
of stomata##3##2##(2008-10#2)(2013-7#1)
of stomatopods##2##2##(2007-12#2)
of stone##7##2##(1991-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
of stones##2##2##(2011-2#2)
of stool##3##2##(1991-3#1)(1991-8#1)(2008-6#1)
of stopping##2##2##(2007-7#1)(2008-11#1)
of storage and##2##3##(2007-12#1)(2008-11#1)
of storage at##7##3##(2008-10#6)(2008-12#1)
of storage in##6##3##(2008-10#3)(2008-5#1)(2009-7#1)(2010-8#1)
of storage space##3##3##(1994-3#2)(1996-1#1)
of storage##45##2##(1992-12#1)(1992-3#1)(1994-3#2)(1996-1#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#2)
of stored potato tubers##2##4##(2008-10#2)
of stored##11##2##(1992-10#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-6#1)(2011-2#1)
of stories##3##2##(1992-3#1)(2008-11#1)(2012-2#1)
of storing##3##2##(1996-12#1)(2008-3#2)
of storytelling##5##2##(1992-3#1)(2008-11#3)(2008-12#1)
of straight##3##2##(1992-8#1)(2008-2#1)(2013-1#1)
of straightforward##2##2##(2008-12#1)(2008-7#1)
of strain 1505##2##3##(2008-10#2)
of strain 50##2##3##(2008-5#2)
of strain 70T01##2##3##(2008-10#2)
of strain A506##4##3##(2008-10#4)
of strain Q8r1-96##2##3##(2008-10#2)
of strain##48##2##(1996-12#1)(1996-4#1)(2007-12#1)(2008-10#32)(2008-3#6)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2012-3#2)
of strain-specific##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
of strains into##3##3##(2008-10#3)
of strains of##4##3##(2008-10#4)
of strains that##3##3##(1992-12#1)(2008-10#1)(2010-4#1)
of strains were##3##3##(1990-6#1)(2008-10#2)
of strains with##2##3##(2008-10#2)
of strains##38##2##(1990-6#1)(1992-12#1)(1993-9#1)(1995-8#1)(2008-10#22)(2008-12#1)(2008-5#2)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
of strains)##2##2##(2008-10#2)
of strangles##2##2##(2013-8#2)
of strategic planning##3##3##(1993-1#1)(1995-1#1)(1997-1#1)
of strategic##11##2##(1991-8#1)(1993-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#2)(2008-12#1)(2009-9#1)(2012-12#1)
of strategies for##8##3##(1994-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#3)
of strategies in##2##3##(2007-8#1)(2008-8#1)
of strategies that##2##3##(2010-11#1)(2013-8#1)
of strategies to##7##3##(1996-9#1)(2007-12#1)(2008-11#3)(2012-3#1)(2013-1#1)
of strategies##26##2##(1993-12#1)(1994-3#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#3)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
of stratification##2##2##(2008-7#1)(2011-2#1)
of stratified##3##2##(2008-2#2)(2009-4#1)
of stratospheric aerosols##3##3##(2008-2#3)
of stratospheric##11##2##(1991-5#1)(2008-2#4)(2008-3#6)
of stratum corneum##13##3##(2008-5#13)
of strawberry and##2##3##(2008-10#2)
of strawberry leaf blight##2##4##(2008-10#2)
of strawberry leaflets##2##3##(2008-10#2)
of strawberry leaves##3##3##(2008-10#3)
of strawberry plants##2##3##(2008-10#2)
of strawberry production##2##3##(2008-10#2)
of strawberry##25##2##(2008-10#25)
of stray light##3##3##(2008-3#3)
of stray##5##2##(2008-3#3)(2011-1#2)
of streams##2##2##(2008-10#1)(2009-8#1)
of street##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
of strength##4##2##(2007-8#2)(2008-4#1)(2013-8#1)
of strengthening##6##2##(1991-12#1)(2012-12#1)(2012-3#4)
of streptavidin in##2##3##(1990-2#1)(2008-10#1)
of streptavidin##9##2##(1990-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#3)
of streptokinase from##2##3##(2012-2#2)
of streptokinase##11##2##(1994-12#1)(1994-6#1)(1997-4#1)(2012-2#8)
of streptomycin sulfate##4##3##(2008-10#4)
of streptozotocin (STZ)-induced##2##3##(1991-12#1)(2008-10#1)
of streptozotocin##5##2##(1991-12#1)(2008-10#2)(2009-11#1)(2011-3#1)
of stress and##4##3##(1996-4#1)(2008-10#1)(2009-9#1)(2010-7#1)
of stress are##2##3##(2008-11#1)(2008-5#1)
of stress in the##2##4##(2008-11#1)(2008-7#1)
of stress in##6##3##(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-1#1)(2013-1#1)
of stress on distress##2##4##(2012-3#2)
of stress on the##3##4##(1995-12#1)(1997-4#1)(2008-7#1)
of stress on##11##3##(1994-2#1)(1995-12#1)(1997-4#1)(2008-6#1)(2008-7#2)(2012-3#4)(2013-1#1)
of stress proteins in##3##4##(1992-5#1)(1993-6#1)(2008-7#1)
of stress proteins##4##3##(1992-5#1)(1993-6#1)(2008-11#1)(2008-7#1)
of stress response##3##3##(2011-2#2)(2012-2#1)
of stress responses##2##3##(2008-7#1)(2012-2#1)
of stress that##2##3##(1996-4#1)(2012-3#1)
of stress urinary incontinence##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
of stress##85##2##(1991-12#2)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-9#1)(1997-4#1)(2007-2#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#9)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#2)(2013-7#1)
of stress-induced##3##2##(1994-8#1)(1996-9#1)(2008-11#1)
of stressed##2##2##(2008-10#1)(2008-5#1)
of stressful life events##2##4##(2011-2#2)
of stressful##3##2##(1992-1#1)(2011-2#2)
of stressor effects##2##3##(2008-11#2)
of stressors and##2##3##(1990-5#1)(2009-8#1)
of stressors##3##2##(1990-5#1)(2009-6#1)(2009-8#1)
of stretch##2##2##(1990-8#1)(1996-3#1)
of stretched##2##2##(1992-9#1)(2008-3#1)
of stretching##3##2##(1993-11#1)(2008-6#2)
of striatal dopamine receptors##2##4##(1994-5#1)(1995-2#1)
of striatal dopamine##4##3##(1994-5#1)(1995-2#2)(2008-7#1)
of striatal##17##2##(1990-7#2)(1991-6#1)(1993-12#3)(1994-5#1)(1995-12#3)(1995-2#2)(1995-5#1)(1996-2#1)(1997-2#1)(2008-5#1)(2008-7#1)
of strict##3##2##(2007-7#1)(2008-12#1)(2008-7#1)
of strictures##2##2##(2013-1#1)(2013-8#1)
of stridor##2##2##(1991-11#1)(2013-8#1)
of striga##3##2##(2008-10#3)
of strip##3##2##(2008-10#2)(2012-3#1)
of stripe rust##2##3##(2008-10#2)
of stripping potentiometry##2##3##(2008-10#2)
of stripping##5##2##(2008-10#5)
of stroke and the##2##4##(2010-10#1)(2011-1#1)
of stroke and##7##3##(1990-3#1)(1991-11#1)(2008-2#1)(2008-8#2)(2010-10#1)(2011-1#1)
of stroke are##3##3##(2007-10#1)(2008-8#2)
of stroke by##2##3##(2007-10#1)(2008-8#1)
of stroke caused by##2##4##(2007-10#2)
of stroke in Japan##2##4##(2008-8#2)
of stroke in patients with##2##5##(2007-8#1)(2008-8#1)
of stroke in the##4##4##(2007-8#2)(2008-8#1)(2009-7#1)
of stroke in##18##3##(1995-5#1)(2007-8#3)(2008-7#2)(2008-8#11)(2009-7#1)
of stroke is##2##3##(2007-10#1)(2008-9#1)
of stroke onset##3##3##(2007-10#2)(2008-8#1)
of stroke or##4##3##(1991-11#1)(2007-10#1)(2007-7#1)(2011-2#1)
of stroke patients##6##3##(1995-5#1)(2007-10#3)(2007-9#1)(2008-8#1)
of stroke risk factors##3##4##(2007-10#1)(2007-9#1)(2008-2#1)
of stroke risk##4##3##(2007-10#2)(2007-9#1)(2008-2#1)
of stroke symptoms##3##3##(2007-10#1)(2010-10#2)
of stroke##144##2##(1990-3#1)(1991-11#4)(1993-12#1)(1995-5#7)(1996-11#2)(2007-10#47)(2007-7#1)(2007-8#4)(2007-9#3)(2008-2#4)(2008-3#2)(2008-7#3)(2008-8#48)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#3)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of strokes##4##2##(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)
of stromal cells##4##3##(1994-9#2)(1995-12#1)(2010-3#1)
of stromal##11##2##(1993-9#1)(1994-7#1)(1994-9#4)(1995-12#1)(2008-11#1)(2010-3#1)(2011-1#1)(2012-1#1)
of strong and##2##3##(1995-3#1)(2008-7#1)
of strong earthquakes##2##3##(1996-4#2)
of strong ligands##2##3##(1990-8#2)
of strong##41##2##(1990-8#2)(1992-1#1)(1992-6#1)(1992-7#1)(1994-5#1)(1995-3#1)(1996-4#2)(1996-6#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#2)(2008-9#3)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
of stronger##4##2##(1995-5#2)(2008-3#1)(2008-9#1)
of strongly reducing species of V##2##6##(2008-10#2)
of strongly##10##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2011-1#1)
of strontium 89 (Metastron)##2##4##(2007-11#2)
of strontium 89##3##3##(2007-11#3)
of strontium ion##3##3##(2008-10#3)
of strontium or lanthanum##3##4##(2008-10#3)
of strontium##13##2##(2007-11#3)(2008-10#10)
of structural and##6##3##(1990-12#1)(1991-6#1)(2008-10#2)(2011-1#1)(2012-3#1)
of structural changes##2##3##(2008-10#1)(2008-7#1)
of structural damage##2##3##(1990-7#1)(2013-8#1)
of structural features##2##3##(2008-10#2)
of structural genes##3##3##(1990-5#1)(2008-11#1)(2008-9#1)
of structural information about the##2##5##(2008-7#1)(2008-8#1)
of structural information##4##3##(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
of structural models##2##3##(2009-4#1)(2010-4#1)
of structural similarity##2##3##(1990-4#1)(1992-6#1)
of structural woody habitat##2##4##(2010-8#2)
of structural##63##2##(1990-12#1)(1990-4#3)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-6#2)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-3#3)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
of structurally and functionally##2##4##(2007-12#1)(2008-11#1)
of structurally##12##2##(1992-8#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)
of structure and##6##3##(1992-3#1)(2007-12#3)(2012-2#1)(2012-3#1)
of structure elucidation of##2##4##(2008-12#1)(2011-2#1)
of structure to##2##3##(1996-2#1)(2008-5#1)
of structure##22##2##(1992-3#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of structure-selective ligand binding##2##4##(2008-4#2)
of structured student tutorial support##2##5##(2008-11#2)
of structured##13##2##(2007-10#1)(2008-10#1)(2008-11#3)(2008-3#3)(2009-10#1)(2009-11#1)(2010-3#1)(2012-12#2)
of structures and##5##3##(2008-12#2)(2008-4#1)(2010-5#1)(2011-7#1)
of structures for##2##3##(2007-11#1)(2008-4#1)
of structures in the##2##4##(1995-3#1)(1997-5#1)
of structures of##2##3##(2008-10#1)(2008-3#1)
of structures with##4##3##(1994-5#1)(1996-3#1)(2008-3#1)(2013-1#1)
of structures##25##2##(1994-12#1)(1994-5#1)(1995-3#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-4#2)(2008-8#1)(2009-7#1)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#1)
of student nurses##7##3##(2008-11#5)(2010-3#1)(2013-8#1)
of student##21##2##(1995-3#2)(2008-11#11)(2008-12#3)(2010-3#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
of students and##5##3##(1997-5#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
of students had##2##3##(1991-9#1)(2008-11#1)
of students in##2##3##(2008-12#1)(2012-2#1)
of students to##2##3##(2008-11#2)
of students undertaking##2##3##(2008-11#2)
of students who had##2##4##(2008-11#1)(2013-1#1)
of students who##3##3##(2008-11#2)(2013-1#1)
of students with##2##3##(2008-12#1)(2012-2#1)
of students##47##2##(1991-9#1)(1992-1#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-11#19)(2008-12#7)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
of students' clinical##2##3##(2008-12#2)
of students' competence##2##3##(1993-1#1)(2008-12#1)
of students'##13##2##(1993-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#6)(2012-3#1)(2013-7#1)
of studied##5##2##(2008-10#2)(2008-7#2)(2013-1#1)
of studies and##3##3##(2006-10#1)(2008-6#1)(2012-3#1)
of studies are##2##3##(1997-1#1)(2012-2#1)
of studies examining##2##3##(2008-4#1)(2008-7#1)
of studies have been##3##4##(1995-5#1)(2008-10#1)(2008-4#1)
of studies have reported##2##4##(2008-9#1)(2013-8#1)
of studies have shown that##3##5##(2008-11#1)(2012-12#1)(2012-2#1)
of studies have shown##4##4##(1992-2#1)(2008-11#1)(2012-12#1)(2012-2#1)
of studies have##14##3##(1992-2#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
of studies in##3##3##(2008-7#1)(2008-8#1)(2009-11#1)
of studies of the##3##4##(1997-2#1)(2007-12#1)(2011-2#1)
of studies of##10##3##(1990-8#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-7#1)(2011-2#1)
of studies on the##5##4##(1993-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-3#1)
of studies on##13##3##(1992-3#1)(1993-5#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-8#1)(2010-5#1)(2011-3#1)(2012-3#1)
of studies reporting##2##3##(2008-7#1)(2013-1#1)
of studies support the##2##4##(1996-5#1)(2011-2#1)
of studies that have##2##4##(2008-2#1)(2012-2#1)
of studies that##6##3##(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
of studies which##2##3##(1997-1#1)(2008-11#1)
of studies##102##2##(1990-8#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
of study and##2##3##(2008-11#1)(2013-8#1)
of study are##2##3##(1993-6#1)(2008-2#1)
of study area##2##3##(2008-12#1)(2013-8#1)
of study for##2##3##(2007-2#1)(2008-11#1)
of study in##3##3##(2008-12#1)(2010-10#1)(2012-3#1)
of study is in##2##4##(1990-6#1)(2012-2#1)
of study is to##2##4##(2012-3#2)
of study is##5##3##(1990-6#1)(2012-2#1)(2012-3#2)(2013-7#1)
of study of##3##3##(1997-2#1)(2013-1#2)
of study on##3##3##(1994-5#1)(2008-11#1)(2010-10#1)
of study patients##2##3##(1993-12#1)(2010-12#1)
of study that##3##3##(1997-7#1)(2007-10#1)(2008-12#1)
of study was##4##3##(1995-9#1)(2007-7#1)(2008-9#1)(2012-3#1)
of study##76##2##(1990-12#1)(1990-6#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-9#1)(1997-2#1)(1997-7#2)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#3)
of study-specific##2##2##(1995-12#1)(2008-10#1)
of studying the##9##3##(1993-6#1)(1995-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2013-1#1)
of studying##17##2##(1993-6#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#2)(2010-3#1)(2011-2#1)(2013-1#2)
of stunning##2##2##(2008-3#1)(2011-1#1)
of stunting and##3##3##(2008-1#1)(2008-10#1)(2010-6#1)
of stunting##5##2##(2008-1#1)(2008-10#1)(2010-6#2)(2011-1#1)
of stuttering##3##2##(2008-2#3)
of stylet##2##2##(2008-10#2)
of styrene and##4##3##(2008-10#2)(2008-11#1)(2010-2#1)
of styrene##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2010-2#2)(2010-5#1)
of sub-10-fs pulses##3##3##(2007-11#1)(2007-12#2)
of sub-10-fs##6##2##(2007-11#1)(2007-12#5)
of sub-cellular compartments##2##3##(2010-2#2)
of sub-cellular localization##2##3##(2010-2#2)
of sub-cellular##6##2##(2009-8#1)(2010-2#5)
of sub-chronic##2##2##(1996-12#2)
of subacromial space##2##3##(2007-11#2)
of subacromial##3##2##(2007-11#3)
of subacute##4##2##(1991-11#1)(1991-9#1)(2007-11#1)(2010-9#1)
of subarachnoid haemorrhage##3##3##(1995-9#1)(2008-7#2)
of subarachnoid hemorrhage##2##3##(1995-5#1)(2008-2#1)
of subarachnoid##5##2##(1995-5#1)(1995-9#1)(2008-2#1)(2008-7#2)
of subcapital growth plate##2##4##(2007-11#2)
of subcellular##5##2##(1995-6#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-12#1)
of subclinical atherosclerosis##5##3##(2008-11#3)(2013-1#2)
of subclinical cryptosporidiosis##2##3##(1996-12#2)
of subclinical##12##2##(1991-2#1)(1996-12#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#2)(2013-1#2)
of subcortical##2##2##(2008-2#1)(2008-7#1)
of subcutaneous fat##7##3##(1996-3#1)(2011-1#1)(2012-2#5)
of subcutaneous lipomatous soft-tissue##2##4##(2012-2#2)
of subcutaneous tissue##2##3##(1997-3#1)(2010-6#1)
of subcutaneous##21##2##(1991-5#1)(1991-6#3)(1996-3#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-6#1)(2009-12#1)(2010-6#1)(2011-1#1)(2012-2#7)(2012-3#1)(2013-1#1)
of subgenus Leishmania (Viannia) DNA##2##5##(2013-1#2)
of subgraphs##2##2##(2010-10#2)
of subgroup##9##2##(1994-11#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-9#1)(2012-3#1)
of subgroups##2##2##(1996-2#1)(2008-5#1)
of subject##2##2##(1993-11#1)(2008-10#1)
of subject-specific##2##2##(2008-6#1)(2013-1#1)
of subjective and objective measures##2##5##(2007-12#1)(2008-3#1)
of subjective and objective##3##4##(1992-9#1)(2007-12#1)(2008-3#1)
of subjective##10##2##(1992-9#1)(2007-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#2)
of subjectively##2##2##(2008-7#1)(2013-1#1)
of subjects from##2##3##(2008-12#1)(2011-2#1)
of subjects had##2##3##(1992-6#1)(2010-1#1)
of subjects in##4##3##(1995-5#1)(1995-9#1)(2009-7#1)(2009-8#1)
of subjects on the##2##4##(1991-6#1)(2008-7#1)
of subjects on##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
of subjects was##2##3##(2008-6#1)(2012-2#1)
of subjects were##4##3##(2008-11#1)(2008-7#2)(2010-1#1)
of subjects who##3##3##(1992-6#1)(2008-11#1)(2013-8#1)
of subjects with hypercholesterolemia##2##4##(2008-7#1)(2008-8#1)
of subjects with the##2##4##(2008-3#1)(2009-9#1)
of subjects with##20##3##(1991-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
of subjects##77##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#3)(1996-5#1)(1996-7#1)(1997-1#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#5)(2012-3#3)(2013-8#2)
of submaximal##2##2##(1991-8#1)(2013-8#1)
of submerged##2##2##(2008-7#2)
of submicron##2##2##(2008-10#1)(2008-11#1)
of submucosal hematoma of the esophagus##2##6##(2011-2#2)
of submucosal##4##2##(1990-5#1)(2008-12#1)(2011-2#2)
of subordinate##3##2##(1992-1#2)(2008-8#1)
of subpicosecond##6##2##(2007-11#3)(2007-12#2)(2008-2#1)
of subpopulation##2##2##(2008-10#1)(2008-12#1)
of subpopulations##4##2##(1997-4#1)(2008-10#2)(2008-9#1)
of subsequent complications##2##3##(2008-7#1)(2012-12#1)
of subsequent##31##2##(1990-2#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2009-8#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#2)
of subsets of##2##3##(1997-8#1)(2008-3#1)
of subsets##4##2##(1997-8#1)(2008-3#1)(2008-9#2)
of substance P (SP) and##2##5##(1992-3#1)(1992-9#1)
of substance P##8##3##(1992-3#1)(1992-9#1)(1994-8#5)(2008-7#1)
of substance abuse##4##3##(2008-6#1)(2009-5#1)(2010-11#1)(2013-8#1)
of substance abusers##3##3##(1991-1#1)(1994-2#1)(2011-1#1)
of substance use##8##3##(1994-2#1)(2008-5#1)(2008-6#1)(2009-7#4)(2010-10#1)
of substance##29##2##(1991-1#2)(1992-3#1)(1992-9#1)(1994-2#3)(1994-8#5)(2008-5#1)(2008-6#4)(2008-7#2)(2009-5#1)(2009-7#4)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
of substances in a##2##4##(2008-11#1)(2013-8#1)
of substances in##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2013-8#1)
of substances that##2##3##(2008-10#1)(2008-3#1)
of substances##19##2##(1990-3#1)(1993-12#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-5#1)(2012-3#1)(2013-8#2)
of substantia nigra##2##3##(1990-5#1)(1995-12#1)
of substantial##9##2##(1991-1#1)(1991-12#1)(1992-11#1)(1993-2#1)(1995-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
of substituents##3##2##(1991-5#1)(2009-10#2)
of substituted norbornadienes##2##3##(2009-9#2)
of substituted##14##2##(1996-2#1)(2007-11#5)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-9#2)
of substitution of##3##3##(2008-8#1)(2011-2#2)
of substitution##13##2##(1992-3#2)(1992-6#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)
of substitutive##2##2##(2008-3#1)(2013-1#1)
of substrate and##6##3##(1991-3#1)(1993-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-3#1)
of substrate converted##2##3##(2008-6#1)(2008-7#1)
of substrate dissolution##2##3##(2008-7#2)
of substrate in##2##3##(1995-2#1)(2008-7#1)
of substrate proteins##2##3##(2009-6#1)(2009-7#1)
of substrate solution with or without inhibitor##2##7##(2008-4#2)
of substrate specificity##2##3##(2007-11#1)(2011-2#1)
of substrate##52##2##(1990-5#1)(1990-7#1)(1991-12#2)(1991-3#1)(1992-3#2)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#11)(2008-8#1)(2009-11#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
of substrate/product##3##2##(1995-5#3)
of substrates and inhibitors##2##4##(1994-8#2)
of substrates and##7##3##(1992-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(2008-3#1)(2008-4#1)
of substrates##24##2##(1992-11#2)(1992-6#2)(1992-8#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#3)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2010-4#1)
of subsystems##2##2##(2008-10#1)(2008-11#1)
of subtalar joint##2##3##(2012-2#2)
of subtalar##3##2##(2008-12#1)(2012-2#2)
of subtelomeric DNA##2##3##(1991-7#1)(1997-6#1)
of subtelomeric##3##2##(1991-7#1)(1997-6#2)
of subtilisin##6##2##(1992-11#2)(1992-4#1)(2008-7#3)
of subtle##3##2##(2008-7#1)(2012-1#1)(2013-1#1)
of subtotal##2##2##(1991-5#1)(2008-7#1)
of subunit assembly##3##3##(1990-8#1)(1997-2#2)
of subunit##10##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#2)(1994-6#1)(1997-2#2)(2008-4#1)
of subunits as##2##3##(1991-10#1)(1992-8#1)
of subunits of##3##3##(1990-5#1)(1992-6#1)(2011-2#1)
of subunits##11##2##(1990-5#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-11#1)(1994-6#1)(1997-6#1)(2011-2#1)
of subwavelength##12##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#7)
of success and##2##3##(2008-3#1)(2013-8#1)
of success in##5##3##(2007-11#1)(2008-1#1)(2008-8#1)(2012-3#2)
of success or##2##3##(1996-3#1)(2007-4#1)
of success that##3##3##(1993-3#2)(2011-1#1)
of success was##2##3##(1991-2#1)(1994-3#1)
of success##27##2##(1991-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1996-3#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
of successes and##2##3##(1994-12#1)(1994-3#1)
of successful service redeployment##2##4##(1993-1#2)
of successful treatment##3##3##(1991-4#1)(2008-10#1)(2010-3#1)
of successful##35##2##(1991-1#1)(1991-2#1)(1991-4#1)(1993-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of successfully##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)
of successive##9##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
of succinic acid in biotechnological processes##2##6##(2008-10#2)
of succinic acid in##3##4##(2008-10#3)
of succinic acid##6##3##(1990-8#1)(2008-10#3)(2008-6#2)
of succinic semialdehyde##2##3##(1997-2#2)
of succinic##10##2##(1990-8#1)(1995-11#1)(1997-2#2)(2008-10#4)(2008-6#2)
of such a critical##2##4##(2008-8#2)
of such a lesion##3##4##(2008-1#1)(2008-7#1)(2010-7#1)
of such a method##3##4##(2008-10#2)(2008-5#1)
of such a new##3##4##(1990-12#1)(1990-3#1)(2011-2#1)
of such a program##2##4##(1992-12#1)(1992-3#1)
of such a sensor##3##4##(2007-12#1)(2008-10#1)(2010-2#1)
of such a system##6##4##(1992-2#1)(1994-1#1)(2008-2#2)(2008-3#2)
of such a##93##3##(1990-12#2)(1990-3#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-7#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
of such activities##2##3##(1991-12#1)(2008-11#1)
of such alterations##2##3##(2008-12#1)(2011-2#1)
of such an approach##5##4##(1992-8#1)(1996-11#1)(2007-8#1)(2008-3#1)(2012-12#1)
of such an assessment##2##4##(2008-11#2)
of such an event##2##4##(1997-5#1)(2008-11#1)
of such an##32##3##(1990-6#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-1#1)(2012-1#1)(2012-12#1)
of such antibodies##2##3##(2008-10#1)(2008-4#1)
of such background signals##2##4##(2008-3#2)
of such background##3##3##(1994-12#1)(2008-3#2)
of such cases will##2##4##(2007-7#1)(2011-2#1)
of such cases##10##3##(2007-7#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
of such children##2##3##(2007-12#1)(2012-12#1)
of such complex##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of such compounds##2##3##(1991-12#1)(1993-12#1)
of such conditions##2##3##(1990-12#1)(2009-3#1)
of such data##7##3##(1991-12#2)(2008-3#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
of such devices is##2##4##(2009-11#1)(2010-5#1)
of such devices##5##3##(1997-1#1)(2008-3#2)(2009-11#1)(2010-5#1)
of such disasters##2##3##(1991-2#1)(1993-1#1)
of such drugs##2##3##(2008-3#1)(2010-12#1)
of such effects##2##3##(1996-6#1)(2008-9#1)
of such efforts##2##3##(1993-2#1)(1994-12#1)
of such elements##2##3##(2008-10#1)(2008-3#1)
of such experiments##2##3##(2008-1#1)(2008-7#1)
of such factors as##2##4##(2008-11#1)(2008-8#1)
of such factors##3##3##(2007-11#1)(2008-11#1)(2008-8#1)
of such filters##2##3##(2007-12#1)(2008-2#1)
of such findings##2##3##(1992-12#1)(1995-11#1)
of such food##2##3##(2008-1#1)(2008-10#1)
of such genes is##2##4##(2008-10#1)(2008-4#1)
of such genes##4##3##(1993-9#1)(1994-8#1)(2008-10#1)(2008-4#1)
of such growth##2##3##(1996-5#1)(2008-11#1)
of such infections##3##3##(2009-2#1)(2011-1#1)(2013-8#1)
of such injuries##4##3##(1990-2#1)(1990-9#1)(1993-3#1)(2007-11#1)
of such interactions##2##3##(2008-10#1)(2010-10#1)
of such lasers##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
of such lesions is##2##4##(2008-11#1)(2012-3#1)
of such lesions##4##3##(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
of such materials##2##3##(2008-10#1)(2010-10#1)
of such measures##2##3##(2008-3#1)(2009-6#1)
of such methods##2##3##(1992-6#1)(2008-11#1)
of such models##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
of such modifications##2##3##(2008-10#1)(2013-8#1)
of such ontologies would##2##4##(2009-5#2)
of such patients with##2##4##(2008-7#1)(2011-2#1)
of such patients##12##3##(1990-2#1)(1991-11#1)(1995-11#1)(1997-8#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
of such programs##5##3##(1991-1#1)(1992-1#1)(1995-3#1)(2012-12#2)
of such sensors##2##3##(2008-10#2)
of such sequences##2##3##(1997-4#2)
of such studies is##2##4##(2008-10#1)(2010-12#1)
of such studies##8##3##(1993-6#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#2)
of such system##2##3##(2008-5#1)(2013-8#1)
of such systems is##2##4##(2008-3#1)(2013-8#1)
of such systems##8##3##(1996-1#1)(1997-6#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
of such techniques##3##3##(1994-9#1)(2008-10#2)
of such technologies##2##3##(2008-2#1)(2012-2#1)
of such tools##2##3##(1993-12#1)(2013-1#1)
of such training##2##3##(2007-2#1)(2012-3#1)
of such traits##2##3##(2007-12#1)(2008-8#1)
of such trials##3##3##(1994-9#1)(2010-3#1)(2013-7#1)
of such variance##2##3##(1994-3#1)(2007-8#1)
of such##541##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#2)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#4)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2007-10#3)(2007-11#11)(2007-12#16)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#56)(2008-11#35)(2008-12#9)(2008-2#19)(2008-3#39)(2008-4#9)(2008-5#12)(2008-6#4)(2008-7#15)(2008-8#16)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-5#8)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#9)(2010-4#1)(2010-5#6)(2010-7#2)(2011-1#8)(2011-2#13)(2011-3#2)(2012-1#2)(2012-12#8)(2012-2#16)(2012-3#5)(2013-1#23)(2013-7#1)(2013-8#12)
of sucrase-isomaltase gene##2##3##(1990-12#2)
of sucrase-isomaltase##4##2##(1990-12#4)
of sucrose and##2##3##(1990-8#1)(2008-10#1)
of sucrose in##5##3##(2008-10#4)(2011-2#1)
of sucrose##23##2##(1990-8#1)(1992-9#1)(1993-6#2)(1995-3#1)(2007-11#1)(2008-10#12)(2008-5#2)(2010-12#1)(2011-2#2)
of sudden cardiac death##6##4##(2009-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
of sudden cardiac##7##3##(2009-5#1)(2010-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
of sudden death in##2##4##(1992-11#1)(2008-12#1)
of sudden death syndrome##3##4##(2008-10#3)
of sudden death##8##3##(1992-11#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of sudden infant death syndrome##4##5##(1991-11#2)(1991-9#1)(2007-12#1)
of sudden infant death##8##4##(1991-11#2)(1991-9#2)(1992-4#2)(1996-9#1)(2007-12#1)
of sudden##32##2##(1991-11#3)(1991-9#2)(1992-11#2)(1992-4#2)(1993-8#1)(1996-9#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
of suffering from##2##3##(2012-1#1)(2012-3#1)
of suffering##6##2##(1991-8#1)(1996-3#1)(2011-2#1)(2012-1#1)(2012-3#2)
of sufficient quality##3##3##(2008-10#1)(2008-3#2)
of sufficient##20##2##(1994-3#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
of sugar beet##13##3##(2008-10#5)(2008-12#5)(2008-5#2)(2012-3#1)
of sugar in the##2##4##(2008-10#1)(2008-9#1)
of sugar in##3##3##(1993-9#1)(2008-10#1)(2008-9#1)
of sugar transport##2##3##(1991-12#1)(2008-10#1)
of sugar utilization##2##3##(2008-6#2)
of sugar##33##2##(1991-12#1)(1993-11#2)(1993-9#3)(1997-2#1)(2008-10#8)(2008-12#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#2)
of sugar-sweetened beverages##3##3##(2011-2#2)(2012-1#1)
of sugarcane (Saccharum##2##3##(2008-10#2)
of sugarcane##15##2##(2008-10#12)(2011-2#1)(2013-1#2)
of sugars and##4##3##(2008-10#3)(2008-6#1)
of sugars##14##2##(2008-10#4)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of suggested##3##2##(1995-1#1)(2008-12#1)(2013-1#1)
of suggestions##2##2##(2008-12#1)(2010-2#1)
of suicidal behavior##2##3##(2013-1#2)
of suicidal ideation##3##3##(1992-1#1)(2010-6#1)(2013-1#1)
of suicidal##11##2##(1992-1#2)(1992-5#1)(2008-6#1)(2010-6#3)(2010-7#1)(2013-1#3)
of suicide by##3##3##(2009-2#1)(2011-2#2)
of suicide in Abitibi-Temiscamingue##2##4##(1996-1#2)
of suicide in older##2##4##(2009-5#2)
of suicide in##9##3##(1996-1#2)(2009-10#1)(2009-5#3)(2010-6#1)(2011-2#1)(2012-12#1)
of suicide prevention centers##2##4##(1991-12#2)
of suicide substrates##2##3##(1990-8#1)(2008-5#1)
of suicide##30##2##(1990-8#1)(1991-12#3)(1996-1#2)(2008-5#1)(2008-7#2)(2009-10#2)(2009-2#1)(2009-5#5)(2009-7#3)(2010-6#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
of suitability##2##2##(1992-4#1)(2007-2#1)
of suitable##21##2##(1990-6#1)(1994-2#1)(1994-9#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#2)(2009-11#1)(2009-4#1)(2011-3#1)(2013-1#2)
of suitably protected##2##3##(1992-12#1)(2008-4#1)
of suitably##5##2##(1992-12#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#1)
of sulfaguanidine##3##2##(2008-10#3)
of sulfate aerosols##2##3##(2008-3#2)
of sulfate and##3##3##(2008-10#2)(2008-6#1)
of sulfate ion##4##3##(2008-10#4)
of sulfate was##2##3##(2008-6#2)
of sulfate##16##2##(1992-10#1)(2008-10#8)(2008-3#2)(2008-6#3)(2009-8#2)
of sulfated glycosaminoglycans##4##3##(1993-12#3)(1995-2#1)
of sulfated##6##2##(1991-12#1)(1992-12#1)(1993-12#3)(1995-2#1)
of sulfathiazole in##2##3##(2008-10#2)
of sulfhydryl groups##4##3##(1991-5#1)(1992-5#1)(1992-8#1)(1993-6#1)
of sulfhydryl##6##2##(1991-5#1)(1992-5#2)(1992-8#1)(1993-6#1)(1995-6#1)
of sulfide silver staining##3##4##(1994-6#3)
of sulfide##25##2##(1994-6#3)(2008-10#21)(2008-11#1)
of sulfides##2##2##(2008-10#1)(2008-6#1)
of sulfisoxazole was##2##3##(2008-12#2)
of sulfisoxazole##5##2##(2008-12#5)
of sulfite ion##2##3##(2008-10#2)
of sulfite ions##2##3##(2008-10#2)
of sulfite reductase##2##3##(1990-5#1)(1993-8#1)
of sulfite##21##2##(1990-5#1)(1993-8#2)(2008-10#18)
of sulfonamide##5##2##(2008-10#2)(2009-3#2)(2009-8#1)
of sulfonamides and quinolones on##2##5##(2008-10#2)
of sulfonamides on##2##3##(1991-5#1)(2008-10#1)
of sulfonamides##11##2##(1991-5#1)(2008-10#9)(2013-1#1)
of sulfonylurea##3##2##(1992-3#1)(1994-8#1)(2008-10#1)
of sulfonylureas##3##2##(1991-12#1)(1992-3#1)(2008-3#1)
of sulfosalicylic acid##2##3##(2008-10#2)
of sulfur and##2##3##(2008-10#1)(2008-9#1)
of sulfur dioxide in##3##4##(2008-10#3)
of sulfur dioxide##4##3##(2008-10#4)
of sulfur##22##2##(1996-2#1)(1997-7#2)(2008-10#16)(2008-5#1)(2008-9#1)(2011-2#1)
of sulfuric acid##7##3##(2008-10#5)(2008-2#1)(2010-6#1)
of sulfuric##8##2##(2008-10#6)(2008-2#1)(2010-6#1)
of sulindac and##2##3##(1992-3#1)(2009-12#1)
of sulphamethoxazole##2##2##(2008-10#2)
of sulphate conjugated##2##3##(1997-7#2)
of sulphate##9##2##(1997-7#2)(2008-10#7)
of sulphated##2##2##(1993-6#1)(1994-8#1)
of sulphide at##2##3##(2008-10#2)
of sulphide##8##2##(2008-10#8)
of sulphite##2##2##(2008-10#2)
of sulphur compounds##2##3##(2008-10#2)
of sulphur dioxide##2##3##(2008-10#2)
of sulphur in##5##3##(2008-10#5)
of sulphur spa therapy with##2##5##(2008-4#2)
of sulphur##15##2##(2008-10#11)(2008-11#1)(2008-4#3)
of sulphuric acid##4##3##(2008-10#4)
of sulphuric##5##2##(2008-10#5)
of sulphydryl compounds##2##3##(1992-8#2)
of sulphydryl##3##2##(1992-8#2)(2008-10#1)
of sum##2##2##(2007-12#1)(2008-7#1)
of summary##2##2##(1993-12#1)(1994-9#1)
of summation##3##2##(2008-10#3)
of summer##5##2##(2008-10#3)(2012-2#1)(2013-1#1)
of sun care products##3##4##(2008-5#3)
of sun exposure in##2##4##(2011-2#2)
of sun exposure##3##3##(2011-2#3)
of sun protection factors##3##4##(2008-5#3)
of sun reactive skin##2##4##(1991-6#1)(2008-5#1)
of sun##13##2##(1991-6#1)(2008-2#1)(2008-3#1)(2008-5#7)(2011-2#3)
of sunburn cells in##2##4##(2008-5#2)
of sunburn##3##2##(1992-6#1)(2008-5#2)
of sunflower (Helianthus##2##3##(2008-10#2)
of sunflower##10##2##(2008-10#10)
of sunlight intensity##2##3##(2008-6#1)(2008-8#1)
of sunlight is##2##3##(2008-10#1)(2011-2#1)
of sunlight##14##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#6)
of sunscreen lotions##2##3##(2008-5#2)
of sunscreen products##2##3##(2008-5#2)
of sunscreen##13##2##(2008-10#1)(2008-3#1)(2008-5#10)(2008-8#1)
of sunscreening agents##2##3##(2008-5#2)
of sunscreens is##2##3##(2008-5#2)
of sunscreens##13##2##(1991-6#2)(2008-3#1)(2008-5#10)
of sunset yellow##2##3##(2008-10#2)
of superabsorbent polymer##3##3##(2008-12#3)
of superabsorbent##4##2##(2008-11#1)(2008-12#3)
of supercontinuum##2##2##(2007-11#2)
of supercritical CO(2)##2##3##(2008-10#2)
of supercritical carbon dioxide##3##4##(2008-10#1)(2010-4#2)
of supercritical fluid extraction##2##4##(2008-10#1)(2012-3#1)
of supercritical fluid##3##3##(2008-10#2)(2012-3#1)
of supercritical##10##2##(2008-10#6)(2010-4#2)(2012-2#1)(2012-3#1)
of superficial bladder cancer##2##4##(1993-11#1)(2007-10#1)
of superficial bladder##5##3##(1993-11#1)(1993-9#2)(2007-10#1)(2008-1#1)
of superficial lesions##2##3##(2008-7#1)(2011-1#1)
of superficial mycosis##2##3##(2008-5#2)
of superficial##21##2##(1993-11#1)(1993-12#1)(1993-9#2)(2007-10#1)(2008-1#1)(2008-5#5)(2008-6#1)(2008-7#3)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
of superheated water##2##3##(2008-10#2)
of superimposed##3##2##(1995-3#1)(2008-3#2)
of superior vena cava##4##4##(2007-8#4)
of superior vena##5##3##(2007-8#4)(2011-2#1)
of superior##16##2##(1991-5#1)(1993-12#1)(1994-3#1)(1997-3#1)(2007-8#4)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of superior-posterior radiograms##2##3##(2007-8#2)
of supernatant##5##2##(1997-4#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
of supernatants##2##2##(2013-1#2)
of supernumerary chromosomes##2##3##(2008-5#1)(2010-3#1)
of supernumerary##6##2##(1990-5#2)(2008-3#1)(2008-5#1)(2010-3#1)(2013-1#1)
of superoxide (O(2)##2##3##(2008-10#2)
of superoxide anion and hydrogen peroxide##2##6##(1994-8#1)(2008-10#1)
of superoxide anion##9##3##(1993-6#3)(1994-8#1)(1995-6#1)(2008-10#2)(2008-4#1)(2012-2#1)
of superoxide dismutase (SOD) and##2##5##(1994-6#1)(2012-2#1)
of superoxide dismutase (SOD)##8##4##(1992-9#1)(1994-6#1)(1997-4#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
of superoxide dismutase and catalase##3##5##(1992-11#1)(1994-6#2)
of superoxide dismutase##18##3##(1990-3#2)(1991-12#1)(1992-11#1)(1992-9#1)(1994-6#4)(1995-3#1)(1997-4#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of superoxide generation##2##3##(1993-6#1)(1994-11#1)
of superoxide radical##2##3##(1994-11#1)(2010-5#1)
of superoxide radicals##3##3##(1995-3#1)(1995-6#1)(2008-4#1)
of superoxide##43##2##(1990-3#2)(1991-12#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-6#4)(1994-11#3)(1994-6#4)(1994-8#1)(1995-3#2)(1995-6#2)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#7)(2008-4#3)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
of superparamagnetic##2##2##(2012-2#1)(2013-1#1)
of superresolution##2##2##(2008-2#1)(2008-3#1)
of superresolving##2##2##(2007-12#1)(2008-3#1)
of supervised##3##2##(2008-10#1)(2009-7#2)
of supervision##3##2##(1992-11#1)(1992-6#1)(1995-3#1)
of supervisory##2##2##(2012-3#1)(2013-1#1)
of supplemental vitamin E##2##4##(1992-9#2)
of supplemental##4##2##(1992-9#2)(2007-10#1)(2007-7#1)
of supplementation of##2##3##(2008-11#1)(2008-7#1)
of supplementation##8##2##(2008-11#2)(2008-5#4)(2008-7#1)(2011-1#1)
of supplements and##2##3##(2008-11#1)(2009-5#1)
of supplements##3##2##(2008-11#1)(2009-5#1)(2013-7#1)
of supply##3##2##(1996-3#1)(2007-11#1)(2012-12#1)
of support during##2##3##(1993-3#1)(2013-1#1)
of support for##4##3##(1993-1#2)(2008-1#1)(2008-11#1)
of support in##2##3##(2009-7#1)(2010-1#1)
of support services##2##3##(1993-1#2)
of support to##3##3##(1995-1#1)(1997-2#1)(2009-9#1)
of support##31##2##(1992-3#1)(1993-1#4)(1993-3#1)(1994-1#2)(1994-3#2)(1995-1#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
of supporting electrolyte##3##3##(2008-10#3)
of supporting the##2##3##(2008-7#1)(2009-5#1)
of supporting##18##2##(1994-5#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
of supportive cancer therapy##3##4##(2008-7#3)
of supportive care in##3##4##(2007-5#1)(2008-7#2)
of supportive care##9##3##(1991-8#1)(2007-5#2)(2008-7#4)(2011-2#2)
of supportive therapy##2##3##(2008-7#1)(2011-2#1)
of supportive##21##2##(1991-8#1)(1993-1#1)(1993-12#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-7#9)(2009-1#1)(2011-2#3)(2012-12#1)
of suppressing the##5##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
of suppressing##8##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2013-1#1)
of suppression of the##2##4##(2008-2#1)(2008-7#1)
of suppression of##8##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2013-7#1)
of suppression was##2##3##(2008-10#1)(2009-11#1)
of suppression##17##2##(1994-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-11#2)(2012-12#2)(2013-7#1)
of suppressive##2##2##(2008-10#1)(2008-8#1)
of suppressiveness##5##2##(2008-10#5)
of supracondylar humerus fractures in children##2##6##(2009-3#1)(2013-1#1)
of supracondylar humerus fractures in##3##5##(2009-3#1)(2013-1#2)
of supracondylar##4##2##(2009-3#1)(2010-11#1)(2013-1#2)
of supramolecular##2##2##(1993-12#1)(2010-12#1)
of supratentorial##3##2##(2008-7#1)(2012-12#2)
of suprathreshold##3##2##(2008-9#2)(2011-2#1)
of supraventricular tachycardia##2##3##(2008-7#1)(2012-3#1)
of supraventricular##3##2##(2008-7#1)(2012-1#1)(2012-3#1)
of surface acoustic waves##4##4##(2007-11#1)(2008-10#1)(2008-3#2)
of surface acoustic##5##3##(2007-11#2)(2008-10#1)(2008-3#2)
of surface active##2##3##(2008-10#2)
of surface and##7##3##(1990-12#2)(1996-12#1)(2007-5#1)(2008-10#1)(2008-9#2)
of surface charge##4##3##(1994-5#1)(1997-2#1)(2008-8#1)(2013-1#1)
of surface defects on thin metallic wires##2##7##(2008-3#2)
of surface expression of##2##4##(1994-6#1)(2008-4#1)
of surface markers##2##3##(2008-4#1)(2008-9#1)
of surface plasmon resonance (SPR)##2##5##(2008-10#1)(2008-9#1)
of surface plasmon resonance##4##4##(1992-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
of surface plasmon##6##3##(1992-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
of surface reliefs##2##3##(2008-3#2)
of surface roughness##5##3##(2008-2#1)(2008-3#2)(2009-7#1)(2012-2#1)
of surface tension##3##3##(1994-5#1)(2008-3#1)(2013-8#1)
of surface water##6##3##(2008-10#2)(2008-11#1)(2008-8#3)
of surface waves##3##3##(2008-2#2)(2008-3#1)
of surface##122##2##(1990-12#2)(1990-5#2)(1992-11#1)(1993-12#1)(1994-5#3)(1994-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#23)(2008-11#3)(2008-2#6)(2008-3#19)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#4)(2013-8#3)
of surface-bound molecules##2##3##(2008-2#2)
of surface-bound##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
of surface-enhanced Raman scattering##3##4##(2008-10#1)(2013-8#2)
of surface-enhanced Raman spectroscopy (SERS)##2##5##(2008-10#1)(2012-1#1)
of surface-enhanced Raman spectroscopy##3##4##(2008-10#1)(2012-1#1)(2013-8#1)
of surface-enhanced Raman##6##3##(2008-10#2)(2012-1#1)(2013-8#3)
of surface-enhanced##7##2##(2008-10#2)(2012-1#1)(2013-8#4)
of surface-patterned nanostructures##2##3##(2008-10#2)
of surface-plasmon polaritons##2##3##(2008-3#2)
of surface-plasmon##4##2##(2008-3#4)
of surface-relief##2##2##(2008-3#2)
of surfaces and##2##3##(2007-12#1)(2009-5#1)
of surfaces from##2##3##(2008-3#2)
of surfaces in##2##3##(2008-3#2)
of surfaces is##2##3##(2008-10#1)(2008-3#1)
of surfaces with##3##3##(2008-3#1)(2008-4#1)(2010-12#1)
of surfaces##21##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#12)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)
of surfactant concentration##2##3##(2008-10#2)
of surfactant micelles##2##3##(2008-10#2)
of surfactant preparations##2##3##(2007-11#2)
of surfactant##31##2##(1990-11#1)(1992-5#1)(1994-5#4)(1996-5#1)(1996-6#1)(2007-11#4)(2008-10#14)(2008-5#2)(2010-11#1)(2010-3#1)(2011-2#1)
of surfactants and##2##3##(2008-10#1)(2008-6#1)
of surfactants in##2##3##(2008-10#2)
of surfactants##19##2##(2008-10#11)(2008-5#4)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)
of surgeonfish##3##2##(2008-5#3)
of surgeons and##2##3##(2008-10#1)(2011-2#1)
of surgeons##6##2##(2008-10#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)
of surgery and the##2##4##(2007-12#1)(2007-8#1)
of surgery and##10##3##(1993-1#1)(1993-6#1)(2007-12#1)(2007-5#1)(2007-8#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
of surgery for##6##3##(1990-9#1)(1991-3#1)(1994-12#1)(2009-5#1)(2010-7#1)(2012-3#1)
of surgery in the treatment of##2##6##(2007-11#2)
of surgery in the##4##4##(2007-11#2)(2007-8#1)(2011-2#1)
of surgery in##7##3##(2007-11#2)(2007-8#2)(2008-6#1)(2010-8#1)(2011-2#1)
of surgery is##4##3##(2007-11#1)(2010-3#1)(2011-2#2)
of surgery of##2##3##(1990-6#1)(2007-11#1)
of surgery on##2##3##(2008-7#1)(2012-3#1)
of surgery was##2##3##(1992-11#1)(2008-7#1)
of surgery were##2##3##(1993-12#1)(2011-2#1)
of surgery##98##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-3#3)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-1#1)(1997-7#1)(2007-11#8)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#5)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#4)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#10)(2013-1#5)
of surgical and adjuvant##2##4##(2008-6#1)(2010-12#1)
of surgical and##7##3##(1990-12#1)(1993-5#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-12#1)(2013-1#1)
of surgical approach##4##3##(1992-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
of surgical approaches##3##3##(1991-3#1)(2007-12#1)(2008-7#1)
of surgical care##3##3##(2007-8#1)(2008-4#1)(2010-8#1)
of surgical closure##2##3##(2012-1#2)
of surgical complications##4##3##(1993-3#1)(2007-8#1)(2008-9#1)(2011-1#1)
of surgical correction##2##3##(2007-7#1)(2011-2#1)
of surgical excision##3##3##(1991-6#1)(2007-12#1)(2008-9#1)
of surgical infections in##2##4##(1990-2#1)(1992-6#1)
of surgical instruments##2##3##(2009-12#1)(2009-4#1)
of surgical intervention are##2##4##(1990-8#1)(2007-12#1)
of surgical intervention##7##3##(1990-8#1)(2007-12#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
of surgical management of##2##4##(2007-12#1)(2008-10#1)
of surgical margins##3##3##(1995-4#3)
of surgical procedure##3##3##(2012-2#2)(2013-1#1)
of surgical procedures##6##3##(1991-6#1)(2007-11#1)(2007-8#1)(2008-7#2)(2008-8#1)
of surgical resection##8##3##(1990-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-3#1)(2011-1#1)(2013-8#1)
of surgical site infection##2##4##(2010-12#1)(2012-3#1)
of surgical site infections in##3##5##(2008-10#2)(2009-3#1)
of surgical site infections##4##4##(2008-10#2)(2009-3#1)(2012-3#1)
of surgical site##8##3##(2008-10#2)(2009-3#1)(2010-12#1)(2012-3#3)(2013-1#1)
of surgical technique##3##3##(2007-11#1)(2007-8#1)(2009-8#1)
of surgical techniques##3##3##(1994-5#1)(2009-10#1)(2010-8#1)
of surgical therapy##2##3##(1990-5#1)(2011-3#1)
of surgical treatment of metastatic bone tumors##2##7##(2007-11#2)
of surgical treatment of##11##4##(1990-5#1)(1997-2#1)(2007-11#5)(2007-8#1)(2008-8#1)(2012-1#1)(2013-1#1)
of surgical treatment##25##3##(1990-5#1)(1990-9#2)(1992-6#1)(1993-3#1)(1994-12#1)(1997-2#1)(2007-11#8)(2007-8#3)(2008-10#1)(2008-8#2)(2011-2#1)(2012-1#1)(2013-1#2)
of surgical##146##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-3#1)(1991-6#2)(1992-5#1)(1992-6#3)(1993-3#3)(1993-5#1)(1994-12#2)(1994-5#1)(1995-3#3)(1995-4#3)(1996-10#1)(1996-11#1)(1996-3#1)(1997-2#2)(2007-11#10)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#5)(2011-1#3)(2011-2#5)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#9)(2013-8#1)
of surgically treated##2##3##(2008-7#1)(2011-2#1)
of surgically##7##2##(1996-1#1)(1997-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
of surprise and##2##3##(1990-11#2)
of surrogate##2##2##(2008-11#1)(2008-7#1)
of surrogates##2##2##(1995-5#1)(2008-10#1)
of surrounding##6##2##(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#1)
of surveillance and##5##3##(1997-2#1)(2007-12#1)(2008-7#1)(2009-12#1)(2009-8#1)
of surveillance##10##2##(1993-2#1)(1997-2#1)(1997-3#2)(2007-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
of survey##3##2##(1993-2#1)(1997-3#1)(2009-4#1)
of surveys##3##2##(1991-3#1)(1993-1#1)(1993-6#1)
of survival and the##2##4##(2007-8#1)(2013-1#1)
of survival and##8##3##(1994-6#1)(1996-3#1)(2007-11#1)(2007-8#1)(2010-8#1)(2013-1#1)(2013-7#2)
of survival by##2##3##(1995-4#1)(2007-8#1)
of survival curves##2##3##(1995-1#1)(1995-3#1)
of survival in##3##3##(1994-12#1)(2007-8#1)(2011-1#1)
of survival of##2##3##(2008-5#1)(2013-1#1)
of survival time##2##3##(1991-2#1)(2012-3#1)
of survival was##3##3##(1991-6#1)(2007-8#1)(2008-7#1)
of survival##58##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-11#3)(2007-5#1)(2007-8#6)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
of survivin##5##2##(2010-1#1)(2011-2#4)
of surviving##14##2##(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
of survivors of##4##3##(1990-5#1)(2008-11#3)
of survivors##9##2##(1990-11#1)(1990-5#1)(1991-4#1)(2008-11#3)(2008-5#2)(2011-3#1)
of susceptibility testing and##2##4##(2008-8#1)(2008-9#1)
of susceptibility to##6##3##(1992-2#1)(2008-10#2)(2009-5#1)(2012-3#2)
of susceptibility##18##2##(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
of susceptible and resistant cultivars##2##5##(2008-10#2)
of susceptible and resistant##5##4##(2008-10#5)
of susceptible and##8##3##(2008-10#7)(2011-2#1)
of susceptible animals##2##3##(2007-6#1)(2011-2#1)
of susceptible crops##5##3##(2008-10#5)
of susceptible cultivars##2##3##(2008-10#2)
of susceptible host tissue##3##4##(2008-10#3)
of susceptible host##4##3##(2008-10#4)
of susceptible plants##2##3##(2008-10#2)
of susceptible potato cv##2##4##(2008-10#2)
of susceptible potato##3##3##(2008-10#3)
of susceptible tissue##2##3##(2008-10#2)
of susceptible##45##2##(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(2007-6#1)(2008-10#36)(2008-8#1)(2011-2#3)
of suspected MDR-TB##2##3##(2013-1#2)
of suspected acute##3##3##(1995-11#2)(2010-8#1)
of suspected breast cancer local recurrences##2##6##(1990-6#2)
of suspected##27##2##(1990-12#1)(1990-6#3)(1992-11#1)(1992-3#1)(1995-11#2)(1996-6#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#3)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of suspended matter##2##3##(2008-10#1)(2008-5#1)
of suspended particles and##2##4##(2008-2#2)
of suspended particulate##2##3##(2008-2#1)(2008-3#1)
of suspended solids##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
of suspended##15##2##(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2010-5#1)
of suspension cells##3##3##(2008-11#3)
of suspension##9##2##(2008-10#1)(2008-11#5)(2008-7#1)(2008-8#2)
of suspensions of##2##3##(1994-12#1)(2008-3#1)
of suspensions##3##2##(1994-12#1)(2008-3#2)
of suspicion is required to##5##5##(1995-10#1)(2007-7#1)(2008-1#1)(2010-1#1)(2012-12#1)
of suspicion is##8##3##(1993-6#1)(1995-10#1)(2007-7#3)(2008-1#1)(2010-1#1)(2012-12#1)
of suspicion##25##2##(1992-5#1)(1993-6#1)(1995-10#1)(2006-10#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#2)
of suspicious##2##2##(1990-6#1)(2008-10#1)
of sustainability##2##2##(1997-7#2)
of sustained and transient##2##4##(2008-9#2)
of sustained and##3##3##(2008-4#1)(2008-9#2)
of sustained release##2##3##(2008-11#1)(2012-2#1)
of sustained##16##2##(1990-3#1)(1991-12#1)(1992-8#1)(1994-5#1)(1995-2#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-4#1)(2012-2#1)(2012-4#1)(2013-1#1)
of sustaining##4##2##(1993-5#1)(2008-10#1)(2008-2#1)(2008-4#1)
of suture##2##2##(1993-9#1)(1995-1#1)
of sutured##2##2##(1993-11#1)(2013-1#1)
of suxamethonium##2##2##(1996-8#1)(2012-2#1)
of swainsonine##3##2##(2008-11#3)
of swallowing##4##2##(1993-12#2)(2013-1#1)(2013-8#1)
of swallows and martins##2##4##(2008-8#2)
of swarming in##2##3##(2009-6#2)
of sweat##5##2##(1991-6#2)(1992-3#1)(2008-10#1)(2008-5#1)
of sweet cherry##2##3##(2008-10#2)
of sweet orange##4##3##(2008-10#4)
of sweet potato feathery mottle potyvirus##2##6##(2008-10#2)
of sweet potato##4##3##(2008-10#4)
of sweet##14##2##(2008-10#12)(2008-2#1)(2008-5#1)
of swelling of the##2##4##(2009-5#1)(2013-1#1)
of swelling##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
of swimmers##2##2##(1996-8#1)(2009-1#1)
of swimming behavior##2##3##(2008-4#1)(2008-5#1)
of swimming##5##2##(1990-11#1)(1991-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
of swine pepsin##3##3##(1996-5#3)
of swine##7##2##(1996-5#3)(2011-2#1)(2013-1#3)
of switching junctions##2##3##(2007-12#2)
of syllable##2##2##(2008-9#1)(2013-8#1)
of symbiotic##2##2##(2007-12#1)(2008-11#1)
of symmetric##6##2##(1993-8#1)(2007-11#3)(2008-3#1)(2008-8#1)
of symmetrical##5##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
of symmetry and##2##3##(2008-6#1)(2012-1#1)
of symmetry##15##2##(1990-8#2)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#1)(2012-1#1)
of sympathetic##6##2##(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
of sympathovagal##2##2##(2011-1#1)(2012-2#1)
of sympathy##3##2##(2012-2#3)
of sympatric species##2##3##(2008-9#2)
of sympatric##6##2##(2008-10#3)(2008-9#2)(2010-8#1)
of sympatry##2##2##(2008-10#2)
of symptom development##2##3##(2008-10#2)
of symptom expression and##2##4##(2008-10#2)
of symptom expression##3##3##(2008-10#3)
of symptom onset##3##3##(2007-10#1)(2007-9#1)(2008-9#1)
of symptom severity##4##3##(2008-10#4)
of symptom##19##2##(2007-10#1)(2007-9#1)(2008-10#12)(2008-7#2)(2008-9#1)(2009-9#1)(2010-6#1)
of symptomatic carotid##2##3##(2008-8#2)
of symptomatic illness##2##3##(2007-2#1)(2011-2#1)
of symptomatic plants##3##3##(2008-10#3)
of symptomatic trees##3##3##(2008-10#3)
of symptomatic##40##2##(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-7#2)(2008-8#4)(2008-9#1)(2010-3#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
of symptomatology##8##2##(1990-9#1)(1994-6#1)(1996-5#1)(1996-9#2)(2008-10#1)(2011-1#1)(2012-12#1)
of symptomless##3##2##(2008-10#3)
of symptoms and the##4##4##(2006-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
of symptoms and##22##3##(1991-2#1)(1991-6#1)(1992-5#1)(1992-9#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#1)
of symptoms by##2##3##(2008-5#1)(2008-7#1)
of symptoms in##11##3##(1990-2#1)(1997-6#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2011-8#1)(2012-12#1)
of symptoms induced by##2##4##(2008-10#2)
of symptoms induced##3##3##(2008-10#3)
of symptoms of##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
of symptoms on##3##3##(2008-10#3)
of symptoms to##3##3##(2008-3#1)(2008-6#1)(2013-1#1)
of symptoms was##12##3##(1990-10#1)(1995-8#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#3)(2012-12#1)(2013-1#1)
of symptoms##135##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#4)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#3)(1992-5#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#5)(2008-7#13)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-10#1)(2011-2#10)(2011-8#1)(2012-12#9)(2012-2#2)(2013-1#8)(2013-7#2)(2013-8#1)
of synapse##2##2##(2009-11#1)(2009-8#1)
of synapses##7##2##(1992-12#1)(1994-8#1)(1996-2#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
of synaptic activity##3##3##(1996-12#1)(2009-3#1)(2013-8#1)
of synaptic connections##2##3##(1997-2#1)(2008-11#1)
of synaptic efficacy##2##3##(1994-8#1)(2008-7#1)
of synaptic homeostasis##4##3##(2009-9#4)
of synaptic plasticity in this##2##5##(1995-12#1)(2008-4#1)
of synaptic plasticity in##3##4##(1995-12#1)(2008-4#2)
of synaptic plasticity##9##3##(1993-12#1)(1995-12#1)(2008-4#3)(2009-8#2)(2009-9#1)(2012-2#1)
of synaptic strength##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
of synaptic transmission and plasticity##2##5##(2009-8#2)
of synaptic transmission and##3##4##(2008-7#1)(2009-8#2)
of synaptic transmission in the##3##5##(1993-12#1)(1995-12#1)(2008-5#1)
of synaptic transmission in##4##4##(1993-12#1)(1995-12#1)(1995-2#1)(2008-5#1)
of synaptic transmission##20##3##(1993-12#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-4#3)(2008-5#2)(2008-7#2)(2009-8#2)(2009-9#1)
of synaptic vesicles##5##3##(1993-12#1)(1997-7#2)(2008-1#1)(2008-8#1)
of synaptic##62##2##(1990-3#1)(1990-9#1)(1993-12#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#6)(1995-2#2)(1996-12#1)(1996-2#2)(1996-5#3)(1997-2#1)(1997-3#1)(1997-7#4)(2008-1#1)(2008-11#3)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-8#5)(2009-9#7)(2012-2#1)(2013-8#2)
of synaptophysin##3##2##(1996-5#1)(2012-3#1)(2013-1#1)
of synaptosomes with##2##3##(1995-11#1)(1995-3#1)
of synchronization##4##2##(2007-11#1)(2007-9#1)(2008-11#1)(2012-2#1)
of synchronized##3##2##(1994-5#1)(2012-2#1)(2013-1#1)
of synchronous and##2##3##(1992-8#1)(2008-10#1)
of synchronous fluorescence spectroscopy##2##4##(2008-10#2)
of synchronous luminescence##2##3##(2008-10#2)
of synchronous##17##2##(1991-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-3#1)(2009-1#1)(2013-1#1)(2013-8#1)
of synchronously##2##2##(2007-11#2)
of synchrony##3##2##(2008-11#3)
of synchrotron radiation in##2##4##(2008-10#1)(2008-3#1)
of synchrotron radiation##3##3##(2008-10#2)(2008-3#1)
of synchrotron##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
of syncytiotrophoblast in resorption villi of placentas##2##7##(2011-1#2)
of syncytiotrophoblast in resorption villi of##5##6##(2011-1#5)
of syncytiotrophoblast in resorption villi##6##5##(2011-1#6)
of syncytiotrophoblast##7##2##(2011-1#7)
of syndicate learning##3##3##(2012-1#3)
of syndicate##4##2##(2012-1#4)
of syndrome##4##2##(1990-6#1)(1994-7#1)(2008-10#1)(2008-12#1)
of syndromes##4##2##(1997-5#1)(2007-11#1)(2007-7#1)(2008-7#1)
of synergetics##3##2##(2008-1#3)
of synergy##4##2##(1994-11#1)(2008-10#2)(2008-11#1)
of syngeneic##2##2##(1990-12#1)(2013-1#1)
of synovial bursae##2##3##(2007-11#2)
of synovial fluid##4##3##(1990-6#2)(2008-10#1)(2010-10#1)
of synovial membrane##2##3##(2013-1#2)
of synovial sarcoma##3##3##(2008-6#1)(2009-3#1)(2013-1#1)
of synovial tissue##2##3##(1991-5#1)(2013-1#1)
of synovial##16##2##(1990-6#2)(1991-5#1)(1992-3#2)(2007-11#2)(2008-10#1)(2008-6#2)(2009-3#1)(2010-10#1)(2013-1#4)
of syntactic##2##2##(2008-2#1)(2008-7#1)
of synthesis and##2##3##(1990-8#1)(1994-8#1)
of synthesis conditions and##2##4##(2008-1#1)(2010-4#1)
of synthesis of##2##3##(2008-5#1)(2009-8#1)
of synthesis##12##2##(1990-12#1)(1990-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-4#1)
of synthesizing##2##2##(2008-3#1)(2009-12#1)
of synthetic and natural##2##4##(2008-10#1)(2010-10#1)
of synthetic and##5##3##(2008-10#3)(2010-10#1)(2011-2#1)
of synthetic biology##3##3##(2009-5#2)(2012-2#1)
of synthetic mixtures of##2##4##(2008-10#2)
of synthetic mixtures##4##3##(2008-10#4)
of synthetic peptides to##2##4##(2008-2#1)(2008-4#1)
of synthetic peptides##15##3##(1990-7#1)(1992-6#1)(1994-9#1)(2008-10#1)(2008-2#3)(2008-4#7)(2012-1#1)
of synthetic playing surfaces##2##4##(2013-1#2)
of synthetic samples##2##3##(2008-10#2)
of synthetic##90##2##(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#25)(2008-11#2)(2008-2#7)(2008-3#3)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
of syphilis in##2##3##(2007-7#2)
of syphilis##8##2##(1995-2#1)(1997-5#1)(2007-7#3)(2008-10#1)(2011-2#2)
of syringaldazine##2##2##(2008-10#2)
of system is##2##3##(2007-11#1)(2013-8#1)
of system variables##2##3##(1990-7#1)(2008-10#1)
of system##15##2##(1990-7#1)(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2012-3#1)(2013-8#2)
of systematic error##2##3##(2008-10#1)(2008-3#1)
of systematic errors in##2##4##(2007-11#1)(2008-3#1)
of systematic errors##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of systematic patient education##2##4##(1993-12#2)
of systematic screening##2##3##(1991-3#1)(2013-1#1)
of systematic##27##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1993-12#2)(1993-2#1)(1994-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#6)(2008-7#1)(2010-2#1)(2011-2#2)(2013-1#1)
of systemic acquired resistance##3##4##(2008-10#3)
of systemic acquired##4##3##(2008-10#4)
of systemic autoimmune diseases##2##4##(2008-10#1)(2012-3#1)
of systemic autoimmune##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
of systemic disease##4##3##(2008-10#2)(2008-6#1)(2009-8#1)
of systemic infection##2##3##(2008-10#1)(2008-11#1)
of systemic infections##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
of systemic inflammatory reaction##2##4##(2007-12#2)
of systemic inflammatory##3##3##(2007-12#2)(2010-5#1)
of systemic lupus erythematosus (SLE)##5##5##(2006-10#1)(2008-1#2)(2011-2#2)
of systemic lupus erythematosus##13##4##(2006-10#3)(2007-7#1)(2008-1#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
of systemic resistance##9##3##(2008-10#9)
of systemic vascular##2##3##(2009-5#2)
of systemic##86##2##(1990-3#1)(1991-2#1)(1992-9#1)(1993-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#3)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#23)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#4)
of systems biology##2##3##(2012-2#1)(2012-3#1)
of systems of##2##3##(2010-12#1)(2013-1#1)
of systems that##2##3##(1994-8#1)(1996-12#1)
of systems with##6##3##(2008-10#2)(2008-3#3)(2008-7#1)
of systems##25##2##(1992-12#1)(1994-8#1)(1995-3#1)(1996-12#2)(2007-12#1)(2008-10#3)(2008-3#4)(2008-7#4)(2009-10#2)(2010-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
of systolic and##2##3##(1990-8#1)(2008-1#1)
of systolic blood##2##3##(1991-10#1)(2010-11#1)
of systolic hypertension##2##3##(2008-1#1)(2011-1#1)
of systolic##11##2##(1990-8#1)(1991-10#1)(1991-12#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2010-11#1)(2011-1#1)
of t-PA##3##2##(2008-11#3)
of t-PA/PAI-1 complexes by monocytes##2##5##(1995-8#2)
of t-PA/PAI-1 complexes##3##3##(1995-8#3)
of tNOX##3##2##(2008-7#1)(2009-9#2)
of tPA in the##2##4##(2008-8#1)(2010-3#1)
of tPA##5##2##(2008-11#2)(2008-8#2)(2010-3#1)
of tRNA genes and##2##4##(2008-9#2)
of tRNA genes##3##3##(1995-8#1)(2008-9#2)
of tRNA##8##2##(1992-6#2)(1995-8#1)(2008-4#2)(2008-8#1)(2008-9#2)
of tRNA(Gly)1##2##2##(1997-7#2)
of tRNA(Leu)##2##2##(2008-4#1)(2008-8#1)
of tRNA(fMet)##2##2##(1995-6#2)
of tRNA2(fMet)##3##2##(1993-11#3)
of tRNAs##2##2##(1994-8#1)(2012-12#1)
of tablet##7##2##(2010-5#7)
of tablets##6##2##(2008-10#1)(2010-3#2)(2010-4#1)(2010-5#2)
of tachykinin NK1 and NK2 receptor antagonists##2##7##(1997-4#2)
of tachykinin receptors##2##3##(2008-8#2)
of tachykinin##4##2##(1997-4#2)(2008-8#2)
of tacrine##2##2##(2011-3#1)(2012-3#1)
of tacrolimus##2##2##(2008-10#1)(2011-2#1)
of tactile##3##2##(2008-5#1)(2009-8#2)
of tadalafil in pharmaceutical preparation##2##5##(2008-10#2)
of tadalafil in pharmaceutical##3##4##(2008-10#3)
of tadalafil in##4##3##(2008-10#3)(2008-11#1)
of tadalafil##5##2##(2008-10#4)(2008-11#1)
of tagged##2##2##(2010-8#2)
of tagitinin C in##2##4##(2008-10#2)
of tagitinin C##3##3##(2008-10#3)
of tags##2##2##(2008-2#1)(2010-8#1)
of tai chi##2##3##(2008-10#2)
of tail markings##3##3##(2008-9#3)
of tail##10##2##(1993-1#1)(1993-3#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#4)
of tailoring##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
of take-all epidemics on winter wheat yield formation##2##8##(2008-10#2)
of take-all epidemics##3##3##(2008-10#3)
of take-all on##2##3##(2008-10#2)
of take-all##11##2##(2008-10#11)
of taking##12##2##(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
of talk##2##2##(2008-9#1)(2010-2#1)
of tall fescue##3##3##(2008-10#3)
of tamoxifen as##2##3##(1995-9#1)(2008-10#1)
of tamoxifen on serum cholesterol##2##5##(1993-12#2)
of tamoxifen on##4##3##(1993-12#4)
of tamoxifen##11##2##(1993-12#4)(1994-7#1)(1995-9#1)(1997-7#1)(2008-10#4)
of tan spot and##3##4##(2008-10#3)
of tan spot caused by##2##5##(2008-10#2)
of tan spot of wheat##4##5##(2008-10#4)
of tan spot##16##3##(2008-10#16)
of tandem repeats##2##3##(1990-12#1)(1995-12#1)
of tandem##9##2##(1990-12#1)(1993-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2013-8#1)
of tandemly##2##2##(1990-5#1)(1991-8#1)
of tangential##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of tankships on the marine environment##2##6##(2008-11#2)
of tannic acid##4##3##(2008-10#4)
of tanshinones##3##2##(2008-10#3)
of tantalum##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
of tap and mineral##2##4##(2008-10#2)
of tap water##2##3##(2008-10#2)
of tap##4##2##(2008-10#4)
of tape##2##2##(1991-12#1)(2008-10#1)
of taperin##2##2##(2012-12#2)
of tapwater##2##2##(2008-10#2)
of tarabine PFS and adriblastina##3##5##(2008-10#3)
of target DNA##4##3##(2008-10#3)(2013-1#1)
of target analytes##3##3##(2008-10#2)(2008-8#1)
of target and##2##3##(1990-12#1)(2008-10#1)
of target attainment##2##3##(2011-2#2)
of target cells following##2##4##(1990-5#1)(2008-4#1)
of target cells to##2##4##(2008-4#2)
of target cells##15##3##(1990-5#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)
of target gene##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
of target genes##8##3##(1991-2#1)(1997-4#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
of target mRNA##4##3##(1996-12#1)(2008-4#3)
of target mRNAs##3##3##(2010-11#1)(2011-2#1)(2013-1#1)
of target proteins##2##3##(2008-11#1)(2008-4#1)
of target receptor##2##3##(2008-8#2)
of target##77##2##(1990-12#1)(1990-5#1)(1991-2#1)(1994-2#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#4)
of targeted##23##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#3)(2012-1#1)(2012-2#2)
of targeting##6##2##(1995-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-1#1)
of targets and##2##3##(2008-11#1)(2013-1#1)
of targets for##2##3##(2008-4#1)(2008-5#1)
of targets in##3##3##(2008-10#1)(2009-8#1)(2010-12#1)
of targets##14##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
of tartaric acid released##3##4##(2008-5#3)
of tartaric acid##9##3##(2008-10#3)(2008-5#6)
of tartaric##11##2##(2008-10#5)(2008-5#6)
of tartrate##2##2##(2008-10#1)(2008-6#1)
of tartrazine##2##2##(2008-10#2)
of task##6##2##(1991-1#1)(1994-8#1)(2008-11#2)(2008-8#1)(2011-2#1)
of task-irrelevant##2##2##(2008-11#1)(2012-2#1)
of tasks##5##2##(1996-2#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-3#1)
of taste are##2##3##(1991-3#1)(2008-9#1)
of taste in##2##3##(2008-7#1)(2008-9#1)
of taste##13##2##(1991-3#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#4)(2012-12#1)(2012-3#1)(2013-1#1)
of tau protein##3##3##(1995-12#1)(2011-2#2)
of tau with##3##3##(1993-6#2)(1995-12#1)
of tau##11##2##(1992-3#1)(1993-6#2)(1995-12#4)(2008-3#1)(2011-2#3)
of taurine in##4##3##(1992-9#1)(2008-10#3)
of taurine##10##2##(1992-9#1)(2008-10#7)(2008-5#1)(2008-7#1)
of tax-exemption##2##2##(1993-1#1)(1995-2#1)
of taxa##3##2##(2008-8#1)(2010-3#2)
of taxane therapy##2##3##(2008-9#2)
of taxol##3##2##(1994-11#2)(1995-3#1)
of taxonomic##4##2##(2008-5#2)(2008-8#1)(2008-9#1)
of te##2##2##(2008-11#2)
of tea##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
of teacher##3##2##(2008-12#2)(2009-7#1)
of teachers##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
of teachers'##2##2##(2009-7#1)(2012-1#1)
of teaching and assessing##2##4##(2008-11#2)
of teaching and learning##3##4##(1996-1#1)(2008-12#1)(2012-1#1)
of teaching and##6##3##(1996-1#1)(2008-11#2)(2008-12#1)(2012-1#1)(2013-1#1)
of teaching hospitals##3##3##(1992-12#1)(1997-1#1)(2008-11#1)
of teaching##26##2##(1992-12#2)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-1#1)(2007-5#1)(2008-11#3)(2008-12#3)(2008-7#1)(2009-2#1)(2012-1#3)(2013-1#2)(2013-8#2)
of team##5##2##(1993-12#1)(1994-12#1)(1996-3#1)(2011-1#2)
of teamwork##2##2##(1996-1#1)(2013-1#1)
of tear##2##2##(2011-7#1)(2013-8#1)
of teas##2##2##(2008-11#2)
of tebuconazole##4##2##(2008-10#4)
of technical and##3##3##(1991-1#1)(2008-3#2)
of technical difficulties##2##3##(2007-8#1)(2011-1#1)
of technical grade##2##3##(2008-10#2)
of technical objects##2##3##(2008-3#2)
of technical oils in supercritical##2##5##(2008-10#2)
of technical##24##2##(1991-1#1)(1991-12#1)(1992-1#3)(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#5)(2008-5#1)(2008-9#1)(2011-1#1)
of technique and##2##3##(2008-1#1)(2011-2#1)
of technique##7##2##(2007-11#1)(2008-1#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
of techniques for##4##3##(2007-8#1)(2008-10#2)(2008-11#1)
of techniques have been##2##4##(2007-11#1)(2010-7#1)
of techniques such as##2##4##(2010-7#1)(2012-2#1)
of techniques that##4##3##(1992-12#1)(1994-1#1)(2008-9#1)(2009-12#1)
of techniques used##2##3##(2007-11#1)(2011-2#1)
of techniques##31##2##(1991-3#1)(1992-12#1)(1992-6#1)(1994-1#1)(1995-5#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#2)
of technological advances##2##3##(2011-1#1)(2013-8#1)
of technological and##2##3##(2006-10#1)(2010-12#1)
of technological breakthroughs##2##3##(2008-9#1)(2013-8#1)
of technological##12##2##(1991-5#1)(1992-3#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-9#1)(2010-12#1)(2011-1#1)(2013-8#2)
of technologies##6##2##(1995-5#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#2)
of technologists##4##2##(1992-1#2)(1992-3#1)(1994-9#1)
of technology in health care##2##5##(2008-1#1)(2008-10#1)
of technology in health##3##4##(2008-1#1)(2008-10#1)(2012-12#1)
of technology in##6##3##(2008-1#1)(2008-10#1)(2008-12#2)(2008-8#1)(2012-12#1)
of technology##29##2##(1992-1#1)(1992-12#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-10#4)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)
of teeth##9##2##(1991-2#1)(1991-6#1)(2007-12#1)(2008-5#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of teicoplanin##4##2##(2008-10#4)
of telemedicine##9##2##(1996-11#2)(1996-3#4)(2008-11#1)(2008-7#1)(2013-1#1)
of teleost##3##2##(1995-12#1)(1997-9#1)(2008-7#1)
of teleosts##2##2##(1995-2#1)(2010-5#1)
of telephone##2##2##(2007-11#1)(2008-11#1)
of teleradiology##3##2##(2007-11#3)
of telescope mirrors##2##3##(2008-3#2)
of telescope##4##2##(2008-3#4)
of teliospore germination##2##3##(2008-10#2)
of teliospores##4##2##(2008-10#4)
of tellurite-based erbium-doped fiber##3##4##(2007-12#3)
of tellurium in##4##3##(2008-10#4)
of tellurium(IV)##3##2##(2008-10#3)
of telomerase activity and telomere##2##5##(2008-11#2)
of telomerase activity and##3##4##(2007-12#1)(2008-11#2)
of telomerase activity in##2##4##(2008-11#1)(2008-6#1)
of telomerase activity##5##3##(2007-12#1)(2008-11#3)(2008-6#1)
of telomerase and##2##3##(2008-11#2)
of telomerase##13##2##(2007-12#1)(2008-11#6)(2008-5#1)(2008-6#2)(2008-9#2)(2011-1#1)
of telomere biology##2##3##(2008-11#1)(2012-3#1)
of telomere length##2##3##(2008-9#2)
of telomere repeats##3##3##(2008-11#1)(2011-1#2)
of telomere##13##2##(2008-1#1)(2008-11#2)(2008-9#3)(2011-1#3)(2012-3#3)(2013-1#1)
of telomeres and telomerase##2##4##(2006-10#1)(2008-1#1)
of telomeres and##6##3##(2006-10#1)(2008-1#1)(2008-11#2)(2011-2#1)(2012-3#1)
of telomeres##12##2##(2006-10#1)(2008-1#1)(2008-11#5)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)
of telomeric DNA##4##3##(1990-5#4)
of telomeric##6##2##(1990-5#4)(2009-5#1)(2010-2#1)
of temperate##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
of temperature (5 to##2##4##(2008-10#2)
of temperature and duration of##3##5##(2008-10#3)
of temperature and humidity on##2##5##(2011-2#2)
of temperature and humidity##3##4##(2011-2#3)
of temperature and leaf wetness duration on##2##7##(2008-10#2)
of temperature and moisture##3##4##(2008-10#2)(2008-2#1)
of temperature and pH##2##4##(2008-10#1)(2008-5#1)
of temperature and pain##2##4##(2008-7#2)
of temperature and pressure##4##4##(2008-3#3)(2008-6#1)
of temperature and strain##2##4##(2007-11#2)
of temperature and##47##3##(1992-5#1)(1992-8#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#14)(2008-2#3)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#2)(2011-2#3)(2012-4#1)
of temperature changes##2##3##(2007-12#1)(2008-3#1)
of temperature in the range##2##5##(1997-2#1)(2008-10#1)
of temperature in##3##3##(1997-2#1)(2008-10#1)(2013-7#1)
of temperature is##2##3##(2008-2#1)(2008-9#1)
of temperature measurement with multiband##2##5##(2008-3#2)
of temperature measurements##2##3##(2008-3#2)
of temperature on the##11##4##(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(2008-10#4)(2008-3#2)(2011-2#1)
of temperature on##25##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
of temperature resolution of##2##4##(2008-3#2)
of temperature sensitive##2##3##(2008-10#1)(2011-2#1)
of temperature was##3##3##(2008-10#1)(2008-6#1)(2010-4#1)
of temperature##146##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#2)(1992-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#54)(2008-11#6)(2008-2#10)(2008-3#22)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-8#2)(2011-2#5)(2012-2#1)(2012-4#1)(2013-7#1)(2013-8#2)
of temperature)##2##2##(2008-7#2)
of temperature-sensitive##3##2##(1990-5#1)(1997-3#1)(2008-10#1)
of temperatures &gt##3##3##(1995-6#1)(2008-10#2)
of temperatures and##3##3##(2008-10#2)(2008-3#1)
of temperatures of##2##3##(2008-10#1)(2008-8#1)
of temperatures##20##2##(1995-6#1)(2008-10#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-8#1)
of tempered##2##2##(2008-10#1)(2008-3#1)
of template##7##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)
of temporal and spatial##4##4##(2007-11#1)(2008-3#1)(2008-8#1)(2009-11#1)
of temporal and##6##3##(2007-11#2)(2008-3#1)(2008-8#2)(2009-11#1)
of temporal bone##5##3##(2008-9#2)(2011-2#3)
of temporal broadening##2##3##(2008-3#2)
of temporal lobe##2##3##(1996-7#1)(2008-4#1)
of temporal patterns of##2##4##(1993-12#1)(2008-9#1)
of temporal phase##2##3##(2007-12#1)(2008-3#1)
of temporal prediction##2##3##(2009-7#1)(2013-8#1)
of temporal##43##2##(1992-11#1)(1993-12#1)(1993-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#6)(2009-11#1)(2009-7#2)(2009-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
of temporally##7##2##(2007-12#4)(2008-10#1)(2008-2#1)(2009-9#1)
of temporary##7##2##(1993-12#1)(1993-5#1)(2008-1#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
of temporomandibular joint##3##3##(1995-10#1)(2007-12#1)(2009-4#1)
of temporomandibular##5##2##(1995-10#1)(2007-12#1)(2009-4#1)(2013-1#2)
of ten lambs##2##3##(1996-12#2)
of ten lots##2##3##(2006-11#2)
of ten patients##2##3##(1994-2#1)(2008-6#1)
of ten##53##2##(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#3)(1992-11#1)(1993-12#1)(1994-2#2)(1994-9#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2006-11#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
of tendon##3##2##(1997-5#1)(2013-1#2)
of tendons##4##2##(2008-7#2)(2008-9#1)(2013-1#1)
of tens of##8##3##(2007-12#3)(2008-10#2)(2008-3#3)
of tensile##4##2##(2008-5#1)(2012-2#1)(2013-1#2)
of tension##6##2##(1995-2#1)(1995-3#1)(1996-4#1)(2008-7#1)(2009-3#1)(2011-1#1)
of terahertz (THz) pulses##2##4##(2007-11#1)(2007-12#1)
of terahertz (THz)##5##3##(2007-11#2)(2007-12#3)
of terahertz electromagnetic##2##3##(2007-12#1)(2012-2#1)
of terahertz imaging##3##3##(2008-3#1)(2012-12#2)
of terahertz pulse##2##3##(2007-12#1)(2010-5#1)
of terahertz pulses in##2##4##(2007-12#1)(2008-2#1)
of terahertz pulses##6##3##(2007-12#5)(2008-2#1)
of terahertz radiation##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
of terahertz##26##2##(2007-11#4)(2007-12#14)(2008-2#1)(2008-3#2)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
of terazosin##3##2##(2008-10#3)
of terbinafine against##2##3##(2008-3#1)(2008-5#1)
of terbinafine##9##2##(2008-10#4)(2008-3#1)(2008-5#4)
of terbium##5##2##(2008-10#3)(2008-2#2)
of terbium(III)##2##2##(2008-10#1)(2008-4#1)
of terfenadine##3##2##(1992-8#3)
of term##4##2##(2007-11#1)(2008-11#1)(2008-12#1)(2011-1#1)
of terminal complementarity##2##3##(1994-8#2)
of terminal differentiation##4##3##(1990-11#1)(1990-5#1)(1991-5#1)(2009-3#1)
of terminal ureter##2##3##(2009-5#1)(2013-1#1)
of terminal values##2##3##(2011-1#2)
of terminal##21##2##(1990-11#1)(1990-5#1)(1991-5#1)(1994-8#2)(1995-11#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
of terminally differentiated##2##3##(1995-2#1)(2009-10#1)
of terminally ill patients##2##4##(1990-10#1)(2007-11#1)
of terminally ill##3##3##(1990-10#1)(1994-12#1)(2007-11#1)
of terminally##6##2##(1990-10#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-7#1)(2009-10#1)
of termination of translation##2##4##(2008-11#2)
of termination##4##2##(2008-11#3)(2009-12#1)
of terminology and##3##3##(1995-1#1)(2008-4#1)(2012-2#1)
of terminology##7##2##(1990-3#1)(1991-12#1)(1995-1#1)(2008-4#1)(2012-2#1)(2013-1#2)
of termite##3##2##(2011-2#3)
of terms and analytic methods##2##5##(1996-2#2)
of terms and##3##3##(1996-2#2)(2008-7#1)
of terms##10##2##(1993-12#1)(1995-3#1)(1996-2#3)(2008-2#2)(2008-7#2)(2011-2#1)
of ternary and multicomponent complexes##2##5##(2008-10#2)
of ternary complex##2##3##(1994-6#1)(2008-10#1)
of ternary complexes##3##3##(2008-10#3)
of ternary mixtures of##3##4##(2008-10#3)
of ternary mixtures##7##3##(2008-10#6)(2013-8#1)
of ternary##16##2##(1994-6#1)(2008-10#14)(2013-8#1)
of terpene##2##2##(2008-10#1)(2008-6#1)
of terpenes in water##2##4##(2008-10#2)
of terpenes##5##2##(2008-10#4)(2011-2#1)
of terpenoid##4##2##(1990-11#1)(1994-8#1)(2008-10#1)(2012-2#1)
of terrestrial impact##2##3##(1997-5#2)
of terrestrial##9##2##(1991-6#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-6#1)(2012-3#1)
of territory##3##2##(2008-8#3)
of tert-butyl chloride##2##3##(2011-1#2)
of tert-butyl##6##2##(2007-11#1)(2008-12#2)(2009-8#1)(2011-1#2)
of tertiary or##2##3##(2008-4#2)
of tertiary##4##2##(2008-4#3)(2011-1#1)
of test results##4##3##(1995-12#1)(2007-2#1)(2007-7#2)
of test samples##2##3##(2008-10#1)(2008-2#1)
of test solution##2##3##(2008-10#1)(2012-2#1)
of test solutions##3##3##(2008-10#3)
of test takers##2##3##(2009-12#2)
of test##35##2##(1995-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of testable hypotheses##2##3##(2008-7#1)(2009-6#1)
of tested compounds##3##3##(2008-10#2)(2008-5#1)
of tested##9##2##(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-8#1)(2013-1#1)
of testes##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
of testicles##2##2##(2012-12#1)(2013-1#1)
of testicular cancer##3##3##(2007-5#1)(2008-7#1)(2009-5#1)
of testicular function##2##3##(2011-2#2)
of testicular neoplasms##3##3##(2007-5#3)
of testicular torsion##3##3##(2008-10#3)
of testicular tubules##2##3##(1990-9#1)(2010-5#1)
of testicular tumors##2##3##(1990-9#1)(1992-5#1)
of testicular tumours##3##3##(1996-8#1)(2011-2#2)
of testicular##30##2##(1990-5#1)(1990-9#3)(1992-5#1)(1995-5#1)(1996-8#1)(2007-5#5)(2008-10#6)(2008-12#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#4)(2012-3#2)(2013-1#2)
of testing for##4##3##(2008-4#2)(2009-11#1)(2012-3#1)
of testing in##2##3##(2008-10#1)(2012-2#1)
of testing is##2##3##(1995-9#1)(2009-12#1)
of testing the##3##3##(2008-10#1)(2008-12#1)(2009-9#1)
of testing##33##2##(1992-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-5#1)(1995-9#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
of testis##5##2##(1994-11#1)(2008-10#1)(2009-7#1)(2010-11#1)(2013-8#1)
of testosterone (T)##3##3##(1991-5#1)(1996-2#1)(2008-3#1)
of testosterone in aqueous##2##4##(2008-10#2)
of testosterone in##6##3##(1995-2#1)(2008-10#2)(2008-5#1)(2012-2#1)(2012-3#1)
of testosterone on##3##3##(1996-5#2)(2008-9#1)
of testosterone to##2##3##(1993-8#1)(2008-2#1)
of testosterone##41##2##(1990-11#1)(1990-12#1)(1990-2#3)(1991-5#2)(1992-12#2)(1993-8#3)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#4)(1996-2#1)(1996-5#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2012-2#3)(2012-3#1)(2013-8#1)
of tests and##5##3##(1990-9#1)(1994-3#1)(2007-7#1)(2008-10#1)(2013-1#1)
of tests on##2##3##(2008-10#1)(2009-4#1)
of tests to##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
of tests used for##2##4##(2008-7#1)(2008-9#1)
of tests were##2##3##(2008-10#1)(2008-5#1)
of tests##35##2##(1990-3#2)(1990-9#3)(1994-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-7#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#1)(2013-1#2)
of tetanus toxin##4##3##(1995-2#1)(2008-10#3)
of tetanus##5##2##(1992-5#1)(1995-2#1)(2008-10#3)
of tetanus-induced##2##2##(1992-12#1)(2008-7#1)
of tethered cord syndrome##2##4##(2008-7#1)(2009-3#1)
of tethered##3##2##(2008-11#1)(2008-7#1)(2009-3#1)
of tetrabromoindate(III)##2##2##(2008-10#2)
of tetrabutylammonium bromide##4##3##(2008-10#4)
of tetrabutylammonium##7##2##(2008-10#7)
of tetracarboxylate-18-crown-6##2##2##(2008-10#2)
of tetracycline (TC)##2##3##(2008-10#2)
of tetracycline antibiotics##3##3##(2008-10#3)
of tetracycline##12##2##(1997-7#1)(1997-8#1)(2008-10#9)(2008-11#1)
of tetracyclines in##3##3##(2008-10#3)
of tetracyclines##6##2##(2008-10#6)
of tetragonal##2##2##(2008-10#1)(2008-3#1)
of tetrahydrobiopterin##2##2##(1993-8#1)(1994-11#1)
of tetrahydrofuran##5##2##(2007-11#1)(2008-10#3)(2008-5#1)
of tetrahydroisoquinoline##4##2##(2007-11#2)(2011-3#2)
of tetrakis rare-earth chromophores in rare-earth-doped##2##6##(2008-2#2)
of tetrakis##3##2##(2008-10#1)(2008-2#2)
of tetramerization##2##2##(1993-8#2)
of tetramers##5##2##(1994-8#1)(1997-2#3)(2010-8#1)
of tetramethylpyrazine##4##2##(1991-6#4)
of tetraphenylporphyrin##2##2##(2008-10#2)
of text##2##2##(2008-11#1)(2008-7#1)
of texture at##2##3##(2013-8#2)
of texture##6##2##(2008-10#1)(2008-2#1)(2008-5#2)(2013-8#2)
of th##2##2##(2008-11#1)(2013-8#1)
of thalamic oscillations##2##3##(2008-2#2)
of thalamic##5##2##(2008-2#5)
of thalassemia##4##2##(1993-8#1)(2008-10#2)(2011-2#1)
of thaliblastine##2##2##(1992-2#2)
of thalidomide in##7##3##(1991-11#1)(1991-6#1)(2008-3#1)(2008-5#4)
of thalidomide##11##2##(1991-11#1)(1991-6#1)(2008-3#1)(2008-5#8)
of thallium in##5##3##(1991-12#1)(1994-5#2)(2008-10#2)
of thallium##14##2##(1991-12#3)(1994-5#3)(2008-10#8)
of thallium(I)##5##2##(2008-10#5)
of thallium(III) salts##2##3##(2007-11#2)
of thapsigargin##3##2##(1991-6#1)(1992-5#1)(2008-4#1)
of that approach##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
of that care##2##3##(1991-3#1)(1994-2#1)
of that fact##2##3##(2008-10#1)(2008-12#1)
of that for##3##3##(1990-9#1)(1994-2#1)(2008-6#1)
of that in the control##2##5##(1994-12#1)(2008-9#1)
of that in the##4##4##(1990-11#1)(1994-12#1)(2008-3#1)(2008-9#1)
of that in##9##3##(1990-11#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2012-3#1)
of that observed in##4##4##(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
of that observed##5##3##(1996-12#1)(1997-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
of that obtained##3##3##(2008-10#2)(2008-11#1)
of that of insulin##2##4##(2008-9#2)
of that of the control##2##5##(1997-2#2)
of that of the##5##4##(1992-6#1)(1997-2#2)(2008-7#1)(2008-8#1)
of that of##21##3##(1990-11#1)(1992-6#1)(1993-8#1)(1994-6#1)(1996-5#1)(1997-2#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-11#1)
of that period##2##3##(2008-12#2)
of that predicted##2##3##(1996-2#1)(2007-12#1)
of that process##3##3##(1994-2#1)(2007-12#1)(2008-3#1)
of that region##2##3##(1994-8#1)(2008-5#1)
of that value##4##3##(1995-5#1)(2008-10#3)
of that year##2##3##(1990-2#1)(1997-3#1)
of that##154##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#6)(2008-2#4)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#6)(2008-9#7)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
of thaxtomin##2##2##(2008-10#2)
of the &lt##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
of the &quot##66##3##(1990-12#1)(1990-5#2)(1991-12#2)(1991-4#3)(1992-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-2#2)(1995-5#3)(1995-6#2)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-10#2)(2007-11#3)(2008-1#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
of the '90s##3##3##(1990-4#1)(1994-3#2)
of the 'König' reaction##6##4##(1993-8#6)
of the 'natural##2##3##(1994-12#1)(2010-2#1)
of the (23)Na frequency##2##4##(1997-7#2)
of the 0##7##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)
of the 1 375 and 1 638 cm(-1)##2##8##(2013-8#2)
of the 1##30##3##(1992-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-11#1)(1996-2#3)(1996-5#3)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the 1-deoxy-1-phosphatidylethanolamino-lactitol-type##2##3##(1994-3#2)
of the 1-year##2##3##(1991-8#1)(2012-12#1)
of the 10##18##3##(1990-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2011-2#1)(2012-12#1)
of the 100##2##3##(1994-11#1)(2008-9#1)
of the 11 patients##3##4##(1996-9#1)(1997-7#1)(2008-10#1)
of the 11##14##3##(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#2)(2010-4#1)(2012-12#1)
of the 118##2##3##(1996-1#1)(2012-2#1)
of the 12 patients##2##4##(1997-7#1)(1997-8#1)
of the 12##14##3##(1997-7#1)(1997-8#2)(2007-2#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#1)(2013-1#1)
of the 13 patients##2##4##(2008-5#1)(2008-7#1)
of the 13##10##3##(1991-12#1)(1992-6#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-9#1)
of the 135##2##3##(2008-10#1)(2012-12#1)
of the 13C NMR##2##4##(1992-12#1)(1993-11#1)
of the 13th##2##3##(1996-5#1)(2008-11#1)
of the 14 patients##2##4##(1991-4#1)(1996-11#1)
of the 14##15##3##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-4#2)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the 15##9##3##(1992-1#1)(1993-3#1)(1995-3#1)(2008-10#2)(2008-9#2)(2010-8#1)(2012-3#1)
of the 150 kDa##2##4##(1990-5#1)(1997-2#1)
of the 16 participating##2##4##(2008-11#1)(2013-1#1)
of the 16##11##3##(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
of the 160##2##3##(2008-10#2)
of the 164##2##3##(2007-7#1)(2008-3#1)
of the 16S rDNA gene##2##5##(2008-12#2)
of the 16S rDNA##3##4##(1997-3#1)(2008-12#2)
of the 16S rRNA gene##3##5##(2008-10#2)(2009-6#1)
of the 16S rRNA##5##4##(2008-10#4)(2009-6#1)
of the 16S##9##3##(1997-3#1)(2008-10#5)(2008-12#2)(2009-6#1)
of the 16S-23S rDNA##2##4##(2008-10#2)
of the 16S-23S##3##3##(2008-10#3)
of the 16th century]##2##4##(2008-11#2)
of the 17 compounds##2##4##(2008-10#1)(2008-11#1)
of the 17##10##3##(1990-2#1)(1991-4#1)(2008-1#2)(2008-10#5)(2008-11#1)
of the 171##2##3##(1993-2#2)
of the 175R protein##2##4##(1993-2#2)
of the 17th century##2##4##(2008-10#2)
of the 17th##7##3##(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
of the 18##10##3##(1992-3#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2009-8#1)
of the 18th century##2##4##(1993-11#1)(2012-2#1)
of the 18th##6##3##(1993-11#2)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the 19##6##3##(1992-2#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-2#1)
of the 1960s##2##3##(1997-2#1)(1997-3#1)
of the 1970s##3##3##(1991-2#1)(2008-1#1)(2012-12#1)
of the 1980s##7##3##(1991-3#1)(1993-2#1)(1993-3#1)(1994-11#1)(1997-3#1)(2011-2#2)
of the 1988##2##3##(1992-1#1)(1995-6#1)
of the 1990##2##3##(1992-3#1)(1993-1#1)
of the 1990s##9##3##(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-8#1)
of the 1991##3##3##(1996-1#1)(1997-4#1)(2009-3#1)
of the 1992##3##3##(1994-3#1)(1996-3#1)(1996-4#1)
of the 1993##2##3##(1994-1#1)(1994-3#1)
of the 1997##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
of the 1998##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
of the 19th century and##2##5##(2009-7#1)(2011-2#1)
of the 19th century##7##4##(1991-6#1)(1994-5#1)(2008-12#1)(2008-8#1)(2009-7#2)(2011-2#1)
of the 19th##8##3##(1991-6#1)(1994-5#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-7#2)(2011-2#1)
of the 1H##2##3##(1994-3#1)(1994-5#1)
of the 1st and##2##4##(1990-10#2)
of the 1st##7##3##(1990-10#3)(2008-10#2)(2008-4#1)(2008-6#1)
of the 2 lead ECG##2##5##(2009-3#2)
of the 2 lead##3##4##(2009-3#3)
of the 2##27##3##(1990-12#1)(1990-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-5#2)(1995-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-7#1)(2009-2#1)(2009-3#3)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
of the 2-D##2##3##(2008-3#1)(2008-4#1)
of the 2-amino-6-chloro-4-cyclopropyl-7-fluoro-5-methoxy-pyrido[1##2##3##(2010-2#2)
of the 20 patients##3##4##(2008-6#3)
of the 20##11##3##(1990-11#1)(1993-11#1)(2008-10#3)(2008-6#3)(2011-2#2)(2012-1#1)
of the 2002##2##3##(2008-10#1)(2011-2#1)
of the 2003##2##3##(2007-4#1)(2008-9#1)
of the 2004##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
of the 2008##3##3##(2010-8#1)(2012-1#1)(2012-2#1)
of the 2008-2009##3##3##(2010-3#3)
of the 2009##3##3##(2010-12#1)(2011-2#2)
of the 20S proteasome##3##4##(2008-4#2)(2008-5#1)
of the 20S##4##3##(2008-4#2)(2008-5#2)
of the 20th century##16##4##(1994-12#1)(2006-10#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-4#1)(2009-7#4)(2010-1#1)(2010-10#1)(2011-7#1)
of the 20th##18##3##(1994-12#1)(1997-2#1)(2006-10#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-4#1)(2009-7#4)(2010-1#1)(2010-10#1)(2011-1#1)(2011-7#1)
of the 21##6##3##(1991-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the 21st century##8##4##(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)
of the 21st##9##3##(1994-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)
of the 22##4##3##(1997-8#1)(2008-3#2)(2008-7#1)
of the 22q11##3##3##(1997-3#2)(2012-12#1)
of the 23##5##3##(1991-9#1)(1994-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
of the 23S ribosomal##2##4##(1995-8#2)
of the 23S##3##3##(1992-3#1)(1995-8#2)
of the 24##9##3##(1991-8#1)(1993-2#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
of the 24-hydroxylase##2##3##(1994-11#2)
of the 24-kDa oleosin##2##4##(2009-10#2)
of the 240##2##3##(1990-5#1)(2008-1#1)
of the 25##9##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)
of the 252-day reproductive period##3##5##(1997-4#3)
of the 26##3##3##(1993-12#1)(1996-11#1)(2011-2#1)
of the 27##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
of the 28##4##3##(1996-7#1)(2008-3#1)(2008-6#1)(2008-7#1)
of the 287 were related to##2##6##(2013-1#2)
of the 28S rRNA##2##4##(2008-5#1)(2010-4#1)
of the 28S##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
of the 29##5##3##(1991-12#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-5#1)
of the 296##2##3##(2008-10#2)
of the 2nd and 3rd##2##5##(2010-3#2)
of the 2nd##3##3##(2008-10#1)(2010-3#2)
of the 3##22##3##(1990-11#2)(1991-5#1)(1992-5#1)(1993-8#1)(1995-4#1)(1996-2#2)(1997-4#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-7#1)
of the 3' end##3##4##(1997-4#2)(2007-12#1)
of the 3' untranslated##3##4##(1991-2#1)(1997-4#1)(1997-8#1)
of the 3'##16##3##(1991-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)
of the 3'-terminal region of##2##5##(1997-2#1)(2008-10#1)
of the 3'-terminal##3##3##(1997-2#1)(2008-10#2)
of the 3-4 hydrophobic repeat to the stability of the two-stranded alpha-helical coiled-coil##2##13##(1992-6#2)
of the 3-D cross-correlation function##2##5##(2008-2#2)
of the 3-D##6##3##(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#1)
of the 3-phosphoglycerate##2##3##(1991-9#2)
of the 30##13##3##(1990-8#1)(1995-4#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
of the 30S##3##3##(1993-11#1)(2009-9#2)
of the 31 kDa protein##2##5##(1990-2#2)
of the 31##4##3##(1990-2#3)(1990-9#1)
of the 32##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
of the 32-##2##3##(1995-6#1)(2008-10#1)
of the 33##6##3##(1994-2#1)(1996-12#1)(1997-5#1)(2008-9#1)(2011-2#2)
of the 34##8##3##(1993-3#1)(1994-12#1)(1996-3#1)(2008-7#1)(2009-7#4)
of the 36 patients##2##4##(1990-11#1)(1997-5#1)
of the 36##3##3##(1990-11#1)(1990-2#1)(1997-5#1)
of the 37 degrees C-grown##2##5##(2008-5#2)
of the 37##6##3##(1990-8#1)(1993-3#1)(2008-5#2)(2009-7#1)(2010-8#1)
of the 38##3##3##(1996-3#1)(2008-12#1)(2011-2#1)
of the 3D object##2##4##(2008-3#2)
of the 3D reference object##2##5##(2008-3#2)
of the 3D##6##3##(2008-3#5)(2012-2#1)
of the 3rd##2##3##(1994-2#1)(1995-11#1)
of the 4 patients were##2##5##(1991-2#1)(2007-8#1)
of the 4 patients##3##4##(1991-2#1)(2007-8#1)(2011-1#1)
of the 4##14##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-2#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-5#1)(2011-1#2)
of the 40 patients##2##4##(2008-4#1)(2008-9#1)
of the 400##4##3##(1990-3#1)(1996-2#1)(1997-3#1)(2011-2#1)
of the 42##2##3##(1994-7#1)(2013-8#1)
of the 43 kDa##2##4##(1991-12#1)(2009-7#1)
of the 43##4##3##(1991-11#1)(1991-12#1)(1996-3#1)(2009-7#1)
of the 45##7##3##(1993-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)
of the 45-kDa protein##2##4##(1991-8#1)(1994-11#1)
of the 46 patients##3##4##(1992-3#2)(1997-3#1)
of the 46##6##3##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#2)(1997-3#1)
of the 484##2##3##(1991-12#2)
of the 49##2##3##(2008-1#1)(2008-6#1)
of the 4th##2##3##(2008-12#1)(2011-2#1)
of the 5 patients had##2##5##(2007-10#1)(2007-11#1)
of the 5 patients##3##4##(2007-10#1)(2007-11#1)(2011-2#1)
of the 5##15##3##(1991-8#1)(1994-6#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the 5' end of the##4##6##(1991-11#1)(2008-10#3)
of the 5' flanking region##2##5##(1993-2#1)(2008-7#1)
of the 5' region of the##2##6##(1995-2#1)(2008-8#1)
of the 5' untranslated region of##2##6##(1991-9#1)(2012-2#1)
of the 5' untranslated region##5##5##(1991-9#1)(1992-11#1)(1992-3#1)(2008-10#1)(2012-2#1)
of the 5' untranslated##6##4##(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(2008-10#1)(2012-2#1)
of the 5'##22##3##(1991-11#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#3)(1995-2#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
of the 5'-UTR##5##3##(1996-5#5)
of the 5'-flanking region of the##4##6##(1993-8#2)(1994-9#1)(1997-7#1)
of the 5'-flanking region of##5##5##(1993-8#2)(1994-9#1)(1997-7#1)(1997-8#1)
of the 5'-flanking region were##3##5##(1991-11#2)(1993-2#1)
of the 5'-flanking region##11##4##(1991-11#2)(1993-2#1)(1993-8#2)(1994-11#1)(1994-9#1)(1997-7#2)(1997-8#1)(2010-5#1)
of the 5'-flanking sequence##2##4##(1990-8#1)(1995-6#1)
of the 5'-flanking##14##3##(1990-8#1)(1991-11#3)(1993-2#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-6#1)(1997-7#2)(1997-8#1)(2010-5#1)
of the 5'-untranslated region (UTR)##2##5##(1990-12#1)(1996-5#1)
of the 5'-untranslated##3##3##(1990-12#1)(1993-2#1)(1996-5#1)
of the 5-HT1A receptor##3##4##(1993-3#1)(1994-2#1)(1995-12#1)
of the 5-HT1A##4##3##(1993-3#1)(1993-9#1)(1994-2#1)(1995-12#1)
of the 5-HT2 receptor##2##4##(1991-12#1)(1993-9#1)
of the 5-HT2C receptor##2##4##(1996-12#2)
of the 5-amino##2##3##(1993-1#2)
of the 50##3##3##(1993-2#1)(2008-10#2)
of the 50%##3##3##(2009-8#1)(2012-2#2)
of the 500##3##3##(2008-9#1)(2010-5#2)
of the 51##2##3##(1996-12#1)(2008-12#1)
of the 52##3##3##(2008-10#2)(2012-12#1)
of the 54##2##3##(2008-10#2)
of the 55 kDa##2##4##(1994-2#2)
of the 55##3##3##(1994-2#2)(1996-12#1)
of the 56##2##3##(1990-3#1)(2010-9#1)
of the 57##3##3##(1990-8#1)(2008-10#1)(2009-10#1)
of the 58K##2##3##(1997-3#1)(2008-8#1)
of the 5HT3 antagonist ondansetron##2##5##(1991-1#1)(2008-6#1)
of the 5th International##2##4##(2008-5#1)(2009-6#1)
of the 5th##4##3##(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
of the 6 patients with##2##5##(1994-7#1)(2010-8#1)
of the 6 patients##3##4##(1994-7#1)(2008-1#1)(2010-8#1)
of the 6##9##3##(1994-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
of the 61##2##3##(1993-9#1)(2008-8#1)
of the 63 patients with##2##5##(1992-11#1)(2008-1#1)
of the 67 K protein##3##5##(1995-12#3)
of the 67##4##3##(1995-12#3)(2013-8#1)
of the 69##2##3##(1990-8#1)(2008-10#1)
of the 695##2##3##(1992-12#1)(1992-9#1)
of the 6th##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
of the 7 patients##2##4##(1990-3#1)(1991-5#1)
of the 7##12##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1995-4#1)(2008-10#1)(2008-5#1)(2012-12#2)(2013-1#1)
of the 75th##2##3##(1997-3#1)(2007-11#1)
of the 79##2##3##(1996-8#1)(1997-2#1)
of the 793/B serotype##3##4##(2008-5#3)
of the 7th##2##3##(2009-9#1)(2013-8#1)
of the 83 kDa peptide##2##5##(1990-11#2)
of the 84##2##3##(1993-2#1)(2012-3#1)
of the 8th##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
of the 9 species##3##4##(2008-12#3)
of the 9##6##3##(1991-5#1)(2008-12#3)(2008-3#1)(2011-2#1)
of the 90##3##3##(2007-11#1)(2008-10#2)
of the 99##2##3##(1991-9#1)(2007-8#1)
of the 9th##4##3##(1991-9#1)(1992-3#1)(2008-8#1)(2009-2#1)
of the A subunit##2##4##(1995-2#1)(1995-6#1)
of the A##13##3##(1990-12#1)(1992-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-5#1)(2012-3#1)
of the A(549)/DDP cells##2##4##(2008-9#2)
of the A(section)E((R))##2##3##(2008-9#2)
of the A* state##2##4##(2009-6#2)
of the A1##2##3##(1990-5#1)(2008-9#1)
of the A2 and A4##2##5##(2008-9#2)
of the A2 segment##3##4##(1996-3#3)
of the A2##8##3##(1996-3#3)(2008-10#2)(2008-12#1)(2008-9#2)
of the A6 mAb##2##4##(1994-5#2)
of the AA##4##3##(1990-12#1)(2011-2#3)
of the AAC##2##3##(2008-10#2)
of the ABC##2##3##(2008-7#1)(2011-2#1)
of the ABCD##2##3##(2008-3#1)(2009-10#1)
of the ABL##3##3##(2008-2#3)
of the ACL##2##3##(2013-1#2)
of the ACS##2##3##(2008-5#2)
of the ACTH##2##3##(1994-2#1)(2011-1#1)
of the ACh##2##3##(2008-5#1)(2009-12#1)
of the AChE##2##3##(1995-3#1)(2008-10#1)
of the AChR##2##3##(1997-5#1)(2012-2#1)
of the ADA##3##3##(1995-6#1)(1996-1#1)(1997-5#1)
of the ADH1##2##3##(1990-5#2)
of the ADR##2##3##(2008-10#1)(2011-2#1)
of the AF4Q initiative##2##4##(2013-1#2)
of the AFC##4##3##(2011-2#4)
of the AFLP markers##2##4##(2008-10#2)
of the AFLP##5##3##(2008-10#5)
of the AGL2 gene family##2##5##(1997-2#1)(1997-8#1)
of the AGT##3##3##(1993-11#1)(1995-5#2)
of the AGabaA a(3) ion##2##5##(2012-12#2)
of the AHRA Statistical Resource Committee salary survey##2##8##(1991-12#1)(1991-3#1)
of the AHRA's##2##3##(1992-12#1)(1993-2#1)
of the AIDS epidemic##7##4##(1990-12#2)(1990-3#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-5#1)
of the AIDS##10##3##(1990-12#2)(1990-3#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-5#1)(2010-10#1)
of the AL##2##3##(1992-12#2)
of the AM##2##3##(1994-2#1)(2008-7#1)
of the AML##3##3##(2008-10#2)(2008-6#1)
of the ANCOVA with equal##3##5##(2012-1#3)
of the ANCOVA with##4##4##(2012-1#4)
of the AO##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the AP site##2##4##(1995-2#1)(2008-10#1)
of the AP##3##3##(1995-2#1)(2008-10#1)(2010-4#1)
of the AR##2##3##(2008-8#1)(2011-2#1)
of the ASA##2##3##(1997-6#2)
of the ASD##2##3##(2008-3#1)(2013-1#1)
of the ASMF##2##3##(2008-3#2)
of the AT1 receptor subtype##2##5##(1994-8#1)(1994-9#1)
of the AT1 receptor##3##4##(1994-8#2)(1994-9#1)
of the ATP and##2##4##(1993-8#1)(1994-6#1)
of the ATP##3##3##(1993-8#2)(1994-6#1)
of the ATP-dependent##3##3##(1995-8#2)(1997-4#1)
of the ATPase##4##3##(1992-6#2)(1997-2#1)(2012-3#1)
of the AVM by##2##4##(2008-7#2)
of the AVM##5##3##(2008-7#5)
of the AWI 31##2##4##(1997-2#2)
of the Ac##2##3##(2012-3#2)
of the Academy of##2##4##(2009-7#1)(2012-2#1)
of the Acceptability E-scale##2##4##(2010-10#2)
of the Achatina##2##3##(1991-5#2)
of the Achilles tendon##2##4##(2009-10#1)(2012-1#1)
of the Achilles##3##3##(2009-10#1)(2011-2#1)(2012-1#1)
of the Act##3##3##(1993-3#2)(1997-8#1)
of the Adair constants##2##4##(1990-8#2)
of the Addenbrooke's Cognitive##2##4##(2013-1#2)
of the Adh gene##2##4##(1997-8#2)
of the Advanced##2##3##(2008-2#1)(2008-3#1)
of the African American##2##4##(2010-8#2)
of the African##5##3##(1992-8#1)(2008-4#1)(2008-7#1)(2010-8#2)
of the Age of Enlightenment##3##5##(2008-12#3)
of the Agency for##2##4##(1993-12#1)(2011-2#1)
of the Ah##2##3##(1992-12#1)(1993-12#1)
of the Ailanthus##2##3##(2013-8#2)
of the Airy##2##3##(2007-11#2)
of the Al##2##3##(2008-10#2)
of the Alu##2##3##(1991-5#1)(1997-2#1)
of the Alzheimer amyloid protein precursor (APP)##2##7##(1992-8#1)(1994-11#1)
of the Alzheimer amyloid##4##4##(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)
of the Alzheimer##10##3##(1992-12#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#3)(1996-11#1)(2008-7#1)
of the Alzheimer's##3##3##(1991-11#1)(1992-12#1)(2008-6#1)
of the Amazon##2##3##(2010-7#2)
of the American College of Physicians##3##6##(1993-12#2)(2010-8#1)
of the American College of##4##5##(1993-12#2)(2007-8#1)(2010-8#1)
of the American Heart Association##4##5##(1996-6#1)(2009-5#1)(2012-12#1)(2012-3#1)
of the American Medical Association##2##5##(1991-8#2)
of the American Society for##2##5##(1997-7#1)(2011-2#1)
of the American Society of##6##5##(2008-5#1)(2008-7#4)(2008-8#1)
of the American Society##8##4##(1997-7#1)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#1)
of the American##39##3##(1991-8#2)(1993-12#4)(1994-12#1)(1995-1#1)(1995-6#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
of the Americans with Disabilities Act##4##6##(1992-12#1)(1993-3#1)(1994-2#1)(1995-6#1)
of the Americans##5##3##(1992-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-6#1)
of the Andean##2##3##(1997-6#1)(2013-7#1)
of the Andes##3##3##(2008-5#2)(2008-8#1)
of the Antarctic##3##3##(1991-5#1)(2013-8#2)
of the Anterior##2##3##(2008-12#1)(2013-1#1)
of the Apple##2##3##(2008-10#2)
of the Arabidopsis thaliana##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
of the Arabidopsis##7##3##(1995-2#2)(1997-6#1)(1997-8#1)(2008-10#2)(2012-3#1)
of the Arctic##2##3##(1991-5#1)(2010-8#1)
of the Arina##2##3##(2008-10#2)
of the Armed##2##3##(1995-6#1)(2011-1#1)
of the ArsA protein##2##4##(1994-5#2)
of the Asian##4##3##(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
of the Aspergillus##2##3##(2008-10#2)
of the Association for the Care of Children's Health##2##9##(1992-3#1)(1994-3#1)
of the Association for##3##4##(1992-3#1)(1994-3#2)
of the Association of##6##4##(1991-3#1)(2007-12#1)(2007-8#1)(2009-11#1)(2010-3#1)(2012-12#1)
of the Association##11##3##(1991-3#1)(1992-3#1)(1994-3#2)(2007-12#1)(2007-8#1)(2008-10#1)(2009-11#1)(2010-3#1)(2011-4#1)(2012-12#1)
of the Australian##8##3##(1994-12#1)(1994-2#1)(2007-12#2)(2007-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
of the Autographa californica##2##4##(1993-12#1)(1997-3#1)
of the Autonomous##2##3##(2011-2#1)(2012-12#1)
of the B cell##2##4##(1994-12#1)(2008-4#1)
of the B chromosome number##2##5##(2008-12#2)
of the B chromosomes##2##4##(2008-12#1)(2008-5#1)
of the B##24##3##(1990-11#2)(1990-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#1)(2011-2#3)(2012-3#1)
of the B1##2##3##(1994-5#1)(1994-9#1)
of the BBA##4##3##(2008-11#4)
of the BBB##3##3##(2008-7#2)(2008-8#1)
of the BBWV-K##2##3##(2008-10#2)
of the BK channel in##2##5##(2008-8#1)(2009-2#1)
of the BK channel##3##4##(2008-8#1)(2009-2#2)
of the BM##2##3##(1991-8#1)(2009-5#1)
of the BMI##4##3##(2007-8#2)(2008-12#1)(2009-2#1)
of the BPI##2##3##(2008-7#2)
of the BPs##3##3##(2008-7#3)
of the BTB##4##3##(2009-10#3)(2012-2#1)
of the BZD##2##3##(1991-12#2)
of the Bacillus cereus group##2##5##(2011-2#2)
of the Bacillus subtilis##7##4##(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-7#1)
of the Bacillus##12##3##(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-7#1)(2008-10#2)(2008-3#1)(2011-2#2)
of the Bacterium##2##3##(2008-10#2)
of the Bahian##2##3##(2009-10#2)
of the Balkan##2##3##(2011-1#2)
of the Baltic Sea##4##4##(2008-11#2)(2008-5#1)(2010-8#1)
of the Bantu##2##3##(1991-11#1)(2008-12#1)
of the Barley##2##3##(2008-10#2)
of the Basque##2##3##(2008-10#2)
of the Bcl-2 family of##2##5##(2008-11#1)(2009-12#1)
of the Bcl-2 family##5##4##(2008-11#2)(2009-12#1)(2011-2#2)
of the Bcl-2##6##3##(2008-11#3)(2009-12#1)(2011-2#2)
of the Bean##2##3##(2008-10#2)
of the Berlin Deinstitutionalisation##2##4##(2007-1#2)
of the Berlin##3##3##(1994-6#1)(2007-1#2)
of the Biocontrol Agent Pseudomonas##2##5##(2008-10#2)
of the Biocontrol##5##3##(2008-10#5)
of the Biological Control##2##4##(2008-10#2)
of the Blue Cross and Blue Shield##2##7##(1994-12#1)(2008-4#1)
of the Blue##3##3##(1994-12#1)(1997-6#1)(2008-4#1)
of the BmNPV##2##3##(1997-3#2)
of the Board of##3##4##(1993-3#1)(2008-10#1)(2008-8#1)
of the Board##5##3##(1993-3#3)(2008-10#1)(2008-8#1)
of the Bogota##5##3##(2012-12#4)(2013-1#1)
of the Boltzmann##2##3##(2007-12#2)
of the Boston EMS STEMI Triage Plan and Treatment Registry##2##10##(2008-3#2)
of the Boston##3##3##(2008-3#3)
of the Bradford Hill criteria for causality##2##7##(2013-8#2)
of the Bragg grating##3##4##(2007-11#2)(2008-2#1)
of the Bragg##7##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)
of the Brassaia strains##2##4##(2008-10#2)
of the Brazilian##7##3##(1991-12#1)(1991-9#1)(2008-10#1)(2009-10#1)(2013-8#3)
of the Breast##7##3##(1994-12#1)(1994-7#2)(1995-4#2)(1997-1#1)(1997-7#1)
of the Bright/ARID##2##3##(2009-7#2)
of the Brillouin backscattered light##2##5##(2008-3#2)
of the Brillouin##3##3##(2007-12#1)(2008-3#2)
of the British##5##3##(1992-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#1)
of the Brugada syndrome##3##4##(2008-12#3)
of the Bs##3##3##(2008-12#1)(2008-5#1)(2010-3#1)
of the Button##2##3##(2008-5#2)
of the C##20##3##(1990-5#1)(1994-12#3)(1994-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-1#1)
of the C-4 methyl##2##4##(1996-5#1)(2007-12#1)
of the C-9 and C-9a substituents##2##6##(1995-5#2)
of the C-terminal region of the##2##6##(1992-6#1)(2008-4#1)
of the C-terminal region of##3##5##(1992-6#1)(1993-8#1)(2008-4#1)
of the C-terminal##18##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-6#1)(1992-8#2)(1993-8#1)(1994-9#2)(1995-6#1)(2008-10#1)(2008-11#3)(2008-4#2)(2009-7#2)
of the C-terminus##4##3##(1996-7#1)(1997-3#1)(2011-2#1)(2012-2#1)
of the C1 screw##2##4##(2012-12#2)
of the C103S mutant of the N-terminal domain of DsbD from Neisseria##2##12##(2009-7#2)
of the C2 content##2##4##(2007-12#2)
of the C2##4##3##(1993-11#1)(2007-12#2)(2012-3#1)
of the CA3##2##3##(1990-5#1)(2008-11#1)
of the CALUX (DX##2##4##(2008-10#2)
of the CALUX bioassay for##2##5##(2008-10#2)
of the CALUX##7##3##(2008-10#7)
of the CAM##3##3##(2008-1#1)(2008-10#1)(2009-5#1)
of the CARS##2##3##(2007-11#1)(2008-2#1)
of the CBS##3##3##(1993-8#3)
of the CC##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
of the CCAAT transcription##2##4##(1993-2#2)
of the CCD camera##2##4##(2008-2#1)(2008-3#1)
of the CCD##9##3##(2007-11#1)(2008-2#5)(2008-3#3)
of the CCOP and##2##4##(1992-12#2)
of the CCOP##4##3##(1992-12#4)
of the CD _ 2##2##5##(2008-5#2)
of the CD##7##3##(1990-5#1)(1994-5#1)(2008-10#3)(2008-5#2)
of the CD4 Ag##2##4##(1993-3#2)
of the CD4##5##3##(1993-3#3)(2009-8#1)(2013-8#1)
of the CDC##2##3##(1996-1#1)(2012-12#1)
of the CDS##2##3##(2008-3#2)
of the CE##4##3##(1997-2#1)(2008-10#1)(2008-5#2)
of the CEA##3##3##(1990-5#1)(1992-11#1)(1994-5#1)
of the CFH and Worland strains##2##6##(2008-10#2)
of the CFH##4##3##(2008-10#4)
of the CGA molecule##2##4##(1992-9#2)
of the CH##2##3##(2008-10#1)(2008-2#1)
of the CH(2) symmetric##2##4##(2008-10#2)
of the CH(2)##7##3##(1997-2#1)(2008-10#5)(2008-5#1)
of the CIP##2##3##(2008-10#2)
of the CL reaction##2##4##(2008-10#2)
of the CL##5##3##(2008-10#5)
of the CM##3##3##(2008-10#2)(2011-2#1)
of the CMS##2##3##(1996-7#2)
of the CNS to##2##4##(1995-5#1)(2008-5#1)
of the CNS##23##3##(1990-3#1)(1991-2#1)(1994-9#1)(1995-12#2)(1995-5#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#4)(2008-7#6)(2010-12#1)(2011-2#1)(2013-1#1)
of the CNTs##2##3##(2011-2#2)
of the CO 2 laser##2##5##(1991-3#1)(1992-3#1)
of the CO 2##3##4##(1991-3#1)(1992-3#2)
of the CO##10##3##(1991-3#1)(1992-3#2)(1992-6#1)(1994-11#1)(1996-2#1)(2007-11#1)(2008-2#2)(2008-8#1)
of the CO(2)##5##3##(2008-10#1)(2008-2#3)(2012-3#1)
of the CO-diffusion capacity##2##4##(1992-6#2)
of the COOH-terminal domain of the##2##6##(1992-3#1)(1995-6#1)
of the COOH-terminal##3##3##(1990-2#1)(1992-3#1)(1995-6#1)
of the COP procedure##2##4##(2012-12#2)
of the COP##6##3##(1994-1#2)(2008-2#1)(2009-7#1)(2012-12#2)
of the COXI##2##3##(1993-2#1)(1995-6#1)
of the CP gene##7##4##(1997-6#1)(2008-10#6)
of the CP genes##3##4##(2008-10#3)
of the CP##17##3##(1997-6#2)(2008-10#15)
of the CPAx##2##3##(2012-12#2)
of the CPC##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the CPMG##2##3##(2011-1#1)(2011-2#1)
of the CPTQ##3##3##(2008-12#3)
of the CPU##2##3##(2008-3#2)
of the CR##2##3##(1993-6#1)(2010-8#1)
of the CRF##2##3##(2008-4#2)
of the CSF##3##3##(2006-12#1)(2008-12#1)(2008-3#1)
of the CSL molecules##2##4##(1990-2#2)
of the CT and MRI##2##5##(2007-11#2)
of the CT##5##3##(1991-12#1)(2007-11#2)(2008-7#1)(2012-2#1)
of the CTL##2##3##(2008-8#2)
of the CTV##4##3##(2008-10#3)(2008-2#1)
of the CV##2##3##(1993-12#1)(2008-10#1)
of the CYP1A1 gene##2##4##(1994-6#2)
of the CYP1A1##4##3##(1994-6#2)(1994-8#1)(2011-1#1)
of the CYP2E1##2##3##(1990-11#1)(2008-8#1)
of the CYP3A##3##3##(1994-5#1)(2011-2#2)
of the Ca##2##3##(2008-10#1)(2011-1#1)
of the Ca(2+)##4##3##(2008-11#1)(2008-4#2)(2012-2#1)
of the Ca(2+)-dependent##2##3##(1994-6#1)(2008-8#1)
of the Ca2+##7##3##(1990-12#1)(1990-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(2009-3#1)
of the CaM-BP68##2##3##(1994-5#2)
of the Caenorhabditis elegans##2##4##(1993-12#1)(1995-6#1)
of the California##5##3##(1996-3#1)(2008-10#2)(2010-8#2)
of the Canadian##19##3##(1991-3#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2009-5#1)(2013-1#1)
of the Candida##2##3##(1990-5#1)(1991-9#1)
of the Care##2##3##(1995-3#1)(2010-7#1)
of the Caribbean##4##3##(2007-12#2)(2007-8#1)(2012-1#1)
of the Catholic University of Chile##2##6##(2013-1#2)
of the Catholic##5##3##(1990-6#1)(1994-1#1)(2011-2#1)(2013-1#2)
of the Catphan##3##3##(2012-1#3)
of the Cd and Pb##2##5##(2008-10#2)
of the Center for##2##4##(1997-2#1)(2008-12#1)
of the Center of##2##4##(1994-1#1)(2007-8#1)
of the Center##4##3##(1994-1#1)(1997-2#1)(2007-8#1)(2008-12#1)
of the Centers for Disease Control and Prevention's##2##8##(1997-2#1)(2008-11#1)
of the Centers for Disease Control and##3##7##(1996-1#1)(1997-2#1)(2008-11#1)
of the Centre hospitalier Robert-Giffard##2##5##(2008-2#2)
of the Centre hospitalier##3##4##(2008-2#3)
of the Cervical##2##3##(2008-12#2)
of the Child##3##3##(2008-9#2)(2010-1#1)
of the Children's##4##3##(1994-3#1)(1996-7#1)(2008-11#1)(2008-6#1)
of the Chinese Version of the Mood Disorder Questionnaire##2##9##(2011-1#2)
of the Chinese elderly##2##4##(2008-7#2)
of the Chinese hamster##2##4##(1994-12#1)(1997-7#1)
of the Chinese##8##3##(1994-12#1)(1995-6#1)(1997-7#1)(2008-7#2)(2008-8#1)(2011-1#2)
of the Chlamydia##3##3##(1991-9#1)(2008-5#1)(2008-9#1)
of the Citrus##2##3##(2008-10#2)
of the City##2##3##(1991-12#1)(2011-2#1)
of the Clarion CII##2##4##(2008-9#2)
of the Clarion##4##3##(2008-9#4)
of the Clearinghouse##5##3##(1994-1#3)(1996-3#2)
of the Clinical##5##3##(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(2008-12#1)
of the Clostridium##2##3##(1997-4#1)(2008-5#1)
of the Co(2+)##3##3##(2008-3#3)
of the Cognitive##2##3##(1991-1#1)(2008-12#1)
of the Colorado potato beetle##2##5##(2008-10#2)
of the Colorado##3##3##(2008-10#3)
of the Committee on##2##4##(1991-1#1)(2007-11#1)
of the Common##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
of the Comprehensive##2##3##(2011-2#1)(2012-3#1)
of the Council##2##3##(1991-8#1)(1995-6#1)
of the CpG island##2##4##(1997-4#2)
of the CpG##3##3##(1995-2#1)(1997-4#2)
of the CpIr(CO)(PR(3)) complexes##2##4##(1996-2#2)
of the Cr##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
of the Cr(4+)##2##3##(2008-3#2)
of the Cr(VI)##3##3##(2008-10#3)
of the Cr2 gene##2##4##(2008-10#2)
of the Croatian##2##3##(2008-10#1)(2011-2#1)
of the Csfm##2##3##(1990-5#2)
of the D##7##3##(1993-2#2)(2007-12#2)(2008-10#2)(2013-1#1)
of the D(1)##2##3##(2007-11#2)
of the D-loop##2##3##(2008-5#1)(2008-8#1)
of the D222A##2##3##(1992-6#2)
of the DCC##2##3##(1992-10#1)(2007-12#1)
of the DCP-1##2##3##(2008-3#2)
of the DDR##2##3##(2011-2#2)
of the DFB##2##3##(2008-3#2)
of the DG##2##3##(2009-8#1)(2012-12#1)
of the DH##2##3##(2008-10#1)(2008-8#1)
of the DHFR##2##3##(1994-12#1)(1995-2#1)
of the DIAL technique##2##4##(2008-2#1)(2008-3#1)
of the DIAL##5##3##(2008-2#4)(2008-3#1)
of the DLPE/POPC mixtures##4##4##(1994-3#4)
of the DMPC/sphingosine##2##3##(1994-3#2)
of the DNA binding site for##2##6##(1991-5#1)(1992-8#1)
of the DNA binding##4##4##(1990-11#1)(1991-5#1)(1992-8#1)(1996-3#1)
of the DNA double##2##4##(1996-2#1)(2008-10#1)
of the DNA extraction##2##4##(2012-3#2)
of the DNA fragments##2##4##(2008-10#2)
of the DNA hybridization##2##4##(2008-10#2)
of the DNA molecules##2##4##(1995-8#1)(2008-2#1)
of the DNA polymerase##3##4##(1992-3#1)(1997-6#1)(2009-8#1)
of the DNA sequence##2##4##(1997-7#1)(2008-8#1)
of the DNA sequences##2##4##(1993-6#1)(2008-10#1)
of the DNA##47##3##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
of the DNA-binding##2##3##(1995-8#1)(2008-2#1)
of the DNB and##2##4##(1993-3#2)
of the DNB##3##3##(1993-3#3)
of the DPH probe##2##4##(1990-2#1)(2008-9#1)
of the DPH2##4##3##(1993-9#4)
of the DPM##2##3##(2008-5#2)
of the DRG##2##3##(1992-2#1)(1994-12#1)
of the DRR206 promoter##2##4##(2008-10#2)
of the DRUJ##2##3##(2008-9#2)
of the DSES##2##3##(2009-11#2)
of the Danish##2##3##(1990-12#1)(1992-5#1)
of the Debye approximation##2##4##(2007-12#2)
of the Dengue fever vector Aedes aegypti (Diptera##2##8##(2008-5#2)
of the Department of Health##4##5##(1991-2#1)(1992-1#1)(1997-3#1)(2011-2#1)
of the Department of##21##4##(1990-10#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the Department##25##3##(1990-10#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
of the Diagnostic and Statistical Manual of Mental Disorders##2##9##(2011-2#2)
of the Diagnostic##3##3##(2008-11#1)(2011-2#2)
of the Diskus has##2##4##(1996-2#2)
of the Dominican Republic##2##4##(2008-10#1)(2008-5#1)
of the Doppler shift##2##4##(2007-12#1)(2008-3#1)
of the Doppler##6##3##(2007-12#2)(2008-3#4)
of the Drosophila melanogaster##4##4##(1993-2#1)(1993-6#2)(1994-12#1)
of the Drosophila suppressor of forked##2##6##(1995-6#2)
of the Drosophila visual system##2##5##(2007-12#1)(2008-9#1)
of the Drosophila##19##3##(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#3)(1995-6#3)(1997-3#1)(1997-8#1)(2007-12#1)(2008-9#4)(2009-3#1)(2012-3#1)
of the Dutch##4##3##(1994-5#1)(1997-8#1)(2009-8#1)(2013-8#1)
of the E##12##3##(1990-11#2)(1992-9#2)(1993-12#1)(1995-11#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-12#1)(2008-4#1)
of the E2F##3##3##(1995-2#2)(2012-12#1)
of the EBV##3##3##(1997-3#1)(2008-5#1)(2008-8#1)
of the ECG##2##3##(1991-3#1)(1992-6#1)
of the ECM##3##3##(2008-11#1)(2009-12#1)(2009-8#1)
of the ED##3##3##(1997-8#1)(2007-5#1)(2009-6#1)
of the EDTA##4##3##(2008-10#3)(2008-11#1)
of the EEG##2##3##(2009-8#1)(2010-8#1)
of the EGF receptor##2##4##(1993-8#2)
of the EGF##3##3##(1993-8#2)(2007-12#1)
of the EGFR gene##2##4##(1993-3#1)(2008-4#1)
of the EGFR##5##3##(1993-3#1)(2008-4#2)(2008-5#1)(2011-2#1)
of the ELISA##4##3##(1990-2#1)(1995-2#1)(2008-4#1)(2011-2#1)
of the EM##2##3##(2008-2#2)
of the EMG##2##3##(2008-9#1)(2013-1#1)
of the ENS##2##3##(2008-8#2)
of the ENTO##2##3##(1994-3#2)
of the EO##4##3##(2008-2#2)(2013-1#2)
of the EORTC##2##3##(1992-10#1)(2008-6#1)
of the EP##2##3##(1994-12#1)(2008-10#1)
of the EPO##3##3##(2008-11#2)(2008-5#1)
of the EPR##2##3##(1993-11#1)(1997-7#1)
of the EQ-5D##2##3##(2009-11#2)
of the ER retention##2##4##(2008-8#2)
of the ER##11##3##(1993-6#1)(2008-11#3)(2008-8#2)(2009-8#2)(2011-2#2)(2012-2#1)
of the ER-ICA assay##2##4##(1992-10#2)
of the ERG##2##3##(2009-12#2)
of the ERK and##2##4##(2008-3#1)(2008-4#1)
of the ERK##4##3##(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)
of the ESPU##2##3##(2008-10#2)
of the ET-1##2##3##(1992-3#1)(1995-11#1)
of the ETA receptor##4##4##(1992-9#3)(1994-8#1)
of the ETAAS instrument##2##4##(2008-10#2)
of the EU##4##3##(2008-10#3)(2011-2#1)
of the Early##4##3##(2008-10#3)(2008-5#1)
of the Earth##9##3##(1997-5#1)(2008-12#1)(2008-3#7)
of the Earth's surface##2##4##(2008-2#2)
of the Earth's##5##3##(2008-2#2)(2008-3#3)
of the East##3##3##(2009-7#1)(2010-1#1)(2010-8#1)
of the Ebro river basin##2##5##(2008-10#2)
of the Ecuadorian A2##2##4##(2008-10#2)
of the Ecuadorian##3##3##(2008-10#2)(2008-8#1)
of the Edge Hill##2##4##(2009-10#2)
of the Effects of##3##4##(2008-10#3)
of the Egyptian##2##3##(2008-10#2)
of the Ehrlich##2##3##(1990-5#1)(2012-3#1)
of the Eighth##3##3##(1991-1#1)(2008-9#1)(2010-6#1)
of the El##3##3##(1992-5#1)(1994-2#1)(2008-5#1)
of the English language##2##4##(2009-5#1)(2012-3#1)
of the English##5##3##(2008-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the Escherichia coli chromosome##2##5##(1994-12#1)(1995-2#1)
of the Escherichia coli rnpB##2##5##(1997-2#2)
of the Escherichia coli##25##4##(1990-11#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-12#4)(1996-6#3)(1997-2#2)(2013-1#1)
of the Eu(3+) ions##2##4##(2007-12#1)(2008-3#1)
of the Eu(III) bound to the FA##2##7##(2008-10#2)
of the Eu(III)##5##3##(2008-10#5)
of the Euclidean##2##3##(2008-3#1)(2011-2#1)
of the European Society of##5##5##(1993-12#1)(2008-7#3)(2012-2#1)
of the European Union##2##4##(1997-6#1)(2008-10#1)
of the European part of##2##5##(1994-9#1)(2011-2#1)
of the European##25##3##(1990-2#1)(1993-12#1)(1994-9#1)(1997-6#2)(2008-10#7)(2008-3#1)(2008-7#5)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the F plasmid##2##4##(1990-11#2)
of the F protein##2##4##(2007-6#1)(2008-5#1)
of the F##9##3##(1990-11#2)(1991-7#1)(1992-7#1)(2007-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
of the F(1) generation were##3##5##(2008-10#3)
of the F(1)##8##3##(2008-10#8)
of the F(2)##2##3##(2008-10#2)
of the F(3)##3##3##(2008-10#3)
of the F-actin##2##3##(1993-8#1)(2008-10#1)
of the F3##2##3##(2008-12#2)
of the FA##2##3##(2008-10#2)
of the FAB classification##2##4##(1991-2#1)(1992-10#1)
of the FAD##2##3##(1990-7#1)(1992-1#1)
of the FAS##2##3##(2009-8#1)(2009-9#1)
of the FBG##3##3##(2007-11#1)(2007-12#2)
of the FCU##2##3##(2013-7#2)
of the FDTD##4##3##(2008-3#4)
of the FGF##2##3##(1994-11#1)(2012-12#1)
of the FHL tendon##2##4##(2009-10#2)
of the FHL##3##3##(2009-10#2)(2012-3#1)
of the FI##3##3##(2008-10#3)
of the FIA system##3##4##(2008-10#3)
of the FIA##4##3##(1995-3#1)(2008-10#3)
of the FKNMS##2##3##(2007-5#2)
of the FLAG peptides##2##4##(1997-3#2)
of the FMOC##2##3##(2008-10#2)
of the FMR1 gene##2##4##(2009-5#2)
of the FNR protein##2##4##(1992-3#2)
of the FNR##3##3##(1992-3#3)
of the Fab##4##3##(1993-6#1)(1995-5#3)
of the Fabry-Perot cavity##4##4##(2007-12#1)(2008-3#2)(2013-8#1)
of the Fabry-Perot##8##3##(2007-11#1)(2007-12#2)(2008-3#4)(2013-8#1)
of the Faculty of Medicine of the University of##2##9##(1994-2#1)(2009-7#1)
of the Faculty of Medicine##3##5##(1994-2#1)(2009-7#1)(2010-8#1)
of the Family##4##3##(1997-6#1)(2008-10#1)(2008-9#2)
of the Fantastic questionnaire##2##4##(2012-12#2)
of the Fd##2##3##(1993-6#2)
of the Fe(3+)##2##3##(2008-10#1)(2008-9#1)
of the Fe-Fe distance##2##4##(1995-6#1)(2009-11#1)
of the Federal##7##3##(1993-1#1)(1994-2#1)(1995-1#1)(1997-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
of the Fermi##2##3##(2008-10#2)
of the Fiji##2##3##(2008-1#2)
of the Finnish##2##3##(1996-3#1)(2007-7#1)
of the First##5##3##(1994-7#1)(1996-2#2)(2011-2#1)(2013-1#1)
of the Food and Drug Administration##2##6##(1997-5#1)(2008-8#1)
of the Food##5##3##(1997-5#1)(2008-10#2)(2008-8#1)(2012-2#1)
of the Form 90##3##4##(2008-6#3)
of the Fourier transform##2##4##(2008-3#2)
of the Fourier##4##3##(2008-3#4)
of the Fragile X##2##4##(2009-5#2)
of the French##8##3##(1990-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-9#2)(2011-3#1)(2012-2#1)
of the Fresnel##4##3##(2008-2#1)(2008-3#3)
of the FucT-VI gene##2##4##(1992-8#2)
of the Functional Movement Screen##2##5##(2011-2#2)
of the Functional##3##3##(2009-11#1)(2011-2#2)
of the Fusarium graminearum##2##4##(2008-10#2)
of the Fusarium oxysporum##2##4##(2008-10#2)
of the Fusarium##5##3##(1995-2#1)(2008-10#4)
of the Future Search##2##4##(1996-3#2)
of the G##3##3##(1993-1#1)(1994-12#1)(2008-11#1)
of the G-CSFR##6##3##(1994-11#6)
of the G-protein##2##3##(1996-2#1)(2008-7#1)
of the G1##2##3##(1997-7#1)(2008-11#1)
of the GA##3##3##(1993-12#3)
of the GABA##3##3##(1992-3#1)(1995-11#1)(1996-12#1)
of the GABAB##2##3##(1993-12#2)
of the GAL##2##3##(1995-2#1)(1997-3#1)
of the GAP-43##3##3##(1994-2#2)(2008-7#1)
of the GAP1##2##3##(1990-5#2)
of the GAPDH##2##3##(1991-9#1)(1995-6#1)
of the GB virus##2##4##(2008-10#2)
of the GBC##2##3##(2010-12#2)
of the GC##5##3##(1993-3#1)(2008-10#3)(2008-7#1)
of the GCN5 gene##2##4##(1997-3#2)
of the GFAP##2##3##(1997-2#1)(2011-2#1)
of the GHR##2##3##(2008-4#2)
of the GM##2##3##(2011-2#2)
of the GM3 was##2##4##(1990-5#2)
of the GM3##3##3##(1990-5#2)(1991-2#1)
of the GNP##2##3##(1991-3#1)(2013-1#1)
of the GP##2##3##(1990-6#1)(2007-12#1)
of the GP's##2##3##(1997-4#2)
of the GST##4##3##(1990-2#1)(1994-2#1)(2009-11#2)
of the GTPase##2##3##(1992-11#1)(1992-8#1)
of the Gaussian beam##2##4##(2008-3#2)
of the Gaussian field##2##4##(2008-3#2)
of the Gaussian mirror spot size##2##6##(2008-2#2)
of the Gaussian##10##3##(2008-10#1)(2008-2#4)(2008-3#5)
of the Gene Ontology project##2##5##(2008-9#2)
of the Gene Ontology##4##4##(2008-7#2)(2008-9#2)
of the General Health Questionnaire (GHQ 20)##2##7##(2008-1#2)
of the General Health Questionnaire##3##5##(2008-1#2)(2008-3#1)
of the General##6##3##(1992-5#1)(1996-7#1)(2008-1#2)(2008-3#1)(2012-2#1)
of the Genetic Analysis Workshop 17##2##6##(2012-3#2)
of the Genetic##3##3##(2008-10#1)(2012-3#2)
of the Genome##2##3##(2008-10#1)(2008-4#1)
of the Genomic##41##3##(2011-2#41)
of the Genus##4##3##(2008-10#3)(2010-2#1)
of the Georgia##3##3##(1996-12#2)(2010-12#1)
of the German Health##2##4##(2009-7#1)(2012-2#1)
of the German##7##3##(1997-8#1)(2008-8#1)(2009-7#2)(2012-2#3)
of the Global##3##3##(2008-2#1)(2009-6#1)(2010-5#1)
of the Glu-50--&gt##2##3##(1995-6#2)
of the Golgi complex##3##4##(2008-7#3)
of the Golgi##8##3##(1992-12#1)(1993-12#2)(2008-11#1)(2008-7#3)(2012-2#1)
of the Gompertz##2##3##(1993-12#1)(2008-1#1)
of the Gouy##2##3##(2007-11#1)(2007-12#1)
of the Government##3##3##(1995-3#2)(2008-5#1)
of the Great##4##3##(2008-10#1)(2009-7#1)(2013-1#1)(2013-8#1)
of the Green's function##2##4##(2008-3#2)
of the Group##2##3##(1997-7#1)(2008-11#1)
of the Gulf of##2##4##(2007-5#1)(2008-5#1)
of the Gulf##4##3##(1997-4#1)(2007-5#1)(2008-5#1)(2012-2#1)
of the Gus##2##3##(1993-8#2)
of the H##6##3##(1997-6#1)(2008-10#4)(2008-11#1)
of the H(2)O##2##3##(2008-2#1)(2008-3#1)
of the H-Wave(R) device##3##4##(2010-1#3)
of the H-point standard##2##4##(2008-10#2)
of the H-point##3##3##(2008-10#3)
of the H1##4##3##(1992-11#1)(1992-9#2)(1993-6#1)
of the H2##2##3##(1991-9#1)(1992-9#1)
of the HA##5##3##(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)
of the HA-PEO hydrogel##2##4##(2008-5#2)
of the HA1 gene were##2##5##(1994-8#2)
of the HA1 gene##3##4##(1994-8#3)
of the HA1##4##3##(1994-8#3)(1997-6#1)
of the HAs##2##3##(2008-10#1)(2008-5#1)
of the HBV##2##3##(1997-4#2)
of the HBX protein##3##4##(2008-8#3)
of the HCV##2##3##(2008-8#1)(2013-1#1)
of the HD##3##3##(2007-7#1)(2007-8#1)(2008-1#1)
of the HDC##2##3##(1997-1#2)
of the HER2##3##3##(1993-1#1)(1995-2#1)(2009-9#1)
of the HERG##2##3##(1996-2#1)(2008-8#1)
of the HII phase and##2##5##(1990-12#2)
of the HIS3##2##3##(1997-4#2)
of the HIV epidemic in##2##5##(1990-12#1)(1995-1#1)
of the HIV epidemic##8##4##(1990-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(2010-5#2)
of the HIV infected##2##4##(1993-12#1)(1993-8#1)
of the HIV##19##3##(1990-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-6#1)(2007-2#1)(2008-4#2)(2010-5#2)(2010-8#1)(2011-2#1)
of the HIV-1##7##3##(1994-8#1)(1997-4#1)(2008-2#1)(2011-3#3)(2013-1#1)
of the HIV/AIDS##2##3##(1994-2#1)(2007-7#1)
of the HMG##2##3##(1993-2#1)(2008-8#1)
of the HMG2 gene##3##4##(1995-2#3)
of the HMO##4##3##(1991-1#2)(1993-3#1)(1994-12#1)
of the HN##2##3##(2007-6#1)(2008-11#1)
of the HOOK##2##3##(2008-8#2)
of the HPA axis##4##4##(1994-2#2)(1995-12#1)(2008-4#1)
of the HPI##2##3##(1996-2#2)
of the HPLC method##2##4##(2008-10#2)
of the HPSAM##2##3##(2008-10#2)
of the HR##2##3##(2008-11#1)(2013-8#1)
of the HRP-rotating biosensor##2##4##(2008-10#2)
of the Haemophilus influenzae##2##4##(2008-11#1)(2008-7#1)
of the Hall technique##3##4##(2013-1#3)
of the Hartmann test##2##4##(2008-3#2)
of the Hartmanngram##2##3##(2008-3#2)
of the Harvard##2##3##(1990-11#1)(2010-5#1)
of the Haversian canals##2##4##(1995-6#1)(2013-1#1)
of the HeNe##2##3##(2007-12#2)
of the Health Care Financing Administration##2##6##(1991-1#1)(1997-2#1)
of the Health Care Financing##9##5##(1991-1#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)
of the Health Care Quality Improvement##2##6##(1991-1#1)(1993-2#1)
of the Health Care Quality##3##5##(1991-1#1)(1993-2#1)(1996-2#1)
of the Health Care##14##4##(1991-1#2)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#1)
of the Health Centers##2##4##(2008-9#2)
of the Health Plan Employer Data##2##6##(1996-3#1)(1997-2#1)
of the Health Plan##3##4##(1995-1#1)(1996-3#1)(1997-2#1)
of the Health##23##3##(1991-1#2)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#3)(1996-3#3)(1997-2#2)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-9#2)
of the Hematology and Oncology##2##5##(2008-9#2)
of the Hematology and##3##4##(2008-9#3)
of the Hg##3##3##(2007-11#1)(2008-10#2)
of the HiRIS##2##3##(2008-10#2)
of the Hibiscus rosa-sinensys##2##4##(2008-10#2)
of the Hip##2##3##(2007-11#1)(2012-12#1)
of the History of Medicine##2##5##(1994-2#1)(1995-12#1)
of the Hox gene##2##4##(2007-12#1)(2008-1#1)
of the Hox##3##3##(2007-12#2)(2008-1#1)
of the Hsp70##2##3##(1991-9#1)(2009-5#1)
of the Hubble Space Telescope##2##5##(2008-2#1)(2008-3#1)
of the Human Genome##3##4##(1994-9#1)(2007-3#1)(2008-4#1)
of the Human##6##3##(1994-9#1)(2007-3#1)(2008-11#1)(2008-4#2)(2009-10#1)
of the Hv145SV##2##3##(2008-10#2)
of the Hydrogen##2##3##(1991-8#1)(2008-10#1)
of the Hydrolight##4##3##(2008-2#1)(2008-3#3)
of the IA-1##3##3##(1997-7#3)
of the IABP##2##3##(2010-8#2)
of the IAC##3##3##(2008-10#3)
of the IAR##2##3##(2012-2#2)
of the IC##2##3##(2008-10#2)
of the ICA##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
of the ICU environment##2##4##(1992-2#2)
of the ICU##5##3##(1992-2#4)(1995-12#1)
of the IGF-I##2##3##(1991-5#1)(2008-11#1)
of the IGF-II gene##2##4##(1992-9#2)
of the IGF-II##3##3##(1992-9#2)(2008-6#1)
of the IL-6 receptor##2##4##(1990-5#1)(1994-2#1)
of the IL-6##7##3##(1990-5#2)(1994-2#1)(1995-2#1)(1996-2#2)(2009-6#1)
of the ILR1-like family##2##4##(2008-7#2)
of the ILS##2##3##(2008-10#1)(2008-3#1)
of the IN subtype##2##4##(2008-2#2)
of the INM##2##3##(2011-2#2)
of the IP3-sensitive Ca2+ store##2##5##(1993-8#2)
of the IR##8##3##(1994-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
of the ISE##2##3##(2008-10#2)
of the ISEs##4##3##(2008-10#4)
of the ISFET##2##3##(2008-10#2)
of the ISO gene##2##4##(1990-11#2)
of the ISO##3##3##(1990-11#2)(2008-2#1)
of the ITFDE##2##3##(1993-12#2)
of the ITS and##2##4##(2008-10#1)(2010-3#1)
of the ITS region##6##4##(2008-10#4)(2009-2#1)(2010-3#1)
of the ITS##13##3##(2008-10#10)(2009-2#1)(2010-3#2)
of the IVC##6##3##(2008-7#1)(2011-2#3)(2013-1#2)
of the IVF patients had##2##5##(1990-2#2)
of the IgG##8##3##(1990-12#2)(1994-11#1)(1994-3#1)(1994-9#1)(2007-10#1)(2008-1#1)(2008-11#1)
of the Ilizarov apparatus##2##4##(2007-11#2)
of the Ilizarov##3##3##(2007-11#2)(2008-8#1)
of the Impact of##4##4##(2008-1#1)(2008-10#1)(2010-2#1)(2010-8#1)
of the Implementation of##2##4##(2008-10#1)(2008-12#1)
of the Implementation##3##3##(1996-1#1)(2008-10#1)(2008-12#1)
of the Indian##7##3##(1992-12#1)(1994-8#1)(1997-8#1)(2008-10#2)(2011-2#1)(2013-8#1)
of the Information##2##3##(1991-9#1)(2011-2#1)
of the Initiative##2##3##(1995-3#1)(1996-12#1)
of the Institut##2##3##(1992-9#1)(2008-11#1)
of the Institute of##2##4##(1990-2#1)(1996-4#1)
of the Institute##5##3##(1990-2#1)(1996-4#1)(2008-10#1)(2008-5#1)(2010-1#1)
of the Instituto##2##3##(2013-1#1)(2013-7#1)
of the Interaction Between##2##4##(2008-10#2)
of the Internal##2##3##(2008-10#2)
of the International Society for##3##5##(2007-12#1)(2008-12#1)(2009-11#1)
of the International Society of##2##5##(2008-5#1)(2011-2#1)
of the International Society##5##4##(2007-12#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)
of the International Task Force for Disease Eradication##2##8##(1993-12#2)
of the International##24##3##(1990-11#2)(1991-12#1)(1991-5#1)(1993-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-8#1)
of the Internet and##2##4##(1994-3#1)(2008-11#1)
of the Internet##5##3##(1994-12#1)(1994-3#1)(1996-2#1)(2008-11#1)(2009-5#1)
of the Inverness Blood Grouping System##2##6##(1994-6#2)
of the Israeli##2##3##(2008-10#1)(2013-1#1)
of the Istituto##2##3##(1991-12#1)(2010-4#1)
of the Italian NEO-PI-R##2##4##(2008-11#2)
of the Italian Society##3##4##(1991-6#1)(2011-2#2)
of the Italian##19##3##(1990-3#1)(1991-6#2)(1991-8#1)(1992-9#1)(1993-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#3)(2010-11#1)(2010-3#1)(2011-2#3)
of the JNK pathway##4##4##(2008-1#4)
of the Jackson Hole Group##3##5##(1993-12#1)(1994-1#2)
of the Jacobian matrix##2##4##(2008-3#1)(2008-9#1)
of the Japanese Society of##2##5##(1994-12#1)(2010-1#1)
of the Japanese##11##3##(1994-12#1)(1995-2#1)(2008-1#1)(2008-5#1)(2008-6#2)(2010-1#1)(2011-1#2)(2011-3#1)(2012-1#1)
of the Joint##3##3##(1993-2#2)(2008-8#1)
of the Journal of##7##4##(2008-10#3)(2008-3#1)(2009-10#1)(2009-8#1)(2011-2#1)
of the Journal##11##3##(1994-3#1)(1997-1#1)(2008-10#4)(2008-3#1)(2009-10#1)(2009-8#1)(2011-2#1)(2011-4#1)
of the K##3##3##(1997-2#1)(1997-7#2)
of the K+##2##3##(1990-12#1)(1991-11#1)
of the KDR##4##3##(1992-9#1)(1994-11#3)
of the KP theory##2##4##(2009-9#2)
of the KP##3##3##(2009-6#1)(2009-9#2)
of the Kalman filter##2##4##(2008-2#1)(2008-3#1)
of the Keck##3##3##(2008-3#3)
of the Kingdom##2##3##(2008-1#1)(2008-10#1)
of the Kirchhoff##3##3##(2007-11#1)(2008-3#2)
of the Kjeldahl method##2##4##(2008-10#2)
of the Knee##2##3##(2010-12#1)(2013-1#1)
of the Korean##2##3##(2008-10#1)(2009-3#1)
of the Kromoscopic##2##3##(2008-3#2)
of the Kubelka-Munk##2##3##(2008-10#1)(2008-3#1)
of the L##7##3##(1992-8#1)(1995-5#1)(2008-10#4)(2011-2#1)
of the L-A dsRNA virus##3##5##(1997-3#3)
of the L-A##4##3##(1997-3#4)
of the L-arginine-nitric oxide pathway##2##5##(1993-3#1)(1995-12#1)
of the L-type##2##3##(1990-8#1)(1995-3#1)
of the L1##3##3##(1991-11#1)(1997-2#1)(2011-2#1)
of the L3##2##3##(1991-11#1)(1992-8#1)
of the L4##2##3##(2008-7#1)(2011-2#1)
of the L5##2##3##(2007-11#2)
of the LATEBLIGHT Model##3##4##(2008-10#3)
of the LCD##2##3##(2008-2#1)(2010-9#1)
of the LD##2##3##(2007-11#1)(2008-3#1)
of the LDL receptor##6##4##(1990-7#4)(1995-6#1)(2008-6#1)
of the LDL##10##3##(1990-7#4)(1993-6#1)(1994-3#2)(1995-5#1)(1995-6#1)(2008-6#1)
of the LE model##4##4##(2008-10#4)
of the LEAP##2##3##(1996-3#2)
of the LED##2##3##(2008-3#2)
of the LES##2##3##(2011-2#1)(2013-8#1)
of the LG##2##3##(2008-10#2)
of the LH##3##3##(1995-2#1)(2009-10#2)
of the LHR##2##3##(1996-5#2)
of the LIDT of##2##4##(2008-3#2)
of the LIF calibration##2##4##(2008-2#2)
of the LII##2##3##(2008-3#2)
of the LITA graft were##2##5##(2007-8#2)
of the LITA graft##3##4##(2007-8#3)
of the LP(11) mode##4##4##(2007-11#1)(2007-12#3)
of the LPIA##4##3##(2008-3#4)
of the LPL gene##3##4##(1993-3#2)(1994-11#1)
of the LPL##4##3##(1993-3#2)(1994-11#2)
of the Lambda##2##3##(1994-2#1)(2008-10#1)
of the Lang-Kobayashi##2##3##(2007-11#1)(2007-12#1)
of the Langmuir##3##3##(1994-5#1)(2008-10#2)
of the Latex beads##3##4##(2008-6#3)
of the Leishmania genus##2##4##(2013-1#2)
of the Leishmania##3##3##(2008-8#1)(2013-1#2)
of the Leydig##2##3##(1990-6#1)(2009-10#1)
of the LiF##2##3##(2008-3#2)
of the Literature##12##3##(1997-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
of the LnDOTP(5)(-)##2##3##(1997-7#2)
of the London##2##3##(2008-11#1)(2012-2#1)
of the Lung##3##3##(2010-8#2)(2013-1#1)
of the M RNA##2##4##(2008-10#2)
of the M##14##3##(1993-12#1)(1995-5#1)(1997-3#2)(1997-4#1)(2008-10#3)(2008-3#3)(2008-5#1)(2009-6#1)(2010-8#1)
of the M(2)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of the M1##2##3##(1992-10#1)(2013-8#1)
of the M2(D)##2##3##(2008-8#2)
of the MA and##3##4##(2008-10#2)(2008-3#1)
of the MADS##2##3##(1997-8#2)
of the MAP kinase##4##4##(1995-2#1)(1995-8#1)(1997-6#1)(2008-4#1)
of the MAPK##4##3##(1995-2#1)(2009-8#3)
of the MC##2##3##(2007-11#2)
of the MCA was##2##4##(2007-10#2)
of the MCA##5##3##(2007-10#3)(2008-12#2)
of the MCF-7##2##3##(1994-12#1)(2008-11#1)
of the MCMC##2##3##(2009-12#1)(2012-7#1)
of the MCP's##2##3##(2008-3#2)
of the MDCK and the dog##2##6##(1995-11#2)
of the MDCK##3##3##(1995-11#2)(2008-11#1)
of the MDM2 gene##2##4##(1994-12#2)
of the MDM2##3##3##(1994-12#3)
of the MDR1 and##2##4##(2007-10#2)
of the MDR1 gene##2##4##(2008-11#2)
of the MDR1##6##3##(1994-5#1)(2007-10#3)(2008-11#2)
of the MED-EL##2##3##(2008-9#2)
of the MFS##3##3##(1994-1#2)(2011-1#1)
of the MGMT##2##3##(1992-3#2)
of the MHC class I##2##5##(2008-4#2)
of the MHC##6##3##(1995-5#1)(1997-6#1)(1997-9#1)(2008-4#3)
of the MIB1##2##3##(1997-7#2)
of the MLL##2##3##(2011-3#2)
of the MMDM##2##3##(2008-3#2)
of the MMRPE##2##3##(2013-1#2)
of the MP##2##3##(2008-9#2)
of the MR##2##3##(2008-10#1)(2011-1#1)
of the MRP encoded protein P190##2##6##(2008-11#2)
of the MRP##3##3##(2008-11#3)
of the MRP/GS-X pump##2##4##(2008-11#2)
of the MS was##2##4##(2008-3#2)
of the MS##11##3##(2008-10#2)(2008-3#8)(2012-3#1)
of the MT isoforms##3##4##(2008-10#3)
of the MT##5##3##(2008-10#5)
of the MTC test##3##4##(2008-7#3)
of the MVB group##2##4##(2007-7#2)
of the MYC##2##3##(2009-2#1)(2011-2#1)
of the Maillard reaction##2##4##(1991-5#1)(1994-6#1)
of the Markov model##2##4##(2008-6#1)(2008-8#1)
of the Markov##3##3##(2008-6#1)(2008-7#1)(2008-8#1)
of the Maslach Burnout Inventory##2##5##(2008-10#1)(2008-11#1)
of the Massachusetts##11##3##(1990-5#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)
of the McGill##2##3##(2009-12#1)(2011-2#1)
of the Medicaid##4##3##(1991-3#1)(1994-2#1)(1996-1#1)(1997-2#1)
of the Medical University in##2##5##(2007-11#1)(2007-8#1)
of the Medical University##3##4##(2007-11#1)(2007-8#1)(2008-7#1)
of the Medical##10##3##(1996-1#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
of the Medicare and Medicaid##3##5##(1991-12#2)(1996-3#1)
of the Medicare fee schedule (MFS)##2##6##(1994-1#1)(1996-1#1)
of the Medicare fee schedule##4##5##(1993-3#1)(1994-1#2)(1996-1#1)
of the Medicare hospice benefit##2##5##(1991-3#1)(1994-12#1)
of the Medicare population##2##4##(1993-12#1)(1995-12#1)
of the Medicare program##2##4##(1991-1#1)(1995-2#1)
of the Medicare prospective payment system##3##6##(1991-3#1)(1992-1#1)(1993-12#1)
of the Medicare##26##3##(1991-1#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-12#2)(1993-12#2)(1993-3#2)(1994-1#3)(1994-12#3)(1994-3#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-3#1)(2008-6#1)
of the Mediterranean seagrass Posidonia oceanica to##2##7##(2013-1#2)
of the Mediterranean##6##3##(2008-10#2)(2010-1#1)(2011-2#1)(2013-1#2)
of the Member##2##3##(2008-10#1)(2011-2#1)
of the Memphis Business Group on Health##2##7##(1994-12#2)
of the Metropolitan##2##3##(2008-5#1)(2013-1#1)
of the Mexican Society of##2##5##(2008-10#2)
of the Mexican##6##3##(1993-6#1)(2008-10#3)(2008-5#2)
of the Mi##2##3##(1995-11#2)
of the Mid Staffordshire##2##4##(2013-8#2)
of the Middle East##2##4##(2007-2#1)(2009-2#1)
of the Middle##3##3##(2007-2#1)(2009-2#1)(2013-1#1)
of the Millennium Development Goals (MDGs)##2##6##(2008-8#1)(2010-12#1)
of the Millennium Development Goals##3##5##(2008-8#1)(2010-12#1)(2010-5#1)
of the Ministry of Health##3##5##(2011-2#1)(2013-1#1)(2013-7#1)
of the Ministry of##5##4##(1991-3#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the Monte Carlo technique##2##5##(2008-2#1)(2008-3#1)
of the Monte Carlo##3##4##(2008-2#2)(2008-3#1)
of the Montreal Protocol##2##4##(1992-3#1)(1996-1#1)
of the Mos##2##3##(1994-8#2)
of the Mueller matrix##7##4##(2007-11#2)(2008-2#2)(2008-3#3)
of the Mueller##8##3##(2007-11#2)(2008-2#3)(2008-3#3)
of the Multidimensional 10 Commandments Questionnaire (M10CQ)##2##7##(2008-12#2)
of the Multidimensional##3##3##(2008-12#2)(2012-2#1)
of the Municipal Forest##2##4##(2008-5#2)
of the Municipal##3##3##(1997-5#1)(2008-5#2)
of the Mycobacterium##2##3##(1992-12#1)(2008-8#1)
of the N gene##2##4##(2008-10#2)
of the N##6##3##(2008-10#5)(2008-4#1)
of the N-linked##4##3##(1993-11#1)(1993-8#1)(2008-11#1)(2008-7#1)
of the N-methyl-D-aspartate receptor##2##4##(1994-8#1)(1997-2#1)
of the N-methyl-D-aspartate##4##3##(1994-8#1)(1995-12#1)(1997-2#2)
of the N-terminal domain of##6##5##(2006-6#1)(2008-9#1)(2009-7#3)(2011-1#1)
of the N-terminal domain##8##4##(1992-9#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-7#3)(2011-1#1)
of the N-terminal region##2##4##(1996-3#1)(2009-7#1)
of the N-terminal##32##3##(1990-12#1)(1990-7#3)(1991-10#1)(1992-8#2)(1992-9#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-6#1)(2006-6#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#6)(2011-1#1)(2011-2#1)
of the N-terminus of the##2##5##(1990-2#2)
of the N-terminus of##4##4##(1990-2#2)(1991-9#1)(1997-9#1)
of the N-terminus##6##3##(1990-2#2)(1990-7#1)(1991-9#1)(1992-8#1)(1997-9#1)
of the NAC##2##3##(1996-5#2)
of the NADH##6##3##(1993-11#1)(1994-11#1)(1995-3#2)(2008-11#1)(2010-5#1)
of the NADPH oxidase in##2##5##(1990-2#1)(1990-5#1)
of the NAc##3##3##(2008-7#3)
of the NB##2##3##(1991-9#1)(2008-3#1)
of the NC strip##2##4##(2008-10#2)
of the NC##4##3##(1996-7#2)(2008-10#2)
of the NHS##4##3##(2008-7#1)(2013-1#1)(2013-8#2)
of the NILs##6##3##(2008-10#6)
of the NIMH##5##3##(1997-5#5)
of the NIST##2##3##(2008-10#1)(2008-3#1)
of the NMDA receptor##12##4##(1993-12#2)(1994-6#1)(1994-8#4)(1995-5#1)(1996-2#3)(2008-7#1)
of the NMDA##13##3##(1993-12#2)(1994-6#1)(1994-8#4)(1995-5#1)(1996-2#3)(2008-7#1)(2012-12#1)
of the NMDA/R1 receptor subunit##2##5##(1995-12#2)
of the NMR##3##3##(1994-5#1)(2008-10#1)(2009-9#1)
of the NO##5##3##(1993-6#1)(1995-5#2)(2008-2#1)(2011-2#1)
of the NOM##2##3##(1992-5#1)(2008-3#1)
of the NOS##2##3##(2008-10#2)
of the NPC##8##3##(2011-2#8)
of the NPY gene##3##4##(1992-12#3)
of the NTPDase##2##3##(2008-4#2)
of the Na##2##3##(1994-8#2)
of the Na(+)-H+ antiport systems##2##5##(1992-5#2)
of the Na(+)-H+##3##3##(1992-5#3)
of the Na+##3##3##(1992-12#1)(1995-12#1)(1997-8#1)
of the Na+/K(+)-ATPase##5##3##(1990-12#1)(1990-2#1)(1990-5#2)(1994-12#1)
of the Nafion/MV##2##3##(2008-10#2)
of the Nation's##5##3##(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(2008-6#1)
of the National Cancer Institute##4##5##(1991-3#1)(1993-6#1)(2008-10#1)(2012-3#1)
of the National Health Service (NHS)##2##6##(2011-2#1)(2013-1#1)
of the National Health Service##3##5##(2008-12#1)(2011-2#1)(2013-1#1)
of the National Health##4##4##(1997-3#1)(2008-12#1)(2011-2#1)(2013-1#1)
of the National Institute of Obstetrics and Gynecology on the##2##10##(1991-3#2)
of the National Institute of##3##5##(1991-3#2)(2008-7#1)
of the National Library of Medicine##3##6##(1992-2#1)(1995-1#1)(2010-4#1)
of the National Library of##4##5##(1992-2#1)(1993-3#1)(1995-1#1)(2010-4#1)
of the National##37##3##(1991-12#1)(1991-3#3)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-6#1)(1997-3#2)(1997-6#2)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the Nd##5##3##(2007-11#1)(2008-10#2)(2008-2#2)
of the Nd(3+)##2##3##(2007-11#1)(2008-3#1)
of the Nervous System##2##4##(2008-2#1)(2009-5#1)
of the Netherlands##7##3##(1991-8#2)(1992-2#2)(1996-3#1)(2008-10#1)(2010-8#1)
of the Network##2##3##(1991-3#1)(2008-3#1)
of the New World Sciurus##2##5##(2008-5#2)
of the New World##3##4##(2008-5#2)(2011-2#1)
of the New York State##2##5##(1992-8#1)(1996-2#1)
of the New York##7##4##(1990-3#1)(1991-12#1)(1992-8#1)(1994-12#1)(1996-2#1)(2008-8#1)(2011-2#1)
of the New Zealand Intensive Medicines Monitoring Programme##2##8##(2008-11#1)(2008-8#1)
of the New##13##3##(1990-3#1)(1991-12#1)(1992-8#1)(1994-1#1)(1994-12#1)(1996-2#1)(2008-11#1)(2008-5#2)(2008-8#2)(2011-2#2)
of the Nordic##2##3##(2008-10#1)(2011-4#1)
of the North American##7##4##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)
of the North##9##3##(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#2)
of the Northern##10##3##(1996-12#1)(2008-1#5)(2008-10#1)(2011-1#1)(2013-8#2)
of the Norwegian Medical Association##2##5##(1990-6#1)(1997-6#1)
of the Norwegian population##3##4##(1990-6#2)(1992-11#1)
of the Norwegian##10##3##(1990-6#3)(1992-11#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-6#1)(2010-6#1)(2011-2#1)
of the Nur77 family##2##4##(1994-12#2)
of the O##3##3##(1997-4#1)(2008-10#1)(2013-1#1)
of the O-H##2##3##(2008-3#1)(2009-10#1)
of the OB-fold##2##3##(2010-10#2)
of the OCT##2##3##(2007-12#1)(2011-7#1)
of the OECD##2##3##(2011-1#2)
of the OH stretching##2##4##(2007-12#1)(2008-2#1)
of the OH##4##3##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the OPO##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
of the OPV##2##3##(1994-9#2)
of the ORA##2##3##(2008-2#2)
of the ORF##2##3##(2008-7#1)(2008-8#1)
of the ORFs##4##3##(1994-12#2)(1997-3#2)
of the OSC##2##3##(2008-5#1)(2008-6#1)
of the Oct-2 POU domain##2##5##(1992-6#2)
of the Oct-2##3##3##(1992-6#2)(1994-12#1)
of the Old World##2##4##(2008-5#2)
of the Omnibus##2##3##(1991-1#1)(1997-3#1)
of the Ontario##2##3##(1994-8#1)(2011-2#1)
of the Optical Properties##2##4##(2008-2#1)(2008-3#1)
of the Optical##7##3##(2008-2#3)(2008-3#4)
of the Order##2##3##(2008-3#1)(2010-1#1)
of the Organization for Economic Cooperation and Development##2##8##(1993-2#1)(1994-1#1)
of the Organization##3##3##(1993-2#1)(1994-1#1)(1996-11#1)
of the Orinoco Oil Belt##2##5##(2008-10#2)
of the Ox IgG1 Fab##2##5##(1993-6#2)
of the Ox IgG3##2##4##(1993-6#2)
of the Ox##4##3##(1993-6#4)
of the P##14##3##(1990-12#1)(1993-9#1)(2008-10#8)(2009-2#1)(2010-2#1)(2012-1#1)(2013-1#1)
of the P-glycoprotein##5##3##(1992-12#1)(1995-11#1)(2008-11#3)
of the P-type##2##3##(1990-12#1)(1993-11#1)
of the P2##4##3##(1990-11#1)(1990-8#1)(1995-8#2)
of the P2Y##2##3##(1995-11#1)(2008-4#1)
of the P2Y(1) receptor##3##4##(2008-4#3)
of the P450##2##3##(2009-9#2)
of the PA method##2##4##(2012-2#2)
of the PAC##2##3##(1995-5#1)(2008-10#1)
of the PACE##3##3##(1992-1#1)(2008-7#2)
of the PAH##2##3##(2008-10#1)(2010-10#1)
of the PAHs##2##3##(2008-10#2)
of the PAI##2##3##(2008-10#2)
of the PANAS##2##3##(2013-8#2)
of the PANI film##2##4##(2008-10#2)
of the PAP##2##3##(2008-11#2)
of the PB films##2##4##(2008-10#2)
of the PB layer##3##4##(2008-10#3)
of the PB##7##3##(1997-2#1)(2008-10#6)
of the PBMCs##2##3##(1997-2#2)
of the PBS##2##3##(2008-11#1)(2008-2#1)
of the PCR product##2##4##(1994-12#1)(2008-10#1)
of the PCR products##4##4##(1992-9#1)(2008-10#3)
of the PCR##7##3##(1992-9#1)(1993-8#1)(1994-12#1)(2008-10#4)
of the PD catheter##2##4##(2011-2#2)
of the PD##4##3##(2008-7#2)(2011-2#2)
of the PDA##4##3##(2008-10#1)(2008-12#2)(2012-12#1)
of the PDC##2##3##(2007-7#2)
of the PDFE##2##3##(2008-2#2)
of the PDGF##2##3##(1992-9#1)(1994-6#1)
of the PDGF-betaR##2##3##(1997-7#2)
of the PDO##2##3##(2008-10#1)(2008-5#1)
of the PE absorption coefficient##2##5##(2008-3#2)
of the PE##3##3##(1991-1#1)(2008-3#2)
of the PEG hydrogel group compared with 66##2##8##(2012-3#2)
of the PEG##3##3##(2008-3#1)(2012-3#2)
of the PG##2##3##(1990-2#2)
of the PGs##2##3##(1990-2#2)
of the PI##2##3##(1992-6#1)(2008-8#1)
of the PI3K-Akt pathway##2##4##(2013-7#2)
of the PICOC##2##3##(2008-2#2)
of the PISHG##2##3##(2008-3#2)
of the PKC##3##3##(1992-9#1)(1995-5#1)(1996-5#1)
of the PLS##2##3##(2007-11#1)(2008-5#1)
of the PMD##2##3##(2007-11#1)(2007-12#1)
of the POA neurons##2##4##(2008-8#2)
of the PPAR-α##2##3##(2013-7#2)
of the PPS##2##3##(2008-2#2)
of the PPTg##2##3##(1994-2#2)
of the PQ(35) transition##2##4##(2008-3#2)
of the PR and##2##4##(2008-10#1)(2010-1#1)
of the PR##3##3##(1996-5#1)(2008-10#1)(2010-1#1)
of the PS/PDI##2##3##(2008-3#2)
of the PSF##4##3##(2008-2#1)(2008-3#3)
of the PSR##2##3##(2008-3#2)
of the PTS strain under aerobic conditions##2##7##(2008-7#2)
of the PVP##2##3##(2008-10#1)(2010-4#1)
of the PVY 1-2 HC##2##5##(2008-10#2)
of the PVY##3##3##(2008-10#3)
of the Pacific salmon##3##4##(1990-12#1)(1995-11#2)
of the Pacific##10##3##(1990-12#1)(1995-11#2)(2008-1#1)(2008-10#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-7#2)
of the Pap smear##3##4##(1991-6#1)(1992-3#2)
of the Pap##4##3##(1991-6#2)(1992-3#2)
of the Paramecium aurelia##4##4##(2008-12#4)
of the Pediatric##2##3##(2008-9#1)(2010-3#1)
of the People's Republic of China in##2##7##(2007-7#1)(2008-7#1)
of the Peruvian##3##3##(2011-2#1)(2013-8#2)
of the Petrous##2##3##(2011-2#2)
of the Pharmaceutical##2##3##(2008-10#1)(2008-11#1)
of the Phase Metrics DFHT IV##2##6##(2008-3#2)
of the Phytophthora genus-specific##2##4##(2008-10#2)
of the Phytophthora sp-h isolates##2##5##(2008-10#2)
of the Phytophthora##6##3##(2008-10#5)(2008-11#1)
of the Pierre Auger##2##4##(2008-3#2)
of the Pinewood Nematode##2##4##(2008-10#2)
of the Plant Ontology Consortium##4##5##(2008-7#4)
of the Plant-Parasitic Nematode##2##4##(2008-10#2)
of the Plasmodium yoelii##2##4##(1994-12#1)(2008-3#1)
of the Plasmodium##3##3##(1994-12#1)(2008-3#1)(2012-12#1)
of the Pleistocene##3##3##(2008-8#1)(2008-9#1)(2010-8#1)
of the Plum##2##3##(2008-10#1)(2011-2#1)
of the Pm-AMP1##2##3##(2008-10#2)
of the Polish Society of Internal##2##6##(2008-7#2)
of the Polish Society of Pediatric Oncology and Hematology]##3##9##(2008-9#3)
of the Polish Society of##7##5##(2007-8#1)(2008-7#2)(2008-9#3)(2009-5#1)
of the Polish##11##3##(2007-8#2)(2008-12#1)(2008-7#2)(2008-9#3)(2009-5#1)(2011-2#1)(2013-8#1)
of the Polyscias strains##2##4##(2008-10#2)
of the Population##2##3##(1996-3#1)(2008-10#1)
of the Positive and Negative##2##5##(1996-5#1)(2013-8#1)
of the Postharvest##2##3##(2008-10#2)
of the President of the##2##5##(1992-3#1)(2008-7#1)
of the Primary##2##3##(1996-2#1)(2008-10#1)
of the Prussian Blue##2##4##(2008-10#2)
of the Public Health##2##4##(1996-2#1)(2012-12#1)
of the Pythium##2##3##(2008-10#2)
of the Pyy##2##3##(1994-12#2)
of the Q biotype##2##4##(2011-2#2)
of the Q##4##3##(2008-3#2)(2011-2#2)
of the Q-switched##2##3##(2007-12#1)(2008-3#1)
of the QCM with LB##2##5##(2008-10#2)
of the QCM##4##3##(2008-10#4)
of the QD##2##3##(2008-7#2)
of the QIs##2##3##(1996-2#2)
of the QRS duration##2##4##(2008-10#1)(2010-1#1)
of the QTL##3##3##(2008-10#3)
of the Qinghai-Tibet Plateau##2##4##(2008-9#2)
of the Quality Assurance##2##4##(1997-2#1)(2008-11#1)
of the Questionnaire##2##3##(2009-10#1)(2012-3#1)
of the QuickVue##2##3##(2011-2#2)
of the R##7##3##(1990-8#1)(1993-6#1)(1995-8#1)(2007-11#1)(2008-10#2)(2010-10#1)
of the R-D-LSI##2##3##(2012-2#2)
of the RAND##2##3##(2008-10#2)
of the RAPD##2##3##(2008-10#1)(2008-5#1)
of the RB##2##3##(1993-8#1)(2008-10#1)
of the RBC##2##3##(1995-2#1)(2013-1#1)
of the RCA##2##3##(1992-3#2)
of the RFLP##2##3##(2008-10#1)(2008-5#1)
of the RGD sequence##3##4##(1995-6#3)
of the RGD##4##3##(1995-6#3)(2008-7#1)
of the RGD-BBN##2##3##(2010-6#2)
of the RI##2##3##(2008-10#2)
of the RN as##2##4##(2008-1#1)(2008-12#1)
of the RN##4##3##(2008-1#1)(2008-12#3)
of the RNA 4##2##4##(2008-10#2)
of the RNA polymerase##4##4##(1995-6#2)(1997-2#1)(2008-10#1)
of the RNA secondary##2##4##(1991-9#1)(2008-4#1)
of the RNA##19##3##(1991-9#1)(1993-12#1)(1993-3#1)(1995-6#2)(1997-2#1)(2008-10#6)(2008-2#1)(2008-4#3)(2008-7#1)(2009-7#1)(2010-6#1)
of the RPT technique##2##4##(2008-3#2)
of the RTP emission##2##4##(2008-10#2)
of the RTP##4##3##(2008-10#4)
of the Radiology##3##3##(1990-10#1)(1992-1#1)(2008-6#1)
of the Raman effect##2##4##(2007-12#1)(2008-10#1)
of the Raman scattering coefficient##2##5##(2008-2#1)(2008-3#1)
of the Raman scattering##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
of the Raman##21##3##(1991-5#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#6)(2008-4#1)(2011-1#2)(2013-8#2)
of the Raman-scattering coefficient##2##4##(2008-2#1)(2008-3#1)
of the Raman-scattering coefficients##2##4##(2008-2#2)
of the Raman-scattering##4##3##(2008-2#3)(2008-3#1)
of the Ras superfamily##3##4##(1995-2#2)(1995-8#1)
of the Ras##4##3##(1994-8#1)(1995-2#2)(1995-8#1)
of the Rayleigh##3##3##(2008-3#3)
of the Red Cross##2##4##(1991-11#1)(2008-10#1)
of the Red##3##3##(1991-11#1)(2008-10#1)(2009-2#1)
of the Regional##2##3##(2008-10#2)
of the Rep gene##2##4##(2008-10#2)
of the Rep##4##3##(2008-10#4)
of the Republic of##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
of the Resilience Scale##2##4##(2011-1#2)
of the Review##3##3##(1997-2#1)(1997-3#2)
of the Rex-1 gene##3##4##(1994-9#3)
of the Rh##3##3##(1992-12#1)(1994-12#1)(2008-2#1)
of the River##2##3##(2008-10#1)(2010-8#1)
of the Road Map##2##4##(2011-1#2)
of the Robert##2##3##(1996-12#1)(2011-2#1)
of the Role of##3##4##(2008-10#3)
of the Ronchi##2##3##(2008-3#2)
of the Royal College of Physicians of London##3##8##(1990-9#1)(1996-8#2)
of the Royal College of##4##5##(1990-9#1)(1994-12#1)(1996-8#2)
of the Royal College##5##4##(1990-9#1)(1994-12#1)(1996-8#2)(2008-11#1)
of the Royal##10##3##(1990-9#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-8#2)(2008-1#1)(2008-11#1)(2008-8#1)(2010-12#1)
of the RyR1s##4##3##(2008-9#4)
of the S RNA##2##4##(2008-10#2)
of the S phase##2##4##(1994-8#1)(2008-9#1)
of the S##14##3##(1990-5#1)(1993-1#1)(1993-2#1)(1994-8#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)
of the S-phase fraction##2##4##(1993-1#1)(1993-11#1)
of the S-type##2##3##(1993-5#1)(1995-8#1)
of the S1##4##3##(1997-3#2)(2007-11#1)(2008-5#1)
of the SAM##5##3##(2008-10#5)
of the SAR##2##3##(2008-8#2)
of the SC##6##3##(2008-5#6)
of the SCN##4##3##(1993-12#1)(1993-9#2)(1994-2#1)
of the SEA##2##3##(1993-6#2)
of the SF-36##4##3##(1994-3#2)(2008-8#1)(2012-12#1)
of the SGLT1##2##3##(1991-12#2)
of the SH field##2##4##(2007-12#2)
of the SI##2##3##(2007-12#1)(2008-10#1)
of the SIA system##3##4##(2008-10#3)
of the SIP##2##3##(2008-3#2)
of the SMF##2##3##(2007-11#1)(2008-10#1)
of the SOA##2##3##(2007-12#2)
of the SOHO##2##3##(2008-2#1)(2008-3#1)
of the SPE##2##3##(1997-2#1)(2011-2#1)
of the SPR##5##3##(2008-10#4)(2008-3#1)
of the SS##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
of the SSCT##4##3##(2008-9#4)
of the ST##5##3##(2008-10#4)(2008-7#1)
of the STARD##2##3##(2008-12#2)
of the STR##2##3##(1994-12#1)(2008-12#1)
of the SVZ##2##3##(2008-7#2)
of the Saccharomyces cerevisiae##7##4##(1990-5#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-3#1)(1997-8#1)
of the Saccharomyces##8##3##(1990-5#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-3#1)(1997-8#1)(2012-3#1)
of the Sagnac interferometer##2##4##(2007-11#1)(2008-2#1)
of the Sagnac##4##3##(2007-11#2)(2008-2#2)
of the SalI##2##3##(1991-9#1)(1994-12#1)
of the Salmonella typhimurium##3##4##(1991-12#1)(1996-6#1)(2011-1#1)
of the Salmonella##4##3##(1991-12#1)(1996-2#1)(1996-6#1)(2011-1#1)
of the Scarlet Pimpernel##2##4##(2008-10#2)
of the Schiff base with##2##5##(1995-5#1)(2008-10#1)
of the Schiff base##7##4##(1994-5#2)(1995-5#3)(2008-10#2)
of the Schlieren effect##2##4##(2008-10#2)
of the School of Medicine##2##5##(1992-1#1)(2012-3#1)
of the School of##3##4##(1992-1#1)(2008-10#1)(2012-3#1)
of the Se-enriched##2##3##(2008-10#1)(2010-11#1)
of the Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##2##7##(2008-3#2)
of the Sea-viewing Wide##3##4##(2008-3#3)
of the SeaWiFS bands##2##4##(2008-3#2)
of the SeaWiFS##7##3##(2008-2#1)(2008-3#6)
of the Self-Help Clearinghouse##2##4##(1994-1#2)
of the Sertoli cells##2##4##(2009-10#1)(2013-1#1)
of the Sexual Function Questionnaire##3##5##(2012-3#3)
of the Sialis-type##2##3##(2008-12#2)
of the Sika Deer (Cervus##2##5##(2008-5#2)
of the Silesian##2##3##(2007-11#1)(2008-9#1)
of the Slp gene##3##4##(1995-2#3)
of the Slp##4##3##(1995-2#4)
of the Sm##2##3##(1993-2#1)(2008-10#1)
of the Social##2##3##(2012-12#2)
of the Society for##3##4##(2008-7#1)(2011-1#1)(2012-1#1)
of the Society##5##3##(2008-10#1)(2008-7#2)(2011-1#1)(2012-1#1)
of the Solar##2##3##(2008-2#1)(2008-3#1)
of the Sonoran Desert##2##4##(2008-10#2)
of the Soret band##2##4##(1992-12#1)(1995-2#1)
of the Soret##3##3##(1992-12#1)(1995-2#1)(2009-2#1)
of the South American##2##4##(2010-3#1)(2011-2#1)
of the South##4##3##(2008-1#1)(2010-3#1)(2011-2#2)
of the Southern##3##3##(1990-8#1)(2013-7#2)
of the Soviet Union##2##4##(2008-12#2)
of the Soybean##2##3##(2008-10#2)
of the Spanish##8##3##(1990-8#1)(1993-5#1)(1995-2#1)(2008-10#3)(2008-6#1)(2011-1#1)
of the Spectralon##3##3##(2008-2#3)
of the SrTiO(3)##2##3##(2008-3#2)
of the Src##2##3##(1995-6#1)(2011-2#1)
of the St##2##3##(1996-3#1)(2007-9#1)
of the Staphylococcus aureus##2##4##(1996-12#1)(1996-6#1)
of the State of##4##4##(1991-8#2)(1997-3#1)(2010-10#1)
of the State##9##3##(1991-8#2)(1995-12#1)(1997-3#1)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the States have##2##4##(1994-3#2)
of the States##4##3##(1994-3#2)(1995-1#1)(1997-2#1)
of the Stokes##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of the Strehl##2##3##(2008-3#2)
of the Strengths and Difficulties Questionnaire##2##6##(2008-10#2)
of the Streptococcus##2##3##(2011-1#1)(2011-2#1)
of the Streptomyces coelicolor chromosome##2##5##(1994-12#2)
of the Streptomyces coelicolor##3##4##(1994-12#2)(1995-8#1)
of the Streptomyces##4##3##(1994-12#3)(1995-8#1)
of the Stroke Belt Consortium##2##5##(2007-9#2)
of the Stroke##3##3##(2007-9#2)(2012-12#1)
of the Strong##2##3##(1996-9#1)(2012-3#1)
of the Stroop##2##3##(2007-8#1)(2013-1#1)
of the Structure##2##3##(1996-2#2)
of the Sun##2##3##(2008-3#2)
of the Swiss Canton of Vaud##2##6##(1993-9#2)
of the Swiss Federal Office of Statistics##2##7##(1991-11#2)
of the Swiss##7##3##(1991-11#2)(1991-2#1)(1993-9#2)(2008-3#1)(2011-2#1)
of the Sylvian fissure##2##4##(1996-7#1)(2006-12#1)
of the Syphilis Study at Tuskegee##2##6##(2013-1#2)
of the Syrian hamster##2##4##(1990-7#1)(1996-8#1)
of the T##12##3##(1990-7#2)(1991-3#1)(1992-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
of the T(in) channel##4##4##(2008-4#4)
of the T(in)##6##3##(1995-2#1)(2008-4#5)
of the T-DNA##3##3##(1990-11#1)(2008-10#2)
of the T-matrix##3##3##(2008-3#3)
of the T-quaternary structure##2##4##(1992-3#2)
of the T3##2##3##(1995-8#1)(2008-10#1)
of the T4##2##3##(1990-5#1)(1997-3#1)
of the T7 RNA polymerase##2##5##(1990-11#1)(2008-8#1)
of the TDT##2##3##(2008-4#1)(2008-9#1)
of the TDX system##3##4##(1993-8#3)
of the TEMPO+ behind-the-ear speech processor##2##6##(2008-9#2)
of the TEMPO+##3##3##(2008-9#3)
of the TGF-beta##2##3##(1995-2#1)(2008-9#1)
of the TGF-beta1/SMAD signaling pathway in##2##6##(2011-2#2)
of the TGF-beta1/SMAD signaling pathway##4##5##(2011-2#4)
of the TGF-beta1/SMAD##5##3##(2011-2#5)
of the TH##2##3##(1993-8#1)(2011-2#1)
of the THG microscope##2##4##(2008-3#2)
of the THz##4##3##(2007-12#2)(2008-3#1)(2011-1#1)
of the TLR4##2##3##(2008-10#1)(2013-8#1)
of the TM##7##3##(1994-3#2)(2009-7#5)
of the TMJ##2##3##(2011-2#1)(2012-3#1)
of the TNF##3##3##(2007-8#1)(2008-8#1)(2009-3#1)
of the TNF-beta gene##2##4##(1997-7#2)
of the TNF-beta##3##3##(1997-7#3)
of the TP53##2##3##(2008-7#1)(2009-8#1)
of the TQM process##2##4##(1993-3#1)(1994-1#1)
of the TSH receptor##6##4##(1990-12#2)(1991-9#1)(1992-12#2)(1996-5#1)
of the TSH##8##3##(1990-12#3)(1991-9#1)(1992-12#2)(1993-8#1)(1996-5#1)
of the TSI##4##3##(2012-3#4)
of the TSPO##2##3##(2012-2#2)
of the TSPO-targeted probe##2##4##(2012-2#2)
of the TUNEL##2##3##(2008-11#1)(2010-1#1)
of the TYLCV##3##3##(2008-10#3)
of the Tapajos##2##3##(2013-7#2)
of the Tapajós##2##3##(2013-7#2)
of the Technical##2##3##(2008-11#1)(2008-12#1)
of the Third##4##3##(2008-7#1)(2011-2#3)
of the Thirteenth Amendment##2##4##(2011-2#2)
of the Ti plasmid##2##4##(1990-11#1)(2008-10#1)
of the Ti##9##3##(1990-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#2)
of the TiO(2)##2##3##(2008-10#1)(2008-3#1)
of the TiO2##3##3##(2007-12#3)
of the Torpedo##2##3##(1993-3#1)(1994-5#1)
of the Toyota##2##3##(2012-2#1)(2013-8#1)
of the Translocator Protein##2##4##(2012-2#2)
of the Trinidad##2##3##(2008-8#1)(2008-9#1)
of the Tutotest##3##3##(2008-10#3)
of the TxtA##2##3##(2008-10#2)
of the Ty1##2##3##(1995-9#2)
of the U##18##3##(1990-11#1)(1990-4#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
of the U-G units##2##4##(1997-3#2)
of the U2##2##3##(1993-8#1)(1995-6#1)
of the UK##6##3##(2007-2#1)(2008-11#2)(2008-12#2)(2011-2#1)
of the URA3##3##3##(1991-7#2)(2008-10#1)
of the US Congress##2##4##(1994-8#1)(2008-1#1)
of the US##15##3##(1990-9#1)(1994-8#1)(1995-6#1)(1997-2#2)(2008-1#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
of the US-1 genotype##2##4##(2008-10#2)
of the US-1##3##3##(2008-10#3)
of the US-7 and##2##4##(2008-10#2)
of the US-7##3##3##(2008-10#3)
of the US-8 genotype##2##4##(2008-10#2)
of the US-8##6##3##(2008-10#6)
of the USA##4##3##(1996-11#1)(2008-4#1)(2008-9#1)(2010-4#1)
of the USP##2##3##(2008-10#2)
of the USPHS Syphilis Study at Tuskegee##2##7##(2013-1#2)
of the UV##11##3##(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#3)(2009-12#1)(2011-2#1)
of the UV-induced##2##3##(2007-11#1)(2008-3#1)
of the UVA/UVB ratio##2##4##(2008-5#2)
of the Unified##2##3##(2008-7#1)(2012-3#1)
of the Unit##2##3##(2007-11#1)(2012-3#1)
of the United Kingdom##2##4##(2008-11#1)(2011-2#1)
of the United Kingdom's##3##4##(1995-3#1)(2008-11#1)(2008-5#1)
of the United States Department of Agriculture's##2##7##(2008-3#2)
of the United States and Canada##3##6##(2008-10#3)
of the United States and##5##5##(2008-10#5)
of the United States in##2##5##(1993-2#1)(2008-10#1)
of the United States##50##4##(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-12#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-8#1)
of the United##56##3##(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-3#1)(2013-8#1)
of the University Hospital of##3##5##(1991-3#1)(1996-11#1)(2011-2#1)
of the University Hospital##4##4##(1991-3#1)(1996-11#1)(2011-2#2)
of the University of##26##4##(1990-10#1)(1990-9#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
of the University##31##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
of the Upper Galilee##2##4##(2011-2#2)
of the Urinary Bladder##2##4##(2008-10#1)(2008-12#1)
of the V##2##3##(2008-10#2)
of the V-ATPase##4##3##(1993-11#2)(1995-6#2)
of the VDR gene##2##4##(2008-4#1)(2013-1#1)
of the VIP##2##3##(1990-5#1)(1993-9#1)
of the VLO##3##3##(1994-3#3)
of the VO(2)##2##3##(2007-11#2)
of the VSF##2##3##(2008-3#2)
of the Venezuelan##3##3##(2008-5#3)
of the Vmax##2##3##(1990-11#1)(1994-6#1)
of the W54S##2##3##(1997-2#2)
of the WHO##2##3##(1997-5#1)(2013-8#1)
of the WNN model##2##4##(2008-10#2)
of the WSMV##3##3##(2008-10#3)
of the WT##2##3##(1995-5#1)(2012-12#1)
of the WWTP##2##3##(2008-10#2)
of the Water Framework Directive##3##5##(2008-10#3)
of the Wei-Lin-Weissfeld##2##3##(1997-4#2)
of the Weibull##2##3##(2008-10#1)(2010-4#1)
of the West Indies##8##4##(2011-2#8)
of the Western##5##3##(1993-11#1)(1997-2#1)(2008-10#1)(2010-3#1)(2011-2#1)
of the Wigner##2##3##(2007-11#1)(2007-12#1)
of the World Federation of Neurosurgical Societies##2##7##(2008-2#1)(2011-2#1)
of the World Health Organization##4##5##(1990-11#1)(1991-12#1)(2008-11#1)(2013-1#1)
of the World Health##5##4##(1990-11#1)(1991-12#1)(2008-11#1)(2012-12#1)(2013-1#1)
of the World Organisation for Animal Health##2##7##(2011-2#2)
of the World##14##3##(1990-11#1)(1991-12#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
of the Wölter mirror##2##4##(2008-2#2)
of the X and Y##2##5##(1994-1#1)(2008-7#1)
of the X chromosome##3##4##(1994-8#1)(2008-12#1)(2012-1#1)
of the X##10##3##(1993-6#1)(1994-1#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2012-1#1)
of the X-ray##6##3##(1995-2#1)(2008-11#1)(2012-12#1)(2013-8#3)
of the XE-2100##2##3##(2008-10#2)
of the XIII Congress##2##4##(1994-2#1)(1994-9#1)
of the XIIIth##2##3##(2008-5#2)
of the Xanthomonas avr/pth##3##4##(2008-10#3)
of the Xanthomonas##4##3##(2008-10#4)
of the Xenopus laevis##4##4##(1993-12#1)(1993-6#2)(1994-12#1)
of the Xenopus vitellogenin A2 gene##2##6##(1992-6#2)
of the Xenopus##9##3##(1992-6#2)(1993-12#1)(1993-6#3)(1994-12#1)(1997-7#1)(2008-5#1)
of the Y chromosome##2##4##(1993-9#1)(2012-3#1)
of the Y##3##3##(1993-9#1)(2012-3#1)(2013-8#1)
of the YAC##2##3##(1996-10#1)(1996-12#1)
of the Yanomámi##3##3##(1991-12#3)
of the Yb##5##3##(2008-2#1)(2008-3#4)
of the Z-scan technique as a method to##2##8##(2007-12#2)
of the Z-scan technique##3##4##(2007-11#1)(2007-12#2)
of the Zernike##3##3##(2007-12#1)(2008-3#2)
of the Zeus##2##3##(2007-8#1)(2011-2#1)
of the Zn##2##3##(2008-10#2)
of the ZnO##2##3##(2009-8#1)(2010-4#1)
of the Zone##2##3##(2008-3#1)(2008-7#1)
of the aa sequence##2##4##(1990-5#1)(1993-2#1)
of the aa##3##3##(1990-5#1)(1993-12#1)(1993-2#1)
of the abdomen showed##3##4##(2011-2#1)(2013-8#2)
of the abdomen##12##3##(1990-6#1)(1991-2#1)(1991-9#1)(2008-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
of the abdominal wall is##2##5##(1990-5#1)(1991-9#1)
of the abdominal wall##8##4##(1990-5#1)(1991-12#1)(1991-9#1)(1996-3#1)(2008-10#2)(2011-2#1)(2012-12#1)
of the abdominal##21##3##(1990-5#2)(1990-6#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-6#1)(1996-3#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-12#2)
of the abducens nerve##2##4##(2012-3#2)
of the abilities##2##3##(2010-2#2)
of the ability of the##4##5##(1997-7#1)(2008-3#1)(2008-5#1)(2010-10#1)
of the ability of these##2##5##(2007-12#1)(2008-10#1)
of the ability of##14##4##(1994-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#4)(2008-9#2)(2010-10#1)
of the ability to##5##4##(1995-2#1)(2007-12#1)(2008-12#1)(2010-12#1)(2012-3#1)
of the ability##20##3##(1994-8#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-9#2)(2010-10#1)(2010-12#1)(2012-3#1)
of the abiotic##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
of the ablated##2##3##(2008-10#1)(2008-3#1)
of the ablation##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
of the abnormal##5##3##(1990-5#1)(1992-3#1)(2007-10#1)(2008-7#2)
of the above mentioned parameters##2##5##(1990-9#1)(2008-10#1)
of the above mentioned##9##4##(1990-9#1)(2007-11#1)(2008-10#5)(2011-2#2)
of the above parameters##5##4##(1994-5#1)(1996-5#1)(2008-8#1)(2013-1#2)
of the above species##2##4##(2008-10#2)
of the above three##2##4##(2008-10#1)(2008-5#1)
of the above two##2##4##(1995-11#1)(2008-4#1)
of the above##46##3##(1990-9#2)(1992-3#1)(1994-5#1)(1995-11#1)(1996-3#1)(1996-5#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
of the above-mentioned##5##3##(1997-7#1)(2007-12#1)(2008-4#1)(2008-8#2)
of the absence of##11##4##(1992-1#1)(1992-4#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)(2009-9#1)(2010-12#1)
of the absolute value of the##2##6##(2008-3#2)
of the absolute##12##3##(2008-10#1)(2008-2#3)(2008-3#6)(2009-3#1)(2010-1#1)
of the absorbance and##2##4##(1992-8#1)(2008-10#1)
of the absorbance maximum##2##4##(1991-12#1)(2008-10#1)
of the absorbance of the##3##5##(2008-10#3)
of the absorbance of##5##4##(2008-10#5)
of the absorbance##15##3##(1991-12#1)(1992-8#1)(2008-10#12)(2008-8#1)
of the absorber##2##3##(2007-12#1)(2012-2#1)
of the absorbing##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of the absorption and the reduced scattering coefficients##2##8##(2008-3#2)
of the absorption and##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
of the absorption coefficient and##2##5##(2008-2#2)
of the absorption coefficient is##2##5##(2008-3#2)
of the absorption coefficient of##4##5##(2008-2#2)(2008-3#2)
of the absorption coefficient##16##4##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#8)
of the absorption of the##4##5##(1993-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the absorption of##5##4##(1993-11#1)(2007-11#1)(2008-2#1)(2008-3#2)
of the absorption spectra##2##4##(2008-10#1)(2008-2#1)
of the absorption##41##3##(1993-11#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#19)(2008-6#1)(2009-9#1)
of the abundant##3##3##(1990-5#1)(2008-10#1)(2012-2#1)
of the academic##6##3##(1994-12#1)(1997-1#1)(1997-2#1)(2008-11#2)(2012-3#1)
of the acceptor##6##3##(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#3)
of the accessible##3##3##(1997-6#1)(2008-11#1)(2010-5#1)
of the accessions were##2##4##(2008-10#2)
of the accessions##3##3##(2008-10#3)
of the accessory glands##3##4##(2007-12#1)(2008-7#2)
of the accessory##9##3##(1992-8#1)(2007-12#2)(2008-10#1)(2008-7#3)(2012-2#1)(2013-1#1)
of the accident##3##3##(2008-4#2)(2009-10#1)
of the accompanying##3##3##(2007-11#1)(2008-7#1)(2012-2#1)
of the accumulated##2##3##(1990-8#1)(1992-3#1)
of the accumulating##2##3##(2008-7#1)(2012-3#1)
of the accumulation of##2##4##(2008-10#1)(2008-8#1)
of the accumulation##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
of the accuracy of the##5##5##(2008-10#2)(2008-3#3)
of the accuracy of##10##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#1)(2012-3#1)
of the accuracy##12##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-8#1)(2012-3#1)
of the acetabular roof##2##4##(2007-8#2)
of the acetabular##4##3##(2007-8#2)(2008-11#1)(2008-8#1)
of the acetabulum##6##3##(2008-5#2)(2008-8#1)(2009-4#2)(2013-1#1)
of the acetate##2##3##(1997-2#1)(2008-10#1)
of the acetylcholine##2##3##(1992-3#1)(2008-10#1)
of the achievements##3##3##(2008-12#1)(2010-8#1)(2013-7#1)
of the achromatic##4##3##(2008-2#2)(2008-3#2)
of the acid and the##2##5##(2008-10#1)(2008-5#1)
of the acid and##3##4##(1990-7#1)(2008-10#1)(2008-5#1)
of the acid solid solution##2##5##(2008-5#2)
of the acid##17##3##(1990-7#1)(2008-10#9)(2008-5#6)(2008-7#1)
of the acid-base##3##3##(2008-10#3)
of the acidic##6##3##(1990-7#1)(1993-11#1)(1994-5#1)(2006-6#1)(2008-10#2)
of the acidity##4##3##(2008-10#4)
of the acids##3##3##(2008-10#2)(2012-1#1)
of the acinar cells##2##4##(1992-8#1)(1995-11#1)
of the acorn barnacle Megabalanus rosa##4##6##(1990-5#4)
of the acoustic field##2##4##(2008-2#2)
of the acoustic##5##3##(2008-2#2)(2008-3#1)(2009-3#1)(2009-5#1)
of the acquired##5##3##(1990-6#1)(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#1)
of the acrosome and##3##4##(2008-7#3)
of the acrosome reaction##3##4##(2008-8#3)
of the acrosome##6##3##(2008-7#3)(2008-8#3)
of the act##2##3##(1994-1#1)(2009-10#1)
of the actin cytoskeleton in##3##5##(2008-10#1)(2008-11#1)(2009-10#1)
of the actin cytoskeleton##8##4##(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)
of the actin##16##3##(1992-3#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-9#1)(2009-10#2)(2009-7#1)(2011-1#1)(2012-12#1)
of the actin-binding protein##2##4##(1994-8#1)(2011-1#1)
of the action of##8##4##(1992-6#1)(1993-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
of the action potential##4##4##(1991-5#2)(1996-2#1)(2009-5#1)
of the action##15##3##(1991-5#2)(1992-6#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-5#1)
of the actions of##4##4##(1990-5#1)(1993-11#1)(2008-4#2)
of the actions##5##3##(1990-5#1)(1993-11#1)(2007-8#1)(2008-4#2)
of the activated##7##3##(1994-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-7#1)(2008-10#2)
of the activation motif##2##4##(1997-3#2)
of the activation of##5##4##(1996-2#1)(2008-10#1)(2008-6#1)(2009-6#1)(2009-8#1)
of the activation parameters##2##4##(1996-2#1)(2008-10#1)
of the activation##14##3##(1996-2#2)(1997-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)
of the activators##2##3##(1993-12#1)(1993-3#1)
of the active components##2##4##(1996-2#1)(2008-10#1)
of the active form##2##4##(1991-6#1)(1995-2#1)
of the active ingredient##5##4##(2008-5#3)(2011-2#2)
of the active ingredients##2##4##(2008-5#1)(2010-9#1)
of the active material##2##4##(2008-3#1)(2008-5#1)
of the active principle##2##4##(2008-10#2)
of the active site cysteine##2##5##(1995-2#1)(1995-5#1)
of the active site of the enzyme##3##7##(1994-8#1)(2008-4#1)(2009-9#1)
of the active site of##6##5##(1990-2#1)(1991-5#1)(1992-11#1)(1994-8#1)(2008-4#1)(2009-9#1)
of the active site serine residue##2##6##(1992-6#2)
of the active site##19##4##(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-6#4)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-4#1)(2009-9#1)(2010-11#1)
of the active sites##2##4##(1992-8#1)(2008-10#1)
of the active##63##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-6#7)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-8#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#2)
of the active-site##4##3##(1994-5#1)(1995-2#1)(1995-6#1)(2009-9#1)
of the activin##2##3##(1992-6#1)(1994-9#1)
of the activities of the##3##5##(1995-5#1)(2012-12#1)(2013-1#1)
of the activities of##6##4##(1990-8#1)(1994-1#1)(1995-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
of the activities##12##3##(1990-8#1)(1994-1#1)(1994-11#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2012-12#1)(2013-1#1)
of the activity coefficients of##3##5##(1990-8#1)(2008-10#2)
of the activity coefficients##5##4##(1990-8#1)(2008-10#4)
of the activity of the##6##5##(1990-11#1)(1990-2#1)(1995-12#1)(1995-2#1)(2008-10#2)
of the activity of##19##4##(1990-11#2)(1990-2#1)(1990-7#1)(1993-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
of the activity##37##3##(1990-11#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#10)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-3#1)
of the actual##15##3##(1991-12#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#2)
of the aculeus##2##3##(2008-6#2)
of the acute coronary##2##4##(2008-10#1)(2010-12#1)
of the acute##15##3##(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)
of the acutely compensated state##2##5##(1991-2#2)
of the acutely lethal##3##4##(1995-2#1)(1997-3#2)
of the acutely##6##3##(1991-2#2)(1995-2#1)(1996-9#1)(1997-3#2)
of the acyl##3##3##(1990-8#1)(1993-11#1)(2008-10#1)
of the adaptive immune##2##4##(2008-10#1)(2013-8#1)
of the adaptive##8##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-8#1)
of the added inulin was##2##5##(2011-1#2)
of the added##10##3##(1990-5#1)(1990-8#1)(1994-5#1)(2008-10#3)(2011-1#2)(2011-2#2)
of the addition of the##2##5##(1995-1#1)(1997-1#1)
of the addition of##9##4##(1991-3#1)(1993-12#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-6#1)(2010-11#1)
of the additional##5##3##(1992-5#1)(2006-12#1)(2007-11#1)(2008-10#2)
of the additive##5##3##(2007-8#1)(2008-2#2)(2008-6#1)(2013-7#1)
of the adduct##2##3##(1994-5#1)(2008-10#1)
of the adducts##2##3##(1993-11#1)(2008-10#1)
of the adenine##4##3##(1992-6#1)(1994-12#1)(1995-3#1)(1995-8#1)
of the adenoma##2##3##(1990-11#1)(1996-11#1)
of the adenomas##2##3##(1990-11#1)(2013-8#1)
of the adenomatous##2##3##(2008-1#1)(2008-10#1)
of the adenosine##4##3##(1990-12#1)(1993-11#1)(2008-4#2)
of the adenovirus##3##3##(1993-2#1)(1997-2#1)(2008-11#1)
of the adenylate##3##3##(1992-3#1)(1994-5#1)(1996-2#1)
of the adequacy of##4##4##(1995-1#1)(1996-3#2)(2011-1#1)
of the adherent##3##3##(2008-10#1)(2008-11#2)
of the adhesion##4##3##(1992-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
of the adhesive##8##3##(2008-3#2)(2008-5#2)(2008-9#1)(2010-4#3)
of the adipocyte##3##3##(1992-12#1)(2008-3#1)(2008-5#1)
of the adiponectin gene##2##4##(2011-1#2)
of the adipose##4##3##(1992-9#1)(1994-12#1)(2008-5#2)
of the adjacent##6##3##(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
of the administration of##3##4##(1995-12#1)(1996-2#1)(2010-3#1)
of the administrative##2##3##(1997-2#1)(2013-8#1)
of the admixtures##2##3##(2008-10#2)
of the adolescent##4##3##(1993-3#1)(1994-2#1)(2008-11#1)(2011-1#1)
of the adolescents in##2##4##(2008-9#1)(2012-12#1)
of the adolescents##5##3##(1990-2#1)(2008-9#2)(2010-11#1)(2012-12#1)
of the adrenal cortex##6##4##(1990-11#1)(1990-5#2)(2008-4#2)(2011-1#1)
of the adrenal gland and##2##5##(2008-4#1)(2011-2#1)
of the adrenal gland in the##2##6##(1990-5#2)
of the adrenal gland##8##4##(1990-5#2)(1991-6#1)(2008-12#1)(2008-4#1)(2011-2#2)(2013-1#1)
of the adrenal##18##3##(1990-11#1)(1990-5#4)(1991-6#1)(1994-2#1)(1996-12#1)(1996-5#1)(2008-12#1)(2008-4#3)(2011-1#1)(2011-2#3)(2013-1#1)
of the adsorbed species##2##4##(2008-10#2)
of the adsorbed##10##3##(2008-10#9)(2011-2#1)
of the adsorbent##3##3##(2008-10#3)
of the adsorption of##2##4##(2008-10#2)
of the adsorption##10##3##(1997-2#1)(2008-10#7)(2008-2#1)(2013-8#1)
of the adult brain##2##4##(1996-12#1)(2008-7#1)
of the adult head##2##4##(2008-3#2)
of the adult mouse##2##4##(1995-2#1)(2010-11#1)
of the adult population had diabetes##2##6##(2013-8#2)
of the adult population in##2##5##(2008-11#1)(2013-8#1)
of the adult population##10##4##(1996-6#1)(1997-2#1)(2008-11#1)(2008-8#2)(2013-7#1)(2013-8#4)
of the adult rat##5##4##(1993-9#1)(1995-12#1)(1995-5#1)(2008-11#1)(2012-2#1)
of the adult##40##3##(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#4)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#4)
of the adults are overweight or obese and##2##8##(2013-8#2)
of the adults##9##3##(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#4)
of the advancement##2##3##(2010-11#1)(2010-8#1)
of the advances##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
of the advantages of##4##4##(1991-2#1)(2007-12#1)(2008-8#1)(2010-12#1)
of the advantages##6##3##(1991-2#1)(1993-2#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
of the adventitia##3##3##(1991-8#1)(1997-8#2)
of the adventitious root was##3##5##(2008-12#3)
of the adverse effects of##2##5##(2008-10#1)(2012-12#1)
of the adverse##10##3##(1991-12#1)(1992-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the aerodynamic##2##3##(1992-3#1)(2008-11#1)
of the aerosol extinction coefficient##2##5##(2008-2#1)(2008-3#1)
of the aerosol optical##2##4##(2008-2#1)(2008-3#1)
of the aerosol refractive index##3##5##(2008-2#1)(2008-3#2)
of the aerosol##23##3##(1992-3#2)(1994-12#1)(1995-3#1)(2008-10#3)(2008-2#6)(2008-3#10)
of the aetiology and##2##4##(1997-1#1)(2008-12#1)
of the aetiology of##3##4##(2008-10#1)(2009-4#1)(2010-1#1)
of the aetiology##6##3##(1997-1#1)(2008-10#1)(2008-12#1)(2009-4#2)(2010-1#1)
of the affected individuals##2##4##(1997-4#1)(2010-8#1)
of the affected patients##2##4##(2008-10#1)(2009-4#1)
of the affected site##2##4##(2011-2#1)(2012-1#1)
of the affected##30##3##(1991-3#1)(1992-5#1)(1993-12#1)(1994-5#1)(1996-12#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-6#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)
of the affection##2##3##(1993-5#1)(2007-8#1)
of the affinity##8##3##(1992-6#1)(1993-1#1)(1994-2#1)(1995-11#1)(1997-4#1)(2008-10#2)(2008-7#1)
of the aforementioned##4##3##(2008-10#1)(2008-5#1)(2009-11#1)(2013-1#1)
of the age groups##2##4##(1996-5#1)(2008-7#1)
of the age of the##2##5##(1990-11#1)(1992-10#1)
of the age of##3##4##(1990-11#1)(1992-10#1)(2008-10#1)
of the age##8##3##(1990-11#1)(1992-10#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the aged##10##3##(1991-11#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-2#2)(2008-5#1)(2008-7#1)
of the ageing##2##3##(1992-11#1)(2011-1#1)
of the agent##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
of the agents##6##3##(1990-6#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
of the ages##2##3##(1993-2#1)(2008-7#1)
of the aggrecan gene##2##4##(1992-1#2)
of the aggrecan##4##3##(1992-1#4)
of the aggregated##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
of the aggregates##3##3##(1990-12#1)(2008-10#1)(2010-8#1)
of the aggressive##2##3##(2008-10#2)
of the aging##9##3##(1991-12#1)(1994-6#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2013-7#1)
of the agonist##4##3##(1990-7#2)(1992-5#1)(1994-6#1)
of the agonists##3##3##(1995-11#2)(1995-12#1)
of the agr##2##3##(1995-8#2)
of the air##6##3##(1991-11#1)(2007-8#1)(2008-10#3)(2008-11#1)
of the airborne##3##3##(2008-10#1)(2008-3#2)
of the airway circulation##3##4##(1996-1#1)(1997-1#2)
of the airway##9##3##(1992-2#1)(1996-1#2)(1997-1#2)(2007-12#3)(2009-9#1)
of the airways##6##3##(1994-11#1)(1996-7#2)(1997-2#1)(2009-1#1)(2009-4#1)
of the albumin-fixed membrane was##2##5##(2008-5#2)
of the alcohol##11##3##(1992-7#1)(1993-12#1)(1994-11#1)(1994-6#1)(1997-8#1)(2008-10#4)(2008-5#1)(2011-1#1)
of the alcoholic##2##3##(2008-10#2)
of the alcohols with##2##4##(1996-5#1)(2008-10#1)
of the alcohols##3##3##(1992-6#1)(1996-5#1)(2008-10#1)
of the aldehyde dehydrogenase##2##4##(1994-12#1)(1995-2#1)
of the algae##4##3##(2008-10#3)(2008-5#1)
of the alginate##2##3##(2008-11#1)(2008-7#1)
of the algorithm and##2##4##(2008-3#2)
of the algorithm is demonstrated##2##5##(2007-12#1)(2007-7#1)
of the algorithm is##8##4##(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-6#1)
of the algorithm to##2##4##(2008-2#2)
of the algorithm##33##3##(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-2#9)(2008-3#13)(2008-6#3)(2008-7#1)(2009-9#1)(2010-8#1)(2012-2#1)
of the algorithms and##2##4##(2007-11#1)(2008-3#1)
of the algorithms##4##3##(2007-11#1)(2008-3#3)
of the alien##2##3##(2008-10#1)(2008-5#1)
of the alignment##4##3##(1994-8#1)(2007-12#1)(2008-3#1)(2008-4#1)
of the alimentary##2##3##(2008-5#1)(2008-7#1)
of the aliphatic##3##3##(1994-8#1)(1996-5#1)(2010-4#1)
of the alkali##3##3##(1992-8#1)(2008-10#2)
of the alkaline##3##3##(1992-3#1)(1997-4#2)
of the alkyl##4##3##(1994-12#1)(2008-10#1)(2008-5#2)
of the allele##2##3##(1993-3#1)(2012-2#1)
of the allelic##2##3##(2008-10#1)(2008-8#1)
of the allocation of##3##4##(1991-6#1)(2008-7#1)(2012-2#1)
of the allograft##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
of the allometric##2##3##(2008-5#1)(2010-8#1)
of the allosteric inhibitor##2##4##(1995-2#1)(2008-4#1)
of the allosteric interaction of semi-rigid verapamil analogues with##2##9##(1995-11#2)
of the allosteric##6##3##(1990-8#1)(1995-11#2)(1995-2#1)(2008-4#1)(2012-1#1)
of the alloy##2##3##(2009-7#2)
of the almond##2##3##(2008-10#1)(2008-11#1)
of the alpha 1 (I)##2##5##(1991-5#2)
of the alpha 1 subunit##2##5##(1994-6#1)(1996-2#1)
of the alpha 1##4##4##(1991-5#2)(1994-6#1)(1996-2#1)
of the alpha 4 beta 2##2##6##(1995-11#2)
of the alpha subunit of##2##5##(1995-2#1)(2012-2#1)
of the alpha subunit##4##4##(1995-2#1)(1995-8#1)(2008-11#1)(2012-2#1)
of the alpha##20##3##(1991-5#3)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-11#1)(2012-2#1)
of the alpha-MSH##2##3##(1993-5#2)
of the alpha-amino##2##3##(1992-6#1)(1992-8#1)
of the alpha-chain of##2##4##(1990-5#1)(1995-6#1)
of the alpha-myosin heavy chain##2##5##(1991-9#2)
of the alpha-subunit of the##2##5##(1990-11#1)(1991-3#1)
of the alpha-subunit##7##3##(1990-11#3)(1991-3#3)(1995-6#1)
of the alpha-subunits##2##3##(1995-6#2)
of the alphabet##2##3##(2008-3#1)(2013-8#1)
of the already##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
of the alterations##3##3##(1992-12#1)(1992-5#1)(2008-7#1)
of the altered enzyme##2##4##(1992-1#2)
of the altered mineral metabolism##2##5##(2009-1#2)
of the altered##7##3##(1992-1#2)(2009-1#2)(2010-3#1)(2013-1#1)(2013-8#1)
of the alternating##2##3##(1997-3#1)(2009-6#1)
of the alternative procedure##2##4##(2008-10#1)(2008-11#1)
of the alternative##7##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)
of the aluminum##2##3##(2007-8#1)(2008-10#1)
of the alveolar epithelium##2##4##(1995-8#2)
of the alveolar##5##3##(1992-12#1)(1995-8#2)(2010-12#1)(2012-12#1)
of the ambiguity function##2##4##(2007-11#1)(2008-3#1)
of the ambiguity##3##3##(2007-11#1)(2008-3#1)(2010-11#1)
of the american##10##3##(2008-10#7)(2008-3#1)(2008-8#1)(2011-2#1)
of the amide##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
of the amine group##2##4##(2008-10#2)
of the amine groups##2##4##(2008-10#2)
of the amine##8##3##(1990-5#1)(2008-10#7)
of the amines##2##3##(1996-5#1)(2010-8#1)
of the amino acid sequence of the##3##7##(1990-5#1)(1993-8#1)(2008-10#1)
of the amino acid sequence of##5##6##(1990-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(2008-10#1)
of the amino acid sequence##6##5##(1990-5#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(2008-10#1)
of the amino acid sequences of the##2##7##(1991-12#1)(1993-3#1)
of the amino acid sequences of##5##6##(1990-7#1)(1991-12#2)(1991-2#1)(1993-3#1)
of the amino acid sequences##6##5##(1990-7#1)(1991-12#2)(1991-2#1)(1993-3#1)(2010-5#1)
of the amino acid substitutions##2##5##(1990-8#1)(1997-9#1)
of the amino acid##25##4##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-8#1)(1997-9#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)
of the amino acids##10##4##(1992-8#1)(1993-11#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)
of the amino group##2##4##(1992-3#1)(2008-10#1)
of the amino##40##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-9#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-5#2)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
of the amino-terminal##3##3##(1990-5#1)(1991-12#1)(1995-6#1)
of the amniotic##2##3##(2008-10#1)(2008-9#1)
of the amorphous content of##2##5##(2008-10#2)
of the amorphous##4##3##(2008-10#3)(2010-8#1)
of the amount of##24##4##(1990-10#1)(1992-12#1)(1993-6#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#1)
of the amount##27##3##(1990-10#1)(1990-3#1)(1992-12#1)(1993-6#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#1)
of the amounts of##4##4##(2007-11#1)(2008-10#3)
of the amperometric response##2##4##(2008-10#2)
of the amperometric##4##3##(2008-10#4)
of the amphibian##2##3##(1990-12#1)(1997-3#1)
of the amphipathic##3##3##(1990-2#1)(1990-5#1)(1995-5#1)
of the amphiphilic##3##3##(1994-11#1)(1994-5#1)(2008-5#1)
of the amplicons##2##3##(2008-10#2)
of the amplified DNA##3##4##(1990-12#1)(2008-5#1)(2011-2#1)
of the amplified fragments##3##4##(1992-8#1)(2008-10#1)(2012-2#1)
of the amplified gene##2##4##(2008-11#2)
of the amplified products##2##4##(2008-10#2)
of the amplified spontaneous emission##2##5##(2007-12#1)(2008-2#1)
of the amplified##21##3##(1990-12#1)(1992-8#1)(1996-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)
of the amplifier gain##2##4##(2007-11#1)(2008-3#1)
of the amplifier##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
of the amplitude and##2##4##(2007-11#1)(2007-12#1)
of the amplitude of the##3##5##(1997-4#1)(2007-12#1)(2008-2#1)
of the amplitude##7##3##(1997-4#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
of the amygdala in##3##4##(1993-12#1)(2008-11#1)(2008-6#1)
of the amygdala##24##3##(1991-10#2)(1993-12#8)(1993-6#3)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-10#2)(2008-11#3)(2008-6#1)(2008-7#1)
of the amyloid beta-protein##2##4##(1991-11#1)(1991-2#1)
of the amyloid precursor protein##3##5##(1992-12#1)(1993-11#2)
of the amyloid##11##3##(1991-11#2)(1991-2#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#2)(1993-3#1)(2008-5#1)
of the anaerobic##2##3##(2008-9#1)(2010-12#1)
of the anal##5##3##(2011-2#3)(2013-1#2)
of the analog##3##3##(1991-5#1)(1992-6#1)(1997-6#1)
of the analogs##2##3##(1994-5#1)(1995-3#1)
of the analogues##2##3##(1992-6#1)(2012-2#1)
of the analysed##2##3##(2008-10#2)
of the analyser##2##3##(2008-10#2)
of the analyses##4##3##(1995-5#1)(2008-11#1)(2008-12#1)(2008-7#1)
of the analysis have been##2##5##(1996-12#1)(2010-5#1)
of the analysis is##2##4##(2008-2#1)(2008-9#1)
of the analysis of the##3##5##(1993-12#1)(2008-10#2)
of the analysis of##12##4##(1990-8#1)(1993-12#1)(2008-10#6)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
of the analysis##43##3##(1990-6#1)(1990-8#1)(1993-12#1)(1994-9#1)(1995-12#1)(1996-12#2)(2008-10#15)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2010-3#1)(2010-5#2)(2012-2#2)(2013-1#1)
of the analyte and##3##4##(2008-10#3)
of the analyte by##3##4##(2008-10#2)(2009-8#1)
of the analyte from the##2##5##(2008-10#2)
of the analyte from##3##4##(1996-5#1)(2008-10#2)
of the analyte in the##6##5##(2008-10#5)(2010-5#1)
of the analyte in##8##4##(2008-10#7)(2010-5#1)
of the analyte pulse##2##4##(2008-10#2)
of the analyte solution##4##4##(2008-10#4)
of the analyte was##3##4##(2008-10#3)
of the analyte with##3##4##(2008-10#3)
of the analyte##63##3##(1996-5#1)(2008-10#56)(2008-7#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-8#2)
of the analytes can be##2##5##(2008-10#2)
of the analytes from##3##4##(2008-10#3)
of the analytes in##4##4##(2008-10#4)
of the analytes on the##3##5##(2008-10#2)(2008-3#1)
of the analytes on##6##4##(2008-10#5)(2008-3#1)
of the analytes retained on##2##5##(2008-10#2)
of the analytes retained##3##4##(2008-10#3)
of the analytes was##2##4##(2008-10#2)
of the analytes were investigated##2##5##(2008-10#2)
of the analytes were##6##4##(2008-10#6)
of the analytes with the##2##5##(2008-10#2)
of the analytes##49##3##(1997-2#1)(2008-1#1)(2008-10#46)(2008-3#1)
of the analytical characteristics##2##4##(2008-10#2)
of the analytical performances##2##4##(2008-10#2)
of the analytical procedure##5##4##(2008-10#5)
of the analytical properties##2##4##(2008-10#2)
of the analytical results##2##4##(2008-10#2)
of the analytical signal##2##4##(2008-10#2)
of the analytical signals##2##4##(2008-10#2)
of the analytical solution##2##4##(2007-11#1)(2008-3#1)
of the analytical system##2##4##(2008-10#2)
of the analytical##39##3##(2007-11#2)(2008-10#34)(2008-3#2)(2010-11#1)
of the analyzed##6##3##(2008-10#3)(2008-7#2)(2012-2#1)
of the anastomosis##6##3##(1990-6#1)(1991-3#1)(2007-8#2)(2008-10#1)(2008-12#1)
of the anatomic##3##3##(1990-9#1)(2006-12#1)(2013-8#1)
of the anatomical##7##3##(1990-6#1)(1995-2#1)(2008-10#1)(2009-10#1)(2011-2#3)
of the anatomy and##3##4##(2007-8#1)(2008-8#1)(2010-6#1)
of the anatomy##4##3##(2007-8#1)(2008-8#1)(2010-6#1)(2013-1#1)
of the ancestral##4##3##(1991-6#1)(1995-8#1)(2008-8#1)(2013-1#1)
of the androgen receptor##4##4##(1995-3#2)(2009-4#1)(2011-2#1)
of the anesthetic##2##3##(1990-12#1)(2009-8#1)
of the aneurysm##8##3##(1997-3#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the aneurysmal sac##2##4##(1997-3#2)
of the aneurysmal##3##3##(1997-3#2)(2012-2#1)
of the angiotensin II##2##4##(1994-8#1)(2008-8#1)
of the angiotensin receptors##3##4##(1991-9#1)(1994-2#2)
of the angiotensin##6##3##(1990-12#1)(1991-9#1)(1994-2#2)(1994-8#1)(2008-8#1)
of the angiotensin-converting enzyme (ACE) inhibitor##2##6##(1990-2#1)(2008-7#1)
of the angiotensin-converting enzyme##3##4##(1990-2#1)(2008-12#1)(2008-7#1)
of the angle between##2##4##(2007-12#1)(2008-3#1)
of the angle of incidence##4##5##(2008-2#1)(2008-3#3)
of the angle of##6##4##(2008-2#2)(2008-3#4)
of the angle##12##3##(2007-12#1)(2008-2#2)(2008-3#9)
of the angular distribution##2##4##(2007-11#1)(2008-3#1)
of the angular response##2##4##(2008-2#1)(2008-3#1)
of the angular variation of##2##5##(2008-3#2)
of the angular##16##3##(1995-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#8)
of the animal models##3##4##(2008-7#1)(2010-4#1)(2010-6#1)
of the animal##20##3##(1990-2#1)(1995-12#1)(1996-2#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-6#1)(2013-7#1)
of the animals was##3##4##(1991-2#1)(2008-2#1)(2008-5#1)
of the animals##23##3##(1991-2#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-3#1)(2011-2#2)(2013-8#1)
of the anion and##2##4##(1994-5#1)(2007-12#1)
of the anion exchanger##2##4##(2008-10#2)
of the anion##5##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#1)
of the anionic form of##2##5##(1995-6#1)(2008-10#1)
of the anionic##6##3##(1990-5#1)(1995-6#1)(2008-10#4)
of the anions in##2##4##(2008-10#2)
of the anions##5##3##(1995-5#1)(2008-10#3)(2010-4#1)
of the anisotropic##3##3##(2008-3#3)
of the ankle joint##5##4##(2009-7#2)(2010-3#1)(2010-5#1)(2012-2#1)
of the ankle using##2##4##(2008-8#1)(2012-2#1)
of the ankle##16##3##(1995-12#1)(2007-11#1)(2008-12#1)(2008-8#2)(2009-7#2)(2010-3#1)(2010-5#1)(2012-2#5)(2012-3#1)(2013-1#1)
of the annexin##4##3##(1993-8#1)(1995-11#2)(2008-11#1)
of the annual##8##3##(1992-2#2)(1992-3#1)(1994-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-5#1)
of the annulus##3##3##(1996-6#3)
of the anomalous##6##3##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)
of the answers##3##3##(1994-1#1)(1996-9#1)(2012-2#1)
of the ant##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
of the antagonist in##2##4##(2008-10#2)
of the antagonist##12##3##(1995-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#8)
of the antagonistic##3##3##(2007-12#1)(2008-10#2)
of the antecedents and consequences of##2##6##(2007-7#1)(2008-11#1)
of the antecedents##3##3##(1996-3#1)(2007-7#1)(2008-11#1)
of the antenna of the grasshopper Schistocerca gregaria##2##8##(2007-12#2)
of the antenna##6##3##(2007-12#6)
of the antennal##3##3##(2007-12#2)(2008-7#1)
of the anterior abdominal wall##3##5##(1991-1#2)(2012-12#1)
of the anterior cerebral artery##2##5##(1997-3#1)(2008-7#1)
of the anterior cerebral##3##4##(1997-3#1)(2008-7#2)
of the anterior cruciate ligament##4##5##(2007-8#2)(2009-1#1)(2013-1#1)
of the anterior horn##2##4##(1990-9#1)(2008-7#1)
of the anterior segment##2##4##(2010-9#1)(2011-7#1)
of the anterior tibial artery##2##5##(2008-12#1)(2009-3#1)
of the anterior wall of the frontal sinus##2##8##(2006-12#2)
of the anterior##50##3##(1990-9#2)(1991-1#2)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1997-3#1)(2006-12#4)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#1)(2013-1#2)
of the anti-FLAG mAbs##2##4##(1997-3#2)
of the anti-HIV agent 2'##2##5##(1990-10#1)(1991-3#1)
of the anti-Stokes##2##3##(2007-11#1)(2008-3#1)
of the anti-apoptotic proteins Bcl-2##2##5##(2012-12#2)
of the anti-apoptotic##3##3##(2010-1#1)(2012-12#2)
of the anti-inflammatory drug##3##4##(2008-10#2)(2009-11#1)
of the anti-inflammatory##4##3##(1990-5#1)(2008-10#2)(2009-11#1)
of the anti-oncogenic##2##3##(1997-7#2)
of the antibiotic 2##2##4##(2008-10#2)
of the antibiotic##12##3##(1990-2#1)(1991-2#1)(1992-12#2)(1996-3#1)(1997-2#2)(2008-10#3)(2008-9#1)(2010-5#1)
of the antibiotics##2##3##(1991-1#1)(2008-10#1)
of the antibodies and##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
of the antibodies recognized##3##4##(1994-9#1)(1995-3#2)
of the antibodies##15##3##(1992-11#1)(1994-9#2)(1995-3#2)(1997-7#1)(2008-10#6)(2008-4#1)(2008-7#1)(2009-2#1)
of the antibody is##2##4##(1994-8#1)(2008-7#1)
of the antibody response##5##4##(2008-10#4)(2008-4#1)
of the antibody were##2##4##(1991-5#1)(2008-8#1)
of the antibody##22##3##(1991-5#1)(1994-8#2)(1995-5#1)(1997-2#2)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)
of the anticancer##2##3##(2008-10#1)(2008-11#1)
of the anticipated##2##3##(2008-10#1)(2008-3#1)
of the anticoagulant effect##2##4##(2008-10#2)
of the anticoagulant##3##3##(2008-10#3)
of the antidepressant fluoxetine##2##4##(2008-10#2)
of the antidepressant##4##3##(2008-10#3)(2008-6#1)
of the antiepileptic##2##3##(2008-6#1)(2013-1#1)
of the antifouling biocides##2##4##(2008-11#2)
of the antifouling##3##3##(2008-10#1)(2008-11#2)
of the antifungal##4##3##(2008-10#3)(2013-1#1)
of the antigen by##3##4##(1990-12#2)(1994-2#1)
of the antigen is##2##4##(1990-12#1)(2008-8#1)
of the antigen##14##3##(1990-12#5)(1992-9#1)(1994-11#2)(1994-2#1)(1995-11#2)(2008-11#2)(2008-8#1)
of the antigen-antibody complex##2##4##(2008-10#1)(2008-4#1)
of the antigen-antibody##4##3##(2008-10#3)(2008-4#1)
of the antigens##3##3##(1990-12#2)(1995-5#1)
of the antihypertensive##3##3##(1990-8#1)(1992-8#1)(2008-10#1)
of the antimicrobial##5##3##(1991-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
of the antimony##2##3##(2008-10#2)
of the antioxidant activity of##3##5##(2008-10#3)
of the antioxidant capacity of##3##5##(2008-10#3)
of the antioxidant##16##3##(1996-12#1)(2007-11#1)(2008-10#8)(2008-2#2)(2010-5#1)(2011-1#1)(2013-8#2)
of the antioxidants##6##3##(1992-9#1)(1993-2#1)(2008-10#2)(2008-5#2)
of the antipsychotic##2##3##(1997-7#1)(2008-6#1)
of the antisense##2##3##(1991-9#1)(2008-11#1)
of the antisera##2##3##(2008-5#1)(2010-6#1)
of the antithrombotic##2##3##(2006-6#1)(2007-11#1)
of the antitumor##2##3##(1995-2#1)(2013-1#1)
of the antiviral##4##3##(1990-10#1)(1994-11#2)(1994-6#1)
of the aorta and##3##4##(1997-8#1)(2008-3#1)(2012-1#1)
of the aorta##19##3##(1990-2#1)(1991-9#1)(1996-11#1)(1997-8#2)(2007-11#2)(2007-8#4)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-3#1)
of the aortic arch##8##4##(2007-8#2)(2008-8#4)(2010-7#1)(2010-8#1)
of the aortic valve##3##4##(1997-5#1)(2007-8#1)(2012-2#1)
of the aortic##16##3##(1991-9#1)(1997-5#1)(1997-6#1)(2007-8#4)(2007-9#1)(2008-8#4)(2009-7#1)(2010-7#1)(2010-8#1)(2012-2#1)
of the aperture##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of the apertures##3##3##(2008-2#2)(2008-3#1)
of the apex##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
of the aphid Schizaphis graminum##2##5##(1996-12#1)(2008-10#1)
of the aphid##10##3##(1996-12#3)(2007-12#1)(2008-10#5)(2011-2#1)
of the apical cell##2##4##(2007-12#1)(2009-8#1)
of the apical##9##3##(2007-12#1)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#4)
of the apo B gene##2##5##(1997-8#2)
of the apo B##3##4##(1994-3#1)(1997-8#2)
of the apo##5##3##(1991-12#1)(1993-6#1)(1994-3#1)(1997-8#2)
of the apo-E##2##3##(2008-10#2)
of the apolipoprotein B gene##2##5##(1995-2#1)(1997-8#1)
of the apolipoprotein E##2##4##(1995-5#1)(2008-4#1)
of the apolipoprotein##5##3##(1993-6#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-4#1)
of the apoptosis##2##3##(2008-10#1)(2008-11#1)
of the apoptotic##5##3##(1995-12#1)(2008-8#2)(2009-3#1)(2010-1#1)
of the apparatus##6##3##(1997-6#1)(2008-3#5)
of the apparent diffusion coefficient##3##5##(2008-10#1)(2008-11#1)(2010-12#1)
of the apparent##13##3##(1990-11#1)(1990-4#1)(1991-9#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2010-12#1)
of the appearance of##3##4##(1991-12#1)(1994-11#1)(2011-2#1)
of the appendicular##4##3##(1991-11#1)(2007-12#1)(2010-3#1)(2011-2#1)
of the appendix##4##3##(1993-12#2)(1997-8#1)(2008-12#1)
of the apple snail##2##4##(2008-11#2)
of the apple##6##3##(2008-10#4)(2008-11#2)
of the applicability of##2##4##(1993-6#1)(2010-11#1)
of the applicable##2##3##(1992-12#1)(2008-11#1)
of the applicants##3##3##(1992-5#1)(1995-5#1)(1997-3#1)
of the application of the##5##5##(1990-9#1)(1992-9#1)(2008-10#1)(2008-3#1)(2010-9#1)
of the application of these##2##5##(2008-10#1)(2012-2#1)
of the application of##21##4##(1990-9#1)(1992-9#1)(1995-5#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)
of the application##25##3##(1990-9#1)(1992-9#1)(1995-5#1)(1996-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the applications of##3##4##(2007-11#1)(2008-4#1)(2008-9#1)
of the applications##6##3##(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)
of the applied current##3##4##(2008-10#3)
of the applied treatment##2##4##(2008-10#2)
of the applied voltage##3##4##(2008-2#1)(2013-8#2)
of the applied##15##3##(1995-3#2)(2008-10#10)(2008-2#1)(2013-8#2)
of the appressoria##2##3##(2008-10#2)
of the approach and##3##4##(1995-2#1)(1996-1#1)(1996-2#1)
of the approach is##2##4##(1996-5#1)(2008-10#1)
of the approach of##2##4##(2012-12#1)(2013-1#1)
of the approach to##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
of the approach##21##3##(1990-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-12#2)(2013-1#1)
of the approaches##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
of the appropriate##19##3##(1991-3#1)(1991-9#1)(1993-12#1)(1994-3#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-3#3)(2008-9#1)(2011-2#1)
of the approval##2##3##(1991-3#1)(2010-4#1)
of the approximate##3##3##(2008-2#2)(2008-3#1)
of the approximately##2##3##(1990-8#1)(2009-7#1)
of the approximation##5##3##(1996-3#1)(2008-3#1)(2009-9#1)(2012-1#1)(2013-1#1)
of the aptamers##2##3##(2007-11#1)(2013-1#1)
of the aquatic HS##2##4##(2008-10#2)
of the aquatic environment##2##4##(2008-10#1)(2008-11#1)
of the aquatic##5##3##(2008-10#3)(2008-11#1)(2010-6#1)
of the aqueous extract of##2##5##(2008-5#1)(2011-1#1)
of the aqueous extract##3##4##(2008-11#1)(2008-5#1)(2011-1#1)
of the aqueous glucose##2##4##(2008-2#2)
of the aqueous leaf extract of##2##6##(2013-7#2)
of the aqueous leaves extracts of##2##6##(2008-12#2)
of the aqueous leaves extracts##3##5##(2008-12#3)
of the aqueous phase##6##4##(2008-10#6)
of the aqueous##24##3##(1994-12#1)(1994-3#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#2)(2008-5#1)(2010-3#1)(2011-1#1)(2013-7#2)
of the aquo-met and cyano-met derivatives of the loggerhead sea turtle (Caretta caretta) myoglobin##2##14##(1995-3#2)
of the architecture of the##2##5##(1993-5#1)(1994-2#1)
of the architecture of##3##4##(1993-5#1)(1994-2#1)(2009-2#1)
of the arcjet plume##2##4##(2008-3#2)
of the arcjet##4##3##(2008-2#2)(2008-3#2)
of the area of the##2##5##(1997-3#1)(2008-2#1)
of the area of##4##4##(1997-3#1)(2007-11#2)(2008-2#1)
of the area under the ROC curve##3##7##(2008-10#1)(2012-1#2)
of the area under the##6##5##(1990-7#1)(2008-10#2)(2012-1#2)(2012-3#1)
of the area##20##3##(1990-7#1)(1991-8#1)(1992-6#1)(1997-3#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-2#1)(2008-5#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-7#1)
of the areas of##2##4##(1991-2#1)(2010-9#1)
of the areas##6##3##(1991-2#1)(1996-4#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-9#1)
of the arm##8##3##(1994-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)
of the aromatase##2##3##(1991-5#1)(1993-8#1)
of the aromatic##4##3##(1996-5#1)(2008-10#2)(2010-4#1)
of the arrangement##3##3##(1996-3#1)(2008-3#1)(2008-7#1)
of the array of##2##4##(1991-3#1)(2011-2#1)
of the array##8##3##(1991-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)
of the arrested cells##2##4##(1991-2#1)(1992-3#1)
of the arsenic species was performed by##2##7##(2008-10#2)
of the arsenic species##3##4##(2008-10#3)
of the arsenic##5##3##(2008-10#5)
of the art and##3##4##(1993-3#1)(2008-11#1)(2010-11#1)
of the art of##4##4##(2008-3#1)(2008-5#1)(2009-12#1)(2012-2#1)
of the art##32##3##(1991-9#1)(1993-3#2)(1994-8#1)(1995-2#1)(1995-5#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)
of the arterial wall##4##4##(2007-8#1)(2008-3#1)(2009-1#1)(2011-2#1)
of the arterial##13##3##(1993-1#1)(1995-8#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-1#1)(2011-2#1)
of the arteries##3##3##(1991-3#1)(2007-8#1)(2008-7#1)
of the arteriovenous##2##3##(1993-6#1)(2011-3#1)
of the artery##6##3##(1995-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
of the arthropod nervous system##2##5##(2007-12#2)
of the arthropod##7##3##(2007-12#5)(2008-6#2)
of the article is##2##4##(1993-3#1)(2009-5#1)
of the article##9##3##(1990-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1997-3#1)(2009-4#2)(2009-5#1)(2013-8#1)
of the articles in this special##2##6##(1994-3#1)(1997-1#1)
of the articles##5##3##(1992-6#1)(1994-3#1)(1997-1#1)(1997-3#1)(2012-2#1)
of the articular cartilage##2##4##(1997-6#1)(2008-8#1)
of the articular##4##3##(1997-6#1)(2007-11#2)(2008-8#1)
of the artificial##6##3##(1991-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
of the aryl hydrocarbon##3##4##(1995-11#1)(2008-7#2)
of the ascending aorta after##2##5##(1997-5#1)(2007-8#1)
of the ascending aorta was##3##5##(1997-5#1)(2007-8#2)
of the ascending aorta##19##4##(1997-5#4)(1997-8#1)(2007-8#13)(2010-8#1)
of the ascidian##2##3##(1993-6#1)(2008-6#1)
of the ascospore##3##3##(2008-10#3)
of the asparagus##2##3##(2008-10#2)
of the aspartate##4##3##(1992-8#3)(1992-9#1)
of the aspect##2##3##(2007-11#1)(2008-2#1)
of the assay are##2##4##(2008-10#1)(2008-9#1)
of the assay extends from##2##5##(2008-11#2)
of the assay is##3##4##(1992-9#1)(2008-10#1)(2008-9#1)
of the assay was##5##4##(1992-6#1)(2008-10#3)(2010-4#1)
of the assay were##2##4##(1991-5#1)(2013-8#1)
of the assay##38##3##(1990-12#1)(1991-5#2)(1992-6#1)(1992-9#1)(1997-2#1)(1997-4#2)(2008-10#15)(2008-11#3)(2008-4#1)(2008-9#3)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the assays##4##3##(1997-3#1)(2008-10#3)
of the assemblage##2##3##(2007-11#1)(2008-9#1)
of the assembled##2##3##(1996-6#1)(2008-10#1)
of the assessment and##3##4##(1992-12#1)(2009-5#1)(2012-2#1)
of the assessment of the##3##5##(1996-12#1)(2008-10#1)(2008-3#1)
of the assessment of##5##4##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
of the assessment##11##3##(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-5#1)(2012-2#2)(2013-1#1)
of the assigned##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
of the assistants##2##3##(1992-1#1)(2013-1#1)
of the associated##13##3##(1991-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#2)(2013-1#2)
of the association between##7##4##(1991-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-1#1)
of the association of##5##4##(2006-10#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
of the association##19##3##(1991-8#2)(1993-2#1)(2006-10#1)(2008-10#5)(2008-7#2)(2008-8#1)(2009-7#3)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the associations##2##3##(1995-2#1)(2008-5#1)
of the assumed##2##3##(2008-10#1)(2011-2#1)
of the assumption##2##3##(2008-3#1)(2012-1#1)
of the assumptions##7##3##(1994-11#1)(1994-9#1)(2007-11#1)(2008-3#2)(2008-9#1)(2012-2#1)
of the asthma##3##3##(2008-12#2)(2009-6#1)
of the asthmatic##2##3##(2007-6#1)(2007-8#1)
of the astrocyte##3##3##(1990-7#1)(1996-2#1)(2008-11#1)
of the asymmetric##2##3##(1995-2#1)(2007-11#1)
of the asymmetry##3##3##(2007-11#1)(2008-2#1)(2008-5#1)
of the asymptomatic period##3##4##(1997-3#3)
of the asymptomatic##4##3##(1996-9#1)(1997-3#3)
of the asymptotic technique##2##4##(2008-3#2)
of the asymptotic##4##3##(1996-3#1)(2008-3#3)
of the atheromatous plaque and##2##5##(2009-5#2)
of the atherosclerosis##2##3##(2008-10#1)(2012-3#1)
of the atherosclerotic disease##2##4##(1991-6#1)(1997-3#1)
of the atherosclerotic plaque##3##4##(2008-7#1)(2010-9#1)(2011-2#1)
of the atherosclerotic process##2##4##(1997-3#1)(2008-10#1)
of the atherosclerotic##7##3##(1991-6#1)(1997-3#2)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)
of the atlas##3##3##(1997-4#1)(2013-1#2)
of the atmosphere and##2##4##(2008-2#2)
of the atmosphere with##3##4##(2008-2#1)(2008-3#2)
of the atmosphere##24##3##(2008-2#13)(2008-3#10)(2012-3#1)
of the atmospheric aerosol##2##4##(2008-2#2)
of the atmospheric##17##3##(1996-1#1)(2008-10#1)(2008-2#7)(2008-3#7)(2013-8#1)
of the atom##2##3##(1996-3#1)(2007-11#1)
of the atomic##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-7#1)
of the atoms in##2##4##(1991-5#1)(2007-12#1)
of the atrial septal##2##4##(2008-11#2)
of the atrial##4##3##(1990-9#1)(2007-8#1)(2008-11#2)
of the attempts##2##3##(1994-2#1)(2008-11#1)
of the attention is##2##4##(2008-10#1)(2011-2#1)
of the attention##4##3##(1997-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
of the attenuated##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
of the attenuation##2##3##(2007-11#1)(2008-2#1)
of the atypical##3##3##(2008-11#1)(2008-7#1)(2009-8#1)
of the audit tool##2##4##(2008-11#2)
of the audit##5##3##(1993-1#2)(2007-11#1)(2008-11#2)
of the auditory cortex##4##4##(1993-9#1)(2010-7#3)
of the auditory nerve##2##4##(2008-8#1)(2008-9#1)
of the auditory##13##3##(1991-1#1)(1993-9#1)(1995-5#1)(2008-4#1)(2008-8#2)(2008-9#3)(2010-5#1)(2010-7#3)
of the authentic##5##3##(1990-12#1)(1990-2#2)(1995-2#1)(2008-10#1)
of the author##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
of the author's##2##3##(1994-12#1)(2009-10#1)
of the authors##12##3##(1994-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#1)
of the authors'##3##3##(1993-9#1)(2007-11#1)(2011-1#1)
of the autocorrelation function##2##4##(2008-3#1)(2008-8#1)
of the autocorrelation##4##3##(2008-3#2)(2008-8#1)(2013-1#1)
of the autofluorescence##3##3##(2007-11#1)(2008-3#2)
of the autoimmune##2##3##(1991-5#1)(2013-8#1)
of the autologous##2##3##(2008-11#1)(2012-12#1)
of the automated system##2##4##(2008-10#2)
of the automated##9##3##(1993-12#1)(2007-7#1)(2008-10#7)
of the automatic##3##3##(2008-10#2)(2008-3#1)
of the automation##2##3##(2008-10#2)
of the autonomic nervous system (ANS)##3##6##(2009-11#1)(2011-1#1)(2013-8#1)
of the autonomic nervous system##5##5##(2007-10#1)(2009-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the autonomic nervous##6##4##(2007-10#1)(2009-11#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the autonomic##9##3##(2007-10#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#3)
of the autophagy##2##3##(2013-1#2)
of the autosampler in the##2##5##(2008-10#2)
of the autumnal##4##3##(2008-11#1)(2008-8#2)(2010-8#1)
of the auxiliary##3##3##(1995-3#1)(2008-3#1)(2008-8#1)
of the availability of##2##4##(2008-10#1)(2009-10#1)
of the availability##3##3##(1993-8#1)(2008-10#1)(2009-10#1)
of the available data##5##4##(1991-12#1)(1994-6#1)(1996-1#1)(1997-4#1)(2010-8#1)
of the available evidence##2##4##(1992-2#1)(1993-12#1)
of the available information##2##4##(1991-9#1)(2013-8#1)
of the available literature##4##4##(2007-11#1)(2008-8#1)(2009-4#1)(2012-12#1)
of the available treatments##2##4##(2008-7#1)(2011-2#1)
of the available##31##3##(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-6#1)(1996-1#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
of the average of the##2##5##(2008-2#1)(2008-3#1)
of the average values##2##4##(2008-10#1)(2013-8#1)
of the average##27##3##(1991-9#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the avian##2##3##(1995-2#1)(2009-2#1)
of the axial ligand##2##4##(1996-2#1)(1997-7#1)
of the axial##12##3##(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#3)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
of the axilla##7##3##(2008-12#1)(2008-5#6)
of the axillary artery##2##4##(2008-7#2)
of the axillary microflora##2##4##(2008-5#2)
of the axillary nodes##2##4##(2008-10#2)
of the axillary##10##3##(2008-10#2)(2008-5#4)(2008-7#3)(2013-1#1)
of the axis##2##3##(2007-12#1)(2008-3#1)
of the axon##2##3##(2012-2#2)
of the axonal##2##3##(1995-2#1)(2008-6#1)
of the axoneme##2##3##(1991-2#2)
of the azobenzene##3##3##(2008-10#3)
of the b##2##3##(2008-10#1)(2008-7#1)
of the baboon and##2##4##(1993-6#1)(2008-9#1)
of the baboon##4##3##(1993-6#1)(1994-12#2)(2008-9#1)
of the baby##5##3##(1994-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-3#1)
of the back##7##3##(1996-9#1)(1997-3#1)(2008-5#1)(2008-6#2)(2012-2#1)(2013-1#1)
of the backbone and##2##4##(1995-5#1)(2008-4#1)
of the backbone##5##3##(1995-2#1)(1995-5#1)(2008-4#1)(2009-2#1)(2009-7#1)
of the background and##2##4##(2007-12#1)(2008-10#1)
of the background signals##3##4##(2008-3#3)
of the background##13##3##(1994-2#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#4)
of the backscatter##2##3##(2008-2#1)(2008-3#1)
of the backscattered beam##2##4##(2008-2#2)
of the backscattered intensity in##2##5##(2008-3#2)
of the backscattered intensity##3##4##(2008-3#3)
of the backscattered laser pulse##2##5##(2008-3#2)
of the backscattered light##5##4##(2008-2#2)(2008-3#3)
of the backscattered##13##3##(2007-12#1)(2008-2#4)(2008-3#8)
of the backscattering coefficient##2##4##(2008-2#1)(2008-3#1)
of the backscattering##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
of the baclofen##2##3##(2008-10#1)(2011-2#1)
of the bacteria or##2##4##(2006-6#1)(2008-5#1)
of the bacteria to##3##4##(2008-11#1)(2008-8#1)(2011-2#1)
of the bacteria##21##3##(1991-11#1)(1993-2#1)(1995-2#1)(1996-12#3)(1997-4#3)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-2#1)
of the bacterial chloramphenicol acetyltransferase##2##5##(1993-3#1)(1993-8#1)
of the bacterial community##2##4##(2008-10#1)(2010-6#1)
of the bacterial populations##2##4##(2008-10#2)
of the bacterial spot pathogen##2##5##(2008-10#2)
of the bacterial##30##3##(1991-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the bacterially expressed##2##4##(1994-11#1)(1994-5#1)
of the bacteriophage T7##3##4##(1991-5#1)(1992-12#2)
of the bacteriophage##5##3##(1990-5#1)(1991-5#1)(1992-12#2)(2008-8#1)
of the bacterium##12##3##(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-7#2)(2008-8#1)(2009-8#1)
of the baculovirus expression system##2##5##(2008-2#2)
of the baculovirus##6##3##(1997-3#3)(2008-2#3)
of the bags##2##3##(2008-10#1)(2012-1#1)
of the balance##2##3##(1992-12#1)(1994-8#1)
of the ball lens##3##4##(2011-1#3)
of the ball##6##3##(2009-7#2)(2011-1#3)(2011-2#1)
of the balloon##3##3##(1997-6#1)(2008-5#1)(2008-7#1)
of the band##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
of the bands in##2##4##(2008-10#1)(2008-9#1)
of the bands##5##3##(1994-6#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)
of the bandwidth##4##3##(2008-10#1)(2008-3#3)
of the bare##3##3##(2008-10#3)
of the barium##2##3##(2008-10#2)
of the barley##5##3##(2008-10#4)(2008-9#1)
of the barndoor skate##2##4##(2009-4#2)
of the barrier function in a reconstituted human epidermis##2##9##(2008-5#2)
of the barrier##7##3##(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)
of the barriers to##3##4##(1993-12#1)(1997-2#1)(2008-8#1)
of the barriers##5##3##(1993-12#1)(1994-1#1)(1997-2#1)(2008-11#1)(2008-8#1)
of the basal cell##2##4##(2007-12#2)
of the basal ganglia##6##4##(1995-3#1)(1995-5#1)(1996-12#2)(1997-3#1)(2013-8#1)
of the basal medium##2##4##(2008-11#2)
of the basal nuclear complex##2##5##(1996-12#2)
of the basal##24##3##(1991-9#1)(1992-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#4)(1996-5#1)(1997-3#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-5#2)(2008-9#1)(2010-4#1)(2013-8#1)
of the base of tongue that required reconstructive surgery##2##9##(2013-1#2)
of the base of tongue##4##5##(2013-1#4)
of the base of##6##4##(1994-1#1)(2008-7#1)(2013-1#4)
of the base##16##3##(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-1#1)(1997-2#1)(2008-10#4)(2008-7#1)(2012-2#1)(2013-1#4)
of the baseline##8##3##(1990-11#1)(1991-9#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)
of the bases##4##3##(1995-1#1)(2008-6#1)(2009-7#2)
of the basic concepts##2##4##(1994-3#1)(2007-12#1)
of the basic##27##3##(1990-2#1)(1994-3#1)(1994-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#5)(2008-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2013-1#3)
of the basilar artery##5##4##(1997-6#1)(2007-10#1)(2011-2#1)(2013-8#2)
of the basilar membrane##2##4##(2008-9#1)(2012-2#1)
of the basilar##8##3##(1997-6#1)(2007-10#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
of the basin##2##3##(1997-5#1)(2008-11#1)
of the basis##4##3##(2008-10#1)(2008-2#1)(2008-6#2)
of the basolateral amygdala##5##4##(1990-5#1)(1993-6#2)(1995-12#1)(2008-7#1)
of the basolateral##6##3##(1990-5#2)(1993-6#2)(1995-12#1)(2008-7#1)
of the batch##6##3##(2008-10#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
of the battered##3##3##(1995-5#3)
of the bcl-2 product##2##4##(1994-10#2)
of the bcl-2##7##3##(1993-3#1)(1994-10#3)(2008-11#3)
of the bead##2##3##(2008-10#1)(2008-7#1)
of the beads task##2##4##(2012-1#2)
of the beads##4##3##(2008-10#1)(2008-11#1)(2012-1#2)
of the beam attenuation coefficient##4##5##(2008-2#1)(2008-3#3)
of the beam attenuation##5##4##(2008-2#1)(2008-3#4)
of the beam former##2##4##(2008-3#2)
of the beam profile##2##4##(2008-2#1)(2008-3#1)
of the beam splitter##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the beam that##2##4##(2007-12#1)(2008-3#1)
of the beam##46##3##(2007-11#4)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#25)
of the beam's##2##3##(2007-11#1)(2007-12#1)
of the beam-splitting cube##2##4##(2008-3#2)
of the beams##7##3##(2006-4#1)(2008-2#4)(2008-3#2)
of the bean##3##3##(2008-10#2)(2008-8#1)
of the beat frequency##3##4##(2007-11#1)(2008-3#2)
of the beat##7##3##(2007-11#1)(2007-12#4)(2008-3#2)
of the beginning of##2##4##(1993-12#1)(2008-10#1)
of the behavior of##7##4##(1994-8#1)(2008-10#2)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
of the behavior##8##3##(1994-8#1)(2008-10#3)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
of the behavioral##4##3##(1992-11#1)(1993-3#1)(2008-8#1)(2008-9#1)
of the behaviour##3##3##(1993-12#1)(2008-10#2)
of the benchmark##3##3##(2012-12#2)(2012-2#1)
of the benchmarking##2##3##(1995-12#1)(2008-11#1)
of the bend##2##3##(1996-2#1)(2008-3#1)
of the bending##2##3##(2008-3#1)(2008-7#1)
of the beneficial effects of##2##5##(2008-7#1)(2012-2#1)
of the beneficial##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
of the beneficiaries##2##3##(1991-3#1)(1994-3#1)
of the benefit##5##3##(1993-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(2012-2#1)
of the benefits and costs##2##5##(1995-3#1)(2009-4#1)
of the benefits and##4##4##(1995-3#1)(1997-3#1)(2009-4#1)(2010-5#1)
of the benefits of##4##4##(1990-11#1)(1993-1#1)(1996-3#1)(2009-9#1)
of the benefits##10##3##(1990-11#1)(1993-1#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-1#1)(2009-4#1)(2009-9#1)(2010-5#1)(2012-12#1)
of the benign##4##3##(1997-3#1)(2007-12#1)(2010-12#1)(2011-2#1)
of the bent##5##3##(1993-8#1)(2008-3#4)
of the bentonite##2##3##(2008-10#2)
of the benzodiazepine##4##3##(1994-2#1)(1995-11#2)(2008-10#1)
of the benzoyl carbanion##2##4##(2007-11#2)
of the benzoyl##4##3##(1990-9#1)(2007-11#2)(2010-8#1)
of the benzylic substituent##2##4##(1995-3#2)
of the best characterized##5##4##(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
of the best possible##2##4##(1995-1#1)(2012-3#1)
of the best##33##3##(1991-6#1)(1993-12#1)(1993-8#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
of the beta 1##2##4##(1991-2#1)(1995-6#1)
of the beta chain##2##4##(1990-12#1)(1993-8#1)
of the beta subunit of##3##5##(1994-11#1)(1994-8#1)(1995-2#1)
of the beta subunit##7##4##(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#2)
of the beta##22##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#3)(1993-6#2)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(2008-10#1)(2008-11#1)
of the beta(2a)##3##3##(2008-8#3)
of the beta-1##2##3##(1991-12#2)
of the beta-adrenergic##2##3##(1995-3#1)(2008-9#1)
of the beta-binomial distribution##5##4##(2008-10#5)
of the beta-binomial##10##3##(2008-10#9)(2010-3#1)
of the beta-chain of bovine hemoglobin##2##6##(1995-3#2)
of the beta-chain##3##3##(1993-8#1)(1995-3#2)
of the beta-lactamase##2##3##(1992-6#1)(1997-4#1)
of the beta-protein##2##3##(1992-12#2)
of the beta-subunit of##3##4##(1993-8#1)(1996-12#1)(1997-4#1)
of the beta-subunit##4##3##(1992-9#1)(1993-8#1)(1996-12#1)(1997-4#1)
of the beta-tubulin gene##2##4##(2008-10#2)
of the beta-tubulin##4##3##(2008-10#3)(2010-3#1)
of the better##3##3##(1993-12#1)(2008-10#1)(2013-7#1)
of the bias##4##3##(1996-3#1)(2008-10#1)(2008-2#1)(2013-8#1)
of the bicyclic##2##3##(1991-8#1)(1996-5#1)
of the biggest##5##3##(1991-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
of the bilateral common carotid arteries##2##6##(2007-10#1)(2008-7#1)
of the bilateral##5##3##(1997-6#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-3#1)
of the bilaterian##2##3##(2010-4#2)
of the bilayer##9##3##(1990-2#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(2008-10#3)
of the bilayers##2##3##(2008-10#1)(2008-8#1)
of the bile##5##3##(1991-3#2)(2008-11#2)(2013-1#1)
of the biliary tract in geriatric##2##6##(1992-9#2)
of the biliary tract##14##4##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1992-9#5)(2008-4#4)
of the biliary tree##2##4##(2012-12#1)(2013-1#1)
of the biliary##17##3##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-9#5)(2008-4#4)(2012-12#1)(2013-1#1)
of the binary power law##3##5##(2008-10#3)
of the binary##9##3##(1995-5#1)(2008-10#8)
of the binding characteristics of##2##5##(1991-9#1)(1994-5#1)
of the binding data##2##4##(1991-5#1)(1993-1#1)
of the binding of the##3##5##(1995-2#1)(1997-2#1)(2008-6#1)
of the binding of##8##4##(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-6#1)(2008-7#1)
of the binding protein##2##4##(1990-11#1)(1994-2#1)
of the binding site for##2##5##(1990-7#1)(2010-10#1)
of the binding site##5##4##(1990-7#1)(1992-6#1)(1992-9#1)(1995-3#1)(2010-10#1)
of the binding sites##4##4##(1993-3#1)(1994-5#1)(2008-10#2)
of the binding##38##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-5#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#5)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)
of the binomial distribution##2##4##(2008-10#2)
of the bioactive glass##2##4##(2009-7#2)
of the bioactive##4##3##(2009-7#2)(2011-1#1)(2012-2#1)
of the bioassay##2##3##(2008-10#1)(2008-5#1)
of the biocatalyst##4##3##(1991-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
of the biochemical and##2##4##(1994-8#1)(2012-2#1)
of the biochemical##7##3##(1994-8#1)(1997-2#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
of the biocompatibility of##2##4##(2009-11#1)(2012-2#1)
of the biocontrol agent##2##4##(2008-10#2)
of the biocontrol agents##2##4##(2008-10#2)
of the biocontrol fungus Trichoderma harzianum ThzID1##2##7##(2008-10#2)
of the biocontrol isolates##2##4##(2008-10#2)
of the biocontrol##10##3##(2008-10#10)
of the bioelectrode is##2##4##(2008-10#2)
of the bioelectrode##3##3##(2008-10#3)
of the biofilm##7##3##(2008-7#3)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the biological activities of the GPIs##2##7##(2013-8#2)
of the biological activity##4##4##(1990-7#1)(1992-8#1)(2008-8#1)(2009-3#1)
of the biological control agent##2##5##(2008-10#2)
of the biological control##3##4##(2008-10#3)
of the biological function of##2##5##(1991-2#1)(2008-7#1)
of the biological function##3##4##(1991-2#1)(2008-4#1)(2008-7#1)
of the biological functions of##2##5##(1993-11#1)(2009-11#1)
of the biological role of##2##5##(1993-6#1)(2008-4#1)
of the biological sample##2##4##(2007-11#1)(2008-10#1)
of the biological##40##3##(1990-7#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
of the biology and##3##4##(2008-10#1)(2013-1#2)
of the biology of the##4##5##(1994-8#1)(2008-10#1)(2008-7#2)
of the biology of##11##4##(1993-12#1)(1994-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)
of the biology##15##3##(1993-12#1)(1994-11#1)(1994-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
of the bioluminescence##2##3##(2008-10#1)(2011-1#1)
of the biomass dry weight##2##5##(2008-7#2)
of the biomass##5##3##(2008-7#3)(2008-8#2)
of the biomechanical##2##3##(2008-8#1)(2009-7#1)
of the biomolecules##2##3##(2008-9#1)(2013-8#1)
of the biopsies obtained for##2##5##(2008-1#2)
of the biopsies##7##3##(1992-10#1)(1994-1#1)(1994-6#1)(2008-1#3)(2008-11#1)
of the biopsy##2##3##(1991-2#1)(2007-10#1)
of the bioreactor##3##3##(2008-11#1)(2008-7#2)
of the biosensor for##2##4##(2008-10#2)
of the biosensor in the##3##5##(2008-10#3)
of the biosensor was##2##4##(2008-10#2)
of the biosensor##24##3##(2008-10#24)
of the biosensors was evaluated##2##5##(2008-10#2)
of the biosensors##6##3##(2008-10#6)
of the biosynthesis of##3##4##(1994-11#1)(2012-2#1)(2013-8#1)
of the biosynthetic##2##3##(1993-5#2)
of the biotin transport##3##4##(1992-6#3)
of the bipartite##2##3##(2008-10#2)
of the birds##2##3##(1997-3#1)(2008-5#1)
of the birefringence of the##2##5##(2007-12#1)(2008-2#1)
of the birefringence of##6##4##(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)
of the birefringence that##2##4##(2008-3#2)
of the birefringence##13##3##(1990-7#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#7)(2009-11#1)
of the birefringent##2##3##(2008-3#2)
of the birth##4##3##(1991-6#1)(1992-6#1)(2008-4#1)(2008-7#1)
of the bisphenol##2##3##(2008-10#1)(2013-1#1)
of the black##6##3##(2007-11#1)(2008-3#1)(2008-7#2)(2009-4#1)(2012-2#1)
of the bladder and##4##4##(1997-7#2)(2008-10#1)(2011-2#1)
of the bladder in a child##2##6##(2008-10#2)
of the bladder in##6##4##(2007-10#2)(2008-10#2)(2008-4#1)(2011-2#1)
of the bladder is a rare##2##6##(1992-12#1)(2010-12#1)
of the bladder##39##3##(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#2)(1993-2#1)(1994-2#1)(1994-3#2)(1996-12#1)(1997-4#1)(1997-7#2)(2007-10#3)(2008-10#14)(2008-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#3)
of the blank signal##4##4##(2008-10#4)
of the blank signal)##2##4##(2008-10#2)
of the blank##16##3##(2008-10#16)
of the blank) and##2##4##(2008-10#2)
of the blank)##3##3##(2008-10#3)
of the blind##2##3##(1991-9#1)(2008-7#1)
of the block##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
of the blood coagulation##2##4##(1993-11#1)(1993-3#1)
of the blood flow##2##4##(2008-10#1)(2008-12#1)
of the blood glucose##2##4##(1992-9#1)(2011-3#1)
of the blood pressure##6##4##(1992-2#1)(1997-5#1)(2008-5#1)(2008-7#2)(2013-8#1)
of the blood supply##2##4##(1996-9#1)(2007-11#1)
of the blood vessel##2##4##(1996-3#1)(2008-3#1)
of the blood##34##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#2)
of the blood-brain barrier (BBB)##3##5##(1990-5#1)(1996-5#1)(2008-7#1)
of the blood-brain barrier in the##2##6##(1994-5#1)(1995-12#1)
of the blood-brain barrier in##3##5##(1990-5#1)(1994-5#1)(1995-12#1)
of the blood-brain barrier##13##4##(1990-5#2)(1992-3#2)(1994-5#1)(1995-12#3)(1996-5#1)(2008-7#2)(2008-8#1)(2013-1#1)
of the bloom##2##3##(2008-8#2)
of the blue color##3##4##(2008-10#3)
of the blue complex##2##4##(2008-10#2)
of the blue crab##3##4##(1994-11#1)(2007-12#2)
of the blue##14##3##(1992-11#1)(1994-11#1)(2007-12#5)(2008-10#6)(2008-5#1)
of the board##3##3##(1995-12#1)(1995-6#1)(2007-9#1)
of the board's role##2##4##(1995-12#1)(2008-11#1)
of the body and##4##4##(1992-5#1)(2008-10#2)(2011-2#1)
of the body of##3##4##(2007-12#1)(2009-7#1)(2010-5#1)
of the body to##2##4##(2007-7#1)(2008-5#1)
of the body were##2##4##(1992-3#1)(2008-5#1)
of the body##47##3##(1990-9#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-5#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#2)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#4)
of the body's##3##3##(1992-11#1)(1997-6#1)(2008-5#1)
of the bolometers##2##3##(2008-3#2)
of the bolus##2##3##(1995-12#1)(2008-10#1)
of the bonding##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
of the bone and##4##4##(2008-10#1)(2010-6#2)(2013-8#1)
of the bone grafts##2##4##(2007-11#2)
of the bone in##3##4##(2007-8#1)(2010-3#1)(2012-2#1)
of the bone is##3##4##(1991-11#1)(2008-6#1)(2011-2#1)
of the bone marrow##3##4##(2008-11#1)(2009-2#1)(2010-8#1)
of the bone tissue##2##4##(1995-6#2)
of the bone union##3##4##(2007-8#3)
of the bone##38##3##(1991-11#3)(1991-12#1)(1993-11#1)(1995-6#3)(2007-11#5)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-3#2)(2010-6#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
of the bony##3##3##(2007-12#1)(2009-4#1)(2012-2#1)
of the border##2##3##(1990-11#1)(1997-3#1)
of the borderline##2##3##(1990-2#1)(1992-1#1)
of the boronic acid group##2##5##(2008-10#2)
of the both##3##3##(2007-6#1)(2008-10#1)(2013-1#1)
of the bottom layer##2##4##(2008-2#1)(2012-3#1)
of the bottom##8##3##(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the bound##13##3##(1990-10#1)(1990-12#3)(1991-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1994-5#1)(2007-11#1)(2008-7#1)(2008-8#1)
of the boundaries##2##3##(1996-4#1)(2008-11#1)
of the boundary between##2##4##(2013-1#1)(2013-7#1)
of the boundary##6##3##(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#1)(2013-7#1)
of the bovine gene##2##4##(1991-2#2)
of the bovine##16##3##(1990-7#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-9#1)(1994-8#2)(1995-11#1)(1996-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-3#1)
of the bowel wall##3##4##(1992-5#1)(2012-2#2)
of the bowel##6##3##(1992-5#2)(1993-9#1)(1994-9#1)(2012-2#2)
of the bowels##2##3##(1996-6#1)(2009-10#1)
of the boy##3##3##(1995-5#2)(2012-2#1)
of the boys and##3##4##(1991-9#3)
of the brachial plexus##2##4##(2009-3#2)
of the brachial##5##3##(2009-1#3)(2009-3#2)
of the brain and spinal cord##3##6##(1995-3#1)(2008-7#1)(2010-8#1)
of the brain and##15##4##(1990-11#1)(1990-6#1)(1994-6#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-8#3)(2011-1#1)(2012-1#1)
of the brain are##4##4##(1995-5#1)(1997-6#1)(2008-11#1)(2010-12#1)
of the brain as##2##4##(2009-12#1)(2009-6#1)
of the brain death##2##4##(1995-6#1)(2007-11#1)
of the brain following##2##4##(1995-12#1)(1996-12#1)
of the brain for##3##4##(2008-1#2)(2012-1#1)
of the brain had##2##4##(1991-6#1)(2008-7#1)
of the brain has##2##4##(2007-12#1)(2008-11#1)
of the brain in##4##4##(2007-12#1)(2008-4#1)(2010-11#1)(2013-1#1)
of the brain is##3##4##(1995-11#1)(2007-12#1)(2008-11#1)
of the brain of##4##4##(1996-5#1)(2007-12#1)(2008-4#1)(2008-7#1)
of the brain revealed a##2##5##(2006-10#1)(2008-12#1)
of the brain revealed##3##4##(2006-10#1)(2008-12#1)(2009-3#1)
of the brain reward##2##4##(2007-8#1)(2008-7#1)
of the brain stem##4##4##(1995-12#1)(2008-7#2)(2009-3#1)
of the brain that##3##4##(1996-12#1)(2008-4#1)(2009-5#1)
of the brain was##3##4##(1992-11#1)(1997-2#1)(2010-1#1)
of the brain were##2##4##(1992-8#1)(2008-8#1)
of the brain##130##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#4)(1996-5#3)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#14)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#3)(2012-2#4)(2013-1#3)(2013-7#1)
of the brain's##2##3##(2007-8#1)(2009-8#1)
of the brain-gut axis##2##4##(2009-10#2)
of the brains of##4##4##(2007-10#1)(2007-12#1)(2008-11#1)(2011-2#1)
of the brains##6##3##(2007-10#2)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
of the brainstem were##2##4##(1993-12#1)(2011-2#1)
of the brainstem##4##3##(1993-12#1)(1994-2#1)(2008-4#1)(2011-2#1)
of the branch##3##3##(2008-3#2)(2008-9#1)
of the branched##2##3##(1996-5#1)(1997-2#1)
of the branches of the##2##5##(1997-3#1)(2009-3#1)
of the branches##3##3##(1997-3#1)(2008-7#1)(2009-3#1)
of the branchial heart complex of Sepia officinalis L##2##9##(2008-7#2)
of the branchial heart##4##4##(2008-7#4)
of the branchial podocytes##2##4##(2008-7#2)
of the branchial##6##3##(2008-7#6)
of the branching##2##3##(2007-12#1)(2012-2#1)
of the breakdown##3##3##(1994-2#1)(1996-4#1)(2010-3#1)
of the breakpoints##2##3##(2008-5#1)(2013-1#1)
of the breakup##2##3##(2007-12#1)(2008-7#1)
of the breast and##5##4##(1994-12#1)(1994-2#1)(2008-11#1)(2010-7#1)(2013-8#1)
of the breast cancer##2##4##(1993-8#1)(1994-12#1)
of the breast coexisting with##2##5##(1994-7#1)(1995-4#1)
of the breast in##3##4##(1990-11#1)(1994-12#1)(2007-8#1)
of the breast is a##2##5##(1995-4#1)(2008-1#1)
of the breast is##3##4##(1992-2#1)(1995-4#1)(2008-1#1)
of the breast with##3##4##(1993-8#1)(1994-6#1)(2012-3#1)
of the breast##60##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-2#3)(1992-5#1)(1992-8#1)(1993-12#2)(1993-5#2)(1993-6#1)(1993-8#3)(1994-12#4)(1994-2#1)(1994-6#2)(1994-7#5)(1994-8#1)(1995-4#5)(1995-9#1)(1997-8#2)(2007-10#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2009-1#1)(2009-2#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#4)
of the breeding##4##3##(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
of the bridging ligand##2##4##(1997-7#2)
of the bridging##5##3##(1997-7#4)(2008-10#1)
of the brief##2##3##(2008-11#1)(2009-5#1)
of the bright##2##3##(2008-3#2)
of the brine shrimp Artemia##2##5##(1994-8#1)(2008-9#1)
of the broad##5##3##(1992-3#1)(1997-3#1)(2008-5#2)(2008-8#1)
of the broader##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
of the broiler isolates##2##4##(1997-3#2)
of the broiler##3##3##(1997-3#2)(2008-10#1)
of the bromate##2##3##(2008-10#1)(2010-5#1)
of the bronchial vasculature##2##4##(1997-1#2)
of the bronchial##11##3##(1990-9#1)(1991-12#1)(1991-9#1)(1994-9#1)(1995-12#1)(1997-1#4)(2007-8#1)(2008-1#1)
of the bronchiolar stem##2##4##(2013-1#2)
of the bronchoscopic##2##3##(2007-8#1)(2010-8#1)
of the brood##2##3##(2008-12#1)(2008-9#1)
of the brown##5##3##(2008-10#2)(2008-12#2)(2013-1#1)
of the bubble##5##3##(2008-11#5)
of the bubbles##2##3##(2009-11#2)
of the buccal mucosa##3##4##(1992-9#1)(1995-9#1)(2013-1#1)
of the buccal##6##3##(1992-9#1)(1995-9#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the budding yeast Saccharomyces cerevisiae##2##6##(1990-5#1)(1997-7#1)
of the budding yeast##3##4##(1990-5#1)(1997-7#1)(2008-9#1)
of the budding##4##3##(1990-5#1)(1996-6#1)(1997-7#1)(2008-9#1)
of the buffer solution##2##4##(2008-10#2)
of the buffer solutions##2##4##(1990-8#1)(2008-10#1)
of the buffer##14##3##(1990-8#1)(1991-5#1)(2007-12#1)(2008-10#10)(2008-3#1)
of the building##3##3##(1992-2#2)(2010-7#1)
of the bulk material##2##4##(2010-4#1)(2012-2#1)
of the bulk of the##2##5##(2008-3#1)(2010-8#1)
of the bulk of##4##4##(1990-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
of the bulk solvent##2##4##(2008-10#2)
of the bulk##19##3##(1990-5#1)(1992-6#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-6#2)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)
of the bullfrog Rana catesbeiana##2##5##(1992-3#1)(1993-5#1)
of the burden of disease##2##5##(2012-12#2)
of the burden of stroke in##3##6##(2008-8#3)
of the burden of stroke##4##5##(2008-8#4)
of the burden of##7##4##(2008-8#4)(2012-12#3)
of the burden##8##3##(2008-8#4)(2011-2#1)(2012-12#3)
of the burned##3##3##(1991-3#1)(1994-5#1)(2011-2#1)
of the burnout syndrome##4##4##(2011-2#3)(2013-1#1)
of the burnout##5##3##(2011-2#4)(2013-1#1)
of the c##3##3##(2008-3#2)(2010-8#1)
of the c-Ki-ras gene##2##4##(1992-8#2)
of the c-Ki-ras##3##3##(1992-8#3)
of the c-fos promoter##2##4##(1994-11#2)
of the c-fos##3##3##(1992-9#1)(1994-11#2)
of the c-myc gene##5##4##(1992-8#2)(1992-9#1)(1993-2#2)
of the c-myc##7##3##(1992-2#1)(1992-8#2)(1992-9#1)(1993-2#2)(2008-11#1)
of the cAMP##3##3##(1994-8#1)(1996-5#1)(2008-11#1)
of the cDNA clones##3##4##(1993-6#1)(1996-10#1)(1996-2#1)
of the cDNA encoding##2##4##(1991-6#1)(1993-2#1)
of the cDNA for##2##4##(1995-2#1)(1996-12#1)
of the cDNA in##2##4##(1990-12#1)(1994-8#1)
of the cDNA sequence##5##4##(1991-11#1)(1992-10#1)(1994-8#1)(1996-12#1)(2008-4#1)
of the cDNA##31##3##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-8#3)(1995-2#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-5#1)
of the cDNAs##4##3##(1991-5#1)(1994-11#1)(1995-8#2)
of the cPLA2##3##3##(1993-11#3)
of the cabbage looper moth##2##5##(1990-8#2)
of the cabbage##3##3##(1990-8#2)(2008-8#1)
of the cabin##2##3##(1996-12#1)(2007-2#1)
of the cadmium##3##3##(2008-10#3)
of the calcaneus##3##3##(2007-11#2)(2010-11#1)
of the calcified##2##3##(2009-7#1)(2013-8#1)
of the calcitonin gene##3##4##(1990-12#2)(1990-2#1)
of the calcitonin/alpha-CGRP##2##3##(1992-6#2)
of the calcium channel##2##4##(1993-12#1)(1996-5#1)
of the calcium##9##3##(1991-5#1)(1991-8#1)(1993-12#1)(1995-11#2)(1995-3#1)(1996-5#1)(2008-10#2)
of the calcium-binding##2##3##(1991-5#1)(1994-5#1)
of the calculated phase##2##4##(2008-3#2)
of the calculated##8##3##(2008-2#1)(2008-3#5)(2012-12#1)(2013-1#1)
of the calculation##2##3##(1992-12#1)(2008-2#1)
of the calf and##2##4##(1991-6#1)(2007-11#1)
of the calf uterine androgen receptor##2##6##(1990-11#2)
of the calf##7##3##(1990-11#2)(1991-6#1)(2007-11#1)(2008-10#1)(2009-3#1)(2011-2#1)
of the calibration curve is##2##5##(2008-10#2)
of the calibration curve was##3##5##(2008-10#3)
of the calibration curve##11##4##(2008-10#11)
of the calibration curves##6##4##(2008-10#4)(2008-2#1)(2009-8#1)
of the calibration graph is##5##5##(2008-10#5)
of the calibration graph##7##4##(2008-10#7)
of the calibration graphs##2##4##(2008-10#2)
of the calibration matrix##2##4##(2008-10#2)
of the calibration model##2##4##(2007-12#1)(2008-10#1)
of the calibration models##2##4##(2008-10#2)
of the calibration##51##3##(1995-9#1)(2007-12#1)(2008-10#43)(2008-2#3)(2008-3#2)(2009-8#1)
of the calibrator##4##3##(1995-2#1)(2008-10#3)
of the calves##2##3##(1997-5#1)(2010-2#1)
of the camera is##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the camera##6##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-6#2)
of the campaign was##2##4##(2008-12#2)
of the campaign##6##3##(1992-2#1)(1995-1#1)(1996-8#1)(2008-12#2)(2008-9#1)
of the canal##2##3##(2007-12#1)(2008-11#1)
of the canalicular##2##3##(1994-12#2)
of the cancer##10##3##(1990-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
of the candidate genes##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
of the candidate##9##3##(1993-9#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of the canine##2##3##(1990-11#1)(2008-11#1)
of the cannabinoid##3##3##(1991-4#1)(2008-7#2)
of the canonical##2##3##(1992-6#1)(2008-4#1)
of the canopy##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
of the cantilever##2##3##(2008-3#1)(2012-2#1)
of the cap site##2##4##(1991-6#1)(1995-6#1)
of the cap structure##5##4##(1997-2#2)(2008-10#2)(2008-9#1)
of the cap##7##3##(1991-6#1)(1995-6#1)(1997-2#2)(2008-10#2)(2008-9#1)
of the capabilities of##2##4##(2008-10#1)(2011-1#1)
of the capacity of##2##4##(2010-10#1)(2013-8#1)
of the capacity##4##3##(1996-5#1)(2010-10#1)(2010-4#1)(2013-8#1)
of the capillary##12##3##(1994-9#4)(1996-5#1)(2008-10#4)(2008-3#2)(2011-1#1)
of the capital##2##3##(2007-8#1)(2010-5#1)
of the capsid protein##2##4##(2007-6#1)(2008-10#1)
of the capsid##6##3##(1991-5#1)(1992-8#1)(2007-6#1)(2008-10#3)
of the capture##2##3##(1990-12#1)(2012-2#1)
of the carbohydrate moiety##3##4##(1990-11#2)(1990-7#1)
of the carbohydrate##6##3##(1990-11#2)(1990-7#1)(1996-6#1)(2008-8#1)(2013-8#1)
of the carbohydrates##2##3##(2008-3#1)(2008-9#1)
of the carbon content of##2##5##(2008-10#1)(2008-3#1)
of the carbon source##3##4##(1995-9#1)(2008-6#2)
of the carbon##10##3##(1995-6#1)(1995-9#1)(2008-10#4)(2008-3#1)(2008-6#2)(2011-2#1)
of the carbonyl##3##3##(1995-5#1)(1996-5#1)(2008-10#1)
of the carboxy##2##3##(1993-8#2)
of the carboxy-terminal##2##3##(1994-6#1)(2008-11#1)
of the carboxyl group##2##4##(1993-11#1)(1993-3#1)
of the carboxyl terminus##2##4##(1992-3#1)(1995-2#1)
of the carboxyl##4##3##(1992-3#1)(1993-11#1)(1993-3#1)(1995-2#1)
of the carboxylic acid##4##4##(1995-5#2)(1996-7#1)(2008-10#1)
of the carboxylic##7##3##(1991-9#1)(1995-5#2)(1996-7#1)(2008-10#3)
of the carcases##2##3##(1997-5#2)
of the carcinogenic##4##3##(1990-5#2)(1992-5#1)(2008-10#1)
of the cardiac alpha 1 subunit##2##6##(1994-6#2)
of the cardiac rhythm##4##4##(2011-1#4)
of the cardiac##20##3##(1992-3#1)(1994-6#2)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-1#4)(2012-3#1)
of the cardiovascular system##8##4##(2008-10#2)(2008-3#1)(2008-5#1)(2009-9#2)(2010-5#1)(2013-8#1)
of the cardiovascular##14##3##(1990-12#1)(1990-9#1)(1995-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-9#2)(2010-5#1)(2013-1#1)(2013-8#1)
of the care plan##3##4##(1993-3#1)(2013-1#2)
of the care##12##3##(1993-12#1)(1993-3#1)(1997-1#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the caregiving##2##3##(1992-3#1)(2008-7#1)
of the carotenoids##3##3##(1992-9#1)(2010-2#2)
of the carotid arteries##6##4##(2006-12#1)(2008-7#4)(2011-2#1)
of the carotid artery and the##2##6##(2007-10#1)(2011-2#1)
of the carotid artery##7##4##(1993-3#1)(2007-10#1)(2008-7#1)(2009-7#2)(2011-2#2)
of the carotid plaque##2##4##(2008-8#2)
of the carotid##19##3##(1991-5#1)(1992-6#1)(1993-3#1)(2006-12#1)(2007-10#1)(2008-7#6)(2008-8#2)(2009-7#2)(2010-6#1)(2011-2#3)
of the carp##2##3##(2008-5#2)
of the carpal##3##3##(2008-9#2)(2013-1#1)
of the carpophores##2##3##(1997-2#1)(2008-11#1)
of the carrier concentration##2##4##(2008-10#1)(2008-3#1)
of the carrier ligands##2##4##(2010-11#1)(2013-1#1)
of the carrier solution##4##4##(2008-10#4)
of the carrier##22##3##(1990-11#2)(1991-5#2)(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2013-1#1)
of the carrier-envelope phase of##2##5##(2007-11#2)
of the carrier-envelope phase##3##4##(2007-11#2)(2007-12#1)
of the carrier-envelope##5##3##(2007-11#4)(2007-12#1)
of the carriers##2##3##(2007-12#1)(2008-11#1)
of the cartilage##3##3##(1990-3#1)(2008-3#1)(2009-1#1)
of the cartilaginous##2##3##(2007-11#1)(2010-8#1)
of the cascade##4##3##(1992-2#1)(1994-6#1)(2008-3#1)(2009-10#1)
of the cascaded##3##3##(2007-12#3)
of the case are##2##4##(1990-9#1)(2008-7#1)
of the case law##3##4##(1993-1#1)(1993-12#1)(1994-3#1)
of the case##17##3##(1990-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-1#2)
of the cases and##6##4##(1992-2#1)(1993-2#1)(2007-7#2)(2008-11#1)(2008-5#1)
of the cases are##2##4##(1995-12#1)(2008-1#1)
of the cases by##2##4##(1990-9#1)(2008-5#1)
of the cases described in the literature##2##7##(1992-12#1)(2013-1#1)
of the cases have been##3##5##(1992-9#1)(1995-6#1)(2007-7#1)
of the cases have##5##4##(1992-9#1)(1995-6#1)(2007-11#1)(2007-7#1)(2007-8#1)
of the cases it was##2##5##(1991-12#1)(1991-8#1)
of the cases of##7##4##(1995-8#1)(2007-7#3)(2008-7#1)(2009-4#1)(2011-2#1)
of the cases received##2##4##(1991-9#1)(2012-3#1)
of the cases studied##2##4##(1993-2#1)(2012-3#1)
of the cases the##3##4##(1991-2#1)(1991-9#1)(2013-1#1)
of the cases was##2##4##(1991-8#1)(2008-10#1)
of the cases were reported##2##5##(1995-12#1)(1997-8#1)
of the cases were##5##4##(1993-2#1)(1995-12#1)(1996-9#1)(1997-8#1)(2013-8#1)
of the cases with##2##4##(1993-8#1)(2011-1#1)
of the cases##130##3##(1990-10#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#3)(1993-8#1)(1994-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-3#2)(1996-6#2)(1996-9#2)(1997-6#1)(1997-8#2)(2006-12#1)(2007-11#2)(2007-7#10)(2007-8#6)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#2)
of the cat##2##3##(1993-6#1)(2008-8#1)
of the catabolic##2##3##(1994-12#1)(2012-1#1)
of the catalyst##5##3##(2008-10#4)(2010-4#1)
of the catalytic activity of the##2##6##(2008-10#2)
of the catalytic activity##3##4##(1992-3#1)(2008-10#2)
of the catalytic domain of Cex##2##6##(1992-11#2)
of the catalytic domain##3##4##(1992-11#2)(1995-8#1)
of the catalytic hydrogen signal##2##5##(2008-10#2)
of the catalytic reaction##3##4##(2008-10#3)
of the catalytic subunit of protein##3##6##(1992-12#1)(1994-9#1)(1995-8#1)
of the catalytic subunit of##6##5##(1992-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)
of the catalytic subunit##8##4##(1992-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-8#1)
of the catalytic triad##2##4##(1992-3#1)(1995-3#1)
of the catalytic##38##3##(1990-8#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1997-7#1)(2008-10#10)(2008-11#1)(2010-12#2)
of the cataract##2##3##(2010-8#2)
of the catechol##4##3##(2008-10#3)(2009-9#1)
of the categories##2##3##(2010-2#1)(2012-1#1)
of the category &quot##2##4##(1995-6#1)(2009-10#1)
of the category##3##3##(1990-11#1)(1995-6#1)(2009-10#1)
of the catfish##2##3##(2008-5#1)(2008-7#1)
of the cathepsin##3##3##(1992-9#1)(1995-2#1)(1995-6#1)
of the catheter and##2##4##(1993-5#1)(2011-2#1)
of the catheter fragment##2##4##(2007-7#2)
of the catheter##16##3##(1993-5#1)(1996-3#1)(1997-3#1)(2007-7#3)(2008-5#1)(2009-9#1)(2010-8#3)(2011-2#5)
of the catheters##2##3##(1997-3#1)(2008-10#1)
of the cation channel##2##4##(2008-8#2)
of the cation##6##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-8#3)
of the cationic probe##4##4##(1992-6#4)
of the cationic surfactant##2##4##(2008-10#1)(2008-8#1)
of the cationic##11##3##(1992-6#4)(1996-5#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#1)
of the cations##6##3##(2008-10#6)
of the cats were##2##4##(2012-3#1)(2013-8#1)
of the cats##6##3##(1990-9#1)(2008-8#1)(2012-3#3)(2013-8#1)
of the cattle##2##3##(2010-4#1)(2012-3#1)
of the caudal##8##3##(1990-5#1)(1990-9#1)(1992-8#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
of the caudate##2##3##(2007-8#1)(2008-6#1)
of the caudate-putamen##3##3##(1995-12#2)(2008-7#1)
of the causal agent##3##4##(2008-10#3)
of the causal organism##2##4##(2008-10#2)
of the causal##10##3##(2008-10#8)(2008-6#1)(2010-5#1)
of the causative agent##3##4##(1994-5#1)(2008-8#1)(2011-2#1)
of the causative##4##3##(1994-5#1)(1997-3#1)(2008-8#1)(2011-2#1)
of the cause and##2##4##(1991-11#1)(2011-2#1)
of the cause of##2##4##(1990-9#1)(1991-7#1)
of the cause##7##3##(1990-9#1)(1991-11#2)(1991-7#1)(2011-1#1)(2011-2#2)
of the causes of low##2##5##(2010-12#1)(2010-8#1)
of the causes of##13##4##(1990-8#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the causes##16##3##(1990-8#1)(1991-6#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#2)(2007-11#2)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the caustic##2##3##(2008-2#2)
of the cavernous sinus##2##4##(1990-12#1)(1993-9#1)
of the cavity and the##2##5##(2008-10#1)(2008-2#1)
of the cavity design##3##4##(2007-12#1)(2008-3#2)
of the cavity in##2##4##(1996-5#1)(2008-3#1)
of the cavity is##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of the cavity length and##2##5##(2007-11#1)(2007-12#1)
of the cavity length##3##4##(2007-11#2)(2007-12#1)
of the cavity##32##3##(1996-5#1)(2007-11#4)(2007-12#8)(2008-10#1)(2008-2#3)(2008-3#14)(2009-9#1)
of the cecum##3##3##(2007-12#1)(2008-12#2)
of the cell and##6##4##(2007-12#1)(2008-2#1)(2008-6#2)(2008-9#1)(2013-1#1)
of the cell culture##5##4##(1996-2#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-2#1)
of the cell cycle by##2##5##(1994-3#1)(1997-1#1)
of the cell cycle in##4##5##(2008-11#1)(2008-4#2)(2008-9#1)
of the cell cycle were##3##5##(1993-12#1)(2008-7#1)(2011-1#1)
of the cell cycle##34##4##(1993-12#1)(1993-9#1)(1994-3#3)(1994-8#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#11)(2008-4#3)(2008-7#2)(2008-9#3)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the cell growth##2##4##(1992-9#1)(2008-11#1)
of the cell is##4##4##(1993-8#1)(2008-1#1)(2008-2#1)(2009-10#1)
of the cell line to##2##5##(2008-11#2)
of the cell line##8##4##(1990-5#1)(2008-11#7)
of the cell lines are##2##5##(1994-12#1)(2008-11#1)
of the cell lines##7##4##(1992-8#1)(1994-12#1)(2008-11#4)(2008-8#1)
of the cell lysate##2##4##(1997-4#1)(2008-10#1)
of the cell membrane##11##4##(1991-5#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
of the cell population##4##4##(2008-11#2)(2008-7#1)(2013-1#1)
of the cell proliferation##3##4##(1997-2#3)
of the cell size##4##4##(1995-9#3)(2008-7#1)
of the cell surface##6##4##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-9#2)
of the cell suspension##2##4##(2008-11#2)
of the cell volume##2##4##(2008-11#1)(2008-7#1)
of the cell wall##8##4##(2008-10#4)(2010-4#1)(2012-1#1)(2012-2#2)
of the cell##180##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#2)(1991-6#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-2#1)(1995-8#1)(1995-9#4)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2007-12#3)(2008-1#3)(2008-10#13)(2008-11#44)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#6)(2009-10#3)(2009-11#2)(2009-2#2)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-4#2)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)
of the cell-associated##3##3##(1992-5#1)(1992-9#1)(1993-6#1)
of the cells and was##3##5##(2008-10#1)(2008-11#2)
of the cells and##9##4##(1990-8#1)(1995-12#1)(2008-10#3)(2008-11#4)
of the cells at##4##4##(2008-11#4)
of the cells by##2##4##(1992-5#1)(2008-11#1)
of the cells co-cultured with the##2##6##(2009-7#2)
of the cells from##2##4##(1990-8#1)(1996-5#1)
of the cells grown##2##4##(2008-11#1)(2008-5#1)
of the cells in##5##4##(1995-9#1)(2008-11#4)
of the cells into the##2##5##(2008-1#1)(2008-4#1)
of the cells into##3##4##(2008-1#1)(2008-10#1)(2008-4#1)
of the cells is##2##4##(1995-2#1)(2008-8#1)
of the cells to the##2##5##(1992-11#1)(1992-3#1)
of the cells to##6##4##(1990-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(2008-11#2)
of the cells was##8##4##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2013-1#1)(2013-7#1)
of the cells were##4##4##(1991-5#1)(1994-8#1)(2008-11#1)(2008-6#1)
of the cells with##12##4##(1993-9#2)(1994-11#2)(1995-11#1)(1995-12#1)(1997-1#4)(2008-11#1)(2008-4#1)
of the cells##122##3##(1990-11#1)(1990-5#2)(1990-8#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#4)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#4)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#35)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2009-7#2)(2009-8#1)(2010-3#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-7#1)
of the cells'##2##3##(2012-2#1)(2013-8#1)
of the cellular systems##2##4##(1995-6#1)(1996-6#1)
of the cellular##33##3##(1991-12#1)(1992-3#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the cellulase-encoding##2##3##(1991-9#2)
of the cellulose##3##3##(2008-6#1)(2008-7#1)(2013-8#1)
of the center of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the center##8##3##(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#1)
of the central and peripheral nervous##3##6##(2008-4#1)(2008-7#2)
of the central and peripheral##4##5##(2008-4#1)(2008-7#2)(2010-6#1)
of the central and##5##4##(2008-4#1)(2008-7#2)(2009-9#1)(2010-6#1)
of the central beta-noradrenergic##2##4##(1997-2#2)
of the central cell##4##4##(2008-11#1)(2008-9#3)
of the central glycine##2##4##(2008-8#2)
of the central metabolism##2##4##(2008-7#2)
of the central nervous system (CNS)##8##6##(1991-2#1)(1995-5#1)(1996-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
of the central nervous system and##4##6##(2008-2#1)(2008-9#1)(2012-2#2)
of the central nervous system by##3##6##(2008-7#1)(2011-2#1)(2012-12#1)
of the central nervous system##46##5##(1990-3#1)(1990-8#1)(1991-2#2)(1993-9#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-12#2)(1997-2#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of the central nucleus of the amygdala##3##7##(1993-12#3)
of the central nucleus of the##4##6##(1993-12#3)(2012-3#1)
of the central part of the##2##6##(1994-3#2)
of the central##95##3##(1990-3#2)(1990-8#1)(1991-2#2)(1992-1#1)(1992-3#1)(1993-12#5)(1993-9#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#2)(1996-12#2)(1996-2#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#5)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
of the centroid##2##3##(2008-3#1)(2009-9#1)
of the centromere of##2##4##(2008-5#1)(2012-3#1)
of the centrosome protein##2##4##(2008-9#2)
of the century##10##3##(1991-11#1)(1992-2#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2009-10#1)
of the ceramic##2##3##(2007-11#1)(2008-5#1)
of the ceramide moiety##2##4##(1990-7#1)(1993-11#1)
of the ceramide##4##3##(1990-7#1)(1993-11#1)(1994-5#1)(2008-5#1)
of the cerebellar##5##3##(1997-3#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the cerebellum##11##3##(1991-1#1)(1992-6#1)(1996-5#3)(2007-8#2)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
of the cerebral cortex##2##4##(2008-11#1)(2011-2#1)
of the cerebral##10##3##(1992-12#1)(1994-2#1)(1994-5#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
of the cerebrospinal fluid##3##4##(1995-5#1)(2008-7#1)(2011-2#1)
of the cerebrovascular##2##3##(1992-2#1)(2012-3#1)
of the cerebrum##3##3##(2008-9#3)
of the certified reference##3##4##(2008-10#3)
of the certified values##2##4##(2008-10#2)
of the certified##10##3##(2008-10#8)(2008-12#2)
of the cervical and##2##4##(2007-11#1)(2013-1#1)
of the cervical cancer##4##4##(2007-8#1)(2011-3#1)(2012-3#1)(2013-7#1)
of the cervical esophagus##2##4##(2013-1#2)
of the cervical spine are##2##5##(1997-4#1)(2011-2#1)
of the cervical spine revealed##2##5##(2009-3#2)
of the cervical spine##18##4##(1997-4#1)(2006-10#1)(2007-8#2)(2009-3#3)(2010-12#3)(2011-2#4)(2012-12#2)(2013-1#2)
of the cervical##34##3##(1990-6#1)(1991-2#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-8#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#3)(2010-12#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-7#1)
of the cervix and##2##4##(1996-2#1)(2013-7#1)
of the cervix in##4##4##(1991-3#1)(1994-5#2)(1996-6#1)
of the cervix was##2##4##(1992-2#1)(1996-12#1)
of the cervix##18##3##(1990-8#3)(1991-3#1)(1992-2#1)(1994-1#1)(1994-3#2)(1994-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-7#1)
of the chain is##2##4##(1994-3#2)
of the chain of##3##4##(1994-2#1)(2008-12#1)(2010-8#1)
of the chain##11##3##(1990-2#1)(1994-2#1)(1994-3#3)(1995-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)
of the chain-length##2##3##(1990-11#1)(1990-7#1)
of the chains##2##3##(2010-2#1)(2013-1#1)
of the chalcogenide##2##3##(2007-11#1)(2008-10#1)
of the challenge##2##3##(2008-10#1)(2013-1#1)
of the challenges and##5##4##(1996-2#1)(2007-12#1)(2008-1#1)(2010-5#1)(2010-6#1)
of the challenges facing##2##4##(2008-1#1)(2008-7#1)
of the challenges of##2##4##(2008-11#1)(2011-1#1)
of the challenges##12##3##(1996-2#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
of the chamber##2##3##(2008-11#1)(2008-7#1)
of the change in the##2##5##(1990-5#1)(1997-2#1)
of the change in##6##4##(1990-5#1)(1997-2#1)(2008-10#3)(2013-1#1)
of the change of##3##4##(2008-10#2)(2008-8#1)
of the change##16##3##(1990-5#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-8#1)(2013-1#1)
of the changed##2##3##(1996-2#1)(2007-11#1)
of the changes in##9##4##(1990-6#1)(1994-1#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-9#1)(2013-8#1)
of the changes of##2##4##(2008-5#1)(2008-8#1)
of the changes##23##3##(1990-6#1)(1991-12#1)(1992-8#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-8#1)
of the changing##5##3##(1995-11#1)(1996-3#1)(2007-10#1)(2007-11#1)(2008-10#1)
of the channel##13##3##(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#1)(2008-2#1)(2008-3#3)(2008-8#3)(2009-11#1)(2012-2#1)
of the channels##6##3##(1995-12#1)(1995-2#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the chaotic##2##3##(2007-11#1)(2010-1#1)
of the characteristic features of##2##5##(2008-5#1)(2010-7#1)
of the characteristic features##3##4##(2008-11#1)(2008-5#1)(2010-7#1)
of the characteristic##18##3##(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#2)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
of the characteristics of the##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
of the characteristics of##11##4##(1990-11#1)(1990-5#1)(1992-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
of the characteristics##13##3##(1990-11#1)(1990-5#1)(1992-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
of the characterization of##3##4##(1994-2#1)(1995-6#1)(2008-11#1)
of the characterization##5##3##(1994-2#1)(1995-6#1)(2008-11#1)(2008-3#2)
of the charge is##2##4##(2007-11#2)
of the charge##11##3##(1992-3#1)(1992-9#1)(1994-9#1)(1995-5#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-7#1)
of the charged##2##3##(1990-8#1)(1994-9#1)
of the cheek##3##3##(2008-4#2)(2008-5#1)
of the chelate is 1##3##5##(2008-10#3)
of the chelate##6##3##(2008-10#6)
of the chelating resin##2##4##(2008-10#2)
of the chelating##6##3##(2008-10#6)
of the chemical alternatives##2##4##(2008-10#2)
of the chemical composition of##3##5##(2008-11#1)(2008-2#1)(2008-3#1)
of the chemical composition##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
of the chemical environment of##2##5##(2008-10#2)
of the chemical species##3##4##(2008-10#2)(2008-3#1)
of the chemical##44##3##(1991-8#1)(1992-3#1)(1992-6#2)(1993-12#1)(1995-11#2)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-8#1)
of the chemicals##6##3##(1995-6#2)(1996-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
of the chemiluminescence##5##3##(1991-5#1)(2008-10#4)
of the chemoattractant##3##3##(1994-6#1)(1997-3#2)
of the chemokine##6##3##(1994-9#1)(2008-11#1)(2009-12#1)(2011-2#2)(2013-1#1)
of the chemometric##3##3##(2008-10#2)(2008-3#1)
of the chemostat culture##2##4##(2008-6#1)(2008-7#1)
of the chemotherapy##3##3##(1990-9#1)(1991-3#1)(2008-7#1)
of the chest and##4##4##(2007-11#1)(2007-8#1)(2012-2#2)
of the chest demonstrated##2##4##(2007-8#1)(2008-1#1)
of the chest revealed a##2##5##(1991-9#1)(2008-7#1)
of the chest revealed##3##4##(1991-9#1)(2007-8#1)(2008-7#1)
of the chest wall##12##4##(2007-8#2)(2008-6#4)(2012-2#6)
of the chest##24##3##(1991-9#1)(2007-11#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-3#1)(2008-6#5)(2008-7#1)(2012-2#8)
of the chestnut blight fungus##3##5##(2008-10#3)
of the chick##3##3##(1990-5#2)(1996-5#1)
of the chicken Z chromosome##2##5##(2008-5#2)
of the chicken beta##2##4##(1991-5#2)
of the chicken embryo##3##4##(1992-3#1)(2007-6#1)(2008-12#1)
of the chicken##22##3##(1991-5#3)(1991-6#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-8#1)(1997-6#1)(1997-7#1)(1997-9#1)(2007-6#1)(2008-12#1)(2008-5#5)
of the chickpea cultivar##3##4##(2008-10#3)
of the chicks##2##3##(2008-12#1)(2008-6#1)
of the child and##3##4##(1995-5#1)(2008-11#1)(2013-1#1)
of the child with##4##4##(1990-10#1)(2008-11#2)(2013-8#1)
of the child##33##3##(1990-10#1)(1992-12#1)(1993-12#2)(1994-12#1)(1994-6#1)(1995-5#6)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-9#1)(2009-5#1)(2010-9#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the child's body##2##4##(1992-1#1)(2009-4#1)
of the child's##7##3##(1992-1#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#1)
of the childbearing woman##2##4##(2013-1#2)
of the children and their##2##5##(1991-2#1)(2007-12#1)
of the children and##4##4##(1991-2#1)(2007-12#1)(2008-11#1)(2012-12#1)
of the children are##2##4##(1990-6#1)(2008-9#1)
of the children had##4##4##(1997-4#1)(2006-10#1)(2012-12#1)(2012-2#1)
of the children were##8##4##(1990-12#2)(1993-6#1)(1995-6#1)(1996-1#1)(2006-10#1)(2012-12#1)(2013-8#1)
of the children with##11##4##(1996-1#2)(2007-11#1)(2008-11#2)(2008-4#2)(2010-8#2)(2011-1#1)(2012-2#1)
of the children##51##3##(1990-12#5)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-9#1)(1997-4#2)(2006-10#3)(2007-11#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-9#5)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
of the children's##5##3##(1993-6#1)(1995-12#1)(1995-6#2)(2008-3#1)
of the chimeric##2##3##(1991-5#1)(1997-2#1)
of the chiral##5##3##(1995-2#1)(1997-2#1)(2008-10#3)
of the chirp##2##3##(2008-2#2)
of the chloramphenicol##2##3##(1991-2#1)(2008-11#1)
of the chloride conductance in##2##5##(1995-11#2)
of the chloride ion##2##4##(2008-10#2)
of the chloride##6##3##(1995-11#2)(1997-7#1)(2008-10#3)
of the chloroplast genome##2##4##(1997-2#1)(2008-12#1)
of the chloroplast signal recognition particle##2##6##(2009-7#2)
of the chloroplast##6##3##(1990-7#1)(1997-2#2)(2008-12#1)(2009-7#2)
of the choice of##2##4##(1991-3#1)(2008-8#1)
of the choice##4##3##(1991-3#1)(1991-4#1)(2008-10#1)(2008-8#1)
of the choledochus##2##3##(1990-6#1)(1991-5#1)
of the cholesteric##2##3##(2007-11#1)(2007-12#1)
of the cholesterol content##2##4##(2008-10#1)(2008-6#1)
of the cholesterol##4##3##(1994-8#1)(2008-10#2)(2008-6#1)
of the chondral##2##3##(2007-11#1)(2011-2#1)
of the chorion##3##3##(2007-12#1)(2008-12#2)
of the choroid plexus##2##4##(1996-12#1)(1996-5#1)
of the choroid##4##3##(1996-12#1)(1996-5#1)(1997-3#1)(2013-1#1)
of the chromatic##3##3##(2007-12#1)(2008-3#2)
of the chromatographic##6##3##(2008-10#5)(2008-5#1)
of the chromium##5##3##(2008-10#4)(2008-2#1)
of the chromophore in##2##4##(2008-10#1)(2008-8#1)
of the chromophore##6##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-8#1)(2009-9#1)
of the chromophores##2##3##(1996-5#1)(2009-9#1)
of the chromosomal##6##3##(1994-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-3#1)(2012-3#1)
of the chromosome##16##3##(1990-5#1)(1990-8#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-3#1)(2013-8#1)
of the chromosomes##7##3##(1997-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)
of the chronic##9##3##(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)
of the chronically##5##3##(1992-1#1)(1993-11#2)(1997-1#1)(2008-3#1)
of the cibarial armature##2##4##(2008-5#2)
of the cibarial##3##3##(2008-5#3)
of the cicatricial wall##2##4##(2012-1#2)
of the cichlid##2##3##(2008-7#1)(2010-8#1)
of the ciliary##2##3##(1992-8#1)(2011-2#1)
of the cilium##2##3##(2008-7#1)(2013-1#1)
of the circadian##7##3##(1993-12#2)(1993-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
of the circle of Willis##2##5##(1993-12#1)(2008-7#1)
of the circle of##3##4##(1993-12#1)(2008-3#1)(2008-7#1)
of the circle##4##3##(1993-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
of the circuit and##2##4##(2008-11#1)(2010-9#1)
of the circuit##5##3##(2008-11#2)(2008-3#1)(2010-11#1)(2010-9#1)
of the circular##5##3##(1991-9#1)(2008-3#2)(2008-6#2)
of the circularly##2##3##(2007-12#1)(2008-2#1)
of the circulation of the##2##5##(1992-7#1)(2007-10#1)
of the circulation##4##3##(1992-7#1)(1997-7#1)(2007-10#1)(2008-3#1)
of the circulatory system in##2##5##(2007-12#1)(2008-7#1)
of the circulatory system##4##4##(2007-12#1)(2008-7#2)(2013-8#1)
of the circulatory##5##3##(2007-12#1)(2008-10#1)(2008-7#2)(2013-8#1)
of the cis##5##3##(2007-12#2)(2008-9#1)(2010-2#2)
of the cited##2##3##(2008-10#2)
of the cities##2##3##(2008-11#1)(2013-1#1)
of the citrate##2##3##(1992-9#1)(2012-5#1)
of the city of##8##4##(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)
of the city##15##3##(1990-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#2)
of the cladding##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
of the clamping##2##3##(2008-10#1)(2011-2#1)
of the class I##3##4##(1991-2#1)(1995-12#1)(2008-4#1)
of the class of##2##4##(1994-5#1)(2008-9#1)
of the class##12##3##(1991-12#1)(1991-2#1)(1992-6#1)(1994-5#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#2)
of the classic##8##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2010-7#1)
of the classical##16##3##(1991-12#1)(1991-8#1)(1995-12#1)(1996-3#1)(2007-11#2)(2008-10#2)(2008-3#3)(2009-5#1)(2011-1#1)(2012-2#2)(2012-3#1)
of the classification##5##3##(1991-12#1)(1991-9#1)(2007-11#1)(2008-4#1)(2010-6#1)
of the clavicle##4##3##(2007-8#3)(2009-3#1)
of the claw##3##3##(2011-1#1)(2011-2#2)
of the cleavage##3##3##(1992-11#1)(1995-6#2)
of the cleaved##3##3##(1994-8#1)(1997-7#1)(2008-10#1)
of the cleft##3##3##(2007-12#2)(2012-12#1)
of the clientele##2##3##(1991-12#1)(2008-2#1)
of the clinical and pathological##2##5##(1991-12#1)(2011-2#1)
of the clinical and radiological##4##5##(1997-3#1)(2006-7#1)(2008-6#1)(2012-12#1)
of the clinical and##9##4##(1991-12#1)(1997-3#1)(2006-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-12#1)
of the clinical curriculum##3##4##(1992-6#3)
of the clinical features##2##4##(2008-5#1)(2008-7#1)
of the clinical history##2##4##(1992-5#1)(2012-12#1)
of the clinical phenotype and the##2##6##(2007-7#1)(2011-2#1)
of the clinical picture##4##4##(1990-3#1)(1997-6#2)(2007-10#1)
of the clinical presentation##2##4##(2009-4#1)(2009-8#1)
of the clinical records##2##4##(1992-9#1)(1993-11#1)
of the clinical team##2##4##(2008-1#1)(2008-11#1)
of the clinical trial##3##4##(1992-9#1)(2008-7#1)(2013-8#1)
of the clinical trials##2##4##(1996-8#1)(2008-5#1)
of the clinical##77##3##(1990-10#1)(1990-3#3)(1991-12#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-12#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-8#1)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the clinically##3##3##(1997-2#1)(2007-11#1)(2008-5#1)
of the clinician##2##3##(2007-9#1)(2012-1#1)
of the clinician-trainer program##2##4##(2008-11#2)
of the clonal##6##3##(1994-11#1)(2008-10#3)(2008-5#1)(2008-9#1)
of the clone##4##3##(1990-11#3)(1997-2#1)
of the cloned fragments##2##4##(2008-10#2)
of the cloned gene product was##2##6##(1994-3#2)
of the cloned gene product##3##5##(1994-3#3)
of the cloned gene##5##4##(1991-9#1)(1994-3#3)(1995-6#1)
of the cloned human##2##4##(1991-12#1)(1993-11#1)
of the cloned receptor##2##4##(1990-8#1)(1992-3#1)
of the cloned##29##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-3#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#3)(1995-6#1)(1997-4#3)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
of the clones was##2##4##(1996-10#1)(2008-11#1)
of the clones##14##3##(1991-6#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-3#1)(1996-10#2)(1997-2#2)(1997-4#1)(1997-8#1)(2008-11#1)(2008-9#2)
of the close##6##3##(1990-11#1)(1991-6#1)(2007-5#1)(2008-11#1)(2008-3#1)(2013-1#1)
of the closed##4##3##(1992-3#1)(2008-7#2)(2012-12#1)
of the cloud##10##3##(1992-3#1)(2008-10#1)(2008-2#5)(2008-3#3)
of the cluster##5##3##(1990-5#1)(1996-6#1)(2007-12#1)(2008-1#1)(2013-1#1)
of the clustering##2##3##(2008-10#2)
of the clusters##4##3##(1995-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
of the coalition##2##3##(2009-10#1)(2009-11#1)
of the coastal##3##3##(2008-8#1)(2010-4#1)(2010-8#1)
of the coat protein (CP) and##2##6##(2008-10#2)
of the coat protein (CP) gene was##2##7##(2008-10#1)(2008-8#1)
of the coat protein (CP) gene##3##6##(2008-10#2)(2008-8#1)
of the coat protein (CP)##6##5##(2008-10#5)(2008-8#1)
of the coat protein gene##3##5##(1997-2#1)(2008-10#2)
of the coat protein##16##4##(1991-5#3)(1997-2#2)(2008-10#10)(2008-8#1)
of the coat##17##3##(1991-5#3)(1997-2#2)(2008-10#11)(2008-8#1)
of the coated vesicle V-ATPase##2##5##(1995-6#2)
of the coated##7##3##(1995-6#2)(2007-12#1)(2008-10#3)(2010-5#1)
of the coating##7##3##(2008-10#2)(2008-3#2)(2008-5#1)(2009-7#1)(2013-1#1)
of the coatings##3##3##(2008-3#2)(2010-4#1)
of the cobalt complex##2##4##(2008-10#2)
of the cochlea and the cochlear implant##2##7##(2012-2#2)
of the cochlea and the##3##5##(2012-2#3)
of the cochlea and##4##4##(2008-9#1)(2012-2#3)
of the cochlea##6##3##(2008-9#2)(2012-2#4)
of the cochlear implant##2##4##(2008-9#1)(2012-2#1)
of the cochlear##3##3##(2008-9#1)(2012-2#2)
of the coding region for##2##5##(1990-7#2)
of the coding region of the chicken##2##7##(1993-6#2)
of the coding region of the##3##6##(1993-6#2)(2008-4#1)
of the coding region of##6##5##(1993-2#1)(1993-6#2)(1995-12#1)(2008-4#1)(2008-8#1)
of the coding region##9##4##(1990-7#2)(1993-2#1)(1993-6#3)(1995-12#1)(2008-4#1)(2008-8#1)
of the coding regions##2##4##(1991-9#1)(2008-10#1)
of the coding sequences##5##4##(1992-3#1)(1995-8#1)(1996-10#1)(1996-2#2)
of the coding##22##3##(1990-7#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#3)(1994-2#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-2#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-8#1)
of the codon##4##3##(1991-11#1)(1992-11#1)(1994-8#1)(1997-8#1)
of the coefficient##2##3##(2008-10#1)(2008-6#1)
of the coefficients##2##3##(2008-3#1)(2008-6#1)
of the coenzyme##5##3##(1992-6#3)(2008-10#1)(2013-8#1)
of the coevolution##2##3##(2008-8#2)
of the coexistence of##2##4##(2007-11#1)(2008-1#1)
of the cofactor##4##3##(1990-7#1)(1994-5#3)
of the cognate##5##3##(1990-3#1)(1995-8#1)(1996-5#1)(2008-9#2)
of the cognitive and##2##4##(2007-8#1)(2008-9#1)
of the cognitive deficits observed##2##5##(1993-12#1)(1995-11#1)
of the cognitive##8##3##(1991-6#1)(1993-12#1)(1995-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)
of the coherence##4##3##(2008-2#1)(2008-3#3)
of the coherent and##2##4##(2008-10#1)(2008-3#1)
of the coherent##8##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
of the cohort were##3##4##(1993-12#1)(2012-12#2)
of the cohort##6##3##(1993-12#1)(1994-2#1)(1995-8#1)(2012-12#2)(2013-1#1)
of the coiled##3##3##(1992-9#1)(2008-2#1)(2011-2#1)
of the cold##2##3##(2008-11#1)(2011-2#1)
of the colicin E1 channel peptide##2##6##(1995-5#2)
of the collaborative##2##3##(2008-10#1)(2013-1#1)
of the collagen##6##3##(1992-6#2)(2007-8#1)(2008-7#1)(2009-7#1)(2013-1#1)
of the collapse##2##3##(2007-12#1)(2008-12#1)
of the collateral##2##3##(1991-2#1)(1997-3#1)
of the collected data##2##4##(2008-10#1)(2008-11#1)
of the collected##5##3##(1991-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
of the collecting##2##3##(2008-2#1)(2011-2#1)
of the collection##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
of the collector##2##3##(2008-10#2)
of the colon and rectum##2##5##(2011-2#1)(2013-1#1)
of the colon and##3##4##(1990-2#1)(2011-2#1)(2013-1#1)
of the colon in##2##4##(1991-6#1)(2006-8#1)
of the colon is##4##4##(1990-9#1)(1991-5#1)(1993-8#1)(2010-12#1)
of the colon with##2##4##(1990-3#1)(2008-11#1)
of the colon##27##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-5#1)(1991-6#2)(1993-8#2)(1993-9#1)(1994-2#2)(1997-8#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
of the colonic##3##3##(2009-1#1)(2010-8#1)(2011-2#1)
of the colonies##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#2)
of the colonization process##2##4##(2008-10#1)(2008-8#1)
of the colonization##3##3##(2008-10#1)(2008-8#2)
of the colony##5##3##(2008-10#3)(2008-6#1)(2009-5#1)
of the color centers##2##4##(2007-12#1)(2008-3#1)
of the color of the##2##5##(2008-10#2)
of the color##9##3##(2007-12#1)(2008-10#4)(2008-3#3)(2008-5#1)
of the colored##2##3##(2008-10#2)
of the colour##3##3##(1992-11#1)(2008-10#2)
of the coloured complex##2##4##(2008-10#2)
of the coloured##6##3##(2008-10#6)
of the colposcopy directed##2##4##(2008-11#2)
of the column##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
of the columns##4##3##(2008-10#4)
of the comb spectrum##2##4##(2007-12#2)
of the comb##4##3##(2007-12#4)
of the combination of##10##4##(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#2)
of the combination##15##3##(1995-5#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2013-8#2)
of the combined method of##2##5##(2008-10#1)(2013-1#1)
of the combined probe##2##4##(2008-3#2)
of the combined use of##2##5##(1997-7#1)(2008-7#1)
of the combined##16##3##(1992-9#1)(1993-6#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#5)(2008-7#1)(2010-12#1)(2013-1#1)
of the combustion products##2##4##(1996-12#2)
of the combustion##3##3##(1996-12#2)(2008-11#1)
of the comet assay##3##4##(1997-4#3)
of the comet##4##3##(1997-4#3)(1997-5#1)
of the commercial##10##3##(1994-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)
of the commercially available##2##4##(2008-10#2)
of the common bean (Phaseolus vulgaris)##2##6##(2008-10#2)
of the common bean##4##4##(2008-10#4)
of the common bile duct##6##5##(1990-5#2)(1990-6#1)(1990-9#1)(1996-11#1)(2009-9#1)
of the common carotid artery##3##5##(2008-7#2)(2009-12#1)
of the common methods##2##4##(2007-8#1)(2008-4#1)
of the common region##2##4##(2008-10#2)
of the common##51##3##(1990-5#2)(1990-6#1)(1990-9#1)(1991-8#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the commonest##2##3##(2011-1#1)(2012-3#1)
of the commonly used##2##4##(2007-12#1)(2010-11#1)
of the commonly##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2010-11#1)
of the communication##6##3##(2007-11#1)(2008-11#1)(2008-3#3)(2012-3#1)
of the communications##2##3##(2008-9#2)
of the community health##3##4##(1996-2#1)(1997-2#2)
of the community##21##3##(1991-1#1)(1992-1#1)(1993-2#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-6#1)(2011-2#1)(2013-1#2)
of the company's##2##3##(1990-2#1)(1992-3#1)
of the comparison##5##3##(1996-3#1)(2008-10#1)(2008-2#2)(2010-2#1)
of the competition##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
of the competitive inhibitor##2##4##(1992-8#1)(2008-10#1)
of the competitive interaction##2##4##(2008-10#2)
of the competitive##6##3##(1992-8#1)(2008-10#5)
of the complement system##4##4##(1991-2#1)(2007-7#1)(2008-10#1)(2012-3#1)
of the complement##9##3##(1991-2#1)(1993-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
of the complementary target##2##4##(2008-10#2)
of the complementary##9##3##(1990-12#2)(1994-8#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-9#1)
of the complete ITS##2##4##(2008-10#2)
of the complete system##2##4##(2008-3#2)
of the complete##27##3##(1990-8#2)(1991-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-8#2)(1996-8#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-6#2)(2011-1#1)
of the completed##3##3##(1992-3#2)(2012-12#1)
of the complex amplitude of the##2##6##(2007-11#1)(2007-12#1)
of the complex amplitude##4##4##(2007-11#2)(2007-12#2)
of the complex and##2##4##(2010-6#1)(2011-2#1)
of the complex are##5##4##(1995-2#1)(2008-10#3)(2009-10#1)
of the complex biological##2##4##(2008-4#1)(2008-9#1)
of the complex formation##3##4##(1997-2#1)(2008-10#2)
of the complex formed##3##4##(1994-5#1)(2008-10#1)(2009-8#1)
of the complex has been##2##5##(2008-10#2)
of the complex impedance##2##4##(2008-10#1)(2008-7#1)
of the complex in##2##4##(2008-10#2)
of the complex index of refraction and##3##7##(2008-2#2)(2008-3#1)
of the complex index of refraction##5##6##(2008-2#4)(2008-3#1)
of the complex is 1##2##5##(2008-10#2)
of the complex is##9##4##(2007-12#1)(2008-10#8)
of the complex of the##2##5##(1991-2#1)(2008-10#1)
of the complex of##5##4##(1991-2#1)(1993-8#2)(2008-10#1)(2008-11#1)
of the complex refractive index of##2##6##(2008-2#1)(2008-3#1)
of the complex refractive index##8##5##(2008-2#2)(2008-3#6)
of the complex refractive##9##4##(2007-11#1)(2008-2#2)(2008-3#6)
of the complex species##3##4##(2008-10#3)
of the complex was##9##4##(1990-5#2)(1994-11#1)(2007-12#1)(2008-10#5)
of the complex with##4##4##(1992-2#1)(2008-10#2)(2011-1#1)
of the complex##140##3##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-2#2)(1994-5#2)(1995-2#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#8)(2007-7#1)(2008-1#1)(2008-10#53)(2008-11#2)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#2)(2010-6#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#2)
of the complexation reaction##2##4##(2008-10#2)
of the complexation##5##3##(2008-10#5)
of the complexed##2##3##(2008-10#2)
of the complexes and##2##4##(1990-12#1)(2008-10#1)
of the complexes at##2##4##(1993-11#1)(2008-10#1)
of the complexes is##2##4##(1996-2#1)(2008-10#1)
of the complexes of##5##4##(2007-11#1)(2008-10#4)
of the complexes##29##3##(1990-12#1)(1990-2#1)(1991-2#1)(1993-11#1)(1994-5#1)(1996-2#2)(2007-11#1)(2008-10#18)(2008-3#1)(2008-5#1)(2010-7#1)
of the complexing agent was##2##5##(2008-10#2)
of the complexing agent##5##4##(2008-10#5)
of the complexity of the##7##5##(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-12#1)
of the complexity of##11##4##(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2012-12#1)
of the complicated##3##3##(2008-3#1)(2012-3#1)(2013-8#1)
of the complications and##2##4##(1997-3#1)(2008-6#1)
of the complications can be##2##5##(1992-5#1)(2007-11#1)
of the complications of##5##4##(2006-10#1)(2007-7#1)(2008-1#1)(2009-7#1)(2011-2#1)
of the complications##14##3##(1990-6#1)(1992-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#1)
of the component materials##2##4##(2008-3#2)
of the component proteins##3##4##(1992-12#1)(1992-9#1)(2008-7#1)
of the component##17##3##(1991-12#1)(1992-12#1)(1992-9#1)(1993-5#1)(2008-10#4)(2008-3#5)(2008-7#1)(2010-2#1)(2012-1#1)(2013-8#1)
of the components and##3##4##(2008-10#2)(2008-3#1)
of the components is##2##4##(1992-9#1)(2008-10#1)
of the components of the##9##5##(1991-12#1)(1991-2#1)(1996-12#1)(2008-10#4)(2008-3#1)(2009-10#1)
of the components of##16##4##(1991-12#1)(1991-2#1)(1993-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
of the components##34##3##(1990-7#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-1#1)(1995-5#1)(1996-12#1)(1996-2#2)(2007-11#1)(2008-10#15)(2008-11#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)
of the composite materials##2##4##(2008-10#1)(2009-7#1)
of the composite##12##3##(1994-3#1)(2008-10#4)(2008-3#2)(2008-5#1)(2009-6#1)(2009-7#3)
of the composites##3##3##(2008-3#1)(2008-5#1)(2010-4#1)
of the composition of sialoliths##2##5##(2008-10#2)
of the composition of the##6##5##(1994-12#1)(2008-10#5)
of the composition of##12##4##(1994-12#1)(2008-10#10)(2009-7#1)
of the composition##16##3##(1990-5#1)(1994-12#1)(2007-12#1)(2008-10#12)(2009-7#1)
of the compost mix##2##4##(2008-10#2)
of the compost water extract##2##5##(2008-10#2)
of the compost##7##3##(2008-10#6)(2008-12#1)
of the compound in##2##4##(2008-10#2)
of the compound that##2##4##(1990-5#1)(2008-2#1)
of the compound to##2##4##(2008-10#2)
of the compound##23##3##(1990-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-6#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2009-10#1)(2009-6#1)(2011-3#1)
of the compounds and##2##4##(2008-10#1)(2012-12#1)
of the compounds are##2##4##(2008-10#1)(2009-8#1)
of the compounds at##2##4##(2008-10#1)(2011-3#1)
of the compounds most frequently##2##5##(2008-10#2)
of the compounds present##2##4##(2008-10#2)
of the compounds tested##2##4##(1992-11#1)(1993-6#1)
of the compounds was##4##4##(1993-11#1)(1995-2#1)(2008-10#2)
of the compounds were##4##4##(1995-3#1)(2008-10#2)(2008-5#1)
of the compounds##44##3##(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#24)(2008-12#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-3#1)(2012-12#1)
of the compressed pulses##2##4##(2007-12#1)(2008-2#1)
of the compression##3##3##(2007-11#1)(2008-9#1)(2013-8#1)
of the computational##3##3##(1992-9#1)(2008-3#1)(2008-7#1)
of the computed##3##3##(2007-11#1)(2008-3#1)(2009-9#1)
of the computer program##2##4##(2008-10#1)(2008-7#1)
of the computer##8##3##(1991-9#1)(1992-12#1)(2008-10#1)(2008-7#1)(2010-5#2)(2010-8#1)(2013-8#1)
of the concentrate was##2##4##(2008-10#1)(2012-2#1)
of the concentrated##4##3##(2008-10#4)
of the concentration and##2##4##(2008-10#1)(2008-3#1)
of the concentration of the##2##5##(1996-5#1)(2008-10#1)
of the concentration of##32##4##(1996-5#2)(2007-12#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-3#1)(2013-8#1)
of the concentration range##2##4##(2008-10#2)
of the concentration##41##3##(1996-5#2)(2007-12#1)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2010-3#1)(2013-8#1)
of the concentration-response##2##3##(1990-12#1)(2008-10#1)
of the concentrations of##4##4##(1994-11#1)(1996-5#1)(2008-10#2)
of the concentrations##7##3##(1994-11#1)(1996-5#1)(2008-10#4)(2013-7#1)
of the concentrator##2##3##(2008-3#2)
of the concept and##2##4##(1993-2#1)(2009-5#1)
of the concept of##15##4##(1993-1#1)(1993-12#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-6#2)(2013-7#1)
of the concept##23##3##(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2012-3#1)(2013-7#1)
of the concepts##2##3##(2007-12#1)(2008-9#1)
of the conclusions##4##3##(1993-6#1)(1995-11#1)(2008-10#1)(2010-6#1)
of the concomitant##2##3##(2008-10#1)(2011-2#1)
of the concurrent##2##3##(1992-5#1)(1994-11#1)
of the condensation##2##3##(2008-10#1)(2010-12#1)
of the condensed tannin##2##4##(2008-10#2)
of the condition##16##3##(1990-3#1)(1990-9#1)(1992-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
of the conditional##3##3##(1996-4#1)(2008-10#2)
of the conditioned##2##3##(1993-5#1)(1993-9#1)
of the conditions for##2##4##(2008-10#2)
of the conditions of##2##4##(2008-10#1)(2013-1#1)
of the conditions##7##3##(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2013-1#1)
of the conducting airways##2##4##(1991-12#1)(2013-1#1)
of the conducting##4##3##(1991-12#1)(2008-10#1)(2013-1#2)
of the conference##8##3##(1993-12#1)(1994-3#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
of the configuration##7##3##(1996-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)
of the conflict##2##3##(2011-1#1)(2012-12#1)
of the conflicting##2##3##(1995-1#1)(2008-9#1)
of the confocal##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the conformation##2##3##(1992-5#1)(1992-8#1)
of the conformational##4##3##(1992-6#1)(1993-11#1)(1997-6#1)(2009-5#1)
of the conformations of##2##4##(1993-3#1)(2008-8#1)
of the confounding factors##2##4##(2008-7#1)(2011-1#1)
of the congruence##2##3##(2007-8#1)(2010-12#1)
of the conical##2##3##(2007-10#1)(2008-2#1)
of the conically sculpted##2##4##(1995-2#2)
of the conidia##4##3##(2008-10#4)
of the conjugate beam##2##4##(2007-12#1)(2008-2#1)
of the conjugate##7##3##(1994-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
of the conjugated##3##3##(1991-5#1)(1992-3#1)(2008-10#1)
of the connecting peptide##3##4##(2008-9#3)
of the connective tissue##5##4##(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#2)
of the connective##6##3##(1990-2#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#2)
of the connectivity index##2##4##(2007-11#2)
of the consensus values##2##4##(2008-10#2)
of the consensus##10##3##(1993-8#1)(1994-5#1)(1995-2#1)(2007-4#1)(2008-10#5)(2011-2#1)
of the consequences of##4##4##(2008-2#1)(2009-7#1)(2011-2#2)
of the conservative##2##3##(2007-11#1)(2008-8#1)
of the conserved##8##3##(1990-12#1)(1990-5#1)(1996-12#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-6#1)
of the considered##3##3##(1994-3#1)(2008-10#2)
of the constituent##2##3##(2008-10#1)(2012-2#1)
of the constituents##5##3##(2008-10#1)(2008-11#1)(2009-7#2)(2011-3#1)
of the constitutional##2##3##(1996-9#1)(2011-2#1)
of the constitutive law parameters##2##5##(1996-4#2)
of the constitutive##6##3##(1995-11#1)(1996-4#3)(2009-3#1)(2012-1#1)
of the constraining##2##3##(2008-8#1)(2012-1#1)
of the construct##2##3##(2008-10#1)(2013-1#1)
of the construction of##2##4##(2008-10#1)(2008-3#1)
of the construction##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
of the constructs##2##3##(2008-8#1)(2011-2#1)
of the consultant##2##3##(1996-2#1)(2012-3#1)
of the consultation##2##3##(2008-10#1)(2011-2#1)
of the consultations##2##3##(1994-6#1)(1997-6#1)
of the consumer##5##3##(1994-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the consumers##2##3##(2008-8#1)(2010-8#1)
of the consumption of##4##4##(2008-10#1)(2012-12#1)(2012-2#2)
of the consumption##5##3##(2008-10#1)(2012-12#1)(2012-2#2)(2013-1#1)
of the contact surface##2##4##(2008-10#2)
of the contact##9##3##(1993-1#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2013-1#1)
of the contaminant's##2##3##(2008-3#2)
of the contemporary literature##2##4##(2007-12#1)(2011-2#1)
of the contemporary##6##3##(1990-11#1)(1996-1#1)(2007-12#1)(2011-2#3)
of the content of##6##4##(1991-6#1)(2008-10#2)(2008-7#1)(2011-3#1)(2012-2#1)
of the content##7##3##(1991-6#1)(2008-10#2)(2008-7#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the context##2##3##(2008-7#1)(2009-6#1)
of the continent##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
of the continuation of##2##4##(2008-4#1)(2011-2#1)
of the continuous##13##3##(1993-3#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-7#1)
of the continuum##6##3##(1994-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
of the contour##2##3##(2007-11#1)(2008-3#1)
of the contract##4##3##(1993-12#1)(1994-2#1)(1996-12#1)(2007-4#1)
of the contralateral##11##3##(1990-12#1)(1990-9#1)(1993-12#1)(1993-3#2)(1994-2#1)(1996-12#1)(2007-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
of the contrast material##2##4##(2008-7#2)
of the contrast##11##3##(2008-3#3)(2008-6#2)(2008-7#5)(2011-2#1)
of the contribution from##3##4##(1992-5#1)(2008-3#2)
of the contribution of the##2##5##(2008-12#1)(2008-3#1)
of the contribution of##11##4##(1992-5#1)(1993-1#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2011-1#2)
of the contribution##16##3##(1991-12#1)(1992-5#2)(1993-1#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2011-1#2)
of the contributions of##2##4##(1992-11#1)(2008-10#1)
of the contributions##4##3##(1992-11#1)(1997-2#1)(2007-11#1)(2008-10#1)
of the control diet##2##4##(1993-12#1)(2012-2#1)
of the control group (P &lt##2##6##(1994-3#1)(2012-3#1)
of the control group##20##4##(1993-12#1)(1994-3#1)(1994-5#1)(1996-7#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#4)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the control groups in both studies##2##7##(2008-9#2)
of the control groups##13##4##(2008-5#2)(2008-8#1)(2008-9#10)
of the control knees and##2##5##(2008-8#2)
of the control level##2##4##(1994-12#2)
of the control of##2##4##(1994-5#1)(2011-1#1)
of the control rats##3##4##(1991-5#1)(1993-11#1)(1995-12#1)
of the control value##2##4##(1992-6#1)(1992-8#1)
of the control##83##3##(1990-11#1)(1990-7#2)(1991-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#16)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of the controlling##2##3##(2007-11#1)(2008-10#1)
of the controls for##2##4##(2008-10#1)(2008-9#1)
of the controls##20##3##(1990-2#2)(1992-9#1)(1996-11#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-8#4)(2008-9#6)(2011-1#1)(2013-8#1)
of the controversies##2##3##(2008-8#1)(2012-2#1)
of the conus##2##3##(2008-7#1)(2012-2#1)
of the convective##2##3##(2008-3#2)
of the conventional method##4##4##(1990-8#1)(2008-12#2)(2008-8#1)
of the conventional##33##3##(1990-8#2)(1991-6#1)(2007-12#3)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-8#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of the convergence##2##3##(2008-3#1)(2009-3#1)
of the conversion of##5##4##(1995-3#1)(2008-10#1)(2008-8#2)(2010-5#1)
of the conversion##6##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-5#1)
of the convex##2##3##(2008-2#1)(2008-6#1)
of the convolution##4##3##(2008-2#1)(2008-3#3)
of the coordinate##2##3##(2008-10#1)(2010-7#1)
of the coordination complex##2##4##(2008-10#1)(2010-12#1)
of the coordination##4##3##(1997-7#1)(2008-10#1)(2010-12#1)(2011-1#1)
of the copolymer##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
of the copper oxide##2##4##(2008-10#2)
of the copper##5##3##(2008-10#4)(2008-9#1)
of the copper(II)##2##3##(2008-10#2)
of the coracoid##2##3##(2013-1#2)
of the cord##4##3##(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
of the core material##2##4##(2009-8#2)
of the core##16##3##(1991-2#1)(1991-9#1)(1993-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-8#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the core-histone genes##2##4##(1990-5#2)
of the corn##3##3##(1990-7#1)(2008-6#1)(2008-8#1)
of the cornea##11##3##(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2011-7#1)(2013-1#1)
of the corneal##4##3##(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)
of the corneocyte##3##3##(2008-5#3)
of the coronary arteries in##2##5##(2012-3#2)
of the coronary arteries##8##4##(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-3#4)
of the coronary artery##2##4##(2008-12#1)(2013-2#1)
of the coronary syndromes]##2##4##(2008-10#2)
of the coronary##18##3##(1995-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-2#1)
of the corpora cavernosa and##2##5##(2008-10#2)
of the corpora cavernosa##3##4##(2008-10#3)
of the corpus callosum is##2##5##(1996-5#1)(2008-7#1)
of the corpus callosum##9##4##(1996-2#1)(1996-5#2)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#1)
of the corpus spongiosum##2##4##(2009-5#1)(2013-1#1)
of the corpus vertebrae##2##4##(2007-11#2)
of the corpus##15##3##(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#2)(2007-11#2)(2008-6#1)(2008-7#2)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
of the correct##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
of the correction##3##3##(2008-2#2)(2013-8#1)
of the correlation between the##2##5##(2008-10#1)(2008-2#1)
of the correlation between##5##4##(1994-2#1)(1995-9#1)(2008-10#2)(2008-2#1)
of the correlation coefficients##2##4##(2008-10#2)
of the correlation function##4##4##(2008-3#4)
of the correlation time of##3##5##(2008-10#2)(2008-3#1)
of the correlation time##4##4##(2008-10#2)(2008-3#2)
of the correlation##19##3##(1994-2#1)(1995-2#1)(1995-9#1)(2008-10#6)(2008-2#2)(2008-3#8)
of the correlations##3##3##(1997-3#1)(2009-11#1)(2013-8#1)
of the correlator and##2##4##(2008-3#2)
of the correlator##4##3##(2008-3#4)
of the corresponding gene##6##4##(1990-11#1)(1993-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2011-1#1)
of the corresponding genes##5##4##(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#1)(2009-8#1)
of the corresponding proteins##4##4##(1997-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
of the corresponding##74##3##(1990-11#2)(1990-5#2)(1991-12#1)(1991-6#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#5)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)
of the corrugated##2##3##(2008-3#2)
of the cortex##10##3##(1990-12#1)(1990-9#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#3)
of the cortical##8##3##(1994-3#2)(1996-5#1)(2008-5#1)(2008-7#1)(2010-7#3)
of the cortistatin##3##3##(2009-11#3)
of the cos##2##3##(1990-11#1)(1996-2#1)
of the cosmetic##4##3##(2008-5#2)(2010-8#2)
of the cost function##2##4##(2008-2#2)
of the cost of##7##4##(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the cost##13##3##(1995-1#1)(1995-2#1)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
of the costs and##4##4##(1993-12#1)(2008-10#1)(2010-8#1)(2010-9#1)
of the costs##5##3##(1993-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2010-9#1)
of the couch in psychoanalysis##2##5##(2011-2#2)
of the couch##3##3##(2011-2#3)
of the counter ion##2##4##(2008-10#2)
of the counterpart##2##3##(1993-8#1)(1994-11#1)
of the countries##4##3##(1990-12#1)(2007-11#1)(2008-8#1)(2010-5#1)
of the country were##2##4##(2008-12#1)(2012-12#1)
of the country##22##3##(1993-12#1)(1994-6#1)(1996-1#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
of the country]##2##3##(2009-5#1)(2013-1#1)
of the counts##2##3##(1990-2#1)(1996-3#1)
of the couple##2##3##(1993-2#1)(1996-9#1)
of the coupled##8##3##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)
of the coupler##7##3##(2007-12#2)(2008-2#3)(2008-3#2)
of the couples##2##3##(1996-9#2)
of the coupling efficiency##2##4##(2008-2#1)(2008-3#1)
of the coupling products##2##4##(2008-10#1)(2009-11#1)
of the coupling##8##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)
of the course of pregnancy and labor##2##7##(2012-3#2)
of the course of##6##4##(1992-5#1)(1994-5#1)(2007-10#1)(2007-2#1)(2012-3#2)
of the course##19##3##(1992-5#1)(1994-5#1)(2007-10#1)(2007-2#1)(2008-11#8)(2008-12#2)(2012-12#2)(2012-3#2)(2013-8#1)
of the covariance matrix##2##4##(1992-6#1)(1997-3#1)
of the covariance##4##3##(1992-6#1)(1997-3#2)(2008-3#1)
of the covariates##5##3##(1994-2#1)(1997-4#1)(2008-8#1)(2010-8#1)(2011-1#1)
of the cover##2##3##(2008-10#1)(2008-2#1)
of the coverage##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
of the cows##3##3##(1990-6#2)(1991-3#1)
of the cox I and II##2##6##(2008-10#2)
of the coxa##2##3##(2007-12#1)(2008-5#1)
of the crack##2##3##(2009-7#1)(2010-4#1)
of the cranial##6##3##(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#3)
of the craniofacial region##3##4##(1996-6#1)(2007-12#1)(2008-9#1)
of the craniofacial skeleton##4##4##(2010-6#4)
of the craniofacial##8##3##(1996-6#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-6#4)
of the craniosynostoses##2##3##(2007-12#2)
of the cranium##7##3##(1996-9#2)(2008-7#2)(2009-6#1)(2010-6#1)(2013-8#1)
of the cream##2##3##(2008-5#2)
of the creams##2##3##(2008-5#2)
of the creatine transporter##3##4##(2008-5#3)
of the creatine##4##3##(1994-8#1)(2008-5#3)
of the creation of##2##4##(2008-10#1)(2008-11#1)
of the cricopharyngeal muscle##3##4##(1997-2#1)(2011-1#2)
of the cricopharyngeal##4##3##(1997-2#1)(2011-1#3)
of the crisis##3##3##(1993-12#1)(1996-8#1)(2013-1#1)
of the criterion##2##3##(2008-10#1)(2010-2#1)
of the critical steps##3##4##(2008-8#1)(2008-9#1)(2009-4#1)
of the critical##16##3##(1990-3#1)(1992-12#1)(1995-12#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
of the crop##3##3##(2008-10#2)(2008-8#1)
of the cropping##2##3##(2008-10#2)
of the cross##6##3##(1996-9#1)(2008-10#3)(2008-3#2)
of the cross-linked##2##3##(1995-6#1)(2010-4#1)
of the cross-linking reaction##2##4##(1992-3#1)(1994-5#1)
of the cross-linking##3##3##(1992-3#1)(1994-5#1)(2008-5#1)
of the cross-validation##2##3##(2010-3#1)(2011-3#1)
of the crown##4##3##(2008-10#3)(2013-1#1)
of the crude extract of##2##5##(2008-12#1)(2011-1#1)
of the crude extract##3##4##(2008-10#1)(2008-12#1)(2011-1#1)
of the crude##10##3##(1990-2#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2011-1#1)(2013-1#1)
of the crust##2##3##(1996-4#1)(1997-5#1)
of the crustacean##2##3##(1990-2#1)(2007-12#1)
of the cryopreservation##2##3##(1996-8#2)
of the crypts##2##3##(2009-12#1)(2011-2#1)
of the crystal structure of the##2##6##(1990-7#1)(1994-3#1)
of the crystal structure of##3##5##(1990-7#1)(1994-3#1)(2012-2#1)
of the crystal structure##4##4##(1990-7#1)(1994-3#1)(2008-4#1)(2012-2#1)
of the crystal temperature##2##4##(2007-11#1)(2007-12#1)
of the crystal##30##3##(1990-7#1)(1992-8#1)(1994-3#1)(2006-4#1)(2007-11#5)(2007-12#3)(2008-2#9)(2008-3#6)(2008-4#1)(2012-2#1)(2013-1#1)
of the crystalline##7##3##(1993-8#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
of the cube##4##3##(2008-2#1)(2008-3#3)
of the cultivars##7##3##(2008-10#7)
of the cultivated##2##3##(2008-10#1)(2008-12#1)
of the cultivation of##3##4##(2008-11#3)
of the cultivation##4##3##(2008-11#3)(2008-6#1)
of the culturable##2##3##(2008-10#2)
of the cultural##4##3##(2008-1#1)(2008-10#2)(2012-3#1)
of the culture and##2##4##(2008-11#1)(2008-7#1)
of the culture medium##5##4##(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(2008-11#1)
of the culture under no CO(2) supply was##2##8##(2008-11#2)
of the culture under##4##4##(2008-11#4)
of the culture##26##3##(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(2008-11#12)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2010-12#1)(2013-1#1)
of the cultured##2##3##(2008-11#2)
of the cultures##9##3##(1996-5#1)(2008-10#2)(2008-11#6)
of the cumulative##3##3##(2008-10#2)(2008-7#1)
of the current debate##2##4##(1993-12#1)(2008-11#1)
of the current health care##2##5##(1993-12#1)(1997-3#1)
of the current knowledge on the##2##6##(2009-4#1)(2011-7#1)
of the current knowledge on##3##5##(2008-11#1)(2009-4#1)(2011-7#1)
of the current literature##10##4##(1997-8#1)(2007-4#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#1)
of the current management##2##4##(2008-1#1)(2013-8#1)
of the current methods##3##4##(1997-7#1)(2008-10#1)(2008-11#1)
of the current paper##2##4##(1997-3#1)(2010-10#1)
of the current research in##2##5##(2009-5#1)(2010-12#1)
of the current research##4##4##(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)
of the current state of##4##5##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the current status of##2##5##(2008-1#1)(2008-4#1)
of the current study was to##8##6##(2007-12#2)(2009-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of the current study##13##4##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2009-2#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
of the current##110##3##(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#8)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#3)(2009-12#2)(2009-2#2)(2009-4#4)(2009-5#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#8)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
of the currently available##2##4##(2008-11#1)(2012-3#1)
of the currently##10##3##(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
of the curriculum##6##3##(1994-1#2)(1994-12#1)(2008-11#1)(2008-12#1)(2012-12#1)
of the curvature of##2##4##(2007-11#1)(2008-9#1)
of the curvature##3##3##(2007-11#1)(2008-3#1)(2008-9#1)
of the curve##11##3##(1993-1#1)(2007-11#3)(2008-10#2)(2008-7#2)(2010-3#1)(2011-2#2)
of the curves for##3##4##(2008-10#1)(2008-7#2)
of the curves##9##3##(1994-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)
of the cut##2##3##(2008-7#1)(2009-12#1)
of the cutaneous##6##3##(1990-9#1)(1992-6#1)(2008-5#3)(2009-1#1)
of the cuticle of##2##4##(2007-12#1)(2008-10#1)
of the cuticle##10##3##(1993-12#1)(2007-12#3)(2008-10#5)(2008-5#1)
of the cuticular hydrocarbons##2##4##(2008-9#2)
of the cuticular##7##3##(2007-12#4)(2008-5#1)(2008-9#2)
of the cutoff##2##3##(1992-6#2)
of the cuts##3##3##(1996-5#1)(2008-3#2)
of the cw##4##3##(2008-2#2)(2008-3#2)
of the cyanide##2##3##(1993-8#1)(2008-10#1)
of the cycle##5##3##(1990-12#1)(1991-11#1)(1994-9#2)(2008-10#1)
of the cycles##2##3##(1994-7#2)
of the cyclic AMP##3##4##(1990-12#1)(1993-6#1)(1997-2#1)
of the cyclic##6##3##(1990-12#1)(1993-6#1)(1996-12#1)(1997-2#1)(2008-10#2)
of the cyclin##3##3##(1997-4#1)(1997-8#1)(2012-3#1)
of the cyclin-dependent kinase inhibitor##2##5##(2008-11#2)
of the cyclo-oxygenase##2##3##(1995-11#1)(1995-6#1)
of the cyclodextrin##2##3##(2008-10#2)
of the cyclooxygenase##2##3##(1994-5#2)
of the cylinder##7##3##(2007-11#1)(2008-2#1)(2008-3#3)(2009-2#2)
of the cylinder's##3##3##(2008-2#1)(2008-3#2)
of the cylindrical##2##3##(2008-10#1)(2008-3#1)
of the cyst and##2##4##(1991-8#1)(2008-10#1)
of the cyst was##4##4##(1997-8#1)(2007-7#1)(2007-8#1)(2008-7#1)
of the cyst##13##3##(1990-6#1)(1991-8#3)(1997-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)
of the cysteine residues##2##4##(1992-5#1)(1993-9#1)
of the cysteine##5##3##(1992-5#1)(1993-11#1)(1993-9#1)(1997-6#2)
of the cystic duct##5##4##(1992-9#3)(2008-12#2)
of the cystic fibrosis##2##4##(1990-8#1)(2007-6#1)
of the cystic##12##3##(1990-8#1)(1992-9#3)(1993-9#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-3#1)
of the cysts##6##3##(1995-12#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the cytobrush##2##3##(1992-1#2)
of the cytochrome P450 superfamily##2##5##(1995-5#1)(2008-4#1)
of the cytochrome b##3##4##(1995-11#1)(2008-10#1)(2009-9#1)
of the cytochrome c##2##4##(1995-2#1)(1997-3#1)
of the cytochrome oxidase##3##4##(1995-6#2)(2008-11#1)
of the cytochrome##17##3##(1992-3#1)(1993-6#1)(1994-5#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#2)
of the cytokine receptor superfamily##2##5##(1996-2#2)
of the cytokine##4##3##(1994-9#1)(1996-2#3)
of the cytokines on##2##4##(1990-2#1)(1994-6#1)
of the cytokines##3##3##(1990-2#1)(1994-6#1)(2008-11#1)
of the cytological##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
of the cytomegalovirus##3##3##(1995-12#1)(2007-12#1)(2008-11#1)
of the cytoplasm##5##3##(1991-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-7#1)
of the cytoplasmic membrane##2##4##(1990-8#2)
of the cytoplasmic##4##3##(1990-8#2)(1997-7#1)(2008-2#1)
of the cytoskeletal##2##3##(1997-2#1)(2008-11#1)
of the cytoskeleton##2##3##(2008-10#1)(2011-2#1)
of the cytosol fraction##2##4##(1990-11#1)(2008-10#1)
of the cytosol##8##3##(1990-11#1)(1990-5#2)(1995-11#1)(2008-1#2)(2008-10#1)(2009-10#1)
of the cytosolic PKC##2##4##(1997-6#2)
of the cytosolic##8##3##(1990-5#1)(1990-7#1)(1994-11#2)(1994-2#1)(1997-6#2)(2009-12#1)
of the cytostatic genes##2##4##(2008-7#2)
of the cytostatic##3##3##(2008-7#3)
of the cytotoxic##5##3##(1990-12#2)(1993-1#1)(2008-11#1)(2010-12#1)
of the daily dose##2##4##(1992-10#1)(2011-2#1)
of the daily##6##3##(1992-10#1)(1996-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
of the damage and##2##4##(2007-8#1)(2011-1#1)
of the damage was##2##4##(1997-4#1)(2008-5#1)
of the damage##7##3##(1997-4#1)(2007-8#1)(2008-2#1)(2008-5#2)(2009-10#1)(2011-1#1)
of the damaged##2##3##(2007-11#1)(2008-2#1)
of the damages##2##3##(1995-6#1)(2009-8#1)
of the damped##2##3##(2008-10#1)(2009-10#1)
of the dansyl derivative##3##4##(1996-5#2)(2008-10#1)
of the dansyl##6##3##(1994-5#2)(1996-5#2)(2008-10#2)
of the dark##8##3##(1994-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#2)
of the data and##5##4##(1995-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-3#1)
of the data for##2##4##(2008-3#1)(2008-9#1)
of the data from the##2##5##(2008-10#2)
of the data from##6##4##(2008-10#2)(2008-3#3)(2008-7#1)
of the data have been##2##5##(1994-6#1)(2008-10#1)
of the data in##6##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
of the data indicated##2##4##(2008-10#2)
of the data is##7##4##(1990-3#1)(1994-5#1)(1997-4#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-9#1)
of the data of##4##4##(1997-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
of the data on##2##4##(2008-11#1)(2008-3#1)
of the data presented##2##4##(2008-10#1)(2008-5#1)
of the data set##3##4##(1997-6#1)(2008-10#2)
of the data sets at the##2##6##(2008-10#2)
of the data sets using##2##5##(2008-10#2)
of the data sets##5##4##(2008-10#5)
of the data that##2##4##(1995-6#1)(2008-9#1)
of the data to##6##4##(1997-8#1)(2008-10#3)(2008-11#1)(2010-8#1)
of the data was##4##4##(1995-8#1)(2007-10#1)(2008-10#1)(2008-11#1)
of the data with##3##4##(2008-10#1)(2009-5#1)(2009-6#1)
of the data##126##3##(1990-3#1)(1990-8#3)(1991-12#1)(1991-2#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#4)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the database##9##3##(1991-3#1)(1992-12#1)(1994-1#1)(1994-12#1)(1997-3#1)(2008-4#1)(2008-7#1)(2010-5#2)
of the dataset##2##3##(2008-10#1)(2008-7#1)
of the daughter##2##3##(2009-10#1)(2009-2#1)
of the day##10##3##(1991-9#1)(1992-1#1)(1992-3#1)(1995-1#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-6#1)(2011-2#1)
of the days##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
of the de novo##2##4##(1997-3#1)(2008-4#1)
of the de##4##3##(1997-3#1)(2008-10#2)(2008-4#1)
of the dead##2##3##(1991-11#1)(2011-2#1)
of the death machinery##2##4##(2008-8#1)(2009-3#1)
of the death of##3##4##(2007-11#2)(2013-1#1)
of the death##7##3##(1991-12#1)(2007-11#2)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#1)
of the deaths##5##3##(1995-3#1)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
of the debate##2##3##(1997-1#1)(2008-8#1)
of the debris##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
of the decapeptide##2##3##(1992-12#1)(2008-4#1)
of the decay##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
of the decaying tissue##2##4##(2008-10#2)
of the deceased and##2##4##(1995-6#1)(2007-11#1)
of the deceased##4##3##(1995-6#2)(2007-11#1)(2011-2#1)
of the decision##2##3##(2008-10#2)
of the decision-making##2##3##(2011-2#1)(2012-2#1)
of the decomposition of##3##4##(1992-12#1)(2008-10#1)(2008-2#1)
of the decrease in##6##4##(1990-5#1)(1991-3#1)(2006-6#1)(2008-10#2)(2009-7#1)
of the decrease##7##3##(1990-5#1)(1991-3#1)(1995-2#1)(2006-6#1)(2008-10#2)(2009-7#1)
of the decreased##4##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-8#1)
of the decreasing##2##3##(2008-10#1)(2012-3#1)
of the decrypting phase mask##2##5##(2008-3#2)
of the deduced amino acid (aa)##2##6##(1991-6#1)(1994-12#1)
of the deduced amino acid sequence##3##6##(1993-9#1)(1997-2#1)(2008-8#1)
of the deduced amino acid sequences of the##2##8##(2008-10#2)
of the deduced amino acid sequences of##3##7##(1993-2#1)(2008-10#2)
of the deduced amino acid sequences##5##6##(1993-2#1)(2008-10#3)(2008-9#1)
of the deduced amino acid##10##5##(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1997-2#1)(2008-10#3)(2008-8#1)(2008-9#1)
of the deduced##20##3##(1991-6#2)(1991-9#1)(1992-8#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#3)(1997-2#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)
of the deep##2##3##(2008-9#2)
of the defect##16##3##(1991-2#1)(1997-3#1)(2007-11#5)(2007-12#2)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
of the defective##2##3##(1995-9#1)(2008-11#1)
of the defects##3##3##(1990-5#1)(2007-11#2)
of the defense##6##3##(1992-12#1)(1995-6#1)(2008-10#1)(2008-9#3)
of the defensive##2##3##(2007-12#2)
of the deficiency##4##3##(1993-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the deficit##2##3##(1990-3#1)(2008-8#1)
of the defined##2##3##(2008-10#1)(2008-11#1)
of the defining##2##3##(2010-8#1)(2013-1#1)
of the definition and##2##4##(2008-10#1)(2008-2#1)
of the definition of##2##4##(2008-10#1)(2008-7#1)
of the definition##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
of the definitions##2##3##(1991-2#1)(1993-2#1)
of the definitive##2##3##(2007-12#1)(2010-3#1)
of the deformable mirror##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the deformation##5##3##(2008-10#1)(2008-3#2)(2009-6#1)(2009-7#1)
of the deformity##4##3##(2007-12#1)(2007-8#1)(2008-8#1)(2009-3#1)
of the degeneration##2##3##(1992-12#1)(1994-8#1)
of the degenerative##2##3##(2007-11#1)(2011-2#1)
of the degradation products of##2##5##(2008-10#2)
of the degradation products##6##4##(2008-10#6)
of the degradation##9##3##(2008-10#8)(2008-11#1)
of the degree of##26##4##(1991-5#1)(1992-1#1)(1993-2#1)(1995-2#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#2)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the degree to which##3##5##(2008-2#1)(2008-4#1)(2008-7#1)
of the degree##29##3##(1991-5#1)(1992-1#1)(1993-2#1)(1995-2#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the delay between##3##4##(1991-2#1)(2008-12#1)(2008-3#1)
of the delay in##2##4##(1991-9#1)(2007-2#1)
of the delay of##2##4##(2008-10#1)(2012-12#1)
of the delay##10##3##(1990-11#1)(1991-2#1)(1991-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-8#1)
of the delayed##2##3##(1992-6#1)(1995-5#1)
of the deleted##2##3##(1997-3#1)(2008-10#1)
of the deletion##3##3##(1990-7#1)(1994-11#1)(1996-12#1)
of the delivered##3##3##(1997-8#1)(2008-11#1)(2008-3#1)
of the delivery system##2##4##(1995-1#1)(2012-6#1)
of the delta##2##3##(1993-8#1)(1995-3#1)
of the deltoid##3##3##(2010-4#1)(2013-8#2)
of the demand for##3##4##(1995-6#1)(1996-3#1)(2011-2#1)
of the demand##4##3##(1994-1#1)(1995-6#1)(1996-3#1)(2011-2#1)
of the demands##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
of the dementia##3##3##(1996-11#1)(2008-3#1)(2008-7#1)
of the demographic##8##3##(1992-5#2)(1995-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)
of the denatured##3##3##(1990-5#1)(1992-6#1)(2009-9#1)
of the dendritic region##2##4##(2007-12#2)
of the dendritic tree##2##4##(1994-2#2)
of the dendritic##6##3##(1994-2#3)(2007-12#2)(2013-1#1)
of the density of##6##4##(1996-2#1)(2008-10#3)(2008-8#2)
of the density##14##3##(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2013-8#1)
of the density-dependent##2##3##(2008-7#1)(2008-9#1)
of the dental##9##3##(1990-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the dentate gyrus##5##4##(1990-7#1)(1993-12#1)(1994-8#1)(1995-12#2)
of the dentate##6##3##(1990-7#1)(1991-7#1)(1993-12#1)(1994-8#1)(1995-12#2)
of the dentist##3##3##(1990-10#1)(1996-3#1)(2011-1#1)
of the dentition##2##3##(2008-7#1)(2012-3#1)
of the denture##2##3##(2013-1#2)
of the department of##3##4##(1990-10#1)(2008-10#1)(2013-8#1)
of the department##6##3##(1990-10#1)(2008-10#1)(2008-12#3)(2013-8#1)
of the departmental portfolio##2##4##(2008-12#2)
of the departments and municipalities##2##5##(2012-12#2)
of the departments of##2##4##(1997-3#1)(2012-12#1)
of the departments##7##3##(1990-9#1)(1993-10#2)(1997-3#1)(2012-12#3)
of the dependence of the##4##5##(2007-11#2)(2007-12#1)(2008-2#1)
of the dependence of##10##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)
of the dependence on##3##4##(2007-11#1)(2008-3#2)
of the dependence##13##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#2)
of the dependencies##2##3##(1996-5#1)(2008-3#1)
of the depolarization##3##3##(1992-6#1)(2008-3#1)(2008-7#1)
of the deposited##3##3##(2008-10#1)(2008-3#2)
of the deposition##4##3##(1994-12#1)(2008-10#2)(2008-2#1)
of the depressed##2##3##(1996-5#1)(2008-7#1)
of the depth of##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
of the depth##7##3##(2007-12#1)(2008-2#1)(2008-3#4)(2011-2#1)
of the derivative##3##3##(2008-10#2)(2008-3#1)
of the derivatives##10##3##(1990-5#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2011-2#1)
of the derivatized##3##3##(2008-10#2)(2008-7#1)
of the derived##10##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-8#1)
of the dermal##3##3##(1992-12#1)(2011-2#1)(2012-3#1)
of the dermis and##2##4##(2008-5#1)(2008-9#1)
of the dermis##11##3##(2008-5#5)(2008-9#5)(2012-12#1)
of the descending aorta##2##4##(2007-8#2)
of the descending thoracic##3##4##(2008-10#1)(2010-8#2)
of the descending##6##3##(1993-9#1)(2007-8#2)(2008-10#1)(2010-8#2)
of the described system##2##4##(2008-10#1)(2008-8#1)
of the described##7##3##(1990-9#2)(2008-10#2)(2008-8#1)(2008-9#1)(2013-8#1)
of the design and##2##4##(2008-3#1)(2012-3#1)
of the design of##2##4##(2008-2#1)(2008-3#1)
of the design##18##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#9)(2010-10#1)(2011-2#1)(2012-3#2)
of the designed##6##3##(1991-9#1)(2008-10#2)(2008-3#2)(2011-2#1)
of the designs##3##3##(1994-9#1)(2008-3#1)(2009-7#1)
of the desired image##4##4##(2008-2#1)(2008-3#3)
of the desired products##2##4##(2008-4#1)(2009-12#1)
of the desired##18##3##(1992-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-2#1)
of the desquamation process##2##4##(2008-5#2)
of the desquamation##3##3##(2008-5#3)
of the detailed##3##3##(1995-5#1)(2007-12#1)(2008-7#1)
of the detected##10##3##(1994-1#1)(1995-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
of the detection limit of##3##5##(2008-10#3)
of the detection limit##4##4##(2008-10#4)
of the detection limits##2##4##(2008-10#2)
of the detection method##2##4##(1997-4#1)(2008-2#1)
of the detection of##2##4##(1996-3#1)(2008-10#1)
of the detection##17##3##(1995-6#1)(1996-3#1)(1997-4#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-9#1)
of the detector is##2##4##(2008-2#1)(2008-3#1)
of the detector##15##3##(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#6)
of the detectors##2##3##(2008-2#1)(2008-3#1)
of the detergent##3##3##(1990-2#1)(1994-12#1)(1994-9#1)
of the detergents##2##3##(1994-12#2)
of the determinants of##2##4##(1992-2#1)(2008-8#1)
of the determinants##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
of the determination is##2##4##(2008-10#2)
of the determination of##15##4##(1992-5#1)(2008-10#13)(2008-3#1)
of the determination was 1##3##5##(2008-10#3)
of the determination was##9##4##(2008-10#9)
of the determination##30##3##(1992-5#1)(2008-10#27)(2008-3#1)(2008-5#1)
of the determinations##5##3##(2008-10#5)
of the determined##6##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the detuning##2##3##(2007-11#1)(2007-12#1)
of the deutocerebrum##2##3##(2007-12#2)
of the developed formulation##2##4##(2012-2#2)
of the developed method and##2##5##(2008-10#1)(2008-3#1)
of the developed method for##4##5##(2008-10#4)
of the developed method is##2##5##(2008-10#2)
of the developed method was##6##5##(2008-10#6)
of the developed method##28##4##(2008-10#27)(2008-3#1)
of the developed model##3##4##(2007-11#1)(2008-3#1)(2009-3#1)
of the developed procedure##5##4##(2008-10#5)
of the developed system##3##4##(2008-10#1)(2008-3#1)(2010-8#1)
of the developed technique##2##4##(2008-10#2)
of the developed##62##3##(1996-2#1)(2007-11#1)(2008-10#49)(2008-3#4)(2009-3#1)(2010-8#2)(2011-1#1)(2012-2#2)(2012-6#1)
of the developing##16##3##(1994-2#1)(2007-12#3)(2008-10#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
of the development and##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
of the development of a new##3##6##(1995-3#1)(1997-4#1)(2008-5#1)
of the development of a##8##5##(1992-1#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)
of the development of the##6##5##(1990-11#1)(1990-6#1)(1996-12#1)(2008-10#1)(2009-9#1)(2010-5#1)
of the development of this##2##5##(1994-6#1)(2007-8#1)
of the development of##43##4##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
of the development##50##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-12#2)(1996-8#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
of the developmental##9##3##(1993-12#2)(1996-9#1)(1997-2#1)(2007-8#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)
of the developments in##2##4##(2008-10#1)(2008-12#1)
of the deviance##2##3##(1994-9#1)(1996-3#1)
of the device and##3##4##(2008-3#1)(2008-9#1)(2012-3#1)
of the device are##2##4##(2008-2#1)(2008-3#1)
of the device as##2##4##(2008-2#1)(2008-3#1)
of the device in the##3##5##(2007-12#1)(2008-11#1)(2008-2#1)
of the device in##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2010-6#1)
of the device is##7##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
of the device to##4##4##(1994-3#1)(2007-11#1)(2007-8#1)(2008-3#1)
of the device was##2##4##(2008-10#1)(2008-11#1)
of the device were##2##4##(2007-8#1)(2008-3#1)
of the device##59##3##(1994-3#1)(1996-6#1)(2007-11#6)(2007-12#6)(2007-8#4)(2008-10#2)(2008-11#5)(2008-2#7)(2008-3#13)(2008-7#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-6#2)(2010-7#2)(2012-2#1)(2012-3#2)(2013-1#1)
of the devices##5##3##(1993-12#1)(2008-3#2)(2008-9#1)(2010-12#1)
of the diabetes##3##3##(1993-11#1)(2008-1#1)(2008-3#1)
of the diabetic men##2##4##(2008-7#1)(2011-2#1)
of the diabetic##7##3##(1990-3#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#3)
of the diagnoses were##3##4##(2007-12#2)(2012-12#1)
of the diagnoses##5##3##(1997-8#2)(2007-12#2)(2012-12#1)
of the diagnosis and##4##4##(1997-3#1)(2007-11#1)(2011-2#1)(2013-1#1)
of the diagnosis of##5##4##(1990-8#1)(1997-3#1)(2007-11#1)(2010-6#1)(2013-8#1)
of the diagnosis##20##3##(1990-8#1)(1991-12#2)(1996-9#1)(1997-3#2)(2007-11#2)(2007-5#1)(2007-8#1)(2010-6#1)(2011-2#7)(2013-1#1)(2013-8#1)
of the diagnostic criteria##2##4##(2008-7#1)(2011-2#1)
of the diagnostic process and##2##5##(1990-9#1)(2008-10#1)
of the diagnostic##18##3##(1990-9#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-1#2)(1996-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the dialysate##2##3##(2008-1#1)(2008-10#1)
of the dialysis##6##3##(1996-12#1)(2007-7#1)(2008-1#3)(2008-5#1)
of the diameter of the##2##5##(2008-2#1)(2008-3#1)
of the diameter of##4##4##(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
of the diameter##5##3##(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
of the diaphragm is##3##4##(2007-8#1)(2010-5#2)
of the diaphragm##6##3##(1991-3#1)(2007-8#2)(2009-6#1)(2010-5#2)
of the diastolic##3##3##(1996-6#2)(2008-8#1)
of the diazonium##2##3##(2008-10#2)
of the dielectric susceptibility##2##4##(2007-12#2)
of the dielectric##8##3##(1993-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
of the diet of##2##4##(1997-3#1)(2008-5#1)
of the diet##8##3##(1990-6#1)(1990-8#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-7#1)
of the dietitian##3##3##(1993-12#1)(1993-3#1)(1994-2#1)
of the diets##2##3##(1991-12#1)(1993-11#1)
of the difference between the##2##5##(2008-5#1)(2008-7#1)
of the difference between##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
of the difference##9##3##(1990-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)
of the differences between##4##4##(1992-2#1)(1994-8#1)(1997-6#1)(2008-10#1)
of the differences in their##2##5##(1996-5#1)(2008-10#1)
of the differences in##8##4##(1992-12#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#1)
of the differences##16##3##(1992-12#1)(1992-2#1)(1994-8#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
of the different approaches##2##4##(2008-10#2)
of the different classes##4##4##(2008-10#1)(2012-12#3)
of the different humic##2##4##(2008-10#2)
of the different imaging techniques##2##5##(2011-2#1)(2012-2#1)
of the different mechanisms##2##4##(1993-3#1)(2008-8#1)
of the different methods##2##4##(2008-10#1)(2008-2#1)
of the different species##4##4##(1993-11#1)(1994-6#1)(2008-10#2)
of the different types of##2##5##(2008-10#1)(2012-2#1)
of the different##107##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#2)(1995-12#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(2007-10#2)(2007-12#2)(2008-1#5)(2008-10#33)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2009-1#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-9#1)(2013-8#2)
of the differential absorption lidar##2##5##(2008-2#1)(2008-3#1)
of the differential diagnosis##2##4##(1990-5#1)(2011-1#1)
of the differential group delay##3##5##(2007-11#1)(2007-12#2)
of the differential pulse##3##4##(2008-10#3)
of the differential scattering cross section##2##6##(2008-2#1)(2008-3#1)
of the differential##24##3##(1990-5#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-2#3)(2008-3#5)(2008-7#1)(2009-8#1)(2011-1#1)
of the differentially expressed proteins##2##5##(2011-3#2)
of the differentially##3##3##(2008-7#1)(2011-3#2)
of the differentiated##2##3##(1995-3#1)(2008-9#1)
of the differentiation process##4##4##(1992-3#1)(2008-3#3)
of the differentiation##10##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)
of the difficulties##5##3##(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
of the difficulty in##6##4##(1990-12#1)(2008-11#1)(2008-3#1)(2010-3#1)(2013-1#2)
of the difficulty involved in##2##5##(2009-3#1)(2012-2#1)
of the difficulty of##4##4##(1992-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
of the difficulty##13##3##(1990-12#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
of the diffracted light##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the diffracted##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
of the diffraction efficiency of##2##5##(2008-2#1)(2008-3#1)
of the diffraction efficiency##6##4##(2007-12#2)(2008-2#2)(2008-3#2)
of the diffraction limit##2##4##(2008-3#1)(2009-5#1)
of the diffraction pattern##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
of the diffraction##27##3##(1992-4#1)(1992-9#1)(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#13)(2009-5#1)
of the diffraction-limited spot##2##4##(2008-3#2)
of the diffractive optical##2##4##(2008-2#1)(2008-3#1)
of the diffractive##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
of the diffuse attenuation coefficient##2##5##(2008-3#2)
of the diffuse backscattering##2##4##(2008-3#2)
of the diffuse reflectivity of##2##5##(2008-3#2)
of the diffuse##9##3##(2007-12#1)(2008-3#8)
of the diffuse-sunlight##2##3##(2008-3#2)
of the diffuser as##2##4##(2008-2#2)
of the diffuser##3##3##(2007-11#1)(2008-2#2)
of the diffusion abnormality at 48 hours##2##7##(2007-10#2)
of the diffusion abnormality##3##4##(2007-10#3)
of the diffusion approximation in##2##5##(2008-2#1)(2008-3#1)
of the diffusion approximation##6##4##(2008-2#3)(2008-3#3)
of the diffusion coefficient##2##4##(2008-3#1)(2008-5#1)
of the diffusion equation##5##4##(2007-11#2)(2008-2#2)(2008-3#1)
of the diffusion##19##3##(1990-12#1)(2007-10#3)(2007-11#2)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)
of the digestion##4##3##(2008-10#3)(2008-5#1)
of the digestive system##2##4##(2008-5#1)(2009-10#1)
of the digestive tract##8##4##(1990-6#1)(1990-8#2)(1991-6#1)(2008-5#1)(2011-2#3)
of the digestive##12##3##(1990-6#1)(1990-8#2)(1991-6#1)(2007-12#1)(2008-5#2)(2009-10#1)(2011-2#3)(2013-1#1)
of the digital##4##3##(2008-10#1)(2008-2#1)(2008-9#2)
of the dimer##7##3##(1991-7#1)(1995-5#1)(1997-7#1)(2008-10#2)(2008-8#2)
of the dimeric##5##3##(1990-5#1)(1995-5#1)(2008-10#1)(2010-2#2)
of the dimerization equilibrium##2##4##(2008-10#2)
of the dimerization##3##3##(2008-10#3)
of the dimers was##2##4##(2009-9#2)
of the dimorphic##2##3##(2008-5#1)(2013-7#1)
of the dinucleotide##2##3##(1997-6#1)(2008-4#1)
of the diode laser##2##4##(2007-12#1)(2008-10#1)
of the diode##7##3##(2007-12#2)(2008-10#1)(2008-3#4)
of the diode-laser sensor##2##4##(2008-2#1)(2008-3#1)
of the diol##2##3##(1991-5#1)(2008-7#1)
of the dipole particles##2##4##(1992-12#2)
of the dipole##8##3##(1992-12#2)(1992-6#1)(2007-11#2)(2007-12#1)(2008-3#1)(2010-8#1)
of the direct##11##3##(1994-2#1)(2008-10#7)(2008-2#2)(2008-3#1)
of the direct-binary-search algorithm for hologram synthesis##2##7##(2008-3#2)
of the direction of##5##4##(1997-3#1)(2008-3#3)(2008-8#1)
of the direction##9##3##(1992-2#1)(1993-12#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)
of the directly##2##3##(2007-8#1)(2008-10#1)
of the director##2##3##(2008-3#2)
of the disability##2##3##(2008-9#1)(2011-2#1)
of the disaccharide##2##3##(1992-6#1)(1995-11#1)
of the disaster##3##3##(1991-2#1)(2008-2#1)(2013-1#1)
of the disc##9##3##(1994-11#1)(1996-6#1)(2007-11#1)(2007-8#1)(2009-4#4)(2011-2#1)
of the discharge##2##3##(2007-12#1)(2008-3#1)
of the disciplines##2##3##(1991-2#1)(2008-10#1)
of the discolored region##2##4##(1995-11#2)
of the discolored##3##3##(1995-11#3)
of the discomfort##2##3##(1996-9#1)(2008-4#1)
of the discovery and##2##4##(1997-1#1)(2008-6#1)
of the discovery of##2##4##(2009-10#1)(2009-12#1)
of the discovery##5##3##(1995-12#1)(1997-1#1)(2008-6#1)(2009-10#1)(2009-12#1)
of the discrepancy between##2##4##(1990-8#1)(2008-8#1)
of the discrepancy##3##3##(1990-8#1)(2008-2#1)(2008-8#1)
of the discriminations##2##3##(1993-12#2)
of the discussion##4##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the disease and its##4##5##(1991-2#1)(2008-1#1)(2008-5#1)(2012-12#1)
of the disease and the##6##5##(1991-6#1)(2007-8#1)(2008-10#2)(2008-8#1)(2013-7#1)
of the disease and##29##4##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1995-9#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-7#1)
of the disease are##7##4##(1991-9#1)(1993-6#1)(1994-11#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
of the disease as##5##4##(1993-11#1)(2008-11#3)(2008-8#1)
of the disease both##2##4##(2007-7#1)(2008-7#1)
of the disease but##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
of the disease cycle##3##4##(2008-10#3)
of the disease from##4##4##(2008-10#2)(2008-8#1)(2010-4#1)
of the disease gene##3##4##(1993-1#1)(1995-5#1)(1997-8#1)
of the disease has##3##4##(1997-6#1)(2007-12#1)(2008-10#1)
of the disease in 2##2##5##(1991-8#1)(1992-6#1)
of the disease in a##2##5##(2007-7#1)(2008-10#1)
of the disease in the##5##5##(1990-9#1)(1994-9#1)(2008-10#2)(2008-8#1)
of the disease in##27##4##(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-2#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-10#10)(2008-8#1)(2011-2#1)(2012-3#1)
of the disease is##16##4##(1991-11#1)(1991-2#1)(1991-8#1)(1992-5#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-7#3)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
of the disease itself##2##4##(1990-6#1)(2008-10#1)
of the disease may##2##4##(2008-7#1)(2011-2#1)
of the disease or##4##4##(1994-12#1)(2010-5#1)(2010-6#1)(2012-2#1)
of the disease process##4##4##(1995-5#1)(2010-3#1)(2010-8#1)(2012-3#1)
of the disease progress curve##3##5##(2008-10#3)
of the disease regardless##2##4##(1990-11#1)(2008-10#1)
of the disease should##2##4##(2008-10#1)(2013-1#1)
of the disease status of##2##5##(1992-3#1)(2008-10#1)
of the disease through##3##4##(2006-6#1)(2007-12#1)(2008-10#1)
of the disease to##2##4##(2008-10#1)(2011-2#1)
of the disease was##8##4##(1991-8#1)(1992-8#1)(1997-5#1)(2008-10#3)(2011-2#1)(2013-1#1)
of the disease were studied##3##5##(1991-5#1)(2008-5#1)(2008-7#1)
of the disease were##5##4##(1990-10#1)(1991-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
of the disease with##4##4##(1990-2#1)(1997-8#1)(2008-10#1)(2008-7#1)
of the disease##369##3##(1990-10#2)(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#6)(1990-9#2)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#5)(1991-8#4)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-2#2)(1995-4#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-3#3)(1997-5#1)(1997-6#3)(1997-8#6)(2006-6#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#6)(2008-1#7)(2008-10#63)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#27)(2008-8#7)(2008-9#6)(2009-10#2)(2009-5#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#10)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#4)(2011-1#4)(2011-2#26)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#3)
of the diseased##6##3##(1994-11#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the diseases##11##3##(1993-11#1)(1997-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2010-12#1)(2011-1#1)
of the dish##4##3##(2011-2#4)
of the dishes##2##3##(1995-8#1)(2008-11#1)
of the disk##11##3##(1995-11#1)(2008-2#3)(2008-3#6)(2009-3#1)
of the disorder and##4##4##(2008-2#1)(2008-7#2)(2008-9#1)
of the disorder in##2##4##(1997-8#1)(2008-1#1)
of the disorder##24##3##(1995-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#1)
of the disorders##3##3##(1997-5#1)(2008-3#1)(2013-7#1)
of the dispersal##2##3##(2008-10#2)
of the dispersed##2##3##(2007-12#1)(2008-10#1)
of the dispersion##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
of the displaced##2##3##(1991-9#1)(2012-12#1)
of the displacement of##2##4##(2010-7#1)(2013-1#1)
of the displacement##4##3##(2008-3#1)(2008-7#1)(2010-7#1)(2013-1#1)
of the displacements##2##3##(2008-2#2)
of the display##4##3##(2008-3#3)(2013-8#1)
of the dissected##2##3##(2007-8#1)(2008-11#1)
of the dissociation constants of##2##5##(1993-8#1)(2008-10#1)
of the dissociation constants##3##4##(1992-3#1)(1993-8#1)(2008-10#1)
of the dissociation##5##3##(1992-3#1)(1993-8#1)(2008-10#3)
of the dissolution##2##3##(2010-3#1)(2010-5#1)
of the dissolved organic carbon##2##5##(2008-10#2)
of the dissolved##7##3##(2008-10#7)
of the distal end of the##2##6##(1997-6#1)(2007-8#1)
of the distal esophagus##2##4##(2009-3#1)(2013-1#1)
of the distal femoral##2##4##(1993-8#1)(2013-1#1)
of the distal radius##10##4##(2008-9#6)(2009-3#3)(2013-1#1)
of the distal tibia##3##4##(2007-8#2)(2011-2#1)
of the distal##47##3##(1991-12#1)(1993-6#1)(1993-8#1)(1997-6#1)(1997-8#1)(2007-7#2)(2007-8#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-3#4)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
of the distance between the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
of the distance from##2##4##(2008-10#1)(2008-3#1)
of the distance##10##3##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)
of the distinct##2##3##(1997-1#1)(2010-9#1)
of the distinctions between##2##4##(2008-11#1)(2008-12#1)
of the distinctive##2##3##(2008-10#1)(2010-3#1)
of the distribution and##2##4##(2008-10#1)(2008-2#1)
of the distribution function##2##4##(2008-2#1)(2008-3#1)
of the distribution of the##2##5##(2008-10#1)(2008-2#1)
of the distribution of##23##4##(1992-2#1)(1992-6#1)(1995-11#1)(1997-2#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-8#5)(2008-9#2)(2010-10#1)(2012-2#1)
of the distribution ratio##2##4##(2008-10#2)
of the distribution##37##3##(1992-2#1)(1992-6#1)(1995-11#1)(1996-5#1)(1997-2#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#5)(2008-9#2)(2010-10#1)(2012-2#1)(2012-3#1)
of the distributions##3##3##(1996-3#1)(2008-10#1)(2008-2#1)
of the district##3##3##(1993-3#1)(1996-1#1)(1997-6#1)
of the disturbance##2##3##(2008-3#1)(2008-9#1)
of the disturbed##2##3##(1997-4#1)(2012-1#1)
of the disturbing##3##3##(2008-3#3)
of the disulfide bonds##2##4##(1990-5#1)(1993-8#1)
of the disulfide##3##3##(1990-5#1)(1993-8#1)(1997-4#1)
of the disulphide##2##3##(2008-10#2)
of the dither modulation##2##4##(2007-12#2)
of the diuretic amiloride##2##4##(2008-10#1)(2008-4#1)
of the divalent##2##3##(1994-5#1)(2008-10#1)
of the divergence of##2##4##(2008-3#1)(2010-3#1)
of the diverse##3##3##(2008-1#1)(2008-3#1)(2008-7#1)
of the diversity of##5##4##(1990-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
of the diversity##7##3##(1990-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
of the diverticulum##2##3##(1991-6#1)(1992-1#1)
of the dnaA region of the##2##6##(1996-12#2)
of the doctor##3##3##(1992-11#1)(1997-6#1)(2010-12#1)
of the doctor-patient relationship in##2##5##(2011-2#2)
of the doctor-patient##4##3##(1997-6#2)(2011-2#2)
of the doctors##3##3##(1991-6#1)(1995-6#1)(1996-8#1)
of the document##2##3##(2007-9#1)(2011-1#1)
of the documented##2##3##(1992-11#1)(2008-11#1)
of the dog##2##3##(1991-3#1)(1995-11#1)
of the dogs##5##3##(1991-6#1)(1992-5#2)(2012-3#2)
of the domain##4##3##(1996-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
of the domain-inverted##2##3##(2007-12#1)(2008-2#1)
of the domains##6##3##(1994-5#1)(1994-8#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-3#1)
of the dome##2##3##(2008-5#1)(2010-5#1)
of the domestic##3##3##(1997-2#1)(2007-12#1)(2008-12#1)
of the dominant##12##3##(1990-11#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
of the donor##12##3##(1991-7#1)(1993-12#1)(1994-6#1)(1994-9#1)(2007-11#1)(2010-10#1)(2011-2#6)
of the donor's##2##3##(1994-9#1)(2011-2#1)
of the donors##4##3##(1994-9#1)(1997-1#1)(2008-7#1)(2011-2#1)
of the dopamine uptake system##2##5##(1995-11#2)
of the dopamine##7##3##(1994-5#1)(1995-11#3)(1995-2#1)(2008-7#2)
of the dopaminergic antagonist##2##4##(1993-5#1)(1995-5#1)
of the dopaminergic##5##3##(1992-10#1)(1993-5#1)(1994-5#1)(1995-5#1)(2009-6#1)
of the doped##2##3##(2007-11#1)(2009-2#1)
of the dorsal and##2##4##(1991-12#1)(1996-12#1)
of the dorsal horn##9##4##(1990-7#2)(1993-12#1)(1995-12#2)(1996-12#1)(1997-3#3)
of the dorsal nucleus of the lateral lemniscus##2##8##(1997-3#2)
of the dorsal nucleus of##3##5##(1991-7#1)(1997-3#2)
of the dorsal root##2##4##(1996-5#1)(2011-2#1)
of the dorsal##30##3##(1990-7#2)(1991-12#1)(1991-5#1)(1991-7#1)(1993-12#2)(1993-5#1)(1995-12#3)(1996-12#2)(1996-2#1)(1996-5#2)(1997-3#5)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-8#2)
of the dorsalis pedis artery##2##5##(2010-7#2)
of the dorsolateral##2##3##(2007-12#2)
of the dorsoventral axis in the##2##6##(1991-5#1)(2010-4#1)
of the dosage##2##3##(2007-12#1)(2008-11#1)
of the dose##6##3##(1992-10#2)(1995-3#1)(1996-6#1)(2008-7#2)
of the dose-response curve##2##4##(1994-11#1)(1997-1#1)
of the dose-response##5##3##(1994-11#1)(1996-6#1)(1997-1#1)(2008-7#2)
of the double##7##3##(1991-5#1)(1992-6#1)(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)
of the double-edge technique for##2##5##(2008-2#1)(2008-3#1)
of the double-edge technique##4##4##(2008-2#3)(2008-3#1)
of the double-edge##5##3##(2008-2#3)(2008-3#2)
of the double-stranded DNA##2##4##(2010-5#2)
of the double-stranded##3##3##(2008-10#1)(2010-5#2)
of the doubled##2##3##(2007-11#1)(2008-10#1)
of the doubly ligated species##2##5##(1990-8#2)
of the doubly ligated##3##4##(1990-8#2)(1997-2#1)
of the doubly##6##3##(1990-8#2)(1991-3#1)(1997-2#1)(2008-2#1)(2008-3#1)
of the downregulated##2##3##(2008-7#1)(2012-12#1)
of the downstream flanking region of the##2##7##(1991-9#2)
of the downstream##8##3##(1991-9#2)(1992-9#1)(1995-2#1)(1997-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
of the draft##3##3##(2008-9#2)(2010-3#1)
of the drain##2##3##(2011-2#2)
of the drawbacks of##2##4##(2008-7#1)(2012-1#1)
of the drawn##3##3##(2008-3#1)(2009-10#2)
of the dried##2##3##(2008-10#1)(2010-4#1)
of the driving##2##3##(2007-11#1)(2007-12#1)
of the droplet##5##3##(1994-9#1)(2008-10#2)(2008-3#1)(2012-2#1)
of the droplets##2##3##(1996-3#1)(2008-10#1)
of the dropping mercury electrode##2##5##(2008-10#2)
of the drug and##2##4##(1993-6#1)(2008-10#1)
of the drug at##3##4##(1991-10#1)(2008-10#2)
of the drug by##2##4##(2008-7#1)(2010-8#1)
of the drug discovery##2##4##(2008-10#1)(2008-7#1)
of the drug from##2##4##(2008-10#1)(2009-11#1)
of the drug in human serum##2##6##(2008-10#2)
of the drug in human##3##5##(2008-10#3)
of the drug in the##2##5##(1990-11#1)(2008-10#1)
of the drug in##15##4##(1990-11#1)(2008-10#13)(2008-8#1)
of the drug molecule##3##4##(2008-10#2)(2008-7#1)
of the drug on##6##4##(1994-8#1)(1996-3#1)(1997-2#1)(2008-7#1)(2008-8#1)(2012-1#1)
of the drug to##3##4##(1990-3#1)(2008-10#1)(2008-11#1)
of the drug treatment##3##4##(1990-3#1)(2008-5#1)(2011-2#1)
of the drug was##6##4##(1990-6#1)(1991-6#1)(1996-7#1)(2008-1#1)(2008-10#1)(2010-5#1)
of the drug were observed at##2##6##(2008-10#1)(2008-11#1)
of the drug were observed##3##5##(1990-9#1)(2008-10#1)(2008-11#1)
of the drug were##4##4##(1990-9#1)(1997-2#1)(2008-10#1)(2008-11#1)
of the drug with##2##4##(2008-10#2)
of the drug##101##3##(1990-11#3)(1990-2#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-10#1)(1991-3#4)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#4)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)
of the drug-treated L5178Y lymphoma line##2##6##(1992-9#2)
of the drugs for##2##4##(2008-10#1)(2012-12#1)
of the drugs have##2##4##(2010-11#1)(2013-1#1)
of the drugs in urine##2##5##(2008-10#2)
of the drugs in##8##4##(1990-8#1)(2008-10#7)
of the drugs on##3##4##(1995-6#1)(2008-10#2)
of the drugs studied##2##4##(2008-10#2)
of the drugs used##2##4##(1994-11#1)(2011-1#1)
of the drugs##44##3##(1990-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-4#2)(2008-10#20)(2008-7#2)(2008-8#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the dry season##2##4##(2007-2#1)(2008-5#1)
of the dry##4##3##(2007-2#1)(2008-5#2)(2013-7#1)
of the drying process##2##4##(2008-2#1)(2008-7#1)
of the drying##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
of the dsRNA##3##3##(2008-10#3)
of the dsRNAs##2##3##(2008-10#2)
of the dual##5##3##(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
of the duct##2##3##(1991-9#1)(2011-2#1)
of the duct-mucosa pancreaticojejunostomy##3##4##(2008-10#3)
of the duodenum##7##3##(1990-10#3)(1997-3#1)(2008-12#1)(2011-2#1)(2013-1#1)
of the duplex##3##3##(1995-5#1)(2008-10#1)(2012-3#1)
of the dura##4##3##(2008-7#1)(2009-8#2)(2011-2#1)
of the durability of resistance##4##5##(2008-10#4)
of the dural##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
of the duration of the##2##5##(2008-10#1)(2010-8#1)
of the duration of##7##4##(1990-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2011-3#1)
of the dust samples##2##4##(2010-5#2)
of the dwellings##2##3##(1995-6#2)
of the dye are at##2##5##(2008-10#2)
of the dye molecules##3##4##(1991-5#1)(2007-11#1)(2010-4#1)
of the dye were##3##4##(2008-10#2)(2008-3#1)
of the dye##31##3##(1991-5#2)(1992-6#1)(1993-11#1)(1994-12#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-9#2)(2010-4#3)
of the dyes##7##3##(1990-6#1)(2008-10#3)(2008-3#2)(2008-5#1)
of the dying##6##3##(1990-10#1)(1991-12#1)(1991-2#1)(1997-6#1)(2010-10#1)(2010-8#1)
of the dynactin complex##2##4##(1995-2#2)
of the dynamic range of the##2##6##(2007-11#1)(2013-8#1)
of the dynamic range##4##4##(2007-11#1)(2008-3#2)(2013-8#1)
of the dynamic##14##3##(1996-4#1)(2007-11#2)(2008-10#1)(2008-3#4)(2008-9#2)(2009-3#1)(2009-7#1)(2011-1#1)(2013-8#1)
of the dynamics of the##6##5##(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
of the dynamics of##17##4##(1993-5#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#3)(2008-9#1)(2010-3#1)
of the dynamics##20##3##(1993-5#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#3)(2008-9#2)(2010-3#1)(2010-4#1)
of the dysplastic hip##3##4##(2007-11#1)(2007-8#2)
of the dystrophin gene##2##4##(1997-3#2)
of the ear##6##3##(1995-9#1)(2008-1#1)(2008-7#1)(2010-8#3)
of the earlier##2##3##(2008-10#1)(2009-5#1)
of the earliest##5##3##(1997-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
of the early embryonic##2##4##(2007-12#1)(2008-11#1)
of the early phases##2##4##(1991-8#1)(2008-11#1)
of the early stages of biofilm formation##2##7##(2008-9#1)(2013-8#1)
of the early stages of##3##5##(2008-4#1)(2008-9#1)(2013-8#1)
of the early studies##2##4##(2008-11#1)(2008-2#1)
of the early##35##3##(1991-6#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-7#1)(1995-11#1)(1996-2#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the ears##2##3##(1991-3#1)(2008-8#1)
of the earth##2##3##(2008-10#1)(2008-5#1)
of the earthquake##4##3##(1996-4#2)(2013-1#1)(2013-8#1)
of the earthworm##2##3##(2008-5#1)(2008-9#1)
of the ease of##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
of the ease##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
of the east##2##3##(2007-5#1)(2008-10#1)
of the ecological approach##3##4##(2011-1#2)(2013-7#1)
of the ecological##6##3##(2007-10#1)(2008-11#1)(2008-5#1)(2011-1#2)(2013-7#1)
of the ecology of##6##4##(2008-10#4)(2008-8#1)(2008-9#1)
of the ecology##7##3##(2008-10#4)(2008-8#1)(2008-9#2)
of the economic downturn##2##4##(2012-3#2)
of the economic##9##3##(1993-12#1)(1995-11#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#2)(2012-3#2)
of the economically##3##3##(2008-10#1)(2010-3#1)(2013-8#1)
of the economy##2##3##(2008-11#1)(2008-6#1)
of the ecosystem##2##3##(2008-8#1)(2009-4#1)
of the edge image motion##2##5##(2008-3#2)
of the edge image##3##4##(2008-3#3)
of the edge##8##3##(2007-11#1)(2008-2#1)(2008-3#6)
of the edible##2##3##(2008-10#1)(2013-7#1)
of the editing protein##2##4##(1994-8#2)
of the editorials##2##3##(2011-1#2)
of the education and training programme on##2##7##(2008-12#2)
of the education##4##3##(2008-12#3)(2011-2#1)
of the educational##7##3##(1992-1#1)(2008-11#2)(2009-7#1)(2010-9#1)(2011-1#1)(2013-7#1)
of the eel##2##3##(2008-5#2)
of the efe gene##4##4##(2008-10#4)
of the efe##5##3##(2008-10#5)
of the effect of a##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
of the effect of an##2##5##(2008-3#1)(2009-6#1)
of the effect of the##2##5##(2008-2#1)(2008-8#1)
of the effect of##75##4##(1990-11#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
of the effect on##2##4##(2008-3#1)(2008-5#1)
of the effect that##3##4##(2008-3#1)(2013-1#2)
of the effect##91##3##(1990-11#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#11)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
of the effective size of a##2##6##(2007-12#1)(2008-8#1)
of the effective telescope area##2##5##(2008-2#2)
of the effective##17##3##(1991-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#3)(2008-8#1)(2011-2#1)
of the effectiveness of a##7##5##(1994-12#1)(1995-3#1)(2008-7#4)(2012-3#1)
of the effectiveness of different##2##5##(2011-2#1)(2013-1#1)
of the effectiveness of##24##4##(1990-2#1)(1990-6#1)(1994-12#1)(1995-3#1)(1996-1#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#4)(2010-10#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the effectiveness##26##3##(1990-2#1)(1990-6#1)(1994-12#1)(1995-3#1)(1996-1#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#4)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the effector##2##3##(1992-6#1)(2008-10#1)
of the effects of CR on##2##6##(1994-5#1)(2008-11#1)
of the effects of a##3##5##(1997-8#1)(2008-3#2)
of the effects of spectral##2##5##(2007-11#1)(2008-3#1)
of the effects of the##7##5##(1995-12#1)(1996-3#1)(2008-10#2)(2008-3#2)(2011-2#1)
of the effects of these##2##5##(2009-12#2)
of the effects of this##3##5##(2008-3#2)(2013-7#1)
of the effects of two##2##5##(1994-5#1)(2007-11#1)
of the effects of various##2##5##(2008-3#1)(2008-5#1)
of the effects of##103##4##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#3)(1994-9#2)(1995-12#3)(1996-2#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#2)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-7#2)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
of the effects on##2##4##(2008-3#1)(2011-2#1)
of the effects##115##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#3)(1994-9#2)(1995-12#3)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-7#2)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
of the efficacy and##2##4##(1994-8#1)(2008-5#1)
of the efficacy of the##4##5##(1991-12#1)(1997-3#1)(2011-1#1)(2013-7#1)
of the efficacy of##16##4##(1991-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#4)(2011-1#1)(2012-2#1)(2013-7#1)
of the efficacy##21##3##(1991-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#5)(2011-1#1)(2012-2#1)(2013-7#1)
of the efficiency and##2##4##(1997-1#1)(2013-1#1)
of the efficiency of the##2##5##(2007-11#1)(2011-1#1)
of the efficiency of##6##4##(2007-11#1)(2007-12#1)(2008-3#2)(2008-8#1)(2011-1#1)
of the efficiency##11##3##(1997-1#1)(2007-11#1)(2007-12#2)(2008-3#4)(2008-8#1)(2011-1#1)(2013-1#1)
of the effluent##2##3##(2008-10#2)
of the efforts##2##3##(1997-1#1)(2012-3#1)
of the egg##8##3##(1991-5#1)(1993-6#1)(2007-11#1)(2008-11#1)(2008-12#3)(2008-8#1)
of the eggs##6##3##(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2010-8#1)
of the egl1 gene##2##4##(2008-10#2)
of the eigenvalue##2##3##(2008-3#2)
of the eight patients##2##4##(1994-9#1)(2011-2#1)
of the eight##20##3##(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
of the ejaculatory duct##2##4##(2008-7#2)
of the ejaculatory ducts##3##4##(1997-8#3)
of the ejaculatory##5##3##(1997-8#3)(2008-7#2)
of the elastic##6##3##(1992-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)
of the elbow##4##3##(1992-5#1)(2008-8#1)(2008-9#1)(2010-11#1)
of the elderly and##5##4##(1994-6#4)(2013-1#1)
of the elderly in##4##4##(1993-3#1)(1995-5#1)(2007-11#1)(2009-5#1)
of the elderly population of the##2##6##(2008-7#2)
of the elderly population##8##4##(2008-7#4)(2010-10#1)(2011-2#1)(2011-7#1)(2012-2#1)
of the elderly##31##3##(1990-3#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-6#4)(1995-3#1)(1995-5#1)(1996-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-7#5)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the electric field of##2##5##(2007-12#2)
of the electric field strength##2##5##(2008-10#1)(2008-3#1)
of the electric field##14##4##(1990-12#1)(1990-7#1)(1996-12#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#5)
of the electric##15##3##(1990-12#1)(1990-7#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#5)
of the electrical##5##3##(2008-10#1)(2008-2#1)(2009-10#1)(2009-11#1)(2012-12#1)
of the electrically evoked##2##4##(1995-12#2)
of the electrically##6##3##(1990-5#2)(1995-12#2)(2008-3#2)
of the electro-optic##2##3##(2007-12#1)(2008-2#1)
of the electroactive##4##3##(2008-10#4)
of the electrochemical behavior of##2##5##(2008-10#2)
of the electrochemical##7##3##(2008-10#7)
of the electrochemically accumulated ahODN-Cu(I) complex##2##6##(2008-10#2)
of the electrochemically accumulated##3##4##(2008-10#3)
of the electrochemically##5##3##(2008-10#5)
of the electrode and##4##4##(2008-10#3)(2008-9#1)
of the electrode array##5##4##(2008-10#1)(2008-9#3)(2010-2#1)
of the electrode by##2##4##(2008-10#2)
of the electrode can be##2##5##(2008-10#2)
of the electrode can##3##4##(2008-10#3)
of the electrode could be##2##5##(2008-10#1)(2008-7#1)
of the electrode double##2##4##(2008-10#2)
of the electrode prepared##2##4##(2008-10#2)
of the electrode response##3##4##(2008-10#3)
of the electrode surface##4##4##(2008-10#4)
of the electrode was 3##2##5##(2008-10#2)
of the electrode was about##2##5##(2008-10#2)
of the electrode was discussed##2##5##(2008-10#2)
of the electrode was##14##4##(2008-10#14)
of the electrode were##2##4##(2008-10#2)
of the electrode##83##3##(2008-10#71)(2008-2#1)(2008-7#2)(2008-9#8)(2010-2#1)
of the electrodes and##2##4##(2008-10#2)
of the electrodes is##2##4##(2010-7#1)(2011-1#1)
of the electrodes was##3##4##(2008-10#3)
of the electrodes##25##3##(2007-12#1)(2008-10#21)(2009-10#1)(2010-7#1)(2011-1#1)
of the electrolyte##4##3##(2008-10#4)
of the electrolytic##2##3##(2008-10#2)
of the electromagnetic field in##2##5##(2007-12#1)(2008-3#1)
of the electromagnetic field##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
of the electromagnetic fields##2##4##(2008-2#2)
of the electromagnetic spectrum##3##4##(2008-2#2)(2012-12#1)
of the electromagnetic##13##3##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#3)(2012-12#1)
of the electron##8##3##(1990-2#1)(1991-12#1)(1992-3#1)(2006-4#1)(2008-10#1)(2008-3#1)(2009-11#1)(2011-1#1)
of the electron-phonon coupling factor##2##5##(2008-3#2)
of the electron-phonon coupling##3##4##(1990-4#1)(2008-3#2)
of the electronic properties##2##4##(1996-2#1)(2008-10#1)
of the electronic##11##3##(1993-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(2008-10#3)(2008-7#2)(2010-7#1)(2012-2#1)
of the electronics##2##3##(2008-3#1)(2008-5#1)
of the electrons##2##3##(2008-3#1)(2008-7#1)
of the electrons'##2##3##(2007-11#2)
of the electrophoretic##2##3##(1992-6#1)(1997-2#1)
of the electropolymerization##2##3##(2008-10#2)
of the electrostatic##2##3##(2008-4#1)(2009-5#1)
of the element is##2##4##(2008-10#1)(2008-3#1)
of the element##12##3##(1990-3#1)(1995-8#2)(2007-12#1)(2008-10#4)(2008-3#3)(2009-6#1)
of the elemental##3##3##(1993-6#1)(2008-10#1)(2013-7#1)
of the elements and the##2##5##(2008-10#1)(2013-1#1)
of the elements and##3##4##(2008-10#2)(2013-1#1)
of the elements in the##2##5##(2008-10#2)
of the elements in##3##4##(2008-10#3)
of the elements of##4##4##(1996-9#1)(2008-10#1)(2008-2#1)(2008-7#1)
of the elements was##2##4##(2008-10#2)
of the elements were##4##4##(2008-10#4)
of the elements##31##3##(1996-9#1)(2008-10#24)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#2)
of the elevated##4##3##(1992-7#1)(1997-5#1)(2008-4#1)(2011-2#1)
of the elevation of##2##4##(2008-11#1)(2010-11#1)
of the elevation##3##3##(2008-11#1)(2008-3#1)(2010-11#1)
of the eleven##3##3##(1992-11#1)(1992-3#1)(2008-10#1)
of the elimination##2##3##(1994-2#1)(2012-12#1)
of the elite##2##3##(2007-11#1)(2011-2#1)
of the elliptical##3##3##(2007-11#2)(2008-3#1)
of the elongated##2##3##(1997-6#1)(2007-12#1)
of the eluates##2##3##(2008-10#2)
of the eluent##6##3##(2008-10#5)(2008-7#1)
of the eluted metals##2##4##(2008-10#2)
of the embryo##10##3##(1993-12#1)(1994-9#1)(2007-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-12#1)
of the embryonic brain##5##4##(2007-12#5)
of the embryonic hindgut##2##4##(2008-10#2)
of the embryonic##13##3##(1996-5#1)(2007-12#7)(2008-10#3)(2008-5#1)(2012-12#1)
of the emergence##2##3##(2008-10#1)(2008-11#1)
of the emergency department##3##4##(2008-3#2)(2010-12#1)
of the emergency##7##3##(1994-5#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#1)
of the emergent##2##3##(2010-1#1)(2011-2#1)
of the emerging trends in the##2##6##(1997-2#1)(2008-12#1)
of the emerging##8##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-1#2)(2012-2#1)
of the emission of the##2##5##(2007-12#1)(2008-10#1)
of the emission of##5##4##(2007-11#1)(2007-12#2)(2008-10#2)
of the emission spectrum##2##4##(1996-12#1)(2008-2#1)
of the emission wavelength##2##4##(2008-10#1)(2008-2#1)
of the emission##14##3##(1990-5#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)
of the emitted radiation##2##4##(2008-2#2)
of the emitted##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of the emitting##2##3##(1995-6#1)(2012-2#1)
of the empirical literature##2##4##(2007-12#2)
of the empirical##7##3##(1995-11#1)(1996-1#1)(2007-12#2)(2008-2#2)(2010-3#1)
of the employees##2##3##(1996-9#1)(2011-2#1)
of the emulsion##3##3##(2008-10#1)(2008-5#2)
of the emulsions##4##3##(2008-10#1)(2008-5#2)(2008-8#1)
of the enamel##3##3##(1993-11#1)(2012-2#1)(2013-1#1)
of the enantiomer##2##3##(2008-6#1)(2013-1#1)
of the enantiomeric composition of##2##5##(2008-10#2)
of the enantiomeric##4##3##(1995-6#1)(2008-10#3)
of the enantiomers of##2##4##(2008-10#1)(2008-11#1)
of the enantiomers##6##3##(1995-2#1)(2008-10#4)(2008-11#1)
of the encapsulated##3##3##(2008-10#1)(2008-5#2)
of the enclosure or##2##4##(1996-12#1)(2013-8#1)
of the enclosure##3##3##(1996-12#1)(2008-9#1)(2013-8#1)
of the encoded protein##2##4##(1990-12#1)(2008-9#1)
of the encoded proteins##2##4##(1994-12#1)(2008-7#1)
of the encoded##6##3##(1990-12#1)(1992-3#1)(1994-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
of the encoding##3##3##(2008-3#3)
of the encounters##3##3##(1991-6#3)
of the encrypted image##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the end of##4##4##(1992-9#1)(2008-6#1)(2011-1#1)(2012-7#1)
of the end point##2##4##(2008-10#2)
of the end##8##3##(1992-12#1)(1992-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2011-1#1)(2012-7#1)
of the endemic##5##3##(1996-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
of the endocrine##6##3##(1991-7#1)(1996-6#1)(2008-4#1)(2008-7#1)(2010-11#2)
of the endogenous##17##3##(1991-9#1)(1992-9#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the endometrium is##2##4##(2011-2#1)(2012-3#1)
of the endometrium##15##3##(1993-9#1)(1994-9#4)(1995-3#1)(1996-2#2)(2011-1#1)(2011-2#4)(2012-3#2)
of the endonuclease##3##3##(1990-7#1)(1992-12#1)(1995-2#1)
of the endoplasmic reticulum (ER)##2##5##(1994-11#1)(2013-1#1)
of the endoplasmic reticulum##8##4##(1993-8#1)(1994-11#1)(1996-3#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
of the endoscope##2##3##(2008-5#1)(2012-12#1)
of the endosymbiont of the aphid##2##6##(1996-12#2)
of the endosymbiont##3##3##(1996-12#3)
of the endothelial cell##2##4##(1991-2#1)(1993-8#1)
of the endothelial##4##3##(1991-2#1)(1992-9#1)(1993-8#1)(2008-7#1)
of the endothelin##2##3##(1990-2#1)(1993-6#1)
of the endothelium and##2##4##(1995-2#1)(2008-10#1)
of the endothelium##5##3##(1990-12#1)(1992-11#1)(1995-2#1)(2007-8#1)(2008-10#1)
of the endovascular##3##3##(1996-9#1)(2008-7#1)(2008-8#1)
of the energetic##2##3##(2008-3#2)
of the energy from##3##4##(2008-3#3)
of the energy##17##3##(1993-5#1)(1994-2#1)(1997-6#1)(2007-11#2)(2008-3#8)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
of the enhanced##8##3##(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
of the enhancement##6##3##(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
of the enhancer##3##3##(1990-11#1)(1991-11#1)(1995-8#1)
of the enormous##2##3##(2008-9#1)(2010-4#1)
of the enrichment##3##3##(2008-10#3)
of the enteric##2##3##(2008-7#2)
of the enthalpy##2##3##(1990-8#1)(2008-10#1)
of the entire ITS region##2##5##(2008-10#2)
of the entire beam##2##4##(2007-11#1)(2008-3#1)
of the entire genome and##3##5##(1996-6#2)(2011-2#1)
of the entire genome of##2##5##(1996-6#1)(2008-10#1)
of the entire genome##6##4##(1996-6#3)(1996-8#1)(2008-10#1)(2011-2#1)
of the entire group##2##4##(2008-1#1)(2008-10#1)
of the entire sequence##3##4##(1993-8#1)(1995-9#1)(2013-8#1)
of the entire##61##3##(1991-11#2)(1991-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-6#3)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
of the entorhinal cortex##7##4##(1994-3#1)(1994-8#1)(1997-3#1)(2008-11#4)
of the entrapped##3##3##(1990-2#2)(2008-11#1)
of the entry inhibitors##2##4##(2011-2#2)
of the env gene##2##4##(2007-6#2)
of the envelope##2##3##(1995-5#1)(2009-7#1)
of the environment and##2##4##(2008-3#1)(2008-9#1)
of the environment being##2##4##(2008-10#1)(2008-2#1)
of the environment of##2##4##(1992-12#1)(1995-5#1)
of the environment on##2##4##(2007-8#1)(2008-10#1)
of the environment##30##3##(1992-12#1)(1993-12#1)(1994-3#2)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-5#1)
of the environmental##12##3##(1992-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-5#1)
of the enzymatic activities##2##4##(1990-3#1)(1993-12#1)
of the enzymatic activity of##3##5##(1990-5#1)(2008-10#1)(2008-11#1)
of the enzymatic activity##4##4##(1990-5#1)(2008-10#2)(2008-11#1)
of the enzymatic hydrolysis of##2##5##(2008-10#1)(2008-6#1)
of the enzymatic hydrolysis##4##4##(2008-10#3)(2008-6#1)
of the enzymatic##21##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#3)
of the enzymatically##2##3##(1994-6#1)(2008-10#1)
of the enzyme [Schirmer##2##4##(1995-2#1)(1995-5#1)
of the enzyme activity and##2##5##(1991-12#1)(1997-6#1)
of the enzyme activity by##2##5##(1990-5#1)(1992-11#1)
of the enzyme activity expressed##3##5##(1992-6#1)(1993-9#1)(2008-8#1)
of the enzyme activity was##3##5##(2008-10#3)
of the enzyme activity##13##4##(1990-5#1)(1991-12#1)(1992-11#2)(1992-6#1)(1993-9#1)(1997-6#1)(2008-10#5)(2008-8#1)
of the enzyme and the##2##5##(2008-10#2)
of the enzyme and##7##4##(1992-6#1)(1993-11#1)(2008-10#4)(2008-6#1)
of the enzyme are##2##4##(1991-6#1)(2008-7#1)
of the enzyme at##3##4##(1993-8#1)(1994-6#1)(2008-10#1)
of the enzyme by##8##4##(1990-8#1)(1993-11#2)(1993-9#1)(1994-11#1)(1997-8#1)(2008-7#1)(2009-7#1)
of the enzyme electrode##3##4##(2008-10#3)
of the enzyme for##5##4##(1990-5#1)(1990-7#2)(1992-11#1)(1993-3#1)
of the enzyme from##5##4##(1995-8#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)
of the enzyme glucose oxidase##2##5##(2008-10#2)
of the enzyme had##2##4##(1992-6#1)(1995-8#1)
of the enzyme has been##2##5##(2008-10#1)(2008-7#1)
of the enzyme heme oxygenase##2##5##(1994-5#1)(1995-2#1)
of the enzyme in the##5##5##(1990-5#1)(1992-9#1)(2008-10#3)
of the enzyme in##8##4##(1990-11#1)(1990-5#1)(1992-9#1)(1996-2#1)(2008-10#4)
of the enzyme increased##2##4##(1990-5#1)(1990-7#1)
of the enzyme is##5##4##(1991-5#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-8#1)
of the enzyme on##3##4##(1990-7#1)(1995-6#1)(2008-10#1)
of the enzyme reaction product##2##5##(1997-2#1)(2008-10#1)
of the enzyme reaction##6##4##(1990-5#1)(1997-2#1)(1997-6#1)(2008-10#3)
of the enzyme reactor##2##4##(2008-10#1)(2008-6#1)
of the enzyme that##2##4##(1990-5#1)(1992-6#1)
of the enzyme to the##2##5##(1992-12#1)(1995-8#1)
of the enzyme to##5##4##(1990-2#1)(1992-12#1)(1995-8#1)(1997-2#1)(2008-10#1)
of the enzyme tyrosinase##2##4##(1992-3#1)(2008-5#1)
of the enzyme was##7##4##(1991-8#1)(1992-11#1)(1992-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-6#1)
of the enzyme were##2##4##(1992-12#1)(1996-5#1)
of the enzyme which##2##4##(1992-9#1)(2008-11#1)
of the enzyme with##6##4##(1990-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-6#1)(2008-10#1)
of the enzyme##233##3##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#14)(1990-7#7)(1990-8#3)(1990-9#1)(1991-12#4)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#6)(1992-12#5)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#4)(1992-9#3)(1993-11#6)(1993-3#1)(1993-6#5)(1993-8#4)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#4)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#9)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#1)(2008-10#41)(2008-11#4)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the enzyme(s)##2##3##(1990-7#1)(1994-8#1)
of the enzyme-catalyzed reaction##4##4##(2008-10#4)
of the enzyme-catalyzed##5##3##(2008-10#4)(2010-4#1)
of the enzyme-inhibitor adduct##2##4##(1992-6#2)
of the enzyme-inhibitor##3##3##(1992-6#2)(1993-11#1)
of the enzyme-substrate complex##2##4##(1990-8#1)(2008-5#1)
of the enzymes involved in##2##5##(2011-1#1)(2013-1#1)
of the enzymes##14##3##(1990-5#1)(1991-5#3)(1994-11#1)(1996-12#1)(1997-6#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
of the epidemic in##2##4##(1990-12#1)(1995-6#1)
of the epidemic##25##3##(1990-12#2)(1990-6#1)(1993-3#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-10#17)(2012-3#1)
of the epidemics##3##3##(2008-10#3)
of the epidemiological##2##3##(2013-1#2)
of the epidemiologist on the health care management team##2##9##(1994-3#2)
of the epidemiologist##3##3##(1994-3#3)
of the epidemiology and##2##4##(2008-10#1)(2008-4#1)
of the epidemiology of##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
of the epidemiology##8##3##(2008-10#3)(2008-4#1)(2008-8#1)(2009-10#1)(2010-6#1)(2012-12#1)
of the epidermal growth factor receptor##4##6##(1991-11#1)(1993-8#1)(1995-6#1)(2008-7#1)
of the epidermal growth factor##5##5##(1991-11#1)(1993-8#1)(1995-6#1)(2008-7#1)(2011-2#1)
of the epidermal##7##3##(1991-11#1)(1993-8#1)(1995-6#1)(2008-5#1)(2008-7#2)(2011-2#1)
of the epidermis and##3##4##(2008-5#1)(2008-9#2)
of the epidermis##22##3##(1994-5#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-10#3)(2008-4#2)(2008-5#6)(2008-9#5)(2010-6#1)
of the epididymis##5##3##(1992-3#1)(2008-9#2)(2011-1#2)
of the epigenetic##2##3##(2008-8#1)(2009-3#1)
of the epilepsy##3##3##(1997-8#1)(2008-8#1)(2010-8#1)
of the epileptic##2##3##(2008-11#1)(2009-8#1)
of the epiphysis##2##3##(2007-11#1)(2008-8#1)
of the epistatic interactions##2##4##(2008-4#2)
of the epithelial cycle##3##4##(2009-10#2)(2012-2#1)
of the epithelial##9##3##(1992-5#1)(2007-12#1)(2008-8#1)(2009-10#2)(2012-1#2)(2012-2#1)(2013-1#1)
of the epithelium##6##3##(1991-5#1)(1997-1#1)(2008-5#1)(2008-7#1)(2011-2#2)
of the epitopes##2##3##(2006-6#1)(2008-10#1)
of the epoxidation of##2##4##(1990-12#1)(2007-11#1)
of the epoxidation##3##3##(1990-12#1)(1996-5#1)(2007-11#1)
of the epoxy##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
of the equation##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the equations##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
of the equatorial##3##3##(1997-7#2)(2008-3#1)
of the equilibrium constant##2##4##(1997-2#1)(2008-10#1)
of the equilibrium distribution of the##2##6##(2008-10#2)
of the equilibrium##10##3##(1990-7#1)(1997-2#1)(2008-10#6)(2008-9#2)
of the equipment##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-3#1)
of the equivalence point##2##4##(2008-10#2)
of the equivalent##5##3##(1995-12#1)(1995-2#1)(2007-11#1)(2008-3#1)(2012-3#1)
of the error of##2##4##(2008-3#2)
of the error##10##3##(1995-3#1)(2008-10#2)(2008-2#3)(2008-3#3)(2012-2#1)
of the error-reduction##2##3##(2007-11#1)(2008-3#1)
of the errors of##2##4##(2008-10#1)(2008-3#1)
of the errors##8##3##(1992-6#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)
of the erythrocyte sedimentation rate##2##5##(1997-6#1)(2007-7#1)
of the erythrocyte##4##3##(1990-11#1)(1997-6#1)(2007-7#1)(2008-11#1)
of the erythroid##2##3##(1991-5#1)(1994-8#1)
of the eschar showed##2##4##(2013-8#2)
of the eschar##4##3##(2013-8#4)
of the esophageal##2##3##(2013-8#2)
of the esophagus and##3##4##(2007-7#1)(2009-3#1)(2011-2#1)
of the esophagus in##2##4##(2008-5#1)(2011-2#1)
of the esophagus with##2##4##(2008-12#1)(2013-8#1)
of the esophagus##23##3##(1992-6#1)(1992-9#1)(1993-8#2)(2007-7#1)(2008-12#1)(2008-5#4)(2009-3#2)(2011-2#6)(2013-8#5)
of the esophagus]##2##3##(1992-9#1)(1996-3#1)
of the essential amino acid##2##5##(2008-3#1)(2008-5#1)
of the essential amino##3##4##(2008-3#1)(2008-5#1)(2012-2#1)
of the essential oil of the fruits##2##7##(2008-11#1)(2008-12#1)
of the essential oil of the##3##6##(2008-11#2)(2008-12#1)
of the essential oil of##4##5##(2008-11#3)(2008-12#1)
of the essential oil were##2##5##(2007-1#1)(2012-3#1)
of the essential oil##10##4##(2007-1#1)(2008-11#3)(2008-12#2)(2012-3#2)(2013-1#2)
of the essential oils##5##4##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)
of the essential role of##2##5##(1995-12#1)(2013-8#1)
of the essential##27##3##(1994-8#1)(1995-12#1)(1997-3#2)(2007-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#2)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of the established##4##3##(2008-10#1)(2008-5#1)(2010-10#1)(2010-5#1)
of the establishment of##2##4##(1997-7#1)(2009-10#1)
of the establishments##3##3##(1996-1#2)(2008-12#1)
of the estimate of the##2##5##(2007-12#1)(2008-10#1)
of the estimate of##3##4##(1994-2#1)(2007-12#1)(2008-10#1)
of the estimated value##2##4##(2008-10#2)
of the estimated##13##3##(1992-3#1)(1993-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2010-8#1)(2012-12#1)
of the estimates##6##3##(1997-3#1)(2008-8#2)(2010-3#2)(2012-12#1)
of the estimation##2##3##(1997-3#1)(2008-3#1)
of the estimator##2##3##(2010-3#1)(2012-1#1)
of the estrogen receptor##3##4##(1990-5#1)(1994-12#1)(2007-10#1)
of the estrogen##6##3##(1990-5#1)(1991-2#1)(1994-12#1)(1996-5#1)(2007-10#1)(2008-10#1)
of the estrous cycle##3##4##(1992-9#1)(1993-11#2)
of the estrous##4##3##(1992-9#2)(1993-11#2)
of the etalon is##2##4##(2008-3#2)
of the etalon##8##3##(2008-2#3)(2008-3#5)
of the etched##2##3##(2008-10#2)
of the etching##3##3##(2008-10#2)(2008-3#1)
of the ethanol extract of##2##5##(2011-3#1)(2013-7#1)
of the ethanol##5##3##(2008-10#3)(2011-3#1)(2013-7#1)
of the ethical##2##3##(2008-11#1)(2008-9#1)
of the ethics##2##3##(1993-1#1)(2007-3#1)
of the ethnic groups##2##4##(2008-9#1)(2011-2#1)
of the ethnic##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
of the ethyl##2##3##(2008-10#1)(2010-2#1)
of the ethylene##2##3##(2007-12#1)(2008-10#1)
of the etiologic agent##2##4##(2012-3#2)
of the etiologic##3##3##(2008-7#1)(2012-3#2)
of the etiology of the##2##5##(2007-12#1)(2013-1#1)
of the etiology of##6##4##(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2013-1#2)
of the etiopathogenesis of##2##4##(1990-6#1)(1991-2#1)
of the eukaryotic cell##2##4##(1993-9#1)(2008-7#1)
of the eukaryotic nucleus##2##4##(2008-8#2)
of the eukaryotic##11##3##(1990-11#1)(1993-9#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)
of the evacuation##2##3##(1991-2#1)(1996-12#1)
of the evaluated##4##3##(2008-3#1)(2012-12#1)(2013-1#2)
of the evaluation of##4##4##(1996-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
of the evaluation##11##3##(1996-5#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the evanescent field##2##4##(2007-12#1)(2008-2#1)
of the evanescent##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
of the event##5##3##(2007-10#1)(2008-11#1)(2010-2#1)(2010-8#2)
of the event-related##2##3##(2008-11#2)
of the events##4##3##(1996-11#1)(2008-11#1)(2008-4#1)(2009-10#1)
of the everyday##2##3##(1995-6#1)(2009-11#1)
of the evidence in##3##4##(2008-6#2)(2013-1#1)
of the evidence is##3##4##(1992-5#1)(2008-7#1)(2008-8#1)
of the evidence to support this##2##6##(2008-6#1)(2008-8#1)
of the evidence to support##3##5##(2008-11#1)(2008-6#1)(2008-8#1)
of the evidence##23##3##(1992-5#1)(1993-12#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2013-1#1)(2013-8#2)
of the evidence-based##3##3##(2008-12#1)(2013-1#1)(2013-8#1)
of the evolution of the##5##5##(1990-3#1)(2007-12#1)(2008-2#1)(2008-3#2)
of the evolution of##26##4##(1990-3#1)(1991-1#1)(1994-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-5#1)
of the evolution##28##3##(1990-3#1)(1991-1#1)(1994-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-5#1)
of the evolutionary##7##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-7#1)
of the evolved##3##3##(2008-10#2)(2011-1#1)
of the exact##10##3##(1996-3#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)
of the examination##5##3##(1990-3#2)(2007-11#1)(2008-7#1)(2013-8#1)
of the examinations##2##3##(1995-5#1)(1996-9#1)
of the examined##8##3##(1991-2#1)(2008-10#4)(2008-12#1)(2012-12#1)(2013-1#1)
of the example##2##3##(2008-3#1)(2011-1#1)
of the examples##2##3##(1991-12#1)(2007-11#1)
of the excellent##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
of the excess##3##3##(2008-10#2)(2008-11#1)
of the exchange##4##3##(1992-4#1)(1997-7#1)(2008-10#1)(2008-11#1)
of the exchanger##2##3##(2008-10#2)
of the excised specimen##2##4##(2009-5#1)(2011-1#1)
of the excised tumor##2##4##(1990-12#1)(2012-12#1)
of the excised##6##3##(1990-12#1)(1991-5#1)(1995-4#1)(2009-5#1)(2011-1#1)(2012-12#1)
of the excision##3##3##(1995-9#1)(2008-5#1)(2008-7#1)
of the excitation beam##3##4##(2008-3#3)
of the excitation laser##2##4##(2008-3#2)
of the excitation light##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
of the excitation##15##3##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#8)
of the excitatory amino acid##2##5##(2008-7#2)
of the excitatory amino##3##4##(1990-11#1)(2008-7#2)
of the excitatory##5##3##(1990-11#1)(1995-12#1)(1997-2#1)(2008-7#2)
of the excited state##2##4##(2007-12#1)(2009-12#1)
of the excited transitions##2##4##(2008-3#2)
of the excited##9##3##(1992-12#1)(2007-12#2)(2008-10#1)(2008-3#4)(2009-12#1)
of the excited-state absorption##2##4##(2008-3#2)
of the exciting light##2##4##(2007-12#1)(2008-2#1)
of the exciting##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of the excretory##2##3##(2007-12#1)(2008-5#1)
of the executive##3##3##(2007-8#1)(2012-1#1)(2013-8#1)
of the exercise##6##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2013-8#1)
of the exercises##3##3##(2007-11#3)
of the existence and uniqueness of##2##6##(2008-11#1)(2009-10#1)
of the existence and##3##4##(2007-12#1)(2008-11#1)(2009-10#1)
of the existence of a##3##5##(1990-8#1)(2008-10#1)(2013-8#1)
of the existence of##16##4##(1990-8#1)(1995-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#2)
of the existence##20##3##(1990-8#1)(1993-2#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#2)
of the existing literature##3##4##(1993-12#1)(2007-2#1)(2008-2#1)
of the existing methods for##2##5##(2008-5#1)(2008-7#1)
of the existing##21##3##(1992-3#1)(1993-12#1)(1995-1#1)(1996-2#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
of the exit site##3##4##(2007-12#1)(2007-7#2)
of the exit##4##3##(2007-12#1)(2007-7#2)(2008-3#1)
of the exogenous##4##3##(1990-10#1)(2008-11#1)(2008-8#1)(2010-10#1)
of the exon 8##2##4##(1993-8#2)
of the exon##7##3##(1991-5#1)(1992-8#1)(1993-8#3)(1995-6#1)(1997-8#1)
of the exons##2##3##(1992-3#1)(1997-2#1)
of the expanded##3##3##(1991-12#1)(2008-10#1)(2010-9#1)
of the expansion##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
of the expected genetic##2##4##(2008-10#1)(2010-5#1)
of the expected##18##3##(1990-6#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)
of the experience of##3##4##(1995-1#1)(2008-2#1)(2012-3#1)
of the experience##6##3##(1995-1#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-3#1)
of the experiences of##5##4##(1992-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
of the experiment and##2##4##(2008-10#1)(2008-7#1)
of the experiment##37##3##(1992-2#1)(1992-9#2)(1997-4#3)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#3)(2012-1#2)(2013-1#1)(2013-7#2)
of the experimental and calculated##2##5##(2008-3#2)
of the experimental and theoretical##2##5##(2008-2#1)(2008-3#1)
of the experimental and##5##4##(2008-2#1)(2008-3#3)(2011-1#1)
of the experimental conditions##8##4##(2008-10#7)(2008-3#1)
of the experimental data##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
of the experimental design##2##4##(2008-10#1)(2011-1#1)
of the experimental parameters##3##4##(2008-10#2)(2013-8#1)
of the experimental results##5##4##(2007-12#1)(2008-2#2)(2008-5#1)(2008-7#1)
of the experimental setup##2##4##(2008-3#1)(2010-10#1)
of the experimental variables##2##4##(2008-10#2)
of the experimental##62##3##(1993-12#1)(1994-8#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#23)(2008-12#1)(2008-2#6)(2008-3#13)(2008-5#2)(2008-7#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
of the experimentally##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
of the experiments showed that the##2##6##(2007-12#1)(2008-3#1)
of the experiments##13##3##(1991-9#1)(1995-3#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)
of the expert##4##3##(2008-10#2)(2008-4#1)(2010-8#1)
of the experts'##2##3##(1992-9#1)(2013-1#1)
of the explicit##2##3##(2008-8#1)(2011-2#1)
of the exponential phase##3##4##(2008-11#3)
of the exponential##5##3##(1996-1#1)(2008-11#3)(2008-2#1)
of the exposed##7##3##(1995-3#1)(2008-10#1)(2009-1#1)(2011-2#2)(2013-1#2)
of the exposure##9##3##(1991-12#1)(1993-3#1)(2007-12#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-11#1)
of the expressed enzyme##2##4##(1991-5#1)(1993-8#1)
of the expressed protein##4##4##(1995-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
of the expressed##11##3##(1991-5#2)(1993-8#1)(1995-11#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
of the expression cassette##3##4##(1997-4#2)(2008-8#1)
of the expression of lamins A and C is##2##9##(1992-12#2)
of the expression of the##5##5##(1990-7#1)(1992-9#1)(1995-12#1)(2008-11#1)(2008-4#1)
of the expression of these##2##5##(1995-12#1)(2012-1#1)
of the expression of##32##4##(1990-12#1)(1990-7#1)(1990-8#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#3)(2008-10#2)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of the expression plasmids##2##4##(2008-9#2)
of the expression vector##3##4##(1997-8#2)(2008-4#1)
of the expression##48##3##(1990-12#1)(1990-7#1)(1990-8#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#3)(1996-8#1)(1997-4#2)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2010-3#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
of the expressions##2##3##(2008-11#1)(2011-2#1)
of the extended boundary condition method##3##6##(2008-3#3)
of the extended##7##3##(1993-12#1)(1993-6#1)(2008-3#3)(2008-5#1)(2011-1#1)
of the extensor tendons##2##4##(2007-8#2)
of the extensor##3##3##(1997-2#1)(2007-8#2)
of the extent of the##2##5##(1994-9#1)(2010-6#1)
of the extent of##15##4##(1991-12#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-6#1)
of the extent to which##2##5##(1994-12#1)(2010-9#1)
of the extent##18##3##(1991-12#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2010-6#1)(2010-9#1)
of the external auditory##2##4##(1994-2#1)(2008-9#1)
of the external buffer##2##4##(1990-11#2)
of the external carotid artery##6##5##(1997-3#2)(1997-6#4)
of the external carotid##8##4##(1996-9#1)(1997-3#2)(1997-6#4)(2013-1#1)
of the external iliac##2##4##(2011-2#2)
of the external medium##3##4##(2008-3#2)(2008-5#1)
of the external mirror##2##4##(2008-3#2)
of the external##37##3##(1990-11#3)(1990-3#1)(1994-2#1)(1995-5#2)(1996-9#1)(1997-3#2)(1997-6#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#2)(2011-2#2)(2012-12#1)(2013-1#2)
of the extinction spectrum##2##4##(2008-3#1)(2009-12#1)
of the extinction##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)
of the extra##2##3##(2007-8#1)(2008-10#1)
of the extracellular domain of the##2##6##(1990-12#1)(2008-8#1)
of the extracellular domain of##4##5##(1990-12#1)(1992-12#1)(1995-11#1)(2008-8#1)
of the extracellular domain##5##4##(1990-12#1)(1992-12#1)(1995-11#1)(2008-11#1)(2008-8#1)
of the extracellular environment##2##4##(2008-7#2)
of the extracellular matrix##12##4##(1990-5#1)(1993-9#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2013-8#1)
of the extracellular protease##2##4##(2008-10#2)
of the extracellular##33##3##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-11#3)(1996-5#1)(1997-3#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#2)(2010-10#1)(2013-8#1)
of the extracranial##5##3##(1992-5#1)(2008-7#4)
of the extract and##6##4##(2008-10#4)(2008-11#1)(2008-5#1)
of the extract in##2##4##(2008-10#1)(2008-5#1)
of the extract##20##3##(1992-3#1)(1994-11#1)(1994-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#2)(2009-6#1)(2010-3#1)(2010-5#1)
of the extracted complexes##3##4##(2008-10#3)
of the extracted species is##2##5##(2008-10#2)
of the extracted species##6##4##(2008-10#6)
of the extracted##18##3##(2008-10#14)(2008-7#1)(2008-8#1)(2012-1#2)
of the extracting solvent##2##4##(2008-10#2)
of the extracting##4##3##(2008-10#4)
of the extraction and##4##4##(2008-10#3)(2012-1#1)
of the extraction of##3##4##(2008-10#3)
of the extraction procedures##2##4##(2008-10#2)
of the extraction process##4##4##(2008-10#4)
of the extraction vessel##2##4##(2008-10#2)
of the extraction##34##3##(2008-10#33)(2012-1#1)
of the extracts of##2##4##(2008-10#1)(2008-5#1)
of the extracts were##3##4##(1996-5#1)(2008-10#2)
of the extracts##14##3##(1992-8#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-3#2)(2012-1#1)(2013-1#1)
of the extraocular muscles##2##4##(1997-3#1)(2011-1#1)
of the extrapyramidal system##2##4##(2008-7#2)
of the extrapyramidal##3##3##(2008-7#2)(2008-9#1)
of the extremely high##2##4##(2008-3#1)(2009-3#1)
of the extremely##6##3##(2008-10#1)(2008-3#2)(2009-3#1)(2011-2#1)(2011-3#1)
of the extremities or##2##4##(2008-3#1)(2008-6#1)
of the extremities##15##3##(1990-12#1)(1992-6#4)(2008-3#1)(2008-6#4)(2010-3#2)(2012-1#1)(2013-1#2)
of the extremity and superficial trunk##3##6##(1993-9#1)(2008-6#2)
of the extremity##10##3##(1992-6#2)(1993-9#1)(2008-6#3)(2010-3#4)
of the eye and##2##4##(1995-3#1)(2008-4#1)
of the eye is##3##4##(2007-12#2)(2008-11#1)
of the eye##23##3##(1991-5#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#5)(2008-11#2)(2008-4#1)(2008-5#2)(2009-3#1)(2010-1#1)(2011-1#2)(2011-2#2)(2011-7#2)
of the eyeball##2##3##(2008-6#1)(2009-2#1)
of the eyes and##2##4##(1996-12#1)(2007-10#1)
of the eyes##4##3##(1996-12#1)(2007-10#1)(2012-12#1)(2013-8#1)
of the eyespot##5##3##(2008-10#1)(2009-10#1)(2012-2#1)(2012-3#2)
of the fabella##2##3##(2011-2#2)
of the fabricated##11##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2009-11#1)(2013-1#1)
of the fabrication process##2##4##(2008-2#1)(2008-3#1)
of the face and neck##3##5##(1996-11#1)(2010-6#1)(2011-1#1)
of the face and##5##4##(1996-11#1)(2008-5#1)(2010-1#1)(2010-6#1)(2011-1#1)
of the face with##2##4##(2010-1#1)(2012-3#1)
of the face##33##3##(1995-6#1)(1996-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#5)(2009-8#1)(2010-1#6)(2010-6#1)(2011-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#1)
of the facet joint##3##4##(1996-9#1)(2011-2#2)
of the facet joints##3##4##(1996-9#2)(2009-3#1)
of the facet##6##3##(1996-9#3)(2009-3#1)(2011-2#2)
of the facets##2##3##(2008-2#1)(2008-3#1)
of the facial nerve##7##4##(2006-12#1)(2008-12#2)(2008-9#2)(2011-2#1)(2012-3#1)
of the facial skeleton##2##4##(2007-12#2)
of the facial skin##3##4##(2008-5#3)
of the facial##17##3##(1996-5#1)(2006-12#1)(2007-12#3)(2008-12#2)(2008-5#3)(2008-6#2)(2008-9#2)(2011-2#2)(2012-3#1)
of the facilities##2##3##(1995-2#1)(2008-8#1)
of the facility##2##3##(1992-2#1)(1994-3#1)
of the fact that the##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
of the fact that they##2##5##(1994-2#1)(2008-11#1)
of the fact that##24##4##(1991-2#1)(1994-2#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
of the factor is##2##4##(1990-11#1)(1993-6#1)
of the factor##4##3##(1990-11#1)(1993-6#2)(2008-12#1)
of the factor(s)##2##3##(1992-12#2)
of the factors contributing to##2##5##(1991-1#1)(2012-3#1)
of the factors driving the##2##5##(1991-3#1)(2008-8#1)
of the factors responsible for##5##5##(1992-12#1)(1995-12#1)(1997-4#1)(2008-12#1)(2013-8#1)
of the factors that influence the##3##6##(1995-2#1)(2008-10#2)
of the factors that influence##4##5##(1995-2#1)(2008-10#2)(2012-1#1)
of the factors that##9##4##(1995-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2009-8#1)(2012-1#1)(2013-1#2)
of the factors which##2##4##(1992-6#1)(2008-7#1)
of the factors##34##3##(1991-1#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the faculty##3##3##(1992-1#1)(1993-2#1)(2009-10#1)
of the faecal occult blood##2##5##(1993-8#2)
of the failing##2##3##(2011-2#2)
of the failure of##2##4##(1997-3#1)(2008-8#1)
of the failure##3##3##(1997-3#1)(2008-11#1)(2008-8#1)
of the fall##2##3##(2008-10#1)(2013-1#1)
of the fallopian tube##4##4##(1992-1#2)(1992-12#1)(1993-2#1)
of the familial##3##3##(1997-5#1)(2008-7#1)(2010-4#1)
of the families##6##3##(1991-11#1)(1997-2#1)(2007-6#1)(2008-1#1)(2012-3#1)(2013-8#1)
of the family Araceae##2##4##(2008-10#2)
of the family Brachyspiraceae##3##4##(2011-2#3)
of the family Geodermatophilaceae##2##4##(2011-2#2)
of the family Luteoviridae##2##4##(2008-10#2)
of the family Potyviridae and##2##5##(2008-10#2)
of the family Potyviridae##9##4##(2008-10#9)
of the family Synergistaceae##2##4##(2011-2#2)
of the family environment##2##4##(2008-7#1)(2012-3#1)
of the family members##2##4##(1990-10#1)(2008-11#1)
of the family of##4##4##(1990-8#1)(1992-12#1)(1995-3#1)(1996-12#1)
of the family physician##2##4##(1995-11#1)(1997-4#1)
of the family##102##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-8#2)(2008-10#26)(2008-11#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-11#1)(2011-2#31)(2012-12#1)(2012-3#2)(2013-8#1)
of the far-field##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
of the farm##2##3##(1990-9#1)(2007-7#1)
of the fast Fourier transform##2##5##(2008-2#1)(2008-3#1)
of the fast##6##3##(1991-12#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
of the fat pads##2##4##(2008-11#2)
of the fat##5##3##(1997-3#1)(2008-11#2)(2012-2#1)(2013-1#1)
of the fatal##2##3##(2007-12#1)(2011-2#1)
of the father##2##3##(2012-12#1)(2012-3#1)
of the fathers in Group##2##5##(2010-3#2)
of the fathers##3##3##(1994-6#1)(2010-3#2)
of the fatigue##2##3##(2013-8#2)
of the fattening diet on the##2##6##(2010-4#2)
of the fatty acid##5##4##(1990-11#2)(2008-5#1)(2010-12#1)(2010-4#1)
of the fatty acids##2##4##(2008-10#1)(2011-1#1)
of the fatty##7##3##(1990-11#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)
of the fault zone##2##4##(1996-4#2)
of the fault##5##3##(1996-4#5)
of the feasibility of##5##4##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
of the features of##2##4##(2007-11#1)(2012-2#1)
of the features##12##3##(1994-1#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-12#1)(2010-12#1)(2012-2#2)(2013-8#1)
of the fecal##2##3##(2008-10#1)(2012-3#1)
of the federal##3##3##(1991-12#1)(1993-1#1)(2007-12#1)
of the fee schedule##2##4##(1992-1#1)(1994-1#1)
of the fee##3##3##(1992-1#1)(1993-3#1)(1994-1#1)
of the feed##5##3##(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)
of the feedback##7##3##(1994-12#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#2)
of the feeder##2##3##(1993-9#1)(2008-10#1)
of the feeding apparatus##4##4##(2010-8#4)
of the feeding##8##3##(2008-7#3)(2008-9#1)(2010-8#4)
of the feeds##2##3##(2008-10#2)
of the feet##9##3##(1994-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2010-9#1)(2012-3#1)(2013-1#3)
of the female reproductive system##2##5##(2007-12#1)(2007-7#1)
of the female reproductive##3##4##(2007-12#1)(2007-7#1)(2009-12#1)
of the female##29##3##(1990-11#1)(1991-2#1)(1991-6#2)(1992-3#1)(1992-4#2)(1992-6#1)(1994-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-3#1)
of the females##8##3##(1992-6#1)(1993-11#1)(1994-2#1)(1995-3#1)(1997-4#2)(2008-7#1)(2013-8#1)
of the femoral head during pregnancy##2##6##(2009-3#2)
of the femoral head is a##2##6##(2009-3#2)
of the femoral head occurring##2##5##(2007-8#1)(2009-3#1)
of the femoral head##18##4##(1992-6#1)(2007-8#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#9)(2009-4#1)
of the femoral neck in##2##5##(2006-10#1)(2009-3#1)
of the femoral neck##11##4##(2006-10#2)(2007-11#1)(2007-8#4)(2009-3#3)(2013-1#1)
of the femoral nerve##2##4##(1993-12#1)(2009-3#1)
of the femoral##40##3##(1992-3#1)(1992-6#1)(1993-12#1)(1995-6#1)(2006-10#2)(2007-11#1)(2007-8#7)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#13)(2009-4#2)(2013-1#5)
of the femoropatellar joint##3##4##(2007-11#2)(2012-3#1)
of the femtosecond##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of the femur and##3##4##(2007-11#1)(2008-7#1)(2013-1#1)
of the femur##27##3##(1991-11#1)(2007-11#11)(2007-2#1)(2007-8#5)(2008-4#1)(2008-7#1)(2009-3#2)(2009-4#1)(2011-2#1)(2013-1#3)
of the fenestrated##2##3##(2010-12#1)(2013-8#1)
of the fermentation##4##3##(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
of the ferric##2##3##(2008-10#1)(2011-2#1)
of the ferritin##2##3##(1990-5#1)(2008-1#1)
of the fertility##2##3##(2009-10#1)(2009-12#1)
of the fetal hydantoin syndrome##2##5##(1990-5#2)
of the fetal##4##3##(1990-5#2)(1992-6#1)(1994-5#1)
of the fetus and the##2##5##(2007-11#1)(2012-3#1)
of the fetus and##3##4##(2007-11#1)(2010-11#1)(2012-3#1)
of the fetus##12##3##(1993-12#1)(1994-5#1)(1994-7#2)(2007-11#2)(2007-2#1)(2008-2#1)(2010-11#2)(2011-2#1)(2012-3#1)
of the fetuses##3##3##(1991-3#1)(2008-11#1)(2012-3#1)
of the few studies##2##4##(1990-8#1)(2008-11#1)
of the few##12##3##(1990-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-9#1)(2013-7#1)
of the fiber Bragg##2##4##(2007-11#2)
of the fiber and the##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
of the fiber can be##2##5##(2007-11#2)
of the fiber core##6##4##(2007-12#5)(2008-3#1)
of the fiber is##2##4##(2008-3#2)
of the fiber laser##3##4##(2007-11#1)(2008-3#2)
of the fiber to##2##4##(2008-2#2)
of the fiber was##3##4##(1992-1#1)(2008-10#2)
of the fiber##60##3##(1992-1#3)(2007-11#15)(2007-12#12)(2008-10#7)(2008-2#4)(2008-3#18)(2008-6#1)
of the fiber's##4##3##(2007-11#2)(2008-3#2)
of the fiber-optic##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
of the fibers##6##3##(1991-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-3#1)
of the fibre##4##3##(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)
of the fibres##2##3##(1997-4#1)(2008-5#1)
of the fibrillar material##2##4##(1994-5#2)
of the fibrillar##3##3##(1994-5#2)(2010-4#1)
of the fibroblast growth factor-2##2##5##(1997-4#2)
of the fibroblast growth##3##4##(1997-4#3)
of the fibroblast##4##3##(1997-4#3)(2008-11#1)
of the fibronectin##2##3##(1990-7#1)(1993-12#1)
of the fibrous##2##3##(2008-10#1)(2008-11#1)
of the field EPSP##2##4##(1991-12#1)(1996-5#1)
of the field can be##2##5##(2007-11#1)(2008-3#1)
of the field experiment##3##4##(2008-10#3)
of the field in the##2##5##(2008-3#1)(2010-8#1)
of the field is##2##4##(2007-12#1)(2008-12#1)
of the field isolates##2##4##(2008-10#2)
of the field of view##3##5##(2007-11#1)(2008-3#2)
of the field of##10##4##(1991-6#1)(1992-1#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-12#1)
of the field##50##3##(1991-12#1)(1991-6#1)(1992-1#1)(1994-3#2)(1995-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#5)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
of the fields in##3##4##(2008-10#2)(2008-3#1)
of the fields##9##3##(1992-11#1)(2008-1#1)(2008-10#5)(2008-3#2)
of the fifteen beta-agonists##2##4##(2011-1#2)
of the fifth##5##3##(1995-2#1)(1997-8#1)(2008-10#2)(2012-12#1)
of the fight against##2##4##(2009-10#1)(2011-2#1)
of the fight##3##3##(2008-7#1)(2009-10#1)(2011-2#1)
of the filamentous##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
of the film is##3##4##(2008-10#3)
of the film thickness##3##4##(2008-10#3)
of the film##31##3##(2007-11#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2013-1#1)
of the films and##3##4##(2008-10#2)(2008-2#1)
of the films is##3##4##(2008-10#1)(2009-11#2)
of the films was##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
of the films were##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
of the films##25##3##(2007-11#2)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#5)(2009-11#3)
of the filter##16##3##(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#6)
of the filtering##2##3##(2007-11#1)(2008-1#1)
of the filters##3##3##(2008-2#1)(2008-3#2)
of the filtrate##2##3##(1994-5#1)(2008-7#1)
of the final product##5##4##(1994-12#1)(2008-5#1)(2008-7#1)(2012-2#2)
of the final products##2##4##(2008-4#1)(2011-2#1)
of the final protein##2##4##(2008-1#1)(2008-5#1)
of the final##34##3##(1994-12#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
of the finding##2##3##(2010-12#1)(2013-1#1)
of the findings for##3##4##(1993-11#1)(1994-2#1)(1997-1#1)
of the findings on##2##4##(2008-11#1)(2008-12#1)
of the findings was##2##4##(1991-6#1)(1993-6#1)
of the findings with##2##4##(1994-1#1)(1994-3#1)
of the findings##23##3##(1990-11#1)(1990-8#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#2)(2009-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
of the fine##4##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)
of the finger##4##3##(2008-9#3)(2009-2#1)
of the fingers##2##3##(2009-5#1)(2012-2#1)
of the finished##2##3##(2007-11#1)(2008-10#1)
of the finite size of the##4##6##(2008-2#3)(2008-3#1)
of the finite##6##3##(2008-2#4)(2008-3#2)
of the fire ant Solenopsis saevissima##2##6##(2007-12#2)
of the fire##7##3##(1996-12#5)(2007-12#2)
of the firm##2##3##(1993-3#1)(1997-1#1)
of the first (ED50##2##4##(1995-12#2)
of the first 12##2##4##(1990-2#1)(1990-7#1)
of the first and second##8##5##(1990-8#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)
of the first and##10##4##(1990-8#1)(1996-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)
of the first base##2##4##(1992-11#1)(2008-10#1)
of the first case and is a##2##7##(2007-10#2)
of the first case##3##4##(2007-10#2)(2010-4#1)
of the first five##2##4##(1990-3#1)(1993-3#1)
of the first international classifications of mental health and developmental disorders of infancy and early##2##15##(2013-8#2)
of the first layer##4##4##(2008-12#1)(2008-2#3)
of the first line##3##4##(2007-8#1)(2008-2#1)(2013-8#1)
of the first metacarpal##2##4##(2008-9#2)
of the first metatarsal##3##4##(2008-12#3)
of the first method##2##4##(2008-3#1)(2008-8#1)
of the first or##2##4##(1990-8#1)(2008-7#1)
of the first part of##2##5##(2010-12#1)(2013-8#1)
of the first permanent##2##4##(2013-1#2)
of the first round of##2##5##(1995-12#1)(2007-11#1)
of the first semester in##2##5##(2008-10#1)(2012-3#1)
of the first semester##4##4##(2007-10#1)(2008-10#1)(2012-3#2)
of the first stage##2##4##(2008-10#1)(2013-8#1)
of the first symptomatic fruit##2##5##(2008-10#2)
of the first three##4##4##(1990-5#1)(1992-4#1)(2008-3#2)
of the first two##12##4##(1997-3#1)(2006-10#1)(2008-10#2)(2008-12#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
of the first year of##2##5##(1995-1#1)(2008-12#1)
of the first year##6##4##(1991-6#1)(1995-1#1)(1996-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
of the first##205##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-12#3)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#23)(2008-11#4)(2008-12#9)(2008-2#9)(2008-3#12)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#7)(2009-10#2)(2009-2#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#9)(2011-8#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#6)
of the first- and the second-order##2##6##(2008-2#1)(2008-3#1)
of the first-derivative##2##3##(2008-10#2)
of the first-order##6##3##(2008-2#3)(2008-3#3)
of the first-round##2##3##(1997-4#1)(2008-10#1)
of the fish community##2##4##(2011-2#1)(2013-7#1)
of the fish##6##3##(1992-8#1)(1997-4#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
of the fishery##2##3##(2007-5#2)
of the fishes##2##3##(2008-7#1)(2008-8#1)
of the fistula##11##3##(1993-5#1)(1995-11#1)(1996-12#1)(1996-9#2)(1997-3#2)(2008-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
of the fistulas##3##3##(1993-2#1)(1995-11#1)(2008-7#1)
of the fit and##2##4##(2008-6#1)(2013-8#1)
of the fit parameters##2##4##(2008-3#2)
of the fit##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-8#1)
of the fitness##4##3##(2008-10#1)(2008-9#2)(2013-1#1)
of the five Taiwan##3##4##(2008-10#3)
of the five isolates##2##4##(2008-10#2)
of the five##37##3##(1990-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-3#1)(2011-2#1)
of the fixation##3##3##(2007-11#2)(2008-10#1)
of the fixed polarizer##2##4##(2008-3#2)
of the fixed##4##3##(2008-10#1)(2008-3#2)(2008-7#1)
of the fixing##2##3##(2007-11#1)(2008-3#1)
of the flagella##2##3##(2007-12#1)(2008-10#1)
of the flagellum##3##3##(2008-7#3)
of the flame##4##3##(2008-10#4)
of the flanking##2##3##(2008-10#1)(2008-9#1)
of the flap##6##3##(1991-5#2)(2007-12#1)(2007-5#1)(2008-4#1)(2008-9#1)
of the flaps and##2##4##(1990-6#1)(2008-4#1)
of the flaps##3##3##(1990-6#1)(2008-4#1)(2009-5#1)
of the flat-field##2##3##(2008-3#2)
of the flathead mullet Mugil cephalus##2##6##(2010-8#2)
of the flavin##3##3##(1992-1#2)(1995-5#1)
of the flavonoid##2##3##(2008-10#1)(2009-10#1)
of the flavonoids##2##3##(2007-11#1)(2008-11#1)
of the fleece##2##3##(1997-5#2)
of the flexor digitorum superficialis##3##5##(2008-9#2)(2012-2#1)
of the flexor##7##3##(2007-8#1)(2008-9#3)(2009-5#1)(2010-7#1)(2012-2#1)
of the flight##4##3##(2008-2#2)(2008-3#2)
of the floristic##2##3##(2008-8#1)(2013-7#1)
of the flotation##2##3##(2008-10#2)
of the flow cell##5##4##(2008-10#5)
of the flow channel##2##4##(2008-3#1)(2013-1#1)
of the flow cytometric##2##4##(1990-12#1)(2008-9#1)
of the flow injection##5##4##(2008-10#5)
of the flow rates##2##4##(2008-10#2)
of the flow system##4##4##(2008-10#4)
of the flow velocity##2##4##(2008-3#2)
of the flow##34##3##(1990-12#1)(2007-11#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-9#2)(2013-1#1)(2013-8#1)
of the flow-injection##2##3##(2008-10#2)
of the flowers of P##2##5##(2012-3#2)
of the flowers of##3##4##(2012-3#3)
of the flowers##5##3##(2008-12#1)(2008-5#1)(2012-3#3)
of the flowing##3##3##(2008-10#2)(2011-2#1)
of the fluctuation method##2##4##(2010-9#2)
of the fluctuations in##2##4##(2008-2#1)(2008-9#1)
of the fluctuations##4##3##(1996-4#1)(2008-2#1)(2008-3#1)(2008-9#1)
of the fluid##3##3##(1990-8#1)(1991-8#1)(2008-3#1)
of the fluorescence at##2##4##(2007-12#1)(2008-3#1)
of the fluorescence emission##3##4##(2008-10#1)(2008-3#2)
of the fluorescence intensity of the##3##6##(1990-12#1)(2008-10#2)
of the fluorescence intensity of##5##5##(1990-12#1)(2008-10#4)
of the fluorescence intensity##9##4##(1990-12#1)(2008-10#5)(2008-3#2)(2008-4#1)
of the fluorescence lifetime##3##4##(2008-2#1)(2008-3#2)
of the fluorescence of the##2##5##(2008-10#2)
of the fluorescence of##6##4##(1990-5#1)(2008-10#4)(2008-3#1)
of the fluorescence quantum yield##2##5##(2008-3#2)
of the fluorescence resonance energy##2##5##(2008-10#1)(2008-9#1)
of the fluorescence signal##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the fluorescence signals##2##4##(2008-10#1)(2008-2#1)
of the fluorescence##53##3##(1990-12#1)(1990-5#1)(1994-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#6)(2008-3#14)(2008-4#2)(2008-7#2)(2008-9#1)
of the fluorescent dye##2##4##(1991-11#1)(1992-6#1)
of the fluorescent phospholipid##2##4##(1993-11#1)(1994-5#1)
of the fluorescent probe##3##4##(1990-7#1)(1992-6#1)(2008-10#1)
of the fluorescent pseudomonad community##2##5##(2008-10#2)
of the fluorescent pseudomonad##3##4##(2008-10#3)
of the fluorescent signal##2##4##(2008-11#1)(2008-2#1)
of the fluorescent##22##3##(1990-7#1)(1991-11#1)(1992-6#2)(1993-11#1)(1994-5#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)
of the fluorescing##2##3##(1995-2#1)(2008-10#1)
of the fluoride##2##3##(2008-10#2)
of the fluorophore##2##3##(1997-2#1)(2008-2#1)
of the fluorophores##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
of the fly ash##4##4##(2008-10#4)
of the fly##6##3##(2008-10#4)(2008-11#1)(2008-6#1)
of the focal plane##2##4##(2008-3#2)
of the focal point##4##4##(2007-12#2)(2008-3#2)
of the focal spot##2##4##(2008-3#1)(2011-1#1)
of the focal##14##3##(2007-12#2)(2008-2#2)(2008-3#6)(2008-8#2)(2010-12#1)(2011-1#1)
of the focus on##2##4##(1993-11#1)(2010-8#1)
of the focus##9##3##(1991-12#2)(1993-11#1)(2008-10#3)(2010-8#1)(2012-3#2)
of the focused##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the focusing lens##2##4##(2008-3#2)
of the focusing##3##3##(2007-11#1)(2008-3#2)
of the foetal##2##3##(1995-8#1)(2008-7#1)
of the foetus after##2##4##(1992-4#1)(1996-11#1)
of the foetus##10##3##(1991-9#2)(1992-4#3)(1993-6#1)(1996-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
of the folate##3##3##(1993-12#1)(1994-6#1)(1995-2#1)
of the fold##2##3##(2009-9#2)
of the folded##6##3##(1990-5#1)(1991-6#1)(2008-2#1)(2009-7#1)(2009-9#1)(2013-1#1)
of the folding##3##3##(1992-3#2)(1995-5#1)
of the follicle cells##3##4##(2008-6#3)
of the follicle##7##3##(1990-8#1)(2008-12#1)(2008-5#1)(2008-6#3)(2011-2#1)
of the follicular##3##3##(2008-12#2)(2012-3#1)
of the follow-up period##5##4##(2008-3#1)(2008-7#3)(2013-8#1)
of the follow-up##12##3##(1990-8#1)(1992-6#1)(1992-8#1)(1993-10#1)(2008-3#1)(2008-7#3)(2008-8#2)(2011-2#1)(2013-8#1)
of the following diseases##3##4##(1994-3#1)(2009-5#1)(2011-1#1)
of the following four##4##4##(1991-2#1)(1992-2#1)(2008-10#1)(2008-9#1)
of the following methods##2##4##(1995-12#1)(2007-11#1)
of the following parameters##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
of the following study##2##4##(2008-7#1)(2011-1#1)
of the following##56##3##(1990-2#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
of the food canal of nematodes that##2##7##(2008-10#2)
of the food canal of##3##5##(2008-10#3)
of the food chain##2##4##(2008-9#2)
of the food supply##3##4##(1990-6#1)(2007-12#2)
of the food web##4##4##(2008-8#1)(2008-9#3)
of the food##17##3##(1990-6#1)(2007-12#2)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#5)(2010-4#1)(2011-2#1)(2012-2#1)
of the foot and ankle##5##5##(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
of the foot and##6##4##(2008-12#1)(2011-2#2)(2012-2#2)(2012-3#1)
of the foot are##2##4##(2009-10#1)(2012-12#1)
of the foot is##2##4##(2010-3#1)(2010-5#1)
of the foot protein##4##4##(1992-3#4)
of the foot##26##3##(1992-3#4)(2007-11#1)(2008-12#3)(2008-7#1)(2009-10#2)(2009-3#1)(2010-3#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)
of the foraging##2##3##(2008-8#1)(2008-9#1)
of the foramen magnum##2##4##(1996-9#2)
of the foramen##3##3##(1996-9#2)(2012-12#1)
of the forbidden##2##3##(2007-11#1)(2007-12#1)
of the force##5##3##(2007-11#3)(2009-7#1)(2010-3#1)
of the forces##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
of the forearm##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
of the forecast##2##3##(1996-4#1)(2008-10#1)
of the forehead##3##3##(1992-2#1)(1997-3#1)(2006-12#1)
of the foreign##7##3##(1994-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
of the forelimbs##3##3##(1993-3#1)(1996-6#1)(2012-3#1)
of the forest##4##3##(2008-5#2)(2008-6#1)(2008-9#1)
of the forestomach in 100 mg/kg females##2##7##(2008-9#2)
of the forestomach in##4##4##(2008-9#4)
of the forestomach##5##3##(2008-9#5)
of the form of##3##4##(1992-3#1)(2008-2#1)(2013-1#1)
of the form##7##3##(1992-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
of the forma specialis##2##4##(2008-10#2)
of the formal potential##3##4##(2008-10#3)
of the formal##4##3##(2008-10#3)(2013-1#1)
of the formation and##3##4##(2008-10#3)
of the formation of a##3##5##(1993-11#2)(2008-10#1)
of the formation of the##4##5##(2008-10#1)(2008-3#1)(2011-2#1)(2012-5#1)
of the formation of##18##4##(1991-5#1)(1992-3#1)(1992-5#1)(1993-11#2)(1994-11#1)(1995-12#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-2#1)(2012-5#1)
of the formation##22##3##(1991-5#1)(1992-3#1)(1992-5#1)(1993-11#2)(1994-11#1)(1995-12#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-7#1)(2011-2#1)(2012-5#1)
of the formed complex##2##4##(1991-2#1)(2008-10#1)
of the formed complexes##2##4##(2008-10#2)
of the formed##17##3##(1991-2#1)(1994-3#1)(2008-10#14)(2011-2#1)
of the former were##2##4##(2008-6#1)(2008-8#1)
of the former##20##3##(1992-12#1)(1992-8#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
of the forms##4##3##(1991-6#1)(1992-8#1)(2011-1#1)(2012-3#1)
of the formula##2##3##(2008-5#2)
of the formulation##6##3##(2008-10#2)(2008-5#3)(2011-3#1)
of the formulations##2##3##(2008-5#1)(2010-5#1)
of the forward##3##3##(1991-12#1)(1991-9#1)(2008-3#1)
of the foundation##2##3##(2008-5#1)(2011-2#1)
of the founding##3##3##(1996-6#1)(2008-10#1)(2008-8#1)
of the four domains##2##4##(1992-4#2)
of the four groups##7##4##(1991-8#2)(1992-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
of the four mammalian##2##4##(1997-7#1)(2008-7#1)
of the four##88##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-8#2)(1992-11#2)(1992-3#2)(1992-4#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1995-12#1)(1995-4#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#30)(2008-3#3)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
of the four-pass##2##3##(2008-2#2)
of the fourteen##2##3##(2008-4#1)(2009-11#1)
of the fourth and fifth##3##5##(1997-3#2)(2008-10#1)
of the fourth and##4##4##(1997-3#2)(2008-10#1)(2012-9#1)
of the fourth ventricle##5##4##(1996-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
of the fourth##19##3##(1992-12#2)(1992-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#2)
of the fraction of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of the fraction##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the fractional Fourier transform##2##5##(2008-2#2)
of the fractional##7##3##(1993-5#1)(2008-2#4)(2008-3#2)
of the fractions##3##3##(1990-8#1)(2008-11#2)
of the fracture and##3##4##(2007-8#1)(2010-3#1)(2013-1#1)
of the fracture##13##3##(2007-11#2)(2007-8#4)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2011-2#2)(2013-1#1)
of the fractured##2##3##(2013-1#1)(2013-8#1)
of the fractures##4##3##(2007-11#2)(2007-8#1)(2013-8#1)
of the fragment##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
of the fragments could##2##4##(1995-11#1)(2008-9#1)
of the fragments##7##3##(1992-3#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)
of the fragrance##7##3##(2008-5#7)
of the frail elderly##3##4##(1991-12#1)(1993-1#2)
of the framework##3##3##(1996-1#1)(2009-1#1)(2013-1#1)
of the free amino##2##4##(1990-5#1)(2007-11#1)
of the free and##3##4##(2008-10#2)(2008-6#1)
of the free carriers in metallic##2##6##(2008-3#2)
of the free carriers##3##4##(2008-3#3)
of the free energies of##2##5##(1990-8#2)
of the free radical##2##4##(2007-11#1)(2009-12#1)
of the free wall##2##4##(2008-7#1)(2010-10#1)
of the free##39##3##(1990-3#1)(1990-5#2)(1990-8#2)(1991-5#2)(1991-9#1)(1994-3#1)(1994-5#1)(1996-5#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#10)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-2#1)(2010-6#1)(2012-2#1)
of the free-running##3##3##(2008-2#1)(2008-3#2)
of the free-space diffraction efficiency##2##5##(2007-12#1)(2008-3#1)
of the free-space##3##3##(2007-12#1)(2008-3#2)
of the frequency and##2##4##(1991-6#1)(2011-2#1)
of the frequency comb is##2##5##(2007-12#2)
of the frequency of##3##4##(1991-9#1)(2008-10#1)(2008-3#1)
of the frequency shift##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
of the frequency##22##3##(1991-6#1)(1991-9#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#4)(2008-3#7)(2008-6#1)(2011-2#1)
of the fresh##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
of the freshwater bryozoan Cristatella mucedo##2##6##(2011-2#2)
of the freshwater##7##3##(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#3)
of the fringe patterns##3##4##(2008-2#1)(2008-3#2)
of the fringe spacing##2##4##(2008-3#2)
of the fringe visibility##2##4##(2008-3#2)
of the fringe##12##3##(2008-2#3)(2008-3#9)
of the fringes of##2##4##(2008-2#2)
of the fringes##3##3##(2008-2#2)(2008-3#1)
of the frog Rana##2##4##(1993-5#1)(2008-7#1)
of the frog##4##3##(1993-3#1)(1993-5#2)(2008-7#1)
of the front##3##3##(2008-3#2)(2012-12#1)
of the frontal cortex##2##4##(1991-5#2)
of the frontal lobe##4##4##(1997-2#1)(2008-9#3)
of the frontal##14##3##(1991-5#2)(1992-8#1)(1997-2#1)(2006-12#3)(2008-5#1)(2008-9#4)(2010-8#1)(2012-8#1)
of the fruit fly##3##4##(2007-12#1)(2008-9#2)
of the fruit##11##3##(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#3)
of the fucoidan extracts on##2##5##(2008-11#2)
of the full width at half-maximum##2##6##(2008-2#1)(2008-3#1)
of the full##17##3##(1991-1#1)(1992-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2010-5#1)(2012-2#1)(2013-1#1)
of the full-length cDNA was##2##5##(1990-2#1)(1997-7#1)
of the full-length cDNA##3##4##(1990-2#1)(1997-7#2)
of the full-length##7##3##(1990-2#1)(1991-5#1)(1992-6#1)(1997-7#2)(2008-10#1)(2008-8#1)
of the fully##3##3##(2010-3#1)(2011-2#2)
of the fume##4##3##(2008-10#4)
of the function of the##2##5##(2008-7#1)(2009-8#1)
of the function of##9##4##(1993-11#1)(1994-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the function##12##3##(1993-11#1)(1994-11#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the functional anatomy##2##4##(2012-2#1)(2012-3#1)
of the functional and##2##4##(2007-12#1)(2008-7#1)
of the functional domains##2##4##(1990-7#1)(1993-12#1)
of the functional form##2##4##(2008-7#1)(2012-2#1)
of the functional##37##3##(1990-7#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1997-8#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
of the functionally##2##3##(1990-7#1)(2009-10#1)
of the functions of##2##4##(2008-6#1)(2012-2#1)
of the functions##5##3##(1997-2#1)(2008-6#1)(2009-5#1)(2009-9#1)(2012-2#1)
of the fundamental and##2##4##(2007-12#1)(2013-8#1)
of the fundamental equilibrium constants##2##5##(2008-10#2)
of the fundamental mode in##2##5##(2007-12#1)(2008-2#1)
of the fundamental mode##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
of the fundamental radiation##2##4##(2007-11#1)(2008-2#1)
of the fundamental##26##3##(1992-3#1)(1995-8#1)(2007-11#6)(2007-12#6)(2008-10#3)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#2)(2013-8#1)
of the fungal community isolated from##2##6##(2008-10#2)
of the fungal community##3##4##(2008-10#3)
of the fungal pathogen##3##4##(2008-10#3)
of the fungal##21##3##(2008-10#20)(2008-8#1)
of the fungi##10##3##(2008-10#8)(2008-5#1)(2008-8#1)
of the fungicide applications##2##4##(2008-10#2)
of the fungicide cymoxanil in##2##5##(1991-5#2)
of the fungicide##10##3##(1991-5#2)(2008-10#8)
of the fungicides##4##3##(2008-10#3)(2008-5#1)
of the fungus Leptolegnia chapmanii (Oomycetes##2##6##(2008-5#2)
of the fungus and##2##4##(2008-10#2)
of the fungus in the##3##5##(2008-10#3)
of the fungus in##6##4##(2008-10#6)
of the fungus to##4##4##(2008-10#3)(2008-5#1)
of the fungus was##4##4##(2008-10#3)(2008-5#1)
of the fungus were##2##4##(2008-10#2)
of the fungus##55##3##(1991-5#1)(1994-11#1)(2008-1#1)(2008-10#45)(2008-5#5)(2009-2#1)(2011-1#1)
of the funnel warts##3##4##(2007-12#3)
of the funnel##4##3##(1990-5#1)(2007-12#3)
of the fused##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
of the fusiform rust##2##4##(2008-10#2)
of the fusion protein##3##4##(1994-8#1)(1997-4#1)(2008-1#1)
of the fusion proteins##2##4##(1997-7#1)(2008-6#1)
of the fusion##10##3##(1994-8#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the future for##2##4##(1992-1#1)(2007-7#1)
of the future will##2##4##(1992-12#1)(1994-12#1)
of the future##26##3##(1990-11#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-2#3)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#3)
of the gain and##2##4##(2007-12#1)(2008-3#1)
of the gain medium##3##4##(2008-2#1)(2008-3#2)
of the gain##14##3##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#4)
of the gain-scheduling##2##3##(2008-10#2)
of the gains##2##3##(1995-6#1)(2008-2#1)
of the gait performance##2##4##(2012-12#1)(2013-1#1)
of the gait##4##3##(2007-10#1)(2012-12#1)(2013-1#2)
of the gallbladder in a##2##5##(1990-6#1)(1991-12#1)
of the gallbladder is##2##4##(1991-6#1)(2011-2#1)
of the gallbladder##18##3##(1990-6#2)(1991-12#3)(1991-6#2)(1991-8#1)(1992-6#1)(1992-9#1)(2009-3#4)(2010-12#1)(2011-2#2)(2012-3#1)
of the gamma##2##3##(1995-12#1)(2008-1#1)
of the ganglia##2##3##(1996-5#1)(2008-7#1)
of the ganglioside##3##3##(1990-8#1)(1991-5#1)(1994-3#1)
of the gap##4##3##(2007-11#1)(2008-3#3)
of the gaps##3##3##(1997-1#1)(2012-12#2)
of the gas in the##2##5##(2008-10#2)
of the gas##10##3##(1997-1#1)(2007-12#2)(2008-10#3)(2008-3#2)(2009-9#1)(2012-2#1)
of the gaseous##3##3##(2007-12#1)(2008-10#2)
of the gastric##13##3##(1990-9#2)(1992-8#1)(1997-1#3)(1997-4#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
of the gastrin##2##3##(1992-3#1)(1992-8#1)
of the gastrocnemius##2##3##(1995-2#1)(2012-2#1)
of the gastrointestinal mucosa##2##4##(1996-3#1)(2012-1#1)
of the gastrointestinal tract and##2##5##(2008-7#1)(2011-2#1)
of the gastrointestinal tract is##3##5##(1990-11#1)(2008-7#1)(2009-1#1)
of the gastrointestinal tract##26##4##(1990-11#1)(1990-8#1)(1991-6#1)(1995-6#1)(2008-10#2)(2008-7#4)(2009-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
of the gastrointestinal##35##3##(1990-11#1)(1990-8#1)(1991-6#1)(1995-11#1)(1995-6#2)(1996-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#4)(2009-1#1)(2009-5#1)(2011-2#4)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
of the gate##5##3##(1995-1#1)(2008-7#2)(2009-11#1)(2012-2#1)
of the gaze shift##2##4##(2008-11#2)
of the gcs gene##2##4##(1997-7#2)
of the gel network##2##4##(2008-5#2)
of the gel##16##3##(1990-11#1)(1993-8#1)(1996-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)
of the gene and the##2##5##(1996-8#1)(2008-7#1)
of the gene and##5##4##(1994-11#1)(1995-8#1)(1996-2#1)(1996-8#1)(2008-7#1)
of the gene coding for the##2##6##(1992-3#1)(1993-8#1)
of the gene coding for##3##5##(1992-3#1)(1993-8#1)(1996-8#1)
of the gene encoding a##2##5##(1994-12#1)(1994-8#1)
of the gene encoding for the##2##6##(1992-9#1)(1997-6#1)
of the gene encoding human##3##5##(1991-6#2)(1997-7#1)
of the gene encoding the##14##5##(1991-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#3)(1995-6#1)(1996-12#1)(1996-8#1)(2008-5#1)(2008-9#1)
of the gene encoding##33##4##(1990-5#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#5)(1994-8#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
of the gene expression##5##4##(1991-5#1)(1993-8#1)(1997-6#1)(2009-9#1)(2013-1#1)
of the gene for##4##4##(1994-11#1)(1994-8#1)(1994-9#1)(2010-4#1)
of the gene in##4##4##(1991-9#1)(1995-3#1)(1997-1#1)(2008-10#1)
of the gene is##2##4##(1992-9#1)(1993-8#1)
of the gene or##2##4##(1996-2#1)(2008-10#1)
of the gene therapy##2##4##(2008-5#1)(2013-8#1)
of the gene was determined##2##5##(1991-11#1)(1997-8#1)
of the gene was##6##4##(1991-11#1)(1993-9#1)(1997-8#1)(2008-5#1)(2008-8#2)
of the gene##123##3##(1990-12#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-9#3)(1992-12#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#7)(1993-3#3)(1993-6#1)(1993-8#8)(1993-9#3)(1994-11#2)(1994-12#7)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2008-10#7)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2013-1#3)(2013-8#1)
of the genera Sphaerochaeta##2##4##(2013-8#2)
of the genera##7##3##(1997-4#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#2)
of the general health##2##4##(2008-10#1)(2013-1#1)
of the general population of the##2##6##(1991-2#1)(1993-9#1)
of the general population##17##4##(1991-2#3)(1993-1#1)(1993-9#1)(1997-3#2)(2008-12#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the general practitioner##2##4##(1993-11#1)(1995-11#1)
of the general practitioners##5##4##(1993-2#3)(1997-4#2)
of the general public##2##4##(2008-7#1)(2013-8#1)
of the general##44##3##(1990-5#1)(1991-2#3)(1993-1#1)(1993-11#1)(1993-2#3)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-3#2)(1997-4#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
of the generalized##10##3##(1990-3#1)(1991-9#1)(1995-9#1)(2007-11#2)(2008-2#2)(2008-3#2)(2012-2#1)
of the generated data##2##4##(2008-10#1)(2008-7#1)
of the generated##14##3##(1990-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-7#1)
of the generation##2##3##(2007-12#1)(2008-4#1)
of the generative##3##3##(2007-12#1)(2009-12#1)(2010-4#1)
of the genes are##2##4##(1993-6#1)(2008-10#1)
of the genes encoding the##4##5##(1991-6#1)(1992-9#1)(1996-2#1)(2008-7#1)
of the genes encoding##8##4##(1991-6#1)(1992-9#1)(1993-12#1)(1996-2#1)(1997-7#1)(2008-6#1)(2008-7#1)(2010-7#1)
of the genes for##5##4##(1990-2#1)(1992-3#1)(1997-2#1)(2006-10#1)(2010-11#1)
of the genes have##2##4##(1996-2#1)(2008-9#1)
of the genes in##4##4##(1990-5#1)(1992-3#1)(2008-10#2)
of the genes involved in the##2##6##(1990-5#1)(2008-9#1)
of the genes involved in##4##5##(1990-5#1)(2008-10#1)(2008-9#2)
of the genes were##3##4##(2008-10#2)(2009-10#1)
of the genes##61##3##(1990-2#1)(1990-5#2)(1991-5#1)(1991-6#1)(1992-3#3)(1992-9#1)(1993-12#2)(1993-6#2)(1994-8#1)(1995-2#1)(1996-10#1)(1996-2#2)(1997-2#1)(1997-6#2)(1997-7#3)(1997-8#3)(2006-10#1)(2008-10#8)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-7#2)(2012-3#1)(2013-1#1)(2013-8#1)
of the genetic basis of##4##5##(2008-1#1)(2008-10#1)(2008-8#1)(2012-3#1)
of the genetic code##2##4##(1994-5#1)(1997-6#1)
of the genetic connectedness measures among##2##6##(2012-1#2)
of the genetic dissection of complex##2##6##(1994-9#2)
of the genetic distance##2##4##(1997-5#1)(2008-10#1)
of the genetic diversity##5##4##(1995-2#1)(2008-10#3)(2010-7#1)
of the genetic effect##2##4##(1994-2#1)(2012-3#1)
of the genetic map##2##4##(2008-10#1)(2012-3#1)
of the genetic structure of##4##5##(2008-10#2)(2008-8#1)(2011-2#1)
of the genetic structure##5##4##(2008-10#3)(2008-8#1)(2011-2#1)
of the genetic variance##2##4##(2008-10#1)(2008-5#1)
of the genetic variation for##2##5##(2008-10#2)
of the genetic variation##4##4##(2008-10#4)
of the genetic##58##3##(1994-2#2)(1994-5#1)(1994-9#2)(1995-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#1)
of the genetically##2##3##(2008-10#2)
of the genetics of##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
of the genetics##6##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-3#1)
of the geniculate##2##3##(2011-2#2)
of the genital##5##3##(2007-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-3#1)
of the genitalia##3##3##(1997-3#1)(2008-10#2)
of the genitourinary##2##3##(1990-6#1)(2007-12#1)
of the genome by##3##4##(1993-11#1)(1995-6#1)(2012-3#1)
of the genome contains##2##4##(1996-2#1)(2008-10#1)
of the genome of the##6##5##(1995-12#1)(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)
of the genome of##13##4##(1992-6#1)(1995-12#1)(1995-8#2)(1996-6#2)(1997-3#2)(2008-10#4)(2010-8#1)
of the genome that##2##4##(2008-4#1)(2010-3#1)
of the genome to##2##4##(1995-4#1)(2008-11#1)
of the genome was##3##4##(1996-6#1)(2008-10#2)
of the genome##67##3##(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-6#7)(1997-3#2)(2007-11#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#2)(2010-3#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
of the genomes of##7##4##(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
of the genomes##8##3##(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)
of the genomic regions##3##4##(1996-12#1)(2008-10#1)(2009-10#1)
of the genomic sequence##3##4##(1992-3#1)(1993-3#1)(2008-1#1)
of the genomic##18##3##(1990-8#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)
of the genotype##2##3##(2008-10#1)(2013-8#1)
of the genotypes in##2##4##(2008-7#1)(2011-2#1)
of the genotypes##8##3##(2008-10#6)(2008-7#1)(2011-2#1)
of the genotyping primers##2##4##(2008-9#2)
of the genus Aminobacterium##2##4##(2011-2#2)
of the genus Aminomonas##2##4##(2011-2#2)
of the genus Arcanobacterium##2##4##(2011-2#2)
of the genus Arcobacter##2##4##(2011-2#2)
of the genus Astyanax##2##4##(2010-8#2)
of the genus Cellulomonas##3##4##(2011-2#3)
of the genus Closterovirus##2##4##(2008-10#2)
of the genus Ferrimonas##2##4##(2011-2#2)
of the genus Haloterrigena##2##4##(2011-2#2)
of the genus Hypolobocera##2##4##(2008-5#2)
of the genus Intrasporangium##2##4##(2011-2#2)
of the genus Meiothermus and only the third genome sequence to be published from a member of the family Thermaceae##2##20##(2011-2#2)
of the genus Meiothermus##3##4##(2011-2#3)
of the genus Methanoplanus are##2##5##(2011-2#2)
of the genus Methanoplanus##3##4##(2011-2#3)
of the genus Microsomacanthus Lopez-Neyra##2##5##(2011-2#2)
of the genus Microsomacanthus##4##4##(2011-2#4)
of the genus Nocardiopsis##2##4##(2011-2#2)
of the genus Olsenella##2##4##(2011-2#2)
of the genus Potyvirus##6##4##(2008-10#6)
of the genus Puntius Hamilton 1822 harvested from 15##2##9##(2008-12#2)
of the genus Puntius Hamilton 1822##4##6##(2008-12#4)
of the genus Sinularia##3##4##(2010-2#3)
of the genus Sulfurimonas##2##4##(2011-2#2)
of the genus Sulfurospirillum##2##4##(2011-2#2)
of the genus Thermobispora##2##4##(2011-2#2)
of the genus Thermosediminibacter##2##4##(2011-2#2)
of the genus Tobamovirus##3##4##(2008-10#3)
of the genus Tospovirus##2##4##(2008-10#2)
of the genus Trichovirus##4##4##(2008-10#4)
of the genus Tymovirus##2##4##(2008-10#2)
of the genus##152##3##(1997-2#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#43)(2008-11#1)(2008-12#4)(2008-5#14)(2008-6#6)(2008-9#1)(2009-5#1)(2010-1#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-8#3)(2011-2#61)(2013-1#3)(2013-7#2)(2013-8#1)
of the geographic area##2##4##(1991-3#1)(2011-2#1)
of the geographic##6##3##(1991-3#2)(2008-10#2)(2011-2#2)
of the geographical##2##3##(2008-8#1)(2013-7#1)
of the geometric mean##2##4##(2011-2#2)
of the geometric##5##3##(2008-3#3)(2011-2#2)
of the geometrical##3##3##(1997-4#1)(2007-11#1)(2008-3#1)
of the geometrical-optics approximation##2##4##(2008-2#1)(2008-3#1)
of the geometrical-optics##3##3##(2008-2#1)(2008-3#2)
of the geometry of the##2##5##(2008-10#1)(2008-2#1)
of the geometry of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the gerbil##2##3##(1990-7#1)(1992-11#1)
of the geriatric##2##3##(2010-1#1)(2011-2#1)
of the germ tubes##2##4##(2008-7#2)
of the germ##7##3##(2008-10#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-3#1)
of the germinal vesicle##2##4##(2007-12#1)(2008-7#1)
of the germline##3##3##(1992-10#1)(2010-5#1)(2012-3#1)
of the giant##3##3##(1997-6#1)(2008-8#1)(2011-2#1)
of the ginbuna##2##3##(2008-5#2)
of the gingiva##2##3##(2009-8#1)(2012-3#1)
of the gingival##2##3##(2012-3#1)(2013-1#1)
of the girls##2##3##(1991-9#1)(2013-1#1)
of the girls)##2##3##(1991-9#2)
of the given##4##3##(2007-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
of the gland and##2##4##(2007-12#2)
of the gland opening##3##4##(2007-12#3)
of the gland##11##3##(2007-12#7)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
of the glans penis##3##4##(2007-7#2)(2007-8#1)
of the glass electrode##3##4##(2008-10#3)
of the glass##23##3##(1995-3#1)(2007-12#4)(2008-10#11)(2008-2#1)(2008-3#4)(2010-2#1)(2010-4#1)
of the glassy carbon electrode##3##5##(1995-6#1)(2008-10#2)
of the glassy##4##3##(1995-3#1)(1995-6#1)(2008-10#2)
of the glial##5##3##(1997-2#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)
of the global##17##3##(1990-12#1)(1994-12#1)(1996-5#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
of the globular##2##3##(1995-12#1)(2009-7#1)
of the glomerular basement membrane##2##5##(2007-7#1)(2008-1#1)
of the glomerular##3##3##(1996-6#1)(2007-7#1)(2008-1#1)
of the glomerulonephritis##2##3##(1993-2#2)
of the gloves##4##3##(1995-6#2)(2012-2#2)
of the glucagon receptor##2##4##(1995-11#2)
of the glucagon##3##3##(1995-11#2)(2011-2#1)
of the glucocorticoid receptor##5##4##(1991-12#1)(1993-8#1)(1996-12#3)
of the glucose biosensor##2##4##(2008-10#1)(2010-5#1)
of the glucose concentration##2##4##(1994-5#1)(2008-10#1)
of the glucose sensing##2##4##(2008-11#2)
of the glucose##12##3##(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-5#1)
of the glutamate dehydrogenase##2##4##(2008-11#1)(2008-8#1)
of the glutamate transporter##2##4##(1993-3#1)(1995-11#1)
of the glutamate##7##3##(1993-3#1)(1994-6#1)(1995-11#1)(2008-11#1)(2008-7#2)(2008-8#1)
of the glutamine synthetase##2##4##(2008-10#1)(2008-2#1)
of the glutamine##3##3##(1997-1#1)(2008-10#1)(2008-2#1)
of the glutathione##3##3##(1991-9#1)(1994-9#2)
of the gluteal region##2##4##(1992-2#1)(2010-8#1)
of the glutinous##2##3##(2008-10#2)
of the glycan##2##3##(1990-7#1)(1991-12#1)
of the glyceraldehyde-3-phosphate dehydrogenase gene##2##5##(1995-6#1)(2008-10#1)
of the glycine cleavage##2##4##(1992-10#1)(1997-1#1)
of the glycine receptor##3##4##(1992-11#3)
of the glycine##6##3##(1990-12#1)(1992-10#1)(1992-11#3)(1997-1#1)
of the glycine-rich##3##3##(1997-7#2)(2008-10#1)
of the glycolytic enzymes##2##4##(1994-8#1)(1997-2#1)
of the glycolytic##3##3##(1990-7#1)(1994-8#1)(1997-2#1)
of the glycoprotein##3##3##(1993-6#1)(1994-8#1)(2008-7#1)
of the glycoproteins##2##3##(2008-7#1)(2010-12#1)
of the glycosidic##2##3##(1993-3#1)(2010-5#1)
of the glycosylation##3##3##(1992-6#1)(2008-7#1)(2010-11#1)
of the glycyl radical##2##4##(1995-2#2)
of the goals of##5##4##(1994-2#1)(1994-3#1)(2008-10#1)(2008-9#2)
of the goals##6##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-9#2)(2012-3#1)
of the goats##2##3##(1997-8#1)(2010-2#1)
of the gold##4##3##(2008-10#3)(2008-3#1)
of the gonadal steroid environment##2##5##(2008-11#2)
of the gonadal steroid##3##4##(2008-11#3)
of the gonadal##4##3##(2008-11#3)(2008-6#1)
of the good##2##3##(2007-11#1)(2009-10#1)
of the government to##2##4##(1994-7#1)(1995-3#1)
of the government##4##3##(1994-7#2)(1995-3#1)(2007-7#1)
of the gradient##6##3##(2007-11#1)(2008-10#2)(2008-3#2)(2008-8#1)
of the graft##8##3##(1996-2#1)(1996-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2011-3#1)
of the grafted polymer##2##4##(2008-10#1)(2009-10#1)
of the grafted##4##3##(2008-10#2)(2009-10#1)(2010-4#1)
of the grafts##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
of the grammatical##2##3##(1991-2#1)(2008-4#1)
of the grant##4##3##(1992-12#1)(1995-6#2)(1996-2#1)
of the granule cell##2##4##(1994-8#1)(2009-8#1)
of the granule##3##3##(1994-8#1)(2009-8#2)
of the granules were##2##4##(2008-10#2)
of the granules##4##3##(2008-10#2)(2008-5#1)(2010-11#1)
of the grapes##3##3##(2008-10#3)
of the graphite##6##3##(2008-10#6)
of the grasshopper Schistocerca gregaria##6##5##(2007-12#6)
of the grasshopper##9##3##(2007-12#6)(2008-5#1)(2008-9#1)(2013-7#1)
of the grating amplitude##2##4##(2008-3#2)
of the grating and##2##4##(2008-3#2)
of the grating aperture##2##4##(2008-3#2)
of the grating diffraction efficiency##2##5##(2008-2#1)(2008-3#1)
of the grating is##2##4##(2008-3#2)
of the grating with##2##4##(2007-11#2)
of the grating##52##3##(2007-11#3)(2007-12#4)(2008-2#8)(2008-3#37)
of the gratings##11##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
of the gravity waves##2##4##(2008-3#2)
of the gravity##4##3##(2008-10#1)(2008-3#2)(2009-8#1)
of the grazing season##2##4##(1991-8#1)(1996-12#1)
of the great vessels##3##4##(1990-11#1)(1996-11#1)(2012-2#1)
of the great##15##3##(1990-11#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-4#1)(2008-10#2)(2008-9#2)(2009-10#1)(2010-5#2)(2010-6#1)(2012-2#1)(2012-3#1)
of the greater prairie chicken##2##5##(2008-9#2)
of the greater##7##3##(2006-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)
of the greatest##6##3##(1996-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)
of the green fluorescent protein##2##5##(2009-6#1)(2009-9#1)
of the green toad##2##4##(2008-12#2)
of the green##8##3##(2007-12#2)(2008-11#1)(2008-12#2)(2009-6#1)(2009-9#1)(2012-3#1)
of the greenhouse effect##3##4##(1991-6#2)(1992-3#1)
of the greenhouse##5##3##(1991-6#2)(1992-3#2)(2008-10#1)
of the grey##2##3##(2008-9#1)(2009-9#1)
of the groE##2##3##(1996-12#1)(2008-10#1)
of the groove##6##3##(2008-2#3)(2008-3#2)(2008-8#1)
of the grooves##3##3##(1995-8#1)(2007-12#1)(2008-3#1)
of the gross##3##3##(1993-1#1)(2008-3#1)(2008-4#1)
of the ground squirrel##3##4##(1990-5#1)(2008-8#2)
of the ground##7##3##(1990-5#1)(2008-3#3)(2008-8#2)(2012-2#1)
of the ground-based##2##3##(2008-2#1)(2008-3#1)
of the group and##4##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the group in##3##4##(2008-11#1)(2008-9#1)(2012-1#1)
of the group of##2##4##(2008-10#1)(2008-7#1)
of the group##32##3##(1991-12#1)(1993-1#1)(1995-1#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#1)
of the group-velocity##2##3##(2007-11#2)
of the groups##10##3##(1990-8#1)(1994-11#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#1)(2013-7#1)
of the growing cells##2##4##(1991-2#1)(1995-11#1)
of the growing season##6##4##(2008-10#4)(2009-2#1)(2012-5#1)
of the growing##15##3##(1991-2#1)(1993-1#1)(1993-3#1)(1995-11#1)(2008-10#5)(2008-7#1)(2009-2#1)(2010-2#1)(2012-1#1)(2012-5#1)(2013-1#1)
of the grown##2##3##(2013-1#2)
of the growth and##2##4##(2008-4#1)(2013-8#1)
of the growth factor##5##4##(1997-1#1)(1997-7#2)(2008-8#1)(2009-8#1)
of the growth hormone receptor##2##5##(2008-1#1)(2008-4#1)
of the growth hormone##4##4##(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
of the growth in##2##4##(2008-10#1)(2009-10#1)
of the growth kinetics##2##4##(2008-11#1)(2008-7#1)
of the growth medium with##2##5##(1994-12#1)(1996-6#1)
of the growth medium##6##4##(1991-11#2)(1994-12#2)(1996-6#1)(2008-11#1)
of the growth of##6##4##(1993-3#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
of the growth phase##3##4##(2008-11#3)
of the growth plate##3##4##(2007-11#2)(2012-1#1)
of the growth rate##4##4##(2008-11#3)(2009-6#1)
of the growth substrate##2##4##(2008-7#2)
of the growth##56##3##(1991-11#2)(1993-3#1)(1994-12#2)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#10)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
of the gsa-1 gene##2##4##(1997-7#2)
of the guanine##4##3##(1991-5#1)(1992-3#1)(2008-10#2)
of the guest molecules##2##4##(2008-10#1)(2008-2#1)
of the guest##6##3##(1997-7#1)(2008-10#4)(2008-2#1)
of the guests##2##3##(2008-10#1)(2010-4#1)
of the guide##3##3##(1996-2#1)(1996-9#1)(2008-3#1)
of the guided light##2##4##(2008-10#2)
of the guided modes##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of the guided##7##3##(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)
of the guideline##4##3##(1995-6#1)(2008-10#2)(2010-8#1)
of the guidelines for the##2##5##(2008-7#1)(2012-12#1)
of the guidelines##10##3##(1990-6#2)(1994-2#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the guiding##3##3##(1995-3#1)(2007-11#1)(2007-12#1)
of the guinea pig extraocular muscles##3##6##(1997-3#3)
of the guinea pig##6##4##(1992-8#1)(1995-12#2)(1997-3#3)
of the guinea-pig##6##3##(1990-5#1)(1994-6#1)(1997-4#2)(1997-7#2)
of the gut##12##3##(1993-6#2)(1995-6#1)(2007-12#1)(2010-5#1)(2011-1#1)(2011-2#6)
of the h-lamp-2##2##3##(1994-11#2)
of the hIL-6##2##3##(2008-11#2)
of the hP2Y(1) receptor##3##4##(2008-4#3)
of the hTERT mRNA and##2##5##(2008-11#2)
of the hTERT##4##3##(2008-11#4)
of the habitat for##2##4##(2008-10#1)(2008-8#1)
of the habitat##5##3##(2008-10#2)(2008-5#1)(2008-8#2)
of the habitats##2##3##(2007-10#1)(2013-7#1)
of the haemagglutinin##2##3##(1997-6#2)
of the haemagglutinin-neuraminidase (HN)##2##4##(2007-6#2)
of the haematoma and##2##4##(2008-7#2)
of the haematoma##4##3##(1997-3#1)(2008-7#3)
of the hair and##2##4##(2008-5#2)
of the hair follicle##2##4##(2008-5#1)(2012-2#1)
of the hair##19##3##(1993-9#1)(2008-5#17)(2012-2#1)
of the hairy##2##3##(1990-9#1)(2008-7#1)
of the half##2##3##(2008-10#1)(2008-11#1)
of the hallmarks of##4##4##(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
of the hallux##2##3##(2009-10#1)(2012-2#1)
of the halo##2##3##(2008-2#1)(2008-3#1)
of the hamster##4##3##(1995-12#1)(1995-5#1)(1996-8#1)(2008-9#1)
of the hand and##7##4##(2007-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
of the hand is##2##4##(2007-8#1)(2008-9#1)
of the hand##24##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-6#4)(2008-7#2)(2008-9#7)(2009-3#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the hands and feet##3##5##(2007-7#1)(2008-7#1)(2013-1#1)
of the hands and##4##4##(2007-7#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the hands in##2##4##(1994-11#1)(1997-3#1)
of the hands##9##3##(1994-11#1)(1997-3#1)(2006-10#1)(2007-7#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the hard palate##3##4##(1991-11#2)(2013-1#1)
of the hard##5##3##(1991-11#3)(2008-10#1)(2013-1#1)
of the harmonics in##2##4##(2008-3#2)
of the hazards of##4##4##(1991-5#1)(2008-11#2)(2010-3#1)
of the head and neck are##2##6##(1993-8#1)(1995-8#1)
of the head and neck##14##5##(1990-6#2)(1993-8#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
of the head and##18##4##(1990-6#2)(1993-8#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#3)
of the head of the##4##5##(1990-9#1)(1991-11#1)(1994-6#1)(1995-6#1)
of the head of##5##4##(1990-9#1)(1991-11#1)(1994-6#1)(1995-6#1)(2007-12#1)
of the head##38##3##(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#2)(1993-12#2)(1993-8#1)(1994-6#2)(1995-6#1)(1995-8#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
of the headspace##2##3##(2008-10#1)(2011-2#1)
of the health and##5##4##(1992-3#1)(1997-4#1)(2008-2#1)(2010-9#1)(2013-8#1)
of the health care delivery system##3##6##(1993-12#1)(1995-2#1)(1995-3#1)
of the health care industry##3##5##(1991-1#1)(1991-12#1)(1993-12#1)
of the health care system in##2##6##(1992-12#1)(1992-2#1)
of the health care system##8##5##(1992-12#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)
of the health care team##3##5##(1995-3#2)(2008-11#1)
of the health care##32##4##(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#4)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-8#2)(2008-1#1)(2008-11#2)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
of the health sector##4##4##(1992-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
of the health services##6##4##(1990-11#1)(1990-8#1)(1992-11#1)(1997-3#1)(2008-1#1)(2008-12#1)
of the health status of##2##5##(1990-6#1)(1995-12#1)
of the health system in##2##5##(1996-12#1)(2010-8#1)
of the health system##10##4##(1994-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-5#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
of the health##76##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-3#2)(1997-4#1)(1997-8#3)(2007-5#1)(2008-1#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#4)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#4)
of the healthcare##2##3##(1992-11#1)(2013-8#1)
of the healthy##9##3##(1994-3#1)(1995-12#1)(2008-10#2)(2008-11#2)(2009-12#1)(2012-3#2)
of the hearing##3##3##(2008-9#3)
of the heart and##7##4##(1996-2#1)(2007-8#3)(2008-5#1)(2008-7#1)(2011-1#1)
of the heart during coronary##2##5##(2007-8#2)
of the heart during##3##4##(2007-8#2)(2010-8#1)
of the heart in##2##4##(1993-12#1)(2007-8#1)
of the heart is##3##4##(1990-3#1)(2007-7#1)(2008-7#1)
of the heart through##2##4##(2008-8#1)(2010-8#1)
of the heart was##2##4##(1993-12#1)(2009-11#1)
of the heart with##2##4##(2008-7#1)(2009-1#1)
of the heart##52##3##(1990-3#1)(1991-11#2)(1991-6#1)(1993-12#3)(1993-6#1)(1994-11#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-8#10)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#2)(2009-1#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-8#5)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
of the heat shock protein 70##2##6##(1995-11#1)(2008-10#1)
of the heat shock protein##4##5##(1994-11#1)(1995-11#1)(2008-10#1)(2008-7#1)
of the heat shock response##2##5##(1994-11#1)(2008-7#1)
of the heat shock##10##4##(1992-12#1)(1994-11#2)(1994-8#2)(1995-11#1)(1995-2#1)(2008-10#1)(2008-7#2)
of the heat##13##3##(1992-12#1)(1994-11#2)(1994-8#2)(1995-11#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-3#1)
of the heated##2##3##(2007-12#1)(2008-2#1)
of the heating##2##3##(2008-10#1)(2008-2#1)
of the heavy chain of##2##5##(1990-5#1)(1995-2#1)
of the heavy chain##4##4##(1990-5#1)(1993-6#1)(1995-2#1)(1997-9#1)
of the heavy metal##3##4##(1997-4#1)(2008-10#2)
of the heavy metals##2##4##(1995-3#1)(2008-12#1)
of the heavy##14##3##(1990-5#1)(1992-3#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-9#1)(2008-10#4)(2008-12#1)(2008-2#1)
of the height##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the helical##7##3##(1993-11#3)(1995-6#1)(2008-10#1)(2008-4#2)
of the helix##6##3##(1992-6#1)(1993-11#1)(1994-5#3)(2008-10#1)
of the helper virus##2##4##(2008-10#2)
of the helper##4##3##(1994-12#1)(2008-10#3)
of the hematoma was##2##4##(2008-7#1)(2012-12#1)
of the hematoma##3##3##(2008-7#2)(2012-12#1)
of the heme##10##3##(1990-8#1)(1992-12#1)(1993-8#1)(1994-5#3)(1994-8#2)(1995-3#1)(2008-3#1)
of the hemodynamic##2##3##(1992-3#1)(2008-11#1)
of the hemoglobin##2##3##(1990-8#2)
of the hemorrhagic##2##3##(2008-7#1)(2010-6#1)
of the hepatic##12##3##(1990-2#1)(1990-3#1)(1993-12#3)(1993-2#1)(1993-9#1)(1995-12#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
of the hepatitis B virus##4##5##(1993-6#1)(1997-6#2)(2009-7#1)
of the hepatitis B##5##4##(1993-6#1)(1995-2#1)(1997-6#2)(2009-7#1)
of the hepatitis C virus##3##5##(1994-8#1)(2008-10#1)(2013-8#1)
of the hepatitis C##4##4##(1994-11#1)(1994-8#1)(2008-10#1)(2013-8#1)
of the hepatitis E virus##2##5##(1997-4#2)
of the hepatitis##12##3##(1993-6#1)(1994-11#2)(1994-8#1)(1995-2#1)(1997-4#2)(1997-6#2)(2008-10#1)(2009-7#1)(2013-8#1)
of the hepatocyte##6##3##(1993-8#1)(1996-11#1)(2008-11#2)(2008-9#2)
of the hepatocytes##2##3##(1993-3#1)(2008-11#1)
of the hepatoma##2##3##(2008-11#2)
of the herbal granules##2##4##(2010-5#2)
of the herbal##4##3##(2010-5#2)(2011-2#1)(2013-1#1)
of the herbicide desmetryne##2##4##(2008-10#2)
of the herbicide##12##3##(2008-10#10)(2008-2#1)(2010-1#1)
of the herbicides from##2##4##(2008-10#1)(2008-11#1)
of the herbs##2##3##(2008-10#1)(2013-1#1)
of the herds##2##3##(1992-5#2)
of the hernia##2##3##(1993-9#1)(2009-8#1)
of the heterocyclic##3##3##(1992-2#1)(2007-11#1)(2012-2#1)
of the heterodimeric##3##3##(1993-11#1)(1993-8#1)(2011-2#1)
of the heterogeneity of##2##4##(2011-2#1)(2012-12#1)
of the heterogeneity##4##3##(1994-5#1)(2011-2#2)(2012-12#1)
of the heterogeneous##4##3##(1995-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
of the heterologous##2##3##(2008-10#1)(2008-11#1)
of the hexagonal column##3##4##(2008-3#3)
of the hexagonal##4##3##(1990-2#1)(2008-3#3)
of the hexamer motif##2##4##(1997-2#2)
of the hexamer##5##3##(1995-11#1)(1995-8#1)(1997-2#3)
of the hexameric##2##3##(1995-11#1)(1997-7#1)
of the hexapeptide##2##3##(2008-5#2)
of the hexose##2##3##(1993-3#1)(2010-2#1)
of the hidden##3##3##(1996-12#1)(2008-6#1)(2008-7#1)
of the hierarchical##2##3##(1992-5#1)(2008-11#1)
of the high affinity##4##4##(1990-5#1)(1991-11#1)(1994-11#1)(2008-11#1)
of the high level of##2##5##(2008-7#1)(2009-3#1)
of the high molecular weight##2##5##(2008-10#1)(2008-5#1)
of the high risk##3##4##(1993-6#1)(2011-1#1)(2012-1#1)
of the high##54##3##(1990-2#1)(1990-5#1)(1991-11#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-3#1)(2010-1#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
of the high-affinity##3##3##(1992-6#1)(1995-2#1)(2009-7#1)
of the high-energy##2##3##(1990-11#1)(2008-3#1)
of the high-resolution##3##3##(2008-2#1)(2008-3#2)
of the higher##10##3##(1992-3#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
of the highest risk##2##4##(1993-11#1)(2008-10#1)
of the highest##15##3##(1993-11#1)(1994-2#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#1)
of the highest-order##2##3##(2007-11#2)
of the highly conserved##2##4##(1994-11#1)(2008-8#1)
of the highly##13##3##(1990-5#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-11#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
of the hind leg##2##4##(2007-12#2)
of the hind##3##3##(2007-12#3)
of the hip (DDH)##4##4##(2007-11#1)(2007-8#2)(2013-8#1)
of the hip -##2##4##(2007-11#2)
of the hip and the##2##5##(2007-8#1)(2013-1#1)
of the hip and##3##4##(1995-5#1)(2007-8#1)(2013-1#1)
of the hip in##3##4##(2007-11#1)(2007-8#2)
of the hip is still##2##5##(2007-11#1)(2007-8#1)
of the hip is##3##4##(2007-11#1)(2007-8#1)(2009-3#1)
of the hip joint and##2##5##(1997-6#1)(2007-11#1)
of the hip joint in##4##5##(2007-11#2)(2007-8#2)
of the hip joint##16##4##(1997-6#2)(2007-11#5)(2007-8#7)(2008-6#1)(2008-8#1)
of the hip joints##2##4##(2007-11#1)(2008-6#1)
of the hip using##2##4##(2007-8#2)
of the hip##63##3##(1991-11#1)(1995-5#1)(1997-6#2)(2007-11#21)(2007-8#25)(2008-4#1)(2008-6#2)(2008-8#2)(2009-3#2)(2009-7#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the hippocampal lesioned##2##4##(1990-11#2)
of the hippocampal region##3##4##(1992-11#1)(1994-3#2)
of the hippocampal##10##3##(1990-11#2)(1992-11#1)(1994-3#2)(1995-3#1)(1996-7#1)(2008-11#2)(2013-8#1)
of the hippocampus and in the##2##6##(1995-5#1)(1997-2#1)
of the hippocampus and the##2##5##(1994-3#1)(1995-12#1)
of the hippocampus and##8##4##(1992-11#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(2008-11#1)
of the hippocampus in##2##4##(1994-6#1)(1996-12#1)
of the hippocampus induced by##2##5##(1993-6#1)(1995-12#1)
of the hippocampus##30##3##(1990-11#1)(1992-11#1)(1993-12#2)(1993-6#2)(1994-3#3)(1994-6#3)(1994-8#2)(1995-12#2)(1995-5#1)(1996-12#2)(1996-9#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)
of the hips treated with Frejka pillow and##2##8##(2007-8#2)
of the hips##5##3##(2007-11#2)(2007-8#2)(2013-8#1)
of the histograms##2##3##(2008-10#1)(2008-2#1)
of the histological##2##3##(1992-8#1)(2011-7#1)
of the histology##2##3##(2008-3#1)(2009-1#1)
of the histone##3##3##(1992-8#1)(1994-9#1)(2009-5#1)
of the historical development of##2##5##(2008-6#1)(2013-1#1)
of the historical##6##3##(1995-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the history and physical##2##5##(2007-7#1)(2010-1#1)
of the history and##3##4##(2007-7#1)(2008-5#1)(2010-1#1)
of the history of##9##4##(1993-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-6#1)
of the history##14##3##(1993-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-1#1)(2010-6#1)
of the hitherto##3##3##(1990-11#1)(1997-4#1)(2008-10#1)
of the hole##3##3##(2007-11#1)(2007-12#2)
of the holes##2##3##(2007-11#1)(2007-12#1)
of the hollow##3##3##(2008-11#1)(2008-3#2)
of the holoenzyme##3##3##(1990-8#2)(2008-11#1)
of the hologram##9##3##(2007-12#1)(2008-2#3)(2008-3#5)
of the holograms##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of the holographic aerial image-recording technique##2##6##(2008-3#2)
of the holographic gratings##2##4##(2008-2#1)(2008-3#1)
of the holographic##8##3##(2007-11#1)(2008-2#1)(2008-3#6)
of the home in##2##4##(2007-12#2)
of the home##8##3##(1995-12#1)(1995-3#1)(2007-12#4)(2007-8#1)(2011-2#1)
of the homeobox-containing##3##3##(1992-3#1)(1994-11#2)
of the homeopathic##3##3##(2008-10#3)
of the homologous##5##3##(1990-2#1)(1991-9#1)(1992-8#1)(1993-9#1)(2011-2#1)
of the homologs##3##3##(2008-10#2)(2011-2#1)
of the homozygous##2##3##(1996-12#1)(2008-10#1)
of the honey bee##2##4##(2008-6#1)(2013-1#1)
of the honey##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
of the horizontal##3##3##(1994-3#1)(2007-12#1)(2008-5#1)
of the hormetic##4##3##(2008-7#4)
of the hormonal##2##3##(2007-8#1)(2009-2#1)
of the hormone in##2##4##(1990-2#1)(2010-5#1)
of the hormone##10##3##(1990-12#1)(1990-2#1)(1991-3#1)(1993-9#1)(1995-12#1)(2008-3#2)(2010-5#1)(2011-1#1)(2013-8#1)
of the hormones##4##3##(1994-8#1)(1995-11#1)(2008-1#1)(2009-8#1)
of the hospital and##2##4##(1993-2#1)(2008-8#1)
of the hospital##30##3##(1991-1#2)(1991-3#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#2)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#2)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
of the hospital's##5##3##(1995-3#1)(1996-12#1)(1996-2#1)(2008-3#1)(2010-4#1)
of the hospitals##2##3##(1994-2#1)(1996-1#1)
of the host and##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
of the host by##2##4##(2008-10#2)
of the host cell wall##2##5##(2008-10#2)
of the host cell##5##4##(2008-10#3)(2008-11#2)
of the host defense system##2##5##(1992-10#1)(2013-1#1)
of the host defense##3##4##(1992-10#1)(2008-10#1)(2013-1#1)
of the host gene##2##4##(2008-10#1)(2013-1#1)
of the host plant by##2##5##(2008-10#2)
of the host plant##5##4##(2007-12#1)(2008-10#4)
of the host population##5##4##(1994-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
of the host species##4##4##(2008-10#2)(2008-8#2)
of the host tissue##2##4##(2008-10#2)
of the host tissues##2##4##(2008-10#2)
of the host##88##3##(1990-11#1)(1992-10#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-3#2)(1997-6#1)(2007-12#6)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#8)(2008-9#1)(2009-5#1)(2009-8#3)(2010-1#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#1)
of the hot##2##3##(2009-5#1)(2011-2#1)
of the house##2##3##(1995-6#1)(2010-5#1)
of the hsp70##5##3##(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#2)
of the human 1##2##4##(1990-12#1)(1993-3#1)
of the human A(3) receptor##2##5##(2008-4#2)
of the human AT2R##2##4##(1994-9#2)
of the human ER gene##2##5##(1993-6#2)
of the human GABAA receptor##2##5##(1995-11#2)
of the human IGF-II gene##2##5##(1990-11#2)
of the human NGF##2##4##(1990-8#2)
of the human and##4##4##(1993-6#1)(1997-6#1)(1997-7#1)(2010-5#1)
of the human beta-like globin##3##5##(2008-8#3)
of the human body and##2##5##(2012-3#2)
of the human body##5##4##(1990-2#1)(2008-7#1)(2012-3#2)(2013-1#1)
of the human brain##5##4##(1991-5#1)(1992-3#1)(1994-2#1)(2009-12#1)(2012-12#1)
of the human breast##2##4##(1993-9#1)(2008-3#1)
of the human c-erbA alpha gene##2##6##(1993-3#2)
of the human c-fos##2##4##(1991-12#2)
of the human c-myc gene##3##5##(1992-8#3)
of the human c-myc##4##4##(1992-8#3)(1997-7#1)
of the human cardiac alpha-myosin heavy chain gene##2##8##(1991-9#2)
of the human cell##2##4##(1990-11#1)(1994-6#1)
of the human cerebrum##7##4##(2008-9#7)
of the human chromosome##2##4##(1996-8#1)(1997-8#1)
of the human colon tumor cell lines##2##7##(1992-2#2)
of the human colon##3##4##(1992-2#2)(1992-8#1)
of the human endogenous retrovirus-like sequence##2##6##(1996-12#2)
of the human endometrium##2##4##(1994-9#2)
of the human epidermal growth factor receptor##2##7##(2008-7#1)(2011-2#1)
of the human erythrocyte L-isoaspartyl/D-aspartyl##2##5##(1991-2#2)
of the human erythrocyte##4##4##(1990-11#1)(1991-2#2)(2008-11#1)
of the human estrogen receptor gene##2##6##(1992-3#2)
of the human eye##4##4##(2007-11#1)(2008-3#2)(2011-7#1)
of the human factor##2##4##(1990-5#1)(2008-12#1)
of the human fast skeletal troponin T (TNNT3) gene##2##9##(2008-7#2)
of the human gastrointestinal tract##2##5##(2008-4#1)(2010-10#1)
of the human gene##4##4##(1990-7#1)(1991-6#1)(1991-7#1)(1997-7#1)
of the human genome##6##4##(2008-11#1)(2008-4#2)(2008-7#3)
of the human heart##2##4##(1993-12#1)(1996-2#1)
of the human immune system##3##5##(2008-4#2)(2011-2#1)
of the human immunodeficiency virus (HIV)##3##6##(1991-9#1)(1993-12#1)(2012-2#1)
of the human immunodeficiency virus##5##5##(1991-9#1)(1993-12#1)(1994-8#1)(1997-7#1)(2012-2#1)
of the human insulin##2##4##(1997-8#1)(2008-11#1)
of the human left ventricle##2##5##(2013-1#2)
of the human lung##2##4##(1992-12#1)(2008-11#1)
of the human muscle glycogen phosphorylase gene##2##7##(1991-11#2)
of the human platelet##3##4##(1992-8#1)(2006-6#2)
of the human population##2##4##(2008-5#1)(2012-3#1)
of the human promyelocytic##2##4##(1991-12#1)(1994-6#1)
of the human psoas major muscle##2##6##(2011-2#2)
of the human retina##2##4##(2007-11#2)
of the human skin##2##4##(2008-5#1)(2009-11#1)
of the human thyrotropin (TSH) receptor##2##6##(1991-5#1)(1991-9#1)
of the human thyrotropin##3##4##(1991-5#1)(1991-9#1)(1995-12#1)
of the human type I insulin-like growth factor receptor##2##9##(1991-7#2)
of the human type##3##4##(1991-7#2)(1994-11#1)
of the human##285##3##(1990-11#7)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#4)(1991-9#6)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#2)(1992-8#7)(1992-9#1)(1993-11#4)(1993-12#8)(1993-2#2)(1993-3#6)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#7)(1995-11#5)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#4)(1996-2#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-2#4)(1997-4#3)(1997-6#2)(1997-7#9)(1997-8#3)(1997-9#1)(2006-6#3)(2007-11#6)(2007-7#1)(2008-10#1)(2008-11#12)(2008-12#1)(2008-3#5)(2008-4#11)(2008-5#5)(2008-7#10)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#3)(2011-2#9)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)
of the humeral bone##3##4##(2007-11#3)
of the humeral head##3##4##(2008-7#1)(2008-8#2)
of the humeral##8##3##(2007-11#3)(2007-8#1)(2008-7#1)(2008-8#2)(2012-3#1)
of the humerii##2##3##(2013-8#2)
of the humerus and##2##4##(2013-8#2)
of the humerus were##2##4##(2013-8#2)
of the humerus##14##3##(1995-6#2)(2007-11#1)(2007-8#1)(2008-7#2)(2013-1#1)(2013-8#7)
of the humoral immune##2##4##(1996-9#1)(2008-4#1)
of the humoral response##2##4##(1991-12#1)(2008-10#1)
of the humoral##6##3##(1991-12#1)(1996-9#1)(2008-10#1)(2008-4#1)(2011-1#2)
of the hybrid method##3##4##(2008-3#3)
of the hybrid##12##3##(2008-2#3)(2008-3#4)(2008-5#1)(2008-9#2)(2009-2#1)(2010-4#1)
of the hybrids##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
of the hydatid##2##3##(1991-8#1)(2010-12#1)
of the hydration process in 3CaO##2##6##(2008-10#2)
of the hydration process##3##4##(2008-10#3)
of the hydration##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
of the hydride##2##3##(1994-11#1)(2008-10#1)
of the hydrocarbon chain##3##4##(1990-7#1)(1992-8#1)(2008-10#1)
of the hydrocarbon chains##2##4##(1992-9#1)(1993-11#1)
of the hydrocarbon##5##3##(1990-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(2008-10#1)
of the hydrocarbons##3##3##(1992-3#1)(2008-10#2)
of the hydrogel##5##3##(2008-5#4)(2010-2#1)
of the hydrogen bond##2##4##(1992-3#1)(2008-10#1)
of the hydrogen coma##2##4##(1991-8#2)
of the hydrogen##6##3##(1991-8#2)(1992-3#1)(1992-6#1)(2008-10#2)
of the hydrolysates by##2##4##(2008-6#1)(2008-7#1)
of the hydrolysates##4##3##(1990-7#1)(2008-6#1)(2008-7#2)
of the hydrolysis of wheat starch##2##6##(2008-7#2)
of the hydrolysis of##5##4##(1992-8#1)(1993-8#2)(2008-7#2)
of the hydrolysis##8##3##(1992-8#1)(1993-8#2)(2008-10#2)(2008-7#2)(2010-3#1)
of the hydrolytic##2##3##(1995-2#1)(2008-10#1)
of the hydropathy##3##3##(1990-5#2)(1990-8#1)
of the hydroperoxo##2##3##(1996-2#2)
of the hydrophilic##4##3##(1990-11#1)(1990-2#1)(1995-11#1)(2008-10#1)
of the hydrophobic##10##3##(1991-6#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-2#1)
of the hydroxide residue with##3##5##(2008-10#3)
of the hydroxy##2##3##(2007-11#1)(2008-5#1)
of the hydroxyl radical##2##4##(1991-9#1)(2008-10#1)
of the hydroxyl##7##3##(1991-9#1)(1993-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
of the hyperparasite##3##3##(2008-10#1)(2008-9#2)
of the hypersensitive response (HR)##3##5##(2008-10#3)
of the hypersensitive response##4##4##(2008-10#4)
of the hyphae##2##3##(2008-10#1)(2008-7#1)
of the hypodermis##2##3##(2008-10#1)(2008-5#1)
of the hypophysis##2##3##(1992-12#1)(2009-8#1)
of the hypothalamic paraventricular nucleus##3##5##(1993-12#1)(1994-8#2)
of the hypothalamic paraventricular##4##4##(1993-12#2)(1994-8#2)
of the hypothalamic-pituitary-adrenal (HPA) axis##2##5##(2008-4#1)(2013-1#1)
of the hypothalamic-pituitary-adrenal axis and##2##5##(2008-4#1)(2013-8#1)
of the hypothalamic-pituitary-adrenal axis##4##4##(1997-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
of the hypothalamic-pituitary-adrenal##6##3##(1997-2#1)(2008-4#2)(2008-5#1)(2013-1#1)(2013-8#1)
of the hypothalamo-pituitary-adrenal##2##3##(1994-2#2)
of the hypothalamus##14##3##(1993-12#3)(1993-5#1)(1994-2#4)(1994-5#1)(1995-12#1)(1996-12#2)(1996-2#1)(2008-7#1)
of the hypotheses##2##3##(2008-9#2)
of the hypothesis that##3##4##(1995-11#1)(1995-2#1)(2009-2#1)
of the hypothesis##8##3##(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(2008-11#1)(2008-9#1)(2009-2#1)(2013-1#1)
of the hypovirulent isolate##2##4##(2008-10#2)
of the hypovirulent##3##3##(2008-10#3)
of the ice crystals##2##4##(2008-2#1)(2008-3#1)
of the ice##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of the ideal##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
of the ideas##2##3##(2008-11#1)(2012-1#1)
of the identified##13##3##(1993-6#1)(1995-11#1)(2008-10#3)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
of the identity of##3##4##(1990-12#1)(1997-3#1)(2008-10#1)
of the idler light was##2##5##(2007-12#2)
of the idler##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
of the ileocecal valve##2##4##(1994-5#1)(2010-12#1)
of the ileostomy##2##3##(2009-5#2)
of the ileum##2##3##(2013-1#1)(2013-7#1)
of the iliac##2##3##(1991-11#1)(2008-12#1)
of the illness and##4##4##(1992-11#1)(1992-12#1)(2008-7#1)(2011-1#1)
of the illness##16##3##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1996-1#1)(1996-11#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#2)(2012-2#1)(2012-3#1)
of the illuminated##3##3##(2008-3#3)
of the illuminating beam##2##4##(2008-2#1)(2008-3#1)
of the illuminating##5##3##(2008-2#2)(2008-3#3)
of the illumination source##3##4##(2007-11#2)(2008-3#1)
of the illumination##10##3##(2007-11#2)(2008-2#1)(2008-3#7)
of the image and##2##4##(2008-3#2)
of the image is##2##4##(1995-11#1)(2008-1#1)
of the image of##2##4##(2008-2#1)(2010-8#1)
of the image##30##3##(1995-11#1)(1995-6#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#10)(2008-4#1)(2010-12#1)(2010-8#1)(2010-9#1)(2013-8#1)
of the images##8##3##(1995-11#1)(2007-11#1)(2008-2#1)(2008-3#3)(2012-2#1)(2013-8#1)
of the imaginary##3##3##(2007-12#1)(2008-3#2)
of the imaging system##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
of the imaging##13##3##(1991-12#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#5)(2008-7#1)
of the imidazole##2##3##(2008-10#2)
of the immature stages of##2##5##(2007-10#1)(2008-5#1)
of the immature##5##3##(1994-3#1)(1996-5#1)(2007-10#1)(2008-5#1)(2008-7#1)
of the immediate early##3##4##(1993-12#1)(1993-8#1)(1995-12#1)
of the immediate##7##3##(1990-3#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-12#1)(2008-6#1)(2008-7#1)
of the immobilization and##2##4##(2007-11#1)(2008-10#1)
of the immobilization##3##3##(2007-11#1)(2008-10#2)
of the immobilized enzymes##2##4##(2008-10#2)
of the immobilized##20##3##(1990-12#1)(1993-11#2)(2008-10#13)(2008-12#1)(2008-7#3)
of the immune response##9##4##(1993-12#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2013-1#2)
of the immune system and##4##5##(1990-9#1)(1995-12#1)(1996-11#1)(2012-3#1)
of the immune system for##2##5##(1993-3#1)(2008-10#1)
of the immune system in##4##5##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the immune system to##2##5##(2009-12#1)(2013-7#1)
of the immune system##34##4##(1990-9#1)(1993-3#1)(1995-12#1)(1996-11#1)(2007-2#1)(2007-5#1)(2008-10#8)(2008-4#7)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
of the immune##46##3##(1990-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-4#7)(2008-9#1)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)
of the immunization##3##3##(1995-5#1)(2008-9#1)(2013-1#1)
of the immunoaffinity-purified##2##3##(1990-7#1)(1997-4#1)
of the immunoassay##3##3##(2008-10#3)
of the immunogenicity of##3##4##(1995-5#1)(2008-10#1)(2008-8#1)
of the immunoglobulin superfamily##3##4##(2008-7#1)(2009-6#1)(2009-8#1)
of the immunoglobulin##8##3##(1991-9#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)
of the immunological agglutination##3##4##(1990-12#3)
of the immunological synapse##2##4##(2008-4#2)
of the immunological##8##3##(1990-12#3)(2008-10#2)(2008-4#2)(2008-9#1)
of the immunoprecipitated##3##3##(1992-9#1)(2008-2#2)
of the immunoreaction##2##3##(1994-2#1)(2008-10#1)
of the immunoreactive##2##3##(1990-7#1)(1994-9#1)
of the immunosensing device##2##4##(2008-10#2)
of the immunosensor##6##3##(2008-10#5)(2008-7#1)
of the immunosuppressive##2##3##(1993-11#1)(2008-1#1)
of the impact and##2##4##(2011-2#1)(2012-3#1)
of the impact flux##2##4##(1997-5#2)
of the impact of the##6##5##(1991-2#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-12#1)(2009-2#1)
of the impact of these##2##5##(2007-11#1)(2007-5#1)
of the impact of##28##4##(1991-2#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-5#1)(2007-11#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
of the impact that##2##4##(2008-10#1)(2008-3#1)
of the impact##35##3##(1991-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-5#3)(2007-11#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
of the impacts of##2##4##(1992-3#1)(2008-1#1)
of the impedance##2##3##(2008-10#2)
of the implant##10##3##(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#2)(2011-2#1)
of the implanted##5##3##(1995-11#1)(1997-4#1)(2007-8#1)(2008-9#2)
of the implants##3##3##(2008-6#1)(2013-1#2)
of the implementation and##2##4##(2007-12#1)(2011-2#1)
of the implementation of a##3##5##(2008-9#1)(2012-2#1)(2013-1#1)
of the implementation of an##2##5##(2008-7#1)(2011-2#1)
of the implementation of the##3##5##(1991-1#1)(2008-2#1)(2013-1#1)
of the implementation of##12##4##(1991-1#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the implementation##16##3##(1991-1#1)(1994-3#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
of the implemented##2##3##(2011-3#1)(2012-12#1)
of the implications of##4##4##(1994-2#1)(1996-2#1)(2008-7#1)(2013-1#1)
of the implications##5##3##(1994-2#1)(1996-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
of the importance of early##2##5##(2007-12#1)(2008-11#1)
of the importance of the##2##5##(2007-8#1)(2010-12#1)
of the importance of this##3##5##(1990-5#1)(2008-10#2)
of the importance of##27##4##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1995-1#1)(1997-3#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#3)(2009-7#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
of the importance##28##3##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1995-1#1)(1997-3#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#4)(2009-7#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
of the important factors##2##4##(2008-8#1)(2008-9#1)
of the important role of##2##5##(2008-1#1)(2009-4#1)
of the important##37##3##(1992-12#1)(1992-3#2)(1993-3#1)(1994-3#2)(1995-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
of the imported##2##3##(2008-10#2)
of the imprinted polymer##3##4##(2008-10#3)
of the imprinted##5##3##(2008-10#5)
of the improved##4##3##(1993-8#1)(2008-2#2)(2008-3#1)
of the improvement##4##3##(1996-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
of the impulse##2##3##(1990-8#1)(2008-3#1)
of the impurities##4##3##(2008-10#2)(2010-2#2)
of the impurity##3##3##(2007-11#1)(2008-10#2)
of the in situ##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
of the in vitro##9##4##(1991-3#1)(1993-3#1)(2008-5#4)(2008-7#1)(2009-6#1)(2010-5#1)
of the in vivo##7##4##(1995-3#1)(1997-3#1)(1997-4#1)(2008-5#2)(2008-7#1)(2009-12#1)
of the in##20##3##(1991-3#1)(1993-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#7)(2008-7#2)(2009-12#1)(2009-6#1)(2010-5#1)
of the in-plane##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the inactivation of##2##4##(1993-11#1)(1995-5#1)
of the inactivation##5##3##(1990-8#1)(1991-5#1)(1993-11#1)(1995-5#1)(2008-7#1)
of the inactive##4##3##(1990-3#1)(1993-6#1)(1994-12#1)(2013-1#1)
of the inadequate##2##3##(1992-12#1)(2008-10#1)
of the inbred lines##2##4##(2008-10#1)(2008-5#1)
of the inbred##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
of the incidence of##10##4##(1990-3#1)(1997-5#1)(2008-10#6)(2008-7#1)(2009-8#1)
of the incidence##17##3##(1990-3#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
of the incident beam##9##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
of the incident beams##2##4##(2008-3#2)
of the incident field##2##4##(2007-11#1)(2008-2#1)
of the incident laser beam##4##5##(2007-12#1)(2008-3#3)
of the incident light##7##4##(2007-11#1)(2007-12#2)(2008-3#4)
of the incident radiation##2##4##(2008-2#1)(2008-3#1)
of the incident##37##3##(2007-11#5)(2007-12#8)(2008-11#1)(2008-2#4)(2008-3#19)
of the incinerated##2##3##(1995-6#2)
of the included##2##3##(2008-10#1)(2013-8#1)
of the inclusion complex##5##4##(2008-10#5)
of the inclusion complexes##2##4##(2008-10#2)
of the inclusion of##3##4##(1995-1#1)(2008-10#1)(2008-3#1)
of the inclusion##17##3##(1995-1#1)(2008-10#14)(2008-3#2)
of the inclusions##3##3##(2008-10#2)(2008-2#1)
of the incoherent##2##3##(2008-2#1)(2008-3#1)
of the incoming wave##2##4##(2007-11#1)(2008-3#1)
of the incoming##8##3##(2007-11#2)(2008-1#3)(2008-2#1)(2008-3#2)
of the incorporation of##4##4##(1992-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
of the increase in##8##4##(1990-7#1)(1991-12#1)(1993-8#1)(1994-6#1)(2008-10#3)(2008-11#1)
of the increase of##2##4##(2008-10#1)(2008-9#1)
of the increase##12##3##(1990-7#1)(1991-12#1)(1993-8#1)(1994-6#1)(2008-10#6)(2008-11#1)(2008-9#1)
of the increased##8##3##(1990-6#1)(1994-11#1)(1995-2#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-7#1)
of the increasing number of##2##5##(2008-8#1)(2011-2#1)
of the increasing prevalence of##2##5##(2010-5#1)(2012-3#1)
of the increasing##10##3##(1990-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-3#1)
of the increment##2##3##(2010-10#1)(2012-2#1)
of the incubation period##2##4##(1992-6#1)(2008-10#1)
of the incubation##7##3##(1990-12#1)(1991-2#1)(1992-6#1)(1995-2#1)(2008-10#2)(2011-2#1)
of the independent variable##2##4##(2008-11#2)
of the independent##7##3##(1993-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#3)
of the index of refraction##5##5##(1991-9#1)(2008-2#2)(2008-3#2)
of the index of##7##4##(1991-9#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
of the index##17##3##(1991-9#1)(1996-1#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#1)(2011-2#2)
of the indications##3##3##(1990-9#1)(2009-4#1)(2012-2#1)
of the indicator##8##3##(1990-12#1)(1990-2#1)(2008-10#4)(2008-9#2)
of the indicators##2##3##(1996-2#1)(2008-10#1)
of the indices of refraction of##2##6##(2008-2#2)
of the indices of##4##4##(2008-11#1)(2008-2#2)(2013-8#1)
of the indices##5##3##(2007-11#1)(2008-11#1)(2008-2#2)(2013-8#1)
of the indigenous##2##3##(2008-10#2)
of the indirect##2##3##(2008-10#1)(2008-8#1)
of the individual and##2##4##(1993-12#1)(2008-10#1)
of the individual components of the##2##6##(1994-2#1)(2008-10#1)
of the individual components of##3##5##(1994-2#1)(2008-10#1)(2008-12#1)
of the individual components##5##4##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)
of the individual emitters##2##4##(2007-11#1)(2008-3#1)
of the individual patient and##2##5##(1996-8#1)(2013-8#1)
of the individual patient##3##4##(1996-8#1)(2013-1#1)(2013-8#1)
of the individual species##2##4##(2008-10#2)
of the individual##75##3##(1990-5#1)(1990-6#2)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#3)(1995-2#1)(1995-5#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-7#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
of the individual's##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
of the individuals##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
of the induced absorption##2##4##(2007-12#1)(2008-3#1)
of the induced##18##3##(1990-7#1)(1991-7#1)(1992-9#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-3#4)(2008-5#1)(2009-10#1)(2012-2#1)(2012-3#1)
of the inducer##3##3##(1990-11#1)(1991-9#1)(1994-12#1)
of the inducible isoform##2##4##(1995-11#2)
of the inducible##5##3##(1993-6#1)(1994-8#1)(1995-11#2)(1995-6#1)
of the induction of##6##4##(1995-11#1)(2008-10#2)(2008-11#1)(2011-2#2)
of the induction##9##3##(1990-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2011-2#2)
of the industrial production of##2##5##(2008-6#1)(2012-2#1)
of the industrial##4##3##(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)
of the industry##7##3##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-5#1)
of the infant##5##3##(1992-11#1)(2007-10#1)(2009-12#1)(2010-9#1)(2011-1#1)
of the infant's##2##3##(1993-3#1)(2009-11#1)
of the infants were##2##4##(1991-11#1)(1994-6#1)
of the infants##6##3##(1991-11#1)(1994-6#2)(2008-10#1)(2009-9#1)(2012-2#1)
of the infants'##2##3##(2007-8#1)(2008-10#1)
of the infected##12##3##(1990-6#1)(1990-9#1)(1991-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
of the infection and##2##4##(2008-10#1)(2008-5#1)
of the infection in##4##4##(1990-9#1)(2008-1#1)(2008-7#1)(2008-9#1)
of the infection of##2##4##(2008-10#1)(2008-5#1)
of the infection process##3##4##(2008-10#3)
of the infection##34##3##(1990-9#1)(1991-6#1)(1992-6#1)(1994-5#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#4)(2012-12#1)
of the infections##2##3##(1994-6#1)(2007-10#1)
of the infectious agent##2##4##(1995-5#1)(1996-3#1)
of the infectious##8##3##(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#2)(2010-6#1)(2011-2#1)(2012-3#1)
of the inferior competitor##2##4##(2008-8#2)
of the inferior vena cava##4##5##(2007-8#2)(2008-7#1)(2013-1#1)
of the inferior vena##5##4##(2007-8#2)(2008-7#1)(2009-5#1)(2013-1#1)
of the inferior##9##3##(1990-9#1)(2007-8#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2013-1#1)
of the infirmary##2##3##(2008-10#2)
of the inflammation##2##3##(2007-12#1)(2008-11#1)
of the inflammatory process##4##4##(1992-6#1)(1993-1#1)(2009-12#1)(2009-5#1)
of the inflammatory reaction##2##4##(2008-5#1)(2013-8#1)
of the inflammatory response##3##4##(1991-8#1)(2006-10#1)(2010-8#1)
of the inflammatory##14##3##(1990-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-12#2)(2009-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
of the inflorescence##2##3##(2008-10#2)
of the influence of age##2##5##(2008-8#1)(2010-10#1)
of the influence of the##4##5##(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)
of the influence of##20##4##(1990-11#1)(1993-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2013-1#1)
of the influenza virus##2##4##(1997-6#1)(2012-12#1)
of the influenza##6##3##(1997-6#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the information available##2##4##(2008-4#1)(2011-2#1)
of the information storage##2##4##(2007-8#1)(2008-3#1)
of the information##23##3##(1995-2#1)(1996-3#2)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
of the infrabuccal##2##3##(2007-12#2)
of the infrared detection efficiency of##2##6##(2007-11#2)
of the infrared##6##3##(2007-11#2)(2007-12#1)(2008-3#2)(2013-8#1)
of the infusion##3##3##(1997-3#1)(2008-7#2)
of the ingested##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
of the ingroup and outgroup##2##5##(2009-11#2)
of the inhaled##5##3##(1990-8#2)(1992-3#1)(2007-11#1)(2013-1#1)
of the inherent optical properties of##2##6##(2008-3#2)
of the inherent optical properties##3##5##(2008-3#3)
of the inherent##8##3##(1994-5#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)
of the inherited##2##3##(1997-7#1)(2008-7#1)
of the inhibition of##6##4##(1990-5#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-8#1)(2013-7#1)
of the inhibition period and##3##5##(1991-12#3)
of the inhibition period##4##4##(1991-12#4)
of the inhibition##20##3##(1990-5#1)(1991-12#4)(1992-6#2)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-8#1)(2013-7#1)
of the inhibitor to##2##4##(2008-4#1)(2008-6#1)
of the inhibitor##17##3##(1990-11#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-2#1)(1996-12#1)(2007-7#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2013-1#1)
of the inhibitors##9##3##(1992-3#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-5#1)(2009-9#1)
of the inhibitory effect##3##4##(1992-12#1)(1993-12#1)(2008-10#1)
of the inhibitory##20##3##(1990-2#3)(1992-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)
of the inhomogeneity##2##3##(1996-4#1)(2008-7#1)
of the initial activity##2##4##(1990-2#1)(2008-10#1)
of the initial and##2##4##(1993-11#1)(2008-10#1)
of the initial inoculum##2##4##(2008-10#2)
of the initial##61##3##(1990-12#3)(1990-2#2)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-5#1)(2007-12#2)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#2)
of the initially##2##3##(2008-2#2)
of the initiative##4##3##(1994-12#1)(1995-2#1)(2008-11#1)(2012-2#1)
of the initiator##3##3##(1990-8#1)(1991-12#1)(2012-12#1)
of the injected dose##2##4##(1993-11#1)(2013-1#1)
of the injected sample##2##4##(2008-10#2)
of the injected##9##3##(1991-12#1)(1993-11#1)(1993-6#1)(1995-12#2)(2008-10#3)(2013-1#1)
of the injection##8##3##(1993-3#1)(1994-9#1)(1997-5#2)(2007-12#1)(2008-10#2)(2008-12#1)
of the injured extremity##2##4##(2007-11#2)
of the injured were##2##4##(1992-6#1)(2007-2#1)
of the injured##12##3##(1990-6#1)(1992-6#1)(1992-9#1)(1995-8#1)(1997-3#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)(2012-7#1)
of the injuries##3##3##(1990-6#1)(1995-8#1)(2008-9#1)
of the injury##6##3##(1994-5#1)(1996-5#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
of the innate immune system##6##5##(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the innate immune##7##4##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the innate##8##3##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the inner arms##2##4##(1991-2#2)
of the inner core##3##4##(1995-3#2)(2008-8#1)
of the inner ear##5##4##(1993-9#1)(1994-9#1)(1995-5#1)(2008-4#1)(2008-9#1)
of the inner##25##3##(1991-2#2)(1991-5#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-3#3)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
of the innovative##2##3##(1997-3#1)(2008-5#1)
of the inoculated stalk pieces##2##5##(2008-10#2)
of the inoculated##10##3##(2008-10#7)(2008-5#2)(2012-3#1)
of the inoculum##5##3##(1991-11#1)(2008-10#3)(2008-5#1)
of the inositol##4##3##(1990-7#2)(1993-6#1)(2010-9#1)
of the inpatient##3##3##(1992-3#1)(1993-12#1)(2010-12#1)
of the input and the reference##2##6##(2007-12#1)(2008-3#1)
of the input and##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the input light##3##4##(2008-2#1)(2008-3#2)
of the input pulse##2##4##(2007-12#2)
of the input pulses##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of the input spike trains##2##5##(2008-11#2)
of the input##35##3##(1992-6#1)(1993-12#1)(2007-11#4)(2007-12#7)(2008-11#2)(2008-2#8)(2008-3#10)(2010-8#1)(2012-2#1)
of the inputs##4##3##(1992-2#1)(2007-11#1)(2008-3#2)
of the insanity defense##5##4##(2011-1#5)
of the insect brain##2##4##(2007-12#2)
of the insect##10##3##(2007-12#5)(2008-10#1)(2008-11#2)(2008-3#1)(2012-2#1)
of the insert##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
of the inserted gene(s)##2##4##(1997-8#2)
of the inserted genes##2##4##(1997-8#2)
of the inserted##7##3##(1994-12#1)(1997-8#4)(2007-8#1)(2008-10#1)
of the insertion of##2##4##(2008-12#1)(2013-1#1)
of the insertion##7##3##(1990-11#1)(2008-12#1)(2008-3#1)(2009-7#3)(2013-1#1)
of the inserts##2##3##(2008-10#1)(2008-5#1)
of the insights##2##3##(2008-9#1)(2009-5#1)
of the insoluble##2##3##(1990-5#1)(1994-12#1)
of the instability##3##3##(2007-11#1)(2011-7#1)(2012-3#1)
of the instantaneous##3##3##(1990-11#1)(2007-12#1)(2010-8#1)
of the institution##5##3##(1994-1#1)(1994-12#1)(2008-9#1)(2009-7#1)(2012-12#1)
of the institution's##3##3##(1991-3#1)(1996-2#1)(1996-3#1)
of the instrument for##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
of the instrument in##2##4##(2008-1#1)(2008-2#1)
of the instrument is##4##4##(2007-11#1)(2008-10#1)(2008-3#2)
of the instrument we##2##4##(2007-12#1)(2008-3#1)
of the instrument were##2##4##(2008-11#1)(2013-8#1)
of the instrument##43##3##(1993-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#18)(2008-9#1)(2009-12#1)(2012-2#1)(2013-8#3)
of the instrument's performance##2##4##(2007-11#1)(2008-3#1)
of the instrument's##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
of the instrumental##6##3##(1991-3#1)(2008-10#3)(2008-3#2)
of the instruments##8##3##(2008-10#1)(2008-3#3)(2010-5#1)(2011-2#1)(2013-1#2)
of the insulin gene##2##4##(2008-4#1)(2010-11#1)
of the insulin receptor kinase##2##5##(1991-12#2)
of the insulin receptor##12##4##(1990-11#2)(1991-12#5)(1992-12#1)(1993-8#1)(1994-12#1)(1997-6#1)(2008-4#1)
of the insulin##23##3##(1990-11#2)(1991-12#5)(1992-12#1)(1992-3#2)(1992-6#2)(1993-8#1)(1994-12#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-4#2)(2010-11#4)
of the insurance##2##3##(1997-5#1)(2008-7#1)
of the intact and##2##4##(1996-12#1)(2010-4#1)
of the intact jejunum##2##4##(2008-10#2)
of the intact##17##3##(1991-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-4#1)(2013-8#1)
of the integral##2##3##(2008-2#1)(2012-1#1)
of the integrase##2##3##(1992-6#1)(1997-3#1)
of the integrate-and-fire type##2##4##(2008-11#2)
of the integrated##8##3##(1997-2#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-3#2)(2013-8#2)
of the integration method and##2##5##(2008-3#2)
of the integration method##3##4##(2008-3#3)
of the integration of##3##4##(2008-10#1)(2009-12#1)(2012-3#1)
of the integration##9##3##(2007-11#1)(2008-10#1)(2008-3#5)(2009-12#1)(2012-3#1)
of the integrin##6##3##(1992-12#1)(1994-6#1)(1994-9#2)(2006-6#1)(2008-1#1)
of the integrity of the##3##5##(2008-10#1)(2011-2#1)(2012-3#1)
of the intellectual##4##3##(1993-12#1)(2011-2#2)(2012-2#1)
of the intelligentsia in##2##4##(2008-12#2)
of the intended##3##3##(2007-11#1)(2009-8#1)(2012-12#1)
of the intensities of##2##4##(1994-7#1)(2008-8#1)
of the intensity and the phase of the##2##8##(2007-11#1)(2007-12#1)
of the intensity and##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of the intensity distribution##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the intensity of the##4##5##(2007-11#1)(2007-12#1)(2008-10#2)
of the intensity of##12##4##(1992-1#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)
of the intensity profile of the##2##6##(2008-2#1)(2008-3#1)
of the intensity##33##3##(1992-1#1)(1997-2#1)(2007-11#7)(2007-12#3)(2008-10#6)(2008-2#7)(2008-3#7)(2008-4#1)
of the inter atrial septum##2##5##(2012-3#2)
of the interacting waves##4##4##(2007-11#2)(2007-12#2)
of the interacting##7##3##(2007-11#2)(2007-12#2)(2008-11#2)(2009-12#1)
of the interaction between the##2##5##(2008-10#1)(2008-7#1)
of the interaction between##14##4##(1992-12#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2013-1#1)
of the interaction of the##3##5##(1994-5#1)(2008-2#1)(2008-3#1)
of the interaction of##14##4##(1993-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2013-7#1)
of the interaction##46##3##(1992-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-10#1)(2008-10#20)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-5#1)(2013-1#1)(2013-7#1)
of the interactions between##6##4##(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)
of the interactions of##3##4##(1991-9#1)(1997-2#1)(2012-3#1)
of the interactions##15##3##(1991-9#1)(1992-3#1)(1992-6#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
of the intercellular##4##3##(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
of the intercept##3##3##(2008-10#3)
of the interconnect##2##3##(2008-3#2)
of the interdependence between##2##4##(2009-8#2)
of the interface is##2##4##(2007-12#1)(2008-3#1)
of the interface of##2##4##(2008-10#1)(2008-8#1)
of the interface##7##3##(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)
of the interfaces##4##3##(2008-3#4)
of the interfacial##4##3##(1994-9#1)(2008-10#2)(2008-3#1)
of the interference fringes##4##4##(2008-3#4)
of the interference of##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
of the interference pattern##4##4##(2007-11#1)(2008-3#3)
of the interference signal##3##4##(2007-11#1)(2008-3#2)
of the interference##24##3##(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#11)(2013-8#1)
of the interferences##2##3##(2008-10#2)
of the interfering cations##2##4##(2008-10#2)
of the interfering##3##3##(2008-10#3)
of the interferogram##2##3##(2008-2#2)
of the interferograms##3##3##(2008-2#2)(2008-3#1)
of the interferometer and##2##4##(2007-11#1)(2008-3#1)
of the interferometer is##5##4##(2007-12#1)(2008-3#4)
of the interferometer with##2##4##(2007-11#1)(2008-3#1)
of the interferometer##20##3##(2007-11#5)(2007-12#2)(2008-2#2)(2008-3#11)
of the interferometric signal##2##4##(2008-3#2)
of the interferometric##5##3##(2007-11#2)(2008-3#3)
of the intergenic region##2##4##(2008-10#2)
of the intergenic spacer (IGS)##2##5##(2008-10#2)
of the intergenic spacer##3##4##(2008-10#3)
of the intergenic##5##3##(2008-10#5)
of the interhyoid muscle##4##4##(2011-2#4)
of the interhyoid##5##3##(2011-2#5)
of the interior of##3##4##(1994-11#1)(2007-11#2)
of the interior residues##2##4##(1995-11#2)
of the interior##7##3##(1992-3#1)(1994-11#1)(1995-11#2)(2007-11#2)(2008-3#1)
of the interlaboratory study were##2##5##(2008-10#1)(2008-5#1)
of the interleukin-2 receptor##3##4##(1990-5#1)(1991-9#1)(1997-5#1)
of the intermediate results##2##4##(2008-3#2)
of the intermediate##16##3##(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#2)(2010-10#1)(2013-1#1)
of the intermediates##4##3##(1990-8#2)(1994-12#1)(1997-4#1)
of the internal auditory canal##2##5##(2006-12#1)(2008-7#1)
of the internal carotid artery in##2##6##(2007-10#1)(2008-7#1)
of the internal carotid artery##9##5##(2006-12#1)(2007-10#1)(2008-7#5)(2011-2#1)(2012-3#1)
of the internal field##3##4##(2008-2#2)(2008-3#1)
of the internal jugular##5##4##(1992-12#2)(2012-3#3)
of the internal standard##2##4##(2008-10#1)(2008-9#1)
of the internal transcribed spacer (ITS) region of the ribosomal##2##10##(2008-10#1)(2008-5#1)
of the internal transcribed spacer (ITS) region of the##3##9##(2008-10#2)(2008-5#1)
of the internal transcribed spacer (ITS) region of##6##8##(2008-10#5)(2008-5#1)
of the internal transcribed spacer (ITS) region##8##7##(2008-10#7)(2008-5#1)
of the internal transcribed spacer (ITS) regions of##2##8##(2008-10#2)
of the internal transcribed spacer (ITS) regions##3##7##(2008-10#3)
of the internal transcribed spacer (ITS)##13##6##(2008-10#11)(2008-5#1)(2010-10#1)
of the internal transcribed spacer 1##3##6##(2008-10#3)
of the internal transcribed spacer of the##2##7##(2008-10#2)
of the internal transcribed spacer region##4##6##(2008-10#4)
of the internal transcribed spacer regions of##2##7##(2008-10#2)
of the internal transcribed spacer##26##5##(2008-10#24)(2008-5#1)(2010-10#1)
of the internal transcribed##27##4##(2008-10#24)(2008-5#1)(2009-2#1)(2010-10#1)
of the internal##77##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-5#1)(1996-9#1)(2006-12#2)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#30)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#6)(2008-9#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#5)
of the internalization of##2##4##(2007-12#2)
of the international##7##3##(1991-9#1)(1993-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
of the internet##4##3##(2008-12#2)(2012-3#2)
of the interplay between##4##4##(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)
of the interpretation of##2##4##(1994-2#1)(1997-8#1)
of the interpretation##3##3##(1994-2#1)(1995-11#1)(1997-8#1)
of the interrelations##2##3##(1993-12#1)(1993-6#1)
of the interrelationship##2##3##(2008-10#1)(2011-2#1)
of the interrelationships of##2##4##(2008-4#1)(2008-7#1)
of the interrelationships##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
of the interspecific##2##3##(2008-10#1)(2008-8#1)
of the intervention and##2##4##(2008-1#1)(2008-8#1)
of the intervention are##2##4##(1995-12#1)(2013-1#1)
of the intervention was##2##4##(2008-2#1)(2008-8#1)
of the intervention##22##3##(1993-1#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-8#3)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the interventions were##2##4##(2012-2#2)
of the interventions##8##3##(1995-3#1)(1996-2#1)(2009-11#1)(2009-6#1)(2012-2#3)(2013-1#1)
of the intervertebral disc##11##4##(2007-11#7)(2007-8#3)(2012-2#1)
of the intervertebral##14##3##(2007-11#9)(2007-8#3)(2010-9#1)(2012-2#1)
of the interview transcripts##3##4##(1993-3#1)(2009-5#1)(2013-1#1)
of the interview##7##3##(1990-6#1)(1993-3#1)(1997-1#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
of the interviewees##2##3##(2008-12#1)(2011-2#1)
of the intestinal mucosa##2##4##(1996-3#1)(2008-7#1)
of the intestinal##12##3##(1992-12#2)(1992-6#1)(1993-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-1#2)(2012-1#1)
of the intestine##4##3##(1990-2#2)(1993-9#1)(2008-5#1)
of the intestines##2##3##(1992-11#1)(2008-10#1)
of the intimal hyperplasia in##2##5##(2006-6#2)
of the intracavity laser##2##4##(2007-11#1)(2007-12#1)
of the intracavity##9##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#4)
of the intracellular Ca2+ concentration##2##5##(1992-8#1)(1994-6#1)
of the intracellular##17##3##(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#1)(2008-11#2)(2008-4#2)(2008-7#2)
of the intracranial##4##3##(2006-12#1)(2007-9#1)(2008-7#1)(2011-2#1)
of the intramuscular connective tissue##2##5##(2010-2#1)(2013-1#1)
of the intramuscular fat##2##4##(2010-4#2)
of the intramuscular##4##3##(2010-2#1)(2010-4#2)(2013-1#1)
of the intranasal##2##3##(2007-11#1)(2008-10#1)
of the intrathoracic##3##3##(1993-5#2)(2007-8#1)
of the intrauterine##2##3##(1994-3#1)(1994-9#1)
of the intravesical##2##3##(2008-10#2)
of the intricate##3##3##(1993-5#1)(2008-10#1)(2010-8#1)
of the intrinsic function##2##4##(2008-3#2)
of the intrinsic##19##3##(1990-11#1)(1990-5#1)(1991-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-8#1)(2009-12#1)
of the introduced plasmid##2##4##(1994-9#1)(2008-8#1)
of the introduced##7##3##(1994-9#1)(2008-10#4)(2008-5#1)(2008-8#1)
of the introduction of a##3##5##(1997-3#1)(2008-11#2)
of the introduction of new##3##5##(1995-5#1)(2007-12#1)(2008-10#1)
of the introduction of the##2##5##(2008-11#1)(2011-1#1)
of the introduction of##12##4##(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
of the introduction##13##3##(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
of the intron##5##3##(1991-5#1)(1992-10#1)(1993-12#1)(1994-12#1)(1995-8#1)
of the introns##3##3##(1995-6#1)(1997-6#1)(1997-8#1)
of the inulinase##2##3##(2008-6#1)(2011-1#1)
of the invading##2##3##(2008-10#2)
of the invasion process##2##4##(1994-9#1)(2008-10#1)
of the invasion##4##3##(1991-12#1)(1994-9#1)(2008-10#1)(2013-1#1)
of the inverse##3##3##(2008-2#1)(2008-3#2)
of the inversion algorithm##2##4##(2008-3#2)
of the inversion##5##3##(2008-3#4)(2013-1#1)
of the inverted##5##3##(1990-2#1)(2008-2#1)(2008-3#2)(2008-5#1)
of the investigated compounds in##2##5##(2008-10#2)
of the investigated compounds##4##4##(2007-11#1)(2008-10#3)
of the investigated drugs##4##4##(2008-10#3)(2008-11#1)
of the investigated species##2##4##(2007-12#2)
of the investigated##25##3##(1990-11#1)(1995-3#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-11#1)(2008-3#3)(2013-8#1)
of the investigation of##2##4##(2008-10#1)(2008-11#1)
of the investigation##9##3##(1993-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#1)
of the investigations##2##3##(2009-5#1)(2013-1#1)
of the invited##2##3##(1995-12#1)(2008-7#1)
of the involved hip##2##4##(2007-8#1)(2008-12#1)
of the involved##9##3##(1992-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#1)
of the involvement of##10##4##(1991-9#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-7#2)(2011-1#1)(2012-1#1)
of the iodate##2##3##(2008-10#2)
of the iodide##2##3##(1996-2#1)(2008-10#1)
of the ion associate##3##4##(2008-10#3)
of the ion association##4##4##(2008-10#4)
of the ion exchanger##4##4##(2008-10#4)
of the ion pair##2##4##(2008-10#2)
of the ion transport##2##4##(1997-1#2)
of the ion##23##3##(1990-12#1)(1997-1#2)(1997-7#1)(2008-10#17)(2008-7#1)(2013-8#1)
of the ion-pair formed between##2##5##(2008-10#2)
of the ion-pair##4##3##(2008-10#4)
of the ionic fraction of heavy metals##2##7##(2008-10#2)
of the ionic strength##4##4##(1997-2#1)(2008-10#3)
of the ionic##14##3##(1997-2#1)(2008-10#11)(2008-9#1)(2010-7#1)
of the ionization##2##3##(2008-10#1)(2008-3#1)
of the ipsilateral##4##3##(1992-3#1)(1993-3#1)(1996-12#1)(2008-12#1)
of the iron chalcogenide glass##2##5##(2008-10#2)
of the iron##10##3##(1991-5#2)(1992-8#1)(1993-11#1)(1995-11#1)(2007-7#1)(2008-10#3)(2011-2#1)
of the iron(III)##2##3##(1997-7#1)(2008-10#1)
of the irradiance##4##3##(2008-3#3)(2011-1#1)
of the irradiated LDH##2##4##(2011-2#2)
of the irradiated##8##3##(1993-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-7#1)
of the irradiation##2##3##(2007-11#1)(2008-8#1)
of the irrigation methods##2##4##(2008-10#2)
of the irrigation##5##3##(2008-10#5)
of the ischemic##4##3##(2008-10#2)(2008-2#1)(2009-10#1)
of the islet##4##3##(1992-6#1)(1995-8#1)(2010-11#2)
of the islets##3##3##(1995-2#1)(2010-11#2)
of the isoamylase##2##3##(1990-11#2)
of the isocoumarin ring##2##4##(1991-3#2)
of the isolate##6##3##(2008-10#5)(2008-7#1)
of the isolated clones##3##4##(1993-6#1)(1995-2#1)(1996-10#1)
of the isolated compounds##2##4##(2008-11#1)(2013-1#1)
of the isolated enzyme##3##4##(1990-7#1)(1992-3#1)(1993-11#1)
of the isolated mature##2##4##(2008-11#2)
of the isolated proteins and##2##5##(1992-3#1)(1994-5#1)
of the isolated proteins##3##4##(1992-3#1)(1993-6#1)(1994-5#1)
of the isolated##34##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-3#4)(1993-11#3)(1993-6#2)(1993-8#1)(1994-5#2)(1995-2#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#5)(2009-10#1)(2010-12#1)(2010-4#1)(2013-1#1)
of the isolates and##2##4##(2008-12#2)
of the isolates belonged to##2##5##(2008-10#2)
of the isolates from##2##4##(1992-2#1)(1997-4#1)
of the isolates in the##2##5##(2008-10#1)(2008-5#1)
of the isolates in##4##4##(2008-10#3)(2008-5#1)
of the isolates were resistant##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
of the isolates were##14##4##(1991-8#1)(2007-7#1)(2008-10#8)(2008-5#1)(2008-7#2)(2011-2#1)
of the isolates##56##3##(1991-8#1)(1992-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-7#2)(2008-10#34)(2008-12#3)(2008-5#2)(2008-7#3)(2010-10#1)(2010-8#1)(2011-2#4)(2012-3#1)
of the isolation of##2##4##(1990-7#1)(2008-5#1)
of the isolation##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
of the isomers##2##3##(2008-10#2)
of the isoprenoid metabolism##2##4##(1990-12#1)(2012-2#1)
of the isotope##2##3##(2008-10#1)(2008-9#1)
of the isozyme##2##3##(1991-12#1)(2008-10#1)
of the issue of##2##4##(2008-11#1)(2009-6#1)
of the issue##5##3##(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2013-1#1)
of the issues involved in##3##5##(1991-12#2)(1993-2#1)
of the issues involved##4##4##(1991-12#2)(1993-2#1)(2008-9#1)
of the issues surrounding##2##4##(2008-10#1)(2013-8#1)
of the issues that##6##4##(1991-3#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)
of the issues##22##3##(1991-12#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#2)(2008-9#1)(2009-6#1)(2013-8#1)
of the items##5##3##(1990-11#1)(1994-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
of the iterative##3##3##(2008-10#1)(2008-3#2)
of the iturin lipopeptides##2##4##(1994-2#2)
of the jaw##7##3##(1997-3#1)(2008-7#2)(2010-9#1)(2011-2#2)(2012-12#1)
of the jaws##10##3##(2007-12#3)(2008-1#2)(2012-12#3)(2013-1#2)
of the jejunum##5##3##(1990-9#1)(1992-5#1)(1995-3#2)(2008-10#1)
of the jelly##3##3##(1992-8#1)(2008-8#2)
of the job##2##3##(1991-2#1)(1992-1#1)
of the joint is##2##4##(2007-8#1)(2011-1#1)
of the joint transform power##2##5##(2008-2#1)(2008-3#1)
of the joint transform##4##4##(2008-2#2)(2008-3#2)
of the joint##27##3##(2007-11#6)(2007-8#5)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#2)(2011-1#1)(2011-2#2)(2013-1#1)
of the joints##3##3##(1990-6#1)(2007-11#1)(2009-7#1)
of the journal##7##3##(1991-2#1)(1992-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2013-1#2)
of the judge##2##3##(2009-8#2)
of the junction##2##3##(2007-12#1)(2008-7#1)
of the karyosome capsule##2##4##(2007-12#2)
of the karyosome in##2##4##(2007-12#1)(2008-7#1)
of the karyosome##6##3##(2007-12#3)(2008-7#3)
of the keratin##3##3##(1991-12#1)(2008-5#1)(2009-10#1)
of the keratinocytes##2##3##(1993-11#1)(1995-11#1)
of the kernel##2##3##(2008-1#1)(2008-2#1)
of the key enzymes##4##4##(1994-12#1)(1994-3#1)(2008-9#2)
of the key##39##3##(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of the kidney and##3##4##(2007-7#1)(2008-10#1)(2008-12#1)
of the kidney in##2##4##(2008-10#2)
of the kidney parenchyma##2##4##(2011-1#2)
of the kidney##23##3##(1994-5#1)(2007-7#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-1#2)(2011-2#2)(2013-1#2)
of the kidneys in##2##4##(2008-4#2)
of the kidneys##11##3##(2007-7#2)(2008-1#1)(2008-4#7)(2012-1#1)
of the kinase##12##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-2#4)(1995-6#1)(2013-8#1)
of the kind of##3##4##(2008-10#1)(2008-7#1)(2009-10#1)
of the kind##4##3##(2008-10#2)(2008-7#1)(2009-10#1)
of the kindling-like state##2##4##(1997-2#2)
of the kinetic constants##2##4##(1991-3#1)(2008-10#1)
of the kinetic data##2##4##(1995-5#1)(2008-10#1)
of the kinetic parameters##4##4##(1990-5#1)(1992-3#1)(1995-12#1)(2009-11#1)
of the kinetic##14##3##(1990-5#2)(1991-3#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-6#1)(2009-10#1)(2009-11#1)(2010-5#1)
of the kinetics of the##2##5##(2008-10#1)(2010-5#1)
of the kinetics of##6##4##(1990-8#1)(1994-12#1)(1994-5#1)(2008-10#1)(2010-5#2)
of the kinetics##7##3##(1990-8#1)(1994-12#1)(1994-5#1)(2008-10#1)(2010-5#3)
of the kinoform##2##3##(2008-2#2)
of the knee and hip##3##5##(2007-8#3)
of the knee and##4##4##(2007-8#4)
of the knee are##2##4##(2007-8#1)(2012-2#1)
of the knee in##3##4##(2008-8#1)(2009-3#1)(2012-3#1)
of the knee is a##2##5##(2010-12#1)(2013-1#1)
of the knee is##3##4##(2007-8#1)(2010-12#1)(2013-1#1)
of the knee joint##16##4##(1997-8#1)(2007-11#5)(2007-8#8)(2009-3#1)(2009-4#1)
of the knee joints##3##4##(2007-11#1)(2011-2#2)
of the knee performed##2##4##(2007-11#1)(2012-2#1)
of the knee##70##3##(1990-11#1)(1993-3#1)(1996-3#3)(1997-8#1)(2007-11#12)(2007-8#21)(2008-11#2)(2008-12#2)(2008-6#1)(2008-8#2)(2009-3#2)(2009-4#1)(2010-12#4)(2011-2#4)(2012-2#7)(2012-3#1)(2013-1#5)
of the knees##2##3##(2008-7#1)(2013-1#1)
of the knowledge and##2##4##(1991-1#1)(2012-12#1)
of the knowledge##7##3##(1991-1#1)(2008-7#3)(2012-12#1)(2012-3#2)
of the known##13##3##(1992-12#1)(1992-3#1)(1993-6#1)(1995-2#1)(1996-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#1)
of the label##2##3##(1991-5#1)(2008-11#1)
of the labeled##5##3##(1990-12#1)(1992-12#1)(1994-2#1)(1994-6#1)(2008-10#1)
of the labelled claim##2##4##(1996-2#2)
of the labelled##5##3##(1994-2#1)(1996-2#2)(2008-10#2)
of the labial gland##2##4##(2007-12#2)
of the labium##2##3##(2007-12#2)
of the laboratories##3##3##(2007-7#1)(2008-10#2)
of the laboratory##14##3##(1990-8#1)(1992-11#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-2#1)(2013-7#1)
of the labrum is##2##4##(2007-12#2)
of the labrum##5##3##(2007-12#5)
of the lac##5##3##(1990-5#2)(1992-3#1)(1995-2#1)(2008-10#1)
of the lacZ alpha fragment##2##5##(1997-4#2)
of the lacZ##7##3##(1991-7#1)(1997-4#2)(1997-6#2)(1997-7#1)(2009-12#1)
of the lack of effect##2##5##(2012-2#1)(2013-1#1)
of the lack of##15##4##(1990-6#1)(1992-9#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-8#1)
of the lacquer films##2##4##(2008-10#2)
of the lacrimal##4##3##(1995-9#1)(2011-1#2)(2011-2#1)
of the lactate##3##3##(1990-8#1)(1994-9#1)(2008-10#1)
of the lactone##2##3##(1994-3#1)(2007-11#1)
of the lag period##2##4##(2008-10#2)
of the lag time between##2##5##(2008-10#2)
of the lag##6##3##(2008-10#4)(2008-5#1)(2011-2#1)
of the lagoon##2##3##(2013-7#2)
of the lake##2##3##(1996-6#2)
of the lamellar##2##3##(2008-2#1)(2008-5#1)
of the lamina##3##3##(1997-3#1)(2008-4#1)(2013-7#1)
of the laminin fragments##2##4##(1997-1#2)
of the laminin##4##3##(1991-2#1)(1997-1#2)(2013-8#1)
of the lamprey##4##3##(1993-3#1)(1997-3#3)
of the lanthanide##3##3##(1990-11#1)(2008-10#1)(2008-4#1)
of the lanthanides##2##3##(2008-10#2)
of the laparoscopic##2##3##(2013-1#2)
of the large and##2##4##(1997-6#1)(2011-2#1)
of the large bowel##6##4##(1993-8#1)(1993-9#4)(2008-10#1)
of the large intestine##6##4##(1990-11#1)(1991-6#1)(1993-9#2)(2007-8#1)(2011-2#1)
of the large number of##3##5##(2008-1#1)(2008-6#1)(2012-1#1)
of the large subunit##5##4##(1992-8#3)(2008-10#1)(2010-4#1)
of the large##49##3##(1990-11#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#3)(1993-8#3)(1993-9#6)(1996-5#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#3)(2009-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)
of the larger##6##3##(1990-11#1)(1993-12#1)(1994-1#1)(1997-4#1)(2008-3#1)(2011-2#1)
of the largest##13##3##(1991-2#1)(1993-12#1)(1995-6#1)(1997-5#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
of the larvae##7##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2010-8#1)(2011-2#1)
of the larval##6##3##(2007-12#3)(2008-10#1)(2008-7#2)
of the larynx##10##3##(1991-4#1)(1992-2#2)(1993-6#3)(1993-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
of the laser and##3##4##(2008-3#3)
of the laser as##2##4##(1991-1#1)(2008-3#1)
of the laser beam and##2##5##(2008-3#2)
of the laser beam##21##4##(1993-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#10)
of the laser cavity##2##4##(2007-12#1)(2008-3#1)
of the laser current##2##4##(2008-3#2)
of the laser diode##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
of the laser has been##2##5##(2008-3#2)
of the laser in the##2##5##(2008-3#2)
of the laser in##3##4##(2008-3#2)(2012-3#1)
of the laser is demonstrated##2##5##(2007-11#1)(2007-12#1)
of the laser is##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
of the laser light##2##4##(2007-11#1)(2008-2#1)
of the laser performance##3##4##(2008-2#1)(2008-3#2)
of the laser power##3##4##(1992-12#1)(2008-3#2)
of the laser radiation were##2##5##(2008-2#1)(2008-3#1)
of the laser radiation##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the laser source##4##4##(2008-2#2)(2008-3#1)(2008-9#1)
of the laser system##2##4##(2008-2#2)
of the laser temporal pulse##2##5##(2008-10#2)
of the laser was##2##4##(2008-3#1)(2012-3#1)
of the laser with the##2##5##(2007-11#1)(2008-10#1)
of the laser##111##3##(1991-1#1)(1991-3#1)(1992-12#1)(1993-3#2)(2007-11#11)(2007-12#19)(2008-10#6)(2008-2#25)(2008-3#42)(2008-9#1)(2012-3#2)
of the laser's output##2##4##(2008-3#2)
of the laser's##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
of the laser-induced fluorescence##2##4##(2008-3#2)
of the laser-induced##4##3##(2007-12#1)(2008-3#3)
of the laserlike##2##3##(2007-12#1)(2008-3#1)
of the lasers##3##3##(2007-11#1)(2008-3#2)
of the lasing##4##3##(2007-12#2)(2008-2#2)
of the last 30 years##2##5##(2008-5#1)(2013-1#1)
of the last century##3##4##(2007-8#1)(2008-7#1)(2013-7#1)
of the last four phases of the strategy##2##8##(1996-1#1)(1996-2#1)
of the last instar larva and pupa of Cryptophlebia cortesi Clarke##2##11##(2008-6#2)
of the last two decades##3##5##(2007-12#1)(2008-5#1)(2010-10#1)
of the last##31##3##(1990-10#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-5#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
of the late blight pathogen Phytophthora infestans##2##7##(2008-10#2)
of the late blight pathogen##4##5##(2008-10#4)
of the late##10##3##(1995-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#2)
of the latent##6##3##(1992-12#1)(1992-2#2)(2008-10#1)(2009-4#1)(2010-11#1)
of the later##2##3##(1992-5#1)(2008-7#1)
of the lateral hypothalamus##3##4##(1992-10#1)(1996-2#1)(2009-10#1)
of the lateral nucleus of the amygdala##2##7##(1993-6#2)
of the lateral recess##2##4##(2008-7#1)(2011-2#1)
of the lateral ventricle##3##4##(1996-7#1)(2008-7#2)
of the lateral ventricles##3##4##(1991-8#1)(1996-5#2)
of the lateral##40##3##(1991-8#1)(1992-10#1)(1993-12#3)(1993-2#1)(1993-6#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#6)(1997-8#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
of the latest##3##3##(1992-9#1)(2008-8#1)(2009-10#1)
of the latex films##2##4##(2008-10#2)
of the latex##6##3##(1990-7#1)(2008-10#4)(2008-5#1)
of the latissimus dorsi##2##4##(1990-9#1)(2013-1#1)
of the latter and##2##4##(2008-8#1)(2009-8#1)
of the latter in##2##4##(1991-11#1)(2008-10#1)
of the latter on##2##4##(1997-2#1)(2007-11#1)
of the latter species##2##4##(2008-10#1)(2011-2#1)
of the latter to##3##4##(1993-11#1)(1997-4#1)(2008-2#1)
of the latter two##2##4##(1990-7#1)(2008-10#1)
of the latter type of##2##5##(2007-12#1)(2010-5#1)
of the latter were##2##4##(2008-1#1)(2008-7#1)
of the latter##45##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#2)(2013-7#1)
of the lattice##3##3##(1992-4#1)(2007-11#1)(2008-2#1)
of the law and##4##4##(1993-2#1)(1994-1#1)(1997-8#1)(2008-3#1)
of the law##8##3##(1991-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-8#1)(2008-3#1)
of the layer##5##3##(1991-5#1)(1994-6#1)(2007-12#1)(2008-3#2)
of the layers##3##3##(2007-11#1)(2008-3#2)
of the layout area##2##4##(2008-6#2)
of the lead complex##2##4##(2008-10#2)
of the lead##8##3##(2008-10#5)(2008-11#1)(2011-2#1)(2013-8#1)
of the leading##17##3##(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-8#2)
of the leaf rust resistance##2##5##(2008-10#2)
of the leaf rust##3##4##(2008-10#3)
of the leaf##12##3##(2008-10#9)(2008-5#2)(2010-3#1)
of the leaf-cutting ant##2##4##(2008-6#1)(2008-8#1)
of the leaf-drop symptom##2##4##(2008-10#2)
of the leafhopper##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
of the learning##6##3##(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the least##8##3##(1991-8#1)(1992-2#1)(2008-10#3)(2008-6#1)(2012-12#1)(2013-1#1)
of the least-squares##2##3##(2008-2#1)(2008-3#1)
of the leaves of##4##4##(1992-2#1)(2008-10#1)(2010-2#1)(2010-3#1)
of the leaves##10##3##(1992-2#1)(2008-10#3)(2008-11#2)(2010-2#1)(2010-3#3)
of the leaving group at##2##5##(1993-8#1)(1995-5#1)
of the leaving group##5##4##(1993-8#4)(1995-5#1)
of the lectin##7##3##(1990-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(2008-10#2)
of the lectins##4##3##(1990-7#1)(1995-11#3)
of the lecturer in##2##4##(2008-11#2)
of the lecturer practitioner##6##4##(2008-11#4)(2008-12#2)
of the lecturer##9##3##(2008-11#7)(2008-12#2)
of the leech##4##3##(1991-5#2)(1996-12#2)
of the left and right##4##5##(1991-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
of the left anterior descending coronary artery##2##7##(2008-7#1)(2013-1#1)
of the left anterior##3##4##(2008-7#2)(2013-1#1)
of the left arm##3##4##(1995-6#1)(2007-12#1)(2009-3#1)
of the left atrial appendage##3##5##(2007-8#2)(2010-12#1)
of the left atrial##4##4##(2007-8#2)(2008-11#1)(2010-12#1)
of the left atrium##4##4##(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
of the left branch##2##4##(2008-10#1)(2010-3#1)
of the left breast##2##4##(2011-2#1)(2012-3#1)
of the left cardiac sympathetic nerve##2##6##(2008-9#2)
of the left cardiac##3##4##(2007-8#1)(2008-9#2)
of the left cervical##2##4##(1991-3#1)(2013-8#1)
of the left coronary artery##2##5##(1991-9#1)(2007-8#1)
of the left eye##3##4##(1993-12#1)(2011-2#1)(2013-8#1)
of the left internal carotid artery##2##6##(2008-7#1)(2010-3#1)
of the left internal##3##4##(2007-8#1)(2008-7#1)(2010-3#1)
of the left kidney and##3##5##(2011-2#1)(2013-1#2)
of the left kidney##5##4##(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#2)
of the left lateral wall of##2##6##(1993-12#1)(2011-2#1)
of the left lateral##3##4##(1993-12#1)(2008-7#1)(2011-2#1)
of the left lower lobe##3##5##(1991-3#1)(2007-8#2)
of the left lung##3##4##(1991-9#1)(2008-4#2)
of the left masseter muscle##2##5##(2008-10#1)(2008-4#1)
of the left middle cerebral artery##2##6##(2008-7#1)(2013-8#1)
of the left renal artery##2##5##(1990-2#1)(2008-1#1)
of the left superior##2##4##(1996-2#1)(2011-2#1)
of the left testis##2##4##(2008-6#1)(2011-2#1)
of the left upper##2##4##(2008-6#1)(2011-1#1)
of the left ventricle and##2##5##(2011-1#1)(2013-8#1)
of the left ventricle##21##4##(1992-9#1)(1997-8#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#2)(2009-12#1)(2010-5#1)(2011-1#2)(2012-1#2)(2013-1#6)(2013-8#1)
of the left ventricular##4##4##(1990-9#1)(2008-10#1)(2010-8#1)(2011-1#1)
of the left##123##3##(1990-2#1)(1990-3#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-12#1)(2007-7#4)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#5)(2008-7#9)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#4)
of the leg##5##3##(2007-12#2)(2008-12#1)(2008-5#1)(2009-3#1)
of the legal and##2##4##(1992-3#1)(1993-3#1)
of the legal system##3##4##(1995-1#2)(1996-3#1)
of the legal##9##3##(1991-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1995-1#2)(1996-3#1)(2008-11#1)
of the legislation##2##3##(1997-3#1)(2007-2#1)
of the legs##5##3##(2007-12#1)(2007-2#1)(2008-5#2)(2013-8#1)
of the length of the##7##5##(1991-9#1)(1992-8#1)(1992-9#1)(1996-9#1)(2007-12#1)(2008-3#1)(2009-10#1)
of the length##9##3##(1991-9#1)(1992-8#1)(1992-9#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-10#1)
of the lengthening##4##3##(2007-11#2)(2007-8#1)(2009-2#1)
of the lens is##2##4##(2008-2#1)(2008-3#1)
of the lens##9##3##(2007-12#1)(2008-2#1)(2008-3#4)(2011-1#1)(2011-2#1)(2012-2#1)
of the lenses##2##3##(2008-2#1)(2008-3#1)
of the lenslet##2##3##(2008-3#2)
of the lesion and##7##4##(1990-3#1)(1993-9#1)(1997-6#1)(2008-6#1)(2008-7#2)(2009-1#1)
of the lesion is##2##4##(1990-3#1)(2007-8#1)
of the lesion on##3##4##(1996-3#1)(2012-12#1)(2012-2#1)
of the lesion revealed##2##4##(1993-3#1)(2010-6#1)
of the lesion was##4##4##(2007-7#1)(2011-1#1)(2011-2#2)
of the lesion were##2##4##(1996-3#1)(2012-3#1)
of the lesion with preservation of##2##6##(2007-12#1)(2008-6#1)
of the lesion##50##3##(1990-3#2)(1991-3#1)(1991-9#1)(1992-10#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-3#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-6#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of the lesioned hemisphere in##2##5##(1995-12#1)(2008-11#1)
of the lesioned##3##3##(1995-12#1)(1997-6#1)(2008-11#1)
of the lesions and##2##4##(2008-10#1)(2008-8#1)
of the lesions in##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
of the lesions was##2##4##(1995-4#1)(2013-1#1)
of the lesions were##4##4##(1995-4#1)(2007-2#2)(2007-8#1)
of the lesions##29##3##(1990-10#1)(1991-11#1)(1991-2#1)(1992-8#1)(1995-11#1)(1995-4#2)(1996-1#1)(1996-5#1)(1996-6#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the less##5##3##(1990-5#1)(1993-6#1)(1996-5#1)(1997-4#1)(1997-7#1)
of the lessons learned##3##4##(1995-12#1)(2007-11#1)(2009-10#1)
of the lessons##5##3##(1995-12#1)(1996-12#1)(2007-11#1)(2008-12#1)(2009-10#1)
of the level of##14##4##(1991-11#1)(1993-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
of the level##19##3##(1991-11#1)(1993-11#1)(1993-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
of the levels managed with##2##5##(2008-11#2)
of the levels of##13##4##(1990-6#1)(1993-12#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the levels##17##3##(1990-6#1)(1993-12#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the libraries##2##3##(1991-3#1)(1997-3#1)
of the lichen##3##3##(2008-11#2)(2008-5#1)
of the lidar ratio##3##4##(2008-2#3)
of the lidar return##2##4##(2008-2#1)(2008-3#1)
of the lidar signal##3##4##(2008-2#2)(2008-3#1)
of the lidar##18##3##(2008-2#9)(2008-3#9)
of the life cycle of##2##5##(1997-7#1)(2008-10#1)
of the life cycle##8##4##(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-12#1)
of the life##19##3##(1990-3#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-10#1)(2012-2#1)(2012-3#1)
of the lifestyle##2##3##(1990-9#1)(2009-9#1)
of the lifetime of##2##4##(1992-5#1)(2008-10#1)
of the lifetime##3##3##(1992-12#1)(1992-5#1)(2008-10#1)
of the ligament##2##3##(2008-6#1)(2009-7#1)
of the ligament-to-bone attachment##2##4##(2009-7#2)
of the ligament-to-bone##3##3##(2009-7#3)
of the ligaments##2##3##(2008-6#1)(2009-7#1)
of the ligand and##2##4##(1995-5#1)(2008-10#1)
of the ligand as##2##4##(2008-10#2)
of the ligand or macromolecule##2##5##(1997-2#2)
of the ligand##22##3##(1990-12#1)(1990-5#2)(1990-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#3)(1997-7#2)(2008-10#10)
of the ligand-binding domain of the##2##6##(1991-12#2)
of the ligand-binding domain##4##4##(1991-12#2)(2008-8#2)
of the ligand-binding##5##3##(1991-12#2)(2008-4#1)(2008-8#2)
of the ligands and the##2##5##(2008-10#1)(2008-5#1)
of the ligands##10##3##(1990-8#1)(1993-11#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-7#1)
of the light absorption##2##4##(2008-3#2)
of the light beam is##2##5##(2008-2#1)(2008-3#1)
of the light beam##3##4##(2008-2#2)(2008-3#1)
of the light chain##4##4##(1990-11#1)(1993-11#1)(1994-11#2)
of the light field##2##4##(2008-3#2)
of the light incident##2##4##(2008-2#1)(2008-3#1)
of the light reflected##2##4##(2008-3#2)
of the light scattered by##2##5##(2007-11#1)(2007-12#1)
of the light source are##2##5##(2008-3#2)
of the light source##15##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#10)(2008-5#1)
of the light used##2##4##(2007-12#1)(2009-5#1)
of the light##64##3##(1990-11#1)(1992-4#1)(1993-11#1)(1994-11#2)(1997-6#2)(2007-11#5)(2007-12#6)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#23)(2008-4#2)(2008-5#3)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
of the light-harvesting##2##3##(2008-4#1)(2012-6#1)
of the light-scattering##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of the likelihood of##3##4##(2008-10#1)(2008-4#1)(2012-12#1)
of the likelihood ratio##5##4##(1996-12#1)(2008-10#3)(2008-3#1)
of the likelihood##10##3##(1996-12#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
of the likely##3##3##(1996-1#1)(2010-12#1)(2010-4#1)
of the limb and##2##4##(1995-8#1)(2007-11#1)
of the limb bud##3##4##(1992-8#1)(1993-12#1)(1995-8#1)
of the limb##12##3##(1990-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-3#1)(2012-3#1)
of the limbic system##3##4##(1992-12#3)
of the limbs##4##3##(1996-6#1)(2006-10#1)(2007-11#1)(2010-6#1)
of the limitations and##4##4##(1993-11#1)(2008-10#2)(2008-7#1)
of the limitations of the##3##5##(1992-3#1)(2008-11#1)(2008-5#1)
of the limitations of##5##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
of the limitations##11##3##(1992-3#1)(1993-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
of the limited number of##2##5##(2008-10#1)(2008-8#1)
of the limited##8##3##(1995-2#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
of the limits of##3##4##(1996-9#1)(2007-10#1)(2008-2#1)
of the line shape##2##4##(2008-2#2)
of the line##11##3##(1995-8#2)(2007-12#1)(2008-2#3)(2008-3#5)
of the line-of-sight##2##3##(2007-11#1)(2008-3#1)
of the lineages##5##3##(1991-9#1)(2008-10#2)(2008-9#1)(2009-2#1)
of the linear polarization of the##2##6##(2008-2#2)
of the linear polarization##3##4##(2008-2#3)
of the linear regression##2##4##(2008-3#1)(2010-5#1)
of the linear##25##3##(1992-6#1)(1994-12#2)(2008-10#6)(2008-2#4)(2008-3#8)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
of the linear-no threshold theory##2##5##(2008-7#2)
of the linearly polarized##2##4##(2007-12#1)(2008-2#1)
of the linearly##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-7#1)
of the lines##5##3##(2008-10#3)(2008-2#1)(2008-8#1)
of the linewidth of##2##4##(2008-2#2)
of the linewidth##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of the link between##2##4##(2009-4#1)(2009-9#1)
of the link##4##3##(2007-11#1)(2008-10#1)(2009-4#1)(2009-9#1)
of the linkage system##2##4##(1990-8#2)
of the linkage##4##3##(1990-8#2)(1994-11#1)(1995-8#1)
of the linker##2##3##(2009-6#1)(2010-5#1)
of the linking##2##3##(2008-3#1)(2008-4#1)
of the lip##2##3##(2010-3#1)(2012-12#1)
of the lipase##2##3##(1994-3#1)(2009-8#1)
of the lipid bilayer##4##4##(1990-11#1)(1991-5#1)(1992-9#1)(2008-9#1)
of the lipid layer##2##4##(1992-6#1)(2008-8#1)
of the lipid##34##3##(1990-11#1)(1990-2#3)(1990-7#1)(1991-5#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1995-5#2)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
of the lipid-stimulated##2##3##(1992-9#2)
of the lipids at##2##4##(1994-3#1)(2008-10#1)
of the lipids##6##3##(1991-5#1)(1994-3#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
of the lipopeptide##2##3##(1991-12#1)(1997-2#1)
of the lipophilic surfactant##2##4##(2008-5#2)
of the lipophilic##8##3##(1990-11#1)(1993-11#1)(2008-10#3)(2008-5#3)
of the lipopolysaccharide##2##3##(1992-12#1)(2011-2#1)
of the lipoprotein lipase gene##2##5##(1992-9#1)(1993-3#1)
of the lipoprotein##5##3##(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(2008-5#1)
of the liposomal##2##3##(1990-2#1)(2007-11#1)
of the liposome##2##3##(1994-12#1)(1994-5#1)
of the liposomes##3##3##(1991-5#1)(1994-11#1)(1994-3#1)
of the liquid crystal##5##4##(2007-11#1)(2007-12#2)(2008-2#2)
of the liquid crystalline##3##4##(1992-9#1)(2007-12#1)(2008-7#1)
of the liquid sample##2##4##(2007-12#1)(2008-10#1)
of the liquid##22##3##(1992-5#2)(1992-9#1)(1995-3#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)
of the liquid-crystal##4##3##(2007-11#3)(2008-3#1)
of the literature and a##2##5##(2006-5#1)(2008-10#1)
of the literature and the##2##5##(1990-10#1)(2007-8#1)
of the literature and##20##4##(1990-10#1)(1990-3#1)(1991-1#1)(1991-3#1)(1993-11#1)(1993-3#1)(1995-3#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the literature as##3##4##(1996-12#1)(2008-1#1)(2009-7#1)
of the literature concerning##4##4##(2008-2#1)(2008-8#1)(2010-9#1)(2011-2#1)
of the literature from##3##4##(2008-10#2)(2008-7#1)
of the literature is based on##2##6##(1995-9#1)(2008-11#1)
of the literature is##10##4##(1990-3#1)(1991-3#1)(1995-9#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-12#1)
of the literature on the##8##5##(1992-1#1)(1993-11#1)(1996-12#1)(1996-3#1)(2008-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
of the literature on##22##4##(1992-1#1)(1993-11#1)(1993-6#1)(1996-12#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
of the literature pertaining to##2##5##(1993-1#1)(2007-11#1)
of the literature pertaining##3##4##(1993-1#1)(2007-11#1)(2008-8#1)
of the literature related to##2##5##(2008-12#1)(2009-1#1)
of the literature revealed##4##4##(1992-12#1)(1995-1#1)(2006-10#1)(2008-12#1)
of the literature showed##4##4##(1992-5#1)(2008-7#1)(2011-2#2)
of the literature shows that##5##5##(2008-10#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
of the literature shows##6##4##(1990-6#1)(2008-10#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
of the literature was##6##4##(1995-5#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)
of the literature##245##3##(1990-10#1)(1990-3#3)(1990-6#1)(1991-1#1)(1991-12#2)(1991-3#2)(1991-6#2)(1992-1#2)(1992-12#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#2)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#4)(2007-12#1)(2007-2#6)(2007-5#3)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#19)(2008-11#12)(2008-12#9)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#6)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-3#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#19)(2011-3#1)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#18)(2013-7#1)(2013-8#4)
of the literature]##20##3##(1990-5#1)(1990-6#1)(1992-5#1)(1992-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-1#2)
of the lithium##4##3##(1997-7#1)(2008-10#3)
of the lived experience##2##4##(2008-11#2)
of the liver and##5##4##(1995-11#1)(1997-3#1)(2009-8#2)(2012-2#1)
of the liver in a##2##5##(1992-2#1)(2010-11#1)
of the liver in##5##4##(1990-11#1)(1991-12#1)(1992-2#1)(2008-7#1)(2010-11#1)
of the liver is##4##4##(1990-10#1)(2009-8#1)(2010-12#1)(2013-8#1)
of the liver to##3##4##(1995-8#1)(2008-5#1)(2012-2#1)
of the liver using##2##4##(2009-12#1)(2012-1#1)
of the liver was##2##4##(1993-6#1)(2011-1#1)
of the liver with##3##4##(2009-1#1)(2010-12#1)(2013-1#1)
of the liver##74##3##(1990-10#2)(1990-11#4)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-6#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#6)(2009-9#1)(2010-11#1)(2010-12#6)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
of the liver]##3##3##(1991-3#1)(1993-5#1)(1997-7#1)
of the living##6##3##(2008-10#2)(2008-9#1)(2009-7#1)(2011-2#2)
of the lizard Anolis carolinensis##2##5##(2011-2#2)
of the load##2##3##(2008-5#2)
of the loaded resin##2##4##(2008-10#2)
of the loading##2##3##(2008-6#1)(2009-7#1)
of the local DIC##3##4##(2011-1#3)
of the local and##2##4##(1997-3#1)(2008-12#1)
of the local environment##2##4##(2008-8#1)(2012-7#1)
of the local intensity##2##4##(2008-3#1)(2008-7#1)
of the local##35##3##(1991-3#1)(1992-6#1)(1993-1#1)(1994-3#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#3)(2011-2#1)(2012-7#1)(2013-7#1)
of the localization and##2##4##(2008-1#1)(2012-2#1)
of the localization##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2012-1#1)(2012-2#1)
of the locally##2##3##(2008-2#1)(2012-3#1)
of the location and##2##4##(2008-2#1)(2008-3#1)
of the location of the##7##5##(1994-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)
of the location of##10##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)
of the location##13##3##(1991-6#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)
of the locations##2##3##(1995-2#1)(2008-2#1)
of the loci##2##3##(1995-11#1)(2008-5#1)
of the locomotor system##4##4##(1990-6#1)(2007-11#2)(2007-8#1)
of the locomotor##7##3##(1990-6#1)(1993-12#1)(2007-11#4)(2007-8#1)
of the locus coeruleus##3##4##(1995-12#1)(2008-7#2)
of the locus##4##3##(1995-12#1)(2008-7#2)(2010-8#1)
of the locust##3##3##(2007-12#3)
of the log##2##3##(2008-10#1)(2008-3#1)
of the logarithm of##2##4##(2008-10#2)
of the long arm of chromosome##2##6##(2008-9#1)(2012-12#1)
of the long arm of the##2##6##(2008-10#1)(2012-1#1)
of the long arm of##8##5##(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-12#1)
of the long arm##9##4##(1997-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-12#1)
of the long arms of##2##5##(2008-5#1)(2008-7#1)
of the long arms##3##4##(2008-5#2)(2008-7#1)
of the long bones##4##4##(2007-11#1)(2008-12#1)(2008-4#1)(2010-6#1)
of the long##26##3##(1996-7#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-3#2)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
of the long-lived component##2##4##(1991-12#2)
of the long-term##10##3##(1990-6#1)(1991-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)(2013-1#2)
of the longer A beta 42 in##2##7##(1996-5#2)
of the longer##6##3##(1993-12#1)(1996-5#2)(2008-10#1)(2008-3#1)(2009-9#1)
of the longest##6##3##(1993-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
of the longitudinal##5##3##(2007-11#1)(2008-3#1)(2008-7#2)(2011-1#1)
of the loop##8##3##(1995-1#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
of the loss of the##2##5##(2009-8#1)(2012-2#1)
of the loss of##8##4##(1992-2#1)(1994-7#1)(1997-7#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
of the loss##10##3##(1992-2#1)(1994-7#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
of the lost activity##2##4##(1994-8#1)(1995-6#1)
of the low affinity##2##4##(1990-5#1)(2008-7#1)
of the low contrast##2##4##(2012-1#2)
of the low level of##2##5##(2008-10#1)(2008-7#1)
of the low##31##3##(1990-5#2)(1991-2#1)(1992-12#1)(1995-8#2)(1996-9#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#5)(2010-8#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-8#2)
of the lower and upper##2##5##(2012-2#1)(2013-1#1)
of the lower esophageal sphincter##2##5##(1992-6#1)(2013-8#1)
of the lower extremities##9##4##(1995-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
of the lower extremity##3##4##(2008-6#1)(2009-8#1)(2011-2#1)
of the lower female genital tract##2##6##(1994-1#1)(1996-12#1)
of the lower female##3##4##(1994-1#1)(1996-12#2)
of the lower genital tract##3##5##(1991-2#2)(1994-1#1)
of the lower jaw##2##4##(2007-5#1)(2008-5#1)
of the lower leg with##2##5##(2012-12#2)
of the lower leg##13##4##(1990-11#2)(1994-6#1)(1997-8#2)(2007-11#1)(2007-8#5)(2012-12#2)
of the lower limb##4##4##(1990-6#1)(1995-2#1)(2008-6#1)(2011-2#1)
of the lower limbs and##2##5##(1991-11#1)(2012-2#1)
of the lower limbs is##3##5##(1990-3#1)(1997-3#1)(2008-8#1)
of the lower limbs##17##4##(1990-3#2)(1990-6#1)(1991-11#1)(1991-6#2)(1993-5#1)(1997-3#2)(2007-11#1)(2007-8#1)(2008-8#2)(2009-3#1)(2012-1#2)(2012-2#1)
of the lower limbs]##2##4##(1990-6#1)(1991-6#1)
of the lower lip##3##4##(1991-8#2)(2013-1#1)
of the lower##85##3##(1990-11#2)(1990-3#2)(1990-6#3)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#4)(1991-8#2)(1992-5#1)(1992-6#1)(1993-5#1)(1994-1#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-4#1)(1997-3#3)(1997-4#1)(1997-8#3)(2007-11#3)(2007-5#1)(2007-8#9)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#1)
of the lowest##9##3##(1991-6#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-2#2)
of the luciferase##2##3##(1992-9#1)(2008-11#1)
of the lucigenin##2##3##(2008-10#2)
of the lumbar spine##12##4##(1991-11#2)(2007-11#2)(2008-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)
of the lumbar##16##3##(1991-11#2)(1996-6#1)(2007-11#3)(2008-12#1)(2008-7#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)
of the lumbo-sacral spine##3##4##(2007-11#3)
of the lumen of##2##4##(2008-10#1)(2010-4#1)
of the lumen##5##3##(1992-5#1)(1996-3#1)(2008-10#1)(2008-3#1)(2010-4#1)
of the luminal##2##3##(1992-9#1)(1995-11#1)
of the luminescent##2##3##(2008-10#1)(2008-2#1)
of the luminous##2##3##(2008-2#1)(2008-3#1)
of the lunar##4##3##(2008-2#1)(2011-1#2)(2013-8#1)
of the lung and##4##4##(1994-2#1)(1996-3#1)(1997-1#1)(2008-12#1)
of the lung can be##2##5##(1992-12#1)(2013-7#1)
of the lung in##3##4##(1991-12#1)(2008-2#1)(2010-7#1)
of the lung is##2##4##(1991-2#1)(2008-7#1)
of the lung tissue##2##4##(1991-12#1)(1996-3#1)
of the lung##52##3##(1990-3#1)(1990-8#1)(1991-12#4)(1991-2#3)(1991-6#1)(1992-11#1)(1992-12#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-9#1)(1996-3#2)(1997-1#3)(1997-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#4)(2008-7#4)(2008-8#1)(2009-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#4)(2013-7#1)
of the lungs and##3##4##(1996-3#1)(2007-12#1)(2011-2#1)
of the lungs##17##3##(1991-9#2)(1996-3#1)(1997-1#2)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
of the luteal##3##3##(1990-8#1)(1992-9#1)(1994-9#1)
of the luxA and luxB genes of Xenorhabdus luminescens##2##9##(1990-7#2)
of the lymph node##2##4##(1990-5#1)(1990-6#1)
of the lymph nodes##2##4##(1996-3#1)(2007-5#1)
of the lymph##4##3##(1990-5#1)(1990-6#1)(1996-3#1)(2007-5#1)
of the lymphatic##3##3##(1990-3#1)(2008-4#1)(2013-1#1)
of the lymphoid##8##3##(1992-12#2)(2008-10#1)(2008-4#2)(2008-7#1)(2009-8#1)(2011-2#1)
of the lysosomal enzyme##2##4##(1990-5#1)(1997-7#1)
of the lysosomal enzymes##2##4##(1991-12#1)(2012-3#1)
of the lysosomal system##3##4##(1992-12#1)(2008-7#2)
of the lysosomal##10##3##(1990-5#1)(1991-12#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-5#1)(1997-7#1)(2008-7#2)(2012-3#1)
of the mAb##3##3##(1997-6#1)(2008-11#2)
of the mRNA encoding##3##4##(1993-6#1)(1994-12#1)(2008-9#1)
of the mRNA for##4##4##(1991-12#1)(1992-6#1)(1996-12#1)(2008-11#1)
of the mRNA has##2##4##(1993-2#1)(1993-8#1)
of the mRNA in the##3##5##(1990-11#1)(1992-6#1)(2008-9#1)
of the mRNA was##2##4##(1992-9#2)
of the mRNA##23##3##(1990-11#1)(1991-12#2)(1992-1#1)(1992-11#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-9#3)(2013-1#1)
of the mRNAs##2##3##(1990-3#1)(1992-6#1)
of the macrocycle##2##3##(2008-10#1)(2009-10#1)
of the macromolecular##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
of the macronuclear DNA##2##4##(1994-12#2)
of the macrophage##3##3##(1990-5#1)(1991-5#1)(1994-6#1)
of the macrophages##2##3##(1992-12#1)(1995-5#1)
of the magnet of a cochlear implant receiver stimulator package following minor head trauma##2##14##(2008-9#2)
of the magnet##4##3##(2008-10#1)(2008-9#2)(2010-4#1)
of the magnetic beads##3##4##(2008-10#3)
of the magnetic field##8##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#3)
of the magnetic##17##3##(1993-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2009-11#1)(2012-1#3)(2012-2#1)
of the magnetization##4##3##(1997-7#1)(2006-4#1)(2008-10#1)(2009-6#1)
of the magnitude of the##4##5##(1994-2#1)(2007-12#1)(2008-3#1)(2011-2#1)
of the magnitude of##6##4##(1992-6#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-3#1)(2011-2#1)
of the magnitude##9##3##(1992-6#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
of the magnitudes of##2##4##(2008-10#1)(2008-3#1)
of the main advantages of##2##5##(2007-11#1)(2008-3#1)
of the main chain and##3##5##(2008-9#2)(2009-7#1)
of the main concepts##2##4##(2012-12#1)(2013-1#1)
of the main constituents of##2##5##(2008-11#2)
of the main constituents##3##4##(2008-11#3)
of the main factors##3##4##(1994-12#1)(2008-10#1)(2011-1#1)
of the main goals of##2##5##(2009-10#1)(2009-6#1)
of the main objectives in##2##5##(2008-11#1)(2011-2#1)
of the main objectives of the##2##6##(2006-10#1)(2011-2#1)
of the main objectives##4##4##(2006-10#1)(2008-11#1)(2011-2#2)
of the main problems##2##4##(2008-11#1)(2008-5#1)
of the main reasons why##2##5##(2008-10#1)(2009-11#1)
of the main structural elements##2##5##(1997-4#2)
of the main techniques##2##4##(2007-7#1)(2008-11#1)
of the main##102##3##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-6#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#9)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
of the maintenance trial##2##4##(2012-2#2)
of the maintenance##3##3##(2012-2#2)(2013-8#1)
of the major NORs##2##4##(1993-12#2)
of the major challenges in##2##5##(2008-4#1)(2011-2#1)
of the major component##2##4##(1992-3#1)(2008-10#1)
of the major components##2##4##(2008-10#1)(2008-5#1)
of the major exoglucanase##2##4##(1997-1#2)
of the major form of##2##5##(1993-5#1)(2008-4#1)
of the major histocompatibility complex (MHC)##2##6##(1990-5#1)(2008-1#1)
of the major histocompatibility##3##4##(1990-5#1)(2008-1#1)(2008-4#1)
of the major limitations##2##4##(2008-8#1)(2011-2#1)
of the major obstacles##3##4##(1996-5#1)(2008-12#1)(2008-4#1)
of the major problems in##2##5##(2010-8#1)(2012-12#1)
of the major problems##4##4##(1997-2#1)(2008-12#1)(2010-8#1)(2012-12#1)
of the major##127##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#2)(1993-5#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
of the majority of cases##2##5##(1991-3#1)(2010-3#1)
of the majority of the##2##5##(2011-2#1)(2012-2#1)
of the majority of##7##4##(1991-3#1)(1997-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
of the malaria##4##3##(2012-12#4)
of the male accessory glands##2##5##(2007-12#1)(2008-7#1)
of the male accessory##3##4##(1991-5#1)(2007-12#1)(2008-7#1)
of the male genital tract##2##5##(2012-1#1)(2012-2#1)
of the male genital##3##4##(2008-7#1)(2012-1#1)(2012-2#1)
of the male rat##2##4##(1991-2#2)
of the male rats##2##4##(1990-11#1)(1994-2#1)
of the male urogenital##2##4##(1994-11#1)(2013-1#1)
of the male##29##3##(1990-11#1)(1991-2#2)(1991-5#1)(1992-2#2)(1992-3#2)(1992-6#2)(1994-11#1)(1994-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the males##4##3##(1993-11#1)(1994-2#1)(1995-3#1)(2012-12#1)
of the malformation##3##3##(1990-8#1)(1990-9#2)
of the malignancy##2##3##(1990-8#1)(1992-9#1)
of the malignant polyp##2##4##(2009-12#2)
of the malignant##9##3##(1990-5#1)(1990-6#1)(1996-6#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-3#1)
of the mammalian brain##3##4##(1995-6#1)(2008-11#2)
of the mammalian host##2##4##(2008-9#1)(2011-2#1)
of the mammalian##22##3##(1990-2#1)(1990-7#2)(1991-6#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#2)(2008-11#4)(2008-9#2)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
of the mammary gland##2##4##(2009-12#1)(2012-1#1)
of the mammary glands were##2##5##(2012-1#1)(2012-12#1)
of the mammary glands##5##4##(2012-1#1)(2012-12#4)
of the mammary##8##3##(2009-12#2)(2012-1#2)(2012-12#4)
of the managed care system##4##5##(2006-10#4)
of the managed care##5##4##(1991-3#1)(2006-10#4)
of the managed##6##3##(1991-3#1)(1994-3#1)(2006-10#4)
of the management of##10##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-5#1)(2012-3#1)(2013-1#2)
of the management##14##3##(1992-12#1)(1993-1#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-5#1)(2012-3#1)(2013-1#2)
of the managerial functions##2##4##(1994-3#2)
of the managerial##3##3##(1994-3#2)(2008-1#1)
of the mandible##4##3##(1997-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the mandibular##3##3##(1993-1#1)(2012-12#1)(2012-2#1)
of the manifold##2##3##(2008-10#2)
of the mannitol permease##4##4##(1991-10#4)
of the manual methods##2##4##(1991-3#1)(2008-10#1)
of the manual##8##3##(1991-3#1)(1996-3#1)(2008-10#3)(2008-7#1)(2010-10#1)(2012-2#1)
of the manufacturing process##3##4##(1995-5#1)(2008-3#1)(2008-5#1)
of the manufacturing##5##3##(1995-5#2)(2008-10#1)(2008-3#1)(2008-5#1)
of the many advantages of##2##5##(2007-11#1)(2008-4#1)
of the many##23##3##(1992-2#1)(1994-12#1)(1996-3#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
of the mapping##3##3##(2008-5#2)(2008-9#1)
of the marginal##5##3##(1995-9#1)(1997-3#1)(2008-7#2)(2009-8#1)
of the marine mollusc Aplysia##2##5##(1994-8#1)(1997-6#1)
of the marine ornamental##2##4##(2007-5#2)
of the marine##10##3##(1994-8#1)(1996-2#1)(1997-6#1)(2007-5#2)(2008-10#1)(2008-6#2)(2010-8#1)(2013-1#1)
of the marked strain##2##4##(2008-10#2)
of the marked##4##3##(2008-10#3)(2008-5#1)
of the marker genes##2##4##(2008-10#1)(2008-8#1)
of the marker##7##3##(2007-11#1)(2007-12#2)(2008-10#3)(2008-8#1)
of the markers in##3##4##(2008-10#1)(2008-5#2)
of the markers of##2##4##(1997-7#1)(2013-8#1)
of the markers##8##3##(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-9#1)(2013-8#1)
of the market##9##3##(1991-12#1)(1993-2#2)(1994-3#2)(1995-1#1)(1997-5#1)(2008-10#1)(2010-5#1)
of the marketing##2##3##(1993-12#1)(2008-12#1)
of the marks##2##3##(1996-3#1)(2008-11#1)
of the masculine##2##3##(2008-11#1)(2013-1#1)
of the mask##2##3##(2007-12#1)(2008-3#1)
of the masking effect##2##4##(2008-10#1)(2008-5#1)
of the masking##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
of the mass and##2##4##(2010-11#1)(2011-2#1)
of the mass of##4##4##(1992-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
of the mass##26##3##(1990-12#1)(1991-5#1)(1992-2#1)(1994-3#1)(2006-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-4#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the masses##2##3##(1990-3#1)(2008-10#1)
of the masseter muscle in##3##5##(2010-6#1)(2013-1#2)
of the masseter muscle##4##4##(1996-2#1)(2010-6#1)(2013-1#2)
of the masticatory##2##3##(1990-9#1)(2010-9#1)
of the mastoid process##4##4##(2008-7#3)(2008-9#1)
of the mastoid##6##3##(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)
of the matched cord##2##4##(2010-11#2)
of the matched##3##3##(2008-3#1)(2010-11#2)
of the mate recognition system##3##5##(2008-8#1)(2008-9#2)
of the material for##2##4##(2008-10#1)(2008-7#1)
of the material is##2##4##(2007-12#2)
of the material##30##3##(1992-12#1)(1995-8#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-10#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the materials and##2##4##(2008-2#1)(2011-2#1)
of the materials was##2##4##(2008-5#1)(2009-3#1)
of the materials##13##3##(1990-9#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the maternal##9##3##(1994-11#1)(1994-3#1)(1996-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-1#1)
of the mathematical##4##3##(1996-12#1)(2007-11#1)(2008-10#1)(2009-8#1)
of the mating##4##3##(1996-2#1)(2008-10#3)
of the matrices##6##3##(1996-5#1)(2007-11#1)(2008-10#2)(2008-2#2)
of the matrix is##2##4##(2008-10#2)
of the matrix##32##3##(1990-8#1)(1992-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#5)(2010-5#1)(2010-8#1)(2012-2#1)
of the mats##2##3##(1990-11#1)(2011-2#1)
of the matter##3##3##(1994-3#1)(2008-10#1)(2010-7#1)
of the mature protein##8##4##(1990-8#2)(1991-8#1)(1991-9#1)(1992-3#4)
of the mature##18##3##(1990-8#2)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#4)(1993-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-10#1)(2007-12#1)(2008-10#1)(2012-12#1)
of the maxilla##4##3##(2007-12#1)(2008-6#1)(2012-12#1)(2013-1#1)
of the maxillary sinus##6##4##(1993-1#1)(2008-2#1)(2008-3#1)(2011-7#1)(2012-12#1)(2013-7#1)
of the maxillary stylets##2##4##(2007-12#2)
of the maxillary##12##3##(1993-1#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#2)(2011-7#1)(2012-12#1)(2013-7#1)
of the maximal power##2##4##(2008-3#1)(2011-2#1)
of the maximal##10##3##(1990-12#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-6#1)(1997-7#1)(2008-3#2)(2008-7#1)(2011-2#1)
of the maximum possible##2##4##(2008-10#2)
of the maximum##34##3##(1990-7#1)(1991-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
of the maximum-likelihood##2##3##(2007-12#1)(2008-2#1)
of the maze##2##3##(1993-5#1)(2008-11#1)
of the meals##3##3##(2008-3#1)(2013-7#2)
of the mean intensity of##2##5##(2008-2#2)
of the mean square##2##4##(2008-3#1)(2012-2#1)
of the mean value##2##4##(2008-10#2)
of the mean##32##3##(1991-12#1)(1993-12#2)(1994-12#1)(1994-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the meaning of##4##4##(1993-1#1)(2008-11#1)(2008-6#1)(2010-2#1)
of the means##2##3##(1997-2#1)(2008-7#1)
of the measurand and##2##4##(2008-3#2)
of the measure##4##3##(1990-2#1)(1996-3#1)(2008-1#1)(2008-11#1)
of the measured data##3##4##(2008-11#1)(2008-3#2)
of the measured radiance##2##4##(2008-2#2)
of the measured shape##2##4##(2008-6#2)
of the measured##35##3##(2007-11#1)(2007-12#5)(2008-10#2)(2008-11#2)(2008-2#9)(2008-3#13)(2008-6#2)(2013-1#1)
of the measurement and##4##4##(2008-10#2)(2008-3#2)
of the measurement error##2##4##(2008-3#2)
of the measurement of a##2##5##(2008-10#1)(2008-3#1)
of the measurement of##4##4##(2008-10#1)(2008-3#3)
of the measurement results##2##4##(2008-3#1)(2009-11#1)
of the measurement system##2##4##(2008-10#1)(2008-3#1)
of the measurement##31##3##(1997-6#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#17)(2009-11#1)
of the measurements at##2##4##(2008-10#1)(2008-3#1)
of the measurements made##3##4##(1996-1#1)(2008-10#2)
of the measurements was##2##4##(2008-10#2)
of the measurements##16##3##(1994-11#1)(1996-1#1)(2008-10#8)(2008-3#6)
of the measures##4##3##(1990-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
of the measuring##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
of the meat##7##3##(2008-10#1)(2010-4#5)(2013-1#1)
of the mecA gene##3##4##(2008-10#2)(2011-2#1)
of the mechanical and##2##4##(2007-7#1)(2012-2#1)
of the mechanical properties##3##4##(2008-3#1)(2008-5#1)(2012-2#1)
of the mechanical##11##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#2)(2010-4#1)(2010-8#1)(2012-2#2)
of the mechanism and##3##4##(2008-10#2)(2010-12#1)
of the mechanism governing##2##4##(1990-8#1)(2008-7#1)
of the mechanism of action of##2##6##(1991-5#1)(2008-11#1)
of the mechanism of action##3##5##(1991-5#1)(2008-11#1)(2008-5#1)
of the mechanism of the##3##5##(1992-3#1)(2008-10#1)(2008-11#1)
of the mechanism of##15##4##(1991-5#1)(1992-3#1)(1994-8#1)(1996-12#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
of the mechanism that##2##4##(2008-11#1)(2008-3#1)
of the mechanism##25##3##(1990-8#1)(1991-5#1)(1992-3#1)(1994-8#1)(1996-12#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-3#2)(2013-8#1)
of the mechanisms and##3##4##(1997-7#1)(2008-10#1)(2012-12#1)
of the mechanisms by which##3##5##(1995-6#1)(2008-1#1)(2013-1#1)
of the mechanisms involved##3##4##(1995-2#1)(1997-3#1)(2008-4#1)
of the mechanisms leading to##3##5##(1992-9#1)(1996-5#1)(2012-1#1)
of the mechanisms of##16##4##(1992-3#1)(1994-11#1)(1995-11#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#2)
of the mechanisms underlying the##6##5##(1993-8#1)(1995-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the mechanisms underlying##7##4##(1993-8#1)(1995-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the mechanisms##51##3##(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)
of the medaka##2##3##(2008-5#2)
of the media as well as##2##6##(2008-3#1)(2009-5#1)
of the media used##2##4##(2008-1#1)(2008-12#1)
of the media##12##3##(1993-12#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2009-5#1)(2013-1#1)
of the medial epicondyle of the humerus##2##7##(1995-6#2)
of the medial prefrontal cortex##3##5##(1994-8#1)(1996-2#1)(1997-2#1)
of the medial prefrontal##4##4##(1991-2#1)(1994-8#1)(1996-2#1)(1997-2#1)
of the medial##26##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1993-12#3)(1994-8#2)(1995-6#2)(1996-12#1)(1996-2#3)(1997-2#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the median domain##2##4##(2007-12#2)
of the median nerve is##2##5##(2008-9#2)
of the median nerve##7##4##(1992-6#1)(2008-9#6)
of the median##10##3##(1992-6#1)(1996-12#1)(2007-12#2)(2008-9#6)
of the mediastinal##2##3##(2012-3#1)(2013-7#1)
of the mediastinum is##2##4##(1991-8#2)
of the mediastinum##7##3##(1990-8#2)(1991-8#2)(2007-8#1)(2008-6#1)(2011-2#1)
of the mediating##2##3##(2009-7#1)(2013-8#1)
of the mediators##2##3##(2008-10#1)(2009-7#1)
of the medical and##3##4##(1997-3#1)(2007-7#1)(2010-11#1)
of the medical care##2##4##(1991-6#1)(1996-12#1)
of the medical literature##4##4##(1992-12#1)(2007-5#2)(2012-3#1)
of the medical profession##6##4##(1991-11#1)(1995-11#1)(1996-11#1)(2009-10#1)(2009-5#1)(2013-1#1)
of the medical records##3##4##(1991-1#1)(2008-9#1)(2011-2#1)
of the medical staff##5##4##(1992-2#1)(1994-2#2)(1997-1#1)(2012-2#1)
of the medical##48##3##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-2#1)(1993-3#1)(1994-2#3)(1995-11#3)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
of the medication##5##3##(1992-12#1)(1997-2#1)(2008-7#2)(2010-5#1)
of the medicine##2##3##(1996-11#1)(2010-8#1)
of the medium and the##3##5##(2007-12#1)(2008-10#2)
of the medium and##6##4##(1996-4#1)(2007-12#2)(2008-10#2)(2008-11#1)
of the medium is##3##4##(1991-5#1)(1994-6#1)(2008-2#1)
of the medium perfusion rate##2##5##(2008-11#2)
of the medium that##2##4##(2008-11#1)(2008-3#1)
of the medium was increased##3##5##(2008-3#1)(2008-7#1)(2010-2#1)
of the medium##42##3##(1991-2#1)(1991-5#1)(1994-6#1)(1996-4#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#7)(2008-2#3)(2008-3#12)(2008-6#2)(2008-7#1)(2010-2#1)(2012-1#1)
of the medulla##3##3##(1993-12#1)(1997-2#1)(2008-5#1)
of the medullary cavity##2##4##(2010-3#1)(2013-1#1)
of the medullary##4##3##(1992-8#1)(2007-7#1)(2010-3#1)(2013-1#1)
of the meeting was##3##4##(1994-9#1)(2008-5#2)
of the meeting##7##3##(1994-9#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-11#1)
of the melanotrope cells##3##4##(1993-5#3)
of the melatonin biosynthesis##2##4##(1994-5#2)
of the melatonin##3##3##(1994-5#2)(1995-3#1)
of the members of the##4##5##(1993-12#1)(1997-6#1)(2007-7#1)(2008-10#1)
of the members of##6##4##(1993-12#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-9#1)
of the membrane anchor##2##4##(1994-8#2)
of the membrane and##6##4##(1994-11#1)(1994-2#1)(2008-10#2)(2008-9#1)(2013-7#1)
of the membrane can##2##4##(2008-10#1)(2008-2#1)
of the membrane disks modified by 5 mg of the##2##10##(2008-10#2)
of the membrane disks modified by##4##6##(2008-10#4)
of the membrane disks modified##5##5##(2008-10#5)
of the membrane in##5##4##(1990-11#1)(2009-11#1)(2009-9#1)(2011-1#1)(2012-2#1)
of the membrane of##2##4##(1996-2#1)(2008-7#1)
of the membrane potential##3##4##(1990-12#1)(1992-3#1)(1992-6#1)
of the membrane proteins##3##4##(1993-8#1)(2008-4#1)(2008-7#1)
of the membrane was##4##4##(2008-10#2)(2008-5#1)(2011-2#1)
of the membrane##84##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#4)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#3)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#24)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
of the membrane-bound##5##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#1)(1995-6#1)
of the membranes were##2##4##(2008-5#1)(2011-2#1)
of the membranes with##3##4##(1992-7#1)(1993-3#1)(1995-11#1)
of the membranes##11##3##(1990-11#1)(1992-7#1)(1993-3#1)(1995-11#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
of the memory##2##3##(2008-3#1)(2010-8#1)
of the men and##4##4##(1994-11#1)(2013-1#1)(2013-8#2)
of the men##10##3##(1991-12#2)(1994-11#1)(2008-4#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
of the meniscus##3##3##(2007-12#1)(2008-3#2)
of the menopause##2##3##(1993-11#1)(2011-2#1)
of the menstrual cycle##3##4##(1994-7#1)(1994-9#1)(2012-3#1)
of the mental health##2##4##(1992-1#1)(2008-2#1)
of the mental##4##3##(1992-1#1)(2008-2#1)(2012-3#2)
of the mentally ill and##2##5##(2008-2#1)(2008-7#1)
of the mentally ill##6##4##(1992-3#1)(1995-2#1)(1996-1#1)(2008-2#1)(2008-7#1)(2009-7#1)
of the mentally retarded##2##4##(1992-5#2)
of the mentally##9##3##(1992-3#1)(1992-5#2)(1995-2#1)(1996-1#1)(2008-2#1)(2008-7#1)(2009-7#1)(2012-1#1)
of the mentioned##3##3##(2008-2#1)(2010-6#1)(2011-2#1)
of the mercury film##2##4##(2008-10#2)
of the mercury##5##3##(2008-10#4)(2008-6#1)
of the merits of##2##4##(1993-2#1)(2008-11#1)
of the mesencephalic locomotor region##2##5##(1994-2#1)(1997-2#1)
of the mesenchymal##2##3##(1990-5#1)(2008-11#1)
of the mesenteron##2##3##(2008-7#2)
of the mesopontine complex##2##4##(1996-12#2)
of the message##3##3##(1993-3#1)(2007-12#1)(2010-8#1)
of the metabolic inhibitor tissue homogenate##2##6##(2010-8#2)
of the metabolic syndrome and its##2##6##(2008-3#1)(2008-7#1)
of the metabolic syndrome and##4##5##(2008-1#1)(2008-3#2)(2008-7#1)
of the metabolic syndrome as##2##5##(2008-1#2)
of the metabolic syndrome in a clinical##2##7##(2008-3#2)
of the metabolic syndrome in a##3##6##(2008-3#3)
of the metabolic syndrome in##7##5##(2008-10#1)(2008-3#4)(2008-5#1)(2011-2#1)
of the metabolic syndrome that##2##5##(2008-1#1)(2008-6#1)
of the metabolic syndrome##36##4##(1990-2#1)(2008-1#9)(2008-10#1)(2008-11#1)(2008-3#17)(2008-5#2)(2008-6#2)(2008-7#1)(2010-5#1)(2011-2#1)
of the metabolic##54##3##(1990-2#2)(1991-12#1)(1991-9#1)(1994-2#1)(1996-11#1)(2008-1#9)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#19)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#1)
of the metabolism of##4##4##(1992-11#1)(1993-6#1)(2008-10#1)(2008-7#1)
of the metabolism##6##3##(1992-11#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#2)
of the metabolites were##2##4##(2008-10#1)(2008-11#1)
of the metabolites##7##3##(1990-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-3#2)
of the metacarpophalangeal##2##3##(1992-5#1)(2008-9#1)
of the metal cluster##3##4##(1994-5#3)
of the metal ion to##3##5##(1997-4#1)(2008-10#2)
of the metal ion##6##4##(1992-11#1)(1997-4#1)(2008-10#4)
of the metal ions in##2##5##(2008-10#2)
of the metal ions##18##4##(2008-10#16)(2010-11#1)(2013-8#1)
of the metal species##2##4##(2008-10#2)
of the metal##64##3##(1991-12#1)(1992-11#1)(1994-5#5)(1994-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#43)(2008-3#3)(2009-11#2)(2009-9#1)(2010-11#2)(2013-8#1)
of the metallic##4##3##(1990-7#1)(2008-10#3)
of the metalloporphyrins##2##3##(2010-6#2)
of the metalloproteinase##2##3##(1994-8#1)(2010-1#1)
of the metals and##2##4##(2008-10#1)(2010-11#1)
of the metals in##2##4##(2008-10#1)(2013-8#1)
of the metals##13##3##(1997-7#1)(2008-10#8)(2008-12#1)(2008-6#1)(2010-11#1)(2013-8#1)
of the metastasis##3##3##(1991-6#1)(2007-11#1)(2009-10#1)
of the metastatic##6##3##(1991-4#1)(1991-6#1)(1993-12#1)(1997-7#1)(2009-3#2)
of the methane##2##3##(2008-2#2)
of the methanol##2##3##(1997-7#1)(2008-7#1)
of the methanolic##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
of the methionine##2##3##(1995-5#1)(2013-8#1)
of the method and its##2##5##(2008-10#2)
of the method and the##2##5##(2008-2#1)(2008-7#1)
of the method and##6##4##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
of the method are all satisfactory##2##6##(2008-10#2)
of the method are less than##3##6##(2008-10#3)
of the method are presented##2##5##(2008-10#1)(2008-3#1)
of the method are##19##4##(1990-11#1)(1994-9#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#4)(2008-9#1)
of the method by##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
of the method can be##3##5##(1991-5#1)(2008-10#2)
of the method developed##2##4##(2008-10#1)(2008-5#1)
of the method for routine##2##5##(2007-10#1)(2008-10#1)
of the method for the determination of##2##7##(2008-10#2)
of the method for the##5##5##(2008-10#5)
of the method for##21##4##(2007-10#1)(2008-10#17)(2008-2#2)(2008-3#1)
of the method has been##8##5##(2008-10#8)
of the method have been##3##5##(2008-10#2)(2008-4#1)
of the method in##8##4##(1994-12#1)(2008-10#3)(2008-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
of the method is 0##8##5##(2008-10#8)
of the method is demonstrated by##3##6##(2008-10#2)(2008-3#1)
of the method is discussed##2##5##(2008-3#2)
of the method is evaluated##2##5##(2008-10#2)
of the method is that##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
of the method is the use of##2##7##(2007-11#1)(2008-10#1)
of the method is##49##4##(1990-8#1)(1990-9#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#28)(2008-11#1)(2008-2#4)(2008-3#8)(2011-1#1)
of the method of##7##4##(1993-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
of the method proposed by##2##5##(2008-3#2)
of the method proposed##3##4##(2008-10#1)(2008-3#2)
of the method to a##2##5##(2008-2#1)(2010-2#1)
of the method to real samples##3##6##(2008-10#3)
of the method to real##4##5##(2008-10#4)
of the method to the analysis of##4##7##(2008-10#3)(2008-3#1)
of the method to the determination of##2##7##(2008-10#2)
of the method to the##9##5##(2008-10#7)(2008-2#1)(2008-3#1)
of the method to##28##4##(1990-12#1)(1996-3#1)(1997-6#1)(2008-10#16)(2008-2#3)(2008-3#4)(2009-7#1)(2010-2#1)
of the method used##2##4##(1996-2#1)(2008-4#1)
of the method using##2##4##(2008-10#1)(2010-7#1)
of the method varied##2##4##(2008-10#2)
of the method was 0##4##5##(1995-6#1)(2008-10#3)
of the method was 12##2##5##(2008-10#2)
of the method was carried out##2##6##(2007-11#1)(2008-10#1)
of the method was checked by##2##6##(2008-10#2)
of the method was checked##3##5##(2008-10#3)
of the method was confirmed by##2##6##(2008-10#2)
of the method was demonstrated by the##4##7##(2008-10#4)
of the method was demonstrated by##7##6##(2008-10#7)
of the method was demonstrated for##2##6##(2008-10#1)(2008-5#1)
of the method was demonstrated##10##5##(1994-9#1)(2008-10#8)(2008-5#1)
of the method was established by##2##6##(1990-8#1)(2008-10#1)
of the method was estimated##4##5##(2008-10#4)
of the method was evaluated##3##5##(2008-10#3)
of the method was tested by##2##6##(2008-10#2)
of the method was tested##7##5##(2008-10#6)(2010-4#1)
of the method was##64##4##(1990-8#1)(1992-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#53)(2008-5#2)(2010-4#1)(2011-1#1)
of the method were##9##4##(1990-8#1)(2008-10#5)(2008-5#2)(2011-1#1)
of the method##350##3##(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#224)(2008-11#5)(2008-12#4)(2008-2#15)(2008-3#34)(2008-4#3)(2008-5#6)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the methodological##2##3##(1993-2#1)(2013-1#1)
of the methodology are##2##4##(2008-10#1)(2008-2#1)
of the methodology##12##3##(1996-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
of the methods and##2##4##(2008-10#1)(2008-4#1)
of the methods are##2##4##(1995-2#1)(2008-10#1)
of the methods for##3##4##(2008-4#1)(2012-1#1)(2013-8#1)
of the methods in##2##4##(2008-10#2)
of the methods to##2##4##(2008-10#2)
of the methods was##7##4##(2008-10#6)(2008-7#1)
of the methods were##3##4##(2008-10#3)
of the methods##43##3##(1990-6#1)(1995-2#1)(2007-11#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-5#1)(2012-1#1)(2013-8#1)
of the methyl groups##2##4##(2007-12#1)(2011-1#1)
of the methyl##4##3##(1994-9#1)(2007-12#1)(2008-10#1)(2011-1#1)
of the methylated HA##2##4##(2008-10#2)
of the methylene group##2##4##(1997-1#2)
of the mice developed##2##4##(1995-12#1)(2013-1#1)
of the mice##9##3##(1995-12#1)(1995-9#2)(1997-4#1)(2008-7#2)(2012-2#2)(2013-1#1)
of the micellar system##4##4##(1990-5#4)
of the micellar##7##3##(1990-5#4)(1993-11#1)(2008-10#1)(2008-8#1)
of the micro##2##3##(1997-3#1)(2011-1#1)
of the microbe##2##3##(2008-10#1)(2011-2#1)
of the microbial biomass##2##4##(2008-6#2)
of the microbial complex##2##4##(2008-10#2)
of the microbial##12##3##(1992-8#1)(2008-10#6)(2008-11#1)(2008-6#3)(2008-7#1)
of the microbiota##2##3##(2011-2#2)
of the microchannel##2##3##(2007-10#1)(2008-10#1)
of the microchannels##2##3##(2007-5#1)(2008-10#1)
of the microchip##2##3##(2007-11#1)(2008-10#1)
of the microcirculation##3##3##(1990-8#1)(2010-7#2)
of the microenvironment##2##3##(2009-10#1)(2009-4#1)
of the microflora##2##3##(2008-10#1)(2008-5#1)
of the microfluidic##3##3##(2008-10#3)
of the microlens##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of the microlenses##2##3##(2008-3#2)
of the microorganism##2##3##(2008-10#1)(2010-12#1)
of the microorganisms##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
of the microplot trials was##2##5##(2008-10#2)
of the micropylar##2##3##(2007-12#1)(2009-12#1)
of the microscope are##2##4##(2007-11#1)(2008-3#1)
of the microscope##8##3##(2007-11#1)(2008-3#4)(2009-12#1)(2009-7#1)(2010-1#1)
of the microscopic##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
of the microsensor##2##3##(2008-10#2)
of the microsomal fraction##2##4##(1993-3#1)(1997-4#1)
of the microsomal##3##3##(1992-6#1)(1993-3#1)(1997-4#1)
of the microsomes##2##3##(1991-10#1)(1997-7#1)
of the microspheres##2##3##(2008-2#1)(2008-7#1)
of the microstructure##4##3##(2007-11#1)(2008-3#1)(2009-7#2)
of the microtubules##2##3##(1992-5#1)(2008-7#1)
of the microvasculature##2##3##(1991-9#1)(2009-10#1)
of the microvilli##2##3##(2008-7#2)
of the microwave##2##3##(2008-10#1)(2013-8#1)
of the middle and##2##4##(2006-12#1)(2008-9#1)
of the middle cerebral artery##11##5##(2007-10#3)(2008-12#2)(2008-4#1)(2008-7#5)
of the middle ear##2##4##(1991-3#1)(1995-5#1)
of the middle fossa##2##4##(2006-12#1)(2011-2#1)
of the middle meningeal artery##2##5##(2008-12#2)
of the middle turbinate in##2##5##(2008-5#2)
of the middle##29##3##(1991-3#1)(1994-8#2)(1995-5#1)(2006-12#2)(2007-10#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-3#1)(2011-2#1)
of the midface##2##3##(1996-6#1)(2012-12#1)
of the midget##3##3##(2008-5#3)
of the midgut##6##3##(1997-3#1)(2007-12#2)(2008-10#1)(2008-7#2)
of the migraine attack##2##4##(2008-9#2)
of the migraine##3##3##(1994-11#1)(2008-9#2)
of the migrant##2##3##(2008-3#1)(2013-8#1)
of the migration time and peak area##2##7##(2008-10#2)
of the migration time and##3##5##(2008-10#3)
of the migration time##4##4##(2008-10#4)
of the milk replacers##2##4##(2010-2#2)
of the milk samples##2##4##(2008-10#2)
of the milk##9##3##(1991-8#1)(2008-10#4)(2010-2#2)(2012-2#2)
of the mind##4##3##(2008-5#2)(2009-10#1)(2012-2#1)
of the mineral##5##3##(1991-6#1)(2008-10#2)(2008-5#1)(2013-8#1)
of the mineralogical##2##3##(2008-10#2)
of the minimal##3##3##(1991-11#1)(1992-2#1)(1995-2#1)
of the minimum number of##2##5##(2008-3#2)
of the minimum##8##3##(1993-1#1)(1996-3#1)(2008-10#2)(2008-3#4)
of the minor NORs##2##4##(1993-12#2)
of the minor##8##3##(1993-12#2)(1993-3#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-8#1)
of the mirror is##2##4##(2007-11#1)(2007-12#1)
of the mirror##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
of the mirrors##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
of the mismatch##2##3##(2008-2#1)(2009-2#1)
of the missing##2##3##(1995-6#1)(2010-5#1)
of the mitochondria in##2##4##(1994-11#1)(2009-11#1)
of the mitochondria##5##3##(1994-11#1)(2008-10#1)(2008-7#1)(2009-11#2)
of the mitochondrial DNA control region##3##6##(1996-6#1)(2009-2#1)(2010-8#1)
of the mitochondrial DNA##7##4##(1994-11#4)(1996-6#1)(2009-2#1)(2010-8#1)
of the mitochondrial cytochrome b gene##3##6##(2008-5#1)(2010-8#2)
of the mitochondrial cytochrome oxidase##2##5##(2008-10#1)(2011-2#1)
of the mitochondrial cytochrome##5##4##(2008-10#1)(2008-5#1)(2010-8#2)(2011-2#1)
of the mitochondrial derivatives##3##4##(2007-12#3)
of the mitochondrial gene for##2##5##(2008-2#1)(2008-6#1)
of the mitochondrial gene##3##4##(1993-2#1)(2008-2#1)(2008-6#1)
of the mitochondrial genome##3##4##(1995-11#1)(1995-12#1)(1995-6#1)
of the mitochondrial permeability transition##2##5##(2008-1#1)(2010-3#1)
of the mitochondrial respiratory chain##2##5##(1996-5#1)(2011-2#1)
of the mitochondrial##45##3##(1990-5#1)(1991-6#1)(1993-2#2)(1994-11#4)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-2#3)(2013-8#1)
of the mitogen activated protein kinase##2##6##(2012-2#1)(2013-7#1)
of the mitogen##3##3##(1991-2#1)(2012-2#1)(2013-7#1)
of the mitogen-activated protein kinase##2##5##(1995-2#1)(2008-11#1)
of the mitogen-activated protein##3##4##(1995-2#1)(2008-11#1)(2010-10#1)
of the mitogen-activated##4##3##(1995-2#1)(2008-11#1)(2008-7#1)(2010-10#1)
of the mitogenic##3##3##(1990-12#1)(1997-1#1)(2008-2#1)
of the mitosene##2##3##(1992-3#2)
of the mitotic chromosomes and##2##5##(2008-1#2)
of the mitotic spindle##2##4##(2008-8#1)(2008-9#1)
of the mitotic##4##3##(2008-1#2)(2008-8#1)(2008-9#1)
of the mitral valve##11##4##(1994-3#1)(2007-8#3)(2010-12#1)(2013-1#6)
of the mitral##14##3##(1990-3#1)(1994-3#1)(2007-8#4)(2008-10#1)(2010-12#1)(2013-1#6)
of the mixed culture was##2##5##(2008-7#2)
of the mixed culture##3##4##(2008-6#1)(2008-7#2)
of the mixed type##2##4##(1995-4#1)(2011-1#1)
of the mixed##21##3##(1990-11#1)(1990-7#1)(1991-5#1)(1995-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-1#1)(2013-1#1)
of the mixing##4##3##(2007-10#1)(2008-2#3)
of the mixture##21##3##(1990-12#1)(1994-9#1)(1997-7#1)(1997-8#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
of the mixtures in##2##4##(2008-10#2)
of the mixtures were##2##4##(1993-8#1)(2008-10#1)
of the mixtures##8##3##(1992-5#1)(1993-8#1)(2008-10#6)
of the mobile phase composition##2##5##(1996-5#1)(2008-10#1)
of the mobile phase was##2##5##(2008-10#2)
of the mobile phase##15##4##(1991-5#1)(1996-5#1)(2008-10#12)(2011-1#1)
of the mobile##20##3##(1991-5#1)(1994-3#1)(1996-5#1)(2008-10#15)(2011-1#1)(2012-12#1)
of the modal birefringence of##2##5##(2008-3#2)
of the modal##8##3##(2008-2#1)(2008-3#7)
of the modality##2##3##(2008-7#1)(2013-1#1)
of the mode cleaner##2##4##(2008-2#2)
of the mode field##2##4##(2008-2#1)(2008-3#1)
of the mode of##2##4##(1997-6#1)(2013-1#1)
of the mode##8##3##(1997-6#1)(2007-12#2)(2008-2#3)(2008-3#1)(2013-1#1)
of the mode-locked##2##3##(2007-11#1)(2008-3#1)
of the model and##4##4##(2008-10#2)(2010-5#1)(2010-8#1)
of the model are##5##4##(1996-1#1)(1997-8#1)(2008-10#2)(2012-1#1)
of the model at##2##4##(2008-11#1)(2008-3#1)
of the model developed##2##4##(1992-3#1)(2008-2#1)
of the model for the##3##5##(2008-2#3)
of the model for##7##4##(1992-1#1)(1994-5#1)(2008-2#3)(2008-3#1)(2008-6#1)
of the model in##3##4##(2007-11#1)(2008-11#1)(2008-7#1)
of the model is evaluated##2##5##(2008-11#1)(2008-7#1)
of the model is that##2##5##(1997-8#1)(2008-2#1)
of the model is##10##4##(1997-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
of the model parameters##3##4##(1994-11#1)(2008-7#1)(2008-8#1)
of the model plant##2##4##(2008-10#1)(2011-1#1)
of the model showed##2##4##(1992-9#1)(2008-10#1)
of the model to##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
of the model using##2##4##(2008-10#1)(2008-9#1)
of the model was##3##4##(1995-9#1)(2007-11#1)(2008-2#1)
of the model##120##3##(1990-12#1)(1990-8#1)(1992-1#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-9#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#4)(2007-11#2)(2008-10#21)(2008-11#10)(2008-2#10)(2008-3#12)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#7)(2009-10#1)(2009-4#1)(2010-5#2)(2010-8#1)(2011-1#3)(2012-1#1)(2013-7#1)(2013-8#1)
of the modeled##2##3##(2008-3#1)(2013-1#1)
of the modeless laser##3##4##(2008-2#3)
of the modeling##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
of the models in##2##4##(2008-11#1)(2008-8#1)
of the models to##2##4##(2008-10#1)(2008-2#1)
of the models##11##3##(1992-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
of the modern##10##3##(1991-5#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)
of the modes##3##3##(2008-2#2)(2009-12#1)
of the modified Einthoven triangle##2##5##(2010-8#2)
of the modified and unmodified##2##5##(1993-11#1)(2008-10#1)
of the modified cytochrome c##2##5##(1995-2#2)
of the modified cytochrome##3##4##(1995-2#3)
of the modified electrode was##2##5##(2008-10#2)
of the modified electrode were##2##5##(2008-10#2)
of the modified electrode##8##4##(1995-6#1)(2008-10#7)
of the modified enzyme##2##4##(2008-10#2)
of the modified silica gel##2##5##(2008-10#2)
of the modified silica##3##4##(2008-10#3)
of the modified surface##2##4##(2008-10#2)
of the modified technique##2##4##(2007-12#1)(2007-8#1)
of the modified triangular interferometer##2##5##(2008-3#2)
of the modified##59##3##(1990-7#1)(1990-9#1)(1991-5#1)(1993-11#3)(1995-2#3)(1995-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#25)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#1)
of the modifier##5##3##(2008-10#5)
of the modifiers##2##3##(2008-10#2)
of the modulation of##2##4##(2008-4#2)
of the modulation##7##3##(2008-2#2)(2008-3#2)(2008-4#2)(2009-5#1)
of the modulatory##2##3##(1995-11#1)(2008-2#1)
of the module##2##3##(1996-7#1)(2008-11#1)
of the modulus##2##3##(2008-2#1)(2009-7#1)
of the moiré fringes##6##4##(2008-2#1)(2008-3#5)
of the moiré##8##3##(2008-2#1)(2008-3#7)
of the moisture##2##3##(2008-10#2)
of the molar##6##3##(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)
of the molecular and cellular##2##5##(2008-7#2)
of the molecular basis of##4##5##(2008-1#1)(2008-11#1)(2011-2#2)
of the molecular biology##2##4##(1997-7#1)(2012-3#1)
of the molecular environment##2##4##(1990-2#1)(2008-2#1)
of the molecular events##4##4##(2008-10#1)(2008-7#2)(2010-12#1)
of the molecular forms of##2##5##(1993-8#1)(2008-4#1)
of the molecular genetics##2##4##(2007-7#1)(2009-3#1)
of the molecular mass##2##4##(2008-10#1)(2008-4#1)
of the molecular masses of##3##5##(1990-12#1)(1993-8#1)(1996-5#1)
of the molecular mechanism of##2##5##(1994-11#1)(1996-4#1)
of the molecular mechanisms##4##4##(2008-11#1)(2009-3#1)(2010-5#1)(2011-3#1)
of the molecular##65##3##(1990-12#2)(1990-2#1)(1991-12#1)(1993-12#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-3#3)(2009-7#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#3)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of the molecule and##2##4##(1992-4#1)(2009-12#1)
of the molecule is##2##4##(1990-5#1)(1997-6#1)
of the molecule##50##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-3#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#5)(2008-11#4)(2008-4#3)(2008-5#2)(2008-8#1)(2009-12#1)(2013-1#1)
of the molecules and##2##4##(1992-9#1)(2009-9#1)
of the molecules are##3##4##(1997-7#1)(2009-5#1)(2012-2#1)
of the molecules in##2##4##(1992-9#1)(2008-8#1)
of the molecules that##2##4##(2008-8#1)(2013-8#1)
of the molecules##23##3##(1991-2#1)(1992-8#1)(1992-9#3)(1994-8#1)(1995-5#1)(1995-6#1)(1997-7#2)(2007-11#1)(2008-10#4)(2008-4#1)(2008-8#2)(2009-5#2)(2009-9#1)(2012-2#1)(2013-8#1)
of the molt-inhibiting hormone##2##4##(2007-12#1)(2008-6#1)
of the molybdenum blue##2##4##(2008-10#2)
of the molybdenum##5##3##(1997-7#1)(2008-10#4)
of the moment##2##3##(1996-4#1)(2007-10#1)
of the monitored##2##3##(2007-12#1)(2008-10#1)
of the monitoring program##2##4##(1997-4#1)(2008-10#1)
of the monitoring##5##3##(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
of the monkey##2##3##(1991-4#1)(2009-5#1)
of the monoamine neurotransmitters in the##2##6##(2008-10#2)
of the monoamine oxidase##2##4##(1996-5#1)(2008-7#1)
of the monoamine##6##3##(1993-12#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-7#1)
of the monoclonal antibody##2##4##(1991-5#1)(2008-11#1)
of the monoclonal##3##3##(1991-5#1)(2008-11#2)
of the monocyte##3##3##(1993-9#1)(1994-9#1)(1995-4#1)
of the monolayer in the##2##5##(2008-10#2)
of the monolayer##7##3##(1994-3#1)(2008-10#4)(2008-11#2)
of the monolithic##3##3##(2008-10#1)(2008-3#2)
of the monomer 13##2##4##(1992-12#2)
of the monomer and##3##4##(2008-10#2)(2012-1#1)
of the monomer##12##3##(1992-12#4)(1992-4#1)(2008-10#4)(2008-3#1)(2008-8#1)(2012-1#1)
of the monomeric##6##3##(1991-7#1)(1994-11#1)(1997-4#1)(2008-10#3)
of the monomers##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
of the mononuclear##2##3##(2008-4#2)
of the month##4##3##(2008-3#2)(2010-5#1)(2011-2#1)
of the moon##2##3##(2008-2#1)(2008-3#1)
of the more advanced##2##4##(2008-1#1)(2008-11#1)
of the more common##7##4##(2008-12#2)(2008-2#1)(2008-9#2)(2009-9#1)(2012-2#1)
of the more##31##3##(1992-6#1)(1993-12#1)(1994-12#1)(1994-5#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#3)(2009-9#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)
of the morphological##6##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
of the morphology and##2##4##(2008-11#1)(2008-5#1)
of the morphology of the##3##5##(2007-8#2)(2013-7#1)
of the morphology of##4##4##(2007-8#3)(2013-7#1)
of the morphology##6##3##(2007-8#3)(2008-11#1)(2008-5#1)(2013-7#1)
of the mortality rate##2##4##(2008-9#2)
of the mortality##6##3##(1997-7#1)(2007-10#1)(2008-9#3)(2010-7#1)
of the mosquito##2##3##(2011-2#2)
of the moss Physcomitrella patens##3##5##(2010-2#3)
of the moss##4##3##(2008-10#1)(2010-2#3)
of the most abundant##5##4##(2008-10#2)(2010-11#1)(2011-2#1)(2013-8#1)
of the most accurate##2##4##(2007-12#1)(2008-10#1)
of the most active##6##4##(1991-6#1)(1995-3#1)(1997-4#1)(2007-5#1)(2008-6#1)(2008-8#1)
of the most appropriate##4##4##(2008-10#2)(2011-2#1)(2012-12#1)
of the most challenging##6##4##(1991-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
of the most common causes of##2##6##(2007-7#1)(2008-7#1)
of the most common complaints##2##5##(2011-2#1)(2012-2#1)
of the most common sites of##2##6##(2013-1#1)(2013-8#1)
of the most common sites##3##5##(2013-1#2)(2013-8#1)
of the most common##71##4##(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1994-5#1)(1995-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-8#3)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
of the most commonly seen lower reproductive tract infections among women aged 25 - 54 years in Beijing##2##18##(2011-1#2)
of the most commonly used##6##5##(2008-11#1)(2008-4#1)(2008-9#2)(2010-6#1)(2012-2#1)
of the most commonly##12##4##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)
of the most densely populated##2##5##(2008-2#1)(2013-1#1)
of the most destructive##4##4##(2008-10#3)(2009-2#1)
of the most difficult##7##4##(1995-1#1)(2007-7#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the most effective methods##2##5##(2007-11#1)(2011-1#1)
of the most effective##8##4##(2007-11#2)(2008-10#1)(2009-11#1)(2009-3#1)(2011-1#2)(2013-8#1)
of the most efficient##2##4##(1993-11#1)(2008-11#1)
of the most exciting##2##4##(2008-9#1)(2010-7#1)
of the most frequent and##2##5##(2011-2#2)
of the most frequent##12##4##(1993-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-12#2)(2011-2#3)(2013-1#3)
of the most frequently encountered##2##5##(1997-3#1)(2011-3#1)
of the most frequently performed##2##5##(2007-8#1)(2013-1#1)
of the most frequently used##3##5##(1994-6#1)(2008-4#1)(2010-6#1)
of the most frequently##8##4##(1994-6#1)(1997-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-3#1)(2013-1#1)
of the most general##2##4##(2008-3#1)(2010-12#1)
of the most important and##5##5##(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-7#1)
of the most important aspects of##2##6##(1992-2#1)(2013-1#1)
of the most important characteristics##2##5##(1992-9#1)(2013-8#1)
of the most important factors that##2##6##(2008-3#2)
of the most important factors##3##5##(2008-3#2)(2013-1#1)
of the most important functions##2##5##(2008-10#1)(2008-11#1)
of the most important gluconeogenic##2##5##(1994-8#2)
of the most important issues in##2##6##(2008-7#1)(2008-9#1)
of the most important issues##3##5##(1995-1#1)(2008-7#1)(2008-9#1)
of the most important##83##4##(1990-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#2)(1996-7#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-2#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-8#1)(2010-10#2)(2010-7#3)(2010-9#1)(2011-10#1)(2011-2#8)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of the most informative##2##4##(2008-12#1)(2008-9#1)
of the most interesting##5##4##(2007-5#1)(2008-2#2)(2008-5#1)(2009-8#1)
of the most intriguing##2##4##(1992-2#1)(2008-5#1)
of the most likely##2##4##(1996-2#1)(2008-10#1)
of the most modern##2##4##(1992-9#1)(2008-9#1)
of the most often##3##4##(2008-10#2)(2009-8#1)
of the most popular##7##4##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)
of the most potent##5##4##(1992-9#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-8#1)
of the most prevalent diseases##3##5##(2008-10#1)(2012-3#1)(2013-1#1)
of the most prevalent##8##4##(1991-9#1)(2007-2#1)(2008-10#2)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
of the most primitive##4##4##(1994-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
of the most probable##2##4##(2007-7#1)(2012-3#1)
of the most prominent##6##4##(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
of the most promising##4##4##(2008-3#1)(2008-7#1)(2009-2#1)(2013-7#1)
of the most recent literature##2##5##(1991-2#1)(2008-8#1)
of the most recent studies##2##5##(1995-6#1)(2012-1#1)
of the most recent##12##4##(1991-2#1)(1992-8#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-11#1)(2012-1#1)
of the most recently##2##4##(2008-11#1)(2011-2#1)
of the most relevant##4##4##(1997-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
of the most reliable##4##4##(1993-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
of the most remarkable##2##4##(1994-3#1)(2008-8#1)
of the most representative##2##4##(2008-5#1)(2010-1#1)
of the most robust##2##4##(1997-7#1)(2008-10#1)
of the most salient##2##4##(1994-1#1)(2008-10#1)
of the most serious##3##4##(1991-3#1)(2007-7#1)(2008-10#1)
of the most significant##5##4##(1993-12#1)(2007-11#1)(2008-1#2)(2013-1#1)
of the most successful approaches##2##5##(2009-2#1)(2009-3#1)
of the most suitable##3##4##(1992-10#1)(2008-10#2)
of the most widely distributed##3##5##(2008-10#3)
of the most widely##14##4##(2006-10#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-2#1)
of the most##450##3##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-10#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-7#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#5)(1997-8#3)(2006-10#1)(2007-11#11)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#3)(2008-1#7)(2008-10#68)(2008-11#13)(2008-12#9)(2008-2#5)(2008-3#7)(2008-4#11)(2008-5#15)(2008-6#4)(2008-7#19)(2008-8#10)(2008-9#19)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#2)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#7)(2011-10#2)(2011-2#30)(2011-3#4)(2012-1#3)(2012-12#7)(2012-2#14)(2012-3#6)(2013-1#24)(2013-7#6)(2013-8#6)
of the mother and##3##4##(1997-8#1)(2009-9#1)(2010-10#1)
of the mother##15##3##(1990-6#1)(1991-9#1)(1993-6#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-1#2)(2012-2#1)
of the mothers##13##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1993-12#1)(1993-6#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-1#3)
of the motifs##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
of the motion of##2##4##(2007-11#2)
of the motivational##2##3##(1996-5#1)(2010-10#1)
of the motor evoked potential##2##5##(2008-7#2)
of the motor##11##3##(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(2008-4#1)(2008-7#3)(2010-1#1)(2010-7#1)
of the mouse DNA polymerase alpha-primase complex##2##7##(1990-7#2)
of the mouse and##3##4##(1991-2#1)(1993-3#1)(1993-6#1)
of the mouse embryo##2##4##(1991-12#1)(2008-10#1)
of the mouse lactoferrin gene##3##5##(1992-12#3)
of the mouse##62##3##(1990-7#2)(1991-12#1)(1991-2#3)(1991-6#2)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-12#3)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2013-8#1)
of the mouth in##4##4##(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
of the mouth##13##3##(1990-12#1)(1990-8#1)(2008-11#1)(2008-5#4)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the mouthparts of##2##4##(2007-12#2)
of the mouthparts##3##3##(2007-12#3)
of the movement##7##3##(1996-1#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)
of the movements##3##3##(2007-12#1)(2008-11#1)(2012-3#1)
of the moving##6##3##(2007-11#1)(2008-10#1)(2008-3#3)(2011-2#1)
of the mtDNA##3##3##(1994-11#1)(1994-8#1)(2008-12#1)
of the mu receptor##2##4##(1995-6#2)
of the mu##3##3##(1991-9#1)(1995-6#2)
of the much larger##2##4##(1991-9#1)(2008-7#1)
of the much##3##3##(1991-9#1)(2008-2#1)(2008-7#1)
of the mucosa##7##3##(1990-9#1)(2008-5#2)(2012-1#1)(2013-1#2)(2013-8#1)
of the mucosal##4##3##(1994-6#1)(2008-11#2)(2010-9#1)
of the multidimensional##2##3##(1995-3#1)(2007-12#1)
of the multidisciplinary##4##3##(2008-8#1)(2010-11#1)(2013-1#2)
of the multidrug resistance##2##4##(2008-11#2)
of the multidrug##3##3##(2008-11#3)
of the multifarious##3##3##(2008-12#1)(2013-1#2)
of the multilayer coatings##2##4##(2008-2#1)(2008-3#1)
of the multilayer grating##2##4##(2008-3#2)
of the multilayer##12##3##(2008-10#1)(2008-2#4)(2008-3#7)
of the multiple mechanisms##2##4##(2010-1#1)(2012-12#1)
of the multiple##19##3##(1990-5#1)(1993-6#1)(1995-2#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-5#2)(2010-1#1)(2012-12#2)
of the multiple-scattering parameters##2##4##(2008-3#2)
of the multiple-scattering##3##3##(2008-2#1)(2008-3#2)
of the multivariate##2##3##(2008-10#2)
of the multiwavelength##2##3##(2007-12#1)(2008-3#1)
of the municipalities##4##3##(1991-6#1)(1992-2#1)(2012-12#2)
of the municipality##4##3##(2012-12#3)(2012-3#1)
of the murine LHR##2##4##(1996-5#2)
of the murine##18##3##(1991-6#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-5#4)(1997-7#1)(1997-8#1)(2008-11#1)(2008-4#1)
of the muscarinic receptors in the##2##6##(1990-5#2)
of the muscarinic##3##3##(1990-5#2)(1993-12#1)
of the muscle##11##3##(1991-2#1)(1994-8#1)(1997-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2011-1#1)(2013-1#1)
of the muscles##9##3##(2007-11#1)(2007-8#2)(2008-12#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-1#1)
of the muscular ideal##2##4##(2007-12#2)
of the muscular##3##3##(2007-12#2)(2008-8#1)
of the musculoskeletal system##4##4##(2008-6#1)(2008-8#1)(2009-7#1)(2010-9#1)
of the mutant LPL##2##4##(1992-3#2)
of the mutant enzyme##3##4##(1992-6#1)(1995-6#1)(1997-7#1)
of the mutant enzymes were##2##5##(1995-2#1)(1995-5#1)
of the mutant proteins##2##4##(1993-11#1)(1995-5#1)
of the mutant strains##2##4##(1990-5#1)(2008-7#1)
of the mutant##30##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#5)(1995-6#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
of the mutants is##2##4##(1995-5#1)(2008-9#1)
of the mutants##16##3##(1990-8#1)(1991-2#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-7#2)(2008-9#4)(2011-1#1)(2012-3#1)
of the mutated##4##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
of the mutation in##3##4##(1993-8#1)(1993-9#1)(1994-11#1)
of the mutation##11##3##(1990-2#1)(1991-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1995-12#1)(1997-3#2)(2011-1#1)
of the mutational##2##3##(2008-7#1)(2009-5#1)
of the mutationally altered##2##4##(1990-8#2)
of the mutations on##3##4##(1991-10#1)(1992-9#1)(1995-6#1)
of the mutations##11##3##(1990-8#1)(1991-10#1)(1991-5#1)(1992-9#1)(1995-6#1)(1997-2#2)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
of the mutual##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
of the mycelium##5##3##(2008-10#4)(2008-7#1)
of the mycoparasite##3##3##(2008-10#3)
of the mycorrhizosphere##2##3##(2008-10#2)
of the mycotoxin##2##3##(2008-10#2)
of the myelin##3##3##(1996-12#1)(2008-7#2)
of the myelination of the##2##5##(1996-5#2)
of the myocardial##3##3##(1997-3#1)(1997-6#1)(2010-6#1)
of the myocardium##10##3##(1990-9#2)(1992-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
of the myocytic calcium channel blocker diltiazem##2##7##(2008-7#2)
of the myofibroma##2##3##(2010-6#2)
of the myogenic##2##3##(1992-8#1)(1995-6#1)
of the myosin subfragment 1##2##5##(1992-4#1)(1994-8#1)
of the myosin##6##3##(1990-5#1)(1991-2#1)(1992-4#1)(1994-8#2)(2008-5#1)
of the nail##3##3##(2008-9#1)(2010-5#1)(2013-1#1)
of the name##4##3##(2008-10#3)(2010-4#1)
of the nanocarrier binding##2##4##(2008-12#2)
of the nanoclusters##2##3##(2008-10#2)
of the nanocomposites##2##3##(2008-10#1)(2008-8#1)
of the nanoelectrodes##2##3##(2008-10#2)
of the nanofilter##2##3##(2008-10#2)
of the nanoparticles##6##3##(2008-10#4)(2009-11#1)(2010-12#1)
of the nanosheets##2##3##(2008-10#2)
of the nanostructure of##2##4##(2008-10#1)(2012-2#1)
of the narrow##3##3##(1992-12#1)(2008-2#2)
of the narrow-band##3##3##(2007-12#1)(2008-2#1)(2008-6#1)
of the narrow-bandpass##2##3##(2008-3#2)
of the nasal cavity and paranasal sinuses##2##7##(1990-6#1)(1992-10#1)
of the nasal cavity and##3##5##(1990-6#1)(1992-10#2)
of the nasal cavity##4##4##(1990-6#1)(1992-10#2)(2007-7#1)
of the nasal mucosa##2##4##(1996-3#1)(1996-5#1)
of the nasal septum##5##4##(2009-1#1)(2012-12#4)
of the nasal##21##3##(1990-6#1)(1990-9#1)(1992-10#2)(1993-8#1)(1993-9#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-1#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#5)
of the nascent##2##3##(1993-3#1)(1995-2#1)
of the nasopharyngeal##2##3##(1995-10#1)(2008-10#1)
of the natal##2##3##(2008-8#1)(2013-8#1)
of the nation##5##3##(1991-11#1)(1991-8#1)(1994-3#1)(2008-11#1)(2011-2#1)
of the nation's##4##3##(1994-12#1)(1995-6#1)(1997-6#1)(2008-11#1)
of the national average##2##4##(1992-12#1)(2008-10#1)
of the national economy##2##4##(1994-2#1)(2010-1#1)
of the national##18##3##(1992-1#1)(1992-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#2)(2010-1#1)(2011-2#2)(2012-12#3)(2012-2#1)
of the native and reconstituted##2##5##(1992-8#1)(1993-8#1)
of the native and##4##4##(1992-8#1)(1993-8#1)(2008-1#1)(2008-4#1)
of the native enzyme and##2##5##(1992-11#1)(1993-11#1)
of the native enzyme##12##4##(1990-11#4)(1990-5#1)(1992-11#1)(1993-11#1)(1994-11#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#1)
of the native human##2##4##(1990-12#1)(1992-8#1)
of the native protein##4##4##(1990-8#1)(2008-11#1)(2008-4#1)(2008-7#1)
of the native state##3##4##(1992-3#1)(1992-6#1)(1993-11#1)
of the native##50##3##(1990-11#6)(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#1)
of the natural background##2##4##(1994-9#1)(2008-10#1)
of the natural heme##2##4##(1990-8#2)
of the natural history of this##2##6##(1990-12#1)(2008-7#1)
of the natural history of##5##5##(1990-12#1)(1996-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
of the natural history##7##4##(1990-12#1)(1996-6#1)(1996-9#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)
of the natural products##2##4##(2009-10#1)(2010-2#1)
of the natural##50##3##(1990-12#1)(1990-7#1)(1990-8#2)(1991-3#1)(1992-3#1)(1994-9#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#2)
of the naturally occurring amino##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
of the naturally occurring##6##4##(1992-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-5#1)
of the naturally##7##3##(1992-12#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-5#1)
of the nature and##4##4##(1992-11#1)(1993-1#1)(1994-1#1)(2008-10#1)
of the nature of the##10##5##(1992-3#1)(1992-6#1)(2008-10#6)(2009-4#1)(2012-2#1)
of the nature of##19##4##(1992-3#1)(1992-6#1)(1993-2#2)(1994-11#1)(1995-1#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-2#1)
of the nature##24##3##(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#2)(1994-1#1)(1994-11#1)(1995-1#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-2#1)
of the near field##2##4##(2007-11#1)(2008-3#1)
of the near##3##3##(1994-12#1)(2007-11#1)(2008-3#1)
of the near-field optical##2##4##(2008-2#1)(2008-3#1)
of the near-infrared##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the nearly##2##3##(1996-1#1)(2008-2#1)
of the nebulizer##5##3##(1994-12#2)(1995-12#1)(1995-3#1)(1996-3#1)
of the nebulizers##2##3##(1995-3#2)
of the necessary##3##3##(1990-8#1)(2008-1#1)(2008-3#1)
of the neck and##5##4##(1994-2#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
of the neck##22##3##(1990-6#1)(1991-11#1)(1991-2#1)(1994-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#3)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)
of the necrotic##4##3##(2008-10#1)(2009-1#1)(2011-2#2)
of the need for##12##4##(1992-12#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2013-1#1)
of the need to##7##4##(1992-1#1)(1995-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
of the need##20##3##(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#1)(2009-8#1)(2011-2#2)(2013-1#1)
of the needle##5##3##(1992-12#1)(2007-8#2)(2010-8#1)(2012-2#1)
of the needles##2##3##(2007-7#2)
of the negative binomial distribution##2##5##(2008-10#2)
of the negative##13##3##(1992-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-9#1)(2010-7#1)
of the nematic##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of the nematode Caenorhabditis elegans##2##5##(1995-3#1)(1996-6#1)
of the nematode population##3##4##(2008-10#3)
of the nematode##14##3##(1992-9#1)(1995-3#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-8#1)
of the nematodes##5##3##(2008-10#4)(2008-8#1)
of the neocortex##5##3##(1990-5#1)(2008-1#1)(2008-11#2)(2010-7#1)
of the neomycin resistance##2##4##(2008-11#2)
of the neonatal##3##3##(1992-8#1)(1996-5#1)(1997-3#1)
of the neonate##3##3##(1992-5#1)(2012-12#1)(2012-3#1)
of the neonates##2##3##(2011-1#2)
of the neoplasm as##2##4##(1993-6#1)(2007-7#1)
of the neoplasm##7##3##(1990-10#1)(1990-3#1)(1991-2#1)(1993-6#1)(1997-8#1)(2007-7#1)(2011-2#1)
of the neoplastic cells##2##4##(1992-2#1)(1997-1#1)
of the neoplastic##3##3##(1992-2#1)(1997-1#1)(2013-1#1)
of the neotropical##2##3##(2008-5#1)(2008-7#1)
of the nephrotic syndrome##2##4##(1996-6#1)(2007-7#1)
of the nerve##7##3##(2007-8#1)(2008-2#1)(2008-9#3)(2011-2#1)(2012-2#1)
of the nervous system and##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
of the nervous system are##2##5##(2008-5#1)(2010-12#1)
of the nervous system on experimentally induced urethral inflammation##2##9##(1990-7#2)
of the nervous system on##3##5##(1990-7#2)(1994-2#1)
of the nervous system##30##4##(1990-7#2)(1990-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1997-6#3)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-3#2)(2010-12#1)(2011-2#2)(2012-3#2)
of the nervous##32##3##(1990-7#2)(1990-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-6#3)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-3#2)(2010-12#1)(2011-2#2)(2012-3#2)
of the net##5##3##(1993-11#1)(1994-9#1)(2008-10#2)(2008-4#1)
of the network and##3##4##(1993-12#1)(2008-11#1)(2008-2#1)
of the network##9##3##(1993-12#1)(1994-8#1)(1996-4#2)(2008-11#1)(2008-2#2)(2010-10#1)(2011-2#1)
of the network's##4##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
of the networks##7##3##(2008-11#2)(2009-7#2)(2010-10#1)(2010-4#1)(2012-2#1)
of the neural network##6##4##(2008-10#2)(2008-3#2)(2008-8#1)(2009-5#1)
of the neural precursor cells##2##5##(2008-11#2)
of the neural##23##3##(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#5)(2008-3#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#2)(2010-8#1)(2012-12#1)(2012-2#2)
of the neuraxis##2##3##(2008-10#1)(2008-7#1)
of the neurites##3##3##(2008-11#3)
of the neuroanatomical##2##3##(1990-7#1)(2008-4#1)
of the neurobiology of##3##4##(2008-11#1)(2008-4#1)(2009-10#1)
of the neurochemical##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
of the neurogenic##2##3##(2008-7#1)(2012-7#1)
of the neurohypophyseal##3##3##(1997-8#3)
of the neurologic##2##3##(2008-7#1)(2012-3#1)
of the neurological##8##3##(1991-11#1)(1991-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-12#1)(2008-7#1)
of the neuromuscular##3##3##(2008-8#1)(2009-12#1)(2013-1#1)
of the neuron##5##3##(1992-12#1)(1993-12#2)(2008-3#1)(2008-4#1)
of the neuronal cytoskeleton##2##4##(1996-5#1)(1997-2#1)
of the neuronal##12##3##(1990-5#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-8#1)(2009-10#1)(2009-8#1)(2012-2#1)
of the neurones##2##3##(1995-12#1)(1997-3#1)
of the neurons##8##3##(1991-5#1)(1992-12#1)(1994-2#1)(2008-11#2)(2008-8#1)(2009-8#1)(2013-8#1)
of the neuropeptide##2##3##(1993-3#1)(2013-7#1)
of the neurotoxin##5##3##(1990-5#1)(1993-12#1)(1994-11#3)
of the neurotransmitter##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
of the neurotrophin##2##3##(1994-8#1)(2012-12#1)
of the neurovascular##2##3##(2008-3#1)(2013-1#1)
of the neutral##8##3##(1991-9#1)(1992-6#1)(2008-10#3)(2008-3#1)(2009-11#1)(2009-7#1)
of the neutrophil##5##3##(1992-8#1)(1993-6#1)(1994-8#2)(2008-10#1)
of the new Medicare##3##4##(1992-1#2)(2007-9#1)
of the new algorithm is##3##5##(2008-10#1)(2008-3#2)
of the new approach##5##4##(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#1)
of the new compounds showed##2##5##(2008-11#1)(2012-2#1)
of the new compounds##5##4##(1992-3#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
of the new host##2##4##(2008-8#2)
of the new method##6##4##(1997-8#1)(2008-10#3)(2008-3#1)(2008-6#1)
of the new millennium##4##4##(1993-2#1)(2007-12#1)(2008-1#1)(2008-11#1)
of the new modified alumina sorbent for##2##7##(2008-10#2)
of the new species##2##4##(2008-10#1)(2008-5#1)
of the new technique##2##4##(2008-2#1)(2008-3#1)
of the new##142##3##(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#8)(2008-2#10)(2008-3#16)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
of the newborn is##2##4##(2012-2#2)
of the newborn##18##3##(1992-12#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(2007-11#2)(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
of the newborns##2##3##(2007-11#1)(2011-1#1)
of the newer##6##3##(1994-1#1)(2007-11#1)(2008-5#1)(2009-5#1)(2010-6#1)(2013-1#1)
of the newly defined##2##4##(1995-6#1)(2008-3#1)
of the newly developed##4##4##(2008-10#2)(2008-3#1)(2010-11#1)
of the newly formed##2##4##(2008-10#1)(2008-9#1)
of the newly proposed method##2##5##(2008-3#2)
of the newly proposed##3##4##(2008-3#3)
of the newly synthesized##2##4##(2007-11#1)(2008-10#1)
of the newly##22##3##(1993-6#1)(1995-6#1)(1996-6#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-3#5)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)
of the next generation of##3##5##(1991-6#1)(1996-11#1)(2008-2#1)
of the next generation##5##4##(1991-6#1)(1996-11#1)(2008-11#2)(2008-2#1)
of the next##11##3##(1991-6#1)(1995-2#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)
of the next-generation##2##3##(2008-10#1)(2008-3#1)
of the nickel##5##3##(1997-7#1)(2007-12#1)(2008-10#3)
of the nicotinic##2##3##(1996-12#1)(2012-2#1)
of the nidus in##2##4##(1996-3#1)(2008-7#1)
of the nidus##10##3##(1991-2#1)(1996-3#1)(2008-7#7)(2008-9#1)
of the nigral##2##3##(1992-11#2)
of the nigrostriatal dopaminergic##2##4##(1992-7#1)(1996-12#1)
of the nigrostriatal system##2##4##(1993-5#1)(1994-8#1)
of the nigrostriatal##4##3##(1992-7#1)(1993-5#1)(1994-8#1)(1996-12#1)
of the nine##13##3##(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-3#1)
of the nineteenth century##9##4##(1991-12#1)(2008-2#1)(2009-10#1)(2009-7#1)(2010-1#2)(2011-2#2)(2012-2#1)
of the nipple##2##3##(1997-5#1)(2011-2#1)
of the nitrate##3##3##(1991-9#1)(1993-6#1)(2008-10#1)
of the nitric oxide##3##4##(2008-10#1)(2012-8#1)(2013-7#1)
of the nitro groups##2##4##(1995-3#1)(2008-10#1)
of the nitro##4##3##(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#1)
of the nitrogen fixation##2##4##(2008-9#2)
of the nitrogen##8##3##(1995-11#1)(1996-2#1)(2008-3#1)(2008-9#3)(2011-2#1)(2013-8#1)
of the nitrogen-centered radical##3##4##(1993-11#3)
of the nitrosamino##2##3##(1996-5#2)
of the noble scallop##2##4##(2013-8#2)
of the noble##3##3##(2008-10#1)(2013-8#2)
of the nociceptive##2##3##(1997-2#1)(2009-12#1)
of the nodule##3##3##(2008-1#1)(2008-7#1)(2012-3#1)
of the nodules##3##3##(2008-1#1)(2011-1#1)(2012-3#1)
of the noise##10##3##(2007-12#1)(2008-2#1)(2008-3#6)(2008-6#1)(2008-8#1)
of the non##4##3##(2007-8#1)(2008-10#2)(2008-7#1)
of the non-ergot dopamine agonist##2##5##(2008-7#2)
of the non-ionic surfactant##2##4##(2008-10#2)
of the non-specific immunologically-mediated resistance##2##5##(2011-1#2)
of the non-specific##4##3##(1991-11#1)(2008-10#1)(2011-1#2)
of the noncatalytic##2##3##(1992-6#1)(1993-11#1)
of the noncoding##2##3##(2007-10#1)(2008-11#1)
of the nonionic surfactant##2##4##(2008-10#1)(2011-2#1)
of the nonlinear Schrödinger equation##3##5##(2007-11#2)(2007-12#1)
of the nonlinear coefficient##3##4##(2007-11#2)(2007-12#1)
of the nonlinear optical##2##4##(2007-11#1)(2007-12#1)
of the nonlinear phase shift##2##5##(2007-11#1)(2007-12#1)
of the nonlinear phase##3##4##(2007-11#2)(2007-12#1)
of the nonlinear response of##2##5##(2008-2#2)
of the nonlinear##29##3##(2007-11#9)(2007-12#5)(2008-2#6)(2008-3#7)(2008-7#1)(2009-5#1)
of the nonlinearity##2##3##(2007-11#1)(2008-2#1)
of the nonparametric##3##3##(2008-10#1)(2009-10#1)(2009-5#1)
of the nonprofit hospital##2##4##(1993-2#1)(1996-2#1)
of the nonprofit##3##3##(1993-2#1)(1994-2#1)(1996-2#1)
of the nonstructural protein##2##4##(2008-10#1)(2009-7#1)
of the nonstructural##4##3##(2008-10#3)(2009-7#1)
of the nootropics##2##3##(1993-12#2)
of the noradrenergic##2##3##(1995-12#1)(2012-12#1)
of the normal appendix##2##4##(1997-8#2)
of the normal boiling points of##2##6##(2007-11#2)
of the normal controls##5##4##(2008-10#3)(2008-7#2)
of the normal human skin##2##5##(2007-7#1)(2010-10#1)
of the normal human##3##4##(2007-7#1)(2010-10#1)(2013-7#1)
of the normal rat##2##4##(2008-7#1)(2008-9#1)
of the normal##43##3##(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-8#2)(2007-11#3)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
of the normalized##6##3##(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#3)
of the north-western zone of the Bogota Savanna##2##8##(2012-12#2)
of the north-western zone of the Bogota##3##7##(2012-12#3)
of the northeastern##2##3##(1996-4#1)(2011-2#1)
of the northern##7##3##(1990-11#1)(2007-5#1)(2008-5#3)(2008-9#1)(2013-8#1)
of the nose##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
of the nosology##2##3##(1993-11#1)(2011-1#1)
of the novel##28##3##(1992-3#1)(1993-11#1)(1994-12#1)(1995-12#2)(1995-3#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-2#1)(2011-1#2)(2011-2#3)(2012-12#1)
of the novelty filter##2##4##(2008-2#2)
of the nt##2##3##(1991-6#1)(1993-6#1)
of the nuclear envelope##3##4##(1995-2#1)(2011-2#2)
of the nuclear hormone receptor superfamily##3##6##(1993-6#1)(1995-2#1)(2006-8#1)
of the nuclear lamina##2##4##(1992-12#1)(2008-8#1)
of the nuclear membrane##2##4##(2008-9#1)(2011-2#1)
of the nuclear receptor family##2##5##(2008-1#1)(2008-4#1)
of the nuclear receptor superfamily##2##5##(1994-12#1)(2008-3#1)
of the nuclear receptor##6##4##(1994-11#1)(1994-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)
of the nuclear ribosomal DNA##4##5##(2008-10#4)
of the nuclear ribosomal##9##4##(2008-10#9)
of the nuclear##40##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-2#2)(2006-8#1)(2008-1#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#6)
of the nuclear-encoded##2##3##(1990-5#1)(2010-4#1)
of the nuclei##4##3##(1993-6#1)(2007-12#1)(2008-5#1)(2008-9#1)
of the nucleic acid##2##4##(2008-10#1)(2008-4#1)
of the nucleic acids##2##4##(1994-3#1)(2008-2#1)
of the nucleic##4##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
of the nucleobase##2##3##(1996-5#1)(2008-4#1)
of the nucleolar##4##3##(1991-2#1)(1994-9#1)(2008-8#2)
of the nucleosides##2##3##(1990-7#1)(1996-5#1)
of the nucleotide and amino acid##2##6##(1990-7#1)(2011-1#1)
of the nucleotide and##3##4##(1990-7#1)(2008-10#1)(2011-1#1)
of the nucleotide sequence of the##4##6##(1992-11#1)(1994-12#1)(1995-8#1)(2008-10#1)
of the nucleotide sequence of##8##5##(1990-11#1)(1990-2#1)(1992-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(2008-10#2)
of the nucleotide sequence##10##4##(1990-11#1)(1990-2#1)(1992-11#1)(1994-12#2)(1995-6#2)(1995-8#1)(2008-10#2)
of the nucleotide sequences of##2##5##(2008-10#1)(2008-5#1)
of the nucleotide sequences##3##4##(2008-10#2)(2008-5#1)
of the nucleotide##19##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1993-11#1)(1994-12#2)(1995-6#2)(1995-8#1)(2008-10#5)(2008-4#1)(2008-5#2)(2011-1#1)
of the nucleotide-binding##2##3##(1995-6#1)(2008-11#1)
of the nucleotides##2##3##(1990-8#1)(2008-11#1)
of the nucleus accumbens and its##2##6##(1993-6#1)(2008-7#1)
of the nucleus accumbens and##3##5##(1993-6#1)(1994-2#1)(2008-7#1)
of the nucleus accumbens##11##4##(1993-6#4)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-7#1)
of the nucleus and##2##4##(2008-7#1)(2011-2#1)
of the nucleus basalis##3##4##(1992-10#1)(1993-3#1)(1995-12#1)
of the nucleus in##2##4##(2008-9#1)(2011-2#1)
of the nucleus pulposus##2##4##(2007-8#2)
of the nucleus##35##3##(1991-5#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#4)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-7#7)(2008-9#1)(2009-7#1)(2011-2#6)
of the null##4##3##(2008-3#2)(2008-7#1)(2008-8#1)
of the nulling##2##3##(2007-11#1)(2008-3#1)
of the number and##5##4##(1993-3#1)(1994-9#1)(2008-4#1)(2013-1#2)
of the number of cells##2##5##(2008-2#1)(2008-4#1)
of the number of##62##4##(1990-11#2)(1990-6#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of the number##72##3##(1990-11#2)(1990-6#1)(1991-2#1)(1991-3#1)(1993-3#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
of the numbers##3##3##(2007-5#1)(2008-2#1)(2008-7#1)
of the numerical aperture##3##4##(2007-12#1)(2008-2#2)
of the numerical##8##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-9#1)(2012-3#2)
of the numerous##5##3##(1992-1#1)(2008-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
of the nurse##10##3##(2008-1#1)(2008-11#4)(2008-12#1)(2008-6#2)(2011-2#1)(2012-3#1)
of the nurses##5##3##(1990-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
of the nursing curriculum##3##4##(2008-12#2)(2010-3#1)
of the nursing home##2##4##(1992-3#1)(2008-11#1)
of the nursing profession##2##4##(1996-3#1)(2011-1#1)
of the nursing staff]##2##4##(1994-3#1)(1994-5#1)
of the nursing workforce##2##4##(2012-3#2)
of the nursing##16##3##(1992-3#1)(1993-3#1)(1994-3#2)(1994-5#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2010-3#1)(2011-1#1)(2012-3#3)
of the nutrient foramen##6##4##(2013-8#6)
of the nutrient##9##3##(2008-10#2)(2008-7#1)(2013-8#6)
of the nutritional status##2##4##(1991-12#1)(2010-4#1)
of the nutritional##4##3##(1991-12#1)(2008-10#1)(2010-4#1)(2012-2#1)
of the oak##2##3##(2008-5#1)(2012-6#1)
of the obese##5##3##(1996-12#1)(2008-10#1)(2011-1#1)(2013-1#2)
of the object by##2##4##(2008-11#1)(2008-9#1)
of the object in the##2##5##(1995-2#1)(2008-2#1)
of the object in##4##4##(1995-2#1)(2008-11#2)(2008-2#1)
of the object is##2##4##(2008-3#2)
of the object spectrum##2##4##(2008-3#2)
of the object structure##2##4##(2008-2#1)(2012-1#1)
of the object to be##4##5##(2008-3#2)(2012-12#2)
of the object wave##2##4##(2008-3#2)
of the object with a##2##5##(2007-11#1)(2008-2#1)
of the object with##3##4##(2007-11#2)(2008-2#1)
of the object##49##3##(1991-6#1)(1993-6#1)(1995-2#1)(1996-2#1)(2007-11#3)(2007-12#2)(2008-11#4)(2008-2#9)(2008-3#18)(2008-7#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
of the objective lens and##4##5##(2007-12#2)(2008-3#2)
of the objective lens##8##4##(2007-12#2)(2008-2#2)(2008-3#4)
of the objective##13##3##(1994-2#1)(2007-12#3)(2008-2#2)(2008-3#6)(2012-3#1)
of the objectives##3##3##(1996-2#1)(2007-11#1)(2010-3#1)
of the objects in##3##4##(1992-11#1)(2008-3#1)(2009-12#1)
of the objects##9##3##(1992-11#1)(2007-11#1)(2008-2#1)(2008-3#5)(2009-12#1)
of the obligately anaerobic bacterium Bacteroides gingivalis##2##7##(1990-11#2)
of the obligatory##2##3##(1997-8#1)(2011-1#1)
of the observation of##4##4##(2007-11#1)(2008-11#1)(2008-3#2)
of the observation period##6##4##(1992-6#1)(1993-3#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-6#1)
of the observation##11##3##(1992-6#1)(1993-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)
of the observations##6##3##(1996-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
of the observed HIV-positive population size##3##6##(2008-1#3)
of the observed effects##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
of the observed patterns of##2##5##(2008-8#2)
of the observed patterns##4##4##(2008-8#4)
of the observed variation##2##4##(1995-3#1)(2013-7#1)
of the observed##46##3##(1992-6#2)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#7)(2008-7#3)(2008-8#7)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-7#1)
of the observer##3##3##(2008-2#1)(2008-5#1)(2009-11#1)
of the obstruction##2##3##(2007-12#1)(2011-2#1)
of the obstructive##2##3##(2007-12#1)(2013-1#1)
of the obtained results##4##4##(2007-10#1)(2008-10#3)
of the obtained##16##3##(1992-8#1)(1996-10#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-5#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#1)
of the occipital##3##3##(1990-8#1)(2008-7#2)
of the occluded##2##3##(1997-8#1)(2008-12#1)
of the occlusion and the##2##5##(1996-6#1)(2010-9#1)
of the occlusion##4##3##(1996-6#1)(2007-10#1)(2008-11#1)(2010-9#1)
of the occupational##2##3##(1996-3#1)(2008-11#1)
of the occurrence of a##2##5##(2007-8#1)(2012-2#1)
of the occurrence of##11##4##(1996-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the occurrence##12##3##(1996-3#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the ocean color##2##4##(2008-2#1)(2008-3#1)
of the ocean##8##3##(2008-2#4)(2008-3#4)
of the odds##2##3##(2010-12#1)(2012-3#1)
of the odontogenic keratocyst##5##4##(2007-12#5)
of the odontoid process##2##4##(2011-2#2)
of the odor##2##3##(2008-10#1)(2008-4#1)
of the oesophagus and stomach in chinchilla (Chinchilla##2##8##(2013-8#2)
of the oesophagus##11##3##(1990-12#1)(1990-9#1)(1993-6#1)(2007-8#2)(2008-1#3)(2008-11#1)(2013-8#2)
of the of##2##3##(2008-10#1)(2012-2#1)
of the offending drug##4##4##(1993-6#1)(2008-7#2)(2008-8#1)
of the offending##5##3##(1993-6#1)(2008-7#2)(2008-8#1)(2010-5#1)
of the official##3##3##(1993-5#1)(1997-6#1)(2008-10#1)
of the offspring##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
of the oil##8##3##(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#3)(2011-1#1)(2011-2#1)
of the oils##2##3##(2008-10#1)(2008-12#1)
of the old##5##3##(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)
of the older person##5##4##(2010-10#4)(2011-1#1)
of the older##11##3##(1992-9#2)(1995-5#1)(2008-6#1)(2010-10#4)(2011-1#1)(2013-1#2)
of the oldest##6##3##(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the oleosin##2##3##(2009-10#2)
of the olfactory bulb##6##4##(1990-7#1)(2009-12#5)
of the olfactory nerve##2##4##(1995-12#2)
of the olfactory organ##2##4##(2007-12#2)
of the olfactory system##2##4##(2008-6#1)(2008-7#1)
of the olfactory##14##3##(1990-7#1)(1995-12#2)(2007-12#3)(2008-6#1)(2008-7#1)(2009-12#6)
of the oligomer##2##3##(1994-5#1)(2011-2#1)
of the oligomeric structure##2##4##(1997-8#1)(2008-4#1)
of the oligomeric##4##3##(1992-11#1)(1995-2#1)(1997-8#1)(2008-4#1)
of the oligonucleotide##10##3##(1993-11#1)(1996-12#1)(2008-10#3)(2008-4#4)(2012-3#1)
of the oligosaccharide##8##3##(1990-9#1)(1992-12#1)(1993-11#2)(1994-9#1)(1995-11#1)(1995-5#1)(2008-7#1)
of the oligosaccharides##6##3##(1990-9#1)(1991-12#1)(1992-10#1)(1993-11#1)(2008-10#1)(2008-11#1)
of the on-line##4##3##(2008-10#4)
of the oncogenic##2##3##(1991-12#1)(2008-7#1)
of the oncology##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
of the one##2##3##(1997-2#1)(2007-11#1)
of the one-dimensional##3##3##(1993-5#1)(2007-12#1)(2008-3#1)
of the ongoing##5##3##(1991-1#1)(1991-6#1)(1993-12#1)(1996-3#1)(2009-4#1)
of the only##4##3##(1993-6#1)(1994-9#1)(1996-11#1)(2008-10#1)
of the onset of symptoms##2##5##(2008-7#1)(2008-9#1)
of the onset of##12##4##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)
of the onset##13##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)
of the ontology##2##3##(2008-7#2)
of the oocyte##6##3##(2007-12#3)(2008-12#1)(2008-7#1)(2013-1#1)
of the open reading frame of##2##6##(1992-6#2)
of the open reading frame##8##5##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-6#1)(1995-8#1)(1997-2#1)
of the open reading frames##4##5##(1996-3#2)(2011-1#2)
of the open reading##13##4##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-3#2)(1997-2#1)(2011-1#3)
of the open##18##3##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-3#2)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#3)(2012-12#1)(2013-8#1)
of the operated joint##2##4##(2007-8#2)
of the operated patients##2##4##(2011-2#1)(2013-1#1)
of the operated##6##3##(2007-11#1)(2007-8#2)(2008-5#1)(2011-2#1)(2013-1#1)
of the operating room environment##2##5##(1991-1#1)(2008-8#1)
of the operating room##3##4##(1991-1#2)(2008-8#1)
of the operating##7##3##(1991-1#2)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
of the operation is##2##4##(1991-3#1)(1991-5#1)
of the operation of##2##4##(1995-6#1)(2008-10#1)
of the operation##17##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-9#1)(1995-6#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2009-10#1)(2011-1#1)
of the operative treatment of##2##5##(2007-11#1)(2007-8#1)
of the operative##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2010-8#1)(2013-8#1)
of the operator##3##3##(1991-6#1)(1992-6#1)(2008-10#1)
of the opinion that the##2##5##(2008-1#1)(2008-7#1)
of the opinions of##2##4##(2008-12#2)
of the opportunities##2##3##(1993-3#1)(2008-1#1)
of the opportunity to##2##4##(2008-4#1)(2008-7#1)
of the opportunity##3##3##(2007-9#1)(2008-4#1)(2008-7#1)
of the opposite##7##3##(2007-11#1)(2008-2#2)(2008-9#1)(2009-10#1)(2011-1#1)(2013-8#1)
of the opposition##2##3##(1995-1#1)(2012-2#1)
of the optic lobe##2##4##(2007-12#1)(2008-5#1)
of the optic nerve##5##4##(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)
of the optic##11##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2010-5#1)(2011-2#2)
of the optical axis with respect to the plane of incidence##2##11##(2008-3#2)
of the optical axis##5##4##(2007-11#1)(2008-3#4)
of the optical carrier##2##4##(2007-12#2)
of the optical coefficients##2##4##(2008-2#2)
of the optical constants##6##4##(2008-2#2)(2008-3#4)
of the optical depth##2##4##(2008-2#1)(2008-3#1)
of the optical excitation##2##4##(2007-11#1)(2007-12#1)
of the optical fiber##2##4##(2008-10#1)(2008-3#1)
of the optical field##5##4##(2007-11#3)(2008-3#2)
of the optical fluctuation##2##4##(2008-3#2)
of the optical frequency in a##2##6##(2007-11#1)(2008-2#1)
of the optical frequency##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of the optical near field##2##5##(2007-11#2)
of the optical parameters##4##4##(2008-2#1)(2008-3#3)
of the optical properties of the##3##6##(2008-2#2)(2008-3#1)
of the optical properties of##9##5##(2008-10#1)(2008-2#3)(2008-3#5)
of the optical properties##10##4##(2008-10#1)(2008-2#3)(2008-3#6)
of the optical signal##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of the optical spectrum##3##4##(2007-11#1)(2008-3#1)(2011-2#1)
of the optical system for##2##5##(2008-2#1)(2008-3#1)
of the optical system##12##4##(2007-12#1)(2008-2#4)(2008-3#7)
of the optical##124##3##(2007-11#16)(2007-12#14)(2008-10#4)(2008-2#19)(2008-3#63)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#3)
of the optically##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of the optics##3##3##(2007-12#1)(2008-3#2)
of the optimal##13##3##(1996-3#1)(1997-3#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-8#1)(2010-8#1)
of the optimisation##2##3##(2008-10#2)
of the optimised BCR SEP##2##5##(2008-10#2)
of the optimization##7##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)
of the optimized concentrators##2##4##(2008-3#2)
of the optimized procedure##2##4##(2008-10#2)
of the optimized##11##3##(1993-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2013-1#1)
of the optimum##19##3##(1990-7#2)(1994-12#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-2#3)(2008-3#5)(2008-9#1)(2013-8#1)
of the options##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
of the optode membrane##3##4##(2008-10#3)
of the optode##5##3##(2008-10#5)
of the oral and maxillofacial region##2##6##(2007-12#1)(2008-7#1)
of the oral and maxillofacial##4##5##(2007-12#2)(2008-7#2)
of the oral and##5##4##(2007-12#2)(2008-7#2)(2013-1#1)
of the oral cavity or##2##5##(1991-6#1)(2007-12#1)
of the oral cavity##13##4##(1990-3#1)(1991-6#1)(1992-8#1)(1995-9#1)(2007-12#3)(2008-4#1)(2012-3#3)(2013-1#2)
of the oral##28##3##(1990-10#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-8#2)(1995-9#1)(2007-10#1)(2007-12#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-4#1)(2010-5#1)(2012-3#3)(2013-1#3)
of the orbit and frontal sinus##2##6##(2011-2#2)
of the orbit##9##3##(1996-6#1)(2008-10#1)(2008-6#2)(2008-9#1)(2011-2#3)(2012-3#1)
of the orbitofrontal##2##3##(2009-10#1)(2012-12#1)
of the orbits##2##3##(2011-2#2)
of the orchard##6##3##(2008-10#6)
of the orchards##2##3##(2008-10#2)
of the order Acipenseriformes##2##4##(2008-8#2)
of the order in the##3##5##(2008-10#2)(2008-5#1)
of the order of 0##4##5##(2007-11#1)(2008-10#1)(2008-3#1)(2010-9#1)
of the order of 1##6##5##(2007-12#1)(2008-2#1)(2008-3#3)(2010-9#1)
of the order of 10##3##5##(1995-11#1)(2008-3#1)(2010-9#1)
of the order of 100 m##2##6##(1996-4#2)
of the order of 100##6##5##(1996-4#2)(2007-11#1)(2008-2#2)(2008-7#1)
of the order of 5##2##5##(2008-2#1)(2008-3#1)
of the order of 50##2##5##(2007-11#1)(2007-12#1)
of the order of a few##4##6##(2008-2#1)(2008-3#3)
of the order of less than##2##6##(2008-10#1)(2008-3#1)
of the order of magnitude of##2##6##(2008-3#2)
of the order of several##3##5##(1997-6#1)(2008-3#2)
of the order of tens of##3##6##(2007-12#1)(2008-10#1)(2008-3#1)
of the order of the##2##5##(1996-3#1)(2007-11#1)
of the order of##84##4##(1992-3#1)(1995-11#1)(1996-3#1)(1996-4#2)(1997-6#1)(2007-11#6)(2007-12#11)(2008-10#9)(2008-2#14)(2008-3#34)(2008-7#1)(2010-9#3)
of the order##96##3##(1990-12#1)(1992-3#1)(1995-11#1)(1996-3#1)(1996-4#2)(1997-6#1)(2007-11#6)(2007-12#13)(2008-10#12)(2008-2#14)(2008-3#34)(2008-5#1)(2008-7#1)(2008-8#2)(2010-9#3)(2011-2#2)(2013-1#1)
of the ordered##2##3##(1990-5#1)(1992-11#1)
of the ordinary##5##3##(1993-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)
of the organ##5##3##(1990-11#1)(1994-6#1)(2008-5#2)(2011-2#1)
of the organelle##2##3##(2008-10#1)(2011-2#1)
of the organic carbon##2##4##(2008-10#2)
of the organic crystal DAST##2##5##(2007-12#2)
of the organic crystal N-(4-nitrophenyl)-L-prolinol##2##5##(2007-12#2)
of the organic crystal##4##4##(2007-12#4)
of the organic phase##3##4##(2008-10#3)
of the organic solvent##3##4##(1996-5#1)(2008-10#2)
of the organic##31##3##(1995-6#1)(1996-5#2)(2007-12#6)(2008-10#17)(2008-11#1)(2008-5#1)(2008-8#1)(2013-8#2)
of the organism and##3##4##(1994-5#1)(2011-2#1)(2013-8#1)
of the organism in##2##4##(1996-11#1)(1997-1#1)
of the organism to##2##4##(1990-8#1)(1997-6#1)
of the organism##27##3##(1990-8#1)(1991-9#1)(1994-5#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#7)(2013-8#1)
of the organisms##6##3##(2008-11#1)(2008-3#1)(2008-5#2)(2011-1#1)(2012-1#1)
of the organization and##4##4##(1993-12#1)(1994-11#1)(2010-9#1)(2012-2#1)
of the organization of the##3##5##(1995-5#2)(2008-1#1)
of the organization of##5##4##(1993-6#1)(1995-11#1)(1995-5#2)(2008-1#1)
of the organization through the##2##5##(1993-12#1)(1995-12#1)
of the organization##20##3##(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-5#2)(1996-3#1)(1997-2#1)(2007-4#1)(2008-1#1)(2010-9#1)(2012-2#1)
of the organization's##2##3##(1993-1#1)(2007-4#1)
of the organizational##3##3##(1992-12#1)(2008-11#1)(2013-1#1)
of the organizations##2##3##(1994-12#1)(2013-1#1)
of the organs##2##3##(2007-8#1)(2013-8#1)
of the oriental##2##3##(2008-6#1)(2011-2#1)
of the orientation of the##7##5##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
of the orientation of##8##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
of the orientation##14##3##(1990-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)
of the origin and##5##4##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
of the origin of the##3##5##(2008-10#1)(2008-3#1)(2008-4#1)
of the origin of##11##4##(1990-11#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
of the origin##18##3##(1990-11#2)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)
of the original data can be achieved##2##7##(2008-3#2)
of the original data##4##4##(2008-10#2)(2008-3#2)
of the original hybrid linear analysis (HLA) method##2##8##(2008-10#2)
of the original object##2##4##(2008-3#2)
of the original observations##2##4##(1995-2#1)(2012-1#1)
of the original signal##2##4##(2007-11#1)(2008-3#1)
of the original system##3##4##(2008-3#2)(2008-8#1)
of the original tumor##2##4##(1990-2#1)(2011-2#1)
of the original version##2##4##(2007-8#1)(2012-12#1)
of the original##77##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-11#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-2#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#13)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-1#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)
of the oropharyngeal##2##3##(2011-1#1)(2013-1#1)
of the orthogonal##2##3##(2008-10#1)(2008-2#1)
of the orthorhombic crystal form##2##5##(1993-8#1)(2008-8#1)
of the oscillation period##2##4##(2008-10#1)(2010-10#1)
of the oscillations is equal to the##2##7##(2008-3#2)
of the oscillations##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
of the oscillator##3##3##(1990-8#1)(2007-12#1)(2008-3#1)
of the osseous##2##3##(2010-5#1)(2011-2#1)
of the ossified cochlea##2##4##(2008-9#2)
of the other components of##2##5##(2010-7#1)(2012-3#1)
of the other components##3##4##(2008-10#1)(2010-7#1)(2012-3#1)
of the other five##2##4##(2008-9#1)(2012-1#1)
of the other hospitals##2##4##(1992-2#2)
of the other one##2##4##(1995-3#1)(2008-10#1)
of the other species##2##4##(2008-10#1)(2010-3#1)
of the other three##2##4##(2008-10#1)(2009-10#1)
of the other two groups##2##5##(2008-10#2)
of the other two##6##4##(1991-6#1)(1993-11#1)(1993-6#1)(2008-10#3)
of the other##96##3##(1990-11#1)(1990-5#2)(1991-6#1)(1991-9#1)(1992-2#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
of the others##3##3##(2007-12#1)(2007-7#1)(2008-5#1)
of the otolith##2##3##(2008-7#2)
of the outbreak and##3##4##(2011-3#1)(2013-1#1)(2013-8#1)
of the outbreak##7##3##(2008-8#2)(2011-3#1)(2013-1#1)(2013-8#3)
of the outcome of##2##4##(2008-7#1)(2008-8#1)
of the outcome##7##3##(1994-3#1)(1996-5#1)(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
of the outcomes##4##3##(1994-3#1)(1996-2#1)(2008-4#1)(2009-6#1)
of the outer layer##5##4##(1992-6#1)(2008-10#1)(2008-3#2)(2008-7#1)
of the outer membrane in##2##5##(1997-8#1)(2008-5#1)
of the outer membrane##3##4##(1997-8#2)(2008-5#1)
of the outer membrane)##2##4##(1997-8#2)
of the outer##26##3##(1992-12#2)(1992-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-4#1)(1997-8#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2010-1#1)(2011-2#1)(2012-2#1)
of the output beam was##2##5##(2007-12#1)(2011-1#1)
of the output of a mode-locked##2##6##(2007-11#2)
of the output of a##5##5##(2007-11#3)(2007-12#1)(2008-7#1)
of the output of##8##4##(2007-11#3)(2007-12#3)(2008-2#1)(2008-7#1)
of the output power##4##4##(2008-2#1)(2008-3#3)
of the output pulse peak power and##2##7##(2008-3#2)
of the output pulses##2##4##(2007-12#2)
of the output radiation##2##4##(2007-11#2)
of the output signal##4##4##(2007-11#2)(2008-10#2)
of the output##43##3##(1993-6#1)(2007-11#10)(2007-12#10)(2008-10#2)(2008-2#5)(2008-3#11)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the outstanding##2##3##(1995-3#1)(2011-2#1)
of the outward##2##3##(1997-2#1)(2008-3#1)
of the ovarian follicles##2##4##(2008-12#2)
of the ovarian surface##2##4##(2011-2#2)
of the ovarian##14##3##(1991-4#1)(1991-9#1)(1992-3#2)(1996-1#2)(2007-12#1)(2008-12#2)(2008-4#1)(2011-2#2)(2012-3#2)
of the ovary and##2##4##(1993-2#1)(2007-4#1)
of the ovary are##2##4##(1991-5#1)(2010-12#1)
of the ovary in##2##4##(2007-12#1)(2008-12#1)
of the ovary is##5##4##(1991-5#1)(1996-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
of the ovary##32##3##(1990-2#1)(1991-5#3)(1992-3#1)(1993-2#1)(1993-9#4)(1995-12#1)(1996-2#2)(1997-8#1)(2007-12#1)(2007-4#3)(2007-8#2)(2008-12#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-1#3)(2013-7#1)(2013-8#3)
of the overall fluorescence)##2##4##(1991-5#2)
of the overall management##2##4##(2007-6#1)(2008-9#1)
of the overall method##2##4##(2008-10#2)
of the overall##45##3##(1990-12#1)(1990-7#1)(1991-5#3)(1991-8#1)(1992-2#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)
of the overexpressed##4##3##(1994-12#1)(1994-5#2)(2009-8#1)
of the overlap of##2##4##(2008-10#1)(2008-3#1)
of the overlap##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the overlapping ORFs 3 and 4##2##7##(2008-10#2)
of the overlapping##9##3##(1996-12#1)(1996-8#1)(2008-10#6)(2008-3#1)
of the overlay##2##3##(2007-11#1)(2008-3#1)
of the overweight##2##3##(2008-10#2)
of the oviduct##2##3##(1990-8#1)(2008-7#1)
of the ovipositor##2##3##(2007-12#2)
of the oxidant##8##3##(1995-8#1)(2008-10#7)
of the oxidase##4##3##(1991-2#1)(1993-8#1)(1994-8#1)(2008-10#1)
of the oxidation of##3##4##(2008-10#3)
of the oxidation reaction of##2##5##(2008-10#2)
of the oxidation reaction##3##4##(2008-10#3)
of the oxidation state of##2##5##(2008-10#2)
of the oxidation state##3##4##(2007-11#1)(2008-10#2)
of the oxidation##17##3##(1997-7#1)(2007-11#1)(2008-10#14)(2012-3#1)
of the oxidative##4##3##(1994-5#1)(2008-10#2)(2011-1#1)
of the oxidized##9##3##(1990-5#1)(1993-8#1)(1994-8#1)(2008-10#3)(2008-11#1)(2009-7#2)
of the oxidizing##2##3##(2008-10#2)
of the oxygen atoms##2##4##(1995-5#1)(1997-7#1)
of the oxygen##7##3##(1995-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2013-8#3)
of the oxygen-binding##2##3##(1990-8#2)
of the oxygen-evolving##2##3##(1996-10#1)(1997-4#1)
of the oxygenated##2##3##(1993-8#1)(1994-6#1)
of the ozone##6##3##(1991-6#1)(2008-11#1)(2008-3#4)
of the p##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
of the p53 gene##4##4##(1991-11#2)(1993-11#1)(2008-10#1)
of the p53 protein##3##4##(1992-3#1)(2008-5#1)(2013-7#1)
of the p53 tumor suppressor##2##5##(1994-5#1)(1994-8#1)
of the p53##16##3##(1991-11#2)(1992-3#1)(1993-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#2)(2012-12#1)(2013-7#1)
of the pH and##2##4##(2008-10#2)
of the pH on the##2##5##(2008-10#1)(2010-4#1)
of the pH on##3##4##(2008-10#1)(2010-4#1)(2013-8#1)
of the pH##14##3##(1990-11#1)(1990-5#1)(2008-10#10)(2010-4#1)(2013-8#1)
of the pK(a)##3##3##(2008-10#3)
of the packet##2##3##(2008-3#2)
of the paediatric##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
of the pain##13##3##(1991-11#1)(1992-2#2)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2013-1#1)
of the painful##2##3##(2007-11#1)(2010-7#1)
of the pair##2##3##(1995-2#1)(2008-7#1)
of the paired t-test##2##4##(2008-10#2)
of the palate##3##3##(1991-2#1)(1996-8#1)(2009-1#1)
of the palladium##2##3##(2008-10#2)
of the palm##3##3##(2008-6#3)
of the palmar##3##3##(2008-9#1)(2011-2#2)
of the pancreas and##7##4##(1990-6#1)(1991-3#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
of the pancreas in##4##4##(1992-5#1)(2008-3#1)(2008-7#1)(2013-1#1)
of the pancreas is##5##4##(1990-3#1)(1991-3#1)(2012-2#1)(2013-1#2)
of the pancreas was diagnosed##2##5##(2007-10#1)(2013-1#1)
of the pancreas##54##3##(1990-3#2)(1990-6#1)(1990-9#7)(1991-3#2)(1992-5#2)(1992-9#1)(1994-3#2)(1994-8#1)(1997-5#1)(2007-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#5)(2010-10#1)(2010-11#1)(2010-12#2)(2012-2#4)(2012-3#1)(2013-1#12)
of the pancreatic duct##2##4##(2008-10#2)
of the pancreatic head and##2##5##(1990-9#1)(2008-10#1)
of the pancreatic head##4##4##(1990-9#1)(2008-10#2)(2008-6#1)
of the pancreatic##12##3##(1990-9#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-7#2)(2010-12#1)(2013-8#1)
of the pancreaticoduodenal##2##3##(1991-6#1)(2008-7#1)
of the pandemic##3##3##(2008-10#1)(2011-2#2)
of the panel##3##3##(1997-6#1)(2008-5#1)(2011-2#1)
of the panels##2##3##(2008-2#2)
of the paper is to present the##3##7##(2007-11#1)(2011-2#1)(2013-1#1)
of the paper is to##5##5##(1996-9#1)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the paper is##7##4##(1996-1#1)(1996-9#1)(2007-11#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the paper was##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
of the paper##19##3##(1991-2#1)(1996-1#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#3)(2009-6#2)(2009-8#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#1)
of the papers##6##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-3#1)
of the papillae##2##3##(2008-5#1)(2011-2#1)
of the papillary##2##3##(1990-9#1)(2008-5#1)
of the parabolic##2##3##(2008-2#1)(2008-3#1)
of the paradigm##2##3##(1995-5#1)(2013-8#1)
of the parahippocampal region##2##4##(1993-5#2)
of the parallel##5##3##(1991-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)
of the parallel-slab division-of-amplitude photopolarimeter##2##5##(2008-3#2)
of the parameter and##2##4##(2008-11#1)(2009-5#1)
of the parameter values##2##4##(2008-10#1)(2008-12#1)
of the parameter##8##3##(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-5#1)
of the parameters affecting the##2##5##(2008-10#2)
of the parameters in the##4##5##(1992-6#1)(1995-9#1)(2008-7#1)(2010-8#1)
of the parameters in##5##4##(1992-6#1)(1995-9#1)(2007-12#1)(2008-7#1)(2010-8#1)
of the parameters of the##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
of the parameters of##8##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-1#1)
of the parameters that affect the##2##6##(2008-10#1)(2008-11#1)
of the parameters that affect##3##5##(1992-3#1)(2008-10#1)(2008-11#1)
of the parameters that characterize the##2##6##(2008-2#1)(2008-3#1)
of the parameters that##9##4##(1992-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
of the parameters##34##3##(1992-3#1)(1992-6#1)(1995-9#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-3#1)
of the parametric##4##3##(2007-11#1)(2008-3#1)(2009-10#2)
of the paranasal sinuses##3##4##(1991-6#1)(2008-11#1)(2011-2#1)
of the parasite##18##3##(1991-2#1)(1992-9#1)(1993-6#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
of the parasites##6##3##(1996-12#1)(1997-4#1)(2007-7#2)(2008-5#1)(2008-8#1)
of the parasitic wasp Diachasmimorpha longicaudata (Hymenoptera##2##7##(2007-12#2)
of the parasitic wasp##3##4##(1990-11#1)(2007-12#2)
of the parasitic##7##3##(1990-11#1)(1990-7#1)(2007-12#2)(2008-8#1)(2009-8#1)(2012-2#1)
of the parasitoid##4##3##(2007-12#3)(2008-8#1)
of the parathyroid glands##2##4##(1990-6#1)(1990-9#1)
of the parathyroid##4##3##(1990-6#2)(1990-9#1)(2008-5#1)
of the paraventricular nucleus (PVN)##2##5##(1995-12#1)(1996-12#1)
of the paraxial##2##3##(2007-12#1)(2008-2#1)
of the parent and##2##4##(2008-10#2)
of the parent compound##2##4##(1995-6#1)(2008-11#1)
of the parent compounds##2##4##(1994-3#1)(2009-12#1)
of the parent drug and the##2##6##(2008-10#1)(2011-3#1)
of the parent drug##4##4##(2008-10#3)(2011-3#1)
of the parent ion##2##4##(2008-10#2)
of the parent##21##3##(1990-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-3#1)
of the parent-child relationship##2##4##(1995-5#1)(1996-9#1)
of the parental lines##2##4##(2008-10#1)(2008-5#1)
of the parental##17##3##(1990-8#1)(1991-12#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2012-3#1)
of the parents in##2##4##(2007-7#1)(2008-5#1)
of the parents is a##2##5##(1990-6#1)(2013-1#1)
of the parents##10##3##(1990-6#1)(1995-5#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-1#1)
of the parietal and##2##4##(1995-6#1)(2012-1#1)
of the parietal cell##2##4##(1997-1#2)
of the parietal##6##3##(1992-3#1)(1995-6#1)(1997-1#2)(1997-6#1)(2012-1#1)
of the parotid gland##8##4##(1991-6#2)(2007-10#1)(2007-5#1)(2009-3#1)(2013-1#1)(2013-8#2)
of the partial least##2##4##(2008-10#2)
of the partial least-squares algorithm##2##5##(2008-10#2)
of the partial resistance##2##4##(2008-10#2)
of the partial##13##3##(1992-3#1)(1993-12#1)(1997-7#1)(2007-12#1)(2008-10#7)(2009-9#1)(2011-2#1)
of the partially ligated##2##4##(1990-8#1)(1997-2#1)
of the partially##7##3##(1990-8#1)(1993-8#1)(1996-3#1)(1997-2#2)(2007-7#1)(2008-10#1)
of the participants had##2##4##(1994-12#1)(2008-10#1)
of the participants reported##2##4##(2009-6#1)(2010-7#1)
of the participants were##2##4##(2011-1#1)(2013-1#1)
of the participants##24##3##(1991-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the participants'##4##3##(2007-12#1)(2008-11#1)(2013-1#2)
of the participating##7##3##(1994-3#1)(1996-9#1)(2008-11#1)(2008-12#2)(2012-3#1)(2013-1#1)
of the particle size distribution##3##5##(2008-3#3)
of the particle size##7##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
of the particle##26##3##(1994-11#1)(1994-3#1)(2007-11#5)(2008-10#2)(2008-2#3)(2008-3#12)(2008-7#1)(2009-5#1)
of the particles in the##2##5##(2008-10#1)(2008-2#1)
of the particles in##3##4##(2008-10#2)(2008-2#1)
of the particles with##2##4##(1992-6#1)(2008-3#1)
of the particles##21##3##(1990-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1996-11#1)(2008-10#6)(2008-2#1)(2008-3#5)(2008-5#2)(2013-1#2)
of the particular##8##3##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of the particulate##5##3##(2008-2#1)(2008-3#4)
of the partition coefficient of##2##5##(2008-10#2)
of the partition coefficient##3##4##(2008-10#3)
of the partition##5##3##(1995-8#1)(2008-10#4)
of the partner##2##3##(2007-8#1)(2010-5#1)
of the partnership##3##3##(1997-2#2)(2010-5#1)
of the passage of##3##4##(1996-11#1)(2008-10#1)(2011-2#1)
of the passenger##2##3##(1991-10#1)(1996-12#1)
of the passive##3##3##(1993-12#1)(2007-11#1)(2008-10#1)
of the past##19##3##(1993-12#2)(1993-3#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
of the pasture##4##3##(2008-5#2)(2010-2#2)
of the patch clamp technique##2##5##(1993-3#1)(1994-11#1)
of the patch##8##3##(1990-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-5#2)(2008-8#1)(2008-9#1)
of the patch-clamp technique##3##4##(1992-11#1)(1993-3#1)(1995-2#1)
of the patella##9##3##(2007-11#2)(2007-8#5)(2013-1#2)
of the patellar tendon##3##4##(2009-4#1)(2013-1#2)
of the patellar##4##3##(1997-8#1)(2009-4#1)(2013-1#2)
of the patent##2##3##(2009-11#2)
of the path length##2##4##(2008-3#2)
of the path##6##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)
of the pathogen after##2##4##(2008-10#2)
of the pathogen and the##7##5##(2007-12#1)(2008-10#6)
of the pathogen and##12##4##(2007-12#1)(2008-10#10)(2008-9#1)
of the pathogen at the##2##5##(2008-10#2)
of the pathogen between##2##4##(2008-10#2)
of the pathogen by##2##4##(2008-10#2)
of the pathogen collected##3##4##(2008-10#3)
of the pathogen did not##2##5##(2008-10#2)
of the pathogen has##2##4##(2008-10#2)
of the pathogen in the##4##5##(2008-10#4)
of the pathogen in##13##4##(2008-10#12)(2008-5#1)
of the pathogen into##3##4##(2008-10#3)
of the pathogen on the##2##5##(2008-10#2)
of the pathogen on##5##4##(2008-10#5)
of the pathogen population##4##4##(2008-10#4)
of the pathogen through##2##4##(2008-10#2)
of the pathogen to##4##4##(2008-10#3)(2009-2#1)
of the pathogen was##7##4##(2008-10#7)
of the pathogen were##6##4##(2008-10#6)
of the pathogen##146##3##(2007-12#1)(2008-10#137)(2008-5#1)(2008-9#3)(2009-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
of the pathogen's##2##3##(2008-10#2)
of the pathogenesis and##3##4##(2008-9#1)(2009-2#1)(2012-2#1)
of the pathogenesis of these##2##5##(2007-10#1)(2007-7#1)
of the pathogenesis of##14##4##(1990-9#1)(1994-3#1)(1995-12#1)(1997-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-5#1)(2013-1#1)
of the pathogenesis##17##3##(1990-9#1)(1994-3#1)(1995-12#1)(1997-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
of the pathogenesis-related##2##3##(2008-10#2)
of the pathogenic##7##3##(1991-9#1)(2008-10#4)(2009-10#1)(2012-3#1)
of the pathogenicity##2##3##(2008-10#1)(2008-12#1)
of the pathogens##8##3##(1993-2#1)(2008-10#6)(2008-7#1)
of the pathological##6##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
of the pathology of##2##4##(2007-8#1)(2008-10#1)
of the pathology##8##3##(1992-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#2)
of the pathophysiological##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
of the pathophysiology and##2##4##(1994-6#1)(2008-8#1)
of the pathophysiology of##6##4##(1996-2#1)(2008-12#1)(2008-6#1)(2011-2#2)(2013-8#1)
of the pathophysiology##10##3##(1994-6#1)(1996-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of the pathway##10##3##(1990-7#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)
of the pathways##4##3##(1996-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
of the patient and his##2##5##(1991-6#1)(1996-3#1)
of the patient and the##2##5##(2010-3#1)(2012-3#1)
of the patient and to##2##5##(2008-10#1)(2013-8#1)
of the patient and##17##4##(1990-6#1)(1990-9#1)(1991-6#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-3#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the patient are##2##4##(2008-8#1)(2009-3#1)
of the patient as##2##4##(2010-12#1)(2011-2#1)
of the patient before##2##4##(1997-4#1)(2013-8#1)
of the patient care process##2##5##(1995-3#2)
of the patient care##3##4##(1995-12#1)(1995-3#2)
of the patient experience##2##4##(2009-8#1)(2012-3#1)
of the patient for##2##4##(1990-2#1)(1992-3#1)
of the patient in the##3##5##(2007-10#1)(2011-2#1)(2013-8#1)
of the patient in##4##4##(2007-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
of the patient is##6##4##(1990-3#1)(1991-11#2)(1995-2#1)(2008-1#1)(2010-3#1)
of the patient on##2##4##(2008-3#1)(2011-2#1)
of the patient or##2##4##(1991-2#1)(2008-2#1)
of the patient population##3##4##(1995-1#1)(1997-8#1)(2010-12#1)
of the patient to##3##4##(1992-3#1)(2007-11#1)(2011-1#1)
of the patient was##4##4##(1991-5#1)(2007-8#1)(2008-1#1)(2008-9#1)
of the patient with chronic##2##5##(2008-3#1)(2008-9#1)
of the patient with##5##4##(1997-4#1)(2008-10#2)(2008-3#1)(2008-9#1)
of the patient##129##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#5)
of the patient's history##2##4##(1990-6#1)(2008-8#1)
of the patient's physical##2##4##(1992-12#1)(2007-11#1)
of the patient's##30##3##(1990-11#1)(1990-6#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-2#1)(1997-4#1)(2006-5#1)(2007-10#3)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
of the patients after surgical treatment of bone metastases##2##9##(2007-11#2)
of the patients also##2##4##(1992-6#1)(2007-7#1)
of the patients and##8##4##(1990-8#1)(1991-3#1)(1992-2#1)(1994-11#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
of the patients are##3##4##(2007-8#1)(2008-7#1)(2010-3#1)
of the patients because##2##4##(1996-3#1)(2008-10#1)
of the patients died##3##4##(1996-6#1)(2008-11#1)(2011-3#1)
of the patients had a##4##5##(1991-6#1)(1993-2#1)(2008-1#1)(2010-6#1)
of the patients had##27##4##(1990-12#1)(1990-2#1)(1991-2#2)(1991-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
of the patients have##3##4##(2008-10#1)(2010-3#1)(2011-1#1)
of the patients in the##4##5##(1990-5#1)(1994-3#1)(1997-5#2)
of the patients in##6##4##(1990-5#1)(1994-3#1)(1997-5#2)(2011-1#1)(2011-2#1)
of the patients is an##2##5##(1990-10#1)(2011-2#1)
of the patients must be##2##5##(1997-8#1)(2012-3#1)
of the patients presented with##2##5##(1997-3#1)(2013-8#1)
of the patients receiving##3##4##(2008-1#1)(2008-5#1)(2013-1#1)
of the patients reported side effects##2##6##(1991-3#1)(1993-2#1)
of the patients reported##5##4##(1991-3#1)(1992-5#2)(1993-2#1)(1997-2#1)
of the patients showed##4##4##(1991-6#1)(1996-7#1)(2007-11#1)(2013-1#1)
of the patients suffering from##2##5##(2008-7#1)(2012-12#1)
of the patients that##2##4##(1995-11#1)(2008-8#1)
of the patients to##2##4##(1995-11#1)(2008-10#1)
of the patients treated##2##4##(1990-6#1)(2011-1#1)
of the patients was##20##4##(1991-8#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-4#1)(1997-8#1)(2007-7#1)(2008-1#5)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#2)(2011-3#1)(2012-3#1)
of the patients were on##2##5##(2008-1#1)(2012-5#1)
of the patients were##28##4##(1990-6#1)(1990-9#1)(1992-6#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
of the patients who scored##2##5##(2008-1#2)
of the patients who##11##4##(1990-12#1)(1992-6#1)(1996-11#1)(1997-3#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
of the patients with Lbs##2##5##(2008-7#2)
of the patients with a##2##5##(1990-10#1)(2008-11#1)
of the patients with cancer of the pancreas##3##8##(2008-7#3)
of the patients with cancer of the##4##7##(2008-7#4)
of the patients with##34##4##(1990-10#1)(1990-2#1)(1990-6#1)(1992-11#1)(1992-4#2)(1992-5#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#7)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#2)
of the patients without##4##4##(1991-6#1)(2007-8#1)(2008-7#2)
of the patients would##2##4##(1997-6#1)(2010-3#1)
of the patients##335##3##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#6)(1991-12#2)(1991-2#4)(1991-3#5)(1991-5#1)(1991-6#4)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-4#3)(1992-5#7)(1992-6#4)(1992-8#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#4)(1995-11#3)(1995-12#1)(1995-4#1)(1995-5#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#2)(1996-9#5)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#4)(2007-10#7)(2007-11#12)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#13)(2007-8#11)(2008-1#28)(2008-10#11)(2008-11#9)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#19)(2008-8#5)(2008-9#5)(2009-2#1)(2009-3#3)(2009-4#1)(2010-3#3)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#14)(2011-2#19)(2011-3#3)(2012-12#4)(2012-2#1)(2012-3#9)(2012-5#1)(2013-1#10)(2013-8#5)
of the patients) and##2##4##(1991-4#1)(2007-7#1)
of the pattern of##4##4##(1990-12#1)(1992-12#1)(1996-9#1)(2008-3#1)
of the pattern##9##3##(1990-12#1)(1992-12#1)(1996-9#1)(2008-3#3)(2009-8#1)(2011-2#2)
of the patterns##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
of the pea##3##3##(2008-10#2)(2009-8#1)
of the peak corresponds to##2##5##(2008-10#2)
of the peak current##5##4##(2008-10#5)
of the peak height##2##4##(2008-10#2)
of the peak intensity##3##4##(2008-3#3)
of the peak##24##3##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2013-1#1)
of the peak)##2##3##(2008-2#1)(2008-3#1)
of the peaks are##3##4##(2008-10#2)(2008-3#1)
of the peaks##9##3##(2008-10#8)(2008-3#1)
of the pecten##2##3##(2008-5#2)
of the pectins##2##3##(2008-10#2)
of the pectoralis major##2##4##(2009-1#1)(2012-2#1)
of the pectoralis##3##3##(2009-1#1)(2010-9#1)(2012-2#1)
of the pediatric##3##3##(1992-3#1)(2007-12#2)
of the pedigrees##2##3##(2008-1#2)
of the pedunculopontine tegmental nucleus##3##5##(1994-2#2)(1994-3#1)
of the pedunculopontine##4##3##(1994-2#2)(1994-3#2)
of the peg##2##3##(2007-12#1)(2010-11#1)
of the pelvic girdle##2##4##(2008-6#1)(2008-7#1)
of the pelvic##9##3##(1990-5#2)(1990-6#1)(1992-3#1)(1993-8#1)(1994-3#1)(2008-6#1)(2008-7#1)(2012-1#1)
of the pelvis##19##3##(1991-12#1)(1992-12#2)(2007-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#10)(2013-1#1)
of the penetration##3##3##(1991-12#1)(2008-2#1)(2012-3#1)
of the penicillin##3##3##(1995-3#1)(2008-10#1)(2011-1#1)
of the penile##3##3##(1992-8#1)(2008-10#1)(2013-8#1)
of the penis in a##2##5##(2008-10#2)
of the penis is##2##4##(1990-12#1)(2008-10#1)
of the penis##17##3##(1990-12#2)(1991-8#1)(1992-8#1)(2008-10#4)(2008-6#1)(2009-5#5)(2012-12#1)(2013-1#1)(2013-8#1)
of the pentose phosphate pathway##2##5##(2009-5#1)(2010-12#1)
of the people of##2##4##(1997-4#1)(2010-8#1)
of the people##13##3##(1990-12#1)(1994-8#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the peptide backbone##2##4##(1992-6#1)(2008-4#1)
of the peptide bond##2##4##(1992-6#1)(1993-11#1)
of the peptide in the##3##5##(1992-6#2)(2008-6#1)
of the peptide is##2##4##(1994-11#1)(2008-8#1)
of the peptide that##3##4##(1994-12#1)(1995-6#1)(1996-12#1)
of the peptide was##2##4##(1991-5#1)(1993-8#1)
of the peptide were##2##4##(1994-5#1)(1995-5#1)
of the peptide##49##3##(1990-5#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-12#3)(1997-4#2)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)
of the peptides##19##3##(1990-11#2)(1990-5#1)(1991-2#1)(1992-9#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#2)(1997-2#1)(2008-10#1)(2008-6#1)(2009-10#1)(2011-2#2)(2012-1#1)
of the peptone##3##3##(2008-7#3)
of the perceived##4##3##(1994-1#1)(1996-2#1)(2008-6#1)(2009-7#1)
of the percent##2##3##(2008-12#1)(2008-3#1)
of the percentage of diseased##2##5##(2008-10#2)
of the percentage of##10##4##(1991-5#1)(1991-9#1)(2008-10#7)(2011-1#1)
of the percentage##11##3##(1991-5#1)(1991-9#1)(2008-10#7)(2010-1#1)(2011-1#1)
of the perchlorate##2##3##(2008-10#2)
of the perforant##2##3##(1990-5#1)(1990-7#1)
of the performance of a##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
of the performance of the##8##5##(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#1)
of the performance of##23##4##(1995-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#4)(2008-9#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the performance##27##3##(1995-12#2)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#4)(2008-9#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the performances of##2##4##(1991-3#1)(2008-3#1)
of the performed operation##2##4##(2007-11#1)(2008-10#1)
of the perfusate##3##3##(1991-9#2)(1992-3#1)
of the perfusion of##2##4##(2008-10#1)(2008-4#1)
of the perfusion rate##2##4##(2008-11#2)
of the perfusion system##2##4##(2008-11#1)(2012-2#1)
of the perfusion##6##3##(2008-10#1)(2008-11#3)(2008-4#1)(2012-2#1)
of the peri-implant##3##3##(2013-1#3)
of the perikaryon##3##3##(2008-7#3)
of the perinuclear##3##3##(2008-7#3)
of the period and##2##4##(1996-3#1)(2011-2#1)
of the period##6##3##(1996-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
of the periodic##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of the periodontal##4##3##(2012-3#3)(2013-1#1)
of the perioperative##2##3##(2006-10#1)(2012-2#1)
of the peripheral benzodiazepine receptor##2##5##(1995-12#1)(2008-8#1)
of the peripheral nervous system##5##5##(1994-11#1)(1995-12#1)(1996-2#1)(2007-10#1)(2013-1#1)
of the peripheral or##2##4##(1990-8#1)(2008-9#1)
of the peripheral##19##3##(1990-8#1)(1992-10#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-12#2)(1995-5#1)(1996-2#1)(2007-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
of the periradicular##2##3##(2008-7#1)(2013-1#1)
of the perisomatic space##3##4##(1994-2#3)
of the peritoneal##4##3##(1994-9#1)(2008-1#1)(2011-2#2)
of the peritrophic membrane##3##4##(2007-12#1)(2008-7#2)
of the permanent##4##3##(1992-2#1)(2007-12#1)(2009-7#1)(2013-1#1)
of the permanganates##2##3##(2008-10#2)
of the permeant##2##3##(1991-5#1)(2008-5#1)
of the permease##2##3##(1991-10#1)(1993-11#1)
of the peroxyl radical##2##4##(1990-5#2)
of the persimmon bark borer##2##5##(2008-10#2)
of the persimmon##3##3##(2008-10#3)
of the persistent##2##3##(2008-11#1)(2008-8#1)
of the person##7##3##(1992-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1997-2#1)(2008-10#1)(2010-6#1)
of the personal##2##3##(2008-11#1)(2008-5#1)
of the personnel##3##3##(1992-11#1)(1995-2#1)(2010-9#1)
of the persons##4##3##(1994-11#1)(1995-8#1)(2007-11#1)(2008-7#1)
of the pertinent literature##2##4##(2007-7#1)(2012-2#1)
of the pertinent##6##3##(1996-6#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-12#1)(2012-2#1)
of the perturbation of##2##4##(1997-6#1)(2008-10#1)
of the perturbation##6##3##(1997-6#1)(2008-10#1)(2008-3#4)
of the pest##5##3##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
of the pesticide##14##3##(2008-10#10)(2008-7#2)(2011-1#1)(2013-1#1)
of the pesticides##6##3##(2007-5#1)(2008-10#3)(2008-11#2)
of the petH##2##3##(1992-3#2)
of the petrous##3##3##(2008-7#1)(2011-2#2)
of the phage 434 repressor##2##5##(1990-5#1)(2008-8#1)
of the phage##8##3##(1990-5#1)(1990-7#1)(1994-12#1)(1995-8#1)(2008-10#3)(2008-8#1)
of the phalanges##2##3##(1994-6#1)(1997-3#1)
of the phantom##3##3##(2008-3#2)(2011-1#1)
of the pharmaceutical industry##2##4##(1991-3#1)(2008-11#1)
of the pharmaceutical##4##3##(1991-3#2)(2008-11#2)
of the pharmacists##2##3##(2011-1#2)
of the pharmacokinetic##2##3##(1991-2#1)(2008-10#1)
of the pharmacological##4##3##(1990-3#2)(2008-10#2)
of the pharmacy##5##3##(2011-1#5)
of the pharynx##2##3##(1997-7#1)(2011-2#1)
of the phase I study##2##5##(2008-5#2)
of the phase I##3##4##(1995-12#1)(2008-5#2)
of the phase and##2##4##(2008-2#1)(2008-3#1)
of the phase change##2##4##(2008-3#2)
of the phase difference between the##2##6##(2008-3#2)
of the phase difference between##4##5##(2007-12#1)(2008-3#3)
of the phase difference##5##4##(2007-12#1)(2008-3#4)
of the phase distribution##2##4##(2008-3#2)
of the phase distributions##2##4##(2008-2#1)(2008-3#1)
of the phase function##5##4##(2008-2#2)(2008-3#3)
of the phase gradient##2##4##(2008-3#2)
of the phase map##2##4##(2008-3#2)
of the phase modulation of##2##5##(2008-2#1)(2008-3#1)
of the phase modulation##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the phase of the##6##5##(2007-11#2)(2007-12#1)(2008-3#3)
of the phase of##9##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
of the phase shift on##2##5##(2008-2#2)
of the phase shift##3##4##(2008-2#2)(2008-3#1)
of the phase transition##2##4##(2007-11#1)(2008-10#1)
of the phase variation##2##4##(2008-3#2)
of the phase##77##3##(1995-12#1)(2007-11#11)(2007-12#4)(2008-10#1)(2008-2#13)(2008-3#41)(2008-5#3)(2008-8#1)(2012-2#2)
of the phase-matching condition##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the phase-matching##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of the phases of##2##4##(2008-2#1)(2008-3#1)
of the phases##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the phenolate##2##3##(1990-5#1)(1996-2#1)
of the phenolic##5##3##(1990-5#1)(2008-10#3)(2008-5#1)
of the phenomena of##2##4##(2008-5#1)(2010-10#1)
of the phenomena##6##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)
of the phenomenon##9##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-10#1)(2009-8#1)
of the phenotype##2##3##(2012-2#1)(2012-3#1)
of the phenotypes##3##3##(1991-9#1)(1997-8#1)(2013-1#1)
of the phenotypic variance##8##4##(2008-10#8)
of the phenotypic variation for resistance##2##6##(2008-10#2)
of the phenotypic variation for the 5-day reading##2##8##(2008-10#2)
of the phenotypic variation for##6##5##(2008-10#6)
of the phenotypic variation in##2##5##(2008-10#2)
of the phenotypic variation##14##4##(2008-10#14)
of the phenotypic##27##3##(2008-10#25)(2008-8#1)(2012-3#1)
of the phenyl ring##4##4##(1994-12#1)(1995-11#1)(1995-5#1)(2013-1#1)
of the phenyl##5##3##(1994-12#1)(1995-11#1)(1995-5#1)(1997-7#1)(2013-1#1)
of the pheromone signal-transduction pathway##2##5##(1997-4#2)
of the pheromone##4##3##(1997-4#2)(2008-10#1)(2008-6#1)
of the phi##2##3##(2008-11#1)(2008-3#1)
of the philosophical and##2##4##(2008-7#2)
of the philosophical##3##3##(2008-4#1)(2008-7#2)
of the philosophy##2##3##(2007-11#1)(2012-2#1)
of the phloem##3##3##(2008-10#2)(2008-11#1)
of the phosphatase 2A catalytic subunit##3##6##(1992-9#3)
of the phosphatase##7##3##(1992-12#2)(1992-9#3)(1995-2#2)
of the phosphate##4##3##(1994-11#1)(2008-10#3)
of the phosphatidylinositol##3##3##(1992-6#1)(1994-11#1)(1994-6#1)
of the phosphointermediate of##2##4##(1990-11#1)(1995-6#1)
of the phospholipid##2##3##(1992-10#1)(1994-3#1)
of the phospholipids##3##3##(1993-8#1)(1994-3#1)(2008-10#1)
of the phosphomolybdenum blue##2##4##(2008-10#2)
of the phosphonate##2##3##(2008-10#2)
of the phosphopeptide is##2##4##(1990-11#2)
of the phosphopeptide##3##3##(1990-11#3)
of the phosphoramidites##2##3##(2008-4#2)
of the phosphorescence emission##3##4##(2008-10#3)
of the phosphorescence##4##3##(1992-12#1)(2008-10#3)
of the phosphorus##3##3##(1997-7#2)(2008-11#1)
of the phosphorylated residues##2##4##(1992-6#1)(1994-11#1)
of the phosphorylated##5##3##(1992-6#1)(1994-11#1)(1997-1#1)(1997-2#1)(2008-8#1)
of the phosphorylating##2##3##(1991-12#2)
of the phosphorylation of##2##4##(1995-12#1)(2009-3#1)
of the phosphorylation##3##3##(1995-12#1)(1995-6#1)(2009-3#1)
of the photoacoustic signal##3##4##(2008-3#3)
of the photoacoustic##4##3##(2008-3#3)(2011-7#1)
of the photoactive##3##3##(1992-8#3)
of the photocatalytic##2##3##(1994-3#1)(2008-10#1)
of the photochemical##2##3##(2008-3#2)
of the photocurrent##2##3##(2008-2#1)(2008-3#1)
of the photodetector and##2##4##(2008-2#2)
of the photodetector##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
of the photodiode##3##3##(2008-2#1)(2008-3#2)
of the photomultiplier tube##2##4##(2008-3#2)
of the photon transport equation##2##5##(2007-11#1)(2008-2#1)
of the photon##10##3##(1992-11#1)(2007-11#1)(2008-2#2)(2008-3#5)(2012-2#1)
of the photon-echo##2##3##(2007-12#1)(2008-2#1)
of the photon-number##2##3##(2007-11#1)(2007-12#1)
of the photonic switch##2##4##(2008-3#2)
of the photonic##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
of the photoproducts##2##3##(1992-8#1)(2008-10#1)
of the photoreceptive system##2##4##(2008-5#2)
of the photorefractive##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the photosensitizers##2##3##(1993-11#1)(2008-11#1)
of the photosynthetic apparatus##3##4##(2008-10#2)(2012-6#1)
of the photosynthetic##4##3##(1990-7#1)(2008-10#2)(2012-6#1)
of the phycobilisomes##2##3##(1992-3#2)
of the phyllosilicate##2##3##(2008-6#2)
of the phylogenetic##5##3##(1996-5#1)(2007-12#1)(2008-1#2)(2010-6#1)
of the phylum Spirochaetes##2##4##(2013-8#2)
of the phylum##4##3##(2011-2#1)(2013-8#3)
of the physical and chemical environment##2##6##(2008-10#1)(2008-8#1)
of the physical and chemical##4##5##(1992-8#1)(2008-10#2)(2008-8#1)
of the physical and##6##4##(1992-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#1)
of the physical map##2##4##(1997-2#1)(2012-3#1)
of the physical properties of the##2##6##(2008-5#2)
of the physical properties of##3##5##(2008-5#3)
of the physical##34##3##(1990-9#1)(1992-2#1)(1992-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
of the physically##2##3##(2008-3#1)(2013-1#1)
of the physician in##2##4##(1993-2#1)(1995-2#1)
of the physician##5##3##(1991-6#1)(1993-2#2)(1995-2#1)(2012-12#1)
of the physician's##2##3##(2008-4#1)(2013-1#1)
of the physician-patient relationship##2##4##(2008-4#1)(2011-2#1)
of the physicians in Saudi Arabia towards##2##7##(2007-7#1)(2008-1#1)
of the physicians##10##3##(1992-3#1)(1992-6#1)(1993-11#1)(1995-5#1)(1997-3#2)(1997-6#1)(2007-7#1)(2008-1#2)
of the physicians'##3##3##(1995-2#2)(1996-1#1)
of the physicochemical properties of the##2##6##(2008-5#2)
of the physicochemical##6##3##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#2)
of the physiologic##2##3##(2008-5#1)(2010-6#1)
of the physiological and##3##4##(1997-3#1)(2008-7#1)(2009-12#1)
of the physiological##22##3##(1990-11#1)(1995-11#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-2#1)(2012-2#2)(2013-1#1)
of the phytase expressed by P##2##6##(2008-4#2)
of the phytopathogenic##2##3##(1997-4#1)(2008-10#1)
of the picture##3##3##(1993-12#1)(1993-3#1)(2008-7#1)
of the piezoelectric quartz crystal##2##5##(2008-10#2)
of the piezoelectric##5##3##(2008-10#4)(2009-5#1)
of the pig PGI##2##4##(1990-11#2)
of the pig##4##3##(1990-11#3)(1991-12#1)
of the pigment##3##3##(1991-12#1)(1992-8#1)(2007-11#1)
of the pigments##4##3##(2008-10#4)
of the pilot study##3##4##(2010-3#2)(2012-3#1)
of the pilot##7##3##(1993-1#1)(2007-5#1)(2008-4#1)(2010-3#2)(2010-9#1)(2012-3#1)
of the pineal gland##6##4##(1994-2#1)(1994-5#5)
of the pineal hormone melatonin##2##5##(1990-2#2)
of the pineal organ##2##4##(1994-5#2)
of the pineal##15##3##(1990-2#2)(1994-2#1)(1994-5#9)(1995-12#1)(2012-2#1)(2013-7#1)
of the pink##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
of the pioneers##4##3##(1993-6#1)(2008-5#1)(2012-2#2)
of the piperidine##2##3##(1995-3#2)
of the pitfalls##2##3##(1993-2#1)(2008-9#1)
of the pituitary gland##7##4##(1996-11#1)(1996-2#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
of the pituitary##15##3##(1990-7#1)(1993-5#2)(1994-12#1)(1994-5#1)(1996-11#1)(1996-2#1)(1997-3#1)(2008-7#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)
of the pivotal##2##3##(2008-7#2)
of the pixel##2##3##(2007-11#1)(2008-3#1)
of the pixelated##2##3##(2008-3#2)
of the placebo group##2##4##(1992-5#1)(2008-6#1)
of the placebo##4##3##(1992-5#1)(2008-5#1)(2008-6#1)(2013-8#1)
of the placenta##6##3##(1992-10#1)(1992-4#1)(1992-8#1)(1995-12#1)(2012-12#1)(2013-1#1)
of the plan##3##3##(1992-12#1)(2008-2#2)
of the planar##2##3##(2008-10#2)
of the planarian##3##3##(2008-5#3)
of the plane of##4##4##(2008-3#3)(2009-8#1)
of the planned##2##3##(2010-7#1)(2012-3#1)
of the planning##4##3##(1996-1#1)(2008-2#1)(2008-6#1)(2009-11#1)
of the plant and##4##4##(2008-10#2)(2008-8#1)(2009-10#1)
of the plant is##2##4##(2008-10#1)(2008-12#1)
of the plant species##2##4##(2008-10#1)(2008-8#1)
of the plant##51##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-6#2)(2009-8#3)(2010-10#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
of the plant-pathogenic##3##3##(2008-10#3)
of the plants##14##3##(1995-2#1)(2008-10#11)(2008-12#1)(2008-8#1)
of the plasma membrane and##3##5##(1991-5#1)(2008-10#1)(2010-3#1)
of the plasma membrane by##2##5##(1992-9#1)(2009-8#1)
of the plasma membrane in##3##5##(1990-11#1)(1992-12#1)(2008-7#1)
of the plasma membrane of##3##5##(1990-12#1)(2008-11#1)(2008-7#1)
of the plasma membrane##26##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1994-12#1)(1995-2#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#1)
of the plasma##35##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-8#1)(1995-2#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#1)
of the plasmalemma##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
of the plasmid DNA##2##4##(1990-11#1)(1995-2#1)
of the plasmid##8##3##(1990-11#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#2)
of the plasmid-encoded##2##3##(1991-10#1)(1994-12#1)
of the plasmids##3##3##(1990-5#1)(1991-9#1)(1994-12#1)
of the plastic surgery##2##4##(1993-9#1)(2010-8#1)
of the plastic##8##3##(1991-3#1)(1993-9#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)
of the plasticizer admixtures##2##4##(2008-10#2)
of the plasticizer##4##3##(2008-10#4)
of the plasticizers##2##3##(2008-10#2)
of the plastid##3##3##(1997-6#1)(2011-2#1)(2013-1#1)
of the plate##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
of the plateau##3##3##(1994-6#1)(2008-9#1)(2013-1#1)
of the platelet fibrinogen receptor##2##5##(1997-7#1)(2006-6#1)
of the platelet##9##3##(1992-11#1)(1992-6#3)(1995-2#1)(1996-7#1)(1997-7#1)(2006-6#1)(2008-5#1)
of the platform##4##3##(2008-10#2)(2008-7#1)(2009-9#1)
of the platinum group elements##3##5##(2008-10#2)(2008-11#1)
of the platinum##5##3##(2008-10#4)(2008-11#1)
of the pleura##10##3##(1991-12#1)(2007-5#2)(2007-8#4)(2010-8#1)(2011-1#2)
of the pleural cavity##2##4##(1995-6#1)(2007-8#1)
of the pleural##5##3##(1995-6#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-8#1)
of the plot of##2##4##(2008-10#1)(2008-3#1)
of the plot##5##3##(2008-10#4)(2008-3#1)
of the plots##2##3##(2008-10#2)
of the plume##3##3##(2008-2#1)(2008-3#2)
of the point##8##3##(2008-10#2)(2008-12#1)(2008-3#4)(2010-12#1)
of the pointing##2##3##(2008-2#1)(2008-3#1)
of the points##5##3##(2007-11#2)(2008-3#1)(2008-6#1)(2009-2#1)
of the pol##2##3##(1995-2#1)(1997-8#1)
of the polar##10##3##(1990-11#1)(1990-5#1)(1992-10#1)(1992-6#2)(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
of the polarimeter##2##3##(2007-12#1)(2008-2#1)
of the polarization mode##2##4##(2007-11#1)(2007-12#1)
of the polarization of the##2##5##(2007-11#1)(2008-3#1)
of the polarization of##3##4##(2007-11#1)(2008-3#1)(2008-9#1)
of the polarization state of a##3##6##(2007-11#2)(2008-3#1)
of the polarization state of the##2##6##(2008-3#2)
of the polarization state of##8##5##(2007-11#3)(2007-12#1)(2008-3#4)
of the polarization state##10##4##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)
of the polarization##29##3##(2007-11#6)(2007-12#5)(2008-2#5)(2008-3#11)(2008-9#1)(2013-7#1)
of the polarizer##5##3##(2007-12#1)(2008-3#4)
of the polarizing##2##3##(2008-3#2)
of the polarographic##2##3##(2008-10#2)
of the pole##3##3##(2011-2#3)
of the policies##2##3##(1993-3#1)(2010-6#1)
of the policy##3##3##(1996-12#1)(2008-6#1)(2011-2#1)
of the polio##2##3##(2007-10#1)(2008-4#1)
of the political##3##3##(1995-2#1)(1996-12#1)(2008-2#1)
of the pollen tube##2##4##(2008-11#1)(2009-8#1)
of the pollen##5##3##(2008-10#1)(2008-11#1)(2009-8#1)(2012-7#2)
of the pollutants##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
of the poly(A)##2##3##(1994-11#1)(1997-2#1)
of the poly(sodium 4-styrenesulfonate) coatings##2##5##(2008-10#2)
of the poly(sodium##3##3##(2008-10#3)
of the polyadenylation##2##3##(1994-11#1)(2010-4#1)
of the polyamine site of##2##5##(1996-2#2)
of the polyamine##3##3##(1990-7#1)(1996-2#2)
of the polycrystalline##2##3##(1996-2#1)(2008-2#1)
of the polycystic ovary syndrome##4##5##(2008-3#1)(2008-4#3)
of the polyethylene glycol##2##4##(2008-3#1)(2011-2#1)
of the polyethylene##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
of the polygenic inheritance of##2##5##(2008-10#2)
of the polymer and##3##4##(1995-11#1)(1995-6#1)(2008-10#1)
of the polymer matrix##3##4##(2008-3#1)(2008-7#1)(2010-4#1)
of the polymer##28##3##(1995-11#1)(1995-2#1)(1995-6#2)(2007-12#2)(2008-10#9)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#5)(2010-5#2)
of the polymerase chain reaction (PCR)##3##6##(1994-12#1)(2008-10#1)(2008-4#1)
of the polymerase chain reaction##7##5##(1990-3#1)(1990-7#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
of the polymerase chain##8##4##(1990-3#1)(1990-7#1)(1992-6#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2013-8#1)
of the polymerase##12##3##(1990-3#1)(1990-7#1)(1992-6#1)(1993-12#1)(1994-12#2)(1997-3#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
of the polymeric matrix##2##4##(2008-10#2)
of the polymeric##8##3##(1990-8#1)(2007-11#1)(2008-10#5)(2008-5#1)
of the polymers##7##3##(1994-11#1)(2008-10#2)(2008-3#1)(2010-5#1)(2013-1#2)
of the polymorphic##5##3##(1994-9#1)(1995-6#1)(2008-10#1)(2008-4#2)
of the polypeptide chain##4##4##(1992-8#1)(1994-2#1)(1997-6#1)(2008-8#1)
of the polypeptide to##2##4##(1990-5#1)(1993-8#1)
of the polypeptide##9##3##(1990-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(1997-6#1)(2008-8#1)
of the polypyrrole##2##3##(2008-10#2)
of the polyunsaturated fatty##2##4##(1995-11#1)(2008-7#1)
of the polyurethane##4##3##(2007-7#1)(2008-10#1)(2009-7#1)(2013-8#1)
of the poor##5##3##(1996-1#2)(2008-10#1)(2008-7#1)(2009-5#1)
of the poorest##2##3##(2008-7#1)(2012-12#1)
of the popliteal##2##3##(1991-3#2)
of the popular##4##3##(1995-3#1)(2007-11#1)(2007-7#1)(2009-7#1)
of the population and the##2##5##(2007-11#1)(2013-1#1)
of the population and##5##4##(1992-1#1)(1996-3#1)(2007-11#1)(2008-1#1)(2013-1#1)
of the population at##2##4##(1993-11#1)(1997-6#1)
of the population being##2##4##(2008-7#1)(2008-9#1)
of the population by##3##4##(1991-3#1)(2008-1#1)(2012-2#1)
of the population densities##2##4##(2008-10#2)
of the population density##2##4##(2008-10#2)
of the population dynamics of##2##5##(2008-10#1)(2008-9#1)
of the population has##4##4##(1992-3#1)(1997-5#1)(1997-8#1)(2008-7#1)
of the population in the##4##5##(2008-10#1)(2008-5#1)(2008-6#2)
of the population in##6##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)
of the population is##5##4##(1994-9#1)(2010-1#1)(2010-7#1)(2012-12#2)
of the population of a##2##5##(1995-9#1)(2007-2#1)
of the population of the##2##5##(1997-5#1)(2008-3#1)
of the population of##9##4##(1994-1#1)(1995-9#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
of the population spike in##2##5##(1991-12#2)
of the population spike##5##4##(1990-7#1)(1991-12#3)(1995-12#1)
of the population that##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
of the population to##2##4##(1997-2#1)(2008-9#1)
of the population was##3##4##(2007-12#1)(2008-10#1)(2011-1#1)
of the population were##3##4##(2012-12#3)
of the population##142##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#3)(1991-3#1)(1992-1#2)(1992-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#25)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#7)(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#9)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#10)
of the populations of##4##4##(1993-6#1)(1997-2#1)(2008-10#1)(2008-8#1)
of the populations were##2##4##(2008-10#1)(2008-5#1)
of the populations##20##3##(1993-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#7)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)
of the porcine##5##3##(1991-6#1)(1996-12#1)(2008-5#1)(2012-2#2)
of the pore##4##3##(2008-4#1)(2008-8#2)(2011-2#1)
of the porous##4##3##(1990-8#1)(2008-3#2)(2008-5#1)
of the porphyrin##8##3##(1991-5#1)(1992-8#1)(2008-10#4)(2010-6#2)
of the porphyrins##3##3##(1992-9#2)(2008-10#1)
of the port##2##3##(2007-7#1)(2007-8#1)
of the portal vein##3##4##(1995-2#1)(2009-11#1)(2009-9#1)
of the portal##4##3##(1993-3#1)(1995-2#1)(2009-11#1)(2009-9#1)
of the position of the##2##5##(2007-12#1)(2008-2#1)
of the position of##3##4##(1991-6#1)(2007-12#1)(2008-2#1)
of the position##5##3##(1991-6#1)(1993-10#1)(2007-12#1)(2008-2#2)
of the positioning of the##2##5##(2008-9#2)
of the positive results##2##4##(2011-1#1)(2011-2#1)
of the positive##18##3##(1992-2#1)(1992-5#1)(1994-3#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#1)(2011-3#1)
of the positively charged##4##4##(1990-5#1)(1994-3#1)(1997-8#1)(2008-10#1)
of the possibility of##5##4##(1996-3#1)(2007-12#1)(2008-12#1)(2011-2#1)(2013-1#1)
of the possibility##10##3##(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2013-1#2)
of the possible association##2##4##(2011-2#2)
of the possible complications##2##4##(1994-3#1)(2012-12#1)
of the possible role of##3##5##(1995-9#2)(2011-3#1)
of the possible##29##3##(1990-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-9#2)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)
of the post-lead-time survival##2##4##(1995-12#2)
of the post-operative##2##3##(1990-9#1)(2008-5#1)
of the post-reproductive period##2##4##(1997-4#2)
of the posterior canal wall##2##5##(2008-9#2)
of the posterior lobe##2##4##(1997-8#1)(2012-3#1)
of the posterior maxilla##2##4##(2007-12#2)
of the posterior part of the##2##6##(2007-12#1)(2008-2#1)
of the posterior pituitary##3##4##(1997-8#1)(2007-10#1)(2008-4#1)
of the posterior tibial tendon##2##5##(1990-9#2)
of the posterior##40##3##(1990-9#2)(1991-2#1)(1993-12#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#3)(2007-10#1)(2007-12#5)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the posterolateral corner##2##4##(2011-2#1)(2012-2#1)
of the posterolateral##4##3##(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the postnatal development of##2##5##(1993-12#1)(2011-2#1)
of the postnatal##3##3##(1993-12#1)(2009-8#1)(2011-2#1)
of the postoperative##2##3##(1991-5#1)(2011-2#1)
of the postsynaptic density##2##4##(2008-11#1)(2012-3#1)
of the postsynaptic neuron##2##4##(1997-7#1)(2009-8#1)
of the postsynaptic##7##3##(1996-12#1)(1997-2#2)(1997-7#1)(2008-11#1)(2009-8#1)(2012-3#1)
of the postulated##4##3##(1990-7#1)(1995-5#1)(2008-11#1)(2008-5#1)
of the potassium##4##3##(1995-8#1)(2008-10#3)
of the potato##9##3##(2008-10#9)
of the potent##6##3##(1991-3#1)(1991-5#1)(1992-10#1)(1993-8#1)(2006-10#1)(2010-4#1)
of the potential benefits##2##4##(1994-3#1)(2008-11#1)
of the potential buffer##2##4##(2008-10#2)
of the potential for##7##4##(1996-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
of the potential genes##2##4##(1997-6#1)(1997-8#1)
of the potential impact of##2##5##(2008-8#1)(2012-12#1)
of the potential of##4##4##(1996-3#1)(2008-10#2)(2008-3#1)
of the potential##56##3##(1991-7#1)(1994-3#2)(1994-6#1)(1995-9#1)(1996-12#2)(1996-3#4)(1996-5#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#15)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-4#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the potentially##2##3##(2008-10#1)(2013-1#1)
of the potentiometric titration##2##4##(2008-10#2)
of the potentiometric##3##3##(2008-10#3)
of the powder pharmaceutical samples of sulfaguanidine##2##7##(2008-10#2)
of the powder##6##3##(2008-10#3)(2008-5#1)(2010-5#1)(2011-2#1)
of the power spectra##2##4##(2008-3#2)
of the power spectral##2##4##(2008-3#1)(2010-8#1)
of the power##13##3##(2008-10#1)(2008-2#2)(2008-3#7)(2009-5#1)(2010-11#1)(2010-8#1)
of the practical##7##3##(1992-3#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
of the practice##8##3##(1994-12#1)(1995-1#1)(1995-5#1)(2008-10#1)(2008-11#3)(2010-1#1)
of the practitioners##3##3##(2008-1#2)(2008-9#1)
of the pre- and##2##4##(1991-1#1)(2010-8#1)
of the pre-clinical##2##3##(2009-7#1)(2013-1#1)
of the preS2 region of the hepatitis B virus##2##9##(1997-6#2)
of the preS2 region##3##4##(1993-8#1)(1997-6#2)
of the preceding##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
of the precipitate##5##3##(2008-10#4)(2013-8#1)
of the precipitated##3##3##(2008-7#1)(2013-1#2)
of the precipitates##2##3##(2007-11#1)(2008-10#1)
of the precise##2##3##(2008-10#1)(2012-2#1)
of the precision of the##2##5##(2008-10#1)(2008-3#1)
of the precision##3##3##(2008-10#2)(2008-3#1)
of the precursor of##6##4##(1990-8#1)(1991-12#1)(1991-7#1)(1993-3#1)(1994-6#1)(1997-1#1)
of the precursor##17##3##(1990-7#1)(1990-8#1)(1991-12#2)(1991-7#2)(1992-12#1)(1992-6#1)(1993-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-6#1)(2013-1#1)
of the predator##4##3##(2008-8#2)(2008-9#1)(2010-8#1)
of the predicted amino acid sequence##2##6##(1995-8#1)(2008-10#1)
of the predicted and the measured##2##6##(2007-12#1)(2008-3#1)
of the predicted polypeptide##2##4##(1990-5#1)(1995-6#1)
of the predicted##27##3##(1990-5#2)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-8#2)
of the prediction##3##3##(1995-6#1)(2008-11#2)
of the predictions of##2##4##(1992-3#1)(2008-10#1)
of the predictions##5##3##(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)
of the predictor##2##3##(2008-6#1)(2010-12#1)
of the predictors of##2##4##(2008-11#1)(2009-11#1)
of the predictors##4##3##(1995-12#1)(2008-11#2)(2009-11#1)
of the predominant##5##3##(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
of the preference of##2##4##(1996-5#1)(2008-4#1)
of the preferential##3##3##(1993-12#1)(1997-2#1)(2008-10#1)
of the prefrontal##2##3##(1994-8#1)(2008-11#1)
of the pregnancies##3##3##(1992-6#1)(1995-6#1)(2008-11#1)
of the pregnancy##2##3##(1996-9#1)(2007-11#1)
of the pregnant women##3##4##(1990-2#1)(1997-3#1)(1997-4#1)
of the pregnant##8##3##(1990-2#1)(1997-3#1)(1997-4#1)(2008-7#1)(2008-8#3)(2009-10#1)
of the preliminary##3##3##(2008-7#1)(2012-1#1)(2013-1#1)
of the premature##3##3##(2007-7#1)(2009-5#1)(2011-2#1)
of the prenatal##2##3##(2007-11#1)(2008-4#1)
of the preoperative##2##3##(1997-8#1)(2008-5#1)
of the prepairing mechanism##2##4##(2008-10#2)
of the preparation of##3##4##(2008-10#2)(2008-4#1)
of the preparation##8##3##(1990-11#1)(1992-5#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-4#1)
of the preparations##3##3##(2008-10#1)(2008-5#2)
of the prepared##6##3##(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#2)(2013-8#1)
of the preprohormone##2##3##(2008-4#2)
of the preregistration##2##3##(1995-6#2)
of the prescribed##2##3##(2008-3#1)(2009-11#1)
of the prescription##2##3##(1995-11#1)(2008-11#1)
of the presence and##2##4##(2008-10#2)
of the presence of a##3##5##(1991-2#1)(2007-12#1)(2007-7#1)
of the presence of an##4##5##(1991-11#1)(1991-4#1)(1992-6#1)(1993-8#1)
of the presence of the##5##5##(2008-10#2)(2008-11#1)(2008-3#1)(2010-3#1)
of the presence of##48##4##(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-8#2)(1994-2#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#3)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
of the presence or absence of##8##6##(1990-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(2007-10#1)(2008-10#2)(2008-8#1)
of the presence##59##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#22)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
of the presenilin##2##3##(1996-2#2)
of the present article is to##2##6##(2008-11#1)(2012-2#1)
of the present article##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
of the present case##2##4##(1997-7#1)(2008-7#1)
of the present experiment##2##4##(1992-7#1)(2008-12#1)
of the present experiments##3##4##(1992-11#1)(1992-8#1)(1997-4#1)
of the present investigation was##3##5##(1992-3#1)(2008-4#2)
of the present investigation##6##4##(1992-3#1)(1995-3#1)(2008-4#2)(2013-1#1)(2013-8#1)
of the present investigations##2##4##(2008-6#1)(2008-7#1)
of the present method for##2##5##(1996-5#1)(2008-10#1)
of the present method##7##4##(1993-8#1)(1996-5#1)(2008-10#5)
of the present paper was##2##5##(1990-5#1)(1991-9#1)
of the present paper##4##4##(1990-5#1)(1991-9#1)(2007-12#1)(2012-3#1)
of the present procedure##2##4##(2008-10#2)
of the present report##2##4##(2011-2#1)(2013-7#1)
of the present research##2##4##(2008-12#1)(2013-8#1)
of the present results with##2##5##(1991-5#1)(2008-2#1)
of the present results##5##4##(1991-5#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
of the present review is to evaluate the##2##8##(2008-10#1)(2009-7#1)
of the present review is to##3##6##(2008-10#1)(2009-7#1)(2010-1#1)
of the present review##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-1#1)(2011-1#1)
of the present situation##2##4##(1991-3#1)(1991-6#1)
of the present study is to assess the##2##8##(2008-11#1)(2012-3#1)
of the present study is to assess##3##7##(2008-11#1)(2011-2#1)(2012-3#1)
of the present study is to investigate the##2##8##(2008-10#1)(2008-5#1)
of the present study is to investigate##3##7##(2007-10#1)(2008-10#1)(2008-5#1)
of the present study is to##15##6##(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the present study is##16##5##(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)
of the present study provide##2##5##(2008-10#1)(2008-5#1)
of the present study suggest that##5##6##(1996-7#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-5#1)
of the present study was the##2##6##(2010-5#1)(2012-2#1)
of the present study was to assess the##2##8##(2007-8#1)(2009-2#1)
of the present study was to assess##3##7##(2007-8#1)(2009-2#1)(2012-2#1)
of the present study was to clarify the##2##8##(2007-10#1)(2012-2#1)
of the present study was to compare##2##7##(1993-12#1)(2008-12#1)
of the present study was to determine if##2##8##(1996-5#1)(2008-10#1)
of the present study was to determine whether##2##8##(1995-12#1)(2008-12#1)
of the present study was to determine##7##7##(1995-12#1)(1996-5#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)
of the present study was to develop##2##7##(2008-10#1)(2008-11#1)
of the present study was to evaluate##11##7##(1993-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-3#1)(2013-1#3)
of the present study was to examine the effect of##2##10##(2008-7#1)(2010-6#1)
of the present study was to examine the##7##8##(1992-2#1)(2007-11#1)(2008-7#1)(2010-6#1)(2011-2#2)(2013-8#1)
of the present study was to examine##10##7##(1992-2#1)(2007-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the present study was to identify the##3##8##(1994-5#1)(2011-2#2)
of the present study was to investigate the effect of##4##10##(2007-10#1)(2008-12#1)(2010-2#2)
of the present study was to investigate the##16##8##(1990-9#1)(1995-12#1)(1997-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-1#1)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
of the present study was to investigate whether##3##8##(2008-11#1)(2011-2#1)(2012-12#1)
of the present study was to investigate##21##7##(1990-9#1)(1995-12#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-2#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
of the present study was to##87##6##(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#4)(2008-5#7)(2008-7#3)(2009-1#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#5)
of the present study was##90##5##(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#4)(2008-5#7)(2008-7#3)(2009-1#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#5)
of the present study were to##5##6##(1996-3#1)(2007-12#1)(2008-10#1)(2010-2#1)(2012-2#1)
of the present study were##7##5##(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-2#1)(2012-2#1)
of the present study##144##4##(1990-2#1)(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#2)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-3#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#6)(2008-2#1)(2008-5#12)(2008-7#5)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-2#4)(2010-3#1)(2010-5#4)(2010-6#1)(2011-1#1)(2011-2#13)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2012-5#2)(2013-1#10)(2013-7#1)(2013-8#6)
of the present system##2##4##(1994-1#1)(2008-2#1)
of the present work is to##5##6##(1995-6#1)(1997-2#1)(2008-1#1)(2008-8#1)(2009-12#1)
of the present work is##7##5##(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)
of the present work was to evaluate the##3##8##(1993-11#1)(2008-5#1)(2012-2#1)
of the present work was to investigate##2##7##(1990-12#1)(1992-12#1)
of the present work was to##13##6##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
of the present work##22##4##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
of the present##241##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#30)(2008-11#9)(2008-12#8)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#15)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#4)(2010-3#2)(2010-5#5)(2010-6#1)(2011-1#3)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#5)(2012-5#2)(2013-1#13)(2013-7#2)(2013-8#9)
of the present-day##3##3##(2008-10#1)(2008-3#2)
of the presentation##2##3##(2008-10#1)(2011-2#1)
of the presentations of##2##4##(2006-10#1)(2008-10#1)
of the presentations##4##3##(2006-10#1)(2008-10#1)(2008-5#2)
of the presented model##2##4##(2008-10#1)(2008-8#1)
of the presented##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
of the presenting symptoms##2##4##(1990-6#1)(1991-11#1)
of the press##3##3##(1990-12#1)(1996-2#1)(2009-10#1)
of the pressure and##2##4##(2008-10#1)(2009-6#1)
of the pressure##6##3##(2008-10#4)(2008-3#1)(2009-6#1)
of the presumed##3##3##(1994-12#1)(1995-6#1)(2011-2#1)
of the presynaptic neuron##2##4##(1997-7#2)
of the presynaptic##4##3##(1995-12#1)(1997-7#2)(2008-3#1)
of the prevailing##2##3##(2008-5#1)(2008-8#1)
of the prevalence of##7##4##(1994-6#1)(1994-9#1)(1996-1#1)(2007-12#1)(2007-9#1)(2010-1#1)(2010-2#1)
of the prevalence##9##3##(1994-6#2)(1994-9#1)(1996-1#1)(2007-12#1)(2007-9#1)(2008-4#1)(2010-1#1)(2010-2#1)
of the preventive effect of##2##5##(2008-5#1)(2009-8#1)
of the preventive##4##3##(1993-9#1)(1996-2#1)(2008-5#1)(2009-8#1)
of the previous study##2##4##(1990-2#1)(1994-3#1)
of the previous work##2##4##(2009-7#1)(2012-2#1)
of the previous##14##3##(1990-2#1)(1990-5#2)(1991-12#1)(1994-3#1)(2008-10#3)(2008-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2012-2#2)
of the previously described##5##4##(2008-10#2)(2008-3#1)(2008-4#1)(2012-2#1)
of the previously published##2##4##(1993-8#1)(2010-2#1)
of the previously reported##5##4##(1993-8#1)(1997-7#1)(2007-11#1)(2008-10#1)(2012-12#1)
of the previously##20##3##(1990-12#1)(1991-2#1)(1991-9#1)(1993-8#2)(1994-3#1)(1995-11#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the prey by##2##4##(2007-12#1)(2008-8#1)
of the prey##7##3##(2007-12#1)(2008-12#1)(2008-8#2)(2008-9#2)(2010-8#1)
of the prg isolates were##2##5##(2008-10#2)
of the primary and metastatic##2##5##(1992-6#2)
of the primary and recurrent##2##5##(1991-6#2)
of the primary and secondary##2##5##(1992-6#2)
of the primary and##8##4##(1991-6#2)(1992-6#4)(2008-8#1)(2010-12#1)
of the primary coating##2##4##(2007-11#2)
of the primary electron donor is##2##6##(2008-8#2)
of the primary electron donor##4##5##(1992-6#1)(1993-11#1)(2008-8#2)
of the primary health care##2##5##(2008-1#2)
of the primary inoculum##2##4##(2008-10#2)
of the primary lesion##4##4##(1991-5#1)(1992-2#1)(2007-12#1)(2008-10#1)
of the primary outcomes##2##4##(2008-7#1)(2010-1#1)
of the primary structure of the##2##6##(1994-9#1)(2008-10#1)
of the primary structures##2##4##(1993-12#1)(1993-3#1)
of the primary tumor and##2##5##(2008-10#1)(2010-3#1)
of the primary tumor was##2##5##(1992-6#1)(2008-6#1)
of the primary tumor##16##4##(1990-6#1)(1991-3#1)(1992-6#2)(1992-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-6#1)(2010-3#3)(2011-1#1)(2012-3#1)(2013-1#1)
of the primary tumour##4##4##(1991-6#1)(2008-1#1)(2008-6#1)(2011-3#1)
of the primary##113##3##(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#5)(1992-2#1)(1992-6#8)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#5)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#4)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#3)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
of the primate##5##3##(1995-11#1)(1995-5#3)(2008-1#1)
of the primers tested with##2##5##(2008-5#2)
of the primers tested##3##4##(2008-10#1)(2008-5#2)
of the primers##6##3##(2008-10#4)(2008-5#2)
of the principal##13##3##(1991-9#1)(1992-3#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#3)(2009-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
of the principle of the##2##5##(2008-12#1)(2008-4#1)
of the principle of##5##4##(1992-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)
of the principle##10##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)
of the principles and##3##4##(1993-12#1)(1995-3#1)(1997-3#1)
of the principles of##5##4##(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#2)
of the principles##11##3##(1993-12#1)(1995-1#1)(1995-3#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-12#1)
of the prism##2##3##(2007-12#1)(2008-3#1)
of the prismatic##2##3##(2007-12#1)(2008-2#1)
of the private##2##3##(2008-6#1)(2012-3#1)
of the pro-apoptotic##2##3##(2009-12#1)(2012-12#1)
of the proU operon##2##4##(1994-12#2)
of the proU##3##3##(1994-12#3)
of the probability of developing the disease in the##2##9##(1992-9#2)
of the probability of##6##4##(1992-9#2)(1997-3#1)(2008-2#1)(2009-10#1)(2012-3#1)
of the probe array##4##4##(2007-12#2)(2008-3#2)
of the probe beam##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of the probe is##2##4##(2008-2#1)(2010-5#1)
of the probe light##2##4##(2007-12#1)(2008-3#1)
of the probe pulse##4##4##(2007-11#1)(2007-12#3)
of the probe to the##3##5##(1992-6#2)(2008-4#1)
of the probe##41##3##(1990-11#1)(1992-6#4)(1995-11#1)(2007-11#2)(2007-12#10)(2008-10#6)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#1)(2010-5#1)
of the probes##8##3##(2008-10#3)(2008-2#2)(2008-4#1)(2010-5#2)
of the probiotic##4##3##(2011-2#2)(2013-1#2)
of the problem and##2##4##(2008-10#1)(2012-12#1)
of the problem in the##2##5##(2008-10#1)(2011-2#1)
of the problem in##4##4##(1993-11#1)(2008-10#1)(2009-4#1)(2011-2#1)
of the problem is##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
of the problem of##3##4##(1993-11#1)(1996-6#1)(1997-7#1)
of the problem under##2##4##(2008-3#1)(2013-8#1)
of the problem]##2##3##(1991-6#1)(2013-1#1)
of the problems associated with##2##5##(2011-1#1)(2011-2#1)
of the problems encountered##2##4##(1990-9#1)(2009-6#1)
of the problems in##2##4##(1994-2#1)(2008-10#1)
of the problems of##4##4##(1991-3#1)(2008-11#1)(2009-5#1)(2011-2#1)
of the problems##22##3##(1990-9#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#3)
of the proboscis##2##3##(1994-8#1)(2007-12#1)
of the procarcinogen benzo[a]pyrene##2##4##(1995-5#2)
of the procedure and##3##4##(1995-12#1)(2007-8#1)(2008-11#1)
of the procedure developed by##2##5##(1994-12#1)(2008-9#1)
of the procedure for##2##4##(2008-10#2)
of the procedure in##2##4##(2008-10#1)(2008-7#1)
of the procedure is illustrated##4##5##(2008-10#3)(2010-5#1)
of the procedure is##9##4##(1996-12#1)(2008-10#4)(2008-3#3)(2010-5#1)
of the procedure to##2##4##(2008-10#1)(2008-3#1)
of the procedure was##8##4##(1990-7#1)(2008-10#7)
of the procedure were##3##4##(2008-10#3)
of the procedure##61##3##(1990-7#1)(1990-9#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-8#1)(1996-12#1)(1997-3#1)(2006-6#1)(2007-12#2)(2007-8#3)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#2)(2011-2#5)(2012-2#1)
of the procedures in##2##4##(2007-11#1)(2007-8#1)
of the procedures##9##3##(1996-6#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-4#1)(2012-12#1)
of the process and its##2##5##(1991-1#1)(2008-1#1)
of the process and##3##4##(1991-1#1)(2008-1#1)(2008-12#1)
of the process has been##2##5##(1995-1#1)(2008-6#1)
of the process is##2##4##(2008-10#1)(2008-4#1)
of the process of hologram formation##2##6##(2008-2#2)
of the process of the##2##5##(1994-7#1)(2008-12#1)
of the process of##12##4##(1994-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
of the process##57##3##(1990-11#1)(1990-6#1)(1991-1#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
of the processed##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2012-1#1)(2013-1#1)
of the processes involved in##2##5##(1996-12#1)(2009-2#1)
of the processes involved##4##4##(1996-12#1)(1997-5#1)(2008-9#1)(2009-2#1)
of the processes of the##2##5##(2008-7#1)(2010-9#1)
of the processes of##5##4##(2008-10#2)(2008-7#1)(2010-9#1)(2012-3#1)
of the processes##15##3##(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#1)(2009-2#1)(2010-9#1)(2012-3#1)(2013-8#1)
of the processing of##2##4##(1990-8#1)(1993-6#1)
of the processing##6##3##(1990-8#1)(1991-2#1)(1993-5#1)(1993-6#1)(2008-11#1)(2013-8#1)
of the produced water##3##4##(2008-7#1)(2013-1#2)
of the produced##12##3##(1997-4#1)(2008-10#2)(2008-11#3)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the producer##3##3##(2008-11#3)
of the producing##2##3##(1992-9#1)(1994-2#1)
of the product and##2##4##(1995-5#1)(2008-5#1)
of the product in##2##4##(1991-7#1)(2008-7#1)
of the product of the##5##5##(2008-10#2)(2008-2#1)(2008-3#2)
of the product of##8##4##(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)
of the product##46##3##(1990-8#1)(1991-7#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the production of##7##4##(1990-2#1)(1991-9#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
of the production process##4##4##(2008-11#1)(2012-2#2)(2013-8#1)
of the production##14##3##(1990-2#1)(1991-9#1)(1992-9#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-2#3)(2013-8#1)
of the productivity##2##3##(2008-11#2)
of the products of##6##4##(1992-12#1)(1994-8#1)(1995-3#1)(1996-12#2)(2008-10#1)
of the products##22##3##(1991-3#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
of the profession##15##3##(1991-2#1)(1993-1#2)(1993-2#1)(1995-1#2)(1996-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2012-3#4)
of the professional staff##2##4##(1991-12#1)(2008-8#1)
of the professional##8##3##(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-8#1)(2012-2#1)
of the professionals'##2##3##(2011-2#1)(2013-1#1)
of the profile of##3##4##(2007-12#1)(2008-1#1)(2008-10#1)
of the profile##8##3##(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-5#1)
of the profiles##2##3##(1997-3#1)(2011-2#1)
of the progenitor##2##3##(1994-5#1)(2008-8#1)
of the progeny of##2##4##(2008-10#1)(2012-2#1)
of the progeny##3##3##(2008-10#2)(2012-2#1)
of the prognosis for##2##4##(2008-7#1)(2012-2#1)
of the prognosis##6##3##(1990-9#1)(1996-11#1)(1997-3#1)(2008-7#1)(2010-8#1)(2012-2#1)
of the prognostic##3##3##(1990-6#1)(1990-9#1)(1995-9#1)
of the program is to improve##2##6##(1993-12#1)(2008-4#1)
of the program is to##3##5##(1993-12#1)(2008-11#1)(2008-4#1)
of the program statement##2##4##(1996-2#2)
of the program to##3##4##(1991-2#1)(2008-3#1)(2008-7#1)
of the program was to##2##5##(1992-1#1)(1993-12#1)
of the program##34##3##(1991-12#3)(1991-2#2)(1992-1#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-7#1)(2012-12#1)(2013-1#3)
of the program's##2##3##(1996-1#1)(2008-6#1)
of the programme is##2##4##(2008-11#1)(2008-12#1)
of the programme##9##3##(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)(2011-2#1)(2012-12#1)
of the programming##2##3##(2007-12#1)(2008-9#1)
of the programs##5##3##(1992-1#1)(1996-1#1)(1997-2#1)(2008-6#1)(2008-9#1)
of the progress##5##3##(1992-8#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
of the progression of##3##4##(2008-1#1)(2008-7#1)(2011-2#1)
of the prohormone##2##3##(1992-12#1)(2008-4#1)
of the project are to##2##5##(1996-1#1)(2008-6#1)
of the project are##3##4##(1993-3#1)(1996-1#1)(2008-6#1)
of the project##18##3##(1992-3#1)(1993-3#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)(2012-2#2)
of the projected##3##3##(2008-3#2)(2010-11#1)
of the projectile##2##3##(2009-10#2)
of the projection system##2##4##(2008-2#1)(2008-3#1)
of the projection##6##3##(1992-10#1)(2008-2#1)(2008-3#4)
of the projector##2##3##(2008-3#2)
of the projects##2##3##(1994-1#1)(1997-2#1)
of the prolapse##2##3##(2013-1#2)
of the proliferating##2##3##(2008-5#1)(2009-9#1)
of the proliferation of##4##4##(1992-2#1)(2008-11#1)(2008-6#1)(2008-8#1)
of the proliferation##5##3##(1992-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
of the proliferation-associated##2##3##(1993-11#1)(1994-7#1)
of the proliferative lymphocytes##2##4##(2008-9#2)
of the proliferative##9##3##(1992-3#1)(1992-8#1)(1995-6#1)(1997-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)
of the prolonged##4##3##(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
of the prominent##3##3##(1991-8#1)(2008-5#1)(2008-6#1)
of the promoter for##2##4##(1995-2#1)(1995-6#1)
of the promoter region of##3##5##(1993-2#1)(1993-3#1)(1997-7#1)
of the promoter region##7##4##(1993-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2011-1#1)
of the promoter regions##2##4##(1997-2#1)(2012-3#1)
of the promoter##23##3##(1990-11#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1995-2#2)(1995-6#2)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-11#1)(2008-8#2)(2008-9#1)(2011-1#2)(2012-3#1)
of the prongs##2##3##(2008-7#2)
of the propagating light##2##4##(2008-2#1)(2008-3#1)
of the propagating photons##2##4##(2008-3#2)
of the propagating pulse##2##4##(2007-11#1)(2007-12#1)
of the propagating##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
of the propagation of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of the propagation properties of the LP(11) mode##2##8##(2007-12#2)
of the propagation##12##3##(1991-12#3)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)
of the propeptide##2##3##(1991-9#1)(1995-3#1)
of the proper##9##3##(1991-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the properties of the##2##5##(2009-3#1)(2013-1#1)
of the properties of##16##4##(1990-12#1)(1996-1#1)(1996-4#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2013-1#1)
of the properties##17##3##(1990-12#1)(1993-8#1)(1996-1#1)(1996-4#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2013-1#1)
of the proportion of##6##4##(1992-12#1)(1996-3#1)(2008-10#3)(2010-4#1)
of the proportions of##2##4##(1990-12#1)(1992-9#1)
of the proportions##3##3##(1990-12#1)(1992-9#1)(1997-3#1)
of the proposal##3##3##(1992-2#3)
of the proposed algorithm##2##4##(2008-3#1)(2009-12#1)
of the proposed approach and##2##5##(2007-11#1)(2008-10#1)
of the proposed approach##6##4##(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
of the proposed diet##2##4##(2008-3#2)
of the proposed managed care##2##5##(1994-2#2)
of the proposed method and##2##5##(2008-10#2)
of the proposed method are##5##5##(2008-10#3)(2008-3#2)
of the proposed method for determining##2##6##(2008-10#2)
of the proposed method for the##2##6##(2008-10#2)
of the proposed method for##10##5##(2008-10#10)
of the proposed method is evaluated by##2##7##(2008-2#1)(2008-3#1)
of the proposed method is##16##5##(2008-10#13)(2008-2#1)(2008-3#2)
of the proposed method was checked##4##6##(2008-10#4)
of the proposed method was evaluated by analyzing##2##8##(2008-10#2)
of the proposed method was evaluated by##4##7##(2008-10#4)
of the proposed method was##18##5##(2008-10#18)
of the proposed method##79##4##(2007-11#1)(2007-12#1)(2008-10#65)(2008-2#1)(2008-3#10)(2010-2#1)
of the proposed methodology has been##2##6##(2008-10#2)
of the proposed methodology was##2##5##(2008-10#2)
of the proposed methodology##6##4##(2008-10#5)(2008-2#1)
of the proposed methods##7##4##(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)
of the proposed model##4##4##(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
of the proposed models##2##4##(2008-10#1)(2009-8#1)
of the proposed numerical##2##4##(2008-2#1)(2011-1#1)
of the proposed procedure for##2##5##(2008-10#2)
of the proposed procedure is##2##5##(2008-10#2)
of the proposed procedure##11##4##(2008-10#9)(2008-3#1)(2009-9#1)
of the proposed scheme##2##4##(2008-3#2)
of the proposed sensor##4##4##(2008-10#4)
of the proposed system is##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
of the proposed system was##3##5##(2008-10#3)
of the proposed system##12##4##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#4)
of the proposed technique was##3##5##(2008-10#3)
of the proposed technique##12##4##(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#4)
of the proposed treatment##3##4##(1997-8#3)
of the proposed##224##3##(1990-6#1)(1990-9#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-2#1)(1996-1#1)(1996-8#1)(1997-8#3)(2007-11#5)(2007-12#3)(2008-10#125)(2008-2#12)(2008-3#33)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)
of the prospective payment system##4##5##(1991-1#1)(1991-2#2)(1992-12#1)
of the prospective payment##5##4##(1991-1#2)(1991-2#2)(1992-12#1)
of the prospective##6##3##(1991-1#2)(1991-2#2)(1992-12#1)(2012-12#1)
of the prostate gland##2##4##(2008-12#1)(2008-7#1)
of the prostate##16##3##(1990-9#1)(1991-8#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-1#1)
of the prosthesis##10##3##(1997-6#1)(2007-8#2)(2008-11#1)(2009-1#1)(2009-3#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
of the prosthetic##2##3##(1992-10#1)(2007-12#1)
of the protease##6##3##(1991-9#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-4#1)
of the protection against##2##4##(2008-10#1)(2008-11#1)
of the protection##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)
of the protective effect of##2##5##(1995-12#1)(2011-1#1)
of the protective##7##3##(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
of the protein and lipid##3##5##(1993-11#1)(2008-5#1)(2008-9#1)
of the protein and the##2##5##(1997-2#1)(2009-3#1)
of the protein and##9##4##(1990-7#2)(1993-11#1)(1994-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)
of the protein are##3##4##(1991-5#1)(1994-8#1)(2009-7#1)
of the protein as determined by##2##6##(1990-5#1)(1993-3#1)
of the protein as##3##4##(1990-5#1)(1993-3#1)(2008-8#1)
of the protein bands##2##4##(1994-9#1)(2010-3#1)
of the protein by##3##4##(1991-9#1)(1996-3#1)(1997-2#1)
of the protein complex##3##4##(1997-7#1)(2008-5#1)(2011-2#1)
of the protein components##2##4##(2008-7#1)(2013-8#1)
of the protein fraction##2##4##(1994-11#1)(2011-2#1)
of the protein from the nucleus to the cytoplasm##2##9##(1992-3#1)(1993-9#1)
of the protein from the##3##5##(1992-3#1)(1993-9#1)(2009-12#1)
of the protein in the##3##5##(1991-2#1)(1997-3#1)(2011-2#1)
of the protein in##7##4##(1991-2#2)(1992-3#1)(1995-3#1)(1997-3#1)(2008-10#1)(2011-2#1)
of the protein is##6##4##(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1994-8#1)
of the protein itself##2##4##(1995-12#1)(1997-2#1)
of the protein kinase C (PKC)##2##6##(1990-5#1)(1992-9#1)
of the protein kinase##6##4##(1990-5#1)(1992-12#1)(1992-9#1)(1995-2#1)(1997-2#1)(2013-8#1)
of the protein multilayer##2##4##(2008-2#2)
of the protein of interest##3##5##(1992-5#1)(2008-4#1)(2008-9#1)
of the protein sequence##4##4##(1992-8#1)(2008-2#1)(2008-4#2)
of the protein structure is##2##5##(2008-4#1)(2008-7#1)
of the protein structure##4##4##(1997-6#1)(2008-4#1)(2008-7#1)(2009-9#1)
of the protein substrate##2##4##(1992-11#1)(1995-2#1)
of the protein to the##2##5##(1990-5#1)(1992-3#1)
of the protein to##6##4##(1990-5#1)(1992-3#1)(1994-11#1)(2008-4#1)(2008-9#1)(2012-1#1)
of the protein was##3##4##(1993-9#1)(1997-2#2)
of the protein were##2##4##(1993-2#1)(2009-11#1)
of the protein##192##3##(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#3)(1990-7#3)(1990-8#2)(1991-2#3)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#6)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#7)(1993-12#2)(1993-2#3)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-5#7)(1994-6#2)(1994-8#6)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-3#1)(1997-2#6)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#5)(2008-2#7)(2008-4#14)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#9)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#2)
of the protein(s)##2##3##(1992-12#1)(1997-4#1)
of the protein-coding##2##3##(1997-2#1)(2011-2#1)
of the proteinase inhibitors##2##4##(1996-2#2)
of the proteinase##5##3##(1990-2#1)(1992-9#1)(1996-2#2)(2008-11#1)
of the proteins are##3##4##(1993-11#1)(1997-2#1)(2008-10#1)
of the proteins in the##4##5##(1990-12#1)(1995-6#1)(2008-10#1)(2008-6#1)
of the proteins in##5##4##(1990-12#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-6#1)
of the proteins is##3##4##(1993-6#1)(1997-3#1)(2008-10#1)
of the proteins of the##2##5##(2008-5#1)(2011-2#1)
of the proteins of##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
of the proteins##40##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#2)(1993-11#1)(1993-6#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
of the proteolytic activity##3##4##(1992-9#1)(2008-6#1)(2010-12#1)
of the proteolytic##7##3##(1992-9#1)(1994-11#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)
of the proteome##4##3##(2008-4#1)(2008-7#1)(2009-6#1)(2010-6#1)
of the proto-oncogene##2##3##(1997-7#1)(2011-2#1)
of the protocol to##2##4##(2012-3#1)(2013-8#1)
of the protocol will##2##4##(2008-8#1)(2008-9#1)
of the protocol##11##3##(1991-6#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the protocols##9##3##(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the proton##5##3##(1990-12#1)(1990-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
of the protonated##3##3##(1995-6#1)(2008-10#2)
of the protonation##3##3##(2008-10#2)(2009-9#1)
of the prototype##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
of the prototypic##2##3##(1990-7#1)(2008-10#1)
of the provider's##2##3##(2008-11#1)(2013-8#1)
of the province of##2##4##(2008-10#1)(2009-7#1)
of the province##6##3##(1992-10#2)(2008-10#1)(2008-12#1)(2009-7#1)(2013-1#1)
of the provision of##3##4##(1995-3#1)(2008-10#1)(2012-2#1)
of the provisions##3##3##(1991-3#1)(1992-3#1)(1993-1#1)
of the proximal and##2##4##(2008-11#1)(2012-12#1)
of the proximal epiphysis##3##4##(2007-11#3)
of the proximal femur##10##4##(2007-11#7)(2008-6#1)(2009-3#1)(2013-1#1)
of the proximal humerus fractures##2##5##(2007-8#2)
of the proximal humerus##5##4##(2007-8#2)(2008-6#3)
of the proximal interphalangeal##2##4##(2008-9#1)(2011-2#1)
of the proximal phalanx##2##4##(2010-3#2)
of the proximal##44##3##(1990-8#1)(1993-8#1)(1994-5#2)(1996-5#1)(2007-11#12)(2007-12#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#4)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
of the proximate##2##3##(2008-8#1)(2010-2#1)
of the pseudocysts##2##3##(1991-8#1)(2013-1#1)
of the psoas##2##3##(1991-3#1)(1996-6#1)
of the psychiatric##6##3##(1993-2#1)(1993-6#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)
of the psychological##5##3##(1990-10#1)(1996-9#1)(2008-2#1)(2008-5#1)(2012-5#1)
of the psychopathology##2##3##(2008-1#1)(2009-7#1)
of the psychosocial##2##3##(2007-12#1)(2012-12#1)
of the public and private##2##5##(1996-2#1)(2011-2#1)
of the public and##5##4##(1995-5#1)(1996-12#1)(1996-2#2)(2011-2#1)
of the public health##5##4##(1992-4#1)(1995-12#1)(1997-2#1)(2008-10#1)(2012-12#1)
of the public##20##3##(1992-4#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#3)(2012-12#1)
of the publications##2##3##(2008-1#1)(2010-8#1)
of the published literature was combined with a consensus process around the interpretation of the evidence in the context of conventional practice to develop an evidence-based practice guideline##2##28##(2008-6#2)
of the published literature##4##4##(2008-4#1)(2008-6#3)
of the published##8##3##(1994-12#1)(2008-3#1)(2008-4#1)(2008-6#3)(2011-1#1)(2012-12#1)
of the pulmonary arteries##4##4##(2008-10#1)(2008-7#3)
of the pulmonary artery##4##4##(2008-11#1)(2010-10#3)
of the pulmonary vascular##4##4##(1991-8#1)(2006-10#1)(2008-10#1)(2010-6#1)
of the pulmonary##17##3##(1991-3#1)(1991-8#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2010-10#3)(2010-5#1)(2010-6#1)(2013-8#1)
of the pulse is##2##4##(2007-12#1)(2008-2#1)
of the pulse train##3##4##(2007-11#2)(2007-12#1)
of the pulse##29##3##(1990-8#1)(1993-1#1)(2007-11#9)(2007-12#11)(2008-2#1)(2008-3#6)
of the pulse-pair##2##3##(2008-2#2)
of the pulsed##3##3##(1991-3#1)(2008-3#2)
of the pulses##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
of the pump and the##2##5##(2007-12#1)(2008-3#1)
of the pump and##3##4##(2007-12#1)(2008-3#2)
of the pump beam was##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
of the pump beam##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
of the pump laser##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
of the pump pulse##2##4##(2007-11#2)
of the pump source##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the pump##33##3##(1992-1#1)(2007-11#7)(2007-12#9)(2008-10#1)(2008-2#6)(2008-3#8)(2008-5#1)
of the pumped##2##3##(2008-3#2)
of the pumping##3##3##(2007-12#2)(2008-3#1)
of the pupil##4##3##(2008-2#1)(2008-3#1)(2008-7#2)
of the pure analyte##2##4##(2008-10#2)
of the pure component spectra##2##5##(2007-12#2)
of the pure component##3##4##(2007-12#3)
of the pure##19##3##(1990-2#1)(1995-4#1)(1996-2#1)(1997-5#1)(2007-12#4)(2008-10#7)(2008-12#1)(2008-5#1)(2009-3#1)(2010-10#1)
of the purification##2##3##(1992-6#1)(2008-4#1)
of the purified enzyme was##3##5##(1990-11#1)(1991-8#1)(1997-6#1)
of the purified enzyme##8##4##(1990-11#1)(1990-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1997-4#1)(1997-6#1)
of the purified protein##5##4##(1992-3#2)(1992-8#1)(2008-10#1)(2008-2#1)
of the purified recombinant##2##4##(1990-12#1)(2008-8#1)
of the purified##35##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-8#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-8#2)(2012-2#1)
of the purine##2##3##(2008-10#2)
of the purity of##2##4##(1992-11#1)(2008-10#1)
of the purple color##2##4##(2008-10#2)
of the purple##5##3##(1991-8#1)(2008-10#3)(2010-2#1)
of the purpose and##2##4##(1995-1#1)(1995-12#1)
of the purpose##3##3##(1995-1#1)(1995-12#1)(2008-9#1)
of the putative##30##3##(1990-7#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-12#2)(1993-2#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2009-10#1)(2009-11#1)(2009-9#1)(2013-1#1)
of the putatively##2##3##(1990-7#1)(2008-10#1)
of the pyridine##3##3##(1992-1#1)(1993-8#1)(2009-11#1)
of the pyrolysis##2##3##(2008-10#1)(2008-3#1)
of the pyruvate##4##3##(1990-8#1)(1992-8#1)(1993-8#1)(2008-10#1)
of the quadrat##3##3##(2008-10#3)
of the quadratic##4##3##(2007-12#2)(2008-2#2)
of the quadrature##2##3##(2008-2#1)(2011-1#1)
of the quadriceps muscle of the thigh##2##7##(2007-11#2)
of the quadriceps muscle##4##4##(2007-11#2)(2008-4#1)(2012-3#1)
of the quadriceps##8##3##(2007-11#2)(2007-8#2)(2008-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
of the qualitative##4##3##(1990-8#1)(1997-3#1)(2008-12#1)(2012-3#1)
of the quality and##2##4##(2008-7#1)(2009-7#1)
of the quality factor##4##4##(2007-12#3)(2010-4#1)
of the quality of care##3##5##(1993-3#1)(1995-2#1)(2010-12#1)
of the quality of prenatal##2##5##(1993-3#1)(1996-6#1)
of the quality of the##3##5##(1993-1#1)(2008-11#1)(2012-2#1)
of the quality of##19##4##(1992-2#1)(1993-1#1)(1993-3#2)(1995-2#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
of the quality##33##3##(1991-2#1)(1992-2#1)(1993-1#1)(1993-3#2)(1994-2#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
of the quantification##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
of the quantitative##7##3##(1990-9#1)(1992-3#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-11#1)
of the quantities of##2##4##(2008-10#2)
of the quantity of##4##4##(1992-3#1)(1995-5#1)(2008-10#2)
of the quantum dots by##3##5##(1995-3#1)(2007-11#1)(2008-7#1)
of the quantum dots##5##4##(1995-3#1)(2007-11#2)(2008-7#2)
of the quantum noise##2##4##(2007-12#2)
of the quantum##9##3##(1995-3#1)(2007-11#3)(2007-12#3)(2008-7#2)
of the quantum-sized ZnO##2##4##(2009-8#2)
of the quaternary##3##3##(1995-11#1)(1997-2#1)(2008-4#1)
of the quenching effect##2##4##(2008-10#2)
of the quenching##6##3##(1997-7#1)(2008-10#4)(2008-2#1)
of the questionnaire##4##3##(1996-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
of the questionnaires##2##3##(1994-2#1)(2009-12#1)
of the questions##10##3##(1990-2#1)(1996-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-1#3)
of the rDNA##8##3##(2008-10#7)(2008-5#1)
of the rPRL##2##3##(1994-8#2)
of the rRNA##3##3##(2008-10#1)(2010-4#2)
of the rVLM##2##3##(1997-6#2)
of the rabbit skeletal muscle ryanodine##2##6##(1994-9#1)(2008-9#1)
of the rabbit##10##3##(1990-6#1)(1991-12#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
of the race##2##3##(2008-10#1)(2009-7#1)
of the radial artery to##2##5##(2007-8#1)(2011-2#1)
of the radial artery##8##4##(1990-8#2)(2007-8#2)(2008-7#1)(2011-2#2)(2013-1#1)
of the radial breathing##2##4##(2008-10#2)
of the radial nerve##3##4##(2008-7#2)(2012-2#1)
of the radial##23##3##(1990-8#2)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#2)(2008-3#1)(2008-7#3)(2011-2#5)(2012-2#2)(2013-1#1)
of the radiance##4##3##(2008-2#2)(2008-3#2)
of the radiation dose##2##4##(2008-2#1)(2008-5#1)
of the radiation oncologist##2##4##(2009-11#1)(2011-2#1)
of the radiation##28##3##(2006-4#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#3)(2009-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
of the radiative transfer equation##5##5##(2007-12#1)(2008-2#3)(2008-3#1)
of the radiative transfer##8##4##(2007-12#1)(2008-2#4)(2008-3#3)
of the radiative##13##3##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#4)
of the radical to##3##4##(1995-2#2)(2008-10#1)
of the radical##8##3##(1995-2#2)(1996-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
of the radicals##3##3##(2007-11#1)(2008-10#2)
of the radioactive##3##3##(1990-2#1)(1992-3#1)(1994-5#1)
of the radioisotope##2##3##(1990-11#1)(1992-2#1)
of the radiolabeled##4##3##(1992-12#1)(1994-5#2)(1994-8#1)
of the radiolabelled##2##3##(1994-12#1)(2007-12#1)
of the radiological##4##3##(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
of the radiology department##4##4##(1995-2#1)(1996-1#1)(2012-2#2)
of the radiology##5##3##(1995-2#1)(1995-3#1)(1996-1#1)(2012-2#2)
of the radiotherapy##2##3##(2008-10#1)(2008-2#1)
of the radius and the##3##5##(1995-6#2)(2008-3#1)
of the radius##6##3##(1991-11#1)(1991-4#1)(1995-6#3)(2008-3#1)
of the rain##2##3##(2008-10#1)(2008-5#1)
of the rainbow trout egg envelope##2##6##(1994-5#2)
of the rainbow trout##3##4##(1994-5#2)(2008-5#1)
of the rainbow##4##3##(1994-5#2)(2008-2#1)(2008-5#1)
of the rainy season to##2##5##(2007-2#1)(2013-7#1)
of the rainy season##3##4##(2007-2#1)(2013-7#2)
of the random birefringence##2##4##(2007-12#2)
of the random##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
of the randomized##2##3##(1995-11#1)(2008-10#1)
of the range of validity of##2##6##(2008-3#2)
of the range of##10##4##(2007-8#1)(2008-3#2)(2008-8#5)(2008-9#1)(2011-1#1)
of the range##14##3##(2007-8#1)(2008-10#2)(2008-3#3)(2008-8#5)(2008-9#1)(2010-9#1)(2011-1#1)
of the rapeseed oil was converted at##2##7##(2008-6#2)
of the rapid##9##3##(1993-8#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)(2010-7#1)
of the rapidly exchangeable sites##2##5##(1995-6#2)
of the rapidly growing##3##4##(1992-3#1)(2011-2#1)(2013-1#1)
of the rapidly##6##3##(1992-3#1)(1995-6#2)(2008-12#1)(2011-2#1)(2013-1#1)
of the rare earth elements##2##5##(2008-10#2)
of the rare earth##3##4##(2008-10#3)
of the rare earths##5##4##(1992-11#1)(2008-10#4)
of the rare##19##3##(1992-11#1)(1994-11#1)(1997-5#1)(2008-10#9)(2008-3#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
of the ras superfamily##2##4##(1992-8#1)(1994-6#1)
of the ras##3##3##(1992-8#2)(1994-6#1)
of the rat adrenal##2##4##(1990-5#1)(1996-5#1)
of the rat and##4##4##(1991-2#1)(1991-4#1)(1993-3#1)(1994-9#1)
of the rat at the##2##5##(1993-12#1)(2008-8#1)
of the rat at##3##4##(1993-12#1)(1994-2#1)(2008-8#1)
of the rat bladder##3##4##(1990-5#3)
of the rat brain##7##4##(1992-10#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-5#1)(2008-10#1)
of the rat class I alcohol dehydrogenase##2##7##(1993-3#2)
of the rat gene##3##4##(1991-7#1)(1993-8#1)(1994-11#1)
of the rat in##2##4##(1995-12#1)(2008-7#1)
of the rat is##2##4##(1992-3#1)(1994-8#1)
of the rat kidney##2##4##(1992-6#1)(1995-12#1)
of the rat liver##2##4##(1990-5#1)(2008-10#1)
of the rat neuronal cell##4##5##(1993-6#1)(2008-11#3)
of the rat spinal cord##3##5##(1993-12#1)(1994-2#1)(1995-12#1)
of the rat stomach##2##4##(1997-4#2)
of the rat trachea##2##4##(2008-9#2)
of the rat vibrissal##2##4##(2011-2#2)
of the rat##134##3##(1990-12#2)(1990-5#7)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#7)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#8)(1993-3#7)(1993-6#1)(1993-8#6)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#9)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#5)(1997-4#3)(1997-6#2)(2008-10#2)(2008-11#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-5#1)(2011-2#3)(2013-1#2)(2013-8#1)
of the rate constant##2##4##(1996-12#1)(2008-10#1)
of the rate of##21##4##(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#2)(1993-12#1)(1994-8#1)(1995-11#1)(1996-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-5#1)(2013-7#1)
of the rate##31##3##(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-12#2)(1996-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2013-7#1)
of the ratio between the##2##5##(2008-10#1)(2008-11#1)
of the ratio between##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
of the ratio of the##5##5##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
of the ratio of##9##4##(1994-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#1)
of the ratio spectra##3##4##(2008-10#3)
of the ratio##24##3##(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#3)(2011-1#1)(2012-2#1)(2012-3#1)
of the rats with##2##4##(1997-2#1)(2008-10#1)
of the rats##11##3##(1993-8#1)(1993-9#1)(1995-3#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#2)
of the raw materials##2##4##(2008-10#2)
of the raw##5##3##(2008-10#4)(2010-4#1)
of the ray optics model##3##5##(2008-3#3)
of the rays##5##3##(2007-12#2)(2008-10#1)(2008-3#2)
of the rbcS##3##3##(1993-12#2)(1994-8#1)
of the rds1 gene##2##4##(1995-8#2)
of the reactant##2##3##(2013-8#2)
of the reaction between##6##4##(2008-10#6)
of the reaction by##2##4##(2008-10#1)(2008-9#1)
of the reaction conditions##2##4##(1996-2#1)(1997-2#1)
of the reaction is##5##4##(1996-5#1)(2008-10#3)(2009-10#1)
of the reaction medium##2##4##(2008-10#2)
of the reaction mixture##3##4##(1992-9#1)(2008-10#1)(2008-4#1)
of the reaction of##6##4##(2008-10#6)
of the reaction products##6##4##(1990-7#2)(1996-12#1)(2008-10#1)(2008-4#1)(2009-8#1)
of the reaction system##2##4##(2008-10#1)(2011-1#1)
of the reaction was##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
of the reaction were##2##4##(1997-2#1)(2008-10#1)
of the reaction with##2##4##(2008-10#2)
of the reaction##79##3##(1990-7#2)(1991-5#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-2#2)(2007-12#2)(2007-5#1)(2008-10#44)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
of the reactions##6##3##(2007-11#1)(2008-10#3)(2013-8#2)
of the reactivation##2##3##(1995-6#1)(2008-7#1)
of the reactive oxygen species (ROS)##2##6##(2008-10#1)(2013-1#1)
of the reactive oxygen species##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
of the reactive site peptide bond##2##6##(1991-8#2)
of the reactive##7##3##(1991-8#2)(2008-10#2)(2009-8#1)(2011-2#1)(2013-1#1)
of the reactivity of##3##4##(2007-11#1)(2008-10#1)(2008-9#1)
of the reactor##5##3##(1991-5#1)(2008-10#2)(2008-11#2)
of the reading frame##2##4##(1992-9#1)(1997-4#1)
of the reading##4##3##(1992-9#1)(1997-4#1)(2008-12#1)(2008-3#1)
of the readout##5##3##(2008-2#2)(2008-3#3)
of the reagent and##3##4##(2008-10#3)
of the reagent solution in##2##5##(2008-10#2)
of the reagent##17##3##(1993-11#1)(2007-10#1)(2008-10#14)(2008-4#1)
of the reagents##7##3##(2008-10#5)(2008-4#1)(2010-3#1)
of the real and the imaginary parts of##2##8##(2007-11#1)(2007-12#1)
of the real and##3##4##(1997-7#1)(2007-11#1)(2007-12#1)
of the real##16##3##(1992-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#2)(2010-11#1)
of the real-time##3##3##(2008-2#1)(2011-1#1)(2013-8#1)
of the reality##2##3##(2008-11#1)(2012-3#1)
of the rearing##3##3##(1990-3#1)(1991-2#1)(2007-12#1)
of the reasons for the##3##5##(1996-2#1)(2008-8#1)(2013-1#1)
of the reasons for##7##4##(1996-2#1)(1997-3#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)
of the reasons##15##3##(1991-9#1)(1994-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2012-2#2)(2013-1#1)
of the received##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
of the receiver##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
of the receiver-stimulator##2##3##(2008-9#2)
of the recent advances##2##4##(2008-7#1)(2012-3#1)
of the recent improvements##2##4##(2008-2#1)(2012-8#1)
of the recent literature##4##4##(1990-6#1)(1991-12#1)(2011-2#1)(2013-1#1)
of the recent past and measures taken##2##7##(1991-3#2)
of the recent research in this##2##6##(2006-10#1)(2008-10#1)
of the recent##26##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-4#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-11#1)(2011-2#2)(2012-3#1)(2012-8#1)(2013-1#1)
of the recently described##2##4##(2008-10#1)(2008-6#1)
of the recently developed##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of the recently proposed##2##4##(2008-10#1)(2008-7#1)
of the recently published##2##4##(1992-4#1)(2008-12#1)
of the recently##15##3##(1991-2#1)(1991-9#1)(1992-4#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
of the receptive##2##3##(1994-9#1)(2008-8#1)
of the receptor and##5##4##(1995-6#1)(1995-8#1)(2008-4#2)(2011-2#1)
of the receptor is##2##4##(1990-11#1)(1995-6#1)
of the receptor to##3##4##(1994-11#1)(2008-10#1)(2008-4#1)
of the receptor was##2##4##(1990-2#1)(1992-8#1)
of the receptor##48##3##(1990-11#3)(1990-2#1)(1991-5#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-5#2)(1997-2#1)(2006-6#1)(2008-10#2)(2008-4#4)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
of the receptors for##2##4##(1993-8#1)(2008-10#1)
of the receptors of##2##4##(1993-2#1)(2009-8#1)
of the receptors##9##3##(1993-2#1)(1993-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2009-6#1)(2009-8#1)
of the recipient##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
of the reciprocal##2##3##(1990-11#1)(2008-5#1)
of the reciprocity theorem##2##4##(2008-3#2)
of the recognition sequence of##2##5##(1994-12#1)(1995-8#1)
of the recognition sequence##3##4##(1994-12#1)(1995-3#1)(1995-8#1)
of the recognition##6##3##(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(2008-11#1)(2013-1#1)
of the recognized##4##3##(1990-12#1)(1991-12#1)(1997-5#1)(2008-10#1)
of the recombinant E##2##4##(2008-7#1)(2011-1#1)
of the recombinant human alpha A- and beta-interferons##2##8##(1990-2#2)
of the recombinant human##7##4##(1990-2#2)(1990-5#2)(1990-8#1)(1994-5#2)
of the recombinant protein was##2##5##(2008-11#1)(2008-8#1)
of the recombinant protein##6##4##(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)
of the recombinant proteins##2##4##(1994-5#1)(2011-2#1)
of the recombinant##39##3##(1990-11#1)(1990-2#2)(1990-5#2)(1990-8#1)(1991-9#1)(1992-6#1)(1994-12#2)(1994-5#3)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#7)(2008-7#2)(2008-8#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
of the recombinants##2##3##(1995-2#1)(1997-4#1)
of the recombinase activating gene 1##2##6##(1994-11#2)
of the recommended##5##3##(2008-10#1)(2008-5#1)(2010-1#1)(2010-4#1)(2011-2#1)
of the reconstituted InsP(3) receptor##2##5##(2008-8#2)
of the reconstituted##5##3##(1990-11#1)(1995-2#1)(2008-4#1)(2008-8#2)
of the reconstructed image is##2##5##(2007-11#1)(2008-3#1)
of the reconstructed image##5##4##(2007-11#3)(2008-3#2)
of the reconstructed images##2##4##(2007-11#1)(2008-3#1)
of the reconstructed##19##3##(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)
of the reconstruction##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2011-2#1)
of the reconstructive##4##3##(2007-12#3)(2011-2#1)
of the record##2##3##(1997-3#1)(2008-4#1)
of the recorded##11##3##(1990-8#1)(1993-12#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)
of the recording medium##2##4##(2007-12#2)
of the recording of##2##4##(1995-12#2)
of the recording##12##3##(1991-12#1)(1995-12#2)(2007-12#3)(2008-2#1)(2008-3#5)
of the records##2##3##(2008-7#1)(2008-9#1)
of the recovered##6##3##(1993-8#1)(1995-6#1)(2008-10#3)(2010-4#1)
of the recovery of##2##4##(1995-6#1)(2008-12#1)
of the recovery##9##3##(1990-5#1)(1991-2#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
of the recruitment##3##3##(2010-3#1)(2012-12#1)(2012-2#1)
of the rectal##2##3##(1990-9#1)(2013-8#1)
of the rectified##3##3##(2007-11#3)
of the rectum and##4##4##(1992-5#1)(2007-8#1)(2012-1#1)(2012-12#1)
of the rectum##14##3##(1990-10#1)(1992-5#1)(1993-8#3)(2007-12#1)(2007-2#1)(2007-8#1)(2012-1#1)(2012-12#3)(2013-8#2)
of the rectus femoris##2##4##(2008-12#1)(2011-2#1)
of the rectus##4##3##(2008-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
of the recurrent##6##3##(1991-11#1)(1991-6#1)(1997-4#1)(2008-2#1)(2008-9#2)
of the recurring##2##3##(1997-4#1)(2008-5#1)
of the red blood cell##2##5##(1997-6#1)(2011-2#1)
of the red blood##3##4##(1997-6#1)(2011-2#1)(2012-2#1)
of the red cell membrane##2##5##(1997-6#1)(2008-11#1)
of the red##12##3##(1992-11#1)(1992-8#1)(1997-5#1)(1997-6#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2011-2#1)(2012-2#1)
of the redox state of##2##5##(1991-2#1)(2008-10#1)
of the redox##9##3##(1991-2#1)(1992-8#1)(2008-10#6)(2009-8#1)
of the reduced scattering##2##4##(2008-2#2)
of the reduced##12##3##(1992-6#2)(1994-5#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2011-2#1)
of the reduced/denatured RNase A##2##5##(2011-1#2)
of the reducing end##3##4##(1992-12#1)(1995-11#1)(2011-1#1)
of the reducing##4##3##(1992-12#1)(1995-11#1)(2008-10#1)(2011-1#1)
of the reductase was##3##4##(1996-3#2)(2008-11#1)
of the reduction in##4##4##(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
of the reduction of##6##4##(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#1)
of the reduction product##2##4##(2008-10#2)
of the reduction##20##3##(1991-8#2)(1995-3#1)(1996-6#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)
of the reductive##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
of the reef-building##2##3##(1992-6#2)
of the reference beam and##2##5##(2008-3#2)
of the reference beam##8##4##(2007-11#1)(2008-2#1)(2008-3#6)
of the reference strains##2##4##(2008-5#1)(2011-1#1)
of the reference surface##2##4##(2008-3#2)
of the reference wave##2##4##(2008-3#2)
of the reference##35##3##(1995-1#1)(1995-3#1)(2007-11#2)(2008-10#7)(2008-2#4)(2008-3#16)(2008-5#2)(2011-1#1)(2011-2#1)
of the reflectance of##2##4##(2008-2#1)(2008-3#1)
of the reflectance##6##3##(2008-2#2)(2008-3#4)
of the reflectances of the##2##5##(2008-2#1)(2008-3#1)
of the reflectances##3##3##(2008-2#1)(2008-3#2)
of the reflected beam##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the reflected fringe system##2##5##(2008-3#2)
of the reflected light##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the reflected##13##3##(2007-12#2)(2008-2#3)(2008-3#8)
of the reflection of##2##4##(2008-2#1)(2008-3#1)
of the reflection##11##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)(2013-1#1)
of the reflective##2##3##(2008-3#1)(2012-12#1)
of the reflectivity##4##3##(2007-11#1)(2008-3#3)
of the reflectors##2##3##(2008-3#1)(2008-7#1)
of the reform of##2##4##(2008-2#2)
of the reform##4##3##(2007-5#1)(2008-2#3)
of the reforms##2##3##(1997-5#1)(2012-1#1)
of the refraction##3##3##(2007-11#1)(2008-2#1)(2009-6#1)
of the refractive index and the##4##6##(2008-3#4)
of the refractive index and##7##5##(2007-11#1)(2008-3#6)
of the refractive index is##4##5##(2007-11#1)(2008-3#3)
of the refractive index of a##2##6##(2008-3#2)
of the refractive index of the##2##6##(2008-2#1)(2008-3#1)
of the refractive index of##9##5##(2007-11#1)(2008-2#2)(2008-3#6)
of the refractive index##36##4##(2007-11#3)(2007-12#3)(2008-2#8)(2008-3#22)
of the refractive indices of the##2##6##(2008-2#1)(2008-3#1)
of the refractive indices of##6##5##(2008-2#1)(2008-3#5)
of the refractive indices##7##4##(2008-2#2)(2008-3#5)
of the refractive##44##3##(2007-11#3)(2007-12#3)(2008-2#10)(2008-3#27)(2012-12#1)
of the refractive-index change##3##4##(2007-12#1)(2008-3#2)
of the refractive-index difference between the##2##6##(2008-2#2)
of the refractive-index##13##3##(2007-12#1)(2008-2#4)(2008-3#8)
of the refractory ward and 'rumpus room'##2##7##(2008-7#2)
of the refractory##3##3##(2008-10#1)(2008-7#2)
of the regenerated gratings##2##4##(2013-8#2)
of the regenerated##3##3##(2012-12#1)(2013-8#2)
of the regeneration##2##3##(1992-6#1)(2008-10#1)
of the regenerative##2##3##(1993-3#1)(2009-10#1)
of the region of the##2##5##(1995-6#1)(2007-8#1)
of the region of##4##4##(1995-6#1)(2007-8#1)(2008-3#1)(2010-6#1)
of the region was##2##4##(2008-3#1)(2008-8#1)
of the region##25##3##(1991-7#1)(1993-6#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-6#1)(2012-2#2)(2013-1#2)
of the regional##5##3##(1997-6#1)(2007-12#1)(2009-1#1)(2011-2#2)
of the regions##5##3##(1995-2#1)(1996-8#1)(1997-8#1)(2008-10#2)
of the regression analysis between observed and estimated SSR##2##9##(2008-10#2)
of the regression coefficients##2##4##(2008-10#2)
of the regression line##2##4##(2008-10#2)
of the regression model##2##4##(2008-10#1)(2008-3#1)
of the regression models##2##4##(1990-2#1)(2010-11#1)
of the regression##15##3##(1990-2#1)(2008-10#9)(2008-3#3)(2008-6#1)(2010-11#1)
of the regular##2##3##(1994-12#1)(2008-10#1)
of the regularization parameter##2##4##(2008-10#1)(2008-3#1)
of the regularized##2##3##(2008-3#1)(2008-6#1)
of the regulated CFCs##2##4##(1992-3#2)
of the regulated##3##3##(1992-3#2)(2008-4#1)
of the regulation of##8##4##(1991-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)
of the regulations##3##3##(1993-12#1)(1993-3#1)(1995-6#1)
of the regulator##4##3##(1990-7#2)(1995-2#2)
of the regulatory subunit##2##4##(1990-8#1)(1995-11#1)
of the regulatory##15##3##(1990-7#2)(1990-8#1)(1993-5#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
of the rehabilitation##6##3##(1993-12#1)(1995-5#1)(2008-9#1)(2010-10#1)(2013-1#2)
of the related##9##3##(1991-2#1)(1992-8#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-12#1)(2013-8#1)
of the relation between##6##4##(1993-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)
of the relation of##2##4##(1996-2#1)(2012-12#1)
of the relation##9##3##(1993-11#1)(1996-2#1)(2007-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-12#1)
of the relational##2##3##(1990-3#1)(1996-2#1)
of the relations##3##3##(2010-2#2)(2010-8#1)
of the relationship between oral##2##5##(2008-11#1)(2008-4#1)
of the relationship between structure and function in the brain##2##10##(2009-5#2)
of the relationship between structure and##4##6##(2009-5#2)(2010-4#1)(2012-2#1)
of the relationship between the##9##5##(1992-6#1)(1994-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#1)(2012-5#1)
of the relationship between##46##4##(1992-1#1)(1992-6#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-2#2)(1994-5#2)(1995-3#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-10#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)
of the relationship of melancholia and the mother##2##8##(2008-12#2)
of the relationship of##7##4##(1990-5#1)(1990-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-10#1)
of the relationship##57##3##(1990-5#1)(1990-8#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-5#2)(1995-3#1)(1997-8#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-10#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)
of the relationships between##7##4##(1991-6#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)
of the relationships##9##3##(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)
of the relative abundance of##2##5##(1994-11#1)(2008-8#1)
of the relative importance of the##3##6##(1992-2#1)(2008-2#1)(2008-9#1)
of the relative importance of##4##5##(1992-2#1)(2008-2#1)(2008-8#1)(2008-9#1)
of the relative##38##3##(1991-8#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-8#3)(2008-9#1)(2010-12#1)(2012-2#1)
of the relatively high##2##4##(1994-1#1)(1997-8#1)
of the relatively##10##3##(1992-3#1)(1994-1#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)
of the relaxation##7##3##(1994-8#2)(2007-12#2)(2008-2#1)(2008-3#1)(2012-7#1)
of the relay##2##3##(2008-3#2)
of the release of##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
of the release##6##3##(2008-10#4)(2008-12#1)(2008-8#1)
of the relevant##21##3##(1990-8#1)(1992-1#1)(1993-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the reliability of##3##4##(1994-3#1)(2008-10#1)(2008-3#1)
of the reliability##4##3##(1993-11#1)(1994-3#1)(2008-10#1)(2008-3#1)
of the relocation##2##3##(2007-5#1)(2013-7#1)
of the remainder##2##3##(2008-10#1)(2009-10#1)
of the remaining nidus##2##4##(2008-7#2)
of the remaining##42##3##(1990-6#1)(1990-8#1)(1991-11#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1995-11#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2009-8#1)(2009-9#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
of the remarkable##6##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-10#1)
of the remodeling##2##3##(2007-11#1)(2011-2#1)
of the renal artery##2##4##(1992-5#1)(1993-3#1)
of the renal parenchyma##2##4##(1993-2#1)(2011-2#1)
of the renal pelvis##2##4##(2008-1#1)(2011-2#1)
of the renal sodium channel##2##5##(1997-3#2)
of the renal tubular##2##4##(2008-8#1)(2013-1#1)
of the renal##29##3##(1990-8#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1996-6#1)(1997-3#2)(2007-7#1)(2008-1#6)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#2)(2011-3#1)(2013-1#4)(2013-8#1)
of the renin-angiotensin system and##2##5##(1993-12#1)(2008-4#1)
of the renin-angiotensin system##3##4##(1993-12#1)(2008-11#1)(2008-4#1)
of the renin-angiotensin-aldosterone system##3##4##(1996-6#1)(2011-2#1)(2013-8#1)
of the renin-angiotensin-aldosterone##4##3##(1996-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the rep gene##2##4##(2008-10#2)
of the repair##3##3##(2008-8#2)(2008-9#1)
of the repeat##2##3##(2008-4#1)(2009-5#1)
of the repeatability of measurements##2##5##(1996-3#1)(2008-10#1)
of the replacement##2##3##(2008-10#1)(2008-9#1)
of the replicase##2##3##(2008-10#1)(2008-9#1)
of the replication of##2##4##(2008-4#1)(2011-3#1)
of the replication##8##3##(1990-11#1)(1992-3#1)(1993-9#1)(1994-12#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-3#1)
of the report##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
of the reported cases of##2##5##(1994-9#1)(1995-3#1)
of the reported cases##5##4##(1994-9#1)(1995-3#1)(2008-1#1)(2009-3#1)(2011-1#1)
of the reported findings##2##4##(2007-7#1)(2009-8#1)
of the reported##15##3##(1994-12#1)(1994-9#1)(1995-3#2)(1997-1#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)
of the reporter gene##7##4##(1994-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)
of the reporter##11##3##(1992-12#1)(1994-2#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-9#1)(2011-1#1)
of the reporting forms##2##4##(2012-12#2)
of the reporting##5##3##(1994-2#1)(2007-2#1)(2012-12#3)
of the reports##2##3##(2008-11#2)
of the representation##2##3##(2009-10#1)(2012-3#1)
of the reproductive tract##4##4##(1991-12#1)(1993-2#1)(1994-9#1)(2007-12#1)
of the reproductive##12##3##(1990-12#1)(1991-12#1)(1993-2#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
of the required plastic deformation##2##5##(2008-7#2)
of the required##9##3##(1994-12#1)(1995-6#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
of the requirements for##2##4##(2010-12#1)(2013-1#1)
of the requirements of##3##4##(1993-3#1)(1996-1#1)(2008-7#1)
of the requirements##8##3##(1993-11#1)(1993-3#1)(1996-1#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
of the research and development##2##5##(2008-11#1)(2008-5#1)
of the research and##3##4##(1996-2#1)(2008-11#1)(2008-5#1)
of the research data##4##4##(2008-10#3)(2008-11#1)
of the research on##2##4##(2009-7#1)(2013-1#1)
of the research process##2##4##(2009-4#1)(2011-1#1)
of the research was to##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
of the research was##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
of the research were##2##4##(2008-10#2)
of the research##43##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
of the researcher's##2##3##(1997-1#1)(2008-4#1)
of the researchers##2##3##(2010-9#1)(2011-2#1)
of the resected specimen showed##2##5##(2008-10#1)(2011-2#1)
of the resected specimen##3##4##(1992-6#1)(2008-10#1)(2011-2#1)
of the resected##5##3##(1992-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
of the reservoir##2##3##(2008-10#1)(2008-3#1)
of the resident##2##3##(2008-10#1)(2008-4#1)
of the residual yolk sac had no effect on serum total lipids##2##12##(2008-12#2)
of the residual yolk sac##6##5##(2008-12#6)
of the residual##16##3##(1992-8#1)(1993-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#6)(2008-3#1)(2009-3#1)(2010-12#1)(2012-2#1)
of the residuals##5##3##(1995-9#1)(2008-10#3)(2011-2#1)
of the residue##4##3##(2008-10#3)(2008-7#1)
of the residues##2##3##(1994-5#1)(1996-7#1)
of the resin and the##2##5##(2008-10#1)(2010-4#1)
of the resin for the##2##5##(2008-10#2)
of the resin for##5##4##(2008-10#5)
of the resin material##2##4##(2008-10#2)
of the resin##19##3##(2008-10#17)(2008-8#1)(2010-4#1)
of the resin-phase##2##3##(2008-10#2)
of the resins##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
of the resist##3##3##(2007-12#3)
of the resistance gene##4##4##(2008-10#3)(2008-5#1)
of the resistance genes##3##4##(2008-10#3)
of the resistance of##2##4##(2008-10#2)
of the resistance to##2##4##(2007-10#1)(2008-10#1)
of the resistance##21##3##(2007-10#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-5#1)(2012-3#1)
of the resistant genotype##2##4##(2008-10#2)
of the resistant lines##2##4##(2008-10#2)
of the resistant##15##3##(2007-7#1)(2008-10#12)(2008-11#1)(2011-2#1)
of the resolution##5##3##(1997-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)
of the resolved##3##3##(1995-3#1)(2007-12#1)(2008-2#1)
of the resonance wavelength##2##4##(2007-11#1)(2007-12#1)
of the resonance##9##3##(1990-8#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
of the resonant##8##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
of the resonator##11##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)(2010-4#1)
of the resource##3##3##(1995-3#1)(2008-8#1)(2010-4#1)
of the resources##6##3##(1994-3#1)(2008-4#2)(2008-8#1)(2010-4#1)(2011-2#1)
of the respective gene##2##4##(1994-8#1)(2010-12#1)
of the respective##31##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#2)(1996-2#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-12#1)(2011-2#1)
of the respiration##2##3##(1994-11#1)(2011-1#1)
of the respiratory burst##2##4##(1993-6#1)(1994-6#1)
of the respiratory chain##5##4##(1994-11#1)(1995-11#2)(2008-7#1)(2011-2#1)
of the respiratory rhythm generator##2##5##(1992-8#2)
of the respiratory rhythm##3##4##(1992-8#2)(1995-12#1)
of the respiratory system##6##4##(1992-2#1)(1996-3#1)(2008-5#2)(2010-7#1)(2013-7#1)
of the respiratory tract##4##4##(1992-3#1)(1994-12#2)(2008-10#1)
of the respiratory##31##3##(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#1)(2010-7#1)(2011-2#1)(2013-7#1)
of the respondents had##6##4##(1996-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
of the respondents to##2##4##(2008-11#1)(2010-8#1)
of the respondents were##2##4##(2008-9#1)(2013-1#1)
of the respondents##28##3##(1991-6#2)(1992-5#1)(1994-1#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
of the responders##4##3##(1990-2#1)(1997-8#2)(2011-2#1)
of the response in##3##4##(1994-8#1)(1997-3#1)(2008-3#1)
of the response of M##2##5##(2008-10#2)
of the response of##10##4##(1997-8#1)(2008-10#7)(2008-11#1)(2013-7#1)
of the response reached##2##4##(1990-7#1)(2008-4#1)
of the response to##6##4##(1990-11#1)(1991-1#1)(1995-11#1)(2008-1#1)(2008-4#1)(2010-3#1)
of the response##49##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-8#2)(1995-11#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
of the responses of the##2##5##(1997-2#1)(2008-10#1)
of the responses of##3##4##(1997-2#1)(2008-10#1)(2009-8#1)
of the responses to##2##4##(1996-1#1)(2008-11#1)
of the responses##10##3##(1992-11#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
of the responsible genes##2##4##(1997-7#1)(2007-10#1)
of the responsible##5##3##(1995-11#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-10#1)
of the responsivity##2##3##(2008-2#1)(2008-3#1)
of the rest of##2##4##(2007-11#1)(2012-2#1)
of the rest##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
of the resting##7##3##(1990-6#1)(1992-6#1)(1993-12#1)(1994-3#1)(1997-7#1)(2008-5#1)(2013-8#1)
of the restored##2##3##(1991-5#1)(2008-3#1)
of the restriction##2##3##(1993-12#1)(2006-8#1)
of the resultant##10##3##(1994-5#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
of the resulting fragments##2##4##(1992-3#1)(1993-6#1)
of the resulting modified##2##4##(2008-10#2)
of the resulting##54##3##(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2007-11#3)(2007-12#1)(2008-10#22)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the results and##4##4##(1996-5#1)(2006-4#1)(2008-4#1)(2011-2#1)
of the results are##3##4##(2008-2#3)
of the results collected during##2##5##(1991-12#1)(2013-1#1)
of the results derived by##2##5##(2007-10#1)(2008-3#1)
of the results for##9##4##(1993-12#1)(1995-1#1)(2007-11#1)(2008-10#3)(2008-6#1)(2009-7#1)(2011-2#1)
of the results is##5##4##(1991-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-7#1)
of the results obtained by the##2##6##(2008-10#2)
of the results obtained by##3##5##(2008-10#3)
of the results obtained for##3##5##(2008-10#3)
of the results obtained with##3##5##(1992-6#1)(2007-11#1)(2008-5#1)
of the results obtained##15##4##(1990-6#1)(1991-3#1)(1992-6#1)(1993-8#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-5#2)
of the results of studies##2##5##(1994-5#1)(2011-2#1)
of the results of the##7##5##(1991-3#1)(1992-11#1)(1993-1#1)(1994-2#1)(1997-8#1)(2008-4#1)(2011-2#1)
of the results of##22##4##(1990-9#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-1#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)
of the results reported##2##4##(2008-3#1)(2013-1#1)
of the results to##3##4##(1994-2#1)(2008-3#1)(2008-4#1)
of the results was##3##4##(2008-10#3)
of the results were##3##4##(2008-10#2)(2008-5#1)
of the results with##5##4##(2007-12#1)(2008-10#3)(2008-2#1)
of the results##109##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-3#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#3)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#30)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#1)(2013-1#4)
of the retained##3##3##(1991-3#1)(2008-10#1)(2009-12#1)
of the retardance##3##3##(2008-2#1)(2008-3#2)
of the retention indices of the hydrocarbons on##2##8##(2008-10#2)
of the retention##8##3##(1996-5#1)(2008-10#7)
of the reticular lamina##3##4##(1995-5#3)
of the reticular##4##3##(1994-3#1)(1995-5#3)
of the retina##11##3##(1997-3#1)(2007-11#2)(2008-8#4)(2011-1#1)(2011-2#2)(2011-7#1)
of the retinal##7##3##(1995-5#1)(2007-12#2)(2008-3#1)(2010-10#1)(2011-1#1)(2011-7#1)
of the retinoblastoma gene product##3##5##(1992-8#1)(1995-2#1)(1997-7#1)
of the retinoblastoma gene##4##4##(1992-8#1)(1995-2#1)(1997-7#1)(2010-3#1)
of the retrieval##11##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#7)(2013-8#1)
of the retrieved aerosol-extinction##2##4##(2008-3#2)
of the retrieved profiles##2##4##(2008-3#2)
of the retrieved##14##3##(2007-12#1)(2008-2#1)(2008-3#10)(2008-8#2)
of the retrograde##3##3##(1992-12#1)(2007-8#2)
of the retroperitoneal##2##3##(2008-6#1)(2012-3#1)
of the retroperitoneum##4##3##(1992-12#1)(2008-6#2)(2013-1#1)
of the return##3##3##(2008-2#2)(2008-9#1)
of the revenue##2##3##(1992-1#1)(1992-12#1)
of the review is##2##4##(1992-1#1)(2013-8#1)
of the review##9##3##(1992-1#3)(1994-8#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-8#1)
of the revised##5##3##(1992-1#1)(2007-12#1)(2007-5#1)(2009-9#1)(2010-5#1)
of the reward##2##3##(1993-6#1)(2010-10#1)
of the rf##3##3##(2007-12#2)(2008-3#1)
of the rheumatoid##2##3##(1990-6#1)(2007-8#1)
of the rho/rac proteins##3##4##(1990-2#3)
of the rhythm to##2##4##(1994-2#1)(2008-5#1)
of the rhythm##4##3##(1994-2#1)(2008-5#2)(2008-6#1)
of the rib##2##3##(2007-8#1)(2013-1#1)
of the ribbon-like structures##2##4##(1992-6#2)
of the ribbon-like##3##3##(1992-6#2)(2008-10#1)
of the ribosomal DNA##4##4##(2008-10#4)
of the ribosomal RNA##2##4##(2008-10#1)(2008-5#1)
of the ribosomal genes##2##4##(2008-10#2)
of the ribosomal##11##3##(2008-10#9)(2008-5#1)(2012-12#1)
of the ribosome##6##3##(2007-12#2)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)
of the ribozyme in##2##4##(1993-9#1)(2008-9#1)
of the ribozyme##6##3##(1993-9#3)(1994-11#2)(2008-9#1)
of the rice blast fungus##3##5##(2008-10#3)
of the rice##12##3##(2008-10#5)(2008-8#1)(2008-9#6)
of the right MCA##2##4##(2008-12#2)
of the right arm of##2##5##(1993-11#1)(1997-3#1)
of the right atrium and##2##5##(2007-8#2)
of the right atrium##4##4##(1997-6#1)(2007-8#3)
of the right breast##2##4##(1994-12#1)(2008-10#1)
of the right coronary artery##3##5##(1994-11#1)(2007-8#2)
of the right coronary##4##4##(1994-11#1)(2007-8#3)
of the right eye##3##4##(2011-1#1)(2012-2#1)(2013-7#1)
of the right foot##2##4##(2008-12#1)(2009-10#1)
of the right hemisphere are##2##5##(1990-3#2)
of the right hemisphere##7##4##(1990-3#4)(1996-2#3)
of the right kidney##3##4##(1994-5#1)(2007-10#1)(2007-7#1)
of the right lung##4##4##(2007-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
of the right middle cerebral artery##3##6##(1996-3#1)(2008-7#2)
of the right middle##4##4##(1996-3#2)(2008-7#2)
of the right pulmonary artery##3##5##(1997-5#1)(2008-11#1)(2010-10#1)
of the right ventricle in##2##5##(2008-11#1)(2009-10#1)
of the right ventricle##6##4##(2007-8#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-3#1)
of the right ventricular outflow tract##2##6##(2007-8#1)(2013-2#1)
of the right##90##3##(1990-11#1)(1990-3#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-2#3)(1996-3#2)(1997-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#12)(2008-10#1)(2008-11#3)(2008-12#8)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2010-10#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-2#1)(2013-7#1)(2013-8#1)
of the ring laser##2##4##(2007-11#1)(2008-2#1)
of the ring##10##3##(1994-12#1)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#1)(2010-12#1)
of the rise##2##3##(2008-2#1)(2008-5#1)
of the risk factors for##4##5##(2007-11#1)(2008-10#1)(2010-10#1)(2011-2#1)
of the risk factors##8##4##(1993-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-2#1)
of the risk in##2##4##(1992-3#1)(2011-2#1)
of the risk of##22##4##(1992-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the risk##45##3##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#2)(1995-6#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
of the risks of##3##4##(2007-2#2)(2008-4#1)
of the risks##7##3##(2007-10#1)(2007-2#2)(2008-4#1)(2010-10#1)(2010-12#2)
of the rms##2##3##(2008-3#2)
of the road##2##3##(2010-11#1)(2011-1#1)
of the robot is##2##4##(2012-1#1)(2012-2#1)
of the robot##6##3##(2011-1#1)(2012-1#4)(2012-2#1)
of the robust##2##3##(2008-10#2)
of the rock##2##3##(2008-10#2)
of the rod##2##3##(1990-11#1)(2008-2#1)
of the rodenticides warfarin##2##4##(2008-10#2)
of the role and##2##4##(2008-12#1)(2009-9#1)
of the role of the##3##5##(1995-2#1)(2012-1#1)(2012-3#1)
of the role of##55##4##(1990-11#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#2)(1993-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
of the role##68##3##(1990-11#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#2)(1993-6#1)(1995-12#1)(1995-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
of the roles of##4##4##(2008-4#1)(2008-9#1)(2010-3#1)(2012-3#1)
of the roles##6##3##(1994-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-3#1)(2012-3#1)
of the romance##2##3##(2012-2#2)
of the root and##3##4##(2008-10#2)(2013-1#1)
of the root bark of##2##5##(2008-10#1)(2008-11#1)
of the root canal##2##4##(2013-1#2)
of the root cap##2##4##(2008-10#1)(2009-8#1)
of the root system##4##4##(2008-10#4)
of the root##25##3##(1995-12#1)(2008-10#15)(2008-11#1)(2009-6#2)(2009-8#2)(2012-3#1)(2013-1#3)
of the root-knot nematode Meloidogyne javanica##2##6##(2008-10#2)
of the root-knot nematode Meloidogyne##3##5##(2008-10#3)
of the root-knot nematode##4##4##(2008-10#4)
of the roots of##4##4##(2008-10#1)(2010-6#1)(2011-1#1)(2013-1#1)
of the roots##8##3##(1995-9#1)(2008-10#3)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
of the rostral##5##3##(1993-12#1)(1997-6#2)(2008-7#1)(2011-1#1)
of the rosy bitterling##2##4##(2008-5#2)
of the rotation##2##3##(2008-3#2)
of the rotational motion##2##4##(1990-2#1)(1994-3#1)
of the rotational##7##3##(1990-2#1)(1990-7#1)(1993-12#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the rotator cuff##5##4##(1994-2#1)(2007-11#2)(2012-12#2)
of the rotator##6##3##(1990-3#1)(1994-2#1)(2007-11#2)(2012-12#2)
of the rotenone-sensitive##2##3##(1990-11#2)
of the rough endoplasmic reticulum##2##5##(2008-7#2)
of the rough##5##3##(2008-3#3)(2008-7#2)
of the routine investigations##2##4##(2008-9#1)(2010-6#1)
of the routine##5##3##(1993-2#1)(1994-6#1)(2008-2#1)(2008-9#1)(2010-6#1)
of the rows##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
of the rules##3##3##(1995-6#2)(2013-1#1)
of the rupture##3##3##(1995-5#1)(2009-9#1)(2011-3#1)
of the rural##3##3##(2008-12#1)(2008-6#1)(2011-1#1)
of the ryanodine receptor##2##4##(1994-8#1)(1997-3#1)
of the ryanodine sensitive ion channel##2##6##(1994-8#2)
of the ryanodine##4##3##(1994-8#3)(1997-3#1)
of the sTT/PSA ratio##3##4##(2012-12#3)
of the sac##4##3##(1995-11#2)(2007-12#1)(2008-6#1)
of the saccharide##2##3##(1991-7#1)(2008-10#1)
of the sacral##2##3##(2007-11#1)(2008-3#1)
of the sacroiliac joints##3##4##(1990-6#1)(2006-10#1)(2011-2#1)
of the sacroiliac##4##3##(1990-6#1)(2006-10#1)(2011-2#2)
of the safety and efficacy of##2##6##(1994-5#1)(2011-2#1)
of the safety of##4##4##(1990-11#1)(1990-6#1)(1995-5#1)(2008-7#1)
of the safety##9##3##(1990-11#1)(1990-6#1)(1991-6#1)(1994-5#1)(1995-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
of the sag##2##3##(2008-5#2)
of the sagitta##2##3##(2013-7#2)
of the said##2##3##(2008-10#2)
of the saline matrix##2##4##(2008-10#2)
of the saline##5##3##(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
of the salivary glands##3##4##(2008-4#3)
of the salivary##6##3##(2008-4#3)(2009-3#2)(2011-2#1)
of the salt##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
of the same acids##4##4##(1995-5#4)
of the same age and sex##2##6##(1990-11#1)(1991-11#1)
of the same age group##3##5##(1990-2#1)(2008-1#1)(2011-2#1)
of the same age##12##4##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#1)(1995-9#1)(1996-6#1)(2007-12#1)(2008-1#2)(2008-7#1)(2011-2#1)
of the same analytes##2##4##(2008-10#1)(2008-3#1)
of the same brand##2##4##(2008-10#1)(2013-1#1)
of the same chronological age##2##5##(1995-5#1)(2010-4#1)
of the same compounds##3##4##(2008-10#2)(2008-4#1)
of the same family##8##4##(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2010-3#1)(2012-12#1)
of the same length##2##4##(2008-9#1)(2011-2#1)
of the same magnitude##2##4##(1993-2#1)(2008-10#1)
of the same material##3##4##(2007-11#1)(2010-4#1)(2013-8#1)
of the same or##2##4##(2008-10#1)(2008-8#1)
of the same order of magnitude as the##2##8##(1992-6#1)(2007-11#1)
of the same order of magnitude as##3##7##(1991-2#1)(1992-6#1)(2007-11#1)
of the same order##5##4##(1991-2#1)(1991-5#1)(1992-6#1)(2007-11#1)(2008-2#1)
of the same population##2##4##(2008-10#2)
of the same product##2##4##(2008-3#1)(2009-10#1)
of the same sample##2##4##(2008-10#2)
of the same sex##4##4##(1994-5#1)(2008-7#1)(2008-9#2)
of the same size##8##4##(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)
of the same species##8##4##(1995-2#1)(2008-10#2)(2008-7#1)(2008-8#2)(2012-2#2)
of the same system##2##4##(2008-10#1)(2012-2#1)
of the same tumor##2##4##(1991-6#1)(1992-9#1)
of the same type as##2##5##(1997-6#1)(2008-11#1)
of the same type of##3##5##(1997-4#1)(2008-12#2)
of the same type##8##4##(1995-12#1)(1997-4#2)(1997-6#1)(2008-11#1)(2008-12#2)(2008-9#1)
of the same##222##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#9)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#4)(2008-1#2)(2008-10#49)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#9)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-4#2)(2013-1#3)(2013-8#1)
of the sample and of the##2##6##(2008-10#1)(2008-3#1)
of the sample and of##3##5##(2008-10#2)(2008-3#1)
of the sample and##11##4##(1997-2#1)(2007-12#1)(2008-10#7)(2008-3#1)(2009-8#1)
of the sample in##6##4##(2008-10#5)(2008-9#1)
of the sample introduction##2##4##(2008-10#2)
of the sample is##6##4##(1995-12#1)(2008-10#3)(2008-3#2)
of the sample matrix##3##4##(2008-10#3)
of the sample medium##2##4##(2008-3#2)
of the sample plug##2##4##(2008-10#2)
of the sample reported##2##4##(2008-4#2)
of the sample set##2##4##(2013-8#2)
of the sample solution on##2##5##(2008-10#2)
of the sample solution was##2##5##(2008-10#2)
of the sample solution##11##4##(2008-10#11)
of the sample surface##2##4##(2008-2#1)(2008-3#1)
of the sample to##5##4##(2008-10#3)(2008-3#1)(2011-2#1)
of the sample treated##2##4##(2008-9#1)(2013-1#1)
of the sample was##5##4##(2007-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
of the sample were##4##4##(1992-5#1)(1995-5#1)(2007-2#1)(2008-12#1)
of the sample with##4##4##(1996-5#1)(2007-12#1)(2008-10#2)
of the sample zone##2##4##(2008-10#2)
of the sample##151##3##(1990-12#2)(1991-2#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-4#2)(2007-11#3)(2007-12#6)(2007-2#2)(2008-10#85)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#4)(2008-5#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#4)(2013-8#4)
of the sample)##2##3##(2008-10#1)(2012-3#1)
of the sampled##4##3##(2008-10#2)(2008-5#1)(2013-7#1)
of the samples and##6##4##(2008-10#5)(2008-11#1)
of the samples are##3##4##(2008-10#3)
of the samples by##2##4##(2008-10#2)
of the samples did not##2##5##(2008-10#1)(2008-11#1)
of the samples from##4##4##(1995-11#1)(2008-12#3)
of the samples have##2##4##(2008-10#2)
of the samples in MeOH##2##5##(2008-10#2)
of the samples in##8##4##(1990-8#1)(2008-10#6)(2008-3#1)
of the samples is##2##4##(2008-10#2)
of the samples of##2##4##(2008-10#2)
of the samples studied##2##4##(1996-12#1)(2008-10#1)
of the samples that##2##4##(2008-10#1)(2008-2#1)
of the samples was##3##4##(2008-10#3)
of the samples were##8##4##(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-1#1)(2012-3#1)
of the samples with##5##4##(1995-6#1)(2008-10#4)
of the samples##108##3##(1990-12#1)(1990-8#1)(1994-6#3)(1995-11#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#58)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#4)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of the sampling grid##3##4##(2008-10#3)
of the sampling points##2##4##(2008-3#2)
of the sampling##20##3##(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2013-7#2)
of the samplings##2##3##(2008-10#1)(2008-6#1)
of the sarcoplasmic reticulum##3##4##(1990-2#1)(1991-12#1)(1992-3#1)
of the satellite##2##3##(2008-3#2)
of the saturable absorber##2##4##(2008-2#1)(2008-3#1)
of the saturated##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)
of the saturation##2##3##(2008-2#1)(2008-3#1)
of the savings##2##3##(1990-4#1)(1992-2#1)
of the scaffold##3##3##(2009-7#2)(2012-1#1)
of the scalar##4##3##(2008-2#2)(2008-3#2)
of the scale parameter##2##4##(1996-3#2)
of the scale##9##3##(1996-3#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-1#1)
of the scalp##8##3##(1996-7#1)(2007-7#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-5#1)
of the scan##3##3##(2008-10#2)(2009-2#1)
of the scandium-alizarin red S complex onto a carbon paste electrode##2##11##(2008-10#2)
of the scanning##2##3##(2007-12#1)(2008-3#1)
of the scans##2##3##(1996-7#1)(2008-7#1)
of the scaphoid##4##3##(2008-9#4)
of the scapular##2##3##(2010-9#1)(2012-3#1)
of the scar##5##3##(2009-6#1)(2012-1#2)(2013-8#2)
of the scattered field to the##2##6##(2007-12#1)(2008-3#1)
of the scattered field##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
of the scattered fields##2##4##(2008-2#1)(2008-3#1)
of the scattered light##12##4##(2007-12#1)(2008-2#3)(2008-3#8)
of the scattered wave is shown to##2##7##(2008-2#1)(2008-3#1)
of the scattered wave##6##4##(2008-2#1)(2008-3#5)
of the scattered##28##3##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#18)(2009-11#1)
of the scatterers are##2##4##(2008-2#1)(2008-3#1)
of the scatterers##3##3##(2008-2#2)(2008-3#1)
of the scattering angle##3##4##(2008-2#1)(2008-3#2)
of the scattering coefficient##5##4##(2008-2#1)(2008-3#4)
of the scattering delay##3##4##(2008-2#3)
of the scattering layer##3##4##(2008-2#3)
of the scattering matrix##2##4##(2008-3#2)
of the scattering medium##3##4##(2008-3#3)
of the scattering object##2##4##(2007-12#1)(2008-2#1)
of the scattering phase function##3##5##(2008-2#2)(2008-3#1)
of the scattering phase##4##4##(2008-2#2)(2008-3#2)
of the scattering properties of##2##5##(2008-2#1)(2008-3#1)
of the scattering##49##3##(2007-11#1)(2007-12#1)(2008-2#22)(2008-3#23)(2008-6#1)(2008-9#1)
of the scheme is##2##4##(2008-2#1)(2008-3#1)
of the scheme##4##3##(1991-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
of the schizo-obsessive subtype##2##4##(2008-3#2)
of the school##5##3##(1990-6#1)(1991-12#1)(1993-1#1)(2008-12#1)(2010-1#1)
of the sciatic nerve##6##4##(1990-7#2)(1993-12#2)(1996-5#1)(2008-7#1)
of the sciatic##8##3##(1990-7#2)(1993-12#2)(1996-5#1)(1997-3#1)(2008-6#1)(2008-7#1)
of the science##7##3##(1992-3#1)(1997-1#1)(2008-10#1)(2009-5#2)(2009-7#1)(2010-9#1)
of the scientific literature##3##4##(1993-6#1)(2008-3#1)(2013-1#1)
of the scientific##8##3##(1993-6#1)(1996-6#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-2#1)(2013-1#1)
of the scope of##3##4##(1991-12#1)(2008-1#1)(2009-6#1)
of the score and##2##4##(2008-10#1)(2012-3#1)
of the scores##2##3##(2008-11#2)
of the scoring system##2##4##(2012-12#1)(2013-1#1)
of the scorpion Centruroides noxius Hoffmann##2##6##(1993-6#1)(2008-7#1)
of the scorpion##4##3##(1990-8#1)(1993-6#1)(2007-12#1)(2008-7#1)
of the screen##3##3##(2008-2#1)(2008-3#2)
of the screening##9##3##(1990-2#2)(1992-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-2#1)
of the screws##3##3##(1991-9#1)(2007-11#1)(2008-10#1)
of the scute##2##3##(2008-7#2)
of the sea surface##4##4##(2008-2#1)(2008-3#3)
of the sea##8##3##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#3)
of the search##2##3##(2008-6#1)(2012-3#1)
of the season in##2##4##(2007-5#1)(2008-8#1)
of the season##9##3##(2007-5#2)(2008-10#4)(2008-8#3)
of the seasonal ascospore release occurred##2##6##(2008-10#2)
of the seawater eels##2##4##(2008-5#2)
of the seawater##3##3##(2008-3#1)(2008-5#2)
of the second and third##4##5##(1993-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
of the second group##2##4##(1994-6#1)(2009-4#1)
of the second harmonic##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2013-1#1)
of the second messenger##3##4##(1993-6#1)(2010-11#1)(2013-7#1)
of the second method##2##4##(2008-3#1)(2008-8#1)
of the second one##2##4##(2008-10#1)(2009-8#1)
of the second order##3##4##(2008-10#1)(2008-11#1)(2009-7#1)
of the second particle##2##4##(2008-3#2)
of the second substrate##2##4##(1992-3#1)(2008-11#1)
of the second week##3##4##(1997-2#1)(2008-7#1)(2008-8#1)
of the second##82##3##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#2)(1991-8#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
of the second-harmonic generation of a short pulse##3##8##(2008-2#3)
of the second-harmonic wave##2##4##(2007-12#2)
of the second-harmonic##10##3##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
of the second-order advantage##2##4##(2008-10#2)
of the second-order nonlinear##4##4##(2007-11#1)(2007-12#3)
of the second-order##13##3##(1993-8#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#3)
of the secondary spectrum##3##4##(2008-3#3)
of the secondary structure##3##4##(1995-11#1)(2008-4#1)(2012-2#1)
of the secondary##20##3##(1991-3#1)(1995-11#1)(1995-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2010-2#2)(2012-12#1)(2012-2#2)
of the secreted##5##3##(1991-9#1)(1997-1#1)(1997-4#2)(2008-11#1)
of the secretion of##2##4##(1990-11#1)(2008-11#1)
of the secretion##4##3##(1990-11#1)(2006-6#1)(2007-12#1)(2008-11#1)
of the secretory##9##3##(1990-12#1)(1991-5#1)(1993-12#1)(1997-3#1)(2007-12#2)(2008-11#1)(2008-7#2)
of the sections##2##3##(2008-4#1)(2009-1#1)
of the sector##2##3##(1995-3#1)(2008-10#1)
of the security##5##3##(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2010-8#1)
of the sedative##2##3##(2008-6#1)(2010-3#1)
of the sediment##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
of the seed lots##2##4##(2008-10#2)
of the seed oils##2##4##(2008-11#2)
of the seed##14##3##(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-9#1)(2009-10#1)(2013-8#1)
of the seedlings##4##3##(2008-10#2)(2008-5#1)(2011-10#1)
of the seeds##6##3##(2007-11#1)(2008-12#1)(2008-9#1)(2011-1#2)(2013-7#1)
of the segment##8##3##(2007-12#2)(2008-10#3)(2008-3#1)(2008-5#2)
of the seismicity##3##3##(1996-4#3)
of the seizure##2##3##(2008-7#1)(2010-12#1)
of the selected##16##3##(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
of the selection of##2##4##(2007-8#1)(2011-2#1)
of the selection process##2##4##(1997-1#1)(2008-6#1)
of the selection##9##3##(1997-1#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
of the selective##8##3##(1994-5#1)(1995-12#2)(2008-10#2)(2008-3#1)(2008-4#1)(2012-3#1)
of the selectivity##2##3##(2008-10#1)(2008-8#1)
of the selenium##4##3##(2008-10#4)
of the self##4##3##(2008-11#2)(2012-12#1)(2012-2#1)
of the self-assembled##3##3##(1997-4#1)(2008-10#2)
of the self-system##2##3##(2009-7#1)(2010-4#1)
of the sellar region##5##4##(2012-3#5)
of the semantic##3##3##(1991-2#1)(1996-7#1)(2010-5#1)
of the semiconductor##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
of the seminal vesicle##4##4##(2008-11#2)(2011-2#2)
of the seminal vesicles##2##4##(1997-8#1)(2012-12#1)
of the seminal##10##3##(1997-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#1)
of the seminiferous epithelial cycle##2##5##(2009-10#2)
of the seminiferous epithelium##4##4##(2009-10#4)
of the seminiferous##8##3##(2008-7#1)(2009-10#6)(2012-2#1)
of the senescent##2##3##(1996-9#1)(2013-7#1)
of the sense##4##3##(1994-11#1)(2008-1#1)(2008-5#1)(2008-7#1)
of the sensing film##3##4##(2008-10#3)
of the sensing##12##3##(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
of the sensitive##4##3##(1991-12#1)(2008-10#2)(2008-11#1)
of the sensitivity of the system to##2##7##(2008-11#1)(2008-2#1)
of the sensitivity of the##5##5##(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
of the sensitivity of##10##4##(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#2)
of the sensitivity to##3##4##(2008-3#3)
of the sensitivity##19##3##(1990-12#1)(1990-7#1)(1993-8#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#2)(2010-6#1)(2011-1#1)
of the sensitized film##2##4##(2008-10#2)
of the sensitized##3##3##(2008-10#3)
of the sensor are##2##4##(2008-3#2)
of the sensor for##3##4##(2008-10#3)
of the sensor is 6##2##5##(2008-10#2)
of the sensor is about##2##5##(2008-10#2)
of the sensor is based on##2##6##(2008-10#1)(2008-3#1)
of the sensor is##13##4##(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#3)
of the sensor response##4##4##(2008-10#3)(2008-3#1)
of the sensor to the##2##5##(2008-10#1)(2008-3#1)
of the sensor to##6##4##(2008-10#4)(2008-2#1)(2008-3#1)
of the sensor was evaluated##2##5##(2008-10#2)
of the sensor was##9##4##(2008-10#9)
of the sensor were##3##4##(2008-10#3)
of the sensor##81##3##(2007-11#1)(2007-12#1)(2008-10#58)(2008-2#2)(2008-3#14)(2009-9#1)(2010-2#3)(2013-1#1)
of the sensorimotor cortex##2##4##(1995-11#1)(1996-2#1)
of the sensors##5##3##(2008-10#5)
of the sensory attributes##2##4##(2008-10#1)(2012-2#1)
of the sensory cell##2##4##(2007-12#1)(2008-7#1)
of the sensory##15##3##(1990-5#1)(1993-12#1)(2007-12#5)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-8#1)
of the separate##2##3##(1995-5#1)(2008-10#1)
of the separated analytes##2##4##(2008-10#2)
of the separated##5##3##(2007-12#1)(2008-10#3)(2010-5#1)
of the separation channel##2##4##(2008-10#2)
of the separation of##3##4##(2008-10#2)(2011-1#1)
of the separation##16##3##(1990-8#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#9)(2010-5#1)(2011-1#1)(2012-1#1)
of the septohippocampal system##2##4##(1993-12#2)
of the septohippocampal##3##3##(1993-12#3)
of the septum##3##3##(1994-8#1)(1997-3#1)(2008-7#1)
of the sequence of events##2##5##(2008-11#1)(2012-3#1)
of the sequence of##7##4##(1991-2#1)(1993-2#1)(2008-10#1)(2008-11#2)(2009-10#1)(2012-3#1)
of the sequence revealed that##2##5##(1990-2#1)(1996-12#1)
of the sequence revealed##3##4##(1990-2#1)(1996-12#1)(1996-3#1)
of the sequence space##2##4##(1997-6#1)(2008-7#1)
of the sequence##30##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
of the sequenced##4##3##(1995-8#1)(1997-6#1)(1997-8#1)(2008-8#1)
of the sequences of the##2##5##(1991-2#1)(1995-11#1)
of the sequences of##4##4##(1991-2#1)(1995-11#1)(1997-8#1)(2010-4#1)
of the sequences##16##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#2)(2010-4#1)
of the sequencing##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
of the sequential injection##2##4##(2008-10#2)
of the sequential##4##3##(2008-10#3)(2008-11#1)
of the serial##3##3##(1991-12#1)(1991-6#1)(2008-11#1)
of the series of##3##4##(1994-8#1)(1996-2#1)(2011-2#1)
of the series##9##3##(1994-8#1)(1996-2#1)(2008-10#2)(2008-3#2)(2009-8#1)(2011-2#2)
of the serine##7##3##(1990-7#2)(1991-6#1)(1993-3#1)(1995-2#1)(1997-1#1)(2009-10#1)
of the serious##5##3##(2008-11#1)(2009-6#2)(2012-12#1)(2013-8#1)
of the seriousness of##2##4##(1990-3#1)(1995-6#1)
of the serogroup Y##2##4##(2007-12#2)
of the seronegative##2##3##(1994-6#1)(1995-9#1)
of the serotonin transporter##3##4##(1996-7#1)(2012-3#2)
of the serotonin##5##3##(1996-5#1)(1996-7#1)(2008-7#1)(2012-3#2)
of the serotype of##2##4##(1997-3#1)(2008-10#1)
of the serum ferritin##2##4##(2012-12#1)(2013-8#1)
of the serum triglyceride##2##4##(1991-12#2)
of the serum##22##3##(1991-12#3)(1991-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the service is##2##4##(1992-11#1)(2011-1#1)
of the service##14##3##(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
of the services offered##2##4##(1994-12#1)(1995-1#1)
of the services provided##2##4##(1992-1#1)(1995-1#1)
of the services##7##3##(1992-1#1)(1994-12#1)(1995-1#2)(2007-7#1)(2008-4#1)(2013-1#1)
of the session##4##3##(1991-12#1)(2007-12#1)(2008-6#1)(2012-3#1)
of the set of##6##4##(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
of the set##14##3##(1992-12#1)(1994-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#2)(2013-1#1)
of the settlement##3##3##(1995-12#1)(1997-5#1)(2008-9#1)
of the setup##5##3##(2007-11#2)(2008-3#2)(2010-12#1)
of the seven other##2##4##(1992-8#1)(2008-6#1)
of the seven##22##3##(1992-8#1)(1993-12#1)(1993-3#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)(2012-3#1)
of the seventh##2##3##(2008-10#1)(2008-12#1)
of the several##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
of the severe##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
of the severity of the##2##5##(2007-8#2)
of the severity of##9##4##(1990-3#1)(2007-8#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
of the severity##11##3##(1990-3#1)(2007-8#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)
of the sex pheromone##3##4##(2007-12#1)(2008-10#2)
of the sex##8##3##(1990-2#1)(1994-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
of the sexes##6##3##(1991-6#1)(2008-7#1)(2008-9#4)
of the sexual##10##3##(1992-9#1)(1993-3#1)(1996-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-3#1)
of the sexually##3##3##(1992-3#1)(1995-5#1)(2012-12#1)
of the shaft##2##3##(2007-11#1)(2011-2#1)
of the sham##2##3##(2008-5#1)(2012-7#1)
of the shampoo##4##3##(2008-10#1)(2008-5#3)
of the shape of##5##4##(1993-12#1)(1993-3#1)(2008-2#1)(2008-3#2)
of the shape##7##3##(1993-12#1)(1993-3#1)(1995-9#1)(2008-2#1)(2008-3#3)
of the shaped##2##3##(2007-12#1)(2008-3#1)
of the sheath##5##3##(2007-12#1)(2007-7#1)(2008-10#3)
of the sheep##3##3##(1993-8#1)(1996-12#1)(2008-10#1)
of the shell##2##3##(2008-3#1)(2012-2#1)
of the shift in the##2##5##(2007-11#1)(2011-2#1)
of the shift in##3##4##(2007-11#1)(2008-3#1)(2011-2#1)
of the shift##7##3##(2007-11#2)(2007-12#2)(2008-3#2)(2011-2#1)
of the shifts##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
of the shoot##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2012-1#1)
of the short arm of chromosome##2##6##(2008-10#1)(2012-3#1)
of the short##7##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-3#1)
of the shortened##2##3##(2007-11#1)(2012-2#1)
of the shorter##2##3##(1992-5#1)(2006-12#1)
of the shoulder joint is##2##5##(1991-4#1)(2008-8#1)
of the shoulder##32##3##(1990-12#1)(1990-3#1)(1991-4#1)(1997-5#2)(1997-6#1)(2007-11#14)(2007-8#3)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#3)(2013-1#2)
of the siblings##2##3##(1995-12#1)(2011-1#1)
of the sickle cell##2##4##(2013-8#2)
of the side chain at##2##5##(1995-5#1)(2008-8#1)
of the side chain of##3##5##(1992-1#1)(2007-11#1)(2008-10#1)
of the side chain##7##4##(1992-1#1)(1993-6#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
of the side chains##4##4##(1993-11#2)(1993-12#1)(2008-10#1)
of the side##15##3##(1990-10#1)(1992-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
of the sigma##3##3##(1994-12#2)(1996-3#1)
of the sigmoid colon##5##4##(1991-4#2)(1991-6#1)(2010-12#1)(2011-2#1)
of the sigmoid##6##3##(1991-4#2)(1991-6#1)(2008-11#1)(2010-12#1)(2011-2#1)
of the sign##2##3##(2008-10#1)(2008-3#1)
of the signal and##5##4##(1997-7#1)(2007-11#1)(2007-12#2)(2008-3#1)
of the signal from##2##4##(2008-2#2)
of the signal peptide##2##4##(1997-4#1)(2008-6#1)
of the signal sequence##5##4##(1991-6#2)(1993-9#1)(2008-11#2)
of the signal transducers and activators of transcription##2##8##(1996-2#1)(2011-2#1)
of the signal transduction##3##4##(1995-12#1)(1996-5#1)(1997-2#1)
of the signal was##2##4##(2008-10#1)(2008-3#1)
of the signal##53##3##(1991-6#2)(1993-9#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#11)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#2)
of the signal-to-noise ratio with respect to the##2##8##(2008-2#1)(2008-3#1)
of the signal-to-noise ratio##7##4##(2008-2#2)(2008-3#5)
of the signal-to-noise##8##3##(2008-10#1)(2008-2#2)(2008-3#5)
of the signals##9##3##(1992-6#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
of the significance of the##2##5##(2008-7#1)(2012-3#1)
of the significance of##7##4##(1990-2#1)(1991-12#1)(1992-11#1)(2007-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the significance##8##3##(1990-2#1)(1990-8#1)(1991-12#1)(1992-11#1)(2007-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the significant##6##3##(1992-2#1)(2008-10#4)(2008-12#1)
of the signs and symptoms of##2##6##(2007-2#1)(2007-7#1)
of the signs##4##3##(1996-9#1)(2007-2#1)(2007-7#1)(2008-5#1)
of the sika deer##2##4##(2008-5#2)
of the silent##3##3##(2008-4#2)(2008-7#1)
of the silica gel##2##4##(2008-10#2)
of the silica##10##3##(2008-10#9)(2010-12#1)
of the silicon##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
of the silkmoth##3##3##(2007-12#1)(2008-6#1)(2008-7#1)
of the silkworm##7##3##(1990-12#1)(1995-11#2)(1997-4#1)(2008-11#1)(2008-5#1)(2008-9#1)
of the silver##8##3##(1996-2#1)(2008-10#2)(2008-3#4)(2008-5#1)
of the silyl##2##3##(2008-4#2)
of the simian immunodeficiency virus##2##5##(1992-6#1)(1997-3#1)
of the simian##3##3##(1992-6#1)(1997-3#1)(2008-9#1)
of the similarities##2##3##(1992-9#1)(2007-12#1)
of the simple##6##3##(1990-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)
of the simplest##4##3##(2008-10#2)(2008-8#1)(2009-8#1)
of the simplicity of##2##4##(2008-10#1)(2008-7#1)
of the simulated##3##3##(1997-2#1)(2007-12#1)(2008-3#1)
of the simulation##7##3##(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)
of the simultaneous determination of##2##5##(2008-10#1)(2008-3#1)
of the simultaneous##7##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-5#1)(2009-7#1)
of the single intradermal comparative tuberculin test##2##7##(1997-8#2)
of the single##17##3##(1993-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#2)(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#2)(2010-12#1)(2011-1#1)(2013-1#1)
of the single-frequency##2##3##(2008-2#2)
of the single-scattering albedo##3##4##(2008-2#1)(2008-3#2)
of the single-scattering##5##3##(2008-2#2)(2008-3#3)
of the singly##4##3##(1990-8#1)(1996-2#1)(1996-7#1)(2007-12#1)
of the sinus of Valsalva and of the ascending aorta##3##10##(1997-5#3)
of the sinus##8##3##(1996-9#1)(1997-5#3)(2006-12#1)(2007-12#1)(2008-5#1)(2012-8#1)
of the sinusoidal##3##3##(1995-2#1)(2008-3#2)
of the sisters-in-charge##2##3##(2010-3#2)
of the site of##8##4##(1994-5#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-7#1)
of the site##19##3##(1990-7#1)(1994-5#2)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
of the sites##4##3##(1993-11#1)(1997-4#1)(2007-12#1)(2013-1#1)
of the situation in##2##4##(2009-8#1)(2013-1#1)
of the situation##9##3##(1990-3#1)(1993-1#1)(1993-3#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-12#1)(2013-1#2)
of the six patients##2##4##(1992-2#1)(2013-8#1)
of the six variables##2##4##(2008-10#2)
of the six##32##3##(1990-5#1)(1991-6#1)(1992-2#1)(1994-8#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-2#1)(2010-4#1)(2010-6#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the sixth##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
of the size and##2##4##(2008-8#1)(2013-1#1)
of the size distribution##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
of the size of the##5##5##(1997-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-10#1)
of the size of##7##4##(1993-8#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-10#1)
of the size##14##3##(1993-8#1)(1996-6#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2013-1#1)
of the skeletal muscle##5##4##(1992-3#1)(1993-8#1)(1994-2#1)(2008-2#1)(2008-7#1)
of the skeletal##6##3##(1992-3#1)(1993-8#1)(1994-2#1)(2007-12#1)(2008-2#1)(2008-7#1)
of the skill##3##3##(2007-12#1)(2008-11#2)
of the skin after##2##4##(2008-5#1)(2012-3#1)
of the skin and##11##4##(1991-11#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-5#3)(2009-4#1)(2012-1#1)(2012-12#1)(2013-7#1)
of the skin at the site of application##3##8##(2008-9#3)
of the skin at the site of##5##7##(2008-9#5)
of the skin at##6##4##(2008-3#1)(2008-9#5)
of the skin before and after##2##6##(2008-10#2)
of the skin by##3##4##(2008-5#1)(2009-6#1)(2013-1#1)
of the skin lesions##4##4##(1990-3#2)(1991-4#1)(2011-2#1)
of the skin or##2##4##(2008-10#1)(2008-5#1)
of the skin over##2##4##(2008-10#1)(2008-5#1)
of the skin surface and##2##5##(2008-5#2)
of the skin surface##7##4##(2008-5#7)
of the skin tissue##2##4##(1992-9#1)(2008-3#1)
of the skin were##3##4##(2008-5#1)(2008-6#2)
of the skin##130##3##(1990-3#2)(1990-6#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-6#2)(1997-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-5#61)(2008-6#4)(2008-7#1)(2008-9#10)(2009-4#1)(2009-6#2)(2010-3#2)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
of the skin's##3##3##(2008-5#3)
of the skull base##5##4##(2006-12#2)(2008-7#2)(2011-2#1)
of the skull##21##3##(1991-3#1)(1994-2#1)(1995-6#1)(2006-12#4)(2007-11#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#2)(2011-2#2)(2013-1#1)
of the sky radiance##2##4##(2008-2#1)(2008-3#1)
of the sky##6##3##(2007-12#1)(2008-2#4)(2008-3#1)
of the slab is##3##4##(1995-6#2)(2008-3#1)
of the slab##6##3##(1995-6#3)(2008-3#3)
of the sleep##3##3##(1996-7#1)(2009-8#1)(2011-2#1)
of the sleeve##2##3##(2008-11#2)
of the slit##2##3##(2008-2#2)
of the slope of the##2##5##(2008-10#1)(2008-3#1)
of the slope##5##3##(2008-10#2)(2008-3#2)(2013-8#1)
of the slow##8##3##(1991-12#1)(1992-6#1)(1993-5#1)(1993-8#1)(1996-5#1)(2007-12#1)(2008-10#2)
of the slowest##4##3##(1990-7#1)(2007-9#1)(2008-3#1)(2013-8#1)
of the slowly varying envelope approximation##2##6##(2007-11#2)
of the small and large##2##5##(1994-11#1)(2008-7#1)
of the small and##3##4##(1994-11#1)(2008-10#1)(2008-7#1)
of the small bowel##12##4##(1990-11#2)(1992-5#2)(2008-6#1)(2009-1#1)(2009-4#1)(2010-12#2)(2011-2#3)
of the small intestine and##3##5##(1995-3#1)(2010-12#1)(2011-2#1)
of the small intestine##15##4##(1990-11#1)(1991-5#2)(1992-5#1)(1992-6#3)(1995-12#1)(1995-3#2)(1997-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
of the small intestine]##2##4##(1992-5#2)
of the small number of##2##5##(1995-5#1)(1997-8#1)
of the small size VLDL##2##5##(1993-8#2)
of the small size of##2##5##(2008-10#1)(2009-3#1)
of the small size##4##4##(1993-8#2)(2008-10#1)(2009-3#1)
of the small##65##3##(1990-11#3)(1990-2#1)(1991-5#2)(1991-8#1)(1992-5#5)(1992-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-1#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#4)(2013-7#1)
of the small-angle##3##3##(2008-3#2)(2009-12#1)
of the smaller##2##3##(1990-11#1)(2012-2#1)
of the smallest##4##3##(2008-5#1)(2011-2#2)(2012-2#1)
of the smokers##2##3##(1990-6#1)(1993-2#1)
of the smoking##3##3##(1996-3#1)(1997-7#1)(2013-1#1)
of the smooth muscle##5##4##(1994-9#1)(1995-12#1)(1997-1#1)(2007-8#1)(2011-2#1)
of the smooth##7##3##(1990-7#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-8#1)(2009-12#1)(2011-2#1)
of the snake##3##3##(1995-5#1)(1997-2#1)(2010-3#1)
of the so-called##13##3##(1993-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-8#1)
of the social##19##3##(1993-1#1)(1993-11#1)(1995-11#1)(1995-5#1)(2007-10#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#2)(2013-1#2)
of the society##6##3##(2008-10#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
of the sodium##7##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)
of the soft tissues in##2##5##(2010-3#1)(2012-2#1)
of the soft tissues##6##4##(1995-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#1)
of the soft##11##3##(1991-3#1)(1995-3#1)(2007-12#1)(2008-10#2)(2009-4#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#2)
of the software##4##3##(1995-6#1)(2008-11#1)(2012-1#2)
of the soil microbial community##2##5##(2008-10#2)
of the soil microbial##3##4##(1990-9#1)(2008-10#2)
of the soil##12##3##(1990-9#1)(2008-10#9)(2008-11#1)(2010-10#1)
of the soils##2##3##(2008-10#2)
of the sol-gel##3##3##(2008-10#3)
of the solar spectrum##2##4##(2008-2#1)(2008-3#1)
of the solar##6##3##(2008-2#2)(2008-3#4)
of the solid content of the porous material##2##8##(2008-3#2)
of the solid particles##2##4##(1990-12#1)(2008-10#1)
of the solid phase##2##4##(1990-12#1)(2008-10#1)
of the solid solution##2##4##(2007-11#1)(2008-10#1)
of the solid##17##3##(1990-12#2)(2007-11#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#2)
of the solid-state##2##3##(1991-11#1)(2008-2#1)
of the solitary##5##3##(1993-12#2)(1996-5#1)(2008-7#1)(2012-2#1)
of the soliton pulse##2##4##(2007-11#2)
of the soliton##5##3##(2007-11#2)(2007-12#3)
of the solubility of##2##4##(2008-10#1)(2008-5#1)
of the solubility##5##3##(2008-10#4)(2008-5#1)
of the solubilized##2##3##(1990-2#1)(1990-5#1)
of the soluble protein##3##4##(1994-6#1)(1995-2#2)
of the soluble##16##3##(1990-2#1)(1992-12#3)(1992-6#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-8#1)(2008-11#2)(2008-9#1)
of the solute and the##2##5##(2008-10#2)
of the solute in the##2##5##(2008-10#2)
of the solute##11##3##(1994-9#1)(2008-10#8)(2008-3#1)(2010-2#1)
of the solutes##4##3##(1996-5#1)(2008-10#3)
of the solution and##2##4##(2008-10#2)
of the solution from the##2##5##(2008-10#2)
of the solution was##4##4##(1990-8#1)(2008-10#2)(2013-1#1)
of the solution##35##3##(1990-5#2)(1990-8#1)(1995-3#1)(1996-3#1)(2008-10#23)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2013-1#1)
of the solutions is##2##4##(2008-10#1)(2008-3#1)
of the solutions##14##3##(1991-1#1)(1991-9#1)(1997-4#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-12#1)
of the solvation##3##3##(2010-7#1)(2011-3#1)(2013-1#1)
of the solvent and the##2##5##(2008-10#2)
of the solvent and##3##4##(2008-10#3)
of the solvent systems##2##4##(2008-10#2)
of the solvent##20##3##(1996-2#2)(2008-10#15)(2008-3#1)(2008-7#1)(2013-1#1)
of the solvents were##2##4##(2008-10#2)
of the solvents##3##3##(2008-10#3)
of the somatic gonad##2##4##(2007-12#1)(2012-12#1)
of the somatic##5##3##(1991-12#1)(2007-12#2)(2008-7#1)(2012-12#1)
of the somatosensory##2##3##(1994-3#1)(2008-5#1)
of the somatostatin##3##3##(1995-8#2)(2010-11#1)
of the sorbed##2##3##(2008-10#2)
of the sorbent##5##3##(2008-10#5)
of the sorghum##2##3##(2008-10#2)
of the sorption of##2##4##(2008-10#2)
of the sorption##5##3##(2008-10#5)
of the sort##2##3##(2008-4#1)(2008-9#1)
of the sound##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
of the source and##2##4##(2008-10#1)(2008-3#1)
of the source is##2##4##(2008-3#2)
of the source population##2##4##(2008-10#2)
of the source##24##3##(2006-4#1)(2007-11#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#9)(2011-1#1)(2012-2#1)
of the sources of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
of the sources##4##3##(1990-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
of the southern Ryukyus##2##4##(2010-3#2)
of the southern red tabira bitterling Acheilognathus tabira jordani##2##9##(2010-8#2)
of the southern red##3##4##(2010-8#2)(2013-1#1)
of the southern##11##3##(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-3#2)(2010-8#2)(2011-2#1)(2013-1#1)
of the soybean fields in##2##5##(2008-10#2)
of the soybean##4##3##(1996-12#1)(2008-10#3)
of the spa##2##3##(1992-11#1)(2008-4#1)
of the space##2##3##(2008-3#1)(2009-10#1)
of the space-charge field##2##4##(2007-11#2)
of the spacer##6##3##(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-3#1)
of the spatial and temporal##4##5##(2007-12#2)(2008-11#1)(2008-3#1)
of the spatial and##5##4##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)
of the spatial coherence##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the spatial distribution of##4##5##(1990-7#1)(2008-10#2)(2008-3#1)
of the spatial relationships among##2##5##(2007-5#1)(2008-9#1)
of the spatial resolution##2##4##(2008-2#1)(2011-1#1)
of the spatial##39##3##(1990-7#1)(1993-5#1)(2007-11#5)(2007-12#4)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#7)(2008-8#3)(2008-9#2)(2009-10#2)(2011-1#1)
of the spatially varying##2##4##(2008-3#1)(2013-1#1)
of the spatially##4##3##(2008-3#2)(2011-2#1)(2013-1#1)
of the spatiotemporal##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
of the special##4##3##(1993-3#1)(1996-3#1)(2008-4#1)(2008-8#1)
of the specialist##2##3##(1993-5#1)(2008-7#1)
of the specialized##2##3##(1992-6#1)(1995-6#1)
of the species and##3##4##(1994-9#1)(2008-5#1)(2012-3#1)
of the species are##3##4##(2008-11#1)(2008-8#1)(2010-8#1)
of the species examined##2##4##(1996-5#2)
of the species found##2##4##(2008-5#1)(2013-7#1)
of the species in the##3##5##(2008-10#2)(2008-5#1)
of the species in##5##4##(2008-10#3)(2008-5#1)(2012-5#1)
of the species is##3##4##(2008-5#1)(2013-7#2)
of the species of##2##4##(2008-10#1)(2013-7#1)
of the species studied##2##4##(2007-11#1)(2010-5#1)
of the species was##2##4##(2008-10#1)(2011-2#1)
of the species##61##3##(1990-8#1)(1994-9#1)(1995-6#1)(1996-5#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#8)(2008-6#1)(2008-8#4)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#2)(2012-5#1)(2013-7#4)
of the specific activity of the##2##6##(2008-10#1)(2008-4#1)
of the specific energy##3##4##(1990-11#1)(2008-7#2)
of the specific glucose##2##4##(1994-5#1)(2008-11#1)
of the specific microbe##2##4##(2011-2#2)
of the specific##44##3##(1990-11#1)(1992-9#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of the specificity of##2##4##(1991-9#1)(2009-4#1)
of the specimen##10##3##(1994-9#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
of the specimens were##2##4##(2013-7#2)
of the specimens##7##3##(2006-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-7#2)
of the speckle signal##2##4##(2008-3#2)
of the speckle##12##3##(2007-11#1)(2007-12#2)(2008-3#9)
of the speckles##2##3##(2008-2#2)
of the spectra of##4##4##(1992-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
of the spectra##11##3##(1992-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-8#1)(2010-2#1)
of the spectral and##2##4##(2008-10#1)(2008-3#1)
of the spectral bandwidth##3##4##(2008-3#3)
of the spectral distribution of the##2##6##(2008-2#2)
of the spectral distribution##3##4##(2008-2#2)(2008-3#1)
of the spectral features##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the spectral information##2##4##(2008-3#2)
of the spectral reflectance##3##4##(2008-2#2)(2008-3#1)
of the spectral response of##3##5##(2008-2#2)(2008-3#1)
of the spectral response##5##4##(2008-2#3)(2008-3#2)
of the spectral##48##3##(2007-11#1)(2007-12#4)(2008-10#7)(2008-2#14)(2008-3#18)(2008-8#1)(2013-8#3)
of the spectrometer with##2##4##(2008-10#1)(2008-3#1)
of the spectrometer##11##3##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)
of the spectrophotometer##2##3##(2008-10#1)(2008-3#1)
of the spectrophotometric##2##3##(2008-10#2)
of the spectroscopic##5##3##(2008-10#3)(2010-2#2)
of the spectrum and##2##4##(2007-12#1)(2008-3#1)
of the spectrum by##2##4##(2008-10#1)(2008-3#1)
of the spectrum is##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
of the spectrum of the##2##5##(2008-3#1)(2009-6#1)
of the spectrum of##6##4##(1990-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-2#1)
of the spectrum##42##3##(1990-5#3)(1995-5#1)(2007-11#4)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#10)(2008-7#1)(2009-6#1)(2011-2#3)(2012-2#1)(2013-8#2)
of the specular peak perpendicular to the principal plane##2##9##(2008-3#2)
of the speech##3##3##(2008-2#1)(2008-9#2)
of the speed of##3##4##(1993-12#1)(2008-2#1)(2008-3#1)
of the sperm##7##3##(1991-11#1)(1994-8#2)(2008-7#1)(2008-8#2)(2012-2#1)
of the spermathecal##3##3##(2008-5#2)(2008-8#1)
of the spermatic cord##3##4##(2008-10#1)(2008-6#2)
of the spermatozoa with##2##4##(2008-8#1)(2011-1#1)
of the spermatozoa##8##3##(2007-12#1)(2008-7#2)(2008-8#2)(2011-1#3)
of the spermatozoon##2##3##(2008-7#1)(2008-8#1)
of the sphenoid sinus##3##4##(2008-7#2)(2012-3#1)
of the sphenoid##7##3##(2008-10#3)(2008-7#3)(2012-3#1)
of the sphere##4##3##(2008-2#3)(2008-3#1)
of the spherical##2##3##(1996-5#1)(2008-2#1)
of the spheroidal functions##2##4##(2008-2#2)
of the spider##3##3##(1993-11#1)(2007-12#1)(2008-5#1)
of the spike AHP##2##4##(1992-3#2)
of the spike##9##3##(1992-3#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)
of the spiked amount##2##4##(2008-10#2)
of the spiked mercury(II)##2##4##(2008-10#2)
of the spiked##14##3##(2008-10#14)
of the spin##3##3##(1993-8#1)(2008-2#1)(2009-5#1)
of the spinach##2##3##(2008-10#2)
of the spinal arteriovenous malformation (AVM)##2##6##(2008-7#1)(2013-1#1)
of the spinal canal##3##4##(2007-11#1)(2007-8#2)
of the spinal column##2##4##(2007-11#1)(2007-8#1)
of the spinal cord and the##2##6##(1992-12#1)(2008-7#1)
of the spinal cord and##4##5##(1992-12#1)(2007-11#1)(2008-7#1)(2009-3#1)
of the spinal cord##24##4##(1990-5#1)(1990-7#2)(1991-6#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-9#1)(2007-10#2)(2007-11#1)(2008-5#2)(2008-7#7)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the spinal dorsal horn##2##5##(1997-2#2)
of the spinal##44##3##(1990-5#1)(1990-7#2)(1991-6#1)(1992-12#2)(1995-12#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(2007-10#2)(2007-11#3)(2007-8#4)(2008-5#2)(2008-7#10)(2008-9#1)(2009-3#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
of the spindle cell##2##4##(2008-10#1)(2011-2#1)
of the spindle##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
of the spine and##6##4##(1991-11#1)(2007-11#2)(2008-8#1)(2010-1#1)(2012-2#1)
of the spine in##2##4##(1990-12#1)(2011-2#1)
of the spine trauma##4##4##(2007-11#4)
of the spine##32##3##(1990-12#1)(1990-6#1)(1991-11#1)(1996-6#1)(2007-11#14)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-3#1)(2011-2#3)(2012-2#1)
of the spleen and##3##4##(1990-3#1)(1995-3#1)(2012-3#1)
of the spleen##14##3##(1990-3#1)(1992-5#1)(1993-9#1)(1994-9#1)(1995-3#1)(1997-3#1)(2008-11#2)(2008-7#2)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the splenic artery##2##4##(2008-7#1)(2011-2#1)
of the splenic##4##3##(1993-12#2)(2008-7#1)(2011-2#1)
of the splenocolic##2##3##(1990-3#2)
of the spliceosome by##2##4##(2008-2#2)
of the spliceosome##4##3##(1995-6#2)(2008-2#2)
of the split-step##3##3##(2008-3#3)
of the spontaneous Brillouin backscattered light##3##6##(2008-3#3)
of the spontaneous##11##3##(1990-3#1)(1992-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)
of the spontaneously##2##3##(1992-9#1)(1994-8#1)
of the spore##2##3##(2008-10#2)
of the spores were##2##4##(2008-10#2)
of the spores##6##3##(2008-10#5)(2011-2#1)
of the sporocysts##2##3##(1996-12#2)
of the sporophyte##2##3##(2009-6#1)(2013-7#1)
of the spot size##2##4##(2008-10#1)(2008-2#1)
of the spot##3##3##(2008-10#2)(2008-2#1)
of the spots##2##3##(2008-10#1)(2008-3#1)
of the spray##2##3##(1996-3#1)(2008-3#1)
of the spread of##5##4##(1996-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)
of the square wave##3##4##(2008-10#3)
of the square##6##3##(1997-7#1)(2008-10#4)(2008-3#1)
of the stability constant##3##4##(2008-10#3)
of the stability constants for##2##5##(2008-10#2)
of the stability constants of##2##5##(2008-10#2)
of the stability constants##4##4##(2008-10#4)
of the stability of the##2##5##(2008-10#2)
of the stability of##7##4##(2008-10#3)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)
of the stability##19##3##(1992-6#1)(2007-11#1)(2008-10#11)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)
of the stabilizing##2##3##(1992-6#1)(1997-4#1)
of the stable##7##3##(1991-11#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
of the stacked##2##3##(2008-10#1)(2008-2#1)
of the staff and##2##4##(1996-3#1)(2008-12#1)
of the staff##6##3##(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-12#1)(2013-1#1)
of the stage of##2##4##(1996-8#1)(2012-3#1)
of the stage##4##3##(1995-2#1)(1996-8#1)(2008-2#1)(2012-3#1)
of the stages##2##3##(2008-3#1)(2013-1#1)
of the staging##2##3##(1990-12#1)(2008-10#1)
of the stained##2##3##(2008-3#1)(2008-9#1)
of the staining##2##3##(2008-9#2)
of the standard additions method in flame atomic absorption spectrometry##2##10##(2008-10#2)
of the standard additions method##5##5##(2008-10#5)
of the standard curve##3##4##(2008-10#2)(2010-11#1)
of the standard logrank##2##4##(1997-3#2)
of the standard##41##3##(1990-11#1)(1990-5#1)(1995-9#1)(1996-8#1)(1997-3#3)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-11#2)(2011-1#1)(2012-3#1)(2013-1#1)
of the standardized##2##3##(2008-10#1)(2008-5#1)
of the standards##4##3##(1994-3#1)(1996-3#1)(2006-5#1)(2008-10#1)
of the standing##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
of the starch##3##3##(2007-11#1)(2008-8#1)(2009-8#1)
of the start of##2##4##(2008-3#1)(2008-9#1)
of the starting material##2##4##(1990-12#1)(2008-5#1)
of the starting##8##3##(1990-12#1)(1991-5#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)
of the startle response to##2##5##(2008-11#1)(2008-4#1)
of the startle response##3##4##(2008-11#1)(2008-4#2)
of the startle##4##3##(2008-11#2)(2008-4#2)
of the state of polarization##2##5##(2008-2#1)(2008-3#1)
of the state of the##4##5##(1990-8#1)(1991-11#1)(2008-10#1)(2008-7#1)
of the state of##10##4##(1990-8#1)(1991-11#1)(1991-2#1)(1993-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
of the state##21##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-2#1)(1996-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
of the state's##3##3##(1991-8#1)(1992-8#1)(2012-12#1)
of the states of##2##4##(1991-12#1)(2008-3#1)
of the static##4##3##(1993-9#1)(2008-2#1)(2008-6#1)(2013-8#1)
of the stationary phase and##2##5##(2008-10#1)(2008-7#1)
of the stationary phase##9##4##(2008-10#6)(2008-7#2)(2011-2#1)
of the stationary##11##3##(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)
of the statistic##4##3##(1992-6#1)(2008-10#2)(2013-8#1)
of the statistical##6##3##(2007-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-3#1)
of the status of the##4##5##(1994-2#1)(1995-3#1)(2007-7#1)(2009-12#1)
of the status of##5##4##(1994-2#1)(1995-3#1)(2007-7#1)(2008-7#1)(2009-12#1)
of the status##6##3##(1994-2#1)(1995-3#1)(2007-7#1)(2008-7#2)(2009-12#1)
of the statute##2##3##(1993-1#1)(1993-2#1)
of the statutory##2##3##(1992-12#1)(2008-10#1)
of the stay##2##3##(1992-12#2)
of the steady-state##7##3##(1993-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)
of the stem cell##4##4##(1992-12#1)(1994-11#1)(2008-11#1)(2012-2#1)
of the stem to##2##4##(2008-10#2)
of the stem##17##3##(1992-12#1)(1992-3#2)(1994-11#1)(2008-10#4)(2008-11#3)(2008-5#1)(2009-4#1)(2009-6#2)(2012-2#1)(2013-1#1)
of the stenosis##4##3##(2007-8#2)(2008-8#1)(2013-1#1)
of the stent##3##3##(1994-11#1)(2008-7#1)(2010-12#1)
of the steps##5##3##(1993-2#1)(1995-9#1)(2008-1#1)(2010-1#1)(2011-1#1)
of the sternum (pectus##2##4##(2012-2#2)
of the sternum##4##3##(2007-8#2)(2012-2#2)
of the sternum?##2##3##(2007-8#2)
of the steroid binding##2##4##(1990-12#1)(1991-12#1)
of the steroid##11##3##(1990-11#2)(1990-12#1)(1991-12#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-2#1)
of the steroids tested##2##4##(1990-11#1)(1994-9#1)
of the sterols##2##3##(1997-2#2)
of the stick insect##2##4##(2007-12#2)
of the stigma and##2##4##(2008-10#1)(2010-8#1)
of the stigma##3##3##(2008-10#2)(2010-8#1)
of the stimulant##2##3##(1992-3#1)(2008-7#1)
of the stimulated Raman gain##2##5##(2007-11#2)
of the stimulated##3##3##(2007-11#2)(2008-2#1)
of the stimulated-emission cross section in an end-pumped solid-state laser##2##10##(2007-11#2)
of the stimulation##5##3##(1994-9#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-10#1)
of the stimulatory##2##3##(1990-12#1)(1994-2#1)
of the stimuli##8##3##(1992-11#1)(1992-6#1)(1993-3#1)(1994-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-8#1)
of the stimulus##7##3##(1992-6#1)(1993-12#1)(1996-2#1)(2007-12#1)(2007-9#2)(2008-11#1)
of the stir bar##2##4##(2008-10#2)
of the stoichiometric##2##3##(2008-10#2)
of the stoichiometry of##2##4##(1995-6#1)(2008-10#1)
of the stomach with##3##4##(1991-8#1)(1992-6#1)(2008-1#1)
of the stomach##39##3##(1990-9#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-9#2)(1997-1#2)(2007-5#1)(2008-1#1)(2008-12#2)(2008-5#3)(2008-7#9)(2009-3#3)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
of the stomach]##2##3##(1990-6#1)(1991-11#1)
of the stones##2##3##(2011-2#1)(2013-7#1)
of the stop##2##3##(2008-2#1)(2008-3#1)
of the storage##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
of the straight line##2##4##(2008-10#2)
of the straight##5##3##(1996-6#1)(2008-10#3)(2009-6#1)
of the strain##8##3##(1996-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)
of the strains produced##2##4##(2008-10#2)
of the strains that##2##4##(2008-10#2)
of the strains were##6##4##(2008-10#3)(2008-12#1)(2010-8#1)(2011-2#1)
of the strains##30##3##(1991-3#1)(1996-12#1)(1997-9#1)(2007-6#1)(2008-10#19)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#2)(2010-8#1)(2011-2#1)
of the strategic plan##3##4##(1992-3#3)
of the strategic##6##3##(1992-3#3)(1994-2#1)(1997-1#1)(2008-4#1)
of the strategies##6##3##(1991-12#1)(1992-1#1)(1997-7#1)(2007-10#1)(2008-10#1)(2010-11#1)
of the strategy##7##3##(1992-1#1)(1992-6#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the stratospheric aerosol layer##2##5##(2008-2#2)
of the stratospheric aerosol##3##4##(2008-2#3)
of the stratum corneum (SC)##3##5##(2008-10#1)(2008-5#2)
of the stratum corneum cell matrix postulates##2##7##(2008-5#2)
of the stratum corneum lipids##4##5##(2008-5#4)
of the stratum corneum of##2##5##(2008-5#2)
of the stratum corneum##42##4##(2008-10#1)(2008-5#40)(2010-8#1)
of the straw pretreated by CTSR with##2##7##(2013-1#2)
of the strawberry##2##3##(2008-10#2)
of the stream##2##3##(1995-3#1)(2009-8#1)
of the streams##3##3##(2008-10#3)
of the strength of##3##4##(2008-7#1)(2008-8#1)(2010-4#1)
of the strength##4##3##(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
of the strengths##2##3##(1991-1#1)(2013-1#1)
of the streptavidin##2##3##(2008-7#1)(2009-12#1)
of the stress and##2##4##(1995-1#1)(2013-7#1)
of the stress reaction##2##4##(2008-5#2)
of the stress##20##3##(1994-2#1)(1995-1#1)(1996-4#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-7#2)
of the stress-induced##2##3##(1994-2#2)
of the stress-related##2##3##(2009-8#1)(2012-1#1)
of the stress-responsive##2##3##(1996-2#1)(2009-10#1)
of the stressful##2##3##(2008-11#1)(2012-3#1)
of the stressor##3##3##(2008-11#2)(2008-4#1)
of the stressosome##2##3##(2009-8#2)
of the stretch##2##3##(1993-9#1)(2008-8#1)
of the striatum##3##3##(1997-3#2)(2013-8#1)
of the stroke##4##3##(1995-5#1)(2007-10#1)(2010-12#1)(2011-1#1)
of the stromal##2##3##(2007-11#1)(2011-1#1)
of the strong##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
of the strongly##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
of the structural##16##3##(1991-12#1)(1991-6#1)(1992-6#1)(1996-9#1)(1997-4#1)(2007-11#2)(2008-10#4)(2008-3#2)(2008-4#1)(2008-8#2)
of the structurally related##2##4##(1993-11#1)(2008-10#1)
of the structurally##6##3##(1993-11#1)(1993-2#1)(1995-3#1)(2008-10#1)(2009-7#1)(2010-4#1)
of the structure and##9##4##(1991-5#1)(1992-12#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)(2013-1#1)
of the structure is##4##4##(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
of the structure of a##2##5##(1992-9#1)(1997-3#1)
of the structure of the##8##5##(1990-12#1)(1991-5#1)(1994-11#1)(1996-12#1)(2008-6#1)(2010-4#1)(2010-8#1)(2013-1#1)
of the structure of##18##4##(1990-12#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2013-1#2)
of the structure##50##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-5#2)(1991-6#2)(1992-12#3)(1992-4#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2013-1#3)
of the structure-activity relationships##3##4##(1991-3#1)(2008-11#1)(2008-4#1)
of the structured##2##3##(2008-11#1)(2008-7#1)
of the structures##7##3##(1990-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
of the student##4##3##(2008-11#3)(2008-12#1)
of the students and##3##4##(2008-11#1)(2013-8#2)
of the students had##4##4##(1992-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
of the students reported##2##4##(1991-9#1)(2013-8#1)
of the students would##2##4##(1993-3#2)
of the students##21##3##(1991-9#1)(1992-6#4)(1993-3#4)(2008-11#3)(2009-5#1)(2013-1#1)(2013-8#7)
of the students' perceptions##2##4##(2009-7#1)(2012-3#1)
of the students'##3##3##(2008-11#1)(2009-7#1)(2012-3#1)
of the studied cases##3##4##(1993-2#1)(2008-11#1)(2011-2#1)
of the studied drug##2##4##(2008-10#2)
of the studied drugs##4##4##(2008-10#4)
of the studied dyes##2##4##(2008-10#2)
of the studied films##2##4##(2007-12#1)(2008-3#1)
of the studied patients##2##4##(1990-6#1)(2013-1#1)
of the studied##42##3##(1990-6#1)(1993-2#1)(1994-2#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-2#2)(2011-2#1)(2013-1#1)(2013-8#1)
of the studies are##2##4##(2008-12#1)(2011-2#1)
of the studies is##2##4##(2011-1#1)(2011-2#1)
of the studies##34##3##(1990-6#1)(1992-11#2)(1992-3#2)(1994-2#1)(1994-6#1)(1995-2#1)(1996-9#3)(1997-1#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#3)
of the study and##5##4##(1992-5#1)(2007-5#1)(2008-12#1)(2009-11#1)(2011-2#1)
of the study are##3##4##(2007-10#1)(2008-11#1)(2013-1#1)
of the study area##2##4##(2008-12#2)
of the study for##2##4##(2008-10#1)(2008-7#1)
of the study in##3##4##(2008-5#1)(2010-11#1)(2010-9#1)
of the study indicate that##2##5##(1996-1#1)(2008-12#1)
of the study indicated that##2##5##(2007-10#1)(2008-1#1)
of the study is to evaluate the risk of##2##9##(2007-11#1)(2011-2#1)
of the study is to evaluate the##3##7##(2007-11#1)(2011-2#2)
of the study is to examine##2##6##(2010-9#1)(2011-1#1)
of the study is to present##2##6##(1997-3#1)(2007-8#1)
of the study is to##17##5##(1993-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#2)
of the study is##23##4##(1993-3#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#3)(2013-1#2)(2013-8#1)
of the study of##6##4##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-1#1)
of the study participants##3##4##(2008-12#1)(2010-7#1)(2013-1#1)
of the study patients were##2##5##(2007-7#1)(2008-1#1)
of the study patients##6##4##(2007-7#1)(2008-1#4)(2013-1#1)
of the study period##6##4##(2006-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#2)
of the study population##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
of the study results##2##4##(1992-12#1)(2007-8#1)
of the study showed that##5##5##(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the study showed##7##4##(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the study subjects and the##2##6##(1990-8#1)(2011-2#1)
of the study subjects with##2##5##(1994-2#1)(2013-1#1)
of the study subjects##5##4##(1990-8#1)(1994-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
of the study was the assessment of the##2##8##(2007-11#1)(2012-2#1)
of the study was the assessment of##3##7##(2007-11#2)(2012-2#1)
of the study was the##8##5##(1994-7#1)(2007-11#3)(2007-8#1)(2008-12#1)(2008-5#1)(2012-2#1)
of the study was to analyze##3##6##(2007-8#1)(2008-12#1)(2012-3#1)
of the study was to assess the##3##7##(2008-5#1)(2008-7#1)(2012-3#1)
of the study was to assess##4##6##(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the study was to compare the##5##7##(1997-8#1)(2011-2#1)(2013-1#3)
of the study was to compare##10##6##(1990-2#1)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#4)
of the study was to determine the changes in##2##9##(2011-1#1)(2012-2#1)
of the study was to determine the##6##7##(2007-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
of the study was to determine##11##6##(1990-8#1)(1994-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
of the study was to evaluate the##8##7##(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2013-1#1)
of the study was to evaluate##14##6##(1996-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
of the study was to examine##4##6##(2008-11#2)(2009-5#1)(2011-2#1)
of the study was to identify the##3##7##(1996-12#1)(2009-7#1)(2010-1#1)
of the study was to identify##4##6##(1996-12#1)(2009-7#1)(2010-1#1)(2013-1#1)
of the study was to investigate##6##6##(1994-6#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)
of the study was to##84##5##(1990-2#2)(1990-8#1)(1991-12#1)(1991-5#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#5)(2008-12#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#3)
of the study was##99##4##(1990-2#2)(1990-8#1)(1991-12#1)(1991-5#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-6#1)(1994-7#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#5)(2008-12#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#3)
of the study were##13##4##(1990-10#2)(1991-1#1)(1992-12#1)(1992-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-1#1)(2012-3#2)
of the study##318##3##(1990-10#2)(1990-2#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#4)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-10#8)(2007-11#12)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#6)(2007-8#9)(2008-1#12)(2008-10#20)(2008-11#14)(2008-12#12)(2008-3#3)(2008-4#1)(2008-5#14)(2008-6#3)(2008-7#16)(2008-8#3)(2008-9#30)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-10#2)(2010-11#3)(2010-3#4)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#12)(2013-1#15)(2013-8#6)
of the study's##2##3##(1995-1#1)(2012-3#1)
of the stump and##2##4##(1991-6#1)(2007-11#1)
of the subarachnoid##2##3##(2008-7#2)
of the subclavian artery##3##4##(1993-3#1)(2008-7#2)
of the subclavian##4##3##(1993-3#1)(2008-7#3)
of the subcutaneous tissue##2##4##(2008-5#1)(2008-9#1)
of the subcutaneous##5##3##(1997-4#1)(2006-10#1)(2008-5#2)(2008-9#1)
of the subepithelial##2##3##(2009-8#1)(2013-1#1)
of the subesophageal ganglion##3##4##(2008-5#2)(2008-9#1)
of the subgroup##2##3##(1994-12#1)(2008-4#1)
of the subject##13##3##(1991-1#1)(1991-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-1#1)(2013-1#2)
of the subject's##4##3##(2008-11#1)(2009-11#1)(2011-2#1)(2013-8#1)
of the subjects had##2##4##(2008-6#1)(2008-7#1)
of the subjects were##5##4##(1991-2#1)(1995-11#1)(1996-5#1)(2008-12#1)(2013-1#1)
of the subjects##34##3##(1990-10#3)(1990-3#1)(1991-2#3)(1991-3#1)(1995-11#2)(1996-5#1)(2006-8#2)(2008-1#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#3)(2009-10#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the submandibular gland##3##4##(2008-8#1)(2011-1#1)(2011-2#1)
of the submandibular##4##3##(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
of the submucosal##3##3##(1992-2#1)(1993-9#1)(2008-12#1)
of the subscapularis##2##3##(2012-12#2)
of the subsequent##8##3##(1990-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-4#1)
of the substance##3##3##(1990-6#1)(1995-1#1)(2008-5#1)
of the substances##7##3##(1994-12#1)(1995-2#1)(1997-2#1)(2008-10#2)(2010-8#1)(2013-1#1)
of the substantia nigra pars compacta##2##6##(1996-12#2)
of the substantia nigra pars##3##5##(1996-12#2)(2008-12#1)
of the substantia nigra##6##4##(1990-5#1)(1996-12#4)(2008-12#1)
of the substituent##2##3##(2007-11#1)(2008-10#1)
of the substituents##3##3##(1996-2#1)(1997-7#1)(2009-7#1)
of the substitutions was##2##4##(1990-12#1)(2013-1#1)
of the substrate and##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
of the substrate between##2##4##(1990-5#2)
of the substrate in##5##4##(1990-5#1)(1994-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
of the substrate is##2##4##(1992-6#1)(2008-2#1)
of the substrate specificity##2##4##(1990-5#1)(2008-7#1)
of the substrate to##2##4##(2008-3#1)(2008-6#1)
of the substrate##55##3##(1990-5#5)(1990-8#2)(1991-5#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
of the substrate's##2##3##(1996-2#1)(2008-3#1)
of the substrate-binding##2##3##(1995-3#1)(2008-6#1)
of the substrates##11##3##(1990-7#2)(1991-3#1)(1993-6#1)(1994-5#3)(2008-10#3)(2008-3#1)
of the subsynovial connective tissue##2##5##(2008-9#2)
of the subtelomeric##2##3##(1997-6#1)(2009-10#1)
of the subthalamic nucleus##2##4##(2008-2#1)(2012-2#1)
of the subthalamo-pallidal complex in Parkinson's disease during deep brain stimulation##2##11##(2009-8#2)
of the subunit##3##3##(1991-12#1)(1992-8#1)(2009-11#1)
of the subunits##5##3##(1992-3#2)(2008-2#1)(2008-9#2)
of the success of##2##4##(1994-9#1)(2008-11#1)
of the success##4##3##(1994-9#1)(2008-11#1)(2010-11#1)(2012-3#1)
of the successful use of##2##5##(1990-8#1)(2007-8#1)
of the successful##4##3##(1990-8#1)(2007-8#1)(2008-6#1)(2011-2#1)
of the sucrose##2##3##(2008-10#2)
of the sudden infant death syndrome (SIDS)##2##7##(1991-11#1)(1992-11#1)
of the sudden##3##3##(1991-11#1)(1992-11#2)
of the sugar beet##2##4##(2008-10#1)(2008-12#1)
of the sugar chains of##2##5##(1993-11#1)(2008-4#1)
of the sugar moiety##2##4##(1992-6#1)(2008-4#1)
of the sugar##11##3##(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)
of the sugars##2##3##(2008-10#2)
of the suggested method##2##4##(2008-10#1)(2008-2#1)
of the suicidal##3##3##(2010-6#3)
of the sulfate##3##3##(1992-12#1)(2008-10#2)
of the sulfhydryl##2##3##(1992-12#1)(1995-6#1)
of the sulfur##3##3##(1995-3#1)(2008-10#1)(2010-11#1)
of the sun and##3##4##(1994-3#2)(2008-3#1)
of the sun##6##3##(1991-6#1)(1994-3#2)(2008-3#1)(2011-2#2)
of the sunlight##2##3##(2008-5#1)(2011-2#1)
of the super##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
of the supercontinuum##3##3##(2007-11#3)
of the superfamily of##4##4##(1992-11#1)(1995-12#1)(2008-1#1)(2008-11#1)
of the superficial##5##3##(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
of the superior ankle joint##2##5##(2007-8#2)
of the superior colliculus##3##4##(1991-5#2)(1993-3#1)
of the superior laryngeal nerve##2##5##(1993-12#1)(1996-5#1)
of the superior mesenteric artery##6##5##(1991-5#1)(2007-5#1)(2013-1#4)
of the superior##22##3##(1991-5#3)(1991-6#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2007-5#1)(2007-8#2)(2008-12#1)(2011-2#1)(2013-1#4)
of the supernatant##4##3##(1991-5#1)(1995-6#1)(2008-10#2)
of the superoxide anion##3##4##(1990-5#2)(2008-11#1)
of the supplements##2##3##(2008-3#1)(2011-1#1)
of the support##6##3##(1990-2#1)(2007-6#1)(2008-11#1)(2009-12#1)(2010-6#1)(2010-8#1)
of the supporting electrolyte##4##4##(2008-10#4)
of the supporting##7##3##(1994-12#1)(2008-10#6)
of the suppressive##2##3##(2008-10#1)(2008-4#1)
of the surface and##2##4##(2008-3#1)(2008-5#1)
of the surface components##2##4##(1991-12#2)
of the surface flux##2##4##(2008-10#1)(2008-2#1)
of the surface is##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
of the surface of a##3##5##(2008-3#1)(2008-4#1)(2008-7#1)
of the surface of the##4##5##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
of the surface of##7##4##(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)
of the surface velocity of debris flow##2##7##(2008-2#1)(2008-3#1)
of the surface with##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
of the surface##73##3##(1990-12#1)(1991-12#2)(1994-3#1)(1994-6#2)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#5)(2008-10#14)(2008-11#2)(2008-2#7)(2008-3#21)(2008-4#4)(2008-5#4)(2008-7#3)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
of the surfaces of the##2##5##(2008-3#2)
of the surfaces of##3##4##(2008-3#2)(2010-8#1)
of the surfaces##6##3##(2008-3#3)(2008-6#1)(2008-7#1)(2010-8#1)
of the surfactant and##2##4##(2008-10#1)(2009-12#1)
of the surfactant##15##3##(1990-11#1)(1994-9#1)(1996-5#2)(1997-1#1)(2008-10#6)(2008-5#2)(2008-7#1)(2009-12#1)
of the surfactants and##3##4##(2008-10#2)(2012-2#1)
of the surfactants##9##3##(1996-5#2)(2008-10#3)(2008-5#3)(2012-2#1)
of the surgeon##7##3##(1996-12#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-8#2)(2011-1#1)
of the surgery in##2##4##(1990-9#1)(2008-10#1)
of the surgery##6##3##(1990-9#1)(2008-10#1)(2008-7#1)(2012-12#2)(2013-1#1)
of the surgical procedure##4##4##(2007-11#1)(2008-8#3)
of the surgical procedures##2##4##(2007-11#1)(2012-12#1)
of the surgical specimen revealed##2##5##(2011-2#1)(2013-1#1)
of the surgical specimen##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
of the surgical techniques##2##4##(1990-6#1)(1992-9#1)
of the surgical treatment of##2##5##(1990-3#1)(1990-9#1)
of the surgical treatment##4##4##(1990-3#1)(1990-9#1)(1992-9#1)(2012-12#1)
of the surgical##29##3##(1990-3#1)(1990-6#1)(1990-9#1)(1992-3#1)(1992-9#2)(1993-9#1)(1995-4#1)(1996-1#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
of the surgically##2##3##(1990-6#1)(1992-9#1)
of the surrounding environment##2##4##(1993-3#1)(2010-10#1)
of the surrounding fluid##2##4##(2007-11#1)(2011-1#1)
of the surrounding medium##2##4##(2008-2#1)(2008-3#1)
of the surrounding##12##3##(1993-1#1)(1993-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
of the surveillance##2##3##(1996-11#1)(2011-2#1)
of the survey were##3##4##(1991-12#1)(1996-1#1)(2008-10#1)
of the survey##23##3##(1990-3#4)(1991-12#1)(1991-2#1)(1991-5#1)(1994-1#1)(1995-12#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2009-2#1)(2012-2#1)(2013-1#2)
of the surveyed##2##3##(2007-11#1)(2013-1#1)
of the survival curve##3##4##(1995-3#3)
of the survival##6##3##(1995-3#3)(2008-1#1)(2008-10#1)(2008-11#1)
of the surviving##2##3##(1993-11#1)(2008-9#1)
of the survivors##2##3##(1993-11#1)(1995-5#1)
of the susceptibility##2##3##(2007-12#1)(2008-12#1)
of the susceptible potato##2##4##(2008-10#2)
of the susceptible##8##3##(2008-10#8)
of the suspended##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2009-7#1)
of the suspension##3##3##(2007-12#1)(2008-10#2)
of the switch##2##3##(2008-3#1)(2011-2#1)
of the switching##2##3##(2007-11#1)(2008-7#1)
of the swollen##2##3##(2008-5#1)(2009-5#1)
of the symmetric##2##3##(2008-10#2)
of the symmetry of##2##4##(2007-11#1)(2008-3#1)
of the symmetry##3##3##(2007-11#2)(2008-3#1)
of the sympathetic and##2##4##(2007-8#1)(2008-10#1)
of the sympathetic nervous system##3##5##(1991-2#1)(1997-2#1)(2012-2#1)
of the sympathetic nervous##4##4##(1991-2#1)(1997-2#1)(2008-5#1)(2012-2#1)
of the sympathetic##7##3##(1991-2#1)(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
of the symphysis pubis##2##4##(1994-3#1)(2012-12#1)
of the symposium##2##3##(2008-10#1)(2008-5#1)
of the symptom##5##3##(1991-11#1)(2008-5#1)(2011-2#3)
of the symptoms and##4##4##(1991-12#1)(2008-7#1)(2010-3#1)(2011-2#1)
of the symptoms of##3##4##(2007-11#1)(2012-2#2)
of the symptoms##29##3##(1990-11#1)(1991-11#1)(1991-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-7#2)(2009-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of the synapse##2##3##(2008-7#1)(2009-11#1)
of the synapses##2##3##(1995-12#1)(2008-7#1)
of the synapsins##2##3##(1994-8#2)
of the synaptic##3##3##(2008-1#1)(2008-11#1)(2012-12#1)
of the synchronized##2##3##(2007-11#1)(2008-11#1)
of the synchrotron##2##3##(2008-3#1)(2008-4#1)
of the syndrome and##3##4##(1990-2#1)(2007-11#1)(2008-1#1)
of the syndrome of##2##4##(1995-5#1)(2011-1#1)
of the syndrome##18##3##(1990-2#3)(1991-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of the synergid##2##3##(2008-11#1)(2009-8#1)
of the synovial membrane and##2##5##(1996-6#1)(2009-3#1)
of the synovial membrane##3##4##(1992-4#1)(1996-6#1)(2009-3#1)
of the synovial##4##3##(1992-4#1)(1996-6#1)(2009-3#1)(2011-2#1)
of the synthesis are##2##4##(2008-3#1)(2009-11#1)
of the synthesis matrix##2##4##(2007-12#2)
of the synthesis of the##2##5##(1991-10#1)(1992-3#1)
of the synthesis of##7##4##(1990-2#1)(1991-10#1)(1992-12#1)(1992-3#1)(1997-3#1)(2008-4#1)(2008-7#1)
of the synthesis##14##3##(1990-2#1)(1991-10#1)(1992-12#1)(1992-3#1)(1997-3#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)
of the synthesized compounds##3##4##(2007-11#1)(2012-2#1)(2012-3#1)
of the synthesized proteins##2##4##(1993-2#1)(2008-1#1)
of the synthesized##16##3##(1993-2#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-6#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
of the synthetic glucocorticoid##2##4##(1991-5#1)(1995-8#1)
of the synthetic##17##3##(1991-5#1)(1992-6#1)(1992-8#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-3#1)
of the syrB gene##3##4##(2008-10#3)
of the system and the##4##5##(1996-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
of the system and to##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
of the system and##14##4##(1994-12#1)(1996-1#1)(1996-3#1)(2008-10#3)(2008-2#3)(2008-3#3)(2010-12#1)(2012-3#1)
of the system are##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
of the system as a##2##5##(2008-10#1)(2012-2#1)
of the system as well as##3##6##(2007-11#1)(2008-10#1)(2010-4#1)
of the system as##6##4##(1991-2#1)(2007-11#1)(2008-10#2)(2010-4#1)(2012-2#1)
of the system by##2##4##(2008-10#1)(2008-3#1)
of the system can be##2##5##(2008-10#1)(2008-3#1)
of the system can##3##4##(2008-10#2)(2008-3#1)
of the system compared##2##4##(2008-3#1)(2008-9#1)
of the system for the##2##5##(2008-5#2)
of the system for##7##4##(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)
of the system from the##2##5##(2008-2#1)(2011-2#1)
of the system have##2##4##(2008-10#1)(2008-3#1)
of the system is 3##2##5##(2008-3#2)
of the system is set by the##2##7##(2008-3#2)
of the system is##28##4##(2007-11#2)(2007-12#5)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#6)(2008-8#1)
of the system of##3##4##(1996-2#1)(2007-12#1)(2012-3#1)
of the system to##7##4##(1992-12#2)(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
of the system was ascertained by analyzing a set of##2##10##(2008-10#2)
of the system was##18##4##(1994-1#1)(1997-1#1)(2008-10#14)(2008-2#1)(2013-8#1)
of the system were optimized##3##5##(2008-10#3)
of the system were##8##4##(1992-12#1)(2008-10#6)(2008-12#1)
of the system will be discussed##2##6##(2008-10#1)(2008-2#1)
of the system will##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
of the system with##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
of the system without##2##4##(2008-10#2)
of the system##210##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#5)(2007-12#9)(2007-5#1)(2007-8#2)(2008-10#63)(2008-11#7)(2008-12#2)(2008-2#22)(2008-3#35)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#4)(2013-8#2)
of the system's##5##3##(1991-12#1)(2008-10#2)(2008-2#1)(2013-1#1)
of the systematic error##2##4##(2007-12#1)(2008-10#1)
of the systematic errors##3##4##(1990-8#1)(2008-3#2)
of the systematic##8##3##(1990-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)
of the systemic##3##3##(2008-10#2)(2010-11#1)
of the systems to##2##4##(2008-10#1)(2008-2#1)
of the systems were##2##4##(2008-10#1)(2008-8#1)
of the systems##14##3##(1991-1#1)(1994-3#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)
of the t(2g) orbitals##2##4##(1997-7#2)
of the t(2g)##3##3##(1997-7#3)
of the tablets##2##3##(2008-10#2)
of the tactile##3##3##(1997-2#1)(2008-5#2)
of the tagged gene##2##4##(1997-8#2)
of the tagged##5##3##(1997-8#3)(2007-11#1)(2007-12#1)
of the tail domain of##2##5##(1990-11#1)(2009-7#1)
of the tail##5##3##(1990-11#1)(1995-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
of the talus##7##3##(2008-12#1)(2009-1#1)(2009-5#1)(2010-5#3)(2012-2#1)
of the tandem##2##3##(1992-11#2)
of the tapered##2##3##(2008-3#2)
of the target and##2##4##(2008-3#1)(2008-7#1)
of the target area##2##4##(1994-8#1)(2008-10#1)
of the target cell##2##4##(2008-11#2)
of the target cells##2##4##(1990-12#1)(2008-4#1)
of the target compounds in##2##5##(2007-11#1)(2013-1#1)
of the target compounds##6##4##(2007-11#1)(2008-10#4)(2013-1#1)
of the target molecule##2##4##(2008-6#1)(2009-10#1)
of the target population##4##4##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
of the target protein##4##4##(2008-11#1)(2008-2#2)(2008-4#1)
of the target sequence##2##4##(1994-12#1)(2008-2#1)
of the target species##4##4##(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the target##67##3##(1990-11#1)(1990-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#6)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#3)(2009-7#1)(2011-1#2)(2012-1#1)(2012-12#2)(2013-1#3)
of the target's##2##3##(2008-3#1)(2010-7#1)
of the targeted##6##3##(1995-6#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-12#1)
of the targets##6##3##(1991-5#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
of the task##16##3##(1991-2#1)(1994-1#1)(1994-3#1)(2007-6#2)(2008-10#2)(2008-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
of the tasks##4##3##(1992-11#1)(1993-12#1)(2008-4#1)(2011-2#1)
of the tau##2##3##(1995-2#1)(2008-9#1)
of the taxa##2##3##(2008-10#1)(2010-3#1)
of the teaching##2##3##(2008-12#2)
of the team##9##3##(1991-2#1)(1992-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(2007-5#1)(2008-10#1)(2009-6#1)(2010-11#1)
of the tear##2##3##(2009-4#1)(2013-8#1)
of the technical##4##3##(1997-8#1)(2008-7#1)(2010-9#1)(2013-1#1)
of the technique and##8##4##(1990-10#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-7#1)
of the technique are##6##4##(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-1#1)
of the technique by##3##4##(2007-12#2)(2008-3#1)
of the technique for##3##4##(2008-2#1)(2008-3#1)(2009-12#1)
of the technique in the##2##5##(2007-8#1)(2013-8#1)
of the technique in##3##4##(2007-8#1)(2008-2#1)(2013-8#1)
of the technique is discussed##2##5##(2007-12#1)(2008-3#1)
of the technique is##12##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#6)(2009-5#1)
of the technique of##2##4##(2007-12#1)(2008-9#1)
of the technique to##4##4##(2008-3#3)(2008-4#1)
of the technique was##6##4##(1991-2#1)(1991-5#1)(2007-11#1)(2008-10#2)(2008-2#1)
of the technique##73##3##(1990-10#1)(1991-2#1)(1991-5#1)(1995-11#1)(1997-2#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-2#8)(2008-3#22)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
of the techniques and##3##4##(2008-11#1)(2008-4#1)(2009-4#1)
of the techniques are##2##4##(2008-10#1)(2008-7#1)
of the techniques that##2##4##(1995-5#1)(2008-9#1)
of the techniques##15##3##(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2011-2#1)
of the technologies##2##3##(2008-11#1)(2011-1#1)
of the technology to##2##4##(2008-9#2)
of the technology##8##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)
of the teeth and##2##4##(1995-9#1)(2013-8#1)
of the teeth##8##3##(1995-9#1)(1997-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the telencephalon##3##3##(1994-3#2)(1995-12#1)
of the teleomorph##2##3##(2008-10#2)
of the teleost##2##3##(1995-2#1)(2008-7#1)
of the telescope##5##3##(1991-2#1)(2008-3#4)
of the temperature and pH##2##5##(2008-10#2)
of the temperature and##5##4##(2007-11#1)(2008-10#2)(2008-2#1)(2011-1#1)
of the temperature dependence of the##3##6##(2007-12#1)(2008-3#2)
of the temperature dependence of##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of the temperature distribution##2##4##(2008-3#1)(2008-7#1)
of the temperature##25##3##(1995-2#2)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#1)(2011-1#1)
of the temperature-dependent##3##3##(2008-3#2)(2013-8#1)
of the template##3##3##(1994-8#1)(2008-10#1)(2008-8#1)
of the temporal and##2##4##(2007-11#1)(2007-12#1)
of the temporal bone are##2##5##(2006-12#1)(2011-2#1)
of the temporal bone##8##4##(2006-12#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)
of the temporal evolution of the##2##6##(2007-12#1)(2008-2#1)
of the temporal lobe##4##4##(1991-12#1)(2008-4#1)(2011-2#2)
of the temporal profiles##2##4##(1994-3#1)(2007-11#1)
of the temporal##33##3##(1991-12#1)(1993-12#1)(1993-5#2)(1994-3#1)(1994-9#1)(1997-8#1)(2006-12#3)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)(2011-2#4)
of the temporo-mandibular joint##3##4##(2011-2#3)
of the ten##7##3##(1990-2#1)(1992-8#1)(1995-12#1)(1996-2#1)(2008-5#1)(2008-7#1)(2013-7#1)
of the tennis serve##2##4##(2011-2#2)
of the tension##2##3##(1991-12#1)(2012-2#1)
of the tensor##2##3##(2007-11#1)(2008-5#1)
of the term##2##3##(1993-2#1)(2008-11#1)
of the terminal CN groups##2##5##(2008-10#2)
of the terminal##15##3##(1990-11#1)(1990-9#1)(1993-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-9#1)
of the terminally##2##3##(1990-10#1)(2008-5#1)
of the termite##2##3##(2007-12#1)(2011-2#1)
of the terms##4##3##(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
of the ternary complex##4##4##(1993-8#1)(1995-5#1)(2008-10#2)
of the ternary##9##3##(1993-8#1)(1995-5#1)(2008-10#5)(2008-2#1)(2009-11#1)
of the terpenoids##2##3##(1990-11#1)(2008-10#1)
of the terrestrial##4##3##(1990-5#1)(2008-3#1)(2008-6#1)(2008-7#1)
of the territory##2##3##(2008-8#2)
of the test sample##2##4##(2008-10#1)(2008-9#1)
of the test samples##3##4##(2008-10#2)(2008-4#1)
of the test specimen##2##4##(2008-10#2)
of the test with##2##4##(1992-9#1)(1996-3#1)
of the test##55##3##(1990-6#1)(1991-12#4)(1992-9#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the tested samples##2##4##(1997-4#1)(2008-10#1)
of the tested substances##2##4##(2008-10#1)(2008-5#1)
of the tested##25##3##(1995-12#2)(1996-7#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the testicular##2##3##(2008-10#1)(2009-11#1)
of the testing##6##3##(1990-11#1)(1994-2#1)(1996-6#1)(2008-3#1)(2008-5#1)(2008-7#1)
of the testis and##2##4##(2008-10#1)(2008-7#1)
of the testis is a rare##2##6##(2007-8#1)(2011-2#1)
of the testis##14##3##(1991-6#1)(1992-6#1)(1994-11#1)(1995-3#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
of the tests##10##3##(1990-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
of the tetracycline##3##3##(1994-12#1)(2008-10#2)
of the tetrapeptide Pro-D-Phe-Pro-Gly in##2##5##(1991-5#2)
of the tetrapeptide##3##3##(1991-5#2)(1997-3#1)
of the tetrapyrrole##4##3##(1991-5#1)(1995-3#1)(2011-1#2)
of the text##3##3##(2008-10#2)(2010-8#1)
of the thalassaemia patients##2##4##(2013-8#2)
of the the##3##3##(1990-5#1)(2007-12#1)(2008-7#1)
of the theoretical value##2##4##(1994-3#1)(2008-3#1)
of the theoretical##15##3##(1991-12#1)(1993-3#1)(1994-3#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
of the theory is##2##4##(1991-1#1)(2008-2#1)
of the theory of##4##4##(2008-3#2)(2008-8#1)(2012-3#1)
of the theory##15##3##(1991-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#3)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the theory-practice gap##2##4##(2008-11#2)
of the therapeutic##11##3##(1990-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the therapeutical##2##3##(1995-12#1)(2012-7#1)
of the therapy is##2##4##(1991-12#1)(1997-3#1)
of the therapy##10##3##(1991-12#1)(1991-2#1)(1992-12#1)(1994-2#1)(1997-3#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
of the thermal characteristics of##3##5##(2007-8#1)(2008-2#1)(2008-3#1)
of the thermal lens was##2##5##(2008-2#2)
of the thermal lens##7##4##(2008-2#3)(2008-3#4)
of the thermal##24##3##(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-8#2)(2011-1#1)(2011-2#2)(2012-6#1)
of the thermally induced##2##4##(2008-2#1)(2008-3#1)
of the thermally##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the thermodynamic parameters##2##4##(1990-7#1)(1993-8#1)
of the thermodynamic##10##3##(1990-7#1)(1993-8#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-4#1)
of the theta##2##3##(2008-11#2)
of the thickness of the##3##5##(1991-5#1)(1994-3#1)(2007-12#1)
of the thickness of##4##4##(1991-5#1)(1994-3#1)(2007-12#1)(2008-10#1)
of the thickness##9##3##(1991-5#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)
of the thigh##12##3##(1991-3#2)(1991-6#1)(1997-3#1)(2007-11#5)(2008-12#1)(2008-6#1)(2013-1#1)
of the thin films##3##4##(2008-3#3)
of the thin ideal##2##4##(2007-12#2)
of the thin##9##3##(1991-5#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)
of the thiocyanato-complexes##2##3##(2008-10#2)
of the thiol##4##3##(1995-6#1)(2008-10#2)(2008-11#1)
of the third and fourth##3##5##(1990-8#1)(2008-5#2)
of the third harmonic##2##4##(2007-11#1)(2008-3#1)
of the third millennium##2##4##(2008-10#2)
of the third trimester##2##4##(1997-8#1)(2007-12#1)
of the third ventricle##5##4##(2008-7#5)
of the third##33##3##(1990-3#2)(1990-8#3)(1991-2#1)(1992-12#2)(1993-6#1)(1994-12#1)(1994-6#2)(1995-3#1)(1995-8#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2013-1#2)
of the third-harmonic##2##3##(2007-11#1)(2007-12#1)
of the third-order nonlinear optical##2##5##(2007-11#1)(2007-12#1)
of the third-order##6##3##(2007-11#1)(2007-12#3)(2008-3#2)
of the thirteen bisquinolines had##2##5##(1992-6#2)
of the thirteen##3##3##(1992-6#2)(1994-2#1)
of the thirty##3##3##(1995-6#1)(2008-12#2)
of the thoracic aorta##4##4##(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
of the thoracic duct##2##4##(2008-4#1)(2012-3#1)
of the thoracic wall##2##4##(1992-6#1)(2012-2#1)
of the thoracic##19##3##(1990-3#1)(1991-5#1)(1992-6#1)(1995-12#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
of the thoracolumbar spine##2##4##(2008-7#1)(2012-12#1)
of the thorax and##2##4##(2007-12#1)(2012-2#1)
of the thorax##12##3##(1991-12#1)(1993-3#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of the thought##2##3##(2011-2#2)
of the thousands of##2##4##(2008-7#1)(2009-12#1)
of the three arsenic species##2##5##(2008-10#2)
of the three clonal lineages of##2##6##(2009-2#2)
of the three components##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
of the three compounds##3##4##(1992-11#1)(2008-10#1)(2011-2#1)
of the three different##2##4##(2008-10#1)(2008-7#1)
of the three dyes##2##4##(2008-10#2)
of the three families##2##4##(2008-7#1)(2008-8#1)
of the three genera##2##4##(1996-6#1)(2008-10#1)
of the three groups##7##4##(2007-6#1)(2008-10#3)(2008-12#1)(2010-3#1)(2013-8#1)
of the three human##2##4##(1993-12#1)(1994-6#1)
of the three isolates##2##4##(2008-10#2)
of the three loop##2##4##(1997-1#2)
of the three main##5##4##(1994-5#1)(2008-10#2)(2012-2#1)(2012-3#1)
of the three major classes of##2##6##(1995-11#1)(2008-4#1)
of the three major##7##4##(1995-11#1)(1997-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-2#1)
of the three metals##2##4##(2008-10#2)
of the three methods##2##4##(2008-10#2)
of the three proteins##2##4##(1994-8#2)
of the three resources##2##4##(2011-2#2)
of the three species##4##4##(2011-3#2)(2012-8#1)(2012-9#1)
of the three test emulsions##2##5##(2008-5#2)
of the three types of##5##5##(1995-11#1)(1997-4#1)(2008-10#1)(2009-7#2)
of the three types##6##4##(1992-1#1)(1995-11#1)(1997-4#1)(2008-10#1)(2009-7#2)
of the three##202##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#59)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#3)(2009-4#1)(2009-7#3)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#3)
of the three-dimensional##7##3##(1993-11#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
of the three-way##2##3##(2008-10#2)
of the threshold##3##3##(1990-11#1)(2008-2#1)(2008-7#1)
of the thrombotic##3##3##(1990-3#1)(2006-6#1)(2008-7#1)
of the thrombus was##2##4##(1990-8#1)(2013-1#1)
of the thumb##5##3##(1990-8#1)(2008-9#4)
of the thylakoid membranes##2##4##(1990-5#1)(1997-4#1)
of the thymic##2##3##(1991-8#1)(2013-7#1)
of the thymidine##3##3##(1993-11#1)(1993-12#1)(2008-4#1)
of the thymus is##2##4##(1997-5#1)(2010-2#1)
of the thymus##8##3##(1991-12#1)(1997-5#1)(1997-7#2)(1997-9#1)(2008-10#1)(2008-9#1)(2010-2#1)
of the thyroid and##2##4##(2008-4#1)(2009-3#1)
of the thyroid gland in##2##5##(2008-7#1)(2012-1#1)
of the thyroid gland##10##4##(1990-3#1)(1990-8#1)(1992-2#1)(1993-5#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#2)
of the thyroid in##4##4##(1992-2#2)(2008-6#1)(2011-1#1)
of the thyroid##26##3##(1990-3#1)(1990-8#1)(1992-2#3)(1992-8#2)(1993-5#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#3)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#2)
of the thyroid]##2##3##(1992-5#1)(1996-6#1)
of the thyrotropin receptor##2##4##(1996-5#1)(2008-4#1)
of the thyrotropin##3##3##(1992-12#1)(1996-5#1)(2008-4#1)
of the tibia##9##3##(2008-6#2)(2009-3#4)(2011-2#1)(2013-8#2)
of the tibial##8##3##(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the tick##6##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#1)(2013-8#1)
of the tick-borne pathogen##2##4##(2013-8#2)
of the tightly##2##3##(1992-6#1)(2009-5#1)
of the tilt##2##3##(2008-2#2)
of the tilted##2##3##(2007-12#1)(2008-3#1)
of the time and##4##4##(1990-9#1)(1992-12#1)(2008-10#1)(2010-9#1)
of the time axis##2##4##(1995-9#1)(2008-8#1)
of the time course of##2##5##(1995-12#1)(2008-10#1)
of the time course##3##4##(1995-12#2)(2008-10#1)
of the time interval##2##4##(2008-9#1)(2013-1#1)
of the time necessary##2##4##(2008-10#2)
of the time of##3##4##(1992-8#1)(2008-10#2)
of the time temperature superposition##2##5##(2008-5#2)
of the time the##2##4##(1992-2#1)(1992-8#1)
of the time to##2##4##(1996-4#1)(2007-12#1)
of the time##58##3##(1990-9#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-8#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
of the time-dependent##4##3##(1995-6#1)(2007-12#1)(2008-2#1)(2008-7#1)
of the timing of##3##4##(2008-10#2)(2010-12#1)
of the timing##5##3##(2007-8#1)(2008-10#2)(2008-7#1)(2010-12#1)
of the tip of the##2##5##(1991-3#1)(2010-8#1)
of the tip of##3##4##(1991-3#1)(2008-10#1)(2010-8#1)
of the tip##6##3##(1991-3#1)(2007-12#2)(2008-10#2)(2010-8#1)
of the tip-sample##2##3##(2007-12#1)(2008-3#1)
of the tips##2##3##(2007-12#1)(2008-7#1)
of the tissue by##2##4##(2008-3#1)(2012-2#1)
of the tissue to##2##4##(1993-12#1)(2008-3#1)
of the tissue##29##3##(1991-12#1)(1991-3#1)(1993-12#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2009-11#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the tissues was##2##4##(1994-5#1)(2008-9#1)
of the tissues##14##3##(1993-12#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-8#1)(2012-1#1)(2013-1#2)
of the title compound##2##4##(2008-10#1)(2013-1#1)
of the title compounds##4##4##(1994-3#1)(1997-4#1)(2007-11#1)(2012-3#1)
of the title##7##3##(1994-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
of the titrant##12##3##(2008-10#12)
of the titration and##2##4##(2008-10#2)
of the titration curve##2##4##(2008-10#2)
of the titration##10##3##(1991-8#1)(2008-10#9)
of the toad##3##3##(1993-5#2)(2008-6#1)
of the tobacco##3##3##(1992-2#1)(2008-10#1)(2008-7#1)
of the toll-like receptor##2##4##(2008-3#1)(2009-8#1)
of the tongue##7##3##(1997-4#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
of the tonoplast##2##3##(2008-10#1)(2008-11#1)
of the tool##7##3##(2008-11#3)(2008-12#1)(2008-9#1)(2009-11#1)(2012-2#1)
of the tools of##2##4##(2008-12#1)(2008-9#1)
of the tools##8##3##(1996-3#1)(1997-7#1)(2008-12#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-12#1)
of the tooth##8##3##(1991-2#1)(1996-2#1)(1997-4#2)(2008-7#2)(2009-4#1)(2013-1#1)
of the top of##2##4##(2008-3#2)
of the top##11##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#2)(2010-4#1)(2013-1#1)
of the topic##2##3##(2008-9#1)(2012-2#1)
of the topics addressed##2##4##(2008-4#1)(2008-5#1)
of the topics##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
of the topography##4##3##(2008-11#1)(2008-3#2)(2012-1#1)
of the torso##2##3##(2008-7#1)(2010-8#1)
of the tospoviruses##2##3##(2008-10#2)
of the total amount of##4##5##(2008-10#4)
of the total amount##5##4##(1996-5#1)(2008-10#4)
of the total bacterial##2##4##(2008-8#1)(2010-4#1)
of the total cellular##2##4##(1995-11#1)(2008-9#1)
of the total concentration of##2##5##(2008-10#2)
of the total culture##2##4##(2008-11#2)
of the total disease that##2##5##(2008-10#2)
of the total dose##4##4##(2007-10#2)(2007-9#1)(2008-7#1)
of the total gene##2##4##(2008-10#1)(2010-1#1)
of the total genetic variation was distributed##2##7##(2008-10#2)
of the total genetic variation##4##5##(2008-10#4)
of the total genetic##6##4##(2008-10#6)
of the total health##2##4##(1992-11#1)(1997-2#1)
of the total number of##5##5##(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
of the total of##3##4##(1991-8#1)(2008-5#1)(2013-1#1)
of the total phenotypic variance##2##5##(2008-10#1)(2012-3#1)
of the total phenotypic variation for resistance in##2##8##(2008-10#2)
of the total phenotypic variation##3##5##(2008-10#3)
of the total phenotypic##6##4##(2008-10#5)(2012-3#1)
of the total population of the##2##6##(2008-1#1)(2008-5#1)
of the total population##7##4##(2008-1#2)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
of the total power##2##4##(2007-11#1)(2010-8#1)
of the total protein##5##4##(2008-10#2)(2008-6#3)
of the total proteins in the##2##6##(2008-8#2)
of the total proteins in##3##5##(2008-8#3)
of the total radioactivity##2##4##(1992-2#1)(1993-11#1)
of the total recording time##2##5##(1992-8#1)(2007-12#1)
of the total recovery was##2##5##(2008-10#1)(2008-5#1)
of the total scattered##2##4##(2008-2#2)
of the total soluble protein##2##5##(1994-5#1)(2008-9#1)
of the total suspended##2##4##(2013-1#1)(2013-8#1)
of the total value of##2##5##(2007-5#1)(2008-10#1)
of the total variance and##3##5##(2008-10#2)(2008-5#1)
of the total variance in the##2##6##(2008-10#1)(2008-8#1)
of the total variance in##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
of the total variance of##2##5##(1993-8#1)(2008-10#1)
of the total variance##16##4##(1993-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
of the total variation##3##4##(2008-10#2)(2008-8#1)
of the total##224##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#5)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-10#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-5#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#71)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#6)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#9)(2008-9#3)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#4)
of the total)##7##3##(1991-12#1)(1994-6#1)(2008-10#4)(2008-8#1)
of the toxic effects of##2##5##(2008-1#1)(2010-4#1)
of the toxic##10##3##(1995-3#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)
of the toxicity of##3##4##(1992-3#1)(1994-5#1)(1996-12#1)
of the toxicity##9##3##(1990-5#1)(1992-3#1)(1994-5#1)(1996-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-3#1)
of the toxin##11##3##(1991-12#1)(1991-5#1)(1994-2#3)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
of the toxins produced##2##4##(1997-4#1)(2008-10#1)
of the toxins##4##3##(1990-5#1)(1993-12#1)(1997-4#1)(2008-10#1)
of the trace metals##2##4##(2008-10#1)(2008-5#1)
of the trace##8##3##(2008-10#5)(2008-5#1)(2013-1#2)
of the tracer##3##3##(1990-12#1)(1995-12#1)(2010-2#1)
of the trachea##6##3##(1991-11#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-8#2)
of the tracheae##2##3##(2007-12#2)
of the tracheal walls##2##4##(2007-12#2)
of the tracheal##6##3##(1996-3#1)(1997-1#1)(2007-12#3)(2013-1#1)
of the tracheobronchial circulation in##2##5##(1996-1#1)(1997-1#1)
of the tracked##4##3##(2007-11#1)(2008-6#1)(2009-12#1)(2012-2#1)
of the tracking##2##3##(2008-2#2)
of the trade##2##3##(2007-5#1)(2010-11#1)
of the traditional##16##3##(1991-2#1)(1992-1#1)(1994-2#1)(1995-1#1)(1996-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-12#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
of the trained##2##3##(2008-12#1)(2013-1#1)
of the training program##3##4##(1991-2#1)(2007-4#1)(2008-1#1)
of the training##17##3##(1991-2#1)(1991-3#2)(1991-5#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-7#1)(2013-8#1)
of the trait##3##3##(2009-4#1)(2012-3#2)
of the trans isomer##2##4##(1991-5#2)
of the trans##6##3##(1990-9#1)(1991-5#2)(2008-10#1)(2010-2#2)
of the transcatheter##3##3##(1997-8#1)(2010-8#1)(2013-1#1)
of the transcript##6##3##(1991-5#2)(1993-12#1)(1996-10#1)(1996-12#1)(1997-7#1)
of the transcription bubble##2##4##(1995-2#2)
of the transcription factor##10##4##(1991-9#1)(1992-8#2)(1993-9#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
of the transcription factors##2##4##(1997-7#2)
of the transcription of##2##4##(1991-12#1)(2008-1#1)
of the transcription start point (tsp)##2##6##(1993-2#1)(1994-12#1)
of the transcription start site##2##5##(1994-8#2)
of the transcription start##4##4##(1993-2#1)(1994-12#1)(1994-8#2)
of the transcription##24##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-8#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#2)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-1#1)
of the transcriptional status of##2##5##(1995-2#1)(2013-1#1)
of the transcriptional##8##3##(1990-11#1)(1992-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-9#2)(2013-1#1)
of the transcriptome##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
of the transcripts of the##2##5##(1990-8#1)(1997-2#1)
of the transcripts##4##3##(1990-8#1)(1996-8#1)(1997-2#2)
of the transducer##2##3##(2008-10#1)(2008-3#1)
of the transfected cells##3##4##(1992-9#1)(1994-8#1)(2008-11#1)
of the transfected##6##3##(1992-9#1)(1994-6#1)(1994-8#2)(2008-11#1)(2008-2#1)
of the transfecting##2##3##(1997-7#1)(2008-11#1)
of the transfer of the##2##5##(1993-11#1)(1994-12#1)
of the transfer of##4##4##(1993-11#1)(1994-12#1)(2008-10#2)
of the transfer##8##3##(1991-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-3#1)
of the transferred##2##3##(1990-7#1)(2008-8#1)
of the transformants##6##3##(1990-5#1)(1990-8#1)(1997-8#1)(2008-10#2)(2008-8#1)
of the transformation frequency below the spontaneous##2##7##(2008-7#2)
of the transformation of##2##4##(1995-4#1)(2008-10#1)
of the transformation zone##4##4##(1994-12#1)(1994-2#2)(2011-2#1)
of the transformation##8##3##(1994-12#1)(1994-2#2)(1995-4#1)(2008-10#1)(2008-7#2)(2011-2#1)
of the transformations##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
of the transformed cell##2##4##(1993-6#1)(2008-11#1)
of the transformed cells##2##4##(1992-9#1)(2008-11#1)
of the transformed##9##3##(1992-9#1)(1993-6#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-3#1)
of the transforming growth factor##2##5##(2008-11#1)(2011-2#1)
of the transforming##3##3##(1993-2#1)(2008-11#1)(2011-2#1)
of the transfusion##2##3##(1996-9#1)(1997-5#1)
of the transgene in##2##4##(1995-2#1)(2008-10#1)
of the transgene##15##3##(1990-8#1)(1993-6#1)(1994-8#1)(1995-2#1)(2008-10#8)(2008-8#2)(2012-3#1)
of the transgenes and##2##4##(1994-5#1)(2008-11#1)
of the transgenes##3##3##(1994-5#1)(2008-11#1)(2011-1#1)
of the transgenic lines##2##4##(2008-10#2)
of the transgenic##3##3##(1995-2#1)(2008-10#2)
of the transient##6##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#3)
of the transition state##3##4##(1990-5#2)(2008-4#1)
of the transition to adulthood##2##5##(2009-7#1)(2011-2#1)
of the transition##18##3##(1990-5#2)(1991-6#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-3#3)(2008-4#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-7#1)
of the transitions##2##3##(2008-2#1)(2011-3#1)
of the translation initiation##4##4##(1992-11#1)(1997-2#1)(1997-6#1)(2013-7#1)
of the translation start site##2##5##(2008-11#1)(2008-9#1)
of the translation##9##3##(1990-5#1)(1992-11#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-7#1)(2013-8#1)
of the translational start##2##4##(1990-11#1)(2008-4#1)
of the translational##6##3##(1990-11#1)(1990-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)
of the translocation##5##3##(1991-5#1)(1992-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
of the transmembrane domain of the TSH receptor##2##8##(1992-12#2)
of the transmembrane##7##3##(1990-5#1)(1992-12#2)(1994-12#1)(1996-4#1)(2008-4#2)
of the transmission of##4##4##(1997-3#1)(2008-3#2)(2011-3#1)
of the transmission spectra of##2##5##(2008-3#2)
of the transmission##23##3##(1997-3#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-3#10)(2009-11#1)(2011-3#1)
of the transmittance and the##2##5##(2008-3#2)
of the transmittance##5##3##(2008-2#2)(2008-3#3)
of the transmitted beam##3##4##(2007-12#1)(2008-3#2)
of the transmitted light##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
of the transmitted##13##3##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#7)
of the transmitter##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of the transparent##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
of the transplant##2##3##(1997-8#1)(2008-1#1)
of the transplantation##3##3##(1995-9#1)(1996-9#1)(2008-5#1)
of the transplanted##4##3##(1991-5#1)(2008-10#1)(2008-9#1)(2010-11#1)
of the transport of##3##4##(2007-11#1)(2008-10#1)(2008-9#1)
of the transport##11##3##(1991-5#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)
of the transposon##2##3##(1997-2#1)(2008-10#1)
of the transverse carpal ligament##2##5##(2008-9#2)
of the transverse sinus##3##4##(2006-12#1)(2008-7#2)
of the transverse##15##3##(1991-2#1)(1993-3#1)(1993-9#1)(2006-12#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#2)(2012-2#1)(2013-1#1)
of the trap##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
of the trapping##2##3##(1992-9#1)(2008-10#1)
of the traumatic event##2##4##(2008-10#1)(2008-6#1)
of the traumatic##6##3##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-1#2)
of the treated embryos##2##4##(2008-11#1)(2008-12#1)
of the treated mice##2##4##(2008-4#1)(2008-8#1)
of the treated patients##2##4##(2007-7#1)(2013-8#1)
of the treated##22##3##(1992-6#1)(1994-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-1#2)(2012-12#1)(2013-8#2)
of the treating physician##2##4##(1993-12#1)(2011-1#1)
of the treatment effect##3##4##(1992-6#1)(1994-11#1)(1997-4#1)
of the treatment groups##4##4##(1991-2#1)(1994-12#3)
of the treatment of renal##2##5##(1992-5#1)(2008-10#1)
of the treatment of the##2##5##(1996-6#1)(2007-8#1)
of the treatment of##17##4##(1992-1#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
of the treatment protocol##2##4##(2007-8#1)(2013-8#1)
of the treatment regime##3##4##(2011-1#1)(2011-2#1)(2012-12#1)
of the treatment results of##2##5##(2007-11#1)(2008-7#1)
of the treatment results##3##4##(2007-11#1)(2008-7#1)(2011-2#1)
of the treatment to##2##4##(1994-2#1)(2013-8#1)
of the treatment was##4##4##(1992-3#1)(1994-7#1)(2007-7#1)(2012-3#1)
of the treatment##88##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-7#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#8)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-2#1)(2010-11#1)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
of the treatments##8##3##(1995-2#1)(1995-5#2)(2008-10#2)(2010-11#1)(2011-1#1)(2012-5#1)
of the tree canopy##2##4##(2008-10#2)
of the tree##9##3##(1995-3#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)
of the trees in a##2##5##(2008-10#2)
of the trial##21##3##(1991-3#3)(1994-6#2)(1994-9#1)(2008-10#4)(2008-5#1)(2008-8#3)(2009-4#2)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
of the trials##8##3##(1997-1#1)(2008-10#4)(2008-4#2)(2009-9#1)
of the triangle##2##3##(2008-6#1)(2011-2#1)
of the triceps##5##3##(2007-11#3)(2008-5#1)(2008-9#1)
of the tricuspid valve##3##4##(1997-2#1)(2007-8#1)(2012-12#1)
of the tricuspid##4##3##(1997-2#1)(2007-8#2)(2012-12#1)
of the tricyclic##2##3##(1996-5#2)
of the trigeminal ganglion##2##4##(1997-3#1)(2008-7#1)
of the trigeminal nerve##7##4##(1990-12#1)(1996-5#2)(2011-2#4)
of the trigeminal##11##3##(1990-12#1)(1996-5#3)(1997-3#1)(2008-7#1)(2008-9#1)(2011-2#4)
of the triple test in##2##5##(1990-10#1)(1996-12#1)
of the triple test##3##4##(1990-10#2)(1996-12#1)
of the triple##7##3##(1990-10#2)(1996-12#1)(1997-4#1)(2008-10#2)(2008-5#1)
of the triplet##2##3##(1997-7#1)(2010-4#1)
of the trophic##3##3##(1997-1#1)(2008-5#2)
of the tropical##7##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
of the tropospheric##2##3##(2008-3#2)
of the true##19##3##(1990-6#1)(1992-3#1)(1993-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
of the truncated##3##3##(1993-6#2)(1994-8#1)
of the trunk##7##3##(1995-8#2)(2007-8#2)(2008-5#1)(2008-6#2)
of the tryptic##2##3##(1997-2#1)(2008-10#1)
of the tryptophan##2##3##(2008-10#1)(2010-5#1)
of the tsx gene##2##4##(1990-11#2)
of the tuatara##2##3##(2010-3#2)
of the tube and##2##4##(2008-7#1)(2010-5#1)
of the tube##7##3##(1994-9#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)
of the tuber##2##3##(2008-10#2)
of the tuberculosis##3##3##(2007-8#1)(2010-4#1)(2013-8#1)
of the tuberomammillary##2##3##(1994-3#2)
of the tubes with##2##4##(2008-7#1)(2011-1#1)
of the tubes##5##3##(1992-6#1)(2008-7#2)(2011-1#1)(2012-2#1)
of the tubule##2##3##(2007-12#1)(2008-7#1)
of the tubulin##3##3##(1991-5#1)(1993-8#1)(1995-5#1)
of the tumor and chemotherapy##2##5##(2009-3#1)(2011-1#1)
of the tumor and##10##4##(1990-9#1)(1993-11#1)(1993-6#1)(2007-11#2)(2008-11#1)(2009-3#1)(2010-5#1)(2011-1#1)(2013-8#1)
of the tumor cells in##2##5##(1991-6#1)(1994-7#1)
of the tumor cells##5##4##(1991-6#1)(1992-9#2)(1994-7#1)(2008-8#1)
of the tumor in the##2##5##(2008-10#1)(2011-2#1)
of the tumor in##4##4##(2007-11#1)(2008-10#1)(2011-2#2)
of the tumor microenvironment##3##4##(2010-3#1)(2011-1#1)(2013-8#1)
of the tumor position##3##4##(2009-11#3)
of the tumor showed##2##4##(2007-10#1)(2008-11#1)
of the tumor suppressor##3##4##(2007-8#1)(2008-7#1)(2013-1#1)
of the tumor vasculature##2##4##(1993-9#1)(1994-5#1)
of the tumor was##6##4##(1992-10#1)(1994-7#1)(2007-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
of the tumor with##2##4##(2009-3#1)(2013-1#1)
of the tumor##90##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-8#1)(1992-9#7)(1993-11#1)(1993-6#1)(1993-9#2)(1994-5#2)(1994-6#1)(1994-7#2)(1994-9#2)(1995-4#1)(1997-1#1)(2006-12#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-8#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#3)(2009-3#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
of the tumors##8##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-9#2)(2006-12#1)(2008-6#1)(2010-3#1)
of the tumour was##3##4##(2008-7#2)(2012-12#1)
of the tumour##30##3##(1991-11#1)(1991-6#1)(1993-8#1)(2007-11#3)(2008-10#2)(2008-4#1)(2008-6#5)(2008-7#11)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
of the tumours were##4##4##(1990-12#2)(2006-8#2)
of the tumours##11##3##(1990-12#2)(1993-5#1)(2006-8#6)(2008-10#1)(2013-1#1)
of the tungsten##2##3##(2008-10#2)
of the tunica##2##3##(2008-10#1)(2009-10#1)
of the tuning##4##3##(2007-11#1)(2008-2#2)(2012-3#1)
of the tunnel##4##3##(1991-12#1)(1994-11#2)(2007-12#1)
of the tunneling##4##3##(1995-2#1)(2007-12#2)(2008-3#1)
of the turbid##4##3##(2008-2#2)(2008-3#2)
of the turbulence##3##3##(2007-12#1)(2008-3#2)
of the twelve##3##3##(1994-9#1)(2008-8#1)(2011-3#1)
of the twentieth century##7##4##(2008-10#1)(2009-7#2)(2010-1#1)(2011-2#3)
of the twentieth##8##3##(2008-10#1)(2009-7#2)(2010-1#2)(2011-2#3)
of the twenty-first century##4##4##(1994-2#1)(1997-1#1)(1997-3#1)(2008-12#1)
of the two analytes##3##4##(2008-10#3)
of the two analytical methods##2##5##(2008-10#1)(2010-5#1)
of the two beams##2##4##(2007-12#1)(2008-3#1)
of the two cell lines##3##5##(2008-11#1)(2008-9#2)
of the two cell##4##4##(1990-11#1)(2008-11#1)(2008-9#2)
of the two components##4##4##(1995-3#1)(2007-12#2)(2008-6#1)
of the two compounds##2##4##(2008-10#2)
of the two constituents##2##4##(2008-10#2)
of the two coupled##2##4##(2007-12#1)(2008-3#1)
of the two different##4##4##(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
of the two diseases##5##4##(2008-10#5)
of the two domains of##2##5##(1991-9#1)(1995-6#1)
of the two drugs##5##4##(1990-9#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-2#1)
of the two enzymes##2##4##(1995-5#1)(2008-10#1)
of the two epitopes##2##4##(1995-2#1)(2008-8#1)
of the two forms of##3##5##(1991-12#1)(2008-10#1)(2010-5#1)
of the two genes##5##4##(1991-9#1)(1993-6#1)(1995-8#1)(1997-7#1)(2008-9#1)
of the two groups were##3##5##(1996-5#1)(2007-7#1)(2008-6#1)
of the two groups##9##4##(1991-3#1)(1995-12#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
of the two is##2##4##(2011-2#2)
of the two isolates##2##4##(2008-10#2)
of the two kinds of macrocycle stationary phases##2##8##(2008-10#2)
of the two kinds of##3##5##(2008-10#2)(2008-8#1)
of the two lasers##3##4##(2008-3#2)(2011-1#1)
of the two layers##3##4##(2008-2#2)(2008-3#1)
of the two main components of##2##6##(1993-8#1)(2008-1#1)
of the two main##4##4##(1993-8#1)(2008-1#1)(2008-10#1)(2010-8#1)
of the two major##7##4##(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
of the two metals##2##4##(2008-10#2)
of the two methods##4##4##(1995-2#1)(2008-10#3)
of the two models##2##4##(2008-10#1)(2009-8#1)
of the two most##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
of the two pathogens##2##4##(2008-10#1)(2010-4#1)
of the two phases##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
of the two procedures##2##4##(2008-10#2)
of the two proteins was##2##5##(1990-12#1)(1994-11#1)
of the two proteins##4##4##(1990-12#1)(1990-7#1)(1991-12#1)(1994-11#1)
of the two resistance##2##4##(2008-10#2)
of the two series of##2##5##(1995-11#1)(2008-10#1)
of the two series##3##4##(1995-11#1)(2008-10#1)(2008-4#1)
of the two sets of##2##5##(1994-9#1)(2008-10#1)
of the two species##10##4##(1994-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2011-2#2)(2012-5#1)
of the two strains##2##4##(2008-10#1)(2009-6#1)
of the two study groups##2##5##(1991-11#1)(2010-4#1)
of the two substrates##4##4##(1994-5#2)(1997-2#1)(2008-7#1)
of the two subunits##4##4##(1991-10#1)(1991-12#1)(1993-11#1)(1993-8#1)
of the two tasks##2##4##(1991-2#1)(1994-8#1)
of the two techniques##5##4##(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-9#1)
of the two tryptophan residues##2##5##(1992-6#1)(1993-11#1)
of the two types of##3##5##(1991-12#1)(2008-2#1)(2008-5#1)
of the two types##4##4##(1991-12#1)(2007-7#1)(2008-2#1)(2008-5#1)
of the two viruses##4##4##(2007-6#1)(2008-10#2)(2008-9#1)
of the two wave fronts##2##5##(2008-2#1)(2008-3#1)
of the two years##2##4##(2008-10#1)(2008-5#1)
of the two##398##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#6)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#7)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#5)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#4)(2007-12#9)(2007-6#1)(2007-7#2)(2008-1#4)(2008-10#97)(2008-11#11)(2008-12#4)(2008-2#13)(2008-3#30)(2008-4#8)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#14)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-12#1)(2012-2#6)(2012-3#1)(2012-5#2)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#4)
of the two-color##2##3##(2008-3#2)
of the two-component##2##3##(1996-12#2)
of the two-dimensional emissivity##2##4##(2008-3#2)
of the two-dimensional##10##3##(2008-10#1)(2008-2#1)(2008-3#8)
of the two-node model##2##4##(1992-3#2)
of the two-photon excitation##2##4##(2008-2#1)(2008-3#1)
of the two-photon##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
of the two-state##3##3##(1990-8#1)(1997-2#2)
of the two-winged Cloeodes##2##4##(2013-8#2)
of the tympanic##2##3##(2008-2#1)(2008-4#1)
of the type 1##2##4##(1992-3#1)(2008-3#1)
of the type I##2##4##(1992-5#1)(2008-11#1)
of the type II##3##4##(1995-2#2)(2008-4#1)
of the type and##5##4##(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
of the type of fracture##2##5##(2007-8#1)(2011-2#1)
of the type of##22##4##(1990-5#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2009-7#1)(2010-11#1)(2011-2#2)
of the type##46##3##(1990-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-12#1)
of the types of##8##4##(1990-6#1)(1992-12#1)(1993-1#1)(1997-2#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
of the types##10##3##(1990-6#1)(1992-12#1)(1993-1#1)(1997-2#1)(2006-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
of the typical##13##3##(1992-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2012-2#1)
of the tyrosinase gene promoter##2##5##(1994-12#2)
of the tyrosinase gene##3##4##(1994-12#2)(1997-4#1)
of the tyrosinase##5##3##(1994-12#2)(1997-4#1)(2008-10#1)(2008-5#1)
of the tyrosine kinase##3##4##(1991-12#1)(1991-6#1)(2008-6#1)
of the tyrosine##4##3##(1991-12#1)(1991-6#1)(2008-6#1)(2012-2#1)
of the ubiquitous##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
of the ulna##3##3##(2011-2#2)(2013-1#1)
of the ulnar nerve##7##4##(1992-6#1)(2008-12#1)(2008-9#5)
of the ulnar##11##3##(1992-6#1)(2007-11#1)(2008-12#1)(2008-9#8)
of the ultimate##4##3##(1995-5#1)(2008-2#1)(2008-3#1)(2008-7#1)
of the ultrasonic separation##2##4##(2008-11#2)
of the ultrasonic##7##3##(2007-11#1)(2008-10#2)(2008-11#3)(2010-8#1)
of the ultrasound##2##3##(1996-11#1)(2008-5#1)
of the ultrastructure of##2##4##(2007-12#1)(2008-10#1)
of the umbilical artery##2##4##(1990-8#1)(1995-6#1)
of the umbilical##5##3##(1990-8#1)(1995-6#1)(2008-10#1)(2013-1#2)
of the unaffected##2##3##(2007-11#1)(2010-3#1)
of the unavailability##2##3##(2008-7#1)(2010-8#1)
of the uncertainties##6##3##(1995-6#1)(2007-11#2)(2008-3#3)
of the uncertainty associated with the##2##6##(2008-10#2)
of the uncertainty##6##3##(1994-1#1)(2008-10#3)(2008-8#1)(2009-8#1)
of the uncoated##2##3##(2008-10#1)(2008-3#1)
of the uncomplexed##2##3##(2008-10#2)
of the unconscious##2##3##(2007-7#1)(2008-12#1)
of the undergraduate##3##3##(1991-6#1)(2010-2#1)(2013-1#1)
of the underlying disease##3##4##(1997-4#1)(2011-2#1)(2011-3#1)
of the underlying malignancy##2##4##(2007-7#1)(2011-2#1)
of the underlying wave front##2##5##(2008-3#2)
of the underlying##39##3##(1994-3#1)(1996-7#1)(1997-4#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#4)
of the unfolding##3##3##(1995-2#1)(1995-5#1)(2007-12#1)
of the unicellular cyanobacterium##5##4##(1995-6#1)(1995-8#1)(1996-6#3)
of the uniform##2##3##(2007-12#1)(2008-2#1)
of the uniformity##2##3##(2008-12#1)(2008-3#1)
of the uninsured##3##3##(1992-2#1)(1993-2#1)(1994-2#1)
of the unique features##2##4##(2007-12#1)(2008-11#1)
of the unique##15##3##(1991-1#1)(1996-1#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
of the unit is##3##4##(2008-11#1)(2008-4#2)
of the unit##13##3##(1992-9#1)(1995-12#1)(2007-10#2)(2008-11#1)(2008-4#4)(2008-7#2)(2010-8#1)(2013-1#1)
of the units##5##3##(1995-6#3)(2008-1#1)(2008-9#1)
of the universal##2##3##(2008-8#1)(2011-2#1)
of the universe##3##3##(1995-6#1)(1996-12#1)(2008-4#1)
of the unknown##7##3##(2007-12#1)(2008-10#3)(2011-2#2)(2012-3#1)
of the unliganded##2##3##(1990-8#1)(1995-5#1)
of the unquantified##2##3##(2008-4#2)
of the unstable##3##3##(2007-6#1)(2008-3#2)
of the unstirred layers##2##4##(1991-5#2)
of the unstirred##7##3##(1991-5#7)
of the untrained##2##3##(2013-1#1)(2013-8#1)
of the untreated##6##3##(1991-12#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-7#2)
of the unusual##8##3##(1990-8#1)(1992-9#1)(1994-3#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-4#1)(2013-8#1)
of the upcoming##3##3##(2008-11#2)(2008-3#1)
of the upper aerodigestive tract##2##5##(2008-1#1)(2009-5#1)
of the upper airway##2##4##(1990-6#1)(2007-12#1)
of the upper airways##3##4##(1991-6#1)(1996-6#1)(1997-4#1)
of the upper and lower##6##5##(1990-11#1)(1992-11#2)(1992-12#1)(2008-10#1)(2009-5#1)
of the upper digestive tract##2##5##(1993-9#1)(2011-2#1)
of the upper extremities##3##4##(1991-4#1)(1997-4#1)(2007-8#1)
of the upper extremity##6##4##(2008-12#1)(2008-9#2)(2010-8#1)(2011-2#2)
of the upper jaw##2##4##(2013-1#1)(2013-7#1)
of the upper limb##3##4##(2007-8#1)(2009-1#2)
of the upper lobe##2##4##(1991-9#1)(2008-4#1)
of the upper moieties##2##4##(2008-7#2)
of the upper respiratory tract##4##5##(1990-8#1)(1995-12#1)(2008-10#1)(2012-12#1)
of the upper trapezius##2##4##(2010-9#2)
of the upper##67##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-12#2)(1996-12#1)(1996-4#1)(1996-6#1)(1997-4#2)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#4)(2009-1#2)(2009-5#2)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-7#2)
of the upstream sequences##2##4##(1990-8#1)(2008-9#1)
of the upstream##7##3##(1990-8#1)(1991-6#1)(1991-9#2)(1993-9#1)(1997-2#1)(2008-9#1)
of the uptake and##2##4##(2008-10#1)(2008-9#1)
of the uptake of##2##4##(1992-3#1)(1995-6#1)
of the uptake##5##3##(1992-3#1)(1995-6#1)(2008-10#2)(2008-9#1)
of the upwelling##3##3##(2008-2#1)(2008-3#2)
of the urea cycle##2##4##(1991-9#1)(2008-7#1)
of the urea##6##3##(1991-9#1)(1993-11#1)(1995-6#1)(2008-10#2)(2008-7#1)
of the ureter##9##3##(1997-3#1)(1997-4#1)(2008-10#1)(2009-5#3)(2013-7#3)
of the urethra and##2##4##(2008-10#2)
of the urethra##6##3##(1990-7#1)(1996-12#1)(2008-10#4)
of the urethral##4##3##(1990-7#1)(1992-1#1)(1996-11#1)(2013-1#1)
of the uridine##2##3##(1993-8#1)(1995-8#1)
of the urinary bladder##13##4##(1991-6#1)(1992-12#1)(1993-2#2)(1993-9#2)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#3)(2012-12#1)
of the urinary tract and##2##5##(1996-12#1)(2008-10#1)
of the urinary tract##11##4##(1990-11#2)(1996-12#1)(2007-5#2)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the urinary##29##3##(1990-11#2)(1991-6#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-8#1)(1993-9#2)(1995-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-5#2)(2008-10#4)(2008-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the urine##3##3##(1995-3#1)(2008-10#2)
of the urogenital tract##4##4##(1995-5#1)(1997-2#1)(1997-6#1)(2008-5#1)
of the use of a##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
of the use of different##3##5##(2008-10#3)
of the use of heteropoly anions##2##6##(2008-10#2)
of the use of the##8##5##(1991-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)
of the use of##75##4##(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-6#1)(1996-8#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
of the use##76##3##(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-6#1)(1996-8#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
of the used##3##3##(2008-10#2)(2008-11#1)
of the usefulness of##2##4##(1997-6#1)(2006-4#1)
of the user##3##3##(1997-1#1)(2008-7#1)(2011-1#1)
of the users of##2##4##(1997-6#1)(2008-11#1)
of the users##7##3##(1991-1#1)(1995-2#1)(1997-6#2)(2008-11#1)(2012-2#1)(2013-1#1)
of the usual abdominal##2##4##(1994-2#1)(1997-3#1)
of the usual##14##3##(1990-3#1)(1992-3#1)(1992-9#1)(1994-2#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2012-3#1)
of the uterine cervix##6##4##(1990-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#2)
of the uterine##15##3##(1990-6#1)(1991-3#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-11#2)
of the uterus and##2##4##(2012-2#1)(2012-3#1)
of the uterus##13##3##(1990-10#1)(1994-9#2)(2008-1#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the utility of##5##4##(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)
of the utility##6##3##(1993-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)
of the utilization of##2##4##(1991-12#1)(2008-7#1)
of the vaccinated animals##2##4##(1995-9#2)
of the vaccinated##3##3##(1995-9#2)(2011-2#1)
of the vaccination##4##3##(2009-12#1)(2011-2#3)
of the vaccine##8##3##(1990-9#1)(1995-5#1)(1996-12#1)(2008-11#2)(2011-2#1)(2013-1#1)(2013-8#1)
of the vaccines##2##3##(1995-5#1)(2010-4#1)
of the vaccinia virus##2##4##(2008-2#2)
of the vacuolar type##2##4##(1994-6#1)(1994-8#1)
of the vacuolar##4##3##(1994-6#2)(1994-8#1)(2008-11#1)
of the vacuum disc##2##4##(2012-2#2)
of the vacuum##3##3##(2007-8#1)(2012-2#2)
of the vagina##3##3##(1990-2#1)(1994-1#1)(2013-1#1)
of the vaginal##5##3##(1991-12#1)(1991-3#1)(1992-12#1)(1996-9#1)(2008-10#1)
of the vagus nerve##3##4##(1993-12#2)(1995-12#1)
of the vagus##7##3##(1993-12#5)(1994-2#1)(1995-12#1)
of the validation of##2##4##(1997-2#1)(2008-10#1)
of the validation##7##3##(1997-2#1)(2008-10#5)(2008-3#1)
of the validity of##3##4##(1991-2#1)(2007-11#1)(2007-12#1)
of the value of the##3##5##(1995-1#1)(2008-3#2)
of the value of##7##4##(1990-7#1)(1994-7#1)(1995-1#1)(1995-2#1)(1997-7#1)(2008-3#2)
of the value##10##3##(1990-7#1)(1994-7#1)(1995-1#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-3#2)(2012-2#1)
of the values of the##4##5##(1995-5#1)(2007-11#1)(2008-12#1)(2008-3#1)
of the values of##5##4##(1994-12#1)(1995-5#1)(2007-11#1)(2008-12#1)(2008-3#1)
of the values##8##3##(1990-3#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
of the valve##5##3##(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the van Cittert-Zernike theorem##3##5##(2007-12#2)(2008-2#1)
of the van der Waals##2##5##(1995-3#1)(2013-1#1)
of the van##5##3##(1995-3#1)(2007-12#2)(2008-2#1)(2013-1#1)
of the vapor##2##3##(2008-10#2)
of the vapour pressure of the##2##6##(2008-5#2)
of the variability between##2##4##(2008-10#2)
of the variability in##5##4##(1992-6#1)(2007-3#1)(2008-10#2)(2013-7#1)
of the variability was##2##4##(2008-10#1)(2008-7#1)
of the variability##15##3##(1992-5#1)(1992-6#1)(2007-3#1)(2008-10#10)(2008-7#1)(2013-7#1)
of the variable region##2##4##(2008-11#1)(2008-8#1)
of the variable##7##3##(1990-8#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
of the variables affecting##2##4##(2008-10#2)
of the variables and##2##4##(2008-10#2)
of the variables##18##3##(1991-12#1)(1993-5#1)(1994-3#1)(2008-10#9)(2008-11#1)(2011-2#3)(2012-12#1)(2012-2#1)
of the variance explained##2##4##(2011-1#2)
of the variance in social function in the##2##8##(2013-1#2)
of the variance in the##8##5##(1995-3#1)(2007-10#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-3#1)
of the variance in##25##4##(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#2)(2007-10#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#3)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of the variance of the##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
of the variance of##5##4##(2007-11#1)(2008-10#2)(2008-3#1)(2009-5#1)
of the variance##46##3##(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#2)(2007-10#2)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-3#3)(2013-1#3)(2013-8#1)
of the variant enzymes##2##4##(2011-2#2)
of the variant##6##3##(1990-8#1)(1994-2#1)(2008-7#1)(2008-8#1)(2011-2#2)
of the variation for resistance in##2##6##(2008-10#2)
of the variation for resistance##3##5##(2008-10#3)
of the variation in disease##2##5##(2008-10#2)
of the variation in##23##4##(1993-3#1)(1994-2#2)(1997-5#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
of the variation of the##2##5##(2008-2#1)(2008-3#1)
of the variation was##2##4##(2008-10#1)(2013-8#1)
of the variation##38##3##(1992-6#1)(1993-3#1)(1994-2#2)(1997-5#1)(2008-10#17)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the variations in the##3##5##(1993-2#1)(2013-8#2)
of the varicella##2##3##(2008-11#1)(2008-7#1)
of the variety of##2##4##(1996-12#1)(2010-3#1)
of the variety##5##3##(1996-12#1)(2008-5#2)(2010-3#1)(2010-6#1)
of the various complex##2##4##(2008-10#1)(2008-3#1)
of the various factors that##2##5##(1990-3#1)(2013-1#1)
of the various factors##3##4##(1990-3#1)(2012-12#1)(2013-1#1)
of the various methods##3##4##(1992-9#1)(2008-2#1)(2009-7#1)
of the various protocols##2##4##(2008-9#1)(2013-8#1)
of the various species##2##4##(2008-10#1)(2010-12#1)
of the various types of##2##5##(1992-12#1)(2008-10#1)
of the various##92##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#6)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
of the vas deferens##6##4##(1994-8#1)(1997-8#1)(2008-10#4)
of the vas##7##3##(1994-8#2)(1997-8#1)(2008-10#4)
of the vascular smooth muscle cells##2##6##(1995-11#1)(2009-1#1)
of the vascular##19##3##(1992-12#2)(1992-3#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-1#1)(2011-2#1)(2012-2#1)
of the vasculature##2##3##(1991-2#1)(1997-3#1)
of the vasopressin V1##2##4##(1995-12#2)
of the vector##11##3##(1990-11#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2010-1#1)(2011-2#1)
of the vectorial##2##3##(2007-11#1)(2008-3#1)
of the vectors##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
of the vegetation##2##3##(2008-5#1)(2008-8#1)
of the vehicle control groups##7##5##(2008-9#7)
of the vehicle control##8##4##(2008-9#8)
of the vehicle controls##28##4##(2008-9#28)
of the vehicle##38##3##(1997-6#1)(2008-5#1)(2008-9#36)
of the vehicles on the##2##5##(2008-5#2)
of the vein of##2##4##(1996-6#1)(2006-12#1)
of the vein##4##3##(1996-6#1)(2006-12#1)(2008-7#1)(2012-3#1)
of the velocity and the##2##5##(2007-12#1)(2008-3#1)
of the velocity##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of the vena cava##2##4##(1992-9#1)(2010-4#1)
of the venom##4##3##(2008-5#3)(2008-7#1)
of the venous##5##3##(2008-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
of the ventilator##4##3##(1995-12#1)(2007-8#1)(2011-1#1)(2011-2#1)
of the ventral nerve cord##3##5##(2007-12#3)
of the ventral tegmental area##2##5##(1997-2#1)(2008-7#1)
of the ventral##16##3##(1993-12#2)(1993-6#2)(1997-2#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
of the ventricles##2##3##(1992-11#1)(2008-6#1)
of the ventricular rate##2##4##(2010-12#1)(2012-3#1)
of the ventricular##4##3##(1990-9#1)(2008-7#1)(2010-12#1)(2012-3#1)
of the ventrolateral##2##3##(1994-3#1)(1997-6#1)
of the ventromedial##2##3##(2008-4#1)(2013-1#1)
of the vertebrae##7##3##(2007-11#6)(2008-11#1)
of the vertebral artery##3##4##(1991-8#1)(1993-3#1)(2008-7#1)
of the vertebral bodies##3##4##(1997-3#1)(2007-11#1)(2012-1#1)
of the vertebral body and##2##5##(2007-11#1)(2007-8#1)
of the vertebral body##5##4##(2007-11#2)(2007-8#1)(2012-1#1)(2012-2#1)
of the vertebral column##2##4##(2007-11#1)(2011-2#1)
of the vertebral venous##2##4##(2011-2#2)
of the vertebral##20##3##(1991-8#2)(1993-3#1)(1995-3#2)(1997-3#1)(2007-11#4)(2007-8#1)(2008-7#2)(2011-2#3)(2012-1#2)(2012-2#2)
of the vertebrate##7##3##(1992-8#1)(1995-5#1)(1997-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2013-1#1)
of the vertical cell##2##4##(2009-7#2)
of the vertical##10##3##(2008-2#2)(2008-3#3)(2008-5#1)(2009-7#3)(2009-8#1)
of the very complex##3##4##(1992-5#1)(2008-10#1)(2011-1#1)
of the very low##2##4##(1992-10#1)(2013-1#1)
of the very##11##3##(1992-10#1)(1992-5#1)(1992-6#1)(1997-4#1)(2007-10#1)(2008-10#3)(2009-4#1)(2011-1#1)(2013-1#1)
of the vesicles##5##3##(1990-2#2)(2008-10#1)(2008-5#2)
of the vesicular##3##3##(1994-8#1)(1995-12#1)(2008-11#1)
of the vessel##11##3##(1991-8#1)(1993-8#1)(1994-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#2)(2011-2#1)
of the vessels##7##3##(2007-7#3)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
of the vestibular##5##3##(1990-10#1)(1990-6#1)(1991-2#1)(1995-8#1)(2011-2#1)
of the viability##3##3##(1992-2#1)(2008-5#1)(2012-12#1)
of the viable cell density##2##5##(2008-11#2)
of the viable cell##4##4##(2008-11#4)
of the vibration##3##3##(2008-2#2)(2008-3#1)
of the vibrational##5##3##(2007-11#1)(2008-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
of the vibrissal FSC##2##4##(2011-2#2)
of the victim was##2##4##(1995-3#1)(2011-2#1)
of the victim##3##3##(1995-3#1)(2011-1#1)(2011-2#1)
of the victims of##3##4##(1995-11#1)(2009-6#1)(2013-1#1)
of the victims##7##3##(1991-2#1)(1995-11#1)(1996-11#1)(2007-2#1)(2009-6#2)(2013-1#1)
of the viewing##2##3##(2008-3#2)
of the villus##2##3##(1991-12#2)
of the viral RNA was##2##5##(1997-2#1)(2008-10#1)
of the viral RNA##4##4##(1997-2#1)(2008-10#3)
of the viral S RNA##2##5##(2008-10#2)
of the viral genome##6##4##(1991-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)
of the viral proteins##2##4##(2008-10#1)(2008-8#1)
of the viral##40##3##(1991-5#1)(1991-6#1)(1992-12#4)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-3#1)
of the virulence factors of##2##5##(2008-10#1)(2008-9#1)
of the virulence##8##3##(2008-10#6)(2008-9#1)(2009-8#1)
of the virulent##5##3##(1994-12#1)(2008-10#4)
of the virus and##5##4##(1994-8#1)(1996-11#1)(2008-10#2)(2008-5#1)
of the virus as##2##4##(1990-2#1)(2008-11#1)
of the virus by##3##4##(2008-10#3)
of the virus for##2##4##(2008-10#1)(2008-4#1)
of the virus from##3##4##(2008-10#3)
of the virus in##10##4##(2007-8#1)(2008-10#6)(2008-9#1)(2011-1#2)
of the virus life cycle##2##5##(2008-10#1)(2013-1#1)
of the virus that##2##4##(2007-12#1)(2010-10#1)
of the virus to##3##4##(1992-5#1)(2008-10#2)
of the virus was##2##4##(2008-10#2)
of the virus##81##3##(1990-2#1)(1992-5#1)(1993-3#1)(1994-8#3)(1996-11#1)(1997-4#1)(2007-10#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#3)(2009-11#1)(2010-1#1)(2010-10#1)(2011-1#3)(2011-3#1)(2012-12#1)(2013-1#3)
of the viruses was##2##4##(2008-10#2)
of the viruses##9##3##(2007-10#1)(2008-10#5)(2010-4#1)(2011-2#2)
of the viscosity distribution##2##4##(2007-11#2)
of the viscosity##3##3##(2007-11#2)(2008-10#1)
of the visible##8##3##(1992-1#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-3#4)
of the visit##2##3##(1996-1#1)(2012-12#1)
of the visual cortex##2##4##(2011-2#2)
of the visual input in##4##5##(1991-2#4)
of the visual input##5##4##(1991-2#5)
of the visual stimulus##3##4##(1992-11#2)(2009-10#1)
of the visual system##4##4##(1993-12#1)(1995-5#2)(2008-10#1)
of the visual world##2##4##(1993-9#1)(2012-3#1)
of the visual##29##3##(1991-2#6)(1992-11#2)(1993-12#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-5#2)(1995-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#4)(2012-3#2)(2013-8#1)
of the vital##6##3##(1992-11#1)(1994-7#1)(1997-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
of the vitality##2##3##(1994-7#1)(2011-2#1)
of the vitamin D##3##4##(2008-1#1)(2008-4#1)(2013-1#1)
of the vitamin K cycle##2##5##(2009-11#2)
of the vitamin K##3##4##(2009-11#3)
of the vitamin##14##3##(1991-12#1)(1992-9#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-11#4)(2013-1#2)
of the vitelline##3##3##(1993-6#2)(1994-5#1)
of the vocabulary##3##3##(2008-7#1)(2011-2#2)
of the vocal cord##2##4##(1991-4#1)(2008-2#1)
of the vocal cords##2##4##(2008-11#1)(2008-8#1)
of the vocal##5##3##(1991-4#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
of the voice##2##3##(2008-9#1)(2011-1#1)
of the volar forearm##3##4##(2008-5#3)
of the volar##5##3##(2008-5#3)(2008-9#2)
of the volatile##6##3##(2007-12#1)(2008-10#3)(2008-5#1)(2009-8#1)
of the voltage##3##3##(2007-12#1)(2008-8#2)
of the voltammetric##7##3##(2008-10#7)
of the volume##7##3##(2007-12#4)(2008-2#1)(2008-3#2)
of the volumes##2##3##(2008-10#1)(2009-2#1)
of the volumetric##2##3##(2008-11#1)(2008-7#1)
of the volunteer##2##3##(1993-12#1)(1994-3#1)
of the volunteers##3##3##(1996-5#1)(2008-5#2)
of the vulnerable plaque##3##4##(2012-2#3)
of the vulnerable##4##3##(2008-8#1)(2012-2#3)
of the vulva##8##3##(1992-3#4)(1994-1#1)(2007-12#1)(2008-7#2)
of the w##2##3##(1991-5#2)
of the waiting time##2##4##(1991-11#1)(2008-5#1)
of the waiting##3##3##(1991-11#2)(2008-5#1)
of the waiver##3##3##(1992-2#2)(1997-2#1)
of the walking legs##3##4##(2007-12#3)
of the walking##4##3##(2007-12#4)
of the wall velocity##2##4##(2009-6#2)
of the wall##11##3##(1997-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-6#4)(2012-2#1)
of the walls of the##2##5##(2007-12#1)(2011-1#1)
of the walls of##3##4##(2007-12#2)(2011-1#1)
of the walls##5##3##(2007-12#3)(2009-11#1)(2011-1#1)
of the war##2##3##(2008-10#1)(2008-6#1)
of the wards##7##3##(2010-3#5)(2013-1#2)
of the waste##3##3##(2008-10#3)
of the water barrier function##2##5##(2008-5#2)
of the water column##5##4##(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#1)
of the water in##3##4##(2008-10#1)(2008-3#2)
of the water sample##3##4##(2008-10#3)
of the water samples##3##4##(2008-10#2)(2013-8#1)
of the water##40##3##(1990-9#1)(1991-5#2)(1993-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-6#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#6)(2008-8#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
of the water-leaving##2##3##(2008-2#1)(2008-3#1)
of the water-vapor mixing ratio##2##5##(2008-3#2)
of the water-vapor##3##3##(2008-3#3)
of the wave front under##2##5##(2008-3#2)
of the wave front##9##4##(2007-12#1)(2008-2#2)(2008-3#6)
of the wave fronts##3##4##(2007-11#1)(2008-3#2)
of the wave##17##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#11)
of the wave-front##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
of the waveguide and##2##4##(2008-3#2)
of the waveguide can##2##4##(2007-12#1)(2008-3#1)
of the waveguide polymers##2##4##(2008-2#2)
of the waveguide##17##3##(1992-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#6)
of the waveguides##2##3##(2008-2#1)(2008-3#1)
of the wavelength are##2##4##(2007-11#1)(2008-2#1)
of the wavelength dependence of the##2##6##(2007-11#1)(2008-2#1)
of the wavelength of the##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the wavelength of##7##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
of the wavelength range and##2##5##(2008-10#1)(2008-2#1)
of the wavelength range##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
of the wavelength##22##3##(2007-11#5)(2007-12#1)(2008-10#2)(2008-2#7)(2008-3#7)
of the wavelengths##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of the waves##2##3##(2008-10#1)(2008-3#1)
of the wax matrix##6##4##(2008-5#6)
of the way##5##3##(1990-11#1)(1992-12#1)(2008-11#1)(2011-2#1)(2012-12#1)
of the ways##4##3##(1992-12#1)(1997-2#1)(2007-4#1)(2008-7#1)
of the weak##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
of the weakest##2##3##(2008-5#1)(2012-3#1)
of the weakly##2##3##(2008-7#1)(2011-2#1)
of the weapon##2##3##(1995-11#1)(2008-10#1)
of the weed##2##3##(2008-10#1)(2008-5#1)
of the weight of##4##4##(1996-8#1)(2009-12#1)(2012-12#2)
of the weight##7##3##(1996-8#2)(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#2)
of the welfare state?]##2##4##(1996-8#2)
of the welfare##3##3##(1996-8#3)
of the well known##3##4##(1991-2#1)(1992-3#1)(2008-11#1)
of the well##7##3##(1991-2#1)(1992-3#1)(2007-12#1)(2008-11#3)(2012-12#1)
of the well-known##15##3##(1994-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-6#1)(2009-12#1)
of the western world##2##4##(1990-2#1)(2008-2#1)
of the western##7##3##(1990-2#1)(1994-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
of the wet##4##3##(2008-10#1)(2008-5#2)(2010-8#1)
of the wetting##4##3##(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
of the wheat##6##3##(2008-10#5)(2008-5#1)
of the whispering-gallery modes##2##4##(2007-11#2)
of the white matter##8##4##(1991-12#1)(1995-5#1)(1996-11#2)(2008-11#1)(2010-12#2)(2011-1#1)
of the white pine blister rust##2##6##(2008-10#2)
of the white pine##3##4##(2008-10#3)
of the white##17##3##(1991-12#1)(1992-8#1)(1995-5#1)(1996-11#2)(1997-5#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-12#1)
of the whitefly Bemisia tabaci##2##5##(2008-10#1)(2011-2#1)
of the whitefly##3##3##(2008-10#2)(2011-2#1)
of the whole analytical procedure##2##5##(2008-10#2)
of the whole body##3##4##(1992-3#1)(2008-10#1)(2008-7#1)
of the whole cortical##2##4##(1995-5#1)(2008-7#1)
of the whole group##2##4##(1990-6#1)(1993-12#1)
of the whole procedure##3##4##(2008-10#2)(2011-2#1)
of the whole system##2##4##(2008-2#1)(2008-3#1)
of the whole##53##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-5#2)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#3)(2011-2#1)(2013-8#1)
of the wide variety of##3##5##(2008-11#1)(2008-8#1)(2008-9#1)
of the wide##11##3##(1990-6#1)(1991-11#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
of the widely used##7##4##(1994-1#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-9#1)
of the widely##9##3##(1994-1#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#1)
of the widespread##5##3##(1990-7#1)(1992-2#1)(1993-3#1)(2008-10#2)
of the wild type and##2##5##(2008-10#1)(2008-8#1)
of the wild type##18##4##(1990-5#1)(1990-7#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-8#3)(2010-10#1)(2013-8#1)
of the wild##22##3##(1990-5#1)(1990-7#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#1)(1995-5#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#4)(2010-10#1)(2013-8#1)
of the wild-type and Del 49 enzymes##2##7##(1995-2#2)
of the wild-type and##3##4##(1995-2#2)(1997-3#1)
of the wild-type enzyme##12##4##(1990-10#2)(1990-8#3)(1992-6#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-4#1)
of the wild-type level of##2##5##(1995-2#2)
of the wild-type strain on##2##5##(2008-10#2)
of the wild-type strain##5##4##(2008-10#4)(2008-6#1)
of the wild-type##41##3##(1990-10#2)(1990-8#3)(1991-10#1)(1991-12#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-5#4)(1994-6#1)(1995-12#1)(1995-2#6)(1995-5#2)(1995-6#1)(1995-8#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#2)(2009-10#1)
of the wine##3##3##(2008-10#3)
of the wing##3##3##(2007-12#2)(2009-5#1)
of the wings##4##3##(1990-9#1)(2008-3#2)(2013-8#1)
of the winter##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
of the wire##2##3##(2007-8#1)(2012-1#1)
of the wireless##3##3##(2010-10#1)(2010-2#1)(2010-8#1)
of the withdrawal syndrome##3##4##(1991-12#3)
of the withdrawal##4##3##(1991-12#3)(2008-11#1)
of the women had##4##4##(1990-8#1)(1995-8#1)(2008-11#1)(2011-1#1)
of the women in##2##4##(2008-11#1)(2009-11#1)
of the women were##6##4##(1991-6#1)(1996-6#1)(2008-11#1)(2008-5#1)(2013-8#2)
of the women##27##3##(1990-8#1)(1991-6#1)(1994-11#1)(1995-8#1)(1996-1#1)(1996-6#2)(2007-11#1)(2008-11#3)(2008-5#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-3#3)(2011-1#3)(2011-2#2)(2013-1#2)(2013-8#2)
of the women's##4##3##(1994-3#2)(1995-8#1)(2012-12#1)
of the wood##7##3##(2008-10#1)(2008-3#2)(2009-8#1)(2013-8#3)
of the word##6##3##(1995-5#2)(2008-1#2)(2008-3#1)(2008-5#1)
of the work is##2##4##(2007-11#1)(2010-8#1)
of the work of##4##4##(1992-11#1)(1996-1#1)(2007-10#1)(2009-7#1)
of the work reported here##2##5##(1991-5#1)(2008-5#1)
of the work##23##3##(1991-5#1)(1992-11#1)(1995-2#1)(1996-1#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#2)
of the worker##3##3##(2008-6#3)
of the workforce reported exposure to a coworker who approved of##2##11##(2012-12#2)
of the workforce reported exposure to a coworker who used or was impaired by##2##14##(2012-12#2)
of the workforce reported exposure to a coworker who##4##9##(2012-12#4)
of the workforce reported that they could easily##2##8##(2012-12#2)
of the workforce reported##6##4##(2012-12#6)
of the workforce##7##3##(2011-1#1)(2012-12#6)
of the working electrode##4##4##(2008-10#4)
of the working##13##3##(1991-3#1)(1993-2#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-6#1)(2013-1#1)
of the workplace##4##3##(1997-2#1)(2008-9#2)(2011-1#1)
of the workshop on##2##4##(1992-1#1)(2008-10#1)
of the workshop was##2##4##(2008-10#1)(2013-8#1)
of the workshop##6##3##(1992-1#1)(1996-4#1)(2008-10#2)(2011-2#1)(2013-8#1)
of the workshops and##2##4##(2008-12#1)(2011-2#1)
of the workshops##4##3##(2008-12#3)(2011-2#1)
of the world and##3##4##(2010-10#1)(2010-5#1)(2012-2#1)
of the world population##2##4##(2008-3#1)(2008-7#1)
of the world##71##3##(1990-2#1)(1991-6#1)(1992-9#1)(1994-1#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the world's most##3##4##(1994-3#1)(2008-10#1)(2012-2#1)
of the world's population##5##4##(2008-3#1)(2008-5#2)(2009-10#1)(2013-7#1)
of the world's##16##3##(1990-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
of the worst##2##3##(2007-11#1)(2011-2#1)
of the wound site##2##4##(2008-10#1)(2012-3#1)
of the wound##6##3##(1990-2#1)(1996-9#1)(2008-10#2)(2008-4#1)(2012-3#1)
of the wound-healing process##2##4##(2008-7#1)(2012-12#1)
of the wrist##6##3##(2008-7#1)(2008-9#4)(2011-2#1)
of the writing beams##2##4##(2007-11#1)(2007-12#1)
of the writing##7##3##(1991-1#1)(2007-11#1)(2007-12#2)(2008-3#2)(2010-10#1)
of the written##3##3##(2007-11#1)(2008-11#1)(2009-9#1)
of the x-ray##6##3##(2008-3#4)(2010-1#1)(2012-1#1)
of the xylem vessels##2##4##(2007-12#1)(2008-10#1)
of the xylem##3##3##(2007-12#1)(2008-10#2)
of the xylose##3##3##(2008-6#3)
of the year##23##3##(1990-12#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-5#4)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the yeast Candida oleophila##2##5##(2008-10#2)
of the yeast HIS3 mRNA##2##5##(1997-4#2)
of the yeast Saccharomyces cerevisiae##2##5##(1996-6#1)(1997-3#1)
of the yeast cell##2##4##(1991-5#1)(1993-8#1)
of the yeast interactome##2##4##(2008-7#2)
of the yeast##39##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1993-8#3)(1993-9#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#3)(2008-10#5)(2008-5#2)(2008-7#4)
of the yield components##2##4##(2008-10#1)(2008-12#1)
of the yield of##2##4##(1995-2#1)(2008-12#1)
of the yield##4##3##(1995-2#1)(2008-10#1)(2008-12#2)
of the young people##2##4##(1995-8#2)
of the young##7##3##(1991-12#1)(1995-8#2)(2007-7#1)(2008-1#2)(2008-7#1)
of the younger and##3##4##(1992-9#3)
of the younger patients##4##4##(1994-6#4)
of the younger##8##3##(1992-9#3)(1994-6#4)(2009-10#1)
of the youngest##2##3##(2007-8#1)(2008-10#1)
of the zero-order##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of the zinc##8##3##(1991-5#1)(2008-10#5)(2009-12#1)(2010-10#1)
of the zinc-binding##2##3##(2008-1#1)(2013-7#1)
of the zone of##2##4##(2008-10#1)(2008-9#1)
of the zone##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
of the##62247##2##(1990-10#62)(1990-11#304)(1990-12#252)(1990-2#201)(1990-3#130)(1990-4#7)(1990-5#351)(1990-6#154)(1990-7#206)(1990-8#266)(1990-9#145)(1991-1#78)(1991-10#20)(1991-11#144)(1991-12#369)(1991-2#230)(1991-3#181)(1991-4#31)(1991-5#267)(1991-6#227)(1991-7#37)(1991-8#130)(1991-9#220)(1992-1#114)(1992-10#53)(1992-11#162)(1992-12#349)(1992-2#159)(1992-3#407)(1992-4#41)(1992-5#142)(1992-6#374)(1992-7#11)(1992-8#247)(1992-9#259)(1993-1#100)(1993-10#5)(1993-11#277)(1993-12#441)(1993-2#199)(1993-3#270)(1993-5#87)(1993-6#274)(1993-8#284)(1993-9#167)(1994-1#96)(1994-10#9)(1994-11#263)(1994-12#373)(1994-2#285)(1994-3#291)(1994-5#288)(1994-6#199)(1994-7#38)(1994-8#304)(1994-9#198)(1995-1#93)(1995-10#1)(1995-11#260)(1995-12#348)(1995-2#401)(1995-3#265)(1995-4#30)(1995-5#322)(1995-6#387)(1995-8#189)(1995-9#64)(1996-1#117)(1996-10#28)(1996-11#59)(1996-12#337)(1996-2#344)(1996-3#238)(1996-4#67)(1996-5#302)(1996-6#153)(1996-7#46)(1996-8#61)(1996-9#106)(1997-1#138)(1997-2#413)(1997-3#414)(1997-4#297)(1997-5#120)(1997-6#254)(1997-7#317)(1997-8#261)(1997-9#23)(2006-10#57)(2006-12#57)(2006-4#18)(2006-5#3)(2006-6#34)(2006-7#1)(2006-8#14)(2006-9#1)(2007-1#10)(2007-10#223)(2007-11#1523)(2007-12#1739)(2007-2#67)(2007-3#4)(2007-4#23)(2007-5#98)(2007-6#41)(2007-7#241)(2007-8#604)(2007-9#24)(2008-1#546)(2008-10#11104)(2008-11#1915)(2008-12#741)(2008-2#2098)(2008-3#4283)(2008-4#868)(2008-5#1699)(2008-6#659)(2008-7#1969)(2008-8#1150)(2008-9#1269)(2009-1#56)(2009-10#294)(2009-11#171)(2009-12#169)(2009-2#103)(2009-3#176)(2009-4#116)(2009-5#228)(2009-6#145)(2009-7#313)(2009-8#277)(2009-9#146)(2010-1#109)(2010-10#152)(2010-11#161)(2010-12#239)(2010-2#146)(2010-3#236)(2010-4#220)(2010-5#227)(2010-6#123)(2010-7#104)(2010-8#352)(2010-9#89)(2011-1#646)(2011-10#11)(2011-2#2031)(2011-3#94)(2011-4#5)(2011-6#1)(2011-7#21)(2011-8#1)(2012-1#237)(2012-12#570)(2012-2#892)(2012-3#687)(2012-4#2)(2012-5#15)(2012-6#8)(2012-7#15)(2012-8#8)(2012-9#5)(2013-1#1330)(2013-2#2)(2013-3#1)(2013-7#219)(2013-8#778)
of theanine##4##2##(2008-11#4)
of their C-terminal##2##3##(1993-8#1)(2010-7#1)
of their ability to##8##4##(1992-9#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)
of their accuracy##3##3##(2008-10#1)(2008-7#1)(2011-7#1)
of their actions##3##3##(1993-5#1)(2008-11#1)(2013-7#1)
of their activities##2##3##(1997-3#1)(1997-4#1)
of their activity##2##3##(1997-8#1)(2008-10#1)
of their actual##3##3##(2008-2#1)(2008-3#2)
of their age##2##3##(2008-1#1)(2012-2#1)
of their amino acid##2##4##(1992-12#1)(2008-7#1)
of their amino##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
of their beneficial effects##2##4##(2013-7#1)(2013-8#1)
of their binding##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
of their biological##4##3##(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)
of their care##2##3##(2012-2#1)(2013-1#1)
of their chemical properties##3##4##(2008-10#2)(2008-11#1)
of their chemical##5##3##(1990-3#1)(2008-10#2)(2008-11#1)(2013-8#1)
of their child##2##3##(1993-12#1)(2008-2#1)
of their children##4##3##(1995-1#1)(2011-1#1)(2012-3#2)
of their clinical##9##3##(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)
of their communities##2##3##(1995-2#1)(2011-2#1)
of their complexes with##3##4##(2008-10#3)
of their components##2##3##(2008-10#2)
of their consumption##2##3##(1991-9#1)(2011-1#1)
of their contents##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
of their control rats##2##4##(2008-12#2)
of their corresponding##2##3##(1992-8#1)(2009-10#1)
of their course##2##3##(2008-11#2)
of their customers'##2##3##(1992-1#2)
of their daily##3##3##(1993-3#1)(2008-11#1)(2012-2#1)
of their degradation##2##3##(1990-7#1)(2009-8#1)
of their degree of##2##4##(2008-9#1)(2013-1#1)
of their detection##3##3##(2008-10#2)(2008-11#1)
of their development and##3##4##(1992-6#1)(2008-1#1)(2008-4#1)
of their development##5##3##(1992-6#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-8#1)
of their developmental##2##3##(1991-2#1)(1994-9#1)
of their different##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)
of their disease##4##3##(1990-6#1)(2007-11#1)(2008-6#1)(2008-8#1)
of their distribution##2##3##(1990-5#1)(2008-10#1)
of their effect on the##2##5##(2008-10#2)
of their effect on##4##4##(2008-10#2)(2008-8#1)(2008-9#1)
of their effect##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2012-1#1)
of their effectiveness##4##3##(1993-11#1)(1993-3#1)(1994-2#1)(2012-12#1)
of their effects on##3##4##(2008-10#1)(2008-8#2)
of their effects##6##3##(1992-5#1)(1994-8#1)(2008-10#2)(2008-8#2)
of their efforts##4##3##(1991-8#1)(2008-1#1)(2008-10#1)(2010-10#1)
of their employment##2##3##(1995-1#1)(2007-12#1)
of their evolutionary history##2##4##(2010-5#1)(2010-6#1)
of their evolutionary##4##3##(2008-8#1)(2010-2#1)(2010-5#1)(2010-6#1)
of their experience##2##3##(1994-2#1)(2009-5#1)
of their experiences##3##3##(2008-11#1)(2009-12#1)(2010-3#1)
of their expression in##2##4##(2008-8#1)(2011-2#1)
of their expression##9##3##(1992-3#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-5#1)(2011-2#1)
of their families##2##3##(1992-12#1)(2008-7#1)
of their family##3##3##(1993-3#1)(1995-1#1)(2008-11#1)
of their function##2##3##(1992-9#1)(2008-5#1)
of their functional##2##3##(1990-8#1)(2013-1#1)
of their functions##3##3##(2008-8#1)(2009-10#1)(2011-1#1)
of their genetic##3##3##(1992-10#1)(2008-10#1)(2008-12#1)
of their genomic DNA##2##4##(2008-10#1)(2008-7#1)
of their geographical##3##3##(2008-8#2)(2009-6#1)
of their growth kinetics##2##4##(2008-11#2)
of their growth##4##3##(2008-11#2)(2008-7#1)(2012-2#1)
of their health care##2##4##(1994-1#1)(2008-10#1)
of their health##5##3##(1994-1#1)(2008-10#1)(2010-3#1)(2010-9#2)
of their histologic##2##3##(1994-1#1)(2010-3#1)
of their host##2##3##(2009-8#1)(2010-3#1)
of their hosts##4##3##(2008-8#1)(2012-2#2)(2013-1#1)
of their hydrolysis##2##3##(2008-10#1)(2008-4#1)
of their identification##2##3##(1992-6#1)(2008-11#1)
of their identity##2##3##(2008-10#1)(2008-11#1)
of their illness##5##3##(1992-12#1)(1996-1#1)(2008-11#1)(2012-3#1)(2013-1#1)
of their impact on the##2##5##(2008-10#1)(2012-2#1)
of their impact on##3##4##(1992-12#1)(2008-10#1)(2012-2#1)
of their importance##2##3##(2008-7#1)(2012-12#1)
of their in##3##3##(1995-3#1)(2008-8#1)(2009-12#1)
of their increasing##3##3##(1994-3#2)(2011-2#1)
of their indications##2##3##(1993-2#1)(2007-8#1)
of their individual##4##3##(1995-6#1)(1996-12#1)(2008-7#1)(2009-8#1)
of their infection##2##3##(2010-11#1)(2010-12#1)
of their inherent##2##3##(2008-3#1)(2010-3#1)
of their initial##3##3##(1994-2#1)(2008-6#1)(2010-8#1)
of their insolubility in##2##4##(2007-11#1)(2011-1#1)
of their interaction with##3##4##(1994-2#1)(2008-12#1)(2011-2#1)
of their interaction##6##3##(1994-2#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
of their involvement in##2##4##(1994-11#1)(2011-2#1)
of their involvement##3##3##(1994-11#1)(1995-3#1)(2011-2#1)
of their key##2##3##(2008-3#1)(2012-3#1)
of their knowledge and##2##4##(1993-2#1)(2011-3#1)
of their knowledge##4##3##(1993-2#1)(2008-11#1)(2011-3#1)(2013-8#1)
of their learning##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
of their life##4##3##(2007-11#1)(2008-7#2)(2013-7#1)
of their limited##2##3##(1996-4#1)(2011-2#1)
of their lives##10##3##(1993-3#1)(1994-9#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#2)
of their local##3##3##(1996-3#1)(1997-3#1)(2008-7#1)
of their mRNAs##2##3##(1990-7#1)(1993-9#1)
of their main##2##3##(2008-10#2)
of their mechanisms of action##3##5##(1995-5#1)(2012-3#1)(2013-1#1)
of their medication##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
of their mitogenic##2##3##(1996-5#1)(2008-11#1)
of their molecular##5##3##(1990-12#1)(1992-6#1)(1995-6#1)(1996-2#1)(2008-4#1)
of their more##3##3##(2013-1#3)
of their native##2##3##(1990-8#1)(2008-4#1)
of their new##3##3##(1992-1#1)(2008-11#1)(2010-4#1)
of their nursing##2##3##(2008-12#1)(2013-1#1)
of their occupation##2##3##(2008-11#1)(2009-12#1)
of their occurrence and##3##4##(2008-10#1)(2012-2#1)(2013-8#1)
of their overall##4##3##(1991-2#1)(1993-2#1)(2011-1#1)(2012-4#1)
of their own health##2##4##(1996-6#1)(2013-7#1)
of their own##19##3##(1990-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-7#1)
of their parents##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
of their patient##2##3##(1994-12#1)(1994-2#1)
of their patients##7##3##(1990-9#1)(1992-1#1)(1992-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2013-8#1)
of their peers##3##3##(1997-1#1)(2009-7#1)(2013-1#1)
of their perceived##2##3##(1996-2#1)(2011-2#1)
of their performance##3##3##(2008-11#1)(2008-7#1)(2009-9#1)
of their personal##2##3##(1990-5#1)(1996-1#1)
of their physical##2##3##(2008-12#1)(2011-1#1)
of their potential##6##3##(1995-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)
of their primary##3##3##(1991-12#1)(1995-3#1)(2012-12#1)
of their production##5##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
of their professional##2##3##(1997-7#1)(2008-11#1)
of their proliferative##2##3##(2008-5#1)(2008-7#1)
of their properties##3##3##(2008-2#1)(2008-6#1)(2008-8#1)
of their receptors##2##3##(1994-8#1)(2009-8#1)
of their relationships##2##3##(1997-2#1)(2007-2#1)
of their relative##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
of their reproducibility##2##3##(2008-10#1)(2008-5#1)
of their resistance##3##3##(1993-2#1)(2007-11#1)(2008-10#1)
of their respective##7##3##(1990-5#1)(1990-7#1)(1992-1#1)(1994-1#1)(1996-3#1)(2008-10#1)(2008-9#1)
of their responses##3##3##(1996-7#1)(2007-11#1)(2008-12#1)
of their responsiveness to these##2##5##(1990-7#1)(1995-12#1)
of their results##2##3##(2007-8#1)(2010-3#1)
of their retention##3##3##(2008-10#3)
of their role in the##2##5##(2008-10#1)(2010-1#1)
of their role in##4##4##(1994-11#1)(2007-10#1)(2008-10#1)(2010-1#1)
of their role##8##3##(1993-6#1)(1994-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-11#1)(2011-1#1)
of their sequences##2##3##(1995-6#1)(2008-7#1)
of their services##2##3##(1992-2#1)(2008-11#1)
of their shape##2##3##(1993-11#1)(2008-2#1)
of their solutions##2##3##(2008-10#1)(2008-9#1)
of their spatial##2##3##(2008-8#1)(2010-10#1)
of their speech##2##3##(2007-7#1)(2008-4#1)
of their spinal pathway during##2##5##(1996-5#2)
of their spinal pathway##3##4##(1996-5#3)
of their stability##2##3##(2008-10#1)(2012-3#1)
of their state##2##3##(1990-5#1)(2007-6#1)
of their students##3##3##(2008-11#1)(2008-12#1)(2010-3#1)
of their studies##2##3##(2008-7#1)(2011-1#1)
of their study##2##3##(1990-5#1)(2009-7#1)
of their surgery##2##3##(1995-1#1)(2012-3#1)
of their targets##2##3##(2009-8#1)(2012-2#1)
of their three##2##3##(2008-9#1)(2010-2#1)
of their time in##2##4##(1994-2#1)(2008-11#1)
of their time##4##3##(1994-2#2)(2008-11#1)(2010-8#1)
of their total FTEs as##2##5##(1996-3#2)
of their total##8##3##(1992-5#1)(1996-3#3)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#1)
of their training##3##3##(1992-6#1)(2008-11#2)
of their underlying##2##3##(2008-8#1)(2009-11#1)
of their understanding of##2##4##(2008-12#2)
of their understanding##3##3##(2008-12#2)(2009-12#1)
of their unique##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
of their use in##2##4##(1991-12#1)(2008-10#1)
of their use##10##3##(1990-2#1)(1991-12#2)(1992-3#1)(2008-10#1)(2008-11#3)(2008-8#1)(2013-8#1)
of their work##6##3##(1991-12#1)(1994-12#1)(1995-6#1)(2008-12#1)(2008-7#1)(2012-2#1)
of their working##2##3##(1992-6#1)(2008-10#1)
of their##1059##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#8)(1990-6#4)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#3)(1991-12#7)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#7)(1992-5#3)(1992-6#9)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#6)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#6)(1994-11#4)(1994-12#5)(1994-2#7)(1994-3#6)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#10)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#8)(1995-5#3)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#11)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#12)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#3)(2006-5#2)(2007-10#6)(2007-11#12)(2007-12#15)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#4)(2008-1#9)(2008-10#118)(2008-11#63)(2008-12#20)(2008-2#19)(2008-3#26)(2008-4#17)(2008-5#29)(2008-6#10)(2008-7#37)(2008-8#33)(2008-9#31)(2009-10#7)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#10)(2009-6#4)(2009-7#8)(2009-8#11)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#18)(2010-4#8)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#19)(2011-2#29)(2011-3#1)(2011-7#2)(2012-1#3)(2012-12#15)(2012-2#23)(2012-3#17)(2012-4#2)(2012-5#1)(2013-1#42)(2013-7#7)(2013-8#16)
of them admitted to##2##4##(2008-7#1)(2012-3#1)
of them and##3##3##(1994-8#1)(2007-11#1)(2013-8#1)
of them are in##2##4##(2008-10#1)(2011-2#1)
of them are not##2##4##(1990-6#1)(1996-4#1)
of them are present in##2##5##(2008-10#1)(2012-2#1)
of them are probably##2##4##(1994-8#1)(2008-9#1)
of them are##24##3##(1990-6#1)(1991-5#1)(1994-8#1)(1995-12#1)(1996-4#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-9#2)(2009-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of them as##2##3##(2010-10#1)(2010-8#1)
of them being##6##3##(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#2)(2013-1#1)
of them can be##2##4##(2008-9#1)(2013-8#1)
of them contained##4##3##(1993-8#1)(1995-12#1)(2008-10#2)
of them could##4##3##(1995-8#1)(2007-11#1)(2011-1#1)(2013-1#1)
of them died##2##3##(1995-2#1)(2011-2#1)
of them encode##3##3##(1993-2#1)(2008-4#2)
of them exhibit significant similarity to known proteins##2##8##(1996-8#1)(1997-7#1)
of them from##3##3##(2011-2#2)(2013-1#1)
of them had a##6##4##(1990-3#1)(1991-11#1)(1991-2#1)(1997-6#1)(2008-7#1)(2011-2#1)
of them had no##3##4##(1996-2#1)(2007-8#1)(2011-2#1)
of them had##30##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-4#1)(1992-10#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
of them has##4##3##(2008-1#1)(2008-10#1)(2011-2#2)
of them have been##3##4##(1990-3#1)(1997-8#1)(2009-10#1)
of them have##9##3##(1990-3#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of them in##5##3##(1993-6#1)(2007-11#1)(2008-10#2)(2008-2#1)
of them is##7##3##(1992-3#1)(1992-9#1)(1996-11#1)(2008-10#3)(2009-2#1)
of them may be##2##4##(1995-8#1)(2011-1#1)
of them may##4##3##(1995-8#1)(2008-7#1)(2011-1#1)(2013-1#1)
of them on##2##3##(2008-11#1)(2011-2#1)
of them presented with##3##4##(1991-8#1)(2008-7#1)(2013-1#1)
of them presented##5##3##(1991-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
of them reported##2##3##(2011-2#1)(2013-8#1)
of them showed##5##3##(1992-12#1)(1995-12#1)(2008-5#2)(2010-2#1)
of them the##3##3##(1994-3#1)(2008-10#2)
of them underwent##3##3##(2008-1#1)(2008-3#1)(2010-3#1)
of them used##2##3##(1990-10#1)(2011-2#1)
of them was##7##3##(1993-5#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-9#1)(2012-3#1)
of them were identified as##3##5##(2008-10#1)(2008-5#1)(2010-12#1)
of them were##52##3##(1990-2#1)(1990-3#1)(1990-6#1)(1992-10#1)(1993-2#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-9#3)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#3)(2013-7#1)
of them with##3##3##(1991-8#1)(2008-10#2)
of them##405##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#4)(1990-7#2)(1991-11#3)(1991-12#1)(1991-2#5)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#5)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(1997-9#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#12)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#5)(2008-1#5)(2008-10#56)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#10)(2008-5#12)(2008-6#1)(2008-7#17)(2008-8#4)(2008-9#16)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#6)(2011-1#11)(2011-2#27)(2012-1#5)(2012-12#8)(2012-2#4)(2012-3#10)(2012-4#1)(2013-1#19)(2013-7#6)(2013-8#6)
of them)##2##2##(2008-10#1)(2009-9#1)
of themes##2##2##(2008-11#1)(2010-10#1)
of themselves##5##2##(1995-3#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
of theophylline in tea and drug formulation##2##7##(2008-10#2)
of theophylline on ion transport in##2##6##(2008-1#2)
of theophylline##9##2##(1990-8#1)(1991-2#2)(2007-8#1)(2008-1#2)(2008-10#3)
of theoretical and experimental##3##4##(2008-3#3)
of theoretical and##6##3##(1990-12#1)(2008-3#5)
of theoretical knowledge##3##3##(2008-1#1)(2008-11#2)
of theoretical maximum##2##3##(2008-6#2)
of theoretical studies##2##3##(2007-11#1)(2008-9#1)
of theoretical yield##2##3##(2008-6#2)
of theoretical##39##2##(1990-12#1)(1992-5#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#8)(2008-6#6)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
of theories##3##2##(2008-9#1)(2011-1#1)(2013-8#1)
of theory and##3##3##(1993-3#1)(2007-12#1)(2012-3#1)
of theory of mind##3##4##(2008-12#1)(2012-1#2)
of theory to practice##3##4##(2008-11#3)
of theory##19##2##(1993-3#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-9#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-3#1)
of therapeutic aerosols##2##3##(1995-3#1)(1996-2#1)
of therapeutic agents##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
of therapeutic antibodies##5##3##(2008-11#3)(2010-11#2)
of therapeutic applications##2##3##(1994-5#1)(1997-8#1)
of therapeutic approaches##2##3##(2008-5#1)(2008-9#1)
of therapeutic benefit in##2##4##(2008-10#1)(2008-3#1)
of therapeutic communication##2##3##(2008-11#2)
of therapeutic drug##2##3##(2008-6#1)(2012-2#1)
of therapeutic drugs##4##3##(1994-11#1)(2008-3#1)(2008-8#1)(2009-6#1)
of therapeutic effects##2##3##(1997-2#1)(2012-3#1)
of therapeutic efficacy##3##3##(2008-11#1)(2009-12#1)(2009-8#1)
of therapeutic failure##2##3##(2008-10#1)(2012-2#1)
of therapeutic intervention##3##3##(1994-8#1)(2007-11#2)
of therapeutic interventions##3##3##(2008-11#1)(2010-2#1)(2013-7#1)
of therapeutic methods##2##3##(1990-6#1)(2013-1#1)
of therapeutic proteins##5##3##(2008-10#2)(2008-11#2)(2013-8#1)
of therapeutic strategies for##2##4##(2007-8#1)(2011-9#1)
of therapeutic strategies##3##3##(1990-6#1)(2007-8#1)(2011-9#1)
of therapeutic targets##2##3##(2008-5#1)(2009-12#1)
of therapeutic vaccines##2##3##(2007-12#1)(2008-4#1)
of therapeutic value##3##3##(1991-9#1)(1993-2#1)(2009-8#1)
of therapeutic##95##2##(1990-6#3)(1991-11#2)(1991-9#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
of therapies##4##2##(1995-4#1)(1995-6#1)(2008-7#2)
of therapists' supervision time##2##4##(1995-3#2)
of therapy and##10##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of therapy are##2##3##(1994-7#1)(2012-3#1)
of therapy can be##2##4##(2008-3#1)(2011-1#1)
of therapy can##3##3##(1996-6#1)(2008-3#1)(2011-1#1)
of therapy for both##2##4##(2007-12#1)(2008-11#1)
of therapy for##17##3##(1991-6#1)(1992-2#2)(2007-10#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#3)(2012-2#1)
of therapy has##2##3##(1996-3#1)(2007-10#1)
of therapy in the##5##4##(1995-5#1)(2007-7#1)(2008-10#2)(2009-6#1)
of therapy in##8##3##(1995-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-6#1)(2009-9#1)(2013-1#1)
of therapy is to eliminate or##2##6##(2012-3#1)(2013-8#1)
of therapy is##4##3##(1990-10#1)(2009-10#1)(2012-3#1)(2013-8#1)
of therapy of##2##3##(2008-1#1)(2011-2#1)
of therapy on##2##3##(1996-2#1)(2013-8#1)
of therapy progress feedback##2##4##(2012-2#2)
of therapy progress##4##3##(2012-2#4)
of therapy than##3##3##(2008-5#1)(2008-8#2)
of therapy was##2##3##(2007-12#1)(2008-1#1)
of therapy were##2##3##(1992-10#1)(2013-1#1)
of therapy with##4##3##(1994-6#1)(1996-3#1)(2013-1#2)
of therapy##157##2##(1990-10#1)(1990-12#3)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-6#3)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-9#2)(1994-12#1)(1994-6#3)(1994-7#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#2)(2007-10#3)(2007-11#5)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#4)(2008-3#7)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#5)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#10)(2013-8#4)
of therapy]##2##2##(1992-5#1)(2012-3#1)
of thermal and##4##3##(1995-2#1)(2007-12#1)(2008-3#1)(2009-5#1)
of thermal annealing##2##3##(2008-2#2)
of thermal conductivity##2##3##(2008-3#2)
of thermal decomposition products##2##4##(2008-10#2)
of thermal decomposition##4##3##(2008-10#4)
of thermal denaturation##2##3##(1993-11#1)(1997-2#1)
of thermal effects in a diode-end-pumped##2##6##(2008-2#2)
of thermal effects##3##3##(2008-2#2)(2008-3#1)
of thermal fluctuations##2##3##(2008-3#2)
of thermal hyperalgesia in a##2##5##(1995-12#1)(1996-5#1)
of thermal hyperalgesia induced by##3##5##(1995-12#2)(2008-7#1)
of thermal hyperalgesia##6##3##(1995-12#4)(1996-5#1)(2008-7#1)
of thermal inactivation##2##3##(2008-10#2)
of thermal infrared##2##3##(2007-11#1)(2008-3#1)
of thermal injury on##3##4##(2008-9#3)
of thermal injury##4##3##(1995-1#1)(2008-9#3)
of thermal ionization mass spectrometry##2##5##(1992-7#1)(2008-10#1)
of thermal lens spectrometry##3##4##(2008-10#3)
of thermal lensing##7##3##(2007-11#1)(2008-10#2)(2008-3#4)
of thermal loading##2##3##(2008-2#2)
of thermal treatment##2##3##(2007-11#1)(2008-10#1)
of thermal##80##2##(1990-2#2)(1992-3#1)(1992-7#1)(1993-11#1)(1995-1#1)(1995-12#4)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#5)(2007-12#4)(2008-10#19)(2008-2#9)(2008-3#17)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
of thermally evaporated germanium thin##2##5##(2008-2#2)
of thermally induced birefringence##2##4##(2008-2#1)(2008-3#1)
of thermally induced##4##3##(1994-5#1)(2008-2#1)(2008-3#2)
of thermally##15##2##(1994-5#1)(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#4)(2009-5#1)(2011-1#1)
of thermodynamic##7##2##(1990-8#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-3#1)
of thermodynamics##4##2##(1993-12#1)(2008-3#1)(2008-5#2)
of thermogenesis##2##2##(2013-1#2)
of thermolysin##3##2##(1994-5#3)
of thermoregulation##3##2##(2007-10#1)(2009-8#1)(2011-2#1)
of thermosensitive##2##2##(2013-1#2)
of thermostable##4##2##(1997-4#2)(2008-10#1)(2008-7#1)
of these &quot##2##3##(2008-1#1)(2009-7#1)
of these 11##3##3##(1991-8#1)(2008-10#1)(2010-3#1)
of these 2##6##3##(1992-2#1)(1992-6#1)(1992-8#1)(1997-2#1)(2009-1#1)(2013-7#1)
of these 23##2##3##(1996-1#1)(2008-10#1)
of these 3##2##3##(1990-6#1)(1991-3#1)
of these G-protein alpha-subunits##2##4##(1991-9#1)(1994-6#1)
of these M##2##3##(2008-10#1)(2008-5#1)
of these ORFs##5##3##(1991-9#1)(1995-9#1)(1997-3#2)(2008-10#1)
of these PCR##2##3##(1991-9#1)(2008-10#1)
of these QTL##2##3##(2008-10#1)(2009-5#1)
of these a##2##3##(2008-11#1)(2013-8#1)
of these abnormalities##2##3##(1993-8#1)(2008-4#1)
of these absorption##2##3##(2008-10#1)(2013-8#1)
of these activities##6##3##(1991-1#1)(1991-5#1)(1994-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
of these advantages##2##3##(1994-3#1)(2012-2#1)
of these adverse effects##3##4##(1991-11#1)(2007-7#1)(2011-2#1)
of these agents has##2##4##(2007-12#1)(2011-2#1)
of these agents have##2##4##(2007-11#1)(2008-8#1)
of these agents in##5##4##(1995-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
of these agents is##2##4##(2008-3#1)(2010-3#1)
of these agents##38##3##(1990-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
of these alterations on##2##4##(1990-2#1)(1996-2#1)
of these alterations##6##3##(1990-2#1)(1996-2#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-12#1)
of these amino acids##3##4##(1995-6#1)(2008-10#2)
of these analogs##2##3##(1994-11#1)(2009-2#1)
of these analyses##6##3##(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
of these analytes##5##3##(1996-5#2)(2008-10#3)
of these and other##2##4##(2008-10#1)(2008-9#1)
of these and##9##3##(1990-5#1)(1993-6#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-1#1)
of these animals##6##3##(1994-2#1)(1996-12#2)(2008-10#1)(2008-12#1)(2008-9#1)
of these anions##2##3##(1991-8#1)(2008-10#1)
of these annulenes##2##3##(1996-5#2)
of these antibiotics##3##3##(2008-10#2)(2008-11#1)
of these antibodies had##2##4##(1991-5#1)(1991-9#1)
of these antibodies##6##3##(1991-5#1)(1991-9#1)(1996-11#2)(1997-7#1)(2008-1#1)
of these antibody##2##3##(1991-12#1)(2009-11#1)
of these antioxidants##3##3##(2008-10#2)(2009-12#1)
of these approaches##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#2)(2013-1#2)
of these are##10##3##(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-12#1)(2010-11#1)(2012-2#2)
of these areas##10##3##(1992-3#1)(1994-8#1)(1997-2#2)(1997-3#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)
of these aspects##2##3##(2008-10#1)(2008-11#1)
of these assays are##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
of these assays##9##3##(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2011-1#1)
of these associations##4##3##(1997-3#1)(2008-10#1)(2009-7#1)(2012-12#1)
of these attitudes##2##3##(1996-2#1)(2010-10#1)
of these bacteria were##2##4##(1993-2#1)(2008-10#1)
of these bacteria##10##3##(1993-2#1)(2008-10#7)(2008-9#1)(2011-2#1)
of these bacterial##2##3##(1997-8#1)(2009-5#1)
of these bands##4##3##(1996-4#1)(2008-10#2)(2008-5#1)
of these beams##2##3##(2007-12#2)
of these behaviors##4##3##(1993-6#1)(2008-4#3)
of these being##2##3##(1995-2#1)(2011-1#1)
of these benefits##2##3##(1991-8#1)(2010-1#1)
of these benzamides##2##3##(1990-5#1)(2008-10#1)
of these biologicals##2##3##(2007-11#1)(2008-11#1)
of these biosensors##2##3##(2008-10#2)
of these cDNA clones##2##4##(1990-12#1)(1993-11#1)
of these cDNAs##4##3##(1993-12#2)(1993-8#1)(1994-12#1)
of these calibration curves##2##4##(2008-10#1)(2008-3#1)
of these campaigns##2##3##(2008-3#1)(2008-9#1)
of these can be##2##4##(2006-10#1)(2012-2#1)
of these can##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
of these cancers##2##3##(2008-11#1)(2013-1#1)
of these cases are##4##4##(1991-8#1)(2010-1#1)(2013-1#2)
of these cases could##2##4##(1997-6#1)(2008-7#1)
of these cases had##2##4##(1992-8#1)(2008-7#1)
of these cases should##2##4##(2007-7#1)(2010-8#1)
of these cases##32##3##(1991-12#2)(1991-8#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
of these categories and##2##4##(2008-11#1)(2008-12#1)
of these categories##4##3##(1995-6#1)(2007-4#1)(2008-11#1)(2008-12#1)
of these cell bioassay systems##2##5##(2008-10#2)
of these cell lines##9##4##(1990-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-6#1)(2008-11#2)(2008-4#1)
of these cell types##2##4##(2008-4#1)(2008-7#1)
of these cell##15##3##(1990-5#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2010-3#1)
of these cells are##2##4##(2008-4#1)(2008-9#1)
of these cells in a##2##5##(2008-11#1)(2010-1#1)
of these cells in the##3##5##(1992-9#1)(1996-12#1)(2009-5#1)
of these cells in##7##4##(1992-9#1)(1996-12#1)(2008-11#1)(2009-5#1)(2010-1#1)(2012-2#1)(2013-8#1)
of these cells is##2##4##(1992-12#1)(1994-9#1)
of these cells to##2##4##(1996-2#1)(2009-3#1)
of these cells were##5##4##(1992-6#1)(1993-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
of these cells with##4##4##(1991-9#1)(1992-9#1)(1993-6#1)(1995-12#1)
of these cells##65##3##(1990-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#3)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of these challenges##6##3##(2007-12#1)(2007-5#1)(2008-1#1)(2009-12#1)(2010-10#1)(2011-1#1)
of these changes can##2##4##(1991-2#1)(2007-12#1)
of these changes have been##2##5##(1992-3#1)(2013-7#1)
of these changes in##2##4##(2007-8#1)(2008-2#1)
of these changes on##2##4##(1992-1#1)(2010-2#1)
of these changes were##2##4##(2008-12#1)(2011-1#1)
of these changes##24##3##(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-11#1)(1995-1#1)(1995-3#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
of these channels##7##3##(1994-11#2)(1994-2#1)(2008-5#1)(2008-7#1)(2008-8#2)
of these characteristic##2##3##(2010-10#1)(2012-12#1)
of these characteristics##5##3##(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#2)
of these chemicals in##2##4##(1993-3#1)(2008-10#1)
of these chemicals##9##3##(1993-3#1)(2008-10#6)(2008-11#1)(2008-2#1)
of these children were##2##4##(1990-12#1)(1996-1#1)
of these children##10##3##(1990-12#1)(1994-6#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#2)
of these chromosomes##3##3##(1996-12#1)(1997-5#1)(2008-7#1)
of these classes of##2##4##(1997-2#1)(2007-10#1)
of these clinical##4##3##(1994-12#1)(2010-6#1)(2013-7#2)
of these clones were##2##4##(1991-12#1)(2008-11#1)
of these clones##4##3##(1991-12#1)(1997-8#2)(2008-11#1)
of these clusters##4##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-5#1)
of these companies##2##3##(1995-1#2)
of these complexes in the##2##5##(1996-2#1)(2008-10#1)
of these complexes in##4##4##(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#1)
of these complexes##12##3##(1992-9#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-11#1)
of these complications##4##3##(1991-5#1)(2007-6#1)(2008-7#1)(2011-2#1)
of these components in##2##4##(1994-5#1)(1997-3#1)
of these components is##2##4##(1996-9#1)(2009-8#1)
of these components##13##3##(1994-5#1)(1996-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)
of these compounds against##2##4##(1992-9#1)(2008-10#1)
of these compounds and##6##4##(1990-7#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-11#1)
of these compounds are##6##4##(1992-8#1)(2007-11#1)(2008-10#4)
of these compounds for the##2##5##(1995-12#1)(2008-11#1)
of these compounds for##3##4##(1995-12#2)(2008-11#1)
of these compounds has##2##4##(2008-10#1)(2008-11#1)
of these compounds in natural##2##5##(2008-10#2)
of these compounds in the##3##5##(1990-5#1)(2008-10#1)(2010-5#1)
of these compounds in##17##4##(1990-12#1)(1990-5#1)(1994-2#1)(2008-10#11)(2008-5#2)(2010-5#1)
of these compounds on the##2##5##(2008-10#2)
of these compounds on##4##4##(1990-11#1)(1993-12#1)(2008-10#2)
of these compounds showed##3##4##(1995-3#1)(2007-11#1)(2009-12#1)
of these compounds to##2##4##(1993-11#1)(2008-10#1)
of these compounds was##11##4##(1993-11#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2012-2#1)
of these compounds were##11##4##(1990-11#1)(1990-8#1)(1993-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-5#1)(2011-2#2)
of these compounds with##6##4##(1991-5#1)(1992-11#1)(2008-10#1)(2009-7#1)(2009-9#1)(2012-3#1)
of these compounds##108##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#3)(1995-3#1)(1995-6#1)(2007-11#6)(2008-10#44)(2008-11#6)(2008-4#1)(2008-5#3)(2008-8#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#1)
of these concepts##3##3##(2007-4#1)(2008-10#1)(2008-7#1)
of these concerns##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
of these conditions are##4##4##(1991-8#1)(2007-7#1)(2010-5#1)(2013-1#1)
of these conditions in##3##4##(2008-2#1)(2008-8#1)(2012-2#1)
of these conditions is##2##4##(1994-2#1)(2012-7#1)
of these conditions were##2##4##(2008-8#2)
of these conditions##27##3##(1990-7#1)(1991-8#1)(1993-6#1)(1994-2#1)(1994-9#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#4)(2008-9#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
of these considerations##2##3##(1991-3#1)(2011-1#1)
of these constructs##2##3##(2008-11#1)(2008-12#1)
of these control##3##3##(2008-10#2)(2013-8#1)
of these countries##4##3##(1994-12#1)(2008-4#1)(2009-10#1)(2012-12#1)
of these criteria##7##3##(1993-8#1)(1995-2#1)(1997-8#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-5#1)
of these critical##2##3##(1995-2#1)(2011-1#1)
of these currently##2##3##(2008-11#1)(2013-1#1)
of these cytokines##4##3##(1990-2#1)(1994-11#1)(2006-10#1)(2008-9#1)
of these data are##2##4##(2008-4#1)(2009-4#1)
of these data is##3##4##(1993-11#1)(1995-9#1)(2007-12#1)
of these data##19##3##(1992-12#1)(1993-11#1)(1995-9#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
of these databases##2##3##(1997-1#1)(2009-3#1)
of these deletants##2##3##(2008-8#2)
of these deliberations##2##3##(2007-12#1)(2008-11#1)
of these derivatives##2##3##(1992-9#1)(2012-3#1)
of these descriptors##2##3##(2008-10#2)
of these developments##5##3##(1991-2#1)(1993-1#1)(2007-5#1)(2008-10#1)(2010-12#1)
of these devices and##4##4##(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
of these devices are discussed##2##5##(2007-12#1)(2010-11#1)
of these devices are##3##4##(2007-11#1)(2007-12#1)(2010-11#1)
of these devices for##2##4##(2007-2#1)(2008-7#1)
of these devices is##2##4##(2008-5#1)(2010-8#1)
of these devices##18##3##(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)
of these diabetic##2##3##(2008-1#1)(2008-10#1)
of these diagnostic##2##3##(1990-12#1)(1992-6#1)
of these differences in##3##4##(1993-12#1)(2008-8#2)
of these differences##12##3##(1991-12#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)
of these different##2##3##(1997-7#1)(2008-10#1)
of these dinucleotides##2##3##(2008-4#2)
of these disease##3##3##(2008-3#2)(2010-4#1)
of these disease-associated##2##3##(1997-8#1)(2011-1#1)
of these diseases and##3##4##(2007-7#1)(2011-1#1)(2013-1#1)
of these diseases are##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
of these diseases is the##2##5##(1994-5#1)(1996-5#1)
of these diseases##25##3##(1992-9#1)(1994-5#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of these disorders are##2##4##(1997-7#1)(2008-8#1)
of these disorders##13##3##(1990-9#1)(1992-1#1)(1994-2#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
of these domains##2##3##(1992-4#1)(2008-7#1)
of these drug effects##2##4##(2008-3#2)
of these drug##3##3##(2008-3#2)(2013-1#1)
of these drugs in the treatment of##3##7##(1996-3#1)(2007-11#2)
of these drugs in the##4##5##(1996-3#1)(2007-11#2)(2010-6#1)
of these drugs in##9##4##(1991-8#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-6#3)
of these drugs is##4##4##(2010-11#2)(2010-4#1)(2010-5#1)
of these drugs may##3##4##(2008-10#1)(2008-8#1)(2009-4#1)
of these drugs on##2##4##(2008-10#1)(2013-1#1)
of these drugs with##3##4##(1995-5#1)(2008-8#1)(2013-8#1)
of these drugs##49##3##(1990-3#1)(1991-1#1)(1991-8#2)(1991-9#1)(1992-12#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-11#2)(2008-10#11)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
of these dyes##2##3##(2008-10#1)(2010-2#1)
of these early##3##3##(1990-8#1)(1994-6#1)(1994-8#1)
of these effects and##3##4##(1997-2#1)(2008-3#1)(2008-5#1)
of these effects##14##3##(1991-2#1)(1992-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)
of these electrodes in##2##4##(2008-10#2)
of these electrodes to##2##4##(2008-10#2)
of these electrodes##7##3##(2008-10#7)
of these elements are##2##4##(2010-9#1)(2013-1#1)
of these elements from##2##4##(2008-10#2)
of these elements in the##2##5##(1990-5#1)(2008-10#1)
of these elements in##4##4##(1990-5#1)(2008-10#2)(2009-6#1)
of these elements##21##3##(1990-5#1)(1993-6#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
of these enigmatic##3##3##(2007-7#1)(2009-3#1)(2011-2#1)
of these entities##3##3##(1996-3#1)(2008-3#1)(2010-7#1)
of these enzymes has been##2##5##(2008-10#1)(2012-12#1)
of these enzymes in##5##4##(1990-7#1)(1991-11#1)(1995-11#1)(1995-3#1)(2008-11#1)
of these enzymes were##2##4##(2008-10#1)(2008-4#1)
of these enzymes##29##3##(1990-7#4)(1990-8#1)(1991-11#1)(1991-5#2)(1992-8#1)(1993-11#1)(1994-8#2)(1995-11#1)(1995-3#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2012-12#1)(2013-8#1)
of these equations##2##3##(2008-10#1)(2008-3#1)
of these error##2##3##(2008-3#2)
of these errors##5##3##(2008-3#4)(2009-9#1)
of these events##7##3##(1991-12#1)(1992-11#1)(2008-10#2)(2008-4#1)(2008-9#2)
of these examples##2##3##(2008-12#1)(2008-3#1)
of these experimental##2##3##(2007-12#1)(2008-10#1)
of these experiments are##2##4##(1990-11#1)(2006-4#1)
of these experiments##10##3##(1990-11#1)(1992-3#1)(1994-3#1)(1995-6#1)(2006-4#1)(2008-10#4)(2008-6#1)
of these expressions##2##3##(2007-12#1)(2008-3#1)
of these extracts##2##3##(2008-5#1)(2013-1#1)
of these extremely##2##3##(2007-8#1)(2008-1#1)
of these factors and##2##4##(2008-3#1)(2011-1#1)
of these factors are##5##4##(1993-12#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)
of these factors in##5##4##(2008-12#1)(2008-2#1)(2011-2#2)(2013-8#1)
of these factors is##2##4##(2008-10#1)(2009-10#1)
of these factors on##4##4##(2008-10#3)(2008-3#1)
of these factors to##2##4##(1995-3#1)(1996-12#1)
of these factors##34##3##(1990-12#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-8#1)
of these features##4##3##(1991-12#1)(1994-6#1)(2007-12#1)(2008-3#1)
of these films##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of these filters are##2##4##(2007-11#1)(2008-3#1)
of these filters##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)
of these findings are discussed##9##5##(1991-2#1)(1993-1#1)(1994-2#1)(2008-1#1)(2008-12#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
of these findings are##11##4##(1991-2#1)(1993-1#1)(1994-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#2)
of these findings for the##5##5##(1991-5#1)(2008-10#1)(2009-11#1)(2009-9#1)(2012-1#1)
of these findings for##13##4##(1991-5#1)(1992-3#1)(2008-10#2)(2008-3#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2012-1#1)(2012-2#1)
of these findings in##4##4##(1994-11#1)(1996-3#1)(2008-10#1)(2011-2#1)
of these findings##52##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-3#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-9#2)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#5)(2012-2#1)(2013-1#2)(2013-8#2)
of these fish were##2##4##(2008-5#1)(2010-8#1)
of these fish##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
of these five##6##3##(1993-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2013-1#1)
of these formae speciales##2##4##(2008-10#2)
of these forms##4##3##(1990-12#1)(1990-2#1)(2008-3#1)(2008-9#1)
of these four##6##3##(2008-10#5)(2008-9#1)
of these fractions##4##3##(1990-12#1)(1990-5#1)(1997-2#1)(2008-10#1)
of these fractures##2##3##(2013-1#2)
of these fragments##2##3##(1993-11#1)(2008-11#1)
of these functions##8##3##(1990-3#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
of these funds##2##3##(1996-1#2)
of these fungi##4##3##(2008-10#2)(2013-1#2)
of these gene##5##3##(2006-10#1)(2008-4#1)(2008-6#1)(2012-12#2)
of these genes are##3##4##(2008-8#1)(2011-2#1)(2013-8#1)
of these genes has##2##4##(1990-5#1)(1991-9#1)
of these genes in the##2##5##(2008-10#1)(2008-4#1)
of these genes in##9##4##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2011-2#1)
of these genes may##2##4##(1990-3#1)(2008-9#1)
of these genes to##2##4##(2008-10#2)
of these genes were##6##4##(2008-10#3)(2008-7#1)(2008-8#1)(2013-8#1)
of these genes##60##3##(1990-3#1)(1990-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-9#1)(1994-9#1)(1995-12#3)(1996-12#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-4#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
of these genomic##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
of these glands##2##3##(2007-12#2)
of these glasses##2##3##(2007-12#1)(2008-2#1)
of these gradients##2##3##(2010-3#2)
of these gratings##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
of these groups is##2##4##(2008-10#2)
of these groups##7##3##(1991-12#1)(2008-10#3)(2008-11#1)(2010-2#1)(2013-7#1)
of these growth factors##2##4##(1992-9#1)(2010-10#1)
of these growth##3##3##(1992-9#1)(2008-11#1)(2010-10#1)
of these guidelines##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
of these had developed AIDS and##3##6##(1996-11#3)
of these had##10##3##(1990-11#1)(1994-2#1)(1995-9#1)(1996-11#4)(2008-5#1)(2008-6#1)(2012-12#1)
of these have been##4##4##(1994-9#1)(2008-7#1)(2008-9#1)(2009-8#1)
of these have##7##3##(1994-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2013-1#1)
of these health##3##3##(1996-12#1)(2008-4#2)
of these herbicides in##4##4##(2008-10#4)
of these herbicides##6##3##(1996-3#1)(2008-10#5)
of these heuristic algorithms##2##4##(2010-2#2)
of these high##3##3##(1993-11#1)(1997-3#1)(2008-10#1)
of these highly##4##3##(2008-1#1)(2008-5#2)(2010-6#1)
of these hormones##3##3##(1996-12#1)(2008-1#1)(2008-4#1)
of these hospitals##2##3##(1992-12#1)(1992-2#1)
of these human##2##3##(1990-5#1)(1994-5#1)
of these hypotheses##3##3##(2008-6#1)(2008-9#2)
of these ideas##3##3##(1992-3#1)(2007-11#1)(2008-7#1)
of these immunological##2##3##(2007-11#1)(2013-7#1)
of these in vitro##2##4##(2008-10#1)(2008-5#1)
of these in##7##3##(1993-12#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
of these indicators##2##3##(1992-10#1)(1994-2#1)
of these indices##2##3##(2008-8#1)(2012-3#1)
of these individuals##9##3##(1991-11#1)(1995-3#2)(1997-8#1)(2008-11#3)(2008-7#1)(2010-11#1)
of these infants##3##3##(1992-3#2)(2011-2#1)
of these infections##8##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#3)
of these inhibitors was##2##4##(1991-2#1)(1992-6#1)
of these inhibitors##6##3##(1991-2#1)(1992-12#1)(1992-6#3)(1997-3#1)
of these initial##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
of these injuries can be##3##5##(1994-3#2)(2008-8#1)
of these injuries##7##3##(1990-6#1)(1994-3#2)(2007-8#1)(2008-8#1)(2008-9#1)(2010-9#1)
of these innovative##2##3##(1991-12#1)(2008-10#1)
of these instruments##6##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
of these interactions is##3##4##(1993-1#1)(2008-10#1)(2011-2#1)
of these interactions##7##3##(1993-1#1)(2007-12#1)(2008-10#3)(2009-7#1)(2011-2#1)
of these interventions in##2##4##(2008-10#1)(2008-2#1)
of these interventions##8##3##(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#3)(2013-1#1)
of these investigations##2##3##(2008-3#1)(2012-12#1)
of these ions##12##3##(1996-7#1)(2008-10#11)
of these is##6##3##(1992-11#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
of these islands##3##3##(1990-5#1)(2008-8#2)
of these isoforms##2##3##(1990-12#1)(2008-10#1)
of these isolates was##3##4##(2008-10#3)
of these isolates were determined##2##5##(2008-10#2)
of these isolates were##8##4##(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
of these isolates##24##3##(1995-12#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
of these issues is##2##4##(2007-12#1)(2011-1#1)
of these issues with##2##4##(1996-3#1)(2010-5#1)
of these issues##15##3##(1990-6#1)(1991-2#1)(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2010-5#1)(2011-1#1)
of these items##3##3##(1996-3#1)(2008-7#2)
of these junctions##2##3##(1993-6#1)(2007-12#1)
of these kinases##2##3##(2008-9#1)(2012-12#1)
of these large##3##3##(1992-2#1)(2011-1#1)(2012-3#1)
of these lasers##2##3##(2008-3#2)
of these latter##3##3##(2008-10#1)(2008-7#2)
of these lesions has##2##4##(2007-10#1)(2008-5#1)
of these lesions is##2##4##(2008-7#1)(2012-2#1)
of these lesions may##2##4##(2007-12#1)(2010-8#1)
of these lesions##16##3##(1992-2#1)(1994-6#1)(1995-2#1)(1996-9#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
of these ligands##2##3##(1993-11#1)(1994-11#1)
of these light##2##3##(1991-8#1)(1993-9#1)
of these limitations##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
of these lineages##3##3##(1993-3#1)(2008-10#2)
of these lines##2##3##(2008-10#2)
of these lipids##4##3##(1992-8#1)(1993-8#1)(1994-3#1)(2008-10#1)
of these local##2##3##(2008-11#1)(2008-3#1)
of these loci on##2##4##(2008-10#1)(2008-5#1)
of these loci##5##3##(1991-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-8#1)
of these mRNAs##4##3##(1994-8#1)(1996-12#1)(2008-10#1)(2008-7#1)
of these markers in##2##4##(1994-7#1)(2012-1#1)
of these markers##7##3##(1991-2#1)(1994-7#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
of these materials in##2##4##(2008-3#1)(2010-12#1)
of these materials is##2##4##(2008-11#1)(2009-7#1)
of these materials##18##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
of these matrices##2##3##(2008-10#1)(2008-3#1)
of these measurements##6##3##(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)
of these measures to##2##4##(2008-8#1)(2009-10#1)
of these measures##11##3##(1990-2#1)(1992-11#1)(1992-9#1)(1994-3#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-1#1)
of these mechanisms in##2##4##(2011-2#2)
of these mechanisms is##2##4##(1990-2#1)(2008-7#1)
of these mechanisms to##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
of these mechanisms##15##3##(1990-2#1)(1993-9#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2011-2#3)(2012-12#1)
of these media##3##3##(1991-8#1)(2012-2#2)
of these medications##3##3##(2006-10#1)(2008-8#1)(2011-2#1)
of these membranes to##2##4##(1991-5#1)(2009-8#1)
of these membranes##3##3##(1991-5#1)(1992-7#1)(2009-8#1)
of these mental##2##3##(2012-1#1)(2013-8#1)
of these metabolites##4##3##(1991-5#1)(1994-8#1)(2008-10#1)(2008-11#1)
of these metagenomes##2##3##(2011-2#1)(2012-2#1)
of these metal ions were##2##5##(2008-10#2)
of these metal ions##15##4##(2008-10#14)(2008-5#1)
of these metals in the##2##5##(2008-10#1)(2011-1#1)
of these metals in##6##4##(2008-10#4)(2011-1#2)
of these metals was##2##4##(2008-10#2)
of these metals were##2##4##(1997-4#1)(2008-10#1)
of these metals##14##3##(1997-4#1)(2008-10#10)(2008-12#1)(2011-1#2)
of these methods are##3##4##(1995-2#1)(2008-10#1)(2008-9#1)
of these methods for##3##4##(1992-6#2)(2008-9#1)
of these methods to##3##4##(1994-9#1)(2008-10#1)(2008-8#1)
of these methods was##2##4##(2008-10#1)(2012-2#1)
of these methods with##2##4##(1992-1#1)(2010-3#1)
of these methods##32##3##(1992-1#1)(1992-6#3)(1994-9#1)(1995-2#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
of these microbes##2##3##(2008-10#1)(2011-2#1)
of these microorganisms##2##3##(2007-11#1)(2008-10#1)
of these mixtures##2##3##(1993-8#1)(2008-10#1)
of these modalities are##2##4##(1995-5#1)(2008-8#1)
of these modalities##3##3##(1995-5#1)(2008-8#1)(2013-1#1)
of these models are##2##4##(1996-4#1)(2009-5#1)
of these models to##2##4##(2008-8#1)(2012-4#1)
of these models was##2##4##(2008-5#1)(2012-2#1)
of these models##19##3##(1994-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-9#1)(2012-2#2)(2012-4#1)(2013-1#1)
of these modifications##3##3##(1991-12#1)(1992-3#1)(2009-5#1)
of these modified##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)
of these molecular##4##3##(2008-1#1)(2008-2#1)(2009-5#1)(2013-1#1)
of these molecules in##4##4##(1991-2#1)(2007-5#1)(2008-5#1)(2010-10#1)
of these molecules with##2##4##(2008-10#1)(2009-10#1)
of these molecules##23##3##(1991-12#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#3)(2009-10#1)(2010-10#1)(2012-12#1)(2013-8#1)
of these mothers##2##3##(1991-11#1)(2008-2#1)
of these mutants were##2##4##(1993-11#1)(1995-2#1)
of these mutants##11##3##(1990-7#1)(1993-11#1)(1995-2#2)(1997-3#1)(1997-4#1)(2008-10#3)(2008-8#1)(2008-9#1)
of these mutations on##2##4##(2008-11#2)
of these mutations##11##3##(1990-8#1)(1993-11#1)(1993-3#1)(1995-6#1)(1997-8#1)(2008-11#2)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
of these nanoparticles##4##3##(2008-7#1)(2009-2#1)(2010-6#1)(2013-1#1)
of these natural##3##3##(1992-3#1)(2007-5#1)(2008-11#1)
of these neoplasms##3##3##(1990-5#1)(2012-2#1)(2013-1#1)
of these nerves may##2##4##(2008-2#2)
of these nerves##3##3##(2008-2#2)(2011-2#1)
of these networks##2##3##(1996-3#1)(2008-7#1)
of these neurological##2##3##(1995-12#1)(2007-7#1)
of these neurons##11##3##(1990-11#1)(1993-12#2)(1994-2#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-11#3)(2008-4#1)
of these neurotransmitters in the##2##5##(1992-12#1)(2008-7#1)
of these neurotransmitters##4##3##(1992-12#1)(1995-12#1)(2008-2#1)(2008-7#1)
of these new therapeutic##2##4##(1993-2#1)(2010-5#1)
of these new##13##3##(1993-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)
of these nine##2##3##(1996-3#1)(2008-10#1)
of these novel##10##3##(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
of these nuclear##2##3##(1991-12#1)(1994-12#1)
of these nucleosides##2##3##(1992-3#2)
of these objects##2##3##(2007-11#1)(2008-3#1)
of these observations are##2##4##(1995-3#1)(2008-8#1)
of these observations to##2##4##(2008-7#1)(2011-2#1)
of these observations##12##3##(1990-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-2#1)
of these oligosaccharides##3##3##(1991-12#1)(2008-12#1)(2012-2#1)
of these operations##2##3##(2008-10#1)(2008-3#1)
of these options##4##3##(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)
of these organisms in the##2##5##(2011-2#2)
of these organisms is still##2##5##(2008-9#1)(2013-7#1)
of these organisms is##3##4##(2007-7#1)(2008-9#1)(2013-7#1)
of these organisms##11##3##(2007-7#2)(2008-11#1)(2008-9#3)(2011-2#3)(2012-2#1)(2013-7#1)
of these organizations##3##3##(1992-12#1)(1994-12#1)(1996-3#1)
of these organs##2##3##(1990-11#1)(2010-11#1)
of these other##2##3##(2011-2#1)(2012-3#1)
of these painful##2##3##(1992-5#1)(2008-7#1)
of these papers are tabulated##7##5##(2007-8#7)
of these papers##8##3##(2007-8#7)(2008-1#1)
of these parameters are##2##4##(2008-5#1)(2008-7#1)
of these parameters for##2##4##(1992-6#1)(2008-10#1)
of these parameters in##2##4##(2007-8#1)(2008-10#1)
of these parameters on the##2##5##(2008-10#1)(2011-2#1)
of these parameters on##4##4##(2008-10#3)(2011-2#1)
of these parameters##21##3##(1992-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2011-2#1)
of these parasites##4##3##(2007-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of these pathogens are##2##4##(2008-10#2)
of these pathogens##9##3##(1995-5#1)(2007-12#1)(2007-7#1)(2008-10#6)
of these pathways is##2##4##(1995-12#1)(2012-3#1)
of these pathways##7##3##(1995-11#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
of these patients and##6##4##(1991-6#1)(2007-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
of these patients are also##2##5##(2008-2#1)(2011-1#1)
of these patients are##8##4##(1990-9#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-8#2)(2011-1#1)(2013-1#1)
of these patients as##2##4##(2008-7#1)(2012-3#1)
of these patients had an##2##5##(1992-2#1)(2012-3#1)
of these patients had##10##4##(1990-12#1)(1991-4#1)(1992-2#1)(1995-2#1)(2007-10#2)(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
of these patients have been##2##5##(1994-3#1)(2011-1#1)
of these patients is##3##4##(1990-9#1)(2006-10#1)(2009-12#1)
of these patients may##2##4##(2008-1#1)(2011-1#1)
of these patients required##4##4##(1992-2#1)(2007-7#1)(2008-6#1)(2012-2#1)
of these patients to##2##4##(2008-3#1)(2010-6#1)
of these patients was##3##4##(1991-3#1)(2008-7#1)(2012-3#1)
of these patients were##8##4##(1990-8#1)(1991-2#1)(1994-9#1)(1996-9#1)(2008-7#1)(2008-9#1)(2013-1#2)
of these patients##118##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#4)(1991-8#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-2#2)(1996-9#1)(1997-4#1)(1997-8#3)(2006-10#2)(2006-12#1)(2007-10#5)(2007-11#3)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-12#1)(2009-5#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#1)
of these patterns on the##2##5##(2008-2#1)(2008-3#1)
of these patterns##7##3##(1994-2#1)(2008-10#1)(2008-2#3)(2008-3#2)
of these peaks##5##3##(1990-5#2)(2008-10#1)(2008-9#1)(2009-6#1)
of these people##2##3##(2008-1#1)(2012-12#1)
of these peptides to##2##4##(1994-11#1)(2008-10#1)
of these peptides##14##3##(1990-11#1)(1990-12#2)(1991-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-6#1)(2011-2#1)
of these persons##3##3##(1994-2#1)(2012-2#2)
of these pesticides##4##3##(2008-10#4)
of these phages##2##3##(1994-12#2)
of these phase##2##3##(2007-11#1)(2008-3#1)
of these phenomena##8##3##(1991-1#1)(1991-12#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)
of these phenotypes##3##3##(1994-11#1)(2008-8#1)(2013-1#1)
of these plants##6##3##(2008-10#4)(2009-8#1)(2010-3#1)
of these plasmids##2##3##(2008-5#2)
of these polarization##2##3##(2008-2#1)(2008-3#1)
of these policies##3##3##(1993-3#1)(1997-7#1)(2008-7#1)
of these pollutants##2##3##(2008-10#1)(2011-1#1)
of these polymers##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
of these polymorphic##2##3##(2008-9#1)(2013-8#1)
of these polymorphisms##4##3##(2008-10#1)(2008-4#1)(2012-12#2)
of these populations are##2##4##(2008-10#1)(2008-8#1)
of these populations changed##2##4##(2008-10#2)
of these populations##11##3##(2008-1#1)(2008-10#6)(2008-8#1)(2012-3#2)(2012-7#1)
of these predictions##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
of these preliminary##2##3##(1995-2#1)(2008-3#1)
of these preparations##2##3##(1991-9#1)(2011-1#1)
of these probes##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
of these problems##8##3##(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
of these procedures##8##3##(1991-6#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)
of these processes are##2##4##(2008-10#1)(2008-8#1)
of these processes is##2##4##(2007-8#1)(2011-2#1)
of these processes may##2##4##(2008-11#1)(2008-5#1)
of these processes##18##3##(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of these products is##3##4##(1993-11#1)(2008-10#2)
of these products to##2##4##(2008-10#1)(2008-6#1)
of these products##16##3##(1993-11#1)(1997-3#1)(2006-12#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-8#1)(2012-2#2)
of these profiles##2##3##(2008-10#1)(2008-3#1)
of these programs##11##3##(1995-1#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-3#2)(2012-12#1)(2013-1#4)
of these projects##2##3##(2008-10#1)(2008-8#1)
of these promoters##2##3##(1995-2#1)(1997-4#1)
of these properties##5##3##(1994-8#1)(2008-7#2)(2011-2#1)(2012-2#1)
of these proteases##2##3##(1994-6#1)(2012-3#1)
of these protein##3##3##(1990-5#1)(2008-10#1)(2008-11#1)
of these proteins are##2##4##(1993-2#1)(2008-7#1)
of these proteins by##2##4##(1994-9#1)(2007-12#1)
of these proteins in##6##4##(1994-9#1)(1995-2#2)(2008-11#1)(2008-8#1)(2013-8#1)
of these proteins is##2##4##(2008-11#1)(2008-7#1)
of these proteins may##2##4##(1994-8#1)(2011-2#1)
of these proteins were##2##4##(1994-12#1)(1995-6#1)
of these proteins##38##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of these protocols##3##3##(1994-3#1)(2008-4#1)(2008-9#1)
of these proved to be##2##5##(1995-3#1)(2007-8#1)
of these providers##2##3##(1997-1#1)(1997-2#1)
of these publications##2##3##(2010-8#1)(2011-2#1)
of these pumps##3##3##(2011-2#3)
of these putative##4##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
of these questions##4##3##(1991-3#1)(1995-11#1)(1995-5#1)(2008-7#1)
of these rare##4##3##(2007-5#1)(2010-1#1)(2010-12#1)(2011-2#1)
of these reactions##7##3##(1995-6#1)(2008-10#4)(2008-7#1)(2010-8#1)
of these reagents##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
of these receptors are##2##4##(1993-2#1)(2012-1#1)
of these receptors##15##3##(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#2)(1996-12#1)(2008-10#1)(2008-4#2)(2012-1#1)
of these recommendations##3##3##(1994-2#1)(2007-2#1)(2008-6#1)
of these reference##3##3##(2008-10#2)(2008-2#1)
of these regions##7##3##(1991-10#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(2010-5#1)
of these regulatory##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
of these relationships##5##3##(2008-10#1)(2008-8#1)(2009-8#2)(2010-2#1)
of these repeats##2##3##(1992-10#1)(2008-10#1)
of these reports##3##3##(2010-3#1)(2013-1#1)(2013-8#1)
of these researches##2##3##(1991-9#1)(2011-3#1)
of these residues in the##2##5##(1993-8#1)(1995-5#1)
of these residues##5##3##(1992-4#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-5#1)
of these resources##2##3##(2008-7#1)(2013-7#1)
of these results and##3##4##(2008-10#1)(2008-3#1)(2009-8#1)
of these results are discussed##3##5##(1991-12#1)(2008-11#1)(2008-2#1)
of these results are##5##4##(1991-12#1)(1991-5#1)(2008-11#1)(2008-2#1)(2008-4#1)
of these results for the##3##5##(1994-1#1)(1996-2#1)(2008-10#1)
of these results for##8##4##(1991-5#1)(1994-1#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
of these results in##4##4##(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
of these results is##3##4##(1995-2#1)(2008-3#1)(2010-3#1)
of these results to the##2##5##(2007-11#1)(2008-3#1)
of these results to##5##4##(1995-3#1)(2007-11#2)(2008-10#1)(2008-3#1)
of these results with##3##4##(1993-12#1)(1995-2#1)(2008-12#1)
of these results##57##3##(1991-12#1)(1991-5#2)(1993-1#1)(1993-11#2)(1993-12#1)(1994-1#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
of these risk factors##4##4##(2008-1#1)(2009-4#1)(2009-8#1)(2010-6#1)
of these risk##5##3##(2008-1#1)(2009-4#1)(2009-8#1)(2010-6#1)(2012-2#1)
of these roles##3##3##(2008-12#1)(2010-5#1)(2011-1#1)
of these same##6##3##(1994-2#1)(1995-1#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-2#1)
of these samples is##2##4##(2008-2#1)(2008-3#1)
of these samples was##2##4##(2008-10#2)
of these samples##13##3##(1994-8#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
of these seaweeds revealed##2##4##(2008-11#2)
of these secondary##2##3##(1997-3#1)(2007-11#1)
of these sensors were##2##4##(2008-10#2)
of these sensors##6##3##(2008-10#5)(2008-7#1)
of these sequence##2##3##(1994-11#1)(1995-3#1)
of these sequences##6##3##(1990-12#1)(1993-6#1)(2008-10#4)
of these services were##2##4##(1994-1#1)(2012-12#1)
of these services##6##3##(1994-1#3)(1995-2#1)(1997-8#1)(2012-12#1)
of these sets##2##3##(2008-3#1)(2010-9#1)
of these side effects##2##4##(1991-6#1)(2007-7#1)
of these signaling##2##3##(2008-9#1)(2009-9#1)
of these signals##3##3##(2008-10#1)(2008-4#1)(2009-3#1)
of these signs##2##3##(2007-7#1)(2008-1#1)
of these simulations##3##3##(1993-11#1)(2008-3#2)
of these sites was kinetically ordered##2##6##(1995-2#2)
of these sites##11##3##(1993-11#1)(1994-6#1)(1994-8#1)(1995-2#3)(1996-12#1)(1996-3#1)(2012-2#2)(2013-7#1)
of these six##3##3##(1991-3#1)(1994-6#1)(2010-4#1)
of these solutions##3##3##(1997-4#1)(2008-12#1)(2008-2#1)
of these sources##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
of these special##2##3##(2008-12#1)(2008-2#1)
of these species and##2##4##(2008-10#1)(2008-5#1)
of these species are##3##4##(2007-12#1)(2008-5#1)(2008-9#1)
of these species in the##2##5##(2008-10#1)(2008-5#1)
of these species in##4##4##(2008-10#2)(2008-5#1)(2010-8#1)
of these species is##2##4##(2008-10#1)(2008-9#1)
of these species##27##3##(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
of these specific##3##3##(1994-2#1)(2008-11#1)(2010-8#1)
of these spectra##2##3##(2008-10#2)
of these spectral##2##3##(1995-5#1)(2008-3#1)
of these stages##2##3##(2008-10#1)(2013-8#1)
of these steps##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
of these steroids into##2##4##(1990-2#1)(2012-3#1)
of these steroids##7##3##(1990-11#1)(1990-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(2008-9#1)(2012-3#1)
of these strains was##2##4##(2008-10#2)
of these strains were##2##4##(2008-10#2)
of these strains##13##3##(1993-12#1)(1995-8#1)(2008-10#9)(2008-8#1)(2009-6#1)
of these strategies are##2##4##(1995-8#1)(2008-11#1)
of these strategies##9##3##(1991-6#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#2)
of these structural##2##3##(1992-8#1)(1995-6#1)
of these structures in##3##4##(2009-12#1)(2011-2#1)(2012-2#1)
of these structures to##2##4##(2007-12#2)
of these structures##15##3##(1990-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
of these students##2##3##(2008-11#1)(2013-8#1)
of these studies have been##2##5##(2008-5#1)(2008-7#1)
of these studies in##2##4##(1995-3#1)(2010-12#1)
of these studies is##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
of these studies was##4##4##(1992-11#1)(1994-10#1)(2008-10#1)(2009-8#1)
of these studies##45##3##(1991-9#1)(1992-11#3)(1993-11#1)(1993-3#1)(1994-10#1)(1994-5#1)(1995-3#1)(1996-2#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
of these subjects##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
of these sublines##2##3##(2008-11#2)
of these subpopulations##2##3##(2008-11#1)(2008-4#1)
of these substances##10##3##(1990-3#1)(1991-9#1)(1994-3#1)(1994-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-7#1)
of these substitutions##3##3##(1990-8#1)(1994-8#1)(1995-2#1)
of these substrates##3##3##(1996-5#1)(2008-11#1)(2008-6#1)
of these sunscreens##2##3##(2008-5#2)
of these surfaces##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
of these symmetries##2##3##(2008-3#1)(2010-8#1)
of these symptoms in##2##4##(2008-6#1)(2011-2#1)
of these symptoms##6##3##(1991-8#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-6#1)(2011-2#1)
of these syndromes##4##3##(1996-6#1)(2009-12#2)(2012-2#1)
of these synthetic##2##3##(1993-8#1)(2008-6#1)
of these systems are compared##2##5##(2008-3#1)(2011-2#1)
of these systems are##3##4##(1994-12#1)(2008-3#1)(2011-2#1)
of these systems in a##2##5##(2008-3#2)
of these systems in##4##4##(1994-1#1)(2008-3#2)(2008-8#1)
of these systems is##2##4##(2008-11#1)(2011-7#1)
of these systems should##2##4##(1997-6#1)(2008-10#1)
of these systems##31##3##(1994-1#1)(1994-12#2)(1994-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)
of these techniques are##4##4##(1991-3#1)(1991-9#1)(2008-3#1)(2010-6#1)
of these techniques for##2##4##(2008-8#1)(2013-1#1)
of these techniques has##2##4##(2008-1#1)(2009-5#1)
of these techniques in the##2##5##(2008-11#1)(2012-2#1)
of these techniques in##3##4##(2008-11#1)(2012-2#1)(2012-3#1)
of these techniques is##5##4##(1994-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)
of these techniques##30##3##(1991-3#1)(1991-9#1)(1994-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
of these technologies##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-7#1)
of these tests##12##3##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-3#1)(2011-2#3)
of these theoretical##2##3##(2008-2#1)(2010-3#1)
of these theories##2##3##(2007-8#1)(2008-2#1)
of these therapeutic##3##3##(2008-5#1)(2008-8#1)(2009-7#1)
of these therapies##3##3##(1990-9#1)(2008-10#1)(2008-7#1)
of these three compounds##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of these three parameters##2##4##(2008-10#1)(2013-8#1)
of these three types of##2##5##(1995-11#1)(2008-7#1)
of these three##30##3##(1992-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1996-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#1)(2012-2#2)(2013-8#1)
of these tissues to##3##4##(1994-9#1)(2008-6#1)(2013-1#1)
of these tissues##6##3##(1990-11#1)(1994-9#1)(1995-8#1)(2008-6#1)(2009-7#1)(2013-1#1)
of these tools is##2##4##(2008-10#1)(2011-2#1)
of these tools to##2##4##(2008-12#1)(2011-2#1)
of these tools##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)
of these toxins##2##3##(2008-10#1)(2008-5#1)
of these trajectories##2##3##(2008-7#1)(2009-9#1)
of these transcription factors##2##4##(2008-9#1)(2012-3#1)
of these transcription##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
of these transcripts##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
of these transgenic##2##3##(2008-10#2)
of these transport##2##3##(1990-12#1)(2011-2#1)
of these transporters in##2##4##(2008-7#1)(2012-12#1)
of these transporters##4##3##(2008-7#3)(2012-12#1)
of these treatments##5##3##(1990-5#1)(2007-8#1)(2008-10#1)(2010-1#1)(2012-12#1)
of these trends##2##3##(1997-2#1)(2008-8#1)
of these trials##5##3##(1995-2#1)(1996-11#1)(1997-4#1)(2010-6#1)(2012-12#1)
of these tumor##2##3##(1990-12#1)(1992-9#1)
of these tumors and##3##4##(1992-5#1)(1993-6#1)(2013-8#1)
of these tumors##16##3##(1990-10#1)(1991-8#1)(1992-5#1)(1993-6#1)(1995-2#1)(1997-1#1)(2010-9#3)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
of these tumours##3##3##(1997-3#1)(2008-7#1)(2013-8#1)
of these two amino##2##4##(1990-11#1)(2008-10#1)
of these two approaches##2##4##(2008-10#1)(2008-4#1)
of these two components##3##4##(1994-12#1)(2008-3#1)(2012-12#1)
of these two disorders##2##4##(2009-7#1)(2012-3#1)
of these two factors##2##4##(1992-12#1)(2008-10#1)
of these two forms##2##4##(1994-11#1)(2007-7#1)
of these two genera##3##4##(2008-10#3)
of these two genes was##2##5##(1991-9#1)(2008-1#1)
of these two genes##4##4##(1991-5#1)(1991-9#1)(1994-11#1)(2008-1#1)
of these two herbs on##2##5##(1992-2#2)
of these two isolates##2##4##(2008-10#2)
of these two methods##2##4##(1995-9#1)(1996-5#1)
of these two parameters##2##4##(1992-6#1)(2008-7#1)
of these two peptides##2##4##(1990-5#1)(1992-9#1)
of these two processes##2##4##(2009-2#1)(2009-8#1)
of these two proteins##3##4##(1992-12#1)(1995-3#1)(2008-5#1)
of these two signals##2##4##(2008-3#2)
of these two species##4##4##(1995-8#1)(2006-11#1)(2008-10#1)(2008-5#1)
of these two types of##8##5##(1990-7#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-2#1)(2012-3#1)
of these two viruses##2##4##(2007-6#1)(2008-10#1)
of these two##112##3##(1990-11#2)(1990-5#1)(1990-7#3)(1991-12#1)(1991-5#2)(1991-9#3)(1992-12#3)(1992-2#2)(1992-6#2)(1992-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#2)(2009-10#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#3)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
of these type##2##3##(1991-3#1)(2008-10#1)
of these types of##4##4##(1991-1#1)(1993-2#1)(2008-7#1)(2010-5#1)
of these uncertainties##2##3##(2008-10#1)(2009-11#1)
of these unique##3##3##(1997-2#1)(2007-11#1)(2012-2#1)
of these units##3##3##(1994-9#1)(2008-10#1)(2013-1#1)
of these values##7##3##(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)
of these variables in##3##4##(1991-6#1)(1994-8#1)(1996-12#1)
of these variables were##2##4##(1993-8#1)(2013-1#1)
of these variables##11##3##(1991-6#1)(1993-8#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-5#2)(2011-2#1)(2013-1#1)
of these variants##3##3##(1992-9#1)(1995-6#2)
of these variations are##2##4##(1997-2#1)(2007-10#1)
of these variations##5##3##(1993-1#1)(1997-2#1)(2007-10#1)(2008-7#1)(2013-1#1)
of these various##4##3##(1990-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
of these vectors##3##3##(1993-12#1)(1993-2#1)(1994-5#1)
of these viruses##11##3##(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#7)(2013-8#1)
of these was##4##3##(1990-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
of these were further##2##4##(2008-10#1)(2008-7#1)
of these were treated##2##4##(1997-3#1)(1997-4#1)
of these were##23##3##(1991-2#1)(1991-4#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2011-1#1)(2012-2#1)
of these women##6##3##(1991-9#1)(1996-12#1)(1997-7#1)(2008-5#1)(2009-9#1)(2011-2#1)
of these works##2##3##(2010-11#1)(2013-7#1)
of these yeasts##2##3##(2008-5#1)(2013-1#1)
of these##3846##2##(1990-10#4)(1990-11#14)(1990-12#23)(1990-2#9)(1990-3#7)(1990-5#20)(1990-6#4)(1990-7#16)(1990-8#15)(1990-9#9)(1991-1#7)(1991-10#1)(1991-11#7)(1991-12#29)(1991-2#17)(1991-3#12)(1991-4#2)(1991-5#20)(1991-6#16)(1991-7#1)(1991-8#12)(1991-9#19)(1992-1#6)(1992-10#4)(1992-11#9)(1992-12#19)(1992-2#10)(1992-3#23)(1992-4#2)(1992-5#3)(1992-6#17)(1992-7#2)(1992-8#13)(1992-9#17)(1993-1#8)(1993-11#23)(1993-12#25)(1993-2#14)(1993-3#9)(1993-5#2)(1993-6#15)(1993-8#21)(1993-9#6)(1994-1#8)(1994-10#2)(1994-11#21)(1994-12#22)(1994-2#23)(1994-3#14)(1994-5#12)(1994-6#17)(1994-7#2)(1994-8#21)(1994-9#18)(1995-1#10)(1995-11#15)(1995-12#22)(1995-2#38)(1995-3#26)(1995-5#18)(1995-6#26)(1995-8#8)(1995-9#5)(1996-1#11)(1996-10#1)(1996-11#11)(1996-12#21)(1996-2#22)(1996-3#17)(1996-4#4)(1996-5#14)(1996-6#8)(1996-7#1)(1996-9#4)(1997-1#6)(1997-2#22)(1997-3#24)(1997-4#16)(1997-5#1)(1997-6#6)(1997-7#18)(1997-8#19)(1997-9#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#2)(2007-10#15)(2007-11#56)(2007-12#63)(2007-2#7)(2007-4#5)(2007-5#10)(2007-6#2)(2007-7#23)(2007-8#27)(2008-1#46)(2008-10#654)(2008-11#150)(2008-12#44)(2008-2#86)(2008-3#145)(2008-4#94)(2008-5#98)(2008-6#43)(2008-7#149)(2008-8#93)(2008-9#96)(2009-1#1)(2009-10#30)(2009-11#12)(2009-12#24)(2009-2#5)(2009-3#9)(2009-4#9)(2009-5#21)(2009-6#7)(2009-7#14)(2009-8#22)(2009-9#22)(2010-1#11)(2010-10#12)(2010-11#15)(2010-12#16)(2010-2#16)(2010-3#24)(2010-4#16)(2010-5#15)(2010-6#13)(2010-7#9)(2010-8#20)(2010-9#14)(2011-1#47)(2011-10#1)(2011-2#115)(2011-3#6)(2011-7#1)(2012-1#21)(2012-12#43)(2012-2#79)(2012-3#37)(2012-4#1)(2012-7#3)(2013-1#86)(2013-7#15)(2013-8#45)
of theses##4##2##(2008-2#2)(2012-3#1)(2013-1#1)
of theta phase precession in##2##5##(2008-11#2)
of theta##4##2##(2007-12#1)(2008-11#2)(2008-8#1)
of thiamine and benfotiamine##2##4##(2012-4#2)
of thiamine with##2##3##(2008-10#2)
of thiamine##15##2##(2008-1#3)(2008-10#10)(2012-4#2)
of thick##10##2##(1997-3#1)(2008-10#3)(2008-2#4)(2008-3#2)
of thickness and##2##3##(2008-3#2)
of thickness##4##2##(2008-2#2)(2008-3#2)
of thickness-modulated designs are##2##4##(2008-2#1)(2008-3#1)
of thienorphine metabolism##2##3##(2011-3#2)
of thienorphine##9##2##(2011-3#9)
of thigh##2##2##(2008-5#2)
of thigmotaxis##2##2##(1994-3#2)
of thin Al2O3 films##2##4##(2008-3#2)
of thin absorbing films##6##4##(2008-2#2)(2008-3#4)
of thin and##2##3##(2008-2#1)(2008-7#1)
of thin clouds##2##3##(2008-3#2)
of thin films and multilayer##2##5##(2008-2#1)(2008-3#1)
of thin films of##2##4##(2008-2#1)(2008-3#1)
of thin films##14##3##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#6)
of thin liquid films##3##4##(2008-10#1)(2008-3#2)
of thin##57##2##(1997-7#2)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#10)(2008-3#22)(2008-7#1)(2009-7#2)(2010-11#1)
of thin-film materials##2##3##(2007-11#1)(2008-3#1)
of thin-film##10##2##(2007-11#2)(2008-10#2)(2008-3#6)
of things to##2##3##(1995-2#1)(2008-7#1)
of things##4##2##(1995-2#1)(2008-7#1)(2012-3#2)
of thinking about##4##3##(1992-1#1)(2008-6#1)(2010-5#1)(2013-8#1)
of thinking##12##2##(1992-1#1)(1993-6#1)(1994-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
of thinning##2##2##(2008-3#2)
of thiobarbituric acid reactive substances (TBARS)##2##6##(1995-3#1)(2011-2#1)
of thiobarbituric acid reactive substances##4##5##(1992-3#2)(1995-3#1)(2011-2#1)
of thiobarbituric acid reactive##5##4##(1992-3#2)(1995-3#1)(2011-2#1)(2012-2#1)
of thiobarbituric acid##6##3##(1992-3#2)(1995-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
of thiobarbituric##9##2##(1992-3#2)(1995-12#3)(1995-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
of thiocyanate in##3##3##(2008-10#3)
of thiocyanate##11##2##(2008-10#11)
of thiocyanato-complexes##2##2##(2008-10#2)
of thiocytosine##2##2##(2008-10#2)
of thioethers##2##2##(1994-8#1)(2008-11#1)
of thiol compounds##2##3##(1992-8#1)(2008-10#1)
of thiol groups##2##3##(1991-9#1)(1992-3#1)
of thiol##12##2##(1991-9#3)(1992-3#1)(1992-8#1)(1994-8#1)(1995-5#1)(2008-10#4)(2010-11#1)
of thiol-containing##3##2##(1991-9#2)(2008-10#1)
of thiolic proteins##2##3##(2008-10#2)
of thiols at##2##3##(2008-10#2)
of thiols in##3##3##(1995-5#1)(2008-10#2)
of thiols##12##2##(1991-9#1)(1995-5#1)(1995-6#1)(2008-10#6)(2009-9#1)(2010-11#2)
of thiopental##2##2##(1990-12#1)(2012-12#1)
of thiorphan##2##2##(1996-2#2)
of thiosulfate##3##2##(2008-10#3)
of thiourea B13 analogues was##2##5##(2011-2#2)
of thiourea##8##2##(1995-12#1)(2008-10#5)(2011-2#2)
of thioxanthones##3##2##(2012-3#3)
of thiram##3##2##(2008-10#3)
of third generation##3##3##(1995-9#1)(1996-11#1)(2007-7#1)
of third##11##2##(1992-3#1)(1993-1#1)(1994-12#1)(1995-9#1)(1996-11#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
of third-harmonic generation (THG)##2##4##(2007-11#1)(2008-3#1)
of third-harmonic##3##2##(2007-11#1)(2008-3#2)
of third-order##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
of thirteen##8##2##(1997-2#1)(2007-10#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of this &quot##9##3##(1990-8#2)(1997-3#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-8#1)
of this 1##2##3##(1991-2#1)(2008-10#1)
of this AHRA membership survey reports on information relating to staff utilization in##2##13##(1994-1#1)(1994-2#1)
of this DNA##2##3##(1991-9#1)(2008-4#1)
of this RNA##3##3##(1990-5#1)(1992-8#1)(2008-10#1)
of this aberration##2##3##(2008-10#1)(2008-6#1)
of this activity##4##3##(1994-1#1)(2008-11#1)(2008-12#1)(2012-12#1)
of this actual##2##3##(1997-2#1)(2012-12#1)
of this adhesion##2##3##(1993-6#1)(2008-10#1)
of this advanced##2##3##(1995-9#1)(2010-12#1)
of this age##4##3##(2008-11#1)(2008-12#1)(2010-8#1)(2011-1#1)
of this agent in##2##4##(1995-12#1)(2009-9#1)
of this agent##7##3##(1995-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-9#1)(2012-2#1)(2013-8#1)
of this algorithm##4##3##(2007-11#1)(2008-3#2)(2013-8#1)
of this alpha##2##3##(1990-12#1)(1995-11#1)
of this analysis indicate that the##2##6##(1994-3#1)(1997-5#1)
of this analysis is##3##4##(1994-11#1)(1995-12#1)(2008-12#1)
of this analysis##20##3##(1991-12#1)(1991-9#1)(1992-3#1)(1994-11#2)(1994-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2009-2#1)(2011-2#1)
of this analyte##2##3##(2008-10#2)
of this analytical##2##3##(2008-10#2)
of this and other##2##4##(2008-10#1)(2008-3#1)
of this and similar##3##4##(2008-6#1)(2011-1#1)(2011-2#1)
of this and##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
of this anomaly##2##3##(1991-9#1)(1993-9#1)
of this apparently##2##3##(1997-1#1)(2008-10#1)
of this approach are##5##4##(2008-10#2)(2008-2#2)(2010-11#1)
of this approach for##4##4##(1994-5#1)(2007-12#1)(2008-3#1)(2010-8#1)
of this approach in##2##4##(2008-5#1)(2010-5#1)
of this approach is limited##2##5##(2008-3#1)(2012-3#1)
of this approach is that it##3##6##(2008-2#1)(2008-4#1)(2012-1#1)
of this approach is that##7##5##(2008-2#1)(2008-4#2)(2009-2#1)(2010-7#1)(2012-1#2)
of this approach is##15##4##(1992-3#1)(1997-2#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-2#1)(2009-8#1)(2010-7#1)(2012-1#2)(2012-3#1)
of this approach that##2##4##(2008-5#1)(2012-12#1)
of this approach to##5##4##(1996-12#1)(2007-12#2)(2008-11#1)(2008-2#1)
of this approach was demonstrated##2##5##(1996-12#1)(2013-1#1)
of this approach was##6##4##(1996-12#1)(2008-10#4)(2013-1#1)
of this approach we##2##4##(2008-3#2)
of this approach##67##3##(1992-3#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)
of this are discussed##2##4##(2008-10#1)(2008-7#1)
of this area##9##3##(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-9#2)(2013-8#1)
of this arrangement##2##3##(1996-2#1)(2008-11#1)
of this article are to describe##2##6##(2012-12#1)(2013-1#1)
of this article are to##3##5##(2011-1#1)(2012-12#1)(2013-1#1)
of this article examines##2##4##(1995-1#1)(2012-12#1)
of this article is to describe a##2##7##(2008-12#1)(2011-2#1)
of this article is to describe the##5##7##(1994-1#1)(2007-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
of this article is to describe##11##6##(1994-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-12#2)(2008-5#1)(2009-10#1)(2011-2#2)(2012-2#1)
of this article is to discuss##3##6##(1995-1#1)(1996-2#1)(2008-7#1)
of this article is to emphasize##2##6##(1994-11#1)(2010-4#1)
of this article is to familiarize##2##6##(2011-2#1)(2012-3#1)
of this article is to present a##3##7##(1993-12#1)(2012-12#1)(2013-1#1)
of this article is to present##7##6##(1993-12#1)(1997-8#1)(2007-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
of this article is to provide a##5##7##(1997-3#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
of this article is to provide##9##6##(1994-3#1)(1997-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of this article is to report##2##6##(2008-11#1)(2013-1#1)
of this article is to review##13##6##(1994-11#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2013-8#2)
of this article is to##76##5##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#3)
of this article is##85##4##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#3)
of this article was to describe##2##6##(2010-10#1)(2010-3#1)
of this article was to review the##2##7##(2011-1#1)(2011-7#1)
of this article was to review##4##6##(2008-8#1)(2011-1#1)(2011-7#1)(2012-2#1)
of this article was to##7##5##(2008-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
of this article was##9##4##(1993-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
of this article will##2##4##(1996-1#1)(2008-5#1)
of this article##140##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-11#2)(1994-3#2)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#5)(2011-2#9)(2011-7#1)(2012-1#3)(2012-12#4)(2012-2#14)(2012-3#7)(2013-1#7)(2013-8#3)
of this assay are##2##4##(1991-9#1)(1997-4#1)
of this assay is##2##4##(2008-10#1)(2008-4#1)
of this assay##11##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1995-11#1)(1997-4#1)(2008-10#4)(2008-4#1)
of this assessment##2##3##(2008-11#1)(2011-3#1)
of this association##6##3##(1991-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2013-1#1)
of this assumption##2##3##(2008-3#1)(2012-2#1)
of this bacterial##2##3##(2008-10#2)
of this bacterium##2##3##(1993-8#1)(2008-9#1)
of this behavior##5##3##(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2013-1#1)
of this biological##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
of this brief##3##3##(2006-6#1)(2008-6#1)(2008-7#1)
of this cDNA##5##3##(1990-12#4)(2008-6#1)
of this cancer##5##3##(1992-5#1)(2009-4#1)(2010-12#2)(2012-2#1)
of this capacity##2##3##(1993-11#1)(2010-12#1)
of this case is that##2##5##(2008-1#1)(2010-6#1)
of this case report is to##2##6##(2008-8#1)(2010-9#1)
of this case report##5##4##(2008-1#1)(2008-8#1)(2010-9#1)(2012-12#1)(2013-8#1)
of this case study##5##4##(1991-1#1)(1992-3#1)(1993-1#1)(2010-5#1)(2012-12#1)
of this case##21##3##(1990-6#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
of this category of##2##4##(1991-8#1)(2008-6#1)
of this cell line##4##4##(1990-5#1)(1992-8#1)(2008-11#2)
of this cell##6##3##(1990-5#1)(1991-2#1)(1992-8#1)(1993-6#1)(2008-11#2)
of this century##2##3##(2007-8#1)(2008-11#1)
of this change in##2##4##(2008-10#1)(2010-3#1)
of this change##5##3##(1995-3#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-7#1)
of this chapter is to##2##5##(2008-9#1)(2010-4#1)
of this chapter##3##3##(2008-4#1)(2008-9#1)(2010-4#1)
of this chromosome##3##3##(1997-6#1)(2007-12#1)(2008-10#1)
of this chronic##2##3##(1992-2#1)(1993-8#1)
of this class of compounds##2##5##(1993-8#2)
of this class of##9##4##(1991-12#1)(1993-8#2)(1994-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
of this class##10##3##(1991-12#1)(1993-8#2)(1994-12#1)(1997-7#1)(2008-10#2)(2008-4#1)(2012-3#1)(2013-1#1)
of this clinical##3##3##(1993-2#1)(2011-1#1)(2011-2#1)
of this clone in##2##4##(1993-6#1)(1994-8#1)
of this clone##6##3##(1990-2#1)(1992-3#1)(1993-6#2)(1994-8#1)(1995-2#1)
of this cohort##2##3##(1994-12#1)(1994-5#1)
of this collaborative##2##3##(2008-11#1)(2008-12#1)
of this combination##3##3##(1997-3#1)(1997-6#1)(2008-12#1)
of this combined##3##3##(1996-7#1)(2008-7#1)(2013-1#1)
of this commentary is to discuss##2##6##(2009-5#1)(2012-2#1)
of this common and##2##4##(1991-8#1)(2012-12#1)
of this common##5##3##(1991-8#1)(2007-10#1)(2009-6#1)(2010-5#1)(2012-12#1)
of this comparison##2##3##(2008-3#1)(2012-12#1)
of this complex and##2##4##(2008-10#1)(2008-7#1)
of this complex entity##2##4##(1996-12#1)(2010-6#1)
of this complex##18##3##(1990-5#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-8#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#5)(2009-8#1)(2010-6#1)
of this complexity##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
of this complication in##3##4##(2008-1#1)(2013-1#2)
of this complication##11##3##(1990-6#1)(1991-3#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-7#2)(2008-9#1)(2013-1#3)
of this compound##9##3##(1993-1#1)(1995-2#1)(2008-10#6)(2008-5#1)
of this concept##3##3##(1992-12#1)(2008-1#1)(2008-10#1)
of this condition and##3##4##(2010-12#1)(2010-5#1)(2011-2#1)
of this condition in##3##4##(2008-1#1)(2008-5#1)(2008-6#1)
of this condition is##6##4##(2007-8#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
of this condition with##2##4##(2008-5#1)(2008-7#1)
of this condition##38##3##(1991-7#1)(1992-5#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
of this configuration##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of this congress was##2##4##(2008-5#2)
of this conserved##2##3##(1995-2#1)(2008-4#1)
of this construct##2##3##(2010-6#1)(2012-1#1)
of this correlation##2##3##(1992-6#1)(2008-3#1)
of this cross##3##3##(1994-12#1)(2008-4#1)(2009-11#1)
of this data##4##3##(1997-4#1)(2008-3#1)(2008-4#1)(2012-3#1)
of this decline##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
of this delivery##2##3##(2008-1#1)(2008-5#1)
of this dependence##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2009-8#1)
of this derivative##2##3##(1997-2#1)(2008-10#1)
of this design##4##3##(1994-2#1)(2008-10#1)(2008-3#2)
of this detection##2##3##(2008-10#2)
of this detector##2##3##(2008-10#2)
of this devastating##2##3##(2009-8#1)(2010-3#1)
of this device for##2##4##(2008-10#1)(2008-3#1)
of this device in##2##4##(2008-10#1)(2008-3#1)
of this device##10##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2011-2#1)
of this diagnosis##4##3##(2011-1#1)(2013-1#3)
of this diagnostic##3##3##(1990-6#1)(1990-9#1)(2011-1#1)
of this diet##2##3##(1995-3#1)(2013-1#1)
of this difference##3##3##(1992-11#1)(2008-2#1)(2009-12#1)
of this differential##2##3##(2008-3#1)(2012-8#1)
of this discipline##2##3##(2007-8#1)(2013-8#1)
of this discussion##4##3##(1994-2#1)(2008-10#1)(2009-9#1)(2010-3#1)
of this disease among##2##4##(1992-2#1)(2008-5#1)
of this disease and##2##4##(2007-11#1)(2010-5#1)
of this disease are discussed##2##5##(1990-6#1)(2008-10#1)
of this disease are##4##4##(1990-6#1)(1992-6#1)(1997-8#1)(2008-10#1)
of this disease in##2##4##(2008-10#1)(2012-3#1)
of this disease is##3##4##(2008-7#1)(2010-5#1)(2011-2#1)
of this disease may##2##4##(1996-12#1)(2010-6#1)
of this disease on the##2##5##(2008-11#1)(2012-12#1)
of this disease was##2##4##(2008-10#2)
of this disease##92##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#3)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
of this disorder is##4##4##(2007-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
of this disorder##22##3##(1990-3#1)(1994-9#1)(1997-3#1)(2007-10#1)(2007-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
of this distinction##2##3##(2008-11#2)
of this document is to##4##5##(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
of this domain##4##3##(1990-11#1)(1991-10#1)(1991-3#1)(2013-1#1)
of this drug in##6##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-6#2)
of this drug with##2##4##(2008-10#1)(2012-12#1)
of this drug##18##3##(1990-8#1)(1991-12#1)(1997-2#3)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2010-2#1)(2012-12#1)
of this dsRNA##4##3##(2008-10#4)
of this effect at##2##4##(1990-3#1)(2008-7#1)
of this effect in##2##4##(1990-6#1)(2008-9#1)
of this effect is dependent on##2##6##(1997-2#1)(2008-5#1)
of this effect is##5##4##(1991-9#1)(1997-2#1)(2008-2#1)(2008-5#1)(2009-8#1)
of this effect##24##3##(1990-3#1)(1990-6#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-8#2)(1997-2#2)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)
of this electrode was##3##4##(2008-10#3)
of this electrode##9##3##(2008-10#9)
of this element in##3##4##(2008-10#3)
of this element is##2##4##(2008-10#2)
of this element##12##3##(2008-10#11)(2009-9#1)
of this enhancement##2##3##(1995-12#1)(2009-7#1)
of this enquiry##2##3##(1995-8#1)(2008-10#1)
of this entirely##2##3##(1993-2#1)(1995-3#1)
of this entity is##3##4##(2007-12#1)(2011-1#1)(2013-8#1)
of this entity##11##3##(1990-10#1)(1993-8#1)(1993-9#1)(2007-12#1)(2008-11#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
of this enzyme activity##2##4##(2008-6#2)
of this enzyme during##2##4##(2008-10#1)(2008-7#1)
of this enzyme has##2##4##(1993-8#1)(1994-11#1)
of this enzyme in##3##4##(1991-5#1)(1994-6#1)(1994-8#1)
of this enzyme may be##2##5##(1997-2#1)(1997-4#1)
of this enzyme to##2##4##(1993-5#1)(2008-10#1)
of this enzyme was##3##4##(1990-5#1)(1991-11#1)(1992-6#1)
of this enzyme##37##3##(1990-12#1)(1990-5#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-6#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-2#1)
of this examination##2##3##(1994-2#1)(2013-8#1)
of this exciting##2##3##(1991-3#1)(2013-1#1)
of this experience##3##3##(2008-11#2)(2008-6#1)
of this experiment is##2##4##(2008-3#2)
of this experiment was to##3##5##(1993-12#1)(1997-2#1)(2009-4#1)
of this experiment##9##3##(1993-12#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-10#1)
of this extract##3##3##(2008-11#1)(2008-5#1)(2009-6#1)
of this factor##3##3##(1991-8#1)(2008-3#1)(2009-3#1)
of this family of##5##4##(1996-12#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-10#1)
of this family##23##3##(1990-12#1)(1991-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#2)(2012-3#1)
of this feature##5##3##(1996-5#1)(1996-9#1)(2007-12#1)(2008-6#1)(2010-5#1)
of this fiber##2##3##(2007-11#1)(2008-2#1)
of this finding##6##3##(1990-12#1)(1990-6#1)(2008-1#1)(2008-6#1)(2009-3#1)(2011-1#1)
of this flap##4##3##(2007-12#4)
of this form of##6##4##(1990-2#1)(1990-5#1)(1994-6#1)(2008-10#1)(2012-2#2)
of this form##8##3##(1990-2#1)(1990-5#1)(1991-9#1)(1994-6#1)(1995-5#1)(2008-10#1)(2012-2#2)
of this formula##2##3##(2008-3#1)(2008-5#1)
of this fragment##2##3##(2008-8#1)(2012-12#1)
of this function##3##3##(1990-3#1)(1997-4#1)(2008-6#1)
of this functional group##2##4##(2008-10#2)
of this functional##4##3##(1993-2#1)(2008-10#2)(2008-7#1)
of this fungal##2##3##(2008-10#2)
of this fungus##9##3##(2008-10#8)(2008-5#1)
of this gene contains##2##4##(1993-12#1)(2008-11#1)
of this gene in##4##4##(1994-5#1)(1997-7#1)(2008-10#1)(2008-8#1)
of this gene is##4##4##(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#1)
of this gene was##5##4##(1994-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)
of this gene with##3##4##(1993-6#1)(1997-3#1)(2008-10#1)
of this gene##35##3##(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-6#2)(1997-3#1)(1997-7#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#1)
of this genetic##3##3##(1996-12#1)(2010-4#1)(2013-1#1)
of this genomic##2##3##(2008-8#1)(2013-8#1)
of this genotype##2##3##(2008-10#2)
of this genus##6##3##(2008-10#2)(2008-5#2)(2008-9#1)(2013-1#1)
of this goal##2##3##(2008-11#1)(2010-3#1)
of this good##2##3##(2008-10#2)
of this group of patients##3##5##(1993-12#1)(1994-2#1)(2008-6#1)
of this group of##7##4##(1992-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(2008-5#1)(2008-6#2)
of this group##19##3##(1992-1#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#2)
of this heterogeneity##2##3##(1990-12#1)(2008-9#1)
of this highly##4##3##(1991-1#1)(2008-9#1)(2009-4#1)(2011-2#1)
of this hormone##3##3##(1991-6#1)(1993-6#1)(2008-1#1)
of this hypothesis##7##3##(1990-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2012-3#1)
of this idea##2##3##(2009-6#1)(2012-2#1)
of this illness##3##3##(1990-9#1)(1993-3#1)(2008-6#1)
of this impairment##2##3##(1995-5#1)(2008-7#1)
of this important##9##3##(1992-3#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#1)
of this in vivo##2##4##(2008-10#1)(2008-5#1)
of this in##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
of this increase##3##3##(1990-8#1)(1991-3#1)(1991-8#1)
of this increased##3##3##(1994-11#1)(2008-10#1)(2008-3#1)
of this index##3##3##(1991-6#1)(2008-10#1)(2008-12#1)
of this infection##2##3##(2007-12#1)(2013-1#1)
of this information##7##3##(1997-4#1)(2008-11#3)(2008-4#1)(2008-9#1)(2013-1#1)
of this infrequent##2##3##(1992-6#1)(2012-3#1)
of this initiative##2##3##(1991-12#1)(2013-8#1)
of this injury##2##3##(2012-12#1)(2013-1#1)
of this insect##2##3##(2008-6#1)(2008-7#1)
of this insoluble##2##3##(2007-7#1)(2008-5#1)
of this institution##3##3##(1991-9#1)(2008-8#2)
of this instrument##10##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#5)(2010-11#1)(2012-2#1)
of this integrated##2##3##(2008-10#1)(2008-2#1)
of this interaction in##3##4##(2008-9#1)(2012-1#1)(2012-2#1)
of this interaction##6##3##(1995-2#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-2#1)
of this interferometer##3##3##(2007-12#1)(2008-3#2)
of this international##2##3##(2008-4#1)(2011-2#1)
of this intervention is##2##4##(1990-9#1)(2008-3#1)
of this intervention##6##3##(1990-9#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-4#1)
of this inversion##2##3##(2008-3#2)
of this investigation was to##5##5##(2006-6#1)(2008-10#1)(2009-3#1)(2011-1#1)(2013-8#1)
of this investigation was##6##4##(2006-6#1)(2008-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
of this investigation##14##3##(1990-6#1)(2006-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of this ion##4##3##(1994-8#1)(1996-7#1)(2008-10#2)
of this is a##2##4##(1990-11#1)(2012-2#1)
of this is the##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
of this is##9##3##(1990-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)
of this issue##2##3##(2008-11#1)(2011-2#1)
of this journal##4##3##(1992-2#1)(1992-3#1)(2008-7#1)(2013-1#1)
of this kinase##3##3##(1990-7#1)(1995-11#1)(1995-6#1)
of this kind are##2##4##(1995-5#1)(2009-8#1)
of this kind in##2##4##(2007-8#1)(2008-3#1)
of this kind of##15##4##(1990-6#1)(1992-8#1)(1993-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
of this kind##30##3##(1990-6#1)(1991-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
of this knowledge##3##3##(1991-2#1)(1995-5#1)(2011-2#1)
of this large##2##3##(2008-10#1)(2009-4#1)
of this laser is##2##4##(2008-2#1)(2008-3#1)
of this laser##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
of this latter group##2##4##(1992-5#2)
of this lectin##2##3##(1990-7#1)(1993-3#1)
of this lesion is##2##4##(1991-6#2)
of this lesion##11##3##(1990-9#1)(1991-6#2)(1994-8#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#2)(2013-1#1)
of this line##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
of this lineage##4##3##(1995-12#1)(1995-2#1)(2008-10#2)
of this linear##2##3##(2007-12#1)(2008-2#1)
of this literature review will##2##5##(2008-5#1)(2009-5#1)
of this literature##4##3##(1995-3#1)(2008-10#1)(2008-5#1)(2009-5#1)
of this locus##3##3##(1996-10#1)(1997-3#1)(2008-10#1)
of this mRNA##2##3##(1992-12#1)(1994-11#1)
of this magnitude##4##3##(1993-12#1)(1993-9#1)(2008-10#1)(2013-1#1)
of this malformation##3##3##(2008-7#1)(2009-5#2)
of this malignancy##2##3##(2007-4#1)(2012-2#1)
of this manuscript##3##3##(2010-3#1)(2010-7#1)(2011-2#1)
of this material were##2##4##(2008-10#1)(2008-3#1)
of this material##11##3##(1990-9#1)(1991-12#1)(1995-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-8#1)
of this matrix##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
of this matter##2##3##(2008-9#1)(2011-2#1)
of this measure##2##3##(2007-12#1)(2010-6#1)
of this mechanism##2##3##(1995-8#1)(2009-3#1)
of this meeting##6##3##(2008-2#1)(2008-5#4)(2009-4#1)
of this member of the##2##5##(2007-7#1)(2008-10#1)
of this membrane##3##3##(1990-8#1)(2008-10#2)
of this metal##3##3##(2008-10#3)
of this method and##2##4##(1990-3#1)(2008-3#1)
of this method are that##2##5##(2008-10#1)(2008-3#1)
of this method are##7##4##(1997-2#1)(2008-10#4)(2008-3#1)(2008-4#1)
of this method for the##4##5##(1994-5#1)(2008-10#1)(2008-12#1)(2012-3#1)
of this method for##10##4##(1993-12#1)(1994-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-12#1)(2012-3#1)
of this method in##3##4##(2007-12#1)(2008-10#1)(2008-6#1)
of this method include##3##4##(1994-8#1)(2008-10#1)(2012-3#1)
of this method is demonstrated by##2##6##(2007-11#1)(2008-10#1)
of this method is demonstrated##6##5##(2007-11#2)(2008-10#1)(2008-3#3)
of this method is its##3##5##(2007-11#1)(2007-12#1)(2008-11#1)
of this method is that it##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
of this method is that##7##5##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
of this method is##28##4##(1996-2#1)(1996-3#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#5)(2010-11#1)
of this method of##2##4##(2008-11#1)(2008-3#1)
of this method on##2##4##(2008-10#1)(2008-7#1)
of this method to##10##4##(1994-9#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)
of this method was demonstrated by##3##6##(2008-10#3)
of this method was tested##2##5##(2008-10#2)
of this method was##17##4##(1990-2#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-8#1)
of this method with##3##4##(2007-12#1)(2008-10#2)
of this method##115##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1993-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-10#47)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#1)(2012-3#3)(2013-8#1)
of this methodology to##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
of this methodology##13##3##(2008-10#5)(2008-12#1)(2008-2#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this minimally invasive##2##4##(1991-6#1)(2011-2#1)
of this mixture##2##3##(1997-7#1)(2008-10#1)
of this model and##2##4##(1993-2#1)(2007-12#1)
of this model are##2##4##(2008-2#1)(2008-4#1)
of this model is##6##4##(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-3#1)
of this model to##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
of this model##29##3##(1992-4#1)(1993-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
of this modified##2##3##(1994-12#1)(2008-2#1)
of this modulation is##2##4##(2008-3#1)(2013-8#1)
of this module is##2##4##(2008-11#1)(2008-12#1)
of this module##3##3##(2008-11#2)(2008-12#1)
of this molecular##2##3##(2008-10#2)
of this molecule##5##3##(1992-6#1)(1996-2#1)(2008-5#1)(2008-7#1)(2012-12#1)
of this motif##2##3##(1991-7#1)(1992-4#1)
of this mucin##2##3##(1992-11#2)
of this multivariate##2##3##(1992-12#1)(2008-10#1)
of this mushroom##2##3##(1997-2#1)(2008-12#1)
of this mutant##2##3##(1994-11#1)(1997-2#1)
of this mutation is##2##4##(1997-2#1)(2006-8#1)
of this mutation##9##3##(1990-5#1)(1991-8#2)(1995-2#1)(1995-9#1)(1997-2#1)(2006-8#1)(2008-2#2)
of this mycoparasite##2##3##(2008-10#2)
of this naturalistic study was to##2##6##(1993-12#1)(2009-11#1)
of this naturalistic##3##3##(1993-12#1)(2007-11#1)(2009-11#1)
of this nature##4##3##(1992-11#1)(1992-12#1)(1995-11#1)(2008-7#1)
of this neoplasm and##2##4##(1992-5#1)(1994-2#1)
of this neoplasm##4##3##(1992-2#1)(1992-5#1)(1994-2#1)(2008-9#1)
of this network##2##3##(2008-2#1)(2008-4#1)
of this neuropeptide##2##3##(1991-1#1)(1996-5#1)
of this new algorithm are##2##5##(2008-2#1)(2008-3#1)
of this new algorithm##3##4##(2008-2#1)(2008-3#2)
of this new method is##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
of this new method##6##4##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-9#1)
of this new technique##2##4##(1990-3#1)(2007-11#1)
of this new##41##3##(1990-3#1)(1991-12#1)(1992-8#1)(1995-1#2)(1995-6#1)(1996-11#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
of this newly developed method was##4##6##(2008-10#4)
of this newly developed##5##4##(2008-10#4)(2008-3#1)
of this newly##8##3##(2008-10#6)(2008-3#2)
of this novel approach to##2##5##(2008-2#1)(2008-8#1)
of this novel approach##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
of this novel##19##3##(1990-12#1)(1992-12#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2011-1#1)
of this objective is##2##4##(2008-3#1)(2010-12#1)
of this observation are##2##4##(1991-6#1)(2008-3#1)
of this observation is discussed##2##5##(1993-6#1)(1995-12#1)
of this observation##8##3##(1991-11#1)(1991-6#1)(1993-6#1)(1995-12#1)(2008-3#2)(2011-2#1)(2012-12#1)
of this oil##3##3##(2008-12#1)(2008-3#1)(2010-5#1)
of this on##2##3##(2008-10#1)(2008-3#1)
of this operation##5##3##(1990-6#1)(1990-9#1)(1991-5#1)(1994-3#1)(2008-3#1)
of this opportunity##2##3##(1993-12#1)(1993-2#1)
of this optical##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
of this optode##2##3##(2008-10#2)
of this organ##5##3##(2007-12#2)(2008-10#2)(2008-5#1)
of this organelle##3##3##(2008-11#2)(2008-9#1)
of this organism causing##2##4##(2007-7#1)(2012-12#1)
of this organism##26##3##(1996-8#1)(2007-7#1)(2008-10#2)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#18)(2012-12#1)
of this organization##2##3##(1991-2#1)(2008-11#1)
of this paper are to##5##5##(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2013-8#1)
of this paper is an##2##5##(2007-11#1)(2012-2#1)
of this paper is that##2##5##(1994-11#1)(2008-11#1)
of this paper is the##2##5##(2008-10#2)
of this paper is to describe the##5##7##(1992-1#1)(1992-2#1)(2008-11#2)(2008-5#1)
of this paper is to describe##7##6##(1992-1#1)(1992-2#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)
of this paper is to determine##2##6##(2007-7#1)(2011-1#1)
of this paper is to discuss the##3##7##(2008-11#1)(2009-10#1)(2012-12#1)
of this paper is to discuss##4##6##(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
of this paper is to evaluate the##3##7##(1991-4#1)(2011-2#1)(2013-1#1)
of this paper is to present##7##6##(2007-7#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#2)(2012-3#1)
of this paper is to provide a##2##7##(1996-3#1)(2012-12#1)
of this paper is to provide##5##6##(1992-3#1)(1996-3#1)(2007-4#1)(2011-2#1)(2012-12#1)
of this paper is to report on##3##7##(2008-11#2)(2010-3#1)
of this paper is to report the##2##7##(2013-1#2)
of this paper is to report##5##6##(2008-11#2)(2010-3#1)(2013-1#2)
of this paper is to review##4##6##(1993-5#1)(2008-10#1)(2010-12#1)(2013-1#1)
of this paper is to summarize the##2##7##(2008-5#1)(2009-4#1)
of this paper is to##64##5##(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#7)
of this paper is##74##4##(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-11#1)(1996-3#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#4)(2008-11#9)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)
of this paper was to determine##2##6##(2011-2#1)(2013-1#1)
of this paper was to##7##5##(1992-2#1)(2008-11#1)(2009-8#2)(2010-3#1)(2011-2#1)(2013-1#1)
of this paper##97##3##(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-5#1)(1994-11#1)(1994-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#2)(2008-10#5)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
of this parameter##5##3##(1995-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
of this parasite##2##3##(2008-10#1)(2009-5#1)
of this particular##4##3##(1990-11#1)(2008-11#1)(2008-6#1)(2008-9#1)
of this pathogen in##3##4##(2008-10#2)(2008-9#1)
of this pathogen##16##3##(2008-10#14)(2008-9#2)
of this pathology##9##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-8#1)(2007-8#1)(2009-3#1)(2013-1#3)
of this pathway in##3##4##(1993-3#1)(2009-8#1)(2010-3#1)
of this pathway##10##3##(1993-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)
of this patient##6##3##(1992-5#1)(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
of this peptide fragment##2##4##(1992-6#1)(2008-10#1)
of this peptide in##3##4##(1990-12#1)(1992-11#1)(2008-10#1)
of this peptide to##2##4##(1995-2#1)(1996-5#1)
of this peptide was##3##4##(1997-3#2)(1997-8#1)
of this peptide were##2##4##(1991-9#1)(1992-9#1)
of this peptide##15##3##(1990-12#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-3#2)(1997-8#1)(2008-10#2)
of this period##4##3##(1992-6#1)(2008-5#1)(2008-8#1)(2009-2#1)
of this phase II study##2##5##(2008-10#1)(2008-6#1)
of this phase##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
of this phenomenon is##2##4##(2008-2#1)(2008-7#1)
of this phenomenon remains##2##4##(2008-12#1)(2012-3#1)
of this phenomenon##18##3##(1991-6#1)(1992-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of this phylum##2##3##(2008-10#1)(2013-8#1)
of this pictorial essay is to##4##6##(1997-8#1)(2012-2#3)
of this pictorial review is to##2##6##(2012-2#2)
of this pictorial##6##3##(1997-8#1)(2012-2#5)
of this pilot study was to##9##6##(1995-3#1)(2008-11#1)(2008-12#4)(2011-2#1)(2013-1#2)
of this pilot study##12##4##(1993-1#1)(1995-3#1)(2008-11#1)(2008-12#5)(2008-7#1)(2011-2#1)(2013-1#2)
of this pilot##15##3##(1993-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-12#5)(2008-7#2)(2011-2#1)(2013-1#2)
of this plant and##2##4##(2008-11#1)(2011-10#1)
of this plant##9##3##(2008-10#3)(2008-11#2)(2008-12#1)(2010-3#1)(2011-1#1)(2011-10#1)
of this plasmid##2##3##(1993-9#1)(2008-10#1)
of this point##2##3##(2008-10#1)(2008-3#1)
of this polarization##2##3##(2007-12#1)(2008-2#1)
of this polymer##2##3##(1996-5#1)(2011-1#1)
of this population and##2##4##(1993-12#1)(2008-10#1)
of this population is##3##4##(1994-2#1)(2008-10#1)(2009-5#1)
of this population##17##3##(1991-6#2)(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-12#1)
of this possible complication##2##4##(2008-12#1)(2012-3#1)
of this possible##5##3##(1990-11#1)(2008-12#2)(2012-3#1)(2012-5#1)
of this potential##2##3##(2007-11#1)(2008-7#1)
of this powerful##2##3##(1996-2#1)(2011-1#1)
of this prediction##2##3##(2007-12#1)(2013-8#1)
of this preliminary study##3##4##(1993-12#1)(1996-5#1)(2013-1#1)
of this preliminary##5##3##(1993-12#1)(1996-5#1)(2008-12#2)(2013-1#1)
of this preparation##3##3##(1990-12#1)(2008-11#1)(2008-7#1)
of this probe##2##3##(1990-11#1)(2008-10#1)
of this problem##9##3##(1995-5#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
of this procedure are##2##4##(1990-9#1)(2007-11#1)
of this procedure is##3##4##(2008-10#2)(2008-4#1)
of this procedure to##2##4##(2008-10#1)(2008-4#1)
of this procedure##17##3##(1990-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#3)
of this process and##2##4##(1996-7#1)(2008-2#1)
of this process can##2##4##(1992-3#1)(2010-8#1)
of this process in##2##4##(2008-10#1)(2008-11#1)
of this process is##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
of this process were##2##4##(1991-3#1)(2008-10#1)
of this process##27##3##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-6#1)(1996-7#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#3)(2008-7#1)(2010-8#1)(2011-2#1)
of this product##4##3##(2008-10#2)(2008-5#1)(2010-8#1)
of this program is##2##4##(1993-1#1)(2008-11#1)
of this program were##2##4##(2012-12#1)(2012-3#1)
of this program##13##3##(1993-1#1)(1996-2#2)(1997-1#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2012-12#2)(2012-3#1)
of this programme##4##3##(1990-11#1)(2008-11#2)(2008-7#1)
of this project is##2##4##(2008-11#1)(2010-7#1)
of this project was to##9##5##(1991-9#1)(1994-3#1)(1995-3#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2013-1#1)
of this project was##11##4##(1991-9#1)(1994-3#1)(1995-3#2)(1996-2#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2013-1#1)
of this project##16##3##(1991-9#1)(1994-3#1)(1995-3#3)(1996-2#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
of this property of the##2##5##(2008-11#1)(2008-3#1)
of this prospective##6##3##(1997-3#2)(2007-10#1)(2010-5#2)(2011-2#1)
of this protection##2##3##(2008-10#1)(2011-2#1)
of this protein in the##2##5##(1993-11#1)(1997-2#1)
of this protein in##8##4##(1990-5#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-8#1)(1997-2#1)
of this protein is##2##4##(1991-9#1)(2012-12#1)
of this protein on##2##4##(1994-3#1)(2008-7#1)
of this protein to##4##4##(1990-11#1)(1992-12#1)(1992-8#1)(1993-6#1)
of this protein##34##3##(1990-11#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
of this protocol##2##3##(2008-3#1)(2008-9#1)
of this qualitative study was to explore##3##7##(2008-12#1)(2009-9#1)(2010-10#1)
of this qualitative study was to##4##6##(2008-12#1)(2009-9#1)(2010-10#1)(2011-2#1)
of this qualitative##6##3##(2008-12#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-12#1)
of this questionnaire##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
of this randomized##2##3##(2009-12#1)(2011-2#1)
of this range##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
of this rare complication of##2##5##(2007-10#1)(2012-12#1)
of this rare complication##3##4##(2007-10#1)(2008-2#1)(2012-12#1)
of this rare condition##2##4##(2008-10#1)(2012-3#1)
of this rare disease##2##4##(2013-1#2)
of this rare neoplasm##2##4##(1991-5#1)(1993-8#1)
of this rare tumor##3##4##(1991-6#1)(2010-3#1)(2011-2#1)
of this rare##23##3##(1991-2#1)(1991-5#1)(1991-6#1)(1993-8#1)(1994-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-6#2)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
of this reaction##11##3##(1994-8#1)(1995-6#1)(2008-10#7)(2009-10#2)
of this receptor gene##3##4##(1991-5#3)
of this receptor in##3##4##(1990-11#1)(1991-2#1)(2008-5#1)
of this receptor##11##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#3)(1994-8#2)(2008-4#2)(2008-5#1)
of this reduction##3##3##(1991-6#1)(2008-10#2)
of this regimen##2##3##(1990-12#1)(2008-10#1)
of this region in our##2##5##(1990-6#1)(1997-5#1)
of this region in##3##4##(1990-6#1)(1994-2#1)(1997-5#1)
of this region should##2##4##(1996-11#1)(2010-12#1)
of this region##26##3##(1990-6#1)(1992-8#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
of this regulatory##4##3##(1991-2#1)(1995-2#1)(1995-8#1)(1997-9#1)
of this relationship are discussed##2##5##(1995-3#1)(2008-2#1)
of this relationship are##3##4##(1995-3#1)(2008-10#1)(2008-2#1)
of this relationship##10##3##(1993-12#1)(1994-5#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
of this report is to##10##5##(1992-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
of this report is##11##4##(1992-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
of this report##20##3##(1991-2#1)(1992-12#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)
of this research is the##3##5##(1995-6#1)(2008-10#1)(2008-2#1)
of this research is to##3##5##(1994-8#1)(2008-12#1)(2008-3#1)
of this research is##9##4##(1994-8#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-8#1)(2012-1#1)
of this research was the##3##5##(2008-10#1)(2008-5#1)(2011-1#1)
of this research was to determine##3##6##(1994-3#1)(2008-12#1)(2008-7#1)
of this research was to develop##2##6##(2008-5#1)(2012-2#1)
of this research was to evaluate the##2##7##(2008-10#1)(2013-7#1)
of this research was to evaluate##3##6##(2008-10#1)(2011-2#1)(2013-7#1)
of this research was to##20##5##(1990-9#1)(1994-3#1)(2008-10#5)(2008-12#2)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
of this research was##25##4##(1990-9#1)(1994-3#1)(2007-11#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
of this research were##7##4##(1995-2#1)(2008-1#1)(2008-10#4)(2010-3#1)
of this research##53##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-1#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
of this residue##5##3##(1991-9#1)(1994-5#1)(1995-2#2)(1995-5#1)
of this resistance##5##3##(2008-10#3)(2011-2#1)(2012-3#1)
of this response##4##3##(1993-12#1)(1993-8#1)(2008-12#1)(2010-1#1)
of this result and the##2##5##(1995-9#1)(2008-9#1)
of this result##8##3##(1992-3#1)(1995-9#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#2)
of this retrospective study was to##6##6##(2007-7#1)(2007-8#2)(2011-2#2)(2012-1#1)
of this retrospective study##7##4##(2007-7#1)(2007-8#2)(2011-2#2)(2012-1#1)(2012-3#1)
of this retrospective##9##3##(2007-7#1)(2007-8#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
of this review are to##3##5##(1990-11#1)(2007-8#1)(2008-8#1)
of this review are##4##4##(1990-11#1)(2007-8#1)(2008-8#1)(2009-5#1)
of this review article##5##4##(2006-12#1)(2007-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
of this review focuses##2##4##(1997-2#1)(2012-12#1)
of this review is that##2##5##(2008-8#1)(2008-9#1)
of this review is to describe##2##6##(2008-1#1)(2010-11#1)
of this review is to discuss the##4##7##(2007-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
of this review is to evaluate the##2##7##(2008-3#1)(2012-2#1)
of this review is to evaluate##3##6##(2007-8#1)(2008-3#1)(2012-2#1)
of this review is to examine the##2##7##(2008-5#1)(2009-12#1)
of this review is to give##2##6##(2008-5#1)(2011-3#1)
of this review is to illustrate the##3##7##(2008-7#1)(2012-2#2)
of this review is to illustrate##4##6##(2008-7#1)(2008-8#1)(2012-2#2)
of this review is to provide##2##6##(2008-11#1)(2009-6#1)
of this review is to##33##5##(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#2)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#3)
of this review is##40##4##(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#3)
of this review suggest##2##4##(2011-2#2)
of this review to provide the##2##6##(2007-7#1)(2012-12#1)
of this review was to investigate the##2##7##(2009-11#1)(2013-1#1)
of this review was to##7##5##(1996-6#1)(2008-5#1)(2009-11#1)(2010-6#1)(2013-1#3)
of this review was##8##4##(1996-6#1)(2008-5#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-1#3)
of this review##83##3##(1990-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-6#3)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#10)
of this risk##2##3##(1997-4#1)(2011-2#1)
of this role##4##3##(1993-3#2)(2008-12#1)(2009-8#1)
of this sample##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
of this scale##2##3##(2008-6#1)(2012-12#1)
of this scheme are##2##4##(2007-12#1)(2008-2#1)
of this scheme is given##2##5##(2008-2#1)(2008-3#1)
of this scheme##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
of this segment##3##3##(1995-3#1)(2007-12#1)(2008-9#1)
of this sensor##7##3##(2007-11#1)(2008-10#6)
of this sensory##2##3##(2009-12#1)(2011-2#1)
of this sequence has##2##4##(1996-12#1)(1997-3#1)
of this sequence to##2##4##(1994-9#1)(2008-10#1)
of this sequence##12##3##(1990-5#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-9#2)(1996-12#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-6#1)(2008-10#1)
of this series##6##3##(1996-9#1)(2008-10#2)(2008-11#2)(2012-12#1)
of this set##2##3##(2007-11#1)(2008-7#1)
of this signaling##2##3##(1997-4#1)(2009-6#1)
of this simple##6##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-5#1)
of this site##2##3##(1990-8#1)(2013-8#1)
of this small study##2##4##(2007-10#1)(2008-11#1)
of this small##4##3##(2007-10#1)(2007-8#1)(2008-11#2)
of this solution##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
of this source##3##3##(2007-12#1)(2008-2#2)
of this space##2##3##(1991-2#1)(2007-12#1)
of this special issue##2##4##(2009-8#1)(2010-4#1)
of this special##4##3##(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)
of this species are not##2##5##(2008-8#1)(2013-1#1)
of this species are##3##4##(2008-8#2)(2013-1#1)
of this species in the##4##5##(2008-11#1)(2008-5#1)(2008-6#1)(2013-7#1)
of this species in##5##4##(2008-11#1)(2008-5#2)(2008-6#1)(2013-7#1)
of this species is##3##4##(2008-12#2)(2008-5#1)
of this species##36##3##(1996-6#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-5#9)(2008-6#2)(2008-8#2)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#3)
of this specific##3##3##(1994-8#1)(2009-10#1)(2011-2#1)
of this spectrometer##2##3##(2008-2#1)(2008-3#1)
of this spectrum##3##3##(1994-5#1)(2008-3#1)(2008-4#1)
of this stabilization##2##3##(1994-11#1)(2007-12#1)
of this state##2##3##(2008-10#1)(2009-9#1)
of this strain##2##3##(2008-10#1)(2011-2#1)
of this strategy##4##3##(1996-2#1)(2008-8#1)(2009-4#1)(2012-12#1)
of this structural##2##3##(1992-12#1)(2008-8#1)
of this structure##5##3##(1991-5#1)(1992-12#1)(1993-6#1)(2007-11#1)(2007-12#1)
of this study and##4##4##(1990-6#1)(2008-5#1)(2008-8#1)(2013-1#1)
of this study are discussed##3##5##(1993-1#1)(2007-11#1)(2008-3#1)
of this study are of interest for##2##7##(1993-9#1)(2008-3#1)
of this study are to determine##2##6##(2008-6#1)(2012-2#1)
of this study are to##5##5##(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
of this study are##22##4##(1992-8#1)(1993-1#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
of this study can be##2##5##(1995-9#1)(2013-1#1)
of this study demonstrate that##4##5##(1994-6#1)(2008-10#2)(2008-5#1)
of this study demonstrate##7##4##(1994-6#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
of this study demonstrated##5##4##(1992-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
of this study has been to determine the##2##8##(2008-5#2)
of this study has##3##4##(2008-5#2)(2009-7#1)
of this study have##2##4##(2008-10#2)
of this study indicate that##16##5##(1990-5#1)(1990-6#1)(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-6#2)(2009-7#1)(2011-2#2)
of this study indicate##17##4##(1990-5#1)(1990-6#1)(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-7#1)(2011-2#2)
of this study indicated##4##4##(1993-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
of this study is that##3##5##(1997-8#1)(2008-3#1)(2013-1#1)
of this study is the##3##5##(2007-8#1)(2008-10#1)(2008-3#1)
of this study is to assess the##3##7##(2008-11#1)(2008-5#1)(2012-3#1)
of this study is to assess##4##6##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
of this study is to compare the##3##7##(2007-8#1)(2011-2#1)(2012-12#1)
of this study is to compare##5##6##(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
of this study is to describe the##3##7##(1995-4#1)(2010-7#1)(2011-2#1)
of this study is to describe##4##6##(1995-4#1)(2008-11#1)(2010-7#1)(2011-2#1)
of this study is to determine##5##6##(2008-5#1)(2011-2#3)(2013-1#1)
of this study is to develop a##2##7##(2011-1#1)(2013-8#1)
of this study is to develop##4##6##(2008-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
of this study is to evaluate the##10##7##(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#3)(2011-2#2)(2013-1#1)
of this study is to evaluate##14##6##(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#3)(2011-2#3)(2013-1#2)
of this study is to examine##3##6##(2008-10#1)(2011-2#1)(2013-8#1)
of this study is to identify##4##6##(2008-12#1)(2012-3#1)(2013-8#2)
of this study is to investigate the##7##7##(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#1)
of this study is to investigate##9##6##(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#2)(2011-3#1)(2012-2#1)
of this study is to present a##3##7##(2009-6#1)(2011-2#1)(2012-12#1)
of this study is to present##5##6##(1996-1#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
of this study is to provide##2##6##(2009-7#1)(2012-12#1)
of this study is to##86##5##(1992-12#1)(1992-2#1)(1995-4#1)(1996-1#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
of this study is##96##4##(1992-12#1)(1992-2#1)(1995-4#1)(1996-1#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#6)
of this study revealed that##3##5##(1997-8#1)(2007-12#1)(2008-5#1)
of this study should be##2##5##(1995-5#1)(2010-4#1)
of this study show that##5##5##(1990-12#1)(2008-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
of this study show##8##4##(1990-12#1)(2008-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#3)
of this study showed that##5##5##(2008-12#3)(2013-1#2)
of this study showed##6##4##(2007-2#1)(2008-12#3)(2013-1#2)
of this study shows that##2##5##(1995-6#1)(2008-12#1)
of this study shows##3##4##(1995-6#1)(2008-12#1)(2008-7#1)
of this study suggest that the##2##6##(1990-2#1)(1994-2#1)
of this study suggest that##19##5##(1990-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
of this study suggest##21##4##(1990-2#1)(1991-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of this study suggested that##3##5##(1992-2#1)(1995-4#1)(2011-3#1)
of this study suggested##4##4##(1992-2#1)(1995-4#1)(2009-5#1)(2011-3#1)
of this study to##5##4##(1990-11#1)(1995-12#1)(2008-11#1)(2008-3#1)(2009-10#1)
of this study was a##2##5##(1993-3#1)(2007-11#1)
of this study was that##2##5##(2008-10#1)(2009-7#1)
of this study was the##2##5##(2007-8#1)(2013-1#1)
of this study was to analyse##4##6##(2007-11#1)(2008-6#1)(2010-3#1)(2013-8#1)
of this study was to analyze the##7##7##(2007-6#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-3#1)
of this study was to analyze##12##6##(2007-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-4#2)(2011-2#2)(2012-3#2)(2013-1#1)
of this study was to apply##3##6##(2008-10#1)(2008-5#1)(2013-1#1)
of this study was to assess the feasibility##2##8##(1997-8#1)(2007-10#1)
of this study was to assess the##24##7##(1990-6#1)(1992-10#1)(1992-12#1)(1997-8#1)(2007-10#1)(2007-7#2)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
of this study was to assess whether##2##7##(1991-6#1)(2008-7#1)
of this study was to assess##33##6##(1990-6#1)(1991-6#1)(1992-10#1)(1992-12#1)(1994-3#1)(1997-8#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#4)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
of this study was to characterize the##2##7##(2007-8#1)(2008-11#1)
of this study was to characterize##3##6##(2007-8#1)(2008-11#2)
of this study was to compare the incidence of##2##9##(2008-7#1)(2009-7#1)
of this study was to compare the##17##7##(1992-10#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
of this study was to compare##31##6##(1992-10#1)(1994-12#1)(1994-2#1)(2007-10#2)(2007-8#3)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of this study was to contribute##2##6##(2011-2#1)(2013-7#1)
of this study was to define##3##6##(1995-2#1)(2008-9#1)(2011-2#1)
of this study was to describe the clinical##2##8##(2007-2#1)(2010-5#1)
of this study was to describe the##7##7##(2007-2#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-1#2)(2013-7#1)
of this study was to describe##10##6##(2007-2#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-7#1)
of this study was to determine if##6##7##(1995-2#1)(1996-5#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-1#1)
of this study was to determine the accuracy of##2##9##(2012-1#1)(2012-2#1)
of this study was to determine the effect of##4##9##(1991-8#1)(1994-2#1)(2008-10#1)(2011-2#1)
of this study was to determine the effects of##8##9##(2008-10#1)(2008-5#3)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
of this study was to determine the influence of##2##9##(2007-11#1)(2011-2#1)
of this study was to determine the proportion##2##8##(1997-6#1)(2012-12#1)
of this study was to determine the relationship between##3##9##(2008-10#1)(2008-12#1)(2012-2#1)
of this study was to determine the relationship##4##8##(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#1)
of this study was to determine the relative##2##8##(1992-11#1)(2010-8#1)
of this study was to determine the##59##7##(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-5#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-3#1)(2013-8#4)
of this study was to determine whether there are##2##9##(2008-7#1)(2010-7#1)
of this study was to determine whether##18##7##(1990-10#1)(1993-9#1)(1994-11#1)(1995-3#1)(1997-8#1)(2007-10#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
of this study was to determine which##2##7##(2012-2#1)(2013-1#1)
of this study was to determine##90##6##(1990-10#1)(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#4)(2009-5#3)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-3#1)(2013-8#5)
of this study was to develop a##6##7##(2007-10#1)(2008-5#2)(2008-6#1)(2010-2#1)(2012-4#1)
of this study was to develop an##6##7##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this study was to develop and evaluate##2##8##(2008-10#2)
of this study was to develop and validate##2##8##(2012-1#2)
of this study was to develop and##6##7##(2008-10#2)(2010-9#1)(2011-2#1)(2012-1#2)
of this study was to develop##24##6##(2007-10#1)(2008-10#4)(2008-11#3)(2008-5#5)(2008-6#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-4#1)(2013-1#1)
of this study was to elucidate the##3##7##(1995-6#1)(2008-10#1)(2008-8#1)
of this study was to establish the##3##7##(1994-2#1)(2007-11#1)(2013-7#1)
of this study was to establish##5##6##(1994-2#1)(2007-11#1)(2008-11#1)(2013-1#1)(2013-7#1)
of this study was to estimate the##5##7##(1996-1#1)(2008-7#2)(2008-8#1)(2011-2#1)
of this study was to evaluate a##3##7##(2008-10#1)(2009-5#1)(2013-8#1)
of this study was to evaluate the early and##2##9##(2007-8#1)(2008-12#1)
of this study was to evaluate the effect of##5##9##(1992-8#1)(2008-1#1)(2008-5#1)(2012-2#2)
of this study was to evaluate the effects of##3##9##(1993-12#1)(2008-12#1)(2013-1#1)
of this study was to evaluate the efficacy of##3##9##(2008-5#1)(2009-8#1)(2013-1#1)
of this study was to evaluate the impact of##3##9##(1996-1#1)(2007-11#1)(2008-12#1)
of this study was to evaluate the influence of##3##9##(2008-12#1)(2009-8#1)(2013-1#1)
of this study was to evaluate the prevalence of##4##9##(2008-12#2)(2008-7#1)(2012-3#1)
of this study was to evaluate the results of##2##9##(2008-9#1)(2011-2#1)
of this study was to evaluate the role of##2##9##(2007-7#1)(2013-1#1)
of this study was to evaluate the use of##2##9##(1990-11#1)(2013-1#1)
of this study was to evaluate the##64##7##(1990-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-1#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#10)
of this study was to evaluate whether##4##7##(2008-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
of this study was to evaluate##91##6##(1990-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#1)(1996-1#1)(1996-12#1)(1997-8#3)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#9)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#11)(2013-8#3)
of this study was to examine the possible##2##8##(1996-2#1)(2011-2#1)
of this study was to examine the##23##7##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
of this study was to examine##33##6##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-6#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
of this study was to explore##13##6##(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of this study was to formulate an##2##7##(2008-5#1)(2012-7#1)
of this study was to further characterize the##2##8##(1992-12#1)(2008-10#1)
of this study was to further##3##6##(1992-12#1)(2008-10#1)(2008-11#1)
of this study was to identify the##5##7##(2008-1#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-10#1)
of this study was to identify##14##6##(1990-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-11#1)(2011-2#2)
of this study was to improve the##2##7##(2008-11#1)(2012-3#1)
of this study was to improve##3##6##(2008-11#1)(2009-4#1)(2012-3#1)
of this study was to investigate how##4##7##(1996-6#1)(1997-8#1)(2008-9#1)(2013-7#1)
of this study was to investigate the effect of##9##9##(1995-3#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
of this study was to investigate the effects of##5##9##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this study was to investigate the effects##6##8##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this study was to investigate the expression of##2##9##(1992-8#1)(2008-10#1)
of this study was to investigate the influence of##2##9##(2008-12#1)(2011-1#1)
of this study was to investigate the prevalence##2##8##(2008-7#1)(2012-1#1)
of this study was to investigate the relationship between##2##9##(2009-7#1)(2013-1#1)
of this study was to investigate the##54##7##(1992-11#1)(1992-8#1)(1994-12#1)(1995-3#1)(1996-3#1)(2007-10#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#5)(2013-7#1)
of this study was to investigate whether##7##7##(1997-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of this study was to investigate##74##6##(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#3)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#3)
of this study was to isolate##2##6##(1993-8#1)(2008-10#1)
of this study was to perform##2##6##(2009-8#1)(2011-2#1)
of this study was to present##4##6##(1994-2#1)(2008-10#2)(2008-6#1)
of this study was to quantify the##3##7##(2007-10#1)(2008-10#1)(2009-5#1)
of this study was to report##2##6##(2008-9#2)
of this study was to test##7##6##(1993-12#2)(2007-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-3#1)
of this study was to understand the##2##7##(2008-11#1)(2011-1#1)
of this study was to use##7##6##(1993-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
of this study was to verify the##3##7##(2008-6#1)(2008-7#2)
of this study was to verify##5##6##(1996-3#1)(2008-6#1)(2008-7#2)(2010-9#1)
of this study was to##556##5##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#7)(2006-8#2)(2007-10#15)(2007-11#8)(2007-12#2)(2007-2#3)(2007-6#5)(2007-7#6)(2007-8#18)(2008-1#4)(2008-10#42)(2008-11#19)(2008-12#30)(2008-3#4)(2008-4#7)(2008-5#37)(2008-6#13)(2008-7#23)(2008-8#8)(2008-9#22)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#12)(2011-2#35)(2011-7#1)(2012-1#6)(2012-12#5)(2012-2#16)(2012-3#14)(2012-4#1)(2012-7#1)(2013-1#36)(2013-3#1)(2013-7#8)(2013-8#14)
of this study was twofold##2##5##(1994-1#1)(2010-8#1)
of this study was##571##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#7)(2006-8#2)(2007-10#15)(2007-11#9)(2007-12#2)(2007-2#3)(2007-6#6)(2007-7#7)(2007-8#19)(2008-1#4)(2008-10#43)(2008-11#20)(2008-12#30)(2008-3#4)(2008-4#7)(2008-5#37)(2008-6#13)(2008-7#24)(2008-8#8)(2008-9#22)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#12)(2011-2#35)(2011-7#1)(2012-1#6)(2012-12#5)(2012-2#16)(2012-3#14)(2012-4#1)(2012-7#1)(2013-1#37)(2013-3#1)(2013-7#8)(2013-8#14)
of this study were (i) to##2##6##(2008-5#1)(2008-8#1)
of this study were to (i)##4##6##(2008-10#2)(2010-12#1)(2013-1#1)
of this study were to characterize##2##6##(2008-10#1)(2013-1#1)
of this study were to describe the##2##7##(2008-6#1)(2013-1#1)
of this study were to describe##3##6##(2008-6#1)(2009-5#1)(2013-1#1)
of this study were to determine the prevalence of##3##9##(2008-12#1)(2008-3#1)(2008-8#1)
of this study were to determine the##8##7##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
of this study were to determine##10##6##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
of this study were to evaluate##5##6##(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-3#1)
of this study were to identify##3##6##(2008-10#1)(2008-11#1)(2013-1#1)
of this study were to investigate##3##6##(2008-12#1)(2010-2#1)(2011-2#1)
of this study were to##41##5##(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#6)
of this study were##53##4##(1991-2#1)(1993-12#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#6)
of this study##914##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#3)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#4)(1992-8#3)(1992-9#1)(1993-1#2)(1993-12#7)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#5)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#9)(2006-12#1)(2006-8#2)(2007-10#16)(2007-11#10)(2007-12#3)(2007-2#5)(2007-6#6)(2007-7#11)(2007-8#23)(2008-1#6)(2008-10#92)(2008-11#40)(2008-12#50)(2008-3#13)(2008-4#10)(2008-5#55)(2008-6#19)(2008-7#36)(2008-8#14)(2008-9#25)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#5)(2009-5#12)(2009-6#5)(2009-7#10)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#10)(2010-4#6)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#12)(2010-9#4)(2011-1#21)(2011-2#59)(2011-3#2)(2011-7#1)(2012-1#9)(2012-12#8)(2012-2#18)(2012-3#18)(2012-4#1)(2012-7#1)(2013-1#65)(2013-3#1)(2013-7#8)(2013-8#20)
of this subject##2##3##(2008-10#1)(2008-11#1)
of this subset##2##3##(2008-9#1)(2010-12#1)
of this substance##2##3##(2008-11#2)
of this substrate##2##3##(1994-5#1)(1996-12#1)
of this subunit##2##3##(1995-2#1)(2009-7#1)
of this survey indicate a##2##5##(1995-1#1)(2008-12#1)
of this survey indicate##3##4##(1990-3#1)(1995-1#1)(2008-12#1)
of this survey was to##3##5##(1991-12#1)(1993-5#1)(2011-2#1)
of this survey##13##3##(1990-3#1)(1991-12#1)(1993-5#1)(1995-1#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2011-2#2)
of this syndrome is##2##4##(2008-12#2)
of this syndrome##12##3##(1995-12#1)(1997-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#2)(2008-3#1)(2012-2#1)(2013-1#2)
of this synthetic##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
of this system are##2##4##(1990-11#1)(2008-10#1)
of this system for##5##4##(1994-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
of this system is##10##4##(1992-3#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#4)
of this system##37##3##(1990-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-1#1)
of this systematic review##3##4##(2008-10#1)(2012-3#1)(2013-8#1)
of this systematic##4##3##(2008-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
of this target##2##3##(2008-2#1)(2008-9#1)
of this technique and##3##4##(2008-7#2)(2008-8#1)
of this technique are discussed##2##5##(1993-10#1)(2007-11#1)
of this technique are##5##4##(1993-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
of this technique as a##4##5##(2007-12#1)(2008-10#2)(2008-5#1)
of this technique by##2##4##(2007-12#1)(2008-3#1)
of this technique for##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
of this technique has##2##4##(2008-4#1)(2011-2#1)
of this technique in the##2##5##(2008-2#1)(2013-1#1)
of this technique in##8##4##(1993-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#3)
of this technique include##3##4##(2007-11#1)(2008-2#1)(2010-7#1)
of this technique is##6##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
of this technique to##4##4##(1993-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
of this technique##64##3##(1992-2#1)(1993-10#2)(1993-3#1)(2007-10#1)(2007-11#5)(2007-12#9)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#5)
of this technology for##3##4##(2008-6#1)(2008-7#2)
of this technology in##3##4##(1991-11#1)(1996-1#1)(2008-10#1)
of this technology to##2##4##(2008-10#1)(2013-8#1)
of this technology##16##3##(1991-11#1)(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
of this test##9##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
of this theory##2##3##(2008-7#1)(2010-10#1)
of this therapeutic##2##3##(1995-5#1)(2007-12#1)
of this therapy is##2##4##(2012-12#1)(2013-8#1)
of this therapy##7##3##(1993-11#1)(2007-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
of this tissue##3##3##(1992-9#2)(1995-12#1)
of this tool##6##3##(1995-2#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-7#1)(2013-1#1)
of this trade-off##3##3##(2008-8#3)
of this transcription factor##5##4##(1990-5#1)(1994-8#1)(1995-2#1)(2009-8#2)
of this transporter##2##3##(1995-8#1)(1996-5#1)
of this treatment are##2##4##(2008-8#1)(2011-1#1)
of this treatment in##2##4##(1994-12#1)(2008-11#1)
of this treatment##17##3##(1990-12#1)(1991-3#1)(1992-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
of this trial##2##3##(1991-9#1)(2011-2#1)
of this tumor and##2##4##(2013-1#1)(2013-7#1)
of this tumor##7##3##(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
of this two-part series##2##4##(1993-2#1)(1996-2#1)
of this type are##4##4##(1994-5#1)(2008-3#2)(2009-5#1)
of this type in##2##4##(1994-8#1)(2012-12#1)
of this type is##3##4##(1990-5#1)(2008-10#1)(2011-2#1)
of this type of filter##2##5##(2007-11#1)(2008-3#1)
of this type of intervention by##2##6##(2008-9#1)(2012-2#1)
of this type of intervention##4##5##(1994-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
of this type of##29##4##(1993-1#1)(1994-1#1)(1994-6#1)(1994-8#1)(1997-8#2)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)
of this type##51##3##(1990-5#1)(1991-11#1)(1992-1#1)(1993-1#1)(1994-1#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)
of this uncommon disease##3##4##(1993-5#1)(2008-12#1)(2008-7#1)
of this uncommon##10##3##(1993-5#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
of this understanding##2##3##(2008-12#2)
of this unique enzyme##2##4##(1996-2#1)(1997-9#1)
of this unique##6##3##(1993-11#1)(1996-2#1)(1997-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
of this unit is to##8##5##(2008-4#4)(2008-9#4)
of this unit is##13##4##(2008-4#8)(2008-9#5)
of this unit##21##3##(2008-2#2)(2008-4#14)(2008-9#5)
of this unusual neoplasm##2##4##(2008-10#1)(2009-3#1)
of this unusual##5##3##(2006-12#1)(2007-5#1)(2008-10#2)(2009-3#1)
of this variation##4##3##(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#1)
of this variety##5##3##(1993-2#1)(1995-11#1)(1996-3#1)(2008-5#2)
of this vector##2##3##(1997-4#1)(2008-8#1)
of this very##2##3##(2008-6#1)(2008-9#1)
of this virus##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
of this work has##2##4##(2008-10#1)(2012-3#1)
of this work is that##3##5##(1990-7#1)(2008-5#1)(2008-7#1)
of this work is the##4##5##(2008-10#3)(2008-4#1)
of this work is to find##2##6##(2008-5#1)(2009-6#1)
of this work is to##19##5##(2007-11#3)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
of this work is##27##4##(1990-7#1)(2007-11#3)(2008-10#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
of this work was the##3##5##(2007-11#1)(2008-1#1)(2008-10#1)
of this work was to develop##3##6##(1997-2#1)(2012-2#2)
of this work was to evaluate the##5##7##(1997-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
of this work was to evaluate##8##6##(1997-8#1)(2008-10#2)(2008-5#3)(2013-1#1)(2013-8#1)
of this work was to study the##6##7##(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-7#1)
of this work was to study##9##6##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#2)
of this work was to##44##5##(1993-12#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#11)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
of this work was##48##4##(1993-12#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#12)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
of this work were to##3##5##(2008-10#3)
of this work##94##3##(1990-7#1)(1990-9#1)(1992-4#1)(1993-12#1)(1995-12#1)(1995-5#2)(1997-2#1)(1997-8#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#3)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#1)
of this##4610##2##(1990-10#2)(1990-11#19)(1990-12#23)(1990-2#11)(1990-3#8)(1990-5#21)(1990-6#14)(1990-7#8)(1990-8#10)(1990-9#10)(1991-1#5)(1991-10#2)(1991-11#7)(1991-12#19)(1991-2#19)(1991-3#15)(1991-4#1)(1991-5#15)(1991-6#20)(1991-7#3)(1991-8#10)(1991-9#20)(1992-1#9)(1992-10#6)(1992-11#12)(1992-12#21)(1992-2#14)(1992-3#23)(1992-4#5)(1992-5#9)(1992-6#12)(1992-7#1)(1992-8#18)(1992-9#7)(1993-1#14)(1993-10#2)(1993-11#8)(1993-12#34)(1993-2#17)(1993-3#19)(1993-5#5)(1993-6#17)(1993-8#23)(1993-9#11)(1994-1#8)(1994-10#1)(1994-11#14)(1994-12#15)(1994-2#21)(1994-3#19)(1994-5#20)(1994-6#12)(1994-8#29)(1994-9#9)(1995-1#12)(1995-11#12)(1995-12#16)(1995-2#31)(1995-3#20)(1995-4#2)(1995-5#17)(1995-6#20)(1995-8#15)(1995-9#5)(1996-1#14)(1996-10#2)(1996-11#4)(1996-12#20)(1996-2#28)(1996-3#10)(1996-4#1)(1996-5#10)(1996-6#5)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#9)(1997-2#28)(1997-3#27)(1997-4#19)(1997-5#2)(1997-6#9)(1997-7#10)(1997-8#23)(1997-9#3)(2006-10#2)(2006-12#6)(2006-6#4)(2006-8#3)(2007-10#32)(2007-11#77)(2007-12#95)(2007-2#8)(2007-3#1)(2007-4#6)(2007-5#5)(2007-6#9)(2007-7#26)(2007-8#52)(2007-9#2)(2008-1#47)(2008-10#653)(2008-11#169)(2008-12#135)(2008-2#106)(2008-3#187)(2008-4#67)(2008-5#173)(2008-6#72)(2008-7#145)(2008-8#92)(2008-9#107)(2009-1#1)(2009-10#26)(2009-11#12)(2009-12#14)(2009-2#15)(2009-3#15)(2009-4#16)(2009-5#32)(2009-6#18)(2009-7#21)(2009-8#31)(2009-9#20)(2010-1#6)(2010-10#14)(2010-11#19)(2010-12#23)(2010-2#11)(2010-3#34)(2010-4#19)(2010-5#28)(2010-6#20)(2010-7#12)(2010-8#34)(2010-9#10)(2011-1#66)(2011-10#1)(2011-2#209)(2011-3#11)(2011-7#4)(2012-1#21)(2012-12#59)(2012-2#94)(2012-3#69)(2012-4#1)(2012-5#1)(2012-7#2)(2012-8#1)(2013-1#180)(2013-3#1)(2013-7#24)(2013-8#54)
of thoracic and lumbar##2##4##(2008-12#1)(2008-7#1)
of thoracic aorta##2##3##(2008-10#1)(2009-8#1)
of thoracic injuries##2##3##(2007-8#1)(2010-9#1)
of thoracic sclerites of mosquitoes (Diptera##2##6##(2013-1#2)
of thoracic sclerites##3##3##(2013-1#3)
of thoracic##21##2##(1991-3#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-8#2)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#3)
of thoracolumbar##2##2##(2008-8#1)(2010-8#1)
of thoracoscopic##2##2##(2010-8#1)(2012-1#1)
of thorium and##4##3##(2008-10#4)
of thorium##14##2##(2008-10#14)
of thorium(IV)##4##2##(2008-10#4)
of those affected##2##3##(1995-1#1)(2010-5#1)
of those associated with##2##4##(2007-11#1)(2007-9#1)
of those at##3##3##(2007-10#1)(2008-12#1)(2011-2#1)
of those changes##2##3##(1993-1#1)(1993-12#1)
of those children##2##3##(1993-3#1)(2010-11#1)
of those clones##2##3##(1992-8#1)(2008-11#1)
of those factors##3##3##(1992-3#1)(2007-12#1)(2011-2#1)
of those from##4##3##(1990-2#1)(1994-8#1)(2008-10#2)
of those genes##2##3##(2008-7#1)(2012-3#1)
of those in##3##3##(2008-4#1)(2010-10#1)(2011-2#1)
of those involved##3##3##(1994-1#1)(1995-8#1)(1996-9#1)
of those lines##2##3##(2008-10#2)
of those new##2##3##(2008-11#1)(2010-8#1)
of those not##3##3##(1990-6#1)(1993-1#1)(2008-3#1)
of those obtained##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
of those on##4##3##(1996-3#1)(2008-11#2)(2008-6#1)
of those patients with##2##4##(2008-9#1)(2011-2#1)
of those patients##4##3##(2008-1#1)(2008-9#1)(2011-2#1)(2013-8#1)
of those presenting##3##3##(2007-10#1)(2008-1#1)(2008-3#1)
of those principles##2##3##(1996-2#2)
of those problems##4##3##(1997-1#1)(2011-2#1)(2013-1#2)
of those proteins##3##3##(1990-7#1)(2008-4#1)(2009-12#1)
of those receptors##2##3##(2008-4#2)
of those released from##2##4##(2008-11#2)
of those species##2##3##(2008-10#2)
of those surveyed##2##3##(1997-3#1)(2008-1#1)
of those tested##2##3##(1990-5#1)(1997-2#1)
of those that##2##3##(2009-10#1)(2011-2#1)
of those treated with##2##4##(1993-2#1)(2008-3#1)
of those treated##5##3##(1992-9#1)(1993-2#1)(2007-8#1)(2008-3#1)(2008-5#1)
of those under##2##3##(1993-2#1)(2011-2#1)
of those were##2##3##(2008-12#1)(2012-2#1)
of those who are##3##4##(1992-2#1)(1994-1#1)(2008-10#1)
of those who were##3##4##(1993-3#1)(1997-8#1)(2012-2#1)
of those who##22##3##(1990-6#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-3#2)(1994-1#1)(1994-3#3)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)
of those whose##2##3##(2011-1#1)(2013-8#1)
of those with a##2##4##(2008-7#1)(2009-2#1)
of those with##20##3##(1990-6#1)(1990-9#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1996-3#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-2#1)
of those without##2##3##(1990-9#1)(1993-8#1)
of those##266##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-8#2)(1994-1#3)(1994-11#1)(1994-12#3)(1994-3#5)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#3)(2007-10#4)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#24)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#11)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#5)
of thought suppression##2##3##(2009-11#2)
of thought##9##2##(1997-2#1)(2008-11#1)(2008-2#2)(2009-11#2)(2010-1#1)(2012-12#1)(2012-3#1)
of thoughts##2##2##(2010-6#1)(2012-12#1)
of thousands of genes##3##4##(2008-7#2)(2011-3#1)
of thousands of##16##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#6)(2009-4#1)(2009-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
of threat##3##2##(2012-2#3)
of threatened##2##2##(1991-9#1)(1993-6#1)
of three amino acid residues##2##5##(1993-11#1)(2008-8#1)
of three and##2##3##(1990-6#1)(2008-10#1)
of three bacterial##2##3##(2008-10#1)(2011-1#1)
of three basic##4##3##(2007-11#1)(2007-12#1)(2008-7#1)(2010-2#1)
of three case studies##2##4##(1991-1#1)(1991-12#1)
of three cases##11##3##(1991-12#1)(1991-6#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of three chemical##2##3##(2008-10#1)(2008-5#1)
of three classes of##2##4##(1994-9#1)(1995-2#1)
of three clinical trials##3##4##(2008-6#1)(2008-8#1)(2012-3#1)
of three clinical##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
of three dental##2##3##(2012-2#1)(2013-1#1)
of three different restriction enzymes##2##5##(2008-10#2)
of three different types of##2##5##(2008-10#1)(2010-8#1)
of three different##28##3##(1991-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-2#2)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
of three differently##2##3##(1997-4#1)(2008-10#1)
of three dimensional##3##3##(1995-8#1)(2012-2#1)(2012-3#1)
of three distinct##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2009-4#1)
of three doses of##3##4##(1995-12#1)(1995-3#1)(2011-2#1)
of three doses##4##3##(1995-12#1)(1995-3#1)(2011-2#1)(2013-8#1)
of three dyes##2##3##(2008-10#2)
of three enzymes##3##3##(2008-10#2)(2008-11#1)
of three flavonoids##2##3##(2008-10#2)
of three genes##2##3##(1994-12#1)(1995-8#1)
of three groups##5##3##(1991-1#1)(1994-1#1)(2008-1#1)(2008-10#2)
of three highly##3##3##(2008-10#1)(2008-3#2)
of three hours##2##3##(1996-6#1)(2011-1#1)
of three human##4##3##(1991-6#1)(2008-11#2)(2008-6#1)
of three important##2##3##(2008-10#1)(2008-3#1)
of three independent##5##3##(2007-11#2)(2008-10#2)(2009-2#1)
of three instruments##2##3##(2008-3#1)(2013-1#1)
of three isolates of##2##4##(2008-12#1)(2008-6#1)
of three isolates##5##3##(2008-10#2)(2008-12#1)(2008-6#1)(2011-1#1)
of three key##2##3##(1995-2#1)(2008-11#1)
of three kinds of##3##4##(1992-8#1)(2008-10#1)(2008-7#1)
of three large##3##3##(1994-9#1)(1995-12#1)(2011-2#1)
of three layers##6##3##(2008-10#4)(2010-8#2)
of three lipid##2##3##(1994-3#1)(1994-5#1)
of three main##3##3##(1996-1#1)(1997-2#1)(2008-10#1)
of three major##5##3##(1991-9#1)(1993-12#1)(1997-8#1)(2008-10#1)(2010-3#1)
of three members##2##3##(1993-12#1)(2009-6#1)
of three methods##3##3##(1994-12#1)(2008-6#1)(2010-8#1)
of three months and##3##4##(1991-11#1)(1993-6#1)(2008-11#1)
of three months##7##3##(1991-11#1)(1992-11#1)(1993-6#1)(2008-1#1)(2008-11#1)(2013-1#2)
of three new##3##3##(1997-3#1)(2008-10#2)
of three novel##2##3##(2012-3#1)(2013-1#1)
of three of the##5##4##(1990-6#1)(1994-12#1)(1994-5#1)(2008-5#1)(2010-6#1)
of three of##7##3##(1990-6#1)(1994-12#1)(1994-5#1)(2008-5#2)(2009-11#1)(2010-6#1)
of three patients##5##3##(1990-9#1)(1991-8#1)(2007-11#1)(2008-11#2)
of three pediatric patients with##2##5##(2011-1#1)(2013-8#1)
of three phase##2##3##(2008-3#1)(2008-7#1)
of three plant##2##3##(2008-10#1)(2013-8#1)
of three selected##2##3##(1993-11#1)(2008-10#1)
of three sequential##2##3##(1996-5#1)(2008-10#1)
of three species of##5##4##(2007-12#2)(2008-10#1)(2008-9#1)(2010-2#1)
of three species##7##3##(2007-12#2)(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
of three stages##3##3##(1996-3#1)(2008-6#1)(2009-5#1)
of three strains of the##2##5##(2008-10#1)(2008-11#1)
of three strains of##5##4##(1994-2#1)(2008-10#3)(2008-11#1)
of three such##2##3##(2007-11#1)(2007-12#1)
of three surgical##2##3##(1994-3#1)(1995-12#1)
of three tissues##2##3##(2008-3#2)
of three to##4##3##(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#1)
of three trials##2##3##(2008-1#1)(2008-10#1)
of three trials)##2##3##(2008-10#2)
of three types of##4##4##(2008-1#1)(2008-11#1)(2008-3#2)
of three types##5##3##(1995-5#1)(2008-1#1)(2008-11#1)(2008-3#2)
of three was##3##3##(1990-6#1)(2008-10#2)
of three whitefly-borne closteroviruses##2##4##(2008-10#2)
of three years##5##3##(1991-6#1)(1993-9#1)(2007-11#1)(2008-1#1)(2010-10#1)
of three##532##2##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#1)(1991-6#4)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#6)(1993-12#5)(1993-3#3)(1993-6#4)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-11#8)(2007-12#11)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#146)(2008-11#23)(2008-12#7)(2008-2#16)(2008-3#22)(2008-4#3)(2008-5#16)(2008-6#9)(2008-7#13)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#10)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#10)(2012-3#4)(2012-5#2)(2013-1#14)(2013-7#3)(2013-8#4)
of three-dimensional (3-D)##2##3##(2007-12#1)(2011-1#1)
of three-dimensional (3D)##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
of three-dimensional images##2##3##(2007-11#2)
of three-dimensional objects##4##3##(1996-2#1)(2007-12#1)(2008-3#2)
of three-dimensional topological##2##3##(2008-2#1)(2012-2#1)
of three-dimensional##39##2##(1991-5#1)(1996-2#1)(2007-11#9)(2007-12#5)(2008-11#1)(2008-2#7)(2008-3#8)(2008-6#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of three-way data##2##3##(2008-10#2)
of three-way##8##2##(2008-10#8)
of threedimensional##2##2##(1995-11#1)(2013-1#1)
of threshold##8##2##(1993-12#1)(1996-4#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)
of thresholds##3##2##(2008-7#1)(2009-9#1)(2012-1#1)
of thrips##3##2##(2008-10#3)
of thrombi##3##2##(2008-1#1)(2008-12#1)(2011-1#1)
of thrombin##11##2##(1990-7#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-8#1)(1994-5#1)(1997-2#1)(2008-4#1)(2009-12#2)
of thrombo-embolic##2##2##(1997-6#2)
of thrombocytes in##2##3##(2013-1#2)
of thrombocytes##4##2##(2013-1#4)
of thrombocytopenia##5##2##(1990-10#1)(2008-8#3)(2013-1#1)
of thromboembolic complications##4##3##(1990-12#1)(1997-6#1)(2007-8#2)
of thromboembolic diseases##2##3##(1992-9#1)(2010-3#1)
of thromboembolic events##2##3##(1994-3#1)(2008-10#1)
of thromboembolic##12##2##(1990-12#1)(1991-3#1)(1992-9#1)(1994-3#1)(1997-6#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-2#1)
of thromboembolism and##2##3##(2007-8#1)(2008-7#1)
of thromboembolism were##2##3##(1990-12#2)
of thromboembolism##10##2##(1990-12#2)(2006-10#1)(2007-8#5)(2008-7#1)(2010-6#1)
of thrombolysis##5##2##(1990-3#1)(1994-3#2)(2007-10#1)(2009-11#1)
of thrombolytic therapy##6##3##(1993-9#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-7#1)
of thrombolytics##4##2##(1997-3#1)(2006-7#1)(2006-8#1)(2007-11#1)
of thrombomodulin##2##2##(1990-5#1)(1997-2#1)
of thrombopoiesis##2##2##(2006-6#2)
of thrombopoietin##2##2##(2008-8#2)
of thrombosis of##2##3##(1996-6#1)(1997-3#1)
of thrombosis##11##2##(1996-6#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#3)(2011-2#1)
of thrombospondin##4##2##(1993-6#1)(1993-9#1)(1994-5#1)(1997-7#1)
of thrombotic thrombocytopenic purpura##2##4##(1991-3#1)(1995-3#1)
of thrombotic##7##2##(1991-3#1)(1991-9#1)(1995-3#1)(1996-2#1)(2010-6#1)(2011-2#2)
of thromboxane A2##5##3##(1990-3#1)(1990-8#1)(1991-5#1)(1993-11#2)
of thromboxane B2##4##3##(1990-12#1)(1990-3#1)(1991-8#1)(1993-8#1)
of thromboxane##13##2##(1990-12#1)(1990-3#2)(1990-8#1)(1991-5#2)(1991-8#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-8#1)
of thrombus formation##2##3##(2006-6#1)(2008-11#1)
of thrombus##6##2##(2006-6#1)(2007-8#1)(2008-11#2)(2008-9#1)(2013-1#1)
of thulium laser##2##3##(2008-2#1)(2008-3#1)
of thumb for##2##3##(2008-3#1)(2008-8#1)
of thumb##12##2##(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#4)(2009-10#1)
of thylakoid##3##2##(2008-8#2)(2009-10#1)
of thylakoids##3##2##(1991-12#2)(2009-10#1)
of thyme##2##2##(2010-3#1)(2012-2#1)
of thymic##6##2##(1992-2#1)(2008-10#2)(2008-8#1)(2010-2#1)(2013-7#1)
of thymidine into##2##3##(1991-5#1)(1992-8#1)
of thymidine##9##2##(1991-5#1)(1992-8#1)(1993-12#4)(1994-10#1)(2008-5#1)(2008-9#1)
of thymidylate synthase##3##3##(1990-7#1)(1993-11#2)
of thymocyte##3##2##(2008-10#3)
of thymocytes by##2##3##(1990-5#1)(2008-8#1)
of thymocytes in##2##3##(2008-10#1)(2008-8#1)
of thymocytes is##2##3##(2008-8#2)
of thymocytes##14##2##(1990-5#2)(1991-12#2)(1995-5#1)(2008-10#1)(2008-8#7)(2013-7#1)
of thymol##2##2##(1997-2#1)(2008-10#1)
of thymoma##2##2##(2007-8#2)
of thymopentin##2##2##(1990-2#1)(1991-3#1)
of thymopoiesis##3##2##(2008-4#3)
of thymostimulin##2##2##(1991-5#2)
of thymus and##3##3##(1995-12#1)(2008-5#1)(2012-1#1)
of thymus##8##2##(1995-12#3)(2008-4#1)(2008-5#2)(2008-8#1)(2012-1#1)
of thyrocytes##2##2##(2012-3#1)(2013-8#1)
of thyroglobulin##6##2##(1991-5#1)(1992-12#3)(1993-3#1)(1995-12#1)
of thyroid cancer##3##3##(1990-3#1)(2008-5#1)(2012-2#1)
of thyroid carcinoma is##2##4##(1990-8#1)(2013-1#1)
of thyroid carcinoma##4##3##(1990-8#2)(2012-3#1)(2013-1#1)
of thyroid carcinomas##2##3##(1993-3#1)(2008-5#1)
of thyroid dysfunction##2##3##(1991-8#1)(2008-6#1)
of thyroid function in##3##4##(2008-11#1)(2008-4#2)
of thyroid function##9##3##(2008-11#1)(2008-4#4)(2008-6#3)(2013-1#1)
of thyroid gland diseases##2##4##(2013-1#2)
of thyroid gland##5##3##(2008-12#1)(2008-9#2)(2013-1#2)
of thyroid hormone on##2##4##(1996-5#1)(2013-8#1)
of thyroid hormone##7##3##(1994-11#2)(1995-2#2)(1996-5#1)(2013-7#1)(2013-8#1)
of thyroid hormones and##3##4##(1995-8#1)(1997-3#1)(2011-2#1)
of thyroid hormones on the##2##5##(2008-6#1)(2013-8#1)
of thyroid hormones on##3##4##(1993-12#1)(2008-6#1)(2013-8#1)
of thyroid hormones were##2##4##(1990-3#1)(2012-2#1)
of thyroid hormones##10##3##(1990-3#1)(1993-12#1)(1995-8#1)(1997-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
of thyroid lobes##2##3##(1991-12#1)(2012-3#1)
of thyroid nodules##2##3##(2011-1#1)(2013-7#1)
of thyroid stimulating hormone (TSH)##3##5##(1990-8#1)(1994-9#1)(1995-5#1)
of thyroid##72##2##(1990-3#2)(1990-5#1)(1990-8#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#7)(2008-7#4)(2008-9#2)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#2)
of thyrotoxicosis##3##2##(2007-5#1)(2008-7#2)
of thyrotropin and##2##3##(1994-11#1)(1994-6#1)
of thyrotropin receptor##2##3##(1994-11#2)
of thyrotropin##7##2##(1991-12#1)(1994-11#3)(1994-6#2)(2011-1#1)
of thyrotropin-releasing hormone##2##3##(1992-8#1)(2013-7#1)
of thyroxine (T4)##2##3##(2008-6#1)(2008-7#1)
of thyroxine##8##2##(1991-5#1)(1993-12#2)(1997-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-8#1)
of tibia##4##2##(2007-11#1)(2010-11#1)(2012-2#2)
of tibial dyschondroplasia##2##3##(1991-9#1)(1997-3#1)
of tibial shaft##2##3##(2010-11#2)
of tibial##13##2##(1990-6#1)(1991-3#1)(1991-9#1)(1997-3#1)(2007-11#2)(2008-8#1)(2009-7#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-3#1)
of tick##3##2##(2008-8#1)(2010-10#2)
of tick-borne encephalitis virus##2##4##(2007-2#1)(2008-8#1)
of tick-borne encephalitis##3##3##(2007-2#1)(2008-8#2)
of tick-borne##4##2##(2007-2#1)(2008-8#2)(2010-1#1)
of ticks##4##2##(1997-7#1)(2008-8#2)(2010-1#1)
of ticlopidine##3##2##(1991-3#2)(1996-3#1)
of tight##6##2##(1993-1#1)(1995-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
of tightly bound##3##3##(1990-10#1)(1994-5#1)(1997-4#1)
of tightly##5##2##(1990-10#1)(1991-5#1)(1994-5#1)(1997-4#1)(2008-3#1)
of tilapia##3##2##(2008-5#3)
of tillage practices##3##3##(2008-10#3)
of tillage##4##2##(2008-10#4)
of tillers##2##2##(2008-10#2)
of tilt##4##2##(2008-2#4)
of tilted##2##2##(2008-2#1)(2011-7#1)
of tilting##2##2##(1996-2#1)(2007-11#1)
of time (i##2##3##(2008-10#1)(2008-4#1)
of time after##4##3##(1991-5#1)(1992-3#1)(1996-11#1)(2008-10#1)
of time and##20##3##(1991-5#1)(1992-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
of time as a##2##4##(2007-12#1)(2011-2#1)
of time as##4##3##(1995-6#1)(2007-12#1)(2008-12#1)(2011-2#1)
of time averaging##2##3##(2008-3#2)
of time by a##2##4##(2008-10#1)(2008-11#1)
of time by##3##3##(2008-10#1)(2008-11#2)
of time can be##2##4##(2008-11#1)(2008-6#1)
of time can##3##3##(1996-1#1)(2008-11#1)(2008-6#1)
of time during##2##3##(2008-3#1)(2008-9#1)
of time for##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
of time in a##2##4##(2008-4#1)(2009-7#1)
of time in the##2##4##(1996-3#1)(1997-2#1)
of time in##6##3##(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)
of time of##6##3##(1993-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
of time or##2##3##(1997-8#1)(2008-10#1)
of time series##4##3##(1991-10#1)(2008-8#2)(2013-8#1)
of time spent##7##3##(2008-2#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#2)
of time the##2##3##(1994-11#1)(2008-8#1)
of time to##17##3##(1995-3#1)(1995-9#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of time was##2##3##(2007-11#1)(2008-11#1)
of time when##3##3##(1993-2#1)(2008-10#1)(2008-2#1)
of time with##3##3##(1995-3#1)(2008-1#1)(2011-3#1)
of time##237##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#3)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-11#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#41)(2008-11#22)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#2)
of time)##2##2##(1996-5#1)(2007-12#1)
of time-delayed##2##2##(2007-11#1)(2007-12#1)
of time-dependent##4##2##(1993-8#1)(2008-2#1)(2008-7#1)(2008-8#1)
of time-resolved fluorescence##2##3##(2008-10#1)(2008-9#1)
of time-resolved optical tomography##2##4##(2008-3#2)
of time-resolved reflectance##2##3##(2007-12#2)
of time-resolved transmittance##2##3##(2008-2#1)(2008-3#1)
of time-resolved##13##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#6)(2008-9#1)
of time-varying##2##2##(1992-3#1)(2008-3#1)
of timely##4##2##(1995-3#1)(2008-3#1)(2011-2#1)(2012-12#1)
of times##15##2##(1991-6#2)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#3)(2010-6#1)(2011-2#1)
of timing and##3##3##(2008-10#1)(2008-12#2)
of timing##5##2##(2008-10#2)(2008-12#2)(2011-1#1)
of tin and##3##3##(2008-10#3)
of tin in##7##3##(2008-10#7)
of tin oxide thin##2##4##(2008-10#2)
of tin oxide##4##3##(2008-10#4)
of tin##22##2##(2008-10#22)
of tin(IV)##3##2##(2008-10#3)
of tinea capitis##2##3##(2008-5#2)
of tinea##6##2##(2007-7#1)(2008-5#4)(2012-3#1)
of tinned##2##2##(2008-1#2)
of tinnitus##4##2##(1995-6#1)(1996-6#2)(2010-7#1)
of tiny##2##2##(1991-9#1)(2008-3#1)
of tip##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
of tissue absorption coefficients##2##4##(2008-2#2)
of tissue and##3##3##(1995-2#2)(2013-1#1)
of tissue at the##2##4##(1992-12#1)(2008-11#1)
of tissue balancing##2##3##(2013-1#2)
of tissue culture##5##3##(2008-12#1)(2008-4#3)(2008-9#1)
of tissue damage in##2##4##(1996-2#1)(2011-2#1)
of tissue damage##4##3##(1990-12#1)(1996-2#1)(2011-2#1)(2012-12#1)
of tissue development##2##3##(2010-10#1)(2012-2#1)
of tissue differentiation##3##3##(2008-2#1)(2008-4#1)(2010-3#1)
of tissue engineering##5##3##(2009-11#1)(2010-10#2)(2010-9#1)(2012-3#1)
of tissue extracts##2##3##(1996-3#1)(2012-1#1)
of tissue factor##2##3##(1994-9#1)(2008-10#1)
of tissue for##2##3##(2008-3#2)
of tissue from##3##3##(2007-8#1)(2008-10#2)
of tissue homeostasis##3##3##(2008-5#1)(2009-3#1)(2010-3#1)
of tissue in##2##3##(1996-5#1)(2010-8#1)
of tissue inhibitor of##2##4##(1994-5#1)(1997-4#1)
of tissue injury##2##3##(1994-11#1)(1995-2#1)
of tissue is##2##3##(1991-9#1)(2008-3#1)
of tissue necrosis##2##3##(1996-5#1)(2008-10#1)
of tissue optical properties from##2##5##(2008-2#1)(2008-3#1)
of tissue optical properties##8##4##(2008-2#2)(2008-3#5)(2011-1#1)
of tissue optical##9##3##(2008-2#2)(2008-3#6)(2011-1#1)
of tissue regeneration##2##3##(1993-2#1)(2013-8#1)
of tissue samples##4##3##(2008-10#1)(2008-4#2)(2012-3#1)
of tissue sections##3##3##(2007-11#1)(2008-4#2)
of tissue specimens##4##3##(1994-2#1)(2008-1#1)(2008-5#1)(2013-8#1)
of tissue storage##2##3##(2010-8#2)
of tissue structure##3##3##(2007-11#2)(2009-12#1)
of tissue to##3##3##(1996-12#1)(2010-8#1)(2012-2#1)
of tissue transglutaminase##2##3##(1994-9#1)(2008-1#1)
of tissue##176##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#4)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#4)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#19)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-10#3)(2010-3#2)(2010-5#1)(2010-8#5)(2010-9#3)(2011-1#7)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#3)
of tissue-specific##2##2##(1992-6#1)(2008-7#1)
of tissue-type plasminogen activator##3##4##(1991-3#1)(1995-8#1)(1997-1#1)
of tissue-type plasminogen##4##3##(1991-3#1)(1995-8#2)(1997-1#1)
of tissuelike##2##2##(2008-3#2)
of tissues and##3##3##(1992-9#1)(1994-6#1)(1996-6#1)
of tissues are##2##3##(1994-11#1)(2008-1#1)
of tissues from##3##3##(1993-3#1)(1994-11#1)(2008-3#1)
of tissues with##2##3##(2008-4#1)(2008-9#1)
of tissues##35##2##(1990-11#1)(1991-12#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#3)(1994-6#1)(1996-6#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-8#1)
of titanium dioxide##3##3##(2007-12#1)(2008-10#2)
of titanium oxide films##3##4##(2008-2#2)(2008-8#1)
of titanium oxide##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
of titanium phosphate##2##3##(2008-10#2)
of titanium##22##2##(2007-12#1)(2007-7#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#4)(2013-1#1)
of titanium(IV)##2##2##(2008-10#2)
of titrant##4##2##(2008-10#4)
of titration##3##2##(2008-10#3)
of titrations##2##2##(1996-12#1)(2008-10#1)
of tobacco by##2##3##(2008-10#1)(2008-6#1)
of tobacco cells##4##3##(2009-6#4)
of tobacco in##2##3##(2008-10#2)
of tobacco mosaic virus##4##4##(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
of tobacco protoplasts or leaf##2##5##(2008-10#2)
of tobacco smoke##2##3##(1991-4#1)(2013-1#1)
of tobacco thrips##3##3##(2008-10#3)
of tobacco use##4##3##(1991-5#2)(1994-3#1)(1997-1#1)
of tobacco##54##2##(1990-8#1)(1991-4#2)(1991-5#3)(1992-6#1)(1992-8#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#20)(2008-6#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#4)(2009-7#2)(2012-12#1)(2012-2#1)(2013-1#5)
of toborinone in##2##3##(2008-5#2)
of toborinone##3##2##(2008-5#3)
of tocopherol acetate into SLN leads to an##2##8##(2008-5#2)
of tocopherol##5##2##(2008-10#1)(2008-5#3)(2011-1#1)
of tocopherols##2##2##(1992-9#1)(2008-5#1)
of today##8##2##(1992-3#2)(1992-6#1)(1996-3#1)(2008-10#1)(2009-9#1)(2012-2#1)(2013-7#1)
of today's##6##2##(1996-2#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-2#1)
of toe##2##2##(2009-2#1)(2010-3#1)
of tolcapone##2##2##(1995-5#2)
of tolerable##2##2##(2007-8#1)(2008-10#1)
of tolerance to the##2##4##(1992-3#1)(2011-1#1)
of tolerance to##6##3##(1992-3#1)(1995-11#1)(1996-2#1)(2008-10#1)(2009-7#1)(2011-1#1)
of tolerance##17##2##(1991-1#1)(1991-5#1)(1991-9#1)(1992-3#1)(1995-11#1)(1996-2#3)(2008-10#5)(2008-3#1)(2008-4#1)(2009-7#1)(2011-1#1)
of tolerating##2##2##(2007-8#1)(2008-2#1)
of toll-like##2##2##(2009-3#1)(2013-7#1)
of toluene in##2##3##(2008-10#1)(2008-7#1)
of toluene##12##2##(2008-10#7)(2008-6#1)(2008-7#4)
of toluidine##2##2##(2008-10#2)
of tomato and##4##3##(2008-10#4)
of tomato by##3##3##(2008-10#3)
of tomato caused by##2##4##(2008-10#2)
of tomato chromosome##3##3##(2008-10#1)(2008-5#2)
of tomato have##2##3##(2008-10#2)
of tomato in##2##3##(2008-10#2)
of tomato leaves##2##3##(2008-10#2)
of tomato mottle##2##3##(2008-10#2)
of tomato plants##7##3##(2008-10#7)
of tomato spotted wilt virus##2##5##(2008-10#2)
of tomato spotted wilt##3##4##(2008-10#3)
of tomato under##3##3##(2008-10#3)
of tomato yellow leaf curl##2##5##(2008-10#2)
of tomato##69##2##(1992-8#1)(2008-10#61)(2008-5#5)(2008-7#1)(2008-8#1)
of tomographic##3##2##(1991-2#1)(1992-5#1)(2007-12#1)
of tonal##2##2##(2013-8#2)
of tone##3##2##(2008-9#2)(2013-8#1)
of tongue##8##2##(1995-8#1)(2007-12#1)(2007-8#1)(2013-1#5)
of too##4##2##(2007-11#1)(2008-10#2)(2013-8#1)
of tool##2##2##(2009-2#1)(2012-2#1)
of tools for##5##3##(2007-12#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
of tools to##2##3##(1994-3#1)(1995-2#1)
of tools##12##2##(1994-3#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
of tooth avulsion##2##3##(2008-12#2)
of tooth##16##2##(1991-2#1)(2008-12#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#5)(2013-8#1)
of toothless##2##2##(2013-1#2)
of toothpaste##2##2##(2008-5#1)(2011-2#1)
of top##7##2##(1993-12#2)(1994-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-12#1)
of top1-cleavable complexes##2##3##(1995-5#2)
of top3##2##2##(2010-2#2)
of topical therapeutics##2##3##(2011-1#2)
of topical##21##2##(1992-8#1)(1996-2#1)(1997-8#1)(2007-11#2)(2007-7#2)(2008-3#1)(2008-5#8)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#1)
of topically applied##5##3##(2008-5#5)
of topics in the##2##4##(1994-2#1)(2008-5#1)
of topics##6##2##(1994-12#1)(1994-2#1)(1996-11#1)(2008-5#2)(2012-2#1)
of topiramate##2##2##(2008-7#2)
of topographic##2##2##(1991-1#1)(1993-9#1)
of topographical##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
of topoisomerase I##7##3##(1990-7#1)(1993-8#2)(1994-8#1)(2008-11#2)(2008-8#1)
of topoisomerase##9##2##(1990-7#1)(1993-8#4)(1994-8#1)(2008-11#2)(2008-8#1)
of topological defects##2##3##(2008-7#1)(2009-11#1)
of topological##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)
of toroidal surfaces##2##3##(2008-3#2)
of tort reform##2##3##(1991-1#2)
of torture##6##2##(1990-6#1)(1995-11#3)(1996-3#2)
of tospovirus##3##2##(2008-10#3)
of tospoviruses##4##2##(2008-10#4)
of total APP##3##3##(1996-12#3)
of total As##3##3##(2008-10#3)
of total Cr##2##3##(2008-10#2)
of total DNA##4##3##(1990-5#1)(2008-10#2)(2012-3#1)
of total FA content in##2##5##(2012-1#2)
of total N##2##3##(2008-5#2)
of total RNA from##3##4##(1993-2#1)(2009-12#1)(2010-2#1)
of total RNA##8##3##(1993-2#1)(1994-11#1)(2008-1#1)(2008-4#1)(2009-12#2)(2010-2#1)(2011-2#1)
of total acidity##2##3##(2008-10#1)(2012-2#1)
of total and dissolved##2##4##(2008-10#2)
of total and protein-bound homocysteine in##2##6##(2008-10#2)
of total and##9##3##(1991-6#1)(1991-8#1)(1995-3#1)(2007-2#1)(2008-10#5)
of total ankle##2##3##(2009-7#2)
of total antioxidant capacity in green tea##2##7##(2008-10#2)
of total antioxidant capacity##3##4##(2008-10#3)
of total arsenic##7##3##(1995-11#1)(2008-10#6)
of total bacteria and##2##4##(2008-10#2)
of total bacteria##3##3##(2008-10#2)(2009-4#1)
of total bacterial population##2##4##(2007-7#1)(2008-10#1)
of total bacterial##4##3##(1992-12#1)(2007-7#1)(2008-10#1)(2008-4#1)
of total bilirubin##4##3##(2008-10#2)(2013-1#2)
of total body##3##3##(2007-11#1)(2008-10#1)(2010-3#1)
of total cell protein##2##4##(2008-11#2)
of total cell##3##3##(2008-11#2)(2009-3#1)
of total cells##3##3##(2008-10#1)(2008-7#2)
of total cellular RNA##2##4##(1994-12#1)(2008-4#1)
of total cellular protein##2##4##(1990-5#2)
of total cellular##5##3##(1990-5#2)(1994-12#1)(1994-8#1)(2008-4#1)
of total cholesterol##8##3##(1991-11#1)(1991-2#1)(1994-12#1)(1996-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of total chromium in##4##4##(2008-10#4)
of total chromium##5##3##(2008-10#5)
of total coverings##3##3##(1990-2#3)
of total culturable##3##3##(2008-10#2)(2010-4#1)
of total developmental time spent in a particular##2##8##(2008-8#2)
of total dissolved##3##3##(2008-10#3)
of total energy intake##2##4##(1990-2#1)(2008-5#1)
of total flavones from##2##4##(2012-3#1)(2013-8#1)
of total fluorine in##3##4##(2008-10#3)
of total gaseous selenium in##2##5##(2008-10#2)
of total genomic DNA##3##4##(2008-1#1)(2008-10#2)
of total glycoalkaloids content in##2##5##(2008-10#2)
of total glycoalkaloids content##4##4##(2008-10#4)
of total hip arthroplasty (THA)##2##5##(2013-1#2)
of total hip arthroplasty##5##4##(2007-8#1)(2008-8#2)(2013-1#2)
of total hip##9##3##(1996-6#1)(2007-11#1)(2007-8#1)(2008-8#3)(2009-3#1)(2013-1#2)
of total homocysteine##2##3##(2008-8#2)
of total hospital##3##3##(1992-2#1)(1993-1#1)(1995-1#1)
of total inorganic arsenic##2##4##(2008-10#2)
of total inorganic##5##3##(2008-10#5)
of total internal reflection##6##4##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)
of total knee##3##3##(2007-8#1)(2013-1#2)
of total lipids)##2##3##(2008-11#2)
of total mercury in##5##4##(2008-10#5)
of total mercury##12##3##(2008-10#12)
of total nitrogen##2##3##(2008-10#2)
of total nucleated cells##2##4##(2008-11#1)(2008-8#1)
of total nucleic##2##3##(2008-10#1)(2008-9#1)
of total or##2##3##(2007-11#1)(2008-10#1)
of total phosphorus in soya food##2##6##(2008-10#2)
of total phosphorus in##3##4##(2008-10#3)
of total phosphorus##6##3##(2008-10#6)
of total plasma##2##3##(1993-11#1)(2008-4#1)
of total polar parts##2##4##(2008-10#2)
of total protein and##2##4##(1992-6#1)(2008-4#1)
of total protein in human serum samples##2##7##(2008-10#2)
of total protein in human serum##3##6##(2008-10#3)
of total protein##12##3##(1992-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-3#1)
of total proteins in##2##4##(2008-10#1)(2008-12#1)
of total proteins##5##3##(2008-10#4)(2008-12#1)
of total quality management (TQM) and##2##6##(1993-3#1)(1995-3#1)
of total quality management (TQM)##3##5##(1993-3#1)(1995-1#1)(1995-3#1)
of total quality management##9##4##(1993-3#1)(1994-1#2)(1995-1#1)(1995-3#3)(1996-2#1)(2008-12#1)
of total quality##10##3##(1993-3#1)(1994-1#2)(1995-1#1)(1995-3#3)(1996-2#1)(2007-8#1)(2008-12#1)
of total reflection##4##3##(2008-2#1)(2008-3#3)
of total sialic acids##2##4##(2008-11#2)
of total sialic##3##3##(1995-12#1)(2008-11#2)
of total soluble phenolic compounds##2##5##(2008-10#2)
of total soluble sugars##2##4##(2008-12#2)
of total soluble##7##3##(1993-9#1)(2008-10#2)(2008-12#3)(2011-2#1)
of total spending##2##3##(1992-3#1)(1996-2#1)
of total tRNA from##2##4##(2008-4#2)
of total thallium##2##3##(2008-10#2)
of total variance##2##3##(2012-3#1)(2013-1#1)
of total water##3##3##(2008-10#1)(2008-5#2)
of total##403##2##(1990-12#1)(1990-2#5)(1990-5#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#6)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(2007-1#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#141)(2008-11#12)(2008-12#8)(2008-2#4)(2008-3#10)(2008-4#10)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#15)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#12)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#2)
of totally endoscopic single##2##4##(2007-8#2)
of totally##3##2##(2007-7#1)(2007-8#2)
of touch##6##2##(1995-8#1)(1995-9#1)(2008-1#2)(2008-7#1)(2008-9#1)
of toughness##2##2##(2012-2#1)(2013-1#1)
of tourniquet ischemia on##2##4##(2006-12#2)
of tourniquet ischemia##4##3##(2006-12#4)
of tourniquet##5##2##(2006-12#5)
of town##2##2##(1994-12#1)(2011-2#1)
of toxic and##2##3##(2008-10#1)(2008-8#1)
of toxic chemicals##2##3##(2008-11#1)(2011-1#1)
of toxic effects##6##3##(1992-3#1)(1996-3#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-4#1)
of toxic metal##3##3##(2008-10#2)(2009-7#1)
of toxic species##2##3##(2008-10#2)
of toxic substances##4##3##(2008-10#2)(2008-11#2)
of toxic##56##2##(1991-12#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-11#1)(1996-12#4)(1996-3#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-5#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
of toxicant##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
of toxicants##8##2##(2008-10#4)(2008-11#2)(2008-7#1)(2012-2#1)
of toxicities##2##2##(1993-12#1)(2008-8#1)
of toxicity and##3##3##(2008-5#2)(2008-7#1)
of toxicity of##2##3##(1992-9#1)(2008-11#1)
of toxicity##33##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-9#1)(1996-12#2)(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#3)(2012-1#1)(2012-3#1)(2012-7#1)
of toxicologic##2##2##(2010-5#1)(2012-1#1)
of toxicological##3##2##(2011-1#1)(2012-1#2)
of toxicology##2##2##(1994-12#1)(2008-10#1)
of toxin A##2##3##(2007-12#2)
of toxin B##4##3##(2007-12#4)
of toxin in##2##3##(2008-10#1)(2008-5#1)
of toxin production##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
of toxin##20##2##(1994-2#2)(2007-12#7)(2008-10#6)(2008-5#3)(2011-1#1)(2011-2#1)
of toxins and##3##3##(1997-6#1)(2008-10#1)(2012-12#1)
of toxins or##2##3##(2008-10#1)(2008-7#1)
of toxins##11##2##(1994-5#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-12#1)
of toxoplasmosis in##5##3##(1991-2#1)(1992-2#1)(2007-10#1)(2007-7#2)
of toxoplasmosis##7##2##(1991-2#1)(1991-6#1)(1992-2#1)(1995-9#1)(2007-10#1)(2007-7#2)
of trabecular bone##3##3##(1993-11#1)(2008-7#1)(2009-7#1)
of trabecular##4##2##(1993-11#1)(2008-5#1)(2008-7#1)(2009-7#1)
of trace Cd and Pb in environmental and biological samples##2##10##(2008-10#2)
of trace Cd and Pb##3##5##(2008-10#3)
of trace Cd##4##3##(2008-10#4)
of trace amount of##22##4##(2008-10#22)
of trace amount##23##3##(2008-10#23)
of trace amounts of NADH##2##5##(2008-10#2)
of trace amounts of beryllium##3##5##(2008-10#3)
of trace amounts of bromide##3##5##(2008-10#3)
of trace amounts of copper in##2##6##(2008-10#2)
of trace amounts of copper##5##5##(2008-10#5)
of trace amounts of formaldehyde in air##3##7##(2008-10#3)
of trace amounts of germanium by##2##6##(2008-10#2)
of trace amounts of##92##4##(2008-10#92)
of trace and##5##3##(2008-10#5)
of trace cadmium##2##3##(2008-10#2)
of trace chromium(VI)##2##3##(2008-10#2)
of trace cobalt##4##3##(2008-10#4)
of trace constituents##3##3##(2008-10#2)(2008-2#1)
of trace copper##3##3##(2008-10#3)
of trace element##3##3##(2008-10#1)(2011-2#2)
of trace elements in solid##2##5##(2008-10#2)
of trace elements in the##2##5##(2008-10#2)
of trace elements in##19##4##(2008-10#17)(2011-2#1)(2013-8#1)
of trace elements is##2##4##(2008-10#2)
of trace elements were##2##4##(2008-10#2)
of trace elements##38##3##(2008-10#35)(2010-11#1)(2011-2#1)(2013-8#1)
of trace gases##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
of trace heavy metals in##2##5##(2008-10#2)
of trace heavy metals##4##4##(2008-10#4)
of trace impurities in##2##4##(2008-10#2)
of trace iron in beer##2##5##(2008-10#2)
of trace lead in water##3##5##(2008-10#2)(2013-8#1)
of trace lead##9##3##(2008-10#6)(2013-8#3)
of trace levels of##22##4##(1990-8#1)(2008-10#21)
of trace manganese##7##3##(2008-10#7)
of trace mercury by##3##4##(2008-10#3)
of trace mercury##12##3##(2008-10#12)
of trace metal ions in##2##5##(2008-10#2)
of trace metal ions##5##4##(2008-10#5)
of trace metal##8##3##(2008-10#8)
of trace metals and##2##4##(1994-8#1)(2008-10#1)
of trace metals by##5##4##(2008-10#5)
of trace metals in water##2##5##(2008-10#2)
of trace metals in##16##4##(2008-10#16)
of trace metals using a##2##5##(2008-10#2)
of trace metals##35##3##(1994-8#1)(2008-10#33)(2012-2#1)
of trace species##2##3##(2008-2#2)
of trace vanadium##3##3##(2008-10#3)
of trace water in##3##4##(2008-10#3)
of trace##382##2##(1990-8#1)(1994-8#1)(2007-12#1)(2008-10#359)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2010-11#1)(2011-2#3)(2012-2#1)(2013-8#4)
of traceability##3##2##(2008-10#1)(2010-4#2)
of tracer eluted##2##3##(1990-12#2)
of tracer##6##2##(1990-12#2)(1993-11#1)(1994-12#1)(1996-12#1)(2011-2#1)
of tracers##2##2##(2008-10#1)(2010-7#1)
of traces of Ni in##2##5##(2008-10#2)
of traces of Ni##3##4##(2008-10#3)
of traces of cobalt##2##4##(2008-10#2)
of traces of gold##2##4##(2008-10#2)
of traces of silver ions onto polyurethane foam##2##8##(2008-10#2)
of traces of##25##3##(2008-10#24)(2013-1#1)
of traces##27##2##(2008-10#26)(2013-1#1)
of trachea##3##2##(2010-7#1)(2013-1#2)
of tracheal obstruction##2##3##(2013-1#2)
of tracheal##3##2##(2009-5#1)(2013-1#2)
of trachoma##2##2##(2010-8#2)
of track offset##3##3##(2008-2#3)
of tracking##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
of traction induced##2##3##(2008-9#2)
of trade in##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
of trade##5##2##(2007-12#1)(2008-12#2)(2008-7#1)(2008-9#1)
of traditional Chinese medicine injections##3##5##(2011-2#2)(2011-3#1)
of traditional Chinese medicine##5##4##(2011-2#3)(2011-3#1)(2013-1#1)
of traditional Chinese##8##3##(1997-2#1)(2011-2#4)(2011-3#1)(2013-1#2)
of traditional medicine##2##3##(1992-5#1)(2008-1#1)
of traditional practices##2##3##(1997-7#2)
of traditional techniques##2##3##(2008-12#1)(2010-8#1)
of traditional##51##2##(1990-10#1)(1991-12#1)(1992-12#1)(1992-5#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#3)(2009-6#1)(2010-12#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#5)
of traffic##7##2##(1992-2#1)(1992-6#1)(1995-12#1)(2008-11#2)(2008-3#1)(2011-2#1)
of trained nurses##2##3##(2009-4#2)
of trained##8##2##(1993-11#1)(1993-5#1)(2007-2#1)(2009-4#2)(2010-4#1)(2011-2#2)
of trainees##2##2##(1994-12#1)(2010-8#1)
of training and##6##3##(1995-6#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)
of training for##3##3##(1991-3#1)(1994-3#1)(1997-2#1)
of training of##2##3##(1994-3#1)(1996-12#1)
of training programs##2##3##(1992-12#1)(2011-1#1)
of training set##2##3##(2008-10#2)
of training##50##2##(1991-11#1)(1991-3#2)(1992-12#3)(1992-2#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#5)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
of trait##7##2##(1994-12#1)(2008-11#2)(2008-7#1)(2009-8#1)(2012-3#2)
of traits that##4##3##(2008-10#1)(2008-11#1)(2008-8#2)
of traits##17##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#9)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#2)
of trajectories##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
of trajectory##2##2##(2008-12#1)(2008-3#1)
of trajectory-specific##2##2##(1994-8#2)
of tramadol in##2##3##(1996-5#2)
of tramadol##4##2##(1996-5#3)(2008-10#1)
of tranilast##3##2##(1995-11#1)(2008-5#2)
of trans-acting##2##2##(1994-8#1)(2010-5#1)
of trans-beta-carotene in rat and beef livers##2##7##(2008-10#2)
of trans-beta-carotene in##3##3##(2008-10#3)
of trans-beta-carotene##4##2##(2008-10#4)
of trans-tamoxifen##2##2##(2008-11#2)
of transactions##2##2##(2008-11#1)(2012-3#1)
of transaldolase and phosphoglycerate mutase I##2##6##(2010-12#2)
of transaminases##3##2##(1992-5#1)(1996-11#1)(2012-12#1)
of transbronchial##2##2##(2009-7#1)(2010-8#1)
of transcranial Doppler ultrasound (TCD)##2##5##(2007-10#1)(2012-3#1)
of transcranial##6##2##(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2011-2#1)(2012-3#1)
of transcript abundance##2##3##(2008-11#1)(2008-7#1)
of transcript##9##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-7#3)(2009-8#1)
of transcription (STAT)##4##3##(2011-2#2)(2012-3#2)
of transcription and##2##3##(1993-3#1)(1994-11#1)
of transcription by##2##3##(1992-8#1)(1996-2#1)
of transcription complexes##2##3##(1995-2#1)(1995-6#1)
of transcription factor##6##3##(1996-2#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-1#1)
of transcription factors and##2##4##(2009-10#1)(2009-8#1)
of transcription factors binding##2##4##(2008-7#1)(2008-9#1)
of transcription factors##23##3##(1991-5#1)(1992-12#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(2007-12#1)(2008-4#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#2)(2010-2#1)(2011-1#1)(2012-2#1)
of transcription in##2##3##(2008-11#1)(2009-3#1)
of transcription initiation##2##3##(1997-7#1)(1997-8#1)
of transcription of the##5##4##(1992-1#1)(1992-12#1)(1997-2#1)(1997-7#2)
of transcription of##11##3##(1992-1#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#2)(2008-11#1)(2008-9#2)
of transcription##87##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#2)(1992-1#1)(1992-12#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#3)(1995-2#3)(1995-3#1)(1995-6#4)(1996-2#4)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-8#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
of transcription)##2##2##(2008-1#1)(2009-3#1)
of transcriptional activation of##2##4##(1992-8#1)(1994-11#1)
of transcriptional activation##4##3##(1992-8#1)(1994-11#1)(1997-2#1)(2008-9#1)
of transcriptional activity##2##3##(1991-9#1)(1995-2#1)
of transcriptional changes##2##3##(2010-11#1)(2012-2#1)
of transcriptional control##2##3##(2008-7#1)(2012-2#1)
of transcriptional factors##2##3##(1994-6#1)(2012-2#1)
of transcriptional regulation##5##3##(1991-2#1)(1992-8#1)(2008-11#1)(2008-9#1)(2012-3#1)
of transcriptional start##2##3##(1995-6#1)(2008-4#1)
of transcriptional##36##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-4#2)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#3)(2012-3#2)
of transcriptionally active##2##3##(1990-7#1)(2008-2#1)
of transcriptome##2##2##(2009-10#1)(2013-1#1)
of transcripts from##3##3##(1992-11#1)(1992-6#1)(2008-10#1)
of transcripts in##2##3##(1996-12#1)(2011-2#1)
of transcripts of the##2##4##(1992-5#1)(2008-8#1)
of transcripts of##3##3##(1992-5#1)(2008-10#1)(2008-8#1)
of transcripts##23##2##(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
of transcutaneous##2##2##(2011-2#1)(2012-3#1)
of transdermal glyceryl trinitrate##2##4##(2007-10#1)(2008-8#1)
of transdermal granisetron in##2##4##(2010-12#2)
of transdermal granisetron##3##3##(2010-12#3)
of transdermal##6##2##(2007-10#1)(2008-8#1)(2010-12#3)(2013-8#1)
of transduced##2##2##(1997-4#1)(2008-11#1)
of transducers##2##2##(2008-10#1)(2008-3#1)
of transduction##4##2##(1996-2#1)(2008-11#1)(2008-8#1)(2010-10#1)
of transepidermal water loss##2##4##(2008-5#2)
of transesterification##2##2##(2008-7#1)(2013-1#1)
of transfected Chinese hamster##2##4##(1995-12#1)(2008-11#1)
of transfected cells##2##3##(1995-5#1)(2008-2#1)
of transfected##12##2##(1992-3#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-11#2)(2008-2#2)(2008-9#1)
of transfection##8##2##(1992-6#1)(1994-9#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-6#1)
of transfer function coefficients##2##4##(2011-2#2)
of transfer of learning##2##4##(2008-11#2)
of transfer of the##2##4##(1993-11#1)(2008-10#1)
of transfer of##5##3##(1992-5#1)(1993-11#1)(2008-10#1)(2008-11#2)
of transfer to the##2##4##(2008-2#1)(2008-3#1)
of transfer to##4##3##(2008-2#1)(2008-3#1)(2011-2#2)
of transfer##21##2##(1990-11#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#2)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2011-2#5)(2013-1#1)
of transferred##2##2##(1993-11#1)(2010-9#1)
of transferrin##8##2##(1992-5#1)(1993-8#2)(1995-11#1)(2008-10#3)(2013-7#1)
of transferring##2##2##(1996-11#1)(2009-10#1)
of transformants##7##2##(1990-5#1)(2008-10#5)(2011-1#1)
of transformation of##2##3##(2008-10#1)(2008-2#1)
of transformation zone##2##3##(2012-3#2)
of transformation##12##2##(1991-8#1)(1992-2#1)(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2012-3#3)
of transformations##5##2##(1996-3#1)(1997-3#1)(2008-6#1)(2008-7#1)(2010-4#1)
of transformed cells##5##3##(1991-7#1)(1993-11#1)(1994-11#1)(2008-10#1)(2011-2#1)
of transformed human##2##3##(1994-12#1)(2008-10#1)
of transformed mouse##2##3##(1991-2#1)(2008-11#1)
of transformed phenotype##2##3##(1995-9#1)(2008-11#1)
of transformed##20##2##(1991-2#1)(1991-7#1)(1993-11#2)(1994-11#2)(1994-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#2)
of transformer oil##2##3##(2008-10#2)
of transformer##3##2##(2008-10#3)
of transforming a##2##3##(2008-10#1)(2008-3#1)
of transforming growth factor beta (TGF-beta)##2##6##(2008-11#1)(2008-12#1)
of transforming growth factor beta##4##5##(1995-2#1)(2008-11#2)(2008-12#1)
of transforming growth factor##5##4##(1993-3#1)(1995-2#1)(2008-11#2)(2008-12#1)
of transforming growth##7##3##(1990-2#2)(1993-3#1)(1995-2#1)(2008-11#2)(2008-12#1)
of transforming##11##2##(1990-2#2)(1990-5#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)
of transfused##3##2##(1991-8#2)(2011-2#1)
of transfusion##8##2##(1990-3#1)(1994-12#1)(1995-9#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
of transfusion-transmitted##2##2##(2012-12#2)
of transgene expression##4##3##(1997-1#1)(1997-8#1)(2008-2#1)(2008-5#1)
of transgene integration##2##3##(1995-2#1)(2008-11#1)
of transgene##8##2##(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)
of transgenes##6##2##(1993-6#2)(2008-11#1)(2008-4#1)(2008-9#2)
of transgenesis in N##2##4##(2012-3#2)
of transgenic D##3##3##(2013-1#3)
of transgenic animals##5##3##(1993-12#1)(1993-6#1)(1994-5#2)(1995-2#1)
of transgenic lines##2##3##(2008-10#2)
of transgenic livestock##3##3##(1995-2#1)(2008-11#2)
of transgenic mice expressing##2##4##(1994-8#1)(1997-7#1)
of transgenic mice##10##3##(1990-11#1)(1994-8#1)(1997-7#1)(2008-11#1)(2008-2#2)(2008-4#4)
of transgenic plants containing the##2##5##(2008-9#2)
of transgenic plants containing##3##4##(2008-9#3)
of transgenic plants##7##3##(2008-8#3)(2008-9#4)
of transgenic rabbits##3##3##(2008-11#1)(2008-12#2)
of transgenic tobacco plants##2##4##(1991-7#1)(2008-10#1)
of transgenic tomato##3##3##(2008-10#3)
of transgenic##56##2##(1990-11#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-2#2)(1997-7#1)(2006-12#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#5)(2010-5#1)(2011-2#2)(2013-1#3)
of transglutaminase##4##2##(1992-8#2)(1994-9#1)(2008-5#1)
of transgression##2##2##(2008-10#1)(2008-12#1)
of transient absorption##3##3##(2008-10#1)(2008-3#2)
of transient acoustic fields##2##4##(2008-2#2)
of transient currents##2##3##(2007-11#1)(2008-3#1)
of transient gene expression in##2##5##(2008-11#2)
of transient pores##2##3##(2010-10#1)(2011-1#1)
of transient receptor potential##3##4##(2009-12#1)(2009-9#1)(2013-1#1)
of transient##42##2##(1990-5#1)(1992-11#1)(1992-8#1)(1995-12#1)(1996-9#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
of transition metal ions##2##4##(2008-10#1)(2010-11#1)
of transition metal##4##3##(2008-10#3)(2010-11#1)
of transition metals in human hair##2##6##(2008-10#2)
of transition metals in##4##4##(2008-10#2)(2008-5#1)(2010-11#1)
of transition metals##6##3##(2008-10#3)(2008-5#1)(2010-11#1)(2011-1#1)
of transition##15##2##(1991-12#2)(1997-2#1)(2008-1#1)(2008-10#7)(2008-5#1)(2010-11#2)(2011-1#1)
of transitional cell carcinoma##2##4##(2007-10#1)(2011-2#1)
of transitional##4##2##(1993-12#1)(2007-10#1)(2008-4#1)(2011-2#1)
of transitions##2##2##(2008-9#1)(2009-10#1)
of translated##2##2##(2008-10#1)(2010-1#1)
of translating the##2##3##(2008-3#1)(2009-10#1)
of translating##5##2##(2008-1#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-6#1)
of translation and##2##3##(2008-11#1)(2012-2#1)
of translation elongation factor##3##4##(2008-10#2)(2008-8#1)
of translation in##3##3##(1994-6#1)(2007-12#1)(2008-11#1)
of translation initiation sites##2##4##(1997-6#2)
of translation initiation##4##3##(1994-6#1)(1997-6#2)(2008-11#1)
of translation of##2##3##(1995-12#1)(2010-9#1)
of translation##30##2##(1991-1#1)(1991-12#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-6#1)(1997-6#2)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#7)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-2#1)
of translational control##3##3##(2007-12#1)(2013-8#2)
of translational regulation##4##3##(1992-8#1)(2008-9#1)(2009-3#2)
of translational research in##2##4##(2010-10#2)
of translational##17##2##(1992-8#1)(1993-11#1)(1994-12#1)(1995-9#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#2)(2010-4#1)(2013-8#2)
of translocation##3##2##(1991-12#1)(2008-7#1)(2008-8#1)
of transmembrane proteins##6##3##(1994-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#2)
of transmembrane signaling##2##3##(1991-12#1)(2008-9#1)
of transmembrane##16##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-12#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#2)(2010-10#1)(2012-12#1)(2012-2#1)
of transmissible##2##2##(1996-5#1)(2008-10#1)
of transmission among##3##3##(2012-2#1)(2013-8#2)
of transmission and reflection##2##4##(2008-3#2)
of transmission and##3##3##(2008-3#2)(2013-1#1)
of transmission at##2##3##(1997-2#1)(1997-5#1)
of transmission by##2##3##(1995-6#1)(2008-10#1)
of transmission electron microscopy (TEM)##2##5##(2008-10#1)(2008-5#1)
of transmission electron microscopy##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
of transmission of infection##3##4##(2009-5#1)(2010-5#2)
of transmission of pathogens##2##4##(2007-7#1)(2013-1#1)
of transmission of##10##3##(1993-3#1)(1996-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2010-4#1)(2010-5#2)(2013-1#1)
of transmission through##2##3##(2007-11#1)(2008-10#1)
of transmission##60##2##(1992-6#2)(1993-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1997-2#1)(1997-5#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#5)(2008-10#13)(2008-2#3)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#2)
of transmission-type holographic##2##3##(2008-2#2)
of transmittance##4##2##(2008-3#3)(2008-5#1)
of transmitted K65R and other tenofovir resistance mutations across##2##9##(2013-1#2)
of transmitted##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#3)
of transmitting the##2##3##(2008-10#2)
of transmitting##4##2##(1992-9#1)(2007-12#1)(2008-10#2)
of transmural##2##2##(2008-11#1)(2012-2#1)
of transparency##4##2##(2007-11#1)(2008-11#1)(2011-2#2)
of transparent and##2##3##(1994-3#1)(2007-12#1)
of transparent plates##2##3##(2008-3#2)
of transparent##15##2##(1994-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2009-11#1)
of transpedicular screw##3##3##(2007-11#3)
of transpedicular screws##2##3##(2007-11#2)
of transpedicular spine##2##3##(2007-11#2)
of transpedicular##7##2##(2007-11#7)
of transplant##11##2##(1995-12#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2011-3#1)
of transplantable##3##2##(1991-3#2)(1992-1#1)
of transplantation and##2##3##(2008-10#1)(2008-4#1)
of transplantation in##2##3##(1991-11#1)(2008-12#1)
of transplantation of mesenchymal stem cells on neuronal survival##2##9##(2012-1#2)
of transplantation##17##2##(1991-11#1)(2006-10#2)(2007-7#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-1#2)(2012-7#1)
of transplanted bone marrow cells##2##5##(2010-11#2)
of transplanted##9##2##(1991-3#1)(2007-4#1)(2008-10#1)(2010-10#1)(2010-11#3)(2011-1#1)(2011-2#1)
of transplants##3##2##(2008-10#1)(2009-3#1)(2011-2#1)
of transport is##2##3##(2008-10#2)
of transport of##3##3##(1994-6#1)(1995-11#1)(2010-8#1)
of transport proteins##2##3##(2008-11#1)(2011-2#1)
of transport was##2##3##(1995-11#1)(2008-10#1)
of transport##25##2##(1990-11#2)(1994-12#1)(1994-6#1)(1995-11#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#4)(2012-12#1)
of transportation##3##2##(1992-5#1)(2008-9#1)(2013-1#1)
of transporter##3##2##(1993-3#1)(1995-6#1)(1996-5#1)
of transporters##3##2##(1994-12#1)(2008-11#1)(2009-5#1)
of transporting##2##2##(2007-12#1)(2008-9#1)
of transposable elements and##2##4##(2009-10#1)(2009-6#1)
of transposable elements in plants##2##5##(2009-6#2)
of transposable elements in##3##4##(2009-6#2)(2010-5#1)
of transposable elements##10##3##(2008-10#2)(2009-10#3)(2009-6#4)(2010-5#1)
of transposable##11##2##(1995-12#1)(2008-10#2)(2009-10#3)(2009-6#4)(2010-5#1)
of transposition##3##2##(1994-12#1)(1995-8#1)(2008-10#1)
of transposon##3##2##(1996-12#1)(2008-10#1)(2010-5#1)
of transracial##2##2##(2008-5#2)
of transradial approach for##2##4##(2011-2#2)
of transradial approach##3##3##(2011-2#3)
of transradial##7##2##(2011-2#7)
of transrectal sonography##2##3##(2011-2#2)
of transrectal##3##2##(1997-8#1)(2011-2#2)
of transthyretin in##2##3##(1991-2#2)
of transthyretin##5##2##(1990-5#2)(1991-2#3)
of transvaginal##2##2##(1991-11#1)(1995-3#1)
of transverse myelitis##2##3##(2012-3#2)
of transverse##6##2##(2007-12#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-7#1)
of transverse-sigmoid sinus dural arteriovenous malformations##2##6##(2006-12#1)(2008-7#1)
of transversely##2##2##(2007-12#1)(2008-10#1)
of trap trees##2##3##(2011-2#2)
of trapping##5##2##(2007-11#1)(2008-10#3)(2010-4#1)
of traps was##2##3##(2013-7#2)
of traps##6##2##(1994-3#1)(1997-7#1)(2013-7#4)
of trastuzumab##6##2##(2008-10#1)(2012-12#2)(2013-1#3)
of trauma and##2##3##(2007-8#1)(2008-5#1)
of trauma exposure##2##3##(2009-4#1)(2012-12#1)
of trauma to##2##3##(2010-6#1)(2012-2#1)
of trauma##22##2##(1990-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
of trauma-focused research on##2##4##(2009-4#2)
of trauma-focused research##3##3##(2009-4#3)
of trauma-related##3##2##(2008-8#1)(2012-2#2)
of traumatic brain injury (TBI)##3##5##(1993-12#1)(2008-9#1)(2012-2#1)
of traumatic brain injury##5##4##(1990-12#2)(1993-12#1)(2008-9#1)(2012-2#1)
of traumatic brain##6##3##(1990-12#3)(1993-12#1)(2008-9#1)(2012-2#1)
of traumatic rupture of##2##4##(2008-12#1)(2010-8#1)
of traumatic##25##2##(1990-12#3)(1993-12#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
of travel health advice and##3##5##(2007-2#3)
of travel medicine##2##3##(2007-2#2)
of travel##12##2##(2007-2#8)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
of travel-related##2##2##(2007-2#1)(2011-2#1)
of traveler's diarrhea##2##3##(1993-3#1)(2008-8#1)
of travelers who##2##3##(1996-8#1)(2008-10#1)
of travelers##5##2##(1996-8#1)(2008-10#2)(2010-12#1)(2011-2#1)
of travellers##5##2##(1996-8#1)(2007-2#4)
of trazodone##2##2##(1995-2#1)(2008-10#1)
of treadmill running on##2##4##(2008-12#2)
of treadmill running##3##3##(2008-12#2)(2013-1#1)
of treadmill##4##2##(2008-12#2)(2010-12#1)(2013-1#1)
of treated and untreated##2##4##(1995-6#1)(2008-3#1)
of treated and##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
of treated cells##2##3##(1994-6#1)(2008-9#1)
of treated hypertensives##2##3##(2008-10#2)
of treated patients was##2##4##(2007-11#1)(2011-1#1)
of treated patients##4##3##(1990-3#1)(1991-2#1)(2007-11#1)(2011-1#1)
of treated plants##3##3##(2008-10#3)
of treated rats##2##3##(1993-12#1)(2013-8#1)
of treated##33##2##(1990-3#1)(1991-2#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of treating a##2##3##(1995-6#1)(2012-12#1)
of treating hypertension##2##3##(1992-6#1)(2009-9#1)
of treating the##3##3##(1992-5#1)(2013-1#2)
of treating##28##2##(1991-2#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-3#1)(1995-6#2)(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
of treatment (prednisolone##2##3##(2008-1#2)
of treatment and prognosis##2##4##(2006-8#1)(2007-12#1)
of treatment and the##3##4##(1991-6#1)(2012-12#1)(2013-7#1)
of treatment and##23##3##(1991-6#1)(1992-3#1)(1992-9#1)(1996-3#1)(1996-9#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2009-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
of treatment are##9##3##(1991-1#1)(1992-4#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#1)
of treatment by##4##3##(1996-7#1)(2007-8#1)(2008-12#1)(2008-5#1)
of treatment can##2##3##(1995-6#1)(1996-11#1)
of treatment discontinuations##2##3##(2008-11#1)(2008-3#1)
of treatment during##2##3##(2008-10#1)(2013-1#1)
of treatment effectiveness##2##3##(1993-12#1)(2008-6#1)
of treatment effects##8##3##(1996-6#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#2)(2012-2#1)(2012-6#1)
of treatment failure##2##3##(2008-6#1)(2008-7#1)
of treatment for children##2##4##(2009-4#1)(2011-2#1)
of treatment for chronic##2##4##(2008-10#1)(2013-1#1)
of treatment for renal##2##4##(1991-12#1)(2007-7#1)
of treatment for##31##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-3#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
of treatment from##2##3##(2008-10#1)(2011-1#1)
of treatment in a##2##4##(1990-5#1)(1996-3#1)
of treatment in patients with##2##5##(1994-12#1)(2008-10#1)
of treatment in the##3##4##(2007-11#1)(2008-10#1)(2010-11#1)
of treatment in##16##3##(1990-5#1)(1992-5#1)(1994-12#1)(1996-3#1)(1996-7#1)(2007-11#4)(2007-7#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-6#1)(2013-1#1)
of treatment is the##2##4##(1997-2#1)(2013-1#1)
of treatment is##16##3##(1993-3#1)(1993-6#1)(1995-2#1)(1997-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#4)
of treatment method##2##3##(2007-11#1)(2011-2#1)
of treatment modalities##6##3##(1992-3#1)(1996-1#1)(2007-11#1)(2008-7#1)(2011-2#2)
of treatment of chronic##2##4##(1991-6#1)(2011-2#1)
of treatment of hypertension##2##4##(2008-7#1)(2009-9#1)
of treatment of patients with##2##5##(2011-1#1)(2012-3#1)
of treatment of patients##3##4##(2008-3#1)(2011-1#1)(2012-3#1)
of treatment of the##5##4##(1991-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
of treatment of##39##3##(1990-2#1)(1991-12#1)(1991-6#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-8#1)(2007-11#3)(2007-12#1)(2007-8#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#3)
of treatment on the##2##4##(1992-9#1)(2008-11#1)
of treatment on##6##3##(1992-9#1)(2008-11#1)(2008-7#1)(2013-1#3)
of treatment options##4##3##(1993-1#1)(2008-1#1)(2008-12#1)(2009-3#1)
of treatment or##2##3##(1992-5#1)(2008-7#1)
of treatment outcome##4##3##(2007-8#1)(2008-9#1)(2011-2#2)
of treatment outcomes##3##3##(1997-2#1)(2010-12#1)(2011-2#1)
of treatment parameters##2##3##(2007-4#1)(2008-10#1)
of treatment planning##2##3##(1994-8#1)(2009-11#1)
of treatment protocols for patient##3##5##(2012-12#3)
of treatment protocols##4##3##(1995-8#1)(2012-12#3)
of treatment provided##2##3##(2007-8#1)(2012-3#1)
of treatment response##5##3##(1995-2#1)(2007-2#1)(2010-12#1)(2010-6#1)(2011-2#1)
of treatment results##2##3##(2007-8#1)(2011-2#1)
of treatment strategies##4##3##(2008-8#2)(2010-11#1)(2012-1#1)
of treatment to##2##3##(2007-8#1)(2013-1#1)
of treatment using##2##3##(2008-2#1)(2008-7#1)
of treatment was##10##3##(1991-2#1)(1991-8#1)(1994-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2008-6#1)(2009-11#1)(2010-8#1)(2013-1#1)
of treatment were##8##3##(1996-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
of treatment which##2##3##(1997-6#1)(2013-8#1)
of treatment will##2##3##(2008-12#1)(2008-5#1)
of treatment with the##4##4##(1992-4#1)(2007-8#1)(2008-5#2)
of treatment with##30##3##(1990-11#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-12#2)(1995-8#2)(1996-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#2)
of treatment##527##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#4)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#6)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#5)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#3)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(2006-8#1)(2007-10#3)(2007-11#16)(2007-12#11)(2007-2#1)(2007-4#2)(2007-7#9)(2007-8#26)(2007-9#1)(2008-1#7)(2008-10#21)(2008-11#13)(2008-12#13)(2008-2#7)(2008-3#11)(2008-4#5)(2008-5#12)(2008-6#12)(2008-7#20)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#8)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#5)(2011-1#13)(2011-10#1)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#14)(2012-2#8)(2012-3#14)(2012-6#1)(2013-1#33)(2013-7#1)(2013-8#10)
of treatment)##2##2##(2008-10#1)(2011-2#1)
of treatment-related##3##2##(2008-7#2)(2008-9#1)
of treatment-resistant##4##2##(2008-12#1)(2012-12#3)
of treatments for##3##3##(2006-12#1)(2008-7#1)(2010-12#1)
of treatments on##2##3##(1997-4#1)(2008-9#1)
of treatments to##2##3##(1995-12#1)(2009-8#1)
of treatments was##2##3##(2008-10#2)
of treatments##29##2##(1990-2#2)(1995-12#2)(1995-2#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
of tree seedlings##2##3##(2008-10#1)(2008-5#1)
of tree species##2##3##(2009-8#1)(2012-6#1)
of tree##13##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2012-6#1)
of trees at##2##3##(2008-10#1)(2008-9#1)
of trees in##2##3##(2008-10#2)
of trees to##3##3##(2008-10#2)(2012-8#1)
of trees##19##2##(2008-10#12)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-10#1)(2012-8#1)(2013-7#1)
of trehalose##7##2##(1993-8#1)(1997-2#2)(2008-10#2)(2013-1#2)
of tremendous##6##2##(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)
of tremolite##6##2##(1991-12#6)
of tremor##7##2##(2008-7#7)
of trends in##4##3##(1991-2#1)(1993-1#1)(1995-3#1)(2008-1#1)
of trends##7##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1995-3#1)(2007-12#1)(2008-1#1)
of tri- and##2##3##(2008-10#1)(2009-6#1)
of tri-Calciphor (trimer of 16##2##5##(1994-6#2)
of triacylglycerols##2##2##(2008-11#1)(2008-5#1)
of trial##5##2##(1993-12#1)(1993-3#1)(1995-1#1)(2008-5#1)(2009-6#1)
of trials in##4##3##(1990-11#1)(1994-2#2)(2009-9#1)
of trials to##2##3##(1993-3#1)(1995-12#1)
of trials##20##2##(1990-11#2)(1993-12#2)(1993-3#1)(1994-2#2)(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#2)
of triamcinolone acetonide##2##3##(1991-9#1)(2010-12#1)
of triamcinolone##5##2##(1991-9#1)(1992-5#1)(1996-3#1)(2010-12#1)(2011-2#1)
of triangle##2##2##(2008-10#1)(2008-6#1)
of triangular##4##2##(2008-3#3)(2008-5#1)
of triazine##3##2##(2008-10#2)(2010-8#1)
of triazines from soils##2##4##(2008-10#2)
of triazines##4##2##(2008-10#4)
of tributyltin##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2009-12#1)
of trichinosis##2##2##(2008-10#2)
of trichloroacetic acid (TCA)##2##4##(2008-10#2)
of trichloroacetic acid##3##3##(2008-10#3)
of trichloroethylene (TCE)##3##3##(2008-10#2)(2010-4#1)
of trichloroethylene##8##2##(2008-10#6)(2008-7#1)(2010-4#1)
of trichodiene synthase##3##3##(1995-2#3)
of trichomoniasis##2##2##(2008-10#1)(2008-5#1)
of triclosan##2##2##(2008-5#2)
of tricyclic antidepressant##2##3##(2008-10#1)(2010-1#1)
of tricyclic antidepressants##4##3##(1991-11#2)(2008-10#1)(2012-2#1)
of tricyclic##7##2##(1990-11#1)(1991-11#2)(2008-10#2)(2010-1#1)(2012-2#1)
of tricycloillicinone##3##2##(2009-11#3)
of triethanolamine (TEA)##2##3##(2008-10#2)
of triethanolamine##4##2##(2008-10#3)(2008-4#1)
of triethylamine##4##2##(2007-11#1)(2008-10#1)(2008-7#2)
of trifluoroethanol##3##2##(1995-2#2)(2009-8#1)
of triflupromazine##2##2##(2008-10#2)
of trifluridine##2##2##(1994-8#2)
of trifoliate orange##4##3##(2008-10#4)
of trigeminal##3##2##(1990-9#1)(1996-5#1)(2011-2#1)
of trigger##6##2##(2008-12#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-9#1)
of triggering##4##2##(1992-3#1)(2008-1#1)(2011-1#1)(2012-7#1)
of triggers##2##2##(2008-10#1)(2008-11#1)
of triglyceride-rich lipoproteins##4##3##(1995-6#4)
of triglyceride-rich##5##2##(1995-6#4)(2008-6#1)
of triglycerides##7##2##(1992-12#1)(1992-3#1)(1997-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
of trihalomethanes (THMs)##2##3##(2008-10#2)
of trihalomethanes in##3##3##(2008-10#3)
of trihalomethanes##7##2##(2008-10#7)
of trimellitic##2##2##(2008-10#2)
of trimeperidine##2##2##(2012-3#2)
of trimethylamine dehydrogenase##2##3##(1995-2#2)
of trimethylamine in##2##3##(2008-10#2)
of trimethylamine##5##2##(1995-2#2)(2008-10#3)
of trimethylolpropane triacrylate##2##3##(2008-9#2)
of trimethylphosphine binding to##2##4##(1990-8#2)
of trinitrophenol##2##2##(2008-10#2)
of trinitrotoluene (TNT)##2##3##(2008-10#2)
of trinitrotoluene##3##2##(2008-10#3)
of triosephosphates##2##2##(2008-1#2)
of triphenylphosphane##2##2##(2013-1#2)
of triple##4##2##(1995-5#1)(2009-12#1)(2013-1#2)
of triplet##5##2##(1992-8#2)(1995-8#1)(2008-10#1)(2008-3#1)
of triplex##3##2##(1995-5#3)
of triplexes##2##2##(1993-8#1)(2008-8#1)
of triploid crucian carp##2##4##(2010-5#2)
of triploid##3##2##(2009-12#1)(2010-5#2)
of tripropylamine##2##2##(2008-10#1)(2010-7#1)
of tris(2##5##2##(2008-10#5)
of tris-(2##2##2##(2008-10#2)
of trisomy 21##3##3##(1997-4#1)(2009-10#1)(2012-3#1)
of trisomy X##2##3##(1997-5#1)(2012-3#1)
of trisomy##9##2##(1996-12#1)(1997-4#1)(1997-5#1)(2009-10#1)(2012-3#5)
of triterpenic derivatives##2##3##(2008-5#2)
of tritiated##2##2##(2008-11#1)(2008-9#1)
of tritium##2##2##(1991-5#1)(1994-5#1)
of tritrophic food chains##2##4##(2008-9#2)
of trivalent##12##2##(2008-10#10)(2011-2#2)
of trkB##3##2##(1996-12#3)
of trolox##2##2##(2008-10#1)(2008-5#1)
of trophectoderm##2##2##(1991-12#1)(2012-12#1)
of trophic cascades##4##3##(2008-8#4)
of trophic factors##3##3##(1996-2#1)(2008-8#1)(2012-1#1)
of trophic##16##2##(1990-3#1)(1996-2#2)(1997-6#1)(2007-7#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-3#1)
of trophozoite##2##2##(1990-2#2)
of tropical diseases##3##3##(2011-2#2)(2012-2#1)
of tropical medicine##3##3##(1995-9#1)(2010-1#2)
of tropical##26##2##(1992-7#1)(1995-9#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-1#2)(2010-7#1)(2011-2#3)(2012-2#2)(2013-7#1)
of tropomyosin##3##2##(1992-9#3)
of troponin##3##2##(1995-5#2)(2012-3#1)
of tropospheric aerosols##3##3##(2008-2#2)(2008-3#1)
of tropospheric and stratospheric##2##4##(2008-11#1)(2008-3#1)
of tropospheric ozone##5##3##(1992-3#1)(2008-2#2)(2008-3#2)
of tropospheric particle size distributions##3##5##(2008-3#3)
of tropospheric##14##2##(1992-3#1)(2008-11#1)(2008-2#4)(2008-3#8)
of trouble##2##2##(2008-10#1)(2008-6#1)
of trout##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
of troutCYP1A gene##2##3##(2008-11#2)
of trp aporepressor from Escherichia coli##2##6##(1990-7#2)
of true##21##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#3)
of truly##4##2##(2007-11#1)(2008-10#2)(2008-5#1)
of truncated and##2##3##(2008-11#1)(2008-8#1)
of truncated##8##2##(1991-10#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
of trunk strength and stability##2##5##(2008-12#2)
of trunk##4##2##(2008-12#2)(2012-12#1)(2013-1#1)
of trust and##3##3##(1995-12#1)(2008-1#1)(2012-12#1)
of trust in##5##3##(2007-11#1)(2008-3#1)(2009-6#2)(2011-2#1)
of trust##13##2##(1994-2#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-6#2)(2010-5#1)(2011-2#1)(2012-12#1)
of trustees##2##2##(1993-2#2)
of trypan##2##2##(2008-10#1)(2008-11#1)
of trypanosomiasis in##2##3##(2013-1#2)
of trypanosomiasis##3##2##(2013-1#3)
of trypanozoon infection##5##3##(2011-2#5)
of trypsin and##2##3##(1992-9#1)(1993-3#1)
of trypsin##15##2##(1990-8#2)(1991-5#1)(1992-3#2)(1992-9#2)(1993-3#1)(1994-6#1)(1997-2#2)(2008-11#1)(2008-7#3)
of tryptic##3##2##(1990-7#1)(1995-6#1)(2008-10#1)
of tryptophan residues##3##3##(1992-6#1)(1995-2#1)(1995-6#1)
of tryptophan##13##2##(1992-6#2)(1995-2#2)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#3)
of tryptophans##2##2##(1991-12#1)(1993-11#1)
of ts mutants##2##3##(2008-10#2)
of tsetse flies##2##3##(2013-8#2)
of tuatara##2##2##(2010-3#2)
of tubal pregnancy##2##3##(1994-3#2)
of tubal sterility##2##3##(1994-12#2)
of tubal##7##2##(1991-11#1)(1991-12#1)(1994-12#2)(1994-3#2)(2011-1#1)
of tube##2##2##(2009-8#1)(2012-2#1)
of tuber-borne sclerotia##2##3##(2008-10#2)
of tuber-borne##3##2##(2008-10#3)
of tubercular##5##2##(1997-8#2)(2008-4#1)(2010-8#1)(2012-12#1)
of tuberculin##2##2##(1990-6#1)(2013-1#1)
of tuberculosis (TB)##3##3##(2008-1#1)(2009-4#1)(2013-1#1)
of tuberculosis among people living with HIV/AIDS##5##7##(2011-1#5)
of tuberculosis and##2##3##(1996-3#1)(2008-5#1)
of tuberculosis at##2##3##(2009-7#1)(2011-2#1)
of tuberculosis cases##2##3##(1995-9#1)(2013-8#1)
of tuberculosis in the##2##4##(2008-7#1)(2009-7#1)
of tuberculosis in##10##3##(1996-3#1)(2008-1#1)(2008-7#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#3)
of tuberculosis infection##4##3##(1990-6#2)(2008-10#1)(2010-11#1)
of tuberculosis was##2##3##(1990-9#1)(2012-3#1)
of tuberculosis##57##2##(1990-6#3)(1990-9#1)(1993-11#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-3#5)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-7#2)(2010-11#1)(2011-1#5)(2011-2#8)(2012-3#4)(2013-1#5)(2013-8#1)
of tuberculous meningitis##3##3##(2011-2#2)(2013-7#1)
of tuberculous spinal cord compression##2##5##(2008-7#2)
of tuberculous##10##2##(1990-6#1)(2007-8#2)(2008-7#2)(2009-5#1)(2011-2#3)(2013-7#1)
of tuberous sclerosis##2##3##(2008-1#1)(2010-6#1)
of tuberous##3##2##(2008-1#1)(2008-11#1)(2010-6#1)
of tubers##2##2##(2008-10#2)
of tubes##4##2##(1991-12#1)(1996-2#1)(2008-10#1)(2013-1#1)
of tubing##4##2##(1997-3#3)(2008-10#1)
of tubular degeneration##2##3##(2008-5#1)(2008-9#1)
of tubular transporters##2##3##(2009-12#2)
of tubular##10##2##(1990-5#1)(1990-9#1)(1992-9#1)(1993-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#2)
of tubules##3##2##(2007-12#1)(2008-7#2)
of tubulin and##2##3##(1992-6#1)(1995-3#1)
of tubulin##16##2##(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#4)(1994-5#3)(1995-3#1)(1995-5#4)(2010-7#1)
of tumor and##5##3##(1990-2#1)(1993-11#1)(1993-9#1)(2007-11#1)(2009-3#1)
of tumor angiogenesis##2##3##(2007-8#1)(2008-10#1)
of tumor cell growth##4##4##(2007-5#1)(2008-4#2)(2008-6#1)
of tumor cell lines##2##4##(1992-9#1)(2012-12#1)
of tumor cell##12##3##(1991-12#1)(1992-9#1)(1997-7#1)(2007-5#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-12#1)
of tumor cells in##3##4##(2008-11#1)(2008-4#1)(2009-3#1)
of tumor cells to##4##4##(1991-2#1)(2008-10#1)(2008-11#1)(2009-9#1)
of tumor cells##36##3##(1991-2#1)(1992-3#1)(1992-8#1)(1993-9#2)(1994-5#2)(1994-6#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#6)(2008-4#5)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-3#2)
of tumor development##2##3##(1992-5#1)(1993-8#1)
of tumor growth and##2##4##(2009-3#1)(2012-2#1)
of tumor growth##8##3##(1990-7#1)(1993-1#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
of tumor invasion##3##3##(2008-11#2)(2013-8#1)
of tumor lysis syndrome in adults with hematologic malignancies##2##9##(2008-7#2)
of tumor malignancy##2##3##(1993-8#1)(2012-2#1)
of tumor necrosis factor alpha##2##5##(1992-7#1)(2011-2#1)
of tumor necrosis factor##11##4##(1990-12#1)(1992-3#1)(1992-7#1)(1994-11#1)(1994-8#1)(1995-12#2)(2006-10#1)(2008-5#1)(2011-2#2)
of tumor necrosis factor-alpha (TNF-alpha) and##2##6##(2007-8#1)(2008-10#1)
of tumor necrosis factor-alpha (TNF-alpha) on##2##6##(1992-3#1)(2008-9#1)
of tumor necrosis factor-alpha (TNF-alpha)##7##5##(1992-12#1)(1992-3#1)(1995-9#1)(2007-8#1)(2008-10#2)(2008-9#1)
of tumor necrosis factor-alpha and##2##5##(1995-10#1)(2008-5#1)
of tumor necrosis factor-alpha##11##4##(1992-12#1)(1992-3#1)(1994-6#1)(1995-10#1)(1995-9#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
of tumor necrosis factor-α##2##4##(2011-1#1)(2013-1#1)
of tumor necrosis##26##3##(1990-12#1)(1992-12#1)(1992-3#3)(1992-7#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
of tumor progression and metastasis##2##5##(1997-4#1)(2012-1#1)
of tumor progression##8##3##(1991-2#1)(1993-9#1)(1997-4#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
of tumor recurrence after##2##4##(2009-1#1)(2011-2#1)
of tumor recurrence##5##3##(1991-4#1)(2009-1#1)(2009-5#1)(2011-2#2)
of tumor regression##3##3##(1992-12#1)(1994-5#1)(1995-9#1)
of tumor resection##2##3##(2007-11#1)(2011-2#1)
of tumor response to##2##4##(1995-9#1)(2010-3#1)
of tumor stage##2##3##(1990-12#1)(2008-1#1)
of tumor suppressor genes##3##4##(1990-12#1)(2007-11#1)(2011-2#1)
of tumor suppressor##5##3##(1990-12#1)(1995-6#1)(2007-11#1)(2008-6#1)(2011-2#1)
of tumor tissue##3##3##(1997-8#1)(2007-11#1)(2008-4#1)
of tumor vasculature##2##3##(1993-9#1)(2008-3#1)
of tumor##192##2##(1990-12#4)(1990-2#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#3)(1993-5#1)(1993-8#3)(1993-9#6)(1994-11#2)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-6#1)(1995-9#4)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#6)(2007-4#2)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-11#11)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#5)(2009-5#3)(2009-6#2)(2009-9#1)(2010-11#1)(2010-3#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#5)
of tumor-associated##2##2##(1993-11#1)(2008-6#1)
of tumor-bearing mice##7##3##(1990-7#4)(1994-3#1)(2008-9#2)
of tumor-bearing##8##2##(1990-2#1)(1990-7#4)(1994-3#1)(2008-9#2)
of tumor-immune##3##2##(2013-8#3)
of tumor-induced##2##2##(1995-3#1)(2008-11#1)
of tumor-infiltrating##2##2##(2011-1#1)(2012-2#1)
of tumor-related##3##2##(1990-12#1)(2008-6#1)(2008-7#1)
of tumor-specific##2##2##(1994-5#1)(2011-1#1)
of tumoral##2##2##(2007-11#1)(2010-9#1)
of tumorigenesis induced by##2##4##(2008-11#2)
of tumorigenesis##7##2##(1995-10#1)(1995-9#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
of tumorigenic##3##2##(1995-9#1)(1997-1#1)(2009-3#1)
of tumorigenicity##2##2##(1992-2#1)(2008-9#1)
of tumorous##2##2##(2008-5#1)(2009-10#1)
of tumors and##6##3##(2007-11#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-12#1)
of tumors in the proximal##2##5##(2010-3#2)
of tumors in the##4##4##(2010-3#3)(2011-2#1)
of tumors in##6##3##(1994-8#1)(2010-3#3)(2011-2#1)(2012-2#1)
of tumors is##2##3##(1991-12#1)(2013-7#1)
of tumors to##2##3##(2013-7#2)
of tumors with a##2##4##(1991-4#1)(2010-12#1)
of tumors with##3##3##(1990-2#1)(1991-4#1)(2010-12#1)
of tumors##58##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-9#1)(1994-8#1)(1995-4#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#6)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#2)
of tumour and##2##3##(2008-2#1)(2008-6#1)
of tumour cell##2##3##(2008-11#1)(2009-4#1)
of tumour cells##6##3##(1992-9#4)(1997-3#1)(2008-5#1)
of tumour growth##2##3##(1993-8#1)(1993-9#1)
of tumour hypoxia and the##2##5##(2009-4#1)(2011-2#1)
of tumour hypoxia and##3##4##(2009-4#1)(2011-2#2)
of tumour hypoxia##4##3##(2009-4#2)(2011-2#2)
of tumour necrosis##3##3##(1992-8#1)(2008-10#1)(2012-1#1)
of tumour perfusion##2##3##(2008-7#2)
of tumour recurrence##2##3##(2008-7#1)(2013-1#1)
of tumour spread##3##3##(2008-1#1)(2012-2#2)
of tumour##47##2##(1990-11#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-3#1)(1993-8#1)(1993-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#8)(2008-7#5)(2009-4#4)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
of tumours of the##2##4##(2007-11#1)(2008-6#1)
of tumours##14##2##(1991-11#1)(1993-9#2)(1997-2#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)
of tuna ferrocytochrome c##2##4##(1994-5#2)
of tuna##3##2##(1994-5#2)(2011-2#1)
of tunable diode lasers##3##4##(2007-12#1)(2008-3#2)
of tunable far-infrared##2##3##(2007-11#1)(2008-2#1)
of tunable##22##2##(2007-11#5)(2007-12#3)(2008-2#7)(2008-3#5)(2012-2#1)(2013-8#1)
of tungsten in tobacco##2##4##(2008-10#2)
of tungsten in##7##3##(2008-10#7)
of tungsten##18##2##(2007-12#1)(2008-10#17)
of tunicamycin##4##2##(1993-6#1)(1994-8#1)(2008-11#1)(2013-1#1)
of tuning##2##2##(2007-11#1)(2008-3#1)
of tunnel length##2##3##(2013-1#2)
of tunnel##4##2##(2011-2#2)(2013-1#2)
of tunneling##3##2##(1992-11#1)(2007-11#1)(2008-3#1)
of tunnels##4##2##(2009-10#1)(2011-2#3)
of turbid biological##2##3##(2008-2#1)(2008-3#1)
of turbid media##8##3##(2008-2#1)(2008-3#6)(2009-10#1)
of turbid samples##2##3##(2008-3#2)
of turbid water##2##3##(2008-2#2)
of turbid##15##2##(1995-2#1)(2008-2#4)(2008-3#9)(2009-10#1)
of turbine design##2##3##(2008-6#2)
of turbot##3##2##(2010-5#1)(2010-8#1)(2012-2#1)
of turbulence by##2##3##(2007-12#1)(2008-3#1)
of turbulence##10##2##(2007-12#1)(2008-12#1)(2008-3#8)
of turbulence-induced phase distortions##2##4##(2008-3#2)
of turbulence-induced##5##2##(2008-3#5)
of turbulent##3##2##(2008-3#2)(2008-8#1)
of turkey##4##2##(1990-12#1)(1993-3#1)(1997-6#2)
of turkeys##3##2##(2007-6#1)(2007-8#1)(2013-1#1)
of turning##3##2##(1996-1#1)(2008-9#1)(2011-1#1)
of turnip mosaic virus##2##4##(2008-10#2)
of turnip##3##2##(1997-3#1)(2008-10#2)
of turnover##3##2##(1991-1#1)(1996-2#1)(2007-12#1)
of twelve##8##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
of twenty##6##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
of twenty-five##4##2##(1990-3#1)(1993-2#1)(2008-7#1)(2011-2#1)
of twenty-one##3##2##(1993-12#1)(1996-12#1)(2007-12#1)
of twice##2##2##(2008-2#1)(2008-3#1)
of twin births##3##3##(1990-6#3)
of twin##9##2##(1990-6#3)(1991-3#1)(1995-6#1)(2007-11#2)(2010-8#2)
of twins##2##2##(1997-7#1)(2008-7#1)
of two Chinese-version sexual##2##4##(2010-5#2)
of two Chinese-version##3##3##(2010-5#3)
of two Egyptian species of bats##2##6##(1994-11#2)
of two active##5##3##(1991-12#1)(1995-5#1)(1997-7#1)(2008-10#2)
of two adjacent##2##3##(1990-5#1)(2007-12#1)
of two alternative##4##3##(2007-12#1)(2008-3#1)(2008-8#2)
of two bacterial##2##3##(1995-5#1)(2008-10#1)
of two binary##2##3##(2008-3#2)
of two binding sites##2##4##(1995-5#1)(2008-10#1)
of two cDNAs encoding##3##4##(1993-2#1)(2008-7#2)
of two calibration##2##3##(2008-10#2)
of two case reports##2##4##(1990-12#1)(1996-3#1)
of two cases and review of the literature##2##8##(1992-12#1)(2011-2#1)
of two cases and review of the##3##7##(1992-12#1)(2011-2#1)(2012-3#1)
of two cases and review of##4##6##(1992-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
of two cases and##6##4##(1992-12#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#1)
of two cases of##3##4##(1990-2#1)(2008-10#1)(2011-2#1)
of two cases##36##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
of two cases]##3##3##(2013-1#3)
of two classes of##5##4##(1993-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(2008-10#1)
of two clinical cases]##2##4##(2008-10#1)(2013-8#1)
of two clinical##5##3##(1992-6#1)(2008-10#1)(2008-11#2)(2013-8#1)
of two closely spaced##2##4##(2008-10#1)(2008-2#1)
of two closely##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
of two clusters of##3##4##(1994-5#1)(2008-10#2)
of two cohorts of patients with##2##6##(2012-2#1)(2013-1#1)
of two cohorts of##3##4##(2008-11#1)(2012-2#1)(2013-1#1)
of two cohorts##4##3##(2008-11#1)(2012-2#2)(2013-1#1)
of two commercial##6##3##(2008-10#4)(2008-3#1)(2011-1#1)
of two commercially available##2##4##(2008-5#2)
of two common##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2010-5#1)
of two complementary##2##3##(1992-6#1)(1995-5#1)
of two components##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
of two consecutive##2##3##(2008-10#2)
of two coupled##3##3##(2008-3#1)(2009-8#1)(2013-8#1)
of two cyanine dye films##2##5##(2008-3#2)
of two cyclic##2##3##(1993-5#1)(2008-10#1)
of two cysteine residues##2##4##(1992-8#1)(1995-2#1)
of two day##2##3##(2008-11#1)(2008-12#1)
of two different extraction methods##2##5##(2008-10#2)
of two different polyamines##3##4##(2008-12#3)
of two different subunits##2##4##(1991-10#2)
of two different thin##2##4##(2009-7#2)
of two different##60##3##(1990-11#1)(1990-12#2)(1991-10#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-11#2)(2007-12#4)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)
of two dissimilar##3##3##(1990-2#1)(1993-11#1)(2008-3#1)
of two distinct##14##3##(1990-11#1)(1994-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-6#1)(2013-8#1)
of two divergent##3##3##(1995-5#1)(1995-8#1)(2008-10#1)
of two domains##2##3##(1997-3#1)(2007-11#1)
of two experiments##2##3##(2008-10#1)(2008-3#1)
of two fiber##2##3##(2007-12#1)(2008-3#1)
of two fields##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of two fluoquinolones##2##3##(2008-10#2)
of two forms of##5##4##(1992-12#1)(1992-6#1)(1995-5#1)(2008-7#1)(2008-9#1)
of two further##2##3##(1990-5#1)(2008-10#1)
of two genes##4##3##(1991-6#1)(1993-3#1)(2008-10#2)
of two genotypes of##2##4##(2008-10#2)
of two genotypes##3##3##(2008-10#2)(2011-1#1)
of two glucose##2##3##(1994-12#2)
of two group treatments##2##4##(2011-1#2)
of two groups of##5##4##(1991-1#1)(1996-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
of two groups##10##3##(1990-12#1)(1991-1#1)(1992-2#1)(1996-8#1)(2007-8#1)(2008-10#3)(2010-4#1)(2013-1#1)
of two high-resolution##2##3##(2008-2#1)(2008-4#1)
of two highly##2##3##(2008-10#1)(2008-11#1)
of two homologous##2##3##(1997-2#1)(1997-7#1)
of two human##5##3##(1993-8#1)(1993-9#1)(1994-6#1)(2008-11#1)(2009-2#1)
of two identical##5##3##(1990-2#1)(1992-6#1)(1997-2#1)(2007-11#1)(2008-12#1)
of two immiscible##2##3##(1993-8#1)(2008-10#1)
of two important##3##3##(2007-11#1)(2008-9#1)(2011-1#1)
of two in##2##3##(1996-12#1)(2008-10#1)
of two independent##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
of two independently##2##3##(2008-3#1)(2009-7#1)
of two interacting##2##3##(2009-8#1)(2011-2#1)
of two interspecific##2##3##(2008-10#2)
of two isoforms of##2##4##(1994-8#1)(1995-2#1)
of two isolates##5##3##(2008-10#5)
of two isomers##2##3##(2008-10#2)
of two kinds of##2##4##(2008-11#1)(2008-8#1)
of two kinds##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
of two layers##3##3##(2008-10#2)(2008-12#1)
of two ligands##2##3##(2008-10#2)
of two main##3##3##(2008-11#2)(2008-12#1)
of two major##8##3##(1990-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#1)
of two mechanisms##3##3##(2008-7#1)(2010-5#1)(2012-2#1)
of two metabolites##2##3##(1995-3#1)(2008-10#1)
of two metal##2##3##(2008-10#2)
of two methods##5##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-7#1)
of two missense##2##3##(1995-8#1)(1997-7#1)
of two molecular##2##3##(2008-11#1)(2008-4#1)
of two molecules of collagenase##2##5##(1992-2#2)
of two molecules of##5##4##(1990-11#1)(1992-2#2)(1992-3#1)(1994-9#1)
of two monoclonal antibodies##3##4##(1990-12#1)(1992-2#1)(1994-5#1)
of two months##6##3##(1995-11#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-2#1)(2013-1#1)
of two mosquito##2##3##(2007-5#1)(2008-5#1)
of two mutually##3##3##(2007-11#1)(2008-11#1)(2008-8#1)
of two neighboring##2##3##(2007-11#1)(2008-3#1)
of two new##10##3##(1992-2#1)(1993-6#1)(1993-8#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)
of two nonidentical subunits##2##4##(1992-9#1)(2008-8#1)
of two novel##8##3##(1993-6#1)(1993-8#1)(2007-11#2)(2008-10#1)(2008-9#2)(2011-2#1)
of two of the##7##4##(1993-6#1)(1993-9#1)(1995-6#1)(2008-10#3)(2008-8#1)
of two of these##4##4##(1990-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
of two of##13##3##(1990-12#1)(1993-6#1)(1993-9#1)(1995-6#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#1)
of two or more##10##4##(1992-12#1)(1993-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#2)(2009-5#1)(2010-1#1)
of two or##14##3##(1992-12#1)(1993-2#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-3#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
of two orchid viruses##3##4##(2008-10#3)
of two orders of magnitude##3##5##(2008-10#3)
of two other##7##3##(1990-5#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-11#1)(2007-8#1)(2009-4#1)
of two parts##4##3##(1993-1#1)(2008-7#1)(2013-1#2)
of two patients who##2##4##(1997-8#1)(2012-12#1)
of two patients with##5##4##(1996-9#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)
of two patients##12##3##(1992-5#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-12#3)
of two peaks##3##3##(1990-8#2)(1991-12#1)
of two phases##5##3##(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
of two phenolic##2##3##(2008-10#1)(2011-1#1)
of two plane##2##3##(2007-11#1)(2008-3#1)
of two populations of##3##4##(1993-5#1)(2008-4#1)(2008-5#1)
of two populations##4##3##(1993-5#1)(2008-12#1)(2008-4#1)(2008-5#1)
of two potential##2##3##(1991-9#1)(2008-10#1)
of two protein##2##3##(1993-3#1)(1997-4#1)
of two proteins##4##3##(1992-9#1)(1993-12#1)(2008-4#1)(2010-12#1)
of two putative##3##3##(1992-3#1)(1992-9#1)(1993-9#1)
of two recently##4##3##(1995-3#1)(1997-4#1)(2008-3#1)(2013-1#1)
of two related##3##3##(1992-1#1)(1993-12#1)(2008-7#1)
of two representative##2##3##(2008-10#2)
of two rice##2##3##(1997-8#1)(2008-10#1)
of two sample##4##3##(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
of two samples##2##3##(1993-1#1)(2008-10#1)
of two second-order##2##3##(2007-11#1)(2008-6#1)
of two sensory##2##3##(1993-12#1)(2008-7#1)
of two separate##9##3##(1992-1#1)(1992-6#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-9#1)(2009-3#1)(2011-2#1)
of two series of##3##4##(1995-3#1)(1997-7#1)(2008-10#1)
of two sets of##3##4##(1996-2#1)(2007-5#1)(2008-3#1)
of two single-mode##2##3##(2007-11#1)(2008-3#1)
of two sites##2##3##(1992-6#1)(1997-3#1)
of two spatial##2##3##(2008-10#1)(2008-8#1)
of two spatially##2##3##(2007-12#1)(2008-10#1)
of two species of##9##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
of two species##14##3##(1997-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#1)(2013-1#1)(2013-7#1)
of two specific##3##3##(1994-11#1)(2008-3#1)(2008-5#1)
of two stocks of the##2##5##(2010-8#2)
of two strains of##7##4##(1997-3#2)(2008-10#2)(2008-6#1)(2013-8#2)
of two streams of##2##4##(1996-1#1)(2008-10#1)
of two structurally##2##3##(2008-10#1)(2008-7#1)
of two studies##2##3##(2008-12#1)(2013-1#1)
of two subgroups##2##3##(2008-10#1)(2008-5#1)
of two subunits##2##3##(1993-11#1)(1995-6#1)
of two surface##2##3##(2008-3#1)(2008-6#1)
of two synchronized##2##3##(2007-11#1)(2008-3#1)
of two systems##2##3##(1990-8#1)(2007-8#1)
of two tandem##3##3##(1991-9#1)(1994-12#1)(2008-9#1)
of two techniques##2##3##(2007-11#1)(2008-10#1)
of two terms##2##3##(2008-2#1)(2008-3#1)
of two to##2##3##(1992-1#1)(2008-10#1)
of two tones##3##3##(1995-12#1)(2008-4#1)(2013-8#1)
of two treatment##2##3##(2008-5#1)(2012-2#1)
of two treatments##3##3##(1995-2#1)(1995-9#1)(2008-9#1)
of two types of##14##4##(1992-6#1)(1992-8#2)(1993-11#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2012-1#1)
of two types##17##3##(1991-2#1)(1992-6#1)(1992-8#2)(1993-11#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-1#1)
of two variants of##2##4##(1990-7#1)(2012-1#1)
of two viruses that##2##4##(2008-10#2)
of two viruses##3##3##(1995-2#1)(2008-10#2)
of two wavelengths are##2##4##(2008-2#1)(2008-3#1)
of two wavelengths##6##3##(2008-2#1)(2008-3#5)
of two ways##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of two weeks##9##3##(1990-6#1)(1990-9#1)(1991-12#1)(1995-8#1)(1996-1#1)(2008-4#1)(2008-8#1)(2010-2#2)
of two wheat##2##3##(2008-12#1)(2008-8#1)
of two years##7##3##(1991-12#1)(1995-5#1)(2007-8#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of two##1204##2##(1990-10#1)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#4)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#8)(1991-2#4)(1991-3#2)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#10)(1992-8#5)(1992-9#7)(1993-1#6)(1993-11#8)(1993-12#7)(1993-2#5)(1993-3#4)(1993-5#3)(1993-6#4)(1993-8#8)(1993-9#4)(1994-11#12)(1994-12#10)(1994-2#1)(1994-3#5)(1994-5#9)(1994-6#7)(1994-8#7)(1994-9#7)(1995-11#2)(1995-12#2)(1995-2#10)(1995-3#5)(1995-5#10)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#9)(1997-3#13)(1997-4#7)(1997-5#1)(1997-6#5)(1997-7#9)(1997-8#4)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#39)(2007-12#47)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#8)(2008-1#5)(2008-10#242)(2008-11#37)(2008-12#27)(2008-2#34)(2008-3#92)(2008-4#17)(2008-5#27)(2008-6#11)(2008-7#22)(2008-8#31)(2008-9#25)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#9)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#4)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#12)(2011-2#30)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#18)(2012-3#6)(2012-5#1)(2013-1#30)(2013-7#5)(2013-8#12)
of two- and three-dimensional##2##4##(2008-2#1)(2008-3#1)
of two- and##3##3##(2008-2#1)(2008-3#2)
of two-color##6##2##(2007-11#1)(2007-12#1)(2008-3#3)(2008-4#1)
of two-dimensional (2D)##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of two-dimensional arrays##2##3##(2008-3#1)(2008-4#1)
of two-dimensional echocardiography##2##3##(2007-8#1)(2011-2#1)
of two-dimensional gel electrophoresis##2##4##(1993-9#1)(2008-7#1)
of two-dimensional gel##3##3##(1990-7#1)(1993-9#1)(2008-7#1)
of two-dimensional phase##2##3##(2008-3#2)
of two-dimensional##37##2##(1990-11#1)(1990-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1996-2#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-2#4)(2008-3#14)(2008-4#2)(2008-7#2)(2011-2#1)
of two-photon absorption coefficients for CdSe and GaSe##2##8##(2008-3#2)
of two-photon absorption in##3##4##(2007-11#2)(2008-2#1)
of two-photon absorption##7##3##(2007-11#4)(2008-2#1)(2008-3#2)
of two-photon excitation##8##3##(2007-11#3)(2008-1#1)(2008-3#2)(2011-1#2)
of two-photon excited fluorescence (TPF)##2##5##(2008-10#1)(2008-3#1)
of two-photon fluorescence imaging through a scattering medium##2##8##(2008-2#2)
of two-photon fluorescence##4##3##(2008-2#2)(2008-3#2)
of two-photon##24##2##(2007-11#8)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#8)(2011-1#2)
of two-photon-excited##2##2##(2007-12#1)(2008-3#1)
of two-stage repair##3##3##(2008-10#1)(2009-5#2)
of two-stage##6##2##(2008-10#3)(2008-8#1)(2009-5#2)
of two-way##2##2##(2008-10#1)(2010-8#1)
of tymoviruses##2##2##(2008-10#2)
of tympanic membrane##2##3##(2009-7#1)(2012-8#1)
of type 1 diabetes mellitus##3##5##(1990-6#1)(2008-1#1)(2008-10#1)
of type 1 diabetes##10##4##(1990-6#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
of type 1##17##3##(1990-6#1)(1992-6#1)(1993-6#2)(2007-5#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-4#1)
of type 2 diabetes (T2D) and##2##6##(2008-1#1)(2013-8#1)
of type 2 diabetes (T2D)##3##5##(2008-1#1)(2009-3#1)(2013-8#1)
of type 2 diabetes and##5##5##(2008-1#2)(2008-11#1)(2012-2#1)(2013-1#1)
of type 2 diabetes in##6##5##(1994-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
of type 2 diabetes mellitus (T2DM)##4##6##(2008-1#1)(2008-3#1)(2009-11#1)(2009-9#1)
of type 2 diabetes mellitus and metabolic syndrome##2##8##(2008-1#1)(2008-3#1)
of type 2 diabetes mellitus and##4##6##(2008-1#1)(2008-3#1)(2012-2#2)
of type 2 diabetes mellitus is##2##6##(2008-1#1)(2008-3#1)
of type 2 diabetes mellitus##18##5##(2008-1#3)(2008-10#1)(2008-3#8)(2009-11#1)(2009-9#1)(2012-1#1)(2012-2#3)
of type 2 diabetes##45##4##(1994-12#1)(1996-11#1)(2007-5#1)(2008-1#10)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#10)(2008-7#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
of type 2 lepra reaction##3##5##(2009-5#3)
of type 2##51##3##(1994-12#1)(1996-11#1)(2007-5#1)(2008-1#11)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#10)(2008-7#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
of type A aortic##2##4##(2007-8#2)
of type A##6##3##(1990-5#2)(1994-2#1)(2007-8#2)(2013-1#1)
of type B##5##3##(1997-6#2)(2008-10#2)(2008-7#1)
of type I collagen##7##4##(1995-5#1)(1997-1#2)(2008-1#1)(2008-5#1)(2008-9#2)
of type I diabetes##2##4##(1993-12#1)(2008-9#1)
of type I endoleaks##2##4##(2007-8#2)
of type I error##4##4##(2008-10#3)(2013-1#1)
of type I iodothyronine 5'-deiodinase##2##5##(1990-12#2)
of type I##29##3##(1990-12#2)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#2)(1995-12#1)(1995-5#1)(1997-1#2)(1997-4#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2013-1#1)
of type II##11##3##(1994-5#3)(1996-11#1)(1996-12#1)(2007-11#2)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)
of type III##2##3##(1993-6#1)(2013-8#1)
of type IV collagen in the##2##6##(1994-7#2)
of type IV collagen in##3##5##(1994-7#2)(2010-11#1)
of type IV collagen##4##4##(1994-7#3)(2010-11#1)
of type IV collagenase##3##4##(2008-11#1)(2008-8#2)
of type IV##8##3##(1994-7#3)(2008-11#1)(2008-8#2)(2010-11#1)(2011-3#1)
of type VII collagen##3##4##(1992-3#3)
of type VIII collagen##2##4##(1990-8#2)
of type of##4##3##(1994-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
of type##152##2##(1990-12#2)(1990-5#3)(1990-6#1)(1990-8#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-7#3)(1995-12#1)(1995-5#2)(1996-11#2)(1996-12#1)(1997-1#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#3)(2007-8#4)(2008-1#14)(2008-10#16)(2008-11#5)(2008-12#2)(2008-3#11)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#4)
of types of##4##3##(2008-10#1)(2008-11#1)(2009-9#1)(2012-2#1)
of types##9##2##(1993-9#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-11#1)(2009-9#1)(2012-2#1)
of typical and##3##3##(1994-9#1)(2008-10#1)(2011-2#1)
of typical imaging features##2##4##(2012-3#1)(2013-8#1)
of typical##32##2##(1992-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of typically##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
of tyramine oxidase##2##3##(2009-9#2)
of tyrosinase activity##2##3##(1992-3#2)
of tyrosinase and DOPA auto-oxidation##2##5##(2008-5#2)
of tyrosinase and##4##3##(1995-2#1)(2008-5#3)
of tyrosinase##14##2##(1992-3#2)(1995-2#1)(2007-10#1)(2008-10#5)(2008-5#5)
of tyrosine 252##3##3##(2008-4#3)
of tyrosine by##2##3##(1990-5#1)(2008-5#1)
of tyrosine hydroxylase (TH)##3##4##(1993-8#1)(1997-5#1)(2008-10#1)
of tyrosine hydroxylase##5##3##(1992-12#1)(1993-8#2)(1997-5#1)(2008-10#1)
of tyrosine kinase activity##2##4##(1994-8#1)(2008-3#1)
of tyrosine kinase##6##3##(1992-3#1)(1994-8#1)(1995-2#1)(2008-3#1)(2011-2#2)
of tyrosine kinases##5##3##(1992-12#2)(1993-8#1)(1995-6#1)(2013-1#1)
of tyrosine phosphorylation and##2##4##(1994-6#2)
of tyrosine phosphorylation in##4##4##(1992-3#1)(1993-3#1)(2008-4#1)(2012-3#1)
of tyrosine phosphorylation##9##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-6#2)(1996-2#2)(2008-4#1)(2012-3#1)
of tyrosine residues of##4##4##(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
of tyrosine residues##7##3##(1997-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)
of tyrosine##46##2##(1990-5#3)(1992-12#4)(1992-3#2)(1993-3#2)(1993-8#3)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#2)(2012-3#2)(2013-1#1)
of tyrosines##2##2##(1992-12#2)
of tyrosyl##3##2##(1997-7#1)(2008-1#1)(2008-8#1)
of uPA##3##2##(1990-12#2)(2008-11#1)
of ubiquitin and##2##3##(1994-9#1)(1995-5#1)
of ubiquitin in##2##3##(1994-9#1)(1995-3#1)
of ubiquitin##9##2##(1994-9#2)(1995-3#2)(1995-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
of ubiquitin-protein##3##2##(1995-6#2)(2008-4#1)
of ulcer##4##2##(1996-11#1)(2006-10#1)(2007-8#1)(2008-12#1)
of ulcerative colitis##8##3##(1996-8#1)(2007-10#2)(2008-12#1)(2008-5#4)
of ulcerative##11##2##(1992-3#2)(1996-8#1)(2007-10#2)(2008-12#2)(2008-5#4)
of ultra trace amounts of##8##5##(2008-10#8)
of ultra trace##14##3##(2008-10#14)
of ultra##15##2##(2008-10#14)(2010-4#1)
of ultra-micro amounts of sulfur in igneous##2##7##(2008-10#2)
of ultra-trace elements##2##3##(2008-10#2)
of ultra-trace level##2##3##(2008-10#2)
of ultra-trace##13##2##(2008-10#13)
of ultrabrief pulse width##2##4##(2012-12#2)
of ultracold##2##2##(2007-11#1)(2012-2#1)
of ultrafast optical waveforms##2##4##(2007-12#2)
of ultrafast##13##2##(2007-11#6)(2007-12#7)
of ultrafiltration for##2##3##(2008-10#2)
of ultrafiltration##16##2##(2007-12#1)(2008-1#6)(2008-10#7)(2008-7#1)(2012-3#1)
of ultrapure water##2##3##(2008-1#1)(2008-10#1)
of ultrapure##3##2##(2008-1#2)(2008-10#1)
of ultrashort laser pulses##4##4##(2007-12#1)(2008-3#3)
of ultrashort light pulses##2##4##(2007-11#2)
of ultrashort optical pulses by##2##5##(2007-12#2)
of ultrashort optical pulses##7##4##(2007-11#2)(2007-12#5)
of ultrashort pulses##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
of ultrashort##24##2##(2007-11#7)(2007-12#13)(2008-3#4)
of ultrasmooth nanostructured diamond films##2##5##(2008-10#2)
of ultrasonic and thermo-chemical pre-treatments on##2##6##(2013-1#2)
of ultrasonic##14##2##(1993-2#2)(2007-11#2)(2008-10#4)(2008-3#2)(2008-5#1)(2013-1#2)(2013-8#1)
of ultrasonographic##2##2##(2008-8#1)(2009-4#1)
of ultrasonography and##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
of ultrasonography##8##2##(1991-6#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#2)
of ultrasound examinations##2##3##(2007-11#1)(2007-4#1)
of ultrasound in##4##3##(1994-6#1)(2008-10#1)(2011-2#1)(2012-2#1)
of ultrasound##19##2##(1992-12#1)(1994-6#1)(1995-12#1)(2007-11#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-5#2)(2010-8#1)(2011-2#2)(2012-2#2)
of ultrasound-assisted extraction##4##3##(2008-10#3)(2013-1#1)
of ultrasound-assisted##5##2##(2008-10#4)(2013-1#1)
of ultrasound-guided##4##2##(2008-8#1)(2009-4#1)(2012-2#2)
of ultrasounds##2##2##(2008-10#1)(2008-5#1)
of ultrathin##7##2##(1990-4#1)(2006-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)
of ultratrace amounts of##2##4##(2008-10#2)
of ultratrace##3##2##(2008-10#3)
of ultraviolet (UV)##3##3##(1991-6#1)(2008-3#1)(2008-5#1)
of ultraviolet radiation##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
of ultraviolet##14##2##(1991-6#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#4)(2008-5#3)(2011-2#1)
of ultrawideband##2##2##(2007-12#2)
of umbilical cord##4##3##(2008-11#1)(2009-8#1)(2012-12#2)
of umbilical##6##2##(1994-3#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#2)
of unaffected##4##2##(1992-9#1)(1997-5#1)(2007-2#1)(2008-5#1)
of unanesthetized rats##3##3##(1992-3#1)(1997-2#2)
of unanswered questions##2##3##(1995-12#1)(2008-2#1)
of unbalanced##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
of unbound HI 6 in##2##5##(1997-7#2)
of unbound##3##2##(1997-7#2)(2008-10#1)
of uncalibrated##3##2##(2008-10#2)(2008-6#1)
of uncapped##2##2##(2008-10#2)
of uncertainty associated with the##2##5##(2008-10#1)(2009-11#1)
of uncertainty in the##3##4##(2008-3#1)(2008-7#1)(2009-11#1)
of uncertainty in##7##3##(2008-10#3)(2008-3#1)(2008-7#2)(2009-11#1)
of uncertainty##24##2##(1992-12#1)(1993-12#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-7#3)(2009-11#2)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
of unchanged##2##2##(1992-6#1)(1995-6#1)
of uncommon##2##2##(2007-7#1)(2011-7#1)
of uncompensated care##2##3##(1996-1#1)(2008-11#1)
of uncomplicated##5##2##(1993-2#1)(2007-2#1)(2008-9#1)(2010-8#1)(2013-1#1)
of unconjugated bilirubin between##2##4##(1992-3#2)
of unconjugated##3##2##(1990-12#1)(1992-3#2)
of unconsciousness##3##2##(1995-3#1)(2012-12#1)(2012-3#1)
of uncontrolled##3##2##(2008-10#2)(2013-1#1)
of uncorrelated##2##2##(2008-11#1)(2008-3#1)
of undefined##3##2##(2008-10#3)
of under##6##2##(1990-12#1)(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)
of underarm##2##2##(2008-5#2)
of underdeveloped##2##2##(1990-2#1)(2008-11#1)
of undergoing a##2##3##(1996-12#1)(2008-11#1)
of undergoing##4##2##(1996-12#1)(1996-5#1)(2007-12#1)(2008-11#1)
of undergraduate education##2##3##(2010-3#2)
of undergraduate nurses to##2##4##(2008-12#1)(2012-3#1)
of undergraduate nursing##2##3##(2008-11#1)(2008-12#1)
of undergraduate##12##2##(1993-2#1)(2008-11#2)(2008-12#6)(2010-3#2)(2012-3#1)
of underground##2##2##(2008-10#1)(2008-6#1)
of underivatized amino acids in##3##5##(2008-10#3)
of underivatized amino acids##5##4##(2008-10#5)
of underlying disease##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
of underlying mechanisms##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
of underlying##19##2##(2006-10#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
of underreporting##3##2##(1991-6#1)(1997-3#2)
of understanding of the##3##4##(2008-1#1)(2008-11#1)(2008-7#1)
of understanding of##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
of understanding the##8##3##(1990-5#1)(1993-11#1)(1996-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of understanding##36##2##(1990-5#1)(1991-9#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-12#1)(2010-12#1)(2010-3#2)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of undertaking##3##2##(2008-11#3)
of underwater##3##2##(2008-2#2)(2008-3#1)
of underweight##3##2##(2007-12#1)(2010-7#1)(2011-1#1)
of undesirable##5##2##(1993-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
of undesired##3##2##(1994-12#1)(1995-2#1)(2008-6#1)
of undetected##2##2##(1995-12#1)(2012-2#1)
of undetermined##2##2##(2008-1#1)(2008-9#1)
of undifferentiated cells##2##3##(2008-11#1)(2009-8#1)
of undifferentiated##6##2##(1990-6#1)(2008-11#3)(2009-12#1)(2009-8#1)
of undigested##4##2##(1993-11#1)(2008-10#2)(2008-12#1)
of undoped##2##2##(2008-10#1)(2008-2#1)
of unemployed workers##4##3##(2013-1#4)
of unemployed##5##2##(2013-1#5)
of unemployment or economic inactivity##2##5##(2013-1#2)
of unemployment##5##2##(1997-2#1)(2008-1#1)(2013-1#3)
of unenhanced##2##2##(1995-6#2)
of unequal##3##2##(1992-12#1)(1994-2#1)(2008-8#1)
of unexpected and##2##3##(1994-3#1)(1996-6#1)
of unexpected##9##2##(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-12#1)
of unexplained##3##2##(1992-11#1)(2007-10#1)(2013-8#1)
of unfamiliar##2##2##(1996-5#1)(2008-11#1)
of unfed larvae and adult mites of Platytrombidium fasciatum (C##2##10##(2007-12#2)
of unfertilized eggs##2##3##(1993-6#2)
of unfertilized##3##2##(1993-6#2)(2011-2#1)
of unfilled##2##2##(1991-2#1)(1993-6#1)
of unfixed##2##2##(2008-4#2)
of unfolding##6##2##(1991-6#1)(1993-11#1)(1995-5#3)(2008-4#1)
of unfractionated heparin##2##3##(2013-8#2)
of unhealthy weight##4##3##(2008-11#1)(2012-2#3)
of unhealthy##6##2##(2008-11#2)(2011-2#1)(2012-2#3)
of uniaxial##3##2##(2008-3#1)(2011-2#1)(2012-7#1)
of unicellular##2##2##(2008-12#1)(2013-1#1)
of unidentified cadavers##2##3##(2008-12#2)
of unidentified human genes##6##4##(1995-8#2)(1996-10#1)(1996-2#3)
of unidentified##12##2##(1993-9#1)(1995-8#2)(1996-10#1)(1996-2#3)(2007-8#1)(2008-12#2)(2011-2#1)(2012-12#1)
of uniform cells##2##3##(1991-8#1)(2009-12#1)
of uniform output couplers for far-infrared lasers##2##7##(2007-12#2)
of uniform##12##2##(1991-8#1)(1995-2#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-12#1)
of uniformly##2##2##(2008-10#1)(2008-3#1)
of unilateral stereotactic pallidotomy##2##4##(2008-7#2)
of unilateral##13##2##(1997-2#1)(2008-10#1)(2008-7#4)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#3)
of uninfected##6##2##(1994-11#2)(1996-12#1)(2008-10#2)(2008-7#1)
of uninoculated##2##2##(2008-10#2)
of uninsured patients##2##3##(1995-1#2)
of uninsured##7##2##(1993-12#1)(1994-12#1)(1995-1#2)(1997-2#1)(2013-1#2)
of unintended##3##2##(1992-12#1)(2008-10#1)(2008-3#1)
of union##4##2##(1994-3#1)(2012-2#2)(2013-1#1)
of unique##21##2##(1995-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)
of units of##4##3##(2007-7#1)(2008-1#1)(2008-12#1)(2012-3#1)
of units##12##2##(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-3#1)
of unity##5##2##(1990-11#1)(2008-2#1)(2008-3#3)
of univalent metal##3##3##(2008-10#3)
of univariate and##2##3##(2009-10#1)(2013-1#1)
of univariate##5##2##(1993-12#1)(2008-10#1)(2008-6#1)(2009-10#1)(2013-1#1)
of universal cholesterol screening##2##4##(2013-1#2)
of universal guidelines##2##3##(2010-11#1)(2010-3#1)
of universal health##2##3##(1991-2#1)(1996-2#1)
of universal##14##2##(1991-2#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(2007-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#3)
of universe##2##2##(2013-1#2)
of university programs in health administration##2##6##(1994-1#1)(1996-3#1)
of university students##2##3##(2011-1#1)(2012-12#1)
of university##13##2##(1994-1#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-11#2)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
of unknown aetiology##2##3##(1996-3#1)(2010-3#1)
of unknown cause##6##3##(1990-6#1)(1992-8#1)(1994-9#1)(2008-5#1)(2008-7#2)
of unknown composition##3##3##(1992-12#1)(2008-10#2)
of unknown etiology that##2##4##(2008-10#1)(2010-11#1)
of unknown etiology##14##3##(1991-2#1)(1995-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
of unknown function##16##3##(1992-9#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-7#2)(2008-9#2)(2009-10#1)(2010-10#3)
of unknown origin in##2##4##(1996-6#1)(2008-11#1)
of unknown origin##11##3##(1990-2#1)(1996-11#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
of unknown primary##4##3##(1992-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
of unknown##79##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-3#2)(1996-6#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-10#4)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of unlabeled peptide##2##3##(1996-5#2)
of unlabeled##8##2##(1991-12#2)(1993-9#1)(1996-5#2)(2008-4#2)(2008-9#1)
of unlabelled##4##2##(1990-12#1)(1990-8#1)(1994-8#1)(1997-1#1)
of unmatched##2##2##(1992-9#1)(2008-9#1)
of unmet need##2##3##(2008-7#1)(2010-8#1)
of unmet##5##2##(1993-2#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
of unmodified##4##2##(2008-10#2)(2008-4#2)
of unmyelinated##4##2##(1993-12#4)
of unnatural##4##2##(2008-4#3)(2008-7#1)
of unnecessary##8##2##(1995-12#1)(2008-10#2)(2008-4#1)(2011-2#2)(2013-1#2)
of unoriented##3##2##(1991-9#1)(2010-4#2)
of unpackaged##2##2##(1991-5#1)(1992-8#1)
of unparallel grating planes in##2##5##(2008-3#2)
of unplanned##3##2##(2007-11#1)(2007-7#1)(2010-6#1)
of unpolarized light##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of unprecedented##2##2##(1996-2#1)(2011-1#1)
of unpredictable##3##2##(1992-11#1)(1994-5#1)(2008-7#1)
of unprocessed##2##2##(1997-4#1)(2012-12#1)
of unprotected##5##2##(2008-1#1)(2008-12#1)(2011-1#1)(2013-1#2)
of unproven##2##2##(2008-12#1)(2008-4#1)
of unrecognized##2##2##(2008-10#1)(2009-6#1)
of unrelated fungi##2##3##(2008-10#2)
of unrelated##8##2##(1994-12#1)(1997-3#1)(2008-10#3)(2008-8#1)(2012-2#1)(2012-3#1)
of unresectable or metastatic##3##4##(1994-2#1)(2008-6#2)
of unresectable##5##2##(1994-2#1)(2008-6#3)(2010-3#1)
of unrestrained##2##2##(1995-2#2)
of unruptured##3##2##(1995-11#1)(2008-7#1)(2009-7#1)
of unsafe abortion and##2##4##(2011-1#2)
of unsafe abortion##3##3##(2011-1#2)(2012-12#1)
of unsatisfactory##2##2##(2007-11#1)(2011-2#1)
of unsaturated fatty acids##2##4##(1993-6#1)(1996-3#1)
of unsaturated fatty##3##3##(1993-6#2)(1996-3#1)
of unsaturated##5##2##(1993-6#2)(1994-3#1)(1996-3#1)(2010-4#1)
of unsaturation of the##2##4##(1995-5#1)(2010-4#1)
of unsaturation##8##2##(1990-2#1)(1990-5#1)(1993-11#1)(1995-11#2)(1995-5#1)(2008-10#1)(2010-4#1)
of unstable angina and non-ST elevation myocardial infarction##2##8##(2008-3#2)
of unstable angina pectoris and acute myocardial infarction##3##8##(1991-9#3)
of unstable angina##7##3##(1991-9#3)(2008-3#3)(2010-12#1)
of unstable resonators##2##3##(2008-2#1)(2008-3#1)
of unstable##17##2##(1991-9#3)(1994-11#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)
of unstained##2##2##(2007-12#1)(2011-1#1)
of unstimulated##3##2##(1991-2#1)(1992-12#1)(1996-2#1)
of unstirred##2##2##(2008-10#1)(2008-11#1)
of untreated##9##2##(1992-11#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#1)
of unusual##8##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)
of unusually##2##2##(2009-12#1)(2009-7#1)
of unvaccinated##2##2##(1994-9#1)(2009-5#1)
of unwanted cells##2##3##(2008-9#1)(2009-10#1)
of unwanted immunogenicity##4##3##(2008-10#4)
of unwanted##13##2##(1991-3#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)
of unwinding##2##2##(1995-3#1)(1997-4#1)
of unwrapping##2##2##(2008-3#2)
of up to 1##5##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)
of up to 10 mg/kg/day##2##5##(1992-11#2)
of up to 10##3##4##(1992-11#2)(2008-5#1)
of up to 100##2##4##(1991-2#1)(2008-10#1)
of up to 12##2##4##(2007-8#1)(2008-9#1)
of up to 15##3##4##(1994-6#1)(1997-4#1)(2008-10#1)
of up to 18##2##4##(2007-12#1)(2011-2#1)
of up to 2##4##4##(2008-10#2)(2008-7#1)(2013-8#1)
of up to 20##2##4##(1990-2#1)(2008-4#1)
of up to 20%##2##4##(2007-2#1)(2010-8#1)
of up to 3##3##4##(2008-11#1)(2009-11#1)(2012-3#1)
of up to 30 days##2##5##(1997-4#1)(2010-8#1)
of up to 30##6##4##(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#2)(2010-8#1)
of up to 40%##2##4##(2008-10#1)(2008-7#1)
of up to 5##2##4##(2007-11#1)(2008-3#1)
of up to 50##2##4##(2007-11#1)(2008-3#1)
of up to 6##3##4##(1990-10#1)(1996-6#1)(2008-10#1)
of up to 85##2##4##(2008-10#1)(2008-11#1)
of up to approximately##2##4##(2008-11#1)(2008-7#1)
of up to four##3##4##(1991-5#1)(2008-2#1)(2012-2#1)
of up to three##2##4##(2008-10#1)(2008-11#1)
of up to##101##3##(1990-10#2)(1990-2#1)(1991-2#1)(1991-5#1)(1992-11#2)(1993-11#1)(1993-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#3)(1997-6#1)(2007-11#6)(2007-12#10)(2007-2#1)(2007-8#1)(2008-10#21)(2008-11#5)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of updating##2##2##(2008-7#1)(2012-2#1)
of upland##2##2##(2008-10#1)(2008-9#1)
of upper airway obstruction##2##4##(1995-8#1)(2008-11#1)
of upper airway##3##3##(1995-8#1)(1997-6#1)(2008-11#1)
of upper and lower layers##2##5##(2008-3#2)
of upper and lower##3##4##(2008-3#3)
of upper extremity##3##3##(2007-7#1)(2011-2#2)
of upper gastrointestinal##3##3##(1991-8#1)(2007-2#1)(2012-2#1)
of upper limb##2##3##(2007-11#1)(2007-8#1)
of upper respiratory symptoms##2##4##(2009-4#1)(2013-8#1)
of upper respiratory##4##3##(2009-4#1)(2011-2#1)(2013-8#2)
of upper##30##2##(1990-6#1)(1991-8#1)(1995-10#1)(1995-8#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-3#3)(2009-4#1)(2009-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
of upper- and lower-limb##2##4##(2011-2#2)
of uppercase##2##2##(2008-6#2)
of upstream##7##2##(1990-5#1)(1992-3#1)(1997-7#1)(2008-11#2)(2010-8#1)(2012-2#1)
of uptake and##4##3##(1992-9#1)(1995-11#1)(2008-10#2)
of uptake##14##2##(1991-5#1)(1992-6#1)(1992-9#1)(1995-11#3)(2008-10#6)(2008-5#1)(2013-8#1)
of upwelling ecosystems##2##3##(2008-5#2)
of upwelling##4##2##(2008-2#1)(2008-3#1)(2008-5#2)
of urachal cyst associated with##3##5##(2009-5#3)
of urachal##4##2##(2008-6#1)(2009-5#3)
of urachal-sigmoid fistula associated with diverticular disease##2##7##(2008-6#2)
of uranium (VI)##3##3##(2008-10#3)
of uranium and##3##3##(2008-10#3)
of uranium at##2##3##(2008-10#2)
of uranium by##4##3##(2008-10#4)
of uranium from##5##3##(2008-10#5)
of uranium in##7##3##(2008-10#7)
of uranium is##2##3##(2008-10#2)
of uranium isotopes##2##3##(2008-10#2)
of uranium with##3##3##(2008-10#3)
of uranium##43##2##(2008-10#41)(2010-5#1)(2013-1#1)
of uranium(VI) and thorium(IV)##3##4##(2008-10#3)
of uranium(VI) and##4##3##(2008-10#4)
of uranium(VI) from##2##3##(2008-10#2)
of uranium(VI) in##2##3##(2008-10#2)
of uranium(VI) present in 1000ml##2##5##(2008-10#2)
of uranium(VI) present in##3##4##(2008-10#3)
of uranium(VI) with##2##3##(2008-10#2)
of uranium(VI)##18##2##(2008-10#18)
of uranium(VI)-tributylphosphate##2##2##(2008-10#2)
of uranyl ion from aqueous##2##5##(2008-10#2)
of uranyl ion##4##3##(2008-10#4)
of uranyl##10##2##(2008-10#10)
of urate and##2##3##(1993-2#1)(2008-10#1)
of urate oxidase crystal growth##2##5##(2008-10#2)
of urate oxidase##3##3##(2008-10#3)
of urate##6##2##(1993-2#1)(2008-10#5)
of urban and rural##2##4##(1992-12#2)
of urban##18##2##(1992-12#4)(1995-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-8#2)
of urban-rural differences in##2##4##(1992-12#1)(2008-11#1)
of urbanization##2##2##(2008-6#2)
of urea (1##2##3##(2008-10#2)
of urea and potassium##3##4##(2008-10#3)
of urea and##8##3##(1990-8#1)(2008-10#5)(2008-4#1)(2013-8#1)
of urea by##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
of urea concentration##5##3##(1993-11#1)(2008-1#3)(2008-10#1)
of urea from##2##3##(1991-9#1)(2008-10#1)
of urea in alcoholic beverages##2##5##(2008-10#2)
of urea in##4##3##(2008-10#4)
of urea##52##2##(1990-8#1)(1991-9#1)(1992-11#1)(1993-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(2008-1#6)(2008-10#25)(2008-2#1)(2008-4#4)(2008-7#1)(2011-1#1)(2013-8#5)
of urease##5##2##(1994-6#1)(2008-10#4)
of uredinia##2##2##(2008-10#2)
of urediniospores##4##2##(2008-10#4)
of uremic patients##2##3##(2007-7#1)(2008-1#1)
of uremic##4##2##(2007-7#1)(2008-1#1)(2008-5#1)(2013-1#1)
of ureteral obstruction secondary to##2##5##(2007-10#2)
of ureteral obstruction##3##3##(2007-10#2)(2011-1#1)
of ureteral##10##2##(1990-11#1)(1991-11#1)(1997-4#1)(2007-10#2)(2008-1#1)(2008-10#1)(2009-1#1)(2011-1#1)(2013-1#1)
of ureteric##6##2##(1991-9#1)(1997-3#2)(2008-1#1)(2008-8#2)
of ureters with##2##3##(2008-10#2)
of urethan##3##2##(1992-5#3)
of urethral diverticulum##2##3##(2008-10#2)
of urethral plate##2##3##(2009-5#2)
of urethral##6##2##(1990-7#1)(2008-10#3)(2009-5#2)
of urge urinary incontinence##2##4##(2008-3#2)
of urgency##2##2##(2008-11#1)(2008-7#1)
of urgent##2##2##(2007-8#1)(2008-10#1)
of uric acid (UA)##3##4##(2008-10#3)
of uric acid and##4##4##(2008-10#3)(2009-6#1)
of uric acid by##2##4##(2008-10#1)(2011-2#1)
of uric acid in human urine##2##6##(1997-2#1)(2008-10#1)
of uric acid in##8##4##(1997-2#1)(2008-10#7)
of uric acid is##2##4##(2008-10#2)
of uric acid##29##3##(1997-2#1)(2008-10#21)(2008-4#1)(2008-5#2)(2009-6#1)(2011-2#3)
of uric##30##2##(1997-2#1)(2008-10#22)(2008-4#1)(2008-5#2)(2009-6#1)(2011-2#3)
of uricase##5##2##(1990-11#2)(1992-8#2)(1995-3#1)
of uridine diphosphate##2##3##(1995-8#2)
of uridine##5##2##(1993-11#1)(1993-8#1)(1995-8#2)(2008-4#1)
of urinary 8OHdG##2##3##(2008-10#2)
of urinary Hg##2##3##(1993-8#2)
of urinary beta-core##2##3##(1996-12#2)
of urinary bladder diverticulum##3##4##(2011-2#3)
of urinary bladder##11##3##(1992-11#1)(2008-7#2)(2009-5#1)(2009-7#1)(2011-2#3)(2012-1#3)
of urinary dolichols##2##3##(1991-12#2)
of urinary free noradrenaline##2##4##(1990-8#2)
of urinary incontinence##7##3##(1994-5#1)(1996-2#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-3#1)
of urinary neopterin and serum##2##5##(2008-10#2)
of urinary nucleosides##3##3##(1990-8#1)(1997-2#2)
of urinary pseudouridine and 1-methyladenosine##2##5##(1992-3#2)
of urinary schistosomiasis##2##3##(1996-12#1)(2008-10#1)
of urinary tract infection among##2##5##(2008-4#1)(2010-8#1)
of urinary tract infection##7##4##(2008-10#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
of urinary tract infections in##2##5##(2007-10#2)
of urinary tract infections##7##4##(1993-2#1)(1997-4#1)(2007-10#2)(2009-5#1)(2010-3#1)(2011-2#1)
of urinary tract##18##3##(1992-12#1)(1992-6#1)(1993-2#1)(1997-4#1)(2007-10#2)(2008-10#2)(2008-4#1)(2009-5#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
of urinary##92##2##(1990-11#1)(1990-3#1)(1990-8#6)(1991-12#2)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-12#1)(1994-5#1)(1995-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#4)(1997-4#1)(2007-10#3)(2008-1#1)(2008-10#15)(2008-3#1)(2008-4#2)(2008-7#2)(2009-5#3)(2009-6#5)(2009-7#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
of urine and##2##3##(1993-12#1)(2008-10#1)
of urine as##2##3##(2008-10#1)(2011-2#1)
of urine from##2##3##(1993-2#1)(2012-3#1)
of urine in##2##3##(2008-1#1)(2012-3#1)
of urine sample##2##3##(2008-10#2)
of urine samples of##2##4##(1993-8#1)(2008-10#1)
of urine samples##6##3##(1990-12#1)(1990-2#1)(1990-8#1)(1993-8#1)(2008-10#2)
of urine were##2##3##(2008-10#2)
of urine##42##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1996-12#3)(1996-5#2)(2007-10#2)(2008-1#2)(2008-10#14)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
of urogenital##6##2##(1990-9#1)(1991-11#1)(1994-11#1)(1997-3#1)(1997-6#1)(2008-10#1)
of urokinase##5##2##(1990-12#1)(1993-11#1)(1997-4#1)(2008-7#2)
of urokinase-type plasminogen activator##2##4##(1990-12#1)(1993-12#1)
of urologic##2##2##(2008-7#1)(2013-8#1)
of urological complications##3##3##(2008-1#3)
of urological##4##2##(1991-8#1)(2008-1#3)
of urology##2##2##(2008-1#1)(2011-2#1)
of uropathogenic##2##2##(1995-2#1)(2007-7#1)
of uroporphyrinogen III##2##3##(1991-5#2)
of us##15##2##(1994-1#3)(1994-2#4)(1995-2#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-8#1)
of usable##3##2##(1993-12#1)(2007-11#1)(2008-3#1)
of usage##3##2##(1994-2#1)(1997-1#1)(2010-12#1)
of use are##2##3##(2008-11#1)(2009-10#1)
of use for##4##3##(1996-9#1)(2008-11#1)(2008-2#1)(2010-8#1)
of use in the##4##4##(1997-1#1)(2008-1#1)(2008-2#1)(2008-3#1)
of use in##10##3##(1996-9#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2012-3#1)
of use is##2##3##(2008-1#1)(2011-1#1)
of use of the##4##4##(1994-2#1)(1994-3#1)(2008-10#1)(2012-3#1)
of use of##22##3##(1990-6#1)(1990-8#1)(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2009-12#1)(2010-3#2)(2010-6#1)(2012-3#1)(2013-1#4)
of use##67##2##(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
of used##6##2##(2008-10#3)(2008-11#1)(2011-2#2)
of useful##12##2##(1992-8#1)(1994-11#1)(1996-10#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-12#1)
of user##2##2##(2008-3#1)(2008-7#1)
of users of##3##3##(1991-1#1)(2011-1#1)(2012-3#1)
of users##13##2##(1991-1#4)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-8#1)
of using PBL in a##2##5##(2008-12#2)
of using a##26##3##(1997-2#1)(1997-3#1)(2007-12#3)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
of using an##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#2)
of using both the##2##4##(2008-10#1)(2008-3#1)
of using both##3##3##(2008-10#2)(2008-3#1)
of using it in##2##4##(2010-12#1)(2012-12#1)
of using it##4##3##(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
of using laser##2##3##(2008-10#2)
of using such##2##3##(1996-12#1)(2007-12#1)
of using the##28##3##(1992-3#1)(1992-5#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-11#4)(2007-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#2)
of using them##2##3##(1995-6#1)(2011-2#1)
of using this technique for##2##5##(2008-10#2)
of using this##12##3##(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#1)
of using##223##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#39)(2008-11#16)(2008-12#4)(2008-2#8)(2008-3#27)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#8)(2009-5#3)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
of usual##4##2##(1991-12#1)(2008-10#1)(2009-7#1)(2011-2#1)
of uterine arteries##2##3##(1994-9#2)
of uterine cancer##3##3##(1991-12#3)
of uterine cervical carcinoma##2##4##(1994-8#1)(2007-4#1)
of uterine cervical##3##3##(1994-8#1)(2007-4#1)(2012-12#1)
of uterine epithelial cells is##2##5##(2008-6#2)
of uterine epithelial cells##5##4##(2008-6#5)
of uterine##32##2##(1991-12#3)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#6)(1996-1#1)(2007-4#1)(2008-6#5)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
of uterus##3##2##(2008-11#1)(2012-3#1)(2013-7#1)
of utilization and##2##3##(1991-3#1)(1995-12#1)
of utilization management##3##3##(1995-2#1)(1997-2#2)
of utilization review##3##3##(1991-3#2)(1996-12#1)
of utilization##15##2##(1991-3#3)(1992-3#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(2007-10#1)(2012-12#1)(2012-2#1)
of utilizing##9##2##(2008-10#3)(2008-3#1)(2008-6#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
of utmost importance for the##2##5##(2008-10#1)(2011-1#1)
of utmost importance for##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
of utmost importance in the##3##5##(1993-3#1)(2008-10#1)(2013-8#1)
of utmost importance##12##3##(1991-6#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
of utmost##14##2##(1991-6#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
of uveal melanoma##2##3##(1991-6#1)(2008-7#1)
of uveal##3##2##(1991-6#1)(2008-7#1)(2013-8#1)
of uvomorulin##3##2##(1990-11#1)(1994-6#2)
of v##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
of v(i) and v(j)##2##4##(2008-10#2)
of vWF and##2##3##(2008-11#1)(2013-8#1)
of vacant sites##2##3##(2008-10#2)
of vacant##6##2##(1991-11#1)(2008-10#4)(2008-9#1)
of vaccinated##4##2##(1995-5#1)(2007-2#1)(2008-5#1)(2010-4#1)
of vaccination against##2##3##(2012-12#1)(2013-1#1)
of vaccination as##2##3##(2007-6#1)(2011-1#1)
of vaccination on##2##3##(1996-3#2)
of vaccination##22##2##(1990-2#1)(1995-3#1)(1996-3#3)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-4#5)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
of vaccinations in##2##3##(1997-3#1)(2007-11#1)
of vaccinations##3##2##(1997-3#1)(2007-11#1)(2012-12#1)
of vaccine and##2##3##(1995-5#1)(2011-1#1)
of vaccine efficacy##3##3##(1994-2#2)(1995-5#1)
of vaccine safety##2##3##(1995-5#2)
of vaccine##20##2##(1993-3#1)(1994-2#3)(1995-5#5)(1997-8#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)
of vaccines against##2##3##(1994-11#1)(2008-11#1)
of vaccines##12##2##(1993-3#1)(1994-11#1)(1994-9#1)(1995-5#3)(2007-6#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
of vacuma##2##2##(2008-10#2)
of vacuolar ATPase##2##3##(1995-6#2)
of vacuoles##3##2##(2007-12#2)(2008-7#1)
of vacuum ultraviolet##3##3##(2008-2#3)
of vacuum##5##2##(2008-10#2)(2008-2#3)
of vacuum-ultraviolet##2##2##(2007-11#1)(2008-3#1)
of vaginal cylinders##2##3##(2009-2#2)
of vaginal hysterectomy##3##3##(1995-12#1)(1996-2#1)(2010-3#1)
of vaginal##16##2##(1992-1#1)(1993-1#1)(1995-12#1)(1996-2#1)(2007-10#3)(2007-7#1)(2008-10#1)(2009-2#2)(2009-7#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-1#1)
of vague##3##2##(2009-4#1)(2010-4#1)(2013-1#1)
of valaciclovir##2##2##(1995-6#2)
of valid##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
of validation##5##2##(2008-10#3)(2008-7#1)(2010-10#1)
of validity of the first Born##2##6##(2008-2#2)
of validity of the##7##4##(2008-11#1)(2008-2#3)(2008-3#3)
of validity of##10##3##(2008-11#1)(2008-2#4)(2008-3#5)
of validity##12##2##(2008-11#1)(2008-2#4)(2008-3#6)(2012-12#1)
of valinomycin##2##2##(1992-12#1)(1994-12#1)
of valproic acid##4##3##(2010-3#1)(2013-1#3)
of valproic##5##2##(2010-3#1)(2011-1#1)(2013-1#3)
of valsartan##2##2##(2011-1#2)
of valuable##2##2##(2008-10#1)(2010-5#1)
of value for##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
of value in##10##3##(1990-12#1)(1992-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#3)
of value resin composites##2##4##(2012-2#2)
of value to the##2##4##(1997-4#1)(2008-1#1)
of value to##8##3##(1992-1#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-3#1)
of value##32##2##(1990-12#1)(1992-1#2)(1993-2#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-9#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
of values for##2##3##(2008-3#1)(2010-2#1)
of values of##3##3##(2008-3#1)(2013-1#2)
of values was##2##3##(2008-3#1)(2008-7#1)
of values##25##2##(1990-2#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
of valve##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
of van der Waals##3##4##(2008-10#2)(2009-11#1)
of van der##4##3##(2008-10#2)(2009-11#1)(2011-1#1)
of vanadate to##2##3##(1990-2#2)
of vanadate##5##2##(1990-2#2)(1994-11#1)(1997-1#1)(2008-10#1)
of vanadium (V)##2##3##(2008-10#1)(2011-2#1)
of vanadium accumulation##2##3##(1990-2#1)(1990-5#1)
of vanadium and molybdenum##3##4##(2008-10#3)
of vanadium and##9##3##(2007-11#1)(2008-10#8)
of vanadium by##3##3##(2008-10#3)
of vanadium from##2##3##(2008-10#2)
of vanadium in a##2##4##(2008-10#2)
of vanadium in parenteral##2##4##(2008-10#2)
of vanadium in soil##2##4##(2008-10#2)
of vanadium in the range##2##5##(2008-10#2)
of vanadium in the##4##4##(2008-10#4)
of vanadium in water##2##4##(2008-10#2)
of vanadium in##26##3##(2008-10#26)
of vanadium pentoxide##2##3##(1996-2#2)
of vanadium species##2##3##(2008-10#2)
of vanadium##67##2##(1990-2#1)(1990-5#4)(1996-2#2)(2007-11#1)(2008-10#58)(2011-2#1)
of vanadium(IV) and total vanadium##3##5##(2008-10#3)
of vanadium(IV)##4##2##(2008-10#4)
of vanadium(V) and##2##3##(2008-10#2)
of vanadium(V) with##3##3##(2008-10#3)
of vanadium(V)##10##2##(2008-10#10)
of vanadyl##3##2##(1990-2#1)(1994-6#1)(2008-10#1)
of vancomycin and its##2##4##(2008-10#2)
of vancomycin and##4##3##(2008-10#3)(2011-2#1)
of vancomycin associated renal toxicity##2##5##(2012-12#2)
of vancomycin in##2##3##(2007-7#1)(2008-10#1)
of vancomycin##14##2##(2007-12#2)(2007-7#2)(2008-10#6)(2011-2#1)(2012-12#3)
of vancomycin-resistant##2##2##(2007-12#1)(2009-5#1)
of vanillin and PHB##2##4##(2008-10#2)
of vanillin and##4##3##(2008-10#4)
of vanillin##6##2##(2008-10#6)
of vapor##4##2##(2008-10#2)(2008-3#2)
of vaporization##2##2##(2008-3#1)(2010-4#1)
of vapors##3##2##(2008-10#2)(2008-3#1)
of var genes##2##3##(2012-3#2)
of var##3##2##(2009-10#1)(2012-3#2)
of variability in the##5##4##(2008-1#1)(2008-10#3)(2009-6#1)
of variability in##13##3##(2008-1#1)(2008-10#4)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
of variability which##2##3##(2008-10#1)(2013-7#1)
of variability##33##2##(1990-2#1)(1991-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
of variable length##4##3##(1992-6#1)(2008-10#3)
of variable regions##2##3##(2008-10#1)(2008-8#1)
of variable size##3##3##(2008-10#2)(2008-6#1)
of variable thickness##2##3##(2007-12#1)(2008-10#1)
of variable##35##2##(1990-12#1)(1990-5#1)(1992-6#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-3#1)
of variables and##3##3##(1995-9#1)(2008-1#1)(2008-10#1)
of variables in##2##3##(2008-10#1)(2008-4#1)
of variables that##2##3##(1992-2#1)(2008-10#1)
of variables was##3##3##(1992-2#1)(2008-10#2)
of variables##31##2##(1992-2#2)(1994-3#1)(1995-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
of variance (ANOVA) was##2##4##(1994-2#1)(2008-10#1)
of variance (ANOVA)##11##3##(1994-2#1)(1995-2#1)(2008-10#6)(2009-2#1)(2012-2#1)(2013-1#1)
of variance and##5##3##(1990-3#1)(1993-5#1)(2008-10#1)(2013-1#2)
of variance in##7##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-12#2)(2010-5#1)(2013-8#1)
of variance revealed##3##3##(2009-11#1)(2012-3#1)(2013-1#1)
of variance showed that the##2##5##(1993-2#1)(2013-1#1)
of variance showed that##3##4##(1993-2#2)(2013-1#1)
of variance was used to##2##5##(1991-2#1)(2008-6#1)
of variance with##2##3##(2008-10#1)(2008-4#1)
of variance##66##2##(1990-2#1)(1990-3#2)(1990-8#1)(1991-2#1)(1992-2#1)(1993-2#2)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
of variance)##2##2##(2008-10#1)(2008-3#1)
of variances##2##2##(2008-10#2)
of variant##6##2##(1991-12#1)(1993-3#1)(1994-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
of variants of##2##3##(2008-10#1)(2010-5#1)
of variants##3##2##(1991-12#1)(2008-10#1)(2010-5#1)
of variation (C##3##3##(1993-8#1)(1996-5#2)
of variation among##2##3##(1995-5#1)(2008-1#1)
of variation and##3##3##(1996-6#1)(2010-5#1)(2012-3#1)
of variation between##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
of variation for##7##3##(1990-2#1)(1993-8#1)(2008-10#4)(2008-5#1)
of variation in body##2##4##(2008-9#1)(2013-7#1)
of variation in disease severity##2##5##(2008-10#2)
of variation in the##4##4##(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
of variation in##24##3##(1990-8#1)(1990-9#1)(1997-1#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
of variation is##4##3##(1992-3#1)(1994-9#1)(1996-3#1)(2011-2#1)
of variation less than##4##4##(2008-10#3)(2011-2#1)
of variation of 1##2##4##(2008-10#2)
of variation of 5##2##4##(2008-10#2)
of variation of the##5##4##(1990-8#1)(2008-10#3)(2008-7#1)
of variation of##16##3##(1990-8#1)(1995-2#1)(1996-3#1)(2008-10#11)(2008-7#1)(2012-2#1)
of variation ranged from##2##4##(1990-11#1)(2008-10#1)
of variation was##3##3##(2008-10#2)(2008-3#1)
of variation were estimated##2##4##(2008-10#2)
of variation were##14##3##(1990-12#1)(1995-12#1)(2008-10#10)(2008-3#1)(2010-5#1)
of variation##129##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#1)(2007-5#1)(2008-1#1)(2008-10#50)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#2)(2009-10#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-2#7)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#2)
of variation)##3##2##(1991-5#1)(1995-2#1)(2008-8#1)
of variations in##5##3##(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#2)
of variations of##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
of variations##16##2##(1995-8#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-1#1)(2012-3#1)(2013-8#1)
of varicella and##2##3##(2008-4#2)
of varicella##8##2##(1997-5#1)(2008-12#2)(2008-4#2)(2008-7#1)(2009-5#1)(2010-8#1)
of varices##3##2##(2009-8#1)(2009-9#2)
of varicose veins##2##3##(2011-3#2)
of varicose##3##2##(1997-3#1)(2011-3#2)
of varied##6##2##(1994-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)
of varieties##2##2##(2008-12#1)(2009-6#1)
of various aspects##3##3##(1994-2#1)(2008-11#1)(2008-5#1)
of various base metals##2##4##(2008-10#2)
of various biomolecules##4##3##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
of various carbohydrates##2##3##(2008-10#2)
of various cations and anions##2##5##(2008-10#2)
of various cations and##3##4##(1997-7#1)(2008-10#2)
of various cations##4##3##(1997-7#1)(2008-10#3)
of various cell lines##2##4##(1993-3#1)(2008-11#1)
of various cell types##4##4##(1994-11#1)(2010-7#1)(2011-1#1)(2012-3#1)
of various cell##8##3##(1992-10#1)(1993-3#1)(1994-11#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
of various chemical modifiers##2##4##(2008-10#2)
of various combinations of##3##4##(1996-12#1)(2008-2#1)(2010-4#1)
of various components##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
of various compositions##2##3##(2008-10#2)
of various compounds##3##3##(2008-10#3)
of various concentrations of##4##4##(1992-5#1)(1992-8#1)(1996-5#1)(2008-12#1)
of various diseases##5##3##(1997-2#1)(2008-10#3)(2008-7#1)
of various drugs##2##3##(2008-2#1)(2010-12#1)
of various factors on##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
of various factors to##2##4##(2008-11#1)(2009-4#1)
of various factors##7##3##(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2013-8#1)
of various foreign##3##3##(2008-10#3)
of various forms of##2##4##(2008-5#1)(2013-8#1)
of various genomic##2##3##(2008-7#1)(2009-5#1)
of various health##2##3##(1996-1#1)(2013-7#1)
of various human##3##3##(1993-3#2)(2008-2#1)
of various ions##4##3##(2008-10#4)
of various kinds of##5##4##(1993-9#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-4#1)
of various kinds##6##3##(1993-9#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-6#1)
of various lengths##2##3##(1996-5#1)(2008-9#1)
of various metal ions##2##4##(2008-10#2)
of various metal##3##3##(2008-10#3)
of various methods##3##3##(2007-8#1)(2008-7#1)(2012-1#1)
of various molecular##2##3##(2008-10#1)(2013-1#1)
of various mutants##2##3##(1993-2#1)(1994-8#1)
of various organic##4##3##(2008-10#3)(2009-8#1)
of various organs##3##3##(1991-12#1)(1997-8#1)(2008-10#1)
of various origin##2##3##(2009-4#2)
of various parameters on##2##4##(2008-10#1)(2013-1#1)
of various parameters##9##3##(2008-10#6)(2008-5#1)(2008-7#1)(2013-1#1)
of various parts of the##2##5##(2008-10#1)(2009-9#1)
of various procedures##2##3##(2007-12#2)
of various proportions##2##3##(2008-10#2)
of various protein##2##3##(2008-2#1)(2010-12#1)
of various proteins##4##3##(1991-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
of various recombinant##2##3##(1994-8#1)(2008-11#1)
of various risk factors##2##4##(2008-7#1)(2011-1#1)
of various scattering media (aerosols##2##5##(2008-3#2)
of various sites##2##3##(1990-8#1)(2008-8#1)
of various size##2##3##(1993-9#1)(2008-1#1)
of various sizes and##2##4##(1997-3#1)(2013-1#1)
of various sizes##10##3##(1995-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
of various solvents##2##3##(2008-10#2)
of various species##3##3##(1991-12#1)(2008-10#1)(2008-8#1)
of various strains of##2##4##(1994-2#1)(2008-8#1)
of various techniques of spinal anesthesia in day##2##8##(2012-3#2)
of various techniques of##3##4##(2007-11#1)(2012-3#2)
of various techniques##6##3##(2007-11#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-3#2)
of various tissues##5##3##(1993-12#1)(1997-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
of various treatment##2##3##(2007-12#1)(2009-8#1)
of various types of cancer##2##5##(2008-8#1)(2013-8#1)
of various types of##15##4##(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#2)(2012-2#1)(2013-8#1)
of various types##18##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#2)(2012-2#1)(2013-8#1)
of various##487##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#9)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#4)(2006-10#2)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#111)(2008-11#25)(2008-12#5)(2008-2#19)(2008-3#29)(2008-4#14)(2008-5#23)(2008-6#3)(2008-7#19)(2008-8#11)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#9)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#7)
of varying composition##2##3##(1995-5#1)(2008-10#1)
of varying concentrations of##2##4##(2008-10#1)(2011-1#1)
of varying concentrations##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
of varying degrees of##2##4##(1991-6#1)(2008-7#1)
of varying lengths##2##3##(1995-6#1)(2008-11#1)
of varying severity##3##3##(1995-12#1)(2011-2#1)(2012-2#1)
of varying the##8##3##(1991-1#1)(2008-3#4)(2010-6#1)(2011-2#1)(2012-2#1)
of varying##65##2##(1990-9#1)(1991-1#1)(1991-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-11#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2012-4#1)(2013-8#1)
of varying-coefficient models##2##3##(1997-7#2)
of vas##2##2##(1997-8#1)(2010-4#1)
of vascular access in##3##4##(2007-7#3)
of vascular access##10##3##(2007-7#9)(2013-1#1)
of vascular anatomy##2##3##(2008-7#1)(2012-2#1)
of vascular and##2##3##(2011-2#1)(2013-1#1)
of vascular bundle implantation##2##4##(2009-3#2)
of vascular calcification##2##3##(2009-1#1)(2012-12#1)
of vascular complications in##3##4##(2008-1#3)
of vascular complications##5##3##(2008-1#3)(2011-2#2)
of vascular corrosion casts##3##4##(2011-2#3)
of vascular dementia##4##3##(1996-11#1)(2007-10#2)(2008-7#1)
of vascular disease##4##3##(1990-3#1)(1993-2#1)(1997-8#1)(2008-3#1)
of vascular diseases##5##3##(1991-11#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-4#1)
of vascular endothelial cells##5##4##(1996-12#3)(1997-1#1)(2008-3#1)
of vascular endothelial growth factor (VEGF) and##2##7##(2008-7#1)(2009-5#1)
of vascular endothelial growth factor (VEGF)##4##6##(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)
of vascular endothelial growth factor and its receptor##2##8##(2008-9#1)(2009-5#1)
of vascular endothelial growth factor##7##5##(2008-7#1)(2008-9#3)(2009-5#2)(2011-1#1)
of vascular endothelial##14##3##(1996-12#4)(1997-1#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-5#2)(2011-1#1)
of vascular endothelium##2##3##(1994-8#1)(2013-8#1)
of vascular function##2##3##(1993-6#1)(2013-8#1)
of vascular injury##8##3##(1992-12#2)(1994-5#1)(2007-10#4)(2013-1#1)
of vascular invasion##2##3##(1990-10#1)(2011-2#1)
of vascular pericytes##2##3##(1993-3#2)
of vascular permeability factor##3##4##(1991-2#1)(1991-9#2)
of vascular plants##3##3##(2008-9#2)(2009-8#1)
of vascular risk factors##2##4##(2007-10#1)(2008-7#1)
of vascular smooth muscle cells (VSMC)##2##6##(1990-12#1)(2008-1#1)
of vascular smooth muscle cells##5##5##(1990-12#2)(1992-8#1)(1994-11#1)(2008-1#1)
of vascular smooth muscle##10##4##(1990-12#3)(1990-8#2)(1992-8#1)(1994-11#2)(2008-1#1)(2010-12#1)
of vascular tissues##2##3##(1993-8#1)(2008-9#1)
of vascular tone##2##3##(2008-1#1)(2008-5#1)
of vascular wall##2##3##(2006-6#1)(2009-7#1)
of vascular##137##2##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-12#3)(1992-8#2)(1992-9#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#4)(1996-9#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-10#8)(2007-7#11)(2008-1#7)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#6)(2008-9#6)(2009-1#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#4)
of vasculitis and##2##3##(2010-6#1)(2011-2#1)
of vasculitis##7##2##(1997-8#1)(2007-10#1)(2008-1#2)(2008-3#1)(2010-6#1)(2011-2#1)
of vasoactive intestinal peptide##2##4##(1994-3#2)
of vasoactive intestinal##4##3##(1990-5#1)(1994-3#2)(2012-3#1)
of vasoactive##8##2##(1990-3#1)(1990-5#1)(1994-3#2)(1994-9#1)(1996-2#1)(2009-8#1)(2012-3#1)
of vasoconstrictor##2##2##(1991-3#1)(1993-1#1)
of vasodilator##2##2##(1996-6#1)(2008-3#1)
of vasodilators##3##2##(1995-11#1)(2008-3#2)
of vasodilatory##2##2##(1997-1#1)(2007-9#1)
of vasopressin and##2##3##(1992-5#1)(1994-9#1)
of vasopressin##11##2##(1992-5#2)(1994-2#1)(1994-9#2)(1995-12#1)(1997-4#2)(2007-9#1)(2013-1#2)
of vasopressin-containing cells##2##3##(1993-12#2)
of vasopressors##2##2##(2012-3#1)(2013-1#1)
of vasospasm##8##2##(1991-3#1)(1994-11#1)(1997-3#1)(2008-3#2)(2008-7#1)(2012-3#2)
of vast##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
of vector and##2##3##(1994-8#1)(2008-10#1)
of vector control##2##3##(2010-1#2)
of vector translation coefficients##2##4##(2008-2#2)
of vector transmission##2##3##(2008-10#2)
of vector##20##2##(1994-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-8#1)(2010-1#2)(2013-1#1)
of vector-borne##2##2##(2008-8#1)(2010-1#1)
of vectors carrying##3##3##(2008-10#1)(2008-11#2)
of vectors that##2##3##(1994-5#1)(2008-11#1)
of vectors##14##2##(1994-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#6)(2008-2#1)(2012-2#1)(2013-1#1)
of vegetable oils##6##3##(1990-8#1)(2008-10#1)(2012-2#1)(2013-1#3)
of vegetable##10##2##(1990-8#1)(1997-4#1)(2008-10#3)(2012-2#2)(2013-1#3)
of vegetables and##4##3##(2011-2#1)(2012-12#2)(2012-2#1)
of vegetables##9##2##(1992-12#1)(1992-8#1)(2008-10#3)(2011-2#1)(2012-12#2)(2012-2#1)
of vegetation and##2##3##(2008-3#1)(2008-9#1)
of vegetation heterogeneity##2##3##(2008-8#2)
of vegetation on##2##3##(2008-5#1)(2008-8#1)
of vegetation##15##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2013-7#1)(2013-8#3)
of vegetative and##2##3##(2009-10#1)(2010-9#1)
of vegetative compatibility groups##2##4##(2008-10#2)
of vegetative compatibility##3##3##(2008-10#3)
of vegetative##11##2##(1991-10#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-10#1)(2010-9#1)
of vehicle##6##2##(1994-8#1)(1995-3#1)(2008-9#3)(2011-2#1)
of vein formation##2##3##(2009-6#2)
of vein graft##2##3##(1996-2#1)(2011-3#1)
of vein##5##2##(1996-2#1)(2009-6#3)(2011-3#1)
of veins##3##2##(1991-9#1)(2008-7#1)(2009-6#1)
of velocity and##2##3##(2008-2#1)(2008-3#1)
of velocity##7##2##(2008-10#2)(2008-2#1)(2008-3#4)
of venous and arterial##2##4##(2008-10#1)(2011-3#1)
of venous blood##2##3##(2008-7#1)(2009-6#1)
of venous drainage##2##3##(2010-8#1)(2012-12#1)
of venous leg##2##3##(1990-6#1)(1997-3#1)
of venous stroke##3##3##(2007-10#3)
of venous thromboembolic disease in primary care]##2##7##(1996-3#1)(1996-9#1)
of venous thromboembolism in##3##4##(1993-5#1)(2010-11#2)
of venous thromboembolism prophylaxis##2##4##(2011-2#1)(2012-2#1)
of venous thromboembolism##13##3##(1993-5#2)(1996-11#2)(2007-10#1)(2010-11#3)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
of venous thrombosis##3##3##(1994-9#1)(1997-3#1)(2010-11#1)
of venous##44##2##(1990-3#2)(1990-6#2)(1992-5#1)(1993-5#2)(1994-9#1)(1996-11#2)(1996-3#1)(1996-9#1)(1997-3#2)(2007-10#4)(2007-7#2)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#4)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of ventilation##6##2##(1994-6#1)(1996-12#1)(1997-1#1)(2008-5#1)(2008-8#1)(2010-7#1)
of ventilator-assisted children##4##3##(2010-7#4)
of ventral##9##2##(1991-2#1)(1992-10#1)(1993-6#1)(2008-5#1)(2009-5#2)(2009-7#1)(2011-2#1)(2012-2#1)
of ventricle##2##2##(2007-8#1)(2011-2#1)
of ventricular activation time##2##4##(2008-7#2)
of ventricular arrhythmias##2##3##(2009-10#1)(2012-3#1)
of ventricular assist devices##2##4##(2010-6#2)
of ventricular fibrillation##2##3##(1995-12#1)(2010-1#1)
of ventricular tachycardia##3##3##(1995-12#1)(2009-10#1)(2009-4#1)
of ventricular##25##2##(1990-9#1)(1991-2#1)(1992-5#1)(1993-1#2)(1994-12#1)(1994-8#1)(1995-12#2)(1996-6#1)(2008-7#5)(2009-10#2)(2009-4#1)(2010-1#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-3#1)
of ventriculoperitoneal shunt##2##3##(2012-12#1)(2012-2#1)
of verapamil##4##2##(1990-3#1)(1991-8#1)(1994-8#1)(1995-11#1)
of verbal descriptors of dyspnea##2##5##(2008-10#2)
of verbal##11##2##(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-7#1)(2013-1#2)
of verbascoside##2##2##(2008-8#2)
of vertebra##2##2##(2007-11#2)
of vertebrae##4##2##(1994-12#1)(2007-11#2)(2008-4#1)
of vertebral artery dissection##2##4##(1991-8#1)(2011-2#1)
of vertebral artery##4##3##(1991-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
of vertebral body##7##3##(2007-8#5)(2008-6#1)(2008-7#1)
of vertebral fractures treatment##2##4##(2007-11#2)
of vertebral fractures##5##3##(2007-11#2)(2007-8#1)(2008-11#2)
of vertebral##27##2##(1991-8#1)(1993-2#1)(1995-3#1)(2007-11#5)(2007-8#9)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
of vertebrate##18##2##(1992-8#1)(1993-11#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of vertebrates and##2##3##(2008-7#2)
of vertebrates##10##2##(1993-2#1)(1995-11#1)(1996-5#1)(2008-7#3)(2009-5#1)(2010-3#2)(2010-5#1)
of vertebro- and kyphoplasty##2##4##(2007-8#2)
of vertebrobasilar##3##2##(1993-3#1)(2007-10#1)(2011-2#1)
of vertebroplasty##2##2##(2007-8#1)(2008-7#1)
of vertical profiles##2##3##(2008-3#2)
of vertical transmission of HBV from HBsAg-positive father to infant##2##10##(2011-1#2)
of vertical transmission of HBV##3##5##(2011-1#3)
of vertical transmission##4##3##(2011-1#3)(2011-3#1)
of vertical##16##2##(1996-3#1)(2008-3#7)(2008-7#1)(2008-8#1)(2011-1#3)(2011-3#2)(2013-1#1)
of vertical-cavity lasers##2##3##(2008-2#1)(2008-3#1)
of vertical-cavity surface-emitting laser##3##4##(2007-12#1)(2008-3#2)
of vertical-cavity surface-emitting lasers (VCSEL's)##2##5##(2008-3#2)
of vertical-cavity surface-emitting lasers##6##4##(2007-11#1)(2008-3#5)
of vertical-cavity surface-emitting##9##3##(2007-11#1)(2007-12#1)(2008-3#7)
of vertical-cavity##11##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)
of vertically##2##2##(2007-11#1)(2009-5#1)
of vertiginous##2##2##(2008-2#2)
of very early##2##3##(2008-11#1)(2009-11#1)
of very high molecular weight##2##5##(1991-12#1)(1991-2#1)
of very high##11##3##(1991-12#1)(1991-2#1)(1992-9#1)(1994-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2011-2#1)
of very large##3##3##(1994-12#1)(2007-11#1)(2008-3#1)
of very late##2##3##(1997-3#1)(2008-11#1)
of very low density lipoprotein##2##5##(1993-8#1)(2008-10#1)
of very low density lipoproteins##3##5##(1991-12#1)(1992-12#2)
of very low density##6##4##(1991-12#1)(1992-12#2)(1993-8#1)(2008-10#1)(2013-1#1)
of very low levels of##2##5##(1990-12#1)(2008-10#1)
of very low levels##3##4##(1990-12#1)(2008-10#2)
of very low##21##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-12#2)(1993-3#1)(1993-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#2)(2010-7#1)(2013-1#1)
of very small amounts of##2##5##(2008-10#1)(2008-9#1)
of very small##5##3##(1990-3#1)(1991-12#1)(2008-10#2)(2008-9#1)
of very thin##2##3##(2008-3#1)(2008-5#1)
of very weak##2##3##(2007-11#1)(2008-10#1)
of very##71##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1997-3#1)(2006-5#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#18)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2010-10#2)(2010-7#1)(2011-2#4)(2013-1#1)
of vesical##3##2##(1997-7#1)(2008-7#1)(2012-3#1)
of vesicle##6##2##(1997-2#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
of vesicles by##2##3##(1992-6#1)(2013-7#1)
of vesicles with##2##3##(1990-12#1)(1997-3#1)
of vesicles##17##2##(1990-12#1)(1990-2#1)(1992-6#2)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2012-2#1)(2013-7#1)
of vesico-ureteric##2##2##(2008-4#1)(2012-3#1)
of vesicoureteral reflux##6##3##(2007-9#1)(2008-1#1)(2008-10#4)
of vesicular intracellular##2##3##(1994-3#1)(1996-5#1)
of vesicular stomatitis virus##3##4##(1992-12#1)(1993-6#1)(1994-8#1)
of vesicular stomatitis##4##3##(1992-12#1)(1993-6#1)(1994-8#1)(2008-1#1)
of vesicular##10##2##(1992-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)
of vessel wall##3##3##(2008-7#1)(2009-10#1)(2013-1#1)
of vessel walls##2##3##(1994-9#1)(2008-11#1)
of vessel##11##2##(1994-9#2)(1995-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2013-1#1)
of vessels##12##2##(1990-8#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-7#1)(2012-3#1)(2013-8#2)
of vestibular stimulation##2##3##(1995-8#1)(1997-2#1)
of vestibular##5##2##(1991-2#1)(1995-8#1)(1997-2#1)(2010-11#1)(2012-3#1)
of veterinary##8##2##(1997-7#2)(2008-10#2)(2010-11#1)(2010-4#2)(2011-2#1)
of viability and##2##3##(2008-11#2)
of viability of##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
of viability##18##2##(1995-12#1)(1995-2#1)(2008-11#7)(2008-7#1)(2008-9#2)(2012-2#4)(2012-3#1)(2013-1#1)
of viable bacteria##2##3##(1995-2#1)(2008-9#1)
of viable cell concentration##2##4##(2008-11#1)(2008-7#1)
of viable cell##4##3##(2008-11#3)(2008-7#1)
of viable cells in##3##4##(2008-11#3)
of viable cells##13##3##(1994-2#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#1)(2008-9#2)(2010-4#1)(2012-2#1)
of viable sclerotia##2##3##(2008-10#2)
of viable spores##2##3##(2008-10#1)(2011-2#1)
of viable##46##2##(1993-3#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#8)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#8)(2010-4#1)(2011-2#1)(2012-2#2)
of vibration##4##2##(2008-3#4)
of vibrationally excited##2##3##(2008-3#2)
of vibrations on the##2##4##(2008-10#1)(2008-3#1)
of vibrations##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of vicarious##2##2##(1991-3#1)(2012-12#1)
of vice##2##2##(2011-2#1)(2012-3#1)
of victimization##5##2##(2008-10#1)(2008-12#1)(2009-7#1)(2012-12#2)
of victims##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
of video game play##2##4##(2013-1#2)
of video game##3##3##(2012-12#1)(2013-1#2)
of video##9##2##(1991-6#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#2)
of video-assisted thoracic surgery lobectomy##2##5##(2007-8#1)(2012-1#1)
of video-assisted thoracic surgery##5##4##(2007-8#4)(2012-1#1)
of video-assisted##6##2##(2007-8#5)(2012-1#1)
of videoconferencing##3##2##(2008-11#3)
of videotaped##2##2##(1993-2#1)(2008-8#1)
of videotapes##2##2##(1993-12#1)(1993-2#1)
of view and##11##3##(1992-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)
of view in##3##3##(2008-2#2)(2013-1#1)
of view is##6##3##(2007-11#1)(2008-3#4)(2010-4#1)
of view of a##2##4##(1992-3#1)(2007-11#1)
of view of the##8##4##(1992-11#1)(1992-3#1)(1994-2#1)(1995-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
of view of##32##3##(1990-3#1)(1991-2#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-3#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2013-8#2)
of view or from##2##4##(2008-11#1)(2008-3#1)
of view##166##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#14)(2008-3#38)(2008-5#1)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#7)(2013-8#6)
of viewing angles##2##3##(2008-2#1)(2008-3#1)
of viewing##5##2##(2008-2#2)(2008-3#3)
of views##4##2##(1994-1#1)(2008-12#1)(2008-3#1)(2013-1#1)
of vigabatrin in##2##3##(1992-3#2)
of vigabatrin##4##2##(1992-3#2)(2013-1#2)
of vigor##2##2##(2008-10#1)(2008-9#1)
of villous##2##2##(1990-10#1)(2013-1#1)
of vimentin##2##2##(2008-8#1)(2012-2#1)
of vincristine##2##2##(1990-11#1)(2012-2#1)
of vines infected with##2##4##(2008-10#2)
of vines infected##4##3##(2008-10#4)
of vines##7##2##(2008-10#7)
of vinorelbine##2##2##(1994-8#2)
of vinyl aziridines and aziridinylen-ynes##2##5##(2009-12#2)
of vinyl##5##2##(2008-10#1)(2008-5#1)(2009-12#2)(2009-5#1)
of violating the##3##3##(1993-6#1)(2008-7#2)
of violations of##3##3##(2010-5#1)(2013-1#1)(2013-8#1)
of violence and##3##3##(1991-12#1)(2013-1#1)(2013-8#1)
of violence in the##3##4##(1991-12#1)(2013-1#2)
of violence is##2##3##(1991-12#1)(2013-8#1)
of violence they##2##3##(2008-2#1)(2009-5#1)
of violence##25##2##(1991-12#3)(1995-2#1)(1996-6#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-9#2)(2009-5#2)(2009-9#1)(2012-12#1)(2013-1#6)(2013-8#2)
of violent incidents##2##3##(1993-12#1)(2012-3#1)
of violent##9##2##(1990-6#1)(1991-6#1)(1993-12#1)(1996-2#2)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of viraemia##2##2##(1991-3#1)(1994-5#1)
of viral DNA replication##2##4##(1995-6#1)(1997-3#1)
of viral DNA##6##3##(1993-8#1)(1994-8#1)(1995-6#1)(1997-3#1)(2009-11#1)(2011-2#1)
of viral RNA##10##3##(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-9#2)(2009-2#1)(2010-5#1)
of viral RNAs##3##3##(1997-3#1)(2008-9#2)
of viral and##4##3##(1992-3#1)(1995-2#1)(2008-11#2)
of viral coat protein##2##4##(2008-10#2)
of viral contamination##2##3##(1990-2#1)(2008-11#1)
of viral gene##2##3##(1997-4#1)(2008-8#1)
of viral genomes##2##3##(2008-11#1)(2008-9#1)
of viral hepatitis##3##3##(2006-10#1)(2007-7#1)(2008-7#1)
of viral infection and##3##4##(2008-11#1)(2008-9#2)
of viral infection##6##3##(2008-11#2)(2008-9#2)(2011-2#1)(2013-1#1)
of viral infections##5##3##(2007-12#1)(2008-11#1)(2008-5#1)(2010-5#1)(2013-1#1)
of viral mRNA##3##3##(1991-2#2)(1995-9#1)
of viral miRNAs##3##3##(2013-1#3)
of viral particles##2##3##(2008-4#1)(2011-3#1)
of viral populations##2##3##(2008-10#1)(2012-2#1)
of viral protein##3##3##(1992-12#1)(1994-8#1)(2011-2#1)
of viral quasispecies##4##3##(2013-8#4)
of viral replication##3##3##(1997-3#1)(2008-5#1)(2011-3#1)
of viral resistance##2##3##(2008-10#1)(2012-2#1)
of viral vectors##2##3##(2008-11#2)
of viral##113##2##(1990-2#1)(1990-5#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#12)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#11)(2009-11#1)(2009-2#1)(2009-5#1)(2010-5#3)(2011-1#1)(2011-2#6)(2011-3#2)(2012-2#5)(2013-1#7)(2013-8#5)
of viral-cellular interactions##2##3##(2006-10#1)(2008-9#1)
of virgin##3##2##(1991-12#1)(2012-2#1)(2013-1#1)
of virion sense##2##3##(2008-9#2)
of virion##4##2##(1991-6#1)(2008-10#1)(2008-9#2)
of viroid##2##2##(2008-10#1)(2008-9#1)
of virosomes##2##2##(1990-2#2)
of virtual reality##2##3##(2010-1#1)(2010-4#1)
of virtual##4##2##(2008-3#1)(2008-6#1)(2010-1#1)(2010-4#1)
of virtually all##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
of virtually any##2##3##(1997-7#1)(2011-2#1)
of virtually##5##2##(1996-12#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
of virulence among##3##3##(2008-10#2)(2008-11#1)
of virulence and##4##3##(2008-10#3)(2013-8#1)
of virulence by##2##3##(2008-10#1)(2009-8#1)
of virulence factors##5##3##(1995-8#1)(2008-10#1)(2009-2#2)(2009-8#1)
of virulence in the##2##4##(2008-10#2)
of virulence in##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of virulence is##2##3##(2008-10#2)
of virulence phenotypes##2##3##(2008-10#2)
of virulence were##3##3##(2008-10#3)
of virulence##45##2##(1995-8#1)(2007-10#1)(2008-10#30)(2008-11#2)(2008-8#4)(2009-2#2)(2009-8#3)(2013-1#1)(2013-8#1)
of virulent C##2##3##(1996-12#1)(2008-10#1)
of virulent and non-virulent##2##4##(2008-5#2)
of virulent##7##2##(1996-12#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-9#1)
of viruliferous aphids##2##3##(2008-10#2)
of viruliferous nematodes##2##3##(2008-10#2)
of viruliferous##7##2##(2008-10#7)
of virus accumulation##4##3##(2008-10#4)
of virus and##5##3##(1995-3#1)(2008-10#3)(2008-5#1)
of virus in the##2##4##(1995-5#1)(1997-4#1)
of virus in##7##3##(1995-5#2)(1997-4#1)(2008-10#4)
of virus infection##4##3##(2008-10#2)(2008-9#1)(2012-2#1)
of virus particle##2##3##(1997-3#1)(2011-2#1)
of virus particles##3##3##(1997-3#1)(2008-10#2)
of virus replication##2##3##(1994-11#2)
of virus structure##2##3##(2008-10#2)
of virus transmission##2##3##(2008-10#1)(2008-12#1)
of virus was##2##3##(2008-10#1)(2012-3#1)
of virus##74##2##(1990-11#1)(1990-6#1)(1994-11#3)(1994-8#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-6#2)(2007-10#2)(2007-2#1)(2008-10#36)(2008-11#3)(2008-12#2)(2008-4#4)(2008-5#3)(2008-9#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
of virus-infected cells##3##3##(1994-11#1)(1997-3#1)(2008-11#1)
of virus-infected##4##2##(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)
of virus-specific##2##2##(2008-10#1)(2010-5#1)
of virus-virus interactions##2##3##(1997-3#1)(2008-10#1)
of viruses in##2##3##(1994-8#1)(2008-10#1)
of viruses is##2##3##(1995-2#1)(2012-2#1)
of viruses##20##2##(1994-11#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-9#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#3)(2010-4#1)(2012-2#1)(2013-1#1)
of visceral fat##3##3##(2008-11#1)(2012-2#2)
of visceral larva migrans##2##4##(2012-2#2)
of visceral leishmaniasis in##4##4##(2007-12#2)(2008-7#1)(2012-2#1)
of visceral leishmaniasis##10##3##(1990-9#1)(2007-12#4)(2007-7#1)(2008-7#2)(2008-8#1)(2012-2#1)
of visceral##21##2##(1990-10#1)(1990-9#1)(1991-12#1)(1996-6#1)(1997-8#1)(2007-12#4)(2007-7#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-2#6)
of viscosity##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
of viscous##3##2##(1990-4#1)(2009-10#1)(2011-1#1)
of visibility##2##2##(2008-2#1)(2008-5#1)
of visible and near infrared reflectance##2##6##(2010-4#2)
of visible light##2##3##(1994-5#1)(2008-3#1)
of visible symptoms##2##3##(2008-10#2)
of visible##22##2##(1993-12#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#2)(2009-5#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-9#1)(2013-1#1)
of vision and##3##3##(1994-1#1)(2008-9#1)(2013-8#1)
of vision in##3##3##(1994-8#1)(2011-1#1)(2011-2#1)
of vision loss##3##3##(2008-1#1)(2011-1#2)
of vision##23##2##(1992-7#1)(1993-12#1)(1994-1#1)(1994-8#1)(1994-9#1)(1995-1#1)(2006-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#3)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
of visiting##3##2##(1990-9#1)(2008-12#1)(2012-2#1)
of visits and##2##3##(1992-6#1)(2008-11#1)
of visits to##3##3##(1990-9#1)(1992-5#1)(2008-7#1)
of visits##9##2##(1990-9#1)(1991-12#1)(1992-5#1)(1992-6#1)(1995-3#2)(2008-1#1)(2008-11#1)(2008-7#1)
of visual and##2##3##(2008-8#1)(2009-9#1)
of visual attention##3##3##(2008-11#1)(2008-9#1)(2010-5#1)
of visual cortex##4##3##(1994-8#1)(2007-8#1)(2008-11#1)(2012-2#1)
of visual cortical##2##3##(1991-5#1)(2009-10#1)
of visual function##4##3##(2011-7#1)(2013-1#3)
of visual hallucinations##2##3##(2011-2#1)(2013-8#1)
of visual loss##3##3##(2008-8#1)(2012-2#1)(2013-7#1)
of visual processing##2##3##(1995-5#1)(2012-2#1)
of visual stimuli##3##3##(2008-4#1)(2008-5#1)(2008-8#1)
of visual symptoms##2##3##(2008-10#2)
of visual##62##2##(1990-10#1)(1991-11#1)(1991-12#2)(1991-5#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#2)(2012-1#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#3)
of visualization##4##2##(2008-10#1)(2008-11#2)(2008-6#1)
of visualizing##2##2##(2008-10#1)(2012-2#1)
of visually##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
of vital importance##2##3##(1994-2#1)(2008-5#1)
of vital##16##2##(1993-2#1)(1994-2#1)(1994-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#3)(2010-6#1)(2011-2#1)(2012-12#2)(2013-8#1)
of vitamin A acetate for##3##5##(2008-11#3)
of vitamin A acetate##5##4##(2008-11#5)
of vitamin A and##2##4##(1993-3#1)(2011-2#1)
of vitamin A capsule##2##4##(2007-11#2)
of vitamin A deficiency##3##4##(1991-8#3)
of vitamin A##17##3##(1991-8#3)(1992-9#1)(1993-3#1)(1997-8#1)(2007-11#2)(2008-11#5)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)
of vitamin B(2)##2##3##(2008-10#2)
of vitamin B12 on##2##4##(1993-12#1)(2010-1#1)
of vitamin B12##9##3##(1990-3#1)(1992-9#1)(1993-12#4)(2010-1#3)
of vitamin B6##2##3##(2013-1#2)
of vitamin C and##2##4##(2008-5#1)(2010-11#1)
of vitamin C in##3##4##(2008-10#3)
of vitamin C supplementation on hepatic cytochrome P450##2##8##(1996-12#2)
of vitamin C supplementation on##3##5##(1996-12#2)(1997-3#1)
of vitamin C##23##3##(1992-9#4)(1996-12#2)(1997-3#1)(2008-10#6)(2008-12#1)(2008-5#3)(2010-11#1)(2011-1#4)(2012-2#1)
of vitamin D and##3##4##(2008-10#1)(2010-10#1)(2012-3#1)
of vitamin D deficiency##4##4##(2012-2#1)(2012-3#2)(2013-1#1)
of vitamin D status in##2##5##(2013-7#2)
of vitamin D through##2##4##(2008-7#1)(2012-3#1)
of vitamin D##34##3##(1991-11#1)(1992-1#3)(1994-3#2)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#4)(2010-10#1)(2011-1#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#2)
of vitamin D(2)##5##3##(2008-10#5)
of vitamin D(3)##3##3##(2008-10#2)(2012-12#1)
of vitamin E in##4##4##(1992-9#2)(1994-6#1)(2008-5#1)
of vitamin E on##3##4##(1990-2#1)(1993-6#1)(2011-1#1)
of vitamin E##19##3##(1990-2#2)(1990-8#1)(1992-9#4)(1993-6#3)(1994-5#2)(1994-6#1)(2008-5#2)(2010-12#1)(2011-1#2)(2013-1#1)
of vitamin E-modified dialyzers##4##4##(2007-7#2)(2008-1#2)
of vitamin E-modified##6##3##(2007-7#3)(2008-1#3)
of vitamin K(1)##3##3##(2008-10#3)
of vitamin K3##2##3##(1991-12#1)(2008-10#1)
of vitamin and mineral supplementation##2##5##(1990-3#2)
of vitamin and mineral##3##4##(1990-3#2)(2008-11#1)
of vitamin and##4##3##(1990-3#2)(2008-10#1)(2008-11#1)
of vitamin pills##3##3##(1996-8#1)(2008-10#2)
of vitamin##142##2##(1990-2#2)(1990-3#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#3)(1992-1#3)(1992-12#1)(1992-9#12)(1993-12#4)(1993-3#1)(1993-6#3)(1994-3#2)(1994-5#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#3)(2008-1#5)(2008-10#27)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#9)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#2)
of vitamins A and E##2##5##(2007-7#1)(2008-10#1)
of vitamins and amino acids##2##5##(2008-11#2)
of vitamins##16##2##(1992-9#5)(1997-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-8#1)(2010-1#1)(2013-1#1)
of vitellin##2##2##(2007-12#1)(2008-6#1)
of vitellogenesis the##2##3##(2007-12#2)
of vitellogenesis##4##2##(2007-12#2)(2008-12#1)(2008-7#1)
of vitellogenin##2##2##(2008-6#1)(2010-4#1)
of vitiligo##6##2##(2007-7#3)(2007-8#1)(2009-1#1)(2013-1#1)
of vitreous##6##2##(2008-3#2)(2008-5#3)(2011-2#1)
of vivax malaria##3##3##(2007-2#1)(2012-12#2)
of vocabulary and##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
of vocabulary##5##2##(2008-12#1)(2008-9#2)(2011-2#2)
of vocal folds##2##3##(2012-2#2)
of vocal##3##2##(2008-9#1)(2012-2#2)
of vocalization##2##2##(1994-8#1)(2010-2#1)
of vocational rehabilitation##2##3##(1992-3#1)(2009-10#1)
of vocational##3##2##(1992-3#1)(1996-8#1)(2009-10#1)
of voice##6##2##(2008-11#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
of voiding##2##2##(2008-10#1)(2012-3#1)
of volar##2##2##(2008-9#2)
of volatile and semivolatile pollutants in##2##6##(2008-10#2)
of volatile and semivolatile##3##4##(2008-10#3)
of volatile and##5##3##(2008-10#4)(2009-8#1)
of volatile chloro-organic compounds in##2##5##(2008-10#2)
of volatile compounds from##2##4##(2008-10#1)(2009-8#1)
of volatile compounds##6##3##(2008-10#4)(2009-8#1)(2011-10#1)
of volatile elements##2##3##(2008-10#2)
of volatile fatty acids##2##4##(2008-5#1)(2013-1#1)
of volatile fatty##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
of volatile oils##3##3##(2008-11#3)
of volatile organic compounds (VOCs)##3##5##(2008-10#3)
of volatile organic compounds in##2##5##(2008-10#1)(2008-11#1)
of volatile organic compounds##11##4##(1995-6#1)(2008-10#8)(2008-11#1)(2008-3#1)
of volatile organic##13##3##(1995-6#1)(2008-10#10)(2008-11#1)(2008-3#1)
of volatile##57##2##(1990-2#1)(1992-3#1)(1995-6#1)(1997-4#1)(2007-11#2)(2008-10#35)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2009-8#2)(2011-1#1)(2011-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
of volatiles from##3##3##(2008-10#2)(2013-8#1)
of volatiles##7##2##(2008-10#5)(2009-8#1)(2013-8#1)
of voles##2##2##(1996-6#1)(2012-1#1)
of volition##2##2##(1991-5#1)(2008-6#1)
of voltage and##2##3##(1992-11#1)(2013-8#1)
of voltage dependent##2##3##(1997-4#1)(2009-12#1)
of voltage##7##2##(1992-11#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-3#1)(2009-12#1)(2013-8#1)
of voltage-activated##2##2##(1993-12#1)(2008-8#1)
of voltage-dependent Ca2+ channels##3##4##(1995-12#1)(1996-5#1)(2008-8#1)
of voltage-dependent Cl(-)-channels of##2##4##(1993-3#2)
of voltage-dependent calcium channels##2##4##(1996-2#1)(2008-8#1)
of voltage-dependent##10##2##(1993-3#3)(1995-12#1)(1996-2#1)(1996-5#1)(2008-8#3)(2009-8#1)
of voltage-gated Ca2+##2##3##(1992-12#1)(2009-7#1)
of voltage-gated calcium channels##3##4##(2008-12#1)(2008-8#1)(2008-9#1)
of voltage-gated sodium channels##2##4##(2008-5#1)(2012-3#1)
of voltage-gated sodium##3##3##(2008-5#1)(2012-12#1)(2012-3#1)
of voltage-gated##10##2##(1992-12#1)(1994-5#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
of voltammetric##6##2##(2008-10#6)
of voltammetry##2##2##(2008-10#2)
of volume density and absolute volume of syncytiotrophoblast in resorption villi of##2##12##(2011-1#2)
of volume fraction##2##3##(2008-3#1)(2009-6#1)
of volume holograms in##2##4##(2008-2#1)(2008-3#1)
of volume holograms##5##3##(2008-2#1)(2008-3#4)
of volume holographic##4##3##(2008-2#2)(2008-3#2)
of volume rendering technique##2##4##(2007-11#2)
of volume##29##2##(2007-11#2)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#3)(2011-2#1)(2013-1#1)
of volumes##2##2##(2008-10#1)(2008-9#1)
of volumetric apparatus##2##3##(2008-10#2)
of volumetric##7##2##(1996-2#1)(2008-10#5)(2011-7#1)
of voluntary alcohol consumption##2##4##(1993-12#2)
of voluntary exercise on azoxymethane-induced hepatocarcinogenesis##2##6##(1992-3#2)
of voluntary organizations##2##3##(1996-2#2)
of voluntary##12##2##(1992-3#2)(1993-12#3)(1996-2#2)(2008-1#1)(2008-11#1)(2013-1#3)
of volunteer administrators##2##3##(1993-1#1)(1993-2#1)
of volunteer management##2##3##(1994-3#2)
of volunteer services##2##3##(1993-1#1)(1994-3#1)
of volunteer work##2##3##(1994-2#1)(1995-2#1)
of volunteer##20##2##(1992-12#1)(1992-3#2)(1993-1#3)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#8)(1995-2#1)(1996-12#1)(1997-2#1)
of volunteerism##2##2##(1992-3#1)(1993-2#1)
of volunteers and##2##3##(1992-3#1)(2008-7#1)
of volunteers are##2##3##(1993-2#1)(1994-2#1)
of volunteers##20##2##(1992-3#1)(1993-12#1)(1993-2#2)(1994-2#2)(1994-3#5)(1995-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
of vomiting##4##2##(2007-12#1)(2008-12#1)(2012-2#1)(2012-3#1)
of von Recklinghausen's disease##2##4##(1991-2#1)(1992-9#1)
of von Willebrand's disease##2##4##(1992-11#1)(2011-1#1)
of von Willebrand's##3##3##(1992-11#1)(2011-1#2)
of von##9##2##(1991-2#1)(1992-11#1)(1992-9#2)(1994-11#2)(2011-1#2)(2012-3#1)
of vowel-to-vowel coarticulation##2##3##(2013-8#2)
of vulnerability to##3##3##(1994-2#1)(2008-9#1)(2012-2#1)
of vulnerability##10##2##(1990-5#1)(1994-2#2)(2008-2#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#3)
of vulnerable plaques##3##3##(2008-10#2)(2008-7#1)
of vulnerable populations##3##3##(1995-2#1)(2009-7#1)(2012-2#1)
of vulnerable##11##2##(1995-2#1)(2008-10#5)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
of vulva##3##2##(1993-1#2)(2007-7#1)
of vulvar##3##2##(1990-10#1)(1993-9#2)
of w-3##2##2##(2008-9#2)
of wage##2##2##(1992-1#1)(1994-12#1)
of waist circumference##2##3##(1996-8#1)(2011-2#1)
of waist##3##2##(1996-8#1)(2011-2#2)
of waiting list data##2##4##(1991-11#1)(1993-2#1)
of waiting list##4##3##(1991-11#3)(1993-2#1)
of waiting lists##2##3##(1991-11#1)(1993-2#1)
of waiting##11##2##(1991-11#6)(1993-2#2)(1996-1#1)(1997-4#1)(2007-7#1)
of waking##3##2##(2007-8#2)(2013-8#1)
of walking ability##2##3##(1996-9#1)(2010-10#1)
of walking##8##2##(1993-12#2)(1995-2#1)(1996-9#1)(2007-11#1)(2009-4#1)(2010-10#1)(2013-8#1)
of wall appositions##2##3##(2008-10#2)
of wall tilt on the##2##5##(2007-11#2)
of wall##8##2##(2007-11#2)(2008-10#4)(2008-6#1)(2011-2#1)
of warfarin in##3##3##(1990-12#1)(2010-4#1)(2011-1#1)
of warfarin##10##2##(1990-12#4)(1990-9#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#1)
of warm##4##2##(1993-12#1)(1995-9#1)(2008-8#1)(2009-9#1)
of warmth##2##2##(2008-1#1)(2009-11#1)
of washed##5##2##(1994-9#1)(2008-10#1)(2008-4#1)(2008-8#2)
of washes##2##2##(1994-11#1)(2008-10#1)
of waste analysis##2##3##(2008-10#2)
of waste management##2##3##(1996-1#1)(2008-12#1)
of waste polymers##3##3##(2008-10#3)
of waste water##4##3##(2008-10#3)(2008-6#1)
of waste##17##2##(1996-1#1)(2008-10#13)(2008-12#1)(2008-6#1)(2011-2#1)
of wastewater treatment##2##3##(2008-10#2)
of wastewater##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
of water and the##2##4##(1990-8#1)(2008-10#1)
of water and wastewater##2##4##(2008-10#2)
of water and##21##3##(1990-5#1)(1990-8#1)(1993-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-3#4)(2008-4#1)(2008-8#1)(2009-10#1)
of water for the##2##4##(2008-10#1)(2008-7#1)
of water for##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
of water from the##2##4##(2008-10#1)(2008-3#1)
of water have been##3##4##(1992-9#1)(2008-10#1)(2012-5#1)
of water ice##3##3##(2008-3#3)
of water in the##5##4##(1990-7#1)(2008-10#3)(2011-1#1)
of water in##12##3##(1990-7#1)(1992-9#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
of water into the##2##4##(2008-3#1)(2009-11#1)
of water is##3##3##(2008-10#2)(2013-1#1)
of water levels##2##3##(1996-6#1)(2008-5#1)
of water molecules##9##3##(1995-11#1)(1997-2#1)(2008-10#5)(2008-2#1)(2010-12#1)
of water movement##2##3##(2007-12#1)(2008-10#1)
of water on##2##3##(1996-5#1)(2008-3#1)
of water quality##2##3##(2008-10#1)(2008-5#1)
of water salinity##2##3##(2008-10#1)(2013-7#1)
of water sample in the presence of 1% non-ionic surfactant##2##10##(2008-10#2)
of water sample##4##3##(2008-10#4)
of water samples and##3##4##(2008-10#3)
of water samples##13##3##(2008-10#12)(2008-11#1)
of water stress##3##3##(2008-12#2)(2009-8#1)
of water supply##2##3##(2008-11#1)(2011-2#1)
of water to##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
of water treatment##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
of water vapor in air##2##5##(2008-3#2)
of water vapor in the##2##5##(2008-3#2)
of water vapor in##5##4##(2008-3#5)
of water vapor##8##3##(2008-2#1)(2008-3#7)
of water##214##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#3)(1993-12#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#80)(2008-11#8)(2008-12#8)(2008-2#9)(2008-3#30)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2012-5#1)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#1)
of water-leaving radiance##3##3##(2008-2#2)(2008-3#1)
of water-leaving radiances##2##3##(2008-3#2)
of water-leaving reflectance##2##3##(2008-2#1)(2008-3#1)
of water-leaving##8##2##(2008-2#4)(2008-3#4)
of water-soluble organic##2##3##(2008-10#2)
of water-soluble vitamins excreted in##2##5##(2008-10#2)
of water-soluble vitamins##5##3##(2008-10#5)
of water-soluble##19##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-4#1)(2008-10#12)(2008-11#1)(2008-5#1)(2009-12#1)
of water-vapor measurements by##2##4##(2008-2#1)(2008-3#1)
of water-vapor##3##2##(2008-2#2)(2008-3#1)
of waterborne##4##2##(1996-6#1)(2007-10#1)(2010-4#2)
of watermelon seedlings##2##3##(2008-10#2)
of watermelon##6##2##(2008-10#6)
of waters##8##2##(2007-7#1)(2008-10#6)(2008-3#1)
of wave fronts of##2##4##(2007-11#1)(2008-3#1)
of wave fronts##3##3##(2007-11#1)(2008-3#2)
of wave propagation in##2##4##(2008-3#1)(2008-7#1)
of wave propagation##4##3##(2007-12#2)(2008-3#1)(2008-7#1)
of wave##11##2##(2007-11#2)(2007-12#3)(2008-3#5)(2008-7#1)
of wave-front distortions##2##3##(2008-3#2)
of wave-front##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
of waveforms##2##2##(2007-12#1)(2008-3#1)
of waveguide##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
of waveguides and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of waveguides##6##2##(2007-11#2)(2008-2#3)(2008-3#1)
of wavelength modulation##2##3##(2008-2#1)(2008-3#1)
of wavelength##27##2##(2007-11#3)(2007-12#2)(2008-10#3)(2008-2#6)(2008-3#11)(2013-1#2)
of wavelength-modulation##2##2##(2008-3#2)
of wavelengths in##2##3##(2007-11#1)(2008-3#1)
of wavelengths of##2##3##(2007-12#1)(2011-2#1)
of wavelengths##22##2##(2007-11#4)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#11)(2011-2#1)
of wavelet transform##3##3##(2008-10#1)(2008-3#2)
of wavelet##6##2##(2008-10#2)(2008-3#4)
of waves##4##2##(2007-11#2)(2008-3#2)
of wax and oil##3##4##(2008-5#3)
of wax##6##2##(2008-5#5)(2011-2#1)
of ways to##4##3##(1994-1#1)(2009-4#1)(2012-3#1)(2013-1#1)
of ways##20##2##(1992-12#1)(1992-3#2)(1994-1#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-3#2)(2013-1#1)
of weak acids in##3##4##(2008-10#3)
of weak acids##6##3##(2008-10#5)(2008-9#1)
of weak nucleophiles in high-performance liquid##2##6##(1990-8#2)
of weak##19##2##(1990-8#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-9#1)(2009-9#1)
of weaker##2##2##(1995-5#1)(2008-11#1)
of weakly absorbing##2##3##(2008-2#1)(2008-3#1)
of weakly##8##2##(1990-8#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
of weakness and##2##3##(2008-12#1)(2008-6#1)
of weakness##3##2##(2008-12#1)(2008-6#1)(2010-8#1)
of weaning##5##2##(1992-11#1)(1995-12#1)(2007-6#1)(2013-1#2)
of wear metals in##3##4##(2008-10#3)
of wear##10##2##(2008-10#3)(2008-8#6)(2012-12#1)
of weasel##2##2##(1994-8#2)
of weather conditions##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of weather variables##2##3##(2008-10#2)
of weather##9##2##(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)
of weathered##2##2##(2008-10#1)(2008-11#1)
of web##2##2##(2008-7#1)(2008-9#1)
of wedge##2##2##(1990-2#1)(2008-3#1)
of weed emergence##2##3##(2008-12#2)
of weed##4##2##(2008-10#1)(2008-12#3)
of weeds and##2##3##(2008-10#1)(2008-12#1)
of weeds##7##2##(2008-10#4)(2008-12#1)(2013-8#2)
of weekly##3##2##(1992-10#1)(1994-2#1)(2008-7#1)
of weeks##4##2##(1991-2#1)(1991-3#1)(2008-7#1)(2010-12#1)
of weevils##2##2##(2008-7#1)(2011-2#1)
of weight and##4##3##(1990-9#1)(1993-3#1)(2012-2#1)(2013-1#1)
of weight loss on##2##4##(2008-3#1)(2013-8#1)
of weight loss##4##3##(2008-3#3)(2013-8#1)
of weight was##2##3##(1993-3#1)(1996-8#1)
of weight were##2##3##(1991-2#1)(2013-7#1)
of weight##22##2##(1990-9#1)(1991-11#1)(1991-2#2)(1992-11#1)(1993-2#1)(1993-3#2)(1996-8#1)(2007-12#1)(2008-3#3)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of weight-for-height##2##2##(1991-12#2)
of weight-related words##2##3##(2007-12#2)
of weight-related##3##2##(2007-12#3)
of weighting##2##2##(1990-8#1)(2011-1#1)
of welfare##2##2##(1994-3#1)(1996-2#1)
of well characterized##2##3##(1992-6#1)(2008-11#1)
of well trained##2##3##(1993-11#1)(1994-8#1)
of well##11##2##(1992-6#1)(1993-11#1)(1994-8#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-7#1)(2010-3#1)(2011-2#1)
of well-being##9##2##(1995-2#1)(1996-11#1)(1996-7#2)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)
of well-characterized patients##2##3##(2010-5#1)(2012-3#1)
of well-characterized##4##2##(1995-5#1)(2008-3#1)(2010-5#1)(2012-3#1)
of well-child care##2##3##(1996-1#1)(2010-8#1)
of well-defined redox peaks##2##4##(2008-10#2)
of well-defined redox##4##3##(2008-10#4)
of well-defined##15##2##(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of well-differentiated##3##2##(2009-10#1)(2009-3#1)(2012-3#1)
of well-documented##3##2##(1993-11#1)(1996-4#1)(2008-4#1)
of wellbeing##3##2##(2008-10#2)(2008-7#1)
of wells##3##2##(2007-12#1)(2008-10#2)
of western white pine##4##4##(2008-10#4)
of western##15##2##(2007-12#1)(2007-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#3)
of wet##12##2##(1992-2#1)(1997-4#1)(2008-10#5)(2008-4#1)(2008-5#2)(2009-4#1)(2011-1#1)
of wetness or##2##3##(2008-10#2)
of wetness was##2##3##(2008-10#2)
of wetness##13##2##(2008-10#13)
of wetted and##2##3##(2008-10#1)(2008-3#1)
of wetting and drying##3##4##(2008-10#3)
of wetting##7##2##(2008-10#6)(2013-8#1)
of wh-questions in##2##3##(2011-1#2)
of wh-questions##4##2##(2011-1#4)
of what are##2##3##(1992-6#1)(2008-2#1)
of what can be##2##4##(2008-2#1)(2008-7#1)
of what can##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
of what constitutes a##2##4##(1992-9#1)(2010-10#1)
of what constitutes##3##3##(1992-9#1)(2010-10#1)(2013-1#1)
of what could##2##3##(2011-1#1)(2011-2#1)
of what has been##3##4##(1990-8#1)(2008-2#1)(2008-8#1)
of what is known about##2##5##(1992-1#1)(2008-11#1)
of what is##14##3##(1992-1#1)(1992-12#1)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-3#1)
of what may##2##3##(1995-11#1)(1995-6#1)
of what the##2##3##(1991-3#1)(2008-11#1)
of what was##2##3##(2008-6#1)(2012-2#1)
of what we believe##2##4##(2008-3#1)(2008-9#1)
of what we##6##3##(1991-12#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)
of what##67##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
of wheat (Triticum aestivum)##3##4##(2008-10#2)(2008-11#1)
of wheat (Triticum##4##3##(2008-10#3)(2008-11#1)
of wheat and barley##4##4##(2008-10#4)
of wheat and wild oats##2##5##(2008-10#2)
of wheat and##11##3##(2008-10#10)(2008-11#1)
of wheat are##2##3##(2008-10#2)
of wheat bugs##4##3##(2013-8#4)
of wheat by##2##3##(2008-10#2)
of wheat chromosomes##2##3##(2008-5#1)(2008-8#1)
of wheat germ agglutinin##2##4##(1991-12#1)(2008-7#1)
of wheat germ##3##3##(1991-12#1)(2008-7#1)(2008-9#1)
of wheat grown##3##3##(2008-10#2)(2008-12#1)
of wheat in the##2##4##(2008-10#1)(2011-2#1)
of wheat in##9##3##(2008-10#7)(2011-2#1)(2012-2#1)
of wheat is caused by the##2##6##(2008-10#2)
of wheat is caused by##4##5##(2008-10#4)
of wheat is##5##3##(2008-10#5)
of wheat leaf##2##3##(2008-10#2)
of wheat plants##2##3##(2008-12#2)
of wheat production##2##3##(2008-10#1)(2008-12#1)
of wheat seed germination##2##4##(2008-12#2)
of wheat seed##3##3##(2008-10#1)(2008-12#2)
of wheat streak mosaic virus (WSMV) has been##2##8##(2008-10#2)
of wheat stripe rust##3##4##(2008-10#3)
of wheat that is##2##4##(2008-10#2)
of wheat that##4##3##(2008-10#4)
of wheat to##3##3##(2008-10#2)(2010-6#1)
of wheat worldwide##3##3##(2008-10#2)(2011-10#1)
of wheat##151##2##(1991-12#1)(1992-12#1)(1997-8#1)(2008-10#115)(2008-11#2)(2008-12#11)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-6#1)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#4)
of wheatgrass chromosomes##2##3##(2008-8#2)
of wheelchair##4##2##(2013-1#4)
of wheeze##2##2##(1991-11#1)(2008-12#1)
of when to##2##3##(2008-4#1)(2010-4#1)
of when##4##2##(1997-8#1)(2008-2#1)(2008-4#1)(2010-4#1)
of where##6##2##(1996-1#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-2#1)
of whether a##2##3##(1991-3#1)(2008-3#1)
of whether an##2##3##(2008-5#1)(2011-2#1)
of whether it##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
of whether or not##2##4##(1994-2#1)(2008-12#1)
of whether the##19##3##(1991-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
of whether there##2##3##(2010-6#1)(2012-2#1)
of whether to##4##3##(1996-2#1)(1997-1#1)(2008-7#1)(2008-9#1)
of whether##65##2##(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of whey proteins##4##3##(2008-10#1)(2008-7#3)
of whey##6##2##(2008-10#2)(2008-7#4)
of which 12 presented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which 12##3##3##(1994-5#1)(2007-8#2)
of which 13 represented the best evidence##2##7##(2007-8#2)
of which 13##3##3##(2007-8#2)(2011-2#1)
of which 15##3##3##(1994-2#1)(2007-7#1)(2007-8#1)
of which 17##2##3##(2008-12#1)(2011-2#1)
of which 4##3##3##(2007-8#1)(2008-9#2)
of which 5##2##3##(2008-11#1)(2011-1#1)
of which 6 were##2##4##(2008-12#1)(2013-8#1)
of which 9##2##3##(1992-6#1)(2008-12#1)
of which a##5##3##(1993-8#1)(2007-12#1)(2008-3#2)(2013-8#1)
of which also controlled resistance to isolate MG96-36##2##8##(2008-10#2)
of which also##7##3##(2007-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2013-8#1)
of which are described##4##4##(1996-2#1)(2008-4#1)(2008-9#1)(2011-1#1)
of which are difficult to##2##5##(2010-3#1)(2012-2#1)
of which are highly##2##4##(2008-10#1)(2010-12#1)
of which are in the##2##5##(2008-10#1)(2008-11#1)
of which are in##5##4##(1990-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
of which are known##2##4##(1992-5#1)(1994-10#1)
of which are regulated##2##4##(1995-2#1)(2013-1#1)
of which are used##2##4##(2007-12#1)(2010-7#1)
of which are##74##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#3)(2008-8#3)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
of which belonged to##2##4##(2008-5#1)(2012-3#1)
of which can be prevented##2##5##(2008-7#1)(2013-1#1)
of which can be##9##4##(1993-3#1)(1993-9#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-1#1)
of which can##13##3##(1993-3#1)(1993-9#2)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2013-1#1)
of which contain##3##3##(1994-9#1)(2008-10#2)
of which contained##4##3##(1992-2#1)(2008-10#1)(2010-10#1)(2012-2#1)
of which contains##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
of which contribute##2##3##(2008-10#1)(2008-8#1)
of which correspond to##4##4##(1995-9#3)(1996-3#1)
of which could be##2##4##(2007-11#1)(2008-10#1)
of which could##3##3##(2007-11#1)(2007-4#1)(2008-10#1)
of which depend##2##3##(1994-2#1)(2008-2#1)
of which depends on##2##4##(2007-12#1)(2008-3#1)
of which did not##2##4##(2009-12#1)(2010-1#1)
of which encode proteins##2##4##(1993-12#1)(1996-3#1)
of which encode##4##3##(1993-12#1)(1995-11#1)(1996-2#1)(1996-3#1)
of which express##2##3##(1993-8#1)(1994-12#1)
of which form##2##3##(2008-9#1)(2010-3#1)
of which had not been##2##5##(1995-6#1)(2008-10#1)
of which had##10##3##(1994-2#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
of which has a##2##4##(1995-8#1)(1997-2#1)
of which has the##2##4##(2008-11#1)(2008-3#1)
of which has##8##3##(1990-11#1)(1991-2#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-3#1)(2009-3#1)
of which have been shown to##2##6##(2008-8#2)
of which have been##8##4##(1992-5#1)(1992-9#1)(1993-11#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-8#2)
of which have##20##3##(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2011-10#1)(2011-2#1)(2012-12#1)
of which in the##2##4##(2008-10#2)
of which in##3##3##(2008-10#2)(2011-3#1)
of which include##2##3##(2008-5#1)(2008-9#1)
of which includes##2##3##(2008-10#1)(2008-12#1)
of which is a##2##4##(1992-12#1)(2009-8#1)
of which is based on##2##5##(2008-3#1)(2012-2#1)
of which is dependent on##2##5##(1990-11#1)(2008-8#1)
of which is largely unknown##2##5##(2008-11#1)(2008-4#1)
of which is not##2##4##(1992-4#1)(2008-10#1)
of which is the##4##4##(1991-9#1)(1997-1#1)(2008-5#1)(2009-7#1)
of which is to##3##4##(1993-6#1)(1994-12#1)(2012-3#1)
of which is unknown##2##4##(2007-11#1)(2008-7#1)
of which is##70##3##(1990-11#2)(1990-5#1)(1991-12#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(2007-11#4)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of which it##2##3##(2007-11#1)(2008-1#1)
of which may be##4##4##(1994-2#1)(2008-10#1)(2008-7#1)(2010-11#1)
of which may##11##3##(1990-5#1)(1994-2#1)(1996-6#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)
of which must be##2##4##(1991-11#1)(2008-9#1)
of which occurs##2##3##(1993-2#1)(1995-6#1)
of which one##3##3##(1993-5#1)(2008-10#2)
of which only about##2##4##(2007-5#1)(2008-10#1)
of which only four##2##4##(2010-1#1)(2011-1#1)
of which only##7##3##(1990-11#1)(2007-5#1)(2008-10#1)(2009-6#1)(2010-1#1)(2011-1#1)(2012-2#1)
of which play a role in##2##6##(2008-3#1)(2010-7#1)
of which remains##2##3##(1997-7#1)(2008-7#1)
of which require##2##3##(2008-11#1)(2008-4#1)
of which result in##2##4##(1994-11#1)(2009-10#1)
of which result##3##3##(1994-11#1)(2009-10#1)(2011-1#1)
of which resulted in##2##4##(1995-11#1)(2012-3#1)
of which serves as a##2##5##(2008-10#2)
of which seven##2##3##(2007-8#1)(2008-4#1)
of which showed##7##3##(1990-11#1)(1991-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(2007-7#1)(2011-2#1)
of which the first##2##4##(1994-12#1)(1996-6#1)
of which the##23##3##(1992-2#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#2)(2009-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
of which they##3##3##(1992-6#1)(1997-5#1)(2013-1#1)
of which three##2##3##(2007-8#1)(2008-10#1)
of which two##3##3##(2007-8#1)(2008-10#1)(2010-2#1)
of which was greater##2##4##(1991-12#1)(2008-10#1)
of which was##20##3##(1991-12#2)(1991-5#1)(1991-9#1)(1992-1#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)
of which we are aware##2##5##(1995-8#1)(2007-12#1)
of which we##3##3##(1995-8#1)(2007-12#1)(2010-12#1)
of which were in##3##4##(1990-11#1)(2008-7#1)(2011-2#1)
of which were measured##2##4##(1995-12#1)(2008-3#1)
of which were related to##2##5##(2007-8#1)(2008-3#1)
of which were used##2##4##(1995-2#1)(2012-2#1)
of which were##53##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-8#1)(1994-12#2)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
of which will##3##3##(1996-1#1)(2006-10#1)(2008-5#1)
of which##650##2##(1990-11#6)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#12)(1994-2#9)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#6)(1995-9#3)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#6)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#14)(2007-12#13)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#13)(2008-1#6)(2008-10#78)(2008-11#25)(2008-12#13)(2008-2#6)(2008-3#24)(2008-4#18)(2008-5#20)(2008-6#1)(2008-7#22)(2008-8#20)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#19)(2011-3#4)(2012-12#7)(2012-2#13)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#11)
of whirlpools##3##2##(1992-11#3)
of whistleblowing##3##2##(2011-1#3)
of white blood cells##2##4##(2008-9#1)(2012-2#1)
of white blood##3##3##(2008-9#1)(2010-12#1)(2012-2#1)
of white fir trees##2##4##(2008-10#2)
of white light##3##3##(2007-12#2)(2008-2#1)
of white matter##5##3##(1991-12#1)(2010-12#2)(2011-1#1)(2013-1#1)
of white pine blister rust##4##5##(2008-10#4)
of white spot lesion formation##2##5##(2009-7#2)
of white spot##3##3##(2009-7#3)
of white wines##2##3##(2008-10#2)
of white##40##2##(1991-11#1)(1991-12#1)(1996-2#1)(2007-12#2)(2008-10#15)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#4)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of white-light##3##2##(2007-11#2)(2008-2#1)
of whiteflies##2##2##(2008-10#1)(2011-2#1)
of who##2##2##(1995-5#1)(2010-12#1)
of whole blood##8##3##(1990-2#1)(1996-2#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
of whole body##2##3##(1996-5#1)(2008-5#1)
of whole cells##2##3##(2008-10#1)(2008-9#1)
of whole genome##2##3##(2008-10#1)(2009-10#1)
of whole grains##2##3##(2010-1#1)(2012-1#1)
of whole plasma##2##3##(2008-10#1)(2008-3#1)
of whole##42##2##(1990-2#1)(1993-8#1)(1994-8#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-6#1)(2007-9#1)(2008-10#9)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-7#1)(2012-1#1)(2013-1#2)(2013-8#3)
of whole-body##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
of whole-cell##2##2##(2008-8#1)(2011-3#1)
of whole-genome##4##2##(2008-4#1)(2008-7#2)(2012-3#1)
of whom 1##3##3##(2010-8#1)(2011-2#1)(2012-1#1)
of whom are##5##3##(1990-6#1)(1993-6#1)(2009-5#1)(2012-12#1)(2012-3#1)
of whom became##2##3##(1991-11#1)(1996-7#1)
of whom had##12##3##(1991-11#1)(1991-6#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#2)(2011-2#1)
of whom have##2##3##(1997-2#1)(2013-1#1)
of whom sustained##2##3##(2007-7#1)(2013-1#1)
of whom underwent##2##3##(2008-11#1)(2011-2#1)
of whom were##14##3##(1990-5#1)(1991-3#1)(1993-2#1)(1995-11#1)(1996-6#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#2)
of whom##81##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#3)(1995-11#1)(1995-6#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#3)(2007-1#1)(2007-7#3)(2008-1#6)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#4)
of whooping cough##2##3##(1997-8#1)(2008-8#1)
of whose##3##2##(1994-12#1)(2007-10#1)(2007-12#1)
of why the##3##3##(1992-9#1)(2008-11#1)(2008-9#1)
of why##9##2##(1992-9#1)(1993-1#1)(1995-8#1)(1997-3#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)
of wide local excision##2##4##(1990-2#1)(2008-6#1)
of wide##12##2##(1990-2#1)(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-3#1)
of widely##5##2##(1996-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#1)
of wider##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
of widespread##10##2##(1991-5#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
of width##2##2##(2007-11#1)(2008-10#1)
of wigs##3##2##(2012-3#3)
of wild and cultivated##2##4##(2008-10#1)(2013-8#1)
of wild and##4##3##(2008-10#1)(2009-2#1)(2013-1#1)(2013-8#1)
of wild animals and##2##4##(2013-7#2)
of wild birds##2##3##(2007-2#1)(2011-2#1)
of wild type##12##3##(1993-11#1)(1997-3#3)(1997-7#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2013-1#1)
of wild##36##2##(1993-11#1)(1995-2#1)(1995-9#1)(1997-3#3)(1997-7#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
of wild-caught##2##2##(2008-8#1)(2009-5#1)
of wild-type CN##2##3##(2008-9#2)
of wild-type TRbeta1##2##3##(1995-8#2)
of wild-type and mutant proteins##2##5##(1990-8#1)(1991-6#1)
of wild-type and mutant##5##4##(1990-8#1)(1991-6#1)(1992-4#1)(2008-7#2)
of wild-type and##6##3##(1990-8#1)(1991-6#1)(1992-4#1)(1995-2#1)(2008-7#2)
of wild-type##42##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-5#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
of wildlife##7##2##(1990-3#1)(2008-12#1)(2008-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
of wilt symptoms##2##3##(2008-10#2)
of wilt##5##2##(2008-10#5)
of wilting##3##2##(2008-10#2)(2008-12#1)
of wind speed##2##3##(2008-3#2)
of wind##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
of wind-dispersed ascospores##2##3##(2008-10#2)
of windows##2##2##(2008-3#1)(2008-6#1)
of wine samples##2##3##(2008-10#2)
of wine yeast##2##3##(2012-3#2)
of wine##15##2##(2008-10#11)(2008-7#2)(2012-3#2)
of wines and##2##3##(2008-10#2)
of wines##6##2##(2008-10#6)
of winning##2##2##(1996-3#1)(2009-9#1)
of winter barley##4##3##(2008-10#2)(2008-11#2)
of winter wheat (Triticum aestivum)##2##5##(2008-10#1)(2008-12#1)
of winter wheat##7##3##(2008-10#5)(2008-12#2)
of winter##15##2##(2008-10#8)(2008-11#2)(2008-12#2)(2010-8#1)(2012-4#1)(2013-7#1)
of wire##7##2##(2007-8#6)(2011-2#1)
of wired sternotomy closures##2##4##(2007-8#2)
of wireless##3##2##(2008-10#1)(2008-7#1)(2010-8#1)
of witches'-broom##2##2##(2008-10#2)
of withdrawal of##2##3##(1992-3#1)(2010-11#1)
of withdrawal##10##2##(1991-12#1)(1992-11#1)(1992-3#2)(1995-12#2)(1996-7#1)(2010-11#1)(2011-2#2)
of withdrawing##2##2##(2007-10#1)(2008-3#1)
of within-field##3##2##(2008-10#3)
of wobbly possum disease in##2##5##(1997-8#2)
of wolfberry fruit##2##3##(2013-8#2)
of women affected by##2##4##(1991-2#1)(2011-2#1)
of women aged##6##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-1#1)(1996-6#1)(2008-5#1)
of women and children in##2##5##(1990-2#1)(2009-9#1)
of women and children##3##4##(1990-2#2)(2009-9#1)
of women and men aged 40-42##2##6##(1991-6#2)
of women and##16##3##(1990-2#2)(1991-6#3)(1995-6#1)(1996-12#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-9#1)(2012-3#1)(2013-1#1)
of women as##2##3##(1991-6#1)(2008-3#1)
of women from different ethnic groups##2##6##(2008-5#2)
of women from different ethnic##3##5##(2008-5#3)
of women had##3##3##(1990-6#1)(2008-3#1)(2011-2#1)
of women in the##7##4##(1993-6#2)(1996-9#1)(2007-2#1)(2008-1#1)(2010-3#1)(2013-1#1)
of women in this##2##4##(2012-3#1)(2013-1#1)
of women in##16##3##(1992-12#1)(1993-6#4)(1994-2#1)(1996-9#1)(2007-2#1)(2008-1#1)(2009-10#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
of women of childbearing age##2##5##(2010-4#1)(2013-1#1)
of women of##4##3##(1992-9#1)(1996-12#1)(2010-4#1)(2013-1#1)
of women on the##2##4##(2008-2#1)(2011-1#1)
of women on##3##3##(2008-2#1)(2011-1#2)
of women regarding##2##3##(1990-8#1)(1997-3#1)
of women reporting cervical##2##4##(1990-12#2)
of women residing in two regions of##2##7##(2007-8#2)
of women to##5##3##(1996-11#1)(2007-8#1)(2008-1#1)(2013-1#2)
of women treated##3##3##(1992-3#1)(1993-2#1)(1994-12#1)
of women undergoing##4##3##(1994-9#1)(1995-12#1)(2008-4#1)(2008-7#1)
of women was##2##3##(2008-12#1)(2010-3#1)
of women who##11##3##(1991-6#1)(1992-2#1)(1996-12#1)(2008-2#1)(2009-9#1)(2011-2#3)(2013-1#3)
of women with advanced##2##4##(1992-2#1)(1992-5#1)
of women with breast##2##4##(2008-10#1)(2012-2#1)
of women with epilepsy##2##4##(2008-11#1)(2013-8#1)
of women with##20##3##(1990-9#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-8#1)(1995-11#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
of women working in##2##4##(2009-7#1)(2013-1#1)
of women##168##2##(1990-12#3)(1990-2#4)(1990-6#3)(1990-8#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#6)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-9#2)(1993-2#1)(1993-6#7)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-6#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-12#2)(2007-2#3)(2007-4#2)(2007-8#5)(2008-1#6)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-3#3)(2010-4#1)(2011-1#4)(2011-2#10)(2012-2#2)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#2)
of women's experiences##2##3##(2012-1#1)(2013-8#1)
of women's health##5##3##(1994-3#2)(1996-3#1)(1997-4#1)(2010-6#1)
of women's##20##2##(1991-6#3)(1994-3#2)(1996-1#1)(1996-3#2)(1997-4#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
of wood and##2##3##(1992-10#1)(2008-10#1)
of wood is##2##3##(2010-4#1)(2013-1#1)
of wood that##2##3##(2012-12#1)(2013-1#1)
of wood##13##2##(1992-10#1)(1997-6#1)(2008-10#4)(2008-12#1)(2010-4#3)(2012-12#1)(2013-1#2)
of wood-rotting##2##2##(2008-10#2)
of wooden artifacts##2##3##(2008-2#2)
of wooden##4##2##(2008-10#2)(2008-2#2)
of woody plants##3##3##(2008-10#2)(2008-9#1)
of woody##6##2##(2008-10#4)(2008-9#1)(2012-6#1)
of wool##2##2##(2008-10#1)(2008-5#1)
of word##9##2##(2008-11#5)(2009-2#2)(2012-3#1)(2013-8#1)
of words##15##2##(1990-8#2)(1991-2#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-11#2)(2009-8#1)(2010-7#1)(2012-3#2)(2013-8#2)
of work and##4##3##(1993-3#1)(2007-12#1)(2008-11#1)(2011-2#1)
of work in##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
of work of adhesion##2##4##(2008-7#2)
of work of##3##3##(2008-11#1)(2008-7#2)
of work on##2##3##(1991-1#1)(2006-12#1)
of work##53##2##(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#4)(1994-11#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2013-1#8)
of worker##6##2##(1997-3#1)(2008-11#1)(2008-8#2)(2011-1#1)(2013-1#1)
of workers and##3##3##(2008-5#1)(2009-12#1)(2013-1#1)
of workers who lost their job in the city of Medellin##2##11##(2013-1#2)
of workers##18##2##(1994-5#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#3)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
of workers' health##2##3##(2011-2#1)(2013-1#1)
of workers'##3##2##(1995-2#1)(2011-2#1)(2013-1#1)
of working conditions##2##3##(2008-10#1)(2012-12#1)
of working day losses##2##4##(2011-1#2)
of working electrode##4##3##(2008-10#4)
of working in a##2##4##(2008-11#2)
of working in##5##3##(1997-4#1)(2008-11#2)(2008-2#1)(2011-1#1)
of working life##4##3##(1992-3#1)(2008-11#2)(2008-9#1)
of working memory functions##2##4##(1994-8#1)(2012-3#1)
of working memory##7##3##(1992-10#1)(1993-3#1)(1994-8#1)(2007-8#1)(2008-8#1)(2012-3#2)
of working##52##2##(1990-11#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-8#2)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
of workload##3##2##(1996-1#1)(2011-2#2)
of workplace conversations##2##3##(2011-1#2)
of workplace violence##5##3##(1996-12#1)(1996-2#1)(1997-2#1)(2008-7#2)
of workplace##12##2##(1996-12#1)(1996-2#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-1#3)(2012-12#1)
of workshops##3##2##(2007-8#1)(2008-12#1)(2008-5#1)
of world##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
of worldwide##5##2##(1994-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
of worm##3##2##(1996-12#3)
of worsening##5##2##(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
of worship##2##2##(2010-10#2)
of wound dressing##3##3##(2011-2#3)
of wound healing##6##3##(1990-9#1)(1995-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
of wound infections##3##3##(1990-3#1)(2007-8#1)(2012-2#1)
of wound##22##2##(1990-3#2)(1990-9#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#5)(2012-2#1)
of wounded##3##2##(2008-10#3)
of wounds in##2##3##(2008-11#1)(2008-5#1)
of wounds to##2##3##(2011-2#1)(2012-3#1)
of wounds##12##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
of wrinkle detection##2##3##(2008-5#2)
of wrinkles##10##2##(1991-6#1)(2008-5#8)(2011-2#1)
of wrist joint##2##3##(2012-1#2)
of wrist pain##3##3##(2008-9#2)(2012-3#1)
of wrist##6##2##(2008-10#1)(2008-9#2)(2012-1#2)(2012-3#1)
of writing an abstract##2##4##(2008-12#1)(2011-2#1)
of writing##8##2##(1992-9#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#2)
of written##8##2##(1995-2#1)(1996-1#1)(2007-2#1)(2007-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2013-8#1)
of wt-p53##2##2##(1993-11#2)
of x rays in##3##4##(2008-3#3)
of x rays##6##3##(2007-11#1)(2008-3#5)
of x##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
of x-ray##9##2##(2007-11#4)(2007-8#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-2#1)
of x-rays##5##2##(2007-11#1)(2008-9#1)(2013-1#3)
of xanthine oxidase##2##3##(1991-9#1)(1996-9#1)
of xanthine##6##2##(1991-9#4)(1996-9#1)(1997-3#1)
of xanthogranulomatous##2##2##(1991-8#1)(2013-1#1)
of xanthophores##2##2##(2008-5#2)
of xenobiotic##2##2##(1993-11#1)(2008-6#1)
of xenobiotics and##2##3##(2008-12#1)(2010-11#1)
of xenobiotics in the##4##4##(1990-6#1)(2008-10#1)(2008-11#2)
of xenobiotics##11##2##(1990-6#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2010-11#1)
of xenogeneic##4##2##(2011-2#2)(2012-3#1)(2013-7#1)
of xenon##2##2##(2010-12#2)
of xerosis##2##2##(2008-5#2)
of xerotic##2##2##(2008-5#2)
of xinfeng capsule on##2##4##(2013-1#1)(2013-8#1)
of xylan hydrolysis in co- and countercurrent##2##7##(2013-1#2)
of xylan##5##2##(2008-8#1)(2013-1#4)
of xylanase##6##2##(1993-3#2)(2008-6#4)
of xylem and phloem##2##4##(2008-10#1)(2012-8#1)
of xylem cavitation caused by pine wilt disease##2##8##(2008-10#2)
of xylem parenchyma cells##2##4##(2008-10#1)(2008-11#1)
of xylem##9##2##(2008-10#7)(2008-11#1)(2012-8#1)
of xylenol orange##2##3##(2008-10#2)
of xylitol##3##2##(2008-6#3)
of xylose##7##2##(2008-10#1)(2008-6#6)
of xylose-fermenting Zymomonas mobilis##2##4##(2008-6#2)
of yak meat##2##3##(2010-4#2)
of yak##3##2##(2010-4#3)
of year##6##2##(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)
of years in##2##3##(1993-12#1)(2009-1#1)
of years of##4##3##(1991-12#1)(1993-12#2)(2011-2#1)
of years##21##2##(1991-12#2)(1992-1#1)(1992-12#1)(1993-12#3)(1993-3#1)(1995-8#1)(1996-11#1)(1996-9#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-1#1)(2011-2#2)
of yeast cells##6##3##(1991-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)
of yeast chromosome XIV##2##4##(1995-9#1)(1996-3#1)
of yeast chromosome##5##3##(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#2)
of yeast extract##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
of yeast in##2##3##(1995-9#1)(2008-8#1)
of yeast strains##4##3##(1992-10#1)(2008-10#1)(2008-8#1)(2009-12#1)
of yeast tRNA(Ala)##2##3##(2008-8#2)
of yeast tRNA(phe)##2##3##(1993-3#2)
of yeast to##2##3##(2008-12#1)(2011-1#1)
of yeast##78##2##(1990-11#2)(1990-7#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-3#2)(1993-9#2)(1994-6#2)(1995-2#1)(1995-6#4)(1995-9#5)(1996-3#2)(1996-6#2)(1997-3#2)(1997-4#2)(1997-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#9)(2009-12#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#2)
of yeasts##9##2##(1997-4#1)(2008-5#5)(2008-9#2)(2011-2#1)
of yellow gene##3##3##(2008-8#3)
of yellow oleander##2##3##(2008-12#2)
of yellow pages##2##3##(1993-12#1)(1997-1#1)
of yellow rust##2##3##(2008-10#2)
of yellow##13##2##(1993-12#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-12#2)(2008-8#3)
of yellowish##2##2##(1993-3#1)(2008-5#1)
of yet##2##2##(2008-1#1)(2008-10#1)
of yield losses##2##3##(2008-10#2)
of yield strength##2##3##(2009-11#1)(2009-7#1)
of yield##9##2##(2008-10#6)(2008-4#1)(2009-11#1)(2009-7#1)
of yielding##2##2##(2009-7#1)(2010-4#1)
of yolk DNA##2##3##(2008-4#2)
of yolk##4##2##(2008-4#2)(2008-6#1)(2010-5#1)
of young adults##12##3##(1991-1#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
of young and aged rats were##2##6##(1990-5#1)(1990-7#1)
of young and aged##3##4##(1990-5#1)(1990-7#1)(2008-5#1)
of young and old rats##3##5##(1994-6#1)(2008-7#1)(2009-12#1)
of young and old##4##4##(1990-3#1)(1994-6#1)(2008-7#1)(2009-12#1)
of young and##11##3##(1990-3#1)(1990-5#1)(1990-7#1)(1994-5#1)(1994-6#1)(1997-9#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
of young children##10##3##(1994-11#1)(1994-3#1)(1995-2#1)(1996-3#1)(2008-6#1)(2008-9#4)(2009-9#1)
of young individuals##2##3##(1993-1#1)(2008-9#1)
of young male offspring of rat dams with diabetes induced by streptozotocin##2##12##(2012-3#2)
of young males##3##3##(1991-6#1)(1996-6#1)(2009-5#1)
of young men##2##3##(1997-2#1)(2009-5#1)
of young people who##2##4##(2011-1#1)(2012-2#1)
of young people##6##3##(2008-11#1)(2008-7#1)(2011-1#2)(2012-2#2)
of young pigs##2##3##(2013-1#1)(2013-8#1)
of young rats##3##3##(1990-5#1)(1996-5#2)
of young urologists##2##3##(2011-2#2)
of young women##6##3##(1991-6#1)(1996-12#1)(1997-7#1)(2007-12#1)(2009-10#1)(2010-9#1)
of young##104##2##(1990-3#2)(1990-5#3)(1990-7#1)(1991-1#1)(1991-6#2)(1993-1#2)(1993-2#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-7#1)(1997-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#9)(2009-10#1)(2009-12#3)(2009-5#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#8)(2012-3#3)(2012-9#1)(2013-1#6)(2013-8#2)
of younger and##2##3##(2009-12#1)(2013-7#1)
of younger patients##2##3##(1997-7#1)(2008-11#1)
of younger##9##2##(1997-7#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#2)(2010-4#1)(2013-7#1)
of your Patient Focused##2##4##(1994-1#1)(1994-2#1)
of your staff##2##3##(1991-3#1)(1997-2#1)
of your##21##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-12#1)(1995-2#1)(1997-2#1)(2007-10#1)(2008-1#2)(2011-2#1)
of youth in##2##3##(2008-11#1)(2012-12#1)
of youth who##2##3##(1994-2#1)(2008-11#1)
of youth with##2##3##(1992-3#1)(2010-11#1)
of youth##17##2##(1990-12#1)(1992-3#1)(1994-2#1)(2008-11#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#2)
of youth's##2##2##(2009-7#2)
of youths##2##2##(2008-12#2)
of ytterbium##3##2##(2007-12#2)(2008-10#1)
of ytterbium-doped##3##2##(2007-12#1)(2008-3#2)
of yttrium from heavy lanthanide by##2##6##(2008-10#2)
of yttrium##7##2##(1992-11#1)(2008-10#6)
of zearalenone##2##2##(1997-6#1)(2008-10#1)
of zebra##2##2##(1997-2#1)(2010-1#1)
of zebrafish##11##2##(1992-9#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-3#1)
of zeolite on the##2##4##(1992-3#2)
of zeolite##5##2##(1992-3#3)(2008-10#2)
of zero##11##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#3)
of zero-order##2##2##(2008-2#1)(2008-3#1)
of zeta-crystallin/quinone reductase##2##3##(1992-11#1)(1993-3#1)
of zidovudine##2##2##(1990-8#1)(1993-3#1)
of zigzag patterns##2##3##(2008-10#2)
of zigzag##3##2##(2008-10#2)(2009-11#1)
of zinc (Zn)##2##3##(2010-2#1)(2012-2#1)
of zinc acetate##3##3##(2008-7#1)(2010-10#2)
of zinc binding motif##2##4##(2008-1#2)
of zinc binding##4##3##(2008-1#2)(2008-10#2)
of zinc by##2##3##(2008-1#1)(2008-10#1)
of zinc can##2##3##(2008-10#1)(2008-7#1)
of zinc compounds by##2##4##(2008-10#2)
of zinc compounds##3##3##(2008-10#3)
of zinc deficiency in##2##4##(2007-12#1)(2012-2#1)
of zinc deficiency##7##3##(2007-12#1)(2008-10#4)(2012-2#2)
of zinc finger##2##3##(1991-2#1)(1991-5#1)
of zinc from##4##3##(2008-10#4)
of zinc in plant##2##4##(2008-10#2)
of zinc in##17##3##(1995-5#1)(2008-10#14)(2010-2#1)(2013-8#1)
of zinc into##2##3##(2008-10#2)
of zinc ions##4##3##(2008-10#2)(2008-11#1)(2010-11#1)
of zinc is##3##3##(2008-10#2)(2013-7#1)
of zinc myoglobin##3##3##(1997-7#3)
of zinc on cadmium##2##4##(2008-7#2)
of zinc on##3##3##(2008-10#1)(2008-7#2)
of zinc per enzyme subunit##2##5##(1994-5#1)(1994-6#1)
of zinc per##4##3##(1994-5#3)(1994-6#1)
of zinc pyrithione##2##3##(2008-10#1)(2008-5#1)
of zinc traces##4##3##(2008-10#4)
of zinc using##2##3##(2008-10#2)
of zinc##117##2##(1990-11#1)(1990-5#4)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#1)(1994-5#5)(1994-6#4)(1995-5#1)(1997-4#1)(1997-7#3)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#68)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2010-10#3)(2010-11#1)(2010-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of zinc(II) and##3##3##(1992-11#1)(2008-10#1)(2010-11#1)
of zinc(II)##8##2##(1992-11#1)(2008-10#6)(2010-11#1)
of ziprasidone##3##2##(2008-6#3)
of zirconia##4##2##(2008-10#1)(2009-8#3)
of zirconium and hafnium##2##4##(2008-10#2)
of zirconium and##3##3##(2008-10#3)
of zirconium##14##2##(1990-5#3)(2008-10#11)
of zirconium(IV) iodovanadate##2##3##(2008-10#2)
of zirconium(IV)##6##2##(2008-10#6)
of zoledronic acid##2##3##(2008-7#1)(2013-1#1)
of zoledronic##4##2##(2008-7#2)(2013-1#2)
of zolpidem##3##2##(2011-2#3)
of zone-circulating flow injection analysis##2##5##(2008-10#2)
of zoonotic parasites##2##3##(2011-2#2)
of zoonotic##7##2##(2008-12#2)(2011-2#3)(2012-12#1)(2013-1#1)
of zoosporangia and##2##3##(2008-10#2)
of zoosporangia##4##2##(2008-10#4)
of zoospores##4##2##(2008-10#4)
of zygomycosis##2##2##(2008-5#2)
of zymosan##3##2##(1991-12#1)(2008-12#2)
of {[HC(3##2##2##(1996-2#2)
of ~0##11##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#1)
of ~1##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
of ~10 mum##2##3##(2007-12#1)(2008-2#1)
of ~10##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of ~10(-5)##2##2##(2007-11#1)(2008-3#1)
of ~100##2##2##(2007-11#1)(2008-3#1)
of ~11##2##2##(2007-11#1)(2008-3#1)
of ~15##2##2##(2007-11#1)(2007-12#1)
of ~150##2##2##(2008-2#1)(2009-9#1)
of ~2##3##2##(2007-12#1)(2008-2#2)
of ~20##3##2##(2007-12#1)(2008-3#1)(2010-4#1)
of ~26##2##2##(2007-11#1)(2007-12#1)
of ~3##4##2##(2007-11#2)(2008-3#2)
of ~30 nm##2##3##(2007-11#1)(2009-2#1)
of ~30##4##2##(2007-11#1)(2007-12#1)(2009-2#1)(2009-6#1)
of ~5##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
of ~50##2##2##(2008-3#2)
of ~6##4##2##(2007-11#3)(2008-2#1)
of ~8##2##2##(2007-11#1)(2008-2#1)
of α7 nAChRs in the##2##5##(2011-1#2)
of β-catenin##6##2##(2012-2#3)(2013-1#3)
of β-cell##6##2##(2010-11#4)(2012-12#1)(2013-7#1)
of β-lactam##3##2##(2011-1#1)(2013-1#2)
of β-peptides##2##2##(2011-1#2)
of γ rays##2##3##(2013-1#2)
of γ-aminobutyric acid##2##3##(2012-2#1)(2013-1#1)
of ∼30##2##2##(2011-2#2)
of##311407##1##(1990-10#233)(1990-11#1148)(1990-12#1319)(1990-2#1051)(1990-3#635)(1990-4#41)(1990-5#1437)(1990-6#751)(1990-7#786)(1990-8#1201)(1990-9#598)(1991-1#518)(1991-10#82)(1991-11#630)(1991-12#1781)(1991-2#1186)(1991-3#891)(1991-4#138)(1991-5#1111)(1991-6#894)(1991-7#127)(1991-8#708)(1991-9#999)(1992-1#499)(1992-10#270)(1992-11#745)(1992-12#1404)(1992-2#795)(1992-3#1771)(1992-4#173)(1992-5#672)(1992-6#1357)(1992-7#75)(1992-8#1146)(1992-9#1120)(1993-1#567)(1993-10#35)(1993-11#1197)(1993-12#1846)(1993-2#953)(1993-3#1265)(1993-5#341)(1993-6#1190)(1993-7#3)(1993-8#1222)(1993-9#824)(1994-1#461)(1994-10#62)(1994-11#1295)(1994-12#1625)(1994-2#1448)(1994-3#1331)(1994-5#1184)(1994-6#1107)(1994-7#223)(1994-8#1462)(1994-9#919)(1995-1#469)(1995-10#28)(1995-11#1120)(1995-12#1919)(1995-2#2038)(1995-3#1445)(1995-4#97)(1995-5#1283)(1995-6#1538)(1995-8#930)(1995-9#349)(1996-1#639)(1996-10#119)(1996-11#432)(1996-12#1777)(1996-2#1704)(1996-3#1155)(1996-4#285)(1996-5#1343)(1996-6#649)(1996-7#234)(1996-8#279)(1996-9#467)(1997-1#764)(1997-2#1857)(1997-3#1743)(1997-4#1426)(1997-5#569)(1997-6#1030)(1997-7#1360)(1997-8#1079)(1997-9#82)(2006-10#491)(2006-11#8)(2006-12#160)(2006-4#64)(2006-5#18)(2006-6#139)(2006-7#13)(2006-8#44)(2006-9#3)(2007-1#53)(2007-10#1259)(2007-11#6003)(2007-12#6737)(2007-2#503)(2007-3#28)(2007-4#168)(2007-5#462)(2007-6#232)(2007-7#1625)(2007-8#2430)(2007-9#145)(2008-1#3373)(2008-10#60193)(2008-11#11356)(2008-12#4734)(2008-2#7519)(2008-3#14809)(2008-4#5041)(2008-5#7584)(2008-6#3370)(2008-7#9946)(2008-8#7067)(2008-9#7025)(2009-1#226)(2009-10#1329)(2009-11#882)(2009-12#969)(2009-2#554)(2009-3#781)(2009-4#727)(2009-5#1364)(2009-6#829)(2009-7#1343)(2009-8#1645)(2009-9#920)(2010-1#621)(2010-10#948)(2010-11#1070)(2010-12#1486)(2010-2#771)(2010-3#1437)(2010-4#1295)(2010-5#1302)(2010-6#875)(2010-7#701)(2010-8#1929)(2010-9#524)(2011-1#3935)(2011-10#68)(2011-2#10744)(2011-3#628)(2011-4#13)(2011-5#3)(2011-6#4)(2011-7#110)(2011-8#10)(2011-9#14)(2012-1#1310)(2012-10#1)(2012-12#3390)(2012-2#5660)(2012-3#4587)(2012-4#39)(2012-5#80)(2012-6#65)(2012-7#86)(2012-8#59)(2012-9#31)(2013-1#8945)(2013-2#4)(2013-3#8)(2013-7#1172)(2013-8#4250)
of&gt##2##1##(2007-5#2)
of&lt##2##1##(2007-5#1)(2008-1#1)
of) the##2##2##(1993-9#1)(1994-8#1)
of)##6##1##(1990-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(2008-10#2)
of1 approximately 15 were##2##4##(2008-11#2)
of1##5##1##(2008-11#4)(2013-8#1)
of8##2##1##(2008-11#1)(2013-1#1)
ofA##7##1##(2008-5#2)(2008-7#1)(2008-8#3)(2013-7#1)
ofADHD in adults##2##3##(2013-7#2)
ofADHD in##3##2##(2013-7#3)
ofAFM1 in##2##2##(2008-12#2)
ofAFM1##3##1##(2008-12#3)
ofAplysia##2##1##(2008-7#2)
ofBacillus##2##1##(2008-8#2)
ofE6##2##1##(2008-8#2)
ofEurycoma longifolia Jack##2##3##(2008-11#2)
ofGanoderma lucidum##2##2##(2008-11#2)
ofGossypium##3##1##(2008-8#3)
ofLentinula edodes and##2##3##(2008-11#2)
ofLycium chinense##2##2##(2008-11#2)
ofNfbp6##2##1##(2008-8#2)
ofO##2##1##(2008-8#2)
ofP##2##1##(2008-11#1)(2008-4#1)
ofPTSD was##2##2##(2013-8#2)
ofRhizobium meliloti##2##2##(2008-8#2)
ofS##3##1##(2008-11#1)(2008-9#1)(2013-7#1)
ofSalvia miltiorrhiza##2##2##(2008-11#2)
ofXa4##2##1##(2008-8#2)
ofa##10##1##(2008-11#3)(2008-5#1)(2009-8#2)(2013-7#1)(2013-8#3)
ofasyip gene##2##2##(2008-8#2)
ofcell##2##1##(2008-11#1)(2008-9#1)
ofcells in the##2##3##(2008-11#2)
ofcells in##3##2##(2008-11#3)
ofcells##5##1##(2008-11#5)
off a##5##2##(1992-11#1)(1993-9#1)(2007-12#1)(2008-3#1)(2012-2#1)
off and on##2##3##(2008-3#1)(2008-4#1)
off and the##2##3##(2008-10#1)(2008-2#1)
off and##6##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
off at##2##2##(2007-11#1)(2013-1#1)
off axis##4##2##(2008-2#1)(2008-3#3)
off by##2##2##(1993-12#1)(2007-12#1)
off during##2##2##(1992-3#1)(1993-2#1)
off from the##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
off from##6##2##(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)
off in the##2##3##(2008-7#1)(2010-4#1)
off in##4##2##(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)
off of a##2##3##(1994-3#1)(2009-3#1)
off of##6##2##(1994-3#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-3#1)
off on##3##2##(1996-1#1)(2008-2#1)(2011-2#1)
off or##3##2##(1997-7#2)(2013-7#1)
off phase matching##2##3##(2007-11#2)
off road driving]##4##3##(1990-6#4)
off road##5##2##(1990-6#5)
off the substrate##2##3##(2007-12#1)(2008-5#1)
off the##37##2##(1990-3#1)(1990-8#1)(1995-12#1)(1996-2#1)(2007-12#6)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#3)(2012-3#2)
off to a##2##3##(1991-5#1)(1994-3#1)
off to##4##2##(1991-5#1)(1994-3#1)(2008-10#1)(2008-4#1)
off with##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
off work##2##2##(2008-5#1)(2011-2#1)
off##191##1##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#5)(1990-8#1)(1991-5#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#2)(1997-3#1)(1997-6#2)(1997-7#2)(2007-11#6)(2007-12#8)(2007-7#2)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#5)(2008-2#11)(2008-3#20)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#4)(2008-8#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
off&quot##4##1##(1990-8#1)(1997-2#1)(2008-7#1)(2011-1#1)
off)##2##1##(1995-3#1)(2008-9#1)
off-axis Hermite-Gaussian##2##2##(2008-3#2)
off-axis alignment##2##2##(2008-3#2)
off-axis angle##2##2##(2008-2#1)(2008-3#1)
off-axis angles##4##2##(2008-2#1)(2008-3#3)
off-axis detectors in##2##3##(2008-3#2)
off-axis detectors##3##2##(2008-3#3)
off-axis higher-order##2##2##(2008-2#2)
off-axis holographic recording##2##3##(2007-11#1)(2008-3#1)
off-axis holography##2##2##(2007-11#1)(2008-3#1)
off-axis lens##2##2##(2008-3#2)
off-axis parabolic##2##2##(2007-12#1)(2008-3#1)
off-axis position##2##2##(2007-11#1)(2008-3#1)
off-axis##66##1##(2007-11#5)(2007-12#2)(2008-2#13)(2008-3#46)
off-diagonal##3##1##(2008-2#1)(2008-3#1)(2008-8#1)
off-label##8##1##(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2013-1#1)
off-line analysis of##2##3##(2008-2#1)(2013-8#1)
off-line and##2##2##(2008-10#1)(2008-11#1)
off-line by##2##2##(2008-10#1)(2008-7#1)
off-line derivatizations of##2##3##(1990-8#2)
off-line methods##3##2##(2008-11#2)(2008-3#1)
off-line sample##2##2##(2008-10#2)
off-line with##2##2##(2008-10#2)
off-line##42##1##(1990-8#2)(1997-3#1)(2007-12#1)(2008-10#20)(2008-11#6)(2008-2#1)(2008-3#2)(2008-7#6)(2009-6#1)(2011-1#1)(2013-8#1)
off-loading##2##1##(2011-1#2)
off-normal##2##1##(2008-3#2)
off-pump coronary artery bypass grafting##4##5##(2007-8#3)(2010-8#1)
off-pump coronary artery bypass surgery##2##5##(2006-10#1)(2007-8#1)
off-pump coronary artery bypass##8##4##(2006-10#1)(2007-8#5)(2010-8#2)
off-pump coronary bypass##2##3##(2007-8#2)
off-pump coronary surgery##2##3##(2007-8#1)(2013-8#1)
off-pump coronary##12##2##(2006-10#1)(2007-8#8)(2010-8#2)(2013-8#1)
off-pump##24##1##(2006-10#1)(2007-8#20)(2010-8#2)(2013-8#1)
off-resonant##2##1##(2007-11#1)(2007-12#1)
off-specular peak in the forward scattering direction##2##7##(2008-2#2)
off-state UPDRS motor##2##3##(2008-7#2)
off-state##3##1##(2008-3#1)(2008-7#2)
off-the-shelf optics##2##2##(2008-3#2)
off-the-shelf##6##1##(2008-3#4)(2009-3#1)(2011-1#1)
offence##2##1##(1995-3#1)(2008-9#1)
offender##5##1##(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-2#1)
offenders in domestic homicide cases were##2##6##(2011-2#2)
offenders in##3##2##(2008-11#1)(2011-2#2)
offenders with##3##2##(2009-7#2)(2010-6#1)
offenders##21##1##(2007-9#1)(2008-11#3)(2008-12#2)(2008-6#2)(2009-7#4)(2010-6#1)(2011-2#7)(2012-3#1)
offending drug##6##2##(1993-6#1)(2008-7#2)(2008-8#3)
offending##24##1##(1993-6#1)(2006-10#1)(2007-9#2)(2008-12#3)(2008-7#3)(2008-8#3)(2009-7#6)(2009-8#4)(2010-5#1)
offense##5##1##(1992-1#1)(1996-5#1)(2008-9#2)(2011-2#1)
offenses##6##1##(1992-9#1)(1994-2#1)(1996-5#3)(2011-2#1)
offensive from##2##2##(1992-12#2)
offensive##12##1##(1992-12#6)(1993-2#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-9#1)(2012-3#1)
offer a means of##2##4##(1996-1#1)(2008-10#1)
offer a means##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
offer a model for##2##4##(1991-1#1)(2013-7#1)
offer a more##2##3##(2008-11#1)(2008-5#1)
offer a new##2##3##(2008-7#1)(2013-7#1)
offer a paradigm##2##3##(2008-11#1)(2012-12#1)
offer a potential##2##3##(2008-1#1)(2008-8#1)
offer a rapid##2##3##(2007-12#1)(2008-3#1)
offer a safe##2##3##(1992-2#1)(2011-2#1)
offer a theoretical##2##3##(2007-8#1)(2008-9#1)
offer a unique##2##3##(2008-7#1)(2009-6#1)
offer a##62##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#3)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#2)(2013-7#2)
offer an advantage##2##3##(2008-11#1)(2008-2#1)
offer an alternative to##3##4##(2008-1#1)(2008-10#2)
offer an important##2##3##(2008-1#1)(2013-8#1)
offer an##21##2##(1994-12#1)(1994-9#1)(1995-1#1)(1996-3#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
offer any##3##2##(1991-2#1)(1997-3#1)(2008-9#1)
offer as a##2##3##(1996-5#1)(2012-12#1)
offer better##5##2##(1991-6#1)(1995-8#1)(2008-2#1)(2009-9#1)(2010-5#1)
offer clinicians##2##2##(2008-7#1)(2012-2#1)
offer coverage to##2##3##(1995-6#1)(1996-3#1)
offer excellent##2##2##(2008-3#1)(2012-2#1)
offer formal##2##2##(1992-12#1)(1994-12#1)
offer future##2##2##(2008-11#1)(2008-7#1)
offer good##2##2##(1997-8#1)(2008-2#1)
offer great##3##2##(1992-12#1)(2008-10#1)(2012-12#1)
offer greater##3##2##(1994-6#1)(2008-2#1)(2012-12#1)
offer important##5##2##(1997-5#1)(2010-5#1)(2011-2#2)(2012-12#1)
offer improved##4##2##(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
offer in##3##2##(1996-9#1)(2008-11#1)(2008-12#1)
offer information##2##2##(1996-6#1)(2009-3#1)
offer insight into##3##3##(2009-11#1)(2009-7#1)(2011-1#1)
offer insights into##2##3##(1994-3#1)(2013-1#1)
offer insights##3##2##(1994-3#1)(2013-1#2)
offer many##3##2##(1994-2#1)(2008-7#2)
offer more##2##2##(2007-12#1)(2011-2#1)
offer much##2##2##(2007-7#1)(2008-8#1)
offer new therapeutic##2##3##(2008-7#1)(2012-2#1)
offer new##12##2##(1993-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#4)(2010-3#1)(2012-2#1)(2013-1#2)
offer no##3##2##(1991-11#1)(1992-3#1)(2008-10#1)
offer of##4##2##(1992-5#1)(1994-6#1)(1997-2#1)(2011-2#1)
offer opportunities for##2##3##(2007-3#1)(2013-1#1)
offer opportunities to##3##3##(1993-2#1)(1996-7#1)(2010-3#1)
offer opportunities##5##2##(1993-2#1)(1996-7#1)(2007-3#1)(2010-3#1)(2013-1#1)
offer potential as a##2##4##(2007-11#1)(2009-10#1)
offer potential##5##2##(1991-12#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
offer powerful##2##2##(2008-10#1)(2008-8#1)
offer protection against the##2##4##(2008-12#1)(2013-1#1)
offer protection against##3##3##(1993-11#1)(2008-12#1)(2013-1#1)
offer protection##4##2##(1993-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
offer several advantages##2##3##(2008-10#1)(2010-5#1)
offer several##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
offer significant advantages##2##3##(1997-4#1)(2008-7#1)
offer significant##3##2##(1992-1#1)(1997-4#1)(2008-7#1)
offer some##8##2##(1994-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-3#1)
offer the advantage of##2##4##(2008-10#1)(2008-9#1)
offer the best##3##3##(1994-6#1)(2008-10#1)(2012-12#1)
offer the most##3##3##(1995-3#1)(2011-1#1)(2011-2#1)
offer the opportunity##2##3##(2008-8#1)(2008-9#1)
offer the possibility of##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
offer the possibility to##3##4##(1996-6#1)(2008-10#1)(2009-6#1)
offer the possibility##7##3##(1996-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-6#1)
offer the potential##2##3##(1994-8#1)(2013-1#1)
offer the promise of##2##4##(2008-5#1)(2008-7#1)
offer the##28##2##(1990-8#1)(1991-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-6#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
offer their##2##2##(1994-3#1)(2007-3#1)
offer useful##3##2##(2007-10#1)(2008-3#1)(2009-5#1)
offer valuable##4##2##(2008-10#1)(2008-8#1)(2010-7#1)(2012-2#1)
offer various##2##2##(2008-2#1)(2008-7#1)
offer##354##1##(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#3)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#8)(1996-12#1)(1996-3#5)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#32)(2008-11#18)(2008-12#5)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#29)(2008-8#14)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#11)(2012-3#3)(2013-1#12)(2013-7#4)(2013-8#1)
offered a number of##2##4##(2008-11#1)(2008-5#1)
offered a##12##2##(1995-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2010-10#1)(2010-5#1)(2012-2#1)
offered an##3##2##(1995-3#1)(2008-12#1)(2008-2#1)
offered and##2##2##(2008-11#1)(2010-9#1)
offered any##2##2##(1997-5#1)(2008-7#1)
offered as a##2##3##(1991-1#1)(1994-12#1)
offered as part of##2##4##(1993-12#1)(2008-9#1)
offered as##6##2##(1991-1#1)(1993-12#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-9#1)
offered at##5##2##(1992-2#1)(1994-12#1)(1996-1#1)(2008-11#1)(2013-1#1)
offered by a##2##3##(1993-12#1)(2007-11#1)
offered by the##11##3##(1990-3#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
offered by##37##2##(1990-3#1)(1990-9#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-4#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
offered for consideration##2##3##(2008-10#1)(2008-5#1)
offered for##5##2##(1992-12#2)(1993-3#1)(2008-10#1)(2008-5#1)
offered high##2##2##(2012-12#2)
offered in##8##2##(1994-3#1)(2008-12#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#2)
offered on##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
offered surgery##2##2##(1992-9#1)(2011-2#1)
offered the##7##2##(1991-2#1)(1995-6#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)
offered through##3##2##(1995-1#1)(2008-8#1)(2013-1#1)
offered to explain##2##3##(2008-10#1)(2008-7#1)
offered to families##2##3##(1991-12#2)
offered to patients##2##3##(1992-12#1)(1994-3#1)
offered to physicians##3##3##(1992-3#1)(1993-3#1)(2008-11#1)
offered to the##5##3##(1991-2#1)(1995-6#1)(2007-8#1)(2008-11#1)(2010-3#1)
offered to##27##2##(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-5#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
offered##204##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#3)(1991-6#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-9#3)(1993-12#4)(1993-3#2)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#2)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#25)(2008-11#12)(2008-12#11)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#1)
offering a##15##2##(1992-1#1)(1992-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-8#1)
offering an##4##2##(2008-10#1)(2009-6#1)(2013-1#2)
offering health##3##2##(1994-3#1)(2008-7#1)(2010-3#1)
offering recommendations for##2##3##(2008-11#1)(2012-2#1)
offering the possibility of##2##4##(2008-2#1)(2008-5#1)
offering the possibility##3##3##(1996-11#1)(2008-2#1)(2008-5#1)
offering the##11##2##(1991-1#1)(1995-1#1)(1996-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
offering them##3##2##(1993-12#1)(2013-1#2)
offering##82##1##(1991-1#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#9)(2013-8#1)
offerings to##2##2##(1994-3#1)(1997-2#1)
offerings##9##1##(1992-12#1)(1992-3#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#3)
offers a brief##2##3##(2008-11#1)(2012-12#1)
offers a convenient##2##3##(2007-11#1)(2008-8#1)
offers a detailed##2##3##(1996-6#1)(2008-4#1)
offers a good##2##3##(1994-9#1)(2008-10#1)
offers a highly##2##3##(2008-10#1)(2008-11#1)
offers a low-cost##2##3##(2008-11#1)(2010-5#1)
offers a more##3##3##(2008-10#1)(2010-7#1)(2012-12#1)
offers a new##4##3##(1994-6#1)(2007-12#1)(2008-7#1)(2012-2#1)
offers a novel##3##3##(1994-5#1)(2008-10#1)(2013-1#1)
offers a number of advantages over##3##6##(2007-11#1)(2008-2#1)(2008-4#1)
offers a number of advantages##4##5##(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
offers a number of##6##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#2)(2012-12#1)
offers a potential##3##3##(2007-12#1)(2008-10#2)
offers a powerful##2##3##(1991-5#1)(1995-2#1)
offers a simple##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)
offers a unique##5##3##(1994-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)
offers a valuable way in which N low-power laser elements##2##10##(2008-3#2)
offers a valuable##3##3##(2008-3#2)(2012-2#1)
offers a##102##2##(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-6#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#7)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
offers advantages##4##2##(2008-1#1)(2008-10#2)(2009-12#1)
offers advice on##3##3##(1991-12#1)(2008-4#2)
offers an acceptable alternative##2##4##(1994-12#1)(2011-2#1)
offers an alternative to biopsy##2##5##(2012-2#2)
offers an alternative to##5##4##(1996-12#1)(1997-3#1)(2008-11#1)(2012-2#2)
offers an alternative##7##3##(1996-12#1)(1996-5#1)(1997-3#1)(2008-11#1)(2010-12#1)(2012-2#2)
offers an attractive##2##3##(2010-3#1)(2011-1#1)
offers an easy##2##3##(2008-10#1)(2008-7#1)
offers an explanation for##2##4##(2008-9#1)(2010-12#1)
offers an ideal##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
offers an overview of##4##4##(1993-11#1)(1996-12#1)(2008-4#1)(2008-9#1)
offers an##41##2##(1993-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
offers better##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
offers considerable promise##2##3##(1994-3#1)(2008-10#1)
offers convenient##2##2##(2008-3#1)(2008-4#1)
offers distinct##2##2##(1993-3#1)(2008-10#1)
offers extremely##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
offers good##2##2##(2008-10#1)(2012-12#1)
offers great sensitivity##2##3##(2008-10#1)(2008-3#1)
offers great##4##2##(1997-4#1)(2008-10#2)(2008-3#1)
offers greater##2##2##(2010-4#1)(2011-2#1)
offers guidance for interpreting##2##4##(2008-4#2)
offers guidance##3##2##(2008-4#2)(2010-9#1)
offers high##3##2##(2008-10#3)
offers improved##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
offers insight into the##2##4##(2008-3#1)(2010-9#1)
offers insight##3##2##(2008-10#1)(2008-3#1)(2010-9#1)
offers many advantages over other##2##5##(1994-5#1)(2012-2#1)
offers many advantages over##5##4##(1994-5#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
offers many advantages##6##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
offers many potential advantages##2##4##(2008-1#1)(2008-4#1)
offers many##11##2##(1994-5#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
offers new potentialities for##2##4##(1991-11#1)(1995-12#1)
offers new##5##2##(1991-11#1)(1995-12#1)(1997-8#1)(2012-12#2)
offers no##3##2##(1994-1#2)(1996-2#1)
offers novel##2##2##(2008-9#1)(2013-1#1)
offers possible##2##2##(1992-3#1)(1993-1#1)
offers practical##2##2##(1994-12#1)(2011-2#1)
offers promise for##2##3##(1993-11#1)(2008-7#1)
offers promise##3##2##(1993-11#1)(1997-3#1)(2008-7#1)
offers recommendations##3##2##(1996-1#1)(2009-5#1)(2011-2#1)
offers safety##2##2##(2008-10#1)(2012-2#1)
offers several advantages over conventional##2##5##(2008-1#1)(2008-10#1)
offers several advantages over##4##4##(1991-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
offers several advantages##6##3##(1991-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
offers several##9##2##(1991-9#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)
offers significant##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2010-8#1)
offers some##11##2##(1990-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-1#1)(2008-10#3)(2008-9#1)
offers suggestions for##2##3##(1991-2#1)(1992-12#1)
offers suggestions##4##2##(1991-2#1)(1992-12#1)(1995-1#1)(1995-12#1)
offers the ability to##2##4##(2008-11#1)(2008-9#1)
offers the advantage of##4##4##(2007-11#1)(2008-10#2)(2008-5#1)
offers the advantage##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
offers the advantages of##4##4##(2008-10#2)(2008-2#1)(2010-7#1)
offers the best##4##3##(1991-2#1)(1996-3#1)(2008-2#1)(2008-9#1)
offers the following##2##3##(1997-4#1)(2008-10#1)
offers the opportunity for##2##4##(2010-11#1)(2012-2#1)
offers the opportunity to##2##4##(2007-7#1)(2008-1#1)
offers the opportunity##4##3##(2007-7#1)(2008-1#1)(2010-11#1)(2012-2#1)
offers the possibility of##4##4##(2007-11#2)(2008-10#1)(2008-7#1)
offers the possibility##5##3##(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)
offers the potential for##4##4##(1996-12#1)(2008-11#2)(2008-4#1)
offers the potential of##3##4##(1997-2#1)(2008-10#1)(2008-8#1)
offers the potential##8##3##(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)
offers the unique##4##3##(2007-12#1)(2008-4#1)(2008-9#1)(2011-7#1)
offers the##52##2##(1990-5#1)(1991-2#1)(1991-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
offers unique##3##2##(2007-11#1)(2008-8#1)(2009-9#1)
offers us##2##2##(1995-12#1)(2012-2#1)
offers##398##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#2)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#3)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#2)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#61)(2008-11#21)(2008-12#2)(2008-2#14)(2008-3#18)(2008-4#24)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#13)(2009-10#3)(2009-12#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#5)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#12)(2012-3#3)(2013-1#4)(2013-8#2)
office and##5##2##(1991-2#1)(1993-1#1)(1996-12#1)(2009-8#1)(2010-7#1)
office building##2##2##(1997-3#1)(2008-5#1)
office paper&gt##2##2##(2008-10#2)
office to##2##2##(1990-4#1)(2007-10#1)
office visits##5##2##(1995-3#1)(1997-2#1)(2009-6#1)(2010-8#2)
office was##3##2##(1995-12#1)(2008-1#2)
office##79##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1991-1#3)(1991-12#4)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#7)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
office-based surgical safety##2##3##(2013-1#2)
office-based surgical##3##2##(2013-1#3)
office-based##11##1##(1994-2#1)(2008-11#1)(2008-4#1)(2011-2#2)(2012-1#1)(2013-1#5)
office]##3##1##(1993-10#1)(1995-5#1)(1997-2#1)
officer in##3##2##(1993-2#1)(1995-6#1)(1996-3#1)
officer of##2##2##(1995-5#1)(1995-6#1)
officer##24##1##(1991-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#3)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#3)(1997-5#1)(2011-2#1)
officer&quot##3##1##(1993-2#3)
officer-involved##2##1##(2009-2#2)
officers and##3##2##(1993-3#1)(2008-1#1)(2013-8#1)
officers in##5##2##(1990-3#1)(1992-12#1)(1995-5#1)(1996-9#1)(2008-1#1)
officers of##2##2##(1995-3#1)(2009-7#1)
officers##55##1##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#3)(1992-12#2)(1992-2#2)(1993-2#2)(1993-3#2)(1994-2#1)(1995-3#1)(1995-5#3)(1995-6#8)(1996-12#3)(1996-2#2)(1996-9#1)(1997-2#2)(1997-8#2)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-12#1)(2013-8#1)
offices in##2##2##(2008-11#1)(2009-11#1)
offices of the##2##3##(2009-4#1)(2010-12#1)
offices##23##1##(1991-5#3)(1992-1#1)(1992-3#1)(1994-2#2)(1995-5#1)(1996-2#2)(2008-10#1)(2008-11#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#5)(2010-6#1)(2013-1#1)
official and reported methods##2##4##(2008-10#2)
official guidelines##3##2##(1995-6#1)(2007-2#1)(2008-1#1)
official method of the##3##4##(2008-10#3)
official method of##4##3##(2008-10#4)
official method##16##2##(2008-10#16)
official methods for##2##3##(2008-10#2)
official methods##8##2##(2008-10#6)(2008-11#1)(2008-5#1)
official records##3##2##(2008-12#2)(2009-10#1)
official statistics##2##2##(1990-6#1)(1991-9#1)
official##78##1##(1990-6#1)(1991-3#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#3)(2007-2#1)(2008-1#2)(2008-10#32)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2009-10#4)(2009-7#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)
officialdom##2##1##(2008-7#1)(2009-10#1)
officially accepted##2##2##(1996-3#1)(2008-5#1)
officially in##2##2##(1990-3#1)(2007-4#1)
officially##9##1##(1990-3#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-4#1)(2008-5#1)(2010-4#1)
officials and##7##2##(1995-12#1)(1996-1#2)(1996-12#1)(2009-10#1)(2012-12#1)(2013-7#1)
officials are##2##2##(1995-12#1)(2008-6#1)
officials as##2##2##(1994-3#1)(2008-10#1)
officials come to##2##3##(1995-6#2)
officials from##2##2##(2008-11#1)(2012-1#1)
officials sought##2##2##(1991-1#1)(2011-2#1)
officials##46##1##(1990-2#1)(1991-1#1)(1993-1#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#4)(1995-6#6)(1996-1#3)(1996-12#2)(1996-3#1)(1996-5#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#2)(2011-2#3)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
officinalis seeds##4##2##(2012-3#4)
officinalis##16##1##(1990-11#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)(2011-2#1)(2012-3#5)(2013-1#1)
officinalis)##3##1##(2008-10#2)(2008-5#1)
offline##10##1##(1991-2#1)(2007-12#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
offloading##2##1##(2010-11#1)(2011-2#1)
offset and##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
offset at##2##2##(1996-4#1)(2008-3#1)
offset by a##3##3##(1992-12#1)(1997-1#1)(2008-8#1)
offset by increased##2##3##(1993-12#1)(2008-8#1)
offset by the##2##3##(2008-1#1)(2013-1#1)
offset by##15##2##(1992-12#1)(1993-12#2)(1993-3#1)(1995-1#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-3#2)(2008-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
offset frequency##3##2##(2007-11#3)
offset from the##2##3##(2008-3#1)(2011-2#1)
offset in the##2##3##(2008-2#1)(2008-3#1)
offset in##6##2##(1994-9#1)(1995-1#1)(2008-2#2)(2008-3#1)(2011-2#1)
offset of 0##2##3##(2008-2#2)
offset of a##2##3##(1996-5#1)(2008-2#1)
offset of the##2##3##(2007-11#1)(2008-3#1)
offset of##7##2##(1996-5#1)(2007-11#1)(2008-2#3)(2008-3#2)
offset the##4##2##(2008-10#1)(2008-8#1)(2010-2#2)
offset to the##2##3##(1994-12#1)(2008-6#1)
offset was##2##2##(1995-1#1)(2009-3#1)
offset##88##1##(1992-12#2)(1993-12#3)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#4)(1996-4#1)(1996-5#2)(1997-1#1)(2007-11#9)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#12)(2008-3#22)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-2#7)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
offsets of##3##2##(2008-3#2)(2011-2#1)
offsets that##2##2##(2008-2#1)(2008-3#1)
offsets the##2##2##(1992-12#1)(2013-1#1)
offsets##22##1##(1992-12#1)(2007-11#1)(2008-2#7)(2008-3#9)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
offsetting##2##1##(1993-12#1)(2008-3#1)
offshoot of##2##2##(2011-2#1)(2012-2#1)
offshore platforms##2##2##(1990-11#2)
offshore water##2##2##(2007-5#2)
offshore##17##1##(1990-11#2)(2007-5#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#3)(2010-8#1)(2011-2#4)(2013-7#1)
offspring and##6##2##(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
offspring density##3##2##(2008-9#3)
offspring environment##2##2##(2008-8#2)
offspring fitness##4##2##(2008-8#4)
offspring fitness/propagule size##2##3##(2008-8#2)
offspring from the##2##3##(2008-10#1)(2012-12#1)
offspring from##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
offspring is##2##2##(2008-8#1)(2008-9#1)
offspring of the##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
offspring of##22##2##(1995-8#1)(2007-5#2)(2008-1#1)(2008-10#4)(2008-7#2)(2008-8#3)(2009-5#1)(2009-8#2)(2010-4#1)(2012-2#2)(2012-3#3)
offspring or##2##2##(2008-9#2)
offspring retention##3##2##(2008-8#3)
offspring survival##7##2##(2008-8#6)(2008-9#1)
offspring survivorship and growth##3##4##(2012-12#3)
offspring to##2##2##(2008-8#2)
offspring was##2##2##(1995-12#1)(2012-12#1)
offspring were produced##2##3##(2008-10#1)(2008-9#1)
offspring were##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)
offspring with##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
offspring##160##1##(1991-1#1)(1991-5#2)(1993-2#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#49)(2008-9#33)(2009-3#2)(2009-5#1)(2009-8#3)(2010-4#4)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#7)(2012-2#3)(2012-3#9)(2013-1#5)(2013-8#1)
offspring)##4##1##(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
ofglaA##3##1##(2008-8#3)
ofglutamine##2##1##(2008-11#2)
ofglycosylation##2##1##(2008-11#2)
ofin vitro##2##2##(2008-11#1)(2008-8#1)
ofinterest in##2##2##(2008-11#1)(2013-8#1)
ofinterest##3##1##(2008-11#1)(2013-8#2)
ofjoint##2##1##(2008-11#1)(2013-1#1)
ofloxacin (OFLO) and##2##3##(2008-10#2)
ofloxacin and##2##2##(2008-7#1)(2012-3#1)
ofloxacin in##5##2##(2008-10#5)
ofloxacin is##2##2##(1990-2#1)(2008-10#1)
ofloxacin was##2##2##(1996-2#1)(2008-5#1)
ofloxacin##39##1##(1990-2#2)(1994-3#1)(1996-2#1)(2007-7#2)(2008-10#25)(2008-5#3)(2008-7#2)(2012-3#3)
ofobject##2##1##(2008-2#2)
ofoperation##2##1##(2008-11#1)(2008-2#1)
ofsuch##2##1##(2008-11#1)(2013-8#1)
ofsufficient##2##1##(2008-11#1)(2013-8#1)
oft##2##1##(2007-7#1)(2008-11#1)
often a &quot##2##3##(2007-1#1)(2012-2#1)
often a##24##2##(1991-3#1)(1993-1#1)(1993-11#1)(1995-1#2)(2007-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
often accompanied by##4##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)
often accompanied##5##2##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
often accompany##3##2##(1994-5#1)(2012-12#1)(2013-1#1)
often achieved##2##2##(1993-2#1)(2008-10#1)
often affected by##3##3##(1995-2#1)(2008-1#1)(2008-5#1)
often affected##6##2##(1990-6#1)(1995-2#1)(2007-2#1)(2008-1#1)(2008-5#1)(2010-11#1)
often ambiguous##2##2##(2007-4#1)(2008-7#1)
often and##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
often appear##2##2##(2008-9#1)(2010-10#1)
often applied to##2##3##(2008-5#1)(2009-11#1)
often applied##4##2##(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#1)
often are not##2##3##(1992-2#1)(2009-4#1)
often are##11##2##(1990-6#1)(1992-2#1)(1993-2#1)(1994-2#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
often arise##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2013-7#1)
often as a##3##3##(1990-5#1)(2009-12#1)(2010-4#1)
often as an##2##3##(1994-11#1)(2010-11#1)
often as##11##2##(1990-5#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
often asked##2##2##(2008-10#1)(2012-12#1)
often associated with a##4##4##(2007-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
often associated with the##2##4##(2012-12#1)(2012-3#1)
often associated with##40##3##(1990-5#1)(1991-5#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)
often associated##42##2##(1990-5#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)
often associates with##2##3##(2007-10#1)(2008-8#1)
often assumed to be##3##4##(1997-7#1)(2008-9#1)(2013-1#1)
often assumed##6##2##(1997-7#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
often asymptomatic##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
often at high##2##3##(2008-10#1)(2011-2#1)
often at the##3##3##(1990-11#1)(2012-2#1)(2012-3#1)
often at##7##2##(1990-11#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
often attempt##2##2##(2008-10#1)(2008-5#1)
often based on##10##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-2#3)(2012-2#1)
often be##22##2##(1991-6#1)(1993-3#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#3)(2013-8#2)
often becomes##2##2##(1996-2#1)(2008-1#1)
often been considered##2##3##(2008-3#1)(2012-2#1)
often been##20##2##(1990-2#1)(1992-1#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
often being##2##2##(2008-10#1)(2009-8#1)
often breaks##2##2##(2008-6#1)(2010-3#1)
often called &quot##2##3##(2008-1#1)(2011-7#1)
often called##4##2##(2008-1#2)(2011-7#1)(2012-12#1)
often can be##2##3##(2008-12#1)(2008-3#1)
often can##3##2##(1994-9#1)(2008-12#1)(2008-3#1)
often cannot be##2##3##(1992-3#1)(2011-2#1)
often carried out##3##3##(1992-11#1)(2008-12#1)(2010-11#1)
often cause##2##2##(2007-11#1)(2011-2#1)
often caused##3##2##(1990-9#1)(1994-11#1)(2011-1#1)
often causes##3##2##(1991-3#1)(2008-10#1)(2012-12#1)
often causing##2##2##(2008-10#1)(2010-12#1)
often characterized by##2##3##(2008-10#1)(2008-4#1)
often cited##2##2##(1992-8#1)(2008-5#1)
often clustered##2##2##(2008-10#1)(2009-5#1)
often conflicting##2##2##(1990-8#1)(1996-1#1)
often confusing##2##2##(2008-8#1)(2013-1#1)
often considered to##2##3##(1996-2#1)(2008-4#1)
often considered##6##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
often contains##2##2##(2008-4#1)(2008-5#1)
often contaminated with##2##3##(1991-12#1)(2012-2#1)
often correlated with##2##3##(1996-2#1)(2008-11#1)
often demonstrate##2##2##(1990-11#1)(2013-1#1)
often derived##2##2##(2008-10#1)(2008-6#1)
often described as##4##3##(1994-11#1)(2008-11#1)(2008-7#1)(2012-12#1)
often described##5##2##(1994-11#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
often determine##2##2##(1994-12#1)(1997-3#1)
often develop##3##2##(1990-2#1)(2008-1#1)(2008-10#1)
often diagnosed##4##2##(1993-3#1)(1997-8#1)(2011-2#1)(2012-3#1)
often differ in##2##3##(1995-5#1)(2008-9#1)
often differ##4##2##(1995-5#1)(2007-4#1)(2008-10#1)(2008-9#1)
often difficult because##2##3##(2008-10#1)(2008-7#1)
often difficult to##5##3##(2008-10#1)(2008-3#2)(2010-5#1)(2011-1#1)
often difficult##14##2##(1993-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
often discussed##2##2##(1993-12#1)(1997-3#1)
often display##2##2##(1995-11#1)(2008-8#1)
often do not##6##3##(1991-12#1)(1991-2#1)(2007-5#1)(2008-3#1)(2012-12#1)(2012-2#1)
often does not##2##3##(2008-8#1)(2010-12#1)
often does##3##2##(1992-11#1)(2008-8#1)(2010-12#1)
often due to##3##3##(2009-10#1)(2011-2#1)(2012-2#1)
often employed for##2##3##(2008-3#1)(2010-6#1)
often employed##4##2##(2008-3#2)(2010-6#1)(2012-2#1)
often encounter patients##2##3##(2009-7#1)(2013-1#1)
often encounter##4##2##(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
often encountered in##3##3##(1993-8#1)(2008-3#2)
often encountered when##2##3##(2008-10#1)(2008-4#1)
often encountered##6##2##(1993-3#1)(1993-8#1)(2008-10#1)(2008-3#2)(2008-4#1)
often evaluate##2##2##(1994-12#1)(2008-9#1)
often exceeded##2##2##(2008-10#1)(2012-3#1)
often excessively##2##2##(2012-12#1)(2013-8#1)
often exhibit##7##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-8#1)
often experience a lack of involvement##2##6##(2011-2#2)
often experience##6##2##(1993-12#1)(2007-2#1)(2008-7#1)(2010-8#1)(2011-2#2)
often fail to##2##3##(1990-8#1)(1991-12#1)
often fail##3##2##(1990-8#1)(1991-12#1)(2011-2#1)
often fails to meet the##2##5##(1997-1#1)(2011-2#1)
often fails##4##2##(1997-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
often fatal##3##2##(1991-2#1)(2006-7#1)(2008-10#1)
often feel##4##2##(1992-2#1)(1997-5#1)(2007-11#1)(2008-1#1)
often find themselves##2##3##(1992-12#1)(1993-12#1)
often find##3##2##(1992-12#1)(1993-12#1)(2013-8#1)
often found in##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
often found on the##2##4##(1993-1#1)(2008-10#1)
often found on##3##3##(1993-1#1)(2008-10#2)
often found##14##2##(1990-12#1)(1993-1#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#2)(2010-4#1)
often generated##2##2##(2008-10#2)
often given##2##2##(1997-2#1)(2013-1#1)
often go##2##2##(2007-6#1)(2012-3#1)
often had##6##2##(1991-11#1)(1994-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
often hampered by the##3##4##(1990-12#1)(2008-2#1)(2011-3#1)
often hampered by##5##3##(1990-12#1)(1992-9#1)(2008-10#1)(2008-2#1)(2011-3#1)
often happens##3##2##(2008-1#1)(2012-2#1)(2013-1#1)
often has been##3##3##(2008-10#3)
often has##5##2##(2007-8#1)(2008-10#3)(2012-12#1)
often have a##4##3##(2008-4#1)(2010-1#1)(2010-4#1)(2012-12#1)
often have limited##2##3##(1992-8#1)(2008-7#1)
often have##23##2##(1991-12#2)(1992-8#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-4#3)(2010-7#1)(2010-8#1)(2012-12#2)
often hidden##2##2##(2007-4#1)(2008-10#1)
often higher##2##2##(2008-10#1)(2010-4#1)
often highly##3##2##(1991-3#1)(2006-12#1)(2008-2#1)
often identified##2##2##(2008-12#1)(2013-1#1)
often ignored##3##2##(1992-3#1)(1993-12#1)(2008-4#1)
often impractical##2##2##(2008-3#1)(2010-10#1)
often in children##2##3##(1992-4#1)(2007-11#1)
often in patients##2##3##(2006-10#1)(2012-3#1)
often in the elderly##2##4##(1991-6#1)(1994-6#1)
often in the##8##3##(1991-6#1)(1994-6#1)(1996-11#1)(2007-8#1)(2008-4#1)(2009-12#1)(2011-1#1)(2013-1#1)
often in women##2##3##(1992-3#1)(2011-1#1)
often in##34##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-11#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-12#1)(2009-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
often inadequate to##2##3##(2011-2#1)(2013-7#1)
often inadequate##3##2##(2010-10#1)(2011-2#1)(2013-7#1)
often include##4##2##(2007-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
often includes##2##2##(2008-5#1)(2008-7#1)
often incomplete##2##2##(1990-7#1)(1992-11#1)
often indicated##2##2##(1991-6#1)(2007-11#1)
often ineffective##2##2##(1992-9#1)(1996-11#1)
often involve##9##2##(1992-9#1)(1993-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
often involved in##4##3##(1997-8#1)(2008-1#2)(2010-12#1)
often involved##6##2##(1997-8#1)(2008-1#2)(2008-7#1)(2010-1#1)(2010-12#1)
often involves the##2##3##(2008-4#1)(2008-5#1)
often involves##10##2##(1995-12#1)(1997-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
often is##11##2##(1990-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
often isolated##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
often lack##3##2##(1996-3#1)(2010-3#1)(2013-8#1)
often lacking##2##2##(1992-4#1)(2009-4#1)
often large##2##2##(1993-9#1)(2007-4#1)
often lead to##4##3##(2007-7#1)(2008-1#1)(2008-5#1)(2010-6#1)
often lead##5##2##(2007-7#1)(2008-1#1)(2008-5#1)(2009-6#1)(2010-6#1)
often leads to##8##3##(1996-11#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2012-3#2)
often leads##9##2##(1996-11#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2012-2#1)(2012-3#2)
often led to##2##3##(2008-10#1)(2012-12#1)
often less##2##2##(1995-6#1)(2008-9#1)
often lethal##3##2##(1995-2#1)(2008-5#1)(2008-9#1)
often limited by the##2##4##(2008-10#1)(2009-11#1)
often limited by##5##3##(1995-5#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)
often limited to##3##3##(1996-12#1)(2008-9#1)(2013-1#1)
often limited##13##2##(1994-12#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#1)(2011-7#1)(2013-1#1)
often linked to##2##3##(1996-6#1)(2012-2#1)
often linked##4##2##(1996-6#1)(2008-1#1)(2009-7#1)(2012-2#1)
often low##2##2##(2011-2#1)(2012-3#1)
often made by##2##3##(1993-12#1)(2013-8#1)
often made##6##2##(1993-12#1)(1997-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
often makes it##2##3##(2008-11#1)(2008-12#1)
often makes##3##2##(1991-2#1)(2008-11#1)(2008-12#1)
often misdiagnosed##3##2##(2007-11#1)(2009-9#1)(2010-10#1)
often missed by##2##3##(1996-2#1)(2011-2#1)
often missed##4##2##(1996-2#1)(2008-7#1)(2010-4#1)(2011-2#1)
often more##5##2##(1990-5#1)(1995-11#1)(2008-5#1)(2008-8#1)(2010-10#1)
often much##2##2##(2008-9#1)(2010-3#1)
often must##2##2##(2008-11#1)(2011-2#1)
often need to##2##3##(1992-1#1)(2012-2#1)
often need##3##2##(1992-1#1)(2011-2#1)(2012-2#1)
often needed##2##2##(2008-4#1)(2008-8#1)
often needs##2##2##(2009-12#1)(2010-8#1)
often neglected##3##2##(1995-2#1)(2008-12#1)(2013-1#1)
often no##2##2##(2007-7#1)(2007-8#1)
often not##16##2##(1990-3#1)(1991-1#1)(1992-3#1)(1993-11#1)(1994-3#1)(2007-6#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
often noted##2##2##(1993-9#1)(2008-10#1)
often obscured##2##2##(1993-9#1)(2012-3#1)
often observed in##3##3##(1993-12#1)(2011-2#1)(2013-1#1)
often observed##9##2##(1993-12#1)(1996-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
often obtained##5##2##(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)
often occur as##2##3##(2008-8#2)
often occur in##3##3##(1994-3#1)(2008-7#1)(2011-2#1)
often occur##9##2##(1994-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)
often occurred##4##2##(1993-12#1)(1994-5#1)(1995-2#1)(1996-1#1)
often occurs at##2##3##(2008-2#1)(2011-2#1)
often occurs##5##2##(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#2)
often of##2##2##(2008-7#1)(2009-5#1)
often on the##2##3##(1992-1#1)(2008-9#1)
often on##3##2##(1992-1#1)(2008-8#1)(2008-9#1)
often only##2##2##(1997-3#1)(2008-9#1)
often overlap##2##2##(2008-8#1)(2012-3#1)
often overlooked##14##2##(1993-12#1)(1996-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#1)
often override##2##2##(2007-5#1)(2008-8#1)
often performed##3##2##(1990-12#1)(2008-7#1)(2010-12#1)
often poor##3##2##(2008-11#1)(2008-8#1)(2010-1#1)
often poorly##2##2##(1995-2#1)(2008-7#1)
often preferred##2##2##(2011-2#1)(2013-1#1)
often present at##2##3##(1997-2#1)(2008-10#1)
often present in the##2##4##(2007-12#1)(2008-1#1)
often present in##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
often present with a##2##4##(2008-10#1)(2010-9#1)
often present with##4##3##(2008-10#1)(2008-11#1)(2010-9#1)(2011-1#1)
often present##17##2##(1991-8#1)(1992-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)
often presents##7##2##(1992-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-10#1)
often produce##2##2##(2007-12#1)(2008-3#1)
often produced##2##2##(2008-12#1)(2008-9#1)
often provide##2##2##(1992-4#1)(1996-1#1)
often provides##2##2##(2008-10#1)(2009-8#1)
often reached##2##2##(1990-12#1)(2008-3#1)
often reduced##2##2##(2008-7#1)(2008-9#1)
often referred to as##6##4##(2007-9#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2013-7#1)
often referred##7##2##(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2013-7#1)
often related to##6##3##(1993-9#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
often remain##2##2##(1997-3#1)(2009-8#1)
often report##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
often reported in##2##3##(1991-12#1)(1997-3#1)
often reported##6##2##(1991-12#1)(1992-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-2#1)
often require orthopedic##2##3##(2008-7#1)(2008-8#1)
often require##10##2##(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-2#2)(2013-8#1)
often required in##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
often required to##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
often required##11##2##(1994-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
often requires##10##2##(1994-9#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#2)
often requiring##2##2##(2008-1#1)(2013-7#1)
often resistant to##2##3##(2008-7#1)(2013-1#1)
often resolves spontaneously##2##3##(2007-8#1)(2011-1#1)
often respond##2##2##(2007-12#1)(2012-12#1)
often responsible for##2##3##(2008-1#1)(2011-2#1)
often result in##3##3##(1993-12#1)(2008-12#1)(2012-2#1)
often resulting in##2##3##(2008-10#1)(2008-8#1)
often results from##2##3##(2008-10#1)(2008-2#1)
often results in a##3##4##(2006-10#1)(2008-6#1)(2011-2#1)
often results in##6##3##(1991-3#1)(1994-11#1)(2006-10#1)(2008-6#1)(2011-2#2)
often results##8##2##(1991-3#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#2)
often reveal##2##2##(1995-2#1)(2011-2#1)
often run##2##2##(2008-2#1)(2012-2#1)
often seen as##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
often seen in##7##3##(1992-5#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-7#1)(2010-7#1)(2012-12#1)
often seen##15##2##(1992-5#1)(1995-8#1)(1996-11#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-8#1)
often selected##2##2##(2008-10#1)(2008-12#1)
often show a##2##3##(2008-9#1)(2009-8#1)
often show##6##2##(1997-3#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)
often shows##2##2##(1997-3#1)(2008-12#1)
often start##2##2##(1990-2#1)(2008-11#1)
often suffer from##4##3##(1997-7#1)(2008-11#1)(2008-2#1)(2013-7#1)
often suffer##5##2##(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2013-7#1)
often suggested##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
often suggests##2##2##(1997-3#1)(2009-9#1)
often than not##2##3##(2008-1#1)(2008-10#1)
often than##22##2##(1990-12#1)(1990-8#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-3#1)
often the case##5##3##(1995-1#1)(2006-10#1)(2008-4#1)(2009-11#1)(2011-2#1)
often the data##2##3##(1991-12#1)(1992-9#1)
often the first##7##3##(1993-2#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
often the only##2##3##(2011-2#1)(2012-5#1)
often the primary##2##3##(2008-3#1)(2012-2#1)
often the##33##2##(1991-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-1#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-1#2)
often thought to##2##3##(2008-9#1)(2009-8#1)
often thought##3##2##(2008-9#1)(2009-8#1)(2010-8#1)
often to##5##2##(1997-4#1)(2008-11#2)(2008-3#1)(2013-1#1)
often treated with##2##3##(2010-12#1)(2013-1#1)
often triggered by##2##3##(1991-5#1)(2009-6#1)
often unavailable##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
often unclear##3##2##(2007-8#1)(2009-5#1)(2009-6#1)
often underestimated##4##2##(1997-3#1)(2010-5#1)(2012-12#1)(2013-8#1)
often undergo##4##2##(2008-8#1)(2009-3#1)(2012-2#2)
often unique##2##2##(1994-8#1)(2010-7#1)
often unknown##5##2##(1996-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
often unpredictable##2##2##(1993-12#1)(2007-12#1)
often unrecognised##2##2##(1990-3#1)(1992-9#1)
often use##2##2##(1996-3#1)(2009-4#1)
often used as a##6##4##(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
often used as the##3##4##(2007-12#1)(2008-10#1)(2010-12#1)
often used as##10##3##(1992-3#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-1#1)
often used for##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
often used in##12##3##(2006-4#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-10#1)(2010-6#1)
often used to##13##3##(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
often used##51##2##(1992-3#1)(1993-2#1)(1995-11#1)(1996-3#1)(1997-6#1)(2006-4#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)
often varies##2##2##(2008-3#1)(2008-9#1)
often very##2##2##(2008-9#1)(2012-2#1)
often was##3##2##(2008-10#2)(2008-12#1)
often were##7##2##(2008-10#6)(2011-1#1)
often with an##2##3##(1992-3#1)(2007-4#1)
often with##10##2##(1992-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-4#2)(2008-10#1)(2011-2#1)(2013-1#1)
often work##2##2##(2008-6#1)(2008-7#1)
often##1531##1##(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#4)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#5)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#11)(1992-4#4)(1992-5#6)(1992-6#1)(1992-8#4)(1992-9#9)(1993-1#3)(1993-11#4)(1993-12#15)(1993-2#7)(1993-3#6)(1993-6#2)(1993-8#1)(1993-9#8)(1994-1#2)(1994-11#7)(1994-12#9)(1994-2#4)(1994-3#10)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#8)(1996-2#12)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#3)(1996-8#1)(1997-1#6)(1997-2#9)(1997-3#19)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#11)(2006-10#13)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#4)(2007-11#11)(2007-12#16)(2007-2#5)(2007-4#9)(2007-5#7)(2007-6#3)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#27)(2008-10#138)(2008-11#57)(2008-12#24)(2008-2#31)(2008-3#35)(2008-4#36)(2008-5#37)(2008-6#17)(2008-7#60)(2008-8#65)(2008-9#58)(2009-10#4)(2009-11#7)(2009-12#7)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#10)(2009-6#11)(2009-7#5)(2009-8#13)(2009-9#12)(2010-1#7)(2010-10#9)(2010-11#6)(2010-12#16)(2010-2#5)(2010-3#11)(2010-4#16)(2010-5#13)(2010-6#8)(2010-7#6)(2010-8#10)(2010-9#3)(2011-1#22)(2011-2#85)(2011-3#4)(2011-7#4)(2012-1#6)(2012-12#31)(2012-2#43)(2012-3#34)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#66)(2013-7#7)(2013-8#19)
often)##2##1##(2011-2#2)
often-cited##2##1##(2008-9#1)(2012-2#1)
oftener##3##1##(2013-1#3)
oftenly##2##1##(2007-8#2)
ofthe DMN and its##2##4##(2013-8#2)
ofthe DMN##3##2##(2013-8#3)
ofthe artery##2##2##(2013-8#2)
ofthe disease##2##2##(2013-8#2)
ofthe##44##1##(2008-11#17)(2008-2#6)(2008-9#2)(2009-8#1)(2013-8#18)
ofthese##2##1##(2008-2#1)(2013-8#1)
ogt##4##1##(1992-8#4)
ohio##2##1##(2008-10#1)(2012-2#1)
ohmic##2##1##(2007-11#1)(2008-10#1)
oil (SFO)##2##2##(1992-5#1)(2013-1#1)
oil adulteration##2##2##(2008-10#2)
oil and grease (FOG)##2##4##(2013-1#2)
oil and##30##2##(1990-7#2)(1996-6#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#4)
oil are##2##2##(2008-3#1)(2013-1#1)
oil as the##3##3##(1992-2#1)(2008-10#1)(2008-6#1)
oil as##7##2##(1992-2#1)(2008-10#2)(2008-5#1)(2008-6#2)(2011-2#1)
oil biodiesel##2##2##(2009-3#2)
oil bodies##7##2##(2009-10#6)(2011-2#1)
oil body##2##2##(2009-10#2)
oil by##8##2##(2008-10#4)(2008-9#4)
oil coated fiber##2##3##(2008-10#2)
oil combinations##2##2##(2008-8#2)
oil concentration##3##2##(2008-10#3)
oil content and##2##3##(2008-5#1)(2012-2#1)
oil droplet size##2##3##(2008-7#2)
oil droplets##5##2##(2008-10#1)(2008-3#1)(2008-5#3)
oil exhibited##2##2##(2008-5#1)(2008-6#1)
oil extracted from the##4##4##(2008-5#3)(2013-1#1)
oil extracted from##5##3##(2008-5#3)(2010-3#1)(2013-1#1)
oil extracted##6##2##(2008-10#1)(2008-5#3)(2010-3#1)(2013-1#1)
oil fed##2##2##(1990-7#1)(1994-2#1)
oil field##2##2##(2008-11#1)(2011-2#1)
oil film##2##2##(2008-3#2)
oil for##6##2##(1990-2#1)(2008-10#1)(2008-5#2)(2009-3#1)(2013-1#1)
oil formulations were##2##3##(2008-10#1)(2012-12#1)
oil from the##2##3##(2008-10#1)(2011-1#1)
oil from##7##2##(2008-10#1)(2008-12#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
oil has been##2##3##(2008-10#1)(2008-5#1)
oil has##4##2##(2008-10#1)(2008-12#1)(2008-5#2)
oil immersion##2##2##(2007-11#1)(2013-1#1)
oil improves##2##2##(2008-5#1)(2013-1#1)
oil in the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
oil in water##2##3##(2008-5#2)
oil in water&quot##2##3##(2008-10#2)
oil in##20##2##(1992-2#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#4)(2008-6#1)(2012-3#1)(2013-8#1)
oil industry##4##2##(2008-10#1)(2011-1#2)(2013-1#1)
oil into##3##2##(2008-10#3)
oil is##4##2##(2008-10#1)(2008-6#1)(2013-1#2)
oil lamps found in##2##4##(2008-10#2)
oil lamps##4##2##(2008-10#4)
oil medium##3##2##(2008-10#1)(2009-5#2)
oil mixtures##3##2##(2008-10#2)(2008-3#1)
oil of ajedra##2##3##(2008-5#2)
oil of the##9##3##(2008-11#7)(2008-12#2)
oil of##23##2##(2008-11#17)(2008-12#2)(2008-5#4)
oil on##8##2##(1992-2#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-5#1)(2012-2#1)
oil or##4##2##(2009-8#1)(2012-1#1)(2012-2#2)
oil palm biosolid extract##3##4##(2011-2#3)
oil palm shell##2##3##(2013-1#2)
oil palm##7##2##(2008-10#2)(2011-2#3)(2013-1#2)
oil phase##7##2##(2008-5#6)(2008-6#1)
oil polyurethane composite##3##3##(2008-10#3)
oil refinery##3##2##(2008-10#2)(2011-2#1)
oil sample##3##2##(2008-10#3)
oil samples in##3##3##(2008-10#3)
oil samples varied in all cases between 1##2##8##(2008-10#2)
oil samples was##2##3##(2008-10#2)
oil samples##20##2##(2008-10#18)(2011-2#2)
oil should be##2##3##(1990-2#1)(2008-5#1)
oil showed##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
oil spill##6##2##(1997-4#3)(2008-10#2)(2008-11#1)
oil supplementation##3##2##(2010-1#2)(2012-1#1)
oil to##2##2##(2008-10#1)(2008-5#1)
oil treatment##3##2##(1992-2#1)(2008-9#2)
oil was found to##2##4##(2008-11#1)(2009-3#1)
oil was used for##2##4##(2008-11#1)(2010-5#1)
oil was used##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
oil was##15##2##(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2009-3#2)(2009-5#1)(2010-5#1)(2012-3#1)
oil were##5##2##(2007-1#1)(2008-10#2)(2012-3#2)
oil with##3##2##(2008-10#2)(2008-6#1)
oil##506##1##(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#2)(1992-2#7)(1992-5#1)(1992-9#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-5#1)(1996-6#1)(1997-4#3)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#186)(2008-11#32)(2008-12#10)(2008-2#1)(2008-3#16)(2008-4#1)(2008-5#64)(2008-6#18)(2008-7#3)(2008-8#2)(2008-9#9)(2009-10#11)(2009-3#11)(2009-5#6)(2009-8#4)(2010-1#3)(2010-3#6)(2010-5#9)(2010-6#1)(2011-1#9)(2011-2#18)(2012-1#2)(2012-12#1)(2012-2#13)(2012-3#6)(2013-1#26)(2013-7#4)(2013-8#2)
oil) and##3##2##(1990-7#1)(2008-10#1)(2013-1#1)
oil) were##2##2##(2008-10#1)(2008-6#1)
oil)##15##1##(1990-7#1)(1991-6#1)(1994-5#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#1)
oil-contaminated##3##1##(2008-11#1)(2011-1#2)
oil-film##2##1##(2008-3#2)
oil-immersion objective##3##2##(2007-12#1)(2008-3#2)
oil-immersion##4##1##(2007-12#1)(2008-3#3)
oil-in-water (o/w)##2##2##(2008-11#1)(2008-5#1)
oil-in-water emulsion##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
oil-in-water##11##1##(1992-9#1)(2008-10#2)(2008-11#3)(2008-5#4)(2013-1#1)
oils also##2##2##(2008-10#1)(2008-12#1)
oils and their main components##2##5##(2008-10#1)(2008-11#1)
oils and their##6##3##(2008-10#3)(2008-11#1)(2008-5#2)
oils and##23##2##(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#5)(2009-3#1)(2012-12#1)(2012-2#1)
oils as##3##2##(2008-2#1)(2009-3#2)
oils by##10##2##(2008-10#9)(2008-5#1)
oils extracted from##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
oils extracted##4##2##(2008-10#1)(2010-3#1)(2013-1#2)
oils from##7##2##(2008-10#4)(2008-12#1)(2010-3#1)(2011-2#1)
oils has##2##2##(2008-10#2)
oils have##2##2##(2008-11#1)(2009-3#1)
oils in excess methanol##4##4##(2013-1#4)
oils in##10##2##(1997-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#5)
oils is##3##2##(2008-10#3)
oils of##10##2##(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2012-2#1)(2013-1#1)
oils on the basis of##2##5##(2008-10#2)
oils the##2##2##(2008-10#1)(2008-5#1)
oils used##2##2##(2008-10#2)
oils using##2##2##(2008-10#2)
oils were determined##2##3##(2008-11#1)(2008-5#1)
oils were prepared##2##3##(2008-10#2)
oils were tested##2##3##(2008-10#1)(2008-11#1)
oils were##14##2##(2008-10#5)(2008-11#3)(2008-12#3)(2008-5#2)(2012-2#1)
oils with##2##2##(2008-10#1)(2008-5#1)
oils without titration##3##3##(2008-10#3)
oils##192##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1994-2#1)(1995-5#1)(1997-2#1)(2007-1#1)(2007-11#1)(2008-10#93)(2008-11#20)(2008-12#9)(2008-2#1)(2008-3#4)(2008-5#18)(2008-6#1)(2008-8#3)(2009-3#4)(2010-1#1)(2010-3#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#12)
oilseed poppy##2##2##(2008-10#2)
oilseed radish##2##2##(2008-10#2)
oilseed rape##10##2##(2008-10#9)(2011-2#1)
oilseed##16##1##(2008-10#15)(2011-2#1)
oilseeds##4##1##(2008-10#3)(2010-7#1)
oily paste extracts##2##3##(2008-10#2)
oily phase##2##2##(2008-5#2)
oily##7##1##(2008-10#3)(2008-3#1)(2008-5#3)
ointment bases##2##2##(2008-5#2)
ointment prepared from ethanolic extract of Lemon verbena##2##8##(2008-12#2)
ointment##13##1##(1993-11#1)(1997-2#1)(2007-12#1)(2007-7#4)(2008-10#1)(2008-12#2)(2008-5#2)(2011-2#1)
ointments##4##1##(1995-5#1)(1997-2#2)(2007-11#1)
okadaic acid (IC50 =##2##4##(1995-8#2)
okadaic acid (OA)##2##3##(1993-8#1)(1994-11#1)
okadaic acid and##5##3##(1992-12#2)(1993-8#1)(1995-3#1)(1997-6#1)
okadaic acid on##3##3##(1992-12#1)(1992-8#1)(1993-8#1)
okadaic acid##34##2##(1990-12#1)(1991-5#3)(1992-12#4)(1992-8#4)(1992-9#3)(1993-8#4)(1994-11#3)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-8#3)(1997-6#1)(2008-2#1)(2008-4#1)
okadaic##36##1##(1990-12#1)(1991-5#3)(1992-12#4)(1992-8#4)(1992-9#5)(1993-8#4)(1994-11#3)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-8#3)(1997-6#1)(2008-2#1)(2008-4#1)
olanzapine##9##1##(2008-3#1)(2008-6#4)(2008-7#1)(2010-2#3)
old (20##2##2##(2008-3#1)(2013-7#1)
old WAG/Rij rats##2##3##(1990-2#2)
old Wistar##2##2##(1995-8#1)(2011-1#1)
old age are##2##3##(2012-1#1)(2012-3#1)
old age is##4##3##(1990-11#2)(2012-1#1)(2013-7#1)
old age##37##2##(1990-11#4)(1990-3#3)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
old and older##2##3##(2008-10#1)(2008-4#1)
old and young larvae##2##4##(2008-12#2)
old and young##7##3##(1994-6#1)(2008-12#2)(2009-10#2)(2009-12#1)(2009-8#1)
old and##24##2##(1991-9#1)(1994-6#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
old animals##6##2##(1991-12#1)(1993-12#1)(1994-6#1)(1996-5#1)(2008-3#1)(2008-7#1)
old as##4##2##(1991-12#2)(1996-3#1)(2008-9#1)
old at##2##2##(2008-10#1)(2008-6#1)
old baby##3##2##(1992-4#1)(2010-4#2)
old boy with##5##3##(1991-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-8#1)
old boy##13##2##(1991-11#1)(1993-6#1)(1996-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
old but##2##2##(1990-3#2)
old cells##2##2##(1994-5#1)(2008-7#1)
old child who##3##3##(2007-7#1)(2010-5#1)(2013-1#1)
old child##5##2##(1995-11#1)(2007-7#2)(2010-5#1)(2013-1#1)
old children##5##2##(1992-1#1)(2008-1#1)(2009-11#1)(2013-1#2)
old cuticle##3##2##(2008-7#3)
old female patient with##3##4##(2008-1#1)(2009-4#1)(2011-2#1)
old female patient##8##3##(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-8#1)
old female presented to##2##4##(2011-2#1)(2013-1#1)
old female presented##4##3##(1994-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
old female was##2##3##(1997-6#1)(2011-1#1)
old female who presented with##2##5##(2009-7#1)(2011-2#1)
old female with##4##3##(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
old female##29##2##(1993-5#1)(1994-7#1)(1995-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
old fetuses##2##2##(2007-11#2)
old for##3##2##(1996-11#1)(2013-1#2)
old gentleman##2##2##(2007-8#1)(2010-5#1)
old girl##5##2##(1994-2#1)(2008-7#1)(2011-1#1)(2011-2#2)
old had##2##2##(1990-6#1)(2013-8#1)
old hens was##2##3##(2012-1#2)
old hens##3##2##(2012-1#3)
old in##8##2##(1994-6#1)(1997-4#1)(1997-7#1)(2010-3#2)(2011-1#1)(2011-2#2)
old lacquer-ware##2##2##(2008-10#2)
old lady who##2##3##(2008-7#1)(2012-2#1)
old lady##6##2##(2007-7#2)(2008-7#1)(2010-12#1)(2012-2#1)(2013-7#1)
old male Wistar rats##2##4##(1995-12#1)(2013-1#1)
old male with##2##3##(2007-7#1)(2011-2#1)
old male##24##2##(1995-12#1)(1997-6#2)(2007-7#1)(2008-7#6)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
old man developed##2##3##(1990-9#1)(1993-8#1)
old man who presented##2##4##(1991-11#1)(2011-2#1)
old man who##4##3##(1991-11#1)(2009-1#1)(2011-2#2)
old man with a##2##4##(1997-6#1)(2013-7#1)
old man with##8##3##(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-7#1)
old man##28##2##(1990-9#1)(1991-11#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1997-6#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
old mice by##2##3##(1994-5#1)(2013-7#1)
old mice##7##2##(1994-5#2)(2012-2#2)(2013-7#3)
old mouse##2##2##(1990-3#1)(1994-5#1)
old of##3##2##(2008-12#2)(2010-7#1)
old ones##4##2##(2007-12#1)(2008-7#2)(2008-8#1)
old or##3##2##(1991-9#1)(1996-2#1)(2011-2#1)
old patient with##6##3##(1994-5#1)(2008-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#1)
old patient##16##2##(1994-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
old people##6##2##(1990-11#1)(1994-6#2)(2007-11#1)(2008-7#1)(2008-9#1)
old problem##3##2##(1990-3#1)(1993-8#1)(2010-8#1)
old questions##2##2##(2008-11#1)(2012-2#1)
old rat##3##2##(1994-8#1)(1996-12#1)(2009-12#1)
old rats were##2##3##(1991-12#1)(1994-6#1)
old rats##30##2##(1991-12#4)(1994-11#1)(1994-6#9)(1994-8#1)(1996-5#1)(1997-2#1)(2008-7#12)(2009-12#1)
old subjects##4##2##(1994-6#1)(1996-2#1)(1996-8#1)(2008-7#1)
old than##3##2##(2008-7#2)(2010-8#1)
old tissues##2##2##(1994-5#2)
old were##5##2##(1997-6#1)(2008-1#1)(2011-2#1)(2012-12#2)
old who attended a##2##4##(2008-8#1)(2010-10#1)
old who##4##2##(2007-2#1)(2008-7#1)(2008-8#1)(2010-10#1)
old with a##2##3##(1990-10#1)(2007-7#1)
old with##4##2##(1990-10#1)(2007-7#1)(2008-6#1)(2008-9#1)
old woman and##2##3##(1990-2#1)(2009-1#1)
old woman is presented##3##4##(1990-6#1)(1991-5#1)(2007-8#1)
old woman presented with##2##4##(1990-6#1)(2011-2#1)
old woman who##4##3##(1997-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
old woman with##3##3##(1990-12#1)(1991-6#1)(2013-1#1)
old woman##33##2##(1990-12#2)(1990-2#2)(1990-6#2)(1991-5#2)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-11#1)(1997-6#2)(2007-12#1)(2007-8#3)(2008-5#1)(2009-1#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
old women##3##2##(1997-4#1)(2007-8#1)(2008-10#1)
old##659##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#12)(1990-6#8)(1990-9#3)(1991-1#4)(1991-11#5)(1991-12#10)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#5)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#12)(1994-6#19)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#2)(1995-8#2)(1995-9#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#12)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#2)(2007-6#2)(2007-7#7)(2007-8#14)(2008-1#17)(2008-10#35)(2008-11#7)(2008-12#17)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#3)(2008-7#64)(2008-8#12)(2008-9#14)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#5)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#7)(2011-1#11)(2011-2#45)(2012-1#9)(2012-12#14)(2012-2#13)(2012-3#14)(2012-5#1)(2013-1#31)(2013-7#7)(2013-8#11)
old&quot##4##1##(1994-5#1)(2008-10#1)(2012-2#1)(2013-1#1)
old) and##7##2##(1993-12#1)(1994-6#1)(2008-10#1)(2008-7#2)(2010-12#1)(2013-8#1)
old) were##4##2##(2008-12#1)(2008-9#1)(2010-12#1)(2012-2#1)
old) with##4##2##(2008-6#1)(2012-12#1)(2013-1#2)
old)##53##1##(1990-10#1)(1992-11#2)(1993-12#4)(1994-6#2)(1996-5#1)(1996-8#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-8#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
older Americans##2##2##(1994-1#1)(1996-12#1)
older Maori##4##2##(2008-1#4)
older Māori##2##2##(2012-12#2)
older New##2##2##(2012-12#2)
older adolescents##3##2##(2010-1#2)(2013-1#1)
older adult##11##2##(1996-2#1)(2008-10#1)(2009-12#2)(2010-10#2)(2013-1#4)(2013-7#1)
older adulthood##2##2##(2010-3#1)(2012-2#1)
older adults and##3##3##(2010-8#1)(2013-1#2)
older adults are##5##3##(1992-1#1)(1996-1#1)(2007-12#1)(2013-1#2)
older adults in##6##3##(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#2)
older adults living##2##3##(2008-5#2)
older adults to##3##3##(2008-1#1)(2010-4#1)(2013-1#1)
older adults were##2##3##(2008-12#1)(2011-1#1)
older adults with##10##3##(1992-1#1)(1992-6#1)(2010-11#4)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
older adults##90##2##(1991-12#1)(1992-1#4)(1992-12#1)(1992-6#2)(1995-12#1)(1996-1#1)(1997-3#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-4#2)(2010-7#2)(2010-8#5)(2011-1#7)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#15)(2013-8#1)
older adults' health##2##3##(2009-7#1)(2010-10#1)
older adults'##5##2##(2009-7#3)(2010-10#1)(2013-1#1)
older age groups##5##3##(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
older age##20##2##(1993-12#1)(1996-11#1)(2007-10#3)(2008-1#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
older ages##4##2##(1992-6#2)(2009-7#2)
older and younger##3##3##(1994-6#1)(2009-8#2)
older and##12##2##(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(2008-10#2)(2009-8#2)(2011-2#2)(2013-8#1)
older animals##6##2##(1990-3#1)(1994-5#2)(2008-3#1)(2009-12#1)(2010-2#1)
older at##2##2##(2010-11#2)
older athletes##4##2##(2013-1#4)
older berries##5##2##(2008-10#5)
older child##2##2##(2008-2#1)(2008-9#1)
older children and adolescents##3##4##(1995-12#2)(2011-2#1)
older children and adults##2##4##(1996-2#1)(2011-2#1)
older children and##6##3##(1995-12#2)(1996-2#1)(2008-10#1)(2011-2#2)
older children with##4##3##(1991-2#2)(2007-8#1)(2013-1#1)
older children##22##2##(1991-2#2)(1992-3#1)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1996-2#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#3)(2013-1#1)
older control##4##2##(2008-10#4)
older dogs##3##2##(1996-12#1)(2012-3#2)
older donors##2##2##(2011-2#2)
older formulations##2##2##(2008-2#1)(2008-4#1)
older healthy##2##2##(1992-9#1)(2013-1#1)
older individuals with##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
older individuals##8##2##(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-1#1)
older men and women##3##4##(1995-3#1)(2009-11#1)(2012-12#1)
older men and##4##3##(1995-3#1)(2009-11#1)(2009-5#1)(2012-12#1)
older men with heart trouble##2##5##(2009-7#2)
older men with##4##3##(2008-4#2)(2009-7#2)
older men##14##2##(1995-3#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#2)(2012-12#1)
older mothers##4##2##(1997-3#2)(2010-2#2)
older ones##3##2##(1991-2#1)(1992-8#1)(1995-5#1)
older participants##2##2##(2009-3#1)(2012-1#1)
older patients with cancer##5##4##(2008-7#2)(2010-11#3)
older patients with##16##3##(1991-1#1)(1992-9#2)(1996-7#1)(2007-8#1)(2008-7#2)(2010-10#1)(2010-11#4)(2010-8#1)(2011-1#1)(2011-2#2)
older patients##37##2##(1991-1#2)(1991-12#1)(1992-9#2)(1995-5#1)(1996-7#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2010-10#2)(2010-11#4)(2010-12#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-2#1)(2013-8#2)
older people and their##3##4##(1997-3#1)(2010-10#1)(2011-1#1)
older people and##5##3##(1997-3#1)(2010-10#2)(2011-1#1)(2013-1#1)
older people as well as##2##5##(2010-10#2)
older people as##3##3##(2010-10#3)
older people in their own##2##5##(2010-10#2)
older people in##8##3##(1991-2#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#4)
older people is##2##3##(2008-3#1)(2010-10#1)
older people to remain##3##4##(2010-10#1)(2013-1#2)
older people to##4##3##(2010-10#2)(2013-1#2)
older people with##2##3##(1991-1#1)(2013-8#1)
older people##73##2##(1991-1#1)(1991-2#1)(1994-12#1)(1995-3#1)(1996-11#4)(1997-3#2)(2008-1#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#2)(2010-10#32)(2010-3#2)(2011-1#2)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#3)
older people's dignity##2##3##(2010-10#2)
older people's lived experiences##2##4##(2010-10#2)
older people's##5##2##(2010-10#5)
older persons in##5##3##(1995-1#1)(1997-2#1)(1997-3#1)(2010-10#2)
older persons##13##2##(1994-2#1)(1995-1#2)(1997-2#1)(1997-3#1)(2008-3#1)(2010-10#4)(2011-1#1)(2011-2#1)(2012-2#1)
older population##5##2##(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
older pregnant women##2##3##(2011-1#2)
older subjects##7##2##(1995-5#1)(1996-2#1)(2008-3#2)(2008-6#1)(2008-7#2)
older taxa have older##2##4##(2008-11#2)
older than 18 years##2##4##(2010-5#1)(2011-1#1)
older than 30##2##3##(2008-10#1)(2008-7#1)
older than 50 years##2##4##(1993-8#1)(2012-1#1)
older than 60 years##4##4##(2007-12#1)(2011-2#2)(2012-3#1)
older than 60##5##3##(2007-12#1)(2008-4#1)(2011-2#2)(2012-3#1)
older than 65 years of age##4##6##(2010-3#1)(2011-2#3)
older than 65 years##14##4##(1992-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2010-4#1)(2011-2#6)(2012-3#1)(2013-1#1)
older than 65##18##3##(1990-2#1)(1992-5#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2010-4#2)(2011-2#6)(2012-3#1)(2013-1#1)
older than 75 years##2##4##(2008-3#1)(2008-4#1)
older than 75##3##3##(1992-6#1)(2008-3#1)(2008-4#1)
older than the##4##3##(1994-6#1)(1996-9#1)(2008-12#1)(2009-2#1)
older than two##2##3##(1994-6#1)(2010-10#1)
older than##61##2##(1990-12#1)(1990-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-6#3)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#1)(2009-1#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
older volunteers##3##2##(1991-12#1)(1996-3#1)(2008-3#1)
older white men##2##3##(2009-5#1)(2009-7#1)
older women##26##2##(1994-2#1)(1996-8#1)(2008-3#7)(2008-7#1)(2009-10#1)(2010-10#4)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
older workers##3##2##(2008-6#3)
older##659##1##(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#6)(1991-11#3)(1991-12#4)(1991-2#4)(1991-9#1)(1992-1#4)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#7)(1992-8#1)(1992-9#6)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#4)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#6)(1996-3#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#6)(1997-8#1)(2007-10#6)(2007-11#1)(2007-12#9)(2007-7#5)(2007-8#5)(2008-1#10)(2008-10#29)(2008-11#16)(2008-12#7)(2008-2#2)(2008-3#32)(2008-4#16)(2008-5#7)(2008-6#10)(2008-7#19)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#11)(2009-8#8)(2010-1#5)(2010-10#68)(2010-11#13)(2010-12#1)(2010-2#5)(2010-3#7)(2010-4#5)(2010-5#2)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#22)(2011-2#39)(2012-1#5)(2012-12#21)(2012-2#14)(2012-3#11)(2013-1#49)(2013-7#1)(2013-8#13)
older) were enrolled##2##3##(1990-3#1)(1995-9#1)
older) were##3##2##(1990-3#1)(1993-2#1)(1995-9#1)
older)##7##1##(1990-3#1)(1991-9#1)(1993-2#1)(1995-9#1)(2009-7#1)(2010-12#1)(2011-2#1)
olderthan##2##1##(2009-8#2)
oldest age groups##2##3##(1993-12#1)(2008-7#1)
oldest age##5##2##(1993-12#1)(2008-7#1)(2011-2#1)(2012-3#2)
oldest child##2##2##(2011-2#1)(2013-1#1)
oldest old##7##2##(1994-5#2)(2007-10#1)(2010-12#1)(2010-3#3)
oldest##40##1##(1990-3#1)(1992-4#1)(1993-12#1)(1994-5#2)(1994-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(2007-10#1)(2008-10#4)(2008-7#3)(2009-7#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
oleaginous yeast Cryptococcus curvatus##2##4##(1996-6#2)
oleaginous yeast##5##2##(1996-6#2)(2011-1#2)(2013-1#1)
oleaginous##7##1##(1996-6#2)(2011-1#2)(2013-1#3)
oleander leaf##3##2##(2008-10#3)
oleander##11##1##(2008-10#9)(2008-12#2)
oleanders##2##1##(2008-10#2)
oleanolic acid##4##2##(2007-1#1)(2008-5#1)(2011-1#1)(2012-2#1)
oleate##3##1##(1990-2#1)(1992-3#1)(2008-10#1)
olefin##5##1##(1996-5#1)(2008-2#2)(2009-10#1)(2009-6#1)
olefins##5##1##(1997-7#1)(2007-11#1)(2008-10#1)(2010-4#1)(2011-2#1)
oleic (C18##2##2##(2008-10#1)(2008-11#1)
oleic acid to##2##3##(1992-12#1)(1993-9#1)
oleic acid##26##2##(1990-2#1)(1990-5#2)(1990-7#3)(1992-12#1)(1992-8#1)(1993-6#4)(1993-9#4)(1994-2#1)(1994-3#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)
oleic acid)##2##2##(2008-10#1)(2009-11#1)
oleic and##3##2##(1994-8#1)(2008-11#1)(2008-12#1)
oleic or##2##2##(1994-2#1)(1994-8#1)
oleic##43##1##(1990-2#3)(1990-5#2)(1990-7#3)(1992-12#1)(1992-8#1)(1993-6#4)(1993-9#4)(1994-2#2)(1994-3#1)(1994-8#2)(1996-6#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-7#2)(2009-11#1)(2010-4#1)(2013-1#2)
oleophila##10##1##(2008-10#10)
oleosin knockdown shows##2##3##(2009-10#2)
oleosin knockdown##4##2##(2009-10#4)
oleosin##10##1##(2009-10#8)(2011-2#2)
oleracea##11##1##(2008-10#7)(2008-8#1)(2012-3#3)
oleracea)##4##1##(2008-10#4)
olfaction and##2##2##(2008-9#2)
olfaction##5##1##(1993-3#1)(2008-9#3)(2012-2#1)
olfactive character##2##2##(2008-5#2)
olfactometer##2##1##(2009-8#1)(2013-8#1)
olfactory bulb (OB)##3##3##(1990-7#1)(2012-2#1)(2013-1#1)
olfactory bulb and##7##3##(1997-4#1)(2008-11#1)(2009-12#2)(2013-1#3)
olfactory bulb in##2##3##(1996-5#1)(2009-12#1)
olfactory bulb##35##2##(1990-11#1)(1990-7#3)(1992-8#2)(1993-3#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-4#1)(2008-11#1)(2008-6#2)(2008-7#5)(2009-12#7)(2012-2#3)(2013-1#5)
olfactory bulbs##5##2##(1993-3#1)(1994-2#1)(1996-5#2)(2008-7#1)
olfactory conditioning##2##2##(1994-8#2)
olfactory cues##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
olfactory ensheathing cells##3##3##(2008-7#3)
olfactory ensheathing##5##2##(2008-7#5)
olfactory epithelium##8##2##(1991-5#1)(1995-12#1)(2008-5#3)(2008-6#1)(2012-1#2)
olfactory groove meningioma##3##3##(2006-12#2)(2008-8#1)
olfactory groove meningiomas##3##3##(2006-12#3)
olfactory groove##7##2##(2006-12#6)(2008-8#1)
olfactory learning in##2##3##(2009-8#1)(2012-2#1)
olfactory learning##8##2##(1994-3#1)(2009-8#3)(2012-2#4)
olfactory lobe##2##2##(2007-12#2)
olfactory lobes of ethanol treated male rats##2##7##(1993-6#2)
olfactory nerve##7##2##(1993-3#1)(1995-12#4)(2008-5#2)
olfactory neurons##2##2##(1991-5#2)
olfactory notes##2##2##(2012-2#2)
olfactory receptor neurons (ORNs)##2##4##(2007-12#2)
olfactory receptor neurons##4##3##(2007-12#3)(2009-12#1)
olfactory receptor##5##2##(2007-12#3)(2009-12#2)
olfactory sensilla##2##2##(2007-12#1)(2008-7#1)
olfactory sensory units##3##3##(2007-12#3)
olfactory signal termination##2##3##(1991-2#2)
olfactory stimulation##2##2##(1994-8#1)(2008-10#1)
olfactory system##6##2##(1990-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)
olfactory systems##3##2##(2007-12#1)(2008-7#1)(2009-10#1)
olfactory tract transection##2##3##(2013-1#2)
olfactory tract##4##2##(2008-6#1)(2013-1#3)
olfactory tubercle##5##2##(1991-2#2)(1991-5#1)(1993-6#1)(1996-12#1)
olfactory##151##1##(1990-11#1)(1990-5#3)(1990-7#3)(1991-2#10)(1991-5#4)(1992-8#3)(1993-12#1)(1993-3#5)(1993-6#3)(1994-2#1)(1994-3#3)(1994-8#3)(1995-12#5)(1996-12#2)(1996-5#5)(1997-3#1)(1997-4#1)(2006-12#6)(2007-12#19)(2008-10#1)(2008-11#2)(2008-5#11)(2008-6#6)(2008-7#15)(2008-8#1)(2009-10#1)(2009-12#10)(2009-8#3)(2012-1#2)(2012-2#12)(2013-1#8)
olfactory-specific##2##1##(1991-2#2)
oligandrin treatment##2##2##(2008-10#2)
oligandrin##6##1##(2008-10#6)
oligandrum and##4##2##(2008-10#4)
oligandrum isolates##2##2##(2008-10#2)
oligandrum or oligandrin were##2##4##(2008-10#2)
oligandrum or##3##2##(2008-10#3)
oligandrum was##3##2##(2008-10#3)
oligandrum##29##1##(2008-10#29)
oligo decoys##2##2##(2008-9#2)
oligo##5##1##(1990-5#1)(2008-10#1)(2008-9#3)
oligo(dN)##5##1##(1991-12#5)
oligo(dT)##5##1##(1990-7#3)(1991-12#1)(2008-10#1)
oligo(ethylene oxide) dodecyl ethers##2##4##(1994-12#2)
oligo(ethylene##4##1##(1994-12#2)(2008-10#1)(2008-4#1)
oligo-gene##2##1##(2007-12#2)
oligoadenylates##2##1##(1994-11#2)
oligoarthritis##5##1##(1990-6#1)(2006-10#2)(2012-2#2)
oligoclonal##4##1##(1997-8#1)(2008-11#2)(2011-2#1)
oligodendrocyte progenitor##2##2##(2008-12#1)(2008-7#1)
oligodendrocyte progenitors##4##2##(1996-12#2)(2008-7#2)
oligodendrocyte##18##1##(1995-12#1)(1996-12#6)(1996-5#1)(2008-12#1)(2008-7#8)(2012-2#1)
oligodendrocytes and astrocytes##5##3##(1996-5#3)(2008-11#1)(2008-7#1)
oligodendrocytes and##8##2##(1996-5#4)(2008-11#1)(2008-7#3)
oligodendrocytes from##2##2##(1991-5#1)(2008-7#1)
oligodendrocytes in##2##2##(1991-5#1)(1995-5#1)
oligodendrocytes##39##1##(1991-5#4)(1995-5#3)(1996-12#2)(1996-2#1)(1996-5#13)(2008-11#3)(2008-12#1)(2008-7#10)(2009-6#2)
oligodendrogenesis##3##1##(2008-7#3)
oligodendroglioma##7##1##(2007-10#3)(2011-1#3)(2012-1#1)
oligodendrogliomas##2##1##(1991-8#1)(2008-11#1)
oligodeoxynucleotide decoys##2##2##(2008-9#2)
oligodeoxynucleotide##10##1##(1993-6#1)(1995-12#1)(2008-11#2)(2008-4#1)(2008-9#3)(2011-2#1)(2012-2#1)
oligodeoxynucleotides (ODNs)##3##2##(1996-12#1)(2008-10#2)
oligodeoxynucleotides##28##1##(1991-12#1)(1992-6#3)(1993-3#3)(1993-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-7#1)(2008-10#8)(2008-11#1)(2008-4#5)(2008-9#1)(2011-2#1)
oligodeoxyribonucleotide primers##4##2##(1990-11#1)(1993-9#1)(1994-12#2)
oligodeoxyribonucleotide##16##1##(1990-11#2)(1990-5#3)(1991-9#1)(1993-12#2)(1993-9#1)(1994-12#2)(1995-5#1)(1997-7#1)(2008-4#3)
oligodeoxyribonucleotides to##2##2##(1994-12#1)(2008-4#1)
oligodeoxyribonucleotides##22##1##(1990-5#1)(1991-9#2)(1993-2#1)(1993-6#1)(1994-12#3)(1995-8#1)(1997-2#1)(2008-4#12)
oligogenic##2##1##(2008-10#1)(2008-4#1)
oligohydramnios##4##1##(2008-7#1)(2012-12#2)(2012-3#1)
oligohydramnious##2##1##(2011-2#2)
oligomer can##2##2##(1990-7#2)
oligomer structure##2##2##(1994-11#1)(2008-9#1)
oligomer##29##1##(1990-11#1)(1990-7#5)(1991-5#1)(1992-6#1)(1993-8#1)(1994-11#2)(1994-5#5)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#1)
oligomeric complexes##2##2##(1994-8#1)(2008-8#1)
oligomeric protein##2##2##(1994-8#1)(2010-9#1)
oligomeric stilbenes##2##2##(2008-10#2)
oligomeric structure with##2##3##(2008-4#1)(2012-1#1)
oligomeric structure##5##2##(1994-6#1)(1997-8#1)(2008-4#2)(2012-1#1)
oligomeric##20##1##(1990-12#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#2)(1997-8#1)(2008-10#3)(2008-4#2)(2008-8#1)(2010-9#2)(2011-2#1)(2012-1#1)
oligomerization domain##3##2##(1990-11#1)(2011-1#1)(2013-8#1)
oligomerization of the##2##3##(1991-5#1)(1994-11#1)
oligomerization of##4##2##(1991-5#1)(1994-11#1)(1994-8#1)(1995-5#1)
oligomerization##17##1##(1990-11#2)(1991-5#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-5#1)(2008-10#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
oligomerize##2##1##(2008-10#1)(2011-2#1)
oligomers and##2##2##(2007-12#1)(2008-10#1)
oligomers are##2##2##(1994-11#1)(1994-8#1)
oligomers have##2##2##(1995-11#1)(2010-8#1)
oligomers of##6##2##(1991-5#1)(1995-11#2)(1995-5#1)(2006-12#1)(2008-10#1)
oligomers##42##1##(1990-11#1)(1990-7#1)(1991-5#1)(1991-9#2)(1992-11#1)(1993-11#1)(1994-11#2)(1994-8#2)(1995-11#4)(1995-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-4#5)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
oligonucleosomal##2##1##(2008-10#1)(2008-8#1)
oligonucleotide &quot##2##2##(2008-1#1)(2008-9#1)
oligonucleotide and##5##2##(1992-6#1)(2008-4#3)(2009-12#1)
oligonucleotide containing##2##2##(1993-11#1)(1995-5#1)
oligonucleotide designed to##3##3##(1992-12#1)(2008-10#2)
oligonucleotide duplex##2##2##(1993-11#2)
oligonucleotide in##3##2##(1993-11#1)(1997-8#1)(2008-11#1)
oligonucleotide microarray##2##2##(2011-2#1)(2012-3#1)
oligonucleotide primer##2##2##(1996-12#1)(2008-10#1)
oligonucleotide primers derived from##2##4##(1997-6#1)(2008-10#1)
oligonucleotide primers designed##2##3##(1995-11#1)(2008-10#1)
oligonucleotide primers for##2##3##(2008-10#2)
oligonucleotide primers##18##2##(1992-3#1)(1993-3#1)(1995-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
oligonucleotide probe##10##2##(1991-12#1)(1992-9#1)(1993-3#1)(1996-2#1)(1997-8#2)(2008-10#3)(2008-9#1)
oligonucleotide probes are##3##3##(2008-10#1)(2008-4#2)
oligonucleotide probes##16##2##(1992-3#1)(1992-8#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-4#4)(2008-9#2)
oligonucleotide sequences##2##2##(1993-12#1)(2008-10#1)
oligonucleotide strands##2##2##(2008-4#2)
oligonucleotide synthesis##8##2##(1997-7#1)(2008-4#7)
oligonucleotide to GABAA receptor gamma 2 subunit##2##7##(1995-11#1)(1995-12#1)
oligonucleotide was##2##2##(1995-5#1)(2008-10#1)
oligonucleotide##161##1##(1990-2#1)(1991-12#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#7)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-5#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-5#4)(1996-12#3)(1996-2#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2008-1#2)(2008-10#38)(2008-11#6)(2008-2#1)(2008-4#40)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-12#2)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
oligonucleotide-directed mutagenesis##4##2##(1990-10#1)(1992-3#1)(1995-2#1)(1995-5#1)
oligonucleotides and their analogs##2##4##(2008-4#2)
oligonucleotides and##7##2##(2008-10#1)(2008-2#2)(2008-4#3)(2011-1#1)
oligonucleotides are##2##2##(1990-7#1)(2008-4#1)
oligonucleotides as##2##2##(1991-5#1)(2008-11#1)
oligonucleotides can be##2##3##(2008-4#2)
oligonucleotides containing the##2##3##(1991-3#1)(1992-3#1)
oligonucleotides containing##6##2##(1991-3#1)(1992-3#1)(1993-11#1)(1995-2#1)(2008-4#2)
oligonucleotides derived from##2##3##(1994-11#1)(2008-10#1)
oligonucleotides designed##3##2##(1993-8#1)(1996-8#1)(2008-10#1)
oligonucleotides in##3##2##(1992-11#1)(2008-2#1)(2008-4#1)
oligonucleotides into##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
oligonucleotides is##2##2##(2007-11#1)(2008-4#1)
oligonucleotides on crosslinked poly(vinyl alcohol)##2##5##(2008-10#2)
oligonucleotides on##3##2##(2008-10#3)
oligonucleotides or##2##2##(2008-10#1)(2011-2#1)
oligonucleotides that are##2##3##(2007-12#1)(2008-4#1)
oligonucleotides that##4##2##(2007-12#1)(2008-10#1)(2008-4#2)
oligonucleotides to##2##2##(1991-12#1)(2008-2#1)
oligonucleotides via##2##2##(2008-4#2)
oligonucleotides was##2##2##(2008-10#1)(2008-11#1)
oligonucleotides were##4##2##(1993-8#1)(2008-10#2)(2011-2#1)
oligonucleotides with##4##2##(2008-10#2)(2008-4#2)
oligonucleotides##128##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#5)(1994-11#2)(1994-12#2)(1995-12#1)(1995-2#8)(1995-5#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-2#4)(2008-4#37)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#10)(2012-2#1)
oligopeptide substrates##5##2##(1991-9#5)
oligopeptide##12##1##(1991-9#5)(1992-11#1)(1996-6#2)(2008-5#1)(2008-8#3)
oligopeptides##7##1##(1990-2#1)(1992-12#1)(1992-9#1)(1994-11#1)(2008-10#1)(2008-5#1)(2010-10#1)
oligopolies##2##1##(1996-12#1)(1997-2#1)
oligoribonucleotide##3##1##(2008-4#3)
oligosaccharide binding##2##2##(1993-8#1)(1995-5#1)
oligosaccharide chain##3##2##(1994-8#1)(1995-5#1)(2008-4#1)
oligosaccharide chains##10##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-9#2)(2008-11#1)(2008-4#3)
oligosaccharide distribution##2##2##(2008-7#2)
oligosaccharide on##4##2##(1991-9#1)(1992-12#3)
oligosaccharide preparation##2##2##(2008-12#2)
oligosaccharide side chains##2##3##(1994-11#1)(1995-11#1)
oligosaccharide substrates##2##2##(1990-7#1)(2008-7#1)
oligosaccharide synthesis##2##2##(1997-4#2)
oligosaccharide##70##1##(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-12#9)(1993-11#6)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#3)(1994-9#4)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#1)(1997-4#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#8)(2008-7#8)(2009-8#1)(2012-2#1)
oligosaccharides and##4##2##(1991-12#1)(2009-2#1)(2010-11#1)(2010-2#1)
oligosaccharides are##5##2##(1995-6#1)(2008-11#1)(2008-6#1)(2012-2#2)
oligosaccharides by##2##2##(1993-11#2)
oligosaccharides composed of##2##3##(1995-6#2)
oligosaccharides containing##2##2##(1990-12#1)(2008-11#1)
oligosaccharides from##2##2##(1993-11#1)(1994-5#1)
oligosaccharides have##2##2##(1993-11#1)(1995-6#1)
oligosaccharides having##3##2##(1994-5#2)(1995-2#1)
oligosaccharides in##5##2##(1991-12#1)(1993-11#1)(1994-9#1)(1995-2#1)(2012-2#1)
oligosaccharides obtained##3##2##(1990-9#2)(1992-12#1)
oligosaccharides of##2##2##(1992-12#1)(2008-5#1)
oligosaccharides on##3##2##(1992-10#2)(2008-4#1)
oligosaccharides was##2##2##(2008-10#1)(2008-12#1)
oligosaccharides were##4##2##(1990-9#1)(1993-11#2)(2008-7#1)
oligosaccharides with##3##2##(1991-9#1)(1993-11#1)(2008-10#1)
oligosaccharides##98##1##(1990-12#3)(1990-7#3)(1990-9#3)(1991-12#5)(1991-9#1)(1992-10#7)(1992-12#4)(1993-1#1)(1993-11#12)(1993-8#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#8)(1995-8#1)(1997-2#1)(1997-4#3)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-2#7)
oligospora##2##1##(2008-10#2)
oligosymptomatic##2##1##(1996-8#1)(2007-2#1)
oligothiophenes##2##1##(2011-2#2)
oligotrophic##7##1##(2008-10#5)(2008-2#1)(2008-3#1)
oliguric##3##1##(2008-1#1)(2008-4#2)
olivacea##3##1##(2008-8#3)
olivaceus##5##1##(2008-6#2)(2010-8#3)
olivary##6##1##(1994-2#1)(1997-2#1)(1997-3#4)
olive (Olea##2##2##(2008-10#2)
olive knot disease##2##3##(2008-10#2)
olive leaf samples##2##3##(2008-10#2)
olive leaves##2##2##(2008-10#1)(2008-12#1)
olive oil and##2##3##(2012-2#1)(2013-1#1)
olive oil production##2##3##(2008-10#2)
olive oil was##2##3##(2008-10#2)
olive oil##28##2##(1990-8#1)(1994-2#1)(1995-11#1)(2008-10#14)(2008-5#2)(2009-3#1)(2009-5#2)(2012-2#3)(2013-1#3)
olive plants##5##2##(2008-10#5)
olive trees##5##2##(2008-10#5)
olive##63##1##(1990-8#1)(1990-9#1)(1994-2#2)(1994-5#1)(1995-11#1)(2007-7#1)(2008-10#39)(2008-12#3)(2008-5#3)(2009-3#1)(2009-5#2)(2012-2#4)(2013-1#3)(2013-8#1)
olivine##3##1##(2008-10#3)
olivo-cerebellar##2##1##(1994-2#2)
olmesartan medoxomil##3##2##(2008-11#3)
om##3##1##(2008-11#1)(2012-12#2)
omalizumab in##2##2##(2010-5#2)
omalizumab##7##1##(2009-6#2)(2010-5#5)
oman##4##1##(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
omasum##2##1##(2011-2#2)
ombudsman##3##1##(1992-4#1)(1993-12#1)(1996-2#1)
ombudsmen##3##1##(1996-2#3)
omega =##2##2##(1990-5#1)(2008-9#1)
omega##13##1##(1990-5#1)(1990-8#1)(1991-5#1)(1992-8#6)(1995-2#1)(2008-2#1)(2008-9#2)
omega(0)##3##1##(2008-2#1)(2008-3#2)
omega(1)##2##1##(2010-7#2)
omega(2)##2##1##(2010-7#2)
omega-3 ethyl ester concentrate##6##4##(2008-3#6)
omega-3 fatty acid##2##3##(2012-1#1)(2013-1#1)
omega-3 fatty acids##4##3##(1990-2#1)(1990-5#2)(2008-6#1)
omega-3 fatty##6##2##(1990-2#1)(1990-5#2)(2008-6#1)(2012-1#1)(2013-1#1)
omega-3 polyunsaturated fatty acids##2##4##(2013-1#2)
omega-3 polyunsaturated##3##2##(2010-1#1)(2013-1#2)
omega-3##17##1##(1990-2#1)(1990-5#3)(2008-3#6)(2008-6#1)(2010-1#2)(2012-1#1)(2013-1#3)
omega-Aga-IIIA##2##1##(1993-11#2)
omega-Aga-IVA##2##1##(1993-11#2)
omega-conotoxin GVIA##4##2##(1993-9#1)(1996-5#3)
omega-conotoxin##8##1##(1992-7#1)(1993-3#1)(1993-9#2)(1996-5#4)
omega-triphenylalcohols and##2##2##(1992-8#2)
omenta##3##1##(2008-1#3)
omental cakes##4##2##(2012-2#4)
omental flap##2##2##(2009-7#1)(2012-2#1)
omental##8##1##(1990-2#1)(1992-2#1)(2009-7#1)(2012-2#5)
omentectomy##2##1##(2013-1#1)(2013-8#1)
omentum##13##1##(1995-11#3)(2007-2#1)(2007-8#4)(2008-1#1)(2008-12#1)(2012-2#1)(2013-1#2)
omentum-derived mesothelial cells##2##3##(2013-1#2)
omeprazole administration)##2##2##(2012-2#2)
omeprazole##20##1##(1991-2#1)(1993-11#6)(1996-11#1)(2008-11#2)(2008-7#1)(2012-2#8)(2012-3#1)
omics##3##1##(2009-12#1)(2010-2#1)(2010-5#1)
omics&quot##2##1##(2012-3#1)(2013-8#1)
ominidirectional reflection##2##2##(2007-12#2)
omission of##6##2##(1990-8#1)(1995-11#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-8#1)
omission##11##1##(1990-8#1)(1994-12#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)(2013-8#3)
omissions of##2##2##(2013-8#2)
omissions##6##1##(2009-8#1)(2012-1#1)(2013-8#4)
omit##4##1##(1990-11#1)(1996-3#1)(1996-6#1)(2008-10#1)
omitted from the##2##3##(1993-2#1)(2008-11#1)
omitted from##3##2##(1993-2#1)(1997-7#1)(2008-11#1)
omitted variables##3##2##(1992-6#3)
omitted##21##1##(1990-8#1)(1991-3#1)(1992-6#5)(1993-1#2)(1993-2#1)(1996-11#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
omitting a switch##2##3##(2008-3#2)
omitting##5##1##(1995-2#1)(2008-10#1)(2008-3#2)(2009-8#1)
ommata##2##1##(1993-12#2)
ommatidia##5##1##(2007-12#5)
omnibus##3##1##(1992-6#1)(1996-3#1)(1997-2#1)
omnidirectional ranges##2##2##(2007-12#2)
omnidirectional reflection##3##2##(2008-3#3)
omnidirectional reflectors##2##2##(2008-3#2)
omnidirectional##16##1##(2007-12#5)(2008-10#1)(2008-3#10)
omnipresent##2##1##(1994-9#1)(2008-10#1)
omnivory##6##1##(2008-8#1)(2008-9#5)
omp1##2##1##(1993-9#2)
ompH##2##1##(1990-11#2)
omphalocele with##3##2##(1997-3#1)(2008-10#1)(2010-8#1)
omphalocele##10##1##(1990-9#1)(1997-3#3)(2008-10#4)(2010-8#2)
on &quot##45##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-12#1)(1993-5#2)(1994-2#2)(1996-12#1)(1996-9#3)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#7)(2008-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
on 'Harbin'##2##2##(2008-10#2)
on 'Picra'##2##2##(2008-10#2)
on 'Seri 82'##2##3##(2008-10#2)
on 'Sumner'##2##2##(2008-10#2)
on (1)##8##2##(1994-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-5#2)(2012-2#1)
on 0##3##2##(1995-8#1)(2008-10#1)(2008-3#1)
on 1 January 1991##2##4##(1992-9#1)(1997-8#1)
on 1 January##3##3##(1992-9#1)(1997-8#1)(2008-8#1)
on 1 of##2##3##(2008-10#1)(2013-1#1)
on 1##21##2##(1992-9#1)(1994-6#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
on 1-year-old##2##2##(2008-10#2)
on 10 plants##2##3##(2008-10#2)
on 10##22##2##(1991-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-7#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#2)(2013-1#1)
on 100 mg##2##3##(2008-10#1)(2008-5#1)
on 100##6##2##(1992-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
on 11##4##2##(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
on 12 October##2##3##(2008-10#1)(2008-3#1)
on 12##5##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
on 12-lipoxygenase##2##2##(1991-8#1)(1994-8#1)
on 13C##2##2##(1990-11#1)(1991-5#1)
on 14 patients##2##3##(2007-11#1)(2011-2#1)
on 14##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
on 14-3-3##3##2##(2008-11#2)(2010-12#1)
on 15##6##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)
on 150##2##2##(1991-6#1)(1996-3#1)
on 16##5##2##(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
on 17##3##2##(2008-10#1)(2008-5#1)(2009-4#1)
on 17p##2##2##(1994-12#1)(2008-4#1)
on 18##7##2##(1993-2#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-9#1)
on 19##6##2##(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
on 2##14##2##(1991-6#1)(1992-10#1)(1992-12#1)(1996-11#1)(1997-2#2)(2008-10#3)(2008-11#1)(2009-2#1)(2009-5#1)(2011-1#1)(2013-1#1)
on 20 July 1997##2##4##(2008-3#2)
on 20 June##2##3##(2008-3#2)
on 20##6##2##(2008-3#5)(2010-12#1)
on 21 patients##3##3##(1991-5#1)(1993-9#1)(2007-7#1)
on 21##4##2##(1991-5#1)(1993-9#1)(2007-7#1)(2008-5#1)
on 22##7##2##(1991-4#1)(1994-5#2)(2007-11#1)(2008-10#2)(2008-7#1)
on 24##5##2##(1990-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-9#1)
on 25##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
on 26##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2012-2#1)
on 27##2##2##(1990-3#1)(2008-4#1)
on 28##3##2##(2009-10#1)(2011-2#1)(2012-12#1)
on 3 consecutive days##2##4##(1995-5#1)(2007-7#1)
on 3##11##2##(1992-2#1)(1995-12#1)(1995-5#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)
on 30##8##2##(1993-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-5#2)(2013-1#1)
on 31 January 1998##2##4##(2008-3#2)
on 31##4##2##(2008-3#2)(2008-5#1)(2013-1#1)
on 33##2##2##(1991-6#1)(2008-5#1)
on 34##3##2##(1991-12#1)(2008-10#1)(2008-12#1)
on 36 patients##2##3##(2007-8#1)(2013-1#1)
on 36##3##2##(2007-8#1)(2008-12#1)(2013-1#1)
on 39##2##2##(1995-6#1)(2010-9#1)
on 4##8##2##(1991-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-1#1)
on 40##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2012-3#1)
on 42##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
on 43##2##2##(2007-11#1)(2008-1#1)
on 45##3##2##(2007-10#1)(2008-10#1)(2013-1#1)
on 5##11##2##(1992-5#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2012-12#1)(2013-1#1)
on 5-HT##3##2##(1995-12#1)(1996-12#1)(2008-8#1)
on 5-HT2##2##2##(1995-12#1)(1995-3#1)
on 50##4##2##(2007-5#1)(2008-10#1)(2008-5#1)(2009-7#1)
on 540 individuals##2##3##(1997-5#2)
on 540##3##2##(1997-5#3)
on 56##2##2##(1993-1#1)(1996-3#1)
on 58##2##2##(2007-7#1)(2008-10#1)
on 6##4##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-12#1)
on 60##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
on 65##2##2##(2007-8#1)(2011-2#1)
on 7##5##2##(1992-9#1)(1993-1#1)(2008-10#1)(2008-6#1)(2012-1#1)
on 70##2##2##(2011-1#1)(2011-2#1)
on 7A of##2##3##(2008-10#2)
on 80##2##2##(2008-10#1)(2009-6#1)
on 9##5##2##(1991-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)
on 9-15##2##2##(2008-7#1)(2013-1#1)
on A gossypii##2##3##(2008-6#2)
on A##8##2##(2008-10#1)(2008-6#7)
on AC##2##2##(2008-10#2)
on ACL reconstructed knees##2##4##(2013-1#2)
on AChE##2##2##(2008-10#1)(2008-11#1)
on AD##3##2##(1992-12#2)(2008-7#1)
on AIDS##3##2##(1991-8#1)(1991-9#1)(1997-7#1)
on APC##3##2##(1993-11#1)(1997-2#2)
on AQP2##2##2##(2012-12#2)
on AR##2##2##(2008-3#1)(2012-2#1)
on ART##7##2##(2009-10#1)(2010-8#2)(2011-1#1)(2012-12#3)
on Acb##2##2##(2007-8#2)
on Acute##3##2##(2007-7#1)(2008-1#1)(2013-1#1)
on Adult##2##2##(2008-10#2)
on Aerosols##2##2##(1995-3#1)(1996-2#1)
on African American##2##3##(2009-5#1)(2012-12#1)
on African##3##2##(2009-11#1)(2009-5#1)(2012-12#1)
on Aging##4##2##(1994-2#1)(1995-3#1)(2009-5#1)(2010-5#1)
on Alfalfa##2##2##(2008-10#2)
on Alzheimer's disease##2##3##(2008-5#1)(2011-3#1)
on Alzheimer's##4##2##(1992-12#1)(2008-5#1)(2011-3#1)(2012-3#1)
on Amberlite XAD-16##2##3##(2008-10#2)
on Amberlite XAD-4 resin##2##4##(2008-10#2)
on Amberlite XAD-4##4##3##(2008-10#4)
on Amberlite##11##2##(2008-10#11)
on American##5##2##(1994-12#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-8#1)
on Animal##2##2##(2008-7#1)(2013-1#1)
on Antimicrobial##3##2##(2007-1#1)(2008-5#1)(2013-8#1)
on Aphis gossypii Glover##2##4##(2008-6#2)
on Apple##2##2##(2008-10#2)
on Arabidopsis##3##2##(2008-10#2)(2009-8#1)
on Asian##3##2##(2008-10#2)(2008-8#1)
on Aspergillus fumigatus immobilized Diaion HP-2MG##2##6##(2008-10#2)
on Au nanocrystalline films##3##4##(2009-11#3)
on Au substrates##2##3##(2008-10#2)
on Au##6##2##(2008-10#3)(2009-11#3)
on B cell##4##3##(1990-12#1)(2008-4#2)(2008-9#1)
on B##6##2##(1990-12#1)(2008-10#1)(2008-4#2)(2008-9#1)(2013-7#1)
on BMCTV-infected##2##2##(2008-10#2)
on BMI##2##2##(2012-2#1)(2012-3#1)
on BP##2##2##(2010-7#2)
on BSA##2##2##(1991-5#1)(2008-10#1)
on Bio-Gel P-60##2##3##(1990-5#1)(1992-9#1)
on Blanquilla pears##2##3##(2008-10#2)
on Brassica##2##2##(2008-10#2)
on British##2##2##(1991-1#1)(2013-1#1)
on C##8##2##(2008-10#4)(2008-6#3)(2013-8#1)
on C(18) bonded##2##3##(2008-10#2)
on C(18)##5##2##(2008-10#5)
on C18##3##2##(1992-12#1)(1996-5#1)(2008-10#1)
on C2C12##2##2##(2008-4#1)(2009-6#1)
on CABS can##2##3##(2008-10#2)
on CABS was##2##3##(2008-10#2)
on CABS were##2##3##(2008-10#2)
on CABS##8##2##(2008-10#8)
on CAPD##2##2##(2008-1#1)(2011-2#1)
on CCK##2##2##(1990-12#1)(1996-12#1)
on CD##2##2##(1991-1#1)(2008-7#1)
on CD-ROM##4##2##(1991-1#3)(1995-3#1)
on CHO##3##2##(2008-11#2)(2011-2#1)
on CHROMagar Candida##2##3##(2008-5#2)
on CI 13227##3##3##(2008-10#3)
on CI##5##2##(2008-10#4)(2008-8#1)
on CNS##3##2##(1990-9#1)(2008-12#1)(2008-5#1)
on CS##2##2##(1995-3#1)(1995-5#1)
on CT and##2##3##(2007-10#1)(2011-1#1)
on CT or##3##3##(2008-1#1)(2008-9#1)(2012-12#1)
on CT scan##2##3##(2009-9#1)(2010-12#1)
on CT##20##2##(1997-8#3)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
on CVD##4##2##(2008-7#1)(2009-4#1)(2013-1#2)
on CVP##2##2##(2008-10#2)
on CYP2E expression##2##3##(1996-12#2)
on Ca##2##2##(2008-10#1)(2010-2#1)
on Ca2+ movements and contractions##2##5##(1995-12#2)
on Ca2+##12##2##(1990-7#1)(1990-8#1)(1991-6#1)(1992-5#1)(1992-9#1)(1995-11#2)(1995-12#2)(1996-2#2)(1997-7#1)
on Caco-2 cells##2##3##(2008-11#1)(2011-2#1)
on Cancer##3##2##(2009-4#1)(2012-2#1)(2013-1#1)
on Cardiac##2##2##(2008-8#1)(2011-2#1)
on Cardiovascular##2##2##(2012-2#1)(2013-1#1)
on Cell##2##2##(2008-11#1)(2008-9#1)
on Cerebral##2##2##(2008-10#1)(2008-8#1)
on Chickpea##2##2##(2008-10#2)
on Chiclayo##2##2##(2013-1#2)
on Children's##2##2##(2012-2#1)(2013-1#1)
on Chinese##6##2##(1995-11#1)(2008-10#2)(2009-7#1)(2011-2#2)
on Chiralpak IA and Chiralpak IB columns##2##7##(2008-10#2)
on Chr##2##2##(1994-12#1)(2008-9#1)
on Chromosome##2##2##(2008-10#2)
on Circulating##2##2##(2012-3#2)
on Clinical##2##2##(2008-5#1)(2012-12#1)
on Clinton plan##2##3##(1994-2#2)
on Computational##2##2##(2008-7#1)(2013-8#1)
on Con##2##2##(1994-8#1)(2006-6#1)
on Conidial Germination##2##3##(2008-10#2)
on Cotton##2##2##(2008-10#2)
on D##2##2##(1990-2#1)(1992-6#1)
on DCT domain for biomedical##2##5##(2010-8#2)
on DCT domain##3##3##(2010-8#3)
on DCs##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
on DI##2##2##(2008-10#2)
on DIV21##2##2##(2008-11#2)
on DNA extracted from##2##4##(2008-10#2)
on DNA synthesis and cell proliferation##2##6##(1990-12#1)(1995-11#1)
on DNA synthesis and cell##3##5##(1990-12#1)(1993-8#1)(1995-11#1)
on DNA synthesis##8##3##(1990-12#1)(1990-7#1)(1992-3#1)(1993-6#1)(1993-8#2)(1995-11#1)(1997-7#1)
on DNA##39##2##(1990-12#1)(1990-7#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-7#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-6#1)(2010-5#1)
on DSKNPH in##3##3##(2008-10#3)
on DWI##2##2##(2007-10#1)(2009-11#1)
on Day 14##2##3##(2008-10#1)(2008-9#1)
on Day 21##2##3##(2008-9#2)
on Day 7##2##3##(2008-10#1)(2008-11#1)
on Day##9##2##(1995-3#1)(2008-10#2)(2008-11#2)(2008-9#4)
on Days##3##2##(2008-10#2)(2011-2#1)
on December##5##2##(2007-12#1)(2010-1#1)(2010-12#3)
on Development of Fusarium Wilt##2##5##(2008-10#2)
on Development of##3##3##(2008-10#3)
on Development##4##2##(2008-10#3)(2008-5#1)
on Dowex-50WX8##2##2##(2008-10#2)
on Drosophila##2##2##(2008-9#1)(2012-3#1)
on Drug##3##2##(1996-4#2)(2011-2#1)
on ELISA##2##2##(1994-2#1)(1996-12#1)
on EMG##2##2##(2010-5#1)(2012-12#1)
on EPO##3##2##(2007-7#1)(2008-1#1)(2008-11#1)
on Earth##7##2##(1997-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-9#1)(2012-3#1)
on Erikson's##2##2##(2008-12#2)
on Escherichia coli##3##3##(1990-5#1)(2011-3#1)(2012-2#1)
on Eucalyptus##3##2##(2008-10#1)(2010-3#2)
on Exubera##2##2##(2008-8#1)(2009-12#1)
on F##3##2##(1991-7#1)(2008-10#2)
on FN expression##2##3##(1994-9#2)
on FN##4##2##(1993-9#1)(1994-9#2)(2012-2#1)
on FN- and##2##3##(2009-11#2)
on February 25##2##3##(1992-3#1)(1997-2#1)
on February##4##2##(1992-3#1)(1997-2#2)(2013-8#1)
on Federal##2##2##(1994-1#1)(1996-1#1)
on Fru 2##2##3##(1994-3#2)
on Functional Genomics##3##3##(2008-7#3)
on Fusarium head blight##3##4##(2008-10#3)
on Fusarium##5##2##(2008-10#5)
on G##2##2##(1996-4#1)(2010-8#1)
on G-actin##3##2##(1992-4#2)(2008-1#1)
on GAL##2##2##(1995-2#1)(1996-12#1)
on GC electrode##2##3##(2008-10#2)
on GH secretion##2##3##(2007-7#2)
on GH##5##2##(2007-7#3)(2010-8#1)(2013-1#1)
on GI##2##2##(2013-1#2)
on Genetic##2##2##(2008-10#1)(2013-1#1)
on Germination##2##2##(2008-10#2)
on Google##2##2##(2010-8#1)(2013-1#1)
on Growth Rate##2##3##(2008-10#1)(2013-8#1)
on Growth##3##2##(2008-10#2)(2013-8#1)
on H##3##2##(2008-10#2)(2008-11#1)
on HA##2##2##(2009-7#1)(2011-1#1)
on HAART##2##2##(2007-7#1)(2010-9#1)
on HBV##2##2##(2011-1#1)(2012-12#1)
on HD##6##2##(2007-7#5)(2012-12#1)
on HIV prevention##3##3##(1990-6#1)(1996-4#1)(2008-1#1)
on HIV transmission##2##3##(2013-8#2)
on HIV##11##2##(1990-6#1)(1991-11#1)(1995-2#1)(1996-4#1)(2008-1#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-8#3)
on HIV-1 transmission##2##3##(1992-8#1)(2013-8#1)
on HIV-1##9##2##(1992-8#1)(2011-3#6)(2013-1#1)(2013-8#1)
on HIV-1(IIIB)##2##2##(2011-3#2)
on HIV-infected##2##2##(1991-5#1)(2010-5#1)
on HIV/AIDS##7##2##(1995-12#2)(1995-6#2)(1997-3#1)(2008-7#1)(2011-2#1)
on HLA##3##2##(1997-9#1)(2008-8#1)(2011-2#1)
on HPLC##4##2##(1994-6#1)(2008-10#1)(2009-8#1)(2012-3#1)
on HRCT##2##2##(2012-2#2)
on HRP##3##2##(2008-10#2)(2012-4#1)
on HRT##4##2##(2008-5#4)
on HaCat##2##2##(2011-3#2)
on Health##11##2##(1991-2#1)(1994-12#4)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-12#1)(2012-12#1)
on Heartland##2##2##(2008-10#2)
on High##3##2##(1994-9#1)(1997-2#1)(2008-7#1)
on Human##6##2##(1996-11#1)(1996-5#1)(2008-1#1)(2008-4#1)(2010-2#1)(2012-2#1)
on Hybrid##2##2##(2008-10#1)(2013-8#1)
on ICH##2##2##(2007-10#1)(2008-10#1)
on ICP##2##2##(2008-7#1)(2013-8#1)
on IFN##3##2##(1993-2#1)(2008-11#1)(2009-8#1)
on IL-1 beta##2##3##(1996-12#1)(2007-2#1)
on IL-1##3##2##(1996-12#1)(2007-2#2)
on IL-3##2##2##(1994-10#1)(2008-5#1)
on IL-6 production##2##3##(2008-10#2)
on IL-6##3##2##(2008-10#2)(2008-4#1)
on IR##3##2##(2013-1#1)(2013-8#2)
on ITS##3##2##(2008-10#3)
on IgE##2##2##(2007-6#1)(2008-11#1)
on IgG-Sepharose and nickel##2##4##(1996-12#2)
on In##2##2##(2008-10#1)(2011-1#1)
on Infection of##3##3##(2008-10#3)
on Infection##5##2##(2008-10#5)
on Italian##2##2##(1994-2#1)(2008-5#1)
on January 1##3##3##(1994-1#1)(1996-3#1)(2008-11#1)
on January##5##2##(1994-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
on Japanese##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
on Jeffrey pine in Lake Tahoe##2##6##(2008-10#2)
on Jeffrey pine##3##3##(2008-10#3)
on July##2##2##(1991-12#1)(2009-5#1)
on June##3##2##(1995-6#1)(2009-11#1)(2009-7#1)
on K1a##2##2##(2008-6#2)
on Kleinert's##2##2##(2009-9#2)
on L##3##2##(2008-10#2)(2009-8#1)
on L-6 cells from rat skeletal muscle##2##7##(1995-8#2)
on L5-S1##3##2##(2007-11#3)
on LAT cell##3##3##(1990-6#3)
on LATVs##2##2##(2013-1#2)
on LDL oxidation##2##3##(1992-9#1)(1995-12#1)
on LDL##6##2##(1992-9#1)(1993-6#2)(1995-12#1)(2008-3#1)(2011-1#1)
on LG10##2##2##(2008-10#2)
on LG7##3##2##(2008-10#3)
on LGs 3##2##3##(2008-10#2)
on LHR##2##2##(1996-5#2)
on LM##2##2##(1992-5#1)(2008-3#1)
on LPS-induced cytokine production and##2##5##(2008-10#2)
on LPS-induced cytokine production##3##4##(2008-10#3)
on Langmuir-Blodgett (LB)##2##3##(2008-11#1)(2010-10#1)
on Langmuir-Blodgett##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
on Leaves##2##2##(2008-10#2)
on Lemna minor##2##3##(2008-10#1)(2011-1#1)
on Lettuce##5##2##(2008-10#5)
on LiTaO(3)##2##2##(2008-10#1)(2008-3#1)
on Long-term##2##2##(2007-7#1)(2010-9#1)
on Lr26##3##2##(2008-10#3)
on Lyme disease##2##3##(1991-3#1)(2008-11#1)
on Lyme##3##2##(1991-3#1)(2008-11#2)
on M##5##2##(2008-10#2)(2009-12#1)(2010-8#1)(2011-2#1)
on MAPK##2##2##(1995-6#2)
on MCI GEL ProtEx##2##4##(1997-2#2)
on MIN and##2##3##(2008-10#2)
on MIN##5##2##(2008-10#5)
on MIR604##6##2##(2011-2#6)
on MLC601##3##2##(2013-1#3)
on MMP-1 and TIMP-1##2##4##(2008-5#2)
on MR images##5##3##(1997-8#4)(2007-11#1)
on MR imaging##3##3##(1997-8#3)
on MR mammography and the##2##5##(1997-8#2)
on MR##11##2##(1997-8#10)(2007-11#1)
on MRI##12##2##(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#1)
on MS medium containing sucrose##3##5##(2013-1#3)
on MS medium##4##3##(2008-12#1)(2013-1#3)
on MS##6##2##(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#3)
on MSV-infected##2##2##(2008-10#2)
on MTSC4##2##2##(2008-8#2)
on March 22##2##3##(1991-11#1)(1996-12#1)
on March##6##2##(1991-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2010-6#1)(2012-2#1)
on Mars##3##2##(1995-3#1)(2008-10#1)(2008-4#1)
on Matrigel##2##2##(2008-11#1)(2012-5#1)
on May 12##2##3##(1997-2#1)(2012-1#1)
on May 14##2##3##(1996-5#2)
on May##11##2##(1995-6#1)(1996-5#5)(1997-2#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
on Medicaid##2##2##(1993-3#1)(1994-2#1)
on Medicare##6##2##(1990-4#1)(1992-1#1)(1992-2#1)(1994-1#1)(1994-2#1)(2012-2#1)
on Medicare/Medicaid issues in health care##2##6##(2008-11#2)
on N##13##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#1)
on NMDA##2##2##(1995-12#1)(2011-1#1)
on NO production##3##3##(2008-8#2)(2013-1#1)
on NO##4##2##(1992-5#1)(2008-8#2)(2013-1#1)
on Na(+)##2##2##(2008-10#1)(2008-8#1)
on Na+##2##2##(1990-11#1)(1992-6#1)
on New##2##2##(2008-10#1)(2008-11#1)
on Northern##2##2##(1994-9#1)(1997-7#1)
on Norway spruce seedlings##2##4##(2008-10#2)
on Norway spruce##3##3##(2008-10#3)
on November##4##2##(1995-2#1)(2007-12#1)(2008-10#1)(2010-12#1)
on OC symptom##2##3##(2008-6#2)
on ODS##2##2##(2008-10#2)
on October##4##2##(1991-1#1)(1994-9#1)(2009-5#1)(2012-12#1)
on Olive##2##2##(2008-10#1)(2008-12#1)
on P##12##2##(2008-10#4)(2008-5#1)(2008-6#1)(2011-2#6)
on P1##2##2##(1996-2#1)(2013-8#1)
on PBL##2##2##(2008-12#1)(2013-1#1)
on PCs##2##2##(1994-2#1)(2008-9#1)
on PD##3##2##(2011-2#3)
on PDA##3##2##(2008-10#3)
on PKC##5##2##(1991-5#1)(1993-8#1)(1994-11#1)(2008-8#2)
on PMET##2##2##(2009-9#2)
on PND 7##2##3##(1993-11#2)
on PND##3##2##(1993-11#3)
on POMC##3##2##(1993-5#1)(2008-4#2)
on PPV-infected peach##2##3##(2008-10#2)
on Peach##2##2##(2008-10#2)
on Percoll##2##2##(1991-11#1)(2008-11#1)
on Physical Activity and##2##4##(2008-12#1)(2011-2#1)
on Physical##3##2##(2008-12#1)(2010-1#1)(2011-2#1)
on Population##4##2##(1994-9#2)(2008-10#1)(2008-11#1)
on Populus deltoides##2##3##(2008-10#1)(2011-2#1)
on Populus##3##2##(2008-10#2)(2011-2#1)
on Professional##2##2##(1993-3#1)(1995-2#1)
on Prunus spp##2##3##(2008-10#2)
on Prunus##3##2##(2008-10#2)(2011-2#1)
on Pseudomonas##2##2##(2008-10#2)
on PubMed##3##2##(2009-5#1)(2012-3#2)
on Public Health##2##3##(1997-2#1)(2009-5#1)
on Pythium root rot##2##4##(2008-10#2)
on Q##2##2##(1991-12#1)(2012-6#1)
on Quality of##3##3##(2010-8#1)(2013-1#2)
on Quality##5##2##(1995-12#1)(1996-3#1)(2010-8#1)(2013-1#2)
on R##3##2##(2008-10#3)
on RAPD##6##2##(2008-10#6)
on RGS(003)##2##2##(2011-2#2)
on RL##3##2##(2008-10#3)
on RNA##8##2##(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
on RTXd35##3##2##(2013-8#3)
on Radiation Protection##5##3##(1994-12#1)(1995-1#1)(1995-2#2)(1996-6#1)
on Raman##2##2##(2010-10#1)(2011-1#1)
on Repeated##2##2##(2008-10#1)(2011-2#1)
on Rhodnius neglectus##2##3##(2013-7#2)
on Rice##2##2##(2008-10#2)
on S##6##2##(1991-5#1)(2008-10#4)(2010-12#1)
on SAH-hydrolase activity##2##3##(1994-8#2)
on SAPC##2##2##(1997-2#2)
on SAT-1 activity##2##3##(1991-2#2)
on SCEs##2##2##(1990-6#1)(2008-4#1)
on SDS-PAGE##10##2##(1990-12#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-8#1)(2009-9#1)
on SDS-polyacrylamide gel electrophoresis##2##4##(1991-5#1)(1992-8#1)
on SDS-polyacrylamide##5##2##(1991-5#1)(1992-8#1)(1994-5#1)(1997-4#1)(2008-11#1)
on SG assembly##2##3##(2012-12#2)
on SLM(046)##3##2##(2011-2#3)
on SO(2)##2##2##(2008-3#1)(2011-1#1)
on SOHO##3##2##(2008-2#1)(2008-3#2)
on SPE##2##2##(2008-10#2)
on SSR##3##2##(2008-10#3)
on Sabouraud's dextrose agar##2##4##(2007-7#1)(2008-5#1)
on Sabouraud's##3##2##(2007-7#1)(2008-5#1)(2009-11#1)
on Saccharomyces cerevisiae immobilized sepiolite##2##5##(2008-10#2)
on Saccharomyces cerevisiae immobilized##3##4##(2008-10#3)
on Saccharomyces cerevisiae##5##3##(1996-3#1)(2008-10#3)(2011-2#1)
on Sephadex G-200##2##3##(1992-3#2)
on Sephadex G-75##2##3##(1990-7#1)(1995-6#1)
on Sephadex##13##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1992-3#2)(1995-6#1)(2008-10#3)
on September##2##2##(2010-12#1)(2011-2#1)
on Ser-139##2##2##(2008-9#2)
on Sf9##2##2##(2008-11#2)
on Si wafers we show that##2##6##(2008-3#2)
on Si wafers##3##3##(2008-2#1)(2008-3#2)
on Si##9##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#4)(2009-11#2)
on Social##4##2##(1993-3#1)(2007-7#1)(2011-1#2)
on South##2##2##(2009-11#1)(2013-8#1)
on Southern##2##2##(2008-5#1)(2012-2#1)
on Spore##2##2##(2008-10#2)
on Sporulation of##3##3##(2008-10#3)
on St##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
on Standards##2##2##(2008-10#1)(2008-7#1)
on State##2##2##(1994-2#1)(2008-1#1)
on Stellaria media##2##3##(2008-10#2)
on Stroke##3##2##(2007-9#1)(2008-8#2)
on Sw 72469-6##3##3##(2008-10#3)
on T cell##3##3##(1991-9#1)(1992-2#1)(2012-3#1)
on T cells##2##3##(2007-5#1)(2013-7#1)
on T lymphocytes##2##3##(1993-9#1)(1994-3#1)
on T##12##2##(1991-6#1)(1991-9#1)(1992-2#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-8#2)(2007-5#1)(2008-7#1)(2012-3#1)(2013-7#1)
on T-cell proliferation##2##3##(1990-5#1)(2008-11#1)
on T-cell##4##2##(1990-5#1)(1993-12#1)(1993-9#1)(2008-11#1)
on T1-weighted images and##2##4##(1991-11#1)(2007-11#1)
on T1-weighted images##4##3##(1991-11#1)(2007-11#1)(2008-7#2)
on T1-weighted##8##2##(1991-11#1)(2006-12#1)(2007-11#1)(2008-7#2)(2012-2#2)(2012-3#1)
on T2- and##2##3##(2008-10#1)(2009-11#1)
on T2-WI##3##2##(1997-8#3)
on T2-weighted and##2##3##(2006-10#1)(2012-3#1)
on T2-weighted##5##2##(1991-11#1)(2006-10#1)(2006-12#1)(2009-11#1)(2012-3#1)
on T7##2##2##(1997-4#1)(2008-8#1)
on TB##2##2##(2010-4#1)(2010-5#1)
on TPH degradation##2##3##(2008-6#2)
on TSPO##2##2##(2012-2#2)
on TSWV-infected plants##4##3##(2008-10#4)
on Teflon##2##2##(2008-10#1)(2008-5#1)
on The##4##2##(1995-6#1)(1996-1#1)(2008-3#1)(2008-7#1)
on Ti##3##2##(2008-3#3)
on TiO2##3##2##(2007-12#2)(2008-10#1)
on Tobacco##4##2##(2008-10#4)
on Tomato and Potato in##2##5##(2008-10#2)
on Turkish##2##2##(2008-1#1)(2008-10#1)
on U##2##2##(1992-1#1)(2008-11#1)
on U-937 cells##2##3##(1994-2#2)
on UI##3##2##(2011-1#3)
on US hospitals##3##3##(2008-11#3)
on US##5##2##(2008-1#1)(2008-11#3)(2012-12#1)
on United##2##2##(1995-1#1)(2008-12#1)
on V/K##3##2##(1992-3#3)
on V8 agar##2##3##(2008-10#2)
on VEGF-induced##2##2##(2008-10#2)
on VRCs and##2##3##(2008-11#2)
on VSMCs##2##2##(1994-6#2)
on Vancouver Island##2##3##(2008-10#2)
on Verticillium dahliae##2##3##(2008-10#2)
on Verticillium wilt##2##3##(2008-10#2)
on Verticillium##4##2##(2008-10#4)
on Vibrio fischeri##3##3##(2008-10#2)(2012-3#1)
on WR##2##2##(2008-6#2)
on Waters##2##2##(2008-10#1)(2011-1#1)
on Western blot##2##3##(1993-12#1)(1997-7#1)
on Western blots##6##3##(1991-2#1)(1992-3#1)(1992-8#1)(1995-12#2)(1995-6#1)
on Western##10##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#2)(1995-6#1)(1997-7#1)(2010-9#1)
on Wheat Seedlings##2##3##(2008-10#2)
on Wheat##5##2##(2008-10#5)
on Wild##2##2##(2008-10#2)
on Winter Wheat##2##3##(2008-10#2)
on Winter##4##2##(2008-10#4)
on Wnt/β-catenin signaling##2##3##(2013-1#2)
on Wound Healing##2##3##(2008-10#1)(2009-12#1)
on X-ray film##2##3##(1991-12#1)(2012-3#1)
on X-ray##6##2##(1991-12#1)(2007-11#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
on XGal plates##2##3##(1993-12#1)(1997-4#1)
on Xenopus oocytes##2##3##(1995-11#1)(1997-2#1)
on Yield##2##2##(2008-10#2)
on [Ca2+]c##2##2##(1991-12#1)(1995-8#1)
on [Formula##2##2##(2008-11#1)(2013-1#1)
on a &quot##3##3##(1990-9#1)(1992-12#1)(1995-2#1)
on a 0##2##3##(2007-11#1)(2008-2#1)
on a 1##6##3##(1991-5#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)
on a 2##2##3##(1992-3#1)(2008-3#1)
on a 50##3##3##(1996-5#1)(2007-5#1)(2008-10#1)
on a Au(111)##2##3##(2008-10#2)
on a Brassica##2##3##(2008-10#2)
on a C(18) column and##2##5##(2008-10#1)(2012-2#1)
on a C(18) column##5##4##(2008-10#4)(2012-2#1)
on a C(18)##8##3##(2008-10#7)(2012-2#1)
on a C18 column using##2##5##(1995-6#1)(2008-10#1)
on a C18 column with##2##5##(1990-8#1)(2011-1#1)
on a C18 column##5##4##(1990-8#1)(1993-9#1)(1995-6#1)(2008-10#1)(2011-1#1)
on a C18##6##3##(1990-8#1)(1993-9#1)(1995-6#1)(2008-10#1)(2011-1#1)(2011-3#1)
on a CCD chip##2##4##(2008-2#2)
on a CCD##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
on a FR5 schedule of reinforcement##2##6##(1993-6#2)
on a FR5 schedule##3##4##(1993-6#3)
on a Si substrate##2##4##(2007-11#1)(2008-2#1)
on a Spherisorb##2##3##(1996-5#1)(2008-10#1)
on a background of##2##4##(2008-1#1)(2009-3#1)
on a better##2##3##(2007-8#1)(2010-4#1)
on a bicycle##2##3##(2008-6#1)(2008-7#1)
on a binary##2##3##(2008-10#1)(2008-3#1)
on a broad range of##3##5##(2008-10#2)(2011-1#1)
on a capillary##2##3##(2008-10#1)(2008-3#1)
on a capillary-assembled microchip##2##4##(2007-8#2)
on a case by case basis##2##6##(1993-9#1)(2008-8#1)
on a case mix##2##4##(1991-12#1)(1996-2#1)
on a case##9##3##(1991-12#1)(1993-9#1)(1994-11#1)(1996-2#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
on a case-by-case basis##4##4##(1994-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
on a cell##2##3##(1995-11#1)(2008-9#1)
on a chelating resin##2##4##(2008-10#2)
on a child##2##3##(2008-9#1)(2009-12#1)
on a chip##6##3##(2008-10#4)(2008-11#1)(2011-1#1)
on a circular##2##3##(2008-3#1)(2009-7#1)
on a clear##2##3##(1990-2#1)(2009-10#1)
on a clinical##4##3##(1990-3#1)(1997-3#1)(2008-3#1)(2009-9#1)
on a cohort of##4##4##(2007-7#1)(2008-12#1)(2008-4#1)(2010-8#1)
on a collection of##2##4##(2008-10#1)(2009-10#1)
on a column of##3##4##(1990-8#1)(2008-10#1)(2008-4#1)
on a column##7##3##(1990-8#1)(2008-10#5)(2008-4#1)
on a combination of characteristics##2##5##(2008-8#1)(2008-9#1)
on a combination of the##5##5##(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
on a combination of##21##4##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#2)(2012-1#1)(2013-1#1)
on a commercial scale##2##4##(2007-5#1)(2011-2#1)
on a commercial##4##3##(1997-5#1)(2007-5#1)(2008-3#1)(2011-2#1)
on a commodity##2##3##(2008-6#1)(2009-6#1)
on a common##6##3##(1996-1#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2013-8#1)
on a comparative##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
on a comparison of two cohorts##2##6##(2012-2#2)
on a comparison of##3##4##(1994-3#1)(2012-2#2)
on a comparison##4##3##(1994-3#1)(2008-3#1)(2012-2#2)
on a complete##2##3##(2008-3#1)(2011-2#1)
on a comprehensive##4##3##(1995-5#1)(2008-1#1)(2008-4#1)(2012-3#1)
on a computer##5##3##(1995-3#1)(1995-6#1)(2008-10#1)(2008-2#1)(2011-2#1)
on a consecutive series of##4##5##(1990-8#1)(1991-8#1)(2012-5#1)(2013-1#1)
on a consecutive##5##3##(1990-12#1)(1990-8#1)(1991-8#1)(2012-5#1)(2013-1#1)
on a continuous##6##3##(1990-2#1)(1993-2#1)(2008-10#4)
on a continuum of##2##4##(1992-1#1)(2008-12#1)
on a continuum##5##3##(1992-1#1)(1992-3#1)(2008-12#1)(2008-4#1)(2010-8#1)
on a conventional##8##3##(1993-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
on a correlation between##2##4##(2006-10#1)(2008-10#1)
on a correlation##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
on a critical##2##3##(2008-10#1)(2013-1#1)
on a daily basis##8##4##(1991-12#1)(1993-9#1)(1995-3#1)(2006-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)
on a daily##9##3##(1991-12#1)(1993-9#1)(1995-3#1)(2006-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-9#1)
on a dark##2##3##(2007-12#1)(2008-1#1)
on a data set##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
on a detailed##2##3##(1996-2#1)(2012-2#1)
on a dielectric sphere in##3##5##(2008-2#1)(2008-3#2)
on a dielectric sphere##4##4##(2008-2#2)(2008-3#2)
on a dielectric##5##3##(2008-2#2)(2008-3#3)
on a diet containing##2##4##(2010-10#1)(2010-4#1)
on a diet##3##3##(2010-10#1)(2010-4#1)(2010-8#1)
on a different##3##3##(1992-12#1)(1993-2#1)(2008-3#1)
on a discontinuous##2##3##(1996-2#1)(2008-10#1)
on a disease##3##3##(1993-3#1)(2008-10#1)(2013-8#1)
on a dry weight##2##4##(1992-3#1)(2008-7#1)
on a dry##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
on a dynamic##2##3##(2007-12#1)(2008-3#1)
on a few selected##2##4##(2010-10#1)(2011-2#1)
on a filter##3##3##(2008-10#2)(2008-3#1)
on a flat##3##3##(2008-2#2)(2012-2#1)
on a flow cytometer##3##4##(2006-6#1)(2008-9#2)
on a flow##6##3##(2006-6#1)(2008-10#3)(2008-9#2)
on a flow-through##2##3##(2008-10#2)
on a free##2##3##(1994-2#1)(1994-8#1)
on a frequency-doubled##2##3##(2007-11#1)(2007-12#1)
on a fully##2##3##(2008-3#2)
on a gas##2##3##(2008-10#2)
on a general##2##3##(1992-1#1)(2009-11#1)
on a genetic algorithm##2##4##(2008-3#1)(2008-8#1)
on a genetic##3##3##(2008-3#2)(2008-8#1)
on a genome##2##3##(2008-8#1)(2009-12#1)
on a genome-wide basis##2##4##(2008-2#1)(2011-2#1)
on a genome-wide scale##2##4##(2008-7#1)(2012-3#1)
on a genome-wide##4##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
on a genomic##2##3##(2008-10#1)(2008-7#1)
on a given day##2##4##(1997-4#1)(2008-8#1)
on a given##9##3##(1992-9#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-3#1)
on a glass plate##2##4##(2008-2#1)(2008-3#1)
on a glass##8##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
on a glassy carbon disc electrode##2##6##(2008-10#2)
on a glassy carbon electrode (GCE)##3##6##(2008-10#3)
on a glassy carbon electrode and##3##6##(2008-10#2)(2013-1#1)
on a glassy carbon electrode surface##2##6##(2008-10#2)
on a glassy carbon electrode was##2##6##(2008-10#2)
on a glassy carbon electrode##20##5##(2008-10#19)(2013-1#1)
on a glassy carbon##23##4##(2008-10#22)(2013-1#1)
on a global scale##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
on a global##8##3##(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
on a gold electrode##4##4##(2008-10#4)
on a gold##11##3##(2008-10#10)(2010-4#1)
on a graphical##2##3##(2008-6#1)(2011-2#1)
on a graphics##2##3##(2008-6#1)(2011-1#1)
on a graphite##2##3##(2007-12#1)(2008-10#1)
on a group of##4##4##(1990-10#1)(1996-9#1)(2009-3#1)(2012-12#1)
on a group##5##3##(1990-10#1)(1996-9#1)(1997-2#1)(2009-3#1)(2012-12#1)
on a hanging mercury drop electrode (HMDE)##4##7##(2008-10#4)
on a hanging mercury drop electrode##8##6##(2008-10#8)
on a high level of##3##5##(1993-6#1)(1996-7#1)(2011-2#1)
on a high##5##3##(1993-6#1)(1996-7#1)(1997-4#1)(2011-2#2)
on a high-power##2##3##(2008-3#2)
on a highly##2##3##(2008-10#2)
on a homogeneous##2##3##(1997-3#1)(2008-10#1)
on a host##3##3##(1997-5#1)(2008-10#2)
on a hot plate##2##4##(2008-10#2)
on a hot##3##3##(2008-10#2)(2008-7#1)
on a human##5##3##(1990-11#1)(1990-2#1)(1994-2#1)(2008-3#2)
on a hybrid##2##3##(2007-12#1)(2008-10#1)
on a large scale##7##4##(1994-6#1)(1997-3#1)(2008-10#3)(2009-12#1)(2013-8#1)
on a large set of##2##5##(2008-2#1)(2009-10#1)
on a large##18##3##(1994-3#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
on a large-scale##2##3##(2008-10#1)(2012-2#1)
on a larger scale##2##4##(1992-5#1)(2008-1#1)
on a larger##4##3##(1992-5#1)(2008-1#1)(2008-11#1)(2011-2#1)
on a lidar##2##3##(2008-3#2)
on a likelihood##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
on a lipophilic##2##3##(2008-10#2)
on a liquid##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
on a local scale##2##4##(2008-10#1)(2008-8#1)
on a local##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
on a long##2##3##(2010-4#1)(2013-7#1)
on a macroporous##3##3##(2008-10#3)
on a mathematical model##2##4##(2008-3#2)
on a measure of##2##4##(2007-7#1)(2010-10#1)
on a medical##2##3##(1994-3#1)(2008-3#1)
on a melamine-formaldehyde resin##2##4##(2008-10#2)
on a metallic##2##3##(2007-12#1)(2008-7#1)
on a microcolumn packed with##3##5##(2008-10#3)
on a microcolumn##4##3##(2008-10#4)
on a microscopic##3##3##(1992-5#1)(2008-3#2)
on a mini-column packed with##2##5##(2008-10#2)
on a minicolumn##2##3##(2008-10#2)
on a minimal medium##2##4##(2008-10#2)
on a minimum##2##3##(1992-6#1)(2013-1#1)
on a model##6##3##(2007-12#2)(2007-6#1)(2008-3#1)(2012-1#1)(2013-1#1)
on a modern##4##3##(1994-2#1)(2007-9#1)(2008-3#1)(2009-6#1)
on a modified##10##3##(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
on a molar basis##2##4##(1994-12#1)(2008-6#1)
on a molecular level##3##4##(1990-2#1)(2010-9#2)
on a molecular##6##3##(1990-2#1)(2007-12#1)(2008-10#2)(2010-9#2)
on a molecularly imprinted##2##4##(2008-10#2)
on a monthly basis##2##4##(2008-12#1)(2011-2#1)
on a more##3##3##(2007-10#1)(2008-2#1)(2009-6#1)
on a mouse##2##3##(2008-11#2)
on a moving##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
on a national level##2##4##(1994-2#1)(2008-3#1)
on a national scale##2##4##(1997-1#1)(2008-10#1)
on a national##4##3##(1994-2#1)(1997-1#1)(2008-10#1)(2008-3#1)
on a natural##2##3##(2008-5#2)
on a new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##2##8##(2008-10#2)
on a new##22##3##(1991-3#1)(1994-6#1)(1995-9#1)(1996-2#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
on a newly##2##3##(2008-10#2)
on a novel##10##3##(1990-7#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
on a number of different##2##5##(1992-12#1)(2007-12#1)
on a number of important##2##5##(2008-10#1)(2011-2#1)
on a number of##17##4##(1992-11#1)(1992-12#1)(1995-11#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
on a nylon##2##3##(2008-10#1)(2008-7#1)
on a packed##2##3##(2008-10#2)
on a par with##3##4##(1993-1#1)(2008-11#1)(2012-2#1)
on a particular##4##3##(1994-11#1)(1995-3#1)(1997-3#1)(2008-8#1)
on a patient who##3##4##(1993-9#1)(2007-8#1)(2011-2#1)
on a patient with##5##4##(1996-3#1)(2006-12#1)(2008-7#1)(2009-4#1)(2011-3#1)
on a patient##10##3##(1993-9#1)(1996-3#1)(1997-3#1)(2006-12#1)(2007-8#2)(2008-7#1)(2009-4#1)(2011-2#1)(2011-3#1)
on a patient's##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
on a per##8##3##(1992-1#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)
on a perfect##3##3##(1990-3#1)(2008-3#2)
on a personal##2##3##(1993-3#1)(2008-10#1)
on a phylogenetic##2##3##(1996-6#1)(2010-6#1)
on a piezoelectric transducer##2##4##(2008-10#1)(2008-3#1)
on a piezoelectric##3##3##(2008-10#2)(2008-3#1)
on a planar##5##3##(2007-12#1)(2008-10#2)(2008-3#2)
on a plane##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
on a plant##3##3##(2008-10#2)(2008-7#1)
on a plastic##2##3##(2007-11#1)(2008-5#1)
on a plasticized##2##3##(2008-10#2)
on a platinum (Pt) electrode##2##5##(2008-10#2)
on a platinum electrode##2##4##(2008-10#2)
on a platinum##5##3##(2008-10#5)
on a polycarbonate chip##2##4##(2008-10#2)
on a polydimethylsiloxane##2##3##(2008-10#2)
on a polymeric##2##3##(2008-10#2)
on a polystyrene##3##3##(2008-11#2)(2008-2#1)
on a population basis##3##4##(1995-12#1)(2008-7#1)(2008-9#1)
on a population##4##3##(1995-12#1)(2008-7#1)(2008-9#1)(2009-5#1)
on a porous graphitized carbon##2##5##(1996-5#2)
on a porous##3##3##(1996-5#2)(2012-4#1)
on a positive##2##3##(1991-4#1)(2010-10#1)
on a power analysis##2##4##(2008-9#1)(2013-1#1)
on a pressed##2##3##(2008-11#1)(2008-2#1)
on a previous##4##3##(1990-5#1)(1995-3#1)(2008-10#1)(2010-10#1)
on a previously reported##2##4##(1993-3#1)(2008-3#1)
on a previously##3##3##(1993-3#1)(1994-12#1)(2008-3#1)
on a project##2##3##(1995-2#1)(2006-5#1)
on a protein##2##3##(1995-11#1)(2008-4#1)
on a public health##4##4##(2011-1#2)(2012-12#2)
on a puréed diet##2##4##(1995-3#2)
on a qualitative##4##3##(2008-1#1)(2008-9#1)(2009-5#1)(2013-8#1)
on a quantitative##2##3##(2008-8#1)(2013-1#1)
on a quartz##4##3##(2007-12#1)(2008-10#3)
on a random sample##2##4##(2008-7#1)(2010-6#1)
on a random##3##3##(1995-4#1)(2008-7#1)(2010-6#1)
on a range of##7##4##(1991-7#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)
on a rare##3##3##(2010-6#1)(2012-3#1)(2013-1#1)
on a reasonably##2##3##(1993-12#1)(1996-12#1)
on a recent##2##3##(1992-1#1)(2010-11#1)
on a reference material##2##4##(2008-10#2)
on a reference##3##3##(2008-10#2)(2008-9#1)
on a reflective##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
on a regional basis##3##4##(1994-3#1)(1995-5#1)(2008-3#1)
on a regional level##3##4##(1994-2#1)(2008-10#2)
on a regional scale##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
on a regional##12##3##(1993-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
on a regular basis to##2##5##(1997-8#1)(2011-2#1)
on a regular basis##13##4##(1994-3#1)(1995-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
on a regular##17##3##(1994-3#1)(1995-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#3)
on a relatively##3##3##(1995-9#1)(1996-4#1)(2008-9#1)
on a relevant##3##3##(2008-8#2)(2011-1#1)
on a report##2##3##(1994-1#1)(1997-2#1)
on a representative sample of##2##5##(2008-12#1)(2013-1#1)
on a representative##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
on a research##2##3##(2010-1#1)(2011-1#1)
on a retrospective##3##3##(1990-9#1)(1992-8#1)(1993-6#1)
on a reverse phase C(18) column##2##6##(2008-10#1)(2011-2#1)
on a reversed-phase C18##2##4##(2008-10#2)
on a reversed-phase##9##3##(1990-8#4)(1997-2#1)(2008-10#4)
on a review of the##2##5##(1993-6#1)(1996-2#1)
on a review of##7##4##(1993-6#1)(1994-1#1)(1996-2#1)(1997-2#1)(2006-7#1)(2008-12#1)(2011-2#1)
on a review##8##3##(1993-6#1)(1994-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-7#1)(2008-12#1)(2011-2#1)
on a rotating##7##3##(1990-12#1)(2008-10#4)(2008-2#1)(2008-5#1)
on a routine basis##4##4##(2008-3#3)(2008-4#1)
on a sample of 18##2##5##(1997-5#1)(2008-10#1)
on a sample of##12##4##(1990-8#1)(1994-6#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-1#1)
on a sample##14##3##(1990-8#1)(1994-6#1)(1997-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-1#1)
on a satellite##3##3##(2008-3#2)(2010-9#1)
on a scale from 0 to##2##6##(1995-8#1)(2008-9#1)
on a scale from##3##4##(1992-3#1)(1995-8#1)(2008-9#1)
on a scale of 0-10##3##5##(2008-7#1)(2013-1#2)
on a scale of##6##4##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
on a scale##11##3##(1992-3#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
on a scanning##3##3##(2008-3#2)(2008-9#1)
on a screen##3##3##(1996-2#1)(2008-3#1)(2009-5#1)
on a screen-printed##2##3##(2008-10#2)
on a selective medium##3##4##(2008-10#3)
on a selective##5##3##(2008-10#3)(2008-2#2)
on a self-assembled##2##3##(1990-4#1)(2008-10#1)
on a semiconductor##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
on a separate occasion##2##4##(1991-6#1)(2008-3#1)
on a separate##4##3##(1991-6#1)(2008-2#1)(2008-3#2)
on a series of##11##4##(1992-10#1)(1992-12#2)(1993-5#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
on a set of##11##4##(1996-3#1)(1997-5#1)(2008-10#5)(2008-3#2)(2009-11#1)(2009-3#1)
on a shared##2##3##(2008-2#1)(2012-2#1)
on a sheep##2##3##(2011-2#2)
on a side##2##3##(2008-2#1)(2008-8#1)
on a sidearm##2##3##(2008-3#2)
on a significant##2##3##(2008-3#1)(2008-8#1)
on a silica##4##3##(2008-10#4)
on a silicon##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
on a silver##3##3##(2008-10#1)(2008-3#2)
on a similar##2##3##(2008-10#1)(2010-10#1)
on a simple##14##3##(1996-5#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)
on a single day##2##4##(2008-12#1)(2013-8#1)
on a single slide##2##4##(2008-4#1)(2008-7#1)
on a single substrate##2##4##(2008-3#2)
on a single##45##3##(1992-1#1)(1992-6#1)(1994-9#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
on a single-crystal##2##3##(2007-12#1)(2009-11#1)
on a single-shot basis##2##4##(2007-11#1)(2007-12#1)
on a slide glass##2##4##(1991-5#1)(2007-11#1)
on a small number of##2##5##(2010-7#1)(2012-2#1)
on a small##12##3##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#2)(2010-7#1)(2010-8#1)(2012-2#1)
on a solid phase##2##4##(2008-10#1)(2008-11#1)
on a solid support##6##4##(2008-10#2)(2008-4#3)(2009-12#1)
on a solid##9##3##(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2009-12#1)
on a soluble##2##3##(2008-10#1)(2008-7#1)
on a spatial##3##3##(1993-3#1)(2011-1#1)(2012-2#1)
on a specialized##2##3##(1996-1#1)(2008-7#1)
on a specific##9##3##(1991-2#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
on a spectral##2##3##(2007-11#1)(2008-3#1)
on a standard##8##3##(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2009-3#2)(2013-1#1)
on a statistical##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
on a stratified##2##3##(1995-9#1)(1997-3#1)
on a strong##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
on a study##3##3##(1996-12#1)(2008-9#1)(2009-5#1)
on a subjective##2##3##(1991-12#1)(2011-1#1)
on a subsequent##2##3##(2008-10#2)
on a subset of the##3##5##(1996-7#1)(2008-10#1)(2011-2#1)
on a subset of##5##4##(1996-7#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)
on a substrate##2##3##(1996-12#1)(2008-3#1)
on a successful##2##3##(1994-12#1)(2012-1#1)
on a sufficient##3##3##(2007-12#1)(2008-10#2)
on a surface of a glass##2##6##(1991-5#1)(2008-2#1)
on a surface##8##3##(1991-5#1)(1992-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-2#1)
on a survey of##3##4##(1993-1#1)(1995-1#1)(1997-3#1)
on a survey##5##3##(1993-1#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-9#1)
on a susceptible##5##3##(2008-10#5)
on a synthetic##2##3##(1992-12#1)(2009-9#1)
on a systematic##4##3##(1991-9#1)(1996-12#1)(2008-10#1)(2011-2#1)
on a target##2##3##(1994-2#1)(2007-12#1)
on a task##2##3##(2008-1#1)(2008-2#1)
on a test of##2##4##(1993-3#1)(2010-7#1)
on a test##4##3##(1993-3#1)(2008-3#2)(2010-7#1)
on a thin##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
on a thorough history and physical examination##2##7##(2008-8#1)(2012-2#1)
on a thorough##4##3##(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
on a three##2##3##(1990-11#1)(2010-3#1)
on a time scale of##2##5##(1994-11#1)(1997-2#1)
on a time##3##3##(1994-11#1)(1997-2#2)
on a timely basis##2##4##(1996-2#1)(1997-2#1)
on a total of##3##4##(2007-12#1)(2008-5#1)(2010-4#1)
on a transparent##3##3##(2008-10#1)(2008-3#2)
on a treadmill##7##3##(1991-3#1)(2007-10#1)(2008-10#1)(2009-5#1)(2013-1#2)(2013-8#1)
on a tungsten wire##2##4##(2008-10#2)
on a two##2##3##(1990-3#1)(2008-10#1)
on a two-step##2##3##(2008-10#1)(2008-3#1)
on a variety of##15##4##(1992-11#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#2)
on a very##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
on a victim's##2##3##(2008-10#1)(2008-11#1)
on a visual##3##3##(1991-2#2)(2009-3#1)
on a voluntary basis##2##4##(1994-3#1)(2008-10#1)
on a voluntary##3##3##(1990-6#1)(1994-3#1)(2008-10#1)
on a water##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
on a wave-front##3##3##(2008-3#3)
on a weak##2##3##(2007-11#1)(2008-10#1)
on a weekly basis##4##4##(1997-4#2)(2008-5#1)(2011-2#1)
on a wide range of##5##5##(1991-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
on a wide##9##3##(1991-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
on a woman's##2##3##(1996-8#1)(1997-7#1)
on a worldwide##3##3##(2008-10#3)
on a##2118##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#14)(1990-9#2)(1991-1#2)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#4)(1992-12#10)(1992-2#4)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#6)(1993-12#5)(1993-2#5)(1993-3#12)(1993-5#1)(1993-6#8)(1993-8#1)(1993-9#8)(1994-1#3)(1994-11#3)(1994-12#7)(1994-2#8)(1994-3#12)(1994-5#2)(1994-6#10)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#6)(1995-12#10)(1995-2#10)(1995-3#12)(1995-4#1)(1995-5#3)(1995-6#8)(1995-8#2)(1995-9#4)(1996-1#5)(1996-11#1)(1996-12#9)(1996-2#16)(1996-3#6)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#17)(1997-3#13)(1997-4#8)(1997-5#9)(1997-6#1)(1997-7#3)(1997-8#4)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#6)(2007-11#72)(2007-12#73)(2007-2#3)(2007-5#8)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#16)(2008-10#532)(2008-11#51)(2008-12#25)(2008-2#100)(2008-3#248)(2008-4#35)(2008-5#22)(2008-6#25)(2008-7#64)(2008-8#39)(2008-9#36)(2009-10#7)(2009-11#8)(2009-12#6)(2009-2#1)(2009-3#9)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#9)(2010-4#12)(2010-5#6)(2010-6#7)(2010-7#2)(2010-8#9)(2010-9#5)(2011-1#28)(2011-2#45)(2011-3#4)(2011-9#1)(2012-1#7)(2012-12#13)(2012-2#30)(2012-3#18)(2012-4#1)(2012-5#1)(2013-1#40)(2013-7#2)(2013-8#21)
on abdominal##6##2##(1995-3#1)(2007-12#3)(2008-12#1)(2008-8#1)
on abortion##9##2##(1990-10#1)(1990-3#1)(1994-2#2)(1996-5#1)(2008-11#3)(2010-12#1)
on about##3##2##(1990-12#1)(2008-7#1)(2008-8#1)
on absolute##2##2##(2008-10#1)(2013-1#1)
on absorbance##4##2##(2007-11#1)(2008-10#2)(2010-5#1)
on absorption##10##2##(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#3)
on academic##6##2##(1996-3#1)(1997-1#1)(1997-2#1)(2009-4#1)(2009-7#1)(2010-3#1)
on access to care##3##4##(1995-12#2)(1996-1#1)
on access to##6##3##(1992-2#1)(1994-1#1)(1995-12#2)(1996-1#1)(1996-3#1)
on access##9##2##(1992-2#1)(1994-1#2)(1994-12#1)(1995-12#2)(1996-1#1)(1996-3#1)(1997-2#1)
on account of a##2##4##(2008-2#1)(2011-2#1)
on account of the##4##4##(1992-5#1)(1993-3#1)(1995-2#1)(2007-11#1)
on account of##13##3##(1990-12#2)(1990-8#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-2#2)(2011-2#1)
on accreditation##2##2##(1993-12#1)(1996-12#1)
on accumulated##2##2##(1990-9#1)(2008-5#1)
on accumulation of##2##3##(1997-1#1)(2008-12#1)
on accumulation##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
on accuracy##4##2##(2008-10#3)(2012-2#1)
on accurate##2##2##(1990-10#1)(2010-8#1)
on acetate##3##2##(2008-6#1)(2008-7#2)
on acetylcholine##2##2##(1993-5#1)(2008-10#1)
on acid and pepsin secretion##2##5##(1997-1#2)
on acid##6##2##(1997-1#3)(2008-10#3)
on acid-base##2##2##(2008-10#2)
on acidic##3##2##(1990-2#1)(2008-10#1)(2012-6#1)
on acidified##2##2##(2008-10#2)
on acoustic##2##2##(2007-12#1)(2012-2#1)
on acquisition and retention of##2##5##(1993-12#1)(2012-2#1)
on acquisition##4##2##(1993-12#1)(1993-3#1)(2012-2#2)
on actin##2##2##(1992-4#1)(1994-5#1)
on action##4##2##(1995-3#1)(2007-6#1)(2008-4#2)
on activated carbon (AC) as##2##5##(2008-10#2)
on activated carbon and##2##4##(2008-10#2)
on activated carbon##16##3##(2008-10#16)
on activated##18##2##(2008-10#17)(2008-5#1)
on activation of##6##3##(1990-12#1)(1992-5#1)(1997-2#1)(2008-4#2)(2008-8#1)
on activation##8##2##(1990-12#1)(1992-5#1)(1997-2#1)(2008-4#3)(2008-8#1)(2010-3#1)
on active patches##2##3##(2008-6#2)
on active range of##2##4##(2008-12#2)
on active##10##2##(2007-12#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-7#1)
on activities of daily##2##4##(2011-2#1)(2012-2#1)
on activities of the Canadian Committee on Antibiotic Resistance##2##9##(2007-12#2)
on activities of##5##3##(2007-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
on activities##6##2##(1996-3#1)(2007-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
on activity and##2##3##(2008-8#1)(2010-12#1)
on activity of##3##3##(1992-11#1)(1992-5#1)(2008-10#1)
on activity##9##2##(1990-6#1)(1992-11#1)(1992-5#1)(2008-10#1)(2008-8#4)(2010-12#1)
on actual##5##2##(2008-11#1)(2008-3#2)(2008-7#1)(2011-3#1)
on acupuncture skills##3##3##(2012-3#3)
on acupuncture##5##2##(2008-10#2)(2012-3#3)
on acute pulmonary##2##3##(2010-10#1)(2012-2#1)
on acute##19##2##(1994-12#1)(1995-12#3)(1996-3#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
on adaptive##4##2##(2008-9#2)(2010-2#1)(2011-1#1)
on added##2##2##(1991-6#1)(2008-3#1)
on addition of##5##3##(1992-3#1)(1993-11#1)(1994-6#1)(2008-2#1)(2012-3#1)
on adequate##2##2##(1990-6#1)(2010-6#1)
on adhesion of##2##3##(1997-7#1)(2008-5#1)
on adhesion##4##2##(1992-12#1)(1997-7#1)(2008-5#1)(2008-9#1)
on adjacent##6##2##(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-3#1)
on administrative##2##2##(1995-6#1)(2010-5#1)
on admission and discharge##2##4##(1992-1#1)(2008-6#1)
on admission and##5##3##(1992-1#1)(2007-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
on admission to##2##3##(1994-2#1)(2008-3#1)
on admission##31##2##(1992-1#1)(1992-12#1)(1992-6#2)(1994-2#1)(1994-3#1)(1995-11#1)(2007-10#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#5)(2011-2#2)(2013-1#2)
on adolescent##9##2##(1994-2#1)(2007-12#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-7#1)(2013-1#2)
on adolescents'##4##2##(2009-7#4)
on adsorption##3##2##(2008-10#3)
on adult fecundity##2##3##(2008-11#2)
on adult##15##2##(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#2)(2012-2#1)(2012-3#1)
on adult-born##3##2##(2012-2#3)
on adults##5##2##(2008-9#1)(2012-2#1)(2013-1#3)
on advance##2##2##(1993-2#1)(2012-3#1)
on advanced##4##2##(1992-8#1)(2008-3#1)(2011-2#1)(2012-3#1)
on adverse events##2##3##(1994-2#1)(2008-10#1)
on adverse##6##2##(1994-2#1)(1994-6#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
on aerosol##4##2##(1997-1#1)(2008-11#1)(2008-3#2)
on affect regulation##2##3##(2013-1#2)
on aflatoxin production##2##3##(1992-9#2)
on aflatoxin##3##2##(1992-9#2)(2008-10#1)
on agar media##3##3##(2008-10#3)
on agar plates##2##3##(2008-10#1)(2010-4#1)
on agar##10##2##(1993-8#1)(2008-10#7)(2010-4#1)(2012-2#1)
on agarose gel electrophoresis##2##4##(1991-5#1)(1996-12#1)
on agarose gel##3##3##(1991-5#1)(1996-12#1)(2006-8#1)
on agarose gels##2##3##(1992-3#1)(2008-10#1)
on agarose##5##2##(1991-5#1)(1992-3#1)(1996-12#1)(2006-8#1)(2008-10#1)
on age and##2##3##(2008-11#1)(2008-5#1)
on age at##3##3##(1994-11#1)(2008-8#2)
on age##19##2##(1991-5#1)(1991-6#1)(1992-2#1)(1994-11#1)(1994-9#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-3#1)(2012-2#1)
on age-related##2##2##(2008-3#1)(2010-10#1)
on ageing##3##2##(2008-10#1)(2010-10#1)(2010-12#1)
on agency##2##2##(1995-3#1)(1997-3#1)
on aggregation of##2##3##(1997-3#1)(2008-1#1)
on aggregation##3##2##(1997-3#1)(2008-1#1)(2008-8#1)
on aggressive##2##2##(1995-2#1)(2008-1#1)
on aging processes##2##3##(2008-10#1)(2013-7#1)
on aging##4##2##(2008-10#1)(2009-5#1)(2013-1#1)(2013-7#1)
on air##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
on airway##2##2##(1991-4#1)(1996-12#1)
on alcohol and##2##3##(1994-2#1)(2008-1#1)
on alcohol consumption##2##3##(1994-2#2)
on alcohol##9##2##(1994-2#3)(2008-1#1)(2008-11#1)(2008-2#1)(2010-1#1)(2012-12#1)(2012-2#1)
on alfalfa (Medicago##2##3##(2008-10#1)(2011-2#1)
on alfalfa and##2##3##(2008-10#2)
on alfalfa##4##2##(2008-10#3)(2011-2#1)
on aligned##2##2##(2009-9#2)
on alignment of##2##3##(1996-12#1)(2008-10#1)
on alignment##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
on alkaline hydrolysis##2##3##(2008-10#2)
on alkane##2##2##(1991-9#2)
on all aspects##2##3##(1996-1#1)(2012-1#1)
on all findings##2##3##(2008-7#1)(2011-2#1)
on all five##2##3##(1997-6#1)(2008-10#1)
on all of the##4##4##(1992-11#1)(2007-11#1)(2008-10#1)(2009-2#1)
on all of these##3##4##(1997-3#1)(2008-11#1)(2009-11#1)
on all of##7##3##(1992-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-2#1)
on all patients##5##3##(2006-8#2)(2007-7#1)(2008-6#1)(2012-2#1)
on all six##2##3##(2008-12#1)(2008-3#1)
on all the##10##3##(1990-3#1)(1992-2#2)(1992-8#1)(1993-12#1)(1995-1#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
on all##87##2##(1990-2#1)(1990-3#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-8#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2010-11#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
on allele##2##2##(1994-3#1)(2008-10#1)
on allergies##2##2##(1994-2#1)(2010-5#1)
on allogeneic##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
on almost all##2##3##(2010-3#2)
on alpha##5##2##(1993-3#1)(1995-11#1)(2008-10#2)(2008-8#1)
on alterations in##2##3##(2008-5#2)
on alterations##3##2##(2008-5#2)(2008-7#1)
on alternative##4##2##(1996-2#1)(1997-6#1)(2008-4#1)(2008-6#1)
on alumina##5##2##(2007-11#1)(2008-10#4)
on aluminum##2##2##(1992-11#1)(2009-12#1)
on ambulatory##2##2##(1997-3#1)(2010-12#1)
on amino acid sequence##2##4##(1991-5#1)(2008-10#1)
on amino acid##3##3##(1990-12#1)(1991-5#1)(2008-10#1)
on aminopropyl-glass##2##2##(2008-10#2)
on ammonium##3##2##(2008-10#3)
on amorphous##2##2##(2008-2#2)
on amperometric##2##2##(2008-10#2)
on amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
on amplified fragment length polymorphism##4##5##(2008-10#4)
on amylase release##2##3##(1992-12#2)
on amylase##3##2##(1992-12#2)(2008-12#1)
on an &quot##2##3##(1993-11#1)(2008-6#1)
on an ABI##2##3##(2007-7#1)(2008-12#1)
on an E##2##3##(1993-9#1)(1994-11#1)
on an Ultimate##2##3##(2011-1#1)(2011-2#1)
on an active##3##3##(2008-11#2)(2009-9#1)
on an analogy##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
on an analysis of##5##4##(1990-11#1)(1990-6#1)(1993-12#1)(2008-10#1)(2008-9#1)
on an anion##2##3##(2008-10#2)
on an anion-exchange column##4##4##(2008-10#4)
on an anion-exchange resin loaded with 1##2##7##(2008-10#2)
on an anion-exchange resin##6##4##(2008-10#6)
on an anion-exchange##10##3##(2008-10#10)
on an appropriate##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
on an array of##7##4##(2008-10#4)(2008-2#2)(2008-3#1)
on an array##8##3##(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)
on an as-needed##2##3##(2008-8#2)
on an asymmetric##2##3##(2008-3#1)(2009-9#1)
on an average##8##3##(2008-3#1)(2008-8#4)(2010-6#1)(2010-8#1)(2012-2#1)
on an earlier##2##3##(1997-3#1)(2013-8#1)
on an efficient##2##3##(2008-2#1)(2008-3#1)
on an electrode##2##3##(2008-10#2)
on an emergency basis##2##4##(1992-1#1)(2011-1#1)
on an enzyme##2##3##(1994-8#1)(1995-3#1)
on an erbium-doped fiber amplifier##2##5##(2008-2#2)
on an evaluation of##4##4##(1993-12#1)(1994-1#1)(2008-10#1)(2008-12#1)
on an evaluation##5##3##(1993-12#1)(1994-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
on an evolutionarily##2##3##(1997-1#1)(2010-1#1)
on an experimental##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
on an expression##2##3##(1991-2#1)(2008-3#1)
on an improved##3##3##(2007-12#1)(2011-3#1)(2013-1#1)
on an in vitro model##2##5##(1992-8#1)(2008-10#1)
on an in vitro##3##4##(1992-8#1)(2008-10#1)(2008-5#1)
on an in##5##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
on an individual basis##2##4##(1995-2#1)(2008-9#1)
on an individual##6##3##(1995-2#1)(1996-12#1)(2008-10#2)(2008-9#1)(2013-8#1)
on an individual's##2##3##(1994-3#1)(2013-8#1)
on an industrial scale##3##4##(2008-5#1)(2008-7#1)(2008-9#1)
on an inert##2##3##(1990-7#1)(2008-10#1)
on an initial##4##3##(1997-5#2)(2008-11#1)(2008-5#1)
on an inpatient##3##3##(1994-9#1)(1995-2#1)(1996-5#1)
on an integrated##3##3##(2007-11#1)(2008-10#2)
on an intermediate##3##3##(1990-5#1)(2007-11#1)(2008-10#1)
on an ion##2##3##(2008-10#2)
on an issue##2##3##(2008-11#1)(2008-12#1)
on an octylsilica gel column##2##5##(1996-5#2)
on an ongoing basis to##2##5##(1991-12#1)(1993-12#1)
on an ongoing basis##3##4##(1991-12#1)(1993-12#2)
on an open##2##3##(1993-2#1)(2007-11#1)
on an optical disk##4##4##(2008-3#4)
on an optical fractal synthesizer##2##5##(2008-3#2)
on an optical##13##3##(1997-2#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#7)
on an optically addressed liquid-crystal##2##5##(2007-11#1)(2007-12#1)
on an optically##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
on an organic##2##3##(2008-3#1)(2012-8#1)
on an out-patient##2##3##(2008-5#1)(2008-9#1)
on an outpatient basis and##2##5##(1993-6#1)(1994-2#1)
on an outpatient basis##5##4##(1993-6#1)(1994-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
on an outpatient##6##3##(1993-2#1)(1993-6#1)(1994-2#1)(1996-3#1)(2008-11#1)(2013-1#1)
on an understanding of##2##4##(2008-10#1)(2009-9#1)
on an##372##2##(1990-10#1)(1990-11#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#7)(1993-2#4)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-9#1)(1996-12#2)(1996-3#2)(1996-5#6)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#3)(2007-11#9)(2007-12#12)(2007-7#2)(2008-1#1)(2008-10#81)(2008-11#12)(2008-12#9)(2008-2#21)(2008-3#38)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#10)(2008-9#7)(2009-1#1)(2009-11#1)(2009-3#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#3)
on analysis of##10##3##(2007-12#1)(2007-8#1)(2008-10#6)(2008-8#1)(2009-5#1)
on analysis##12##2##(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-10#1)(2009-5#1)
on analytes##2##2##(2008-10#2)
on analytical##4##2##(2008-10#4)
on analyzing the##2##3##(2011-2#2)
on analyzing##3##2##(2008-8#1)(2011-2#2)
on anatomical##6##2##(1990-8#1)(2008-11#1)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#1)
on ancient##2##2##(2008-10#1)(2012-2#1)
on and off states##2##4##(2008-2#1)(2008-3#1)
on and off years##2##4##(2008-12#2)
on and off##12##3##(2007-11#2)(2007-12#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-8#1)
on and##32##2##(1990-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-8#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)
on angiogenesis of##2##3##(2008-11#1)(2011-2#1)
on angiogenesis##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
on angiographic##3##2##(1997-8#1)(2007-7#1)(2007-8#1)
on angiography##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
on animal##8##2##(1992-2#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)
on animals and##2##3##(2010-4#1)(2013-1#1)
on animals##6##2##(1994-6#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
on annual##3##2##(1997-1#1)(2007-7#1)(2008-10#1)
on another##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
on antibiotic use##2##3##(1996-11#1)(2013-8#1)
on antibiotic##4##2##(1996-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
on antibody production##3##3##(1993-12#1)(2008-11#2)
on antibody##5##2##(1993-12#1)(2008-11#3)(2009-6#1)
on anticancer##2##2##(1991-8#1)(2013-1#1)
on antigen##2##2##(1993-3#1)(2008-11#1)
on antigen-induced##2##2##(1992-3#1)(1997-7#1)
on antigenic##2##2##(1994-8#1)(2007-12#1)
on antimicrobial##2##2##(2008-8#1)(2013-1#1)
on antioxidant##2##2##(1994-6#1)(2011-2#1)
on antiretroviral therapy (ART)##2##4##(2011-2#1)(2012-12#1)
on antiretroviral therapy in##2##4##(2009-7#1)(2012-12#1)
on antiretroviral therapy##6##3##(2008-1#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#2)
on antiretroviral##7##2##(2008-1#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#2)
on anxiety and##2##3##(2009-3#1)(2013-1#1)
on anxiety##6##2##(1991-2#1)(2008-12#1)(2009-12#1)(2009-3#1)(2012-2#1)(2013-1#1)
on any of the##6##4##(1991-3#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
on any of##8##3##(1991-3#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
on any##18##2##(1991-3#1)(1993-1#1)(1993-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#2)
on aortic##3##2##(1990-7#1)(2009-12#1)(2011-2#1)
on aperture shape##2##3##(2008-3#2)
on apoptosis induction##2##3##(2008-8#1)(2009-3#1)
on apoptosis of pancreatic##2##4##(2010-12#1)(2012-3#1)
on apoptosis##8##2##(1994-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-12#1)(2012-3#1)
on apoptotic cell death##2##4##(1996-12#1)(2008-8#1)
on apoptotic##4##2##(1996-12#1)(2008-11#2)(2008-8#1)
on apparent##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
on appeal##3##2##(1991-3#1)(1997-5#2)
on appearance##4##2##(2007-12#2)(2008-10#1)(2009-9#1)
on apple leaves##2##3##(2008-10#2)
on apple##14##2##(2008-10#14)
on apples##7##2##(2008-10#7)
on application of##4##3##(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
on applying a##2##3##(2008-5#1)(2009-11#1)
on applying##4##2##(2008-10#1)(2008-5#1)(2009-11#1)(2010-11#1)
on appressorium formation of##2##4##(2008-10#2)
on approaches that##2##3##(2008-9#1)(2010-7#1)
on appropriate##7##2##(1991-3#1)(1994-12#1)(1995-5#1)(2008-5#1)(2008-7#2)(2013-1#1)
on apricot and##2##3##(2008-10#2)
on aqueous##5##2##(1990-7#1)(1994-6#1)(2008-10#2)(2012-1#1)
on arachidonic acid metabolism##2##4##(1994-8#2)
on arachidonic acid##3##3##(1994-8#2)(2008-11#1)
on arbitrary##2##2##(2008-3#1)(2010-2#1)
on areas##2##2##(2008-10#1)(2012-3#1)
on armaments##3##2##(1990-2#2)(2013-1#1)
on array##3##2##(2008-2#2)(2008-3#1)
on arrays##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)
on arrival in the##2##4##(2010-7#1)(2013-1#1)
on arterial##5##2##(2007-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
on arthropods##2##2##(2007-12#1)(2011-2#1)
on artificial##2##2##(2007-8#1)(2008-5#1)
on as##2##2##(1994-2#1)(2008-10#1)
on ascospore release##3##3##(2008-10#3)
on ascospore##5##2##(2008-10#5)
on aspects of##5##3##(1993-1#1)(1995-1#1)(1996-1#1)(2009-6#1)(2011-2#1)
on aspects##7##2##(1993-1#1)(1995-1#1)(1996-1#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
on assay##2##2##(2008-10#1)(2009-6#1)
on assessing##2##2##(2007-12#1)(2007-4#1)
on assessment and##2##3##(1994-11#1)(1996-1#1)
on assessment##6##2##(1994-11#1)(1994-2#1)(1996-1#1)(2013-1#2)(2013-7#1)
on assessments##2##2##(2008-10#1)(2012-3#1)
on assisting##2##2##(2010-9#1)(2012-2#1)
on associated##2##2##(1996-6#1)(1997-8#1)
on association##3##2##(1995-2#1)(2011-2#1)(2013-7#1)
on associations between##2##3##(2012-1#2)
on assumptions##2##2##(1996-12#1)(2008-10#1)
on asthma##6##2##(2008-10#2)(2010-9#1)(2012-12#2)(2013-1#1)
on asymptomatic##2##2##(2008-10#1)(2009-5#1)
on at least##4##3##(1993-1#1)(1994-12#1)(2008-10#1)(2011-2#1)
on at##5##2##(1993-1#1)(1994-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
on atherogenic dyslipidaemia##2##3##(2012-2#2)
on atherosclerosis##2##2##(1994-9#1)(2012-2#1)
on atmospheric##7##2##(1997-5#1)(2008-11#2)(2008-2#3)(2011-2#1)
on atrial##3##2##(2013-1#2)(2013-8#1)
on attachment##4##2##(1990-8#1)(2007-12#1)(2008-10#2)
on attainment of##2##3##(2008-3#1)(2012-5#1)
on attention##2##2##(2008-6#1)(2012-12#1)
on attitudes and##2##3##(2008-1#1)(2008-11#1)
on attitudes##6##2##(1997-5#1)(2008-1#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-7#1)
on auditory##2##2##(2008-9#1)(2010-12#1)
on autograft##2##2##(2007-8#1)(2009-3#1)
on autoimmunity##3##2##(2006-10#1)(2007-5#2)
on automated coagulation analysers##2##4##(2008-10#2)
on automated##5##2##(1991-5#1)(2008-10#2)(2008-9#1)(2010-2#1)
on available##7##2##(1996-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)
on average 0##3##3##(1996-2#1)(2008-7#1)(2012-2#1)
on average 25%##2##3##(2008-3#1)(2008-9#1)
on average 4##2##3##(2008-5#1)(2008-6#1)
on average below 5##2##4##(2008-5#2)
on average between##2##3##(2008-10#1)(2008-5#1)
on average for##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
on average in##2##3##(1996-2#1)(2008-10#1)
on average than##2##3##(2008-3#2)
on average##103##2##(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#2)(1994-1#1)(1994-2#3)(1994-3#1)(1995-12#1)(1996-11#2)(1996-2#2)(1996-3#4)(1996-9#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on average)##9##2##(1992-5#1)(1995-11#1)(1996-6#1)(1997-2#3)(2011-2#3)
on averaging the##2##3##(2008-10#1)(2008-3#1)
on axial##2##2##(1991-11#1)(2012-2#1)
on axillary skin##4##3##(2008-5#4)
on axillary##6##2##(2008-5#5)(2009-8#1)
on axis##2##2##(2008-3#2)
on azoxymethane-induced##3##2##(1992-3#2)(1992-9#1)
on baccalaureate##2##2##(1991-1#1)(2012-3#1)
on bacteria##4##2##(1997-2#2)(2007-11#1)(2008-10#1)
on bacterial##9##2##(1993-8#1)(2008-10#2)(2008-5#1)(2008-8#2)(2010-1#1)(2012-3#1)(2013-1#1)
on bacteriorhodopsin##2##2##(2007-12#1)(2008-2#1)
on baculovirus##2##2##(2013-8#2)
on baker's yeast##3##3##(2010-7#3)
on balance##2##2##(1996-7#2)
on banana##3##2##(2008-10#3)
on band##3##2##(1997-8#1)(2008-10#1)(2008-3#1)
on bare##4##2##(2008-10#3)(2008-7#1)
on barium##2##2##(1993-9#1)(2008-8#1)
on barley and##2##3##(2008-10#2)
on barley##10##2##(2008-10#9)(2008-5#1)
on barrier function##2##3##(2008-5#2)
on barrier##3##2##(2008-5#2)(2008-7#1)
on basal PGI2 release##2##4##(1995-11#2)
on basal##12##2##(1992-7#1)(1994-3#1)(1995-11#2)(1995-12#1)(1997-7#1)(2008-11#1)(2008-6#3)(2012-12#1)(2012-3#1)
on baseline##5##2##(1995-12#1)(2007-10#1)(2008-10#1)(2008-3#2)
on basic##10##2##(1991-12#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-3#1)
on basidiomycete sources of##2##4##(2013-1#2)
on basis of##5##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
on beam##4##2##(2007-11#1)(2008-3#3)
on bean leaf##2##3##(2008-10#2)
on bean##10##2##(2008-10#8)(2008-8#2)
on beans##2##2##(2008-10#2)
on beating heart##2##3##(2007-8#1)(2012-3#1)
on beating##3##2##(2007-8#1)(2012-3#2)
on behalf of the##4##4##(1991-2#1)(1994-1#1)(1995-6#1)(2013-8#1)
on behalf of##12##3##(1991-2#1)(1992-1#1)(1992-3#1)(1994-1#1)(1995-6#3)(1997-5#1)(2010-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
on behavior and##2##3##(2008-8#1)(2013-1#1)
on behavior of##2##3##(2008-10#1)(2011-2#1)
on behavior##12##2##(1995-12#3)(2008-10#2)(2008-4#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
on behavioral##6##2##(1997-2#1)(2008-11#2)(2009-11#1)(2012-2#1)(2013-1#1)
on behaviour##2##2##(2008-12#1)(2010-2#1)
on behavioural##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
on benchmarking##2##2##(1997-1#2)
on benzodiazepines##3##2##(1991-12#2)(2010-1#1)
on beta-cyclodextrin##2##2##(2008-10#2)
on beta-glucans##2##2##(1991-5#2)
on bias##2##2##(1997-3#1)(2008-2#1)
on bile##2##2##(1993-3#1)(2012-2#1)
on binding of##4##3##(1993-6#1)(1997-4#1)(2008-10#1)(2009-7#1)
on binding##8##2##(1990-2#1)(1992-3#1)(1993-6#1)(1995-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-7#1)
on biochemical and##2##3##(2009-8#1)(2012-3#1)
on biochemical##5##2##(1994-12#1)(2007-11#1)(2009-8#1)(2012-3#2)
on biocontrol##3##2##(2008-10#3)
on biologic##3##2##(2008-11#1)(2013-1#1)(2013-7#1)
on biological agents##3##3##(1992-12#3)
on biological control of fire blight##2##6##(2008-10#2)
on biological control of##6##4##(2008-10#6)
on biological control##7##3##(2008-10#6)(2011-2#1)
on biological mechanisms##3##3##(2008-7#1)(2009-5#1)(2013-1#1)
on biological tissues##4##3##(1995-6#1)(2008-2#1)(2008-3#2)
on biological##27##2##(1992-12#3)(1995-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#3)(2012-2#2)(2013-1#1)
on biology##2##2##(2007-11#1)(2008-9#1)
on biomedical##4##2##(2008-7#2)(2009-11#1)(2012-12#1)
on biopsy##2##2##(2007-8#1)(2010-12#1)
on biosensors##2##2##(2008-10#2)
on biotin transport##2##3##(1992-6#2)
on bird##2##2##(2008-5#1)(2008-8#1)
on birth##7##2##(1991-6#1)(1997-6#1)(1997-7#2)(2011-1#1)(2012-12#2)
on bispectral index##2##3##(2012-12#2)
on black##5##2##(1996-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
on bladder##4##2##(1990-8#1)(1992-3#1)(1997-7#1)(2008-10#1)
on blood agar##3##3##(1996-11#2)(2012-12#1)
on blood flow##3##3##(2007-12#1)(2008-12#2)
on blood glucose##2##3##(1997-2#1)(2010-4#1)
on blood pressure and##7##4##(1991-6#1)(1995-11#1)(1997-8#1)(2008-7#3)(2012-12#1)
on blood pressure in##2##4##(2008-1#1)(2011-2#1)
on blood pressure##20##3##(1991-6#2)(1993-2#1)(1995-11#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#5)(2008-8#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
on blood samples from##2##4##(1992-6#1)(1994-6#1)
on blood vessels##2##3##(1997-6#1)(2008-5#1)
on blood##51##2##(1990-2#1)(1991-6#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-2#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-1#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
on blossoms##5##2##(2008-10#5)
on board UK##3##3##(2007-2#3)
on board the##3##3##(2008-3#2)(2011-2#1)
on board##16##2##(1991-1#1)(2007-2#5)(2008-10#1)(2008-11#1)(2008-3#3)(2010-5#1)(2011-2#4)
on body balance##3##3##(2008-12#2)(2010-9#1)
on body composition and features of the metabolic syndrome##2##9##(2008-5#2)
on body composition and##4##4##(2008-5#3)(2012-3#1)
on body composition##8##3##(2008-5#5)(2008-7#1)(2010-8#1)(2012-3#1)
on body image and##3##4##(2007-12#3)
on body image##7##3##(2007-12#7)
on body mass index (BMI)##2##5##(2012-2#1)(2013-1#1)
on body mass index##3##4##(2009-6#1)(2012-2#1)(2013-1#1)
on body mass##5##3##(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-1#1)
on body temperature##2##3##(1995-3#1)(2007-10#1)
on body weight and##2##4##(2007-12#1)(2012-2#1)
on body weight or##2##4##(2008-6#1)(2012-2#1)
on body weight##6##3##(2007-12#1)(2008-5#1)(2008-6#1)(2012-1#1)(2012-2#2)
on body##41##2##(1995-3#1)(1997-7#1)(2007-10#1)(2007-12#11)(2008-11#1)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
on bone and##2##3##(2007-11#1)(2011-1#1)
on bone marrow##2##3##(1993-3#1)(1997-8#1)
on bone metabolism##2##3##(2007-7#1)(2008-7#1)
on bone mineral density (BMD)##2##5##(2011-2#2)
on bone mineral density and##2##5##(1995-11#1)(2008-11#1)
on bone mineral density##5##4##(1995-11#1)(2008-11#1)(2011-2#3)
on bone resorption in##2##4##(1993-6#1)(1995-3#1)
on bone tunnel surface##2##4##(2013-1#2)
on bone##34##2##(1991-11#2)(1991-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#3)(2013-1#3)
on boron-doped diamond##2##3##(2008-10#2)
on both RNA##2##3##(2008-4#1)(2013-8#1)
on both a##2##3##(1995-3#1)(2008-7#1)
on both apertures##2##3##(2007-11#2)
on both columns##2##3##(2008-10#2)
on both crops##3##3##(2008-10#3)
on both cultivars##4##3##(2008-10#4)
on both general##2##3##(1991-2#1)(2012-2#1)
on both host##2##3##(2008-10#1)(2008-8#1)
on both hosts##3##3##(2008-10#3)
on both of these##3##4##(1991-12#1)(2008-11#1)(2011-2#1)
on both patients##2##3##(2008-8#1)(2013-1#1)
on both sides of the pelvis##3##6##(2011-2#3)
on both sides of the##15##5##(1990-11#1)(1990-2#1)(1991-8#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#4)(2012-12#1)(2013-7#1)
on both sides##25##3##(1990-11#1)(1990-2#1)(1991-8#1)(1993-12#1)(1995-1#1)(1995-8#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#2)(2009-1#1)(2009-6#1)(2011-2#4)(2012-12#1)(2013-7#1)
on both surfaces##2##3##(2007-12#1)(2010-10#1)
on both synthetic##2##3##(2008-5#1)(2013-1#1)
on both the relative##2##4##(1995-5#1)(2008-8#1)
on both the##38##3##(1990-11#1)(1990-7#1)(1990-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1997-2#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
on both types##2##3##(2008-9#1)(2013-1#1)
on both##220##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#61)(2008-11#7)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#8)(2008-7#8)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#2)
on bovine adrenal##2##3##(1994-5#1)(1994-8#1)
on bovine##6##2##(1994-5#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-5#1)
on bradykinin- and platelet-activating##2##4##(1992-3#2)
on brain stem##2##3##(1993-5#1)(2011-2#1)
on brain##24##2##(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
on branches##2##2##(2008-10#1)(2010-10#1)
on breast cancer cell##3##4##(1992-9#1)(1994-12#1)(2012-3#1)
on breast cancer##9##3##(1990-6#1)(1992-9#1)(1994-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
on breast##11##2##(1990-6#2)(1992-9#1)(1994-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
on breastfeeding##3##2##(2007-2#1)(2008-11#1)(2012-2#1)
on breath hydrogen excretion##2##4##(1996-6#2)
on breeding##2##2##(2008-8#1)(2008-9#1)
on bringing##2##2##(2008-10#1)(2010-12#1)
on broader indications than##2##4##(1993-6#2)
on broader##4##2##(1993-6#2)(1997-2#1)(2008-2#1)
on broiler##2##2##(1995-9#1)(1997-3#1)
on bud break were##2##4##(2012-4#2)
on bud break##3##3##(2012-4#3)
on building materials##2##3##(2008-10#2)
on building##6##2##(2008-10#3)(2009-5#1)(2012-3#1)(2013-1#1)
on bulk metals##2##3##(2008-7#2)
on bulk##4##2##(2007-12#1)(2008-7#2)(2013-8#1)
on burnout##2##2##(1991-3#1)(2009-5#1)
on business##2##2##(1996-2#1)(1997-2#1)
on by VATS##2##3##(2008-10#2)
on by the##3##3##(1991-3#1)(1996-8#1)(2006-12#1)
on by##13##2##(1990-11#1)(1991-3#1)(1991-4#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(2006-12#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-1#1)
on cAMP##2##2##(1993-3#2)
on cadaver##4##2##(2007-11#1)(2008-3#1)(2012-2#2)
on cadaveric##2##2##(2009-4#1)(2011-2#1)
on cadmium toxicity##3##3##(1993-12#2)(2008-7#1)
on cadmium##7##2##(1993-12#3)(1996-7#1)(2008-10#1)(2008-7#2)
on calcareous##2##2##(2012-6#1)(2012-9#1)
on calcineurin##2##2##(2008-1#1)(2008-9#1)
on calcium##7##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-11#1)(1997-7#2)(2012-1#1)
on calculated##3##2##(1992-9#1)(2008-10#1)(2008-9#1)
on calibrated##2##2##(1990-2#1)(2008-3#1)
on calibration##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2010-11#1)
on call in##2##3##(2008-8#2)
on cancer cells##4##3##(1994-2#1)(2008-11#1)(2009-12#1)(2013-8#1)
on cancer research##3##3##(1990-2#1)(2009-4#1)(2010-9#1)
on cancer risk##2##3##(2011-2#1)(2012-6#1)
on cancer##21##2##(1990-2#1)(1992-8#1)(1992-9#1)(1994-2#1)(1997-3#1)(1997-5#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-6#1)(2013-8#1)
on canine rabies##2##3##(2011-2#2)
on canine##3##2##(2011-2#2)(2012-12#1)
on cannabis##2##2##(2008-1#1)(2008-12#1)
on canola##3##2##(2008-10#2)(2011-2#1)
on cantaloupe##2##2##(2008-10#2)
on capacity##3##2##(2007-2#1)(2008-10#1)(2008-12#1)
on capsules extended##3##3##(1997-3#3)
on capsules##4##2##(1997-3#4)
on carbachol-stimulated##2##2##(1997-1#2)
on carbohydrate##2##2##(1991-12#1)(2009-10#1)
on carbon film electrodes##2##4##(2008-10#2)
on carbon nanotubes##2##3##(2008-7#1)(2011-2#1)
on carbon paste##3##3##(2008-10#3)
on carbon##18##2##(1995-5#1)(1997-6#2)(2007-11#1)(2008-10#12)(2008-7#1)(2011-2#1)
on carcass traits and fatty acid compositions in Japanese Black cattle##2##11##(2010-2#2)
on carcass##4##2##(2010-2#2)(2012-2#2)
on carcinogenesis in various organs##2##5##(1992-9#2)
on carcinogenesis##3##2##(1992-9#2)(2012-1#1)
on cardiac function and##2##4##(2011-2#2)
on cardiac##15##2##(1991-6#1)(1992-3#2)(1994-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
on cardiocytes impaired by##2##4##(2011-3#2)
on cardiomyocytes##2##2##(2009-2#2)
on cardiopulmonary bypass##6##3##(2006-10#1)(2007-8#4)(2012-2#1)
on cardiovascular disease##2##3##(2008-3#1)(2009-9#1)
on cardiovascular morbidity and mortality##2##5##(2008-7#2)
on cardiovascular outcomes##2##3##(2008-3#1)(2011-2#1)
on cardiovascular system##2##3##(2013-1#2)
on cardiovascular##19##2##(2008-3#2)(2008-7#2)(2008-8#1)(2009-9#2)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
on care##8##2##(1992-1#1)(1995-2#1)(1997-1#1)(2008-7#1)(2010-9#1)(2012-3#3)
on careful##3##2##(1994-12#1)(1994-6#1)(2012-3#1)
on caring##3##2##(1992-3#1)(2009-5#1)(2012-3#1)
on carnation##4##2##(2008-10#4)
on carrier-envelope phase##2##3##(2007-11#2)
on carrot##3##2##(2008-10#3)
on cartilage##2##2##(2008-5#1)(2011-2#1)
on case##5##2##(1996-3#1)(1997-2#1)(1997-3#2)(2007-11#1)
on cases##2##2##(1993-12#1)(2008-8#1)
on cassava##3##2##(1991-12#1)(2008-10#2)
on castor##2##2##(2008-12#1)(2008-6#1)
on catheter##3##2##(2007-7#1)(2010-9#1)(2011-2#1)
on caudate##2##2##(1996-5#1)(2008-7#1)
on cauliflower plants##2##3##(2008-10#1)(2011-2#1)
on cauliflower##6##2##(2008-10#5)(2011-2#1)
on celery##2##2##(2008-10#2)
on cell adhesion##2##3##(1997-7#1)(2012-12#1)
on cell attachment and##2##4##(2008-5#1)(2009-12#1)
on cell culture##3##3##(2008-11#2)(2009-5#1)
on cell cycle progression##4##4##(1994-11#1)(1994-8#1)(1996-3#1)(2008-9#1)
on cell cycle##7##3##(1994-11#1)(1994-8#1)(1996-3#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
on cell division##2##3##(1992-9#1)(2008-1#1)
on cell growth and##7##4##(1993-12#1)(1994-8#1)(1996-2#1)(2008-11#2)(2011-2#2)
on cell growth in##2##4##(2008-11#1)(2010-8#1)
on cell growth of##2##4##(2008-11#2)
on cell growth##22##3##(1990-5#1)(1990-8#2)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-11#10)(2008-7#1)(2010-8#1)(2011-2#2)
on cell membranes##3##3##(1990-12#1)(1991-9#1)(2008-8#1)
on cell proliferation and##3##4##(1992-8#1)(1994-2#1)(1995-11#1)
on cell proliferation were studied in human breast cancer cells##2##10##(2008-11#2)
on cell proliferation were##4##4##(2008-11#4)
on cell proliferation##13##3##(1990-11#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#5)(2012-2#1)
on cell surface##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
on cell surfaces##5##3##(1991-9#2)(1995-5#1)(2006-12#1)(2008-8#1)
on cell survival##2##3##(1994-2#1)(2008-11#1)
on cell viability and##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
on cell viability##4##3##(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
on cell##98##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-9#4)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-2#3)(1994-8#2)(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#27)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
on cells of##2##3##(2011-1#1)(2011-2#1)
on cells##12##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
on cellular calcium##2##3##(1991-12#1)(1995-5#1)
on cellular proliferation##3##3##(2008-7#1)(2013-7#2)
on cellular radiation##2##3##(2008-9#2)
on cellular##25##2##(1991-12#1)(1991-5#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-3#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#3)(2013-7#2)
on cellulose nitrate##2##3##(1992-6#1)(2008-10#1)
on cellulose via##2##3##(2008-10#2)
on cellulose##8##2##(1991-12#1)(1992-6#1)(2008-10#5)(2008-5#1)
on central##2##2##(2011-2#1)(2011-3#1)
on centroids##2##2##(2008-10#1)(2008-3#1)
on ceramic##3##2##(1997-4#1)(2006-4#1)(2008-10#1)
on cerebellar##4##2##(1995-5#1)(1996-5#1)(2007-10#1)(2012-2#1)
on cerebral blood flow in##2##5##(2007-10#2)
on cerebral blood flow##5##4##(2007-10#3)(2007-8#1)(2008-7#1)
on cerebral metabolic##2##3##(1991-1#2)
on cerebral metabolism##3##3##(1991-5#1)(1994-2#1)(1997-7#1)
on cerebral##16##2##(1990-5#1)(1991-1#2)(1991-5#1)(1993-12#1)(1994-2#1)(1995-12#1)(1997-7#1)(2007-10#4)(2007-8#1)(2008-7#2)(2012-3#1)
on certain##8##2##(1994-8#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#1)
on cervical cancer##2##3##(1992-10#1)(2011-1#1)
on cervical##6##2##(1992-10#2)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)
on cesium##2##2##(1993-8#1)(1994-8#1)
on change in##3##3##(1995-11#1)(2009-7#1)(2010-10#1)
on changes in cell##2##4##(1994-11#1)(2012-2#1)
on changes in the##4##4##(1996-12#1)(1997-6#1)(2007-11#1)(2012-2#1)
on changes in##8##3##(1994-11#1)(1994-12#1)(1996-12#1)(1997-6#1)(2007-11#1)(2011-1#1)(2012-2#2)
on changes of##5##3##(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#2)
on changes##13##2##(1994-11#1)(1994-12#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
on changing##3##2##(1990-5#1)(1995-6#1)(2007-11#1)
on channel activity##2##3##(2008-8#2)
on channel##5##2##(1995-5#1)(2008-3#1)(2008-8#3)
on characteristic##2##2##(2008-11#1)(2011-2#1)
on characteristics of##4##3##(2008-7#1)(2009-12#1)(2009-7#1)(2012-3#1)
on characteristics##5##2##(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-3#1)
on charity##2##2##(1992-3#1)(1995-2#1)
on chemical analysis##2##3##(1994-5#1)(2008-10#1)
on chemical constituents of##4##4##(2012-3#2)(2013-8#2)
on chemical##17##2##(1994-5#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#3)(2013-8#2)
on chemically modified##7##3##(2008-10#7)
on chemically##8##2##(1995-9#1)(2008-10#7)
on chemiluminescence##3##2##(2008-10#3)
on chemotactic##2##2##(1991-2#1)(2010-8#1)
on chemotherapy##4##2##(2007-5#2)(2010-11#1)(2012-3#1)
on chest X-ray##4##3##(1991-12#3)(2008-1#1)
on chest##9##2##(1991-12#3)(2007-8#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
on chicken##6##2##(1991-6#1)(1996-5#1)(2007-6#1)(2008-12#1)(2008-8#1)(2011-1#1)
on child health##2##3##(1995-1#1)(2008-11#1)
on child##10##2##(1995-1#1)(1996-2#1)(2008-11#2)(2008-2#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
on childhood##4##2##(1995-12#1)(2008-11#1)(2010-6#2)
on children and##4##3##(2008-11#3)(2012-3#1)
on children##11##2##(1992-3#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-11#3)(2009-12#1)(2011-2#2)(2012-3#1)
on children's health##2##3##(2008-11#1)(2013-1#1)
on children's##12##2##(1992-3#1)(1996-1#1)(2007-11#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-1#1)(2013-1#2)
on chip##7##2##(2008-7#1)(2009-10#2)(2010-11#1)(2010-8#2)(2011-1#1)
on chiral##2##2##(2008-10#2)
on chitin##2##2##(2008-10#2)
on chitosan##4##2##(2008-10#4)
on choice of##2##3##(1995-1#1)(2008-10#1)
on cholesterol##5##2##(1990-8#1)(1995-12#2)(1995-5#1)(2012-3#1)
on cholinergic##3##2##(1993-12#1)(1995-12#1)(2009-3#1)
on cholinesterase##2##2##(2008-10#2)
on choosing##3##2##(1994-7#1)(2008-11#1)(2008-7#1)
on chromatin##4##2##(1990-2#1)(1995-2#1)(2008-4#1)(2009-12#1)
on chromatographic##2##2##(2008-10#1)(2008-5#1)
on chromosomal##2##2##(2008-2#1)(2012-12#1)
on chromosome 1##13##3##(1995-8#3)(1996-10#4)(2008-10#4)(2009-10#1)(2012-2#1)
on chromosome 10##2##3##(1990-3#1)(2012-3#1)
on chromosome 11##6##3##(1991-6#1)(2008-10#2)(2008-8#3)
on chromosome 11p15##2##3##(2008-1#1)(2008-7#1)
on chromosome 11q13##2##3##(1997-8#2)
on chromosome 12##5##3##(1996-12#1)(2008-10#4)
on chromosome 12p and##2##4##(1997-5#2)
on chromosome 16##3##3##(1993-12#1)(1996-2#2)
on chromosome 17p13##2##3##(1993-11#1)(2010-3#1)
on chromosome 1AS##2##3##(2008-10#2)
on chromosome 1H##2##3##(2008-10#2)
on chromosome 2##4##3##(1993-2#1)(1997-5#1)(2008-10#1)(2008-9#1)
on chromosome 2(2H)##2##3##(2008-10#2)
on chromosome 3##9##3##(1990-5#2)(1997-5#1)(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#1)(2012-3#1)
on chromosome 4##7##3##(1997-2#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-3#1)(2012-3#1)
on chromosome 4q##2##3##(2012-3#2)
on chromosome 5 explained##2##4##(2008-10#2)
on chromosome 5##8##3##(1993-2#1)(1996-10#2)(1997-6#1)(1997-8#1)(2008-10#3)
on chromosome 5(1H)##2##3##(2008-10#2)
on chromosome 5BL##2##3##(2008-10#2)
on chromosome 6##2##3##(1997-5#1)(2008-9#1)
on chromosome 6p21##2##3##(2008-1#2)
on chromosome 6q##3##3##(2009-4#1)(2012-3#2)
on chromosome 7(5H) at a distance of##2##7##(2008-10#2)
on chromosome 7(5H)##3##3##(2008-10#3)
on chromosome 7A##2##3##(2008-10#2)
on chromosome 7DL##2##3##(2008-10#2)
on chromosome 7DS in##2##4##(2008-10#2)
on chromosome 7DS##3##3##(2008-10#3)
on chromosome 8##4##3##(1993-2#1)(2008-8#1)(2008-9#2)
on chromosome 9##3##3##(2009-6#1)(2010-3#1)(2011-2#1)
on chromosome II and##2##4##(1993-12#1)(1996-6#1)
on chromosome IV##5##3##(1996-6#2)(1997-8#1)(2008-5#1)(2012-3#1)
on chromosome IX##2##3##(1996-3#2)
on chromosome XV##3##3##(1995-6#2)(1996-3#1)
on chromosome arm##3##3##(2008-10#1)(2012-3#2)
on chromosome##172##2##(1990-3#1)(1990-5#2)(1991-10#1)(1991-6#1)(1993-11#4)(1993-12#2)(1993-2#3)(1994-6#1)(1994-9#2)(1995-2#1)(1995-6#3)(1995-8#5)(1996-10#6)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#4)(1997-2#3)(1997-3#1)(1997-5#6)(1997-6#4)(1997-7#2)(1997-8#4)(2007-7#2)(2008-1#6)(2008-10#52)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#4)(2011-2#3)(2012-2#1)(2012-3#14)
on chromosomes 1 and##2##4##(1996-10#1)(2008-10#1)
on chromosomes 1##11##3##(1996-10#1)(1996-12#1)(1997-5#2)(2008-10#4)(2008-8#2)(2008-9#1)
on chromosomes 10 and 12##2##5##(1996-12#2)
on chromosomes 10 and##3##4##(1996-12#3)
on chromosomes 10##4##3##(1996-12#3)(2008-10#1)
on chromosomes 1AS##2##3##(2008-10#2)
on chromosomes 2##3##3##(1997-5#1)(2008-10#2)
on chromosomes 3##3##3##(2008-10#2)(2008-8#1)
on chromosomes 4q##2##3##(2012-3#2)
on chromosomes##36##2##(1995-6#1)(1996-10#1)(1996-12#4)(1997-3#1)(1997-5#4)(2008-10#15)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2012-3#2)
on chronic dialysis##4##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)
on chronic hemodialysis##5##3##(2008-1#2)(2013-1#1)(2013-8#2)
on chronic##23##2##(1991-8#1)(1992-9#1)(1993-2#1)(1994-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
on circulating##2##2##(1994-5#1)(2010-5#1)
on citrus##7##2##(2008-10#7)
on classical##3##2##(1996-4#1)(2008-8#1)(2012-3#1)
on classification##2##2##(2008-6#1)(2011-1#1)
on clear##2##2##(1994-1#1)(2008-3#1)
on clinical and##5##3##(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#2)
on clinical applications##2##3##(1997-2#1)(2012-2#1)
on clinical features and##2##4##(2007-7#1)(2012-3#1)
on clinical grounds##4##3##(1994-7#1)(2007-7#1)(2008-7#1)(2008-8#1)
on clinical management##2##3##(2011-2#1)(2012-1#1)
on clinical outcome in##2##4##(2007-12#1)(2008-7#1)
on clinical outcome##5##3##(2006-10#1)(2007-12#1)(2008-3#2)(2008-7#1)
on clinical outcomes##3##3##(1994-1#1)(2009-12#1)(2011-2#1)
on clinical practice##4##3##(2008-11#4)
on clinical##65##2##(1991-3#2)(1992-12#1)(1993-3#1)(1994-1#2)(1994-5#1)(1994-7#1)(1995-5#1)(1996-1#1)(1997-2#2)(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#5)(2013-1#2)
on clinically##2##2##(2008-11#1)(2010-8#1)
on cloning efficiency##2##3##(2008-9#2)
on cloud##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
on cloudy days##2##3##(2008-10#2)
on cluster##4##2##(2008-1#1)(2008-10#3)
on clusters##2##2##(2008-10#1)(2010-10#1)
on coagulation time##2##3##(2008-9#2)
on coagulation##4##2##(2008-10#1)(2008-9#2)(2009-4#1)
on coarse spatial scales##2##4##(2008-8#2)
on coarse##3##2##(2008-8#3)
on cobalt##3##2##(2008-10#3)
on cocaine self-administration##2##3##(1991-1#2)
on cocaine##3##2##(1991-1#3)
on coffee leaves##2##3##(2008-10#2)
on cognition and##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
on cognition##4##2##(1991-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
on cognitive function in##2##4##(2012-2#1)(2012-3#1)
on cognitive function##4##3##(2012-1#2)(2012-2#1)(2012-3#1)
on cognitive functions##2##3##(1991-12#1)(2008-7#1)
on cognitive performance##2##3##(2011-1#1)(2012-12#1)
on cognitive##16##2##(1990-3#1)(1991-12#1)(1996-11#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
on coherent##3##2##(2007-12#1)(2008-3#2)
on cohorts##2##2##(2008-10#1)(2012-3#1)
on cold##4##2##(1990-2#2)(2008-10#2)
on collagen gel was##2##4##(1994-8#2)
on collagen gel##4##3##(1994-8#4)
on collagen synthesis##2##3##(2008-5#1)(2008-9#1)
on collagen type##2##3##(1990-12#1)(2008-11#1)
on collagen##15##2##(1990-12#1)(1994-8#7)(2008-11#3)(2008-5#3)(2008-9#1)
on collagen-coated##2##2##(2008-11#2)
on collected##2##2##(2008-2#1)(2011-10#1)
on collecting information on##2##4##(1996-2#1)(2008-10#1)
on colony##4##2##(1992-11#1)(2008-10#3)
on colorectal##2##2##(2008-10#1)(2008-11#1)
on colour##2##2##(1990-12#1)(2008-5#1)
on column##2##2##(2008-10#1)(2008-6#1)
on columns of##3##3##(1992-12#1)(1996-5#1)(2008-5#1)
on columns##4##2##(1992-12#1)(1992-6#1)(1996-5#1)(2008-5#1)
on combination##2##2##(2011-2#1)(2013-1#1)
on combined##2##2##(2008-10#1)(2009-7#1)
on combining##5##2##(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)
on combustion products##2##3##(1996-12#2)
on combustion##3##2##(1996-12#2)(2008-11#1)
on commercial##5##2##(2008-10#4)(2008-6#1)
on commercially##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
on common bean##4##3##(2008-10#4)
on common##15##2##(1996-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
on communication##2##2##(1997-2#1)(2012-3#1)
on communications##2##2##(1993-12#1)(1994-2#1)
on communities##2##2##(2010-8#1)(2013-1#1)
on community##9##2##(1990-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-10#1)(2013-1#1)
on comorbid##2##2##(2012-2#2)
on comparative##2##2##(2008-10#1)(2008-7#1)
on comparing##2##2##(2008-7#1)(2012-2#1)
on competition for##2##3##(2008-8#1)(2008-9#1)
on competition##4##2##(1991-1#1)(2008-8#1)(2008-9#2)
on competitive##2##2##(1995-9#1)(2008-10#1)
on complementary##4##2##(2008-10#3)(2012-3#1)
on complete##2##2##(2008-10#1)(2011-2#1)
on completion of##2##3##(2009-12#1)(2012-3#1)
on complex formation##2##3##(1995-2#2)
on complex##9##2##(1995-2#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2013-1#1)
on complexation of##2##3##(2008-10#2)
on complexation##5##2##(2008-10#5)
on complexes that##2##3##(2010-5#1)(2012-3#1)
on complexes##4##2##(2009-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
on complication##2##2##(2007-11#1)(2010-4#1)
on components of##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
on components##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2009-7#1)
on composite##2##2##(2008-10#1)(2009-6#1)
on compound##3##2##(1997-7#1)(2008-4#1)(2008-5#1)
on compounds##2##2##(2008-5#1)(2013-1#1)
on computed tomography (CT) scan##2##5##(2008-7#1)(2011-2#1)
on computed tomography (CT)##6##4##(2007-10#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#2)
on computed tomography##11##3##(2007-10#1)(2008-3#1)(2008-7#3)(2009-3#1)(2011-2#2)(2012-2#2)(2013-1#1)
on computer##3##2##(1992-12#1)(2008-2#1)(2012-3#1)
on computerized##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
on concave and convex##2##4##(2007-8#2)
on concave##3##2##(2007-8#3)
on concentrations##2##2##(1995-11#1)(2008-10#1)
on conditional##3##2##(1995-9#1)(2008-5#1)(2012-2#1)
on conditioned##3##2##(1993-5#1)(2008-6#2)
on conditions##2##2##(2008-8#1)(2009-3#1)
on conducting##3##2##(1996-12#1)(1996-3#1)(2008-10#1)
on conformation and##2##3##(2008-8#2)
on conformational##2##2##(2008-10#1)(2013-8#1)
on conidia germination##2##3##(2008-10#2)
on conidia##3##2##(2008-10#3)
on conidial germination and appressorium formation##2##6##(2008-10#2)
on conidial##4##2##(2008-10#4)
on conservative##2##2##(1990-2#1)(2011-2#1)
on conserved##2##2##(2008-7#1)(2011-1#1)
on constitutive##3##2##(2006-6#2)(2009-4#1)
on construction of##2##3##(2008-10#1)(2008-11#1)
on construction##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
on consumer##5##2##(1997-3#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
on consumers'##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
on consumption##2##2##(2008-10#1)(2011-2#1)
on contaminated##2##2##(2008-11#1)(2008-6#1)
on contemporary##3##2##(1990-8#1)(2008-12#1)(2009-8#1)
on content of##2##3##(2012-1#1)(2012-3#1)
on content words##2##3##(2008-2#2)
on content##5##2##(2008-2#2)(2012-1#1)(2012-3#2)
on continuous ambulatory peritoneal dialysis (CAPD)##2##6##(2007-12#1)(2008-1#1)
on continuous ambulatory peritoneal dialysis##5##5##(2007-12#4)(2008-1#1)
on continuous ambulatory##6##3##(1997-8#1)(2007-12#4)(2008-1#1)
on continuous##20##2##(1991-5#1)(1993-2#1)(1997-8#1)(2007-12#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)
on contraction##2##2##(1991-12#1)(1994-11#1)
on contrast##2##2##(2011-2#1)(2013-1#1)
on control##5##2##(1992-11#1)(1993-8#1)(2008-10#2)(2010-4#1)
on controlled pore glass##7##4##(2008-10#7)
on controlled##11##2##(2007-12#1)(2008-10#10)
on controlled-pore##2##2##(2008-10#2)
on conventional##10##2##(1991-11#1)(1993-8#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)
on corn and##2##3##(2008-10#2)
on corn meal agar##2##4##(2008-10#1)(2008-5#1)
on corn##11##2##(2008-10#8)(2008-5#1)(2011-2#2)
on cornmeal agar##2##3##(2008-10#2)
on coronary artery bypass graft##2##5##(1992-11#1)(2008-12#1)
on coronary artery##4##3##(1992-11#1)(2008-12#1)(2010-2#1)(2010-8#1)
on coronary heart disease##2##4##(2008-3#1)(2010-8#1)
on coronary##8##2##(1992-11#1)(2008-12#1)(2008-3#2)(2009-9#1)(2010-2#1)(2010-8#2)
on correct##4##2##(2007-12#1)(2008-10#2)(2010-12#1)
on cortical##8##2##(1991-12#1)(1997-2#1)(2008-11#2)(2008-6#2)(2009-7#1)(2010-9#1)
on corticosterone level##2##3##(2013-1#2)
on cortisol##2##2##(1990-12#1)(2010-4#1)
on cosmetic##2##2##(1995-8#1)(2010-8#1)
on cost##6##2##(1992-1#1)(1993-3#1)(1996-3#1)(2007-7#1)(2009-8#1)(2011-2#1)
on costs and##3##3##(1991-1#1)(1993-12#1)(1994-3#1)
on costs of##2##3##(1991-1#1)(2008-10#1)
on costs##7##2##(1991-1#2)(1993-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(2008-10#1)
on cotton##5##2##(2008-10#3)(2008-6#1)(2011-2#1)
on cotyledons##2##2##(2008-10#2)
on coulometric titration##2##3##(2008-10#2)
on coupled##5##2##(1992-11#1)(2007-12#2)(2008-3#1)(2008-8#1)
on coupling##6##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
on cowpea##3##2##(2008-10#3)
on cranial##3##2##(2007-10#2)(2012-3#1)
on craniofacial##2##2##(2007-12#2)
on creating##2##2##(1995-1#1)(2008-12#1)
on criteria##4##2##(1990-3#1)(1991-12#1)(1997-5#1)(2011-2#1)
on critical##7##2##(1993-2#1)(1996-7#1)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#1)
on cross-modal##2##2##(2008-8#1)(2012-1#1)
on crosslinked##3##2##(2008-10#3)
on crystal##3##2##(1991-8#1)(2008-7#1)(2008-8#1)
on crystalline##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
on cucumber##11##2##(2008-10#8)(2008-12#1)(2009-12#1)(2013-8#1)
on cucurbit##2##2##(2008-10#2)
on cucurbits##2##2##(2008-10#1)(2013-8#1)
on cultivars##2##2##(2008-10#2)
on cultivated##3##2##(2008-10#2)(2012-3#1)
on cultural##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
on culture media##2##3##(2008-10#2)
on culture##5##2##(1993-2#1)(2007-7#1)(2007-8#1)(2008-10#2)
on cultured##10##2##(1992-12#2)(1992-5#1)(1993-5#1)(1995-12#1)(1997-1#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-2#1)
on cumulative feed consumption##2##4##(2008-12#2)
on curcumin##2##2##(2008-10#1)(2013-1#1)
on curing##2##2##(2008-10#1)(2011-2#1)
on current data##3##3##(2009-8#1)(2010-5#1)(2013-8#1)
on current##24##2##(1992-6#1)(1993-2#1)(1995-1#1)(1997-2#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
on currently available##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
on curved surfaces##2##3##(2008-2#1)(2008-3#1)
on customer##2##2##(1995-12#1)(1996-3#1)
on cut##2##2##(2008-10#1)(2011-2#1)
on cutaneous##2##2##(2007-2#1)(2007-7#1)
on cv##11##2##(2008-10#10)(2008-6#1)
on cvs##4##2##(2008-10#3)(2008-6#1)
on cyclic AMP##5##3##(1993-5#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-4#1)
on cyclic##9##2##(1993-5#1)(1995-11#2)(1995-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-4#1)
on cytokine and##3##3##(2008-10#1)(2008-11#2)
on cytokine secretion##2##3##(2008-10#1)(2008-11#1)
on cytokine##7##2##(1993-8#1)(2008-10#3)(2008-11#3)
on cytological##4##2##(1993-11#1)(1997-2#1)(2007-7#1)(2008-10#1)
on cytoplasmic##2##2##(1991-12#1)(1994-8#1)
on cytoskeletal##2##2##(1994-8#1)(2009-9#1)
on cytosolic free##3##3##(1992-3#2)(2013-1#1)
on cytosolic phospholipase A2 activation in rabbit platelets##2##8##(1995-11#2)
on cytosolic##7##2##(1990-5#1)(1992-3#2)(1994-6#1)(1995-11#2)(2013-1#1)
on d##2##2##(2008-8#2)
on daily##8##2##(1995-3#1)(1997-1#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
on damaged##2##2##(1995-2#1)(2008-7#1)
on damping-off##2##2##(2008-10#2)
on data collected##5##3##(1994-6#1)(2008-10#1)(2008-12#1)(2009-5#1)(2013-1#1)
on data from a sample of##2##6##(1997-4#1)(2008-12#1)
on data from a##4##4##(1997-4#1)(2008-10#1)(2008-12#1)(2011-1#1)
on data from the##7##4##(1990-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-2#1)
on data from##23##3##(1990-11#1)(1993-1#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)
on data gathered##2##3##(1990-12#1)(2009-9#1)
on data obtained from##2##4##(2008-10#1)(2008-11#1)
on data obtained##4##3##(2008-10#1)(2008-11#2)(2012-3#1)
on data quality##2##3##(2008-3#1)(2010-1#1)
on data##52##2##(1990-11#1)(1990-12#2)(1991-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
on day 0##5##3##(1991-8#1)(1996-12#1)(2008-10#2)(2008-4#1)
on day 1##18##3##(1990-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1995-11#1)(1995-12#1)(2007-10#4)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
on day 10##4##3##(1993-6#1)(1994-2#1)(2007-2#1)(2008-10#1)
on day 11##3##3##(1994-6#1)(1997-6#1)(2009-6#1)
on day 12##3##3##(1992-5#1)(1995-12#2)
on day 14##3##3##(2006-6#1)(2007-11#1)(2008-8#1)
on day 16##3##3##(1993-12#1)(1993-6#2)
on day 17##2##3##(1995-12#1)(2012-2#1)
on day 2 and##2##4##(1992-3#1)(1994-8#1)
on day 2##5##3##(1991-4#1)(1992-3#1)(1994-8#1)(2008-3#1)(2010-7#1)
on day 20 of##3##4##(1993-12#1)(1996-12#1)(2011-1#1)
on day 20##7##3##(1993-12#1)(1995-12#2)(1996-12#1)(2008-10#1)(2010-4#1)(2011-1#1)
on day 21##2##3##(1995-11#1)(2006-6#1)
on day 28##3##3##(2008-7#3)
on day 3##8##3##(1994-2#3)(1994-8#1)(2008-11#1)(2008-9#2)(2010-10#1)
on day 4 of##2##4##(2008-10#1)(2008-9#1)
on day 4##6##3##(1994-5#2)(1995-11#1)(1996-2#1)(2008-10#1)(2008-9#1)
on day 40##2##3##(2008-10#1)(2008-7#1)
on day 5 of decidualization##2##5##(1997-6#2)
on day 5 of lactation##2##5##(1992-5#2)
on day 5 of##4##4##(1992-5#2)(1997-6#2)
on day 5##9##3##(1992-5#2)(1994-2#2)(1997-6#2)(2007-10#1)(2009-10#1)(2013-1#1)
on day 6##3##3##(1995-2#1)(2010-7#1)(2012-12#1)
on day 64##3##3##(2008-7#3)
on day 7 and##2##4##(1995-12#1)(2008-10#1)
on day 7##7##3##(1992-11#1)(1994-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
on day 8##4##3##(1993-12#1)(2008-12#1)(2008-8#1)(2011-2#1)
on day of##2##3##(2008-3#1)(2012-2#1)
on day##127##2##(1990-2#4)(1990-5#2)(1991-4#2)(1991-5#2)(1991-8#2)(1992-11#1)(1992-3#2)(1992-5#3)(1993-12#3)(1993-6#3)(1994-2#6)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#7)(1995-2#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-6#3)(2006-6#3)(2007-10#5)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#7)
on days 0##4##3##(1995-12#2)(1997-6#1)(2008-10#1)
on days 1 and 8##2##5##(1994-7#1)(2008-10#1)
on days 1 and##4##4##(1990-2#1)(1994-7#1)(2008-10#1)(2009-11#1)
on days 1##13##3##(1990-2#2)(1991-2#1)(1991-4#1)(1991-8#1)(1994-7#1)(2007-10#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-12#1)(2012-2#1)
on days 1-3##2##3##(1990-2#2)
on days 20##2##3##(1993-12#2)
on days 4##2##3##(1994-5#1)(2010-7#1)
on days 5##2##3##(1993-12#2)
on days 7##2##3##(2006-6#1)(2011-2#1)
on days on which##4##4##(2009-7#4)
on days with##2##3##(2008-10#2)
on days##53##2##(1990-11#1)(1990-2#4)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-12#7)(1993-2#2)(1994-5#1)(1994-7#1)(1995-12#3)(1997-6#1)(2006-6#1)(2007-10#2)(2008-10#9)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#5)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
on dead##2##2##(2008-10#2)
on death##6##2##(1994-1#3)(2007-10#2)(2011-2#1)
on decaying cephalopod beaks##2##4##(2011-2#2)
on decentralization##3##2##(1992-5#1)(2008-1#1)(2012-3#1)
on decision making##2##3##(2010-8#1)(2013-7#1)
on decision-making##2##2##(2008-11#1)(2011-1#1)
on decreasing##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
on dedicated##2##2##(2008-3#1)(2008-9#1)
on defined##3##2##(1990-6#1)(1995-11#1)(2008-11#1)
on delayed##3##2##(1992-11#1)(1993-3#1)(2008-5#1)
on demand for##3##3##(2008-10#1)(2008-12#2)
on demand##6##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-12#2)(2008-7#1)
on demographic##4##2##(1997-1#1)(2008-12#1)(2008-8#1)(2009-10#1)
on demonstrating##2##2##(1991-11#1)(2007-8#1)
on denaturation##2##2##(1997-2#2)
on dendritic##2##2##(2008-10#1)(2008-11#1)
on density##3##2##(2008-12#1)(2008-2#1)(2008-4#1)
on dental##3##2##(1991-2#1)(2008-12#1)(2013-1#1)
on depression##8##2##(1995-1#1)(1995-2#1)(1995-3#1)(2007-1#1)(2008-4#1)(2010-2#2)(2011-2#1)
on derivatization##3##2##(2008-10#3)
on design of##3##3##(2008-11#2)(2008-3#1)
on designing##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
on detached leaflets##2##3##(2008-10#2)
on detached##5##2##(2008-10#4)(2011-2#1)
on detailed##2##2##(1997-3#1)(2008-11#1)
on detection of the##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
on detection of##8##3##(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
on detection##9##2##(1997-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
on determination of##7##3##(2008-10#5)(2008-3#2)
on determining the##2##3##(2008-3#1)(2013-1#1)
on developing countries and##2##4##(2009-4#1)(2011-2#1)
on developing countries##3##3##(2009-4#2)(2011-2#1)
on developing##9##2##(1993-11#1)(2007-12#1)(2008-11#1)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#2)
on development and##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
on development of a##2##4##(2008-10#1)(2011-2#1)
on development of the##2##4##(1995-5#1)(1996-5#1)
on development of##14##3##(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#1)
on development##21##2##(1994-3#1)(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)
on developmental##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
on diabetes and##2##3##(2008-1#2)
on diabetes control in type 2 diabetic patients##2##8##(2011-2#2)
on diabetes control##3##3##(2011-2#3)
on diabetes mellitus##2##3##(2008-3#1)(2011-2#1)
on diabetes##14##2##(1994-12#1)(2008-1#5)(2008-3#1)(2011-2#4)(2012-5#1)(2013-8#2)
on diabetic nephropathy##4##3##(1994-3#3)(2008-1#1)
on diagnosis and##5##3##(1995-1#2)(2008-12#1)(2012-2#1)(2013-1#1)
on diagnosis##8##2##(1995-1#2)(2008-12#1)(2009-5#1)(2010-6#1)(2012-2#1)(2013-1#2)
on diagnostic and##2##3##(2010-5#1)(2013-1#1)
on diagnostic##10##2##(1997-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-7#1)
on dialysis and##4##3##(2007-7#2)(2008-1#2)
on dialysis##23##2##(1991-6#1)(1996-2#1)(1997-1#1)(2007-7#7)(2008-1#7)(2008-10#1)(2008-4#1)(2010-5#1)(2011-2#3)
on dialyzer##2##2##(2008-1#2)
on dielectric##2##2##(2008-3#1)(2010-12#1)
on diet##4##2##(1990-8#1)(1991-12#1)(2008-9#1)(2009-4#1)
on dietary protein and weight reduction##2##6##(2008-3#2)
on dietary##6##2##(1991-12#1)(2008-3#2)(2010-6#1)(2012-2#1)(2013-1#1)
on diets##2##2##(2008-5#1)(2008-6#1)
on differences between the##2##4##(2008-9#1)(2011-1#1)
on differences in the##3##4##(1996-8#1)(2008-10#1)(2008-12#1)
on differences in##8##3##(1993-2#1)(1996-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-2#1)
on differences##11##2##(1993-2#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-1#1)
on different aspects of##3##4##(1990-6#1)(1994-6#1)(2012-1#1)
on different days of the estrous cycle##2##7##(1993-11#2)
on different days##4##3##(1990-12#1)(1993-11#2)(2008-1#1)
on different host##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
on different hosts##2##3##(2008-10#2)
on different models##2##3##(2009-1#1)(2012-1#1)
on different parameters##2##3##(2008-7#1)(2011-3#1)
on different sites##2##3##(1997-8#1)(2008-10#1)
on different trophic levels##2##4##(2009-2#1)(2013-1#1)
on different types of##3##4##(1996-4#1)(2008-10#1)(2008-2#1)
on different##83##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1993-11#2)(1993-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-8#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#5)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
on differential hosts##2##3##(2008-10#2)
on differential##13##2##(1991-6#1)(1993-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)
on differentiated##2##2##(1992-3#1)(1995-6#1)
on differentiation##2##2##(1997-2#1)(2010-3#1)
on diffuse correlation spectroscopy##2##4##(2011-1#2)
on diffuse##5##2##(1995-8#1)(2008-2#1)(2008-3#1)(2011-1#2)
on diffusion##5##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
on diffusion-weighted##2##2##(2007-10#1)(2009-11#1)
on digestible AA##2##3##(2008-12#2)
on dihydropyridine-sensitive Ca2+##2##3##(1993-3#2)
on direct determination##3##3##(2008-10#3)
on direct observation of##2##4##(1990-8#1)(2008-8#1)
on direct##14##2##(1990-8#1)(1994-1#2)(2007-10#1)(2008-10#7)(2008-8#1)(2010-5#1)(2011-1#1)
on direction of##2##3##(2009-2#1)(2013-1#1)
on direction##3##2##(2008-8#1)(2009-2#1)(2013-1#1)
on disability pensions##2##3##(1993-6#2)
on disability##5##2##(1993-6#2)(1997-6#1)(2007-10#1)(2008-7#1)
on disc##2##2##(2007-11#1)(2012-12#1)
on discharge##6##2##(1991-3#1)(1994-2#1)(1995-3#1)(1997-3#1)(2008-3#1)(2013-1#1)
on discrete##2##2##(1996-12#1)(2008-9#1)
on discrimination of##2##3##(1992-10#1)(2013-8#1)
on disease and##2##3##(2007-8#1)(2008-10#1)
on disease control in##2##4##(2008-10#1)(2008-7#1)
on disease development##3##3##(2008-10#3)
on disease incidence##5##3##(2008-10#5)
on disease progression in##2##4##(2008-10#2)
on disease progression##4##3##(2008-10#4)
on disease severity in the##2##5##(2008-10#2)
on disease severity##5##3##(2008-10#5)
on disease suppressiveness of soils##2##5##(2008-10#2)
on disease##43##2##(1990-11#1)(1993-12#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
on diseased##2##2##(2008-10#2)
on diseases and##2##3##(1990-12#1)(2008-10#1)
on diseases##5##2##(1990-12#1)(1995-9#1)(2007-5#1)(2008-10#1)(2010-8#1)
on dispersion##2##2##(2007-12#2)
on dispersion-managed solitons##2##3##(2007-11#1)(2007-12#1)
on dispersion-managed##3##2##(2007-11#2)(2007-12#1)
on dissolution##2##2##(2007-12#1)(2008-5#1)
on distal##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
on distinct##7##2##(2008-10#1)(2008-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
on distribution of##3##3##(1995-3#1)(2008-10#2)
on distribution##7##2##(1994-5#1)(1995-3#1)(2008-10#5)
on divalent##3##2##(1991-5#1)(1992-9#1)(1993-8#1)
on diverse##2##2##(2007-8#1)(2011-3#1)
on documentation and##2##3##(1994-12#1)(1997-6#1)
on domestic##2##2##(2009-8#1)(2011-1#1)
on dopamine biosynthesis##2##3##(2008-11#2)
on dopamine release##2##3##(1996-12#1)(1997-2#1)
on dopamine##9##2##(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2009-7#1)
on dopaminergic nerve terminals##3##4##(1995-12#2)(1996-12#1)
on dopaminergic##5##2##(1995-12#2)(1996-12#1)(2008-7#1)(2013-1#1)
on dormancy progression in apricot##2##5##(2012-8#2)
on dose##5##2##(1994-8#1)(1997-7#1)(2007-10#1)(2008-7#1)(2013-8#1)
on double-stranded##2##2##(2010-5#1)(2013-1#1)
on dried##4##2##(2008-10#2)(2008-12#2)
on drought##2##2##(2012-8#1)(2012-9#1)
on drug concentration##3##3##(1996-3#2)(2007-11#1)
on drug release##2##3##(2011-1#1)(2012-2#1)
on drug##18##2##(1995-2#1)(1996-10#1)(1996-3#3)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
on drug-resistance##2##2##(2007-2#1)(2012-2#1)
on drugs##3##2##(1993-3#1)(2008-5#1)(2008-8#1)
on dry##3##2##(2008-10#2)(2008-5#1)
on dual##3##2##(2008-10#2)(2011-3#1)
on duration##2##2##(2008-7#1)(2011-1#1)
on duty##3##2##(1991-6#1)(1992-11#1)(2008-8#1)
on dye##3##2##(2008-3#2)(2008-9#1)
on dynamic##4##2##(2008-3#1)(2009-10#1)(2010-10#1)(2011-3#1)
on each dimension##2##3##(2008-12#1)(2011-2#1)
on each explant##3##3##(2008-12#3)
on each host##2##3##(2008-10#1)(2008-9#1)
on each individual##4##3##(1990-5#1)(1994-9#1)(1997-7#1)(2013-8#1)
on each item##2##3##(2011-1#1)(2011-2#1)
on each of the##4##4##(1991-2#1)(1992-2#1)(1995-2#1)(2011-1#1)
on each of##8##3##(1991-2#1)(1992-2#1)(1992-6#1)(1995-2#1)(1995-9#1)(1997-4#1)(2007-5#1)(2011-1#1)
on each patient##2##3##(2007-9#1)(2009-6#1)
on each side##3##3##(2007-12#1)(2008-5#1)(2013-1#1)
on each trial##3##3##(1993-12#1)(2008-5#2)
on each##70##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#2)(1997-7#2)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#2)(2008-5#5)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#4)(2012-8#1)(2013-1#4)(2013-8#1)
on earlier##2##2##(2008-3#1)(2008-8#1)
on early diagnosis and##2##4##(2009-1#1)(2012-2#1)
on early diagnosis##3##3##(1991-2#1)(2009-1#1)(2012-2#1)
on early##16##2##(1991-2#1)(1991-3#1)(1994-1#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-1#1)(2010-12#1)(2011-1#1)(2012-2#3)
on echocardiography and##2##3##(2007-8#1)(2011-2#1)
on echocardiography##5##2##(2007-10#1)(2007-7#2)(2007-8#1)(2011-2#1)
on ecological and##2##3##(1997-7#1)(2010-12#1)
on ecological communities##2##3##(2008-9#1)(2013-1#1)
on ecological##8##2##(1997-7#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
on economic##2##2##(1993-3#1)(1994-12#1)
on edema formation in##2##4##(1992-6#1)(2008-2#1)
on edible##3##2##(2008-12#2)(2010-7#1)
on educating##2##2##(2008-1#1)(2012-3#1)
on educational##3##2##(1992-1#1)(2008-11#1)(2008-9#1)
on effect of##2##3##(1994-6#1)(2008-10#1)
on effect##3##2##(1994-6#1)(2008-10#1)(2012-3#1)
on effective##8##2##(1995-2#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
on effectiveness##2##2##(1994-11#1)(2010-4#1)
on effects##3##2##(1994-5#1)(2011-2#1)(2013-8#1)
on efficacy and##2##3##(2008-5#1)(2010-8#1)
on efficacy of##5##3##(1995-10#1)(2008-5#3)(2013-1#1)
on efficacy##10##2##(1995-10#1)(2008-5#6)(2010-8#1)(2012-3#1)(2013-1#1)
on efficient##6##2##(1992-12#1)(1993-2#1)(1994-2#1)(2007-12#3)
on egg size##2##3##(1991-5#1)(2008-8#1)
on egg##4##2##(1991-5#1)(2008-8#1)(2010-2#1)(2010-8#1)
on eggs##2##2##(2008-6#1)(2008-8#1)
on eicosanoid##2##2##(1991-5#2)
on eight different##2##3##(2008-10#1)(2012-2#1)
on eight##7##2##(2007-8#1)(2008-10#5)(2012-2#1)
on either a##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
on either side of the##9##5##(1996-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-7#1)
on either side of##11##4##(1991-5#1)(1996-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-7#1)
on either side##12##3##(1991-5#1)(1996-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#1)(2013-7#1)
on either the##5##3##(1994-11#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-3#1)
on either##41##2##(1990-11#1)(1990-12#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-4#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-7#1)
on elastic properties of##2##4##(2010-3#1)(2010-8#1)
on elastic##4##2##(2008-3#1)(2008-6#1)(2010-3#1)(2010-8#1)
on elderly patients##2##3##(1992-9#1)(1993-9#1)
on electric hot plate##2##4##(2008-10#2)
on electric##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
on electrical##6##2##(1994-5#1)(2008-10#1)(2008-2#1)(2009-3#2)(2013-8#1)
on electro-optic##2##2##(2007-12#1)(2013-8#1)
on electrochemical##5##2##(2008-10#5)
on electrode##3##2##(2008-10#3)
on electrodeposited##2##2##(2008-10#2)
on electrodes modified##2##3##(2008-10#2)
on electrodes##4##2##(2008-10#4)
on electron##5##2##(1993-12#1)(1994-10#1)(2007-11#1)(2008-10#1)(2010-4#1)
on electronic##4##2##(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#1)
on electrostatic interaction##3##3##(2008-10#3)
on electrostatic interactions##2##3##(2008-10#2)
on electrostatic##6##2##(2008-10#6)
on embryonic day 15##2##4##(1993-3#1)(1996-12#1)
on embryonic##4##2##(1993-3#1)(1994-3#1)(1995-5#1)(1996-12#1)
on emergence##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
on emergency##3##2##(2009-4#1)(2011-2#1)(2012-3#1)
on emerging##3##2##(1995-1#1)(2007-12#1)(2011-2#1)
on emotional##7##2##(2007-6#1)(2008-2#2)(2008-5#1)(2008-6#1)(2012-1#1)(2013-8#1)
on empirical##10##2##(1992-1#1)(1992-12#1)(1993-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
on employees##2##2##(1994-2#1)(1997-3#1)
on enabling##2##2##(2007-11#1)(2010-8#1)
on endocrine##2##2##(1996-5#1)(2012-3#1)
on endogenous##5##2##(1991-5#1)(1994-2#1)(1996-2#1)(2012-3#1)(2013-7#1)
on endoscopic examination##2##3##(2008-5#2)
on endoscopic##3##2##(2008-5#2)(2011-2#1)
on endothelial progenitor##2##3##(2010-6#1)(2013-1#1)
on endothelial##4##2##(1990-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
on energetic##2##2##(2008-3#1)(2008-9#1)
on energy##3##2##(1993-12#1)(2008-11#1)(2012-12#1)
on enhancement of##2##3##(2008-11#1)(2012-2#1)
on enhancing##3##2##(1996-2#1)(2008-12#2)
on environmental and##3##3##(1990-9#1)(2008-10#1)(2008-8#1)
on environmental conditions##3##3##(1991-6#1)(2008-10#2)
on environmental surfaces##2##3##(2007-12#2)
on environmental##12##2##(1990-9#1)(1991-6#1)(1992-3#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#2)
on enzymatic hydrolysis##2##3##(2008-6#2)
on enzymatic##7##2##(2008-10#1)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#1)(2011-2#1)
on enzyme function##2##3##(1991-3#1)(2008-2#1)
on enzyme mechanism##2##3##(1990-7#1)(2009-9#1)
on enzyme##11##2##(1990-5#1)(1990-7#1)(1991-3#1)(1994-6#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-9#1)
on epidemic velocity##2##3##(2008-10#2)
on epidemics of potato late blight in##2##7##(2008-10#2)
on epidemics of##3##3##(2008-10#3)
on epidemics##4##2##(2008-10#3)(2008-12#1)
on epidemiological and##2##3##(1997-8#1)(2010-4#1)
on epidemiological##4##2##(1997-8#1)(2008-10#1)(2010-4#1)(2013-1#1)
on epidemiology##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
on epidermal##2##2##(1990-12#1)(2008-5#1)
on epileptic##2##2##(2010-8#1)(2012-3#1)
on episodic memory functioning in##2##5##(2008-7#2)
on epithelial cells##2##3##(1997-1#1)(2008-12#1)
on epithelial##3##2##(1997-1#1)(2008-12#1)(2011-1#1)
on equilibrium##2##2##(1995-8#1)(2008-10#1)
on equity in##2##3##(1990-12#1)(1996-1#1)
on equivalent##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
on erbium-doped##2##2##(2007-11#1)(2007-12#1)
on erythrocyte##3##2##(1992-6#1)(1994-12#1)(2008-10#1)
on erythroid##2##2##(1991-12#1)(2008-8#1)
on erythropoiesis##3##2##(2013-1#3)
on established##4##2##(2008-10#1)(2008-9#1)(2009-6#1)(2010-3#1)
on estimates of##2##3##(1992-9#1)(1994-11#1)
on estimating##2##2##(1996-6#1)(2008-8#1)
on estradiol##2##2##(2008-11#1)(2008-12#1)
on estrogen##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
on estrus##4##2##(1992-9#1)(1993-11#1)(2008-12#1)(2008-8#1)
on ethanol##2##2##(2008-10#1)(2009-12#1)
on ethanol-induced motor incoordination##2##4##(1997-2#2)
on ethical issues##2##3##(2008-11#1)(2009-4#1)
on ethics##6##2##(1991-12#1)(1992-1#1)(1992-2#2)(1994-3#1)(1997-6#1)
on ethnic differences##2##3##(2008-1#1)(2013-8#1)
on ethylene##4##2##(1994-6#1)(2008-10#1)(2008-3#2)
on evaluation of##4##3##(1992-12#1)(2008-10#2)(2013-8#1)
on every dimension##2##3##(2008-10#1)(2010-7#1)
on every##10##2##(1992-6#1)(1994-1#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
on evidence##10##2##(1993-12#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-3#1)
on evolution of##2##3##(2008-7#1)(2008-8#1)
on evolution##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
on evolutionary##6##2##(2008-1#2)(2010-3#1)(2010-4#1)(2010-7#1)(2013-1#1)
on examination##2##2##(1993-12#1)(2008-10#1)
on examining##2##2##(1994-2#1)(2008-3#1)
on excised##6##2##(2008-10#2)(2008-12#2)(2008-5#2)
on excitation##3##2##(2007-12#1)(2008-3#1)(2009-6#1)
on excitatory synaptic transmission in the##2##6##(1997-2#2)
on excitatory##3##2##(1996-5#1)(1997-2#2)
on excited-state##3##2##(2007-11#1)(2008-2#2)
on exercise tolerance##2##3##(2010-8#1)(2013-7#1)
on exercise##7##2##(1995-3#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-3#1)(2012-12#1)(2013-7#1)
on exertion and##3##3##(1991-5#1)(2008-1#1)(2013-7#1)
on exertion##5##2##(1991-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-7#1)
on existing##7##2##(1990-2#1)(1992-12#1)(1996-12#1)(2007-7#1)(2011-9#1)(2012-1#1)(2012-12#1)
on expanding##2##2##(2008-10#1)(2011-1#1)
on expectations##2##2##(1996-3#1)(2008-9#1)
on expected##2##2##(1994-2#1)(1996-9#1)
on experience##6##2##(1992-6#1)(1993-3#1)(2008-10#1)(2009-9#1)(2011-3#2)
on experiences##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
on experimental data##2##3##(2008-7#2)
on experimental models of##2##4##(1994-12#1)(2008-10#1)
on experimental models##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
on experimental results##2##3##(2008-7#1)(2012-2#1)
on experimental##19##2##(1992-11#1)(1992-2#1)(1994-12#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-7#3)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
on experimentally induced##4##3##(1990-7#2)(2007-6#1)(2008-12#1)
on experimentally##7##2##(1990-7#2)(2007-6#1)(2008-10#2)(2008-12#1)(2009-11#1)
on experiments##3##2##(1994-5#1)(2008-11#1)(2008-7#1)
on expert opinion##2##3##(2010-6#1)(2011-2#1)
on expert##4##2##(2010-6#1)(2011-10#1)(2011-2#1)(2013-1#1)
on exposure time##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
on exposure to a##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
on exposure to##9##3##(1992-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-9#1)
on exposure##13##2##(1992-9#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-9#1)(2011-2#1)
on expression and##3##3##(1990-2#1)(2012-2#2)
on expression of##12##3##(1992-12#1)(1994-11#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-9#2)(2011-2#2)(2012-3#2)(2013-8#1)
on expression##16##2##(1990-2#1)(1991-12#1)(1992-12#1)(1994-11#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-9#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
on extended##2##2##(1996-2#1)(2007-11#1)
on extensive##5##2##(1991-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
on external##8##2##(1995-11#1)(1995-2#1)(2007-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
on extinction##5##2##(1997-5#1)(2008-3#1)(2008-8#2)(2008-9#1)
on extracellular Ca2+##2##3##(1991-12#1)(1995-12#1)
on extracellular##7##2##(1990-12#1)(1990-5#1)(1991-12#1)(1995-12#1)(1997-7#1)(2008-4#1)(2008-6#1)
on extraction efficiency##3##3##(2008-10#3)
on extraction time##2##3##(2008-10#2)
on extraction##13##2##(2008-10#12)(2012-3#1)
on exudates##2##2##(2008-6#2)
on fabrication##2##2##(2007-11#1)(2010-9#1)
on face##3##2##(2012-2#1)(2013-1#2)
on facial##2##2##(2008-11#1)(2008-9#1)
on factor##2##2##(1993-11#1)(2008-9#1)
on factors such as##2##4##(1996-12#1)(2008-10#1)
on factors that##4##3##(2006-6#2)(2008-10#1)(2008-9#1)
on factors##10##2##(1990-9#1)(1996-12#1)(2006-6#2)(2007-6#1)(2008-10#3)(2008-9#1)(2010-5#1)
on faculty##2##2##(2012-1#1)(2012-3#1)
on familiarity##2##2##(2008-8#1)(2013-1#1)
on families of##2##3##(1995-12#1)(2008-10#1)
on families##5##2##(1995-12#1)(2008-10#1)(2009-9#1)(2010-12#1)(2011-1#1)
on family##9##2##(1992-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2013-1#4)
on farms in the##2##4##(1991-8#1)(2010-4#1)
on farms##6##2##(1991-8#1)(2007-6#1)(2008-12#2)(2010-4#1)(2012-3#1)
on fasting##2##2##(2010-10#2)
on fatigue and##2##3##(2013-1#1)(2013-8#1)
on fatty acid##3##3##(2008-10#2)(2013-1#1)
on fatty##4##2##(1997-3#1)(2008-10#2)(2013-1#1)
on feather##2##2##(2008-6#2)
on features##2##2##(2008-11#1)(2008-2#1)
on fecundity##3##2##(2008-9#1)(2011-2#2)
on feedback##3##2##(2008-12#2)(2008-6#1)
on feeding##5##2##(2007-12#2)(2008-11#1)(2008-4#1)(2013-7#1)
on female##12##2##(1990-9#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
on females##3##2##(2008-12#1)(2008-5#1)(2008-8#1)
on femtosecond##2##2##(2007-12#1)(2011-1#1)
on femurs of##2##3##(2013-1#2)
on ferritin##2##2##(1990-5#1)(2012-1#1)
on fertility##9##2##(1990-2#1)(1991-12#1)(1991-8#1)(1996-11#1)(1997-6#1)(2011-1#1)(2011-2#3)
on ferulic acid##2##3##(2008-10#1)(2013-8#1)
on fetal development##2##3##(2008-4#1)(2008-9#1)
on fetal loss and under-2-years child mortality##2##7##(2011-1#2)
on fetal##8##2##(1996-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-3#1)
on fiber##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
on fibroblast proliferation##2##3##(2010-3#2)
on fibroblast##6##2##(1995-3#1)(2008-7#1)(2010-3#3)(2013-1#1)
on fibroblasts##2##2##(1995-11#1)(2011-1#1)
on fibronectin##8##2##(2008-11#6)(2011-2#1)(2012-2#1)
on field##6##2##(2008-10#3)(2008-9#1)(2013-1#1)(2013-7#1)
on field-grown##2##2##(2008-10#2)
on filamentous bacteriophages##2##3##(1997-4#1)(2008-8#1)
on film##3##2##(1997-8#1)(2008-3#2)
on filter paper##10##3##(2008-10#6)(2008-5#1)(2011-2#2)(2012-2#1)
on filter##12##2##(2008-10#8)(2008-5#1)(2011-2#2)(2012-2#1)
on filters##5##2##(2008-10#3)(2008-9#2)
on final##3##2##(2007-11#1)(2008-5#1)(2008-8#1)
on financial##2##2##(1992-12#1)(1996-2#1)
on finding##2##2##(2007-12#1)(2008-7#1)
on findings from##2##3##(2008-1#2)
on findings##4##2##(1996-3#1)(2008-1#2)(2011-2#1)
on fine##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
on finger##2##2##(2008-1#1)(2013-8#1)
on finishing##2##2##(2008-12#2)
on first strand cDNA##2##4##(1994-11#1)(1994-9#1)
on first##9##2##(1994-11#1)(1994-9#1)(2008-1#1)(2008-10#2)(2009-2#1)(2009-5#1)(2011-1#1)(2011-10#1)
on fish growth##2##3##(2010-5#1)(2013-7#1)
on fish##8##2##(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-7#1)
on fishes##3##2##(2010-8#3)
on fitness##5##2##(2008-10#1)(2008-8#1)(2012-3#3)
on fitting##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#1)
on five continents##2##3##(2008-10#2)
on five different##2##3##(2008-10#2)
on five##19##2##(1990-9#1)(1997-1#1)(1997-5#1)(2006-12#1)(2008-10#8)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2013-1#1)(2013-8#1)
on fixed##4##2##(1990-5#1)(2008-11#1)(2010-8#1)(2013-8#1)
on flax roots##2##3##(2008-10#2)
on flax##3##2##(2008-10#3)
on flexible##3##2##(1991-8#1)(2008-10#1)(2009-11#1)
on flexion and internal rotation##2##5##(2009-3#2)
on flocculation##2##2##(2008-7#2)
on flow cytometry##2##3##(2008-9#1)(2011-2#1)
on flow injection##3##3##(2008-10#3)
on flow rate##2##3##(1996-2#1)(2008-10#1)
on flow##9##2##(1996-2#1)(2008-10#5)(2008-9#2)(2011-2#1)
on flower petals##3##3##(2008-10#3)
on flower##4##2##(2008-10#4)
on flowers##3##2##(2008-10#3)
on fluid##3##2##(1994-6#1)(2007-12#1)(2012-2#1)
on fluorescence enhancement##2##3##(2008-10#1)(2011-1#1)
on fluorescence##14##2##(1990-8#1)(2008-1#1)(2008-10#9)(2008-3#2)(2011-1#1)
on fluorescent##2##2##(2008-10#1)(2013-1#1)
on focal cerebral##2##3##(2008-7#1)(2010-11#1)
on focal##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
on fodrin##2##2##(2011-1#2)
on foliage until##2##3##(2008-10#2)
on foliage##10##2##(2008-10#10)
on foliar##3##2##(2008-10#2)(2011-10#1)
on follow up##2##3##(1990-8#1)(2013-1#1)
on follow-up MR##3##3##(1996-6#3)
on follow-up##14##2##(1995-5#1)(1996-6#3)(2006-12#1)(2007-11#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-2#3)(2013-8#1)
on food##10##2##(1994-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#3)
on foot##3##2##(2010-3#1)(2013-1#2)
on for##10##2##(1990-9#1)(1991-8#1)(1992-1#1)(1992-12#2)(2007-8#3)(2008-10#1)(2008-5#1)
on formal##2##2##(1996-3#1)(2010-4#1)
on formalin-fixed##3##2##(1993-12#1)(2008-9#1)(2013-1#1)
on formation of the##2##4##(2007-11#1)(2008-10#1)
on formation of##7##3##(1993-8#1)(1994-3#1)(2007-11#1)(2008-10#3)(2009-8#1)
on formation##8##2##(1993-8#1)(1994-3#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-8#1)
on four different##2##3##(2008-10#2)
on four##20##2##(1990-8#1)(1993-2#1)(1993-3#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-7#3)(2011-1#1)(2012-3#2)(2012-7#1)
on fracture##9##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#2)
on frequency##2##2##(2007-11#1)(2008-3#1)
on fresh##3##2##(2008-5#2)(2008-9#1)
on friction##2##2##(1990-6#1)(2010-10#1)
on fringe##7##2##(2008-2#3)(2008-3#4)
on from the##2##3##(2008-11#2)
on frozen section##2##3##(1995-4#2)
on frozen##3##2##(1995-4#2)(1997-7#1)
on fruit of##2##3##(2008-10#2)
on fruit##10##2##(2008-10#10)
on fruits and##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
on fruits##6##2##(2007-12#1)(2008-10#4)(2008-9#1)
on fully##3##2##(1990-2#1)(2008-10#2)
on function##2##2##(2008-2#2)
on functional magnetic resonance imaging##2##5##(2007-10#1)(2011-1#1)
on functional recovery##2##3##(2008-12#1)(2013-1#1)
on functional##14##2##(1991-2#1)(1993-1#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-1#1)
on functionalized##3##2##(2008-10#3)
on fungal growth##3##3##(2008-10#3)
on fungal##6##2##(2008-10#5)(2008-7#1)
on fungicide-amended medium##2##3##(2008-10#2)
on fungicide-amended##3##2##(2008-10#3)
on further##7##2##(1991-3#1)(1992-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)
on fusarium head blight and##2##5##(2008-10#2)
on fused-silica substrates##2##3##(2008-3#2)
on fusion##2##2##(1992-6#1)(2012-2#1)
on future trends in##2##4##(1991-5#1)(1994-1#1)
on future##7##2##(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1994-1#1)(2008-11#1)(2008-7#1)
on g-KGM##2##2##(2011-2#2)
on gait##3##2##(2013-1#3)
on gallbladder##2##2##(1992-6#1)(2011-2#1)
on ganglion##2##2##(1993-12#1)(1997-3#1)
on garlic and chives##2##4##(2008-10#2)
on garlic and##3##3##(2008-10#3)
on gas##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-4#1)
on gastric adenocarcinoma##2##3##(2008-12#1)(2008-9#1)
on gastric emptying##2##3##(1997-4#1)(2013-1#1)
on gastric mucosal##2##3##(1993-11#1)(2012-3#1)
on gastric##9##2##(1992-6#1)(1993-11#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
on gastrointestinal##3##2##(1995-3#1)(1996-12#1)(2012-3#1)
on gel##4##2##(1991-2#1)(1993-8#1)(2008-10#1)(2008-8#1)
on gender and##3##3##(2009-5#1)(2011-1#1)(2012-2#1)
on gender##6##2##(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
on gene expression and##2##4##(1996-12#1)(2008-10#1)
on gene expression##8##3##(1996-12#2)(2008-10#4)(2011-1#1)(2013-1#1)
on gene function##3##3##(2008-7#2)(2008-8#1)
on gene##24##2##(1993-6#2)(1996-12#2)(2008-10#6)(2008-5#1)(2008-7#5)(2008-8#3)(2010-10#1)(2011-1#1)(2012-3#2)(2013-1#1)
on general##10##2##(1990-3#1)(1991-3#1)(1993-12#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
on generation of##2##3##(1993-6#1)(2008-10#1)
on genes and##2##3##(2009-5#1)(2010-12#1)
on genes##8##2##(1991-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#3)
on genetic and##2##3##(2008-9#1)(2013-1#1)
on genetic distances##2##3##(2008-10#1)(2013-1#1)
on genetic engineering##2##3##(2007-8#1)(2012-2#1)
on genetic variation##2##3##(1995-2#1)(1996-6#1)
on genetic##28##2##(1995-2#1)(1996-6#1)(1997-6#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on genetically##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
on genetics##4##2##(2007-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
on genome##4##2##(1997-7#1)(2008-7#1)(2011-2#1)(2012-3#1)
on genome-wide##2##2##(2009-5#2)
on genomic##8##2##(1993-12#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-7#1)
on genotype##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
on genotypes##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
on geometrical##3##2##(2008-3#3)
on geranium plants##2##3##(2008-10#2)
on geranium seedlings##3##3##(2008-10#3)
on geranium##7##2##(2008-10#6)(2008-5#1)
on germination and seedling growth of V##2##7##(2008-12#2)
on germination and seedling growth of Vigna radiata (L##2##9##(2008-12#2)
on germination and seedling growth of Vigna radiata##4##8##(2008-12#4)
on germination and seedling growth of##6##6##(2008-12#6)
on germination and##7##3##(2008-12#6)(2011-2#1)
on germination of##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
on germination##11##2##(2008-10#2)(2008-12#7)(2011-2#2)
on giant unilamellar vesicles##2##4##(2012-2#2)
on ginseng##3##2##(2008-10#3)
on glass by##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
on glass fiber filters##2##4##(2008-10#2)
on glass fiber##3##3##(2007-5#1)(2008-10#2)
on glass substrates##2##3##(2007-11#1)(2008-2#1)
on glass surfaces##2##3##(2008-10#2)
on glass##22##2##(1991-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#12)(2008-2#2)(2008-8#1)(2009-7#3)
on glassy carbon (GC) electrode##2##5##(2008-10#2)
on glassy carbon (GC) electrodes##2##5##(2008-10#2)
on glassy carbon (GC)##4##4##(2008-10#4)
on glassy carbon and##2##4##(2008-10#2)
on glassy carbon electrode (GCE)##2##5##(2008-10#2)
on glassy carbon electrode##6##4##(2008-10#6)
on glassy carbon electrodes##3##4##(2008-10#2)(2013-1#1)
on glassy carbon##17##3##(2008-10#16)(2013-1#1)
on glial##2##2##(2008-7#1)(2011-1#1)
on global##8##2##(1996-7#1)(2007-11#1)(2007-2#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-2#1)
on glucagon##2##2##(1994-11#1)(2010-11#1)
on glucocorticoid##2##2##(1995-12#1)(2008-8#1)
on glucocorticoid-mediated##2##2##(1994-9#1)(1997-4#1)
on gluconeogenesis##2##2##(1994-8#1)(2010-11#1)
on glucose and##5##3##(1994-12#1)(1994-6#2)(1994-8#1)(2008-3#1)
on glucose metabolism in##2##4##(1994-3#1)(1994-6#1)
on glucose output in##2##4##(1994-6#2)
on glucose output##3##3##(1994-6#3)
on glucose transport##4##3##(1992-11#2)(1997-6#1)(2008-3#1)
on glucose##23##2##(1992-11#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#6)(1994-8#1)(1997-6#1)(2008-10#3)(2008-3#2)(2008-7#3)(2010-2#1)
on glutamine##2##2##(1994-5#1)(2008-11#1)
on glycemic##2##2##(2008-3#1)(2010-10#1)
on glycerol##4##2##(1990-5#1)(2008-5#1)(2008-6#2)
on glycoprotein##2##2##(1991-8#1)(2008-5#1)
on glycosylation##2##2##(2009-2#2)
on goat##2##2##(2007-12#1)(2010-2#1)
on gold nanoparticles##2##3##(2008-10#1)(2008-11#1)
on gold surfaces##2##3##(2008-10#2)
on gold##12##2##(2007-11#1)(2008-10#9)(2008-11#1)(2013-8#1)
on golf courses in##2##4##(2008-10#2)
on graduate##2##2##(1991-8#1)(2012-3#1)
on graft survival##2##3##(1991-11#1)(2007-8#1)
on grain yield##2##3##(2008-12#1)(2008-8#1)
on grape berries##2##3##(2008-10#2)
on grape##5##2##(2008-10#5)
on grapefruit##3##2##(2008-10#3)
on grapevine leaf##2##3##(2008-10#2)
on grapevine##4##2##(2008-10#4)
on graphite##4##2##(1990-4#1)(2008-10#3)
on grating##3##2##(2008-2#1)(2008-3#2)
on greater##2##2##(2008-4#1)(2013-1#1)
on green##3##2##(2008-10#1)(2011-2#2)
on grooming##4##2##(1993-12#2)(1994-8#1)(1996-2#1)
on gross##3##2##(2008-5#2)(2010-6#1)
on ground##2##2##(1997-7#1)(2008-8#1)
on grounds##2##2##(1991-9#1)(2008-1#1)
on group##4##2##(1992-1#1)(2008-8#2)(2013-1#1)
on groups##2##2##(1997-8#1)(2008-5#1)
on growing tumor cells##2##4##(1992-8#2)
on growth and##8##3##(1993-12#1)(2008-12#3)(2008-6#1)(2008-7#1)(2011-2#2)
on growth hormone##3##3##(2007-11#1)(2008-7#1)(2010-5#1)
on growth of##12##3##(1990-11#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
on growth performance##2##3##(2013-1#2)
on growth rate and##2##4##(2008-11#1)(2010-8#1)
on growth rate##6##3##(2007-11#3)(2008-11#1)(2008-12#1)(2010-8#1)
on growth##51##2##(1990-11#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1996-12#1)(2007-11#6)(2008-10#4)(2008-11#4)(2008-12#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2013-1#3)
on guinea pig##2##3##(1992-12#1)(2008-3#1)
on gut microbiota and##2##4##(2011-2#1)(2012-1#1)
on habitat selection##2##3##(2008-9#1)(2010-8#1)
on habituation##2##2##(2009-8#1)(2012-2#1)
on haematological parameters of##2##4##(2008-7#2)
on haematological##3##2##(1995-3#1)(2008-7#2)
on haemodialysis##2##2##(1990-3#1)(1991-11#1)
on hair##6##2##(2008-5#6)
on hand##5##2##(2007-12#3)(2008-9#1)(2013-1#1)
on hands and##2##3##(2007-10#1)(2012-1#1)
on hands##3##2##(2007-10#2)(2012-1#1)
on hardness##2##2##(2008-12#1)(2010-10#1)
on having##2##2##(1996-2#1)(2008-4#1)
on hazard##3##2##(1995-11#1)(1997-4#1)(2011-2#1)
on head movements in##2##4##(1993-12#2)
on head##4##2##(1993-12#2)(2008-11#1)(2013-1#1)
on healing##2##2##(1996-3#1)(1997-6#1)
on health and safety##2##4##(2007-2#1)(2008-9#1)
on health and##6##3##(1992-3#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
on health care costs and##2##5##(1995-2#1)(2008-11#1)
on health care costs##3##4##(1991-12#1)(1995-2#1)(2008-11#1)
on health care for##3##4##(1993-12#1)(1994-3#2)
on health care reform and##2##5##(1993-12#1)(1994-12#1)
on health care reform##6##4##(1993-12#2)(1994-12#2)(1995-2#1)(1996-1#1)
on health care use##2##4##(1994-1#1)(1995-12#1)
on health care##32##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-12#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-7#2)
on health economics##3##3##(1997-8#1)(2008-6#1)(2013-8#1)
on health human resources##2##4##(2011-2#2)
on health of##2##3##(2008-7#1)(2011-2#1)
on health outcomes##4##3##(2010-7#1)(2012-12#2)(2013-1#1)
on health policy##2##3##(1994-12#1)(1995-1#1)
on health promotion##4##3##(2007-12#1)(2008-1#1)(2008-12#2)
on health reform##2##3##(1993-3#1)(1994-1#1)
on health system reform##2##4##(1996-1#2)
on health system##3##3##(1996-1#2)(2008-11#1)
on health##98##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#3)(1992-3#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
on health-care##2##2##(1991-8#1)(2009-11#1)
on health-related quality of life##2##5##(2008-7#1)(2009-5#1)
on health-related##5##2##(2008-7#1)(2009-5#2)(2011-2#2)
on healthcare reform##2##3##(1993-12#2)
on healthcare##6##2##(1992-12#1)(1993-12#2)(1996-2#1)(1996-3#1)(1997-3#1)
on healthy plants##2##3##(2008-10#2)
on healthy population##2##3##(2008-1#1)(2008-5#1)
on healthy##15##2##(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#3)(2010-12#1)(2013-7#1)
on heart disease##2##3##(1991-3#1)(1997-1#1)
on heart rate and##2##4##(2010-5#1)(2013-1#1)
on heart rate variability##2##4##(2008-12#1)(2010-12#1)
on heart rate##6##3##(2008-12#1)(2010-12#1)(2010-5#3)(2013-1#1)
on heart##11##2##(1991-3#1)(1997-1#1)(2008-12#1)(2010-12#1)(2010-5#3)(2013-1#4)
on heating##2##2##(1991-5#1)(2008-3#1)
on helper##2##2##(2008-10#1)(2008-4#1)
on hematologic##2##2##(2008-7#2)
on hematological changes in##2##4##(2010-5#2)
on hematopoietic##2##2##(2008-11#2)
on hemimethylated DNA templates##2##4##(1990-11#2)
on hemodialysis (HD)##2##3##(2008-4#1)(2011-2#1)
on hemodialysis##16##2##(1991-6#1)(1993-6#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#4)
on hemodynamic##4##2##(1996-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on hemoglobin##2##2##(2013-7#1)(2013-8#1)
on hepatic microsomal##3##3##(1994-11#1)(2008-8#2)
on hepatic##15##2##(1992-10#1)(1993-8#1)(1994-11#2)(1994-8#1)(1996-12#2)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#2)(2013-1#3)
on hepatoma##2##2##(2008-11#2)
on her back##2##3##(2009-2#1)(2012-12#1)
on her face##3##3##(2012-3#1)(2013-1#2)
on her left##2##3##(1996-11#1)(2010-8#1)
on her##10##2##(1992-12#1)(1995-12#1)(1996-11#1)(2009-2#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#2)
on herbivore##3##2##(2008-8#3)
on herbivores##2##2##(2008-9#2)
on high performance liquid chromatography##3##5##(1991-8#1)(1993-12#1)(2008-10#1)
on high resolution##2##3##(2008-10#1)(2012-2#1)
on high standards of##2##4##(1992-9#1)(2009-7#1)
on high##13##2##(1991-1#1)(1991-8#1)(1992-9#1)(1993-12#1)(1995-11#1)(2008-10#3)(2008-2#2)(2009-7#1)(2012-2#1)(2013-7#1)
on high-performance liquid chromatography##3##4##(1990-8#1)(2008-10#2)
on high-resolution##6##2##(1991-12#1)(2008-3#2)(2011-2#1)(2012-2#2)
on higher##3##2##(1992-1#1)(1992-2#1)(2013-8#1)
on highly reflective##2##3##(2008-2#1)(2008-3#1)
on highly susceptible##2##3##(2008-10#2)
on highly##15##2##(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#5)(2010-11#1)
on hip##2##2##(2008-12#1)(2012-12#1)
on hippocampal processing##2##3##(1993-12#2)
on hippocampal##6##2##(1993-12#2)(1995-12#1)(2008-7#2)(2011-2#1)
on his back##2##3##(1996-9#1)(2008-5#1)
on his behavioral state##2##4##(2009-8#2)
on his experience##2##3##(1994-12#1)(2008-4#1)
on his or her##2##4##(2008-11#1)(2010-2#1)
on his own##2##3##(2007-11#1)(2012-2#1)
on his right##5##3##(1991-6#1)(2008-5#1)(2011-2#1)(2012-3#2)
on his wrist##2##3##(2012-2#2)
on his##36##2##(1991-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#2)
on his/her##2##2##(2008-8#1)(2012-12#1)
on histamine release##2##3##(1991-12#1)(2008-10#1)
on histologic examination##2##3##(1991-6#1)(2010-6#1)
on histologic##5##2##(1991-6#1)(1997-8#1)(2007-8#1)(2008-9#1)(2010-6#1)
on histological examination##3##3##(2007-8#1)(2008-5#1)(2011-3#1)
on histological##10##2##(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#2)
on histology##7##2##(1990-6#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
on histopathological##4##2##(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
on historical##5##2##(1996-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-6#1)
on history and##3##3##(2007-5#1)(2008-12#1)(2013-1#1)
on holding##2##2##(1995-3#1)(2009-5#1)
on home health##2##3##(1991-12#1)(1992-12#1)
on home##5##2##(1991-12#1)(1992-12#1)(1994-2#1)(1995-3#1)(2008-1#1)
on homeownership##2##2##(2011-2#2)
on homocysteine##2##2##(2008-3#1)(2010-5#1)
on homogenates##2##2##(1995-3#1)(2007-11#1)
on honey##2##2##(2008-6#1)(2011-2#1)
on hormonal activity##2##3##(1995-12#1)(2012-1#1)
on hormone##2##2##(1991-2#1)(2008-11#1)
on hospital admission##4##3##(1994-12#1)(2007-8#1)(2008-7#1)(2010-6#1)
on hospital governance##2##3##(1994-1#1)(1995-3#1)
on hospital profitability##2##3##(2008-11#2)
on hospital##22##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-7#1)(2010-6#1)
on hospitals##6##2##(1993-1#1)(1993-2#1)(1996-2#1)(2008-11#2)(2008-12#1)
on host growth and yield##2##5##(2008-10#2)
on host plants##2##3##(2008-10#1)(2009-2#1)
on host##19##2##(1994-2#1)(1997-7#1)(2008-10#8)(2008-8#5)(2008-9#2)(2009-2#1)(2013-1#1)
on host-diversity effects##2##3##(2008-10#2)
on household##2##2##(1991-1#1)(2011-2#1)
on how and##2##3##(1994-12#1)(2008-9#1)
on how best to##3##4##(2008-7#1)(2008-8#1)(2013-1#1)
on how effectively##2##3##(2007-12#1)(2008-10#1)
on how nonprofit##2##3##(1991-12#1)(2008-11#1)
on how our##2##3##(2008-6#1)(2009-5#1)
on how stresses##2##3##(2009-7#2)
on how the##12##3##(1992-12#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-11#1)
on how these##5##3##(1993-3#1)(2006-10#1)(2009-5#1)(2010-5#1)(2013-8#1)
on how they##5##3##(1991-3#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
on how this##2##3##(2008-11#1)(2012-12#1)
on how to access##2##4##(2008-4#1)(2009-10#1)
on how to avoid##2##4##(1995-2#1)(2013-1#1)
on how to deal with##2##5##(2008-11#1)(2012-3#1)
on how to handle##3##4##(1994-3#1)(2012-2#2)
on how to obtain##2##4##(1993-12#1)(1997-2#1)
on how to use##5##4##(1990-2#2)(1996-6#1)(2008-4#2)
on how to##42##3##(1990-2#2)(1993-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-6#2)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#1)(2010-11#2)(2010-12#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
on how we##3##3##(1995-3#1)(1997-3#1)(2008-12#1)
on how well##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
on how##142##2##(1990-12#1)(1990-2#2)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-3#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-1#3)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#6)(2008-4#6)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#5)
on human PBL##2##3##(1997-4#2)
on human arterial##2##3##(1995-8#1)(2010-7#1)
on human blood coagulation##2##4##(1997-4#2)
on human breast cancer cells##2##5##(1992-5#1)(1994-12#1)
on human breast cancer##3##4##(1992-5#1)(1994-12#1)(1997-7#1)
on human cervical##2##3##(1992-2#1)(2008-8#1)
on human chromosome 1##2##4##(1994-12#1)(2008-9#1)
on human chromosome##12##3##(1990-5#1)(1991-9#1)(1994-12#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
on human health##12##3##(2007-7#1)(2008-10#6)(2008-8#3)(2010-4#1)(2011-2#1)
on human intestinal cell line Caco-2##2##6##(2008-11#2)
on human laryngeal epidermoid carcinoma##2##5##(2008-10#2)
on human lung cancer##2##4##(2008-7#1)(2013-1#1)
on human melanocytes##3##3##(1995-2#3)
on human periodontal ligament##2##4##(2013-1#2)
on human peripheral blood##2##4##(1995-3#1)(2008-11#1)
on human peripheral##3##3##(1990-8#1)(1995-3#1)(2008-11#1)
on human skin##11##3##(1995-3#1)(2008-5#10)
on human stratum corneum##2##4##(2008-5#2)
on human subjects##2##3##(1995-2#1)(2008-5#1)
on human##121##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-8#4)(1996-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#5)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#9)(2008-3#1)(2008-4#4)(2008-5#16)(2008-7#3)(2008-8#9)(2008-9#3)(2009-11#1)(2010-4#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
on humans##5##2##(1992-12#1)(1992-9#1)(1996-12#1)(2010-4#1)(2012-12#1)
on humoral immunity##2##3##(2008-10#2)
on hybrid##5##2##(1996-12#1)(2007-12#1)(2008-10#2)(2012-3#1)
on hybridization##2##2##(2008-10#2)
on hybridoma cells##2##3##(2008-11#2)
on hybridoma##5##2##(2008-11#5)
on hydrogen peroxide##4##3##(1991-9#1)(2008-10#3)
on hydrogen production##2##3##(2013-1#2)
on hydrogen##7##2##(1991-9#1)(2008-10#4)(2013-1#2)
on hydrophilic surfaces##2##3##(2008-10#1)(2008-7#1)
on hydrophilic##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
on hydrophobic##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
on hydrothermal##2##2##(2008-10#2)
on hydroxychloroquine##2##2##(2013-1#2)
on hydroxyl-terminated SAMs##2##3##(2008-10#2)
on hydroxyl-terminated##3##2##(2008-10#3)
on hydroxyurea##2##2##(2007-11#1)(2009-2#1)
on hypertension##4##2##(2008-1#2)(2008-7#1)(2011-2#1)
on hyphal##3##2##(2008-10#3)
on hypothalamic##2##2##(1995-12#1)(2008-7#1)
on hypoxia##2##2##(2008-10#1)(2010-11#1)
on ice##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
on identification##2##2##(2012-1#1)(2013-8#1)
on identified##2##2##(1992-3#1)(2008-10#1)
on identifying##6##2##(1994-9#1)(1995-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
on illness##2##2##(1994-6#1)(1995-3#1)
on image quality##4##3##(2008-2#2)(2012-1#1)(2013-8#1)
on image##8##2##(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-1#1)(2013-8#1)
on images##3##2##(1995-6#1)(2008-2#2)
on imaging##11##2##(1994-12#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#1)
on immature fruit was##2##4##(2008-10#2)
on immature fruit##4##3##(2008-10#4)
on immature##6##2##(2008-10#6)
on immobilized recombinant##2##3##(1994-6#1)(2008-10#1)
on immobilized##10##2##(1994-6#1)(2008-10#8)(2011-2#1)
on immune function is##2##4##(2008-9#2)
on immune function##5##3##(1995-8#1)(2008-10#1)(2008-9#2)(2010-12#1)
on immune response in##2##4##(2008-7#1)(2008-8#1)
on immune response##4##3##(1992-9#2)(2008-7#1)(2008-8#1)
on immune##14##2##(1992-9#3)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)
on immunity##2##2##(2008-7#1)(2008-8#1)
on immunization##7##2##(1990-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-11#2)
on immunoblots##6##2##(1990-11#1)(1990-5#1)(1991-9#1)(1995-6#2)(1997-4#1)
on immunohistochemical##2##2##(2012-2#1)(2013-8#1)
on immunologic##2##2##(1994-9#1)(1997-8#1)
on immunological##2##2##(2011-2#2)
on impaired##2##2##(2007-8#1)(2011-2#1)
on implant##2##2##(2007-8#1)(2009-4#1)
on implementation##3##2##(1997-2#1)(2008-3#1)(2011-2#1)
on implementing a##3##3##(1993-2#1)(1997-2#1)(2008-3#1)
on implications##2##2##(2012-12#2)
on important##7##2##(1994-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-4#1)(2011-2#1)
on improved##2##2##(2010-3#1)(2013-8#1)
on improving the##3##3##(1993-3#1)(1996-2#1)(2010-7#1)
on improving##15##2##(1991-1#1)(1991-6#1)(1993-3#1)(1996-2#2)(1996-3#1)(2007-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
on in situ##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
on in the##6##3##(1994-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
on in vitro growth of##2##5##(1992-8#1)(2008-10#1)
on in vitro translocation of a model protein into Vibrio alginolyticus inside-out membrane vesicles##2##14##(1997-8#2)
on in vitro##17##3##(1992-8#1)(1995-8#1)(1996-2#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#2)
on in vivo##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
on in##36##2##(1992-8#1)(1994-1#1)(1995-8#1)(1996-2#1)(1997-7#1)(1997-8#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
on incidence and##3##3##(1995-5#1)(2008-10#2)
on incidence at##2##3##(2008-10#2)
on incidence##12##2##(1994-9#1)(1995-5#2)(2007-12#1)(2008-10#6)(2009-12#1)(2013-1#1)
on incident rain intensity##2##4##(2008-10#2)
on incident##3##2##(1991-2#1)(2008-10#2)
on inclusion##3##2##(2008-10#2)(2012-12#1)
on increase of##2##3##(1995-8#1)(2008-5#1)
on increased##4##2##(1993-12#1)(1995-3#1)(2007-11#1)(2012-12#1)
on increases in##3##3##(1992-3#1)(1994-8#1)(1994-9#1)
on increasing the##2##3##(1990-8#1)(2008-11#1)
on increasing##7##2##(1990-8#1)(1991-5#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#1)
on incubation period##2##3##(2008-10#2)
on incubation##4##2##(1990-11#1)(1992-12#1)(2008-10#2)
on independent component analysis##3##4##(2008-10#2)(2009-11#1)
on independent##7##2##(2008-10#2)(2008-8#2)(2009-11#2)(2010-8#1)
on indicators of##2##3##(2008-11#1)(2012-12#1)
on indices of##3##3##(1992-3#1)(2008-4#1)(2008-5#1)
on indirect##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
on indium tin oxide##2##4##(2008-10#1)(2008-12#1)
on individual ADL items##2##4##(2011-2#2)
on individual faults##2##3##(1996-4#2)
on individual or##2##3##(2007-12#1)(2008-10#1)
on individual##35##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-3#1)(1993-5#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-3#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-8#1)
on individuals##5##2##(1997-8#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-9#1)
on individuals'##2##2##(2008-7#1)(2013-1#1)
on induced##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
on induction of##5##3##(1993-12#1)(2007-11#1)(2008-10#2)(2012-3#1)
on infant##5##2##(1990-12#1)(1995-2#1)(2007-2#1)(2010-6#1)(2011-1#1)
on infarct size and##3##4##(1992-5#3)
on infected plants##4##3##(2008-10#4)
on infected source plants##2##4##(2008-10#2)
on infected##17##2##(2008-10#16)(2008-6#1)
on infection efficiency##3##3##(2008-10#3)
on infection of##5##3##(1997-4#1)(1997-6#1)(2008-10#3)
on infection##19##2##(1993-6#1)(1995-6#1)(1997-4#1)(1997-6#2)(2008-10#11)(2010-10#2)(2011-2#1)
on infections##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
on inferences##2##2##(1995-2#1)(2008-12#1)
on infested potato seed tubers##2##5##(2008-10#2)
on infested##3##2##(2008-10#3)
on inflammation and##2##3##(1992-6#1)(2013-1#1)
on inflammatory cytokines##2##3##(2012-12#1)(2013-8#1)
on inflammatory##3##2##(2011-1#1)(2012-12#1)(2013-8#1)
on influenza##6##2##(1992-9#1)(1995-6#1)(2009-5#2)(2011-2#2)
on information obtained from a##2##5##(1994-3#1)(2008-12#1)
on information of##2##3##(2008-3#1)(2011-2#1)
on information##17##2##(1990-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-8#2)(2011-2#2)
on infrared##7##2##(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
on inhaled##4##2##(1991-12#1)(1992-3#1)(2008-11#1)(2012-1#1)
on inhibition of##2##3##(2008-11#1)(2012-2#1)
on inhibition##3##2##(1992-2#1)(2008-11#1)(2012-2#1)
on inhibitor length##2##3##(1992-8#2)
on inhibitor##3##2##(1992-8#2)(1993-8#1)
on inhibitory##5##2##(1996-12#1)(1996-5#1)(2008-5#1)(2012-2#1)(2013-1#1)
on initial##7##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)
on initiation of##3##3##(2008-10#2)(2008-3#1)
on injured##2##2##(1996-5#1)(1997-6#1)
on injury##2##2##(1996-6#1)(2007-11#1)
on inoculated plants##2##3##(2008-10#2)
on inoculated seedlings##2##3##(2008-10#2)
on inoculated trees and##2##4##(2008-10#2)
on inoculated##12##2##(2008-10#12)
on inoculum##2##2##(2008-10#2)
on inositol phospholipids pathway in human thyroid##2##7##(1994-11#1)(1994-6#1)
on inositol##4##2##(1990-12#1)(1990-7#1)(1994-11#1)(1994-6#1)
on inpatient##3##2##(1992-1#1)(1995-1#1)(2009-6#1)
on insect abundances##4##3##(2008-8#4)
on insect diversity##2##3##(2008-8#2)
on insect##11##2##(2008-8#9)(2012-2#1)(2013-7#1)
on insertion##2##2##(1991-10#1)(2008-10#1)
on instrument##2##2##(2008-3#2)
on insufficient##2##2##(2008-6#1)(2008-8#1)
on insulin binding and##2##4##(1990-7#1)(1997-1#1)
on insulin binding##4##3##(1990-7#1)(1995-11#1)(1997-1#2)
on insulin receptors##2##3##(1994-6#1)(2010-11#1)
on insulin resistance##2##3##(2008-3#2)
on insulin secretion##3##3##(1994-8#1)(1995-8#1)(2011-1#1)
on insulin##14##2##(1990-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-1#2)(2008-3#4)(2010-11#1)(2010-12#1)(2011-1#1)
on insurance##4##2##(1991-12#1)(1994-2#2)(2008-6#1)
on intact##6##2##(1990-12#1)(1990-5#1)(2007-11#1)(2008-10#1)(2008-5#2)
on integrated##7##2##(1994-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
on integrating##2##2##(1996-3#1)(2012-2#1)
on integration##2##2##(2008-10#1)(2009-6#1)
on integrative painting##2##3##(2007-7#2)
on intensity of##2##3##(2010-3#1)(2011-2#1)
on intensity##5##2##(2007-11#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-2#1)
on intentions to##2##3##(1994-3#1)(2009-10#1)
on interaction##3##2##(2008-10#3)
on interactions between##2##3##(2006-6#1)(2008-2#1)
on interactions##4##2##(2006-6#2)(2008-2#1)(2010-11#1)
on interdisciplinary##2##2##(2010-1#1)(2012-3#1)
on interleukin-2##2##2##(1992-8#1)(1994-5#1)
on intermediate##3##2##(2008-7#2)(2012-12#1)
on internal carotid##2##3##(2011-3#1)(2012-3#1)
on internal##5##2##(1993-12#1)(1997-3#1)(2008-11#1)(2011-3#1)(2012-3#1)
on international development##2##3##(2008-11#1)(2010-9#1)
on international level##2##3##(2007-8#1)(2013-1#1)
on international##9##2##(2007-8#1)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
on interobserver##5##2##(2008-7#4)(2009-2#1)
on interpretation of##2##3##(1992-11#1)(2007-11#1)
on intervention##2##2##(2008-4#1)(2010-10#1)
on interventions that##2##3##(1992-12#1)(2011-1#1)
on interventions##5##2##(1992-12#1)(2008-3#1)(2011-1#3)
on interviews with##3##3##(1995-12#1)(2010-10#1)(2013-1#1)
on intestinal##5##2##(1990-3#1)(1992-6#1)(1992-9#1)(1994-12#1)(2008-5#1)
on intracavity##4##2##(2007-11#3)(2008-3#1)
on intracellular Ca2+##2##3##(1991-2#1)(1995-11#1)
on intracellular##9##2##(1991-2#1)(1994-6#2)(1995-11#2)(1996-2#1)(2008-7#2)(2010-8#1)
on intracranial pressure (ICP)##2##4##(1993-1#1)(2008-7#1)
on intracranial pressure##4##3##(1993-1#2)(2008-7#1)(2008-9#1)
on intracranial##5##2##(1993-1#2)(2007-10#1)(2008-7#1)(2008-9#1)
on intraoperative##2##2##(2008-7#1)(2010-7#1)
on intraoral##2##2##(1993-12#1)(2013-1#1)
on intravenous##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
on intrinsic##2##2##(2008-8#1)(2009-7#1)
on invasion and##2##3##(2008-11#1)(2008-4#1)
on invasion##4##2##(2008-11#3)(2008-4#1)
on invasive##2##2##(1990-12#1)(1997-3#1)
on invertase##2##2##(2008-10#1)(2008-12#1)
on investigating##2##2##(1994-9#1)(2008-10#1)
on investment for##2##3##(2008-7#1)(2010-12#1)
on investment##7##2##(2007-9#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-1#2)
on investments##2##2##(1995-1#1)(1996-1#1)
on ion exchange columns by##2##5##(2008-10#2)
on ion exchange##3##3##(2008-10#3)
on ion transport in the##2##5##(2008-1#1)(2008-12#1)
on ion transport in##3##4##(2008-1#2)(2008-12#1)
on ion transport##5##3##(1992-6#1)(2008-1#2)(2008-12#1)(2010-7#1)
on ion##16##2##(1990-5#1)(1992-6#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-8#1)(2010-7#2)
on ionic strength##5##3##(2008-10#5)
on irradiation of##2##3##(1995-6#1)(2010-12#1)
on irradiation with##2##3##(2008-3#1)(2008-5#1)
on irradiation##5##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
on ischemia-reperfusion##3##2##(1995-12#2)(2008-10#1)
on islands has##2##3##(1996-6#1)(2008-8#1)
on islands##8##2##(1996-6#6)(2008-8#2)
on islet##4##2##(2010-11#3)(2013-8#1)
on isoelectric focusing##2##3##(1992-11#1)(1992-8#1)
on isolated##6##2##(1994-11#1)(1994-12#1)(2008-12#1)(2008-9#1)(2010-2#1)(2010-3#1)
on isolates##2##2##(2008-10#2)
on issues of##2##3##(1992-2#1)(1997-1#1)
on issues relating to##2##4##(1995-5#1)(2008-7#1)
on issues##10##2##(1991-2#1)(1992-2#1)(1995-5#1)(1996-2#1)(1997-1#2)(2008-12#1)(2008-7#1)(2009-11#1)(2012-2#1)
on it##13##2##(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2012-3#1)(2013-7#1)
on items##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
on iterative##2##2##(2008-10#1)(2008-3#1)
on its ability to##3##4##(1993-9#1)(1994-3#1)(2008-3#1)
on its associated##2##3##(2008-10#1)(2011-1#1)
on its biological activity##2##4##(1992-8#1)(2008-8#1)
on its biological##3##3##(1992-8#1)(2008-10#1)(2008-8#1)
on its central##2##3##(1991-5#1)(2008-3#1)
on its efficacy##2##3##(2008-12#1)(2010-12#1)
on its own##9##3##(1990-12#1)(1990-5#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)
on its reaction with##5##4##(1995-5#1)(2008-10#4)
on its resonance##2##3##(2008-3#1)(2013-8#1)
on its role in##3##4##(2008-8#1)(2011-1#1)(2011-2#1)
on its size##2##3##(2008-10#1)(2008-5#1)
on its structural##2##3##(2009-10#1)(2009-5#1)
on its surface and##2##4##(2008-3#1)(2008-5#1)
on its surface##10##3##(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)
on its vascular pedicle##2##4##(2007-12#1)(2008-6#1)
on its##192##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#63)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#15)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#9)(2008-9#7)(2009-10#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
on job##5##2##(1991-12#1)(1991-3#1)(1994-1#1)(1995-1#1)(2009-7#1)
on joint##2##2##(2008-5#1)(2010-9#1)
on jugular venous##2##3##(2008-7#2)
on juvenile growth and##2##4##(2008-11#2)
on juvenile survival and growth##2##5##(2008-11#2)
on juvenile##5##2##(2008-11#4)(2013-1#1)
on kcat##3##2##(1992-8#1)(1994-5#1)(1995-2#1)
on key##6##2##(1994-3#1)(1996-12#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)
on kidneys of streptozotocin-induced diabetic##2##5##(2011-3#2)
on kindling##2##2##(1994-2#1)(2012-12#1)
on kinetic##2##2##(1995-12#1)(2008-10#1)
on kinetics and##2##3##(1990-3#1)(2008-8#1)
on knowledge of the##3##4##(2008-3#2)(2009-4#1)
on knowledge##14##2##(1990-6#1)(1990-8#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-4#1)(2009-5#1)(2012-3#2)(2013-1#3)
on labeling##2##2##(2008-4#1)(2010-7#1)
on labor progress##3##3##(2007-2#1)(2013-1#2)
on labor##4##2##(2007-2#1)(2011-2#1)(2013-1#2)
on laboratory##8##2##(1995-1#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-3#1)
on lactation##2##2##(2012-2#2)
on language##3##2##(2010-4#1)(2012-2#1)(2013-8#1)
on large spatial scales##2##4##(2008-9#1)(2013-1#1)
on large##16##2##(1992-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#1)
on large-scale##4##2##(2007-11#1)(2008-3#2)(2013-1#1)
on larger##2##2##(2008-1#1)(2008-8#1)
on larvae of the##2##4##(2008-5#1)(2013-8#1)
on larvae of##3##3##(2008-5#2)(2013-8#1)
on larval##3##2##(2008-8#1)(2011-2#2)
on laryngeal##2##2##(1992-9#1)(2013-7#1)
on laser fluence##2##3##(2008-2#1)(2008-3#1)
on laser##11##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2009-5#1)(2011-2#1)
on laser-induced##5##2##(2008-3#3)(2013-8#2)
on late blight##2##3##(2008-10#2)
on late events##2##3##(2007-12#1)(2008-7#1)
on late##5##2##(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
on later##2##2##(2009-5#1)(2013-1#1)
on later-life appraisals##2##3##(2013-1#2)
on lateral##5##2##(1993-6#1)(2007-11#1)(2008-2#1)(2008-8#1)(2012-12#1)
on laying performance##3##3##(2010-2#1)(2012-2#2)
on lead##3##2##(2008-10#2)(2011-2#1)
on leaf disks##3##3##(2008-10#3)
on leaf surfaces##2##3##(2008-10#2)
on leaf tissue##2##3##(2008-10#2)
on leaf##15##2##(2008-10#13)(2012-5#2)
on learning abilities##2##3##(1994-8#2)
on learning and memory##4##4##(1993-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
on learning and##5##3##(1993-3#1)(1994-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
on learning resources##2##3##(2008-11#2)
on learning##12##2##(1993-3#1)(1994-3#1)(1994-8#2)(1996-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2013-8#1)
on leaves and stems##3##4##(2008-10#3)
on leaves and##12##3##(2008-10#12)
on leaves of cvs##2##4##(2008-10#2)
on leaves of##6##3##(2008-10#6)
on leaves sprayed in##2##4##(2008-10#2)
on leaves sprayed with M##3##5##(2008-10#3)
on leaves sprayed##5##3##(2008-10#5)
on leaves##48##2##(2008-10#47)(2010-3#1)
on leek##2##2##(2008-10#2)
on left##4##2##(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
on legal##3##2##(1991-1#1)(1991-9#1)(2012-12#1)
on length of stay and##2##5##(1995-12#1)(2012-2#1)
on length of stay##5##4##(1993-12#1)(1993-2#2)(1995-12#1)(2012-2#1)
on length##6##2##(1993-12#1)(1993-2#2)(1995-12#1)(2012-1#1)(2012-2#1)
on lesbian##2##2##(2008-12#2)
on lesion##10##2##(1994-2#1)(1995-12#1)(2008-10#7)(2012-3#1)
on lesions##2##2##(1997-4#1)(2010-8#1)
on less##2##2##(1995-2#1)(2007-8#1)
on lessons##2##2##(2008-1#1)(2008-12#1)
on lettuce##10##2##(2008-10#10)
on leukemia cells##2##3##(2009-12#1)(2011-2#1)
on leukocytes##3##2##(2006-6#2)(2008-5#1)
on level of##2##3##(2008-10#1)(2008-5#1)
on level##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
on levels of##6##3##(1994-2#1)(1994-3#1)(1995-6#1)(1997-7#1)(2008-8#1)(2011-2#1)
on levels##7##2##(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-8#1)(2011-2#1)
on liability issues##2##3##(1991-1#1)(2008-6#1)
on liability##4##2##(1991-1#1)(1994-3#1)(1996-5#1)(2008-6#1)
on lichen##2##2##(2008-10#2)
on lidar##3##2##(2008-2#1)(2008-3#2)
on life##8##2##(1990-3#1)(1992-9#1)(1995-1#3)(2008-7#1)(2010-1#1)(2010-5#1)
on life-history traits##2##3##(2008-8#1)(2008-9#1)
on life-history##5##2##(2008-8#3)(2008-9#1)(2011-2#1)
on lifestyle##3##2##(2010-12#1)(2010-7#2)
on lifting##2##2##(1990-12#1)(2009-6#1)
on ligand##4##2##(1992-9#1)(2008-10#3)
on ligands##2##2##(1995-5#1)(2012-3#1)
on light intensity##2##3##(2008-3#2)
on light##11##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2012-3#1)
on limb##2##2##(2008-1#2)
on limitations##2##2##(1995-2#1)(2009-11#1)
on limited##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
on limiting##3##2##(2008-4#1)(2011-2#1)(2012-1#1)
on line preconcentration and##2##4##(2008-10#2)
on line preconcentration##3##3##(2008-10#3)
on line##15##2##(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#1)(2013-8#1)
on lines##2##2##(2008-10#1)(2008-3#1)
on linkage group##6##3##(2008-10#5)(2013-8#1)
on linkage##11##2##(1994-2#1)(1995-11#1)(2008-10#8)(2013-8#1)
on lipase##2##2##(2008-6#1)(2008-7#1)
on lipid levels##3##3##(1991-6#1)(1994-11#1)(2013-1#1)
on lipid profile and##2##4##(2012-2#1)(2012-3#1)
on lipid profile##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
on lipid##18##2##(1991-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2010-4#2)(2012-2#1)(2012-3#1)(2013-1#2)
on lipolysis was examined in##2##5##(1991-12#1)(2008-6#1)
on lipoprotein (a)##2##3##(1990-12#2)
on liposome coated silica chromatography##2##5##(2008-10#2)
on liposomes trapping Tb/citrate complex##2##5##(2008-10#2)
on liquid##8##2##(2007-12#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-5#2)(2013-1#1)
on liquid-liquid extraction##3##3##(2008-10#3)
on listener perceptions of##3##4##(2011-1#3)
on literature data##2##3##(2008-8#2)
on literature##4##2##(1990-6#1)(2007-11#1)(2008-8#2)
on litter performance and##2##4##(2010-2#2)
on live##2##2##(2008-1#1)(2008-12#1)
on liver##7##2##(1990-3#1)(1993-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
on living##6##2##(2007-11#1)(2008-1#1)(2008-10#3)(2011-2#1)
on local conditions##3##3##(1993-11#1)(1994-3#1)(2007-12#1)
on local##22##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)
on location##6##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
on locomotor activity##4##3##(1993-12#1)(1993-5#1)(1994-8#1)(1996-5#1)
on long##3##2##(2007-11#1)(2008-10#2)
on long-term care##2##3##(1994-12#2)
on long-term effects##2##3##(2009-7#1)(2010-11#1)
on long-term survival##3##3##(1991-12#1)(2008-11#1)(2009-5#1)
on long-term treatment##3##3##(1993-11#1)(1995-8#1)(2008-3#1)
on long-term##22##2##(1991-12#2)(1993-11#1)(1994-12#2)(1995-12#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-5#1)(2009-7#1)(2010-11#1)(2013-1#1)(2013-8#2)
on longer##2##2##(2008-10#1)(2008-7#1)
on longevity and aging##3##4##(2008-7#3)
on longevity and##4##3##(2008-12#1)(2008-7#3)
on longevity##6##2##(2008-11#2)(2008-12#1)(2008-7#3)
on low density lipoprotein metabolism in##2##6##(1993-6#1)(1994-8#1)
on low dose##2##3##(2009-5#1)(2013-1#1)
on low molecular weight heparin hemodialysis##2##6##(2013-1#2)
on low##16##2##(1992-8#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2009-5#2)(2012-1#1)(2012-12#1)(2013-1#3)
on low-density lipoprotein##2##3##(1994-11#1)(2011-1#1)
on low-income##2##2##(2009-11#1)(2009-7#1)
on low-temperature-grown##2##2##(2008-2#2)
on lower extremity##2##3##(2008-12#1)(2008-7#1)
on lower##7##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)
on lung cancer##4##3##(1996-3#1)(2010-8#1)(2011-1#2)
on lung##6##2##(1991-9#1)(1996-3#1)(2010-8#1)(2011-1#2)(2011-2#1)
on lymphocyte##4##2##(1991-6#1)(1995-3#2)(2008-7#1)
on lymphocytes##4##2##(1995-5#1)(1995-8#2)(2013-8#1)
on lysosomal##2##2##(1990-5#1)(1995-6#1)
on mRNA##2##2##(1995-6#1)(2013-1#1)
on macrocyclic##4##2##(2008-10#4)
on macroporous##2##2##(2008-11#1)(2008-6#1)
on magnetic beads##2##3##(2008-10#2)
on magnetic resonance imaging (MRI)##2##5##(1995-5#1)(2012-3#1)
on magnetic resonance imaging of##2##5##(2012-2#1)(2013-1#1)
on magnetic resonance imaging##11##4##(1995-5#1)(1996-7#1)(2008-7#2)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on magnetic resonance##12##3##(1995-5#1)(1996-5#1)(1996-7#1)(2008-7#2)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on magnetic##17##2##(1995-5#1)(1996-5#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on maintaining a##2##3##(1993-3#1)(2010-7#1)
on maintaining##6##2##(1991-5#1)(1993-3#1)(1996-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
on maintenance HD##4##3##(2007-7#4)
on maintenance hemodialysis##8##3##(2007-7#3)(2008-1#5)
on maintenance##13##2##(2007-7#7)(2007-8#1)(2008-1#5)
on maize leaves##3##3##(2008-10#3)
on maize##9##2##(2008-10#7)(2008-12#1)(2008-8#1)
on major##6##2##(1993-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#2)
on making##4##2##(1995-1#1)(1997-6#1)(2008-11#1)(2010-7#1)
on malaria##7##2##(2008-8#3)(2010-3#1)(2010-5#1)(2012-12#1)(2013-8#1)
on male##13##2##(1991-2#1)(1995-6#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)
on males##4##2##(2008-5#1)(2008-8#3)
on malignant##2##2##(1993-9#1)(2010-11#1)
on mammalian cells##3##3##(1994-2#1)(1994-5#1)(2008-9#1)
on mammalian##7##2##(1994-2#2)(1994-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)
on mammary epithelial##2##3##(1994-11#2)
on mammary##3##2##(1994-11#2)(1995-9#1)
on managed care##4##3##(1994-3#1)(1995-3#1)(1996-12#1)(1997-2#1)
on managed##7##2##(1994-12#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-12#1)(1997-2#1)
on management of##3##3##(1994-11#1)(2008-1#1)(2008-10#1)
on management##11##2##(1994-1#2)(1994-11#1)(1995-1#1)(2008-1#3)(2008-10#2)(2008-11#1)(2011-1#1)
on managerial##2##2##(1997-2#1)(2012-3#1)
on managing##3##2##(1991-12#1)(1996-6#1)(2009-5#1)
on manganese##3##2##(2008-10#3)
on manual##2##2##(2008-9#1)(2013-1#1)
on many different##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
on many factors##5##3##(1993-2#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
on many host##2##3##(2008-10#2)
on many of the##2##4##(2008-10#1)(2008-6#1)
on many##22##2##(1993-2#1)(1995-6#1)(2007-11#2)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
on marble##4##2##(2008-10#4)
on markers##2##2##(2008-5#1)(2008-9#1)
on market##2##2##(1991-1#1)(1997-3#1)
on mass##9##2##(1990-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
on masticatory muscle reflexes##2##4##(1996-2#2)
on material##7##2##(1997-6#1)(2007-11#2)(2008-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
on materials##3##2##(2007-6#2)(2008-10#1)
on maternal behavior in##2##4##(1990-12#1)(2008-11#1)
on maternal health##2##3##(2011-1#2)
on maternal##17##2##(1990-12#1)(1991-12#1)(1992-12#1)(1993-3#1)(2008-11#1)(2008-8#4)(2008-9#2)(2009-7#1)(2009-9#1)(2011-1#3)(2011-2#1)
on mathematical##2##2##(2007-5#1)(2012-2#1)
on mating##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
on matrix##2##2##(2008-10#1)(2008-5#1)
on mature##6##2##(2008-10#5)(2008-11#1)
on maximal##6##2##(1995-12#1)(1995-6#1)(2007-9#1)(2008-10#2)(2008-9#1)
on maximum##6##2##(1996-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-8#1)
on mean##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
on measurable parameters##2##3##(2007-8#2)
on measurable##4##2##(2007-8#2)(2008-2#1)(2008-8#1)
on measured##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
on measurement of the##3##4##(2008-2#1)(2008-3#2)
on measurement of##9##3##(1991-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2010-5#2)
on measurement results##2##3##(2008-10#1)(2008-3#1)
on measurement##13##2##(1991-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-8#1)(2010-5#2)(2012-2#1)
on measurements of the##4##4##(1991-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
on measurements of##12##3##(1991-11#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-9#1)
on measurements##17##2##(1991-11#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#8)(2008-9#1)
on measures of##11##3##(1991-3#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
on measuring##6##2##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
on meat and##2##3##(2010-4#1)(2013-1#1)
on meat##3##2##(2010-4#1)(2013-1#2)
on mechanical##7##2##(2007-10#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-7#1)(2011-1#1)
on mechanisms involved in##2##4##(1993-5#1)(1995-11#1)
on mechanisms##6##2##(1993-5#1)(1994-1#1)(1995-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
on media amended with##3##4##(2008-10#3)
on media##5##2##(1995-8#1)(2008-10#4)
on medial##2##2##(2006-10#1)(2008-8#1)
on mediated##2##2##(1991-3#1)(2008-10#1)
on medical and##2##3##(1992-12#1)(1994-5#1)
on medical ethics##2##3##(1993-2#1)(2009-6#1)
on medical malpractice claims##2##4##(1992-2#1)(1993-1#1)
on medical malpractice##3##3##(1992-2#1)(1993-1#1)(1993-12#1)
on medical treatment##2##3##(1995-12#1)(2008-11#1)
on medical##27##2##(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-3#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-6#1)(2012-12#2)(2012-3#1)
on medication##5##2##(2006-10#1)(2008-11#1)(2010-4#1)(2010-8#1)(2013-1#1)
on medicine and##4##3##(1994-5#1)(2008-11#1)(2008-7#2)
on medium containing##3##3##(1991-7#1)(1997-7#1)(2013-1#1)
on medium with##2##3##(2008-9#1)(2013-1#1)
on medium##7##2##(1991-7#1)(1997-7#1)(2008-7#2)(2008-9#1)(2013-1#2)
on megakaryocytic differentiation of L8057##2##5##(1991-12#2)
on megakaryocytic differentiation##3##3##(1991-12#3)
on melanogenesis and##2##3##(1991-5#1)(2008-5#1)
on melanogenesis##4##2##(1991-5#1)(2008-5#3)
on melanoma cells##4##3##(1990-5#1)(1993-5#1)(2008-11#1)(2009-10#1)
on melanoma skin cancer##2##4##(2012-3#2)
on melanoma##7##2##(1990-5#1)(1993-5#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-3#2)
on melt inclusions in Martian##2##5##(2008-10#2)
on membrane fluidity and##3##4##(1990-12#1)(1995-11#2)
on membrane potential##2##3##(1990-12#1)(1992-3#1)
on membrane##13##2##(1990-12#2)(1990-2#1)(1992-3#1)(1994-3#1)(1995-11#2)(2006-6#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-5#1)(2013-7#1)
on membranes prepared##2##3##(2008-11#2)
on membranes##4##2##(1991-12#1)(1994-11#1)(2008-11#2)
on memory processes##2##3##(1992-8#1)(1993-12#1)
on memory##15##2##(1992-8#1)(1993-12#3)(1994-8#2)(1995-12#1)(1997-2#1)(2007-8#1)(2008-12#2)(2009-6#1)(2009-8#1)(2013-7#2)
on men##2##2##(1991-6#1)(2008-1#1)
on mental health##9##3##(1996-8#1)(2008-12#1)(2009-10#2)(2010-2#1)(2012-3#2)(2013-1#2)
on mental##14##2##(1990-3#1)(1991-8#2)(1993-11#1)(1996-8#1)(2008-12#1)(2009-10#2)(2010-2#1)(2012-3#3)(2013-1#2)
on mercury electrodes##2##3##(2008-10#2)
on mercury##5##2##(2008-10#5)
on mesalazine##2##2##(2010-11#1)(2010-12#1)
on mesoporous##2##2##(2008-10#2)
on metabolism and##2##3##(2008-11#1)(2012-3#1)
on metabolism##6##2##(1991-6#1)(1992-11#1)(1995-6#1)(1996-7#1)(2008-11#1)(2012-3#1)
on metabotropic##2##2##(1996-5#1)(2009-3#1)
on metal ion##2##3##(2008-10#2)
on metal##9##2##(2008-1#1)(2008-10#7)(2008-7#1)
on metallic##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
on metaphase chromosomes##2##3##(1993-12#1)(2011-2#1)
on metapopulation survival##2##3##(2008-8#2)
on metapopulation##3##2##(2008-8#3)
on meteorological and environmental##2##4##(2008-8#2)
on methane##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
on methanol##3##2##(1995-9#2)(1997-6#1)
on methodological##2##2##(1996-2#1)(2010-10#1)
on methodology##2##2##(2008-11#1)(2008-5#1)
on methods for##2##3##(2008-1#1)(2008-4#1)
on methods##3##2##(2008-1#1)(2008-4#1)(2010-9#1)
on methotrexate##2##2##(1992-8#1)(2012-2#1)
on methylation##2##2##(1993-6#1)(2008-4#1)
on mice##2##2##(2008-4#1)(2011-2#1)
on microRNA##2##2##(2011-2#1)(2012-2#1)
on microalgae growth and##2##4##(2013-1#2)
on microbial communities##2##3##(2008-10#2)
on microbial##7##2##(2007-3#1)(2008-10#6)
on microcarrier##2##2##(2008-11#1)(2008-9#1)
on microcarriers in bioreactors##2##4##(2008-11#2)
on microcarriers in##4##3##(2008-11#4)
on microcarriers##10##2##(2008-11#9)(2012-3#1)
on microcrystalline naphthalene in the pH range of##2##8##(2008-10#2)
on microcrystalline naphthalene in the pH range##5##7##(2008-10#5)
on microcrystalline naphthalene or by##2##5##(2008-10#2)
on microcrystalline naphthalene or##3##4##(2008-10#3)
on microcrystalline naphthalene##11##3##(2008-10#11)
on microcrystalline##12##2##(2008-10#12)
on microfluidic##2##2##(2008-10#2)
on microglia##3##2##(2008-4#1)(2008-6#2)
on microglial##2##2##(2008-4#1)(2008-7#1)
on microscope slides##2##3##(2008-9#2)
on microscope##4##2##(2008-10#1)(2008-2#1)(2008-9#2)
on microscopic examination##3##3##(2006-10#1)(2008-10#1)(2010-4#1)
on microscopic##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2010-4#1)
on microtiter plates##2##3##(1993-6#1)(2008-10#1)
on mid-term memory and swim speed in the##2##8##(2008-12#2)
on mid-term##3##2##(2008-12#2)(2011-2#1)
on migration##4##2##(1994-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
on migratory##2##2##(2008-5#1)(2010-8#1)
on mineralisation##2##2##(2007-8#2)
on minimal##2##2##(2008-10#2)
on minority##2##2##(2010-1#1)(2010-8#1)
on mission##2##2##(1991-3#1)(1992-3#1)
on mitochondria##2##2##(2008-11#1)(2008-7#1)
on mitochondrial##9##2##(1991-2#1)(1996-5#1)(2008-10#2)(2010-3#2)(2011-2#1)(2013-8#2)
on mitogen-activated protein##2##3##(2008-7#1)(2008-8#1)
on mitotic##2##2##(1990-11#1)(1992-12#1)
on mitoxantrone##2##2##(1991-4#2)
on mixing##3##2##(2007-11#1)(2008-10#2)
on mixture##2##2##(2008-10#1)(2008-12#1)
on mixtures of##2##3##(2008-10#1)(2008-7#1)
on mixtures##4##2##(2008-10#2)(2008-7#2)
on mode of##2##3##(2010-8#1)(2011-1#1)
on mode##3##2##(2008-3#1)(2010-8#1)(2011-1#1)
on model solutions##2##3##(2008-10#2)
on model##11##2##(1997-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#2)
on modeling the##2##3##(2007-12#1)(2013-1#1)
on modeling##3##2##(2007-12#1)(2009-9#1)(2013-1#1)
on models of##2##3##(1992-6#1)(2008-10#1)
on models##5##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
on modern##7##2##(2006-12#1)(2008-10#3)(2008-12#1)(2009-12#1)(2011-3#1)
on modified##6##2##(2008-10#1)(2008-11#1)(2008-8#2)(2012-7#1)(2013-8#1)
on modulation##2##2##(2008-2#1)(2008-3#1)
on molecular##21##2##(1995-3#1)(1996-9#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
on monitoring the##2##3##(2008-10#2)
on monitoring##5##2##(1997-2#1)(2007-6#1)(2008-10#2)(2009-7#1)
on monoclonal antibody##2##3##(2008-11#2)
on monocyte##2##2##(1992-12#1)(1993-6#1)
on monocytes##2##2##(1995-6#1)(1996-12#1)
on mononuclear##2##2##(2008-10#1)(2013-7#1)
on mood and##2##3##(2008-12#1)(2009-10#1)
on mood##3##2##(1991-8#1)(2008-12#1)(2009-10#1)
on moral##2##2##(2008-11#2)
on morbidity and mortality##4##4##(1993-2#1)(2006-10#1)(2007-12#1)(2008-1#1)
on more than one##2##4##(1994-2#1)(2008-9#1)
on more than##8##3##(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-2#1)
on more##15##2##(1990-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1996-3#1)(2007-8#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#2)
on morning##3##2##(1996-1#1)(1996-2#1)(2011-2#1)
on morphine##2##2##(1996-2#1)(1997-2#1)
on morphine- and##2##3##(1990-7#2)
on morphological##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
on morphology and##3##3##(2008-10#2)(2009-2#1)
on morphology was##3##3##(1996-6#1)(2008-8#1)(2011-2#1)
on morphology##11##2##(1996-6#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
on morphometric##3##2##(2007-11#1)(2008-12#1)(2008-7#1)
on mortality and##6##3##(1990-5#1)(1992-12#1)(1995-5#1)(2008-6#1)(2008-9#1)(2010-11#1)
on mortality from##2##3##(1991-6#1)(1995-2#1)
on mortality of##2##3##(1995-3#1)(2013-1#1)
on mortality##25##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#2)(2007-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#5)(2013-1#1)
on most##7##2##(1995-2#1)(2007-2#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-12#1)
on mothers'##2##2##(2009-7#1)(2011-1#1)
on motoneurones##2##2##(1997-2#2)
on motor function##2##3##(2011-2#2)
on motor##6##2##(2007-8#1)(2008-7#2)(2011-2#2)(2012-3#1)
on mouse skin##3##3##(1990-7#1)(1992-2#1)(1992-9#1)
on mouse##15##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-2#2)(2008-5#1)(2008-8#1)(2010-11#2)(2013-1#1)
on mtDNA##2##2##(2008-12#1)(2008-8#1)
on much##3##2##(1994-6#1)(1995-12#1)(1997-6#1)
on mucociliary##2##2##(1991-9#1)(1997-1#1)
on mucosal##4##2##(1997-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
on mucus transport##2##3##(1996-1#2)
on mulberry leaves##3##3##(2008-10#3)
on mulberry##4##2##(2008-10#4)
on multidisciplinary##3##2##(1994-1#1)(2007-11#1)(2011-3#1)
on multiple##20##2##(1993-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
on multivariate analysis##2##3##(2011-2#1)(2013-1#1)
on multivariate##5##2##(2007-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
on murine##6##2##(1990-11#1)(1993-3#1)(1993-6#1)(2007-7#1)(2008-11#1)(2012-2#1)
on muscarinic receptors##2##3##(1995-11#2)
on muscarinic##3##2##(1995-11#2)(1996-2#1)
on muscle##8##2##(1991-12#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#2)(2009-1#1)
on muscular##3##2##(2008-5#1)(2008-9#1)(2012-3#1)
on mutant##2##2##(1995-6#1)(2009-10#1)
on mutations##2##2##(2008-7#1)(2008-8#1)
on mutual##2##2##(1996-3#1)(2008-10#1)
on my##2##2##(2011-2#1)(2012-12#1)
on mycelial growth of R##2##5##(2008-10#2)
on mycelial growth##4##3##(2008-10#4)
on mycelial##5##2##(2008-10#5)
on myocardial cells##2##3##(1997-6#1)(2013-1#1)
on myocardial function##2##3##(1995-3#1)(2013-8#1)
on myocardial infarction##2##3##(2012-3#1)(2013-1#1)
on myocardial##13##2##(1991-2#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-6#1)(2012-3#2)(2013-1#2)(2013-8#4)
on nanosized##3##2##(2008-10#3)
on nanotubes##3##2##(2008-7#2)(2010-2#1)
on naphthalene##2##2##(2008-10#2)
on national health##3##3##(1993-12#1)(1994-3#1)(2008-8#1)
on national##7##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(2008-11#1)(2008-8#1)(2012-2#1)
on nationwide##2##2##(1992-11#1)(2011-2#1)
on native polyacrylamide##2##3##(2008-2#1)(2010-3#1)
on native##8##2##(1990-7#1)(1991-12#1)(1994-8#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2010-3#1)
on natural killer cell activity##2##5##(2007-11#1)(2008-10#1)
on natural##15##2##(1997-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-8#4)(2009-10#1)(2013-7#1)
on naturally infected##2##3##(2008-10#1)(2008-7#1)
on near-isogenic##2##2##(2008-10#2)
on nearby##2##2##(2008-5#1)(2009-10#1)
on necessary##2##2##(1997-3#1)(2011-2#1)
on necrosis##2##2##(1993-2#1)(2008-10#1)
on necrotic##4##2##(2008-10#4)
on negative##3##2##(2008-6#2)(2009-5#1)
on neighboring##2##2##(2008-10#1)(2008-7#1)
on neonatal rat##2##3##(2008-10#1)(2010-12#1)
on neonatal##4##2##(1991-3#1)(2008-10#1)(2010-12#1)(2011-1#1)
on nerve##3##2##(1994-12#1)(1996-5#1)(2010-8#1)
on network##2##2##(2008-11#1)(2009-9#1)
on networks##2##2##(2008-7#1)(2010-10#1)
on neural##7##2##(1990-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)
on neurite##2##2##(2008-11#1)(2008-4#1)
on neuroleptics##2##2##(1995-8#1)(2008-9#1)
on neurological##2##2##(2010-9#1)(2013-1#1)
on neuronal activity##3##3##(1990-7#1)(2008-7#2)
on neuronal survival##3##3##(1993-3#1)(2012-1#2)
on neuronal##15##2##(1990-7#1)(1993-3#1)(1995-5#1)(1996-12#2)(2008-3#1)(2008-7#5)(2009-12#1)(2012-1#2)(2013-1#1)
on neurons in the##3##4##(1993-12#1)(1996-12#1)(2008-4#1)
on neurons##5##2##(1993-12#2)(1996-12#1)(2008-4#1)(2008-7#1)
on neuropeptide Y##2##3##(1995-12#1)(2012-3#1)
on neuropeptide##3##2##(1995-12#2)(2012-3#1)
on neurotransmission##2##2##(1993-12#1)(2012-2#1)
on neutral##2##2##(2008-10#1)(2010-12#1)
on neutrophil##6##2##(1993-3#1)(1993-8#1)(1994-8#2)(1996-11#1)(2008-10#1)
on new##18##2##(1994-12#1)(1994-9#1)(1995-12#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
on newly##3##2##(1994-9#1)(1996-1#1)(2008-10#1)
on nickel##3##2##(1994-5#1)(2008-10#2)
on nine##7##2##(2008-10#3)(2008-12#1)(2008-5#1)(2009-7#1)(2013-7#1)
on nitrate##2##2##(2008-10#1)(2011-1#1)
on nitric oxide production##2##4##(2013-1#2)
on nitric oxide##4##3##(2008-9#2)(2013-1#2)
on nitrogen##9##2##(1995-11#1)(1995-3#3)(1996-5#2)(2012-1#1)(2013-8#2)
on no##2##2##(1990-3#1)(2007-8#1)
on nociception##2##2##(1990-7#1)(1997-2#1)
on noise##2##2##(2008-3#1)(2011-1#1)
on nonlinear regression##2##3##(2008-10#1)(2008-3#1)
on nonlinear##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
on nonpreferred resources##2##3##(2008-9#2)
on noradrenaline##2##2##(1997-4#1)(2008-6#1)
on normal and##3##3##(2006-6#1)(2008-11#1)(2012-2#1)
on normal human##2##3##(2008-11#1)(2008-4#1)
on normal##20##2##(1990-12#1)(1991-9#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#2)(2006-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
on novel hosts##2##3##(2008-8#2)
on novel##6##2##(2008-10#2)(2008-8#3)(2010-11#1)
on nuclear and##2##3##(2008-10#2)
on nuclear##5##2##(1990-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
on nucleotide##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
on number of##2##3##(2008-10#1)(2013-8#1)
on number##6##2##(2008-10#1)(2008-3#3)(2009-5#1)(2013-8#1)
on numbers of##2##3##(1991-11#1)(2008-7#1)
on numerous##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
on nurses##2##2##(1995-3#1)(2008-9#1)
on nurses'##6##2##(1995-2#1)(2008-11#1)(2010-10#1)(2011-1#2)(2013-1#1)
on nursing care##2##3##(1995-1#1)(2009-10#1)
on nursing education##3##3##(1990-2#1)(1991-2#1)(1996-3#1)
on nursing home##2##3##(1992-3#1)(1995-2#1)
on nursing practice##2##3##(2008-11#2)
on nursing students'##2##3##(2008-11#2)
on nursing##23##2##(1990-2#1)(1991-2#1)(1992-3#1)(1994-2#2)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-11#4)(2008-12#1)(2008-8#1)(2009-10#1)(2012-3#4)(2013-1#2)
on nutrient availability##2##3##(2008-5#1)(2013-1#1)
on nutrient intake##3##3##(1994-12#1)(2008-12#1)(2012-2#1)
on nutrient##7##2##(1994-12#1)(2008-10#1)(2008-12#2)(2008-5#1)(2012-2#1)(2013-1#1)
on nutrition and##2##3##(2007-12#1)(2008-9#1)
on nutritional##3##2##(1997-4#1)(2011-2#1)(2013-1#1)
on nylon filters##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
on nylon membranes##2##3##(2008-10#1)(2008-7#1)
on nylon##7##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)
on nymphs and##2##3##(2013-7#1)(2013-8#1)
on nymphs##3##2##(2013-7#1)(2013-8#2)
on oat and##2##3##(2008-10#2)
on object##2##2##(2008-2#1)(2008-7#1)
on objective##2##2##(2007-12#1)(2009-9#1)
on objects##2##2##(2007-12#1)(2008-6#1)
on observation of##4##3##(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#1)
on observations of##5##3##(1996-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
on observations##9##2##(1996-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
on observed##6##2##(1990-8#1)(1991-8#1)(1994-12#1)(2007-11#1)(2008-10#2)
on obtaining##2##2##(2007-2#1)(2008-3#1)
on occasion##3##2##(1995-6#1)(2007-12#1)(2008-5#1)
on occasions when##2##3##(1990-2#1)(2012-1#1)
on occasions##4##2##(1990-2#1)(1997-4#1)(2007-6#1)(2012-1#1)
on occupational##4##2##(1991-6#1)(2008-8#1)(2009-12#1)(2010-12#1)
on octadecyl silica##3##3##(2008-10#3)
on offspring##5##2##(2008-8#1)(2008-9#3)(2012-3#1)
on older berries##2##3##(2008-10#2)
on older##8##2##(1995-12#1)(2008-10#4)(2009-7#1)(2010-1#1)(2012-2#1)
on olfactory##2##2##(1994-8#1)(2012-2#1)
on olive plants##2##3##(2008-10#2)
on on-line##2##2##(2008-10#2)
on one aspect of##2##4##(1994-1#1)(2007-10#1)
on one face of the##2##5##(1992-12#1)(1992-3#1)
on one face of##3##4##(1992-12#1)(1992-3#1)(1993-11#1)
on one hand and##4##4##(1993-12#1)(2008-12#1)(2010-6#1)(2012-2#1)
on one hand##7##3##(1990-12#1)(1993-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-6#1)(2012-2#1)
on one of the two##2##5##(1994-8#1)(2008-7#1)
on one of the##7##4##(1994-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)
on one of##8##3##(1993-6#1)(1994-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)
on one or both##2##4##(2008-10#1)(2012-2#1)
on one or more##2##4##(1996-7#1)(2008-10#1)
on one or##4##3##(1996-7#1)(2008-10#2)(2012-2#1)
on one side and##3##4##(2008-10#1)(2012-2#2)
on one side of##2##4##(2007-11#1)(2011-2#1)
on one side##11##3##(1993-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
on one##70##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-7#1)(1997-5#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#1)
on one's##2##2##(2008-10#1)(2009-9#1)
on onion##2##2##(2008-10#2)
on online end-user##2##3##(1991-3#2)
on only one##7##3##(1990-11#1)(1991-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)(2013-1#1)
on only the##2##3##(1994-6#1)(2008-4#1)
on only##13##2##(1990-11#1)(1991-5#1)(1992-12#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#1)
on ontogenically resistant berries##2##4##(2008-10#2)
on operative##2##2##(2007-11#1)(2009-7#1)
on opiate substitution therapy##2##4##(2012-1#2)
on opiate##3##2##(1991-1#1)(2012-1#2)
on opioid##2##2##(1995-3#1)(1996-12#1)
on opium poppy##2##3##(2008-10#2)
on opposite##3##2##(1993-11#1)(1996-6#1)(2008-3#1)
on optical parametric##4##3##(2007-11#2)(2007-12#2)
on optical properties##3##3##(2008-2#1)(2008-3#2)
on optical##31##2##(2007-11#7)(2007-12#4)(2008-11#1)(2008-2#6)(2008-3#10)(2008-5#1)(2009-7#1)(2012-2#1)
on optimal##8##2##(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
on optimization of the##2##4##(2007-11#1)(2013-1#1)
on optimization of##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
on optimizing##4##2##(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#1)
on or in the##2##4##(2008-10#2)
on or off depending on##2##5##(1994-12#1)(2009-8#1)
on or##8##2##(1990-2#1)(1991-8#1)(1994-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-8#1)
on oral##9##2##(1991-4#1)(1996-11#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
on orbit##3##2##(2008-3#2)(2012-3#1)
on organic hydroperoxides##2##3##(2008-10#2)
on organic matter##2##3##(2008-11#2)
on organic##9##2##(1994-5#1)(1995-9#1)(2008-10#4)(2008-11#2)(2013-1#1)
on organisms##2##2##(2008-10#1)(2008-8#1)
on organization##3##2##(1990-12#1)(1995-8#1)(2011-2#1)
on organizational##4##2##(1996-12#1)(2008-1#1)(2010-9#1)(2011-2#1)
on orientation##2##2##(2010-2#1)(2012-2#1)
on orogastric and systemic candidiasis in immunodeficient mice##2##8##(2008-5#2)
on osteoblast##2##2##(1991-12#1)(2008-8#1)
on osteocalcin##2##2##(1990-2#1)(1993-3#1)
on osteoclast formation##2##3##(1993-8#1)(2008-5#1)
on osteosarcoma##2##2##(2010-3#1)(2013-8#1)
on other components##2##3##(2008-10#1)(2009-11#1)
on other host##2##3##(2008-10#2)
on other hosts##4##3##(2008-10#4)
on other susceptible##2##3##(2008-10#2)
on other##56##2##(1991-4#1)(1991-9#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
on others##6##2##(1993-12#1)(1997-5#1)(2007-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
on our ability to##2##4##(1994-12#1)(2009-3#1)
on our data##3##3##(1996-11#1)(2007-12#1)(2008-2#1)
on our experience with##3##4##(1996-8#1)(2007-6#1)(2008-7#1)
on our experience##4##3##(1996-8#1)(2007-6#1)(2008-7#1)(2011-2#1)
on our findings##4##3##(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
on our previous##3##3##(2008-11#1)(2008-9#1)(2010-11#1)
on our##59##2##(1990-12#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-11#1)(1996-8#2)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#6)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-7#1)(2013-8#1)
on outcome in##4##3##(1994-8#1)(2006-10#1)(2008-6#1)(2011-2#1)
on outcome measures##2##3##(2008-7#1)(2011-1#1)
on outcome##10##2##(1994-8#1)(2006-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
on outcomes##8##2##(1991-12#1)(1995-1#1)(1995-2#1)(1996-2#2)(2007-10#1)(2010-3#1)(2011-1#1)
on ovarian##3##2##(1990-10#1)(2008-12#1)(2013-1#1)
on overall survival##2##3##(2007-4#1)(2011-2#1)
on overall##7##2##(1992-1#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)
on overcoming##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
on overlapping##2##2##(1997-5#1)(2008-8#1)
on oxidative stress in the heart and##2##7##(2013-1#2)
on oxidative stress in##3##4##(2009-12#1)(2013-1#2)
on oxidative stress##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#2)
on oxidative##8##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-1#2)
on oxygen binding##2##3##(1990-8#1)(2013-8#1)
on oxygen##7##2##(1990-8#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-8#1)
on ozone##4##2##(1996-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
on p##18##2##(2008-10#1)(2008-11#3)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
on p-tert-butyl-calix[8]arene-bonded silica gel stationary phase by HPLC##2##8##(2008-10#2)
on p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##3##6##(2008-10#3)
on p53##2##2##(1995-11#1)(2013-1#1)
on pH and##3##3##(2008-10#2)(2008-6#1)
on pH##15##2##(1990-7#2)(1990-8#1)(2008-10#9)(2008-11#1)(2008-6#1)(2011-2#1)
on page##5##2##(2007-11#2)(2012-12#3)
on pain and##2##3##(1995-5#1)(2007-8#1)
on pain intensity##2##3##(2009-12#2)
on pain##10##2##(1995-5#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-12#2)(2010-1#1)(2012-2#1)(2012-3#1)
on paired##2##2##(2008-11#1)(2008-7#1)
on palpation##2##2##(2009-6#1)(2010-3#1)
on pancreatic##4##2##(1992-2#1)(1993-6#1)(2013-1#2)
on panicle and shoot blight of pistachio##2##7##(2008-10#2)
on panicle and shoot blight##3##5##(2008-10#3)
on paper substrates##2##3##(2012-2#2)
on paper##3##2##(2008-10#1)(2012-2#2)
on paraffin sections##2##3##(1995-4#1)(2008-4#1)
on paraffin##3##2##(1991-2#1)(1995-4#1)(2008-4#1)
on parameter##2##2##(2008-2#1)(2008-8#1)
on parameters of the##2##4##(2008-3#1)(2011-1#1)
on parameters of##4##3##(2008-3#2)(2011-1#1)(2013-1#1)
on parameters##7##2##(2008-10#1)(2008-3#2)(2011-1#1)(2012-2#1)(2013-1#2)
on parasite##2##2##(1990-8#1)(1995-12#1)
on parasitism##2##2##(2008-6#2)
on parental##3##2##(1994-8#1)(2010-5#1)(2010-9#1)
on parents and##2##3##(1990-2#1)(2012-3#1)
on parents'##3##2##(1991-12#1)(1993-6#1)(2011-1#1)
on partial##5##2##(1993-8#1)(2008-10#2)(2011-2#1)(2013-8#1)
on partially##3##2##(1992-11#1)(2007-11#1)(2008-10#1)
on participant##2##2##(2008-9#1)(2013-8#1)
on participants'##2##2##(2007-10#1)(2008-11#1)
on participation##2##2##(2007-6#1)(2013-1#1)
on particle##7##2##(1991-12#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
on particles##2##2##(2008-2#1)(2012-1#1)
on particular##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
on partition##2##2##(2008-10#1)(2008-5#1)
on partitioning of##2##3##(1997-3#1)(2008-8#1)
on passive##2##2##(1992-6#1)(2010-8#1)
on past##6##2##(1991-1#1)(1991-5#1)(1997-2#1)(2008-7#1)(2012-3#2)
on pasture##2##2##(2010-2#1)(2013-1#1)
on patch##4##2##(1997-2#1)(2008-8#1)(2008-9#2)
on pathogen evolution##2##3##(2008-10#2)
on pathogen populations##2##3##(2008-10#2)
on pathogen##8##2##(2008-10#8)
on pathogenicity##3##2##(2008-10#3)
on pathogens##2##2##(2009-2#1)(2009-6#1)
on pathology##2##2##(2006-8#1)(2012-1#1)
on pathways##2##2##(2007-10#1)(2012-3#1)
on patient and##4##3##(1992-3#1)(2008-11#2)(2011-2#1)
on patient attitudes##2##3##(2011-2#2)
on patient care##3##3##(1995-3#1)(2010-8#1)(2011-2#1)
on patient demographics##2##3##(2007-10#1)(2011-2#1)
on patient management##5##3##(1996-2#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-6#1)
on patient outcomes##5##3##(1994-3#1)(2007-12#1)(2008-7#1)(2013-1#2)
on patient satisfaction##3##3##(1996-3#1)(1997-3#1)(2010-2#1)
on patient##44##2##(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#5)(2013-1#4)
on patient's##8##2##(1992-2#1)(2008-10#1)(2008-7#2)(2009-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
on patients and their families##2##5##(2008-11#1)(2011-2#1)
on patients and##6##3##(2008-1#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-5#1)(2011-2#1)
on patients receiving##2##3##(2008-7#1)(2008-8#1)
on patients with cancer##2##4##(2008-7#1)(2012-3#1)
on patients with##7##3##(1997-8#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
on patients##28##2##(1994-12#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
on patients'##9##2##(1994-1#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
on patterns of##6##3##(1996-6#1)(2007-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
on patterns##8##2##(1996-6#1)(2007-10#2)(2007-7#1)(2008-5#1)(2008-8#2)(2008-9#1)
on pd 7 and pd 14##2##6##(2008-7#2)
on pd 7##4##3##(2008-7#4)
on pea##5##2##(2008-10#5)
on peach##2##2##(2008-10#2)
on peak##4##2##(2007-10#1)(2007-8#1)(2008-10#2)
on pear and apple trees##2##5##(2008-10#2)
on pear and apple##4##4##(2008-10#4)
on pear leaves##2##3##(2008-10#2)
on pear##16##2##(2008-10#16)
on peas##4##2##(2008-10#4)
on pectin##3##2##(2008-10#3)
on pediatric##3##2##(1993-12#1)(2011-1#2)
on pension plans##2##3##(1993-3#2)
on penultimate leaf was##2##4##(2008-10#2)
on pepper##2##2##(2008-10#2)
on peptide##2##2##(2008-10#2)
on percent##5##2##(2008-10#3)(2008-5#1)(2010-8#1)
on percutaneous##3##2##(2006-10#1)(2008-5#1)(2009-11#1)
on perennial ryegrass##2##3##(2008-10#2)
on perennial##3##2##(2008-10#3)
on performance in the##2##4##(2007-12#1)(2008-8#1)
on performance in##6##3##(1990-3#1)(1994-3#1)(2007-12#2)(2008-8#1)(2011-2#1)
on performance of##4##3##(1993-12#1)(1995-12#1)(2008-12#1)(2008-3#1)
on performance##18##2##(1990-3#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-12#1)(1997-3#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
on perinatal outcome##2##3##(2012-3#2)
on perinatal##4##2##(2007-4#1)(2012-3#3)
on periodically poled LiNbO(3)##2##4##(2007-12#2)
on periodically poled##20##3##(2007-11#6)(2007-12#10)(2008-3#4)
on peripheral blood lymphocytes##3##4##(1990-5#1)(2008-9#2)
on peripheral blood##5##3##(1990-5#1)(2008-4#1)(2008-9#2)(2011-2#1)
on peripheral##8##2##(1990-5#1)(1996-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
on periphery of##2##3##(2009-2#1)(2010-7#1)
on periphery##3##2##(2009-2#2)(2010-7#1)
on peritoneal dialysis and##2##4##(2007-12#1)(2008-1#1)
on peritoneal dialysis##6##3##(2007-12#2)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)
on peritoneal inflammation in##2##4##(2008-12#2)
on peritoneal##11##2##(2007-12#3)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2011-2#3)
on peritonitis##2##2##(2008-12#1)(2011-2#1)
on permanent##2##2##(2008-3#1)(2012-3#1)
on personal##10##2##(1991-9#1)(1992-1#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-5#1)(2010-8#2)
on personnel##2##2##(1990-11#1)(2010-8#1)
on pesticide##2##2##(2008-11#1)(2008-12#1)
on petals##2##2##(2008-10#2)
on petioles##2##2##(2008-10#2)
on phage##4##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#1)
on phantoms##2##2##(2008-3#2)
on pharmaceutical##7##2##(2007-11#1)(2008-10#3)(2009-10#1)(2009-3#2)
on pharmacy##2##2##(2008-6#1)(2010-3#1)
on phase modulation##2##3##(2007-11#2)
on phase##7##2##(2007-11#2)(2008-10#1)(2008-3#3)(2013-8#1)
on phenotype##2##2##(2008-10#1)(2011-1#1)
on phenotypic##2##2##(2008-8#1)(2010-4#1)
on philanthropy##2##2##(1995-3#1)(1997-3#1)
on phosphatidylethanolamine lipid polymorphism##2##4##(1990-2#2)
on phosphoinositide hydrolysis##2##3##(1993-3#1)(1997-1#1)
on phosphoinositide##3##2##(1993-3#1)(1994-9#1)(1997-1#1)
on phospholipase A2##2##3##(1990-2#1)(1994-3#1)
on phospholipase##5##2##(1990-2#1)(1993-3#1)(1994-3#1)(2008-11#1)(2008-8#1)
on phospholipid and##2##3##(1993-6#1)(2008-8#1)
on photocatalytic##2##2##(2008-10#2)
on photochemical##2##2##(2008-10#1)(2008-11#1)
on photoinduced##3##2##(2007-11#2)(2008-2#1)
on photon migration##3##3##(2008-3#3)
on photon##5##2##(2008-3#4)(2008-7#1)
on photosynthesis##2##2##(2008-10#2)
on phylogenetic analysis using##2##4##(2008-10#2)
on phylogenetic##5##2##(1990-11#1)(2008-10#3)(2008-8#1)
on phylogeny##2##2##(2008-8#1)(2010-6#1)
on physical activity##3##3##(2008-12#1)(2008-7#1)(2010-8#1)
on physical and mental##2##4##(2009-3#1)(2011-1#1)
on physical and##3##3##(2009-3#1)(2010-6#1)(2011-1#1)
on physical examination##4##3##(2006-5#1)(2008-12#1)(2008-6#1)(2013-8#1)
on physical##25##2##(1990-2#1)(1993-1#1)(1997-7#1)(2006-5#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#3)
on physician liability##2##3##(1993-2#2)
on physician##12##2##(1991-12#2)(1991-9#1)(1992-12#1)(1993-2#2)(1994-1#1)(1994-2#2)(1996-12#1)(1997-3#1)(2013-7#1)
on physicians and##3##3##(1992-3#1)(1996-2#1)(2008-6#1)
on physicians##7##2##(1992-2#1)(1992-3#1)(1993-12#2)(1995-2#1)(1996-2#1)(2008-6#1)
on physicians'##3##2##(1991-12#1)(1992-12#1)(2009-3#1)
on physiologic##3##2##(1991-1#1)(2007-10#1)(2012-12#1)
on physiological##6##2##(1990-9#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
on phytoplankton##2##2##(2009-8#1)(2013-8#1)
on pictures 1 and 2##2##5##(2013-1#2)
on pistachio##2##2##(2008-10#2)
on pixels##3##2##(2008-3#3)
on placebo##8##2##(1991-3#1)(1992-5#2)(1994-11#1)(2008-5#2)(2008-6#2)
on placement##4##2##(2008-11#3)(2008-12#1)
on plain abdominal##2##3##(1991-8#1)(2012-2#1)
on plain radiographs##2##3##(2008-9#1)(2010-5#1)
on plain##5##2##(1991-8#1)(2007-11#1)(2008-9#1)(2010-5#1)(2012-2#1)
on planar##4##2##(1994-2#1)(1997-7#1)(2008-2#1)(2008-4#1)
on plant biomass##2##3##(2008-8#2)
on plant fitness##2##3##(2008-8#2)
on plant growth##6##3##(2008-10#4)(2008-7#1)(2012-7#1)
on plant surfaces##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
on plant##34##2##(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-8#1)(2011-2#1)(2012-5#1)(2012-6#1)(2012-7#1)
on plantar##2##2##(2009-6#1)(2011-2#1)
on plants grown in##3##4##(2008-10#3)
on plants in the##2##4##(2008-10#2)
on plants in##3##3##(2008-10#3)
on plants infected with##3##4##(2008-10#3)
on plants inoculated with##2##4##(2008-10#2)
on plants of##4##3##(2008-10#4)
on plants##32##2##(1997-3#1)(2008-10#27)(2008-8#2)(2008-9#1)(2011-2#1)
on plasma lipid##4##3##(2008-7#1)(2011-1#1)(2012-2#2)
on plasma lipids of##2##4##(1992-11#1)(2008-7#1)
on plasma lipids##3##3##(1992-11#1)(2008-7#1)(2012-2#1)
on plasma##18##2##(1991-9#1)(1992-11#1)(1993-1#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
on plasmids##2##2##(1991-7#2)
on plastic and##3##3##(2008-11#3)
on plastic dishes##2##3##(2008-11#2)
on plastic##14##2##(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)
on plated leaf##2##3##(2008-10#2)
on platelet activation##4##3##(1992-4#1)(2011-2#3)
on platelet aggregation##2##3##(1991-12#1)(1991-9#1)
on platelet and##2##3##(2008-7#2)
on platelet function##5##3##(1991-11#1)(1991-12#2)(1997-4#1)(2006-6#1)
on platelet##20##2##(1990-10#1)(1991-11#1)(1991-12#3)(1991-9#1)(1992-4#1)(1994-8#2)(1997-4#1)(2006-6#2)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#4)
on platelets and##2##3##(2006-6#1)(2008-4#1)
on platelets##3##2##(2006-6#2)(2008-4#1)
on plates##2##2##(2008-10#2)
on platinum##3##2##(2008-10#3)
on pods##5##2##(2008-10#5)
on point##5##2##(2011-2#5)
on polarization##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
on polarized##3##2##(2007-11#2)(2009-8#1)
on policies##2##2##(1995-3#1)(2012-2#1)
on policy##4##2##(1991-1#1)(1996-3#1)(2009-11#1)(2012-12#1)
on polished##2##2##(2008-3#1)(2013-1#1)
on political##4##2##(1993-6#1)(1996-1#1)(2008-1#1)(2008-7#1)
on pollen##4##2##(1992-3#1)(2008-10#2)(2008-8#1)
on pollinator##2##2##(2008-8#2)
on polyacrylamide gels##2##3##(1993-8#1)(2008-10#1)
on polyacrylamide##4##2##(1993-8#2)(2008-10#1)(2009-6#1)
on polycrystalline##2##2##(1996-2#1)(2008-10#1)
on polymer film##2##3##(2008-10#2)
on polymer##3##2##(2008-10#2)(2008-9#1)
on polypharmacy##2##2##(2008-3#1)(2011-2#1)
on polyphenols##2##2##(2012-12#1)(2013-1#1)
on polysaccharides##2##2##(2008-5#1)(2008-6#1)
on poor##2##2##(1992-2#1)(2008-10#1)
on poorly##2##2##(1994-5#1)(2008-2#1)
on population dynamics and##2##4##(2008-8#1)(2013-7#1)
on population dynamics of##2##4##(2008-10#2)
on population dynamics##6##3##(1994-8#1)(2008-10#3)(2008-8#1)(2013-7#1)
on population growth and##2##4##(2008-11#2)
on population##19##2##(1991-6#1)(1994-8#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-8#6)(2008-9#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
on populations##6##2##(1990-8#1)(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
on porous graphitic carbon##2##4##(1990-8#2)
on porous##12##2##(1990-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)
on position##2##2##(2008-10#1)(2011-1#1)
on positive##6##2##(1990-11#1)(1993-6#1)(2008-11#1)(2011-2#2)(2012-2#1)
on possible mechanisms##3##3##(2008-10#2)(2009-8#1)
on possible##8##2##(1995-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
on post-infection##2##2##(2008-10#1)(2008-11#1)
on post-mortem##2##2##(2008-7#1)(2013-1#1)
on posterior gills of the mangrove crab Ucides cordatus##2##9##(2008-7#2)
on posterior##3##2##(1993-5#1)(2008-7#2)
on postinfection##2##2##(2008-10#2)
on postnatal day##2##3##(1996-12#1)(2012-12#1)
on postnatal##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
on postoperative pain and##2##4##(2012-1#1)(2012-12#1)
on postoperative pain##3##3##(1992-8#1)(2012-1#1)(2012-12#1)
on postoperative##10##2##(1992-8#1)(1994-3#1)(1997-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
on postsurgical adhesion formation##2##4##(1995-12#2)
on postsynaptic##2##2##(1994-8#1)(1995-5#1)
on potato and tomato##3##4##(2008-10#3)
on potato and##4##3##(2008-10#4)
on potato based ready-to-eat food products##2##6##(2011-2#2)
on potato dextrose agar (PDA)##2##5##(2008-10#2)
on potato dextrose agar##10##4##(2008-10#10)
on potato##29##2##(2008-10#27)(2011-2#2)
on potential##13##2##(1994-3#1)(1995-2#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#2)(2013-1#1)
on powdery mildew##2##3##(2008-10#2)
on power##2##2##(1996-3#1)(2011-2#1)
on practical##3##2##(1995-5#1)(2007-10#1)(2008-3#1)
on practice##6##2##(1996-2#1)(2008-11#5)
on pre- and##4##3##(1994-2#1)(2008-1#2)(2012-2#1)
on predicted##2##2##(1991-12#1)(2009-5#1)
on predicting##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
on predictions of##2##3##(2008-8#1)(2013-8#1)
on pregnancy##7##2##(1991-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2011-2#1)(2013-1#2)
on preliminary##3##2##(1995-3#1)(2008-12#1)(2008-5#1)
on prenatal maternal stress##2##4##(2008-2#2)
on prenatal##3##2##(1992-9#1)(2008-2#2)
on preoperative##8##2##(2006-10#1)(2006-12#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
on prescribing patterns##2##3##(2008-11#2)
on prescribing##4##2##(2008-11#4)
on prescription##3##2##(1990-2#2)(2008-11#1)
on presence of##3##3##(1990-2#1)(2008-10#2)
on present##2##2##(1996-12#1)(2008-12#1)
on presentation##2##2##(2007-7#1)(2008-10#1)
on pressure##2##2##(1990-9#2)
on prevalence##2##2##(2008-1#1)(2013-1#1)
on preventing infection##2##3##(2007-2#1)(2008-10#1)
on preventing##5##2##(1993-2#1)(1994-2#1)(2007-2#1)(2008-10#1)(2013-1#1)
on prevention and##3##3##(1994-12#1)(2007-7#1)(2010-5#1)
on prevention of##5##3##(1993-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
on prevention##12##2##(1991-3#1)(1993-11#1)(1994-12#1)(1997-5#1)(2007-7#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)
on preventive measures##3##3##(2008-10#1)(2010-1#1)(2011-1#1)
on preventive services##2##3##(1994-2#1)(1995-2#1)
on preventive##6##2##(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2010-1#1)(2011-1#1)
on previous##13##2##(1994-3#1)(2008-3#4)(2008-7#3)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)
on previously##11##2##(1990-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
on prey fitness##2##3##(2008-8#2)
on prey##3##2##(2008-8#3)
on prg##2##2##(2008-10#2)
on primary and##2##3##(1997-6#1)(2008-10#1)
on primary care##2##3##(1991-1#1)(1994-6#1)
on primary prevention##2##3##(1996-12#1)(2008-11#1)
on primary##17##2##(1991-1#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#1)
on principles##2##2##(2008-12#1)(2010-5#1)
on prior experience##2##3##(2010-8#2)
on privacy##2##2##(1992-4#1)(1996-5#1)
on private##3##2##(1993-1#1)(1995-3#1)(1996-12#1)
on probe##2##2##(1994-5#1)(2009-5#1)
on probing##2##2##(2008-12#1)(2013-1#1)
on problem##3##2##(1994-2#1)(2008-12#1)(2010-10#1)
on problems of##4##3##(1990-3#1)(1994-3#1)(2007-8#1)(2009-12#1)
on problems##7##2##(1990-3#1)(1994-3#1)(1997-3#1)(2007-8#1)(2009-12#1)(2010-8#1)(2011-2#1)
on processes##2##2##(1993-6#1)(2008-7#1)
on product##4##2##(1992-1#1)(2008-5#1)(2008-7#2)
on production of##3##3##(1990-5#1)(2008-11#2)
on production##6##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-8#1)
on productivity in##2##3##(2008-7#1)(2008-8#1)
on productivity##4##2##(1991-2#1)(1992-3#1)(2008-7#1)(2008-8#1)
on professional##2##2##(1995-3#1)(2008-11#1)
on prognosis and##4##3##(1991-8#1)(2011-1#2)(2013-1#1)
on prognosis##10##2##(1990-8#1)(1991-6#1)(1991-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
on program##4##2##(1992-3#1)(1993-3#1)(2009-8#1)(2013-1#1)
on progression of##4##3##(1995-12#1)(1996-3#1)(2008-1#1)(2013-1#1)
on proliferation and apoptosis in##2##5##(2011-2#2)
on proliferation and apoptosis of##2##5##(2011-2#1)(2013-1#1)
on proliferation and apoptosis##4##4##(2011-2#3)(2013-1#1)
on proliferation and##6##3##(2006-6#1)(2008-11#1)(2011-2#3)(2013-1#1)
on proliferation of human##2##4##(1993-9#1)(1995-3#1)
on proliferation of##6##3##(1993-9#1)(1995-3#1)(1997-2#1)(2010-12#2)(2011-3#1)
on proliferation##17##2##(1991-5#1)(1992-2#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-2#1)(2006-6#1)(2008-11#2)(2010-12#2)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#1)
on prolonged##2##2##(2008-5#1)(2013-1#1)
on promoter##2##2##(2008-10#1)(2013-1#1)
on promoting cell growth##2##4##(2008-11#2)
on promoting##8##2##(1992-9#1)(1994-3#2)(2008-11#4)(2008-9#1)
on propagating##2##2##(1996-4#1)(2009-5#1)
on propagation##2##2##(2007-11#1)(2007-12#1)
on proper##4##2##(2007-8#1)(2008-12#1)(2010-9#1)(2011-2#1)
on properties##4##2##(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)
on proposed##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
on prospective##2##2##(2010-3#1)(2013-7#1)
on prostate cancer##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
on protection##2##2##(2007-2#1)(2008-8#1)
on protective##2##2##(2008-12#1)(2010-12#1)
on protein kinase C activity in##2##6##(1990-8#1)(1993-12#1)
on protein kinase C and##2##5##(1994-5#1)(2008-11#1)
on protein kinase C##7##4##(1990-8#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-12#1)(2008-11#1)
on protein kinase##8##3##(1990-8#1)(1991-5#1)(1992-6#1)(1993-12#2)(1994-5#1)(1995-12#1)(2008-11#1)
on protein synthesis in##3##4##(2008-11#3)
on protein synthesis##12##3##(1990-11#1)(1995-12#1)(2008-11#10)
on protein##36##2##(1990-11#1)(1990-8#1)(1991-5#1)(1992-6#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#12)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
on proteins##9##2##(1993-3#1)(2008-10#2)(2008-4#4)(2010-5#1)(2012-1#1)
on proteolytic##2##2##(2008-10#1)(2008-4#1)
on provider education##2##3##(1997-2#2)
on provider##4##2##(1994-1#1)(1994-3#1)(1997-2#2)
on providing##5##2##(1997-6#1)(2008-10#1)(2008-11#1)(2013-1#2)
on psychiatric symptoms##4##3##(2012-1#3)(2013-8#1)
on psychiatric##9##2##(1991-1#1)(1991-3#1)(1992-12#1)(2008-6#1)(2012-1#3)(2012-3#1)(2013-8#1)
on psychiatry##2##2##(1992-6#1)(1993-12#1)
on psychological##8##2##(1992-1#1)(1993-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-4#1)(2009-7#1)(2012-3#1)
on psychosis in##2##3##(2011-1#2)
on psychosis##3##2##(2011-1#3)
on public health##10##3##(1995-12#1)(1995-2#1)(1996-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
on public##15##2##(1991-5#1)(1992-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
on published##5##2##(2007-10#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
on pulmonary function##5##3##(1991-12#1)(1993-2#1)(1997-1#1)(2011-2#1)(2013-1#1)
on pulmonary##9##2##(1991-12#1)(1993-2#1)(1996-3#1)(1997-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
on pulse duration##2##3##(1991-2#1)(2007-11#1)
on pulse##3##2##(1991-2#1)(2007-11#2)
on pump power##2##3##(2008-3#2)
on pump##4##2##(2008-2#1)(2008-3#3)
on pure water absorption##2##4##(2008-3#2)
on pure##4##2##(1997-6#1)(2008-3#2)(2008-8#1)
on purified##2##2##(2008-10#1)(2009-6#1)
on purine##3##2##(1996-5#1)(1997-7#1)(2008-9#1)
on purpose##2##2##(2008-10#1)(2012-3#1)
on pyrolytic graphite (PG) electrodes were##2##6##(2008-10#2)
on pyrolytic graphite (PG) electrodes##3##5##(2008-10#3)
on pyrolytic graphite (PG)##4##4##(2008-10#4)
on pythium##2##2##(2008-10#2)
on quadrat##3##2##(2008-10#3)
on qualitative##5##2##(2008-10#2)(2008-3#1)(2009-5#1)(2011-1#1)
on quality and cost##2##4##(1994-1#1)(1996-2#1)
on quality and##4##3##(1994-1#1)(1995-2#1)(1996-2#1)(2012-2#1)
on quality assessment##2##3##(1993-2#1)(2007-5#1)
on quality care##2##3##(2008-1#1)(2008-3#1)
on quality of care##4##4##(1992-1#1)(1996-1#1)(1996-12#1)(1997-3#1)
on quality of life and##4##5##(2008-7#1)(2009-5#1)(2012-1#1)(2012-3#1)
on quality of life of##2##5##(2008-4#1)(2012-3#1)
on quality of life##17##4##(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
on quality of##23##3##(1992-1#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#2)
on quality##37##2##(1992-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
on quantitative##10##2##(1990-12#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#1)
on quantum##2##2##(1992-8#1)(2009-6#1)
on quartz##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
on questions that##2##3##(1992-5#1)(1995-1#1)
on questions##5##2##(1992-1#1)(1992-5#1)(1995-1#1)(2008-1#1)(2008-11#1)
on quitting intentions in##2##4##(2010-2#2)
on quitting##3##2##(2010-2#2)(2011-2#1)
on radiance##2##2##(2008-3#2)
on radiation protection##2##3##(1995-1#1)(2012-2#1)
on radiation##7##2##(1994-2#1)(1995-1#1)(1996-11#1)(1997-8#1)(2008-7#1)(2008-9#1)(2012-2#1)
on radiograms##4##2##(2007-11#2)(2007-8#2)
on radiographic##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
on radiographs##3##2##(1992-5#1)(2011-2#1)(2013-1#1)
on radiologic##2##2##(1994-1#1)(2012-2#1)
on radiology##5##2##(1991-2#1)(1995-1#1)(2010-8#1)(2012-2#2)
on radish##2##2##(2008-10#1)(2008-12#1)
on random##6##2##(1997-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)
on randomized##3##2##(2007-10#1)(2007-7#1)(2008-12#1)
on range of motion##2##4##(2007-11#1)(2009-1#1)
on rapid and##2##3##(1991-2#1)(2008-10#1)
on rapid##3##2##(1991-2#1)(2008-10#2)
on rare variants##2##3##(2012-3#2)
on rare##4##2##(2008-10#2)(2012-3#2)
on rat hepatic##2##3##(1991-2#1)(1994-11#1)
on rat liver##3##3##(1992-12#1)(2008-10#2)
on rat##18##2##(1990-12#2)(1990-2#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#3)(2011-1#1)(2012-3#1)
on rates of##2##3##(2008-10#1)(2008-9#1)
on rational##3##2##(1993-2#1)(2008-7#1)(2009-6#1)
on rats##7##2##(1994-8#1)(2008-10#1)(2009-11#1)(2010-5#1)(2011-1#3)
on raw##2##2##(2008-10#1)(2008-8#1)
on reaction with##5##3##(2008-10#3)(2010-8#1)(2011-1#1)
on reaction##13##2##(1992-3#1)(2008-10#3)(2008-4#1)(2009-12#1)(2009-2#4)(2010-8#1)(2011-1#1)(2013-1#1)
on reading##6##2##(2008-11#1)(2008-12#2)(2008-5#1)(2010-12#1)(2013-8#1)
on real data##2##3##(2009-5#1)(2011-2#1)
on real samples##5##3##(2008-10#5)
on real##15##2##(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
on real-life##2##2##(2012-1#1)(2013-1#1)
on real-time##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
on recent advances in the##2##5##(2008-7#1)(2009-8#1)
on recent advances in##3##4##(2008-7#1)(2009-8#1)(2012-3#1)
on recent advances##4##3##(2008-10#1)(2008-7#1)(2009-8#1)(2012-3#1)
on recent developments##2##3##(1996-3#1)(2011-2#1)
on recent findings##4##3##(1991-3#1)(2008-1#1)(2011-1#1)(2011-2#1)
on recent progress##2##3##(1990-6#1)(2009-7#1)
on recent studies##2##3##(1996-1#1)(2013-1#1)
on recent##34##2##(1990-6#1)(1991-3#1)(1993-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#4)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)
on recently dead chestnut wood##2##5##(2008-10#2)
on recently##6##2##(2008-10#2)(2008-5#1)(2010-9#1)(2012-2#2)
on receptor activator of##2##4##(2011-1#1)(2013-1#1)
on receptor##5##2##(1991-12#1)(1993-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
on receptor-ligand##2##2##(1995-11#1)(2009-2#1)
on recognition##4##2##(1997-7#1)(2007-8#1)(2008-6#1)(2009-11#1)
on recombinant protein expression##2##4##(2008-11#1)(2008-7#1)
on recombinant protein##3##3##(2008-11#2)(2008-7#1)
on recombinant##6##2##(1992-10#1)(1995-11#1)(1995-2#1)(2008-11#2)(2008-7#1)
on recording##2##2##(2008-3#2)
on recovery from##5##3##(1990-7#1)(1991-2#1)(2010-7#1)(2012-2#1)(2013-8#1)
on recovery of##3##3##(1990-7#2)(1991-2#1)
on recovery##13##2##(1990-7#3)(1991-2#2)(1991-5#1)(2008-10#2)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
on recurrent##2##2##(1993-8#1)(2008-11#1)
on red##7##2##(1992-12#1)(1994-3#1)(2008-10#3)(2008-5#1)(2008-8#1)
on reduced##3##2##(1991-9#1)(1997-6#1)(2007-12#1)
on reducing the##2##3##(2007-8#1)(2008-10#1)
on reducing their##2##3##(2008-8#1)(2010-9#1)
on reducing##13##2##(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)
on reduction of##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
on reduction##4##2##(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#1)
on reflectance data##2##3##(2008-2#2)
on reflectance measurements##2##3##(2008-10#1)(2008-3#1)
on reflectance##6##2##(2008-10#2)(2008-2#2)(2008-3#2)
on reflection from##3##3##(2007-11#2)(2008-3#1)
on reflection##11##2##(2007-11#4)(2008-11#1)(2008-2#4)(2008-3#2)
on reflux##2##2##(1992-9#1)(2008-10#1)
on regional##3##2##(1991-10#1)(1992-12#1)(2006-10#1)
on regular##7##2##(2007-7#2)(2008-1#2)(2008-11#2)(2008-8#1)
on regulation of##3##3##(1992-11#1)(2008-7#1)(2010-10#1)
on regulation##4##2##(1991-12#1)(1992-11#1)(2008-7#1)(2010-10#1)
on regulatory##3##2##(1995-5#1)(2008-7#1)(2008-8#1)
on rehabilitation outcome##2##3##(2007-11#1)(2007-8#1)
on rehabilitation##4##2##(1995-5#1)(2007-11#1)(2007-8#1)(2009-8#1)
on related##2##2##(1995-2#1)(2010-10#1)
on relationships##3##2##(2008-11#1)(2010-9#1)(2013-1#1)
on relative abundance##2##3##(2012-6#2)
on relative##8##2##(1994-9#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-6#2)
on relatively##4##2##(1995-3#1)(2008-10#2)(2008-5#1)
on relaxation##2##2##(1994-8#1)(2008-5#1)
on release of##3##3##(1995-3#1)(1997-7#1)(2008-4#1)
on relevant##6##2##(1996-2#1)(1996-3#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-2#1)
on religion and##2##3##(2009-11#1)(2009-7#1)
on remote sensing##2##3##(2008-2#1)(2013-8#1)
on renal function##5##3##(1992-8#1)(2007-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
on renal gluconeogenesis is##2##4##(1994-8#2)
on renal replacement therapy##2##4##(2007-7#1)(2011-2#1)
on renal transplantation##3##3##(2007-12#1)(2008-1#2)
on renal##17##2##(1992-8#1)(1994-8#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-12#1)(2011-2#3)(2011-3#1)(2012-3#1)
on replacement##2##2##(2011-2#2)
on reports##2##2##(1992-12#1)(2012-2#1)
on representative##2##2##(2008-10#1)(2008-3#1)
on reproduction##3##2##(2008-4#1)(2008-8#1)(2010-5#1)
on reproductive health##4##3##(2008-1#2)(2008-11#2)
on reproductive performance##2##3##(1996-1#1)(2010-8#1)
on reproductive##8##2##(1996-1#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#1)(2010-8#1)
on request##3##2##(1996-11#1)(2008-3#1)(2008-7#1)
on research and##2##3##(1995-1#1)(1995-2#1)
on research in##2##3##(2008-3#1)(2010-12#1)
on research##14##2##(1994-9#1)(1995-1#2)(1995-2#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-12#1)(2013-1#1)
on researchers##2##2##(1991-12#1)(2008-6#1)
on residents##2##2##(1991-8#1)(2007-7#1)
on residual##3##2##(2007-11#1)(2009-8#1)(2013-1#1)
on residues##3##2##(2008-10#3)
on resin##2##2##(2008-10#1)(2008-12#1)
on resistance to##4##3##(2008-10#3)(2008-8#1)
on resistance##9##2##(2008-10#4)(2008-8#2)(2012-3#2)(2013-1#1)
on resistant cultivars##2##3##(2008-10#2)
on resistant##7##2##(2008-10#6)(2011-2#1)
on resolution##3##2##(2008-10#2)(2012-3#1)
on resonance##3##2##(2008-10#3)
on resource allocation##2##3##(2008-11#1)(2008-8#1)
on resource##7##2##(1997-3#1)(2008-11#1)(2008-8#3)(2008-9#1)(2010-8#1)
on resources##2##2##(1991-1#1)(2008-12#1)
on respiration##3##2##(2008-12#1)(2009-5#1)(2012-2#1)
on respiratory##3##2##(1990-2#1)(1991-6#1)(2008-7#1)
on responding with conditioned reinforcement##2##5##(1993-6#2)
on response##8##2##(1993-6#1)(1996-5#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-12#1)(2013-7#1)
on responses to##3##3##(1992-12#1)(1996-3#1)(1997-4#1)
on responses##4##2##(1992-12#1)(1992-3#1)(1996-3#1)(1997-4#1)
on resting##4##2##(1993-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
on restoration##2##2##(2008-3#1)(2008-5#1)
on restriction fragment length##2##4##(2008-10#1)(2008-5#1)
on restriction##3##2##(1997-6#1)(2008-10#1)(2008-5#1)
on restructuring##3##2##(1992-12#1)(1993-2#1)(1996-12#1)
on results from##4##3##(1991-6#1)(2007-12#1)(2008-10#1)(2010-10#1)
on results obtained##4##3##(2008-10#1)(2009-8#1)(2011-2#2)
on results of##6##3##(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-2#2)
on results##16##2##(1991-6#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-8#1)(2010-10#2)(2011-2#2)(2012-2#2)
on retention and selectivity of##2##5##(2008-10#2)
on retention and##3##3##(2008-10#2)(2012-2#1)
on retention of##3##3##(1993-5#3)
on retention##10##2##(1993-5#3)(2008-10#6)(2012-2#1)
on retinal##4##2##(1992-3#1)(1994-5#1)(2008-3#1)(2013-1#1)
on retrieval and relearning##2##4##(1995-12#2)
on retrievals##3##2##(2008-2#1)(2008-3#2)
on retrieved##3##2##(2008-2#1)(2008-3#2)
on retrospective studies##2##3##(2008-7#1)(2012-3#1)
on retrospective##4##2##(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
on reversed-phase##4##2##(1990-5#1)(1996-5#2)(2008-5#1)
on reversing##2##2##(1993-12#1)(2008-11#1)
on reward-related brain function##2##4##(2013-8#2)
on reward-related##3##2##(1993-6#1)(2013-8#2)
on rhizosphere colonization##2##3##(2008-10#2)
on rhizosphere##3##2##(2008-10#3)
on rice (Oryza##2##3##(1996-12#1)(2008-10#1)
on rice chromosome##3##3##(1996-10#1)(2008-10#1)(2008-8#1)
on rice line##2##3##(2008-10#2)
on rice plants##2##3##(2008-10#1)(2013-8#1)
on rice##17##2##(1996-10#1)(1996-12#1)(2008-10#11)(2008-12#1)(2008-8#2)(2013-8#1)
on right##3##2##(2006-10#1)(2010-4#1)(2011-2#1)
on rights and##2##3##(2008-11#1)(2009-10#1)
on risk factors##5##3##(1993-12#1)(1996-3#1)(1997-1#1)(2009-10#1)(2012-12#1)
on risk of cancer##2##4##(1994-2#1)(2008-11#1)
on risk of##3##3##(1994-2#1)(1997-8#1)(2008-11#1)
on risk##16##2##(1992-3#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-5#1)(2012-1#1)(2012-12#1)
on risky##2##2##(2007-12#1)(2009-4#1)
on room air and##2##4##(2007-12#1)(2010-7#1)
on room air##3##3##(2007-12#1)(2010-7#2)
on root##5##2##(2008-10#3)(2008-12#1)(2010-5#1)
on roots of wheat grown in##2##6##(2008-10#2)
on roots of wheat##4##4##(2008-10#4)
on roots of##7##3##(2008-10#7)
on roots##12##2##(2008-10#12)
on rough lemon##2##3##(2008-10#2)
on routine##6##2##(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
on row distances##2##3##(2008-12#2)
on row##3##2##(2008-12#3)
on rural##4##2##(1991-1#1)(1994-2#1)(2011-1#1)(2013-1#1)
on rye##3##2##(2008-10#3)
on safe##4##2##(1996-6#1)(1997-6#1)(2013-1#2)
on safety##7##2##(1993-3#1)(1994-5#1)(2007-10#1)(2008-11#3)(2010-6#1)
on sample preparation##2##3##(2008-10#1)(2009-4#1)
on sample##9##2##(2008-10#4)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)
on samples of##2##3##(2008-10#1)(2008-2#1)
on samples##10##2##(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
on sampling##3##2##(2008-10#2)(2012-3#1)
on sand##2##2##(2011-2#1)(2013-1#1)
on saphenous vein##3##3##(1996-2#2)(2007-8#1)
on scanning##2##2##(2008-10#1)(2008-2#1)
on scar##3##2##(2007-11#2)(2008-9#1)
on scats of##2##3##(2008-5#2)
on scattering##2##2##(2008-2#2)
on schedule##3##2##(1997-2#1)(2008-7#1)(2010-8#1)
on schizophrenia##2##2##(1997-5#1)(2012-1#1)
on school outcomes##2##3##(2009-7#1)(2012-2#1)
on school##4##2##(2009-7#1)(2012-2#2)(2013-8#1)
on science##2##2##(2011-1#1)(2013-1#1)
on scientific##5##2##(1992-6#1)(1994-2#1)(1994-6#1)(2008-7#1)(2008-9#1)
on sclerotia viability and##2##4##(2008-10#2)
on screen-printed carbon##2##3##(2008-10#2)
on screening and##2##3##(2007-4#1)(2008-10#1)
on screening##4##2##(1993-3#1)(2007-4#1)(2008-10#1)(2011-2#1)
on second##4##2##(2008-10#3)(2008-12#1)
on second-order##3##2##(2007-12#1)(2008-2#2)
on secondary##4##2##(1991-3#1)(1994-2#1)(2007-11#1)(2008-4#1)
on sections from##2##3##(1990-12#1)(2008-7#1)
on sections##3##2##(1990-12#1)(1997-7#1)(2008-7#1)
on seed germination##4##3##(2008-12#2)(2008-7#1)(2008-8#1)
on seed##7##2##(2008-10#1)(2008-12#3)(2008-7#1)(2008-8#2)
on seedling##5##2##(2008-10#4)(2008-5#1)
on seedlings of##3##3##(2008-10#2)(2008-8#1)
on seedlings##6##2##(2008-10#5)(2008-8#1)
on seeds##2##2##(2008-5#1)(2011-1#1)
on segments of##2##3##(2008-10#2)
on seizure##3##2##(1997-3#3)
on selected##14##2##(1991-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#2)
on selection of the##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
on selection of##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
on selection##8##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
on selective media##3##3##(2008-10#3)
on selective##8##2##(2007-8#1)(2008-10#7)
on selectivity of##2##3##(1995-3#1)(2008-10#1)
on selectivity##5##2##(1995-3#1)(2008-10#4)
on selenium (Se)##2##3##(2011-1#1)(2011-2#1)
on selenium##4##2##(2009-10#1)(2011-1#1)(2011-2#2)
on self-assembled monolayers##2##3##(2008-10#2)
on self-assembled##7##2##(2008-10#6)(2010-4#1)
on self-report##3##2##(2008-12#1)(2010-8#1)(2011-1#1)
on self-reported##5##2##(1991-6#1)(1994-2#1)(2008-4#1)(2009-11#1)(2012-1#1)
on semiconductors##2##2##(2008-3#1)(2012-2#1)
on sensing##3##2##(2008-10#2)(2008-11#1)
on sensitive##3##2##(1991-2#1)(2008-10#2)
on sensitivity to##2##3##(1997-7#1)(2008-2#1)
on sensitivity##7##2##(1997-7#1)(2008-10#4)(2008-2#2)
on sensitizing potency##2##3##(2008-5#2)
on sensitizing##3##2##(2008-5#3)
on sensor##3##2##(2008-10#3)
on sensory and##2##3##(1995-5#1)(2007-12#1)
on sensory##5##2##(1995-5#1)(2006-12#1)(2007-12#1)(2008-5#1)(2011-2#1)
on separate##7##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
on separation##8##2##(2008-10#8)
on separations of##2##3##(1994-9#2)
on sequence comparisons##2##3##(1990-12#1)(2008-10#1)
on sequence information##2##3##(2008-7#1)(2011-2#1)
on sequence##14##2##(1990-12#1)(1995-6#1)(1996-10#1)(1997-8#1)(2008-10#6)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
on sequences##7##2##(1991-6#1)(1992-4#1)(2007-11#1)(2008-10#3)(2011-2#1)
on sequential##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-2#1)(2010-7#1)
on serial##5##2##(1990-12#1)(1996-6#1)(1997-2#1)(2008-11#1)(2013-8#1)
on serine and##2##3##(1991-2#1)(2008-4#1)
on serine##6##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-8#1)(2008-4#1)(2008-8#1)
on serum adiponectin levels in children with vitamin##2##8##(2011-1#2)
on serum concentrations of##2##4##(1995-2#1)(1996-11#1)
on serum lipid##2##3##(2008-10#1)(2008-3#1)
on serum##26##2##(1992-11#1)(1992-9#1)(1993-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
on service delivery##2##3##(1993-1#1)(1995-3#1)
on service quality##2##3##(1994-2#1)(1995-3#1)
on service##5##2##(1991-3#1)(1993-1#1)(1994-2#1)(1995-3#2)
on seven##12##2##(1990-12#1)(1996-3#1)(2008-10#4)(2008-12#2)(2008-9#2)(2010-10#1)(2013-7#1)
on several aspects of##2##4##(1997-1#1)(2008-11#1)
on several components##2##3##(2008-10#1)(2010-6#1)
on several different##2##3##(1996-3#1)(2008-10#1)
on several occasions##2##3##(1995-5#1)(2010-8#1)
on several other##2##3##(2008-10#1)(2008-4#1)
on several tumor##2##3##(1990-11#1)(2009-3#1)
on several types of##2##4##(2008-10#1)(2010-1#1)
on several##47##2##(1990-11#1)(1990-5#1)(1991-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-1#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-12#1)(2009-3#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
on severe##2##2##(2008-10#1)(2010-2#1)
on severity and##2##3##(2007-7#1)(2008-10#1)
on severity of##5##3##(1996-1#1)(1996-7#1)(2008-10#1)(2009-5#1)(2011-1#1)
on severity##11##2##(1996-1#1)(1996-7#1)(2007-7#1)(2008-10#3)(2009-5#1)(2011-1#2)(2011-3#1)(2013-1#1)
on sex differences in##3##4##(2008-8#2)(2008-9#1)
on sex##8##2##(1991-12#1)(1994-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-3#2)
on sexual behavior##2##3##(1991-2#1)(2012-1#1)
on sexual behaviour##3##3##(1996-6#1)(2008-11#1)(2011-1#1)
on sexual differentiation##2##3##(2008-5#2)
on sexual function##2##3##(2009-5#2)
on sexual orientation and##2##4##(1996-5#1)(2008-12#1)
on sexual selection##2##3##(2008-8#2)
on sexual##17##2##(1991-2#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-5#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
on shape##2##2##(2008-6#2)
on ships##2##2##(2008-10#1)(2008-11#1)
on shoots##2##2##(2008-10#2)
on short length scales##2##4##(2008-7#2)
on short##8##2##(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#3)
on short-term##3##2##(1996-2#1)(2008-1#1)(2008-8#1)
on sialylation of##2##3##(2008-7#2)
on side effects##3##3##(1991-6#1)(1993-2#1)(1993-3#1)
on side##4##2##(1991-6#1)(1993-2#1)(1993-3#1)(2011-1#1)
on signal transduction##2##3##(2009-8#1)(2010-11#1)
on signal##10##2##(1992-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#2)(2011-2#1)
on signaling##2##2##(2008-10#1)(2009-3#1)
on signals of##4##3##(2008-10#1)(2008-8#3)
on significant##5##2##(1991-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
on silencing##2##2##(2010-1#1)(2011-1#1)
on silica gel and##3##4##(2008-10#2)(2013-8#1)
on silica gel##20##3##(2008-10#17)(2008-11#1)(2010-4#1)(2013-8#1)
on silica is##2##3##(2008-10#2)
on silica surface were##2##4##(2008-10#2)
on silica surface##3##3##(2008-10#3)
on silica##43##2##(1996-5#1)(2007-11#3)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)(2013-8#1)
on silicon surfaces##2##3##(2008-7#2)
on silicon wafers##2##3##(2007-11#1)(2008-3#1)
on silicon##14##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-7#3)(2009-10#1)
on silk fibroin##2##3##(2008-11#2)
on silver##7##2##(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
on similar##4##2##(2008-10#1)(2008-9#2)(2010-5#1)
on similarities in##2##3##(1997-7#1)(2008-1#1)
on simple and##2##3##(2008-6#1)(2012-1#1)
on simple##14##2##(1990-9#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#2)(2009-11#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
on simulated##6##2##(2008-3#2)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#1)
on simultaneous##6##2##(1997-7#1)(2007-12#1)(2008-10#3)(2008-6#1)
on single##10##2##(1990-8#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#2)(2012-2#1)
on site A##3##3##(1996-2#3)
on site B##2##3##(1996-2#2)
on site##13##2##(1996-2#5)(2008-10#5)(2008-11#2)(2013-8#1)
on six##10##2##(1993-12#1)(1994-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-9#1)
on size and##2##3##(2007-5#1)(2008-3#1)
on size##8##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2012-12#1)
on size-exclusion chromatography##2##3##(1992-9#2)
on skeletal muscle##3##3##(2008-5#2)(2013-1#1)
on skeletal##4##2##(2008-5#2)(2013-1#2)
on skin barrier##2##3##(2008-5#2)
on skin carcinogenesis##2##3##(1993-9#2)
on skin penetration##2##3##(2008-3#1)(2013-1#1)
on skin##28##2##(1992-8#1)(1993-9#2)(1997-3#3)(2008-3#1)(2008-5#16)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
on sky##2##2##(2007-12#1)(2008-3#1)
on sleep##7##2##(1990-5#1)(1995-12#1)(2007-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
on slowing##2##2##(2008-12#1)(2012-12#1)
on small##16##2##(1993-12#1)(1994-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
on smoking cessation##2##3##(1994-2#1)(2009-7#1)
on smoking for##2##3##(1995-6#2)
on smoking##13##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-2#1)(1995-6#3)(1996-3#1)(2008-10#2)(2009-7#1)
on smooth muscle##2##3##(1991-5#1)(1991-8#1)
on smooth##3##2##(1991-5#1)(1991-8#1)(2007-12#1)
on social and##2##3##(2008-11#1)(2008-12#1)
on social support and##2##4##(1992-3#1)(2010-3#1)
on social support in##2##4##(1992-3#2)
on social support##4##3##(1992-3#3)(2010-3#1)
on social##18##2##(1992-3#3)(1995-5#1)(1996-11#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
on society##2##2##(2008-1#1)(2012-2#1)
on sodium and glucose##2##4##(1994-6#2)
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis##2##6##(1990-11#1)(1992-12#1)
on sodium##8##2##(1990-11#1)(1992-12#1)(1992-6#1)(1994-6#2)(1995-3#1)(1997-4#2)
on soft agar##2##3##(2008-8#2)
on soft substrates for use as##2##6##(2009-11#2)
on soft substrates##3##3##(2009-11#3)
on soft##9##2##(2008-10#2)(2008-5#1)(2008-8#2)(2009-11#3)(2012-2#1)
on soil microbial##2##3##(2008-10#2)
on soil pH##2##3##(2008-12#1)(2012-6#1)
on soil texture##2##3##(2008-10#2)
on soil##21##2##(2008-10#12)(2008-12#2)(2008-6#1)(2008-9#2)(2010-5#1)(2010-8#1)(2012-6#1)(2012-9#1)
on solar elevation##2##3##(2008-2#1)(2008-3#1)
on solar##3##2##(2008-2#2)(2008-3#1)
on solid media##4##3##(1994-6#1)(1997-4#1)(2008-2#1)(2008-9#1)
on solid phase##8##3##(1997-4#1)(2008-10#6)(2008-4#1)
on solid samples##2##3##(2008-10#2)
on solid sorbents##2##3##(2008-10#2)
on solid substrates##2##3##(2008-10#1)(2009-6#1)
on solid supports##3##3##(1997-3#1)(2008-10#2)
on solid surfaces##2##3##(2008-4#1)(2009-11#1)
on solid##30##2##(1993-8#1)(1994-6#2)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#1)(2008-10#14)(2008-2#1)(2008-4#2)(2008-9#2)(2009-11#1)(2009-6#1)(2011-1#1)
on solid-phase extraction##6##3##(2008-10#6)
on solid-phase##12##2##(1992-6#1)(2008-10#9)(2008-2#2)
on solution##5##2##(2008-10#4)(2008-9#1)
on solutions containing##3##3##(2008-10#3)
on solutions##4##2##(1994-3#1)(2008-10#3)
on somatic##4##2##(1992-2#1)(1997-2#1)(2008-12#1)(2010-5#1)
on some agro-physiological traits of##2##5##(2008-12#2)
on some aspects of##4##4##(2008-12#1)(2009-10#1)(2011-1#1)(2012-12#1)
on some basic##3##3##(1991-12#1)(2008-4#1)(2008-8#1)
on some biochemical##2##3##(2008-12#2)
on some of the##8##4##(1992-12#1)(1993-12#1)(1994-2#1)(2007-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
on some physiological and##2##4##(2008-7#1)(2012-2#1)
on some physiological##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
on some recent##2##3##(1997-3#1)(2011-2#1)
on some##62##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
on sorghum##2##2##(2008-10#2)
on sorption##2##2##(2008-10#2)
on source plants##4##3##(2008-10#4)
on source##7##2##(2008-10#4)(2008-4#1)(2013-8#2)
on sources##2##2##(2009-10#1)(2010-5#1)
on soybean##13##2##(2008-10#12)(2008-8#1)
on space##4##2##(2008-2#1)(2008-8#3)
on spatial learning in the##2##5##(1993-12#1)(1994-8#1)
on spatial learning##4##3##(1991-7#1)(1993-12#1)(1994-8#1)(2012-2#1)
on spatial statistics##2##3##(2008-10#1)(2008-8#1)
on spatial##14##2##(1991-7#1)(1993-12#2)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2012-2#1)
on special##2##2##(1991-11#1)(2007-11#1)
on specialty##2##2##(1994-1#1)(2007-4#1)
on species diversity##2##3##(2008-9#1)(2009-2#1)
on species richness##3##3##(2008-8#3)
on species##13##2##(1992-11#1)(2007-5#2)(2008-8#5)(2008-9#1)(2009-2#1)(2012-9#1)(2013-1#1)(2013-7#1)
on specific##31##2##(1993-1#1)(1993-2#1)(1995-3#2)(1995-9#2)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-9#2)(2011-1#1)(2013-1#1)(2013-8#3)
on specimens from##2##3##(2008-5#1)(2009-11#1)
on specimens##5##2##(2008-10#2)(2008-5#1)(2008-6#1)(2009-11#1)
on spectral##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
on spectrophotometric##5##2##(2008-10#5)
on spectroscopic##3##2##(2007-12#2)(2008-10#1)
on speech perception##4##3##(2008-9#4)
on speech##7##2##(2007-7#1)(2008-2#2)(2008-9#4)
on spending##2##2##(1991-3#1)(1992-3#1)
on sperm parameters##2##3##(2008-12#2)
on sperm##9##2##(2007-12#2)(2008-12#2)(2008-4#2)(2012-3#1)(2013-1#1)(2013-8#1)
on spermidine and##2##3##(2009-6#2)
on spherical##2##2##(2008-2#1)(2008-3#1)
on spiked##6##2##(2008-10#5)(2008-12#1)
on spinal##5##2##(2007-11#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)
on splenic##3##2##(1990-3#1)(2008-10#2)
on spontaneous and##2##3##(1994-6#1)(2006-6#1)
on spontaneous##7##2##(1993-9#1)(1994-6#1)(1995-12#1)(1997-7#1)(2006-6#1)(2007-12#1)(2011-2#1)
on spore release of Bremia lactucae##2##6##(2008-10#2)
on spore release##4##3##(2008-10#4)
on spore##13##2##(2008-10#11)(2011-2#2)
on sport##2##2##(2009-1#1)(2013-1#1)
on sports##2##2##(1993-3#1)(2009-7#1)
on sporulation of Bremia lactucae##2##5##(2008-10#2)
on sporulation##3##2##(2008-10#3)
on spread of##3##3##(2008-10#2)(2008-9#1)
on spread##6##2##(1996-5#1)(2008-10#4)(2008-9#1)
on spring##2##2##(1990-8#1)(2008-10#1)
on stability and##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
on stability##6##2##(2007-11#1)(2008-10#2)(2008-9#2)(2013-8#1)
on stabilizing##2##2##(1993-11#1)(2008-7#1)
on stable##3##2##(1996-12#1)(2008-6#1)(2008-8#1)
on staff##3##2##(1994-3#1)(2008-10#1)(2010-5#1)
on stainless steel##2##3##(2010-4#1)(2011-2#1)
on stainless##3##2##(2010-4#1)(2011-2#2)
on standard##15##2##(1991-12#1)(1993-9#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-1#1)
on standardized##6##2##(2007-10#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
on standing##2##2##(2008-10#1)(2010-10#1)
on state and local##2##4##(1993-2#1)(2011-9#1)
on state##3##2##(1993-2#1)(1997-1#1)(2011-9#1)
on static##2##2##(1993-12#1)(2008-9#1)
on statin therapy##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
on stationary phases of different polarity##2##6##(2008-10#2)
on statistical##7##2##(2008-10#3)(2008-11#2)(2008-3#2)
on steady-state##2##2##(1995-12#1)(2008-3#1)
on stem##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
on stems##2##2##(2008-10#2)
on steroid##2##2##(2008-10#1)(2008-7#1)
on steroids and##2##3##(1995-10#1)(2013-1#1)
on steroids##3##2##(1995-10#2)(2013-1#1)
on stochastic##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
on stomach##3##2##(1996-12#2)(1997-7#1)
on stomatal guard##2##3##(2008-10#2)
on stomatal##3##2##(2008-10#2)(2008-8#1)
on strategic management##3##3##(1992-12#1)(1993-12#2)
on strategic##5##2##(1992-12#1)(1993-12#2)(1993-2#1)(1995-2#1)
on strategies##3##2##(1993-3#1)(1995-12#1)(2012-12#1)
on stratospheric and##2##3##(2008-2#1)(2008-3#1)
on stratospheric##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
on stratum corneum##4##3##(2008-10#1)(2008-5#3)
on strawberry and##2##3##(2008-10#2)
on strawberry leaves##3##3##(2008-10#3)
on strawberry##14##2##(2008-10#13)(2008-12#1)
on strength and##2##3##(2007-8#1)(2012-2#1)
on strength##4##2##(2007-8#1)(2008-5#2)(2012-2#1)
on stress##3##2##(1994-12#1)(1994-2#1)(2013-1#1)
on stripe rust##2##3##(2008-10#2)
on stripping##2##2##(2008-10#2)
on stroke##3##2##(1991-11#1)(2008-8#2)
on structural##7##2##(1991-8#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-12#1)
on structures##2##2##(1992-8#1)(2008-5#1)
on student##5##2##(1994-2#1)(2008-11#2)(2013-1#2)
on studies of the##2##4##(2008-7#1)(2009-7#1)
on studies of##6##3##(2008-10#2)(2008-11#2)(2008-7#1)(2009-7#1)
on studies with##2##3##(2008-7#1)(2012-12#1)
on studies##12##2##(2008-10#3)(2008-11#2)(2008-7#2)(2009-7#1)(2011-1#1)(2012-12#3)
on study##5##2##(1993-1#1)(1997-1#1)(2008-10#1)(2010-3#1)(2011-2#1)
on studying the##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
on subjective##7##2##(1991-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-1#2)
on subjects##2##2##(2008-11#1)(2008-5#1)
on subsequent##5##2##(1993-1#1)(1994-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
on subsets of##3##3##(1993-12#1)(2008-4#1)(2008-7#1)
on substance##4##2##(1994-3#1)(1994-8#1)(2008-4#1)(2009-7#1)
on substrate specificity##2##3##(1990-7#1)(2008-7#1)
on substrate##8##2##(1990-11#1)(1990-7#1)(1990-8#1)(1995-2#1)(1997-4#1)(2008-3#1)(2008-6#1)(2008-7#1)
on substrates##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
on successful##2##2##(2007-12#1)(2012-12#1)
on such interactions##2##3##(2008-10#2)
on such##19##2##(1994-1#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
on sucrose density gradients##2##4##(1992-12#1)(2008-4#1)
on sugar beet##2##3##(2008-10#2)
on sugar##5##2##(1994-6#1)(1995-9#1)(2008-10#2)(2008-6#1)
on suicidality##2##2##(2009-7#2)
on suicide##4##2##(1996-1#2)(2013-1#1)(2013-8#1)
on suitable##2##2##(2008-11#1)(2008-3#1)
on sun-exposed areas of the##2##5##(2010-6#1)(2010-8#1)
on sun-exposed areas##3##3##(2010-6#2)(2010-8#1)
on sun-exposed##4##2##(2010-6#2)(2010-8#1)(2011-2#1)
on sunny days##4##3##(2008-10#4)
on sunscreen##2##2##(2008-5#2)
on supercritical##3##2##(2008-10#2)(2010-10#1)
on superoxide##2##2##(1990-5#1)(1996-2#1)
on supply of##2##3##(2008-7#1)(2009-8#1)
on supply##3##2##(1992-1#1)(2008-7#1)(2009-8#1)
on support##2##2##(1996-3#2)
on suppression of##3##3##(2008-10#3)
on surface plasmon resonance##6##4##(2008-10#5)(2009-5#1)
on surface preparations##2##3##(1993-9#2)
on surface##20##2##(1993-9#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-7#1)(2009-11#1)(2009-5#1)(2012-2#1)(2012-7#1)(2013-8#1)
on surface-bound##2##2##(1997-2#2)
on surface-plasmon##5##2##(2008-2#1)(2008-3#4)
on surfaces of##5##3##(2008-10#3)(2008-6#1)(2013-8#1)
on surfaces##17##2##(1990-8#1)(1997-3#1)(2007-11#4)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-5#1)(2013-8#2)
on surfactant##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
on surgery##2##2##(1997-3#1)(2008-11#1)
on surgical##7##2##(1993-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-7#1)(2012-3#1)
on surveillance##4##2##(1996-1#1)(2007-12#1)(2008-6#1)(2011-2#1)
on survival and##3##3##(2008-8#1)(2011-2#1)(2013-7#1)
on survival in##2##3##(2007-5#1)(2008-7#1)
on survival of##7##3##(1994-2#1)(2008-10#5)(2008-7#1)
on survival or##4##3##(1995-2#1)(2008-8#1)(2008-9#2)
on survival time##3##3##(1994-2#1)(2007-11#2)
on survival times##2##3##(2008-10#1)(2012-12#1)
on survival##37##2##(1990-12#1)(1990-2#1)(1994-2#2)(1995-2#2)(1997-5#1)(2007-11#2)(2007-5#2)(2008-10#8)(2008-2#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)
on survivors of##2##3##(1995-11#1)(2008-11#1)
on survivorship of##2##3##(2008-9#1)(2011-2#1)
on susceptibility##4##2##(1996-5#1)(2008-10#3)
on susceptible cultivars##3##3##(2008-10#3)
on susceptible##14##2##(2008-10#12)(2008-9#1)(2011-2#1)
on suspended carriers##2##3##(2008-7#2)
on suspended##4##2##(2008-10#1)(2008-2#1)(2008-7#2)
on sustained##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
on swards##2##2##(2008-10#2)
on swine##2##2##(2008-10#1)(2013-8#1)
on sympathetic##2##2##(1990-12#1)(2008-7#1)
on symptom expression##3##3##(2008-10#3)
on symptom##5##2##(2008-10#5)
on symptomless strawberry##2##3##(2008-10#2)
on symptomless##3##2##(2008-10#3)
on symptoms of##4##3##(2008-10#1)(2010-12#1)(2013-1#2)
on symptoms##6##2##(2008-10#3)(2010-12#1)(2013-1#2)
on synaptic##2##2##(1996-5#1)(2009-8#1)
on synchronization of##3##3##(2007-11#2)(2008-11#1)
on synthesis##3##2##(1995-2#1)(2008-4#1)(2012-1#1)
on synthesized##3##2##(2008-3#2)(2009-10#1)
on synthetic data##2##3##(2008-3#1)(2012-12#1)
on synthetic samples prepared with the##2##6##(2008-10#2)
on synthetic samples prepared##4##4##(2008-10#4)
on synthetic samples##5##3##(2008-10#5)
on synthetic##13##2##(1990-6#1)(2008-10#6)(2008-3#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
on system##3##2##(1990-11#1)(2008-3#1)(2008-9#1)
on systematic reviews##2##3##(2007-5#1)(2011-2#1)
on systematic##5##2##(2007-11#1)(2007-5#1)(2010-10#1)(2011-2#1)(2012-3#1)
on systemic and##2##3##(1992-8#1)(2008-10#1)
on systemic##6##2##(1992-5#1)(1992-8#1)(2008-10#2)(2008-12#1)(2009-8#1)
on systems##2##2##(2013-8#2)
on tNOX##2##2##(2009-9#2)
on tall fescue##4##3##(2008-10#4)
on tall##5##2##(2008-10#4)(2009-2#1)
on tapered##2##2##(2007-12#1)(2008-10#1)
on target cells##4##3##(1990-8#1)(1991-9#1)(1993-3#1)(2008-12#1)
on target genes and##2##4##(2008-4#1)(2011-2#1)
on target##13##2##(1990-8#1)(1991-9#1)(1992-6#1)(1993-3#2)(1996-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
on targets##2##2##(2009-8#1)(2013-1#1)
on tasks##4##2##(2008-11#1)(2009-2#1)(2012-1#2)
on teaching clinical chemistry##2##4##(1994-12#2)
on teaching##9##2##(1994-12#3)(1995-2#1)(2008-10#1)(2008-11#3)(2011-2#1)
on technological and##2##3##(2008-9#1)(2010-12#1)
on technology and##2##3##(1992-1#1)(2008-12#1)
on technology##3##2##(1992-1#1)(1994-12#1)(2008-12#1)
on teicoplanin##4##2##(2008-10#4)
on temperature and##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
on temperature in the##2##4##(2008-10#2)
on temperature was##2##3##(2007-11#1)(2008-10#1)
on temperature##22##2##(1992-6#1)(1993-1#1)(1996-2#4)(2007-11#3)(2008-10#7)(2008-3#4)(2008-8#1)(2011-2#1)
on temporal##7##2##(1993-1#1)(2007-11#1)(2008-3#1)(2008-8#2)(2009-5#1)(2011-2#1)
on ten##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-10#2)
on tensile##2##2##(2008-12#1)(2012-2#1)
on testing##2##2##(2008-10#1)(2013-8#1)
on tests of##4##3##(1993-12#1)(1995-11#2)(2007-8#1)
on tests##5##2##(1993-12#1)(1995-11#2)(2007-8#2)
on thallium##2##2##(1996-2#1)(2008-10#1)
on that of##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
on that side##2##3##(2008-10#1)(2009-6#1)
on that##18##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
on the &quot##7##3##(1993-9#1)(1994-5#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
on the 1##7##3##(1991-9#1)(1993-11#4)(2008-10#1)(2012-2#1)
on the 11##3##3##(2008-10#2)(2011-2#1)
on the 1st##2##3##(1990-12#1)(2008-10#1)
on the 2##2##3##(2007-12#1)(2008-10#1)
on the 3'##3##3##(1993-12#1)(1993-6#1)(2008-9#1)
on the 30th##2##3##(2008-12#1)(2012-3#1)
on the 4##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
on the 4th day##2##4##(2008-10#2)
on the 4th##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
on the 5' end of the##2##6##(2008-10#1)(2008-9#1)
on the 5'##5##3##(1993-12#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-9#1)
on the 5th day##2##4##(2007-10#1)(2008-11#1)
on the 7th##2##3##(2007-2#1)(2008-10#1)
on the 9th##2##3##(2008-11#1)(2008-12#1)
on the AFM##2##3##(2007-12#1)(2008-2#1)
on the American##3##3##(2008-11#1)(2008-4#1)(2012-3#1)
on the Atlantic##2##3##(2008-10#1)(2012-12#1)
on the Au surface##2##4##(2008-10#2)
on the B##2##3##(1996-2#1)(2008-10#1)
on the BMI##2##3##(2007-8#1)(2008-3#1)
on the C##2##3##(2008-5#1)(2013-1#1)
on the CALUX##2##3##(2008-10#2)
on the CCD##3##3##(2007-12#1)(2008-3#2)
on the CL reaction between luminol##2##6##(2008-10#2)
on the CL reaction of##4##5##(2008-10#4)
on the CL reaction##6##4##(2008-10#6)
on the CL##9##3##(2008-10#9)
on the CR lever##2##4##(1993-6#2)
on the Ca(2+)-activated##2##3##(1992-6#1)(1997-2#1)
on the Canadian##2##3##(1995-2#1)(2007-12#1)
on the Collins test##2##4##(1994-8#2)
on the DNA##9##3##(1993-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
on the DOF##4##3##(2010-8#4)
on the Development of##2##4##(2008-10#2)
on the Dimension clinical chemistry system##2##6##(2008-10#2)
on the Dimension##3##3##(2008-10#3)
on the Dimension((R))##2##3##(2008-10#2)
on the EGFR##2##3##(2008-4#1)(2008-5#1)
on the Earth##3##3##(1997-5#2)(2011-2#1)
on the European##2##3##(2008-5#1)(2013-8#1)
on the Faraday effect for measuring ac##2##7##(2008-3#2)
on the Five Factor##2##4##(2011-1#2)
on the GCE##2##3##(2008-10#1)(2013-1#1)
on the GH##2##3##(2008-7#1)(2011-1#1)
on the GPU##2##3##(2011-1#1)(2013-8#1)
on the GaAs##2##3##(2009-11#2)
on the Genetic##2##3##(2008-10#1)(2012-3#1)
on the Geriatric Depression Scale##2##5##(2007-10#1)(2008-7#1)
on the Global##2##3##(2008-12#1)(2008-3#1)
on the HPLC##4##3##(1990-8#2)(2008-5#1)(2008-6#1)
on the IL-1##2##3##(1995-2#1)(2007-11#1)
on the Internet##17##3##(1995-12#1)(1996-12#3)(1996-2#1)(1996-8#1)(2007-2#1)(2008-11#3)(2008-2#1)(2008-4#1)(2009-5#2)(2010-12#1)(2011-1#1)(2012-2#1)
on the Iowa##2##3##(2008-10#1)(2013-1#1)
on the Küplüce man made mounds##2##6##(2008-12#2)
on the LB films##3##4##(2008-11#3)
on the LB membranes##4##4##(2008-11#4)
on the LB##7##3##(2008-11#7)
on the LPP test##2##4##(1994-8#2)
on the Lambertian##2##3##(2008-2#1)(2008-3#1)
on the M side of##2##5##(2011-2#2)
on the MIMS response##2##4##(2008-10#2)
on the MMP-1##2##3##(2008-5#1)(2012-3#1)
on the MR##2##3##(1995-4#1)(1996-6#1)
on the MX line##2##4##(2008-10#2)
on the Mach-Zehnder##2##3##(2008-3#2)
on the Medical Ward##2##4##(1992-12#2)
on the Medicare program and##2##5##(1997-3#1)(2008-10#1)
on the Medicare##4##3##(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#1)
on the Mini Mental State##2##5##(2008-7#1)(2011-2#1)
on the Morris water##2##4##(1992-11#1)(2011-2#1)
on the N-terminal##7##3##(1991-10#1)(1993-9#1)(1994-12#1)(1995-2#1)(2008-6#1)(2009-2#1)(2012-2#1)
on the National##5##3##(1994-12#1)(1995-11#1)(1996-11#1)(2008-3#1)(2012-3#1)
on the Norwegian##2##3##(1991-6#1)(1997-6#1)
on the Olympus##3##3##(1992-6#3)
on the P##2##3##(2008-10#1)(2010-8#1)
on the Pacific##2##3##(1996-4#1)(2008-10#1)
on the Poincaré sphere##4##4##(2007-12#1)(2008-3#3)
on the Positive and Negative Syndrome Scale##2##7##(2008-6#1)(2011-1#1)
on the Pt##2##3##(2008-10#1)(2008-11#1)
on the R##2##3##(1995-3#1)(2008-2#1)
on the RA molecule##2##4##(2008-11#2)
on the RRE##4##3##(1993-8#4)
on the Raman##2##3##(2007-11#1)(2013-8#1)
on the S column##2##4##(1995-3#2)
on the S##3##3##(1995-3#2)(2008-12#1)
on the SAMs##2##3##(2008-10#2)
on the SM##2##3##(2008-5#2)
on the SPQ-B##2##3##(2008-1#2)
on the SPR sensor##2##4##(2008-10#1)(2008-4#1)
on the SPR##3##3##(2008-10#2)(2008-4#1)
on the SS##2##3##(2010-4#2)
on the Social Determinants of Health##2##6##(2010-12#1)(2011-1#1)
on the TSST-1 molecule##2##4##(1993-3#2)
on the US health care system##2##6##(2008-11#2)
on the Upper##2##3##(1993-6#1)(2008-2#1)
on the VAS##2##3##(2007-8#1)(2012-2#1)
on the Web##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2010-3#1)
on the West Fore Reef##3##5##(2007-5#3)
on the World Wide Web##3##5##(1996-11#1)(2008-10#1)(2008-4#1)
on the World##4##3##(1996-11#1)(2007-2#1)(2008-10#1)(2008-4#1)
on the World-Wide Web##2##4##(1996-12#1)(2008-3#1)
on the X chromosome##4##4##(1996-12#2)(2008-9#1)(2010-4#1)
on the X-ray##2##3##(1993-8#1)(2008-7#1)
on the Y-BOCS##2##3##(2008-3#2)
on the Zernike polynomials##3##4##(2008-3#3)
on the abaxial##2##3##(2008-10#1)(2008-5#1)
on the abdominal##2##3##(2007-12#1)(2011-2#1)
on the ability of a##5##5##(1991-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(2013-8#1)
on the ability of the##7##5##(1997-8#2)(2008-10#3)(2008-11#1)(2012-12#1)
on the ability of##33##4##(1990-11#1)(1991-12#1)(1991-3#1)(1992-4#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
on the ability to isolate##2##5##(2008-10#1)(2009-6#1)
on the ability to##11##4##(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-11#1)(2009-6#1)(2010-4#1)(2012-1#1)(2012-12#1)
on the ability##44##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-4#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
on the above parameters##2##4##(2007-11#1)(2013-1#1)
on the above##11##3##(1994-3#1)(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2012-2#1)(2013-1#1)
on the absolute##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
on the absorbance##5##3##(2008-10#5)
on the absorption of buagafuran in lumen##2##7##(2011-3#2)
on the absorption of buagafuran in##3##6##(2011-3#3)
on the absorption spectra of the complexes of##2##8##(2008-10#2)
on the absorption spectra of##3##5##(2008-10#3)
on the absorption spectrum of##2##5##(2008-2#1)(2008-5#1)
on the absorption spectrum##3##4##(2008-11#1)(2008-2#1)(2008-5#1)
on the absorption##14##3##(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-3#4)
on the academic performance##3##4##(2013-8#3)
on the academic##4##3##(2008-12#1)(2013-8#3)
on the accumulation of##4##4##(2008-10#3)(2008-5#1)
on the accumulation##5##3##(1994-6#1)(2008-10#3)(2008-5#1)
on the accuracy and##4##4##(2008-10#2)(2008-3#2)
on the accuracy of the##6##5##(2008-10#1)(2008-3#4)(2010-12#1)
on the accuracy of##13##4##(1993-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-9#1)(2010-12#1)(2011-1#1)
on the accuracy##21##3##(1993-9#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-3#10)(2008-9#1)(2010-12#1)(2011-1#1)
on the acquisition of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
on the actin##2##3##(1990-12#1)(2008-10#1)
on the action of##3##4##(1995-11#1)(1997-2#1)(1997-6#1)
on the action pattern of porcine pancreatic alpha-amylase##2##8##(1990-9#2)
on the action##7##3##(1990-9#2)(1995-11#1)(1997-2#1)(1997-6#1)(2008-4#2)
on the activated##2##3##(1994-8#1)(2008-10#1)
on the activation of##2##4##(1997-4#1)(2012-3#1)
on the activation##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
on the active site##2##4##(1990-5#1)(1994-8#1)
on the active##5##3##(1990-5#1)(1991-6#1)(1994-8#1)(2008-10#1)(2008-8#1)
on the activities of##5##4##(1990-8#1)(1993-9#1)(1994-8#1)(1995-5#1)(2008-10#1)
on the activities##6##3##(1990-8#1)(1993-9#1)(1994-8#1)(1995-5#1)(2008-10#1)(2013-1#1)
on the activity of the##6##5##(1993-9#1)(1994-6#1)(1995-6#1)(2008-10#1)(2010-9#1)(2013-1#1)
on the activity of##24##4##(1990-5#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
on the activity##28##3##(1990-5#1)(1992-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
on the actual##8##3##(1993-12#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
on the acute##2##3##(1994-12#1)(2012-2#1)
on the addition of##3##4##(1993-11#1)(2008-10#1)(2010-12#1)
on the adhesion##3##3##(2008-11#1)(2009-8#1)(2012-5#1)
on the adoption of##4##4##(1997-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
on the adrenal##2##3##(2011-1#1)(2011-2#1)
on the adsorbent##2##3##(2008-10#1)(2008-4#1)
on the adsorption of##6##4##(2008-10#6)
on the adsorption##10##3##(2008-10#9)(2011-2#1)
on the advantages of##3##4##(1996-11#2)(2008-3#1)
on the advantages##4##3##(1996-11#2)(2008-3#1)(2012-2#1)
on the aerosol##2##3##(2008-2#1)(2008-3#1)
on the affected##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
on the affinity of##2##4##(1994-5#2)
on the age of##2##4##(2008-9#1)(2013-1#1)
on the age##4##3##(1990-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
on the aggregation of##3##4##(1996-2#1)(2008-10#2)
on the alien##3##3##(2008-5#3)
on the alpha##4##3##(1992-12#2)(1994-5#1)(1995-11#1)
on the amino acid sequence##3##5##(1992-3#1)(1994-6#1)(1997-4#1)
on the amino acid##8##4##(1992-3#2)(1994-6#1)(1994-8#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-5#1)
on the amount of##19##4##(1990-2#1)(1991-8#1)(1993-8#1)(1994-12#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)
on the amount##22##3##(1990-2#1)(1991-8#1)(1992-3#1)(1993-8#1)(1994-12#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)
on the amperometric##3##3##(2008-10#3)
on the amplitude##2##3##(1997-4#1)(2010-3#1)
on the amplitudes of##3##4##(1997-2#2)(2008-2#1)
on the amygdala##2##3##(1992-8#1)(2008-6#1)
on the analysis of the##4##5##(2007-11#1)(2008-12#1)(2008-3#1)(2013-8#1)
on the analysis of##19##4##(1994-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2010-10#1)(2010-9#1)(2013-8#1)
on the analysis##21##3##(1994-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2010-10#1)(2010-12#1)(2010-9#1)(2013-8#1)
on the analyte##3##3##(2008-10#3)
on the analytical performance of the##2##6##(2008-10#2)
on the analytical signal##4##4##(2008-10#4)
on the analytical##13##3##(2008-10#11)(2008-3#1)(2011-2#1)
on the analyzed##3##3##(2008-10#1)(2009-10#1)(2012-3#1)
on the anatomical##3##3##(2009-11#1)(2009-2#1)(2013-8#1)
on the angle##2##3##(2008-1#1)(2008-3#1)
on the angular##2##3##(2008-2#1)(2008-3#1)
on the animal##2##3##(2008-4#1)(2010-1#1)
on the anisotropy##3##3##(1991-5#1)(2007-11#1)(2008-3#1)
on the antagonistic##2##3##(2008-12#1)(2008-9#1)
on the antenna of##2##4##(2007-12#1)(2008-10#1)
on the antenna##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
on the anterior##3##3##(1996-9#1)(2008-10#1)(2008-12#1)
on the aortic##2##3##(1990-11#1)(2010-8#1)
on the aperture size##2##4##(2007-12#1)(2008-2#1)
on the apical membrane of##2##5##(2008-4#1)(2008-6#1)
on the apical membrane##3##4##(2008-4#2)(2008-6#1)
on the apomorphine (0##2##4##(1995-12#2)
on the appearance of##4##4##(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)
on the applicability of##2##4##(1994-2#1)(1997-4#1)
on the application of a##3##5##(2008-10#2)(2008-3#1)
on the application of these##2##5##(2007-4#1)(2008-9#1)
on the application of##22##4##(1993-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on the application##23##3##(1993-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on the applications##2##3##(1990-8#1)(1994-1#1)
on the applied##8##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
on the approach to##3##4##(1993-6#1)(2008-10#1)(2008-4#1)
on the approach##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
on the approaches##2##3##(2008-12#1)(2008-5#1)
on the appropriate##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
on the aqueous two-phase system##2##5##(2008-10#1)(2008-6#1)
on the aqueous##4##3##(2008-10#2)(2008-6#1)(2009-4#1)
on the area of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
on the area##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
on the arrested heart##3##4##(2007-8#3)
on the arrested##5##3##(2007-12#1)(2007-8#4)
on the assay##3##3##(1992-9#1)(1993-8#1)(2008-1#1)
on the assessment and management of foot ulcers for people with diabetes##2##12##(2010-10#2)
on the assessment of##5##4##(2008-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2010-5#1)
on the assessment##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2010-10#2)(2010-5#1)
on the associated##2##3##(2008-5#1)(2013-8#1)
on the association between##7##4##(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#2)(2013-1#2)
on the association of the##2##5##(2008-3#1)(2010-12#1)
on the association of##6##4##(1991-4#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#2)
on the association##14##3##(1991-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
on the assumption of##3##4##(1994-2#1)(2008-10#2)
on the assumption that##13##4##(1992-12#1)(1992-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#1)
on the assumption##16##3##(1992-12#1)(1992-6#1)(1994-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#1)
on the assumptions of##2##4##(2008-3#1)(2013-7#1)
on the assumptions##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
on the atmospheric##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
on the atomic##2##3##(2008-3#1)(2013-1#1)
on the atomization##2##3##(2008-10#2)
on the attachment##2##3##(1993-5#1)(1994-5#1)
on the auditory##2##3##(2008-9#1)(2013-1#1)
on the availability of##13##4##(1990-12#1)(1991-1#1)(1992-3#1)(1993-11#1)(1994-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2013-8#1)
on the available evidence##2##4##(2008-12#1)(2008-9#1)
on the available literature##2##4##(2007-4#1)(2008-11#1)
on the available##8##3##(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-2#1)
on the average##14##3##(1993-12#1)(1994-3#1)(1996-4#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-9#1)(2011-2#1)(2012-3#2)
on the axillary##2##3##(2008-5#2)
on the axis##2##3##(2007-12#1)(2008-2#1)
on the baby's##2##3##(2008-11#1)(2008-2#1)
on the back of a##2##5##(2008-11#2)
on the back of the##2##5##(1990-6#1)(2008-2#1)
on the back of##4##4##(1990-6#1)(2008-11#2)(2008-2#1)
on the back##10##3##(1990-6#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2011-2#2)
on the background##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2012-2#1)
on the bacterial##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
on the balance between##2##4##(2008-11#1)(2013-7#1)
on the bare##2##3##(2008-10#2)
on the barley##2##3##(2008-10#1)(2008-5#1)
on the basal##3##3##(1995-2#1)(2008-12#1)(2008-5#1)
on the base of##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
on the base##6##3##(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
on the baseline##2##3##(1992-7#1)(2009-9#1)
on the bases of##3##4##(1995-2#1)(2008-10#1)(2008-7#1)
on the bases##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
on the basic knowledge##2##4##(2008-10#1)(2011-2#1)
on the basic##4##3##(1992-11#1)(1996-3#1)(2008-10#1)(2011-2#1)
on the basis of CT findings##2##6##(1997-8#1)(2008-1#1)
on the basis of a single##2##6##(2008-6#1)(2013-1#1)
on the basis of a##26##5##(1990-2#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
on the basis of amino acid sequence##3##7##(1990-5#1)(1990-7#1)(1992-7#1)
on the basis of an original##2##6##(2007-12#1)(2008-3#1)
on the basis of an##8##5##(1994-11#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)
on the basis of chemical##2##5##(2008-10#1)(2010-5#1)
on the basis of clinical##3##5##(1990-6#1)(2012-12#1)(2013-1#1)
on the basis of conventional##2##5##(1994-11#1)(2007-11#1)
on the basis of data##3##5##(1990-9#1)(2007-8#1)(2008-2#1)
on the basis of differences##2##5##(2008-10#1)(2013-1#1)
on the basis of differential staining with##2##7##(1997-8#1)(2008-9#1)
on the basis of efficiency##2##5##(1997-1#1)(2008-10#1)
on the basis of experimental results##2##6##(2008-2#2)
on the basis of host reactions##2##6##(2008-10#2)
on the basis of individual##2##5##(2007-8#1)(2008-11#1)
on the basis of its##6##5##(1992-12#1)(1992-9#1)(1993-11#1)(2008-10#2)(2008-3#1)
on the basis of molecular##2##5##(2008-7#1)(2008-8#1)
on the basis of sclerotial morphology##2##6##(2008-10#2)
on the basis of sequence##2##5##(1995-8#1)(1996-6#1)
on the basis of spectral##2##5##(2008-11#1)(2010-3#1)
on the basis of spectroscopic##3##5##(2007-11#1)(2008-10#1)(2013-1#1)
on the basis of the available literature##2##7##(2007-11#1)(2009-4#1)
on the basis of the mechanism of the##2##8##(1992-3#1)(2008-10#1)
on the basis of the response of the##2##8##(2008-10#2)
on the basis of the results of##2##7##(2007-11#1)(2008-10#1)
on the basis of the results##3##6##(2007-11#1)(2008-10#1)(2008-6#1)
on the basis of the##64##5##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#5)(2007-8#2)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-12#1)
on the basis of their##26##5##(1990-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
on the basis of these##7##5##(2007-4#1)(2008-10#3)(2008-5#1)(2009-11#1)(2013-1#1)
on the basis of this##3##5##(1990-6#1)(2008-12#1)(2008-2#1)
on the basis of two##2##5##(1990-12#1)(2008-10#1)
on the basis of##362##4##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-3#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-11#11)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#9)(2008-1#5)(2008-10#67)(2008-11#10)(2008-12#2)(2008-2#15)(2008-3#23)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2010-1#1)(2010-11#2)(2010-3#6)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#3)
on the basis that##3##4##(1997-1#1)(1997-8#1)(2008-5#1)
on the basis##367##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-3#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#3)(2007-11#11)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#9)(2008-1#5)(2008-10#67)(2008-11#10)(2008-12#2)(2008-2#16)(2008-3#23)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2010-1#1)(2010-11#2)(2010-3#6)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#3)
on the basolateral##2##3##(2007-12#1)(2008-8#1)
on the battery##2##3##(1996-5#1)(2008-10#1)
on the beads##4##3##(1995-6#1)(2008-10#2)(2012-1#1)
on the beam##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
on the beating heart##5##4##(2007-8#5)
on the behavior and##2##4##(1991-12#1)(2009-8#1)
on the behavior of the##3##5##(1990-8#1)(2008-10#1)(2011-2#1)
on the behavior of##7##4##(1990-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2011-2#2)
on the behavior##10##3##(1990-8#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#2)
on the behavioral##2##3##(1991-1#1)(1993-12#1)
on the behaviour of the##2##5##(2008-10#1)(2008-5#1)
on the behaviour of##4##4##(2008-10#2)(2008-5#2)
on the benefits of##5##4##(1995-12#1)(1995-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
on the benefits##8##3##(1995-12#2)(1995-6#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
on the best##5##3##(1991-3#1)(1991-6#1)(1996-2#1)(2008-11#1)(2008-9#1)
on the beta##2##3##(1997-1#1)(2010-5#1)
on the bilayer##2##3##(1990-2#1)(2008-4#1)
on the binding of##10##4##(1990-12#1)(1991-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#3)(2008-3#1)
on the binding to##2##4##(1992-9#1)(1995-6#1)
on the binding##17##3##(1990-12#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#3)(1995-6#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
on the biochemical origins of##2##5##(2008-5#2)
on the biochemical##6##3##(1991-9#1)(1993-8#2)(2008-5#2)(2011-2#1)
on the biodiversity##2##3##(2008-8#1)(2012-2#1)
on the biological activity##2##4##(1997-4#1)(1997-7#1)
on the biological control##2##4##(2008-10#1)(2008-8#1)
on the biological sample##2##4##(2008-10#1)(2008-7#1)
on the biological##12##3##(1991-12#1)(1992-8#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-7#2)(2008-8#2)(2010-10#1)
on the biology and##2##4##(2008-12#1)(2008-6#1)
on the biology of##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
on the biology##5##3##(2008-10#1)(2008-12#2)(2008-6#2)
on the biomass of##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
on the biomass##6##3##(2008-10#4)(2008-8#1)(2013-1#1)
on the biosensor##6##3##(2008-10#6)
on the blood##7##3##(1996-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
on the blue##2##3##(1994-5#1)(2008-3#1)
on the body##3##3##(2008-6#1)(2008-8#1)(2012-3#1)
on the bone##2##3##(2008-12#1)(2010-9#1)
on the bottom of the vial##2##6##(2008-3#2)
on the bottom of the##4##5##(2008-10#1)(2008-3#2)(2012-4#1)
on the bottom of##6##4##(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-4#1)
on the bottom##10##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-4#1)
on the brain##12##3##(1991-5#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
on the brains of##2##4##(2007-12#1)(2008-7#1)
on the breeding##2##3##(2010-8#1)(2013-7#1)
on the buccal##2##3##(1991-2#1)(2012-3#1)
on the calcium##3##3##(1997-7#1)(2008-4#2)
on the calculated##4##3##(2007-11#1)(2008-10#3)
on the calculation of the##2##5##(2008-2#1)(2008-3#1)
on the calculation of##6##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
on the calculation##8##3##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)
on the calibration##2##3##(2008-10#1)(2008-3#1)
on the capacity of##3##4##(2008-6#1)(2012-12#2)
on the capacity to##2##4##(1995-11#1)(2008-11#1)
on the capacity##5##3##(1995-11#1)(2008-11#1)(2008-6#1)(2012-12#2)
on the carbon##6##3##(1992-11#1)(1995-6#1)(2008-10#4)
on the carcinogenicity of asbestos fibers##2##6##(1991-12#2)
on the cardiovascular system##3##4##(2008-10#1)(2008-7#2)
on the cardiovascular##5##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-7#2)
on the care of##2##4##(2008-1#1)(2010-8#1)
on the care##3##3##(1996-1#1)(2008-1#1)(2010-8#1)
on the carrier##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
on the carrier-envelope phase##2##4##(2007-11#1)(2007-12#1)
on the cartridge##2##3##(2008-10#2)
on the case of##2##4##(1992-5#1)(2008-9#1)
on the case##5##3##(1992-5#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#1)
on the cast films##3##4##(2008-11#3)
on the cast membranes made of##2##6##(2008-11#2)
on the cast membranes was##2##5##(2008-11#2)
on the cast membranes##4##4##(2008-11#4)
on the cast##8##3##(2008-11#8)
on the category##2##3##(1996-2#1)(2008-9#1)
on the cation##3##3##(2008-10#3)
on the causes of##4##4##(2008-10#2)(2008-11#1)(2012-12#1)
on the causes##5##3##(2007-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
on the cavity##2##3##(2007-11#1)(2008-3#1)
on the cell line##3##4##(1991-6#1)(1992-2#1)(2008-11#1)
on the cell membrane##5##4##(1991-12#1)(1992-12#1)(1993-9#1)(1997-7#1)(2009-12#1)
on the cell surface and##3##5##(1992-11#1)(1995-2#1)(1996-5#1)
on the cell surface of##5##5##(1990-12#1)(1990-7#1)(1991-9#1)(2008-10#1)(2008-11#1)
on the cell surface##19##4##(1990-12#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-11#1)(1994-11#2)(1994-6#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#1)(2013-8#1)
on the cell##46##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
on the cells##2##3##(1992-8#1)(2008-8#1)
on the cellular##8##3##(1994-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-12#3)(2011-1#1)
on the cellulose tris(3##2##4##(2008-10#2)
on the central cholinergic system##2##5##(1991-12#1)(2008-10#1)
on the central coast##2##4##(2008-10#1)(2008-5#1)
on the central nervous system##6##5##(1990-5#1)(1990-9#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
on the central nervous##7##4##(1990-5#1)(1990-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
on the central##12##3##(1990-5#1)(1990-9#1)(1991-12#1)(1992-8#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-1#1)
on the cesium##2##3##(2008-3#2)
on the challenges##3##3##(1990-4#1)(1996-2#1)(2008-10#1)
on the change in the##2##5##(2008-2#1)(2008-3#1)
on the change in##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
on the change##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
on the changes in##7##4##(1990-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-4#1)(2012-1#1)
on the changes##10##3##(1990-8#1)(1992-1#1)(1996-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-1#1)
on the channel##3##3##(2008-2#1)(2008-8#1)(2010-8#1)
on the characterisation of##2##4##(1995-3#1)(2008-10#1)
on the characteristic##3##3##(2008-3#2)(2011-2#1)
on the characteristics of the##12##5##(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)
on the characteristics of##15##4##(1994-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
on the characteristics##16##3##(1994-2#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
on the characterization of the##2##5##(1994-5#1)(1996-2#1)
on the characterization of##3##4##(1994-5#1)(1996-2#1)(2008-8#1)
on the charge##3##3##(2008-10#3)
on the cheek##5##3##(2008-5#5)
on the chemical composition of the##2##6##(1994-12#1)(2008-3#1)
on the chemical composition of##3##5##(1994-12#1)(2008-3#1)(2013-1#1)
on the chemical structure##2##4##(2009-10#1)(2012-3#1)
on the chemical##22##3##(1993-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#2)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#3)
on the chemiluminescence (CL) reaction between##2##6##(2008-10#2)
on the chemiluminescence (CL) reaction##3##5##(2008-10#3)
on the chemiluminescence (CL)##4##4##(2008-10#3)(2010-4#1)
on the chemiluminescence emission##2##4##(2008-10#2)
on the chemiluminescence generated##2##4##(2008-10#2)
on the chemiluminescence##15##3##(2008-10#14)(2010-4#1)
on the chemiluminescent reaction of##2##5##(2008-10#2)
on the chemistry of groundwater samples##2##6##(2013-1#2)
on the chest wall##4##4##(1991-12#1)(2009-3#1)(2010-6#1)(2013-1#1)
on the chest##6##3##(1991-12#1)(2007-10#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
on the child##3##3##(1995-5#1)(2006-10#1)(2008-11#1)
on the children's##2##3##(1993-1#1)(2011-2#1)
on the chip##2##3##(2008-10#2)
on the chiral##2##3##(2008-10#2)
on the choice of##3##4##(1994-2#1)(2008-10#1)(2008-2#1)
on the chromatogram##3##3##(2008-10#3)
on the chromatographic behavior of##2##5##(2008-10#2)
on the chromatographic##5##3##(2008-10#5)
on the chromosomal##2##3##(2008-11#1)(2008-12#1)
on the chromosome of##2##4##(1997-2#1)(2008-10#1)
on the chromosome##6##3##(1996-10#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-9#1)
on the circadian##2##3##(2008-5#2)
on the circular##2##3##(1994-12#1)(1996-6#1)
on the classical##4##3##(1990-8#1)(2007-11#1)(2008-11#1)(2009-9#1)
on the classification##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
on the clinical and##5##4##(1994-5#1)(2007-12#2)(2010-6#1)(2012-12#1)
on the clinical applications of##2##5##(2010-11#1)(2012-2#1)
on the clinical presentation##2##4##(2012-2#1)(2013-1#1)
on the clinical##22##3##(1990-11#1)(1990-2#1)(1990-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
on the clinician's##2##3##(2007-12#1)(2008-3#1)
on the cloud##2##3##(2008-10#1)(2008-3#1)
on the coagulation##2##3##(1994-9#1)(2008-10#1)
on the coating##2##3##(2008-10#1)(2013-1#1)
on the cognitive##3##3##(1994-6#1)(2008-2#1)(2009-10#1)
on the coherence function##2##4##(2008-3#2)
on the coherence##3##3##(2008-3#3)
on the collected##2##3##(1994-8#1)(2010-8#1)
on the collection##3##3##(1996-3#1)(2007-11#1)(2008-12#1)
on the colloid##3##3##(2008-2#3)
on the colonization of##2##4##(2008-10#2)
on the color of##3##4##(2009-8#3)
on the color stability of##2##5##(2010-3#1)(2012-7#1)
on the color##9##3##(2008-10#3)(2008-3#1)(2009-8#3)(2010-3#1)(2012-7#1)
on the column was##2##4##(2008-10#2)
on the column##13##3##(1990-11#1)(1991-5#1)(2008-10#11)
on the combination of##8##4##(2008-10#3)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#2)
on the combined##6##3##(2008-10#5)(2008-2#1)
on the combustion##2##3##(1996-12#1)(2008-10#1)
on the common##3##3##(1996-3#1)(2012-3#1)(2013-1#1)
on the comparative##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
on the comparison of the##2##5##(1990-8#1)(2008-10#1)
on the comparison of##3##4##(1990-8#1)(2008-10#2)
on the comparison##4##3##(1990-8#1)(1996-3#1)(2008-10#2)
on the compensation##2##3##(1993-5#1)(1996-2#1)
on the competitive intensity between the competing pairs##2##8##(2008-8#2)
on the competitive##7##3##(2008-10#5)(2008-8#2)
on the complementary strand##2##4##(1994-12#1)(1997-3#1)
on the complete##2##3##(1994-12#1)(2008-7#1)
on the complex formation of##2##5##(2008-10#2)
on the complex formation##3##4##(2008-10#3)
on the complex##11##3##(2008-1#1)(2008-10#8)(2008-3#1)(2009-5#1)
on the complexation of copper(II) by phenolic acids##2##8##(2008-10#2)
on the complexation of##4##4##(2008-10#4)
on the complexation reaction##3##4##(2008-10#3)
on the complexation##10##3##(2008-10#10)
on the composition and##3##4##(2007-12#1)(2008-7#1)(2012-3#1)
on the composition of##5##4##(1997-7#1)(2008-10#2)(2008-8#1)(2013-1#1)
on the composition##8##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
on the computational##2##3##(2008-2#1)(2010-9#1)
on the computer##4##3##(1992-4#1)(1995-2#1)(1996-9#1)(2008-11#1)
on the concentration and lipophilicity of##2##6##(2008-10#2)
on the concentration and##6##4##(1993-12#1)(2008-10#5)
on the concentration of the##3##5##(1991-8#1)(1992-12#1)(2008-7#1)
on the concentration of##27##4##(1991-8#1)(1992-12#2)(1992-5#1)(1996-5#1)(1997-4#2)(2008-10#10)(2008-5#1)(2008-7#2)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
on the concentration##35##3##(1991-8#1)(1992-12#2)(1992-5#1)(1993-12#1)(1996-5#1)(1997-4#2)(2008-10#16)(2008-5#1)(2008-7#2)(2009-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
on the concentrations of##4##4##(2008-10#1)(2008-9#1)(2012-1#1)(2013-8#1)
on the concept of the##2##5##(1997-6#1)(2010-12#1)
on the concept of##17##4##(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
on the concept that##2##4##(1997-4#1)(2008-3#1)
on the concept##20##3##(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
on the conceptual##2##3##(2008-7#1)(2013-8#1)
on the condition of the##3##5##(1991-3#1)(2007-12#1)(2008-6#1)
on the condition of##5##4##(1991-3#1)(1997-3#1)(2007-12#1)(2008-6#1)(2008-9#1)
on the condition##6##3##(1991-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
on the conditions of the##2##5##(1990-8#1)(1992-8#1)
on the conditions of##5##4##(1990-8#1)(1992-8#1)(1996-2#1)(2008-10#1)(2008-2#1)
on the conditions##6##3##(1990-8#1)(1992-8#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-2#1)
on the conduct of##2##4##(2007-10#1)(2009-4#1)
on the conduct##3##3##(2007-10#1)(2009-4#1)(2010-3#1)
on the conductivity and##2##4##(2008-10#1)(2010-4#1)
on the confidence##2##3##(2008-10#2)
on the conformation of the##4##5##(1994-5#1)(2008-10#1)(2008-8#1)(2009-9#1)
on the conformation of##6##4##(1994-5#1)(1996-2#1)(2008-10#1)(2008-8#2)(2009-9#1)
on the conformation##8##3##(1994-5#1)(1996-2#1)(2008-10#1)(2008-8#2)(2009-3#2)(2009-9#1)
on the conformational##2##3##(1995-6#1)(2008-10#1)
on the connection between##2##4##(2008-7#1)(2012-2#1)
on the consequences of##2##4##(2009-4#1)(2011-1#1)
on the construction and##2##4##(2009-8#1)(2010-8#1)
on the construction of##4##4##(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
on the construction##6##3##(2008-11#1)(2008-4#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-8#1)
on the consumption of##2##4##(1994-5#1)(2008-10#1)
on the content##2##3##(1990-5#1)(2008-5#1)
on the continent##2##3##(1990-6#1)(2008-10#1)
on the continuous##5##3##(1992-11#1)(1997-7#1)(2008-10#2)(2012-2#1)
on the continuum##2##3##(1991-1#1)(2008-10#1)
on the contralateral side##2##4##(1996-9#1)(2006-12#1)
on the contralateral##5##3##(1995-12#1)(1996-5#1)(1996-9#1)(2006-12#1)(2008-10#1)
on the contrary##12##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#2)(1994-11#1)(1997-1#1)(1997-8#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
on the contrast in the##2##5##(2008-3#2)
on the contrast##3##3##(2007-12#1)(2008-3#2)
on the contribution of##7##4##(1993-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)
on the control of the##2##5##(2008-5#1)(2010-3#1)
on the control of##10##4##(1993-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
on the control##13##3##(1993-6#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
on the conversion##2##3##(2008-10#1)(2013-1#1)
on the convex##2##3##(2008-10#1)(2012-2#1)
on the cooperative##2##3##(1990-8#1)(2008-4#1)
on the copper wire##2##4##(2008-10#2)
on the corneal graft##3##4##(2011-2#3)
on the corneal##4##3##(2011-2#4)
on the corner of##2##4##(2008-8#2)
on the coronary##3##3##(1994-11#1)(2012-2#1)(2012-3#1)
on the correct##4##3##(1993-6#1)(2008-7#1)(2008-9#1)(2010-12#1)
on the correlation between the##2##5##(1997-6#1)(2012-3#1)
on the correlation between##3##4##(1997-6#1)(2008-10#1)(2012-3#1)
on the correlation##7##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-8#1)
on the cortex##2##3##(2008-7#1)(2010-3#1)
on the cost of##3##4##(1992-12#1)(1996-1#1)(2008-9#1)
on the cost##4##3##(1992-12#1)(1992-2#1)(1996-1#1)(2008-9#1)
on the costs##2##3##(2008-9#1)(2011-1#1)
on the coupling##8##3##(2007-11#1)(2008-10#6)(2008-3#1)
on the course of##5##4##(1991-9#1)(2007-8#2)(2008-3#1)(2011-2#1)
on the criteria##2##3##(1992-12#1)(2008-3#1)
on the critical##6##3##(1994-5#1)(1996-5#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#1)
on the cross##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
on the crystal##2##3##(2007-12#1)(2012-2#1)
on the cued##2##3##(1994-8#1)(2010-5#1)
on the cultural##4##3##(1996-8#1)(2008-4#1)(2008-5#1)(2010-1#1)
on the culture##7##3##(2008-10#1)(2008-11#2)(2008-9#1)(2009-6#1)(2012-3#1)(2013-1#1)
on the cultured##2##3##(1993-3#1)(2008-11#1)
on the current knowledge of##2##5##(2008-10#1)(2011-1#1)
on the current state##2##4##(2011-2#1)(2013-1#1)
on the current##23##3##(1994-1#1)(1994-11#2)(1995-8#1)(2007-2#2)(2008-10#2)(2008-11#3)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
on the cut-off value##2##4##(1997-3#2)
on the cylinder##2##3##(2008-3#1)(2009-2#1)
on the cytoplasmic free##2##4##(1993-3#2)
on the cytoplasmic##3##3##(1993-3#2)(2008-7#1)
on the cytosolic##2##3##(1992-6#1)(1994-6#1)
on the cytotoxic##2##3##(1990-12#1)(1992-9#1)
on the cytotoxicity of##2##4##(1992-3#1)(2008-8#1)
on the daily##2##3##(2011-1#2)
on the data set##2##4##(2008-10#1)(2012-3#1)
on the data##11##3##(1991-5#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-3#2)(2012-3#1)
on the day before ovulation##2##5##(1994-7#2)
on the day before##7##4##(1992-6#1)(1994-7#2)(2008-8#3)(2012-2#1)
on the day of operation##2##5##(1990-2#1)(2007-8#1)
on the day of surgery##4##5##(2008-8#3)(2012-2#1)
on the day of the##3##5##(1996-1#1)(2007-10#1)(2008-10#1)
on the day of##18##4##(1990-2#1)(1996-1#2)(1996-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#3)(2010-6#1)(2012-2#1)
on the day##29##3##(1990-2#1)(1992-6#1)(1992-7#1)(1994-6#1)(1994-7#2)(1996-1#2)(1996-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#6)(2010-6#2)(2012-2#2)
on the decay##2##3##(2008-3#2)
on the decision to##2##4##(1997-1#1)(2008-9#1)
on the decision##5##3##(1995-9#1)(1997-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
on the decisional##2##3##(2008-10#1)(2011-1#1)
on the deep##2##3##(2008-10#1)(2011-2#1)
on the definition of##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
on the deflection##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
on the degree of the##4##5##(2008-10#3)(2013-1#1)
on the degree of##33##4##(1990-9#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-8#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-2#1)(2013-1#3)
on the degree to which##2##5##(2008-8#1)(2008-9#1)
on the degree##35##3##(1990-9#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-8#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#2)(2009-8#1)(2011-2#1)(2013-1#3)
on the delivery of##3##4##(1995-1#1)(2008-10#1)(2008-5#1)
on the delivery##4##3##(1994-12#1)(1995-1#1)(2008-10#1)(2008-5#1)
on the demand for##2##4##(1990-2#2)
on the densities of##2##4##(1994-2#1)(2008-9#1)
on the densities##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
on the density##2##3##(2008-12#1)(2008-3#1)
on the deployment of##2##4##(2008-10#1)(2008-11#1)
on the derivative##2##3##(2007-11#1)(2008-10#1)
on the derivatization reaction##3##4##(2008-10#3)
on the derivatization##5##3##(2008-10#5)
on the derived##3##3##(2008-2#3)
on the design and##4##4##(1992-2#1)(1996-2#1)(2007-12#1)(2008-3#1)
on the design of the##2##5##(2007-12#1)(2008-3#1)
on the design of##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)
on the design##14##3##(1992-2#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-8#1)(2012-2#2)
on the detailed##3##3##(2007-5#1)(2008-3#1)(2008-4#1)
on the details of##2##4##(1997-5#1)(2008-3#1)
on the detected##2##3##(2008-3#2)
on the detection and##2##4##(1990-6#1)(2008-4#1)
on the detection of##16##4##(1990-12#1)(1991-5#1)(1992-6#1)(2007-2#1)(2008-10#9)(2008-2#1)(2008-8#1)(2009-3#1)
on the detection##20##3##(1990-12#1)(1990-6#1)(1991-5#1)(1992-6#1)(2007-2#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)
on the detector##6##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
on the determination of bismuth##2##5##(2008-10#2)
on the determination of the##5##5##(1995-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
on the determination of these##2##5##(2008-10#2)
on the determination of trace##2##5##(2008-10#1)(2013-8#1)
on the determination of##51##4##(1990-8#1)(1991-12#1)(1994-3#1)(1995-12#1)(2008-10#44)(2008-2#1)(2008-3#1)(2013-8#1)
on the determination##53##3##(1990-8#1)(1991-12#1)(1994-3#1)(1995-12#1)(2008-10#46)(2008-2#1)(2008-3#1)(2013-8#1)
on the developing##3##3##(1995-12#1)(2008-10#1)(2012-12#1)
on the development and##5##4##(1993-9#1)(1996-2#1)(2007-11#1)(2012-12#1)(2012-2#1)
on the development of a##2##5##(1996-12#1)(2010-4#1)
on the development of an##4##5##(2008-11#2)(2011-2#1)(2012-2#1)
on the development of cognition##2##5##(2009-7#2)
on the development of humoral##2##5##(1993-12#2)
on the development of new##3##5##(1994-9#1)(2008-5#1)(2010-7#1)
on the development of novel##2##5##(2008-10#1)(2011-2#1)
on the development of orthopaedic##2##5##(2007-8#2)
on the development of the##11##5##(1993-3#1)(1995-12#2)(1996-12#1)(1996-3#1)(2008-10#3)(2008-12#1)(2010-1#1)(2010-4#1)
on the development of##77##4##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#14)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-4#3)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#2)
on the development##83##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-4#3)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
on the developmental##2##3##(1991-8#1)(2007-11#1)
on the diagnosis and management of##5##6##(2007-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
on the diagnosis and treatment of##2##6##(2008-2#1)(2013-1#1)
on the diagnosis and##8##4##(1995-9#1)(2007-7#1)(2008-2#1)(2010-12#2)(2012-2#1)(2013-1#2)
on the diagnosis##9##3##(1995-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-12#2)(2012-2#1)(2013-1#2)
on the diagnostic accuracy of##2##5##(2008-12#1)(2009-4#1)
on the diagnostic utility of##2##5##(2008-12#1)(2012-2#1)
on the diagnostic##11##3##(1990-2#1)(1994-9#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-4#1)(2012-12#1)(2012-2#2)
on the diagonal##3##3##(2007-12#1)(2008-4#1)(2008-8#1)
on the difference in##3##4##(2008-10#3)
on the difference of the##2##5##(2008-10#1)(2012-3#1)
on the difference##9##3##(2008-10#6)(2008-2#1)(2008-5#1)(2012-3#1)
on the differences in##2##4##(2008-4#1)(2008-9#1)
on the differences##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
on the different##20##3##(1991-2#1)(2008-10#6)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
on the differential##10##3##(1991-11#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-9#1)(2010-7#1)
on the differentiation of##4##4##(1990-11#1)(1991-9#1)(2008-11#1)(2008-7#1)
on the differentiation##5##3##(1990-11#1)(1991-9#1)(2008-11#1)(2008-7#1)(2010-12#1)
on the difficulties##2##3##(1992-5#1)(1993-8#1)
on the diffraction##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
on the diffusion of##2##4##(2007-12#1)(2008-10#1)
on the diffusion##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
on the dimension of##2##4##(2009-11#2)
on the dimensions##2##3##(2009-5#1)(2010-3#1)
on the direct##11##3##(2008-10#9)(2008-3#1)(2008-8#1)
on the discovery##2##3##(2008-10#2)
on the disease##5##3##(2008-10#3)(2012-2#1)(2013-8#1)
on the dispersion of##3##4##(2008-10#2)(2008-2#1)
on the dispersion##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
on the dissociation constants##2##4##(2008-10#2)
on the dissociation##5##3##(2008-10#3)(2008-9#1)(2012-12#1)
on the dissolution##2##3##(2008-10#2)
on the distal part of the##2##6##(2012-1#1)(2013-1#1)
on the distal##10##3##(1996-8#1)(2007-12#5)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
on the distance between the##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
on the distance##5##3##(1994-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
on the distribution and##2##4##(1994-5#1)(2008-11#1)
on the distribution of the##2##5##(2008-10#1)(2011-1#1)
on the distribution of##13##4##(1990-12#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#2)
on the distribution##19##3##(1990-12#1)(1991-12#1)(1991-5#1)(1994-5#2)(1996-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#2)
on the diversity##5##3##(1992-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-3#1)
on the doctors'##2##3##(1993-11#1)(2011-2#1)
on the donor##5##3##(1996-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
on the dopamine##2##3##(1991-12#1)(1995-2#1)
on the dopaminergic##2##3##(1995-5#1)(2008-7#1)
on the doping##2##3##(1993-3#1)(2008-10#1)
on the dorsal side of the##2##6##(2008-5#1)(2008-7#1)
on the dorsal side of##3##5##(2008-5#1)(2008-7#1)(2011-2#1)
on the dorsal side##4##4##(2008-5#2)(2008-7#1)(2011-2#1)
on the dorsal##8##3##(2007-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
on the dorsum of the##2##5##(2008-6#1)(2012-3#1)
on the dorsum of##3##4##(2008-6#1)(2010-3#1)(2012-3#1)
on the dose##3##3##(1993-9#1)(1994-8#1)(2008-8#1)
on the drug for##2##4##(2008-8#1)(2012-3#1)
on the drug or##2##4##(1992-9#1)(2008-10#1)
on the drug##8##3##(1992-3#1)(1992-9#1)(1996-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-3#1)
on the dual##2##3##(2008-10#2)
on the duration of the##3##5##(1992-6#1)(2008-11#1)(2008-2#1)
on the duration of##6##4##(1990-5#1)(1992-6#1)(2008-11#2)(2008-2#1)(2008-3#1)
on the dye##2##3##(1991-5#1)(2008-2#1)
on the dynamic##6##3##(2008-10#3)(2008-3#1)(2008-7#1)(2013-7#1)
on the dynamics of disease##2##5##(2008-10#1)(2008-9#1)
on the dynamics of the##2##5##(2008-10#1)(2008-11#1)
on the dynamics of##8##4##(1995-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-1#1)
on the dynamics##10##3##(1995-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-8#1)
on the early##6##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
on the earth's surface##2##4##(2008-10#1)(2010-5#1)
on the ease of##2##4##(2008-10#1)(2012-3#1)
on the ecological##8##3##(2007-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#2)
on the economic##2##3##(1995-5#1)(2009-10#1)
on the edge of##3##4##(1996-3#1)(2007-12#1)(2008-9#1)
on the edge##5##3##(1996-3#1)(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
on the effect of different##2##5##(2008-10#1)(2012-8#1)
on the effect of the##2##5##(2008-11#1)(2011-2#1)
on the effect of##29##4##(1990-12#1)(1991-2#1)(1992-9#1)(1994-6#1)(1995-9#1)(1997-7#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#2)(2012-8#1)
on the effect that##2##4##(2008-10#1)(2008-8#1)
on the effect##32##3##(1990-12#1)(1991-2#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-9#1)(1997-7#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#2)(2012-8#1)
on the effective##7##3##(1990-11#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
on the effectiveness of the##2##5##(2008-10#1)(2013-1#1)
on the effectiveness of##12##4##(1992-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#3)
on the effectiveness##13##3##(1992-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
on the effector##2##3##(1995-2#1)(2011-2#1)
on the effects and##2##4##(1996-3#1)(2007-12#1)
on the effects of a##2##5##(2008-11#1)(2013-1#1)
on the effects of prenatal##2##5##(2011-2#1)(2012-2#1)
on the effects of the##2##5##(2012-12#1)(2013-1#1)
on the effects of various##2##5##(1991-2#1)(1992-6#1)
on the effects of##38##4##(1990-3#1)(1991-2#3)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-5#4)(2008-7#3)(2009-11#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
on the effects##42##3##(1990-3#1)(1991-2#3)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#4)(2008-7#3)(2009-11#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
on the efficacy and safety of##2##6##(2008-6#1)(2013-1#1)
on the efficacy of##15##4##(1990-3#1)(1993-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-10#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
on the efficacy##19##3##(1990-3#1)(1993-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
on the efficiency of the##3##5##(2008-10#1)(2008-6#1)(2010-3#1)
on the efficiency of##13##4##(1992-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-3#1)(2013-1#1)
on the efficiency##14##3##(1992-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2013-1#1)
on the eighth day##3##4##(1994-3#1)(2007-12#1)(2011-2#1)
on the eighth##4##3##(1994-3#1)(2007-12#1)(2011-2#2)
on the elderly##2##3##(2008-10#1)(2011-2#1)
on the electric##3##3##(2007-12#1)(2010-6#1)(2013-1#1)
on the electrical##2##3##(1990-11#1)(1990-5#1)
on the electrocardiogram##2##3##(2012-2#1)(2013-1#1)
on the electrochemical##5##3##(2008-10#2)(2008-8#2)(2010-6#1)
on the electrode and##2##4##(1990-5#1)(2008-10#1)
on the electrode response##2##4##(2008-10#2)
on the electrode surface and##2##5##(2008-10#2)
on the electrode surface via##2##5##(2008-10#2)
on the electrode surface##21##4##(2008-10#21)
on the electrode##38##3##(1990-5#1)(2008-10#37)
on the electronic##2##3##(2008-10#2)
on the electrostatic interaction between##2##5##(2012-6#1)(2013-1#1)
on the electrostatic##3##3##(2008-10#1)(2012-6#1)(2013-1#1)
on the elements of##2##4##(2007-12#1)(2007-8#1)
on the elevated##2##3##(2011-2#1)(2013-1#1)
on the elevation##2##3##(2008-3#1)(2008-8#1)
on the emergence##3##3##(2011-2#2)(2012-2#1)
on the emission of rubidium##2##5##(2008-10#2)
on the emission of##3##4##(2008-10#3)
on the emission##5##3##(2007-12#1)(2008-10#4)
on the end of##4##4##(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#1)
on the end##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#1)
on the endocrine##2##3##(1991-3#1)(2008-11#1)
on the endometrium##2##3##(1994-9#1)(2011-2#1)
on the endoplasmic reticulum membrane##2##5##(1995-6#2)
on the endoplasmic reticulum##3##4##(1995-6#2)(2008-11#1)
on the endothelial##2##3##(1995-2#1)(2008-4#1)
on the ends of##2##4##(2006-10#1)(2007-11#1)
on the energetic##2##3##(2008-8#1)(2012-12#1)
on the energy metabolism##2##4##(2008-11#2)
on the energy##5##3##(2008-10#1)(2008-11#2)(2008-2#1)(2009-8#1)
on the enhanced##2##3##(1992-9#1)(2008-10#1)
on the enhancing effect of##2##5##(2008-10#2)
on the enhancing effect##3##4##(2008-10#3)
on the enrichment##2##3##(2011-2#2)
on the entire##6##3##(1996-12#1)(1997-3#1)(2008-10#1)(2009-2#1)(2012-12#1)(2013-7#1)
on the entrance##2##3##(2008-2#1)(2008-3#1)
on the environment in##2##4##(1991-12#1)(2009-10#1)
on the environment##7##3##(1991-12#1)(1991-6#1)(2008-10#4)(2009-10#1)
on the enzymatic##4##3##(2008-10#2)(2008-12#1)(2013-1#1)
on the enzyme activity##2##4##(1990-5#1)(1993-3#1)
on the enzyme##10##3##(1990-5#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-7#1)
on the enzymes##2##3##(1993-9#1)(2007-11#1)
on the epidemiology and management of##2##6##(2007-12#1)(2008-10#1)
on the epidemiology and##3##4##(2007-12#1)(2008-10#2)
on the epidemiology of the##2##5##(2008-10#1)(2008-9#1)
on the epidemiology of##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
on the epidemiology##6##3##(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)
on the epidermis##3##3##(2007-12#1)(2008-5#2)
on the epithelial cells##2##4##(1997-2#1)(1997-6#1)
on the epithelial##3##3##(1997-2#1)(1997-6#2)
on the equilibrium##5##3##(1995-5#1)(2008-10#3)(2009-10#1)
on the establishment of a##3##5##(1996-2#1)(2011-1#1)(2013-1#1)
on the establishment of##6##4##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
on the establishment##7##3##(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
on the estimated##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
on the estimation of the##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
on the estimation of##8##4##(1992-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)
on the etiology and##2##4##(2009-9#1)(2013-8#1)
on the etiology of##3##4##(1992-8#1)(1996-11#1)(2007-10#1)
on the etiology##7##3##(1990-9#1)(1992-8#1)(1996-11#1)(2007-10#1)(2008-1#1)(2009-9#1)(2013-8#1)
on the evaluation of##6##4##(1993-6#1)(1995-2#1)(2008-10#3)(2008-5#1)
on the evaluation##7##3##(1993-6#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-5#1)
on the evidence##6##3##(1993-12#1)(1994-11#1)(2010-1#1)(2011-2#1)(2013-1#2)
on the evolution of life-history##2##5##(2008-8#2)
on the evolution of the##10##5##(1991-6#1)(1995-11#1)(1997-5#1)(1997-9#1)(2007-12#2)(2008-10#2)(2008-8#1)(2012-12#1)
on the evolution of##24##4##(1991-5#1)(1991-6#1)(1995-11#1)(1995-5#1)(1997-5#1)(1997-9#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-8#6)(2008-9#2)(2012-12#1)(2012-3#2)
on the evolution##25##3##(1991-5#1)(1991-6#1)(1993-2#1)(1995-11#1)(1995-5#1)(1997-5#1)(1997-9#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-8#6)(2008-9#2)(2012-12#1)(2012-3#2)
on the evolutionary process##2##4##(1994-3#1)(2012-3#1)
on the evolutionary relations among##2##5##(2008-7#1)(2008-8#1)
on the evolutionary##7##3##(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#2)
on the evolving##2##3##(2007-12#1)(2009-5#1)
on the exact##4##3##(2007-12#1)(2008-3#1)(2008-9#2)
on the example of##3##4##(1994-2#1)(2008-10#1)(2012-2#1)
on the excess##2##3##(1995-2#1)(2008-10#1)
on the exchange##2##3##(2008-10#1)(2008-11#1)
on the excitation and emission##2##5##(2007-11#1)(2008-10#1)
on the excitation##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
on the excitation-beam##2##3##(2008-3#2)
on the excretion##2##3##(1990-5#1)(1994-5#1)
on the existence of##7##4##(1994-2#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
on the existence##8##3##(1994-2#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
on the existing##4##3##(1992-1#1)(2012-3#1)(2013-1#2)
on the exit site of long term central##2##8##(2007-7#2)
on the exit##5##3##(2007-7#2)(2008-2#2)(2008-3#1)
on the expected##3##3##(1993-1#1)(2008-10#1)(2011-2#1)
on the experience of the##3##5##(1992-3#1)(2008-6#1)(2012-12#1)
on the experience of##9##4##(1992-3#1)(1994-1#1)(2008-12#2)(2008-6#1)(2008-7#2)(2012-12#2)
on the experience##10##3##(1992-3#1)(1994-1#1)(1995-12#1)(2008-12#2)(2008-6#1)(2008-7#2)(2012-12#2)
on the experiences of##3##4##(1997-1#1)(2008-12#1)(2009-7#1)
on the experiences##5##3##(1995-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-7#1)
on the experimental results##2##4##(2008-10#1)(2008-8#1)
on the experimental##14##3##(1990-8#1)(1996-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-11#1)
on the exposure of##2##4##(1993-8#1)(2008-8#1)
on the exposure##4##3##(1992-11#1)(1993-8#1)(2008-8#1)(2013-1#1)
on the expression and##4##4##(1990-2#1)(1991-9#1)(2007-12#1)(2013-8#1)
on the expression level##2##4##(2008-10#1)(2010-5#1)
on the expression of resistance##2##5##(2008-10#2)
on the expression of the aggrecan##2##6##(1992-1#2)
on the expression of the##7##5##(1991-12#1)(1992-1#2)(1993-5#1)(1994-11#1)(1997-3#1)(2008-5#1)
on the expression of##43##4##(1990-3#1)(1990-5#1)(1991-12#1)(1992-1#2)(1992-3#1)(1992-8#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-8#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
on the expression##53##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-8#1)(1993-5#2)(1993-6#2)(1994-11#1)(1994-8#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#3)
on the extent of the##2##5##(2007-12#1)(2008-7#1)
on the extent of##6##4##(1997-8#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-8#1)
on the extent to which##4##5##(1993-8#1)(1995-3#1)(2009-5#2)
on the extent##11##3##(1993-11#1)(1993-8#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#2)
on the external surface##3##4##(2008-10#3)
on the external##8##3##(1993-12#1)(1996-9#2)(2007-12#1)(2008-10#4)
on the extracellular##3##3##(1990-11#1)(1990-5#2)
on the extract##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
on the extraction and##2##4##(2008-10#2)
on the extraction efficiency of##2##5##(2008-10#2)
on the extraction of the##2##5##(2008-10#2)
on the extraction of##8##4##(2008-10#7)(2012-1#1)
on the extraction##21##3##(2008-10#19)(2011-1#1)(2012-1#1)
on the extraction-ability and -selectivity##2##5##(2008-10#2)
on the fabrication##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
on the face and##2##4##(2010-6#1)(2011-2#1)
on the face##8##3##(1993-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#2)
on the facial##2##3##(1996-2#1)(2008-12#1)
on the fact that the##6##5##(1992-9#1)(2008-10#4)(2008-3#1)
on the fact that there##2##5##(2008-10#1)(2008-4#1)
on the fact that##19##4##(1990-11#1)(1992-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#2)(2008-4#2)(2010-4#1)
on the fact##20##3##(1990-11#1)(1992-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2010-4#1)
on the factors that##3##4##(1991-2#1)(1995-12#1)(2013-1#1)
on the factors##6##3##(1991-2#1)(1992-2#1)(1995-12#1)(1996-3#1)(2009-6#1)(2013-1#1)
on the family##6##3##(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#2)
on the farm##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
on the fault##4##3##(1996-4#3)(2008-3#1)
on the feasibility##2##3##(2010-3#1)(2010-8#1)
on the features of##2##4##(2007-12#1)(2010-8#1)
on the features##3##3##(2007-12#1)(2009-7#1)(2010-8#1)
on the federal##2##3##(2008-11#1)(2009-7#1)
on the female##3##3##(1994-5#1)(1995-6#2)
on the fiber##4##3##(2007-12#2)(2008-2#1)(2009-11#1)
on the fibre##2##3##(2008-10#2)
on the field##4##3##(1993-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
on the fifth day of##2##5##(1993-12#1)(2008-12#1)
on the fifth day##3##4##(1993-12#1)(2007-11#1)(2008-12#1)
on the fifth postoperative day##2##5##(2007-4#1)(2011-1#1)
on the fifth##5##3##(1993-12#1)(2007-11#1)(2007-4#1)(2008-12#1)(2011-1#1)
on the film and the##2##5##(2008-10#1)(2008-3#1)
on the film and##3##4##(2008-10#2)(2008-3#1)
on the film##6##3##(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)
on the films##2##3##(2008-11#1)(2008-3#1)
on the filter were##2##4##(2008-10#2)
on the filter##8##3##(2008-10#5)(2008-3#2)(2010-8#1)
on the final height##2##4##(2007-11#2)
on the final outcome of##2##5##(2007-11#1)(2009-5#1)
on the final outcome##3##4##(1991-6#1)(2007-11#1)(2009-5#1)
on the final##11##3##(1991-6#1)(2007-11#4)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#2)(2010-12#1)
on the financing##3##3##(1992-1#1)(1993-3#1)(2012-1#1)
on the finding of##4##4##(1990-11#1)(1990-9#1)(1996-11#1)(2008-1#1)
on the finding##7##3##(1990-11#1)(1990-9#1)(1995-6#1)(1996-11#1)(2008-1#1)(2008-10#1)(2009-10#1)
on the findings of a##3##5##(1995-2#1)(1996-3#1)(2007-2#1)
on the findings of##7##4##(1995-2#1)(1996-3#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-2#1)
on the findings##14##3##(1991-12#1)(1995-2#1)(1996-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-8#2)
on the first day after##2##5##(1990-12#1)(2007-8#1)
on the first day of life##2##6##(1990-12#1)(1993-12#1)
on the first day of##4##5##(1990-12#2)(1993-12#1)(2013-1#1)
on the first day##8##4##(1990-12#4)(1993-12#1)(2007-8#1)(2008-5#1)(2013-1#1)
on the first few##2##4##(1990-9#1)(2008-11#1)
on the first phase##2##4##(1995-12#1)(2008-12#1)
on the first postoperative day##2##5##(1990-2#1)(2007-10#1)
on the first upper true leaves at 14##2##8##(2008-10#2)
on the first##37##3##(1990-12#4)(1990-2#1)(1990-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1997-3#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
on the five##2##3##(1997-5#1)(2008-10#1)
on the flexural strength##3##4##(2008-12#2)(2009-7#1)
on the floor##5##3##(1996-5#1)(1997-2#1)(2008-11#1)(2008-6#2)
on the flow rate##3##4##(2008-10#3)
on the flow##4##3##(2008-10#4)
on the fluorescence characteristics of the##2##6##(2008-10#1)(2008-3#1)
on the fluorescence emission of##2##5##(2008-10#1)(2008-3#1)
on the fluorescence enhancement of##3##5##(2008-10#3)
on the fluorescence intensity##2##4##(2008-10#1)(2008-2#1)
on the fluorescence of##3##4##(2008-10#2)(2008-9#1)
on the fluorescence##23##3##(1996-2#1)(2008-10#16)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)
on the fluorescent##2##3##(2008-10#2)
on the focal plane##2##4##(2008-3#2)
on the focal##3##3##(2008-2#1)(2008-3#2)
on the folding##2##3##(1991-6#1)(1992-6#1)
on the following day##2##4##(2008-3#1)(2008-7#1)
on the following##19##3##(1990-9#1)(1991-6#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
on the forehead##4##3##(2008-5#3)(2010-6#1)
on the foreign##2##3##(1993-6#1)(2009-11#1)
on the formation and##3##4##(1990-2#1)(2008-10#2)
on the formation of an##3##5##(2008-10#3)
on the formation of the complex##2##6##(2008-10#2)
on the formation of the##10##5##(1991-3#1)(1993-3#1)(2008-10#7)(2011-2#1)
on the formation of##43##4##(1991-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(2007-11#1)(2008-10#35)(2010-10#1)(2010-5#1)(2011-2#1)
on the formation##48##3##(1990-2#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(2007-11#1)(2008-10#39)(2010-10#1)(2010-5#1)(2011-2#1)
on the formulation##4##3##(1995-12#1)(2008-5#2)(2012-12#1)
on the found##2##3##(2008-10#2)
on the four##2##3##(1993-2#1)(1997-8#1)
on the fourth day##3##4##(2008-5#1)(2009-12#1)(2012-2#1)
on the fraction of##4##4##(1994-5#1)(2008-10#2)(2011-3#1)
on the free energy##2##4##(1992-6#1)(2010-7#1)
on the free##5##3##(1992-6#1)(1994-3#1)(1994-6#1)(2010-7#1)(2012-2#1)
on the frequency and##2##4##(1993-12#1)(2008-1#1)
on the frequency of##6##4##(1990-8#1)(1992-11#1)(1993-1#1)(1997-1#1)(1997-3#1)(2008-5#1)
on the frequency##11##3##(1990-8#1)(1992-11#1)(1993-1#1)(1993-12#1)(1997-1#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-5#1)
on the fringe##3##3##(2008-2#1)(2008-3#2)
on the front##5##3##(2007-12#1)(2008-10#1)(2008-3#3)
on the fruit fly##2##4##(2010-5#1)(2013-8#1)
on the fruit##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
on the full##2##3##(2007-11#1)(2012-2#1)
on the function and##4##4##(1992-9#1)(1994-5#1)(1994-6#1)(2008-11#1)
on the function of the##2##5##(1990-11#1)(1997-7#1)
on the function of##9##4##(1990-11#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)
on the function##13##3##(1990-11#1)(1992-9#1)(1994-5#2)(1994-6#1)(1996-2#1)(1997-7#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)
on the functional properties of##3##5##(1990-8#1)(1995-12#2)
on the functional##12##3##(1990-7#1)(1990-8#1)(1995-12#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)
on the functions of##2##4##(2007-12#1)(2013-1#1)
on the functions##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
on the future of health##2##5##(1991-12#1)(1997-2#1)
on the future of##6##4##(1991-12#1)(1997-2#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
on the future##9##3##(1991-12#1)(1997-2#1)(2008-11#1)(2008-8#1)(2010-3#2)(2011-1#1)(2012-12#1)(2013-1#1)
on the gain margin##2##4##(2008-3#2)
on the gastric##4##3##(1990-9#1)(1995-11#2)(2008-1#1)
on the gating##2##3##(1990-11#1)(2008-8#1)
on the gel##2##3##(1993-8#1)(2008-10#1)
on the gene expression of RXR alpha##2##7##(1993-3#2)
on the gene expression of##3##5##(1992-6#1)(1993-3#2)
on the gene expression##4##4##(1992-6#1)(1993-3#2)(1993-9#1)
on the gene##8##3##(1992-3#1)(1992-6#1)(1993-3#2)(1993-9#1)(1996-6#1)(2008-7#1)(2012-3#1)
on the general##6##3##(1993-12#1)(1993-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-3#1)
on the generalizability of##2##4##(1993-3#1)(2013-8#1)
on the generation of##10##4##(1991-12#1)(1991-5#1)(1996-2#1)(2007-11#2)(2008-2#1)(2008-4#2)(2008-5#2)
on the generic##2##3##(1996-3#1)(2008-6#1)
on the genes##4##3##(1996-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
on the genetic background##2##4##(1996-5#1)(2012-3#1)
on the genetic map of##3##5##(1996-12#2)(2008-10#1)
on the genetic map##7##4##(1992-4#1)(1996-10#1)(1996-12#2)(1996-6#1)(2008-10#1)(2008-5#1)
on the genetic structure of##3##5##(2008-8#1)(2012-3#1)(2013-8#1)
on the genetic##25##3##(1992-4#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-6#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-8#1)
on the genetics and##2##4##(2008-10#1)(2008-8#1)
on the genetics of resistance in##2##6##(2008-10#1)(2011-10#1)
on the genetics of##4##4##(2007-10#1)(2008-10#2)(2011-10#1)
on the genetics##6##3##(2007-10#1)(2008-10#3)(2008-8#1)(2011-10#1)
on the genome of Synechocystis sp##4##6##(1996-8#1)(1997-2#1)(1997-6#2)
on the genome of##5##4##(1995-6#1)(1996-8#1)(1997-2#1)(1997-6#2)
on the genome##10##3##(1995-6#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-6#2)(2008-6#1)(2012-3#1)
on the genomic##4##3##(1994-12#1)(1997-3#1)(2008-10#1)(2013-8#1)
on the geometric##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
on the geometry##2##3##(2008-9#1)(2009-12#1)
on the germination of seeds of Kwao Kreu Kao (Pueraria candollei Grah##2##12##(2008-12#2)
on the giant##3##3##(2008-7#1)(2013-7#2)
on the gingiva##4##3##(1993-1#2)(2012-12#1)(2012-3#1)
on the glass surface##2##4##(1991-5#1)(2013-1#1)
on the glass##6##3##(1991-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2013-1#1)
on the glassy carbon electrode (GCE)##2##6##(2008-10#2)
on the glassy carbon electrode##3##5##(2008-10#3)
on the glassy carbon##4##4##(2008-10#4)
on the global##2##3##(2008-9#1)(2011-2#1)
on the glucose##4##3##(2008-10#3)(2012-12#1)
on the glutamate-induced rise in##2##5##(1995-12#2)
on the goals and##2##4##(1994-3#1)(1996-1#1)
on the goals##3##3##(1994-1#1)(1994-3#1)(1996-1#1)
on the gold electrode surface##2##5##(2008-10#2)
on the gold electrode##3##4##(2008-10#3)
on the gold##5##3##(2008-10#4)(2008-2#1)
on the government's##2##3##(1996-5#1)(2008-11#1)
on the graphite electrode surface##2##5##(2008-10#2)
on the graphite##4##3##(2008-10#4)
on the grating length##2##4##(2007-12#1)(2008-3#1)
on the grating plane##2##4##(2008-3#2)
on the grating##13##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#7)
on the ground of the##2##5##(2008-8#1)(2009-6#1)
on the ground##8##3##(1990-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)
on the grounds that it##2##5##(1995-12#1)(1997-4#1)
on the grounds that##5##4##(1991-12#1)(1991-7#1)(1995-12#1)(1997-4#1)(2011-2#1)
on the grounds##6##3##(1991-12#1)(1991-7#1)(1995-12#1)(1997-4#1)(2011-1#1)(2011-2#1)
on the group##3##3##(2008-2#1)(2009-10#1)(2013-8#1)
on the grove floor##3##4##(2008-10#3)
on the growth and development of##3##6##(2007-12#1)(2008-12#2)
on the growth and metabolism of##2##6##(2008-11#2)
on the growth and##14##4##(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)
on the growth of human##4##5##(1990-7#1)(1993-9#1)(1994-8#1)(2008-11#1)
on the growth of the##3##5##(1992-8#2)(2008-12#1)
on the growth of##33##4##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#2)(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the growth performance##5##4##(2010-2#4)(2012-2#1)
on the growth rate of the##2##6##(2008-10#1)(2008-7#1)
on the growth rate of##3##5##(2008-10#1)(2008-12#1)(2008-7#1)
on the growth rate##4##4##(2008-10#2)(2008-12#1)(2008-7#1)
on the growth##61##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#3)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#9)(2008-12#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#4)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-8#1)
on the guinea pig##2##4##(1992-12#1)(1992-6#1)
on the hair cycle##2##4##(2008-5#2)
on the hair##5##3##(2008-5#4)(2008-8#1)
on the hands of##2##4##(2007-12#1)(2008-10#1)
on the hands##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
on the hanging mercury drop electrode##2##6##(2008-10#2)
on the head##6##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
on the health care system##2##5##(1994-12#1)(2008-1#1)
on the health care##13##4##(1991-12#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1996-1#1)(1997-3#2)(2008-1#1)(2013-1#2)
on the health of##4##4##(2008-11#1)(2008-12#1)(2012-12#2)
on the health##27##3##(1991-12#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2012-12#2)(2013-1#3)
on the healthy##3##3##(2009-6#1)(2012-3#1)(2013-7#1)
on the heart##5##3##(2008-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)
on the heat tolerance of##2##5##(2010-4#2)
on the heat##3##3##(2008-3#1)(2010-4#2)
on the heterogeneity of the test##2##6##(2008-10#2)
on the heterogeneity of##3##4##(2007-6#1)(2008-10#2)
on the hexagonal column##2##4##(2008-3#2)
on the high seas##2##4##(2007-5#1)(2008-10#1)
on the high##9##3##(1993-6#1)(1994-11#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)
on the higher##3##3##(2008-10#2)(2011-2#1)
on the highly##2##3##(2008-10#1)(2008-7#1)
on the hippocampus##2##3##(2008-4#1)(2008-7#1)
on the histological##2##3##(1990-7#1)(1993-11#1)
on the history of##2##4##(2008-6#1)(2012-3#1)
on the history##3##3##(2008-6#1)(2012-12#1)(2012-3#1)
on the holographic##3##3##(2008-3#3)
on the horizontal##2##3##(2008-3#1)(2008-8#1)
on the hospital##3##3##(1992-3#1)(1993-1#1)(1993-3#1)
on the host and##2##4##(2008-10#2)
on the host cell##2##4##(2008-11#1)(2010-1#1)
on the host from which##2##5##(2008-10#2)
on the host##15##3##(1991-5#1)(2008-10#10)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)
on the hsp70##2##3##(2013-1#2)
on the human erythrocyte membrane##2##5##(1990-12#1)(2008-11#1)
on the human##12##3##(1990-12#1)(1992-6#1)(1994-6#1)(2008-10#2)(2008-11#2)(2008-5#3)(2011-1#1)(2012-3#1)
on the humoral immune##2##4##(2008-11#2)
on the hybrid##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
on the hydration##2##3##(2008-10#1)(2008-5#1)
on the hydrogen##2##3##(1992-12#1)(1995-2#1)
on the hydrolysis of##5##4##(1994-3#1)(1994-5#2)(2008-10#1)(2013-1#1)
on the hydrolysis##6##3##(1990-11#1)(1994-3#1)(1994-5#2)(2008-10#1)(2013-1#1)
on the hydrophilic##4##3##(1990-11#1)(1990-2#1)(2008-3#1)(2009-12#1)
on the hydrophobic##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
on the hypothesis that##4##4##(2008-11#1)(2009-8#1)(2010-8#1)(2013-1#1)
on the idea of##4##4##(2007-12#2)(2008-3#1)(2012-2#1)
on the idea##5##3##(2007-12#2)(2008-3#1)(2009-5#1)(2012-2#1)
on the identification of##9##4##(1990-7#1)(1991-12#1)(1991-5#1)(1996-12#1)(1997-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-8#1)
on the identified##2##3##(1993-12#1)(2008-12#1)
on the identity of the##3##5##(1993-11#1)(2008-5#1)(2008-8#1)
on the iliac artery##2##4##(2008-3#1)(2012-1#1)
on the illumination##2##3##(2008-3#2)
on the image formation##2##4##(2008-3#2)
on the image##6##3##(2008-2#3)(2008-3#3)
on the images of##2##4##(2010-8#1)(2011-1#1)
on the imaging##5##3##(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)
on the immediate##2##3##(2008-7#1)(2009-5#1)
on the immobilization of##3##4##(2008-10#3)
on the immobilization##4##3##(2008-10#4)
on the immobilized##2##3##(2008-10#2)
on the immune response to##2##5##(1993-8#1)(1997-4#1)
on the immune response##3##4##(1992-9#1)(1993-8#1)(1997-4#1)
on the immune responses##2##4##(1995-5#1)(1997-4#1)
on the immune status of the##2##6##(2007-2#1)(2008-5#1)
on the immune system and##2##5##(1990-11#1)(2013-1#1)
on the immune system of##3##5##(1993-12#1)(2008-10#2)
on the immune system were evaluated##2##6##(2008-10#2)
on the immune system were##3##5##(1993-12#1)(2008-10#2)
on the immune system##14##4##(1990-11#1)(1991-1#1)(1993-12#3)(1995-12#1)(2008-10#7)(2013-1#1)
on the immune##24##3##(1990-11#1)(1991-1#1)(1992-9#1)(1993-12#3)(1993-8#1)(1995-12#2)(1995-5#1)(1997-4#2)(2007-2#2)(2008-10#8)(2008-5#1)(2013-1#1)
on the impact of the##2##5##(1994-1#2)
on the impact of##11##4##(1994-1#2)(1995-6#1)(1997-6#1)(2007-11#1)(2008-11#3)(2008-3#1)(2008-5#1)(2012-2#1)
on the impact on##2##4##(2006-10#1)(2008-8#1)
on the impact##13##3##(1994-1#2)(1995-6#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
on the implant##2##3##(2008-9#1)(2009-7#1)
on the implementation of##4##4##(1995-3#1)(2008-3#2)(2009-4#1)
on the implementation strategies adopted for the instruments##2##8##(2013-1#2)
on the implementation##7##3##(1995-3#1)(2008-10#1)(2008-3#2)(2009-4#1)(2013-1#2)
on the implications of##4##4##(1994-1#1)(2008-10#1)(2008-7#2)
on the importance of the##3##5##(1991-3#1)(1996-3#1)(2010-12#1)
on the importance of##21##4##(1990-3#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
on the importance##22##3##(1990-3#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
on the important##2##3##(2006-10#1)(2010-11#1)
on the improvement##2##3##(2010-11#1)(2010-6#1)
on the in vitro##13##4##(1990-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-3#3)
on the in vivo##2##4##(1996-12#1)(2012-2#1)
on the in##15##3##(1990-2#1)(1992-8#1)(1993-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-3#3)(2012-2#1)
on the incidence and severity of##2##6##(2007-8#1)(2008-10#1)
on the incidence and##3##4##(2007-8#1)(2008-10#2)
on the incidence of##11##4##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-12#1)
on the incidence##15##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2012-12#1)
on the inclusion##3##3##(1990-2#1)(2008-10#1)(2009-6#1)
on the incorporation of##7##4##(1991-12#1)(1993-12#1)(2006-4#1)(2007-11#2)(2008-10#1)(2008-11#1)
on the increase in##2##4##(1992-8#1)(2008-1#1)
on the increase of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
on the increase##8##3##(1992-8#1)(1995-11#1)(2008-1#3)(2008-10#1)(2008-5#1)(2012-2#1)
on the incubation##2##3##(1992-9#1)(2008-10#1)
on the index##2##3##(2007-11#1)(2008-2#1)
on the indications##2##3##(2007-11#1)(2011-2#1)
on the individual##9##3##(1993-3#1)(1995-2#1)(1996-5#1)(1996-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#2)
on the induced##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
on the induction of DNA##2##5##(1991-12#1)(1997-4#1)
on the induction of##10##4##(1990-2#1)(1991-12#1)(1991-6#1)(1993-11#1)(1994-10#1)(1997-4#2)(2008-11#1)(2008-12#1)(2008-4#1)
on the induction##11##3##(1990-2#1)(1991-12#1)(1991-6#1)(1993-11#1)(1994-10#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
on the infection of##2##4##(2008-10#1)(2008-8#1)
on the infection##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
on the inflammatory process##2##4##(2008-10#1)(2008-3#1)
on the inflammatory response##2##4##(1994-5#1)(2010-2#1)
on the inflammatory##5##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)
on the influence of a##2##5##(2008-5#1)(2013-7#1)
on the influence of##10##4##(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
on the information##9##3##(1991-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(2006-10#1)(2008-12#1)(2009-5#1)
on the inhibition of gastric##2##5##(2008-11#1)(2013-1#1)
on the inhibition of##7##4##(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-9#1)(2013-1#1)
on the inhibition##10##3##(1997-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-2#1)(2009-9#1)(2013-1#1)
on the inhibitory##6##3##(1990-12#1)(1992-6#1)(1995-11#1)(2008-10#2)(2010-11#1)
on the initial MR##2##4##(1996-6#1)(2007-10#1)
on the initial##11##3##(1992-6#1)(1996-6#1)(1997-4#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
on the injection##6##3##(2007-12#1)(2008-10#3)(2008-12#1)(2010-1#1)
on the injury rate##2##4##(2008-11#2)
on the innate##2##3##(2008-10#1)(2013-1#1)
on the inner surface of the##3##6##(2008-10#2)(2008-2#1)
on the inner surface of##4##5##(2008-10#2)(2008-2#2)
on the inner##8##3##(2008-10#5)(2008-2#2)(2010-9#1)
on the input plane##2##4##(2008-3#2)
on the input##9##3##(2007-11#3)(2007-12#2)(2008-3#3)(2008-9#1)
on the inside of##2##4##(2008-10#1)(2008-2#1)
on the inside##3##3##(2008-10#2)(2008-2#1)
on the instrument##2##3##(2008-10#1)(2008-3#1)
on the insulin##2##3##(2008-11#1)(2008-9#1)
on the intact side##2##4##(1996-2#2)
on the intact##4##3##(1990-2#1)(1996-2#2)(2008-10#1)
on the integrated platform of##3##5##(2008-10#3)
on the integration of##5##4##(1995-1#1)(2008-10#3)(2009-5#1)
on the integration##6##3##(1995-1#1)(2008-10#3)(2008-3#1)(2009-5#1)
on the integrity of##5##4##(1990-5#2)(1995-2#1)(2008-2#1)(2009-2#1)
on the integument##2##3##(1991-2#1)(2007-12#1)
on the intelligentsia##2##3##(2008-12#2)
on the intensity of##4##4##(1995-12#2)(2008-9#1)(2012-3#1)
on the intensity##8##3##(1995-12#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
on the interaction between the##2##5##(2008-10#1)(2010-7#1)
on the interaction between##10##4##(2008-1#1)(2008-10#6)(2009-5#1)(2010-7#1)(2012-12#1)
on the interaction of the##2##5##(1992-12#1)(1995-5#1)
on the interaction of##16##4##(1992-12#1)(1992-6#1)(1994-8#1)(1995-5#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-9#1)
on the interaction##28##3##(1992-12#1)(1992-6#1)(1994-8#1)(1995-5#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
on the interactions between##3##4##(2008-11#1)(2008-8#2)
on the interactions of the##2##5##(1993-6#1)(2010-4#1)
on the interactions##5##3##(1993-6#1)(2008-11#1)(2008-8#2)(2010-4#1)
on the interactive##2##3##(2011-1#1)(2012-12#1)
on the interface of the##2##5##(2007-12#1)(2012-3#1)
on the interface##3##3##(2007-12#1)(2010-8#1)(2012-3#1)
on the interference##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
on the internal##3##3##(1990-2#1)(2008-10#1)(2008-2#1)
on the international##2##3##(1991-11#1)(2010-12#1)
on the internet##9##3##(1994-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-3#1)
on the interpretation of the##2##5##(2008-7#1)(2009-6#1)
on the interpretation of##5##4##(1994-11#1)(1994-3#1)(2008-12#1)(2008-7#1)(2009-6#1)
on the interpretation##6##3##(1994-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)
on the interval of the##2##5##(2008-5#2)
on the intestinal##3##3##(2008-11#3)
on the intracellular nucleotide##2##4##(2008-11#2)
on the intracellular##9##3##(1994-12#1)(1995-8#1)(2008-11#3)(2008-4#1)(2009-7#1)(2011-1#1)(2012-1#1)
on the intraocular pressure##2##4##(2012-12#1)(2013-1#1)
on the invasion of##4##4##(2008-11#3)(2008-4#1)
on the invasion##6##3##(2008-10#1)(2008-11#4)(2008-4#1)
on the inverse##2##3##(2008-10#1)(2008-2#1)
on the inversion##5##3##(2008-3#2)(2012-1#1)(2013-1#1)(2013-8#1)
on the investigation##3##3##(2007-12#2)(2013-1#1)
on the ion##3##3##(2008-10#3)
on the ion-pairing principle using##2##5##(2008-10#2)
on the ionic strength and##2##5##(1990-12#1)(1990-2#1)
on the ionic strength##3##4##(1990-12#1)(1990-2#1)(2008-10#1)
on the ionization of##2##4##(2008-10#2)
on the island of Krk##2##5##(2011-1#2)
on the island of##7##4##(1995-6#1)(2008-10#2)(2008-5#1)(2011-1#2)(2011-2#1)
on the island##10##3##(1995-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-1#3)(2011-2#1)(2013-8#1)
on the isolate##2##3##(2008-10#1)(2011-2#1)
on the isolated gamma subunit is at##2##7##(2008-8#2)
on the isolated##3##3##(1996-9#1)(2008-8#2)
on the isolation##2##3##(2008-10#1)(2008-11#1)
on the isomer##2##3##(2008-5#1)(2009-9#1)
on the isothermal characteristics of##2##5##(1997-2#2)
on the isothermal##3##3##(1997-2#3)
on the issue of##4##4##(1992-2#1)(2008-9#1)(2009-10#2)
on the issue##7##3##(1992-2#1)(1994-1#2)(2008-2#1)(2008-9#1)(2009-10#2)
on the issues of##2##4##(1991-3#1)(1993-2#1)
on the issues##4##3##(1991-3#1)(1993-2#1)(1994-12#1)(2012-3#1)
on the job in##2##4##(1993-2#2)
on the job##7##3##(1993-2#3)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)
on the joint##2##3##(1994-3#1)(2012-3#1)
on the key##4##3##(1991-7#1)(1992-9#1)(2008-11#1)(2010-12#1)
on the kidney##2##3##(1996-12#1)(2010-12#1)
on the kind of##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
on the kind##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
on the kinetic##5##3##(1993-8#1)(1995-2#1)(1996-2#1)(2008-10#2)
on the kinetics of##5##4##(1994-5#1)(2008-10#3)(2008-8#1)
on the kinetics##7##3##(1994-5#1)(1995-12#1)(2008-10#3)(2008-7#1)(2008-8#1)
on the knee##2##3##(2007-11#1)(2009-10#1)
on the knowledge of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
on the knowledge##6##3##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
on the known##4##3##(1992-12#1)(1996-12#1)(2009-5#1)(2013-1#1)
on the labeling pattern of the##2##6##(2008-7#2)
on the laboratory##2##3##(2008-5#1)(2008-6#1)
on the lack of##5##4##(1993-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
on the land##2##3##(1992-8#1)(2013-8#1)
on the large##4##3##(1996-4#1)(2008-10#1)(2008-7#1)(2009-8#1)
on the laser##8##3##(2007-12#3)(2008-2#2)(2008-3#2)(2011-1#1)
on the late control##2##4##(2013-1#2)
on the late##3##3##(2008-9#1)(2013-1#2)
on the lateral##2##3##(2007-11#1)(2008-10#1)
on the latest##5##3##(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)
on the latter##3##3##(1997-1#1)(2008-10#2)
on the leaf surface##2##4##(2008-10#2)
on the leaf##8##3##(2008-10#8)
on the learning##2##3##(2008-11#1)(2010-2#1)
on the leaves of##2##4##(2008-10#1)(2011-3#1)
on the leaves##5##3##(2008-10#4)(2011-3#1)
on the left arm of chromosome IX##2##7##(1995-6#1)(1995-9#1)
on the left arm of chromosome##7##6##(1993-9#1)(1995-6#1)(1995-9#2)(1996-3#2)(1996-6#1)
on the left arm of##9##5##(1993-9#1)(1995-6#1)(1995-9#3)(1996-3#2)(1996-6#2)
on the left arm##10##4##(1993-9#1)(1995-11#1)(1995-6#1)(1995-9#3)(1996-3#2)(1996-6#2)
on the left eye##4##4##(2011-2#4)
on the left main stem##2##5##(1990-9#2)
on the left side of the##5##6##(1993-6#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-1#1)
on the left side##16##4##(1993-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
on the left thumb##2##4##(2010-6#2)
on the left##47##3##(1990-9#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#3)(1996-3#2)(1996-6#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-6#4)(2011-1#1)(2011-2#9)(2012-3#2)(2013-1#2)(2013-8#1)
on the legal##2##3##(1992-2#1)(2013-1#1)
on the legs##2##3##(1997-5#1)(2012-3#1)
on the length of##2##4##(1996-12#1)(2008-10#1)
on the length##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2009-3#1)
on the lensing signal##2##4##(2008-2#2)
on the lensing##3##3##(2008-2#3)
on the lesioned side##2##4##(1996-5#1)(1997-2#1)
on the leukemia cell##2##4##(2007-4#1)(2008-9#1)
on the level of individuals##2##5##(2008-10#1)(2008-7#1)
on the level of membrane fatty acid composition##2##8##(2011-1#2)
on the level of the##4##5##(1991-12#1)(1994-5#1)(1995-8#1)(2008-5#1)
on the level of##29##4##(1991-12#1)(1991-8#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-8#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2013-1#3)
on the level##31##3##(1991-12#1)(1991-8#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2013-1#3)
on the levels of NADPH-dependent cytosolic 3##2##7##(1991-5#2)
on the levels of##8##4##(1991-5#2)(1992-8#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#2)
on the levels##9##3##(1991-5#2)(1992-8#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#2)(2013-8#1)
on the lidar##4##3##(2008-2#2)(2008-3#2)
on the life##7##3##(1995-12#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-10#1)(2013-1#1)
on the lifetime##2##3##(2008-3#1)(2009-9#1)
on the light##10##3##(1990-8#1)(1992-6#1)(1996-3#1)(2008-10#1)(2008-2#2)(2008-3#3)(2012-2#1)
on the likelihood of##2##4##(1995-12#1)(2010-10#1)
on the limb##2##3##(2007-8#2)
on the limitations of##3##4##(1993-9#1)(2008-11#1)(2012-12#1)
on the limits##2##3##(2008-10#1)(2008-2#1)
on the line##3##3##(2008-2#1)(2008-3#2)
on the linear relationship between the changes in the##2##9##(2008-10#2)
on the linear relationship between the##3##6##(2008-10#3)
on the linear##5##3##(1995-9#1)(2007-11#1)(2008-10#3)
on the link between##5##4##(2008-11#2)(2010-1#2)(2012-12#1)
on the link##6##3##(2008-11#2)(2010-1#2)(2010-12#1)(2012-12#1)
on the linkage map##7##4##(1996-12#4)(1996-6#2)(2008-8#1)
on the linkage##8##3##(1996-12#4)(1996-6#2)(2008-8#1)(2012-3#1)
on the lipid composition of rat##3##6##(1990-7#2)(1994-6#1)
on the lipid composition of##4##5##(1990-7#2)(1994-2#1)(1994-6#1)
on the lipid composition##5##4##(1990-7#2)(1994-2#1)(1994-6#1)(2008-5#1)
on the lipid metabolism##2##4##(1992-11#1)(2008-11#1)
on the lipid##12##3##(1990-2#2)(1990-7#2)(1991-5#1)(1992-11#1)(1994-2#1)(1994-6#1)(2008-11#1)(2008-5#2)(2009-8#1)
on the liposome surface##2##4##(2008-10#2)
on the liposome##3##3##(1994-9#1)(2008-10#2)
on the liquid-liquid extraction of##2##5##(2008-10#2)
on the list of##2##4##(1995-6#1)(2011-2#1)
on the literature##8##3##(1997-3#1)(2007-11#3)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
on the liver##4##3##(1991-7#1)(1994-9#1)(1995-6#1)(1996-5#1)
on the lives of##2##4##(1997-2#1)(2008-11#1)
on the loading##2##3##(2008-10#1)(2009-7#1)
on the local##10##3##(1995-11#1)(1995-12#1)(2007-4#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the localization##2##3##(2008-9#1)(2012-3#1)
on the location and##3##4##(2008-3#1)(2012-12#1)(2013-1#1)
on the location of the##3##5##(1992-8#1)(2007-11#1)(2008-3#1)
on the location of##4##4##(1992-8#1)(2007-11#1)(2008-11#1)(2008-3#1)
on the location##9##3##(1992-8#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-9#1)(2012-12#1)(2013-1#2)
on the locations of##2##4##(2008-10#1)(2008-11#1)
on the locomotor rhythm##2##4##(2008-5#1)(2008-6#1)
on the locomotor##3##3##(2008-5#2)(2008-6#1)
on the log##2##3##(1997-8#1)(2008-10#1)
on the long arm of chromosome##7##6##(2008-10#3)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long arm of wheat##2##6##(2008-10#2)
on the long arm of##11##5##(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long arm##12##4##(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long##13##3##(1997-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long-term##6##3##(1995-11#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-8#1)
on the loss of##2##4##(1993-11#1)(2008-2#1)
on the low##3##3##(1993-6#1)(2008-7#1)(2009-8#1)
on the lower bole##2##4##(2008-10#2)
on the lower rim##2##4##(1996-5#2)
on the lower##7##3##(1996-5#2)(2007-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
on the lowered side and a decrease on the lifted side##2##11##(2008-5#2)
on the lumbosacral area##2##4##(2010-6#2)
on the lymphoid tissues##2##4##(1996-12#2)
on the lymphoid##3##3##(1996-12#3)
on the magnetic beads##2##4##(2008-10#2)
on the magnetic##3##3##(2008-10#3)
on the magnitude of the##3##5##(2008-10#1)(2008-3#1)(2008-8#1)
on the magnitude of##6##4##(1994-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)
on the magnitude##7##3##(1994-5#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-1#1)
on the main##10##3##(1993-2#1)(1994-12#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#2)(2012-3#1)
on the major##8##3##(1991-12#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
on the man made mounds in the##3##7##(2008-12#3)
on the management of##10##4##(2007-12#1)(2008-3#2)(2008-8#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-1#1)
on the management##12##3##(1993-1#1)(2007-12#1)(2008-3#3)(2008-8#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-1#1)
on the manner##2##3##(1992-1#1)(2008-10#1)
on the mapping of##2##4##(2008-10#1)(2008-11#1)
on the margins##2##3##(1997-8#1)(2008-9#1)
on the marine environment##3##4##(2008-11#3)
on the marker##2##3##(2008-10#2)
on the market for##5##4##(1990-6#1)(1992-3#2)(1994-2#1)(2007-8#1)
on the market##18##3##(1990-6#1)(1991-2#1)(1992-3#2)(1994-2#1)(1994-5#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2013-8#1)
on the mass of##2##4##(1997-5#1)(2008-9#1)
on the material##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
on the maternal##2##3##(1995-8#1)(2013-1#1)
on the maturation##2##3##(1995-6#1)(2007-3#1)
on the mature##5##3##(1990-12#1)(1995-12#1)(2006-6#1)(2008-9#2)
on the maxillary##2##3##(2007-12#1)(2010-11#1)
on the maximum##4##3##(2008-1#1)(2008-6#2)(2012-3#1)
on the mean##7##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-7#1)
on the meaning of##3##4##(1993-2#1)(1994-9#1)(2011-3#1)
on the meaning##4##3##(1993-2#1)(1994-9#1)(2009-6#1)(2011-3#1)
on the measured##12##3##(1994-12#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2010-8#1)(2013-7#1)
on the measurement accuracy##2##4##(2008-3#2)
on the measurement of optical properties##2##6##(2008-3#2)
on the measurement of the##8##5##(2008-10#6)(2008-3#1)(2008-4#1)
on the measurement of##22##4##(1997-4#1)(2008-10#11)(2008-3#7)(2008-4#1)(2008-9#2)
on the measurement##30##3##(1997-4#1)(2008-10#12)(2008-2#3)(2008-3#10)(2008-4#1)(2008-9#2)(2012-3#1)
on the measurements of##3##4##(2008-10#2)(2008-3#1)
on the measurements##4##3##(1993-11#1)(2008-10#2)(2008-3#1)
on the mechanical properties and##2##5##(2010-4#1)(2012-2#1)
on the mechanical properties of the##2##6##(2008-6#1)(2011-2#1)
on the mechanical properties of##6##5##(2008-10#1)(2008-6#1)(2009-7#2)(2011-2#2)
on the mechanical properties##11##4##(2008-10#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-7#3)(2010-4#1)(2011-2#2)(2012-2#1)
on the mechanical##18##3##(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#4)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#2)
on the mechanism and##2##4##(2007-11#1)(2008-10#1)
on the mechanism of action of##2##6##(1997-2#1)(2008-10#1)
on the mechanism of action##4##5##(1993-12#1)(1997-2#1)(2008-10#1)(2010-11#1)
on the mechanism of##12##4##(1990-11#1)(1990-2#1)(1993-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2010-10#1)(2010-11#1)
on the mechanism##15##3##(1990-11#1)(1990-2#1)(1993-12#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2009-9#1)(2010-10#1)(2010-11#1)
on the mechanisms by which##2##5##(2010-1#1)(2013-1#1)
on the mechanisms of##7##4##(1996-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
on the mechanisms##12##3##(1993-6#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-1#1)(2013-1#2)
on the medial surface of##2##5##(2007-12#1)(2008-5#1)
on the medial##5##3##(2007-12#2)(2008-5#1)(2008-9#1)(2011-1#1)
on the median##2##3##(2008-10#1)(2013-8#1)
on the medical##9##3##(1992-2#1)(1994-2#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#2)
on the medium##6##3##(1990-12#1)(2006-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
on the membrane by##2##4##(2008-10#1)(2010-5#1)
on the membrane potential##3##4##(1990-5#1)(1993-11#1)(1997-1#1)
on the membrane##15##3##(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1995-2#1)(1997-1#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-5#2)
on the membranes##3##3##(1990-2#1)(1992-6#2)
on the mercury electrode##3##4##(2008-10#3)
on the mercury##6##3##(2008-10#6)
on the metabolic##4##3##(1990-5#1)(1991-12#1)(2012-2#1)(2013-1#1)
on the metabolism of##6##4##(1992-3#1)(1993-6#1)(1995-11#1)(2008-11#2)(2011-2#1)
on the metal ion##2##4##(2008-10#2)
on the metal surface##3##4##(2007-12#2)(2008-5#1)
on the metal##12##3##(1994-5#1)(1996-2#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-5#1)(2010-11#1)
on the metallic##2##3##(2008-10#1)(2008-3#1)
on the method of##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
on the method used for##2##5##(2008-10#1)(2011-2#1)
on the method used##4##4##(2007-11#1)(2008-10#2)(2011-2#1)
on the method##10##3##(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
on the microbiology of##2##4##(1997-5#1)(2012-2#1)
on the microcarrier##2##3##(2008-11#1)(2008-9#1)
on the microchip##2##3##(2008-10#2)
on the microelectrode##2##3##(2008-10#2)
on the microsecond time scale##2##5##(1990-8#1)(1995-2#1)
on the microsecond##3##3##(1990-8#1)(1995-2#1)(2008-2#1)
on the microshear bond strength of##3##6##(2013-1#3)
on the microstructure of##2##4##(2008-5#2)
on the micturition reflex in anesthetized rats##2##7##(1990-5#2)
on the micturition reflex##3##4##(1990-5#2)(1992-3#1)
on the migration of##3##4##(2008-1#1)(2008-10#1)(2010-7#1)
on the migration##5##3##(2008-1#1)(2008-10#2)(2010-7#1)(2012-3#1)
on the mitochondrial##2##3##(2010-4#1)(2011-2#1)
on the mixed##2##3##(2008-10#2)
on the mixture##2##3##(2008-10#1)(2008-6#1)
on the mode of##3##4##(1997-2#1)(1997-7#1)(2010-4#1)
on the mode##4##3##(1997-2#1)(1997-7#1)(2008-2#1)(2010-4#1)
on the model of##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
on the model##11##3##(1996-12#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#1)
on the modified electrode##3##4##(2008-10#3)
on the modified##9##3##(2008-10#7)(2008-3#2)
on the modulation of##4##4##(1991-9#1)(1993-6#1)(2007-11#1)(2009-8#1)
on the modulation##6##3##(1991-9#1)(1993-6#1)(2007-11#1)(2008-3#2)(2009-8#1)
on the moiré fringes in Talbot interferometry##2##7##(2008-3#2)
on the moiré fringes in##3##5##(2008-3#3)
on the moiré fringes##4##4##(2008-3#4)
on the moiré##5##3##(2008-2#1)(2008-3#4)
on the molar absorptivity##2##4##(2008-10#2)
on the molar##3##3##(2008-10#3)
on the mole fraction scale##2##5##(1990-8#2)
on the molecular and##2##4##(2007-10#1)(2009-8#1)
on the molecular basis of##2##5##(1990-8#1)(2008-8#1)
on the molecular level##2##4##(2008-10#1)(2008-7#1)
on the molecular mechanism of##2##5##(2011-3#1)(2012-1#1)
on the molecular mechanisms of##4##5##(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
on the molecular mechanisms##7##4##(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
on the molecular structure##2##4##(1994-5#1)(2006-6#1)
on the molecular##26##3##(1990-8#1)(1994-5#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
on the monitoring of##2##4##(2008-10#2)
on the morbidity and mortality of the##2##7##(2012-3#1)(2013-8#1)
on the morbidity and mortality of##3##6##(2008-8#1)(2012-3#1)(2013-8#1)
on the morbidity and mortality##4##5##(2006-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
on the more##6##3##(1992-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
on the morphological##4##3##(2007-12#1)(2008-3#1)(2008-5#2)
on the morphology and##3##4##(1996-5#1)(2008-10#1)(2011-2#1)
on the morphology of##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
on the morphology##7##3##(1996-5#1)(2008-10#3)(2008-6#1)(2011-2#1)(2013-1#1)
on the mortality of##2##4##(2008-1#1)(2008-10#1)
on the mortality##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
on the most##10##3##(1996-1#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)
on the mother's##3##3##(1992-4#2)(2008-11#1)
on the motion##2##3##(1996-12#1)(2008-3#1)
on the motor##2##3##(1991-2#1)(2008-7#1)
on the multiplicity##2##3##(1997-3#1)(2008-4#1)
on the multivariate##2##3##(1992-6#1)(2009-12#1)
on the nanometer scale##2##4##(2007-12#1)(2008-2#1)
on the nanoscale##3##3##(2008-7#1)(2009-4#1)(2010-4#1)
on the nasolabial fold and chin##2##6##(2008-5#2)
on the nasolabial fold##3##4##(2008-5#3)
on the national##3##3##(1995-1#1)(1995-2#1)(2008-1#1)
on the native fluorescence##2##4##(2008-10#2)
on the native##5##3##(1995-3#1)(2008-10#2)(2008-2#1)(2011-3#1)
on the natural history of##3##5##(1991-6#1)(2008-10#1)(2011-3#1)
on the natural history##4##4##(1991-6#1)(2008-10#1)(2009-8#1)(2011-3#1)
on the natural##9##3##(1991-6#1)(1992-9#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-3#1)
on the nature and##7##4##(1996-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-11#1)(2012-12#1)
on the nature of the##12##5##(1990-5#1)(1990-8#1)(1994-11#1)(1994-5#1)(2008-10#4)(2008-3#2)(2008-8#1)(2013-1#1)
on the nature of##24##4##(1990-5#1)(1990-8#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2013-1#2)
on the nature##31##3##(1990-5#1)(1990-8#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#2)
on the necessity of##2##4##(2008-10#1)(2011-1#1)
on the neck##4##3##(1992-12#1)(1997-6#1)(2008-7#1)(2010-12#1)
on the need for##2##4##(2008-10#1)(2008-5#1)
on the need##4##3##(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
on the needs of the##3##5##(1993-1#2)(1996-1#1)
on the needs of##5##4##(1993-1#2)(1993-12#1)(1996-1#1)(2010-6#1)
on the needs##6##3##(1991-6#1)(1993-1#2)(1993-12#1)(1996-1#1)(2010-6#1)
on the negative##2##3##(1994-2#1)(2011-2#1)
on the nerve##3##3##(2006-12#1)(2010-1#1)(2011-1#1)
on the nervous tissue##2##4##(1990-3#1)(2006-12#1)
on the network##5##3##(1997-3#3)(2007-12#1)(2012-3#1)
on the neural##3##3##(2008-9#1)(2009-8#1)(2013-1#1)
on the neuromuscular##2##3##(1992-8#1)(2008-12#1)
on the new##9##3##(1992-1#1)(2008-10#6)(2008-7#1)(2008-8#1)
on the newer##2##3##(2012-2#1)(2013-1#1)
on the night side of##2##5##(1991-5#2)
on the night##3##3##(1991-5#2)(2008-2#1)
on the nitrosation##3##3##(1992-8#2)(2008-10#1)
on the nonlinear##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
on the normal##7##3##(1993-11#1)(1993-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
on the nose##3##3##(2008-5#3)
on the nuclear##2##3##(1995-2#1)(2008-10#1)
on the nucleotide##4##3##(1993-12#1)(2007-6#1)(2008-10#2)
on the number and##3##4##(1994-6#2)(2008-10#1)
on the number of people##2##5##(1994-2#1)(1995-12#1)
on the number of##22##4##(1990-12#1)(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)
on the number##27##3##(1990-12#1)(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#2)
on the numbers of##2##4##(2008-9#2)
on the numbers##3##3##(2008-8#1)(2008-9#2)
on the numerical aperture##2##4##(2007-11#1)(2007-12#1)
on the numerical##6##3##(2007-11#2)(2007-12#1)(2008-3#2)(2008-6#1)
on the nutrient##2##3##(2008-10#1)(2013-8#1)
on the object surface##2##4##(2008-2#1)(2008-3#1)
on the object##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
on the observation of##4##4##(1994-3#1)(2007-11#2)(2007-8#1)
on the observation that##4##4##(1994-5#1)(1997-6#1)(2008-4#1)(2008-6#1)
on the observation##9##3##(1994-3#1)(1994-5#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)
on the observations##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
on the observed##7##3##(1994-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)
on the obtained##6##3##(2008-10#4)(2013-8#2)
on the occasion of his##2##5##(1990-8#1)(1992-5#1)
on the occasion of the##2##5##(1994-3#1)(1997-3#1)
on the occasion of##6##4##(1990-8#1)(1992-5#1)(1994-3#1)(1997-3#1)(2008-11#1)(2013-1#1)
on the occipital scalp##2##4##(2010-6#2)
on the occipital##3##3##(2008-7#1)(2010-6#2)
on the occurrence and##2##4##(2008-10#1)(2008-8#1)
on the occurrence of##7##4##(1992-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-8#1)
on the occurrence##9##3##(1992-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#1)
on the olfactory epithelium##2##4##(2008-5#1)(2008-6#1)
on the one hand and##4##5##(1991-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
on the one hand the##2##5##(1991-11#1)(2008-3#1)
on the one hand##24##4##(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1994-1#1)(1994-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2013-1#1)
on the one##25##3##(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1994-1#1)(1994-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2013-1#1)
on the ongoing##2##3##(1994-12#1)(2011-1#1)
on the onset of##3##4##(1990-11#1)(1991-12#1)(2009-8#1)
on the operated##2##3##(2007-8#1)(2008-5#1)
on the operating##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
on the operative##2##3##(2007-8#1)(2012-12#1)
on the opposite side##5##4##(2008-3#1)(2008-5#1)(2009-6#2)(2011-1#1)
on the opposite##7##3##(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#2)(2011-1#1)(2012-4#1)
on the optical and##2##4##(2008-10#1)(2008-3#1)
on the optical axis##4##4##(2007-12#1)(2008-3#3)
on the optical biosensor##2##4##(1997-2#2)
on the optical properties of the##2##6##(2008-3#2)
on the optical properties of##6##5##(2007-11#2)(2008-2#1)(2008-3#2)(2011-1#1)
on the optical properties##7##4##(2007-11#2)(2008-2#1)(2008-3#2)(2010-9#1)(2011-1#1)
on the optical thickness of the##2##6##(2007-11#1)(2008-3#1)
on the optical##34##3##(1997-2#2)(2007-11#5)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#18)(2010-9#1)(2011-1#1)
on the optimal##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
on the optimum##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
on the oral##3##3##(1993-1#1)(2011-2#1)(2011-7#1)
on the orange-spotted grouper##2##4##(2010-5#2)
on the orchard floor and##2##5##(2008-10#2)
on the orchard floor##5##4##(2008-10#5)
on the orchard##6##3##(2008-10#6)
on the order of 0##2##5##(2007-12#1)(2008-10#1)
on the order of 1##3##5##(2008-8#1)(2008-9#1)(2009-7#1)
on the order of 10##3##5##(1995-6#1)(2008-7#1)(2009-12#1)
on the order of a##2##5##(2009-11#1)(2009-5#1)
on the order of##19##4##(1992-2#1)(1993-11#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)
on the order##20##3##(1992-2#1)(1993-11#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)
on the organization of##2##4##(1994-5#1)(2008-3#1)
on the organization##3##3##(1994-5#1)(1995-12#1)(2008-3#1)
on the orientation of the##3##5##(2006-4#1)(2008-3#2)
on the orientation##4##3##(2006-4#1)(2008-10#1)(2008-3#2)
on the origin and##2##4##(2012-3#2)
on the origin of##8##4##(1990-8#2)(2008-10#3)(2010-1#1)(2011-2#1)(2013-1#1)
on the origin##10##3##(1990-8#2)(2008-10#3)(2010-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
on the original article##3##4##(2013-1#3)
on the original data##2##4##(2008-10#1)(2008-8#1)
on the original##11##3##(1990-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
on the oscillating##3##3##(2008-10#3)
on the osmotic##3##3##(1990-2#1)(1994-2#1)(2009-12#1)
on the other hand is##2##5##(2007-11#1)(2008-5#1)
on the other hand##60##4##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#3)(2009-5#2)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
on the other side##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
on the other##91##3##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#1)(2009-5#2)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
on the outcome of rehabilitation##2##5##(2007-11#1)(2007-8#1)
on the outcome of the##2##5##(2009-12#1)(2011-2#1)
on the outcome of##12##4##(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
on the outcome##17##3##(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
on the outcomes of##2##4##(1996-3#1)(2008-4#1)
on the outcomes##5##3##(1991-12#1)(1994-11#1)(1996-3#1)(2008-4#1)(2013-1#1)
on the outer coast##2##4##(1990-11#2)
on the outer##6##3##(1990-11#2)(1995-2#1)(2007-12#1)(2008-10#1)(2008-5#1)
on the outermost##2##3##(2008-10#1)(2008-5#1)
on the output plane##3##4##(2008-3#3)
on the output##9##3##(2007-12#1)(2008-2#2)(2008-3#5)(2010-8#1)
on the outside of the##3##5##(2008-10#1)(2012-2#2)
on the outside##4##3##(1996-12#1)(2008-10#1)(2012-2#2)
on the overall##13##3##(1991-2#1)(1993-5#1)(1994-12#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2011-2#1)(2012-2#1)
on the oxidant and antioxidant status##2##6##(2008-12#2)
on the oxidation of N##2##5##(2008-10#2)
on the oxidation of methylene blue (MB)##2##7##(2008-10#2)
on the oxidation of##39##4##(2008-10#39)
on the oxidation reaction of##5##5##(2008-10#5)
on the oxidation##46##3##(2008-10#46)
on the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone##2##7##(2008-10#2)
on the oxidative coupling of##4##5##(2008-10#4)
on the oxidative coupling##5##4##(2008-10#5)
on the oxide surface##2##4##(2009-11#2)
on the oxygen##2##3##(1993-8#1)(2013-8#1)
on the ozone##3##3##(1996-1#1)(2008-2#1)(2008-3#1)
on the pH and ionic strength##2##6##(1990-12#1)(2008-10#1)
on the pH and##4##4##(1990-12#1)(2008-10#2)(2008-3#1)
on the pH of the##4##5##(1991-5#1)(1995-6#1)(2008-10#2)
on the pH##14##3##(1990-12#1)(1991-5#1)(1993-8#1)(1995-6#1)(2008-10#9)(2008-3#1)
on the pKa of the leaving group##2##7##(1993-8#2)
on the pad##3##3##(2008-5#3)
on the parameters of the##5##5##(1993-3#1)(2008-10#2)(2009-10#1)(2011-2#1)
on the parameters of##6##4##(1993-3#1)(2008-10#2)(2009-10#1)(2011-2#1)(2013-8#1)
on the parameters##10##3##(1990-11#1)(1993-3#1)(1995-9#1)(2008-10#2)(2009-10#2)(2009-5#1)(2011-2#1)(2013-8#1)
on the parasite##2##3##(1997-7#1)(2012-2#1)
on the parasites of##2##4##(2013-1#2)
on the parents##2##3##(1992-4#1)(2013-1#1)
on the parhelic circle##3##4##(2008-3#3)
on the parietal##2##3##(1992-6#1)(2008-10#1)
on the part of the##5##5##(1990-11#1)(1995-2#1)(1995-5#1)(2008-12#1)(2008-9#1)
on the part of##14##4##(1990-11#1)(1992-1#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
on the partial##2##3##(1990-2#1)(2008-10#1)
on the partially##2##3##(1990-5#1)(2008-5#1)
on the particle size##3##4##(1997-2#1)(2008-5#1)(2008-8#1)
on the particle##7##3##(1992-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)
on the particles##3##3##(1997-2#1)(2008-10#2)
on the particular##2##3##(2008-10#1)(2008-3#1)
on the partition##2##3##(2008-11#1)(2008-6#1)
on the partitioning##2##3##(2008-10#2)
on the passage##2##3##(1995-2#1)(2008-9#1)
on the path to##2##4##(1996-3#1)(2011-2#1)
on the path##4##3##(1996-3#1)(2008-3#2)(2011-2#1)
on the pathogen in##2##4##(2008-10#2)
on the pathogen##6##3##(2008-10#5)(2008-9#1)
on the pathogenesis of##11##4##(1994-7#1)(1996-11#1)(2006-6#1)(2008-1#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
on the pathogenicity##2##3##(2008-10#1)(2008-11#1)
on the pathological##3##3##(1997-3#1)(2008-10#1)(2008-6#1)
on the pathology and##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
on the pathophysiology of##2##4##(2008-4#1)(2010-12#1)
on the pathophysiology##6##3##(2008-4#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
on the patient##10##3##(1990-11#1)(1993-2#1)(1994-2#1)(1995-2#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
on the patient's##12##3##(1991-6#1)(1994-3#1)(1996-9#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2013-1#1)
on the patients##3##3##(1990-2#1)(2009-10#1)(2011-2#1)
on the patients'##3##3##(1991-2#1)(2009-1#1)(2011-2#1)
on the pattern of##4##4##(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)
on the pattern##6##3##(1991-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
on the patterns##2##3##(2008-2#1)(2012-2#1)
on the peak##5##3##(2007-10#1)(2008-10#4)
on the perceived##5##3##(2008-2#1)(2011-2#1)(2013-1#3)
on the percent##3##3##(2008-10#3)
on the percentage of##8##4##(1995-5#1)(2008-10#4)(2010-4#2)(2011-2#1)
on the perception of##3##4##(2012-3#1)(2013-8#2)
on the perception##5##3##(1991-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
on the performance of a##5##5##(2008-3#4)(2009-11#1)
on the performance of an optical##2##6##(2008-10#1)(2008-2#1)
on the performance of the##5##5##(1991-2#1)(1992-12#1)(1992-2#1)(2008-10#1)(2008-6#1)
on the performance of##32##4##(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1994-1#2)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#9)(2008-6#1)(2009-11#2)(2011-2#1)
on the performance##33##3##(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1994-1#2)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#9)(2008-6#1)(2009-11#2)(2011-2#1)
on the performances of the##2##5##(2008-10#2)
on the perineum##2##3##(2008-7#2)
on the periodontal##3##3##(1996-2#1)(2008-1#1)(2012-3#1)
on the peripheral##2##3##(2011-2#1)(2012-3#1)
on the periphery of##2##4##(2007-12#1)(2008-9#1)
on the periphery##3##3##(2007-12#1)(2008-12#1)(2008-9#1)
on the permeation profile of flavonoids##2##6##(2008-5#2)
on the permeation##3##3##(2008-10#1)(2008-5#2)
on the peroxidase##2##3##(2008-10#2)
on the personal##3##3##(2008-11#1)(2008-2#1)(2009-7#1)
on the perspective of##2##4##(2008-1#1)(2010-10#1)
on the pharmacokinetic##2##3##(2011-2#1)(2013-8#1)
on the pharmacokinetics of YH439 and its metabolites in rats##2##10##(2008-11#2)
on the pharmacokinetics of##3##4##(2008-11#2)(2011-2#1)
on the pharmacokinetics##4##3##(2008-11#2)(2011-2#1)(2012-3#1)
on the pharmacological##2##3##(2008-5#1)(2012-12#1)
on the phase##5##3##(1992-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
on the phenomenology of##2##4##(2008-11#1)(2010-6#1)
on the phenomenon##3##3##(1993-6#1)(2008-10#1)(2008-9#1)
on the phenotype##3##3##(1995-8#1)(2008-6#1)(2012-2#1)
on the phenotypes##2##3##(2008-4#1)(2008-8#1)
on the phosphatase activity##2##4##(1997-2#1)(2008-9#1)
on the phosphate##2##3##(2008-10#1)(2010-10#1)
on the phospholipid##3##3##(1992-3#2)(2008-10#1)
on the phosphorylation state of##2##5##(1994-6#1)(1997-2#1)
on the photochemical##2##3##(2008-10#1)(2008-11#1)
on the photodetector##2##3##(2008-2#1)(2008-3#1)
on the photorefractive##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
on the photosynthetic##2##3##(2008-10#2)
on the physical characteristics of the##2##6##(1990-9#1)(1996-3#1)
on the physical characteristics of##3##5##(1990-9#1)(1996-3#1)(2008-7#1)
on the physical map of##3##5##(1995-6#1)(1997-6#1)(1997-8#1)
on the physical map##4##4##(1995-6#1)(1997-6#1)(1997-8#1)(1997-9#1)
on the physical properties of the##2##6##(2008-5#1)(2013-1#1)
on the physical properties of##5##5##(1991-1#1)(1993-11#1)(2008-5#1)(2013-1#1)(2013-7#1)
on the physical##22##3##(1990-5#1)(1990-9#1)(1991-1#1)(1993-11#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-1#1)(2013-7#2)
on the physico-chemical##2##3##(1992-6#1)(2008-10#1)
on the physiological##3##3##(2008-7#2)(2009-8#1)
on the physiology of the##2##5##(1993-2#1)(2011-1#1)
on the pineal gland##2##4##(1994-2#1)(1995-3#1)
on the plain film##2##4##(2007-11#2)
on the planning and##2##4##(1993-12#1)(1996-2#1)
on the plant surface##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
on the plant##9##3##(1992-3#1)(2008-10#4)(2008-8#2)(2009-8#2)
on the plasma concentration of##2##5##(2013-8#2)
on the plasma membrane of the##3##6##(1994-11#1)(2008-8#2)
on the plasma membrane of##4##5##(1993-3#1)(1994-11#1)(2008-8#2)
on the plasma membrane##6##4##(1993-3#1)(1994-11#1)(1994-3#1)(2008-4#1)(2008-8#2)
on the plasma##13##3##(1991-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-4#1)(2008-8#2)(2012-2#1)(2013-8#2)
on the plate##3##3##(2008-10#2)(2012-3#1)
on the platelet surface and##2##5##(1990-5#1)(2006-6#1)
on the platelet surface##3##4##(1990-5#1)(1994-12#1)(2006-6#1)
on the platelet##4##3##(1990-5#1)(1993-6#1)(1994-12#1)(2006-6#1)
on the plates##2##3##(2008-10#1)(2008-11#1)
on the point-spread function##2##4##(2008-3#2)
on the polar##2##3##(1994-5#1)(2008-11#1)
on the polarity of##2##4##(2008-5#1)(2012-12#1)
on the polarization direction of##2##5##(2008-3#2)
on the polarization of the incident##2##6##(2007-11#1)(2008-3#1)
on the polarization of##4##4##(2007-11#1)(2008-3#3)
on the polarization state of the incident##2##7##(2008-2#1)(2008-3#1)
on the polarization##12##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#6)
on the polarized##2##3##(2008-2#1)(2008-3#1)
on the poling##2##3##(2007-12#2)
on the polymer surface##2##4##(2008-10#1)(2008-5#1)
on the polymer##5##3##(2008-10#4)(2008-5#1)
on the polymerase##3##3##(1993-8#1)(2008-10#2)
on the population dynamics of##2##5##(1994-8#1)(2010-12#1)
on the population dynamics##4##4##(1994-8#1)(2008-8#1)(2010-12#1)(2013-8#1)
on the population level##2##4##(2010-12#1)(2011-1#1)
on the population structure##2##4##(2008-10#2)
on the population##18##3##(1991-6#1)(1994-8#1)(2008-1#1)(2008-10#5)(2008-8#2)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
on the position of the desired image##2##7##(2008-3#2)
on the position of the##4##5##(2008-2#1)(2008-3#2)(2009-5#1)
on the position of##5##4##(2008-2#1)(2008-3#2)(2009-5#1)(2010-2#1)
on the positive inotropic##2##4##(1997-7#2)
on the positive##7##3##(1990-10#1)(1993-1#1)(1997-7#2)(1997-8#1)(2007-7#1)(2012-12#1)
on the possibilities##2##3##(2008-11#1)(2008-6#1)
on the possibility that##2##4##(2008-1#1)(2008-4#1)
on the possibility##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
on the possible##9##3##(1990-6#1)(1993-2#1)(1993-5#1)(2007-12#2)(2008-1#1)(2008-11#1)(2012-2#1)(2013-8#1)
on the posterior##7##3##(1991-6#1)(1993-1#1)(1994-11#1)(2007-10#1)(2007-8#1)(2010-5#1)(2013-1#1)
on the postnatal##2##3##(1993-12#1)(2012-2#1)
on the potential of##2##4##(2008-11#1)(2012-12#1)
on the potential response of the##2##6##(2008-10#2)
on the potential response of##3##5##(2008-10#3)
on the potential role of##3##5##(2008-1#1)(2008-5#1)(2012-12#1)
on the potential##22##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-5#1)(2010-3#1)(2011-3#1)(2012-12#2)(2013-7#1)(2013-8#1)
on the potentiometric selectivity##2##4##(2008-10#2)
on the power of##2##4##(2008-11#1)(2008-2#1)
on the power##6##3##(1992-6#1)(2008-11#1)(2008-2#2)(2008-8#1)(2010-10#1)
on the powerful##2##3##(2008-3#1)(2011-2#1)
on the practical aspects of##2##5##(2008-11#1)(2010-3#1)
on the practical implications of using##2##6##(2008-11#1)(2008-4#1)
on the practical##4##3##(2008-11#2)(2008-4#1)(2010-3#1)
on the practice of##4##4##(1991-6#1)(2007-7#1)(2008-11#2)
on the practice##5##3##(1991-6#1)(2007-7#1)(2008-11#3)
on the precipitation##3##3##(2008-10#2)(2008-7#1)
on the precision##3##3##(2008-10#3)
on the preclinical##2##3##(2007-5#1)(2008-10#1)
on the preconcentration of##2##4##(2008-10#2)
on the preconcentration##4##3##(2008-10#4)
on the prediction##3##3##(1993-12#1)(2008-10#2)
on the predictive##2##3##(1992-2#1)(2008-10#1)
on the premise that##5##4##(1992-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
on the preparation of##3##4##(2006-12#1)(2008-5#1)(2012-3#1)
on the prescribed##2##3##(2007-4#1)(2008-10#1)
on the presence and##2##4##(1997-8#1)(2008-10#1)
on the presence in##2##4##(1990-5#1)(1993-8#1)
on the presence of a##2##5##(1993-9#1)(2007-12#1)
on the presence of extracellular Ca2+##2##6##(1991-5#1)(1994-6#1)
on the presence of extracellular##4##5##(1991-5#1)(1992-3#1)(1993-12#1)(1994-6#1)
on the presence of the##3##5##(1991-3#1)(1994-12#1)(1995-2#1)
on the presence of##48##4##(1990-2#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
on the presence or absence of##6##6##(2008-10#3)(2008-12#1)(2008-8#1)(2010-7#1)
on the presence##58##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
on the present##4##3##(1994-2#1)(2008-1#1)(2009-10#1)(2011-2#1)
on the pressor response##2##4##(1992-8#2)
on the pressor##3##3##(1992-8#2)(1997-2#1)
on the pressure##3##3##(2008-2#1)(2010-2#1)(2010-9#1)
on the prevalence of the##2##5##(2008-1#1)(2008-3#1)
on the prevalence of##16##4##(1991-11#1)(1991-4#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-8#3)
on the prevalence##17##3##(1991-11#1)(1991-4#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-8#3)
on the prevention and##3##4##(2008-7#1)(2010-5#1)(2013-1#1)
on the prevention of cervical cancer##2##6##(2011-1#2)
on the prevention of##6##4##(2007-2#1)(2007-7#1)(2011-1#3)(2013-8#1)
on the prevention##9##3##(2007-2#1)(2007-7#1)(2008-7#1)(2010-5#1)(2011-1#3)(2013-1#1)(2013-8#1)
on the prey##2##3##(2008-9#1)(2012-3#1)
on the primary and##2##4##(1992-6#1)(2008-10#1)
on the primary##8##3##(1990-12#1)(1992-6#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-8#1)
on the principal##2##3##(2008-10#1)(2010-11#1)
on the principle of##7##4##(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2012-12#1)
on the principle that##2##4##(1994-2#1)(2008-4#1)
on the principle##10##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-12#1)
on the principles of##5##4##(1991-2#1)(1992-12#1)(1996-12#1)(2008-10#1)(2013-1#1)
on the probability of##4##4##(1993-8#1)(1996-7#1)(2008-8#1)(2011-2#1)
on the probable##2##3##(2008-3#1)(2009-6#1)
on the problem of##3##4##(1994-2#1)(1995-5#1)(2010-4#1)
on the problems##4##3##(1990-2#1)(1993-9#1)(2008-4#1)(2008-8#1)
on the procedure##2##3##(1996-8#1)(2008-10#1)
on the process of care##3##5##(1996-3#1)(1997-1#1)(2008-3#1)
on the process of##11##4##(1991-5#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)
on the process##13##3##(1991-5#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)
on the processes##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
on the processing##2##3##(2008-9#1)(2010-4#1)
on the product##4##3##(1991-5#1)(1997-3#1)(2008-11#1)(2012-12#1)
on the production and##4##4##(2008-10#2)(2012-3#1)(2013-1#1)
on the production of recombinant##2##5##(2008-11#2)
on the production of##15##4##(1990-2#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-5#1)(2008-6#1)(2011-2#2)
on the production##21##3##(1990-2#1)(1994-3#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-5#2)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
on the profile of##2##4##(1994-9#1)(2010-3#1)
on the prognosis of##2##4##(1996-3#1)(2007-4#1)
on the progression of##2##4##(1994-3#1)(2008-7#1)
on the proliferation and invasion of hepatoma cells in culture##2##10##(2008-11#2)
on the proliferation and invasion of##5##6##(2008-11#5)
on the proliferation and##7##4##(1995-2#1)(2008-11#5)(2011-2#1)
on the proliferation of esophageal cancer##2##6##(2012-2#2)
on the proliferation of human##3##5##(1994-3#1)(2008-11#1)(2008-8#1)
on the proliferation of osteoblastic MC3T3-E1 cells##2##7##(1991-12#2)
on the proliferation of the##2##5##(2008-11#2)
on the proliferation of three human breast cancer cell lines that differed in their estrogen receptor contents##2##17##(2008-11#2)
on the proliferation of##22##4##(1990-12#2)(1990-7#1)(1991-12#2)(1994-11#1)(1994-3#2)(2008-11#6)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
on the proliferation##30##3##(1990-12#2)(1990-7#1)(1991-12#2)(1993-6#1)(1994-11#1)(1994-3#2)(1995-2#1)(2008-11#11)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
on the promotion of##3##4##(2008-9#1)(2010-10#1)(2012-12#1)
on the propagation of intense##2##5##(2007-12#2)
on the propagation##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
on the proper##3##3##(1991-3#1)(2007-11#1)(2010-9#1)
on the properties of the##4##5##(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
on the properties of##13##4##(1990-8#1)(1991-4#1)(1991-5#1)(1993-9#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-5#1)
on the properties##14##3##(1990-8#1)(1991-4#1)(1991-5#1)(1993-9#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)
on the proportion of##4##4##(2008-10#3)(2012-2#1)
on the proportion##5##3##(2008-10#4)(2012-2#1)
on the proposed##8##3##(1993-8#1)(1996-1#1)(2008-10#2)(2008-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
on the protection##2##3##(1990-2#1)(1997-1#1)
on the protein expression of##2##5##(2008-12#1)(2013-8#1)
on the protein kinase##2##4##(1995-8#1)(1997-2#1)
on the protein level##2##4##(2008-4#1)(2008-7#1)
on the protein##11##3##(1994-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2013-8#1)
on the protonation##2##3##(2008-10#2)
on the provision of##5##4##(1994-2#1)(1995-2#1)(1996-5#1)(2007-10#1)(2008-11#1)
on the proximal##3##3##(1994-5#1)(1996-2#1)(2013-8#1)
on the psychological and##2##4##(1993-12#1)(2008-2#1)
on the psychological##5##3##(1993-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
on the psychometric properties of the##2##6##(2009-9#1)(2011-2#1)
on the psychometric##4##3##(1990-3#1)(2009-9#1)(2011-2#2)
on the psychophysiological responses to imagined exercise##2##7##(1992-12#2)
on the public health##5##4##(1991-3#1)(1995-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
on the pulse##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
on the pump power##2##4##(2007-11#1)(2007-12#1)
on the pump##5##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)
on the purpose##2##3##(1996-2#1)(2008-9#1)
on the push-pull tracking-error signal##2##5##(2008-3#2)
on the push-pull##4##3##(2008-2#1)(2008-3#3)
on the qualitative##2##3##(2008-10#1)(2011-2#1)
on the quality and##3##4##(1992-2#1)(1993-12#1)(1997-1#1)
on the quality of care in##2##6##(1994-12#1)(2012-3#1)
on the quality of care##3##5##(1994-12#1)(2008-3#1)(2012-3#1)
on the quality of life and##4##6##(1991-12#1)(1992-1#1)(2007-7#1)(2011-2#1)
on the quality of life of##4##6##(1990-10#1)(2007-11#2)(2010-11#1)
on the quality of life##12##5##(1990-10#1)(1991-12#1)(1992-1#1)(1996-7#1)(2007-11#2)(2007-7#1)(2009-11#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
on the quality of the##10##5##(1990-3#1)(2007-11#1)(2008-10#2)(2008-3#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on the quality of##35##4##(1990-10#1)(1990-3#1)(1991-11#1)(1991-12#1)(1992-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(2007-11#3)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2009-11#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
on the quality##41##3##(1990-10#1)(1990-3#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-1#1)(2007-11#3)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2009-11#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
on the quantification of##2##4##(2008-10#1)(2008-3#1)
on the quantitative##5##3##(2008-10#1)(2009-12#1)(2009-3#1)(2012-2#1)(2012-3#1)
on the quantity and##2##4##(2008-5#1)(2008-9#1)
on the quantity##3##3##(2008-5#1)(2008-9#1)(2009-9#1)
on the quartz##2##3##(2008-10#1)(2008-5#1)
on the quenching##4##3##(2008-10#3)(2013-8#1)
on the question of##5##4##(1990-2#1)(1991-3#1)(2008-12#1)(2008-7#1)(2012-2#1)
on the radiation##2##3##(2008-9#1)(2013-8#1)
on the radical##2##3##(2008-10#1)(2008-3#1)
on the random##3##3##(1995-2#1)(2008-3#1)(2008-8#1)
on the range of##3##4##(2007-8#1)(2008-10#1)(2009-1#1)
on the rapid##5##3##(2008-10#4)(2008-7#1)
on the rat##4##3##(1992-12#1)(1993-6#1)(1997-2#1)(2008-4#1)
on the rate at which##2##5##(2008-10#1)(2010-8#1)
on the rate of transport##2##5##(2008-10#2)
on the rate of##17##4##(1992-2#1)(1992-5#1)(1995-3#2)(2008-10#8)(2008-11#1)(2008-6#1)(2009-8#2)(2011-1#1)
on the rate##22##3##(1992-2#1)(1992-5#1)(1995-2#1)(1995-3#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-6#1)(2009-8#2)(2010-8#1)(2011-1#1)
on the ratio between the##2##5##(2007-12#1)(2008-3#1)
on the ratio of the##2##5##(2008-10#1)(2008-3#1)
on the ratio of##6##4##(1996-4#1)(2008-10#3)(2008-3#1)(2008-5#1)
on the ratio##8##3##(1996-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)
on the rationale##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
on the raw##2##3##(2010-8#1)(2012-2#1)
on the reaction conditions##2##4##(1992-12#1)(2008-10#1)
on the reaction of##29##4##(1993-11#1)(1994-5#1)(2008-10#27)
on the reaction rate##3##4##(2008-10#2)(2008-7#1)
on the reaction with##3##4##(2008-10#2)(2008-5#1)
on the reaction##60##3##(1992-12#1)(1993-11#1)(1994-5#1)(1996-5#2)(2008-10#50)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)
on the reactions of the##2##5##(2008-10#2)
on the reactivity of##2##4##(1990-5#1)(1996-2#1)
on the reactivity##3##3##(1990-5#1)(1995-8#1)(1996-2#1)
on the real##2##3##(2008-10#1)(2009-12#1)
on the recent##12##3##(1994-12#1)(1994-6#1)(1996-4#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
on the reciprocal of##2##4##(1990-11#1)(2008-10#1)
on the recombinant protein production##2##5##(2008-11#2)
on the recommended##2##3##(2013-1#1)(2013-8#1)
on the reconstitution##3##3##(1990-8#1)(1995-8#2)
on the reconstruction##2##3##(2008-2#1)(2008-3#1)
on the recovery of the analyte##3##6##(2008-10#3)
on the recovery of the##6##5##(2008-10#6)
on the recovery of##16##4##(2008-10#14)(2012-3#1)(2013-1#1)
on the recovery##18##3##(2008-10#15)(2012-3#1)(2013-1#2)
on the red blood cells##2##5##(1994-12#1)(1995-3#1)
on the red##5##3##(1994-12#1)(1994-5#1)(1995-3#1)(2008-11#1)(2008-3#1)
on the redox reaction between##4##5##(2008-10#4)
on the redox reaction of##2##5##(2008-10#2)
on the redox reaction##6##4##(2008-10#6)
on the redox##9##3##(1991-2#1)(1995-5#1)(2008-10#7)
on the reduction of nitrate to##2##6##(2008-10#2)
on the reduction of##12##4##(1992-8#1)(2008-10#11)
on the reduction##14##3##(1992-8#1)(2008-10#12)(2008-3#1)
on the reflectance##3##3##(2008-10#1)(2008-2#2)
on the refractive index of the##2##6##(2007-12#1)(2008-2#1)
on the refractive index##3##4##(2007-12#1)(2008-2#2)
on the refractive##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
on the region of##3##4##(2008-5#1)(2012-3#1)(2013-1#1)
on the regions##2##3##(2008-11#1)(2008-2#1)
on the regression parameters##2##4##(1992-9#1)(2008-7#1)
on the regression##6##3##(1992-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)
on the regulation of PEPCK gene expression##2##7##(1995-6#2)
on the regulation of PEPCK gene##3##6##(1995-6#2)(1996-2#1)
on the regulation of the##2##5##(1994-6#1)(2009-5#1)
on the regulation of##12##4##(1994-6#1)(1995-6#2)(1996-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
on the regulatory##4##3##(1994-5#1)(1997-2#1)(2011-2#1)(2013-8#1)
on the relation between##4##4##(1990-8#1)(1991-6#1)(2008-3#1)(2011-1#1)
on the relations between##3##4##(1996-1#1)(2011-1#1)(2013-8#1)
on the relationship between burnout##2##5##(1997-1#1)(2008-11#1)
on the relationship between the##7##5##(1994-2#1)(1995-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
on the relationship between##27##4##(1991-2#1)(1991-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)
on the relationship of##2##4##(2008-10#1)(2011-2#1)
on the relationship##32##3##(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#3)
on the relationships between##2##4##(2008-1#1)(2010-3#1)
on the relationships##4##3##(1993-11#1)(2008-1#1)(2008-2#1)(2010-3#1)
on the relative importance##2##4##(2007-2#1)(2010-1#1)
on the relative##17##3##(1991-5#1)(1991-9#1)(1992-9#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#1)
on the release of##15##4##(1990-12#2)(1990-2#2)(1991-12#1)(1991-5#1)(1992-7#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-6#1)(2009-11#1)
on the release##19##3##(1990-12#2)(1990-2#2)(1991-12#1)(1991-5#1)(1992-7#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-11#1)
on the relevance of##3##4##(1993-3#1)(2008-10#1)(2011-1#1)
on the reliability and validity of##2##6##(1992-3#1)(2009-9#1)
on the reliability of##2##4##(2008-10#2)
on the reliability##4##3##(1992-3#1)(2008-10#2)(2009-9#1)
on the removal of##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
on the renal##3##3##(1992-8#1)(2007-10#1)(2010-4#1)
on the replication of Bombyx mori nucleopolyhedrovirus##2##7##(2008-11#2)
on the replication of##3##4##(1995-2#1)(2008-11#2)
on the replication##4##3##(1995-2#1)(2008-11#2)(2013-1#1)
on the reproducibility##2##3##(2008-1#1)(2008-10#1)
on the reproductive health##2##4##(2008-11#1)(2011-1#1)
on the reproductive##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
on the required##2##3##(2008-11#1)(2010-8#1)
on the requirements of##3##4##(2007-7#1)(2008-1#1)(2008-3#1)
on the requirements##4##3##(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)
on the research of##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
on the research##8##3##(1992-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
on the resin were##2##4##(2008-10#2)
on the resin##7##3##(2008-10#7)
on the resistant##2##3##(2008-10#2)
on the resolution were##3##4##(2008-10#3)
on the resolution##4##3##(1997-2#1)(2008-10#3)
on the resonance##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-9#1)
on the respiratory activity of##2##5##(2008-10#1)(2008-5#1)
on the respiratory##4##3##(1992-3#1)(1997-1#1)(2008-10#1)(2008-5#1)
on the response of the##4##5##(1992-3#1)(2008-10#2)(2008-7#1)
on the response of##9##4##(1992-3#1)(2008-10#6)(2008-7#1)(2009-10#1)
on the response properties of the##2##6##(2008-10#2)
on the response to##3##4##(1995-12#1)(2008-10#1)(2013-7#1)
on the response##19##3##(1992-3#1)(1995-12#1)(2008-10#14)(2008-7#1)(2009-10#1)(2013-7#1)
on the responses of##6##4##(1990-7#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)
on the responses##7##3##(1990-7#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)
on the restorative role of##2##5##(2008-12#2)
on the result##2##3##(2008-2#1)(2013-8#1)
on the resulting##7##3##(1997-3#1)(2007-7#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-2#1)
on the results obtained##5##4##(2008-10#2)(2008-3#1)(2010-3#1)(2010-5#1)
on the results of a##3##5##(1992-3#1)(2008-1#1)(2009-10#1)
on the results of hysteroscopic endometrial##2##6##(1996-2#2)
on the results of the##5##5##(1994-2#1)(1995-12#1)(2008-10#2)(2008-7#1)
on the results of these##2##5##(2008-10#1)(2008-7#1)
on the results of this study##5##6##(1990-6#1)(1995-1#1)(2008-10#2)(2008-5#1)
on the results of this##9##5##(1990-6#1)(1995-1#1)(2008-10#5)(2008-5#1)(2011-2#1)
on the results of##37##4##(1990-6#1)(1990-8#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-1#2)(1995-12#1)(1996-2#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
on the results##49##3##(1990-6#1)(1990-8#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-1#2)(1995-12#1)(1996-2#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
on the retention and enantioselectivity##2##5##(2008-10#2)
on the retention behavior##3##4##(2008-10#3)
on the retention of the##2##5##(2008-10#2)
on the retention of##9##4##(1994-1#1)(1996-5#2)(2008-10#5)(2008-11#1)
on the retention##17##3##(1992-6#1)(1994-1#1)(1996-5#3)(2008-10#10)(2008-11#2)
on the retrieval of##5##4##(2008-2#3)(2008-3#2)
on the retrieval##6##3##(2008-2#4)(2008-3#2)
on the retrieved##2##3##(2008-2#1)(2008-3#1)
on the reverse##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
on the review of##3##4##(2008-11#1)(2008-4#1)(2013-1#1)
on the rheological##3##3##(2008-5#2)(2011-2#1)
on the rheology of hair shampoo containing##2##7##(2008-5#2)
on the rheology##3##3##(2008-5#3)
on the right and##2##4##(2011-2#2)
on the right arm of chromosome VII##2##7##(1995-6#2)
on the right arm of chromosome XI##2##7##(1996-6#2)
on the right arm of chromosome##8##6##(1990-12#1)(1995-6#3)(1995-9#1)(1996-6#3)
on the right arm of##10##5##(1990-12#1)(1995-6#3)(1995-9#1)(1996-6#3)(1997-3#2)
on the right arm##11##4##(1990-12#1)(1995-6#3)(1995-9#1)(1996-6#4)(1997-3#2)
on the right side and##3##5##(2007-7#1)(2008-7#2)
on the right side of the pelvis##3##7##(2011-2#3)
on the right side of the##5##6##(2010-4#1)(2011-2#4)
on the right side##16##4##(2007-7#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#2)(2010-4#1)(2010-7#2)(2011-2#5)(2013-7#1)
on the right track for##2##5##(1995-12#1)(2008-10#1)
on the right##48##3##(1990-12#1)(1995-12#1)(1995-4#1)(1995-6#3)(1995-9#1)(1996-3#2)(1996-6#4)(1997-3#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#3)(2010-4#1)(2010-6#3)(2010-7#2)(2011-2#11)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
on the rise##9##3##(1993-5#1)(1994-1#1)(1995-12#1)(2008-11#2)(2008-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
on the risk factors##5##4##(1996-2#1)(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
on the risk for##3##4##(2008-10#1)(2009-10#1)(2009-8#1)
on the risk of##9##4##(1991-8#1)(1994-3#1)(1996-3#1)(2007-2#1)(2008-4#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-1#1)
on the risk##19##3##(1991-8#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
on the road to##2##4##(2009-12#1)(2013-8#1)
on the road##4##3##(1996-3#1)(2008-8#1)(2009-12#1)(2013-8#1)
on the rod##2##3##(1997-2#2)
on the role of the##11##5##(2008-10#3)(2008-4#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
on the role of##49##4##(1990-6#1)(1990-8#1)(1991-1#1)(1994-5#1)(1994-9#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-10#3)(2009-12#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
on the role##55##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1994-5#1)(1994-9#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-10#3)(2009-12#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
on the roles of##5##4##(1994-1#1)(2009-3#1)(2011-2#1)(2012-12#2)
on the roles##6##3##(1994-1#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-12#2)
on the roof of##2##4##(2008-5#1)(2010-5#1)
on the root and##2##4##(2008-10#2)
on the root surface##2##4##(2008-10#2)
on the root##6##3##(2008-10#5)(2010-3#1)
on the roots##2##3##(2008-10#1)(2012-6#1)
on the safety and security of##2##6##(1992-2#1)(1996-12#1)
on the safety and##3##4##(1992-2#1)(1996-12#1)(2012-12#1)
on the safety of##2##4##(2008-10#1)(2013-1#1)
on the safety##7##3##(1992-2#1)(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
on the same data##2##4##(1996-12#1)(2007-11#1)
on the same day##6##4##(1995-5#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
on the same filament##2##4##(2008-10#2)
on the same gel##3##4##(2008-2#1)(2008-4#1)(2010-3#1)
on the same host##3##4##(2008-10#3)
on the same individual##2##4##(1996-3#1)(2008-10#1)
on the same leaf##2##4##(2008-10#2)
on the same level##4##4##(1990-12#1)(1991-11#1)(1992-5#1)(2008-2#1)
on the same patient##2##4##(1996-3#2)
on the same side as the##2##6##(2011-2#1)(2013-1#1)
on the same side of the##3##6##(1991-9#1)(2007-12#1)(2008-10#1)
on the same side##6##4##(1991-9#1)(2007-12#1)(2008-10#1)(2011-2#2)(2013-1#1)
on the same##87##3##(1990-12#2)(1990-2#2)(1991-11#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-3#3)(1997-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on the sample surface##2##4##(1994-9#1)(2008-3#1)
on the sample width##2##4##(2008-3#2)
on the sample##16##3##(1994-9#1)(2008-10#8)(2008-3#6)(2011-2#1)
on the samples##2##3##(2008-7#1)(2010-8#1)
on the sampling##3##3##(2008-10#2)(2011-2#1)
on the scale of##3##4##(1992-1#1)(2008-7#1)(2012-1#1)
on the scale##6##3##(1992-1#1)(2007-11#1)(2008-10#2)(2008-7#1)(2012-1#1)
on the scalp##5##3##(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
on the scattering properties of##2##5##(2007-11#1)(2008-3#1)
on the scattering properties##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
on the scattering##7##3##(2007-11#1)(2008-2#2)(2008-3#3)(2009-10#1)
on the scientific##4##3##(1995-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
on the screen##4##3##(2008-10#1)(2008-2#3)
on the search for new##2##5##(2008-1#1)(2008-10#1)
on the search##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
on the season##2##3##(2008-10#1)(2011-2#1)
on the second and##3##4##(2007-10#1)(2007-12#2)
on the second day of shifted training##2##7##(1993-12#2)
on the second day of##3##5##(1993-12#2)(2011-1#1)
on the second day##5##4##(1993-12#2)(1995-5#1)(2011-1#1)(2012-12#1)
on the second##21##3##(1993-12#2)(1993-6#1)(1995-5#1)(1996-3#1)(2007-10#1)(2007-12#4)(2008-10#3)(2008-11#2)(2009-2#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
on the secondary effect of##2##5##(1990-8#1)(2008-9#1)
on the secondary##7##3##(1990-8#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
on the secretion of##4##4##(1990-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
on the secretion##7##3##(1990-5#1)(1993-5#1)(1995-8#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
on the selected##3##3##(1991-12#1)(2008-10#1)(2010-7#1)
on the selection of##6##4##(1995-9#1)(2008-10#1)(2010-4#1)(2011-2#3)
on the selective##5##3##(1990-12#1)(1991-9#1)(2008-10#3)
on the selectivity of ISEs##2##5##(2008-10#2)
on the selectivity##7##3##(2008-10#7)
on the sensitivity of the##4##5##(2008-10#3)(2008-4#1)
on the sensitivity of##11##4##(1990-5#1)(1994-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
on the sensitivity##12##3##(1990-5#1)(1994-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
on the sensitizing effect of##3##5##(2008-10#3)
on the sensor chip##4##4##(2008-10#4)
on the sensor response##2##4##(2008-10#2)
on the sensor surface##5##4##(1997-2#1)(2008-10#4)
on the sensor##13##3##(1997-2#1)(2008-10#12)
on the sensory organ##2##4##(1993-12#2)
on the separation and##3##4##(2008-10#3)
on the separation of the##2##5##(2008-10#2)
on the separation of##8##4##(2008-10#8)
on the separation##12##3##(2007-12#1)(2008-10#11)
on the sequence analysis of##2##5##(2008-10#1)(2008-8#1)
on the sequence##11##3##(1991-9#1)(1992-9#1)(2008-10#5)(2008-4#2)(2008-8#1)(2010-4#1)
on the sequence-specific##2##3##(2008-10#1)(2008-7#1)
on the sequential injection##3##4##(2008-10#3)
on the sequential##5##3##(2008-10#4)(2008-12#1)
on the serum and##2##4##(2008-3#1)(2011-1#1)
on the serum##7##3##(1990-3#1)(2008-1#1)(2008-3#1)(2010-2#1)(2010-6#1)(2011-1#1)(2013-1#1)
on the services##3##3##(1991-3#1)(1993-12#1)(1995-1#1)
on the seventh day of##2##5##(2007-8#1)(2008-5#1)
on the seventh##3##3##(2007-10#1)(2007-8#1)(2008-5#1)
on the severity and##2##4##(2011-2#1)(2013-1#1)
on the severity of##8##4##(1997-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
on the severity##10##3##(1997-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
on the sex##3##3##(1994-6#1)(1997-6#1)(2013-1#1)
on the sexual##4##3##(1991-2#2)(2008-11#1)(2010-12#1)
on the shape of the dose response##2##7##(2008-7#2)
on the shape of the##5##5##(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#2)
on the shape of##9##4##(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-8#1)
on the shape##11##3##(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2010-8#1)
on the shelf are##2##4##(2010-8#2)
on the shelf##3##3##(2010-8#3)
on the shooting hand##2##4##(1995-11#2)
on the short arm of barley chromosome##2##7##(2008-10#2)
on the short arm of chromosome 6##2##7##(2008-10#1)(2008-4#1)
on the short arm of chromosome##7##6##(2008-10#5)(2008-4#1)(2012-3#1)
on the short arm of##12##5##(1996-2#1)(2008-10#9)(2008-4#1)(2012-3#1)
on the short arm##14##4##(1996-2#1)(2008-10#10)(2008-4#1)(2008-5#1)(2012-3#1)
on the short- and##2##4##(1994-2#1)(2008-3#1)
on the shoulder##3##3##(2008-12#1)(2009-1#2)
on the side contralateral to##2##5##(2007-7#1)(2008-7#1)
on the side ipsilateral to the##2##6##(1992-10#1)(1996-5#1)
on the side of the##3##5##(2008-10#1)(2009-6#2)
on the side##9##3##(1992-10#1)(1992-5#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#2)(2011-1#1)
on the sides##2##3##(2007-5#1)(2008-10#1)
on the sign of the##2##5##(2008-3#1)(2009-7#1)
on the sign##3##3##(2008-3#1)(2008-8#1)(2009-7#1)
on the signal##9##3##(2007-12#1)(2008-10#5)(2008-2#2)(2008-4#1)
on the significance of##5##4##(1991-2#1)(1995-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
on the silica surface##2##4##(2008-10#2)
on the silica##5##3##(1995-3#1)(2008-10#3)(2010-4#1)
on the silicon##2##3##(2008-10#2)
on the simultaneous##8##3##(1995-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)
on the single##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
on the site of##3##4##(1994-3#1)(2007-12#1)(2008-5#1)
on the site##5##3##(1990-8#1)(1994-3#1)(2007-12#1)(2008-5#2)
on the situation in##2##4##(2008-1#1)(2011-2#1)
on the situation##3##3##(2008-1#1)(2011-2#2)
on the size and shape of##3##6##(1995-5#1)(2008-1#1)(2013-8#1)
on the size and the##2##5##(2008-10#1)(2008-3#1)
on the size and##10##4##(1993-2#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-8#1)
on the size distribution##2##4##(2008-2#1)(2008-9#1)
on the size of the##11##5##(1993-5#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
on the size of##17##4##(1993-5#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
on the size##30##3##(1993-2#1)(1993-5#1)(1995-5#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the skeleton##3##3##(1993-11#1)(1996-5#1)(2012-3#1)
on the skills and##2##4##(2008-11#1)(2008-12#1)
on the skills##3##3##(2008-11#1)(2008-12#2)
on the skin and##4##4##(2008-5#3)(2012-2#1)
on the skin of female##2##5##(1990-7#1)(1992-2#1)
on the skin of##3##4##(1990-7#1)(1992-2#1)(2008-5#1)
on the skin surface##3##4##(2008-5#3)
on the skin##31##3##(1990-7#1)(1991-6#1)(1992-2#1)(1994-11#1)(1996-2#1)(2008-12#1)(2008-5#21)(2008-6#1)(2011-3#1)(2012-12#1)(2012-2#1)
on the skull##2##3##(1995-6#1)(2012-12#1)
on the slider##2##3##(2008-3#2)
on the slope of the##2##5##(1995-3#1)(2008-2#1)
on the slope##4##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
on the slopes of##2##4##(2007-11#1)(2008-8#1)
on the so-called##2##3##(2009-11#1)(2012-2#1)
on the social##8##3##(1991-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-9#1)(2010-8#1)(2013-8#1)
on the sodium##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
on the soft##2##3##(1990-6#1)(2010-3#1)
on the soil surface and##2##5##(2008-10#1)(2010-5#1)
on the soil surface##9##4##(2008-10#6)(2008-11#1)(2010-5#2)
on the soil##15##3##(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#2)
on the solid phase extraction of##3##6##(2008-10#3)
on the solid phase##9##4##(1991-5#1)(1997-3#1)(2006-12#1)(2008-10#6)
on the solid support of glass slides##2##7##(2008-10#2)
on the solid support##4##4##(2008-10#4)
on the solid##17##3##(1991-5#1)(1997-3#1)(2006-12#1)(2008-10#14)
on the solubility of##4##4##(2008-10#3)(2010-5#1)
on the solubility##8##3##(2008-10#5)(2010-5#1)(2013-1#2)
on the solution##4##3##(1997-2#1)(2008-10#1)(2008-2#2)
on the soot##2##3##(2008-3#2)
on the sorbent##4##3##(2008-10#4)
on the sorption of##6##4##(2008-10#6)
on the sorption##9##3##(2008-10#9)
on the sound##3##3##(2008-2#2)(2008-8#1)
on the soybean stems and leaves##2##6##(2011-2#2)
on the soybean##3##3##(2008-10#1)(2011-2#2)
on the space##2##3##(2008-8#1)(2008-9#1)
on the spatial coherence##2##4##(2007-12#1)(2008-2#1)
on the spatial memory##2##4##(1993-5#1)(2011-2#1)
on the spatial##20##3##(1993-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#4)(2009-9#1)(2011-2#1)(2013-7#2)(2013-8#1)
on the species##4##3##(1997-4#1)(2008-10#1)(2008-5#2)
on the specific##17##3##(1992-2#1)(1996-2#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
on the specimen##3##3##(1991-6#1)(2008-3#1)(2009-7#1)
on the spectral and##2##4##(2007-12#1)(2008-3#1)
on the spectral frequency##2##4##(2007-11#1)(2008-2#1)
on the spectral##13##3##(1992-12#1)(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#5)
on the spectrophotometric determination of##2##5##(2008-10#2)
on the spectroscopic##3##3##(2008-10#3)
on the spectroscopy##2##3##(2008-3#1)(2008-7#1)
on the spectrum are##2##4##(2007-11#1)(2008-3#1)
on the spectrum##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
on the speed of##2##4##(1994-8#1)(2009-7#1)
on the sperm acrosome##2##4##(1992-8#1)(2008-8#1)
on the spherical##2##3##(2008-7#1)(2011-2#1)
on the spontaneous##4##3##(1990-11#1)(1993-9#1)(1995-12#1)(2011-2#1)
on the sporulation##4##3##(2008-10#4)
on the spread of##2##4##(1994-6#1)(2008-10#1)
on the spread##3##3##(1994-6#1)(2008-10#2)
on the stability and##4##4##(1995-5#1)(2008-3#1)(2008-5#1)(2011-2#1)
on the stability of a##2##5##(2008-5#1)(2008-9#1)
on the stability of the##3##5##(1990-2#1)(1996-2#1)(1996-5#1)
on the stability of##17##4##(1990-2#1)(1992-1#1)(1993-12#1)(1994-3#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
on the stability##21##3##(1990-2#1)(1992-1#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)
on the stage of##6##4##(1991-6#1)(1993-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
on the standard deviation##2##4##(2008-10#1)(2008-3#1)
on the standard##7##3##(1991-11#1)(1993-12#1)(2007-12#1)(2008-10#3)(2008-3#1)
on the state of the##3##5##(1990-2#1)(2008-4#1)(2008-8#1)
on the state of##7##4##(1990-2#1)(1993-5#1)(1994-5#1)(1994-9#1)(2008-3#1)(2008-4#1)(2008-8#1)
on the stationary phase was##2##5##(2008-10#2)
on the stationary phase##6##4##(2008-10#6)
on the statistical##6##3##(1994-2#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)
on the status of##2##4##(1993-3#1)(1994-1#1)
on the stem##4##3##(2008-10#4)
on the stiffness##2##3##(2009-7#1)(2012-2#1)
on the stimulated##2##3##(1990-7#1)(2008-5#1)
on the stoichiometry of##2##4##(2008-10#1)(2008-7#1)
on the strain and##2##4##(2008-11#1)(2008-5#1)
on the strain##4##3##(2008-11#1)(2008-5#3)
on the strains##2##3##(2008-10#2)
on the strand##2##3##(1993-12#1)(1994-9#1)
on the strategy##2##3##(1994-3#1)(2008-6#1)
on the streets##2##3##(1992-5#1)(2012-2#1)
on the strength of the expression vector##2##7##(1997-8#2)
on the strength of the##4##5##(1997-8#2)(2007-11#1)(2008-11#1)
on the strength of##7##4##(1997-1#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)
on the strength##8##3##(1994-8#1)(1997-1#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)
on the strengths and##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
on the strengths of##2##4##(2008-8#1)(2012-2#1)
on the strengths##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
on the stress of##2##4##(1994-12#1)(2012-1#1)
on the stress##4##3##(1994-12#1)(2008-5#1)(2009-4#1)(2012-1#1)
on the striatal##2##3##(1996-2#1)(2008-7#1)
on the strong##2##3##(2008-10#2)
on the structural and##2##4##(1995-12#1)(2008-3#1)
on the structural dynamics of##2##5##(2008-10#2)
on the structural##12##3##(1995-12#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
on the structure and function of##3##6##(1992-11#1)(1992-3#1)(2008-11#1)
on the structure and##5##4##(1990-5#1)(1992-11#1)(1992-3#1)(2007-11#1)(2008-11#1)
on the structure of maize##2##5##(2013-8#2)
on the structure of the##4##5##(1992-6#1)(1994-2#1)(1994-5#1)(2008-8#1)
on the structure of##11##4##(1992-4#1)(1992-6#1)(1994-2#1)(1994-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#2)
on the structure##19##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-2#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#1)(2013-1#1)(2013-8#2)
on the structures and emulsifying properties of caseins##2##8##(2013-8#2)
on the structures and##3##4##(2008-3#1)(2013-8#2)
on the structures##4##3##(2008-10#1)(2008-3#1)(2013-8#2)
on the students'##4##3##(2008-11#2)(2008-12#1)(2009-8#1)
on the studied##3##3##(2008-10#2)(2012-3#1)
on the study of##8##4##(2008-10#2)(2008-12#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-8#1)
on the study##10##3##(1992-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-8#1)
on the subject and##2##4##(1997-2#1)(2008-11#1)
on the subject of##3##4##(2006-10#1)(2008-2#1)(2008-7#1)
on the subject##19##3##(1994-1#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
on the subjects##2##3##(2008-7#1)(2012-3#1)
on the subsequent development of##2##5##(1997-6#1)(2008-10#1)
on the subsequent##7##3##(1993-3#1)(1994-12#1)(1994-8#1)(1997-6#1)(2008-10#3)
on the substrate##8##3##(1991-9#1)(1992-3#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-7#1)
on the subunit##2##3##(1991-10#1)(2008-8#1)
on the success of##2##4##(2008-8#1)(2013-8#1)
on the successful##2##3##(1995-11#1)(1997-3#1)
on the sun##2##3##(1992-7#1)(2008-5#1)
on the supply of##2##4##(1992-3#1)(1994-3#1)
on the support##4##3##(1997-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
on the supposition that##2##4##(1990-8#1)(2008-9#1)
on the supramolecular system##2##4##(2008-10#2)
on the supramolecular##4##3##(2008-10#4)
on the surface and##6##4##(2006-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-3#1)
on the surface of a glassy carbon electrode by##2##9##(2008-10#2)
on the surface of a glassy carbon electrode##4##8##(1990-12#1)(2008-10#3)
on the surface of a##15##5##(1990-12#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-8#1)(2008-9#1)
on the surface of an##2##5##(2008-10#1)(2010-5#1)
on the surface of bacteriophage##2##5##(1995-2#1)(2008-8#1)
on the surface of electrode##2##5##(2008-10#2)
on the surface of human PMNs##2##6##(1996-2#2)
on the surface of human##3##5##(1994-11#1)(1996-2#2)
on the surface of infected##2##5##(2008-10#2)
on the surface of silica gel##2##6##(2008-10#2)
on the surface of target cells##2##6##(2006-10#1)(2010-10#1)
on the surface of the electrode##4##6##(2008-10#4)
on the surface of the filamentous bacteriophage##2##7##(2008-10#1)(2008-8#1)
on the surface of the glassy carbon electrode##2##8##(2008-10#2)
on the surface of the host##2##6##(2008-10#2)
on the surface of the membrane##2##6##(2008-10#2)
on the surface of the sample##2##6##(2008-10#2)
on the surface of the##63##5##(1990-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-9#1)(2007-12#2)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
on the surface of##149##4##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#3)(1995-6#2)(1996-2#2)(2006-10#1)(2007-12#3)(2007-6#1)(2008-10#73)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
on the surface structure##2##4##(1997-6#1)(2013-1#1)
on the surface was##4##4##(1991-5#1)(2008-10#2)(2008-3#1)
on the surface which##2##4##(2008-5#2)
on the surface##195##3##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-6#2)(1996-2#2)(1996-4#1)(1996-5#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-6#1)(2008-10#84)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#4)
on the surface-plasmon##2##3##(2008-2#1)(2008-3#1)
on the surfaces of the##2##5##(2008-10#2)
on the surfaces of##7##4##(1994-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-7#1)
on the surfaces##12##3##(1994-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2010-7#1)
on the surgical treatment of##2##5##(2008-10#1)(2008-9#1)
on the surgical treatment##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
on the surgical##4##3##(2008-10#1)(2008-9#1)(2010-12#1)(2010-7#1)
on the survival and##4##4##(2008-5#1)(2009-10#1)(2010-2#1)(2010-8#1)
on the survival of patients with##2##6##(2008-11#1)(2008-2#1)
on the survival of the##2##5##(2008-10#1)(2013-1#1)
on the survival of##11##4##(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
on the survival##16##3##(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
on the susceptibility of##2##4##(1994-5#1)(2011-2#1)
on the susceptible cultivar##2##4##(2008-10#2)
on the susceptible cv##3##4##(2008-10#3)
on the susceptible##9##3##(2008-10#9)
on the symptoms of##2##4##(2007-6#1)(2008-10#1)
on the symptoms##3##3##(2007-6#1)(2008-10#2)
on the synthesis of##3##4##(1991-5#1)(1993-3#1)(1997-4#1)
on the synthesis##4##3##(1991-5#1)(1993-3#1)(1997-4#1)(2008-11#1)
on the synthetic##2##3##(1991-6#1)(2010-2#1)
on the system##5##3##(2008-10#3)(2008-2#1)(2010-4#1)
on the systematic##2##3##(1991-3#1)(1994-12#1)
on the systemic##3##3##(2008-10#1)(2010-3#1)(2010-6#1)
on the tail##2##3##(2008-3#2)
on the target##6##3##(2008-10#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-1#1)
on the teaching##2##3##(2008-11#1)(2009-2#1)
on the technique##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
on the techniques for##2##4##(2008-2#1)(2008-9#1)
on the techniques##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
on the telomeric##2##3##(1994-11#1)(2008-12#1)
on the temperature dependence of the##2##6##(2008-2#2)
on the temperature##9##3##(1994-5#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-8#1)(2012-5#1)
on the template##2##3##(2008-9#1)(2012-3#1)
on the temporal and spatial##2##5##(2007-12#1)(2008-10#1)
on the temporal and##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
on the temporal dynamics of##2##5##(2008-10#2)
on the temporal##12##3##(1990-5#1)(1990-8#1)(2007-11#2)(2007-12#2)(2008-10#4)(2009-1#1)(2012-2#1)
on the tensile##2##3##(2008-12#1)(2009-7#1)
on the terminal##2##3##(2008-11#1)(2012-3#1)
on the test##3##3##(1992-1#1)(1993-6#1)(2013-8#1)
on the testes of##2##4##(2008-5#2)
on the testosterone displacement equilibrium from its##2##7##(2008-10#2)
on the theoretical##2##3##(2008-3#1)(2008-6#1)
on the theory of##7##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#2)
on the theory##9##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#2)(2013-8#2)
on the therapeutic##4##3##(1997-4#1)(2008-4#1)(2010-12#1)(2012-2#1)
on the thickness and the##2##5##(2008-3#2)
on the thickness of the outer layer##2##7##(2008-3#2)
on the thickness of the##5##5##(2007-11#1)(2008-2#1)(2008-3#2)(2009-5#1)
on the thickness##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2009-5#1)
on the third postoperative day##4##5##(1993-1#1)(2010-6#3)
on the third##8##3##(1990-7#1)(1993-1#1)(1995-6#1)(2007-12#1)(2008-2#1)(2010-6#3)
on the three##4##3##(1993-2#1)(2008-10#1)(2008-5#1)(2010-3#1)
on the three-dimensional##3##3##(1995-2#1)(2008-11#1)(2008-2#1)
on the threshold current##2##4##(2008-3#2)
on the threshold##3##3##(2008-3#3)
on the throughput##2##3##(2008-2#1)(2008-3#1)
on the thyroid gland##2##4##(1993-5#1)(2013-1#1)
on the thyroid##5##3##(1990-6#1)(1992-8#1)(1993-5#1)(2008-7#1)(2013-1#1)
on the tilt of the##2##5##(1994-5#1)(2008-2#1)
on the time scale of##3##5##(1994-12#1)(2007-11#1)(2011-2#1)
on the time##16##3##(1994-10#1)(1994-12#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-8#2)(2011-2#3)
on the time-domain##2##3##(2007-12#1)(2008-3#1)
on the timing of##7##4##(1992-12#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-7#1)(2009-5#1)
on the timing##9##3##(1990-5#1)(1992-12#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-5#1)
on the tip of the##3##5##(1990-8#1)(2007-8#1)(2008-10#1)
on the tip of##4##4##(1990-8#1)(2007-12#1)(2007-8#1)(2008-10#1)
on the tissue surface##2##4##(2009-11#1)(2013-1#1)
on the tissue##4##3##(2008-8#1)(2009-11#1)(2009-7#1)(2013-1#1)
on the tongue##5##3##(1993-1#3)(2009-12#1)(2013-1#1)
on the top of the##2##5##(2008-10#1)(2008-2#1)
on the top##5##3##(2008-10#2)(2008-11#1)(2008-2#2)
on the topic##10##3##(1994-2#2)(2007-8#1)(2008-1#1)(2008-11#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
on the topics##3##3##(1995-2#1)(2011-2#1)(2012-3#1)
on the total number of##2##5##(2008-3#1)(2011-3#1)
on the total##11##3##(1991-9#1)(2008-10#6)(2008-3#1)(2010-10#1)(2011-3#1)(2012-2#1)
on the toxic##2##3##(2008-10#1)(2013-1#1)
on the toxicity of##3##4##(1995-3#1)(1996-12#1)(2011-2#1)
on the toxicology##5##3##(2008-8#1)(2008-9#2)(2013-1#2)
on the traditional##2##3##(2008-10#1)(2009-5#1)
on the trait##4##3##(2008-8#3)(2012-3#1)
on the transcription##3##3##(1994-11#1)(2008-11#1)(2008-4#1)
on the transducer##2##3##(2008-10#2)
on the transient##2##3##(2007-11#1)(2008-10#1)
on the transients##2##3##(2008-2#1)(2008-3#1)
on the translocation##2##3##(1997-8#1)(2008-6#1)
on the transmembrane##2##3##(1994-3#1)(2012-2#1)
on the transmission of##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
on the transmission##5##3##(2007-11#1)(2008-10#2)(2008-3#2)
on the transport of Hct##3##5##(2011-3#3)
on the transport of hydrochlorothiazide##2##5##(2011-3#2)
on the transport of##8##4##(1990-12#1)(2009-10#1)(2011-2#1)(2011-3#5)
on the treatment and##2##4##(1990-3#1)(2007-11#1)
on the treatment of a##2##5##(1991-2#1)(1992-6#1)
on the treatment of patients with##3##6##(1992-1#1)(1996-7#1)(2012-3#1)
on the treatment of the##2##5##(2008-10#1)(2009-9#1)
on the treatment of##18##4##(1991-2#1)(1992-1#1)(1992-6#2)(1993-3#1)(1993-9#1)(1996-11#1)(1996-7#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-2#2)(2012-3#1)
on the treatment results##2##4##(2011-2#2)
on the treatment##23##3##(1990-3#1)(1991-2#1)(1992-1#1)(1992-6#2)(1993-3#1)(1993-9#1)(1996-11#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-2#4)(2012-3#1)
on the trunk##3##3##(2007-7#1)(2008-5#1)(2010-6#1)
on the tumor##6##3##(2008-11#2)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
on the two different##2##4##(1996-2#1)(2008-3#1)
on the two surfaces##2##4##(2008-12#1)(2010-10#1)
on the two##15##3##(1994-12#1)(1994-5#2)(1994-8#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)
on the two-dimensional##2##3##(2008-3#2)
on the two-photon fluorescence spectroscopy of##2##6##(2008-3#2)
on the two-photon##3##3##(2007-11#1)(2008-3#2)
on the type II enzyme##2##5##(1995-3#2)
on the type and##3##4##(2008-2#1)(2008-8#1)(2013-1#1)
on the type of##32##4##(1991-11#1)(1991-12#1)(1992-2#1)(1994-7#1)(1995-5#1)(1997-2#3)(1997-4#1)(2007-11#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)
on the type##37##3##(1991-11#1)(1991-12#1)(1992-2#1)(1994-7#1)(1995-3#2)(1995-5#1)(1997-2#3)(1997-4#1)(2007-11#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
on the types of##5##4##(1991-10#1)(1992-1#1)(1994-5#1)(2008-12#1)(2011-2#1)
on the typical##4##3##(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
on the ultimate##2##3##(2008-11#1)(2010-8#1)
on the ultrastructural##2##3##(2011-2#2)
on the ultrastructure of##2##4##(2008-10#1)(2008-7#1)
on the umbilicus##2##3##(2010-6#2)
on the underlying##10##3##(1990-2#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-4#1)(2008-10#1)(2010-10#1)(2010-7#1)
on the understanding of##3##4##(2008-10#2)(2012-3#1)
on the unique##4##3##(1991-12#1)(2007-11#1)(2008-8#1)(2010-1#1)
on the unit##2##3##(1990-9#1)(2010-2#1)
on the upper##8##3##(1993-9#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)
on the uptake of##3##4##(1991-9#1)(1994-8#1)(2008-10#1)
on the uptake##4##3##(1990-11#1)(1991-9#1)(1994-8#1)(2008-10#1)
on the uric acid##2##4##(1990-11#1)(2008-10#1)
on the urinary##2##3##(1993-8#1)(2012-12#1)
on the use of a##16##5##(1990-5#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#4)(2013-8#1)
on the use of an##4##5##(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
on the use of animal##2##5##(2008-7#1)(2013-1#1)
on the use of conventional##2##5##(2008-11#1)(2008-7#1)
on the use of light##2##5##(2007-11#1)(2008-3#1)
on the use of pediatric medicines and their##2##8##(2008-9#2)
on the use of the##17##5##(1992-12#1)(1995-1#1)(1995-5#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2009-9#1)(2010-5#1)
on the use of these##4##5##(1996-2#1)(1997-4#1)(2008-3#1)(2008-9#1)
on the use of two##2##5##(1990-12#1)(1991-3#1)
on the use of##154##4##(1990-12#2)(1990-5#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#48)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#16)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
on the usefulness of##3##4##(1991-3#1)(2008-4#1)(2009-4#1)
on the usefulness##4##3##(1991-3#1)(2008-4#1)(2009-4#1)(2013-1#1)
on the uses of##2##4##(1991-12#1)(2010-5#1)
on the utilisation of##2##4##(2008-10#2)
on the utility of##2##4##(2008-9#1)(2010-9#1)
on the utilization of##4##4##(1996-2#1)(2008-10#2)(2008-4#1)
on the vaccine##2##3##(1995-5#2)
on the validity##2##3##(1995-2#1)(2011-2#1)
on the value of the##2##5##(1996-2#1)(2008-2#1)
on the value of##9##4##(1990-5#1)(1990-6#1)(1994-3#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)
on the values##2##3##(1990-7#1)(2011-2#1)
on the variance##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
on the variation##2##3##(2008-3#1)(2013-8#1)
on the various##8##3##(1990-12#1)(1993-5#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-2#1)
on the vascular smooth muscle##2##5##(1995-12#1)(2008-7#1)
on the vascular##5##3##(1995-12#1)(2007-10#1)(2008-7#1)(2009-5#1)(2009-7#1)
on the velocity of##2##4##(2008-11#1)(2009-8#1)
on the ventral side of the##2##6##(2007-12#1)(2008-5#1)
on the ventral##6##3##(1993-12#1)(2007-12#1)(2008-5#3)(2008-9#1)
on the verge of##2##4##(1997-6#1)(2008-11#1)
on the vertex of##2##4##(2008-9#1)(2013-8#1)
on the vertex##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
on the vessel##5##3##(1990-8#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-6#1)
on the viability and##3##4##(1990-6#1)(2008-5#1)(2008-7#1)
on the viability of##7##4##(2008-10#3)(2008-7#2)(2009-12#1)(2011-2#1)
on the viability##12##3##(1990-6#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#1)
on the video##2##3##(1992-12#1)(2013-1#1)
on the view of##2##4##(1995-2#1)(2008-11#1)
on the view##3##3##(1995-2#1)(2008-11#2)
on the viral complementary strand##3##5##(2008-10#3)
on the viral##6##3##(2008-10#4)(2009-8#1)(2012-2#1)
on the virus##2##3##(1997-1#1)(2008-10#1)
on the visible and near-ultraviolet##2##5##(2008-3#2)
on the visual system##2##4##(2008-8#1)(2009-12#1)
on the visual##3##3##(1992-11#1)(2008-8#1)(2009-12#1)
on the voltammetric response##2##4##(2008-10#2)
on the voltammetric##4##3##(2008-10#4)
on the waiting list##2##4##(1991-11#1)(2011-2#1)
on the waiting##3##3##(1991-11#1)(2008-9#1)(2011-2#1)
on the wall##2##3##(1990-9#1)(2008-11#1)
on the walls of the##2##5##(2008-10#2)
on the walls of##5##4##(2008-10#5)
on the walls##6##3##(2007-10#1)(2008-10#5)
on the water##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
on the waveguide surface##2##4##(2008-3#2)
on the waveguide##3##3##(2008-2#1)(2008-3#2)
on the wavelength##6##3##(2007-11#2)(2008-3#4)
on the web##2##3##(2008-12#1)(2008-7#1)
on the west##2##3##(2007-5#2)
on the wheat##2##3##(2008-10#2)
on the whole##5##3##(1994-9#1)(2008-10#2)(2008-2#1)(2008-7#1)
on the width of the##2##5##(2008-10#1)(2008-3#1)
on the width##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
on the willingness of##2##4##(2007-10#1)(2007-7#1)
on the work of##2##4##(2008-11#2)
on the work##3##3##(1997-8#1)(2008-11#2)
on the working electrode##3##4##(2008-10#3)
on the working##4##3##(2008-10#3)(2009-2#1)
on the world##2##3##(2008-11#2)
on the year##2##3##(2008-10#2)
on the yield of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
on the yield##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)
on the zinc##2##3##(2008-10#2)
on the##11823##2##(1990-10#6)(1990-11#36)(1990-12#49)(1990-2#52)(1990-3#20)(1990-4#1)(1990-5#51)(1990-6#19)(1990-7#20)(1990-8#49)(1990-9#21)(1991-1#12)(1991-10#3)(1991-11#15)(1991-12#55)(1991-2#44)(1991-3#29)(1991-4#3)(1991-5#39)(1991-6#40)(1991-7#5)(1991-8#11)(1991-9#24)(1992-1#22)(1992-10#4)(1992-11#22)(1992-12#50)(1992-2#28)(1992-3#39)(1992-4#10)(1992-5#22)(1992-6#53)(1992-7#5)(1992-8#36)(1992-9#26)(1993-1#27)(1993-11#35)(1993-12#67)(1993-2#32)(1993-3#43)(1993-5#22)(1993-6#38)(1993-8#45)(1993-9#29)(1994-1#25)(1994-10#2)(1994-11#40)(1994-12#53)(1994-2#52)(1994-3#46)(1994-5#71)(1994-6#39)(1994-7#6)(1994-8#44)(1994-9#27)(1995-1#13)(1995-11#44)(1995-12#75)(1995-2#69)(1995-3#37)(1995-4#5)(1995-5#36)(1995-6#46)(1995-8#24)(1995-9#15)(1996-1#21)(1996-10#3)(1996-11#11)(1996-12#62)(1996-2#70)(1996-3#47)(1996-4#17)(1996-5#54)(1996-6#29)(1996-7#8)(1996-8#13)(1996-9#12)(1997-1#27)(1997-2#63)(1997-3#44)(1997-4#45)(1997-5#19)(1997-6#36)(1997-7#29)(1997-8#34)(1997-9#2)(2006-10#17)(2006-12#7)(2006-4#3)(2006-6#7)(2006-8#1)(2007-10#39)(2007-11#216)(2007-12#227)(2007-2#22)(2007-3#4)(2007-4#9)(2007-5#16)(2007-6#11)(2007-7#35)(2007-8#77)(2007-9#2)(2008-1#94)(2008-10#2776)(2008-11#454)(2008-12#176)(2008-2#388)(2008-3#742)(2008-4#147)(2008-5#379)(2008-6#120)(2008-7#283)(2008-8#271)(2008-9#217)(2009-1#8)(2009-10#57)(2009-11#31)(2009-12#30)(2009-2#20)(2009-3#21)(2009-4#31)(2009-5#56)(2009-6#28)(2009-7#47)(2009-8#59)(2009-9#34)(2010-1#20)(2010-10#34)(2010-11#26)(2010-12#56)(2010-2#29)(2010-3#60)(2010-4#62)(2010-5#45)(2010-6#45)(2010-7#26)(2010-8#75)(2010-9#20)(2011-1#123)(2011-10#2)(2011-2#342)(2011-3#30)(2011-7#4)(2012-1#34)(2012-12#105)(2012-2#177)(2012-3#164)(2012-4#2)(2012-5#3)(2012-6#3)(2012-7#1)(2012-8#1)(2012-9#2)(2013-1#296)(2013-7#27)(2013-8#173)
on their ability to##6##4##(1995-2#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
on their activity##2##3##(1994-6#1)(2008-10#1)
on their behalf##2##3##(2009-5#2)
on their biological##2##3##(1995-8#1)(2008-5#1)
on their capability to##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
on their clinical##3##3##(2007-12#1)(2008-5#1)(2012-1#1)
on their concentration##2##3##(2008-10#1)(2009-4#1)
on their development##2##3##(1992-9#1)(2008-10#1)
on their different##3##3##(2008-10#2)(2009-5#1)
on their efficacy and##2##4##(2008-5#1)(2012-2#1)
on their efficacy##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
on their energy##2##3##(2008-7#1)(2011-2#1)
on their experience##3##3##(1990-5#1)(1995-1#1)(2006-12#1)
on their experiences##2##3##(2009-5#1)(2010-8#1)
on their feeding##2##3##(2010-8#1)(2011-2#1)
on their first##4##3##(1991-2#1)(2008-12#3)
on their function and##2##4##(2007-12#1)(2010-11#1)
on their high##2##3##(2008-1#1)(2008-11#1)
on their host of origin##2##5##(2008-10#2)
on their host##3##3##(2008-10#2)(2013-1#1)
on their level of##2##4##(2007-10#1)(2008-12#1)
on their location##2##3##(2008-10#1)(2008-7#1)
on their medication##2##3##(2008-11#2)
on their own experiences##2##4##(2007-11#1)(2008-11#1)
on their own to##2##4##(1992-11#1)(1997-3#1)
on their own##19##3##(1992-11#1)(1992-3#1)(1993-3#2)(1995-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-11#4)(2008-5#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-3#1)(2012-3#1)
on their performance##2##3##(1992-11#1)(2008-3#1)
on their personal##2##3##(2008-11#1)(2010-3#1)
on their physico-chemical properties##2##4##(2008-5#2)
on their possible##2##3##(1993-1#1)(2010-6#1)
on their response to##2##4##(1990-11#1)(2013-8#1)
on their response##3##3##(1990-11#1)(2009-12#1)(2013-8#1)
on their school performance##2##4##(2007-12#1)(2009-7#1)
on their school##3##3##(2007-12#1)(2008-11#1)(2009-7#1)
on their sensitivity##2##3##(1995-12#1)(2008-2#1)
on their size##2##3##(1990-6#1)(2008-10#1)
on their surface##4##3##(1994-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
on their unique##2##3##(2008-1#1)(2013-1#1)
on their use##3##3##(2007-8#1)(2010-8#1)(2012-1#1)
on their way##2##3##(1993-6#1)(2009-4#1)
on their work##2##3##(1995-6#1)(2012-12#1)
on their##315##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#48)(2008-11#27)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#12)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#4)
on them in##2##3##(1995-12#1)(2010-9#1)
on them##12##2##(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-9#2)(2012-12#1)(2013-1#1)(2013-8#1)
on themselves##2##2##(2008-11#2)
on theoretical##5##2##(1996-3#1)(1997-1#1)(2008-10#2)(2010-12#1)
on theory##2##2##(1994-12#1)(2013-1#1)
on therapeutic##10##2##(1991-7#1)(2007-8#1)(2008-11#2)(2008-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
on therapy##7##2##(1996-11#1)(2007-7#1)(2008-1#1)(2009-11#1)(2010-12#1)(2011-2#1)(2011-3#1)
on thermal lens##2##3##(2008-10#1)(2008-3#1)
on thermal##7##2##(1995-12#1)(1996-12#1)(2008-10#4)(2008-3#1)
on thermally##2##2##(2007-12#1)(2011-1#1)
on thermodynamic##3##2##(1995-5#1)(2008-10#1)(2013-1#1)
on these and other##2##4##(1992-9#1)(2012-2#1)
on these and##3##3##(1992-9#1)(1996-3#1)(2012-2#1)
on these cells##7##3##(1990-2#2)(1993-5#1)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#1)
on these components##2##3##(2007-7#1)(2008-10#1)
on these conditions##3##3##(1993-3#1)(1996-2#1)(2012-2#1)
on these disorders##2##3##(2008-7#1)(2012-3#1)
on these enzymes##2##3##(1990-8#1)(2007-7#1)
on these four##3##3##(1996-1#1)(2011-1#1)(2012-3#1)
on these issues##3##3##(1993-3#1)(2008-11#1)(2009-12#1)
on these leaves##2##3##(2008-10#2)
on these media##2##3##(2008-10#1)(2010-6#1)
on these observations##5##3##(1993-3#1)(1995-5#1)(2008-7#1)(2009-10#1)(2009-12#1)
on these parameters##3##3##(1991-5#1)(2008-10#1)(2008-2#1)
on these results##28##3##(1990-12#1)(1990-2#1)(1990-3#1)(1994-7#1)(1995-4#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2012-12#1)
on these seven##2##3##(2008-10#2)
on these studies##2##3##(2010-3#1)(2011-2#1)
on these three##3##3##(1996-1#1)(2008-10#1)(2013-1#1)
on these topics##3##3##(2012-3#1)(2013-1#2)
on these transitions##2##3##(2007-12#1)(2009-5#1)
on these two##4##3##(1993-2#1)(2008-10#1)(2010-11#1)(2011-2#1)
on these variables##4##3##(2007-12#1)(2008-8#1)(2012-2#1)(2013-7#1)
on these##202##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1992-10#2)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#4)(2007-7#2)(2008-1#2)(2008-10#44)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#5)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#5)
on thesurface of##2##3##(2008-11#2)
on thick##2##2##(2008-2#1)(2008-3#1)
on thin##10##2##(2008-10#4)(2008-2#1)(2008-3#5)
on thin-layer chromatography (TLC) plates##2##5##(1996-2#1)(2008-10#1)
on thin-layer plates##2##3##(2008-10#1)(2008-5#1)
on thin-layer##6##2##(1996-2#1)(2008-10#4)(2008-5#1)
on thirty##2##2##(2007-2#1)(2013-8#1)
on this approach##2##3##(2008-2#1)(2010-5#1)
on this basis##2##3##(2008-10#1)(2008-2#1)
on this case report##2##4##(2006-10#1)(2011-2#1)
on this cell##2##3##(2008-11#1)(2011-2#1)
on this chromosome##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
on this complex##2##3##(1997-7#1)(2009-10#1)
on this concept##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)
on this effect##2##3##(1995-2#1)(2008-10#1)
on this electrode##2##3##(2008-10#2)
on this enzyme##2##3##(2008-7#2)
on this field##2##3##(1990-9#1)(2013-1#1)
on this information##2##3##(1991-11#1)(2011-1#1)
on this issue##7##3##(1991-3#1)(1992-12#1)(2007-10#1)(2008-1#1)(2008-11#2)(2013-8#1)
on this matter##2##3##(1997-8#1)(2007-5#1)
on this medium##2##3##(2008-10#1)(2008-5#1)
on this method##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
on this newly##2##3##(2008-10#1)(2008-7#1)
on this phenomenon##3##3##(2007-11#1)(2008-10#2)
on this plant##2##3##(2008-10#1)(2013-7#1)
on this problem##4##3##(1992-8#1)(2008-5#1)(2008-8#1)(2008-9#1)
on this process##2##3##(2008-10#1)(2008-11#1)
on this rare##2##3##(2010-3#1)(2010-8#1)
on this situation##3##3##(2011-2#1)(2013-1#2)
on this species##2##3##(2008-10#1)(2008-12#1)
on this specific issue##2##4##(2008-11#1)(2008-9#1)
on this subject##8##3##(1992-1#1)(1994-9#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-6#1)
on this system##2##3##(2008-10#1)(2008-11#1)
on this task##4##3##(1993-3#2)(1994-3#2)
on this technique##2##3##(2008-10#1)(2008-2#1)
on this topic were##2##4##(2008-8#1)(2010-3#1)
on this topic##19##3##(1990-11#1)(1993-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
on this type of##4##4##(1990-2#1)(1992-3#1)(2008-7#1)(2011-3#1)
on this##240##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#5)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#48)(2008-11#15)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#10)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#2)
on thoracic and##2##3##(1996-12#1)(2010-9#1)
on those of##2##3##(1995-11#1)(1995-6#1)
on those that##2##3##(1994-12#1)(2008-10#1)
on those used##2##3##(1994-8#1)(2008-11#1)
on those##25##2##(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)
on three different##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
on three occasions##3##3##(1993-1#1)(1994-12#1)(2007-12#1)
on three parameters##3##3##(2008-10#2)(2013-8#1)
on three separate occasions##2##4##(1991-3#1)(2011-1#1)
on three times##2##3##(2007-7#1)(2008-10#1)
on three##57##2##(1991-1#1)(1991-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2012-6#1)(2013-8#2)
on three-dimensional##6##2##(1994-8#1)(2008-2#2)(2008-3#2)(2013-1#1)
on thromboembolic##2##2##(2008-7#2)
on through a##2##3##(2008-10#1)(2008-7#1)
on thyroid function##2##3##(2008-7#1)(2012-2#1)
on thyroid##8##2##(1991-8#1)(1992-8#1)(1996-5#1)(2008-7#3)(2012-2#1)(2013-1#1)
on time and on##2##4##(1991-1#1)(2008-10#1)
on time and##3##3##(1991-1#1)(1996-11#1)(2008-10#1)
on time scales##3##3##(1996-4#1)(2008-10#1)(2008-4#1)
on time##19##2##(1990-5#1)(1991-1#1)(1993-2#1)(1996-11#1)(1996-4#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
on timing of##2##3##(2008-10#1)(2012-3#1)
on timing##3##2##(2008-10#1)(2009-7#1)(2012-3#1)
on tissue##13##2##(1992-10#1)(1992-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
on titanium foil##2##3##(2009-11#2)
on titanium salts##2##3##(2008-10#1)(2008-5#1)
on titanium##8##2##(2008-10#4)(2008-5#1)(2009-11#2)(2009-7#1)
on to a hanging mercury drop electrode##2##7##(2008-10#2)
on to a##5##3##(2008-10#2)(2008-9#1)(2010-2#1)(2013-1#1)
on to explore##2##3##(1993-2#1)(1994-1#1)
on to the surface##2##4##(2008-10#1)(2008-5#1)
on to the##7##3##(2008-10#4)(2008-5#1)(2009-1#1)(2012-3#1)
on to##36##2##(1990-8#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1996-12#1)(1997-1#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2010-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#2)
on tobacco and##4##3##(2008-10#4)
on tobacco##11##2##(1996-1#1)(1996-8#1)(2008-10#8)(2008-7#1)
on toluene##5##2##(2008-10#1)(2008-7#4)
on tomato and potato##2##4##(2008-10#2)
on tomato and##4##3##(2008-10#4)
on tomato plants grown in##2##5##(2008-10#2)
on tomato plants##4##3##(2008-10#4)
on tomato roots##2##3##(2008-10#2)
on tomato than##2##3##(2008-8#2)
on tomato##24##2##(2008-10#21)(2008-8#3)
on tooth##2##2##(2013-1#2)
on top of a##2##4##(2008-3#2)
on top of an##2##4##(2008-10#1)(2008-3#1)
on top of the##3##4##(2008-10#2)(2008-3#1)
on top of##16##3##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#6)(2011-1#1)(2012-2#1)(2012-3#1)
on top##18##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#6)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
on topics##3##2##(1993-1#1)(1994-3#1)(1997-2#1)
on total and##2##3##(2008-10#1)(2008-12#1)
on total internal reflection##2##4##(2008-2#1)(2008-3#1)
on total##18##2##(1990-8#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)(2013-1#1)
on toughness##2##2##(2012-2#1)(2013-1#1)
on toxicity##2##2##(2008-5#1)(2013-8#1)
on tracheal mucous velocity##2##4##(1991-9#2)
on traditional Chinese medicine##2##4##(2013-1#2)
on traditional##12##2##(1991-3#1)(1993-9#1)(1995-1#1)(2008-10#3)(2008-9#1)(2010-3#1)(2011-1#1)(2011-7#1)(2013-1#2)
on traffic##2##2##(2011-2#1)(2013-8#1)
on training##6##2##(1990-11#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
on transcription of the ada gene##2##6##(1991-9#2)
on transcription of the##4##4##(1991-9#2)(1995-2#1)(1995-6#1)
on transcription##13##2##(1991-9#3)(1992-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
on transcriptional activation##2##3##(1994-11#1)(2009-8#1)
on transcriptional##4##2##(1994-11#1)(2008-8#1)(2009-8#2)
on transformation##3##2##(1994-2#1)(1997-3#1)(2008-10#1)
on transgenic##3##2##(2010-9#1)(2011-2#1)(2013-1#1)
on transient##4##2##(1992-9#1)(1996-5#1)(1996-6#1)(2010-12#1)
on transiently transfected##2##3##(1994-6#1)(2008-7#1)
on translation##2##2##(2008-9#1)(2013-8#1)
on translocation of##2##3##(1995-11#1)(2008-10#1)
on transmission of##2##3##(1991-10#1)(2013-8#1)
on transmission##4##2##(1991-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
on transmittance##2##2##(2008-3#2)
on transparent##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
on transplant##3##2##(2008-1#1)(2008-4#1)(2008-8#1)
on transport of##2##3##(1997-7#1)(2012-2#1)
on transport##5##2##(1990-12#1)(1997-7#1)(2008-11#1)(2011-2#1)(2012-2#1)
on transverse##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
on trap trees##3##3##(2011-2#3)
on trap##5##2##(2008-10#1)(2008-2#1)(2011-2#3)
on travel##3##2##(2007-2#3)
on treated##5##2##(1996-12#1)(2008-10#2)(2008-5#1)(2010-11#1)
on treating the underlying##2##4##(1991-12#1)(2008-3#1)
on treating the##4##3##(1991-12#1)(2008-3#1)(2010-12#1)(2011-1#1)
on treating##7##2##(1991-12#1)(1991-5#1)(2008-3#2)(2010-12#1)(2011-1#1)(2013-1#1)
on treatment and##3##3##(2008-3#1)(2008-5#1)(2010-4#1)
on treatment of##7##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
on treatment outcome##3##3##(2007-8#2)(2010-5#1)
on treatment with##3##3##(1996-5#1)(2008-3#1)(2011-1#1)
on treatment##32##2##(1992-12#1)(1992-6#1)(1993-3#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
on tree##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
on trees and##2##3##(2008-10#2)
on trees##4##2##(2008-10#3)(2008-5#1)
on trends in##2##3##(1991-3#2)
on trends##3##2##(1991-3#2)(1996-3#1)
on trial##3##2##(1994-3#1)(1995-8#1)(2008-3#1)
on trials##5##2##(1994-3#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
on tricyclic##2##2##(1995-3#1)(2006-10#1)
on triple##2##2##(2008-1#1)(2008-10#1)
on trophoblast##3##2##(1994-9#1)(1996-12#1)(2013-1#1)
on true##2##2##(2008-10#1)(2013-1#1)
on tryptophan##2##2##(2008-10#1)(2009-10#1)
on tubal##2##2##(1994-12#1)(1996-3#1)
on tuberculosis##2##2##(2010-8#1)(2011-1#1)
on tumor cells and##2##4##(1992-8#1)(2010-11#1)
on tumor cells##6##3##(1990-11#1)(1992-8#1)(2008-4#1)(2009-2#1)(2010-11#1)(2013-8#1)
on tumor growth##5##3##(1994-12#1)(1994-6#2)(2008-9#1)(2013-7#1)
on tumor##20##2##(1990-11#1)(1990-8#1)(1992-2#1)(1992-8#1)(1994-12#2)(1994-6#2)(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-2#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
on two approaches##2##3##(2008-11#1)(2008-4#1)
on two cases##2##3##(2008-1#1)(2010-12#1)
on two closely related##2##4##(2008-8#1)(2012-3#1)
on two different##6##3##(1990-11#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
on two key##2##3##(2008-9#1)(2009-11#1)
on two new##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
on two occasions##4##3##(1991-8#1)(1997-4#1)(2008-12#1)(2008-9#1)
on two parameters##4##3##(1995-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
on two patients##2##3##(2008-10#1)(2010-5#1)
on two separate##2##3##(2007-2#1)(2008-12#1)
on two types of##3##4##(1992-8#1)(2008-3#1)(2013-1#1)
on two##123##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#3)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#2)(2012-6#1)(2012-9#1)(2013-1#3)(2013-8#1)
on two-dimensional##7##2##(1991-8#1)(1993-11#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
on two-photon fluorescence##3##3##(2007-11#2)(2008-3#1)
on two-photon##7##2##(1992-8#1)(2007-11#3)(2007-12#2)(2008-3#1)
on type and##2##3##(2010-5#1)(2013-8#1)
on type of##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
on type##6##2##(1994-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)(2013-8#1)
on types of##3##3##(1997-1#1)(2009-7#1)(2013-1#1)
on tyrosinase##2##2##(2008-10#1)(2008-5#1)
on tyrosine and##2##3##(1993-9#1)(1996-2#1)
on tyrosine residues in##2##4##(1993-6#1)(1995-8#1)
on tyrosine residues##5##3##(1992-3#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-2#1)
on tyrosine##11##2##(1991-2#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(2012-12#1)
on ultrasonic extraction##2##3##(2008-10#1)(2013-8#1)
on ultrasound##11##2##(1994-6#1)(2008-10#3)(2011-2#3)(2012-2#3)(2012-3#1)
on ultraviolet##2##2##(2008-3#1)(2008-5#1)
on undergraduate##3##2##(2008-11#2)(2013-1#1)
on underlying mechanisms##2##3##(2008-11#2)
on underlying##5##2##(1994-9#1)(2008-11#2)(2010-12#1)(2011-2#1)
on understanding the mechanisms##2##4##(2009-8#1)(2011-1#1)
on understanding the##5##3##(2009-12#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
on understanding##8##2##(1996-2#1)(2008-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
on undifferentiated##2##2##(1990-11#1)(2013-8#1)
on uniform##2##2##(2008-10#1)(2009-4#1)
on uninjured##2##2##(1997-6#2)
on univariate analysis##2##3##(1990-8#1)(2007-8#1)
on university##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
on untreated##9##2##(1994-3#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
on upper##2##2##(2008-10#1)(2008-8#1)
on urban and##2##3##(2010-5#1)(2011-1#1)
on urban##4##2##(1992-12#1)(2008-11#1)(2010-5#1)(2011-1#1)
on uredinial##2##2##(2008-10#2)
on urediniospore germination##2##3##(2008-10#2)
on urinary##8##2##(1990-12#1)(1992-3#1)(1992-8#1)(1995-6#2)(2007-10#1)(2008-12#1)(2011-2#1)
on use of##7##3##(1995-12#1)(1996-3#1)(2008-11#1)(2008-3#3)(2008-6#1)
on use##10##2##(1995-1#1)(1995-12#1)(1996-3#1)(2008-11#2)(2008-3#3)(2008-6#1)(2012-12#1)
on user##2##2##(2011-2#2)
on using a##3##3##(1992-1#1)(2008-3#1)(2008-9#1)
on using the##3##3##(1992-12#1)(2008-2#1)(2008-9#1)
on using##23##2##(1992-1#1)(1992-12#1)(1996-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#4)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
on uterine epithelial cells##2##4##(2008-6#2)
on uterine##3##2##(2008-6#2)(2010-3#1)
on utilization and##2##3##(2012-12#2)
on utilization##6##2##(1994-3#1)(1997-4#1)(2012-12#3)(2013-8#1)
on valid##2##2##(2008-2#2)
on value##4##2##(1990-12#1)(1994-2#1)(1995-1#1)(2007-11#1)
on variables such as##2##4##(1993-1#1)(2011-1#1)
on variables##4##2##(1993-1#1)(1994-2#1)(2008-3#1)(2011-1#1)
on variance##2##2##(2008-3#1)(2008-8#1)
on variation##2##2##(2008-10#1)(2008-3#1)
on variations of##3##3##(1990-9#1)(2008-4#1)(2009-3#1)
on variations##4##2##(1990-9#1)(2007-12#1)(2008-4#1)(2009-3#1)
on various aspects of##2##4##(2008-1#1)(2010-10#1)
on various media##2##3##(2008-3#1)(2011-2#1)
on various system parameters##2##4##(2007-11#1)(2008-2#1)
on various types of##2##4##(2008-1#1)(2008-10#1)
on various##49##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-10#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)
on vascular smooth##2##3##(1995-12#1)(2013-1#1)
on vascular##10##2##(1994-5#1)(1995-12#1)(1997-6#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on vasopressin##2##2##(1994-2#2)
on vegetable##2##2##(2008-10#1)(2008-5#1)
on vegetative##3##2##(2008-10#2)(2012-8#1)
on verbal##3##2##(1990-3#1)(2007-8#1)(2012-3#1)
on vertical##2##2##(2008-2#1)(2008-3#1)
on viability of##2##3##(1990-6#1)(2010-5#1)
on viability##5##2##(1990-6#1)(2008-11#2)(2008-5#1)(2010-5#1)
on viable cell##2##3##(2008-11#2)
on violence in##2##3##(1995-2#1)(2008-11#1)
on violence##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
on viral replication##2##3##(2008-11#1)(2012-3#1)
on viral##8##2##(1992-8#1)(1997-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#1)(2012-3#1)(2013-8#1)
on virulence##5##2##(2008-10#5)
on virus accumulation in##2##4##(2008-10#2)
on virus accumulation##3##3##(2008-10#3)
on virus##9##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#1)
on virus-infected plants##2##3##(2008-10#2)
on viscosity##2##2##(2008-5#2)
on visual cues##3##3##(1991-2#1)(2008-8#1)(2008-9#1)
on visual field##2##3##(2011-2#2)
on visual##18##2##(1991-2#1)(1994-11#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#2)(2013-8#1)
on vitamin##6##2##(1992-9#3)(2008-10#1)(2011-1#1)(2012-2#1)
on volatile##2##2##(2008-5#1)(2011-10#1)
on voltage-dependent gating of a cloned mammalian neuronal##2##8##(1997-2#2)
on volume##2##2##(1991-2#1)(2008-3#1)
on voluntary##3##2##(2009-6#1)(2012-3#1)(2013-1#1)
on waiting lists##2##3##(1991-11#1)(2011-3#1)
on waiting##4##2##(1991-11#1)(2011-3#3)
on warfarin##2##2##(2011-1#1)(2012-1#1)
on waste##2##2##(1994-2#1)(1996-1#1)
on water agar##4##3##(2008-10#4)
on water toxicity##2##3##(2008-10#2)
on water##17##2##(1991-5#1)(2007-5#1)(2008-10#8)(2008-3#3)(2008-8#1)(2009-10#2)(2012-2#1)
on wavelength and##2##3##(2007-11#1)(2008-2#1)
on wavelength##8##2##(1995-3#1)(2007-11#1)(2008-2#4)(2008-3#2)
on ways to##2##3##(1994-2#1)(2008-10#1)
on weather##2##2##(1992-3#1)(2008-10#1)
on weed##3##2##(2008-12#3)
on week 2##2##3##(2013-1#2)
on weekdays##2##2##(2010-6#2)
on weight and##3##3##(2008-12#2)(2008-3#1)
on weight gain##2##3##(1991-2#1)(2007-2#1)
on weight##9##2##(1990-9#1)(1991-2#1)(2007-2#1)(2008-12#2)(2008-3#2)(2011-2#1)(2012-3#1)
on welfare##3##2##(1994-3#2)(1996-11#1)
on well-characterized##2##2##(2008-11#1)(2008-9#1)
on wellness rather than##2##4##(2011-2#1)(2013-8#1)
on what constitutes##2##3##(1995-2#1)(2010-10#1)
on what is##6##3##(2007-11#2)(2007-12#1)(2010-10#1)(2012-12#1)(2013-1#1)
on what it##2##3##(1993-12#1)(2008-1#1)
on what the##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
on what to##2##3##(1996-2#1)(1997-2#1)
on what##31##2##(1991-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-2#2)(1997-2#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#4)(2012-12#3)(2013-1#1)
on wheat and##2##3##(2008-10#1)(2008-8#1)
on wheat chromosome##3##3##(2008-10#2)(2008-5#1)
on wheat germ##3##3##(1990-12#1)(1991-12#1)(1993-8#1)
on wheat yield##2##3##(2008-12#1)(2008-8#1)
on wheat##39##2##(1990-12#1)(1991-12#1)(1993-8#1)(2008-10#31)(2008-12#1)(2008-5#1)(2008-8#2)(2011-1#1)
on when##6##2##(1994-5#1)(1995-1#1)(1995-5#1)(2010-8#1)(2011-2#2)
on where##2##2##(1992-9#1)(2011-2#1)
on whether or not##2##4##(1992-9#1)(2012-2#1)
on whether the##10##3##(1990-8#1)(1991-12#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)(2012-2#1)
on whether they##4##3##(2008-3#1)(2008-5#1)(2011-2#2)
on whether##34##2##(1990-8#1)(1991-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#1)
on which a##2##3##(2008-11#1)(2008-3#1)
on which it##2##3##(2008-11#1)(2008-3#1)
on which the##10##3##(1990-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-3#1)(2012-12#1)
on which they are based##2##5##(2007-11#1)(2008-8#1)
on which they##3##3##(1996-4#1)(2007-11#1)(2008-8#1)
on which to base##5##4##(1992-12#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)
on which to##10##3##(1992-12#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-8#1)
on which viruliferous##2##3##(2008-10#2)
on which we##2##3##(2008-2#1)(2011-2#1)
on which##80##2##(1990-11#1)(1990-3#1)(1991-11#1)(1992-12#2)(1993-12#1)(1994-2#3)(1994-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#4)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#1)(2011-8#1)(2012-12#3)(2013-8#1)
on white fir at Teakettle##2##5##(2008-10#2)
on white fir in Lake Tahoe##2##6##(2008-10#2)
on white fir in##3##4##(2008-10#3)
on white fir##6##3##(2008-10#6)
on whole body sweat rate and##2##6##(2008-5#2)
on whole plants##2##3##(2008-10#2)
on whole##9##2##(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2010-1#2)
on whom##6##2##(1991-8#1)(1994-2#1)(2007-7#1)(2007-8#1)(2009-7#2)
on why##3##2##(1995-2#1)(2008-11#1)(2008-8#1)
on wild##4##2##(2008-10#3)(2013-8#1)
on wild-type##3##2##(1990-12#1)(1991-5#1)(1994-11#1)
on winter wheat in##2##4##(2008-10#1)(2012-2#1)
on winter wheat##7##3##(2008-10#6)(2012-2#1)
on winter##8##2##(2008-10#7)(2012-2#1)
on women with##2##3##(2008-9#1)(2010-12#1)
on women##7##2##(1992-2#1)(1994-12#1)(1994-5#1)(1996-12#1)(2008-9#1)(2010-12#1)(2011-2#1)
on women's##8##2##(1994-3#1)(1996-8#1)(2007-12#1)(2008-11#1)(2010-11#1)(2010-3#2)(2011-1#1)
on wood##6##2##(2007-6#1)(2010-4#3)(2012-5#1)(2013-1#1)
on work##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
on workers'##2##2##(1996-2#1)(2011-2#1)
on working memory##2##3##(2012-3#2)
on working##6##2##(1994-1#1)(2008-12#1)(2008-5#1)(2012-3#2)(2013-8#1)
on wound healing##2##3##(2007-12#1)(2012-12#1)
on wound##3##2##(1990-3#1)(2007-12#1)(2012-12#1)
on wounded apples##2##3##(2008-10#2)
on wounded##3##2##(2008-10#3)
on xylose##3##2##(1995-8#1)(2008-6#1)(2012-3#1)
on yeast##5##2##(1993-2#1)(1995-6#1)(1995-9#1)(2008-6#1)(2010-7#1)
on yield were##2##3##(2008-10#2)
on yield##7##2##(2008-10#5)(2008-12#1)(2009-7#1)
on young adult outcomes##2##4##(2010-7#2)
on young adult##6##3##(2010-7#6)
on young##17##2##(1993-12#2)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-7#7)(2012-1#1)(2012-3#1)(2013-1#2)
on younger patients##2##3##(2012-12#1)(2013-1#1)
on younger##4##2##(2008-10#1)(2012-12#2)(2013-1#1)
on your##2##2##(1995-12#1)(2007-4#1)
on zinc##2##2##(1993-8#1)(2008-10#1)
on α-glucosidase activity in##2##4##(2010-11#2)
on##35998##1##(1990-10#15)(1990-11#99)(1990-12#129)(1990-2#124)(1990-3#65)(1990-4#7)(1990-5#114)(1990-6#54)(1990-7#58)(1990-8#132)(1990-9#49)(1991-1#67)(1991-10#7)(1991-11#46)(1991-12#176)(1991-2#125)(1991-3#92)(1991-4#16)(1991-5#117)(1991-6#97)(1991-7#19)(1991-8#61)(1991-9#83)(1992-1#63)(1992-10#22)(1992-11#66)(1992-12#155)(1992-2#81)(1992-3#168)(1992-4#25)(1992-5#60)(1992-6#113)(1992-7#12)(1992-8#97)(1992-9#100)(1993-1#78)(1993-11#89)(1993-12#235)(1993-2#108)(1993-3#151)(1993-5#47)(1993-6#117)(1993-8#85)(1993-9#75)(1994-1#79)(1994-10#6)(1994-11#105)(1994-12#161)(1994-2#201)(1994-3#161)(1994-5#127)(1994-6#130)(1994-7#14)(1994-8#149)(1994-9#86)(1995-1#67)(1995-10#4)(1995-11#134)(1995-12#230)(1995-2#222)(1995-3#153)(1995-4#12)(1995-5#104)(1995-6#147)(1995-8#83)(1995-9#42)(1996-1#85)(1996-10#15)(1996-11#46)(1996-12#206)(1996-2#211)(1996-3#149)(1996-4#43)(1996-5#153)(1996-6#77)(1996-7#27)(1996-8#30)(1996-9#30)(1997-1#100)(1997-2#212)(1997-3#165)(1997-4#114)(1997-5#99)(1997-6#101)(1997-7#118)(1997-8#115)(1997-9#5)(2006-10#53)(2006-12#25)(2006-4#5)(2006-5#2)(2006-6#36)(2006-7#3)(2006-8#5)(2007-1#3)(2007-10#137)(2007-11#627)(2007-12#662)(2007-2#67)(2007-3#8)(2007-4#21)(2007-5#60)(2007-6#38)(2007-7#144)(2007-8#215)(2007-9#11)(2008-1#349)(2008-10#7993)(2008-11#1316)(2008-12#606)(2008-2#925)(2008-3#1841)(2008-4#483)(2008-5#976)(2008-6#380)(2008-7#996)(2008-8#944)(2008-9#712)(2009-1#26)(2009-10#148)(2009-11#125)(2009-12#123)(2009-2#69)(2009-3#80)(2009-4#94)(2009-5#177)(2009-6#109)(2009-7#167)(2009-8#176)(2009-9#113)(2010-1#66)(2010-10#113)(2010-11#101)(2010-12#184)(2010-2#89)(2010-3#161)(2010-4#164)(2010-5#148)(2010-6#105)(2010-7#93)(2010-8#223)(2010-9#82)(2011-1#452)(2011-10#7)(2011-2#1153)(2011-3#102)(2011-4#1)(2011-7#8)(2011-8#1)(2011-9#3)(2012-1#153)(2012-12#353)(2012-2#658)(2012-3#584)(2012-4#9)(2012-5#16)(2012-6#18)(2012-7#8)(2012-8#9)(2012-9#8)(2013-1#1035)(2013-7#112)(2013-8#512)
on&quot##9##1##(1990-8#1)(1997-2#1)(2008-7#6)(2011-1#1)
on)##4##1##(1995-8#1)(2008-10#2)(2008-6#1)
on-##3##1##(2008-11#1)(2008-7#1)(2012-12#1)
on-axis aberration##2##2##(2008-3#2)
on-axis current##2##2##(2007-12#2)
on-axis##26##1##(2007-11#2)(2007-12#2)(2008-2#8)(2008-3#14)
on-bead##2##1##(2008-2#1)(2013-1#1)
on-bipolar cell##4##2##(1993-8#4)
on-board##5##1##(2008-10#3)(2008-11#1)(2008-2#1)
on-call##2##1##(1996-2#1)(2011-2#1)
on-campus##3##1##(2008-11#2)(2010-11#1)
on-chip capillary electrophoresis##2##3##(2008-10#2)
on-chip separation##2##2##(2008-10#2)
on-chip##17##1##(2008-10#9)(2008-3#2)(2009-12#2)(2009-5#1)(2010-8#1)(2011-1#2)
on-column##9##1##(1996-5#1)(2008-10#7)(2013-1#1)
on-farm measures##2##2##(2011-2#2)
on-farm safety##2##2##(2008-12#2)
on-farm##6##1##(2008-12#4)(2011-2#2)
on-going##14##1##(1991-12#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
on-line UV##3##2##(2008-10#3)
on-line adsorption preconcentration##2##3##(2008-10#2)
on-line analysis of##2##3##(2008-10#2)
on-line analysis##3##2##(2008-10#2)(2013-8#1)
on-line and off-line##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
on-line and##5##2##(2008-10#2)(2008-11#2)(2008-3#1)
on-line atomic absorption##2##3##(2008-10#2)
on-line atomic##3##2##(2008-10#3)
on-line automated##4##2##(2008-10#4)
on-line by flame atomic absorption spectrometry##2##6##(2008-10#2)
on-line by##5##2##(2008-10#4)(2008-11#1)
on-line column enrichment##2##3##(2008-10#2)
on-line column preconcentration##2##3##(2008-10#2)
on-line column##7##2##(1992-11#1)(2008-10#6)
on-line concentration##2##2##(2008-10#2)
on-line coupled continuous flow liquid membrane extraction##2##7##(2008-10#2)
on-line coupled##4##2##(2008-10#4)
on-line coupling of##3##3##(1997-2#1)(2008-10#2)
on-line coupling##5##2##(1997-2#1)(2008-10#4)
on-line derivatization##7##2##(2008-10#7)
on-line detection of the##2##4##(2008-10#1)(2008-4#1)
on-line detection of##3##3##(2008-10#1)(2008-4#1)(2010-11#1)
on-line detection##9##2##(2008-10#6)(2008-11#1)(2008-4#1)(2010-11#1)
on-line determination of##11##3##(2008-10#10)(2010-5#1)
on-line determination##13##2##(2008-10#12)(2010-5#1)
on-line determined##2##2##(2008-10#2)
on-line dilution of the##2##4##(2008-10#2)
on-line dilution##7##2##(2008-10#7)
on-line during##2##2##(1997-2#1)(2008-7#1)
on-line electrogenerated##5##2##(2008-10#5)
on-line extraction and##2##3##(1990-8#1)(2008-10#1)
on-line extraction##3##2##(1990-8#1)(2008-10#2)
on-line flow injection##4##3##(2008-10#4)
on-line flow##6##2##(2008-10#5)(2008-11#1)
on-line flow-injection microwave-assisted mineralization and##2##5##(2008-10#2)
on-line formed##2##2##(2008-10#2)
on-line hydrolysis##3##2##(2008-10#3)
on-line identification of##2##3##(2008-10#1)(2008-11#1)
on-line in a##2##3##(1990-8#1)(2008-10#1)
on-line in the##2##3##(2008-10#2)
on-line in##6##2##(1990-8#1)(2008-10#4)(2008-7#1)
on-line instrumentation##3##2##(2008-10#3)
on-line into##2##2##(2008-10#2)
on-line liquid-liquid extraction##3##3##(2008-10#3)
on-line liquid-liquid##5##2##(2008-10#5)
on-line measurement of##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
on-line measurement##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
on-line measurements are##2##3##(2008-10#1)(2008-3#1)
on-line measurements##5##2##(2008-10#4)(2008-3#1)
on-line method was##3##3##(2008-10#2)(2008-7#1)
on-line method##7##2##(2008-10#5)(2008-3#1)(2008-7#1)
on-line methods##2##2##(2008-1#1)(2008-10#1)
on-line microdialysis sampling##2##3##(2008-10#2)
on-line microdialysis##3##2##(2008-10#3)
on-line mixing and##2##3##(2008-10#2)
on-line mixing##3##2##(2008-10#3)
on-line monitoring of##6##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
on-line monitoring system##2##3##(2007-12#1)(2008-10#1)
on-line monitoring##11##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#2)
on-line multiplexed sorption preconcentration##2##4##(2008-10#2)
on-line of##2##2##(2008-10#2)
on-line oxidation##3##2##(2008-10#3)
on-line pre-reduction##3##2##(2008-10#1)(2009-6#2)
on-line precipitation##4##2##(2008-10#4)
on-line preconcentration and##8##3##(2008-10#8)
on-line preconcentration of cobalt##2##4##(2008-10#2)
on-line preconcentration of##7##3##(2008-10#7)
on-line preconcentration system for zinc determination in##2##7##(2008-10#2)
on-line preconcentration system for##7##4##(2008-10#7)
on-line preconcentration system##10##3##(2008-10#10)
on-line preconcentration with a##2##4##(2008-10#2)
on-line preconcentration with##4##3##(2008-10#4)
on-line preconcentration##35##2##(2008-10#35)
on-line preconcentration/separation and determination##2##4##(2008-10#2)
on-line reaction##3##2##(2008-10#3)
on-line retention of##2##3##(2008-10#2)
on-line sample cleanup##2##3##(2008-10#2)
on-line sample concentration##2##3##(2008-10#2)
on-line sample pretreatment##4##3##(2008-10#4)
on-line sample##14##2##(2008-10#13)(2010-7#1)
on-line separation and##3##3##(2008-10#3)
on-line separation##6##2##(2008-10#6)
on-line sequential injection##3##3##(2008-10#3)
on-line sequential##4##2##(2008-10#4)
on-line solid phase extraction##2##4##(2008-10#2)
on-line solid phase##3##3##(2008-10#3)
on-line solid-phase extraction##8##3##(1997-2#1)(2008-10#7)
on-line sorbent##2##2##(2008-10#2)
on-line sorption##2##2##(2008-10#2)
on-line spectrophotometric##2##2##(2008-10#2)
on-line standard addition##4##3##(2008-10#4)
on-line system for##3##3##(2008-10#3)
on-line system with##3##3##(2008-10#3)
on-line system##11##2##(2008-10#11)
on-line systems##2##2##(2008-10#1)(2008-3#1)
on-line the##2##2##(2008-10#2)
on-line to an##2##3##(2008-10#2)
on-line to##6##2##(2008-10#5)(2008-7#1)
on-line urea##2##2##(2008-1#2)
on-line wavelet transform##5##3##(2008-10#5)
on-line with the##3##3##(2008-10#3)
on-line with##15##2##(2008-10#15)
on-line##472##1##(1990-8#2)(1991-2#1)(1991-5#2)(1992-11#2)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#3)(1997-3#1)(2007-12#1)(2008-1#4)(2008-10#398)(2008-11#17)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#3)(2008-7#11)(2009-6#2)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#2)(2013-1#1)(2013-8#1)
on-off contrast##2##2##(2007-11#1)(2007-12#1)
on-off keying##2##2##(2007-11#2)
on-off##11##1##(1995-6#1)(2007-11#4)(2007-12#2)(2008-11#1)(2008-2#1)(2013-8#2)
on-plate##2##1##(2009-7#2)
on-pump coronary##2##2##(2007-8#1)(2013-1#1)
on-pump to off-pump##2##3##(2007-8#2)
on-pump##7##1##(2007-8#5)(2008-10#1)(2013-1#1)
on-site cancellations##2##2##(1995-1#2)
on-site environmental analysis of explosives##2##5##(2008-10#2)
on-site environmental##3##2##(2008-10#3)
on-site monitoring of##2##3##(2008-10#2)
on-site##35##1##(1993-3#1)(1995-1#2)(1995-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#3)
on-target##7##1##(2007-11#2)(2008-3#2)(2012-2#3)
on-the-job training##2##2##(1993-2#1)(1996-3#1)
on-treatment HBsAg##2##2##(2013-1#2)
on-treatment##6##1##(2009-8#3)(2011-2#1)(2013-1#2)
on/off##3##1##(2008-7#2)(2012-1#1)
onboard a satellite##2##3##(2008-3#2)
onboard the##5##2##(2008-2#2)(2008-3#3)
onboard##14##1##(2007-11#1)(2008-2#4)(2008-3#9)
once a day for##2##4##(1994-6#1)(2008-5#1)
once a day##12##3##(1990-5#1)(1993-11#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2012-12#1)
once a month##2##3##(1991-9#1)(2007-11#1)
once a week for##4##4##(1991-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
once a week##11##3##(1991-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-7#1)
once a year##3##3##(1990-8#1)(1996-12#1)(2007-8#1)
once a##36##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
once after##4##2##(2007-5#1)(2007-8#1)(2008-5#1)(2009-9#1)
once again##11##2##(1991-5#1)(1992-6#1)(1993-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)
once an##2##2##(2008-2#1)(2008-7#1)
once and##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
once before the##2##3##(2007-5#1)(2007-7#1)
once before##3##2##(2007-5#1)(2007-7#1)(2007-8#1)
once but##2##2##(2007-12#1)(2011-1#1)
once by##2##2##(2008-10#1)(2008-6#1)
once daily dosage##2##3##(2007-11#1)(2010-5#1)
once daily for##6##3##(1995-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
once daily in the morning##2##5##(2007-11#2)
once daily in##4##3##(1992-8#1)(2007-11#2)(2012-1#1)
once daily##22##2##(1991-11#1)(1992-8#2)(1995-12#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-7#2)(2008-10#2)(2008-3#3)(2010-5#3)(2012-1#1)(2013-1#1)(2013-8#1)
once during##2##2##(2008-12#1)(2011-2#1)
once each##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
once every##4##2##(1990-8#1)(1991-12#1)(2008-10#2)
once in a##2##3##(2009-3#1)(2013-1#1)
once in every##2##3##(1995-2#1)(2010-8#1)
once in the##6##3##(1990-11#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-12#1)(2013-7#1)
once in##13##2##(1990-11#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-8#1)(2013-1#2)(2013-7#1)
once infected##2##2##(1995-2#1)(2008-10#1)
once it is##2##3##(2008-10#1)(2008-3#1)
once it##5##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
once more##3##2##(1991-11#1)(2008-10#1)(2008-12#1)
once or twice a week##2##5##(1990-3#1)(2013-1#1)
once or twice##5##3##(1990-3#1)(1992-8#1)(1997-4#1)(2012-6#1)(2013-1#1)
once per day##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
once per week##2##3##(1991-12#1)(2008-12#1)
once per year##3##3##(1997-3#2)(2008-2#1)
once per##10##2##(1991-12#1)(1997-3#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
once said##2##2##(1994-1#1)(2011-2#1)
once the##24##2##(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-5#2)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
once there##2##2##(2008-10#1)(2013-1#1)
once they##5##2##(1992-3#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
once thought##2##2##(1992-8#1)(2008-5#1)
once weekly for##2##3##(1992-3#1)(2007-12#1)
once weekly##11##2##(1992-3#1)(2007-12#2)(2008-7#8)
once widely##2##2##(1994-2#1)(2008-5#1)
once##265##1##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#5)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#2)(1994-1#2)(1994-2#2)(1994-3#3)(1994-6#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#40)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#13)(2008-6#5)(2008-7#17)(2008-8#8)(2008-9#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#8)(2013-7#3)(2013-8#3)
once-daily amlodipine##3##2##(2008-3#3)
once-daily dosing##2##2##(1992-8#1)(2013-1#1)
once-daily##14##1##(1992-8#4)(2007-1#1)(2008-3#4)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
onchocerciasis are##2##2##(1991-12#2)
onchocerciasis##7##1##(1991-12#3)(1991-9#2)(2010-8#1)(2011-2#1)
onco-antigens##4##1##(2013-1#4)
oncocytoma is##2##2##(1990-5#1)(1992-5#1)
oncocytoma##4##1##(1990-5#2)(1992-5#2)
oncofetal##3##1##(1994-9#2)(1996-12#1)
oncogene activated##2##2##(2008-11#2)
oncogene and##4##2##(1991-4#1)(1995-8#1)(2008-11#1)(2010-3#1)
oncogene expression in##2##3##(1992-3#1)(1995-8#1)
oncogene expression##3##2##(1991-5#1)(1992-3#1)(1995-8#1)
oncogene family##3##2##(1993-6#1)(1994-10#2)
oncogene in##2##2##(1992-8#1)(1994-8#1)
oncogene of the##2##3##(1994-12#1)(2008-9#1)
oncogene on##2##2##(1994-10#1)(2010-3#1)
oncogene product##4##2##(1990-12#1)(1991-9#1)(1994-8#1)(1995-2#1)
oncogene products##4##2##(1990-9#1)(1995-2#1)(2008-11#1)(2008-4#1)
oncogene transfection##3##2##(2008-11#3)
oncogene##54##1##(1990-12#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-6#2)(1994-10#3)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-8#2)(1996-12#1)(1997-7#1)(2008-11#13)(2008-4#2)(2008-6#1)(2008-9#1)(2010-3#2)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#1)
oncogene-transfected##2##1##(1995-9#1)(2008-11#1)
oncogenes and tumor suppressor genes##2##5##(2008-7#1)(2009-5#1)
oncogenes and##3##2##(1990-12#1)(2008-7#1)(2009-5#1)
oncogenes in##6##2##(1991-5#1)(1996-7#1)(2008-11#3)(2008-6#1)
oncogenes may##2##2##(1991-12#1)(1997-7#1)
oncogenes such as##2##3##(2008-11#2)
oncogenes##46##1##(1990-12#1)(1990-8#3)(1991-12#1)(1991-4#2)(1991-5#2)(1995-2#6)(1995-9#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-7#3)(2007-10#1)(2008-11#13)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-2#3)
oncogenesis and##2##2##(2008-6#1)(2013-1#1)
oncogenesis##9##1##(1992-2#1)(1992-8#1)(1992-9#1)(1994-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
oncogenic forms of##2##3##(1994-10#1)(2008-5#1)
oncogenic pathways##2##2##(2008-7#1)(2013-8#1)
oncogenic potential##2##2##(1995-2#1)(1996-1#1)
oncogenic transformation##4##2##(1994-8#2)(1995-2#1)(2012-12#1)
oncogenic##43##1##(1991-12#2)(1991-4#1)(1991-6#1)(1992-2#1)(1994-1#2)(1994-10#1)(1994-8#4)(1995-2#5)(1996-1#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
oncogenicity##2##1##(1992-9#1)(1995-12#1)
oncologic and functional outcome##2##4##(2008-6#2)
oncologic and functional##4##3##(2008-6#3)(2010-3#1)
oncologic and##7##2##(1997-8#1)(2007-11#2)(2008-6#3)(2010-3#1)
oncologic outcome##2##2##(2011-2#2)
oncologic resection##2##2##(2012-2#2)
oncologic resections##2##2##(2012-2#2)
oncologic##31##1##(1991-12#1)(1991-3#1)(1997-8#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-6#5)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#4)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#2)
oncological centers##2##2##(2011-2#2)
oncological diseases##3##2##(2007-10#1)(2008-10#1)(2013-1#1)
oncological treatment##3##2##(2007-11#1)(2008-5#1)(2012-3#1)
oncological##33##1##(1991-12#1)(1992-5#1)(1993-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#4)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#3)(2013-1#1)(2013-8#1)
oncologist and##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
oncologist##14##1##(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2009-11#2)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
oncologists and other##2##3##(2011-2#1)(2012-3#1)
oncologists and##8##2##(1991-2#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
oncologists in##2##2##(2011-3#1)(2013-1#1)
oncologists to plan##2##3##(2008-6#1)(2013-8#1)
oncologists to##3##2##(2008-6#1)(2012-3#1)(2013-8#1)
oncologists##27##1##(1991-2#1)(1992-12#1)(1993-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
oncology agents##2##2##(2008-6#2)
oncology and palliative care##2##4##(2008-7#1)(2012-3#1)
oncology and##10##2##(1991-3#1)(1993-2#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-3#1)(2012-3#1)
oncology centers##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
oncology clinical##2##2##(2012-3#1)(2013-1#1)
oncology community##2##2##(2008-6#2)
oncology departments##2##2##(2007-4#2)
oncology in Poland in years##2##5##(2008-9#2)
oncology in Poland##3##3##(2008-9#3)
oncology in the United States##2##5##(2010-3#2)
oncology in the##3##3##(1991-8#1)(2010-3#2)
oncology in##7##2##(1991-8#1)(2008-6#1)(2008-9#3)(2010-3#2)
oncology is##3##2##(2007-4#1)(2010-5#1)(2011-2#1)
oncology patients undergoing##2##3##(1994-12#1)(2007-7#1)
oncology patients##11##2##(1992-12#2)(1994-12#2)(1995-12#1)(1996-6#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-7#1)
oncology practice##2##2##(2011-2#1)(2012-3#1)
oncology practices##3##2##(2010-9#2)(2012-3#1)
oncology research##2##2##(2010-5#2)
oncology setting##3##2##(2008-11#1)(2012-3#2)
oncology staff##2##2##(2012-1#2)
oncology team##2##2##(2008-7#1)(2010-3#1)
oncology treatment##2##2##(2007-11#1)(2007-4#1)
oncology##132##1##(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-12#2)(1993-2#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#6)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#3)(2008-5#1)(2008-6#8)(2008-7#12)(2008-8#5)(2008-9#6)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#5)(2010-5#4)(2010-7#1)(2010-9#3)(2011-2#7)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#3)
oncology]##2##1##(1990-3#1)(2007-3#1)
oncolytic activity##3##2##(2013-1#3)
oncolytic viruses and a##2##4##(1995-2#1)(2013-8#1)
oncolytic viruses##9##2##(1995-2#1)(2007-11#1)(2013-1#2)(2013-8#5)
oncolytic##15##1##(1995-2#2)(2007-11#1)(2013-1#7)(2013-8#5)
oncomiR##2##1##(2011-2#2)
oncophora##3##1##(1996-12#3)
oncoprotein##7##1##(1993-9#1)(1994-7#1)(2008-11#1)(2011-2#2)(2012-2#2)
oncoproteins##5##1##(1994-6#1)(2008-11#1)(2011-2#1)(2012-12#2)
oncoretroviral vectors##2##2##(2008-2#2)
oncosis##3##1##(2008-8#3)
oncostatin M##7##2##(1994-11#5)(1996-2#1)(1996-5#1)
ondansetron in##3##2##(2008-7#2)(2010-7#1)
ondansetron##13##1##(1991-1#1)(1995-9#1)(2008-5#2)(2008-6#1)(2008-7#7)(2010-7#1)
one (0##3##2##(2007-8#1)(2008-1#1)(2008-9#1)
one (1##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
one (Mr##2##2##(1990-5#1)(1997-7#1)
one 1##3##2##(2008-9#3)
one 12##2##2##(2008-9#1)(2010-12#1)
one 4##2##2##(1991-8#1)(2009-3#1)
one 50##2##2##(1994-2#1)(2008-9#1)
one British##2##2##(1992-4#1)(1994-12#1)
one Ca2+##3##2##(1990-11#2)(1995-6#1)
one DNA fingerprint##3##3##(2008-10#3)
one DNA##5##2##(1990-5#1)(2008-10#4)
one MCG##2##2##(2008-10#2)
one QTL affected##2##3##(2008-10#2)
one QTL for##2##3##(2008-8#2)
one QTL##4##2##(2008-10#2)(2008-8#2)
one RAPD##2##2##(2008-10#2)
one School of##2##3##(2008-11#1)(2008-12#1)
one State##2##2##(1991-2#1)(1997-2#1)
one Zn2+##3##2##(1997-4#3)
one a##4##2##(1996-3#1)(1997-3#1)(2008-10#2)
one abnormal##3##2##(2008-1#2)(2011-2#1)
one additional##8##2##(1995-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
one adult##2##2##(1992-8#1)(1997-6#1)
one affected##3##2##(1995-11#1)(2008-1#1)(2008-7#1)
one after the##2##3##(2007-11#1)(2008-10#1)
one after##5##2##(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)
one allele##3##2##(1994-8#1)(2008-9#1)(2012-12#1)
one alpha##2##2##(1991-12#1)(2012-12#1)
one alternative##2##2##(2008-10#1)(2008-9#1)
one amino acid##2##3##(1991-12#1)(1997-4#1)
one among##3##2##(1994-7#1)(2008-5#1)(2012-3#1)
one analysis##2##2##(2008-10#2)
one analyte##2##2##(2008-10#2)
one and a half years##2##5##(2008-10#1)(2008-12#1)
one and a half##8##4##(1993-2#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2010-6#1)(2011-1#1)
one and a half-year##2##4##(2007-7#1)(2008-10#1)
one and a##12##3##(1992-6#1)(1993-2#1)(1996-6#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-9#1)(2010-6#1)(2011-1#1)
one and four##3##3##(1997-8#1)(2008-12#1)(2010-3#1)
one and half years##2##4##(2007-7#1)(2010-11#1)
one and only##2##3##(1995-5#1)(2009-2#1)
one and the same##2##4##(1995-6#1)(2008-6#1)
one and the##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
one and three##2##3##(2008-1#1)(2013-1#1)
one and two dimensions##2##4##(1997-6#1)(2008-2#1)
one and two##7##3##(1997-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-10#1)
one and##48##2##(1992-6#1)(1993-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2013-1#1)
one angle of##2##3##(2008-3#1)(2009-11#1)
one angle##4##2##(2008-3#2)(2009-11#1)(2010-3#1)
one another and##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)
one another by##3##3##(2008-2#1)(2008-9#1)(2010-12#1)
one another in##7##3##(1992-3#1)(1993-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)
one another to##2##3##(2007-12#1)(2011-1#1)
one another##67##2##(1990-11#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-9#2)(1993-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#3)(2013-8#1)
one another's##3##2##(1996-1#1)(2008-11#1)(2013-8#1)
one aperture##3##2##(2007-11#2)(2008-3#1)
one application##6##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
one approach to##4##3##(1993-3#1)(1996-12#1)(2008-11#1)(2013-1#1)
one approach##7##2##(1993-3#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
one arbitrary##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
one are##2##2##(2008-11#1)(2008-4#1)
one area of##3##3##(1991-12#1)(2008-9#1)(2012-12#1)
one area##6##2##(1991-12#1)(1995-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
one arm of the##2##4##(1995-3#1)(2008-3#1)
one arm##4##2##(1995-3#1)(2007-10#1)(2007-11#1)(2008-3#1)
one as##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2009-5#1)
one aspect of a##2##4##(2007-10#1)(2013-1#1)
one aspect of the##2##4##(1994-1#1)(2008-12#1)
one aspect of##5##3##(1994-1#1)(2007-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
one aspect##6##2##(1993-2#1)(1994-1#1)(2007-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
one associated##2##2##(2008-10#1)(2009-11#1)
one at a time##4##4##(2008-10#2)(2008-7#1)(2013-1#1)
one at the##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
one at##16##2##(1991-12#1)(1991-9#1)(1994-11#1)(1995-12#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
one band##4##2##(1997-2#1)(2008-10#3)
one base##3##2##(2008-10#2)(2008-4#1)
one based on the##2##4##(1995-2#1)(2013-1#1)
one based on##7##3##(1993-11#1)(1995-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2013-1#1)
one beam##2##2##(2008-3#2)
one because##2##2##(1991-3#1)(2013-1#1)
one before##2##2##(1990-12#1)(2008-1#1)
one being##8##2##(1991-9#1)(1995-8#1)(2007-12#1)(2008-7#2)(2008-8#1)(2010-2#1)(2013-1#1)
one best##2##2##(1996-1#1)(1996-2#1)
one between the##2##3##(1996-2#1)(2008-7#1)
one between##3##2##(1996-2#1)(2008-12#1)(2008-7#1)
one bite##2##2##(1996-11#1)(2008-4#1)
one but##2##2##(2008-10#1)(2008-4#1)
one by one##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
one by##10##2##(1994-11#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-8#1)(2011-2#1)
one cDNA clone##3##3##(2008-8#3)
one cDNA##5##2##(1993-6#1)(2008-8#4)
one calibration line##2##3##(2007-12#1)(2008-10#1)
one can achieve##3##3##(2007-12#1)(2008-3#2)
one can be##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
one can conclude that##2##4##(2008-2#1)(2009-12#1)
one can deduce##2##3##(1993-11#1)(2008-3#1)
one can determine the##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
one can determine##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
one can easily##3##3##(1991-3#1)(2008-3#1)(2009-4#1)
one can eliminate##2##3##(2008-3#2)
one can evaluate the##2##4##(2008-2#1)(2008-3#1)
one can obtain a##3##4##(2008-2#2)(2008-3#1)
one can obtain##6##3##(1992-6#1)(2008-2#2)(2008-3#3)
one can predict the##2##4##(2008-10#1)(2008-11#1)
one can use##5##3##(1994-11#1)(2008-2#3)(2008-3#1)
one can##86##2##(1990-7#1)(1991-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-9#1)(2007-11#8)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#18)(2008-3#21)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
one cannot##5##2##(1991-12#1)(1995-9#1)(1997-3#1)(2007-12#1)(2008-2#1)
one capsule##2##2##(1997-2#1)(2011-2#1)
one case and##5##3##(1992-4#1)(2007-11#2)(2008-5#1)(2008-7#1)
one case each of##3##4##(1996-11#1)(2008-5#1)(2008-9#1)
one case of acute##2##4##(2008-5#1)(2012-12#1)
one case of##23##3##(1993-5#1)(1993-9#1)(1997-3#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)
one case the##7##3##(1990-8#1)(1991-2#1)(1992-8#1)(1994-9#1)(2007-11#1)(2007-6#1)(2007-8#1)
one case was##2##3##(2007-7#1)(2008-7#1)
one case with##2##3##(1991-12#1)(1994-6#1)
one case##87##2##(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-5#1)(1993-9#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#2)(1997-3#2)(1997-8#1)(2006-12#1)(2007-11#9)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#11)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)
one catalytic##2##2##(1992-3#1)(1992-6#1)
one cavity##2##2##(2007-11#1)(2008-10#1)
one cell##8##2##(1997-3#2)(2007-12#1)(2008-11#2)(2008-8#1)(2009-2#1)(2012-12#1)
one cellular##2##2##(1996-10#1)(2009-8#1)
one central##2##2##(2007-12#1)(2008-7#1)
one centre##2##2##(2008-9#1)(2012-2#1)
one century##3##2##(1996-6#1)(2009-12#1)(2012-2#1)
one change##2##2##(1993-8#1)(2012-3#1)
one child##6##2##(1990-8#1)(1993-2#1)(2008-9#2)(2011-2#1)(2012-2#1)
one chromosome##2##2##(2008-10#1)(2008-12#1)
one class of##4##3##(1990-8#1)(1993-1#1)(1993-12#1)(2008-10#1)
one class##7##2##(1990-8#1)(1993-1#2)(1993-12#1)(2008-10#1)(2008-11#2)
one climatic area##2##3##(2008-10#2)
one climatic##3##2##(2008-10#2)(2013-1#1)
one clone##4##2##(1994-6#1)(1995-2#1)(2008-4#1)(2008-9#1)
one cluster##4##2##(2008-10#2)(2008-6#1)(2009-5#1)
one common##5##2##(1991-5#1)(1992-12#1)(1993-12#1)(2007-12#1)(2012-3#1)
one community hospital##3##3##(1994-3#1)(1995-3#1)(2009-2#1)
one community##4##2##(1994-3#1)(1995-3#1)(2009-2#1)(2011-2#1)
one compartment##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
one complete##4##2##(2008-8#2)(2008-9#1)(2009-10#1)
one component of the##3##4##(1992-9#1)(2008-11#1)(2008-3#1)
one component of this##2##4##(1993-9#1)(2008-10#1)
one component of##8##3##(1992-9#1)(1993-9#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
one component##13##2##(1992-9#1)(1993-9#1)(1996-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2012-12#1)
one comprising##2##2##(2008-10#1)(2008-5#1)
one condition##2##2##(2007-2#1)(2012-12#1)
one consisting of##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)
one contained the##2##3##(2008-10#2)
one continuous##2##2##(2008-10#1)(2008-2#1)
one control and##2##3##(2011-2#1)(2013-1#1)
one control##6##2##(1997-6#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
one copy of the##2##4##(2008-8#1)(2012-3#1)
one copy of##6##3##(1990-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)
one copy##8##2##(1990-5#1)(2007-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)
one corresponding to##2##3##(1990-3#1)(2011-2#1)
one could##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
one cross##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
one cultivar##4##2##(2008-10#4)
one cycle of##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
one cytoplasmic##2##2##(1991-2#1)(1997-7#1)
one daughter##2##2##(2009-12#1)(2009-2#1)
one day in##2##3##(1997-7#1)(2008-5#1)
one day later##2##3##(2009-7#2)
one day to##2##3##(1991-3#1)(2008-3#1)
one day##19##2##(1991-3#1)(1993-2#1)(1995-2#1)(1997-7#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#2)(2011-2#2)(2012-8#1)
one death##5##2##(1991-3#1)(1997-8#1)(2007-8#1)(2008-7#1)(2013-8#1)
one designed##2##2##(2008-10#1)(2008-5#1)
one died##3##2##(1997-3#1)(2007-8#1)(2012-12#1)
one diffraction##2##2##(2008-3#2)
one dimension##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)
one direction##4##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
one disease##2##2##(1994-2#1)(2010-1#1)
one dog##3##2##(2008-6#3)
one domain##2##2##(1991-7#1)(2008-7#1)
one dominant gene and one recessive gene##2##7##(2008-10#2)
one dominant gene##3##3##(2008-10#3)
one dominant##6##2##(2008-10#4)(2009-11#1)(2009-6#1)
one dose of##3##3##(1990-2#1)(1994-7#2)
one dose##6##2##(1990-2#1)(1994-7#2)(2007-11#1)(2007-12#1)(2008-7#1)
one drop of##3##3##(1993-3#2)(2008-10#1)
one drop##4##2##(1993-3#2)(1994-2#1)(2008-10#1)
one drug##2##2##(1991-1#1)(2012-3#1)
one dual-rail optical##2##3##(2008-3#2)
one due to##3##3##(2008-10#1)(2008-6#2)
one each from##2##3##(2008-10#2)
one each had##2##3##(1995-12#1)(2008-1#1)
one each##5##2##(1995-12#1)(2008-1#1)(2008-10#2)(2012-2#1)
one electron##3##2##(2008-10#2)(2009-9#1)
one element of##2##3##(2007-12#1)(2008-11#1)
one element##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
one encoding##2##2##(1991-9#1)(2008-11#1)
one end and##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
one end of a##2##4##(2007-11#1)(2008-10#1)
one end of##3##3##(1995-2#1)(2007-11#1)(2008-10#1)
one end##13##2##(1995-2#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)
one enzyme##7##2##(1992-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)
one episode##5##2##(1994-6#1)(2008-10#2)(2008-6#2)
one equivalent of##2##3##(2009-2#1)(2010-2#1)
one essential##2##2##(2008-4#1)(2010-5#1)
one establishment every##2##3##(2008-10#2)
one ewe to##2##3##(2009-4#2)
one example of the##3##4##(2006-4#1)(2008-4#1)(2010-9#1)
one example of##6##3##(2006-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-9#1)
one example##8##2##(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-9#1)
one exception##4##2##(1994-2#1)(1995-12#1)(2008-10#2)
one existing##2##2##(2008-2#1)(2008-9#1)
one experiment##7##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)
one explanation for the##2##4##(1991-12#1)(2011-1#1)
one explanation##3##2##(1991-12#1)(2010-8#1)(2011-1#1)
one exposure##2##2##(2007-11#1)(2008-10#1)
one eye##6##2##(1994-8#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
one facility##6##2##(1991-3#2)(1996-11#1)(2008-11#1)(2013-1#2)
one factor##5##2##(1995-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
one faculty##2##2##(1993-2#1)(2008-12#1)
one family##3##2##(1991-12#1)(1994-8#1)(2008-10#1)
one farm##2##2##(1994-7#1)(1997-5#1)
one female##4##2##(1991-8#1)(2008-5#1)(2008-9#1)(2009-4#1)
one fetus##2##2##(1993-12#1)(2012-3#1)
one fiber##2##2##(2008-10#1)(2008-3#1)
one field##11##2##(2007-6#1)(2008-10#9)(2011-2#1)
one fifth of##4##3##(1990-11#1)(2007-2#1)(2008-8#1)(2012-3#1)
one fifth##5##2##(1990-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2012-3#1)
one focuses##3##2##(2008-2#1)(2008-8#2)
one for 1##2##3##(2008-10#1)(2008-9#1)
one for amplification##2##3##(2008-10#1)(2008-3#1)
one for each##3##3##(1994-8#1)(2007-11#1)(2008-2#1)
one for the upwelling radiance##2##5##(2008-2#2)
one for the##14##3##(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-6#1)
one for##55##2##(1992-6#2)(1993-6#1)(1993-8#1)(1994-8#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#4)(2008-6#2)(2008-7#1)(2008-9#5)(2009-3#2)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
one form of##9##3##(1991-8#1)(1992-3#1)(1993-6#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-5#1)
one format##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
one found solely in##2##4##(2008-10#2)
one found##3##2##(2008-10#2)(2008-2#1)
one fourth of patients##2##4##(2007-10#1)(2010-4#1)
one fourth of##3##3##(1990-12#1)(2007-10#1)(2010-4#1)
one fourth##4##2##(1990-12#1)(2007-10#1)(2008-8#1)(2010-4#1)
one fraction##2##2##(1992-11#1)(2008-10#1)
one fracture##2##2##(2008-6#1)(2009-4#1)
one from chrysanthemum and##2##4##(2008-10#2)
one from each##2##3##(1992-8#1)(2011-2#1)
one from the##8##3##(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-8#1)(2011-2#1)
one from##25##2##(1990-3#1)(1992-12#1)(1992-8#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2010-8#1)(2011-2#2)
one functional##3##2##(1991-5#1)(1992-3#1)(2008-11#1)
one fungicide##2##2##(2008-10#1)(2008-7#1)
one gene##13##2##(1990-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-8#1)(1994-9#1)(2008-10#4)(2009-5#2)(2013-8#1)
one genotype##7##2##(2008-10#6)(2013-8#1)
one genus##2##2##(2008-3#1)(2008-7#1)
one given##2##2##(2008-10#2)
one grating##2##2##(2007-11#1)(2008-3#1)
one greenhouse strain##2##3##(2011-2#2)
one greenhouse##3##2##(2008-10#1)(2011-2#2)
one group and##2##3##(2008-10#1)(2011-2#1)
one group of rats##2##4##(1994-8#1)(2009-11#1)
one group of##6##3##(1990-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)
one group was treated with##2##5##(2008-12#2)
one group was##3##3##(2008-12#3)
one group##26##2##(1990-2#1)(1993-12#1)(1994-8#1)(1996-2#1)(1996-9#1)(2007-7#1)(2008-10#9)(2008-12#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
one had a##3##3##(1992-6#1)(2007-8#1)(2008-6#1)
one had the##2##3##(2008-9#1)(2013-1#1)
one had##23##2##(1991-12#1)(1992-6#4)(1997-5#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2012-3#1)(2013-1#2)
one half of the##8##4##(1990-8#1)(1992-9#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-2#1)(2008-9#2)
one half of##12##3##(1990-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-2#2)(2008-9#2)(2011-2#1)
one half##16##2##(1990-8#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#2)(2011-2#1)
one hand and##8##3##(1991-6#1)(1993-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-2#1)(2013-1#1)
one hand##45##2##(1990-12#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-1#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
one haplotype##3##2##(2008-10#2)(2008-11#1)
one has been##2##3##(2007-8#1)(2008-10#1)
one has the##2##3##(1990-6#1)(2008-10#1)
one has to##2##3##(2007-12#1)(2013-8#1)
one has##15##2##(1990-6#1)(1991-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-10#7)(2013-8#1)
one have##2##2##(2010-4#1)(2011-2#1)
one having##2##2##(1991-12#1)(2008-10#1)
one health care##3##3##(1992-2#1)(1995-2#1)(2008-1#1)
one health##5##2##(1992-2#1)(1992-9#1)(1995-2#1)(2008-1#1)(2008-7#1)
one hospital##6##2##(1990-9#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)
one hospital's##4##2##(1992-1#1)(1992-2#1)(1994-3#1)(1996-12#1)
one host species##2##3##(2008-10#1)(2008-9#1)
one host##5##2##(2008-10#3)(2008-9#2)
one hour after##3##3##(1994-8#2)(2007-8#1)
one hour later##2##3##(2008-4#1)(2008-5#1)
one hour of exposure##2##4##(1994-9#1)(2013-1#1)
one hour of##5##3##(1992-6#1)(1994-9#1)(1996-11#1)(2010-8#1)(2013-1#1)
one hour post dialysis##3##4##(2008-4#3)
one hour##29##2##(1990-12#2)(1992-2#1)(1992-6#2)(1994-8#2)(1994-9#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
one hundred##6##2##(1995-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-10#1)
one hybridization##2##2##(1997-3#1)(2008-10#1)
one hydrophilic##2##2##(2008-5#1)(2010-5#1)
one hypothesis##2##2##(2008-10#1)(2008-8#1)
one image at a time##2##5##(2008-3#1)(2013-1#1)
one image##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
one imaging##2##2##(1997-8#1)(2008-12#1)
one implant##2##2##(2013-1#2)
one important##2##2##(1997-3#1)(2010-3#1)
one in a##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
one in each##3##3##(1992-5#1)(1996-2#1)(2008-10#1)
one in terms of##2##4##(1991-3#1)(2010-10#1)
one in the former##2##4##(1992-1#2)
one in the##16##3##(1990-10#1)(1992-1#2)(1994-8#2)(1995-5#2)(1997-4#2)(2007-12#1)(2007-8#1)(2008-12#1)(2010-8#2)(2011-2#2)
one in which the##5##4##(2009-7#1)(2011-2#3)(2012-12#1)
one in which##9##3##(1991-9#1)(1995-8#1)(2008-8#2)(2009-7#1)(2011-2#3)(2012-12#1)
one in##57##2##(1990-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-5#1)(1993-12#1)(1994-8#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#4)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#6)(2012-12#1)(2013-1#3)
one includes##2##2##(2007-11#2)
one including##2##2##(2008-10#1)(2009-10#1)
one individual##7##2##(1991-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-8#1)
one infected##2##2##(2010-6#2)
one infectious##2##2##(1993-3#1)(2008-10#1)
one inland##2##2##(2008-2#1)(2012-12#1)
one instance##4##2##(1996-12#1)(2008-10#1)(2009-1#1)(2010-4#1)
one institution's experience##2##3##(1994-3#1)(2009-11#1)
one instrument##3##2##(1996-2#1)(1997-8#1)(2008-3#1)
one instrumental##2##2##(2008-10#1)(2008-2#1)
one irreversible##2##2##(2008-10#2)
one is a##5##3##(2007-2#1)(2008-10#1)(2008-3#1)(2009-3#1)(2013-1#1)
one is an##2##3##(1990-7#1)(2008-8#1)
one is dealing with##5##4##(1994-3#1)(2007-11#1)(2007-12#1)(2008-3#2)
one is of##2##3##(2007-8#1)(2008-1#1)
one is that##2##3##(2008-11#1)(2008-6#1)
one is the##5##3##(1994-5#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-2#1)
one is##51##2##(1990-7#1)(1994-3#1)(1994-5#1)(1996-4#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
one isolate from##2##3##(2008-10#2)
one isolate of##7##3##(2007-6#1)(2008-10#6)
one isolate##17##2##(2007-6#1)(2008-10#14)(2008-5#1)(2012-2#1)
one issue##2##2##(1993-12#1)(2008-12#1)
one iteration##2##2##(2008-3#2)
one kidney##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
one kind of##2##3##(2008-10#1)(2013-8#1)
one knee joint##2##3##(2007-8#2)
one knee##3##2##(2007-8#2)(2013-1#1)
one known##2##2##(2008-4#1)(2010-12#1)
one laboratory##2##2##(2008-5#2)
one large Brazilian kindred##2##4##(1994-8#2)
one large open reading frame##2##5##(2008-10#2)
one large##13##2##(1993-2#1)(1994-8#2)(1997-5#1)(2008-10#4)(2008-5#1)(2008-8#2)(2010-8#1)(2012-3#1)
one laser beam##2##3##(2007-11#1)(2008-2#1)
one latent period##2##3##(2008-10#2)
one lateral##3##2##(1993-3#1)(2007-12#1)(2008-3#1)
one layer of##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#2)
one layer##10##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
one leg##3##2##(1992-5#1)(1994-12#1)(1997-4#1)
one lesion per leaf was expected following##2##7##(2008-10#2)
one lesion##3##2##(1997-8#1)(2008-10#2)
one level##2##2##(2007-11#1)(2008-1#1)
one library##2##2##(1997-6#1)(2010-4#1)
one line containing the PinII##2##5##(2008-10#2)
one line##5##2##(1993-3#1)(2008-10#3)(2008-2#1)
one lineage##3##2##(2008-10#3)
one linkage##2##2##(2008-10#1)(2012-3#1)
one local##2##2##(1992-6#1)(2008-10#1)
one location##5##2##(1994-12#1)(2008-10#4)
one locus with##2##3##(1995-5#1)(2008-10#1)
one locus##7##2##(1995-5#1)(2008-10#3)(2008-12#2)(2008-9#1)
one long open reading frame encoding a##2##7##(1990-5#1)(2008-10#1)
one louse##2##2##(1996-12#2)
one lung##4##2##(1993-3#1)(2008-10#1)(2010-7#1)(2011-2#1)
one made##2##2##(2008-2#1)(2008-5#1)
one main##2##2##(2008-10#1)(2008-7#1)
one major cluster##2##3##(2008-10#1)(2008-5#1)
one major##18##2##(1990-11#1)(1990-6#1)(1990-7#1)(1994-1#1)(1994-12#1)(1995-6#1)(1997-8#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
one male##3##2##(2007-7#1)(2008-12#1)(2008-8#1)
one mating type##2##3##(2008-10#2)
one mating##3##2##(2008-10#2)(2008-8#1)
one may##8##2##(1991-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
one means of##2##3##(2008-11#1)(2008-12#1)
one mechanism by which##2##4##(1993-11#1)(2008-8#1)
one mechanism for##2##3##(1993-6#1)(1995-5#1)
one mechanism of##2##3##(1990-2#1)(2008-10#1)
one mechanism##9##2##(1990-2#1)(1993-11#1)(1993-6#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)
one medical##3##2##(1990-10#1)(1994-11#1)(2008-11#1)
one medium##2##2##(1994-6#1)(2008-11#1)
one megabase##3##2##(1995-12#2)(2012-2#1)
one member of##2##3##(1990-12#1)(1997-4#1)
one member##3##2##(1990-12#1)(1995-3#1)(1997-4#1)
one method to##2##3##(1996-12#1)(2008-9#1)
one method##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
one might expect##2##3##(1992-6#1)(2008-12#1)
one might##9##2##(1992-6#1)(1995-5#1)(1996-3#1)(1996-9#1)(2007-4#1)(2008-12#2)(2012-2#1)(2012-8#1)
one milk replacer##2##3##(2010-2#2)
one million people##2##3##(2008-10#1)(2008-11#1)
one million##10##2##(1990-3#1)(1992-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-3#1)
one minute##3##2##(1990-8#1)(2008-11#1)(2008-5#1)
one missing row##2##3##(2007-11#1)(2007-12#1)
one model##2##2##(2008-10#1)(2010-9#1)
one molecule at a##2##4##(1995-11#1)(2008-3#1)
one molecule of##5##3##(1990-9#2)(1991-2#1)(1994-5#2)
one molecule##11##2##(1990-9#2)(1991-2#1)(1994-5#2)(1995-11#1)(1995-3#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)
one month after the##3##4##(1990-9#1)(2008-5#1)(2013-8#1)
one month after##9##3##(1990-9#1)(1991-2#1)(1991-3#1)(1997-3#1)(2007-2#1)(2008-5#1)(2008-8#2)(2013-8#1)
one month and##3##3##(1992-11#1)(2007-7#1)(2008-10#1)
one month in##2##3##(1990-2#1)(2008-11#1)
one month later##2##3##(2008-11#1)(2008-5#1)
one month of age##3##4##(2012-2#3)
one month of##5##3##(2011-1#1)(2012-2#3)(2013-1#1)
one month or##2##3##(2007-2#1)(2008-9#1)
one month to##2##3##(1991-9#1)(2007-7#1)
one month##49##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-6#1)(1996-3#2)(1997-3#1)(1997-8#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#2)
one more##10##2##(1991-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-5#2)(2011-2#1)
one most##2##2##(2010-5#1)(2010-6#1)
one muscle group##2##3##(2010-7#2)
one must take##2##3##(2008-2#1)(2008-3#1)
one must##15##2##(1994-9#2)(1996-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-5#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
one mutant##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
one need##2##2##(1997-6#1)(2012-2#1)
one needs to develop##2##4##(2008-3#1)(2008-7#1)
one needs to##7##3##(1997-7#2)(2008-10#1)(2008-3#2)(2008-7#2)
one needs##9##2##(1997-7#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)
one neuron##3##2##(1990-5#1)(1993-12#1)(1997-3#1)
one not##2##2##(2008-9#1)(2011-1#1)
one novel##2##2##(2008-12#1)(2008-4#1)
one nucleotide##2##2##(1991-2#1)(2008-9#1)
one nursing##2##2##(1994-3#1)(2008-12#1)
one obtains a##2##3##(1996-3#1)(2008-3#1)
one obtains an estimate of the##2##6##(1997-3#2)
one obtains##5##2##(1996-3#1)(1997-3#2)(2008-2#1)(2008-3#1)
one occasion##2##2##(1990-8#1)(1994-2#1)
one ochre mutation##2##3##(2008-9#2)
one of a number of##5##5##(1992-5#1)(2008-11#2)(2008-3#1)(2012-2#1)
one of a##11##3##(1992-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-3#2)(2007-5#1)(2008-11#2)(2008-3#1)(2012-2#1)
one of five locations##2##4##(1992-11#1)(2008-4#1)
one of five##10##3##(1991-2#1)(1992-11#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
one of four types of##2##5##(2009-8#1)(2012-2#1)
one of four##16##3##(1992-1#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-9#1)
one of his##2##3##(1993-12#1)(1995-6#1)
one of its components##2##4##(2007-12#1)(2008-6#1)
one of its##12##3##(1992-8#1)(1994-12#2)(1996-3#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)
one of nine##2##3##(1993-2#1)(2008-10#1)
one of our patients##2##4##(1991-3#1)(2008-7#1)
one of our##3##3##(1991-3#1)(2008-11#1)(2008-7#1)
one of seven##3##3##(1995-12#1)(2007-2#1)(2008-10#1)
one of several##14##3##(1990-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#1)
one of six##6##3##(2007-12#1)(2008-10#3)(2008-12#1)(2009-7#1)
one of the 3##2##4##(2008-9#1)(2013-7#1)
one of the antagonists##2##4##(1995-11#1)(2008-8#1)
one of the authors##3##4##(2007-5#1)(2008-11#2)
one of the basic##4##4##(1994-3#1)(2007-10#2)(2007-11#1)
one of the best characterized##2##5##(1995-8#1)(2008-10#1)
one of the best predictors of##2##6##(2008-10#1)(2008-6#1)
one of the best sources of##2##6##(2008-7#1)(2012-3#1)
one of the best##13##4##(1991-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2012-3#1)
one of the biggest##2##4##(2008-7#1)(2012-2#1)
one of the causes of##4##5##(1994-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
one of the cell##2##4##(2008-10#1)(2008-11#1)
one of the children##2##4##(1994-12#1)(2008-9#1)
one of the common##7##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
one of the components of the##3##6##(1991-2#1)(2008-10#2)
one of the components##4##4##(1991-2#1)(2008-10#3)
one of the compounds##2##4##(1992-3#1)(2008-10#1)
one of the control##2##4##(1990-11#1)(1996-1#1)
one of the earliest##2##4##(2008-11#1)(2010-3#1)
one of the eight##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
one of the elements##2##4##(2008-10#1)(2013-1#1)
one of the factors in##2##5##(1997-8#1)(2009-5#1)
one of the factors responsible for##4##6##(1992-12#1)(1995-12#1)(2008-12#1)(2013-8#1)
one of the factors##15##4##(1991-1#1)(1992-12#1)(1994-6#1)(1995-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2013-8#1)
one of the few##8##4##(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-7#1)
one of the first to##2##5##(2008-11#1)(2012-3#1)
one of the first##15##4##(1993-12#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
one of the five##3##4##(1997-7#1)(2008-10#1)(2008-3#1)
one of the following##10##4##(1991-2#1)(1992-8#1)(1993-1#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)
one of the founding##2##4##(2008-10#1)(2008-8#1)
one of the four##7##4##(1990-5#1)(1994-8#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-12#1)
one of the fundamental##4##4##(1995-8#1)(2008-8#2)(2013-8#1)
one of the great##2##4##(2007-4#1)(2008-9#1)
one of the greatest##2##4##(2008-10#1)(2008-2#1)
one of the highest in##2##5##(2008-11#1)(2010-10#1)
one of the highest##7##4##(2008-11#3)(2008-5#1)(2010-10#1)(2010-9#1)(2011-2#1)
one of the important##16##4##(1992-12#1)(1993-3#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
one of the key enzymes##3##5##(1994-12#1)(2008-9#2)
one of the key##9##4##(1994-12#1)(1996-1#1)(2008-11#2)(2008-8#1)(2008-9#2)(2010-10#1)(2013-1#1)
one of the largest##7##4##(1991-2#1)(1995-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
one of the leading causes of##9##6##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-2#3)(2013-8#1)
one of the leading##13##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#4)(2013-8#2)
one of the least##3##4##(1991-8#1)(2012-12#1)(2013-1#1)
one of the ligands##2##4##(1990-8#1)(1997-4#1)
one of the main causes of##3##6##(1997-3#1)(2008-1#1)(2011-2#1)
one of the main causes##4##5##(1997-3#1)(2008-1#1)(2011-2#1)(2012-3#1)
one of the main factors in##2##6##(1994-12#1)(2011-1#1)
one of the main objectives##2##5##(2006-10#1)(2011-2#1)
one of the main sources of##2##6##(2008-10#1)(2013-1#1)
one of the main##29##4##(1991-6#1)(1992-12#1)(1993-12#1)(1994-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
one of the major causes of##4##6##(2008-11#2)(2009-12#1)(2009-4#1)
one of the major complications##4##5##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
one of the major factors in##2##6##(1997-6#1)(2008-10#1)
one of the major factors##4##5##(1997-6#1)(2008-1#1)(2008-10#1)(2012-2#1)
one of the major obstacles to##2##6##(1996-5#1)(2008-12#1)
one of the major risk factors##2##6##(2008-11#1)(2011-1#1)
one of the major##49##4##(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
one of the many##7##4##(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)
one of the mechanisms responsible for##2##6##(2008-10#1)(2008-11#1)
one of the mechanisms##8##4##(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)(2012-12#1)(2012-3#1)
one of the members of##2##5##(2007-7#1)(2008-9#1)
one of the more##4##4##(1994-12#1)(1994-5#1)(2008-10#1)(2008-9#1)
one of the most abundant##2##5##(2010-11#1)(2011-2#1)
one of the most active##2##5##(1995-3#1)(2008-6#1)
one of the most challenging##5##5##(1991-12#1)(2008-3#1)(2011-2#2)(2012-2#1)
one of the most common cause of##2##7##(2008-10#1)(2013-1#1)
one of the most common childhood##2##6##(2008-9#1)(2011-2#1)
one of the most common chronic##2##6##(1991-2#1)(2008-1#1)
one of the most common infectious diseases##2##7##(1997-8#2)
one of the most common##45##5##(1990-8#1)(1990-9#1)(1991-2#1)(1995-3#1)(1997-7#1)(1997-8#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#3)(2013-1#7)(2013-7#1)(2013-8#3)
one of the most commonly performed##2##6##(2011-2#2)
one of the most commonly##4##5##(2008-11#1)(2011-2#2)(2012-1#1)
one of the most devastating diseases of##3##7##(1997-7#1)(2008-10#1)(2011-2#1)
one of the most devastating##5##5##(1997-7#1)(2008-10#2)(2011-2#1)(2012-3#1)
one of the most difficult challenges##2##6##(2007-7#1)(2009-3#1)
one of the most difficult##6##5##(1995-1#1)(2007-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
one of the most effective##6##5##(2007-11#1)(2008-10#1)(2009-11#1)(2009-3#1)(2011-1#1)(2013-8#1)
one of the most fascinating##2##5##(2008-11#1)(2008-12#1)
one of the most frequent complications##2##6##(2007-7#1)(2008-1#1)
one of the most frequent##6##5##(2007-7#1)(2008-1#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
one of the most frequently##2##5##(2007-8#1)(2008-4#1)
one of the most fundamental##2##5##(2010-12#1)(2012-2#1)
one of the most important challenges##2##6##(2008-7#1)(2011-2#1)
one of the most important factors##2##6##(2008-3#1)(2013-1#1)
one of the most important foliar diseases of##2##8##(2008-10#2)
one of the most important issues##2##6##(1995-1#1)(2008-7#1)
one of the most important risk factors##2##7##(2008-10#1)(2013-7#1)
one of the most important##53##5##(1990-12#1)(1993-6#1)(1994-1#1)(1995-1#1)(1996-7#1)(1997-6#1)(2007-11#2)(2007-2#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-10#1)(2011-2#7)(2012-1#1)(2013-1#3)(2013-7#2)(2013-8#1)
one of the most interesting##3##5##(2008-2#1)(2008-5#1)(2009-8#1)
one of the most popular##4##5##(1997-2#1)(2007-11#1)(2008-5#1)(2009-8#1)
one of the most potent##4##5##(2008-10#1)(2008-4#1)(2010-4#1)(2010-8#1)
one of the most powerful##5##5##(1995-3#1)(2008-10#2)(2008-7#1)(2008-9#1)
one of the most prevalent diseases##2##6##(2008-10#1)(2012-3#1)
one of the most prevalent##5##5##(1991-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)
one of the most prominent##5##5##(1995-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
one of the most promising##3##5##(2008-3#1)(2008-7#1)(2013-7#1)
one of the most rapidly##4##5##(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
one of the most reliable##3##5##(2008-10#1)(2011-2#1)(2012-12#1)
one of the most sensitive##4##5##(2008-10#3)(2008-7#1)
one of the most significant##3##5##(2007-11#1)(2008-1#1)(2013-1#1)
one of the most useful##2##5##(2007-11#1)(2009-5#1)
one of the most widely used##6##6##(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
one of the most widely##11##5##(2006-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
one of the most##260##4##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-5#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1995-1#2)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#39)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-10#2)(2011-2#23)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#18)(2013-7#5)(2013-8#5)
one of the municipalities##2##4##(1991-6#1)(1992-2#1)
one of the naturally occurring##2##5##(2008-5#2)
one of the oldest##4##4##(2008-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
one of the parents##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
one of the patients##2##4##(1996-6#1)(2007-11#1)
one of the positive##2##4##(2008-8#1)(2011-3#1)
one of the possible##2##4##(2008-9#1)(2012-12#1)
one of the primary factors##2##5##(2008-10#1)(2008-5#1)
one of the primary##7##4##(1991-1#1)(1993-1#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
one of the rare##5##4##(1992-11#1)(1997-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
one of the rarest##2##4##(1997-7#1)(2010-3#1)
one of the reasons for##3##5##(2008-10#2)(2008-8#1)
one of the responsible##2##4##(1995-5#1)(1997-7#1)
one of the seven##2##4##(2008-10#1)(2008-12#1)
one of the six##3##4##(1994-8#1)(2008-10#1)(2012-12#1)
one of the strongest##2##4##(2012-12#1)(2013-1#1)
one of the three##12##4##(1992-6#1)(1993-6#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
one of the tools##3##4##(1996-3#1)(2008-9#1)(2009-10#1)
one of the two substrates##2##5##(1997-2#1)(2008-7#1)
one of the two##41##4##(1991-9#1)(1992-3#2)(1993-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
one of the##943##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#2)(1994-1#3)(1994-12#9)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#6)(1995-5#4)(1995-6#7)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#5)(1996-5#4)(1996-6#1)(1996-7#1)(1997-2#10)(1997-3#8)(1997-4#3)(1997-5#3)(1997-6#6)(1997-7#5)(1997-8#5)(2006-10#3)(2007-10#4)(2007-11#16)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#6)(2008-1#11)(2008-10#146)(2008-11#35)(2008-12#19)(2008-2#14)(2008-3#30)(2008-4#12)(2008-5#29)(2008-6#6)(2008-7#35)(2008-8#33)(2008-9#26)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#6)(2010-2#4)(2010-3#5)(2010-4#6)(2010-5#3)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#14)(2011-10#2)(2011-2#48)(2011-3#5)(2012-1#5)(2012-12#19)(2012-2#19)(2012-3#16)(2013-1#41)(2013-7#7)(2013-8#18)
one of their most##2##4##(2008-4#1)(2011-2#1)
one of their##4##3##(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
one of them the##2##4##(2008-10#2)
one of them was##5##4##(1993-5#1)(1994-6#1)(1995-6#1)(2008-10#2)
one of them##31##3##(1990-6#1)(1990-7#2)(1991-2#2)(1991-8#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-6#1)(1997-2#1)(2008-10#11)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2013-1#3)(2013-8#1)
one of these drugs##2##4##(1991-8#1)(2012-2#1)
one of these filters##2##4##(2008-2#1)(2008-3#1)
one of these genes##2##4##(1992-9#1)(1997-2#1)
one of these patients##2##4##(2008-2#1)(2011-1#1)
one of these sites##2##4##(1994-6#1)(2013-7#1)
one of these three##2##4##(1994-9#1)(2008-10#1)
one of these##56##3##(1990-10#1)(1990-12#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-8#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
one of those##5##3##(1992-3#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-7#1)
one of three groups##3##4##(1991-1#1)(2008-10#2)
one of three##23##3##(1991-1#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-4#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#2)(2013-7#1)
one of two different##3##4##(1990-12#1)(2008-10#1)(2009-8#1)
one of two specific##2##4##(1994-11#1)(2008-5#1)
one of two strains of M##2##6##(1997-3#2)
one of two ways##2##4##(2008-10#1)(2008-3#1)
one of two##41##3##(1990-12#2)(1990-8#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-8#1)(1996-6#1)(1997-3#4)(1997-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-9#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
one of which also##2##4##(2008-10#2)
one of which encodes##2##4##(1993-3#1)(1994-12#1)
one of which had##3##4##(1994-2#1)(1997-2#1)(2008-7#1)
one of which is##14##4##(1990-11#1)(1991-12#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#2)
one of which was##4##4##(2008-10#1)(2008-6#1)(2009-10#1)(2011-2#1)
one of which##40##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-12#1)(1993-2#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#2)(2010-10#1)(2011-2#1)
one of whom##2##3##(2008-7#1)(2011-2#1)
one of##1304##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#4)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#3)(1991-12#6)(1991-2#7)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#6)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#5)(1992-2#4)(1992-3#4)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#7)(1993-5#1)(1993-6#6)(1993-8#5)(1994-1#3)(1994-11#3)(1994-12#13)(1994-2#7)(1994-3#4)(1994-5#8)(1994-6#5)(1994-8#6)(1994-9#6)(1995-1#2)(1995-11#2)(1995-12#7)(1995-2#7)(1995-3#8)(1995-5#5)(1995-6#10)(1995-8#7)(1995-9#1)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#9)(1996-3#8)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#14)(1997-3#17)(1997-4#4)(1997-5#3)(1997-6#7)(1997-7#7)(1997-8#5)(2006-10#3)(2007-10#5)(2007-11#17)(2007-12#22)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#6)(2008-1#12)(2008-10#203)(2008-11#53)(2008-12#25)(2008-2#19)(2008-3#44)(2008-4#22)(2008-5#37)(2008-6#10)(2008-7#47)(2008-8#40)(2008-9#37)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#13)(2009-9#5)(2010-1#1)(2010-10#6)(2010-11#6)(2010-12#7)(2010-2#4)(2010-3#7)(2010-4#8)(2010-5#3)(2010-7#6)(2010-8#10)(2010-9#2)(2011-1#17)(2011-10#2)(2011-2#61)(2011-3#5)(2012-1#5)(2012-12#22)(2012-2#28)(2012-3#19)(2012-9#1)(2013-1#47)(2013-7#11)(2013-8#22)
one on his##2##3##(2008-5#2)
one on one##2##3##(1991-3#1)(2008-8#1)
one on the##3##3##(1994-8#1)(2008-5#1)(2013-7#1)
one on##15##2##(1991-3#1)(1994-8#1)(1997-5#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#5)(2008-8#1)(2011-2#1)(2013-7#1)
one onion##2##2##(2008-10#2)
one opal mutation##2##3##(2008-9#2)
one open reading frame##2##4##(1991-9#1)(1995-8#1)
one or a few##4##4##(1990-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
one or a##7##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)
one or both glycosylation sites##2##5##(1992-3#2)
one or both of the##2##5##(1992-6#1)(2008-10#1)
one or both of these##5##5##(1991-12#1)(1991-3#1)(1994-6#1)(1995-11#1)(2008-10#1)
one or both of##8##4##(1991-12#1)(1991-3#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(2008-10#2)
one or both##26##3##(1991-12#1)(1991-3#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
one or more R genes##2##5##(2008-10#2)
one or more chronic diseases##2##5##(1992-4#1)(1994-6#1)
one or more chronic##3##4##(1992-4#1)(1993-3#1)(1994-6#1)
one or more of 12##2##5##(2008-10#1)(2008-11#1)
one or more of the following##5##6##(1991-9#1)(1992-5#1)(2008-10#1)(2008-2#1)(2009-6#1)
one or more of the##12##5##(1991-9#1)(1992-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-6#2)
one or more of these##5##5##(1994-6#1)(2008-1#2)(2008-5#1)(2011-2#1)
one or more of##20##4##(1991-9#1)(1992-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#2)(2011-2#1)
one or more proteins##2##4##(2008-10#1)(2008-4#1)
one or more specific##3##4##(2008-1#1)(2008-4#1)(2009-5#1)
one or more##102##3##(1991-1#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#4)(1995-5#4)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#2)(2008-1#4)(2008-10#20)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#2)(2009-6#3)(2010-11#1)(2011-1#2)(2011-2#4)(2013-1#3)(2013-8#2)
one or multiple##2##3##(2011-2#1)(2012-3#1)
one or other of these##2##5##(1993-2#1)(2007-6#1)
one or other of##3##4##(1993-2#2)(2007-6#1)
one or other##5##3##(1991-8#1)(1993-2#2)(2007-6#1)(2008-11#1)
one or several##7##3##(1990-5#1)(1994-9#1)(1995-8#1)(2008-12#1)(2008-3#2)(2009-5#1)
one or the other##7##4##(1991-9#1)(1994-11#1)(1995-2#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-12#1)
one or two genotypes##2##4##(2008-10#2)
one or two pairs##2##4##(1993-12#1)(2007-12#1)
one or two years##2##4##(1994-6#1)(2013-1#1)
one or two##47##3##(1990-11#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-5#2)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#3)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
one or##210##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#4)(1994-9#3)(1995-11#1)(1995-2#5)(1995-3#1)(1995-5#4)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#38)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#9)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
one order of magnitude for##3##5##(1991-5#1)(1995-5#1)(2007-12#1)
one order of magnitude##8##4##(1991-5#1)(1995-5#1)(2007-12#2)(2008-10#4)
one organic##2##2##(2008-7#1)(2010-4#1)
one orientation##2##2##(1991-11#1)(1995-3#1)
one oscillation period##2##3##(2008-2#2)
one other case of##2##4##(1990-5#1)(2008-12#1)
one other enzyme##2##3##(1990-12#1)(1995-12#1)
one other##13##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1994-6#1)(1995-12#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-8#1)
one out of the##2##4##(1991-8#1)(1995-6#1)
one out of##9##3##(1991-8#1)(1992-5#2)(1992-6#1)(1995-6#1)(2007-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
one ovary was##2##3##(1992-3#2)
one over the##2##3##(1996-9#1)(2008-5#1)
one over##4##2##(1996-9#1)(2008-3#1)(2008-5#1)(2009-5#1)
one oxygen##2##2##(2008-3#1)(2008-4#1)
one page##2##2##(2009-10#1)(2010-2#1)
one pair of##6##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)(2012-3#1)
one pair##7##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-7#1)(2012-3#1)
one paper##2##2##(2008-11#1)(2012-3#1)
one parameter##4##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
one parasitoid species##3##3##(2010-2#3)
one parent##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
one part##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
one partial##2##2##(2008-6#1)(2008-9#1)
one particular##6##2##(1991-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)
one partner##2##2##(1997-6#1)(2011-1#1)
one pathogen##2##2##(2008-10#2)
one pathway##4##2##(1990-11#1)(2008-1#1)(2008-4#1)(2010-3#1)
one patient (6##2##3##(2008-1#1)(2008-10#1)
one patient developed##2##3##(2007-8#1)(2008-1#1)
one patient died##5##3##(1991-8#1)(1996-9#1)(2008-10#1)(2008-6#1)(2008-7#1)
one patient experienced mild##2##4##(2008-9#1)(2012-3#1)
one patient had a##2##4##(1994-11#1)(1996-6#1)
one patient had##8##3##(1992-4#1)(1994-11#1)(1996-6#1)(2007-7#2)(2007-8#1)(2008-6#2)
one patient in##2##3##(1996-8#1)(2008-5#1)
one patient reported##2##3##(2006-10#1)(2007-8#1)
one patient was found to##2##5##(2008-7#1)(2011-1#1)
one patient was##4##3##(1994-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
one patient who was reoperated##2##5##(2007-8#2)
one patient who##3##3##(1997-6#1)(2007-8#2)
one patient with a##2##4##(1996-9#1)(2007-8#1)
one patient with##11##3##(1990-12#2)(1991-5#1)(1993-5#1)(1994-12#1)(1994-9#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)
one patient##98##2##(1990-12#2)(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-5#1)(1997-6#2)(1997-8#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-7#7)(2007-8#7)(2008-1#6)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#10)(2008-9#2)(2009-12#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
one patients with##2##3##(2011-1#1)(2013-8#1)
one patients##5##2##(2007-11#2)(2011-1#1)(2013-8#2)
one peak at##2##3##(2008-10#1)(2009-9#1)
one peak##4##2##(1990-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
one pediatric##2##2##(2010-2#1)(2011-2#1)
one peptide##4##2##(1993-6#1)(1995-3#1)(2008-8#1)(2012-12#1)
one per##3##2##(1996-2#1)(2008-10#2)
one percent of##2##3##(1996-3#1)(2013-1#1)
one percent##3##2##(1996-3#1)(2013-1#2)
one period of##2##3##(2008-3#1)(2011-2#1)
one period##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
one permanent##2##2##(1997-3#1)(2008-10#1)
one person##4##2##(1995-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
one phase##2##2##(1997-1#1)(2008-3#1)
one photon##2##2##(2007-11#1)(2007-12#1)
one phototype##2##2##(2008-5#2)
one physician##2##2##(1997-2#1)(2011-2#1)
one plane##2##2##(2008-3#1)(2008-8#1)
one plant species##3##3##(2008-10#2)(2008-8#1)
one plant##7##2##(1994-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
one point##3##2##(2006-4#1)(2008-5#1)(2008-6#1)
one polarization##3##2##(2008-2#1)(2008-3#2)
one policy##2##2##(1993-3#1)(1996-3#1)
one polypeptide##4##2##(1991-12#1)(1992-8#1)(1993-2#1)(2008-8#1)
one population of##2##3##(2007-8#1)(2008-10#1)
one population##6##2##(2007-8#1)(2008-10#4)(2008-8#1)
one positive clone##2##3##(1997-6#1)(2008-9#1)
one positive##4##2##(1992-5#1)(1994-12#1)(1997-6#1)(2008-9#1)
one possible mechanism##2##3##(1993-6#1)(1995-3#1)
one possible##10##2##(1993-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-3#3)(2011-2#1)(2012-1#1)
one pot##2##2##(1996-5#1)(2009-10#1)
one potential well##2##3##(1996-2#2)
one potential##6##2##(1996-2#2)(1997-2#1)(2007-8#1)(2008-10#1)(2012-12#1)
one pregnancy##5##2##(1994-8#1)(2008-4#1)(2012-12#3)
one presenting##2##2##(2008-11#1)(2008-7#1)
one previous##3##2##(1992-7#1)(2008-10#1)(2012-12#1)
one previously published##2##3##(2008-10#1)(2008-9#1)
one previously##3##2##(2008-10#2)(2008-9#1)
one primer##3##2##(2008-10#1)(2008-2#2)
one procedure##2##2##(1991-2#1)(2008-10#1)
one process##3##2##(1995-3#1)(1996-2#1)(2008-3#1)
one produced##2##2##(1997-6#1)(2008-8#1)
one product##2##2##(1994-8#1)(2008-10#1)
one protein of##2##3##(2008-10#1)(2008-4#1)
one protein##12##2##(1990-5#1)(2008-10#2)(2008-4#3)(2008-9#3)(2009-9#1)(2010-12#1)(2012-2#1)
one pump##2##2##(2007-12#1)(2008-10#1)
one putative##3##2##(1990-11#1)(1993-3#1)(1993-6#1)
one quarter of the##3##4##(1993-12#1)(2008-11#1)(2008-2#1)
one quarter##5##2##(1993-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
one race of P##2##4##(2008-10#2)
one race of##4##3##(2008-10#4)
one race##5##2##(2008-10#5)
one reason why##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
one reason##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
one receptor##2##2##(1990-8#2)
one recessive gene was detected in BBA 809##2##8##(2008-10#2)
one recessive gene was detected in BBA##3##7##(2008-10#3)
one recessive gene was detected in##4##6##(2008-10#4)
one recessive gene##8##3##(2008-10#7)(2008-9#1)
one reference electrode##2##3##(2008-10#2)
one region##4##2##(1991-2#1)(1996-4#1)(2011-2#1)(2012-3#1)
one related to##3##3##(1990-2#1)(1996-12#1)(2008-7#1)
one renal##2##2##(2008-4#1)(2011-2#1)
one report##3##2##(2008-12#1)(2009-3#1)(2013-8#1)
one representative##2##2##(2008-10#2)
one residue##2##2##(1991-10#1)(2008-11#1)
one rice##2##2##(2008-10#1)(2009-10#1)
one root##3##2##(2008-3#2)(2013-1#1)
one round of##3##3##(1990-5#1)(2008-7#1)(2008-9#1)
one rural##2##2##(1995-3#1)(2010-3#1)
one sample in##2##3##(2008-10#1)(2008-5#1)
one sample of##3##3##(2008-10#2)(2008-3#1)
one sample to##2##3##(1994-2#1)(2008-10#1)
one sample was##2##3##(2008-10#2)
one sample##19##2##(1994-2#1)(1994-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
one season##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
one segment##3##2##(2008-10#3)
one sensor##2##2##(2007-11#1)(2008-10#1)
one sequence##4##2##(1997-4#1)(1997-6#1)(2008-4#1)(2011-2#1)
one series##3##2##(2008-11#1)(2008-4#1)(2010-3#1)
one serum##2##2##(2008-11#2)
one service##2##2##(1996-2#1)(2008-11#1)
one session##4##2##(2008-5#2)(2010-12#1)(2010-8#1)
one set of##9##3##(1995-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)
one setting##2##2##(2007-8#1)(2013-8#1)
one should be cautious##2##4##(2008-5#1)(2008-7#1)
one should be##4##3##(2008-5#2)(2008-7#1)(2012-2#1)
one should consider##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
one should preferably##2##3##(2008-8#2)
one should##14##2##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2012-2#1)
one showed##2##2##(1994-6#1)(2008-7#1)
one showing##2##2##(2008-4#1)(2008-5#1)
one side and the##2##4##(2008-10#1)(2008-2#1)
one side and##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#2)
one side of the##7##4##(1990-11#1)(1991-5#1)(1993-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
one side of##10##3##(1990-11#1)(1991-5#1)(1993-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
one side##25##2##(1990-11#1)(1991-5#1)(1993-3#2)(1994-7#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
one significant##4##2##(1990-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
one simulation##2##2##(2008-2#1)(2008-8#1)
one single molecule##2##3##(2008-5#1)(2010-6#1)
one single##22##2##(1990-11#1)(1992-11#1)(1993-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#2)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
one site##11##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-5#1)(2008-10#2)(2008-8#1)(2011-2#1)
one size##2##2##(1994-3#1)(2013-8#1)
one small##3##2##(2008-4#1)(2008-5#1)(2012-12#1)
one source##2##2##(2007-8#1)(2008-8#1)
one species of##3##3##(1991-8#1)(2008-12#1)(2008-5#1)
one species to##4##3##(1992-11#1)(2008-8#1)(2012-2#2)
one species##21##2##(1991-8#1)(1992-11#1)(1993-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
one specific##8##2##(1993-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#1)
one specimen##2##2##(2008-5#2)
one spray##2##2##(2008-10#2)
one stage##5##2##(1992-8#1)(1994-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
one standard drink##2##3##(2009-7#2)
one standard solution##3##3##(2008-10#3)
one standard##6##2##(2008-10#3)(2008-3#1)(2009-7#2)
one step closer to##2##4##(2007-9#1)(2008-6#1)
one step further##2##3##(2008-9#1)(2009-9#1)
one step##28##2##(1994-12#1)(1996-2#1)(1996-5#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)
one still##2##2##(2008-3#1)(2012-2#1)
one stone##2##2##(2011-2#1)(2012-3#1)
one strain##9##2##(1996-12#1)(2008-10#6)(2008-11#1)(2008-8#1)
one strand of the##2##4##(1997-9#1)(2008-2#1)
one strand##4##2##(1997-9#1)(2008-2#2)(2008-4#1)
one strategy##2##2##(1991-1#1)(2007-8#1)
one student##2##2##(1992-3#1)(2008-11#1)
one study showed##3##3##(2011-2#2)(2013-1#1)
one study##15##2##(1991-1#1)(1991-12#1)(1992-3#1)(1995-2#1)(2006-4#1)(2007-11#1)(2008-5#1)(2009-11#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
one subpopulation##2##2##(2008-10#2)
one subunit##6##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-11#1)(2009-7#1)
one successful##2##2##(1992-12#1)(2008-8#1)
one such case in##2##4##(2008-7#1)(2011-1#1)
one such case##6##3##(2007-7#2)(2008-7#2)(2011-1#1)(2012-12#1)
one such device##2##3##(1993-5#1)(2008-7#1)
one such model that##2##4##(1997-3#1)(2008-1#1)
one such model##3##3##(1997-3#1)(2008-1#1)(2008-9#1)
one such##31##2##(1991-12#1)(1993-5#1)(1995-1#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#1)
one synapse##2##2##(1996-2#1)(2013-8#1)
one syncytial##2##2##(2013-1#2)
one system##5##2##(1994-12#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
one teaching##2##2##(1993-2#1)(2008-12#1)
one temperature##3##2##(2008-10#1)(2008-8#2)
one tenth of the##3##4##(1994-11#1)(2008-10#1)(2008-2#1)
one tenth of##4##3##(1994-11#1)(2007-2#1)(2008-10#1)(2008-2#1)
one tenth that of##2##4##(2007-12#1)(2010-6#1)
one tenth##7##2##(1994-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2010-6#1)
one test##5##2##(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
one that involves##2##3##(2008-11#1)(2008-9#1)
one that is##7##3##(1995-5#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-3#1)
one that provides##2##3##(2008-4#1)(2008-9#1)
one that uses##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
one that##41##2##(1990-12#1)(1992-11#1)(1992-2#1)(1992-9#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-3#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-2#2)
one the##6##2##(1990-9#1)(1995-2#1)(1996-9#1)(2007-11#1)(2008-12#1)(2013-8#1)
one theoretical##2##2##(1994-5#1)(2012-2#1)
one third of all##2##4##(2008-12#1)(2008-8#1)
one third of our##2##4##(2007-10#1)(2008-8#1)
one third of the##9##4##(1992-3#1)(1993-10#1)(1997-4#1)(2008-1#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
one third of##24##3##(1992-3#1)(1993-10#1)(1993-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
one third##36##2##(1990-8#1)(1990-9#1)(1992-3#1)(1993-10#1)(1993-6#1)(1997-2#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
one thousand##3##2##(2007-7#1)(2008-11#1)(2008-2#1)
one time##11##2##(1995-10#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
one to calculate the##2##4##(2007-12#1)(2008-3#1)
one to conclude##2##3##(1995-3#1)(2008-10#1)
one to control##2##3##(2007-12#1)(2008-4#1)
one to detect##2##3##(2008-10#1)(2008-9#1)
one to determine the##2##4##(2008-10#1)(2008-9#1)
one to determine##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
one to evaluate##2##3##(2008-10#2)
one to five##3##3##(2008-10#3)
one to four##5##3##(2008-10#3)(2008-9#1)(2012-12#1)
one to measure the##3##4##(2007-11#2)(2010-7#1)
one to measure##4##3##(2007-11#2)(2008-2#1)(2010-7#1)
one to monitor##2##3##(2008-2#1)(2008-9#1)
one to obtain a##2##4##(2008-2#1)(2008-3#1)
one to obtain##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
one to overcome the##2##4##(2007-12#1)(2008-3#1)
one to phenotype##2##3##(2008-10#2)
one to reduce the##2##4##(2008-10#1)(2008-2#1)
one to resolve##2##3##(2008-2#1)(2008-3#1)
one to retrieve##3##3##(2008-3#3)
one to six##2##3##(2008-10#2)
one to study##2##3##(2008-2#1)(2012-3#1)
one to the##2##3##(2009-1#1)(2011-1#1)
one to three##2##3##(2008-10#2)
one to two##6##3##(1992-11#1)(1993-12#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-8#1)
one to use##2##3##(2008-3#1)(2013-1#1)
one to##128##2##(1990-12#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#7)(2007-12#9)(2008-1#4)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#23)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-1#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
one told##2##2##(2009-10#1)(2011-2#1)
one tool in the##2##4##(2008-10#1)(2010-11#1)
one tool in##3##3##(1995-12#1)(2008-10#1)(2010-11#1)
one trait##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
one transgenic##2##2##(1990-11#1)(2011-2#1)
one transverse##3##2##(2007-11#2)(2007-12#1)
one treatment##6##2##(1992-5#1)(1995-2#1)(2007-12#1)(2008-7#1)(2012-12#2)
one trial##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
one type of effect##2##4##(1991-1#2)
one type of##17##3##(1991-1#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-7#1)(2012-12#1)(2013-8#1)
one type##18##2##(1991-1#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-7#1)(2012-12#1)(2013-8#1)
one typical##2##2##(1996-12#1)(2011-1#1)
one unique##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
one university in##2##3##(2008-11#1)(2008-12#1)
one university##4##2##(2008-11#2)(2008-12#2)
one ureter##2##2##(1996-3#1)(2008-10#1)
one uses##3##2##(2008-2#1)(2008-3#2)
one using##6##2##(1993-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-1#1)
one vineyard##2##2##(2008-10#2)
one virus##3##2##(2008-10#3)
one was associated with##2##4##(2008-10#1)(2008-11#1)
one was##29##2##(1990-3#1)(1990-5#1)(1990-9#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#2)
one wavelength are##2##3##(2008-2#1)(2008-3#1)
one wavelength##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
one way ANOVA##2##3##(2010-3#1)(2013-8#1)
one way in which##2##4##(2007-2#1)(2011-1#1)
one way of##3##3##(2007-12#1)(2008-2#1)(2010-10#1)
one way to##4##3##(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#1)
one way##15##2##(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-2#1)(2010-10#1)(2010-3#1)(2011-1#2)(2013-8#1)
one we##2##2##(2007-11#1)(2008-2#1)
one week after the##3##4##(2008-4#1)(2011-1#1)(2013-1#1)
one week after##8##3##(1991-2#1)(1996-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#2)
one week before##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
one week later##2##3##(1993-3#1)(2013-1#1)
one week of##3##3##(1992-4#1)(2007-10#1)(2011-2#1)
one week period##2##3##(2008-7#1)(2011-1#1)
one week##35##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-9#2)(1997-6#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-12#2)(2011-1#2)(2011-2#2)(2013-1#4)
one well-defined##3##2##(2008-10#3)
one where##5##2##(1997-4#1)(1997-7#1)(2008-12#1)(2008-7#1)(2010-10#1)
one which can##3##3##(1991-11#1)(1997-7#1)(2008-7#1)
one which##14##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1993-1#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-7#2)(2013-1#1)
one who##4##2##(1994-1#1)(1996-2#1)(2007-2#1)(2008-6#1)
one will##2##2##(1994-12#1)(2009-10#1)
one with a##12##3##(1992-1#1)(1992-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2012-1#2)(2013-1#1)
one with acute##2##3##(2008-5#1)(2008-7#1)
one with the##5##3##(1990-3#1)(1993-11#1)(2008-10#2)(2013-8#1)
one with##48##2##(1990-3#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-11#1)(1995-11#1)(1995-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#4)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
one without##4##2##(1990-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
one would expect##2##3##(1995-12#1)(2008-11#1)
one year after the##7##4##(1996-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#2)
one year after##21##3##(1991-8#1)(1992-4#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
one year and##8##3##(1990-12#1)(1990-9#1)(1994-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
one year at##3##3##(1997-6#1)(2006-8#1)(2008-1#1)
one year follow up##3##4##(1991-2#1)(2013-1#2)
one year from##2##3##(2007-11#1)(2013-8#1)
one year in a##2##4##(2007-10#1)(2008-3#1)
one year in the##2##4##(1993-12#1)(1994-7#1)
one year in##8##3##(1991-11#1)(1993-12#1)(1994-12#1)(1994-7#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-3#1)
one year later##6##3##(2007-12#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-12#1)
one year of age##3##4##(1991-11#1)(1991-6#2)
one year of##10##3##(1991-11#2)(1991-2#1)(1991-6#2)(1996-1#1)(2011-1#1)(2012-12#1)(2013-1#2)
one year old##2##3##(2013-8#2)
one year period##6##3##(1996-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-2#1)
one year was##4##3##(1996-6#1)(2008-10#1)(2010-8#2)
one year were##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
one year##148##2##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-2#2)(1991-6#4)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#2)(1995-1#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#7)(2011-1#4)(2011-2#6)(2012-12#4)(2012-3#5)(2013-1#13)(2013-8#7)
one year's treatment##2##3##(1995-3#2)
one year's##3##2##(1990-11#1)(1995-3#2)
one young##2##2##(1992-12#1)(2011-1#1)
one##5881##1##(1990-10#3)(1990-11#22)(1990-12#25)(1990-2#14)(1990-3#15)(1990-5#25)(1990-6#8)(1990-7#12)(1990-8#28)(1990-9#14)(1991-1#10)(1991-10#2)(1991-11#12)(1991-12#28)(1991-2#29)(1991-3#21)(1991-4#3)(1991-5#11)(1991-6#18)(1991-7#2)(1991-8#17)(1991-9#19)(1992-1#10)(1992-10#5)(1992-11#11)(1992-12#18)(1992-2#17)(1992-3#29)(1992-4#7)(1992-5#17)(1992-6#33)(1992-7#3)(1992-8#15)(1992-9#15)(1993-1#6)(1993-10#1)(1993-11#19)(1993-12#36)(1993-2#25)(1993-3#28)(1993-5#7)(1993-6#26)(1993-8#13)(1993-9#10)(1994-1#8)(1994-11#20)(1994-12#38)(1994-2#27)(1994-3#21)(1994-5#18)(1994-6#22)(1994-7#10)(1994-8#30)(1994-9#22)(1995-1#9)(1995-10#2)(1995-11#15)(1995-12#27)(1995-2#35)(1995-3#42)(1995-5#26)(1995-6#24)(1995-8#15)(1995-9#7)(1996-1#14)(1996-10#8)(1996-11#10)(1996-12#27)(1996-2#43)(1996-3#29)(1996-4#8)(1996-5#17)(1996-6#12)(1996-7#2)(1996-8#7)(1996-9#14)(1997-1#7)(1997-2#38)(1997-3#49)(1997-4#29)(1997-5#15)(1997-6#28)(1997-7#32)(1997-8#28)(1997-9#2)(2006-10#5)(2006-12#5)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-10#22)(2007-11#103)(2007-12#131)(2007-2#19)(2007-3#1)(2007-4#4)(2007-5#10)(2007-6#11)(2007-7#49)(2007-8#52)(2007-9#2)(2008-1#88)(2008-10#971)(2008-11#205)(2008-12#109)(2008-2#171)(2008-3#263)(2008-4#111)(2008-5#171)(2008-6#78)(2008-7#196)(2008-8#167)(2008-9#185)(2009-1#5)(2009-10#29)(2009-11#13)(2009-12#14)(2009-2#16)(2009-3#13)(2009-4#16)(2009-5#25)(2009-6#10)(2009-7#14)(2009-8#26)(2009-9#15)(2010-1#10)(2010-10#15)(2010-11#16)(2010-12#26)(2010-2#23)(2010-3#21)(2010-4#24)(2010-5#14)(2010-6#11)(2010-7#16)(2010-8#40)(2010-9#5)(2011-1#62)(2011-10#3)(2011-2#204)(2011-3#8)(2012-1#15)(2012-12#74)(2012-2#76)(2012-3#71)(2012-8#2)(2012-9#1)(2013-1#169)(2013-7#23)(2013-8#91)
one's ability to##2##3##(2009-4#1)(2012-1#1)
one's life##2##2##(2008-7#1)(2013-1#1)
one's own institution##2##3##(2009-4#2)
one's own##13##2##(1992-11#1)(1993-12#1)(1995-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-4#3)(2009-9#1)(2010-10#1)
one's professional##2##2##(2007-2#1)(2008-12#1)
one's##47##1##(1991-2#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#4)(2009-9#2)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
one) were##2##2##(1993-11#1)(1995-11#1)
one)##12##1##(1990-2#1)(1990-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-5#2)(2012-2#1)
one- and two-dimensional 1H##2##4##(1995-11#1)(1995-2#1)
one- and two-dimensional##7##3##(1995-11#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
one- and##11##2##(1995-11#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-4#1)
one- or two-dimensional gel electrophoresis##2##5##(1993-8#1)(2008-9#1)
one- or two-dimensional##5##3##(1993-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
one- or##6##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
one-##18##1##(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2010-4#1)
one-beam cross-correlation##3##2##(2008-2#1)(2008-3#2)
one-beam interferometer with##2##3##(2007-12#2)
one-beam##8##1##(2007-12#4)(2008-2#1)(2008-3#3)
one-carbon donor##2##2##(1992-10#2)
one-carbon##5##1##(1992-10#2)(2009-12#1)(2011-2#1)(2012-2#1)
one-channel##4##1##(2008-3#1)(2008-9#3)
one-color laser##2##2##(2008-3#2)
one-color##4##1##(2008-2#1)(2008-3#3)
one-day##6##1##(1994-7#1)(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
one-dimensional (1-D)##3##2##(2008-3#3)
one-dimensional model##4##2##(1996-4#1)(2008-3#3)
one-dimensional objects is presented##2##4##(2007-12#1)(2008-2#1)
one-dimensional objects##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
one-dimensional photonic##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
one-dimensional profilometer##2##2##(2008-3#2)
one-dimensional radiative transfer##2##3##(2008-3#2)
one-dimensional sample##3##2##(2007-12#3)
one-dimensional spatial##2##2##(2007-12#1)(2008-3#1)
one-dimensional wavelet##3##2##(2008-10#2)(2008-2#1)
one-dimensional##116##1##(1990-11#1)(1993-5#1)(1994-12#1)(1996-4#1)(1997-7#1)(2007-11#10)(2007-12#17)(2008-10#7)(2008-11#2)(2008-2#17)(2008-3#44)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
one-electron reduced to the##2##4##(2008-10#2)
one-electron reduction of##3##3##(1994-8#2)(1997-4#1)
one-electron##9##1##(1993-8#1)(1994-8#2)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#3)
one-fifth of the##4##3##(1994-3#1)(2007-11#1)(2008-3#1)(2008-7#1)
one-fifth of##6##2##(1994-3#1)(1996-11#1)(2007-11#1)(2008-3#2)(2008-7#1)
one-fifth##7##1##(1994-3#1)(1996-11#1)(2007-11#1)(2008-3#2)(2008-7#1)(2012-1#1)
one-fourth of the##3##3##(1997-1#1)(2008-10#1)(2008-8#1)
one-fourth of##6##2##(1990-5#1)(1997-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)
one-frequency##2##1##(2008-10#2)
one-group##2##1##(1996-3#1)(2011-1#1)
one-half of the##8##3##(1990-12#1)(1991-1#1)(1994-12#1)(1995-3#1)(2008-10#1)(2012-2#1)(2013-1#2)
one-half of##14##2##(1990-12#1)(1991-1#2)(1991-2#1)(1992-1#1)(1993-9#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#2)
one-half the##3##2##(1990-8#1)(1994-11#1)(1995-5#1)
one-half##26##1##(1990-12#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-2#2)(2013-1#2)
one-hour##2##1##(2008-10#1)(2008-12#1)
one-layer##3##1##(2007-11#1)(2008-10#1)(2008-3#1)
one-lung ventilation##3##2##(2006-10#1)(2011-2#2)
one-month##5##1##(2008-3#1)(2008-5#1)(2011-3#1)(2013-1#2)
one-month-old infant with##2##3##(2008-11#1)(2011-1#1)
one-photon##9##1##(2007-11#1)(2007-12#1)(2008-3#6)(2011-1#1)
one-pot synthesis##3##2##(1997-3#1)(2012-2#1)(2012-3#1)
one-pot tandem##2##2##(2009-12#1)(2012-3#1)
one-pot##17##1##(1996-5#2)(1997-3#2)(2007-11#1)(2008-10#3)(2008-11#2)(2009-12#1)(2011-3#1)(2012-2#1)(2012-3#4)
one-quarter of the##3##3##(1996-1#1)(2007-11#1)(2008-9#1)
one-quarter of##4##2##(1996-1#1)(2007-11#1)(2008-9#1)(2010-9#1)
one-shot cases##3##2##(1993-1#3)
one-shot sensor##4##2##(2008-10#4)
one-shot##8##1##(1993-1#3)(2008-10#5)
one-sided##6##1##(1992-6#1)(1995-6#1)(2006-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
one-stage repair##2##2##(2009-5#2)
one-stage##10##1##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#4)(2012-1#1)(2013-8#1)
one-step RT-PCR##5##2##(2008-9#1)(2013-8#4)
one-step process##5##2##(1995-5#1)(2008-3#2)(2009-11#1)(2013-1#1)
one-step purification##2##2##(1992-11#1)(1993-6#1)
one-step##50##1##(1990-12#1)(1991-2#1)(1992-11#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#4)
one-stop shopping##3##2##(1996-1#1)(1997-3#2)
one-stop##4##1##(1996-1#1)(1997-3#3)
one-tailed##3##1##(1995-9#1)(2012-2#1)(2013-8#1)
one-tenth of##2##2##(2008-5#1)(2010-6#1)
one-tenth the##2##2##(2008-10#1)(2008-6#1)
one-tenth##4##1##(2008-10#1)(2008-5#1)(2008-6#1)(2010-6#1)
one-third of cases##2##3##(2007-12#1)(2012-2#1)
one-third of the total##2##4##(1992-3#1)(2008-12#1)
one-third of the##12##3##(1992-3#1)(1992-5#1)(1992-9#1)(1995-6#1)(1997-2#1)(1997-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)
one-third of##27##2##(1992-3#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#2)
one-third the##3##2##(1990-8#1)(2008-9#1)(2011-2#1)
one-third##40##1##(1990-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
one-time##4##1##(1990-8#1)(1991-2#1)(2008-10#1)(2008-11#1)
one-to-one mappings##2##2##(2010-10#2)
one-to-one relationship##2##2##(1994-2#1)(2008-10#1)
one-to-one##12##1##(1994-2#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-3#1)(2010-10#2)
one-trial passive avoidance task##2##4##(1993-12#1)(2008-6#1)
one-trial passive avoidance##3##3##(1993-12#1)(2008-6#2)
one-trial##6##1##(1992-10#1)(1993-12#1)(1994-3#1)(2008-6#2)(2008-7#1)
one-tube##2##1##(2008-10#1)(2008-9#1)
one-twentieth of the##2##3##(1990-11#1)(2008-7#1)
one-way ANOVA##6##2##(2008-10#1)(2008-12#2)(2010-8#1)(2011-2#1)(2013-1#1)
one-way analysis of variance##3##4##(1993-2#1)(2008-10#1)(2011-2#1)
one-way##20##1##(1993-2#2)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-7#1)(2010-8#3)(2011-2#2)(2013-1#2)
one-week##5##1##(1997-7#1)(2008-11#1)(2009-5#1)(2011-3#2)
one-year follow up##2##3##(2007-7#1)(2010-8#1)
one-year mortality##2##2##(2006-8#2)
one-year period##4##2##(1995-3#1)(1997-1#1)(2007-7#1)(2013-1#1)
one-year survival##2##2##(1995-2#1)(2008-10#1)
one-year##20##1##(1990-11#1)(1990-2#1)(1991-6#1)(1995-2#1)(1995-3#1)(1997-1#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#1)
one-year-old##3##1##(1991-8#1)(2008-8#1)(2009-8#1)
onemacr##6##1##(1996-2#4)(1997-7#2)
onerous##3##1##(1994-2#1)(1996-5#1)(2007-8#1)
ones a##2##2##(2008-10#2)
ones and##8##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
ones are##3##2##(1991-6#1)(1994-2#1)(2007-12#1)
ones by##3##2##(1993-11#1)(2007-12#1)(2008-10#1)
ones for##2##2##(2008-10#1)(2008-2#1)
ones from##2##2##(2008-10#1)(2011-1#1)
ones in##6##2##(1992-6#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-12#1)(2013-1#1)
ones is##2##2##(2008-10#1)(2008-3#1)
ones may be##2##3##(2008-10#1)(2008-9#1)
ones measured##2##2##(1997-2#1)(2008-3#1)
ones of##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
ones such as##4##3##(1997-1#1)(2008-12#1)(2009-9#1)(2013-8#1)
ones that##11##2##(1990-11#1)(1990-2#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
ones used##3##2##(1997-4#1)(2008-10#1)(2010-8#1)
ones were##7##2##(1990-8#1)(1991-2#4)(2007-11#1)(2013-8#1)
ones who##5##2##(1992-3#2)(2008-4#1)(2011-1#1)(2013-1#1)
ones with##5##2##(1990-2#1)(2008-10#2)(2012-3#1)(2013-7#1)
ones within the##2##3##(2008-10#1)(2009-5#1)
ones##296##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#1)(2007-11#4)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#52)(2008-11#13)(2008-12#9)(2008-2#5)(2008-3#15)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#8)(2011-2#12)(2011-3#1)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#7)
ones)##3##1##(1997-5#1)(2008-10#1)(2008-11#1)
oneself##3##1##(2008-2#1)(2012-2#2)
onfFN expression##3##2##(1994-9#3)
onfFN##6##1##(1994-9#6)
ongoing assessment##3##2##(1996-2#1)(2011-1#1)(2012-3#1)
ongoing clinical trials are##2##4##(2008-3#1)(2008-7#1)
ongoing clinical trials##7##3##(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-6#1)(2011-7#1)
ongoing clinical##10##2##(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-6#1)(2011-7#1)
ongoing debate about##2##3##(2007-7#1)(2012-3#1)
ongoing debate on the##2##4##(2009-10#1)(2011-2#1)
ongoing debate on##3##3##(1991-1#1)(2009-10#1)(2011-2#1)
ongoing debate##9##2##(1991-1#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
ongoing destruction of the##2##4##(1993-3#1)(1997-5#1)
ongoing destruction##3##2##(1993-3#1)(1997-5#2)
ongoing development of##4##3##(1994-12#1)(2007-5#1)(2008-11#1)(2009-11#1)
ongoing education##2##2##(1996-7#1)(2013-8#1)
ongoing efforts to##3##3##(2008-11#1)(2009-6#1)(2012-12#1)
ongoing efforts##4##2##(2008-11#1)(2009-4#1)(2009-6#1)(2012-12#1)
ongoing engagement in##2##3##(2013-1#2)
ongoing evaluation of##2##3##(1996-2#1)(2010-6#1)
ongoing evaluation##3##2##(1996-2#1)(2008-12#1)(2010-6#1)
ongoing feedback to##2##3##(1996-1#1)(2008-3#1)
ongoing feedback##3##2##(1996-1#1)(1996-3#1)(2008-3#1)
ongoing in##3##2##(2008-7#1)(2009-4#1)(2010-12#1)
ongoing large-scale##2##2##(2011-8#1)(2012-3#1)
ongoing management##3##2##(1993-12#1)(2008-3#1)(2013-8#1)
ongoing process##3##2##(1997-2#1)(2008-7#1)(2013-1#1)
ongoing professional##2##2##(1992-3#1)(2008-11#1)
ongoing quality##2##2##(1993-2#1)(2010-6#1)
ongoing randomized clinical trials##2##4##(2008-11#1)(2008-8#1)
ongoing research##8##2##(1992-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)
ongoing review##2##2##(1996-3#1)(2008-7#1)
ongoing studies##2##2##(2008-10#1)(2008-8#1)
ongoing study##2##2##(1997-5#1)(2008-10#1)
ongoing terror##2##2##(2009-7#2)
ongoing training##2##2##(1993-12#1)(1994-1#1)
ongoing trial##2##2##(1996-6#1)(2012-2#1)
ongoing trials##2##2##(1992-10#1)(2008-3#1)
ongoing##218##1##(1991-1#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#4)(1996-2#3)(1996-3#5)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#12)(2008-12#5)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#16)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#4)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#4)(2010-9#2)(2011-1#4)(2011-2#5)(2011-3#1)(2011-4#1)(2011-7#1)(2011-8#2)(2012-12#7)(2012-2#6)(2012-3#5)(2012-6#1)(2013-1#10)(2013-8#4)
onion and garlic##2##3##(1992-8#2)
onion and##3##2##(1992-8#2)(2008-10#1)
onion cultivars##3##2##(2008-10#3)
onion in##2##2##(2008-10#2)
onion is##2##2##(2008-10#2)
onion plants##3##2##(2008-10#3)
onion strains of Xanthomonas and##2##5##(2008-10#2)
onion yellow##2##2##(2008-10#2)
onion yellows##4##2##(2008-10#4)
onion##48##1##(1992-8#2)(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#42)(2008-12#1)
onions##3##1##(1993-12#2)(2008-10#1)
onium salt##5##2##(2008-10#5)
onium##6##1##(1994-8#1)(2008-10#5)
onlay##5##1##(1992-4#1)(2008-10#1)(2008-7#2)(2013-8#1)
online and##2##2##(2008-12#1)(2009-2#1)
online database##3##2##(1994-1#2)(2009-10#1)
online databases##2##2##(2007-11#1)(2013-1#1)
online health communities##6##3##(2011-2#6)
online health##9##2##(2010-10#2)(2010-4#1)(2011-2#6)
online journals##2##2##(1997-3#1)(2007-2#1)
online learning##2##2##(2008-12#2)
online monitoring of##2##3##(2008-11#1)(2011-2#1)
online options##2##2##(2008-12#2)
online preconcentration and separation##2##4##(2008-10#2)
online preconcentration and##3##3##(2008-10#3)
online preconcentration##4##2##(2008-10#4)
online publication##36##2##(2011-1#15)(2011-2#10)(2012-1#10)(2013-7#1)
online resources##5##2##(1994-12#1)(2008-11#2)(2008-9#1)(2009-8#1)
online searching##2##2##(1991-3#1)(1995-3#1)
online survey##5##2##(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
online system##3##2##(1991-2#1)(1992-12#1)(1995-11#1)
online users##2##2##(2010-10#2)
online##175##1##(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1992-1#1)(1992-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1995-11#1)(1995-3#2)(1996-3#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#16)(2008-11#5)(2008-12#10)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#2)(2010-10#9)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#19)(2011-2#25)(2012-1#14)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#1)
only 0##30##2##(1990-10#1)(1990-6#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-6#2)(1994-7#1)(1997-5#1)(2007-10#2)(2007-12#3)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)
only 1 case##4##3##(1990-12#1)(1991-4#1)(2010-6#1)(2012-3#1)
only 1 of the##2##4##(1994-2#1)(2010-6#1)
only 1 of##3##3##(1994-2#1)(2008-10#1)(2010-6#1)
only 1 patient##2##3##(1990-6#1)(1993-2#1)
only 1 to##2##3##(2008-1#1)(2009-5#1)
only 1##31##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#4)(2009-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
only 1% of##2##3##(2008-4#1)(2008-7#1)
only 1%##5##2##(1992-5#1)(2007-9#1)(2008-4#1)(2008-7#1)(2013-1#1)
only 1-2% of##2##3##(1990-6#1)(2013-8#1)
only 1-5%##2##2##(1992-3#1)(2009-8#1)
only 10##13##2##(1991-4#1)(1995-1#1)(1995-12#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)(2013-8#1)
only 10% of the##5##4##(1995-2#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
only 10% of##7##3##(1992-9#1)(1995-2#1)(1996-11#1)(2007-12#2)(2008-10#1)(2008-9#1)
only 10%##13##2##(1992-9#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-11#2)(2007-12#2)(2008-10#2)(2008-3#2)(2008-9#1)
only 10(-5)##2##2##(1995-8#1)(2008-11#1)
only 100##2##2##(1995-6#1)(2007-7#1)
only 104##2##2##(2007-8#1)(2008-11#1)
only 10min##2##2##(2008-10#2)
only 10ml##2##2##(2008-10#2)
only 11##7##2##(1990-8#1)(1990-9#1)(1995-5#1)(2008-10#2)(2008-8#1)(2013-8#1)
only 11%##2##2##(1990-12#1)(2008-3#1)
only 12##5##2##(2008-10#2)(2011-1#2)(2012-2#1)
only 12%##4##2##(1996-9#1)(2007-11#1)(2013-7#1)(2013-8#1)
only 13##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
only 13% of##2##3##(2006-8#1)(2008-10#1)
only 14 cases##2##3##(1990-6#1)(2012-2#1)
only 14##7##2##(1990-6#1)(1990-9#1)(2008-10#1)(2008-8#1)(2012-2#2)(2012-3#1)
only 14%##2##2##(1990-6#1)(2008-7#1)
only 15##10##2##(1995-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)(2013-1#2)
only 15%##5##2##(1992-6#1)(1993-3#1)(1994-12#1)(2008-7#1)(2013-8#1)
only 16 to##2##3##(2008-10#1)(2008-11#1)
only 16##8##2##(1990-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
only 17##2##2##(1991-4#1)(2008-12#1)
only 17% of##3##3##(2008-10#1)(2008-5#2)
only 18##4##2##(1990-6#1)(1992-12#1)(2008-5#1)(2008-9#1)
only 18%##3##2##(1990-12#1)(1990-6#1)(2008-10#1)
only 19##2##2##(1996-2#1)(2008-10#1)
only 2 cases##2##3##(1993-2#1)(2012-2#1)
only 2 of##3##3##(1990-3#1)(1994-7#1)(2008-10#1)
only 2 patients##3##3##(1990-12#1)(1991-6#1)(2011-2#1)
only 2##32##2##(1990-12#2)(1990-3#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
only 2% of##4##3##(1992-8#1)(1997-2#1)(2010-5#1)(2012-3#1)
only 2%##8##2##(1990-8#1)(1992-8#1)(1994-11#1)(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
only 20 patients##2##3##(2008-11#1)(2008-9#1)
only 20##8##2##(1993-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
only 20% of the##2##4##(1992-5#1)(2011-2#1)
only 20% of##6##3##(1991-8#1)(1992-12#1)(1992-5#1)(1995-5#1)(2008-10#1)(2011-2#1)
only 20%##10##2##(1990-8#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
only 22##2##2##(2007-8#1)(2008-10#1)
only 23% of##2##3##(2008-1#1)(2009-3#1)
only 24##4##2##(1994-12#1)(1996-12#1)(2008-10#1)(2011-1#1)
only 25##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
only 25% of##2##3##(1990-8#1)(1992-11#1)
only 25%##4##2##(1990-8#1)(1992-11#1)(1996-5#1)(2008-3#1)
only 26%##2##2##(1993-8#1)(2010-8#1)
only 27 reported cases##2##4##(2007-8#2)
only 28% of##2##3##(1993-11#1)(1994-12#1)
only 28%##3##2##(1993-11#1)(1993-3#1)(1994-12#1)
only 29%##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
only 3 cases of##2##4##(1992-2#1)(1993-8#1)
only 3##18##2##(1992-2#1)(1992-5#1)(1993-8#1)(1994-7#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#1)
only 3% of the total##2##5##(2008-10#1)(2013-1#1)
only 3% of the##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
only 3%##5##2##(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
only 30##3##2##(2007-12#1)(2008-10#1)(2009-2#1)
only 30%##2##2##(2008-10#1)(2008-3#1)
only 30-40%##2##2##(1990-11#2)
only 33%##3##2##(1994-12#1)(2011-1#1)(2013-7#1)
only 34% of##2##3##(1994-12#1)(2011-1#1)
only 34%##3##2##(1994-12#1)(2008-10#1)(2011-1#1)
only 35##3##2##(1997-2#1)(2008-10#2)
only 35% of##2##3##(1990-5#1)(2008-11#1)
only 38##2##2##(2008-7#1)(2013-8#1)
only 39##2##2##(2007-7#2)
only 39%##2##2##(2007-8#1)(2009-4#1)
only 4 of##2##3##(2007-8#1)(2008-10#1)
only 4##19##2##(1990-11#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#2)(2010-7#1)(2012-2#1)
only 4% of##2##3##(1996-1#1)(2012-12#1)
only 4%##5##2##(1992-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(2012-12#1)
only 40% of##3##3##(1991-5#1)(2008-3#1)(2012-3#1)
only 40%##4##2##(1991-5#1)(1995-12#1)(2008-3#1)(2012-3#1)
only 42% of##2##3##(1994-2#1)(2007-10#1)
only 44##2##2##(2008-10#1)(2011-2#1)
only 45##2##2##(2008-12#1)(2010-6#1)
only 5 to##2##3##(1990-6#1)(1996-12#1)
only 5##11##2##(1990-6#1)(1993-8#1)(1994-2#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#2)
only 5% of all##2##4##(2008-11#1)(2011-2#1)
only 5% of##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
only 5%##8##2##(1992-12#1)(1992-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
only 5-10%##2##2##(1990-2#1)(2009-8#1)
only 50##2##2##(2008-10#1)(2009-7#1)
only 50% of the##2##4##(1996-5#1)(2008-10#1)
only 50% of##3##3##(1996-5#1)(2008-10#1)(2008-2#1)
only 50%##4##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
only 53%##3##2##(1991-6#1)(1993-8#1)(2008-7#1)
only 54%##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
only 56%##2##2##(2012-3#1)(2013-1#1)
only 6 of##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
only 6 patients##2##3##(1992-6#1)(2011-2#1)
only 6##13##2##(1992-5#1)(1992-6#1)(1993-6#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#3)(2012-2#1)
only 6% of the##2##4##(1993-8#1)(1994-2#1)
only 6% of##4##3##(1993-8#1)(1994-2#1)(1995-1#1)(2008-10#1)
only 6%##5##2##(1993-8#1)(1994-2#1)(1995-1#1)(2008-10#2)
only 60%##2##2##(2008-10#1)(2008-7#1)
only 65%##2##2##(2008-10#2)
only 7 days##3##3##(1994-8#1)(1995-3#1)(2008-10#1)
only 7 of##2##3##(2008-10#2)
only 7##10##2##(1991-4#1)(1992-4#1)(1994-8#1)(1995-3#1)(1996-11#1)(2008-10#4)(2008-2#1)
only 8 cases##2##3##(2013-1#2)
only 8##10##2##(1996-5#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2013-1#2)
only 8%##3##2##(1992-6#1)(1997-3#1)(2010-8#1)
only 80##2##2##(2008-10#2)
only 80%##3##2##(1994-7#1)(2008-10#1)(2008-6#1)
only 9##4##2##(1996-3#1)(2008-10#2)(2008-7#1)
only 9%##2##2##(1992-9#1)(2008-9#1)
only A##2##2##(1990-7#1)(2008-9#1)
only B##2##2##(2008-10#2)
only Fe(II)##2##2##(2008-10#2)
only MaYMFV##2##2##(2008-10#2)
only N##2##2##(1997-7#2)
only O##3##2##(2008-5#1)(2012-12#2)
only X##2##2##(2008-10#2)
only a few cases have been reported in##2##8##(1997-8#1)(2013-7#1)
only a few cases of##2##5##(1994-3#1)(2008-12#1)
only a few cases##5##4##(1994-3#1)(1997-8#1)(2008-12#1)(2013-1#1)(2013-7#1)
only a few minutes##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
only a few of these##2##5##(1990-2#1)(2008-8#1)
only a few of##4##4##(1990-2#1)(1992-3#1)(2007-2#1)(2008-8#1)
only a few percent##3##4##(1997-7#1)(2007-12#1)(2008-3#1)
only a few studies##5##4##(2007-7#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
only a few##90##3##(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#3)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#6)(2013-7#2)(2013-8#1)
only a fraction of the##4##5##(1992-5#1)(1996-4#1)(1997-2#1)(2008-6#1)
only a fraction of##5##4##(1992-5#1)(1996-4#1)(1997-2#1)(2008-2#1)(2008-6#1)
only a handful of##2##4##(2007-10#1)(2013-1#1)
only a limited amount of##2##5##(2008-7#1)(2009-12#1)
only a limited number of##3##5##(2007-11#1)(2007-12#1)(2008-6#1)
only a limited##11##3##(1990-6#1)(1995-11#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)
only a little##2##3##(2008-4#1)(2008-9#1)
only a low##2##3##(1990-11#1)(1994-8#1)
only a marginal role in the##2##6##(2008-6#1)(2012-1#1)
only a marginal##4##3##(1990-2#1)(1990-6#1)(2008-6#1)(2012-1#1)
only a minor effect##2##4##(1995-2#1)(2008-10#1)
only a minor role in##2##5##(2008-10#1)(2008-9#1)
only a minor role##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
only a minor##15##3##(1995-11#2)(1995-2#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
only a minority of##2##4##(2008-8#1)(2013-1#1)
only a minority##4##3##(1992-3#1)(2008-8#1)(2013-1#2)
only a moderate##2##3##(1997-6#1)(2010-6#1)
only a modest##4##3##(1991-12#1)(1994-5#1)(1996-5#1)(2008-2#1)
only a part of the##3##5##(1991-12#1)(1996-5#1)(2008-8#1)
only a part of##6##4##(1991-12#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-1#1)
only a partial##5##3##(1995-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)
only a portion of the##2##5##(1992-3#1)(2008-10#1)
only a relatively##2##3##(2008-10#1)(2009-9#1)
only a short##3##3##(1995-5#1)(1997-3#1)(1997-4#1)
only a simple##2##3##(2008-10#1)(2008-5#1)
only a single detector##2##4##(2008-3#2)
only a single haploid##2##4##(2008-10#1)(2009-12#1)
only a single particle##2##4##(1990-12#1)(2008-5#1)
only a single##32##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2013-1#1)
only a slight increase in##2##5##(1992-12#1)(2008-12#1)
only a slight##8##3##(1991-6#1)(1992-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
only a small amount of##2##5##(2008-10#1)(2013-1#1)
only a small effect on##2##5##(1990-2#1)(1995-3#1)
only a small fraction of the##2##6##(2008-7#1)(2010-11#1)
only a small fraction of##5##5##(2008-10#1)(2008-7#1)(2010-11#2)(2010-5#1)
only a small improvement in##2##5##(2008-7#1)(2012-1#1)
only a small increase in##3##5##(1990-12#1)(2008-7#1)(2012-1#1)
only a small number of##5##5##(2007-11#2)(2008-4#1)(2008-7#1)(2011-1#1)
only a small number##6##4##(2007-11#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
only a small part of the##3##6##(1993-6#1)(1994-12#1)(2008-3#1)
only a small percentage of##4##5##(1991-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
only a small portion of##2##5##(2007-10#1)(2009-5#1)
only a small proportion of the##5##6##(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)(2011-2#1)
only a small proportion of##7##5##(1991-11#1)(1994-8#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2011-2#1)
only a small##55##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2009-5#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#1)
only a subset of the##2##5##(2008-8#1)(2012-2#1)
only a trace amount of##2##5##(1991-5#1)(2008-8#1)
only a transient##3##3##(1994-2#1)(1996-4#1)(2008-8#1)
only a very limited##2##4##(2008-10#1)(2008-11#1)
only a very small##3##4##(1992-10#1)(2008-11#1)(2010-5#1)
only a very##6##3##(1992-10#1)(2008-10#2)(2008-11#2)(2010-5#1)
only a weak effect on##2##5##(2008-3#1)(2008-6#1)
only a weak##5##3##(1991-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
only a##347##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-6#3)(1990-8#5)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1993-2#2)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-4#2)(1996-5#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#5)(2007-12#12)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#47)(2008-11#11)(2008-12#4)(2008-2#15)(2008-3#24)(2008-4#7)(2008-5#12)(2008-6#7)(2008-7#13)(2008-8#9)(2008-9#5)(2009-12#2)(2009-2#1)(2009-5#3)(2009-9#3)(2010-10#1)(2010-11#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#5)(2011-1#4)(2011-2#9)(2012-1#4)(2012-2#3)(2012-4#1)(2013-1#12)(2013-7#2)(2013-8#3)
only able to##4##3##(1991-1#1)(2008-8#1)(2011-3#1)(2012-2#1)
only about 1% of all##2##5##(1996-12#1)(2008-4#1)
only about 1%##3##3##(1996-12#1)(2008-4#1)(2010-1#1)
only about 50%##2##3##(1990-2#1)(2008-11#1)
only about a##2##3##(1994-3#1)(2013-1#1)
only about one##2##3##(1990-11#1)(2010-4#1)
only about##25##2##(1990-11#1)(1990-2#2)(1991-12#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(2007-5#2)(2008-10#5)(2008-11#1)(2008-4#1)(2009-11#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
only according to##2##3##(2008-11#1)(2008-4#1)
only accounted for 15##2##4##(2013-1#2)
only achieved##2##2##(2008-10#1)(2008-11#1)
only active##5##2##(1996-5#1)(2008-10#3)(2008-9#1)
only acute##2##2##(2007-10#1)(2012-2#1)
only additive##2##2##(2008-10#1)(2008-11#1)
only adult##2##2##(1994-2#1)(2011-2#1)
only affected##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
only after a##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
only after the##7##3##(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-5#1)(2008-10#1)(2013-1#1)
only after##44##2##(1990-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-5#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#5)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
only against PMA-induced arachidonate release##2##5##(2008-11#2)
only against the##2##3##(1992-8#1)(2008-11#1)
only against##6##2##(1992-8#1)(2008-11#3)(2008-4#1)(2008-7#1)
only age##5##2##(1991-3#1)(2008-10#1)(2008-7#2)(2011-2#1)
only along the##2##3##(2008-3#2)
only amenable##2##2##(2008-9#1)(2010-8#1)
only among##5##2##(2011-2#2)(2012-1#2)(2013-8#1)
only an##15##2##(1993-8#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
only and##7##2##(1993-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
only apparent##2##2##(1991-12#1)(2008-10#1)
only applicable##2##2##(2008-4#1)(2012-2#1)
only applies to##2##3##(2008-10#1)(2008-8#1)
only approximately 1##2##3##(1993-11#1)(2008-11#1)
only approximately 30##2##3##(2008-10#1)(2008-3#1)
only approximately##13##2##(1993-11#1)(1997-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)
only are the##2##3##(2008-7#2)
only are##6##2##(1994-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)
only as a##12##3##(1992-12#1)(1994-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
only as an##6##3##(1990-6#1)(1992-11#1)(1994-12#1)(1995-12#1)(2008-2#1)(2008-4#1)
only as##31##2##(1990-6#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
only associated with##3##3##(2008-8#1)(2009-8#1)(2013-1#1)
only at a##6##3##(1991-6#1)(1994-3#1)(2008-10#3)(2010-9#1)
only at concentrations##4##3##(1990-2#1)(1994-11#1)(1994-8#1)(2008-9#1)
only at high##3##3##(1991-8#1)(1993-9#1)(2008-10#1)
only at higher##3##3##(1994-11#1)(1994-5#1)(2012-12#1)
only at pH##3##3##(1997-4#1)(2008-10#2)
only at the higher inoculum density##2##6##(2008-10#2)
only at the##17##3##(1991-11#2)(1991-12#1)(1993-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2010-12#2)(2012-3#1)
only at very high##2##4##(1992-6#1)(1996-12#1)
only at##64##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#2)(1996-12#2)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-8#1)(2010-12#2)(2010-9#1)(2012-12#1)(2012-3#2)(2013-1#1)
only available##6##2##(1993-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-5#1)
only basal##2##2##(1991-12#1)(1997-1#1)
only based on##3##3##(2010-8#1)(2011-2#1)(2012-3#1)
only be achieved if##2##4##(1992-3#1)(1997-7#1)
only be achieved##5##3##(1992-3#1)(1994-12#1)(1997-7#1)(2008-7#1)(2010-2#1)
only be applied##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
only be detected##2##3##(2008-10#1)(2008-2#1)
only be established##2##3##(2007-7#1)(2008-9#1)
only be explained by the##2##5##(1994-8#1)(2008-10#1)
only be explained##3##3##(1994-8#1)(2008-1#1)(2008-10#1)
only be imaged##2##3##(2008-1#1)(2008-12#1)
only be obtained through##2##4##(2008-9#1)(2009-3#1)
only be obtained##4##3##(1995-2#1)(2008-11#1)(2008-9#1)(2009-3#1)
only be realized##2##3##(1997-3#1)(2008-8#1)
only be reduced##2##3##(2010-2#1)(2010-5#1)
only be used in##2##4##(2008-2#1)(2012-12#1)
only be used when##2##4##(2008-10#2)
only be used with##2##4##(1994-8#1)(2008-9#1)
only be used##9##3##(1994-8#1)(2008-10#2)(2008-2#1)(2008-9#2)(2012-12#1)(2012-2#2)
only be##90##2##(1990-10#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-6#1)(1997-3#3)(1997-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#7)(2009-3#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
only because of##3##3##(1995-2#1)(1996-12#1)(1996-9#1)
only because##6##2##(1995-2#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-1#1)(2012-2#1)
only become##4##2##(1990-11#1)(2008-1#1)(2008-5#1)(2011-3#1)
only been##14##2##(1991-11#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-1#2)
only beginning to##4##3##(2007-12#2)(2008-4#1)(2011-2#1)
only being##2##2##(2008-10#1)(2012-2#1)
only between the##3##3##(1996-12#1)(2009-2#1)(2013-8#1)
only between##6##2##(1996-12#1)(2008-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
only briefly##2##2##(2009-9#1)(2011-1#1)
only by a##6##3##(1991-1#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(2007-12#1)
only by the shape##2##4##(2012-3#2)
only by the##28##3##(1990-11#1)(1990-3#1)(1991-12#1)(1992-4#1)(1993-12#3)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#2)(2009-11#1)(2012-3#2)
only by their##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
only by##96##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1991-1#2)(1991-12#2)(1991-3#1)(1992-2#1)(1992-4#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#6)(2008-1#2)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#2)(2011-2#4)(2012-2#2)(2012-3#4)
only can be##3##3##(2008-3#1)(2009-10#1)(2013-1#1)
only can##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#2)
only case##3##2##(1991-11#1)(2008-5#1)(2009-2#1)
only causes##2##2##(1995-6#1)(2008-3#1)
only chemotaxis but##2##3##(1991-2#2)
only clinical##5##2##(1993-11#1)(2006-12#1)(2007-7#1)(2008-7#1)(2013-1#1)
only collagen##2##2##(1990-12#1)(2008-5#1)
only common##2##2##(2012-3#2)
only completely##2##2##(2008-8#2)
only complication##2##2##(1997-8#1)(2008-10#1)
only composed of##2##3##(2008-10#1)(2008-11#1)
only compound##4##2##(1995-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
only contained##2##2##(1997-2#1)(2008-6#1)
only conventional##2##2##(2008-10#1)(2008-11#1)
only currently##2##2##(2008-10#1)(2009-3#1)
only data##2##2##(2008-10#1)(2008-2#1)
only dependent on##2##3##(1991-8#1)(2008-5#1)
only describes##2##2##(2010-5#1)(2013-1#1)
only detected in the##2##4##(2008-10#2)
only detected in##6##3##(1990-11#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
only detected##9##2##(1990-11#1)(1993-12#1)(2008-10#4)(2008-11#1)(2010-10#1)(2011-2#1)
only determination of##3##3##(2008-10#2)(2009-8#1)
only diagnostic##2##2##(1990-6#1)(2007-8#1)
only did##2##2##(1993-6#1)(1996-1#1)
only differed##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
only difference##5##2##(1990-12#1)(1990-7#1)(1996-12#1)(2008-10#1)(2012-3#1)
only direct##3##2##(1991-12#1)(2008-4#1)(2009-9#1)
only directly##2##2##(1991-12#1)(2008-5#1)
only distantly related to##2##4##(2008-10#2)
only distinct##2##2##(1995-5#1)(2008-10#1)
only documented##2##2##(2008-4#1)(2008-9#1)
only does##4##2##(1996-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
only due to##2##3##(1996-12#1)(2011-2#1)
only during the first##2##4##(2008-10#1)(2008-3#1)
only during the last few##2##5##(1990-3#1)(2013-1#1)
only during the##8##3##(1990-3#1)(1991-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
only during##15##2##(1990-12#1)(1990-3#1)(1991-12#1)(1994-8#1)(1994-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
only effective##8##2##(1992-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)
only efficient##2##2##(1997-7#1)(2009-11#1)
only eight of##2##3##(2008-7#2)
only eight##3##2##(2008-1#1)(2008-7#2)
only emerged##2##2##(2008-10#1)(2010-1#1)
only estimates of##2##3##(1990-8#1)(1996-9#1)
only evident##2##2##(1994-3#1)(1995-11#1)
only exception##3##2##(1990-2#1)(1996-5#1)(2013-1#1)
only express##2##2##(2008-9#1)(2009-3#1)
only expressed in##5##3##(1993-6#1)(1997-7#1)(2008-11#1)(2008-8#1)(2012-3#1)
only expressed##8##2##(1993-6#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-3#1)
only extracted##2##2##(2008-10#1)(2012-1#1)
only extreme##2##2##(1997-7#1)(2010-4#1)
only factor significantly associated with##2##5##(2012-2#2)
only factor##9##2##(1991-2#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
only few cases##3##3##(1991-8#1)(2007-7#1)(2009-5#1)
only few reports##3##3##(2008-10#2)(2008-4#1)
only few studies have##2##4##(2008-9#1)(2011-2#1)
only few studies##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
only few##21##2##(1991-8#1)(1995-2#1)(1997-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
only five and##2##3##(1990-3#1)(2008-3#1)
only five##14##2##(1990-3#1)(1995-1#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
only following##2##2##(1993-12#1)(2008-10#1)
only for 1##2##3##(1997-1#1)(2010-5#1)
only for a few##3##4##(1997-4#1)(2008-8#2)
only for the##20##3##(1991-5#1)(1993-9#1)(1994-2#2)(1996-11#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
only for##91##2##(1990-3#2)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-12#1)(1995-9#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-7#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
only found in##7##3##(1993-9#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-3#1)
only found on##2##3##(1991-7#1)(2008-10#1)
only found##11##2##(1991-7#1)(1993-9#1)(1997-6#1)(2007-6#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
only four cases of##3##4##(2007-7#1)(2007-8#1)(2009-5#1)
only four of##3##3##(1990-5#1)(1994-2#1)(2008-6#1)
only four##22##2##(1990-5#1)(1991-7#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
only free##4##2##(1993-6#1)(1997-2#1)(2008-10#1)(2008-2#1)
only from a##3##3##(1995-5#1)(2007-11#1)(2011-2#1)
only from lung##2##3##(1992-6#1)(2008-5#1)
only from the##13##3##(1991-5#1)(1992-6#2)(1993-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
only from##39##2##(1991-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
only gene##2##2##(2008-10#1)(2012-2#1)
only group##3##2##(2008-10#2)(2013-1#1)
only had##2##2##(1996-12#1)(2010-4#1)
only half of the##3##4##(1991-11#1)(2007-12#1)(2010-8#1)
only half##5##2##(1991-11#1)(1992-6#1)(2007-12#1)(2009-10#1)(2010-8#1)
only has##4##2##(2008-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
only have a##4##3##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
only have##6##2##(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
only high##2##2##(1994-5#1)(2012-1#1)
only highly##2##2##(2008-10#1)(2010-5#1)
only human##2##2##(2008-11#1)(2012-2#1)
only if it##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
only if the##16##3##(1993-3#1)(1995-3#1)(1996-1#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-6#1)(2008-8#3)(2012-3#1)
only if they##2##3##(2010-10#1)(2013-8#1)
only if##45##2##(1990-9#1)(1991-1#1)(1991-11#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
only improve##3##2##(1995-2#1)(2011-1#1)(2013-1#1)
only in 1 case##2##4##(1992-8#1)(1994-1#1)
only in 1##3##3##(1990-6#1)(1992-8#1)(1994-1#1)
only in 14##2##3##(2007-10#1)(2012-3#1)
only in AQP2 transfected cells##2##5##(2012-12#2)
only in a few##2##4##(2008-11#1)(2013-1#1)
only in a minority of##2##5##(1990-6#1)(2012-12#1)
only in a very##2##4##(1993-12#1)(2008-10#1)
only in a##12##3##(1990-2#1)(1990-6#1)(1993-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
only in aged##2##3##(1994-5#1)(2008-7#1)
only in association with##2##4##(2008-7#2)
only in case##2##3##(2009-2#1)(2012-2#1)
only in cases where##2##4##(1992-6#1)(2008-11#1)
only in cases##3##3##(1992-6#1)(2007-11#1)(2008-11#1)
only in cells##2##3##(1997-7#1)(2008-10#1)
only in human##3##3##(1991-12#1)(2008-9#1)(2010-11#1)
only in identifying##2##3##(2008-7#1)(2011-2#1)
only in liver##2##3##(1994-11#1)(1995-3#1)
only in one##5##3##(1990-12#1)(1991-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
only in patients with high##2##5##(2007-8#1)(2008-7#1)
only in patients with##9##4##(1991-12#1)(1996-1#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-4#3)(2008-7#1)
only in rat##2##3##(1991-12#1)(1995-6#1)
only in regions##2##3##(2008-3#2)
only in relation##2##3##(2009-5#1)(2010-1#1)
only in spermatogonia##2##3##(2008-5#1)(2010-5#1)
only in the blue##2##4##(2008-2#1)(2008-3#1)
only in the case of##3##5##(1993-8#1)(2008-10#1)(2008-11#1)
only in the first##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
only in the hippocampus##2##4##(1994-12#1)(2011-2#1)
only in the older DS and##2##6##(1991-1#2)
only in the presence of the##3##6##(1993-6#1)(1994-11#2)
only in the presence of##15##5##(1991-5#1)(1992-7#1)(1993-6#1)(1994-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
only in the salivary glands of##2##6##(2008-10#1)(2013-1#1)
only in the study##2##4##(2009-10#1)(2013-1#1)
only in the triradiate lumen##2##5##(2008-10#2)
only in the##120##3##(1990-11#3)(1990-12#2)(1991-1#2)(1991-5#1)(1991-9#2)(1992-3#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#4)(2007-12#3)(2007-8#2)(2008-10#18)(2008-11#10)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#6)(2013-7#1)
only in their##4##3##(1994-9#1)(1997-7#1)(2008-3#1)(2008-7#1)
only in this##2##3##(1994-9#1)(1997-6#1)
only in those##4##3##(1990-12#1)(1991-5#1)(1992-10#1)(2008-7#1)
only in tissues##2##3##(1990-8#1)(2008-10#1)
only in two##4##3##(1991-2#1)(1996-12#1)(1997-3#1)(2008-8#1)
only in young##2##3##(2008-7#2)
only in##341##2##(1990-11#3)(1990-12#8)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-5#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#55)(2008-11#17)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#14)(2008-6#8)(2008-7#22)(2008-8#4)(2008-9#8)(2009-10#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2012-4#1)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#1)
only includes##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
only increase##5##2##(1993-2#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-4#1)
only increased##4##2##(2007-12#1)(2008-10#3)
only increases the##2##3##(2008-10#1)(2009-9#1)
only increases##3##2##(2008-10#1)(2008-12#1)(2009-9#1)
only individual##3##2##(1996-2#1)(2008-6#1)(2008-7#1)
only induced##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
only inhibits##3##2##(1994-12#1)(1997-6#1)(2012-2#1)
only inorganic##3##2##(2008-10#2)(2008-6#1)
only into##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
only involving##2##2##(2008-10#2)
only is it##2##3##(2008-10#1)(2008-3#1)
only is not##2##3##(2007-12#1)(2008-1#1)
only is the##4##3##(1991-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
only is##10##2##(1991-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-5#1)(2013-1#1)
only isolated##3##2##(1997-2#1)(2008-10#1)(2013-8#1)
only isolates of##2##3##(2008-10#2)
only isolates##5##2##(2008-10#5)
only just##2##2##(2009-8#1)(2012-2#1)
only known##10##2##(1991-5#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-12#1)(2012-2#1)
only less than##2##3##(1996-5#1)(2008-10#1)
only less##3##2##(1996-5#1)(2008-10#2)
only light staining##2##3##(1995-8#1)(2008-7#1)
only lightly##2##2##(1995-12#1)(1996-5#1)
only limited##10##2##(1991-12#1)(1991-3#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-8#1)(2012-12#1)(2012-3#1)
only little##4##2##(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)
only local##3##2##(1993-1#1)(2008-6#1)(2008-8#1)
only located##2##2##(1991-9#1)(2008-9#1)
only logical##2##2##(2007-11#1)(2008-5#1)
only low##3##2##(2008-11#1)(2008-7#1)(2009-11#1)
only marginal##4##2##(1992-10#1)(1996-12#1)(2008-6#1)(2008-7#1)
only marginally affected by##2##4##(1996-11#1)(2008-3#1)
only marginally affected the##2##4##(1995-6#1)(1997-1#1)
only marginally affected##4##3##(1995-6#1)(1996-11#1)(1997-1#1)(2008-3#1)
only marginally##11##2##(1990-5#1)(1992-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-1#1)(2008-10#3)(2008-3#1)(2013-8#1)
only measured##2##2##(1995-11#1)(2008-10#1)
only measurements##2##2##(2008-3#2)
only medical school##2##3##(2010-5#1)(2013-8#1)
only mild##7##2##(1990-11#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#1)
only mildly##2##2##(2011-1#1)(2012-3#1)
only minimal changes in##2##4##(2008-8#1)(2013-8#1)
only minimal##7##2##(1990-11#1)(1993-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
only minimally##4##2##(2007-7#1)(2008-3#1)(2012-2#1)(2013-8#1)
only minor modifications##2##3##(2008-2#1)(2008-4#1)
only minor##16##2##(1990-2#1)(1993-8#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-4#1)(2013-1#1)
only moderate##10##2##(1994-5#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-5#1)(2011-1#1)(2012-3#1)
only moderately##5##2##(1990-8#1)(1994-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
only modest##8##2##(1990-12#1)(1992-3#1)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-7#1)(2010-1#1)
only modestly##2##2##(1991-12#1)(2008-7#1)
only natural##2##2##(1995-11#1)(2008-7#1)
only negligible amounts of##2##4##(1991-12#1)(1996-12#1)
only negligible##3##2##(1991-12#1)(1996-12#1)(2008-2#1)
only neurons##2##2##(1994-8#1)(2008-7#1)
only new##2##2##(2010-12#1)(2010-3#1)
only now##4##2##(1990-5#1)(2008-7#1)(2010-5#1)(2012-2#1)
only observed for##2##3##(1990-3#1)(2009-7#1)
only observed if##2##3##(1993-6#1)(2008-11#1)
only observed in##5##3##(1993-6#1)(1994-6#1)(1997-1#1)(2008-10#1)(2012-5#1)
only observed##15##2##(1990-3#1)(1992-3#1)(1993-6#2)(1994-6#2)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)(2012-5#1)(2013-1#1)
only obvious##2##2##(1991-11#1)(2008-9#1)
only occasional##2##2##(1993-11#1)(2008-12#1)
only occasionally##7##2##(1994-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2011-2#1)
only occur in the##2##4##(1995-8#1)(2010-5#1)
only occur##6##2##(1993-2#1)(1994-3#2)(1995-8#1)(2008-7#1)(2010-5#1)
only occurred in##2##3##(2008-10#1)(2012-12#1)
only occurred when##2##3##(2011-2#1)(2012-3#1)
only occurred##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
only of the##5##3##(2008-11#2)(2008-2#1)(2008-3#2)
only of##21##2##(1991-11#1)(1993-6#1)(1994-2#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-7#1)
only on measurable##2##3##(2007-8#1)(2008-8#1)
only on strawberry##2##3##(2008-10#2)
only on the basis of##3##5##(1997-1#1)(1997-7#1)(2008-2#1)
only on the##34##3##(1990-2#1)(1991-2#2)(1991-3#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
only on their##2##3##(1997-8#1)(2007-7#1)
only on##89##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
only once##9##2##(1990-5#1)(1990-7#1)(1992-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
only one CO molecule##2##4##(1990-3#2)
only one aspect of##2##4##(2008-9#1)(2013-1#1)
only one case of##3##4##(2008-4#1)(2012-3#2)
only one case##12##3##(1990-9#1)(1991-4#1)(1991-8#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-9#1)(2012-3#2)
only one copy of##2##4##(2008-9#1)(2012-3#1)
only one gene##2##3##(2009-5#2)
only one in##2##3##(1996-11#1)(2011-2#1)
only one instance##2##3##(1996-12#1)(2009-1#1)
only one isolate##2##3##(2008-10#1)(2012-2#1)
only one major##2##3##(1990-6#1)(2008-7#1)
only one mating##2##3##(2008-10#1)(2008-8#1)
only one of several##3##4##(1990-2#1)(2008-11#1)(2009-8#1)
only one of the populations##2##5##(2008-8#1)(2008-9#1)
only one of the two##6##5##(2007-12#1)(2008-10#1)(2008-7#2)(2010-5#1)(2011-2#1)
only one of the##23##4##(1991-1#1)(1991-12#1)(1992-5#1)(1994-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
only one of them##3##4##(1991-2#2)(2013-8#1)
only one of these##2##4##(1995-2#1)(2008-10#1)
only one of##35##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-5#1)(1994-12#1)(1995-2#2)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
only one or two lesions##2##5##(2007-2#1)(2012-12#1)
only one or two##7##4##(1993-9#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-12#1)
only one or##9##3##(1991-9#1)(1993-9#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-12#1)
only one other##2##3##(1995-12#1)(2008-12#1)
only one parameter##2##3##(2008-10#1)(2008-7#1)
only one patient##6##3##(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2012-3#1)
only one protein##2##3##(2008-10#1)(2008-9#1)
only one side of the##3##5##(1990-11#1)(1991-5#1)(1997-4#1)
only one single##3##3##(1990-11#1)(2008-11#1)(2013-1#1)
only one species##2##3##(2008-8#1)(2011-2#1)
only one specific##2##3##(2008-11#2)
only one standard solution##2##4##(2008-10#2)
only one strain##2##3##(1996-12#1)(2008-11#1)
only one study showed##2##4##(2011-2#2)
only one study##3##3##(2011-2#2)(2012-12#1)
only one third of the##2##5##(1992-3#1)(2010-11#1)
only one third of##3##4##(1992-3#1)(2007-10#1)(2010-11#1)
only one to##2##3##(2008-10#1)(2008-12#1)
only one type of##4##4##(1991-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
only one##261##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-3#3)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-5#2)(2007-8#3)(2008-1#3)(2008-10#44)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#14)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#5)
only one-third##2##2##(1992-9#1)(2008-10#1)
only or##3##2##(2007-10#1)(2008-3#1)(2008-6#1)
only other##3##2##(1993-6#1)(2008-10#1)(2009-12#1)
only over a##2##3##(2008-10#1)(2008-3#1)
only over##5##2##(1993-6#1)(2008-10#3)(2008-3#1)
only part of a##2##4##(2008-11#1)(2008-6#1)
only part of the##6##4##(1993-12#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-3#1)(2008-7#1)
only part of##9##3##(1993-12#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)
only partial##7##2##(1990-2#1)(1992-7#1)(1994-9#1)(2008-2#1)(2008-9#2)(2011-2#1)
only partially effective##2##3##(2008-10#1)(2008-9#1)
only partially explained by##2##4##(1991-8#1)(2008-10#1)
only partially inhibited##2##3##(1993-6#1)(2009-2#1)
only partially or not##2##4##(2008-6#1)(2008-7#1)
only partially to##2##3##(1994-8#1)(2008-10#1)
only partially understood##2##3##(2008-8#1)(2009-8#1)
only partially##27##2##(1990-5#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
only partly##2##2##(1991-9#1)(1992-12#1)
only pathological##2##2##(2007-11#1)(2010-11#1)
only patients with##3##3##(1991-6#1)(1992-6#1)(2007-8#1)
only patients##5##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-6#1)(2007-8#1)
only performed##3##2##(2006-8#1)(2009-9#1)(2012-12#1)
only poorly##4##2##(1994-3#1)(1997-4#1)(2008-7#1)(2013-1#1)
only positive##3##2##(2008-5#1)(2009-5#1)(2011-2#1)
only positively charged##2##3##(1997-7#1)(2008-10#1)
only possible in##2##3##(2008-10#1)(2012-12#1)
only possible when##2##3##(2008-1#1)(2008-10#1)
only possible##11##2##(1992-5#1)(1994-12#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
only potentially##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
only present in##5##3##(1991-11#1)(1991-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
only present##8##2##(1991-11#1)(1991-9#1)(1996-12#1)(2008-10#2)(2008-5#2)(2011-1#1)
only produce##2##2##(2008-10#1)(2009-2#1)
only produced##2##2##(2008-10#2)
only protein##2##2##(1994-2#1)(2007-12#1)
only provide##4##2##(1994-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
only provided physiotherapy##2##3##(2012-12#2)
only provided the##2##3##(2008-11#1)(2008-8#1)
only provided##9##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
only provides a##2##3##(2008-1#1)(2008-11#1)
only provides##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
only quantitative##2##2##(1994-3#1)(2008-10#1)
only rarely been##5##3##(1991-3#1)(1992-5#1)(2006-10#1)(2011-2#1)(2012-2#1)
only rarely in the##2##4##(2008-10#2)
only rarely##18##2##(1991-3#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-5#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
only readily available##2##3##(2007-12#1)(2008-3#1)
only received##2##2##(2011-2#1)(2013-1#1)
only recently been##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
only recently described##2##3##(1992-10#1)(2011-2#1)
only recently have##2##3##(2008-3#1)(2010-3#1)
only recently##25##2##(1992-1#1)(1992-10#1)(1992-8#1)(1993-1#1)(1994-9#1)(1995-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
only reduced##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
only related to##2##3##(2008-10#1)(2012-12#1)
only relatively##3##2##(1997-3#1)(1997-5#1)(2012-12#1)
only reliable##3##2##(1994-6#1)(1996-12#1)(2008-1#1)
only reported##3##2##(2007-8#1)(2008-1#1)(2012-2#1)
only requires##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
only results in##4##3##(1993-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
only results##5##2##(1990-7#1)(1993-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
only revealed##2##2##(2009-8#1)(2013-1#1)
only sample##2##2##(1994-9#1)(2008-10#1)
only selected##2##2##(1991-2#1)(2011-1#1)
only sensitive##2##2##(2008-10#1)(2013-1#1)
only serum##2##2##(2008-1#1)(2008-10#1)
only serve to##2##3##(2008-11#1)(2012-2#1)
only seven of##2##3##(2008-10#1)(2008-4#1)
only seven##7##2##(1993-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
only several##2##2##(1996-2#1)(2008-10#1)
only short##2##2##(1993-9#1)(1997-4#1)
only significant##12##2##(1991-11#1)(1993-1#1)(1994-2#1)(1995-12#1)(1997-1#1)(2007-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
only significantly##2##2##(1993-12#1)(2008-10#1)
only single genotypic##2##3##(2008-12#2)
only single##6##2##(2008-10#2)(2008-12#2)(2008-8#1)(2012-2#1)
only six##8##2##(1994-6#1)(1995-1#1)(1995-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#1)
only slight##8##2##(1990-12#1)(1991-12#1)(1993-8#1)(1997-6#1)(2007-11#1)(2008-10#2)(2011-1#1)
only slightly enhanced##2##3##(1995-11#1)(2008-5#1)
only slightly inhibited##4##3##(1995-11#1)(1996-2#1)(2008-6#1)(2008-8#1)
only slightly modified##3##3##(1993-11#1)(1994-6#1)(2008-8#1)
only slightly more##2##3##(1991-11#1)(2008-10#1)
only slightly the##2##3##(1990-8#1)(1996-2#1)
only slightly##39##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2010-3#1)(2012-1#1)
only small amounts of##2##4##(2008-10#1)(2008-11#1)
only small and##2##3##(1997-3#1)(1997-4#1)
only small##14##2##(1990-2#1)(1990-7#1)(1991-12#1)(1994-8#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-12#1)
only some of the##3##4##(1990-11#1)(1997-2#1)(2008-11#1)
only some of##5##3##(1990-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
only some##11##2##(1990-11#2)(1991-9#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
only species in##2##3##(2008-10#1)(2011-2#1)
only species of the##2##4##(2011-2#2)
only species of##3##3##(2010-8#1)(2011-2#2)
only species present in##2##4##(1990-2#1)(2008-10#1)
only species##7##2##(1990-2#1)(2008-10#2)(2010-8#1)(2011-2#3)
only starting to##2##3##(2011-1#1)(2013-8#1)
only starting##3##2##(2010-4#1)(2011-1#1)(2013-8#1)
only stimulated##2##2##(1995-8#1)(2008-3#1)
only strains##2##2##(2008-10#2)
only study##2##2##(2008-7#1)(2011-2#1)
only subject##2##2##(2011-2#1)(2013-8#1)
only subjective##2##2##(2006-10#1)(2011-2#1)
only technique##2##2##(2008-11#2)
only that the##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
only that##4##2##(1992-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
only the active##2##3##(1992-12#1)(2013-1#1)
only the enzyme##2##3##(2008-6#2)
only the first##6##3##(1994-3#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-2#1)
only the influence of##2##4##(2008-2#1)(2008-5#1)
only the latter##4##3##(1996-5#1)(2006-10#1)(2008-10#1)(2008-8#1)
only the most common##2##4##(2008-4#1)(2013-7#1)
only the most##5##3##(1992-6#1)(2008-10#2)(2008-4#1)(2013-7#1)
only the number of##3##4##(2008-11#1)(2008-3#1)(2012-4#1)
only the primary##2##3##(1992-6#1)(2008-11#1)
only the region##2##3##(1997-2#1)(2008-1#1)
only the second##9##3##(1993-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
only the third##5##3##(2007-12#1)(2011-2#4)
only the two##3##3##(1993-11#1)(1993-12#1)(2008-7#1)
only the##259##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#43)(2008-11#10)(2008-12#4)(2008-2#8)(2008-3#20)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#6)(2013-7#2)(2013-8#1)
only this##5##2##(1990-11#1)(1991-3#1)(1993-6#1)(1995-2#1)(2008-10#1)
only those##12##2##(1990-2#1)(1990-6#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2010-8#1)(2012-7#1)
only three patients##2##3##(1990-9#1)(2011-2#1)
only three##24##2##(1990-11#1)(1990-9#1)(1991-6#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
only through the##5##3##(1991-3#1)(1992-3#1)(1994-3#1)(2008-2#1)(2009-7#1)
only through##11##2##(1991-3#1)(1992-3#1)(1992-6#1)(1994-3#1)(2008-1#1)(2008-2#3)(2008-8#1)(2008-9#1)(2009-7#1)
only tiny amounts of##2##4##(2008-4#1)(2008-7#1)
only to a##10##3##(1991-6#1)(1991-9#1)(1995-11#1)(1997-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)
only to an##2##3##(1990-8#1)(2008-10#1)
only to atmospheric##2##3##(2008-1#1)(2008-2#1)
only to be##3##3##(2008-10#1)(2009-7#1)(2012-12#1)
only to reduce the##2##4##(2008-10#2)
only to reduce##3##3##(2008-10#2)(2009-11#1)
only to the##20##3##(1991-2#1)(1991-3#2)(1993-6#1)(1994-1#1)(1994-9#1)(1995-11#1)(2006-4#1)(2007-11#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)
only to##115##2##(1990-5#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#3)(2006-4#1)(2007-11#2)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#2)(2010-3#3)(2011-1#2)(2011-2#10)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
only trace##2##2##(2008-10#1)(2008-11#1)
only traces of##3##3##(1990-11#1)(1990-5#1)(2008-10#1)
only treatment##9##2##(1991-6#1)(1996-11#1)(2007-8#1)(2008-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
only true##2##2##(1993-12#1)(1995-5#1)
only tumor##2##2##(1995-2#1)(2008-4#1)
only two cases have been##2##5##(1990-12#1)(2009-6#1)
only two cases of##2##4##(1996-9#1)(2008-2#1)
only two cases##6##3##(1990-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-2#1)(2009-6#1)
only two of the##3##4##(1993-8#1)(2008-10#1)(2008-2#1)
only two of these##2##4##(1996-11#1)(1996-3#1)
only two of##8##3##(1993-8#1)(1996-11#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-5#1)
only two patients##4##3##(1993-1#1)(1994-2#1)(2011-1#1)(2013-1#1)
only two sites##2##3##(2008-10#2)
only two##71##2##(1990-10#1)(1990-12#2)(1990-5#1)(1991-12#2)(1991-6#2)(1992-5#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#3)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#7)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
only under specific##2##3##(1996-2#1)(2008-7#1)
only under##8##2##(1990-3#1)(1992-8#1)(1993-8#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
only up to##3##3##(1993-8#1)(2007-12#1)(2010-5#1)
only used##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
only variable##4##2##(1990-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
only very few##2##3##(2008-11#2)
only very##10##2##(1990-11#1)(1990-5#1)(1992-9#1)(1993-5#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)
only via##3##2##(1990-5#1)(2008-11#1)(2011-2#1)
only viral##2##2##(1995-2#1)(2012-2#1)
only visualized##2##2##(2008-10#2)
only was##8##2##(1992-9#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2010-11#1)
only water and##2##3##(2009-6#1)(2010-6#1)
only water##4##2##(2008-10#1)(2008-7#1)(2009-6#1)(2010-6#1)
only way to##6##3##(1991-11#1)(1994-9#1)(1997-5#1)(2008-11#1)(2008-6#1)(2008-9#1)
only way##10##2##(1991-11#1)(1994-9#2)(1995-1#1)(1997-5#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-7#1)
only weak##6##2##(1991-2#1)(1992-6#1)(1995-12#1)(2008-10#3)
only weakly on the##2##4##(2008-2#1)(2009-5#1)
only weakly on##3##3##(2007-11#1)(2008-2#1)(2009-5#1)
only weakly##12##2##(1990-8#1)(1991-5#1)(1993-11#1)(1996-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)
only were excluded##2##3##(1991-2#1)(2012-12#1)
only were##6##2##(1990-5#1)(1991-2#1)(2007-7#1)(2008-10#1)(2009-4#1)(2012-12#1)
only when the##17##3##(1990-11#1)(1990-7#1)(1992-3#1)(1992-9#1)(1996-2#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)(2009-2#1)(2012-3#1)
only when there##2##3##(1990-2#1)(2008-2#1)
only when they are##2##4##(1996-11#1)(2008-11#1)
only when they##5##3##(1991-12#1)(1996-11#1)(2008-11#1)(2010-4#1)(2010-6#1)
only when##62##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#3)(2008-10#10)(2008-11#5)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
only where##2##2##(2008-3#1)(2008-6#1)
only with a##3##3##(1996-11#1)(2008-2#2)
only with antiestrogen##2##3##(1992-5#2)
only with the##14##3##(1991-6#2)(1992-9#1)(1994-9#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#1)
only with##59##2##(1990-7#1)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-5#3)(1992-9#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#2)
only within the##2##3##(2007-12#1)(2009-7#1)
only within##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-4#1)
only ~10%##2##2##(2007-11#1)(2008-2#1)
only##4954##1##(1990-10#5)(1990-11#33)(1990-12#38)(1990-2#27)(1990-3#22)(1990-5#28)(1990-6#24)(1990-7#16)(1990-8#28)(1990-9#11)(1991-1#9)(1991-11#20)(1991-12#42)(1991-2#26)(1991-3#24)(1991-4#6)(1991-5#18)(1991-6#21)(1991-7#6)(1991-8#15)(1991-9#17)(1992-1#5)(1992-10#6)(1992-11#7)(1992-12#25)(1992-2#10)(1992-3#33)(1992-4#5)(1992-5#17)(1992-6#23)(1992-7#2)(1992-8#12)(1992-9#15)(1993-1#8)(1993-11#20)(1993-12#29)(1993-2#15)(1993-3#13)(1993-5#3)(1993-6#30)(1993-8#32)(1993-9#16)(1994-1#6)(1994-11#14)(1994-12#34)(1994-2#32)(1994-3#23)(1994-5#20)(1994-6#11)(1994-7#5)(1994-8#27)(1994-9#17)(1995-1#13)(1995-11#24)(1995-12#31)(1995-2#37)(1995-3#17)(1995-4#1)(1995-5#20)(1995-6#22)(1995-8#12)(1995-9#1)(1996-1#9)(1996-10#1)(1996-11#18)(1996-12#39)(1996-2#23)(1996-3#11)(1996-4#2)(1996-5#32)(1996-6#7)(1996-7#3)(1996-8#2)(1996-9#6)(1997-1#19)(1997-2#27)(1997-3#35)(1997-4#17)(1997-5#16)(1997-6#19)(1997-7#38)(1997-8#22)(1997-9#1)(2006-10#8)(2006-12#5)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#24)(2007-11#56)(2007-12#106)(2007-2#8)(2007-4#1)(2007-5#5)(2007-6#4)(2007-7#31)(2007-8#38)(2007-9#4)(2008-1#58)(2008-10#820)(2008-11#180)(2008-12#52)(2008-2#110)(2008-3#212)(2008-4#62)(2008-5#136)(2008-6#77)(2008-7#181)(2008-8#134)(2008-9#108)(2009-1#2)(2009-10#15)(2009-11#9)(2009-12#12)(2009-2#13)(2009-3#17)(2009-4#5)(2009-5#22)(2009-6#11)(2009-7#17)(2009-8#29)(2009-9#12)(2010-1#13)(2010-10#8)(2010-11#16)(2010-12#15)(2010-2#9)(2010-3#19)(2010-4#22)(2010-5#25)(2010-6#21)(2010-7#12)(2010-8#26)(2010-9#2)(2011-1#58)(2011-10#1)(2011-2#190)(2011-3#8)(2011-9#1)(2012-1#28)(2012-12#56)(2012-2#85)(2012-3#73)(2012-4#3)(2012-5#2)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#117)(2013-7#16)(2013-8#56)
only) and##2##2##(2011-2#1)(2013-1#1)
only)##19##1##(1990-5#1)(1992-11#1)(1994-6#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#3)
onset Still's##2##2##(1990-9#1)(1995-11#1)
onset after##3##2##(1996-7#1)(2008-7#1)(2011-2#1)
onset age##3##2##(2009-7#3)
onset and clinical##2##3##(2008-7#1)(2013-8#1)
onset and duration of##2##4##(2007-7#1)(2008-4#1)
onset and progression of##6##4##(1993-9#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)
onset and the##4##3##(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
onset and##41##2##(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1996-7#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#5)(2013-1#1)(2013-8#1)
onset at##3##2##(2007-7#1)(2008-3#1)(2008-7#1)
onset before##2##2##(1994-9#1)(2011-2#1)
onset has##2##2##(1994-11#1)(2011-2#1)
onset in##6##2##(1990-5#1)(2006-6#1)(2007-7#1)(2008-7#2)(2009-8#1)
onset is##7##2##(1996-9#1)(2007-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#1)
onset of Alzheimer's disease##3##4##(1996-5#1)(2008-7#2)
onset of Alzheimer's##4##3##(1996-5#1)(2008-7#2)(2008-8#1)
onset of DNA synthesis##3##4##(1994-5#1)(2008-7#2)
onset of DNA##4##3##(1994-3#1)(1994-5#1)(2008-7#2)
onset of a##8##3##(1990-9#2)(1995-3#1)(2008-1#2)(2008-4#1)(2008-5#1)(2010-6#1)
onset of abdominal pain##2##4##(2008-10#1)(2012-12#1)
onset of action than the##2##5##(2008-7#2)
onset of action##6##3##(1993-1#1)(2008-3#1)(2008-7#2)(2012-2#2)
onset of age-related diseases##2##4##(2008-7#1)(2012-2#1)
onset of alcohol dependence##2##4##(1994-2#2)
onset of any##2##3##(1991-12#1)(2013-7#1)
onset of cancer##2##3##(1992-12#1)(2013-7#1)
onset of coma##4##3##(2008-11#1)(2008-7#3)
onset of diabetes##3##3##(1994-12#1)(2010-10#2)
onset of disease##7##3##(1994-11#1)(1994-5#1)(1997-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
onset of estrus##3##3##(2013-1#3)
onset of fever##4##3##(2007-12#2)(2008-11#1)(2013-8#1)
onset of heatstroke##2##3##(1995-12#2)
onset of pseudothecia maturity and seasonal ascospore showers in relation to blackleg##2##12##(2008-10#2)
onset of pseudothecia maturity##5##4##(2008-10#5)
onset of renal##2##3##(2008-1#1)(2013-1#1)
onset of severe##4##3##(2006-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
onset of skin##3##3##(1991-6#1)(2008-5#1)(2010-8#1)
onset of stroke##6##3##(1995-5#1)(2007-10#2)(2008-7#1)(2009-11#1)(2010-10#1)
onset of symptoms and##7##4##(2006-10#1)(2008-10#1)(2008-7#1)(2012-12#4)
onset of symptoms##22##3##(1996-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#5)(2013-1#1)
onset of the disease in##2##5##(1991-12#1)(2008-10#1)
onset of the disease##7##4##(1991-12#1)(1993-9#1)(1994-11#1)(2008-1#1)(2008-10#1)(2011-2#2)
onset of the##35##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-5#2)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
onset of this disease##2##4##(2008-10#1)(2008-5#1)
onset of this##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
onset of treatment##2##3##(1992-5#1)(2007-8#1)
onset of tremor##2##3##(2008-7#2)
onset of type 2 diabetes##3##5##(2008-10#1)(2008-7#1)(2009-12#1)
onset of type##4##3##(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)
onset of##326##2##(1990-11#1)(1990-12#2)(1990-3#3)(1990-5#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1995-12#3)(1995-3#3)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#6)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#3)(2006-6#1)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#32)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#32)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#5)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#14)(2011-7#1)(2012-1#1)(2012-12#13)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#4)
onset or##8##2##(1993-8#1)(2008-1#2)(2008-4#2)(2008-7#1)(2009-3#1)(2011-2#1)
onset than##3##2##(1995-8#1)(2008-1#1)(2008-11#1)
onset time in##2##3##(1990-5#1)(1996-7#1)
onset time##7##2##(1990-5#2)(1996-7#2)(2008-10#1)(2008-5#1)(2013-1#1)
onset times##2##2##(1992-9#1)(1993-3#1)
onset was delayed##2##3##(2008-10#2)
onset was##10##2##(1996-7#1)(2007-8#1)(2008-10#4)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
onset were##6##2##(1994-12#1)(1997-5#1)(2007-10#1)(2008-3#1)(2013-1#2)
onset##582##1##(1990-11#2)(1990-12#2)(1990-3#4)(1990-5#6)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#5)(1994-11#5)(1994-12#2)(1994-2#7)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#6)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#7)(1996-9#2)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#5)(1997-7#1)(1997-8#1)(2006-10#5)(2006-6#2)(2006-8#1)(2007-10#16)(2007-11#6)(2007-12#7)(2007-2#2)(2007-5#2)(2007-7#7)(2007-8#3)(2007-9#3)(2008-1#20)(2008-10#60)(2008-11#11)(2008-12#5)(2008-2#7)(2008-3#10)(2008-4#12)(2008-5#17)(2008-6#4)(2008-7#57)(2008-8#7)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-5#1)(2009-7#9)(2009-8#3)(2009-9#1)(2010-10#6)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#6)(2011-2#30)(2011-7#1)(2012-1#1)(2012-12#17)(2012-2#14)(2012-3#8)(2012-5#1)(2013-1#24)(2013-7#5)(2013-8#9)
onset)##2##1##(1996-7#1)(2008-8#1)
onsite##2##1##(2008-3#2)
ont été##5##2##(2011-2#1)(2013-1#4)
ont##8##1##(2008-5#1)(2011-2#2)(2013-1#5)
ontario##3##1##(2010-9#1)(2011-2#1)(2012-2#1)
onthe##2##1##(2008-11#2)
onto 5##2##2##(2008-10#2)
onto PUFs##2##2##(2008-10#2)
onto a CCD camera##2##4##(2007-12#1)(2008-3#1)
onto a CCD##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
onto a glassy carbon electrode##2##5##(2008-10#2)
onto a glassy carbon##3##4##(2008-10#3)
onto a glassy##4##3##(2008-10#4)
onto a mini-column packed with##2##5##(2008-10#2)
onto a minicolumn packed with##2##5##(2008-10#2)
onto a minicolumn##3##3##(2008-10#3)
onto a phase-only##2##3##(2008-3#2)
onto a piece of wood##2##5##(2013-1#2)
onto a single##4##3##(2007-8#2)(2008-2#1)(2008-3#1)
onto a solid##2##3##(2008-10#1)(2008-11#1)
onto a##105##2##(1990-7#1)(1992-11#1)(1992-8#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-11#4)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#48)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
onto agar##2##2##(2008-10#1)(2008-8#1)
onto an aluminum##2##3##(1991-12#1)(2008-10#1)
onto an object surface##2##4##(2008-3#2)
onto an##13##2##(1991-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#1)(2009-9#1)
onto cell##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
onto detached##2##2##(2008-10#1)(2008-4#1)
onto either##2##2##(1994-12#1)(2008-10#1)
onto glass slides##2##3##(2008-4#1)(2013-8#1)
onto glass substrates##2##3##(2008-10#1)(2008-3#1)
onto glass##6##2##(2008-10#2)(2008-3#1)(2008-4#1)(2009-12#1)(2013-8#1)
onto glassy carbon electrode##2##4##(2008-10#2)
onto glassy carbon##6##3##(2008-10#6)
onto glycidoxypropyl-modified Fractosil 1000)##3##4##(1997-2#3)
onto gold electrode##2##3##(2008-10#2)
onto gold##5##2##(2008-10#4)(2010-4#1)
onto loaded silica gel##2##4##(2008-10#2)
onto loaded##3##2##(2008-10#3)
onto microcrystalline naphthalene or##2##4##(2008-10#2)
onto one end##2##3##(2007-11#1)(2008-2#1)
onto one of the##2##4##(2008-10#1)(2008-2#1)
onto one##4##2##(2007-11#1)(2008-10#1)(2008-2#2)
onto optical##2##2##(2008-3#2)
onto phase-only##2##2##(2008-3#2)
onto planar and##2##3##(2008-3#2)
onto polyurethane foam##5##3##(2008-10#5)
onto polyurethane##6##2##(2008-10#6)
onto silica gel was##3##4##(2008-10#3)
onto silica gel##4##3##(2008-10#4)
onto silica##5##2##(2008-10#5)
onto silicone tubing##2##3##(2008-10#2)
onto solid##3##2##(2008-5#1)(2011-1#1)(2013-8#1)
onto the SC##2##3##(2008-5#2)
onto the SPE##2##3##(2008-10#2)
onto the cells##4##3##(2008-1#2)(2008-2#2)
onto the column##2##3##(2008-10#2)
onto the electrode surface##3##4##(2008-10#3)
onto the electrode##4##3##(2008-10#4)
onto the glassy carbon electrode surface##2##6##(2008-10#2)
onto the gold surface##2##4##(2008-10#2)
onto the gold##3##3##(2008-10#3)
onto the hanging mercury drop electrode for##2##7##(2008-10#2)
onto the resin##3##3##(2008-10#3)
onto the sample surface##2##4##(2008-10#1)(2008-2#1)
onto the surface of a##3##5##(2008-10#3)
onto the surface of the##5##5##(2008-10#3)(2008-5#1)(2009-3#1)
onto the surface of##13##4##(2008-10#9)(2008-5#1)(2009-11#1)(2009-3#1)(2013-1#1)
onto the surface##14##3##(2008-10#9)(2008-2#1)(2008-5#1)(2009-11#1)(2009-3#1)(2013-1#1)
onto the surfaces of##2##4##(2009-3#1)(2013-1#1)
onto the viral capsid##2##4##(1995-2#2)
onto the wells of##2##4##(1990-12#1)(1994-8#1)
onto the##159##2##(1990-12#2)(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-2#4)(1995-6#1)(1996-8#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-1#3)(2008-10#63)(2008-11#3)(2008-2#14)(2008-3#14)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#3)
onto this##2##2##(2008-6#1)(2011-2#1)
onto three##2##2##(2008-10#1)(2008-3#1)
onto various##2##2##(1996-5#1)(2008-10#1)
onto##509##1##(1990-12#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-8#1)(1995-2#5)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1997-2#7)(1997-3#2)(1997-7#2)(2006-12#1)(2007-11#8)(2007-12#10)(2007-8#3)(2008-1#5)(2008-10#226)(2008-11#11)(2008-2#26)(2008-3#50)(2008-4#9)(2008-5#15)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#6)(2009-10#3)(2009-11#5)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#5)(2011-7#1)(2012-1#2)(2012-2#7)(2012-3#3)(2012-4#1)(2012-8#1)(2013-1#9)(2013-8#6)
ontogenesis in##4##2##(1991-12#2)(1993-12#1)(2008-12#1)
ontogenesis of##2##2##(1992-12#1)(2010-8#1)
ontogenesis##11##1##(1990-2#1)(1991-12#3)(1992-12#1)(1993-12#2)(2007-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
ontogenetic data##2##2##(1994-5#1)(2007-12#1)
ontogenetic##8##1##(1994-5#2)(2007-12#2)(2009-6#1)(2010-8#2)(2011-2#1)
ontogenic resistance is##2##3##(2008-10#2)
ontogenic resistance to##3##3##(2008-10#3)
ontogenic resistance##15##2##(2008-10#15)
ontogenic##20##1##(2008-10#17)(2008-11#1)(2008-7#1)(2009-8#1)
ontogeny and##6##2##(1991-5#1)(1992-6#1)(1993-3#1)(2007-12#1)(2008-11#1)(2013-7#1)
ontogeny of the##2##3##(2007-12#1)(2010-3#1)
ontogeny of##12##2##(1991-2#1)(1992-12#1)(1993-12#1)(1993-5#2)(2007-12#2)(2008-10#1)(2008-11#1)(2010-3#1)(2010-8#1)(2012-2#1)
ontogeny was##2##2##(2010-8#2)
ontogeny##27##1##(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#2)(1997-9#1)(2007-12#7)(2008-10#1)(2008-11#2)(2009-6#1)(2010-3#1)(2010-8#4)(2012-2#1)(2013-7#1)
ontological engineering##2##2##(2008-7#2)
ontological##8##1##(2008-7#3)(2008-8#1)(2010-5#1)(2012-2#2)(2013-1#1)
ontologies and##7##2##(2008-7#3)(2008-9#1)(2010-8#3)
ontologies for##4##2##(2008-7#4)
ontologies##31##1##(2008-7#22)(2008-9#1)(2009-10#1)(2009-5#3)(2010-5#1)(2010-8#3)
ontology for the##2##3##(2008-7#2)
ontology of##2##2##(2008-7#2)
ontology##30##1##(2008-12#1)(2008-7#26)(2008-8#1)(2010-5#1)(2011-2#1)
onward transmission##2##2##(2007-12#1)(2012-2#1)
onward##5##1##(1996-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
onwards##17##1##(1991-8#1)(1994-6#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
onycholysis##2##1##(2007-7#1)(2008-9#1)
onychomycosis by##2##2##(2008-5#2)
onychomycosis in##2##2##(2008-3#1)(2009-2#1)
onychomycosis##14##1##(2007-7#2)(2008-3#3)(2008-5#6)(2009-2#3)
oocyst##5##1##(1996-12#3)(2008-5#2)
oocysts of##2##2##(1996-12#1)(2008-5#1)
oocysts were detected##2##3##(1996-12#2)
oocysts##13##1##(1996-12#9)(2007-12#1)(2008-10#1)(2008-5#2)
oocyte expression system##3##3##(1995-2#1)(1997-2#2)
oocyte growth##2##2##(2008-5#1)(2010-5#1)
oocyte maturation##10##2##(1991-12#2)(1992-9#1)(1995-2#2)(2008-5#1)(2008-9#2)(2012-3#1)(2013-1#1)
oocyte nuclei##2##2##(2007-12#2)
oocyte nucleus and##3##3##(1994-11#1)(2007-12#2)
oocyte nucleus##7##2##(1994-11#1)(2007-12#6)
oocyte program##2##2##(1994-9#2)
oocyte recipients##3##2##(1994-9#3)
oocyte to##2##2##(2012-12#1)(2012-2#1)
oocyte##82##1##(1991-11#1)(1991-12#3)(1991-5#1)(1992-11#3)(1992-9#2)(1993-6#1)(1994-11#1)(1994-9#8)(1995-2#4)(1997-2#3)(2007-12#17)(2008-10#3)(2008-12#4)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#2)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)
oocytes (phase##4##2##(2008-8#4)
oocytes after##3##2##(1994-8#1)(2008-8#1)(2013-1#1)
oocytes and in##2##3##(1994-11#1)(2007-12#1)
oocytes and the##3##3##(2007-12#1)(2008-9#1)(2010-2#1)
oocytes and##14##2##(1992-11#1)(1994-11#2)(1994-12#2)(1995-11#1)(2007-12#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
oocytes are##3##2##(1990-10#2)(1994-9#1)
oocytes at##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
oocytes by##5##2##(1992-11#1)(1995-6#1)(1997-2#1)(2013-1#2)
oocytes expressing the alpha 3 beta##2##6##(1995-11#2)
oocytes expressing the##7##3##(1995-11#3)(1997-2#2)(2008-4#2)
oocytes expressing##10##2##(1990-8#1)(1995-11#4)(1997-2#2)(2008-4#3)
oocytes from##3##2##(1995-12#1)(2008-12#1)(2008-8#1)
oocytes in##4##2##(1990-7#1)(1991-12#1)(2008-5#1)(2008-7#1)
oocytes injected with##7##3##(1990-7#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-8#3)
oocytes of##7##2##(1995-2#1)(1997-2#1)(2007-12#1)(2008-7#2)(2008-8#1)(2009-7#1)
oocytes that##3##2##(1990-8#1)(2007-12#1)(2013-1#1)
oocytes to##2##2##(1990-7#1)(2010-8#1)
oocytes were##5##2##(1990-7#1)(2008-8#2)(2008-9#1)(2012-2#1)
oocytes with##2##2##(2008-9#2)
oocytes##156##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-7#4)(1990-8#2)(1991-12#6)(1991-9#1)(1992-11#6)(1992-3#1)(1993-8#1)(1994-11#5)(1994-12#3)(1994-8#5)(1994-9#5)(1995-11#11)(1995-12#2)(1995-2#7)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#5)(2007-12#7)(2008-11#1)(2008-12#6)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#16)(2008-9#15)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#16)
oocytes)##4##1##(2008-8#4)
oogenesis and spermatogenesis##2##3##(2009-7#1)(2010-5#1)
oogenesis and##4##2##(2008-11#1)(2009-3#1)(2009-7#1)(2010-5#1)
oogenesis##18##1##(1994-12#1)(2007-12#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#3)(2009-7#1)(2010-5#2)(2012-3#1)
oogonia##5##1##(2008-10#3)(2010-3#1)(2010-5#1)
oolong and black teas##2##4##(2008-11#2)
oolong and black##3##3##(2008-11#3)
oolong tea##2##2##(2008-10#1)(2008-5#1)
oolong##6##1##(2008-10#1)(2008-11#4)(2008-5#1)
oomycete and fungal##2##3##(2008-10#2)
oomycete pathogens##2##2##(2008-10#2)
oomycete that causes##4##3##(2008-10#4)
oomycete##14##1##(2008-10#14)
oomycetes##11##1##(2008-10#11)
oophorectomized##2##1##(1994-3#2)
oophorectomy##6##1##(1993-12#1)(1993-3#1)(1993-9#1)(2013-1#3)
ooplasm during##2##2##(2008-7#1)(2008-9#1)
ooplasm##7##1##(1994-9#1)(2008-7#1)(2008-9#5)
ooplax##2##1##(2008-5#2)
oospore formation##4##2##(2008-10#4)
oospore production in##2##3##(2008-10#2)
oospore production##5##2##(2008-10#5)
oospore progeny##2##2##(2008-10#2)
oospore##12##1##(2008-10#12)
oospores exposed to##2##3##(2008-10#2)
oospores in the##5##3##(2008-10#5)
oospores in##15##2##(2008-10#15)
oospores of##4##2##(2008-10#4)
oospores per leaflet##3##3##(2008-10#3)
oospores per##5##2##(2008-10#5)
oospores were formed on media amended with##2##7##(2008-10#2)
oospores were recorded in##2##4##(2008-10#2)
oospores were##11##2##(2008-10#11)
oospores##67##1##(2008-10#66)(2010-3#1)
op##7##1##(1990-5#4)(1996-8#1)(2008-10#1)(2012-12#1)
op/op fibroblasts##2##2##(1990-5#2)
op/op mice##3##2##(1990-5#3)
op/op##9##1##(1990-5#5)(1991-5#4)
opacification of the##4##3##(1997-8#1)(2007-12#1)(2011-2#1)(2013-7#1)
opacification of##5##2##(1997-8#1)(2007-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
opacification##11##1##(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#3)(2011-2#1)(2013-7#1)
opacities in##2##2##(2007-7#1)(2013-1#1)
opacities##9##1##(1991-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
opacity and##3##2##(1993-5#1)(2011-7#1)(2012-2#1)
opacity in the##2##3##(2008-1#1)(2008-7#1)
opacity with##3##2##(2008-1#1)(2008-7#1)(2010-10#1)
opacity##20##1##(1993-5#2)(1993-6#1)(1994-9#1)(2007-8#1)(2008-1#2)(2008-3#4)(2008-7#2)(2009-8#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-7#1)(2012-2#1)
opal##3##1##(2008-9#3)
opaque materials##2##2##(2008-2#1)(2008-3#1)
opaque object##2##2##(2007-12#1)(2008-3#1)
opaque##34##1##(1990-3#1)(1993-6#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#13)(2008-5#1)(2008-7#2)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
open a new##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
open a##6##2##(1996-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
open abdominal##3##2##(2008-3#1)(2011-2#2)
open access to##3##3##(1997-3#1)(2008-9#1)(2013-8#1)
open access##5##2##(1992-2#1)(1997-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
open and arthroscopic##2##3##(2007-11#1)(2008-8#1)
open and closed##5##3##(2008-8#1)(2009-9#2)(2010-9#1)(2012-12#1)
open and free##2##3##(1996-11#1)(2007-8#1)
open and##20##2##(1990-11#1)(1992-9#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#2)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#1)
open angle glaucoma##4##3##(2011-2#3)(2012-2#1)
open angle##6##2##(2011-2#5)(2012-2#1)
open areas##2##2##(1994-3#1)(2010-3#1)
open biopsy##4##2##(2008-12#2)(2013-8#2)
open chain polyammonium cations##3##4##(2008-10#3)
open chain polyammonium##4##3##(2008-10#4)
open circuit potential##2##3##(2008-10#2)
open circuit##12##2##(2008-10#11)(2010-12#1)
open circular##2##2##(2008-10#1)(2013-1#1)
open clinical trial##2##3##(1991-8#1)(1996-1#1)
open conformation##2##2##(1995-6#2)
open cranial##2##2##(1990-5#1)(2007-12#1)
open discussion##2##2##(2011-2#1)(2012-3#1)
open end##2##2##(2008-8#2)
open ended questions##2##3##(2012-12#2)
open environment##4##2##(2010-7#1)(2011-1#1)(2013-8#2)
open exchange of##2##3##(1996-1#1)(2010-11#1)
open field and##3##3##(1993-3#1)(1994-3#1)(1996-2#1)
open field behavior##2##3##(1993-5#1)(1994-3#1)
open field##17##2##(1990-5#1)(1992-12#2)(1993-12#1)(1993-3#5)(1993-5#1)(1994-3#2)(1996-2#1)(2008-10#1)(2008-11#2)(2012-12#1)
open focused microwave##2##3##(2008-10#2)
open focused##3##2##(2008-10#3)
open for##2##2##(1994-12#1)(2008-10#1)
open fracture##2##2##(2008-11#1)(2010-12#1)
open fractures involving##2##3##(1991-6#1)(2010-11#1)
open fractures of the tibia##2##5##(2013-8#2)
open fractures of the##3##4##(2008-9#1)(2013-8#2)
open fractures of##6##3##(2007-8#1)(2008-9#2)(2013-8#3)
open fractures##12##2##(1991-6#1)(2007-11#1)(2007-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2013-8#5)
open heart surgery##9##3##(1990-2#2)(1996-9#2)(1997-8#1)(2007-8#3)(2007-9#1)
open heart##13##2##(1990-2#3)(1996-9#2)(1997-8#1)(2007-8#4)(2007-9#1)(2008-5#1)(2012-1#1)
open in##5##2##(2007-12#1)(2008-3#2)(2008-5#1)(2009-10#1)
open into##2##2##(2008-7#2)
open label##3##2##(2007-7#1)(2008-6#1)(2012-2#1)
open letter to##2##3##(2008-6#1)(2008-7#1)
open letter##4##2##(1996-3#1)(2008-6#1)(2008-7#2)
open loop##4##2##(1997-2#1)(2007-11#1)(2008-8#2)
open method##2##2##(2007-11#1)(2007-7#1)
open multicenter##2##2##(1994-6#1)(2008-6#1)
open new possibilities for##2##4##(2007-12#2)
open new possibilities##3##3##(2007-12#2)(2008-4#1)
open new therapeutic##2##3##(2008-7#1)(2010-11#1)
open new##10##2##(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2013-1#1)
open ocean water##3##3##(2008-2#1)(2008-3#2)
open ocean##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
open operation##2##2##(1997-8#2)
open or closed##2##3##(1991-6#1)(2008-10#1)
open or##7##2##(1991-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#3)
open oral challenge##3##3##(2012-3#3)
open probability of##2##3##(1994-11#1)(1995-5#1)
open probability##5##2##(1994-11#1)(1995-5#1)(2008-4#1)(2008-8#2)
open problem##3##2##(2010-3#2)(2013-8#1)
open procedure##4##2##(2008-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
open prospective##2##2##(1991-2#1)(2009-5#1)
open pyeloplasty##3##2##(2007-10#1)(2008-10#2)
open questions and##2##3##(1992-12#1)(2013-8#1)
open questions are##3##3##(2008-8#1)(2009-3#1)(2012-2#1)
open questions##10##2##(1992-12#1)(1997-3#1)(2008-8#3)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#2)
open reading frame (ORF) and##2##5##(1994-12#1)(1997-4#1)
open reading frame (ORF) encoding a protein##2##7##(1994-11#1)(1995-6#1)
open reading frame (ORF) encoding a##4##6##(1993-12#1)(1994-11#1)(1995-6#1)(1997-7#1)
open reading frame (ORF) encoding##5##5##(1993-12#1)(1993-6#1)(1994-11#1)(1995-6#1)(1997-7#1)
open reading frame (ORF) of##9##5##(1991-9#1)(1993-12#1)(1995-8#2)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
open reading frame (ORF) was found##2##6##(1990-11#2)
open reading frame (ORF) was##3##5##(1990-11#2)(1995-8#1)
open reading frame (ORF)##38##4##(1990-11#2)(1991-9#1)(1993-12#4)(1993-6#1)(1994-11#1)(1994-12#6)(1995-6#1)(1995-8#4)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2008-10#4)(2008-7#2)(2008-8#3)(2008-9#1)(2013-1#1)
open reading frame and##2##4##(1990-11#1)(1991-2#1)
open reading frame coding for a##2##6##(1991-9#1)(1993-12#1)
open reading frame encoding a polypeptide of##2##7##(1990-5#1)(2008-8#1)
open reading frame encoding a##12##5##(1990-11#1)(1990-5#2)(1992-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-10#3)(2008-8#2)
open reading frame encoding the##2##5##(2008-10#1)(2009-5#1)
open reading frame encoding##21##4##(1990-11#1)(1990-5#2)(1991-12#1)(1992-9#1)(1994-12#2)(1994-8#1)(1995-6#2)(2008-10#5)(2008-5#1)(2008-8#2)(2009-5#1)(2012-3#1)(2013-1#1)
open reading frame for##2##4##(1997-2#2)
open reading frame from##4##4##(1991-5#1)(1991-6#1)(1995-2#1)(2008-8#1)
open reading frame is not##2##5##(1995-8#1)(2008-2#1)
open reading frame is##4##4##(1993-6#1)(1995-8#1)(1996-10#1)(2008-2#1)
open reading frame of the##5##5##(1992-6#1)(1993-12#1)(1993-6#1)(1995-12#1)(2008-10#1)
open reading frame of unknown function##2##6##(1992-9#1)(1994-6#1)
open reading frame of##45##4##(1990-11#1)(1990-12#1)(1990-5#4)(1991-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-6#2)(1997-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
open reading frame that##4##4##(1992-10#1)(1997-2#1)(2008-10#1)(2008-9#1)
open reading frame was##3##4##(1990-12#1)(1993-3#1)(2008-10#1)
open reading frame which##2##4##(1990-11#1)(1994-11#1)
open reading frame with##3##4##(1993-11#1)(2008-10#1)(2009-5#1)
open reading frame##170##3##(1990-11#6)(1990-12#2)(1990-5#6)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#1)(1994-11#5)(1994-12#10)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#5)(1995-8#11)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#7)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-9#1)(2008-10#22)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#4)(2009-5#2)(2012-3#1)(2013-1#2)(2013-8#1)
open reading frames (ORF)##2##4##(1992-3#1)(2008-10#1)
open reading frames (ORFs) and##2##5##(1996-3#1)(2008-10#1)
open reading frames (ORFs) longer##2##5##(1995-9#1)(1996-3#1)
open reading frames (ORFs) of at least 100 amino acids##2##10##(1995-6#1)(1997-3#1)
open reading frames (ORFs) of unknown function##2##7##(1996-6#1)(1997-3#1)
open reading frames (ORFs) of##6##5##(1995-6#2)(1996-6#1)(1997-3#2)(2008-10#1)
open reading frames (ORFs) were##3##5##(1991-9#1)(1995-9#1)(2008-10#1)
open reading frames (ORFs) with##2##5##(1997-3#1)(2008-7#1)
open reading frames (ORFs)##35##4##(1991-9#1)(1994-12#2)(1995-12#1)(1995-6#2)(1995-9#3)(1996-3#5)(1996-6#4)(1997-3#6)(1997-6#1)(2008-10#9)(2008-7#1)
open reading frames and##3##4##(1996-3#1)(1997-3#2)
open reading frames coding for##2##5##(2008-10#2)
open reading frames encoding the##2##5##(2008-10#2)
open reading frames encoding##4##4##(2008-10#3)(2008-9#1)
open reading frames in##2##4##(1996-3#1)(2008-10#1)
open reading frames including##4##4##(1995-6#2)(1995-9#1)(1996-6#1)
open reading frames of##2##4##(1994-11#1)(2008-10#1)
open reading frames##86##3##(1990-11#2)(1991-7#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#2)(1994-12#2)(1995-12#2)(1995-6#4)(1995-8#1)(1995-9#6)(1996-12#2)(1996-3#8)(1996-6#8)(1997-3#12)(1997-6#1)(1997-7#1)(2008-10#22)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#2)
open reading##259##2##(1990-11#8)(1990-12#2)(1990-5#6)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#1)(1994-11#8)(1994-12#12)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-6#9)(1995-8#12)(1995-9#7)(1996-10#2)(1996-12#3)(1996-3#9)(1996-6#8)(1996-8#1)(1997-2#7)(1997-3#14)(1997-4#3)(1997-6#3)(1997-7#4)(1997-9#1)(2008-10#45)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#6)(2009-5#2)(2011-1#3)(2012-3#1)(2013-1#2)(2013-8#1)
open reduction and internal fixation with##2##6##(2009-3#1)(2012-2#1)
open reduction and internal fixation##5##5##(2008-12#1)(2008-8#1)(2009-3#1)(2012-2#2)
open reduction internal fixation##4##4##(2007-12#1)(2008-8#1)(2009-4#1)(2013-1#1)
open reduction##11##2##(2007-12#2)(2007-8#1)(2008-12#1)(2008-8#2)(2009-3#1)(2009-4#1)(2012-2#2)(2013-1#1)
open repair with##2##3##(2010-8#2)
open repair##6##2##(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
open source##6##2##(2008-7#1)(2009-12#2)(2010-2#1)(2010-8#1)(2013-1#1)
open studies##2##2##(1997-8#1)(2006-10#1)
open study##6##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-11#2)(2008-3#1)
open surgery for##2##3##(1994-5#1)(2013-1#1)
open surgery or##2##3##(1997-4#1)(2008-10#1)
open surgery##15##2##(1994-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-3#1)(2011-2#3)(2013-1#1)
open surgical biopsy##2##3##(1994-7#1)(2008-6#1)
open surgical##11##2##(1994-7#1)(2008-6#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-8#4)
open technique##4##2##(2007-8#2)(2008-12#1)(2011-2#1)
open the possibility of##3##4##(2007-11#1)(2008-4#1)(2012-2#1)
open the possibility##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
open the##7##2##(1992-1#1)(2007-11#1)(2008-10#1)(2008-4#2)(2012-2#1)(2012-3#1)
open thoracotomy##4##2##(2006-10#1)(2007-8#1)(2012-12#2)
open tibial##2##2##(2007-8#1)(2009-3#1)
open time##2##2##(1994-12#2)
open to all##2##3##(1994-1#1)(2008-12#1)
open to the atmosphere##2##4##(2008-3#2)
open to the public##2##4##(1992-9#1)(2008-7#1)
open to the##8##3##(1992-9#1)(1995-3#1)(1997-1#2)(2008-11#1)(2008-3#2)(2008-7#1)
open to##33##2##(1991-4#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-1#2)(1994-12#1)(1995-3#1)(1995-5#1)(1997-1#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#6)(2013-1#2)
open trial##4##2##(2007-7#2)(2008-11#1)(2013-7#1)
open tubular capillary##2##3##(2008-10#2)
open tubular##4##2##(2008-10#4)
open up new opportunities for##2##5##(2008-5#1)(2012-2#1)
open up new##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
open up the##2##3##(1995-4#1)(1996-2#1)
open up##7##2##(1995-4#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-2#1)
open urban##3##2##(2008-10#1)(2008-11#2)
open vessel##5##2##(2008-10#5)
open##783##1##(1990-11#12)(1990-12#3)(1990-2#5)(1990-5#8)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#9)(1993-2#5)(1993-3#7)(1993-5#1)(1993-6#6)(1993-8#1)(1994-1#2)(1994-11#11)(1994-12#16)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#12)(1995-8#12)(1995-9#7)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#11)(1996-4#2)(1996-6#9)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#11)(1997-3#16)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#6)(1997-9#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-11#10)(2007-12#11)(2007-7#4)(2007-8#17)(2007-9#1)(2008-1#1)(2008-10#113)(2008-11#15)(2008-12#7)(2008-2#7)(2008-3#15)(2008-4#6)(2008-5#10)(2008-6#7)(2008-7#28)(2008-8#34)(2008-9#15)(2009-10#4)(2009-12#4)(2009-3#5)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#8)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#30)(2012-1#1)(2012-12#13)(2012-2#11)(2012-3#13)(2013-1#21)(2013-7#1)(2013-8#24)
open- and closed-loop##2##3##(2007-12#1)(2012-2#1)
open- and##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
open-access##4##1##(2010-12#3)(2012-2#1)
open-angle glaucoma##3##2##(2011-1#1)(2011-2#2)
open-angle##6##1##(2011-1#1)(2011-2#5)
open-chain##5##1##(2008-10#1)(2008-11#2)(2010-2#2)
open-channel##2##1##(2008-10#2)
open-circuit##2##1##(2008-10#2)
open-ended questions were##2##3##(2013-1#1)(2013-8#1)
open-ended questions##12##2##(1995-12#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
open-ended##26##1##(1992-12#1)(1993-3#1)(1995-12#4)(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
open-field##3##1##(1993-12#1)(1994-3#2)
open-fringe##2##1##(2008-3#2)
open-heart surgery##5##2##(1995-3#1)(1996-12#1)(2007-8#2)(2008-11#1)
open-label filgrastim##2##2##(2008-7#2)
open-label phase##2##2##(2008-5#1)(2008-6#1)
open-label pilot study##2##3##(2008-5#1)(2008-7#1)
open-label study##5##2##(2008-2#1)(2008-7#1)(2009-11#1)(2010-8#1)(2013-7#1)
open-label trial##3##2##(2007-12#1)(2008-5#1)(2010-11#1)
open-label##27##1##(2007-10#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#8)(2009-11#1)(2010-11#2)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
open-loop##4##1##(2008-1#1)(2008-2#2)(2013-1#1)
open-mesh##3##1##(1997-6#1)(2011-2#2)
open-path instrument##2##2##(2008-2#1)(2008-3#1)
open-path##6##1##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
open-pollinated##2##1##(2008-10#2)
open-set speech perception##2##3##(2008-9#2)
open-set speech recognition##3##3##(2008-9#3)
open-set speech##6##2##(2008-9#6)
open-set##11##1##(2008-9#11)
open-source software##3##2##(2008-4#1)(2011-1#2)
open-source##4##1##(2008-4#1)(2008-7#1)(2011-1#2)
open-state##2##1##(1990-11#1)(2008-8#1)
open-tubular capillary column##2##3##(2008-10#2)
open/closed FIA##2##2##(2008-10#2)
opened a##2##2##(1991-8#1)(1993-8#1)
opened and closed##2##3##(1994-12#1)(2008-12#1)
opened and##5##2##(1990-12#1)(1992-6#1)(1994-12#1)(2008-12#1)(2011-2#1)
opened by the##2##3##(1997-8#1)(2008-10#1)
opened in##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
opened its##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
opened new##2##2##(2008-7#1)(2011-2#1)
opened the##4##2##(2008-11#1)(2008-5#2)(2011-2#1)
opened up the##2##3##(2008-12#1)(2008-7#1)
opened up##5##2##(1995-6#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-4#1)
opened##47##1##(1990-12#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-7#1)
opener##5##1##(1992-9#1)(1997-1#1)(2008-5#1)(2011-1#2)
openers##2##1##(2008-12#1)(2008-5#1)
opening a##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
opening and closing##2##3##(1997-2#1)(2007-8#1)
opening and##11##2##(1996-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-7#4)
opening angle of the##2##4##(2008-10#1)(2008-9#1)
opening angle of##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
opening during##2##2##(1996-9#1)(2012-3#1)
opening in the##3##3##(1994-5#1)(2008-5#1)(2013-7#1)
opening in##5##2##(1990-3#1)(1994-5#1)(2008-5#1)(2012-3#1)(2013-7#1)
opening is##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
opening new##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
opening of the blood-brain barrier in##2##6##(1990-5#1)(1995-12#1)
opening of the vas deferens into Müllerian duct cysts##2##9##(2008-10#2)
opening of the vas deferens into##3##6##(2008-10#3)
opening of the##18##3##(1990-5#1)(1995-12#1)(1995-2#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-3#1)(2011-1#1)(2012-2#1)
opening of##34##2##(1990-5#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-2#2)(2013-1#1)
opening the way to##2##4##(2007-11#1)(2007-8#1)
opening the##5##2##(1995-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-5#1)
opening to##2##2##(2008-10#1)(2012-12#1)
opening up new##2##3##(2009-6#1)(2011-3#1)
opening up##4##2##(1996-3#1)(2008-12#1)(2009-6#1)(2011-3#1)
opening wedge##2##2##(2008-9#1)(2011-2#1)
opening with##2##2##(1995-2#1)(1996-5#1)
opening##131##1##(1990-3#1)(1990-5#1)(1991-2#3)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-8#1)(2006-12#1)(2007-10#4)(2007-11#5)(2007-12#7)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)(2013-7#8)(2013-8#1)
openings are##2##2##(2007-12#1)(2008-7#1)
openings##12##1##(1994-3#1)(1997-1#1)(2007-12#3)(2008-10#3)(2008-5#1)(2008-7#2)(2011-2#1)
openly##4##1##(1992-12#1)(1995-5#1)(1996-11#1)(2008-1#1)
openness and transparency##3##3##(2008-7#1)(2013-8#2)
openness of##2##2##(2008-7#2)
openness to##2##2##(2008-12#1)(2012-12#1)
openness##11##1##(2008-12#1)(2008-7#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#3)
opens a new approach##2##4##(2007-11#1)(2012-2#1)
opens a new##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
opens a##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#3)
opens new avenues##2##3##(2009-6#1)(2012-2#1)
opens new perspectives for##2##4##(2007-12#1)(2008-3#1)
opens new perspectives##4##3##(1993-8#1)(2007-12#2)(2008-3#1)
opens new##8##2##(1993-8#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-2#1)
opens the door##2##3##(2007-11#1)(2008-9#1)
opens the possibility of##2##4##(2007-11#1)(2007-12#1)
opens the possibility to##2##4##(2008-10#1)(2008-3#1)
opens the possibility##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
opens the prospect##2##3##(2008-7#1)(2010-12#1)
opens the way for##4##4##(1992-8#1)(2009-8#1)(2009-9#1)(2011-1#1)
opens the way to##4##4##(1991-1#1)(2008-2#1)(2010-7#1)(2011-2#1)
opens the way##8##3##(1991-1#1)(1992-8#1)(2008-2#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)
opens the##19##2##(1991-1#1)(1992-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
opens up a##3##3##(2010-2#1)(2010-7#1)(2010-8#1)
opens up new possibilities##2##4##(2008-3#1)(2008-8#1)
opens up new##5##3##(1993-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
opens up the possibility of##4##5##(1990-5#1)(2008-11#1)(2008-7#2)
opens up the possibility##5##4##(1990-5#1)(2008-11#1)(2008-7#2)(2009-5#1)
opens up##16##2##(1990-5#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)
opens with detailed discussions on the latest principles of sterile technique and preparation of culture media##2##16##(2008-4#1)(2008-9#1)
opens with##4##2##(2008-4#3)(2008-9#1)
opens##66##1##(1990-5#1)(1990-9#1)(1991-1#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-9#1)(1996-2#1)(1997-6#1)(2007-11#3)(2007-12#4)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#6)
operability of##2##2##(1990-9#1)(2008-11#1)
operability##3##1##(1990-9#1)(2006-10#1)(2008-11#1)
operable breast cancer##10##3##(1991-12#1)(1991-8#2)(1992-10#1)(1992-12#2)(1993-11#2)(1994-6#1)(2007-5#1)
operable breast##12##2##(1991-12#1)(1991-8#2)(1992-10#1)(1992-12#2)(1993-11#3)(1994-12#1)(1994-6#1)(2007-5#1)
operable##20##1##(1991-12#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-3#1)(1993-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-9#1)(1997-8#2)(2007-5#1)(2008-3#1)
operant behavior##2##2##(1997-6#2)
operant conditioning procedure##2##3##(1992-10#1)(2008-4#1)
operant conditioning##5##2##(1992-10#1)(2008-4#1)(2010-2#2)(2013-1#1)
operant responding##3##2##(1993-6#2)(2008-4#1)
operant response##2##2##(1997-6#1)(2008-4#1)
operant##28##1##(1990-12#1)(1990-7#2)(1992-10#1)(1993-6#3)(1994-3#1)(1997-6#5)(2007-8#1)(2008-10#2)(2008-4#5)(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#2)(2013-1#1)
operate a##2##2##(1995-1#1)(2008-3#1)
operate and##6##2##(1994-12#1)(1996-2#1)(2008-10#3)(2008-11#1)
operate at a##2##3##(2007-12#1)(2008-3#1)
operate at the##5##3##(1994-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2012-2#1)
operate at##15##2##(1994-12#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#1)(2009-12#1)(2012-2#1)
operate during##2##2##(2008-4#1)(2008-9#1)
operate in a##4##3##(1997-1#1)(2007-8#1)(2010-7#1)(2012-2#1)
operate in an##2##3##(2008-12#1)(2008-3#1)
operate in different##2##3##(2010-4#1)(2012-2#1)
operate in the##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
operate in##27##2##(1992-10#1)(1997-1#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-5#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
operate more##2##2##(1994-2#1)(2007-12#1)
operate on##3##2##(1997-8#1)(2009-5#1)(2013-1#1)
operate the##4##2##(2008-3#4)
operate through a##2##3##(2007-12#1)(2011-2#1)
operate through##6##2##(1994-5#1)(2007-12#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
operate to##3##2##(1994-3#1)(2007-2#1)(2008-10#1)
operate under##4##2##(1994-12#1)(1994-3#1)(2008-11#1)(2008-3#1)
operate with the##2##3##(2008-2#2)
operate with##7##2##(1993-9#1)(2007-11#1)(2007-5#1)(2008-2#2)(2008-3#2)
operate##129##1##(1990-2#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-12#1)(2009-5#3)(2009-7#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
operated as##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
operated at a##7##3##(2008-10#2)(2008-3#2)(2008-6#1)(2013-1#2)
operated at the##3##3##(1991-9#1)(2008-3#1)(2013-1#1)
operated at##22##2##(1991-5#1)(1991-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2013-1#4)
operated between##3##2##(1993-9#1)(2007-11#1)(2010-11#1)
operated by##7##2##(1993-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
operated control animals treated##2##4##(1992-9#2)
operated control##3##2##(1992-9#2)(1994-3#1)
operated during the##2##3##(1991-6#1)(1996-11#1)
operated during##4##2##(1990-2#1)(1991-6#1)(1996-11#1)(2008-2#1)
operated for a period of##2##5##(2008-6#2)
operated for##16##2##(1990-5#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(2007-8#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-8#2)
operated from##2##2##(2008-3#2)
operated in single mode and##2##5##(2008-2#2)
operated in the##13##3##(1992-6#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-3#2)(2012-3#1)
operated in##26##2##(1991-3#2)(1992-6#1)(1993-9#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#5)(2008-3#1)(2011-1#1)(2011-3#2)(2012-3#1)
operated on a##3##3##(2008-10#3)
operated on and##2##3##(1993-3#1)(2013-1#1)
operated on between##3##3##(1991-6#1)(1992-9#1)(2007-8#1)
operated on both##2##3##(2008-10#1)(2010-8#1)
operated on by##4##3##(1991-4#1)(2006-12#1)(2008-10#1)(2013-1#1)
operated on for##8##3##(1990-9#1)(1991-8#1)(1992-12#2)(2007-8#3)(2008-10#1)
operated on the##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
operated on using##3##3##(1992-1#1)(2007-8#1)(2013-1#1)
operated on##39##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1996-1#1)(1997-6#1)(2006-12#1)(2007-8#7)(2008-10#7)(2008-6#1)(2008-7#2)(2010-8#1)(2012-12#1)(2013-1#4)
operated patients##7##2##(1990-3#1)(1992-6#1)(1992-9#1)(2007-11#2)(2011-2#1)(2013-1#1)
operated under##5##2##(2007-11#1)(2008-10#2)(2008-7#1)(2013-1#1)
operated upon for##2##3##(2008-10#1)(2008-7#1)
operated upon##10##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#1)(1992-5#1)(1992-6#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
operated with a##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
operated with this##2##3##(1990-9#1)(2013-8#1)
operated with##11##2##(1990-9#2)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
operated##230##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#17)(2007-12#4)(2007-8#24)(2008-1#2)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#4)
operates and##2##2##(2008-1#1)(2008-8#1)
operates as a##3##3##(1993-3#1)(2007-12#1)(2008-9#1)
operates as##5##2##(1993-3#1)(2007-12#2)(2008-10#1)(2008-9#1)
operates at a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
operates at##9##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2012-2#1)
operates in a##7##3##(1995-6#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
operates in the##6##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
operates in##20##2##(1993-12#1)(1995-2#1)(1995-6#2)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)
operates on the##2##3##(1994-8#1)(2008-7#1)
operates on##5##2##(1994-8#2)(2008-2#1)(2008-4#1)(2008-7#1)
operates through##2##2##(2008-10#1)(2008-11#1)
operates today##2##2##(2010-12#1)(2012-3#1)
operates under##2##2##(2008-2#1)(2010-3#1)
operates with a##2##3##(2007-12#1)(2008-3#1)
operates with##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
operates##72##1##(1992-2#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#3)(1995-2#1)(1995-6#2)(1997-2#1)(2007-11#4)(2007-12#6)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#14)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
operating a##4##2##(1991-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
operating and##3##2##(1995-1#1)(1996-3#1)(2009-12#1)
operating as efficiently##2##3##(1995-12#1)(2008-12#1)
operating at 1##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
operating at a wavelength of##2##5##(2007-11#1)(2008-3#1)
operating at a##8##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
operating at ambient##2##3##(2008-10#2)
operating at approximately##2##3##(2008-3#1)(2008-7#1)
operating at high##2##3##(1994-12#1)(2008-10#1)
operating at lambda =##2##4##(2008-2#2)
operating at the##8##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)
operating at##56##2##(1994-12#1)(2007-11#8)(2007-12#7)(2008-10#7)(2008-2#15)(2008-3#13)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)
operating between##4##2##(1994-5#1)(2008-2#2)(2008-3#1)
operating budget##3##2##(1991-12#1)(1995-3#1)(1997-8#1)
operating characteristic (ROC) analysis##3##4##(2010-9#1)(2011-1#1)(2012-3#1)
operating characteristic (ROC)##6##3##(2007-8#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
operating characteristic curve##6##3##(2008-10#3)(2008-3#2)(2012-2#1)
operating characteristic##16##2##(2007-8#1)(2008-10#5)(2008-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
operating characteristics of##7##3##(2008-2#2)(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
operating characteristics##10##2##(2008-2#2)(2008-3#2)(2009-10#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
operating conditions and##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
operating conditions are##2##3##(1995-12#1)(2008-10#1)
operating conditions for##2##3##(2008-10#1)(2008-2#1)
operating conditions of##3##3##(2008-10#2)(2008-6#1)
operating conditions##37##2##(1995-12#1)(2007-11#1)(2008-10#12)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#10)(2010-4#1)(2011-2#2)(2012-3#1)
operating costs##4##2##(1991-12#1)(1994-1#1)(1996-2#1)(2008-2#1)
operating curve##7##2##(2008-2#4)(2008-3#1)(2012-3#1)(2013-1#1)
operating during##2##2##(2007-7#1)(2008-5#1)
operating expenses##5##2##(1992-2#1)(1995-1#1)(1996-12#1)(2008-11#2)
operating fiberoptic hysteroscope##2##3##(1991-2#2)
operating in a##8##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)
operating in an##2##3##(1991-12#1)(2007-12#1)
operating in the##27##3##(1990-5#1)(1991-3#1)(1995-12#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#8)(2008-7#3)(2011-2#1)(2012-2#1)
operating in##47##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-3#1)(1995-12#1)(1995-3#1)(2007-11#4)(2007-12#4)(2008-10#6)(2008-11#2)(2008-2#7)(2008-3#10)(2008-5#1)(2008-7#3)(2011-2#2)(2012-2#1)
operating method##2##2##(2007-11#1)(2008-3#1)
operating mode##6##2##(2008-11#5)(2008-9#1)
operating near 1##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
operating near 2##5##3##(2007-12#1)(2008-3#4)
operating near real time##2##4##(2008-3#2)
operating near the##2##3##(2007-11#1)(2007-12#1)
operating near##16##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#10)
operating on a##2##3##(2007-11#1)(2008-9#1)
operating on the##4##3##(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#1)
operating on##13##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#3)(2009-7#1)(2013-1#2)
operating parameters for##2##3##(2008-10#2)
operating parameters of the##2##4##(2008-10#1)(2008-2#1)
operating parameters of##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
operating parameters##13##2##(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
operating performance##2##2##(1991-1#1)(2008-11#1)
operating plants##2##2##(2009-12#2)
operating point is##2##3##(1997-2#1)(2007-11#1)
operating point##4##2##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
operating potential of##2##3##(2008-10#2)
operating potential##4##2##(2008-10#4)
operating pressure##2##2##(2008-7#1)(2009-7#1)
operating principle##2##2##(2008-3#1)(2013-7#1)
operating principles##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
operating procedure for##2##3##(2011-2#2)
operating procedures##6##2##(1990-6#1)(2007-7#1)(2010-11#1)(2010-3#2)(2011-2#1)
operating range##3##2##(2007-11#1)(2008-2#1)(2009-9#1)
operating ratio##3##2##(2008-11#3)
operating regime in##2##3##(2008-3#2)
operating revenue##2##2##(1994-2#2)
operating room##32##2##(1991-1#3)(1991-2#1)(1992-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-4#2)(2008-6#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
operating rooms##3##2##(1991-6#1)(2011-2#2)
operating strategy##3##2##(1994-1#1)(1997-2#1)(2008-11#1)
operating table##4##2##(2008-2#1)(2008-8#1)(2011-2#2)
operating temperature range##2##3##(2008-10#2)
operating temperature##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
operating temperatures##2##2##(2008-2#1)(2011-2#1)
operating the##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
operating time for##3##3##(1996-3#1)(2008-10#1)(2008-6#1)
operating time was##5##3##(1991-1#1)(1995-3#1)(1996-1#1)(2007-7#1)(2008-1#1)
operating time##12##2##(1991-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-3#1)(2012-2#1)
operating under##4##2##(1995-3#1)(1996-2#1)(2008-2#1)(2008-3#1)
operating very##2##2##(1991-1#1)(1993-3#1)
operating voltage##3##2##(1995-3#1)(2007-12#2)
operating with##3##2##(2007-11#1)(2008-3#2)
operating within##2##2##(2009-5#1)(2012-1#1)
operating##446##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#7)(1991-12#5)(1991-2#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#4)(1995-12#3)(1995-3#5)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#5)(1997-2#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#25)(2007-12#19)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#61)(2008-11#17)(2008-12#2)(2008-2#45)(2008-3#63)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#21)(2008-8#6)(2008-9#10)(2009-10#2)(2009-12#3)(2009-5#5)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#23)(2012-1#2)(2012-2#7)(2012-3#7)(2013-1#8)(2013-7#4)(2013-8#3)
operation &quot##3##2##(1993-9#1)(2008-11#2)
operation a##2##2##(2007-11#1)(2007-12#1)
operation and a##2##3##(2008-2#1)(2008-3#1)
operation and control##3##3##(1992-11#1)(2007-8#1)(2008-10#1)
operation and postoperative##2##3##(1990-12#1)(1992-9#1)
operation and the##5##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
operation and##43##2##(1990-12#1)(1990-2#2)(1990-3#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-2#2)(1994-12#1)(1994-3#2)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-7#1)(2011-1#1)
operation are discussed##2##3##(1990-9#1)(2008-3#1)
operation are##8##2##(1990-9#1)(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
operation at a##2##3##(2007-12#2)
operation at##12##2##(1997-2#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#4)(2010-4#1)
operation by##8##2##(1990-2#1)(1993-9#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-8#1)(2011-2#1)
operation can be obtained##2##4##(2008-2#2)
operation can be performed in##2##5##(1997-2#1)(2008-3#1)
operation can be##5##3##(1997-2#1)(2008-2#2)(2008-3#2)
operation can##7##2##(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
operation combined with##2##3##(1992-3#1)(2007-8#1)
operation conditions##4##2##(2008-10#3)(2008-2#1)
operation due to##5##3##(1991-6#1)(1994-5#1)(2007-11#1)(2008-7#2)
operation field##2##2##(2007-8#1)(2013-8#1)
operation for a##3##3##(2008-3#2)(2008-9#1)
operation for the##3##3##(1996-6#1)(2008-3#1)(2011-2#1)
operation for##26##2##(1990-3#1)(1990-6#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-7#1)(2008-9#4)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
operation from##2##2##(2007-12#2)
operation gives##2##2##(2008-10#1)(2008-11#1)
operation has been##2##3##(2007-12#1)(2008-3#1)
operation in a##3##3##(2007-12#2)(2007-8#1)
operation in order to##2##4##(1994-9#1)(2008-10#1)
operation in terms of##2##4##(1991-12#1)(2010-10#1)
operation in the field##2##4##(2008-2#1)(2008-3#1)
operation in the##13##3##(1990-3#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#6)
operation in##33##2##(1990-3#1)(1991-12#1)(1994-9#1)(1995-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#6)(2010-10#1)(2010-8#2)
operation is based on##3##4##(2007-11#1)(2008-10#2)
operation is obtained##2##3##(2008-2#2)
operation is the##3##3##(2007-11#2)(2008-11#1)
operation is##36##2##(1991-3#1)(1991-5#1)(1993-6#1)(2007-11#4)(2007-12#4)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#7)(2008-7#1)(2010-8#1)(2011-2#3)
operation may##2##2##(2011-2#1)(2013-1#1)
operation mode##5##2##(2008-2#1)(2012-2#1)(2013-1#3)
operation of a continuous-wave##2##4##(2008-2#2)
operation of a diode-pumped Nd##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
operation of a diode-pumped##8##4##(2007-12#3)(2008-2#2)(2008-3#3)
operation of a laboratory##2##4##(2008-7#1)(2013-1#1)
operation of a pulsed##2##4##(2008-3#2)
operation of a##48##3##(2007-11#2)(2007-12#10)(2008-10#1)(2008-2#12)(2008-3#14)(2008-4#1)(2008-7#3)(2008-9#2)(2010-12#1)(2012-12#1)(2013-1#1)
operation of an##6##3##(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-3#1)(2011-1#1)
operation of any health##2##4##(1991-12#1)(2008-12#1)
operation of optical##2##3##(2007-12#1)(2008-2#1)
operation of the##39##3##(1990-3#1)(1995-12#1)(2007-11#2)(2007-12#6)(2007-5#1)(2008-10#4)(2008-2#8)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
operation of these##3##3##(2007-11#1)(2008-3#2)
operation of this laser##2##4##(2008-2#1)(2008-3#1)
operation of this##4##3##(1991-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
operation of##136##2##(1990-3#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#3)(2007-11#10)(2007-12#23)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#24)(2008-3#27)(2008-4#4)(2008-6#1)(2008-7#6)(2008-9#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
operation on##4##2##(2008-10#2)(2008-6#1)(2010-8#1)
operation or##3##2##(2008-10#1)(2008-12#1)(2009-5#1)
operation over##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
operation parameters##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
operation periods##2##2##(2008-10#1)(2008-7#1)
operation potential##2##2##(2008-10#2)
operation principle is##2##3##(2007-12#1)(2008-2#1)
operation should be##3##3##(1994-9#1)(1996-11#1)(2007-8#1)
operation showed##2##2##(1994-7#1)(2008-9#1)
operation since##2##2##(2008-10#1)(2008-3#1)
operation that##4##2##(1993-11#1)(2008-3#1)(2008-9#2)
operation the patient##2##3##(2008-6#1)(2010-12#1)
operation the##6##2##(1992-6#1)(1993-6#1)(2007-10#1)(2008-2#1)(2008-6#1)(2010-12#1)
operation theatre##2##2##(2007-11#1)(2012-3#1)
operation time##9##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
operation to##6##2##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-1#1)(2013-7#1)
operation under##5##2##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
operation using##2##2##(2007-8#1)(2010-11#1)
operation was obtained##2##3##(2007-11#1)(2007-12#1)
operation was performed in##2##4##(1994-11#1)(1994-3#1)
operation was##26##2##(1990-9#1)(1991-6#1)(1994-11#1)(1994-3#1)(1996-3#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
operation were##6##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
operation with a##3##3##(1990-3#1)(2008-3#2)
operation with an##2##3##(2008-10#1)(2008-2#1)
operation with the##2##3##(2008-2#1)(2008-3#1)
operation with##16##2##(1990-3#1)(1993-2#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#6)
operation without##6##2##(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
operation##809##1##(1990-12#1)(1990-2#4)(1990-3#8)(1990-6#4)(1990-9#7)(1991-11#1)(1991-12#3)(1991-3#7)(1991-5#2)(1991-6#6)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#6)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#8)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#5)(1997-5#1)(1997-6#1)(1997-8#8)(2006-12#2)(2006-6#2)(2007-10#7)(2007-11#55)(2007-12#64)(2007-5#1)(2007-7#1)(2007-8#45)(2007-9#2)(2008-10#94)(2008-11#23)(2008-12#9)(2008-2#77)(2008-3#115)(2008-4#6)(2008-5#2)(2008-6#8)(2008-7#35)(2008-8#1)(2008-9#13)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#12)(2011-1#7)(2011-2#26)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#6)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#3)
operation) and##2##2##(2007-9#1)(2013-1#1)
operation)##8##1##(1994-3#1)(2007-8#4)(2007-9#1)(2008-3#1)(2013-1#1)
operation]##2##1##(2012-3#1)(2013-8#1)
operational amplifier to##2##3##(2008-10#1)(2010-8#1)
operational amplifier##4##2##(2008-10#3)(2010-8#1)
operational and organizational##2##3##(1994-1#1)(1997-1#1)
operational and storage stability##6##4##(2008-10#6)
operational and##14##2##(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(2008-10#7)(2012-2#1)
operational aspects##2##2##(1993-6#1)(2013-8#1)
operational changes##2##2##(1994-12#1)(1996-3#1)
operational characteristics##7##2##(1995-1#1)(2007-12#1)(2008-10#2)(2008-2#3)
operational conditions were##2##3##(2008-10#2)
operational conditions##10##2##(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2010-4#1)(2010-5#1)
operational data##2##2##(1997-3#1)(2010-8#1)
operational definition of##3##3##(2008-10#1)(2013-1#2)
operational definition##7##2##(2008-10#1)(2013-1#6)
operational environment##2##2##(1994-12#1)(2012-3#1)
operational in##2##2##(2008-2#1)(2008-5#1)
operational issues##6##2##(1992-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
operational lifetime of 8 weeks##2##5##(2008-10#2)
operational lifetime of##3##3##(2008-10#3)
operational lifetime##4##2##(2008-10#4)
operational model##3##2##(1997-3#1)(2008-3#2)
operational pH##2##2##(2008-10#2)
operational parameters had been investigated##2##5##(2008-10#2)
operational parameters have been selected for the drug##2##8##(2008-10#2)
operational parameters have been##3##4##(2008-10#3)
operational parameters##9##2##(2008-10#9)
operational principles##2##2##(2007-12#1)(2008-10#1)
operational processes##2##2##(1993-2#1)(2010-9#1)
operational range##2##2##(2008-10#2)
operational research##3##2##(2007-7#2)(2008-1#1)
operational results##2##2##(2008-2#1)(2009-5#1)
operational stability and##2##3##(2008-10#2)
operational stability of the##3##4##(2008-10#3)
operational stability of##4##3##(2008-10#4)
operational stability##9##2##(2008-10#9)
operational understanding##2##2##(1997-2#1)(2009-5#1)
operational use of##2##3##(2008-8#1)(2011-2#1)
operational##188##1##(1990-5#1)(1991-1#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#3)(1993-6#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#3)(1996-3#5)(1997-1#3)(1997-2#2)(1997-3#3)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#54)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#2)(2009-5#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#1)
operationalising##2##1##(2008-12#2)
operationalizations of##3##2##(1997-1#2)(2008-12#1)
operationalizations##4##1##(1997-1#3)(2008-12#1)
operationalize##4##1##(1991-12#1)(1996-1#1)(2008-1#1)(2011-2#1)
operationalized##2##1##(2009-12#2)
operationally defined as##2##3##(1995-2#1)(1996-12#1)
operationally defined##3##2##(1995-2#1)(1996-12#1)(2008-10#1)
operationally##10##1##(1991-2#1)(1995-2#1)(1996-12#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-12#1)
operations and##15##2##(1991-11#1)(1991-5#1)(1991-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
operations are##11##2##(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-8#1)
operations as##2##2##(1990-3#1)(2008-10#1)
operations at##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-9#1)
operations can be##2##3##(1992-6#1)(2008-10#1)
operations can##3##2##(1992-6#1)(2007-12#1)(2008-10#1)
operations for##9##2##(1990-9#2)(1992-11#1)(1993-3#1)(1993-5#1)(1997-8#2)(2008-9#1)(2010-8#1)
operations from##2##2##(2008-10#1)(2008-3#1)
operations have been##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
operations have##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
operations in a##2##3##(2008-3#1)(2010-8#1)
operations in the##2##3##(2008-9#1)(2011-2#1)
operations in two##2##3##(2007-8#1)(2009-1#1)
operations in##19##2##(1990-3#1)(1992-3#1)(1994-9#1)(1996-3#1)(1997-8#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#3)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
operations may##2##2##(1992-1#1)(2007-8#1)
operations of the##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
operations of##18##2##(1992-3#1)(1993-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-8#1)(2013-1#1)
operations on##2##2##(1992-12#1)(1992-9#1)
operations performed##3##2##(1996-9#1)(2008-6#1)(2013-1#1)
operations required##2##2##(2008-10#1)(2008-3#1)
operations such as##2##3##(2008-3#2)
operations that##2##2##(2008-10#1)(2009-7#1)
operations to##6##2##(1997-1#2)(2007-5#1)(2008-10#1)(2008-3#1)(2010-6#1)
operations was##2##2##(2008-10#1)(2013-1#1)
operations were performed##5##3##(1990-8#1)(1993-3#1)(2007-8#2)(2009-3#1)
operations were##17##2##(1990-8#2)(1993-3#1)(1993-6#1)(1993-9#1)(1995-3#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-3#1)
operations with##2##2##(2007-9#1)(2008-12#1)
operations##262##1##(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#7)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#8)(2007-11#1)(2007-12#6)(2007-5#1)(2007-8#14)(2007-9#4)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#38)(2008-4#5)(2008-6#2)(2008-7#6)(2008-9#7)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#5)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)
operative and postoperative##2##3##(2010-7#1)(2011-2#1)
operative and##4##2##(2007-8#1)(2010-7#1)(2011-2#2)
operative approach##3##2##(1996-1#1)(2008-1#1)(2008-7#1)
operative blood loss##5##3##(1993-12#2)(2008-10#1)(2009-5#1)(2009-7#1)
operative blood##6##2##(1993-12#2)(2008-10#1)(2009-5#1)(2009-7#1)(2010-7#1)
operative complications##2##2##(1991-2#1)(2010-12#1)
operative conditions##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
operative day##2##2##(2007-8#1)(2012-2#1)
operative exposure and##2##3##(2007-8#2)
operative field##7##2##(1995-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-8#2)
operative findings##5##2##(1995-3#1)(1997-8#1)(2008-9#2)(2012-2#1)
operative in##4##2##(1995-2#1)(1995-5#1)(2008-10#2)
operative intervention in##3##3##(1997-8#1)(2008-4#1)(2010-8#1)
operative intervention##6##2##(1997-8#1)(2008-10#1)(2008-4#2)(2010-12#1)(2010-8#1)
operative interventions##2##2##(1991-6#1)(2009-5#1)
operative laparoscopy during the##2##4##(1993-12#2)
operative laparoscopy for##2##3##(1994-3#1)(1996-3#1)
operative laparoscopy has##2##3##(1994-9#1)(1995-2#1)
operative laparoscopy##16##2##(1992-12#1)(1993-12#6)(1993-3#2)(1994-3#1)(1994-9#1)(1995-2#3)(1996-2#1)(1996-3#1)
operative management of##2##3##(2011-2#1)(2013-8#1)
operative management##3##2##(2011-2#2)(2013-8#1)
operative method##2##2##(2008-10#1)(2010-5#1)
operative mortality rate##2##3##(1990-3#1)(1993-5#1)
operative mortality##8##2##(1990-3#1)(1993-5#1)(1994-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)
operative procedure##8##2##(1991-3#1)(1991-6#1)(1992-9#1)(2007-11#3)(2007-12#1)(2008-7#1)
operative procedures##6##2##(1990-9#1)(1995-5#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)
operative repair##2##2##(2009-3#2)
operative risk##2##2##(1990-8#1)(2007-8#1)
operative strategy##2##2##(1990-8#1)(2010-8#1)
operative technique##7##2##(1993-9#1)(2007-8#1)(2008-10#3)(2008-7#1)(2013-8#1)
operative techniques##2##2##(2007-11#1)(2008-8#1)
operative time and##3##3##(1994-12#1)(1995-1#1)(2008-10#1)
operative time was##6##3##(1996-1#1)(1996-2#1)(2007-8#1)(2008-10#3)
operative time##19##2##(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#3)(2007-8#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
operative times##5##2##(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
operative trauma##2##2##(2012-12#1)(2013-8#1)
operative treatment in##2##3##(2007-11#2)
operative treatment of bone metastases to##3##6##(2007-11#3)
operative treatment of the##2##4##(2007-11#1)(2007-8#1)
operative treatment of##16##3##(1991-6#1)(1992-2#2)(1994-3#1)(1994-5#1)(2007-11#7)(2007-8#1)(2008-10#1)(2013-1#2)
operative treatment##32##2##(1991-6#1)(1992-2#2)(1994-3#1)(1994-5#1)(1996-12#1)(2007-11#16)(2007-8#3)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#3)
operative##236##1##(1990-3#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-8#1)(1992-9#1)(1993-12#8)(1993-3#3)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#2)(1995-2#5)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-6#1)(1997-8#2)(2007-11#22)(2007-12#4)(2007-4#1)(2007-8#22)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#5)(2011-2#10)(2012-12#3)(2012-2#10)(2012-3#6)(2013-1#11)(2013-8#3)
operative-technical special features of the##2##5##(2008-10#2)
operative-technical special features##3##3##(2008-10#3)
operatively treated##2##2##(2007-11#1)(2011-2#1)
operatively##14##1##(2007-11#6)(2007-8#1)(2008-3#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
operator and##2##2##(1990-5#2)
operator in##4##2##(1991-2#1)(1995-8#1)(2008-9#2)
operator intervention##2##2##(2008-10#1)(2008-11#1)
operator is##2##2##(2008-3#1)(2012-1#1)
operator region##2##2##(1994-3#1)(1997-6#1)
operator sequence##3##2##(1992-6#2)(2008-11#1)
operator sequences##4##2##(1992-6#3)(2008-11#1)
operator to##5##2##(2007-8#1)(2008-10#2)(2008-11#2)
operator##68##1##(1990-5#6)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-4#4)(1992-6#7)(1993-10#1)(1994-3#2)(1995-8#2)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
operator's##4##1##(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
operators and##2##2##(2008-11#1)(2011-2#1)
operators have##3##2##(1994-6#1)(2010-8#1)(2012-2#1)
operators in##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
operators to##3##2##(1995-3#1)(2008-2#1)(2008-3#1)
operators##40##1##(1990-11#1)(1990-5#1)(1992-10#3)(1994-6#1)(1995-3#2)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#3)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#3)(2013-8#1)
operators'##2##1##(2009-10#1)(2011-2#1)
opercular bones readings##2##3##(2008-5#2)
operculofrontal AVM##2##2##(2008-7#2)
operculum##6##1##(1996-5#1)(2007-12#3)(2008-11#1)(2012-12#1)
operon and##5##2##(1991-7#2)(1992-12#1)(1994-12#1)(2011-1#1)
operon from##2##2##(1994-12#1)(2008-10#1)
operon in##2##2##(1993-9#1)(2008-11#1)
operon is##6##2##(1990-11#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-9#1)
operon of##4##2##(1990-5#1)(1991-9#1)(1994-12#1)(2011-1#1)
operon that##3##2##(1990-11#1)(1995-3#1)(2008-10#1)
operon##50##1##(1990-11#4)(1990-5#1)(1991-7#2)(1991-9#2)(1992-12#3)(1993-9#1)(1994-12#6)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#5)(1995-8#6)(1996-12#3)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#2)
operons across##2##2##(2008-8#2)
operons contain##2##2##(2007-12#2)
operons encoding##2##2##(2011-1#1)(2011-2#1)
operons##22##1##(1995-12#2)(1995-8#1)(2007-12#4)(2008-11#2)(2008-7#1)(2008-8#8)(2011-1#2)(2011-2#2)
ophionines##2##1##(2008-5#2)
ophiuroid##3##1##(2013-8#3)
ophthalmic arteries##2##2##(2006-12#1)(2011-2#1)
ophthalmic artery##8##2##(1992-6#1)(1996-9#1)(2006-12#1)(2008-7#2)(2012-3#2)(2013-1#1)
ophthalmic imaging##4##2##(2007-11#1)(2011-1#1)(2011-7#2)
ophthalmic segment##3##2##(2012-3#3)
ophthalmic solutions##2##2##(2008-10#2)
ophthalmic##43##1##(1992-6#1)(1993-12#1)(1995-9#1)(1996-9#2)(1997-3#1)(2006-12#2)(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#3)(2010-10#1)(2011-1#6)(2011-2#3)(2011-3#1)(2011-7#2)(2012-12#1)(2012-3#7)(2013-1#4)(2013-8#1)
ophthalmologic##3##1##(2008-9#1)(2011-2#1)(2013-1#1)
ophthalmological##3##1##(2008-7#1)(2011-2#1)(2012-12#1)
ophthalmologist##6##1##(1993-11#1)(2013-1#3)(2013-7#2)
ophthalmologists and##2##2##(2010-10#1)(2011-1#1)
ophthalmologists##3##1##(1995-9#1)(2010-10#1)(2011-1#1)
ophthalmology##18##1##(1991-2#1)(1991-9#1)(1992-5#1)(1995-9#1)(2007-11#1)(2008-2#1)(2010-10#3)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-7#2)(2012-3#1)
ophthalmomyiasis##2##1##(2010-10#2)
ophthalmoplegia##6##1##(1990-12#1)(1993-12#1)(2008-7#3)(2013-7#1)
ophthalmoscope##6##1##(2007-11#1)(2008-3#2)(2011-1#3)
ophthalmoscopy##8##1##(1994-12#1)(2007-11#1)(2007-12#1)(2011-1#2)(2011-7#3)
opiate addicts##2##2##(1991-1#1)(2007-2#1)
opiate antagonist##2##2##(1990-7#1)(1991-1#1)
opiate dependence##3##2##(1990-8#1)(1991-1#2)
opiate receptor density##3##3##(1992-5#3)
opiate receptor##6##2##(1991-5#2)(1992-5#3)(1992-8#1)
opiate receptors in##2##3##(1992-5#1)(1997-4#1)
opiate receptors##10##2##(1991-1#4)(1991-5#1)(1992-5#1)(1994-2#1)(1995-12#1)(1997-4#1)(2013-8#1)
opiate use##2##2##(1991-1#1)(2010-11#1)
opiate withdrawal##3##2##(1991-1#1)(1996-5#1)(2008-11#1)
opiate##48##1##(1990-7#1)(1990-8#2)(1991-1#13)(1991-5#3)(1992-5#5)(1992-8#1)(1993-12#2)(1994-2#1)(1994-8#3)(1995-12#3)(1996-5#2)(1997-4#1)(2007-2#1)(2008-10#1)(2008-11#2)(2010-11#4)(2012-1#2)(2013-8#1)
opiate-induced##2##1##(1991-1#1)(2008-9#1)
opiates and##2##2##(1991-1#1)(2010-4#1)
opiates in##2##2##(1991-1#1)(1995-12#1)
opiates##11##1##(1991-1#2)(1993-3#1)(1994-8#1)(1995-12#2)(1996-5#1)(1997-4#1)(2008-4#1)(2008-5#1)(2010-4#1)
opinion about##6##2##(1992-2#2)(1993-1#1)(1997-8#1)(2013-1#2)
opinion and##10##2##(1995-2#2)(1996-1#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
opinion is that##3##3##(1990-6#1)(1993-11#1)(2008-1#1)
opinion is##4##2##(1990-6#1)(1993-11#1)(2008-1#1)(2008-7#1)
opinion leaders##3##2##(2008-11#1)(2008-6#1)(2010-11#1)
opinion of surgical##2##3##(1990-5#1)(1996-11#1)
opinion of the##7##3##(1990-2#2)(1991-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2012-3#1)
opinion of##20##2##(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-3#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
opinion on the##2##3##(2007-2#1)(2008-2#1)
opinion on##9##2##(1993-1#1)(1993-2#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
opinion survey##2##2##(2013-1#2)
opinion that##9##2##(1995-2#1)(1995-5#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#2)
opinion the##4##2##(1994-2#1)(1996-11#1)(2007-8#1)(2009-12#1)
opinion was##3##2##(2009-10#2)(2012-12#1)
opinion when##3##2##(1993-12#2)(1996-9#1)
opinion##115##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1994-2#1)(1994-3#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#9)(2013-8#2)
opinions about a web-based distance##2##5##(2010-10#2)
opinions about the##2##3##(1995-1#1)(2010-10#1)
opinions about##13##2##(1991-3#2)(1991-9#1)(1995-1#2)(2008-11#1)(2009-12#1)(2009-4#1)(2010-10#3)(2010-12#2)
opinions and##4##2##(1991-9#1)(1994-12#1)(2008-1#1)(2012-2#1)
opinions as to the##2##4##(2008-3#1)(2008-5#1)
opinions of the##3##3##(1990-11#1)(1991-2#1)(1996-3#1)
opinions of##13##2##(1990-11#1)(1991-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2007-9#1)(2008-12#3)(2008-2#1)(2008-6#1)(2009-6#1)(2012-3#1)
opinions on the##2##3##(1996-1#1)(2008-10#1)
opinions on##5##2##(1994-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#1)
opinions regarding the##3##3##(2007-4#1)(2008-7#1)(2013-8#1)
opinions regarding##4##2##(2007-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
opinions to##3##2##(2008-5#1)(2013-1#2)
opinions##63##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#3)(1993-1#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-3#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#3)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
opioid abuse##2##2##(2008-6#1)(2009-7#1)
opioid activity##2##2##(1991-1#1)(1995-3#1)
opioid agonist##2##2##(1995-12#1)(2008-7#1)
opioid analgesia##4##2##(1990-7#1)(1995-5#1)(2008-3#1)(2013-1#1)
opioid and##4##2##(1992-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
opioid antagonist##2##2##(1991-5#1)(1993-6#1)
opioid antagonists##4##2##(1991-1#1)(2008-2#2)(2008-7#1)
opioid binding affinity##2##3##(1995-3#2)
opioid binding##4##2##(1991-1#1)(1995-3#3)
opioid compounds##2##2##(1991-1#2)
opioid dependency##2##2##(2008-11#1)(2009-9#1)
opioid dosing##3##2##(2008-7#3)
opioid genes##2##2##(1996-12#2)
opioid mechanisms##2##2##(1995-12#1)(2008-3#1)
opioid peptide levels##2##3##(1995-5#2)
opioid peptide##5##2##(1995-5#3)(2008-3#2)
opioid peptides in##3##3##(1991-1#2)(1994-2#1)
opioid peptides##15##2##(1991-1#2)(1994-2#2)(1994-9#2)(1995-3#1)(1995-6#1)(1996-12#2)(1997-2#1)(2008-3#3)(2009-7#1)
opioid pharmacotherapy##3##2##(2008-4#2)(2008-7#1)
opioid potency##2##2##(1995-3#2)
opioid receptor agonist##2##3##(1995-12#2)
opioid receptor agonists##3##3##(1995-12#2)(2009-7#1)
opioid receptor and##2##3##(1992-3#1)(2008-11#1)
opioid receptor antagonists such as##2##5##(1995-12#1)(2009-7#1)
opioid receptor antagonists##3##3##(1995-11#1)(1995-12#1)(2009-7#1)
opioid receptor cDNA##2##3##(1995-6#2)
opioid receptor homologue##2##3##(1996-12#2)
opioid receptor levels##2##3##(1993-12#2)
opioid receptor##29##2##(1991-5#1)(1992-3#1)(1993-12#4)(1995-11#1)(1995-12#5)(1995-6#5)(1996-12#2)(1996-5#1)(2008-11#6)(2008-3#1)(2009-7#2)
opioid receptor-like (ORL1)##2##3##(1996-2#2)
opioid receptor-like##3##2##(1996-2#2)(2008-11#1)
opioid receptors and##3##3##(1991-1#1)(2008-11#1)(2009-7#1)
opioid receptors in the##3##4##(1993-12#1)(2008-11#2)
opioid receptors in##9##3##(1993-12#1)(2008-11#3)(2008-3#1)(2009-7#4)
opioid receptors##23##2##(1991-1#1)(1991-5#1)(1993-12#3)(1995-11#1)(1995-6#1)(1996-2#1)(2008-11#5)(2008-3#1)(2008-7#1)(2009-12#1)(2009-7#7)
opioid system##3##2##(1991-1#1)(2008-7#1)(2009-7#1)
opioid systems in##2##3##(1991-5#1)(2008-11#1)
opioid systems##4##2##(1991-1#1)(1991-5#2)(2008-11#1)
opioid tolerance##3##2##(1991-1#1)(2009-7#2)
opioid treatment##4##2##(2008-6#3)(2012-1#1)
opioid use##2##2##(2009-2#1)(2013-1#1)
opioid##167##1##(1990-7#1)(1991-1#16)(1991-5#5)(1992-12#4)(1992-3#1)(1993-12#7)(1993-6#1)(1994-2#2)(1994-9#3)(1995-11#2)(1995-12#7)(1995-3#8)(1995-5#4)(1995-6#8)(1996-12#8)(1996-2#4)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#15)(2008-2#3)(2008-3#9)(2008-4#2)(2008-6#9)(2008-7#10)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#14)(2009-9#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#3)(2013-1#6)
opioid-induced##2##1##(1991-1#2)
opioid-mediated##2##1##(1990-7#1)(2008-10#1)
opioidergic##2##1##(2008-2#1)(2009-7#1)
opioids and other##2##3##(2010-4#1)(2011-2#1)
opioids and##4##2##(1997-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
opioids are##2##2##(2008-7#2)
opioids in##8##2##(1991-1#1)(1996-5#1)(2010-8#1)(2011-2#4)(2012-3#1)
opioids like##2##2##(2009-7#2)
opioids such as##2##3##(1995-5#1)(2008-7#1)
opioids##48##1##(1991-1#4)(1991-2#1)(1993-12#1)(1994-9#5)(1995-12#1)(1995-5#1)(1996-5#1)(1997-5#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-5#2)(2009-7#3)(2010-4#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-3#2)(2013-1#5)(2013-8#3)
opium poppy from##2##3##(2008-10#2)
opium poppy##9##2##(2008-10#9)
opium##12##1##(2007-10#1)(2007-7#1)(2008-10#10)
opossum##5##1##(1991-3#1)(1996-5#2)(2008-5#2)
opponent's##4##1##(2008-11#4)
opponents of##2##2##(1994-1#1)(2008-11#1)
opponents##8##1##(1994-1#1)(2008-11#3)(2008-8#1)(2008-9#2)(2009-9#1)
opportune and##2##2##(2008-10#2)
opportune##4##1##(1992-5#1)(2008-10#2)(2013-1#1)
opportunist##3##1##(2007-7#1)(2008-8#2)
opportunistic and##4##2##(2007-2#1)(2008-1#1)(2008-5#1)(2012-3#1)
opportunistic infection and##2##3##(1993-12#1)(2007-7#1)
opportunistic infection in##2##3##(2008-5#1)(2013-8#1)
opportunistic infection of the##2##4##(2007-12#1)(2008-5#1)
opportunistic infection##13##2##(1991-6#1)(1993-12#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#3)(2010-10#1)(2012-3#1)(2013-8#1)
opportunistic infections##7##2##(1994-5#1)(1997-4#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)
opportunistic microorganisms##2##2##(2010-5#1)(2013-1#1)
opportunistic parasitic##2##2##(2007-7#1)(2009-7#1)
opportunistic pathogen of humans##2##4##(1991-9#1)(2008-10#1)
opportunistic pathogen##8##2##(1991-9#1)(1993-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-3#1)
opportunistic pathogens##5##2##(1996-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
opportunistic screening##2##2##(1991-6#1)(1996-6#1)
opportunistic##60##1##(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-11#1)(1996-6#2)(1997-4#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#8)(2008-7#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-5#1)(2011-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
opportunistically##2##1##(2008-1#1)(2008-5#1)
opportunities and challenges##6##3##(2008-10#1)(2008-7#2)(2010-3#1)(2013-1#2)
opportunities and limitations##2##3##(1997-1#1)(2007-2#1)
opportunities and##14##2##(1993-1#1)(1994-2#1)(1997-1#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
opportunities are##4##2##(1992-12#1)(1995-2#1)(2008-8#1)(2012-12#1)
opportunities as##2##2##(1996-3#1)(2008-12#1)
opportunities exist##2##2##(1996-1#1)(2013-1#1)
opportunities for a##2##3##(2008-11#1)(2012-3#1)
opportunities for both##2##3##(1992-3#1)(2008-11#1)
opportunities for dietitians##2##3##(1993-12#2)
opportunities for further improvement##2##4##(1995-3#1)(1996-3#1)
opportunities for further##3##3##(1995-3#1)(1996-3#1)(2009-5#1)
opportunities for improvement##2##3##(1994-2#1)(1997-1#1)
opportunities for learning and##2##4##(2011-1#1)(2012-2#1)
opportunities for learning##3##3##(2011-1#1)(2012-2#1)(2013-8#1)
opportunities for personal##2##3##(1995-1#1)(1997-1#1)
opportunities for postgraduate##2##3##(1993-11#1)(1993-6#1)
opportunities for the development of##2##5##(2008-6#1)(2012-12#1)
opportunities for the##8##3##(1995-1#1)(1997-3#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
opportunities for training and development##2##5##(2011-1#2)
opportunities for##103##2##(1991-12#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-12#1)(1994-2#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#3)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
opportunities in the##3##3##(1994-3#1)(2008-7#1)(2010-2#1)
opportunities in##11##2##(1994-2#1)(1994-3#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
opportunities may##2##2##(2008-3#1)(2010-8#1)
opportunities of##3##2##(2013-1#2)(2013-8#1)
opportunities that are##2##3##(2008-1#1)(2008-11#1)
opportunities that##7##2##(1993-1#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
opportunities to develop##4##3##(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
opportunities to explore##3##3##(1996-7#1)(2009-11#1)(2010-3#1)
opportunities to further##2##3##(1995-3#1)(2008-11#1)
opportunities to improve the##2##4##(1995-3#1)(1997-3#1)
opportunities to increase##2##3##(2008-7#1)(2010-4#1)
opportunities to influence##2##3##(2008-11#1)(2011-1#1)
opportunities to learn##3##3##(1993-2#1)(2011-1#1)(2012-12#1)
opportunities to study##2##3##(1992-9#1)(2010-3#1)
opportunities to##43##2##(1992-9#1)(1993-2#3)(1993-3#1)(1993-6#1)(1995-1#1)(1995-3#2)(1996-2#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
opportunities##265##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#3)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#3)(1995-1#6)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#1)(1996-1#2)(1996-12#10)(1996-2#3)(1996-3#10)(1996-5#1)(1996-7#1)(1997-1#7)(1997-2#2)(1997-3#4)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#18)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#6)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#10)(2012-3#3)(2013-1#14)(2013-8#4)
opportunity and##2##2##(2008-11#1)(2008-5#1)
opportunity exists##2##2##(2007-2#1)(2012-2#1)
opportunity for career development##2##4##(1994-3#2)
opportunity for career##3##3##(1994-1#1)(1994-3#2)
opportunity for participants to##2##4##(2010-11#1)(2012-12#1)
opportunity for sexual selection##4##4##(2008-8#4)
opportunity for the##7##3##(1996-12#1)(1996-3#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
opportunity for vertical transmission##2##4##(2008-9#2)
opportunity for##68##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-4#1)(2010-11#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)
opportunity of##5##2##(1991-2#1)(1995-1#1)(2008-3#1)(2010-1#1)(2012-3#1)
opportunity that##2##2##(2008-11#2)
opportunity to achieve##2##3##(2007-11#1)(2008-12#1)
opportunity to assess the##2##4##(1993-12#1)(2012-3#1)
opportunity to assess##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
opportunity to compare##2##3##(1994-3#1)(1997-8#1)
opportunity to develop##2##3##(2008-11#1)(2010-11#1)
opportunity to enhance the##2##4##(1995-12#1)(2008-3#1)
opportunity to examine##2##3##(2009-10#1)(2011-1#1)
opportunity to explore##3##3##(1993-11#1)(2008-12#1)(2008-4#1)
opportunity to identify##2##3##(1991-6#1)(2012-3#1)
opportunity to improve##4##3##(2008-10#1)(2009-11#1)(2011-2#1)(2013-1#1)
opportunity to observe##2##3##(1991-8#1)(2009-4#1)
opportunity to respond to##4##4##(1991-3#1)(2008-10#3)
opportunity to review##3##3##(2007-2#1)(2008-4#1)(2010-3#1)
opportunity to study the effects of##2##6##(2008-2#2)
opportunity to study the##3##4##(2008-11#1)(2008-2#2)
opportunity to study##6##3##(1993-11#1)(2008-11#1)(2008-2#3)(2009-8#1)
opportunity to test##4##3##(1994-8#1)(2008-1#1)(2008-12#1)(2010-3#1)
opportunity to use##3##3##(1994-6#1)(2008-7#1)(2009-9#1)
opportunity to##131##2##(1991-3#1)(1991-6#3)(1991-8#2)(1992-11#2)(1992-4#1)(1993-1#1)(1993-11#2)(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#10)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#3)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#5)
opportunity##252##1##(1991-2#3)(1991-3#1)(1991-6#3)(1991-8#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#3)(1994-1#5)(1994-12#3)(1994-2#2)(1994-3#5)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#4)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#2)(1997-8#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#6)(2008-10#19)(2008-11#18)(2008-12#8)(2008-2#5)(2008-3#8)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#4)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#6)
oppose the##2##2##(2008-8#1)(2011-2#1)
oppose##6##1##(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
opposed lateral##3##2##(1990-12#1)(1993-9#2)
opposed to a##6##3##(1992-8#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-2#1)
opposed to that##2##3##(2008-11#1)(2008-12#1)
opposed to the##13##3##(1990-2#1)(1990-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-11#1)
opposed to##58##2##(1990-2#1)(1990-3#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#2)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
opposed##70##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#2)(2009-4#1)(2010-11#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-8#1)
opposed-phase images##2##2##(1997-8#2)
opposed-phase imaging##3##2##(1997-8#3)
opposed-phase pulse sequence##3##3##(1997-8#3)
opposed-phase##12##1##(1997-8#12)
opposes the##2##2##(1993-6#1)(2008-9#1)
opposes##4##1##(1993-6#1)(2008-3#1)(2008-9#1)(2013-1#1)
opposing effects of##2##3##(2008-4#1)(2008-8#1)
opposing effects on##2##3##(1994-8#1)(2008-8#1)
opposing effects##4##2##(1994-8#1)(2008-4#1)(2008-8#2)
opposing the##2##2##(2009-10#1)(2012-2#1)
opposing##30##1##(1990-5#1)(1994-3#1)(1994-8#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
opposite DNA##2##2##(1993-11#1)(2009-10#1)
opposite associations##2##2##(2008-8#1)(2010-1#1)
opposite changes##2##2##(2007-12#1)(2008-8#1)
opposite direction##9##2##(1991-5#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-7#2)(2012-2#1)
opposite directions##9##2##(1994-11#1)(1997-3#2)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
opposite effect was##2##3##(1993-12#1)(2008-11#1)
opposite effect##7##2##(1990-12#1)(1993-12#1)(1996-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
opposite effects of##2##3##(1993-3#1)(2012-12#1)
opposite effects on the##2##4##(1994-5#1)(1994-9#1)
opposite effects on##5##3##(1991-2#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-2#1)
opposite effects##8##2##(1991-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-2#1)(2012-12#1)
opposite from the##2##3##(1994-12#2)
opposite of##4##2##(1990-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
opposite pattern was observed##2##4##(1994-6#1)(2010-8#1)
opposite result was obtained##2##4##(2008-3#1)(2008-6#1)
opposite sex##4##2##(1990-8#1)(2008-7#1)(2008-9#2)
opposite sides of the##2##4##(2008-11#1)(2012-4#1)
opposite sides##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-4#1)
opposite signs##3##2##(2007-11#1)(2008-3#1)(2009-11#1)
opposite that##4##2##(1993-11#1)(2007-11#1)(2008-3#2)
opposite the##7##2##(1995-5#1)(2008-10#4)(2008-2#1)(2010-3#1)
opposite to each other##2##4##(1990-12#1)(2008-2#1)
opposite to that of##2##4##(2007-11#1)(2013-7#1)
opposite to that##4##3##(1990-11#1)(1992-5#1)(2007-11#1)(2013-7#1)
opposite to the##4##3##(1994-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
opposite to##11##2##(1990-11#1)(1990-12#1)(1992-5#1)(1992-9#1)(1994-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
opposite trend##3##2##(2008-5#1)(2009-10#1)(2009-2#1)
opposite was found##2##3##(1993-12#1)(1994-3#1)
opposite was observed##2##3##(2008-7#1)(2011-1#1)
opposite was##5##2##(1993-12#1)(1994-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
opposite##167##1##(1990-11#2)(1990-12#2)(1990-6#1)(1990-8#3)(1991-1#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#4)(1997-7#1)(2007-11#9)(2007-12#4)(2007-6#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
oppositely charged##6##2##(1995-5#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-7#1)
oppositely##7##1##(1995-5#1)(1997-6#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-7#1)
opposites##2##1##(2008-12#1)(2009-10#1)
opposition from##3##2##(2008-12#1)(2009-10#1)(2012-1#1)
opposition to##4##2##(1991-3#1)(1995-6#1)(2010-12#1)(2012-2#1)
opposition##15##1##(1991-3#1)(1995-1#1)(1995-6#1)(1996-5#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-2#2)(2013-8#1)
oppositional defiant disorder##2##3##(2006-10#1)(2008-2#1)
oppositional##3##1##(2006-10#1)(2008-2#1)(2012-12#1)
oppressed##2##1##(2008-11#1)(2008-7#1)
oppression##2##1##(1990-6#1)(1991-6#1)
opsin##3##1##(1991-9#1)(1996-2#1)(1996-5#1)
opsonic##2##1##(1993-3#1)(1995-5#1)
opsonin##2##1##(1993-3#1)(2008-4#1)
opsonin-independent##2##1##(2008-6#2)
opsonised##2##1##(1991-12#1)(1996-12#1)
opsonized or not with##2##4##(2008-10#2)
opsonized zymosan##4##2##(1991-2#1)(1991-9#1)(1992-8#1)(1994-11#1)
opsonized##9##1##(1990-12#1)(1991-2#2)(1991-9#1)(1992-8#1)(1994-11#1)(2008-10#3)
opt for##4##2##(2008-10#1)(2009-7#1)(2013-1#2)
opt##5##1##(2008-10#1)(2009-7#1)(2012-2#1)(2013-1#2)
opted to##2##2##(2009-3#1)(2013-8#1)
opted##3##1##(2008-7#1)(2009-3#1)(2013-8#1)
optic atrophy##2##2##(2012-2#2)
optic axis##5##2##(2008-2#2)(2008-3#3)
optic chiasm##2##2##(2008-7#1)(2012-12#1)
optic disc##4##2##(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
optic flow##4##2##(2008-11#1)(2008-9#3)
optic lobe##5##2##(2007-12#3)(2008-5#2)
optic nerve compression##2##3##(2008-7#1)(2011-1#1)
optic nerve head##2##3##(2007-11#1)(2011-1#1)
optic nerve hypoplasia##2##3##(1997-3#1)(2011-1#1)
optic nerve##27##2##(1990-7#1)(1993-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#4)(2011-7#1)(2012-3#2)
optic neuritis##10##2##(1992-3#1)(1995-12#2)(2007-7#1)(2008-1#1)(2011-1#3)(2011-7#1)(2012-3#1)
optic neuropathy in Graves' eye disease##3##6##(2008-7#3)
optic neuropathy in##5##3##(2008-7#4)(2011-1#1)
optic neuropathy##13##2##(1991-12#3)(1992-9#3)(2008-7#5)(2011-1#1)(2013-1#1)
optic probe##3##2##(2008-10#3)
optic sensors##5##2##(2008-10#5)
optic tectum##6##2##(1990-5#1)(1993-12#2)(1997-3#1)(2008-6#2)
optic to##2##2##(2008-11#1)(2008-3#1)
optic tract and##3##3##(2007-10#1)(2007-12#1)(2008-7#1)
optic tract##7##2##(1996-5#3)(2007-10#1)(2007-12#1)(2008-7#2)
optic##158##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#3)(1993-12#3)(1995-12#2)(1995-3#1)(1996-5#3)(1997-3#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#34)(2008-11#6)(2008-2#9)(2008-3#19)(2008-5#8)(2008-6#2)(2008-7#12)(2008-9#3)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#6)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
optica (NMO)##2##2##(2010-12#1)(2013-8#1)
optica##10##1##(2010-12#1)(2011-1#2)(2012-3#2)(2013-8#5)
optical CO(2) sensor based on##2##5##(2008-10#2)
optical Clos##2##2##(2008-2#2)
optical Doppler tomography##2##3##(2007-11#2)
optical Doppler##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
optical Fourier processor##2##3##(2008-3#2)
optical Fourier transformation##2##3##(2007-11#1)(2008-2#1)
optical Fourier##6##2##(2007-11#2)(2008-2#1)(2008-3#2)(2011-1#1)
optical I/O##4##2##(2008-3#4)
optical Kerr effect##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
optical Kerr##6##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
optical aberrations##2##2##(2008-3#2)
optical absorption and##2##3##(2008-3#1)(2010-4#1)
optical absorption coefficient##4##3##(2008-3#4)
optical absorption in##2##3##(2008-10#1)(2011-7#1)
optical absorption of the##2##4##(2008-10#1)(2008-3#1)
optical absorption of##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
optical absorption spectroscopy##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
optical absorption##25##2##(1990-8#1)(1995-2#2)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#12)(2010-4#1)(2011-7#1)(2013-1#1)
optical activity##3##2##(1991-2#1)(2008-3#2)
optical addressing##2##2##(2007-12#2)
optical alignment##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)
optical amplifier##9##2##(2007-11#2)(2007-12#6)(2008-3#1)
optical amplifiers and##4##3##(2007-12#2)(2008-3#2)
optical amplifiers##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
optical analog-to-digital##2##2##(2008-2#1)(2008-3#1)
optical analysis##2##2##(2008-2#1)(2008-3#1)
optical and electrical##3##3##(2008-2#2)(2013-8#1)
optical and electronic microscopy##2##4##(2008-10#1)(2009-7#1)
optical and electronic##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)
optical and magnetic##2##3##(2010-6#2)
optical and mechanical properties##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
optical and mechanical##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
optical and scanning electron##2##4##(2008-10#1)(2010-4#1)
optical and thermal properties##2##4##(2008-3#2)
optical and##37##2##(1994-12#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#7)(2008-3#8)(2008-5#1)(2008-7#1)(2009-7#2)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
optical anisotropy##6##2##(2007-11#2)(2008-3#4)
optical applications##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
optical architecture##2##2##(2007-12#1)(2008-2#1)
optical architectures##2##2##(2008-3#2)
optical arrangement##9##2##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#4)
optical array##4##2##(2008-2#2)(2008-3#2)
optical attenuation##4##2##(2008-2#2)(2008-3#2)
optical axes##2##2##(2008-2#1)(2008-6#1)
optical axis##28##2##(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#18)
optical background##2##2##(2008-3#1)(2008-9#1)
optical backplane demonstrator##2##3##(2008-2#2)
optical backplane##3##2##(2008-2#3)
optical band gap is##2##4##(2013-1#2)
optical bandpass filter##2##3##(2007-11#1)(2008-3#1)
optical bandwidth##3##2##(2008-3#3)
optical beam in##2##3##(2008-3#2)
optical beam##17##2##(2007-11#5)(2007-12#2)(2008-2#2)(2008-3#8)
optical beams by##3##3##(2007-12#3)
optical beams from##2##3##(2008-2#2)
optical beams in##2##3##(2007-12#1)(2008-3#1)
optical beams##12##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#2)
optical beat##2##2##(2008-2#1)(2008-3#1)
optical behavior of##2##3##(2008-10#1)(2008-3#1)
optical behavior##3##2##(2008-10#1)(2008-3#2)
optical binary##2##2##(2008-2#2)
optical biopsy##4##2##(2007-12#1)(2008-3#1)(2012-2#2)
optical biosensor##14##2##(1995-12#1)(1997-2#3)(2008-10#10)
optical bottle beam##2##3##(2007-12#2)
optical breakdown##7##2##(2008-2#4)(2008-3#3)
optical carrier##4##2##(2007-11#1)(2007-12#3)
optical cavities##11##2##(2007-11#2)(2007-12#2)(2008-3#7)
optical cavity and##3##3##(2008-2#1)(2008-3#2)
optical cavity used##2##3##(2007-12#1)(2008-2#1)
optical cavity##15##2##(2007-11#4)(2007-12#1)(2008-2#4)(2008-3#5)(2008-7#1)
optical cell##3##2##(2008-2#1)(2008-3#2)
optical channel waveguides##2##3##(2008-2#2)
optical channel##3##2##(2008-2#2)(2008-3#1)
optical channels##3##2##(2008-2#1)(2008-3#2)
optical characteristics of the##2##4##(2008-3#2)
optical characteristics of##7##3##(2008-2#3)(2008-3#4)
optical characteristics##11##2##(2007-12#1)(2008-2#3)(2008-3#7)
optical characterization of scattering media by##2##6##(2008-3#2)
optical characterization of##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
optical characterization##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)
optical chemical sensor based on##2##5##(2008-10#2)
optical chemical sensor##6##3##(2008-10#6)
optical chemical##7##2##(2008-10#6)(2008-3#1)
optical chromatography##2##2##(2008-10#2)
optical circuit##2##2##(2008-3#2)
optical clock##2##2##(2008-3#2)
optical coatings on##2##3##(2008-3#2)
optical coatings with##2##3##(2008-3#2)
optical coatings##10##2##(2008-2#4)(2008-3#6)
optical code division multiple-access##2##4##(2008-3#2)
optical coefficient##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
optical coefficients of the##3##4##(2008-2#3)
optical coefficients of##4##3##(2008-2#3)(2008-3#1)
optical coefficients##8##2##(2008-2#6)(2008-3#2)
optical coherence microscopy##2##3##(2007-11#1)(2007-12#1)
optical coherence tomograph##2##3##(2008-3#2)
optical coherence tomography (OCT) imaging##2##5##(2007-12#2)
optical coherence tomography (OCT) in##2##5##(2007-11#1)(2011-7#1)
optical coherence tomography (OCT) system##6##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
optical coherence tomography (OCT)##20##4##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#3)(2008-5#2)(2010-12#1)(2011-7#4)(2013-1#2)
optical coherence tomography (SD-OCT) has##2##5##(2011-7#2)
optical coherence tomography and##3##4##(2007-11#2)(2009-5#1)
optical coherence tomography by optimal synthesis of##2##7##(2007-11#2)
optical coherence tomography for imaging##2##5##(2007-12#1)(2011-7#1)
optical coherence tomography for##6##4##(2007-11#1)(2007-12#2)(2009-3#1)(2011-7#1)(2012-2#1)
optical coherence tomography in##2##4##(2008-3#1)(2011-7#1)
optical coherence tomography system##5##4##(2007-11#3)(2008-3#2)
optical coherence tomography##102##3##(2007-11#35)(2007-12#22)(2008-10#1)(2008-2#2)(2008-3#13)(2008-5#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-7#13)(2012-12#2)(2012-2#1)(2013-1#3)
optical coherence##111##2##(2007-11#36)(2007-12#25)(2008-10#1)(2008-2#2)(2008-3#18)(2008-5#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-7#13)(2012-12#2)(2012-2#1)(2013-1#3)
optical coherent transient##4##3##(2007-12#4)
optical coherent##5##2##(2007-12#4)(2008-6#1)
optical communication between##3##3##(2008-2#2)(2008-3#1)
optical communication by##2##3##(2007-12#1)(2008-2#1)
optical communication links##2##3##(2008-2#2)
optical communication##15##2##(2007-11#2)(2007-12#3)(2008-2#8)(2008-3#2)
optical communications and##3##3##(2007-12#1)(2008-3#2)
optical communications##10##2##(2007-11#2)(2007-12#2)(2008-3#6)
optical component##4##2##(2008-2#1)(2008-3#3)
optical components and##2##3##(2007-11#1)(2008-3#1)
optical components for##2##3##(2008-2#1)(2008-3#1)
optical components such as##2##4##(2008-2#1)(2008-3#1)
optical components with##3##3##(2007-12#1)(2008-3#2)
optical components##24##2##(2007-11#4)(2007-12#1)(2008-2#10)(2008-3#8)(2008-9#1)
optical computing##11##2##(2007-12#1)(2008-2#3)(2008-3#7)
optical configuration is##2##3##(2007-11#1)(2008-2#1)
optical configuration of##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
optical configuration##17##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#10)
optical configurations##2##2##(2008-2#1)(2008-3#1)
optical confinement##2##2##(2007-11#1)(2008-3#1)
optical constant##3##2##(2008-3#3)
optical constants and##6##3##(2008-2#2)(2008-3#4)
optical constants are##4##3##(2008-2#1)(2008-3#3)
optical constants in the##2##4##(2008-3#2)
optical constants of a##2##4##(2008-2#1)(2008-3#1)
optical constants of thin films##2##5##(2008-3#2)
optical constants of thin##5##4##(2008-2#2)(2008-3#3)
optical constants of water ice##2##5##(2008-3#2)
optical constants of##18##3##(2007-11#1)(2008-2#5)(2008-3#12)
optical constants##50##2##(2007-11#2)(2008-10#1)(2008-2#13)(2008-3#34)
optical content-addressable parallel processor##2##4##(2008-3#2)
optical contrast##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
optical control##4##2##(2008-2#1)(2008-3#3)
optical controller##3##2##(2008-2#1)(2008-3#2)
optical conversion##2##2##(2007-12#1)(2008-2#1)
optical correlation with##3##3##(2008-3#3)
optical correlation##18##2##(1994-11#1)(2007-12#4)(2008-2#6)(2008-3#7)
optical correlation-based##2##2##(2007-11#1)(2008-3#1)
optical correlator with##3##3##(2008-3#3)
optical correlator##11##2##(2007-12#1)(2008-2#2)(2008-3#8)
optical correlators##8##2##(2008-2#2)(2008-3#6)
optical coupling scheme##2##3##(2008-2#1)(2008-3#1)
optical coupling##9##2##(2007-11#2)(2008-2#5)(2008-3#2)
optical cross sections##3##3##(2008-2#1)(2008-3#2)
optical cross talk between##2##4##(2008-3#2)
optical cross talk##4##3##(2008-3#4)
optical cross##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
optical cross-connect##3##2##(2007-12#2)(2008-3#1)
optical crystals##4##2##(2008-10#1)(2008-2#3)
optical cycles##2##2##(2007-12#2)
optical damage##3##2##(2008-2#1)(2008-3#2)
optical data communications##2##3##(2008-3#2)
optical data links##4##3##(2008-3#4)
optical data storage in##2##4##(2007-12#1)(2008-3#1)
optical data storage systems##3##4##(2008-2#2)(2008-3#1)
optical data storage##21##3##(2007-12#2)(2008-2#6)(2008-3#13)
optical data##41##2##(2007-11#1)(2007-12#4)(2008-2#8)(2008-3#28)
optical data-storage media##4##3##(2008-3#4)
optical data-storage##7##2##(2008-2#2)(2008-3#5)
optical decryption of##2##3##(2008-3#2)
optical degradation##4##2##(2008-2#1)(2008-3#3)
optical delay line is##2##4##(2007-11#1)(2008-3#1)
optical delay line##6##3##(2007-11#3)(2008-3#3)
optical delay##10##2##(2007-11#4)(2008-2#2)(2008-3#4)
optical densities##5##2##(1994-11#1)(1994-5#1)(1996-12#1)(2007-11#1)(2008-3#1)
optical density of##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
optical density readings##3##3##(1994-11#2)(2010-3#1)
optical density##19##2##(1994-11#2)(1997-4#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#2)
optical depth for##2##3##(2008-2#1)(2008-3#1)
optical depth of the##2##4##(2008-2#1)(2008-3#1)
optical depth of##3##3##(2008-2#2)(2008-3#1)
optical depth##21##2##(2008-2#11)(2008-3#10)
optical depths##5##2##(2008-2#3)(2008-3#2)
optical derotator##2##2##(2008-3#2)
optical design and##5##3##(2008-2#1)(2008-3#4)
optical design for##2##3##(2008-3#2)
optical design of##2##3##(2008-3#2)
optical design##15##2##(2008-2#3)(2008-3#11)(2013-8#1)
optical designs##2##2##(2008-3#1)(2008-4#1)
optical detection of##5##3##(1993-11#2)(1997-7#1)(2008-2#1)(2008-3#1)
optical detection##11##2##(1993-11#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#5)(2011-1#1)
optical detector##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
optical device##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
optical devices such as##2##4##(2008-1#1)(2008-2#1)
optical devices##15##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#3)(2008-9#1)(2012-2#1)
optical diagnostics of##2##3##(2008-3#2)
optical diagnostics##3##2##(2008-2#1)(2008-3#2)
optical diffraction##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
optical diode##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
optical disc##2##2##(2008-2#1)(2008-3#1)
optical disk data storage##3##4##(2008-2#2)(2008-3#1)
optical disk is##2##3##(2008-2#1)(2008-3#1)
optical disk readout##5##3##(2008-2#2)(2008-3#3)
optical disk system##2##3##(2008-2#1)(2008-3#1)
optical disk systems##3##3##(2008-2#1)(2008-3#2)
optical disk with a##2##4##(2007-11#1)(2008-3#1)
optical disk with##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
optical disk##37##2##(2007-11#2)(2008-2#17)(2008-3#18)
optical disks##12##2##(2008-2#6)(2008-3#6)
optical displacement sensor##3##3##(2008-2#2)(2008-3#1)
optical distortion##2##2##(2007-11#2)
optical effect in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
optical effect##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
optical effects in##2##3##(1990-8#1)(2008-3#1)
optical effects##5##2##(1990-8#1)(2008-2#1)(2008-3#3)
optical efficiency of the##2##4##(2008-3#2)
optical efficiency of##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
optical efficiency##13##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#6)
optical electric##2##2##(2007-12#2)
optical element and##2##3##(2008-3#2)
optical element that##5##3##(2007-11#2)(2008-3#3)
optical element to##2##3##(2007-12#1)(2008-3#1)
optical element with##2##3##(2008-3#2)
optical element##43##2##(2007-11#3)(2007-12#5)(2008-2#6)(2008-3#29)
optical elements and##4##3##(2008-3#4)
optical elements are##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
optical elements can be##2##4##(2008-2#1)(2008-3#1)
optical elements in##3##3##(2008-2#1)(2008-3#2)
optical elements is##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
optical elements such##2##3##(2008-2#1)(2008-3#1)
optical elements that##2##3##(2007-12#1)(2008-2#1)
optical elements with the##2##4##(2008-3#2)
optical elements with##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
optical elements##91##2##(2007-11#7)(2007-12#4)(2008-2#28)(2008-3#51)(2012-2#1)
optical emission spectrometry (ICP-OES)##12##4##(2008-10#12)
optical emission spectrometry##28##3##(2008-10#28)
optical emission spectroscopy##6##3##(2008-10#2)(2008-2#1)(2010-11#1)(2011-2#2)
optical emission##38##2##(2007-12#1)(2008-10#31)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#2)(2013-8#1)
optical encoder is##2##3##(2008-3#2)
optical encoder##3##2##(2008-3#3)
optical encryption system##2##3##(2008-2#1)(2008-3#1)
optical encryption##3##2##(2008-2#1)(2008-3#2)
optical equipment##2##2##(2007-11#1)(2008-2#1)
optical erasure##2##2##(2008-2#1)(2008-3#1)
optical excitation##4##2##(2007-11#2)(2007-12#2)
optical excitations in##2##3##(2008-7#2)
optical experimental##2##2##(2008-2#1)(2008-3#1)
optical experiments##3##2##(2008-2#1)(2008-3#2)
optical extinction##2##2##(2008-2#1)(2008-3#1)
optical feedback and##2##3##(2007-12#1)(2008-3#1)
optical feedback is##2##3##(2007-12#1)(2008-3#1)
optical feedback##26##2##(2007-11#7)(2007-12#6)(2008-2#1)(2008-3#12)
optical fiber Bragg gratings##2##4##(2007-11#1)(2008-3#1)
optical fiber and the##3##4##(2007-11#1)(2008-3#2)
optical fiber and##9##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#5)
optical fiber assembly##2##3##(2008-10#2)
optical fiber bundle##2##3##(2007-11#1)(2008-7#1)
optical fiber by##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optical fiber coupler##3##3##(2007-11#1)(2007-12#2)
optical fiber current sensor##2##4##(2008-3#2)
optical fiber for##2##3##(2007-11#1)(2008-2#1)
optical fiber gas sensors##2##4##(2008-3#2)
optical fiber grating##2##3##(2008-3#2)
optical fiber has been##4##4##(2007-11#3)(2008-3#1)
optical fiber in##2##3##(2008-3#2)
optical fiber is##8##3##(2007-11#3)(2007-12#3)(2008-3#2)
optical fiber laser##2##3##(2007-12#2)
optical fiber modulator##2##3##(2008-2#2)
optical fiber refractometer based on a path-matching differential interferometer##2##9##(2008-3#2)
optical fiber refractometer based on a##3##6##(2008-3#3)
optical fiber refractometer##4##3##(2008-3#4)
optical fiber sensor for##4##4##(2008-10#4)
optical fiber sensor##8##3##(2007-11#2)(2007-12#1)(2008-10#5)
optical fiber systems##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
optical fiber that##3##3##(2007-12#1)(2008-3#2)
optical fiber tip##2##3##(2008-2#1)(2008-3#1)
optical fiber was##2##3##(2008-10#1)(2008-3#1)
optical fiber with##6##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)
optical fiber##176##2##(2007-11#45)(2007-12#37)(2008-10#21)(2008-2#19)(2008-3#49)(2008-7#1)(2009-12#1)(2010-4#2)(2013-8#1)
optical fibers and##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
optical fibers are##2##3##(2008-2#1)(2008-3#1)
optical fibers by use of a##2##6##(2007-11#1)(2008-3#1)
optical fibers by##7##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
optical fibers for##2##3##(1991-1#1)(2008-3#1)
optical fibers immersed in##2##4##(2007-11#1)(2008-3#1)
optical fibers is##3##3##(2007-11#2)(2008-3#1)
optical fibers of##2##3##(2007-11#1)(2008-3#1)
optical fibers that##2##3##(2007-12#1)(2008-3#1)
optical fibers to##5##3##(2007-11#3)(2008-3#2)
optical fibers were##3##3##(2007-11#2)(2008-9#1)
optical fibers with zero##2##4##(2007-12#2)
optical fibers with##6##3##(2007-11#2)(2007-12#3)(2008-3#1)
optical fibers##104##2##(1991-1#1)(2007-11#37)(2007-12#18)(2008-10#2)(2008-2#11)(2008-3#34)(2008-9#1)
optical field in##2##3##(2007-11#1)(2008-3#1)
optical field is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optical field##19##2##(2007-11#5)(2007-12#4)(2008-2#3)(2008-3#5)(2008-7#1)(2009-5#1)
optical fields##11##2##(1993-5#1)(2007-11#5)(2007-12#2)(2008-3#3)
optical filter##14##2##(2007-11#6)(2008-2#2)(2008-3#5)(2008-9#1)
optical filtering##2##2##(2008-3#1)(2008-9#1)
optical filters##14##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#6)(2008-6#1)(2008-9#2)
optical flow cell##2##3##(2008-10#2)
optical flow technique##2##3##(2010-8#2)
optical flow##5##2##(2008-10#2)(2008-6#1)(2010-8#2)
optical fluctuations##2##2##(2008-3#2)
optical fluorescence##2##2##(2008-3#1)(2010-12#1)
optical forces##2##2##(2007-12#1)(2009-5#1)
optical frequencies##4##2##(2007-12#3)(2008-3#1)
optical frequency comb##6##3##(2007-11#1)(2007-12#3)(2008-3#2)
optical frequency standard##2##3##(2007-12#1)(2008-2#1)
optical frequency standards##3##3##(2007-11#1)(2007-12#2)
optical frequency was##2##3##(2007-12#1)(2008-2#1)
optical frequency##26##2##(2007-11#5)(2007-12#12)(2008-2#4)(2008-3#4)(2011-1#1)
optical frequency-domain##3##2##(2008-3#3)
optical front end##2##3##(2008-3#2)
optical gain##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-6#1)
optical gating (FROG)##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
optical gating##29##2##(2007-11#8)(2007-12#17)(2008-2#1)(2008-3#3)
optical generation and detection of##2##5##(2007-11#2)
optical generation and##3##3##(2007-11#2)(2008-3#1)
optical geometry of the##2##4##(2008-10#1)(2008-3#1)
optical geometry##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
optical glass waveguide gratings##2##4##(2008-3#2)
optical glass##8##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
optical glasses##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
optical guiding##2##2##(2007-11#1)(2008-2#1)
optical head##6##2##(2008-3#6)
optical heterodyne detection##2##3##(2008-2#1)(2008-3#1)
optical heterodyne polarimeter##2##3##(2008-2#2)
optical heterodyne signal##2##3##(2007-12#1)(2008-2#1)
optical heterodyne##8##2##(2007-12#1)(2008-2#5)(2008-3#2)
optical homogeneity##2##2##(2008-2#1)(2013-1#1)
optical image processing##2##3##(2008-2#1)(2008-3#1)
optical image##8##2##(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-8#1)(2011-1#1)
optical images##10##2##(2007-12#2)(2008-2#1)(2009-5#2)(2010-8#5)
optical imaging of##2##3##(2008-2#1)(2009-5#1)
optical imaging reveals##2##3##(2008-11#2)
optical imaging system##2##3##(2008-3#2)
optical imaging systems##2##3##(2008-3#1)(2011-1#1)
optical imaging through##2##3##(2008-3#2)
optical imaging##24##2##(2007-11#1)(2007-12#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2009-5#1)(2010-5#1)(2011-1#3)(2012-12#1)
optical immunosensor##2##2##(2008-10#2)
optical implementation of the##4##4##(2008-2#1)(2008-3#3)
optical implementation of##11##3##(2007-12#2)(2008-2#2)(2008-3#7)
optical implementation##22##2##(2007-12#3)(2008-2#8)(2008-3#11)
optical implementations##2##2##(2008-2#1)(2008-3#1)
optical information processing##2##3##(2008-3#2)
optical information##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
optical injection##3##2##(2007-11#2)(2011-1#1)
optical input and output##2##4##(2008-2#1)(2008-3#1)
optical input-output##3##2##(2008-2#1)(2008-3#2)
optical integrated circuits##3##3##(2007-11#1)(2007-12#1)(2012-2#1)
optical intensity##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
optical interactions##2##2##(2007-12#2)
optical interconnect for##2##3##(2008-2#2)
optical interconnect networks for massively parallel processing##2##7##(2008-2#2)
optical interconnect system##5##3##(2008-2#3)(2008-3#2)
optical interconnect systems is##2##4##(2008-2#1)(2008-3#1)
optical interconnect systems##3##3##(2008-2#1)(2008-3#2)
optical interconnect##23##2##(2008-2#13)(2008-3#10)
optical interconnection module##2##3##(2008-3#2)
optical interconnection modules##2##3##(2008-2#2)
optical interconnection network##2##3##(2008-2#1)(2008-3#1)
optical interconnection system##3##3##(2008-2#1)(2008-3#2)
optical interconnection##19##2##(2008-2#8)(2008-3#11)
optical interconnections##13##2##(2007-11#1)(2008-2#7)(2008-3#5)
optical interconnects based on##2##4##(2008-2#1)(2008-3#1)
optical interconnects##23##2##(2008-2#8)(2008-3#15)
optical interference##5##2##(2008-3#3)(2013-8#2)
optical interferometer##8##2##(2006-4#1)(2007-11#1)(2008-2#2)(2008-3#3)(2011-1#1)
optical interferometers##2##2##(2007-11#2)
optical irradiation##2##2##(1992-4#1)(2007-12#1)
optical isolation of the sampling volume##2##6##(2008-3#2)
optical isolation##3##2##(2008-3#3)
optical isomers##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
optical kicked##2##2##(2007-11#2)
optical laser##3##2##(2008-2#3)
optical layouts##2##2##(2008-3#2)
optical length##2##2##(2007-11#1)(2007-12#1)
optical light##2##2##(2008-2#1)(2011-1#1)
optical limiter##5##2##(2007-12#4)(2008-3#1)
optical limiting behavior##4##3##(2007-11#3)(2008-3#1)
optical limiting performance of a##2##5##(2007-11#2)
optical limiting##18##2##(2007-11#8)(2007-12#3)(2008-2#2)(2008-3#5)
optical line##4##2##(2008-2#1)(2008-3#3)
optical link##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
optical lithographic##2##2##(2008-2#1)(2008-3#1)
optical lithography##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
optical lock-in##2##2##(2008-2#2)
optical loop configuration##2##3##(2007-12#2)
optical loop##16##2##(2007-11#6)(2007-12#8)(2008-3#2)
optical loss did not significantly change##2##6##(2008-2#2)
optical loss of##2##3##(2008-2#2)
optical loss##15##2##(2007-11#3)(2008-2#10)(2008-3#2)
optical low-coherence reflectometry##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
optical low-coherence##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
optical magnetic-field##2##2##(2008-3#2)
optical mammograms##2##2##(2008-3#2)
optical mammography##3##2##(2008-2#1)(2008-3#2)
optical material##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
optical materials##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
optical means##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
optical measurement##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
optical measurements are##2##3##(2007-12#1)(2008-3#1)
optical measurements##8##2##(2007-12#2)(2008-2#2)(2008-3#3)(2008-9#1)
optical media##2##2##(2008-3#1)(2009-5#1)
optical memories##2##2##(2008-2#2)
optical memory in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optical memory system using##2##4##(2007-12#2)
optical memory system##3##3##(2007-12#2)(2008-3#1)
optical memory with urethane-urea copolymers##2##5##(2008-3#2)
optical memory##16##2##(2007-12#8)(2008-2#1)(2008-3#7)
optical method for real-time##2##4##(2007-12#2)
optical method for##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
optical method of##3##3##(2007-12#1)(2009-4#1)(2011-1#1)
optical method##13##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)(2009-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
optical methods for##2##3##(2008-2#1)(2008-3#1)
optical methods##8##2##(2007-5#1)(2008-2#2)(2008-3#5)
optical metrology##5##2##(2008-2#1)(2008-3#4)
optical microcavities##2##2##(2007-11#2)
optical microcavity##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
optical micrographs##2##2##(2008-3#2)
optical microlithography##2##2##(2008-3#2)
optical microscope by##2##3##(2007-12#1)(2009-10#1)
optical microscope is##2##3##(2007-12#1)(2008-9#1)
optical microscope##23##2##(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#6)(2008-5#3)(2008-9#1)(2009-10#1)(2013-1#1)
optical microscopes##6##2##(2008-10#1)(2008-3#3)(2009-5#1)(2013-1#1)
optical microscopy (OM)##2##3##(2008-10#1)(2009-11#1)
optical microscopy and##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)
optical microscopy has been##2##4##(2007-12#1)(2008-2#1)
optical microscopy##38##2##(2007-11#2)(2007-12#7)(2008-10#5)(2008-2#2)(2008-3#11)(2008-5#2)(2009-11#1)(2009-5#3)(2009-7#2)(2010-5#1)(2011-2#1)(2012-2#1)
optical misalignment##3##2##(2008-3#3)
optical model##4##2##(2008-2#2)(2008-3#2)
optical modes were##2##3##(2007-11#2)
optical modes##6##2##(2007-11#3)(2007-12#1)(2008-3#1)(2009-5#1)
optical modulation of the##2##4##(2007-11#1)(2008-3#1)
optical modulation##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
optical modulator##8##2##(2007-11#1)(2008-2#5)(2008-3#2)
optical modulators##2##2##(2007-11#1)(2008-3#1)
optical modules##2##2##(2008-2#1)(2008-3#1)
optical multilayer##2##2##(2008-3#2)
optical multipass cell##2##3##(2008-3#2)
optical multiplication##2##2##(2007-12#1)(2008-2#1)
optical multistage##2##2##(2008-2#2)
optical near field##3##3##(2007-11#2)(2007-12#1)
optical near##5##2##(2007-11#2)(2007-12#3)
optical near-field##2##2##(2007-12#2)
optical network unit##3##3##(2008-2#3)
optical network units##2##3##(2008-2#2)
optical network##11##2##(2008-2#7)(2008-3#4)
optical neuron##2##2##(2008-3#2)
optical nonlinearities##4##2##(2007-11#1)(2008-10#2)(2011-1#1)
optical nonlinearity in##3##3##(2007-12#2)(2008-3#1)
optical nonlinearity of the##2##4##(2007-11#1)(2007-12#1)
optical nonlinearity of##4##3##(2007-11#1)(2007-12#3)
optical nonlinearity##12##2##(2007-11#3)(2007-12#8)(2008-3#1)
optical one-shot sensor##2##3##(2008-10#2)
optical orthogonal signature patterns##2##4##(2008-2#2)
optical oscillator##2##2##(2007-12#2)
optical parallel architecture for##2##4##(2008-2#2)
optical parameter##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
optical parameters for##2##3##(2008-2#1)(2008-3#1)
optical parameters from##2##3##(2008-3#2)
optical parameters of the##3##4##(2008-3#3)
optical parameters of##7##3##(2008-2#1)(2008-3#5)(2013-8#1)
optical parameters that##3##3##(1990-8#1)(2008-3#2)
optical parameters##32##2##(1990-8#3)(1994-3#1)(2007-12#1)(2008-2#4)(2008-3#21)(2013-8#2)
optical parametric amplification and##2##4##(2007-11#2)
optical parametric amplification in##3##4##(2007-11#2)(2007-12#1)
optical parametric amplification##8##3##(2007-11#5)(2007-12#3)
optical parametric amplifier based on##2##5##(2007-11#2)
optical parametric amplifier##12##3##(2007-11#8)(2007-12#1)(2008-2#2)(2008-3#1)
optical parametric chirped pulse amplification##4##5##(2007-11#3)(2008-3#1)
optical parametric generation in##2##4##(2007-12#2)
optical parametric generator based on##2##5##(2007-12#2)
optical parametric generator pumped at##2##5##(2007-12#2)
optical parametric generator##8##3##(2007-12#7)(2008-2#1)
optical parametric oscillation in##3##4##(2007-12#1)(2008-3#2)
optical parametric oscillation with periodically poled LiNbO3##2##7##(2008-3#2)
optical parametric oscillation with periodically poled##3##6##(2007-12#1)(2008-3#2)
optical parametric oscillation##10##3##(2007-11#2)(2007-12#3)(2008-3#5)
optical parametric oscillator (OPO) based on a##2##7##(2007-11#1)(2007-12#1)
optical parametric oscillator (OPO) based on periodically poled##2##8##(2008-3#2)
optical parametric oscillator (OPO) based on##5##6##(2007-11#1)(2007-12#2)(2008-3#2)
optical parametric oscillator (OPO) pumped by a##4##7##(2007-12#2)(2008-2#1)(2008-3#1)
optical parametric oscillator (OPO) pumped##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
optical parametric oscillator (OPO) that is##2##6##(2007-11#1)(2007-12#1)
optical parametric oscillator (OPO) with##3##5##(2007-11#2)(2007-12#1)
optical parametric oscillator (OPO)##29##4##(2007-11#6)(2007-12#10)(2008-10#1)(2008-2#4)(2008-3#7)(2008-5#1)
optical parametric oscillator (SRO)##2##4##(2007-12#2)
optical parametric oscillator as##2##4##(2007-11#1)(2008-3#1)
optical parametric oscillator based on periodically poled lithium niobate##6##9##(2007-11#4)(2007-12#2)
optical parametric oscillator based on periodically poled##7##7##(2007-11#4)(2007-12#3)
optical parametric oscillator based on##9##5##(2007-11#4)(2007-12#5)
optical parametric oscillator for##2##4##(2007-11#2)
optical parametric oscillator pumped by a Ti##2##7##(2007-12#1)(2008-3#1)
optical parametric oscillator pumped by a##5##6##(2007-12#3)(2008-3#2)
optical parametric oscillator that##5##4##(2007-11#3)(2007-12#2)
optical parametric oscillator through##2##4##(2007-11#1)(2008-3#1)
optical parametric oscillator with##2##4##(2007-12#1)(2008-3#1)
optical parametric oscillator##100##3##(2007-11#31)(2007-12#42)(2008-10#1)(2008-2#4)(2008-3#21)(2008-5#1)
optical parametric oscillators (OPO's) based on##2##6##(2007-12#1)(2008-3#1)
optical parametric oscillators (OPO's)##3##4##(2007-12#2)(2008-3#1)
optical parametric oscillators and generators##2##5##(2007-12#2)
optical parametric oscillators##19##3##(2007-11#6)(2007-12#10)(2008-2#1)(2008-3#2)
optical parametric##172##2##(2007-11#60)(2007-12#71)(2008-10#1)(2008-2#9)(2008-3#30)(2008-5#1)
optical part of the##2##4##(2008-2#1)(2011-2#1)
optical particle##2##2##(2008-3#2)
optical path adhesive##2##3##(2008-3#2)
optical path difference (OPD)##2##4##(2008-3#2)
optical path difference deviation##2##4##(2013-8#2)
optical path difference is##2##4##(2007-12#1)(2008-2#1)
optical path difference##17##3##(2007-12#1)(2008-2#3)(2008-3#7)(2013-8#6)
optical path differences##3##3##(2007-11#2)(2008-3#1)
optical path length##13##3##(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#5)(2010-2#1)
optical path lengths##6##3##(2008-2#1)(2008-3#5)
optical path##61##2##(2007-11#3)(2007-12#3)(2008-10#7)(2008-2#12)(2008-3#27)(2010-2#1)(2013-8#8)
optical path-length spectroscopy##2##3##(2008-3#2)
optical path-length##4##2##(2008-3#4)
optical pathlength##4##2##(2008-10#3)(2011-1#1)
optical paths##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
optical pattern recognition##7##3##(2008-3#7)
optical pattern##8##2##(2007-12#1)(2008-3#7)
optical performance and##2##3##(2008-3#2)
optical performance of##3##3##(2008-2#1)(2008-3#2)
optical performance##18##2##(2008-2#5)(2008-3#12)(2008-9#1)
optical phase of the##2##4##(2008-2#1)(2008-3#1)
optical phase of##3##3##(2008-2#1)(2008-3#2)
optical phase shifter-modulator##2##3##(2007-11#2)
optical phase##16##2##(2007-11#3)(2008-2#6)(2008-3#7)
optical phase-locked loop##2##3##(2007-11#1)(2007-12#1)
optical phases##2##2##(2007-11#1)(2008-3#1)
optical phenomena##6##2##(2008-2#4)(2008-3#2)
optical phonons in##2##3##(1992-11#1)(2012-2#1)
optical phonons##3##2##(1992-11#1)(2012-2#2)
optical pickup##6##2##(2007-12#1)(2008-3#5)
optical pickups##2##2##(2007-12#1)(2008-3#1)
optical polarization##3##2##(2008-3#3)
optical polarizing films##3##3##(2008-3#3)
optical poling##4##2##(2007-11#3)(2007-12#1)
optical polymer##2##2##(2008-2#1)(2008-3#1)
optical power into##2##3##(2008-2#2)
optical power of##3##3##(2008-3#3)
optical power transfer to whispering-gallery modes##2##6##(2007-12#2)
optical power##24##2##(2007-11#2)(2007-12#4)(2008-2#10)(2008-3#8)
optical powers##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
optical pressure##2##2##(2008-2#2)
optical probe##5##2##(2008-2#3)(2008-3#1)(2011-1#1)
optical probes##6##2##(2007-12#2)(2008-12#2)(2008-2#1)(2009-7#1)
optical process##2##2##(2007-12#1)(2010-7#1)
optical processes##3##2##(2007-12#2)(2008-3#1)
optical processing##7##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)
optical processor is##2##3##(2008-3#2)
optical processor##3##2##(2008-2#1)(2008-3#2)
optical profilometry##2##2##(2008-3#2)
optical programming pulses to a##2##5##(2007-12#2)
optical propagation##3##2##(2007-12#1)(2008-3#2)
optical properties and size##2##4##(2008-2#1)(2008-3#1)
optical properties and the##2##4##(2008-2#1)(2008-3#1)
optical properties and##11##3##(2008-2#3)(2008-3#7)(2010-9#1)
optical properties are##2##3##(2007-12#1)(2008-3#1)
optical properties at##3##3##(2008-3#2)(2011-1#1)
optical properties by##2##3##(2008-2#1)(2008-3#1)
optical properties for the##2##4##(2008-2#1)(2008-3#1)
optical properties for##3##3##(2008-2#2)(2008-3#1)
optical properties from integrating sphere measurements##2##6##(2008-3#2)
optical properties from##7##3##(2008-2#1)(2008-3#5)(2011-1#1)
optical properties have been##2##4##(2008-3#1)(2010-2#1)
optical properties in the##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
optical properties in turbid media##3##5##(2008-3#3)
optical properties in##10##3##(2007-11#2)(2008-2#4)(2008-3#4)
optical properties of a##6##4##(2007-11#1)(2008-2#2)(2008-3#3)
optical properties of clouds and aerosols##2##6##(2008-3#2)
optical properties of seawater##3##4##(2008-2#2)(2008-3#1)
optical properties of the water##2##5##(2008-2#1)(2008-3#1)
optical properties of the##26##4##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#14)(2009-2#1)
optical properties of thermally##2##4##(2007-12#1)(2008-2#1)
optical properties of tissues##2##4##(2008-2#1)(2008-3#1)
optical properties of two-layer##3##4##(2008-3#3)
optical properties of##103##3##(2007-11#13)(2007-12#4)(2008-10#2)(2008-2#28)(2008-3#51)(2008-7#1)(2009-2#1)(2011-1#1)(2013-8#2)
optical properties on##2##3##(2008-2#1)(2008-3#1)
optical properties that##2##3##(2007-12#1)(2008-3#1)
optical properties typical of##2##4##(2008-3#2)
optical properties##211##2##(2007-11#16)(2007-12#8)(2008-10#5)(2008-2#64)(2008-3#104)(2008-7#3)(2009-11#2)(2009-2#1)(2010-2#1)(2010-9#1)(2011-1#4)(2013-8#2)
optical property of##2##3##(2007-11#1)(2008-3#1)
optical property##12##2##(2007-11#2)(2008-2#3)(2008-3#7)
optical pulse in##2##3##(2007-11#1)(2007-12#1)
optical pulse is##3##3##(2007-11#2)(2007-12#1)
optical pulse sequences##2##3##(2007-11#1)(2007-12#1)
optical pulse train##4##3##(2007-11#1)(2007-12#3)
optical pulse trains##2##3##(2007-12#2)
optical pulse##27##2##(2007-11#9)(2007-12#13)(2008-2#1)(2008-3#3)(2012-2#1)
optical pulses and##3##3##(2007-11#2)(2008-3#1)
optical pulses by##3##3##(2007-12#3)
optical pulses in a##2##4##(2007-11#2)
optical pulses in##5##3##(2007-11#4)(2007-12#1)
optical pulses##32##2##(2007-11#13)(2007-12#11)(2008-2#6)(2008-3#2)
optical purity##5##2##(1990-8#1)(2008-6#2)(2011-1#1)(2013-1#1)
optical qualities##2##2##(2008-3#1)(2011-1#1)
optical quality of the##3##4##(2008-3#3)
optical quality of##5##3##(2008-3#5)
optical quality##13##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#10)
optical radiation##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
optical range##2##2##(2007-12#1)(2008-2#1)
optical read head##2##3##(2008-2#2)
optical readout##4##2##(2008-3#4)
optical receiver##3##2##(2008-2#2)(2008-3#1)
optical receivers##4##2##(2007-12#1)(2008-3#3)
optical recognition of##2##3##(2008-3#2)
optical recognition##3##2##(2007-12#1)(2008-3#2)
optical reconstruction##3##2##(2008-3#1)(2011-1#2)
optical recording##11##2##(1996-5#1)(2007-11#2)(2008-2#2)(2008-3#5)(2008-4#1)
optical rectification and the electro-optic effect##2##6##(2007-12#2)
optical rectification and the##3##4##(2007-12#3)
optical rectification and##4##3##(2007-11#1)(2007-12#3)
optical rectification##10##2##(2007-11#6)(2007-12#4)
optical relay##2##2##(2008-2#1)(2008-3#1)
optical remote-sensing##2##2##(2008-2#1)(2008-3#1)
optical resolution of##3##3##(2007-12#2)(2009-12#1)
optical resolution##7##2##(2007-12#3)(2008-3#1)(2008-9#1)(2009-12#1)(2012-2#1)
optical resonance##2##2##(2008-2#1)(2008-7#1)
optical resonator based on##2##4##(2007-11#1)(2008-3#1)
optical resonator##8##2##(2007-11#2)(2008-3#6)
optical resonators##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
optical response functions##2##3##(2007-12#2)
optical response of##6##3##(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#1)
optical response##13##2##(1990-8#2)(1995-6#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-3#1)
optical responses##2##2##(2008-10#2)
optical ring can##2##3##(2008-3#2)
optical ring##9##2##(2007-11#1)(2007-12#1)(2008-3#7)
optical samples and##2##3##(2008-3#2)
optical sampling##3##2##(2007-11#2)(2008-3#1)
optical scanners##3##2##(2008-3#3)
optical scanning holography##4##3##(2007-12#2)(2008-3#2)
optical scanning##8##2##(2007-12#3)(2008-3#5)
optical scatter##2##2##(2007-12#1)(2008-3#1)
optical scattering##5##2##(2008-2#2)(2008-3#2)(2011-1#1)
optical scatterometry##3##2##(2008-3#3)
optical scheme##2##2##(2008-3#2)
optical scintillation##3##2##(2008-3#3)
optical sectioning##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
optical security##2##2##(2008-3#2)
optical sensing##6##2##(2008-10#5)(2008-3#1)
optical sensor based on##2##4##(2007-11#1)(2008-3#1)
optical sensor for##5##3##(1996-5#1)(2008-10#3)(2008-3#1)
optical sensor system for##2##4##(2008-3#2)
optical sensor system##3##3##(2008-2#1)(2008-3#2)
optical sensor##24##2##(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#6)(2010-5#2)
optical sensors for##3##3##(2008-10#3)
optical sensors##10##2##(2007-12#1)(2008-10#5)(2008-3#4)
optical setup is##5##3##(2008-2#2)(2008-3#3)
optical setup##20##2##(2007-11#3)(2008-2#6)(2008-3#10)(2011-1#1)
optical signal is##2##3##(2007-12#1)(2008-3#1)
optical signal transmission system##2##4##(2007-11#2)
optical signal##24##2##(2007-11#5)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#7)(2008-9#2)
optical signal-to-noise ratio##2##3##(2007-12#2)
optical signal-to-noise##3##2##(2007-12#2)(2008-2#1)
optical signals are##2##3##(2008-3#2)
optical signals in##2##3##(2008-12#1)(2008-3#1)
optical signals to##2##3##(2008-3#2)
optical signals##16##2##(2007-11#2)(2007-12#2)(2008-12#1)(2008-3#10)(2012-2#1)
optical slope efficiency##4##3##(2007-12#1)(2008-2#3)
optical soliton##2##2##(1992-11#1)(2007-12#1)
optical solitons in##3##3##(2007-11#1)(2008-2#2)
optical solitons##5##2##(2007-11#3)(2008-2#2)
optical source##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
optical sources##7##2##(2008-2#4)(2008-3#3)
optical spatial solitons##3##3##(2007-12#2)(2008-3#1)
optical spatial##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
optical spectra of##2##3##(2007-11#1)(2009-9#1)
optical spectra##4##2##(1997-7#1)(2007-11#1)(2007-12#1)(2009-9#1)
optical spectroscopy##6##2##(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#2)(2010-12#1)
optical spectrum analysis##2##3##(2007-11#1)(2008-3#1)
optical spectrum analyzer##2##3##(2007-11#1)(2008-3#1)
optical spectrum##13##2##(1990-5#1)(2007-11#4)(2008-3#4)(2011-2#1)(2013-8#3)
optical storage with##4##3##(2008-3#4)
optical storage##18##2##(1994-3#2)(2007-12#2)(2008-2#1)(2008-3#13)
optical structures##2##2##(2007-11#1)(2008-2#1)
optical study##2##2##(2007-12#1)(2008-3#1)
optical substrate##2##2##(2008-10#1)(2008-3#1)
optical superlattice##4##2##(2007-11#4)
optical surface plasmon resonance##2##4##(2008-10#1)(2008-3#1)
optical surface##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
optical surfaces for the##2##4##(2008-3#2)
optical surfaces##14##2##(2007-12#2)(2008-2#1)(2008-3#10)(2011-2#1)
optical switch for##2##3##(2008-2#1)(2008-3#1)
optical switch##3##2##(2008-2#1)(2008-3#2)
optical switches##2##2##(2007-12#2)
optical switching##7##2##(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#4)
optical system and##4##3##(2008-2#1)(2008-3#3)
optical system based on##2##4##(2008-2#1)(2008-3#1)
optical system consisting of##2##4##(2008-3#2)
optical system design##3##3##(2008-2#1)(2008-3#2)
optical system for##7##3##(2007-12#2)(2008-2#2)(2008-3#2)(2009-2#1)
optical system is##4##3##(2008-3#4)
optical system that##8##3##(2007-12#1)(2008-3#7)
optical system to##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
optical system was##2##3##(2008-2#1)(2008-3#1)
optical system with a##2##4##(2008-3#2)
optical system with##6##3##(2007-12#1)(2008-3#5)
optical system##98##2##(2007-11#2)(2007-12#9)(2008-10#1)(2008-2#18)(2008-3#66)(2008-4#1)(2009-2#1)
optical systems and##4##3##(2008-3#4)
optical systems are##3##3##(2008-2#1)(2008-3#2)
optical systems for##3##3##(2008-2#1)(2008-3#2)
optical systems is##3##3##(2008-3#2)(2013-8#1)
optical systems that##2##3##(2008-2#1)(2008-3#1)
optical systems with##3##3##(2007-12#1)(2008-3#2)
optical systems##49##2##(2007-12#1)(2008-2#10)(2008-3#37)(2013-8#1)
optical technique for measuring##2##4##(2008-2#1)(2008-3#1)
optical technique for##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
optical technique that##2##3##(2008-2#1)(2008-4#1)
optical technique to##2##3##(2007-11#1)(2008-3#1)
optical technique##12##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2011-1#1)
optical techniques and##2##3##(2007-11#1)(2008-3#1)
optical techniques##8##2##(2007-11#1)(2007-12#1)(2008-3#4)(2009-9#1)(2011-1#1)
optical tests##2##2##(2008-2#1)(2008-3#1)
optical thickness at##2##3##(2008-2#1)(2008-3#1)
optical thickness for##2##3##(2008-2#1)(2008-3#1)
optical thickness of the##5##4##(2007-11#1)(2008-3#4)
optical thickness##30##2##(2007-11#2)(2008-2#14)(2008-3#14)
optical thicknesses##8##2##(2008-2#4)(2008-3#4)
optical thin films##2##3##(2008-2#1)(2008-3#1)
optical thin-film coatings is##2##4##(2008-2#1)(2008-3#1)
optical thin-film##3##2##(2008-2#1)(2008-3#2)
optical throughput##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
optical time-division multiplexed##4##3##(2007-11#3)(2008-3#1)
optical time-division##6##2##(2007-11#5)(2008-3#1)
optical time-domain reflectometry##2##3##(2007-12#1)(2008-3#1)
optical time-domain##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
optical tomography in biological tissue##3##5##(2007-12#1)(2008-3#2)
optical tomography##33##2##(2007-11#5)(2007-12#4)(2008-2#3)(2008-3#13)(2011-1#7)(2012-12#1)
optical transfection system##3##3##(2011-1#3)
optical transfection##6##2##(2011-1#6)
optical transfer function##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
optical transition##4##2##(2007-12#3)(2008-3#1)
optical transmission efficiency##2##3##(2008-2#1)(2008-3#1)
optical transmission spectra##3##3##(2007-11#1)(2008-3#2)
optical transmission through##2##3##(2007-12#2)
optical transmission##22##2##(2007-11#5)(2007-12#3)(2008-2#4)(2008-3#9)(2008-7#1)
optical transparency and##2##3##(2008-7#1)(2010-4#1)
optical transparency##4##2##(2008-7#2)(2010-2#1)(2010-4#1)
optical trap##7##2##(2007-11#1)(2008-2#2)(2008-3#3)(2012-2#1)
optical trapping and##3##3##(2007-11#2)(2008-10#1)
optical trapping of##2##3##(2007-12#2)
optical trapping##9##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#3)
optical triangular profilometry##2##3##(2008-3#2)
optical tunnel##2##2##(2008-3#2)
optical tunneling##5##2##(2007-12#3)(2008-3#2)
optical turbulence##3##2##(2008-2#1)(2008-3#2)
optical tweezers by##2##3##(2007-11#1)(2009-12#1)
optical tweezers to##2##3##(2007-11#1)(2012-2#1)
optical tweezers##16##2##(2007-11#10)(2007-12#1)(2008-10#1)(2008-3#2)(2009-12#1)(2012-2#1)
optical vector-matrix multiplier##2##3##(2008-2#1)(2008-3#1)
optical velocimetry##2##2##(2008-2#1)(2011-2#1)
optical video##2##2##(2008-10#1)(2008-2#1)
optical vortex##7##2##(2007-11#3)(2007-12#2)(2009-5#2)
optical vortices##6##2##(2007-11#2)(2007-12#2)(2008-2#2)
optical wave##3##2##(2007-11#2)(2007-12#1)
optical wave-front##2##2##(2008-2#1)(2008-3#1)
optical waveguide spectroscopy##4##3##(2007-11#1)(2008-10#3)
optical waveguide was##2##3##(2007-12#1)(2008-10#1)
optical waveguide##39##2##(2007-11#10)(2007-12#5)(2008-10#14)(2008-2#1)(2008-3#8)(2010-8#1)
optical waveguides and##2##3##(2007-11#1)(2008-2#1)
optical waveguides have been##2##4##(2008-2#2)
optical waveguides is##2##3##(2008-3#2)
optical waveguides were fabricated from fluorinated polyimides##2##7##(2008-2#2)
optical waveguides##28##2##(2007-11#5)(2007-12#3)(2008-10#2)(2008-2#11)(2008-3#6)(2010-8#1)
optical wavelength##7##2##(2007-11#2)(2007-12#3)(2008-3#2)
optical wavelengths##2##2##(2007-12#1)(2008-3#1)
optical wavelet##2##2##(2008-2#1)(2008-3#1)
optical waves##5##2##(2007-12#1)(2008-3#4)
optical wedge##2##2##(2008-3#2)
optical workshop##2##2##(2008-3#2)
optical##4136##1##(1990-12#1)(1990-5#1)(1990-8#10)(1991-1#1)(1991-2#1)(1992-11#2)(1992-4#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-5#1)(1994-11#5)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(2006-4#1)(2007-11#569)(2007-12#582)(2007-5#1)(2008-1#2)(2008-10#215)(2008-11#5)(2008-12#6)(2008-2#773)(2008-3#1645)(2008-4#5)(2008-5#12)(2008-6#8)(2008-7#17)(2008-9#18)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#17)(2009-6#1)(2009-7#8)(2009-9#6)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#11)(2010-9#2)(2011-1#47)(2011-2#10)(2011-7#14)(2012-1#1)(2012-12#4)(2012-2#24)(2013-1#18)(2013-8#24)
optical)##3##1##(2007-12#1)(2008-3#1)(2013-7#1)
optical-beam-induced current##2##2##(2007-12#2)
optical-correlation##2##1##(2008-3#2)
optical-fiber displacement sensor##3##3##(2008-2#2)(2008-3#1)
optical-fiber nanoprobes##2##2##(2008-2#2)
optical-fiber probe##3##2##(2007-12#2)(2008-2#1)
optical-fiber probes##3##2##(2008-2#3)
optical-fiber##25##1##(2007-12#3)(2008-2#8)(2008-3#14)
optical-frequency##3##1##(2007-12#3)
optical-optical conversion efficiency of##3##4##(2007-11#2)(2008-2#1)
optical-pulse trains##2##2##(2007-11#2)
optical-sectioning##3##1##(2007-12#2)(2008-2#1)
optical-thickness##2##1##(2008-2#1)(2008-3#1)
optical-to-optical conversion efficiency of##3##4##(2007-11#2)(2007-12#1)
optical-to-optical conversion efficiency##6##3##(2007-11#2)(2007-12#2)(2008-2#2)
optical-to-optical efficiency was##2##3##(2007-12#1)(2008-3#1)
optical-to-optical efficiency##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
optical-to-optical##10##1##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
optically absorbing##2##2##(2008-3#2)
optically active viologens##2##3##(1997-7#2)
optically active##23##2##(1995-3#1)(1996-2#2)(1996-5#4)(1997-7#2)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#2)(2009-10#1)
optically addressed liquid-crystal spatial light modulator##3##6##(2007-12#2)(2008-3#1)
optically addressed liquid-crystal##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
optically addressed spatial light modulator##3##5##(2008-2#1)(2008-3#2)
optically addressed spatial light##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
optically addressed##14##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#5)
optically and then##2##3##(2007-11#1)(2008-1#1)
optically and##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
optically by##2##2##(2008-2#1)(2008-3#1)
optically controlled##2##2##(2007-12#1)(2008-3#1)
optically dense sprays##2##3##(2008-3#2)
optically dense##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
optically diffuse##3##2##(2008-3#3)
optically evaluated##2##2##(2007-12#1)(2008-3#1)
optically flat##2##2##(2008-2#1)(2008-7#1)
optically in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
optically induced##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
optically pumped lasing in single conjugated polymer nanowires##2##8##(2008-7#2)
optically pumped##9##2##(1994-2#1)(2007-12#4)(2008-3#2)(2008-7#2)
optically pure amino##2##3##(1992-11#1)(1995-3#1)
optically pure##10##2##(1991-5#1)(1992-11#1)(1992-3#1)(1995-3#3)(2008-5#1)(2008-6#3)
optically reconstructed##2##2##(2008-3#2)
optically rectified##2##2##(2007-11#1)(2008-3#1)
optically resolved##2##2##(1994-9#1)(2008-3#1)
optically sensitive##3##2##(2007-12#2)(2008-3#1)
optically thick media##2##3##(2008-10#1)(2008-2#1)
optically thick scattering##3##3##(2008-3#3)
optically thick##17##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#9)
optically thin##3##2##(2008-2#1)(2008-3#2)
optically transparent##4##2##(2007-11#2)(2008-7#1)(2012-2#1)
optically trapped##7##2##(2007-11#3)(2008-3#3)(2012-2#1)
optically with##2##2##(2008-10#1)(2008-2#1)
optically##194##1##(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-3#4)(1996-2#2)(1996-5#4)(1997-7#2)(2007-11#19)(2007-12#33)(2008-1#1)(2008-10#8)(2008-2#26)(2008-3#66)(2008-5#1)(2008-6#3)(2008-7#8)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-1#4)(2012-2#3)
optics and micro-optics##3##3##(2008-3#3)
optics and the##3##3##(2008-3#3)
optics and##18##2##(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-7#1)
optics approach##2##2##(2008-2#1)(2008-3#1)
optics approximation##5##2##(2008-2#3)(2008-3#2)
optics are discussed##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
optics are##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
optics as##3##2##(2008-3#3)
optics at##2##2##(2008-3#2)
optics by##2##2##(2007-11#1)(2008-2#1)
optics calculation of##2##3##(2008-2#1)(2008-3#1)
optics for improving##2##3##(2007-11#1)(2008-3#1)
optics for##10##2##(2007-11#2)(2008-10#1)(2008-3#7)
optics in the##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
optics in which##2##3##(2007-11#1)(2008-2#1)
optics in##16##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#8)
optics is presented##2##3##(2008-2#1)(2008-3#1)
optics is##9##2##(2007-11#2)(2008-2#1)(2008-3#6)
optics of the##2##3##(2008-3#2)
optics of##5##2##(2008-3#5)
optics results##2##2##(2007-12#1)(2008-3#1)
optics system##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
optics systems##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
optics that##3##2##(2007-12#2)(2008-3#1)
optics to##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
optics used##3##2##(2007-12#1)(2008-3#2)
optics when##2##2##(2008-3#2)
optics with a##2##3##(2008-2#1)(2008-3#1)
optics with##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
optics##281##1##(1990-8#1)(2006-4#1)(2007-11#26)(2007-12#21)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#62)(2008-3#147)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#6)(2012-2#1)(2012-3#1)
optics) is##2##2##(2008-3#2)
optics)##4##1##(2008-2#1)(2008-3#3)
optima##10##1##(1991-11#1)(1991-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#2)
optimal activity was##2##3##(1992-9#1)(1997-2#1)
optimal activity##4##2##(1992-9#1)(1997-2#1)(2008-10#1)(2008-5#1)
optimal analytical conditions##3##3##(2008-10#3)
optimal analytical##4##2##(2008-10#4)
optimal and##2##2##(2007-11#1)(2008-11#1)
optimal approximation##2##2##(2008-6#2)
optimal beam##2##2##(2008-2#1)(2008-3#1)
optimal binary phase-only filters##2##4##(2008-2#2)
optimal binary##3##2##(2008-2#3)
optimal care can be##2##4##(2008-11#1)(2011-2#1)
optimal care##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
optimal choice of##2##3##(2008-10#1)(2011-2#1)
optimal choice##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
optimal concentration of##4##3##(1992-8#1)(1994-11#1)(2008-4#2)
optimal concentration##6##2##(1992-8#1)(1994-11#1)(2008-4#2)(2008-8#2)
optimal concentrations of##4##3##(2008-10#2)(2008-11#2)
optimal concentrations##6##2##(1994-8#1)(2007-2#1)(2008-10#2)(2008-11#2)
optimal condition##2##2##(2008-10#1)(2013-1#1)
optimal conditions for the##9##4##(1992-3#1)(2007-11#1)(2008-10#6)(2013-8#1)
optimal conditions for##24##3##(1990-12#1)(1991-5#1)(1992-3#1)(1995-5#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-7#1)(2012-1#1)(2013-8#1)
optimal conditions of##5##3##(2008-10#3)(2008-6#1)(2013-1#1)
optimal conditions was##3##3##(2008-10#2)(2008-6#1)
optimal conditions##88##2##(1990-12#1)(1991-5#2)(1992-3#1)(1995-5#1)(2007-11#1)(2008-10#64)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-7#2)(2012-1#1)(2013-1#3)(2013-8#2)
optimal control##10##2##(1996-7#1)(2007-11#1)(2008-3#1)(2008-6#2)(2009-5#4)(2013-8#1)
optimal cutoff##2##2##(1995-3#1)(2011-1#1)
optimal decision threshold##2##3##(2008-10#2)
optimal decision##5##2##(1991-12#1)(1992-3#1)(2008-10#2)(2012-3#1)
optimal degree##2##2##(1990-12#1)(2010-5#1)
optimal design of a##2##4##(2008-3#2)
optimal design##3##2##(2008-3#2)(2010-2#1)
optimal designs##3##2##(2009-9#3)
optimal detection##2##2##(2008-10#1)(2008-2#1)
optimal distance##2##2##(1995-2#1)(2008-3#1)
optimal dosage and administration of##2##5##(2013-1#2)
optimal dosage and##3##3##(1992-9#1)(2013-1#2)
optimal dosage in##2##3##(1994-6#1)(2008-8#1)
optimal dosage##8##2##(1992-9#1)(1994-6#1)(2008-4#1)(2008-8#1)(2012-12#2)(2013-1#2)
optimal dose##5##2##(1994-6#2)(2008-7#1)(2008-8#1)(2012-12#1)
optimal dosing##2##2##(2008-5#2)
optimal drug##2##2##(1996-2#1)(2010-4#1)
optimal effect##2##2##(2011-1#1)(2011-3#1)
optimal estimation formalism can be used##2##6##(2008-3#2)
optimal experimental conditions##5##3##(2008-10#5)
optimal feed##2##2##(2008-7#2)
optimal filters is##3##3##(2008-2#1)(2008-6#2)
optimal for a##2##3##(1994-2#1)(2007-12#1)
optimal for the##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
optimal for##19##2##(1992-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-5#1)
optimal foraging theory##2##3##(2008-8#1)(2008-9#1)
optimal foraging##6##2##(2008-8#3)(2008-9#3)
optimal frequency##2##2##(1990-11#1)(2007-12#1)
optimal growth##6##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#1)
optimal harvest time##5##3##(2008-11#4)(2008-7#1)
optimal in the presence of##2##5##(1990-2#1)(2007-12#1)
optimal in the##4##3##(1990-2#1)(2007-12#2)(2008-2#1)
optimal in##6##2##(1990-2#1)(2007-12#2)(2008-2#3)
optimal information##2##2##(1997-7#1)(2008-1#1)
optimal initial##2##2##(2008-3#2)
optimal injection##2##2##(2008-10#1)(2008-7#1)
optimal investment in##3##3##(2008-8#2)(2012-3#1)
optimal level of##5##3##(2008-10#1)(2008-8#3)(2013-1#1)
optimal level##7##2##(1996-3#1)(2008-10#1)(2008-8#3)(2009-7#1)(2013-1#1)
optimal levels##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
optimal management of the##3##4##(2007-12#1)(2008-3#1)(2011-3#1)
optimal management of##4##3##(2007-10#1)(2007-12#1)(2008-3#1)(2011-3#1)
optimal management##8##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-10#1)(2011-2#2)(2011-3#1)
optimal measurement##2##2##(2008-10#1)(2008-3#1)
optimal medical therapy##2##3##(2010-6#1)(2011-3#1)
optimal medical treatment##2##3##(2007-8#1)(2008-8#1)
optimal medical##5##2##(2007-7#1)(2007-8#1)(2008-8#1)(2010-6#1)(2011-3#1)
optimal medium##5##2##(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
optimal method of##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
optimal mode##3##2##(1993-11#1)(2008-2#1)(2013-8#1)
optimal orientation##2##2##(1995-11#1)(2008-3#1)
optimal outcome##3##2##(1992-3#1)(2008-1#1)(2008-7#1)
optimal oxygen##3##2##(1996-3#2)(2008-6#1)
optimal pH and temperature for##2##5##(1994-11#1)(2008-10#1)
optimal pH of##3##3##(1993-3#1)(2008-10#2)
optimal pH range##2##3##(1995-2#1)(2008-10#1)
optimal pH##14##2##(1990-2#1)(1991-5#2)(1993-3#1)(1994-11#2)(1995-2#1)(1997-2#1)(2008-10#4)(2009-3#1)(2011-2#1)
optimal pain management in older adults on acute medical units##2##10##(2010-7#2)
optimal pain##3##2##(2009-5#1)(2010-7#2)
optimal performance in##2##3##(1994-12#1)(1996-2#1)
optimal performance##3##2##(1994-12#1)(1996-2#1)(2009-10#1)
optimal phase##3##2##(2008-2#1)(2008-3#2)
optimal physician inquiry starting time##2##5##(2010-8#2)
optimal postoperative##2##2##(2010-11#1)(2013-1#1)
optimal power##2##2##(2008-2#1)(2008-3#1)
optimal propagule size is larger##2##5##(2008-8#2)
optimal protection##2##2##(1995-5#1)(2008-5#1)
optimal range##3##2##(1992-9#1)(1995-1#1)(2008-11#1)
optimal reaction conditions##3##3##(2008-10#2)(2008-8#1)
optimal reaction norms##2##3##(2008-8#2)
optimal reaction##7##2##(2008-10#4)(2008-8#3)
optimal region##4##2##(2008-10#1)(2008-5#2)(2008-6#1)
optimal response##2##2##(2008-10#1)(2012-4#1)
optimal result##2##2##(2013-1#1)(2013-8#1)
optimal results##3##2##(1992-12#1)(2008-4#1)(2011-2#1)
optimal selection of##2##3##(2008-10#1)(2008-3#1)
optimal sensitivity##2##2##(1990-12#1)(2008-10#1)
optimal separation##3##2##(2008-10#3)
optimal setting##2##2##(2008-3#1)(2008-7#1)
optimal size##3##2##(1996-2#1)(2008-2#1)(2008-8#1)
optimal solution##4##2##(2007-8#1)(2008-2#1)(2008-3#1)(2009-7#1)
optimal spatial frequency##2##3##(2008-8#2)
optimal spatial##4##2##(2008-2#1)(2008-3#1)(2008-8#2)
optimal stability##2##2##(2007-12#1)(2008-5#1)
optimal strategy for##2##3##(2008-2#1)(2012-2#1)
optimal strategy##6##2##(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
optimal superposition##2##2##(2008-7#2)
optimal surgical##4##2##(1994-12#1)(2008-12#1)(2009-2#1)(2013-1#1)
optimal synthesis of several##2##4##(2007-11#2)
optimal synthesis of##3##3##(2007-11#3)
optimal synthesis##4##2##(1997-4#1)(2007-11#3)
optimal system##2##2##(1990-8#1)(2008-2#1)
optimal temperature##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
optimal temperatures##2##2##(2008-10#2)
optimal therapeutic##5##2##(2008-10#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)
optimal therapy for##3##3##(1995-2#1)(2009-8#1)(2011-2#1)
optimal therapy##7##2##(1995-2#1)(2007-4#1)(2008-1#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
optimal time##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
optimal to achieve##2##3##(1993-1#1)(2008-7#1)
optimal trade-off##2##2##(2008-3#2)
optimal training##2##2##(2008-10#1)(2008-5#1)
optimal treatment for##5##3##(1995-6#1)(2007-8#1)(2008-6#1)(2008-7#2)
optimal treatment of patients with##2##5##(2006-10#1)(2010-9#1)
optimal treatment of patients##3##4##(2006-10#1)(2008-7#1)(2010-9#1)
optimal treatment of##7##3##(1995-5#1)(1996-9#1)(2006-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-9#1)
optimal treatment strategy##2##3##(2011-2#1)(2013-1#1)
optimal treatment##27##2##(1995-5#1)(1995-6#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#1)
optimal use of the##2##4##(2008-10#1)(2008-3#1)
optimal use of##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#1)
optimal value##4##2##(2008-10#2)(2008-3#2)
optimal values for##2##3##(2008-10#1)(2008-7#1)
optimal values##6##2##(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)
optimal water##2##2##(2008-12#1)(2013-1#1)
optimal wavelength##2##2##(2008-2#1)(2008-7#1)
optimal working conditions##3##3##(2007-12#1)(2008-10#2)
optimal working##4##2##(2007-12#1)(2008-10#2)(2010-10#1)
optimal##780##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#5)(1991-8#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-3#3)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#4)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#1)(2006-10#3)(2007-10#3)(2007-11#13)(2007-12#18)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#6)(2008-1#9)(2008-10#161)(2008-11#34)(2008-12#9)(2008-2#41)(2008-3#52)(2008-4#9)(2008-5#26)(2008-6#23)(2008-7#35)(2008-8#43)(2008-9#15)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#8)(2009-7#5)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#23)(2011-3#5)(2011-7#1)(2012-1#1)(2012-12#9)(2012-2#10)(2012-3#12)(2012-4#1)(2013-1#28)(2013-8#12)
optimal-rotation-angle method##2##2##(2008-2#2)
optimality model##2##2##(2008-8#2)
optimality models##3##2##(2008-8#2)(2008-9#1)
optimality##12##1##(1996-6#1)(1997-8#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-9#1)(2010-1#1)
optimally at##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
optimally foraging##3##2##(2008-8#1)(2008-9#2)
optimally in##2##2##(2008-9#1)(2013-8#1)
optimally shaped##2##2##(2007-12#2)
optimally##36##1##(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-2#2)(1995-5#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-2#2)(2012-2#6)(2013-1#1)(2013-8#1)
optimisation and validation of##2##4##(2008-10#2)
optimisation and##6##2##(2008-10#5)(2008-11#1)
optimisation is##2##2##(2008-11#1)(2010-11#1)
optimisation of a##2##3##(2008-10#2)
optimisation of an on-line preconcentration##2##5##(2008-10#2)
optimisation of the experimental conditions##2##5##(2008-10#2)
optimisation of the experimental##3##4##(2008-10#3)
optimisation of the variables##2##4##(2008-10#2)
optimisation of the##15##3##(2008-10#13)(2008-11#2)
optimisation of##28##2##(1990-2#1)(2007-12#1)(2008-10#22)(2008-11#4)
optimisation process##3##2##(2008-10#3)
optimisation##56##1##(1990-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#41)(2008-11#7)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)
optimise the##8##2##(1993-2#1)(1996-12#1)(2008-10#6)
optimise##20##1##(1990-3#1)(1993-2#1)(1996-12#1)(2007-11#2)(2008-10#10)(2008-11#3)(2008-7#1)(2010-10#1)
optimised and applied##2##3##(2008-10#1)(2011-1#1)
optimised and##10##2##(2008-10#9)(2011-1#1)
optimised by a##2##3##(2008-10#2)
optimised by using##2##3##(2008-10#2)
optimised by##13##2##(2008-10#12)(2012-2#1)
optimised conditions the##3##3##(2008-10#3)
optimised conditions were##2##3##(2008-10#2)
optimised conditions##15##2##(2008-10#14)(2008-8#1)
optimised for##10##2##(2008-10#9)(2008-8#1)
optimised in order to##4##4##(2008-10#4)
optimised in##5##2##(2008-10#4)(2013-1#1)
optimised methods##2##2##(1996-12#1)(2008-10#1)
optimised reverse transcriptase-polymerase chain reaction##2##5##(1996-12#2)
optimised to##7##2##(2008-10#6)(2008-7#1)
optimised##114##1##(1995-3#1)(1996-12#3)(2008-10#102)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#2)(2013-1#1)
optimising all##2##2##(2008-10#1)(2010-12#1)
optimising the##2##2##(2008-10#1)(2008-11#1)
optimising##7##1##(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2010-12#1)(2013-1#1)
optimism and##5##2##(1991-5#1)(2008-6#1)(2009-10#1)(2010-2#1)(2013-7#1)
optimism bias##4##2##(2010-7#4)
optimism##21##1##(1991-5#1)(1992-12#1)(1992-5#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-7#4)(2012-2#1)(2013-7#1)
optimistic about##2##2##(1996-3#1)(1996-4#1)
optimistic##15##1##(1992-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-4#1)(2007-8#2)(2008-12#1)(2008-2#1)(2010-10#3)(2013-8#1)
optimization algorithm is##2##3##(2007-11#1)(2008-3#1)
optimization algorithm##11##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)
optimization algorithms to the design of diffractive##2##7##(2007-12#2)
optimization algorithms to##3##3##(2007-12#2)(2010-2#1)
optimization algorithms##5##2##(2007-12#2)(2008-10#1)(2008-7#1)(2010-2#1)
optimization and characterization##2##3##(2008-10#2)
optimization and##18##2##(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-6#1)
optimization approach##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
optimization by the##2##3##(2008-10#1)(2008-3#1)
optimization by##5##2##(1995-8#1)(2008-10#3)(2008-3#1)
optimization conditions##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
optimization design of diffractive optical elements##2##6##(2008-3#2)
optimization design of##3##3##(2008-3#3)
optimization design##4##2##(2008-3#4)
optimization for the##2##3##(2008-10#1)(2008-6#1)
optimization for##10##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
optimization framework for##2##3##(2008-11#1)(2012-1#1)
optimization has been##2##3##(2008-10#1)(2008-3#1)
optimization in the##2##3##(2008-11#1)(2008-2#1)
optimization in##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
optimization is##6##2##(2008-10#2)(2008-4#1)(2008-6#1)(2010-2#1)(2013-8#1)
optimization method##5##2##(2008-10#2)(2008-7#1)(2012-1#2)
optimization models##2##2##(1995-2#1)(2008-8#1)
optimization of a novel##2##4##(2008-10#1)(2012-2#1)
optimization of a##22##3##(1992-6#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2012-2#1)
optimization of an on-line##2##4##(2008-10#2)
optimization of an##5##3##(2008-10#4)(2008-2#1)
optimization of analytical##2##3##(2008-10#2)
optimization of crystallization conditions is##2##5##(2008-4#2)
optimization of crystallization conditions##3##4##(2008-4#3)
optimization of experimental##3##3##(2008-10#3)
optimization of optical##3##3##(2008-2#1)(2008-3#2)
optimization of oxygen##2##3##(2008-6#1)(2011-2#1)
optimization of preconcentration procedure for##2##5##(2008-10#2)
optimization of single-mode##2##3##(2008-2#2)
optimization of the cavity design##2##5##(2008-3#2)
optimization of the design##2##4##(2007-11#1)(2008-2#1)
optimization of the experimental conditions##2##5##(2008-10#2)
optimization of the experimental parameters##2##5##(2008-10#2)
optimization of the experimental##4##4##(2008-10#4)
optimization of the extraction##3##4##(2008-10#3)
optimization of the fermentation process##2##5##(2008-10#1)(2011-2#1)
optimization of the method##4##4##(2008-10#2)(2008-2#1)(2011-1#1)
optimization of the reaction##2##4##(1996-2#1)(2011-1#1)
optimization of the system##3##4##(2008-10#2)(2008-2#1)
optimization of the##63##3##(1996-2#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#26)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-7#2)(2008-9#2)(2009-2#1)(2011-1#3)(2011-2#2)(2011-3#1)(2013-1#2)
optimization of these##6##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2013-7#1)
optimization of##200##2##(1992-6#1)(1993-11#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#7)(2007-12#6)(2007-6#1)(2008-1#1)(2008-10#75)(2008-11#7)(2008-2#21)(2008-3#24)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#13)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#1)(2011-1#4)(2011-2#4)(2011-3#2)(2012-1#1)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
optimization parameter##2##2##(2008-3#1)(2008-7#1)
optimization point##2##2##(2009-2#2)
optimization points for##2##3##(2009-2#2)
optimization points##8##2##(2009-2#8)
optimization problem##7##2##(1992-12#1)(2008-2#3)(2008-3#1)(2012-1#1)(2013-1#1)
optimization problems##4##2##(2007-9#2)(2008-3#1)(2008-7#1)
optimization procedure that##2##3##(2007-12#1)(2008-2#1)
optimization procedure##8##2##(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
optimization process##9##2##(2008-10#8)(2012-2#1)
optimization routines##2##2##(2008-3#1)(2009-2#1)
optimization scheme##2##2##(2008-3#1)(2011-1#1)
optimization studies##4##2##(2008-10#3)(2008-2#1)
optimization study##6##2##(2008-10#4)(2008-2#1)(2011-2#1)
optimization technique##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
optimization techniques##3##2##(2008-2#1)(2008-5#1)(2011-1#1)
optimization to##2##2##(1995-12#1)(2008-2#1)
optimization was performed##2##3##(2008-10#2)
optimization was##4##2##(1997-3#1)(1997-6#1)(2008-10#2)
optimization with##4##2##(2007-9#1)(2008-11#1)(2009-4#1)(2012-12#1)
optimization##437##1##(1992-12#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#3)(2007-11#9)(2007-12#16)(2007-6#1)(2007-9#4)(2008-1#2)(2008-10#150)(2008-11#17)(2008-2#43)(2008-3#55)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#22)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#2)(2009-2#15)(2009-4#2)(2009-5#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#8)(2011-2#6)(2011-3#2)(2012-1#7)(2012-12#2)(2012-2#8)(2013-1#6)(2013-7#2)(2013-8#3)
optimizations in##2##2##(2008-3#1)(2009-2#1)
optimizations were##2##2##(2008-10#1)(2008-2#1)
optimizations##7##1##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#2)
optimize functional##2##2##(2008-7#1)(2011-2#1)
optimize product quantity##2##3##(2008-10#2)
optimize the clinical##2##3##(2007-8#1)(2008-10#1)
optimize the##90##2##(1992-5#1)(1993-11#1)(1993-5#1)(1994-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#2)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#5)(2013-1#2)(2013-7#1)
optimize these##3##2##(2008-1#1)(2008-5#1)(2013-7#1)
optimize##196##1##(1990-7#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-5#2)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#51)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#19)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
optimized a new##2##3##(2008-10#1)(2008-11#1)
optimized a##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
optimized after##2##2##(2008-3#1)(2013-1#1)
optimized and a##4##3##(2008-10#3)(2008-4#1)
optimized and applied to the determination of##3##7##(2008-10#2)(2009-8#1)
optimized and applied to the##4##5##(1995-3#1)(2008-10#2)(2009-8#1)
optimized and the##10##3##(2008-10#9)(2008-3#1)
optimized and then##2##3##(2008-11#1)(2008-8#1)
optimized and##35##2##(1995-3#1)(2008-10#26)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)
optimized at a##2##3##(2010-5#1)(2012-2#1)
optimized at##3##2##(2007-12#1)(2010-5#1)(2012-2#1)
optimized between##2##2##(2008-10#1)(2010-1#1)
optimized by a##4##3##(2008-10#3)(2008-5#1)
optimized by both static and dynamic methods##4##7##(2008-10#4)
optimized by means of##2##4##(2008-10#2)
optimized by selecting##2##3##(2008-10#1)(2008-7#1)
optimized by the##4##3##(2008-10#2)(2008-3#1)(2011-1#1)
optimized by##35##2##(1994-12#1)(1994-9#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)
optimized combination was##2##3##(2010-5#1)(2012-2#1)
optimized condition##6##2##(2008-10#6)
optimized conditions for##2##3##(2008-10#2)
optimized conditions of##4##3##(2008-10#3)(2011-1#1)
optimized conditions were##6##3##(2008-10#5)(2012-1#1)
optimized conditions##60##2##(2008-10#51)(2008-12#1)(2008-5#1)(2009-6#1)(2011-1#4)(2012-1#1)(2013-1#1)
optimized dose distributions for vaginal cylinders##2##6##(2009-2#2)
optimized dose distributions##3##3##(2009-2#3)
optimized experimental conditions##4##3##(2008-10#3)(2009-12#1)
optimized experimental##5##2##(2008-10#4)(2009-12#1)
optimized extraction##3##2##(2008-10#2)(2008-4#1)
optimized for both##2##3##(2008-2#1)(2008-3#1)
optimized for each##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
optimized for low##2##3##(2007-12#1)(2008-3#1)
optimized for the determination of##4##5##(2008-10#4)
optimized for the##13##3##(2007-12#1)(2008-10#11)(2008-2#1)
optimized for use##2##3##(2008-2#1)(2009-8#1)
optimized for##56##2##(2007-12#3)(2008-10#22)(2008-11#2)(2008-2#6)(2008-3#11)(2008-4#2)(2008-6#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-5#2)(2011-1#2)(2013-1#1)
optimized formulation##2##2##(2010-3#1)(2011-1#1)
optimized from##2##2##(2008-10#1)(2008-3#1)
optimized in the##2##3##(2008-10#2)
optimized in##8##2##(2006-12#1)(2008-10#6)(2011-3#1)
optimized integral##2##2##(2007-12#1)(2009-2#1)
optimized medium##3##2##(2008-11#1)(2008-6#2)
optimized method##6##2##(2008-10#5)(2008-5#1)
optimized microwindows for##2##3##(2008-2#1)(2008-3#1)
optimized model##2##2##(2008-10#1)(2013-8#1)
optimized on##3##2##(2008-10#3)
optimized operational conditions##2##3##(2008-10#2)
optimized optical##2##2##(2008-10#1)(2008-3#1)
optimized parameters##3##2##(2008-10#3)
optimized procedure was##2##3##(2008-10#2)
optimized procedure##4##2##(2008-10#4)
optimized process##2##2##(2008-2#1)(2008-5#1)
optimized protocol##2##2##(2008-10#1)(2008-12#1)
optimized reaction##2##2##(2008-10#1)(2013-8#1)
optimized sample##2##2##(2008-10#1)(2008-9#1)
optimized sampling##2##2##(2007-12#1)(2008-10#1)
optimized separation conditions##2##3##(2008-10#2)
optimized spatial frequency##2##3##(2008-2#2)
optimized system was##2##3##(2008-10#2)
optimized system##8##2##(2007-12#2)(2008-10#3)(2008-3#3)
optimized the##7##2##(2008-11#1)(2008-3#1)(2009-9#2)(2011-2#1)(2012-1#1)(2012-3#1)
optimized through##2##2##(1994-9#1)(2008-10#1)
optimized to allow##2##3##(2008-10#1)(2008-4#1)
optimized to improve the##2##4##(2008-10#1)(2013-8#1)
optimized to maximize the##3##4##(2007-12#1)(2008-10#2)
optimized to obtain##3##3##(2008-10#3)
optimized to yield a##2##4##(2008-10#2)
optimized to##28##2##(1991-5#1)(2007-12#1)(2008-10#14)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#2)
optimized using a##4##3##(2008-10#3)(2008-7#1)
optimized using the##3##3##(2008-10#3)
optimized using##10##2##(2008-10#9)(2008-7#1)
optimized with respect to the##2##5##(1991-5#1)(2008-10#1)
optimized with respect to##5##4##(1991-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
optimized with##7##2##(1991-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)
optimized##578##1##(1990-7#1)(1990-8#1)(1991-5#2)(1992-11#1)(1993-8#2)(1994-12#1)(1994-9#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#12)(2008-1#1)(2008-10#336)(2008-11#12)(2008-12#2)(2008-2#18)(2008-3#54)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#5)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-8#1)(2011-1#21)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#10)(2013-8#8)
optimizer##4##1##(2008-3#4)
optimizes the##5##2##(1996-12#1)(1997-1#1)(2007-11#1)(2008-11#1)(2011-2#1)
optimizes##14##1##(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2010-5#1)(2011-2#2)(2012-2#1)
optimizing a##2##2##(2008-10#1)(2008-3#1)
optimizing patient##2##2##(2008-3#2)
optimizing perfusion##2##2##(2006-10#1)(2008-11#1)
optimizing protein##2##2##(2008-2#1)(2008-5#1)
optimizing standard##2##2##(2009-10#1)(2010-12#1)
optimizing the design of##2##4##(2008-3#1)(2012-1#1)
optimizing the design##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
optimizing the management of##2##4##(2008-7#1)(2013-1#1)
optimizing the##32##2##(1996-12#1)(1996-6#2)(1997-2#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-8#1)(2012-1#1)(2013-1#2)(2013-8#1)
optimizing their##2##2##(1996-1#1)(2013-1#1)
optimizing##89##1##(1993-3#1)(1996-1#1)(1996-12#1)(1996-6#2)(1997-2#1)(2006-10#3)(2007-12#2)(2008-1#4)(2008-10#12)(2008-11#4)(2008-2#5)(2008-3#16)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
optimum SFE conditions##2##3##(2008-10#2)
optimum SFE##3##2##(2008-10#3)
optimum activity at##2##3##(2008-8#1)(2013-1#1)
optimum amount of##3##3##(1996-9#1)(2007-12#1)(2008-10#1)
optimum amounts##2##2##(2008-12#2)
optimum analytical conditions##4##3##(2008-10#4)
optimum analytical##6##2##(2008-10#6)
optimum and##3##2##(2008-10#2)(2008-8#1)
optimum antihypertensive##2##2##(1992-8#2)
optimum at pH##2##3##(1994-3#1)(2006-6#1)
optimum at##8##2##(1994-3#1)(2006-6#1)(2008-10#6)
optimum beam##4##2##(2008-2#1)(2008-3#3)
optimum choice##2##2##(1991-3#1)(2008-3#1)
optimum closed-loop bandwidth##2##3##(2008-2#2)
optimum coacervation occurred##2##3##(2010-5#2)
optimum concentration of##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
optimum concentration was##2##3##(2008-5#1)(2013-1#1)
optimum concentration##8##2##(1996-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2013-1#1)
optimum condition##11##2##(2008-10#11)
optimum conditions established##2##3##(2008-10#2)
optimum conditions for separation##2##4##(2008-10#2)
optimum conditions for the##13##4##(2008-10#13)
optimum conditions for##29##3##(1994-3#1)(2007-12#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2010-5#1)
optimum conditions obtained by the##2##5##(2008-10#2)
optimum conditions obtained##3##3##(2008-10#3)
optimum conditions of##3##3##(2008-10#3)
optimum conditions the##2##3##(2008-10#1)(2008-3#1)
optimum conditions were found to##2##5##(2008-10#2)
optimum conditions were##9##3##(2008-10#9)
optimum conditions##128##2##(1994-3#1)(2007-12#5)(2008-10#114)(2008-11#2)(2008-12#1)(2008-3#3)(2010-5#1)(2013-1#1)
optimum control##2##2##(2008-10#1)(2008-3#1)
optimum design##2##2##(2008-2#1)(2008-3#1)
optimum dose of##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
optimum dose##5##2##(1993-6#1)(2008-10#2)(2008-4#1)(2013-1#1)
optimum experimental conditions for##3##4##(2008-10#3)
optimum experimental conditions were investigated##3##5##(2008-10#3)
optimum experimental conditions were##5##4##(2008-10#5)
optimum experimental conditions##14##3##(2008-10#14)
optimum flow rate of##3##4##(2008-10#3)
optimum flow rate##4##3##(2008-10#4)
optimum for##3##2##(1993-3#1)(2008-10#2)
optimum in##2##2##(1997-4#1)(2008-9#1)
optimum level##3##2##(1997-2#1)(2008-6#1)(2012-2#1)
optimum model##2##2##(2007-10#2)
optimum number of factors##2##4##(2008-10#2)
optimum of##5##2##(1990-2#1)(1993-11#1)(1994-5#1)(2008-10#1)(2008-2#1)
optimum operating conditions##4##3##(2008-10#3)(2008-3#1)
optimum operating##5##2##(2008-10#3)(2008-3#2)
optimum operation##2##2##(2007-12#1)(2008-10#1)
optimum pH and temperature##3##4##(1991-12#1)(1992-11#1)(2008-10#1)
optimum pH and##4##3##(1991-12#1)(1992-11#1)(2008-10#2)
optimum pH for the##4##4##(1990-7#2)(2008-10#2)
optimum pH for##5##3##(1990-2#1)(1990-7#2)(2008-10#2)
optimum pH of##2##3##(1990-12#1)(2008-9#1)
optimum pH range was##2##4##(2008-10#2)
optimum pH range##5##3##(2008-10#5)
optimum pH##35##2##(1990-12#1)(1990-2#1)(1990-7#5)(1991-12#1)(1992-11#1)(1994-8#1)(1997-2#1)(2008-10#23)(2008-9#1)
optimum parameters for##2##3##(2008-10#1)(2013-1#1)
optimum parameters##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
optimum performance is##2##3##(2008-3#2)
optimum performance of##2##3##(2008-10#1)(2010-2#1)
optimum performance##6##2##(2008-10#2)(2008-3#3)(2010-2#1)
optimum polarization orientation of the##2##5##(2008-3#2)
optimum polarization##4##2##(2008-3#4)
optimum procedures##2##2##(2008-10#2)
optimum pyrolysis and atomization temperatures of##3##6##(2008-10#3)
optimum pyrolysis and atomization temperatures##4##5##(2008-10#4)
optimum range##3##2##(2008-10#3)
optimum ratio##3##2##(2007-12#1)(2010-5#1)(2012-2#1)
optimum reaction conditions were##6##4##(2008-10#6)
optimum reaction conditions##12##3##(2008-10#11)(2013-1#1)
optimum response##3##2##(2008-10#2)(2008-6#1)
optimum results for##2##3##(2008-5#1)(2010-5#1)
optimum results##4##2##(2008-3#1)(2008-5#1)(2009-2#1)(2010-5#1)
optimum sample size##2##3##(2007-7#1)(2008-10#1)
optimum sampling depth##2##3##(2008-10#2)
optimum sampling##3##2##(2008-10#2)(2013-7#1)
optimum sensitivity##2##2##(2008-10#1)(2009-12#1)
optimum separation conditions##2##3##(2008-10#2)
optimum separation##5##2##(2008-10#5)
optimum set of##2##3##(2008-2#1)(2008-7#1)
optimum specific##2##2##(1994-3#1)(2009-11#1)
optimum surface##2##2##(2008-2#2)
optimum temperature for##5##3##(2008-10#3)(2008-11#1)(2008-6#1)
optimum temperature of 25##2##4##(2008-10#1)(2008-5#1)
optimum temperature range##2##3##(2008-10#2)
optimum temperature##17##2##(1997-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#2)(2012-2#1)
optimum temperatures##3##2##(2008-10#3)
optimum thickness##2##2##(2007-11#1)(2008-2#1)
optimum transitions for##2##3##(2008-2#1)(2008-3#1)
optimum value##2##2##(2008-10#1)(2008-3#1)
optimum values of##6##3##(1997-6#1)(2008-10#3)(2008-12#1)(2008-3#1)
optimum values##10##2##(1997-6#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)
optimum was##5##2##(1990-5#2)(2008-10#2)(2008-6#1)
optimum wavelength##2##2##(2008-10#1)(2008-2#1)
optimum working##5##2##(2008-10#5)
optimum##576##1##(1990-12#2)(1990-2#3)(1990-5#2)(1990-7#6)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-6#2)(2007-10#5)(2007-11#8)(2007-12#11)(2007-7#2)(2008-10#323)(2008-11#8)(2008-12#11)(2008-2#26)(2008-3#60)(2008-4#3)(2008-5#6)(2008-6#8)(2008-7#4)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#6)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#2)
optimum-design method##2##2##(2013-8#2)
option and##5##2##(1997-4#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
option as##2##2##(2010-3#1)(2013-1#1)
option but##2##2##(2008-11#1)(2012-12#1)
option for a##2##3##(2010-12#1)(2011-3#1)
option for managing##2##3##(2007-12#1)(2008-10#1)
option for many##2##3##(2008-11#1)(2008-6#1)
option for patients with##5##4##(1994-12#1)(2007-8#1)(2008-4#1)(2010-11#1)(2013-8#1)
option for patients##6##3##(1994-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-11#1)(2013-8#1)
option for the control of##3##5##(2007-6#2)(2008-10#1)
option for the correction of##2##5##(2007-12#1)(2009-10#1)
option for the treatment of##4##5##(2006-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
option for the##15##3##(2006-10#1)(2007-12#1)(2007-6#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#2)
option for##71##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#3)
option in a##2##3##(1993-11#1)(2011-1#1)
option in patients##3##3##(2010-12#2)(2011-2#1)
option in the##4##3##(2006-12#1)(2007-11#1)(2011-3#1)(2012-3#1)
option in##24##2##(1993-11#1)(1997-6#1)(2006-12#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-3#2)(2010-12#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
option is available##2##3##(2007-8#1)(2012-2#1)
option is##8##2##(1993-3#1)(1994-2#1)(2007-11#1)(2007-8#2)(2008-7#1)(2012-12#1)(2012-2#1)
option may##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
option of treatment##2##3##(2007-7#1)(2011-2#1)
option of##14##2##(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
option on##2##2##(1991-1#1)(2010-12#1)
option to reduce##2##3##(2008-7#1)(2013-8#1)
option to##13##2##(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-8#1)
option under##2##2##(1992-2#1)(1997-3#1)
option##198##1##(1991-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-3#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#6)(2007-8#7)(2008-1#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#3)(2010-12#8)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#5)(2011-2#19)(2011-3#4)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#7)(2012-8#1)(2013-1#8)(2013-8#5)
option]##2##1##(1991-3#1)(2011-2#1)
optional unit##2##2##(2008-10#2)
optional##17##1##(1992-11#1)(1994-1#1)(1995-11#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2011-2#1)
optionally##5##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)
options and##17##2##(1992-1#1)(1993-2#1)(1994-1#1)(1995-3#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
options are available for##2##4##(2008-1#1)(2010-8#1)
options are available##4##3##(2008-1#1)(2008-7#1)(2010-6#1)(2010-8#1)
options are##14##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
options available for management of##2##5##(2008-8#1)(2010-8#1)
options available for##3##3##(1997-3#1)(2008-8#1)(2010-8#1)
options available to##5##3##(1991-3#1)(1995-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
options available##16##2##(1991-3#1)(1992-12#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
options because of##2##3##(1994-2#1)(2008-10#1)
options for level##2##3##(2011-2#2)
options for management of##2##4##(2008-3#1)(2008-9#1)
options for patients with##2##4##(2007-12#1)(2010-4#1)
options for patients##5##3##(2007-12#1)(2010-4#1)(2011-2#2)(2012-12#1)
options for surgical##2##3##(2008-12#1)(2013-1#1)
options for the treatment of##5##5##(2007-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
options for the treatment##6##4##(2007-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
options for the##11##3##(2007-11#1)(2007-12#2)(2007-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#2)(2012-2#1)(2013-1#1)
options for##78##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(2007-11#2)(2007-12#5)(2007-2#3)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#5)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)
options from##2##2##(2007-2#1)(2008-10#1)
options have##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
options in the##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
options in##17##2##(1993-2#1)(1995-12#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-12#2)(2008-7#2)(2009-5#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
options include##7##2##(1996-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
options including##2##2##(2008-9#1)(2012-3#1)
options is##3##2##(2008-10#2)(2008-11#1)
options of the##3##3##(1992-12#1)(1993-5#1)(2011-2#1)
options of##8##2##(1992-12#1)(1993-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
options or##2##2##(2008-7#1)(2012-2#1)
options that##5##2##(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)
options to restore##2##3##(2008-8#1)(2012-2#1)
options to##13##2##(1992-12#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-8#3)(2011-1#1)(2011-2#1)(2012-2#1)
options vary##2##2##(1991-6#1)(1993-5#1)
options was##2##2##(2008-10#2)
options were##4##2##(1997-4#1)(2008-10#1)(2012-12#1)(2013-1#1)
options will##2##2##(2010-11#1)(2012-3#1)
options with##2##2##(2008-10#1)(2008-8#1)
options##311##1##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1996-1#5)(1996-12#1)(1996-2#4)(1996-3#4)(1996-9#1)(1997-1#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#4)(2008-1#11)(2008-10#20)(2008-11#9)(2008-12#11)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#15)(2008-8#10)(2008-9#12)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-8#9)(2011-1#6)(2011-2#31)(2011-3#3)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#20)(2013-8#4)
options]##2##1##(2008-4#1)(2012-2#1)
opto-electronic##3##1##(2008-7#2)(2010-5#1)
optoacoustic##2##1##(2008-3#2)
optochemical absorbance##2##2##(2007-12#2)
optode is##4##2##(2008-10#4)
optode membrane for##3##3##(2008-10#3)
optode membrane##10##2##(2008-10#10)
optode with##2##2##(2008-10#2)
optode##26##1##(2007-8#1)(2008-10#25)
optodes##5##1##(2007-12#1)(2008-10#4)
optoelectronic PH##2##2##(2008-3#2)
optoelectronic VLSI##2##2##(2008-2#1)(2008-3#1)
optoelectronic and##2##2##(2008-2#1)(2008-3#1)
optoelectronic chips##2##2##(2008-2#2)
optoelectronic circuits##2##2##(2008-3#2)
optoelectronic device##4##2##(2008-3#4)
optoelectronic devices##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
optoelectronic harmonic mixing##2##3##(2007-11#2)
optoelectronic imaging##3##2##(2008-3#3)
optoelectronic implementation##2##2##(2008-3#2)
optoelectronic integrated circuits##3##3##(2008-2#2)(2008-3#1)
optoelectronic integrated##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
optoelectronic interconnects##3##2##(2008-3#3)
optoelectronic system##4##2##(2008-2#2)(2008-3#1)(2008-7#1)
optoelectronic systems##2##2##(2008-2#1)(2008-3#1)
optoelectronic technology##2##2##(2008-3#2)
optoelectronic##97##1##(2007-11#3)(2007-12#5)(2008-1#2)(2008-2#29)(2008-3#54)(2008-7#2)(2009-5#2)
optoelectronics##3##1##(2007-12#2)(2008-2#1)
optofluidic waveguide##2##2##(2010-8#2)
optofluidic##3##1##(2010-8#2)(2011-1#1)
optogeometrical parameters of the##2##4##(2007-12#1)(2008-3#1)
optogeometrical parameters of##3##3##(2007-12#1)(2008-3#2)
optokinetic afternystagmus ct##2##3##(2008-4#2)
optokinetic afternystagmus##8##2##(2008-4#8)
optokinetic nystagmus gain##2##3##(2008-4#2)
optokinetic nystagmus##6##2##(2008-4#5)(2011-2#1)
optokinetic##15##1##(2008-4#13)(2008-8#1)(2011-2#1)
optomechanical##6##1##(2008-2#1)(2008-3#3)(2012-2#2)
optosensing method##2##2##(2008-10#2)
optosensing properties of##2##3##(2008-10#2)
optosensing##11##1##(2008-10#11)
optosensor for##3##2##(2008-10#3)
optosensor##7##1##(2008-10#7)
optrode is##2##2##(2008-10#2)
optrode system##2##2##(2008-10#2)
optrode##8##1##(2008-10#8)
opuntiarum##3##1##(2008-10#3)
opératoires##4##1##(2011-2#2)(2013-1#2)
or &gt##7##2##(2008-10#4)(2008-12#1)(2008-7#1)(2013-1#1)
or &lt##2##2##(2009-1#1)(2013-1#1)
or &quot##72##2##(1990-11#1)(1990-3#1)(1990-9#2)(1991-12#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-2#2)(1994-1#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-4#2)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#2)(2010-3#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
or 'Rely'##2##2##(2008-10#2)
or (2)##5##2##(1990-11#1)(2008-2#1)(2008-6#1)(2008-9#2)
or (3)##4##2##(1992-12#1)(2007-12#1)(2008-10#1)(2013-7#1)
or (4)##2##2##(2011-2#1)(2013-1#1)
or (DOMBT##2##2##(2008-10#2)
or (b)##3##2##(2008-3#1)(2008-5#1)(2013-8#1)
or (ii)##4##2##(1992-9#1)(1995-6#1)(2008-10#1)(2010-5#1)
or (iii)##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
or -10 kPa##2##3##(2008-10#2)
or -10##3##2##(2008-10#2)(2012-2#1)
or -2##2##2##(1995-5#2)
or -4##2##2##(1995-2#1)(1996-5#1)
or -deficient##6##2##(1997-4#6)
or 0##39##2##(1990-2#2)(1990-6#2)(1992-12#1)(1992-9#1)(1993-1#1)(1994-5#3)(1995-12#2)(1995-2#2)(1995-3#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#10)(2008-3#4)(2008-5#2)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)
or 1 mM##2##3##(1995-3#1)(1996-5#1)
or 1 microM##2##3##(1995-11#1)(1995-12#1)
or 1##42##2##(1991-4#1)(1991-5#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-5#1)(1997-4#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#2)(2012-2#1)(2012-7#1)
or 1%##4##2##(1992-3#1)(2008-10#1)(2008-5#2)
or 1/4##2##2##(2008-11#1)(2008-3#1)
or 10 days##2##3##(1990-12#1)(2008-10#1)
or 10##26##2##(1990-12#2)(1991-2#1)(1993-12#1)(1993-6#1)(1994-5#2)(1995-5#1)(1996-5#2)(1997-7#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
or 10%##5##2##(1995-11#1)(1995-5#1)(2008-10#2)(2011-2#1)
or 10(-5)##2##2##(1994-2#1)(1997-4#1)
or 10(8)##2##2##(1991-11#1)(2008-10#1)
or 100 mg bromodichloromethane/kg body weight in corn oil by gavage##2##11##(2008-9#2)
or 100 mg##3##3##(2008-10#1)(2008-9#2)
or 100 mg/kg in corn oil by gavage##2##8##(2008-9#2)
or 100 mg/kg##5##3##(1997-7#1)(2008-9#4)
or 100 ng/ml##2##3##(1995-6#1)(2008-12#1)
or 100##18##2##(1994-11#1)(1995-11#1)(1995-6#1)(1996-12#3)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#6)
or 100%##3##2##(2008-10#2)(2009-8#1)
or 1000##5##2##(1995-11#1)(1995-3#2)(2008-3#1)(2010-2#1)
or 11##3##2##(1994-1#1)(1995-11#1)(2008-6#1)
or 12 mg dicyclohexylcarbodiimide/kg body weight in ethanol##3##8##(2008-9#3)
or 12 mg pentaerythritol triacrylate/kg body weight in acetone 5 days per week for 14 weeks##2##16##(2008-9#2)
or 12 mg pentaerythritol##3##4##(2008-9#3)
or 12 mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for 14 weeks##2##16##(2008-9#2)
or 12 mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for##3##14##(2008-9#3)
or 12 mg##9##3##(2008-9#9)
or 12 mg/kg##2##3##(2008-9#2)
or 12 weeks##3##3##(2008-10#2)(2008-9#1)
or 12##19##2##(1990-9#1)(1992-11#1)(1996-11#1)(2008-10#2)(2008-9#13)(2013-1#1)
or 12)##2##2##(1995-2#1)(2008-10#1)
or 13##4##2##(1995-5#1)(1996-5#1)(2008-1#1)(2008-9#1)
or 14 days##3##3##(1993-12#1)(1995-3#1)(2007-2#1)
or 14##5##2##(1993-12#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-12#1)
or 15##7##2##(1994-8#1)(2008-10#3)(2008-9#2)(2010-2#1)
or 150##2##2##(1992-9#1)(2008-10#1)
or 16 h##2##3##(2010-8#1)(2011-2#1)
or 16##8##2##(1996-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
or 18##6##2##(1990-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
or 2##37##2##(1990-11#2)(1991-5#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1997-7#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#3)(2011-2#1)(2013-1#3)
or 2) and##2##3##(1990-12#1)(2008-10#1)
or 2)##3##2##(1990-12#1)(2008-10#2)
or 20 degrees C##2##4##(2008-10#2)
or 20##7##2##(2007-7#1)(2008-10#3)(2008-11#1)(2010-2#1)(2011-2#1)
or 20%##2##2##(1993-11#1)(2008-4#1)
or 200 mg pentaerythritol triacrylate/kg body weight in acetone 5 days per week for 17 days##2##16##(2008-9#2)
or 200 mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for 16 days##2##16##(2008-9#2)
or 200 mg##5##3##(2008-10#1)(2008-9#4)
or 200##11##2##(1995-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-12#1)
or 21 days##2##3##(1994-3#1)(2008-10#1)
or 21##3##2##(1992-3#1)(1994-3#1)(2008-10#1)
or 24 h##6##3##(1990-12#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
or 24 hours##2##3##(2007-10#1)(2011-1#1)
or 24##14##2##(1990-11#2)(1990-12#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
or 25 degrees C##4##4##(1994-3#1)(2008-10#3)
or 25 mg##2##3##(2008-10#1)(2011-2#1)
or 25##9##2##(1992-8#1)(1994-3#2)(2008-10#5)(2011-2#1)
or 256 mg sodium bromate/kg body weight##2##7##(2008-9#2)
or 256 mg##3##3##(2008-9#3)
or 27##5##2##(1992-8#2)(2008-10#1)(2008-9#2)
or 28 days##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2010-6#1)
or 28##7##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
or 280##3##2##(1992-12#1)(2008-10#2)
or 29##2##2##(1992-11#1)(2008-10#1)
or 3##28##2##(1990-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-6#1)(2007-10#1)(2008-10#5)(2008-5#4)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#3)
or 3% acesulfame potassium (equivalent to average daily doses of approximately##2##11##(2008-9#2)
or 3%##4##2##(2008-9#3)(2011-2#1)
or 3-amino-1##2##2##(1997-4#1)(2009-2#1)
or 30 degrees C at pH##2##6##(2008-10#2)
or 30 degrees C##5##4##(2008-10#5)
or 30 mg/kg##2##3##(1994-2#1)(2008-10#1)
or 30##20##2##(1991-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(2007-11#1)(2008-10#12)(2012-12#1)(2013-1#1)
or 300##3##2##(1992-3#1)(2008-2#1)(2008-5#1)
or 35##2##2##(2008-10#1)(2012-2#1)
or 36 degrees C##2##4##(2008-10#2)
or 360 sec)##2##3##(2008-5#2)
or 4##22##2##(1990-7#1)(1993-1#1)(1993-12#1)(1996-3#1)(1997-6#1)(2007-8#1)(2008-10#7)(2008-7#1)(2008-9#3)(2009-4#1)(2011-2#2)(2013-1#2)
or 4)##3##2##(2008-10#3)
or 40##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
or 400##3##2##(2008-1#1)(2008-5#1)(2008-9#1)
or 4000 U/kg##2##3##(2010-2#2)
or 41 weeks##6##3##(2008-9#6)
or 42##5##2##(2008-10#1)(2008-9#2)(2009-7#1)(2011-2#1)
or 45##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
or 48 h##4##3##(1991-2#1)(2008-10#3)
or 48##5##2##(1991-2#1)(2008-10#3)(2008-9#1)
or 5##22##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-5#1)(1992-8#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-2#1)(2013-1#1)
or 5%##3##2##(1997-2#1)(2008-4#1)(2010-4#1)
or 5'##3##2##(1994-8#1)(2008-10#1)(2008-7#1)
or 5'-GC##2##2##(2008-11#2)
or 5'-N-ethylcarboxamido-adenosine##2##2##(1995-8#2)
or 50 degrees C##2##4##(1997-6#1)(2008-10#1)
or 50 ppm Cd as CdCl(2)##2##6##(1997-4#2)
or 50 ppm Cd as##3##5##(1997-4#3)
or 50 ppm##4##3##(1997-4#3)(2008-5#1)
or 50##20##2##(1992-12#1)(1994-12#1)(1995-8#1)(1997-4#3)(1997-6#1)(2008-10#7)(2008-5#1)(2008-8#5)
or 50%##4##2##(2007-10#1)(2011-2#1)(2013-8#2)
or 500##4##2##(2008-10#1)(2008-3#1)(2008-9#2)
or 52##2##2##(1993-6#1)(2008-10#1)
or 56%##2##2##(1996-12#1)(2009-12#1)
or 6 h##2##3##(1995-12#1)(2008-7#1)
or 6##14##2##(1990-11#1)(1991-6#1)(1991-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
or 60 min##2##3##(1992-10#1)(1995-12#1)
or 60##4##2##(1991-3#1)(1992-10#1)(1995-12#1)(2008-12#1)
or 60%##2##2##(1995-12#1)(1995-3#1)
or 7##10##2##(1990-3#1)(1991-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-9#1)
or 7%##2##2##(1993-8#1)(1996-11#1)
or 70 mg/kg in ethanol##2##5##(2008-9#2)
or 70 mg/kg##3##3##(2008-9#3)
or 70##5##2##(2006-8#1)(2008-9#4)
or 700 mg/L bromodichloromethane for 26 weeks (equivalent to average daily doses of approximately##2##14##(2008-9#2)
or 700 mg/L bromodichloromethane for##3##5##(2008-9#3)
or 700 mg/L##6##3##(2008-9#6)
or 72 h of##2##4##(1995-11#1)(2008-7#1)
or 75##2##2##(2008-10#1)(2008-5#1)
or 8 weeks##2##3##(1992-3#1)(2013-1#1)
or 8##8##2##(1992-3#1)(1994-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
or 800 mg/L sodium bromate for 27 weeks (equivalent to average daily doses of approximately##2##15##(2008-9#2)
or 800 mg/L sodium bromate for 43 weeks (equivalent to average daily doses of approximately##2##15##(2008-9#2)
or 800 mg/L sodium bromate for##4##6##(2008-9#4)
or 800 mg/L##5##3##(2008-9#5)
or 800##6##2##(2008-9#6)
or 9##6##2##(1990-8#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-8#2)
or 90##6##2##(1995-12#1)(2006-8#1)(2007-12#1)(2008-5#2)(2009-5#1)
or 900##2##2##(1990-5#1)(2012-3#1)
or 96##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
or 99%##2##2##(2008-10#2)
or = 0##14##3##(1992-11#1)(1994-12#1)(1996-2#2)(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-2#2)
or = 1##10##3##(1994-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(2008-3#2)(2008-5#1)(2011-2#3)
or = 10 mm##2##4##(1994-9#1)(1997-5#1)
or = 10##5##3##(1993-11#1)(1994-9#1)(1997-1#1)(1997-5#2)
or = 100##2##3##(1994-8#1)(1995-5#1)
or = 14)##2##3##(2008-7#2)
or = 15##2##3##(1994-12#1)(1995-3#1)
or = 2##7##3##(1992-10#1)(1992-9#1)(1995-5#4)(2008-5#1)
or = 20 microM##2##4##(1995-8#2)
or = 20##9##3##(1995-8#4)(1997-1#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)
or = 30##5##3##(1994-12#1)(2007-10#1)(2008-3#1)(2011-2#2)
or = 32##2##3##(1995-6#1)(2008-12#1)
or = 35 yrs)##2##4##(2012-3#2)
or = 35##3##3##(1997-2#1)(2012-3#2)
or = 37##2##3##(1994-3#1)(2008-7#1)
or = 4##3##3##(1996-1#1)(1996-5#1)(2008-5#1)
or = 40##3##3##(1994-9#2)(1995-12#1)
or = 4g/dl##2##3##(1996-12#2)
or = 5##8##3##(1993-8#4)(1994-12#2)(1994-3#1)(1997-5#1)
or = 6 and 40 healthy controls were collected by sterile curette##2##12##(2008-12#2)
or = 70##2##3##(2008-1#1)(2008-3#1)
or = 8##2##3##(1992-9#1)(2008-7#1)
or =##142##2##(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-8#4)(1994-12#8)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#5)(1995-6#3)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#10)(1997-6#3)(1997-8#3)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#1)(2009-5#7)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#2)
or =0##3##2##(2008-10#2)(2009-4#1)
or =1##3##2##(2008-10#2)(2011-2#1)
or =10##2##2##(2008-10#1)(2010-3#1)
or =150 ms in the ischaemic group##2##7##(2008-10#2)
or =150 ms##3##3##(2008-10#3)
or =2##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
or =20##2##2##(2008-11#1)(2011-1#1)
or =25 Kg/m2)##2##3##(2008-10#2)
or =25##5##2##(2008-10#3)(2011-2#2)
or =3##2##2##(2008-10#2)
or =30##3##2##(2008-3#2)(2008-7#1)
or =30%##2##2##(2009-4#2)
or =4##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
or =6##3##2##(2008-10#3)
or =60##3##2##(2008-3#1)(2008-7#2)
or A23187##3##2##(1991-5#1)(1994-3#1)(2008-11#1)
or ACBP##2##2##(1994-8#2)
or ADP##6##2##(1992-3#4)(1992-6#1)(1997-7#1)
or AIDS##6##2##(1992-1#1)(1992-2#1)(1995-6#2)(2008-5#2)
or APLP2 mRNA##2##3##(1996-12#2)
or Ala##2##2##(1990-11#1)(1995-2#1)
or Ar atoms##3##3##(2010-4#3)
or Ar##5##2##(2010-4#5)
or Asian##3##2##(2008-12#1)(2010-11#1)(2010-8#1)
or B##14##2##(1990-8#1)(1993-11#1)(1995-3#1)(1997-5#4)(1997-6#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-6#1)
or BuONa##2##2##(1993-8#2)
or C##13##2##(1992-6#1)(2007-12#2)(2008-10#6)(2008-5#1)(2009-8#1)(2012-3#1)(2013-8#1)
or C-terminal##7##2##(1992-5#1)(1992-9#2)(1996-12#1)(1996-6#1)(2008-9#1)(2011-2#1)
or C6##2##2##(1992-6#1)(2012-2#1)
or CCK-8##2##2##(1995-11#1)(1995-12#1)
or CCK-8-induced [14C]aminopyrine accumulation##2##4##(1995-12#2)
or CFA##2##2##(1995-3#2)
or CHO-CHO##2##2##(2013-1#2)
or CI##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
or CS from the patient perspective is needed##2##8##(2013-1#2)
or CS##3##2##(2008-10#1)(2013-1#2)
or CT##6##2##(2007-11#2)(2007-8#1)(2008-10#1)(2009-7#1)(2013-1#1)
or Ca(2+) channel##2##3##(2008-8#1)(2012-2#1)
or Ca(2+)##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
or Ca2+##3##2##(1990-5#1)(1994-6#1)(1995-5#1)
or CaCl(2)##2##2##(2008-10#2)
or Cl##3##2##(1997-7#3)
or Co(2+)##2##2##(2008-11#1)(2008-8#1)
or Crohn's disease##3##3##(1991-8#1)(1994-2#1)(2009-12#1)
or Cu(II)##2##2##(2008-10#1)(2011-1#1)
or D##7##2##(1994-2#1)(1995-8#1)(2008-10#1)(2009-8#1)(2010-7#3)
or DNA constituents##2##3##(2008-10#2)
or DNA sequence##3##3##(2008-10#1)(2008-9#1)(2009-2#1)
or DNA##25##2##(1992-3#1)(1994-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#5)(2008-9#3)(2009-2#1)
or DTT##6##2##(1992-3#5)(1994-12#1)
or Dynastab stabilizers##2##3##(2007-8#2)
or E##7##2##(1992-9#1)(2008-1#1)(2008-10#5)
or EC##2##2##(1993-6#1)(1994-2#1)
or EGF##2##2##(1990-8#1)(1995-8#1)
or EGTA##2##2##(1993-6#1)(1995-6#1)
or Escherichia coli##2##3##(2008-10#1)(2008-7#1)
or European##2##2##(2007-7#1)(2008-10#1)
or F##7##2##(1992-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#3)
or G##7##2##(1990-12#1)(1992-3#2)(1993-9#1)(2008-10#2)(2013-8#1)
or G-CSF in##2##3##(2008-7#2)
or GM-CSF##4##2##(1993-6#2)(1995-6#1)(1997-4#1)
or GTP gamma S##2##4##(1991-6#1)(1992-8#1)
or GTP##3##2##(1990-7#1)(1991-6#1)(1992-8#1)
or Glu##2##2##(1990-5#1)(1992-6#1)
or H##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
or H2##4##2##(1995-10#2)(2008-10#1)(2008-4#1)
or HAP##3##2##(2008-9#3)
or HIV infection##2##3##(1997-5#1)(2008-10#1)
or HIV##5##2##(1997-3#1)(1997-5#1)(2008-10#1)(2008-12#1)(2009-5#1)
or HLA##2##2##(2008-4#1)(2011-2#1)
or HNO(3)##6##2##(2008-10#6)
or I##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
or IGF##2##2##(1993-9#1)(2008-4#1)
or IGF-I##3##2##(1991-12#1)(1992-3#2)
or II##5##2##(2008-11#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
or III##3##2##(1995-12#1)(2007-12#1)(2008-9#1)
or IL-10##2##2##(1996-12#2)
or IPRO##3##2##(2008-10#3)
or IV##4##2##(1992-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
or IgM##2##2##(1991-11#1)(1996-12#1)
or K+##3##2##(1993-11#1)(1993-3#1)(1995-12#1)
or KCl##2##2##(1992-6#1)(1996-2#1)
or KT##3##2##(2008-9#3)
or L##2##2##(1990-12#1)(2008-5#1)
or LPS##2##2##(1995-12#1)(2008-11#1)
or LS-CMV##2##2##(2008-10#2)
or LTP##2##2##(1995-2#1)(1996-2#1)
or M##9##2##(2007-11#1)(2008-10#7)(2008-3#1)
or MG##2##2##(2007-12#1)(2008-10#1)
or MR##2##2##(1995-3#1)(2012-12#1)
or MRI##8##2##(2007-11#2)(2007-8#1)(2008-1#2)(2008-7#1)(2010-5#1)(2012-12#1)
or MRP##2##2##(2008-11#2)
or MY(2-)) species are##2##4##(2008-10#2)
or Medicaid##2##2##(1992-1#1)(1995-12#1)
or Mg2+##4##2##(1992-3#1)(1995-5#1)(1995-6#1)(1997-3#1)
or Middle##2##2##(2008-10#2)
or Monte Carlo##2##3##(2008-2#1)(2008-4#1)
or N##4##2##(1992-3#1)(2008-10#2)(2008-7#1)
or NADPH##2##2##(1991-2#1)(2008-10#1)
or NMR##3##2##(2008-4#2)(2011-1#1)
or NaOH##2##2##(1992-3#1)(2008-10#1)
or Naphtylazoxine 6S and Cd(2+)##2##5##(2008-10#2)
or Nucleus##3##2##(2008-9#1)(2012-2#2)
or O3##3##2##(1992-9#2)(1995-3#1)
or P &lt##4##3##(2008-10#2)(2011-3#2)
or P##11##2##(1995-11#1)(2008-10#6)(2011-3#2)(2012-12#1)(2012-2#1)
or PB-induced##2##2##(1994-8#2)
or PCR##3##2##(1994-1#1)(2008-10#1)(2008-4#1)
or PGE2##2##2##(1990-11#1)(1993-12#1)
or PKC##3##2##(1991-12#1)(1992-3#2)
or PMA##2##2##(1991-9#1)(1993-6#1)
or PS##2##2##(1993-11#1)(2008-10#1)
or Pseudomonas##2##2##(1993-3#1)(2008-10#1)
or Pt##2##2##(2008-10#1)(2008-11#1)
or Pyricularia grisea##2##3##(2008-10#1)(2008-9#1)
or R##2##2##(1990-8#1)(2008-10#1)
or R1##2##2##(2008-10#1)(2011-2#1)
or RNA probes##3##3##(2008-4#3)
or RNA##6##2##(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)
or RNAi##2##2##(2008-9#1)(2012-2#1)
or RT-PCR##2##2##(1997-3#1)(2008-6#1)
or S##4##2##(2008-10#3)(2009-2#1)
or SA##3##2##(2008-10#2)(2011-2#1)
or SigmaFe##2##2##(2008-10#2)
or Sitisi##2##2##(2008-1#2)
or Swingle citrumelo##2##3##(2008-10#2)
or T cell##2##3##(2008-4#1)(2008-5#1)
or T##8##2##(1993-8#1)(1993-9#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
or T3##2##2##(1993-8#1)(2008-10#1)
or T4##3##2##(1992-5#1)(1997-3#1)(2008-10#1)
or TA1535##2##2##(2008-8#1)(2008-9#1)
or TGF-beta##2##2##(1992-9#1)(2008-6#1)
or TiO(2)##2##2##(2008-10#1)(2010-6#1)
or Tris##4##2##(2008-10#3)(2008-5#1)
or Type##2##2##(2008-3#1)(2008-8#1)
or U0126##2##2##(2008-11#1)(2008-4#1)
or UTR (for##2##3##(2008-10#2)
or UV irradiation##2##3##(2008-5#2)
or UV##3##2##(1994-8#1)(2008-5#2)
or V##4##2##(1992-12#1)(2008-10#1)(2009-6#1)(2012-3#1)
or W##3##2##(2008-10#2)(2010-5#1)
or X##2##2##(1997-7#1)(2008-10#1)
or Zn(2+)##4##2##(2008-10#2)(2008-4#1)(2012-12#1)
or Zn2+##2##2##(1994-5#1)(1995-6#1)
or a circular##2##3##(2008-2#1)(2008-3#1)
or a combination of 4 microg each of##2##8##(2009-5#2)
or a combination of both##3##5##(2008-1#1)(2010-7#1)(2011-1#1)
or a combination of the##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
or a combination of##18##4##(1992-3#1)(1994-11#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)
or a combination##19##3##(1992-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-9#1)
or a control group##3##4##(2007-11#1)(2008-12#1)(2009-12#1)
or a control##8##3##(1991-11#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#1)(2012-3#1)
or a conventional##2##3##(2008-10#2)
or a derivative##2##3##(1992-3#1)(2009-5#1)
or a different##3##3##(2008-3#1)(2008-4#1)(2011-2#1)
or a fluorescent##2##3##(1994-12#1)(2008-4#1)
or a group##2##3##(2010-5#2)
or a high##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
or a laboratory##2##3##(1994-6#1)(2008-3#1)
or a large##4##3##(1990-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
or a long##3##3##(1994-3#2)(2007-12#1)
or a lower##2##3##(2008-7#1)(2012-3#1)
or a mixture of##2##4##(2008-10#1)(2008-7#1)
or a more##2##3##(1992-6#1)(2008-2#1)
or a new##3##3##(2007-10#1)(2008-2#1)(2008-5#1)
or a nuclear##2##3##(1995-2#1)(2008-10#1)
or a part of the##3##5##(1991-12#1)(2008-10#1)(2008-7#1)
or a part of##4##4##(1991-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
or a placebo##3##3##(2008-5#3)
or a product of##2##4##(1990-8#1)(1996-5#1)
or a separate##2##3##(1995-6#1)(1996-3#1)
or a single##3##3##(1995-6#1)(2008-10#1)(2011-1#1)
or a small##2##3##(1995-12#1)(2008-10#1)
or a specific##2##3##(1994-3#1)(2008-4#1)
or a##355##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#7)(1992-5#3)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#7)(1994-5#1)(1994-6#4)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#3)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#47)(2008-11#6)(2008-12#1)(2008-2#21)(2008-3#22)(2008-4#10)(2008-5#9)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#5)(2012-9#1)(2013-1#7)(2013-7#2)(2013-8#10)
or abdominal##8##2##(1990-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
or abiotic##3##2##(2008-10#1)(2008-8#1)(2012-1#1)
or abnormal##7##2##(1995-3#1)(1996-12#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
or abolished##2##2##(1991-6#1)(1992-9#1)
or abortion##2##2##(1994-2#1)(2007-10#1)
or above a##3##3##(1996-12#2)(2008-10#1)
or above##13##2##(1996-12#2)(1996-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#2)(2013-7#1)
or absence of a##7##4##(1991-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
or absence of the##11##4##(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#6)(2008-5#1)(2008-6#1)
or absence of##76##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#3)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#28)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#4)(2009-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)
or absence##82##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#3)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)
or absent##12##2##(1991-11#1)(1992-11#1)(1992-6#1)(1993-9#1)(1995-3#1)(1995-5#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-3#1)(2013-1#1)
or absorbing##4##2##(2008-2#1)(2008-3#2)(2011-2#1)
or absorption##2##2##(2008-3#1)(2008-7#1)
or acceleration##2##2##(2008-10#1)(2013-1#1)
or acceptors##2##2##(1990-7#1)(1994-5#1)
or accessory##2##2##(2008-10#1)(2013-1#1)
or accidental##5##2##(1994-3#1)(2007-11#2)(2008-10#1)(2010-3#1)
or accumulation##2##2##(2008-10#1)(2008-11#1)
or accuracy##2##2##(2008-10#1)(2008-7#1)
or acetone##2##2##(1995-11#1)(2008-10#1)
or acetonitrile##2##2##(1995-6#1)(2008-10#1)
or acid digested##2##3##(2008-10#2)
or acid##5##2##(2008-10#3)(2008-9#1)(2013-1#1)
or acquired##9##2##(1990-6#1)(1991-6#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2013-1#1)
or acquired)##2##2##(2008-11#1)(2011-2#1)
or acquiring##2##2##(1997-3#1)(2008-11#1)
or across##4##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
or act##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
or action##2##2##(1996-2#1)(2010-11#1)
or activated##4##2##(1990-12#1)(1994-11#1)(2008-10#1)(2008-4#1)
or activation of the##2##4##(2008-10#1)(2012-2#1)
or activation of##5##3##(1997-2#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
or activation##7##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#1)(2012-3#1)
or active##6##2##(1991-1#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)
or activity##7##2##(1993-8#1)(1994-5#1)(1995-3#2)(2008-1#1)(2012-2#1)(2013-7#1)
or actual##2##2##(1996-8#1)(2008-12#1)
or acute##7##2##(1992-9#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
or addition of##4##3##(1992-3#1)(2007-8#1)(2008-10#1)(2009-12#1)
or additional##3##2##(2008-10#2)(2008-8#1)
or adherent##3##2##(1990-3#1)(2008-4#2)
or adhesion##2##2##(2008-1#1)(2012-12#1)
or adipose##3##2##(1995-11#1)(2009-10#1)(2012-5#1)
or adjacent to##3##3##(1997-3#1)(2008-7#1)(2009-12#1)
or adjunctive##2##2##(1992-12#1)(2011-2#1)
or adjuvant##2##2##(1994-12#1)(2013-1#1)
or admitted to##2##3##(1995-2#1)(2008-11#1)
or adolescence##2##2##(2007-7#1)(2012-12#1)
or adult##8##2##(1991-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-7#1)
or adults##2##2##(2008-10#2)
or advanced##2##2##(2010-11#1)(2012-2#1)
or adverse effects##2##3##(2010-5#1)(2013-1#1)
or adverse##4##2##(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
or aerobic##2##2##(2008-5#1)(2013-1#1)
or aerosol##3##2##(2008-2#2)(2008-3#1)
or affective##2##2##(1994-2#1)(2008-9#1)
or affinity##5##2##(1994-6#1)(2008-4#1)(2008-6#1)(2008-7#2)
or after a##7##3##(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-9#1)(2012-12#2)
or after stimulation with##2##4##(1991-2#1)(1994-2#1)
or after the##7##3##(1991-3#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
or after their##2##3##(2008-2#1)(2010-3#1)
or after treatment##2##3##(1992-3#1)(2010-8#1)
or after##68##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-5#4)(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#2)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-3#2)(2010-8#3)(2011-2#2)(2012-12#3)(2013-1#4)(2013-8#1)
or against##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
or age##11##2##(1991-2#1)(1993-9#1)(1995-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#2)
or age-related##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)
or aggregate##2##2##(2008-10#2)
or aggregates##3##2##(2008-10#2)(2008-11#1)
or aggressive##2##2##(1995-2#1)(2011-10#1)
or aging##2##2##(2008-4#1)(2011-2#1)
or air##2##2##(1991-12#1)(1992-11#1)
or alcohol##9##2##(1992-12#1)(1994-2#1)(1995-10#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)
or alcoholism##3##2##(1991-12#1)(1993-2#1)(2006-10#1)
or aldehyde##4##2##(1994-8#1)(2010-7#3)
or alkaline phosphatase##4##3##(2008-10#1)(2008-4#3)
or alkaline##8##2##(2007-11#1)(2008-10#4)(2008-4#3)
or all of the##2##4##(1992-12#1)(2008-10#1)
or all of##4##3##(1992-12#1)(2007-12#1)(2008-10#2)
or all three##3##3##(1992-3#1)(1997-3#1)(2008-10#1)
or all##16##2##(1990-12#1)(1992-12#1)(1992-3#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
or all-cause mortality##2##3##(2010-1#1)(2010-2#1)
or allelic##2##2##(2008-10#1)(2013-1#1)
or allergic##3##2##(2008-7#1)(2010-6#1)(2013-1#1)
or allograft##2##2##(2008-5#1)(2010-7#1)
or along##2##2##(1995-8#1)(2008-9#1)
or alpha##3##2##(1995-11#1)(2008-7#1)(2010-7#1)
or altered##7##2##(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
or altering##2##2##(2008-11#1)(2008-7#1)
or alternative##6##2##(1992-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
or alternatively by streaking or spreading a plate##2##8##(2008-2#1)(2008-9#1)
or alternatively by##3##3##(1992-3#1)(2008-2#1)(2008-9#1)
or alternatively##7##2##(1992-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
or ambiguous##2##2##(2008-7#1)(2011-2#1)
or amino##2##2##(2008-9#1)(2013-1#1)
or ammonia##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
or among##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
or amperometric##3##2##(2008-10#3)
or amphetamine (1##2##3##(1994-2#2)
or amphipathic##2##2##(1995-3#1)(2006-12#1)
or amputation##2##2##(1990-3#1)(2008-6#1)
or amygdala##5##2##(1993-6#5)
or an abnormal##2##3##(1994-3#1)(2010-8#1)
or an adjacent##2##3##(1990-5#1)(1997-7#1)
or an alkaline##2##3##(2008-10#1)(2008-7#1)
or an increase in##3##4##(2008-7#1)(2009-12#1)(2012-3#1)
or an increase##4##3##(2008-7#1)(2009-12#1)(2012-3#1)(2012-5#1)
or an integrated##2##3##(1996-1#1)(2008-12#1)
or an object##2##3##(2011-1#1)(2013-8#1)
or an##82##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1994-11#3)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
or anal##2##2##(1996-8#1)(2010-7#1)
or analysis of##3##3##(1992-9#1)(2008-4#2)
or analytical##2##2##(2008-3#1)(2013-1#1)
or anatomical##2##2##(1994-11#1)(2007-10#1)
or androgen##2##2##(1996-5#1)(2008-11#1)
or angiography##2##2##(2007-10#1)(2011-2#1)
or angiotensin II##4##3##(1995-12#1)(1996-2#1)(1996-6#1)(2008-11#1)
or angle##2##2##(2008-3#1)(2011-2#1)
or animal##3##2##(1997-4#1)(2008-11#2)
or animals##4##2##(1990-5#1)(2007-12#1)(2008-9#1)(2013-7#1)
or anionic##2##2##(2008-8#1)(2008-9#1)
or another##6##2##(1991-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
or antagonist##4##2##(1991-6#1)(1992-3#1)(1997-4#1)(2008-9#1)
or antagonistic effects##2##3##(2008-10#2)
or antagonistic##3##2##(2008-10#3)
or anti##2##2##(1991-11#1)(2011-2#1)
or antibodies##4##2##(1997-4#1)(2007-2#1)(2008-10#1)(2010-5#1)
or antibody##2##2##(1994-6#1)(2008-9#1)
or antigen##6##2##(1990-8#1)(1997-7#1)(2008-11#1)(2011-2#2)(2012-2#1)
or antigen-induced##2##2##(1992-11#1)(2008-4#1)
or antisense##2##2##(2008-10#1)(2008-6#1)
or anxiety##2##2##(2008-2#1)(2013-8#1)
or any combination of##2##4##(1991-8#1)(1992-12#1)
or any other##7##3##(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-6#1)(2013-1#1)
or any##17##2##(1991-8#1)(1992-12#1)(1993-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
or apoptosis of##2##3##(2008-5#1)(2012-1#1)
or apoptosis##5##2##(1995-2#2)(2008-11#1)(2008-5#1)(2012-1#1)
or apoptotic##2##2##(2008-10#1)(2008-11#1)
or apple##3##2##(2008-10#3)
or applied##4##2##(2008-10#2)(2008-12#2)
or approaches##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
or approximately##4##2##(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#1)
or aqueous##5##2##(2008-10#5)
or arachidonic acid##2##3##(1992-8#1)(2009-12#1)
or arachidonic##3##2##(1992-8#1)(1994-2#1)(2009-12#1)
or are in##2##3##(1995-5#1)(2008-11#1)
or are not##3##3##(1992-9#1)(2008-4#1)(2008-8#1)
or are##37##2##(1991-1#3)(1991-12#1)(1992-3#1)(1992-9#1)(1995-5#1)(1996-12#2)(1996-5#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#2)
or area of##2##3##(2008-3#1)(2012-2#1)
or area##5##2##(1994-9#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
or around the##2##3##(1992-12#1)(2008-8#1)
or around##3##2##(1992-12#1)(1996-8#1)(2008-8#1)
or arrays##3##2##(2007-11#1)(2008-2#2)
or arrhythmia##2##2##(2008-7#2)
or artery##3##2##(1996-3#1)(2008-4#1)(2008-7#1)
or arthrodesis##2##2##(2008-8#1)(2011-2#1)
or artificial##3##2##(2008-10#2)(2008-11#1)
or as a##20##3##(1991-12#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-8#1)
or as an##8##3##(1996-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#1)
or as part of##5##4##(2007-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
or as result of##2##4##(1997-8#1)(2008-7#1)
or as##81##2##(1990-12#1)(1990-6#1)(1991-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#3)
or ascorbic acid##2##3##(2008-10#1)(2009-10#1)
or assessment##2##2##(2008-10#1)(2008-11#1)
or assisted##7##2##(1991-8#6)(2007-12#1)
or associated with other##2##4##(1993-6#1)(2011-2#1)
or associated with##4##3##(1993-6#1)(2008-5#1)(2008-9#1)(2011-2#1)
or associated##8##2##(1990-2#1)(1991-12#1)(1993-6#1)(1996-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
or association##2##2##(2008-4#1)(2012-2#1)
or associations##4##2##(1997-5#1)(2007-7#2)(2008-4#1)
or asymmetric##2##2##(1997-4#1)(2008-3#1)
or asymptomatic##3##2##(2007-7#1)(2008-12#1)(2009-8#1)
or asystole##2##2##(1992-5#1)(2010-1#1)
or at 45 degrees##3##4##(2008-2#1)(2008-5#2)
or at a##8##3##(1990-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
or at any##2##3##(1991-3#1)(1994-8#1)
or at high##2##3##(1994-2#1)(2008-10#1)
or at least to##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
or at least##17##3##(1993-3#2)(1993-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#2)(2012-1#1)(2012-12#1)(2012-5#1)
or at risk for##2##4##(2008-11#1)(2012-12#1)
or at the time of##2##5##(1994-6#1)(2013-1#1)
or at the##9##3##(1994-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2010-4#1)(2013-1#1)
or at worst##2##3##(2008-11#1)(2011-2#1)
or at##73##2##(1990-9#1)(1991-3#1)(1992-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#14)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-5#1)(2013-1#2)
or atomic##3##2##(2008-10#3)
or atopy##2##2##(2010-6#2)
or atrophy##2##2##(2008-10#1)(2012-2#1)
or atypical##3##2##(1992-9#1)(1996-11#1)(2007-11#1)
or autoimmune diseases##2##3##(1991-11#1)(2010-12#1)
or autoimmune##3##2##(1991-11#1)(2010-12#1)(2011-2#1)
or autoimmunity##2##2##(2008-10#1)(2012-12#1)
or autologous##3##2##(2007-9#1)(2008-4#1)(2011-2#1)
or automatic##2##2##(2008-11#1)(2008-8#1)
or autopsy##2##2##(1990-5#1)(2013-7#1)
or average##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
or avirulent##2##2##(2008-10#2)
or avoid##2##2##(2011-2#1)(2013-1#1)
or avoidance##3##2##(1993-3#1)(1997-7#1)(2008-10#1)
or bFGF##3##2##(1991-12#2)(2008-7#1)
or background##3##2##(2008-9#1)(2010-3#1)(2010-4#1)
or bacteria##2##2##(2008-2#1)(2013-8#1)
or bacterial##6##2##(1995-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#2)
or bad##2##2##(1997-4#1)(2008-11#1)
or based on##2##3##(2008-9#1)(2011-2#1)
or baseline##2##2##(2010-12#1)(2013-8#1)
or basic##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
or be a##2##3##(2007-12#1)(2008-9#1)
or be##8##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)
or beam##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
or became##2##2##(1992-5#1)(2007-10#1)
or because they##3##3##(2008-10#1)(2008-4#1)(2010-7#1)
or because##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)
or become##2##2##(1997-7#1)(2013-1#1)
or becoming##2##2##(2008-9#1)(2012-12#1)
or before##6##2##(1991-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
or behavioral##5##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
or behaviors##3##2##(1996-9#1)(2012-2#1)(2013-1#1)
or behaviour##3##2##(1991-8#1)(1994-2#1)(1995-2#1)
or being##7##2##(1991-8#1)(1997-8#1)(2008-7#1)(2010-3#1)(2012-12#2)(2012-2#1)
or below the##6##3##(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#2)
or below##10##2##(1990-12#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-3#2)
or beneficial##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
or benign##5##2##(1990-3#1)(1990-6#1)(1990-8#1)(1992-2#1)(1993-1#1)
or beta##10##2##(1990-7#3)(1992-3#1)(1992-9#1)(1993-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
or better than the##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
or better than those##2##4##(2008-10#2)
or better than##9##3##(1996-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)
or better##23##2##(1991-3#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2010-7#1)(2013-7#1)
or between groups##2##3##(1997-9#1)(2008-7#1)
or between the##7##3##(1991-8#1)(1993-3#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-12#1)(2009-10#1)
or between##20##2##(1990-12#1)(1991-8#1)(1993-3#1)(1994-6#1)(1996-1#1)(1997-9#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
or bilateral##10##2##(1990-5#1)(1992-11#1)(1993-1#1)(1994-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#2)(2012-12#1)
or binding##2##2##(1997-2#1)(2008-11#1)
or biochemical##6##2##(1990-3#1)(1990-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
or biological##13##2##(1990-9#1)(2006-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)
or biologically##2##2##(1993-9#1)(2008-9#1)
or biopsy##2##2##(2012-2#1)(2013-1#1)
or bisexual##3##2##(1992-2#1)(2008-12#1)(2010-8#1)
or black##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
or bladder##4##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-4#1)
or bleeding##3##2##(1990-11#1)(2008-7#1)(2013-8#1)
or block the##2##3##(1990-5#1)(1994-11#1)
or block##3##2##(1990-5#1)(1994-11#1)(2008-12#1)
or blockade of##2##3##(2008-3#1)(2008-5#1)
or blocked##2##2##(1992-3#1)(2008-2#1)
or blood products##4##3##(1992-6#1)(2009-5#1)(2011-3#1)(2013-1#1)
or blood##9##2##(1992-12#1)(1992-6#1)(1994-9#1)(1997-3#1)(2008-1#1)(2008-11#1)(2009-5#1)(2011-3#1)(2013-1#1)
or blue##3##2##(1990-12#1)(2008-11#1)(2008-3#1)
or body##6##2##(1990-3#1)(1991-11#1)(1995-6#1)(2008-5#1)(2012-2#2)
or bone marrow cells##2##4##(1990-3#1)(2008-4#1)
or bone marrow##6##3##(1990-3#1)(2007-10#1)(2008-4#2)(2008-9#1)(2012-12#1)
or bone##13##2##(1990-3#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
or bony##2##2##(2008-6#1)(2013-1#1)
or both and##2##3##(2008-10#2)
or both fungicides##2##3##(2008-10#2)
or both in the##2##4##(2008-10#1)(2010-3#1)
or both in##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
or both the##2##3##(2010-8#1)(2013-8#1)
or both##93##2##(1990-12#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
or both)##2##2##(1991-4#1)(1994-12#1)
or both?##6##2##(1995-8#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
or bound##4##2##(2008-10#4)
or bovine##4##2##(2008-11#2)(2008-7#1)(2010-8#1)
or brain##7##2##(1990-11#1)(1993-1#1)(1997-9#1)(2008-10#1)(2008-2#2)(2011-2#1)
or brainstem##2##2##(1991-5#1)(2007-10#1)
or breaking##2##2##(1995-2#1)(2008-10#1)
or breeding##2##2##(2008-8#2)
or bright##2##2##(2007-12#1)(2010-1#1)
or bronchial##2##2##(1991-11#1)(2011-3#1)
or buffer##3##2##(1992-11#1)(2009-8#1)(2012-12#1)
or bulbous nose##2##3##(1990-9#1)(1997-3#1)
or buspirone##2##2##(1994-2#1)(2008-6#1)
or by a##15##3##(1990-12#1)(1992-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-4#1)
or by adding##2##3##(2008-10#1)(2008-5#1)
or by addition of##2##4##(1990-11#1)(1995-5#1)
or by an##4##3##(1992-11#1)(1992-12#1)(1994-1#1)(2007-11#1)
or by changes in##2##4##(2008-7#1)(2008-9#1)
or by culture##2##3##(2008-11#1)(2008-5#1)
or by direct##2##3##(1995-2#1)(2008-10#1)
or by exposure to##2##4##(1995-11#1)(2008-4#1)
or by gavage for 26 or 41 weeks##2##8##(2008-9#2)
or by increasing##2##3##(1995-12#1)(2008-10#1)
or by manipulating##2##3##(2008-11#1)(2009-12#1)
or by other##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
or by peptides##2##3##(1994-8#1)(2008-5#1)
or by the##22##3##(1990-7#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-2#2)(2011-2#1)(2012-3#1)
or by treatment with##2##4##(2008-9#1)(2012-2#1)
or by treatment##3##3##(1996-5#1)(2008-9#1)(2012-2#1)
or by use of##2##4##(2008-10#1)(2008-3#1)
or by using##2##3##(2008-10#1)(2012-1#1)
or by##220##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#3)(1996-3#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#39)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#11)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#9)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
or cadmium##2##2##(2008-10#2)
or calcium ionophore##3##3##(1990-12#1)(1993-8#1)(2008-11#1)
or calcium##6##2##(1990-12#1)(1993-8#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-11#1)
or calcium-channel blockers##2##3##(2009-6#2)
or calculated##4##2##(2008-1#1)(2008-10#2)(2011-1#1)
or calvaria##2##2##(2008-11#2)
or can be##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2012-1#1)
or can##8##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2012-1#1)
or cancer##7##2##(1990-8#1)(1996-1#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
or cannot##2##2##(1993-3#1)(2008-8#1)
or captopril##2##2##(1992-11#1)(1996-2#1)
or capture##2##2##(1990-8#1)(2008-10#1)
or carbohydrates##2##2##(1996-12#1)(2008-7#1)
or carbon dioxide##2##3##(1990-11#1)(2011-2#1)
or carbon##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
or carboplatin##2##2##(1990-6#1)(2012-2#1)
or carboxylic##3##2##(2007-12#1)(2008-10#1)(2010-2#1)
or cardiac##4##2##(1995-3#1)(2007-8#1)(2010-6#1)(2010-8#1)
or cardiovascular##3##2##(1993-12#1)(2008-3#1)(2008-6#1)
or care##3##2##(1994-2#1)(1995-3#2)
or caregiver##2##2##(2010-4#1)(2012-12#1)
or catabolic##2##2##(2008-5#1)(2012-2#1)
or catalase##5##2##(1990-2#1)(1995-3#1)(1995-8#1)(2008-2#1)(2012-3#1)
or catalyst##2##2##(2008-10#2)
or caudate nucleus##3##3##(1994-8#1)(1995-5#2)
or cause##5##2##(1991-5#1)(2007-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
or caused by##2##3##(2009-3#1)(2010-6#1)
or cell cultures with##2##4##(2008-10#1)(2008-9#1)
or cell surface##2##3##(1995-2#1)(2008-9#1)
or cell type##2##3##(2008-7#1)(2008-9#1)
or cell##21##2##(1990-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#4)(2011-2#1)(2012-12#1)
or cells from##2##3##(2008-4#1)(2013-8#1)
or cells##9##2##(1991-12#1)(1993-6#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-8#1)
or cellular##4##2##(1994-3#1)(2008-4#2)(2009-7#1)
or censoring##2##2##(2011-2#1)(2012-2#1)
or central nervous##2##3##(2008-9#1)(2011-2#1)
or central##7##2##(1992-11#1)(1993-6#1)(2007-10#2)(2008-10#1)(2008-9#1)(2011-2#1)
or centrifugation##2##2##(1997-3#1)(2008-6#1)
or cerebellopontine angle##2##3##(1994-9#1)(2008-7#1)
or cerebral##6##2##(1994-2#1)(1995-5#1)(1996-8#1)(2008-12#1)(2008-7#1)(2012-12#1)
or cerebrospinal fluid##2##3##(2008-10#1)(2011-2#1)
or cerebrovascular##2##2##(2007-7#1)(2008-3#1)
or certain##3##2##(1994-1#1)(2012-2#1)(2013-1#1)
or cervical##4##2##(2007-10#1)(2008-12#1)(2009-2#1)(2013-8#1)
or cervicitis##2##2##(2011-2#2)
or change in##2##3##(1992-6#1)(2007-6#1)
or change the##2##3##(2007-12#1)(2013-8#1)
or change##9##2##(1992-6#1)(1997-1#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-6#1)(2011-1#1)(2013-8#2)
or changed##2##2##(2008-11#1)(2012-3#1)
or changes in the##2##4##(2008-2#1)(2008-5#1)
or changes in##6##3##(1996-3#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-2#1)
or changing##2##2##(1997-7#1)(2008-9#1)
or characteristics##2##2##(1991-6#1)(2009-7#1)
or charybdotoxin##2##2##(2008-8#1)(2010-12#1)
or chemical modification##2##3##(1990-5#1)(1992-9#1)
or chemical##15##2##(1990-5#1)(1992-9#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-2#2)(2008-5#2)(2009-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
or chemicals##2##2##(1994-3#1)(2008-11#1)
or chemostat##2##2##(2008-11#1)(2008-9#1)
or chemotherapy##7##2##(1993-9#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#1)
or chest pain##2##3##(2007-7#1)(2012-2#1)
or chest wall##3##3##(1991-12#1)(2007-8#2)
or chest##5##2##(1991-12#1)(2007-7#1)(2007-8#2)(2012-2#1)
or chick##2##2##(1990-7#1)(1996-12#1)
or chicken##2##2##(1991-6#1)(2008-10#1)
or child##4##2##(1992-3#1)(1997-6#1)(2008-11#1)(2010-7#1)
or children with##2##3##(1995-6#1)(2009-5#1)
or children##3##2##(1995-6#1)(2009-5#1)(2012-12#1)
or chlorides##2##2##(2007-11#1)(2008-10#1)
or chloroethylclonidine##2##2##(1995-12#2)
or chlortetracycline##3##2##(2008-10#3)
or cholesterol##4##2##(1991-5#1)(1992-9#1)(2008-10#2)
or chromatographic##2##2##(2008-10#2)
or chronic active##2##3##(2008-9#2)
or chronic inflammatory##2##3##(2008-7#1)(2010-6#1)
or chronic obstructive pulmonary disease##3##5##(1991-4#1)(2010-12#1)(2010-2#1)
or chronic##33##2##(1991-12#1)(1991-3#1)(1991-4#1)(1993-3#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#1)
or chronically##4##2##(1992-9#1)(1994-12#1)(1994-6#1)(1996-12#1)
or class I##2##3##(1995-5#1)(2008-5#1)
or class##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
or classic##3##2##(1990-3#1)(2008-8#1)(2010-2#1)
or clear##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
or clinic##3##2##(2009-5#2)(2011-2#1)
or clinical##19##2##(1991-1#1)(1994-12#1)(1995-1#1)(1995-11#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)
or clinically##3##2##(2008-7#1)(2011-2#2)
or clopidogrel##3##2##(2008-11#1)(2009-5#2)
or close to the edge##2##5##(2008-3#1)(2008-6#1)
or close to the##6##4##(1992-12#1)(1996-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)
or close to##7##3##(1992-12#1)(1992-6#1)(1996-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)
or close##12##2##(1992-12#1)(1992-6#1)(1995-2#1)(1996-8#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
or closed circuit anaesthesia##2##4##(2011-2#2)
or closed##6##2##(1991-6#1)(2008-10#1)(2008-2#2)(2011-2#2)
or closely linked##3##3##(2008-10#3)
or closely related##2##3##(1991-9#1)(2008-4#1)
or closely##5##2##(1991-9#1)(2008-10#3)(2008-4#1)
or cluster##4##2##(2007-12#1)(2008-10#2)(2009-11#1)
or clusters##2##2##(2008-2#1)(2013-1#1)
or cobalt(II)##2##2##(2008-10#2)
or cocaine##2##2##(2008-10#1)(2013-8#1)
or coding##2##2##(2011-2#1)(2013-1#1)
or codominant##2##2##(2008-4#1)(2008-5#1)
or cofactor##2##2##(1993-11#1)(2008-4#1)
or cognitive impairment##2##3##(2008-6#1)(2013-1#1)
or cognitive##6##2##(2008-4#2)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
or coil##2##2##(2008-7#1)(2013-7#1)
or cold##2##2##(2008-1#1)(2012-12#1)
or collagen##3##2##(1991-8#1)(1994-9#1)(2012-3#1)
or colon##2##2##(2008-1#1)(2009-4#1)
or colonic##2##2##(1990-6#1)(2012-2#1)
or column##2##2##(2008-10#1)(2008-4#1)
or combination of##3##3##(1992-3#1)(2008-3#1)(2011-2#1)
or combination therapy##2##3##(2010-4#1)(2013-1#1)
or combination##7##2##(1992-10#1)(1992-3#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
or combinations of these##2##4##(1991-5#1)(2010-4#1)
or combinations of##7##3##(1991-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-4#2)(2013-8#1)
or combinations##11##2##(1991-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-4#3)(2012-12#1)(2013-8#1)
or combinations)##2##2##(2008-5#2)
or combined with##7##3##(2007-11#3)(2007-5#1)(2011-2#2)(2013-8#1)
or combined##19##2##(1993-8#1)(2007-11#4)(2007-5#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
or comet##2##2##(1997-4#2)
or commercial##4##2##(1995-9#1)(2008-10#1)(2012-12#1)(2013-7#1)
or common##5##2##(1994-3#1)(2008-10#1)(2012-2#2)(2013-8#1)
or community##3##2##(1991-1#1)(2007-5#1)(2008-3#1)
or comparable##3##2##(1993-12#1)(2007-12#1)(2008-3#1)
or compare##2##2##(2008-8#2)
or comparing##2##2##(2008-4#1)(2012-12#1)
or comparison##3##2##(1994-12#1)(2008-12#1)(2013-8#1)
or complete##13##2##(1990-6#1)(1990-9#1)(1991-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
or completely replacing##2##3##(1993-8#1)(2008-4#1)
or completely##9##2##(1991-12#1)(1993-8#1)(1995-6#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
or complex##6##2##(1996-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)
or complicated##2##2##(2008-10#1)(2008-3#1)
or complication##2##2##(1995-1#1)(2013-1#1)
or complications##6##2##(1992-10#1)(1995-8#1)(2006-12#1)(2007-8#1)(2008-7#2)
or composite##2##2##(1991-4#1)(2008-10#1)
or composition##2##2##(2008-9#1)(2012-3#1)
or compound##2##2##(2008-10#1)(2008-4#1)
or compression##3##2##(1991-5#1)(2008-2#1)(2013-1#1)
or computational##2##2##(2008-11#1)(2009-5#1)
or computed tomography##4##3##(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
or concentrated##3##2##(2008-3#1)(2008-4#1)(2012-12#1)
or conceptual##2##2##(1993-12#1)(2012-12#1)
or concomitant##2##2##(2008-7#1)(2012-2#1)
or concurrent##2##2##(1991-12#1)(2013-8#1)
or conditional##2##2##(2008-7#1)(2008-8#1)
or conditions##3##2##(1994-6#1)(2009-6#1)(2013-8#1)
or conformational changes##2##3##(2013-1#1)(2013-8#1)
or confounding##2##2##(1990-8#1)(2008-7#1)
or congenital##5##2##(1996-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-3#1)
or conservative##5##2##(1993-6#1)(1995-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
or consideration##2##2##(1992-9#1)(1993-1#1)
or consistent##2##2##(1993-9#1)(2012-3#1)
or construct##2##2##(2008-6#1)(2013-1#1)
or content##3##2##(2008-2#1)(2008-9#1)(2009-7#1)
or continuation of##3##3##(1993-12#1)(2011-1#2)
or continuing##3##2##(1992-2#1)(1993-12#1)(2011-1#1)
or continuous##10##2##(1990-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
or contracted##2##2##(1994-12#1)(2008-11#1)
or contribute to the##2##4##(2008-10#2)
or control animals in##2##4##(1992-1#2)
or control the##2##3##(2008-1#1)(2013-1#1)
or control##21##2##(1992-1#2)(1993-1#1)(1993-12#1)(1994-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
or controlled##2##2##(2008-10#2)
or convective##2##2##(1994-9#1)(2008-1#1)
or conventional heating##2##3##(2007-11#1)(2008-5#1)
or conventional##6##2##(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
or conventionally##2##2##(2007-11#1)(2013-1#1)
or copper##2##2##(2008-10#1)(2011-2#1)
or cord blood##2##3##(2008-10#1)(2008-4#1)
or coronary artery disease##2##4##(2008-11#1)(2013-1#1)
or correlated##2##2##(1995-11#1)(2009-9#1)
or cortical##2##2##(2008-1#1)(2008-10#1)
or corticosterone##2##2##(2008-4#1)(2008-5#1)
or cortisol##4##2##(1990-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
or cosmetic##2##2##(2008-5#2)
or cost##4##2##(1992-12#2)(1994-3#1)(2008-3#1)
or cotton##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
or could not##2##3##(1994-1#1)(2008-7#1)
or could##5##2##(1991-12#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-7#1)
or coupled##2##2##(2008-10#1)(2008-4#1)
or covalent grafting##2##3##(2008-10#2)
or create##2##2##(1990-2#1)(2008-12#1)
or creation of a##2##4##(2008-10#1)(2010-8#1)
or creation of##3##3##(2008-10#2)(2010-8#1)
or crisis##3##2##(1994-2#1)(1996-9#1)(2011-2#1)
or critical##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
or critically##2##2##(2008-11#1)(2013-8#1)
or crude##3##2##(1992-8#1)(2008-10#1)(2008-12#1)
or cultivars##2##2##(2008-10#2)
or culture##3##2##(1994-11#1)(2008-10#2)
or current disease##2##3##(2007-12#1)(2012-2#1)
or custom-made##2##2##(2007-11#1)(2008-4#1)
or cutaneous##2##2##(2007-2#1)(2008-5#1)
or cuts##2##2##(2008-12#1)(2009-4#1)
or cw##3##2##(2007-12#2)(2008-3#1)
or cyclic##3##2##(1990-5#1)(2008-10#1)(2010-4#1)
or cysteine##2##2##(1991-9#1)(1995-3#1)
or cytochrome c on##2##4##(1995-5#2)
or cytochrome##4##2##(1994-8#1)(1995-5#2)(2008-9#1)
or cytokine##2##2##(1994-5#1)(1995-2#1)
or cytotoxic T lymphocytes##2##4##(1995-5#1)(2008-4#1)
or cytotoxic therapy##2##3##(1992-10#1)(2008-6#1)
or cytotoxic##5##2##(1990-12#1)(1992-10#1)(1995-5#1)(2008-4#1)(2008-6#1)
or dairy##2##2##(2013-1#2)
or damage##2##2##(1992-11#1)(2008-4#1)
or damaged##4##2##(1992-9#1)(1997-1#1)(2008-10#1)(2008-8#1)
or data##3##2##(1990-11#1)(2008-7#1)(2011-2#1)
or dead##2##2##(2010-3#1)(2012-2#1)
or death in patients with##2##5##(1991-11#1)(2011-2#1)
or death in##3##3##(1991-11#1)(2009-6#1)(2011-2#1)
or death##20##2##(1991-11#2)(1991-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#3)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
or deaths##2##2##(2007-8#1)(2008-3#1)
or decision-making##2##2##(1993-12#1)(2012-12#1)
or decrease in##5##3##(1990-5#1)(1992-8#1)(2008-10#1)(2008-12#1)(2012-12#1)
or decrease the##2##3##(1991-6#1)(2008-3#1)
or decrease their##2##3##(2008-10#1)(2010-12#1)
or decrease##17##2##(1990-5#1)(1990-9#1)(1991-6#1)(1992-8#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
or decreased in##2##3##(1997-7#1)(2008-11#1)
or decreased with##2##3##(2007-8#1)(2008-10#1)
or decreased##17##2##(1991-9#1)(1993-11#1)(1994-8#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
or decreasing the##2##3##(2008-8#1)(2009-12#1)
or decreasing##5##2##(1993-12#1)(1995-3#1)(2008-8#1)(2009-12#1)(2011-2#1)
or defective##2##2##(2007-7#1)(2010-8#1)
or defects##3##2##(2007-11#2)(2008-1#1)
or deficient##3##2##(1994-5#1)(2008-9#1)(2012-2#1)
or defined##2##2##(1994-9#1)(2008-4#1)
or degenerative##2##2##(2009-3#1)(2013-1#1)
or degradation of##3##3##(1993-11#1)(2012-12#2)
or degree of##2##3##(2008-10#1)(2010-5#1)
or degrees of freedom##2##4##(2008-3#2)
or dehydration##2##2##(2008-10#1)(2010-7#1)
or delay##6##2##(1991-9#1)(2008-1#1)(2008-5#1)(2010-10#2)(2013-7#1)
or delayed##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
or delaying disease##2##3##(2008-10#2)
or delaying the##2##3##(2010-6#1)(2011-2#1)
or delaying##4##2##(2008-10#2)(2010-6#1)(2011-2#1)
or delays##2##2##(2008-7#2)
or deleted in##2##3##(1997-7#1)(2011-2#1)
or deleted##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
or deleterious##2##2##(1997-4#1)(2008-8#1)
or deleting##4##2##(2008-11#1)(2009-7#3)
or deletion of the##2##4##(1997-3#1)(2008-9#1)
or deletion of##6##3##(1996-12#1)(1997-3#2)(2007-11#1)(2008-9#1)(2011-1#1)
or deletion##8##2##(1996-12#1)(1997-3#2)(2007-11#1)(2008-10#1)(2008-9#2)(2011-1#1)
or deliberate##2##2##(1992-3#1)(2008-7#1)
or density##5##2##(1993-6#1)(1995-5#1)(2008-5#1)(2008-9#1)(2010-4#1)
or dental##2##2##(2011-2#1)(2012-2#1)
or deoxyribonuclease##2##2##(1991-9#1)(1994-2#1)
or dependency##2##2##(2007-10#2)
or dependent##2##2##(2008-10#1)(2013-7#1)
or dephosphorylated##2##2##(1996-6#1)(1997-2#1)
or depletion of##2##3##(1997-7#1)(2009-8#1)
or depletion##3##2##(1997-7#1)(2009-11#1)(2009-8#1)
or depressed##4##2##(2008-12#1)(2009-7#2)(2013-1#1)
or depression of##2##3##(2008-11#1)(2008-5#1)
or depression##7##2##(1994-2#1)(2008-11#2)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
or derivatization##2##2##(2008-10#2)
or descriptive##2##2##(2008-11#1)(2012-12#1)
or descriptors##2##2##(2008-1#1)(2011-3#1)
or desiccation##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
or desipramine##2##2##(1990-5#1)(1995-12#1)
or detect##2##2##(2008-10#1)(2008-5#1)
or detectable##3##2##(2008-9#1)(2011-1#2)
or detection of##2##3##(2008-11#1)(2012-2#1)
or detection##4##2##(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#1)
or deterioration##2##2##(1995-11#1)(2007-10#1)
or determine##3##2##(1996-6#1)(2008-4#1)(2008-7#1)
or develop##2##2##(2008-12#1)(2009-7#1)
or developing##4##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-6#1)
or development of##3##3##(2008-7#2)(2009-12#1)
or development##4##2##(2008-3#1)(2008-7#2)(2009-12#1)
or device failures##2##3##(2011-1#1)(2011-2#1)
or device##4##2##(1997-2#1)(2010-9#1)(2011-1#1)(2011-2#1)
or dew##2##2##(2008-10#2)
or dexamethasone##4##2##(1990-7#2)(2008-10#2)
or diabetes##10##2##(2007-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
or diabetic nephropathy##2##3##(2008-1#1)(2008-8#1)
or diabetic##4##2##(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
or diagnosis##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
or diagnostic##2##2##(1997-5#1)(2010-6#1)
or dibutyryl##2##2##(1991-3#1)(1995-11#1)
or dichloromethane##2##2##(2008-10#2)
or did not respond##2##4##(1997-5#1)(2012-12#1)
or did not##11##3##(1997-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
or died##2##2##(2007-10#1)(2008-7#1)
or dielectric##2##2##(2007-11#1)(2008-10#1)
or diet##3##2##(2011-2#1)(2013-1#2)
or dietary##2##2##(2008-7#1)(2008-8#1)
or different##11##2##(1996-5#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-3#1)(2012-6#1)
or differential##8##2##(2008-2#2)(2008-3#1)(2008-7#2)(2010-12#3)
or differentiation##3##2##(1997-7#1)(2008-3#1)(2010-12#1)
or difficult to##2##3##(1991-12#1)(2010-11#1)
or difficulty##2##2##(1993-10#1)(2012-3#1)
or diffuse##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
or digoxigenin##2##2##(2008-10#2)
or dilated##2##2##(2009-5#1)(2013-7#1)
or diluted##4##2##(2008-10#3)(2013-1#1)
or direct##11##2##(1994-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#1)(2012-12#1)(2012-3#1)
or directly by##2##3##(2008-4#1)(2011-2#1)
or directly in the##2##4##(2009-10#1)(2012-2#1)
or directly##7##2##(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)
or disability##4##2##(1991-11#1)(1992-2#1)(1995-1#1)(2012-3#1)
or disabling conditions##2##3##(1997-2#2)
or disabling##3##2##(1991-11#1)(1997-2#2)
or disappear##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
or disappearance of##2##3##(1990-5#1)(2007-8#1)
or discontinuation##2##2##(2008-3#1)(2011-1#1)
or discontinuing##2##2##(2008-7#1)(2011-1#1)
or disease of##2##3##(2008-7#1)(2008-9#1)
or disease##15##2##(1993-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#2)
or diseased##2##2##(2008-10#1)(2010-6#1)
or diseases##4##2##(1992-5#1)(1996-3#1)(2008-10#1)(2011-2#1)
or dislocation##2##2##(2008-12#1)(2012-2#1)
or dispersed##2##2##(1991-12#1)(2008-7#1)
or dissection of the##2##4##(2006-12#1)(2008-4#1)
or dissection##3##2##(2006-12#1)(2008-4#1)(2011-2#1)
or dissociative##3##2##(2012-12#1)(2013-1#2)
or distant metastases##4##3##(1990-6#1)(1997-8#1)(2008-10#1)(2008-2#1)
or distant##7##2##(1990-6#2)(1993-1#1)(1997-8#1)(2008-10#2)(2008-2#1)
or distilled water##2##3##(2007-3#1)(2013-1#1)
or distilled##3##2##(1994-9#1)(2007-3#1)(2013-1#1)
or distortion of##3##3##(2008-11#1)(2010-10#1)(2012-2#1)
or distribution of##2##3##(1991-12#1)(1994-5#1)
or distribution##3##2##(1991-12#1)(1994-5#1)(2009-5#1)
or do##3##2##(1996-5#1)(2008-11#1)(2008-9#1)
or does not##3##3##(1991-2#1)(2008-10#1)(2010-10#1)
or donor##4##2##(1991-11#1)(1993-6#1)(1994-9#1)(2008-11#1)
or dopamine##2##2##(1993-12#1)(2012-2#1)
or dorsal caudate-putamen##2##3##(1993-6#2)
or dorsal##3##2##(1993-6#2)(2008-9#1)
or dose##3##2##(2008-7#1)(2009-11#1)(2009-4#1)
or double##2##2##(1992-12#1)(1997-6#1)
or down-regulated##5##2##(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#2)
or downstream of##2##3##(1992-3#1)(1996-12#1)
or downstream##4##2##(1992-3#1)(1996-12#1)(2008-8#1)(2012-2#1)
or dramatic##2##2##(2008-10#2)
or drinking##2##2##(1993-6#1)(2008-10#1)
or droplet aerosols##2##3##(1992-3#1)(2011-1#1)
or drug##11##2##(1990-9#1)(1992-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
or drug-induced##3##2##(1992-2#1)(1992-9#1)(2008-9#1)
or drugs##4##2##(1992-9#2)(2008-4#1)(2013-8#1)
or dry##5##2##(2007-11#1)(2008-10#1)(2008-6#2)(2012-2#1)
or dual##3##2##(2008-3#1)(2011-1#1)(2013-8#1)
or due to##6##3##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
or duodenal##2##2##(1992-9#1)(2008-10#1)
or durations of##2##3##(2008-10#1)(2010-6#1)
or during periods##2##3##(2008-10#2)
or during the##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
or during##20##2##(1990-8#2)(1992-3#1)(1995-5#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-1#1)(2012-2#1)
or dynamic##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
or dysfunction of the##2##4##(2008-9#2)
or dysfunction##4##2##(2008-5#1)(2008-9#2)(2010-3#1)
or dyspnea##2##2##(2010-6#1)(2011-2#1)
or each##2##2##(2008-10#1)(2008-8#1)
or early childhood##3##3##(2007-10#1)(2008-11#1)(2011-1#1)
or early##11##2##(1992-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
or eat##2##2##(1992-12#1)(1993-12#1)
or economic##9##2##(1997-1#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
or effect##4##2##(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
or egg##3##2##(2008-10#1)(2008-11#2)
or either##2##2##(1992-3#1)(2008-11#1)
or elective##3##2##(1992-5#1)(2008-3#1)(2012-1#1)
or electrical stimulation##3##3##(1993-12#2)(1996-6#1)
or electrical##6##2##(1992-3#1)(1993-12#2)(1996-6#1)(2008-10#1)(2008-9#1)
or electrode##2##2##(2008-10#1)(2012-2#1)
or electron withdrawing##2##3##(2009-9#1)(2010-5#1)
or electron##3##2##(1997-3#1)(2009-9#1)(2010-5#1)
or electronic##2##2##(2008-10#1)(2008-3#1)
or electrothermal##2##2##(2008-10#2)
or elevated##5##2##(1993-8#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)
or eliminate the##2##3##(1992-2#1)(2010-7#1)
or eliminate##3##2##(1992-2#1)(1997-7#1)(2010-7#1)
or eliminated##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
or elimination of##3##3##(1992-5#1)(1997-3#1)(2008-5#1)
or elimination##4##2##(1991-9#1)(1992-5#1)(1997-3#1)(2008-5#1)
or else##3##2##(1992-11#1)(1997-7#1)(2007-2#1)
or elsewhere##3##2##(1996-5#1)(2011-2#1)(2012-12#1)
or emotional##5##2##(1990-11#1)(1993-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
or employment##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
or endocrine##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
or endothelial cells##2##3##(1992-3#1)(2008-11#1)
or endothelial##3##2##(1992-3#1)(2008-11#1)(2008-9#1)
or endovascular##4##2##(1995-11#1)(2008-7#1)(2011-2#1)(2011-3#1)
or energy##2##2##(2008-9#1)(2013-1#1)
or enhance##4##2##(1996-12#1)(2006-10#1)(2008-10#1)(2011-2#1)
or enhanced##5##2##(1997-3#1)(2007-12#1)(2008-11#2)(2009-5#1)
or enhancing##2##2##(1994-5#1)(2008-11#1)
or environmental##9##2##(1992-12#1)(1993-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#1)
or environments##2##2##(2008-11#1)(2010-4#1)
or enzymatic##5##2##(2008-10#1)(2008-9#2)(2010-12#1)(2010-7#1)
or enzyme##5##2##(1990-8#1)(1992-6#1)(2008-10#2)(2008-5#1)
or epi##2##2##(2008-6#2)
or epidermal growth factor##2##4##(1993-1#1)(1995-8#1)
or epirubicin##2##2##(2009-4#2)
or epithelial##2##2##(1990-11#1)(2012-2#1)
or equal to 10##2##4##(1991-8#1)(2012-3#1)
or equal to 5##2##4##(1992-5#1)(2012-3#1)
or equal to##51##3##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-6#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#9)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
or equally##2##2##(1995-11#1)(1997-5#1)
or equipment##2##2##(1995-3#1)(2011-2#1)
or ester linkage to##2##4##(2008-10#2)
or ester##3##2##(1991-12#1)(2008-10#2)
or estimated##3##2##(1997-4#1)(2008-10#1)(2008-2#1)
or estradiol plus RU 39##3##5##(1992-5#3)
or etching##2##2##(2008-12#1)(2008-2#1)
or ethanol##3##2##(1993-8#1)(2008-12#2)
or ethnic group##2##3##(2011-2#1)(2013-1#1)
or ethnic##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
or ethyl##2##2##(2008-10#1)(2008-11#1)
or ethylene glycol##2##3##(2008-3#1)(2012-12#1)
or even a single##2##4##(2008-7#1)(2012-12#1)
or even a##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
or even between##2##3##(1996-1#1)(2008-7#1)
or even by##2##3##(1992-5#1)(2008-3#1)
or even harmful##2##3##(2009-11#1)(2013-1#1)
or even higher##2##3##(2008-10#1)(2012-3#1)
or even in##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
or even increased##3##3##(1996-12#1)(2012-1#2)
or even no##3##3##(1993-9#1)(1995-5#1)(2007-2#1)
or even prevent##2##3##(2008-1#1)(2009-12#1)
or even slightly##2##3##(2008-1#1)(2008-10#1)
or even the##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-3#1)
or even to##5##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
or even whole##2##3##(2008-11#1)(2009-10#1)
or even years##2##3##(2008-7#1)(2011-2#1)
or even##116##2##(1990-8#2)(1991-12#2)(1991-8#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-1#1)(1996-12#3)(1996-6#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-6#1)(2008-1#3)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
or every##2##2##(1991-9#1)(2008-7#1)
or exaggerated##3##2##(1996-11#1)(2008-4#1)(2008-9#1)
or exceed the##3##3##(1995-1#1)(2008-6#1)(2011-1#1)
or exceed##5##2##(1994-1#1)(1995-1#1)(2008-6#1)(2010-2#1)(2011-1#1)
or exceeded##3##2##(1993-12#1)(2008-10#1)(2008-6#1)
or excess##2##2##(2008-9#1)(2009-11#1)
or excessive##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
or excluded##2##2##(1991-11#1)(2008-7#1)
or exclusion of##3##3##(1993-2#1)(2012-12#1)(2012-2#1)
or exclusively##2##2##(1997-3#1)(2008-10#1)
or exhibit##2##2##(1993-11#1)(2008-1#1)
or existing##2##2##(2007-7#1)(2009-8#1)
or exocytosis##2##2##(2008-10#1)(2009-6#1)
or exogenous##5##2##(1991-12#1)(1991-9#1)(1992-5#1)(1996-9#1)(2008-3#1)
or expansion of##2##3##(2007-12#1)(2009-11#1)
or expensive##2##2##(1992-12#1)(2008-7#1)
or experience##3##2##(1994-1#1)(2007-11#1)(2008-4#1)
or experimental##4##2##(2008-11#1)(2008-4#1)(2010-5#1)(2013-1#1)
or exposed to the##2##4##(2008-10#1)(2009-9#1)
or exposed to##3##3##(2008-10#2)(2009-9#1)
or exposed##4##2##(2008-10#2)(2009-9#1)(2010-11#1)
or exposure to##2##3##(1996-5#1)(2008-9#1)
or exposure##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
or expression of the##3##4##(1992-9#1)(1993-6#1)(2008-4#1)
or expression of##6##3##(1991-7#1)(1992-9#1)(1993-6#1)(1995-11#1)(2008-4#2)
or expression##7##2##(1991-7#1)(1992-9#1)(1993-6#1)(1995-11#1)(2008-10#1)(2008-4#2)
or extensive##4##2##(1997-8#1)(2008-1#1)(2008-5#1)(2012-12#1)
or external##12##2##(1990-2#4)(1992-3#1)(2007-12#1)(2008-2#2)(2008-7#2)(2009-10#1)(2010-5#1)
or extinction##3##2##(1992-12#1)(2008-8#1)(2008-9#1)
or extracellular##2##2##(2008-4#1)(2013-8#1)
or extracorporeal##2##2##(1991-3#1)(2011-2#1)
or extraintestinal##2##2##(1990-6#1)(2013-1#1)
or extramedullary##2##2##(2012-12#1)(2012-3#1)
or extrinsic##3##2##(1990-5#1)(2008-1#1)(2011-2#1)
or face##3##2##(2007-12#2)(2012-1#1)
or factors##6##2##(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)
or faculty##2##2##(2008-12#1)(2012-1#1)
or fail##2##2##(2010-11#1)(2011-1#1)
or failed to##2##3##(1997-6#1)(2008-11#1)
or failed##5##2##(1997-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)
or failure of the##3##4##(1996-2#1)(2008-12#1)(2011-2#1)
or failure of##6##3##(1996-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)
or failure##10##2##(1996-2#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-2#1)
or fall##2##2##(1996-2#1)(2009-10#1)
or familial##2##2##(1990-2#1)(1991-2#1)
or family history of##4##4##(1990-9#1)(2007-10#1)(2009-9#1)(2010-6#1)
or family##9##2##(1990-9#1)(1993-12#1)(1996-12#1)(2007-10#1)(2008-7#1)(2009-9#2)(2010-6#1)(2013-1#1)
or fat##4##2##(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
or fecal##2##2##(2008-10#1)(2012-3#1)
or feces##3##2##(1996-12#1)(2008-10#1)(2009-6#1)
or feed##2##2##(2008-10#1)(2008-7#1)
or female##20##2##(1994-7#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#12)(2009-9#1)
or femoral##2##2##(2007-8#2)
or fetal##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
or fewer##2##2##(1993-3#1)(2008-3#1)
or fiber##2##2##(2008-3#1)(2011-2#1)
or fibers##2##2##(2008-3#1)(2008-5#1)
or fibrillar##2##2##(2007-12#1)(2008-10#1)
or fibroblasts##2##2##(1990-6#1)(1995-12#1)
or fibrous##2##2##(2010-3#1)(2011-2#1)
or fiction?##2##2##(2008-3#1)(2012-2#1)
or field##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
or filgrastim##2##2##(2008-7#2)
or filtration##2##2##(1997-8#1)(2008-10#1)
or find##2##2##(1996-5#1)(2010-12#1)
or findings##2##2##(2010-3#1)(2012-3#1)
or fine##2##2##(1990-10#1)(2008-4#1)
or first##4##2##(2007-2#1)(2008-1#1)(2008-6#1)(2009-3#1)
or fish##3##2##(1993-8#1)(2008-6#1)(2008-7#1)
or fistula##2##2##(2011-2#2)
or fitness##2##2##(2008-10#1)(2009-3#1)
or five##8##2##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#4)(2008-5#1)
or fixation##3##2##(2008-3#1)(2013-1#2)
or fixed##2##2##(2008-10#1)(2008-4#1)
or flexible##2##2##(2007-12#1)(2008-7#1)
or flow##2##2##(2008-10#1)(2010-4#1)
or fluctuating##2##2##(2007-12#1)(2008-10#1)
or fluorescence detection##2##3##(1991-5#1)(2008-4#1)
or fluorescent##4##2##(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
or focal##2##2##(2008-7#1)(2012-2#1)
or following##8##2##(1992-8#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-11#1)(2009-5#1)
or food samples##2##3##(2008-10#1)(2008-11#1)
or food##11##2##(1993-10#1)(1993-12#2)(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)
or for a##3##3##(1995-6#1)(1996-2#1)(2011-2#1)
or for the##7##3##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#4)
or for their##2##3##(1990-6#1)(2008-10#1)
or for those##4##3##(2008-10#3)(2008-6#1)
or for transient expression##2##4##(2008-1#1)(2008-2#1)
or for whom##2##3##(1992-3#1)(2012-3#1)
or for##68##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-1#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-4#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
or forced##2##2##(1994-7#1)(2010-11#1)
or forskolin##5##2##(1995-8#1)(1997-1#1)(1997-2#3)
or four##10##2##(1996-12#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)
or fragments##3##2##(1993-2#1)(1993-9#1)(1995-11#1)
or free radicals##2##3##(1993-6#1)(2008-1#1)
or free##5##2##(1993-6#1)(2007-5#1)(2008-1#1)(2008-3#1)(2011-2#1)
or frequency of##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
or frequency##4##2##(2007-12#2)(2008-10#1)(2010-12#1)
or frequent##2##2##(1993-3#1)(2008-9#1)
or from a##8##3##(1992-12#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-11#1)
or from an##2##3##(1991-12#1)(2007-12#1)
or from both sources##2##4##(1994-5#2)
or from construction##2##3##(1992-2#1)(1994-3#1)
or from direct##2##3##(1990-5#1)(2008-10#1)
or from the##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)
or from##54##2##(1990-5#1)(1991-12#1)(1992-12#3)(1992-2#2)(1993-12#1)(1993-9#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2011-2#1)(2012-12#1)
or fructose##2##2##(1992-12#1)(1994-8#1)
or full##3##2##(1991-1#1)(1995-2#1)(1995-5#1)
or full-length##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
or fully##7##2##(1992-12#1)(1995-9#1)(2008-10#2)(2009-11#1)(2011-3#1)(2012-12#1)
or function as##3##3##(1992-6#1)(2008-4#1)(2012-2#1)
or function of##3##3##(1994-11#1)(2007-12#1)(2012-12#1)
or function##14##2##(1991-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-3#1)(2007-12#2)(2008-4#1)(2012-12#2)(2012-2#2)(2013-1#1)
or functional##11##2##(1990-11#2)(1992-5#1)(2008-10#1)(2008-4#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
or functionally##2##2##(1997-6#1)(2011-2#1)
or fungal##2##2##(2008-10#2)
or further##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
or fused##3##2##(1995-5#1)(1996-12#1)(2008-8#1)
or future##3##2##(2008-12#1)(2009-6#1)(2010-4#1)
or gain of##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
or gamma##4##2##(1990-5#1)(1995-11#2)(1997-1#1)
or gas##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2010-6#1)
or gastric cancer##2##3##(1990-8#1)(1997-3#1)
or gastric##5##2##(1990-8#1)(1994-8#1)(1997-3#1)(2008-11#2)
or gastrointestinal##2##2##(1992-8#1)(1996-6#1)
or gelatin##2##2##(2009-7#1)(2010-8#1)
or gender##6##2##(1993-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)
or gene##11##2##(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2010-12#1)(2012-3#3)
or general anesthesia##2##3##(1993-1#1)(2008-4#1)
or general markers##2##3##(2008-5#1)(2011-2#1)
or general##17##2##(1991-3#1)(1992-11#1)(1993-1#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
or generated##3##2##(1992-5#1)(2008-4#1)(2012-12#1)
or generic##2##2##(2008-5#1)(2013-1#1)
or genes##7##2##(1995-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
or genetic##8##2##(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
or genetically##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
or genomic DNA##3##3##(1991-7#1)(2008-1#1)(2008-2#1)
or genomic##4##2##(1991-7#1)(2008-1#1)(2008-2#1)(2012-1#1)
or genotypic##2##2##(2008-10#1)(2010-3#1)
or geographic##2##2##(2008-10#2)
or geographical##2##2##(1997-6#1)(2008-10#1)
or germinating##3##2##(1993-6#1)(2008-10#2)
or global##2##2##(2007-7#1)(2010-6#1)
or glucagon##3##2##(1991-12#1)(1994-11#1)(1997-2#1)
or glucose##6##2##(1995-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#2)
or glutamate##2##2##(1996-6#1)(1997-6#1)
or glutamine##3##2##(2008-11#2)(2008-7#1)
or glutathione##2##2##(2008-10#2)
or gold##2##2##(2008-10#2)
or good in##2##3##(1991-3#1)(2008-3#1)
or good##8##2##(1991-3#1)(1991-8#1)(1997-6#1)(2007-11#2)(2008-3#1)(2012-1#1)(2012-3#1)
or government##2##2##(1992-3#1)(2010-12#1)
or grade##4##2##(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)
or graft##5##2##(1994-11#1)(1997-1#1)(2007-7#1)(2011-2#2)
or grass##3##2##(2008-10#3)
or grating##2##2##(2008-3#2)
or greater increases##2##3##(1992-10#1)(2008-10#1)
or greater reactions##2##3##(1993-12#2)
or greater than##12##3##(1990-12#1)(1990-5#1)(1991-2#1)(1995-12#1)(1997-4#3)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
or greater##54##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-10#1)(1993-12#3)(1994-3#1)(1994-5#2)(1995-12#1)(1996-1#1)(1997-4#4)(1997-5#1)(2006-11#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#14)(2011-2#2)(2013-1#2)
or greater)##2##2##(2007-11#1)(2008-3#1)
or green light##2##3##(1992-12#1)(2008-3#1)
or green##6##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
or greenhouse##2##2##(2008-10#2)
or group differences##2##3##(2007-12#1)(2009-3#1)
or group##7##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#1)
or groups of##5##3##(1990-5#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-2#1)
or growth factors##2##3##(1993-8#1)(2008-11#1)
or growth##11##2##(1992-9#2)(1993-6#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)(2011-2#1)
or guanidine##2##2##(1992-3#1)(1995-5#1)
or guardians##2##2##(2008-11#1)(2011-1#1)
or had a##4##3##(2007-12#1)(2008-11#1)(2011-1#1)(2012-3#1)
or had the##2##3##(1992-11#1)(2008-3#1)
or had to##2##3##(2011-3#1)(2013-1#1)
or had##18##2##(1991-9#1)(1992-1#1)(1992-11#1)(1993-9#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
or hair##3##2##(2008-10#2)(2008-7#1)
or hamster##4##2##(1996-5#1)(2008-4#1)(2008-9#2)
or harm##4##2##(2009-7#2)(2011-2#1)(2012-2#1)
or harmful##4##2##(1990-3#1)(1993-11#1)(2009-11#1)(2011-2#1)
or has##6##2##(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#2)(2013-8#1)
or have a##3##3##(2008-10#2)(2008-12#1)
or have been##2##3##(2008-10#1)(2012-2#1)
or have evidence of##2##4##(1995-3#1)(2006-5#1)
or have no##2##3##(2008-5#1)(2009-9#1)
or have only##2##3##(2010-11#1)(2011-2#1)
or have undergone##2##3##(1993-11#1)(1995-11#1)
or have##22##2##(1993-11#1)(1995-11#1)(1995-3#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
or having##7##2##(1991-12#1)(1995-6#1)(2007-11#1)(2008-5#1)(2009-7#1)(2010-8#1)(2013-1#1)
or hazardous##2##2##(1992-1#1)(2008-10#1)
or head##2##2##(2008-11#2)
or healing##2##2##(1997-6#1)(2011-2#1)
or health##4##2##(1992-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
or healthy##5##2##(1994-9#1)(1996-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
or heart disease##2##3##(1997-2#1)(2008-1#1)
or heart##4##2##(1993-1#1)(1997-2#1)(2008-1#2)
or heat##3##2##(1993-8#1)(1995-12#1)(2008-4#1)
or held##2##2##(2008-7#1)(2013-8#1)
or hemoglobin##2##2##(1990-8#1)(1995-2#1)
or hemorrhage##4##2##(1995-1#1)(1995-3#1)(2007-8#1)(2011-2#1)
or heparin##2##2##(1993-12#1)(1997-5#1)
or hepatic##3##2##(1995-11#1)(2008-9#1)(2012-3#1)
or hepatitis B virus##2##4##(1991-6#1)(2009-4#1)
or hepatitis B##3##3##(1991-6#1)(2007-2#1)(2009-4#1)
or hepatitis##5##2##(1991-6#1)(1997-7#1)(2007-2#1)(2008-6#1)(2009-4#1)
or her##22##2##(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2009-10#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
or hereditary##3##2##(1997-4#1)(2008-7#1)(2009-10#1)
or herself to##2##3##(2008-1#1)(2008-7#1)
or heterodimers##2##2##(1996-2#1)(2008-11#1)
or heterogeneous##3##2##(2008-10#1)(2009-10#1)(2012-1#1)
or heterologous##3##2##(1994-8#1)(2008-10#1)(2008-4#1)
or high K+##2##3##(1995-5#2)
or high density##2##3##(1993-9#1)(2008-10#1)
or high dose##2##3##(1990-12#1)(2008-11#1)
or high insertion##2##3##(2013-1#2)
or high levels##2##3##(1996-12#1)(2013-1#1)
or high temperatures##2##3##(2008-8#1)(2008-9#1)
or high##47##2##(1990-12#1)(1990-7#1)(1993-1#1)(1993-9#1)(1994-5#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-4#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-9#1)(2012-3#3)(2012-9#2)(2013-1#7)(2013-8#1)
or high-risk##2##2##(2007-8#1)(2010-11#1)
or higher than##10##3##(1992-9#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2013-1#1)
or higher##29##2##(1990-12#1)(1990-8#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-6#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#2)(2013-1#3)
or higher)##2##2##(2008-5#1)(2012-2#1)
or highly resistant to##2##4##(2008-10#1)(2011-2#1)
or highly##4##2##(2008-10#2)(2011-2#1)(2012-1#1)
or hippocampal##2##2##(1993-3#1)(1995-11#1)
or hippocampus of##2##3##(1996-12#1)(2012-2#1)
or histamine##3##2##(1990-7#2)(1993-6#1)
or histone##2##2##(2008-5#1)(2011-2#1)
or histopathologic##2##2##(1991-12#1)(2013-1#1)
or histopathology##2##2##(2007-10#2)
or home##2##2##(2007-12#1)(2011-2#1)
or horizontal##2##2##(2008-7#2)
or hospital##9##2##(1990-3#1)(1991-3#1)(1992-2#1)(1995-12#2)(2008-11#3)(2009-5#1)
or hospitalization##5##2##(1992-3#1)(1995-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
or hospitalized##2##2##(2009-5#1)(2013-8#1)
or hospitals##3##2##(2007-9#1)(2009-10#1)(2011-1#1)
or host##7##2##(1990-11#1)(2008-10#5)(2009-6#1)
or hot##2##2##(2008-10#1)(2013-7#1)
or house##2##2##(1991-3#1)(2011-2#1)
or how##7##2##(2008-5#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
or human serum##2##3##(1995-12#1)(2008-10#1)
or human##25##2##(1991-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-11#2)(2010-8#1)(2013-1#2)(2013-7#1)
or humans##2##2##(1991-12#1)(2008-7#1)
or hybrid##2##2##(2008-3#1)(2009-10#1)
or hydrogen peroxide##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
or hydrogen##4##2##(1992-12#1)(1992-8#1)(2008-10#1)(2008-5#1)
or hydrophobic interactions##2##3##(1990-5#1)(1996-12#1)
or hydrophobic##6##2##(1990-5#1)(1990-8#1)(1996-12#1)(2008-10#2)(2013-1#1)
or hydroxyl##2##2##(2008-10#1)(2011-2#1)
or hypertension##2##2##(2007-7#1)(2013-1#1)
or hypoplasia##2##2##(2008-1#1)(2011-1#1)
or i##3##2##(1992-12#1)(1992-3#1)(1996-12#1)
or i-propanol##2##2##(2008-10#2)
or ice##3##2##(2008-2#2)(2008-3#1)
or identify##3##2##(2008-11#1)(2010-11#1)(2011-1#1)
or idiopathic##2##2##(2009-5#1)(2010-12#1)
or if all##2##3##(2008-9#2)
or if it##2##3##(2008-2#1)(2008-4#1)
or if the##2##3##(1990-12#1)(2008-10#1)
or if they##2##3##(1992-3#1)(2009-4#1)
or if##22##2##(1990-12#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-3#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
or ignored##4##2##(1992-6#1)(1996-12#1)(2007-8#1)(2008-10#1)
or ill##2##2##(1995-11#1)(2007-8#1)
or illumination##2##2##(2008-3#1)(2009-6#1)
or image##2##2##(1995-2#1)(2007-11#1)
or imaging##4##2##(2008-2#1)(2008-3#1)(2012-12#1)(2012-3#1)
or imidazole##3##2##(1992-6#1)(2009-11#1)(2012-12#1)
or immediately after##2##3##(1993-1#1)(2012-2#1)
or immigration##2##2##(2008-10#2)
or immobilized##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
or immune##3##2##(1991-1#1)(1995-5#1)(2011-2#1)
or immunological##2##2##(2008-10#1)(2011-2#1)
or immunosuppressive##2##2##(1997-2#1)(2006-10#1)
or impaired##4##2##(2008-7#2)(2013-8#2)
or impairment##2##2##(1995-2#1)(2012-12#1)
or implantable##2##2##(2009-5#1)(2010-10#1)
or impossible to##5##3##(1997-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
or impossible##6##2##(1996-2#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
or improve##4##2##(1995-3#2)(2008-11#1)(2010-5#1)
or improved in##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
or improved##6##2##(1994-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
or improvement of the##2##4##(1996-11#1)(2013-1#1)
or improvement of##4##3##(1996-11#1)(2007-7#1)(2011-1#1)(2013-1#1)
or improvement##5##2##(1996-11#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
or improving the##2##3##(1991-7#1)(2008-10#1)
or improving##3##2##(1991-7#1)(1995-12#1)(2008-10#1)
or impurities##3##2##(2008-10#2)(2012-2#1)
or in a mixture##2##4##(2008-10#2)
or in a##12##3##(1991-3#1)(1992-12#1)(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2013-1#1)
or in any##2##3##(1996-1#1)(2008-10#1)
or in association with##4##4##(1997-4#1)(2010-3#1)(2011-2#1)(2013-1#1)
or in association##6##3##(1990-9#1)(1997-4#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
or in cases with##2##4##(2007-8#1)(2008-11#1)
or in close##2##3##(1996-12#1)(2010-7#1)
or in combination with a##3##5##(2008-10#1)(2008-4#1)(2012-12#1)
or in combination with other antihypertensive drugs##2##7##(2008-3#2)
or in combination with other##8##5##(1992-3#1)(1995-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#1)(2013-1#1)
or in combination with##38##4##(1992-3#1)(1992-5#1)(1993-12#2)(1994-8#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-3#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
or in combination##53##3##(1992-3#1)(1992-5#1)(1993-12#2)(1993-6#1)(1994-8#2)(1995-2#1)(1996-12#1)(1997-6#1)(2007-3#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#3)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
or in different##2##3##(2008-10#1)(2008-6#1)
or in hospital##2##3##(2011-2#2)
or in mixtures##2##3##(2008-10#1)(2012-7#1)
or in pairs##2##3##(1997-3#1)(2008-8#1)
or in patients with##3##4##(1990-6#1)(1997-8#1)(2009-9#1)
or in patients##4##3##(1990-6#1)(1997-8#1)(2009-9#1)(2013-1#1)
or in presence of##2##4##(1997-4#1)(2012-2#1)
or in response to##2##4##(1997-7#1)(2008-8#1)
or in situ##3##3##(2008-10#2)(2011-2#1)
or in small groups##2##4##(1996-5#1)(2008-5#1)
or in soil##2##3##(2006-12#1)(2008-10#1)
or in some cases##2##4##(2008-10#1)(2009-6#1)
or in terms of##2##4##(2008-10#1)(2008-7#1)
or in the blood##2##4##(1996-12#1)(2008-5#1)
or in the brain##2##4##(2008-5#1)(2008-9#1)
or in the combination##2##4##(2011-2#1)(2013-1#1)
or in the early##2##4##(1992-3#1)(1994-3#1)
or in the form of##2##5##(2008-8#1)(2013-1#1)
or in the group##2##4##(1992-8#1)(2008-3#1)
or in the nucleus##2##4##(1997-1#1)(2008-9#1)
or in the presence of##9##5##(1990-2#1)(1993-8#2)(1995-8#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-8#1)
or in the##71##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
or in their##2##3##(2008-7#1)(2011-2#1)
or in those treated with##2##5##(1993-2#1)(2010-6#1)
or in those##8##3##(1993-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
or in vitro##11##3##(1990-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-4#3)(2008-9#1)(2011-1#1)(2012-2#1)
or in vivo##5##3##(1992-6#1)(1992-9#1)(1997-4#1)(2006-12#1)(2008-11#1)
or in water##2##3##(2007-11#1)(2008-10#1)
or in which##3##3##(1994-8#1)(1997-2#1)(2008-3#1)
or in##313##2##(1990-12#1)(1990-2#4)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-12#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#7)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#51)(2008-11#12)(2008-12#3)(2008-2#3)(2008-3#15)(2008-4#12)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#10)(2008-9#9)(2009-10#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#1)
or inaccurate##2##2##(1993-12#1)(2013-1#1)
or inactivate##2##2##(2008-10#1)(2009-11#1)
or inadequate##4##2##(1991-12#1)(1994-9#1)(2010-9#1)(2013-1#1)
or inappropriate##5##2##(1997-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
or incidence##4##2##(2008-10#2)(2009-12#1)(2012-3#1)
or inclusion##2##2##(2008-11#1)(2008-8#1)
or incomplete##5##2##(1990-5#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
or incompletely##2##2##(2008-7#1)(2012-3#1)
or inconclusive##2##2##(1997-8#1)(2013-8#1)
or inconsistent##2##2##(2011-1#1)(2013-1#1)
or incorrect##2##2##(1991-6#1)(2008-11#1)
or increase##9##2##(1993-1#1)(1993-11#1)(1993-2#1)(1996-1#1)(1996-11#1)(2008-10#2)(2008-8#1)(2012-12#1)
or increased##17##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2012-3#1)
or increases##2##2##(1992-9#1)(2007-4#1)
or increasing the##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)
or increasing##5##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-7#1)
or independent##6##2##(1993-1#1)(1993-12#1)(1993-2#1)(2009-3#1)(2012-3#1)(2013-1#1)
or indirect##11##2##(1992-9#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2012-2#1)
or indirectly by##2##3##(1991-12#1)(2010-5#1)
or indirectly##21##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-2#1)
or individual##9##2##(1993-1#1)(2008-10#3)(2008-11#2)(2010-8#1)(2012-12#1)(2012-2#1)
or individually##2##2##(1991-1#1)(2012-3#1)
or individuals##2##2##(2008-2#1)(2013-1#1)
or induced by##2##3##(1991-8#1)(2010-4#1)
or induced##10##2##(1990-3#1)(1990-9#1)(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)
or inducible##2##2##(1993-9#1)(2012-12#1)
or inducing##2##2##(2007-12#1)(2008-10#1)
or induction of##3##3##(1995-3#1)(2008-4#1)(2013-1#1)
or induction##4##2##(1995-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
or industry##2##2##(1991-6#1)(1993-11#1)
or ineffective##2##2##(1994-2#1)(2012-2#1)
or infant##2##2##(2007-12#1)(2008-11#1)
or infected with##3##3##(1993-1#1)(1994-3#1)(2007-12#1)
or infected##5##2##(1993-1#1)(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#1)
or infection of##2##3##(2008-10#1)(2013-1#1)
or infection##16##2##(1991-5#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
or infections##4##2##(1995-9#1)(2007-11#2)(2008-10#1)
or infectious##2##2##(1997-7#1)(2010-12#1)
or infiltrating##2##2##(1992-8#1)(1995-4#1)
or inflammation##2##2##(2008-10#1)(2008-7#1)
or inflammatory response##2##3##(2008-12#1)(2011-2#1)
or inflammatory##10##2##(1993-2#1)(1994-3#1)(1997-1#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
or information##3##2##(2007-12#1)(2012-12#1)(2012-3#1)
or infra-red illumination##2##3##(1991-2#2)
or infusion##2##2##(1996-11#1)(2012-2#1)
or inhalation of##4##3##(1992-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
or inhibit the##2##3##(1990-5#1)(2013-1#1)
or inhibit##9##2##(1990-5#1)(1994-8#1)(1995-6#1)(2008-9#1)(2009-5#1)(2009-8#2)(2012-12#1)(2013-1#1)
or inhibition of##5##3##(1992-2#1)(1992-3#1)(1993-12#1)(1996-12#1)(2009-5#1)
or inhibition##7##2##(1992-2#1)(1992-3#1)(1993-12#1)(1996-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
or inhibitors##6##2##(1992-8#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-9#1)(2012-3#1)
or inhibitory effects##2##3##(2008-7#1)(2013-1#1)
or inhibitory##8##2##(1992-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2008-7#2)(2013-1#1)
or inhomogeneous##3##2##(1990-9#2)(2008-3#1)
or initial##2##2##(2008-10#1)(2008-3#1)
or injected with##2##3##(1993-12#1)(2008-10#1)
or injected##3##2##(1992-11#1)(1993-12#1)(2008-10#1)
or injection of##2##3##(1990-5#1)(2008-12#1)
or injection##5##2##(1990-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
or injury##4##2##(1997-2#1)(2009-2#1)(2012-12#1)(2013-8#1)
or insertion##2##2##(2008-11#1)(2013-8#1)
or insertions##2##2##(1993-3#1)(2012-3#1)
or insignificant##2##2##(1992-3#1)(2008-11#1)
or insufficient##2##2##(1990-9#1)(1997-4#1)
or insulin resistance##2##3##(1997-7#1)(2011-2#1)
or insulin##7##2##(1990-8#1)(1993-6#1)(1996-11#1)(1997-7#2)(2008-11#1)(2011-2#1)
or insurance##2##2##(1994-3#1)(1996-2#1)
or intact##5##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
or integration##2##2##(2008-2#1)(2008-4#1)
or intelligence##2##2##(2008-11#1)(2009-9#1)
or intensity##2##2##(1991-12#1)(2012-12#1)
or interaction##3##2##(1993-11#1)(2008-2#1)(2009-3#1)
or interactions between##2##3##(1990-6#1)(2011-2#1)
or interactions##3##2##(1990-6#1)(1994-9#1)(2011-2#1)
or interactive##2##2##(2008-9#1)(2013-8#1)
or interest##2##2##(1992-3#1)(2008-12#1)
or interfere with##5##3##(1993-6#1)(1995-6#1)(2010-3#1)(2010-7#1)(2012-1#1)
or interference with##2##3##(2008-11#1)(2013-7#1)
or intermediate levels of the defense##2##6##(2008-9#2)
or intermediate##8##2##(1991-2#1)(1996-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2013-1#1)
or intermittent##3##2##(2006-10#1)(2008-11#1)(2012-4#1)
or internal##8##2##(1995-5#1)(1996-12#1)(1997-7#1)(2008-1#1)(2010-4#2)(2013-8#2)
or interventional##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
or intestinal##2##2##(1994-2#1)(2008-11#1)
or into the##2##3##(1991-6#1)(1993-6#1)
or into##5##2##(1991-6#1)(1993-6#1)(1994-9#1)(2008-3#1)(2008-4#1)
or intracellular##4##2##(1992-9#1)(1994-11#1)(2008-9#2)
or intracranial##2##2##(2009-7#1)(2012-1#1)
or intramedullary##2##2##(2007-8#1)(2013-1#1)
or intramuscular routes##2##3##(1997-4#1)(1997-6#1)
or intramuscular##4##2##(1990-2#1)(1997-4#1)(1997-6#1)(2008-6#1)
or intranasal##2##2##(2007-11#2)
or intraoperative##2##2##(1991-3#1)(2011-2#1)
or intraperitoneal##4##2##(1992-2#1)(1996-12#1)(2008-10#1)(2012-2#1)
or intravenous##4##2##(1991-9#1)(1995-5#1)(2008-7#1)(2013-1#1)
or intrinsic##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
or introducing a##2##3##(2008-2#1)(2012-2#1)
or invasion##2##2##(2008-10#1)(2013-8#1)
or invasive##2##2##(2008-10#1)(2008-5#1)
or inverse##2##2##(2008-5#1)(2009-7#1)
or ion chromatography##2##3##(2008-10#2)
or ionomycin##2##2##(1995-8#1)(2008-11#1)
or iron##2##2##(2008-10#1)(2012-2#1)
or irregular##2##2##(1994-9#1)(2008-6#1)
or irreversible##2##2##(1996-3#1)(2011-2#1)
or is even##2##3##(1996-7#1)(2008-10#1)
or is it##3##3##(1991-2#1)(2007-12#1)(2009-5#1)
or is##24##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1996-12#1)(1996-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)
or ischemic stroke##2##3##(2008-8#2)
or ischemic##10##2##(1994-11#1)(1995-12#1)(1997-3#1)(2007-8#1)(2008-7#2)(2008-8#2)(2010-4#1)(2010-8#1)
or isolated from##2##3##(1994-5#1)(2012-2#1)
or isolated##6##2##(1994-5#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
or isolates##2##2##(2008-10#1)(2008-9#1)
or isolation##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
or isozyme##2##2##(2008-10#1)(2012-2#1)
or it can be##2##4##(2008-10#1)(2008-7#1)
or it can##3##3##(1994-3#1)(2008-10#1)(2008-7#1)
or it##11##2##(1992-3#1)(1994-2#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2011-2#1)
or itraconazole##2##2##(2007-12#1)(2008-5#1)
or its activity is##2##4##(1997-4#1)(2008-11#1)
or its combination with##2##4##(2012-2#1)(2012-7#1)
or its derivatives##3##3##(1990-6#1)(1995-8#1)(2008-5#1)
or its metabolite##2##3##(1995-3#1)(2008-10#1)
or its##62##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2010-3#1)(2010-5#1)(2011-10#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#3)
or just##4##2##(1993-3#1)(1996-12#1)(2008-4#1)(2011-1#1)
or kainic acid (50 ng/0##2##5##(1995-12#2)
or kainic acid##3##3##(1995-12#3)
or kidney##4##2##(1991-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
or killed##2##2##(2008-11#1)(2008-4#1)
or kinetic##4##2##(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
or knowledge##3##2##(1994-12#1)(2008-9#1)(2012-2#1)
or known##6##2##(1994-9#1)(1996-6#1)(1997-3#1)(2008-3#1)(2008-9#1)(2010-7#1)
or laboratory tests##2##3##(1994-6#1)(2008-5#1)
or laboratory##8##2##(1992-2#1)(1994-12#1)(1994-6#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
or lack of##10##3##(1993-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-12#1)
or lack thereof##3##3##(1995-6#1)(2012-2#1)(2012-3#1)
or lack##15##2##(1991-3#1)(1993-3#1)(1993-6#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
or lacking##2##2##(1994-3#1)(2012-2#1)
or lacrimal##2##2##(2011-1#2)
or laparoscopic##4##2##(1993-3#1)(2009-12#1)(2011-2#2)
or large##11##2##(1990-2#1)(1991-2#2)(1992-11#1)(1994-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
or larger oligosaccharides having##2##4##(1994-5#2)
or larger than##5##3##(1995-9#1)(2007-11#1)(2007-12#2)(2008-8#1)
or larger##17##2##(1992-5#2)(1993-9#1)(1994-5#2)(1995-9#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)
or laryngeal##2##2##(2007-8#1)(2008-2#1)
or laser##7##2##(1992-3#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
or late##7##2##(1990-10#1)(1993-9#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
or latent##2##2##(1990-6#1)(2008-12#1)
or later##5##2##(1990-12#1)(1995-11#1)(2008-9#1)(2010-6#1)(2013-1#1)
or lateral##6##2##(1990-3#1)(1991-2#1)(1992-4#1)(2008-7#1)(2009-8#1)(2013-1#1)
or lead cation##2##3##(2008-10#2)
or lead to##2##3##(1994-5#1)(2008-9#1)
or lead##5##2##(1994-5#1)(2008-10#3)(2008-9#1)
or leaf##8##2##(2008-10#6)(2008-12#1)(2012-9#1)
or leaking##2##2##(1991-5#1)(1993-2#1)
or leaves##3##2##(2008-10#3)
or left main##2##3##(2007-8#1)(2008-11#1)
or left##8##2##(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)(2013-8#1)
or legal##2##2##(2011-2#1)(2012-12#1)
or legislation##2##2##(1996-8#1)(2008-7#1)
or length##2##2##(1991-12#1)(2008-5#1)
or lengthening##2##2##(1997-4#1)(2007-11#1)
or lenses##2##2##(2008-3#2)
or lesion##3##2##(1997-8#1)(2008-10#1)(2012-3#1)
or lesions##2##2##(2008-10#1)(2008-5#1)
or less at birth##2##4##(1991-6#1)(2012-12#1)
or less at##3##3##(1991-6#1)(2008-10#1)(2012-12#1)
or less efficient##2##3##(1995-5#1)(2008-11#1)
or less in##6##3##(1990-8#1)(1995-8#1)(2008-10#2)(2008-9#2)
or less is##3##3##(1993-12#2)(2007-10#1)
or less severe##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
or less specific##2##3##(1991-2#1)(2012-2#1)
or less than the##2##4##(2008-2#2)
or less than##8##3##(1993-6#1)(2008-10#1)(2008-2#2)(2008-6#1)(2009-2#1)(2011-2#2)
or less##95##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#2)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#7)(2009-2#1)(2009-4#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
or less)##3##2##(1991-8#1)(2008-10#1)(2008-7#1)
or lethality##2##2##(1996-12#1)(2009-10#1)
or leucine##3##2##(1992-3#1)(1993-6#1)(1996-6#1)
or level of##2##3##(2008-10#1)(2010-6#1)
or lifestyle##2##2##(2009-11#1)(2010-12#1)
or ligation##2##2##(2007-9#1)(2009-7#1)
or light##2##2##(2008-10#1)(2008-5#1)
or limit the##3##3##(1997-3#1)(2006-10#1)(2011-2#1)
or limit their##2##3##(1991-12#1)(2008-9#1)
or limit##6##2##(1991-12#1)(1997-3#1)(2006-10#1)(2008-9#1)(2009-1#1)(2011-2#1)
or limited##3##2##(2008-10#3)
or linear##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
or linked to a##2##4##(1997-3#1)(2008-8#1)
or linked##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
or lip##2##2##(1991-6#1)(2012-3#1)
or lipid metabolism##2##3##(2008-7#1)(2010-5#1)
or lipid##6##2##(1992-3#1)(1992-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)
or lipopolysaccharide##2##2##(1993-8#1)(2008-10#1)
or lipoprotein##3##2##(1990-8#2)(1995-6#1)
or liquid##10##2##(1991-11#1)(1992-3#2)(2008-10#6)(2008-7#1)
or litter##3##2##(1994-6#2)(1994-8#1)
or live##2##2##(1995-5#1)(2013-7#1)
or lived##2##2##(1994-6#1)(1997-4#1)
or liver##9##2##(1990-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-4#1)(2010-12#1)(2011-2#1)
or living in##2##3##(2008-5#2)
or living##3##2##(2008-2#1)(2008-5#2)
or local##16##2##(1990-9#1)(1993-3#1)(1995-2#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
or localized##2##2##(2008-10#1)(2008-7#1)
or locally##2##2##(1992-9#1)(1996-3#1)
or location##2##2##(2008-10#1)(2011-2#1)
or locations##3##2##(2008-10#3)
or long term##2##3##(1992-3#1)(2008-5#1)
or long##5##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-2#1)
or long-term##6##2##(1991-9#1)(1992-9#1)(1996-3#1)(2007-10#1)(2011-2#1)(2012-5#1)
or longer##15##2##(1990-5#1)(1991-3#1)(1991-5#1)(1993-8#1)(1996-6#1)(1996-9#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)
or loss of##8##3##(1991-12#1)(1994-12#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
or loss##13##2##(1991-12#1)(1993-2#1)(1994-12#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-1#1)
or losses##5##2##(2008-10#4)(2010-3#1)
or lost##2##2##(1994-11#1)(2011-3#1)
or low doses##2##3##(2008-7#1)(2008-8#1)
or low##34##2##(1990-7#1)(1992-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-7#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-7#1)
or low-birth-weight##2##2##(2013-1#2)
or low-density##2##2##(1992-9#1)(2008-6#1)
or lower than##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
or lower##27##2##(1994-8#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
or lumbar##2##2##(1997-4#1)(2008-7#1)
or luminescent substrates##2##3##(2008-4#2)
or lymph##2##2##(2010-7#1)(2010-8#1)
or lyophilized##2##2##(1994-6#1)(2008-10#1)
or mRNA##5##2##(1993-6#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-9#1)
or magnesium##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
or magnetic resonance imaging##4##4##(1996-5#1)(1997-8#1)(2010-12#1)(2013-1#1)
or magnetic resonance##6##3##(1996-5#1)(1997-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
or magnetic##9##2##(1992-11#1)(1996-5#1)(1997-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
or maintain a##2##3##(2008-10#1)(2010-11#1)
or maintain##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2010-2#1)
or maintaining the##2##3##(1990-5#1)(2008-12#1)
or maintaining##3##2##(1990-5#1)(2008-12#1)(2008-7#1)
or maintenance##3##2##(2008-1#1)(2008-12#1)(2011-2#1)
or major depression##2##3##(1995-5#1)(2007-10#1)
or major##12##2##(1990-6#1)(1991-2#1)(1994-6#1)(1995-5#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-5#2)(2011-2#1)(2012-2#1)
or make##2##2##(1995-3#1)(2010-8#1)
or maladaptive##3##2##(2009-11#1)(2012-12#2)
or male##2##2##(1992-11#1)(2013-1#1)
or malformation##2##2##(2008-4#1)(2008-7#1)
or malignant##8##2##(1990-2#1)(1991-2#1)(1992-9#1)(1993-6#1)(1996-3#1)(2008-10#1)(2008-4#1)(2009-12#1)
or maltose##2##2##(1993-12#1)(1996-12#1)
or mammalian##3##2##(1991-1#2)(2008-1#1)
or management##3##2##(1994-2#1)(1997-2#1)(2008-12#1)
or manganese##3##2##(1995-3#1)(2008-10#2)
or manual##3##2##(2008-11#1)(2008-6#1)(2010-5#1)
or many##2##2##(2008-9#2)
or marginal excision and##2##4##(2008-6#2)
or marginal##5##2##(1995-9#1)(2008-6#4)
or markedly##3##2##(1991-2#1)(1993-12#1)(2007-11#1)
or mass##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)
or mastectomy##2##2##(1990-12#1)(1991-4#1)
or matched##2##2##(1992-6#1)(2010-3#1)
or material##2##2##(2008-3#1)(2011-2#1)
or maternal##2##2##(2010-3#1)(2010-6#1)
or mature##2##2##(1992-8#1)(2008-10#1)
or maximum##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
or may be##3##3##(1991-12#1)(2008-7#2)
or may not##17##3##(1990-12#1)(1992-12#1)(1994-2#2)(1995-1#1)(1995-5#1)(2007-10#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
or may##29##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#2)(1995-1#1)(1995-5#1)(1996-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
or mean##7##2##(1990-9#1)(1997-2#1)(2008-1#1)(2008-8#1)(2008-9#2)(2013-1#1)
or measurement of##2##3##(2007-8#1)(2008-10#1)
or measurements##2##2##(1992-3#1)(2007-11#1)
or mechanical##8##2##(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
or mechanism##3##2##(1997-2#1)(2008-8#1)(2010-11#1)
or media##3##2##(1995-12#1)(2008-11#1)(2009-7#1)
or medial##3##2##(1993-11#1)(1997-2#1)(2011-2#1)
or medical treatment##2##3##(2008-12#1)(2011-2#1)
or medical##14##2##(1994-12#1)(1994-3#1)(1997-6#1)(2008-1#1)(2008-12#1)(2009-4#1)(2009-9#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
or medium##4##2##(1992-11#1)(2008-10#2)(2008-8#1)
or melon##2##2##(2008-10#2)
or membrane##3##2##(1992-3#1)(1993-11#1)(2008-5#1)
or men##2##2##(1993-11#1)(2012-12#1)
or mental##2##2##(1997-6#1)(2008-8#1)
or merely##2##2##(1994-12#1)(1995-1#1)
or merge##2##2##(1996-1#1)(2007-12#1)
or metabolic##5##2##(1996-11#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
or metabolism##2##2##(1992-11#1)(1993-12#1)
or metabolite##2##2##(2008-11#1)(2013-1#1)
or metabolites##2##2##(2008-8#1)(2010-11#1)
or metal##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
or metastasis of##2##3##(2008-6#1)(2008-7#1)
or metastasis##4##2##(1993-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
or metastatic disease##3##3##(2008-6#3)
or metastatic##19##2##(1993-8#2)(1994-2#1)(2007-4#1)(2008-6#9)(2009-9#2)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
or metham sodium##2##3##(2008-10#2)
or methanol##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
or methionine##2##2##(1991-9#1)(2008-10#1)
or methods##2##2##(2008-2#1)(2011-1#1)
or methyl##3##2##(1995-3#1)(2008-10#2)
or methylamine##2##2##(1995-9#2)
or methylene##3##2##(1993-8#2)(2008-10#1)
or mice##2##2##(1994-5#1)(2008-4#1)
or micelles##2##2##(1994-3#1)(1994-5#1)
or microarray##2##2##(2008-4#1)(2009-12#1)
or microbial##2##2##(1994-3#1)(2011-2#1)
or microsatellite DNA##2##3##(1995-2#1)(2008-5#1)
or microscopic##2##2##(2008-10#1)(2011-2#1)
or mid##2##2##(2012-12#1)(2013-1#1)
or might##3##2##(1990-6#1)(2007-6#1)(2011-2#1)
or migration##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)
or mild hypothermia##2##3##(1995-11#1)(2011-2#1)
or mild##9##2##(1993-8#1)(1995-11#1)(1996-5#1)(1997-8#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
or milk##2##2##(1992-2#1)(1994-5#1)
or minimal##4##2##(2008-2#1)(2008-9#1)(2010-1#1)(2013-1#1)
or minimize##4##2##(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
or minimum##2##2##(2008-3#1)(2008-7#1)
or minor stroke##4##3##(1991-11#1)(2008-8#3)
or minor##7##2##(1991-11#1)(2007-10#1)(2008-8#4)(2013-8#1)
or misdiagnosed##2##2##(2010-12#1)(2013-8#1)
or missed##2##2##(2008-1#1)(2013-8#1)
or missing##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
or mitochondrial DNA##2##3##(2008-12#1)(2008-5#1)
or mitochondrial##3##2##(1993-6#1)(2008-12#1)(2008-5#1)
or mitotic##2##2##(2008-10#1)(2008-4#1)
or mitral valve##2##3##(1990-12#1)(2011-2#1)
or mitral##3##2##(1990-12#1)(1995-3#1)(2011-2#1)
or mix##2##2##(1997-3#1)(2008-4#1)
or mixed##15##2##(1990-11#1)(1992-10#1)(1994-5#1)(1995-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
or mobile##3##2##(1994-12#1)(2008-9#1)(2013-1#1)
or model##2##2##(2008-2#1)(2011-1#1)
or moderate##7##2##(1995-2#1)(1995-9#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
or moderately##3##2##(2008-10#2)(2008-8#1)
or modification of##2##3##(1992-11#1)(2008-8#1)
or modification##3##2##(1992-11#1)(2008-10#1)(2008-8#1)
or modified##5##2##(1995-1#1)(2008-11#1)(2008-9#1)(2009-9#1)(2011-1#1)
or modify the##2##3##(2009-2#1)(2010-3#1)
or modify##7##2##(1994-1#1)(1994-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-3#1)
or modulated##2##2##(2007-12#1)(2008-7#1)
or modulating the##2##3##(2008-4#1)(2011-2#1)
or molecular##6##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)
or monitoring of##2##3##(2008-10#1)(2012-12#1)
or monitoring##3##2##(2008-10#1)(2010-10#1)(2012-12#1)
or monoclonal antibodies##3##3##(2008-4#3)
or monocytes##3##2##(1990-12#1)(1991-2#1)(2011-2#1)
or moral##3##2##(1996-2#1)(2008-12#1)(2011-2#1)
or more DNA##2##3##(1997-2#1)(2008-10#1)
or more after##2##3##(2008-10#1)(2013-1#1)
or more antibiotics##2##3##(2008-10#1)(2013-8#1)
or more children##3##3##(1990-6#1)(1997-2#2)
or more commonly##3##3##(2006-6#1)(2008-5#1)(2008-7#1)
or more communication related impairments##2##5##(2011-1#2)
or more different##2##3##(1991-1#1)(2010-12#1)
or more for##2##3##(1994-2#1)(2008-3#1)
or more from the##2##4##(1990-11#1)(2008-9#1)
or more from##3##3##(1990-11#1)(2008-5#1)(2008-9#1)
or more hours##3##3##(1991-9#1)(1995-3#1)(2008-10#1)
or more in##5##3##(1990-8#1)(1992-2#1)(1996-4#1)(2007-8#1)(2012-12#1)
or more of the following##6##5##(1991-9#1)(1992-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
or more of the six##2##5##(1996-2#1)(2010-6#1)
or more of the##19##4##(1990-8#1)(1991-9#1)(1992-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#2)(2010-6#1)(2011-1#1)
or more of these##7##4##(1994-6#1)(2008-1#2)(2008-10#1)(2008-5#2)(2011-2#1)
or more of##31##3##(1990-8#1)(1991-9#1)(1992-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#2)(2010-6#1)(2011-1#1)(2011-2#1)
or more particles##2##3##(2008-5#2)
or more positive##2##3##(1997-7#1)(2007-7#1)
or more rarely##2##3##(1990-8#1)(2008-7#1)
or more resistant to##2##4##(1994-5#1)(2008-10#1)
or more sensitive##2##3##(2008-10#2)
or more servings of##3##4##(1997-1#1)(2011-1#2)
or more severe##3##3##(1992-10#2)(2011-1#1)
or more sophisticated##2##3##(1996-7#1)(2007-12#1)
or more than##4##3##(1997-6#1)(2008-10#2)(2011-2#1)
or more to the##2##4##(1991-4#1)(1994-12#1)
or more to##3##3##(1991-4#1)(1994-12#1)(2008-10#1)
or more years of##2##4##(2008-12#1)(2012-12#1)
or more years##7##3##(1991-12#3)(1992-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
or more##336##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#3)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#2)(1995-11#1)(1995-2#5)(1995-3#1)(1995-5#6)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#55)(2008-11#11)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#14)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#4)(2009-6#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#9)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#9)
or more)##4##2##(1991-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
or morphine##2##2##(1996-2#1)(1997-2#1)
or morphology##3##2##(1994-5#1)(1995-6#2)
or mortality between##2##3##(1994-2#1)(2012-3#1)
or mortality##7##2##(1993-11#1)(1994-2#1)(1996-9#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
or mosaic##2##2##(2008-10#1)(2008-3#1)
or most##4##2##(1990-5#1)(1996-3#1)(2008-10#1)(2008-7#1)
or mostly##2##2##(2008-10#2)
or motor##8##2##(1991-5#1)(1991-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
or mouse##7##2##(1993-8#1)(1994-8#1)(1997-4#1)(2008-4#3)(2011-2#1)
or mouth##2##2##(2008-11#1)(2008-6#1)
or movement##5##2##(2007-6#1)(2008-10#1)(2011-2#2)(2013-8#1)
or moving##3##2##(2008-3#1)(2012-2#1)(2012-3#1)
or multiple##27##2##(1992-6#1)(1993-11#1)(1994-12#1)(1994-2#3)(2007-10#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
or murine##3##2##(1994-11#1)(2008-4#1)(2011-2#1)
or muscle##7##2##(1993-11#1)(1994-11#1)(1996-12#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
or muscles##3##2##(2008-6#1)(2009-11#1)(2009-3#1)
or mutant##3##2##(1997-7#1)(2008-1#1)(2008-11#1)
or mutants##2##2##(2008-10#1)(2008-9#1)
or mutated##2##2##(1995-6#1)(1997-3#1)
or mutations in the##2##4##(2008-4#1)(2011-1#1)
or mutations##3##2##(1991-9#1)(2008-4#1)(2011-1#1)
or myelodysplastic syndrome##3##3##(1992-10#1)(2011-2#2)
or myelodysplastic##4##2##(1990-8#1)(1992-10#1)(2011-2#2)
or myocardial##3##2##(1991-11#1)(2008-4#1)(2012-2#1)
or narrow##2##2##(2008-11#1)(2008-3#1)
or nasal##3##2##(1993-11#1)(1995-9#1)(2011-1#1)
or natural##8##2##(2008-10#3)(2010-1#2)(2010-10#1)(2010-7#1)(2013-7#1)
or near the##14##3##(1990-11#2)(1990-7#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-10#3)(2008-2#1)(2008-5#1)
or near##26##2##(1990-11#2)(1990-7#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-3#2)(1994-11#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
or near-infrared##2##2##(2008-3#1)(2008-7#1)
or nearly identical##2##3##(2008-10#1)(2012-2#1)
or nearly##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
or necessarily##2##2##(1992-3#1)(2008-6#1)
or neck##4##2##(1995-8#1)(2008-12#1)(2011-2#1)(2012-2#1)
or necrosis##2##2##(2008-7#1)(2010-3#1)
or necrotic##5##2##(1997-8#1)(2008-10#2)(2008-5#2)
or negative##28##2##(1990-5#1)(1990-8#1)(1991-12#1)(1993-5#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-8#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-8#1)
or negatively##4##2##(2008-10#3)(2008-4#1)
or neither##4##2##(1997-2#1)(1997-5#1)(2008-10#1)(2008-2#1)
or neocortex##2##2##(1994-3#1)(1996-5#1)
or neonatal##5##2##(1994-9#2)(1995-11#1)(2008-11#1)(2008-12#1)
or neoplastic##2##2##(2008-10#1)(2011-2#1)
or nerve##2##2##(1997-3#1)(2008-9#1)
or neural##2##2##(1995-3#1)(2008-6#1)
or neurological##4##2##(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
or neurotization (nerve transfer)##2##4##(2008-9#2)
or neutral##12##2##(1992-6#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-7#1)(2012-2#2)(2012-3#1)
or never##2##2##(2007-12#1)(2009-6#1)
or new##8##2##(1994-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-11#1)(2010-11#1)(2012-12#1)(2013-1#1)
or newly##2##2##(2008-10#1)(2008-7#1)
or niche##2##2##(2008-8#1)(2009-12#1)
or nickel##2##2##(1997-2#1)(2008-10#1)
or nifedipine##2##2##(1994-11#2)
or night blindness##2##3##(1991-8#2)
or night##3##2##(1991-8#2)(2010-10#1)
or nitrate##2##2##(2008-10#2)
or nitrogen##2##2##(1991-6#1)(2008-10#1)
or no activity##2##3##(1992-5#1)(2012-12#1)
or no change in##2##4##(2008-10#2)
or no change##3##3##(1990-3#1)(2008-10#2)
or no damage to##2##4##(2008-10#1)(2009-12#1)
or no damage##3##3##(1994-8#1)(2008-10#1)(2009-12#1)
or no germination occurred##2##4##(2008-10#2)
or no impact##5##3##(1991-6#1)(1993-6#1)(1995-5#1)(2007-11#1)(2012-3#1)
or no interaction##2##3##(2008-10#1)(2011-2#1)
or no response##2##3##(2008-6#1)(2013-1#1)
or no voltage is applied to##2##6##(2008-2#1)(2008-3#1)
or no##111##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#3)(1997-3#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#5)(2008-9#3)(2009-12#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
or non-specific##2##2##(1992-11#1)(2010-6#1)
or none of##3##3##(1990-12#1)(1991-2#1)(2012-3#1)
or none##7##2##(1990-12#1)(1991-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
or none)##2##2##(2008-10#1)(2011-2#1)
or noninoculated##2##2##(2008-10#2)
or nonlinear##2##2##(2007-11#1)(2008-3#1)
or nonneoplastic##9##2##(2008-8#2)(2008-9#6)(2011-2#1)
or normal##12##2##(1992-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2011-1#1)(2013-8#1)
or not and##2##3##(2008-8#1)(2011-2#1)
or not at all##7##4##(1992-10#1)(1994-8#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
or not available##2##3##(2008-10#1)(2008-12#1)
or not the##16##3##(1990-7#1)(1991-7#2)(1994-12#1)(1994-2#1)(1995-8#1)(1996-4#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
or not to know the##2##5##(2013-1#2)
or not to pilot##2##4##(1994-3#2)
or not to##21##3##(1991-2#1)(1991-3#1)(1993-3#1)(1994-3#3)(1995-5#1)(1996-1#2)(2007-12#1)(2008-11#2)(2008-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
or not was##2##3##(1993-3#1)(2008-8#1)
or not with##8##3##(1990-8#1)(1991-2#1)(1991-4#1)(2008-10#4)(2009-3#1)
or not##170##2##(1990-11#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#3)(1994-3#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#2)(2007-8#3)(2008-10#29)(2008-11#17)(2008-12#4)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-8#2)(2011-2#12)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
or not)##3##2##(2008-5#1)(2008-6#1)(2012-3#1)
or not?##5##2##(1994-12#1)(2008-11#2)(2010-4#1)(2011-2#1)
or novel##4##2##(1993-6#1)(2011-3#1)(2012-1#2)
or nuclear##2##2##(1994-9#1)(2013-1#1)
or number of##3##3##(1997-4#1)(2008-10#2)
or number##4##2##(1997-4#1)(2008-10#3)
or nurse##2##2##(1996-1#1)(2008-11#1)
or nursing home##2##3##(2007-12#1)(2009-2#1)
or nursing##3##2##(1991-12#1)(2007-12#1)(2009-2#1)
or nutrient##3##2##(1997-4#2)(2008-10#1)
or nutritional##2##2##(2007-12#1)(2013-7#1)
or nutritive properties##2##3##(2010-7#2)
or obese##14##2##(1996-12#1)(2008-10#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#7)
or obesity##3##2##(2008-1#1)(2008-5#2)
or object##2##2##(2009-10#1)(2009-2#1)
or oblique##2##2##(1995-6#1)(2008-3#1)
or observed##2##2##(1991-12#1)(1996-2#1)
or obtaining##2##2##(1995-6#1)(2008-10#1)
or occasionally##2##2##(1993-1#1)(2013-8#1)
or occupational##5##2##(1991-12#1)(1996-6#1)(2008-4#3)
or occur##2##2##(1993-6#1)(2012-1#1)
or odd-number##2##2##(2008-11#2)
or of a##5##3##(1991-3#1)(1992-5#1)(1993-9#1)(2007-11#1)(2011-2#1)
or of the##12##3##(1990-5#1)(1990-7#1)(1990-8#1)(1992-2#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
or of##48##2##(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-5#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
or offspring##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
or oils##2##2##(1995-5#1)(2008-10#1)
or old##2##2##(2008-7#2)
or older##19##2##(1991-11#1)(1991-9#1)(1992-5#1)(1992-9#3)(1993-8#1)(2007-10#3)(2008-11#2)(2008-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2011-2#1)(2013-8#1)
or older)##2##2##(1995-9#1)(2009-7#1)
or oleic##2##2##(2008-10#1)(2009-11#1)
or oligandrin##3##2##(2008-10#3)
or olive##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
or omental##2##2##(1990-2#1)(2012-2#1)
or on leaves##2##3##(2008-10#2)
or on the##13##3##(1991-2#1)(1992-12#1)(1993-11#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-9#2)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
or on##50##2##(1991-2#1)(1992-12#2)(1992-5#1)(1993-11#1)(1994-9#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
or on-line##4##2##(1992-11#1)(2008-10#2)(2013-8#1)
or one of##3##3##(1994-12#1)(1997-3#1)(2008-4#1)
or one with##2##3##(2008-1#1)(2008-4#1)
or one##18##2##(1991-4#1)(1993-11#1)(1993-12#1)(1994-12#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-12#1)(2013-8#2)
or only rarely##2##3##(1997-2#1)(2008-7#1)
or only slightly##2##3##(1990-2#1)(2008-8#1)
or only with##2##3##(1992-5#1)(2011-3#1)
or only##18##2##(1990-2#1)(1992-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-3#1)
or onset of##2##3##(2008-7#1)(2009-7#1)
or onset##3##2##(2007-7#1)(2008-7#1)(2009-7#1)
or onto##4##2##(1997-2#1)(1997-3#1)(2008-10#1)(2008-4#1)
or open##4##2##(1995-11#1)(1996-9#1)(2007-12#1)(2008-6#1)
or optical##2##2##(2007-12#1)(2008-3#1)
or optimal##2##2##(1996-2#1)(2010-3#1)
or oral##7##2##(1991-9#1)(2007-11#1)(2010-5#1)(2010-6#2)(2011-1#1)(2013-1#1)
or orally##2##2##(2007-11#1)(2013-7#1)
or ordered##2##2##(1991-9#1)(2007-11#1)
or ordinal##2##2##(1997-8#1)(2008-5#1)
or organ##4##2##(1994-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
or organic solvents##2##3##(1990-12#1)(2008-10#1)
or organic##6##2##(1990-12#1)(2008-10#5)
or organization##2##2##(1995-2#1)(1996-2#1)
or organs##6##2##(2007-4#1)(2008-11#2)(2009-12#1)(2010-9#1)(2011-1#1)
or oro-tracheal tube##2##3##(2008-2#2)
or osteoporosis##2##2##(2012-12#1)(2013-1#1)
or other biological##2##3##(1995-12#1)(2010-11#1)
or other causes##2##3##(2008-12#1)(2011-2#1)
or other clinical##2##3##(2007-7#1)(2012-3#1)
or other drugs##3##3##(2009-9#1)(2010-4#1)(2012-3#1)
or other factors##2##3##(2008-12#1)(2011-2#1)
or other forms of##3##4##(1991-11#1)(2008-1#1)(2009-9#1)
or other health care##2##4##(1993-12#1)(2009-5#1)
or other health##3##3##(1993-12#1)(1995-2#1)(2009-5#1)
or other human##2##3##(2007-12#1)(2011-2#1)
or other parts of##2##4##(2007-12#1)(2012-12#1)
or other proteins##2##3##(1995-6#1)(2008-8#1)
or other reasons##2##3##(1994-3#1)(2010-8#1)
or other type of##2##4##(2008-11#1)(2008-4#1)
or other##160##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-3#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#5)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-5#2)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#12)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#2)
or others##3##2##(1991-12#1)(1997-5#1)(2013-8#1)
or otherwise##5##2##(1993-1#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)
or out of the##2##4##(2009-11#1)(2012-3#1)
or out of##4##3##(2008-9#2)(2009-11#1)(2012-3#1)
or outcome of##2##3##(2009-4#1)(2011-2#1)
or outcome##5##2##(1995-12#1)(2008-7#1)(2009-4#1)(2011-2#2)
or outside the##2##3##(1991-6#1)(1995-8#1)
or outside##6##2##(1991-6#1)(1991-9#1)(1995-8#1)(1996-3#1)(2008-8#1)(2012-12#1)
or over##13##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-6#2)(2008-10#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
or overall##2##2##(2008-6#1)(2008-8#1)
or overexpression##2##2##(2008-9#1)(2011-2#1)
or overlap##2##2##(2008-4#1)(2008-7#1)
or overt##2##2##(1994-12#1)(2008-1#1)
or oxidation##2##2##(2008-10#1)(2013-1#1)
or ozone##2##2##(2008-2#1)(2008-3#1)
or p53##2##2##(1995-6#1)(2008-9#1)
or p53175P##2##2##(2008-7#2)
or pH##6##2##(1995-2#1)(1996-3#1)(2008-10#4)
or packed##2##2##(2008-11#2)
or pain##6##2##(1990-11#1)(2006-12#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-8#1)
or palliative##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
or papilla##2##2##(2008-10#1)(2008-5#1)
or papillary##2##2##(1993-2#1)(2010-6#1)
or paracetamol##2##2##(1990-2#1)(1991-9#1)
or paraffin-embedded##2##2##(1997-3#1)(2008-9#1)
or parallel##2##2##(1990-12#1)(2008-3#1)
or paralyzed arm##2##3##(2007-10#2)
or parasitic##2##2##(2008-8#1)(2013-1#1)
or paraxial##2##2##(2008-10#1)(2008-3#1)
or parental##2##2##(1994-2#1)(2010-9#1)
or part of the##2##4##(2008-6#1)(2010-5#1)
or part of##5##3##(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-5#1)
or partial sterility##2##3##(2008-8#1)(2010-3#1)
or partial##22##2##(1990-10#1)(1990-11#1)(1991-6#1)(1992-4#1)(1993-9#1)(1995-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-5#1)(2010-9#1)
or partially purified##2##3##(1995-2#1)(2008-1#1)
or partially##16##2##(1990-8#1)(1994-8#1)(1995-2#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
or particle##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
or partly##2##2##(1995-8#1)(2008-11#1)
or parts of##2##3##(2008-12#1)(2012-12#1)
or parts##4##2##(2008-10#2)(2008-12#1)(2012-12#1)
or passive##4##2##(1995-5#1)(2010-5#1)(2010-8#1)(2011-1#1)
or past##3##2##(1992-2#1)(2008-11#1)(2010-9#1)
or pathogen##5##2##(2008-10#5)
or pathologic##2##2##(1990-6#1)(2011-2#1)
or pathological##8##2##(1993-2#1)(1993-3#1)(1996-6#1)(2008-7#2)(2010-3#1)(2012-2#1)(2013-1#1)
or pathways##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
or patient##6##2##(1991-12#1)(1991-6#1)(1995-3#1)(1996-1#1)(1997-2#1)(2011-2#1)
or patients##8##2##(1990-3#1)(1994-1#1)(1994-3#1)(1997-1#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
or pattern of##2##3##(1992-3#1)(2009-6#1)
or pattern##3##2##(1992-3#1)(2008-11#1)(2009-6#1)
or patterns of##2##3##(2007-12#1)(2008-11#1)
or peat##2##2##(2008-10#2)
or pelvic##3##2##(1990-6#1)(1992-2#1)(1994-12#1)
or peptidase##2##2##(1995-6#1)(2008-4#1)
or peptide##3##2##(1995-5#1)(2008-11#1)(2008-9#1)
or peptides##5##2##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#2)
or per##4##2##(1993-12#1)(1994-8#2)(2008-4#1)
or percent##2##2##(2007-7#1)(2008-10#1)
or perceptions of##3##3##(2008-9#1)(2013-1#2)
or perennial##2##2##(2008-8#1)(2013-8#1)
or performing##2##2##(1994-1#1)(2008-4#1)
or perfusion bioreactors##2##3##(2008-11#2)
or perfusion##4##2##(2008-11#3)(2010-12#1)
or perhaps##7##2##(1992-12#1)(1994-11#1)(2007-11#2)(2008-10#1)(2008-9#1)(2012-2#1)
or peripheral blood##3##3##(2008-11#2)(2008-4#1)
or peripheral##14##2##(1990-2#1)(1992-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#2)(2012-2#1)
or peritoneal##3##2##(1990-6#1)(2008-4#1)(2012-3#1)
or permanent##10##2##(1990-9#1)(1993-9#1)(2008-5#1)(2009-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
or permit##2##2##(2008-9#2)
or persistent##4##2##(1992-6#1)(2007-10#1)(2010-6#1)(2011-1#1)
or personal##2##2##(2008-10#1)(2010-2#1)
or persons##2##2##(1994-11#1)(2011-2#1)
or pharmaceutical##5##2##(1990-9#1)(2008-4#2)(2008-5#2)
or pharmacologic activation##2##3##(1995-6#2)
or pharmacologic##3##2##(1995-6#2)(2011-2#1)
or pharmacological##7##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#2)
or phase##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
or phenylephrine (10##2##3##(1995-12#1)(1997-7#1)
or phenylephrine##3##2##(1991-3#1)(1995-12#1)(1997-7#1)
or phorbol 12-myristate 13-acetate (PMA)##2##5##(1995-2#1)(1995-6#1)
or phorbol ester##2##3##(1990-5#1)(1995-6#1)
or phorbol esters##3##3##(1991-12#1)(1995-6#2)
or phorbol##11##2##(1990-5#1)(1991-12#1)(1991-9#2)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#4)
or phosphate buffer##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
or phosphate##6##2##(1990-2#1)(1993-12#1)(1995-8#1)(2008-10#2)(2008-6#1)
or phosphodiesterase##2##2##(2007-8#1)(2009-2#1)
or phosphomolybdic acid##2##3##(2008-10#2)
or physical##10##2##(1995-6#2)(1996-6#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-2#1)(2012-2#1)
or physically##2##2##(1991-1#1)(2010-3#1)
or physiological##6##2##(1995-3#1)(2008-8#3)(2009-9#1)(2010-4#1)
or pigmentation##2##2##(2008-10#1)(2009-4#1)
or placebo for 6 weeks##2##5##(2008-5#1)(2013-1#1)
or placebo for##8##3##(1992-8#1)(2008-10#2)(2008-5#3)(2012-2#1)(2013-1#1)
or placebo in##2##3##(2013-1#2)
or placebo were##2##3##(1990-5#1)(2008-10#1)
or placebo##23##2##(1990-5#1)(1992-8#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-5#6)(2008-7#1)(2011-1#1)(2012-2#3)(2013-1#4)
or planar##2##2##(2008-3#1)(2012-2#1)
or planned##4##2##(1992-1#1)(1997-2#1)(2008-5#1)(2008-7#1)
or plant##6##2##(1990-12#1)(2008-10#3)(2008-8#1)(2009-8#1)
or plasma##10##2##(1990-2#1)(1990-8#2)(1994-2#1)(1997-3#1)(2008-3#1)(2008-4#2)(2009-6#1)(2011-2#1)
or plastic##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
or platelet derived growth factor##2##5##(1991-12#1)(2013-1#1)
or platelet##4##2##(1991-12#1)(2008-7#1)(2013-1#2)
or plates##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
or pointed##2##2##(1995-2#1)(2008-1#1)
or political##2##2##(2009-10#1)(2009-6#1)
or poly-aspartic##2##2##(2008-11#2)
or polymer##3##2##(2008-10#2)(2008-12#1)
or polymerase##2##2##(2012-2#1)(2012-3#1)
or polyurethane##2##2##(2008-10#1)(2008-2#1)
or poor##6##2##(1992-5#1)(1997-2#1)(2007-11#1)(2008-7#1)(2013-1#2)
or poorly##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
or population##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
or populations##4##2##(2008-10#4)
or porcelain-based materials##2##3##(2008-7#1)(2013-1#1)
or positive##6##2##(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#3)
or possible##4##2##(1996-11#1)(1997-6#1)(2008-10#1)(2008-7#1)
or possibly##5##2##(1990-8#1)(1994-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
or post-QQc cells##3##3##(2012-12#3)
or post-translational modifications##3##3##(1994-2#1)(1994-8#1)(2008-4#1)
or post-translational##6##2##(1992-8#1)(1994-2#1)(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
or posterior##5##2##(1990-11#1)(1994-3#1)(2007-11#1)(2008-3#1)(2008-9#1)
or postnatal##4##2##(1996-1#1)(2007-12#1)(2008-4#1)(2011-1#1)
or postoperative complications##3##3##(1992-2#1)(2012-12#2)
or postoperative##5##2##(1992-2#1)(2007-11#2)(2012-12#2)
or postsynaptic##2##2##(1997-2#1)(2008-4#1)
or potassium##4##2##(2006-4#1)(2008-10#2)(2008-7#1)
or potential risks##2##3##(2008-11#1)(2013-1#1)
or potential##11##2##(2008-1#1)(2008-11#2)(2008-4#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#4)
or powders##2##2##(2008-10#1)(2008-3#1)
or prediction##2##2##(1991-6#1)(2008-8#1)
or predominant##2##2##(1994-8#1)(2007-10#1)
or pregnancy##4##2##(1990-8#1)(1991-3#2)(1994-12#1)
or premature##4##2##(2008-11#1)(2010-10#1)(2010-3#1)(2011-1#1)
or presence of##10##3##(1994-6#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
or presence##12##2##(1991-12#1)(1992-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
or present in##4##3##(1993-9#1)(2007-12#1)(2008-10#1)(2010-6#1)
or present##6##2##(1993-9#1)(2007-12#1)(2008-10#2)(2010-6#1)(2013-8#1)
or pressure##5##2##(1993-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
or prevent##9##2##(1993-2#1)(1996-11#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-5#1)(2011-2#1)
or prevented##2##2##(1992-2#1)(2010-1#1)
or prevention of the##2##4##(2008-3#1)(2009-5#1)
or prevention of##5##3##(1990-5#1)(2008-3#1)(2009-5#1)(2011-2#2)
or prevention##7##2##(1990-5#1)(1996-11#1)(2007-12#1)(2008-3#1)(2009-5#1)(2011-2#2)
or previous##4##2##(1990-6#1)(2008-1#2)(2008-9#1)
or primary care##2##3##(1995-2#1)(2011-2#1)
or primary##5##2##(1995-2#1)(2007-10#1)(2008-3#1)(2011-2#2)
or prion##2##2##(2008-11#1)(2010-11#1)
or prior to##2##3##(2007-11#1)(2008-5#1)
or prior##3##2##(1995-3#1)(2007-11#1)(2008-5#1)
or problematic##2##2##(2008-11#1)(2012-12#1)
or procedures##2##2##(1993-12#1)(2010-11#1)
or processes##2##2##(2008-10#1)(2009-8#1)
or produce##2##2##(2008-10#1)(2008-12#1)
or producing##2##2##(2007-4#1)(2008-10#1)
or product##6##2##(1995-5#1)(1996-12#2)(2008-10#1)(2008-7#1)(2011-2#1)
or production of##2##3##(2008-11#1)(2010-11#1)
or production##4##2##(1993-3#1)(2008-11#2)(2010-11#1)
or productivity##2##2##(1993-2#1)(2008-9#1)
or products##3##2##(1991-9#1)(2007-6#1)(2008-10#1)
or professional##3##2##(1992-1#1)(2008-1#1)(2008-11#1)
or profound##2##2##(1990-9#1)(2012-1#1)
or prognosis##2##2##(1996-4#1)(2007-12#1)
or prognostic##2##2##(1990-2#1)(1991-8#1)
or programmed cell death##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
or progression of disease##2##4##(1990-8#1)(2013-1#1)
or progression of##4##3##(1990-8#1)(2011-2#2)(2013-1#1)
or progression##7##2##(1990-8#1)(1991-8#1)(2008-1#1)(2008-4#1)(2011-2#2)(2013-1#1)
or progressive##3##2##(1994-8#1)(2008-5#1)(2008-6#1)
or proliferation##2##2##(1992-9#1)(2008-10#1)
or prolonged##2##2##(1995-2#1)(2008-10#1)
or prophylactic##2##2##(1993-10#1)(2011-2#1)
or proportion of##2##3##(2011-2#1)(2012-3#1)
or propranolol##4##2##(1990-5#1)(1994-9#2)(1995-3#1)
or prostate##3##2##(1991-12#1)(2008-7#2)
or protease##2##2##(1995-6#1)(2011-3#1)
or protective effects##2##3##(2008-10#1)(2008-7#1)
or protective##4##2##(1995-5#1)(2008-10#2)(2008-7#1)
or protein domains##2##3##(1995-2#1)(2008-4#1)
or protein##19##2##(1991-11#1)(1991-3#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-2#2)(1995-8#1)(1997-4#1)(1997-7#1)(2008-4#4)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
or proteins##7##2##(1995-2#2)(1995-9#1)(2008-10#2)(2009-12#1)(2011-2#1)
or proteinuria##2##2##(2008-8#1)(2011-2#1)
or provide##7##2##(1996-9#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-5#1)
or providing##3##2##(1994-3#1)(2008-1#1)(2013-8#1)
or provocative##2##2##(1997-6#1)(2013-1#1)
or proximal##2##2##(2010-12#1)(2012-3#1)
or psychiatric disorders##2##3##(2008-9#2)
or psychiatric##5##2##(2008-6#1)(2008-9#4)
or psychological##2##2##(2008-7#1)(2013-1#1)
or public##6##2##(1991-3#1)(2008-11#1)(2013-1#3)(2013-8#1)
or publication##2##2##(2008-7#2)
or published##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
or pulmonary##6##2##(1990-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
or pulsed##2##2##(2008-2#1)(2011-2#1)
or pure##2##2##(2008-10#2)
or purple##2##2##(2008-10#1)(2011-2#1)
or putative##4##2##(1993-8#1)(1997-3#1)(2008-10#1)(2008-8#1)
or qualitative##2##2##(2006-6#1)(2008-9#1)
or quality of life##2##4##(1997-8#1)(2008-7#1)
or quality of##5##3##(1992-2#1)(1992-3#1)(1995-2#1)(1997-8#1)(2008-7#1)
or quality##8##2##(1992-2#1)(1992-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
or quantification of##2##3##(2008-10#1)(2010-2#1)
or quantified##2##2##(2008-9#1)(2011-2#1)
or quantitative##4##2##(2008-10#3)(2012-2#1)
or quartz##4##2##(2008-10#3)(2008-3#1)
or quasi-RCTs##2##2##(2008-10#2)
or rabbit##4##2##(1992-6#1)(1995-11#1)(1995-6#1)(2008-4#1)
or radiation therapy##3##3##(2007-7#1)(2008-6#1)(2008-7#1)
or radiation##4##2##(2007-7#1)(2008-6#1)(2008-7#1)(2013-1#1)
or radiographic outcomes##2##3##(2013-1#2)
or radiographic##4##2##(2011-2#1)(2013-1#3)
or radiotherapy##7##2##(1996-9#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-3#1)
or random##6##2##(1990-6#1)(1996-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
or randomly##2##2##(1997-2#1)(2008-10#1)
or rarely##4##2##(2008-10#2)(2008-4#1)(2012-12#1)
or rat liver##2##3##(1993-8#1)(2008-9#1)
or rat##5##2##(1993-8#1)(1994-8#1)(1995-11#1)(1996-12#1)(2008-9#1)
or rats##2##2##(1993-3#1)(2008-4#1)
or reactivation##2##2##(2008-10#1)(2011-2#1)
or reagents##2##2##(2008-10#1)(2009-6#1)
or reasonably##2##2##(2008-4#1)(2008-7#1)
or received##2##2##(2010-6#1)(2011-1#1)
or receiving##2##2##(2011-2#2)
or recent##2##2##(2010-8#1)(2011-2#1)
or receptor##2##2##(2008-7#1)(2013-8#1)
or recombinant##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
or recombination##2##2##(1992-6#1)(2008-10#1)
or reconstructive##2##2##(2008-9#1)(2012-2#1)
or recovery##2##2##(2008-10#1)(2013-8#1)
or rectum##2##2##(1996-12#1)(2008-5#1)
or recurrence of##3##3##(2008-1#1)(2008-6#1)(2010-5#1)
or recurrence##6##2##(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2013-1#1)
or recurrent disease##2##3##(2008-6#1)(2009-11#1)
or recurrent##16##2##(1990-5#1)(1991-2#1)(1993-6#1)(1995-8#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
or red##3##2##(1990-8#1)(1992-12#1)(2008-3#1)
or redox##2##2##(1994-8#1)(2008-10#1)
or reduce the##4##3##(1996-12#1)(1997-2#1)(2008-5#1)(2010-11#1)
or reduce##8##2##(1995-6#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-2#1)
or reduced##7##2##(1992-8#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
or reducing the##5##3##(1990-10#1)(1992-11#1)(1992-3#1)(2011-1#1)(2012-12#1)
or reducing##10##2##(1990-10#1)(1990-5#2)(1992-11#1)(1992-3#1)(1996-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
or reduction of##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
or reduction##4##2##(1996-2#1)(2008-10#1)(2010-10#1)(2013-8#1)
or reference##2##2##(2008-10#2)
or reflective##2##2##(2008-11#2)
or refute##2##2##(1996-3#1)(1997-8#1)
or regain##2##2##(2010-10#1)(2011-1#1)
or regional##10##2##(1990-11#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
or regions##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
or regression of##2##3##(2008-8#1)(2013-8#1)
or regression##3##2##(2008-8#2)(2013-8#1)
or regulating##2##2##(2010-11#1)(2011-2#1)
or regulation##2##2##(1994-3#1)(2012-2#1)
or regulatory##3##2##(1994-1#1)(1994-5#1)(1996-12#1)
or rehabilitation##2##2##(1990-5#1)(2008-8#1)
or rejection of##4##3##(2007-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
or relapsed##4##2##(2007-10#3)(2010-4#1)
or related##9##2##(1992-12#1)(1995-3#1)(2007-6#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
or relative##3##2##(2010-11#1)(2010-5#1)(2012-1#1)
or relatively##2##2##(2008-9#1)(2011-2#1)
or relatives##5##2##(1993-11#1)(1997-6#1)(2008-12#1)(2008-7#1)(2009-6#1)
or releasing##2##2##(2008-12#1)(2008-9#1)
or remain at##2##3##(2008-8#2)
or remain##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
or remained##3##2##(2008-10#3)
or removal of##3##3##(2008-10#2)(2008-11#1)
or renal involvement##2##3##(2011-1#1)(2011-2#1)
or renal##9##2##(1991-11#1)(1993-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#2)
or repair the##2##3##(2008-5#2)
or repair##8##2##(1992-9#1)(2007-8#2)(2008-5#2)(2008-9#1)(2013-8#2)
or repeated##6##2##(1990-7#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-2#1)(2012-2#1)
or replace##2##2##(2008-1#1)(2009-9#1)
or replacement##6##2##(1997-3#1)(2007-12#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
or replacing##2##2##(1991-1#1)(2008-11#1)
or replication##2##2##(1994-8#1)(2010-2#1)
or reporting##2##2##(2008-9#1)(2011-1#1)
or repress##2##2##(2008-4#2)
or repression##2##2##(2008-10#1)(2008-9#1)
or reproductive##4##2##(1992-3#2)(2008-3#1)(2008-9#1)
or research##5##2##(1996-2#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-2#1)
or resection of##2##3##(1990-3#1)(2011-2#1)
or residual##4##2##(1992-9#1)(2007-9#1)(2009-10#1)(2009-11#1)
or resistance to##3##3##(2008-7#1)(2008-9#1)(2010-12#1)
or resistance##9##2##(1993-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
or resistant to##8##3##(1992-7#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
or resistant##15##2##(1992-7#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-2#1)(2008-5#1)(2010-12#1)(2012-12#1)
or resolution of##3##3##(1991-2#1)(2007-8#1)(2008-7#1)
or resources##2##2##(1993-12#1)(1997-8#1)
or respiratory##2##2##(2008-10#1)(2010-1#1)
or response##4##2##(1993-1#1)(2008-9#1)(2012-3#2)
or restoration##3##2##(2008-10#2)(2008-9#1)
or restricted##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
or restriction fragment length polymorphism analysis##2##6##(2008-10#2)
or restrictive##2##2##(2010-6#1)(2011-2#1)
or result from##2##3##(2008-9#1)(2013-1#1)
or retention of##2##3##(1994-3#1)(2008-4#1)
or reticulated##2##2##(2006-6#1)(2008-10#1)
or retinoic acid or##3##4##(1991-12#2)(2008-5#1)
or retinoic acid##5##3##(1991-12#3)(1994-9#1)(2008-5#1)
or retrospective##2##2##(2012-12#1)(2013-1#1)
or return##3##2##(1996-2#1)(2009-10#1)(2013-8#1)
or revascularization##2##2##(1997-3#1)(2008-7#1)
or reversal##2##2##(1991-9#1)(1993-6#1)
or reverse the##5##3##(1992-9#1)(1994-2#1)(1994-5#1)(2011-1#1)(2013-1#1)
or reverse##9##2##(1991-9#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-6#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
or revision##2##2##(2008-9#1)(2013-1#1)
or rheumatoid arthritis##2##3##(2007-11#1)(2008-8#1)
or rheumatoid##3##2##(2007-11#1)(2007-8#1)(2008-8#1)
or rice##2##2##(2008-10#1)(2008-5#1)
or right##7##2##(1993-11#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-8#1)(2009-10#1)
or risk factors for##2##4##(2007-10#1)(2011-2#1)
or risk factors##6##3##(1995-12#1)(2007-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
or risk##14##2##(1991-8#1)(1994-9#1)(1995-12#1)(2007-10#1)(2008-5#1)(2008-7#5)(2011-2#2)(2011-3#1)(2012-2#1)
or risking##2##2##(2008-11#1)(2012-2#1)
or rodent##2##2##(2008-4#1)(2008-7#1)
or role##2##2##(1992-2#1)(1997-7#1)
or root##2##2##(2006-10#1)(2008-10#1)
or roots##2##2##(2008-10#2)
or rotation##2##2##(2008-9#1)(2010-8#1)
or round##2##2##(2008-6#1)(2008-9#1)
or running##2##2##(2008-10#2)
or rupture##4##2##(2007-8#1)(2009-10#1)(2012-2#2)
or rural##2##2##(1991-3#1)(2012-12#1)
or s##2##2##(1993-6#1)(2008-3#1)
or safe##2##2##(1991-9#1)(2008-9#1)
or safety##3##2##(1993-12#1)(1996-3#1)(2008-7#1)
or saline##11##2##(1992-11#1)(1994-8#3)(1995-11#1)(1997-2#1)(2007-10#1)(2010-6#2)(2011-2#1)(2012-5#1)
or salt##2##2##(2008-10#1)(2008-4#1)
or sample registration##2##3##(2012-12#2)
or sample solution was##3##4##(2008-10#3)
or sample##12##2##(2008-10#10)(2012-12#2)
or samples##2##2##(2008-10#1)(2008-2#1)
or sampling##2##2##(1997-5#1)(2008-11#1)
or saralasin##2##2##(1994-8#1)(1994-9#1)
or satellite##3##2##(2007-5#1)(2008-3#2)
or saturation##2##2##(1994-12#1)(2008-10#1)
or scab##2##2##(2008-10#2)
or schizoaffective##3##2##(1996-7#1)(1997-5#1)(2008-3#1)
or screening##2##2##(1997-1#1)(1997-8#1)
or second line##2##3##(1993-2#1)(2011-1#1)
or second##8##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-7#2)(2009-9#1)(2011-1#1)(2013-1#1)
or secondary to##5##3##(1991-12#1)(2008-1#1)(2009-10#1)(2010-4#1)(2011-2#1)
or secondary##21##2##(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-2#1)(1995-10#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)
or sedentary##2##2##(2008-5#1)(2012-2#1)
or sediment##2##2##(2008-10#1)(2008-5#1)
or seed##2##2##(2008-10#1)(2008-9#1)
or segmental##3##2##(1990-2#1)(1995-5#1)(2009-12#1)
or seizure##3##2##(1990-5#1)(1992-12#2)
or select##3##2##(2008-2#1)(2011-1#2)
or selected##2##2##(1992-9#1)(2008-10#1)
or selection##2##2##(1990-9#1)(2006-10#1)
or selective determination of##2##4##(2008-10#2)
or selective##6##2##(1990-2#1)(1996-7#1)(2008-10#4)
or selling##2##2##(2008-12#1)(2009-10#1)
or seminal##3##2##(1991-2#1)(1994-6#1)(1995-3#1)
or sensitive##2##2##(1997-1#1)(2008-8#1)
or sensitivity##3##2##(2008-10#2)(2010-8#1)
or separately##2##2##(2008-3#1)(2008-6#1)
or separation of##2##3##(2008-10#2)
or separation##4##2##(2008-10#4)
or sepsis##3##2##(1994-6#1)(2007-10#1)(2008-5#1)
or septic shock##3##3##(2008-4#1)(2011-2#2)
or sequence##2##2##(2010-8#1)(2011-2#1)
or sequences##2##2##(1991-7#1)(1993-2#1)
or sequential chemotherapy##2##3##(2007-5#1)(2012-3#1)
or sequential##7##2##(2007-5#1)(2008-10#4)(2008-4#1)(2012-3#1)
or sequentially##3##2##(1992-5#1)(1992-6#1)(2008-10#1)
or serum cholesterol##2##3##(1994-11#1)(2009-4#1)
or serum##10##2##(1994-11#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-1#1)
or serum-free##3##2##(1996-5#1)(2008-11#2)
or serve as##3##3##(1991-1#1)(2008-9#1)(2012-2#1)
or serve##4##2##(1991-1#1)(2008-9#1)(2012-2#2)
or service##4##2##(1994-3#1)(1997-3#1)(2008-9#1)(2011-2#1)
or services##5##2##(1994-3#1)(1995-12#1)(1995-3#1)(2008-12#1)(2008-6#1)
or setting##2##2##(2008-11#1)(2008-12#1)
or seven##3##2##(1990-5#1)(1996-8#1)(2008-7#1)
or several##10##2##(1990-5#1)(1994-9#1)(1995-8#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)
or severe##20##2##(1990-12#1)(1990-3#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#4)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#1)
or severely affected##2##3##(2007-10#1)(2008-10#1)
or severely##4##2##(1993-2#1)(2007-10#1)(2008-10#1)(2010-3#1)
or severity of##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
or severity##6##2##(1997-5#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-8#1)
or sex differentiation##2##3##(2010-5#2)
or sex##9##2##(1991-6#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#2)
or sexual##4##2##(2008-10#1)(2008-9#2)(2012-12#1)
or sexually##2##2##(1995-12#1)(2013-1#1)
or sham##3##2##(1993-12#1)(1994-2#1)(2008-7#1)
or shared##2##2##(2008-10#1)(2008-8#1)
or sharp##2##2##(1995-3#1)(2008-9#1)
or shift##2##2##(1994-1#1)(2008-11#1)
or shock##3##2##(1995-2#1)(2008-3#1)(2011-2#1)
or short term##2##3##(2007-11#1)(2012-2#1)
or short##6##2##(2007-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-8#1)
or shortly after##5##3##(1995-12#1)(2008-3#1)(2008-8#2)(2009-7#1)
or shortly##6##2##(1995-12#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-12#1)
or should##3##2##(1990-11#1)(1991-12#1)(2008-9#1)
or shoulder##2##2##(1995-3#1)(2011-2#1)
or showed##2##2##(2008-7#1)(2011-1#1)
or sibling##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
or siblings##2##2##(2007-7#1)(2011-2#1)
or side effects##2##3##(2008-10#1)(2012-12#1)
or side##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)
or sign##4##2##(1991-8#2)(1993-5#1)(2008-9#1)
or significant##6##2##(1996-3#1)(2007-8#1)(2008-3#1)(2012-12#2)(2012-3#1)
or significantly affect##2##3##(1991-1#1)(2008-11#1)
or significantly reduced##3##3##(1990-9#1)(1996-12#1)(2008-8#1)
or significantly##7##2##(1990-9#1)(1991-1#1)(1996-12#1)(2008-11#1)(2008-8#1)(2012-12#2)
or signs of##3##3##(1991-8#1)(2007-8#1)(2008-3#1)
or signs##5##2##(1991-8#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-3#1)
or silenced##2##2##(2008-8#1)(2010-12#1)
or silica gel##2##3##(2007-11#1)(2009-6#1)
or silica##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
or silicon##2##2##(2008-10#1)(2008-4#1)
or silver##3##2##(2008-10#2)(2008-2#1)
or similar risk##2##3##(2008-3#2)
or similar##10##2##(1991-2#1)(1996-12#2)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
or simple##6##2##(1992-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)
or simply##7##2##(2008-2#1)(2009-10#1)(2010-10#1)(2010-12#2)(2011-2#2)
or simultaneous##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
or simultaneously##4##2##(1995-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
or single##8##2##(1994-6#2)(1997-3#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-5#1)
or site##2##2##(1991-6#1)(2008-10#1)
or sites##4##2##(1993-6#1)(1995-2#1)(2008-10#2)
or sitting positions##2##3##(1993-10#1)(2011-2#1)
or six##4##2##(1991-6#1)(2008-8#1)(2011-2#1)(2013-7#1)
or size##6##2##(1996-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-8#1)
or skeletal muscle##2##3##(1990-5#1)(1994-11#1)
or skin##11##2##(1994-11#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-9#1)(2011-2#1)(2013-1#1)
or sleep##5##2##(1994-8#1)(1997-6#2)(2008-8#1)(2012-2#1)
or slightly lower##2##3##(1997-8#1)(2012-12#1)
or slightly##9##2##(1995-11#2)(1996-6#1)(1997-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
or slow down the##2##4##(2008-5#1)(2008-9#1)
or slow##5##2##(1995-8#1)(2007-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
or slowly##2##2##(2008-2#1)(2011-2#1)
or small group##2##3##(2008-10#1)(2013-8#1)
or small groups##2##3##(2008-12#1)(2008-5#1)
or small##20##2##(1990-2#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
or smaller than##3##3##(1995-5#1)(2007-11#1)(2008-2#1)
or smaller##8##2##(1991-5#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-11#1)(2013-1#1)
or so called##2##3##(2008-10#1)(2008-4#1)
or so##9##2##(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
or so-called##3##2##(2008-10#2)(2008-7#1)
or social##8##2##(1990-2#1)(1995-8#1)(1996-1#1)(1996-9#1)(2008-12#1)(2009-7#1)(2013-1#2)
or sodium hydrosulfide##2##3##(2008-5#2)
or sodium##8##2##(1992-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2011-2#1)
or soft tissue##2##3##(2008-6#1)(2013-8#1)
or soft##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
or soil##6##2##(2008-10#5)(2011-1#1)
or solid##2##2##(2008-3#1)(2012-3#1)
or solid-liquid extraction##2##3##(2008-10#2)
or soluble##3##2##(2008-10#1)(2008-4#1)(2012-9#1)
or solution##4##2##(2008-10#2)(2008-4#2)
or solvent##2##2##(2008-10#2)
or some combination of##3##4##(2008-6#2)(2010-2#1)
or some of##2##3##(2010-6#1)(2013-8#1)
or some other##5##3##(1992-9#1)(1996-12#1)(2008-4#1)(2009-9#1)(2010-10#1)
or some##16##2##(1991-3#1)(1992-9#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-8#1)
or sometimes##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
or soon##2##2##(1992-2#1)(2011-1#1)
or sound##2##2##(2008-2#1)(2011-1#1)
or southern##2##2##(1997-8#1)(2008-10#1)
or soybean##2##2##(1995-11#1)(2008-10#1)
or spatial coordinate of the point along##2##7##(2008-10#2)
or spatial##8##2##(1994-8#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)
or special##3##2##(2008-11#1)(2010-11#2)
or species##3##2##(2008-10#1)(2012-9#2)
or specific##14##2##(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#1)
or spectral##2##2##(2008-3#1)(2010-6#1)
or spheroids##2##2##(2008-11#2)
or spin##2##2##(2008-10#1)(2008-9#1)
or spinal cord##3##3##(2007-10#1)(2007-11#1)(2008-12#1)
or spinal##4##2##(2007-10#1)(2007-11#2)(2008-12#1)
or split##2##2##(2008-12#1)(2008-5#1)
or spontaneous##2##2##(1996-9#1)(1997-4#1)
or spore germination##2##3##(2008-10#2)
or spore##3##2##(2008-10#3)
or spray##2##2##(1992-2#1)(2010-4#1)
or spread of##3##3##(2008-10#2)(2010-4#1)
or squamous##2##2##(1990-6#1)(2007-12#1)
or stability##2##2##(2008-10#1)(2012-2#1)
or stabilize##3##2##(1996-2#1)(2008-5#1)(2011-3#1)
or stable disease##2##3##(1993-8#1)(1994-8#1)
or stable##4##2##(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)
or stage##4##2##(1992-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
or stages##2##2##(2010-9#1)(2012-12#1)
or standard##9##2##(1992-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-8#2)
or standardized##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
or state##4##2##(1992-3#1)(1993-2#1)(1995-2#1)(2013-1#1)
or static##2##2##(2008-9#1)(2010-10#1)
or stem##5##2##(2008-10#1)(2011-2#3)(2013-1#1)
or stepped##2##2##(1997-5#1)(2008-3#1)
or steroid##2##2##(2008-1#2)
or sticking##2##2##(2009-7#1)(2012-12#1)
or stiffness##2##2##(2008-5#1)(2008-9#1)
or stimulated##2##2##(1991-5#1)(1992-2#1)
or stimulation of##2##3##(1994-2#1)(2008-11#1)
or stop##2##2##(2007-7#1)(2009-8#1)
or storage##2##2##(2008-4#1)(2010-8#1)
or stored##2##2##(2008-10#1)(2008-9#1)
or strain##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
or strains##2##2##(2008-10#1)(2008-2#1)
or strategies##2##2##(2008-11#1)(2012-3#1)
or strengthening##2##2##(1994-12#1)(2008-5#1)
or stress##6##2##(2008-11#1)(2008-4#1)(2009-10#1)(2009-7#1)(2009-9#1)(2012-2#1)
or strip##2##2##(2008-10#2)
or stroke dementia##2##3##(1990-3#2)
or stroke##6##2##(1990-3#2)(2007-10#1)(2008-8#1)(2010-5#1)(2013-7#1)
or strong##3##2##(2008-10#2)(2008-3#1)
or strongly##2##2##(2008-11#1)(2008-2#1)
or structural##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
or subarachnoid##3##2##(2007-10#1)(2008-7#1)(2009-6#1)
or subject##2##2##(1991-12#1)(2012-1#1)
or substances##2##2##(1993-2#1)(2008-2#1)
or substantially##2##2##(2008-11#1)(2008-8#1)
or substrates##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
or subtle##2##2##(1994-9#1)(2008-4#1)
or sudden cardiac death##2##4##(2007-11#1)(2009-9#1)
or sudden##4##2##(2007-11#1)(2008-7#1)(2009-9#1)(2012-12#1)
or suffer##2##2##(2008-2#1)(2009-10#1)
or sugar##2##2##(2008-6#1)(2009-9#1)
or suggest##2##2##(1990-3#1)(2012-1#1)
or suicide##2##2##(1993-9#1)(2010-6#1)
or sulfur##2##2##(2008-10#1)(2008-7#1)
or superficial##4##2##(1992-2#1)(2007-7#1)(2008-6#1)(2010-7#1)
or superior to##2##3##(1992-1#1)(2008-11#1)
or superior##6##2##(1992-1#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-8#1)
or supplements##2##2##(2008-10#1)(2012-2#1)
or supplied##2##2##(1994-11#1)(1997-3#1)
or support##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
or suppressed##4##2##(1996-2#1)(2008-2#1)(2009-8#1)(2010-9#1)
or suppression of##2##3##(2008-11#1)(2008-9#1)
or suppression##5##2##(2008-11#1)(2008-9#2)(2012-3#2)
or surface##7##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)
or surfactant##2##2##(1994-5#1)(2008-5#1)
or surgery##10##2##(1990-12#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#3)(2012-1#1)(2013-1#1)
or surgical complications##3##3##(2011-2#2)(2013-1#1)
or surgical intervention##3##3##(1990-6#1)(2011-2#1)(2012-2#1)
or surgical therapy##2##3##(2010-12#1)(2013-1#1)
or surgical treatment##3##3##(1996-6#1)(2010-6#1)(2012-3#1)
or surgical##24##2##(1990-5#1)(1990-6#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
or surgically##2##2##(1993-12#1)(2013-1#1)
or surpassed the##2##3##(1994-12#1)(2008-10#1)
or survival of##2##3##(2008-10#1)(2013-8#1)
or survival##4##2##(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
or survive##2##2##(2008-10#1)(2008-9#1)
or surviving##2##2##(1997-5#1)(2008-8#1)
or susceptibility to##2##3##(2008-10#1)(2008-5#1)
or susceptibility##3##2##(2008-10#2)(2008-5#1)
or suspected##4##2##(1995-6#1)(2007-6#1)(2008-1#1)(2008-4#1)
or suspension##4##2##(2008-1#1)(2008-10#2)(2008-11#1)
or suspensions to##2##3##(1994-2#2)
or suspensions##3##2##(1994-2#2)(2008-10#1)
or suspicion of##2##3##(1991-2#1)(2013-1#1)
or sutured##2##2##(2013-1#2)
or sweet##2##2##(2008-10#2)
or swelling##2##2##(2008-6#1)(2008-8#1)
or swine manure##2##3##(2008-10#2)
or symbiotic relationships##2##3##(2008-1#1)(2008-10#1)
or symptom##2##2##(2008-7#1)(2010-1#1)
or symptomatic##5##2##(1990-8#1)(1996-6#2)(2008-10#1)(2012-3#1)
or symptoms##6##2##(1991-8#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
or synergistic##3##2##(1991-8#1)(2008-10#2)
or synergize with##2##3##(1995-8#1)(2009-12#1)
or synthetic##9##2##(1991-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2012-12#1)
or system##2##2##(2008-10#1)(2013-1#1)
or systematic##3##2##(1993-2#1)(2008-4#1)(2009-8#1)
or systemic##10##2##(1992-9#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
or systems##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
or taking##2##2##(1997-3#1)(2009-7#1)
or target##5##2##(1991-9#1)(1994-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
or task##3##2##(1992-1#1)(1995-2#1)(2008-11#1)
or technical##5##2##(2007-10#1)(2008-9#1)(2010-7#1)(2010-8#1)(2013-1#1)
or technological##3##2##(2008-11#1)(2008-2#1)(2011-1#1)
or tegaserod##3##2##(2010-6#3)
or telephone interviews##2##3##(2008-11#2)
or temperature##7##2##(1990-5#1)(1992-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
or temporal##6##2##(1992-8#1)(1996-6#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-5#1)
or temporally##2##2##(2008-10#1)(2008-8#1)
or tender##2##2##(2008-9#1)(2013-8#1)
or tertiary##2##2##(2008-10#1)(2008-4#1)
or test##2##2##(1996-3#1)(2008-5#1)
or testing##2##2##(2008-6#1)(2011-8#1)
or testosterone##3##2##(1990-11#1)(1996-5#1)(2012-2#1)
or that a##2##3##(2008-10#2)
or that are##2##3##(1993-1#1)(2008-4#1)
or that of##3##3##(1995-6#1)(2008-10#1)(2010-1#1)
or that the##3##3##(1992-8#1)(1992-9#1)(1994-9#1)
or that there##2##3##(1990-8#1)(2008-10#1)
or that##33##2##(1990-8#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)
or the B##3##3##(1994-12#1)(1994-5#1)(2008-10#1)
or the absence of##2##4##(2008-7#1)(2011-2#1)
or the activity of##3##4##(1991-8#1)(1994-5#1)(1995-11#1)
or the addition of##4##4##(2007-11#2)(2008-10#1)(2008-11#1)
or the adjacent##3##3##(1993-12#1)(1994-3#1)(2008-10#1)
or the amount of##2##4##(2008-10#1)(2008-9#1)
or the cellular##2##3##(1991-12#1)(2011-2#1)
or the combination of##2##4##(1996-12#1)(2011-1#1)
or the complete##2##3##(2007-12#1)(2008-10#1)
or the control##2##3##(1992-11#1)(1997-7#1)
or the core##2##3##(1997-3#1)(2008-2#1)
or the delta##2##3##(1994-11#1)(1994-12#1)
or the dose##2##3##(1991-11#1)(2013-1#1)
or the duration##2##3##(1992-3#1)(2011-2#1)
or the entire##2##3##(2008-10#1)(2009-2#1)
or the equivalent of##2##4##(2008-10#1)(2009-12#1)
or the expression##2##3##(1990-3#1)(2009-6#1)
or the full labeled rate##2##5##(2008-10#2)
or the heart##2##3##(1993-11#1)(2008-8#1)
or the interest##2##3##(2007-8#1)(2010-2#1)
or the involvement of##2##4##(2007-10#1)(2011-2#1)
or the mixture of##2##4##(2008-10#2)
or the murine##3##3##(1995-11#1)(2008-11#2)
or the number of##5##4##(1991-2#1)(1991-8#1)(2008-10#1)(2013-1#2)
or the occurrence of##2##4##(2008-10#2)
or the optical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
or the other##12##3##(1991-9#1)(1992-2#1)(1994-11#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
or the patient##2##3##(1991-12#1)(1992-1#1)
or the patient's##3##3##(1995-3#1)(1996-2#1)(2007-8#1)
or the presence of##7##4##(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#2)(2010-12#1)(2011-2#1)
or the pulse##2##3##(2007-12#1)(2008-3#1)
or the rate##2##3##(2008-10#1)(2008-8#1)
or the ratio between the##2##5##(2008-10#2)
or the ratio##3##3##(1991-12#1)(2008-10#2)
or the right##2##3##(2008-10#1)(2008-7#1)
or the same##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2009-12#1)
or the saphenous nerve##2##4##(1997-3#2)
or the skin##2##3##(2008-11#1)(2008-5#1)
or the so-called##2##3##(2008-7#1)(2009-11#1)
or the social##2##3##(1992-3#1)(2008-9#1)
or the specific##2##3##(2008-11#2)
or the spinal##2##3##(1996-5#1)(2008-7#1)
or the standard##2##3##(2008-10#1)(2008-7#1)
or the target##2##3##(2009-9#1)(2010-2#1)
or the time##4##3##(1993-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
or the total##2##3##(1995-6#1)(2008-3#1)
or the type of##2##4##(2007-11#1)(2008-10#1)
or the use of##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
or the##524##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#7)(1991-9#2)(1992-1#2)(1992-11#4)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#7)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#6)(1995-12#7)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#4)(1996-9#2)(1997-2#6)(1997-3#8)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#4)(2006-6#1)(2007-10#2)(2007-11#9)(2007-12#11)(2007-4#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#88)(2008-11#22)(2008-12#3)(2008-2#14)(2008-3#36)(2008-4#5)(2008-5#15)(2008-6#5)(2008-7#20)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#12)(2011-7#1)(2012-12#4)(2012-2#8)(2012-3#4)(2012-5#1)(2013-1#8)(2013-8#3)
or their families##3##3##(1991-2#1)(2013-1#2)
or their##39##2##(1991-12#1)(1991-2#1)(1992-3#2)(1992-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
or theoretical##2##2##(2008-12#1)(2012-3#1)
or theory##2##2##(1996-1#1)(2008-10#1)
or therapeutic##11##2##(1990-12#1)(1991-9#1)(1994-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
or therapy##3##2##(1993-6#1)(2007-10#1)(2008-7#1)
or there is##2##3##(1990-3#1)(2008-1#1)
or there##3##2##(1990-3#1)(2007-11#1)(2008-1#1)
or thermal##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
or they may##3##3##(2009-10#1)(2010-12#1)(2012-1#1)
or they##7##2##(1994-2#1)(2008-2#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
or thoracic##2##2##(2012-12#1)(2012-2#1)
or those born##2##3##(2008-11#1)(2011-1#1)
or those who have##2##4##(2008-11#1)(2008-8#1)
or those who##3##3##(1990-8#1)(2008-11#1)(2008-8#1)
or those with##2##3##(1993-3#1)(2007-11#1)
or those##17##2##(1990-8#1)(1993-3#1)(1994-3#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
or three times##4##3##(1994-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
or three##26##2##(1990-12#1)(1990-6#1)(1990-8#2)(1994-1#1)(1994-11#2)(1995-6#1)(1996-12#1)(1997-4#2)(1997-6#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2012-2#1)
or three-dimensional##3##2##(1991-5#1)(2007-11#1)(2008-3#1)
or threonine##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
or thrombin##3##2##(1993-11#1)(1997-7#2)
or thrombocytopenia##2##2##(2008-8#1)(2011-1#1)
or thrombosis##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
or through a##2##3##(1990-5#1)(2013-8#1)
or through the use of##3##5##(1997-7#1)(2008-4#2)
or through the##6##3##(1997-7#1)(2008-10#1)(2008-4#2)(2010-10#1)(2012-2#1)
or through##24##2##(1990-5#1)(1990-7#1)(1993-2#1)(1993-8#1)(1996-5#2)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-6#1)(2012-2#1)(2013-8#1)
or thymus##3##2##(1990-11#1)(2008-10#1)(2008-4#1)
or thyroid##3##2##(1992-12#1)(2012-12#1)(2013-1#1)
or time##5##2##(1995-1#1)(2008-10#2)(2008-8#1)(2012-3#1)
or tissue##11##2##(1992-9#1)(1996-10#1)(2008-4#4)(2008-7#1)(2008-8#2)(2010-6#1)(2011-2#1)
or tissues##7##2##(1995-2#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-2#1)
or to a control group##2##5##(1990-5#1)(2013-1#1)
or to a##17##3##(1990-5#1)(1994-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2013-1#2)
or to achieve##2##3##(1995-2#1)(1997-8#1)
or to any##2##3##(1995-2#1)(2008-3#1)
or to both##2##3##(1997-5#1)(2008-11#1)
or to continue##2##3##(1993-11#1)(1995-12#1)
or to control##2##3##(2009-9#1)(2010-10#1)
or to determine the##2##4##(2006-4#1)(2008-4#1)
or to estimate##2##3##(2008-10#1)(2008-8#1)
or to evaluate##4##3##(1991-1#1)(1991-7#1)(2008-9#1)(2010-6#1)
or to inhibit##2##3##(2008-1#1)(2008-8#1)
or to other##3##3##(1990-3#1)(1997-3#1)(2010-8#1)
or to receive##3##3##(2008-4#1)(2010-3#2)
or to reduce##3##3##(1993-10#1)(1993-11#1)(2008-9#1)
or to start##2##3##(2007-11#1)(2010-9#1)
or to support##2##3##(1996-3#1)(2008-11#1)
or to test the##2##4##(2008-4#2)
or to test##3##3##(2008-10#1)(2008-4#2)
or to the control##2##4##(1993-12#1)(2013-8#1)
or to the##19##3##(1990-8#1)(1991-4#2)(1991-9#1)(1993-12#1)(1994-12#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2013-1#2)(2013-8#1)
or to##157##2##(1990-3#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-4#2)(1991-7#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
or tobacco##2##2##(2008-10#1)(2011-2#1)
or tolerance##4##2##(1995-12#1)(2008-10#2)(2011-10#1)
or tolerance)##2##2##(2008-5#1)(2009-2#1)
or tolerated##2##2##(2008-11#1)(2012-2#1)
or too##4##2##(1993-2#1)(1995-6#1)(2008-8#1)(2009-3#1)
or topical application of##2##4##(1992-9#2)
or total knee##2##3##(1994-3#1)(2007-10#1)
or total##34##2##(1990-12#2)(1990-9#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
or towards##2##2##(2008-11#1)(2012-12#1)
or toxic##5##2##(1991-9#1)(2008-11#1)(2008-7#3)
or toxicity##2##2##(1997-1#1)(2010-11#1)
or trace##3##2##(2008-10#2)(2013-8#1)
or track patients with diabetes##2##5##(2013-8#2)
or traditional##4##2##(1993-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
or training##3##2##(2008-5#1)(2010-3#1)(2013-1#1)
or transfer##2##2##(2008-3#2)
or transforming growth factor##2##4##(1992-9#1)(2011-2#1)
or transforming##3##2##(1992-9#1)(2011-2#2)
or transgenic##3##2##(2008-4#2)(2011-2#1)
or transient##10##2##(1994-6#1)(2007-10#2)(2007-7#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
or transiently##2##2##(1996-5#1)(2008-4#1)
or translation##2##2##(1992-3#1)(2008-3#1)
or translational##2##2##(1993-12#1)(2010-10#1)
or transmission##3##2##(2008-2#1)(2008-3#2)
or transparency##2##2##(2008-11#1)(2008-2#1)
or transplant##2##2##(2008-9#1)(2009-10#1)
or transplantation##2##2##(2007-7#1)(2010-11#1)
or transportation##2##2##(1995-5#1)(2010-8#1)
or trauma##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-8#1)
or traumatic##3##2##(2007-12#1)(2008-9#1)(2012-2#1)
or treated with##4##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
or treated##11##2##(1990-11#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
or treatment delivery##2##3##(1995-2#1)(2008-2#1)
or treatment of##5##3##(1993-2#1)(2007-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
or treatment with##3##3##(1995-12#1)(2008-1#1)(2008-6#1)
or treatment##17##2##(1993-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-2#1)(2011-1#1)(2013-1#1)
or treatments##4##2##(1991-3#1)(1993-12#1)(2008-10#1)(2013-1#1)
or triglycerides##2##2##(1993-12#1)(2010-4#1)
or triple##6##2##(1990-5#1)(1995-11#1)(2008-1#1)(2008-10#2)(2012-3#1)
or true##3##2##(2008-8#2)(2009-7#1)
or truncated##3##2##(1997-3#1)(1997-7#1)(2008-3#1)
or tryptophan methyl ester hydrochloride##2##5##(2008-10#2)
or tubular##2##2##(2008-10#1)(2013-8#1)
or tumor necrosis factor alpha##2##5##(1991-9#1)(1993-12#1)
or tumor##8##2##(1991-8#1)(1991-9#1)(1993-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
or tumour##3##2##(2008-11#1)(2008-2#1)(2009-4#1)
or tungsten##2##2##(2008-10#2)
or turmeric treated groups##2##4##(1994-8#2)
or turmeric##6##2##(1994-8#6)
or twice weekly##2##3##(2007-12#1)(2012-6#1)
or twice##6##2##(1990-3#1)(1992-8#1)(1997-4#1)(2007-12#1)(2012-6#1)(2013-1#1)
or twice-daily##2##2##(2008-5#2)
or two or##2##3##(1990-6#1)(1991-11#1)
or two weeks##2##3##(2011-2#1)(2012-2#1)
or two##67##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-6#2)(1995-3#1)(1996-12#1)(1996-5#2)(1997-7#1)(2006-12#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-2#2)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
or two-dimensional##6##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
or two-stage##2##2##(2008-8#1)(2009-5#1)
or two?##2##2##(1993-9#1)(2008-12#1)
or type 2 diabetes##3##4##(2008-1#1)(2008-3#2)
or type of##8##3##(1995-1#1)(2007-10#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#2)
or type##14##2##(1993-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#2)
or tyrosine##3##2##(1992-6#1)(2008-4#2)
or ultrasonic##2##2##(1990-12#1)(1996-2#1)
or ultrasound##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
or unchanged##2##2##(1997-1#1)(2010-7#1)
or under development##2##3##(2007-7#1)(2011-1#1)
or under##15##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-5#1)(2007-7#1)(2008-10#5)(2008-4#2)(2008-6#1)(2011-1#1)
or underinsured##2##2##(2008-11#2)
or undermine##2##2##(2008-11#1)(2009-11#1)
or unfavorable##3##2##(1994-3#2)(2007-12#1)
or unfolded##3##2##(1993-11#1)(1995-5#1)(2008-4#1)
or unknown##11##2##(1992-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)
or unsuitable##2##2##(2008-9#1)(2010-12#1)
or untreated##5##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
or unwanted##2##2##(1996-3#1)(2012-1#1)
or up to##3##3##(1994-5#1)(2008-10#2)
or upper##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
or upregulated##2##2##(2008-10#1)(2012-2#1)
or urinary##4##2##(1990-5#1)(2007-8#1)(2008-7#1)(2012-3#1)
or urine##5##2##(1990-2#2)(1993-12#2)(2008-1#1)
or use of##7##3##(1993-12#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-8#1)
or use##10##2##(1993-12#1)(1995-3#1)(1996-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-8#1)
or used as##2##3##(2008-2#1)(2013-8#1)
or used in##2##3##(2008-10#2)
or used with##2##3##(1996-3#1)(2011-1#1)
or used##9##2##(1996-3#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
or using##16##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)
or uterus##2##2##(1993-8#1)(1995-11#1)
or utilization##2##2##(1994-12#1)(2011-1#1)
or utilized##2##2##(2008-11#1)(2008-8#1)
or vacuum##2##2##(1995-8#1)(2008-3#1)
or validoxylamine##2##2##(2008-10#2)
or vancomycin##2##2##(2010-4#1)(2011-2#1)
or variable##3##2##(2008-10#1)(2008-8#1)(2012-1#1)
or variants##2##2##(1993-6#1)(2009-2#1)
or variation##2##2##(1993-11#1)(1993-2#1)
or various##4##2##(1994-9#1)(2008-10#2)(2012-2#1)
or varying##2##2##(2008-3#1)(2012-4#1)
or vascular##5##2##(1993-9#1)(2007-8#1)(2008-7#1)(2012-3#1)(2013-8#1)
or vasopressin##4##2##(1991-5#1)(1995-12#1)(1997-4#2)
or vegetables##4##2##(1994-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
or vehicle##12##2##(1991-12#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-5#1)(1994-8#2)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)
or venous##4##2##(1997-6#1)(1997-8#1)(2008-3#1)(2008-7#1)
or ventral##2##2##(1996-2#1)(2007-10#1)
or ventricular##2##2##(2007-9#1)(2009-6#1)
or vertebral##2##2##(1996-9#1)(2007-10#1)
or very low##4##3##(2008-10#1)(2008-7#1)(2009-2#1)(2013-8#1)
or very satisfied with the##2##5##(1992-5#1)(2008-9#1)
or very##22##2##(1990-6#1)(1990-9#1)(1992-12#1)(1992-5#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#2)
or via the##3##3##(1995-3#1)(2008-1#1)(2008-7#1)
or via##11##2##(1995-3#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
or viable##3##2##(2011-2#1)(2013-7#2)
or vibrational##2##2##(1994-11#1)(2007-11#1)
or vice versa##2##3##(1992-6#1)(2008-10#1)
or vincristine##2##2##(2008-6#1)(2012-1#1)
or violated##2##2##(2008-5#1)(2010-10#1)
or viral##10##2##(1991-9#1)(1994-8#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2013-1#1)
or viral-based##2##2##(2010-5#1)(2012-2#1)
or virulence of##2##3##(2008-10#2)
or virulence##3##2##(2008-10#3)
or virus##9##2##(1990-5#3)(2008-10#4)(2008-11#1)(2008-4#1)
or visible##3##2##(2006-12#1)(2008-10#2)
or visual##2##2##(2008-6#1)(2008-9#1)
or vitamin D receptor##2##4##(2008-4#1)(2013-1#1)
or volume##2##2##(2010-2#1)(2012-12#1)
or vomiting##7##2##(1991-9#1)(2008-10#1)(2008-7#5)
or was not##2##3##(1990-6#1)(2008-11#1)
or was##14##2##(1990-5#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#2)
or water##14##2##(1990-8#1)(1991-5#1)(1994-8#1)(2006-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)
or wave-front deformation##3##3##(2008-3#3)
or weak##6##2##(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
or weakly##4##2##(1990-2#1)(1995-2#1)(2007-12#1)(2008-11#1)
or weekly##2##2##(2007-11#1)(2008-5#1)
or weight loss##3##3##(2009-6#1)(2012-3#2)
or weight##4##2##(2009-6#1)(2012-3#2)(2013-8#1)
or well##2##2##(2009-10#1)(2011-2#1)
or were not##2##3##(1994-2#1)(2008-10#1)
or were##30##2##(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#3)(1996-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#5)(2009-6#1)(2011-2#2)
or wet##3##2##(1997-4#1)(2008-3#1)(2013-1#1)
or what##6##2##(1990-2#1)(1992-1#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
or wheat germ##2##3##(1991-12#1)(2008-1#1)
or wheat##3##2##(1991-12#1)(2008-1#1)(2008-10#1)
or when both##2##3##(2008-10#1)(2008-8#1)
or when it is##2##4##(1991-1#1)(2008-4#1)
or when one##2##3##(2008-10#1)(2012-2#1)
or when the ligand is weakly soluble in solvents required for phosphoramidite- or H-phosphonate-mediated oligonucleotide synthesis##2##16##(2008-4#2)
or when the patient##2##4##(1993-2#1)(1997-6#1)
or when the##14##3##(1992-6#1)(1993-2#1)(1995-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
or when there is a##3##5##(2008-10#1)(2008-3#2)
or when there is##4##4##(2008-10#1)(2008-3#2)(2010-3#1)
or when there##5##3##(1995-6#1)(2008-10#1)(2008-3#2)(2010-3#1)
or when they##2##3##(1995-8#1)(2008-4#1)
or when##48##2##(1991-1#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-8#1)(2008-9#2)(2010-3#1)(2011-10#2)(2011-2#2)(2012-12#1)(2012-2#1)
or where a##2##3##(2008-4#1)(2012-12#1)
or where the##4##3##(1990-5#1)(2008-8#2)(2011-2#1)
or where##8##2##(1990-5#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-12#1)
or whether it is##3##4##(1994-5#1)(2008-11#1)(2008-5#1)
or whether it##5##3##(1994-5#1)(2008-11#1)(2008-5#2)(2009-5#1)
or whether or not##2##4##(1991-6#1)(2008-7#1)
or whether the##2##3##(1992-4#2)
or whether they##2##3##(2007-10#1)(2008-5#1)
or whether##14##2##(1991-6#1)(1992-4#2)(1994-5#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-5#1)(2013-1#1)
or which##2##2##(1996-12#1)(2008-11#1)
or who##8##2##(1992-6#1)(1994-1#2)(1996-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)
or whole##6##2##(2007-10#1)(2008-4#2)(2009-4#1)(2011-2#1)(2012-2#1)
or whose##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
or wide##4##2##(2007-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
or will##4##2##(1991-1#1)(2008-10#1)(2009-4#1)(2009-6#1)
or with a##6##3##(1991-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
or with an##3##3##(2008-3#1)(2011-3#1)(2012-3#1)
or with both##2##3##(2008-10#1)(2008-3#1)
or with other##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
or with the##12##3##(1991-11#1)(1991-5#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-12#1)
or with##115##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-5#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-2#2)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)
or withdrawal##2##2##(1997-8#1)(2008-8#1)
or withdrawn##2##2##(2006-10#1)(2013-8#1)
or within 5##2##3##(2007-8#1)(2013-8#1)
or within the##5##3##(1994-5#1)(1997-3#1)(2007-11#1)(2008-7#1)(2011-1#1)
or within##14##2##(1994-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#2)(2013-8#1)
or without a##10##3##(1993-9#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#2)
or without home health##2##4##(1995-3#2)
or without##183##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-2#3)(1996-9#2)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#9)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-8#3)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#5)
or women with##2##3##(2008-10#1)(2008-7#1)
or work##2##2##(1995-2#1)(1996-1#1)
or worse##4##2##(1994-2#3)(2008-5#1)
or worsen##2##2##(1995-2#1)(2007-12#1)
or xylose##2##2##(2008-10#1)(2011-2#1)
or years in the United States##2##6##(1997-2#2)
or years##4##2##(1997-2#2)(2008-7#1)(2011-2#1)
or yeast##3##2##(1990-5#1)(2007-11#1)(2008-6#1)
or yield##3##2##(2008-10#3)
or young##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
or younger##2##2##(2008-10#1)(2011-2#1)
or zero##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
or zinc(II)##2##2##(1991-5#1)(2008-10#1)
or zymosan##2##2##(1991-12#1)(1994-6#1)
or##18964##1##(1990-10#11)(1990-11#63)(1990-12#91)(1990-2#62)(1990-3#45)(1990-4#2)(1990-5#96)(1990-6#50)(1990-7#42)(1990-8#79)(1990-9#37)(1991-1#35)(1991-10#2)(1991-11#54)(1991-12#126)(1991-2#86)(1991-3#54)(1991-4#13)(1991-5#55)(1991-6#51)(1991-7#14)(1991-8#78)(1991-9#74)(1992-1#27)(1992-10#19)(1992-11#52)(1992-12#87)(1992-2#64)(1992-3#136)(1992-4#14)(1992-5#69)(1992-6#79)(1992-7#3)(1992-8#68)(1992-9#89)(1993-1#48)(1993-10#9)(1993-11#86)(1993-12#137)(1993-2#62)(1993-3#62)(1993-5#11)(1993-6#83)(1993-8#79)(1993-9#65)(1994-1#29)(1994-10#5)(1994-11#77)(1994-12#94)(1994-2#107)(1994-3#110)(1994-5#78)(1994-6#76)(1994-7#9)(1994-8#125)(1994-9#66)(1995-1#31)(1995-10#4)(1995-11#103)(1995-12#126)(1995-2#144)(1995-3#111)(1995-4#6)(1995-5#122)(1995-6#110)(1995-8#74)(1995-9#23)(1996-1#48)(1996-10#3)(1996-11#31)(1996-12#155)(1996-2#87)(1996-3#63)(1996-4#15)(1996-5#94)(1996-6#42)(1996-7#12)(1996-8#17)(1996-9#30)(1997-1#49)(1997-2#112)(1997-3#128)(1997-4#103)(1997-5#62)(1997-6#66)(1997-7#103)(1997-8#66)(1997-9#2)(2006-10#41)(2006-11#5)(2006-12#17)(2006-4#4)(2006-5#5)(2006-6#11)(2006-8#5)(2007-1#2)(2007-10#129)(2007-11#235)(2007-12#239)(2007-2#39)(2007-3#6)(2007-4#14)(2007-5#29)(2007-6#17)(2007-7#72)(2007-8#134)(2007-9#10)(2008-1#225)(2008-10#3019)(2008-11#697)(2008-12#207)(2008-2#311)(2008-3#524)(2008-4#590)(2008-5#489)(2008-6#239)(2008-7#692)(2008-8#460)(2008-9#655)(2009-1#9)(2009-10#82)(2009-11#59)(2009-12#57)(2009-2#38)(2009-3#37)(2009-4#44)(2009-5#98)(2009-6#64)(2009-7#62)(2009-8#88)(2009-9#70)(2010-1#42)(2010-10#53)(2010-11#86)(2010-12#101)(2010-2#46)(2010-3#87)(2010-4#83)(2010-5#85)(2010-6#81)(2010-7#61)(2010-8#101)(2010-9#20)(2011-1#225)(2011-10#7)(2011-2#751)(2011-3#23)(2011-7#2)(2011-8#1)(2011-9#1)(2012-1#64)(2012-12#237)(2012-2#350)(2012-3#250)(2012-4#5)(2012-5#7)(2012-6#4)(2012-7#7)(2012-8#2)(2012-9#9)(2013-1#549)(2013-7#57)(2013-8#250)
or/and##8##1##(2007-11#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-3#1)(2013-8#1)
or= 0##4##2##(2008-3#4)
or= Ea##2##2##(2008-11#2)
or=##23##1##(2008-11#4)(2008-2#1)(2008-3#17)(2010-6#1)
oral Candida##2##2##(2008-5#2)
oral Crohn's disease is##2##4##(2012-2#2)
oral Crohn's disease##3##3##(2012-2#3)
oral FSA##2##2##(2012-1#2)
oral absorption##2##2##(2008-5#1)(2008-9#1)
oral administration in##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
oral administration of BIM##2##4##(2008-11#2)
oral administration of YH439##2##4##(2008-11#2)
oral administration of a##2##4##(2008-10#1)(2008-11#1)
oral administration of the##3##4##(1996-5#1)(2008-10#2)
oral administration of##34##3##(1990-6#1)(1990-7#1)(1992-9#1)(1995-12#1)(1996-5#2)(1996-6#1)(1997-7#1)(2008-10#10)(2008-11#10)(2009-8#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
oral administration##50##2##(1990-6#1)(1990-7#1)(1992-9#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-7#1)(2008-10#11)(2008-11#13)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
oral agents##7##2##(2007-12#1)(2008-1#1)(2010-5#1)(2010-6#2)(2011-2#2)
oral aluminum##3##2##(1992-11#3)
oral anaerobic##2##2##(2008-9#2)
oral and gastrointestinal mucositis##2##4##(2008-7#2)
oral and gastrointestinal##3##3##(2008-7#2)(2011-2#1)
oral and intravenous administration##3##4##(2011-1#3)
oral and intravenous##9##3##(1991-12#1)(1994-12#1)(2007-11#1)(2008-7#1)(2011-1#3)(2011-2#2)
oral and maxillofacial surgery##9##4##(1993-1#2)(2007-12#3)(2008-7#4)
oral and maxillofacial##15##3##(1993-1#2)(2007-12#7)(2008-7#6)
oral and systemic health##2##4##(2010-3#1)(2012-3#1)
oral and systemic##3##3##(2010-3#2)(2012-3#1)
oral and topical##3##3##(2007-7#1)(2008-5#1)(2012-12#1)
oral and##44##2##(1991-12#1)(1991-2#1)(1993-1#2)(1994-12#1)(2007-11#2)(2007-12#7)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#9)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#2)(2011-1#4)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)
oral antibiotic treatment##2##3##(2009-5#1)(2011-2#1)
oral antibiotics##2##2##(2010-8#1)(2012-12#1)
oral anticoagulant therapy##2##3##(1997-2#1)(2007-8#1)
oral anticoagulant##3##2##(1997-2#1)(2007-8#1)(2013-8#1)
oral anticoagulants##4##2##(1990-12#1)(1994-3#1)(1996-6#1)(2012-12#1)
oral anticoagulation for##3##3##(1995-11#2)(2007-8#1)
oral anticoagulation therapy##2##3##(2013-1#2)
oral anticoagulation##11##2##(1995-11#2)(1995-5#1)(1997-5#1)(2007-8#3)(2008-3#1)(2008-8#1)(2013-1#2)
oral antidiabetic##2##2##(2008-11#1)(2009-9#1)
oral antifungal##2##2##(2008-3#2)
oral attenuated candidate vaccines against##2##5##(2007-10#2)
oral bacterial##2##2##(1991-3#1)(1992-11#1)
oral bacterium##2##2##(1990-12#1)(1993-9#1)
oral bioavailability##6##2##(1997-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2012-2#2)
oral biofilms##2##2##(2008-9#2)
oral biopsies##2##2##(2012-2#1)(2013-8#1)
oral bisphosphonates##2##2##(2008-11#1)(2008-5#1)
oral cancer cells##3##3##(2010-2#1)(2013-1#2)
oral cancer in##3##3##(2007-2#1)(2008-4#1)(2013-1#1)
oral cancer is##2##3##(2008-1#1)(2010-12#1)
oral cancer##21##2##(1991-6#1)(1992-9#1)(2007-2#1)(2008-1#1)(2008-4#2)(2010-12#2)(2010-2#1)(2013-1#10)(2013-8#2)
oral candidosis##4##2##(2008-5#3)(2013-1#1)
oral care products##2##3##(1997-4#1)(2008-5#1)
oral care##5##2##(1997-4#1)(2008-5#1)(2008-7#2)(2012-2#1)
oral cavity cancers##2##3##(2008-1#1)(2013-1#1)
oral cavity is a##2##4##(2008-7#1)(2012-3#1)
oral cavity is##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
oral cavity of##8##3##(1995-9#1)(2008-12#2)(2008-5#1)(2013-1#4)
oral cavity##55##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-8#2)(1995-9#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-3#4)(2013-1#13)
oral cephalosporin##2##2##(1994-11#2)
oral challenge##4##2##(2008-5#1)(2012-3#3)
oral combination##2##2##(1990-8#1)(2012-2#1)
oral communication##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
oral complications##2##2##(2008-11#1)(2008-7#1)
oral contraception##4##2##(1991-4#1)(1994-5#1)(2009-12#1)(2013-8#1)
oral contraceptive pill##3##3##(2007-12#1)(2010-1#1)(2012-3#1)
oral contraceptive use##2##3##(1990-6#1)(2011-1#1)
oral contraceptive##11##2##(1990-6#1)(1991-4#1)(1994-5#1)(2007-12#1)(2008-7#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
oral contraceptives (OCs)##2##3##(1994-5#1)(1996-11#1)
oral contraceptives##20##2##(1990-2#1)(1990-6#3)(1990-9#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-5#2)(1996-11#1)(1996-2#1)(2007-10#1)(2008-11#2)(2008-7#2)(2008-8#2)(2009-8#1)
oral corticosteroid use##2##3##(2008-11#2)
oral corticosteroid##6##2##(2008-1#1)(2008-11#5)
oral corticosteroids##7##2##(2006-10#1)(2007-7#2)(2008-11#4)
oral delivery of insulin##4##4##(2008-5#1)(2011-1#3)
oral delivery of##5##3##(2008-5#1)(2008-8#1)(2011-1#3)
oral deposition##2##2##(2008-11#1)(2008-8#1)
oral disease##2##2##(2012-2#2)
oral diseases and##3##3##(1991-6#1)(2010-3#2)
oral diseases##6##2##(1991-6#2)(2008-1#2)(2010-3#2)
oral disodium cromoglycate##2##3##(1997-6#2)
oral dosage form of##2##4##(2011-1#1)(2012-2#1)
oral dose of##6##3##(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#2)
oral dose##11##2##(1996-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#2)
oral doses of##5##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
oral dosing##2##2##(2008-11#2)
oral environment##3##2##(2007-12#1)(2008-11#1)(2012-3#1)
oral epithelial cells##2##3##(2013-1#1)(2013-8#1)
oral epithelium##2##2##(2008-7#1)(2013-1#1)
oral etoposide in##2##3##(1993-12#1)(1996-10#1)
oral etoposide##4##2##(1993-12#1)(1996-10#1)(1996-8#1)(2007-7#1)
oral exam##2##2##(2011-2#2)
oral examination##2##2##(2008-1#1)(2011-2#1)
oral feeding##2##2##(2008-10#1)(2012-2#1)
oral fluconazole##2##2##(1991-3#1)(1996-8#1)
oral fludarabine##3##2##(2009-12#3)
oral form##2##2##(2008-11#1)(2012-3#1)
oral formulation##4##2##(2008-5#3)(2008-7#1)
oral formulations##2##2##(2008-5#1)(2010-12#1)
oral function##2##2##(2011-2#2)
oral gavage##4##2##(2008-10#3)(2011-2#1)
oral glucose tolerance test (OGTT)##6##5##(1994-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#1)
oral glucose tolerance test##11##4##(1990-8#1)(1994-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#2)
oral glucose tolerance##12##3##(1990-8#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#2)
oral glucose##15##2##(1990-8#1)(1994-12#1)(1995-11#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-4#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#2)
oral granisetron##6##2##(2010-12#6)
oral health and##4##3##(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#1)
oral health care providers##5##4##(2008-1#3)(2012-3#2)
oral health care##8##3##(2008-1#5)(2012-3#3)
oral health examination##2##3##(2008-12#1)(2011-1#1)
oral health in##2##3##(1991-6#1)(1995-12#1)
oral health of##3##3##(2009-4#1)(2012-3#1)(2013-1#1)
oral health program##2##3##(2008-5#2)
oral health status and##2##4##(2008-1#2)
oral health status of##2##4##(2008-1#1)(2008-5#1)
oral health status##5##3##(2008-1#3)(2008-5#2)
oral health survey##2##3##(2008-1#2)
oral health##47##2##(1991-6#3)(1995-12#4)(2008-1#13)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#1)(2008-9#3)(2009-4#1)(2010-3#1)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)
oral health-related quality of life##2##5##(2011-7#1)(2013-1#1)
oral health-related quality of##3##4##(2011-2#1)(2011-7#1)(2013-1#1)
oral hygiene##12##2##(2007-12#2)(2008-9#2)(2009-7#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#2)
oral hyperkeratosis and##3##3##(2012-3#3)
oral hyperkeratosis##4##2##(2012-3#4)
oral hypoglycemic##2##2##(2009-3#1)(2011-1#1)
oral hypoglycemics##4##2##(1991-12#4)
oral ibuprofen in##2##3##(2012-12#2)
oral ibuprofen##5##2##(2008-10#1)(2012-12#4)
oral ingestion of##2##3##(1995-11#1)(2012-2#1)
oral ingestion##3##2##(1995-11#2)(2012-2#1)
oral insulin drug##2##3##(2011-1#2)
oral insulin##3##2##(2008-5#1)(2011-1#2)
oral intake of##4##3##(2008-11#1)(2012-3#3)
oral intake##6##2##(2008-11#1)(2012-2#2)(2012-3#3)
oral interviews##2##2##(2007-7#1)(2008-7#1)
oral language and##3##3##(2008-12#2)(2012-3#1)
oral lesions by##2##3##(2008-5#1)(2013-1#1)
oral lesions##10##2##(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
oral lichen planus##10##3##(1991-3#1)(2008-4#5)(2009-6#1)(2013-1#3)
oral lichen##11##2##(1991-3#1)(2008-4#6)(2009-6#1)(2013-1#3)
oral linezolid and rifampin##2##4##(2007-12#2)
oral magnesium##3##2##(1990-9#3)
oral malformation##2##2##(2013-1#2)
oral malodour##3##2##(2008-10#2)(2013-7#1)
oral manifestations and##3##3##(2008-5#1)(2010-3#2)
oral manifestations##6##2##(2008-5#1)(2010-3#2)(2012-2#2)(2013-1#1)
oral mode of##2##3##(2008-8#1)(2008-9#1)
oral motor responses##2##3##(1993-12#2)
oral motor##4##2##(1993-12#4)
oral mucosa##10##2##(1991-2#1)(1993-1#3)(2008-3#2)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
oral mucosal##4##2##(2007-12#1)(2009-5#1)(2013-8#2)
oral opening##2##2##(1991-2#1)(2013-1#1)
oral or##4##2##(1990-6#1)(1992-2#1)(2008-9#1)(2010-5#1)
oral pathogens##2##2##(2008-12#2)
oral pathology##2##2##(1990-12#1)(2008-12#1)
oral polio vaccine (OPV)##2##4##(1994-9#1)(2008-4#1)
oral polio vaccine##5##3##(1994-9#2)(2007-10#2)(2008-4#1)
oral polio##6##2##(1994-9#2)(2007-10#3)(2008-4#1)
oral poliovirus vaccine##2##3##(1995-3#2)
oral poliovirus##6##2##(1990-3#1)(1995-3#3)(1995-5#1)(2008-11#1)
oral prednisolone was##2##3##(2007-7#2)
oral prednisolone##5##2##(2007-7#4)(2013-8#1)
oral presentations and more than##2##5##(2008-5#1)(2010-11#1)
oral presentations and##4##3##(2008-5#2)(2008-7#1)(2010-11#1)
oral provocation##2##2##(2013-1#2)
oral reading fluency##4##3##(2008-12#4)
oral rehabilitation of##2##3##(2008-7#1)(2011-2#1)
oral rehabilitation##3##2##(2008-7#1)(2011-2#2)
oral rehydration solution##2##3##(1991-9#2)
oral rehydration##3##2##(1991-9#2)(1992-5#1)
oral route is##2##3##(2010-6#1)(2012-12#1)
oral route##7##2##(2008-5#3)(2009-4#1)(2010-6#1)(2012-12#1)(2012-2#1)
oral saline##2##2##(2008-5#1)(2010-7#1)
oral samples of##2##3##(2008-5#1)(2010-4#1)
oral samples##3##2##(2008-5#1)(2010-4#1)(2013-1#1)
oral secretions##2##2##(1990-11#2)
oral sex##3##2##(1996-5#2)(2009-7#1)
oral squamous cell carcinoma##7##4##(2007-11#1)(2010-12#2)(2013-1#4)
oral squamous##8##2##(1991-2#1)(2007-11#1)(2010-12#2)(2013-1#4)
oral steroids##4##2##(1997-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
oral submucous fibrosis##5##3##(1996-6#1)(2013-1#4)
oral surgery with##3##3##(1993-1#3)
oral surgery##9##2##(1990-10#1)(1990-2#1)(1993-1#7)
oral sustained release##4##3##(2008-11#3)(2012-2#1)
oral tablets##2##2##(1990-2#1)(2010-4#1)
oral tolerance induction##2##3##(2008-11#2)
oral tolerance##7##2##(2008-11#7)
oral toxicity##5##2##(1995-3#2)(2008-5#1)(2011-3#1)(2013-1#1)
oral treatment with##4##3##(1990-11#1)(1991-3#1)(2012-2#1)(2013-7#1)
oral treatment##6##2##(1990-11#1)(1991-3#1)(1992-11#1)(1993-12#1)(2012-2#1)(2013-7#1)
oral vaccination##3##2##(1992-5#1)(1995-5#1)(2010-6#1)
oral vaccine##2##2##(2008-9#1)(2012-3#1)
oral vancomycin##2##2##(1996-3#1)(2009-8#1)
oral##913##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#4)(1990-6#6)(1990-7#2)(1990-8#2)(1990-9#6)(1991-12#5)(1991-2#5)(1991-3#6)(1991-4#3)(1991-6#9)(1991-8#2)(1991-9#4)(1992-11#8)(1992-2#1)(1992-3#2)(1992-5#3)(1992-8#2)(1992-9#4)(1993-1#13)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#4)(1994-9#3)(1995-11#6)(1995-12#5)(1995-2#2)(1995-3#10)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#6)(1996-6#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#4)(2006-6#1)(2007-1#1)(2007-10#8)(2007-11#9)(2007-12#26)(2007-2#2)(2007-6#1)(2007-7#17)(2007-8#6)(2008-1#27)(2008-10#24)(2008-11#56)(2008-12#19)(2008-2#2)(2008-3#12)(2008-4#11)(2008-5#57)(2008-6#2)(2008-7#33)(2008-8#12)(2008-9#20)(2009-10#4)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#19)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#7)(2010-6#6)(2010-7#3)(2010-8#1)(2011-1#26)(2011-2#33)(2011-3#1)(2011-7#3)(2012-1#8)(2012-12#20)(2012-2#35)(2012-3#34)(2012-7#3)(2013-1#81)(2013-7#4)(2013-8#21)
oral-facial-digital##2##1##(1997-3#2)
oralis##2##1##(2006-6#1)(2012-2#1)
orally active##4##2##(1990-11#1)(1993-11#1)(1994-11#1)(1995-12#1)
orally administered HET may##2##4##(2008-10#2)
orally administered to##2##3##(1990-3#1)(2008-10#1)
orally administered##19##2##(1990-2#1)(1990-3#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-12#2)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2009-3#1)(2013-1#1)
orally and##5##2##(1994-6#1)(2007-10#1)(2007-8#1)(2008-8#1)(2012-12#1)
orally at a##2##3##(1994-6#1)(2013-1#1)
orally at doses of##2##4##(2008-5#1)(2012-2#1)
orally at##10##2##(1992-12#1)(1994-6#2)(1995-12#1)(2007-6#1)(2008-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
orally for 7 consecutive days##2##5##(2008-10#1)(2008-11#1)
orally for 8 weeks##2##4##(2008-5#2)
orally for##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
orally given##3##2##(2008-11#2)(2011-2#1)
orally in##5##2##(1990-2#1)(2007-7#1)(2008-5#2)(2012-2#1)
orally or##3##2##(1992-12#1)(2008-1#1)(2008-5#1)
orally to##5##2##(1991-5#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
orally##107##1##(1990-11#1)(1990-2#2)(1990-3#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#3)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#12)(2008-12#3)(2008-3#2)(2008-5#9)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
orally) for 7##2##3##(2011-2#2)
orally)##3##1##(2011-2#3)
orally-administered##2##1##(2007-11#1)(2008-5#1)
orange (AO)##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
orange (Citrus sinensis)##3##3##(2008-10#2)(2012-12#1)
orange (Citrus##4##2##(2008-10#3)(2012-12#1)
orange (XO)##3##2##(2008-10#3)
orange and##8##2##(1995-4#1)(2008-10#5)(2008-11#1)(2008-7#1)
orange as##2##2##(1993-11#1)(2008-10#1)
orange direct count technique##2##4##(1997-4#2)
orange for##2##2##(1991-11#1)(2008-10#1)
orange juice##10##2##(1997-4#1)(2008-10#5)(2008-8#1)(2010-5#3)
orange or##2##2##(1992-3#1)(2008-10#1)
orange than##2##2##(2008-10#2)
orange to##3##2##(2008-10#1)(2012-2#2)
orange with##2##2##(2008-10#2)
orange##111##1##(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-11#2)(1995-2#1)(1995-4#1)(1997-4#3)(2007-12#1)(2008-10#70)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-7#2)(2010-5#3)(2012-12#1)(2012-2#2)
orange)##2##1##(2006-6#1)(2008-10#1)
orange-spotted grouper##4##2##(2010-5#4)
oranges##3##1##(1992-10#1)(2008-10#1)(2008-12#1)
oranges?##2##1##(1996-3#1)(2008-8#1)
orangutan##2##1##(1995-11#1)(1997-6#1)
orbiculare from##2##2##(2008-10#2)
orbiculare##13##1##(2008-10#13)
orbit and##6##2##(2008-6#1)(2010-11#1)(2011-2#3)(2013-1#1)
orbit are##2##2##(2008-2#1)(2011-2#1)
orbit in##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
orbit##39##1##(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-6#4)(2008-7#2)(2008-9#1)(2009-2#2)(2010-10#1)(2010-11#2)(2011-1#2)(2011-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
orbital and##2##2##(2008-10#1)(2011-2#1)
orbital angular momentum is##2##4##(2007-11#2)
orbital angular momentum##3##3##(2007-11#3)
orbital complication of##2##3##(2011-1#2)
orbital complication##3##2##(2011-1#3)
orbital complications##3##2##(2011-1#1)(2013-1#2)
orbital cortex##3##2##(1994-3#3)
orbital decompression for##2##3##(2008-7#2)
orbital decompression##8##2##(2008-7#6)(2013-1#2)
orbital energies##2##2##(1996-5#1)(2012-2#1)
orbital infarction and retinal detachment##2##5##(2013-8#2)
orbital infarction##4##2##(2013-8#4)
orbital radiotherapy##2##2##(2013-1#2)
orbital rhabdomyosarcoma with##3##3##(2010-11#2)(2011-1#1)
orbital rhabdomyosarcoma##4##2##(2010-11#2)(2011-1#2)
orbital rim osteotomy##3##3##(2006-12#3)
orbital rim##4##2##(2006-12#4)
orbital roof##2##2##(2008-8#1)(2009-2#1)
orbital splitting##2##2##(1997-7#2)
orbital wall##4##2##(2008-10#1)(2009-2#1)(2010-10#1)(2013-1#1)
orbital##103##1##(1991-5#1)(1991-6#1)(1992-2#2)(1993-8#2)(1994-3#3)(1994-5#1)(1996-2#6)(1996-5#2)(1997-7#2)(2006-12#5)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#8)(2008-8#2)(2009-2#2)(2010-10#1)(2010-11#3)(2010-5#1)(2011-1#13)(2011-2#8)(2012-12#6)(2012-2#2)(2013-1#14)(2013-7#2)(2013-8#4)
orbitals with the##2##3##(1997-7#2)
orbitals with##3##2##(1997-7#2)(2007-11#1)
orbitals##13##1##(1997-7#7)(2007-11#3)(2010-7#2)(2013-1#1)
orbiting##6##1##(1991-8#1)(2008-3#2)(2011-2#3)
orbitofacial trauma##2##2##(2011-1#2)
orbitofrontal and inferiorfrontal cortices##2##4##(2012-12#2)
orbitofrontal and##5##2##(2009-10#1)(2012-12#3)(2013-1#1)
orbitofrontal cortex and##3##3##(1996-5#1)(2009-10#2)
orbitofrontal cortex##10##2##(1996-5#2)(2007-8#1)(2008-11#1)(2009-10#4)(2012-12#2)
orbitofrontal##17##1##(1996-5#2)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#5)(2011-2#1)(2012-12#5)(2013-1#1)
orbitopterional approach##4##2##(2011-2#4)
orbitotomy##3##1##(2006-12#1)(2008-7#2)
orbitozygomatic craniotomy##3##2##(2006-12#3)
orbitozygomatic##5##1##(2006-12#4)(2008-7#1)
orbits##8##1##(1991-6#1)(1991-8#1)(1992-8#1)(1995-9#1)(2007-12#1)(2011-2#2)(2013-8#1)
orchard and##6##2##(2008-10#6)
orchard block##5##2##(2008-10#5)
orchard blocks##3##2##(2008-10#3)
orchard experiments##3##2##(2008-10#3)
orchard floor##7##2##(2008-10#7)
orchard in##2##2##(2008-10#2)
orchard sites##2##2##(2008-10#2)
orchard soil##5##2##(2008-10#5)
orchard soils were##2##3##(2008-10#2)
orchard soils##11##2##(2008-10#11)
orchard that had##2##3##(2008-10#2)
orchard were##2##2##(2008-10#2)
orchard##96##1##(2008-10#95)(2009-12#1)
orchard)##2##1##(2008-10#2)
orchards and##5##2##(2008-10#4)(2008-12#1)
orchards are##2##2##(2008-10#2)
orchards at##3##2##(2008-10#3)
orchards during##4##2##(2008-10#4)
orchards in California##3##3##(2008-10#3)
orchards in northern##2##3##(2008-10#2)
orchards in the##3##3##(2008-10#3)
orchards in##17##2##(2008-10#16)(2008-6#1)
orchards located in##2##3##(2008-10#2)
orchards over##3##2##(2008-10#3)
orchards were##3##2##(2008-10#3)
orchards with##5##2##(2008-10#5)
orchards##97##1##(2008-10#91)(2008-12#1)(2008-6#4)(2009-12#1)
orchestrate the##2##2##(2008-9#1)(2012-3#1)
orchestrate##8##1##(2007-12#1)(2008-1#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)
orchestrated to##2##2##(2008-10#1)(2008-3#1)
orchestrated##7##1##(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
orchestrating##2##1##(2008-1#1)(2012-2#1)
orchid viruses##4##2##(2008-10#4)
orchid##11##1##(2008-10#10)(2008-6#1)
orchidectomy was##2##2##(2008-6#1)(2012-12#1)
orchidectomy##7##1##(2007-8#1)(2008-6#4)(2012-12#2)
orchidopexy##6##1##(2008-10#2)(2009-7#1)(2011-2#3)
orchiectomized##2##1##(1996-2#2)
orchiectomy and##2##2##(2007-5#1)(2008-10#1)
orchiectomy##8##1##(1995-12#1)(1995-2#1)(1997-3#1)(2007-5#1)(2008-10#4)
orchiopexy##2##1##(2008-10#2)
orchitis##6##1##(1990-9#1)(1997-8#2)(2008-10#1)(2011-2#2)
ord##3##1##(2013-8#3)
order 1##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
order 2##2##2##(1995-5#1)(2008-10#1)
order I##3##2##(2013-8#3)
order alpha##2##2##(1990-4#1)(1995-8#1)
order and##19##2##(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
order are##3##2##(2007-11#2)(2008-2#1)
order as a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
order as##6##2##(1992-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
order between##2##2##(1993-8#1)(1995-3#1)
order by##6##2##(1992-3#1)(1997-5#1)(2007-12#1)(2008-3#3)
order can be##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
order can##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
order derivative##4##2##(2008-10#3)(2010-5#1)
order entry system##2##3##(2013-1#2)
order entry##7##2##(1995-2#3)(2010-8#1)(2013-1#3)
order for the##4##3##(1993-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
order for##18##2##(1991-8#1)(1992-3#2)(1993-1#1)(1994-3#1)(1996-5#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
order from the##2##3##(1995-3#1)(2008-6#1)
order from##3##2##(1995-3#1)(2008-10#1)(2008-6#1)
order in a##2##3##(2008-2#1)(2008-3#1)
order in the##12##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-3#1)(2013-8#1)
order in##24##2##(1990-4#2)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#2)(2013-8#1)
order is##9##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2010-10#1)
order kinetics##7##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#1)(2008-10#2)(2008-11#1)
order linguistic##2##2##(2013-1#2)
order model##2##2##(2008-10#1)(2008-5#1)
order near##4##2##(2008-3#4)
order of a##8##3##(2008-2#2)(2008-3#4)(2009-11#1)(2009-5#1)
order of abundance##2##3##(1992-12#1)(2012-12#1)
order of affinities##2##3##(1995-12#1)(2008-11#1)
order of decreasing##3##3##(1993-9#2)(2008-4#1)
order of elution##2##3##(1990-8#1)(2008-10#1)
order of frequency##4##3##(1990-10#1)(1991-2#1)(1992-8#1)(2008-10#1)
order of increasing##2##3##(2008-10#1)(2008-3#1)
order of magnitude and##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
order of magnitude change in##2##5##(2008-10#2)
order of magnitude larger than that##3##6##(2008-3#2)(2010-8#1)
order of magnitude larger than##7##5##(2007-11#2)(2007-12#1)(2008-3#2)(2009-9#1)(2010-8#1)
order of magnitude less than##2##5##(2008-2#1)(2008-3#1)
order of magnitude less##3##4##(1997-2#1)(2008-2#1)(2008-3#1)
order of magnitude more##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
order of magnitude##68##3##(1990-8#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-11#7)(2007-12#4)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#13)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
order of potency of the##2##5##(1991-2#1)(1995-12#1)
order of potency of##3##4##(1991-12#1)(1991-2#1)(1995-12#1)
order of potency##11##3##(1991-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1995-12#4)(2009-12#1)
order of relative##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
order of the##33##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2010-1#1)(2011-1#2)(2012-1#1)
order of their##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
order of##318##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#5)(1991-5#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-3#3)(1994-6#1)(1994-8#2)(1995-11#4)(1995-12#8)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#4)(1997-2#2)(1997-4#1)(1997-6#2)(2007-11#13)(2007-12#16)(2008-1#1)(2008-10#64)(2008-11#6)(2008-12#1)(2008-2#23)(2008-3#56)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
order on the##2##3##(2008-10#2)
order on##4##2##(2008-10#3)(2008-12#1)
order or##3##2##(1991-5#1)(1994-3#1)(2008-4#1)
order parameter##4##2##(1990-12#1)(1990-2#1)(1994-5#1)(2008-9#1)
order parameters##4##2##(1990-12#1)(1992-9#2)(2008-11#1)
order patterns##3##2##(2008-11#3)
order process##2##2##(1990-11#1)(2009-7#1)
order reaction##3##2##(2008-10#3)
order sets##4##2##(1996-12#2)(2008-3#2)
order statistic##2##2##(2008-3#2)
order substrate binding##2##3##(1995-6#2)
order that##8##2##(1990-11#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2013-1#1)
order to achieve a##8##4##(1991-9#1)(1992-9#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)
order to achieve high##3##4##(1990-12#1)(2008-10#2)
order to achieve the##8##4##(2008-1#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-11#1)(2011-2#1)
order to achieve##29##3##(1990-12#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)
order to acquire##2##3##(2007-7#1)(2008-10#1)
order to adapt##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2011-1#1)
order to add##2##3##(2008-12#1)(2009-9#1)
order to address the##3##4##(2008-11#1)(2008-7#1)(2012-12#1)
order to address these##2##4##(1997-2#1)(2008-1#1)
order to address##7##3##(1992-6#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
order to allow the##5##4##(2008-10#4)(2013-1#1)
order to allow##6##3##(2008-10#4)(2009-4#1)(2013-1#1)
order to analyze the##4##4##(1997-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
order to analyze##9##3##(1992-5#1)(1994-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
order to answer##2##3##(2008-11#1)(2010-2#1)
order to apply##2##3##(2008-10#1)(2008-4#1)
order to ascertain whether##2##4##(2008-11#1)(2010-8#1)
order to ascertain##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
order to assess the##21##4##(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-9#1)(1993-12#1)(1995-5#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#2)(2009-3#1)
order to assess their##2##4##(1992-8#1)(2012-3#1)
order to assess whether##2##4##(2008-7#1)(2012-2#1)
order to assess##36##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-7#6)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
order to attain##4##3##(1997-8#1)(2008-1#1)(2008-10#1)(2010-9#1)
order to avoid the##9##4##(1991-8#1)(1994-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2013-1#1)
order to avoid##26##3##(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1994-11#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
order to be able to##5##5##(1990-6#1)(1991-11#1)(1991-3#1)(1993-12#1)(2008-10#1)
order to be able##6##4##(1990-6#1)(1991-11#1)(1991-3#1)(1993-12#1)(2008-10#1)(2008-11#1)
order to be##21##3##(1990-6#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
order to better understand the##3##5##(1993-8#1)(2008-10#1)(2009-11#1)
order to better understand##4##4##(1993-8#1)(2008-10#1)(2009-11#1)(2013-1#1)
order to better##5##3##(1993-8#1)(2008-10#1)(2009-11#1)(2009-5#1)(2013-1#1)
order to build##2##3##(2008-11#1)(2008-7#1)
order to calculate the##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
order to calculate##4##3##(2008-10#2)(2009-4#1)(2011-2#1)
order to characterize the##8##4##(1995-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)
order to characterize##13##3##(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)
order to check the##3##4##(2008-12#1)(2008-5#1)(2010-8#1)
order to check##8##3##(1992-5#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2012-7#1)
order to clarify the role of##2##6##(1991-12#1)(1991-2#1)
order to clarify the##5##4##(1991-12#2)(1991-2#1)(1992-3#1)(1995-8#1)
order to clarify##9##3##(1991-12#2)(1991-2#1)(1992-3#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)
order to classify##3##3##(1994-6#1)(2010-5#1)(2012-1#1)
order to compare the##6##4##(1994-3#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
order to compare##13##3##(1991-7#1)(1994-3#1)(1994-5#1)(2008-10#5)(2008-5#2)(2011-2#2)(2012-2#1)
order to confirm the##7##4##(1992-12#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)
order to confirm##13##3##(1990-2#1)(1990-5#1)(1992-12#1)(1994-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2012-3#1)
order to construct a##2##4##(2008-10#1)(2008-11#1)
order to contribute to##4##4##(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
order to control the##4##4##(2007-8#1)(2008-10#3)
order to control##6##3##(2007-8#1)(2008-10#3)(2008-11#1)(2013-8#1)
order to decide##3##3##(2007-2#1)(2010-12#1)(2011-2#1)
order to decrease the##3##4##(2008-12#1)(2009-10#1)(2011-2#1)
order to define a##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
order to define the##3##4##(1993-11#1)(2010-11#1)(2010-2#1)
order to define##7##3##(1993-11#1)(2008-11#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
order to demonstrate the##4##4##(2008-10#3)(2008-7#1)
order to demonstrate##10##3##(1996-9#1)(1997-7#1)(2008-10#6)(2008-12#1)(2008-7#1)
order to derive a##3##4##(1992-3#1)(2008-10#2)
order to derive##4##3##(1992-3#1)(2008-10#2)(2008-7#1)
order to describe the##2##4##(2008-11#1)(2008-6#1)
order to describe##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
order to determine if the##2##5##(1990-2#1)(2008-4#1)
order to determine if##3##4##(1990-2#1)(2008-1#1)(2008-4#1)
order to determine the role of##2##6##(1994-11#1)(1995-2#1)
order to determine the##38##4##(1990-11#1)(1990-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
order to determine their##3##4##(2007-12#1)(2008-10#1)(2011-1#1)
order to determine whether##7##4##(1991-12#1)(1991-3#1)(1992-5#1)(1993-12#1)(1994-12#1)(1996-12#1)(1997-3#1)
order to determine which##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
order to determine##78##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#2)(1992-5#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
order to develop a better##2##5##(2007-11#1)(2008-7#1)
order to develop a##12##4##(1990-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)
order to develop an##2##4##(1990-12#1)(2010-5#1)
order to develop##27##3##(1990-12#1)(1990-5#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#2)(2011-2#1)(2012-12#1)
order to differentiate##3##3##(2008-10#3)
order to distinguish between##2##4##(2008-10#2)
order to distinguish##7##3##(1997-3#1)(2008-10#5)(2012-2#1)
order to effect##2##3##(2008-4#1)(2008-7#1)
order to efficiently##2##3##(1996-12#1)(2010-3#1)
order to eliminate the##4##4##(1997-4#1)(2008-10#1)(2010-11#1)(2011-1#1)
order to eliminate##8##3##(1996-3#1)(1997-4#1)(2007-11#2)(2008-10#1)(2010-11#1)(2011-1#1)(2012-3#1)
order to elucidate the role of##2##6##(1992-6#1)(2008-10#1)
order to elucidate the underlying##2##5##(1995-12#1)(2008-5#1)
order to elucidate the##12##4##(1992-6#1)(1992-8#1)(1993-3#1)(1995-12#1)(2008-10#3)(2008-5#2)(2010-4#1)(2011-3#1)(2012-2#1)
order to elucidate##15##3##(1992-6#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-4#1)(2011-3#1)(2012-2#1)
order to enhance the##5##4##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)
order to enhance##11##3##(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
order to ensure a##3##4##(2009-5#1)(2009-6#1)(2012-3#1)
order to ensure that##2##4##(1997-8#1)(2008-11#1)
order to ensure##18##3##(1990-5#1)(1995-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#2)
order to establish a##2##4##(2008-11#1)(2008-7#1)
order to establish##21##3##(1991-6#1)(1995-5#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#1)
order to estimate the##5##4##(1995-6#1)(2008-10#2)(2008-11#1)(2013-8#1)
order to estimate##8##3##(1995-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2009-7#1)(2013-8#1)
order to evaluate the effect of a##2##7##(1995-11#1)(1997-4#1)
order to evaluate the effect of##4##6##(1995-11#1)(1997-4#1)(2008-10#1)(2008-7#1)
order to evaluate the effectiveness of##2##6##(1994-6#1)(2007-11#1)
order to evaluate the effects of##5##6##(1995-2#1)(2007-11#1)(2008-10#2)(2008-12#1)
order to evaluate the##33##4##(1990-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
order to evaluate whether##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
order to evaluate##48##3##(1990-12#1)(1990-2#1)(1990-6#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
order to examine the##10##4##(1990-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)
order to examine##16##3##(1990-8#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-8#1)
order to explain the##3##4##(1994-5#1)(2008-10#2)
order to explain##5##3##(1993-12#1)(1994-5#1)(2008-10#2)(2012-2#1)
order to explore the##6##4##(1995-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-9#1)(2010-10#1)
order to explore##9##3##(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)(2012-3#1)
order to express##2##3##(1994-5#1)(1995-2#1)
order to facilitate the##3##4##(1990-12#1)(1990-7#1)(2008-10#1)
order to facilitate##16##3##(1990-12#1)(1990-7#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
order to find out##4##4##(1991-11#1)(2012-3#1)(2013-1#2)
order to find the##7##4##(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)
order to find##18##3##(1990-5#1)(1991-11#1)(1993-8#1)(1996-5#1)(1997-6#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
order to further##6##3##(1994-1#1)(2008-10#4)(2008-11#1)
order to gain##10##3##(1992-6#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)
order to generate##2##3##(2008-10#1)(2008-8#1)
order to get a##4##4##(2008-10#3)(2013-8#1)
order to get an insight into the##2##7##(2008-11#1)(2008-7#1)
order to get an insight into##3##6##(2008-11#1)(2008-7#1)(2009-12#1)
order to get##14##3##(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#1)(2013-8#1)
order to give##3##3##(1993-1#1)(2008-11#2)
order to have a##2##4##(2008-10#1)(2008-12#1)
order to have##5##3##(1993-11#1)(2008-10#1)(2008-12#2)(2008-7#1)
order to help the##2##4##(1992-2#1)(2008-6#1)
order to help##12##3##(1992-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-4#1)(2012-12#2)(2013-1#1)
order to identify and##3##4##(1997-2#1)(2008-10#1)(2012-2#1)
order to identify new##2##4##(2010-3#1)(2012-1#1)
order to identify the##9##4##(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(2008-10#3)(2010-5#1)(2013-1#1)
order to identify##44##3##(1990-10#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#2)(1997-2#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-4#2)(2008-7#2)(2009-2#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
order to illustrate the##3##4##(1990-8#1)(2007-11#1)(2008-10#1)
order to illustrate##5##3##(1990-8#1)(2007-11#1)(2008-10#3)
order to improve the##27##4##(1991-6#1)(1996-2#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
order to improve##47##3##(1991-3#1)(1991-6#1)(1993-2#1)(1994-11#1)(1996-12#1)(1996-2#1)(2008-10#17)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
order to increase sensitivity##2##4##(2008-10#2)
order to increase the understanding of the##2##7##(1995-1#1)(1997-4#1)
order to increase the##13##4##(1995-1#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
order to increase##26##3##(1995-1#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-7#1)(2012-2#1)(2013-8#1)
order to investigate the mechanism##3##5##(1991-11#1)(1994-8#1)(2008-3#1)
order to investigate the relationship between##5##6##(1994-3#2)(2008-10#1)(2008-9#1)(2011-2#1)
order to investigate the##29##4##(1991-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-8#2)(1995-6#1)(1996-12#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
order to investigate their##4##4##(1990-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
order to investigate whether##3##4##(1994-12#1)(2011-1#1)(2012-5#1)
order to investigate##46##3##(1990-12#1)(1991-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-6#1)(1996-12#2)(1996-5#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#5)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-5#1)(2013-1#1)
order to know the##5##4##(1991-9#1)(2008-10#2)(2008-11#1)(2013-8#1)
order to learn more about the##2##6##(2009-4#1)(2010-11#1)
order to learn##4##3##(1996-12#1)(2009-4#1)(2010-11#1)(2011-2#1)
order to localize##2##3##(1991-9#1)(1997-6#1)
order to make the##5##4##(2008-10#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
order to make##22##3##(1990-3#1)(1991-2#1)(1993-9#1)(1994-1#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-12#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
order to map##2##3##(1991-8#1)(2008-12#1)
order to maximize the##6##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
order to maximize##10##3##(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)
order to measure##8##3##(1994-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#2)(2012-12#1)
order to meet the##7##4##(1994-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)
order to mimic the##2##4##(2009-2#1)(2009-7#1)
order to mimic##3##3##(2008-10#1)(2009-2#1)(2009-7#1)
order to minimise the##2##4##(2010-12#1)(2011-2#1)
order to minimize the risk of##2##6##(1996-3#1)(2007-8#1)
order to minimize the##7##4##(1996-3#1)(1997-6#1)(2007-8#2)(2008-10#3)
order to minimize##10##3##(1993-8#1)(1996-3#1)(1997-6#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-7#1)
order to observe##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
order to obtain a##12##4##(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-2#1)
order to obtain an##4##4##(2008-10#2)(2008-5#1)(2009-7#1)
order to obtain better##3##4##(2008-10#2)(2008-7#1)
order to obtain good##3##4##(1990-5#1)(2008-10#1)(2008-9#1)
order to obtain more##4##4##(1995-5#1)(1996-2#1)(2009-4#1)(2010-1#1)
order to obtain the##14##4##(1994-12#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)
order to obtain##63##3##(1990-5#1)(1991-12#1)(1991-2#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
order to optimize the extraction##2##5##(2008-10#2)
order to optimize the##8##4##(1996-5#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-4#1)
order to optimize##11##3##(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)
order to overcome##13##3##(1990-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
order to perform the##2##4##(2008-10#2)
order to perform##6##3##(2008-10#5)(2010-11#1)
order to permit##2##3##(1992-6#1)(1996-12#1)
order to pinpoint the##2##4##(1990-12#1)(2008-10#1)
order to present##2##3##(2009-11#1)(2013-1#1)
order to preserve##3##3##(2008-10#1)(2008-6#1)(2010-8#1)
order to prevent the##5##4##(1993-8#1)(1994-9#1)(1997-6#1)(2008-1#1)(2008-10#1)
order to prevent this##2##4##(1993-11#1)(2013-1#1)
order to prevent##21##3##(1991-6#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
order to probe the##2##4##(1994-5#1)(1995-5#1)
order to probe##3##3##(1994-5#1)(1995-5#1)(2008-8#1)
order to produce##4##3##(1991-12#1)(1994-9#1)(1996-9#1)(2008-12#1)
order to prove##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
order to provide a##4##4##(1992-6#1)(2008-11#1)(2009-9#1)(2011-2#1)
order to provide##20##3##(1990-2#1)(1991-1#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#2)
order to quantify the##3##4##(1997-6#1)(2008-10#1)(2013-1#1)
order to quantify##7##3##(1997-6#1)(2008-10#3)(2009-7#1)(2012-2#1)(2013-1#1)
order to quantitate##2##3##(1992-6#1)(2008-4#1)
order to raise the##2##4##(2008-8#1)(2011-2#1)
order to raise##3##3##(2008-8#1)(2011-2#2)
order to realize##4##3##(2008-10#1)(2010-11#1)(2010-8#1)(2012-3#1)
order to reduce the risk of##5##6##(1990-2#1)(2008-10#1)(2008-11#1)(2013-8#2)
order to reduce the##15##4##(1990-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
order to reduce##26##3##(1990-2#1)(1991-6#1)(1992-11#1)(1992-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#2)
order to remove the##4##4##(2008-10#4)
order to remove##6##3##(2008-10#4)(2008-6#1)(2013-1#1)
order to respond to the##2##5##(2011-2#1)(2012-12#1)
order to satisfy##3##3##(1994-3#1)(2008-10#1)(2008-9#1)
order to select the##2##4##(1996-6#1)(2008-10#1)
order to select##4##3##(1996-6#1)(2008-10#3)
order to shed light on this##2##6##(1997-2#1)(2013-1#1)
order to shed light on##3##5##(1997-2#1)(2007-12#1)(2013-1#1)
order to shed##4##3##(1997-2#1)(2007-12#1)(2008-11#1)(2013-1#1)
order to show how the##2##5##(2007-8#1)(2008-10#1)
order to show##4##3##(1990-10#1)(2007-8#1)(2008-10#2)
order to simplify the##2##4##(1997-4#1)(2010-8#1)
order to study the influence of##3##6##(1992-6#1)(1994-8#1)(2013-8#1)
order to study the##23##4##(1990-5#1)(1990-6#1)(1991-6#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-6#1)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2011-2#1)(2013-8#1)
order to study##34##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-5#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
order to support##8##3##(1996-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-6#1)(2010-8#1)(2012-3#1)
order to target##2##3##(1997-2#1)(2008-7#1)
order to test the##7##4##(1990-12#1)(1991-5#1)(2008-10#2)(2008-5#1)(2009-9#1)(2012-2#1)
order to test this##3##4##(1995-5#1)(1996-3#1)(2008-7#1)
order to test whether##3##4##(1994-3#1)(2008-10#1)(2008-8#1)
order to test##18##3##(1990-12#1)(1991-5#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
order to understand the role of##3##6##(1997-2#1)(2008-6#1)(2012-3#1)
order to understand the##17##4##(1994-5#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
order to understand##26##3##(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
order to unify##2##3##(2007-11#2)
order to use##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
order to utilize the##2##4##(2008-11#1)(2009-5#1)
order to utilize##3##3##(2008-11#2)(2009-5#1)
order to validate the##6##4##(1997-2#1)(2008-10#3)(2010-12#1)(2011-2#1)
order to validate##8##3##(1995-5#1)(1997-2#1)(2008-10#4)(2010-12#1)(2011-2#1)
order to verify the##5##4##(1991-6#1)(1997-2#1)(2008-10#2)(2008-9#1)
order to verify##7##3##(1991-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-7#1)
order to work##2##3##(1997-5#1)(2008-7#1)
order to##1533##2##(1990-10#2)(1990-11#3)(1990-12#10)(1990-2#8)(1990-3#3)(1990-5#8)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#9)(1991-2#3)(1991-3#5)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#9)(1992-5#5)(1992-6#9)(1992-8#3)(1992-9#8)(1993-1#2)(1993-11#6)(1993-12#11)(1993-2#3)(1993-3#5)(1993-6#6)(1993-8#5)(1993-9#2)(1994-1#5)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#5)(1994-3#8)(1994-5#8)(1994-6#10)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#5)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#7)(1995-5#13)(1995-6#6)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#14)(1996-2#5)(1996-3#5)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#5)(1997-2#14)(1997-3#8)(1997-4#12)(1997-5#2)(1997-6#12)(1997-7#4)(1997-8#5)(2006-10#1)(2006-6#1)(2007-10#7)(2007-11#18)(2007-12#6)(2007-2#4)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#11)(2008-1#28)(2008-10#366)(2008-11#101)(2008-12#39)(2008-2#10)(2008-3#5)(2008-4#21)(2008-5#46)(2008-6#17)(2008-7#61)(2008-8#26)(2008-9#29)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#8)(2009-5#4)(2009-6#5)(2009-7#11)(2009-8#2)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#12)(2010-12#7)(2010-2#3)(2010-3#9)(2010-4#7)(2010-5#11)(2010-6#5)(2010-7#2)(2010-8#12)(2010-9#4)(2011-1#16)(2011-2#53)(2011-3#2)(2011-7#1)(2012-1#6)(2012-12#15)(2012-2#25)(2012-3#22)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#43)(2013-7#8)(2013-8#15)
order transformation rates##2##3##(2012-12#2)
order under##2##2##(2007-12#1)(2008-3#1)
order was##8##2##(1990-11#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-2#2)(2009-8#1)
order with##3##2##(1990-11#1)(2008-10#1)(2009-9#1)
order within##2##2##(1990-5#1)(2010-8#1)
order##2311##1##(1990-10#4)(1990-11#8)(1990-12#14)(1990-2#12)(1990-3#3)(1990-4#3)(1990-5#11)(1990-6#4)(1990-7#1)(1990-8#8)(1990-9#2)(1991-1#1)(1991-11#5)(1991-12#11)(1991-2#8)(1991-3#7)(1991-5#7)(1991-6#6)(1991-7#1)(1991-8#5)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#9)(1992-12#12)(1992-2#6)(1992-3#18)(1992-5#5)(1992-6#12)(1992-8#5)(1992-9#11)(1993-1#3)(1993-11#8)(1993-12#15)(1993-2#5)(1993-3#7)(1993-6#7)(1993-8#10)(1993-9#4)(1994-1#6)(1994-10#1)(1994-11#6)(1994-12#12)(1994-2#5)(1994-3#13)(1994-5#10)(1994-6#13)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#7)(1995-11#8)(1995-12#18)(1995-2#13)(1995-3#12)(1995-5#17)(1995-6#15)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#19)(1996-2#6)(1996-3#7)(1996-4#2)(1996-5#10)(1996-6#1)(1996-7#1)(1996-9#5)(1997-1#5)(1997-2#18)(1997-3#9)(1997-4#14)(1997-5#4)(1997-6#15)(1997-7#6)(1997-8#6)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#7)(2007-11#43)(2007-12#40)(2007-2#4)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#12)(2008-1#29)(2008-10#501)(2008-11#127)(2008-12#44)(2008-2#67)(2008-3#116)(2008-4#30)(2008-5#64)(2008-6#27)(2008-7#73)(2008-8#38)(2008-9#38)(2009-1#1)(2009-10#9)(2009-11#6)(2009-12#7)(2009-2#4)(2009-3#2)(2009-4#9)(2009-5#7)(2009-6#5)(2009-7#14)(2009-8#4)(2009-9#10)(2010-1#6)(2010-10#5)(2010-11#13)(2010-12#7)(2010-2#4)(2010-3#14)(2010-4#8)(2010-5#16)(2010-6#5)(2010-7#3)(2010-8#15)(2010-9#9)(2011-1#22)(2011-2#67)(2011-3#2)(2011-7#1)(2012-1#8)(2012-12#20)(2012-2#38)(2012-3#23)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#57)(2013-7#10)(2013-8#32)
order)##7##1##(1993-12#2)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
order-disorder##2##1##(1992-8#1)(2008-10#1)
order-of-magnitude##6##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-8#1)
order-parameter##2##1##(2008-8#2)
ordered array of##2##3##(2008-3#1)(2008-7#1)
ordered array##3##2##(1996-6#1)(2008-3#1)(2008-7#1)
ordered arrays of##4##3##(2008-7#3)(2010-4#1)
ordered by##2##2##(1993-2#1)(1996-1#1)
ordered for a##2##3##(1994-9#1)(1997-5#1)
ordered set of##2##3##(2008-11#1)(2008-2#1)
ordered structure##2##2##(1990-5#1)(2008-11#1)
ordered to##2##2##(1995-6#1)(1996-5#1)
ordered##89##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#4)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-5#2)(1997-7#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#3)(2010-11#1)(2010-4#3)(2010-5#1)(2011-2#1)(2012-2#3)
ordering and electronic coupling in bilayer nanoscale InAs/GaAs quantum dots separated by a thin##2##14##(2009-11#2)
ordering and##6##2##(1997-7#1)(2008-3#1)(2008-7#1)(2009-11#2)(2013-1#1)
ordering in##4##2##(2008-3#1)(2008-8#1)(2009-11#1)(2012-2#1)
ordering of InGaAs##2##3##(2009-11#2)
ordering of the##6##3##(1993-11#1)(1996-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-3#1)
ordering of##16##2##(1992-9#2)(1993-11#1)(1996-10#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#3)(2010-3#1)(2013-1#1)
ordering with##2##2##(1992-6#1)(2008-10#1)
ordering##48##1##(1990-12#1)(1992-6#3)(1992-9#2)(1993-11#1)(1995-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#7)(2009-5#1)(2010-3#2)(2012-2#3)(2013-1#4)
orderly##12##1##(1991-3#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2012-2#1)(2013-8#1)
orders and##4##2##(2008-2#1)(2008-3#1)(2011-2#2)
orders are##4##2##(1994-3#1)(1995-2#1)(2008-3#2)
orders can be##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
orders can##4##2##(1995-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
orders for##2##2##(2008-10#2)
orders in the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
orders in##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-8#1)
orders is##2##2##(2008-3#1)(2011-2#1)
orders of magnitude (i##2##4##(2008-10#2)
orders of magnitude and##7##4##(2007-12#2)(2008-10#4)(2008-3#1)
orders of magnitude as##2##4##(1992-6#1)(2007-11#1)
orders of magnitude below##2##4##(1990-11#1)(2008-2#1)
orders of magnitude by##3##4##(2008-3#1)(2009-11#1)(2010-5#1)
orders of magnitude faster##2##4##(1995-2#1)(2008-3#1)
orders of magnitude for##2##4##(2007-12#1)(2008-10#1)
orders of magnitude from##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
orders of magnitude greater than##2##5##(1995-6#1)(2008-3#1)
orders of magnitude higher than that of the##2##8##(2007-12#1)(2008-10#1)
orders of magnitude higher than that of##3##7##(1992-8#1)(2007-12#1)(2008-10#1)
orders of magnitude higher than those##3##6##(1990-7#1)(2008-10#1)(2012-2#1)
orders of magnitude higher than##8##5##(1990-7#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2012-2#1)
orders of magnitude higher##9##4##(1990-7#1)(1992-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2012-2#1)
orders of magnitude in##5##4##(1990-5#1)(2008-2#1)(2008-3#2)(2010-8#1)
orders of magnitude larger than the##2##6##(2008-2#1)(2011-1#1)
orders of magnitude larger than##6##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
orders of magnitude less##3##4##(1997-2#1)(2008-11#1)(2008-3#1)
orders of magnitude lower than##6##5##(1990-11#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
orders of magnitude lower##7##4##(1990-11#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
orders of magnitude more sensitive##2##5##(2008-11#1)(2008-8#1)
orders of magnitude of##2##4##(2008-10#2)
orders of magnitude relative to##2##5##(1994-5#1)(1995-2#1)
orders of magnitude smaller than##2##5##(2008-10#1)(2008-2#1)
orders of magnitude than##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
orders of magnitude when##2##4##(2008-10#2)
orders of magnitude with detection limits##2##6##(2008-10#2)
orders of magnitude with##5##4##(2008-10#4)(2009-11#1)
orders of magnitude##131##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-5#3)(1995-2#2)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-11#8)(2007-12#12)(2008-10#46)(2008-11#2)(2008-2#9)(2008-3#18)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#3)(2012-3#1)
orders of magnitude)##3##3##(1995-2#1)(2008-10#2)
orders of scattering##2##3##(2008-3#2)
orders of the##4##3##(1996-1#1)(2008-3#3)
orders of##155##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-5#3)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#11)(2007-12#14)(2008-1#1)(2008-10#49)(2008-11#2)(2008-2#10)(2008-3#27)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-2#3)(2012-3#1)
orders that##2##2##(2007-12#1)(2008-3#1)
orders were##6##2##(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
orders with##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
orders##251##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#3)(1992-3#5)(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#3)(1995-2#6)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#14)(2007-12#18)(2007-5#1)(2008-1#1)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#22)(2008-3#50)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#2)(2013-8#2)
ordinal data##6##2##(1995-9#1)(1996-3#1)(2008-10#4)
ordinal logistic##2##2##(2008-4#1)(2011-2#1)
ordinal responses##3##2##(1993-11#1)(1995-9#1)(1996-3#1)
ordinal scale##3##2##(1995-9#1)(2008-10#1)(2012-1#1)
ordinal##26##1##(1993-11#1)(1995-9#4)(1996-3#2)(1997-4#2)(1997-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
ordinances##2##1##(1996-1#2)
ordinarily##8##1##(1990-5#1)(1991-12#1)(1992-6#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-3#2)
ordinary UV##2##2##(2008-10#2)
ordinary and extraordinary##3##3##(2008-2#2)(2008-3#1)
ordinary and##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
ordinary differential equations##5##3##(2007-12#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-8#1)
ordinary hospital wards##2##3##(1992-6#2)
ordinary least squares regression##3##4##(1993-12#1)(2008-11#1)(2011-2#1)
ordinary least squares##6##3##(1992-6#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
ordinary mean estimator and##2##4##(2008-10#2)
ordinary runs##2##2##(2008-10#2)
ordinary serous and##2##3##(2008-7#2)
ordinary serous##3##2##(2008-7#3)
ordinary strain##2##2##(2008-10#2)
ordinary subjects##2##2##(1991-5#2)
ordinary wards##2##2##(1992-6#2)
ordinary##90##1##(1990-11#1)(1990-6#1)(1991-5#2)(1991-6#3)(1992-5#1)(1992-6#5)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-12#6)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
ordinate##2##1##(2008-10#1)(2008-3#1)
ore and##2##2##(2008-10#2)
ore body rock sample##2##4##(2013-8#2)
ore body rock##6##3##(2013-8#6)
ore body rock--&gt##2##3##(2013-8#2)
ore body##8##2##(2013-8#8)
ore or##2##2##(2008-10#2)
ore samples##10##2##(2007-12#1)(2008-10#9)
ore##37##1##(1990-12#1)(2007-12#2)(2008-10#22)(2013-1#2)(2013-8#10)
ores and##4##2##(2008-10#4)
ores##17##1##(2008-10#15)(2008-12#1)(2008-9#1)
orfs##2##1##(1997-7#2)
org##10##1##(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)(2012-2#1)
org)##10##1##(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-7#1)
org/10##5##1##(2013-8#5)
org/catalog/pubdates##35##1##(2011-1#15)(2011-2#10)(2012-1#10)
organ and the##3##3##(1994-11#1)(1994-5#1)(2011-2#1)
organ and##7##2##(1990-3#1)(1993-12#1)(1994-11#1)(1994-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
organ and/or##2##2##(1991-6#1)(1992-5#1)
organ bath containing Tyrode solution##2##5##(2008-12#1)(2011-1#1)
organ bath experiments##2##3##(1997-4#1)(2009-5#1)
organ bath##5##2##(1993-8#1)(1997-4#1)(2008-12#1)(2009-5#1)(2011-1#1)
organ baths##2##2##(2007-10#1)(2010-3#1)
organ blood flow##2##3##(1991-2#1)(2008-10#1)
organ culture##7##2##(1993-12#1)(1994-2#1)(1995-3#2)(1995-8#2)(2008-11#1)
organ cultures from##2##3##(1991-12#1)(2008-5#1)
organ cultures of##2##3##(1993-8#1)(1997-3#1)
organ cultures##6##2##(1991-12#1)(1993-8#1)(1997-3#1)(2008-11#2)(2008-5#1)
organ damage in##3##3##(1992-6#1)(2008-1#1)(2009-1#1)
organ damage##12##2##(1991-9#1)(1992-6#1)(1994-6#1)(1995-8#1)(2008-1#1)(2009-1#4)(2011-2#1)(2012-12#1)(2012-2#1)
organ donation##15##2##(1991-3#1)(1992-1#1)(1993-2#1)(1994-5#1)(1995-5#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-12#3)(2008-4#2)(2011-2#1)(2012-2#1)
organ donations##2##2##(1993-2#1)(1994-7#1)
organ donors##7##2##(1991-3#1)(2007-8#1)(2008-12#2)(2010-11#2)(2010-12#1)
organ dysfunction##5##2##(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
organ failure and##2##3##(2013-1#2)
organ failure##12##2##(1996-3#1)(1997-1#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#5)
organ for the##2##3##(1996-5#1)(2008-11#1)
organ for##7##2##(1992-12#1)(1996-5#1)(2007-12#2)(2008-11#1)(2011-1#1)(2012-2#1)
organ function##6##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-9#1)(2013-1#1)
organ functions##3##2##(2010-1#1)(2010-11#1)(2013-1#1)
organ growth rates##3##3##(2008-8#3)
organ has##2##2##(1997-1#1)(2007-12#1)
organ in##4##2##(1995-3#1)(2008-7#2)(2010-2#1)
organ injury##4##2##(2008-12#2)(2012-3#1)(2013-1#1)
organ involvement##6##2##(1995-11#1)(1997-8#1)(2008-5#1)(2010-12#2)(2013-1#1)
organ is##3##2##(1992-3#1)(2008-11#1)(2008-9#1)
organ itself##2##2##(1993-12#1)(1994-5#1)
organ of Corti##5##3##(1993-9#2)(1994-6#2)(2008-1#1)
organ of the##3##3##(2007-12#1)(2008-5#1)(2011-1#1)
organ of##19##2##(1990-5#1)(1992-9#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#2)(2007-12#3)(2008-1#1)(2008-11#1)(2008-5#3)(2010-10#1)(2011-1#1)(2011-2#1)
organ preservation##3##2##(1997-2#1)(2007-8#1)(2011-3#1)
organ prolapse##3##2##(2008-12#3)
organ samples##2##2##(2008-10#1)(2008-5#1)
organ sites##2##2##(2008-6#1)(2009-10#1)
organ specific##3##2##(2008-10#1)(2008-8#1)(2009-3#1)
organ system##2##2##(1990-11#1)(2008-7#1)
organ systems##14##2##(1990-11#1)(1993-2#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
organ that##3##2##(2008-3#1)(2008-7#1)(2009-6#1)
organ to##2##2##(2010-5#1)(2013-1#1)
organ transplant recipients##9##3##(1991-11#1)(1997-2#1)(2007-12#4)(2008-10#1)(2008-6#2)
organ transplant##11##2##(1991-11#1)(1997-2#1)(2007-12#4)(2008-10#1)(2008-6#2)(2013-1#1)(2013-8#1)
organ transplantation##11##2##(1996-11#1)(1996-2#1)(1997-5#2)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-3#1)(2009-9#1)(2011-3#1)
organ transplants##4##2##(1991-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
organ weights##7##2##(2008-10#4)(2008-9#2)(2010-7#1)
organ##362##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#6)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-2#4)(1994-5#13)(1994-6#3)(1994-7#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-8#3)(2007-10#3)(2007-11#3)(2007-12#18)(2007-7#3)(2007-8#3)(2008-1#6)(2008-10#18)(2008-11#10)(2008-12#14)(2008-2#5)(2008-3#2)(2008-4#6)(2008-5#17)(2008-6#3)(2008-7#16)(2008-8#7)(2008-9#14)(2009-1#4)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#13)(2011-3#5)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#16)(2013-8#2)
organ-derived##2##1##(1992-9#2)
organ-specific##12##1##(1992-9#3)(1994-5#1)(1996-10#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
organ-tropism##2##1##(1997-4#2)
organellar##6##1##(1990-12#1)(1995-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-3#1)
organelle and##2##2##(1994-8#1)(2008-10#1)
organelle function##2##2##(2008-1#1)(2008-9#1)
organelle##34##1##(1991-8#1)(1992-5#1)(1994-6#1)(1994-8#1)(1996-9#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#3)(2008-7#4)(2008-9#2)(2009-10#2)(2009-5#2)(2011-2#4)(2012-2#1)(2012-3#1)
organelles and##5##2##(2008-3#1)(2008-4#1)(2008-7#2)(2012-1#1)
organelles are##2##2##(2008-2#1)(2008-5#1)
organelles in the##3##3##(2008-11#1)(2008-8#1)(2009-10#1)
organelles in##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)
organelles or##3##2##(1993-11#1)(2008-4#1)(2008-7#1)
organelles such as##2##3##(1994-11#1)(2009-8#1)
organelles that##4##2##(1994-8#1)(2008-1#2)(2009-10#1)
organelles##74##1##(1990-11#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-9#1)(1996-9#1)(1997-6#1)(2007-12#4)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#3)(2009-10#4)(2009-5#2)(2009-8#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)
organgenesis and##2##2##(2008-8#1)(2008-9#1)
organgenesis##3##1##(2008-8#2)(2008-9#1)
organic Ca2+ channel blockers##2##4##(1990-7#1)(1996-2#1)
organic acid anhydrides##2##3##(1995-11#2)
organic acid##9##2##(1994-9#1)(1995-11#2)(2008-10#5)(2008-7#1)
organic acids and##5##3##(2008-10#5)
organic acids in##11##3##(1990-8#1)(1994-9#3)(2008-10#5)(2008-4#1)(2013-8#1)
organic acids like##3##3##(2008-10#1)(2008-7#2)
organic acids##41##2##(1990-8#1)(1992-3#2)(1993-9#1)(1994-9#5)(1995-5#1)(1996-12#1)(2008-10#20)(2008-4#3)(2008-5#1)(2008-7#3)(2012-3#1)(2013-1#1)(2013-8#1)
organic additives and##2##3##(1994-9#1)(2012-12#1)
organic additives##5##2##(1994-9#2)(2008-10#2)(2012-12#1)
organic amendments##6##2##(2008-10#6)
organic amine##4##2##(2008-10#4)
organic amines##3##2##(2008-10#3)
organic and aqueous##3##3##(2008-10#3)
organic and biological##3##3##(2008-10#2)(2012-2#1)
organic and elemental##2##3##(2008-10#2)
organic and inorganic anions##4##4##(2008-10#4)
organic and inorganic semiconductors##2##4##(2008-7#2)
organic and inorganic##21##3##(1997-3#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-7#2)(2009-7#1)(2010-4#1)
organic and##35##2##(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#23)(2008-11#2)(2008-3#1)(2008-7#2)(2009-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
organic anions##5##2##(1992-3#1)(2008-10#2)(2008-11#2)
organic arsenic##4##2##(2008-10#4)
organic bases##2##2##(2008-10#2)
organic carbon (TOC)##2##3##(2008-10#2)
organic carbon and##2##3##(2008-10#1)(2008-12#1)
organic carbon##18##2##(2008-10#12)(2008-12#6)
organic causes##2##2##(1993-2#1)(1997-2#1)
organic chemicals##5##2##(2008-10#3)(2008-11#1)(2009-8#1)
organic chemistry##2##2##(1997-4#1)(2008-10#1)
organic chromophore##3##2##(2008-3#1)(2008-5#2)
organic coffee farms##2##3##(2008-5#2)
organic coffee##4##2##(2008-5#2)(2008-6#2)
organic compound##5##2##(1993-8#1)(2008-3#1)(2011-1#1)(2012-8#1)(2013-8#1)
organic compounds (VOCs)##8##3##(2007-11#1)(2008-10#6)(2011-1#1)
organic compounds and##4##3##(2008-10#3)(2008-7#1)
organic compounds are##3##3##(2008-10#3)
organic compounds at##2##3##(2008-10#2)
organic compounds from##5##3##(2008-10#5)
organic compounds in##7##3##(2008-10#4)(2008-11#1)(2011-1#1)(2013-1#1)
organic compounds were##2##3##(2008-10#2)
organic compounds##89##2##(1992-5#1)(1995-6#1)(2007-11#2)(2008-10#68)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-8#1)(2013-1#1)(2013-8#1)
organic constituents##4##2##(2008-10#3)(2008-7#1)
organic contaminants in the##2##4##(2008-10#2)
organic contaminants in##4##3##(1994-3#1)(2008-10#3)
organic contaminants##5##2##(1994-3#2)(2008-10#3)
organic content and##2##3##(1995-3#1)(2008-12#1)
organic content##4##2##(1995-3#1)(2008-10#2)(2008-12#1)
organic cosolvent##2##2##(2008-10#1)(2010-2#1)
organic crystal##5##2##(2007-12#5)
organic disease##2##2##(1992-11#1)(2008-10#1)
organic disorders##2##2##(2007-7#1)(2007-8#1)
organic dust##5##2##(1995-11#3)(1995-8#1)(2008-10#1)
organic dusts##2##2##(2008-10#1)(2008-11#1)
organic dye##5##2##(2008-10#4)(2008-2#1)
organic dyes in##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
organic dyes##13##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2009-10#1)(2010-4#1)
organic electro-optic##2##2##(2007-12#2)
organic fields##2##2##(2008-10#2)
organic film##2##2##(2008-2#2)
organic fraction of##4##3##(2008-10#4)
organic fraction##5##2##(2008-10#5)
organic geochemistry##2##2##(2008-11#2)
organic group##3##2##(1996-5#1)(2008-10#2)
organic heart##2##2##(1990-3#2)
organic impurities##2##2##(2008-3#2)
organic ion##3##2##(1994-5#1)(2008-10#2)
organic ionic salt##2##3##(2007-12#2)
organic ligand##3##2##(2008-10#3)
organic ligands##8##2##(2008-10#8)
organic liquid##3##2##(2008-10#3)
organic loading rates##2##3##(2008-6#1)(2013-1#1)
organic loading##4##2##(2008-6#1)(2008-7#1)(2013-1#2)
organic material##5##2##(1997-4#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-9#1)
organic materials and##2##3##(1997-2#1)(2008-7#1)
organic materials are##2##3##(2008-3#1)(2008-7#1)
organic materials from##2##3##(1997-2#1)(2008-10#1)
organic materials##11##2##(1991-7#1)(1995-3#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)
organic matrices##2##2##(2008-10#2)
organic matrix in##2##3##(2011-2#1)(2013-8#1)
organic matrix of##2##3##(2008-10#1)(2008-7#1)
organic matrix##7##2##(2008-10#2)(2008-7#2)(2009-7#1)(2011-2#1)(2013-8#1)
organic matter (DOM)##5##3##(2008-10#4)(2008-11#1)
organic matter and##6##3##(2008-10#2)(2008-12#2)(2008-2#1)(2011-2#1)
organic matter are##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
organic matter by##2##3##(2008-11#1)(2008-3#1)
organic matter content and##2##4##(2008-10#2)
organic matter content##7##3##(2008-10#6)(2008-5#1)
organic matter decomposition##2##3##(2008-11#2)
organic matter from##2##3##(2008-10#1)(2013-8#1)
organic matter in##2##3##(2008-11#2)
organic matter on##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
organic matter was##3##3##(2008-10#3)
organic matter were##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
organic matter##83##2##(1992-5#2)(2007-12#1)(2008-10#40)(2008-11#11)(2008-12#5)(2008-2#5)(2008-3#4)(2008-5#5)(2008-6#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#4)
organic matter)##2##2##(2011-2#1)(2012-2#1)
organic matters##2##2##(2008-10#1)(2008-12#1)
organic mercury species##2##3##(2008-10#2)
organic mercury##9##2##(1993-6#1)(2008-10#8)
organic microdrop##2##2##(2008-10#2)
organic modifier and##5##3##(2008-10#5)
organic modifier##15##2##(1990-8#1)(1994-9#1)(1996-5#1)(2008-10#12)
organic moieties##2##2##(1997-2#1)(2008-10#1)
organic molecular##3##2##(2008-3#2)(2009-11#1)
organic molecules##17##2##(1994-2#1)(1997-6#2)(2007-11#2)(2008-10#3)(2008-9#3)(2009-11#2)(2010-11#2)(2010-2#1)(2013-8#1)
organic monolayers##2##2##(1992-8#1)(1994-9#1)
organic nanocolloids##2##2##(2011-2#2)
organic nitrates##4##2##(1991-9#3)(1994-2#1)
organic nitrogen sources##2##3##(1995-9#2)
organic nitrogen##3##2##(1995-9#2)(2008-10#1)
organic optical##2##2##(2007-12#1)(2008-3#1)
organic osmolytes##2##2##(2008-7#1)(2013-1#1)
organic peroxides##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
organic phase containing##2##3##(2008-10#2)
organic phase in the##2##4##(2008-10#2)
organic phase of##2##3##(2008-10#1)(2013-1#1)
organic phase through##2##3##(2008-7#1)(2010-4#1)
organic phase was##4##3##(1992-10#1)(2008-10#3)
organic phase with 1##2##4##(2008-10#2)
organic phase with##5##3##(2008-10#5)
organic phase##55##2##(1992-10#1)(1994-3#1)(1994-8#1)(2008-10#47)(2008-7#1)(2010-4#3)(2013-1#1)
organic phases were##2##3##(1994-3#1)(2008-10#1)
organic phases##8##2##(1994-3#1)(2008-10#6)(2010-4#1)
organic phosphate##4##2##(1990-8#1)(1992-3#1)(2008-10#2)
organic phosphates##3##2##(1990-8#1)(1994-3#1)(2008-10#1)
organic phosphorus##15##2##(1995-11#1)(2008-10#14)
organic phthalates##2##2##(2008-11#2)
organic pollutants (POPs)##2##3##(2008-10#1)(2008-7#1)
organic pollutants in##2##3##(2008-10#2)
organic pollutants##13##2##(1997-4#1)(2008-10#7)(2008-11#2)(2008-7#2)(2010-5#1)
organic polyanions##2##2##(2008-10#2)
organic polymer##4##2##(2008-10#3)(2008-3#1)
organic polymers##2##2##(2008-10#1)(2008-2#1)
organic potato##2##2##(2008-10#2)
organic scaffolds##3##2##(2008-9#1)(2010-12#1)(2012-3#1)
organic silicon sol##4##3##(2008-10#4)
organic silicon##5##2##(2008-10#5)
organic small molecules##4##3##(2008-10#4)
organic soil##2##2##(2008-10#1)(2008-5#1)
organic solutions##2##2##(2008-10#2)
organic solvent and##8##3##(1996-5#1)(2008-10#6)(2008-8#1)
organic solvent as##2##3##(2008-10#2)
organic solvent consumption##2##3##(2008-10#2)
organic solvent extraction##2##3##(2008-10#1)(2008-9#1)
organic solvent has been##2##4##(2008-10#1)(2010-11#1)
organic solvent in##2##3##(2008-10#2)
organic solvent is##3##3##(2008-10#3)
organic solvent modifier##2##3##(2008-10#2)
organic solvent stable proteases##2##4##(2013-1#2)
organic solvent was##4##3##(2008-10#4)
organic solvent##77##2##(1990-5#3)(1992-3#2)(1994-12#2)(1996-5#1)(2008-10#56)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2013-1#4)
organic solvents as the extractants##2##5##(2008-10#2)
organic solvents as##4##3##(2008-10#4)
organic solvents for##2##3##(2008-5#1)(2013-1#1)
organic solvents in##3##3##(1996-5#1)(2008-10#2)
organic solvents on##2##3##(2008-10#1)(2011-1#1)
organic solvents or##2##3##(2008-4#1)(2012-2#1)
organic solvents to##3##3##(1995-3#1)(2008-10#2)
organic solvents were##2##3##(2008-10#2)
organic solvents with##2##3##(2008-10#1)(2008-2#1)
organic solvents##76##2##(1990-12#1)(1990-5#1)(1990-8#2)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-5#1)(2007-11#1)(2008-10#42)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#5)
organic species##4##2##(2008-10#4)
organic substances##3##2##(2008-10#3)
organic substrate##3##2##(2008-10#3)
organic substrates and##2##3##(2008-10#1)(2009-4#1)
organic substrates in##2##3##(1990-9#1)(2008-7#1)
organic substrates##5##2##(1990-9#1)(2008-10#2)(2008-7#1)(2009-4#1)
organic sulfur##3##2##(2008-10#2)(2008-6#1)
organic synthesis##10##2##(1992-11#1)(1997-4#4)(2006-12#1)(2008-10#2)(2009-12#1)(2012-2#1)
organic thin film##3##3##(2007-11#3)
organic thin films##4##3##(2008-3#4)
organic thin##7##2##(2007-11#3)(2008-3#4)
organic vapors investigated##3##3##(2008-10#3)
organic vapors##5##2##(2008-10#5)
organic wastes##2##2##(2008-12#1)(2008-6#1)
organic xenobiotics in##2##3##(2008-11#2)
organic##1032##1##(1990-12#1)(1990-3#3)(1990-5#4)(1990-7#1)(1990-8#6)(1990-9#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#6)(1992-5#6)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#12)(1995-11#6)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-5#5)(1996-6#1)(1997-2#5)(1997-3#1)(1997-4#9)(1997-6#2)(2006-12#1)(2007-11#12)(2007-12#21)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#582)(2008-11#39)(2008-12#17)(2008-2#12)(2008-3#29)(2008-4#5)(2008-5#22)(2008-6#11)(2008-7#41)(2008-8#3)(2008-9#7)(2009-10#6)(2009-11#4)(2009-12#1)(2009-4#2)(2009-7#3)(2009-8#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#10)(2010-5#3)(2010-6#1)(2011-1#6)(2011-2#13)(2012-12#4)(2012-2#5)(2012-3#2)(2012-8#3)(2013-1#16)(2013-7#2)(2013-8#12)
organic-inorganic hybrid multilayers##2##3##(2008-10#2)
organic-inorganic##7##1##(2008-10#3)(2008-5#3)(2008-7#1)
organic-phase##2##1##(2008-10#1)(2008-6#1)
organic/inorganic##3##1##(2008-7#2)(2009-7#1)
organically managed##2##2##(2008-10#2)
organically modified silane##2##3##(2007-12#1)(2008-3#1)
organically modified silicate##2##3##(2008-10#2)
organically modified sol-gel glass##2##4##(2008-10#2)
organically modified##9##2##(2007-12#1)(2008-10#6)(2008-3#1)(2011-1#1)
organically##15##1##(1994-8#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
organics in##2##2##(2008-10#1)(2011-1#1)
organics##5##1##(2008-10#2)(2008-2#1)(2008-6#1)(2011-1#1)
organisation and##5##2##(1990-6#1)(1991-6#1)(1994-12#1)(2008-1#1)(2012-3#1)
organisation in##4##2##(1991-7#1)(1992-2#1)(2007-8#1)(2010-10#1)
organisation is##3##2##(2008-6#1)(2009-6#1)(2010-10#1)
organisation of the##4##3##(1990-11#1)(1994-12#1)(2007-10#1)(2009-7#1)
organisation of these##2##3##(1990-5#1)(1991-7#1)
organisation of##15##2##(1990-11#1)(1990-5#1)(1991-7#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#2)(2010-10#1)(2012-1#1)
organisation##43##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-6#1)(1991-7#2)(1992-2#1)(1993-6#1)(1994-12#3)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#6)(2008-6#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#3)(2012-1#1)(2012-3#1)
organisational and##3##2##(2008-11#3)
organisational##18##1##(1990-12#1)(1994-3#1)(2007-10#1)(2008-11#7)(2008-12#2)(2008-2#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)
organisations and the##2##3##(1997-7#1)(2010-3#1)
organisations and##5##2##(1997-7#1)(2010-3#2)(2011-2#1)(2012-12#1)
organisations are##2##2##(2008-1#1)(2013-1#1)
organisations as##2##2##(2012-2#1)(2013-1#1)
organisations can##2##2##(2008-11#1)(2008-6#1)
organisations in##4##2##(1990-12#1)(2008-12#1)(2013-1#2)
organisations will##2##2##(2008-7#1)(2010-8#1)
organisations##41##1##(1990-12#1)(1997-7#2)(2007-2#8)(2008-1#1)(2008-11#3)(2008-12#3)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#4)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
organise##2##1##(2008-11#1)(2008-6#1)
organised by the European Commission and Ecoles des Mines d'Alès##2##10##(2008-10#2)
organised by the European##3##4##(2008-10#3)
organised by##4##2##(2008-10#3)(2008-5#1)
organised##12##1##(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-12#1)(2008-10#5)(2008-5#1)(2012-12#1)
organising##3##1##(1995-2#1)(2008-11#1)(2011-2#1)
organism Rhodopirellula baltica##2##3##(2011-1#2)
organism against##3##2##(1995-5#1)(2008-11#1)(2008-7#1)
organism and the##3##3##(1990-6#1)(2009-12#1)(2013-1#1)
organism and##13##2##(1990-6#1)(1990-8#2)(1994-5#1)(1995-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
organism are##7##2##(1991-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)
organism before##2##2##(1991-9#1)(2008-7#1)
organism by##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
organism from##3##2##(1991-6#1)(1994-11#1)(2009-2#1)
organism has##2##2##(2007-8#1)(2012-3#1)
organism in the##2##3##(1996-11#1)(1996-8#1)
organism in##9##2##(1991-11#1)(1996-11#1)(1996-8#1)(1997-1#1)(2008-12#1)(2011-2#3)(2013-1#1)
organism is##12##2##(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-2#3)
organism of##4##2##(2008-10#3)(2008-5#1)
organism that##3##2##(1996-6#1)(2008-5#1)(2011-2#1)
organism to study##2##3##(2008-11#1)(2013-8#1)
organism to##13##2##(1990-8#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-2#2)(2011-2#1)(2013-8#1)
organism was##8##2##(1990-2#1)(1992-5#1)(1996-8#1)(2007-7#2)(2007-8#1)(2008-5#2)
organism with##4##2##(2008-10#3)(2011-2#1)
organism##249##1##(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-11#2)(1991-6#2)(1991-9#4)(1992-2#1)(1992-5#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#3)(1997-7#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#10)(2008-7#17)(2008-8#11)(2008-9#13)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#3)(2009-8#4)(2009-9#3)(2010-11#4)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#2)(2010-9#1)(2011-1#6)(2011-2#45)(2012-12#1)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#3)
organism's ability to##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
organism's genetic##2##2##(1994-11#1)(2012-2#1)
organism's##13##1##(1994-11#1)(1994-8#1)(1995-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
organism-level##2##1##(2008-9#1)(2009-12#1)
organismal##3##1##(2010-5#1)(2012-12#1)(2012-3#1)
organismic##2##1##(1997-2#1)(2008-11#1)
organisms against##2##2##(2008-10#1)(2013-8#1)
organisms and cell##2##3##(2008-11#1)(2008-6#1)
organisms and other##2##3##(2008-8#1)(2012-2#1)
organisms and##26##2##(1990-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2012-2#3)(2012-3#2)
organisms are##7##2##(1993-6#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)
organisms as##3##2##(2008-10#1)(2009-5#1)(2012-2#1)
organisms at##2##2##(2008-9#1)(2012-12#1)
organisms by##4##2##(1992-2#1)(2007-7#1)(2008-7#1)(2012-2#1)
organisms can be used##2##4##(2008-10#1)(2008-2#1)
organisms can be##5##3##(2008-10#1)(2008-2#1)(2008-9#2)(2012-3#1)
organisms can##7##2##(1990-2#1)(2008-10#1)(2008-2#1)(2008-9#3)(2012-3#1)
organisms causing serious infections in the hospital##2##7##(2008-7#2)
organisms causing serious infections in##3##5##(2008-7#3)
organisms causing##4##2##(2007-12#1)(2008-7#3)
organisms could##2##2##(2008-8#1)(2009-6#1)
organisms exhibit##2##2##(1990-8#1)(2007-7#1)
organisms exposed##2##2##(2008-11#2)
organisms for##7##2##(2007-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
organisms from the##2##3##(1992-4#1)(2008-10#1)
organisms from##3##2##(1992-4#1)(2008-10#2)
organisms has been##2##3##(2008-11#1)(2008-4#1)
organisms has##4##2##(2008-11#1)(2008-4#1)(2008-9#2)
organisms have been##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
organisms have##9##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
organisms in a##6##3##(1994-11#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
organisms in the##6##3##(2008-10#3)(2011-1#1)(2011-2#2)
organisms in##22##2##(1990-6#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)
organisms including##3##2##(1994-2#1)(2008-9#1)(2012-2#1)
organisms involved in##2##3##(2007-12#1)(2008-7#1)
organisms involved##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
organisms is##8##2##(2007-12#1)(2007-7#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2013-7#1)
organisms isolated from##2##3##(2007-7#1)(2008-7#1)
organisms may##5##2##(1997-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
organisms of##3##2##(2010-4#1)(2010-6#1)(2011-2#1)
organisms on##3##2##(2008-10#1)(2008-8#1)(2010-4#1)
organisms or##2##2##(2008-5#1)(2013-1#1)
organisms produce##2##2##(2008-10#1)(2008-8#1)
organisms ranging from##3##3##(1994-12#1)(2008-8#1)(2009-8#1)
organisms should be##2##3##(2008-5#1)(2009-2#1)
organisms should##3##2##(2008-5#1)(2008-8#1)(2009-2#1)
organisms such as##5##3##(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#2)
organisms tested##2##2##(1996-12#1)(2013-1#1)
organisms that are##3##3##(2008-10#1)(2008-8#2)
organisms that##13##2##(2008-10#2)(2008-8#5)(2008-9#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
organisms to be##2##3##(2008-10#1)(2008-11#1)
organisms to##11##2##(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2012-2#1)
organisms under##3##2##(2008-11#3)
organisms was##3##2##(1996-11#1)(2008-5#1)(2011-1#1)
organisms were Escherichia coli##2##4##(2007-7#1)(2008-7#1)
organisms were isolated##2##3##(1994-12#1)(1997-3#1)
organisms were##16##2##(1990-6#1)(1993-2#1)(1994-12#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2011-2#1)
organisms when##3##2##(1992-6#1)(1994-11#1)(2011-2#1)
organisms will##2##2##(1997-7#1)(2008-2#1)
organisms with a##2##3##(2008-8#2)
organisms with##9##2##(1990-7#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)
organisms##446##1##(1990-11#1)(1990-2#1)(1990-6#3)(1990-7#2)(1990-8#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#3)(1993-2#4)(1993-6#2)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-9#2)(1996-11#3)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#4)(2007-11#4)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#10)(2007-8#1)(2008-10#51)(2008-11#19)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#26)(2008-6#6)(2008-7#39)(2008-8#45)(2008-9#34)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#6)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#3)(2010-9#2)(2011-1#4)(2011-2#26)(2012-1#1)(2012-12#4)(2012-2#14)(2012-3#9)(2013-1#6)(2013-7#3)(2013-8#3)
organisms?##2##1##(2009-12#1)(2010-9#1)
organization &quot##2##2##(1994-1#1)(1996-2#1)
organization and a##2##3##(1992-2#1)(2008-10#1)
organization and cell##3##3##(1994-8#1)(2009-5#1)(2013-1#1)
organization and distribution##2##3##(1996-12#1)(2009-8#1)
organization and evolution##2##3##(1994-11#1)(2008-8#1)
organization and fee-for-service##2##3##(1991-3#1)(1993-12#1)
organization and implementation of##2##4##(1996-2#1)(2008-12#1)
organization and nucleotide##2##3##(1993-6#1)(1994-12#1)
organization and the##6##3##(1990-2#1)(1990-5#1)(1991-12#1)(1994-1#1)(2013-1#2)
organization and##63##2##(1990-2#2)(1990-5#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
organization are##8##2##(1990-5#1)(1991-6#1)(1992-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1997-2#1)(2012-3#1)
organization as well as the##3##5##(1993-12#1)(1993-3#1)(2009-8#1)
organization as well as##4##4##(1993-12#1)(1993-3#1)(1995-2#1)(2009-8#1)
organization as##7##2##(1993-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-2#1)(2008-1#1)(2009-8#1)
organization at##2##2##(2008-12#1)(2008-9#1)
organization between##2##2##(1995-11#1)(2008-8#1)
organization by##4##2##(1992-2#1)(2008-7#1)(2009-10#1)(2012-2#1)
organization can##2##2##(1995-3#1)(2008-1#1)
organization developed##2##2##(1996-3#1)(2008-7#1)
organization during the##3##3##(2008-11#1)(2010-4#1)(2011-2#1)
organization during##5##2##(1995-12#1)(2008-11#2)(2010-4#1)(2011-2#1)
organization for##2##2##(1990-6#1)(1993-12#1)
organization has##2##2##(1994-12#1)(2008-8#1)
organization in the##10##3##(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#2)
organization in##24##2##(1990-5#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#1)
organization into the##2##3##(1997-1#1)(2010-9#1)
organization is a##2##3##(1994-12#1)(2008-12#1)
organization is not##2##3##(1992-9#1)(2009-9#1)
organization is to##2##3##(1994-2#1)(2008-7#1)
organization is##18##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-1#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-9#1)
organization may##4##2##(1991-2#1)(1994-1#1)(1996-2#1)(2008-5#1)
organization members##2##2##(1993-12#1)(1996-2#1)
organization might be##2##3##(1992-11#1)(2008-11#1)
organization might##3##2##(1992-11#1)(2008-11#1)(2008-7#1)
organization must be##2##3##(1994-2#1)(1994-3#1)
organization must##5##2##(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)
organization needs to##2##3##(1995-1#1)(1995-12#1)
organization of a##2##3##(1993-3#1)(1997-6#1)
organization of actin filaments##2##4##(2008-1#1)(2009-9#1)
organization of an##2##3##(2007-12#1)(2008-5#1)
organization of behavior##2##3##(1992-11#1)(2008-11#1)
organization of care of diabetics##2##5##(1990-11#2)
organization of care##3##3##(1990-11#2)(2008-2#1)
organization of health##2##3##(1991-9#1)(1997-8#1)
organization of rDNA##2##3##(2008-5#2)
organization of services##3##3##(2008-2#3)
organization of stroke services##2##4##(2008-8#2)
organization of the future##2##4##(1994-12#1)(2011-2#1)
organization of the human##3##4##(1991-6#1)(1996-12#1)(1997-6#1)
organization of the primate##2##4##(1995-5#2)
organization of the stratum corneum##2##5##(2008-10#1)(2008-5#1)
organization of the##71##3##(1990-11#1)(1991-2#2)(1991-6#4)(1992-10#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#5)(1995-6#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#3)
organization of their##3##3##(1995-2#1)(2008-12#1)(2012-2#1)
organization of these##4##3##(2008-2#1)(2008-7#1)(2009-8#1)(2012-2#1)
organization of this##3##3##(1992-3#1)(1993-6#1)(2009-8#1)
organization of##180##2##(1990-11#3)(1990-5#1)(1991-12#1)(1991-2#4)(1991-6#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#7)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#1)(2007-12#9)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#11)(2008-9#4)(2009-10#4)(2009-11#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#4)
organization on##4##2##(1994-1#1)(1995-12#1)(2008-12#1)(2010-9#1)
organization represents##2##2##(1995-3#1)(1997-1#1)
organization structure##3##2##(1994-12#1)(1996-1#1)(1996-2#1)
organization structures##2##2##(1996-2#1)(1996-3#1)
organization that does not##2##4##(1993-1#1)(1996-3#1)
organization that is##2##3##(2008-4#1)(2008-7#1)
organization that##11##2##(1992-12#1)(1992-8#1)(1993-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
organization through##4##2##(1993-12#1)(1995-12#2)(1997-3#1)
organization to a##2##3##(1997-2#2)
organization to##11##2##(1992-3#1)(1995-3#3)(1996-3#1)(1997-2#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)
organization was observed##2##3##(1997-3#1)(2008-11#1)
organization was typical of##2##4##(2008-10#2)
organization was##8##2##(1991-2#1)(1991-6#1)(1997-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
organization were##2##2##(2008-12#1)(2013-1#1)
organization will##2##2##(1996-3#1)(1997-1#1)
organization with a##2##3##(1996-1#1)(2012-3#1)
organization with##7##2##(1993-12#1)(1994-1#1)(1996-1#1)(1997-7#1)(2007-9#1)(2009-10#1)(2012-3#1)
organization within the##2##3##(1991-2#1)(1991-6#1)
organization within##3##2##(1991-2#1)(1991-6#1)(2008-11#1)
organization##655##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#5)(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#12)(1991-3#3)(1991-6#10)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#7)(1992-3#8)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#6)(1993-12#14)(1993-2#6)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#3)(1994-1#17)(1994-11#4)(1994-12#18)(1994-2#12)(1994-3#12)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#9)(1995-11#2)(1995-12#15)(1995-2#13)(1995-3#18)(1995-5#7)(1995-6#4)(1995-8#2)(1996-1#13)(1996-12#8)(1996-2#15)(1996-3#11)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#10)(1997-2#9)(1997-3#14)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#2)(2006-5#1)(2007-10#2)(2007-12#15)(2007-4#1)(2007-8#5)(2007-9#4)(2008-1#10)(2008-10#32)(2008-11#21)(2008-12#13)(2008-2#9)(2008-3#1)(2008-4#5)(2008-5#12)(2008-6#2)(2008-7#24)(2008-8#17)(2008-9#13)(2009-10#10)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#12)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#4)(2010-9#3)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#13)(2012-3#4)(2012-7#1)(2013-1#10)(2013-8#6)
organization's ability to##2##3##(1995-1#1)(1995-3#1)
organization's professional liability##2##3##(1993-1#2)
organization's##27##1##(1991-1#1)(1992-12#1)(1993-1#4)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)(2009-10#1)(2010-8#1)
organization-wide##7##1##(1993-3#1)(1994-1#1)(1995-3#1)(1996-2#3)(2010-8#1)
organization?##2##1##(1995-12#1)(1996-2#1)
organizational and environmental##2##3##(1992-12#2)
organizational and management##2##3##(1992-1#1)(1992-2#1)
organizational and market characteristics##2##4##(2008-11#2)
organizational and##18##2##(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#3)(2009-5#1)(2011-2#1)
organizational aspects##4##2##(1990-11#1)(1992-12#1)(2007-12#1)(2010-9#1)
organizational behavior##2##2##(1996-3#1)(2008-1#1)
organizational behaviour##3##2##(1994-2#1)(1994-3#2)
organizational change and##2##3##(1996-1#1)(2008-12#1)
organizational change##9##2##(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-1#1)(1997-2#1)(2008-12#1)(2008-6#1)(2009-11#1)
organizational changes##7##2##(1991-12#1)(1996-1#1)(2007-6#1)(2009-10#3)(2012-3#1)
organizational characteristics##2##2##(1992-12#1)(2008-11#1)
organizational climate##2##2##(1993-2#1)(2008-11#1)
organizational commitment##9##2##(1993-2#2)(1995-12#1)(1996-1#6)
organizational concern##2##2##(2008-12#2)
organizational conditions##3##2##(2008-10#1)(2013-1#2)
organizational culture##3##2##(1993-1#1)(1993-2#1)(1994-2#1)
organizational design##2##2##(1994-3#1)(1996-2#1)
organizational development##3##2##(1992-12#1)(1993-12#1)(1994-12#1)
organizational dynamics##2##2##(1996-2#2)
organizational effectiveness##3##2##(1992-12#1)(1994-12#1)(1995-1#1)
organizational environment##4##2##(1992-12#3)(2008-11#1)
organizational factors##2##2##(1996-12#1)(2010-8#1)
organizational forms##2##2##(1992-1#1)(2008-7#1)
organizational goals and##2##3##(1993-1#1)(1996-1#1)
organizational goals##3##2##(1993-1#1)(1996-1#1)(1996-3#1)
organizational growth##3##2##(1993-12#1)(1995-12#1)(1997-1#1)
organizational intelligence##2##2##(2008-1#2)
organizational issues##2##2##(1996-2#1)(2007-12#1)
organizational leadership##2##2##(1994-12#1)(2013-1#1)
organizational model for##2##3##(1994-12#1)(1996-1#1)
organizational model##3##2##(1994-12#1)(1995-1#1)(1996-1#1)
organizational needs##2##2##(1993-1#1)(1994-2#1)
organizational objectives##2##2##(1992-2#1)(1994-2#1)
organizational performance##3##2##(1995-1#1)(1995-12#1)(1995-2#1)
organizational perspective##2##2##(1994-12#1)(1996-2#1)
organizational principles##3##2##(2008-7#1)(2012-2#2)
organizational processes##3##2##(1992-12#1)(1993-12#1)(2008-8#1)
organizational purpose##2##2##(1993-1#2)
organizational renewal##3##2##(1995-1#3)
organizational restructuring##2##2##(1992-1#1)(1997-2#1)
organizational skills##2##2##(1995-3#1)(2012-3#1)
organizational structure and##3##3##(1991-3#1)(1997-2#1)(2009-10#1)
organizational structure based on##2##4##(1992-5#1)(1993-2#1)
organizational structure to##2##3##(1996-1#1)(2010-3#1)
organizational structure##21##2##(1991-1#1)(1991-3#1)(1992-5#2)(1993-2#3)(1994-2#2)(1995-1#1)(1995-3#1)(1996-1#2)(1997-2#1)(2008-10#2)(2008-11#2)(2009-10#1)(2010-3#1)(2013-8#1)
organizational structures and##3##3##(1992-2#1)(1993-12#1)(1993-3#1)
organizational structures##9##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(2008-11#1)
organizational support##2##2##(1993-1#1)(2008-9#1)
organizational tenure##2##2##(2010-6#2)
organizational##225##1##(1990-11#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#4)(1992-12#14)(1992-2#4)(1992-5#3)(1993-1#6)(1993-12#5)(1993-2#13)(1993-3#1)(1994-1#4)(1994-12#11)(1994-2#10)(1994-3#4)(1995-1#11)(1995-12#4)(1995-2#1)(1995-3#5)(1996-1#13)(1996-12#4)(1996-2#7)(1996-3#5)(1996-6#1)(1997-1#5)(1997-2#3)(1997-3#1)(2007-12#2)(2007-6#1)(2008-1#4)(2008-10#6)(2008-11#15)(2008-12#8)(2008-2#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#1)(2009-5#1)(2010-10#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
organizational-level##2##1##(2013-1#2)
organizationally##3##1##(1996-2#1)(1997-3#1)(2012-1#1)
organizations across##2##2##(1992-2#1)(1994-2#1)
organizations and may##2##3##(1993-3#1)(2008-11#1)
organizations and other##2##3##(1991-3#1)(1997-2#1)
organizations and the##5##3##(1991-3#2)(1993-10#1)(2008-12#1)(2013-1#1)
organizations and##32##2##(1990-6#1)(1991-3#3)(1992-2#1)(1993-1#1)(1993-10#1)(1993-3#3)(1994-12#1)(1994-3#2)(1995-2#3)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2010-5#1)(2010-8#1)(2013-1#1)
organizations are increasingly##2##3##(1993-3#1)(2008-12#1)
organizations are now##2##3##(1991-3#1)(1993-1#1)
organizations are presented##2##3##(1994-12#1)(1996-1#1)
organizations are##30##2##(1991-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-12#4)(1994-2#2)(1995-1#2)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#2)(2008-12#2)(2008-7#1)(2008-9#1)
organizations as##3##2##(1992-12#1)(2008-1#1)(2008-12#1)
organizations can##10##2##(1992-3#1)(1993-12#3)(1993-2#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-6#1)
organizations could##2##2##(1995-12#1)(2012-3#1)
organizations have##10##2##(1991-1#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(2007-7#1)(2010-8#1)
organizations in a##2##3##(1991-3#1)(1995-3#1)
organizations in the health##2##4##(1995-2#1)(1995-3#1)
organizations in the##5##3##(1995-2#2)(1995-3#1)(1996-1#1)(2008-12#1)
organizations in##16##2##(1991-3#1)(1994-12#2)(1995-2#3)(1995-3#3)(1996-1#1)(1997-2#1)(1997-3#1)(2006-5#1)(2008-12#1)(2008-7#1)(2013-8#1)
organizations involved in##3##3##(2007-5#1)(2008-11#1)(2012-2#1)
organizations involved##5##2##(1994-12#1)(1996-4#1)(2007-5#1)(2008-11#1)(2012-2#1)
organizations is##6##2##(1991-12#1)(1993-1#1)(1993-12#2)(1994-12#1)(1996-3#1)
organizations may##3##2##(1994-12#1)(1995-2#1)(2008-7#1)
organizations must##6##2##(1993-12#1)(1994-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)
organizations need to##3##3##(1993-3#1)(2007-9#1)(2010-7#1)
organizations need##4##2##(1993-3#1)(1995-2#1)(2007-9#1)(2010-7#1)
organizations of the##4##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
organizations should##3##2##(1992-3#1)(1996-1#1)(1997-1#1)
organizations such as the##3##4##(1995-12#1)(2008-10#1)(2010-1#1)
organizations that are##5##3##(1993-12#1)(1994-1#1)(1995-3#1)(1996-2#1)(1996-3#1)
organizations that have##3##3##(1991-3#1)(1996-2#1)(2009-3#1)
organizations that##17##2##(1991-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#3)(1996-3#1)(1997-2#1)(2008-12#2)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#1)
organizations to##14##2##(1992-1#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-2#2)(2011-2#1)(2013-8#1)
organizations use##2##2##(1994-3#1)(1996-12#1)
organizations were##6##2##(1995-1#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-7#1)(2009-5#1)
organizations will##3##2##(1994-1#1)(1995-2#1)(1996-3#1)
organizations with##6##2##(1991-12#1)(1995-1#1)(1996-2#1)(2008-7#3)
organizations within##2##2##(2008-1#1)(2008-6#1)
organizations working##2##2##(1996-4#1)(2008-6#1)
organizations##430##1##(1990-6#1)(1991-1#4)(1991-12#8)(1991-2#2)(1991-3#16)(1992-1#7)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#6)(1993-1#12)(1993-10#1)(1993-11#1)(1993-12#19)(1993-2#7)(1993-3#9)(1994-1#9)(1994-12#29)(1994-2#15)(1994-3#7)(1994-7#2)(1995-1#12)(1995-12#15)(1995-2#14)(1995-3#10)(1995-6#1)(1996-1#15)(1996-12#7)(1996-2#18)(1996-3#16)(1996-4#3)(1997-1#15)(1997-2#13)(1997-3#15)(1997-5#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#10)(2008-12#13)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#15)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#4)
organizations'##4##1##(1992-1#1)(1992-12#1)(1996-3#1)(2008-11#1)
organizations?##2##1##(2008-6#1)(2008-7#1)
organize a##2##2##(1992-1#1)(2013-7#1)
organize information##2##2##(1997-2#1)(2009-8#1)
organize organ donation##2##3##(2008-4#2)
organize the##10##2##(1992-2#1)(1997-7#1)(2008-1#1)(2009-4#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
organize##33##1##(1990-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
organized a##3##2##(1992-12#1)(1994-7#1)(1996-4#1)
organized and##6##2##(1992-3#1)(1993-12#1)(1997-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
organized around##2##2##(1996-1#1)(2008-11#1)
organized as a##6##3##(1995-2#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-1#1)
organized as##9##2##(1993-12#1)(1994-5#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
organized by the International Society of##2##6##(2008-5#1)(2008-8#1)
organized by the##7##3##(1990-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#2)
organized by##23##2##(1990-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-5#1)(2011-2#2)(2013-1#3)
organized in a##5##3##(1991-2#1)(1993-11#1)(1994-2#1)(2008-7#1)(2009-12#1)
organized in the##3##3##(1993-2#1)(1997-2#1)(2007-11#1)
organized in##19##2##(1991-1#1)(1991-2#2)(1993-11#1)(1993-2#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)
organized into a##4##3##(1993-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
organized into six##2##3##(1996-3#1)(2007-8#1)
organized into##23##2##(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#2)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)
organized medical##2##2##(1992-1#1)(1992-3#1)
organized medicine##3##2##(2007-4#1)(2008-4#1)(2008-6#1)
organized parallel##2##2##(2007-12#1)(2008-5#1)
organized similarly to##2##3##(2008-10#2)
organized structures##2##2##(1994-5#1)(2008-7#1)
organized systems of care##2##4##(1994-2#1)(1996-1#1)
organized systems##3##2##(1994-2#1)(1996-1#1)(2012-2#1)
organized the##2##2##(1996-3#1)(2010-1#1)
organized to##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
organized##168##1##(1990-12#1)(1990-6#4)(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#4)(1996-12#1)(1996-3#2)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#1)
organizer of##2##2##(2011-2#1)(2011-4#1)
organizer regions (NORs)##2##3##(1993-12#1)(2008-12#1)
organizer##10##1##(1993-12#1)(2007-12#1)(2008-12#2)(2008-5#2)(2010-5#1)(2011-2#1)(2011-4#1)(2013-1#1)
organizes the##3##2##(1990-11#1)(2007-12#1)(2012-2#1)
organizes##6##1##(1990-11#1)(1994-12#1)(1995-3#1)(2007-12#2)(2012-2#1)
organizing and##5##2##(1992-3#1)(1997-1#1)(2008-12#1)(2010-5#1)(2013-1#1)
organizing centers##2##2##(1991-5#1)(2012-12#1)
organizing pneumonia##4##2##(2008-1#2)(2010-12#2)
organizing principles##2##2##(2008-11#1)(2012-1#1)
organizing region##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
organizing##44##1##(1991-11#1)(1991-5#2)(1992-3#1)(1993-3#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
organocatalytic##3##1##(2008-7#1)(2011-2#2)
organochlorine compounds in##2##3##(2008-10#1)(2008-8#1)
organochlorine compounds##4##2##(2008-10#3)(2008-8#1)
organochlorine pesticides (OCPs)##2##3##(2008-10#2)
organochlorine pesticides are##2##3##(2008-10#1)(2008-7#1)
organochlorine pesticides from##2##3##(2008-10#2)
organochlorine pesticides##10##2##(1997-4#1)(2008-10#8)(2008-7#1)
organochlorine residuals##3##2##(2008-8#3)
organochlorine##21##1##(1997-4#1)(2007-10#1)(2008-10#14)(2008-7#1)(2008-8#4)
organochlorines##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
organofunctional##3##1##(2009-7#3)
organofunctionalized##3##1##(2008-10#3)
organogenesis and##2##2##(1995-8#1)(2010-8#1)
organogenesis in##2##2##(2008-12#1)(2011-2#1)
organogenesis of##3##2##(2008-12#2)(2011-2#1)
organogenesis##16##1##(1995-8#1)(2007-12#1)(2008-12#4)(2008-7#2)(2008-9#2)(2010-8#2)(2011-2#3)(2012-1#1)
organolead compounds##2##2##(2008-10#2)
organoleptic qualities##2##2##(1997-4#1)(2008-5#1)
organoleptic##6##1##(1997-4#1)(2008-10#1)(2008-5#2)(2010-4#1)(2013-8#1)
organolithium compound##2##2##(1996-5#2)
organolithium##4##1##(1996-5#4)
organomercurials##4##1##(1992-2#1)(2008-10#3)
organomercury##2##1##(2008-10#2)
organometallic##6##1##(2008-10#2)(2009-9#1)(2010-12#2)(2012-3#1)
organophilic##3##1##(1992-3#1)(2008-10#2)
organophosphate poisoning##2##2##(2012-2#2)
organophosphate##16##1##(1990-9#1)(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-5#1)(2009-12#1)(2009-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
organophosphates##4##1##(1994-5#2)(2008-10#1)(2009-3#1)
organophosphorous hydrolase##2##2##(2008-10#2)
organophosphorous##12##1##(1994-5#1)(1995-3#1)(2008-10#6)(2010-5#2)(2013-1#2)
organophosphorus compound##2##2##(1997-4#1)(2008-10#1)
organophosphorus compounds##3##2##(1992-2#1)(1996-12#1)(2007-11#1)
organophosphorus pesticide##4##2##(2008-10#4)
organophosphorus pesticides (OPPs)##2##3##(2008-10#2)
organophosphorus pesticides (OPs)##2##3##(2008-10#2)
organophosphorus pesticides such as##2##4##(2008-10#2)
organophosphorus pesticides##16##2##(2008-10#14)(2008-11#1)(2010-4#1)
organophosphorus##36##1##(1992-11#1)(1992-2#2)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#26)(2008-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
organosilane##2##1##(1997-2#1)(2008-10#1)
organosulfur compounds##2##2##(1992-5#1)(2009-11#1)
organotin complexes##2##2##(2008-10#2)
organotin compounds##5##2##(2008-10#5)
organotin##15##1##(2008-10#14)(2008-5#1)
organotin(IV) complexes##2##2##(2008-10#2)
organotins in##2##2##(2008-10#2)
organotins##5##1##(2008-10#5)
organotypic cultures##4##2##(2008-11#1)(2008-4#3)
organotypic##12##1##(2008-11#2)(2008-4#5)(2008-7#1)(2008-9#1)(2009-9#2)(2013-1#1)
organotypical in vitro model##2##4##(2008-11#2)
organs and are##2##3##(2008-4#1)(2013-8#1)
organs and brain regions##2##4##(1994-5#2)
organs and in the##2##4##(2008-10#1)(2008-9#1)
organs and in##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
organs and systems##2##3##(2008-10#1)(2012-3#1)
organs and tissues##11##3##(1990-8#2)(1991-3#2)(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
organs and##33##2##(1990-8#2)(1991-3#2)(1993-8#1)(1993-9#1)(1994-5#2)(1995-12#2)(1996-12#1)(1996-2#1)(1997-7#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
organs are##4##2##(1995-2#1)(2007-12#1)(2008-5#1)(2008-7#1)
organs as well as##3##4##(1992-6#1)(2007-4#1)(2008-10#1)
organs at risk##5##3##(2008-2#2)(2008-6#1)(2011-2#1)(2013-1#1)
organs at##8##2##(2008-10#1)(2008-2#2)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
organs between##2##2##(2008-5#1)(2008-8#1)
organs both##2##2##(1991-2#1)(2008-12#1)
organs during##2##2##(1992-3#1)(2012-12#1)
organs following##2##2##(1996-6#1)(2008-1#1)
organs for transplantation##2##3##(1991-3#1)(1994-1#1)
organs for##7##2##(1991-3#1)(1994-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-4#1)
organs from##4##2##(1993-2#1)(1996-2#1)(1997-4#1)(2011-2#1)
organs have been##2##3##(2008-5#1)(2011-2#1)
organs have##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
organs in the##6##3##(1996-12#1)(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
organs in##12##2##(1991-8#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
organs including the##2##3##(2008-10#1)(2008-7#1)
organs involved in##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
organs involved##5##2##(2008-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#1)
organs is##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-3#1)
organs may##2##2##(1990-7#1)(2007-12#1)
organs of the##5##3##(1995-8#1)(1996-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
organs of##23##2##(1991-5#1)(1991-8#1)(1992-9#1)(1995-8#1)(1996-12#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
organs on the##2##3##(1997-5#1)(2007-12#1)
organs or systems##2##3##(2008-5#1)(2013-1#1)
organs or tissues##2##3##(1995-2#1)(2008-10#1)
organs or##9##2##(1995-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
organs such as##2##3##(2010-11#1)(2012-12#1)
organs that##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
organs to##4##2##(1990-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
organs using##2##2##(2008-7#1)(2008-8#1)
organs was assessed in##2##4##(1990-12#1)(1996-12#1)
organs was##4##2##(1990-12#2)(1996-12#1)(2008-11#1)
organs were collected##2##3##(2008-5#1)(2013-1#1)
organs were##8##2##(1990-7#1)(1993-3#1)(2007-12#2)(2008-11#1)(2008-5#2)(2013-1#1)
organs##326##1##(1990-11#2)(1990-12#3)(1990-5#1)(1990-7#4)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#3)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#4)(1995-11#1)(1995-12#5)(1995-2#4)(1995-8#1)(1996-12#6)(1996-2#4)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#16)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#34)(2008-11#9)(2008-12#11)(2008-2#2)(2008-4#6)(2008-5#19)(2008-6#3)(2008-7#20)(2008-8#9)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#11)(2013-1#9)(2013-7#1)(2013-8#7)
organs/systems involved##2##2##(2008-1#1)(2011-2#1)
organs/tissues##2##1##(2008-10#1)(2010-11#1)
organs]##4##1##(1992-3#1)(1995-11#1)(2012-3#2)
ori lambda##4##2##(1994-11#4)
ori##8##1##(1994-11#4)(1994-12#3)(1996-6#1)
oriC##2##1##(1990-11#2)
oriLyt replication##3##2##(1997-3#3)
oriLyt##11##1##(1997-3#11)
oriP elements##2##2##(2008-11#2)
oriP##4##1##(2008-11#4)
orient the##4##2##(1990-7#1)(1993-3#1)(2008-3#1)(2011-1#1)
orient to##3##2##(2008-10#1)(2011-2#2)
orient##9##1##(1990-7#1)(1993-3#1)(2008-10#1)(2008-3#1)(2009-8#2)(2011-1#1)(2011-2#2)
oriental melon##4##2##(2008-10#4)
oriental##13##1##(1997-8#3)(2008-10#8)(2008-6#1)(2011-2#1)
orientale##4##1##(2012-3#4)
orientalis##3##1##(2008-5#1)(2008-8#2)
orientated##9##1##(2007-10#1)(2008-10#2)(2008-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
orientation about##2##2##(1997-7#1)(2008-11#1)
orientation and angular distribution of##2##5##(2008-10#2)
orientation and chemicals) of the laboratory in which Professor Chiranjeevi worked##2##11##(2008-10#2)
orientation and chemicals) of the laboratory in which##3##8##(2008-10#3)
orientation and for##2##3##(2008-3#1)(2009-8#1)
orientation and sexual behavior##2##4##(2008-12#2)
orientation and size of##2##4##(1996-2#2)
orientation and the##2##3##(2008-8#2)
orientation and##44##2##(1990-12#1)(1991-6#1)(1992-1#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-8#2)(2010-10#1)(2010-3#1)(2013-1#2)
orientation angle of##2##3##(2008-10#2)
orientation angle##6##2##(2008-10#6)
orientation as a##3##3##(2008-12#1)(2009-7#2)
orientation as##4##2##(1991-9#1)(2008-12#1)(2009-7#2)
orientation at the##3##3##(1995-3#1)(1997-3#1)(2008-10#1)
orientation at##6##2##(1995-3#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
orientation averaging##2##2##(2008-3#2)
orientation by##2##2##(1991-3#1)(2008-3#1)
orientation can be##4##3##(1997-3#1)(2007-11#1)(2008-12#1)(2008-3#1)
orientation changes##2##2##(2007-12#1)(2010-3#1)
orientation distribution##2##2##(2008-3#1)(2012-1#1)
orientation does##2##2##(2008-12#1)(2012-2#1)
orientation effects in##2##3##(1992-3#1)(2007-12#1)
orientation for##3##2##(1995-3#1)(2008-10#2)
orientation from##2##2##(1995-12#1)(2008-8#1)
orientation groups##2##2##(2010-11#2)
orientation in the##5##3##(1991-11#1)(1991-2#1)(1997-4#1)(2008-8#1)(2010-4#1)
orientation in##14##2##(1990-11#1)(1991-11#1)(1991-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-2#1)(2010-4#1)
orientation index##2##2##(2008-8#1)(2008-9#1)
orientation is a##2##3##(1993-12#1)(1997-3#1)
orientation is##11##2##(1991-2#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-2#3)
orientation map##2##2##(2008-11#1)(2010-2#1)
orientation maps##3##2##(2008-11#1)(2010-2#2)
orientation of CaD*##2##3##(1994-5#2)
orientation of a##3##3##(2008-10#1)(2008-2#2)
orientation of the particles##3##4##(2008-3#3)
orientation of the##45##3##(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-4#1)(2006-4#1)(2007-11#7)(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#14)(2008-4#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-5#2)(2013-8#1)
orientation of##91##2##(1990-11#1)(1991-10#1)(1992-6#1)(1993-11#2)(1993-3#2)(1994-12#1)(1994-2#2)(1994-5#5)(1994-9#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-6#1)(2006-4#1)(2007-11#10)(2007-12#5)(2008-10#8)(2008-11#2)(2008-2#7)(2008-3#22)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#2)(2011-3#1)(2013-1#1)(2013-8#1)
orientation on a##2##3##(2009-9#1)(2010-2#1)
orientation on the##4##3##(1992-6#1)(1995-5#1)(2008-10#1)(2008-3#1)
orientation on##8##2##(1992-6#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-2#1)(2011-3#1)
orientation or direction##2##3##(2008-8#2)
orientation or##7##2##(1996-2#2)(2008-11#1)(2008-8#3)(2009-7#1)
orientation preference##2##2##(2012-2#2)
orientation process##2##2##(1996-1#1)(2007-11#1)
orientation program##3##2##(1991-1#1)(1996-1#2)
orientation relative to##2##3##(1991-12#1)(1993-3#1)
orientation selectivity in##2##3##(2008-11#1)(2008-8#1)
orientation selectivity##6##2##(2008-11#1)(2008-8#4)(2012-2#1)
orientation to##7##2##(1993-2#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-2#1)
orientation toward##3##2##(2008-11#2)(2013-1#1)
orientation towards##2##2##(1993-3#1)(2008-8#1)
orientation tuning##3##2##(2008-11#3)
orientation was##4##2##(1991-12#1)(1993-11#1)(2008-8#1)(2009-7#1)
orientation were##6##2##(2008-10#1)(2008-8#2)(2009-7#1)(2009-8#1)(2012-2#1)
orientation with respect to the##2##5##(1990-11#1)(1997-9#1)
orientation with respect to##3##4##(1990-11#1)(1997-9#1)(2008-11#1)
orientation with##4##2##(1990-11#2)(1997-9#1)(2008-11#1)
orientation within their##2##3##(1995-11#1)(2012-2#1)
orientation within##4##2##(1995-11#1)(1996-3#1)(2008-10#1)(2012-2#1)
orientation##415##1##(1990-11#7)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-3#3)(1992-6#2)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#1)(1995-11#5)(1995-12#3)(1995-3#15)(1995-5#3)(1995-6#1)(1996-1#3)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#2)(1997-3#5)(1997-4#1)(1997-6#3)(1997-7#1)(1997-9#1)(2006-4#1)(2007-11#19)(2007-12#20)(2007-7#1)(2007-8#1)(2008-10#31)(2008-11#19)(2008-12#14)(2008-2#25)(2008-3#49)(2008-4#3)(2008-6#5)(2008-7#6)(2008-8#20)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#11)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-1#1)(2012-2#9)(2012-3#1)(2013-1#6)(2013-8#1)
orientation)##3##1##(2008-10#1)(2008-2#2)
orientation-conserved transfer##2##2##(1993-11#2)
orientation-dependent##2##1##(1995-11#1)(2008-8#1)
orientation-independent##2##1##(1995-3#1)(2008-8#1)
orientation-patterned GaAs##2##2##(2007-11#2)
orientation-patterned##3##1##(2007-11#3)
orientational birefringence##2##2##(2008-3#2)
orientational##17##1##(1990-2#2)(1991-5#1)(1992-9#1)(1994-5#1)(1995-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2011-2#1)
orientations and##6##2##(1995-5#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)
orientations are##2##2##(2007-12#1)(2008-3#1)
orientations for the##2##3##(2008-3#2)
orientations for##3##2##(2008-3#3)
orientations of the optical##2##4##(2008-3#2)
orientations of the##7##3##(1992-6#1)(2007-11#1)(2008-2#1)(2008-3#3)(2012-2#1)
orientations of##18##2##(1992-6#1)(1993-8#1)(1995-11#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
orientations were##3##2##(2010-3#1)(2011-2#2)
orientations##72##1##(1990-11#3)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-5#2)(1995-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#15)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-3#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
oriented and##4##2##(2008-10#1)(2009-9#1)(2010-4#1)(2010-8#1)
oriented at##5##2##(2007-11#2)(2008-2#1)(2008-6#1)(2009-7#1)
oriented from##2##2##(2008-10#1)(2009-11#1)
oriented ice crystals##2##3##(2008-3#2)
oriented ice##3##2##(2008-2#1)(2008-3#2)
oriented in a##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
oriented in the same direction as the##2##7##(1994-12#1)(2007-12#1)
oriented in the##7##3##(1994-12#1)(2007-12#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-7#1)
oriented in##13##2##(1993-11#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2009-11#1)(2009-7#1)(2012-2#1)
oriented parallel to the##3##4##(2007-11#1)(2009-10#1)(2010-4#1)
oriented particles##2##2##(2008-3#2)
oriented perpendicular to the##4##4##(1994-12#1)(1995-5#1)(2007-11#1)(2010-4#1)
oriented to##4##2##(1993-2#1)(1995-2#1)(2008-10#1)(2008-2#1)
oriented toward the##3##3##(1990-2#1)(1991-12#1)(1994-3#1)
oriented toward##7##2##(1990-2#1)(1991-12#1)(1992-1#1)(1994-3#1)(2009-5#1)(2011-2#2)
oriented towards the##2##3##(1995-3#1)(2008-5#1)
oriented towards##3##2##(1995-3#1)(2007-11#1)(2008-5#1)
oriented with##2##2##(1993-11#1)(2008-2#1)
oriented##132##1##(1990-11#1)(1990-2#1)(1991-12#1)(1992-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#4)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#3)(2007-11#6)(2007-12#5)(2008-10#8)(2008-11#4)(2008-2#15)(2008-3#24)(2008-5#3)(2008-6#5)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#4)(2009-5#1)(2009-7#4)(2009-9#1)(2010-11#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-8#1)(2013-1#2)
orienting the##2##2##(1991-2#1)(1997-2#1)
orienting themselves on##2##3##(1994-8#2)
orienting toward##2##2##(1994-1#1)(2009-2#1)
orienting##12##1##(1991-2#1)(1992-7#1)(1994-1#1)(1994-8#2)(1995-3#1)(1997-2#1)(2008-11#1)(2009-2#1)(2011-1#1)(2013-8#2)
orifice in##2##2##(2009-10#1)(2013-1#1)
orifice##10##1##(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
orifices##3##1##(1991-6#1)(2008-10#2)
origin (fragment##2##2##(1997-6#2)
origin and distribution of##2##4##(1992-12#1)(1997-1#1)
origin and evolution of the##2##5##(2008-5#1)(2008-7#1)
origin and evolution of##5##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
origin and spread##2##3##(2007-12#1)(2008-9#1)
origin and the##9##3##(1993-6#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
origin and to##2##3##(1990-3#1)(1992-5#1)
origin and##69##2##(1990-3#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#5)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
origin are##4##2##(1991-6#1)(2008-11#1)(2010-12#1)(2011-2#1)
origin as well as##2##4##(2009-4#1)(2011-2#1)
origin as##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
origin can be##2##3##(1992-5#1)(2008-5#1)
origin can##4##2##(1992-5#1)(1994-9#1)(2008-5#1)(2011-2#1)
origin for modern humans##2##4##(1994-3#2)
origin for the##3##3##(1991-12#1)(1992-11#1)(2008-10#1)
origin for##14##2##(1990-5#1)(1991-12#1)(1992-11#1)(1994-3#3)(1995-11#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-7#1)(2013-1#1)
origin from the##6##3##(1990-11#1)(1992-2#1)(1997-2#1)(2008-12#1)(2010-12#1)(2011-2#1)
origin from##9##2##(1990-11#1)(1992-2#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
origin in a##2##3##(2008-11#1)(2008-7#1)
origin in the##9##3##(1990-2#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#1)(2013-8#1)
origin in##27##2##(1990-2#1)(1992-12#1)(1993-8#1)(1995-2#1)(1996-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-1#2)(2013-8#4)
origin is##6##2##(1993-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)
origin may be##2##3##(2008-10#1)(2009-9#1)
origin of DNA replication##2##4##(1990-11#1)(1994-12#1)
origin of DNA##3##3##(1990-11#1)(1994-12#1)(2008-12#1)
origin of F##2##3##(2008-10#2)
origin of Heliosperma##2##3##(2010-6#2)
origin of a##5##3##(1992-8#1)(2008-12#1)(2008-5#1)(2009-2#1)(2012-2#1)
origin of bidirectional replication (ori beta)##2##6##(1994-12#2)
origin of both##2##3##(2007-11#1)(2008-10#1)
origin of differences##2##3##(1997-2#1)(2008-8#1)
origin of inversions##2##3##(2013-1#2)
origin of ovarian cancer##2##4##(2013-8#2)
origin of primary##4##3##(1990-7#1)(2008-10#1)(2008-6#1)(2009-12#1)
origin of replication##9##3##(1990-11#1)(1990-5#1)(1993-12#1)(1994-12#1)(1995-2#2)(2008-10#2)(2011-2#1)
origin of some##2##3##(2008-10#1)(2012-12#1)
origin of the brain##2##4##(2007-12#2)
origin of the left##3##4##(2007-7#1)(2008-12#1)(2013-8#1)
origin of the observed##2##4##(2007-11#1)(2008-3#1)
origin of the pathogen##2##4##(2008-10#1)(2012-2#1)
origin of the##82##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-11#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2009-6#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-8#1)
origin of these species##3##4##(1996-6#1)(2008-9#1)(2010-3#1)
origin of these##5##3##(1996-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)
origin of this##8##3##(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
origin of##217##2##(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#3)(1995-2#3)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-8#2)(2007-11#6)(2007-12#10)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#42)(2008-11#6)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-2#12)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#3)
origin on the##2##3##(1994-12#1)(2012-3#1)
origin or##5##2##(2008-10#2)(2008-9#1)(2011-2#2)
origin should##2##2##(1996-11#1)(2008-8#1)
origin that are##2##3##(2008-10#1)(2008-11#1)
origin that##5##2##(1992-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
origin theory##2##2##(2008-8#2)
origin to##5##2##(1992-5#1)(2008-1#1)(2008-11#1)(2009-5#1)(2013-1#1)
origin using##2##2##(1994-5#1)(2008-12#1)
origin was##6##2##(1997-6#1)(2007-8#1)(2008-7#2)(2010-8#1)(2013-1#1)
origin were##4##2##(1991-11#1)(2008-10#2)(2008-8#1)
origin which##2##2##(1995-2#1)(2009-4#1)
origin with the##2##3##(1992-3#1)(2012-2#1)
origin with##4##2##(1992-3#1)(1994-3#1)(2008-10#1)(2012-2#1)
origin##678##1##(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#6)(1990-5#5)(1990-7#3)(1990-8#2)(1991-11#4)(1991-12#9)(1991-2#1)(1991-3#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#5)(1992-5#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#7)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#6)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#2)(1997-1#2)(1997-2#4)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#6)(2006-12#1)(2007-10#1)(2007-11#8)(2007-12#15)(2007-5#1)(2007-7#3)(2007-8#9)(2008-1#3)(2008-10#139)(2008-11#27)(2008-12#11)(2008-2#12)(2008-3#7)(2008-4#2)(2008-5#22)(2008-6#2)(2008-7#26)(2008-8#20)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#10)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#6)(2010-4#2)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#8)(2011-2#36)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#11)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#30)(2013-7#1)(2013-8#15)
origin)##3##1##(1994-8#1)(1997-3#1)(2007-12#1)
original DNA##2##2##(2008-10#1)(2008-8#1)
original ICH Score##2##3##(2012-3#2)
original activity after##2##3##(2008-10#2)
original activity##3##2##(2008-10#2)(2008-5#1)
original and##9##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2011-3#1)
original application##2##2##(1995-6#1)(2008-5#1)
original article##4##2##(2009-4#1)(2013-1#3)
original brand medicines##2##3##(2011-1#2)
original brand##3##2##(2011-1#3)
original color and##2##3##(2008-10#1)(2008-3#1)
original concept of##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
original culture##2##2##(2008-8#2)
original data was##3##3##(2008-10#2)(2010-8#1)
original data##16##2##(1995-5#1)(2007-12#1)(2008-10#9)(2008-3#2)(2008-8#2)(2010-8#1)
original diagnosis##2##2##(1992-8#1)(2010-10#1)
original equipment manufacturers (OEMs)##2##4##(1996-2#1)(2008-7#1)
original extract##2##2##(2008-10#1)(2008-5#1)
original features##2##2##(2008-6#2)
original host##4##2##(2008-10#3)(2008-8#1)
original information is##2##3##(2008-3#2)
original information##3##2##(2008-3#3)
original level##2##2##(1990-2#1)(2008-11#1)
original location##3##2##(2008-10#1)(2009-4#1)(2012-12#1)
original material##2##2##(2008-10#1)(2011-2#1)
original method of##2##3##(2008-6#1)(2012-3#1)
original method##6##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-3#1)
original operation##2##2##(1990-6#1)(2008-9#1)
original research##3##2##(2007-2#1)(2008-2#1)(2009-10#1)
original samples##3##2##(2008-10#2)(2008-7#1)
original schedule##2##2##(1990-2#2)
original sequence##3##2##(1994-12#1)(2008-3#1)(2008-8#1)
original signal##4##2##(2007-11#2)(2008-3#1)(2008-7#1)
original spatial##2##2##(2007-12#1)(2008-3#1)
original substrate##2##2##(2008-5#1)(2011-2#1)
original technique of##2##3##(1995-9#1)(2008-3#1)
original technique##6##2##(1995-9#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-5#1)
original version##7##2##(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
original##412##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-8#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#4)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#5)(2008-10#79)(2008-11#16)(2008-12#6)(2008-2#8)(2008-3#46)(2008-4#2)(2008-5#16)(2008-6#9)(2008-7#12)(2008-8#13)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#10)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#16)(2013-8#8)
originality##5##1##(1992-6#1)(1997-2#1)(1997-5#1)(2008-8#1)(2010-7#1)
originally characterized##2##2##(2008-7#1)(2012-2#1)
originally conceived##2##2##(2008-11#1)(2012-2#1)
originally described as##2##3##(2006-10#1)(2008-5#1)
originally described by##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
originally described##8##2##(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
originally designed as##2##3##(1992-12#1)(2008-10#1)
originally designed for##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
originally designed to##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
originally designed##9##2##(1992-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
originally detected##2##2##(1993-6#1)(2010-4#1)
originally developed as##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
originally developed by##3##3##(2008-3#2)(2008-5#1)
originally developed for##8##3##(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-3#1)
originally developed questionnaire##2##3##(2009-11#1)(2009-7#1)
originally developed##18##2##(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-3#1)
originally discovered##2##2##(2007-11#1)(2012-12#1)
originally formed##2##2##(2008-10#1)(2013-1#1)
originally found in##3##3##(1992-10#1)(1993-8#1)(2008-10#1)
originally identified as##6##3##(1990-5#1)(1993-6#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-12#1)
originally identified in##2##3##(1990-11#1)(1995-12#1)
originally identified##8##2##(1990-11#1)(1990-5#1)(1993-6#1)(1995-12#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-12#1)
originally isolated from a##2##4##(2008-10#1)(2011-2#1)
originally isolated from##10##3##(1994-11#1)(1996-2#1)(2008-10#2)(2011-2#6)
originally isolated##12##2##(1994-11#1)(1996-2#1)(2008-10#4)(2011-2#6)
originally present##2##2##(2008-10#2)
originally produced##2##2##(2008-11#2)
originally proposed by##4##3##(1990-5#1)(1997-2#1)(2011-1#1)(2012-3#1)
originally proposed to##2##3##(1995-6#1)(2008-3#1)
originally proposed##6##2##(1990-5#1)(1995-6#1)(1997-2#1)(2008-3#1)(2011-1#1)(2012-3#1)
originally scheduled##2##2##(1997-2#1)(2008-5#1)
originally thought to##2##3##(1997-1#1)(2008-4#1)
originally used##2##2##(2007-8#1)(2013-1#1)
originally using##2##2##(2008-7#1)(2009-11#1)
originally##136##1##(1990-11#1)(1990-5#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-7#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#2)
originals##2##1##(2007-11#1)(2008-3#1)
originate from a##3##3##(1990-5#1)(1994-5#1)(1997-8#1)
originate from the##8##3##(1997-1#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-1#1)
originate from##38##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-3#2)(1993-6#1)(1994-5#1)(1997-1#2)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-2#1)(2011-2#4)(2012-2#1)
originate in the##7##3##(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
originate in##10##2##(1995-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)
originate##53##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-3#2)(1993-6#1)(1994-5#1)(1995-3#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#5)(2009-1#1)(2009-2#1)(2010-9#1)(2011-2#5)(2012-2#1)(2013-7#1)
originated as##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
originated at the##3##3##(2008-10#1)(2009-12#1)(2009-7#1)
originated by##2##2##(2008-10#2)
originated from a##4##3##(1993-11#1)(1993-3#1)(1996-2#1)(2008-10#1)
originated from the##10##3##(1995-2#1)(1995-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
originated from##44##2##(1993-11#1)(1993-3#2)(1995-2#1)(1995-9#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#18)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)
originated in the##8##3##(1993-12#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-4#1)(2011-2#1)
originated in##11##2##(1993-12#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-6#1)(2011-2#1)
originated##75##1##(1993-11#1)(1993-12#1)(1993-3#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#3)
originates from a##3##3##(1990-8#1)(2008-10#1)(2010-6#1)
originates from the##10##3##(1993-11#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
originates from##17##2##(1990-8#1)(1993-11#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#1)
originates in the##2##3##(2008-3#1)(2013-8#1)
originates not only from##2##4##(2008-7#2)
originates##26##1##(1990-8#1)(1992-9#1)(1993-11#2)(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-6#1)(2012-3#1)(2013-8#1)
originating from a single##2##4##(2007-12#1)(2008-3#1)
originating from a##10##3##(1995-8#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-6#1)(2013-1#1)
originating from different##3##3##(2008-10#2)(2009-8#1)
originating from the same##2##4##(2007-12#1)(2008-10#1)
originating from the##31##3##(1994-5#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
originating from##102##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#37)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#2)
originating in lateral recess of the fourth ventricle##2##8##(2013-1#2)
originating in the##7##3##(1994-3#1)(2008-10#2)(2008-7#2)(2010-11#1)(2013-1#1)
originating in##13##2##(1994-3#1)(2007-8#1)(2008-10#4)(2008-7#2)(2010-11#1)(2012-2#1)(2013-1#3)
originating##119##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#2)(2007-8#3)(2008-10#43)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#5)(2013-8#3)
origination##4##1##(2008-2#1)(2009-10#3)
origins and##12##2##(1995-11#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2013-1#1)
origins in##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
origins of adult##4##3##(2012-2#2)(2013-1#2)
origins of health##2##3##(1993-2#1)(2012-2#1)
origins of replication##2##3##(1994-12#1)(2010-3#1)
origins of the##10##3##(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2013-7#1)
origins of these##3##3##(1997-2#1)(2008-11#1)(2010-6#1)
origins of##59##2##(1990-7#2)(1992-8#1)(1993-2#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#3)(2013-7#2)(2013-8#2)
origins were##2##2##(2008-10#2)
origins##124##1##(1990-7#2)(1991-12#1)(1991-4#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#7)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#3)
orinocense##3##1##(2008-5#3)
orlistat##6##1##(2008-5#6)
orlon fabric##2##2##(2008-10#2)
orlon##3##1##(2008-10#3)
ormosil-modified electrodes##3##2##(2008-10#3)
ornament##2##1##(2008-8#2)
ornamental crops##3##2##(2008-10#3)
ornamental fish##5##2##(2007-5#3)(2012-2#1)(2013-7#1)
ornamental fisheries##2##2##(2007-5#2)
ornamental plants##4##2##(2008-10#3)(2009-2#1)
ornamental##42##1##(2007-5#8)(2008-10#18)(2008-12#1)(2008-8#3)(2008-9#3)(2009-2#1)(2011-2#6)(2012-2#1)(2013-7#1)
ornamentals##5##1##(2007-5#2)(2008-10#3)
ornamentation in##2##2##(2008-8#1)(2008-9#1)
ornamentation of##2##2##(2008-9#1)(2010-3#1)
ornamentation##7##1##(2008-8#4)(2008-9#2)(2010-3#1)
ornamented males##2##2##(2008-8#2)
ornamented##6##1##(2008-10#1)(2008-5#1)(2008-8#3)(2010-10#1)
ornaments##9##1##(2008-8#9)
ornidazole)##3##1##(2010-5#3)
ornithine aminotransferase##2##2##(1990-5#2)
ornithine decarboxylase (ODC)##4##3##(1993-8#1)(1994-12#1)(1995-8#1)(2008-10#1)
ornithine decarboxylase activity in##2##4##(1992-8#1)(2010-9#1)
ornithine decarboxylase activity##6##3##(1992-8#2)(1992-9#2)(2008-10#1)(2010-9#1)
ornithine decarboxylase and##2##3##(1992-9#1)(1995-8#1)
ornithine decarboxylase gene##4##3##(1991-2#2)(1992-8#2)
ornithine decarboxylase##19##2##(1991-2#2)(1992-8#5)(1992-9#4)(1993-8#1)(1994-12#2)(1995-8#2)(2008-10#2)(2010-9#1)
ornithine##29##1##(1990-2#1)(1990-5#3)(1991-2#2)(1992-8#5)(1992-9#4)(1993-8#1)(1994-12#2)(1995-8#2)(2008-10#3)(2008-7#4)(2009-8#1)(2010-9#1)
oro-dental##2##1##(2010-3#2)
oro-tracheal tube##3##2##(2008-2#3)
oro-tracheal##4##1##(2008-2#4)
orodental infections##2##2##(2007-7#2)
orodispersible tablets of pheniramine maleate##2##5##(2010-3#2)
orofacial clefting##2##2##(2009-6#2)
orofacial clefts##8##2##(2009-10#6)(2012-12#2)
orofacial dyskinesia##3##2##(2012-2#3)
orofacial granulomatosis##3##2##(2009-2#1)(2012-2#2)
orofacial pain##2##2##(2008-5#1)(2012-3#1)
orofacial##25##1##(2007-12#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#7)(2009-2#1)(2009-6#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)
orogastric and##3##2##(2008-5#3)
orogastric##4##1##(2008-5#4)
oromotor##2##1##(1993-12#2)
oropharyngeal adverse events##3##3##(2008-8#3)
oropharyngeal and##3##2##(2008-5#3)
oropharyngeal candidiasis##3##2##(2007-12#1)(2008-5#2)
oropharyngeal clearance##4##2##(1996-2#4)
oropharyngeal##25##1##(1990-9#1)(1996-2#5)(1997-1#1)(2007-11#1)(2007-12#1)(2008-5#6)(2008-8#4)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
oroscopy##3##1##(2013-1#3)
orosomucoid##2##1##(1992-9#1)(2010-12#1)
orotate##4##1##(1994-8#4)
orotic acid##2##2##(2008-10#2)
orotidine 5'-monophosphate##2##2##(1994-8#1)(2006-4#1)
orotidine##3##1##(1994-8#1)(2006-4#1)(2008-10#1)
orphan genes##4##2##(2008-7#4)
orphan receptor##4##2##(1994-12#2)(1995-12#1)(2008-4#1)
orphan receptors##3##2##(1995-12#1)(1996-5#1)(2008-4#1)
orphan##19##1##(1994-12#4)(1995-12#2)(1996-5#2)(2008-4#4)(2008-7#5)(2011-7#1)(2013-1#1)
orphaned##4##1##(1997-6#2)(2008-11#1)(2012-2#1)
orphanin FQ##2##2##(1996-12#1)(1996-5#1)
orphanin##4##1##(1996-12#1)(1996-5#3)
orphans in##2##2##(1997-6#2)
orphans##5##1##(1990-12#1)(1997-6#3)(2008-11#1)
ortho catechol##2##2##(2008-11#2)
ortho ester##2##2##(2007-11#2)
ortho##10##1##(2007-11#3)(2008-10#3)(2008-11#3)(2010-8#1)
ortho-##2##1##(2008-10#2)
ortho-amino substituent of##2##3##(1996-2#2)
ortho-amino substituent##4##2##(1996-2#4)
ortho-amino substituents##2##2##(1996-2#2)
ortho-amino##6##1##(1996-2#6)
ortho-periodic acid as the oxidant##2##5##(2007-11#2)
ortho-phosphate##3##1##(2008-10#2)(2011-1#1)
ortho-phosphates##2##1##(2013-1#2)
ortho-substituted##2##1##(1996-12#1)(2008-10#1)
orthodontic displacement##2##2##(2010-3#2)
orthodontic force##2##2##(2008-11#1)(2013-1#1)
orthodontic management##3##2##(2007-12#3)
orthodontic pain##2##2##(2013-8#2)
orthodontic treatment is##2##3##(2010-3#1)(2012-12#1)
orthodontic treatment##15##2##(2007-12#2)(2009-7#2)(2010-3#2)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#2)
orthodontic##42##1##(1990-10#2)(2007-12#6)(2008-11#1)(2008-12#1)(2009-7#3)(2010-3#6)(2012-12#3)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#6)
orthodontically##2##1##(2007-12#1)(2009-3#1)
orthodontics##9##1##(2007-10#1)(2007-12#2)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
orthodontist##3##1##(2013-1#1)(2013-7#1)(2013-8#1)
orthodontists##2##1##(2012-12#1)(2013-1#1)
orthodox##7##1##(1997-6#1)(2008-11#4)(2011-2#1)(2013-7#1)
orthodromic##2##1##(1997-2#1)(2008-11#1)
orthognathic surgery##5##2##(2007-12#4)(2011-2#1)
orthognathic##6##1##(2007-12#5)(2011-2#1)
orthogonal array design##3##3##(2008-10#3)
orthogonal array##4##2##(2008-10#4)
orthogonal axes##3##2##(1997-7#1)(2008-3#2)
orthogonal components of##2##3##(1990-5#1)(2007-12#1)
orthogonal dashpot system##2##3##(2008-7#2)
orthogonal experimental design##4##3##(2008-10#3)(2008-11#1)
orthogonal linear polarization##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
orthogonal polarization states##2##3##(2007-11#1)(2008-3#1)
orthogonal polarization##13##2##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#4)
orthogonal polarizations##4##2##(2007-11#2)(2008-3#2)
orthogonal signal##2##2##(2008-10#2)
orthogonal to the##3##3##(2008-10#1)(2008-3#2)
orthogonal to##4##2##(2008-10#1)(2008-3#2)(2008-6#1)
orthogonal##89##1##(1990-5#1)(1996-5#1)(1997-7#1)(2007-11#6)(2007-12#15)(2008-10#20)(2008-11#2)(2008-2#10)(2008-3#22)(2008-6#1)(2008-7#2)(2009-11#3)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#1)
orthogonality as a##2##3##(2008-3#1)(2009-3#1)
orthogonality of##2##2##(2008-3#2)
orthogonality##9##1##(2008-10#1)(2008-2#1)(2008-3#4)(2009-3#3)
orthogonally and##2##2##(2008-10#1)(2008-3#1)
orthogonally funtionalised##2##2##(2007-11#2)
orthogonally polarized beams##3##3##(2007-12#1)(2008-3#2)
orthogonally polarized##10##2##(2007-11#1)(2007-12#2)(2008-3#7)
orthogonally##19##1##(1995-11#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-3#8)(2008-6#1)(2009-2#1)
orthographic##6##1##(1991-2#2)(2008-12#1)(2008-6#1)(2012-1#1)(2013-8#1)
orthokeratinized##2##1##(2013-1#2)
ortholoci for##2##2##(2008-10#2)
ortholog of##2##2##(2008-11#1)(2012-3#1)
ortholog##7##1##(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
orthologous genes##2##2##(2008-7#1)(2010-10#1)
orthologous species and##2##3##(2008-7#2)
orthologous to the##2##3##(2010-3#2)
orthologous to##3##2##(2008-7#1)(2010-3#2)
orthologous##13##1##(1993-12#1)(1994-6#2)(2008-1#1)(2008-4#1)(2008-7#4)(2010-10#1)(2010-3#3)
orthologs##4##1##(2008-7#1)(2009-10#2)(2013-1#1)
orthologue##3##1##(1997-7#1)(2008-10#1)(2010-2#1)
orthologues in##2##2##(2008-11#1)(2008-7#1)
orthologues of known##2##3##(2008-7#1)(2010-3#1)
orthologues##11##1##(2008-11#1)(2008-7#8)(2010-3#1)(2011-10#1)
orthonormal##2##1##(2008-2#2)
orthopaedic braces##2##2##(2007-8#2)
orthopaedic departments##2##2##(1990-9#1)(2007-11#1)
orthopaedic hospital##2##2##(1997-7#1)(2008-8#1)
orthopaedic infections##3##2##(2007-11#3)
orthopaedic patients##4##2##(1992-5#1)(2007-10#3)
orthopaedic surgeon##5##2##(1996-3#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
orthopaedic surgeons##4##2##(1991-6#1)(2007-11#1)(2009-3#1)(2013-1#1)
orthopaedic surgery##4##2##(1990-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
orthopaedic##52##1##(1990-9#3)(1991-5#1)(1991-6#1)(1992-5#1)(1994-3#1)(1996-3#2)(1997-7#1)(2007-10#5)(2007-11#7)(2007-8#5)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#1)
orthopaedics and traumatology##2##3##(2007-8#2)
orthopaedics from##2##2##(2007-8#2)
orthopaedics in the##2##3##(2007-8#2)
orthopaedics##13##1##(2007-8#10)(2008-12#2)(2012-2#1)
orthopaedists##2##1##(2007-8#2)
orthopedic appliance##2##2##(2013-1#2)
orthopedic applications##2##2##(2010-3#1)(2012-3#1)
orthopedic devices##4##2##(2007-11#4)
orthopedic hospital in##2##3##(2007-8#1)(2008-8#1)
orthopedic hospital##3##2##(2007-8#2)(2008-8#1)
orthopedic oncology##2##2##(2007-8#1)(2010-3#1)
orthopedic patients##5##2##(2010-6#3)(2011-2#1)(2012-2#1)
orthopedic practice##2##2##(2007-8#1)(2011-2#1)
orthopedic procedures##2##2##(2008-5#1)(2008-8#1)
orthopedic surgeon##4##2##(2007-11#1)(2008-8#1)(2009-3#2)
orthopedic surgeons##8##2##(2007-11#1)(2007-4#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
orthopedic surgery in spinal anesthesia##2##5##(2011-2#2)
orthopedic surgery##15##2##(2007-8#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#9)(2013-1#1)
orthopedic##81##1##(1991-6#1)(1994-3#2)(1996-9#1)(2007-11#11)(2007-4#1)(2007-8#9)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#11)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-6#4)(2011-2#13)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#7)
orthopedics##12##1##(1997-6#2)(2007-11#2)(2007-8#5)(2008-8#1)(2012-2#1)(2013-1#1)
orthopedist##3##1##(1991-3#1)(2009-4#1)(2013-7#1)
orthopedists##5##1##(2007-8#4)(2009-3#1)
orthophosphate and total inorganic phosphates in##3##6##(2008-10#3)
orthophosphate and total##5##3##(2008-10#5)
orthophosphate and##7##2##(2008-10#7)
orthophosphate##32##1##(1993-12#1)(2008-10#31)
orthophosphoric acid)##4##2##(1996-5#1)(2008-10#1)(2008-5#1)(2010-3#1)
orthophosphoric##5##1##(1996-5#2)(2008-10#1)(2008-5#1)(2010-3#1)
orthorhombic crystal form##4##3##(1993-8#1)(2008-8#3)
orthorhombic##18##1##(1992-12#1)(1992-8#1)(1993-8#1)(1996-2#3)(1997-7#4)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#3)(2013-8#1)
orthoses##5##1##(2007-11#3)(2007-8#1)(2010-3#1)
orthosilicate##2##1##(2008-10#1)(2008-6#1)
orthosis##5##1##(2007-11#2)(2007-8#1)(2010-3#2)
orthostatic headache##3##2##(2009-6#3)
orthostatic##6##1##(1994-3#1)(2007-10#1)(2009-6#4)
orthotic management of##2##3##(2007-11#2)
orthotic management##4##2##(2007-11#2)(2007-8#1)(2008-11#1)
orthotic##8##1##(1990-6#1)(2007-11#3)(2007-8#2)(2008-11#1)(2010-3#1)
orthotopic liver transplantation##7##3##(1991-11#2)(1992-12#2)(1993-2#1)(2011-2#1)(2013-8#1)
orthotopic##11##1##(1991-11#2)(1992-12#2)(1993-2#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
orthotropic##2##1##(2009-7#1)(2012-3#1)
orthovanadate##5##1##(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#2)
oryzacystatin##2##1##(2008-10#2)
oryzae NRRL 395##3##3##(2008-6#3)
oryzae Strains##2##2##(2008-10#2)
oryzae and##5##2##(2008-10#4)(2009-10#1)
oryzae in Arabidopsis##2##3##(2012-2#2)
oryzae in Nepal##2##3##(2008-10#2)
oryzae in##10##2##(2008-10#5)(2008-6#1)(2012-2#3)(2013-8#1)
oryzae is##3##2##(2008-10#2)(2012-2#1)
oryzae isolates##2##2##(2008-10#2)
oryzae pv##35##2##(1993-9#1)(2008-10#32)(2008-9#1)(2009-10#1)
oryzae to##2##2##(2008-10#2)
oryzae was##2##2##(2008-10#1)(2009-2#1)
oryzae were##2##2##(2008-10#1)(2008-6#1)
oryzae##115##1##(1992-11#1)(1993-9#3)(2008-10#90)(2008-6#5)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#2)(2012-2#7)(2013-8#1)
oryzae)##2##1##(1990-3#1)(2008-10#1)
oryzae-sativae##3##1##(2008-10#3)
oryzicola##2##1##(2008-10#2)
oryzophilus##6##1##(2013-8#6)
os calcis##3##2##(2008-6#2)(2009-5#1)
os##11##1##(1991-3#1)(1993-12#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2009-5#1)(2009-8#1)
oscillate between##2##2##(2008-3#1)(2008-9#1)
oscillate##5##1##(1990-2#1)(1996-6#1)(2007-12#1)(2008-3#1)(2008-9#1)
oscillated##4##1##(1996-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
oscillates##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
oscillating bubble##2##2##(2008-10#1)(2008-11#1)
oscillating chemical reaction##3##3##(2008-10#3)
oscillating chemical system involving the##2##5##(2008-10#2)
oscillating chemical system##4##3##(2008-10#4)
oscillating chemical##7##2##(2008-10#7)
oscillating reaction is##2##3##(2008-10#2)
oscillating reaction##4##2##(2008-10#4)
oscillating system##2##2##(2008-10#2)
oscillating##46##1##(1990-5#1)(2006-12#1)(2007-11#2)(2007-12#7)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-7#1)(2011-2#3)(2013-1#1)
oscillation amplitude and##2##3##(2008-10#1)(2012-2#1)
oscillation amplitude##7##2##(2008-10#5)(2012-2#2)
oscillation amplitudes of##2##3##(2008-2#2)
oscillation and##2##2##(2008-10#1)(2012-3#1)
oscillation by use of##2##4##(2007-12#1)(2008-3#1)
oscillation frequency##7##2##(2007-11#4)(2007-12#1)(2008-2#2)
oscillation in##12##2##(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-3#2)(2008-7#1)(2008-9#1)
oscillation is##8##2##(2007-11#2)(2007-12#4)(2008-2#1)(2009-5#1)
oscillation of a##2##3##(2008-3#2)
oscillation of the##2##3##(2008-1#1)(2008-3#1)
oscillation of##6##2##(2007-12#1)(2008-1#1)(2008-3#4)
oscillation period of the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
oscillation period##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2010-10#3)
oscillation threshold##4##2##(2007-12#3)(2008-3#1)
oscillation was##4##2##(1995-11#1)(1996-2#1)(2007-12#1)(2008-2#1)
oscillation##122##1##(1990-8#1)(1994-6#6)(1995-11#2)(1995-2#1)(1996-2#3)(2007-11#19)(2007-12#25)(2008-1#1)(2008-10#14)(2008-11#6)(2008-2#11)(2008-3#17)(2008-7#4)(2008-9#1)(2009-5#3)(2009-7#1)(2010-10#3)(2011-1#1)(2012-2#2)(2012-3#1)
oscillations and##4##2##(1992-11#1)(2008-11#1)(2008-2#1)(2008-8#1)
oscillations are##5##2##(1990-5#1)(2007-11#1)(2008-10#1)(2010-10#1)(2013-8#1)
oscillations by##3##2##(1990-5#1)(1990-8#1)(1994-11#1)
oscillations could be##2##3##(1994-11#1)(2013-8#1)
oscillations could##4##2##(1994-11#1)(2011-2#1)(2013-8#2)
oscillations in a##3##3##(1993-5#1)(2007-12#1)(2008-11#1)
oscillations in the##7##3##(1990-5#1)(1992-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2013-8#1)
oscillations in##30##2##(1990-5#3)(1990-8#1)(1991-10#1)(1992-8#1)(1993-5#2)(1994-11#3)(1995-11#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2010-10#1)(2013-8#3)
oscillations is##3##2##(2008-2#1)(2008-3#2)
oscillations of intracellular##2##3##(1990-8#1)(1992-12#1)
oscillations of the##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
oscillations of##16##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-12#1)(1994-11#1)(2007-11#2)(2007-12#2)(2008-3#3)(2008-7#1)(2010-10#2)(2012-2#1)
oscillations on different transitions##3##4##(2007-12#3)
oscillations on##4##2##(2007-12#3)(2008-10#1)
oscillations to##2##2##(2008-3#1)(2009-6#1)
oscillations were found##2##3##(2008-7#1)(2011-2#1)
oscillations were##4##2##(1991-10#1)(1994-6#1)(2008-7#1)(2011-2#1)
oscillations with##2##2##(1994-11#1)(2008-7#1)
oscillations##139##1##(1990-5#6)(1990-8#9)(1991-10#3)(1991-5#4)(1992-11#1)(1992-12#1)(1992-8#1)(1993-5#2)(1994-11#9)(1994-6#4)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#3)(2007-11#4)(2007-12#12)(2008-1#4)(2008-10#5)(2008-11#6)(2008-2#13)(2008-3#9)(2008-7#10)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#2)(2010-10#5)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#9)
oscillator amplifier##2##2##(2007-12#1)(2008-3#1)
oscillator and a##3##3##(2007-11#2)(2007-12#1)
oscillator and##8##2##(1994-5#1)(2007-11#3)(2007-12#1)(2008-3#3)
oscillator by use of an##2##5##(2007-12#2)
oscillator by use of##4##4##(2007-11#1)(2007-12#3)
oscillator for##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
oscillator is##5##2##(1994-5#1)(2007-11#1)(2008-3#3)
oscillator model##2##2##(2007-11#1)(2009-10#1)
oscillator pulses##2##2##(2007-12#2)
oscillator strengths##2##2##(2008-3#1)(2008-7#1)
oscillator that##6##2##(2007-11#4)(2007-12#2)
oscillator to the##2##3##(2007-12#1)(2009-8#1)
oscillator to##5##2##(2007-12#4)(2009-8#1)
oscillator was##3##2##(2008-2#1)(2008-3#2)
oscillator with##7##2##(1990-12#1)(2007-11#2)(2007-12#3)(2008-3#1)
oscillator##185##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1993-12#2)(1994-5#2)(2007-11#50)(2007-12#66)(2008-10#1)(2008-2#14)(2008-3#39)(2008-5#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-7#2)
oscillator-amplifier system is##2##3##(2008-2#1)(2008-3#1)
oscillator-amplifier system##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
oscillator-amplifier##8##1##(2007-12#2)(2008-2#1)(2008-3#5)
oscillators and##4##2##(1994-5#2)(2007-12#2)
oscillators by##2##2##(2007-12#1)(2008-3#1)
oscillators##45##1##(1990-5#1)(1990-8#1)(1994-5#3)(2007-11#10)(2007-12#13)(2008-2#2)(2008-3#9)(2009-8#2)(2010-7#1)(2012-2#3)
oscillatory activity##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
oscillatory behavior in##3##3##(2008-7#3)
oscillatory behavior##7##2##(1990-8#1)(2008-2#1)(2008-3#1)(2008-7#4)
oscillatory patterns##2##2##(2008-7#1)(2009-8#1)
oscillatory##40##1##(1990-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
oscillometric##2##1##(1990-8#2)
osculatum##2##1##(2012-2#2)
oseltamivir was##2##2##(2011-2#1)(2013-1#1)
osm-3##6##1##(1995-3#6)
osmeteria##2##1##(2007-12#2)
osmiophilic material##6##2##(2008-10#6)
osmiophilic##9##1##(1997-2#1)(2008-10#8)
osmium tetroxide##8##2##(1991-7#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#2)
osmium##22##1##(1991-7#1)(1996-2#2)(2007-12#1)(2008-10#14)(2008-4#1)(2008-7#2)(2010-7#1)
osmium(IV) in##2##2##(2008-10#2)
osmium(IV)##3##1##(2008-10#3)
osmolalities##5##1##(1997-7#1)(2008-11#3)(2008-7#1)
osmolality and##3##2##(2008-5#1)(2009-12#1)(2013-1#1)
osmolality compensation##2##2##(2008-11#2)
osmolality of##3##2##(1992-5#1)(2008-11#2)
osmolality##27##1##(1992-5#1)(1997-7#1)(2008-11#17)(2008-5#2)(2009-12#1)(2013-1#2)(2013-8#3)
osmolarities##2##1##(2009-12#2)
osmolarity and##3##2##(1991-5#1)(2008-11#2)
osmolarity from##2##2##(1991-11#1)(1997-1#1)
osmolarity medium##2##2##(2008-11#2)
osmolarity of the##6##3##(1991-11#3)(1993-3#1)(1994-12#2)
osmolarity of##9##2##(1991-11#5)(1993-3#1)(1994-12#2)(2009-12#1)
osmolarity on##2##2##(2008-11#1)(2009-12#1)
osmolarity##44##1##(1991-11#15)(1991-5#1)(1993-3#1)(1994-12#5)(1997-1#1)(2008-1#1)(2008-11#13)(2008-5#1)(2008-8#1)(2009-12#4)(2011-2#1)
osmolytes in##2##2##(1991-11#1)(2013-1#1)
osmolytes##6##1##(1991-11#2)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
osmopriming##2##1##(2008-12#2)
osmoregulation##4##1##(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
osmoregulatory##8##1##(1993-3#2)(2008-7#6)
osmosensor histidine kinase##2##3##(2008-10#2)
osmotic adjustment##3##2##(2008-11#1)(2012-7#2)
osmotic and fungicide##2##3##(2008-10#2)
osmotic coefficients##3##2##(1991-11#3)
osmotic effect##2##2##(2008-12#1)(2008-5#1)
osmotic fragility##2##2##(2008-9#2)
osmotic induction##2##2##(2013-7#2)
osmotic minipumps##2##2##(1994-8#1)(1995-12#1)
osmotic potential##6##2##(2008-10#1)(2008-9#3)(2009-6#1)(2012-7#1)
osmotic pressure of##2##3##(2008-11#1)(2010-7#1)
osmotic pressure was##2##3##(2008-11#1)(2012-12#1)
osmotic pressure##15##2##(2008-11#11)(2008-12#1)(2009-12#1)(2010-7#1)(2012-12#1)
osmotic properties of##2##3##(2008-5#1)(2011-1#1)
osmotic properties##3##2##(2008-5#1)(2009-12#1)(2011-1#1)
osmotic sensitivity##2##2##(2008-10#2)
osmotic shock##6##2##(1990-11#1)(1994-2#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-7#1)
osmotic stimulation of the hypothalamic paraventricular nucleus##2##7##(1994-8#2)
osmotic stimulation of the##3##4##(1994-8#3)
osmotic stress and##2##3##(1992-8#1)(2009-8#1)
osmotic stress##15##2##(1992-8#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-9#3)(2009-8#2)(2013-1#1)(2013-7#1)
osmotic swelling##4##2##(1990-2#2)(1991-5#1)(1994-2#1)
osmotic##91##1##(1990-11#1)(1990-2#3)(1991-11#4)(1991-5#1)(1992-8#1)(1994-12#2)(1994-2#3)(1994-8#4)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#7)(2008-11#15)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#8)(2009-12#4)(2009-6#1)(2009-8#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-7#4)(2013-1#1)(2013-7#3)
osmotically controlled##2##2##(1994-12#2)
osmotically##8##1##(1993-3#1)(1994-12#2)(1995-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
osmotin and thaumatin-like protein##2##4##(2008-10#2)
osmotin promoter##2##2##(2008-8#2)
osmotin##6##1##(2008-10#2)(2008-8#4)
osseointegrate##2##1##(2007-11#1)(2013-1#1)
osseointegration##3##1##(2007-11#3)
osseous involvement##2##2##(2008-1#1)(2010-6#1)
osseous metaplasia##4##2##(1992-2#2)(2011-1#2)
osseous metastases##3##2##(2007-11#2)(2008-7#1)
osseous##26##1##(1991-11#1)(1992-2#2)(1994-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-7#2)(2009-3#1)(2010-3#1)(2010-5#2)(2010-6#3)(2011-1#2)(2011-2#3)(2013-1#2)
ossicle was##3##2##(2008-9#3)
ossicle##8##1##(2007-12#1)(2008-12#2)(2008-9#5)
ossicles are##4##2##(2007-12#4)
ossicles##15##1##(1996-6#1)(2007-12#10)(2008-12#2)(2008-9#2)
ossificans progressiva##2##2##(1997-6#1)(2007-2#1)
ossificans##9##1##(1992-2#3)(1997-6#1)(2007-2#1)(2008-9#1)(2013-1#1)(2013-8#2)
ossification (HO)##2##2##(1994-8#1)(2007-11#1)
ossification of the##2##3##(2008-12#1)(2013-1#1)
ossification of##4##2##(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
ossification##20##1##(1991-2#1)(1994-8#2)(1996-12#1)(1996-6#1)(2007-11#2)(2008-12#2)(2008-9#4)(2012-12#5)(2012-3#1)(2013-1#1)
ossifications##2##1##(1991-11#1)(2011-1#1)
ossified cochlea##5##2##(2008-9#5)
ossified##10##1##(2008-9#8)(2010-8#1)(2013-1#1)
ossify##2##1##(1992-4#1)(2010-8#1)
ossifying fibroma##5##2##(2013-1#2)(2013-7#3)
ossifying fibroma&quot##4##2##(2013-7#4)
ossifying##15##1##(1992-2#2)(2007-12#1)(2008-10#3)(2013-1#2)(2013-7#7)
osteitis##7##1##(1997-3#1)(2006-10#1)(2007-11#2)(2008-2#1)(2009-3#2)
ostensibly##2##1##(1996-6#1)(2008-9#1)
osteo-articular diseases##2##2##(1990-6#1)(1991-9#1)
osteo-articular##5##1##(1990-5#2)(1990-6#2)(1991-9#1)
osteoarthritic##5##1##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
osteoarthritis (OA)##7##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#2)
osteoarthritis and##3##2##(2007-11#1)(2008-9#1)(2011-2#1)
osteoarthritis are##2##2##(2006-10#1)(2007-11#1)
osteoarthritis in##3##2##(2009-3#1)(2011-2#1)(2012-3#1)
osteoarthritis of the knee##9##4##(2007-11#2)(2010-12#3)(2011-2#2)(2013-1#2)
osteoarthritis of##11##2##(2007-11#3)(2010-12#3)(2011-2#3)(2013-1#2)
osteoarthritis##69##1##(1991-11#1)(1991-5#1)(1992-3#2)(1995-9#1)(1996-3#1)(2006-10#1)(2007-11#13)(2007-8#2)(2008-10#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-4#1)(2011-2#8)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#15)
osteoarthrosis##7##1##(1993-2#1)(2007-11#1)(2007-8#2)(2010-10#1)(2010-3#1)(2013-1#1)
osteoarticular allograft reconstruction##3##3##(2008-6#3)
osteoarticular pain##2##2##(2011-2#2)
osteoarticular##12##1##(1996-6#1)(2007-8#1)(2008-6#3)(2008-9#1)(2011-2#5)(2012-3#1)
osteoblast and osteoclast activity##2##4##(2011-2#2)
osteoblast differentiation##3##2##(2008-8#2)(2013-1#1)
osteoblast functions##2##2##(1991-12#1)(2008-11#1)
osteoblast metabolism##3##2##(2008-11#3)
osteoblast mitogenesis##3##2##(1990-11#1)(1993-8#2)
osteoblast proliferation##5##2##(1990-11#1)(1991-12#3)(2008-11#1)
osteoblast##29##1##(1990-11#2)(1991-11#1)(1991-12#5)(1993-8#3)(2007-8#1)(2008-11#10)(2008-8#3)(2011-2#2)(2012-3#1)(2013-1#1)
osteoblast-like cell##3##2##(1993-3#1)(1994-6#1)(2008-11#1)
osteoblast-like cells by##2##3##(2008-11#2)
osteoblast-like cells##16##2##(1990-12#3)(1990-2#3)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(2008-11#4)
osteoblast-like##24##1##(1990-12#3)(1990-2#3)(1992-8#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-2#2)(1994-6#2)(2008-11#5)(2012-1#1)(2012-2#1)
osteoblastic MC3T3-E1 cells##5##3##(1991-12#2)(1997-1#3)
osteoblastic activity##2##2##(2008-7#1)(2011-1#1)
osteoblastic cells##6##2##(1994-11#1)(2008-11#4)(2011-1#1)
osteoblastic metastases##4##2##(1990-12#1)(1991-8#2)(2007-11#1)
osteoblastic##30##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-8#2)(1992-8#1)(1994-11#1)(1994-2#1)(1997-1#3)(2007-11#2)(2008-11#9)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#2)(2013-1#1)
osteoblastic-osteolytic bone metastases##2##3##(2007-11#2)
osteoblastic-osteolytic##3##1##(2007-11#3)
osteoblastoma##3##1##(2007-12#1)(2010-5#2)
osteoblasts and adipocytes##2##3##(2012-2#2)
osteoblasts and cementoblasts##2##3##(2008-11#2)
osteoblasts and##10##2##(1997-1#1)(1997-7#1)(2008-11#3)(2008-8#1)(2010-3#1)(2011-1#1)(2012-2#2)
osteoblasts cultured##2##2##(2008-11#2)
osteoblasts is##2##2##(2008-11#2)
osteoblasts to##3##2##(1993-6#1)(2007-11#1)(2008-11#1)
osteoblasts##45##1##(1990-11#2)(1993-3#2)(1993-6#2)(1993-8#1)(1997-1#3)(1997-7#2)(2007-11#1)(2008-11#15)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-2#2)(2012-4#2)(2013-1#2)
osteocalcin and osteopontin##2##3##(2008-11#2)
osteocalcin and##5##2##(1991-11#2)(2008-11#2)(2010-12#1)
osteocalcin gene expression##2##3##(1993-3#2)
osteocalcin gene##3##2##(1993-3#3)
osteocalcin in##2##2##(1991-11#1)(2011-2#1)
osteocalcin production##2##2##(1990-2#1)(2012-4#1)
osteocalcin##26##1##(1990-2#8)(1991-11#3)(1992-12#1)(1992-6#1)(1993-3#4)(2008-11#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-4#2)
osteochondral allograft##4##2##(2008-6#2)(2012-3#2)
osteochondral allografts##3##2##(2008-6#1)(2012-3#2)
osteochondral defects##2##2##(2012-3#1)(2013-1#1)
osteochondral fracture##4##2##(2008-12#1)(2008-8#2)(2013-1#1)
osteochondral transfer##2##2##(2009-3#2)
osteochondral transplantation##2##2##(2011-2#2)
osteochondral##27##1##(2007-11#1)(2008-12#2)(2008-6#3)(2008-8#2)(2009-1#1)(2009-3#2)(2011-2#8)(2012-3#6)(2013-1#2)
osteochondritis dissecans##3##2##(1992-4#1)(2008-8#2)
osteochondroma##4##1##(1997-8#1)(2008-8#2)(2010-3#1)
osteochondromatosis of the##2##3##(2010-5#1)(2010-7#1)
osteochondromatosis##5##1##(2010-5#3)(2010-7#2)
osteoclast activation##2##2##(1993-8#1)(2013-1#1)
osteoclast activity##3##2##(2011-2#3)
osteoclast and##4##2##(1991-12#1)(1991-5#1)(1993-11#1)(2007-8#1)
osteoclast apoptosis##4##2##(2008-11#4)
osteoclast differentiation from##2##3##(2007-8#1)(2010-10#1)
osteoclast differentiation##6##2##(1991-5#1)(1993-8#1)(2007-8#1)(2008-11#1)(2010-10#1)(2011-2#1)
osteoclast formation##6##2##(1991-5#2)(1993-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
osteoclast##33##1##(1991-11#2)(1991-12#2)(1991-5#4)(1992-3#1)(1993-11#2)(1993-8#3)(2007-8#2)(2008-11#5)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#1)
osteoclast-like##3##1##(1993-8#1)(2008-11#1)(2013-1#1)
osteoclastic activity##2##2##(2008-11#1)(2008-5#1)
osteoclastic bone resorption and##2##4##(1992-3#1)(2008-11#1)
osteoclastic bone resorption##8##3##(1992-3#4)(1993-6#1)(1995-3#1)(2008-11#2)
osteoclastic differentiation##2##2##(1991-5#2)
osteoclastic resorption##3##2##(2008-5#2)(2008-8#1)
osteoclastic##16##1##(1991-5#2)(1992-3#4)(1993-6#1)(1995-3#1)(2008-11#4)(2008-5#3)(2008-8#1)
osteoclastogenesis##4##1##(1994-6#1)(2011-1#2)(2013-1#1)
osteoclasts##35##1##(1990-5#1)(1991-11#1)(1991-5#1)(1992-3#2)(1993-11#1)(1993-8#1)(1997-7#2)(2007-11#1)(2008-11#12)(2008-4#2)(2008-8#3)(2009-3#1)(2010-10#1)(2011-2#3)(2012-2#1)(2012-3#2)
osteocyte##2##1##(2010-9#1)(2013-1#1)
osteocytes##6##1##(2008-11#1)(2010-9#5)
osteodystrophy##9##1##(1990-9#1)(1997-6#1)(2008-4#2)(2010-6#2)(2011-1#1)(2011-2#2)
osteogenesis has##3##2##(2007-12#2)(2007-8#1)
osteogenesis in##5##2##(2007-12#4)(2008-11#1)
osteogenesis is##3##2##(2007-12#3)
osteogenesis##30##1##(1991-5#1)(2007-12#16)(2007-8#6)(2008-11#3)(2008-5#1)(2009-3#1)(2011-2#2)
osteogenic and chondrogenic differentiation potentials of hMSCs##2##7##(2008-11#2)
osteogenic and chondrogenic differentiation potentials of##3##6##(2008-11#3)
osteogenic and chondrogenic differentiation##4##4##(2008-11#4)
osteogenic and##5##2##(2008-11#4)(2013-1#1)
osteogenic differentiation of human##2##4##(2012-1#2)
osteogenic differentiation of##4##3##(2012-1#3)(2012-6#1)
osteogenic differentiation##13##2##(2008-11#8)(2012-1#3)(2012-4#1)(2012-6#1)
osteogenic medium##4##2##(2008-11#3)(2012-4#1)
osteogenic potential##4##2##(2008-11#4)
osteogenic sarcoma of the##6##4##(1992-2#2)(1996-6#1)(2008-6#2)(2011-2#1)
osteogenic sarcoma of##7##3##(1992-2#2)(1996-6#1)(2008-6#3)(2011-2#1)
osteogenic sarcoma##11##2##(1992-12#2)(1992-2#2)(1996-6#1)(2008-6#4)(2011-1#1)(2011-2#1)
osteogenic##53##1##(1992-12#3)(1992-2#2)(1993-11#1)(1994-6#2)(1996-6#1)(2008-11#25)(2008-5#3)(2008-6#4)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-4#2)(2012-6#2)(2013-1#1)
osteoid and##2##2##(2008-6#1)(2010-3#1)
osteoid osteoma in children##2##4##(2007-11#2)
osteoid osteoma of the##2##4##(2008-8#1)(2013-1#1)
osteoid osteoma##11##2##(2007-11#2)(2008-8#2)(2012-12#1)(2012-2#3)(2013-1#3)
osteoid osteomas##2##2##(2013-1#2)
osteoid##17##1##(2007-11#3)(2008-6#1)(2008-8#2)(2010-3#2)(2012-12#1)(2012-2#3)(2013-1#5)
osteolitic##3##1##(2007-11#3)
osteolysis is##2##2##(2007-11#1)(2008-8#1)
osteolysis##13##1##(2007-11#1)(2008-11#1)(2008-8#8)(2013-1#3)
osteolytic lesion##5##2##(2007-11#2)(2008-12#2)(2012-12#1)
osteolytic metastases##2##2##(1991-8#1)(1997-6#1)
osteolytic##11##1##(1991-5#1)(1991-8#1)(1997-5#1)(1997-6#1)(2007-11#2)(2008-12#3)(2008-7#1)(2012-12#1)
osteoma cutis##3##2##(2010-6#3)
osteoma in##3##2##(2007-11#2)(2012-12#1)
osteoma of the##4##3##(2008-8#1)(2010-5#2)(2013-1#1)
osteoma##19##1##(2007-11#2)(2008-8#2)(2010-5#2)(2010-6#3)(2012-12#4)(2012-2#3)(2013-1#3)
osteomalacia in##4##2##(1991-11#1)(1997-4#1)(2008-4#2)
osteomalacia##10##1##(1991-11#1)(1997-4#2)(1997-6#1)(2008-4#2)(2008-6#4)
osteomas##8##1##(2011-2#6)(2013-1#2)
osteomyelitis and##5##2##(2006-10#1)(2007-8#1)(2010-6#1)(2012-2#1)(2013-8#1)
osteomyelitis has##2##2##(2010-6#1)(2012-2#1)
osteomyelitis in a##2##3##(1995-9#1)(2013-8#1)
osteomyelitis in##6##2##(1995-9#1)(2008-9#1)(2010-6#2)(2012-2#1)(2013-8#1)
osteomyelitis is##3##2##(2008-9#1)(2010-6#2)
osteomyelitis of the##6##3##(2007-12#1)(2007-8#3)(2010-6#1)(2012-8#1)
osteomyelitis of##9##2##(2007-12#1)(2007-7#1)(2007-8#3)(2008-9#1)(2010-6#2)(2012-8#1)
osteomyelitis with##2##2##(2008-9#1)(2013-8#1)
osteomyelitis##78##1##(1995-9#1)(2006-10#2)(2007-11#1)(2007-12#4)(2007-7#4)(2007-8#4)(2008-11#1)(2008-9#6)(2009-5#1)(2009-6#1)(2010-3#1)(2010-6#40)(2012-12#1)(2012-2#6)(2012-8#1)(2013-8#4)
osteonal cortical bone is##2##4##(2009-7#2)
osteonal cortical bone##3##3##(2009-7#3)
osteonecrosis and##3##2##(1994-7#2)(2009-3#1)
osteonecrosis of the femoral head associated with pregnancy##2##8##(2009-3#2)
osteonecrosis of the femoral head##6##5##(2009-10#1)(2009-3#5)
osteonecrosis of the jaw##3##4##(2008-7#2)(2012-12#1)
osteonecrosis of the jaws##2##4##(2012-12#2)
osteonecrosis of the##12##3##(2008-7#2)(2009-10#1)(2009-3#5)(2012-12#3)(2012-3#1)
osteonecrosis##23##1##(1994-7#5)(2006-10#1)(2008-7#2)(2009-10#1)(2009-3#8)(2012-12#4)(2012-3#1)(2013-1#1)
osteonecrotic group##2##2##(1994-7#2)
osteopathic literature##2##2##(1991-12#1)(2007-11#1)
osteopathic medicine##2##2##(1991-12#1)(1991-8#1)
osteopathic##10##1##(1991-12#3)(1991-8#1)(2007-11#4)(2008-12#1)(2010-1#1)
osteopathy and##2##2##(2008-12#1)(2010-12#1)
osteopathy##8##1##(1991-11#1)(2007-11#2)(2008-12#1)(2010-12#4)
osteopenia and osteoporosis##2##3##(2007-8#1)(2011-2#1)
osteopenia and##3##2##(2007-8#2)(2011-2#1)
osteopenia##9##1##(1997-7#1)(2007-8#2)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#2)
osteopetrosis is##3##2##(1990-5#1)(2008-11#1)(2012-2#1)
osteopetrosis##8##1##(1990-5#2)(2007-8#1)(2008-11#2)(2012-2#3)
osteophyte##3##1##(2008-8#1)(2011-2#2)
osteophytes##4##1##(1994-11#1)(2007-11#3)
osteophytic##3##1##(2011-2#3)
osteopontin##14##1##(1995-8#1)(2008-11#3)(2008-4#1)(2008-7#6)(2009-7#1)(2010-11#1)(2012-1#1)
osteoporosis and fracture##2##3##(2007-11#1)(2012-12#1)
osteoporosis and to##2##3##(1994-9#1)(2010-3#1)
osteoporosis and##21##2##(1991-12#1)(1992-6#1)(1993-11#1)(1994-7#1)(1994-9#1)(1996-6#1)(1997-6#1)(2007-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#2)(2011-1#1)(2012-12#2)(2012-2#2)
osteoporosis are##2##2##(1993-11#1)(2007-11#1)
osteoporosis as compared##3##3##(2012-2#1)(2013-1#2)
osteoporosis as##5##2##(2007-11#1)(2008-4#1)(2012-2#1)(2013-1#2)
osteoporosis can be##2##3##(1993-11#1)(1996-6#1)
osteoporosis in the##4##3##(1991-11#1)(1996-6#1)(2008-8#1)(2010-3#1)
osteoporosis in##20##2##(1991-11#1)(1993-11#1)(1996-6#1)(2007-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-3#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
osteoporosis is##9##2##(1991-11#1)(2007-11#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-3#2)
osteoporosis of the femoral head##2##5##(2009-3#2)
osteoporosis or##4##2##(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
osteoporosis prevention##2##2##(1993-11#1)(2008-11#1)
osteoporosis than##2##2##(1996-6#2)
osteoporosis treated with##2##3##(1991-11#1)(2007-11#1)
osteoporosis with##4##2##(1991-11#1)(1993-11#2)(2007-11#1)
osteoporosis##222##1##(1990-11#1)(1990-9#1)(1991-11#11)(1991-12#2)(1991-3#1)(1992-3#1)(1992-6#2)(1993-11#29)(1994-7#2)(1994-9#1)(1995-11#2)(1996-11#2)(1996-6#6)(1997-6#8)(1997-7#2)(1997-8#1)(2007-11#24)(2007-7#2)(2007-8#10)(2008-11#6)(2008-12#1)(2008-4#11)(2008-5#2)(2008-6#4)(2008-7#13)(2008-8#14)(2009-12#2)(2009-3#3)(2010-10#1)(2010-3#19)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#8)(2012-2#16)(2013-1#6)(2013-8#2)
osteoporosis]##6##1##(1991-11#2)(1991-3#1)(1994-12#1)(1995-11#1)(1997-6#1)
osteoporotic bone##3##2##(1992-6#1)(2007-8#1)(2011-2#1)
osteoporotic fractures of the proximal##2##5##(2007-11#2)
osteoporotic fractures of the##4##4##(2007-11#3)(2007-8#1)
osteoporotic fractures##13##2##(1991-11#1)(1993-11#1)(1996-8#2)(1997-6#1)(2007-11#4)(2007-8#4)
osteoporotic vertebral compression fractures##2##4##(2007-8#1)(2008-7#1)
osteoporotic vertebral compression##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
osteoporotic vertebral##8##2##(1991-11#2)(2007-11#1)(2007-8#3)(2008-12#1)(2008-7#1)
osteoporotic women##2##2##(2008-11#1)(2012-3#1)
osteoporotic##44##1##(1991-11#5)(1992-6#2)(1993-11#1)(1996-8#2)(1997-6#1)(1997-7#1)(2007-11#8)(2007-8#11)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
osteoprotegerin (OPG) gene##2##3##(2013-1#2)
osteoprotegerin (OPG)##8##2##(2007-8#1)(2008-12#2)(2011-1#2)(2013-1#2)(2013-8#1)
osteoprotegerin##14##1##(2007-8#3)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#2)(2013-1#4)(2013-8#1)
osteoprotic##3##1##(1997-7#3)
osteoradionecrosis of the cervical spine##2##5##(2011-2#2)
osteoradionecrosis##4##1##(2011-2#3)(2013-1#1)
osteosarcoma 29 years after radiation therapy##2##6##(2013-8#2)
osteosarcoma and##5##2##(2010-3#5)
osteosarcoma are##5##2##(2008-6#1)(2010-3#4)
osteosarcoma cell line##2##3##(1993-12#1)(2008-6#1)
osteosarcoma cell lines with##2##4##(1994-2#1)(2010-3#1)
osteosarcoma cell lines##5##3##(1992-8#1)(1994-2#1)(2008-6#1)(2010-3#2)
osteosarcoma cell##9##2##(1992-8#3)(1993-12#1)(1994-2#1)(2008-6#2)(2010-3#2)
osteosarcoma cells##6##2##(1994-6#2)(1995-8#1)(2010-3#2)(2013-8#1)
osteosarcoma has##6##2##(2008-6#1)(2010-3#4)(2013-1#1)
osteosarcoma have##3##2##(2010-3#3)
osteosarcoma in the##5##3##(2008-6#1)(2009-3#1)(2010-3#1)(2013-1#2)
osteosarcoma in##10##2##(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#3)(2013-1#2)(2013-8#1)
osteosarcoma is##8##2##(2008-6#2)(2010-3#6)
osteosarcoma of the extremities##5##4##(1992-6#4)(2010-3#1)
osteosarcoma of the extremity##3##4##(2010-3#3)
osteosarcoma of the orbit##2##4##(2008-6#2)
osteosarcoma of the right##2##4##(1991-11#1)(2008-6#1)
osteosarcoma of the##13##3##(1991-11#1)(1992-6#4)(2008-6#4)(2010-3#4)
osteosarcoma patients prior to##2##4##(2010-3#2)
osteosarcoma patients##7##2##(2010-3#7)
osteosarcoma survivors##2##2##(2010-3#2)
osteosarcoma were treated##2##3##(2008-6#1)(2010-3#1)
osteosarcoma were##3##2##(2008-6#2)(2010-3#1)
osteosarcoma with##5##2##(2008-6#1)(2010-3#3)(2012-1#1)
osteosarcoma##185##1##(1990-12#1)(1991-11#2)(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#4)(1992-8#4)(1993-12#2)(1994-2#1)(1994-6#2)(1995-8#1)(1996-6#1)(2007-5#1)(2008-6#29)(2008-7#1)(2008-8#4)(2009-3#1)(2010-3#116)(2012-1#2)(2013-1#4)(2013-7#1)(2013-8#5)
osteosarcoma)##2##1##(1992-5#1)(1992-6#1)
osteosarcomas are uncommon##2##3##(2008-6#2)
osteosarcomas are##4##2##(2008-6#3)(2013-1#1)
osteosarcomas##9##1##(2008-6#5)(2010-3#3)(2013-1#1)
osteosarcomatous##2##1##(1992-8#1)(2007-8#1)
osteosclerotic##2##1##(2011-2#2)
osteosynthesis##12##1##(2007-11#9)(2007-8#2)(2013-1#1)
osteotomied##2##1##(2007-8#2)
osteotomies of the##2##3##(1996-6#1)(2008-9#1)
osteotomies##12##1##(1996-6#1)(2007-8#2)(2008-8#3)(2008-9#1)(2010-3#1)(2012-2#3)(2013-1#1)
osteotomy and denervation##2##3##(2007-8#2)
osteotomy and##6##2##(2007-8#4)(2008-10#1)(2011-2#1)
osteotomy are##2##2##(2010-11#1)(2012-2#1)
osteotomy fixed with##5##3##(2008-9#1)(2013-1#4)
osteotomy for##2##2##(2008-9#1)(2012-2#1)
osteotomy has been##2##3##(2012-2#2)
osteotomy in the treatment of##3##5##(2006-12#1)(2007-8#1)(2010-11#1)
osteotomy in the##4##3##(2006-12#1)(2007-8#1)(2008-10#1)(2010-11#1)
osteotomy in##10##2##(2006-12#1)(2007-8#1)(2008-10#2)(2009-3#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
osteotomy is a##2##3##(2009-3#1)(2010-3#1)
osteotomy is##6##2##(1997-4#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)
osteotomy of the distal##2##4##(2008-9#1)(2011-2#1)
osteotomy of the##5##3##(2008-9#1)(2009-3#2)(2010-3#1)(2011-2#1)
osteotomy of##6##2##(2007-2#1)(2008-9#1)(2009-3#2)(2010-3#1)(2011-2#1)
osteotomy or##2##2##(2007-12#1)(2012-2#1)
osteotomy performed##2##2##(1990-6#1)(2009-3#1)
osteotomy to##2##2##(2009-3#1)(2013-1#1)
osteotomy was##3##2##(2006-12#1)(2009-3#1)(2011-2#1)
osteotomy with##4##2##(2007-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
osteotomy##83##1##(1990-6#3)(1997-4#2)(1997-6#1)(2006-12#3)(2007-12#4)(2007-2#1)(2007-8#13)(2008-10#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#10)(2010-11#3)(2010-3#3)(2010-5#1)(2011-2#9)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#6)(2013-8#1)
ostertagi##2##1##(1996-12#2)
ostia##3##1##(2007-12#1)(2011-2#2)
ostial lesions##2##2##(1994-9#2)
ostial##5##1##(1994-9#2)(2007-8#2)(2008-11#1)
ostium stenosis##2##2##(2007-8#2)
ostium##9##1##(2007-8#6)(2009-11#1)(2010-12#1)(2013-1#1)
ostracods and##2##2##(2008-5#1)(2013-7#1)
ostreatus in##3##2##(2008-10#2)(2008-5#1)
ostreatus##11##1##(2008-10#3)(2008-5#2)(2011-1#6)
ostrich##2##1##(1996-8#1)(1997-6#1)
ostriches (Struthio camelus)##3##3##(1996-8#1)(1997-6#1)(2013-1#1)
ostriches##8##1##(1996-8#2)(1997-6#3)(2008-5#2)(2013-1#1)
ot##4##1##(1994-12#1)(2007-11#1)(2008-11#1)(2009-10#1)
other &quot##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
other (i##2##2##(2008-11#2)
other 10##4##2##(1990-2#1)(1992-2#1)(2008-12#1)(2008-5#1)
other 12##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
other 13##2##2##(2010-12#1)(2011-1#1)
other 14##2##2##(1997-3#1)(2008-6#1)
other 15##4##2##(1991-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
other 16##2##2##(2008-9#1)(2013-1#1)
other 17##2##2##(2008-8#1)(2011-2#1)
other 2##7##2##(1992-8#1)(1994-7#1)(1995-12#1)(2007-10#2)(2007-8#1)(2013-1#1)
other 3##7##2##(1990-7#1)(1995-12#1)(1996-5#1)(2008-12#1)(2010-10#1)(2013-1#2)
other 5##3##2##(1993-12#1)(1993-9#1)(2008-5#1)
other 8##2##2##(1995-11#1)(2010-3#1)
other AGs of R##3##4##(2008-10#3)
other AGs##4##2##(2008-10#4)
other Arab countries##2##3##(2007-7#1)(2008-1#1)
other Arthropoda##2##2##(2007-12#2)
other Asian##4##2##(1997-4#1)(2007-7#1)(2008-10#1)(2010-3#1)
other B##3##2##(2007-12#1)(2008-10#2)
other Ca2+##2##2##(1994-6#1)(2008-8#1)
other Canadian organizations##2##3##(1993-1#2)
other Canadian##3##2##(1993-1#2)(2008-10#1)
other DNA##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
other DNA-binding proteins##2##3##(1991-7#1)(2008-8#1)
other EDRF inhibitors##2##3##(1991-9#2)
other European countries##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
other European##5##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
other Fusarium##4##2##(1997-6#1)(2008-10#3)
other G protein-coupled receptors##2##4##(1993-6#1)(2008-4#1)
other G##4##2##(1993-11#1)(1993-6#1)(2008-4#1)(2010-3#1)
other Gram-positive##2##2##(2007-12#1)(2009-6#1)
other Gryllus species##2##3##(2008-9#2)
other Hrs##2##2##(1991-10#2)
other IEMAs##2##2##(1993-8#2)
other Japanese##4##2##(2008-10#4)
other LED##2##2##(2008-10#1)(2008-11#1)
other Medicare heart failures##2##4##(1995-3#2)
other Medicare##4##2##(1993-12#1)(1995-3#3)
other Meloidogyne##2##2##(2008-10#2)
other NCDs##4##2##(2013-8#4)
other NSAIDs##2##2##(2008-11#1)(2013-1#1)
other New World##2##3##(2008-10#2)
other New##3##2##(2008-1#1)(2008-10#2)
other OECD countries##3##3##(1993-2#1)(1996-3#2)
other ORFs##3##2##(1995-9#1)(1996-3#1)(1997-3#1)
other P##3##2##(2008-10#3)
other P450##2##2##(2009-9#2)
other Pg genes##3##3##(2008-10#3)
other Phytophthora spp##3##3##(2008-10#3)
other Phytophthora##5##2##(2008-10#5)
other Polish populations##2##3##(2008-12#2)
other QTL##2##2##(2008-10#1)(2013-8#1)
other S##2##2##(1996-3#2)
other SIV strains##2##3##(1997-3#2)
other States##2##2##(1991-2#1)(1996-1#1)
other U##2##2##(2008-10#2)
other V##2##2##(2008-10#2)
other Venturia##2##2##(2008-10#2)
other Western##2##2##(1990-6#1)(2008-10#1)
other X##5##2##(2008-10#5)
other Xanthomonas##3##2##(2008-10#3)
other abdominal##5##2##(1993-5#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
other abnormalities##6##2##(1990-6#1)(1991-3#1)(1997-3#1)(2010-12#1)(2010-8#1)(2012-3#1)
other actin-binding proteins##2##3##(1993-8#1)(2012-2#1)
other active##7##2##(1991-4#1)(1994-6#1)(2008-10#3)(2011-2#1)(2012-2#1)
other activities##3##2##(1991-5#1)(2008-9#1)(2013-1#1)
other additional##2##2##(2008-10#1)(2013-1#1)
other adults##2##2##(2008-9#2)
other advantages##3##2##(2008-10#2)(2011-2#1)
other adverse effects##3##3##(1995-3#1)(1997-7#1)(2013-1#1)
other adverse events##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
other adverse##9##2##(1995-3#1)(1997-7#1)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
other age groups##3##3##(1996-5#1)(2008-12#1)(2011-2#1)
other age##4##2##(1996-5#1)(2008-12#1)(2011-2#1)(2012-3#1)
other agencies##7##2##(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-2#2)
other agents have##2##3##(2007-10#1)(2008-4#1)
other agents##12##2##(1991-9#1)(1995-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)
other agricultural workers##2##3##(2008-12#2)
other agricultural##3##2##(2008-12#2)(2013-8#1)
other alcohols##2##2##(1992-7#1)(2008-10#1)
other alignment##2##2##(2012-2#1)(2013-1#1)
other alkali##5##2##(2008-10#5)
other allergic##2##2##(2010-6#1)(2013-8#1)
other alpha-amylases##2##2##(1997-4#2)
other amines##2##2##(2008-10#2)
other amino acid##2##3##(1991-5#1)(1995-6#1)
other amino acids and##2##4##(2008-10#2)
other amino acids##8##3##(1992-8#1)(1993-9#1)(2008-10#5)(2008-5#1)
other amino##11##2##(1991-5#1)(1992-8#1)(1993-9#1)(1995-6#1)(2008-10#6)(2008-5#1)
other analgesics##2##2##(2011-2#1)(2013-1#1)
other analogs##2##2##(1994-12#1)(2008-4#1)
other analogues##2##2##(2008-10#1)(2008-6#1)
other analytes##7##2##(2008-10#5)(2008-12#1)(2008-3#1)
other analytical parameters##2##3##(2008-10#2)
other anatomic##2##2##(1994-6#1)(2011-2#1)
other and##46##2##(1991-5#1)(1993-11#1)(1993-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
other animals in the population##2##5##(2008-8#2)
other animals##11##2##(1991-8#1)(1993-3#1)(1994-9#1)(1995-2#2)(2008-10#1)(2008-4#1)(2008-8#3)(2010-4#1)
other anionic##2##2##(1992-6#1)(1994-5#1)
other anions and can be used in##2##7##(2008-10#2)
other anions and##3##3##(2008-10#3)
other anions##8##2##(1990-5#1)(2008-10#7)
other antagonists##2##2##(2008-10#2)
other antibiotics##2##2##(1991-4#1)(2008-5#1)
other antibodies##2##2##(1997-7#1)(2008-4#1)
other antiepileptic drugs##4##3##(2008-3#2)(2008-7#1)(2008-8#1)
other antigenic##2##2##(1996-11#1)(2012-2#1)
other antigens##4##2##(1995-5#1)(2008-4#1)(2012-12#1)(2012-2#1)
other antihypertensive drugs in##2##4##(2008-3#2)
other antihypertensive drugs##4##3##(2008-3#3)(2008-8#1)
other antihypertensive##6##2##(1992-6#1)(2008-3#3)(2008-8#1)(2012-3#1)
other anxiety disorders##2##3##(2008-4#1)(2008-6#1)
other apparent##2##2##(1992-9#1)(2008-2#1)
other applications in##2##3##(2007-12#1)(2010-7#1)
other applications of##2##3##(2007-11#1)(2008-2#1)
other applications that##2##3##(2007-12#1)(2012-2#1)
other applications##16##2##(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2010-7#1)(2012-2#1)
other approaches##11##2##(1995-1#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
other appropriate##2##2##(1992-9#1)(2008-1#1)
other are##2##2##(2008-9#1)(2010-12#1)
other area##4##2##(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)
other areas of the##8##4##(1992-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-11#1)(2012-2#1)
other areas of##19##3##(1991-2#1)(1992-8#2)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
other areas##31##2##(1990-6#1)(1991-2#1)(1992-12#1)(1992-8#2)(1996-3#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
other aromatic##3##2##(1996-5#1)(2008-10#2)
other arsenic species##2##3##(2008-10#2)
other arsenic##3##2##(2008-10#3)
other arthropods##2##2##(2007-12#1)(2008-6#1)
other as##6##2##(1993-8#1)(1997-6#1)(2008-10#3)(2010-3#1)
other aspects of##12##3##(1992-12#1)(1993-2#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#2)(2012-3#1)
other aspects##16##2##(1992-12#1)(1993-2#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#2)(2012-3#1)
other atmospheric##2##2##(2008-3#2)
other authors and##2##3##(2011-2#1)(2013-8#1)
other authors##15##2##(1990-10#1)(1990-2#1)(1991-2#1)(1996-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#2)(2011-2#1)(2013-8#1)
other autoimmune diseases##3##3##(2012-3#1)(2013-8#2)
other autoimmune##5##2##(1990-5#1)(1991-8#1)(2012-3#1)(2013-8#2)
other available##7##2##(1990-8#1)(1991-12#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-2#1)
other avian##2##2##(1990-12#1)(1993-6#1)
other bacteria##7##2##(1993-9#1)(2008-10#3)(2008-5#2)(2011-1#1)
other bacterial##7##2##(1994-12#2)(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)
other barriers##3##2##(1997-5#1)(2008-5#1)(2012-3#1)
other based on##3##3##(1993-11#1)(2008-2#1)(2009-5#1)
other basic##2##2##(2008-1#1)(2012-2#1)
other begomoviruses##5##2##(2008-10#5)
other behavioral##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
other behaviors##2##2##(1995-12#1)(2008-11#1)
other beneficial##2##2##(2008-7#1)(2010-10#1)
other benefits##4##2##(1991-12#1)(1991-3#1)(1993-3#1)(2008-8#1)
other benign##2##2##(2010-12#1)(2013-7#1)
other binding##2##2##(2008-10#1)(2008-3#1)
other biological fluids##2##3##(2008-4#2)
other biological parameters##2##3##(2008-9#1)(2010-3#1)
other biological systems##2##3##(2008-9#2)
other biological##14##2##(1992-8#1)(1992-9#1)(1995-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#3)(2010-11#1)(2010-3#1)
other bisphosphonates##2##2##(2007-11#1)(2008-7#1)
other blinding##2##2##(2008-7#1)(2010-10#1)
other blood##2##2##(2007-2#1)(2008-4#1)
other body organs##2##3##(2008-7#2)
other body##6##2##(1992-9#1)(1996-3#1)(2008-5#1)(2008-7#2)(2008-9#1)
other bones##2##2##(2010-3#1)(2010-6#1)
other books##2##2##(2008-10#1)(2010-5#1)
other brain##4##2##(1997-2#1)(2007-12#1)(2008-4#1)(2009-5#1)
other branches of##2##3##(2008-3#1)(2008-5#1)
other breeds##2##2##(2010-4#1)(2012-1#1)
other broods##2##2##(2008-9#2)
other but##5##2##(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
other by##10##2##(1992-6#1)(1994-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-8#1)
other cDNA##2##2##(1990-7#1)(1994-12#1)
other calcium##2##2##(1993-3#1)(1994-9#1)
other can be##2##3##(2008-11#1)(2008-3#1)
other cancer##3##2##(1990-12#1)(1993-9#1)(2012-2#1)
other cancers in##2##3##(1992-5#1)(2008-11#1)
other cancers were##3##3##(1991-3#1)(1993-2#1)(2008-7#1)
other cancers##14##2##(1991-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(2007-4#1)(2008-11#2)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
other cardiac##8##2##(2007-8#1)(2008-12#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#1)
other cardiovascular risk factors in a hypertensive population##2##8##(2010-4#2)
other cardiovascular risk factors##5##4##(1991-4#1)(1996-8#1)(2008-5#1)(2010-4#2)
other cardiovascular##8##2##(1991-4#1)(1996-8#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-4#2)(2011-2#1)
other carriers##2##2##(1994-5#1)(2013-1#1)
other case##5##2##(1990-5#1)(1992-4#1)(1996-5#1)(2008-12#1)(2008-7#1)
other cases and##2##3##(1996-9#1)(2008-1#1)
other cases of##6##3##(1996-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
other cases##18##2##(1990-3#1)(1991-4#1)(1996-6#1)(1996-9#1)(2006-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
other catecholamines##2##2##(1997-3#1)(2008-10#1)
other categories of##5##3##(1990-11#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-1#1)
other categories##6##2##(1990-11#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-1#1)(1996-9#1)
other cations##13##2##(2008-10#13)
other cause##5##2##(1991-4#1)(1993-8#1)(1996-6#1)(2012-3#1)(2013-1#1)
other causes of##6##3##(2008-1#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-1#2)
other causes##17##2##(1993-6#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#2)(2009-8#1)(2011-1#2)(2011-2#1)
other cell cultures##2##3##(1994-3#1)(2008-11#1)
other cell cycle genes##3##4##(2008-10#3)
other cell lineages##2##3##(1995-12#1)(2008-11#1)
other cell lines##6##3##(1990-12#1)(1992-5#1)(2007-10#1)(2008-11#3)
other cell types in##2##4##(2008-4#1)(2008-7#1)
other cell types such as##2##5##(2008-1#1)(2008-11#1)
other cell types##15##3##(1992-10#1)(1995-3#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-7#2)(2010-5#1)(2012-3#1)(2013-1#1)
other cell##34##2##(1990-12#1)(1992-10#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-5#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#11)(2008-4#2)(2008-5#1)(2008-7#2)(2010-5#1)(2012-3#1)(2013-1#1)
other cells of the##2##4##(2008-4#1)(2008-5#1)
other cells##17##2##(1990-9#1)(1991-5#1)(1991-9#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
other cellular and##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
other cellular parameters##2##3##(1993-12#1)(2008-9#1)
other cellular##12##2##(1991-2#1)(1993-12#1)(1996-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
other central nervous system##2##4##(2009-12#1)(2009-7#1)
other centres##2##2##(2008-6#1)(2008-8#1)
other cereals##2##2##(1991-12#1)(2009-10#1)
other challenges##3##2##(1996-3#1)(2008-8#1)(2013-8#1)
other changes in the##2##4##(1991-6#1)(2008-3#1)
other changes in##3##3##(1991-6#1)(2008-3#1)(2011-2#1)
other changes##5##2##(1991-6#1)(1992-3#1)(2008-3#1)(2010-12#1)(2011-2#1)
other channels##2##2##(2008-4#2)
other characteristics of##2##3##(2008-10#1)(2008-8#1)
other characteristics##4##2##(2008-10#3)(2008-8#1)
other charged-surface microcarriers##2##3##(2008-11#2)
other charged-surface##3##2##(2008-11#3)
other chemical##5##2##(2008-10#1)(2008-11#2)(2008-5#2)
other children##3##2##(1993-2#1)(1994-6#1)(2012-12#1)
other chromosomal##3##2##(1995-2#1)(1995-8#1)(1997-9#1)
other chronic conditions##2##3##(2007-6#1)(2012-3#1)
other chronic disease##2##3##(1994-6#1)(2010-1#1)
other chronic##13##2##(1994-12#1)(1994-3#1)(1994-6#1)(2007-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#2)
other class##2##2##(1993-1#1)(2008-8#1)
other classes of##4##3##(2007-7#1)(2008-10#2)(2008-7#1)
other clinical parameters##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
other clinical##18##2##(1993-11#1)(1994-2#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-3#1)
other clinically##3##2##(1991-2#1)(2011-2#2)
other clones##2##2##(1991-2#1)(2008-10#1)
other closely related##2##3##(1992-3#1)(2008-9#1)
other closely##3##2##(1992-3#1)(2008-9#1)(2009-2#1)
other closteroviruses##4##2##(2008-10#4)
other clubs##2##2##(2009-8#2)
other coexisting##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
other cofactors##3##2##(1990-5#1)(1996-8#1)(2011-2#1)
other cognitive processes##2##3##(2009-10#1)(2009-11#1)
other cognitive##5##2##(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)
other combinations of A2 and T2##2##6##(1996-2#2)
other combinations of##3##3##(1996-2#2)(2012-2#1)
other combinations##4##2##(1996-2#2)(2008-12#1)(2012-2#1)
other common##6##2##(2008-10#6)
other commonly used##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
other commonly##7##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#2)
other community##4##2##(1996-1#1)(1996-12#1)(2008-9#1)(2012-2#1)
other comorbidities##2##2##(2009-6#1)(2011-2#1)
other companies##2##2##(1996-5#1)(1997-3#1)
other complex##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
other complexes##3##2##(1993-11#1)(1993-8#1)(2008-10#1)
other complications of##3##3##(1990-5#1)(1992-2#1)(2008-11#1)
other complications##10##2##(1990-2#1)(1990-5#1)(1992-2#1)(2007-10#1)(2007-7#3)(2008-11#2)(2008-12#1)
other components of the##7##4##(1991-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
other components of##12##3##(1991-3#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-7#1)(2012-3#1)
other components##22##2##(1991-3#2)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
other compounds##10##2##(1990-2#1)(1991-5#1)(1991-9#1)(1995-3#1)(2008-10#6)
other conditions##22##2##(1991-2#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
other congenital##3##2##(2007-8#1)(2010-8#1)(2013-1#1)
other conserved##2##2##(1992-3#1)(2008-9#1)
other considerations##3##2##(1992-12#1)(1993-1#1)(1996-1#1)
other contained##2##2##(1990-12#1)(2008-5#1)
other contaminants to##2##3##(1994-3#1)(2008-10#1)
other contaminants##3##2##(1994-3#1)(2008-10#2)
other contextual##2##2##(2008-7#1)(2008-8#1)
other continents##4##2##(2008-10#2)(2008-8#1)(2010-5#1)
other conventional##4##2##(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#1)
other cortical##2##2##(2008-11#1)(2009-6#1)
other countries are##2##3##(1991-9#1)(1993-6#1)
other countries as##2##3##(1990-6#1)(2008-5#1)
other countries in the region##2##5##(2007-7#1)(2008-8#1)
other countries in the##4##4##(2007-7#1)(2008-12#1)(2008-8#1)(2012-12#1)
other countries in##5##3##(2007-7#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-12#1)
other countries is##2##3##(1993-2#1)(2008-12#1)
other countries such as##3##4##(2008-7#1)(2008-8#1)(2010-12#1)
other countries with##2##3##(2010-11#1)(2011-1#1)
other countries##64##2##(1990-11#1)(1990-6#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-6#2)(1994-2#1)(1995-1#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-7#2)(2013-8#1)
other countries]##2##2##(1996-3#1)(2011-3#1)
other critical##5##2##(1996-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-11#1)
other crops##3##2##(2008-10#2)(2013-1#1)
other crystalline##2##2##(2007-12#1)(2008-3#1)
other cultivars##4##2##(2007-1#1)(2008-10#3)
other cultures##3##2##(2008-11#1)(2010-8#1)(2012-3#1)
other current##2##2##(2007-1#1)(2008-5#1)
other currently available##2##3##(1991-8#1)(2008-11#1)
other currently##5##2##(1991-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
other cyanobacterial##2##2##(1992-3#1)(1995-6#1)
other cymbidium##2##2##(1997-2#2)
other cystic##2##2##(2007-10#1)(2008-7#1)
other cytokines##12##2##(1991-5#1)(1992-8#1)(1994-9#1)(1996-2#2)(2008-4#6)(2008-7#1)
other dairy##2##2##(1990-8#1)(1995-8#1)
other data in the literature##2##5##(2008-3#1)(2008-9#1)
other data were##2##3##(1991-1#1)(2011-2#1)
other data##11##2##(1991-1#1)(1994-12#1)(1997-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#2)(2011-2#1)
other databases##3##2##(1991-3#1)(2008-4#1)(2008-8#1)
other degenerative##2##2##(1995-12#1)(2008-9#1)
other demographic or##2##3##(1994-12#1)(2007-10#1)
other demographic##7##2##(1992-8#1)(1993-2#1)(1994-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2013-7#1)
other derivatives were##2##3##(2010-1#1)(2011-2#1)
other derivatives##4##2##(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
other described##2##2##(2008-10#2)
other detection##2##2##(2008-10#1)(2010-6#1)
other developed countries##2##3##(2009-11#1)(2011-2#1)
other developing countries##4##3##(2007-7#1)(2008-11#1)(2009-4#1)(2011-2#1)
other developmental##5##2##(2007-10#1)(2007-12#1)(2008-11#1)(2009-8#1)(2010-10#1)
other devices##4##2##(1991-3#2)(2007-11#1)(2010-10#1)
other diagnoses##2##2##(1990-6#1)(2008-4#1)
other diagnostic##2##2##(1995-1#1)(2012-2#1)
other diets##4##2##(2008-12#2)(2008-3#1)(2012-2#1)
other differences were##2##3##(1995-5#1)(2012-1#1)
other differences##5##2##(1995-11#1)(1995-5#1)(2009-2#1)(2009-5#1)(2012-1#1)
other dimensions of##2##3##(1992-12#1)(2011-2#1)
other dimensions##4##2##(1992-12#1)(2008-11#1)(2008-9#1)(2011-2#1)
other direct##2##2##(1996-2#1)(2008-10#1)
other direction##2##2##(2008-3#1)(2008-7#1)
other directions##2##2##(2008-10#1)(2008-6#1)
other disasters##2##2##(2008-2#1)(2013-1#1)
other disciplines##7##2##(1994-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2011-2#1)(2013-1#1)
other disease processes##2##3##(2006-10#1)(2009-2#1)
other disease##8##2##(1993-11#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-8#1)(2009-2#1)(2012-12#1)
other diseases can##2##3##(1990-6#1)(1992-6#1)
other diseases of##2##3##(1995-5#1)(2008-10#1)
other diseases##36##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-6#2)(1993-12#3)(1993-8#1)(1994-5#3)(1995-5#1)(1997-1#1)(1997-3#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
other disorders and##2##3##(2010-1#1)(2012-3#1)
other disorders including##2##3##(2008-3#1)(2008-7#1)
other disorders##12##2##(1992-4#1)(1997-2#1)(2008-1#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-3#2)
other dithiocarbamates##2##2##(2008-10#2)
other divalent cations##2##3##(1990-5#1)(1991-2#1)
other divalent##3##2##(1990-5#1)(1991-2#1)(2008-10#1)
other diverse##2##2##(2008-10#1)(2009-10#1)
other domains##4##2##(2008-1#1)(2008-3#1)(2008-8#1)(2011-2#1)
other drug use behaviors##3##4##(1996-1#3)
other drug use##5##3##(1996-1#3)(2009-11#1)(2009-7#1)
other drug##6##2##(1996-1#3)(2009-11#1)(2009-7#1)(2012-12#1)
other drugs and##3##3##(1993-11#1)(2009-9#1)(2012-3#1)
other drugs of abuse##3##4##(1991-1#1)(1995-12#1)(2009-7#1)
other drugs of##4##3##(1991-1#1)(1995-12#1)(2008-10#1)(2009-7#1)
other drugs##30##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-1#3)(1993-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#3)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)
other during the##2##3##(1991-12#1)(1997-6#1)
other ecological##3##2##(2008-10#2)(2008-8#1)
other eczema##2##2##(2013-1#2)
other effects##5##2##(1990-12#1)(1990-9#1)(1994-5#1)(2010-8#1)(2013-7#1)
other eight##3##2##(2008-10#3)
other elements of the##2##4##(1995-8#1)(2008-3#1)
other elements of##4##3##(1995-8#1)(1996-1#1)(2008-3#1)(2012-12#1)
other elements##10##2##(1995-8#1)(1996-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2012-12#1)
other emission##2##2##(1992-3#1)(2008-2#1)
other endogenous##2##2##(1991-9#1)(2008-10#1)
other enteric pathogens##2##3##(2008-10#1)(2011-1#1)
other entities##2##2##(1991-3#1)(1993-2#1)
other environmental##13##2##(1991-12#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#2)(2010-5#1)(2013-7#1)
other enzymatic##3##2##(1990-12#1)(1992-6#1)(1996-12#1)
other enzyme##3##2##(1990-12#1)(1995-12#1)(2011-2#1)
other enzymes##9##2##(1990-5#1)(1992-4#1)(1992-8#2)(1995-6#1)(1997-4#1)(2008-4#1)(2008-7#1)(2011-1#1)
other errors##2##2##(2008-2#1)(2008-3#1)
other essential##3##2##(1991-6#1)(1995-2#1)(2008-10#1)
other established methods##2##3##(2008-3#1)(2008-9#1)
other established##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2012-1#1)
other estimates##2##2##(1995-6#1)(2011-3#1)
other ethnic groups##3##3##(2008-3#1)(2009-5#1)(2010-8#1)
other ethnic populations##3##3##(2010-8#1)(2011-1#1)(2012-12#1)
other ethnic##6##2##(2008-3#1)(2009-5#1)(2010-8#2)(2011-1#1)(2012-12#1)
other etiologies of##5##3##(2013-1#4)(2013-8#1)
other etiologies##9##2##(1990-9#1)(2008-1#2)(2013-1#4)(2013-8#2)
other eukaryotes##4##2##(1992-8#1)(1994-12#1)(1996-3#1)(2012-2#1)
other eukaryotic##3##2##(1995-11#1)(1997-6#1)(2008-9#1)
other events##2##2##(2008-9#1)(2010-1#1)
other evidence of##2##3##(2008-7#1)(2011-2#1)
other evidence##5##2##(1993-12#1)(1994-8#1)(2008-7#1)(2009-8#1)(2011-2#1)
other examinations##2##2##(1990-5#1)(1997-4#1)
other examined##3##2##(2007-11#1)(2008-6#1)(2008-8#1)
other examples are##2##3##(2008-5#1)(2012-2#1)
other examples##3##2##(2007-11#1)(2008-5#1)(2012-2#1)
other existing##6##2##(2008-3#3)(2009-12#1)(2009-4#1)(2013-1#1)
other expenses##2##2##(2008-12#1)(2009-10#1)
other experimental results##2##3##(1997-2#1)(2008-3#1)
other experimental##11##2##(1994-8#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)
other experiments##8##2##(1993-6#1)(2006-6#1)(2008-10#4)(2008-3#1)(2008-9#1)
other extracellular##3##2##(2008-4#2)(2008-7#1)
other extraction##3##2##(2008-10#3)
other facial##2##2##(2006-12#1)(2008-5#1)
other facilities##3##2##(1994-3#1)(1995-6#1)(2008-10#1)
other factors (e##2##3##(1990-12#1)(2008-2#1)
other factors are##4##3##(1996-3#1)(2008-1#1)(2012-3#1)(2013-1#1)
other factors in##3##3##(1995-12#1)(2008-2#1)(2010-11#1)
other factors influencing##2##3##(1995-3#1)(2008-12#1)
other factors like##2##3##(2008-11#1)(2008-4#1)
other factors may be##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
other factors should be##2##4##(2008-11#1)(2008-9#1)
other factors such as##6##4##(1994-11#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)
other factors that affect the##2##5##(2008-4#1)(2008-6#1)
other factors that influence##2##4##(1994-12#1)(2008-2#1)
other factors that##4##3##(1994-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
other factors##71##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-3#3)(1996-7#1)(1997-3#1)(1997-7#2)(2007-6#1)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2012-6#2)(2013-1#3)(2013-7#1)
other faculty##2##2##(1993-1#1)(1993-2#1)
other families##7##2##(1993-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2013-8#1)
other family members##3##3##(1992-6#1)(2011-2#1)(2012-12#1)
other family##5##2##(1992-6#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-12#1)
other farmers##3##2##(1996-3#3)
other feature##2##2##(1992-9#1)(2008-3#1)
other features of the metabolic syndrome##2##6##(2008-3#2)
other features of##4##3##(2008-1#1)(2008-3#2)(2009-7#1)
other features##9##2##(1990-8#1)(2008-1#1)(2008-3#3)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
other field##4##2##(1996-1#1)(2008-10#1)(2008-5#1)(2010-2#1)
other fields of##2##3##(2008-11#1)(2011-3#1)
other fields##6##2##(2008-10#3)(2008-11#1)(2011-1#1)(2011-3#1)
other filamentous fungi##2##3##(2008-10#1)(2012-3#1)
other findings##4##2##(1996-12#1)(1997-3#1)(2011-2#1)(2012-3#1)
other fish species##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
other fish##7##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)(2010-5#1)(2012-2#1)
other flow##3##2##(2008-10#3)
other food##2##2##(1997-4#1)(2011-2#1)
other foods##2##2##(1990-2#1)(2011-1#1)
other for##12##2##(1992-8#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-3#4)(2008-4#2)(2011-2#1)
other forearm##3##2##(2008-5#2)(2008-9#1)
other forebrain##3##2##(1993-12#2)(1993-6#1)
other form##3##2##(2008-10#1)(2010-5#1)(2010-6#1)
other forms of##29##3##(1991-1#1)(1991-11#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
other forms##30##2##(1991-1#1)(1991-11#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
other formulations##3##2##(2008-10#2)(2008-5#1)
other four##13##2##(1990-8#1)(1994-6#1)(1995-9#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#6)(2012-2#1)
other fractions##2##2##(2008-10#1)(2008-11#1)
other from the##3##3##(1992-6#1)(2008-3#1)(2010-8#1)
other from##9##2##(1990-5#1)(1992-6#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)
other fullerenes##2##2##(2008-2#2)
other functional##2##2##(2008-4#1)(2013-1#1)
other functions##5##2##(1992-9#1)(2008-4#2)(2008-9#1)(2010-8#1)
other fungal pathogens##2##3##(2008-10#2)
other fungal##5##2##(1997-2#2)(1997-6#1)(2008-10#2)
other fungi##13##2##(1994-3#1)(2008-10#10)(2008-5#1)(2010-7#1)
other fungicides##2##2##(2008-10#2)
other gases##5##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-2#2)
other gastrointestinal##2##2##(2007-8#1)(2013-1#1)
other geminiviruses##2##2##(2008-10#1)(2008-8#1)
other gene##10##2##(1990-11#1)(1994-12#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
other gene-finding programs##2##3##(1996-12#1)(2008-4#1)
other genera##2##2##(2007-12#1)(2008-12#1)
other generating##2##2##(2007-8#1)(2008-7#1)
other genes in##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
other genes##25##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1996-2#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-10#1)(2009-8#1)(2010-3#1)(2012-3#1)
other genetic factors##2##3##(2008-7#1)(2013-1#1)
other genetic##8##2##(1994-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
other genomes##3##2##(2008-2#1)(2008-7#1)(2012-2#1)
other genomic##4##2##(1993-8#2)(2008-10#1)(2010-3#1)
other genotypes (A##2##3##(2008-10#2)
other genotypes##5##2##(2008-10#4)(2008-8#1)
other geographic areas##2##3##(2008-10#1)(2010-8#1)
other geographic##3##2##(1992-8#1)(2008-10#1)(2010-8#1)
other geographical##2##2##(1991-11#1)(2013-7#1)
other governmental##3##2##(1996-1#1)(2008-11#2)
other gram-negative bacteria##2##3##(2008-10#1)(2013-1#1)
other grape##2##2##(2008-10#2)
other grasses##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
other group members##3##3##(2008-9#3)
other group##21##2##(1991-2#2)(1991-6#1)(1992-12#1)(1995-1#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#3)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
other groups are##2##3##(1993-11#1)(1997-6#1)
other groups of##9##3##(1990-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-11#1)(1995-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
other groups##47##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-2#4)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)
other growth factors##2##3##(1990-5#1)(2008-11#1)
other growth##4##2##(1990-5#1)(1992-9#1)(1995-11#1)(2008-11#1)
other health care professionals##8##4##(1994-3#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
other health care providers##5##4##(1992-2#1)(1993-1#1)(1994-12#1)(1997-3#1)(2007-12#1)
other health care##21##3##(1992-2#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#2)(1996-12#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-11#4)(2008-4#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
other health problems##3##3##(2008-1#1)(2008-9#1)(2013-7#1)
other health professionals##2##3##(1994-6#1)(2008-11#1)
other health professions were##2##4##(1991-6#2)
other health professions##4##3##(1991-6#2)(1997-3#1)(2010-3#1)
other health systems##2##3##(1996-12#1)(2010-8#1)
other health##45##2##(1991-3#1)(1991-6#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#3)(1996-12#2)(1997-3#2)(1997-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#1)(2012-12#2)(2013-7#1)
other healthcare##5##2##(1997-2#1)(2010-1#1)(2010-12#1)(2011-2#2)
other heart diseases##2##3##(1990-3#1)(1993-2#1)
other heart##3##2##(1990-3#1)(1992-9#1)(1993-2#1)
other heavy metals and##2##4##(1995-3#1)(2008-10#1)
other heavy metals##3##3##(1995-3#2)(2008-10#1)
other heavy##5##2##(1995-2#1)(1995-3#2)(2008-10#2)
other hematological##3##2##(1993-3#1)(2008-7#1)(2010-11#1)
other hepatic##2##2##(1991-8#1)(2008-5#1)
other herpesviruses##2##2##(1993-11#1)(2007-6#1)
other high-risk##4##2##(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)
other higher##5##2##(1993-6#1)(1994-5#1)(2007-12#1)(2008-12#1)(2008-3#1)
other highly##2##2##(1997-2#1)(2008-7#1)
other histone##2##2##(1990-5#1)(1993-9#1)
other homologous##3##2##(1994-5#1)(1994-8#1)(1997-6#1)
other hormones##2##2##(1990-11#1)(1990-6#1)
other hospital##5##2##(1990-2#1)(1990-9#1)(1993-3#1)(1995-12#1)(2010-8#1)
other hospitals##6##2##(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#2)(2008-11#1)
other host cells##2##3##(2008-10#1)(2012-12#1)
other host plants##3##3##(2008-10#3)
other host species##4##3##(2008-10#3)(2012-12#1)
other host##13##2##(2008-10#10)(2011-2#1)(2012-12#2)
other hosts##20##2##(2008-10#18)(2011-2#2)
other human##8##2##(1993-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
other identifiable##2##2##(2007-7#1)(2008-10#1)
other identified##4##2##(2007-12#2)(2008-10#1)(2013-8#1)
other imaging modalities##2##3##(2008-8#1)(2010-11#1)
other imaging techniques##3##3##(2010-6#1)(2011-2#1)(2012-2#1)
other imaging##10##2##(1991-2#1)(1992-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#2)
other immune cell##2##3##(1992-2#1)(2010-5#1)
other immune##3##2##(1992-2#1)(2008-4#1)(2010-5#1)
other immunological tests were##2##4##(2007-2#2)
other immunological##3##2##(2007-2#2)(2008-10#1)
other important analytical##3##3##(2008-10#2)(2008-2#1)
other important factors##2##3##(2008-7#1)(2011-1#1)
other important##20##2##(1991-3#1)(1992-2#1)(1992-3#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-4#1)(2013-7#1)(2013-8#1)
other in a##7##3##(1991-12#1)(1995-2#1)(2008-10#1)(2009-5#1)(2012-12#2)(2013-7#1)
other in the##10##3##(1996-2#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2013-1#1)
other in their##2##3##(1997-7#1)(2008-3#1)
other in vivo##2##3##(1991-9#1)(2008-10#1)
other in##38##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-9#1)(1992-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
other independent##2##2##(1992-2#1)(2008-7#1)
other indications##2##2##(1995-5#1)(2010-3#1)
other indicators of##2##3##(1997-1#1)(2008-1#1)
other indicators##4##2##(1997-1#1)(2007-7#1)(2008-1#1)(2011-1#1)
other indigenous##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
other individuals##2##2##(1992-2#1)(2010-5#1)
other industries##5##2##(1993-12#2)(1995-12#2)(2009-11#1)
other infection-related##2##2##(2008-7#1)(2009-8#1)
other infections##6##2##(1995-5#1)(1995-9#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
other infectious disease##2##3##(1995-11#1)(2010-2#1)
other infectious##4##2##(1995-11#1)(2008-5#1)(2008-8#1)(2010-2#1)
other inflammatory##4##2##(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
other information##3##2##(1996-11#1)(2008-11#1)(2008-4#1)
other ingredients in##2##3##(2008-10#2)
other inhibitors of##3##3##(1994-11#1)(1995-3#1)(2007-11#1)
other inhibitors##4##2##(1994-11#1)(1995-3#2)(2007-11#1)
other initiatives##2##2##(1995-12#1)(2008-3#1)
other inocula##2##2##(2008-10#2)
other inorganic anions##2##3##(2008-10#2)
other inorganic species##2##3##(2008-10#2)
other inorganic##6##2##(2008-10#5)(2010-12#1)
other insect##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
other instances##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
other institutions as##2##3##(1994-3#1)(1995-1#1)
other institutions##8##2##(1991-3#1)(1994-3#1)(1995-1#1)(1996-1#2)(1997-1#1)(2007-4#1)(2008-9#1)
other interesting##2##2##(2008-11#1)(2008-4#1)
other interferents##2##2##(2008-10#2)
other interfering##3##2##(2008-10#3)
other intracellular##2##2##(1992-12#1)(2008-10#1)
other invasive##3##2##(1990-2#1)(1992-6#1)(2011-2#1)
other investigators##5##2##(1990-3#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-8#1)
other ions##13##2##(2008-10#10)(2008-2#1)(2008-6#1)(2010-11#1)
other is a##6##3##(1993-3#1)(2008-3#4)(2010-8#1)
other is based on##2##4##(2008-10#1)(2008-2#1)
other is the##3##3##(2008-11#1)(2008-2#2)
other is##22##2##(1992-3#1)(1992-9#1)(1993-3#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#6)(2008-9#1)(2009-10#1)(2009-3#1)(2010-8#1)(2013-1#1)
other isoforms##3##2##(1992-3#1)(1996-5#1)(2010-12#1)
other isolates of##2##3##(2008-10#2)
other isolates were##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
other isolates##12##2##(2008-10#9)(2008-7#1)(2008-9#1)(2011-2#1)
other issues of concern##2##4##(1997-1#1)(2013-1#1)
other issues##10##2##(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#2)(1997-5#1)(2008-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
other key##4##2##(1994-1#1)(2008-10#1)(2009-11#1)(2012-2#1)
other kinds of##6##3##(1990-3#1)(1991-3#1)(1993-12#1)(1995-5#1)(2008-3#1)(2012-12#1)
other known genes##4##3##(1996-12#2)(1996-6#1)(1997-6#1)
other known##34##2##(1990-2#1)(1990-8#1)(1991-5#1)(1993-11#1)(1993-6#1)(1994-8#2)(1995-2#5)(1995-3#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
other laboratories##6##2##(1990-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)
other laboratory tests##2##3##(2008-1#1)(2009-3#1)
other laboratory##3##2##(2008-1#1)(2009-3#1)(2012-3#1)
other languages##2##2##(2008-10#1)(2012-3#1)
other large##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
other laser##3##2##(1995-2#1)(2008-3#2)
other layered##2##2##(2008-10#1)(2008-2#1)
other layers##6##2##(1994-2#3)(1997-3#1)(2008-12#1)(2011-2#1)
other leaf rust##2##3##(2008-10#2)
other lesions##2##2##(2006-12#1)(2010-12#1)
other less##4##2##(1992-9#1)(2008-1#1)(2009-12#1)(2012-2#1)
other levels of##2##3##(2007-11#1)(2013-8#1)
other levels##3##2##(2007-11#1)(2009-6#1)(2013-8#1)
other libraries##2##2##(1990-5#1)(1993-1#1)
other lifestyle##5##2##(1993-11#1)(2008-11#1)(2009-5#1)(2013-8#2)
other ligands##5##2##(1996-2#1)(2008-10#2)(2008-7#1)(2009-8#1)
other lipid##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
other liquid##2##2##(2008-10#1)(2011-2#1)
other living organisms##2##3##(2008-10#1)(2011-2#1)
other living##4##2##(1994-2#1)(2008-10#2)(2011-2#1)
other local##3##2##(1994-12#1)(1995-3#1)(1996-9#1)
other location##2##2##(2007-8#2)
other locations##12##2##(1995-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-1#1)(2010-8#1)(2012-3#1)
other loci##2##2##(2008-12#1)(2009-4#1)
other loculoascomycetes##2##2##(2008-10#2)
other luteoviruses##2##2##(2008-10#2)
other main##2##2##(1994-6#1)(2012-2#1)
other maize##2##2##(2011-2#2)
other major##10##2##(1991-2#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
other males##3##2##(1993-11#1)(2008-8#1)(2009-6#1)
other malformations##2##2##(2008-10#1)(2011-1#1)
other malignancies##3##2##(2008-4#1)(2008-6#1)(2010-3#1)
other mammalian species##2##3##(1991-2#1)(1994-12#1)
other mammalian##5##2##(1991-2#1)(1994-12#2)(1994-6#1)(2008-10#1)
other mammals##10##2##(1992-11#1)(1992-12#2)(1993-3#1)(1994-2#1)(1995-6#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
other manifestations##3##2##(2008-1#1)(2008-9#1)(2009-4#1)
other markers of##5##3##(2008-1#1)(2008-5#1)(2010-5#1)(2012-5#1)(2013-8#1)
other markers##8##2##(2008-1#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-3#1)(2012-5#1)(2013-8#1)
other materials##10##2##(1990-2#1)(2007-12#2)(2008-10#3)(2008-9#1)(2013-1#2)(2013-8#1)
other matrix metalloproteinases##2##3##(2008-4#1)(2008-9#1)
other matrix##5##2##(2008-10#3)(2008-4#1)(2008-9#1)
other meaningful##2##2##(2009-10#1)(2012-3#1)
other means of##4##3##(1994-6#1)(1996-3#1)(2008-4#1)(2011-2#1)
other means##6##2##(1994-6#1)(1996-3#1)(1997-5#1)(2008-2#1)(2008-4#1)(2011-2#1)
other measures of##7##3##(1992-12#1)(1994-12#1)(1996-12#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
other measures##8##2##(1992-12#1)(1994-12#1)(1996-12#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
other mechanisms by which##2##4##(1997-7#1)(2008-4#1)
other mechanisms of##3##3##(1991-9#1)(1992-8#1)(2008-10#1)
other mechanisms such as##2##4##(1997-4#1)(2010-12#1)
other mechanisms##18##2##(1991-9#2)(1992-6#1)(1992-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-7#1)(2010-12#1)
other media##4##2##(2008-10#2)(2008-2#1)(2011-1#1)
other mediators that activate##2##4##(2008-4#2)
other mediators##3##2##(2008-4#2)(2008-5#1)
other medical##18##2##(1991-12#1)(1992-1#1)(1992-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-7#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
other members of the family##3##5##(2008-10#1)(2009-10#1)(2012-12#1)
other members of the##23##4##(1991-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)
other members of this family##4##5##(1996-12#1)(2008-10#1)(2008-4#1)(2010-3#1)
other members of this##5##4##(1990-7#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-3#1)
other members of##29##3##(1990-7#1)(1991-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#3)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
other members##30##2##(1990-7#1)(1991-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#3)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
other membrane proteins##2##3##(1993-8#1)(1995-12#1)
other membrane##3##2##(1993-8#1)(1995-12#1)(2008-10#1)
other membranes##6##2##(2007-7#2)(2008-1#2)(2008-10#2)
other men##4##2##(2009-5#2)(2010-8#1)(2011-2#1)
other mental##4##2##(1993-12#1)(2009-7#1)(2010-2#1)(2013-8#1)
other mesenchymal##2##2##(2008-11#1)(2013-1#1)
other metabolic##5##2##(1994-12#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-1#1)
other metal cations##3##3##(2008-10#3)
other metal ions##13##3##(2008-10#13)
other metal##20##2##(2008-10#20)
other metallic##3##2##(2008-10#2)(2008-7#1)
other metals##10##2##(2008-10#8)(2008-5#1)(2010-11#1)
other metastatic##2##2##(1997-3#1)(2008-11#1)
other method##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
other methods are##3##3##(1992-11#1)(1997-5#1)(2008-11#1)
other methods can##2##3##(2008-5#1)(2009-10#1)
other methods of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
other methods such as##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
other methods used##2##3##(1990-3#1)(2007-11#1)
other methods##45##2##(1990-3#2)(1991-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-7#1)(2011-1#1)(2013-8#2)
other microbes##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
other microorganisms##3##2##(2008-10#2)(2008-5#1)
other midline##2##2##(1997-3#2)
other minimally invasive approaches##2##4##(2013-1#2)
other minimally invasive##3##3##(2007-8#1)(2013-1#2)
other minor loci##2##3##(2008-10#1)(2010-5#1)
other minor##7##2##(1990-5#1)(1993-11#1)(1993-12#1)(2008-10#2)(2009-12#1)(2010-5#1)
other mitochondrial##3##2##(1993-2#1)(1995-5#1)(2008-7#1)
other modalities##5##2##(2007-11#1)(2008-1#2)(2008-5#1)(2010-6#1)
other mode##2##2##(2008-10#1)(2009-6#1)
other model organisms##2##3##(2008-4#1)(2008-7#1)
other model##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
other models of##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
other models##9##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-1#1)
other modified##2##2##(1995-5#1)(2008-10#1)
other modular##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
other modules##2##2##(2008-11#2)
other molecular##6##2##(1990-6#1)(2007-4#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
other molecules##7##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2013-1#2)
other monoamine##3##2##(1990-12#1)(1993-3#1)(1996-5#1)
other mononuclear##2##2##(2008-4#2)
other more aggressive##2##3##(2009-8#1)(2013-1#1)
other more##9##2##(1991-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2013-1#1)
other morphological##2##2##(2008-7#1)(2012-3#1)
other multiple##2##2##(2008-4#1)(2011-1#1)
other multivariate statistical##2##3##(2008-10#1)(2010-8#1)
other murine##3##2##(1997-1#2)(2011-2#1)
other mutants##4##2##(1993-11#1)(1995-6#1)(2008-10#1)(2008-8#1)
other mutations##4##2##(1990-8#1)(1997-4#1)(2006-8#1)(2012-12#1)
other nations##2##2##(1993-2#1)(2008-1#1)
other natural##4##2##(2008-8#1)(2013-1#3)
other naturally occurring##2##3##(1990-11#1)(2008-10#1)
other naturally##3##2##(1990-11#1)(2008-10#1)(2009-12#1)
other neighboring##2##2##(2008-12#1)(2008-4#1)
other neoplasms##2##2##(1990-12#1)(2012-2#1)
other nervous system##2##3##(2010-3#1)(2012-3#1)
other neural##2##2##(1994-9#1)(2008-7#1)
other neurochemical##2##2##(1991-5#1)(1996-12#1)
other neurodegenerative diseases##3##3##(2008-5#1)(2010-12#1)(2010-5#1)
other neurodegenerative disorders##2##3##(1994-11#1)(2008-7#1)
other neurodegenerative##6##2##(1994-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)
other neurological##7##2##(1996-12#1)(1996-6#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
other neurons##5##2##(1997-3#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)
other neurotransmitter##3##2##(1993-12#1)(2008-5#1)(2009-6#1)
other neurotransmitters##2##2##(1993-12#1)(2008-7#1)
other new##3##2##(1994-3#1)(2007-12#1)(2008-11#1)
other nonspecific##2##2##(1992-3#1)(1993-3#1)
other not only##2##3##(2008-10#1)(2008-9#1)
other nuclear proteins##2##3##(1991-12#1)(1997-6#1)
other nuclear##5##2##(1991-12#1)(1993-6#1)(1994-3#1)(1997-6#1)(2008-10#1)
other nucleic acids##2##3##(2008-5#2)
other nucleotides##4##2##(2008-4#4)
other objects##2##2##(2008-11#1)(2008-6#1)
other observations##3##2##(1991-12#1)(1994-5#1)(1996-5#1)
other occupational##4##2##(1994-3#2)(2009-12#2)
other occupations##3##2##(1991-4#1)(1993-3#1)(1995-1#1)
other ocular##2##2##(1994-9#1)(2008-7#1)
other of##7##2##(1992-12#1)(1993-2#2)(2007-6#1)(2008-10#2)(2008-6#1)
other official##2##2##(2008-5#1)(2009-7#1)
other on the##3##3##(1997-1#1)(2008-7#1)(2010-8#1)
other on##5##2##(1997-1#1)(2008-7#2)(2008-9#1)(2010-8#1)
other one##11##2##(1995-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-1#1)
other optical systems##2##3##(2008-2#1)(2008-3#1)
other optical##6##2##(2008-2#1)(2008-3#4)(2011-1#1)
other or##3##2##(1992-12#1)(2008-11#1)(2008-6#1)
other oral##4##2##(2007-12#1)(2008-5#2)(2013-8#1)
other orders of##3##3##(2007-12#2)(2008-5#1)
other organ##3##2##(1995-1#1)(2008-7#1)(2010-12#1)
other organic solvents##2##3##(1994-8#1)(2008-11#1)
other organic##7##2##(1990-3#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#1)
other organisms and##2##3##(1995-9#1)(2012-3#1)
other organisms##26##2##(1990-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2012-2#1)(2012-3#1)
other organizations##6##2##(1993-1#1)(1994-12#1)(1994-7#1)(1995-1#1)(2007-7#1)(2012-2#1)
other organs and##3##3##(2007-5#1)(2011-2#1)(2012-3#1)
other organs or##3##3##(1995-2#1)(2008-7#1)(2013-1#1)
other organs##18##2##(1991-9#1)(1994-5#2)(1995-2#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
other outcome##2##2##(2007-12#1)(2013-1#1)
other outcomes##4##2##(1995-2#1)(2008-12#1)(2008-3#1)(2013-8#1)
other outdoor and indoor allergens##2##5##(2013-1#2)
other oxidant##2##2##(2008-10#2)
other oxidative stress##2##3##(1995-5#1)(2010-10#1)
other pH values##2##3##(2008-11#1)(2008-5#1)
other paradigms##2##2##(1996-5#1)(2011-2#1)
other parameter##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
other parameters also##2##3##(2008-9#1)(2013-1#1)
other parameters such as age##2##5##(1990-8#1)(2011-2#1)
other parameters such as##3##4##(1990-8#1)(1992-5#1)(2011-2#1)
other parameters were##2##3##(2008-10#2)
other parameters##21##2##(1990-8#1)(1992-5#2)(1992-9#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
other part of the##4##4##(1990-11#1)(2008-1#1)(2008-9#1)(2011-2#1)
other parties##3##2##(2007-11#1)(2010-12#1)(2011-2#1)
other parts of the##8##4##(1994-5#2)(2007-12#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-5#1)
other parts of##17##3##(1991-12#1)(1994-5#2)(1996-1#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)
other party##3##2##(1992-2#1)(1996-12#1)(2008-8#1)
other patches##2##2##(2008-8#2)
other pathogenic##4##2##(1997-2#1)(2008-12#1)(2008-9#1)(2012-2#1)
other pathogens##9##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
other pathological conditions##2##3##(1993-2#1)(2013-1#1)
other pathological##5##2##(1993-2#1)(2008-7#1)(2010-11#1)(2013-1#2)
other pathologies##4##2##(1993-3#1)(2007-8#1)(2008-7#1)(2011-1#1)
other pathology##2##2##(2008-10#1)(2013-1#1)
other pathosystems##2##2##(2008-10#2)
other pathotypes##2##2##(2008-10#2)
other pathways##3##2##(2008-10#2)(2008-8#1)
other patient##6##2##(1991-2#1)(1995-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2013-1#1)
other patients had##2##3##(1990-2#1)(2011-2#1)
other patients with a##2##4##(1990-12#1)(2006-10#1)
other patients with##4##3##(1990-12#1)(2006-10#1)(2008-7#1)(2010-3#1)
other patients##24##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#2)
other pediatric##2##2##(2006-10#1)(2010-7#1)
other pelvic organs##2##3##(1996-8#1)(2011-1#1)
other people##7##2##(2008-4#1)(2008-6#2)(2009-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
other people's##2##2##(1997-5#1)(2008-11#1)
other peptide hormones##2##3##(1993-5#1)(2011-1#1)
other peptide##4##2##(1992-8#1)(1993-5#1)(2008-10#1)(2011-1#1)
other peptides##7##2##(1990-7#1)(1991-12#2)(1991-2#1)(1993-5#1)(1995-3#1)(2008-9#1)
other perennial##2##2##(2008-5#1)(2011-2#1)
other performance##3##2##(1992-11#2)(2010-4#1)
other person's##2##2##(1996-6#1)(2008-12#1)
other personality##2##2##(1995-11#1)(2009-8#1)
other persons##2##2##(1993-12#1)(1996-3#1)
other phase##2##2##(2008-10#1)(2008-3#1)
other phenomena##2##2##(2008-3#1)(2012-3#1)
other phenotypes##3##2##(1996-12#1)(2008-9#1)(2012-3#1)
other phyla##2##2##(1992-6#1)(2011-2#1)
other physical activities##2##3##(1995-6#1)(1996-6#1)
other physical##7##2##(1990-8#1)(1992-5#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
other physicians##3##2##(1991-12#1)(1995-2#1)(2007-4#1)
other physiological##4##2##(1990-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
other physiologically##2##2##(1994-8#1)(2008-10#1)
other phytochemicals##2##2##(2010-1#1)(2012-2#1)
other phytopathogenic bacteria##2##3##(2008-10#2)
other phytopathogenic fungi##4##3##(1997-4#1)(2008-10#3)
other phytopathogenic##8##2##(1997-4#1)(2008-10#7)
other phytoplasmas##2##2##(2008-10#2)
other places##2##2##(2008-10#1)(2009-10#1)
other plant species##6##3##(2008-10#4)(2008-8#1)(2010-3#1)
other plant viruses##2##3##(2008-10#1)(2008-9#1)
other plant##18##2##(2008-10#11)(2008-11#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#1)
other plants##15##2##(2008-10#6)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#3)(2013-8#1)
other plasma##2##2##(1995-2#1)(2008-10#1)
other polar##2##2##(1991-9#1)(2008-5#1)
other polycyclic aromatic hydrocarbons##2##4##(2008-10#2)
other polymorphisms##2##2##(2008-4#1)(2010-8#1)
other polypeptides##2##2##(1991-2#1)(1993-11#1)
other poorly##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
other popular##2##2##(2008-11#2)
other populations##20##2##(1991-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
other possibility##2##2##(2011-2#1)(2012-2#1)
other possible causes of these##2##5##(2007-7#1)(2008-7#1)
other possible causes of##3##4##(2007-7#1)(2008-7#1)(2008-8#1)
other possible mechanisms##2##3##(1992-3#1)(2008-10#1)
other possible##14##2##(1991-8#1)(1992-11#2)(1992-3#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-12#1)(2013-1#1)
other potential confounders##2##3##(2008-3#1)(2013-1#1)
other potential sources of##2##4##(1996-5#1)(2008-10#1)
other potential##15##2##(1995-6#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
other potentially##2##2##(1992-3#1)(2013-1#1)
other predictor variables##2##3##(2008-10#1)(2008-2#1)
other previous##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
other previously reported##3##3##(1994-8#1)(2008-10#1)(2012-3#1)
other previously##10##2##(1990-7#1)(1994-8#1)(2008-10#6)(2010-6#1)(2012-3#1)
other primary##4##2##(1996-12#1)(1997-8#1)(2010-4#1)(2013-8#1)
other private##3##2##(1992-3#1)(1993-12#1)(1997-1#1)
other problems encountered with##2##4##(2007-10#1)(2008-7#1)
other problems##8##2##(1993-6#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)
other procedures using##2##3##(2008-4#1)(2008-9#1)
other procedures##10##2##(1990-7#1)(1991-2#1)(1995-1#2)(1995-12#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-9#1)
other processes##6##2##(1991-6#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
other processing enzymes##2##3##(1993-5#2)
other processing##3##2##(1993-5#2)(1994-11#1)
other products##6##2##(1991-9#1)(2007-6#2)(2008-10#2)(2008-5#1)
other professional##3##2##(1995-2#1)(2008-11#1)(2012-12#1)
other professionals##2##2##(1996-12#1)(2008-11#1)
other programs##2##2##(1992-2#1)(2008-10#1)
other properties of the##2##4##(1991-5#1)(2012-2#1)
other properties of##3##3##(1991-5#1)(2008-9#1)(2012-2#1)
other properties##12##2##(1991-5#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
other proposed##2##2##(1996-1#1)(2007-12#1)
other protein components##2##3##(1991-12#1)(1995-2#1)
other protein##14##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-11#1)(2013-7#1)
other proteins in##2##3##(1993-11#1)(2010-4#1)
other proteins involved in##3##4##(1996-2#1)(2006-10#1)(2009-8#1)
other proteins such as##2##4##(1993-8#1)(2008-10#1)
other proteins that##3##3##(1992-3#1)(2008-10#1)(2013-8#1)
other proteins were##2##3##(1997-2#1)(2008-12#1)
other proteins##32##2##(1991-4#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-6#2)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
other protocols##2##2##(2008-4#2)
other providers##9##2##(1991-3#1)(1992-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
other provinces##2##2##(2010-12#1)(2013-8#1)
other psychiatric disorders##4##3##(1991-1#1)(2008-1#2)(2008-2#1)
other psychiatric##6##2##(1991-1#1)(1993-12#1)(1994-2#1)(2008-1#2)(2008-2#1)
other psychological##2##2##(1992-5#1)(2010-11#1)
other public##2##2##(1993-6#1)(2011-1#1)
other published methods##2##3##(2008-10#1)(2008-5#1)
other published reports##2##3##(1990-9#1)(2011-1#1)
other published##10##2##(1990-9#1)(1992-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
other putative##2##2##(1995-8#1)(2010-2#1)
other questions##4##2##(1992-12#1)(2008-3#2)(2012-2#1)
other race##2##2##(2008-10#2)
other races##2##2##(1995-2#1)(2008-10#1)
other racial##2##2##(2008-5#1)(2013-1#1)
other rare earth elements##3##4##(2008-10#3)
other rare##8##2##(2008-10#6)(2008-2#1)(2008-9#1)
other rat tissues##2##3##(1991-2#1)(1994-12#1)
other reactions##5##2##(1990-8#1)(1991-3#1)(1992-11#1)(1997-7#1)(2008-7#1)
other reasons##8##2##(1990-3#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
other recent##6##2##(1994-3#1)(1997-3#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
other receptors##2##2##(1995-2#1)(2013-7#1)
other recombinant##3##2##(2008-11#2)(2008-4#1)
other regions in##2##3##(2008-1#1)(2009-5#1)
other regions of the world##4##5##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
other regions of the##7##4##(1993-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-3#1)
other regions##23##2##(1993-12#2)(1993-6#1)(1995-3#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2009-12#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
other regular##2##2##(2008-3#2)
other regulatory##2##2##(1991-3#1)(2008-7#1)
other related##12##2##(1991-6#1)(1992-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-7#1)
other relatives##3##2##(1997-3#1)(1997-8#1)(2011-2#1)
other relevant##7##2##(1994-3#1)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)
other remains##2##2##(2008-11#1)(2009-7#1)
other reported cases##2##3##(2010-8#1)(2013-1#1)
other reported methods##2##3##(2008-10#1)(2009-10#1)
other reported##15##2##(1990-7#1)(1991-6#1)(1992-8#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
other reports of##2##3##(1991-6#1)(2009-8#1)
other reports##11##2##(1990-3#1)(1991-6#1)(1994-2#1)(1997-4#1)(2007-7#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)
other representatives of##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
other research##6##2##(1997-3#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#1)
other researchers##7##2##(2007-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-3#1)
other residues##2##2##(1995-5#1)(2008-8#1)
other resistance genes##2##3##(2008-10#1)(2008-11#1)
other resistant##3##2##(2008-10#3)
other resource poor##2##3##(2007-2#1)(2010-8#1)
other resources##5##2##(1993-12#1)(2007-2#1)(2008-10#2)(2013-7#1)
other respects##2##2##(1993-3#1)(1995-2#1)
other respiratory##5##2##(2007-11#1)(2008-11#1)(2009-3#1)(2011-2#2)
other response##2##2##(2008-10#2)
other results##4##2##(1992-6#1)(1995-2#1)(2007-11#1)(2008-3#1)
other retroviral integrases##2##3##(1997-3#2)
other retroviral##3##2##(1997-3#2)(2008-5#1)
other risk factors##10##3##(1990-3#1)(1992-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-10#1)(2013-1#1)
other risk##13##2##(1990-3#1)(1992-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
other risks##4##2##(1997-4#1)(2008-7#1)(2009-12#1)(2011-2#1)
other rodents##4##2##(2008-4#1)(2010-11#2)(2011-2#1)
other samples##2##2##(1997-5#1)(2012-1#1)
other sampling##3##2##(2008-10#1)(2013-7#2)
other schemes##2##2##(2008-10#1)(2008-3#1)
other screening##2##2##(1992-3#1)(2008-10#1)
other seasonal allergens##3##3##(2011-2#3)
other seed crops##2##3##(2008-10#1)(2013-8#1)
other seed##3##2##(2008-10#2)(2013-8#1)
other selected lanthanides##2##3##(2008-10#2)
other selected##5##2##(1991-12#1)(2008-10#2)(2010-5#1)(2011-2#1)
other selective##2##2##(1991-8#1)(2008-10#1)
other sensors##3##2##(2008-10#2)(2008-3#1)
other sequences##3##2##(1997-3#1)(2008-8#1)(2009-9#1)
other series##2##2##(1993-5#1)(1996-6#1)
other serine proteases##4##3##(1991-9#1)(1995-5#1)(1995-6#1)(2008-4#1)
other serious##2##2##(1995-3#1)(2008-8#1)
other service##3##2##(1994-12#1)(2008-11#1)(2012-3#1)
other services##3##2##(1994-1#1)(2008-1#1)(2010-9#1)
other settings##6##2##(1992-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-7#1)(2013-1#1)
other seven##2##2##(1991-5#1)(2008-2#1)
other several##2##2##(1992-2#1)(2008-10#1)
other severe##2##2##(2007-12#1)(2012-2#1)
other sexually transmitted infections##4##4##(2007-7#1)(2009-5#1)(2011-2#2)
other sexually transmitted##7##3##(1993-6#1)(1993-9#1)(1997-6#1)(2007-7#1)(2009-5#1)(2011-2#2)
other showed##2##2##(1993-6#1)(1994-2#1)
other side effects##3##3##(2009-7#1)(2010-7#1)(2013-1#1)
other side of the##3##4##(1994-2#1)(2008-10#1)(2008-4#1)
other side of##4##3##(1994-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
other side##14##2##(1992-3#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
other signaling##5##2##(2008-11#1)(2008-4#1)(2009-6#2)(2009-8#1)
other signalling##2##2##(1996-2#1)(2008-9#1)
other signals##3##2##(1997-3#1)(2008-11#1)(2012-12#1)
other significant##7##2##(1994-5#1)(1995-6#1)(2008-1#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
other similar cases##2##3##(1992-2#1)(1997-3#1)
other similar##5##2##(1992-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2010-4#1)
other simultaneous##2##2##(1992-12#1)(2008-3#1)
other single##2##2##(2008-2#1)(2011-2#1)
other sisters##2##2##(2011-2#2)
other sites are##2##3##(1995-6#1)(2008-5#1)
other sites in##2##3##(2007-12#1)(2013-1#1)
other sites##21##2##(1991-12#2)(1992-12#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-5#1)(2013-1#1)
other situations##6##2##(1991-12#1)(1991-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-10#1)
other six##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
other skeletal##2##2##(1993-11#1)(2011-1#1)
other skin##4##2##(1991-6#1)(2007-12#1)(2008-5#2)
other small##7##2##(1990-12#1)(1993-11#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-8#1)
other social Hymenoptera##2##3##(2008-8#2)
other social behaviors##2##3##(2008-10#1)(2009-4#1)
other social##8##2##(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
other sociodemographic##2##2##(2011-2#1)(2012-12#1)
other soft tissue##2##3##(2007-12#1)(2008-10#1)
other soft##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
other soil##2##2##(2008-10#1)(2008-11#1)
other solid##6##2##(1994-10#1)(2008-10#1)(2008-3#1)(2008-7#3)
other solvents##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
other sorbent materials##2##3##(2008-10#2)
other sources of funding##2##4##(1994-2#1)(1997-2#1)
other sources of##12##3##(1994-2#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
other sources##21##2##(1990-8#1)(1992-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
other special##2##2##(1996-1#1)(2012-2#1)
other specialists and##2##3##(2011-2#1)(2011-3#1)
other species and##4##3##(1992-12#1)(1997-9#1)(2008-10#1)(2008-3#1)
other species are##2##3##(2008-10#1)(2008-4#1)
other species has##2##3##(2008-10#1)(2008-11#1)
other species in the##2##4##(2008-8#1)(2010-3#1)
other species in##3##3##(2008-5#1)(2008-8#1)(2010-3#1)
other species of Phytophthora##2##4##(2008-10#2)
other species of plants##2##4##(2008-10#1)(2008-6#1)
other species of##17##3##(1993-12#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-6#2)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
other species##94##2##(1990-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-7#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-9#1)(2007-12#3)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#2)(2009-4#4)(2009-8#1)(2010-11#1)(2010-3#2)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
other specific##4##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-8#1)
other spectral regions##2##3##(2008-3#2)
other spectral##3##2##(2008-3#2)(2008-7#1)
other spectroscopic##2##2##(2008-10#1)(2008-4#1)
other spinal##2##2##(2007-11#1)(2011-2#1)
other spirochetes##2##2##(1990-2#1)(2008-9#1)
other stages of##2##3##(2009-10#1)(2009-8#1)
other stages##4##2##(2008-1#1)(2009-10#1)(2009-8#1)(2011-2#1)
other states##6##2##(1992-1#1)(1994-9#1)(1996-12#2)(1997-1#1)(2008-10#1)
other statins##3##2##(2008-5#3)
other stem##2##2##(2008-9#1)(2009-3#1)
other steps##2##2##(2009-2#1)(2011-2#1)
other steroids and##2##3##(1994-9#1)(1995-12#1)
other steroids##3##2##(1992-5#1)(1994-9#1)(1995-12#1)
other stimuli##4##2##(1990-5#1)(2008-4#1)(2009-10#2)
other strains by##2##3##(2008-10#2)
other strains of##5##3##(1991-12#1)(2008-10#2)(2008-7#2)
other strains##21##2##(1991-12#1)(1993-2#1)(1995-9#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-3#1)
other strategies##2##2##(2008-11#1)(2010-7#1)
other stress##2##2##(2008-12#1)(2008-7#1)
other stresses##2##2##(1994-11#1)(2008-7#1)
other stressors##2##2##(1996-12#1)(2008-11#1)
other structural##7##2##(1992-6#1)(1992-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
other structurally similar##2##3##(1990-8#1)(2008-7#1)
other structurally##4##2##(1990-8#1)(1994-5#1)(2008-7#2)
other structures in##2##3##(2007-11#1)(2013-8#1)
other structures##4##2##(1994-2#1)(2007-11#1)(2012-2#1)(2013-8#1)
other studies in##3##3##(1994-1#1)(2013-7#1)(2013-8#1)
other studies of##3##3##(1990-5#1)(2008-9#1)(2011-2#1)
other studies on##2##3##(1994-2#1)(2008-5#1)
other studies that##2##3##(2007-2#1)(2008-3#1)
other studies to##2##3##(1994-9#1)(2008-5#1)
other studies we##2##3##(2008-12#1)(2008-3#1)
other studies##43##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-4#1)(1997-5#1)(1997-9#1)(2007-2#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
other study##2##2##(2007-8#1)(2008-10#1)
other subcellular organelles##2##3##(1990-11#1)(2008-4#1)
other subcellular##3##2##(1990-11#1)(2008-4#1)(2008-9#1)
other subjects in the##2##4##(2010-11#1)(2011-2#1)
other subjects##6##2##(1991-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-2#1)
other subsets##2##2##(2008-10#2)
other substances which##2##3##(1996-1#1)(2008-10#1)
other substances##13##2##(1991-3#1)(1996-1#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#1)
other substrates##4##2##(1991-9#1)(1993-6#1)(1994-8#1)(2008-11#1)
other subtypes##4##2##(1991-12#1)(2008-8#1)(2010-6#1)(2012-2#1)
other subunits##2##2##(2009-2#1)(2009-9#1)
other such##5##2##(1995-2#1)(1997-3#1)(2007-2#1)(2008-4#1)(2008-5#1)
other suggests that##2##3##(1997-8#1)(2009-5#1)
other supportive##2##2##(2007-7#1)(2011-2#1)
other surface##2##2##(1990-8#1)(2011-1#1)
other surgical and##2##3##(1990-6#1)(1994-3#1)
other surgical procedures##2##3##(1991-8#1)(1992-6#1)
other surgical##5##2##(1990-6#1)(1991-8#1)(1992-6#1)(1994-3#1)(2012-3#1)
other symptomatology##2##2##(1996-5#1)(2011-2#1)
other symptoms of##3##3##(1994-2#1)(2008-5#1)(2013-7#1)
other symptoms##10##2##(1994-2#1)(2008-2#1)(2008-5#2)(2009-1#2)(2011-2#2)(2012-3#1)(2013-7#1)
other syndromes##2##2##(2010-1#1)(2011-2#1)
other synthetic##3##2##(1992-12#1)(1995-2#1)(2008-5#1)
other systemic##4##2##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
other systems##19##2##(1994-10#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#1)
other tasks##2##2##(2012-2#1)(2013-1#1)
other taxa in the genus##2##5##(2008-10#2)
other taxa##3##2##(2008-10#3)
other techniques and##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
other techniques##27##2##(1991-2#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#2)
other technological##2##2##(2008-7#1)(2009-11#1)
other technologies##4##2##(1993-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
other term##2##2##(2008-10#1)(2008-2#1)
other terms##2##2##(2008-5#1)(2011-2#1)
other tested##3##2##(1991-3#1)(1997-4#1)(2008-10#1)
other tests of##2##3##(1990-3#1)(2011-2#1)
other tests##6##2##(1990-3#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2011-2#1)
other than Al(3+)##2##3##(2008-10#2)
other than English##2##3##(1996-3#1)(2009-8#1)
other than antibiosis##2##3##(2008-10#2)
other than at##2##3##(1992-9#1)(2013-1#1)
other than breast##2##3##(1991-12#1)(1993-6#1)
other than in Wilson's disease##2##5##(2008-9#2)
other than that of the##2##5##(2008-3#1)(2008-6#1)
other than that##4##3##(1997-4#1)(2008-3#1)(2008-6#1)(2012-12#1)
other than the##26##3##(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#2)
other than their##2##3##(2008-9#1)(2010-8#1)
other than those in stage##2##5##(2007-8#2)
other than those##4##3##(1994-3#1)(2007-8#2)(2008-5#1)
other than##156##2##(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-5#1)(1995-8#3)(1996-12#2)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
other therapeutic approaches##2##3##(2008-11#1)(2008-6#1)
other therapeutic##6##2##(1992-9#1)(1996-1#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-2#1)
other therapies##3##2##(2008-5#1)(2008-8#1)(2012-3#1)
other things##11##2##(1990-2#1)(1994-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
other thiols##2##2##(1991-9#2)
other three##27##2##(1994-8#1)(1994-9#1)(1997-6#1)(2007-8#2)(2008-10#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#3)(2010-2#1)(2012-3#1)(2013-8#1)
other through##2##2##(2008-12#1)(2008-3#1)
other time##5##2##(1997-8#1)(2007-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
other times##5##2##(1993-3#1)(2008-10#1)(2009-8#1)(2012-12#2)
other tissue##6##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)
other tissues examined##2##3##(1994-6#1)(1997-4#1)
other tissues##24##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-4#4)(2008-6#1)(2008-9#1)(2010-3#1)(2010-5#1)
other to##18##2##(1990-2#1)(1995-2#1)(1996-4#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
other tools##2##2##(2008-7#1)(2011-2#1)
other tospoviruses##7##2##(2008-10#7)
other toxic##2##2##(2008-10#1)(2008-11#1)
other traditional##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
other transcription factors required for##2##5##(1990-5#1)(2008-9#1)
other transcription factors##8##3##(1990-5#1)(1994-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
other transfection##2##2##(2008-1#1)(2008-11#1)
other transgenic##2##2##(2008-10#1)(2008-12#1)
other transient##2##2##(1996-4#1)(2008-4#1)
other transition metal##3##3##(2008-10#2)(2008-12#1)
other treatment groups##2##3##(1994-5#1)(1995-3#1)
other treatment modalities##3##3##(1991-9#1)(1993-2#1)(2007-11#1)
other treatment options##2##3##(1996-3#1)(2012-2#1)
other treatment##13##2##(1991-9#1)(1992-1#1)(1993-2#1)(1994-5#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
other treatments##14##2##(2008-10#4)(2008-12#2)(2008-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)
other trials with##2##3##(1997-3#1)(2011-2#1)
other trials##4##2##(1992-6#1)(1996-6#1)(1997-3#1)(2011-2#1)
other tumor##6##2##(1991-8#1)(1993-11#1)(2008-6#2)(2009-3#1)(2012-2#1)
other tumors of##2##3##(1992-9#1)(2011-2#1)
other tumors##10##2##(1991-2#1)(1992-9#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-1#1)
other tumours##2##2##(2008-7#1)(2010-3#1)
other twin##2##2##(2010-1#1)(2010-8#1)
other two clones##2##3##(1993-2#1)(1994-12#1)
other two groups##10##3##(1991-11#1)(2007-8#1)(2008-10#4)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
other two patients##2##3##(2006-12#1)(2012-2#1)
other two##68##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#1)(2006-12#2)(2007-10#1)(2007-8#1)(2008-10#23)(2008-3#2)(2008-7#3)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
other type I##2##3##(2007-11#1)(2008-10#1)
other type of##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2013-1#1)
other type##9##2##(1993-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2013-1#1)
other types of cells##2##4##(2008-12#1)(2008-4#1)
other types of##46##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
other types##51##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
other uncharacterized##2##2##(2008-4#1)(2010-10#1)
other unidentified##2##2##(2008-5#1)(2010-8#1)
other unique##2##2##(1993-8#1)(2008-10#1)
other units##2##2##(2008-9#1)(2012-2#1)
other unknown##3##2##(1993-6#1)(2012-3#2)
other unrelated##2##2##(1997-3#1)(2008-1#1)
other urinary##2##2##(1990-2#1)(1990-9#1)
other useful##3##2##(1993-12#1)(2008-11#1)(2008-2#1)
other uses##2##2##(2008-4#1)(2010-5#1)
other using##2##2##(2008-10#2)
other vaccines##3##2##(1991-5#1)(1994-9#1)(1997-7#1)
other variables were##2##3##(1991-12#1)(1994-9#1)
other variables##18##2##(1990-2#1)(1991-12#1)(1991-6#1)(1994-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#3)
other variants##3##2##(1994-12#1)(2007-11#1)(2008-10#1)
other various##2##2##(2008-10#1)(2008-9#1)
other vascular##4##2##(1991-3#1)(1997-8#1)(2008-8#1)(2009-8#1)
other vectors##2##2##(2008-4#1)(2010-8#1)
other vertebrate##4##2##(1990-11#1)(1993-6#1)(2008-5#1)(2010-3#1)
other vertebrates##3##2##(1993-6#1)(1995-2#2)
other viral##3##2##(1997-8#1)(2008-1#1)(2012-2#1)
other viruses##6##2##(1997-6#1)(2007-12#1)(2008-10#4)
other visual##3##2##(1993-11#1)(1993-6#1)(2009-9#1)
other was##12##2##(1991-3#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#2)(2012-2#1)(2013-1#2)
other wavelengths##3##2##(2008-2#1)(2008-3#2)
other which##5##2##(1990-5#1)(1990-8#2)(1995-6#1)(1997-6#1)
other with a##3##3##(1997-6#1)(2008-2#1)(2008-3#1)
other with##14##2##(1992-2#1)(1993-11#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
other women##2##2##(1994-5#1)(1996-12#1)
other words##14##2##(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
other work##2##2##(1993-12#1)(2009-5#1)
other workers##2##2##(2008-8#1)(2011-1#1)
other works##2##2##(1994-1#1)(2008-10#1)
other zinc##2##2##(2008-10#2)
other##7129##1##(1990-10#2)(1990-11#27)(1990-12#30)(1990-2#30)(1990-3#19)(1990-5#35)(1990-6#16)(1990-7#20)(1990-8#25)(1990-9#10)(1991-1#17)(1991-10#6)(1991-11#10)(1991-12#56)(1991-2#39)(1991-3#28)(1991-4#11)(1991-5#24)(1991-6#23)(1991-7#1)(1991-8#15)(1991-9#24)(1992-1#11)(1992-10#5)(1992-11#16)(1992-12#35)(1992-2#24)(1992-3#33)(1992-4#6)(1992-5#15)(1992-6#28)(1992-7#3)(1992-8#34)(1992-9#30)(1993-1#18)(1993-11#35)(1993-12#50)(1993-2#31)(1993-3#27)(1993-5#7)(1993-6#37)(1993-8#26)(1993-9#15)(1994-1#16)(1994-10#3)(1994-11#17)(1994-12#45)(1994-2#34)(1994-3#36)(1994-5#29)(1994-6#20)(1994-7#5)(1994-8#37)(1994-9#23)(1995-1#17)(1995-11#19)(1995-12#39)(1995-2#69)(1995-3#43)(1995-4#2)(1995-5#24)(1995-6#38)(1995-8#25)(1995-9#5)(1996-1#32)(1996-10#3)(1996-11#4)(1996-12#54)(1996-2#33)(1996-3#39)(1996-4#6)(1996-5#28)(1996-6#18)(1996-7#5)(1996-8#6)(1996-9#9)(1997-1#17)(1997-2#40)(1997-3#61)(1997-4#34)(1997-5#15)(1997-6#29)(1997-7#32)(1997-8#21)(1997-9#3)(2006-10#16)(2006-12#6)(2006-6#6)(2006-8#2)(2007-1#3)(2007-10#21)(2007-11#71)(2007-12#99)(2007-2#24)(2007-3#1)(2007-4#9)(2007-5#3)(2007-6#9)(2007-7#42)(2007-8#43)(2007-9#2)(2008-1#97)(2008-10#1279)(2008-11#263)(2008-12#110)(2008-2#119)(2008-3#210)(2008-4#171)(2008-5#249)(2008-6#89)(2008-7#256)(2008-8#195)(2008-9#163)(2009-1#5)(2009-10#44)(2009-11#21)(2009-12#23)(2009-2#14)(2009-3#14)(2009-4#17)(2009-5#34)(2009-6#23)(2009-7#22)(2009-8#41)(2009-9#23)(2010-1#15)(2010-10#20)(2010-11#31)(2010-12#47)(2010-2#22)(2010-3#36)(2010-4#25)(2010-5#34)(2010-6#26)(2010-7#15)(2010-8#63)(2010-9#8)(2011-1#81)(2011-10#3)(2011-2#251)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#22)(2012-12#63)(2012-2#128)(2012-3#101)(2012-4#1)(2012-5#3)(2012-6#2)(2013-1#170)(2013-7#34)(2013-8#91)
other's##8##1##(1995-5#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2010-11#1)
other) were##2##2##(1990-3#1)(2013-1#1)
other)##6##1##(1990-3#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)
other-evaluative##2##1##(2013-8#2)
others (i##2##2##(1991-7#1)(2008-10#1)
others a##3##2##(1995-5#1)(2008-11#1)(2008-12#1)
others and##10##2##(1991-8#1)(1994-1#1)(1996-5#1)(1996-9#1)(2008-4#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
others appear##3##2##(1991-3#1)(1994-8#1)(2009-5#1)
others are##22##2##(1991-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
others argue##2##2##(2010-3#1)(2012-12#1)
others as##5##2##(2007-7#1)(2008-10#1)(2008-5#2)(2011-1#1)
others at risk##2##3##(1990-3#1)(1993-6#1)
others at##3##2##(1990-3#1)(1993-6#1)(1994-12#1)
others but##2##2##(1997-5#1)(2008-11#1)
others by##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
others can##2##2##(2008-10#1)(2009-6#1)
others did not##2##3##(1997-3#1)(2008-1#1)
others do not##6##3##(2008-1#1)(2008-10#1)(2008-9#2)(2010-3#1)(2012-3#1)
others do##7##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-9#2)(2010-3#1)(2012-3#1)
others for##10##2##(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-12#1)
others found##3##2##(2008-1#1)(2008-11#1)(2008-3#1)
others had##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
others has##2##2##(2008-10#1)(2009-8#1)
others have been##2##3##(2008-10#1)(2011-1#1)
others have##18##2##(1992-3#1)(1994-7#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
others in the##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
others in##21##2##(1992-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-2#2)(2011-2#2)(2012-1#1)(2013-1#1)
others is##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-11#1)(2011-2#1)(2013-8#1)
others may be##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
others may##5##2##(1996-12#1)(2006-10#1)(2008-10#2)(2008-4#1)
others methods##2##2##(2007-8#1)(2010-3#1)
others of##2##2##(1991-6#1)(1994-1#1)
others on##3##2##(1993-3#1)(2008-11#1)(2009-9#1)
others previously##2##2##(1995-3#1)(1995-9#1)
others should##2##2##(1994-12#1)(1997-8#1)
others that##5##2##(1990-5#1)(1991-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
others to##14##2##(1990-3#1)(1990-8#1)(1993-3#3)(1995-1#1)(1995-12#1)(1997-3#1)(1997-5#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)
others using##3##2##(1992-2#1)(1994-3#1)(2008-1#1)
others usually##2##2##(1992-5#1)(2007-12#1)
others were found##2##3##(1995-12#1)(2007-10#1)
others were##13##2##(1990-11#1)(1990-5#1)(1990-6#1)(1993-1#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-3#1)(2013-1#1)
others when##2##2##(1991-12#1)(2008-7#1)
others which##3##2##(1990-5#1)(1994-8#1)(2008-10#1)
others who##5##2##(1992-3#2)(1992-9#1)(2008-9#1)(2011-2#1)
others will require##2##3##(2008-6#1)(2012-2#1)
others will##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
others with##4##2##(2008-3#2)(2008-4#1)(2008-9#1)
others##489##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#2)(1993-8#1)(1994-1#4)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#4)(1994-7#3)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#10)(2008-10#61)(2008-11#27)(2008-12#9)(2008-2#9)(2008-3#12)(2008-4#8)(2008-5#15)(2008-6#2)(2008-7#13)(2008-8#12)(2008-9#16)(2009-10#5)(2009-11#4)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#6)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#3)(2010-8#1)(2011-1#9)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#13)(2013-7#2)(2013-8#15)
others'##7##1##(1991-2#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-9#2)(2012-12#1)
others)##11##1##(1992-3#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#2)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
others?##2##1##(2008-9#1)(2013-8#1)
otherwise advantageous##2##2##(2008-4#1)(2008-5#1)
otherwise are##2##2##(1995-3#1)(2013-8#1)
otherwise be##9##2##(1992-3#1)(1994-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-8#1)(2011-1#1)
otherwise clinically##2##2##(1992-5#1)(2011-2#1)
otherwise fit##2##2##(2007-2#2)
otherwise have##4##2##(1991-6#2)(1997-1#1)(2011-2#1)
otherwise healthy subjects##2##3##(1997-6#1)(2008-11#1)
otherwise healthy##12##2##(1991-8#1)(1994-11#1)(1994-9#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)
otherwise identical##5##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
otherwise intact##3##2##(1994-8#1)(2007-8#1)(2008-7#1)
otherwise interfere with##2##3##(2008-10#2)
otherwise it##3##2##(1994-12#1)(2008-10#1)(2008-7#1)
otherwise known##2##2##(2008-8#1)(2008-9#1)
otherwise mentally##2##2##(2008-3#1)(2011-2#1)
otherwise normal##5##2##(1992-4#1)(1995-5#1)(1996-9#1)(2007-12#1)(2008-10#1)
otherwise not##4##2##(2008-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
otherwise rare##2##2##(2008-2#1)(2008-9#1)
otherwise specified##6##2##(1993-12#1)(2007-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
otherwise stable##2##2##(2008-11#1)(2013-1#1)
otherwise the##3##2##(1997-2#1)(2008-5#1)(2008-7#1)
otherwise they were##2##3##(1991-6#1)(2007-12#1)
otherwise they##4##2##(1991-12#1)(1991-6#1)(2007-12#1)(2008-11#1)
otherwise unremarkable##2##2##(2008-11#1)(2013-1#1)
otherwise unstable##2##2##(2008-8#1)(2012-2#1)
otherwise##167##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#4)(1991-8#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#13)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
otic##2##1##(1995-3#1)(2011-2#1)
otitis externa##5##2##(1991-3#2)(2008-5#2)(2013-7#1)
otitis media and chronic##2##4##(1991-4#1)(2013-8#1)
otitis media and##3##3##(1991-4#1)(2008-9#1)(2013-8#1)
otitis media in##3##3##(1990-3#1)(1991-3#1)(2008-7#1)
otitis media with effusion##2##4##(2008-9#1)(2013-8#1)
otitis media##25##2##(1990-3#1)(1991-3#4)(1991-4#1)(1993-2#1)(1996-11#2)(2007-10#1)(2007-12#1)(2008-11#2)(2008-7#2)(2008-9#7)(2013-1#1)(2013-8#2)
otitis##43##1##(1990-10#1)(1990-3#2)(1991-3#6)(1991-4#1)(1993-2#1)(1994-3#1)(1996-11#2)(2007-10#3)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#7)(2008-7#2)(2008-9#7)(2009-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
otoacoustic emissions##8##2##(2008-1#2)(2008-4#3)(2009-5#3)
otolaryngologists##4##1##(2008-11#1)(2008-7#2)(2008-9#1)
otolaryngology##3##1##(2008-11#2)(2013-8#1)
otolith calcium##3##2##(2008-10#3)
otolith increments##2##2##(2007-5#2)
otolith length##2##2##(2013-7#2)
otolith was##2##2##(2008-7#1)(2013-7#1)
otolith##20##1##(1997-2#1)(2007-5#2)(2008-10#5)(2008-7#4)(2010-8#4)(2013-7#4)
otoliths of##3##2##(2008-10#2)(2010-8#1)
otoliths##11##1##(2008-10#4)(2008-7#3)(2010-8#1)(2013-7#3)
otorhinolaryngological##3##1##(2011-2#2)(2013-1#1)
otorrhoea##2##1##(2008-9#2)
otosclerosis##2##1##(2008-9#1)(2013-1#1)
ototoxic##2##1##(2007-7#1)(2008-4#1)
ototoxicity##8##1##(2007-7#4)(2008-2#4)
ou##12##1##(2008-10#1)(2008-5#2)(2011-2#5)(2013-1#4)
ouabain maximum binding##2##3##(1995-8#2)
ouabain or##2##2##(1990-5#1)(1994-3#1)
ouabain##20##1##(1990-11#3)(1990-12#1)(1990-5#1)(1992-11#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-8#2)(2007-10#1)(2008-1#1)(2008-6#2)(2008-8#3)
ought to be##7##3##(1992-12#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
ought to##9##2##(1992-12#2)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
ounce of prevention##2##3##(1993-1#1)(2013-8#1)
our County##4##2##(2011-2#4)
our Department##6##2##(1992-5#1)(1992-6#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
our IRB##4##2##(2009-4#4)
our Institute##3##2##(1995-10#1)(2007-1#1)(2010-3#1)
our PD##2##2##(2011-2#2)
our ability to understand##2##4##(1995-5#1)(2012-12#1)
our ability to##19##3##(1991-12#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
our ability##21##2##(1991-12#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
our aim was to##2##4##(2008-11#1)(2013-1#1)
our aim##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
our algorithm##6##2##(2008-2#1)(2008-3#1)(2008-6#2)(2009-12#2)
our ambulatory##2##2##(1997-3#2)
our analysis of the##4##4##(1996-3#1)(2008-6#1)(2010-4#1)(2012-3#1)
our analysis of##6##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
our analysis##24##2##(1991-8#1)(1996-3#1)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
our analytical##2##2##(2008-10#2)
our and##2##2##(2008-11#1)(2010-2#1)
our approach is##5##3##(2007-11#2)(2008-10#1)(2008-8#1)(2009-8#1)
our approach to the ossified cochlea##2##6##(2008-9#2)
our approach to the##3##4##(2008-9#3)
our approach to##6##3##(2008-9#3)(2010-10#1)(2011-2#1)(2012-12#1)
our approach we##2##3##(2008-2#1)(2008-3#1)
our approach##33##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
our assay##2##2##(2008-5#1)(2008-6#1)
our assumptions about the##2##4##(1996-3#1)(2008-9#1)
our attempts to##3##3##(2008-8#1)(2010-5#1)(2010-6#1)
our attention on##2##3##(2007-8#1)(2008-10#1)
our attention##7##2##(1991-3#1)(1997-6#1)(2007-8#1)(2008-10#3)(2011-3#1)
our basic##3##2##(1993-2#1)(2008-8#1)(2010-8#1)
our best##6##2##(1996-2#1)(2007-12#1)(2008-3#1)(2010-5#1)(2010-9#1)(2012-2#1)
our bodies##4##2##(1991-6#1)(2008-5#2)(2012-2#1)
our bodies?##2##2##(1992-1#2)
our calculations show that##2##4##(2008-10#2)
our calculations##4##2##(1995-11#1)(2008-10#2)(2013-1#1)
our calibration##2##2##(2010-3#2)
our capabilities##2##2##(2008-3#1)(2008-7#1)
our capacity to##2##3##(2008-11#1)(2009-4#1)
our case was##2##3##(2008-1#2)
our case##28##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-9#1)(2006-10#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-2#3)(2013-1#3)
our cases##6##2##(1990-2#1)(1995-11#1)(2007-10#1)(2007-8#2)(2010-5#1)
our center##11##2##(2007-11#1)(2007-7#2)(2008-1#2)(2008-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
our centre##6##2##(1995-10#1)(2007-11#1)(2008-6#1)(2010-10#1)(2011-1#1)(2013-1#1)
our children?]##2##2##(1996-11#1)(1996-7#1)
our clinic for##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
our clinic##12##2##(2007-8#3)(2008-1#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
our clinical experience##3##3##(2008-8#1)(2013-1#2)
our clinical##10##2##(1991-3#1)(1996-10#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#3)
our cohort##2##2##(2007-10#1)(2012-3#1)
our collaborators##2##2##(1995-2#1)(2009-3#1)
our collection of##3##3##(1995-9#1)(2008-10#1)(2008-9#1)
our communities##2##2##(1994-12#1)(2008-11#1)
our community##3##2##(1994-12#1)(2008-7#1)(2012-3#1)
our comparative##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
our concept of##2##3##(2008-11#1)(2012-2#1)
our conclusions##7##2##(1996-3#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-8#1)(2009-9#1)
our conditions##2##2##(1991-12#1)(1993-2#1)
our contention##2##2##(1995-8#1)(2008-8#1)
our continuing##2##2##(1993-11#1)(1996-2#1)
our country##19##2##(1990-12#1)(1990-9#1)(1992-2#1)(1995-5#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
our criteria##5##2##(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2013-1#1)
our current knowledge of the##5##5##(1997-7#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-8#1)
our current knowledge##9##3##(1997-7#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-8#1)(2012-2#1)
our current understanding of the##4##5##(2009-2#1)(2009-4#1)(2012-2#1)(2013-8#1)
our current understanding of##12##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
our current##30##2##(1992-3#2)(1997-7#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
our data and##2##3##(2008-7#1)(2011-2#1)
our data are##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
our data demonstrate that##2##4##(2008-11#1)(2011-1#1)
our data demonstrate##3##3##(1992-11#1)(2008-11#1)(2011-1#1)
our data indicate that##3##4##(2008-7#1)(2010-4#1)(2012-3#1)
our data show##2##3##(2011-2#1)(2013-7#1)
our data suggest a##2##4##(2008-8#1)(2009-9#1)
our data suggest that the##4##5##(1992-12#1)(1995-6#1)(2008-9#1)(2011-2#1)
our data suggest that##13##4##(1992-12#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
our data suggest##15##3##(1992-12#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
our data support the##3##4##(2007-10#1)(2010-3#1)(2013-7#1)
our data support##5##3##(2007-10#1)(2008-4#1)(2010-11#1)(2010-3#1)(2013-7#1)
our data we##2##3##(1990-8#1)(2007-12#1)
our data with those##2##4##(2008-10#1)(2008-3#1)
our data with##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
our data##71##2##(1990-8#1)(1992-11#1)(1992-12#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)
our decision making and##2##4##(1993-3#1)(2008-7#1)
our department between##3##3##(1997-3#1)(2008-1#1)(2008-9#1)
our department due to##2##4##(2008-12#1)(2011-2#1)
our department for##3##3##(2011-2#1)(2012-3#1)(2013-7#1)
our department with a##3##4##(2008-12#1)(2011-2#2)
our department with##5##3##(2007-8#1)(2008-12#1)(2011-2#2)(2012-3#1)
our department##34##2##(1990-9#2)(1991-11#1)(1993-6#1)(1994-9#1)(1995-4#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
our device##3##2##(2007-11#1)(2007-12#1)(2009-6#1)
our devices##2##2##(2008-7#1)(2012-3#1)
our dialysis##2##2##(2007-7#1)(2008-1#1)
our discussion##6##2##(2008-3#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
our dynamic##3##2##(1996-3#1)(2008-3#1)(2008-6#1)
our earlier findings##2##3##(1991-6#1)(1992-12#1)
our earlier studies##2##3##(1996-12#1)(2008-10#1)
our earlier##12##2##(1991-6#1)(1992-12#1)(1993-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#1)
our economy##2##2##(1993-2#1)(1994-5#1)
our educational##2##2##(2008-12#1)(2010-9#1)
our efforts to##4##3##(1994-1#2)(1997-9#1)(2008-2#1)
our efforts##8##2##(1991-12#1)(1994-1#2)(1997-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)
our empirical##2##2##(1995-2#1)(2008-8#1)
our environment##6##2##(1994-3#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
our estimate##2##2##(2008-3#2)
our estimates##2##2##(1992-9#1)(2008-8#1)
our everyday##3##2##(2009-8#3)
our expectations##2##2##(2007-11#1)(2008-11#1)
our experience in the##2##4##(1990-5#1)(2008-10#1)
our experience in##7##3##(1990-5#1)(1993-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
our experience of a##2##4##(1991-9#1)(1997-3#1)
our experience of##10##3##(1991-9#1)(1995-10#1)(1997-3#2)(2007-8#1)(2008-10#2)(2008-6#1)(2010-8#1)(2012-2#1)
our experience with the use of##2##6##(2007-8#1)(2008-12#1)
our experience with the##5##4##(1996-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)
our experience with##17##3##(1995-3#1)(1996-8#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
our experience##69##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#1)(1996-8#1)(1997-3#3)(1997-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#4)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
our experience]##2##2##(1990-5#1)(1991-3#1)
our experiences##9##2##(1992-4#1)(1992-5#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-7#1)
our experiment##7##2##(1991-12#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-2#1)(2010-8#1)
our experimental conditions##7##3##(1991-12#1)(1994-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
our experimental results##3##3##(1997-2#1)(1997-4#1)(2007-12#1)
our experimental##20##2##(1991-12#1)(1994-6#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
our experimentally##2##2##(2008-3#1)(2008-8#1)
our experiments##12##2##(1990-2#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-5#1)(2010-8#1)(2013-1#1)
our exploration of the##2##4##(1994-1#1)(1997-2#1)
our eyes##2##2##(1994-12#1)(2007-8#1)
our facility##9##2##(1992-2#1)(1992-6#5)(1994-12#1)(2013-8#2)
our film##2##2##(2008-3#1)(2008-5#1)
our finding of a##2##4##(2008-7#1)(2012-2#1)
our finding of##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
our finding##4##2##(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
our findings are contrary to##2##5##(2009-7#2)
our findings are##3##3##(2008-8#1)(2009-7#2)
our findings demonstrate##2##3##(2007-7#1)(2008-9#1)
our findings in##3##3##(1995-11#1)(1995-12#1)(2008-9#1)
our findings indicate that##4##4##(1992-1#1)(2008-9#1)(2009-7#1)(2013-1#1)
our findings indicate##5##3##(1992-1#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
our findings on the##2##4##(2008-8#1)(2008-9#1)
our findings provide##2##3##(2011-2#1)(2013-1#1)
our findings suggest that##3##4##(2012-3#1)(2013-1#2)
our findings suggest##5##3##(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
our findings to##2##3##(1990-6#1)(1993-12#1)
our findings with##2##3##(2008-10#1)(2010-12#1)
our findings##57##2##(1990-6#1)(1992-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#1)(2009-6#1)(2009-7#4)(2009-8#3)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#8)(2013-8#1)
our first##13##2##(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2012-12#2)(2013-8#1)
our focus##2##2##(1995-1#1)(2011-2#1)
our framework##3##2##(2008-7#1)(2010-9#1)(2012-3#1)
our future##6##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-12#1)
our general##3##2##(2007-7#1)(2008-8#2)
our goal##4##2##(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#1)
our group and##2##3##(1991-12#1)(2008-10#1)
our group to##2##3##(2008-5#1)(2008-9#1)
our group with##2##3##(2008-2#1)(2013-1#1)
our group##18##2##(1991-12#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#1)(2013-1#1)
our groupwise registration##2##3##(2011-2#2)
our growing##2##2##(2008-12#1)(2011-2#1)
our health care system##7##4##(1992-3#1)(1994-1#1)(1997-2#1)(2008-1#1)(2008-4#3)
our health care##11##3##(1992-3#1)(1994-1#3)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-4#3)
our health##12##2##(1992-3#1)(1994-1#3)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-4#3)
our healthcare##2##2##(1997-3#1)(2011-2#1)
our high##2##2##(1995-6#1)(2008-11#1)
our high-density##2##2##(1996-12#1)(1997-2#1)
our hospital for##9##3##(1991-12#1)(1994-7#1)(2008-1#2)(2011-2#2)(2013-8#3)
our hospital to##2##3##(2008-1#1)(2008-3#1)
our hospital with##8##3##(1993-6#1)(2007-10#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
our hospital##60##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-1#1)(1997-2#1)(1997-8#1)(2007-10#2)(2007-7#2)(2007-8#3)(2008-1#6)(2008-12#1)(2008-3#1)(2008-7#2)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#5)
our hospitals##3##2##(1990-6#1)(1997-8#1)(2011-2#1)
our hypotheses##2##2##(2010-8#1)(2012-3#1)
our hypothesis that the##2##4##(1994-3#1)(1996-12#1)
our hypothesis that##9##3##(1991-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
our hypothesis##18##2##(1991-12#1)(1992-3#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-5#1)(2012-7#1)(2013-7#1)(2013-8#1)
our idea##2##2##(2007-11#1)(2008-11#1)
our ideas##3##2##(1996-1#1)(2008-6#1)(2010-12#1)
our ignorance of##2##3##(2008-9#1)(2011-2#1)
our imaging##2##2##(1994-12#1)(2012-2#1)
our impression that##2##3##(1994-6#1)(2008-7#1)
our in situ##2##3##(2008-7#1)(2008-8#1)
our in##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
our in-house##2##2##(2008-2#1)(2011-1#1)
our in-patient##2##2##(2008-3#2)
our index##4##2##(1993-9#3)(2008-6#1)
our indications for##2##3##(1994-6#1)(2007-8#1)
our individual##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
our initial experience##2##3##(2010-6#1)(2012-12#1)
our initial##4##2##(2008-10#1)(2008-6#1)(2010-6#1)(2012-12#1)
our institute##4##2##(1995-5#1)(2007-8#1)(2008-11#2)
our institution between##3##3##(2008-6#1)(2012-2#1)(2013-8#1)
our institution has##2##3##(2007-11#1)(2009-11#1)
our institution with##3##3##(2007-8#1)(2008-8#1)(2013-1#1)
our institution##29##2##(1991-8#1)(1992-6#1)(1994-1#1)(1996-3#1)(2007-11#2)(2007-8#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
our institution's##3##2##(1990-11#1)(2008-8#1)(2011-2#1)
our institutional experience##2##3##(2013-1#1)(2013-7#1)
our interest##3##2##(1997-8#1)(2010-7#1)(2013-7#1)
our interpretation##2##2##(2008-12#1)(2008-3#1)
our investigation of##3##3##(2008-3#1)(2008-8#1)(2009-8#1)
our investigation##11##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#2)(2011-2#1)
our investigations of##4##3##(1992-5#1)(2007-12#1)(2008-11#1)(2008-2#1)
our investigations##7##2##(1992-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)
our knowledge about the effects of##2##6##(2009-10#1)(2012-2#1)
our knowledge about the##6##4##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
our knowledge about##9##3##(1997-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#1)
our knowledge and##3##3##(1997-3#1)(2008-3#1)(2010-12#1)
our knowledge for the first time##4##6##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
our knowledge in##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
our knowledge is a new##4##5##(2008-3#4)
our knowledge is a##8##4##(2008-2#1)(2008-3#7)
our knowledge is##10##3##(2007-12#1)(2008-2#1)(2008-3#7)(2010-5#1)
our knowledge no##2##3##(2009-4#1)(2012-12#1)
our knowledge of cancer##2##4##(2008-11#1)(2010-12#1)
our knowledge of plant##2##4##(2008-9#1)(2009-8#1)
our knowledge of the##12##4##(1990-7#1)(1991-11#1)(1994-5#1)(1995-5#1)(2006-12#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
our knowledge of##27##3##(1990-7#1)(1991-11#1)(1994-5#1)(1995-5#1)(1997-1#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
our knowledge on##3##3##(1991-3#1)(2008-7#2)
our knowledge the first##39##4##(2007-11#13)(2007-12#18)(2008-10#1)(2008-2#4)(2008-3#3)
our knowledge the##47##3##(2007-11#17)(2007-12#21)(2008-10#1)(2008-2#5)(2008-3#3)
our knowledge there##2##3##(2012-12#1)(2013-1#1)
our knowledge this is the first report of a##2##9##(2008-9#1)(2009-8#1)
our knowledge this is the first report of##4##8##(2007-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
our knowledge this is the first report##5##7##(2007-8#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-3#1)
our knowledge this is the first##11##6##(1990-12#1)(1991-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-3#1)
our knowledge this is the##14##5##(1990-12#1)(1991-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
our knowledge this##18##3##(1990-12#1)(1991-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
our knowledge##394##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-9#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#4)(2006-12#1)(2007-10#2)(2007-11#38)(2007-12#45)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#4)(2008-10#32)(2008-11#9)(2008-12#4)(2008-2#37)(2008-3#93)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#3)(2010-5#4)(2010-6#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#3)
our knowledge)##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
our lab##8##2##(2008-10#2)(2008-7#2)(2008-8#3)(2009-10#1)
our laboratories##8##2##(1991-12#1)(1997-2#1)(2008-10#4)(2008-4#1)(2012-2#1)
our laboratory for##3##3##(1991-8#1)(1996-1#1)(2008-10#1)
our laboratory has##2##3##(2009-3#1)(2010-3#1)
our laboratory have demonstrated##2##4##(1991-2#1)(1993-6#1)
our laboratory have##4##3##(1991-2#1)(1993-6#1)(2008-10#1)(2008-7#1)
our laboratory showed that##2##4##(1993-1#1)(2009-8#1)
our laboratory##48##2##(1991-2#1)(1991-8#1)(1993-1#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(2007-10#1)(2007-2#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-3#1)(2011-2#1)
our laser##3##2##(2007-11#2)(2008-3#1)
our life##3##2##(2008-1#1)(2008-10#1)(2009-12#1)
our limited##2##2##(2007-8#1)(2012-2#1)
our literature##2##2##(2008-8#1)(2012-2#1)
our lives##5##2##(1993-2#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
our local##2##2##(1993-2#1)(2013-8#1)
our longitudinal##2##2##(2008-7#1)(2011-2#1)
our main##5##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
our major##2##2##(2009-12#1)(2011-2#1)
our management##2##2##(2008-10#1)(2008-9#1)
our material##3##2##(2007-11#1)(2007-8#1)(2013-7#1)
our measured##2##2##(2008-3#2)
our measurement##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
our measurements##9##2##(2007-11#1)(2008-2#2)(2008-3#5)(2008-8#1)
our medical school##2##3##(2007-11#1)(2008-10#1)
our medical service##3##3##(2008-3#3)
our medical##9##2##(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-7#1)(2012-12#1)(2012-2#1)
our members##2##2##(1997-3#1)(2011-2#1)
our method for##3##3##(1991-2#1)(2007-8#1)(2008-3#1)
our method have##2##3##(2007-12#1)(2008-3#1)
our method is##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
our method to##4##3##(2007-12#1)(2008-2#2)(2012-2#1)
our method we##2##3##(2008-2#1)(2008-3#1)
our method##31##2##(1991-2#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)
our methods with##2##3##(2010-8#1)(2012-3#1)
our methods##7##2##(2008-10#1)(2008-6#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-3#1)
our model and##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
our model is##2##3##(2007-12#1)(2008-7#1)
our model of##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
our model predicts##4##3##(2008-8#3)(2012-2#1)
our model the##2##3##(1996-2#1)(2008-3#1)
our model to include##2##4##(1992-3#1)(1994-2#1)
our model to##3##3##(1992-3#1)(1994-2#1)(2008-3#1)
our model##44##2##(1992-3#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-2#3)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
our model's##2##2##(2008-8#1)(2013-8#1)
our modeling##2##2##(2008-3#1)(2013-8#1)
our models##5##2##(1996-4#1)(2008-10#1)(2008-11#1)(2008-8#2)
our molecular##3##2##(2009-6#1)(2011-2#1)(2012-1#1)
our moral##3##2##(2008-11#3)
our mouse model##2##3##(2008-10#1)(2010-3#1)
our nation's health##5##3##(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2010-1#1)
our nation's##9##2##(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2010-1#1)
our national##3##2##(1990-2#1)(1994-2#1)(2008-9#1)
our new##12##2##(1990-8#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2013-1#2)
our newly developed##2##3##(2008-2#1)(2010-8#1)
our newly##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
our numerical model##2##3##(2008-3#2)
our numerical##3##2##(2008-2#1)(2008-3#2)
our objective##2##2##(2010-4#1)(2012-2#1)
our observation##9##2##(1990-7#1)(1991-6#1)(1992-3#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
our observations are##2##3##(1997-6#1)(2008-7#1)
our observations of##2##3##(1996-12#1)(2007-11#1)
our observations##8##2##(1996-12#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-7#2)
our ongoing##5##2##(1997-5#1)(2008-1#1)(2009-6#1)(2011-3#1)(2012-2#1)
our operating##2##2##(1994-1#1)(2013-8#1)
our opinion##12##2##(1990-11#1)(1990-6#1)(1991-5#1)(1991-6#1)(1996-11#1)(1997-8#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2013-8#1)
our optical##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
our optimized##3##2##(2008-11#2)(2008-5#1)
our original method##2##3##(2008-10#1)(2008-3#1)
our original##6##2##(1995-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-6#1)
our own experience##6##3##(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2010-8#1)(2011-2#1)
our own research##3##3##(1997-1#1)(2010-2#1)(2013-1#1)
our own##33##2##(1990-6#1)(1991-11#1)(1991-8#1)(1993-3#1)(1994-1#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-7#4)(2008-8#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
our pathways##2##2##(2008-3#2)
our patient##29##2##(1995-8#1)(1996-8#2)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#5)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
our patients and##2##3##(2007-5#1)(2013-8#1)
our patients are##2##3##(1995-10#1)(2007-2#1)
our patients there##2##3##(2011-2#1)(2013-1#1)
our patients were##3##3##(2008-1#2)(2008-7#1)
our patients with##6##3##(1990-8#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2011-2#1)
our patients##46##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1995-10#1)(1996-3#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#7)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
our policy##2##2##(1992-1#1)(2008-7#1)
our population##14##2##(1994-11#1)(1994-12#1)(1995-12#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
our predictions##3##2##(1992-3#1)(2008-8#1)(2013-1#1)
our preliminary experience##2##3##(2007-8#2)
our preliminary results##3##3##(2008-3#1)(2008-8#1)(2010-4#1)
our preliminary study##2##3##(2013-1#2)
our preliminary##7##2##(2007-8#2)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#2)
our present study##2##3##(2008-10#1)(2011-2#1)
our present##11##2##(1990-8#1)(1991-5#1)(1995-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)
our previous data##2##3##(2008-10#2)
our previous finding that##2##4##(1990-8#1)(1996-12#1)
our previous finding##3##3##(1990-8#1)(1996-12#1)(2008-9#1)
our previous findings of##2##4##(2008-10#2)
our previous findings##10##3##(1993-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#2)(2008-10#2)(2008-8#1)
our previous observations##2##3##(1995-12#1)(1995-2#1)
our previous report##4##3##(1994-8#1)(1997-8#1)(2008-10#1)(2012-12#1)
our previous results##4##3##(1990-8#1)(1997-6#1)(2008-12#1)(2009-8#1)
our previous studies##3##3##(1994-3#1)(2008-8#1)(2008-9#1)
our previous study##8##3##(1991-2#1)(1993-12#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
our previous work##8##3##(1992-2#1)(1994-2#1)(1997-2#1)(2008-10#3)(2008-7#1)(2010-11#1)
our previous##56##2##(1990-5#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-12#3)(1995-2#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)
our previously published##2##3##(2008-2#1)(2008-8#1)
our previously##4##2##(1996-2#1)(1997-4#1)(2008-2#1)(2008-8#1)
our primary##2##2##(2008-7#1)(2013-1#1)
our procedure##2##2##(1995-12#1)(2010-1#1)
our procedures##2##2##(1992-6#1)(2008-3#1)
our products##3##2##(2008-10#2)(2008-5#1)
our profession##9##2##(1992-2#1)(1993-12#1)(1994-12#1)(1995-1#2)(1996-2#1)(2008-4#2)(2012-2#1)
our program##3##2##(1994-9#1)(1997-5#1)(2011-2#1)
our proposal##3##2##(2008-10#1)(2008-3#2)
our proposed##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
our prospective##2##2##(1997-8#1)(2011-2#1)
our protocol##3##2##(1992-6#1)(2008-8#1)(2012-3#1)
our quality of##2##3##(2008-7#2)
our readers##2##2##(2008-8#2)
our recent experience##2##3##(2007-5#1)(2008-7#1)
our recent studies on the##2##5##(2008-5#1)(2011-2#1)
our recent studies##4##3##(1996-4#1)(2008-5#1)(2011-2#2)
our recent study##3##3##(2009-8#2)(2011-2#1)
our recent work##4##3##(1994-11#1)(2007-5#1)(2009-2#1)(2009-3#1)
our recent##27##2##(1994-11#1)(1994-8#1)(1996-4#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#8)(2011-2#3)(2012-12#2)
our recently##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
our recommendations##4##2##(2008-12#1)(2011-2#2)(2012-3#1)
our region##4##2##(2008-1#1)(2009-4#1)(2010-8#1)(2012-12#1)
our research##17##2##(1990-5#1)(1990-6#1)(1991-12#1)(1994-5#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
our responsibilities##2##2##(1996-2#1)(2008-11#1)
our result##2##2##(2008-10#1)(2009-2#1)
our results also##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
our results and the##2##4##(2008-10#1)(2008-2#1)
our results and##6##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-8#1)
our results are consistent with##3##5##(2008-10#1)(2008-8#1)(2009-12#1)
our results are##9##3##(1993-11#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-12#1)
our results demonstrate that##5##4##(1997-7#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
our results demonstrate the##2##4##(2008-7#1)(2012-2#1)
our results demonstrate##7##3##(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
our results demonstrated that##2##4##(2008-7#1)(2010-1#1)
our results demonstrated##3##3##(2008-7#1)(2008-8#1)(2010-1#1)
our results do not##3##4##(1997-5#1)(2008-11#1)(2008-7#1)
our results for the##2##4##(2008-2#1)(2008-3#1)
our results for##3##3##(2008-2#1)(2008-3#2)
our results indicate that##4##4##(1993-9#1)(1995-2#1)(2008-10#1)(2010-7#1)
our results is that##2##4##(1994-5#1)(2008-10#1)
our results on##2##3##(2008-2#1)(2011-2#1)
our results show that the##2##5##(1997-7#1)(2008-1#1)
our results show that##10##4##(1991-12#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
our results show##12##3##(1991-12#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
our results showed that##2##4##(2008-10#1)(2008-9#1)
our results showed##3##3##(2008-10#1)(2008-9#1)(2009-3#1)
our results suggest that the##6##5##(1991-6#1)(1993-3#1)(1994-11#1)(1995-12#1)(2011-2#1)(2013-8#1)
our results suggest that##17##4##(1991-6#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-4#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
our results suggested that##2##4##(2008-8#2)
our results support the##2##4##(1995-12#1)(2013-8#1)
our results to##2##3##(2008-10#1)(2008-3#1)
our results with those##2##4##(2008-7#2)
our results with##3##3##(1990-2#1)(2008-7#2)
our results##120##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#3)
our review of the literature##2##5##(2008-6#1)(2008-7#1)
our review##6##2##(1992-5#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-7#2)
our role as##2##3##(1995-3#1)(2008-10#1)
our roles##2##2##(1996-12#1)(2008-10#1)
our sample of women##2##4##(2008-3#1)(2011-2#1)
our sample of##4##3##(1997-5#1)(2008-3#1)(2011-1#1)(2011-2#1)
our sample##10##2##(1996-7#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
our samples##6##2##(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#1)
our scheme##2##2##(2007-12#1)(2009-5#1)
our scoring function##2##3##(2011-3#2)
our search##3##2##(2007-4#1)(2010-12#1)(2011-2#1)
our second##3##2##(2008-6#1)(2008-8#1)(2012-12#1)
our series##14##2##(1990-12#1)(1990-6#1)(1991-8#1)(1993-5#2)(1997-3#1)(2007-10#1)(2007-7#3)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
our setting##6##2##(1995-10#1)(1996-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
our setup##2##2##(2007-11#2)
our simple##4##2##(2007-12#1)(2008-3#2)(2008-6#1)
our simulation##3##2##(2008-3#1)(2010-8#1)(2012-12#1)
our simulations##2##2##(1993-12#1)(2008-12#1)
our social##2##2##(2008-10#1)(2008-11#1)
our society##15##2##(1990-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-2#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)
our specific##2##2##(1996-2#1)(2008-3#1)
our staff##2##2##(1991-12#2)
our standard##3##2##(1993-12#1)(2009-3#1)(2010-8#1)
our state and##2##3##(1995-1#1)(1996-2#1)
our studies of##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
our studies revealed##2##3##(2008-12#1)(2011-2#1)
our studies##10##2##(1991-12#1)(1995-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
our study and##2##3##(2008-7#1)(2009-3#1)
our study for##2##3##(2008-9#1)(2010-12#1)
our study indicates that##2##4##(2008-11#1)(2012-2#1)
our study is the##2##4##(2008-11#1)(2008-3#1)
our study is##9##3##(2007-11#1)(2008-11#2)(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
our study of##2##3##(1991-6#1)(2009-8#1)
our study population##2##3##(1990-2#1)(2013-1#1)
our study revealed##2##3##(2009-5#1)(2012-3#1)
our study reveals##2##3##(2012-2#1)(2013-1#1)
our study show##4##3##(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)
our study showed that the##2##5##(2011-2#2)
our study showed that##3##4##(2008-7#1)(2011-2#2)
our study shows that##2##4##(2008-3#1)(2008-9#1)
our study suggest that the##2##5##(1992-12#1)(2011-2#1)
our study suggest##3##3##(1992-12#1)(2011-1#1)(2011-2#1)
our study suggests that##3##4##(2007-7#1)(2008-10#1)(2013-7#1)
our study that##2##3##(2008-10#1)(2012-12#1)
our study was##35##3##(1990-5#1)(1991-3#1)(1997-8#3)(2007-8#8)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-3#2)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
our study we wanted to##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
our study we##7##3##(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
our study were##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
our study##146##2##(1990-2#1)(1990-5#3)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-6#1)(1997-5#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#7)(2011-2#14)(2011-7#3)(2012-12#2)(2012-2#3)(2012-3#7)(2012-6#1)(2013-1#12)(2013-7#2)(2013-8#1)
our subjects##2##2##(2008-7#2)
our success##4##2##(1996-12#1)(2007-12#1)(2007-5#1)(2008-6#1)
our surgical##2##2##(2007-8#1)(2011-2#1)
our surprise##2##2##(1992-11#1)(2008-6#1)
our system has##2##3##(2007-11#2)
our system is a##2##4##(2008-10#1)(2008-9#1)
our system is##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
our system##15##2##(2007-11#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-9#1)(2009-3#1)
our systematic##2##2##(2008-2#1)(2008-8#1)
our team##3##2##(1993-5#1)(2008-10#2)
our technique##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#2)(2010-11#1)(2013-1#1)
our tensor##2##2##(2008-6#2)
our tertiary##2##2##(2011-2#1)(2013-1#1)
our test##2##2##(1997-4#1)(2008-7#1)
our testing##2##2##(2008-10#1)(2011-2#1)
our theoretical##7##2##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-9#1)
our theory##2##2##(2008-11#1)(2008-8#1)
our therapeutic##3##2##(1990-2#1)(1996-3#1)(2007-7#1)
our thinking about##2##3##(2008-8#1)(2009-8#1)
our thinking##3##2##(1994-1#1)(2008-8#1)(2009-8#1)
our transform##2##2##(2008-6#2)
our treatment##6##2##(1990-9#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-3#1)
our understanding of how##7##4##(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)
our understanding of the biology of the##2##7##(2008-10#1)(2008-7#1)
our understanding of the biology of##3##6##(2007-10#1)(2008-10#1)(2008-7#1)
our understanding of the ecology of##2##6##(2008-10#2)
our understanding of the evolution##2##5##(1994-5#1)(2008-7#1)
our understanding of the mechanisms of##2##6##(2008-7#1)(2010-3#1)
our understanding of the mechanisms##4##5##(2008-4#1)(2008-7#1)(2010-3#1)(2012-2#1)
our understanding of the molecular mechanisms of##2##7##(2008-11#1)(2009-3#1)
our understanding of the neural##2##5##(2009-9#1)(2012-2#1)
our understanding of the pathophysiology##2##5##(2013-7#1)(2013-8#1)
our understanding of the role of##4##6##(1992-2#1)(1996-5#1)(2010-11#1)(2013-1#1)
our understanding of the role##5##5##(1992-2#1)(1996-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
our understanding of the##63##4##(1991-3#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#10)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
our understanding of these##5##4##(2007-7#1)(2009-3#1)(2009-5#1)(2010-5#1)(2012-3#1)
our understanding of this complex##2##5##(2008-5#1)(2008-7#1)
our understanding of this##4##4##(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
our understanding of##140##3##(1991-3#2)(1992-12#2)(1992-2#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#17)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#2)
our understanding on the##3##4##(2009-9#1)(2011-2#1)(2013-1#1)
our understanding on##4##3##(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
our understanding##147##2##(1991-3#2)(1992-12#2)(1992-2#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#18)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#2)
our unique##3##2##(1992-2#1)(1994-1#1)(2008-3#1)
our unit##4##2##(1993-12#1)(1995-5#1)(2007-7#1)(2008-9#1)
our university hospital##2##3##(2010-6#1)(2012-1#1)
our use of##2##3##(1995-12#1)(1995-2#1)
our view##2##2##(2008-8#1)(2012-3#1)
our views of##2##3##(2008-1#1)(2010-12#1)
our website##2##2##(2008-7#1)(2013-7#1)
our work and##2##3##(2007-8#1)(2008-1#1)
our work##13##2##(1990-12#1)(1992-12#1)(1993-8#1)(1993-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2012-2#1)(2012-3#1)
our##3067##1##(1990-11#2)(1990-12#8)(1990-2#6)(1990-3#1)(1990-5#8)(1990-6#11)(1990-7#3)(1990-8#8)(1990-9#8)(1991-11#4)(1991-12#21)(1991-2#10)(1991-3#12)(1991-5#2)(1991-6#7)(1991-8#5)(1991-9#5)(1992-1#7)(1992-11#2)(1992-12#7)(1992-2#9)(1992-3#9)(1992-4#1)(1992-5#6)(1992-6#10)(1992-8#6)(1992-9#4)(1993-1#8)(1993-11#5)(1993-12#13)(1993-2#9)(1993-3#5)(1993-5#4)(1993-6#4)(1993-8#4)(1993-9#10)(1994-1#19)(1994-11#9)(1994-12#18)(1994-2#8)(1994-3#12)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#5)(1994-9#7)(1995-1#13)(1995-10#5)(1995-11#10)(1995-12#19)(1995-2#13)(1995-3#11)(1995-4#3)(1995-5#10)(1995-6#10)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#6)(1996-12#13)(1996-2#20)(1996-3#10)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#8)(1997-2#16)(1997-3#23)(1997-4#14)(1997-5#8)(1997-6#8)(1997-7#11)(1997-8#18)(1997-9#1)(2006-10#11)(2006-12#2)(2007-1#1)(2007-10#20)(2007-11#86)(2007-12#88)(2007-2#2)(2007-4#2)(2007-5#6)(2007-6#2)(2007-7#28)(2007-8#67)(2007-9#4)(2008-1#57)(2008-10#240)(2008-11#104)(2008-12#39)(2008-2#100)(2008-3#245)(2008-4#23)(2008-5#38)(2008-6#44)(2008-7#139)(2008-8#99)(2008-9#63)(2009-1#3)(2009-10#14)(2009-11#8)(2009-12#14)(2009-2#7)(2009-3#25)(2009-4#18)(2009-5#13)(2009-6#13)(2009-7#10)(2009-8#41)(2009-9#11)(2010-1#6)(2010-10#9)(2010-11#17)(2010-12#24)(2010-2#13)(2010-3#23)(2010-4#10)(2010-5#14)(2010-6#19)(2010-7#9)(2010-8#24)(2010-9#7)(2011-1#41)(2011-2#146)(2011-3#5)(2011-7#4)(2012-1#10)(2012-12#45)(2012-2#82)(2012-3#65)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#127)(2013-7#16)(2013-8#44)
ours##6##1##(1991-12#1)(1992-6#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
ourselves##8##1##(1990-9#1)(1994-1#1)(1994-2#1)(1994-9#1)(1997-8#1)(2009-6#1)(2010-9#1)(2012-12#1)
out a study##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
out a##40##2##(1990-12#1)(1990-9#1)(1991-6#2)(1994-12#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-5#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-11#5)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)
out acute myocardial infarction##2##4##(2008-3#2)
out after##4##2##(1993-12#1)(2008-5#1)(2010-11#1)(2013-1#1)
out again##3##2##(2008-10#1)(2013-1#2)
out along##2##2##(2007-12#1)(2013-1#1)
out an##11##2##(1991-3#1)(1991-5#2)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-3#1)(2013-1#1)
out and the##4##3##(1992-3#1)(2008-10#1)(2010-12#1)(2012-3#1)
out and##29##2##(1992-3#2)(1992-9#1)(2006-10#1)(2007-10#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
out any##2##2##(1994-12#1)(2008-5#1)
out as a major##2##4##(1990-8#1)(2008-12#1)
out as a##7##3##(1990-12#1)(1990-8#1)(1995-5#1)(1995-6#1)(2008-12#1)(2008-3#1)(2012-1#1)
out as the##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
out as##19##2##(1990-12#1)(1990-8#1)(1992-12#1)(1993-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
out at the##13##3##(1994-6#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#3)(2008-3#2)(2009-9#1)(2010-1#1)
out at##59##2##(1990-4#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
out before##2##2##(2007-6#1)(2008-6#1)
out between##5##2##(1990-5#1)(1991-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
out by studies##2##3##(2008-6#1)(2011-2#1)
out by the##25##3##(1990-12#1)(1990-3#1)(1991-12#1)(1994-12#1)(1994-2#1)(2007-10#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-2#1)
out by##146##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1996-12#1)(1996-3#2)(1996-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2008-1#2)(2008-10#74)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)
out for evaluation of##2##4##(1991-11#1)(2008-12#1)
out for the##8##3##(1991-2#1)(1994-5#1)(2008-10#2)(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
out for##43##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
out four##2##2##(2008-5#1)(2009-1#1)
out from the##10##3##(1994-5#1)(2007-12#2)(2008-10#4)(2012-3#1)(2013-1#1)(2013-8#1)
out from##19##2##(1994-5#1)(1997-1#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
out how##6##2##(1990-2#1)(1994-6#1)(1996-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
out if the##4##3##(1992-5#1)(1993-6#1)(1994-9#1)(2009-11#1)
out if##5##2##(1992-5#1)(1993-6#1)(1994-9#1)(2009-11#1)(2013-8#1)
out in 20##3##3##(1996-7#1)(2007-8#1)(2008-6#1)
out in a##32##3##(1990-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-5#1)(2006-4#1)(2007-11#2)(2008-10#15)(2008-11#1)(2008-3#3)(2008-7#1)(2013-1#3)
out in order to##15##4##(1991-9#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2012-3#1)(2013-1#1)
out in the##51##3##(1990-6#1)(1991-6#1)(1992-11#1)(1993-6#1)(1994-10#1)(1995-12#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
out in this##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
out in##255##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#3)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-7#1)(1995-12#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#3)(1997-1#1)(1997-4#2)(1997-5#1)(2006-4#1)(2007-11#10)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#80)(2008-11#8)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#7)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#3)
out into the##4##3##(1991-1#1)(1992-3#1)(1996-12#1)(1996-5#1)
out into##5##2##(1991-1#1)(1992-3#1)(1996-12#1)(1996-5#1)(2008-9#1)
out its##3##2##(1995-2#1)(2010-8#1)(2012-2#1)
out left##2##2##(2007-8#1)(2008-7#1)
out measurements##2##2##(2007-12#1)(2008-3#1)
out more##2##2##(1991-12#1)(2008-7#1)
out of 10 patients##3##4##(1996-9#1)(2008-1#1)(2008-7#1)
out of 10##10##3##(1996-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#2)(2010-12#1)
out of 100##4##3##(1992-2#1)(2008-1#1)(2008-11#1)(2012-2#1)
out of 11##5##3##(1990-8#1)(1997-4#1)(2008-1#1)(2008-4#2)
out of 12 patients##2##4##(1997-7#1)(2008-5#1)
out of 12##6##3##(1997-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#2)
out of 13 patients##2##4##(1990-2#1)(1991-11#1)
out of 13##3##3##(1990-2#1)(1991-11#1)(1994-2#1)
out of 133 responded##2##4##(1995-6#2)
out of 14##3##3##(1991-5#1)(2007-10#1)(2013-1#1)
out of 15 patients##2##4##(1990-8#1)(2008-7#1)
out of 15##6##3##(1990-6#1)(1990-8#1)(1992-8#1)(2008-12#1)(2008-4#1)(2008-7#1)
out of 16##4##3##(1990-12#1)(1990-5#1)(2007-7#1)(2008-5#1)
out of 18 patients##3##4##(1990-8#1)(1992-6#1)(2008-10#1)
out of 18##9##3##(1990-8#1)(1992-6#1)(2008-10#4)(2009-8#3)
out of 20##3##3##(1990-8#1)(1996-9#1)(2009-8#1)
out of 20)##3##3##(2008-5#3)
out of 21##3##3##(1991-9#1)(2008-6#1)(2011-2#1)
out of 22##3##3##(1993-12#1)(1994-3#1)(2008-4#1)
out of 23##2##3##(1990-12#1)(2008-10#1)
out of 24##4##3##(1994-3#1)(2008-6#1)(2009-8#2)
out of 25##3##3##(1994-11#1)(2008-5#1)(2009-8#1)
out of 26##4##3##(1990-12#1)(2008-10#1)(2010-12#1)(2011-1#1)
out of 260##2##3##(2011-1#2)
out of 28##2##3##(1990-2#1)(2013-1#1)
out of 30##3##3##(1991-12#1)(1996-5#1)(2008-8#1)
out of 33##2##3##(2008-12#1)(2009-5#1)
out of 34##2##3##(1997-6#1)(2013-8#1)
out of 38##2##3##(2008-8#1)(2013-8#1)
out of 4##2##3##(1990-6#1)(1997-7#1)
out of 400##2##3##(1993-6#1)(2007-7#1)
out of 42 (with equipment aids##2##6##(2011-2#2)
out of 45 patients##2##4##(1992-5#1)(2008-1#1)
out of 45##3##3##(1992-5#1)(2008-1#1)(2008-9#1)
out of 46##3##3##(1991-8#1)(2008-10#1)(2008-5#1)
out of 48##3##3##(1994-6#1)(2007-7#1)(2008-5#1)
out of 49##2##3##(2008-12#1)(2008-5#1)
out of 5##2##3##(2008-1#1)(2008-4#1)
out of 50##6##3##(1990-12#2)(1992-6#1)(2007-7#2)(2008-5#1)
out of 6##3##3##(1992-3#1)(2009-5#1)(2010-2#1)
out of 68 patients##2##4##(1990-2#1)(2007-11#1)
out of 68##4##3##(1990-2#1)(2007-11#1)(2011-2#1)(2012-3#1)
out of 8##5##3##(1992-5#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
out of 89##2##3##(2007-8#1)(2011-1#1)
out of 9##2##3##(2007-7#1)(2008-7#1)
out of 98##3##3##(1990-3#1)(2007-11#1)(2008-7#1)
out of a number of##2##5##(1995-3#1)(1996-1#1)
out of a total of##3##5##(2007-7#1)(2011-1#1)(2012-2#1)
out of a total##4##4##(1993-6#1)(2007-7#1)(2011-1#1)(2012-2#1)
out of a##11##3##(1992-6#1)(1993-6#1)(1995-3#1)(1996-1#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-11#2)(2011-1#1)(2012-2#1)
out of all##2##3##(2008-11#1)(2009-7#1)
out of control##5##3##(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
out of every##2##3##(1995-12#1)(1996-8#1)
out of favor##2##3##(2008-12#1)(2008-9#1)
out of five##9##3##(1991-9#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
out of four##4##3##(1992-4#1)(1992-5#1)(1997-3#1)(2008-10#1)
out of hours##5##3##(1990-3#2)(1995-9#1)(1997-5#2)
out of its##2##3##(2009-10#1)(2010-9#1)
out of poverty##2##3##(2008-11#2)
out of school##2##3##(2009-7#1)(2011-2#1)
out of seven##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
out of six##4##3##(1996-12#2)(2007-7#1)(2008-2#1)
out of state##2##3##(1994-2#1)(2007-10#1)
out of ten##2##3##(1994-2#1)(2008-7#1)
out of the 10##2##4##(2008-10#1)(2008-12#1)
out of the 11##2##4##(1995-8#1)(2008-10#1)
out of the 15##2##4##(2008-9#1)(2010-8#1)
out of the eight##2##4##(1996-12#1)(2008-10#1)
out of the five##2##4##(1991-8#1)(1996-5#1)
out of the hospital##2##4##(1996-3#1)(2008-12#1)
out of the system##3##4##(1992-3#1)(2008-10#2)
out of the three##2##4##(1995-6#1)(2011-2#1)
out of the##105##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-5#2)(2009-9#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
out of these##7##3##(1991-9#1)(1992-9#1)(1993-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
out of this##2##3##(1996-7#1)(2010-3#1)
out of three##5##3##(1990-6#1)(1991-12#1)(2008-1#1)(2008-5#1)(2010-4#1)
out of total##2##3##(2008-10#1)(2010-12#1)
out of two##2##3##(1992-5#1)(2008-12#1)
out of which##9##3##(2007-2#1)(2007-7#3)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
out of work##2##3##(1997-2#1)(2011-2#1)
out of##450##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#3)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#5)(1994-6#2)(1994-7#2)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#4)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#11)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#12)(2007-8#3)(2008-1#16)(2008-10#40)(2008-11#20)(2008-12#11)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#20)(2008-6#11)(2008-7#13)(2008-8#8)(2008-9#12)(2009-10#3)(2009-11#3)(2009-4#1)(2009-5#5)(2009-7#3)(2009-8#8)(2009-9#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#13)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#6)
out on a##18##3##(1992-5#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
out on an##5##3##(1995-2#1)(2008-2#1)(2008-6#1)(2011-1#2)
out on the##26##3##(1993-9#1)(2007-2#1)(2007-6#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
out on##112##2##(1990-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
out only##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
out or##2##2##(1996-12#1)(2012-2#1)
out other##2##2##(2007-7#1)(2009-6#1)
out over the##5##3##(2008-10#3)(2008-2#1)(2012-2#1)
out over##10##2##(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
out patient##2##2##(2010-5#1)(2013-1#1)
out patients##2##2##(2008-7#1)(2010-5#1)
out possible##2##2##(1996-12#1)(2007-10#1)
out selective##2##2##(1997-6#1)(2008-7#1)
out simultaneously##2##2##(2008-10#1)(2011-2#1)
out some of the causes##2##5##(1991-6#1)(2007-11#1)
out some of the##3##4##(1991-6#1)(2007-11#1)(2012-12#1)
out some##6##2##(1991-6#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-8#1)(2012-12#1)
out successful##2##2##(1995-12#1)(1995-5#1)
out such##2##2##(1991-6#1)(1992-6#1)
out that all##2##3##(2008-10#1)(2008-2#1)
out that the##10##3##(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
out that this##2##3##(2007-11#1)(2013-7#1)
out that##31##2##(1990-2#1)(1992-5#1)(1994-12#1)(1995-4#1)(1996-5#1)(1996-9#1)(2007-11#3)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
out the analysis##2##3##(2008-10#1)(2008-2#1)
out the life##2##3##(1991-8#1)(2010-1#1)
out the measurements##2##3##(2008-2#1)(2008-3#1)
out the need to##2##4##(1991-8#1)(2013-7#1)
out the need##4##3##(1991-8#1)(2007-10#1)(2012-3#1)(2013-7#1)
out the possibility of##4##4##(1994-9#1)(2008-1#1)(2010-4#1)(2011-2#1)
out the possibility that##2##4##(1997-8#1)(2013-1#1)
out the possibility##6##3##(1994-9#1)(1997-8#1)(2008-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
out the same##2##3##(2008-10#1)(2011-1#1)
out the##125##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#2)
out these##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
out this##4##2##(1992-4#1)(1992-8#1)(2011-2#1)(2013-1#1)
out three##2##2##(2008-9#1)(2013-1#1)
out through the##2##3##(1996-12#1)(2008-4#1)
out through##11##2##(1996-1#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
out to a##2##3##(2008-10#1)(2008-3#1)
out to all##2##3##(2008-1#2)
out to assess the##3##4##(1994-3#1)(2008-10#1)(2008-3#1)
out to assess##10##3##(1991-5#1)(1993-8#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
out to be a very##4##5##(1991-5#1)(2008-11#1)(2012-2#2)
out to be a##9##4##(1991-5#1)(1992-4#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#2)
out to be very##2##4##(2008-10#1)(2008-9#1)
out to be##43##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-4#1)(1993-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#5)
out to determine whether##2##4##(1991-8#1)(2012-5#1)
out to determine##23##3##(1991-8#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-5#1)(2013-1#2)
out to develop a##4##4##(2008-10#2)(2008-5#1)(2011-1#1)
out to develop##5##3##(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)
out to establish##4##3##(2008-5#1)(2009-10#1)(2010-11#1)(2012-3#1)
out to evaluate the##10##4##(1990-2#1)(1991-2#1)(1992-6#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-5#1)(2011-2#1)
out to evaluate##13##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-6#1)(2007-7#1)(2008-10#2)(2008-12#3)(2008-3#1)(2010-5#1)(2011-2#1)
out to explore##2##3##(2008-7#2)
out to have##2##3##(2008-10#1)(2008-2#1)
out to test##3##3##(1996-7#1)(2008-10#1)(2008-3#1)
out to the##5##3##(1997-3#1)(2007-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
out to##211##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-7#3)(2008-1#3)(2008-10#30)(2008-11#7)(2008-12#9)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#9)(2011-3#2)(2012-12#2)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#2)
out two##2##2##(1990-7#1)(2008-5#1)
out using a##17##3##(1994-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-1#1)
out using##82##2##(1990-11#1)(1991-5#1)(1991-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#45)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
out weekly##2##2##(1991-11#1)(2013-1#1)
out what##5##2##(1992-8#1)(1994-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
out which##5##2##(1991-12#1)(2008-10#1)(2011-2#3)
out with##84##2##(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#26)(2008-2#3)(2008-3#11)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#4)(2013-7#2)
out within##9##2##(1990-3#2)(1995-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)(2011-2#1)
out##2332##1##(1990-10#3)(1990-11#7)(1990-12#10)(1990-2#14)(1990-3#14)(1990-4#2)(1990-5#7)(1990-6#9)(1990-7#6)(1990-8#8)(1990-9#5)(1991-1#3)(1991-11#7)(1991-12#10)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#13)(1991-6#14)(1991-8#11)(1991-9#11)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#13)(1992-4#4)(1992-5#12)(1992-6#8)(1992-8#7)(1992-9#6)(1993-11#5)(1993-12#9)(1993-2#5)(1993-3#12)(1993-5#3)(1993-6#11)(1993-8#4)(1993-9#2)(1994-1#4)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#12)(1994-3#11)(1994-5#8)(1994-6#8)(1994-7#3)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#13)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#6)(1995-6#8)(1995-8#2)(1995-9#3)(1996-1#5)(1996-11#2)(1996-12#16)(1996-2#6)(1996-3#10)(1996-4#1)(1996-5#11)(1996-6#3)(1996-7#7)(1996-8#2)(1996-9#5)(1997-1#3)(1997-2#12)(1997-3#9)(1997-4#14)(1997-5#5)(1997-6#11)(1997-7#8)(1997-8#4)(1997-9#1)(2006-10#4)(2006-4#1)(2006-5#1)(2007-10#10)(2007-11#54)(2007-12#25)(2007-2#5)(2007-3#1)(2007-4#5)(2007-6#5)(2007-7#27)(2007-8#13)(2008-1#36)(2008-10#522)(2008-11#69)(2008-12#43)(2008-2#65)(2008-3#93)(2008-4#22)(2008-5#90)(2008-6#39)(2008-7#59)(2008-8#28)(2008-9#37)(2009-1#1)(2009-10#12)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#13)(2009-6#7)(2009-7#12)(2009-8#12)(2009-9#9)(2010-1#5)(2010-10#2)(2010-11#10)(2010-12#17)(2010-2#11)(2010-3#9)(2010-4#9)(2010-5#15)(2010-6#2)(2010-7#3)(2010-8#17)(2010-9#2)(2011-1#33)(2011-2#87)(2011-3#4)(2012-1#7)(2012-12#25)(2012-2#48)(2012-3#42)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#81)(2013-7#13)(2013-8#28)
out&quot##3##1##(1993-2#1)(1996-6#1)(2008-12#1)
out'##2##1##(1996-2#1)(2008-9#1)
out)##4##1##(2008-10#1)(2009-7#1)(2011-1#1)(2011-2#1)
out-migration##3##1##(2011-2#3)
out-of-band reflectance##2##2##(2008-3#2)
out-of-band##4##1##(2008-3#4)
out-of-core parallel applications##2##3##(2008-3#2)
out-of-court##2##1##(1995-12#1)(1995-6#1)
out-of-focus images##2##2##(2008-3#2)
out-of-focus##5##1##(2008-3#4)(2008-4#1)
out-of-hours services##3##2##(1997-8#3)
out-of-hours##4##1##(1997-8#3)(2013-1#1)
out-of-phase##5##1##(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-6#1)
out-of-plane branching##2##2##(2008-2#2)
out-of-plane deformation##2##2##(2008-3#2)
out-of-plane deformations##2##2##(2008-3#2)
out-of-plane rotation##2##2##(2008-3#2)
out-of-plane##27##1##(1997-7#1)(2007-11#1)(2008-10#2)(2008-2#7)(2008-3#15)(2009-7#1)
out-of-pocket costs##4##2##(1991-2#2)(1994-3#1)(2008-11#1)
out-of-pocket expenses##3##2##(1995-12#1)(2009-8#1)(2011-1#1)
out-of-pocket spending##3##2##(1992-3#2)(1997-3#1)
out-of-pocket##16##1##(1991-2#2)(1992-3#2)(1994-3#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
out-patient clinic##2##2##(1994-11#1)(2012-2#1)
out-patient treatment##2##2##(1990-2#1)(1995-11#1)
out-patient##19##1##(1990-2#1)(1991-11#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-11#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-2#7)(2012-2#1)(2013-8#1)
out-patients##7##1##(1990-6#1)(1991-6#1)(1992-5#1)(1993-3#1)(1993-8#1)(1996-7#1)(2012-1#1)
out?##3##1##(1993-2#1)(2008-6#1)(2010-3#1)
outbound##5##1##(2008-1#1)(2008-2#1)(2008-8#1)(2010-5#2)
outbreak and##4##2##(1997-3#1)(2011-3#1)(2013-1#1)(2013-8#1)
outbreak control##3##2##(1994-11#1)(2007-12#1)(2008-12#1)
outbreak for##2##2##(2007-5#1)(2008-8#1)
outbreak in##17##2##(1991-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#5)(2008-5#1)(2011-1#3)(2011-2#1)(2012-12#1)
outbreak investigation practicum##3##3##(1996-1#3)
outbreak investigation##5##2##(1996-1#4)(2008-8#1)
outbreak investigations##2##2##(1996-1#2)
outbreak occurred##2##2##(1990-3#1)(2010-5#1)
outbreak of community-associated methicillin-resistant Staphylococcus aureus##2##6##(2008-10#1)(2008-11#1)
outbreak of foodborne##2##3##(2007-12#2)
outbreak of##45##2##(1990-9#2)(1991-11#1)(1991-3#1)(1991-8#1)(1992-5#1)(1993-2#1)(1993-5#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#6)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
outbreak species##4##2##(2008-8#4)
outbreak spread##2##2##(1990-3#1)(2008-12#1)
outbreak strain##4##2##(2008-11#2)(2008-7#1)(2012-3#1)
outbreak##130##1##(1990-12#1)(1990-3#3)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-5#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-6#2)(1996-1#6)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#11)(2007-2#2)(2007-5#1)(2007-7#3)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#13)(2008-5#4)(2008-7#3)(2008-8#13)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#2)(2011-1#5)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-8#3)
outbreak-associated##2##1##(1994-9#1)(2008-11#1)
outbreaks and##8##2##(1997-3#1)(2007-6#1)(2007-7#1)(2008-8#1)(2011-2#2)(2013-8#2)
outbreaks in Taiwan##3##3##(2007-6#3)
outbreaks in##12##2##(1997-6#1)(2007-12#1)(2007-6#3)(2008-10#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)
outbreaks occur##2##2##(1991-8#1)(2012-2#1)
outbreaks occurred in##3##3##(1996-6#1)(1997-3#1)(2011-1#1)
outbreaks of invasive meningococcal disease serogroup C##2##7##(2008-11#2)
outbreaks of the##2##3##(2007-10#1)(2011-1#1)
outbreaks of##28##2##(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#2)(2010-4#1)(2011-1#2)(2012-2#1)(2013-7#1)
outbreaks reported##3##2##(1992-6#1)(2009-2#2)
outbreaks were##3##2##(2009-2#1)(2011-1#1)(2012-2#1)
outbreaks##96##1##(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#2)(1992-6#1)(1996-12#1)(1996-6#2)(1997-3#4)(1997-6#4)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-6#4)(2007-7#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-2#7)(2009-3#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#4)(2011-2#11)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
outbred##4##1##(2008-10#3)(2008-12#1)
outbreeding##4##1##(2008-8#4)
outcome after AVM-ICH##2##3##(2012-3#2)
outcome after laparoscopic##2##3##(2011-1#2)
outcome after resection##2##3##(2007-8#1)(2008-6#1)
outcome after##31##2##(1992-2#1)(1992-3#2)(1993-1#1)(1995-8#1)(1996-7#1)(2007-11#2)(2007-8#3)(2008-12#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-3#4)(2013-1#1)
outcome among##3##2##(2008-8#1)(2010-5#2)
outcome and continuous quality improvement##3##5##(1993-12#3)
outcome and its##2##3##(2008-11#1)(2009-4#1)
outcome and possible treatment##2##4##(2008-7#1)(2010-12#1)
outcome and possible##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
outcome and the##5##3##(1995-2#2)(2007-8#3)
outcome and##37##2##(1993-12#3)(1993-9#1)(1995-2#2)(1996-2#2)(1997-5#1)(2006-10#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#4)(2008-8#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
outcome as a##2##3##(1991-1#1)(1997-4#1)
outcome as##5##2##(1990-10#1)(1991-1#1)(1997-4#1)(2008-5#1)(2010-3#1)
outcome assessment##8##2##(1997-1#1)(2007-8#1)(2008-11#1)(2008-7#4)(2008-8#1)
outcome at 6 months and 2 years##3##7##(2007-10#3)
outcome at 6 months##4##4##(2007-10#4)
outcome at##9##2##(1991-11#1)(1995-11#1)(2007-10#5)(2008-7#1)(2008-8#1)
outcome between the two##2##4##(1997-3#1)(2010-3#1)
outcome between the##3##3##(1997-3#1)(2010-3#1)(2011-2#1)
outcome between these##2##3##(1990-2#1)(2011-2#1)
outcome between##6##2##(1990-2#1)(1997-3#1)(2008-6#1)(2010-3#1)(2011-2#2)
outcome but##2##2##(2007-8#1)(2008-4#1)
outcome by##4##2##(2008-6#1)(2011-2#2)(2012-2#1)
outcome can be##3##3##(2008-11#1)(2010-3#1)(2012-12#1)
outcome compared with the rest of##2##6##(2009-2#1)(2011-2#1)
outcome compared with##4##3##(2009-2#2)(2011-2#1)(2012-3#1)
outcome could##2##2##(1995-11#1)(2013-1#1)
outcome data from##2##3##(1993-3#1)(1995-12#1)
outcome data##15##2##(1993-3#2)(1995-12#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
outcome demonstrates##2##2##(2008-3#1)(2008-8#1)
outcome depends##2##2##(2007-11#1)(2008-10#1)
outcome events (stroke##2##3##(1991-11#2)
outcome focus on##2##3##(1997-4#2)
outcome following##13##2##(1992-3#1)(1995-9#1)(2007-10#1)(2007-7#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-5#1)(2013-8#1)
outcome for both the##2##4##(1991-1#1)(2008-10#1)
outcome for patients with##3##4##(2008-3#1)(2008-9#1)(2010-3#1)
outcome for patients##4##3##(2008-3#1)(2008-9#1)(2010-3#1)(2012-2#1)
outcome for the patient##2##4##(2008-7#1)(2012-3#1)
outcome for the##4##3##(1995-3#1)(2008-7#1)(2011-1#1)(2012-3#1)
outcome for these##2##3##(2007-12#1)(2011-2#1)
outcome for##21##2##(1991-1#1)(1991-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
outcome from##4##2##(1992-1#1)(1995-5#1)(2008-8#1)(2011-2#1)
outcome has##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-1#1)
outcome in a##12##3##(1990-2#1)(1995-11#1)(2007-10#1)(2008-10#2)(2008-6#1)(2009-10#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
outcome in acute##2##3##(2009-7#1)(2013-1#1)
outcome in patients treated with##2##5##(1994-8#1)(2011-2#1)
outcome in patients with##9##4##(2007-10#1)(2007-11#2)(2007-8#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)
outcome in patients##15##3##(1994-8#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#3)
outcome in terms of##2##4##(2008-11#1)(2012-3#1)
outcome in the##7##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)
outcome in these##2##3##(1995-12#1)(2008-7#1)
outcome in this##2##3##(2007-8#1)(2009-10#1)
outcome in women with##2##4##(1994-3#1)(2007-10#1)
outcome in women##3##3##(1994-3#1)(2007-10#1)(2008-10#1)
outcome in##90##2##(1990-2#1)(1991-12#2)(1992-2#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(2006-10#1)(2007-10#5)(2007-11#2)(2007-12#4)(2007-8#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#7)(2008-7#6)(2008-8#2)(2009-10#3)(2009-2#1)(2009-7#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
outcome indicators##5##2##(1995-3#1)(1997-1#4)
outcome information##5##2##(1992-1#1)(1995-2#1)(1995-3#1)(2008-6#1)(2013-1#1)
outcome is to be##2##4##(1995-8#1)(2008-10#1)
outcome is to##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
outcome is##22##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
outcome may be##3##3##(2009-5#1)(2010-11#1)(2012-12#1)
outcome measure in##3##3##(1996-3#1)(2011-2#2)
outcome measure of##2##3##(2007-7#1)(2013-1#1)
outcome measure was the##2##4##(2008-10#1)(2013-1#1)
outcome measure was##6##3##(2008-10#1)(2008-7#1)(2011-2#3)(2013-1#1)
outcome measure##16##2##(1993-1#1)(1995-5#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#5)(2013-1#3)
outcome measurement##4##2##(1993-12#1)(1995-2#1)(1997-2#1)(2007-11#1)
outcome measurements##2##2##(2008-3#1)(2010-12#1)
outcome measures and##2##3##(2008-6#1)(2008-7#1)
outcome measures for##2##3##(1996-1#1)(2011-2#1)
outcome measures in##2##3##(2007-11#1)(2008-4#1)
outcome measures included the##2##4##(2007-10#1)(2008-12#1)
outcome measures included##5##3##(2007-10#1)(2008-12#1)(2008-3#1)(2011-2#2)
outcome measures of##5##3##(1994-11#1)(1996-1#1)(2006-10#1)(2009-11#1)(2011-1#1)
outcome measures used##2##3##(1996-3#1)(2007-11#1)
outcome measures were##8##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#4)(2013-1#1)
outcome measures##67##2##(1991-2#1)(1994-11#1)(1994-2#1)(1995-3#2)(1996-1#2)(1996-3#2)(1996-7#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#10)(2012-2#2)(2013-1#5)
outcome of a##4##3##(1994-1#2)(1994-11#1)(2008-6#1)
outcome of both##3##3##(1991-3#1)(1996-1#1)(2012-2#1)
outcome of cardiac surgery##2##4##(2007-8#1)(2010-8#1)
outcome of care##2##3##(1994-3#1)(1997-3#1)
outcome of childhood##2##3##(1991-8#1)(2011-2#1)
outcome of children with##2##4##(2011-5#1)(2013-7#1)
outcome of immediate##2##3##(2013-1#2)
outcome of infections##3##3##(2009-2#3)
outcome of interactions between##2##4##(2008-8#1)(2012-3#1)
outcome of modified##2##3##(2013-1#2)
outcome of patients with##7##4##(2007-5#1)(2008-6#2)(2010-3#2)(2011-2#1)(2012-3#1)
outcome of patients##8##3##(2007-5#1)(2008-6#2)(2010-3#2)(2011-2#2)(2012-3#1)
outcome of pediatric##2##3##(2011-2#1)(2012-3#1)
outcome of renal##2##3##(2008-1#1)(2008-8#1)
outcome of systemic##2##3##(1993-11#1)(2006-10#1)
outcome of the seminal fluid parameters collected via##2##8##(2011-1#2)
outcome of the##30##3##(1992-3#1)(1993-1#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
outcome of these##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
outcome of this##6##3##(1990-9#1)(2007-8#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
outcome of treatment for##2##4##(2007-10#1)(2008-11#1)
outcome of treatment##8##3##(1991-1#1)(1991-6#1)(1996-9#2)(2007-10#1)(2008-11#2)(2011-1#1)
outcome of##207##2##(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-11#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#5)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#7)(2008-7#15)(2008-8#10)(2008-9#8)(2009-10#4)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#15)(2011-3#1)(2011-5#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#9)(2012-4#1)(2013-1#13)(2013-7#1)(2013-8#4)
outcome on##2##2##(1994-2#1)(2007-8#1)
outcome quality##2##2##(1993-12#1)(2008-11#1)
outcome questionnaires##3##2##(2008-9#1)(2012-12#2)
outcome research in the field##2##5##(1992-1#1)(1993-1#1)
outcome research##6##2##(1992-1#1)(1993-1#1)(2008-11#2)(2009-7#1)(2012-2#1)
outcome should be##2##3##(2008-3#1)(2008-6#1)
outcome than that##2##3##(2008-5#1)(2008-6#1)
outcome than##4##2##(1991-8#1)(2008-11#1)(2008-5#1)(2008-6#1)
outcome that##4##2##(1996-1#1)(2008-11#1)(2008-8#1)(2008-9#1)
outcome to##2##2##(2008-1#1)(2010-8#1)
outcome variable##5##2##(1991-11#1)(1995-12#2)(1996-6#1)(1997-3#1)
outcome variables##4##2##(1994-3#1)(2007-12#1)(2008-7#1)(2012-2#1)
outcome was assessed##2##3##(1997-3#1)(2007-8#1)
outcome was determined##2##3##(1991-12#1)(1996-12#1)
outcome was evaluated##2##3##(1994-9#1)(2007-11#1)
outcome was excellent##2##3##(1994-9#1)(2011-2#1)
outcome was obtained##2##3##(2007-10#1)(2007-8#1)
outcome was that##2##3##(1997-1#1)(2012-12#1)
outcome was the##5##3##(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
outcome was##43##2##(1990-5#1)(1991-12#1)(1992-2#1)(1993-2#1)(1994-9#2)(1996-12#1)(1997-1#1)(1997-3#3)(2007-10#4)(2007-11#5)(2007-5#1)(2007-8#5)(2007-9#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-12#2)(2013-1#3)
outcome were##4##2##(1997-3#1)(2007-8#1)(2012-12#1)(2013-1#1)
outcome will##2##2##(1995-3#1)(2007-8#1)
outcome with a##3##3##(1996-3#1)(2007-8#1)(2010-3#1)
outcome with respect to##3##4##(1992-10#1)(2009-8#1)(2011-2#1)
outcome with##14##2##(1991-2#1)(1992-10#1)(1996-3#1)(2007-12#4)(2007-8#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
outcome##1055##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#3)(1991-11#6)(1991-12#6)(1991-2#7)(1991-3#3)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#2)(1992-12#1)(1992-2#4)(1992-3#8)(1992-4#2)(1992-9#5)(1993-1#4)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#5)(1994-12#4)(1994-2#8)(1994-3#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#8)(1995-3#8)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#4)(1996-5#2)(1996-6#3)(1996-7#2)(1996-9#5)(1997-1#7)(1997-2#2)(1997-3#10)(1997-4#8)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#11)(2006-6#1)(2006-7#1)(2007-10#32)(2007-11#24)(2007-12#17)(2007-2#1)(2007-5#3)(2007-7#10)(2007-8#48)(2007-9#1)(2008-1#17)(2008-10#27)(2008-11#40)(2008-12#18)(2008-2#3)(2008-3#12)(2008-4#8)(2008-5#6)(2008-6#37)(2008-7#65)(2008-8#29)(2008-9#29)(2009-1#1)(2009-10#11)(2009-11#4)(2009-12#3)(2009-2#8)(2009-3#2)(2009-4#6)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#10)(2010-12#6)(2010-2#1)(2010-3#22)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#23)(2011-2#88)(2011-3#1)(2011-5#1)(2012-1#4)(2012-12#31)(2012-2#23)(2012-3#33)(2012-4#1)(2013-1#52)(2013-7#3)(2013-8#12)
outcome)##2##1##(1996-3#1)(2007-8#1)
outcome-adaptive##2##1##(2011-2#2)
outcome-based##4##1##(1995-3#2)(1996-1#1)(1997-3#1)
outcome?##5##1##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
outcome]##6##1##(1993-6#1)(1996-3#1)(2008-11#2)(2009-5#1)(2012-2#1)
outcomes across##2##2##(2009-11#1)(2012-2#1)
outcomes after##15##2##(2007-10#1)(2007-11#1)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
outcomes among patients##3##3##(2007-8#1)(2009-12#1)(2009-8#1)
outcomes among##6##2##(2007-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
outcomes and financial##2##3##(1996-12#1)(2008-3#1)
outcomes and patient satisfaction##3##4##(1995-1#1)(1997-1#1)(2007-12#1)
outcomes and quality##2##3##(1997-2#1)(1997-3#1)
outcomes and reduce##2##3##(1997-2#1)(2012-2#1)
outcomes and risk factors##2##4##(2008-7#1)(2013-8#1)
outcomes and the##2##3##(1994-1#1)(2008-11#1)
outcomes and to##2##3##(2007-11#1)(2012-2#1)
outcomes and##49##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#2)(1997-2#2)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#1)
outcomes are not##2##3##(1995-2#1)(2008-12#1)
outcomes are often##2##3##(1993-12#1)(2009-9#1)
outcomes are##30##2##(1993-12#1)(1994-11#1)(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#3)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
outcomes as##7##2##(1994-1#1)(1996-12#1)(1997-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
outcomes assessment##6##2##(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#2)
outcomes associated with##9##3##(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#2)(2010-9#1)(2012-2#2)
outcomes at the##2##3##(1994-3#1)(2008-8#1)
outcomes at##11##2##(1994-3#2)(2007-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-6#2)(2012-12#1)(2013-1#1)
outcomes between##2##2##(2010-1#1)(2012-3#1)
outcomes but##2##2##(2008-1#1)(2011-1#1)
outcomes by##6##2##(1994-1#1)(1997-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
outcomes can be##4##3##(1995-12#1)(2008-11#1)(2008-9#1)(2009-5#1)
outcomes compared with##2##3##(2008-3#1)(2012-12#1)
outcomes compared##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
outcomes data##7##2##(1997-1#3)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)
outcomes depend##2##2##(2008-3#1)(2008-8#1)
outcomes following C-ADR##4##3##(2012-12#4)
outcomes following##12##2##(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
outcomes for children##3##3##(2008-11#1)(2008-6#1)(2012-12#1)
outcomes for each##2##3##(1996-2#1)(1997-4#1)
outcomes for patients with##9##4##(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
outcomes for patients##11##3##(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
outcomes for the##4##3##(1994-12#1)(2008-11#1)(2008-6#1)(2010-6#1)
outcomes for##51##2##(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-11#5)(2008-12#2)(2008-3#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#4)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
outcomes from##13##2##(1992-2#1)(1996-12#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
outcomes have been##2##3##(2008-12#1)(2013-1#1)
outcomes have improved##2##3##(2008-3#1)(2010-3#1)
outcomes have##6##2##(2008-10#1)(2008-12#1)(2008-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
outcomes in a##4##3##(2008-12#2)(2008-9#2)
outcomes in acute##2##3##(2008-3#1)(2013-1#1)
outcomes in cancer##2##3##(2010-10#1)(2012-12#1)
outcomes in children with##2##4##(2008-10#1)(2012-2#1)
outcomes in children##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
outcomes in patients with##6##4##(2008-12#2)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
outcomes in patients##10##3##(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
outcomes in persons##2##3##(2008-1#1)(2009-10#1)
outcomes in the context of##3##5##(2009-7#1)(2011-2#1)(2011-7#1)
outcomes in the##11##3##(1992-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
outcomes in these patients##2##4##(1997-1#1)(2008-1#1)
outcomes in these##4##3##(1997-1#1)(2008-1#1)(2008-8#1)(2011-2#1)
outcomes in this##2##3##(1995-11#1)(2013-1#1)
outcomes in##89##2##(1992-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#3)(1997-1#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2011-2#14)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
outcomes include##3##2##(2008-8#1)(2011-1#1)(2012-2#1)
outcomes included##3##2##(2007-10#1)(2007-12#1)(2013-1#1)
outcomes including##3##2##(2007-6#1)(2010-6#1)(2012-2#1)
outcomes information##5##2##(1996-1#2)(1996-2#1)(1997-1#2)
outcomes is##8##2##(1991-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2009-11#1)(2011-2#2)(2013-1#1)
outcomes management##18##2##(1991-12#3)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1996-1#1)(1996-2#5)(1997-1#3)(1997-3#1)
outcomes may##4##2##(2008-8#2)(2012-3#1)(2013-1#1)
outcomes measurement into##2##3##(1996-1#2)
outcomes measurement##6##2##(1994-12#1)(1996-1#3)(1997-1#1)(1997-3#1)
outcomes measures##2##2##(1997-2#1)(2009-9#1)
outcomes monitoring##2##2##(1994-1#1)(1995-2#1)
outcomes movement##5##2##(1991-12#1)(1994-11#2)(1996-1#1)(1997-1#1)
outcomes obtained##2##2##(2011-2#1)(2013-1#1)
outcomes of a##6##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
outcomes of care##10##3##(1991-12#1)(1993-3#2)(1994-2#1)(1996-2#1)(2008-6#1)(2012-3#2)(2013-1#2)
outcomes of competition##2##3##(2008-8#2)
outcomes of health care##2##4##(1996-2#1)(2008-4#1)
outcomes of home health care##2##5##(1995-3#2)
outcomes of in vitro##2##4##(2012-2#1)(2013-1#1)
outcomes of interspecific competition##2##4##(2008-8#2)
outcomes of intervention##2##3##(2008-12#1)(2009-5#1)
outcomes of nutrition##3##3##(1994-3#1)(1995-2#1)(1995-3#1)
outcomes of patients with##2##4##(2010-3#1)(2012-3#1)
outcomes of patients##4##3##(2008-3#1)(2008-6#1)(2010-3#1)(2012-3#1)
outcomes of physical##2##3##(2008-12#1)(2011-1#1)
outcomes of the##10##3##(1996-1#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
outcomes of these##4##3##(1996-3#1)(2008-9#1)(2010-1#1)(2010-5#1)
outcomes of this##3##3##(1996-3#1)(2010-5#1)(2012-12#1)
outcomes of treatment##2##3##(2008-12#1)(2013-8#1)
outcomes of##116##2##(1990-3#1)(1991-1#1)(1991-12#2)(1993-3#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#2)(1996-3#4)(1996-5#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-5#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#15)(2013-8#3)
outcomes on##3##2##(1993-2#1)(2008-1#1)(2009-7#1)
outcomes or##4##2##(1995-2#1)(2008-11#1)(2008-8#1)(2010-4#1)
outcomes over time##2##3##(1993-12#1)(2008-12#1)
outcomes over##3##2##(1993-12#1)(2008-12#2)
outcomes related to##2##3##(1995-3#1)(2013-8#1)
outcomes relative to##2##3##(1991-12#1)(2012-12#1)
outcomes remain##2##2##(2008-4#1)(2012-1#1)
outcomes remains##2##2##(1997-1#1)(2008-9#1)
outcomes research##17##2##(1993-12#2)(1993-2#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-2#2)(1996-1#1)(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
outcomes such as##4##3##(2008-11#1)(2008-8#1)(2010-7#1)(2013-8#1)
outcomes suggest that##2##3##(1992-11#1)(2008-9#1)
outcomes than##5##2##(2007-11#1)(2009-5#1)(2012-12#1)(2013-1#2)
outcomes that will##2##3##(2008-11#1)(2009-3#1)
outcomes that##9##2##(1992-12#1)(1996-3#1)(2008-11#2)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
outcomes through##3##2##(2009-8#1)(2011-2#1)(2012-1#1)
outcomes to##9##2##(2007-12#1)(2012-12#5)(2013-1#3)
outcomes was##2##2##(2010-2#1)(2012-2#1)
outcomes were as##2##3##(2011-2#1)(2013-1#1)
outcomes were assessed##2##3##(2007-8#1)(2008-11#1)
outcomes were##21##2##(1995-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2009-11#1)(2009-7#2)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
outcomes when##5##2##(1995-2#1)(2008-2#1)(2008-4#1)(2009-7#1)(2012-12#1)
outcomes while##3##2##(1997-1#1)(2009-8#1)(2013-1#1)
outcomes with##12##2##(1994-12#1)(1997-7#1)(2008-12#2)(2008-3#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
outcomes##1079##1##(1990-3#1)(1991-1#4)(1991-12#11)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#2)(1993-12#6)(1993-2#8)(1993-3#7)(1994-1#8)(1994-11#9)(1994-12#10)(1994-2#7)(1994-3#11)(1994-5#1)(1995-1#5)(1995-11#1)(1995-12#4)(1995-2#19)(1995-3#11)(1995-4#1)(1996-1#15)(1996-12#7)(1996-2#17)(1996-3#10)(1996-4#1)(1996-5#1)(1997-1#22)(1997-2#6)(1997-3#5)(1997-4#4)(1997-7#6)(2006-5#1)(2007-10#12)(2007-11#7)(2007-12#13)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#20)(2008-1#16)(2008-10#15)(2008-11#56)(2008-12#33)(2008-2#6)(2008-3#39)(2008-4#10)(2008-5#3)(2008-6#15)(2008-7#26)(2008-8#27)(2008-9#28)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#7)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#12)(2009-6#3)(2009-7#15)(2009-8#12)(2009-9#11)(2010-1#5)(2010-10#6)(2010-11#2)(2010-12#12)(2010-2#1)(2010-3#11)(2010-4#5)(2010-5#3)(2010-6#11)(2010-7#5)(2010-8#2)(2010-9#3)(2011-1#27)(2011-2#70)(2011-3#1)(2011-7#1)(2012-1#7)(2012-12#48)(2012-2#38)(2012-3#36)(2012-8#1)(2013-1#109)(2013-7#2)(2013-8#24)
outcomes) and##2##2##(1996-12#1)(2011-2#1)
outcomes?##3##1##(1993-2#1)(2008-12#2)
outcoupler##2##1##(2007-11#2)
outcouplers##2##1##(2007-11#2)
outcross success##3##2##(2008-9#3)
outcross##4##1##(2008-9#4)
outcrossed##2##1##(2008-8#1)(2008-9#1)
outcrossing in##4##2##(2008-10#4)
outcrossing##15##1##(2008-10#10)(2008-8#1)(2008-9#2)(2012-3#2)
outdated##8##1##(1994-2#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#3)
outdoor activities##2##2##(2011-2#1)(2012-3#1)
outdoor air pollutants##3##3##(1996-3#2)(2008-10#1)
outdoor air samples##3##3##(2008-10#1)(2010-5#2)
outdoor air##15##2##(1996-3#2)(2008-10#7)(2010-5#6)
outdoor and indoor##3##3##(2013-1#2)(2013-8#1)
outdoor concentrations##2##2##(2008-10#1)(2008-11#1)
outdoor environments##2##2##(1997-4#1)(2010-5#1)
outdoor exposure##2##2##(2008-10#1)(2008-11#1)
outdoor scenes##3##2##(2008-3#2)(2008-6#1)
outdoor##65##1##(1994-3#1)(1995-6#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-4#2)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-5#11)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
outdoors and##4##2##(1991-3#1)(2008-10#1)(2010-5#1)(2012-12#1)
outdoors##13##1##(1991-3#1)(2008-10#4)(2008-3#1)(2008-6#1)(2010-5#2)(2011-2#1)(2012-12#3)
outer and inner##6##3##(1990-11#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
outer cell wall##2##3##(2008-10#1)(2011-2#1)
outer cortex##7##2##(2008-10#5)(2008-7#1)(2012-2#1)
outer cortical##4##2##(1995-6#2)(2008-10#1)(2008-3#1)
outer dendritic##3##2##(2007-12#1)(2008-7#2)
outer diameter of##4##3##(1994-9#1)(2008-2#1)(2008-8#1)(2012-2#1)
outer diameter##8##2##(1994-2#1)(1994-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2012-2#1)
outer dorsal skin layers from##3##5##(2008-11#3)
outer doublet##2##2##(1991-2#2)
outer hair cells##4##3##(1993-9#1)(2008-4#1)(2008-9#1)(2009-9#1)
outer half##2##2##(2008-12#2)
outer islands##2##2##(2008-1#2)
outer layer of##6##3##(1992-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
outer layer##16##2##(1992-6#2)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)
outer layers of##3##3##(2008-11#2)(2009-8#1)
outer layers##4##2##(2008-10#1)(2008-11#2)(2009-8#1)
outer membrane and##2##3##(1994-8#1)(2009-6#1)
outer membrane in##3##3##(1994-12#1)(1997-8#1)(2008-5#1)
outer membrane of##3##3##(1990-11#1)(2008-8#1)(2009-8#1)
outer membrane protein (OMP)##3##4##(1993-9#1)(1995-12#1)(2008-5#1)
outer membrane protein A (OmpA)##2##5##(1997-4#1)(2008-1#1)
outer membrane protein of##5##4##(1991-9#2)(1993-9#1)(1995-12#1)(2008-5#1)
outer membrane protein##13##3##(1990-11#1)(1991-9#2)(1993-12#1)(1993-9#2)(1995-12#2)(1997-4#1)(2008-1#1)(2008-5#3)
outer membrane proteins of##2##4##(2008-12#1)(2008-5#1)
outer membrane proteins##8##3##(1990-12#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
outer membrane vesicles##3##3##(2011-1#2)(2013-8#1)
outer membrane##53##2##(1990-11#4)(1990-12#1)(1991-11#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-8#2)(1995-12#4)(1995-3#1)(1997-4#1)(1997-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
outer membranes##3##2##(1990-5#1)(1991-10#1)(1996-12#1)
outer mitochondrial membrane##3##3##(1994-11#1)(2012-2#2)
outer mitochondrial##4##2##(1994-11#1)(1994-8#1)(2012-2#2)
outer nuclear membrane##3##3##(2008-9#2)(2011-2#1)
outer nuclear##6##2##(1991-10#1)(2008-9#2)(2010-1#1)(2011-2#2)
outer plexiform##2##2##(1996-5#1)(2008-4#1)
outer ring##6##2##(2007-12#1)(2008-10#3)(2012-2#2)
outer root sheath##2##3##(2008-5#1)(2013-8#1)
outer scale L0##2##3##(2008-3#2)
outer scale of turbulence##2##4##(2008-3#2)
outer scale of##3##3##(2008-3#3)
outer scale##9##2##(2008-2#1)(2008-3#8)
outer segment assembly##2##3##(2008-7#2)
outer segment##4##2##(1997-1#1)(2008-7#3)
outer segments##6##2##(1993-8#1)(1995-5#1)(1997-1#1)(2008-4#1)(2008-7#2)
outer shell##2##2##(2008-8#2)
outer surface##8##2##(1990-2#1)(1994-5#1)(1995-5#1)(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
outer surfaces##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
outer to##3##2##(1995-12#1)(1996-2#1)(2012-2#1)
outer wall##2##2##(2008-9#2)
outer zone##3##2##(2008-10#1)(2008-7#2)
outer##253##1##(1990-11#11)(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#2)(1991-11#1)(1991-2#4)(1991-5#1)(1991-9#3)(1992-12#3)(1992-3#3)(1992-6#4)(1993-12#1)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#2)(1994-8#4)(1994-9#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#6)(2006-12#1)(2007-11#1)(2007-12#9)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#10)(2008-12#6)(2008-2#5)(2008-3#14)(2008-4#5)(2008-5#13)(2008-7#17)(2008-8#6)(2008-9#5)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#9)(2013-1#3)(2013-8#4)
outer-layer##2##1##(2008-10#2)
outermost layer of the skin##2##5##(2008-5#2)
outermost layer of##3##3##(2008-5#3)
outermost##15##1##(1997-8#1)(2007-12#1)(2008-10#4)(2008-5#9)
outflow obstruction##6##2##(1991-11#2)(2008-10#3)(2008-7#1)
outflow of the##4##3##(2007-8#1)(2008-10#1)(2008-3#2)
outflow of##5##2##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#2)
outflow to the##2##3##(1992-6#2)
outflow tract##13##2##(1992-9#1)(2007-8#2)(2007-9#2)(2011-1#3)(2012-2#1)(2013-1#1)(2013-2#1)(2013-8#2)
outflow##42##1##(1991-11#2)(1992-6#3)(1992-7#1)(1992-9#1)(1995-12#2)(1996-12#1)(1997-3#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2011-1#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-2#1)(2013-8#2)
outgoing##7##1##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2012-3#1)
outgroup A##3##2##(2008-10#3)
outgroup members##2##2##(2009-11#1)(2012-3#1)
outgroup##26##1##(1995-11#1)(2007-12#5)(2008-10#6)(2008-11#2)(2008-8#1)(2009-11#6)(2010-3#1)(2012-3#3)(2013-8#1)
outgroups##9##1##(1995-11#2)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#3)
outgrowing##3##1##(2007-12#1)(2008-10#1)(2011-1#1)
outgrowth and##8##2##(1990-2#1)(1992-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2011-2#2)
outgrowth in##8##2##(1991-6#1)(1992-6#1)(1995-6#2)(2008-11#3)(2008-4#1)
outgrowth is##2##2##(2011-2#2)
outgrowth of a##2##3##(2008-11#1)(2008-3#1)
outgrowth of the##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
outgrowth of##19##2##(1992-1#1)(1997-6#1)(2007-12#1)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-7#1)(2013-1#1)
outgrowth ofneurites##2##2##(2008-11#2)
outgrowth promoting activity##3##3##(2008-11#3)
outgrowth was##6##2##(2008-11#6)
outgrowth##86##1##(1990-2#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-6#2)(1993-5#1)(1995-2#1)(1995-6#4)(1996-12#1)(1997-3#1)(1997-6#2)(2007-12#2)(2008-10#3)(2008-11#27)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#19)(2012-12#1)(2012-7#1)(2013-1#1)
outgrowths were observed##2##3##(2008-11#2)
outgrowths were##3##2##(2008-11#2)(2011-2#1)
outgrowths##8##1##(2008-11#4)(2008-9#1)(2011-2#3)
outlays##3##1##(1992-3#1)(1993-3#1)(1995-1#1)
outlet and the##2##3##(2008-10#2)
outlet in##2##2##(1994-3#1)(2008-10#1)
outlet obstruction and##2##3##(2008-10#1)(2008-12#1)
outlet obstruction##9##2##(2008-10#2)(2008-12#2)(2011-2#1)(2012-2#3)(2013-1#1)
outlet of##6##2##(2008-10#5)(2008-11#1)
outlet syndrome##5##2##(2008-3#3)(2008-9#1)(2011-3#1)
outlet##35##1##(1994-3#1)(1996-9#2)(2007-12#2)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)
outlets##6##1##(1997-1#2)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
outlier data##4##2##(2008-10#4)
outlier detection##3##2##(2008-10#3)
outlier payments##4##2##(1992-12#3)(1997-1#1)
outlier##22##1##(1992-12#4)(1993-12#1)(1993-3#3)(1993-9#1)(1997-1#1)(2008-10#10)(2009-8#2)
outliers##17##1##(1991-12#1)(1992-12#4)(2008-10#10)(2008-2#2)
outliers)##3##1##(1991-12#1)(2008-10#2)
outline a new##2##3##(2008-4#1)(2008-8#1)
outline a##10##2##(1994-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2010-4#1)(2010-8#1)
outline for##2##2##(1993-3#1)(2011-2#1)
outline how the##2##3##(1992-3#1)(2012-2#1)
outline of the proposed##2##4##(2008-3#1)(2008-6#1)
outline of the##11##3##(1992-12#1)(1993-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-3#1)(2013-1#1)
outline of##16##2##(1992-12#1)(1993-2#1)(1995-6#1)(1996-2#1)(1997-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
outline some##2##2##(1994-5#1)(2008-11#1)
outline the most##2##3##(2011-2#1)(2012-3#1)
outline the rationale##2##3##(2010-5#1)(2010-6#1)
outline the##30##2##(1992-12#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
outline their##3##2##(1993-2#1)(2007-12#1)(2012-3#1)
outline was##2##2##(1992-3#1)(2011-2#1)
outline##92##1##(1991-3#1)(1992-12#2)(1992-3#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-12#2)(2008-10#4)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
outlined above##2##2##(1994-12#1)(1996-3#1)
outlined and##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
outlined as to##2##3##(2008-10#1)(2009-10#1)
outlined as well as##2##4##(1993-3#1)(2011-2#1)
outlined as##5##2##(1993-3#1)(1997-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
outlined by the##4##3##(1996-5#1)(2007-12#2)(2008-8#1)
outlined by##8##2##(1990-10#1)(1996-5#1)(2007-12#2)(2008-11#2)(2008-8#1)(2012-12#1)
outlined for##5##2##(1991-8#1)(2007-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
outlined here##4##2##(1996-2#1)(1997-4#1)(2008-11#1)(2012-2#1)
outlined in the##2##3##(2008-11#1)(2012-3#1)
outlined in this article##2##4##(2012-2#1)(2012-3#1)
outlined in this paper##2##4##(2008-8#1)(2010-8#1)
outlined in this review##2##4##(2008-12#1)(2012-12#1)
outlined in this unit##2##4##(2008-2#1)(2008-4#1)
outlined in this##8##3##(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
outlined in##14##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-8#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
outlined the##5##2##(1990-9#1)(1991-9#1)(1996-12#1)(2008-10#1)(2010-8#1)
outlined##106##1##(1990-10#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#3)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#12)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#2)
outlines a simple##2##3##(2008-3#1)(2008-9#1)
outlines a##11##2##(1992-12#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-12#1)
outlines general##3##2##(1997-2#1)(2008-7#1)(2009-11#1)
outlines how the##3##3##(2007-11#1)(2008-11#2)
outlines how##5##2##(2007-11#1)(2008-11#3)(2010-9#1)
outlines methods##2##2##(2008-4#1)(2008-7#1)
outlines modifications for preparation and transfection of plant protoplasts##2##9##(2008-1#1)(2008-2#1)
outlines several##2##2##(1992-1#1)(1994-3#1)
outlines some of the##3##4##(1994-3#1)(1997-2#1)(2010-4#1)
outlines some##4##2##(1994-3#1)(1997-2#1)(2008-11#1)(2010-4#1)
outlines the development##4##3##(2008-11#1)(2008-12#2)(2010-5#1)
outlines the essential elements of##2##5##(2007-11#1)(2008-4#1)
outlines the problems##2##3##(2008-4#1)(2008-7#1)
outlines the steps##3##3##(1992-1#1)(1995-3#1)(2008-2#1)
outlines the##46##2##(1992-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#2)
outlines this##2##2##(1994-3#1)(2008-12#1)
outlines##111##1##(1992-1#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#5)(1997-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#13)(2008-5#1)(2008-7#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)
outlining the##7##2##(1992-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-8#1)(2012-2#1)
outlining##12##1##(1992-3#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-2#1)
outlook for the##2##3##(1994-2#1)(1995-1#1)
outlook for##6##2##(1993-12#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
outlook of##4##2##(1996-2#1)(1996-5#1)(2010-9#1)(2013-1#1)
outlook on##4##2##(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)
outlook##24##1##(1991-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-1#2)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-9#1)(2013-1#1)
outlooks##3##1##(1995-12#1)(1995-3#1)(2010-4#1)
outlying##2##1##(2008-7#1)(2008-9#1)
outnumbered##4##1##(1992-1#1)(1993-6#1)(2007-11#1)(2008-10#1)
outpatient and##2##2##(1995-12#1)(1996-3#1)
outpatient cardiac##2##2##(1992-1#1)(2008-11#1)
outpatient care##13##2##(1991-1#2)(1993-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-10#1)(2011-1#2)(2013-8#1)
outpatient cases##2##2##(1996-3#1)(2012-12#1)
outpatient chemotherapy##5##2##(1991-3#1)(2010-2#4)
outpatient clinic##11##2##(1995-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
outpatient clinics and##3##3##(1995-8#1)(1996-2#1)(2007-12#1)
outpatient clinics##6##2##(1992-12#2)(1995-8#1)(1996-2#1)(1997-8#1)(2007-12#1)
outpatient department##7##2##(1991-9#1)(1992-12#1)(1996-12#2)(1997-3#1)(2008-1#2)
outpatient departments##3##2##(1996-1#2)(1997-2#1)
outpatient drug##3##2##(1995-1#1)(1995-2#2)
outpatient drugs##2##2##(1995-1#2)
outpatient facilities##2##2##(2008-3#2)
outpatient health care##2##3##(2007-10#2)
outpatient health##4##2##(1993-12#1)(2007-10#2)(2011-2#1)
outpatient hospital##5##2##(1992-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)
outpatient management##2##2##(2006-5#1)(2008-11#1)
outpatient mental health##2##3##(1995-12#1)(2008-6#1)
outpatient oral and maxillofacial surgery##2##5##(1993-1#2)
outpatient physiotherapy services##2##3##(2012-2#2)
outpatient physiotherapy##4##2##(2008-10#2)(2012-2#2)
outpatient prescription drug use##2##4##(1992-1#1)(1995-1#1)
outpatient prescription drug##5##3##(1992-1#2)(1995-1#3)
outpatient procedures##2##2##(1992-12#1)(1996-1#1)
outpatient program##2##2##(1991-1#1)(2008-3#1)
outpatient samples##2##2##(1994-2#2)
outpatient services in##2##3##(2009-9#1)(2010-6#1)
outpatient services##26##2##(1991-2#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#2)(1995-2#1)(1995-3#3)(1996-1#1)(2009-9#1)(2010-6#1)(2010-8#3)
outpatient setting##8##2##(1991-1#1)(1993-12#2)(1995-2#1)(2006-10#1)(2008-3#2)(2009-2#1)
outpatient settings##3##2##(1991-12#1)(2008-8#1)(2013-1#1)
outpatient surgery##6##2##(1991-2#1)(1995-12#1)(1996-3#3)(2009-10#1)
outpatient surgical care##2##3##(1992-6#1)(1995-2#1)
outpatient surgical services##2##3##(1995-12#2)
outpatient surgical##5##2##(1992-6#1)(1995-12#2)(1995-2#1)(2007-7#1)
outpatient treatment##5##2##(1990-11#1)(1990-2#1)(1990-6#1)(1997-3#1)(2008-4#1)
outpatient visits##4##2##(1992-2#1)(1995-1#1)(1995-2#1)(2008-11#1)
outpatient##226##1##(1990-11#2)(1990-2#1)(1990-6#1)(1991-1#6)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#2)(1991-9#1)(1992-1#6)(1992-12#12)(1992-2#3)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#3)(1993-12#12)(1993-2#6)(1993-6#1)(1994-12#3)(1994-2#9)(1994-3#3)(1995-1#7)(1995-11#1)(1995-12#11)(1995-2#11)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#9)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#3)(2006-5#1)(2007-10#3)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-2#4)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
outpatient-based##2##1##(2007-10#1)(2009-12#1)
outpatients and##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2012-5#1)
outpatients in a##2##3##(2008-5#1)(2008-7#1)
outpatients in##4##2##(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)
outpatients with ovarian dysfunction##2##4##(2011-2#2)
outpatients with##12##2##(1990-12#1)(1995-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)(2013-7#1)(2013-8#2)
outpatients##48##1##(1990-12#1)(1991-3#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#3)
outperform##7##1##(1991-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-3#1)(2012-12#1)
outperformed the##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
outperformed##5##1##(2007-11#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
outperforming the##2##2##(2009-11#1)(2010-2#1)
outperforms conventional##2##2##(2008-10#1)(2008-5#1)
outperforms the##2##2##(2012-2#1)(2012-3#1)
outperforms##9##1##(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#2)(2012-3#1)
outpouching##2##1##(2008-10#1)(2008-5#1)
output a##2##2##(2007-11#1)(2008-3#1)
output and the##2##3##(2008-3#1)(2008-8#1)
output and to##2##3##(2007-12#1)(2008-3#1)
output and##34##2##(1991-12#1)(1991-5#1)(1991-6#1)(1995-3#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#3)(2012-3#3)
output are##4##2##(2007-12#2)(2008-3#2)
output as##2##2##(2007-11#1)(2008-10#1)
output at the##3##3##(2008-12#1)(2008-3#1)(2008-5#1)
output at##15##2##(2007-11#3)(2007-12#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-10#1)
output beam divergence##2##3##(2007-12#1)(2008-2#1)
output beam profiles##2##3##(2008-2#1)(2008-3#1)
output beam was##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
output beam with##2##3##(2007-12#1)(2008-2#1)
output beam##17##2##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#5)(2011-1#2)
output but##2##2##(2008-12#1)(2008-9#1)
output by##3##2##(1995-11#1)(2008-4#1)(2008-9#1)
output can be##2##3##(1996-3#1)(2007-11#1)
output characteristics of##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
output characteristics##4##2##(1994-12#1)(1995-3#1)(2008-2#1)(2008-3#1)
output compared with##2##3##(2008-2#2)
output contrast##2##2##(2008-2#1)(2008-3#1)
output coupler##14##2##(2007-12#1)(2008-2#9)(2008-3#4)
output couplers##7##2##(2007-12#5)(2008-3#2)
output coupling mirror##2##3##(2007-11#1)(2008-3#1)
output coupling##12##2##(2007-11#2)(2007-9#1)(2008-2#4)(2008-3#5)
output couplings##2##2##(2008-2#2)
output did not##2##3##(2007-8#1)(2011-2#1)
output end##3##2##(2007-12#1)(2008-3#2)
output energies##2##2##(2008-2#1)(2008-3#1)
output energy at##2##3##(2007-11#1)(2008-3#1)
output energy was##3##3##(2008-2#1)(2008-3#2)
output energy##12##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#4)
output factors##3##2##(2008-3#1)(2010-8#2)
output flux##2##2##(2008-3#2)
output for an##2##3##(2008-3#2)
output for##6##2##(1992-4#1)(1995-2#1)(2008-2#1)(2008-3#2)(2008-7#1)
output frequency##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
output from a##9##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)
output from the##6##3##(1991-7#1)(2007-12#1)(2008-2#1)(2008-3#3)
output from##23##2##(1991-7#1)(1995-11#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#10)
output image##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
output in a##3##3##(1994-6#1)(2007-12#2)
output in the##11##3##(1994-6#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-6#6)(2009-10#1)
output in##18##2##(1994-6#4)(2007-11#1)(2007-12#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#6)(2009-10#1)
output intensity##2##2##(2007-11#1)(2007-12#1)
output is obtained##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
output is##27##2##(1991-2#1)(1993-3#1)(1994-12#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#5)(2008-9#3)(2009-8#2)(2010-2#1)(2010-8#1)(2012-3#1)
output laser##2##2##(2008-3#2)
output layers##5##2##(2008-10#5)
output levels##2##2##(1996-2#1)(2009-4#1)
output mirror reflectivity##2##3##(2008-3#2)
output mirror##5##2##(2008-2#1)(2008-3#4)
output nodes##3##2##(2008-2#3)
output noise##2##2##(2007-12#1)(2010-8#1)
output of a##27##3##(1993-9#1)(2007-11#6)(2007-12#6)(2008-10#2)(2008-2#6)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
output of an amplified##2##4##(2007-11#1)(2007-12#1)
output of an##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
output of each##2##3##(2008-2#1)(2012-2#1)
output of the fiber##2##4##(2007-11#1)(2008-3#1)
output of the filter##2##4##(2008-2#1)(2008-3#1)
output of the system##2##4##(2008-2#2)
output of the##30##3##(1994-8#1)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#7)(2008-9#1)(2009-12#1)(2009-8#1)
output of##86##2##(1993-3#1)(1993-9#1)(1994-8#1)(1996-2#1)(1997-7#1)(2007-11#13)(2007-12#16)(2008-10#7)(2008-11#2)(2008-2#17)(2008-3#15)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#2)
output optical spectrum##3##3##(2013-8#3)
output optical##4##2##(2007-11#1)(2013-8#3)
output or##2##2##(1991-6#1)(2008-2#1)
output ports##2##2##(2007-11#1)(2008-3#1)
output power and##8##3##(2007-12#2)(2008-2#2)(2008-3#3)(2011-1#1)
output power at a##2##4##(2007-12#2)
output power at##9##3##(2007-12#4)(2008-2#5)
output power by##2##3##(2008-3#2)
output power enhancement and threshold reduction##2##6##(2007-12#2)
output power for the##2##4##(2007-11#1)(2008-3#1)
output power from a##2##4##(2007-11#1)(2008-3#1)
output power from##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
output power has been##3##4##(2007-11#2)(2008-2#1)
output power is##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
output power of 1 W##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
output power of 1##8##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
output power of 530 mW##2##5##(2007-12#2)
output power of a##2##4##(2008-3#2)
output power of the##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
output power of up to##2##5##(2007-11#1)(2007-12#1)
output power of##47##3##(2007-11#10)(2007-12#15)(2008-2#8)(2008-3#14)
output power was measured##2##4##(2007-11#1)(2008-2#1)
output power was##9##3##(2007-11#3)(2008-2#3)(2008-3#3)
output power with a##2##4##(2008-3#1)(2011-1#1)
output power with##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2011-1#1)
output power##137##2##(2007-11#25)(2007-12#36)(2008-2#36)(2008-3#38)(2011-1#2)
output powers as high as##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
output powers as##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
output powers from##2##3##(2007-12#1)(2008-3#1)
output powers of 1##2##4##(2007-11#1)(2007-12#1)
output powers of as much as##2##6##(2007-11#1)(2007-12#1)
output powers of##12##3##(2007-11#9)(2007-12#2)(2008-3#1)
output powers##27##2##(2007-11#11)(2007-12#6)(2008-2#4)(2008-3#6)
output pressure##3##2##(2008-10#3)
output pulse duration##2##3##(2008-2#1)(2008-3#1)
output pulse energies##2##3##(2008-3#2)
output pulse energy of##2##4##(2007-12#1)(2008-2#1)
output pulse energy##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
output pulse##13##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#6)
output pulses##9##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#1)
output radiation##3##2##(2007-11#3)
output rate and##2##3##(2008-11#2)
output rate##3##2##(2008-10#1)(2008-11#2)
output rates were##2##3##(2008-10#2)
output rates##6##2##(1995-3#2)(2008-10#4)
output remains##2##2##(2007-12#1)(2008-3#1)
output second-harmonic##2##2##(2008-3#2)
output signal is##2##3##(2007-11#1)(2008-2#1)
output signal power variations##2##4##(2008-2#2)
output signal pulses##2##3##(2007-11#1)(2007-12#1)
output signal was##2##3##(2008-10#1)(2008-3#1)
output signal##19##2##(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#1)(2013-7#1)
output signals##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
output state##2##2##(2007-12#1)(2007-8#1)
output surface##4##2##(2008-2#1)(2008-3#3)
output system##2##2##(1993-6#1)(2010-8#1)
output the##2##2##(2008-3#1)(2008-6#1)
output to##2##2##(2007-9#1)(2008-3#1)
output was##9##2##(1995-12#1)(1996-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
output waveform##2##2##(2007-11#1)(2007-12#1)
output wavelengths##2##2##(2007-12#1)(2008-3#1)
output when##4##2##(2008-2#2)(2008-3#1)(2012-2#1)
output with a##3##3##(2008-2#1)(2008-3#2)
output with##10##2##(2007-12#3)(2008-2#2)(2008-3#4)(2010-3#1)
output##844##1##(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#4)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-3#3)(1993-6#3)(1993-9#1)(1994-12#4)(1994-2#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#8)(1996-2#3)(1996-3#1)(1996-9#2)(1997-7#1)(2007-10#3)(2007-11#98)(2007-12#131)(2007-8#9)(2007-9#3)(2008-10#43)(2008-11#15)(2008-12#6)(2008-2#153)(2008-3#211)(2008-4#12)(2008-5#2)(2008-6#10)(2008-7#5)(2008-8#8)(2008-9#12)(2009-10#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#6)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#1)(2010-8#14)(2011-1#6)(2011-2#3)(2011-3#1)(2012-2#7)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#5)
output)##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
output-power##2##1##(2007-12#1)(2008-3#1)
outputs and inputs##2##3##(1992-2#1)(2010-8#1)
outputs and##7##2##(1992-12#1)(1992-2#1)(1993-1#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)
outputs can##3##2##(2007-12#1)(2008-11#1)(2013-1#1)
outputs of the##7##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-8#1)(2012-1#1)
outputs of##11##2##(1997-7#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-7#1)(2009-8#1)(2012-1#1)
outputs processed by##2##3##(2008-10#2)
outputs##61##1##(1992-12#1)(1992-2#4)(1993-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#4)(2007-12#6)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#2)(2009-8#1)(2010-8#2)(2011-2#2)(2012-1#1)(2013-1#2)
outputs)##2##1##(1996-12#1)(2008-11#1)
outreach and##2##2##(1995-1#1)(2013-1#1)
outreach programs##3##2##(1992-2#1)(1995-1#1)(1996-4#1)
outreach##22##1##(1992-1#1)(1992-2#1)(1994-2#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-4#1)(1997-2#2)(1997-5#1)(2010-5#1)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#3)
outs##6##1##(2008-11#1)(2008-3#3)(2011-2#1)(2012-12#1)
outset##10##1##(1993-1#1)(1995-1#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#1)
outside a##3##2##(2008-2#1)(2011-2#1)(2013-7#1)
outside agencies##5##2##(1991-12#1)(1996-12#2)(2007-2#2)
outside and##2##2##(2008-10#1)(2008-7#1)
outside diameter##2##2##(1993-6#1)(2008-3#1)
outside hospitals##2##2##(1990-2#1)(2011-2#1)
outside microsomes##2##2##(1997-7#2)
outside of a##2##3##(2008-8#1)(2012-12#1)
outside of the clinical##2##4##(2012-2#1)(2013-1#1)
outside of the##27##3##(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2012-12#1)(2012-2#4)(2013-1#2)
outside of##54##2##(1991-9#1)(1992-6#1)(1993-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#2)
outside the US##2##3##(2008-5#2)
outside the acinus##2##3##(2007-12#2)
outside the area##2##3##(1995-9#1)(2008-2#1)
outside the box##2##3##(1997-3#1)(2010-11#1)
outside the company##2##3##(2008-11#2)
outside the cyclodextrin##3##3##(2008-10#3)
outside the egg##2##3##(1991-5#1)(2008-12#1)
outside the focal##2##3##(2008-2#1)(2008-3#1)
outside the home and##2##4##(1993-1#1)(2013-8#1)
outside the home##4##3##(1993-1#1)(1997-3#1)(2013-1#1)(2013-8#1)
outside the hospital##3##3##(1996-1#1)(2008-8#1)(2011-2#1)
outside the plane of##2##4##(2008-3#1)(2010-6#1)
outside the region##3##3##(2008-3#1)(2008-4#2)
outside the##113##2##(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
outside their##9##2##(1991-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
outside##256##1##(1990-2#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-6#2)(1993-9#4)(1994-1#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#3)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#4)(2007-12#9)(2007-2#3)(2007-8#1)(2008-1#3)(2008-10#30)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#13)(2008-4#3)(2008-5#7)(2008-7#12)(2008-8#13)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#2)
outside-out##2##1##(1995-2#2)
outskirts##4##1##(1992-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
outsourcing##5##1##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
outspoken##2##1##(2010-10#2)
outstanding importance##2##2##(1994-5#1)(2008-11#1)
outstanding properties##3##2##(2008-12#1)(2008-5#1)(2010-7#1)
outstanding research##2##2##(2008-10#1)(2013-8#1)
outstanding##37##1##(1991-3#1)(1992-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
outstrip the##2##2##(1996-12#1)(2008-4#1)
outward current##6##2##(1991-5#1)(1993-3#1)(1996-5#1)(2008-8#3)
outward growth of##3##3##(1995-3#1)(2008-10#1)(2009-1#1)
outward rectification##2##2##(1996-2#1)(2011-2#1)
outward rectifying##2##2##(1993-12#1)(2011-2#1)
outward##31##1##(1990-2#1)(1991-5#2)(1993-12#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)
outwardly##3##1##(2008-10#2)(2008-4#1)
outweigh the potential risks##2##4##(2007-8#1)(2008-8#1)
outweigh the risks##2##3##(2010-6#1)(2011-2#1)
outweigh the##14##2##(1992-3#1)(1993-3#1)(1993-8#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-8#2)(2009-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
outweigh##19##1##(1992-3#1)(1993-3#1)(1993-8#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
outweighed by the##4##3##(1993-8#1)(2007-10#1)(2008-12#1)(2008-9#1)
outweighed by##5##2##(1993-8#1)(2007-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
outweighed##8##1##(1992-12#1)(1993-8#1)(1995-3#1)(2007-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-12#1)
outweighing##2##1##(2008-10#1)(2008-7#1)
outweighs the##2##2##(1997-8#1)(2008-10#1)
outweighs##4##1##(1995-2#1)(1997-8#1)(2008-10#1)(2013-1#1)
ovIL4##2##1##(1993-2#2)
ova in##3##2##(1996-12#3)
ova of##2##2##(1996-12#1)(2008-9#1)
ova were##3##2##(1996-12#3)
ova##17##1##(1996-12#11)(2007-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
oval and##2##2##(2008-12#1)(2008-9#1)
oval shape##2##2##(2010-10#1)(2013-8#1)
oval##11##1##(1994-2#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2013-8#1)
ovalbumin (OVA)-specific T cell receptor transgenic##2##6##(2008-11#2)
ovalbumin (OVA)-specific T cell receptor##3##5##(2008-11#3)
ovalbumin (OVA)-specific##4##2##(2008-11#4)
ovalbumin and##4##2##(1990-5#1)(1995-2#1)(1995-6#1)(2008-10#1)
ovalbumin##31##1##(1990-5#1)(1992-3#1)(1994-9#2)(1995-2#3)(1995-6#1)(1996-5#1)(2008-10#11)(2008-11#9)(2008-7#2)
ovale##30##1##(1992-9#3)(1996-11#2)(1996-3#1)(1996-6#2)(2007-10#3)(2007-12#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2011-2#6)(2012-2#1)
ovarian Mr = 80##4##4##(1990-10#4)
ovarian Mr##5##2##(1990-10#5)
ovarian activity##2##2##(2008-12#1)(2008-5#1)
ovarian adenocarcinoma##3##2##(1993-9#1)(1997-8#1)(2013-1#1)
ovarian and##6##2##(1990-9#1)(1995-8#1)(1997-8#1)(2008-4#2)(2011-2#1)
ovarian cancer (EOC) is##2##4##(2010-7#1)(2010-8#1)
ovarian cancer 20 years##2##4##(2011-2#2)
ovarian cancer and##2##3##(2011-2#1)(2012-2#1)
ovarian cancer cells##7##3##(1990-2#1)(1993-9#2)(1994-2#1)(1997-7#2)(2013-1#1)
ovarian cancer patients##7##3##(1990-2#1)(1991-4#1)(1992-9#2)(1993-12#1)(1996-10#1)(2008-4#1)
ovarian cancer##85##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-2#2)(1992-9#4)(1993-12#1)(1993-9#14)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#2)(1996-10#2)(1996-11#1)(1997-7#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#8)
ovarian cancer-associated##2##2##(1991-4#1)(1994-9#1)
ovarian carcinoma are##2##3##(2007-8#1)(2010-7#1)
ovarian carcinoma cell lines##2##4##(2010-7#1)(2012-12#1)
ovarian carcinoma cell##3##3##(2008-4#1)(2010-7#1)(2012-12#1)
ovarian carcinoma cells##4##3##(1993-8#2)(1993-9#1)(2008-4#1)
ovarian carcinoma##27##2##(1990-12#1)(1990-2#2)(1990-6#2)(1991-3#1)(1991-4#1)(1991-8#1)(1993-2#1)(1993-8#2)(1993-9#3)(1997-3#1)(2007-7#1)(2007-8#1)(2008-4#2)(2009-5#1)(2010-7#2)(2012-12#1)(2012-2#1)(2013-1#3)
ovarian carcinoma]##2##2##(1993-9#1)(2013-1#1)
ovarian changes##2##2##(1995-2#1)(2008-4#1)
ovarian cyst##3##2##(1992-3#2)(2013-1#1)
ovarian cystectomy##3##2##(1993-3#1)(1996-3#2)
ovarian cystomas of intestinal type##2##5##(1990-2#2)
ovarian cystomas of intestinal##3##4##(1990-2#3)
ovarian cystomas##4##2##(1990-2#4)
ovarian cysts##2##2##(1994-9#1)(2011-1#1)
ovarian disease##5##2##(1990-2#1)(1992-9#1)(2008-4#2)(2010-8#1)
ovarian endometriosis##3##2##(1994-9#2)(2010-12#1)
ovarian failure##7##2##(1996-2#2)(2008-4#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-8#1)
ovarian follicle##5##2##(1991-9#3)(2008-4#1)(2008-9#1)
ovarian follicles in##2##3##(2008-12#2)
ovarian follicles##14##2##(1995-12#1)(2008-11#1)(2008-12#9)(2008-9#1)(2010-10#1)(2010-8#1)
ovarian function##2##2##(2008-4#1)(2008-9#1)
ovarian growth of flightless##2##4##(2008-9#2)
ovarian growth##4##2##(2008-9#3)(2013-7#1)
ovarian hyperstimulation syndrome and##2##4##(2011-1#1)(2012-3#1)
ovarian hyperstimulation##4##2##(1994-9#2)(2011-1#1)(2012-3#1)
ovarian mass##2##2##(1996-1#1)(2007-4#1)
ovarian masses##7##2##(1993-8#1)(1996-1#5)(2012-1#1)
ovarian metastases##2##2##(1997-3#2)
ovarian response##2##2##(2012-3#2)
ovarian stimulation in##2##3##(2007-7#1)(2012-3#1)
ovarian stimulation##5##2##(1994-9#1)(2007-7#1)(2012-3#3)
ovarian suppression##2##2##(1994-9#2)
ovarian surgery##5##2##(1992-3#5)
ovarian syndrome##7##2##(2007-7#1)(2008-1#1)(2008-3#2)(2010-11#2)(2011-1#1)
ovarian tissue##5##2##(1990-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
ovarian tissues##2##2##(2008-10#1)(2008-11#1)
ovarian tumor cell lines##2##4##(1992-2#2)
ovarian tumor cells##3##3##(2008-11#1)(2008-4#2)
ovarian tumor promoter##2##3##(2007-12#2)
ovarian tumor##11##2##(1992-2#2)(1994-7#1)(2007-12#5)(2008-11#1)(2008-4#2)
ovarian tumors##4##2##(1990-2#1)(1990-6#1)(1994-7#1)(1995-2#1)
ovarian##340##1##(1990-10#7)(1990-11#1)(1990-12#2)(1990-2#13)(1990-6#4)(1990-8#1)(1990-9#2)(1991-3#2)(1991-4#3)(1991-6#2)(1991-8#3)(1991-9#4)(1992-2#4)(1992-3#11)(1992-9#7)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#4)(1993-9#20)(1994-12#2)(1994-2#4)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#12)(1995-12#2)(1995-2#3)(1995-8#7)(1995-9#1)(1996-1#6)(1996-10#2)(1996-11#1)(1996-2#6)(1996-3#2)(1996-5#1)(1997-3#4)(1997-7#4)(1997-8#2)(2007-10#1)(2007-12#5)(2007-4#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#15)(2008-2#2)(2008-3#4)(2008-4#18)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#7)(2009-1#1)(2009-5#4)(2009-7#2)(2010-10#3)(2010-11#5)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#7)(2011-2#19)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#11)(2013-1#11)(2013-7#1)(2013-8#12)
ovariectomized animals##2##2##(1993-9#1)(2008-10#1)
ovariectomized female##2##2##(1992-8#1)(1994-3#1)
ovariectomized##19##1##(1992-5#2)(1992-8#1)(1993-1#1)(1993-9#1)(1994-3#1)(1997-4#10)(2007-8#1)(2008-10#1)(2010-10#1)
ovariectomy##11##1##(1992-12#1)(1992-5#1)(1993-9#1)(1994-12#1)(1997-4#4)(2008-4#1)(2008-5#1)(2012-12#1)
ovaries and##4##2##(1994-2#1)(1995-2#1)(2011-1#1)(2013-7#1)
ovaries for##2##2##(1992-3#2)
ovaries infected with C##2##4##(2008-10#2)
ovaries of the##2##3##(2007-12#1)(2012-3#1)
ovaries of##8##2##(2007-12#2)(2008-12#1)(2008-5#4)(2012-3#1)
ovaries were##4##2##(1992-3#2)(2010-10#1)(2012-3#1)
ovaries##44##1##(1992-3#4)(1994-2#1)(1995-2#3)(2007-12#4)(2008-10#4)(2008-12#3)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
ovariole formation##2##2##(2008-12#2)
ovariole##5##1##(2007-12#1)(2008-12#2)(2008-7#2)
ovarioles of the##2##3##(2008-12#1)(2008-7#1)
ovarioles of##4##2##(2007-12#2)(2008-12#1)(2008-7#1)
ovarioles##7##1##(2007-12#4)(2008-12#2)(2008-7#1)
ovary (CHO) cell line##3##4##(2008-11#3)
ovary (CHO) cell##7##3##(1997-2#1)(2008-11#4)(2008-7#2)
ovary (CHO)##39##2##(1990-12#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#19)(2008-4#1)(2008-7#7)
ovary Psi(w)##2##2##(2008-10#2)
ovary and##15##2##(1991-9#1)(1993-2#1)(1993-3#1)(2007-4#1)(2008-10#2)(2008-12#2)(2008-6#3)(2008-7#1)(2010-5#1)(2012-1#1)(2012-2#1)
ovary cancer -##2##3##(2007-11#2)
ovary during##3##2##(2008-12#1)(2008-9#2)
ovary in##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
ovary of##3##2##(2007-12#1)(2009-7#1)(2010-5#1)
ovary or##2##2##(1991-12#1)(1995-11#1)
ovary syndrome (PCOS) is##4##4##(2008-4#3)(2013-1#1)
ovary syndrome (PCOS)##11##3##(2008-3#1)(2008-4#8)(2013-1#1)(2013-8#1)
ovary syndrome and##2##3##(2012-12#1)(2013-1#1)
ovary syndrome##29##2##(1996-2#2)(2007-7#1)(2008-1#1)(2008-3#6)(2008-4#12)(2008-5#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
ovary tumours##4##2##(2011-1#4)
ovary was longitudinally bivalved with a scalpel##2##7##(1992-3#2)
ovary was##9##2##(1990-8#1)(1992-3#5)(2009-7#1)(2010-5#1)(2011-1#1)
ovary##244##1##(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#5)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#5)(1992-3#9)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#5)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#7)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-11#2)(2007-12#2)(2007-4#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#46)(2008-12#5)(2008-3#7)(2008-4#15)(2008-5#4)(2008-6#5)(2008-7#14)(2008-8#3)(2008-9#4)(2009-7#4)(2010-12#2)(2010-5#6)(2010-7#1)(2010-8#2)(2011-1#10)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
ovary-specific##3##1##(1995-2#1)(2008-4#1)(2008-7#1)
ovatum##3##1##(2010-3#3)
ovatus##3##1##(1997-2#3)
oven at 450W##2##3##(2008-10#2)
oven at##7##2##(2008-10#6)(2013-7#1)
oven temperature##6##2##(2008-10#5)(2012-1#1)
oven##47##1##(1993-12#1)(1997-7#1)(2007-11#1)(2008-10#33)(2008-12#3)(2008-2#2)(2008-3#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
over &quot##2##2##(2008-8#1)(2011-2#1)
over 0##6##2##(1995-2#1)(2008-10#3)(2008-8#1)(2013-1#1)
over 1 year of age##5##5##(2011-2#5)
over 1 year##8##3##(2008-10#1)(2011-2#7)
over 1##20##2##(1991-1#1)(1991-9#1)(1996-3#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#7)
over 10 months##2##3##(2008-1#1)(2008-6#1)
over 10 years of##2##4##(2012-12#1)(2013-1#1)
over 10 years##4##3##(2008-4#1)(2012-12#1)(2013-1#2)
over 10##20##2##(1992-6#1)(1993-6#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-6#2)(2009-8#1)(2010-4#2)(2011-1#1)(2012-12#1)(2013-1#3)
over 10%##2##2##(2007-5#1)(2008-10#1)
over 100 million##2##3##(1992-9#1)(2008-10#1)
over 100##12##2##(1991-5#1)(1992-9#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2012-2#1)
over 100-fold##4##2##(1994-5#1)(1996-2#1)(2008-10#2)
over 100mg of##2##3##(2008-10#2)
over 11##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
over 12 months##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
over 12 weeks##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
over 12##9##2##(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
over 13##3##2##(1991-6#1)(2008-11#1)(2008-7#1)
over 15 nm##2##3##(2007-12#1)(2008-2#1)
over 15##8##2##(1991-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
over 150 days##2##3##(1990-3#2)
over 150##5##2##(1990-3#2)(1997-2#1)(1997-5#1)(2009-8#1)
over 16 years##2##3##(2008-6#2)
over 16##3##2##(2007-12#1)(2008-6#2)
over 18 h##2##3##(1990-6#1)(1995-11#1)
over 18 years##2##3##(1996-4#1)(2008-8#1)
over 18##7##2##(1990-6#1)(1992-3#1)(1995-11#1)(1996-4#1)(1997-8#1)(2008-8#2)
over 19##3##2##(2007-12#1)(2008-10#2)
over 2 months##2##3##(2008-10#2)
over 2 years##9##3##(1996-12#1)(2008-10#6)(2010-10#1)(2010-8#1)
over 2##22##2##(1992-3#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#11)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)
over 20 years ago##2##4##(2008-2#1)(2012-2#1)
over 20 years##7##3##(1992-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
over 20##14##2##(1992-1#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
over 20%##4##2##(1992-2#1)(1992-6#1)(2008-8#1)(2012-3#1)
over 200##11##2##(2007-11#1)(2008-10#6)(2008-2#1)(2008-4#1)(2010-3#1)(2012-2#1)
over 2000##3##2##(2008-11#1)(2008-3#1)(2010-5#1)
over 21 days##2##3##(2008-6#1)(2012-3#1)
over 23##2##2##(1991-2#1)(1992-3#1)
over 24 h##5##3##(2007-12#1)(2008-10#3)(2010-8#1)
over 24 hours##2##3##(1990-11#1)(2008-8#1)
over 24##9##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-8#1)(2013-8#1)
over 25##2##2##(2008-4#1)(2008-7#1)
over 26##3##2##(1996-12#1)(2007-6#1)(2011-2#1)
over 28##2##2##(1992-3#1)(2007-12#1)
over 3 months##2##3##(2008-3#1)(2012-3#1)
over 3 weeks##2##3##(1996-5#1)(2008-10#1)
over 3 years##8##3##(1990-6#1)(2007-8#1)(2008-10#5)(2008-12#1)
over 3##23##2##(1990-6#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-3#1)(1996-5#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
over 30 min##5##3##(1995-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
over 30 months##2##3##(2008-10#1)(2008-12#1)
over 30 years##8##3##(1990-10#1)(1990-3#1)(1996-11#1)(2008-10#2)(2008-6#1)(2010-11#1)(2013-1#1)
over 30##23##2##(1990-10#1)(1990-3#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#2)(2010-3#1)(2011-2#1)(2013-1#1)
over 30% of##2##3##(2008-11#2)
over 300##6##2##(1995-12#1)(2008-11#2)(2008-5#1)(2012-2#2)
over 3000##3##2##(1990-9#1)(2007-12#1)(2008-7#1)
over 31##2##2##(2007-11#1)(2012-3#1)
over 35 years of age were treated##2##7##(2008-10#2)
over 35 years##5##3##(1995-1#1)(2008-10#4)
over 35##11##2##(1990-8#2)(1995-1#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)
over 38##2##2##(2007-6#1)(2011-2#1)
over 4 days##3##3##(1996-2#1)(2008-6#1)(2012-1#1)
over 4 months##4##3##(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
over 4 weeks##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
over 4 years as##2##4##(1993-12#1)(2010-3#1)
over 4 years##3##3##(1993-12#1)(2008-10#1)(2010-3#1)
over 4##19##2##(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-3#1)(2012-1#1)
over 40 years of age##3##5##(1990-6#1)(2008-6#1)(2013-8#1)
over 40 years##7##3##(1990-6#1)(2008-10#1)(2008-6#1)(2013-1#3)(2013-8#1)
over 40##12##2##(1990-6#1)(1992-10#1)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-12#1)(2013-1#3)(2013-8#1)
over 400##6##2##(1992-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-9#1)
over 42##2##2##(1990-5#1)(1993-3#1)
over 45 years##2##3##(2013-1#1)(2013-8#1)
over 45##4##2##(1994-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
over 48##2##2##(1990-12#1)(2008-3#1)
over 5 days##2##3##(2008-10#2)
over 5 years##2##3##(2008-10#1)(2008-5#1)
over 5##10##2##(2007-10#1)(2008-10#4)(2008-11#2)(2008-5#2)(2012-2#1)
over 50 percent##2##3##(1994-6#1)(1996-2#1)
over 50 years of age##3##5##(1993-2#1)(1995-4#1)(2013-8#1)
over 50 years##8##3##(1993-2#2)(1995-4#2)(2008-1#1)(2008-10#1)(2008-3#1)(2013-8#1)
over 50##26##2##(1990-6#1)(1992-9#1)(1993-2#2)(1994-6#1)(1995-4#2)(1996-2#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-9#1)(2009-8#1)(2011-2#4)(2012-12#2)(2013-8#1)
over 50% of the##4##4##(1993-1#1)(2007-5#1)(2008-10#2)
over 50% of##7##3##(1993-1#1)(2007-5#1)(2008-10#3)(2013-1#2)
over 50%##10##2##(1993-1#1)(2007-5#1)(2008-10#4)(2008-2#1)(2011-1#1)(2013-1#2)
over 500##2##2##(1996-12#1)(2008-10#1)
over 55##3##2##(1997-2#1)(2012-3#1)(2013-1#1)
over 6 months##2##3##(2008-10#1)(2011-2#1)
over 6 to##2##3##(2008-10#1)(2009-11#1)
over 6##11##2##(1995-3#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#2)
over 60 years old##2##4##(2008-7#1)(2012-3#1)
over 60 years##8##3##(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#3)
over 60##13##2##(1990-6#1)(1997-4#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-3#3)
over 60% of##4##3##(1992-6#1)(1997-6#1)(2008-8#1)(2013-1#1)
over 60%##8##2##(1992-6#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
over 600##2##2##(2007-11#1)(2008-10#1)
over 65 years in##2##4##(2011-2#1)(2012-12#1)
over 65 years of age##3##5##(2007-11#1)(2008-7#1)(2010-4#1)
over 65 years old were##2##5##(2011-2#1)(2012-12#1)
over 65 years old##3##4##(2011-2#2)(2012-12#1)
over 65 years##11##3##(1995-3#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#4)(2012-12#2)
over 65##15##2##(1992-9#1)(1993-6#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#4)(2012-12#2)
over 7##2##2##(1994-7#1)(2008-6#1)
over 70 percent of##2##4##(1994-2#1)(1996-3#1)
over 70 years##5##3##(1990-6#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)
over 70##9##2##(1990-12#1)(1990-6#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
over 70% of the##2##4##(1995-6#1)(2008-10#1)
over 70% of##4##3##(1995-6#1)(2007-2#1)(2008-10#2)
over 70%##7##2##(1995-6#1)(1996-1#1)(2007-2#1)(2008-10#3)(2010-10#1)
over 700##3##2##(1997-1#1)(2007-11#1)(2010-3#1)
over 72##2##2##(2007-10#1)(2008-10#1)
over 75 years##2##3##(2008-4#1)(2011-2#1)
over 75% of##2##3##(2007-8#1)(2008-1#1)
over 8 years##2##3##(2008-10#1)(2012-2#1)
over 8##5##2##(1997-2#2)(2008-10#1)(2012-12#1)(2012-2#1)
over 80##8##2##(1994-11#1)(1994-2#1)(2007-11#3)(2008-10#1)(2008-7#1)(2008-9#1)
over 80% of the##4##4##(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
over 80% of##5##3##(1996-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
over 80%##8##2##(1996-1#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-7#1)(2013-8#1)
over 9##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
over 90 days##2##3##(2008-10#1)(2010-6#1)
over 90##7##2##(1991-7#1)(1995-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-6#1)(2012-12#1)
over 90% by##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
over 90% of##7##3##(1990-9#1)(1992-9#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
over 90% were##2##3##(2008-10#1)(2008-12#1)
over 90%##20##2##(1990-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
over 95%##4##2##(2008-12#1)(2008-2#1)(2010-8#1)(2012-2#1)
over 96 h##2##3##(1997-1#1)(2010-3#1)
over 96##3##2##(1997-1#1)(2008-10#1)(2010-3#1)
over 98% of the##2##4##(2008-12#1)(2011-2#1)
over 98%##4##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
over Beijing##3##2##(2008-2#3)
over CT##2##2##(2008-1#1)(2008-8#1)
over K(+)##4##2##(2008-10#4)
over Land##2##2##(2008-2#1)(2008-3#1)
over Medicare##3##2##(1993-5#1)(2008-4#1)(2008-7#1)
over YUF##2##2##(2008-11#2)
over a 1##4##3##(1990-11#1)(2008-10#1)(2008-2#1)(2009-7#1)
over a 1-year period##4##4##(2008-5#1)(2009-3#1)(2011-2#1)(2013-8#1)
over a 10##2##3##(2007-8#1)(2010-8#1)
over a 10-year period##5##4##(1990-10#1)(1997-6#1)(2008-10#1)(2008-7#2)
over a 14 month period##2##5##(2012-2#2)
over a 14##3##3##(2008-10#1)(2012-2#2)
over a 2 h period##2##5##(1995-5#1)(2007-12#1)
over a 2##3##3##(1994-1#1)(1995-5#1)(2007-12#1)
over a 2-week period##4##4##(2007-12#1)(2008-11#1)(2009-11#1)(2010-11#1)
over a 2-year period##6##4##(1994-12#1)(1996-3#1)(2008-10#2)(2008-9#1)(2012-5#1)
over a 2-year##7##3##(1994-12#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-9#1)(2012-5#1)
over a 20-year period##2##4##(2013-8#2)
over a 24-h##2##3##(2008-10#1)(2008-3#1)
over a 3-month period##3##4##(2008-10#2)(2012-2#1)
over a 3-year period##6##4##(2008-1#1)(2008-10#4)(2012-2#1)
over a 4-week period##2##4##(2008-3#1)(2012-3#1)
over a 4-year period##2##4##(2008-10#1)(2008-5#1)
over a 5 year##2##4##(1993-9#1)(2008-10#1)
over a 5##3##3##(1991-9#1)(1993-9#1)(2008-10#1)
over a 5-year period##3##4##(2007-2#1)(2010-1#1)(2011-2#1)
over a 6##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
over a 6-day##2##3##(1992-8#1)(2008-11#1)
over a 6-month period##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
over a 6-year period##3##4##(2008-10#2)(2013-1#1)
over a 7-day period##2##4##(1992-12#1)(2009-11#1)
over a 7-year period##2##4##(1994-1#1)(2011-2#1)
over a bandwidth of##2##4##(2008-2#1)(2008-3#1)
over a broad pH range##2##5##(1991-5#1)(2013-1#1)
over a broad range of##7##5##(1997-7#1)(2007-12#1)(2008-3#3)(2008-8#1)(2012-2#1)
over a broad range##9##4##(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-8#1)(2010-12#1)(2012-2#1)
over a broad spectral range##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
over a broad temperature range##3##5##(2008-2#2)(2008-3#1)
over a broad wavelength##2##4##(2007-12#1)(2008-3#1)
over a broad##22##3##(1991-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#8)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
over a broader##2##3##(2008-10#2)
over a century##3##3##(1990-5#1)(2007-12#1)(2009-12#1)
over a circular aperture##3##4##(2008-2#3)
over a concentration range of 0##2##6##(2008-10#2)
over a concentration range of 1##2##6##(2008-10#1)(2011-2#1)
over a concentration range of##4##5##(2008-10#3)(2011-2#1)
over a concentration range##6##4##(2008-10#5)(2011-2#1)
over a decade##9##3##(1994-2#1)(1995-1#2)(1996-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
over a duration of upto six years##2##7##(2008-7#2)
over a few##2##3##(1996-6#1)(2008-3#1)
over a finite##3##3##(2008-3#3)
over a five-year period##4##4##(1991-12#1)(1992-1#1)(2007-7#1)(2008-12#1)
over a four-year period##2##4##(1995-3#1)(2008-7#1)
over a frequency range of##2##5##(1996-5#1)(2008-2#1)
over a hundred##2##3##(1993-12#1)(2012-12#1)
over a large bandwidth##2##4##(2008-3#2)
over a large number of anions##2##6##(2008-10#2)
over a large number of cations##2##6##(2008-10#2)
over a large number of##7##5##(2007-11#1)(2008-10#6)
over a large range of values##2##6##(2008-10#1)(2008-3#1)
over a large range of##3##5##(2008-10#1)(2008-3#2)
over a large spectral##2##4##(2007-11#1)(2008-3#1)
over a large##28##3##(1993-11#1)(1995-2#1)(2007-11#4)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#9)(2008-7#1)(2008-8#1)(2012-3#1)
over a larger##3##3##(2008-10#1)(2008-3#2)
over a linear range of##3##5##(2008-10#3)
over a linear##5##3##(2008-10#4)(2008-9#1)
over a long period of time##2##6##(2008-9#1)(2010-6#1)
over a long period##4##4##(2007-11#1)(2008-9#1)(2010-6#1)(2010-8#1)
over a longer##2##3##(2008-10#1)(2008-3#1)
over a mean of 12##2##5##(1996-7#1)(2012-3#1)
over a mean##5##3##(1996-7#1)(2007-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
over a much##2##3##(1994-3#1)(2008-3#1)
over a number of##2##4##(1991-2#1)(2008-10#1)
over a one year##2##4##(1996-2#1)(2013-1#1)
over a one##3##3##(1996-2#1)(2011-1#1)(2013-1#1)
over a one-year##2##3##(1997-1#1)(2010-7#1)
over a pH range from 3##2##6##(2008-10#2)
over a pH range of 3##2##6##(2008-10#2)
over a pH range of##5##5##(1991-9#1)(2008-10#3)(2012-2#1)
over a pH range##7##4##(1991-9#1)(2008-10#5)(2012-2#1)
over a pH##8##3##(1991-9#2)(2008-10#5)(2012-2#1)
over a period of 1##2##5##(2008-10#1)(2012-12#1)
over a period of 10 months##2##6##(2008-11#1)(2013-8#1)
over a period of 10##6##5##(1994-12#1)(1995-3#1)(2006-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
over a period of 2##2##5##(1991-2#1)(2008-7#1)
over a period of 24 h##2##6##(1997-2#1)(2008-10#1)
over a period of 3##2##5##(2008-10#2)
over a period of 4##3##5##(1991-3#1)(2008-10#2)
over a period of 5 years##2##6##(1997-2#1)(2008-7#1)
over a period of 5##3##5##(1997-2#1)(2008-10#1)(2008-7#1)
over a period of 6 weeks##2##6##(2008-11#1)(2008-6#1)
over a period of 6##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
over a period of five years##2##6##(2008-1#1)(2009-2#1)
over a period of five##3##5##(1995-1#1)(2008-1#1)(2009-2#1)
over a period of four months##2##6##(2007-8#1)(2011-2#1)
over a period of four##3##5##(1991-6#1)(2007-8#1)(2011-2#1)
over a period of one month##2##6##(1993-6#1)(2008-10#1)
over a period of one year##4##6##(1997-6#1)(2007-5#1)(2007-7#1)(2008-3#1)
over a period of one##6##5##(1993-6#1)(1997-6#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)
over a period of six##2##5##(1991-2#1)(2008-6#1)
over a period of three##2##5##(1996-6#1)(2008-11#1)
over a period of time can##2##6##(1996-1#1)(2008-11#1)
over a period of time##9##5##(1990-8#1)(1996-1#1)(1997-4#1)(2008-11#4)(2009-11#1)(2013-8#1)
over a period of two years##2##6##(1991-12#1)(2008-1#1)
over a period of two##4##5##(1991-12#1)(2008-1#1)(2008-2#1)(2008-8#1)
over a period of##77##4##(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
over a period##79##3##(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
over a previous##2##3##(1990-8#1)(2008-2#1)
over a range from##3##4##(1993-9#1)(2008-10#2)
over a range of 0##4##5##(1993-12#1)(2008-10#2)(2008-11#1)
over a range of concentrations##2##5##(1992-6#2)
over a range of inoculum densities##2##6##(2008-10#2)
over a range of pH##2##5##(2008-10#2)
over a range of temperatures from##2##6##(2008-10#1)(2008-3#1)
over a range of temperatures##7##5##(2008-10#2)(2008-3#3)(2008-4#1)(2008-8#1)
over a range of wavelengths##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
over a range of##49##4##(1992-3#1)(1992-6#2)(1993-12#1)(1994-2#1)(1994-8#1)(1997-2#1)(2007-11#4)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2013-1#1)
over a range##54##3##(1992-3#1)(1992-6#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1997-2#1)(2007-11#4)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#7)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2013-1#1)
over a relatively wide range of##2##6##(2008-10#1)(2008-2#1)
over a relatively wide##3##4##(2008-10#2)(2008-2#1)
over a relatively##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
over a seven-month period##2##4##(2007-7#1)(2008-9#1)
over a seven-year period##2##4##(1992-5#1)(2011-3#1)
over a short period of time##4##6##(1993-3#1)(1995-3#1)(1996-3#1)(2008-11#1)
over a short period##7##4##(1990-6#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
over a span of##2##4##(2008-3#1)(2012-3#1)
over a specified##2##3##(2008-10#1)(2008-3#1)
over a temperature range from##2##5##(2008-10#1)(2008-3#1)
over a temperature range##3##4##(2008-10#1)(2008-3#2)
over a time course of##2##5##(2008-11#1)(2008-9#1)
over a time period of##2##5##(2008-1#1)(2008-9#1)
over a time##4##3##(2008-1#1)(2008-11#1)(2008-9#2)
over a total of##2##4##(1994-7#1)(2008-10#1)
over a two-dimensional##2##3##(2008-3#1)(2008-6#1)
over a two-week period in##2##5##(2008-10#1)(2008-3#1)
over a typical##2##3##(2008-2#1)(2011-2#1)
over a variety of##3##4##(2008-10#2)(2008-2#1)
over a very wide concentration##2##5##(2008-10#2)
over a very##3##3##(2008-10#2)(2008-3#1)
over a wavelength range from##2##5##(2008-2#2)
over a wavelength range of##2##5##(2007-11#1)(2008-3#1)
over a wavelength range##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
over a wavelength##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
over a wide concentration range (1##8##6##(2008-10#8)
over a wide concentration range (5##3##6##(2008-10#3)
over a wide concentration range 5##2##6##(2008-10#2)
over a wide concentration range of##2##6##(2008-10#2)
over a wide concentration range##24##5##(1993-8#1)(2008-10#23)
over a wide dynamic range##2##5##(2007-11#1)(2008-10#1)
over a wide frequency range##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
over a wide pH range of##3##6##(2008-10#2)(2010-2#1)
over a wide pH range##12##5##(1993-8#1)(2008-10#10)(2010-2#1)
over a wide range of amplifier##2##6##(2007-11#1)(2008-2#1)
over a wide range of concentrations##2##6##(2008-10#2)
over a wide range of conditions##2##6##(1990-8#1)(2008-10#1)
over a wide range of pH##2##6##(1994-3#1)(2008-10#1)
over a wide range of parameter values##2##7##(2008-3#1)(2008-9#1)
over a wide range of solvent composition (0-60 wt%##2##9##(2008-10#2)
over a wide range of wavelengths##2##6##(2007-11#1)(2008-10#1)
over a wide range of##38##5##(1990-7#1)(1990-8#1)(1991-12#1)(1992-5#1)(1994-3#1)(1996-4#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
over a wide range##44##4##(1990-7#1)(1990-8#1)(1991-12#1)(1992-5#1)(1994-3#1)(1996-4#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#2)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
over a wide spectral range##6##5##(2007-12#1)(2008-3#5)
over a wide spectral##7##4##(2007-12#1)(2008-3#6)
over a wide temperature range##2##5##(1993-8#1)(2008-2#1)
over a wide variety of metal ions##3##7##(2008-10#3)
over a wide variety of other anions##2##7##(2008-10#2)
over a wide variety of other cations including alkali##2##9##(2008-10#2)
over a wide variety of other metal ions and could be used in##2##13##(2008-10#2)
over a wide variety of other metal ions##5##8##(2008-10#5)
over a wide variety of other##9##6##(2008-10#9)
over a wide variety of##17##5##(2008-10#16)(2008-12#1)
over a wide wavelength range##2##5##(2007-12#1)(2008-2#1)
over a wide##122##3##(1990-7#1)(1990-8#1)(1991-12#1)(1992-5#1)(1993-8#3)(1994-3#1)(1996-4#1)(1996-5#1)(2007-11#4)(2007-12#8)(2008-10#66)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#15)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
over a wider##4##3##(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)
over a year##4##3##(1993-9#1)(2007-7#1)(2008-10#1)(2012-12#1)
over a##674##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#4)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#3)(1995-1#3)(1995-2#1)(1995-3#5)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#25)(2007-12#35)(2007-2#1)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#7)(2008-10#177)(2008-11#22)(2008-12#5)(2008-2#43)(2008-3#91)(2008-4#2)(2008-5#11)(2008-6#6)(2008-7#19)(2008-8#9)(2008-9#13)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#8)(2013-8#9)
over about two orders of magnitude##2##6##(2008-10#2)
over about##5##2##(1993-11#1)(2008-10#3)(2010-4#1)
over after##2##2##(2008-10#1)(2008-9#1)
over age##7##2##(1991-3#1)(1994-3#2)(1995-2#1)(1996-7#1)(2008-2#1)(2008-5#1)
over alkali##7##2##(2008-10#7)
over all loci##2##3##(2008-10#1)(2013-8#1)
over all other##2##3##(1995-12#1)(2008-5#1)
over all temperatures##2##3##(2008-10#2)
over all the##6##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#2)
over all##28##2##(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-6#1)(2013-8#1)
over almost##3##2##(2007-11#1)(2008-10#2)
over an 18-month period##2##4##(2007-8#1)(2008-9#1)
over an 8-year period##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
over an area of##4##4##(1990-7#1)(2011-2#1)(2013-7#2)
over an area##5##3##(1990-7#1)(2008-3#1)(2011-2#1)(2013-7#2)
over an average##2##3##(1990-6#1)(2009-9#1)
over an eight##2##3##(2007-5#1)(2008-2#1)
over an entire##2##3##(2008-10#1)(2012-7#1)
over an extended period##2##4##(2009-11#1)(2011-2#1)
over an extended##3##3##(2008-11#1)(2009-11#1)(2011-2#1)
over an observation##2##3##(1992-11#1)(2007-12#1)
over an##43##2##(1990-6#1)(1990-7#1)(1990-8#1)(1992-11#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2011-2#2)(2012-2#3)(2012-7#1)(2013-7#2)
over and above that##4##4##(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
over and above the##2##4##(2008-7#1)(2012-2#1)
over and above##11##3##(1994-2#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-8#1)(2012-2#1)
over and##16##2##(1991-12#1)(1994-2#2)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
over another##4##2##(2007-12#1)(2007-8#1)(2012-12#1)(2013-8#1)
over appropriate##2##2##(1991-5#1)(2008-3#1)
over approximately##4##2##(1993-6#1)(2008-2#1)(2008-3#1)(2009-10#1)
over areas##2##2##(2008-10#1)(2008-7#1)
over aspirin##2##2##(2007-10#1)(2008-10#1)
over at least##4##3##(2008-10#2)(2011-1#1)(2012-4#1)
over basal##2##2##(1993-8#1)(2008-10#1)
over batch##2##2##(2008-11#1)(2008-6#1)
over both the##2##3##(2008-3#1)(2008-8#1)
over both years##2##3##(2008-10#2)
over both##8##2##(1992-6#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#1)
over broad##2##2##(2007-11#1)(2011-2#1)
over classical##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
over control##4##2##(1990-12#1)(1995-8#1)(1997-6#1)(2008-12#1)
over conventional spectrophotometry for##2##4##(2008-10#2)
over conventional##23##2##(1994-12#1)(1994-9#1)(1996-2#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2011-2#1)
over current##5##2##(2007-12#2)(2008-11#1)(2008-7#1)(2010-5#1)
over currently##2##2##(2010-1#1)(2013-1#1)
over decades##2##2##(2007-12#1)(2008-10#1)
over different types of##2##4##(1993-3#1)(2008-3#1)
over different##8##2##(1993-11#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
over distances##2##2##(2008-2#1)(2008-8#1)
over eighteen##2##2##(2007-10#1)(2007-11#1)
over entire##2##2##(2008-10#2)
over evolutionary##2##2##(2008-8#1)(2010-3#1)
over existing methods##2##3##(2008-10#1)(2010-5#1)
over existing##10##2##(1991-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
over expression of##3##3##(2007-12#1)(2011-2#1)(2011-3#1)
over expression##4##2##(2007-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
over extended periods of time##2##5##(2008-10#2)
over extended time periods##2##4##(2008-10#1)(2008-6#1)
over extended##5##2##(2008-10#3)(2008-3#1)(2008-6#1)
over fetal##2##2##(1990-8#1)(2007-11#1)
over first##2##2##(1995-2#1)(2010-6#1)
over five##2##2##(2007-7#1)(2012-3#1)
over food##2##2##(2008-1#1)(2009-10#1)
over four decades##3##3##(2008-10#1)(2013-1#2)
over four##9##2##(1990-2#1)(1994-7#1)(2007-7#1)(2008-10#3)(2008-5#1)(2013-1#2)
over frontal##2##2##(2008-5#1)(2010-5#1)
over fungal##2##2##(2008-10#1)(2008-8#1)
over half a##2##3##(2007-11#1)(2012-3#1)
over half of##5##3##(1992-2#1)(1992-8#1)(1994-2#1)(2011-2#1)(2012-2#1)
over half##8##2##(1992-2#1)(1992-8#1)(1994-2#1)(2007-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
over health care reform##4##4##(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)
over health care##6##3##(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-3#1)
over health##7##2##(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-3#1)(2012-12#1)
over his##2##2##(1993-11#1)(2010-5#1)
over in##4##2##(1995-9#1)(2008-8#1)(2011-1#2)
over interfering cations##2##3##(2008-10#2)
over its entire##2##3##(2008-2#1)(2008-3#1)
over its##6##2##(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2013-1#1)
over land and##2##3##(2008-2#1)(2008-3#1)
over land##6##2##(1990-6#1)(2008-2#2)(2008-3#3)
over large areas##3##3##(2008-10#1)(2008-7#2)
over large##6##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#2)
over left##5##2##(1995-2#1)(2008-10#4)
over local##2##2##(2008-8#2)
over long distances in##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
over long distances##9##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
over long periods of time##5##5##(1995-1#1)(2008-10#1)(2008-11#2)(2011-1#1)
over long periods of##6##4##(1995-1#1)(2008-10#2)(2008-11#2)(2011-1#1)
over long periods##8##3##(1995-1#1)(2008-10#2)(2008-11#4)(2011-1#1)
over long##21##2##(1990-6#1)(1995-1#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
over longer##3##2##(2007-10#1)(2007-11#1)(2008-7#1)
over many years##9##3##(1991-4#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)
over many##19##2##(1991-4#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-4#1)
over more than 10##2##4##(2007-11#1)(2007-12#1)
over more than one##2##4##(2008-11#1)(2011-2#1)
over more than##7##3##(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
over more##8##2##(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
over most of the##2##4##(1992-9#1)(2008-8#1)
over most##3##2##(1992-9#1)(2008-10#1)(2008-8#1)
over mountainous terrain##3##3##(2008-2#3)
over mountainous##4##2##(2008-2#3)(2008-3#1)
over much of##2##3##(2008-2#1)(2010-1#1)
over much##4##2##(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)
over multiple##5##2##(1992-6#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
over narrow##2##2##(2008-10#1)(2008-9#1)
over nearly##3##2##(2007-11#1)(2007-12#1)(2011-1#1)
over nine##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
over one year##4##3##(1991-11#1)(2008-1#1)(2008-5#1)(2008-6#1)
over one##16##2##(1991-11#1)(1992-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#2)
over one's##2##2##(1993-9#1)(2013-1#1)
over one-half of##2##3##(1990-12#1)(1992-1#1)
over optical paths of##2##4##(2008-3#2)
over other alkali metal cations##2##5##(2008-10#2)
over other alkali metal##3##4##(2008-10#3)
over other alkali##4##3##(2008-10#4)
over other forms of##2##4##(2007-12#1)(2009-1#1)
over other mono-##2##3##(2008-10#2)
over other techniques and##2##4##(2007-11#1)(2008-10#1)
over other techniques##3##3##(2007-11#1)(2008-1#1)(2008-10#1)
over other##37##2##(1990-7#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#2)
over others in##2##3##(2011-2#2)
over others##3##2##(2008-8#1)(2011-2#2)
over pH range##2##3##(1997-2#1)(2008-10#1)
over pH##3##2##(1997-2#1)(1997-6#1)(2008-10#1)
over placebo##5##2##(1994-2#1)(2008-10#2)(2008-6#1)(2012-2#1)
over potassium ion##2##3##(2008-10#2)
over previous##7##2##(1990-8#1)(1991-9#1)(2007-12#2)(2008-3#1)(2008-4#1)(2010-3#1)
over previously reported##2##3##(2007-11#1)(2008-10#1)
over previously##4##2##(2007-11#2)(2008-10#1)(2008-7#1)
over ranges of##2##3##(2007-11#1)(2008-3#1)
over recent years##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2013-8#1)
over recent##5##2##(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2013-8#1)
over relatively##3##2##(1996-2#1)(2007-12#1)(2013-8#1)
over reproductive##6##2##(2008-11#1)(2008-8#5)
over seven##3##2##(2008-12#1)(2012-12#1)(2012-3#1)
over several days##2##3##(2008-10#1)(2008-2#1)
over several generations##4##3##(1995-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
over several hours##3##3##(1995-2#1)(2007-11#2)
over several seconds##2##3##(2007-11#1)(2009-5#1)
over several weeks##2##3##(2008-10#2)
over several years and##2##4##(2008-10#2)
over several years##4##3##(2008-10#2)(2008-6#1)(2013-1#1)
over several##27##2##(1990-8#1)(1995-2#1)(1995-8#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
over sex allocation##2##3##(2008-8#2)
over sex##4##2##(2008-8#4)
over sexual##2##2##(2008-7#1)(2012-3#1)
over short distances##4##3##(2008-10#3)(2008-3#1)
over short time scales##2##4##(2007-12#1)(2013-8#1)
over short time##3##3##(2007-12#1)(2012-2#1)(2013-8#1)
over short##8##2##(2007-12#2)(2008-10#3)(2008-3#1)(2012-2#1)(2013-8#1)
over shorter##3##2##(1991-8#1)(1994-6#1)(2009-9#1)
over similar##2##2##(2008-2#1)(2008-3#1)
over six months##2##3##(2008-1#1)(2013-1#1)
over six##6##2##(1996-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
over small##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
over snow##2##2##(2013-8#2)
over some##2##2##(2008-10#1)(2008-9#1)
over space and time##3##4##(2008-10#2)(2010-8#1)
over spatial##2##2##(2008-3#1)(2009-7#1)
over standard fiber##2##3##(2007-12#2)
over standard##6##2##(1991-2#1)(2007-12#3)(2008-3#1)(2012-1#1)
over successive spawnings##4##3##(2010-8#4)
over successive years##3##3##(2008-10#2)(2011-2#1)
over successive##8##2##(2008-10#3)(2010-8#4)(2011-2#1)
over synthetic##2##2##(2007-7#1)(2008-10#1)
over ten##4##2##(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
over that of control##4##4##(2008-11#4)
over that of the##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
over that of##16##3##(1992-3#1)(1993-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)
over that##25##2##(1991-8#1)(1992-3#1)(1993-8#1)(1995-6#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)
over the 0##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
over the 1##2##3##(2008-10#2)
over the 10##2##3##(2008-3#1)(2010-11#1)
over the 10-year period##2##4##(1993-2#1)(1997-2#1)
over the 2##3##3##(1996-2#1)(2008-10#2)
over the 24-h##2##3##(2008-10#1)(2008-9#1)
over the 3##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
over the 30-day experimental period##2##5##(2008-5#2)
over the 5##2##3##(2008-10#1)(2013-8#1)
over the 6##2##3##(2008-10#1)(2009-4#1)
over the Internet##3##3##(2008-4#2)(2008-7#1)
over the age of 50 years##2##6##(1994-12#1)(2007-2#1)
over the age of 50##3##5##(1994-12#2)(2007-2#1)
over the age of##10##4##(1994-12#2)(1996-3#1)(2007-2#1)(2008-3#1)(2008-6#1)(2011-2#4)
over the assessment period##2##4##(2012-12#2)
over the basal##2##3##(1992-3#1)(1993-8#1)
over the body##3##3##(1992-3#1)(2007-12#1)(2008-10#1)
over the cerebral##2##3##(1996-5#1)(2012-2#1)
over the chest##2##3##(2007-7#1)(2008-11#1)
over the choice##2##3##(1996-11#1)(2013-1#1)
over the coming years##2##4##(1993-12#1)(2006-10#1)
over the composition##2##3##(2007-12#1)(2008-7#1)
over the concentration range 0##13##5##(2008-10#13)
over the concentration range 1##4##5##(2008-10#4)
over the concentration range 10(-1)-10(-5) mol l(-1)##2##7##(2008-10#2)
over the concentration range 10(-6)-10(-2)##2##5##(2008-10#2)
over the concentration range 6##2##5##(2008-10#2)
over the concentration range of 0##8##6##(1990-12#1)(2008-10#6)(2011-3#1)
over the concentration range of 1##3##6##(2008-10#3)
over the concentration range of 5##2##6##(2008-10#2)
over the concentration range of##21##5##(1990-12#1)(2008-10#19)(2011-3#1)
over the concentration range##64##4##(1990-12#1)(2008-10#62)(2011-3#1)
over the concentration ranges of##2##5##(2008-10#2)
over the concentration ranges##4##4##(2008-10#4)
over the concentration##69##3##(1990-12#1)(2008-10#66)(2009-12#1)(2011-3#1)
over the control##2##3##(1997-7#1)(2008-11#1)
over the conventional##6##3##(1994-1#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-8#1)
over the corresponding##2##3##(1990-11#1)(2010-6#1)
over the counter##3##3##(1996-5#1)(2006-12#1)(2008-7#1)
over the course of a##4##5##(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#1)
over the course of the experiment##2##6##(2008-10#2)
over the course of the##5##5##(1992-3#1)(2007-11#1)(2008-10#3)
over the course of treatment##4##5##(1996-2#1)(1996-7#1)(2008-12#1)(2012-2#1)
over the course of##27##4##(1992-3#1)(1993-6#1)(1994-12#1)(1996-2#1)(1996-7#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
over the decades##2##3##(2008-7#1)(2012-2#1)
over the dose range##2##4##(1993-6#1)(1994-8#1)
over the entire length##2##4##(1996-6#1)(2007-8#1)
over the entire range of##2##5##(2008-10#1)(2008-6#1)
over the entire range##3##4##(2007-12#1)(2008-10#1)(2008-6#1)
over the entire temperature range##3##5##(1991-5#1)(1995-2#2)
over the entire time##2##4##(1990-8#1)(1997-4#1)
over the entire##36##3##(1990-8#1)(1991-5#1)(1992-3#2)(1995-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
over the first year##2##4##(1995-8#1)(2007-9#1)
over the first##15##3##(1991-2#1)(1992-1#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)
over the five##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
over the following##3##3##(1991-2#1)(1991-5#1)(2007-7#1)
over the four##2##3##(1991-5#1)(1996-9#1)
over the frequency range##4##4##(2007-11#2)(2008-10#1)(2008-3#1)
over the frequency##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
over the full##2##3##(1997-1#1)(2007-11#1)
over the future##2##3##(1994-3#1)(2008-7#1)
over the growing season##4##4##(2008-10#4)
over the investigated##2##3##(1995-3#1)(2008-2#1)
over the landscape##3##3##(2008-10#1)(2008-9#2)
over the last 10 years##5##5##(1996-3#1)(2008-10#2)(2008-11#1)(2012-12#1)
over the last 10##6##4##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-12#1)
over the last 15 years##2##5##(1992-10#1)(1994-6#1)
over the last 2 decades##3##5##(2008-2#1)(2008-9#1)(2012-2#1)
over the last 20 years##2##5##(1991-4#1)(2009-10#1)
over the last 25 years##3##5##(1996-1#1)(1996-11#1)(2008-6#1)
over the last 30 years##2##5##(2008-10#2)
over the last 5 years##3##5##(1996-11#1)(2007-11#1)(2008-10#1)
over the last 50 years##2##5##(1990-6#1)(2007-7#1)
over the last century##2##4##(2007-8#1)(2008-2#1)
over the last decade in the treatment of##2##8##(2008-1#1)(2008-7#1)
over the last decade##19##4##(1992-1#1)(1993-6#1)(1997-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#3)(2008-7#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2013-1#1)
over the last decades##2##4##(2009-4#1)(2011-2#1)
over the last few decades##5##5##(1995-1#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)
over the last few##6##4##(1995-1#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-5#1)
over the last four decades##2##5##(1997-7#1)(2008-3#1)
over the last several years##4##5##(1993-2#1)(1995-2#1)(2007-9#1)(2010-6#1)
over the last two decades##7##5##(1994-3#1)(2008-11#1)(2008-2#1)(2009-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
over the last two years##3##5##(1996-12#1)(2007-4#1)(2008-7#1)
over the last two##11##4##(1994-3#1)(1996-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
over the last years##4##4##(2008-10#1)(2008-5#1)(2011-2#2)
over the last##85##3##(1990-6#1)(1991-4#1)(1992-1#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-5#1)(1997-7#3)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
over the left##3##3##(1993-9#1)(2012-12#1)(2012-3#1)
over the life course##3##4##(2009-10#1)(2012-12#2)
over the long term##8##4##(1992-8#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)
over the medial##2##3##(2010-3#1)(2011-2#1)
over the neck##2##3##(2011-1#1)(2011-2#1)
over the network##2##3##(2008-10#1)(2008-9#1)
over the next 2##2##4##(1994-12#1)(1996-9#1)
over the next 3 days##2##5##(1991-2#1)(2008-10#1)
over the next 3 years##2##5##(1992-5#1)(1996-2#1)
over the next 3##4##4##(1991-2#1)(1992-5#1)(1996-2#1)(2008-10#1)
over the next 60##2##4##(1993-11#1)(2008-10#1)
over the next few years##2##5##(1993-3#1)(1994-3#1)
over the next two decades##2##5##(1991-5#1)(2009-3#1)
over the next two##3##4##(1990-11#1)(1991-5#1)(2009-3#1)
over the next##21##3##(1990-11#1)(1991-2#2)(1991-5#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-9#1)(2008-10#2)(2008-7#1)(2009-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
over the nine##2##3##(2008-10#1)(2008-5#1)
over the ocean by##2##4##(2008-2#1)(2008-3#1)
over the ocean##4##3##(2008-2#3)(2008-3#1)
over the oceans##2##3##(2008-2#1)(2008-3#1)
over the original##2##3##(2008-11#1)(2010-12#1)
over the other in##2##4##(2008-3#1)(2012-12#1)
over the other two##2##4##(2008-10#2)
over the other##11##3##(1996-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
over the pH range##10##4##(1992-6#1)(1995-5#1)(2008-10#8)
over the pH##12##3##(1992-6#1)(1995-5#1)(2008-10#10)
over the past 10 years##7##5##(1992-3#1)(1993-8#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-8#1)(2013-8#1)
over the past 15 years##5##5##(1997-1#1)(2008-11#1)(2012-1#1)(2012-2#2)
over the past 20 years has##2##6##(1992-8#1)(2010-6#1)
over the past 20 years##5##5##(1992-8#1)(2007-7#1)(2008-10#1)(2010-6#1)(2010-7#1)
over the past 25 years##4##5##(1997-1#1)(1997-2#1)(2008-2#1)(2012-2#1)
over the past 30 years##3##5##(2008-7#1)(2010-1#1)(2012-2#1)
over the past 40 years##2##5##(2010-3#1)(2011-2#1)
over the past 50 years##5##5##(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-12#1)
over the past decade##18##4##(1993-1#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
over the past decades##5##4##(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
over the past few years##5##5##(1992-9#1)(1995-12#1)(1995-3#1)(2008-9#1)(2011-2#1)
over the past few##6##4##(1992-9#1)(1995-12#1)(1995-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
over the past four decades##2##5##(1997-1#1)(2011-2#1)
over the past million years##2##5##(1994-3#2)
over the past several years##4##5##(1991-1#1)(1992-2#1)(2008-4#1)(2008-7#1)
over the past several##5##4##(1991-1#1)(1992-2#1)(2008-4#1)(2008-7#1)(2009-7#1)
over the past ten years##2##5##(1990-6#1)(1996-3#1)
over the past three decades##8##5##(1991-12#1)(1996-2#1)(2008-1#1)(2008-11#2)(2010-3#1)(2010-8#2)
over the past three##9##4##(1991-12#1)(1996-2#1)(2008-1#1)(2008-11#2)(2010-3#1)(2010-8#2)(2012-3#1)
over the past twenty years##2##5##(1992-1#1)(2013-8#1)
over the past two decades##7##5##(2007-12#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)
over the past two years##2##5##(1994-1#1)(1996-8#1)
over the past two##9##4##(1994-1#1)(1996-8#1)(2007-12#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)
over the past years##4##4##(1996-3#1)(2008-11#1)(2008-3#1)(2011-2#1)
over the past##113##3##(1990-6#1)(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
over the period from##2##4##(2008-10#1)(2012-12#1)
over the period of##7##4##(1993-2#1)(1996-12#1)(2008-11#2)(2008-6#1)(2009-2#1)(2010-3#1)
over the period##18##3##(1990-3#1)(1990-6#1)(1991-6#1)(1993-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
over the physiological##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
over the potential##3##3##(2008-10#2)(2013-1#1)
over the previous year##2##4##(1991-3#1)(1996-12#1)
over the previous##4##3##(1990-11#1)(1991-3#1)(1996-12#1)(2013-1#1)
over the range 0##24##4##(2007-12#1)(2008-10#22)(2008-5#1)
over the range 0-0##2##4##(2008-10#1)(2008-6#1)
over the range 1##6##4##(2008-10#6)
over the range 3##2##4##(2008-10#2)
over the range 5##2##4##(2008-10#2)
over the range from##5##4##(2008-10#4)(2008-3#1)
over the range of 0##17##5##(1992-8#1)(2008-10#16)
over the range of 1##2##5##(2008-10#1)(2008-11#1)
over the range of 2##4##5##(2008-10#4)
over the range of##42##4##(1992-8#1)(2008-10#37)(2008-11#1)(2008-2#2)(2008-3#1)
over the range studied##2##4##(2008-10#1)(2008-11#1)
over the range##112##3##(1991-12#1)(1992-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#93)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)
over the ranges 0##2##4##(2008-10#2)
over the ranges##4##3##(2007-12#1)(2008-10#3)
over the safety of##2##4##(2010-4#1)(2013-8#1)
over the safety##3##3##(2008-11#1)(2010-4#1)(2013-8#1)
over the same##7##3##(1991-8#1)(1995-1#1)(1995-8#1)(2007-10#1)(2008-10#1)(2011-1#1)(2012-2#1)
over the season##2##3##(2008-10#1)(2008-8#1)
over the source##2##3##(2008-10#1)(2008-3#1)
over the spectral range##3##4##(2007-11#1)(2008-3#2)
over the standard##4##3##(1994-9#1)(2008-3#2)(2008-7#1)
over the study period##5##4##(1992-5#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-8#1)
over the study##6##3##(1992-5#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-8#1)(2011-1#1)
over the subsequent##5##3##(1993-11#1)(1996-2#1)(2007-10#1)(2008-1#2)
over the surface of##4##4##(2008-10#2)(2008-3#1)(2008-7#1)
over the surface##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
over the temperature range of##2##5##(1994-12#1)(2009-9#1)
over the temperature range##4##4##(1990-2#1)(1994-12#1)(1994-5#1)(2009-9#1)
over the three##2##3##(2008-7#1)(2011-3#1)
over the time of##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
over the time##8##3##(2007-8#1)(2008-10#3)(2008-11#1)(2011-1#1)(2012-1#1)(2012-12#1)
over the traditional##4##3##(1990-6#1)(1997-4#1)(2008-10#1)(2008-3#1)
over the two days##2##4##(2008-3#2)
over the two seasons##2##4##(2008-10#1)(2008-5#1)
over the two##6##3##(2008-10#3)(2008-3#2)(2008-5#1)
over the visible and near-infrared##3##5##(2007-11#1)(2008-2#2)
over the wavelength range from##2##5##(2008-2#2)
over the wavelength range of##2##5##(2008-3#2)
over the wavelength range##12##4##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#5)
over the wavelength##13##3##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#6)
over the week##2##3##(2009-11#2)
over the whole##15##3##(1996-5#1)(1997-4#1)(2007-11#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)(2013-8#1)
over the wide##3##3##(2008-10#2)(2008-3#1)
over the working range##2##4##(2008-10#2)
over the working##3##3##(2008-10#3)
over the years has##2##4##(1991-12#1)(2008-2#1)
over the years in##2##4##(2011-2#1)(2012-3#1)
over the years##28##3##(1991-12#2)(1994-12#1)(1996-3#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-8#3)
over the##1116##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#5)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#5)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#5)(1996-11#4)(1996-12#3)(1996-2#9)(1996-3#6)(1996-4#1)(1996-5#9)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#7)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#2)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#5)(2007-11#21)(2007-12#17)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#11)(2007-8#8)(2007-9#3)(2008-1#9)(2008-10#312)(2008-11#28)(2008-12#13)(2008-2#43)(2008-3#67)(2008-4#9)(2008-5#23)(2008-6#11)(2008-7#33)(2008-8#18)(2008-9#21)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#7)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#4)(2010-8#12)(2011-1#16)(2011-2#37)(2011-3#3)(2012-1#2)(2012-12#17)(2012-2#21)(2012-3#11)(2013-1#24)(2013-7#1)(2013-8#16)
over their##13##2##(1992-1#1)(1995-1#1)(1996-1#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-8#3)(2010-10#1)(2011-1#2)(2013-1#1)
over this range of pH values##2##6##(1992-8#2)
over this range##3##3##(1992-8#2)(2008-3#1)
over this##14##2##(1992-8#2)(1993-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
over those##7##2##(1992-3#1)(1994-2#2)(1995-3#1)(1997-3#1)(2008-3#1)(2008-7#1)
over three commercial products##2##4##(2008-10#2)
over three decades##2##3##(2010-12#1)(2011-1#1)
over three orders of magnitude and the##2##7##(2008-10#2)
over three orders of magnitude##6##5##(1991-5#1)(2008-10#5)
over three successive##2##3##(2007-10#1)(2008-10#1)
over three years##3##3##(1990-9#1)(2008-12#1)(2011-2#1)
over three##24##2##(1990-9#1)(1991-5#1)(1992-11#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
over time and space##2##4##(2008-10#1)(2008-8#1)
over time and##12##3##(1990-12#2)(1994-11#1)(1997-3#1)(2008-10#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)
over time as##2##3##(1996-3#1)(2008-10#1)
over time by##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
over time can##2##3##(2008-10#1)(2009-9#1)
over time followed a##2##4##(2008-10#2)
over time for##4##3##(1996-3#1)(2008-10#2)(2010-5#1)
over time from##3##3##(2008-10#2)(2008-9#1)
over time in the##9##4##(1990-12#1)(1997-2#1)(2008-10#4)(2008-2#1)(2009-7#1)(2012-12#1)
over time in##22##3##(1990-12#1)(1993-5#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#2)
over time into a##2##4##(1994-3#1)(2009-9#1)
over time is##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2013-8#1)
over time may be##2##4##(1994-9#1)(2008-2#1)
over time scales of##2##4##(2008-3#2)
over time scales##3##3##(2008-3#3)
over time to##2##3##(1995-2#1)(2008-10#1)
over time was##3##3##(2008-10#2)(2008-6#1)
over time were##5##3##(2008-10#2)(2009-8#1)(2012-12#1)(2012-3#1)
over time when##2##3##(2008-10#2)
over time with##2##3##(2008-10#1)(2008-7#1)
over time within##2##3##(2008-10#1)(2012-12#1)
over time##265##2##(1990-12#4)(1991-1#1)(1991-2#4)(1992-1#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#66)(2008-11#9)(2008-12#8)(2008-2#2)(2008-3#5)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#10)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#3)(2010-3#2)(2010-5#4)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#11)(2013-8#2)
over time)##2##2##(2008-10#1)(2008-9#1)
over time?##3##2##(2008-12#1)(2008-9#1)(2010-12#1)
over to the##3##3##(1991-3#1)(2007-8#1)(2011-2#1)
over to##6##2##(1990-4#1)(1991-3#1)(1995-3#1)(2007-8#1)(2008-7#1)(2011-2#1)
over traditional##8##2##(1993-3#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-11#1)(2010-8#1)
over turbid coastal##2##3##(2008-3#2)
over turbid##3##2##(2008-3#3)
over two growing seasons##3##4##(2008-10#3)
over two hours##2##3##(2008-1#1)(2010-8#1)
over two orders of magnitude##4##5##(1990-5#1)(2008-10#3)
over two seasons##3##3##(2008-10#3)
over two years##5##3##(1997-2#1)(2008-1#1)(2008-4#1)(2009-2#1)(2013-8#1)
over two##31##2##(1990-5#1)(1993-11#1)(1997-2#1)(2006-4#1)(2007-5#1)(2008-1#2)(2008-10#14)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
over twofold##2##2##(2008-10#1)(2008-8#1)
over use of##2##3##(1995-9#1)(1996-2#1)
over various##4##2##(1992-1#1)(2008-3#2)(2012-2#1)
over what##2##2##(2007-11#1)(2008-11#1)
over whether the##2##3##(2007-11#1)(2009-3#1)
over whether##4##2##(2007-11#1)(2008-10#1)(2009-3#1)(2012-12#1)
over which the method was##2##5##(2008-10#2)
over which the##4##3##(1995-6#1)(2008-10#2)(2011-2#1)
over which##19##2##(1990-8#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
over wide concentration range##2##4##(2008-10#2)
over wide concentration##3##3##(2008-10#3)
over wide##9##2##(1992-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-8#1)
over years or##2##3##(2008-10#1)(2013-1#1)
over years##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
over zirconia supported heteropolyacids##2##4##(2013-1#2)
over##3826##1##(1990-10#2)(1990-11#6)(1990-12#12)(1990-2#6)(1990-3#6)(1990-4#1)(1990-5#5)(1990-6#17)(1990-7#3)(1990-8#15)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#10)(1991-2#17)(1991-3#7)(1991-4#2)(1991-5#14)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#8)(1992-1#11)(1992-10#2)(1992-11#5)(1992-12#1)(1992-2#7)(1992-3#16)(1992-4#1)(1992-5#7)(1992-6#12)(1992-7#1)(1992-8#10)(1992-9#12)(1993-1#5)(1993-11#10)(1993-12#13)(1993-2#7)(1993-3#11)(1993-5#2)(1993-6#15)(1993-8#8)(1993-9#9)(1994-1#9)(1994-11#6)(1994-12#20)(1994-2#23)(1994-3#24)(1994-5#10)(1994-6#8)(1994-7#3)(1994-8#7)(1994-9#10)(1995-1#15)(1995-11#7)(1995-12#13)(1995-2#19)(1995-3#15)(1995-4#2)(1995-5#4)(1995-6#8)(1995-8#6)(1995-9#5)(1996-1#10)(1996-10#1)(1996-11#9)(1996-12#13)(1996-2#23)(1996-3#17)(1996-4#6)(1996-5#15)(1996-6#9)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#14)(1997-2#19)(1997-3#12)(1997-4#14)(1997-5#7)(1997-6#12)(1997-7#11)(1997-8#6)(2006-10#7)(2006-12#1)(2006-4#2)(2006-8#1)(2007-10#16)(2007-11#100)(2007-12#107)(2007-2#5)(2007-4#2)(2007-5#10)(2007-6#3)(2007-7#27)(2007-8#22)(2007-9#3)(2008-1#39)(2008-10#923)(2008-11#115)(2008-12#52)(2008-2#145)(2008-3#262)(2008-4#35)(2008-5#71)(2008-6#48)(2008-7#119)(2008-8#85)(2008-9#72)(2009-1#2)(2009-10#12)(2009-11#12)(2009-12#9)(2009-2#5)(2009-3#9)(2009-4#9)(2009-5#14)(2009-6#1)(2009-7#16)(2009-8#23)(2009-9#24)(2010-1#10)(2010-10#11)(2010-11#12)(2010-12#12)(2010-2#5)(2010-3#26)(2010-4#15)(2010-5#18)(2010-6#12)(2010-7#11)(2010-8#37)(2010-9#1)(2011-1#44)(2011-2#135)(2011-3#7)(2011-9#1)(2012-1#11)(2012-12#56)(2012-2#75)(2012-3#40)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#86)(2013-7#6)(2013-8#45)
over- or##2##2##(2008-8#1)(2008-9#1)
over-##3##1##(2008-8#1)(2008-9#1)(2010-12#1)
over-dominance##4##1##(2008-12#1)(2008-8#3)
over-estimated mortality##2##2##(2007-8#2)
over-estimated##3##1##(2007-8#2)(2008-10#1)
over-expressed in a variety of##2##5##(2008-8#1)(2009-3#1)
over-expressed in##7##2##(1991-8#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-8#1)(2012-2#1)
over-expressing Hela cells##2##3##(2011-1#2)
over-expressing NSP 5a3a##2##3##(2011-2#2)
over-expressing##7##1##(2008-5#1)(2010-11#2)(2011-1#2)(2011-2#2)
over-expression of the##4##3##(1993-2#1)(2008-11#2)(2011-2#1)
over-expression of##17##2##(1993-2#1)(1994-9#1)(1995-6#1)(1996-12#2)(2007-12#2)(2008-11#6)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
over-expression##23##1##(1992-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#2)(2007-12#2)(2008-11#9)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
over-five##2##1##(2008-2#2)
over-head traction before##2##3##(2007-8#2)
over-head traction##5##2##(2007-8#5)
over-represented in##4##2##(2008-12#2)(2010-6#1)(2011-1#1)
over-represented##5##1##(2008-10#1)(2008-12#2)(2010-6#1)(2011-1#1)
over-the-counter cosmetics##2##2##(2008-5#1)(2010-8#1)
over-the-counter drugs and beverages##2##4##(2010-9#2)
over-the-counter drugs and food additives in##2##6##(2010-9#2)
over-the-counter drugs and##4##3##(2010-9#4)
over-the-counter##11##1##(1992-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2010-9#4)(2013-1#1)
over-utilization##2##1##(1995-1#1)(2009-4#1)
overactive bladder##6##2##(2008-10#1)(2008-12#1)(2009-2#1)(2009-5#2)(2011-1#1)
overactive##8##1##(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#2)(2009-5#2)(2011-1#1)
overactivity and##2##2##(2008-5#1)(2011-1#1)
overactivity in##2##2##(1993-1#1)(1993-9#1)
overactivity that##2##2##(2008-1#1)(2008-2#1)
overactivity##8##1##(1993-1#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-1#1)
overall Adair##3##2##(1990-8#3)
overall GLF scores##3##3##(1996-7#3)
overall Strehl##3##2##(2008-3#3)
overall acceptability and##2##3##(2010-4#2)
overall acceptability##6##2##(2010-2#2)(2010-4#4)
overall accuracy and precision##2##4##(2008-10#1)(2008-2#1)
overall accuracy##8##2##(1990-6#1)(1990-9#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
overall adequacy of##2##3##(2011-1#1)(2013-8#1)
overall agreement with##2##3##(1997-2#1)(2012-1#1)
overall agreement##8##2##(1992-10#1)(1997-2#1)(2008-10#1)(2009-5#1)(2009-8#2)(2010-12#1)(2012-1#1)
overall aim of##3##3##(2008-11#2)(2012-2#1)
overall aim##4##2##(2008-11#2)(2012-2#2)
overall amino acid identity##2##4##(1995-6#1)(1996-3#1)
overall analysis##4##2##(2008-10#1)(2008-7#2)(2013-8#1)
overall analytical##2##2##(2008-10#2)
overall and in##3##3##(2011-2#3)
overall and##13##2##(1991-12#1)(1991-6#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-1#1)(2011-2#3)
overall annual##2##2##(1996-6#1)(2008-8#1)
overall architecture of the##2##4##(2008-8#1)(2011-2#1)
overall architecture##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
overall assessment of##2##3##(2007-11#1)(2010-9#1)
overall assessment##3##2##(2007-11#1)(2010-9#1)(2011-2#1)
overall average##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)
overall benefit##2##2##(2008-5#1)(2012-2#1)
overall body##6##2##(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
overall cancer##3##2##(1990-2#1)(1997-1#1)(2012-12#1)
overall care of##2##3##(2011-3#1)(2012-3#1)
overall classification##2##2##(2008-6#1)(2010-8#1)
overall clinical##2##2##(1990-6#1)(1994-6#1)
overall conclusions##2##2##(1997-8#1)(2010-9#1)
overall conversion efficiency##2##3##(2007-11#1)(2007-12#1)
overall conversion##3##2##(2007-11#1)(2007-12#1)(2007-8#1)
overall correlation##2##2##(1995-3#1)(2012-2#1)
overall cost savings to##2##4##(1993-12#1)(1997-3#1)
overall cost##5##2##(1993-12#1)(1997-3#1)(2012-3#2)(2013-1#1)
overall data##2##2##(2007-12#1)(2008-3#1)
overall death##2##2##(1991-12#1)(2012-2#1)
overall decrease in##5##3##(1994-12#2)(1997-8#1)(2007-12#1)(2008-6#1)
overall detection##2##2##(2008-10#1)(2011-1#1)
overall diagnostic##2##2##(1996-11#1)(2011-2#1)
overall effect of##2##3##(2008-6#1)(2010-2#1)
overall effectiveness##3##2##(1994-3#1)(2008-10#1)(2012-1#1)
overall efficiency of##7##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
overall efficiency##10##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2010-8#1)
overall estimated##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
overall extraction equilibrium constants##3##4##(2008-10#3)
overall extraction equilibrium##4##3##(2008-10#4)
overall extraction##8##2##(2008-10#8)
overall features##2##2##(2007-11#1)(2008-3#1)
overall fitness##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
overall frequency of##2##3##(2008-10#1)(2012-2#1)
overall frequency##5##2##(2007-11#1)(2008-10#2)(2012-2#2)
overall health and##3##3##(1996-3#1)(2013-1#1)(2013-7#1)
overall health##12##2##(1996-3#1)(2007-11#1)(2008-7#4)(2009-6#1)(2010-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
overall hospital stay##2##3##(1996-3#1)(2012-2#1)
overall hospital##7##2##(1992-9#1)(1993-3#1)(1994-1#1)(1996-3#1)(2008-11#1)(2008-4#1)(2012-2#1)
overall identity to##2##3##(1995-8#1)(1996-3#1)
overall identity##4##2##(1991-9#1)(1995-8#1)(1996-10#1)(1996-3#1)
overall image quality##3##3##(2008-2#2)(2008-8#1)
overall image##4##2##(2007-11#1)(2008-2#2)(2008-8#1)
overall impression##4##2##(2010-8#2)(2012-2#2)
overall improvement in##5##3##(1997-3#1)(2007-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
overall improvement of mastalgia##2##4##(1994-5#2)
overall improvement of##6##3##(1994-5#2)(1995-2#1)(2008-12#1)(2010-2#1)(2011-2#1)
overall improvement##12##2##(1992-6#1)(1994-5#2)(1995-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
overall in##2##2##(2009-5#1)(2010-3#1)
overall incidence of##11##3##(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
overall incidence##13##2##(1994-12#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
overall increase in##2##3##(1993-3#1)(2008-6#1)
overall intensity of##2##3##(2008-10#1)(2008-3#1)
overall job satisfaction##3##3##(1991-2#2)(1993-3#1)
overall length of##2##3##(1994-2#1)(2010-7#1)
overall level of##2##3##(1990-12#1)(1997-3#1)
overall levels of##2##3##(1996-3#1)(2008-12#1)
overall life##2##2##(2007-10#1)(2011-2#1)
overall male-to-female##2##2##(2008-9#2)
overall management##4##2##(2007-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
overall mean intercept##2##3##(2008-10#2)
overall mean regression slope and intercept##2##6##(2008-10#2)
overall mean value##4##3##(2008-3#3)(2008-7#1)
overall mean##12##2##(2008-10#6)(2008-3#3)(2008-7#1)(2008-9#2)
overall membrane##2##2##(1990-12#1)(1993-12#1)
overall metabolic##2##2##(2008-11#1)(2013-1#1)
overall method##4##2##(2008-10#4)
overall microbial##2##2##(2008-10#1)(2008-9#1)
overall mortality rate was##3##4##(1994-11#1)(1994-7#1)(2007-7#1)
overall mortality rate##4##3##(1993-9#1)(1994-11#1)(1994-7#1)(2007-7#1)
overall mortality##10##2##(1993-9#1)(1994-11#1)(1994-7#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-7#2)(2008-8#1)(2012-3#1)
overall network activity##2##3##(2013-8#2)
overall network##3##2##(2012-3#1)(2013-8#2)
overall objective##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
overall optical performance##2##3##(2008-2#1)(2008-3#1)
overall optical##5##2##(2008-2#2)(2008-3#2)(2011-1#1)
overall or##3##2##(2008-6#1)(2010-8#1)(2012-2#1)
overall outcome of##5##3##(2007-10#1)(2007-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
overall outcome##8##2##(2007-10#1)(2007-5#1)(2008-7#2)(2010-12#1)(2010-3#2)(2013-1#1)
overall patient satisfaction##2##3##(1993-12#1)(2010-8#1)
overall patient survival##2##3##(2008-1#1)(2013-1#1)
overall patient##6##2##(1993-12#1)(2008-1#1)(2010-8#1)(2011-2#2)(2013-1#1)
overall perceptions of##2##3##(2007-12#1)(2008-4#1)
overall performance of the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
overall performance of##6##3##(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)
overall performance##9##2##(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)
overall power##2##2##(2008-2#1)(2008-3#1)
overall precision##3##2##(1997-2#1)(2008-10#2)
overall prevalence of##18##3##(1990-2#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
overall prevalence rate of##2##4##(1994-6#1)(2008-3#1)
overall prevalence##21##2##(1990-2#1)(1994-6#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
overall process##4##2##(1996-5#1)(2008-10#1)(2008-12#1)(2009-3#1)
overall productivity##2##2##(2007-5#1)(2008-11#1)
overall prognosis##3##2##(2008-12#1)(2008-4#1)(2008-7#1)
overall protein##2##2##(2008-5#1)(2008-6#1)
overall psychological and##2##3##(2008-4#1)(2009-7#1)
overall psychological##3##2##(2008-4#1)(2009-7#1)(2012-2#1)
overall public health performance##2##4##(1995-12#1)(1996-12#1)
overall public health##3##3##(1995-12#1)(1996-12#1)(1997-3#1)
overall quality of##8##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2010-1#1)(2013-1#1)
overall rate of##9##3##(1991-11#1)(1991-2#1)(1993-11#2)(1994-2#1)(2008-10#1)(2008-7#2)(2012-2#1)
overall rate##11##2##(1991-11#1)(1991-2#1)(1993-11#3)(1994-2#1)(1995-6#1)(2008-10#1)(2008-7#2)(2012-2#1)
overall rating##2##2##(1992-1#2)
overall reaction##4##2##(1990-7#1)(2008-10#3)
overall reduction in the number of##2##6##(2007-7#1)(2008-10#1)
overall reduction in the##3##4##(2007-7#1)(2008-10#2)
overall reduction in##4##3##(2007-10#1)(2007-7#1)(2008-10#2)
overall reduction##7##2##(2007-10#1)(2007-7#1)(2008-10#4)(2008-3#1)
overall response rate##7##3##(1991-4#1)(1992-10#1)(1993-1#1)(2008-10#3)(2012-2#1)
overall response##11##2##(1991-4#1)(1992-10#1)(1993-1#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#1)
overall results##13##2##(1994-8#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
overall rheology of##2##3##(2008-5#1)(2011-1#1)
overall risk##5##2##(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
overall role##2##2##(1993-11#1)(2010-3#1)
overall sample##2##2##(1994-11#1)(2008-2#1)
overall sampling##2##2##(2008-10#1)(2008-3#1)
overall satisfaction##5##2##(1991-3#1)(1996-3#1)(1997-1#1)(1997-3#2)
overall score##4##2##(1996-7#2)(2009-11#2)
overall scores##3##2##(1995-12#1)(2008-7#1)(2010-3#1)
overall sensitivity##4##2##(1996-12#1)(1997-8#1)(2008-3#1)(2011-2#1)
overall sequence##2##2##(1995-12#1)(2008-10#1)
overall similarity of##3##3##(1991-9#1)(1995-5#1)(2008-9#1)
overall similarity##4##2##(1991-9#1)(1995-5#1)(2008-10#1)(2008-9#1)
overall size##2##2##(2008-9#1)(2012-2#1)
overall stability constants##3##3##(2008-10#3)
overall stability of the##3##4##(1992-6#1)(2008-7#1)(2008-8#1)
overall stability of##4##3##(1992-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
overall stability##7##2##(1992-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
overall strategy##3##2##(1991-3#1)(1994-3#1)(1996-1#1)
overall strength of evidence##3##4##(2012-12#3)
overall strength of##4##3##(2008-11#1)(2012-12#3)
overall structural similarity##2##3##(1995-3#1)(2011-1#1)
overall structure is##2##3##(1993-8#2)
overall structure of the##2##4##(1991-5#1)(2008-3#1)
overall structure##8##2##(1991-5#1)(1992-6#1)(1993-11#1)(1993-8#2)(1997-9#1)(2008-3#1)(2009-11#1)
overall success of the##2##4##(2012-12#1)(2013-1#1)
overall success of##3##3##(2012-12#1)(2013-1#2)
overall success rate in##2##4##(1990-6#1)(2008-12#1)
overall success rate##4##3##(1990-6#1)(2008-10#1)(2008-12#1)(2012-2#1)
overall success##9##2##(1990-6#1)(2008-10#1)(2008-12#1)(2012-12#3)(2012-2#1)(2013-1#2)
overall survival (OS) and##2##4##(2008-10#1)(2011-2#1)
overall survival (OS)##11##3##(1991-8#1)(1992-10#1)(1993-1#1)(2008-10#2)(2008-6#1)(2009-4#1)(2011-2#4)
overall survival and disease-free##2##4##(1994-2#1)(2011-2#1)
overall survival and##7##3##(1990-6#1)(1991-4#1)(1994-2#1)(2007-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
overall survival for##3##3##(2010-3#2)(2011-2#1)
overall survival of##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
overall survival rate##4##3##(1994-7#1)(2007-8#1)(2008-11#1)(2010-3#1)
overall survival was 95%##2##4##(1991-8#1)(2007-8#1)
overall survival was##11##3##(1990-12#1)(1991-8#2)(1992-12#1)(2007-8#1)(2008-6#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
overall survival##71##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-4#1)(2007-10#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-6#11)(2008-8#1)(2009-4#1)(2010-11#2)(2010-3#6)(2010-4#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#2)
overall system performance##2##3##(2008-10#1)(2008-3#1)
overall system##8##2##(1994-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2013-1#1)
overall the##2##2##(1990-2#1)(2011-2#1)
overall treatment effect##2##3##(1996-3#1)(2013-1#1)
overall treatment time##2##3##(1992-10#2)
overall treatment##10##2##(1991-12#1)(1992-10#2)(1993-2#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-6#1)(2013-1#2)
overall trend##2##2##(2007-12#1)(2009-12#1)
overall uncertainty##5##2##(2008-10#2)(2008-3#2)(2011-2#1)
overall understanding of the##2##4##(1997-1#1)(2008-10#1)
overall usefulness##2##2##(2008-11#1)(2008-3#1)
overall variability##2##2##(2008-10#1)(2010-3#1)
overall yield and##2##3##(1996-5#1)(2008-10#1)
overall yield of##3##3##(1996-5#2)(2008-4#1)
overall yield##9##2##(1996-5#5)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
overall yields##4##2##(1996-5#1)(2007-11#1)(2008-4#1)(2009-5#1)
overall##1029##1##(1990-11#1)(1990-12#5)(1990-2#6)(1990-3#2)(1990-6#5)(1990-7#1)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#5)(1991-4#3)(1991-5#5)(1991-6#3)(1991-8#6)(1991-9#3)(1992-1#2)(1992-10#6)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#5)(1993-5#2)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#8)(1994-2#6)(1994-3#2)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#7)(1995-2#6)(1995-3#9)(1995-4#3)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#9)(1996-4#1)(1996-5#10)(1996-6#2)(1996-7#6)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#8)(1997-3#10)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#6)(1997-9#1)(2006-12#1)(2006-8#1)(2007-10#7)(2007-11#15)(2007-12#16)(2007-2#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#8)(2007-8#5)(2008-1#15)(2008-10#145)(2008-11#31)(2008-12#19)(2008-2#22)(2008-3#43)(2008-4#14)(2008-5#19)(2008-6#31)(2008-7#40)(2008-8#21)(2008-9#17)(2009-10#2)(2009-11#7)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#3)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#16)(2010-4#10)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#3)(2011-1#15)(2011-10#1)(2011-2#50)(2011-3#3)(2012-1#7)(2012-12#13)(2012-2#42)(2012-3#15)(2012-4#1)(2012-5#1)(2013-1#30)(2013-7#1)(2013-8#11)
overall)##2##1##(1992-8#1)(2008-1#1)
overarching##12##1##(1993-12#1)(1996-2#1)(1996-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#3)(2012-3#1)
overburdened##2##1##(2009-12#1)(2013-8#1)
overcame the resistance##2##3##(2008-10#2)
overcame the##3##2##(1993-12#1)(2008-10#2)
overcame##4##1##(1993-12#1)(2008-10#3)
overcast conditions##2##2##(2008-10#1)(2008-3#1)
overcast##7##1##(1994-3#1)(2008-10#2)(2008-3#4)
overcome a##4##2##(1993-12#1)(2008-1#1)(2008-7#2)
overcome and##3##2##(1997-8#1)(2007-7#1)(2008-10#1)
overcome any##2##2##(1995-1#1)(2008-10#1)
overcome by increasing##2##3##(1997-2#1)(2008-4#1)
overcome by the##5##3##(1990-2#1)(1994-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
overcome by use of##2##4##(2008-3#2)
overcome by##33##2##(1990-2#1)(1990-6#1)(1992-3#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
overcome if##2##2##(2008-10#1)(2009-6#1)
overcome in##2##2##(2008-10#1)(2012-3#1)
overcome its##2##2##(2008-10#1)(2009-11#1)
overcome limitations of##3##3##(2008-1#1)(2008-11#1)(2010-2#1)
overcome problems of##2##3##(1992-1#1)(1994-11#1)
overcome problems related to the##2##5##(1996-12#1)(2008-10#1)
overcome problems##4##2##(1992-1#1)(1994-11#1)(1996-12#1)(2008-10#1)
overcome some of the limitations##3##5##(2008-1#1)(2008-10#1)(2013-1#1)
overcome some of these limitations##2##5##(2008-5#1)(2008-7#1)
overcome some of##5##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
overcome some##6##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
overcome such##4##2##(1993-2#1)(1994-6#1)(2007-11#1)(2008-8#1)
overcome the difficulties##2##3##(1995-6#1)(2008-2#1)
overcome the inhibition##2##3##(1994-2#1)(2008-8#1)
overcome the inhibitory##2##3##(1990-11#1)(1997-4#1)
overcome the limitations of##3##4##(2007-8#1)(2008-10#1)(2012-3#1)
overcome the problem of##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
overcome the weaknesses of##2##4##(1997-3#1)(2011-1#1)
overcome the##63##2##(1990-11#1)(1991-2#3)(1994-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#14)(2008-2#3)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
overcome these barriers##3##3##(2010-11#1)(2013-1#2)
overcome these challenges##3##3##(1996-2#1)(2011-2#1)(2013-8#1)
overcome these difficulties##3##3##(2007-8#1)(2008-7#1)(2009-10#1)
overcome these drawbacks##3##3##(2008-7#1)(2010-5#1)(2010-6#1)
overcome these limitations by##2##4##(2007-11#1)(2009-6#1)
overcome these limitations##6##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-3#1)
overcome these problems##7##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-2#1)(2011-1#1)
overcome these two problems##2##4##(2008-3#1)(2008-5#1)
overcome these##30##2##(1996-2#1)(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
overcome this limitation##8##3##(1994-2#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-11#1)
overcome this problem##8##3##(1995-2#1)(1997-4#2)(2008-10#2)(2008-11#2)(2012-2#1)
overcome this##27##2##(1994-2#1)(1994-6#1)(1995-2#1)(1997-4#2)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
overcome using##2##2##(2008-10#1)(2009-11#1)
overcome with##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
overcome##275##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#6)(2007-7#4)(2007-8#5)(2008-1#6)(2008-10#51)(2008-11#14)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#8)(2013-7#3)(2013-8#3)
overcomes the##14##2##(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
overcomes these##2##2##(2007-11#1)(2008-11#1)
overcomes##23##1##(1996-5#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)
overcoming problems of##2##3##(2008-10#1)(2008-4#1)
overcoming some of the##2##4##(1995-3#1)(2008-4#1)
overcoming the problem of##2##4##(2008-11#2)
overcoming the##14##2##(1991-5#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2009-12#1)(2010-3#1)(2012-1#1)
overcoming this##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
overcoming##43##1##(1991-5#1)(1991-9#1)(1995-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#4)(2009-12#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
overcompensation##3##1##(2008-8#2)(2008-9#1)
overcorrection##2##1##(2008-3#2)
overcoupled##2##1##(2008-2#1)(2008-3#1)
overcrowding and##2##2##(1997-7#1)(2013-1#1)
overcrowding##13##1##(1997-4#1)(1997-7#1)(2008-11#6)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
overdenture##3##1##(2009-4#2)(2013-1#1)
overdentures##5##1##(2013-1#5)
overdetermined##5##1##(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)
overdispersed##3##1##(2008-10#1)(2008-8#2)
overdispersion of disease##2##3##(2008-10#2)
overdispersion##5##1##(2008-10#4)(2008-8#1)
overdominance or underdominance##2##3##(2008-10#2)
overdominance##5##1##(1995-2#1)(2008-10#3)(2013-1#1)
overdosage in a##2##3##(2011-1#2)
overdosage##5##1##(1991-9#2)(2008-11#1)(2011-1#2)
overdose and##2##2##(2008-11#1)(2008-6#1)
overdose have##2##2##(2010-1#2)
overdose in##2##2##(1991-8#1)(1996-8#1)
overdose with##2##2##(1990-6#1)(1991-8#1)
overdose##25##1##(1990-6#1)(1991-1#1)(1991-6#1)(1991-8#4)(1995-8#1)(1996-8#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-1#5)(2011-1#1)(2011-2#1)(2013-1#2)
overdose)##2##1##(1991-9#1)(2008-6#1)
overdoses##3##1##(2010-1#1)(2010-9#1)(2013-1#1)
overdrainage##2##1##(2009-6#1)(2012-12#1)
overdue for##3##2##(2010-8#3)
overdue##6##1##(2008-11#1)(2010-8#4)(2013-1#1)
overestimate the##5##2##(1992-6#1)(1993-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
overestimate##12##1##(1992-6#1)(1993-2#1)(1995-4#1)(1996-12#1)(1996-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
overestimated at##2##2##(2008-10#2)
overestimated in the##3##3##(1990-11#1)(1997-3#1)(2008-10#1)
overestimated in##4##2##(1990-11#1)(1997-3#1)(2008-10#2)
overestimated the##4##2##(2008-10#1)(2008-5#1)(2009-7#1)(2013-1#1)
overestimated##26##1##(1990-11#1)(1993-2#1)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#4)
overestimates##4##1##(2007-12#1)(2008-3#1)(2008-6#1)(2013-1#1)
overestimating the##2##2##(1994-3#1)(2008-10#1)
overestimating##4##1##(1994-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
overestimation of the##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
overestimation of##12##2##(1992-9#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#1)
overestimation##14##1##(1992-9#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2011-1#1)(2011-2#1)
overexposed##2##1##(1996-12#1)(2013-8#1)
overexposure##2##1##(2007-11#1)(2013-8#1)
overexpress the##4##2##(2008-11#2)(2008-6#1)(2012-2#1)
overexpress##11##1##(1990-5#1)(1993-1#1)(1995-2#1)(2008-11#3)(2008-6#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
overexpressed and##2##2##(1995-2#1)(2008-4#1)
overexpressed in E##2##3##(1995-12#1)(2008-7#1)
overexpressed in Escherichia coli##5##4##(1992-3#1)(1992-6#1)(2008-10#2)(2011-2#1)
overexpressed in senescent human fibroblasts##2##5##(1992-9#2)
overexpressed in the##3##3##(1994-12#1)(2008-11#1)(2009-10#1)
overexpressed in##25##2##(1992-3#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-12#1)(1995-12#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#1)
overexpressed maize AChE gene in##2##5##(2009-8#2)
overexpressed the##2##2##(1995-2#1)(2008-10#1)
overexpressed##50##1##(1992-3#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-12#3)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#3)(1997-7#1)(2007-8#1)(2008-10#9)(2008-11#6)(2008-4#2)(2008-7#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
overexpressing EGFR##2##2##(2008-11#2)
overexpressing the human##3##3##(1992-8#2)(1995-6#1)
overexpressing the##8##2##(1992-8#2)(1994-11#1)(1995-6#2)(1997-3#1)(2012-3#1)(2013-1#1)
overexpressing transfectants##2##2##(1993-1#2)
overexpressing##33##1##(1992-8#2)(1993-1#3)(1993-3#1)(1994-11#3)(1995-2#1)(1995-6#2)(1997-3#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#3)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
overexpression and##5##2##(1993-1#1)(1995-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
overexpression has been##2##3##(2012-12#1)(2013-1#1)
overexpression in human cancers##3##4##(1997-7#1)(2011-1#1)(2012-12#1)
overexpression in human##4##3##(1993-1#1)(1997-7#1)(2011-1#1)(2012-12#1)
overexpression in##13##2##(1992-8#1)(1993-1#1)(1995-9#1)(1997-7#1)(2008-7#1)(2008-9#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
overexpression of LDL receptors##2##4##(1990-11#2)
overexpression of a##2##3##(1996-5#1)(1997-7#1)
overexpression of copper- and zinc-containing superoxide dismutase##2##7##(1995-6#2)
overexpression of human##2##3##(1995-6#2)
overexpression of p53 protein##2##4##(2008-10#1)(2009-8#1)
overexpression of p53##5##3##(2008-10#3)(2009-8#1)(2010-10#1)
overexpression of the##11##3##(1991-2#1)(1992-12#1)(1994-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
overexpression of##67##2##(1990-11#3)(1991-12#1)(1991-2#1)(1992-12#2)(1992-8#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-6#7)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#11)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#5)(2013-1#4)
overexpression on the##2##3##(2008-7#1)(2012-2#1)
overexpression on##6##2##(1997-7#2)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
overexpression was##3##2##(1997-7#1)(2007-10#1)(2011-2#1)
overexpression##127##1##(1990-11#3)(1991-12#2)(1991-2#1)(1992-12#2)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#8)(1995-8#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#6)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#14)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#3)(2009-3#1)(2009-8#4)(2010-10#1)(2011-1#7)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#2)
overfilling##2##1##(1991-2#1)(1991-3#1)
overfitting##3##1##(1995-2#1)(1995-9#1)(2008-10#1)
overflow##5##1##(1992-10#1)(1993-12#1)(1997-2#1)(2008-2#1)(2008-7#1)
overglaze##2##1##(1997-4#2)
overgrown##2##1##(1997-5#1)(2008-10#1)
overgrowth in##2##2##(2008-9#1)(2011-2#1)
overgrowth of##2##2##(2008-9#1)(2009-4#1)
overgrowth##24##1##(2008-11#5)(2008-8#1)(2008-9#3)(2009-4#1)(2010-11#1)(2010-3#1)(2010-6#2)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)
overhang##4##1##(1990-10#2)(1993-12#1)(2008-11#1)
overhangs##4##1##(1990-10#1)(2008-4#3)
overhaul of##4##2##(1992-12#1)(1994-8#1)(1995-2#1)(1996-2#1)
overhaul##7##1##(1992-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)
overhauling##2##1##(1995-1#1)(1996-2#1)
overhead drilling##3##2##(2008-12#3)
overhead sprinkling irrigation##2##3##(2008-10#2)
overhead throwing##2##2##(2008-8#2)
overhead##22##1##(1991-2#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#3)(2008-6#1)(2008-8#3)(2013-1#1)
overheating and##2##2##(1992-11#1)(1993-12#1)
overheating##5##1##(1992-11#1)(1992-4#3)(1993-12#1)
overinfuse if##2##2##(2011-2#2)
overjet##4##1##(2009-7#1)(2011-2#3)
overlaid##7##1##(2007-11#2)(2008-3#3)(2008-8#1)(2012-2#1)
overlap among##2##2##(2008-7#1)(2012-2#1)
overlap and##8##2##(1994-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)
overlap at the##2##3##(2008-2#1)(2011-2#1)
overlap at##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
overlap between the two##2##4##(2007-11#1)(2008-10#1)
overlap between the##7##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-1#1)
overlap between##20##2##(1994-12#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)
overlap each other##4##3##(1997-8#1)(2008-11#1)(2008-6#2)
overlap in the imaging##2##4##(1997-8#1)(2008-2#1)
overlap in the##7##3##(1994-3#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)
overlap in##16##2##(1994-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2013-1#1)
overlap is##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
overlap occurred##2##2##(2007-10#2)
overlap of the##7##3##(1990-12#1)(2008-10#3)(2008-2#1)(2010-5#1)(2011-2#1)
overlap of##17##2##(1990-12#1)(1997-7#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-9#1)(2010-1#1)(2010-5#1)(2011-2#1)
overlap the##3##2##(1995-5#1)(1996-2#1)(2007-12#1)
overlap was##4##2##(2008-10#3)(2009-2#1)
overlap with other##2##3##(1994-2#1)(2008-8#1)
overlap with the##8##3##(1993-11#2)(1995-6#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-8#1)(2011-2#1)
overlap with##16##2##(1993-11#2)(1994-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
overlap##148##1##(1990-12#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-5#2)(1995-6#3)(1996-12#3)(1996-2#2)(1996-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#11)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#3)(2009-1#1)(2009-11#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#6)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
overlap-written fiber Bragg gratings##2##4##(2007-12#2)
overlapped a##2##2##(1997-5#1)(2008-10#1)
overlapped absorption##2##2##(2008-10#2)
overlapped in##2##2##(1997-3#1)(2009-6#1)
overlapped linear frequency-chirped##2##3##(2007-11#2)
overlapped peaks##2##2##(2008-10#2)
overlapped the##2##2##(1993-2#1)(2010-8#1)
overlapped those##2##2##(2008-10#1)(2012-2#1)
overlapped with QTL##2##3##(2012-3#2)
overlapped with##6##2##(1992-9#1)(2008-10#1)(2012-1#1)(2012-3#2)(2013-8#1)
overlapped##50##1##(1992-9#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2008-10#21)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-6#1)(2010-8#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
overlapping ORFs##3##2##(1996-3#1)(2008-10#2)
overlapping a##2##2##(1992-12#1)(2008-10#1)
overlapping and##4##2##(1995-9#1)(2007-10#1)(2008-10#1)(2008-3#1)
overlapping antisense##2##2##(2008-7#2)
overlapping between##2##2##(2007-10#1)(2008-10#1)
overlapping but##2##2##(1991-3#1)(1993-12#1)
overlapping cDNA clones##3##3##(1993-3#1)(1996-12#2)
overlapping chromatographic##2##2##(2008-10#2)
overlapping clinical features##2##3##(1991-2#1)(2012-12#1)
overlapping clones covering the##2##4##(2008-8#1)(2013-8#1)
overlapping clones##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
overlapping deletions##3##2##(1993-3#3)
overlapping fluorescence##2##2##(2008-10#2)
overlapping genes in##3##3##(1996-8#1)(1997-7#2)
overlapping genes##5##2##(1996-8#1)(1997-7#4)
overlapping host##2##2##(2008-10#2)
overlapping neural networks##2##3##(1994-8#2)
overlapping of the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
overlapping of##9##2##(1994-9#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-2#1)
overlapping or##2##2##(2012-2#1)(2013-1#1)
overlapping pathways##2##2##(1994-6#1)(1996-12#1)
overlapping peaks##5##2##(2008-10#5)
overlapping peptides##2##2##(1993-3#1)(2008-11#1)
overlapping regions##2##2##(2012-3#2)
overlapping signals##2##2##(2008-10#2)
overlapping spectra##2##2##(2008-10#2)
overlapping spectrophotometric signals##2##3##(2008-10#2)
overlapping the##3##2##(1991-6#1)(1993-8#1)(2008-10#1)
overlapping with the##2##3##(2007-7#1)(2008-10#1)
overlapping with##5##2##(1994-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
overlapping##160##1##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#5)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-7#5)(1997-8#1)(2007-10#2)(2007-12#3)(2007-7#1)(2008-10#49)(2008-11#8)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#7)(2008-8#7)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-8#1)
overlaps the##8##2##(1994-11#1)(1994-8#2)(1997-3#1)(2007-11#1)(2008-10#2)(2008-8#1)
overlaps with##2##2##(1992-12#1)(2013-1#1)
overlaps##17##1##(1990-11#1)(1992-12#1)(1994-11#1)(1994-8#2)(1996-10#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
overlay assay##3##2##(1995-11#1)(2008-10#2)
overlay material##2##2##(2007-11#2)
overlay of##4##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)
overlay waveguide##3##2##(2008-3#3)
overlay waveguides##2##2##(2008-3#2)
overlay##22##1##(1990-8#1)(1994-11#1)(1995-11#1)(2007-11#3)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#7)(2008-5#1)(2010-12#1)
overlayer##6##1##(2008-2#4)(2008-3#2)
overlayers##3##1##(2008-2#2)(2009-10#1)
overlaying##2##1##(2007-11#1)(2009-8#1)
overlays##4##1##(2007-11#1)(2008-3#2)(2013-1#1)
overload and##10##2##(1994-9#2)(1996-2#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
overload in the##3##3##(2010-3#1)(2013-8#2)
overload in##4##2##(2010-3#1)(2012-2#1)(2013-8#2)
overload phenomenon##4##2##(2008-7#4)
overload to##2##2##(2010-3#1)(2013-1#1)
overload##55##1##(1990-9#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-9#2)(1995-8#3)(1996-2#1)(1996-3#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#6)(2008-8#2)(2009-8#1)(2010-1#1)(2010-3#3)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
overload)##2##1##(2008-10#1)(2013-8#1)
overloading##8##1##(1990-6#1)(2007-11#1)(2008-10#1)(2008-7#3)(2011-1#1)(2011-2#1)
overloads##2##1##(2008-12#1)(2008-7#1)
overlook the##3##2##(2009-11#1)(2010-5#2)
overlook##5##1##(2009-11#1)(2010-5#2)(2010-9#1)(2012-12#1)
overlooked and##2##2##(1991-9#1)(2010-3#1)
overlooked because of##2##3##(1993-1#1)(2010-4#1)
overlooked because##5##2##(1993-1#1)(1996-12#1)(1996-6#1)(2009-5#1)(2010-4#1)
overlooked by##4##2##(1991-2#1)(2008-12#1)(2008-2#1)(2011-2#1)
overlooked in the##2##3##(2008-11#1)(2013-8#1)
overlooked in##4##2##(2008-11#1)(2009-6#1)(2011-2#1)(2013-8#1)
overlooked the##2##2##(2008-11#1)(2011-3#1)
overlooked##55##1##(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#2)
overly##3##1##(1995-3#1)(2008-10#1)(2013-8#1)
overlying the##4##2##(1995-11#1)(2009-1#1)(2010-11#1)(2011-2#1)
overlying##17##1##(1990-6#1)(1991-11#1)(1995-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-1#2)(2010-11#1)(2010-3#1)(2011-2#2)
overmodulation##2##1##(2008-3#2)
overnadant##2##1##(2007-10#2)
overnight darkness##2##2##(2008-10#2)
overnight incubation##2##2##(2008-10#1)(2008-4#1)
overnight##33##1##(1990-2#1)(1992-2#1)(1993-12#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#1)(2011-2#6)(2012-8#1)(2013-1#1)
overoxidized PPy film##2##3##(2008-10#2)
overoxidized sulfonated polypyrrole film##2##4##(2008-10#2)
overoxidized sulfonated polypyrrole##3##3##(2008-10#3)
overoxidized##5##1##(2008-10#5)
overpotential of##2##2##(2008-10#2)
overpotential##10##1##(2008-10#10)
overpriced##2##1##(1994-1#2)
overproduced in Escherichia coli##3##4##(1993-9#1)(1995-2#1)(2009-2#1)
overproduced##8##1##(1991-7#1)(1991-9#1)(1993-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#1)(2009-2#1)
overproducer##3##1##(1995-2#1)(1996-12#1)(2012-3#1)
overproduces##2##1##(1991-7#1)(2008-10#1)
overproducing the AddAB##2##3##(1995-8#2)
overproducing##7##1##(1991-12#1)(1995-8#2)(2008-2#2)(2012-2#1)(2012-3#1)
overproduction of H(2)O(2)##2##3##(2008-10#1)(2008-5#1)
overproduction of NO##2##3##(2011-1#2)
overproduction of##16##2##(1990-11#1)(1991-12#1)(1994-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#2)(2013-8#1)
overproduction##22##1##(1990-11#1)(1991-12#1)(1994-12#1)(1995-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-8#1)
overreactivity##2##1##(2012-2#2)
overrepresentation of##2##2##(1993-12#1)(1994-2#1)
overrepresented among the##2##3##(1990-6#1)(1991-5#1)
overrepresented in##3##2##(2008-11#1)(2009-6#1)(2009-8#1)
overrepresented##7##1##(1990-6#1)(1991-5#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-5#2)
override the##2##2##(1996-12#1)(2008-8#1)
override##5##1##(1996-12#1)(2007-5#1)(2008-5#1)(2008-8#1)(2012-12#1)
overriding##7##1##(1990-7#1)(2008-4#1)(2009-12#1)(2010-11#2)(2010-5#1)(2012-1#1)
overrode##2##1##(2008-10#1)(2011-2#1)
overseas military hospitals##3##3##(1995-6#3)
overseas recruitment##2##2##(2008-11#1)(2009-4#1)
overseas##19##1##(1991-5#2)(1994-3#1)(1995-6#3)(1997-2#1)(2007-2#2)(2008-1#1)(2008-11#5)(2008-12#1)(2009-4#1)(2010-1#1)(2011-2#1)
oversee##4##1##(1991-12#1)(1994-3#1)(1996-2#1)(2010-3#1)
oversees##2##1##(1992-8#1)(1997-2#1)
overselection of comorbid cases##3##4##(1997-5#3)
overshadow the##2##2##(1996-11#1)(2008-10#1)
overshadow##3##1##(1994-3#1)(1996-11#1)(2008-10#1)
overshadowed by##2##2##(2008-8#1)(2010-3#1)
overshadowed##5##1##(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
overshadowing##3##1##(2008-5#3)
overshoot of##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
overshoot##7##1##(1990-2#1)(2008-11#4)(2008-7#1)(2010-8#1)
overshot##2##1##(1993-12#1)(1994-3#1)
oversight and##3##2##(1995-12#1)(1995-3#1)(2010-12#1)
oversight of##3##2##(1990-7#1)(2008-9#1)(2012-3#1)
oversight##15##1##(1990-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#2)(2006-5#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#3)
oversimplified##2##1##(1993-6#1)(2008-1#1)
overspray##2##1##(2011-2#2)
oversupplied##2##1##(2008-9#2)
overt aggression##2##2##(2008-12#1)(2010-11#1)
overt and covert##2##3##(1995-12#1)(2012-1#1)
overt clinical##2##2##(2009-1#1)(2011-2#1)
overt diabetes##2##2##(1994-12#1)(2008-1#1)
overt production##2##2##(2012-1#2)
overt##34##1##(1990-3#1)(1990-6#1)(1992-2#1)(1994-12#1)(1995-12#2)(2008-1#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-1#1)(2009-9#2)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#4)
overtime##8##1##(1994-3#1)(1995-5#1)(1996-6#1)(1997-8#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-3#1)
overtly##4##1##(1997-4#1)(2008-11#1)(2010-6#1)(2012-3#1)
overtone absorption##2##2##(2008-10#1)(2008-3#1)
overtone band##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
overtone bands##3##2##(2007-12#2)(2008-2#1)
overtone##17##1##(2007-12#4)(2008-10#2)(2008-2#5)(2008-3#5)(2010-7#1)
overtones and##2##2##(2008-10#1)(2008-2#1)
overtones##6##1##(2008-10#1)(2008-12#1)(2008-2#2)(2009-7#1)(2010-2#1)
overtraining##5##1##(1993-2#3)(2008-5#2)
overtreatment##2##1##(1997-7#1)(2013-1#1)
overturn##4##1##(1992-11#1)(1995-6#1)(2008-10#1)(2008-12#1)
overturning##3##1##(2007-12#1)(2007-5#1)(2009-8#1)
overuse injuries##2##2##(2011-2#1)(2013-1#1)
overuse of##2##2##(1997-1#1)(2013-8#1)
overuse##12##1##(1990-8#1)(1994-3#2)(1996-2#1)(1997-1#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
overusers##2##1##(1990-8#1)(1993-6#1)
overutilized##3##1##(1996-12#1)(1996-9#1)(2009-3#1)
overview about the##2##3##(2006-10#1)(2010-10#1)
overview about##4##2##(2006-10#1)(2008-5#1)(2010-10#1)(2013-1#1)
overview also##2##2##(2008-10#1)(2012-12#1)
overview and##7##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
overview describes##5##2##(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#2)
overview for##4##2##(1992-3#1)(1996-2#1)(2008-4#1)(2008-9#1)
overview is given##2##3##(2008-11#1)(2008-2#1)
overview is presented##3##3##(1990-8#1)(1992-1#1)(2008-10#1)
overview is##6##2##(1990-8#1)(1992-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
overview of a##5##3##(1991-12#1)(1995-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
overview of all##2##3##(1994-2#1)(2011-2#1)
overview of current##6##3##(1994-1#1)(2008-4#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
overview of different##3##3##(2008-3#1)(2012-2#2)
overview of issues##3##3##(2008-4#2)(2010-4#1)
overview of modern##2##3##(2008-4#1)(2010-8#1)
overview of multiple sequence alignment##2##5##(2008-4#2)
overview of published##3##3##(1992-1#1)(2008-8#1)(2010-11#1)
overview of recent developments in##2##5##(2008-10#1)(2008-5#1)
overview of recent##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
overview of several techniques##2##4##(2008-3#1)(2008-4#1)
overview of some of the##4##5##(2007-5#1)(2008-12#1)(2008-4#1)(2008-7#1)
overview of some##6##3##(1995-1#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
overview of the U##2##4##(1993-3#1)(1994-12#1)
overview of the application of##2##5##(2008-10#1)(2008-11#1)
overview of the current knowledge on##2##6##(2008-11#1)(2009-4#1)
overview of the current##9##4##(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
overview of the literature on##2##5##(1993-11#1)(2012-2#1)
overview of the literature##5##4##(1993-11#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-8#1)
overview of the most##6##4##(1991-6#1)(2008-4#1)(2010-11#1)(2010-9#1)(2011-2#1)(2011-3#1)
overview of the pathophysiology of##2##5##(2008-12#1)(2011-2#1)
overview of the published##2##4##(2008-6#1)(2011-1#1)
overview of the recent##2##4##(2012-3#1)(2013-1#1)
overview of the types of##3##5##(1992-12#1)(1997-2#1)(2008-2#1)
overview of the various##4##4##(1992-12#1)(2008-5#1)(2010-12#1)(2011-1#1)
overview of the##150##3##(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-4#1)(2006-10#1)(2007-12#2)(2007-7#2)(2008-1#4)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#1)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#4)
overview of these##4##3##(1992-1#1)(1992-12#1)(1993-2#1)(2008-10#1)
overview of this##5##3##(1994-2#1)(1996-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
overview of various##3##3##(1991-1#1)(2008-4#1)(2012-2#1)
overview of##314##2##(1990-6#1)(1991-1#4)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#3)(1992-3#3)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#4)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(2006-10#1)(2007-12#3)(2007-4#1)(2007-5#3)(2007-7#3)(2008-1#4)(2008-10#21)(2008-11#17)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#30)(2008-5#9)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#7)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-2#21)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#7)(2013-8#5)
overview on the generation of##2##5##(2008-4#2)
overview on the##7##3##(2008-10#1)(2008-11#1)(2008-4#3)(2009-7#1)(2010-11#1)
overview on##10##2##(2008-10#3)(2008-11#1)(2008-4#3)(2009-7#1)(2010-11#1)(2013-8#1)
overview that##2##2##(2008-11#1)(2008-4#1)
overview to##2##2##(2008-2#1)(2011-2#1)
overview##446##1##(1990-6#1)(1990-8#2)(1991-1#4)(1991-12#3)(1991-2#3)(1991-6#1)(1991-8#2)(1992-1#5)(1992-12#4)(1992-3#6)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#4)(1994-1#4)(1994-12#6)(1994-2#4)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#3)(1996-1#3)(1996-12#4)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#2)(1997-8#1)(2006-10#2)(2007-12#3)(2007-4#1)(2007-5#3)(2007-7#4)(2008-1#8)(2008-10#41)(2008-11#25)(2008-12#7)(2008-2#10)(2008-3#4)(2008-4#54)(2008-5#13)(2008-6#8)(2008-7#6)(2008-8#2)(2008-9#20)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#6)(2010-12#7)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#7)(2011-2#28)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#8)(2013-1#10)(2013-8#7)
overviewed##3##1##(2008-10#1)(2012-3#1)(2013-8#1)
overviews of randomized trials##2##4##(1993-12#1)(2009-9#1)
overviews of##4##2##(1993-12#2)(2008-6#1)(2009-9#1)
overviews the##3##2##(1996-3#1)(2008-3#1)(2010-6#1)
overviews##14##1##(1993-12#7)(1996-3#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-9#1)(2010-6#1)
overweight (BMI##2##2##(2008-10#1)(2008-3#1)
overweight adolescents##2##2##(2011-2#1)(2012-12#1)
overweight and obese women##2##4##(2011-1#1)(2013-1#1)
overweight and obese##8##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
overweight and obesity among##4##4##(2011-1#1)(2011-2#1)(2012-12#2)
overweight and obesity and subsequent NCD that are significant factors in the morbidity and mortality of the population##2##18##(2013-8#2)
overweight and obesity and subsequent NCD that are##4##8##(2013-8#4)
overweight and obesity and subsequent NCD that##6##7##(2013-8#6)
overweight and obesity and subsequent NCD##7##6##(2013-8#7)
overweight and obesity and subsequent##8##5##(2013-8#8)
overweight and obesity for##2##4##(2011-2#1)(2012-12#1)
overweight and obesity in##5##4##(2008-3#2)(2009-6#1)(2012-12#1)(2012-3#1)
overweight and obesity is##2##4##(2011-2#1)(2012-2#1)
overweight and obesity were##2##4##(2012-12#1)(2012-3#1)
overweight and obesity##33##3##(2007-12#1)(2008-3#2)(2009-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#6)(2012-2#4)(2012-3#2)(2013-8#9)
overweight and##51##2##(1993-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#12)
overweight children##4##2##(2009-8#3)(2013-1#1)
overweight has##2##2##(2008-11#1)(2008-7#1)
overweight in##4##2##(1993-9#1)(2008-1#1)(2008-10#1)(2011-2#1)
overweight or obese and##3##4##(2008-10#1)(2013-8#2)
overweight or obese##12##3##(2008-10#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#7)
overweight or##13##2##(2008-10#2)(2008-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#7)
overweight patients##5##2##(2008-10#3)(2009-8#1)(2010-10#1)
overweight subjects##2##2##(2008-6#2)
overweight was##2##2##(2008-3#1)(2011-2#1)
overweight women##4##2##(1991-12#1)(2008-5#2)(2013-1#1)
overweight youth##4##2##(2008-3#4)
overweight##142##1##(1990-2#1)(1990-9#1)(1991-12#3)(1993-2#1)(1993-9#1)(1995-5#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-12#6)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#14)(2008-5#4)(2008-6#2)(2008-7#2)(2009-4#1)(2009-6#1)(2009-8#7)(2010-10#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-12#9)(2012-2#8)(2012-3#8)(2013-1#7)(2013-8#23)
overweight/obese##2##1##(2008-5#1)(2013-1#1)
overweight/obesity##3##1##(2009-6#1)(2009-7#1)(2011-1#1)
overwhelm the##2##2##(1993-12#1)(2008-9#1)
overwhelm##4##1##(1993-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
overwhelmed by the##2##3##(2008-11#1)(2008-12#1)
overwhelmed by##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
overwhelmed##5##1##(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)
overwhelming anxiety##2##2##(1992-3#1)(2008-4#1)
overwhelming majority of##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
overwhelming##18##1##(1991-1#1)(1992-3#1)(1994-9#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#3)(2013-1#2)
overwhelmingly positive##2##2##(2011-2#2)
overwhelmingly preferred the##2##3##(1995-8#1)(2008-10#1)
overwhelmingly##8##1##(1995-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#2)
overwinter in##2##2##(2008-10#1)(2008-8#1)
overwinter##3##1##(2008-10#2)(2008-8#1)
overwintered##6##1##(2008-10#6)
overwintering by##2##2##(2008-10#1)(2008-9#1)
overwintering ectotherms##2##2##(2008-8#2)
overwintering##17##1##(2008-10#11)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#1)
overwinters##3##1##(2008-10#3)
oviduct and##3##2##(1990-8#1)(2008-11#1)(2008-5#1)
oviduct transferrin receptor##2##3##(1990-8#2)
oviduct##22##1##(1990-8#4)(1991-6#1)(1992-9#1)(1993-8#1)(2007-12#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)
oviductal parts##3##2##(2008-12#3)
oviductal##5##1##(1997-6#1)(2008-12#4)
oviducts and##2##2##(1990-8#1)(1992-2#1)
oviducts##4##1##(1990-8#1)(1992-2#1)(2007-12#1)(2008-5#1)
ovigerous females##5##2##(2013-1#1)(2013-7#4)
ovine adenovirus##3##2##(1997-3#3)
ovine head impact model##2##4##(2008-7#2)
ovine herpesvirus-2##2##2##(2011-1#2)
ovine hypothalamic##3##2##(1990-7#1)(1992-9#2)
ovine##30##1##(1990-12#2)(1990-7#1)(1991-5#1)(1992-3#1)(1992-9#2)(1993-2#1)(1994-8#1)(1995-11#1)(1996-12#2)(1997-3#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
oviparae##5##1##(2008-9#5)
oviparasitica strain 50##2##3##(2008-10#2)
oviparasitica##9##1##(2008-10#9)
oviparous##2##1##(2007-12#1)(2008-8#1)
oviposit##4##1##(2008-6#1)(2008-9#2)(2013-8#1)
oviposited##2##1##(2007-12#1)(2013-8#1)
ovipositing##2##1##(2007-12#1)(2008-8#1)
oviposition and##2##2##(2007-12#1)(2008-9#1)
oviposition preference##2##2##(2008-8#2)
oviposition##20##1##(1991-5#1)(2007-12#7)(2008-12#1)(2008-8#3)(2008-9#3)(2009-6#1)(2010-8#2)(2011-2#1)(2012-3#1)
ovipositor is##2##2##(2007-12#2)
ovipositor sheaths##2##2##(2007-12#2)
ovipositor##8##1##(2007-12#8)
ovipositors##2##1##(2007-12#1)(2008-5#1)
ovis and##3##2##(1996-12#3)
ovis##7##1##(1996-12#4)(2010-10#2)(2012-2#1)
ovo##6##1##(1996-12#3)(1996-5#1)(2007-12#1)(2008-12#1)
ovoid cells of the branchial heart##2##6##(2008-7#2)
ovoid cells of##3##3##(2008-7#3)
ovoid cells##4##2##(2008-7#4)
ovoid##7##1##(1993-9#1)(2007-12#1)(2008-7#4)(2011-2#1)
ovomucoid third##2##2##(1991-8#2)
ovomucoid##4##1##(1991-8#2)(2008-11#2)
ovulated##2##1##(1994-7#1)(1995-2#1)
ovulation and##2##2##(2011-1#2)
ovulation in##4##2##(1990-9#1)(2008-9#1)(2010-8#1)(2012-12#1)
ovulation induction##4##2##(1994-5#1)(2007-7#1)(2008-1#1)(2011-1#1)
ovulation##23##1##(1990-9#2)(1991-11#1)(1994-5#1)(1994-7#5)(1994-9#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
ovulations##2##1##(1994-7#2)
ovulatory##3##1##(2008-12#1)(2008-4#1)(2011-1#1)
ovule##4##1##(2008-10#1)(2008-8#2)(2009-12#1)
ovules##13##1##(2008-10#1)(2008-5#1)(2008-8#9)(2009-12#1)(2009-8#1)
owe##3##1##(1994-2#1)(2009-5#1)(2013-8#1)
owes##4##1##(2007-5#1)(2008-11#1)(2010-7#1)(2012-2#1)
owing in##2##2##(1995-12#1)(1997-5#1)
owing to a low##2##4##(1995-2#1)(2012-1#1)
owing to a reduction in##2##5##(1990-11#1)(2008-3#1)
owing to a##13##3##(1990-11#1)(1995-2#1)(1995-5#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-11#2)(2012-1#1)(2013-1#1)
owing to either##2##3##(2007-11#1)(2011-2#1)
owing to its##12##3##(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
owing to lack of##4##4##(1992-11#1)(1993-2#1)(1995-5#1)(1996-11#1)
owing to self-phase modulation##2##4##(2007-11#1)(2008-2#1)
owing to surface##2##3##(2008-2#2)
owing to the fact that##2##5##(2008-10#1)(2009-2#1)
owing to the lack of##4##5##(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
owing to the large##2##4##(1994-6#1)(2008-3#1)
owing to the small##2##4##(2007-11#1)(2010-5#1)
owing to the##57##3##(1991-2#1)(1992-6#1)(1994-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2008-10#8)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-5#6)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)
owing to their high##2##4##(2008-10#1)(2013-1#1)
owing to their##8##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-5#1)(2012-2#2)(2013-1#1)
owing to##161##2##(1990-11#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-11#1)(1997-5#1)(1997-8#2)(2007-10#2)(2007-11#6)(2007-12#16)(2007-8#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#16)(2008-3#21)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#7)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#2)
owing##166##1##(1990-11#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-11#1)(1997-5#2)(1997-8#2)(2007-10#2)(2007-11#6)(2007-12#16)(2007-8#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#16)(2008-3#21)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#7)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#3)
owl monkeys (Aotus##3##3##(2008-11#1)(2013-1#2)
owl monkeys##6##2##(2008-11#3)(2013-1#3)
owl##9##1##(1990-5#2)(1997-6#1)(2008-11#3)(2013-1#3)
own abilities##2##2##(2007-11#1)(2009-9#1)
own ability##2##2##(2007-11#1)(2009-3#1)
own and##6##2##(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#2)
own characteristics##2##2##(1996-2#1)(2011-2#1)
own cigarette##2##2##(2009-7#2)
own classification##3##2##(1990-11#1)(2007-8#2)
own clinical##2##2##(2007-11#1)(2010-12#1)
own experience and##2##3##(1995-1#1)(2007-8#1)
own experience at##2##3##(1992-2#1)(1994-3#1)
own experience based on##2##4##(1997-7#1)(2013-1#1)
own experience of##2##3##(1995-6#1)(2008-12#1)
own experience with##4##3##(2007-11#1)(2007-8#2)(2010-8#1)
own experience##28##2##(1992-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1997-7#1)(2007-11#8)(2007-8#6)(2008-1#1)(2008-12#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
own experiences##5##2##(1991-6#1)(2007-11#2)(2008-11#1)(2008-12#1)
own experiments##2##2##(2008-10#1)(2008-11#1)
own health care##2##3##(1993-3#1)(2008-6#1)
own health##9##2##(1991-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-6#3)(2008-6#1)(2013-7#1)
own initiative##2##2##(1996-9#1)(2008-1#1)
own institution##5##2##(1994-2#1)(1994-3#1)(2009-4#3)
own material##3##2##(2007-11#2)(2012-12#1)
own medical##3##2##(1992-12#1)(1993-12#1)(2008-12#1)
own method of##2##3##(2007-11#1)(2007-8#1)
own or##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
own patient##2##2##(1991-8#1)(2008-10#1)
own perception of##2##3##(2007-6#2)
own perception##3##2##(1992-2#1)(2007-6#2)
own personal experience##2##3##(1994-12#1)(2008-11#1)
own personal##6##2##(1992-3#1)(1994-12#1)(2008-1#1)(2008-11#2)(2008-2#1)
own research group##2##3##(2008-10#1)(2010-2#1)
own research##7##2##(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
own right to##2##3##(1990-12#1)(1995-12#1)
own right##9##2##(1990-12#1)(1992-2#1)(1995-12#1)(2008-11#1)(2010-10#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
own series of##2##3##(1994-3#1)(2012-3#1)
own specific##2##2##(1996-9#1)(2008-11#1)
own weight##2##2##(2007-12#1)(2013-1#1)
own words##6##2##(1995-1#1)(2008-4#1)(2008-6#1)(2011-2#3)
own work with##2##3##(2008-12#1)(2008-5#1)
own work##3##2##(1992-11#1)(2008-12#1)(2008-5#1)
own##448##1##(1990-11#1)(1990-12#2)(1990-5#3)(1990-6#3)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#7)(1992-4#1)(1992-6#3)(1992-9#1)(1993-1#3)(1993-12#6)(1993-2#6)(1993-3#8)(1994-1#4)(1994-12#5)(1994-2#4)(1994-3#7)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#10)(1995-10#1)(1995-12#5)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-10#4)(2007-11#20)(2007-12#7)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#11)(2008-1#5)(2008-10#17)(2008-11#26)(2008-12#12)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#6)(2008-6#6)(2008-7#14)(2008-8#12)(2008-9#8)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#5)(2009-9#2)(2010-10#6)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#14)(2011-3#2)(2012-1#2)(2012-12#11)(2012-2#8)(2012-3#10)(2013-1#10)(2013-7#2)(2013-8#3)
owned a##4##2##(1997-4#1)(2008-10#2)(2012-3#1)
owned by##3##2##(1991-12#1)(1995-11#1)(2008-10#1)
owned the##2##2##(2008-10#1)(2008-9#1)
owned##11##1##(1991-12#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#4)(2008-9#1)(2009-8#1)(2012-3#1)
owner and##2##2##(1992-12#1)(2008-5#1)
owner##11##1##(1991-2#1)(1992-12#1)(1994-1#1)(1996-1#1)(1996-5#2)(1997-3#1)(2008-5#1)(2008-8#1)(2011-4#1)(2013-8#1)
owner-evaluated chronic pain index and pain##3##6##(2008-10#3)
owner/dog walkers##4##2##(2013-1#4)
owner/non-dog walkers##2##2##(2013-1#2)
owners in the##2##3##(1996-12#1)(2008-10#1)
owners may##2##2##(2008-8#2)
owners of hunting dogs##3##4##(1991-11#3)
owners to##3##2##(2008-8#1)(2012-12#1)(2013-1#1)
owners were##2##2##(2008-8#1)(2011-2#1)
owners##26##1##(1991-11#3)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#6)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#1)
ownership and##4##2##(1995-1#2)(1995-2#1)(2008-12#1)
ownership of ancillary services##2##4##(1996-1#2)
ownership of the##2##3##(1992-1#1)(1993-3#1)
ownership of##8##2##(1992-1#1)(1993-2#1)(1993-3#1)(1996-1#2)(1997-3#1)(2008-10#2)
ownership status##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
ownership##30##1##(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-1#4)(1995-2#5)(1996-1#2)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
owning##2##1##(1991-1#1)(2013-1#1)
owns##3##1##(1993-8#1)(2008-5#1)(2008-9#1)
ox liver##3##2##(1994-8#2)(2008-4#1)
oxa cages##3##2##(1996-5#3)
oxa##4##1##(1996-5#4)
oxacillin-resistant##2##1##(2011-2#2)
oxaferrocene##2##1##(2008-10#2)
oxalate absorption##4##2##(2012-2#4)
oxalate and##6##2##(1990-12#1)(1990-8#1)(2008-10#3)(2012-2#1)
oxalate contents##2##2##(2008-10#1)(2012-2#1)
oxalate crystals rather than##2##4##(1991-11#1)(1992-9#1)
oxalate crystals##3##2##(1991-11#1)(1992-5#1)(1992-9#1)
oxalate determination in urine##2##4##(1990-12#1)(2008-10#1)
oxalate determination##3##2##(1990-12#1)(2008-10#2)
oxalate films on marble##2##4##(2008-10#2)
oxalate films##3##2##(2008-10#3)
oxalate form of##2##3##(2008-10#2)
oxalate in##7##2##(1990-12#1)(2008-10#5)(2012-2#1)
oxalate ion##2##2##(2008-10#2)
oxalate monohydrate##2##2##(1995-8#2)
oxalate oxidase##2##2##(2008-10#2)
oxalate that is##2##3##(2012-2#2)
oxalate that##3##2##(2008-10#1)(2012-2#2)
oxalate##80##1##(1990-12#3)(1990-8#2)(1991-11#1)(1991-12#2)(1992-5#4)(1992-6#1)(1992-9#5)(1993-3#2)(1995-8#2)(2008-10#48)(2012-2#10)
oxalate)##2##1##(1993-8#1)(1995-12#1)
oxalate-degrading##2##1##(2012-2#2)
oxalates##2##1##(2008-10#2)
oxalic acid digests of##2##4##(1990-8#2)
oxalic acid in##5##3##(1990-8#1)(2008-10#2)(2013-1#2)
oxalic acid was##2##3##(2013-1#2)
oxalic acid##18##2##(1990-8#3)(2008-10#6)(2012-2#3)(2013-1#6)
oxalic##24##1##(1990-8#3)(1994-9#1)(2008-10#10)(2012-2#3)(2013-1#7)
oxalicum##8##1##(2008-10#8)
oxaliplatin with##2##2##(2008-3#1)(2010-11#1)
oxaliplatin##13##1##(2008-3#6)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-11#2)
oxaliplatin-induced peripheral neuropathy##2##3##(2008-3#1)(2008-7#1)
oxaloacetate##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
oxalosis##6##1##(1991-11#3)(1992-5#1)(2011-2#2)
oxamide##2##1##(2008-10#1)(2010-12#1)
oxamniquine##5##1##(2010-12#5)
oxathiaphospholane monomers##2##2##(2008-4#2)
oxathiaphospholane##3##1##(2008-4#3)
oxazolidinone##2##1##(2006-10#1)(2008-8#1)
oxazolone control group##2##3##(2011-3#2)
oxazolone##3##1##(2011-3#2)(2012-12#1)
oxazolone-induced##3##1##(2011-3#3)
oxendolone##7##1##(1990-11#7)
oxibendazole##3##1##(2008-10#3)
oxid-LDL##2##1##(1992-5#2)
oxidant and antioxidant status##3##4##(2008-12#2)(2009-9#1)
oxidant and##5##2##(1992-3#1)(2008-10#1)(2008-12#2)(2009-9#1)
oxidant compounds##3##2##(2008-10#3)
oxidant concentration##4##2##(1995-8#1)(2008-10#3)
oxidant generation##2##2##(1996-2#2)
oxidant in##3##2##(2008-10#2)(2008-5#1)
oxidant is##3##2##(2008-10#3)
oxidant solution##2##2##(2008-10#2)
oxidant than##2##2##(2008-10#1)(2012-12#1)
oxidant to##3##2##(2008-10#3)
oxidant was##2##2##(2008-10#2)
oxidant##72##1##(1990-5#1)(1991-9#2)(1992-10#1)(1992-3#1)(1995-3#1)(1995-8#3)(1996-2#3)(1996-9#2)(2007-11#3)(2008-10#45)(2008-12#2)(2008-5#2)(2009-9#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
oxidant-antioxidant balance##2##2##(1991-9#1)(2008-7#1)
oxidant-antioxidant##3##1##(1991-9#2)(2008-7#1)
oxidant-induced##2##1##(1991-9#1)(2013-1#1)
oxidants and##4##2##(1990-7#1)(1996-2#1)(1996-9#1)(2008-11#1)
oxidants as##2##2##(2008-10#2)
oxidants can be##2##3##(1991-9#1)(2008-5#1)
oxidants can##4##2##(1991-9#1)(1996-2#2)(2008-5#1)
oxidants in liquid phase##2##4##(2008-10#2)
oxidants of##2##2##(1997-7#1)(2008-10#1)
oxidants##29##1##(1990-5#1)(1990-7#1)(1991-9#2)(1996-2#3)(1996-9#1)(1997-7#2)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#1)(2010-1#1)(2010-5#1)(2011-2#1)
oxidase (AOX)##3##2##(1994-6#1)(2008-9#1)(2009-8#1)
oxidase (ChOx) and##2##3##(2008-10#2)
oxidase (ChOx)##5##2##(2008-10#5)
oxidase (EC 1##2##3##(1995-2#1)(2008-10#1)
oxidase (GOD) and##2##3##(2008-10#2)
oxidase (GOD) was immobilized##2##4##(2008-10#2)
oxidase (GOD)##6##2##(2008-10#6)
oxidase (XO)##3##2##(2008-10#2)(2008-11#1)
oxidase (XOD)##3##2##(1993-12#1)(2008-10#2)
oxidase A##3##2##(1991-12#1)(2009-8#1)(2011-2#1)
oxidase I gene##2##3##(2008-6#1)(2011-2#1)
oxidase I##8##2##(1997-7#1)(2007-12#1)(2008-6#2)(2011-2#3)(2013-7#1)
oxidase activation##2##2##(1991-2#1)(2008-1#1)
oxidase activity in##5##3##(1990-12#1)(1990-3#1)(1996-12#1)(2008-10#1)(2008-3#1)
oxidase activity of##2##3##(1990-11#2)
oxidase activity was##4##3##(1991-2#1)(2008-10#1)(2008-7#2)
oxidase activity##20##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-9#1)(2012-2#1)
oxidase and its##2##3##(1995-2#1)(2008-10#1)
oxidase and the##2##3##(2008-10#2)
oxidase and##23##2##(1990-5#1)(1991-5#2)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
oxidase as##3##2##(2008-10#3)
oxidase at##4##2##(1990-3#2)(1997-7#1)(2008-10#1)
oxidase based##2##2##(2008-10#2)
oxidase by##2##2##(1991-2#1)(1993-6#1)
oxidase can be activated##2##4##(1993-8#1)(2008-1#1)
oxidase can##3##2##(1990-3#1)(1993-8#1)(2008-1#1)
oxidase complex##2##2##(1991-2#1)(1993-8#1)
oxidase electrode##3##2##(2008-10#2)(2009-10#1)
oxidase enzyme activity##3##3##(2008-10#3)
oxidase enzyme was##3##3##(2008-10#3)
oxidase enzyme##7##2##(2008-10#6)(2008-6#1)
oxidase enzymes##3##2##(2008-10#2)(2010-1#1)
oxidase from##11##2##(1990-12#1)(1991-12#1)(1991-5#1)(1995-5#2)(1997-7#3)(2008-10#1)(2009-9#1)(2010-9#1)
oxidase has been##3##3##(1992-8#1)(2008-10#1)(2009-8#1)
oxidase immobilized##8##2##(2008-10#8)
oxidase in conjunction with the##2##5##(2008-10#2)
oxidase in the##3##3##(2008-10#3)
oxidase in##21##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-5#1)(1991-9#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#2)(1995-8#1)(2008-10#6)(2008-7#1)(2008-9#1)
oxidase inhibitor##6##2##(1990-2#1)(1991-5#1)(1994-6#1)(1996-9#1)(2008-10#2)
oxidase inhibitors##3##2##(1991-9#1)(2008-6#1)(2011-2#1)
oxidase into##3##2##(1991-5#1)(2008-10#2)
oxidase is a##3##3##(1994-6#1)(2008-1#1)(2008-10#1)
oxidase is##6##2##(1992-12#1)(1992-8#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#1)
oxidase modified carbon##2##3##(2008-10#2)
oxidase of##6##2##(1991-2#1)(1991-9#1)(1992-11#1)(1994-8#1)(2008-10#2)
oxidase on the##5##3##(1992-11#1)(2008-10#4)
oxidase on##7##2##(1991-9#1)(1992-11#1)(2008-10#5)
oxidase promoter##2##2##(1994-11#1)(1997-4#1)
oxidase subunit I##5##3##(1993-2#1)(2010-4#3)(2011-2#1)
oxidase subunit##9##2##(1990-5#1)(1991-6#1)(1993-2#1)(2008-10#2)(2010-4#3)(2011-2#1)
oxidase system##3##2##(1990-5#1)(1993-8#1)(2008-10#1)
oxidase type A from human liver##2##6##(1990-12#2)
oxidase type##3##2##(1990-12#2)(2008-7#1)
oxidase was immobilized on##2##4##(2008-10#2)
oxidase was immobilized##4##3##(2008-10#4)
oxidase was##14##2##(1992-11#1)(1992-8#1)(1993-6#1)(1993-8#1)(2008-10#8)(2008-7#1)(2011-1#1)
oxidase were##3##2##(1990-12#1)(1995-2#1)(2008-10#1)
oxidase with##6##2##(1993-8#1)(1996-9#1)(2008-10#4)
oxidase##379##1##(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#7)(1990-5#6)(1991-12#6)(1991-2#5)(1991-5#11)(1991-6#4)(1991-9#6)(1992-11#9)(1992-12#2)(1992-8#8)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#7)(1993-8#8)(1994-11#1)(1994-3#1)(1994-6#5)(1994-8#5)(1995-11#2)(1995-2#9)(1995-3#2)(1995-5#3)(1995-6#8)(1995-8#3)(1995-9#1)(1996-12#1)(1996-5#4)(1996-9#2)(1997-2#3)(1997-4#1)(1997-7#8)(2007-12#1)(2008-1#3)(2008-10#151)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#4)(2009-6#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
oxidase)##3##1##(2008-10#3)
oxidase-B##2##1##(1994-8#1)(2010-12#1)
oxidase-based enzyme##2##2##(2008-10#2)
oxidase-based##3##1##(2008-10#3)
oxidase-derived##2##1##(1991-9#1)(2009-12#1)
oxidases and##2##2##(1991-5#1)(2008-8#1)
oxidases##20##1##(1990-12#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1994-8#3)(1995-3#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-8#1)(2009-9#1)(2012-2#2)(2013-8#1)
oxidation and dry heat##2##4##(2008-10#2)
oxidation and reduction##4##3##(2008-10#4)
oxidation and##30##2##(1990-7#1)(1992-11#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-11#2)(2008-1#1)(2008-10#14)(2008-4#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-1#1)
oxidation at a##2##3##(1991-5#1)(1991-7#1)
oxidation at##9##2##(1991-5#1)(1991-7#1)(1995-3#1)(2008-10#5)(2008-5#1)
oxidation by hydrogen peroxide##3##4##(2008-10#2)(2011-2#1)
oxidation by the##4##3##(1994-9#1)(2008-10#3)
oxidation by##21##2##(1990-7#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-7#1)(2008-10#12)(2011-2#1)
oxidation capacity##2##2##(1991-12#1)(2008-1#1)
oxidation during##6##2##(1991-12#3)(2008-10#1)(2008-5#2)
oxidation efficiency##2##2##(2008-10#2)
oxidation for##6##2##(2008-10#6)
oxidation in the presence of##2##5##(1991-8#1)(2008-10#1)
oxidation in the##6##3##(1991-8#1)(1995-6#1)(2008-1#2)(2008-10#2)
oxidation in##21##2##(1990-5#1)(1990-9#1)(1991-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-1#3)(2008-10#7)(2008-5#1)(2010-4#2)(2013-1#1)
oxidation is##7##2##(1994-5#1)(2008-1#1)(2008-10#4)(2008-5#1)
oxidation markers##2##2##(2010-4#2)
oxidation metabolites##2##2##(2011-1#1)(2011-3#1)
oxidation method##3##2##(2008-10#3)
oxidation of 1##2##3##(2008-10#2)
oxidation of 2##2##3##(2008-10#2)
oxidation of AA##2##3##(2008-10#2)
oxidation of As(III)##2##3##(2008-10#2)
oxidation of Cr(III) to Cr(VI)##2##5##(2008-10#2)
oxidation of Cr(III)##3##3##(2008-10#3)
oxidation of HSO(3)(-)##3##3##(2008-10#3)
oxidation of LDL##2##3##(1995-12#1)(2008-10#1)
oxidation of N##6##3##(2008-10#6)
oxidation of N-(3-sulfopropyl)-3##2##3##(2008-10#2)
oxidation of NO##4##3##(2008-10#4)
oxidation of a##4##3##(2008-10#4)
oxidation of alcohols##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
oxidation of ammonia to nitrite##2##5##(2008-10#2)
oxidation of ammonia with##2##4##(2008-10#2)
oxidation of ammonia##4##3##(2008-10#4)
oxidation of ascorbate##2##3##(2008-10#2)
oxidation of ascorbic acid##3##4##(2008-10#3)
oxidation of benzoins to##2##4##(2007-11#2)
oxidation of benzoyl hydrazine##2##4##(2008-10#2)
oxidation of cisatracurium##2##3##(2008-10#2)
oxidation of cysteine##3##3##(1991-5#2)(1993-9#1)
oxidation of cytochrome##2##3##(1996-4#1)(2008-10#1)
oxidation of etodolac##3##3##(2008-10#3)
oxidation of glucose in the presence of##2##7##(2008-10#2)
oxidation of glucose##4##3##(1990-7#1)(2008-10#3)
oxidation of hydrazine at##2##4##(2008-10#2)
oxidation of hydrazine##5##3##(2008-10#5)
oxidation of hydrogen peroxide##3##4##(2008-10#3)
oxidation of leuco##2##3##(2008-10#2)
oxidation of luminol by##4##4##(1991-5#1)(2008-10#3)
oxidation of luminol##9##3##(1991-5#1)(2008-10#8)
oxidation of lung lipids##2##4##(1992-9#2)
oxidation of mercury in methyl ethyl ketone##2##7##(2008-10#2)
oxidation of mercury##3##3##(2008-10#3)
oxidation of nitrite ion##5##4##(2008-10#5)
oxidation of paracetamol##2##3##(2008-10#2)
oxidation of phenols##2##3##(1994-5#2)
oxidation of purpurogallin##2##3##(2008-10#2)
oxidation of pyrogallol##3##3##(2008-10#3)
oxidation of resveratrol##2##3##(2008-10#2)
oxidation of the##30##3##(1992-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-8#2)(2009-9#1)
oxidation of these compounds##2##4##(2008-10#2)
oxidation of these##3##3##(2008-10#3)
oxidation of this##2##3##(2008-10#2)
oxidation of##293##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#3)(1991-9#4)(1992-12#2)(1992-3#2)(1992-9#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#5)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-7#2)(2007-11#5)(2008-10#214)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
oxidation or##2##2##(1992-11#1)(1993-11#1)
oxidation peak at 0##2##4##(2008-10#2)
oxidation peak current##3##3##(2008-10#3)
oxidation peak was##3##3##(2008-10#3)
oxidation peak##22##2##(2008-10#22)
oxidation peaks of##2##3##(2008-10#2)
oxidation peaks##6##2##(2008-10#6)
oxidation potential of##3##3##(2008-10#3)
oxidation potential##9##2##(1996-5#1)(2008-10#8)
oxidation process##9##2##(2008-10#7)(2008-5#2)
oxidation processes##3##2##(2008-10#2)(2010-5#1)
oxidation product of##5##3##(1992-12#1)(1995-5#1)(2008-10#3)
oxidation product##7##2##(1992-12#1)(1995-5#1)(2008-10#4)(2008-5#1)
oxidation products##8##2##(2008-1#1)(2008-10#6)(2008-11#1)
oxidation rate##3##2##(1994-5#2)(2008-10#1)
oxidation reaction of##14##3##(2008-10#14)
oxidation reaction with##2##3##(2008-10#2)
oxidation reaction##21##2##(2008-10#21)
oxidation reactions##2##2##(2008-9#1)(2009-2#1)
oxidation results in the##2##4##(2008-10#1)(2010-5#1)
oxidation sensitized by##2##3##(2008-10#2)
oxidation signal##2##2##(2008-10#2)
oxidation state of##8##3##(1992-8#1)(1997-7#1)(2008-10#6)
oxidation state##22##2##(1992-8#1)(1993-8#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#15)(2009-6#1)
oxidation states##17##2##(1993-8#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#11)(2010-6#1)(2012-2#1)
oxidation step##4##2##(2008-10#3)(2012-3#1)
oxidation to the##3##3##(1995-3#1)(1996-5#1)(2013-8#1)
oxidation to##10##2##(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-8#1)
oxidation was##7##2##(1993-3#2)(1994-9#1)(1995-12#1)(2008-4#1)(2008-6#1)(2010-4#1)
oxidation wave of the##2##4##(2008-10#2)
oxidation wave##3##2##(2008-10#3)
oxidation with N-bromosuccinimide##2##3##(2008-10#2)
oxidation with the##2##3##(2008-10#1)(2009-5#1)
oxidation with##10##2##(1995-2#1)(2008-10#8)(2009-5#1)
oxidation##713##1##(1990-12#1)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#5)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#4)(1992-3#2)(1992-8#1)(1992-9#5)(1993-11#1)(1993-3#7)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#3)(1994-2#2)(1994-5#9)(1994-8#4)(1994-9#4)(1995-12#9)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1997-4#3)(1997-7#6)(2007-11#9)(2008-1#12)(2008-10#446)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#25)(2008-6#6)(2008-7#4)(2008-8#6)(2008-9#2)(2009-11#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#3)(2010-4#9)(2010-5#2)(2010-6#1)(2010-7#4)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#5)
oxidation-reduction reactions##3##2##(2008-10#2)(2008-5#1)
oxidation-reduction##6##1##(1991-8#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
oxidation/reduction##2##1##(1991-5#1)(2008-10#1)
oxidations##4##1##(1991-9#1)(2008-4#1)(2008-5#2)
oxidative DNA damage##4##3##(1994-6#1)(2008-10#2)(2008-4#1)
oxidative DNA##5##2##(1994-6#2)(2008-10#2)(2008-4#1)
oxidative activation of##2##3##(1992-9#2)
oxidative and##4##2##(2008-11#2)(2009-5#2)
oxidative burst in##5##3##(1991-2#1)(1995-6#1)(2008-10#3)
oxidative burst##18##2##(1991-2#3)(1995-6#7)(2008-10#7)(2008-9#1)
oxidative changes##3##2##(1991-9#1)(1994-5#1)(2009-9#1)
oxidative cleavage mechanism##2##3##(1993-11#1)(2013-1#1)
oxidative cleavage of prolyl peptides##2##5##(1990-5#2)
oxidative cleavage of##4##3##(1990-5#3)(1997-7#1)
oxidative cleavage##8##2##(1990-5#3)(1993-11#1)(1994-8#2)(1997-7#1)(2013-1#1)
oxidative coupling##10##2##(2008-10#10)
oxidative damage and##3##3##(1995-6#2)(2012-2#1)
oxidative damage during##2##3##(2008-1#1)(2008-3#1)
oxidative damage in the##2##4##(1991-9#1)(2009-12#1)
oxidative damage in##6##3##(1991-9#1)(1997-4#1)(2009-12#3)(2012-2#1)
oxidative damage is##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
oxidative damage of##4##3##(1992-9#1)(2008-10#1)(2008-4#1)(2011-1#1)
oxidative damage to the##2##4##(1992-12#1)(2013-8#1)
oxidative damage to##6##3##(1992-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-8#1)
oxidative damage##45##2##(1991-9#2)(1992-12#1)(1992-9#2)(1995-3#1)(1995-6#3)(1997-4#2)(1997-8#1)(2008-1#3)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2009-10#1)(2009-12#6)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#3)
oxidative damages##2##2##(1995-8#1)(2008-10#1)
oxidative decarboxylation##2##2##(2007-11#1)(2008-6#1)
oxidative decomposition##2##2##(2008-10#2)
oxidative degradation of##4##3##(2008-10#3)(2011-1#1)
oxidative degradation##5##2##(2008-10#3)(2011-1#1)(2013-1#1)
oxidative effects##2##2##(2008-5#2)
oxidative energy##2##2##(1994-5#2)
oxidative fermentation##3##2##(2011-2#3)
oxidative inactivation##2##2##(1992-12#2)
oxidative injury and##2##3##(1997-3#1)(2013-1#1)
oxidative injury##6##2##(1997-3#1)(2008-5#1)(2009-12#1)(2013-1#2)(2013-7#1)
oxidative metabolism##7##2##(1990-7#1)(1993-6#1)(1994-2#2)(2008-10#1)(2008-4#1)(2008-9#1)
oxidative metabolites##3##2##(1990-5#1)(2008-10#1)(2011-3#1)
oxidative modification of LDL##3##4##(2008-10#2)(2009-8#1)
oxidative modification of##8##3##(1990-5#1)(1991-5#1)(1992-9#1)(2008-1#1)(2008-10#2)(2009-8#2)
oxidative modification##22##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-2#2)(1991-5#1)(1992-9#1)(1994-11#3)(1994-9#1)(1995-12#2)(2008-1#2)(2008-10#2)(2009-8#3)
oxidative modifications of lipids##2##4##(2009-8#2)
oxidative modifications of##4##3##(2009-8#4)
oxidative modifications##7##2##(2009-8#7)
oxidative phosphorylation and##2##3##(1994-11#1)(2008-7#1)
oxidative phosphorylation##21##2##(1990-2#3)(1991-5#1)(1991-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
oxidative polymerization and##2##3##(2008-10#1)(2008-7#1)
oxidative polymerization##3##2##(2008-10#1)(2008-7#2)
oxidative pressure##2##2##(2010-5#1)(2012-6#1)
oxidative protein refolding at##2##4##(2011-2#2)
oxidative reaction of##4##3##(2008-10#4)
oxidative reaction##5##2##(2008-10#5)
oxidative reactions##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
oxidative refolding of##2##3##(2011-2#2)
oxidative stress and the##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
oxidative stress and to##2##4##(1994-2#1)(2008-7#1)
oxidative stress and##31##3##(1991-12#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#2)
oxidative stress are##3##3##(1994-6#1)(1995-5#1)(2008-4#1)
oxidative stress by##2##3##(1991-9#1)(2008-7#1)
oxidative stress for##2##3##(1992-9#1)(2009-6#1)
oxidative stress in plasma##2##4##(1993-2#1)(2013-1#1)
oxidative stress in the heart##3##5##(2008-7#1)(2013-1#2)
oxidative stress in the##7##4##(1992-8#1)(2008-7#2)(2009-10#1)(2010-12#1)(2013-1#2)
oxidative stress in##29##3##(1992-8#1)(1993-2#1)(1996-9#2)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#5)(2013-8#1)
oxidative stress induced##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
oxidative stress involved in##2##4##(2008-10#1)(2013-1#1)
oxidative stress is a##2##4##(1995-6#1)(2008-5#1)
oxidative stress is##7##3##(1992-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-8#1)
oxidative stress levels##2##3##(2009-5#1)(2011-1#1)
oxidative stress markers in##2##4##(2010-5#1)(2011-2#1)
oxidative stress markers##6##3##(2010-5#1)(2011-2#2)(2012-5#2)(2013-1#1)
oxidative stress may##2##3##(1991-9#1)(1992-12#1)
oxidative stress of tumor cells##2##5##(2008-11#2)
oxidative stress of##3##3##(2008-11#2)(2008-5#1)
oxidative stress on##2##3##(1991-9#1)(2012-2#1)
oxidative stress responses##3##3##(2008-10#2)(2008-7#1)
oxidative stress that##2##3##(2008-5#1)(2012-12#1)
oxidative stress was##2##3##(2008-10#1)(2008-7#1)
oxidative stress were##3##3##(2011-2#1)(2011-3#1)(2013-8#1)
oxidative stress##215##2##(1991-12#2)(1991-2#1)(1991-9#4)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-2#1)(1993-6#2)(1994-2#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#3)(1995-6#2)(1996-9#4)(2007-7#1)(2008-1#6)(2008-10#24)(2008-11#8)(2008-3#7)(2008-4#2)(2008-5#21)(2008-7#20)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#5)(2009-12#5)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#4)(2011-1#4)(2011-2#13)(2011-3#2)(2012-1#5)(2012-12#3)(2012-2#7)(2012-3#2)(2012-5#5)(2013-1#9)(2013-7#2)(2013-8#5)
oxidative stress-induced##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
oxidative system##5##2##(2009-12#1)(2011-1#4)
oxidative##483##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#5)(1990-7#2)(1991-12#5)(1991-2#7)(1991-5#2)(1991-9#8)(1992-11#3)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#8)(1993-11#1)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#5)(1994-12#1)(1994-2#5)(1994-5#4)(1994-6#6)(1994-8#5)(1994-9#2)(1995-12#3)(1995-3#2)(1995-5#3)(1995-6#13)(1995-8#1)(1996-5#1)(1996-9#4)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2007-11#4)(2007-7#1)(2008-1#12)(2008-10#87)(2008-11#10)(2008-2#1)(2008-3#10)(2008-4#6)(2008-5#31)(2008-6#1)(2008-7#26)(2008-8#4)(2008-9#6)(2009-10#5)(2009-11#5)(2009-12#13)(2009-5#5)(2009-6#2)(2009-8#13)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#5)(2010-7#1)(2010-9#1)(2011-1#13)(2011-2#26)(2011-3#3)(2012-1#5)(2012-12#4)(2012-2#10)(2012-3#3)(2012-5#5)(2012-6#1)(2013-1#17)(2013-7#3)(2013-8#9)
oxidatively damaged##3##2##(1995-2#2)(1997-8#1)
oxidatively modified##2##2##(1993-6#1)(2012-2#1)
oxidatively##9##1##(1993-6#1)(1995-2#2)(1997-4#1)(1997-8#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
oxide (GO)##2##2##(2008-10#1)(2012-2#1)
oxide (ITO) electrode##2##3##(2008-10#1)(2010-5#1)
oxide (ITO)##9##2##(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-11#1)(2010-5#1)(2010-6#1)
oxide (NO) is a##2##4##(2008-7#1)(2009-10#1)
oxide (NO) is##5##3##(2008-10#2)(2008-7#1)(2009-10#1)(2010-7#1)
oxide (NO) production##5##3##(1994-11#1)(1995-11#1)(2008-10#1)(2010-4#1)(2012-3#1)
oxide (NO)##64##2##(1991-3#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
oxide (TOPO)##3##2##(2008-10#3)
oxide and the##2##3##(2008-10#1)(2008-11#1)
oxide and##36##2##(1991-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-4#4)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
oxide as a##3##3##(2008-10#3)
oxide as the##2##3##(1991-12#1)(2008-10#1)
oxide as##9##2##(1991-12#1)(2008-10#7)(2008-6#1)
oxide at##2##2##(2008-10#2)
oxide by##3##2##(1991-12#1)(1993-11#1)(2008-10#1)
oxide coated##4##2##(2008-10#1)(2008-3#1)(2008-8#2)
oxide content##3##2##(2008-10#2)(2010-5#1)
oxide electrodes##2##2##(2008-10#2)
oxide film##4##2##(2008-10#2)(2008-2#1)(2009-7#1)
oxide films##7##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#3)
oxide for##3##2##(1997-1#1)(2008-10#1)(2008-2#1)
oxide from##3##2##(1991-12#1)(2008-3#1)(2009-9#1)
oxide gas##2##2##(2009-12#2)
oxide has been##2##3##(2008-10#2)
oxide in##12##2##(1991-6#1)(1992-8#1)(1993-6#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
oxide is a##2##3##(1993-8#1)(2008-12#1)
oxide is##11##2##(1993-8#1)(1995-12#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)
oxide layer was##2##3##(2008-10#1)(2009-11#1)
oxide layer##5##2##(2007-11#1)(2008-10#3)(2009-11#1)
oxide layers##2##2##(2008-10#2)
oxide levels in##2##3##(2007-10#1)(2009-8#1)
oxide levels##4##2##(2007-10#3)(2009-8#1)
oxide materials##5##2##(2008-3#1)(2010-4#4)
oxide multilayer##2##2##(2007-12#1)(2010-4#1)
oxide multilayers##2##2##(2007-12#1)(2010-4#1)
oxide nanoparticles##11##2##(2008-10#1)(2008-7#2)(2009-8#2)(2012-12#2)(2012-2#1)(2013-1#3)
oxide or##2##2##(1992-3#1)(2007-11#1)
oxide particles##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
oxide pathway in##3##3##(1993-8#1)(1995-12#1)(2009-4#1)
oxide pathway##4##2##(1993-3#1)(1993-8#1)(1995-12#1)(2009-4#1)
oxide production from##2##3##(2008-11#1)(2008-6#1)
oxide production##14##2##(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#4)(2011-1#1)(2013-1#2)(2013-8#1)
oxide reductase from##3##3##(1992-3#1)(1992-8#2)
oxide reductase##4##2##(1992-3#2)(1992-8#2)
oxide stimulates the ADP-ribosylation of##2##5##(1993-3#2)
oxide stimulates##3##2##(1993-3#2)(1994-8#1)
oxide surface##3##2##(2008-10#1)(2009-11#2)
oxide surfaces##3##2##(1990-11#1)(2008-10#1)(2010-6#1)
oxide synthase (NOS)##12##3##(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#2)(1996-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-7#1)(2009-9#1)
oxide synthase inhibitors##2##3##(1992-3#1)(2009-4#1)
oxide synthase##52##2##(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#4)(1993-8#4)(1994-11#1)(1994-8#1)(1995-12#9)(1996-12#4)(1996-5#3)(1997-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-12#1)(2011-1#2)
oxide that##2##2##(2008-10#1)(2008-8#1)
oxide thicknesses of the diodes##2##5##(2008-3#2)
oxide using##4##2##(2008-10#4)
oxide was##5##2##(1992-6#1)(2008-10#2)(2008-12#1)(2010-2#1)
oxide with##5##2##(2008-10#4)(2008-3#1)
oxide##581##1##(1990-11#1)(1990-3#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#6)(1991-9#3)(1992-12#4)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#13)(1993-5#1)(1993-6#4)(1993-8#9)(1994-11#2)(1994-2#1)(1994-6#4)(1994-8#4)(1995-11#6)(1995-12#16)(1995-2#1)(1995-5#5)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#10)(1996-6#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#8)(1997-7#2)(2006-10#1)(2007-10#8)(2007-11#6)(2007-12#8)(2008-1#2)(2008-10#152)(2008-11#11)(2008-12#9)(2008-2#21)(2008-3#27)(2008-4#4)(2008-5#12)(2008-6#10)(2008-7#17)(2008-8#14)(2008-9#3)(2009-10#4)(2009-11#6)(2009-12#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#11)(2010-5#7)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2012-8#3)(2013-1#22)(2013-7#4)(2013-8#2)
oxide) (PEO)##2##2##(2008-10#1)(2008-5#1)
oxide)##17##1##(1994-12#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)
oxide-induced##2##1##(2008-7#1)(2013-7#1)
oxide-mediated##3##1##(1992-6#2)(2008-7#1)
oxides and##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
oxides have been##2##3##(2008-10#1)(2012-2#1)
oxides in the##3##3##(2008-10#3)
oxides in##4##2##(2008-10#3)(2012-2#1)
oxides##44##1##(1991-6#2)(1996-12#1)(2007-11#4)(2008-10#24)(2008-3#2)(2008-5#3)(2010-4#1)(2012-2#6)(2013-1#1)
oxidimetric##2##1##(2008-10#1)(2008-11#1)
oxidisable##3##1##(2008-10#3)
oxidised by##4##2##(1991-12#1)(2008-10#3)
oxidised in##2##2##(2008-10#2)
oxidised##17##1##(1990-5#1)(1991-12#1)(2008-10#14)(2008-11#1)
oxidises##3##1##(2008-10#3)
oxidising##3##1##(2008-10#3)
oxidizability##2##1##(1995-12#1)(2010-12#1)
oxidizable amino acids##3##3##(2008-10#3)
oxidizable molecules##2##2##(2008-10#2)
oxidizable species such as##2##4##(2008-10#2)
oxidizable species##5##2##(2008-10#5)
oxidizable##15##1##(1991-9#1)(2008-10#14)
oxidization of##2##2##(2008-10#2)
oxidization##3##1##(2008-10#3)
oxidize##16##1##(1992-3#1)(1993-12#1)(1994-6#1)(1995-12#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#2)(2013-1#2)
oxidized LDL##13##2##(1990-8#1)(1991-2#1)(1993-6#1)(1996-2#4)(1997-8#1)(2009-8#2)(2010-3#1)(2013-1#1)(2013-7#1)
oxidized LDL-induced##4##2##(1995-12#4)
oxidized Pdx##3##2##(1994-5#3)
oxidized R1##2##2##(1993-11#2)
oxidized and reduced##5##3##(1992-9#1)(1993-11#1)(2008-10#1)(2009-7#2)
oxidized and##9##2##(1992-3#2)(1992-9#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-7#2)
oxidized at potentials##2##3##(1990-8#1)(2008-10#1)
oxidized at##4##2##(1990-8#2)(2008-10#2)
oxidized by H(2)O(2) system containing Cu(2+)##2##6##(2008-10#2)
oxidized by the##3##3##(2008-10#2)(2010-12#1)
oxidized by##18##2##(1990-8#1)(1992-6#1)(2008-10#13)(2009-8#1)(2010-12#1)(2010-8#1)
oxidized form of##3##3##(1992-1#1)(2008-10#2)
oxidized form##5##2##(1992-1#1)(2008-10#3)(2008-11#1)
oxidized glutathione##8##2##(1991-9#1)(1994-9#2)(1995-12#1)(2008-11#2)(2008-4#1)(2011-2#1)
oxidized hemoglobin##3##2##(1990-8#3)
oxidized in##3##2##(2008-10#3)
oxidized insulin##2##2##(1994-6#1)(2008-10#1)
oxidized lipid##2##2##(2008-5#1)(2010-12#1)
oxidized low density lipoprotein##2##4##(1995-2#2)
oxidized low-density lipoprotein##2##3##(1993-6#1)(1996-2#1)
oxidized manganese##2##2##(2008-10#2)
oxidized mitochondrial pyridine nucleotides##2##4##(1994-8#2)
oxidized on the##2##3##(2008-10#1)(2010-5#1)
oxidized on##3##2##(2008-10#2)(2010-5#1)
oxidized product##2##2##(2008-10#2)
oxidized products##2##2##(1994-8#1)(2013-1#1)
oxidized species##2##2##(2008-10#2)
oxidized to nitrate##2##3##(2008-10#2)
oxidized to##23##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-12#2)(1997-7#1)(2008-10#15)(2008-11#1)(2013-1#1)
oxidized with##5##2##(2008-10#5)
oxidized##184##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#11)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-5#7)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#7)(1995-2#4)(1995-5#2)(1995-6#1)(1996-2#6)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#70)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2009-10#2)(2009-7#2)(2009-8#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
oxidizers##2##1##(1995-3#1)(2008-9#1)
oxidizes the##3##2##(1991-7#1)(2008-10#2)
oxidizes##7##1##(1991-7#1)(1996-2#1)(2008-10#4)(2011-2#1)
oxidizing agent is used##2##4##(2008-10#2)
oxidizing agent to##2##3##(2008-10#2)
oxidizing agent##13##2##(1996-5#1)(2008-10#11)(2012-3#1)
oxidizing agents##3##2##(2008-1#1)(2008-10#2)
oxidizing and##2##2##(2008-10#1)(2010-4#1)
oxidizing conditions##2##2##(2008-10#1)(2009-10#1)
oxidizing species##3##2##(1995-3#1)(1995-5#1)(2008-5#1)
oxidizing##39##1##(1991-9#1)(1992-9#1)(1995-3#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#24)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)
oxidoreductase (POR)##2##2##(1995-5#1)(2009-9#1)
oxidoreductase activity##3##2##(1990-11#1)(1992-8#1)(1993-3#1)
oxidoreductase from##3##2##(1993-11#1)(1994-11#1)(2008-6#1)
oxidoreductase##34##1##(1990-11#3)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#5)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#3)(1995-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#2)(2009-6#2)(2009-9#2)
oxidoreductases##4##1##(1994-6#1)(2008-10#2)(2009-9#1)
oxidoreduction##2##1##(1994-6#2)
oxidosqualene##2##1##(1992-8#2)
oximate oxygen from a symmetry-related [Cu(Hdmg)(dmg)](-) fragment##2##7##(1997-7#2)
oximate oxygens##2##2##(1997-7#2)
oximate##5##1##(1997-7#5)
oxime##8##1##(1996-5#3)(1997-7#1)(2008-10#2)(2013-1#2)
oximeter##5##1##(1993-1#1)(2008-3#3)(2013-1#1)
oximeters##2##1##(1995-3#1)(2008-3#1)
oximetry##13##1##(1993-1#4)(1997-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-4#1)
oxinate##2##1##(2008-10#2)
oxine and##2##2##(2008-10#2)
oxine##5##1##(2008-10#5)
oxine-impregnated##2##1##(2008-10#2)
oxo##2##1##(1997-7#1)(2008-10#1)
oxo-arsenosugar-phosphate##2##1##(2008-10#2)
oxo-transfer##2##1##(1996-2#1)(2012-12#1)
oxocarbenium ion##3##2##(1992-12#1)(2009-8#1)(2010-4#1)
oxoiron(IV)##4##1##(2012-12#4)
oxonium salt##2##2##(1996-2#2)
oxotremorine##5##1##(1993-12#3)(1995-12#1)(1997-7#1)
oxy- and chromanoxyl free radicals##2##5##(1991-2#2)
oxy-##3##1##(1991-2#2)(2007-10#1)
oxy-PAH##2##1##(2008-11#2)
oxy-sporum##2##1##(2008-10#2)
oxyR function##2##2##(2008-9#2)
oxyR##3##1##(2008-9#3)
oxyanion##2##1##(1991-3#1)(1992-3#1)
oxyanions##5##1##(1992-3#1)(2008-10#3)(2013-8#1)
oxybenzone and##2##2##(2008-5#2)
oxybenzone##5##1##(2008-5#5)
oxybutynin and tolterodine in##2##4##(2008-3#2)
oxybutynin and tolterodine##3##3##(2008-3#3)
oxybutynin##6##1##(2008-10#3)(2008-3#3)
oxychlorination##2##1##(2009-8#2)
oxychlorine species with chloride in the potential buffer##2##8##(2008-10#2)
oxychlorine species##5##2##(2008-10#5)
oxycocci and##2##2##(2008-10#2)
oxycocci##4##1##(2008-10#4)
oxycodone##2##1##(2007-5#1)(2010-4#1)
oxyethylene units##4##2##(1994-12#1)(2008-10#3)
oxyethylene##5##1##(1994-12#1)(2008-10#4)
oxygen (##3##2##(1995-5#1)(1997-7#1)(2008-10#1)
oxygen (1O2)##3##2##(1992-9#1)(2008-5#2)
oxygen (DO)##9##2##(2008-10#5)(2008-11#3)(2010-4#1)
oxygen (O2)##3##2##(1996-12#1)(2011-1#1)(2013-8#1)
oxygen A-band absorption##2##3##(2008-2#2)
oxygen affinity and##3##3##(1990-8#1)(1992-3#1)(1994-12#1)
oxygen affinity##12##2##(1990-7#2)(1990-8#6)(1992-3#1)(1994-12#1)(2013-8#2)
oxygen after##2##2##(1993-1#1)(1994-3#1)
oxygen and other##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
oxygen and the##3##3##(2008-10#2)(2010-2#1)
oxygen and water##2##3##(1994-3#1)(2007-11#1)
oxygen and##46##2##(1993-1#2)(1993-11#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-6#1)(2007-11#3)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-8#2)(2010-2#1)(2011-2#2)(2013-8#1)
oxygen as the##3##3##(1990-7#1)(2008-3#2)
oxygen as##6##2##(1990-7#2)(2008-10#1)(2008-3#2)(2010-4#1)
oxygen at##8##2##(1992-2#1)(1993-12#2)(1994-8#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-7#1)
oxygen atom of##5##3##(1991-3#1)(1993-8#1)(1996-5#2)(2008-8#1)
oxygen atom##9##2##(1991-3#1)(1993-8#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-4#1)(2008-8#1)(2013-8#1)
oxygen atoms##18##2##(1990-9#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-7#4)(2007-11#2)(2008-10#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#3)
oxygen availability in the##2##4##(1995-12#1)(2013-8#1)
oxygen availability##5##2##(1995-12#1)(2008-7#1)(2012-2#2)(2013-8#1)
oxygen binding to##5##3##(1990-8#4)(1993-8#1)
oxygen binding##13##2##(1990-8#5)(1993-8#2)(1994-5#1)(2009-9#1)(2010-11#1)(2013-8#3)
oxygen but##2##2##(1993-12#1)(2008-9#1)
oxygen by##2##2##(1992-11#1)(1994-5#1)
oxygen carriers##2##2##(2008-10#1)(2008-11#1)
oxygen concentration in##2##3##(2008-3#1)(2008-7#1)
oxygen concentration##10##2##(1995-6#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#2)(2011-2#1)
oxygen concentrations##4##2##(1995-6#1)(1997-4#1)(2007-8#1)(2008-10#1)
oxygen conditions##2##2##(1995-5#1)(2008-10#1)
oxygen consumption and##3##3##(2007-12#1)(2008-4#1)(2013-1#1)
oxygen consumption by##2##3##(1997-1#1)(2008-5#1)
oxygen consumption in the##2##4##(1995-6#1)(1997-1#1)
oxygen consumption in##4##3##(1995-6#1)(1997-1#2)(2008-7#1)
oxygen consumption##25##2##(1991-3#1)(1991-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#2)(2013-1#1)(2013-8#3)
oxygen consumption)##2##2##(1996-5#1)(2013-8#1)
oxygen content##5##2##(1994-12#1)(2006-10#1)(2008-10#2)(2009-7#1)
oxygen deficiency##4##2##(1992-5#1)(1995-11#1)(2007-12#1)(2011-2#1)
oxygen delivery and##2##3##(1996-3#1)(2010-11#1)
oxygen delivery in##3##3##(1996-3#1)(2008-6#1)(2012-3#1)
oxygen delivery to the tissues##2##5##(1996-3#1)(2010-7#1)
oxygen delivery##10##2##(1991-9#1)(1992-2#1)(1996-3#3)(2008-6#1)(2010-11#1)(2010-7#1)(2012-2#1)(2012-3#1)
oxygen demand (BOD)##2##3##(2008-10#2)
oxygen demand##18##2##(2008-10#14)(2008-6#2)(2011-2#1)(2013-1#1)
oxygen demands##2##2##(1991-3#1)(2008-11#1)
oxygen desaturation (SpO2##2##3##(1993-1#2)
oxygen desaturation##3##2##(1993-1#2)(2007-12#1)
oxygen diffusion##3##2##(2008-3#1)(2008-7#1)(2010-4#1)
oxygen during##2##2##(1991-9#1)(2006-10#1)
oxygen electrode##7##2##(1992-11#1)(1995-3#1)(2008-10#5)
oxygen equilibrium curves for##2##4##(1990-8#1)(1993-8#1)
oxygen equilibrium curves##4##3##(1990-8#3)(1993-8#1)
oxygen equilibrium##6##2##(1990-8#3)(1993-8#3)
oxygen evolution##2##2##(1997-4#1)(2008-6#1)
oxygen exchange##2##2##(1995-5#1)(2007-12#1)
oxygen extraction fraction##2##3##(2007-10#1)(2008-7#1)
oxygen flow##2##2##(2008-10#1)(2010-10#1)
oxygen for##10##2##(1993-1#1)(1993-11#1)(1993-12#1)(1994-6#1)(1996-5#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-8#1)(2012-3#1)
oxygen free radical##3##3##(1991-9#1)(2008-8#1)(2011-3#1)
oxygen free radicals and##2##4##(1995-8#1)(1996-2#1)
oxygen free radicals##10##3##(1991-9#2)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-9#1)(2008-4#1)
oxygen free##13##2##(1991-9#3)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-9#1)(2008-4#1)(2008-8#1)(2011-3#1)
oxygen from##3##2##(1997-7#2)(2008-10#1)
oxygen gas##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
oxygen generation##3##2##(1994-8#1)(2008-7#1)(2009-4#1)
oxygen in a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
oxygen in the##8##3##(1990-11#2)(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)
oxygen in##21##2##(1990-11#2)(1994-5#1)(1995-8#1)(2007-10#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-7#1)(2009-2#1)(2012-12#2)
oxygen is##6##2##(1990-7#1)(1990-8#1)(1995-2#1)(2008-10#2)(2008-5#1)
oxygen level##5##2##(1996-3#1)(2008-10#3)(2011-2#1)
oxygen levels##3##2##(1994-3#1)(2009-11#1)(2010-7#1)
oxygen limitation##2##2##(2008-11#1)(2008-6#1)
oxygen metabolism##7##2##(2006-7#1)(2007-10#2)(2008-10#1)(2008-5#1)(2008-7#2)
oxygen metabolites##7##2##(1991-9#1)(1993-6#2)(2012-12#3)(2012-3#1)
oxygen molecule##4##2##(1991-9#1)(1993-8#1)(2008-10#1)(2009-12#1)
oxygen molecules##4##2##(1990-8#2)(2008-10#1)(2013-8#1)
oxygen of the##2##3##(1993-11#1)(1996-2#1)
oxygen of##6##2##(1991-3#1)(1992-6#1)(1993-11#1)(1996-2#2)(1996-5#1)
oxygen on the##2##3##(2008-10#2)
oxygen on##6##2##(1995-3#1)(2008-10#3)(2008-3#1)(2008-9#1)
oxygen or##5##2##(1994-5#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
oxygen partial pressure##10##3##(2007-12#1)(2008-11#6)(2010-8#1)(2013-8#2)
oxygen partial##11##2##(1990-8#1)(2007-12#1)(2008-11#6)(2010-8#1)(2013-8#2)
oxygen persufflation##7##2##(2007-8#7)
oxygen plus##2##2##(2011-2#2)
oxygen pressure##6##2##(2008-11#1)(2008-2#2)(2010-10#1)(2013-1#2)
oxygen products##3##2##(1991-9#2)(2008-4#1)
oxygen quenching of##2##3##(2008-10#2)
oxygen quenching##3##2##(2008-10#2)(2008-3#1)
oxygen radical##4##2##(1991-9#1)(1996-9#1)(2008-10#1)(2008-7#1)
oxygen radicals and##2##3##(1993-8#1)(2010-7#1)
oxygen radicals##16##2##(1990-5#1)(1991-9#3)(1992-11#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-2#3)(1996-9#1)(2008-5#1)(2008-8#2)(2010-7#1)
oxygen reactivity##2##2##(1995-5#2)
oxygen rebound mechanism##2##3##(1997-7#2)
oxygen removal##2##2##(2008-10#2)
oxygen requirement##2##2##(1992-11#1)(1992-2#1)
oxygen rich##2##2##(2011-1#2)
oxygen saturation of##3##3##(2008-3#2)(2010-7#1)
oxygen saturation##23##2##(1993-1#2)(1996-3#1)(2008-3#7)(2008-7#1)(2009-11#1)(2009-4#1)(2010-10#4)(2010-5#1)(2010-7#2)(2010-8#2)(2012-2#1)
oxygen scavenger to##2##3##(2008-10#2)
oxygen sensing##8##2##(2008-10#7)(2008-11#1)
oxygen sensor was##2##3##(2008-10#2)
oxygen sensor##3##2##(2008-10#3)
oxygen species (ROS) is##2##4##(2009-8#1)(2011-1#1)
oxygen species (ROS)##55##3##(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(2006-10#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-6#1)(2013-1#1)(2013-8#2)
oxygen species are##3##3##(1991-9#2)(2008-11#1)
oxygen species have been##3##4##(1994-6#1)(2008-10#1)(2009-6#1)
oxygen species in##8##3##(1991-9#1)(1994-6#1)(1995-8#1)(1997-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)
oxygen species##126##2##(1990-11#1)(1991-9#6)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#4)(1995-8#1)(1996-9#1)(1997-4#2)(2006-10#1)(2008-1#5)(2008-10#19)(2008-11#10)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#6)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-10#1)(2011-2#8)(2012-1#1)(2012-2#3)(2012-6#1)(2013-1#5)(2013-8#5)
oxygen supply in##2##3##(2008-11#1)(2009-11#1)
oxygen supply is##2##3##(1996-3#1)(2008-6#1)
oxygen supply##8##2##(1996-3#2)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-1#1)
oxygen tension and##2##3##(2008-7#1)(2011-1#1)
oxygen tension of##3##3##(2007-2#1)(2008-11#1)(2011-2#1)
oxygen tension##16##2##(1991-2#1)(1994-3#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-11#3)(2008-7#2)(2008-9#2)(2011-1#2)(2011-2#2)
oxygen therapy in##3##3##(2008-8#3)
oxygen therapy##14##2##(1991-6#1)(2006-10#1)(2008-1#2)(2008-8#5)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
oxygen to##8##2##(1990-8#1)(1993-3#1)(1995-2#1)(2008-10#2)(2008-3#2)(2009-11#1)
oxygen transfer coefficient##2##3##(2008-11#1)(2008-6#1)
oxygen transfer##8##2##(1994-11#1)(2008-11#4)(2008-6#1)(2008-7#2)
oxygen transport##2##2##(2008-5#1)(2008-6#1)
oxygen uptake and carbon dioxide production rates##3##7##(2008-11#3)
oxygen uptake and carbon dioxide##6##5##(2008-11#6)
oxygen uptake and##8##3##(2008-11#6)(2008-7#1)(2013-8#1)
oxygen uptake between the estimation and production##2##7##(2013-8#2)
oxygen uptake in##2##3##(2008-12#1)(2013-8#1)
oxygen uptake rate (OUR)##3##4##(2008-11#1)(2008-7#2)
oxygen uptake rate##7##3##(2008-11#4)(2008-7#3)
oxygen uptake##40##2##(2008-10#1)(2008-11#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2013-1#1)(2013-8#17)
oxygen utilization##5##2##(1990-5#3)(2008-7#1)(2012-2#1)
oxygen was##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
oxygen were##2##2##(2008-3#1)(2009-2#1)
oxygen with a##2##3##(2008-10#1)(2009-2#1)
oxygen with##5##2##(2008-10#3)(2008-11#1)(2009-2#1)
oxygen##917##1##(1990-11#4)(1990-12#3)(1990-5#8)(1990-7#8)(1990-8#22)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-6#2)(1991-9#23)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#11)(1993-11#4)(1993-12#14)(1993-3#5)(1993-6#4)(1993-8#9)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#6)(1994-6#5)(1994-8#6)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#7)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#8)(1996-2#9)(1996-3#9)(1996-5#8)(1996-6#1)(1996-9#4)(1997-1#5)(1997-3#1)(1997-4#5)(1997-7#12)(2006-10#5)(2006-7#1)(2007-10#4)(2007-11#9)(2007-12#11)(2007-2#1)(2007-8#10)(2008-1#9)(2008-10#177)(2008-11#54)(2008-12#1)(2008-2#15)(2008-3#41)(2008-4#7)(2008-5#23)(2008-6#16)(2008-7#43)(2008-8#13)(2008-9#9)(2009-10#1)(2009-11#4)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#8)(2010-11#6)(2010-12#3)(2010-2#3)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#11)(2011-10#1)(2011-2#28)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#13)(2012-3#5)(2012-6#1)(2013-1#13)(2013-7#2)(2013-8#43)
oxygen)##4##1##(1993-8#1)(1994-8#1)(2008-10#2)
oxygen-##2##1##(1990-7#1)(2010-5#1)
oxygen-17##7##1##(1990-5#7)
oxygen-atom concentrations##2##2##(2008-3#2)
oxygen-binding behavior of the 24-meric##2##5##(1990-8#2)
oxygen-binding data##4##2##(1990-8#4)
oxygen-binding##12##1##(1990-8#11)(2010-4#1)
oxygen-dependent##3##1##(1991-3#1)(1993-6#1)(1995-5#1)
oxygen-derived free radicals and##2##4##(1995-8#1)(2008-10#1)
oxygen-derived free radicals are##2##4##(2010-10#2)
oxygen-derived free radicals##8##3##(1995-8#1)(1996-9#1)(2008-10#1)(2010-10#2)(2010-3#3)
oxygen-derived##9##1##(1995-8#1)(1996-2#1)(1996-9#1)(2008-10#1)(2010-10#2)(2010-3#3)
oxygen-evolving activity of##2##3##(1997-4#2)
oxygen-evolving center##2##2##(2008-8#2)
oxygen-evolving complex##2##2##(1996-10#2)
oxygen-evolving##6##1##(1996-10#2)(1997-4#2)(2008-8#2)
oxygen-free##2##1##(1993-11#1)(1996-2#1)
oxygen-glucose deprivation or NMDA##2##4##(1996-6#2)
oxygen-induced##3##1##(1993-12#1)(2008-10#1)(2010-7#1)
oxygen-ozone therapy##2##2##(2007-10#2)
oxygen-rich##4##1##(2008-10#1)(2008-11#2)(2011-2#1)
oxygen-sensitive dye ion-pair##2##3##(2008-10#2)
oxygen-sensitive##6##1##(1997-1#1)(2008-10#5)
oxygen-sensitivity of optical sensor using pyrene carboxylic acid##2##8##(2008-10#2)
oxygen-sensitivity##3##1##(2008-10#3)
oxygenase domain##2##2##(2008-10#1)(2009-9#1)
oxygenase##11##1##(1993-6#1)(1994-11#1)(1994-5#2)(1995-2#1)(2008-10#1)(2008-4#2)(2009-9#1)(2010-10#1)(2012-1#1)
oxygenase-1##5##1##(2008-10#1)(2011-2#2)(2013-1#1)(2013-7#1)
oxygenate##2##1##(2007-8#1)(2008-10#1)
oxygenated and##2##2##(2008-11#1)(2011-1#1)
oxygenated##19##1##(1990-8#2)(1991-3#1)(1993-8#1)(1994-6#1)(1995-5#4)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-6#1)(2011-1#1)(2011-2#1)
oxygenates##3##1##(2008-10#1)(2008-11#1)(2010-12#1)
oxygenation and vascularization##2##3##(2008-11#2)
oxygenation and##6##2##(1994-6#3)(2008-11#2)(2010-7#1)
oxygenation during##3##2##(1995-12#1)(2011-2#2)
oxygenation dynamics of tumors##2##4##(2008-3#2)
oxygenation is##2##2##(1995-5#2)
oxygenation of##4##2##(1995-5#1)(1995-6#1)(2008-3#1)(2008-8#1)
oxygenation status##2##2##(1995-9#1)(2008-11#1)
oxygenation##49##1##(1990-8#5)(1991-2#1)(1992-1#1)(1992-4#1)(1994-6#3)(1995-12#1)(1995-5#4)(1995-6#1)(1995-9#2)(1996-3#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-8#4)(2008-11#5)(2008-3#5)(2008-8#2)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-3#3)
oxygenation)##2##1##(2008-10#1)(2008-11#1)
oxygenic photosynthesis##2##2##(1995-6#1)(1996-12#1)
oxygens from##2##2##(1997-7#2)
oxygens##6##1##(1995-5#1)(1997-7#3)(2008-10#2)
oxyhalides and##3##2##(2008-10#3)
oxyhalides##4##1##(2008-10#4)
oxyhemoglobin##8##1##(1990-8#3)(1993-1#1)(1995-5#1)(1997-2#1)(2008-11#2)
oxymatrine##3##1##(2008-10#2)(2013-8#1)
oxymetazoline and##3##2##(1995-11#1)(2008-10#2)
oxymetazoline##7##1##(1995-11#5)(2008-10#2)
oxymethylene##2##1##(2009-2#2)
oxyntic##2##1##(2009-3#2)
oxysporum Fo 90105##2##3##(2008-10#2)
oxysporum and F##3##3##(2008-10#3)
oxysporum and##9##2##(2008-10#9)
oxysporum based on##2##3##(2008-10#2)
oxysporum complex was##2##3##(2008-10#2)
oxysporum complex##5##2##(2008-10#5)
oxysporum expressing##2##2##(2008-10#2)
oxysporum f##198##2##(2008-10#198)
oxysporum from##5##2##(2008-10#5)
oxysporum in the##2##3##(2008-10#2)
oxysporum in##6##2##(1997-4#1)(2008-10#5)
oxysporum isolates##4##2##(2008-10#4)
oxysporum strain##2##2##(2008-10#2)
oxysporum were##3##2##(2008-10#3)
oxysporum##281##1##(1997-4#1)(2008-10#280)
oxysterols##3##1##(1993-6#3)
oxytetracycline (OTC)##4##2##(2008-10#4)
oxytetracycline and##4##2##(1996-6#2)(2008-10#2)
oxytetracycline treatment##2##2##(1996-6#2)
oxytetracycline##17##1##(1991-3#2)(1996-6#5)(2008-10#10)
oxytoca##5##1##(1993-9#1)(2008-8#1)(2010-4#1)(2010-6#2)
oxytocin and aluminum##2##3##(1994-11#2)
oxytocin and angiotensin##3##3##(1994-3#3)
oxytocin and##8##2##(1994-11#2)(1994-3#3)(1994-9#1)(1997-4#2)
oxytocin challenge test##2##3##(2011-2#2)
oxytocin gene##6##2##(1991-2#2)(1992-11#4)
oxytocin genes##2##2##(1991-2#2)
oxytocin##34##1##(1991-2#4)(1992-11#4)(1993-12#1)(1994-11#2)(1994-3#3)(1994-9#3)(1995-12#1)(1996-11#1)(1996-12#3)(1997-4#7)(2008-4#2)(2008-5#1)(2011-2#2)
oyster tissue##4##2##(2008-10#4)
oyster##12##1##(1997-4#4)(2008-10#5)(2008-11#2)(2008-7#1)
oysters from##2##2##(1997-4#1)(2008-7#1)
ozonated##4##1##(1992-5#3)(2008-10#1)
ozonation and##2##2##(1992-5#2)
ozonation of##2##2##(1992-5#1)(2008-9#1)
ozonation process##2##2##(2008-10#2)
ozonation products##2##2##(1992-5#2)
ozonation treatment##2##2##(2008-10#1)(2010-5#1)
ozonation were##2##2##(1992-5#1)(2008-10#1)
ozonation##22##1##(1992-5#7)(2008-10#8)(2008-9#1)(2010-5#2)(2013-1#4)
ozone (O(3))##3##2##(2008-2#2)(2008-5#1)
ozone -##3##2##(2007-11#2)(2007-8#1)
ozone absorption##2##2##(2008-2#1)(2008-3#1)
ozone abundances##6##2##(2008-2#6)
ozone amounts##2##2##(2008-2#2)
ozone and water vapor##2##4##(2008-3#2)
ozone and##8##2##(1992-3#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#3)
ozone as##3##2##(2008-10#2)(2008-3#1)
ozone can##2##2##(1992-3#1)(2008-3#1)
ozone concentration profiles by##2##4##(2008-3#2)
ozone concentration profiles##3##3##(2008-3#3)
ozone concentration##6##2##(2008-10#2)(2008-3#4)
ozone correction##2##2##(2008-3#2)
ozone depleting##2##2##(1992-3#1)(1996-1#1)
ozone depletion##4##2##(1991-5#1)(1991-6#1)(1992-3#1)(1996-1#1)
ozone destruction##6##2##(2012-2#6)
ozone differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
ozone exposure##2##2##(1992-3#1)(2008-10#1)
ozone has##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
ozone hole##4##2##(1991-5#2)(2012-2#2)
ozone in##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#1)
ozone is##4##2##(2008-10#3)(2008-2#1)
ozone layer and##2##3##(1991-6#2)
ozone layer##6##2##(1991-6#3)(1996-1#3)
ozone levels##2##2##(2008-10#1)(2008-11#1)
ozone lidar##3##2##(2008-3#3)
ozone losses##2##2##(1991-5#2)
ozone measurements and##2##3##(2008-2#1)(2008-3#1)
ozone measurements in clouds##2##4##(2008-3#2)
ozone measurements in the##2##4##(2008-3#2)
ozone measurements in##6##3##(2008-3#6)
ozone measurements##13##2##(2008-2#3)(2008-3#10)
ozone monitoring##6##2##(2008-10#3)(2008-2#2)(2008-3#1)
ozone on##3##2##(1992-3#2)(2008-5#1)
ozone profile##5##2##(2008-2#2)(2008-3#3)
ozone profiles##9##2##(2008-2#5)(2008-3#4)
ozone retrieval##5##2##(2008-2#5)
ozone retrievals##3##2##(2008-2#3)
ozone therapy has been##2##4##(2007-11#1)(2012-2#1)
ozone therapy was##2##3##(2007-11#1)(2007-8#1)
ozone therapy##7##2##(2007-11#4)(2007-8#1)(2008-7#1)(2012-2#1)
ozone to##3##2##(2008-10#1)(2008-3#2)
ozone was##2##2##(2007-11#1)(2008-10#1)
ozone##204##1##(1991-12#1)(1991-5#6)(1991-6#4)(1991-9#3)(1992-3#12)(1995-3#1)(1996-1#8)(2007-10#1)(2007-11#9)(2007-12#1)(2007-8#6)(2008-10#35)(2008-11#8)(2008-2#48)(2008-3#43)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#10)(2013-1#2)(2013-8#1)
ozone-column density##3##2##(2008-3#3)
ozonide##2##1##(1996-5#2)
ozonides##7##1##(1996-5#7)
ozonolysis of norbornene derivatives##2##4##(1996-5#2)
ozonolysis##3##1##(1992-12#1)(1996-5#2)
p &gt##5##2##(2011-2#4)(2013-8#1)
p &lt##191##2##(1992-12#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#4)(1995-12#1)(1995-5#2)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#1)(1997-1#1)(1997-2#5)(1997-3#6)(2006-10#2)(2007-12#1)(2007-6#3)(2007-8#1)(2008-1#9)(2008-10#6)(2008-11#5)(2008-12#5)(2008-3#19)(2008-4#1)(2008-5#11)(2008-7#6)(2008-8#3)(2008-9#7)(2009-11#2)(2009-5#1)(2009-6#3)(2009-8#5)(2010-2#4)(2010-8#7)(2011-1#3)(2011-2#18)(2012-12#3)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#10)
p -/+ 0##2##3##(2008-11#2)
p 0##3##2##(1995-9#2)(2010-11#1)
p 1##7##2##(2010-5#2)(2012-2#5)
p = &lt##2##3##(2008-4#1)(2010-12#1)
p = 0##135##3##(1991-11#1)(1991-3#3)(1991-8#4)(1992-2#5)(1993-2#6)(1994-9#5)(1995-9#4)(1996-1#1)(1996-9#2)(1997-2#2)(1997-8#1)(2006-10#2)(2007-11#3)(2007-7#2)(2008-1#5)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#8)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2010-2#2)(2010-3#4)(2010-9#3)(2011-1#2)(2011-2#29)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#4)
p =##148##2##(1991-11#1)(1991-3#3)(1991-8#4)(1992-2#5)(1992-6#1)(1993-2#6)(1994-9#5)(1995-9#4)(1996-1#1)(1996-9#2)(1997-2#2)(1997-8#1)(2006-10#2)(2007-11#3)(2007-7#2)(2008-1#5)(2008-10#2)(2008-11#8)(2008-12#2)(2008-3#10)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-9#3)(2011-1#2)(2011-2#29)(2012-12#2)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#4)
p =0##2##2##(1997-2#1)(2008-11#1)
p K (a##4##3##(2008-10#4)
p and the##2##3##(2008-10#1)(2010-8#1)
p and##7##2##(1996-12#1)(2007-12#1)(2008-10#3)(2010-3#1)(2010-8#1)
p instruments##3##2##(1997-8#3)
p less than 0##35##4##(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-3#1)(1991-4#4)(1991-5#1)(1991-9#7)(1992-12#3)(1992-2#3)(1992-9#2)
p less than##40##3##(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#1)(1990-6#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-4#4)(1991-5#1)(1991-9#7)(1992-12#3)(1992-2#3)(1992-9#2)
p of##3##2##(2008-10#2)(2008-3#1)
p polarization##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
p polarized##2##2##(2007-12#1)(2008-2#1)
p value was##2##3##(1990-12#1)(1994-9#1)
p values &lt##3##3##(2008-3#2)(2011-2#1)
p values##5##2##(1995-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
p ≤ 0##3##3##(2013-8#3)
p ≥ 0##2##3##(2013-8#2)
p##718##1##(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-11#4)(1991-2#3)(1991-3#4)(1991-4#4)(1991-5#1)(1991-8#8)(1991-9#7)(1992-12#10)(1992-2#8)(1992-3#5)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#6)(1993-12#2)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#3)(1994-5#4)(1994-6#5)(1994-7#4)(1994-8#8)(1994-9#6)(1995-1#1)(1995-11#3)(1995-12#29)(1995-2#1)(1995-3#3)(1995-5#4)(1995-9#6)(1996-1#4)(1996-12#8)(1996-2#20)(1996-3#5)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#13)(1997-3#7)(1997-4#6)(1997-6#3)(1997-7#6)(1997-8#4)(2006-10#5)(2006-4#2)(2007-11#11)(2007-12#11)(2007-6#5)(2007-7#2)(2007-8#1)(2008-1#14)(2008-10#45)(2008-11#27)(2008-12#15)(2008-2#1)(2008-3#44)(2008-4#4)(2008-5#27)(2008-6#1)(2008-7#20)(2008-8#5)(2008-9#10)(2009-11#2)(2009-3#2)(2009-5#4)(2009-6#4)(2009-8#5)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#5)(2010-5#10)(2010-7#2)(2010-8#11)(2010-9#3)(2011-1#5)(2011-2#60)(2012-12#5)(2012-2#12)(2012-3#8)(2013-1#29)(2013-7#4)(2013-8#20)
p&gt##8##1##(1996-12#1)(1997-7#2)(2008-9#1)(2009-1#1)(2011-1#2)(2013-1#1)
p&lt##115##1##(1994-12#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-6#13)(2010-8#1)(2010-9#4)(2011-1#12)(2011-2#2)(2012-1#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#7)(2013-8#9)
p'-DBP)##2##1##(2008-10#2)
p'-DDD##3##1##(2008-10#3)
p'-DDE##3##1##(2008-10#3)
p'-DDT and p##2##3##(2008-10#2)
p'-DDT and##5##2##(2008-10#2)(2008-11#3)
p'-DDT##9##1##(2008-10#5)(2008-11#4)
p'-DDT)##2##1##(2008-10#2)
p(low)##5##1##(2008-10#5)
p(m(H)) values##2##2##(2008-10#2)
p(t)##3##1##(2008-10#3)
p(tPA/PAZoA)##2##1##(2008-10#2)
p) basis set##2##3##(2013-1#2)
p)##8##1##(2008-10#1)(2009-9#1)(2010-1#1)(2013-1#5)
p- and s-polarized##2##3##(2008-2#1)(2008-3#1)
p- and##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
p-(dimethylamino)benzaldehyde (DAB) and p-nitrobenzaldehyde (NB)##2##5##(2008-10#2)
p-CMBS##4##1##(1992-6#4)
p-CPA##2##1##(1993-3#2)
p-IPPA##3##1##(1992-10#3)
p-NCC6F4C6F4CNSSN*##2##1##(2007-11#2)
p-NF-kBp65 (Ser 536)##4##3##(2010-3#4)
p-NF-kBp65##7##1##(2010-3#7)
p-aminoacetophenone##5##1##(2008-10#5)
p-aminobenzenesulfonate)-thiourea##2##1##(2008-10#2)
p-aminobenzoate in##2##2##(2008-10#2)
p-aminobenzoate##4##1##(2008-10#3)(2012-3#1)
p-aminobenzoic acid##4##2##(2008-10#3)(2008-5#1)
p-aminohippurate##2##1##(1994-5#1)(2008-1#1)
p-aminophenol##8##1##(1995-11#1)(2008-10#7)
p-aminophenyl##2##1##(2008-10#1)(2009-12#1)
p-benzoquinone (PBQ)##2##2##(2008-10#2)
p-benzoquinone##5##1##(2008-10#5)
p-bromophenacyl##2##1##(1994-3#1)(2009-8#1)
p-chloranil##2##1##(2008-10#2)
p-chlorophenylalanine##2##1##(1992-11#1)(1993-12#1)
p-coumaric acid and##2##3##(2008-10#2)
p-coumaric acid##4##2##(2008-10#3)(2008-11#1)
p-coumaric##5##1##(2008-10#4)(2008-11#1)
p-cresol and##2##2##(1996-5#1)(2011-1#1)
p-cresol##13##1##(1990-8#1)(1991-5#3)(1996-5#1)(2008-10#3)(2011-1#2)(2011-2#3)
p-cyclophane as##2##2##(2008-10#2)
p-cymene##2##1##(2008-11#1)(2012-2#1)
p-dichlorobenzene##2##1##(2008-10#2)
p-dimensional##2##1##(2012-1#2)
p-dimethylaminobenzalhyde##2##1##(2008-10#2)
p-hydroxy-m-methoxyscopolamine##2##1##(2008-10#2)
p-hydroxybenzaldehyde##3##1##(1992-5#2)(2008-10#1)
p-hydroxybenzoic##2##1##(2008-10#2)
p-i-n##2##1##(2008-2#2)
p-iodophenol##4##1##(1991-5#1)(2008-10#3)
p-methoxyanilino-(1##2##1##(2008-10#2)
p-methoxybenzyl##2##1##(1997-4#1)(2008-11#1)
p-nitroanilide##3##1##(1990-7#2)(1995-5#1)
p-nitrobenzoxosulfamate##2##1##(2008-10#2)
p-nitrobenzoyl group##2##2##(1991-12#2)
p-nitrophenol##8##1##(1991-5#2)(1995-3#1)(2008-10#1)(2008-8#2)(2009-8#2)
p-nitrophenyl##6##1##(1990-7#1)(1995-2#1)(1997-4#1)(2008-10#2)(2011-1#1)
p-nitrophenylphosphate as##2##2##(1991-5#1)(2008-10#1)
p-nitrophenylphosphate##4##1##(1991-5#1)(1994-6#1)(2008-10#2)
p-order##2##1##(2008-3#2)
p-polarized light##4##2##(2008-2#1)(2008-3#3)
p-polarized##11##1##(1993-5#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)
p-quinone##2##1##(2008-10#2)
p-substituted N-phenylsulfonylbenzamides##3##2##(2007-11#3)
p-t-butyl calix[4]arene and ethyl bromoacetate##2##5##(2008-10#2)
p-tert-butyl-calix[6]arene-bonded silica gel stationary phase##2##5##(2008-10#2)
p-tert-butyl-calix[8]arene##2##1##(2008-10#2)
p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##6##5##(2008-10#6)
p-tert-butylcalix[4]arene-oxacrown-4##3##1##(2008-10#3)
p-toluenesulfonic acid##5##2##(1996-5#1)(2008-10#2)(2008-5#1)(2009-9#1)
p-toluenesulfonic##6##1##(1996-5#1)(2008-10#3)(2008-5#1)(2009-9#1)
p-type##6##1##(2007-11#1)(2008-10#1)(2009-11#1)(2012-2#1)(2013-8#2)
p-value &lt##3##2##(2011-1#2)(2013-1#1)
p-value##5##1##(2008-8#1)(2011-1#2)(2012-3#1)(2013-1#1)
p-values##4##1##(1994-11#1)(1996-6#1)(2009-11#1)(2012-3#1)
p-xylene##5##1##(2008-10#5)
p1##2##1##(2008-9#2)
p10 promoters##2##2##(1997-4#2)
p10##6##1##(1995-12#1)(1997-4#5)
p101 and##2##2##(1996-2#2)
p101##4##1##(1996-2#4)
p107wee1##4##1##(1991-2#4)
p11##6##1##(1991-6#6)
p115-RhoGEF##2##1##(2008-6#2)
p117 and##2##2##(1996-2#2)
p120 protein##2##2##(1990-11#2)
p120##10##1##(1990-11#6)(1996-2#4)
p123##2##1##(1997-6#2)
p130(Cas)##2##1##(2012-12#2)
p130Cas SD tyrosine phosphorylation##2##4##(2011-1#2)
p130Cas##12##1##(2011-1#9)(2012-12#3)
p150Glued##9##1##(1995-2#9)
p16 expression##3##2##(1997-7#1)(2013-1#2)
p16##8##1##(1997-7#3)(2011-2#1)(2012-3#1)(2013-1#3)
p16(INK4A)##7##1##(2013-1#7)
p16INK4A##7##1##(1997-7#7)
p16INK4a and p16beta transcripts in B-lymphoblastoid cells from##2##8##(1997-7#2)
p16INK4a and p16beta transcripts##3##4##(1997-7#3)
p16INK4a##7##1##(1997-7#7)
p16beta##4##1##(1997-7#4)
p16ink4a##2##1##(2013-8#2)
p17##2##1##(1990-2#2)
p185HER2 overexpression##2##2##(1993-1#2)
p185HER2##5##1##(1993-1#4)(1995-2#1)
p185HER2-overexpressing breast cancer cells##2##4##(1995-2#2)
p185HER2-overexpressing##4##1##(1995-2#4)
p185erbB2##3##1##(1995-2#3)
p20##6##1##(1990-5#1)(2008-10#2)(2008-9#3)
p21 and Gadd45##2##3##(2008-9#2)
p21 and##5##2##(1990-9#1)(2008-11#1)(2008-9#2)(2010-6#1)
p21 expression##2##2##(1995-6#1)(2011-2#1)
p21 protein is known to##2##5##(1991-12#2)
p21 protein is##3##3##(1991-12#2)(1997-7#1)
p21 protein##6##2##(1991-12#5)(1997-7#1)
p21 repression##2##2##(1995-6#2)
p21##36##1##(1990-9#1)(1991-12#7)(1991-5#2)(1995-6#7)(1997-7#3)(2008-11#1)(2008-7#3)(2008-9#4)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#1)
p21(Sdi1/CIP1/WAF1)##2##1##(2008-11#2)
p21(as)/MCF-7##2##1##(2008-9#2)
p21cip1##3##1##(1994-8#1)(2013-1#2)
p21ras GTPase-activating protein##2##3##(1992-12#2)
p21ras##11##1##(1992-12#7)(1993-11#1)(1993-8#2)(1994-12#1)
p22phox##3##1##(2013-8#3)
p23 and p7##7##3##(1992-6#7)
p23##11##1##(1992-6#8)(2008-10#3)
p24##10##1##(1993-8#1)(1995-5#1)(1997-3#1)(1997-4#3)(2011-1#3)(2011-3#1)
p25##2##1##(1990-2#1)(2008-10#1)
p27##8##1##(2008-11#1)(2008-7#3)(2011-2#3)(2012-12#1)
p27rex##3##1##(1991-2#3)
p29##4##1##(1990-11#4)
p30##2##1##(1992-9#1)(2012-3#1)
p300##3##1##(2011-2#3)
p34##8##1##(1994-8#8)
p34cdc2 and CDK2##2##3##(1993-11#2)
p34cdc2##8##1##(1993-11#5)(1993-9#2)(1994-12#1)
p35##12##1##(1995-5#1)(1995-6#2)(1997-3#4)(2008-8#5)
p38 MAP##2##2##(2008-4#1)(2008-7#1)
p38 MAPK##3##2##(2008-11#1)(2008-4#1)(2010-1#1)
p38 and JNK##3##3##(2008-9#1)(2009-6#1)(2012-2#1)
p38 kinase##2##2##(2011-2#2)
p38 mitogen-activated protein kinase (MAPK)##2##5##(2012-3#1)(2013-7#1)
p38 mitogen-activated protein kinase##4##4##(2008-7#1)(2010-10#1)(2012-3#1)(2013-7#1)
p38##28##1##(2008-11#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#8)(2012-2#3)(2012-3#2)(2013-7#3)
p38) and##2##2##(1996-2#1)(2012-2#1)
p38)##3##1##(1996-2#1)(2009-6#1)(2012-2#1)
p4##2##1##(2008-10#1)(2013-8#1)
p40 and p35 mRNA##5##4##(2008-8#5)
p40 of BALB/MK-2 cells was##2##5##(1990-11#2)
p40 of BALB/MK-2 cells##3##4##(1990-11#3)
p40 was##2##2##(1990-11#2)
p40##14##1##(1990-11#7)(2008-8#6)(2008-9#1)
p42/p44##2##1##(1996-2#2)
p42mapk/erk2##2##1##(1995-2#2)
p43##2##1##(1990-5#2)
p44##3##1##(1995-6#2)(2008-8#1)
p44/42##2##1##(2008-4#1)(2009-4#1)
p47-phox##2##1##(1993-8#2)
p48(Cre/+)-LSL-Kras(G12D/+) mice##3##2##(2013-1#3)
p48(Cre/+)-LSL-Kras(G12D/+)##4##1##(2013-1#4)
p50##2##1##(1991-7#1)(1997-3#1)
p53 Abs were##3##3##(2011-2#3)
p53 Abs##6##2##(2011-2#6)
p53 HAPLOINSUFFICIENT MICE##5##3##(2008-8#1)(2008-9#4)
p53 activation##2##2##(2007-8#1)(2009-2#1)
p53 activity##2##2##(1997-7#1)(2009-5#1)
p53 allele##3##2##(1993-11#1)(2009-2#2)
p53 and NF-B##4##3##(2010-10#4)
p53 and T antigen##2##4##(1993-8#2)
p53 and c-erbB-2##3##3##(1994-7#3)
p53 and nuclear factor-B systems##2##5##(2010-10#2)
p53 and nuclear##3##3##(2010-10#3)
p53 and##29##2##(1991-2#1)(1993-8#3)(1994-12#1)(1994-7#3)(2008-10#1)(2008-9#2)(2010-10#7)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)
p53 by##2##2##(1995-2#1)(1995-9#1)
p53 cancer rescue##2##3##(2009-9#2)
p53 cancer##3##2##(2009-9#3)
p53 expression and c-erbB-2 expression##3##5##(1994-7#3)
p53 expression in##4##3##(2008-7#2)(2012-1#1)(2012-12#1)
p53 expression##8##2##(1994-7#4)(2008-7#2)(2012-1#1)(2012-12#1)
p53 function##3##2##(1994-12#2)(1994-5#1)
p53 gene##10##2##(1991-11#3)(1992-3#1)(1993-11#2)(2007-11#1)(2008-10#3)
p53 haploinsufficient mice administered##3##4##(2008-9#3)
p53 haploinsufficient mice exposed to##5##5##(2008-8#1)(2008-9#4)
p53 haploinsufficient mice were administered##4##5##(2008-9#4)
p53 haploinsufficient mice were exposed to##8##6##(2008-9#8)
p53 haploinsufficient mice were exposed##9##5##(2008-9#9)
p53 haploinsufficient mice were##16##4##(2008-8#1)(2008-9#15)
p53 haploinsufficient mice##31##3##(2008-8#4)(2008-9#27)
p53 haploinsufficient##35##2##(2008-8#7)(2008-9#28)
p53 has##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
p53 immunoexpression##2##2##(2013-8#2)
p53 in human##2##3##(1993-9#1)(2009-4#1)
p53 in the##5##3##(1991-2#2)(1992-12#1)(2008-9#1)(2012-1#1)
p53 in##16##2##(1991-2#2)(1992-12#2)(1993-9#1)(1997-7#1)(2008-9#3)(2009-4#1)(2009-9#1)(2011-2#3)(2012-1#1)(2012-2#1)
p53 is##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
p53 level##2##2##(1997-7#2)
p53 locus##3##2##(1995-9#1)(1997-7#1)(2008-4#1)
p53 mice##2##2##(2007-8#1)(2008-9#1)
p53 mutant##2##2##(2008-7#1)(2012-2#1)
p53 mutants##2##2##(2009-9#2)
p53 mutation##2##2##(1991-11#1)(2012-12#1)
p53 mutations in##2##3##(1990-12#1)(1997-8#1)
p53 mutations may##2##3##(1992-3#1)(2011-2#1)
p53 mutations##11##2##(1990-12#3)(1992-3#2)(1993-8#1)(1994-12#1)(1997-8#1)(2009-9#1)(2011-2#2)
p53 on##3##2##(1991-5#1)(1993-9#1)(2012-1#1)
p53 or##3##2##(1993-8#1)(1994-12#1)(2010-10#1)
p53 protein is##2##3##(1991-2#2)
p53 protein##18##2##(1990-12#2)(1991-2#4)(1991-5#1)(1992-3#3)(1994-9#1)(1995-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-8#1)(2013-7#1)
p53 proteins##2##2##(1991-5#1)(2011-2#1)
p53 tumor suppressor gene##4##4##(1994-8#1)(1996-6#1)(2007-5#1)(2009-5#1)
p53 tumor suppressor##8##3##(1994-12#1)(1994-5#1)(1994-8#1)(1996-6#1)(1997-7#1)(2007-5#1)(2009-5#1)(2011-2#1)
p53 was##3##2##(1993-9#1)(2008-10#1)(2012-12#1)
p53 were##2##2##(2008-10#1)(2011-2#1)
p53##305##1##(1990-12#6)(1991-11#4)(1991-2#8)(1991-5#9)(1992-12#6)(1992-3#7)(1992-8#1)(1993-11#4)(1993-8#6)(1993-9#6)(1994-12#13)(1994-5#2)(1994-7#7)(1994-8#1)(1994-9#5)(1995-11#1)(1995-2#3)(1995-6#3)(1995-9#3)(1996-6#1)(1997-7#8)(1997-8#2)(2007-11#1)(2007-5#1)(2007-8#7)(2008-1#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#47)(2009-2#3)(2009-4#7)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#9)(2010-10#13)(2010-3#4)(2010-8#1)(2011-2#33)(2012-1#3)(2012-12#5)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#3)
p53'##2##1##(2007-8#2)
p53(-/-)##4##1##(2008-11#1)(2012-2#3)
p53-carrying##2##1##(2009-4#2)
p53-dependent##8##1##(1997-7#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
p53-independent apoptotic mechanism that operates in a committed##2##8##(1995-6#2)
p53-independent##8##1##(1993-9#1)(1995-6#3)(2008-7#2)(2013-1#2)
p53-mediated cellular response to DNA damage in##2##7##(1995-2#2)
p53-mediated##4##1##(1994-12#1)(1995-2#2)(1997-7#1)
p53/CD95##2##1##(2012-1#2)
p53/CD95L##4##1##(2012-1#4)
p53175P##3##1##(2008-7#3)
p55##2##1##(2008-10#1)(2008-11#1)
p55R##3##1##(1994-2#3)
p56lck##6##1##(1991-11#5)(1993-3#1)
p56lyn##2##1##(1994-8#2)
p59##5##1##(1993-8#4)(2012-3#1)
p6##3##1##(1993-11#1)(1994-1#1)(1996-3#1)
p63##5##1##(1993-8#3)(2010-3#1)(2011-2#1)
p65##7##1##(1995-6#5)(2012-2#2)
p67 in the##2##3##(1994-5#2)
p67##11##1##(1991-5#1)(1994-5#10)
p67-deglycosylase##2##1##(1994-5#2)
p67-phox##3##1##(1993-6#1)(1993-8#2)
p7##8##1##(1992-6#8)
p70##5##1##(1992-5#2)(2008-8#2)(2011-2#1)
p70/p85 ribosomal S6 protein kinase##4##5##(1995-6#4)
p70/p85 ribosomal protein S6 kinase##2##5##(1996-2#2)
p70/p85 ribosomal##6##2##(1995-6#4)(1996-2#2)
p72syk is##6##2##(1992-6#3)(1993-11#3)
p72syk##13##1##(1992-6#6)(1993-11#7)
p73 and##2##2##(2010-3#2)
p73##5##1##(2010-3#4)(2011-2#1)
p75##8##1##(1995-8#4)(1996-12#4)
p75(NTR)##2##1##(2008-7#2)
p75LNGFR##2##1##(1996-12#2)
p75NGFR##2##1##(1993-9#2)
p75R##8##1##(1994-2#8)
p76##3##1##(1992-9#3)
p85 SH2##2##2##(1994-6#2)
p85##5##1##(1994-6#3)(1995-6#1)(1996-2#1)
p94 kinase is##2##3##(1992-3#2)
p94##3##1##(1992-3#3)
p= 0##2##2##(2011-1#1)(2012-3#1)
p=0##78##1##(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#3)(2009-5#1)(2009-7#2)(2010-3#4)(2010-6#1)(2011-1#8)(2011-2#16)(2012-12#6)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
pA##3##1##(2007-11#1)(2009-12#1)(2012-3#1)
pA2 value##3##2##(1995-12#1)(1996-2#2)
pA2##4##1##(1995-12#2)(1996-2#2)
pAB is##2##2##(1992-5#2)
pAB##5##1##(1992-5#5)
pAEA##3##1##(2009-10#3)
pAGluT##2##1##(2008-8#2)
pAL7002##2##1##(1990-5#2)
pAM1Luc##2##1##(1991-9#2)
pAN7-1##2##1##(1991-9#1)(2008-10#1)
pAS2##2##1##(2008-8#1)(2008-9#1)
pASK75##2##1##(1994-12#2)
pASMM##2##1##(2008-8#2)
pAb##2##1##(2008-10#2)
pAs1##2##1##(2008-5#2)
pBEf##2##1##(1994-12#2)
pBLCAT2##3##1##(1994-6#3)
pBR 322##3##2##(1990-11#1)(1990-7#2)
pBR322 plasmid##2##2##(2008-11#1)(2013-1#1)
pBR322##9##1##(1990-11#2)(1990-5#2)(1993-9#1)(1994-9#1)(2008-11#1)(2008-8#1)(2013-1#1)
pBS##2##1##(1993-12#1)(2008-9#1)
pBluescript##2##1##(2008-6#1)(2008-8#1)
pBmgp64Luc##3##1##(2008-11#3)
pC194##2##1##(1993-6#2)
pCN8B12##2##1##(2008-8#2)
pCO(2) measurements##3##2##(2008-10#3)
pCO(2)##10##1##(2008-10#9)(2008-11#1)
pCO2 in##2##2##(2008-11#2)
pCO2##9##1##(2008-11#9)
pCOR2##3##1##(2008-10#3)
pCP##4##1##(2008-10#4)
pCa18b##3##1##(1992-3#3)
pDC-TNF##2##1##(2008-8#2)
pDNA in##2##2##(2013-1#2)
pDNA##9##1##(2013-1#9)
pDPRIS##2##1##(1997-3#2)
pEA29##7##1##(2008-10#7)
pEH74##4##1##(2008-6#4)
pEJ30##4##1##(2008-10#4)
pEP2##2##1##(1990-11#1)(2008-10#1)
pEP36##4##1##(2008-10#4)
pERK##2##1##(2008-12#1)(2011-2#1)
pETH2##3##1##(2008-10#3)
pF##2##1##(2008-10#1)(2008-11#1)
pFFK##2##1##(2008-10#2)
pFn and##2##2##(1995-5#2)
pFn##3##1##(1995-5#3)
pG101##2##1##(2008-10#2)
pGEM-T##3##1##(2008-10#1)(2008-8#1)(2008-9#1)
pGEX-2T##2##1##(1994-12#1)(2008-9#1)
pGP1##3##1##(1995-8#3)
pGP315##2##1##(1991-5#2)
pGPPVPS##2##1##(2008-10#2)
pGT-trp##2##1##(2008-10#2)
pGlu-Glu-ProNH2 is present in the porcine pituitary but##2##8##(1991-12#2)
pGlu-Glu-ProNH2##4##1##(1991-12#4)
pGluHA##4##1##(2008-7#4)
pH &lt##3##2##(1994-12#2)(2008-10#1)
pH (5##2##2##(2008-10#1)(2008-6#1)
pH (6##4##2##(1990-8#1)(1994-3#1)(2008-8#1)(2010-4#1)
pH (7##2##2##(1990-8#1)(2013-1#1)
pH (D)##5##2##(1991-9#5)
pH (pH##3##2##(1990-5#1)(1991-12#1)(2009-11#1)
pH (pHi) was##2##3##(2008-9#1)(2010-8#1)
pH (pHi)##6##2##(1990-2#1)(1994-6#1)(2007-10#1)(2008-9#1)(2010-8#2)
pH 0##2##2##(2008-10#2)
pH 1 and##2##3##(2008-10#2)
pH 1##24##2##(1990-5#1)(1992-12#1)(1995-3#2)(2008-10#18)(2008-11#1)(2013-8#1)
pH 10##25##2##(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#17)(2008-5#2)(2013-1#3)
pH 10)##2##2##(2008-10#2)
pH 11##4##2##(1990-5#1)(1990-8#1)(1992-12#1)(2008-10#1)
pH 11-12##2##2##(2008-10#2)
pH 12##15##2##(1990-8#1)(1996-5#1)(2008-10#10)(2008-11#2)(2008-8#1)
pH 13##4##2##(2008-10#3)(2013-1#1)
pH 2 and##5##3##(1990-8#2)(2008-10#3)
pH 2##63##2##(1990-8#2)(1993-11#1)(1993-8#1)(1994-9#1)(1996-5#2)(1997-2#4)(2008-10#48)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)
pH 3 and##2##3##(2008-10#2)
pH 3##73##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#3)(1994-3#1)(1994-8#1)(1995-5#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#54)(2008-5#1)(2008-6#2)(2010-3#1)(2010-5#2)
pH 4 and 6##3##4##(2008-10#1)(2008-5#2)
pH 4 and##6##3##(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)
pH 4 or##3##3##(2008-10#2)(2012-9#1)
pH 4 solution##3##3##(1990-5#1)(2008-10#2)
pH 4##95##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1997-2#2)(1997-4#3)(2008-10#66)(2008-12#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2009-7#1)(2010-2#1)(2011-2#1)(2012-9#1)(2013-1#2)
pH 4-5##2##2##(2008-10#2)
pH 5 and##2##3##(2008-10#2)
pH 5##123##2##(1990-12#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-2#2)(1997-7#1)(2006-6#1)(2008-10#87)(2008-11#6)(2008-5#1)(2008-6#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
pH 5-6##3##2##(2008-10#3)
pH 5/EDTA##3##2##(1990-11#3)
pH 6 and##2##3##(1990-8#1)(2008-7#1)
pH 6 to##2##3##(2008-10#1)(2010-5#1)
pH 6##92##2##(1990-5#1)(1990-8#3)(1991-5#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-2#3)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#49)(2008-11#2)(2008-5#2)(2008-6#3)(2008-7#1)(2009-11#1)(2010-3#2)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
pH 6-7##2##2##(2008-10#1)(2010-4#1)
pH 6-8##3##2##(1994-8#1)(2008-10#2)
pH 7 and##7##3##(1991-8#1)(1992-4#1)(1994-5#1)(2008-10#2)(2008-8#1)(2013-1#1)
pH 7##155##2##(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#4)(1991-8#4)(1992-10#2)(1992-3#2)(1992-4#1)(1993-8#7)(1994-3#1)(1994-5#2)(1994-8#3)(1995-2#1)(1995-5#3)(1997-2#4)(1997-7#2)(2008-10#85)(2008-11#5)(2008-12#1)(2008-5#4)(2008-6#3)(2008-8#4)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2013-1#1)
pH 8 and##2##3##(2008-10#2)
pH 8##64##2##(1990-5#1)(1992-9#1)(1993-11#2)(1993-8#1)(1993-9#1)(1995-6#2)(1996-12#1)(2008-10#45)(2008-11#2)(2008-6#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
pH 9##44##2##(1990-5#1)(1990-8#1)(1992-12#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#29)(2008-7#1)(2008-9#1)(2009-3#2)(2013-1#2)(2013-8#1)
pH = 3##2##3##(2008-10#2)
pH = 7##2##3##(2008-12#1)(2008-5#1)
pH =##7##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-11#1)(2009-12#2)
pH a##2##2##(2008-10#1)(2013-8#1)
pH accuracy##2##2##(2008-10#2)
pH adjusted to 4##2##4##(2008-10#1)(2011-1#1)
pH adjusted to##5##3##(2008-10#2)(2010-5#1)(2011-1#2)
pH adjusted##7##2##(2008-10#3)(2010-5#1)(2011-1#2)(2012-2#1)
pH adjustment##4##2##(1990-5#1)(2008-10#3)
pH and available##2##3##(2008-10#2)
pH and base excess values##2##5##(1994-7#2)
pH and base excess##3##4##(1994-7#3)
pH and buffer##2##3##(1994-9#1)(2008-10#1)
pH and calcium##2##3##(2008-5#1)(2008-9#1)
pH and column temperature##2##4##(2008-10#2)
pH and concentration##4##3##(2007-7#1)(2008-10#3)
pH and flow rate##5##4##(2008-10#5)
pH and flow##6##3##(2008-10#6)
pH and increasing##2##3##(2008-10#1)(2008-5#1)
pH and incubation time##2##4##(2008-10#1)(2010-5#1)
pH and ionic strength of the##3##6##(2008-10#3)
pH and ionic strength##9##4##(1990-12#1)(1993-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2013-1#1)
pH and osmolarity##2##3##(2008-11#2)
pH and phosphate concentration of##2##5##(2008-10#2)
pH and sample volume##2##4##(2008-10#2)
pH and sample##4##3##(2008-10#4)
pH and supporting electrolyte##2##4##(2008-10#2)
pH and temperature##21##3##(1991-12#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-6#1)(2012-2#1)
pH and that the##2##4##(1991-12#1)(1993-6#1)
pH and that##3##3##(1991-12#1)(1993-6#1)(2008-10#1)
pH and the presence of##2##5##(2008-6#1)(2008-8#1)
pH and the##15##3##(1996-5#1)(2008-10#11)(2008-12#1)(2008-6#1)(2008-8#1)
pH and time of##2##4##(2008-10#2)
pH and##170##2##(1990-12#1)(1990-7#2)(1991-12#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-7#3)(1994-8#3)(1994-9#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-5#2)(2007-7#1)(2008-10#91)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
pH approximately##4##2##(1992-8#1)(2008-10#3)
pH are found##2##3##(2008-5#1)(2009-12#1)
pH are##6##2##(2008-10#2)(2008-5#3)(2009-12#1)
pH around##2##2##(2008-10#1)(2008-7#1)
pH as##3##2##(1994-12#1)(1994-8#1)(2008-10#1)
pH at 7##2##3##(2008-10#1)(2008-11#1)
pH at##7##2##(1990-2#1)(2008-10#5)(2008-11#1)
pH below##2##2##(2008-10#2)
pH between 4 and##2##4##(1990-7#1)(2008-10#1)
pH between##4##2##(1990-7#1)(2008-10#1)(2008-5#2)
pH by##4##2##(1990-12#1)(1995-3#1)(2008-10#2)
pH change from##2##3##(1993-8#1)(2008-10#1)
pH change of##2##3##(2008-5#1)(2013-1#1)
pH change was##2##3##(2009-12#2)
pH change##14##2##(1993-8#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-12#3)(2010-5#1)(2013-1#1)
pH changes##8##2##(2008-10#4)(2012-12#2)(2013-1#2)
pH close to##3##3##(2008-10#2)(2008-5#1)
pH conditions##14##2##(1991-5#1)(1994-8#1)(1995-2#1)(2008-10#7)(2008-5#1)(2009-11#1)(2010-11#1)(2013-1#1)
pH control##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
pH dependence of the folding reaction##2##6##(1992-3#2)
pH dependence of the##12##4##(1990-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-8#1)(1995-2#1)(1996-12#1)(2008-10#3)(2010-4#1)
pH dependence of##15##3##(1990-5#1)(1991-8#2)(1991-9#1)(1992-3#2)(1993-8#2)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#3)(2010-4#1)
pH dependence##18##2##(1990-5#1)(1991-8#4)(1991-9#1)(1992-3#2)(1993-8#2)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#3)(2008-4#1)(2010-4#1)
pH dependency##2##2##(1995-5#2)
pH dependent##14##2##(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(2008-10#6)(2009-12#1)(2013-1#1)
pH determination##2##2##(2008-10#2)
pH did not##2##3##(2008-10#2)
pH dropped##2##2##(2008-10#1)(2008-5#1)
pH effect on##3##3##(2008-10#3)
pH effect##8##2##(1995-2#1)(2008-10#7)
pH effects on the##2##4##(2008-10#1)(2009-12#1)
pH effects##3##2##(2008-10#2)(2009-12#1)
pH electrodes##2##2##(2008-10#2)
pH favored##2##2##(2008-10#2)
pH for the##10##3##(1990-7#2)(1991-5#1)(1997-2#1)(2008-10#6)
pH for##23##2##(1990-2#1)(1990-7#2)(1991-5#2)(1991-9#2)(1994-11#1)(1997-2#1)(2008-10#11)(2009-3#1)(2011-2#2)
pH from 1 to##2##4##(2008-10#2)
pH from 2##3##3##(1994-3#1)(2008-10#2)
pH from the##2##3##(2008-10#1)(2011-2#1)
pH from##13##2##(1991-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(2008-10#8)(2011-2#1)
pH glass electrode##2##3##(2008-10#2)
pH glass##3##2##(2008-10#3)
pH gradient##10##2##(1994-6#1)(1995-2#1)(2008-10#6)(2008-4#1)(2008-7#1)
pH has##3##2##(2008-10#3)
pH higher than##5##3##(1990-2#1)(1994-3#1)(2008-10#3)
pH in the presence of##2##5##(1990-2#1)(1995-5#1)
pH in the range of##4##5##(1995-2#1)(2008-10#2)(2008-8#1)
pH in the##14##3##(1990-2#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-8#1)
pH in##34##2##(1990-2#3)(1990-7#1)(1992-2#1)(1993-5#1)(1993-8#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#14)(2008-5#1)(2008-8#3)(2010-3#1)(2010-4#1)(2010-8#2)
pH increase##2##2##(2008-10#1)(2008-11#1)
pH increased##4##2##(2008-10#3)(2008-6#1)
pH indicator##7##2##(2008-10#7)
pH is a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
pH is##11##2##(2008-10#3)(2008-11#1)(2008-5#4)(2008-8#2)(2008-9#1)
pH leading to##2##3##(1991-12#2)
pH levels##2##2##(2008-10#2)
pH maximum##2##2##(1994-3#1)(2008-10#1)
pH measurement##4##2##(1994-7#1)(2008-10#2)(2013-1#1)
pH measurements and##2##3##(2008-10#2)
pH measurements in##3##3##(1993-11#1)(2008-10#1)(2010-8#1)
pH measurements were##2##3##(1994-7#1)(2008-10#1)
pH measurements##14##2##(1993-11#1)(1994-7#1)(2008-10#11)(2010-8#1)
pH of 1##2##3##(2008-10#2)
pH of 2##2##3##(2008-10#2)
pH of 3##4##3##(1990-12#1)(2008-10#3)
pH of 4##3##3##(2008-10#2)(2012-2#1)
pH of 5##4##3##(2008-10#3)(2008-5#1)
pH of 6##2##3##(2008-10#2)
pH of 7##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
pH of approximately##3##3##(1990-5#1)(2011-2#2)
pH of buffer##2##3##(2008-10#2)
pH of buffers##2##3##(2008-10#2)
pH of mobile phase##2##4##(2008-10#1)(2011-1#1)
pH of sample solution##3##4##(2008-10#3)
pH of sample##4##3##(2008-10#4)
pH of the aqueous phase##4##5##(2008-10#4)
pH of the aqueous##5##4##(2008-10#5)
pH of the buffer##3##4##(1990-8#1)(1991-5#1)(2008-10#1)
pH of the bulk solution##2##5##(2008-6#2)
pH of the bulk##3##4##(2008-10#1)(2008-6#2)
pH of the medium##3##4##(1994-6#1)(2008-10#1)(2008-6#1)
pH of the mixed solution was##3##6##(2008-10#3)
pH of the mixed##4##4##(2008-10#3)(2008-6#1)
pH of the mobile phase##3##5##(2008-10#2)(2011-1#1)
pH of the sample solution##2##5##(2008-10#2)
pH of the sample##3##4##(2008-10#3)
pH of the solution was##2##5##(1990-8#1)(2013-1#1)
pH of the solution##6##4##(1990-5#1)(1990-8#1)(2008-10#3)(2013-1#1)
pH of the substrate##2##4##(2008-10#1)(2008-6#1)
pH of the##57##3##(1990-5#1)(1990-8#2)(1991-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#2)(2008-10#33)(2008-11#1)(2008-5#5)(2008-6#6)(2011-1#1)(2012-2#1)(2013-1#1)
pH of##127##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-5#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#2)(1996-12#1)(2007-3#1)(2008-10#81)(2008-11#2)(2008-12#1)(2008-5#10)(2008-6#7)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
pH on the##16##3##(2008-10#8)(2008-5#5)(2008-8#1)(2010-4#1)(2011-2#1)
pH on their##3##3##(1991-5#1)(2008-10#2)
pH on##29##2##(1991-5#2)(1994-6#1)(2008-10#13)(2008-5#6)(2008-6#1)(2008-8#2)(2009-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
pH optima##3##2##(1991-11#1)(1991-12#1)(2010-3#1)
pH optimum of##3##3##(1990-2#1)(1993-11#1)(1994-5#1)
pH optimum##8##2##(1990-2#2)(1990-5#1)(1991-12#1)(1993-11#1)(1994-5#1)(2008-4#1)(2008-9#1)
pH or##7##2##(1990-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(2008-10#2)(2013-1#1)
pH over the range##2##4##(1991-12#1)(2008-10#1)
pH profiles for##2##3##(1990-7#1)(1991-9#1)
pH profiles of##2##3##(1990-7#1)(2010-3#1)
pH profiles##6##2##(1990-7#2)(1990-8#1)(1991-9#1)(2008-10#1)(2010-3#1)
pH range (6##2##3##(2008-10#2)
pH range (pH##2##3##(1991-5#1)(2008-10#1)
pH range 0##2##3##(2008-10#2)
pH range 1##3##3##(2008-10#3)
pH range 2##6##3##(2008-10#6)
pH range 3-6##2##3##(1997-2#1)(2008-10#1)
pH range 5##4##3##(1992-6#1)(2008-10#3)
pH range 7##3##3##(1995-5#1)(2008-10#2)
pH range and##4##3##(2008-10#3)(2013-1#1)
pH range between##2##3##(2008-10#1)(2008-11#1)
pH range close to deprotonation of##2##6##(2008-10#2)
pH range for##3##3##(1997-2#1)(2008-10#2)
pH range from 2##2##4##(2008-10#2)
pH range from 3##3##4##(2008-10#3)
pH range from 4##2##4##(2008-10#1)(2008-11#1)
pH range from##12##3##(2008-10#11)(2008-11#1)
pH range of 2##11##4##(2008-10#10)(2010-2#1)
pH range of 3##6##4##(2008-10#6)
pH range of 4##4##4##(2008-10#3)(2008-6#1)
pH range of 5##4##4##(2008-10#3)(2013-8#1)
pH range of 6##5##4##(2008-10#4)(2008-7#1)
pH range of 7##2##4##(2008-4#1)(2012-2#1)
pH range of 8##2##4##(2008-10#2)
pH range of the##3##4##(2008-10#3)
pH range of##53##3##(1991-9#1)(1995-2#1)(2008-10#45)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
pH range studied##2##3##(2008-10#1)(2008-6#1)
pH range was between 1 and 8##2##7##(2008-10#2)
pH range was##4##3##(2008-10#4)
pH range within##2##3##(2008-5#1)(2010-8#1)
pH range##169##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-2#2)(2006-6#1)(2008-10#143)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
pH ranges for quantitative sorption##3##5##(2008-10#3)
pH ranges##7##2##(2008-10#6)(2008-4#1)
pH ranging from##2##3##(1990-11#1)(2008-10#1)
pH rate##2##2##(1991-9#2)
pH readings##2##2##(2008-10#2)
pH reduction##2##2##(1995-9#1)(2008-10#1)
pH region##3##2##(2008-10#3)
pH response##5##2##(1997-7#1)(2008-10#4)
pH sensing##3##2##(2008-10#2)(2009-12#1)
pH sensitive##5##2##(1991-12#1)(2008-10#2)(2009-12#1)(2013-1#1)
pH sensitivity##3##2##(2008-10#2)(2009-11#1)
pH sensor and##2##3##(2008-10#2)
pH sensor##7##2##(2008-10#7)
pH sensors based on##3##4##(2008-10#3)
pH sensors##5##2##(2008-10#5)
pH showed that##2##3##(1992-12#1)(2008-10#1)
pH studies##2##2##(2008-10#2)
pH than##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
pH the##6##2##(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-12#1)
pH titration##5##2##(2008-10#4)(2008-9#1)
pH to##8##2##(1991-8#2)(1994-8#2)(2008-10#4)
pH unit##3##2##(1990-2#1)(1991-2#1)(2008-10#1)
pH units##7##2##(1995-5#2)(2008-10#5)
pH using##3##2##(1995-5#1)(2008-10#2)
pH value and##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
pH value for##5##3##(1991-8#1)(2008-10#3)(2011-2#1)
pH value of 10##2##4##(2008-10#2)
pH value of buffer##2##4##(2008-10#2)
pH value of the##2##4##(2008-10#2)
pH value of##9##3##(1993-8#1)(2008-10#8)
pH value##43##2##(1991-8#1)(1993-8#1)(1994-12#1)(2007-10#1)(2008-10#28)(2008-12#1)(2008-5#2)(2009-11#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
pH values &gt##2##3##(1994-11#1)(2008-10#1)
pH values &lt##2##3##(1994-11#1)(2008-10#1)
pH values (2##2##3##(2008-10#2)
pH values (pH##2##3##(1992-8#1)(1994-8#1)
pH values and##4##3##(1993-11#1)(2008-10#2)(2013-8#1)
pH values are##3##3##(2008-10#1)(2008-5#2)
pH values at##2##3##(2008-10#1)(2010-4#1)
pH values below 5##2##4##(2008-5#2)
pH values for##3##3##(2008-10#3)
pH values measured##2##3##(1994-8#1)(2008-10#1)
pH values of the##2##4##(2008-10#2)
pH values of##7##3##(1994-7#1)(2008-10#4)(2008-11#1)(2010-4#1)
pH values ranging from 1##2##5##(2008-10#2)
pH values ranging from##4##4##(2008-10#3)(2010-4#1)
pH values tested##2##3##(2008-10#2)
pH values were##5##3##(2008-10#2)(2008-5#1)(2008-7#2)
pH values##82##2##(1991-2#2)(1991-8#1)(1992-8#5)(1993-11#1)(1993-8#1)(1994-11#5)(1994-7#1)(1994-8#2)(1997-2#1)(1997-4#1)(2008-10#42)(2008-11#1)(2008-3#1)(2008-5#8)(2008-7#2)(2010-4#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
pH variations##2##2##(2008-10#2)
pH was 5##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
pH was adjusted to##3##4##(2008-10#3)
pH was adjusted##4##3##(2008-10#4)
pH was investigated##2##3##(1994-8#1)(2008-10#1)
pH was raised##2##3##(1993-3#1)(1993-6#1)
pH was##26##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-2#1)(2008-10#14)(2008-3#1)(2008-6#2)(2008-8#1)(2009-4#1)(2013-8#1)
pH were studied##2##3##(2008-10#2)
pH were the##2##3##(2008-10#1)(2008-6#1)
pH were##14##2##(1997-4#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
pH whereas##2##2##(1990-8#1)(2008-10#1)
pH which##2##2##(1993-3#1)(2011-2#1)
pH will##2##2##(2008-6#1)(2011-2#1)
pH with a slope of##2##5##(2008-10#2)
pH with##4##2##(2008-10#4)
pH##2425##1##(1990-11#6)(1990-12#10)(1990-2#14)(1990-5#19)(1990-7#16)(1990-8#21)(1991-1#2)(1991-11#2)(1991-12#18)(1991-2#5)(1991-5#11)(1991-8#20)(1991-9#16)(1992-10#2)(1992-11#5)(1992-12#15)(1992-2#1)(1992-3#7)(1992-4#2)(1992-6#6)(1992-8#6)(1992-9#4)(1993-11#16)(1993-12#5)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#27)(1993-9#1)(1994-11#11)(1994-12#10)(1994-2#2)(1994-3#10)(1994-5#14)(1994-6#8)(1994-7#6)(1994-8#23)(1994-9#5)(1995-11#1)(1995-2#24)(1995-3#5)(1995-5#18)(1995-6#11)(1995-8#3)(1995-9#1)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#9)(1997-1#1)(1997-2#23)(1997-4#8)(1997-6#2)(1997-7#7)(2006-6#2)(2007-10#2)(2007-3#2)(2007-7#1)(2008-10#1448)(2008-11#53)(2008-12#11)(2008-3#4)(2008-4#14)(2008-5#94)(2008-6#44)(2008-7#17)(2008-8#27)(2008-9#17)(2009-10#3)(2009-11#7)(2009-12#16)(2009-3#3)(2009-4#3)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#9)(2010-4#14)(2010-5#15)(2010-8#6)(2011-1#12)(2011-2#29)(2011-3#5)(2012-12#3)(2012-2#13)(2012-3#3)(2012-6#2)(2012-9#1)(2013-1#34)(2013-7#2)(2013-8#18)
pH&gt##7##1##(2008-10#6)(2009-11#1)
pH&lt##3##1##(2008-10#3)
pH) and##2##2##(2008-10#2)
pH)##7##1##(1993-8#1)(2008-10#4)(2008-12#1)(2013-8#1)
pH-ISEs with##2##2##(2008-10#2)
pH-ISEs##3##1##(2008-10#3)
pH-Metric determination of acid##2##4##(2008-10#2)
pH-Metric##3##1##(2008-10#3)
pH-controlled##2##1##(1994-12#1)(2008-7#1)
pH-dependent shift in pyruvate metabolism##2##5##(2008-6#2)
pH-dependent spectral changes##2##3##(1992-6#1)(1995-2#1)
pH-dependent spectral##3##2##(1992-6#1)(1995-2#1)(2008-10#1)
pH-dependent##24##1##(1990-5#3)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#2)(1994-8#1)(1995-2#1)(1995-5#1)(1997-7#2)(2008-10#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#1)
pH-electrode##2##1##(2008-10#2)
pH-independent intrinsic enthalpy of acylation##2##5##(1990-8#2)
pH-independent##3##1##(1990-8#2)(1991-9#1)
pH-induced##4##1##(1992-12#1)(1995-6#1)(2008-5#2)
pH-metric data##2##2##(2008-10#2)
pH-metric titration##4##2##(2008-10#4)
pH-metric##15##1##(2008-10#15)
pH-metrically##2##1##(2008-10#1)(2008-5#1)
pH-metry and##3##2##(1996-3#3)
pH-metry##5##1##(1996-3#5)
pH-rate profile##2##2##(2008-10#2)
pH-rate##3##1##(1995-2#1)(2008-10#2)
pH-sensitive field-effect transistors##3##3##(2008-10#3)
pH-sensitive polymer prepared##2##3##(2008-10#2)
pH-sensitive polymer##3##2##(2008-10#3)
pH-sensitive##18##1##(1990-5#1)(1992-7#1)(1997-1#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#2)(2009-11#2)(2013-1#1)
pH-sensitive-liposomes##2##1##(1997-1#2)
pH-sensors##2##1##(2008-10#1)(2013-8#1)
pH-static titration##2##2##(2008-10#2)
pH-static##3##1##(2008-10#3)
pH-values##2##1##(2008-10#1)(2013-1#1)
pH6##2##1##(2008-10#2)
pH=3##2##1##(2008-10#2)
pHSV-IL-1ra particles##2##2##(2008-8#2)
pHSV-IL-1ra##3##1##(2008-8#3)
pHSVLac##2##1##(2008-8#2)
pHg##2##1##(2008-10#1)(2011-1#1)
pHg/pSILBAγ was##2##2##(2011-1#2)
pHg/pSILBAγ##6##1##(2011-1#6)
pHi recovery##2##2##(1990-2#2)
pHi reduction##2##2##(1990-2#2)
pHi##18##1##(1990-2#11)(1991-5#1)(1994-6#2)(2007-10#1)(2008-9#2)(2010-8#1)
pHo 7##2##2##(1992-5#2)
pHs##11##1##(1992-12#1)(2008-10#8)(2009-7#1)(2013-1#1)
pHvG38##2##1##(2008-5#2)
pI &gt##4##2##(1993-8#4)
pI &lt##3##2##(2010-8#3)
pI 5##3##2##(1990-7#1)(2008-11#2)
pI =##2##2##(1992-11#1)(1994-11#1)
pI of 4##2##3##(2008-10#2)
pI of 5##4##3##(1990-5#1)(1990-7#1)(1995-6#1)(1996-5#1)
pI of 8##2##3##(1990-12#1)(2008-10#1)
pI of##12##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-8#1)(1995-6#1)(1996-5#1)(2008-10#5)
pI##40##1##(1990-11#1)(1990-12#2)(1990-5#3)(1990-7#3)(1991-6#1)(1992-11#1)(1992-8#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-8#2)(1995-6#1)(1996-5#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#5)
pI6##3##1##(1991-12#3)
pINSAT2##2##1##(1995-2#2)
pIs of##2##2##(2008-10#1)(2008-6#1)
pJ of##2##2##(2007-11#1)(2007-12#1)
pJ to##2##2##(2007-11#2)
pJ##6##1##(2007-11#3)(2007-12#3)
pJM1##2##1##(2011-2#2)
pJalpha##3##1##(2008-7#3)
pK (a##2##2##(2008-10#2)
pK =##2##2##(1990-8#1)(1991-9#1)
pK of##4##2##(1990-8#1)(1993-8#1)(1994-5#2)
pK values for the##2##4##(1991-9#1)(2008-10#1)
pK values for##3##3##(1990-8#1)(1991-9#1)(2008-10#1)
pK values##7##2##(1990-7#1)(1990-8#1)(1991-9#2)(1995-2#1)(2008-10#2)
pK##21##1##(1990-7#1)(1990-8#4)(1991-9#3)(1993-8#1)(1994-5#3)(1995-2#3)(2008-10#4)(2008-9#2)
pK(0)##3##1##(2008-10#3)
pK(00)##3##1##(2008-10#3)
pK(1)##2##1##(2008-10#2)
pK(2)##3##1##(2008-10#3)
pK(2)&gt##2##1##(2008-10#2)
pK(a) and##4##2##(2008-10#3)(2009-9#1)
pK(a) of##4##2##(2008-10#4)
pK(a) values for##3##3##(1996-2#1)(2008-10#2)
pK(a) values from##2##3##(2008-10#2)
pK(a) values in##2##3##(2007-12#1)(2008-10#1)
pK(a) values of the##2##4##(2008-10#2)
pK(a) values of##6##3##(2008-10#5)(2008-4#1)
pK(a) values were##2##3##(2008-10#2)
pK(a) values##21##2##(1996-2#1)(2007-12#1)(2008-10#18)(2008-4#1)
pK(a) was##2##2##(2008-10#2)
pK(a)##44##1##(1996-2#2)(2007-12#3)(2008-10#36)(2008-4#1)(2009-8#1)(2009-9#1)
pK(a)(T)##2##1##(2008-10#2)
pK(a)(T)(=)8##2##1##(2008-10#2)
pK(a)s##2##1##(2008-10#2)
pK(a2)##2##1##(2008-10#2)
pK(app) values##2##2##(2008-10#2)
pK(app)##4##1##(2008-10#4)
pK(b)##2##1##(2008-10#2)
pKF2##6##1##(1993-12#6)
pKF3##5##1##(1993-12#5)
pKK223-3##5##1##(1990-5#2)(1994-12#2)(1995-8#1)
pKYM is##3##2##(1997-6#3)
pKYM##6##1##(1997-6#6)
pKZ1##4##1##(2008-7#4)
pKa of 11##2##3##(1995-5#1)(2008-10#1)
pKa of the carboxylic acid##2##5##(1995-5#2)
pKa of the##4##3##(1993-8#2)(1995-5#2)
pKa of##9##2##(1990-8#1)(1993-8#2)(1995-5#5)(2008-10#1)
pKa value##4##2##(1992-6#1)(1994-11#1)(1995-5#1)(2008-10#1)
pKa values for##2##3##(1994-9#1)(2009-9#1)
pKa values of buried##2##4##(1997-2#2)
pKa values of##6##3##(1990-8#1)(1995-5#1)(1997-2#2)(2007-11#1)(2008-10#1)
pKa values were determined##2##4##(2007-11#1)(2009-9#1)
pKa values##14##2##(1990-8#1)(1994-9#1)(1995-5#3)(1997-2#3)(2007-11#2)(2008-10#2)(2009-9#2)
pKa##33##1##(1990-5#1)(1990-8#2)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-5#9)(1997-2#5)(2007-11#2)(2008-10#4)(2009-9#2)
pKa's of the##2##3##(2009-9#2)
pKa2##3##1##(1990-5#1)(2008-10#2)
pM and##4##2##(1990-2#1)(1990-5#1)(1991-2#1)(1993-11#1)
pM for##2##2##(2008-10#1)(2011-1#1)
pM##23##1##(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#6)(2010-4#1)(2011-1#1)
pM) and##2##2##(1994-8#1)(1995-2#1)
pM)##14##1##(1990-8#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#4)(1994-8#1)(1995-2#3)(2009-3#1)
pMAG15##2##1##(2008-8#2)
pMCAO##2##1##(2011-2#2)
pMCP9 was##2##2##(1994-11#2)
pMCP9##3##1##(1994-11#3)
pMLZ-4##6##1##(1993-2#6)
pMM237##2##1##(1990-11#2)
pMRfP##2##1##(1994-12#2)
pMT2-cytochrome P450##2##2##(1994-8#2)
pMW119##2##1##(1992-9#2)
pN##2##1##(1991-8#1)(2007-12#1)
pN2##2##1##(1992-5#1)(2007-8#1)
pNF-CAT##3##1##(1994-6#3)
pNJI##2##1##(1990-5#2)
pNL-1##2##1##(2008-8#2)
pO(2)##5##1##(2008-11#5)
pOCs into OCLs##2##3##(2008-11#2)
pOCs into##4##2##(2008-11#4)
pOCs##8##1##(2008-11#8)
pOSEX##4##1##(1994-12#4)
pOX1054##2##1##(1995-8#2)
pPGN##4##1##(1995-3#4)
pQuattro vectors##3##2##(2008-11#3)
pRB binding##2##2##(1995-2#2)
pRB##5##1##(1995-2#3)(2008-11#1)(2013-1#1)
pRT-9 protein##2##2##(1994-6#2)
pRT-9##3##1##(1994-6#3)
pRb##4##1##(1997-7#1)(2008-6#2)(2013-1#1)
pS##6##1##(1993-3#1)(1994-11#1)(1994-12#1)(1995-11#2)(1997-7#1)
pSD5C##2##1##(1997-4#2)
pSILBA##2##1##(2011-1#2)
pSILBAγ##4##1##(2011-1#4)
pSK6##4##1##(1992-9#4)
pSKStrB##2##1##(1994-12#2)
pSTL70##6##1##(2008-10#6)
pSV2neo##2##1##(1995-11#1)(1996-6#1)
pT1##2##1##(2011-2#2)
pT2##2##1##(2011-2#2)
pT3##6##1##(1992-5#1)(2011-2#5)
pT4##2##1##(1992-5#1)(2011-2#1)
pTC excitability##2##2##(2012-2#2)
pTC using##2##2##(2012-2#2)
pTC##6##1##(2012-2#6)
pTLA-GH##3##1##(2010-5#3)
pTNM##2##1##(1994-8#1)(2008-10#1)
pTRE-CAT expression##2##2##(1994-6#2)
pTRE-CAT##3##1##(1994-6#3)
pTet-tTAk##2##1##(2008-2#2)
pTyr##2##1##(1994-6#2)
pU6RZ107##3##1##(2008-9#3)
pUC##3##1##(1990-5#1)(1990-7#1)(1995-8#1)
pUC18##5##1##(1992-3#1)(1994-12#1)(2008-10#2)(2008-5#1)
pUC19 and##2##2##(1992-3#1)(1994-12#1)
pUC19##6##1##(1990-5#1)(1991-9#1)(1992-3#1)(1994-12#1)(2008-4#1)(2008-8#1)
pUCR1##2##1##(2008-7#2)
pUCR2##2##1##(2008-7#2)
pUK##3##1##(1994-12#3)
pVAX1hsp70##2##1##(2009-5#2)
pVL1393##2##1##(1997-4#2)
pW##2##1##(2008-3#2)
pWH14##2##1##(1997-8#2)
pYME1 and pYME2##2##3##(1993-12#2)
pYZ4##2##1##(1990-11#2)
p[H]##2##1##(2008-10#2)
pa##5##1##(1996-2#4)(2008-11#1)
paca##5##1##(2008-5#4)(2013-7#1)
pace and##2##2##(1993-2#1)(2008-12#1)
pace in##2##2##(1994-2#1)(2008-12#1)
pace of information##2##3##(1995-2#1)(1996-2#1)
pace of##9##2##(1995-2#1)(1996-2#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
pace with the##2##3##(1996-2#1)(2008-10#1)
pace with##5##2##(1991-2#1)(1996-2#2)(2008-10#1)(2008-3#1)
pace##32##1##(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
paced rhythm##3##2##(2007-8#2)(2013-1#1)
paced##8##1##(1992-5#1)(1995-12#1)(2007-8#2)(2008-5#1)(2009-10#1)(2009-3#1)(2013-1#1)
pacemaker activity in##2##3##(1996-2#2)
pacemaker and##2##2##(1996-3#1)(2008-12#1)
pacemaker implantation##5##2##(2008-3#2)(2011-2#1)(2013-8#2)
pacemaker in the eye##2##4##(1994-2#2)
pacemaker neurons##2##2##(1994-2#2)
pacemaker##32##1##(1992-4#1)(1994-11#2)(1994-2#5)(1996-2#3)(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
pacemakers##9##1##(1992-4#1)(1994-11#3)(1994-5#1)(2007-8#1)(2008-5#1)(2010-6#1)(2012-3#1)
pachydermatis##2##1##(2008-5#2)
pachyrhizi and P##3##3##(2008-10#3)
pachyrhizi and##4##2##(2008-10#4)
pachyrhizi##10##1##(2008-10#10)
pachytene and##2##2##(2008-5#2)
pachytene bivalents with##2##3##(2008-9#2)
pachytene##8##1##(2008-5#4)(2008-9#2)(2012-2#2)
pacific division meeting##6##3##(2008-11#6)
pacific yew##2##2##(1994-11#2)
pacific##14##1##(1994-11#2)(2008-1#1)(2008-10#2)(2008-11#6)(2012-2#1)(2013-1#1)(2013-7#1)
pacificus##3##1##(2010-6#2)(2010-9#1)
pacifier stiffness##3##2##(2009-6#3)
pacifier use##7##2##(2007-10#6)(2013-7#1)
pacifier##11##1##(2007-10#6)(2009-6#4)(2013-7#1)
pacifiers##6##1##(2007-10#2)(2009-6#4)
pacing##8##1##(1990-3#1)(1992-5#2)(2008-1#1)(2011-2#2)(2012-2#2)
pack##15##1##(1993-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2012-12#4)(2013-8#1)
package and##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
package effects##3##2##(2008-3#3)
package for##6##2##(2008-4#2)(2011-1#2)(2011-3#1)(2012-2#1)
package has##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
package in##3##2##(1995-3#1)(2011-1#1)(2011-2#1)
package inserts##2##2##(1992-12#1)(2008-11#1)
package is##3##2##(2008-11#1)(2008-4#1)(2010-11#1)
package of the##2##3##(1992-5#1)(2008-3#1)
package of##8##2##(1992-5#1)(1993-3#1)(1994-2#1)(1995-6#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#1)
package that##2##2##(2008-10#1)(2008-12#1)
package to##4##2##(1997-5#1)(2008-2#1)(2008-4#1)(2011-1#1)
package will##2##2##(1994-8#1)(2008-6#1)
package##110##1##(1991-3#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#15)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#7)(2012-3#2)(2013-1#1)
package)##2##1##(2006-12#1)(2008-10#1)
packaged and##2##2##(1991-5#1)(2010-1#1)
packaged in##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
packaged##30##1##(1991-5#5)(1992-8#1)(1993-6#1)(1995-8#1)(1996-2#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#1)(2011-2#1)(2013-1#3)
packages and##2##2##(1992-12#1)(2008-4#1)
packages have##2##2##(1994-12#1)(2010-7#1)
packages##22##1##(1992-12#1)(1992-2#1)(1994-12#2)(1995-12#1)(1997-7#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#3)(2009-6#1)(2010-4#1)(2010-7#1)(2013-1#3)
packaging and##5##2##(2008-11#1)(2008-6#2)(2008-9#1)(2009-11#1)
packaging approach in which free-space optical##2##6##(2008-3#2)
packaging architecture is based on a modified folded##2##8##(2008-3#2)
packaging cell lines##2##3##(1990-5#2)
packaging cell##3##2##(1990-5#2)(2008-9#1)
packaging for##2##2##(2010-7#1)(2011-1#1)
packaging in##2##2##(1991-5#1)(1993-6#1)
packaging is##2##2##(1994-3#1)(2010-7#1)
packaging materials##3##2##(2008-10#2)(2010-7#1)
packaging motor##3##2##(2010-5#3)
packaging of the##2##3##(2008-11#1)(2010-2#1)
packaging of##8##2##(1993-2#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-4#2)(2009-8#1)(2010-2#1)
packaging should##2##2##(1994-3#2)
packaging solution##2##2##(2008-3#2)
packaging system##6##2##(1996-2#2)(2008-8#4)
packaging that##2##2##(1994-3#1)(2008-2#1)
packaging##85##1##(1990-11#1)(1990-5#2)(1991-5#2)(1992-8#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#4)(1996-12#2)(1996-2#3)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#8)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
packed against a##2##3##(1992-8#1)(2010-10#1)
packed and##6##2##(1994-5#1)(2008-10#2)(2008-7#1)(2008-9#2)
packed bed##4##2##(1997-2#1)(2008-11#3)
packed by##2##2##(2008-10#1)(2008-9#1)
packed cell##2##2##(2008-11#1)(2013-8#1)
packed cells##3##2##(2008-10#3)
packed column supercritical fluid chromatography##6##5##(2008-10#6)
packed column supercritical fluid##7##4##(2008-10#7)
packed column##15##2##(2008-10#14)(2010-4#1)
packed in a column and determined##5##6##(2008-10#5)
packed in a column##8##4##(2008-10#8)
packed in a flow cell##2##5##(2008-10#2)
packed in a mini-column##2##4##(2008-10#2)
packed in a minicolumn##4##4##(2008-10#4)
packed in a##21##3##(1991-5#1)(2008-10#20)
packed in##24##2##(1990-7#1)(1991-5#1)(2008-10#22)
packed into a small##2##4##(2008-10#2)
packed into a##7##3##(1990-8#1)(2008-10#6)
packed into##10##2##(1990-7#1)(1990-8#1)(2008-10#8)
packed minicolumn is proposed for##2##5##(2008-10#2)
packed minicolumn##4##2##(2008-10#4)
packed red blood cell##2##4##(2008-7#2)
packed red cells##2##3##(2008-10#1)(2013-1#1)
packed red##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
packed with 1##2##3##(2008-10#2)
packed with Amberlite##2##3##(2008-10#2)
packed with Chlorella vulgaris immobilised on silica gel##2##8##(2008-10#2)
packed with YPA(4) chelating resin##2##5##(2008-10#2)
packed with a solid##2##4##(2008-10#2)
packed with a##9##3##(2008-10#9)
packed with activated carbon##3##4##(2008-10#3)
packed with activated##5##3##(2008-10#5)
packed with immobilized##2##3##(2008-10#2)
packed with polytetrafluoroethylene (PTFE)##2##4##(2008-10#2)
packed with polyurethane foam##2##4##(2008-10#2)
packed with silica gel modified with##4##6##(2008-10#4)
packed with silica gel##6##4##(2008-10#6)
packed with the##3##3##(2008-10#3)
packed with##69##2##(1990-8#2)(1991-5#1)(2008-10#63)(2008-11#1)(2008-5#1)(2008-7#1)
packed##189##1##(1990-7#2)(1990-8#3)(1991-5#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#5)(2008-10#128)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
packed-bed bioreactor##4##2##(2008-11#2)(2008-7#2)
packed-bed##6##1##(2008-10#1)(2008-11#3)(2008-7#2)
packed-bedreactor##3##1##(2008-11#3)
packed-column##2##1##(2008-10#2)
packet loss rate##6##3##(2008-3#6)
packet switches##4##2##(2008-3#4)
packet switching##2##2##(2008-3#2)
packet##28##1##(1993-5#1)(2007-12#5)(2008-3#20)(2008-5#2)
packets##9##1##(2007-12#1)(2008-3#7)(2008-5#1)
packing and its##2##3##(2008-10#1)(2009-11#1)
packing and##7##2##(1992-6#1)(1993-8#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)
packing arrangement##2##2##(1992-6#1)(1993-6#1)
packing densities##2##2##(2008-3#2)
packing density of##5##3##(2008-12#1)(2008-3#2)(2008-9#1)(2013-1#1)
packing density##12##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-9#1)(2013-1#1)(2013-7#1)
packing has been##2##3##(2008-10#1)(2009-11#1)
packing has##3##2##(2008-10#2)(2009-11#1)
packing in##2##2##(1992-6#1)(2008-10#1)
packing material##5##2##(2008-10#5)
packing materials##2##2##(2008-10#2)
packing may##2##2##(2008-7#1)(2009-11#1)
packing of the##8##3##(1990-2#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2012-3#1)
packing of##13##2##(1990-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1996-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
packing the##3##2##(2008-10#3)
packing unit##2##2##(1993-6#2)
packing##89##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#2)(1992-6#6)(1993-11#1)(1993-6#3)(1993-8#2)(1994-5#2)(1995-5#1)(1996-9#1)(1997-4#1)(2008-10#31)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#3)(2010-4#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
packinghouse##2##1##(2008-10#1)(2011-2#1)
packinghouses##4##1##(2008-10#4)
packings##4##1##(2008-10#4)
packs##6##1##(1995-12#1)(1997-4#1)(2008-6#2)(2010-3#1)(2013-1#1)
paclitaxel and##6##2##(2008-7#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#2)
paclitaxel formulation##2##2##(2008-3#2)
paclitaxel resistance##6##2##(2010-11#6)
paclitaxel therapy##2##2##(2008-9#2)
paclitaxel treatment##2##2##(2010-11#2)
paclitaxel##44##1##(1995-8#1)(1996-10#1)(2007-7#3)(2008-3#11)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2010-11#10)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#2)
paclitaxel-eluting stent##2##2##(2008-11#2)
paclitaxel-eluting stents##4##2##(2008-11#2)(2008-12#1)(2009-5#1)
paclitaxel-eluting##8##1##(2008-11#5)(2008-12#1)(2009-5#1)(2010-5#1)
paclitaxel-mediated##2##1##(2008-7#1)(2011-2#1)
pact##2##1##(1993-8#1)(1994-2#1)
pacu (Piaractus mesopotamicus)##2##3##(2008-7#2)
pacu##4##1##(2008-7#4)
pad##18##1##(1990-11#2)(1993-6#1)(2008-11#1)(2008-12#3)(2008-5#4)(2008-9#4)(2011-1#1)(2011-2#1)(2012-12#1)
paddle and##2##2##(2008-4#1)(2010-12#1)
paddle##6##1##(2008-11#1)(2008-4#2)(2010-12#2)(2012-2#1)
paddles##2##1##(2010-9#2)
paddlewheel##2##1##(2009-11#2)
paddocks##3##1##(1996-12#2)(2012-12#1)
paddy fields##3##2##(2008-3#2)(2012-1#1)
paddy##9##1##(2008-12#6)(2008-3#2)(2012-1#1)
padi and##2##2##(2008-10#2)
padi can##2##2##(2008-10#2)
padi clones##2##2##(2008-10#2)
padi during##2##2##(2008-10#2)
padi was##2##2##(2008-10#2)
padi##19##1##(2008-10#19)
padlock probes##4##2##(2008-4#3)(2008-9#1)
pads for##2##2##(2008-2#1)(2008-3#1)
pads##15##1##(1996-2#2)(1997-3#1)(2007-5#2)(2008-11#4)(2008-2#2)(2008-3#3)(2012-12#1)
padus##2##1##(2008-10#2)
paediatric acute##2##2##(2008-11#1)(2009-5#1)
paediatric age group##6##3##(2007-8#1)(2008-11#1)(2012-2#1)(2013-8#3)
paediatric age##8##2##(2007-8#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#3)
paediatric and adult##4##3##(2008-9#3)(2010-10#1)
paediatric and##9##2##(2008-11#3)(2008-9#4)(2010-10#1)(2012-3#1)
paediatric cancer##2##2##(2008-11#2)
paediatric cardiac##6##2##(2007-9#5)(2008-11#1)
paediatric case##4##2##(1996-9#1)(2008-11#2)(2013-1#1)
paediatric cochlear implant users##3##4##(2008-9#2)(2011-1#1)
paediatric cochlear implant##6##3##(2008-9#5)(2011-1#1)
paediatric cochlear implantation##9##3##(2008-9#9)
paediatric cochlear##16##2##(2008-9#15)(2011-1#1)
paediatric departments##2##2##(1990-3#1)(1996-9#1)
paediatric emergency department##6##3##(2008-11#5)(2013-1#1)
paediatric emergency medicine##2##3##(2008-11#2)
paediatric emergency##8##2##(2008-11#7)(2013-1#1)
paediatric hospitals##2##2##(2008-11#2)
paediatric intensive care##3##3##(2007-11#1)(2010-7#1)(2013-1#1)
paediatric minor head injuries##2##4##(2008-11#2)
paediatric minor##3##2##(2008-11#3)
paediatric office##2##2##(2009-5#2)
paediatric oncology##3##2##(2007-12#1)(2008-11#1)(2010-11#1)
paediatric pain##2##2##(2008-11#2)
paediatric patient##2##2##(2012-2#1)(2013-1#1)
paediatric patients were##2##3##(2007-8#1)(2011-2#1)
paediatric patients##19##2##(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#2)(2008-7#3)(2008-9#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
paediatric population##9##2##(1996-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2013-1#2)
paediatric residents and##2##3##(2008-11#2)
paediatric residents##4##2##(2008-11#3)(2011-2#1)
paediatric setting##2##2##(2008-11#2)
paediatric surgeons##2##2##(2008-10#2)
paediatric surgery##2##2##(2008-11#1)(2012-2#1)
paediatric urology##6##2##(2008-10#6)
paediatric##200##1##(1990-2#1)(1990-3#2)(1993-12#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-4#1)(1997-8#2)(2007-11#2)(2007-12#2)(2007-8#3)(2007-9#9)(2008-1#1)(2008-10#15)(2008-11#64)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#30)(2009-10#2)(2009-5#4)(2009-7#2)(2010-10#1)(2010-11#1)(2010-7#4)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#13)(2013-8#5)
paediatrician##5##1##(2008-11#3)(2008-3#1)(2013-1#1)
paediatricians for##2##2##(2008-11#2)
paediatricians##11##1##(2008-11#9)(2008-7#1)(2009-5#1)
paediatrics and##2##2##(2008-11#1)(2012-12#1)
paediatrics##12##1##(1990-3#3)(2007-8#2)(2008-11#4)(2008-7#1)(2010-7#1)(2012-12#1)
paeoniflorin and 5-ASA groups (P &lt##2##6##(2011-3#2)
paeoniflorin##8##1##(2008-10#2)(2011-3#6)
paeonol##2##1##(2008-10#2)
page retrieval##2##2##(2008-3#2)
page swap outs##3##3##(2008-3#3)
page##38##1##(1991-5#1)(1995-3#1)(2007-11#6)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#10)(2008-4#1)(2008-7#1)(2009-10#2)(2010-2#1)(2012-12#3)(2012-3#7)(2013-1#1)
page-oriented memories##2##2##(2008-2#1)(2008-3#1)
page-oriented##7##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
pager##2##1##(2010-8#2)
pagers##5##1##(2010-8#5)
pages advertising##3##2##(1993-12#2)(1997-1#1)
pages can##2##2##(2008-3#2)
pages of##5##2##(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#2)
pages that##3##2##(2008-3#3)
pages with illustrations##4##3##(2007-2#4)
pages with##5##2##(2007-2#4)(2008-3#1)
pages##49##1##(1993-12#2)(1996-12#2)(1997-1#4)(2007-11#5)(2007-2#7)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#17)(2008-4#2)(2008-7#2)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#2)
pages)##12##1##(2008-4#12)
paging system##3##2##(2010-8#3)
paging systems are##2##3##(2010-8#2)
paging systems in##2##3##(2010-8#2)
paging systems##5##2##(2010-8#5)
paging##12##1##(2010-8#12)
paid a##5##2##(1990-9#1)(1995-3#1)(2008-11#1)(2009-11#1)(2009-7#1)
paid and##2##2##(1996-2#1)(2011-2#1)
paid by##6##2##(1992-12#1)(1994-2#1)(1996-3#2)(1997-1#1)(2008-11#1)
paid employment##3##2##(1991-9#1)(1993-6#1)(1995-1#1)
paid for the##3##3##(1992-2#1)(1997-2#1)(2008-12#1)
paid for##9##2##(1991-8#2)(1992-2#1)(1992-3#1)(1993-3#1)(1995-11#1)(1996-3#1)(1997-2#1)(2008-12#1)
paid much attention to the##2##5##(1996-12#1)(2009-7#1)
paid to a##2##3##(1995-12#1)(1997-6#1)
paid to the relationship between##2##5##(1992-3#1)(2008-3#1)
paid to the role of##3##5##(1997-4#1)(2009-4#1)(2011-1#1)
paid to the##36##3##(1990-2#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-3#2)(1993-12#1)(1994-3#2)(1995-1#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-2#1)
paid to##76##2##(1990-2#2)(1990-6#1)(1991-11#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-2#1)(2013-8#1)
paid work##2##2##(2008-7#1)(2011-2#1)
paid workers##4##2##(1992-3#4)
paid##131##1##(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#10)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-12#2)(1996-2#3)(1996-3#4)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-2#1)(2013-8#1)
pain (pain##2##2##(2008-7#1)(2010-12#1)
pain -##2##2##(2008-11#1)(2010-10#1)
pain 2##3##2##(1995-3#1)(2009-3#1)(2013-1#1)
pain 48##2##2##(2012-12#1)(2012-3#1)
pain after a##3##3##(1995-3#1)(2006-10#1)(2008-9#1)
pain after##11##2##(1991-11#1)(1993-2#1)(1995-3#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#2)(2009-3#1)(2012-2#1)
pain among##3##2##(1997-4#1)(2007-11#1)(2010-12#1)
pain and a##4##3##(2007-8#1)(2008-10#1)(2010-1#1)(2012-12#1)
pain and allodynia##2##3##(1996-6#1)(2008-9#1)
pain and depression##4##3##(2008-10#1)(2013-1#3)
pain and disability and outcome measures##2##6##(2007-11#2)
pain and disability at 1 year##2##6##(2008-9#2)
pain and disability in##2##4##(2008-9#1)(2013-1#1)
pain and disability##15##3##(1997-6#1)(2007-11#5)(2008-11#1)(2008-12#1)(2008-9#4)(2012-12#2)(2013-1#1)
pain and discomfort associated with##2##5##(2008-12#1)(2011-1#1)
pain and discomfort##4##3##(2008-12#3)(2011-1#1)
pain and dysfunction##2##3##(2007-11#1)(2008-7#1)
pain and fever##3##3##(1991-2#1)(2006-10#1)(2008-10#1)
pain and functional disability were##2##5##(2010-12#1)(2012-1#1)
pain and functional outcomes##3##4##(2012-1#1)(2012-12#2)
pain and functional##5##3##(2010-12#1)(2012-1#2)(2012-12#2)
pain and improve##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
pain and inflammation##2##3##(1995-5#1)(2008-4#1)
pain and instability##2##3##(2012-3#1)(2013-1#1)
pain and joint##2##3##(1990-6#1)(2012-2#1)
pain and loss of##3##4##(1996-6#1)(2010-11#1)(2012-2#1)
pain and much##2##3##(2007-8#1)(2010-9#1)
pain and nausea##3##3##(2012-2#2)(2013-1#1)
pain and no##3##3##(2008-3#2)(2012-2#1)
pain and other##2##3##(1994-11#1)(2012-3#1)
pain and related disorders##5##4##(2008-12#5)
pain and related##7##3##(2008-12#7)
pain and sensory##2##3##(1990-12#1)(2012-12#1)
pain and severe##2##3##(2010-12#1)(2013-8#1)
pain and stiffness##3##3##(2006-10#2)(2011-2#1)
pain and suffering##3##3##(1997-5#1)(2013-1#2)
pain and symptoms##2##3##(2013-1#2)
pain and tenderness##2##3##(1992-5#1)(2008-1#1)
pain and the##4##3##(1991-2#1)(2008-11#1)(2008-12#1)(2008-9#1)
pain and to##2##3##(2010-11#1)(2011-2#1)
pain and transient##2##3##(2007-5#1)(2012-1#1)
pain and vomiting##3##3##(1990-6#1)(1997-8#1)(2013-1#1)
pain and weight loss##4##4##(1997-3#1)(2008-12#1)(2010-12#1)(2011-1#1)
pain and weight##5##3##(1997-3#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-1#1)
pain and##233##2##(1990-11#1)(1990-12#2)(1990-6#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#2)(1993-2#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#4)(2007-11#15)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#25)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#11)(2009-1#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#9)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#4)(2012-12#10)(2012-2#9)(2012-3#5)(2012-8#1)(2013-1#21)(2013-7#1)(2013-8#2)
pain and/or##2##2##(1992-6#1)(2008-7#1)
pain are likely##2##3##(2012-2#1)(2013-8#1)
pain are##10##2##(1992-12#1)(1996-6#1)(2007-8#1)(2008-11#2)(2009-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
pain areas of##3##3##(2010-9#3)
pain as a##3##3##(2007-11#1)(2008-9#1)(2010-3#1)
pain as well as##2##4##(2007-11#1)(2008-10#1)
pain as##9##2##(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
pain assessment and management##2##4##(2010-7#1)(2012-2#1)
pain assessment##24##2##(2008-11#6)(2008-7#2)(2009-3#1)(2010-11#6)(2010-7#2)(2012-2#5)(2013-1#2)
pain assessments##2##2##(2010-6#1)(2012-2#1)
pain associated with##16##3##(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#2)(1995-2#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#1)(2010-12#2)(2010-4#1)
pain associated##17##2##(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#2)(1995-2#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#2)(2010-12#2)(2010-4#1)
pain at least##2##3##(2008-7#1)(2013-1#1)
pain at the injection site##2##5##(2007-11#1)(2011-2#1)
pain at the##7##3##(1991-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-6#2)(2011-2#1)
pain at##12##2##(1991-3#1)(1994-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-6#2)(2011-2#1)(2013-1#1)
pain based on##3##3##(2008-9#2)(2012-2#1)
pain before##2##2##(2007-11#1)(2008-10#1)
pain behavior##2##2##(2008-6#2)
pain behaviour##3##2##(2008-11#2)(2008-4#1)
pain being##3##2##(1990-6#1)(2008-10#1)(2013-1#1)
pain but a##2##3##(2008-3#1)(2009-3#1)
pain but also##2##3##(2008-7#1)(2013-1#1)
pain but no##2##3##(1995-3#1)(2008-7#1)
pain but##7##2##(1995-3#1)(2008-3#1)(2008-7#3)(2009-3#1)(2013-1#1)
pain by##8##2##(1990-3#1)(1990-6#2)(1994-2#1)(1996-9#1)(2007-7#1)(2008-7#1)(2010-7#1)
pain can be##6##3##(1991-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
pain can##8##2##(1991-11#2)(2006-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
pain caused by##5##3##(1991-2#1)(1993-6#1)(1995-2#1)(2007-10#1)(2013-1#1)
pain characteristics##5##2##(2008-3#1)(2010-6#4)
pain complaints in##2##3##(2007-8#2)
pain complaints##5##2##(2007-11#1)(2007-8#3)(2008-5#1)
pain conditions##6##2##(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2013-1#2)
pain control and##4##3##(2008-7#2)(2010-11#1)(2013-1#1)
pain control in##2##3##(2010-7#1)(2012-3#1)
pain control##14##2##(1990-10#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#2)(2010-11#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
pain crisis##2##2##(1992-2#1)(2008-10#1)
pain diagnoses##3##2##(1993-1#1)(2013-1#2)
pain disappeared##4##2##(1991-5#1)(1991-8#1)(1993-3#1)(2008-7#1)
pain disorders##4##2##(1997-8#1)(2008-12#2)(2008-7#1)
pain due to##4##3##(1997-7#1)(2007-8#1)(2010-1#1)(2012-2#1)
pain during the##2##3##(1993-10#1)(2011-2#1)
pain during##11##2##(1990-3#1)(1993-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
pain education program##2##3##(2009-12#2)
pain education##4##2##(2008-11#1)(2009-12#3)
pain episodes##3##2##(2008-11#1)(2008-7#2)
pain evoked by##2##3##(1995-12#1)(2010-9#1)
pain experience##2##2##(2009-3#1)(2012-2#1)
pain experienced##3##2##(2010-11#1)(2011-2#1)(2012-3#1)
pain following##2##2##(1992-5#1)(2012-12#1)
pain for the##4##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
pain for##12##2##(1993-12#1)(1993-6#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
pain from bone##2##3##(1997-3#1)(2008-10#1)
pain from##7##2##(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
pain has been##2##3##(1991-9#1)(2008-4#1)
pain has##4##2##(1991-9#1)(2008-12#1)(2008-4#1)(2011-2#1)
pain have##2##2##(1991-3#1)(2008-7#1)
pain in a##5##3##(1995-12#2)(1997-5#1)(2008-5#1)(2010-12#1)
pain in both##3##3##(1996-11#1)(2006-10#1)(2013-8#1)
pain in childhood##3##3##(1992-5#1)(2008-11#2)
pain in children##3##3##(2008-11#2)(2010-3#1)
pain in her right##3##4##(2006-10#1)(2009-3#1)(2012-3#1)
pain in older##2##3##(2008-7#1)(2013-1#1)
pain in order to##2##4##(1997-2#1)(1997-8#1)
pain in patients with##4##4##(2008-12#2)(2009-4#2)
pain in patients##7##3##(2007-11#1)(2008-12#2)(2009-4#2)(2009-8#1)(2010-7#1)
pain in primary care##2##4##(2008-11#2)
pain in the elderly##2##4##(2008-5#2)
pain in the knee and##2##5##(1995-3#1)(2013-1#1)
pain in the lower##3##4##(2007-2#1)(2009-1#1)(2009-3#1)
pain in the rat##3##4##(2008-4#2)(2008-5#1)
pain in the right##4##4##(1990-9#1)(2007-12#1)(2008-1#1)(2012-12#1)
pain in the upper##2##4##(1991-9#1)(1993-2#1)
pain in the##37##3##(1990-6#1)(1990-9#1)(1991-9#1)(1993-2#1)(1995-3#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
pain in this##2##3##(2008-4#1)(2008-5#1)
pain in##109##2##(1990-6#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-5#2)(1993-2#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-11#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#4)(2009-4#3)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
pain intensity in##2##3##(1995-12#1)(2009-3#1)
pain intensity was##2##3##(1995-12#1)(2010-7#1)
pain intensity##18##2##(1990-12#1)(1995-12#2)(2007-11#1)(2008-12#3)(2008-9#1)(2009-12#4)(2009-3#1)(2010-12#3)(2010-7#1)(2012-2#1)
pain interference##2##2##(2008-12#2)
pain is a common##2##4##(2008-9#1)(2012-2#1)
pain is a major##2##4##(2007-11#1)(2010-12#1)
pain is a subjective##2##4##(2010-6#1)(2012-2#1)
pain is a##9##3##(2007-11#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#2)(2013-1#2)
pain is associated with##2##4##(2008-2#1)(2010-11#1)
pain is often##2##3##(2008-4#1)(2008-7#1)
pain is##37##2##(1990-6#1)(1993-1#1)(1993-6#1)(2007-11#3)(2007-12#1)(2007-7#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)
pain level##6##2##(2007-11#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
pain levels##5##2##(1994-3#1)(2008-12#1)(2008-7#1)(2013-1#2)
pain located##2##2##(2008-10#1)(2011-2#1)
pain management in patients##3##4##(2006-10#1)(2012-3#2)
pain management in##9##3##(2006-10#1)(2006-12#1)(2008-11#1)(2009-12#1)(2010-7#2)(2012-3#2)(2013-8#1)
pain management##44##2##(1991-1#1)(1992-8#1)(1993-12#1)(1994-1#1)(1997-5#1)(1997-8#1)(2006-10#3)(2006-12#3)(2007-11#2)(2007-9#1)(2008-11#4)(2008-7#3)(2009-12#3)(2009-5#1)(2010-11#5)(2010-6#1)(2010-7#2)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
pain may##4##2##(1990-6#1)(2009-12#1)(2012-12#2)
pain mechanisms##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
pain medications##3##2##(2008-7#2)(2010-4#1)
pain more##2##2##(2010-4#1)(2012-12#1)
pain must##2##2##(2008-11#1)(2008-3#1)
pain observation##3##2##(2008-3#2)(2011-2#1)
pain occurs in##3##3##(2011-2#1)(2013-1#2)
pain of acute onset##2##4##(2006-10#1)(2013-1#1)
pain of both##2##3##(1996-8#1)(2012-12#1)
pain of the##2##3##(1994-2#1)(2007-11#1)
pain of##12##2##(1990-9#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-8#1)(2006-10#1)(2007-11#1)(2009-3#1)(2010-1#1)(2012-12#1)(2013-1#1)
pain often##2##2##(2007-8#1)(2008-12#1)
pain on day##2##3##(2008-3#2)
pain on movement##2##3##(1990-9#2)
pain on the##4##3##(1992-5#1)(2007-8#1)(2012-2#1)(2012-3#1)
pain on##16##2##(1990-9#3)(1992-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
pain or##16##2##(1992-2#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)
pain over##2##2##(2008-11#1)(2012-2#1)
pain pathways##2##2##(2008-8#2)
pain patients##19##2##(1991-1#1)(1993-1#5)(2008-3#7)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-2#2)
pain patients]##2##2##(1997-8#1)(2008-12#1)
pain patterns and##2##3##(2007-11#1)(2010-9#1)
pain patterns##3##2##(2007-11#1)(2010-9#1)(2013-1#1)
pain perception and##2##3##(2009-3#1)(2011-2#1)
pain perception##5##2##(1993-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
pain processing##2##2##(2008-7#2)
pain quality##2##2##(2008-7#1)(2012-2#1)
pain rating##6##2##(2008-12#3)(2008-9#2)(2012-2#1)
pain reduction##2##2##(1994-3#1)(2007-8#1)
pain rehabilitation##5##2##(1995-2#1)(2013-1#4)
pain related to##4##3##(1996-3#1)(2006-12#1)(2008-10#1)(2009-11#1)
pain relief (VAS scale)##2##4##(2007-11#2)
pain relief after##2##3##(1990-6#1)(2007-11#1)
pain relief and##3##3##(2008-7#1)(2009-3#1)(2010-10#1)
pain relief for patients##2##4##(2007-8#1)(2013-1#1)
pain relief is##2##3##(1992-5#1)(2008-7#1)
pain relief was##2##3##(2007-11#2)
pain relief were##2##3##(2007-11#1)(2008-9#1)
pain relief with##2##3##(1995-10#1)(2008-7#1)
pain relief##45##2##(1990-6#1)(1992-1#2)(1992-5#1)(1995-1#1)(1995-10#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#14)(2007-6#1)(2007-8#1)(2007-9#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#1)(2013-1#1)
pain reported##2##2##(2009-4#1)(2012-3#1)
pain research##2##2##(2009-12#1)(2012-2#1)
pain resolved##2##2##(2008-10#1)(2013-1#1)
pain response of infants##2##4##(2010-4#2)
pain response##4##2##(1996-12#1)(2008-5#1)(2010-4#2)
pain responses of##2##3##(2010-4#2)
pain responses##3##2##(2008-6#1)(2010-4#2)
pain resulting##3##2##(1992-12#1)(1992-6#2)
pain results from##2##3##(2008-9#1)(2010-7#1)
pain scales##2##2##(2008-5#1)(2011-2#1)
pain score##6##2##(1994-3#2)(2007-11#2)(2008-7#1)(2011-2#1)
pain scores##8##2##(1995-3#1)(2008-10#1)(2008-7#4)(2012-12#1)(2012-2#1)
pain secondary to##2##3##(1993-9#1)(2008-9#1)
pain sensation##6##2##(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)
pain sensations##2##2##(1992-5#1)(2008-4#1)
pain sensitivity##2##2##(1994-3#2)
pain severity##5##2##(2009-3#1)(2010-11#1)(2010-6#3)
pain should be##2##3##(2008-4#1)(2012-12#1)
pain states##6##2##(1996-5#1)(2008-4#2)(2008-7#3)
pain stimulus##2##2##(2010-4#2)
pain subsided##3##2##(1990-12#1)(2007-11#1)(2013-1#1)
pain symptoms##9##2##(2007-11#1)(2007-8#1)(2008-12#2)(2009-10#1)(2009-9#1)(2012-2#1)(2013-1#2)
pain syndrome in##2##3##(1997-1#1)(2008-12#1)
pain syndrome##25##2##(1996-3#1)(1997-1#2)(2007-11#3)(2008-10#1)(2008-12#6)(2008-4#3)(2008-7#1)(2009-11#1)(2009-2#2)(2009-7#1)(2010-3#1)(2010-9#1)(2012-3#2)
pain syndromes##13##2##(1995-5#1)(1995-6#1)(2007-11#1)(2008-12#2)(2008-4#5)(2008-9#1)(2009-12#1)(2012-2#1)
pain than##5##2##(1993-12#1)(1997-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
pain that##4##2##(2007-7#1)(2008-12#1)(2010-8#1)(2013-8#1)
pain the##2##2##(1996-2#1)(2007-8#1)
pain therapy##5##2##(2007-7#1)(2008-11#4)
pain threshold##8##2##(1990-6#2)(1996-2#1)(2008-5#1)(2008-8#1)(2010-12#2)(2013-1#1)
pain thresholds to##3##3##(1993-1#3)
pain thresholds##5##2##(1993-1#4)(2009-2#1)
pain to##5##2##(1993-2#1)(2006-12#1)(2008-9#1)(2009-7#1)(2010-3#1)
pain tolerance##3##2##(2008-10#2)(2009-2#1)
pain transmission##5##2##(1996-12#1)(2008-4#3)(2008-9#1)
pain treatment##11##2##(1997-3#5)(2007-8#1)(2008-7#1)(2009-12#4)
pain underwent a##2##3##(2008-12#1)(2008-9#1)
pain underwent##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
pain was achieved in##2##4##(2007-11#1)(2008-6#1)
pain was evaluated##2##3##(2008-10#1)(2008-7#1)
pain was the##4##3##(1991-2#1)(1992-1#1)(2007-7#1)(2013-1#1)
pain was##29##2##(1991-2#2)(1992-1#1)(1992-5#1)(1995-10#1)(1996-3#1)(1996-6#1)(1997-4#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
pain were measured##2##3##(1993-2#1)(1996-6#1)
pain were the most##2##4##(1991-2#1)(2013-1#1)
pain were##12##2##(1991-2#1)(1991-8#1)(1993-2#1)(1996-6#1)(1997-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
pain who##2##2##(2008-3#1)(2013-1#1)
pain with##14##2##(1992-12#1)(1992-2#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
pain without##3##2##(1992-2#1)(2008-7#1)(2012-2#1)
pain##1816##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#1)(1990-3#2)(1990-6#16)(1990-9#6)(1991-1#2)(1991-11#7)(1991-2#11)(1991-3#5)(1991-5#2)(1991-6#1)(1991-8#5)(1991-9#2)(1992-1#5)(1992-12#5)(1992-2#9)(1992-3#1)(1992-4#1)(1992-5#9)(1992-6#4)(1992-8#1)(1992-9#5)(1993-1#13)(1993-10#1)(1993-12#3)(1993-2#9)(1993-3#3)(1993-6#7)(1993-7#1)(1993-9#5)(1994-1#3)(1994-11#2)(1994-12#2)(1994-2#9)(1994-3#11)(1994-9#3)(1995-1#2)(1995-10#3)(1995-12#9)(1995-2#4)(1995-3#9)(1995-5#3)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#4)(1996-2#9)(1996-3#11)(1996-5#4)(1996-6#6)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#8)(1997-3#16)(1997-4#11)(1997-5#9)(1997-6#3)(1997-7#4)(1997-8#9)(2006-10#14)(2006-12#11)(2007-10#1)(2007-11#117)(2007-12#6)(2007-2#2)(2007-5#4)(2007-6#1)(2007-7#14)(2007-8#43)(2007-9#3)(2008-1#7)(2008-10#58)(2008-11#55)(2008-12#92)(2008-2#3)(2008-3#52)(2008-4#42)(2008-5#20)(2008-6#19)(2008-7#142)(2008-8#42)(2008-9#76)(2009-1#8)(2009-10#4)(2009-11#6)(2009-12#31)(2009-2#5)(2009-3#25)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#6)(2009-8#5)(2009-9#4)(2010-1#17)(2010-10#7)(2010-11#30)(2010-12#39)(2010-3#17)(2010-4#16)(2010-5#3)(2010-6#16)(2010-7#17)(2010-8#6)(2010-9#17)(2011-1#6)(2011-2#73)(2012-1#6)(2012-12#49)(2012-2#75)(2012-3#36)(2012-8#1)(2013-1#108)(2013-7#3)(2013-8#23)
pain&quot##7##1##(2007-11#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
pain)##5##1##(1992-9#1)(1997-3#1)(2008-7#2)(2008-8#1)
pain-free##5##1##(2007-8#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
pain-related##2##1##(1995-12#1)(2008-7#1)
pain?##2##1##(1992-6#1)(2008-7#1)
pain]##9##1##(1991-3#1)(1992-9#1)(1993-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2012-3#2)
painful and disabling##3##3##(2007-11#1)(2009-2#1)(2009-5#1)
painful and##7##2##(1990-6#1)(1995-12#1)(2007-11#1)(2008-10#1)(2009-11#1)(2009-2#1)(2009-5#1)
painful condition that##2##3##(1992-5#1)(2008-12#1)
painful diabetic##3##2##(2008-4#2)(2008-9#1)
painful mass in the##2##4##(2010-5#1)(2013-1#1)
painful mass##3##2##(2007-7#1)(2010-5#1)(2013-1#1)
painful osseous metastases##2##3##(2007-11#2)
painful periods##2##2##(1996-3#1)(2013-1#1)
painful peripheral neuropathies##2##3##(2008-7#2)
painful peripheral##4##2##(1996-5#2)(2008-7#2)
painful procedures##3##2##(1994-12#1)(2008-10#2)
painful regional lymphadenitis##2##3##(1991-4#2)
painful skin##2##2##(1996-6#2)
painful swelling of the##4##4##(1990-11#1)(1991-3#1)(2007-6#1)(2008-1#1)
painful swelling of##5##3##(1990-11#1)(1991-3#1)(2007-6#1)(2007-7#1)(2008-1#1)
painful swelling##7##2##(1990-11#1)(1991-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-3#1)
painful symptoms##2##2##(1992-5#1)(2008-1#1)
painful##108##1##(1990-11#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#3)(1994-12#1)(1995-12#4)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#3)(1997-4#1)(2007-11#7)(2007-12#1)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#5)(2008-4#3)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#3)
painkillers##2##1##(2007-8#1)(2010-12#1)
painless central chondrosarcoma of pubis##2##5##(2008-5#2)
painless swelling##3##2##(2007-7#1)(2008-12#1)(2011-2#1)
painless##28##1##(1991-11#1)(1997-5#1)(2006-12#1)(2007-11#2)(2007-7#3)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
pains and##2##2##(2010-10#1)(2012-2#1)
pains in##2##2##(2008-11#1)(2008-4#1)
pains##19##1##(1991-5#1)(1993-3#1)(1995-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
paint and##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
paint are##2##2##(2007-12#2)
paint layer##3##2##(2007-12#3)
paint##31##1##(1995-6#1)(2007-12#10)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2009-8#1)(2010-4#3)(2012-1#1)
painted in green##2##3##(2008-6#2)
painted metal##2##2##(2007-12#1)(2008-3#1)
painted with##2##2##(2008-10#2)
painted##16##1##(2007-12#3)(2008-10#7)(2008-3#1)(2008-6#2)(2009-7#2)(2010-4#1)
painting and##2##2##(2007-7#1)(2012-3#1)
painting from the##2##3##(2008-10#2)
painting from##3##2##(2008-10#3)
painting is##2##2##(2011-2#1)(2012-2#1)
painting of previously##2##3##(2008-10#1)(2008-4#1)
painting on##2##2##(1992-2#1)(2008-7#1)
painting##36##1##(1991-2#1)(1992-2#1)(1995-6#1)(2007-7#2)(2008-10#15)(2008-4#1)(2008-7#2)(2008-9#4)(2009-2#1)(2010-3#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
paintings from##2##2##(2008-10#1)(2008-3#1)
paintings##21##1##(1995-12#1)(1995-6#1)(2008-10#15)(2008-2#1)(2008-3#2)(2012-2#1)
paints from##2##2##(2008-10#2)
paints##11##1##(1995-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)
pair 3##2##2##(2008-11#1)(2010-3#1)
pair and recombine##2##3##(2008-5#1)(2008-7#1)
pair and##6##2##(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)
pair as a##2##3##(1993-11#1)(2008-11#1)
pair as##5##2##(1993-11#1)(2008-10#3)(2008-11#1)
pair at the##2##3##(1995-5#1)(1995-6#1)
pair at##3##2##(1995-5#1)(1995-6#1)(2008-2#1)
pair based on##3##3##(2008-10#2)(2008-3#1)
pair cDNA##2##2##(1992-8#1)(1994-8#1)
pair formation##4##2##(2008-10#2)(2008-5#1)(2009-5#1)
pair fragment##2##2##(2008-10#2)
pair had##3##2##(2008-12#2)(2008-2#1)
pair in##6##2##(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)
pair is##6##2##(1992-3#1)(1995-5#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)
pair of Ac elements derived from##2##6##(2012-3#2)
pair of cells##2##3##(2007-12#2)
pair of eyes##2##3##(1992-6#1)(2008-5#1)
pair of genes##2##3##(1994-8#1)(2008-5#1)
pair of primers##2##3##(2008-10#2)
pair of prism##2##3##(2007-11#1)(2008-3#1)
pair of well-defined redox##3##4##(2008-10#3)
pair of well-defined##5##3##(2008-10#5)
pair of##134##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1997-5#2)(1997-7#1)(2007-11#9)(2007-12#13)(2007-9#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#21)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#3)(2009-2#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#5)(2013-8#1)
pair on##2##2##(1996-2#1)(2008-10#1)
pair sequence##5##2##(1991-11#1)(1995-6#1)(1996-12#2)(1996-6#1)
pair to##3##2##(2007-11#1)(2008-12#1)(2008-3#1)
pair was used to##2##4##(2007-11#1)(2007-12#1)
pair was##7##2##(1994-9#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-12#1)
pair with##4##2##(1994-8#1)(2008-10#3)
pair##332##1##(1990-11#1)(1990-5#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#9)(1996-12#2)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#5)(1997-7#3)(2007-10#1)(2007-11#15)(2007-12#15)(2007-7#1)(2007-9#1)(2008-10#76)(2008-11#11)(2008-12#12)(2008-2#16)(2008-3#33)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#7)(2008-8#12)(2008-9#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
pair-fed##4##1##(1992-8#1)(1993-12#1)(1993-6#1)(2010-6#1)
pair-wise##4##1##(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
paired and##2##2##(1993-6#1)(2010-8#1)
paired basic amino acids##2##4##(1991-9#2)
paired basic amino##3##3##(1991-9#2)(1993-5#1)
paired bihemispheric##2##2##(1996-3#2)
paired comparisons##2##2##(2008-10#1)(2010-8#1)
paired data##3##2##(1990-6#1)(2008-7#1)(2013-1#1)
paired ducts##2##2##(2007-12#2)
paired helical##3##2##(1991-1#1)(1992-6#2)
paired normal##2##2##(1994-2#1)(2011-2#1)
paired samples##3##2##(1992-3#1)(2007-2#1)(2008-5#1)
paired t##3##2##(1990-12#1)(2010-10#1)(2012-2#1)
paired t-test##11##2##(2008-10#9)(2008-5#1)(2008-7#1)
paired t-tests##3##2##(2009-2#1)(2010-6#1)(2012-1#1)
paired to##2##2##(1993-11#1)(2011-7#1)
paired with a##4##3##(1996-2#1)(1997-8#2)(2008-4#1)
paired with the##2##3##(1993-8#2)
paired with##7##2##(1993-12#1)(1993-8#2)(1996-2#1)(1997-8#2)(2008-4#1)
paired##91##1##(1990-12#1)(1990-6#1)(1991-1#1)(1991-9#2)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#2)(1993-8#2)(1994-2#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-8#2)(2007-12#9)(2007-2#2)(2008-10#16)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
paired-helical filaments##3##2##(2008-7#3)
pairing a##2##2##(2008-4#1)(2010-11#1)
pairing and chiasma formation were##2##5##(2008-5#2)
pairing and chiasma formation##3##4##(2008-5#3)
pairing and##8##2##(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#1)(2011-2#1)
pairing between##2##2##(1990-5#1)(1995-2#1)
pairing of the##2##3##(1993-9#1)(2009-6#1)
pairing of##8##2##(1991-5#1)(1993-9#1)(1994-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)
pairing partner##2##2##(2008-5#1)(2012-3#1)
pairing with##4##2##(1993-11#1)(2008-7#1)(2011-2#2)
pairing##57##1##(1990-5#2)(1991-5#3)(1992-6#2)(1992-8#2)(1993-11#3)(1993-9#1)(1994-5#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#11)(2008-7#5)(2009-5#2)(2009-6#1)(2010-11#1)(2011-2#3)(2012-2#2)(2012-3#1)
pairings between clients and##2##4##(1996-3#2)
pairings##7##1##(1996-3#2)(2008-10#2)(2008-5#3)
pairs also##2##2##(2008-10#1)(2008-5#1)
pairs and their##2##3##(1996-12#1)(2008-1#1)
pairs and##19##2##(1993-11#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2011-2#1)
pairs are##4##2##(1994-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
pairs at##3##2##(1992-6#2)(2007-11#1)
pairs between##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
pairs for each##2##3##(1993-8#1)(2008-10#1)
pairs for the##2##3##(1990-8#1)(2013-8#1)
pairs for##4##2##(1990-8#1)(1993-8#1)(2008-10#1)(2013-8#1)
pairs from##4##2##(1997-5#1)(2007-5#1)(2008-10#1)(2008-12#1)
pairs generated##3##2##(2007-12#2)(2008-10#1)
pairs in a##5##3##(1995-12#1)(2007-11#2)(2007-12#2)
pairs in the##4##3##(2007-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
pairs in##17##2##(1991-5#1)(1995-12#1)(1995-2#1)(1997-9#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#1)
pairs involving##2##2##(1995-6#1)(2008-4#1)
pairs is##5##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
pairs of closely##2##3##(2007-11#1)(2013-7#1)
pairs of extended##2##3##(2008-10#2)
pairs of lateral cardiac arteries and##2##6##(2007-12#2)
pairs of lateral##3##3##(2007-12#2)(2008-5#1)
pairs of loci##2##3##(2008-10#2)
pairs of neurons##2##3##(1995-11#1)(2008-11#1)
pairs of populations##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
pairs of primers##3##3##(2008-10#2)(2008-8#1)
pairs of stimuli##2##3##(1993-12#1)(2011-2#1)
pairs of the##3##3##(1991-11#1)(1997-7#1)(2008-6#1)
pairs of these##2##3##(2007-12#1)(2008-10#1)
pairs of wavelengths##2##3##(2008-10#1)(2008-3#1)
pairs of##128##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-8#1)(1993-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#2)(1996-2#2)(1996-5#3)(1997-3#2)(1997-7#2)(1997-9#1)(2007-11#10)(2007-12#13)(2008-10#29)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
pairs on the##2##3##(2007-12#1)(2009-5#1)
pairs or##3##2##(1994-9#1)(2008-12#1)(2008-2#1)
pairs previously##2##2##(1992-8#1)(2008-5#1)
pairs produced##2##2##(2008-3#1)(2008-5#1)
pairs that##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
pairs to##2##2##(2008-10#1)(2013-1#1)
pairs used##3##2##(1997-5#1)(2008-10#2)
pairs was##4##2##(1995-12#1)(2009-9#2)(2012-12#1)
pairs were analyzed##2##3##(1993-11#1)(2008-2#1)
pairs were designed##2##3##(2008-10#2)
pairs were positive##2##3##(2011-2#2)
pairs were##15##2##(1990-9#1)(1993-11#1)(1994-2#1)(2008-10#6)(2008-12#1)(2008-2#1)(2011-2#4)
pairs with a##4##3##(1991-9#1)(1997-8#1)(1997-9#1)(2007-11#1)
pairs with an##2##3##(1991-12#1)(2008-2#1)
pairs with##16##2##(1991-12#1)(1991-9#1)(1992-11#1)(1993-3#1)(1997-5#2)(1997-8#1)(1997-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2009-5#1)
pairs##386##1##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#4)(1992-8#3)(1993-1#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#6)(1997-5#8)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#3)(2007-10#1)(2007-11#17)(2007-12#22)(2007-5#1)(2008-1#1)(2008-10#79)(2008-11#5)(2008-12#14)(2008-2#16)(2008-3#16)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#8)(2009-11#2)(2009-12#4)(2009-2#1)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#3)(2011-2#13)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
pairs)##9##1##(1991-9#1)(1992-3#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)
pairs/mm##6##1##(2007-12#2)(2008-2#1)(2008-3#3)
pairwise F(ST)##2##2##(2008-10#1)(2011-2#1)
pairwise HAMMER##2##2##(2011-2#2)
pairwise combinations##2##2##(2008-10#1)(2008-8#1)
pairwise comparisons##2##2##(2008-10#1)(2008-5#1)
pairwise contrasts##2##2##(2008-10#2)
pairwise interactions##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
pairwise##41##1##(1994-5#2)(1995-6#1)(2007-10#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2010-11#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-3#4)(2013-8#1)
pal-1##3##1##(1991-5#3)
pal-KTTKS##2##1##(2008-5#2)
palF##2##1##(1997-7#2)
palF15##2##1##(1997-7#2)
palaeoenvironmental##2##1##(2012-7#1)(2012-9#1)
palatability##9##1##(2008-9#2)(2010-4#6)(2012-2#1)
palatable food##3##2##(2008-4#3)
palatable##5##1##(2008-4#3)(2009-5#1)(2012-2#1)
palatal flap##2##2##(2007-12#2)
palatal root##2##2##(2013-1#2)
palatal roots##3##2##(2013-1#3)
palatal##15##1##(2007-12#3)(2008-12#1)(2009-7#1)(2013-1#10)
palate and##3##2##(1990-6#1)(2009-8#1)(2013-1#1)
palate have##2##2##(2010-5#1)(2013-1#1)
palate in a##2##3##(2008-12#1)(2012-3#1)
palate in##4##2##(2008-12#2)(2012-3#1)(2013-1#1)
palate is the most common##2##5##(2009-6#1)(2012-12#1)
palate is##5##2##(1991-2#1)(1991-3#1)(2009-6#1)(2012-12#1)(2013-1#1)
palate patient##3##2##(2007-12#1)(2013-1#2)
palate##52##1##(1990-6#1)(1991-11#2)(1991-2#2)(1991-3#1)(1995-3#2)(1996-8#1)(1997-3#1)(2007-12#6)(2008-10#1)(2008-12#3)(2009-1#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#6)(2012-3#2)(2013-1#11)
palates##2##1##(2009-7#1)(2011-2#1)
palatinose##2##1##(1992-12#2)
pale and##2##2##(2008-1#1)(2008-5#1)
pale eggs##3##2##(2008-8#3)
pale in comparison to the##2##5##(1994-3#1)(2008-11#1)
pale spots##2##2##(2007-12#2)
pale##17##1##(1994-3#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#3)(2008-8#6)(2012-1#1)(2013-1#1)
palea and##3##2##(2008-10#2)(2008-8#1)
palea##10##1##(2008-10#9)(2008-8#1)
paleoanthropologists##2##1##(2008-1#2)
paleontological##3##1##(2008-8#1)(2010-4#1)(2010-5#1)
paleorecords of##2##2##(2008-8#2)
palette##3##1##(2008-10#2)(2013-1#1)
palindromic##6##1##(1990-11#1)(1993-12#1)(2008-10#4)
palladin##2##1##(2009-7#2)
palladium (II)##2##2##(2008-10#2)
palladium (Pd)##3##2##(2008-10#3)
palladium and##5##2##(2008-10#4)(2008-11#1)
palladium as##2##2##(2008-10#2)
palladium by graphite furnace atomic absorption##2##6##(2008-10#2)
palladium by##4##2##(2008-10#4)
palladium catalysts##2##2##(2008-10#2)
palladium complexes##2##2##(2008-10#2)
palladium determination##3##2##(2008-10#3)
palladium film##2##2##(2008-10#2)
palladium in##8##2##(2008-10#8)
palladium with##3##2##(1991-12#1)(2008-10#2)
palladium##71##1##(1991-12#4)(2007-11#1)(2008-10#63)(2008-11#1)(2008-6#1)(2010-4#1)
palladium(0)##2##1##(1996-5#1)(2009-12#1)
palladium(II) and##4##2##(2008-10#4)
palladium(II) in##4##2##(2008-10#4)
palladium(II)##35##1##(2008-10#33)(2013-1#2)
palladium-catalyzed hydrostannation of ethyl ethynyl ether##2##6##(2009-12#2)
palladium-catalyzed hydrostannation of##3##3##(2009-12#3)
palladium-catalyzed##5##1##(2007-11#1)(2009-12#4)
palladium-magnesium nitrate and ammonium dihydrogenphosphate##2##5##(2008-10#2)
palladium-magnesium nitrate##4##2##(2008-10#4)
palladium-magnesium##6##1##(2008-10#6)
palladium-zirconium##3##1##(2008-10#3)
pallens##2##1##(2008-8#2)
palliate##2##1##(2008-7#2)
palliation and##3##2##(2007-10#1)(2007-8#1)(2009-5#1)
palliation in##3##2##(1990-2#1)(2007-11#2)
palliation of malignant##4##3##(2007-8#1)(2008-12#1)(2012-2#2)
palliation of symptoms##2##3##(1991-2#1)(2008-6#1)
palliation of##11##2##(1991-2#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-6#1)(2010-8#2)(2012-2#2)
palliation##33##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#2)(1993-6#1)(1996-3#1)(2007-10#3)(2007-11#2)(2007-8#5)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#2)
palliative and##3##2##(2007-11#1)(2008-6#1)(2012-12#1)
palliative care and##2##3##(2010-10#1)(2012-3#1)
palliative care in the##2##4##(2009-10#1)(2012-12#1)
palliative care##38##2##(1992-2#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-9#3)(2010-10#5)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#1)
palliative chemotherapy##3##2##(1990-12#1)(2008-6#1)(2012-1#1)
palliative medicine##5##2##(2008-7#2)(2012-3#3)
palliative operation##4##2##(1990-9#3)(2008-7#1)
palliative radiation therapy##4##3##(2008-7#3)(2012-12#1)
palliative radiotherapy to##2##3##(2008-10#1)(2008-6#1)
palliative radiotherapy##10##2##(2007-11#4)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
palliative surgery##2##2##(1990-9#1)(2011-2#1)
palliative therapy using strontium 89##2##5##(2007-11#2)
palliative therapy##5##2##(2007-11#3)(2010-3#1)(2012-3#1)
palliative treatment for##2##3##(1996-8#1)(2010-5#1)
palliative treatment in patients with##2##5##(1993-6#1)(2007-11#1)
palliative treatment in##3##3##(1993-6#1)(2007-11#1)(2012-2#1)
palliative treatment of##5##3##(2008-6#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
palliative treatment##13##2##(1993-6#1)(1996-8#1)(1997-3#1)(2007-11#2)(2008-11#1)(2008-6#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
palliative##108##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#5)(1991-12#1)(1991-3#1)(1992-2#2)(1993-6#1)(1994-1#1)(1996-8#1)(1997-3#1)(2007-11#14)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#8)(2009-10#1)(2009-9#4)(2010-10#6)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#12)(2013-1#2)(2013-8#1)
palliatively##3##1##(1990-9#1)(2007-11#1)(2008-6#1)
pallida in##2##2##(2006-11#1)(2008-10#1)
pallida populations##2##2##(2008-10#2)
pallida##11##1##(2006-11#4)(2008-10#6)(2013-7#1)
pallida)##3##1##(2008-10#3)
pallidal##6##1##(1995-5#1)(2008-4#1)(2008-7#4)
pallidotomies##2##1##(2008-7#2)
pallidotomy##7##1##(2008-7#7)
pallidum is##2##2##(2008-7#2)
pallidum##13##1##(1993-6#1)(1995-5#2)(1997-2#1)(1997-5#2)(2008-7#5)(2012-12#2)
pallidus and##2##2##(2008-7#1)(2009-2#1)
pallidus##10##1##(1992-10#1)(1993-12#1)(1996-12#1)(2008-5#2)(2008-7#2)(2009-2#2)(2012-2#1)
pallor of##2##2##(1993-2#1)(2012-2#1)
pallor##6##1##(1993-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
palm oil as##2##3##(2008-6#2)
palm oil##5##2##(2008-12#1)(2008-6#3)(2013-1#1)
palm shell##3##2##(2013-1#3)
palm trees in##2##3##(2008-6#2)
palm trees##7##2##(2008-10#3)(2008-6#4)
palm##45##1##(1994-5#1)(2008-10#17)(2008-12#1)(2008-5#2)(2008-6#9)(2009-5#1)(2011-2#7)(2013-1#7)
palmar and dorsal##2##3##(2008-9#2)
palmar and##3##2##(2008-9#2)(2012-1#1)
palmar arch##4##2##(2008-9#3)(2011-2#1)
palmar defect##2##2##(2008-9#2)
palmar##16##1##(1997-3#1)(2008-10#2)(2008-9#10)(2011-2#2)(2012-1#1)
palmaris longus tendon##2##3##(2008-9#2)
palmaris longus##4##2##(2008-9#3)(2009-1#1)
palmarosa##2##1##(2010-3#2)
palmata##4##1##(1990-11#1)(2007-5#1)(2008-10#2)
palmeri##3##1##(2009-8#2)(2011-2#1)
palmitate (16##2##2##(1990-2#1)(1995-8#1)
palmitate as##3##2##(1992-9#1)(2008-5#1)(2010-10#1)
palmitate##17##1##(1990-2#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-8#1)(2008-5#5)(2008-7#1)(2010-10#1)
palmitic acid (C16##2##3##(1990-8#1)(2011-1#1)
palmitic acid on##4##3##(1995-5#1)(2008-5#2)(2010-12#1)
palmitic acid were##2##3##(1994-5#1)(2010-4#1)
palmitic acid##21##2##(1990-8#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-5#2)(1995-5#2)(2008-10#1)(2008-12#1)(2008-5#5)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)
palmitic and##2##2##(1994-8#1)(2008-12#1)
palmitic fatty acid##3##3##(2013-1#3)
palmitic saturated fatty acid (C##2##5##(2013-1#2)
palmitic saturated fatty acid##5##4##(2013-1#5)
palmitic triglycerides##2##2##(2013-1#2)
palmitic##42##1##(1990-8#1)(1991-3#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-5#2)(1994-8#2)(1995-5#2)(2008-10#4)(2008-12#3)(2008-5#5)(2008-7#1)(2009-6#2)(2010-12#1)(2010-4#1)(2011-1#2)(2013-1#10)
palmitoleic acid##3##2##(1993-6#2)(2011-1#1)
palmitoleic##5##1##(1993-6#2)(2008-10#2)(2011-1#1)
palmitoyl pentapeptide##2##2##(2008-5#2)
palmitoyl##5##1##(1995-2#1)(2007-11#1)(2008-10#1)(2008-5#2)
palmitoyl-CoA was##2##2##(1990-5#1)(1993-6#1)
palmitoyl-CoA##7##1##(1990-5#3)(1992-11#1)(1993-3#1)(1993-6#1)(1995-3#1)
palmitoyl-L-carnitine##3##1##(1990-11#1)(1992-8#2)
palmitoylated##4##1##(1993-11#2)(2008-7#1)(2008-8#1)
palmitoylation##2##1##(2008-7#1)(2008-8#1)
palmitoyloleoylphosphatidylcholine##2##1##(1994-12#1)(2012-2#1)
palmitoyltransferase##5##1##(1990-11#1)(1992-8#1)(1997-3#2)(2012-2#1)
palmivora were##2##2##(2008-10#2)
palmivora##16##1##(2008-10#16)
palmoplantar##2##1##(2006-10#1)(2007-7#1)
palms and soles##2##3##(1997-3#1)(2010-6#1)
palms and##3##2##(1997-3#1)(2008-10#1)(2010-6#1)
palms##9##1##(1997-3#1)(2008-10#4)(2008-5#2)(2010-6#1)(2012-3#1)
palpable breast##2##2##(1990-10#1)(2008-12#1)
palpable mass##5##2##(2008-10#1)(2010-3#1)(2013-1#3)
palpable nodules##2##2##(2010-11#1)(2010-7#1)
palpable##31##1##(1990-10#2)(1990-9#2)(1992-2#1)(1992-4#1)(1994-7#1)(1995-1#1)(1997-4#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#6)(2013-7#1)
palpated##6##1##(1994-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2012-12#1)(2013-8#1)
palpation and##3##2##(1990-9#1)(2008-8#2)
palpation in##2##2##(1990-12#1)(2007-8#1)
palpation of##2##2##(1995-4#1)(2008-12#1)
palpation##18##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-8#1)(1995-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-8#4)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)
palpatory##3##1##(1992-1#1)(2009-6#1)(2009-9#1)
palpebral##4##1##(1997-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
palpitation##2##1##(1993-6#1)(2011-1#1)
palpitations##5##1##(1993-2#1)(1994-11#1)(1997-3#1)(2008-12#1)(2012-3#1)
palsies##18##1##(1996-9#2)(1997-3#1)(2007-10#1)(2008-7#4)(2010-11#1)(2011-2#7)(2012-2#1)(2012-3#1)
palsy (CP)##4##2##(2009-4#2)(2011-2#2)
palsy (PSP)##3##2##(1992-8#1)(2008-7#1)(2012-12#1)
palsy and the##2##3##(2006-12#1)(2011-2#1)
palsy and##9##2##(1991-6#1)(2006-12#1)(2007-10#2)(2007-8#1)(2009-3#1)(2010-9#1)(2011-2#2)
palsy caused by##2##3##(2007-10#1)(2010-7#1)
palsy due to##2##3##(2008-11#1)(2008-9#1)
palsy in##5##2##(1995-6#1)(1997-5#1)(2007-10#1)(2007-8#1)(2011-2#1)
palsy is##5##2##(1995-6#3)(1996-9#1)(2008-9#1)
palsy##93##1##(1991-6#1)(1992-8#2)(1995-6#7)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-12#3)(2007-10#7)(2007-11#1)(2007-8#4)(2008-1#1)(2008-11#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-3#9)(2009-4#5)(2009-5#1)(2009-7#2)(2010-7#1)(2010-9#2)(2011-2#13)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#2)
palustris and##2##2##(1994-3#1)(2008-8#1)
palustris##5##1##(1994-3#1)(1995-8#1)(2008-8#2)(2010-3#1)
palustris)##3##1##(2008-5#1)(2010-3#2)
palynological##2##1##(1991-8#1)(2011-2#1)
pamidronate and##2##2##(2008-6#1)(2012-12#1)
pamidronate in##2##2##(1990-3#1)(2008-7#1)
pamidronate##8##1##(1990-3#1)(2007-11#2)(2008-6#1)(2008-7#3)(2012-12#1)
pamphlets about##2##2##(1990-2#1)(2013-1#1)
pamphlets##13##1##(1990-2#10)(1992-12#1)(2011-1#1)(2013-1#1)
pan##9##1##(1992-8#3)(1997-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-7#1)
pan-Canadian public health##2##3##(2008-11#2)
pan-Canadian##4##1##(2008-11#2)(2010-12#2)
panacea##8##1##(1991-12#1)(1993-7#1)(1994-2#1)(1996-3#1)(1997-3#1)(2008-6#1)(2008-7#1)(2010-1#1)
panamensis##3##1##(2007-11#1)(2013-7#2)
panax##3##1##(2008-10#3)
panbronchiolitis##3##1##(1995-8#3)
pancreas and liver##2##3##(2008-7#2)
pancreas and stomach##2##3##(2008-1#1)(2008-7#1)
pancreas and##25##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#5)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
pancreas as##4##2##(1995-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
pancreas can##2##2##(2008-7#1)(2012-12#1)
pancreas development##4##2##(2009-11#1)(2009-3#1)(2010-11#2)
pancreas in Nepalese##2##3##(2012-3#2)
pancreas in the gallbladder wall##3##5##(1997-8#3)
pancreas in the gallbladder##4##4##(1997-8#3)(2013-8#1)
pancreas in##10##2##(1992-5#1)(1997-8#3)(2008-3#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
pancreas is a##2##3##(2012-2#1)(2013-1#1)
pancreas is##7##2##(1990-3#1)(1991-3#1)(2012-2#2)(2013-1#2)(2013-7#1)
pancreas of##9##2##(1990-2#1)(1995-3#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
pancreas or##2##2##(2010-12#2)
pancreas transplantation##5##2##(1990-5#1)(1995-2#2)(2008-1#1)(2012-2#1)
pancreas was##4##2##(2007-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
pancreas were##2##2##(1990-9#1)(2012-3#1)
pancreas which##2##2##(2012-3#1)(2013-7#1)
pancreas with##2##2##(1990-3#1)(2008-7#1)
pancreas##199##1##(1990-12#5)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#8)(1991-3#2)(1991-7#1)(1991-9#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#2)(1994-8#2)(1995-11#6)(1995-2#6)(1995-3#3)(1995-6#1)(1996-12#1)(1997-5#1)(1997-8#3)(2007-10#2)(2007-5#1)(2008-1#7)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#16)(2008-8#2)(2009-11#3)(2009-3#2)(2010-1#1)(2010-10#2)(2010-11#15)(2010-12#6)(2011-1#1)(2011-2#2)(2012-12#6)(2012-2#15)(2012-3#11)(2013-1#18)(2013-7#8)(2013-8#2)
pancreas)##3##1##(1990-5#1)(1997-5#1)(2008-1#1)
pancreases##2##1##(2010-11#1)(2012-3#1)
pancreata##3##1##(2010-11#2)(2010-12#1)
pancreatectomy##6##1##(1990-6#1)(1990-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
pancreatic OPN##3##2##(2010-11#3)
pancreatic acinar cells##6##3##(1991-5#1)(1993-6#2)(2008-7#1)(2009-7#2)
pancreatic acinar##7##2##(1991-5#1)(1992-8#1)(1993-6#2)(2008-7#1)(2009-7#2)
pancreatic acini and gastric chief cells from guinea pig##3##9##(1994-8#3)
pancreatic acini##11##2##(1991-8#2)(1992-12#2)(1994-8#3)(1995-11#4)
pancreatic adenocarcinoma##4##2##(1991-2#1)(2008-1#1)(2012-12#1)(2013-1#1)
pancreatic alpha-amylase##5##2##(1990-7#1)(1990-9#2)(1992-12#2)
pancreatic and biliary##2##3##(2011-2#2)
pancreatic and peripancreatic##2##3##(2008-3#1)(2012-2#1)
pancreatic and##9##2##(1991-3#1)(1993-12#1)(2008-3#2)(2011-2#4)(2012-2#1)
pancreatic beta cells##6##3##(1997-4#1)(2008-10#1)(2009-3#1)(2009-8#1)(2010-11#2)
pancreatic beta##7##2##(1997-4#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-11#2)
pancreatic beta-cell##3##2##(1994-12#1)(2008-1#1)(2008-11#1)
pancreatic beta-cells##12##2##(1991-12#1)(1994-11#2)(1996-2#2)(1996-5#2)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
pancreatic cancer cells##3##3##(2013-1#3)
pancreatic cancer in##2##3##(1990-9#1)(2013-1#1)
pancreatic cancer mortality##2##3##(1990-6#1)(2009-7#1)
pancreatic cancer##35##2##(1990-6#4)(1990-9#3)(1993-3#1)(1994-3#1)(2009-5#1)(2009-7#1)(2011-2#11)(2012-12#3)(2012-3#2)(2013-1#8)
pancreatic cancer]##4##2##(1990-11#1)(1990-9#2)(2012-3#1)
pancreatic cancers##3##2##(2013-1#3)
pancreatic carcinoma##5##2##(1991-2#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-9#1)
pancreatic cells##5##2##(2008-9#2)(2010-11#3)
pancreatic colipase##2##2##(1990-2#2)
pancreatic disease##2##2##(1993-12#1)(2009-8#1)
pancreatic duct goblet##2##3##(1994-11#2)
pancreatic duct##13##2##(1994-11#2)(2008-10#2)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
pancreatic ductal adenocarcinoma##2##3##(2007-2#1)(2013-1#1)
pancreatic ductal##3##2##(2007-2#1)(2012-2#1)(2013-1#1)
pancreatic ducts##2##2##(1994-11#1)(2013-1#1)
pancreatic elastase##7##2##(1990-2#1)(1991-3#2)(1994-6#1)(2008-5#3)
pancreatic endocrine neoplasms##2##3##(2011-2#2)
pancreatic endocrine tumor##2##3##(2009-4#1)(2010-9#1)
pancreatic endocrine tumors##2##3##(1992-7#1)(2010-9#1)
pancreatic endocrine##7##2##(1992-7#1)(2009-4#1)(2010-11#1)(2010-9#2)(2011-2#2)
pancreatic enzymes##2##2##(2008-8#1)(2011-1#1)
pancreatic epithelial##2##2##(2010-11#1)(2012-12#1)
pancreatic exocrine##2##2##(1993-3#1)(2009-7#1)
pancreatic fistula##3##2##(1991-3#1)(1994-3#1)(2008-3#1)
pancreatic function##3##2##(1992-11#1)(2008-5#1)(2013-7#1)
pancreatic growth##2##2##(1993-6#1)(2012-12#1)
pancreatic hamartoma##4##2##(2013-1#4)
pancreatic head resection##2##3##(2013-7#2)
pancreatic head##10##2##(1990-9#1)(1993-3#1)(2008-10#2)(2008-6#1)(2013-1#1)(2013-7#4)
pancreatic heterotopia##2##2##(2013-7#2)
pancreatic injury##2##2##(2010-1#2)
pancreatic insulin##3##2##(1990-12#1)(1994-11#1)(2010-11#1)
pancreatic islet cell##4##3##(2008-2#2)(2010-11#1)(2012-2#1)
pancreatic islet cells##2##3##(1990-2#1)(2010-11#1)
pancreatic islet isolation##3##3##(2008-11#3)
pancreatic islet##17##2##(1990-2#1)(1991-7#1)(2008-11#3)(2008-2#2)(2010-11#7)(2010-12#1)(2010-9#1)(2012-2#1)
pancreatic islets of##2##3##(1994-8#1)(2010-12#1)
pancreatic islets##20##2##(1990-12#1)(1994-8#2)(1995-8#2)(2008-10#2)(2008-11#2)(2009-3#1)(2009-8#1)(2010-11#6)(2010-12#3)
pancreatic juice##4##2##(1990-12#1)(2009-7#3)
pancreatic lipase##7##2##(1992-12#1)(1992-3#2)(1995-5#3)(2012-3#1)
pancreatic malignancy##2##2##(2013-1#1)(2013-8#1)
pancreatic necrosis##4##2##(2009-5#1)(2013-1#3)
pancreatic neoplasm##2##2##(2012-2#1)(2013-8#1)
pancreatic neoplasms##3##2##(2012-2#3)
pancreatic or periampullary cancer##2##4##(2013-1#2)
pancreatic or periampullary##3##3##(2013-1#3)
pancreatic or##4##2##(1994-8#1)(2013-1#3)
pancreatic polypeptide##2##2##(2008-1#1)(2010-11#1)
pancreatic secretion##3##2##(1992-8#1)(2008-10#1)(2008-7#1)
pancreatic secretory trypsin inhibitor##3##4##(1990-12#2)(1990-8#1)
pancreatic stones and anastomotic stricture after end-to-side pancreaticojejunostomy##2##8##(2013-7#2)
pancreatic tissue##5##2##(1997-8#1)(2012-2#2)(2013-8#2)
pancreatic tissues##4##2##(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
pancreatic trypsin inhibitor##3##3##(1991-11#1)(1997-2#1)(1997-4#1)
pancreatic β##2##2##(2013-7#2)
pancreatic β-cell##6##2##(2010-10#2)(2010-11#4)
pancreatic β-cells##9##2##(2010-10#1)(2010-11#7)(2012-12#1)
pancreatic##370##1##(1990-11#1)(1990-12#5)(1990-2#4)(1990-4#1)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#9)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#7)(1991-5#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#3)(1993-3#3)(1993-6#6)(1994-11#11)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#7)(1995-11#4)(1995-3#1)(1995-5#3)(1995-8#2)(1996-2#2)(1996-5#2)(1997-2#1)(1997-4#2)(1997-8#1)(2007-2#1)(2007-5#2)(2008-1#4)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#9)(2009-8#4)(2010-1#5)(2010-10#3)(2010-11#42)(2010-12#4)(2010-9#3)(2011-1#3)(2011-2#22)(2012-12#9)(2012-2#14)(2012-3#7)(2013-1#43)(2013-7#16)(2013-8#8)
pancreatico-duodenal##2##1##(1990-9#2)
pancreaticoduodenal artery##5##2##(1991-6#2)(2008-7#3)
pancreaticoduodenal##9##1##(1991-6#3)(1995-2#1)(2008-7#4)(2013-1#1)
pancreaticoduodenectomy ad modum Whipple due to##2##6##(2013-1#2)
pancreaticoduodenectomy ad modum Whipple##3##4##(2013-1#3)
pancreaticoduodenectomy##7##1##(1991-3#1)(2012-2#1)(2013-1#5)
pancreaticojejunostomy##6##1##(2008-10#4)(2013-7#2)
pancreaticus caused by##2##3##(2011-2#2)
pancreaticus##4##1##(2011-2#4)
pancreatin##3##1##(2008-10#3)
pancreatitis (AP) is##3##3##(2009-8#1)(2013-1#2)
pancreatitis (AP)##4##2##(2009-8#2)(2013-1#2)
pancreatitis after kidney transplantation##2##4##(2012-12#2)
pancreatitis after##3##2##(1992-4#1)(2012-12#2)
pancreatitis and the##3##3##(1994-3#1)(2008-3#1)(2013-1#1)
pancreatitis and##7##2##(1991-9#1)(1992-11#1)(1994-3#1)(2007-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
pancreatitis following##3##2##(1992-4#1)(2008-12#1)(2013-1#1)
pancreatitis in a##2##3##(2010-6#1)(2012-3#1)
pancreatitis in##5##2##(2007-8#1)(2010-6#2)(2011-2#1)(2012-3#1)
pancreatitis is a##2##3##(2009-7#1)(2012-12#1)
pancreatitis is##5##2##(2009-7#1)(2012-12#1)(2013-1#3)
pancreatitis of##2##2##(1990-3#1)(2013-8#1)
pancreatitis was##3##2##(1990-3#1)(2012-3#1)(2013-8#1)
pancreatitis with##3##2##(2008-7#1)(2012-12#2)
pancreatitis##114##1##(1990-3#4)(1990-9#3)(1991-8#2)(1991-9#1)(1992-11#2)(1992-4#2)(1992-9#1)(1994-3#2)(1997-8#1)(2007-2#3)(2007-8#3)(2008-10#2)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#3)(2009-7#8)(2009-8#6)(2010-6#3)(2011-1#1)(2011-2#6)(2012-12#8)(2012-3#6)(2013-1#26)(2013-8#11)
pancreatitis]##2##1##(1997-3#1)(2012-3#1)
pancreatography##2##1##(1991-3#1)(2010-1#1)
pancytopenia and a##3##3##(2008-4#2)(2010-11#1)
pancytopenia and##4##2##(2006-10#1)(2008-4#2)(2010-11#1)
pancytopenia##16##1##(1990-9#1)(1992-10#1)(1997-3#1)(2006-10#5)(2008-4#2)(2009-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
panda##8##1##(2008-8#4)(2008-9#4)
pandemic (H1N1) 2009 virus##3##4##(2011-2#3)
pandemic (H1N1) 2009##4##3##(2011-2#4)
pandemic H1N1 and seasonal human##2##5##(2013-1#2)
pandemic H1N1##5##2##(2011-2#2)(2013-1#3)
pandemic in##5##2##(2009-7#1)(2011-1#2)(2011-2#2)
pandemic influenza A (H1N1) 2009##3##5##(2011-2#3)
pandemic influenza A(H1N1) 2009##3##4##(2011-2#3)
pandemic influenza in##2##3##(2010-4#1)(2010-5#1)
pandemic influenza##10##2##(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#7)
pandemic spread##6##2##(2008-10#6)
pandemic##80##1##(1990-11#1)(1992-5#1)(1994-1#1)(1994-2#1)(2007-12#4)(2008-10#9)(2008-11#5)(2009-4#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#33)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
pandemics from##2##2##(2007-12#1)(2010-4#1)
pandemics##6##1##(2007-12#1)(2008-10#1)(2010-4#1)(2011-2#2)(2013-8#1)
panel RBRF##2##2##(2008-2#2)
panel analysis##2##2##(1997-2#1)(2007-12#1)
panel data##4##2##(2008-7#2)(2009-11#1)(2013-1#1)
panel for##5##2##(1995-6#1)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#1)
panel has##2##2##(2006-6#1)(2009-6#1)
panel in##4##2##(1994-2#1)(1995-12#1)(2008-2#1)(2010-12#1)
panel included##2##2##(2007-4#1)(2008-7#1)
panel is##3##2##(1996-6#1)(2008-2#1)(2010-12#1)
panel of Canadian##2##3##(2007-12#1)(2008-6#1)
panel of mAbs##2##3##(1993-8#1)(1996-12#1)
panel of monoclonal antibodies##7##4##(1990-12#1)(1991-2#1)(1991-6#1)(1993-1#1)(1995-2#1)(2007-12#1)(2011-2#1)
panel of monoclonal##8##3##(1990-12#1)(1991-2#1)(1991-6#1)(1993-1#1)(1995-2#1)(1997-3#1)(2007-12#1)(2011-2#1)
panel of##66##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-6#2)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
panel selection##2##2##(2012-3#2)
panel survey##2##2##(2009-12#1)(2013-7#1)
panel test##3##2##(2008-10#2)(2008-5#1)
panel that##2##2##(1997-5#1)(2007-11#1)
panel to##3##2##(1997-6#1)(2012-3#2)
panel uniformity##2##2##(2008-2#2)
panel was##2##2##(2007-4#1)(2008-10#1)
panel were##2##2##(1994-2#1)(2007-4#1)
panel with##2##2##(2008-2#1)(2011-2#1)
panel##161##1##(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#4)(1994-3#2)(1994-6#2)(1994-9#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#5)(1996-12#1)(1996-5#1)(1996-6#4)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#4)(1997-8#2)(2006-6#1)(2007-11#2)(2007-12#5)(2007-4#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#3)(2009-7#1)(2010-12#10)(2010-3#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#1)
panelists and##2##2##(2008-5#1)(2008-7#1)
panelists rated##2##2##(2008-5#1)(2010-12#1)
panelists with##3##2##(2008-5#2)(2008-7#1)
panelists##17##1##(2008-5#13)(2008-6#1)(2008-7#2)(2010-12#1)
panelists'##3##1##(2008-5#1)(2010-12#2)
panellists##3##1##(2008-5#2)(2010-4#1)
panels for##2##2##(1991-12#1)(2008-3#1)
panels of##4##2##(1995-3#1)(1996-2#1)(2008-3#1)(2012-2#1)
panels that##2##2##(2008-2#1)(2008-3#1)
panels##25##1##(1991-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#6)(2008-3#5)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)
panhandle structure##2##2##(2008-10#1)(2008-8#1)
panhandle##3##1##(2008-10#2)(2008-8#1)
panic and##3##2##(1990-11#1)(2010-2#1)(2011-2#1)
panic disorder and agoraphobia##2##4##(1990-11#1)(2012-2#1)
panic disorder and##3##3##(1990-11#1)(1997-6#1)(2012-2#1)
panic disorder##21##2##(1990-11#1)(1991-2#1)(1993-12#2)(1996-7#3)(1997-6#1)(2007-1#1)(2007-5#1)(2008-4#1)(2008-6#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
panic##35##1##(1990-11#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#2)(1996-7#3)(1997-6#1)(2007-1#1)(2007-5#1)(2008-11#2)(2008-4#3)(2008-6#2)(2008-7#1)(2010-2#3)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
panicle and paddy by##2##4##(2008-12#2)
panicle and shoot blight of pistachio leaves and fruit##2##9##(2008-10#2)
panicle and shoot blight of pistachio##6##6##(2008-10#6)
panicle and shoot blight severity##3##5##(2008-10#3)
panicle and shoot blight##10##4##(2008-10#10)
panicle and##12##2##(2008-10#10)(2008-12#2)
panicle blast severity##2##3##(2008-10#2)
panicle blast##10##2##(2008-10#10)
panicle##41##1##(2008-10#23)(2008-12#7)(2008-8#2)(2008-9#2)(2009-10#7)
panicles##6##1##(2008-10#1)(2008-12#3)(2008-8#1)(2008-9#1)
paniculata mother plants##2##3##(2008-10#2)
paniculata##5##1##(2008-10#4)(2012-2#1)
paniculate##2##1##(2008-11#2)
panmictic population##3##2##(2008-10#1)(2008-9#2)
panmictic##5##1##(2008-10#3)(2008-9#2)
pannexins##3##1##(2008-7#3)
panniculitis##10##1##(2008-11#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-12#4)(2012-2#1)
panning##5##1##(1994-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
panoply of##3##2##(2008-8#1)(2013-1#2)
panorama##2##1##(1990-6#1)(2008-7#1)
panoramic cameras##3##2##(2008-6#3)
panoramic radiographs##3##2##(2008-12#2)(2009-12#1)
panoramic##15##1##(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#6)(2009-12#1)(2010-3#1)(2012-3#1)
pansy##4##1##(2008-10#1)(2008-7#3)
pantaneiro##3##1##(2010-8#3)
pantoprazole##3##1##(2011-2#1)(2012-3#2)
pantothenate##2##1##(1995-6#1)(2009-7#1)
pants##2##1##(2009-10#1)(2011-2#1)
pap before serving##2##3##(1997-4#2)
pap smear images##2##3##(2008-3#2)
pap smear##4##2##(1990-6#1)(1992-8#1)(2008-3#2)
pap test##2##2##(1990-6#2)
pap##12##1##(1990-6#3)(1992-8#1)(1997-4#6)(2008-3#2)
papain and##2##2##(1990-2#1)(1994-12#1)
papain cleavage##2##2##(1994-8#2)
papain##16##1##(1990-2#3)(1991-12#1)(1992-3#1)(1992-9#1)(1994-12#5)(1994-8#2)(2008-1#1)(2008-11#2)
papain-treated RBCs##2##2##(1994-12#1)(1994-9#1)
papaveracea and##4##2##(2008-10#4)
papaveracea caused##2##2##(2008-10#2)
papaveracea conidia##2##2##(2008-10#2)
papaveracea was more##2##3##(2008-10#2)
papaveracea was##3##2##(2008-10#3)
papaveracea##25##1##(2008-10#25)
papaverine hydrochloride##2##2##(2008-10#2)
papaverine##8##1##(1993-3#1)(2007-8#1)(2008-10#6)
papaya##12##1##(2008-10#12)
papayae##3##1##(2011-2#3)
paper I##7##2##(1995-12#1)(1995-9#1)(1996-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
paper [Appl##5##2##(2008-2#3)(2008-3#2)
paper a new##2##3##(2008-10#1)(2008-2#1)
paper a##11##2##(1994-12#1)(2008-10#7)(2008-11#2)(2008-2#1)
paper addresses the##8##3##(1992-3#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-2#2)
paper addresses##16##2##(1992-2#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-12#1)(2012-2#2)
paper aims to explore##2##4##(2008-11#1)(2012-2#1)
paper aims to##12##3##(1993-3#1)(1996-3#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
paper aims##13##2##(1991-6#1)(1993-3#1)(1996-3#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
paper also shows##2##3##(2008-10#2)
paper also##20##2##(1990-6#1)(1995-9#1)(1996-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-9#1)(2012-12#2)(2013-8#1)
paper analyses the##6##3##(1991-6#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-4#1)
paper analyzes the##4##3##(2009-7#1)(2012-2#1)(2013-1#2)
paper analyzes##6##2##(2008-9#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#2)
paper and wood impregnates##2##4##(2008-9#2)
paper and##16##2##(1995-2#1)(1997-1#1)(2007-6#1)(2008-10#7)(2008-3#2)(2008-9#2)(2010-12#1)(2013-1#1)
paper are##19##2##(1990-12#1)(1992-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2013-7#1)(2013-8#1)
paper argues for the##2##4##(2008-12#1)(2008-7#1)
paper argues that the##2##4##(2008-12#1)(2011-2#1)
paper argues that##8##3##(2008-11#1)(2008-12#2)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
paper argues##11##2##(1996-8#1)(2008-11#1)(2008-12#3)(2008-7#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
paper arose##2##2##(2008-12#1)(2008-9#1)
paper as##13##2##(1993-1#1)(2008-10#1)(2008-12#1)(2011-2#9)(2013-8#1)
paper asserts that##2##3##(1991-3#1)(1993-3#1)
paper attempts to##9##3##(1990-3#1)(1992-3#1)(1993-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-9#1)
paper based##2##2##(2008-12#1)(2013-8#1)
paper begins by examining##2##4##(1996-1#1)(2008-12#1)
paper begins##4##2##(1992-1#1)(1996-1#1)(2008-12#1)(2008-4#1)
paper by the European Society of Radiology##2##7##(2012-2#2)
paper by##14##2##(1996-4#1)(2008-10#2)(2008-3#5)(2008-4#1)(2009-11#1)(2012-2#2)(2013-1#2)
paper chromatography##2##2##(1992-8#1)(1994-9#1)
paper closes with a discussion of##2##6##(1997-4#1)(2010-9#1)
paper compares the results##3##4##(1997-4#1)(2008-10#1)(2012-2#1)
paper compares the##8##3##(1991-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
paper compares##13##2##(1991-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
paper concerns the##3##3##(1991-2#1)(1996-3#1)(1997-7#1)
paper concerns##5##2##(1990-6#1)(1991-2#1)(1996-3#1)(1997-3#1)(1997-7#1)
paper concludes by discussing##2##4##(2008-11#1)(2008-12#1)
paper concludes by##7##3##(1991-3#1)(1992-12#1)(2008-11#4)(2008-12#1)
paper concludes that##3##3##(1992-5#1)(2010-8#1)(2012-1#1)
paper concludes##14##2##(1991-3#1)(1992-12#1)(1992-5#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-5#1)(2010-8#1)(2012-1#1)
paper considers the##6##3##(1992-1#1)(1997-3#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-1#1)
paper considers##14##2##(1992-1#1)(1995-9#1)(1997-3#1)(2008-12#2)(2008-7#3)(2009-6#1)(2010-2#1)(2011-1#2)(2013-1#2)
paper covers##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
paper deals with a##2##4##(2008-10#1)(2012-3#1)
paper deals with the##6##4##(1993-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
paper deals with##12##3##(1993-12#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
paper deals##13##2##(1993-12#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-5#1)(2009-6#1)(2012-3#1)(2013-8#1)
paper defines##2##2##(2007-8#1)(2008-5#1)
paper demonstrates that##2##3##(2008-10#1)(2008-7#1)
paper demonstrates the potential##2##4##(1990-8#1)(2011-1#1)
paper demonstrates the##5##3##(1990-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2011-1#1)
paper demonstrates##9##2##(1990-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-1#1)
paper describes a case of spontaneous##2##6##(1990-9#1)(2013-1#1)
paper describes a case of##4##5##(1990-9#1)(2007-7#1)(2012-3#1)(2013-1#1)
paper describes a case##5##4##(1990-9#1)(2007-7#1)(2008-11#1)(2012-3#1)(2013-1#1)
paper describes a fast and##2##5##(2008-10#2)
paper describes a method for the##2##6##(2008-10#1)(2008-11#1)
paper describes a new##5##4##(2008-10#3)(2008-5#1)(2008-6#1)
paper describes a procedure##4##4##(2008-10#4)
paper describes a series of##2##5##(1992-6#1)(2008-5#1)
paper describes a technique##2##4##(1992-6#1)(2010-7#1)
paper describes a##62##3##(1990-11#1)(1990-12#1)(1990-9#2)(1992-2#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-2#1)(1997-2#2)(1997-3#1)(2007-7#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
paper describes an##14##3##(1993-12#1)(2007-10#1)(2008-10#6)(2008-11#3)(2008-12#1)(2012-2#1)(2013-1#1)
paper describes how the##4##4##(1991-2#1)(1997-2#1)(2009-8#1)(2010-3#1)
paper describes how##9##3##(1991-2#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-12#2)(2009-8#1)(2010-3#1)
paper describes the development of##5##5##(2008-10#3)(2008-11#1)(2010-8#1)
paper describes the development##7##4##(2008-10#5)(2008-11#1)(2010-8#1)
paper describes the project##2##4##(1992-2#1)(2008-1#1)
paper describes the use of##6##5##(1990-6#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
paper describes the##79##3##(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-3#2)(1995-12#2)(1996-12#1)(1996-3#3)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#3)(2008-10#26)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
paper describes##197##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#60)(2008-11#23)(2008-12#10)(2008-3#1)(2008-5#6)(2008-6#5)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#7)
paper describing the##2##3##(2008-11#1)(2013-1#1)
paper develops a##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
paper develops an##2##3##(2008-6#1)(2013-8#1)
paper develops##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-8#1)
paper disc##3##2##(1994-11#2)(2008-12#1)
paper discusses a##3##3##(2008-12#1)(2008-7#1)(2009-3#1)
paper discusses how##4##3##(1992-12#1)(2008-11#1)(2008-12#1)(2009-6#1)
paper discusses the benefits##2##4##(2007-10#1)(2008-3#1)
paper discusses the role of##2##5##(1995-6#1)(2012-2#1)
paper discusses the significance of##2##5##(2008-10#1)(2008-11#1)
paper discusses the##37##3##(1991-3#1)(1993-3#1)(1995-6#1)(1995-9#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#10)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
paper discusses##58##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#11)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
paper electrophoresis##3##2##(1993-11#1)(2008-10#2)
paper emphasizes the##4##3##(1992-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
paper employs##2##2##(1997-2#1)(2013-1#1)
paper evaluates the##5##3##(1995-2#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-12#1)
paper examines a##2##3##(1994-11#1)(2007-5#1)
paper examines some of the##2##5##(2008-5#1)(2010-12#1)
paper examines the##15##3##(1991-6#1)(1992-1#1)(1992-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-8#1)(2011-2#2)
paper examines##35##2##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
paper expands##2##2##(2007-5#1)(2008-1#1)
paper explains the##2##3##(1996-3#1)(2008-10#1)
paper explains##3##2##(1996-3#1)(2008-10#1)(2009-11#1)
paper explores the##15##3##(1992-2#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)
paper explores##25##2##(1992-2#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#3)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
paper focuses on an##2##4##(2008-12#1)(2012-3#1)
paper focuses on the##18##4##(1991-2#1)(1992-1#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
paper focuses on##27##3##(1991-2#1)(1992-1#1)(1995-9#1)(1997-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-5#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
paper focuses##28##2##(1991-2#1)(1992-1#1)(1995-9#1)(1997-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-5#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
paper for the determination of##2##5##(2008-10#2)
paper for the##3##3##(2008-10#3)
paper for##6##2##(1996-6#1)(2007-12#1)(2008-10#3)(2008-5#1)
paper from this laboratory##2##4##(2008-10#2)
paper from##4##2##(2008-10#4)
paper further##2##2##(1995-9#1)(1996-3#1)
paper gives an overview##3##4##(1990-6#1)(2008-10#1)(2013-1#1)
paper gives an##4##3##(1990-6#1)(2008-10#1)(2010-1#1)(2013-1#1)
paper gives##8##2##(1990-6#1)(2008-10#3)(2008-6#1)(2009-10#1)(2010-1#1)(2013-1#1)
paper has##5##2##(1991-1#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-2#1)
paper highlights the dependence##2##4##(2008-10#1)(2009-7#1)
paper highlights the##4##3##(2008-10#1)(2008-11#1)(2009-3#1)(2009-7#1)
paper highlights##12##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
paper illustrates a method##3##4##(1990-7#1)(1992-9#1)(2009-10#1)
paper illustrates the##3##3##(1990-9#1)(1991-3#1)(1994-3#1)
paper illustrates##9##2##(1990-7#1)(1990-9#1)(1991-3#1)(1992-9#1)(1993-1#1)(1994-3#1)(1996-1#1)(1996-3#1)(2009-10#1)
paper in##9##2##(1990-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#4)
paper includes##2##2##(2008-3#1)(2013-1#1)
paper indicates that##2##3##(1991-12#1)(1991-9#1)
paper indicates##3##2##(1991-12#1)(1991-9#1)(2011-2#1)
paper introduces the##3##3##(1995-9#1)(2012-3#2)
paper introduces##14##2##(1990-8#1)(1995-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-8#1)(2012-12#1)(2012-3#2)
paper investigates the##8##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)(2011-1#1)
paper investigates##13##2##(1992-2#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
paper is a##6##3##(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
paper is an evaluation of##2##5##(1992-2#1)(2012-3#1)
paper is an##6##3##(1992-2#1)(1994-2#1)(2007-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
paper is based on a##3##5##(2009-11#1)(2011-2#1)(2013-8#1)
paper is based on##8##4##(1997-6#1)(2007-10#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#1)(2013-8#1)
paper is based##9##3##(1997-6#1)(2007-10#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
paper is the##7##3##(1990-7#1)(1996-1#1)(2008-10#3)(2008-7#1)(2010-10#1)
paper is to demonstrate the use of##2##7##(2008-11#1)(2009-8#1)
paper is to demonstrate the##3##5##(2008-11#2)(2009-8#1)
paper is to describe the##6##5##(1992-1#1)(1992-2#1)(2007-12#1)(2008-11#2)(2008-5#1)
paper is to describe##8##4##(1992-1#1)(1992-2#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)
paper is to present an##2##5##(2007-7#1)(2010-10#1)
paper is to present the##4##5##(2007-11#1)(2011-2#2)(2013-1#1)
paper is to present##11##4##(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
paper is to##74##3##(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1996-3#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#10)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#8)
paper is##131##2##(1990-7#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#2)(2008-10#8)(2008-11#13)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#11)(2013-8#2)
paper it##2##2##(1993-12#1)(2008-10#1)
paper looks at##3##3##(1996-3#1)(2008-5#1)(2008-7#1)
paper making##2##2##(2009-11#1)(2011-2#1)
paper offers a##2##3##(1993-12#1)(2008-10#1)
paper offers an##4##3##(1993-11#1)(2008-10#1)(2008-9#1)(2010-12#1)
paper offers##9##2##(1993-11#1)(1993-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2013-1#1)
paper on##8##2##(1995-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#1)
paper outlines the##8##3##(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-7#1)
paper outlines##20##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-8#1)(2010-9#1)
paper points##3##2##(2010-8#1)(2013-1#2)
paper presented at##2##3##(2008-10#1)(2008-3#1)
paper presented##4##2##(2007-10#2)(2008-10#1)(2008-3#1)
paper presents a case of##3##5##(2008-11#1)(2010-12#1)(2011-2#1)
paper presents a case##4##4##(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
paper presents a review of the##2##6##(2010-1#1)(2010-12#1)
paper presents a##50##3##(1992-3#1)(1995-12#1)(1997-3#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-5#1)(2008-6#6)(2008-7#1)(2009-10#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
paper presents an##13##3##(1992-12#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)
paper presents results of##3##4##(1997-3#1)(2007-8#1)(2009-8#1)
paper presents results##4##3##(1992-5#1)(1997-3#1)(2007-8#1)(2009-8#1)
paper presents the case of a##2##6##(2012-3#1)(2013-7#1)
paper presents the case of##3##5##(1992-1#1)(2012-3#1)(2013-7#1)
paper presents the results of a##5##6##(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)
paper presents the results of##9##5##(2007-11#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-4#2)(2011-2#1)
paper presents the results##10##4##(2007-11#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-4#2)(2010-8#1)(2011-2#1)
paper presents the##32##3##(1991-6#1)(1992-1#1)(1992-2#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#3)(2009-10#3)(2009-4#2)(2010-10#1)(2010-12#1)(2010-8#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
paper presents##123##2##(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#2)(2008-5#2)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-8#7)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
paper proposes a new##3##4##(2008-10#1)(2008-6#1)(2011-3#1)
paper proposes a##13##3##(1994-9#1)(2008-10#3)(2008-11#2)(2008-6#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)
paper proposes an overview##2##4##(2007-12#1)(2013-1#1)
paper proposes an##5##3##(2007-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
paper proposes##20##2##(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-6#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-2#2)(2013-1#1)
paper provide##2##2##(2008-6#1)(2008-7#1)
paper provides a brief##9##4##(1996-9#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
paper provides a##17##3##(1991-1#1)(1996-9#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)
paper provides an overview of##6##5##(1992-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
paper provides an##9##3##(1992-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-1#1)(2013-1#1)
paper provides##33##2##(1991-1#1)(1992-1#1)(1995-11#1)(1996-9#1)(1997-3#1)(2007-5#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
paper reflects on##2##3##(2008-12#1)(2010-9#1)
paper reflects##3##2##(2007-4#1)(2008-12#1)(2010-9#1)
paper reports a case of##5##5##(1990-6#2)(1991-5#1)(1992-6#1)(2012-1#1)
paper reports a case##6##4##(1990-6#2)(1991-5#1)(1992-6#1)(2008-12#1)(2012-1#1)
paper reports a study##3##4##(1991-5#1)(2008-11#1)(2011-1#1)
paper reports a##17##3##(1990-6#4)(1991-5#2)(1992-6#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#2)(2012-1#1)
paper reports on a##5##4##(2008-10#1)(2008-11#2)(2008-12#1)(2013-8#1)
paper reports on##28##3##(1992-5#1)(1994-1#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#2)(2012-3#1)(2013-8#1)
paper reports the case of a##2##6##(1992-6#1)(2008-12#1)
paper reports the results obtained##2##5##(1990-6#1)(2008-10#1)
paper reports the results of a study carried out##2##9##(1993-3#1)(2008-5#1)
paper reports the results of a study##3##7##(1992-5#1)(1993-3#1)(2008-5#1)
paper reports the results of a##6##6##(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(2008-5#1)
paper reports the results of##9##5##(1990-6#1)(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(2008-5#1)(2008-6#1)(2013-1#1)
paper reports the results##11##4##(1990-6#2)(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
paper reports the study of##3##5##(1991-3#1)(2008-10#1)(2008-5#1)
paper reports the use of##5##5##(2008-10#3)(2010-4#1)(2013-1#1)
paper reports the##44##3##(1990-12#1)(1990-6#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-12#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#3)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#4)
paper reports##110##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#6)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-5#2)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-3#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#3)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#4)(2013-8#1)
paper responds to##2##3##(2009-6#1)(2011-2#1)
paper reviews and discusses##2##4##(1992-6#1)(2008-11#1)
paper reviews and##3##3##(1991-12#1)(1992-6#1)(2008-11#1)
paper reviews the##33##3##(1991-1#1)(1993-3#2)(1994-3#1)(1994-6#2)(1996-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#4)(2013-1#3)
paper reviews##71##2##(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-3#2)(1994-3#1)(1994-6#2)(1996-1#1)(1996-11#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-5#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
paper seeks to##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
paper show that the##2##4##(1991-9#1)(1993-6#1)
paper show that##3##3##(1991-9#1)(1993-3#1)(1993-6#1)
paper showed that##2##3##(2008-8#1)(2008-9#1)
paper shows how##5##3##(1996-3#1)(2007-12#1)(2008-7#1)(2009-3#1)(2012-12#1)
paper shows that the##2##4##(2008-10#1)(2008-5#1)
paper shows that##5##3##(1995-3#1)(2008-10#2)(2008-5#1)(2010-5#1)
paper shows##14##2##(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-1#1)(2012-12#1)
paper studied the##2##3##(2008-10#1)(2013-8#1)
paper substrates##3##2##(2007-12#1)(2012-2#2)
paper suggests that##3##3##(1991-2#1)(1991-9#1)(2008-11#1)
paper suggests##10##2##(1991-2#1)(1991-3#1)(1991-9#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
paper that##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
paper the authors##4##3##(1990-2#1)(1993-3#1)(2007-10#1)(2012-3#1)
paper the##22##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-9#2)(1993-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-3#1)(2012-3#2)(2013-1#1)
paper then##2##2##(2008-10#1)(2008-11#1)
paper three##2##2##(2008-8#1)(2011-2#1)
paper to##6##2##(1994-5#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-3#2)
paper using##2##2##(2008-11#1)(2009-11#1)
paper was placed in##2##4##(2008-10#1)(2008-5#1)
paper was to present##2##4##(2007-8#1)(2008-11#1)
paper was to verify##2##4##(1991-9#1)(2008-10#1)
paper was to##12##3##(1991-9#2)(1992-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
paper was##25##2##(1990-5#1)(1991-9#2)(1992-2#1)(1994-3#2)(1994-9#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
paper we analyze the##2##4##(1990-8#1)(2008-11#1)
paper we are##3##3##(2008-7#1)(2013-1#2)
paper we consider##2##3##(2013-8#2)
paper we describe a##5##4##(1990-12#1)(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
paper we describe##15##3##(1990-12#1)(1990-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
paper we have##5##3##(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-3#1)
paper we introduce a##2##4##(2009-2#1)(2013-8#1)
paper we introduce##4##3##(2007-6#1)(2009-2#1)(2010-10#1)(2013-8#1)
paper we present##13##3##(1995-8#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-12#1)(2013-1#2)(2013-8#1)
paper we report##6##3##(1990-11#1)(1991-9#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
paper we will##4##3##(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
paper we##105##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-12#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-8#1)(1995-9#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#10)(2013-8#7)
paper were##2##2##(2008-9#1)(2013-1#1)
paper will address##3##3##(1991-12#1)(1994-3#2)
paper will explore##2##3##(1991-5#1)(1996-1#1)
paper will identify##2##3##(2008-11#2)
paper will provide a##4##4##(1994-3#2)(2008-12#1)(2010-10#1)
paper will provide##5##3##(1994-3#2)(2008-12#2)(2010-10#1)
paper will##47##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#3)(1994-1#4)(1994-3#6)(1995-3#1)(1996-1#2)(1996-2#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-9#1)(2013-8#1)
paper with##4##2##(2007-11#1)(2007-8#1)(2009-3#1)(2011-2#1)
paper##2237##1##(1990-11#6)(1990-12#6)(1990-2#4)(1990-3#3)(1990-5#3)(1990-6#15)(1990-7#3)(1990-8#8)(1990-9#4)(1991-1#5)(1991-12#9)(1991-2#4)(1991-3#11)(1991-4#1)(1991-5#7)(1991-6#5)(1991-8#1)(1991-9#8)(1992-1#14)(1992-11#1)(1992-12#10)(1992-2#11)(1992-3#11)(1992-4#1)(1992-5#5)(1992-6#7)(1992-8#1)(1992-9#9)(1993-1#6)(1993-11#2)(1993-12#9)(1993-2#3)(1993-3#11)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-1#9)(1994-11#7)(1994-12#7)(1994-2#6)(1994-3#15)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#3)(1995-11#8)(1995-12#5)(1995-2#9)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#10)(1996-1#11)(1996-11#3)(1996-12#7)(1996-2#5)(1996-3#16)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#10)(1997-2#13)(1997-3#13)(1997-4#11)(1997-6#3)(1997-7#7)(1997-8#6)(2006-4#1)(2006-6#1)(2007-10#15)(2007-11#21)(2007-12#39)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#13)(2007-6#2)(2007-7#9)(2007-8#8)(2007-9#2)(2008-1#28)(2008-10#470)(2008-11#177)(2008-12#96)(2008-2#27)(2008-3#42)(2008-4#14)(2008-5#45)(2008-6#39)(2008-7#64)(2008-8#13)(2008-9#29)(2009-10#21)(2009-11#15)(2009-12#8)(2009-2#2)(2009-3#12)(2009-4#8)(2009-5#7)(2009-6#18)(2009-7#17)(2009-8#20)(2009-9#12)(2010-1#7)(2010-10#14)(2010-11#6)(2010-12#19)(2010-2#5)(2010-3#9)(2010-4#11)(2010-5#7)(2010-6#4)(2010-7#3)(2010-8#36)(2010-9#5)(2011-1#32)(2011-2#70)(2011-3#8)(2012-1#16)(2012-12#24)(2012-2#51)(2012-3#44)(2012-9#1)(2013-1#86)(2013-7#8)(2013-8#36)
paper&gt##4##1##(2008-10#4)
paper's##2##1##(2008-12#1)(2010-8#1)
paper-based##3##1##(2008-10#1)(2009-11#1)(2013-1#1)
paperback##3##1##(2007-2#3)
paperless and filmless&quot##4##3##(2008-10#4)
paperless##5##1##(2008-10#4)(2010-5#1)
papers and##8##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)
papers are reviewed which concern surgery whilst taking##2##8##(2008-8#2)
papers are reviewed##4##3##(1994-11#1)(2008-8#3)
papers are##16##2##(1993-12#1)(1994-11#1)(2007-8#7)(2008-2#1)(2008-3#1)(2008-8#3)(2010-12#1)(2012-2#1)
papers by##2##2##(1994-11#1)(2008-12#1)
papers detailing##2##2##(1996-2#1)(2008-10#1)
papers examined##2##2##(2013-1#2)
papers from##2##2##(2008-3#2)
papers have been published##2##4##(1993-6#1)(2008-4#1)
papers have been##3##3##(1993-6#1)(2008-11#1)(2008-4#1)
papers have##4##2##(1993-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
papers in##3##2##(1992-6#1)(1996-1#1)(2010-7#1)
papers on the##3##3##(2008-3#2)(2009-10#1)
papers on##11##2##(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-10#1)(2011-1#1)(2012-3#1)
papers presented at the##11##4##(2008-10#9)(2008-2#1)(2010-3#1)
papers presented##12##2##(2007-8#1)(2008-10#9)(2008-2#1)(2010-3#1)
papers published from##2##3##(2008-8#1)(2012-2#1)
papers published in the##4##4##(2008-10#1)(2008-5#2)(2008-7#1)
papers published in##6##3##(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#2)
papers published##10##2##(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#2)
papers reported##2##2##(2008-10#1)(2013-1#1)
papers that describe##2##3##(2008-3#2)
papers that were##2##3##(1993-12#1)(2008-5#1)
papers that##9##2##(1993-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
papers were found using the reported search##4##7##(2007-8#4)
papers were found##7##3##(2007-8#6)(2013-1#1)
papers were identified using the below mentioned search##3##8##(2007-8#3)
papers were identified using the reported search of which##2##9##(2007-8#2)
papers were identified using the##5##5##(2007-8#5)
papers were identified##6##3##(2007-8#5)(2013-8#1)
papers were##19##2##(1997-8#1)(2007-8#11)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#2)
papers##165##1##(1991-5#1)(1992-6#1)(1993-12#2)(1993-6#2)(1994-11#2)(1994-6#1)(1996-1#4)(1996-2#2)(1997-8#2)(2006-10#1)(2007-4#1)(2007-8#21)(2008-1#1)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#14)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#6)(2009-10#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#4)
paperwork##4##1##(1991-9#1)(1996-3#1)(2010-10#1)(2013-8#1)
papilla formation in##2##3##(2008-10#2)
papilla formation##7##2##(2008-10#7)
papilla of##2##2##(2008-5#1)(2011-2#1)
papilla##17##1##(1991-9#1)(2008-10#9)(2008-5#3)(2010-11#1)(2011-2#2)(2013-8#1)
papillae formed##2##2##(2008-10#2)
papillae in##2##2##(2008-10#2)
papillae of the##2##3##(2008-10#1)(2011-2#1)
papillae of##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
papillae was##2##2##(2008-10#2)
papillae were##2##2##(1993-12#1)(2008-5#1)
papillae##38##1##(1991-3#1)(1993-12#3)(1997-4#1)(2008-10#17)(2008-5#11)(2011-2#5)
papillary adenocarcinoma##4##2##(1992-2#3)(1994-9#1)
papillary adenomas and##2##3##(2011-2#2)
papillary adenomas##3##2##(1990-7#1)(2011-2#2)
papillary and##2##2##(1992-8#1)(2012-1#1)
papillary bleeding index##2##3##(2011-2#2)
papillary blood flow##3##3##(2011-2#3)
papillary carcinoma of the male breast##2##6##(1992-2#2)
papillary carcinoma of the##3##4##(1992-2#2)(1996-6#1)
papillary carcinoma was##2##3##(1990-6#1)(2011-2#1)
papillary carcinoma##11##2##(1990-6#1)(1990-9#1)(1992-2#2)(1996-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
papillary dermis##3##2##(2010-6#3)
papillary distortions##2##2##(1993-2#2)
papillary fibroelastoma##3##2##(2007-8#2)(2009-9#1)
papillary mucinous##3##2##(2012-2#2)(2012-3#1)
papillary muscle##3##2##(1997-7#2)(2008-10#1)
papillary muscles##3##2##(1995-12#3)
papillary necrosis causing bilateral ureteric obstruction##2##6##(2008-10#2)
papillary thyroid carcinoma in children and##2##6##(2012-3#2)
papillary thyroid carcinoma in##3##4##(1990-6#1)(2012-3#2)
papillary thyroid carcinoma##8##3##(1990-6#2)(1993-8#1)(2012-3#3)(2013-1#2)
papillary thyroid##11##2##(1990-6#2)(1993-8#1)(2008-10#2)(2012-3#3)(2013-1#3)
papillary tumors##2##2##(1990-7#1)(2006-12#1)
papillary##75##1##(1990-6#4)(1990-7#2)(1990-9#2)(1991-2#1)(1992-2#5)(1992-8#1)(1993-2#3)(1993-8#1)(1994-9#1)(1995-12#4)(1995-8#2)(1996-6#1)(1997-7#2)(2006-12#3)(2007-8#2)(2008-10#6)(2008-12#1)(2008-5#1)(2009-9#1)(2010-6#3)(2011-1#2)(2011-2#10)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#5)(2013-7#2)
papillary-cystic tumor##2##2##(1992-5#2)
papilloferous##2##1##(2008-11#2)
papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene##2##17##(1992-8#2)
papilloma in a 12-year-old girl##2##5##(2008-10#2)
papilloma in##5##2##(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
papilloma virus and##2##3##(2008-11#1)(2008-7#1)
papilloma virus##11##2##(1991-2#3)(1994-8#2)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#2)
papilloma##39##1##(1991-2#9)(1992-8#2)(1994-7#2)(1994-8#2)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#9)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
papillomas at the site of application in##3##7##(2008-9#3)
papillomas at##4##2##(2008-9#4)
papillomas in##3##2##(1992-2#1)(1995-9#1)(2013-1#1)
papillomas of the skin at the site of dermal application##2##10##(2008-9#2)
papillomas of the##5##3##(2008-10#1)(2008-2#1)(2008-9#3)
papillomas##17##1##(1992-2#1)(1992-8#2)(1995-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#8)(2013-1#2)
papillomatosis##2##1##(2013-1#1)(2013-8#1)
papillomavirus (HPV)##8##2##(1992-2#1)(1992-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
papillomavirus in##2##2##(1993-9#1)(2012-12#1)
papillomavirus infection##3##2##(1994-2#2)(2008-4#1)
papillomavirus vaccine##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
papillomavirus##42##1##(1990-5#2)(1992-2#2)(1992-3#2)(1993-9#1)(1994-1#2)(1994-2#2)(1994-8#2)(1995-2#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-9#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#1)
papillomaviruses##4##1##(1994-8#1)(2008-4#1)(2008-9#1)(2013-7#1)
papillotomy##6##1##(1991-3#2)(1997-8#3)(2011-2#1)
papulans##7##1##(2008-10#7)
papules and##3##2##(2009-2#1)(2010-6#1)(2013-8#1)
papules in##2##2##(2011-2#1)(2012-3#1)
papules of##2##2##(2013-8#2)
papules##12##1##(2006-10#1)(2009-2#1)(2010-6#4)(2011-2#1)(2012-3#2)(2013-8#3)
papulonecrotic tuberculids of the glans penis##2##6##(2007-7#2)
papyraceous##2##1##(2010-8#2)
par des##4##2##(2011-2#2)(2013-1#2)
par le##4##2##(2008-5#1)(2011-2#1)(2013-1#2)
par les##3##2##(2008-3#1)(2008-5#2)
par rapport à##2##3##(2011-2#1)(2013-1#1)
par voie##3##2##(2011-2#1)(2013-1#2)
par##32##1##(1990-4#1)(1993-1#1)(2008-11#1)(2008-3#1)(2008-5#7)(2009-10#1)(2011-2#6)(2012-2#1)(2013-1#13)
para##8##1##(1992-9#1)(1994-12#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
para-Cl-phenylazo-R-acid##5##1##(2008-10#5)
para-acrosomal bodies##2##2##(2008-7#2)
para-anal##2##1##(1997-8#1)(2008-10#1)
para-aortic##3##1##(2008-2#1)(2009-11#2)
para-esophageal bronchogenic##2##2##(2007-8#2)
para-substituted phenols##3##2##(2008-10#3)
para-substituted##7##1##(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#4)
parabens##5##1##(2008-10#5)
parabolic flight##2##2##(2009-9#2)
parabolic mirror##2##2##(2007-12#1)(2008-3#1)
parabolic mirrors##2##2##(2008-3#2)
parabolic quantum##2##2##(2008-2#2)
parabolic transitional taper##2##3##(2008-2#2)
parabolic##41##1##(1991-9#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#12)(2008-3#11)(2008-5#1)(2008-7#1)(2009-9#4)(2012-12#1)(2013-8#3)
parabolic-index##3##1##(2008-2#2)(2008-3#1)
paraboliclike quantum##2##2##(2008-2#2)
paraboliclike##3##1##(2008-2#3)
paraboloid##3##1##(2008-2#1)(2008-3#2)
parabrachial nucleus##5##2##(1993-12#2)(2007-10#2)(2009-10#1)
parabrachial##6##1##(1993-12#2)(2007-10#2)(2009-10#2)
paracaval##2##1##(2011-2#2)
paracellular barrier##3##2##(1994-6#2)(2009-8#1)
paracellular permeability##3##2##(1994-6#2)(2008-11#1)
paracellular##7##1##(1994-6#4)(2008-11#1)(2008-7#1)(2009-8#1)
paracentesis##5##1##(2007-12#2)(2008-12#1)(2009-8#1)(2013-1#1)
paracentral##3##1##(1991-12#2)(2008-2#1)
paracetamol (acetaminophen)##2##2##(1990-2#1)(2008-10#1)
paracetamol and##5##2##(2008-10#5)
paracetamol are##2##2##(1995-11#1)(2008-10#1)
paracetamol by##3##2##(2008-10#3)
paracetamol concentration##2##2##(2008-10#2)
paracetamol for##2##2##(1995-11#1)(1995-3#1)
paracetamol gel##2##2##(2010-3#2)
paracetamol has##2##2##(1990-2#1)(1995-11#1)
paracetamol in pharmaceutical formulations using##2##5##(2008-10#2)
paracetamol in pharmaceutical formulations##4##4##(2008-10#4)
paracetamol in##15##2##(1995-11#1)(2008-10#14)
paracetamol was##5##2##(1990-2#1)(2008-10#3)(2010-3#1)
paracetamol##77##1##(1990-2#5)(1990-3#1)(1991-9#1)(1993-2#1)(1995-11#9)(1995-3#1)(1995-5#1)(1996-11#1)(2007-8#1)(2008-10#49)(2010-3#5)(2012-2#1)(2013-1#1)
paraclinical##4##1##(2007-8#1)(2010-12#1)(2011-2#2)
paracoccidioidin##2##1##(2008-5#2)
paracoccidioidomycosis##5##1##(2008-5#5)
paracrine and autocrine##2##3##(2008-5#1)(2011-2#1)
paracrine and##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
paracrine effects##4##2##(1994-9#1)(2012-12#1)(2013-1#2)
paracrine mechanisms##2##2##(1994-9#1)(2012-1#1)
paracrine pathways##2##2##(2006-10#1)(2012-7#1)
paracrine signaling##2##2##(2008-4#1)(2008-7#1)
paracrine signalling##2##2##(1995-8#1)(2008-4#1)
paracrine##47##1##(1992-6#1)(1992-9#3)(1993-3#1)(1993-8#1)(1994-9#5)(1995-12#1)(1995-8#2)(1996-5#2)(2006-10#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#1)
paracrystalline inclusions##2##2##(2007-12#1)(2008-7#1)
paracrystalline##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
paradigm and##6##2##(1993-6#1)(2008-11#1)(2008-12#1)(2010-10#1)(2012-12#1)(2013-7#1)
paradigm as a##2##3##(2008-10#1)(2012-2#1)
paradigm as##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
paradigm for clinical##2##3##(1993-2#1)(2013-8#1)
paradigm for##34##2##(1993-1#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-3#1)(2008-11#1)(2008-3#4)(2008-4#3)(2008-8#1)(2009-12#2)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#5)(2011-9#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
paradigm in the##2##3##(1996-2#1)(2012-1#1)
paradigm in##7##2##(1996-2#1)(2008-4#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
paradigm may##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
paradigm of the##2##3##(2008-7#1)(2010-8#1)
paradigm of##17##2##(2008-1#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2010-8#1)(2011-7#1)
paradigm shift in##6##3##(1996-2#1)(2008-11#2)(2012-1#1)(2012-12#2)
paradigm shift##17##2##(1994-3#1)(1995-3#1)(1996-2#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#2)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#2)(2013-1#1)
paradigm that##4##2##(1994-12#2)(1995-4#1)(2008-11#1)
paradigm to improve##2##3##(2008-12#1)(2013-8#1)
paradigm to investigate##3##3##(2007-9#1)(2009-4#1)(2010-6#1)
paradigm to##12##2##(1992-3#1)(1993-12#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2010-6#1)(2013-1#2)(2013-8#1)
paradigm was used to assess##2##5##(1993-1#1)(2009-10#1)
paradigm was used to##3##4##(1993-1#1)(2009-10#1)(2013-8#1)
paradigm was##7##2##(1993-1#1)(2008-11#1)(2009-10#2)(2011-1#1)(2013-8#2)
paradigm with##2##2##(1992-12#1)(2008-11#1)
paradigm would##2##2##(2008-9#1)(2010-7#1)
paradigm##199##1##(1990-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-3#3)(1995-4#1)(1995-5#2)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#18)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#3)(2008-7#9)(2008-8#8)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#3)(2010-12#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-7#1)(2011-9#1)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#13)
paradigmatic##4##1##(2007-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
paradigms for##2##2##(1996-12#1)(2013-8#1)
paradigms in the##2##3##(2009-12#1)(2012-2#1)
paradigms in##8##2##(1993-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-2#1)
paradigms of##7##2##(1994-3#1)(2008-7#1)(2008-9#2)(2009-8#2)(2011-2#1)
paradigms that##2##2##(2010-6#1)(2012-12#1)
paradigms##52##1##(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-3#1)(1995-4#1)(1996-12#2)(1996-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-6#2)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
paradisi##3##1##(2008-10#2)(2011-2#1)
paradox of##5##2##(1995-9#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)
paradox that##3##2##(2008-1#1)(2008-11#1)(2013-8#1)
paradox##26##1##(1992-5#1)(1994-11#1)(1994-3#1)(1995-9#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2011-2#1)(2012-3#2)(2013-8#2)
paradoxes in##2##2##(2008-12#1)(2011-2#1)
paradoxes##5##1##(2007-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2011-2#1)
paradoxical embolism may be##2##4##(2008-7#2)
paradoxical embolism##5##2##(2007-12#1)(2008-7#3)(2013-8#1)
paradoxical reactions##2##2##(2008-9#1)(2013-1#1)
paradoxical sleep##2##2##(1992-8#1)(1995-12#1)
paradoxical##30##1##(1990-5#1)(1991-12#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#2)(2013-1#3)(2013-8#1)
paradoxically##6##1##(2008-1#1)(2008-5#1)(2008-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
paraduodenal hernia##2##2##(2009-8#2)
paraelectric##8##1##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
paraesthesia##3##1##(2008-12#2)(2008-7#1)
paraffin blocks##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
paraffin embedded##2##2##(1991-4#1)(2012-12#1)
paraffin sections##5##2##(1993-9#1)(1995-4#1)(1996-5#1)(2008-1#1)(2008-4#1)
paraffin was##2##2##(2008-10#1)(2011-2#1)
paraffin wax##3##2##(1991-2#1)(2008-10#1)(2012-3#1)
paraffin##34##1##(1991-2#1)(1991-4#1)(1993-9#1)(1995-11#1)(1995-4#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
paraffin-embedded samples##2##2##(1997-7#1)(2013-8#1)
paraffin-embedded tissue sections##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
paraffin-embedded tissue##11##2##(1996-5#1)(2008-10#1)(2008-4#2)(2008-9#3)(2009-8#1)(2010-2#1)(2010-3#1)(2013-7#1)
paraffin-embedded tissues##2##2##(1997-7#1)(2008-9#1)
paraffin-embedded##22##1##(1991-7#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-4#3)(2008-9#4)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
paraffin-impregnated graphite electrodes##2##3##(2008-10#2)
paraffin-wax##2##1##(1991-2#2)
paraffinic##2##1##(2008-10#1)(2008-5#1)
paraformaldehyde##5##1##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
paragallinarum from China##2##3##(1997-3#2)
paragallinarum from##3##2##(1997-3#3)
paragallinarum##12##1##(1997-3#5)(1997-6#3)(2008-5#4)
paraganglia##5##1##(1996-5#5)
paraganglioma of the##2##3##(2012-2#1)(2013-1#1)
paraganglioma of##3##2##(2012-2#2)(2013-1#1)
paraganglioma was##2##2##(1996-8#1)(2011-2#1)
paraganglioma##16##1##(1990-6#2)(1996-8#2)(1997-8#4)(2011-2#1)(2012-2#6)(2013-1#1)
paragangliomas are rare##2##3##(1990-6#1)(1996-8#1)
paragangliomas are##3##2##(1990-6#1)(1996-8#1)(1997-8#1)
paragangliomas##10##1##(1990-6#1)(1996-8#3)(1997-8#2)(2011-2#1)(2012-2#3)
paragigantocellularis##4##1##(1990-9#2)(1994-2#1)(1997-2#1)
paragraph##3##1##(2008-11#1)(2009-4#1)(2013-1#1)
paragraphs##2##1##(1996-5#1)(2009-4#1)
paragynous antheridia##2##2##(2008-10#1)(2010-3#1)
parahippocampal##4##1##(1992-11#1)(1993-5#3)
parahippocampus##3##1##(1990-11#3)
parainfluenza virus##3##2##(1990-5#2)(2008-11#1)
parainfluenza##4##1##(1990-5#2)(2008-11#1)(2011-2#1)
parakeratosis##5##1##(2008-9#4)(2010-6#1)
parallax##2##1##(2008-3#1)(2010-3#1)
parallel algorithm for##4##3##(2007-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
parallel algorithm##5##2##(2007-11#1)(2007-9#1)(2008-2#1)(2010-8#1)(2011-2#1)
parallel alpha/beta##2##2##(1991-5#1)(1993-11#1)
parallel and perpendicular to the##2##5##(2008-3#2)
parallel and perpendicular to##3##4##(2008-2#1)(2008-3#2)
parallel and perpendicular##4##3##(2008-2#1)(2008-3#3)
parallel and##14##2##(1992-6#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-9#1)
parallel arrays of##2##3##(2008-10#1)(2008-5#1)
parallel arrays##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
parallel clinical trial##2##3##(1994-6#1)(2008-5#1)
parallel computation##2##2##(1990-11#1)(2008-3#1)
parallel computing##2##2##(1990-11#1)(2008-2#1)
parallel correlator##2##2##(2008-3#2)
parallel data##6##2##(1992-3#1)(2008-2#1)(2008-3#4)
parallel detection##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
parallel development##2##2##(2008-12#1)(2008-2#1)
parallel factor analysis (PARAFAC)##4##4##(2008-10#4)
parallel factor analysis##5##3##(2008-10#5)
parallel fashion##3##2##(1994-9#1)(2008-10#1)(2008-4#1)
parallel gains or losses##2##4##(2008-10#2)
parallel gratings##2##2##(2008-3#2)
parallel group design##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
parallel group##4##2##(1990-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
parallel in##4##2##(1990-2#1)(1995-5#1)(2007-7#1)(2008-5#1)
parallel increase in##5##3##(1991-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)
parallel interferometer##2##2##(2007-11#2)
parallel joint transform correlator for##3##5##(2008-3#3)
parallel joint transform correlator##4##4##(2008-3#4)
parallel learning##3##2##(2008-3#2)(2012-12#1)
parallel lines##2##2##(1992-3#2)
parallel manner##3##2##(1994-2#1)(1997-7#1)(2008-9#1)
parallel measurements of##2##3##(1991-5#1)(2008-10#1)
parallel measurements##3##2##(1991-5#1)(2008-10#2)
parallel opposed lateral and vertex fields##2##6##(1993-9#2)
parallel opposed##3##2##(1993-9#2)(2008-11#1)
parallel optical##6##2##(2008-2#2)(2008-3#3)(2012-2#1)
parallel pathways##2##2##(2007-12#1)(2013-1#1)
parallel performance##3##2##(2007-9#2)(2013-1#1)
parallel phase-shifting digital holographic##2##4##(2011-1#2)
parallel photonic integrated circuit##2##4##(2008-3#2)
parallel plate diffusion denuder coupled capillary##2##6##(2008-10#2)
parallel plate diffusion denuder##3##4##(2008-10#3)
parallel plate##5##2##(2008-10#3)(2013-1#2)
parallel processing of##2##3##(2008-10#1)(2008-2#1)
parallel processing systems##2##3##(2008-2#2)
parallel processing##10##2##(1996-5#1)(2008-10#1)(2008-2#5)(2008-3#2)(2010-7#1)
parallel processor for##2##3##(2008-3#2)
parallel processor##3##2##(2008-3#3)
parallel reactions##3##2##(2008-10#2)(2008-11#1)
parallel read-write-erase##2##2##(2008-2#2)
parallel studies##2##2##(2008-7#1)(2009-6#1)
parallel study of##2##3##(2008-10#1)(2011-1#1)
parallel surfaces##2##2##(2008-2#1)(2008-3#1)
parallel the##8##2##(1992-11#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-11#1)(2010-6#1)
parallel those containing##2##3##(1996-5#2)
parallel those##3##2##(1994-3#1)(1996-5#2)
parallel time series of reference##2##5##(2009-9#2)
parallel to each other##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
parallel to the lines##2##4##(2008-3#2)
parallel to the substrate##2##4##(2008-10#1)(2010-4#1)
parallel to the##41##3##(1991-5#1)(1996-4#2)(1996-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#11)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#2)(2011-7#1)
parallel to##65##2##(1991-5#2)(1992-1#1)(1992-9#1)(1993-6#1)(1994-11#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#2)(2011-2#1)(2011-7#1)(2012-3#1)(2013-8#1)
parallel wire##4##2##(2009-3#4)
parallel with a##2##3##(1994-9#1)(2009-10#1)
parallel with the##11##3##(1990-12#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-2#1)(2008-10#1)(2010-9#1)
parallel with##26##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-12#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#2)(2009-10#1)(2010-9#1)
parallel within##2##2##(1995-3#1)(2008-7#1)
parallel##469##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#6)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#6)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#3)(1995-2#4)(1995-3#7)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#8)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#1)(2007-11#19)(2007-12#15)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#57)(2008-11#20)(2008-12#6)(2008-2#33)(2008-3#77)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#17)(2008-8#6)(2008-9#4)(2009-10#5)(2009-12#2)(2009-3#6)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#10)(2013-2#1)(2013-7#1)(2013-8#2)
parallel)##2##1##(1994-6#1)(1996-2#1)
parallel-coupled ring-resonator##2##2##(2007-11#2)
parallel-distributed blind deconvolution method##2##4##(2008-3#2)
parallel-fiber##2##1##(2008-3#2)
parallel-group##4##1##(1994-11#1)(2007-10#2)(2008-2#1)
parallel-hole SPECT##4##2##(2009-8#4)
parallel-hole##6##1##(2009-8#6)
parallel-plate##2##1##(2007-11#2)
parallel-processing##2##1##(2008-3#2)
parallel-slab##6##1##(2008-3#6)
parallel-to-serial##2##1##(2008-2#1)(2008-3#1)
paralleled by a##7##3##(1990-3#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-5#1)(2008-7#1)
paralleled by an##2##3##(1994-11#1)(2008-7#1)
paralleled by increased##2##3##(1992-2#1)(2008-10#1)
paralleled by the##2##3##(1991-5#1)(2013-1#1)
paralleled by##16##2##(1990-3#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-12#2)(1996-12#1)(1996-5#1)(2007-5#1)(2008-10#1)(2008-7#2)(2011-1#1)(2013-1#1)
paralleled that of the##2##4##(1991-8#1)(1993-8#1)
paralleled the##8##2##(1990-2#1)(1990-9#1)(1991-2#1)(1994-7#1)(2008-10#2)(2008-11#1)(2009-9#1)
paralleled with##2##2##(2008-11#1)(2011-2#1)
paralleled##33##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
parallelism of##3##2##(2008-2#1)(2008-3#2)
parallelism##14##1##(2007-12#1)(2008-2#2)(2008-3#7)(2010-11#2)(2010-8#1)(2013-1#1)
parallelization of##2##2##(2007-9#1)(2009-3#1)
parallelization##3##1##(2007-9#1)(2008-3#1)(2009-3#1)
parallelized##5##1##(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#2)
parallelogrammic##2##1##(2008-2#2)
parallels between the##2##3##(2008-4#1)(2012-2#1)
parallels between##5##2##(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#1)
parallels in##2##2##(2008-6#1)(2008-7#1)
parallels that##2##2##(1992-6#1)(2008-10#1)
parallels the##6##2##(1994-8#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2012-1#1)
parallels with##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
parallels##24##1##(1991-12#1)(1991-2#1)(1992-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
paralog##2##1##(2008-1#1)(2009-6#1)
paralogous##2##1##(2008-1#1)(2012-2#1)
paralogs##6##1##(2009-10#1)(2009-6#1)(2010-3#1)(2013-1#3)
paralysis and##5##2##(1997-5#1)(2007-12#1)(2008-8#1)(2009-3#1)(2011-2#1)
paralysis in##3##2##(1992-2#1)(2010-8#1)(2013-1#1)
paralysis is a##2##3##(2007-5#1)(2010-8#1)
paralysis is##4##2##(2007-5#2)(2009-3#1)(2010-8#1)
paralysis of the##4##3##(1996-3#1)(2008-2#2)(2012-1#1)
paralysis##39##1##(1991-12#2)(1991-6#1)(1992-2#1)(1993-1#1)(1996-3#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-5#4)(2008-1#1)(2008-2#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
paralytic acylpolyamines from the##2##4##(1990-5#2)
paralytic##12##1##(1990-5#3)(1994-12#2)(1995-5#3)(1997-8#1)(2007-12#1)(2009-3#2)
paralyzed and##2##2##(1993-12#1)(2009-3#1)
paralyzed##6##1##(1993-12#1)(1997-6#1)(2007-10#2)(2009-3#1)(2013-1#1)
paramagnet##2##1##(2007-11#2)
paramagnetic broadening##2##2##(1994-5#2)
paramagnetic contrast##2##2##(1992-12#1)(2011-1#1)
paramagnetic resonance (EPR) spectroscopy##4##4##(1991-9#1)(2008-10#2)(2008-5#1)
paramagnetic resonance (EPR)##9##3##(1990-2#1)(1991-9#1)(1993-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-5#1)
paramagnetic resonance spectroscopy##5##3##(1993-11#2)(1996-2#1)(1997-1#1)(2008-10#1)
paramagnetic resonance##20##2##(1990-12#1)(1990-2#1)(1991-9#1)(1993-11#4)(1996-2#1)(1997-1#2)(2007-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)
paramagnetic species in the##2##4##(1990-5#2)
paramagnetic species##3##2##(1990-5#2)(2008-10#1)
paramagnetic##38##1##(1990-12#2)(1990-2#1)(1990-5#3)(1991-9#1)(1992-12#1)(1993-11#4)(1994-5#3)(1996-12#1)(1996-2#1)(1997-1#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#1)
paramecia##7##1##(1992-6#1)(2008-5#6)
paramedian##3##1##(1997-6#1)(2007-10#1)(2012-3#1)
parameres##2##1##(2008-5#2)
parameter (the##2##2##(2007-12#1)(2008-10#1)
parameter analyses##2##2##(2008-6#2)
parameter and the##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
parameter and##13##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
parameter are##3##2##(1995-6#1)(2008-2#1)(2008-3#1)
parameter at##2##2##(1996-2#1)(2008-2#1)
parameter difference##2##2##(2008-3#1)(2011-2#1)
parameter estimates derived from##2##4##(2008-10#2)
parameter estimates were used to##2##5##(2008-10#2)
parameter estimates were##3##3##(2008-10#3)
parameter estimates##26##2##(1992-6#1)(1992-9#1)(2008-10#18)(2008-7#1)(2009-10#3)(2009-8#1)(2010-8#1)
parameter estimation##7##2##(1997-4#1)(2008-10#4)(2008-2#1)(2012-3#1)
parameter evaluation and prediction##2##4##(2008-10#2)
parameter exceeds##2##2##(2007-11#1)(2008-3#1)
parameter for each##3##3##(1993-11#1)(2008-10#1)(2009-10#1)
parameter for the automated##2##4##(2008-7#2)
parameter for the##8##3##(1993-12#1)(2007-12#1)(2008-10#3)(2008-7#3)
parameter for##27##2##(1993-11#1)(1993-12#1)(1993-8#1)(1994-7#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#2)(2010-7#1)(2012-3#1)
parameter from##2##2##(2008-10#1)(2011-2#1)
parameter governing the##2##3##(2008-3#1)(2009-10#1)
parameter governing##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
parameter in the##8##3##(1991-2#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-9#1)(2010-2#1)
parameter in##18##2##(1990-12#1)(1991-2#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
parameter influencing##2##2##(2008-10#1)(2008-8#1)
parameter is not##2##3##(2008-3#1)(2010-2#1)
parameter is##14##2##(1991-11#1)(1993-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-9#1)(2010-2#1)
parameter measurements##2##2##(2008-3#2)
parameter n##2##2##(2008-3#1)(2008-7#1)
parameter of a##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
parameter of response##2##3##(2008-10#1)(2008-5#1)
parameter of the beta-binomial distribution##4##5##(2008-10#4)
parameter of the beta-binomial##5##4##(2008-10#5)
parameter of the phase function##2##5##(2008-3#2)
parameter of the##13##3##(1990-7#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#3)(2010-4#1)
parameter of##36##2##(1990-7#1)(1991-10#1)(1991-2#1)(1993-11#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#9)(2008-5#2)(2008-8#1)(2008-9#3)(2010-4#1)
parameter relating##2##2##(2008-3#1)(2008-5#1)
parameter sets for##2##3##(2008-10#2)
parameter sets##4##2##(2008-10#3)(2008-11#1)
parameter settings##2##2##(2008-8#1)(2012-1#1)
parameter space##11##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-8#1)(2012-3#1)
parameter that can be##2##4##(2008-3#1)(2010-12#1)
parameter that##12##2##(1994-11#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-8#1)(2010-12#1)
parameter theta##2##2##(2008-10#1)(2008-8#1)
parameter to be##3##3##(2008-10#2)(2008-6#1)
parameter to estimate##2##3##(1992-12#1)(2008-8#1)
parameter to##18##2##(1992-12#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#3)
parameter under##2##2##(2008-5#1)(2012-2#1)
parameter v##2##2##(2013-8#2)
parameter value##2##2##(2008-10#2)
parameter values for the##2##4##(2008-10#1)(2010-9#1)
parameter values for##4##3##(2008-10#2)(2008-2#1)(2010-9#1)
parameter values in##2##3##(2008-10#1)(2008-12#1)
parameter values##31##2##(1994-2#1)(1997-2#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-2#1)(2010-9#1)(2013-8#1)
parameter variations are studied##2##4##(2008-3#2)
parameter variations##4##2##(2008-2#1)(2008-3#3)
parameter was significantly##2##3##(2008-5#2)
parameter was##14##2##(1990-12#1)(1991-10#1)(1992-10#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-5#4)(2011-2#1)
parameter which##4##2##(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
parameter with##2##2##(2008-5#1)(2011-1#1)
parameter##482##1##(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#4)(2006-12#1)(2007-11#14)(2007-12#14)(2007-8#1)(2008-1#1)(2008-10#115)(2008-11#12)(2008-12#2)(2008-2#35)(2008-3#65)(2008-5#20)(2008-6#9)(2008-7#21)(2008-8#19)(2008-9#10)(2009-10#10)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#8)(2013-8#7)
parameter) values##2##2##(1995-3#2)
parameter)##6##1##(1995-3#2)(2008-10#1)(2008-2#2)(2011-1#1)
parameter-extended##2##1##(2009-4#2)
parameterization and##2##2##(2008-2#1)(2008-3#1)
parameterization of the##5##3##(1997-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
parameterization of##6##2##(1997-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-1#1)
parameterization##13##1##(1997-2#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2012-1#1)
parameterizations are##2##2##(2008-2#2)
parameterizations##5##1##(1995-2#1)(2008-2#3)(2008-3#1)
parameterize the##4##2##(2008-3#1)(2009-11#1)(2010-3#1)(2012-1#1)
parameterize##6##1##(2008-3#1)(2008-8#2)(2009-11#1)(2010-3#1)(2012-1#1)
parameterized for##2##2##(2008-10#1)(2008-11#1)
parameterized in##2##2##(1997-4#1)(2008-3#1)
parameterized with##2##2##(2008-8#1)(2008-9#1)
parameterized##17##1##(1992-3#1)(1992-9#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#6)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
parameters (AUC##2##2##(2011-2#2)
parameters (Vmax and##2##3##(1990-5#1)(1996-7#1)
parameters (alpha##2##2##(2008-10#2)
parameters (concentrations##2##2##(2008-10#2)
parameters (e##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
parameters (i##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
parameters (pH##2##2##(2008-10#1)(2008-3#1)
parameters (temperature##2##2##(2008-10#2)
parameters a##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
parameters affect the##2##3##(1997-4#1)(2008-2#1)
parameters affecting the production and collection of the##2##8##(2008-10#2)
parameters affecting the sensitivity of##2##5##(2008-10#1)(2010-5#1)
parameters affecting the##17##3##(1990-12#1)(2008-10#15)(2010-5#1)
parameters affecting##22##2##(1990-12#1)(1997-2#1)(2008-10#19)(2010-5#1)
parameters after##4##2##(1996-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
parameters alpha and##3##3##(2008-6#2)(2008-9#1)
parameters alpha##4##2##(1991-6#1)(2008-6#2)(2008-9#1)
parameters also##3##2##(1992-12#1)(2008-9#1)(2013-1#1)
parameters and a##3##3##(1995-9#1)(2007-11#1)(2008-3#1)
parameters and clinical##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
parameters and fluid overload problems in patients on##2##8##(2007-7#2)
parameters and fluid overload problems in##3##6##(2007-7#3)
parameters and the##7##3##(1995-8#1)(2008-10#3)(2008-2#1)(2008-3#2)
parameters and their##3##3##(2008-10#2)(2011-2#1)
parameters and to##5##3##(1995-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
parameters and##121##2##(1992-5#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#9)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#5)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#3)(2013-7#4)(2013-8#4)
parameters applied##2##2##(2008-10#1)(2008-11#1)
parameters are also##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
parameters are calculated##2##3##(2008-3#2)
parameters are considered##3##3##(1994-8#1)(2008-3#1)(2008-5#1)
parameters are derived##2##3##(2008-3#2)
parameters are discussed##2##3##(2008-2#1)(2008-7#1)
parameters are estimated##2##3##(2007-12#1)(2008-7#1)
parameters are extracted from##2##4##(2008-3#1)(2010-8#1)
parameters are known and##2##4##(1995-9#1)(2008-3#1)
parameters are necessary to specify the configuration of such a system##2##11##(2008-3#2)
parameters are the##2##3##(2008-10#1)(2008-3#1)
parameters are##70##2##(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#1)(1994-8#1)(1995-9#1)(1997-2#1)(1997-7#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-2#2)(2008-3#20)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
parameters as large as##2##4##(2007-11#1)(2008-3#1)
parameters as well as##2##4##(2008-12#1)(2013-1#1)
parameters as well##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
parameters as##14##2##(1993-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-7#1)(2009-4#1)(2013-1#1)
parameters associated to##2##3##(2008-10#2)
parameters associated with the##4##4##(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
parameters associated with##6##3##(1993-1#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
parameters associated##8##2##(1993-1#1)(1995-5#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
parameters at each##2##3##(1990-8#1)(2008-6#1)
parameters at##7##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)
parameters based on the##2##4##(2008-10#2)
parameters based on##6##3##(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)
parameters being##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
parameters between the##3##3##(2007-8#1)(2008-10#1)(2010-7#1)
parameters between##7##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#1)
parameters but##5##2##(1993-8#1)(2008-3#1)(2008-7#2)(2009-6#1)
parameters by a##2##3##(1997-8#1)(2008-2#1)
parameters by the##2##3##(1997-8#1)(2008-5#1)
parameters by##14##2##(1994-9#1)(1997-8#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#2)(2010-3#1)(2010-8#1)(2012-2#2)
parameters can be measured##3##4##(2008-3#3)
parameters can be used##2##4##(2008-2#1)(2011-1#1)
parameters can be##18##3##(1990-9#1)(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-6#1)(2009-4#1)(2011-1#1)
parameters can lead##2##3##(2008-1#1)(2013-8#1)
parameters can##26##2##(1990-9#1)(1993-11#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2013-8#1)
parameters cannot be##2##3##(2008-10#1)(2008-3#1)
parameters changed##2##2##(2012-1#1)(2013-1#1)
parameters characteristic##2##2##(2008-3#1)(2013-1#1)
parameters characterizing##3##2##(2008-5#1)(2008-6#1)(2011-1#1)
parameters considered##2##2##(2008-3#1)(2008-5#1)
parameters could be##3##3##(1991-12#1)(2007-12#1)(2011-2#1)
parameters could##6##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
parameters decreased##2##2##(1992-5#1)(2008-10#1)
parameters derived from the##2##4##(2008-10#1)(2008-5#1)
parameters derived from##5##3##(1995-5#1)(2008-10#3)(2008-5#1)
parameters describing the##2##3##(2008-10#2)
parameters describing##5##2##(2008-10#4)(2008-7#1)
parameters do not##2##3##(2008-3#1)(2012-12#1)
parameters do##3##2##(1994-3#1)(2008-3#1)(2012-12#1)
parameters during the##4##3##(2006-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
parameters during##8##2##(1990-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-7#1)
parameters estimated by##2##3##(1994-9#1)(2008-7#1)
parameters estimated##3##2##(1994-9#1)(2008-5#1)(2008-7#1)
parameters evaluated were##2##3##(1995-6#1)(2008-1#1)
parameters evaluated##6##2##(1990-9#1)(1992-3#1)(1995-6#1)(2008-1#1)(2011-7#1)(2013-8#1)
parameters for a##3##3##(2008-10#2)(2008-3#1)
parameters for assessing the##2##4##(1990-3#1)(2008-10#1)
parameters for assessment of##2##4##(2008-4#1)(2013-1#1)
parameters for both##3##3##(1995-5#1)(2008-10#2)
parameters for determination of##3##4##(2008-10#2)(2013-1#1)
parameters for the determination of##3##5##(2008-10#3)
parameters for the formation of##2##5##(1992-3#1)(2008-10#1)
parameters for the interaction of##2##5##(2008-10#2)
parameters for the interconversion##3##4##(1990-9#1)(2008-10#2)
parameters for the##41##3##(1990-12#1)(1990-9#1)(1992-3#2)(1993-8#1)(1994-5#1)(1995-2#2)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
parameters for this##2##3##(1992-6#1)(2013-1#1)
parameters for water quality##2##4##(2008-10#2)
parameters for##121##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-10#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#3)(1997-4#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#45)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2013-1#4)
parameters from a##2##3##(2008-8#1)(2011-2#1)
parameters from the##4##3##(1995-9#1)(2007-12#1)(2008-3#2)
parameters from##24##2##(1995-2#1)(1995-5#2)(1995-9#1)(2007-12#2)(2008-2#2)(2008-3#11)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
parameters gave##2##2##(2008-5#1)(2008-7#1)
parameters had##4##2##(1994-5#1)(2008-10#3)
parameters has a##2##3##(2008-10#1)(2008-3#1)
parameters has##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)
parameters have a##2##3##(2008-10#1)(2010-12#1)
parameters have been determined##2##4##(2008-10#1)(2008-3#1)
parameters have been investigated##2##4##(2008-10#2)
parameters have been optimised##2##4##(2008-10#2)
parameters have been##17##3##(1997-2#1)(2008-10#12)(2008-2#2)(2008-3#2)
parameters have##22##2##(1992-8#1)(1997-2#1)(2008-10#15)(2008-2#2)(2008-3#2)(2010-12#1)
parameters in a##4##3##(2008-3#2)(2008-5#1)(2012-2#1)
parameters in all##2##3##(2008-10#1)(2011-1#1)
parameters in comparison##2##3##(1996-12#1)(2010-4#1)
parameters in each##2##3##(1994-3#1)(2008-10#1)
parameters in order to##2##4##(2008-12#1)(2013-1#1)
parameters in patients with##2##4##(2010-12#1)(2013-1#1)
parameters in patients##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
parameters in the model##2##4##(2008-7#2)
parameters in the##29##3##(1990-12#1)(1990-2#1)(1992-6#1)(1994-8#1)(1995-9#3)(1996-5#1)(1996-7#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-8#2)(2011-1#2)(2012-3#1)
parameters in##98##2##(1990-11#1)(1990-12#1)(1990-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-9#3)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-12#3)(2008-2#4)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#5)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
parameters include##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
parameters including pH##2##3##(2008-10#1)(2013-8#1)
parameters including reagent##2##3##(2008-10#2)
parameters including the##2##3##(2008-10#1)(2008-12#1)
parameters including##15##2##(1994-5#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
parameters influence the##3##3##(1996-5#1)(2008-2#1)(2008-3#1)
parameters influencing the##6##3##(1992-9#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-3#1)
parameters influencing##7##2##(1992-9#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
parameters into##2##2##(2008-10#1)(2008-9#1)
parameters investigated##6##2##(1991-1#1)(1994-6#1)(2006-8#1)(2008-10#2)(2008-3#1)
parameters involved in the##2##4##(2008-10#1)(2008-11#1)
parameters involved in##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
parameters involved##6##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
parameters is obtained##3##3##(2008-10#1)(2008-3#2)
parameters is##19##2##(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#6)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
parameters like the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
parameters like##13##2##(2008-10#5)(2008-11#4)(2008-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
parameters may be##2##3##(2008-12#1)(2008-7#1)
parameters measured by##2##3##(1995-5#1)(2008-3#1)
parameters measured##6##2##(1995-5#1)(1996-1#1)(2008-10#1)(2008-3#1)(2012-2#2)
parameters mentioned##2##2##(1990-11#1)(2008-10#1)
parameters most often##2##3##(2008-10#1)(2008-3#1)
parameters necessary for##2##3##(2008-9#1)(2009-4#1)
parameters needed to##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
parameters needed##5##2##(2008-10#1)(2008-3#2)(2008-4#1)(2010-7#1)
parameters obtained were##3##3##(2008-10#2)(2013-7#1)
parameters obtained##8##2##(1995-12#1)(2008-10#4)(2008-3#1)(2013-1#1)(2013-7#1)
parameters of RBC##2##3##(2008-12#2)
parameters of a particle##2##4##(2008-2#1)(2008-3#1)
parameters of a single##2##4##(1990-12#1)(2007-12#1)
parameters of a##14##3##(1990-12#1)(2007-12#4)(2008-2#2)(2008-3#6)(2008-5#1)
parameters of an##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
parameters of artificial##2##3##(2012-1#2)
parameters of both##5##3##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
parameters of cirrus##2##3##(2008-3#2)
parameters of each##2##3##(2008-3#1)(2012-12#1)
parameters of forensic interest##3##4##(2008-12#3)
parameters of healthy##2##3##(2008-5#1)(2011-1#1)
parameters of interest for##2##4##(2008-3#2)
parameters of interest##3##3##(2008-10#1)(2008-3#2)
parameters of laser-induced potentials##2##4##(2012-1#2)
parameters of neural##2##3##(2008-10#1)(2008-7#1)
parameters of protein##2##3##(2008-1#1)(2011-2#1)
parameters of skin##2##3##(2012-3#1)(2013-8#1)
parameters of such##2##3##(2008-3#2)
parameters of synaptic transmission##2##4##(2008-7#1)(2009-9#1)
parameters of the binary##2##4##(2008-10#2)
parameters of the calibration##2##4##(2008-10#1)(2009-8#1)
parameters of the instrument##2##4##(2008-2#1)(2013-8#1)
parameters of the method##2##4##(2008-10#2)
parameters of the model##5##4##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
parameters of the skin##2##4##(2008-3#1)(2008-5#1)
parameters of the structure##2##4##(2007-12#1)(2008-3#1)
parameters of the system##2##4##(2007-11#1)(2008-10#1)
parameters of the underlying##3##4##(2008-4#1)(2008-7#1)(2009-11#1)
parameters of the##112##3##(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-5#2)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#4)(2008-10#25)(2008-11#1)(2008-2#7)(2008-3#26)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#2)(2012-9#1)(2013-1#2)(2013-8#1)
parameters of these##2##3##(1995-2#1)(2008-10#1)
parameters of this##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
parameters of various##2##3##(2008-12#1)(2008-3#1)
parameters of##303##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#10)(2007-6#1)(2008-1#2)(2008-10#58)(2008-11#5)(2008-12#9)(2008-2#21)(2008-3#55)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-8#2)(2011-1#9)(2011-2#12)(2011-3#3)(2012-1#7)(2012-12#1)(2012-2#4)(2012-3#2)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#5)
parameters on the response##2##4##(2008-10#2)
parameters on the retention##2##4##(1996-5#1)(2008-11#1)
parameters on the##22##3##(1991-5#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-11#5)(2008-3#2)(2011-2#2)
parameters on##40##2##(1991-5#1)(1995-5#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#15)(2008-11#7)(2008-3#4)(2008-6#2)(2008-7#2)(2011-2#2)(2013-1#1)
parameters only##3##2##(1996-9#1)(2008-3#1)(2011-10#1)
parameters optimized were##2##3##(2008-10#2)
parameters or##2##2##(2007-12#1)(2011-3#1)
parameters over a##2##3##(2008-2#1)(2008-3#1)
parameters over##5##2##(2006-8#1)(2008-2#1)(2008-3#2)(2013-8#1)
parameters ranged##2##2##(1990-2#1)(2013-7#1)
parameters related to the##11##4##(1993-6#1)(2008-10#6)(2008-2#1)(2008-7#2)(2010-8#1)
parameters related to##14##3##(1993-6#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)
parameters remained##2##2##(1991-6#1)(2013-1#1)
parameters required for##2##3##(2008-2#1)(2008-7#1)
parameters should be##4##3##(2008-10#3)(2008-3#1)
parameters should##5##2##(2006-10#1)(2008-10#3)(2008-3#1)
parameters show##2##2##(1992-9#1)(2008-10#1)
parameters showed##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
parameters simultaneously##2##2##(2008-3#1)(2008-9#1)
parameters studied##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
parameters such as pH##6##4##(2008-10#5)(2008-6#1)
parameters such as sample##2##4##(2008-10#2)
parameters such as temperature##2##4##(2008-10#1)(2008-3#1)
parameters such as the##23##4##(2008-10#13)(2008-2#1)(2008-3#5)(2008-8#1)(2009-8#1)(2011-3#1)(2013-8#1)
parameters such as##77##3##(1990-8#1)(1992-5#1)(1994-5#1)(1997-2#1)(2008-1#1)(2008-10#40)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#2)
parameters such that##2##3##(1993-12#1)(2008-3#1)
parameters such##79##2##(1990-8#1)(1992-5#1)(1993-12#1)(1994-5#1)(1997-2#1)(2008-1#1)(2008-10#40)(2008-12#1)(2008-2#2)(2008-3#12)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#2)
parameters suitable for##2##3##(2008-10#1)(2011-1#1)
parameters than##2##2##(2008-2#1)(2013-8#1)
parameters that affect the##7##4##(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)
parameters that affect##12##3##(1990-12#1)(1992-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
parameters that are##4##3##(1990-5#1)(2008-2#1)(2008-3#2)
parameters that can be##2##4##(2008-11#1)(2008-3#1)
parameters that can##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
parameters that characterize the surface##2##5##(2008-3#2)
parameters that characterize the##6##4##(2007-12#2)(2008-2#1)(2008-3#3)
parameters that characterize##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
parameters that correspond to##2##4##(2008-3#2)
parameters that could##2##3##(2011-2#1)(2012-2#1)
parameters that describe the##3##4##(1990-8#1)(2008-10#1)(2008-5#1)
parameters that describe##4##3##(1990-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
parameters that determine##2##3##(2008-3#1)(2013-8#1)
parameters that have prognostic##2##4##(2008-9#1)(2010-10#1)
parameters that have##5##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-3#1)
parameters that influence the##3##4##(2008-10#3)
parameters that were##2##3##(2008-10#1)(2008-6#1)
parameters that##72##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-3#1)(1995-9#1)(2007-12#3)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-2#3)(2013-8#1)
parameters the##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
parameters through##2##2##(2008-3#2)
parameters to be determined##3##4##(2008-3#3)
parameters to be##7##3##(2008-10#3)(2008-3#4)
parameters to evaluate the##2##4##(2008-10#1)(2012-2#1)
parameters to guide##2##3##(2012-12#1)(2013-1#1)
parameters to the##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
parameters to##38##2##(1991-11#1)(1995-5#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#9)(2008-7#3)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
parameters used to##2##3##(2008-2#1)(2013-1#1)
parameters used##7##2##(1990-5#1)(1992-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
parameters using the##2##3##(2008-5#1)(2008-6#1)
parameters using##6##2##(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-3#1)
parameters was done##2##3##(2008-10#1)(2012-2#1)
parameters was observed##3##3##(1991-11#1)(2011-1#1)(2013-1#1)
parameters was obtained##2##3##(2008-3#1)(2012-2#1)
parameters was##18##2##(1991-11#1)(1996-9#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#2)(2012-2#3)(2013-1#1)
parameters were also##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
parameters were assessed##3##3##(2008-10#2)(2013-1#1)
parameters were calculated using##2##4##(2008-11#1)(2008-5#1)
parameters were calculated##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)
parameters were compared##3##3##(1994-8#1)(1995-4#1)(2008-5#1)
parameters were correlated##2##3##(2008-10#1)(2008-5#1)
parameters were derived from##2##4##(2008-10#1)(2008-5#1)
parameters were determined by##2##4##(2008-3#1)(2011-2#1)
parameters were determined for##2##4##(2006-8#1)(2008-3#1)
parameters were determined##10##3##(1991-5#1)(2006-8#1)(2008-10#2)(2008-3#2)(2008-5#2)(2011-2#2)
parameters were established##2##3##(2008-10#2)
parameters were evaluated in##2##4##(1994-8#1)(2008-7#1)
parameters were evaluated##6##3##(1990-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
parameters were found##2##3##(2008-10#1)(2013-7#1)
parameters were in good agreement##2##5##(2008-2#1)(2008-3#1)
parameters were investigated##5##3##(2008-10#5)
parameters were measured##4##3##(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
parameters were normalized##2##3##(1996-3#1)(2012-3#1)
parameters were not##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2008-6#1)
parameters were observed##2##3##(1991-5#1)(2008-5#1)
parameters were obtained##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#2)
parameters were optimised##4##3##(2008-10#4)
parameters were optimized for the determination of##3##7##(2008-10#3)
parameters were optimized for##4##4##(2008-10#4)
parameters were optimized##12##3##(2008-10#12)
parameters were quantified##2##3##(2008-10#1)(2009-7#1)
parameters were studied##9##3##(1994-3#1)(1994-5#1)(2008-10#6)(2008-5#1)
parameters were tested##3##3##(2008-10#3)
parameters were the##2##3##(2008-10#2)
parameters were used to##4##4##(1996-12#1)(2007-11#2)(2008-7#1)
parameters were used##5##3##(1996-12#1)(2007-11#2)(2008-3#1)(2008-7#1)
parameters were##139##2##(1990-3#1)(1991-5#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#63)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#2)(2010-5#1)(2011-10#1)(2011-2#10)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
parameters which are##2##3##(2008-10#1)(2008-7#1)
parameters which influence##2##3##(2008-10#1)(2012-2#1)
parameters which were##4##3##(2008-10#2)(2008-7#1)(2013-8#1)
parameters which##12##2##(1990-8#1)(1992-12#1)(2008-10#4)(2008-6#1)(2008-7#2)(2012-2#2)(2013-8#1)
parameters with a##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
parameters with those##2##3##(1994-3#1)(1996-2#1)
parameters with##10##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-3#4)(2009-11#1)(2011-10#1)(2013-1#1)
parameters within##2##2##(2008-10#1)(2008-3#1)
parameters##2255##1##(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#10)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#5)(1991-1#3)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#10)(1992-5#5)(1992-6#4)(1992-8#1)(1992-9#9)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#6)(1993-6#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#15)(1994-5#8)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#9)(1995-3#1)(1995-4#1)(1995-5#12)(1995-6#2)(1995-8#2)(1995-9#9)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#8)(1996-7#6)(1996-9#2)(1997-2#17)(1997-3#1)(1997-4#9)(1997-6#4)(1997-7#9)(1997-8#5)(2006-10#1)(2006-8#5)(2007-10#4)(2007-11#38)(2007-12#42)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#4)(2007-8#14)(2008-1#14)(2008-10#580)(2008-11#51)(2008-12#47)(2008-2#116)(2008-3#319)(2008-4#18)(2008-5#68)(2008-6#33)(2008-7#92)(2008-8#34)(2008-9#38)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#10)(2009-6#1)(2009-7#5)(2009-8#8)(2009-9#1)(2010-10#6)(2010-11#6)(2010-12#8)(2010-2#9)(2010-3#10)(2010-4#9)(2010-5#5)(2010-7#3)(2010-8#13)(2011-1#39)(2011-10#3)(2011-2#68)(2011-3#8)(2011-7#1)(2012-1#12)(2012-12#14)(2012-2#34)(2012-3#21)(2012-5#1)(2012-7#1)(2012-9#3)(2013-1#56)(2013-3#1)(2013-7#15)(2013-8#39)
parameters&quot##2##1##(1990-9#1)(2011-2#1)
parameters'##2##1##(2008-10#1)(2008-11#1)
parameters)##6##1##(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)
parameters?##2##1##(2006-10#1)(2007-11#1)
parameters]##4##1##(1990-8#1)(1991-11#1)(2011-2#1)(2012-3#1)
parametres##2##1##(2008-10#1)(2008-5#1)
parametric amplification by##2##3##(2007-12#1)(2008-3#1)
parametric amplification in a##2##4##(2007-11#1)(2007-12#1)
parametric amplification in periodically poled KTiOPO(4)##2##6##(2007-11#1)(2007-12#1)
parametric amplification in##6##3##(2007-11#3)(2007-12#3)
parametric amplification of##5##3##(2007-12#4)(2008-2#1)
parametric amplification##24##2##(2007-11#7)(2007-12#15)(2008-2#1)(2008-3#1)
parametric amplifier pumped by a##2##5##(2007-11#1)(2007-12#1)
parametric amplifier pumped by##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
parametric amplifier with##2##3##(2007-11#2)
parametric amplifier##22##2##(2007-11#11)(2007-12#7)(2008-2#3)(2008-3#1)
parametric amplifiers##2##2##(2007-12#2)
parametric and nonparametric##5##3##(2008-10#1)(2009-10#3)(2012-1#1)
parametric and##6##2##(1997-7#1)(2008-10#1)(2009-10#3)(2012-1#1)
parametric chirped pulse amplification##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
parametric conversion##2##2##(2007-12#2)
parametric downconversion in a##2##4##(2008-3#2)
parametric downconversion##9##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)
parametric gain in a##2##4##(2007-12#1)(2008-3#1)
parametric gain##6##2##(2007-11#4)(2007-12#1)(2008-3#1)
parametric generation in##4##3##(2007-12#4)
parametric generator based on##3##4##(2007-12#3)
parametric generator##11##2##(2007-11#2)(2007-12#8)(2008-2#1)
parametric generators##2##2##(2007-11#2)
parametric interaction in##3##3##(2007-11#1)(2007-12#2)
parametric interaction of##2##3##(2007-12#1)(2008-3#1)
parametric interaction##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
parametric interactions##2##2##(2007-11#2)
parametric model##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
parametric models in##2##3##(1995-9#1)(2013-1#1)
parametric models##5##2##(1995-9#2)(2007-12#1)(2011-1#1)(2013-1#1)
parametric oscillation are##2##3##(2007-12#1)(2008-3#1)
parametric oscillation in periodically poled##2##5##(2007-11#1)(2008-3#1)
parametric oscillation in##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
parametric oscillation is##2##3##(2007-11#1)(2007-12#1)
parametric oscillation of##2##3##(2007-12#1)(2008-3#1)
parametric oscillation##22##2##(2007-11#5)(2007-12#10)(2008-3#7)
parametric oscillator based on##10##4##(2007-11#5)(2007-12#5)
parametric oscillator pumped by a##6##5##(2007-12#3)(2008-2#1)(2008-3#2)
parametric oscillator pumped by##7##4##(2007-12#3)(2008-2#2)(2008-3#2)
parametric oscillator with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
parametric oscillator with##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
parametric oscillator##110##2##(2007-11#33)(2007-12#46)(2008-10#1)(2008-2#6)(2008-3#23)(2008-5#1)
parametric oscillators (OPO's)##4##3##(2007-12#2)(2008-3#2)
parametric oscillators##21##2##(2007-11#6)(2007-12#11)(2008-2#1)(2008-3#3)
parametric power##2##2##(2007-11#1)(2007-12#1)
parametric process##2##2##(2007-11#1)(2007-12#1)
parametric processes in##2##3##(2007-12#2)
parametric processes##4##2##(2007-11#1)(2007-12#3)
parametric solitons##3##2##(2007-11#1)(2007-12#2)
parametric study##2##2##(1991-2#1)(2008-3#1)
parametric wave mixing##2##3##(2007-11#1)(2007-12#1)
parametric##338##1##(1991-12#1)(1991-2#1)(1995-12#1)(1995-9#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2007-11#93)(2007-12#135)(2008-10#12)(2008-11#3)(2008-2#18)(2008-3#45)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
parametrically defined##2##2##(2008-3#2)
parametrically##6##1##(2007-11#1)(2008-3#2)(2008-9#1)(2009-2#1)(2010-12#1)
parametrization##2##1##(2008-6#1)(2010-11#1)
paramo##2##1##(2013-7#2)
paramos##2##1##(2013-7#2)
paramount importance to##7##3##(1991-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2013-7#1)
paramount importance##14##2##(1990-5#1)(1991-5#1)(1994-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
paramount in##3##2##(2007-12#1)(2009-10#1)(2013-7#1)
paramount##23##1##(1990-5#1)(1991-5#1)(1994-12#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#2)
paramyxovirus##4##1##(1997-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
paranasal sinus##3##2##(2008-7#2)(2013-1#1)
paranasal sinuses##13##2##(1990-6#1)(1991-6#1)(1992-10#1)(2006-12#3)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
paranasal sinusitis##5##2##(2010-6#1)(2013-1#4)
paranasal##24##1##(1990-6#1)(1991-6#1)(1992-10#1)(2006-12#3)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#6)
paraneoplasic neurological syndromes##3##3##(1996-11#3)
paraneoplasic##4##1##(1996-11#4)
paraneoplastic neurological##2##2##(2013-1#2)
paraneoplastic sensory neuropathy##2##3##(2009-3#2)
paraneoplastic syndrome##3##2##(2008-6#2)(2013-7#1)
paraneoplastic syndromes##4##2##(1994-9#1)(2009-3#2)(2012-3#1)
paraneoplastic##14##1##(1994-9#1)(1996-11#1)(1997-8#1)(2008-6#2)(2009-3#4)(2012-3#1)(2013-1#3)(2013-7#1)
paranoia##3##1##(1991-1#1)(2008-7#1)(2011-2#1)
paranoid schizophrenia##6##2##(2009-9#2)(2010-6#1)(2011-2#1)(2012-2#2)
paranoid##11##1##(1992-12#1)(1995-11#1)(1996-7#1)(2009-9#2)(2010-6#1)(2011-2#1)(2012-2#3)(2013-7#1)
paraophthalmic##2##1##(2012-3#2)
paraoxon and##2##2##(1996-12#1)(2008-10#1)
paraoxon##17##1##(1996-12#2)(1997-4#2)(2007-11#2)(2008-10#11)
paraoxonase 1 (PON1)##2##3##(2012-12#1)(2013-8#1)
paraoxonase 1##4##2##(2009-12#1)(2012-12#2)(2013-8#1)
paraparesis##13##1##(1991-11#1)(1997-6#1)(2007-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-12#3)(2013-1#3)
parapatellar##3##1##(2012-12#1)(2013-1#2)
parapharyngeal space##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
parapharyngeal##7##1##(2008-7#1)(2009-7#2)(2011-2#2)(2012-3#2)
paraphrenia##4##1##(2011-2#4)
paraphyletic##2##1##(2007-12#2)
paraplegia and##2##2##(2008-12#1)(2013-1#1)
paraplegia following##2##2##(1996-3#1)(2008-7#1)
paraplegia##15##1##(1992-5#1)(1996-3#1)(2007-8#2)(2008-12#2)(2008-7#6)(2010-8#1)(2011-2#1)(2013-1#1)
paraplegic athletes##2##2##(2013-1#2)
paraprofessional##2##1##(1991-12#1)(1992-1#1)
paraprosthetic##2##1##(2007-8#2)
parapsilosis##15##1##(1997-2#3)(2008-5#8)(2010-5#1)(2012-3#2)(2013-1#1)
paraquat herbicide##2##2##(2008-10#2)
paraquat in##7##2##(2008-10#7)
paraquat using a##2##3##(2008-10#2)
paraquat##23##1##(2008-10#19)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
parasagittal AVM##3##2##(2008-7#3)
parasagittal##6##1##(1994-2#1)(2008-7#4)(2013-1#1)
parasellar##2##1##(2006-12#2)
parasexual recombination##3##2##(2008-10#2)(2008-8#1)
parasexual##6##1##(2008-10#5)(2008-8#1)
parasitaemia##3##1##(1994-11#1)(2007-2#1)(2013-1#1)
parasite P##2##2##(2010-2#1)(2012-2#1)
parasite Plasmodium##2##2##(1993-2#1)(2010-2#1)
parasite Toxoplasma gondii##2##3##(2007-7#1)(2009-7#1)
parasite abundance##3##2##(2010-8#2)(2013-1#1)
parasite and host##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
parasite and##10##2##(1992-9#1)(1997-6#1)(2008-10#3)(2008-9#3)(2011-2#1)(2012-2#1)
parasite control of##2##3##(1997-7#1)(2008-9#1)
parasite control##6##2##(1997-7#5)(2008-9#1)
parasite cytoplasm and##2##3##(2012-2#2)
parasite density##2##2##(1994-11#2)
parasite development##2##2##(2008-8#1)(2012-2#1)
parasite growth##2##2##(2010-2#1)(2012-3#1)
parasite in##2##2##(2007-10#1)(2013-1#1)
parasite infection##3##2##(1997-7#1)(2007-6#1)(2008-8#1)
parasite is##5##2##(1990-2#1)(2007-2#1)(2007-6#1)(2008-8#1)(2012-12#1)
parasite isolates##2##2##(2008-12#1)(2013-1#1)
parasite lactate dehydrogenase##2##3##(2007-7#2)
parasite life-history traits##3##3##(2008-8#3)
parasite may##2##2##(2008-8#2)
parasite of the##2##3##(2011-2#2)
parasite of##12##2##(1991-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-9#2)(2010-3#1)(2011-2#2)(2013-1#1)
parasite on##2##2##(2008-8#1)(2010-8#1)
parasite population##2##2##(1997-7#1)(2008-9#1)
parasite populations##3##2##(1997-6#1)(2008-8#2)
parasite prevalence##2##2##(1994-11#2)
parasite species and diagnostic method##2##5##(2012-12#2)
parasite species##7##2##(1996-12#1)(2011-1#1)(2012-12#5)
parasite success##2##2##(2008-8#2)
parasite through##2##2##(2009-5#1)(2010-8#1)
parasite to##3##2##(1996-12#1)(2008-9#1)(2012-2#1)
parasite virulence and##2##3##(2008-8#2)
parasite virulence##13##2##(2008-8#12)(2008-9#1)
parasite was##3##2##(1991-2#1)(2008-3#1)(2008-8#1)
parasite##197##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-5#2)(1992-9#4)(1993-2#3)(1993-6#1)(1994-11#7)(1994-12#2)(1995-12#2)(1996-12#2)(1996-6#1)(1997-3#1)(1997-6#4)(1997-7#9)(2007-10#1)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#3)(2008-10#17)(2008-12#3)(2008-3#1)(2008-8#36)(2008-9#15)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#2)(2010-8#6)(2011-1#2)(2011-2#8)(2012-12#7)(2012-2#13)(2012-3#5)(2013-1#5)(2013-8#2)
parasite)##2##1##(2008-8#1)(2008-9#1)
parasite-host##2##1##(2008-8#1)(2008-9#1)
parasite-induced host sterility##3##3##(2008-9#3)
parasite-induced host##4##2##(2008-9#4)
parasite-mediated selection##3##2##(2012-3#3)
parasite-mediated##4##1##(2009-2#1)(2012-3#3)
parasite-specific##3##1##(2008-10#3)
parasitemia was##2##2##(1995-12#1)(2012-12#1)
parasitemia##6##1##(1991-2#1)(1995-12#1)(2012-12#2)(2012-2#2)
parasites among##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
parasites and diseases##2##3##(1997-7#2)
parasites and free-living animals##2##4##(2008-9#2)
parasites and their hosts##2##4##(1997-7#1)(2012-3#1)
parasites and their prevalences##2##4##(2011-1#2)
parasites and their##4##3##(1997-7#1)(2011-1#2)(2012-3#1)
parasites and##17##2##(1997-7#4)(2007-7#1)(2008-5#1)(2008-9#3)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)
parasites are##7##2##(1997-3#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
parasites face##2##2##(2010-3#2)
parasites from##4##2##(1996-12#1)(2010-12#1)(2013-8#2)
parasites in the Umbozero Lake##2##5##(2011-2#2)
parasites in the##4##3##(1996-3#1)(2008-4#1)(2011-2#2)
parasites in##20##2##(1991-2#1)(1994-11#1)(1995-12#2)(1996-3#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)
parasites is##2##2##(2011-2#2)
parasites of the##3##3##(1997-6#1)(2008-10#1)(2013-1#1)
parasites of##20##2##(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#6)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
parasites on##2##2##(2008-8#1)(2013-1#1)
parasites or##2##2##(1994-3#1)(1997-7#1)
parasites should##2##2##(2008-9#1)(2009-2#1)
parasites than##2##2##(2008-8#1)(2009-2#1)
parasites that##5##2##(2008-8#4)(2008-9#1)
parasites to##3##2##(2008-10#1)(2009-6#1)(2010-3#1)
parasites was##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
parasites were exposed to##2##4##(1997-4#2)
parasites were##9##2##(1997-4#2)(2007-7#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
parasites##212##1##(1990-3#1)(1991-2#1)(1992-2#1)(1993-3#1)(1994-11#6)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-12#6)(1996-3#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#13)(2006-5#1)(2007-12#4)(2007-7#5)(2008-1#1)(2008-10#13)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#25)(2008-9#14)(2009-10#4)(2009-2#3)(2009-6#5)(2010-1#1)(2010-12#3)(2010-2#4)(2010-3#8)(2010-8#1)(2011-1#9)(2011-2#12)(2012-12#4)(2012-2#17)(2012-3#11)(2013-1#13)(2013-8#3)
parasitic and##3##2##(1995-5#1)(2007-2#1)(2008-10#1)
parasitic dermatitis##2##2##(1996-6#2)
parasitic disease##5##2##(1997-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#1)
parasitic diseases in##2##3##(2011-2#1)(2012-3#1)
parasitic diseases##10##2##(1995-9#2)(1996-1#1)(1997-7#1)(2011-2#3)(2012-12#2)(2012-3#1)
parasitic female##2##2##(2008-8#2)
parasitic fitness##3##2##(2008-10#3)
parasitic infection##6##2##(1995-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
parasitic infections##5##2##(1997-7#1)(2007-12#1)(2007-7#1)(2008-12#2)
parasitic nematodes##3##2##(2008-10#2)(2008-8#1)
parasitic on I##3##3##(2008-10#3)
parasitic on cowpea##2##3##(2008-10#2)
parasitic on##5##2##(2008-10#5)
parasitic wasps##2##2##(1990-11#1)(2007-12#1)
parasitic weed##2##2##(2008-10#2)
parasitic##101##1##(1990-11#2)(1990-7#1)(1995-5#2)(1995-9#2)(1996-1#1)(1996-6#2)(1997-7#3)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#1)(2008-10#18)(2008-12#2)(2008-2#5)(2008-3#3)(2008-6#4)(2008-7#2)(2008-8#9)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
parasitica and##3##2##(2008-10#3)
parasitica in North America##2##4##(2008-10#2)
parasitica in##6##2##(2008-10#6)
parasitica isolates##3##2##(2008-10#3)
parasitica on##3##2##(2008-10#3)
parasitica var##7##2##(2008-10#7)
parasitica was##4##2##(2008-10#4)
parasitica were##3##2##(2008-10#3)
parasitica##58##1##(1995-6#1)(2008-10#56)(2008-9#1)
parasiticus during infection of susceptible crops such as maize##2##9##(2008-10#2)
parasiticus##7##1##(1992-9#1)(2008-10#4)(2008-11#2)
parasitised by##2##2##(2010-2#2)
parasitised##4##1##(1996-11#1)(2010-2#3)
parasitism and##2##2##(1997-7#1)(2008-10#1)
parasitism by##3##2##(1995-3#1)(2008-6#1)(2008-8#1)
parasitism in birds##2##3##(2008-8#1)(2008-9#1)
parasitism in##10##2##(2008-6#2)(2008-8#4)(2008-9#2)(2012-12#2)
parasitism index##3##2##(2008-6#2)(2012-12#1)
parasitism is##2##2##(2008-8#1)(2008-9#1)
parasitism may##2##2##(2008-9#2)
parasitism of##6##2##(2008-10#2)(2008-6#3)(2008-8#1)
parasitism rate##2##2##(2008-6#2)
parasitism##70##1##(1991-12#1)(1995-3#1)(1997-7#1)(2008-10#7)(2008-6#17)(2008-8#21)(2008-9#15)(2010-2#1)(2010-8#2)(2012-12#4)
parasitism-specific##2##1##(2007-12#2)
parasitization##2##1##(2008-8#1)(2010-4#1)
parasitize an##2##2##(2008-8#2)
parasitize##8##1##(2008-10#5)(2008-8#2)(2013-8#1)
parasitized by the##2##3##(1992-6#1)(2008-9#1)
parasitized by##9##2##(1992-6#1)(2008-10#1)(2008-6#3)(2008-9#3)(2010-4#1)
parasitized erythrocytes##4##2##(1990-2#2)(1993-8#2)
parasitized more##2##2##(2008-10#2)
parasitized red blood cells##2##4##(1990-12#1)(2012-12#1)
parasitized##32##1##(1990-12#1)(1990-2#5)(1992-6#2)(1993-8#2)(2008-10#8)(2008-6#3)(2008-8#2)(2008-9#3)(2010-4#2)(2012-12#1)(2013-1#1)(2013-8#2)
parasitizes##5##1##(2007-12#3)(2008-10#1)(2010-4#1)
parasitizing##7##1##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
parasitoid Hymenoptera##2##2##(2007-12#1)(2008-9#1)
parasitoid larva##3##2##(2007-12#3)
parasitoid larvae##3##2##(2007-12#3)
parasitoid species##5##2##(2008-8#2)(2010-2#3)
parasitoid virulence##2##2##(2008-8#2)
parasitoid##36##1##(1992-6#1)(2007-12#14)(2008-6#4)(2008-8#8)(2008-9#5)(2009-8#1)(2010-2#3)
parasitoids and##2##2##(2008-6#1)(2011-2#1)
parasitoids were##2##2##(2008-6#1)(2008-9#1)
parasitoids##20##1##(2007-12#1)(2008-6#6)(2008-8#1)(2008-9#8)(2009-8#2)(2010-2#1)(2011-2#1)
parasitological and##2##2##(2007-7#1)(2010-1#1)
parasitological data##2##2##(2008-8#2)
parasitological##13##1##(1996-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-8#2)(2010-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
parasitology in##2##2##(1997-7#1)(2008-9#1)
parasitology##16##1##(1994-12#1)(1997-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2010-1#5)
parasitosis among##3##2##(1996-12#1)(2012-3#2)
parasitosis##5##1##(1996-12#1)(2009-10#1)(2012-3#3)
paraspinal##2##1##(2008-12#2)
parastomal hernias##3##2##(2010-8#1)(2011-2#2)
parastomal##4##1##(2010-8#1)(2011-2#3)
parasympathetic nerves##2##2##(1997-1#1)(2008-3#1)
parasympathetic##15##1##(1990-9#1)(1992-6#1)(1994-9#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-7#4)(2010-5#1)(2011-2#1)(2012-2#2)
parathion##11##1##(1994-5#2)(1995-3#6)(2008-10#3)
parathormone##9##1##(1990-9#1)(1991-11#2)(1992-5#1)(1997-7#1)(2008-1#1)(2008-7#2)(2011-1#1)
parathyroid adenoma and##2##3##(1996-9#1)(2008-5#1)
parathyroid adenoma##9##2##(1996-9#1)(2008-12#1)(2008-5#1)(2009-7#3)(2012-1#3)
parathyroid adenomas and##3##3##(2008-5#3)
parathyroid adenomas##5##2##(2008-10#1)(2008-5#3)(2009-7#1)
parathyroid gland##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
parathyroid glands##4##2##(1990-6#1)(1990-9#1)(2009-7#1)(2013-8#1)
parathyroid hormone (PTH##4##3##(1991-6#1)(1993-12#1)(1993-6#1)(2008-8#1)
parathyroid hormone (PTH)##11##3##(1990-11#1)(1990-2#1)(1991-12#1)(1994-11#1)(1997-7#1)(2008-5#1)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
parathyroid hormone and##2##3##(1992-3#1)(2010-10#1)
parathyroid hormone##36##2##(1990-11#1)(1990-2#2)(1991-12#1)(1991-3#2)(1991-6#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-6#2)(1995-6#2)(1997-7#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#3)(2009-7#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
parathyroid hormone-related peptide##3##3##(1993-3#1)(1995-6#1)(1997-6#1)
parathyroid hormone-related##4##2##(1993-3#1)(1994-7#1)(1995-6#1)(1997-6#1)
parathyroid tissue##2##2##(2008-10#2)
parathyroid##80##1##(1990-11#1)(1990-2#2)(1990-6#2)(1990-9#2)(1991-12#1)(1991-3#2)(1991-6#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-6#2)(1994-7#1)(1995-6#3)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#11)(2008-8#4)(2009-4#1)(2009-7#8)(2010-10#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#1)(2013-7#2)(2013-8#2)
parathyroidectomy##14##1##(1991-11#1)(1991-5#1)(1993-3#2)(1995-11#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#3)(2012-12#3)
parathyroidectomy]##2##1##(1991-5#1)(2009-5#1)
paratuberculosis##6##1##(1991-8#4)(1993-2#1)(1994-7#1)
paraventricular and supraoptic##2##3##(1995-12#1)(1996-12#1)
paraventricular hypothalamic nucleus##2##3##(1994-2#1)(2008-8#1)
paraventricular nucleus (PVN) of the##2##5##(1993-12#1)(1996-12#1)
paraventricular nucleus (PVN)##5##3##(1993-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-4#1)
paraventricular nucleus of the##2##4##(1995-12#1)(1996-12#1)
paraventricular nucleus##16##2##(1993-12#3)(1994-8#2)(1995-12#2)(1996-12#5)(1997-2#1)(2008-4#2)(2008-9#1)
paraventricular##26##1##(1993-12#7)(1994-2#1)(1994-8#2)(1995-12#3)(1996-12#7)(1997-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
paravertebral##7##1##(1992-3#1)(1997-2#3)(1997-6#1)(2013-8#2)
paraxial Gaussian beam##2##3##(2007-12#2)
paraxial Gaussian##3##2##(2007-11#1)(2007-12#2)
paraxial approximation##8##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#1)
paraxial focus##3##2##(2008-2#2)(2008-3#1)
paraxial##30##1##(2007-11#7)(2007-12#5)(2008-10#1)(2008-2#8)(2008-3#9)
parcellation##2##1##(2010-9#2)
pardaxin##2##1##(1994-2#2)
parenchyma and##3##2##(1991-12#1)(2008-10#1)(2013-7#1)
parenchyma cells##12##2##(2008-10#9)(2008-11#2)(2012-5#1)
parenchyma in patients##2##3##(1991-3#1)(2013-7#1)
parenchyma in##4##2##(1991-3#1)(2008-11#1)(2009-8#1)(2013-7#1)
parenchyma##58##1##(1991-12#4)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-9#2)(1995-6#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#3)(2013-7#3)(2013-8#1)
parenchyma)##2##1##(2008-10#1)(2008-4#1)
parenchymal and vascular##2##3##(1996-5#1)(2010-3#1)
parenchymal and##4##2##(1991-6#1)(1996-5#1)(2008-8#1)(2010-3#1)
parenchymal cells##10##2##(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(2008-11#2)(2008-6#1)(2013-8#1)
parenchymal lesions##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
parenchymal liver cells##2##3##(1996-2#1)(2011-2#1)
parenchymal mechanical inhomogeneity and stress##2##5##(2013-7#2)
parenchymal renal##2##2##(2008-1#1)(2008-4#1)
parenchymal##42##1##(1990-6#1)(1991-12#3)(1991-6#1)(1992-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1996-2#1)(1996-5#3)(1996-6#1)(2008-1#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
parenchymatous organ##2##2##(1997-8#1)(2012-12#1)
parenchymatous##8##1##(1992-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-6#1)(2010-6#1)(2012-12#1)
parent Fol007##2##2##(2008-10#2)
parent and offspring##2##3##(2008-9#2)
parent and progeny##2##3##(2008-10#2)
parent and teacher##7##3##(2008-10#2)(2008-2#1)(2009-11#1)(2010-8#1)(2012-2#2)
parent and##17##2##(1992-9#1)(1994-3#1)(1996-2#1)(2008-10#6)(2008-2#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-8#1)(2012-2#2)
parent brain##2##2##(2009-9#2)
parent cell line##2##3##(1992-9#1)(2008-11#1)
parent cell##3##2##(1992-9#1)(2008-11#2)
parent compound##15##2##(1990-12#2)(1990-7#1)(1995-3#2)(1995-6#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#2)(2012-2#1)
parent compounds##5##2##(1994-3#1)(2007-11#1)(2008-10#2)(2009-12#1)
parent drug##14##2##(1994-11#1)(1995-3#1)(2008-10#5)(2008-8#1)(2010-11#3)(2011-3#1)(2013-1#2)
parent education programs##2##3##(1995-1#2)
parent education##8##2##(1991-2#1)(1995-1#4)(2008-9#1)(2011-2#1)(2012-2#1)
parent educational level##2##3##(1990-12#1)(2008-10#1)
parent in the##2##3##(2008-10#1)(2008-11#1)
parent in##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2010-5#1)
parent isolates were##2##3##(2008-10#2)
parent isolates##6##2##(2008-10#6)
parent material##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
parent materials##2##2##(2008-12#2)
parent molecule##4##2##(1992-12#1)(2008-3#1)(2010-7#2)
parent or##2##2##(2012-12#1)(2012-3#1)
parent perceptions##3##2##(1994-2#1)(1995-1#1)(2012-2#1)
parent plants were##2##3##(2008-10#1)(2008-8#1)
parent plants##3##2##(2008-10#2)(2008-8#1)
parent ratings##2##2##(1994-3#1)(2008-2#1)
parent strain##6##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)
parent support groups##3##3##(1995-1#2)(1996-1#1)
parent support##4##2##(1991-12#1)(1995-1#2)(1996-1#1)
parent to##2##2##(1991-12#1)(1992-3#1)
parent training##2##2##(1991-2#1)(2006-10#1)
parent variables##2##2##(1995-2#1)(2008-11#1)
parent was##4##2##(2008-10#3)(2008-9#1)
parent were##2##2##(2008-10#2)
parent##263##1##(1990-12#4)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#4)(1993-1#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#1)(1994-8#2)(1995-1#7)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-4#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-10#89)(2008-11#21)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#5)(2008-9#10)(2009-11#2)(2009-12#3)(2009-7#1)(2009-9#3)(2010-11#5)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
parent's##10##1##(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
parent-adolescent communication##4##2##(1990-12#1)(2013-1#3)
parent-adolescent relationships##4##2##(2008-4#1)(2009-7#3)
parent-adolescent##10##1##(1990-12#2)(2008-4#1)(2009-7#3)(2010-1#1)(2013-1#3)
parent-centered goals for##2##3##(2012-12#2)
parent-centered##3##1##(2010-8#1)(2012-12#2)
parent-child interaction tasks##2##3##(2009-11#2)
parent-child interaction##4##2##(1992-12#1)(2009-11#3)
parent-child interactions##2##2##(1995-1#1)(2009-11#1)
parent-child relations##3##2##(2008-11#1)(2013-1#2)
parent-child relationship##5##2##(1991-8#1)(1992-2#1)(1995-5#1)(1996-9#1)(2013-8#1)
parent-child##16##1##(1991-8#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-5#1)(1996-9#1)(2008-11#1)(2009-11#4)(2012-12#1)(2013-1#3)(2013-8#1)
parent-infant##3##1##(1991-12#1)(2009-9#2)
parent-offspring conflict over##2##3##(2008-8#1)(2008-9#1)
parent-offspring##4##1##(2008-10#1)(2008-8#1)(2008-9#2)
parent-packed##2##1##(2012-12#2)
parent-reported##2##1##(1996-1#1)(2009-2#1)
parentage##6##1##(2007-7#1)(2008-9#3)(2010-8#1)(2011-1#1)
parental DNA##2##2##(1994-12#2)
parental MDCK cells##2##3##(2008-11#2)
parental PC-3M-1E8 cell line##2##4##(2008-9#2)
parental and progeny##2##3##(2008-10#2)
parental and##12##2##(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#1)
parental aspirations for their children's educational attainment##2##7##(2009-7#2)
parental aspirations for their##3##4##(2009-7#3)
parental aspirations##4##2##(2009-7#4)
parental behavior##2##2##(1993-3#1)(2008-8#1)
parental care and##4##3##(2008-8#3)(2008-9#1)
parental care can##2##3##(2008-8#2)
parental care in rats and mice##2##6##(2008-4#2)
parental care in##5##3##(2008-4#2)(2008-8#3)
parental care##24##2##(1995-6#1)(2008-4#2)(2008-8#15)(2008-9#6)
parental cell##2##2##(1994-11#1)(2008-11#1)
parental cells##4##2##(1991-9#1)(1992-8#1)(1993-1#1)(1994-8#1)
parental chromosome##2##2##(1997-7#2)
parental chromosomes##2##2##(2008-10#1)(2008-8#1)
parental clone##2##2##(1994-11#1)(2008-10#1)
parental closeness##2##2##(2010-9#2)
parental cognitions##2##2##(1995-2#2)
parental consent or##2##3##(1994-2#2)
parental consent##4##2##(1994-2#3)(1997-6#1)
parental density##2##2##(2008-9#2)
parental distress##5##2##(1992-2#1)(1996-2#3)(2008-9#1)
parental education and##2##3##(1992-2#1)(2009-7#1)
parental education##5##2##(1992-2#1)(2009-7#3)(2012-2#1)
parental educational##2##2##(2009-7#1)(2010-11#1)
parental effects##3##2##(2008-9#2)(2010-8#1)
parental engagement##3##2##(2009-7#3)
parental genes##2##2##(2009-10#2)
parental history of##2##3##(2010-4#1)(2010-6#1)
parental history##4##2##(2010-4#3)(2010-6#1)
parental investment is##2##3##(2008-8#1)(2008-9#1)
parental investment##15##2##(2008-8#5)(2008-9#10)
parental involvement##2##2##(2009-6#1)(2012-12#1)
parental isolates##6##2##(2008-10#6)
parental lines##7##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#2)
parental medical illness##2##3##(1993-12#2)
parental myeloma##3##2##(1991-12#3)
parental notice##2##2##(1997-6#2)
parental origin##3##2##(1993-1#1)(1997-3#1)(2010-8#1)
parental perceptions of##3##3##(2009-7#3)
parental quality##2##2##(2008-9#1)(2010-9#1)
parental responsibility for##2##3##(2009-5#1)(2010-7#1)
parental responsibility##3##2##(2009-5#1)(2010-5#1)(2010-7#1)
parental right to make##2##4##(1995-12#2)
parental role##2##2##(1992-2#1)(1995-1#1)
parental roles##2##2##(1995-1#1)(2013-1#1)
parental satisfaction##3##2##(1996-2#1)(1996-3#2)
parental species##9##2##(2008-10#2)(2008-8#2)(2009-2#3)(2012-3#2)
parental strain on##2##3##(2008-10#1)(2009-6#1)
parental strain##8##2##(1995-8#1)(2008-10#6)(2009-6#1)
parental strains##7##2##(1993-2#1)(2008-10#4)(2008-12#2)
parental virus##2##2##(2008-10#1)(2008-9#1)
parental visitation##2##2##(1994-2#2)
parental warmth and psychological adjustment##2##5##(2009-11#2)
parental warmth##9##2##(2009-11#3)(2010-1#6)
parental##280##1##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#10)(1994-6#1)(1994-8#3)(1995-1#3)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#8)(1996-3#3)(1996-5#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#3)(2007-12#1)(2008-10#32)(2008-11#10)(2008-12#6)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#25)(2008-9#34)(2009-10#3)(2009-11#4)(2009-2#6)(2009-5#1)(2009-6#2)(2009-7#17)(2009-9#1)(2010-1#7)(2010-11#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#1)
parental-type##2##1##(2008-10#2)
parenteral administration##2##2##(2008-5#1)(2008-9#1)
parenteral and oral##3##3##(1992-11#2)(2010-6#1)
parenteral antibiotic##2##2##(2007-12#1)(2013-8#1)
parenteral drug##2##2##(1990-2#1)(2008-5#1)
parenteral iron##3##2##(2008-7#2)(2013-8#1)
parenteral nutrition (PN)##2##3##(2008-10#1)(2013-1#1)
parenteral nutrition (TPN)##4##3##(1992-9#2)(1994-6#1)(2008-10#1)
parenteral nutrition in##3##3##(1993-5#1)(2009-5#1)(2013-1#1)
parenteral nutrition##17##2##(1991-6#1)(1992-9#3)(1993-5#1)(1994-6#2)(2007-12#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#3)
parenteral solution##2##2##(2008-10#1)(2012-12#1)
parenteral solutions##3##2##(2008-10#3)
parenteral##53##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#3)(1992-9#3)(1993-11#1)(1993-5#1)(1994-6#2)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
parenterally##5##1##(1992-3#1)(1993-3#1)(2008-5#1)(2013-7#1)(2013-8#1)
parentheses)##2##1##(2008-5#1)(2011-1#1)
parenthood and its##2##3##(1995-1#1)(2009-10#1)
parenthood and##3##2##(1995-1#1)(1996-9#1)(2009-10#1)
parenthood##7##1##(1995-1#2)(1996-9#1)(2007-2#2)(2009-10#1)(2009-11#1)
parenting and cognitions##2##3##(2010-1#2)
parenting and##8##2##(2008-12#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-1#4)
parenting behaviors##4##2##(2009-10#1)(2009-12#2)(2009-9#1)
parenting of##2##2##(2009-12#2)
parenting practices##3##2##(2008-11#1)(2009-7#1)(2009-9#1)
parenting satisfaction and efficacy##2##4##(1995-2#2)
parenting self-esteem##2##2##(1995-2#1)(2009-11#1)
parenting skills##4##2##(1992-12#1)(1996-2#1)(1997-3#1)(2009-11#1)
parenting stress##3##2##(1995-1#1)(1996-1#1)(2012-2#1)
parenting style##4##2##(2008-12#1)(2009-7#3)
parenting styles##2##2##(2013-1#2)
parenting##60##1##(1992-12#1)(1995-1#2)(1995-2#4)(1996-1#2)(1996-2#1)(1997-3#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-10#1)(2009-11#4)(2009-12#6)(2009-5#1)(2009-7#12)(2009-9#7)(2010-1#7)(2012-2#2)(2013-1#3)
parents after##2##2##(1996-9#1)(2008-11#1)
parents and F(1)##3##3##(2008-10#3)
parents and a##2##3##(2008-4#1)(2011-1#1)
parents and children##5##3##(1994-2#1)(1995-1#1)(2009-11#1)(2012-12#1)(2013-8#1)
parents and peers##3##3##(1990-2#3)
parents and teachers##4##3##(2009-11#1)(2011-2#1)(2012-12#2)
parents and the##5##3##(1990-12#1)(1994-1#1)(1995-1#1)(2008-10#1)(2009-9#1)
parents and their children##2##4##(1993-12#1)(2008-6#1)
parents and their##5##3##(1990-12#1)(1993-12#1)(2008-11#1)(2008-6#1)(2008-9#1)
parents and##60##2##(1990-12#3)(1990-2#3)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1997-7#2)(2006-8#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-11#3)(2009-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
parents are##13##2##(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)
parents as well as##2##4##(2008-2#1)(2012-12#1)
parents as##4##2##(1992-2#1)(1993-1#1)(2008-2#1)(2012-12#1)
parents felt##2##2##(2008-9#1)(2010-8#1)
parents for##3##2##(1992-2#1)(2008-10#1)(2010-4#1)
parents from##2##2##(1995-1#1)(2008-10#1)
parents had##7##2##(1990-12#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-4#1)(2013-1#1)
parents have##3##2##(1990-12#1)(2012-12#1)(2013-1#1)
parents in the##4##3##(1994-2#2)(2008-10#1)(2010-5#1)
parents in##16##2##(1994-2#2)(1995-12#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
parents is##5##2##(1990-6#1)(1994-6#1)(2009-7#2)(2013-1#1)
parents may be##2##3##(1995-6#1)(2008-12#1)
parents may##5##2##(1994-2#1)(1995-12#1)(1995-6#1)(2008-12#1)(2009-7#1)
parents obtain##2##2##(1993-12#1)(2008-11#1)
parents of children with cancer##2##5##(2010-7#1)(2010-9#1)
parents of children with medically complex needs##2##7##(1992-2#2)
parents of children with moderate mental retardation##2##7##(1993-3#2)
parents of children with severe##2##5##(1993-3#2)
parents of children with##14##4##(1991-8#1)(1992-2#2)(1993-1#1)(1993-3#5)(1995-2#1)(2008-11#1)(2008-9#1)(2010-7#1)(2010-9#1)
parents of children##21##3##(1991-8#1)(1992-2#3)(1993-1#1)(1993-3#5)(1995-2#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-9#2)(2010-7#2)(2010-9#1)(2012-12#1)(2012-2#1)
parents of healthy children##2##4##(1995-2#2)
parents of high-risk newborns##2##4##(1993-3#2)
parents of high-risk##4##3##(1993-3#2)(2008-11#2)
parents of other##2##3##(1996-1#1)(2009-7#1)
parents of young children##2##4##(1994-3#1)(1995-2#1)
parents of##53##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-2#3)(1993-1#1)(1993-3#7)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#5)(1996-1#1)(1996-3#2)(2007-7#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
parents or##6##2##(1995-5#2)(2007-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
parents packing##2##2##(2012-12#2)
parents participated##2##2##(1991-2#1)(2009-5#1)
parents rated##3##2##(2008-12#1)(2008-9#1)(2010-8#1)
parents regarding##2##2##(2007-12#1)(2008-11#1)
parents report##2##2##(1995-12#1)(1996-1#1)
parents reported that##2##3##(1995-12#2)
parents reported##5##2##(1994-12#1)(1995-12#2)(2010-1#1)(2010-10#1)
parents should be##2##3##(1990-2#1)(2008-12#1)
parents should##4##2##(1990-2#1)(2008-12#1)(2008-9#1)(2009-5#1)
parents to##10##2##(1993-1#1)(1994-2#2)(1995-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-12#2)
parents want##2##2##(2008-11#2)
parents were also##2##3##(1995-12#1)(2008-10#1)
parents were asked##2##3##(2007-7#1)(2008-9#1)
parents were##26##2##(1991-11#2)(1991-2#1)(1992-2#2)(1993-12#1)(1994-6#3)(1995-12#2)(1995-2#1)(1997-5#1)(1997-8#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2010-4#1)(2013-1#2)(2013-8#1)
parents when##2##2##(1993-3#1)(2010-3#1)
parents who##10##2##(1994-2#2)(1994-3#1)(1996-5#1)(2007-7#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
parents with a##2##3##(2008-11#1)(2013-1#1)
parents with children##2##3##(1996-3#1)(2012-12#1)
parents with##9##2##(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-12#1)(2013-1#3)
parents##455##1##(1990-12#7)(1990-2#6)(1990-6#2)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#3)(1991-5#1)(1991-8#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#11)(1992-3#2)(1992-4#2)(1993-1#7)(1993-12#4)(1993-2#2)(1993-3#10)(1994-1#2)(1994-12#3)(1994-2#10)(1994-3#4)(1994-6#5)(1995-1#8)(1995-12#16)(1995-2#6)(1995-5#5)(1995-6#4)(1996-1#2)(1996-2#2)(1996-3#4)(1996-5#2)(1996-9#1)(1997-2#2)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#2)(2007-7#11)(2008-1#1)(2008-10#50)(2008-11#27)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#18)(2009-10#1)(2009-11#6)(2009-2#1)(2009-5#3)(2009-6#1)(2009-7#16)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#9)(2010-11#4)(2010-3#1)(2010-4#6)(2010-5#4)(2010-7#3)(2010-8#5)(2010-9#6)(2011-1#11)(2011-2#11)(2012-1#1)(2012-12#20)(2012-2#12)(2012-3#1)(2013-1#21)(2013-7#1)(2013-8#6)
parents' adherence##2##2##(1994-3#2)
parents' and##2##2##(1993-12#1)(2008-9#1)
parents' perceptions of##3##3##(1993-12#1)(2010-8#1)(2011-1#1)
parents' persuasion##2##2##(2010-1#2)
parents' ratings of##2##3##(1995-12#1)(2008-12#1)
parents' right to##2##3##(1993-12#1)(1995-5#1)
parents'##37##1##(1990-2#1)(1991-12#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1994-3#2)(1995-12#1)(1995-5#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#3)(2009-8#1)(2010-1#3)(2010-8#2)(2010-9#1)(2011-1#1)(2012-12#4)(2013-1#4)
parents'/guardians' health literacy##2##3##(2010-9#2)
parents/guardians##8##1##(2008-9#6)(2010-9#2)
parents?##2##1##(1995-5#1)(2009-9#1)
paresis and##2##2##(1994-3#1)(2013-1#1)
paresis##17##1##(1992-5#1)(1992-6#1)(1994-3#1)(1996-8#1)(1997-3#1)(2007-11#2)(2009-4#1)(2011-2#4)(2013-1#5)
paresthesia##6##1##(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
paresthesias##3##1##(1991-3#1)(2008-9#1)(2013-8#1)
paretic##2##1##(2007-10#2)
parhelic circle##5##2##(2008-2#1)(2008-3#4)
parietal and occipital##2##3##(2008-7#1)(2010-7#1)
parietal and visceral##2##3##(2012-1#2)
parietal and##9##2##(1995-6#1)(2007-8#1)(2008-11#1)(2008-7#2)(2010-7#1)(2012-1#2)(2013-8#1)
parietal cell##7##2##(1995-11#4)(1997-1#3)
parietal cells and##2##3##(1997-1#1)(2012-1#1)
parietal cells were##2##3##(1992-3#1)(2012-1#1)
parietal cells##26##2##(1992-3#4)(1992-6#1)(1995-11#3)(1995-6#2)(1997-1#6)(2007-12#5)(2012-1#3)(2013-8#2)
parietal cortex and##3##3##(1991-12#2)(1991-2#1)
parietal cortex##19##2##(1991-12#3)(1991-2#1)(1992-8#1)(1994-3#2)(1996-5#1)(1997-2#3)(2008-11#1)(2008-2#1)(2008-7#3)(2010-7#1)(2013-8#2)
parietal cortical##3##2##(1990-5#1)(2008-2#1)(2010-12#1)
parietal cortices##2##2##(1994-3#1)(2010-7#1)
parietal layer##2##2##(2008-10#2)
parietal lobe##7##2##(1996-5#1)(1997-3#1)(1997-6#1)(2007-10#2)(2008-7#1)(2009-1#1)
parietal lobule##5##2##(1996-2#1)(1996-5#1)(2008-11#3)
parietal pleura##2##2##(2007-5#1)(2007-8#1)
parietal region##2##2##(2008-7#1)(2012-12#1)
parietal regions##4##2##(1991-12#1)(1997-2#1)(2008-11#1)(2012-1#1)
parietal##110##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1992-3#5)(1992-6#1)(1992-8#1)(1994-3#3)(1995-11#7)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#3)(1996-5#6)(1997-1#9)(1997-2#4)(1997-3#1)(1997-6#1)(2007-10#3)(2007-12#5)(2007-5#1)(2007-8#3)(2008-10#2)(2008-11#6)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#7)(2009-1#1)(2009-10#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-1#8)(2012-12#1)(2013-8#6)
parieto-frontal##2##1##(1996-12#1)(2008-11#1)
parish nurse##3##2##(2008-12#3)
parish of Manger##2##3##(1993-3#1)(1993-6#1)
parish of##3##2##(1993-12#1)(1993-3#1)(1993-6#1)
parish##11##1##(1991-12#1)(1993-12#2)(1993-3#1)(1993-6#1)(2008-1#2)(2008-12#3)(2013-1#1)
parish-based clergy##2##2##(2010-2#2)
parity and##3##2##(2008-1#1)(2008-11#1)(2009-4#1)
parity groups##3##2##(1990-6#3)
parity or##2##2##(1993-10#1)(1993-2#1)
parity##23##1##(1990-6#3)(1991-2#1)(1993-10#1)(1993-2#1)(1993-9#1)(1995-1#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-4#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)
park##6##1##(1994-11#1)(2008-5#2)(2008-8#1)(2012-6#1)(2013-1#1)
parkin##3##1##(2008-7#2)(2012-12#1)
parking facility##2##2##(1992-12#1)(1993-12#1)
parking lot##2##2##(1993-12#1)(2008-7#1)
parking security##2##2##(1992-12#2)
parking##12##1##(1991-12#1)(1992-12#3)(1992-2#1)(1993-12#4)(2008-10#2)(2008-7#1)
parkinsonian motor fluctuations##2##3##(2008-7#2)
parkinsonian motor##3##2##(2008-7#2)(2012-2#1)
parkinsonian patients##3##2##(2008-7#3)
parkinsonian rats##3##2##(2008-12#3)
parkinsonian syndromes##2##2##(1993-11#2)
parkinsonian##19##1##(1991-12#1)(1993-11#2)(1996-3#1)(2008-12#3)(2008-7#11)(2012-2#1)
parkinsonism and tremor##2##3##(2008-7#2)
parkinsonism and##7##2##(1997-2#2)(2008-7#5)
parkinsonism with##3##2##(2008-7#3)
parkinsonism##32##1##(1993-3#1)(1997-2#2)(2007-10#1)(2008-7#26)(2009-11#1)(2009-6#1)
parks##2##1##(2011-1#1)(2013-1#1)
parliament##5##1##(1995-3#1)(1996-3#1)(1997-6#1)(2008-11#1)(2013-8#1)
parliamentarian##2##1##(2009-10#1)(2009-7#1)
parlour##3##1##(1996-11#1)(2008-5#2)
parochial##3##1##(1996-1#1)(2008-12#1)(2008-7#1)
paroecandrum##2##1##(2008-10#2)
parosteal osteosarcoma##2##2##(1991-11#1)(2010-3#1)
parotid gland##14##2##(1991-6#2)(2007-10#1)(2007-5#2)(2008-11#1)(2008-4#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#4)
parotid region and##2##3##(2007-5#2)
parotid salivary glands##2##3##(1990-11#2)
parotid##30##1##(1990-11#2)(1991-6#2)(1991-8#3)(1993-12#1)(2007-10#3)(2007-12#1)(2007-5#6)(2008-11#1)(2008-4#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
parotidectomy##7##1##(2007-5#2)(2011-2#3)(2013-8#2)
parotitis##2##1##(2007-2#1)(2011-2#1)
parous##2##1##(2011-2#1)(2013-1#1)
paroxetine##5##1##(1991-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
paroxysmal atrial fibrillation##2##3##(1997-5#1)(2008-1#1)
paroxysmal atrial##3##2##(1997-5#1)(2008-1#1)(2008-4#1)
paroxysmal cold hemoglobinuria##2##3##(1992-3#2)
paroxysmal discharges##3##2##(2008-1#3)
paroxysmal nocturnal hemoglobinuria##3##3##(1992-12#2)(2008-4#1)
paroxysmal nocturnal##5##2##(1992-12#2)(2008-4#1)(2012-2#2)
paroxysmal positional vertigo##7##3##(2008-4#4)(2012-12#1)(2012-2#2)
paroxysmal##27##1##(1992-12#2)(1992-3#2)(1997-5#2)(2008-1#4)(2008-11#2)(2008-2#1)(2008-4#6)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#4)(2012-3#1)
parrots##2##1##(2009-2#1)(2012-2#1)
pars reticulata##4##2##(1993-12#2)(1995-2#1)(2008-12#1)
pars##16##1##(1993-12#2)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#2)(2008-12#1)(2008-6#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
parsed into##2##2##(2008-10#2)
parsed##3##1##(2008-10#3)
parsimonious##4##1##(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
parsimony analysis of##3##3##(2008-10#3)
parsimony and Bayesian##3##3##(2008-10#1)(2010-4#1)(2010-6#1)
parsimony and distance methods##2##4##(1995-3#1)(2008-8#1)
parsimony and##6##2##(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-6#1)
parsimony methods##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
parsimony of##2##2##(2008-10#1)(2010-11#1)
parsimony##21##1##(1995-3#1)(2007-12#1)(2008-10#8)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2010-6#1)
parsing algorithm for##2##3##(2011-3#2)
parsing algorithm##4##2##(2011-3#4)
parsing and reanalysis##2##3##(2007-12#2)
parsing##13##1##(2007-12#4)(2008-1#1)(2008-10#1)(2011-3#7)
parsley plastocyanin##5##2##(1994-5#5)
parsley seed##2##2##(2008-12#2)
parsley##12##1##(1994-5#5)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#2)
part (estimated by##2##3##(2009-8#2)
part (that##2##2##(2013-1#2)
part 1##6##2##(2007-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
part 2##9##2##(1995-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
part 3##2##2##(2007-8#1)(2008-10#1)
part I##15##2##(2008-2#2)(2008-3#3)(2008-4#4)(2008-7#4)(2010-3#2)
part II##12##2##(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2010-3#1)
part a##2##2##(2008-6#1)(2008-8#1)
part and the##2##3##(1994-8#1)(2008-10#1)
part and##5##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
part as##2##2##(1991-12#1)(2008-8#1)
part be##4##2##(1994-11#1)(2007-8#1)(2009-12#1)(2013-1#1)
part because of the##4##4##(1990-11#1)(2007-10#1)(2010-1#1)(2013-8#1)
part because of##7##3##(1990-11#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-8#1)(2010-1#1)(2013-8#1)
part because##12##2##(1990-11#1)(1994-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
part by the##8##3##(1990-8#1)(1993-9#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#2)
part by##26##2##(1990-8#1)(1992-9#1)(1993-2#1)(1993-9#2)(1994-6#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
part discusses##3##2##(2009-6#1)(2011-2#1)(2012-3#1)
part due to its##2##4##(2009-12#1)(2012-2#1)
part due to##10##3##(1991-6#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
part for##2##2##(1991-12#1)(2009-8#1)
part in a##3##3##(1997-6#1)(2009-6#1)(2013-1#1)
part in an##3##3##(1995-5#1)(1995-6#1)(2008-10#1)
part in development of##3##4##(1991-9#1)(2011-2#2)
part in the study##6##4##(1991-8#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-1#1)
part in the##20##3##(1991-3#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)
part in this##5##3##(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
part in##77##2##(1990-10#1)(1990-11#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-3#2)(1993-3#1)(1993-9#2)(1994-2#1)(1995-11#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#7)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#2)
part is##16##2##(1995-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#2)(2009-3#1)(2009-8#1)(2013-1#1)
part of Norway##2##3##(1990-6#1)(1995-6#1)
part of a broader##3##4##(2007-8#1)(2008-11#1)(2013-1#1)
part of a complex##3##4##(1990-2#1)(1997-5#1)(2008-11#1)
part of a flow##2##4##(2008-10#2)
part of a general##4##4##(1995-1#1)(2007-7#1)(2008-10#1)(2009-7#1)
part of a large##4##4##(1991-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
part of a larger study##4##5##(2008-11#2)(2009-12#1)(2010-7#1)
part of a larger##5##4##(1992-1#1)(2008-11#2)(2009-12#1)(2010-7#1)
part of a prevention programme##2##5##(1991-6#2)
part of a research##2##4##(1991-9#1)(2008-10#1)
part of a study of##3##5##(1995-12#1)(2008-6#1)(2009-4#1)
part of a study##4##4##(1995-12#1)(2008-11#1)(2008-6#1)(2009-4#1)
part of a wider##4##4##(1996-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
part of a##131##3##(1990-2#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#3)
part of all##3##3##(1994-12#1)(1995-1#1)(2009-1#1)
part of an integrated management##2##5##(2008-10#2)
part of an integrated##5##4##(2008-10#4)(2008-11#1)
part of an ongoing##3##4##(2008-10#1)(2008-6#1)(2009-11#1)
part of an operon that##2##5##(1990-11#1)(2008-10#1)
part of an##32##3##(1990-10#1)(1990-11#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
part of any##4##3##(1995-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
part of both##2##3##(1995-1#1)(2012-1#1)
part of care##2##3##(1995-2#1)(1997-2#1)
part of complex##3##3##(1993-12#1)(2007-11#1)(2013-1#1)
part of her##4##3##(1995-3#1)(1995-6#1)(1996-6#1)(2013-8#1)
part of human##2##3##(1990-8#1)(1992-3#1)
part of its##6##3##(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
part of larger##2##3##(1994-12#1)(2011-2#1)
part of mainstream##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
part of modern##4##3##(2007-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
part of nursing##5##3##(1997-3#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-7#1)
part of ongoing##2##3##(2007-12#1)(2008-12#1)
part of our##7##3##(1994-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
part of quality##4##3##(1993-8#1)(1994-6#1)(1995-3#1)(1996-3#1)
part of routine##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
part of spine##4##3##(2007-11#1)(2007-8#3)
part of that##2##3##(2007-12#1)(2008-3#1)
part of the Genomic Encyclopedia of Bacteria and Archaea project##39##10##(2011-2#39)
part of the Genomic Encyclopedia of##40##6##(2011-2#40)
part of the analysis##2##4##(1993-12#1)(2008-10#1)
part of the assessment of the##2##6##(1996-12#1)(2008-3#1)
part of the binding site##2##5##(1990-7#1)(1992-6#1)
part of the brain##3##4##(1995-3#1)(1996-12#1)(1996-5#1)
part of the care##3##4##(1993-12#1)(2008-5#1)(2008-7#1)
part of the cell##4##4##(1997-8#1)(2008-10#2)(2008-7#1)
part of the complex refractive index##5##6##(2008-3#5)
part of the complex##6##4##(1994-5#1)(2008-3#5)
part of the continuum of care##2##6##(1994-12#1)(1997-3#1)
part of the country##4##4##(1997-6#1)(2007-10#1)(2007-7#1)(2008-12#1)
part of the data##2##4##(2008-5#1)(2010-8#1)
part of the disc##3##4##(2009-4#3)
part of the disease##2##4##(2008-7#2)
part of the embryonic brain in both insects and vertebrates##2##10##(2007-12#2)
part of the evaluation of##3##5##(2008-8#1)(2008-9#1)(2012-2#1)
part of the extracellular##2##4##(1992-12#1)(2008-5#1)
part of the femur and##2##5##(2007-11#1)(2008-7#1)
part of the femur##3##4##(2007-11#1)(2008-7#1)(2013-1#1)
part of the first##3##4##(1993-6#1)(1994-12#1)(2008-2#1)
part of the head##2##4##(2008-5#1)(2009-4#1)
part of the health care##2##5##(1996-3#1)(2008-11#1)
part of the human##2##4##(1995-12#1)(2012-2#1)
part of the index of refraction##2##6##(2008-3#2)
part of the index##3##4##(2008-3#3)
part of the innate immune system##2##6##(2012-3#1)(2013-8#1)
part of the international##2##4##(1991-9#1)(2008-7#1)
part of the laser##2##4##(2007-12#1)(2008-2#1)
part of the left##3##4##(1991-9#1)(1996-2#1)(2008-7#1)
part of the lung##2##4##(1994-12#2)
part of the metapopulation##3##4##(2008-9#3)
part of the molecular##2##4##(1993-12#1)(2010-4#1)
part of the molecule##3##4##(1990-11#1)(1994-3#1)(1997-9#1)
part of the national##2##4##(1992-1#1)(2012-12#1)
part of the natural##2##4##(1991-3#1)(2011-2#1)
part of the normal human##2##5##(2010-10#1)(2013-7#1)
part of the normal##6##4##(1995-2#1)(2007-6#1)(2008-10#1)(2008-9#1)(2010-10#1)(2013-7#1)
part of the overall##2##4##(2008-10#1)(2008-7#1)
part of the paper##3##4##(1991-2#1)(2009-6#1)(2011-2#1)
part of the population##2##4##(2008-8#1)(2012-12#1)
part of the programme##2##4##(2008-1#1)(2008-12#1)
part of the refractive index is##2##6##(2007-11#1)(2008-3#1)
part of the refractive index##8##5##(2007-11#1)(2008-2#1)(2008-3#6)
part of the region##2##4##(1995-6#1)(2008-10#1)
part of the review##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
part of the same##3##4##(2008-10#3)
part of the spectrum##5##4##(2008-3#2)(2008-7#1)(2011-2#2)
part of the standard##2##4##(2008-10#1)(2012-3#1)
part of the study##5##4##(1996-5#1)(2008-1#2)(2011-3#1)(2013-8#1)
part of the survey##4##4##(1990-3#4)
part of the system##3##4##(1996-3#1)(2008-2#2)
part of the total##2##4##(1992-11#1)(1996-5#1)
part of the training##3##4##(1993-2#1)(1994-1#1)(2008-1#1)
part of the transgene mRNA##2##5##(2008-10#2)
part of the treatment of##3##5##(1992-1#1)(1996-6#1)(2008-1#1)
part of the treatment##8##4##(1991-12#1)(1992-1#1)(1996-6#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
part of the variance##2##4##(2008-10#2)
part of the world##2##4##(2008-1#2)
part of the##569##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-9#3)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#3)(1992-11#3)(1992-12#3)(1992-3#1)(1992-6#7)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#14)(1993-2#1)(1993-3#1)(1993-6#4)(1994-1#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#4)(1996-1#1)(1996-12#6)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#3)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#8)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#11)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#9)(2008-10#57)(2008-11#14)(2008-12#5)(2008-2#10)(2008-3#37)(2008-4#3)(2008-5#18)(2008-6#2)(2008-7#24)(2008-8#8)(2008-9#15)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#3)(2010-5#4)(2010-6#2)(2010-8#6)(2011-1#3)(2011-2#67)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#12)
part of their##22##3##(1992-1#1)(1992-10#1)(1992-3#1)(1993-2#1)(1995-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-2#1)
part of these##5##3##(1993-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
part of this article##2##4##(1997-6#1)(2012-12#1)
part of this##27##3##(1990-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-9#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
part of total##2##3##(1994-1#1)(2007-7#1)
part of treatment##2##3##(1997-2#1)(2007-11#1)
part of two##4##3##(1990-5#1)(2008-10#2)(2009-4#1)
part of##1059##2##(1990-10#2)(1990-11#7)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#1)(1990-9#3)(1991-12#7)(1991-2#4)(1991-3#2)(1991-5#6)(1991-6#7)(1991-7#1)(1991-8#2)(1991-9#9)(1992-1#10)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#10)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#16)(1993-2#5)(1993-3#2)(1993-6#6)(1993-8#4)(1993-9#2)(1994-1#9)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#8)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#8)(1995-5#3)(1995-6#7)(1995-8#2)(1996-1#2)(1996-11#3)(1996-12#10)(1996-2#6)(1996-3#7)(1996-4#3)(1996-5#9)(1996-6#4)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#7)(1997-3#13)(1997-4#8)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#4)(1997-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#5)(2007-11#18)(2007-12#17)(2007-2#1)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#10)(2008-1#15)(2008-10#98)(2008-11#40)(2008-12#13)(2008-2#19)(2008-3#51)(2008-4#13)(2008-5#25)(2008-6#10)(2008-7#43)(2008-8#20)(2008-9#23)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#8)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#11)(2011-2#89)(2011-3#2)(2012-1#5)(2012-12#11)(2012-2#17)(2012-3#10)(2013-1#27)(2013-7#5)(2013-8#19)
part or full-time##3##3##(1992-6#1)(1995-12#2)
part or##6##2##(1992-12#1)(1992-6#1)(1995-12#2)(2008-10#1)(2012-3#1)
part per##2##2##(2008-10#1)(2008-3#1)
part provides##3##2##(2008-4#2)(2010-9#1)
part reviews##3##2##(1995-6#1)(2008-8#2)
part the##9##2##(1991-3#1)(1994-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-1#1)
part to a##3##3##(2008-11#1)(2008-6#1)(2013-7#1)
part to an##2##3##(1994-3#1)(2008-9#1)
part to the ability##2##4##(2007-12#1)(2009-12#1)
part to the##14##3##(1990-8#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-4#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)(2012-12#1)
part to##42##2##(1990-2#2)(1990-4#1)(1990-8#2)(1992-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#3)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-7#1)
part was##8##2##(1991-2#1)(1995-4#1)(1997-4#1)(1997-6#1)(2008-3#2)(2008-6#1)(2009-4#1)
part were##2##2##(1994-8#1)(2011-2#1)
part which##3##2##(1993-2#1)(1994-3#1)(2011-2#1)
part with##4##2##(1995-5#1)(2007-11#1)(2008-10#2)
part##1635##1##(1990-10#3)(1990-11#9)(1990-12#5)(1990-2#9)(1990-3#5)(1990-4#2)(1990-5#7)(1990-6#6)(1990-7#5)(1990-8#6)(1990-9#4)(1991-1#1)(1991-12#13)(1991-2#6)(1991-3#5)(1991-5#7)(1991-6#9)(1991-7#1)(1991-8#3)(1991-9#10)(1992-1#12)(1992-10#1)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#11)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#20)(1993-2#8)(1993-3#5)(1993-6#7)(1993-8#7)(1993-9#10)(1994-1#10)(1994-11#2)(1994-12#9)(1994-2#10)(1994-3#12)(1994-5#4)(1994-6#10)(1994-8#13)(1994-9#5)(1995-1#9)(1995-11#5)(1995-12#17)(1995-2#16)(1995-3#12)(1995-4#1)(1995-5#8)(1995-6#13)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#6)(1996-12#13)(1996-2#8)(1996-3#11)(1996-4#3)(1996-5#10)(1996-6#5)(1996-7#2)(1996-9#7)(1997-1#6)(1997-2#10)(1997-3#14)(1997-4#13)(1997-5#7)(1997-6#8)(1997-7#6)(1997-8#6)(1997-9#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#8)(2007-11#27)(2007-12#28)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#6)(2007-6#1)(2007-7#8)(2007-8#15)(2007-9#1)(2008-1#22)(2008-10#147)(2008-11#65)(2008-12#14)(2008-2#34)(2008-3#77)(2008-4#32)(2008-5#45)(2008-6#16)(2008-7#57)(2008-8#39)(2008-9#35)(2009-1#3)(2009-10#6)(2009-11#5)(2009-12#8)(2009-2#1)(2009-3#5)(2009-4#11)(2009-5#4)(2009-6#14)(2009-7#5)(2009-8#11)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#7)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#7)(2010-5#7)(2010-6#3)(2010-7#1)(2010-8#10)(2010-9#7)(2011-1#16)(2011-2#112)(2011-3#2)(2011-7#1)(2012-1#6)(2012-12#17)(2012-2#26)(2012-3#20)(2012-8#1)(2013-1#44)(2013-7#6)(2013-8#27)
part)##2##1##(2008-4#1)(2013-1#1)
part-time post qualifying nursing students##3##5##(2008-11#3)
part-time post qualifying##4##3##(2008-11#4)
part-time##10##1##(1991-12#1)(1995-12#1)(2008-11#6)(2011-2#1)(2013-7#1)
parthenogenesis induction##3##2##(2008-8#3)
parthenogenesis##9##1##(2008-5#1)(2008-8#3)(2008-9#2)(2010-3#2)(2013-1#1)
parthenogenetic lizards##4##2##(2010-3#4)
parthenogenetic species##3##2##(2008-10#1)(2008-12#1)(2010-3#1)
parthenogenetic##13##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#4)(2010-3#6)
parthenogens are##2##2##(2008-5#1)(2012-3#1)
parthenogens##4##1##(2008-5#2)(2008-9#1)(2012-3#1)
partial AC##2##2##(1994-9#2)
partial CPB##2##2##(2007-8#2)
partial DNA##2##2##(2008-8#2)
partial ORF##2##2##(1995-6#1)(2008-9#1)
partial acid hydrolysis##2##3##(1993-11#1)(2010-2#1)
partial activity##2##2##(1997-4#1)(2008-10#1)
partial agonist at alpha##2##4##(1995-11#2)
partial agonist at##3##3##(1995-11#2)(1995-6#1)
partial agonist##10##2##(1992-10#1)(1992-8#1)(1993-1#1)(1995-11#4)(1995-6#1)(2008-11#1)(2011-2#1)
partial agonists##4##2##(1992-3#1)(1995-3#1)(2009-6#2)
partial amino acid sequence of##2##5##(1992-9#1)(1993-8#1)
partial amino acid sequence##4##4##(1992-12#1)(1992-9#1)(1993-8#1)(1993-9#1)
partial amino acid sequences of##2##5##(1996-8#1)(2008-10#1)
partial amino acid sequences were##2##5##(1992-11#1)(2008-8#1)
partial amino acid sequences##4##4##(1992-11#1)(1996-8#1)(2008-10#1)(2008-8#1)
partial amino acid##8##3##(1992-11#1)(1992-12#1)(1992-9#1)(1993-8#1)(1993-9#1)(1996-8#1)(2008-10#1)(2008-8#1)
partial and full-swing##2##3##(2011-2#2)
partial and##8##2##(1992-9#1)(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
partial blast resistance in##2##4##(2008-10#2)
partial bone resection##3##3##(2007-11#3)
partial breast irradiation##2##3##(2013-1#2)
partial but##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
partial cDNA clones##2##3##(1990-8#2)
partial cDNA encoding##2##3##(1993-6#1)(1995-2#1)
partial cDNA sequences##2##3##(1992-11#1)(1996-10#1)
partial cDNA##13##2##(1990-8#2)(1992-11#1)(1993-3#1)(1993-6#2)(1994-8#1)(1995-2#2)(1996-10#1)(1996-5#1)(1997-6#1)(2008-7#1)
partial cDNAs##4##2##(1991-12#1)(1993-12#2)(2008-7#1)
partial characterization of##9##3##(1990-11#1)(1990-12#1)(1990-2#1)(1992-6#1)(1993-3#1)(1994-6#1)(2008-10#3)
partial characterization##10##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1992-6#1)(1993-3#1)(1994-6#1)(2008-10#3)
partial charges##2##2##(2008-11#1)(2010-7#1)
partial chemical##2##2##(1995-11#1)(2008-10#1)
partial clinical##2##2##(1993-2#1)(1995-5#1)
partial coherence##3##2##(2007-9#1)(2008-2#1)(2008-3#1)
partial complementary DNA##2##3##(1990-5#1)(1991-5#1)
partial complex seizures##2##3##(1990-5#1)(1997-3#1)
partial correlations##2##2##(1992-2#1)(2010-6#1)
partial data sets##2##3##(2008-11#1)(2008-7#1)
partial degradation##3##2##(1996-2#1)(2008-7#1)(2009-7#1)
partial dentures##3##2##(2008-7#1)(2011-2#2)
partial differential equation (PDE)##2##4##(2008-6#1)(2008-7#1)
partial differential equation model of##2##5##(2013-8#2)
partial differential equation model##3##4##(2008-8#1)(2013-8#2)
partial differential equation##6##3##(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#2)
partial differential equations##3##3##(2013-1#1)(2013-8#2)
partial differential##9##2##(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#4)
partial digestion of genomic DNA##2##5##(2008-4#2)
partial digestion of##3##3##(2008-10#1)(2008-4#2)
partial digestion##4##2##(2008-10#2)(2008-4#2)
partial dissolution of the##2##4##(2008-10#2)
partial embolisation##2##2##(1996-6#1)(1996-9#1)
partial gas##2##2##(2008-10#1)(2008-3#1)
partial gastrectomy in##2##3##(1993-2#1)(2009-7#1)
partial gastrectomy##5##2##(1991-6#1)(1993-2#1)(2007-4#1)(2008-5#1)(2009-7#1)
partial hepatectomy and##2##3##(2013-1#1)(2013-7#1)
partial hepatectomy was##2##3##(1993-5#1)(2013-8#1)
partial hepatectomy##18##2##(1990-12#4)(1991-6#1)(1993-5#1)(1994-11#3)(1994-6#1)(1995-6#2)(1996-2#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
partial hospital##2##2##(1991-1#2)
partial hospitalization##13##2##(1991-1#4)(1992-1#9)
partial in##2##2##(1991-8#1)(1995-5#1)
partial least square (PLS)##2##4##(2008-10#2)
partial least square##7##3##(2008-10#5)(2013-8#2)
partial least squares (PLS) algorithm##2##5##(2008-10#2)
partial least squares (PLS) and##4##5##(2008-10#4)
partial least squares (PLS) calibration##4##5##(2008-10#4)
partial least squares (PLS) model##2##5##(2008-10#2)
partial least squares (PLS) multivariate calibration##3##6##(2008-10#3)
partial least squares (PLS) regression was##2##6##(2008-10#2)
partial least squares (PLS) regression##6##5##(2008-10#5)(2013-8#1)
partial least squares (PLS)##31##4##(2008-10#30)(2013-8#1)
partial least squares (PLS-1)##2##4##(2008-10#2)
partial least squares and##3##4##(2008-10#3)
partial least squares based on##2##5##(2008-10#2)
partial least squares calibration model##2##5##(2008-10#2)
partial least squares calibration##7##4##(2008-10#7)
partial least squares modeling##3##4##(2008-10#3)
partial least squares regression (PLS)##5##5##(2008-10#5)
partial least squares regression and##2##5##(2008-10#2)
partial least squares regression##14##4##(2008-10#14)
partial least squares##86##3##(2007-11#1)(2008-10#82)(2008-3#1)(2009-3#1)(2013-8#1)
partial least##94##2##(2007-11#1)(2008-10#88)(2008-3#1)(2009-3#1)(2013-8#3)
partial least-squares (PLS) calibration##2##4##(2008-10#2)
partial least-squares (PLS)##9##3##(2007-11#1)(2008-10#8)
partial least-squares (PLS-1) and##2##4##(2008-10#2)
partial least-squares method##2##3##(2008-10#2)
partial least-squares multivariate calibration##4##4##(2008-10#4)
partial least-squares regression##6##3##(2008-10#6)
partial least-squares##29##2##(2007-11#1)(2008-10#27)(2008-3#1)
partial lesion of##2##3##(1993-5#1)(1994-8#1)
partial library of##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
partial lipodystrophy##3##2##(1996-3#2)(2008-1#1)
partial loss of##2##3##(1995-2#1)(2008-9#1)
partial metabolic##2##2##(1990-11#1)(2011-1#1)
partial migration##2##2##(2008-8#2)
partial mixing##2##2##(2008-6#1)(2008-7#1)
partial molecular##2##2##(1995-5#1)(2008-8#1)
partial nephrectomy in##2##3##(2007-7#1)(2013-1#1)
partial nephrectomy##3##2##(2007-7#1)(2009-2#1)(2013-1#1)
partial neuroprotective activity##2##3##(2013-8#2)
partial nucleotide##3##2##(1992-11#1)(2008-10#2)
partial occlusion of##2##3##(2008-2#1)(2010-4#1)
partial occlusion##3##2##(2008-2#2)(2010-4#1)
partial or complete##7##3##(1990-6#1)(1991-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-7#1)(2013-1#1)
partial or total##7##3##(1992-3#1)(1997-8#1)(2008-9#2)(2009-7#1)(2012-12#1)(2012-3#1)
partial or##18##2##(1990-6#1)(1991-2#1)(1992-3#1)(1995-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
partial pain relief##2##3##(1992-1#1)(2007-11#1)
partial photobleaching##2##2##(2008-3#2)
partial positive##3##2##(1992-3#2)(1995-5#1)
partial pressure of oxygen##2##4##(1993-12#1)(2008-10#1)
partial pressure of##4##3##(1993-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
partial pressure##19##2##(1993-12#1)(2007-12#2)(2008-10#1)(2008-11#7)(2008-3#1)(2008-6#1)(2008-7#3)(2010-8#1)(2013-8#2)
partial pressures of##2##3##(1990-2#1)(2008-3#1)
partial pressures##4##2##(1990-2#1)(1990-8#1)(2007-12#1)(2008-3#1)
partial protection##4##2##(1990-6#1)(1992-7#1)(2008-8#1)(2013-1#1)
partial proteolysis##2##2##(1990-12#1)(1991-12#1)
partial purification of a##2##4##(1990-8#1)(1992-3#1)
partial recovery of##2##3##(1994-6#1)(2008-10#1)
partial recovery##5##2##(1994-6#1)(2008-10#3)(2012-12#1)
partial remission was##2##3##(1997-3#1)(2008-6#1)
partial remission##11##2##(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#2)(1997-3#1)(2008-6#1)(2011-1#1)
partial remissions##3##2##(1990-2#2)(1991-2#1)
partial removal of##2##3##(2007-11#1)(2008-10#1)
partial resection##3##2##(1992-9#1)(2007-11#2)
partial resistance to STB##2##4##(2008-10#2)
partial resistance to##14##3##(2008-10#14)
partial resistance##38##2##(2008-10#38)
partial resolution of the##2##4##(1994-9#1)(2010-10#1)
partial resolution of##3##3##(1994-9#1)(2010-10#1)(2012-3#1)
partial response in##2##3##(2008-6#1)(2013-1#1)
partial response was##2##3##(1992-12#1)(2007-8#1)
partial response##18##2##(1990-12#1)(1990-2#3)(1991-8#1)(1992-10#1)(1992-12#2)(1992-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-6#3)(2010-12#1)(2013-1#1)(2013-8#1)
partial responses were observed##2##4##(1990-10#1)(1990-12#1)
partial responses were##3##3##(1990-10#1)(1990-12#2)
partial responses##12##2##(1990-10#1)(1990-12#2)(1991-2#3)(1992-10#1)(1992-2#1)(1992-8#1)(1993-9#1)(2007-10#1)(2008-6#1)
partial seizures##2##2##(2006-12#1)(2009-9#1)
partial separation of##2##3##(2008-10#2)
partial sequence of a##2##4##(1993-12#1)(1997-7#1)
partial sequence of##6##3##(1993-12#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-8#1)
partial sequence##13##2##(1991-2#1)(1991-5#1)(1993-12#1)(1995-2#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-8#1)
partial sequences from a 3'-directed cDNA library##2##7##(1996-10#1)(1996-2#1)
partial sequences from##3##3##(1996-10#1)(1996-2#1)(2007-12#1)
partial sequences of the##2##4##(2008-10#2)
partial sequences of##3##3##(1996-8#1)(2008-10#2)
partial sequences##8##2##(1996-10#1)(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
partial sequencing of##3##3##(2008-10#2)(2011-1#1)
partial sequencing##5##2##(1992-8#1)(1997-3#1)(2008-10#2)(2011-1#1)
partial splenic embolization##2##3##(2009-9#1)(2013-1#1)
partial sterility##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
partial structural functions of##2##4##(2006-4#2)
partial structural##3##2##(1993-3#1)(2006-4#2)
partial structures##2##2##(2009-9#2)
partial support##3##2##(1995-2#1)(2008-9#1)(2009-8#1)
partial suppression of##4##3##(1994-8#1)(1996-5#1)(2008-1#1)(2008-4#1)
partial tandem##2##2##(2008-10#1)(2011-3#1)
partial thickness flap##2##3##(2012-3#2)
partial thromboplastin time##8##3##(1991-2#1)(1994-9#1)(2007-10#3)(2008-10#1)(2008-7#1)(2008-9#1)
partial thromboplastin##9##2##(1991-2#1)(1994-9#1)(2007-10#3)(2008-10#1)(2008-7#1)(2008-9#2)
partial tone##2##2##(2008-8#2)
partial tumour##2##2##(1997-3#1)(2007-11#1)
partial volume##2##2##(2011-1#2)
partial##792##1##(1990-10#1)(1990-11#2)(1990-12#13)(1990-2#9)(1990-3#2)(1990-5#4)(1990-6#3)(1990-8#4)(1991-1#7)(1991-12#5)(1991-2#8)(1991-3#3)(1991-5#4)(1991-6#5)(1991-8#6)(1991-9#3)(1992-1#11)(1992-10#5)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#2)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#4)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#7)(1995-11#7)(1995-12#1)(1995-2#11)(1995-3#1)(1995-5#6)(1995-6#6)(1996-10#2)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#4)(1997-2#6)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#6)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#2)(2007-10#5)(2007-11#17)(2007-12#16)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#210)(2008-11#20)(2008-12#2)(2008-2#7)(2008-3#19)(2008-4#10)(2008-5#8)(2008-6#8)(2008-7#24)(2008-8#23)(2008-9#13)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#2)(2009-9#7)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#27)(2011-3#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#15)(2013-7#2)(2013-8#18)
partial-hospital program##2##2##(1992-1#2)
partial-hospital programs##2##2##(1992-1#2)
partial-hospital##4##1##(1992-1#4)
partially activated##2##2##(1991-3#1)(1992-3#1)
partially ameliorated##3##2##(1993-12#1)(2008-6#1)(2012-12#1)
partially and##3##2##(1995-2#1)(1995-3#1)(2008-11#1)
partially attributed to##2##3##(1996-2#1)(2008-10#1)
partially blocked by##3##3##(1994-9#1)(1995-6#1)(2008-8#1)
partially blocked##5##2##(1992-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(2008-8#1)
partially by##3##2##(1991-5#1)(2010-2#1)(2011-2#1)
partially castrated##3##2##(2008-9#3)
partially characterized from the##2##4##(1992-6#1)(2008-10#1)
partially characterized##11##2##(1992-6#1)(1994-8#1)(1997-6#1)(2008-10#5)(2008-4#1)(2008-6#1)(2012-1#1)
partially coherent anisotropic##3##3##(2007-11#3)
partially coherent beams##6##3##(2007-11#4)(2007-12#1)(2008-3#1)
partially coherent fields##5##3##(2007-11#1)(2007-12#4)
partially coherent imaging##2##3##(2007-11#1)(2008-3#1)
partially coherent light##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
partially coherent optical##2##3##(2007-12#1)(2008-3#1)
partially coherent twisted anisotropic Gaussian-Schell model##2##6##(2007-11#2)
partially coherent twisted anisotropic##3##4##(2007-11#3)
partially coherent##34##2##(2007-11#15)(2007-12#8)(2008-2#2)(2008-3#9)
partially compensated##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
partially cross-fertile plant species##2##4##(2008-8#2)
partially crosslinked fibers##2##3##(1995-2#2)
partially degraded##3##2##(2008-10#2)(2008-7#1)
partially denatured##3##2##(1991-5#1)(1992-11#1)(2008-8#1)
partially dependent on##3##3##(1990-2#1)(2008-10#2)
partially depolarized##2##2##(1990-8#1)(1992-11#1)
partially developed speckle##3##3##(2008-3#3)
partially digested with##2##3##(1990-5#1)(1991-6#1)
partially digested##3##2##(1990-5#1)(1991-6#1)(1995-8#1)
partially dominant##5##2##(2008-10#5)
partially due to the##3##4##(1993-12#1)(2008-10#1)(2010-5#1)
partially due to##6##3##(1991-12#1)(1993-12#1)(1993-5#1)(1994-11#1)(2008-10#1)(2010-5#1)
partially edentulous##4##2##(2010-12#1)(2013-1#3)
partially effective##5##2##(2008-10#4)(2008-9#1)
partially explained by the##3##4##(1991-8#1)(2008-10#1)(2013-1#1)
partially explained by##8##3##(1991-8#1)(1993-11#1)(2008-10#3)(2008-5#1)(2012-3#1)(2013-1#1)
partially folded##8##2##(1993-9#1)(1995-2#1)(1995-5#1)(1997-2#5)
partially for##2##2##(2008-11#1)(2008-2#1)
partially homologous to##2##3##(1993-9#1)(2008-10#1)
partially ill-defined##3##2##(1994-7#2)(1997-8#1)
partially in##4##2##(1992-8#1)(2008-10#2)(2013-8#1)
partially inactivated##3##2##(1993-11#2)(1993-2#1)
partially incoherent##2##2##(2007-11#1)(2008-3#1)
partially independent##3##2##(2008-8#3)
partially inhibit the##3##3##(1991-9#1)(1994-6#1)(2009-6#1)
partially inhibit##4##2##(1991-12#1)(1991-9#1)(1994-6#1)(2009-6#1)
partially inhibited by##5##3##(1990-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-4#1)
partially inhibited the##2##3##(1996-5#1)(2008-9#1)
partially inhibited##13##2##(1990-2#1)(1992-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-2#1)
partially interdigitated##2##2##(1993-8#2)
partially liganded species##2##3##(1990-8#2)
partially ligated##4##2##(1990-8#2)(1997-2#2)
partially maintained##2##2##(2011-2#1)(2013-8#1)
partially mediated the relation between##2##5##(2007-12#1)(2008-12#1)
partially mediated the##3##3##(2007-12#1)(2008-12#1)(2010-1#1)
partially mediated##4##2##(2007-12#1)(2008-12#1)(2010-1#1)(2013-1#1)
partially obstructing##2##2##(2007-5#1)(2008-10#1)
partially or completely##2##3##(2008-4#2)
partially or##5##2##(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)
partially overcome by##2##3##(1990-2#1)(1994-8#1)
partially overcome##5##2##(1990-2#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#1)
partially overcomes##2##2##(2008-1#1)(2009-12#1)
partially overlapped##2##2##(1996-3#1)(2013-8#1)
partially overlapping##4##2##(1996-3#1)(2008-8#1)(2009-10#1)(2012-1#1)
partially oxidized hemoglobin##2##3##(1990-8#2)
partially oxidized##4##2##(1990-8#3)(1995-2#1)
partially polarized light##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
partially polarized##13##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#5)
partially prevented##2##2##(1997-2#1)(2009-8#1)
partially protected##2##2##(1996-5#1)(2011-2#1)
partially purified and##4##3##(1990-5#1)(1994-11#1)(1997-6#1)(2008-10#1)
partially purified by##3##3##(1991-9#1)(1996-6#1)(2010-2#1)
partially purified chlorosis toxin##3##4##(2008-10#3)
partially purified cytosolic##2##3##(1990-11#1)(1995-11#1)
partially purified enzyme##2##3##(1991-12#1)(2008-10#1)
partially purified from culture##2##4##(2008-10#2)
partially purified from##8##3##(1990-7#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-8#1)
partially purified protein##2##3##(1990-11#1)(2008-1#1)
partially purified##43##2##(1990-11#3)(1990-12#1)(1990-5#3)(1990-7#2)(1991-12#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-8#1)(2010-2#1)(2011-2#1)
partially reactivated##3##2##(1992-12#1)(1993-11#1)(1993-6#1)
partially recessive##3##2##(2008-10#3)
partially recovered##2##2##(2008-11#1)(2008-5#1)
partially reimbursed##2##2##(2008-12#2)
partially related to##2##3##(1990-7#1)(2009-10#1)
partially resected##2##2##(2009-9#1)(2011-2#1)
partially resistant cultivar##3##3##(2008-10#3)
partially resistant cultivars##3##3##(2008-10#3)
partially resistant to##2##3##(2008-10#2)
partially resistant wheat##2##3##(2008-10#2)
partially resistant##21##2##(2008-10#21)
partially resolved##2##2##(1994-9#1)(2008-5#1)
partially responded to##2##3##(1992-12#1)(1994-2#1)
partially responded##3##2##(1992-12#1)(1994-2#1)(2013-8#1)
partially responsible for the##4##4##(1990-5#1)(1993-2#1)(1994-12#1)(2010-3#1)
partially responsible for##5##3##(1990-5#1)(1991-9#1)(1993-2#1)(1994-12#1)(2010-3#1)
partially responsible##6##2##(1990-5#1)(1991-9#1)(1993-2#1)(1994-12#1)(2010-3#1)(2012-2#1)
partially restored##2##2##(1994-8#1)(1996-5#1)
partially reversed##3##2##(1991-5#1)(1994-9#1)(2008-4#1)
partially reversible##2##2##(1991-11#1)(1996-5#1)
partially selective##2##2##(2008-10#2)
partially spatially incoherent##4##3##(2007-11#3)(2007-12#1)
partially suppressed the##2##3##(1996-5#1)(2008-9#1)
partially suppressed##5##2##(1996-5#1)(2007-12#1)(2007-7#1)(2008-8#1)(2008-9#1)
partially to##5##2##(1994-8#1)(2007-8#2)(2008-10#2)
partially transformed##2##2##(1992-6#1)(2008-12#1)
partially unfolded states##3##3##(1995-3#2)(2009-5#1)
partially unfolded##5##2##(1995-3#4)(2009-5#1)
partially##515##1##(1990-11#5)(1990-12#2)(1990-2#5)(1990-5#8)(1990-7#3)(1990-8#9)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-5#2)(1993-6#3)(1993-8#6)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#2)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#6)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#6)(1995-5#4)(1995-6#3)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#1)(1997-2#9)(1997-3#1)(1997-4#2)(1997-6#4)(1997-8#1)(2007-11#23)(2007-12#19)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#93)(2008-11#13)(2008-12#8)(2008-2#8)(2008-3#27)(2008-4#8)(2008-5#11)(2008-6#4)(2008-7#6)(2008-8#16)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#6)(2012-7#1)(2013-1#9)(2013-8#7)
partials##2##1##(2008-8#2)
participant fees##2##2##(1993-2#1)(1994-2#1)
participant in##6##2##(1995-11#1)(1996-2#1)(2007-12#2)(2012-3#1)(2013-1#1)
participant laboratories##2##2##(2008-10#1)(2008-12#1)
participant observation##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
participant observations##2##2##(2008-9#1)(2009-5#1)
participant##59##1##(1992-1#2)(1993-2#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#1)
participant's##7##1##(1996-11#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
participants (N =##3##3##(2009-6#1)(2010-8#2)
participants (n =##4##3##(2008-5#1)(2009-9#1)(2010-4#1)(2012-3#1)
participants about the##2##3##(1997-3#1)(2010-11#1)
participants also##2##2##(2008-11#1)(2008-12#1)
participants and the##2##3##(2011-2#1)(2012-12#1)
participants and their##2##3##(2009-6#1)(2012-12#1)
participants and##16##2##(1995-2#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
participants are##4##2##(1995-2#1)(2008-7#1)(2012-2#2)
participants as##2##2##(2008-10#1)(2011-1#1)
participants at##2##2##(2008-11#1)(2012-12#1)
participants attended to##2##3##(2008-11#2)
participants attended##3##2##(2008-11#2)(2008-6#1)
participants cannot##2##2##(2010-1#1)(2012-2#1)
participants compared with##2##3##(1993-1#1)(2008-10#1)
participants compared##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
participants completed a##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2010-4#1)(2010-7#1)
participants completed trauma-related questionnaires##2##4##(2009-4#2)
participants completed##10##2##(2007-12#1)(2008-1#2)(2008-11#1)(2009-4#2)(2009-9#1)(2010-4#1)(2010-7#1)(2013-1#1)
participants considered##2##2##(2008-12#1)(2011-2#1)
participants could##2##2##(2008-10#1)(2012-3#1)
participants did not##3##3##(1995-1#1)(2009-10#1)(2009-7#1)
participants discussed##3##2##(1994-7#1)(2008-6#1)(2009-3#1)
participants during##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
participants enrolled in the##2##4##(2009-3#1)(2012-12#1)
participants exhibited a##2##3##(2007-12#1)(2007-8#1)
participants exhibited##3##2##(2007-12#1)(2007-8#1)(2009-11#1)
participants for##3##2##(2008-4#2)(2009-6#1)
participants found##3##2##(2008-2#1)(2008-4#1)(2013-1#1)
participants from Britain and Malaysia were asked to rate a set of images of real##2##15##(2007-12#2)
participants from limited resource settings##2##5##(2009-6#2)
participants from the##3##3##(2008-5#1)(2009-1#1)(2013-1#1)
participants from##15##2##(1994-1#1)(2007-12#2)(2008-11#1)(2008-5#3)(2009-1#1)(2009-6#3)(2010-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
participants had a##7##3##(2006-8#1)(2009-10#1)(2009-3#2)(2010-10#1)(2012-12#1)(2013-8#1)
participants had the##2##3##(2008-11#1)(2012-2#1)
participants had##21##2##(1993-3#1)(1994-12#3)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-11#1)(2009-3#2)(2010-10#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
participants high on##2##3##(2007-12#1)(2009-11#1)
participants in Group##2##3##(2011-2#2)
participants in a##4##3##(1993-12#1)(2009-6#1)(2010-11#1)(2011-2#1)
participants in all##2##3##(2009-11#1)(2010-8#1)
participants in both##2##3##(2011-1#1)(2012-2#1)
participants in the##14##3##(1991-8#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
participants in this##2##3##(1992-1#1)(2013-1#1)
participants in##38##2##(1991-8#1)(1992-1#1)(1993-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#3)(2008-5#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2013-1#2)
participants not##3##2##(2008-1#1)(2010-7#1)(2013-7#1)
participants of the##3##3##(2010-1#1)(2012-3#1)(2013-1#1)
participants of##4##2##(2008-12#1)(2010-1#1)(2012-3#1)(2013-1#1)
participants on##2##2##(2008-1#1)(2013-1#1)
participants performed a##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
participants performed##7##2##(2008-11#2)(2009-3#1)(2010-5#1)(2012-3#1)(2013-8#2)
participants reported that they##3##4##(2009-3#1)(2009-6#2)
participants reported##10##2##(1995-1#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-7#1)(2012-1#1)(2012-12#2)
participants revealed##2##2##(2009-9#1)(2010-10#1)
participants showed##4##2##(2008-11#1)(2008-12#1)(2009-8#1)(2010-4#1)
participants thought##2##2##(2008-6#1)(2008-9#1)
participants to evaluate##2##3##(2007-7#1)(2008-12#1)
participants to rate##2##3##(2009-10#1)(2013-8#1)
participants to##17##2##(1992-1#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2012-12#1)(2013-8#1)
participants took##2##2##(2008-2#1)(2009-6#1)
participants underwent functional magnetic resonance imaging##2##6##(2008-11#2)
participants underwent##4##2##(2008-11#2)(2011-2#1)(2012-3#1)
participants used##3##2##(2008-10#1)(2010-8#2)
participants using##5##2##(2008-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
participants viewed##3##2##(2008-11#3)
participants was##7##2##(2008-1#1)(2008-10#2)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
participants were asked to##6##4##(2007-7#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#2)
participants were first##2##3##(2009-11#1)(2012-12#1)
participants were from##3##3##(2007-7#1)(2008-7#1)(2009-6#1)
participants were instructed that##2##4##(2008-11#2)
participants were interviewed##2##3##(2010-10#1)(2011-1#1)
participants were more reliant on body##2##6##(2007-12#2)
participants were more##3##3##(2007-12#2)(2008-12#1)
participants were not satisfied with##2##5##(2007-10#2)
participants were randomized to##2##4##(2009-9#1)(2011-1#1)
participants were randomized##3##3##(2009-9#1)(2010-4#1)(2011-1#1)
participants were randomly assigned##2##4##(2007-11#1)(2010-10#1)
participants were randomly##4##3##(2007-11#1)(2009-5#1)(2010-10#1)(2012-2#1)
participants were recruited##2##3##(2008-10#1)(2009-6#1)
participants were##63##2##(1995-1#2)(1995-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-6#3)(2009-9#3)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#5)
participants who had##6##3##(1992-1#1)(2010-12#1)(2010-7#1)(2013-1#1)(2013-8#2)
participants who reported##2##3##(2008-11#1)(2013-1#1)
participants who were##5##3##(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
participants who##20##2##(1992-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#7)(2013-8#4)
participants with a##5##3##(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
participants with##23##2##(1993-12#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
participants without##2##2##(2007-12#1)(2012-12#1)
participants would##2##2##(1994-1#1)(2008-11#1)
participants##541##1##(1991-3#1)(1991-8#2)(1992-1#3)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#11)(1995-2#3)(1995-5#1)(1996-11#1)(1996-3#6)(1997-3#4)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#8)(2007-12#18)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#10)(2008-10#18)(2008-11#38)(2008-12#26)(2008-2#4)(2008-3#3)(2008-4#9)(2008-5#10)(2008-6#7)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#3)(2009-10#9)(2009-11#12)(2009-2#1)(2009-3#8)(2009-4#11)(2009-5#6)(2009-6#18)(2009-7#2)(2009-8#4)(2009-9#9)(2010-1#4)(2010-10#9)(2010-11#9)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#10)(2010-8#6)(2010-9#4)(2011-1#12)(2011-2#27)(2012-1#4)(2012-12#27)(2012-2#18)(2012-3#15)(2013-1#41)(2013-7#2)(2013-8#24)
participants' experiences of##2##3##(2008-11#1)(2010-10#1)
participants' knowledge##2##2##(2008-3#1)(2009-7#1)
participants'##31##1##(2007-10#2)(2007-12#2)(2008-11#3)(2008-3#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-7#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#7)(2012-3#2)(2013-1#4)
participants)##3##1##(2008-11#1)(2011-1#1)(2012-2#1)
participate in Michael addition reactions with##2##6##(2008-10#2)
participate in a##13##3##(1990-11#1)(1996-1#1)(1996-9#1)(1997-2#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
participate in an##2##3##(1995-6#1)(2008-5#1)
participate in and##3##3##(1995-1#1)(2008-8#1)(2013-1#1)
participate in regulating the expression of##3##6##(1997-7#1)(2010-7#1)(2011-2#1)
participate in regulating##4##3##(1997-7#1)(2008-3#1)(2010-7#1)(2011-2#1)
participate in research##6##3##(1992-6#1)(2007-10#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
participate in sport##2##3##(2009-3#1)(2009-5#1)
participate in the control of##2##5##(1990-12#1)(2008-7#1)
participate in the regulation of##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
participate in the study##6##4##(1994-12#1)(2008-11#1)(2010-1#1)(2010-6#1)(2012-2#2)
participate in the##48##3##(1990-12#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-5#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-2#5)(2013-1#3)(2013-8#1)
participate in these##3##3##(1994-2#1)(2013-1#2)
participate in this##6##3##(1991-2#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)
participate in##145##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-7#1)(2007-10#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#13)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#6)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#1)
participate to##2##2##(2007-10#1)(2013-1#1)
participate##174##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#2)(1995-6#6)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-7#1)(2007-10#4)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#15)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#8)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#10)(2012-1#4)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#11)(2013-8#1)
participated actively in the##2##4##(2008-12#1)(2010-5#1)
participated and##2##2##(2008-11#1)(2009-11#1)
participated as volunteers in##2##4##(2008-12#1)(2012-3#1)
participated as##3##2##(2008-12#1)(2009-2#1)(2012-3#1)
participated for four months in 1992##2##6##(1994-6#2)
participated for##3##2##(1990-6#1)(1994-6#2)
participated in a 12-week##3##4##(2007-12#1)(2008-5#2)
participated in a pilot study##2##5##(2007-10#1)(2010-8#1)
participated in a study of##2##5##(2008-7#1)(2012-12#1)
participated in a workshop##2##4##(2010-5#1)(2011-2#1)
participated in a##23##3##(1991-1#1)(1992-1#1)(1994-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
participated in an##9##3##(1990-6#1)(1991-2#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-11#2)(2009-1#1)(2011-1#1)
participated in one##2##3##(1996-2#1)(2010-7#1)
participated in research##2##3##(2009-6#2)
participated in the study##28##4##(1990-6#1)(1992-3#1)(1993-12#1)(1995-1#1)(1996-1#1)(2006-8#1)(2008-12#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-3#3)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
participated in the survey##4##4##(1992-11#1)(1994-12#1)(2008-12#1)(2010-10#1)
participated in the##45##3##(1990-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-12#5)(2008-7#1)(2008-9#2)(2009-3#1)(2009-7#2)(2010-10#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
participated in this study##14##4##(2007-10#1)(2007-6#1)(2007-8#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
participated in this##21##3##(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
participated in three##2##3##(2008-8#1)(2012-3#1)
participated in##135##2##(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-6#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#4)(2008-11#4)(2008-12#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2010-10#6)(2010-11#2)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#7)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#2)
participated to##2##2##(2007-10#1)(2010-7#1)
participated##173##1##(1990-6#3)(1991-1#1)(1991-12#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-4#1)(1997-6#1)(2006-8#2)(2007-10#4)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#4)(2010-10#6)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#7)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#2)
participates in a##4##3##(1996-12#1)(2007-8#1)(2011-2#1)(2012-1#1)
participates in regulating##2##3##(1996-7#1)(2008-3#1)
participates in regulation of the##2##5##(1995-8#1)(2008-9#1)
participates in the formation of##2##5##(1994-2#1)(2008-12#1)
participates in the processes##2##4##(1992-8#1)(2008-12#1)
participates in the regulation of##3##5##(1995-11#1)(1995-5#1)(2013-1#1)
participates in the##15##3##(1992-12#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-5#2)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#2)(2013-1#2)(2013-7#1)
participates in##42##2##(1991-2#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
participates##46##1##(1991-2#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#3)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
participating alliances##2##2##(2013-1#2)
participating hospitals and the##2##4##(1991-2#1)(1993-9#1)
participating hospitals##5##2##(1991-2#2)(1993-9#1)(1994-3#1)(2008-3#1)
participating in a smoking##2##4##(2007-12#1)(2009-5#1)
participating in a##10##3##(1991-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-5#1)
participating in activities##2##3##(1992-1#1)(1993-2#1)
participating in sport##2##3##(2007-8#2)
participating in the Aligning Forces for Quality initiative##2##8##(2013-1#2)
participating in the Aligning Forces for Quality##3##7##(2013-1#3)
participating in the##21##3##(1991-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-10#1)(2007-6#2)(2008-1#1)(2008-10#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
participating in their##2##3##(2009-8#1)(2013-1#1)
participating in these##2##3##(2008-12#1)(2010-10#1)
participating in this##2##3##(2008-3#1)(2009-4#1)
participating in##56##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-10#2)(2007-12#1)(2007-6#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#6)
participating laboratories##4##2##(2008-10#3)(2008-12#1)
participating physicians##2##2##(2012-3#2)
participating providers##2##2##(1997-1#1)(1997-3#1)
participating schools##2##2##(2008-12#1)(2013-1#1)
participating##105##1##(1990-2#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#4)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(2007-10#2)(2007-12#1)(2007-6#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#12)
participation among##2##2##(2009-4#1)(2012-2#1)
participation and communication##2##3##(2013-1#2)
participation and the##3##3##(1993-3#2)(1995-3#1)
participation and##28##2##(1993-1#1)(1993-3#2)(1995-3#1)(1995-5#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#3)
participation as a##2##3##(2007-10#1)(2008-6#1)
participation as##3##2##(2007-10#1)(2008-5#1)(2008-6#1)
participation by patients##2##3##(1992-12#1)(2008-10#1)
participation by the##2##3##(1992-6#1)(2008-10#1)
participation by##12##2##(1992-1#1)(1992-12#2)(1992-6#1)(1994-12#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)
participation can##2##2##(1994-12#1)(2013-1#1)
participation from##2##2##(2008-12#1)(2012-1#1)
participation has been##2##3##(2008-11#1)(2013-1#1)
participation in a##9##3##(1993-11#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
participation in an##2##3##(2008-10#1)(2012-3#1)
participation in clinical trials##2##4##(2008-11#1)(2012-3#1)
participation in clinical##4##3##(1995-3#1)(2008-11#1)(2008-12#1)(2012-3#1)
participation in health care##3##4##(1997-2#2)(2008-12#1)
participation in health##6##3##(1992-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-12#1)
participation in painting pictures or playing a musical instrument##2##9##(2012-12#2)
participation in research and##2##4##(1997-8#1)(2008-8#1)
participation in research##4##3##(1992-6#1)(1997-8#1)(2008-1#1)(2008-8#1)
participation in social##2##3##(2011-2#1)(2012-12#1)
participation in the operation of community mental health agencies##2##9##(1997-3#2)
participation in the process##2##4##(1994-1#1)(1994-9#1)
participation in the study##2##4##(2011-2#1)(2013-1#1)
participation in the trial##2##4##(1990-2#1)(2008-8#1)
participation in the##25##3##(1990-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-9#1)(1995-3#2)(1995-9#1)(1997-2#1)(1997-3#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#2)(2011-2#2)(2013-1#1)
participation in##115##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1997-2#4)(1997-3#5)(1997-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#7)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
participation is##5##2##(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(2013-1#1)
participation of a##2##3##(1991-8#1)(2012-1#1)
participation of community residents in##2##5##(1995-3#2)
participation of persons with aphasia##2##5##(2012-3#2)
participation of the##9##3##(1992-12#1)(1994-1#1)(1995-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)
participation of these##2##3##(2011-1#1)(2011-2#1)
participation of this##3##3##(1993-3#1)(1995-6#1)(2008-7#1)
participation of women in##2##4##(2012-2#1)(2013-1#1)
participation of##66##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1993-3#2)(1994-1#1)(1994-3#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-12#5)(1997-1#1)(1997-2#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
participation on##2##2##(2008-1#1)(2008-11#1)
participation rate##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
participation rates##3##2##(1994-3#1)(2013-1#2)
participation than##2##2##(2007-6#1)(2010-10#1)
participation through the##2##3##(1994-2#1)(2008-11#1)
participation through##3##2##(1994-2#1)(2008-11#1)(2012-1#1)
participation to##2##2##(1995-2#1)(2013-1#1)
participation was associated with##4##4##(1993-3#2)(2008-12#1)(2012-12#1)
participation was##5##2##(1993-3#2)(2007-10#1)(2008-12#1)(2012-12#1)
participation with##2##2##(2008-1#1)(2010-7#1)
participation##331##1##(1990-10#1)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#4)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#7)(1993-6#2)(1994-1#3)(1994-12#4)(1994-2#1)(1994-3#8)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#10)(1996-2#4)(1996-6#1)(1997-1#2)(1997-2#6)(1997-3#7)(1997-8#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-6#4)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#17)(2008-11#16)(2008-12#16)(2008-3#5)(2008-5#3)(2008-6#7)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#6)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#4)(2010-9#1)(2011-1#6)(2011-2#12)(2011-9#1)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#5)(2013-1#18)(2013-8#2)
participative##6##1##(1993-12#1)(1993-3#2)(1994-2#1)(1997-2#1)(2011-2#1)
participatory research to build community capacity and address mental health disparities and##2##12##(2012-2#2)
participatory research to##3##3##(2011-2#1)(2012-2#2)
participatory research##10##2##(1997-3#4)(2011-2#2)(2012-12#1)(2012-2#3)
participatory##20##1##(1992-1#1)(1997-3#4)(2008-1#1)(2008-11#3)(2009-12#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-8#1)
particle X-ray##2##2##(2013-8#2)
particle aggregates##2##2##(2008-10#1)(2008-2#1)
particle analysis##4##2##(2008-10#4)
particle and##11##2##(1990-12#1)(1993-2#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-6#1)
particle are##2##2##(2007-12#1)(2008-3#1)
particle assembly##3##2##(1993-8#1)(1995-9#1)(2008-8#1)
particle associated##2##2##(1994-8#1)(2008-11#1)
particle beam##2##2##(1997-2#2)
particle bombardment with##2##3##(2008-10#2)
particle bombardment##10##2##(2008-10#9)(2008-5#1)
particle by use of its##2##5##(2008-3#2)
particle by use of##3##4##(2008-2#1)(2008-3#2)
particle by##4##2##(2008-2#1)(2008-3#3)
particle capture by##2##3##(2008-9#2)
particle capture##6##2##(2008-3#1)(2008-9#5)
particle characterization##2##2##(2008-3#2)
particle columns##2##2##(2008-2#2)
particle composition##2##2##(2008-10#1)(2008-3#1)
particle concentration##3##2##(2008-2#2)(2008-3#1)
particle concentrations##4##2##(2007-12#1)(2008-3#3)
particle correction function##2##3##(2008-3#2)
particle counters##2##2##(2008-3#2)
particle counting##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
particle density and##2##3##(2008-2#1)(2008-3#1)
particle density##3##2##(2008-2#2)(2008-3#1)
particle deposition efficiencies##2##3##(1991-12#2)
particle deposition##6##2##(1991-12#4)(1996-1#1)(1996-12#1)
particle diameter of##2##3##(2008-2#2)
particle diameter##6##2##(2008-2#2)(2008-3#3)(2013-1#1)
particle diameters##4##2##(2008-3#3)(2009-9#1)
particle distribution##4##2##(1992-2#1)(1992-3#1)(2008-2#1)(2008-5#1)
particle emissions##3##2##(2008-11#2)(2008-3#1)
particle extinction coefficients##2##3##(2008-3#2)
particle extinction##3##2##(2008-3#3)
particle image velocimetry (PIV)##2##4##(2008-2#2)
particle image velocimetry##8##3##(2008-2#5)(2008-3#3)
particle images##2##2##(2008-3#2)
particle in an##3##3##(2008-2#1)(2008-3#2)
particle in the##5##3##(1992-11#1)(2007-11#1)(2008-10#2)(2008-3#1)
particle in##11##2##(1992-11#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#5)
particle is##8##2##(2007-11#2)(2008-2#2)(2008-3#4)
particle mass##4##2##(1996-2#2)(1997-2#1)(2008-10#1)
particle matter##3##2##(2008-3#3)
particle morphology##2##2##(2008-10#1)(2011-3#1)
particle or##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
particle parameters##5##2##(2008-3#5)
particle phase##2##2##(2008-2#2)
particle population##3##2##(1995-6#1)(2012-2#2)
particle position##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-9#1)
particle refractive index##2##3##(2008-2#1)(2008-3#1)
particle sedimentation##2##2##(1996-2#1)(2012-3#1)
particle shape##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
particle size 3##2##3##(1990-8#1)(1996-5#1)
particle size and concentration##4##4##(1995-3#1)(2008-3#2)(2011-2#1)
particle size and the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
particle size and##21##3##(1995-3#1)(2007-11#2)(2008-10#5)(2008-2#2)(2008-3#5)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
particle size distribution and##5##4##(1996-12#1)(2008-10#3)(2008-3#1)
particle size distribution is##2##4##(2008-3#1)(2008-7#1)
particle size distribution##16##3##(1992-2#1)(1992-3#1)(1993-2#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-7#1)(2013-1#1)
particle size distributions of##2##4##(1997-2#1)(2008-2#1)
particle size distributions##7##3##(1997-2#1)(2008-2#1)(2008-3#5)
particle size during##2##3##(2008-8#1)(2009-11#1)
particle size in##3##3##(1990-8#1)(2008-10#1)(2011-1#1)
particle size is##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
particle size of 3##3##4##(2008-10#1)(2013-8#2)
particle size of the##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
particle size of##12##3##(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-3#1)(2013-8#2)
particle size or fraction of the studied element##2##8##(2008-10#2)
particle size or##3##3##(2008-10#2)(2008-2#1)
particle size selective##2##3##(1992-3#1)(2008-5#1)
particle size smaller than##2##4##(2008-10#1)(2008-5#1)
particle size was developed##2##4##(2008-10#1)(2009-2#1)
particle size was##3##3##(2008-10#2)(2009-2#1)
particle size##143##2##(1990-8#2)(1992-2#1)(1992-3#4)(1993-2#2)(1995-3#2)(1995-8#2)(1996-12#2)(1996-5#1)(1997-1#2)(1997-2#5)(2007-11#4)(2007-12#1)(2008-10#35)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#25)(2008-5#13)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-2#2)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#2)(2013-1#2)(2013-8#4)
particle size) with##2##3##(2008-10#1)(2010-3#1)
particle sizer##2##2##(1993-2#1)(2008-3#1)
particle sizers##2##2##(2008-3#2)
particle sizes and##2##3##(2008-10#1)(2008-3#1)
particle sizes in the##2##4##(2008-2#1)(2008-3#1)
particle sizes of##2##3##(2008-10#1)(2008-7#1)
particle sizes##10##2##(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)
particle sizing in##2##3##(2008-2#1)(2008-3#1)
particle sizing##19##2##(1992-3#1)(1995-3#1)(2008-2#7)(2008-3#10)
particle surface##5##2##(2008-10#1)(2008-3#3)(2013-1#1)
particle surfaces##3##2##(2008-10#1)(2012-1#2)
particle to##3##2##(2007-11#1)(2008-2#1)(2009-5#1)
particle traversal through##2##3##(2008-8#2)
particle traversal##3##2##(2008-8#3)
particle types and##2##3##(2008-3#1)(2008-9#1)
particle vaporization velocimetry##2##3##(2007-12#2)
particle vaporization##3##2##(2007-12#2)(2008-10#1)
particle volume fraction##2##3##(2008-2#1)(2008-3#1)
particle volume##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
particle was##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
particle with##5##2##(1994-8#1)(1995-6#1)(2008-2#3)
particle within##2##2##(2007-12#1)(2008-3#1)
particle##546##1##(1990-11#1)(1990-12#3)(1990-8#2)(1991-12#5)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-3#6)(1993-2#4)(1993-3#1)(1993-8#2)(1994-11#2)(1994-3#2)(1994-8#2)(1995-2#2)(1995-3#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#3)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#11)(1997-3#2)(1997-6#1)(2007-11#20)(2007-12#13)(2007-9#2)(2008-10#93)(2008-11#8)(2008-12#2)(2008-2#69)(2008-3#155)(2008-4#1)(2008-5#18)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#8)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#7)(2011-2#5)(2011-3#3)(2012-1#2)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#6)
particle's##3##1##(2007-11#1)(2008-3#2)
particle-free##2##1##(2008-2#1)(2008-9#1)
particle-image velocimetry in##2##3##(2008-3#2)
particle-image velocimetry##4##2##(2008-3#4)
particle-induced##4##1##(2008-10#2)(2008-3#2)
particle-mediated##3##1##(1995-6#1)(2008-10#2)
particle-particle interactions##2##2##(2009-6#1)(2010-4#1)
particle-particle##3##1##(1990-12#1)(2009-6#1)(2010-4#1)
particle-size and##2##2##(1992-3#1)(2008-3#1)
particle-size distribution from angular light-scattering data##2##6##(2008-3#2)
particle-size distribution##9##2##(2007-12#2)(2008-3#6)(2013-1#1)
particle-size distributions##3##2##(2008-2#1)(2008-3#2)
particle-size##20##1##(1992-3#1)(2007-12#2)(2008-2#3)(2008-3#13)(2013-1#1)
particle-sizing method##2##2##(2008-2#1)(2008-3#1)
particle-sizing##4##1##(2008-2#2)(2008-3#2)
particle/matrix##2##1##(2008-8#1)(2009-7#1)
particles &lt##3##2##(1995-3#1)(1996-12#1)(2008-11#1)
particles (e##2##2##(2008-10#1)(2008-3#1)
particles and in##2##3##(2008-11#1)(2008-9#1)
particles and large##2##3##(2008-10#2)
particles and the##5##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)
particles and their##2##3##(2008-10#1)(2008-11#1)
particles and to##2##3##(2008-3#2)
particles and##42##2##(1990-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
particles are observed##2##3##(1997-3#1)(2008-2#1)
particles are presented##2##3##(1992-12#1)(2008-2#1)
particles are##28##2##(1992-12#1)(1997-2#1)(1997-3#4)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#5)(2008-3#6)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)
particles as a##2##3##(2008-3#1)(2008-7#1)
particles as well as##2##4##(2008-3#2)
particles as##11##2##(1990-6#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-3#3)(2008-7#3)(2012-2#1)
particles at##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
particles by a##2##3##(2007-12#1)(2008-3#1)
particles by##12##2##(1991-5#1)(1992-6#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-4#1)(2009-5#1)
particles can be##4##3##(1994-2#1)(1997-1#1)(2008-10#1)(2008-3#1)
particles can##7##2##(1994-2#1)(1997-1#1)(2008-10#2)(2008-3#3)
particles coated with##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
particles collected in the##2##4##(2008-10#1)(2008-12#1)
particles collected##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
particles containing##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
particles did not##2##3##(2008-10#1)(2008-5#1)
particles due to##2##3##(1990-12#1)(1992-12#1)
particles during##2##2##(2008-3#2)
particles for##5##2##(1994-3#1)(2008-10#2)(2008-9#1)(2013-1#1)
particles formed##3##2##(2008-10#3)
particles from##6##2##(1992-2#1)(1994-11#1)(2008-10#3)(2008-3#1)
particles generated from##2##3##(2008-10#1)(2008-8#1)
particles generated##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
particles had##2##2##(1992-6#1)(2008-10#1)
particles have been##3##3##(2008-3#1)(2009-8#2)
particles have##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#2)
particles in a##5##3##(2007-11#1)(2007-12#1)(2008-3#2)(2008-8#1)
particles in flow##2##3##(2008-2#1)(2008-7#1)
particles in the##24##3##(1991-12#1)(1997-2#2)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#1)(2013-8#1)
particles in water and##2##4##(2008-3#2)
particles in water##5##3##(2008-2#1)(2008-3#4)
particles in##61##2##(1991-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-6#1)(2007-11#4)(2007-12#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
particles injected##2##2##(1991-12#1)(2008-11#1)
particles inside##2##2##(2007-11#1)(2008-3#1)
particles is##14##2##(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-4#1)
particles less than##2##3##(2008-10#1)(2008-3#1)
particles located in the##2##4##(2008-10#1)(2008-2#1)
particles may be##2##3##(1997-2#1)(2008-7#1)
particles may##5##2##(1995-2#1)(1997-2#2)(2008-3#1)(2008-7#1)
particles much##2##2##(2008-2#1)(2008-3#1)
particles obtained by bulk polymerization##2##5##(2008-10#2)
particles of approximately##2##3##(2008-10#2)
particles of known size and##2##5##(2008-2#1)(2008-3#1)
particles of the##4##3##(1996-3#1)(2008-10#2)(2008-5#1)
particles of##37##2##(1991-12#1)(1994-3#2)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#2)(2008-10#16)(2008-2#2)(2008-3#3)(2008-5#3)(2009-6#1)(2011-2#1)
particles on surfaces##3##3##(2007-11#3)
particles on the##6##3##(1990-12#1)(2008-10#2)(2008-3#2)(2009-7#1)
particles on##10##2##(1990-12#1)(2007-11#3)(2008-10#2)(2008-3#3)(2009-7#1)
particles or holes##2##3##(2008-7#2)
particles or##8##2##(2008-2#3)(2008-3#1)(2008-7#2)(2009-3#1)(2009-7#1)
particles per##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
particles produced##3##2##(1997-4#1)(2007-9#1)(2013-8#1)
particles required##2##2##(2008-12#1)(2008-4#1)
particles show##2##2##(2008-3#1)(2009-5#1)
particles showed##3##2##(1994-8#1)(2008-3#1)(2008-8#1)
particles smaller than##2##3##(2007-12#1)(2008-10#1)
particles such as##2##3##(2008-5#1)(2008-9#1)
particles such##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
particles than##2##2##(1995-3#1)(2008-8#1)
particles that are##5##3##(1990-6#1)(2008-2#1)(2008-3#3)
particles that exhibit##2##3##(2008-10#1)(2008-2#1)
particles that##17##2##(1990-6#1)(1993-12#1)(1993-8#1)(1994-12#2)(1997-3#1)(2008-10#3)(2008-2#3)(2008-3#4)(2010-4#1)
particles the##3##2##(2008-2#1)(2008-3#2)
particles through the##2##3##(1997-1#1)(2008-7#1)
particles through##3##2##(1997-1#1)(2008-7#1)(2009-5#1)
particles to the##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
particles to##9##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)
particles used##2##2##(2008-3#1)(2008-9#1)
particles using##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
particles was found to##2##4##(1994-6#1)(2008-4#1)
particles was significantly##3##3##(2008-5#3)
particles was##14##2##(1990-12#1)(1994-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-9#1)(2009-7#1)
particles were characterized##2##3##(2008-10#1)(2013-1#1)
particles were deposited##2##3##(1992-12#1)(1997-1#1)
particles were observed in##3##4##(1997-8#1)(2008-10#2)
particles were observed##5##3##(1995-3#1)(1997-8#1)(2008-10#3)
particles were##42##2##(1990-12#2)(1992-12#2)(1994-10#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-8#1)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-4#1)(2013-1#2)
particles which were##2##3##(2008-10#1)(2008-11#1)
particles which##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
particles while##2##2##(1996-3#1)(2008-10#1)
particles whose##4##2##(1995-6#1)(2007-11#1)(2008-10#1)(2009-7#1)
particles with a##6##3##(2007-11#1)(2008-3#4)(2008-5#1)
particles with an##2##3##(1996-2#1)(2008-10#1)
particles with different aspect ratios##2##5##(2007-11#1)(2008-2#1)
particles with large complex refractive indices##3##6##(2008-3#3)
particles with large##4##3##(2008-2#1)(2008-3#3)
particles with the##3##3##(2008-10#2)(2008-6#1)
particles with##46##2##(1990-12#1)(1990-5#1)(1992-6#1)(1995-5#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#22)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-3#1)
particles within the sampling volume##2##5##(2008-3#2)
particles within the##3##3##(2008-10#1)(2008-3#2)
particles within##6##2##(2008-10#2)(2008-3#3)(2009-7#1)
particles##828##1##(1990-12#13)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#2)(1991-12#6)(1991-2#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#5)(1992-6#5)(1992-8#1)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#4)(1994-6#2)(1994-7#1)(1994-8#7)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#10)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#12)(1996-2#4)(1996-3#4)(1997-1#6)(1997-2#9)(1997-3#10)(1997-4#8)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#27)(2007-12#12)(2007-9#3)(2008-1#3)(2008-10#175)(2008-11#32)(2008-12#8)(2008-2#66)(2008-3#152)(2008-4#10)(2008-5#29)(2008-6#10)(2008-7#21)(2008-8#14)(2008-9#12)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#12)(2009-8#4)(2009-9#1)(2010-2#2)(2010-4#7)(2010-6#3)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#8)(2013-8#6)
particles'##4##1##(2007-11#2)(2008-3#1)(2009-9#1)
particles) and##2##2##(2008-11#1)(2012-12#1)
particles)##6##1##(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#2)(2012-12#1)
particular a##2##2##(1991-1#1)(1994-2#1)
particular advantage##2##2##(2008-10#1)(2012-1#1)
particular advantages##2##2##(2008-3#1)(2008-4#1)
particular agent##2##2##(2009-8#1)(2010-5#1)
particular alignment##2##2##(2007-12#1)(2008-2#1)
particular amino##2##2##(1990-7#1)(2010-4#1)
particular and##4##2##(1990-4#1)(2008-10#1)(2008-8#1)(2010-4#1)
particular application##3##2##(2008-3#3)
particular aspects##2##2##(1991-5#1)(2012-3#1)
particular assay##2##2##(2008-10#1)(2012-3#1)
particular attention in##2##3##(1993-5#1)(2011-2#1)
particular attention is##2##3##(2008-6#1)(2011-3#1)
particular attention to the##5##4##(1990-9#1)(1994-1#1)(2008-4#1)(2008-6#1)(2011-2#1)
particular attention to##13##3##(1990-9#1)(1993-12#1)(1994-1#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
particular attention##24##2##(1990-9#1)(1993-12#1)(1993-5#1)(1994-1#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#1)
particular behaviour##2##2##(2008-10#1)(2011-2#1)
particular benefit##2##2##(2007-11#1)(2008-11#1)
particular biological##3##2##(1996-2#1)(2008-4#1)(2011-3#1)
particular by##5##2##(1992-5#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
particular case of##5##3##(2007-12#1)(2008-2#3)(2012-12#1)
particular case##9##2##(1991-2#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2011-2#1)(2012-12#1)
particular cases##3##2##(2008-10#2)(2008-2#1)
particular cell##7##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#2)
particular challenges in##2##3##(2010-4#1)(2011-2#1)
particular challenges##4##2##(1992-3#1)(2008-11#1)(2010-4#1)(2011-2#1)
particular characteristics##4##2##(1995-12#1)(2008-4#1)(2008-5#1)(2010-2#1)
particular chemical##4##2##(2008-12#1)(2008-4#1)(2008-9#2)
particular class of##2##3##(2007-11#1)(2008-1#1)
particular classes of##2##3##(2010-2#1)(2013-8#1)
particular clinical##3##2##(2007-11#1)(2008-6#1)(2011-2#1)
particular components##2##2##(2007-11#1)(2009-10#1)
particular concern##11##2##(1991-3#1)(1991-4#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
particular conditions of##2##3##(2008-4#1)(2010-7#1)
particular conditions##5##2##(1992-12#2)(2008-4#1)(2010-7#1)(2013-8#1)
particular data##2##2##(2008-10#1)(2010-3#1)
particular definition##2##2##(2008-3#1)(2012-2#1)
particular difficulties##2##2##(1991-3#1)(1995-3#1)
particular domains##2##2##(2012-3#2)
particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels##2##30##(2008-4#2)
particular emphasis is placed on##2##5##(2008-10#1)(2008-4#1)
particular emphasis on the##14##4##(1992-12#1)(1994-9#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2010-9#1)(2012-12#2)
particular emphasis on##24##3##(1992-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2009-8#2)(2010-9#1)(2011-2#1)(2012-12#2)
particular emphasis placed on##2##4##(2008-10#1)(2012-2#1)
particular emphasis to the##2##4##(2011-2#1)(2013-1#1)
particular emphasis##32##2##(1992-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#2)(2009-8#2)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
particular environmental##2##2##(2008-8#2)
particular experimental##2##2##(2008-10#1)(2008-4#1)
particular features##4##2##(1994-11#1)(2008-5#1)(2010-6#1)(2012-1#1)
particular focus on##9##3##(1993-12#1)(1996-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
particular focus##11##2##(1993-12#1)(1996-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
particular food##2##2##(1994-3#1)(2010-1#1)
particular for##11##2##(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2012-2#1)(2013-8#1)
particular form of##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
particular forms of##2##3##(2008-10#1)(2012-2#1)
particular forms##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
particular function##3##2##(2008-11#1)(2008-2#1)(2009-9#1)
particular gene##4##2##(1997-6#1)(2008-4#2)(2009-4#1)
particular genetic##2##2##(2008-4#1)(2008-9#1)
particular group of##4##3##(1990-8#1)(1996-2#1)(2008-11#1)(2008-12#1)
particular groups##2##2##(2007-12#1)(2008-5#1)
particular importance##12##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-9#1)(1997-7#1)(2007-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
particular in##15##2##(1990-11#1)(1991-11#1)(1994-11#1)(1994-3#1)(1995-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
particular interest in##2##3##(2008-9#1)(2012-1#1)
particular interest is##7##3##(1991-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
particular interest to##6##3##(1993-12#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)
particular interest##42##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
particular isolate##2##2##(2008-10#2)
particular it##3##2##(1990-9#1)(1993-1#1)(2008-2#1)
particular method##3##2##(1991-9#1)(2012-2#2)
particular patient##6##2##(1992-8#2)(2006-10#1)(2009-10#1)(2010-6#1)(2011-1#1)
particular physiological##2##2##(2008-4#1)(2008-7#1)
particular plant##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
particular problem##2##2##(2008-10#1)(2008-8#1)
particular problems##2##2##(1994-3#1)(2007-11#1)
particular properties of##2##3##(1995-5#1)(2008-4#1)
particular properties##4##2##(1995-5#1)(2008-4#1)(2008-5#1)(2009-8#1)
particular protein##5##2##(1993-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
particular reference##13##2##(1990-5#1)(1992-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2012-12#1)
particular relevance for##3##3##(2007-12#1)(2012-2#1)(2012-3#1)
particular relevance##8##2##(1994-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
particular risk##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
particular role##2##2##(1994-3#1)(2007-12#1)
particular social##2##2##(2008-12#1)(2009-7#1)
particular soil##2##2##(1990-9#1)(2008-10#1)
particular species##4##2##(2008-12#2)(2008-4#1)(2010-12#1)
particular stage was##2##3##(2008-10#1)(2008-8#1)
particular stage##3##2##(1994-9#1)(2008-10#1)(2008-8#1)
particular system##2##2##(2008-10#1)(2008-3#1)
particular the##28##2##(1991-6#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-6#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
particular they##2##2##(2008-5#1)(2008-7#1)
particular those##7##2##(1994-9#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)
particular time##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
particular to the##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
particular to##6##2##(1993-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-8#1)
particular type of##10##3##(1990-11#1)(1991-8#1)(1993-6#1)(1994-12#1)(1997-4#1)(2008-2#1)(2008-3#2)(2009-1#1)(2012-3#1)
particular types of##3##3##(2008-1#1)(2008-5#2)
particular way##2##2##(2010-2#1)(2012-2#1)
particular we##2##2##(2008-3#1)(2011-1#1)
particular##1152##1##(1990-11#11)(1990-12#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#8)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#5)(1992-5#3)(1992-6#3)(1992-8#7)(1992-9#2)(1993-1#4)(1993-11#6)(1993-12#9)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#5)(1994-3#9)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#6)(1995-5#8)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#8)(1996-2#5)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#7)(1997-8#5)(2006-10#2)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#25)(2007-12#25)(2007-2#6)(2007-4#2)(2007-6#2)(2007-7#6)(2007-8#12)(2008-1#19)(2008-10#108)(2008-11#50)(2008-12#13)(2008-2#45)(2008-3#64)(2008-4#46)(2008-5#30)(2008-6#11)(2008-7#48)(2008-8#39)(2008-9#30)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#9)(2009-8#10)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#13)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#4)(2010-7#6)(2010-8#4)(2010-9#4)(2011-1#13)(2011-2#42)(2011-3#2)(2012-1#10)(2012-12#24)(2012-2#29)(2012-3#20)(2012-5#1)(2012-7#2)(2013-1#23)(2013-7#1)(2013-8#19)
particularities of the##2##3##(2007-10#1)(2009-4#1)
particularities of##5##2##(2007-10#1)(2007-8#1)(2008-8#1)(2009-4#1)(2013-1#1)
particularities##9##1##(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#2)(2013-1#1)(2013-7#1)
particularly a##3##2##(1997-7#1)(2007-10#1)(2008-7#1)
particularly abdominal##2##2##(1997-8#1)(2009-7#1)
particularly abundant in##2##3##(1995-6#1)(2008-10#1)
particularly abundant##3##2##(1995-6#1)(2007-12#1)(2008-10#1)
particularly acute##3##2##(1991-12#1)(2008-2#1)(2008-4#1)
particularly after##5##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
particularly aggressive##2##2##(1991-4#1)(2010-10#1)
particularly all##2##2##(2007-12#1)(2007-8#1)
particularly amino acids##2##3##(2008-11#1)(2013-8#1)
particularly among males##2##3##(1990-6#1)(1994-6#1)
particularly among older adults##2##4##(2013-1#2)
particularly among patients##2##3##(2007-10#1)(2012-3#1)
particularly among##13##2##(1990-6#1)(1994-6#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#2)
particularly apparent in##2##3##(2008-1#1)(2008-10#1)
particularly applicable##4##2##(1992-6#1)(2008-11#1)(2008-3#1)(2008-8#1)
particularly appropriate##2##2##(2008-7#1)(2009-5#1)
particularly as a##2##3##(2008-10#1)(2012-3#1)
particularly as the##2##3##(1991-1#1)(2008-3#1)
particularly as##12##2##(1990-2#1)(1991-1#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-6#1)(2012-12#1)(2012-3#1)
particularly at high##3##3##(1993-11#1)(1993-3#1)(2008-7#1)
particularly at the##6##3##(1997-3#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-10#1)(2013-8#1)
particularly at##21##2##(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-8#1)
particularly attractive for##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2010-7#1)
particularly attractive##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#1)
particularly because##4##2##(1992-11#1)(2007-10#1)(2008-8#1)(2013-1#1)
particularly beneficial##2##2##(1992-9#1)(2009-1#1)
particularly between##3##2##(2008-5#1)(2009-7#1)(2011-2#1)
particularly by the##3##3##(1991-8#1)(2008-11#1)(2008-5#1)
particularly by##6##2##(1991-8#1)(1992-5#1)(1993-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
particularly challenging##6##2##(2007-11#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
particularly common##2##2##(1995-6#1)(2008-9#1)
particularly complex##2##2##(2008-4#1)(2008-7#1)
particularly critical##3##2##(1992-6#1)(2008-2#1)(2008-8#1)
particularly depression##2##2##(2008-11#1)(2008-3#1)
particularly different##2##2##(1997-7#1)(2008-9#1)
particularly difficult and##2##3##(1990-12#1)(2008-4#1)
particularly difficult to##2##3##(1997-6#1)(2010-4#1)
particularly difficult##7##2##(1990-12#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-4#1)
particularly due to##2##3##(1990-2#1)(2008-11#1)
particularly during##3##2##(2008-12#1)(2008-9#1)(2012-12#1)
particularly effective in##5##3##(2007-10#1)(2007-8#1)(2009-9#1)(2010-10#1)(2013-1#1)
particularly effective##7##2##(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-10#1)(2013-1#1)
particularly efficient##4##2##(2008-1#1)(2008-2#1)(2008-4#1)(2013-8#1)
particularly focused on the##2##4##(2008-10#1)(2012-2#1)
particularly for the##6##3##(2008-10#2)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
particularly for##38##2##(1991-12#1)(1993-5#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
particularly from the electronic databases Cumulative Index to Nursing and Allied Health Literature##2##13##(2013-1#2)
particularly from the##3##3##(2008-9#1)(2013-1#2)
particularly from##6##2##(1994-12#1)(2008-5#2)(2008-9#1)(2013-1#2)
particularly given the##2##3##(2007-2#1)(2009-10#1)
particularly helpful##4##2##(2008-1#1)(2008-6#1)(2012-3#1)(2013-1#1)
particularly high in##2##3##(2008-7#1)(2012-2#1)
particularly high levels##2##3##(1995-12#1)(2011-1#1)
particularly high##12##2##(1990-5#1)(1990-6#1)(1993-2#1)(1994-8#1)(1995-12#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
particularly hydrogen##3##2##(2008-10#2)(2008-2#1)
particularly if a##2##3##(1990-5#1)(2008-6#1)
particularly if the##3##3##(1997-3#1)(2008-11#1)(2012-3#1)
particularly if##13##2##(1990-5#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
particularly important and##2##3##(1992-4#1)(2012-2#1)
particularly important for##7##3##(1997-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#2)(2012-2#1)
particularly important in the##3##4##(1992-11#1)(2008-12#1)(2008-7#1)
particularly important in##8##3##(1992-11#1)(1992-5#1)(1993-12#1)(1996-8#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)
particularly important when##2##3##(1996-3#1)(2008-3#1)
particularly important##30##2##(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
particularly in Asian countries over the past decades##2##8##(2013-1#2)
particularly in Asian countries##4##4##(2013-1#4)
particularly in a##3##3##(1991-3#1)(1997-3#1)(2008-10#1)
particularly in an##2##3##(2007-10#1)(2009-6#1)
particularly in areas##3##3##(2007-6#1)(2008-10#1)(2008-9#1)
particularly in children##2##3##(1991-4#1)(2012-12#1)
particularly in patients with##6##4##(1992-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-3#1)
particularly in patients##9##3##(1992-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#2)
particularly in regard to##2##4##(1997-6#1)(2008-4#1)
particularly in relation to##4##4##(1993-3#1)(2009-1#1)(2009-9#1)(2011-2#1)
particularly in respect of##2##4##(2008-10#1)(2013-8#1)
particularly in the cases##2##4##(2008-10#1)(2011-1#1)
particularly in the developing countries##2##5##(2007-7#2)
particularly in the developing##3##4##(2007-7#2)(2008-10#1)
particularly in the elderly##2##4##(1992-8#1)(2008-8#1)
particularly in the field of##3##5##(2008-10#1)(2008-5#1)(2012-12#1)
particularly in the presence of##3##5##(1995-3#1)(2008-4#1)(2012-2#1)
particularly in the##52##3##(1990-12#2)(1990-6#2)(1991-4#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-6#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
particularly in those##3##3##(2007-2#1)(2008-7#1)(2013-1#1)
particularly in women##2##3##(1997-1#1)(2012-2#1)
particularly in young patients##2##4##(2008-8#1)(2011-1#1)
particularly in##160##2##(1990-12#3)(1990-6#2)(1990-9#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-3#3)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#3)
particularly interesting##8##2##(1990-5#1)(1991-6#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
particularly its##2##2##(2008-2#1)(2008-5#1)
particularly large##2##2##(1990-11#1)(1993-12#1)
particularly myocardial infarction##2##3##(1990-2#1)(2009-5#1)
particularly of##2##2##(2007-8#1)(2008-10#1)
particularly older women##2##3##(2013-1#2)
particularly on its##2##3##(2008-11#2)
particularly on the##8##3##(1992-12#1)(1992-2#1)(2008-3#2)(2008-5#1)(2011-2#2)(2012-3#1)
particularly on##15##2##(1992-12#1)(1992-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-3#1)
particularly pertinent##2##2##(1992-1#1)(2012-3#1)
particularly powerful##3##2##(2008-2#1)(2008-4#2)
particularly promising for##3##3##(2009-1#1)(2012-2#1)(2012-6#1)
particularly prone to##3##3##(2008-5#1)(2012-12#1)(2012-3#1)
particularly rare##2##2##(2012-1#1)(2013-1#1)
particularly regarding##3##2##(1991-3#1)(2007-12#1)(2008-5#1)
particularly relevant##3##2##(2008-12#1)(2008-5#1)(2012-12#1)
particularly sensitive to##6##3##(1995-12#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-4#1)
particularly sensitive##8##2##(1993-5#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-4#1)
particularly significant##3##2##(1995-2#1)(1997-7#1)(2013-7#1)
particularly since##4##2##(2008-5#3)(2008-9#1)
particularly small##3##2##(1991-12#1)(2009-10#1)(2012-2#1)
particularly striking##3##2##(2007-12#2)(2013-8#1)
particularly suitable for##7##3##(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-2#1)
particularly suited for##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2012-1#1)
particularly suited to##4##3##(1991-5#1)(1997-3#1)(2007-11#1)(2008-9#1)
particularly suited##9##2##(1991-5#1)(1991-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-1#1)
particularly susceptible to##3##3##(1993-12#1)(2009-8#1)(2010-3#1)
particularly the case for##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
particularly the case##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
particularly the##44##2##(1990-6#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
particularly those in##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
particularly those of the##2##4##(1991-4#1)(2009-5#1)
particularly those of##3##3##(1991-4#1)(2009-12#1)(2009-5#1)
particularly those that##4##3##(1994-7#1)(1996-12#1)(2008-11#1)(2009-3#1)
particularly those which are##2##4##(2008-10#1)(2010-12#1)
particularly those with##2##3##(2007-12#1)(2008-4#1)
particularly those##21##2##(1990-8#1)(1991-4#1)(1994-7#1)(1995-3#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
particularly through##2##2##(2008-10#1)(2013-1#1)
particularly to##9##2##(1993-8#1)(1997-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2010-9#1)
particularly true in the##3##4##(1992-1#1)(1994-12#1)(2013-1#1)
particularly true in##4##3##(1992-1#1)(1994-12#1)(2012-3#1)(2013-1#1)
particularly true##6##2##(1992-1#1)(1994-12#1)(2008-10#2)(2012-3#1)(2013-1#1)
particularly useful as##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
particularly useful for detecting##2##4##(2008-12#1)(2009-7#1)
particularly useful for the##2##4##(1996-12#1)(2008-10#1)
particularly useful for##21##3##(1990-11#1)(1991-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)
particularly useful in the##2##4##(2008-3#1)(2008-8#1)
particularly useful in##13##3##(1992-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#1)
particularly useful to##6##3##(1993-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
particularly useful when there is a##3##6##(2008-10#1)(2008-4#2)
particularly useful when##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
particularly useful##53##2##(1990-11#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#9)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
particularly valuable##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
particularly vulnerable to##3##3##(1991-1#1)(1995-12#1)(2007-12#1)
particularly vulnerable##5##2##(1991-1#1)(1995-12#1)(2007-12#1)(2011-2#1)(2013-1#1)
particularly well suited for##3##4##(1997-6#1)(2008-3#1)(2008-4#1)
particularly well suited to##4##4##(1991-5#2)(2008-3#1)(2013-1#1)
particularly well suited##7##3##(1991-5#2)(1997-6#1)(2008-3#2)(2008-4#1)(2013-1#1)
particularly well##10##2##(1991-5#2)(1997-6#1)(2008-10#2)(2008-3#2)(2008-4#1)(2012-3#1)(2013-1#1)
particularly when it is##2##4##(2011-1#1)(2011-2#1)
particularly when it##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
particularly when the##5##3##(1996-8#1)(2008-10#2)(2008-3#1)(2011-1#1)
particularly when they are##2##4##(1996-2#1)(2013-1#1)
particularly when##32##2##(1992-12#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#3)(2011-10#1)(2011-2#2)(2012-8#1)(2013-1#5)
particularly where the##2##3##(2008-10#1)(2012-1#1)
particularly where##4##2##(2008-10#1)(2009-6#1)(2010-5#1)(2012-1#1)
particularly with bisphosphonates##2##3##(2010-3#2)
particularly with regard to the##2##5##(2007-11#1)(2011-2#1)
particularly with regard to##6##4##(1991-1#1)(1995-1#1)(2007-11#1)(2008-10#2)(2011-2#1)
particularly with respect to the##2##5##(2007-12#1)(2008-10#1)
particularly with respect to##10##4##(1992-9#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)
particularly with the##2##3##(1994-12#1)(2009-11#1)
particularly with##30##2##(1991-1#1)(1992-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)
particularly within##3##2##(1995-12#1)(2009-4#1)(2013-1#1)
particularly worrisome##2##2##(2008-2#1)(2008-8#1)
particularly##949##1##(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#5)(1990-8#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#5)(1991-4#4)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#9)(1993-2#1)(1993-3#9)(1993-5#2)(1993-6#2)(1993-8#2)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#3)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#6)(1997-2#3)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#4)(2006-10#1)(2006-6#1)(2007-10#7)(2007-11#9)(2007-12#19)(2007-2#6)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#14)(2008-10#100)(2008-11#42)(2008-12#15)(2008-2#21)(2008-3#31)(2008-4#38)(2008-5#33)(2008-6#6)(2008-7#27)(2008-8#27)(2008-9#28)(2009-1#3)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#5)(2009-7#6)(2009-8#5)(2009-9#8)(2010-10#6)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#7)(2010-4#9)(2010-5#3)(2010-6#3)(2010-7#3)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#36)(2011-3#1)(2012-1#3)(2012-12#15)(2012-2#31)(2012-3#25)(2012-6#1)(2012-8#1)(2013-1#43)(2013-7#2)(2013-8#15)
particulars##3##1##(1991-2#1)(1993-3#1)(2011-1#1)
particulary those##3##2##(2007-11#2)(2008-7#1)
particulary##4##1##(2007-11#3)(2008-7#1)
particulate and dissolved##2##3##(2008-2#1)(2008-3#1)
particulate and##4##2##(1996-12#1)(1997-2#1)(2008-2#1)(2008-3#1)
particulate by##2##2##(2008-11#1)(2012-2#1)
particulate evidence##3##2##(2012-2#3)
particulate fraction##9##2##(1990-11#1)(1992-11#3)(1992-8#2)(1994-8#1)(1997-1#1)(1997-6#1)
particulate fractions##6##2##(1991-2#1)(1996-5#3)(1997-4#1)(2008-10#1)
particulate inoculum##2##2##(2008-10#2)
particulate matter (PM)##3##3##(2008-10#1)(2008-6#1)(2009-7#1)
particulate matter and the##2##4##(2008-3#1)(2013-8#1)
particulate matter and##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
particulate matter collected##4##3##(2008-10#4)
particulate matter in##3##3##(2008-10#2)(2008-3#1)
particulate matter is##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
particulate matter of emissions and working areas##3##7##(2008-10#3)
particulate matter of emissions and##4##5##(2008-10#4)
particulate matter of##5##3##(2008-10#5)
particulate matter was##2##3##(2008-10#2)
particulate matter##55##2##(2007-12#2)(2008-10#40)(2008-11#2)(2008-3#5)(2008-6#2)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
particulate organic##2##2##(2008-10#1)(2008-5#1)
particulate samples##4##2##(2008-10#1)(2008-3#1)(2008-9#2)
particulate##132##1##(1990-11#1)(1991-12#1)(1991-2#1)(1992-11#4)(1992-6#1)(1992-8#2)(1994-8#2)(1995-3#2)(1995-5#2)(1996-12#2)(1996-5#4)(1997-1#3)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2007-12#2)(2008-10#53)(2008-11#3)(2008-2#8)(2008-3#16)(2008-5#1)(2008-6#3)(2008-9#3)(2009-5#3)(2009-7#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#1)
particulate-phase mercury##3##2##(2008-10#3)
particulates and##5##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
particulates##20##1##(1993-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
parties in the##2##3##(1996-12#1)(2011-2#1)
parties in##3##2##(1994-5#1)(1996-12#1)(2011-2#1)
parties involved in the##2##4##(1994-12#1)(2007-11#1)
parties involved in##3##3##(1994-12#1)(2007-11#1)(2012-12#1)
parties involved##4##2##(1994-12#1)(2007-11#1)(2009-11#1)(2012-12#1)
parties##36##1##(1990-2#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-12#2)(1997-7#1)(2007-11#1)(2007-4#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)
parties'##2##1##(2007-4#1)(2008-8#1)
partir##5##1##(2008-5#4)(2013-1#1)
partisan##2##1##(2008-6#1)(2008-7#1)
partition behavior##2##2##(2008-10#2)
partition chromatography and##2##3##(1994-12#1)(2008-10#1)
partition chromatography##5##2##(1994-12#4)(2008-10#1)
partition coefficient (K)##2##3##(2008-6#2)
partition coefficient (log P)##3##4##(1996-2#1)(2007-11#1)(2008-5#1)
partition coefficient of##6##3##(1990-5#2)(2008-10#2)(2008-5#1)(2012-1#1)
partition coefficient##20##2##(1990-5#2)(1990-9#1)(1993-1#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-5#4)(2008-6#3)(2011-2#1)(2012-1#1)
partition coefficients for##4##3##(2008-10#2)(2010-8#2)
partition coefficients of the##2##4##(1990-5#1)(2008-10#1)
partition coefficients of##9##3##(1990-5#2)(2008-10#4)(2008-5#1)(2008-7#2)
partition coefficients##22##2##(1990-5#2)(1990-8#1)(1991-5#1)(2008-10#12)(2008-5#1)(2008-7#3)(2010-8#2)
partition function##4##2##(1990-8#1)(2009-11#1)(2009-9#2)
partition functions##3##2##(1990-8#2)(2008-3#1)
partition is##2##2##(2007-11#1)(2012-3#1)
partition of the##2##3##(1990-11#1)(1994-12#1)
partition of##6##2##(1990-11#1)(1994-12#2)(1997-7#1)(2008-11#1)(2010-5#1)
partition ratio##2##2##(1993-8#1)(2009-9#1)
partition the##3##2##(1991-7#1)(1992-6#1)(2008-8#1)
partition##100##1##(1990-11#2)(1990-5#4)(1990-8#4)(1990-9#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-12#6)(1995-12#4)(1995-8#1)(1996-2#1)(1997-7#1)(2007-11#5)(2008-10#30)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#3)(2008-8#2)(2009-11#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-3#2)
partitioned in##2##2##(2008-7#1)(2011-2#1)
partitioned into##4##2##(1994-5#1)(2007-11#1)(2008-2#1)(2008-8#1)
partitioned##19##1##(1991-5#1)(1994-5#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#1)
partitioning analysis##5##2##(1991-12#4)(2008-3#1)
partitioning as##2##2##(2008-10#2)
partitioning between the##2##3##(1994-5#1)(1997-2#1)
partitioning between##10##2##(1991-3#2)(1992-6#1)(1993-8#2)(1994-5#1)(1997-2#1)(2008-10#2)(2008-8#1)
partitioning effects##2##2##(1990-5#1)(2008-11#1)
partitioning in##3##2##(2008-10#1)(2010-8#1)(2012-9#1)
partitioning model##2##2##(2013-1#2)
partitioning of failure time##2##4##(1997-3#2)
partitioning of the##8##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)
partitioning of##27##2##(1991-3#1)(1993-9#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
partitioning the##2##2##(2008-5#1)(2009-9#1)
partitioning##89##1##(1990-5#4)(1991-12#5)(1991-3#3)(1992-11#1)(1992-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#2)(2009-8#1)(2009-9#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
partitions##8##1##(1997-7#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#2)(2009-9#1)(2012-3#1)
partitus##4##1##(2007-5#4)
partly abolished##2##2##(1995-8#1)(2011-1#1)
partly as##5##2##(1990-6#1)(1992-4#2)(1995-11#1)(2008-7#1)
partly because of the##4##4##(1992-2#2)(2008-7#1)(2010-12#1)
partly because of##7##3##(1992-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#2)
partly because##12##2##(1992-2#2)(1992-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-2#1)
partly by the##3##3##(1990-2#1)(2008-7#1)(2012-12#1)
partly by##11##2##(1990-2#1)(1991-3#1)(1991-9#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
partly dependent on the##3##4##(1992-3#1)(2008-10#1)(2013-8#1)
partly dependent on##7##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-5#1)(2013-8#1)
partly due to a##2##4##(2009-5#1)(2013-8#1)
partly due to the##6##4##(1991-11#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
partly due to##19##3##(1991-11#1)(1991-12#1)(1992-12#1)(1997-7#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
partly explain the##5##3##(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-2#1)
partly explain##7##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-2#1)
partly explained by##4##3##(2008-11#1)(2010-12#1)(2012-1#1)(2012-3#1)
partly mediated by##2##3##(1996-2#1)(2013-8#1)
partly on##2##2##(1993-2#1)(1994-2#1)
partly preventable##2##2##(2008-7#2)
partly related to##2##3##(2008-1#1)(2008-10#1)
partly through##2##2##(2008-11#1)(2013-7#1)
partly to the##2##3##(2008-10#1)(2010-8#1)
partly to##4##2##(1997-7#1)(2007-12#1)(2008-10#1)(2010-8#1)
partly##156##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-7#6)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#10)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#4)
partner and##6##2##(1994-5#1)(1995-6#1)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
partner benefits##2##2##(1997-3#1)(2008-12#1)
partner during##2##2##(2007-8#1)(2012-3#1)
partner for the##2##3##(1995-12#1)(2013-1#1)
partner in##4##2##(1991-11#1)(1993-2#1)(2008-1#1)(2009-4#1)
partner is##4##2##(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
partner of##2##2##(1990-6#1)(1994-5#1)
partner or##2##2##(2007-12#1)(2011-1#1)
partner selection in##2##3##(1990-11#1)(2009-5#1)
partner selection##6##2##(1990-11#1)(2009-5#4)(2013-8#1)
partner to##4##2##(1991-12#1)(2009-5#2)(2012-12#1)
partner violence and##2##3##(2008-12#1)(2008-6#1)
partner violence##14##2##(2008-12#3)(2008-6#1)(2009-5#2)(2010-11#2)(2010-3#1)(2012-12#4)(2013-1#1)
partner was##3##2##(2009-4#2)(2010-5#1)
partner with##5##2##(1995-3#1)(2010-10#1)(2012-12#1)(2012-2#2)
partner##121##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-5#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#10)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#6)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#9)(2012-3#3)(2013-1#3)(2013-8#2)
partner's support##2##2##(1995-1#2)
partner's##9##1##(1995-1#2)(1995-12#1)(2008-12#1)(2008-3#1)(2008-8#2)(2012-3#1)(2013-8#1)
partner(s)##4##1##(1990-6#1)(1996-2#2)(2013-1#1)
partner)##2##1##(2008-12#2)
partnered gay men##2##3##(2010-8#2)
partnered men##2##2##(2010-8#2)
partnered research##2##2##(2012-2#2)
partnered with##2##2##(2008-11#1)(2012-3#1)
partnered##10##1##(2008-11#1)(2010-8#4)(2012-2#4)(2012-3#1)
partnering with##2##2##(2010-11#1)(2012-2#1)
partnering##6##1##(1994-12#1)(2008-11#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
partners about##2##2##(2008-7#1)(2009-6#1)
partners and##14##2##(1995-12#1)(1995-2#1)(1997-3#3)(2010-10#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#3)
partners are##4##2##(2008-9#2)(2011-1#1)(2012-3#1)
partners as##2##2##(1993-6#1)(2010-5#1)
partners at##3##2##(2009-5#1)(2009-7#1)(2013-1#1)
partners can##2##2##(2008-11#1)(2012-3#1)
partners from##3##2##(2008-12#2)(2010-7#1)
partners has##2##2##(2008-8#1)(2013-1#1)
partners in care##2##3##(1992-3#1)(2008-11#1)
partners in health care##2##4##(1991-3#1)(1992-12#1)
partners in the##9##3##(1991-3#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-1#1)(2013-1#2)
partners in##26##2##(1991-3#2)(1992-12#1)(1992-3#2)(1993-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)
partners is##2##2##(2007-12#1)(2011-1#1)
partners of##6##2##(1991-2#2)(2008-12#1)(2008-6#1)(2009-9#1)(2012-2#1)
partners or##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
partners reported by##2##3##(1993-9#2)
partners reported##3##2##(1993-9#2)(2008-12#1)
partners should be##2##3##(1995-12#1)(2008-7#1)
partners to##5##2##(1996-1#1)(2008-9#1)(2012-12#1)(2013-1#2)
partners was##4##2##(1995-2#2)(2008-12#1)(2011-2#1)
partners were##5##2##(2008-6#1)(2009-5#1)(2010-4#1)(2010-5#1)(2013-1#1)
partners who##4##2##(1994-2#1)(2008-12#1)(2009-5#1)(2010-2#1)
partners with##4##2##(1997-3#1)(2008-6#1)(2009-7#1)(2012-3#1)
partners##189##1##(1990-11#2)(1990-5#2)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#2)(1993-3#1)(1993-6#1)(1993-9#3)(1994-2#1)(1994-5#2)(1995-12#5)(1995-2#6)(1995-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-5#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#10)(2008-4#4)(2008-5#1)(2008-6#7)(2008-7#4)(2008-8#7)(2008-9#5)(2009-4#3)(2009-5#10)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#5)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#3)(2010-5#5)(2010-7#1)(2011-1#11)(2011-2#15)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#14)(2013-8#1)
partners' positive feedback##2##3##(2009-9#2)
partners'##6##1##(2009-5#1)(2009-9#3)(2012-3#2)
partners)##3##1##(1991-6#1)(2011-2#2)
partnership and##3##2##(1994-1#1)(1996-12#1)(2008-11#1)
partnership between the##5##3##(1992-12#1)(1995-3#1)(1996-3#1)(2007-10#1)(2010-5#1)
partnership between##10##2##(1992-12#1)(1994-1#1)(1995-3#1)(1996-3#2)(1997-2#1)(2007-10#1)(2010-3#1)(2010-5#1)(2012-3#1)
partnership factors##3##2##(2009-5#3)
partnership for##4##2##(1995-3#1)(2008-12#1)(2008-2#1)(2012-2#1)
partnership has##3##2##(1992-1#1)(2008-11#1)(2009-11#1)
partnership in##3##2##(1992-1#1)(2008-11#2)
partnership model for##2##3##(2008-12#2)
partnership model##4##2##(2008-1#1)(2008-12#3)
partnership models##3##2##(1994-1#1)(2008-11#2)
partnership of##2##2##(1994-12#1)(2010-4#1)
partnership that has##2##3##(1996-12#1)(2008-11#1)
partnership that##3##2##(1996-12#1)(2008-11#1)(2010-10#1)
partnership with the##6##3##(1997-3#1)(2008-1#1)(2008-11#2)(2008-12#2)
partnership with##15##2##(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2011-2#1)(2012-12#1)
partnership##88##1##(1991-3#1)(1992-1#7)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#4)(1994-12#3)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#2)(2007-10#1)(2008-1#4)(2008-10#1)(2008-11#15)(2008-12#8)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#4)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
partnerships and##5##2##(2008-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
partnerships are##3##2##(2008-3#1)(2009-11#1)(2012-2#1)
partnerships for##3##2##(1996-12#1)(1996-3#1)(1997-1#1)
partnerships in##2##2##(2011-2#1)(2012-2#1)
partnerships to##2##2##(2007-2#1)(2008-8#1)
partnerships with##5##2##(1996-12#2)(1997-2#1)(1997-3#2)
partnerships##52##1##(1992-11#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)
parts and in##2##3##(2008-10#1)(2008-12#1)
parts and##10##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-2#1)
parts are##3##2##(2007-12#1)(2008-11#1)(2010-4#1)
parts for##2##2##(2008-3#1)(2008-9#1)
parts have##2##2##(2008-3#1)(2008-9#1)
parts in 10(12) (ppt)##2##4##(2007-12#1)(2008-3#1)
parts in 10(6) by volume##3##5##(2007-12#2)(2008-2#1)
parts in 10(6) for##4##4##(2008-2#2)(2008-3#2)
parts in 10(6)##12##3##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#5)
parts in 10(9) (ppb)##2##4##(2008-2#1)(2008-3#1)
parts in 10(9) by volume##2##5##(2007-12#2)
parts in 10(9) by##3##4##(2007-12#2)(2008-3#1)
parts in 10(9)##8##3##(2007-12#2)(2008-2#1)(2008-3#5)
parts in##32##2##(2007-11#2)(2007-12#8)(2008-2#6)(2008-3#14)(2008-7#1)(2012-2#1)
parts is##3##2##(1994-8#1)(2008-2#1)(2008-3#1)
parts of Brazil##2##3##(2008-9#2)
parts of Canada##2##3##(2007-12#1)(2008-10#1)
parts of China and##2##4##(2010-3#1)(2011-1#1)
parts of China##4##3##(2010-3#1)(2011-1#3)
parts of Europe##3##3##(2007-2#1)(2008-10#1)(2013-8#1)
parts of a##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
parts of all##2##3##(1991-2#1)(1992-8#1)
parts of epididymis##2##3##(2008-12#2)
parts of the body##3##4##(1997-8#1)(2007-7#2)
parts of the brain##2##4##(2008-7#1)(2009-10#1)
parts of the country##2##4##(1993-12#1)(2011-1#1)
parts of the environment##2##4##(2008-9#1)(2010-5#1)
parts of the gastrointestinal tract##2##5##(2008-7#1)(2012-1#1)
parts of the molecule##3##4##(1990-2#1)(1994-3#1)(2008-10#1)
parts of the object##2##4##(2008-3#1)(2012-2#1)
parts of the plant##5##4##(2007-11#1)(2008-10#4)
parts of the world (e##2##5##(1997-4#1)(2011-2#1)
parts of the world##20##4##(1990-2#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
parts of the##146##3##(1990-12#1)(1990-2#3)(1990-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#1)(1996-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#17)(2008-11#13)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-10#2)(2009-2#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
parts of their##2##3##(2008-7#1)(2008-9#1)
parts of this##3##3##(1995-11#1)(2007-12#1)(2008-10#1)
parts of##219##2##(1990-12#1)(1990-2#4)(1990-6#1)(1991-12#1)(1991-2#1)(1992-8#3)(1992-9#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1996-1#2)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-8#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#15)(2008-12#8)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#12)(2009-10#2)(2009-2#1)(2009-4#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-8#2)(2011-1#9)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#3)
parts per billion (ppb)##2##4##(2008-2#1)(2008-3#1)
parts per billion in##2##4##(2008-2#1)(2008-3#1)
parts per billion##6##3##(2008-2#2)(2008-3#4)
parts per million (ppm)##2##4##(2008-3#2)
parts per million##9##3##(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)
parts per trillion##3##3##(2008-10#3)
parts per##20##2##(2008-10#4)(2008-2#4)(2008-3#11)(2008-7#1)
parts that##2##2##(2007-11#1)(2008-12#1)
parts to##2##2##(2007-12#1)(2010-9#1)
parts were##2##2##(2008-12#1)(2011-2#1)
parts with##2##2##(2008-10#1)(2012-2#1)
parts##390##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-6#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#4)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#1)(2006-6#1)(2007-1#1)(2007-11#8)(2007-12#22)(2007-2#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#50)(2008-11#23)(2008-12#15)(2008-2#23)(2008-3#45)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#15)(2009-10#3)(2009-2#1)(2009-4#4)(2009-7#1)(2009-9#3)(2010-11#2)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#14)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#3)
parts-per-billion level##2##2##(2008-10#2)
parts-per-billions##2##1##(2008-10#2)
parts-per-million##2##1##(2008-10#1)(2012-2#1)
partum##13##1##(1990-3#1)(1990-6#2)(1993-10#1)(1994-7#1)(2007-7#1)(2008-11#2)(2011-2#3)(2013-1#1)(2013-8#1)
parturient##5##1##(1993-10#3)(2009-10#1)(2012-3#1)
parturients##2##1##(2011-1#1)(2011-2#1)
parturition and##2##2##(2008-4#1)(2012-2#1)
parturition##12##1##(1992-5#1)(1993-10#1)(1994-3#1)(1994-9#1)(1996-11#1)(2008-10#1)(2008-4#1)(2010-2#3)(2012-2#1)(2013-8#1)
party is##2##2##(2008-8#1)(2010-6#1)
party payers##3##2##(1992-1#1)(1992-9#1)(1996-12#1)
party to##3##2##(1992-2#2)(2008-8#1)
party##29##1##(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-9#1)(1995-2#1)(1996-12#2)(1996-2#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#3)(2009-5#3)(2010-6#1)(2011-2#1)(2012-12#1)
parva##6##1##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)
parva)##3##1##(2007-12#1)(2008-7#2)
parviflora##4##1##(2008-10#1)(2008-11#3)
parvocellular##5##1##(1993-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)
parvovirus B19 infection##3##3##(1996-3#1)(2011-2#1)(2013-1#1)
parvovirus B19##6##2##(1994-8#1)(1996-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
parvovirus##13##1##(1991-6#2)(1994-8#1)(1996-3#1)(1997-4#1)(2011-2#1)(2012-3#3)(2013-1#4)
parvum plus C##3##3##(2013-1#3)
parvum plus##4##2##(2013-1#4)
parvum##17##1##(1996-12#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#10)
parvus##3##1##(2008-6#3)
pas##4##1##(2008-11#1)(2011-2#1)(2013-1#2)
pass a##2##2##(1994-8#1)(2008-3#1)
pass into the##2##3##(2008-10#1)(2008-5#1)
pass of the##2##3##(2008-2#1)(2008-7#1)
pass of##6##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-7#1)
pass on##2##2##(1991-11#1)(2008-7#1)
pass rates##2##2##(2012-3#2)
pass the##4##2##(1991-1#1)(1995-3#1)(2008-2#1)(2008-9#1)
pass through a##5##3##(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
pass through an##2##3##(2007-11#1)(2008-10#1)
pass through the disk to drain##2##6##(2008-10#2)
pass through the##12##3##(2007-5#1)(2008-10#3)(2008-3#3)(2008-7#2)(2008-9#1)(2010-10#1)(2010-8#1)
pass through##26##2##(1990-5#1)(1992-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
pass##64##1##(1990-5#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#4)(2010-10#1)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
passage 2##2##2##(2008-9#2)
passage and##4##2##(1995-6#1)(2008-12#1)(2013-1#2)
passage cells##3##2##(2008-11#2)(2008-5#1)
passage during##2##2##(1990-5#1)(1991-9#1)
passage in the##2##3##(1992-11#1)(2008-9#1)
passage in##5##2##(1992-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
passage into the##2##3##(1996-9#1)(2008-4#1)
passage of a guidewire##2##4##(2010-12#2)
passage of a##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2010-12#2)(2012-2#1)
passage of aqueous samples through##2##5##(2008-10#2)
passage of aqueous##3##3##(2008-10#3)
passage of cells##2##3##(1995-2#1)(2008-9#1)
passage of the Medicare##2##4##(1991-3#1)(1996-3#1)
passage of the##10##3##(1991-3#1)(1992-8#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#1)
passage of##45##2##(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-2#2)
passage rate of feed through##2##5##(2008-10#2)
passage through the##8##3##(1993-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#2)
passage through##14##2##(1993-9#1)(1995-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-2#2)(2011-1#1)
passage##127##1##(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-4#2)(1992-8#1)(1992-9#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#4)(2008-9#7)(2009-12#1)(2009-2#4)(2009-7#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#4)(2011-3#8)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
passaged##7##1##(1991-2#1)(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#2)
passages and##6##2##(1991-3#1)(1994-12#1)(2008-11#2)(2008-9#1)(2011-1#1)
passages in##10##2##(1992-2#1)(1992-9#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2012-12#1)(2013-1#1)
passages of##3##2##(1994-8#2)(2008-10#1)
passages##49##1##(1990-5#1)(1991-3#1)(1992-2#2)(1992-9#1)(1994-12#1)(1994-8#2)(1994-9#1)(2007-11#1)(2007-6#4)(2008-10#6)(2008-11#11)(2008-12#3)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#2)(2012-12#2)(2013-1#4)(2013-8#1)
passages)##2##1##(2008-11#1)(2009-12#1)
passaging suspension cultures##2##3##(2008-4#1)(2008-9#1)
passaging##7##1##(1993-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
passband##13##1##(2007-11#7)(2008-2#4)(2008-3#2)
passbands##4##1##(2008-2#1)(2008-3#3)
passed a##5##2##(1992-3#1)(2008-5#2)(2008-8#1)(2010-10#1)
passed and##2##2##(1991-1#1)(2008-9#1)
passed away##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
passed by the##3##3##(1990-9#1)(1997-2#1)(2008-10#1)
passed by##4##2##(1990-9#1)(1997-2#1)(2008-10#1)(2008-8#1)
passed from the##2##3##(2008-10#1)(2008-7#1)
passed from##3##2##(2008-10#2)(2008-7#1)
passed in##2##2##(1997-3#1)(2008-10#1)
passed over a##2##3##(1990-5#1)(2008-2#1)
passed over##3##2##(1990-5#1)(2008-10#1)(2008-2#1)
passed the##5##2##(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
passed through a 0##2##4##(2008-10#1)(2008-5#1)
passed through a##17##3##(1991-2#1)(1992-12#1)(1996-8#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-5#2)(2011-1#1)
passed through an##2##3##(2008-10#2)
passed through the flow##2##4##(2008-10#2)
passed through the##24##3##(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-3#2)(2013-1#1)
passed through##48##2##(1991-2#1)(1992-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-10#28)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#2)(2011-1#1)(2013-1#1)
passed to##6##2##(1993-1#1)(1993-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
passed two##2##2##(2007-8#1)(2008-11#1)
passed##111##1##(1990-5#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#43)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2010-10#1)(2011-1#2)(2013-1#2)(2013-8#1)
passenger instability were##2##3##(2013-1#2)
passenger ships##2##2##(2011-2#2)
passenger##23##1##(1991-10#1)(1992-6#2)(1995-12#1)(1996-12#3)(2007-2#6)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#2)(2013-1#5)
passengers##13##1##(1996-12#2)(2007-2#5)(2008-6#1)(2009-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
passerines##3##1##(2008-9#3)
passerinii in##2##2##(2008-10#2)
passerinii##5##1##(2008-10#5)
passes a##2##2##(2008-11#1)(2008-3#1)
passes through a##6##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
passes through an##2##3##(2008-10#2)
passes through the test section##2##5##(2008-3#2)
passes through the##11##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)
passes through##22##2##(2007-11#4)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#4)(2008-7#1)(2009-2#1)
passes##38##1##(1994-8#1)(1996-5#1)(2007-11#5)(2007-12#2)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#8)(2008-7#2)(2009-2#1)(2010-8#1)
passiflora isolates##2##2##(2008-10#2)
passiflora##9##1##(2008-10#9)
passing a##3##2##(2007-12#1)(2008-10#1)(2013-7#1)
passing on##2##2##(1992-3#1)(1996-8#1)
passing the##3##2##(2008-10#2)(2009-9#1)
passing through a##3##3##(2007-11#1)(2008-10#2)
passing through the##13##3##(1992-11#1)(2007-12#1)(2008-10#6)(2008-3#4)(2008-9#1)
passing through##21##2##(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)
passing##55##1##(1992-11#1)(1992-3#1)(1993-9#1)(1996-12#1)(1996-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-7#1)
passion##3##1##(1994-2#1)(2008-12#1)(2010-8#1)
passivating layer##2##2##(2008-10#2)
passivating##3##1##(2008-10#2)(2009-6#1)
passivation##6##1##(2008-10#2)(2010-2#1)(2010-4#3)
passive IR##2##2##(2008-2#2)
passive Q switch##3##3##(2007-11#1)(2008-3#2)
passive Q switching of a 1##2##6##(2008-3#2)
passive Q switching of a##4##5##(2007-11#1)(2008-3#3)
passive Q switching##6##3##(2007-11#2)(2008-3#4)
passive Q##10##2##(2007-11#3)(2008-3#7)
passive Q-switching##2##2##(2008-2#1)(2008-3#1)
passive and active##7##3##(2007-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
passive and##8##2##(2007-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
passive avoidance task##3##3##(1991-2#1)(1993-12#1)(2008-6#1)
passive avoidance##6##2##(1991-2#1)(1992-6#1)(1993-12#2)(2008-6#2)
passive creep-induced stretching##2##3##(2009-7#2)
passive cutaneous anaphylaxis##3##3##(1995-11#1)(2008-10#2)
passive diffusion and##2##3##(2010-12#1)(2011-2#1)
passive diffusion##5##2##(1995-11#1)(2010-11#1)(2010-12#1)(2011-2#2)
passive exposure to tobacco smoke##2##5##(1991-4#1)(1994-2#1)
passive exposure to##3##3##(1991-4#1)(1994-2#1)(2013-1#1)
passive heterodyne##2##2##(2008-2#1)(2008-3#1)
passive immunization##4##2##(1996-3#1)(1997-6#1)(2009-6#1)(2012-2#1)
passive immunotherapy##2##2##(1994-2#1)(2012-2#1)
passive knee##2##2##(2007-11#1)(2013-1#1)
passive membrane##2##2##(1991-5#1)(2011-2#1)
passive mode locking of a diode-pumped##2##6##(2007-11#1)(2008-2#1)
passive mode locking##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
passive mode-locking##2##2##(2007-11#2)
passive neutral##3##2##(2008-10#3)
passive optical##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
passive permeability##3##2##(1990-2#1)(1992-6#1)(1993-3#1)
passive quadrature##3##2##(2007-12#1)(2008-2#2)
passive range of##2##3##(1992-9#1)(2007-11#1)
passive remote-sensing##2##2##(2008-3#2)
passive rewarming##2##2##(2011-2#2)
passive sampler##10##2##(2008-10#9)(2008-11#1)
passive samplers##2##2##(2008-10#1)(2008-11#1)
passive sampling##3##2##(2008-10#3)
passive smoking##4##2##(1990-6#1)(1997-5#1)(2010-12#1)(2012-2#1)
passive stability##2##2##(2007-11#1)(2007-8#1)
passive surveillance##2##2##(1995-3#1)(1997-3#1)
passive to##2##2##(2008-11#1)(2010-12#1)
passive transfer of##2##3##(1992-12#1)(1996-11#1)
passive viewing##2##2##(1994-3#1)(2012-3#1)
passive##218##1##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-12#3)(1993-3#3)(1994-2#2)(1994-3#1)(1995-11#3)(1995-3#1)(1995-5#5)(1995-8#2)(1996-11#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#20)(2007-12#11)(2007-6#1)(2007-8#5)(2008-10#28)(2008-11#4)(2008-12#3)(2008-2#17)(2008-3#34)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#4)
passively Q -switched##6##3##(2007-11#5)(2007-12#1)
passively Q switched with a##2##5##(2007-12#1)(2008-3#1)
passively Q switched##3##3##(2007-12#1)(2008-3#2)
passively Q##9##2##(2007-11#5)(2007-12#2)(2008-3#2)
passively Q-switched Nd##2##3##(2007-12#1)(2008-2#1)
passively Q-switched Yb##2##3##(2007-11#1)(2008-3#1)
passively Q-switched laser##2##3##(2008-3#2)
passively Q-switched operation##2##3##(2008-2#1)(2008-3#1)
passively Q-switched##18##2##(2007-11#6)(2007-12#2)(2008-2#2)(2008-3#8)
passively mode locked##3##3##(2007-12#3)
passively mode-locked Nd##4##3##(2007-11#4)
passively mode-locked Yb##2##3##(2007-11#1)(2007-12#1)
passively mode-locked thin-disk Yb##3##4##(2007-11#3)
passively mode-locked##16##2##(2007-11#13)(2007-12#2)(2008-3#1)
passively quenched##2##2##(2007-12#1)(2008-3#1)
passively##59##1##(1993-1#1)(2007-11#25)(2007-12#10)(2008-10#2)(2008-2#2)(2008-3#16)(2008-8#1)(2010-2#1)(2012-3#1)
past 10 years##19##3##(1992-3#1)(1993-8#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#2)(2012-3#1)(2013-7#1)(2013-8#1)
past 25 years##6##3##(1997-1#1)(1997-2#1)(1997-8#1)(2008-2#1)(2008-7#1)(2012-2#1)
past 5 years##5##3##(1995-3#1)(2008-10#1)(2010-4#1)(2012-1#1)(2012-3#1)
past 5##6##2##(1995-3#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-3#1)
past 6 years##2##3##(1991-3#1)(2013-1#1)
past 6##3##2##(1991-3#2)(2013-1#1)
past achievements##2##2##(2012-3#2)
past and current##4##3##(1996-3#1)(2008-11#1)(2008-4#1)(2011-2#1)
past and future##2##3##(1996-2#1)(2008-1#1)
past and present##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
past and##17##2##(1991-3#3)(1994-6#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)
past decade has##9##3##(1993-1#1)(1993-12#1)(1994-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
past decade##83##2##(1991-12#1)(1991-2#1)(1991-3#2)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
past decades##13##2##(1993-5#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#2)
past editions##2##2##(2008-10#2)
past events##3##2##(1991-3#1)(2008-9#1)(2013-8#1)
past evidence##2##2##(1994-1#1)(2012-3#1)
past experience##4##2##(1991-5#1)(2008-11#1)(2009-12#1)(2011-2#1)
past few decades##9##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
past few years##34##3##(1992-9#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
past few##43##2##(1992-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
past have been##2##3##(1994-12#1)(2013-1#1)
past history of##7##3##(1990-3#1)(1992-2#1)(2006-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
past history##12##2##(1990-3#1)(1992-2#1)(1992-7#2)(1993-6#1)(1996-12#1)(1997-4#1)(2006-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
past in the##2##3##(2008-10#1)(2008-5#1)
past in##4##2##(2008-10#2)(2008-5#1)(2009-10#1)
past medical history and##2##4##(2008-7#1)(2010-10#1)
past medical history##7##3##(2007-12#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
past month use##5##3##(2010-9#5)
past month##7##2##(2010-9#6)(2013-1#1)
past or##2##2##(2012-3#1)(2013-8#1)
past research and##2##3##(1996-2#1)(2007-6#1)
past research##5##2##(1996-2#1)(2007-6#1)(2008-11#1)(2012-2#1)(2013-1#1)
past seven years##2##3##(1997-2#1)(2013-1#1)
past several decades##5##3##(1992-12#1)(2009-7#1)(2011-2#2)(2012-2#1)
past several years##17##3##(1991-1#1)(1992-2#1)(1992-3#2)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-2#1)
past several##22##2##(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-2#1)
past studies##5##2##(1994-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
past tense and##2##3##(2012-1#2)
past tense##4##2##(2012-1#4)
past the##6##2##(1997-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)
past to##3##2##(1994-3#1)(2008-3#1)(2011-2#1)
past year##10##2##(1994-3#1)(1996-2#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-12#1)(2009-7#1)(2009-9#1)(2012-1#1)
past years##11##2##(1990-9#1)(1991-3#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-5#1)(2011-2#1)
past##646##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#2)(1991-3#12)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#5)(1992-5#2)(1992-7#3)(1992-8#3)(1992-9#3)(1993-1#2)(1993-12#7)(1993-3#6)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#9)(1994-5#1)(1994-6#1)(1995-1#4)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#6)(1996-3#4)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#7)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#5)(2006-12#1)(2007-11#4)(2007-12#10)(2007-2#4)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#13)(2008-10#64)(2008-11#37)(2008-12#10)(2008-2#6)(2008-3#15)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#21)(2008-8#20)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#12)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#8)(2010-4#2)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#10)(2010-9#6)(2011-1#8)(2011-2#39)(2012-1#10)(2012-12#13)(2012-2#14)(2012-3#12)(2012-5#1)(2012-7#3)(2012-9#4)(2013-1#20)(2013-7#2)(2013-8#12)
past-temporal##3##1##(2009-5#3)
past]##2##1##(1993-3#1)(1997-5#1)
pasta and##2##2##(2008-10#2)
pasta##3##1##(2008-10#3)
paste based electrodes##2##3##(2008-10#2)
paste based##3##2##(2008-10#3)
paste electrode are##2##3##(2008-10#2)
paste electrode##91##2##(2008-10#90)(2008-6#1)
paste electrodes##15##2##(2008-10#15)
paste extracts##3##2##(2008-10#3)
paste##147##1##(2008-10#142)(2008-6#1)(2010-4#3)(2013-1#1)
pastes##3##1##(2008-10#3)
pasteurellosis##2##1##(1990-3#1)(2008-5#1)
pasteurised##2##1##(2008-10#1)(2010-3#1)
pasteurization##6##1##(1996-12#1)(2008-10#4)(2012-2#1)
pasteurized milk##4##2##(2008-10#1)(2008-12#3)
pasteurized soil##2##2##(2008-10#2)
pasteurized##9##1##(2008-10#5)(2008-12#4)
pastor##3##1##(1993-12#1)(2008-1#1)(2012-3#1)
pastoral care##6##2##(1992-1#2)(1993-12#1)(1993-2#1)(1996-1#1)(2008-12#1)
pastoral systems##2##2##(2011-2#2)
pastoral##17##1##(1991-2#1)(1992-1#3)(1993-12#2)(1993-2#1)(1996-1#1)(2008-12#1)(2010-1#2)(2010-9#2)(2011-2#4)
pastoris and##2##2##(2008-11#1)(2008-4#1)
pastoris showed##2##2##(2008-4#1)(2013-1#1)
pastoris with##2##2##(2008-4#2)
pastoris##32##1##(1994-11#2)(1994-3#2)(1997-4#6)(1997-7#2)(2008-11#1)(2008-4#6)(2008-7#4)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#2)(2013-1#3)
pasture feeding##2##2##(2010-2#1)(2010-4#1)
pasture##31##1##(1994-1#1)(1996-12#4)(2008-10#5)(2008-5#6)(2010-2#7)(2010-4#5)(2013-1#2)(2013-7#1)
pastures and##3##2##(2008-5#1)(2013-7#2)
pastures of##2##2##(2008-5#2)
pastures##15##1##(2008-10#1)(2008-5#5)(2010-2#2)(2011-1#1)(2012-12#1)(2012-7#2)(2013-7#3)
patch and the##4##3##(2008-8#3)(2011-3#1)
patch and##7##2##(2007-8#1)(2008-3#1)(2008-8#3)(2011-2#1)(2011-3#1)
patch area##4##2##(2008-8#4)
patch at##3##2##(1993-11#1)(2007-8#1)(2009-5#1)
patch clamp and##2##3##(2008-8#1)(2009-12#1)
patch clamp recordings##2##3##(2008-1#1)(2008-8#1)
patch clamp technique##5##3##(1993-12#2)(1993-3#1)(1994-11#1)(2008-8#1)
patch clamp##13##2##(1990-7#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-8#1)(1996-5#1)(2008-1#1)(2008-8#3)(2009-12#1)(2011-2#1)
patch closure##3##2##(2007-8#1)(2008-11#1)(2012-1#1)
patch configurations##2##2##(1994-12#1)(2008-8#1)
patch containing tamarind fruit extract##2##5##(2008-5#2)
patch density##3##2##(2008-8#3)
patch diameter and pseudothecia development##2##5##(2008-10#2)
patch diameter##3##2##(2008-10#3)
patch extinction rate##2##3##(2008-8#2)
patch extinction##3##2##(2008-8#3)
patch for##3##2##(2007-8#1)(2008-5#2)
patch in##3##2##(1991-11#1)(1993-10#1)(2011-3#1)
patch isolation##2##2##(2008-8#2)
patch network##3##2##(2008-8#3)
patch networks##2##2##(2008-8#2)
patch occupancy##15##2##(2008-8#11)(2008-9#4)
patch of##6##2##(1992-10#1)(1995-2#1)(2008-5#2)(2010-12#1)(2010-6#1)
patch on##3##2##(1990-3#1)(2011-2#1)(2012-3#1)
patch pipette was##2##3##(1993-12#1)(1995-12#1)
patch pipette##3##2##(1993-12#1)(1995-12#1)(2009-12#1)
patch reefs##2##2##(2007-5#1)(2008-5#1)
patch size##7##2##(1996-4#1)(2008-8#4)(2008-9#2)
patch test##8##2##(2008-5#5)(2009-6#2)(2012-3#1)
patch using##2##2##(2007-8#1)(2008-5#1)
patch was##2##2##(2007-8#1)(2008-5#1)
patch##179##1##(1990-3#2)(1990-7#1)(1991-11#1)(1992-10#1)(1993-10#3)(1993-11#2)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(2007-5#1)(2007-7#1)(2007-8#13)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-3#5)(2008-5#19)(2008-6#1)(2008-8#48)(2008-9#14)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-6#2)(2011-2#5)(2011-3#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
patch&quot##2##1##(2009-10#1)(2009-11#1)
patch-clamp recording##4##2##(1995-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
patch-clamp technique##7##2##(1992-11#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(2012-2#1)
patch-clamp##18##1##(1992-11#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-11#1)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#1)
patched##4##1##(1997-3#1)(2008-3#1)(2008-5#2)
patches and##5##2##(2008-10#1)(2008-9#2)(2012-1#1)(2013-1#1)
patches are##6##2##(1992-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2012-2#1)
patches as well as##2##4##(2008-8#2)
patches as##4##2##(2008-8#3)(2008-9#1)
patches at##2##2##(2008-5#2)
patches for##2##2##(2008-6#1)(2008-8#1)
patches have##3##2##(2008-11#2)(2008-9#1)
patches in the##2##3##(1997-1#1)(2012-3#1)
patches in##5##2##(1997-1#1)(2008-5#2)(2008-8#1)(2012-3#1)
patches is##3##2##(2008-6#1)(2008-8#1)(2008-9#1)
patches of##17##2##(1992-10#1)(1992-12#1)(1994-10#1)(1995-12#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)
patches on the##4##3##(1996-12#1)(2008-7#1)(2010-6#1)(2012-3#1)
patches on##6##2##(1996-12#2)(2008-7#1)(2008-9#1)(2010-6#1)(2012-3#1)
patches or##2##2##(2010-4#1)(2010-6#1)
patches that##4##2##(2007-10#1)(2008-8#3)
patches to##3##2##(2008-5#1)(2008-9#2)
patches were##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
patches with##7##2##(2008-5#3)(2008-8#2)(2008-9#2)
patches##157##1##(1990-11#1)(1991-2#1)(1992-10#2)(1992-12#4)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#4)(1996-4#3)(1997-1#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#14)(2008-6#5)(2008-7#6)(2008-8#42)(2008-9#33)(2010-4#1)(2010-6#3)(2010-8#1)(2012-1#2)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#1)
patching is##2##2##(1993-10#1)(2012-12#1)
patching##7##1##(1993-10#4)(2008-3#1)(2008-5#1)(2012-12#1)
patchwork##6##1##(1995-6#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
patchy infiltrations##2##2##(2008-1#2)
patchy landscapes##2##2##(2008-8#2)
patchy##17##1##(1991-11#1)(1994-12#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-8#5)(2008-9#2)(2010-12#1)(2011-2#2)(2012-2#1)
patella component##2##2##(2013-1#2)
patella fractures##2##2##(2009-3#2)
patella##19##1##(2007-11#2)(2007-8#5)(2009-3#3)(2009-4#1)(2012-12#1)(2013-1#7)
patellar tendon rupture##6##3##(2009-4#4)(2012-12#2)
patellar tendon##14##2##(2008-9#4)(2009-3#1)(2009-4#5)(2012-12#2)(2013-1#2)
patellar##24##1##(1995-8#1)(1997-8#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-4#5)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#6)
patellar-pubic percussion test##2##3##(2008-12#2)
patello-femoral##2##1##(2007-8#2)
patellofemoral pain syndrome##6##3##(1996-3#1)(2008-12#4)(2009-7#1)
patellofemoral##12##1##(1996-3#2)(2007-8#2)(2008-12#6)(2009-7#1)(2013-1#1)
patencies##2##1##(2007-8#1)(2011-3#1)
patency and lower##2##3##(2007-10#1)(2007-7#1)
patency and##7##2##(1993-1#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-1#1)
patency in##4##2##(1990-8#1)(2007-7#1)(2007-8#2)
patency of the##6##3##(1990-6#1)(2007-8#3)(2011-2#2)
patency of##8##2##(1990-6#1)(2007-8#3)(2011-2#2)(2011-3#2)
patency rate and##2##3##(1993-1#1)(1996-2#1)
patency rate of natural arteriovenous fistula but not##2##8##(2007-7#2)
patency rate of natural##3##4##(2007-7#3)
patency rate of the##2##4##(2007-7#1)(2007-8#1)
patency rate of##6##3##(2007-7#4)(2007-8#2)
patency rate##15##2##(1993-1#1)(1996-2#1)(2007-10#2)(2007-7#8)(2007-8#3)
patency rates at 12##2##4##(2007-7#2)
patency rates##8##2##(1997-3#1)(2007-7#7)
patency than##3##2##(2007-8#3)
patency was##9##2##(1993-1#1)(2007-8#5)(2008-1#1)(2011-3#1)(2013-1#1)
patency##73##1##(1990-6#1)(1990-8#1)(1991-11#1)(1993-1#3)(1994-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#4)(2007-7#23)(2007-8#21)(2008-1#3)(2008-2#1)(2009-11#1)(2011-2#2)(2011-3#3)(2013-1#2)(2013-8#1)
patent applications##7##2##(2010-12#7)
patent blue V##2##3##(2008-10#2)
patent ductus arteriosus (PDA)##2##4##(2007-7#1)(2007-8#1)
patent ductus arteriosus##9##3##(1997-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2010-10#2)(2012-3#1)
patent foramen ovale (PFO)##5##4##(1996-6#1)(2007-10#1)(2007-12#1)(2008-7#1)(2011-2#1)
patent foramen ovale in##2##4##(2008-7#1)(2012-2#1)
patent foramen ovale thrombus##3##4##(2011-2#3)
patent foramen ovale##16##3##(1996-6#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-7#3)(2009-10#1)(2011-2#5)(2012-2#1)
patent grafts##2##2##(2007-8#1)(2013-1#1)
patent landscape##4##2##(2009-11#4)
patent offices##6##2##(2009-11#1)(2010-12#5)
patent protection##3##2##(2008-7#2)(2011-3#1)
patent publications##2##2##(2010-12#2)
patent##83##1##(1990-3#1)(1991-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#8)(2010-10#2)(2010-12#16)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
patentability requirements##2##2##(2009-11#1)(2011-1#1)
patentability##3##1##(2008-7#1)(2009-11#1)(2011-1#1)
patented##11##1##(1992-8#1)(1993-11#1)(2008-10#1)(2010-7#6)(2011-2#1)(2012-2#1)
patents and##2##2##(2009-11#1)(2010-7#1)
patents are##3##2##(2009-11#1)(2010-7#2)
patents on##3##2##(2010-7#3)
patents to##2##2##(2008-5#1)(2008-8#1)
patents##27##1##(1994-12#1)(1995-11#1)(2008-5#6)(2008-8#1)(2009-11#6)(2009-12#1)(2010-7#9)(2011-1#2)
paternal care is##4##3##(2008-8#3)(2008-9#1)
paternal care##10##2##(2008-8#5)(2008-9#5)
paternal effects##3##2##(2008-9#2)(2011-2#1)
paternal investment by mating with##2##5##(2008-8#2)
paternal investment##7##2##(2008-8#6)(2008-9#1)
paternal serum HBV-DNA##3##3##(2011-1#3)
paternal##49##1##(1990-11#1)(1992-8#1)(1996-12#1)(1997-3#2)(1997-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#12)(2009-11#2)(2010-11#1)(2010-8#2)(2011-1#6)(2011-2#1)(2012-12#1)(2013-1#1)
paternally derived deletions##4##3##(1997-3#4)
paternally silenced dataset##2##3##(2008-7#2)
paternally silenced##5##2##(2008-7#5)
paternally##10##1##(1997-3#4)(2008-7#5)(2010-11#1)
paternity analysis##2##2##(2008-8#1)(2008-9#1)
paternity casework##4##2##(2008-12#4)
paternity in##5##2##(2008-8#2)(2008-9#3)
paternity testing##5##2##(2008-12#4)(2008-5#1)
paternity##31##1##(2007-12#1)(2008-12#14)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#7)
path analysis##4##2##(1990-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
path and##5##2##(1993-12#1)(2008-2#3)(2008-3#1)
path by##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
path delay##2##2##(2008-3#2)
path difference between the##2##4##(2008-3#2)
path difference between##3##3##(2008-2#1)(2008-3#2)
path difference to##2##3##(2008-2#1)(2013-8#1)
path difference##26##2##(2007-12#4)(2008-2#4)(2008-3#12)(2013-8#6)
path enhancement##2##2##(2008-2#2)
path for the##2##3##(1994-2#1)(2008-3#1)
path for##9##2##(1994-2#1)(2007-7#1)(2008-1#1)(2008-3#3)(2008-6#1)(2011-1#1)(2012-12#1)
path from the##3##3##(2008-11#1)(2008-2#1)(2012-12#1)
path from##5##2##(2008-11#1)(2008-2#1)(2009-7#2)(2012-12#1)
path geometry##2##2##(2008-3#1)(2008-7#1)
path in the##2##3##(1990-5#1)(2008-2#1)
path in##5##2##(1990-5#1)(1993-12#1)(2007-11#1)(2008-2#2)
path integrals##2##2##(1994-2#1)(2008-2#1)
path is##3##2##(2007-2#1)(2008-3#2)
path length L##2##3##(2008-3#2)
path length and a##2##4##(2008-10#1)(2008-2#1)
path length and##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
path length during##2##3##(2008-10#1)(2010-2#1)
path length of##4##3##(2008-2#2)(2008-3#2)
path length##44##2##(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#11)(2008-3#18)(2008-4#1)(2008-7#1)(2010-2#1)
path lengths in##2##3##(2008-3#2)
path lengths##14##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#8)
path of a##2##3##(2008-3#2)
path of the scattering medium##2##5##(2008-3#2)
path of the##16##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-6#2)(2010-8#1)(2013-8#1)
path of##24##2##(1993-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#10)(2008-6#2)(2010-8#1)(2013-8#1)
path radiance##4##2##(2008-2#3)(2008-3#1)
path that##5##2##(2008-1#1)(2008-10#1)(2008-3#2)(2012-3#1)
path through##3##2##(2008-10#1)(2008-2#1)(2009-9#1)
path to the##2##3##(1996-3#1)(2010-3#1)
path to##13##2##(1995-11#1)(1996-1#1)(1996-3#1)(2008-3#2)(2008-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)
path was##2##2##(2007-11#1)(2008-3#1)
path##277##1##(1990-12#1)(1990-5#1)(1990-7#1)(1992-2#1)(1993-12#6)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#4)(1996-1#1)(1996-3#1)(2007-11#13)(2007-12#13)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#20)(2008-11#4)(2008-2#44)(2008-3#105)(2008-4#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#4)(2013-8#8)
path-average dispersion##2##2##(2007-12#2)
path-averaged##3##1##(2007-12#2)(2008-2#1)
path-difference-dependent##2##1##(2008-2#2)
path-history##2##1##(2008-3#2)
path-independent##2##1##(2008-3#2)
path-integral##2##1##(2009-9#2)
path-integrated##2##1##(2008-2#2)
path-length differences##2##2##(2007-11#2)
path-length offsets##2##2##(2008-3#2)
path-length parameter##2##2##(2008-2#2)
path-length##21##1##(2007-11#2)(2008-2#7)(2008-3#12)
path-reversed substrate-guided-wave##2##2##(2008-3#2)
pathlength absorbance spectroscopy##2##3##(2008-10#2)
pathlength and##2##2##(2008-10#1)(2010-7#1)
pathlength##18##1##(2008-10#15)(2010-3#1)(2010-7#1)(2011-1#1)
patho##2##1##(1990-12#1)(2008-1#1)
patho-physiological##2##1##(2008-7#1)(2009-10#1)
patho-types##4##1##(2008-10#4)
pathobiology of##2##2##(1991-12#1)(2008-7#1)
pathobiology##5##1##(1991-12#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-1#1)
pathogen Alternaria##2##2##(1992-8#1)(2008-10#1)
pathogen Aphanomyces euteiches##2##3##(2008-10#2)
pathogen Candida albicans##3##3##(1992-8#1)(2008-4#1)(2009-8#1)
pathogen Cercospora sorghi##2##3##(2008-10#2)
pathogen Cercospora##3##2##(2008-10#3)
pathogen Colletotrichum gloeosporioides##2##3##(2008-10#2)
pathogen Colletotrichum##3##2##(2008-10#3)
pathogen DNA##13##2##(2008-10#13)
pathogen Fusarium oxysporum f##4##4##(2008-10#4)
pathogen Fusarium##5##2##(2008-10#4)(2011-10#1)
pathogen Listeria monocytogenes##2##3##(2008-7#1)(2011-2#1)
pathogen Mycosphaerella##2##2##(2008-10#2)
pathogen Phytophthora##5##2##(2008-10#4)(2009-2#1)
pathogen Pseudomonas syringae pv##2##4##(2008-10#2)
pathogen Puccinia##3##2##(2008-10#3)
pathogen Pythium##2##2##(2008-10#2)
pathogen Venturia inaequalis##3##3##(2008-10#3)
pathogen Xanthomonas oryzae pv##2##4##(2008-10#2)
pathogen Xanthomonas##4##2##(2008-10#3)(2010-10#1)
pathogen adaptation##2##2##(2008-10#2)
pathogen also##4##2##(2008-10#4)
pathogen and host DNA##2##4##(2008-10#2)
pathogen and its##2##3##(1995-5#1)(2008-9#1)
pathogen and##28##2##(1995-5#1)(2007-12#1)(2008-10#22)(2008-8#1)(2008-9#2)(2013-1#1)
pathogen are##3##2##(2008-10#1)(2008-9#2)
pathogen as##5##2##(2008-10#4)(2008-3#1)
pathogen associated##3##2##(1995-2#1)(2008-7#1)(2012-2#1)
pathogen at##3##2##(2008-10#3)
pathogen attack and##2##3##(2008-10#2)
pathogen attack##7##2##(2008-10#7)
pathogen based on##2##3##(2008-10#2)
pathogen by##6##2##(2008-10#5)(2009-6#1)
pathogen can be##6##3##(2008-10#6)
pathogen can have##2##3##(2008-10#2)
pathogen can spread##2##3##(2008-10#2)
pathogen can##13##2##(1990-11#1)(2008-10#12)
pathogen causing##5##2##(2008-10#4)(2008-8#1)
pathogen cell##2##2##(2008-10#2)
pathogen control by##2##3##(2008-10#2)
pathogen control##8##2##(2008-10#7)(2012-2#1)
pathogen culture collections##3##3##(2008-10#3)
pathogen defense in the absence of##2##6##(2008-10#2)
pathogen defense##5##2##(2008-10#4)(2012-1#1)
pathogen densities##2##2##(2008-10#2)
pathogen detection##7##2##(2008-10#5)(2011-1#1)(2011-2#1)
pathogen development##4##2##(2008-10#4)
pathogen did not##4##3##(2008-10#4)
pathogen dissemination##2##2##(2008-10#2)
pathogen diversity##2##2##(2008-10#2)
pathogen dose##2##2##(2008-10#2)
pathogen evolution in cultivar mixtures##2##5##(2008-10#2)
pathogen evolution in##3##3##(2008-10#3)
pathogen evolution##6##2##(2008-10#5)(2011-10#1)
pathogen fitness##2##2##(2008-10#1)(2008-9#1)
pathogen for##2##2##(2006-10#1)(2008-10#1)
pathogen free##3##2##(1991-11#2)(2008-10#1)
pathogen from##6##2##(2008-10#6)
pathogen genotype##2##2##(2008-10#2)
pathogen genotypes##6##2##(2008-10#6)
pathogen germination##2##2##(2008-10#2)
pathogen growth##9##2##(2008-10#9)
pathogen had##3##2##(1993-2#1)(2008-10#2)
pathogen has##6##2##(2008-10#5)(2008-9#1)
pathogen hyphae##3##2##(2008-10#3)
pathogen in Canada##2##3##(2007-12#2)
pathogen in a##2##3##(2008-10#2)
pathogen in planta##3##3##(2008-10#3)
pathogen in the##6##3##(2008-10#4)(2008-9#1)(2012-2#1)
pathogen in vitro##2##3##(2008-10#2)
pathogen in##37##2##(2007-12#2)(2007-7#2)(2008-10#28)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
pathogen infection##5##2##(1997-3#1)(2008-10#1)(2008-9#2)(2009-2#1)
pathogen infection-induced##2##2##(2008-8#2)
pathogen ingress##5##2##(2008-10#5)
pathogen inhibitory activity of##2##4##(2008-10#2)
pathogen inhibitory activity##5##3##(2008-10#5)
pathogen inoculation was##2##3##(2008-10#2)
pathogen inoculation##5##2##(2008-10#5)
pathogen inoculum##6##2##(2008-10#6)
pathogen into##5##2##(2008-10#4)(2011-2#1)
pathogen invasion and##2##3##(2008-10#1)(2008-9#1)
pathogen invasion##3##2##(2008-10#2)(2008-9#1)
pathogen is not##2##3##(2008-10#2)
pathogen is##15##2##(2007-7#1)(2008-10#10)(2008-8#1)(2011-2#2)(2012-2#1)
pathogen isolate##2##2##(2008-10#2)
pathogen isolates##4##2##(2008-10#4)
pathogen life cycle component##2##4##(2008-10#2)
pathogen life cycle##4##3##(2008-10#4)
pathogen lineages##2##2##(2008-10#2)
pathogen migration between##2##3##(2008-10#2)
pathogen occurs in##2##3##(1995-5#1)(2008-10#1)
pathogen of a##3##3##(2008-10#3)
pathogen of citrus##2##3##(2008-10#2)
pathogen of wheat##2##3##(2008-10#2)
pathogen of##26##2##(1991-9#1)(2008-10#23)(2008-9#1)(2011-1#1)
pathogen on##9##2##(2008-10#9)
pathogen or##2##2##(2008-10#2)
pathogen penetration##2##2##(2008-10#2)
pathogen population in##2##3##(2008-10#2)
pathogen population size##2##3##(2008-10#2)
pathogen population structure##2##3##(2008-10#2)
pathogen population was##2##3##(2008-10#2)
pathogen population##35##2##(2008-10#34)(2008-8#1)
pathogen populations##17##2##(2008-10#16)(2008-8#1)
pathogen presence##2##2##(2008-10#2)
pathogen race##3##2##(2008-10#2)(2008-8#1)
pathogen races##3##2##(2008-10#3)
pathogen resistance##6##2##(2008-10#5)(2009-8#1)
pathogen responsible for##2##3##(2008-10#1)(2011-2#1)
pathogen species##6##2##(2008-10#6)
pathogen spores##2##2##(2008-10#2)
pathogen sporulation##4##2##(2008-10#4)
pathogen spread##4##2##(2008-10#4)
pathogen strains##6##2##(2008-10#6)
pathogen suppression##5##2##(2008-10#5)
pathogen survival##4##2##(2008-10#4)
pathogen that has been##2##4##(2011-2#1)(2012-3#1)
pathogen that is##3##3##(2008-10#2)(2010-10#1)
pathogen that##11##2##(2008-10#6)(2008-9#1)(2010-10#1)(2011-2#2)(2012-3#1)
pathogen through##3##2##(2008-10#2)(2013-8#1)
pathogen to##9##2##(2008-10#7)(2009-2#1)(2009-8#1)
pathogen variability##2##2##(2008-10#2)
pathogen virulence##5##2##(2008-10#3)(2008-9#2)
pathogen was observed on##2##4##(2008-10#2)
pathogen was visualized##2##3##(2008-10#2)
pathogen was##21##2##(2007-2#1)(2008-10#19)(2012-3#1)
pathogen were##11##2##(2008-10#11)
pathogen with a##2##3##(2008-10#2)
pathogen with##4##2##(2008-10#3)(2012-3#1)
pathogen##895##1##(1990-11#1)(1991-11#2)(1991-8#1)(1991-9#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-5#3)(1995-8#1)(1997-3#1)(2006-10#1)(2007-12#5)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#737)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#12)(2008-9#23)(2009-12#1)(2009-2#5)(2009-5#1)(2009-6#3)(2009-8#8)(2010-10#4)(2010-3#1)(2010-4#1)(2011-1#5)(2011-10#4)(2011-2#21)(2012-1#1)(2012-2#7)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#7)
pathogen's life cycle##2##3##(2008-10#2)
pathogen's life##3##2##(2008-10#3)
pathogen's##11##1##(2008-10#7)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
pathogen)##3##1##(2008-10#3)
pathogen-associated molecular patterns##2##3##(2008-4#1)(2013-1#1)
pathogen-derived resistance##3##2##(2008-10#3)
pathogen-derived##4##1##(1995-5#1)(2008-10#3)
pathogen-free##2##1##(1992-5#1)(2008-10#1)
pathogen-host combinations##2##2##(2008-10#1)(2008-9#1)
pathogen-host##3##1##(2007-7#1)(2008-10#1)(2008-9#1)
pathogen-induced##3##1##(2008-10#2)(2008-9#1)
pathogen-infested##3##1##(2008-10#3)
pathogen-mimicking##2##1##(2012-2#2)
pathogen-specific##2##1##(2008-10#1)(2012-3#1)
pathogeneses##2##1##(2006-12#1)(2010-5#1)
pathogenesis and clinical##2##3##(2008-3#1)(2013-8#1)
pathogenesis and development of##2##4##(2008-9#1)(2011-2#1)
pathogenesis and growth of##2##4##(2008-10#1)(2008-4#1)
pathogenesis and management of##2##4##(2008-7#1)(2009-4#1)
pathogenesis and management##4##3##(2008-1#1)(2008-7#1)(2009-4#1)(2011-2#1)
pathogenesis and treatment of##6##4##(1990-11#1)(2008-1#1)(2008-12#1)(2010-10#1)(2010-6#1)(2011-1#1)
pathogenesis and treatment##8##3##(1990-11#1)(2008-1#1)(2008-12#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
pathogenesis and##42##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-9#1)(1992-9#1)(1993-5#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
pathogenesis are still##2##3##(2010-12#1)(2013-8#1)
pathogenesis are##3##2##(2010-12#1)(2011-2#1)(2013-8#1)
pathogenesis in##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
pathogenesis is still not##2##4##(2006-6#1)(2011-1#1)
pathogenesis is##11##2##(1991-4#1)(1994-2#1)(1994-8#1)(1997-4#1)(2006-6#1)(2008-7#2)(2010-12#2)(2011-1#1)(2013-1#1)
pathogenesis of DR##2##3##(2008-1#2)
pathogenesis of PTDM##2##3##(2008-1#2)
pathogenesis of Parkinson's disease##2##4##(2008-7#2)
pathogenesis of VC##2##3##(2009-1#2)
pathogenesis of atopic##2##3##(1991-2#1)(2008-10#1)
pathogenesis of chronic##2##3##(2008-7#1)(2009-8#1)
pathogenesis of disorders##2##3##(1990-11#1)(1997-2#1)
pathogenesis of heart##2##3##(1996-9#1)(2008-7#1)
pathogenesis of immune-mediated inflammatory diseases##2##5##(2011-2#2)
pathogenesis of inflammatory##2##3##(2013-1#1)(2013-8#1)
pathogenesis of insulin resistance##3##4##(2008-3#1)(2012-2#1)(2013-1#1)
pathogenesis of malignant##3##3##(2011-2#3)
pathogenesis of metabolic syndrome##2##4##(2008-3#1)(2013-1#1)
pathogenesis of renal##2##3##(1997-7#1)(2008-7#1)
pathogenesis of rheumatoid arthritis##3##4##(2006-10#1)(2007-11#1)(2009-1#1)
pathogenesis of several##2##3##(2010-4#1)(2013-8#1)
pathogenesis of the disease##3##4##(1992-6#1)(1997-6#1)(2008-10#1)
pathogenesis of the##14##3##(1990-11#1)(1991-5#1)(1992-6#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-1#1)(2011-1#1)(2012-2#1)
pathogenesis of this disease##3##4##(1997-8#1)(2010-6#1)(2012-1#1)
pathogenesis of this rare##2##4##(2008-8#1)(2013-1#1)
pathogenesis of this##11##3##(1992-2#1)(1993-9#1)(1997-8#1)(2007-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-6#1)(2012-1#1)(2013-1#1)
pathogenesis of vascular##2##3##(1993-2#1)(2009-6#1)
pathogenesis of##258##2##(1990-11#2)(1990-12#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#5)(2006-10#3)(2006-6#1)(2007-10#5)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-1#16)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#20)(2008-8#4)(2008-9#3)(2009-1#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#8)(2013-1#18)(2013-3#1)(2013-7#1)(2013-8#8)
pathogenesis##398##1##(1990-11#3)(1990-12#1)(1990-6#2)(1990-9#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#4)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#5)(2006-10#5)(2006-12#1)(2006-6#2)(2007-10#5)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#21)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#13)(2008-6#1)(2008-7#28)(2008-8#5)(2008-9#9)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#11)(2010-4#2)(2010-5#4)(2010-6#4)(2010-8#3)(2011-1#8)(2011-2#26)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#11)(2013-1#29)(2013-3#1)(2013-7#2)(2013-8#16)
pathogenesis- related##2##2##(2008-10#2)
pathogenesis-related (PR) genes##4##3##(2008-10#4)
pathogenesis-related (PR) proteins##3##3##(1997-6#1)(2008-10#2)
pathogenesis-related (PR)##8##2##(1997-6#1)(2008-10#7)
pathogenesis-related gene##2##2##(2008-10#2)
pathogenesis-related protein##6##2##(2008-10#4)(2009-8#1)(2011-10#1)
pathogenesis-related proteins##4##2##(2008-10#4)
pathogenesis-related##27##1##(1992-8#1)(1997-6#1)(2008-10#21)(2009-8#1)(2011-10#3)
pathogenesis]##2##1##(1991-2#1)(2011-2#1)
pathogenetic experimentation##4##2##(2008-10#4)
pathogenetic factor##3##2##(1990-3#1)(1991-3#1)(1996-8#1)
pathogenetic factors##2##2##(2008-7#1)(2012-1#1)
pathogenetic mechanism##3##2##(1990-6#1)(2006-12#1)(2008-3#1)
pathogenetic mechanisms of##2##3##(2008-8#1)(2011-1#1)
pathogenetic mechanisms##7##2##(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
pathogenetic##33##1##(1990-3#2)(1990-6#1)(1991-3#1)(1995-8#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#1)
pathogenic E##3##2##(1997-6#1)(2008-9#1)(2011-2#1)
pathogenic Escherichia coli##2##3##(1997-6#1)(2011-2#1)
pathogenic Leptospira##4##2##(2008-9#4)
pathogenic Pythium spp##2##3##(2008-10#2)
pathogenic and non-pathogenic##2##3##(2008-7#1)(2008-9#1)
pathogenic and nonpathogenic isolates from##2##5##(2008-10#2)
pathogenic and nonpathogenic lifestyles##2##4##(2008-10#2)
pathogenic and nonpathogenic##5##3##(2008-10#5)
pathogenic and##13##2##(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#2)(2010-5#1)
pathogenic avian influenza##2##3##(2010-4#1)(2011-3#1)
pathogenic bacteria in##5##3##(1997-4#3)(2007-7#1)(2008-10#1)
pathogenic bacteria##22##2##(1990-8#1)(1994-12#1)(1997-4#4)(1997-6#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-5#2)(2009-6#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-8#1)
pathogenic bacterium##2##2##(2008-10#1)(2013-1#1)
pathogenic factors##4##2##(1991-6#1)(2008-1#1)(2008-7#1)(2008-9#1)
pathogenic fitness##5##2##(2008-10#5)
pathogenic for##2##2##(2007-2#1)(2008-5#1)
pathogenic fungi and##2##3##(2008-10#2)
pathogenic fungi##16##2##(2008-10#8)(2008-11#1)(2008-7#3)(2009-2#1)(2009-9#1)(2011-1#1)(2013-1#1)
pathogenic fungus##5##2##(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
pathogenic in##4##2##(1994-3#1)(2008-10#3)
pathogenic isolates from##3##3##(2008-10#3)
pathogenic isolates##7##2##(2008-10#7)
pathogenic mechanism for##2##3##(2008-1#1)(2010-5#1)
pathogenic mechanism of##5##3##(1996-2#1)(1997-3#1)(2008-2#2)(2013-1#1)
pathogenic mechanism##7##2##(1996-2#1)(1997-3#1)(2008-1#1)(2008-2#2)(2010-5#1)(2013-1#1)
pathogenic mechanisms of the##2##4##(2010-6#1)(2012-12#1)
pathogenic mechanisms of##3##3##(2008-4#1)(2010-6#1)(2012-12#1)
pathogenic mechanisms##12##2##(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
pathogenic microorganisms##13##2##(1994-11#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
pathogenic nematodes##2##2##(2008-10#2)
pathogenic on RL and not on MIN##2##7##(2008-10#2)
pathogenic on both##2##3##(2008-10#2)
pathogenic on lettuce##2##3##(2008-10#2)
pathogenic on potato##3##3##(2008-10#3)
pathogenic on the##2##3##(2008-10#2)
pathogenic on##39##2##(2008-10#39)
pathogenic only on##3##3##(2008-10#3)
pathogenic or are##2##3##(2008-10#1)(2011-2#1)
pathogenic organism is##2##3##(2007-7#1)(2010-6#1)
pathogenic organism##3##2##(2007-7#1)(2010-6#1)(2013-1#1)
pathogenic organisms##4##2##(1994-11#1)(2008-4#2)(2011-2#1)
pathogenic populations##2##2##(2008-10#2)
pathogenic potential and##2##3##(2011-1#1)(2011-2#1)
pathogenic potential##6##2##(1996-12#1)(2008-10#3)(2011-1#1)(2011-2#1)
pathogenic races 0##2##3##(2008-10#2)
pathogenic races##3##2##(2008-10#3)
pathogenic role##6##2##(2007-6#1)(2008-1#1)(2008-5#2)(2010-1#1)(2011-1#1)
pathogenic species##6##2##(2008-10#5)(2008-12#1)
pathogenic spectrum of hand##2##4##(2013-8#2)
pathogenic strain of##3##3##(1992-3#1)(2008-10#2)
pathogenic strains##3##2##(2008-10#3)
pathogenic to all##2##3##(2008-10#2)
pathogenic to asparagus##2##3##(2008-10#2)
pathogenic to pear##2##3##(2008-10#2)
pathogenic to pistachio##2##3##(2008-10#2)
pathogenic to strawberry##3##3##(2008-10#3)
pathogenic to##32##2##(2008-10#31)(2010-3#1)
pathogenic variability of##2##3##(2008-10#2)
pathogenic variability##3##2##(2008-10#3)
pathogenic variation##7##2##(2008-10#7)
pathogenic yeasts##2##2##(1994-2#1)(2008-6#1)
pathogenic##337##1##(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#2)(1992-3#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-6#4)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#2)(2008-1#5)(2008-10#178)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#14)(2009-10#2)(2009-2#1)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
pathogenically##2##1##(2008-10#2)
pathogenicity and virulence##2##3##(2008-10#1)(2009-2#1)
pathogenicity and##10##2##(2007-12#1)(2008-10#7)(2009-2#1)(2012-3#1)
pathogenicity as##2##2##(2008-10#2)
pathogenicity assays##5##2##(2008-10#5)
pathogenicity determinant##3##2##(2008-10#3)
pathogenicity factor##4##2##(2008-10#4)
pathogenicity factors##2##2##(2008-10#2)
pathogenicity groups based on##2##4##(2008-10#2)
pathogenicity groups##5##2##(2008-10#5)
pathogenicity in the##2##3##(2008-10#2)
pathogenicity in##7##2##(2008-10#6)(2012-3#1)
pathogenicity index##3##2##(1997-3#2)(2008-5#1)
pathogenicity island##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
pathogenicity of M##2##3##(2007-12#1)(2008-10#1)
pathogenicity of isolates##2##3##(2008-10#2)
pathogenicity of the##6##3##(2008-10#4)(2008-12#1)(2008-5#1)
pathogenicity of##32##2##(2007-12#1)(2008-10#26)(2008-12#1)(2008-5#2)(2008-6#1)(2012-3#1)
pathogenicity on tomato##2##3##(2008-10#2)
pathogenicity on##21##2##(2008-10#21)
pathogenicity test##2##2##(2008-10#2)
pathogenicity tests on##4##3##(2008-10#4)
pathogenicity tests##20##2##(2008-10#18)(2008-12#2)
pathogenicity to muskmelon##2##3##(2008-10#2)
pathogenicity to onion##2##3##(2008-10#2)
pathogenicity to##12##2##(2008-10#12)
pathogenicity toward##2##2##(2008-10#2)
pathogenicity was##6##2##(2008-10#5)(2011-2#1)
pathogenicity##200##1##(1997-3#2)(2007-12#2)(2007-6#2)(2008-10#170)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#5)(2013-8#2)
pathogens affecting##3##2##(2008-10#1)(2008-12#1)(2009-2#1)
pathogens and pests##2##3##(2008-10#2)
pathogens and that##2##3##(2008-10#2)
pathogens and the##3##3##(2008-10#2)(2009-3#1)
pathogens and their##5##3##(1994-3#1)(2006-10#1)(2007-12#1)(2011-2#1)(2013-1#1)
pathogens and to##2##3##(1996-1#1)(2008-10#1)
pathogens and##42##2##(1994-3#1)(1996-1#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-10#21)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
pathogens are##14##2##(1995-2#1)(2008-10#7)(2008-9#2)(2011-2#3)(2013-1#1)
pathogens as##4##2##(1995-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
pathogens at the##2##3##(2008-10#1)(2011-10#1)
pathogens at##3##2##(2008-10#2)(2011-10#1)
pathogens but##3##2##(2008-10#2)(2008-6#1)
pathogens by##16##2##(1990-6#2)(2008-10#8)(2008-4#2)(2008-6#1)(2012-3#1)(2013-1#2)
pathogens can##2##2##(2008-10#2)
pathogens causing##3##2##(2008-10#2)(2009-4#1)
pathogens except##2##2##(2008-10#2)
pathogens for##8##2##(2008-10#4)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
pathogens from the##3##3##(1995-5#1)(2008-10#1)(2010-3#1)
pathogens from##12##2##(1995-5#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
pathogens had##2##2##(2008-10#2)
pathogens has been##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
pathogens have##8##2##(2008-10#4)(2008-9#2)(2010-4#1)(2011-2#1)
pathogens identified##2##2##(1992-6#1)(2008-10#1)
pathogens in a##2##3##(2008-10#2)
pathogens in nature##2##3##(2008-10#1)(2008-8#1)
pathogens in relation to host specialization##2##6##(2008-10#2)
pathogens in the##7##3##(2008-10#7)
pathogens in##34##2##(1996-11#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
pathogens including##2##2##(2011-2#1)(2013-1#1)
pathogens is a##2##3##(2008-10#2)
pathogens is##8##2##(2008-10#5)(2008-4#1)(2009-10#1)(2012-2#1)
pathogens isolated##2##2##(2008-10#1)(2008-7#1)
pathogens may have##2##3##(1996-6#1)(2008-10#1)
pathogens may##4##2##(1996-6#1)(2008-10#2)(2008-9#1)
pathogens of GSM larvae##2##4##(2009-6#2)
pathogens of Greenshell mussel##2##4##(2009-6#2)
pathogens of cereals and grasses##2##5##(2008-10#2)
pathogens of##26##2##(1995-2#1)(1997-6#1)(2008-10#16)(2009-6#4)(2010-10#1)(2010-12#1)(2013-8#2)
pathogens often##2##2##(2008-10#2)
pathogens on##4##2##(2008-10#3)(2011-2#1)
pathogens or##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
pathogens responsible for##3##3##(1994-11#1)(2008-10#1)(2012-2#1)
pathogens standard##4##2##(1992-12#1)(1993-2#1)(1994-3#2)
pathogens such as Clostridium##2##4##(2010-11#1)(2011-2#1)
pathogens such as##9##3##(1992-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
pathogens than##2##2##(2008-10#1)(2009-5#1)
pathogens that cause##3##3##(2008-9#1)(2009-8#1)(2012-3#1)
pathogens that co-occur##2##3##(2008-10#1)(2010-3#1)
pathogens that could##2##3##(2008-10#1)(2011-2#1)
pathogens that##12##2##(1995-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-3#1)
pathogens to##5##2##(2007-12#1)(2008-10#3)(2009-2#1)
pathogens under##3##2##(2008-10#3)
pathogens via##2##2##(2007-12#1)(2008-9#1)
pathogens was tested##2##3##(2008-10#2)
pathogens was##4##2##(2008-10#4)
pathogens were##12##2##(1994-11#1)(2008-10#8)(2008-12#1)(2011-1#1)(2012-2#1)
pathogens which##2##2##(2008-7#2)
pathogens with##6##2##(2008-10#6)
pathogens##568##1##(1990-6#3)(1991-11#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-2#2)(1994-11#3)(1994-3#5)(1994-6#1)(1995-2#4)(1995-5#4)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-3#1)(2007-4#1)(2007-7#5)(2008-10#306)(2008-11#1)(2008-12#7)(2008-3#2)(2008-4#11)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#22)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#13)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#4)(2010-6#4)(2010-8#1)(2011-1#6)(2011-10#3)(2011-2#26)(2012-1#1)(2012-12#2)(2012-2#15)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#6)
pathogens)##3##1##(2008-10#1)(2010-6#1)(2011-2#1)
pathogens]##2##1##(1994-11#1)(2012-3#1)
pathognomonic for##2##2##(2012-3#1)(2013-7#1)
pathognomonic##6##1##(1990-5#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-7#1)
pathohistological##2##1##(2008-10#1)(2011-2#1)
pathologic anatomy##2##2##(1992-6#1)(2010-11#1)
pathologic and##5##2##(1992-12#1)(1992-6#1)(2008-7#1)(2009-3#1)(2011-2#1)
pathologic calcification##2##2##(2008-4#2)
pathologic changes##4##2##(1990-3#1)(1996-6#1)(2010-6#1)(2012-12#1)
pathologic complete response##3##3##(1990-6#1)(1991-4#1)(2012-3#1)
pathologic conditions##7##2##(1990-12#1)(1991-9#1)(1993-12#1)(1994-8#1)(1996-6#1)(2007-11#1)(2010-6#1)
pathologic diagnosis##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
pathologic effects##2##2##(1991-12#1)(2010-6#1)
pathologic entity##2##2##(2008-10#1)(2012-3#1)
pathologic examination of##2##3##(2009-3#1)(2012-3#1)
pathologic features of##5##3##(1990-6#1)(1991-8#1)(1992-2#1)(2008-1#1)(2009-1#1)
pathologic features##9##2##(1990-6#1)(1991-8#1)(1992-2#1)(1996-7#1)(2008-1#1)(2009-1#1)(2011-2#2)(2012-3#1)
pathologic findings in##2##3##(2008-1#1)(2011-2#1)
pathologic findings of##2##3##(1991-8#1)(2008-9#1)
pathologic findings##7##2##(1991-8#1)(1997-8#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
pathologic fractures##3##2##(2007-11#1)(2008-7#2)
pathologic lesions##2##2##(2008-4#1)(2011-2#1)
pathologic positive sensory phenomena##3##4##(2012-2#3)
pathologic process##3##2##(1992-8#1)(2008-9#1)(2013-1#1)
pathologic processes##2##2##(2008-10#1)(2012-3#1)
pathologic response##3##2##(1990-6#1)(2008-10#1)(2012-3#1)
pathologic significance##2##2##(2007-8#2)
pathologic stage##2##2##(2013-1#2)
pathologic tissue##3##2##(1992-8#2)(2011-1#1)
pathologic##125##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-6#4)(1990-8#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-6#2)(1996-7#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#4)(2008-7#5)(2008-9#8)(2009-1#1)(2009-3#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#3)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#8)(2013-8#2)
pathological EEG patterns##2##3##(2010-11#2)
pathological acid gastro-oesophageal reflux and frequent sinoatrial blocks##2##8##(1996-3#2)
pathological aging##2##2##(2010-1#1)(2012-2#1)
pathological anatomy##2##2##(1990-9#1)(1993-11#1)
pathological and physiological processes##2##4##(1992-8#1)(2008-10#1)
pathological and physiological##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
pathological and##9##2##(1992-8#1)(1994-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)(2012-2#1)
pathological assessment of lymphadenectomy##2##4##(2007-8#2)
pathological assessment##4##2##(2007-8#3)(2008-6#1)
pathological brain##2##2##(2008-7#1)(2009-8#1)
pathological change##2##2##(1991-9#1)(2011-3#1)
pathological changes in the##4##4##(1991-3#1)(2008-5#1)(2013-1#2)
pathological changes in##7##3##(1990-5#1)(1991-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#2)
pathological changes of the##3##4##(1990-9#1)(1991-6#1)(2007-11#1)
pathological changes of##4##3##(1990-9#1)(1991-6#1)(2007-11#1)(2011-2#1)
pathological changes that##2##3##(2008-11#1)(2008-5#1)
pathological changes##29##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1996-11#1)(1997-2#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#4)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
pathological condition##4##2##(1990-5#1)(2011-2#2)(2013-1#1)
pathological conditions such as##2##4##(1992-2#1)(2013-1#1)
pathological conditions##22##2##(1990-8#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-3#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
pathological diagnosis was##2##3##(2008-12#1)(2011-2#1)
pathological diagnosis##6##2##(1992-5#1)(1994-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
pathological effects of##3##3##(2008-6#1)(2010-12#1)(2010-4#1)
pathological evaluation##3##2##(2006-12#1)(2010-3#1)(2010-7#1)
pathological events##2##2##(2010-9#1)(2012-3#1)
pathological examination of the##2##4##(2007-8#1)(2010-1#1)
pathological examination##9##2##(1997-3#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-7#2)
pathological feature##3##2##(1997-3#1)(2008-7#1)(2008-9#1)
pathological features of##10##3##(1991-12#1)(1991-6#1)(1994-8#1)(2008-2#1)(2008-7#3)(2010-11#1)(2010-6#1)(2011-2#1)
pathological features##14##2##(1991-12#1)(1991-6#1)(1994-8#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
pathological findings in##3##3##(1992-5#1)(1993-3#1)(2012-2#1)
pathological findings were##3##3##(1996-9#1)(2007-8#1)(2013-1#1)
pathological findings##16##2##(1992-11#1)(1992-5#1)(1993-3#1)(1995-11#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#3)(2013-1#1)
pathological fracture of the##2##4##(2007-11#1)(2008-12#1)
pathological fracture of##5##3##(2007-11#4)(2008-12#1)
pathological fracture##19##2##(2007-11#18)(2008-12#1)
pathological fractures and impending long bone fractures##2##7##(2007-11#2)
pathological fractures and##4##3##(2007-11#4)
pathological fractures of the##2##4##(2007-11#1)(2008-12#1)
pathological fractures of##3##3##(2007-11#2)(2008-12#1)
pathological fractures##23##2##(2007-11#21)(2008-12#1)(2010-3#1)
pathological gambling##6##2##(2008-11#1)(2008-6#1)(2012-12#2)(2013-8#2)
pathological grief&quot##3##2##(1993-6#3)
pathological hallmark of##2##3##(1996-6#1)(2008-7#1)
pathological manifestations##2##2##(2008-10#1)(2012-2#1)
pathological mechanism##2##2##(2009-10#1)(2009-2#1)
pathological parameters##4##2##(2006-8#4)
pathological pathways##3##2##(2008-7#1)(2010-10#1)(2012-3#1)
pathological process##2##2##(1991-4#1)(1997-3#1)
pathological processes##15##2##(1992-2#1)(1992-6#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
pathological reaction##2##2##(1990-6#2)
pathological responses##2##2##(1992-3#1)(2008-10#1)
pathological role of##4##3##(1997-2#1)(2008-10#1)(2008-4#2)
pathological role##5##2##(1997-2#1)(2008-10#1)(2008-4#2)(2008-5#1)
pathological roles##2##2##(2010-5#1)(2012-2#1)
pathological situations##2##2##(1993-3#1)(2008-7#1)
pathological stage##4##2##(1990-9#1)(2008-12#1)(2010-11#1)(2010-12#1)
pathological states##3##2##(2006-6#1)(2008-5#1)(2012-12#1)
pathological studies##3##2##(2008-5#1)(2008-7#1)(2010-4#1)
pathological verification##2##2##(2011-1#1)(2012-3#1)
pathological##348##1##(1990-11#1)(1990-5#2)(1990-6#7)(1990-8#2)(1990-9#7)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#5)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#5)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#2)(1996-3#3)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#7)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#4)(2007-10#1)(2007-11#45)(2007-4#1)(2007-5#1)(2007-8#6)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#9)(2008-2#1)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#20)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#6)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#8)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#14)(2012-3#9)(2013-1#19)(2013-7#2)(2013-8#8)
pathologically diagnosed##3##2##(1992-2#1)(2012-12#1)(2013-1#1)
pathologically increased##2##2##(2008-10#1)(2009-2#1)
pathologically significant##2##2##(1992-9#1)(2008-7#1)
pathologically##23##1##(1991-8#1)(1992-2#1)(1992-9#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
pathologies and##3##2##(1993-9#1)(2008-1#1)(2013-8#1)
pathologies are##3##2##(2008-12#1)(2008-4#1)(2008-8#1)
pathologies can##2##2##(2008-9#1)(2012-2#1)
pathologies in the##2##3##(1993-5#1)(2012-3#1)
pathologies in##4##2##(1993-5#1)(2008-1#1)(2012-3#2)
pathologies including##2##2##(2010-4#1)(2012-2#1)
pathologies is##2##2##(2007-8#1)(2012-12#1)
pathologies of the biliary tract##2##5##(1992-9#2)
pathologies of the##4##3##(1992-9#2)(2008-7#1)(2013-1#1)
pathologies of##7##2##(1992-9#2)(2007-11#1)(2008-1#1)(2008-7#1)(2011-1#1)(2013-1#1)
pathologies such as##2##3##(2008-1#1)(2011-3#1)
pathologies that##2##2##(2012-3#1)(2013-1#1)
pathologies were##2##2##(1994-12#1)(2012-3#1)
pathologies with##2##2##(1991-9#1)(2007-7#1)
pathologies##87##1##(1990-3#2)(1990-5#2)(1991-12#1)(1991-2#1)(1991-9#2)(1992-9#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#6)(2011-2#3)(2011-3#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#2)
pathologies)##2##1##(1992-9#1)(2012-3#1)
pathologist and##2##2##(1992-8#1)(2007-7#1)
pathologist##15##1##(1991-2#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-1#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-7#1)(2010-8#1)(2012-2#2)
pathologists and##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
pathologists to##2##2##(1997-3#1)(2008-10#1)
pathologists were called upon to help manage##2##7##(2008-10#2)
pathologists##31##1##(1990-10#1)(1991-12#1)(1991-2#1)(1992-8#2)(1994-12#1)(1997-2#2)(1997-3#1)(2007-10#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#5)
pathology and the##3##3##(2007-8#1)(2009-12#1)(2012-1#1)
pathology and##27##2##(1991-2#2)(1994-12#2)(1995-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-1#2)
pathology are##5##2##(1992-6#1)(1994-12#1)(2008-10#2)(2010-1#1)
pathology as##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
pathology at##2##2##(2008-9#1)(2012-3#1)
pathology can be##2##3##(2006-12#1)(2007-9#1)
pathology examination##2##2##(1997-7#1)(2012-12#1)
pathology following##2##2##(1993-12#1)(1997-2#1)
pathology for the##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
pathology for##6##2##(2008-10#3)(2010-1#1)(2011-2#1)(2013-1#1)
pathology has been##2##3##(1991-3#1)(2008-1#1)
pathology has##5##2##(1991-12#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-9#1)
pathology in the form of##2##5##(2008-12#1)(2008-9#1)
pathology in the##9##3##(1990-9#1)(1996-12#1)(1997-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
pathology in##29##2##(1990-9#1)(1991-3#1)(1992-5#1)(1994-6#1)(1996-12#2)(1997-3#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
pathology is strain-specific##2##3##(2008-10#2)
pathology is the##2##3##(2008-10#1)(2008-7#1)
pathology is##9##2##(1990-3#1)(1992-6#1)(2008-10#3)(2008-7#1)(2008-9#2)(2013-1#1)
pathology may##2##2##(2008-1#1)(2012-2#1)
pathology observed##2##2##(1992-12#1)(1995-2#1)
pathology of the urinary##2##4##(1991-6#1)(1996-12#1)
pathology of the##18##3##(1990-10#2)(1990-3#1)(1990-6#1)(1991-6#1)(1996-12#1)(1997-1#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2009-2#2)(2012-1#1)
pathology of##45##2##(1990-10#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#2)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#2)(2009-4#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
pathology or##5##2##(1991-8#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
pathology report##2##2##(2012-12#1)(2013-1#1)
pathology that##5##2##(1991-2#1)(1992-6#1)(2008-10#1)(2008-8#2)
pathology to##3##2##(1994-6#1)(2008-9#1)(2012-3#1)
pathology was##3##2##(1996-9#1)(2008-7#1)(2013-1#1)
pathology##350##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#4)(1990-5#3)(1990-6#5)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#7)(1991-5#1)(1991-6#3)(1991-8#1)(1992-12#3)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-12#7)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#8)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-7#1)(2006-10#4)(2006-12#2)(2006-8#3)(2007-11#7)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#10)(2008-10#38)(2008-11#4)(2008-12#6)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#17)(2008-8#9)(2008-9#20)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#18)(2011-3#1)(2011-7#2)(2012-1#4)(2012-12#8)(2012-2#7)(2012-3#7)(2013-1#21)(2013-8#4)
pathology]##2##1##(1992-6#1)(2007-8#1)
pathomechanism##5##1##(1995-12#1)(1997-3#1)(2007-11#3)
pathomechanisms##7##1##(2007-7#2)(2008-11#1)(2011-1#1)(2012-12#2)(2013-7#1)
pathophysiologic basis as##2##3##(2008-9#1)(2012-3#1)
pathophysiologic basis of##2##3##(2007-10#1)(2010-4#1)
pathophysiologic basis##4##2##(2007-10#1)(2008-9#1)(2010-4#1)(2012-3#1)
pathophysiologic concept##2##2##(2008-10#2)
pathophysiologic mechanisms##6##2##(1991-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)
pathophysiologic##26##1##(1990-2#1)(1991-11#1)(1993-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-10#3)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
pathophysiological and##2##2##(2008-6#1)(2012-2#1)
pathophysiological changes##2##2##(2008-4#1)(2010-10#1)
pathophysiological characteristics##2##2##(1996-9#1)(2011-1#1)
pathophysiological concept##2##2##(2010-12#1)(2010-4#1)
pathophysiological conditions##4##2##(1992-9#1)(2010-11#1)(2011-1#2)
pathophysiological events##2##2##(1990-2#1)(2008-1#1)
pathophysiological mechanism##3##2##(2008-3#1)(2011-2#2)
pathophysiological mechanisms of##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
pathophysiological mechanisms##10##2##(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
pathophysiological processes##2##2##(1990-2#1)(2008-4#1)
pathophysiological role of##3##3##(1994-9#1)(2008-12#1)(2009-10#1)
pathophysiological roles of##2##3##(2008-7#1)(2009-12#1)
pathophysiological roles##3##2##(2008-7#1)(2009-12#1)(2012-12#1)
pathophysiological significance##2##2##(1994-12#1)(2008-5#1)
pathophysiological##63##1##(1990-2#2)(1992-9#1)(1994-12#1)(1994-9#1)(1996-12#3)(1996-2#1)(1996-9#1)(2006-10#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
pathophysiologically##2##1##(2011-2#2)
pathophysiology and therapeutic##2##3##(2008-7#1)(2012-3#1)
pathophysiology and treatment of##7##4##(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
pathophysiology and##26##2##(1992-5#1)(1994-6#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
pathophysiology for##2##2##(1996-5#1)(2011-2#1)
pathophysiology has##2##2##(2008-6#1)(2008-9#1)
pathophysiology is##4##2##(1996-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
pathophysiology of a##2##3##(2012-2#1)(2013-1#1)
pathophysiology of cerebral##2##3##(2008-9#1)(2012-3#1)
pathophysiology of diabetes##3##3##(2008-1#1)(2008-4#1)(2013-7#1)
pathophysiology of neuropsychiatric##3##3##(2008-12#1)(2008-4#1)(2011-1#1)
pathophysiology of the disease##3##4##(2008-1#1)(2008-7#1)(2008-8#1)
pathophysiology of the##7##3##(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)
pathophysiology of these##4##3##(1992-9#1)(2008-7#1)(2011-1#1)(2013-8#1)
pathophysiology of##93##2##(1992-3#1)(1992-9#1)(1993-3#1)(1995-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-6#1)(2006-12#1)(2008-1#7)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#5)(2008-5#1)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#5)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
pathophysiology to##2##2##(2008-9#1)(2010-8#1)
pathophysiology##174##1##(1990-8#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-6#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#6)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#5)(2008-6#6)(2008-7#12)(2008-8#4)(2008-9#7)(2009-10#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#9)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#4)
pathosystem was##2##2##(2008-10#2)
pathosystem##27##1##(2008-10#25)(2011-10#1)(2012-2#1)
pathosystems that##2##2##(2008-10#2)
pathosystems##14##1##(2008-10#14)
pathotype 1##4##2##(2008-10#4)
pathotype 2##4##2##(2008-10#4)
pathotype of A##3##3##(2008-10#3)
pathotype of##4##2##(2008-10#4)
pathotype##39##1##(2008-10#38)(2011-1#1)
pathotypes of Alternaria alternata##2##4##(2008-10#2)
pathotypes of##8##2##(2008-10#8)
pathotypes should##2##2##(2008-10#2)
pathotypes were identified##3##3##(2008-10#3)
pathotypes were##5##2##(2008-10#5)
pathotypes##59##1##(2008-10#58)(2011-1#1)
pathovar of##2##2##(2008-10#2)
pathovar##11##1##(2008-10#11)
pathovars of P##2##3##(2008-10#2)
pathovars of X##4##3##(2008-10#4)
pathovars of Xanthomonas##2##3##(2008-10#2)
pathovars of##10##2##(2008-10#10)
pathovars were##3##2##(2008-10#3)
pathovars##36##1##(1993-9#2)(2008-10#34)
paths and##2##2##(1997-2#1)(2008-7#1)
paths are##4##2##(1993-3#2)(2008-2#1)(2008-6#1)
paths as##2##2##(1995-12#1)(2008-3#1)
paths between##3##2##(2008-3#1)(2008-8#1)(2009-9#1)
paths but also##2##3##(2008-3#1)(2011-2#1)
paths for##2##2##(2009-6#1)(2013-1#1)
paths from the##2##3##(2009-7#1)(2013-8#1)
paths from##3##2##(2008-11#1)(2009-7#1)(2013-8#1)
paths have been##3##3##(1993-3#1)(2008-11#1)(2008-3#1)
paths in##7##2##(1995-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-10#1)
paths is##4##2##(2007-12#1)(2008-2#3)
paths of the##2##3##(2008-3#1)(2009-6#1)
paths of##12##2##(1997-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2009-6#1)
paths through the atmosphere##2##4##(2008-2#1)(2008-3#1)
paths through the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
paths to##3##2##(1993-1#1)(1996-1#1)(2009-11#1)
paths within the##2##3##(2007-11#1)(2009-7#1)
paths##94##1##(1993-1#1)(1993-3#4)(1995-12#8)(1996-1#3)(1997-2#2)(2006-4#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#23)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#3)(2009-11#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
paths)##3##1##(2007-12#1)(2008-3#1)(2013-1#1)
pathway activation##8##2##(1994-11#2)(2008-11#1)(2009-6#2)(2010-12#1)(2013-1#1)(2013-8#1)
pathway analysis##3##2##(2010-12#2)(2013-8#1)
pathway and a##3##3##(2007-12#1)(2008-4#1)(2012-2#1)
pathway and that the##2##4##(2008-11#1)(2008-8#1)
pathway and that##4##3##(1995-12#1)(1996-3#1)(2008-11#1)(2008-8#1)
pathway and the##9##3##(1992-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)
pathway and##40##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#4)(2008-5#1)(2008-8#3)(2009-8#1)(2010-11#1)(2010-4#1)(2011-10#1)(2011-3#1)(2012-1#1)(2012-2#4)(2013-1#1)
pathway are##4##2##(1994-11#1)(2009-10#1)(2011-2#1)(2013-8#1)
pathway as a##3##3##(1994-8#1)(2008-3#1)(2011-2#1)
pathway as##5##2##(1993-12#1)(1994-8#1)(2008-3#1)(2010-2#1)(2011-2#1)
pathway between##2##2##(1997-7#1)(2012-1#1)
pathway by##11##2##(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#2)(1997-4#1)(2008-10#1)(2011-2#2)(2011-3#1)(2012-12#1)
pathway can be##2##3##(2009-8#1)(2010-4#1)
pathway can##6##2##(1997-7#1)(2009-8#2)(2010-4#1)(2012-2#2)
pathway components##2##2##(2008-9#1)(2011-2#1)
pathway could##3##2##(1995-2#1)(2009-6#1)(2011-2#1)
pathway data##2##2##(2010-10#2)
pathway enzyme##2##2##(2008-9#2)
pathway exchange##2##2##(2010-10#2)
pathway flux##3##2##(2008-7#1)(2011-2#2)
pathway for ATP release##2##4##(2008-4#2)
pathway for the##7##3##(1994-8#1)(2008-3#2)(2010-11#1)(2010-2#1)(2010-3#1)(2013-1#1)
pathway for##38##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-12#3)(1992-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-11#2)(2008-3#10)(2008-4#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-3#1)(2012-2#2)(2013-1#1)
pathway found##2##2##(1992-6#1)(2008-11#1)
pathway from##5##2##(1994-12#1)(2009-2#1)(2009-8#1)(2012-1#1)(2013-1#1)
pathway genes##3##2##(2008-10#1)(2008-6#1)(2012-12#1)
pathway has been implicated in##2##5##(2008-1#1)(2010-3#1)
pathway has been##8##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#2)(2012-1#1)
pathway has##12##2##(1995-12#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2012-1#1)
pathway in T##2##3##(2008-10#1)(2008-3#1)
pathway in a##3##3##(2008-7#1)(2010-5#1)(2013-1#1)
pathway in human##5##3##(1994-11#1)(1994-6#1)(2008-1#1)(2010-3#1)(2011-2#1)
pathway in regulating##2##3##(2011-2#1)(2013-1#1)
pathway in the##11##3##(1993-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
pathway in these##2##3##(1991-12#1)(2009-8#1)
pathway in which##2##3##(1990-11#1)(1995-8#1)
pathway in##83##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-12#1)(1993-3#2)(1993-8#2)(1994-11#4)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#4)(2008-10#3)(2008-11#4)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
pathway intermediates##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
pathway into##2##2##(1990-11#1)(2008-12#1)
pathway involved in##2##3##(1996-2#1)(2011-2#1)
pathway involving##5##2##(1994-11#1)(1995-8#2)(2007-12#1)(2008-3#1)
pathway is a##2##3##(2010-3#1)(2012-2#1)
pathway is activated##2##3##(1992-12#1)(2008-1#1)
pathway is also##3##3##(1990-11#1)(2008-1#2)
pathway is blocked by##2##4##(2008-11#1)(2008-7#1)
pathway is important in##2##4##(2010-3#1)(2013-1#1)
pathway is important##3##3##(2010-3#1)(2012-2#1)(2013-1#1)
pathway is##34##2##(1990-11#2)(1991-12#1)(1992-12#2)(1994-12#1)(1994-8#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-3#2)(2011-2#2)(2012-2#3)(2013-1#1)
pathway leading to##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
pathway leading##4##2##(1994-11#1)(2008-10#1)(2008-9#2)
pathway may be##5##3##(1995-12#1)(2008-9#1)(2009-12#1)(2009-6#1)(2013-1#1)
pathway may play##2##3##(1993-3#1)(2008-10#1)
pathway may##10##2##(1993-3#2)(1995-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
pathway mediated by##2##3##(2008-11#1)(2011-2#1)
pathway might##3##2##(1993-3#1)(2008-11#1)(2011-2#1)
pathway model##2##2##(2008-3#1)(2008-7#1)
pathway models##2##2##(2008-7#2)
pathway of Saccharomyces cerevisiae##2##4##(1996-2#1)(1997-4#1)
pathway of cell##2##3##(1995-12#1)(2009-5#1)
pathway of evolution##2##3##(2007-12#1)(2009-5#1)
pathway of the##8##3##(1995-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)(2012-5#1)
pathway of##60##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#3)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-3#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
pathway on##5##2##(1996-12#1)(2008-3#1)(2008-9#2)(2010-8#1)
pathway or##3##2##(1994-6#1)(2008-7#1)(2013-7#1)
pathway plays a crucial role in##2##6##(2008-1#1)(2010-9#1)
pathway plays a##4##3##(2008-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
pathway plays an important role in##3##6##(2009-5#1)(2011-2#1)(2013-7#1)
pathway plays##7##2##(2008-1#1)(2009-5#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
pathway provides a##3##3##(2011-1#1)(2011-2#1)(2013-7#1)
pathway required##2##2##(2010-11#1)(2011-2#1)
pathway systems##2##2##(2009-5#2)
pathway than##2##2##(1993-6#1)(2009-12#1)
pathway that##16##2##(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-3#2)(2010-4#1)(2012-1#1)
pathway through##2##2##(1996-2#1)(2008-7#1)
pathway to activate##2##3##(1994-11#1)(2012-2#1)
pathway to the##4##3##(1992-12#1)(1994-8#1)(2007-7#1)(2009-8#1)
pathway to##23##2##(1992-12#1)(1992-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
pathway towards##2##2##(2008-11#1)(2013-1#1)
pathway usually##2##2##(2011-2#1)(2011-3#1)
pathway was##14##2##(1992-10#2)(1993-2#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-11#4)(2011-2#1)(2012-2#1)(2013-7#1)
pathway were##6##2##(1992-3#1)(2008-11#1)(2009-3#1)(2010-11#2)(2012-2#1)
pathway which may be##2##4##(1996-12#1)(2008-11#1)
pathway which##7##2##(1992-3#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-12#1)(2008-11#1)(2012-3#1)
pathway with##9##2##(1995-6#1)(1996-5#1)(2008-1#1)(2008-11#2)(2010-12#1)(2011-3#2)(2012-12#1)
pathway##881##1##(1990-11#7)(1990-12#4)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#2)(1991-11#1)(1991-12#8)(1991-2#3)(1991-5#3)(1991-6#2)(1991-9#5)(1992-10#4)(1992-11#2)(1992-12#11)(1992-3#4)(1992-6#2)(1992-8#4)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#12)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#28)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#13)(1994-9#5)(1995-11#1)(1995-12#17)(1995-2#17)(1995-3#3)(1995-5#3)(1995-6#9)(1995-8#10)(1995-9#1)(1996-12#6)(1996-2#9)(1996-3#2)(1996-5#11)(1996-6#1)(1996-9#1)(1997-1#11)(1997-2#9)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#1)(2007-11#2)(2007-12#18)(2007-7#3)(2008-1#28)(2008-10#34)(2008-11#58)(2008-12#2)(2008-3#37)(2008-4#26)(2008-5#3)(2008-6#6)(2008-7#33)(2008-8#19)(2008-9#24)(2009-10#6)(2009-11#1)(2009-12#8)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#9)(2009-6#11)(2009-7#4)(2009-8#16)(2009-9#3)(2010-10#8)(2010-11#10)(2010-12#11)(2010-2#4)(2010-3#15)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#5)(2011-10#1)(2011-2#47)(2011-3#17)(2012-1#7)(2012-12#11)(2012-2#28)(2012-3#11)(2012-5#1)(2013-1#28)(2013-7#10)(2013-8#10)
pathway&quot##2##1##(1991-4#2)
pathway(s)##2##1##(1993-3#1)(2011-1#1)
pathway) or##2##2##(2011-1#1)(2012-2#1)
pathway)##8##1##(1991-9#1)(2008-6#1)(2008-8#1)(2010-10#2)(2011-1#1)(2012-2#2)
pathways activate the##2##3##(2008-1#1)(2008-11#1)
pathways activated by##6##3##(2008-4#4)(2008-7#2)
pathways activated##8##2##(1997-7#2)(2008-4#4)(2008-7#2)
pathways allows##2##2##(2009-5#1)(2009-8#1)
pathways and the##7##3##(1996-3#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
pathways and##44##2##(1991-9#1)(1994-5#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
pathways are involved in##2##4##(1994-11#1)(2008-10#1)
pathways are##23##2##(1993-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
pathways as well as##2##4##(2010-10#1)(2011-1#1)
pathways as##4##2##(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)
pathways associated with##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
pathways between the##3##3##(2008-1#1)(2008-9#1)(2010-1#1)
pathways by which##6##3##(1994-11#1)(1997-4#1)(2008-10#2)(2013-1#1)(2013-8#1)
pathways by##14##2##(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2012-3#3)(2013-1#1)(2013-8#1)
pathways can##4##2##(2007-4#1)(2008-10#1)(2008-8#1)(2009-10#1)
pathways controlling##4##2##(1997-2#1)(2008-10#1)(2008-9#1)(2012-12#1)
pathways could##3##2##(1997-7#1)(2008-11#1)(2008-4#1)
pathways downstream##2##2##(2008-11#1)(2008-4#1)
pathways during##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
pathways for the##4##3##(1996-2#1)(2008-11#1)(2009-1#1)(2009-12#1)
pathways for##26##2##(1990-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2010-7#2)(2013-8#1)
pathways from##3##2##(2009-7#1)(2011-1#1)(2012-2#1)
pathways has been##2##3##(2008-3#1)(2009-12#1)
pathways has##4##2##(1996-2#1)(2008-3#1)(2009-12#1)(2009-4#1)
pathways have been##7##3##(2008-10#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-1#1)(2013-8#1)
pathways have##10##2##(2008-10#1)(2008-11#1)(2008-7#3)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
pathways in a##2##3##(1993-11#1)(2008-10#1)
pathways in plants##2##3##(2009-8#1)(2011-2#1)
pathways in the##14##3##(1992-3#1)(1993-5#1)(1994-2#1)(1996-2#1)(2008-3#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-7#1)
pathways in which##3##3##(2008-4#2)(2013-1#1)
pathways in##62##2##(1990-11#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
pathways including##5##2##(1995-2#1)(2008-10#1)(2011-2#2)(2013-7#1)
pathways involved are not##3##4##(1993-12#1)(2008-2#1)(2008-4#1)
pathways involved in cardiac##2##4##(2008-7#2)
pathways involved in the##4##4##(2008-4#1)(2008-7#1)(2009-1#1)(2011-2#1)
pathways involved in##19##3##(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2010-4#2)(2011-2#1)(2012-3#2)(2013-7#1)
pathways involved##25##2##(1993-12#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
pathways is##5##2##(1995-12#1)(1996-2#1)(2007-12#1)(2012-2#1)(2012-3#1)
pathways leading to##6##3##(1992-12#2)(1994-6#1)(2008-4#1)(2009-6#1)(2011-2#1)
pathways leading##7##2##(1992-12#2)(1994-6#1)(1996-2#1)(2008-4#1)(2009-6#1)(2011-2#1)
pathways linked to##2##3##(1996-9#1)(2008-8#1)
pathways linked##3##2##(1996-9#1)(2008-8#1)(2013-7#1)
pathways linking##2##2##(2007-12#1)(2010-10#1)
pathways may be##2##3##(2008-7#1)(2011-2#1)
pathways may have##2##3##(2008-4#1)(2008-6#1)
pathways may##10##2##(1994-5#1)(1996-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
pathways mediating##2##2##(1990-5#1)(2013-8#1)
pathways of apoptosis##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
pathways of entry##3##3##(2008-10#3)
pathways of the##4##3##(1996-2#1)(2009-8#1)(2013-1#1)(2013-7#1)
pathways of##52##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-8#1)(2013-1#3)(2013-7#2)(2013-8#3)
pathways on##3##2##(2008-3#1)(2010-8#1)(2011-2#1)
pathways or##6##2##(1990-7#1)(1993-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
pathways present in##2##3##(1997-6#1)(2012-3#1)
pathways regulate##2##2##(2008-8#1)(2012-2#1)
pathways regulating##3##2##(1996-2#1)(2008-10#1)(2009-8#1)
pathways require##2##2##(2008-2#1)(2012-2#1)
pathways responsible for##5##3##(1997-7#2)(2008-4#1)(2009-11#1)(2012-12#1)
pathways revealed##2##2##(1990-8#1)(2008-7#1)
pathways such as glycolysis##2##4##(2010-7#1)(2012-1#1)
pathways such as##5##3##(2008-10#1)(2008-7#1)(2010-7#2)(2012-1#1)
pathways than##3##2##(2007-11#1)(2009-8#1)(2012-3#1)
pathways that are##4##3##(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
pathways that lead to##3##4##(2008-4#1)(2009-5#1)(2011-1#1)
pathways that might##2##3##(2009-3#1)(2010-12#1)
pathways that regulate##3##3##(2007-12#1)(2008-7#1)(2009-12#1)
pathways that##28##2##(1992-2#1)(1994-8#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
pathways through the##2##3##(1995-2#1)(2013-1#1)
pathways through##6##2##(1993-12#1)(1995-2#1)(2008-8#1)(2011-3#1)(2012-12#1)(2013-1#1)
pathways to improve##2##3##(2008-3#1)(2009-8#1)
pathways to the##4##3##(2008-10#1)(2008-4#1)(2009-8#1)(2012-2#1)
pathways to##20##2##(1994-2#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
pathways triggered by##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
pathways underlying##4##2##(1996-12#1)(2008-7#1)(2009-3#1)(2009-8#1)
pathways upon##3##2##(2007-12#1)(2008-8#1)(2012-1#1)
pathways via##2##2##(1990-12#1)(2012-2#1)
pathways was##2##2##(1996-5#1)(2010-12#1)
pathways were##9##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)
pathways which regulate##2##3##(2008-8#1)(2009-8#1)
pathways which##4##2##(1997-7#1)(2008-5#1)(2008-8#1)(2009-8#1)
pathways with##5##2##(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
pathways within##2##2##(2008-7#1)(2011-2#1)
pathways##792##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-7#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#10)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#5)(1994-8#6)(1995-11#3)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-12#8)(1996-2#16)(1996-3#1)(1996-5#8)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#5)(1997-4#4)(1997-6#2)(1997-7#11)(2006-10#2)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#13)(2007-4#1)(2007-7#1)(2008-1#12)(2008-10#40)(2008-11#49)(2008-12#7)(2008-2#4)(2008-3#33)(2008-4#51)(2008-5#9)(2008-6#7)(2008-7#47)(2008-8#28)(2008-9#18)(2009-1#2)(2009-10#9)(2009-11#3)(2009-12#8)(2009-2#3)(2009-3#7)(2009-4#2)(2009-5#9)(2009-6#8)(2009-7#2)(2009-8#19)(2009-9#1)(2010-1#4)(2010-10#11)(2010-11#5)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#6)(2010-8#6)(2010-9#1)(2011-1#14)(2011-2#45)(2011-3#2)(2012-1#11)(2012-12#9)(2012-2#24)(2012-3#21)(2012-7#1)(2012-8#2)(2013-1#17)(2013-7#9)(2013-8#14)
patient (0##2##2##(1994-2#1)(2007-11#1)
patient (5%)##2##2##(1996-9#1)(2010-7#1)
patient (6##3##2##(2008-1#2)(2008-10#1)
patient (a##2##2##(2008-11#1)(2011-2#1)
patient -##2##2##(2007-11#1)(2007-7#1)
patient 6 years after##2##4##(2011-2#1)(2012-12#1)
patient B##2##2##(1996-5#1)(1996-6#1)
patient ID##2##2##(1997-1#1)(2011-1#1)
patient a##5##2##(1995-8#1)(1996-2#1)(2007-10#1)(2007-8#2)
patient acceptance##2##2##(2008-1#1)(2012-3#1)
patient access to##5##3##(2007-12#1)(2008-6#2)(2011-1#1)(2011-3#1)
patient access##10##2##(1993-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-6#2)(2011-1#1)(2011-3#1)
patient account##2##2##(2007-9#1)(2008-11#1)
patient achieved complete##2##3##(2007-10#1)(2008-10#1)
patient achieved##3##2##(2007-10#2)(2008-10#1)
patient adherence##3##2##(2008-3#2)(2009-9#1)
patient admitted to hospital##2##4##(1992-5#1)(2013-8#1)
patient admitted to##3##3##(1992-5#1)(2011-2#1)(2013-8#1)
patient advocacy##4##2##(1995-3#2)(2008-10#1)(2008-2#1)
patient affected by an##2##4##(1990-3#1)(1993-5#1)
patient affected by##9##3##(1990-3#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(2008-5#1)(2010-7#1)(2013-8#1)
patient affected##10##2##(1990-3#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-9#1)(2008-5#1)(2010-7#1)(2013-8#1)
patient after##9##2##(1995-3#1)(2007-11#4)(2012-12#2)(2012-2#2)
patient age was##3##3##(2009-12#1)(2012-3#1)(2013-1#1)
patient age##20##2##(1990-12#1)(1991-6#1)(1993-12#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2012-3#2)(2013-1#2)
patient aged##2##2##(1992-11#1)(2012-12#1)
patient also had##3##3##(1994-12#1)(2007-7#1)(2010-4#1)
patient also has##2##3##(1995-2#1)(2008-6#1)
patient also##9##2##(1994-12#1)(1995-2#1)(2006-12#1)(2007-7#1)(2008-6#1)(2009-4#1)(2010-4#1)(2012-2#2)
patient and care##2##3##(2010-5#1)(2011-1#1)
patient and caregiver##2##3##(2008-6#1)(2010-5#1)
patient and control groups##2##4##(2007-10#1)(2011-2#1)
patient and control##3##3##(1994-8#1)(2007-10#1)(2011-2#1)
patient and family##7##3##(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-2#1)
patient and from##3##3##(1992-11#1)(2009-6#1)(2011-1#1)
patient and graft##2##3##(2008-1#1)(2008-8#1)
patient and his/her##3##3##(2010-3#1)(2010-6#1)(2013-8#1)
patient and physician##5##3##(2008-11#2)(2008-8#1)(2012-1#1)(2012-3#1)
patient and surgeon##2##3##(2008-10#1)(2011-2#1)
patient and the##14##3##(1991-12#1)(1994-2#1)(1995-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
patient and those##2##3##(2006-10#1)(2007-12#1)
patient and will##2##3##(2010-12#1)(2010-3#1)
patient and##122##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#2)(1995-5#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-5#2)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#7)(2008-10#7)(2008-11#6)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#2)
patient anti-dumping##3##2##(1993-1#1)(1993-2#2)
patient are##7##2##(1996-3#1)(1997-5#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)
patient as a##4##3##(2008-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
patient as##13##2##(1993-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
patient assessment##4##2##(1997-2#1)(2007-12#1)(2010-8#1)(2012-12#1)
patient associated with##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
patient at increased risk for##2##5##(1992-8#1)(2008-8#1)
patient at the time of##2##5##(2008-7#1)(2008-9#1)
patient at the##6##3##(1993-12#1)(1994-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)
patient at##13##2##(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)
patient autonomy##3##2##(1991-2#2)(1992-3#1)
patient became##5##2##(1992-4#1)(1996-3#2)(1997-3#1)(2013-1#1)
patient before the##3##3##(1997-4#1)(2007-10#1)(2008-12#1)
patient before##7##2##(1997-4#1)(2007-10#2)(2007-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
patient behavior##2##2##(1996-2#1)(2007-10#1)
patient behaviors##2##2##(1994-2#1)(2008-6#1)
patient being##3##2##(1991-2#1)(1996-9#1)(2013-8#1)
patient benefit and##2##3##(1992-3#1)(2011-2#1)
patient benefit##3##2##(1992-3#1)(1997-3#1)(2011-2#1)
patient but also##2##3##(1993-11#1)(2013-1#1)
patient but##3##2##(1993-11#1)(2008-10#1)(2013-1#1)
patient by##6##2##(1990-10#1)(1990-11#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-12#1)
patient can##3##2##(1991-6#1)(1997-3#1)(2007-8#1)
patient care and the##2##4##(1994-2#1)(1995-2#1)
patient care and##16##3##(1990-3#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
patient care data##2##3##(1996-1#1)(1997-3#1)
patient care delivery##4##3##(1994-12#1)(1995-12#1)(1995-2#1)(2010-8#1)
patient care in the##3##4##(1996-3#1)(1997-2#1)(2012-3#1)
patient care in##5##3##(1995-1#1)(1996-3#1)(1997-2#1)(2008-11#1)(2012-3#1)
patient care is##2##3##(1992-12#1)(2008-3#1)
patient care or##2##3##(2011-1#1)(2012-12#1)
patient care protocols##3##3##(1994-3#3)
patient care will##2##3##(1993-2#1)(1997-2#1)
patient care with##2##3##(1996-2#1)(2008-7#1)
patient care##153##2##(1990-3#1)(1991-12#5)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1993-1#1)(1993-2#3)(1993-3#4)(1994-1#8)(1994-12#3)(1994-2#2)(1994-3#5)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#11)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#3)(1997-1#6)(1997-2#6)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#11)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
patient care?##3##2##(1993-2#1)(1995-9#1)(2008-11#1)
patient case##2##2##(2008-11#1)(2010-12#1)
patient cases##3##2##(1997-3#2)(2011-1#1)
patient characteristics and##2##3##(1994-12#1)(1995-12#1)
patient characteristics##8##2##(1993-12#1)(1994-12#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-3#1)(2010-7#1)
patient charts##5##2##(1994-3#2)(1996-1#1)(2008-1#1)(2010-6#1)
patient classification system for ambulatory care##2##6##(1994-3#2)
patient classification system##4##3##(1994-3#3)(1995-2#1)
patient classification##9##2##(1993-12#1)(1994-3#3)(1995-2#2)(1996-2#1)(2010-10#2)
patient clinical##2##2##(2008-5#1)(2013-1#1)
patient cohort##2##2##(2007-10#1)(2011-2#1)
patient cohorts##2##2##(2011-2#1)(2013-1#1)
patient comfort##3##2##(2007-10#1)(2007-8#1)(2011-2#1)
patient communication##2##2##(1995-12#1)(2007-11#1)
patient complained of##5##3##(2007-8#1)(2008-6#1)(2009-1#1)(2012-3#1)(2013-1#1)
patient complaint##2##2##(1991-1#1)(2013-1#1)
patient compliance and##2##3##(1996-11#1)(2008-10#1)
patient compliance with##2##3##(1993-11#1)(2008-8#1)
patient compliance##17##2##(1991-6#1)(1992-8#1)(1993-11#1)(1996-11#2)(1996-3#2)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#2)(2010-5#1)(2010-8#1)(2012-2#1)
patient concerns##2##2##(1996-1#1)(2010-8#1)
patient conditions##3##2##(1992-12#1)(2009-3#1)(2011-2#1)
patient consent##2##2##(1992-3#1)(2008-7#1)
patient controlled analgesia##3##3##(1992-2#1)(2007-7#1)(2009-5#1)
patient controlled##5##2##(1992-2#1)(2007-7#1)(2009-5#1)(2010-8#1)(2012-3#1)
patient costs##3##2##(1995-2#1)(1996-2#2)
patient could be##2##3##(2008-7#1)(2011-2#1)
patient could not##2##3##(1996-2#1)(2007-7#1)
patient could##5##2##(1996-2#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-1#1)
patient counselling were##2##3##(2010-5#2)
patient counselling##7##2##(2010-5#7)
patient data and##2##3##(1994-3#1)(2008-6#1)
patient data was##2##3##(1996-5#1)(2008-12#1)
patient data##17##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-8#4)(2012-1#1)
patient day##2##2##(1995-3#1)(2007-10#1)
patient days in##2##3##(1992-2#1)(2008-8#1)
patient days##4##2##(1992-2#1)(1995-1#1)(2007-12#1)(2008-8#1)
patient decision support and decision aids##2##6##(2013-1#2)
patient decision support##7##3##(2013-1#7)
patient decision##9##2##(2010-11#1)(2013-1#8)
patient delay##2##2##(1990-12#1)(2007-10#1)
patient demand##3##2##(1994-1#1)(2009-4#1)(2013-7#1)
patient demographics##9##2##(1995-12#1)(2007-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#3)(2012-1#1)
patient developed a##4##3##(2007-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
patient developed acute##2##3##(2008-1#1)(2009-3#1)
patient developed an##5##3##(2007-7#1)(2008-4#1)(2009-3#1)(2011-1#1)(2013-1#1)
patient developed paraplegia##2##3##(1996-3#1)(2008-7#1)
patient developed severe##3##3##(2006-12#1)(2007-8#1)(2013-1#1)
patient developed##38##2##(1990-8#1)(1992-6#1)(1993-1#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-2#1)(2013-1#3)
patient diagnosed with##3##3##(2008-12#1)(2013-1#1)(2013-8#1)
patient diagnosed##4##2##(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
patient diagnosis and##2##3##(1996-12#1)(2012-2#1)
patient diagnosis##4##2##(1995-2#2)(1996-12#1)(2012-2#1)
patient did not improve##2##4##(1997-4#1)(2008-5#1)
patient did not require##2##4##(2010-8#1)(2011-2#1)
patient did not respond to##2##5##(1991-11#1)(2007-7#1)
patient did not##12##3##(1991-11#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)
patient died after##2##3##(1991-8#1)(2013-1#1)
patient died following##2##3##(1997-8#1)(2010-5#1)
patient died from a##2##4##(1996-6#1)(2008-10#1)
patient died from##5##3##(1991-4#1)(1996-6#1)(1996-9#1)(2008-10#1)(2009-8#1)
patient died in##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
patient died of disease##2##4##(1991-6#1)(2007-10#1)
patient died of her##2##4##(1997-3#1)(2010-12#1)
patient died of##12##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#1)(1994-12#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-6#2)(2008-7#1)(2010-12#1)
patient died on the##3##4##(2007-4#1)(2008-10#1)(2011-2#1)
patient died##43##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-5#1)(1994-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-6#3)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#2)
patient discharge##4##2##(1993-12#1)(1996-1#1)(1996-3#1)(2009-3#1)
patient discomfort##7##2##(1993-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#2)(2013-1#1)
patient during##4##2##(1992-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
patient education about##2##3##(1993-12#1)(2008-8#1)
patient education and##2##3##(1996-1#1)(1996-3#1)
patient education resources##2##3##(1991-3#2)
patient education tool among African American men with prostate cancer##2##10##(2009-5#2)
patient education tool among##3##4##(2009-5#3)
patient education##26##2##(1990-6#1)(1991-3#2)(1992-12#1)(1993-12#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#3)(2010-2#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#2)
patient empowerment##3##2##(1996-7#2)(2009-8#1)
patient evaluation and##2##3##(2008-10#1)(2008-7#1)
patient evaluation##6##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
patient evaluations##2##2##(1991-3#1)(2011-2#1)
patient event##2##2##(2008-11#2)
patient exhibited##2##2##(2012-12#1)(2012-3#1)
patient expectations##2##2##(1995-2#1)(2008-8#1)
patient experience and##3##3##(1996-1#1)(2009-8#1)(2010-3#1)
patient experience in online health communities##2##6##(2011-2#2)
patient experience##9##2##(1993-12#1)(1996-1#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
patient experienced transient##2##3##(2008-9#1)(2012-3#1)
patient experienced##7##2##(1992-4#1)(1994-6#1)(2008-9#2)(2012-12#1)(2012-3#2)
patient experiences##3##2##(1993-11#1)(1993-2#1)(2013-1#1)
patient exposure##2##2##(1992-3#1)(1996-1#1)
patient factors##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
patient failed to respond to##2##5##(1990-2#2)
patient failed to##3##3##(1990-2#2)(2008-9#1)
patient failed##5##2##(1990-2#2)(2008-9#1)(2009-10#1)(2013-1#1)
patient feedback##3##2##(1996-12#3)
patient focused care##11##3##(1993-1#1)(1993-2#3)(1993-3#2)(1994-3#1)(1996-12#1)(1996-2#3)
patient focused restructuring##4##3##(1993-1#1)(1993-12#3)
patient focused##22##2##(1993-1#3)(1993-12#3)(1993-2#4)(1993-3#3)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#4)
patient following##2##2##(2008-7#1)(2011-2#1)
patient for the##2##3##(1996-8#1)(2013-8#1)
patient for##12##2##(1990-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-9#1)(2013-8#1)
patient from a##2##3##(2007-11#1)(2013-1#1)
patient from##13##2##(1992-1#1)(1994-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
patient group and##3##3##(2007-8#2)(2011-2#1)
patient group studied##11##3##(2007-8#11)
patient group was##2##3##(2007-8#1)(2013-1#1)
patient group##40##2##(1990-2#1)(1992-4#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#15)(2008-7#1)(2009-6#1)(2011-1#4)(2011-2#6)(2012-2#2)(2013-1#3)
patient grouping##2##2##(1994-3#1)(1995-3#1)
patient groups##24##2##(1991-1#1)(1991-9#1)(1993-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
patient had a##23##3##(1990-2#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-6#3)(2007-10#1)(2007-8#2)(2008-11#1)(2008-6#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
patient had an uneventful recovery##6##5##(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patient had an uneventful##7##4##(2008-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient had an##14##3##(1991-1#1)(1992-6#1)(1996-5#1)(2006-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient had been##7##3##(1991-3#1)(1994-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
patient had multiple##2##3##(2011-1#1)(2013-1#1)
patient had no##12##3##(1996-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
patient had several##2##3##(2013-8#2)
patient had severe##3##3##(2008-1#1)(2008-6#1)(2013-1#1)
patient had significant##2##3##(2007-10#1)(2008-7#1)
patient had symptoms##2##3##(1991-3#1)(2010-12#1)
patient had##122##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-3#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-3#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-12#2)(2007-7#3)(2007-8#6)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#10)(2008-9#3)(2009-1#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#4)
patient has a##3##3##(1993-11#1)(1995-11#1)(2008-6#1)
patient has been asymptomatic##2##4##(2008-9#1)(2011-2#1)
patient has been##11##3##(1990-5#1)(1991-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
patient has failed to##2##4##(2008-7#1)(2012-2#1)
patient has had##3##3##(1993-6#1)(1996-3#1)(2012-12#1)
patient has reached##2##3##(2007-8#1)(2010-6#1)
patient has survived##2##3##(1990-6#1)(2007-8#1)
patient has##45##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-3#2)(1993-11#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#2)(2008-9#1)(2009-7#1)(2010-6#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
patient having##3##2##(2007-8#1)(2007-9#1)(2013-1#1)
patient health##4##2##(1994-2#1)(2007-12#1)(2008-3#1)(2010-12#1)
patient identification and##2##3##(1996-3#1)(2007-12#1)
patient identification##4##2##(1996-3#1)(2007-12#1)(2011-2#2)
patient improvement##2##2##(2011-2#1)(2012-12#1)
patient in a##4##3##(1994-3#1)(1997-5#1)(2011-2#1)(2013-1#1)
patient in group B##2##4##(1996-6#1)(2007-9#1)
patient in the##11##3##(1992-2#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
patient in this##4##3##(1991-3#1)(2007-7#1)(2008-12#1)(2011-2#1)
patient in view of##2##4##(2007-8#1)(2008-7#1)
patient in whom##5##3##(1993-2#1)(1994-11#1)(2007-8#1)(2008-7#1)(2012-12#1)
patient in##49##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-10#2)(2007-11#3)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
patient included##2##2##(2008-12#1)(2012-3#1)
patient infected with##3##3##(2007-12#1)(2007-7#1)(2011-2#1)
patient information and##3##3##(2011-1#2)(2012-2#1)
patient information leaflets##3##3##(1996-1#1)(2010-5#2)
patient information system##2##3##(1996-3#1)(2012-12#1)
patient information to##2##3##(1993-2#2)
patient information##22##2##(1990-2#1)(1991-3#1)(1992-1#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(2007-9#1)(2010-5#2)(2010-8#4)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
patient injury##5##2##(1991-12#2)(1994-1#1)(2010-9#1)(2011-2#1)
patient interest##2##2##(2012-2#2)
patient interviews##2##2##(1997-2#1)(2008-7#1)
patient into a##2##3##(1994-6#1)(1995-9#1)
patient involvement##2##2##(2008-12#2)
patient is a##4##3##(1993-3#1)(2007-2#1)(2011-2#1)(2012-3#1)
patient is alive##2##3##(1990-2#1)(1991-6#1)
patient is an essential##2##4##(1991-11#1)(1991-5#1)
patient is an##4##3##(1991-11#1)(1991-5#1)(1996-6#1)(2007-7#1)
patient is essential in##2##4##(2007-8#1)(2009-5#1)
patient is in good##3##4##(2008-5#1)(2012-1#1)(2013-8#1)
patient is in##5##3##(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
patient is invited to##2##4##(2010-6#2)
patient is not##3##3##(1991-11#1)(1993-2#1)(2012-12#1)
patient is presented##2##3##(2012-12#1)(2013-7#1)
patient is rare##2##3##(2012-12#1)(2012-2#1)
patient is unable to##2##4##(2008-9#1)(2013-1#1)
patient is under##2##3##(2011-2#1)(2013-1#1)
patient is without##2##3##(1996-3#1)(2008-6#1)
patient is##90##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
patient knowledge of##2##3##(2008-3#1)(2013-1#1)
patient left the##3##3##(2008-12#1)(2013-1#2)
patient left##5##2##(1997-1#1)(2008-12#1)(2008-7#1)(2013-1#2)
patient level##3##2##(1993-1#1)(2012-3#1)(2013-1#1)
patient lost##2##2##(2008-7#1)(2012-3#1)
patient made a full recovery##2##5##(2007-12#1)(2012-12#1)
patient made a##4##3##(1997-6#1)(2007-12#1)(2010-5#1)(2012-12#1)
patient made##8##2##(1993-9#1)(1997-3#1)(1997-6#1)(2007-12#1)(2010-5#1)(2012-12#1)(2012-3#2)
patient maintained##2##2##(2008-1#1)(2010-4#1)
patient management and##4##3##(1991-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
patient management##23##2##(1991-3#1)(1992-6#1)(1995-5#1)(1996-2#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#3)(2012-2#2)(2012-3#2)
patient may have##2##3##(1992-8#1)(1993-1#1)
patient may##4##2##(1992-8#1)(1992-9#1)(1993-1#1)(2010-8#1)
patient monitoring and##3##3##(1994-3#1)(2011-2#1)(2012-2#1)
patient monitoring##5##2##(1993-11#1)(1994-3#1)(2009-3#1)(2011-2#1)(2012-2#1)
patient morbidity and mortality##3##4##(2008-1#2)(2008-8#1)
patient morbidity and##5##3##(2008-1#2)(2008-8#1)(2010-8#1)(2011-7#1)
patient morbidity##7##2##(2007-5#1)(2008-1#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-7#1)
patient must be##3##3##(1996-6#1)(2013-1#1)(2013-8#1)
patient must##4##2##(1995-2#1)(1996-6#1)(2013-1#1)(2013-8#1)
patient need##4##2##(1993-12#2)(2008-10#1)(2012-12#1)
patient needed##2##2##(2007-11#1)(2010-12#1)
patient needs for##2##3##(2013-1#2)
patient needs##6##2##(1994-2#1)(1995-3#1)(2010-1#1)(2013-1#3)
patient of the##3##3##(1990-6#1)(2008-5#1)(2013-1#1)
patient of##21##2##(1990-12#1)(1990-6#1)(1992-1#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
patient on chronic hemodialysis##2##4##(2013-8#2)
patient on the##3##3##(1997-3#1)(2008-2#1)(2011-2#1)
patient on##14##2##(1991-3#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
patient operated##2##2##(2007-11#1)(2013-1#1)
patient or a##2##3##(1992-3#1)(2013-8#1)
patient or##12##2##(1991-2#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
patient outcome##7##2##(1995-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-2#1)(2013-8#1)
patient outcomes and##6##3##(1993-2#1)(1995-12#1)(2007-10#1)(2012-2#1)(2013-1#2)
patient outcomes in##5##3##(1994-3#1)(1995-2#1)(2007-12#1)(2009-11#1)(2011-2#1)
patient outcomes of care##2##4##(2012-3#2)
patient outcomes of##4##3##(2012-3#2)(2013-1#2)
patient outcomes##51##2##(1993-2#2)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#14)
patient over##3##2##(1994-1#1)(2011-1#1)(2012-3#1)
patient participation and##2##3##(2008-11#1)(2010-10#1)
patient participation##4##2##(1993-12#1)(2008-11#1)(2008-6#1)(2010-10#1)
patient perceptions of the##2##4##(1995-2#2)
patient perceptions of##3##3##(1995-2#2)(1996-1#1)
patient perspective##3##2##(2013-1#3)
patient population and##2##3##(2012-1#1)(2013-8#1)
patient population has##2##3##(2011-2#1)(2013-1#1)
patient population##45##2##(1992-3#1)(1992-5#1)(1995-1#1)(1995-2#1)(1996-9#2)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
patient populations and##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
patient populations will have to be##2##6##(1995-3#1)(2012-2#1)
patient populations with##2##3##(2007-12#1)(2013-1#1)
patient populations##27##2##(1992-12#1)(1992-3#3)(1994-6#1)(1995-2#2)(1995-3#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
patient positioning##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
patient preference##4##2##(1992-3#1)(2008-1#1)(2009-11#1)(2010-8#1)
patient preferences for##2##3##(2008-4#1)(2009-11#1)
patient preferences##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)
patient preparation##2##2##(2007-12#1)(2008-5#1)
patient presentation##2##2##(2007-10#1)(2008-10#1)
patient presented a##2##3##(1994-8#1)(2013-1#1)
patient presented at##2##3##(2008-6#1)(2008-7#1)
patient presented with a##11##4##(1991-8#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-3#1)(2010-6#1)(2013-1#1)
patient presented with an##2##4##(1992-2#1)(2011-1#1)
patient presented with pain##2##4##(2007-7#1)(2009-3#1)
patient presented with##33##3##(1991-8#1)(1992-2#1)(1996-9#1)(1997-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#5)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
patient presented##43##2##(1991-8#1)(1992-2#1)(1994-8#1)(1996-9#1)(1997-5#1)(2006-12#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#6)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)
patient presenting with##7##3##(2008-12#2)(2008-4#1)(2008-7#1)(2011-2#3)
patient presenting##10##2##(2008-12#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
patient presents with##5##3##(1997-1#1)(2007-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
patient presents##7##2##(1997-1#1)(2007-2#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
patient privacy##3##2##(2008-7#1)(2010-8#1)(2011-1#1)
patient problems##3##2##(2008-12#1)(2013-1#2)
patient prognosis##2##2##(2008-1#1)(2008-11#1)
patient prospects##2##2##(1997-1#2)
patient race/ethnicity##2##2##(2011-2#2)
patient ratings of##2##3##(1991-3#1)(2008-4#1)
patient ratings##3##2##(1991-3#2)(2008-4#1)
patient received a##2##3##(2007-11#1)(2012-3#1)
patient received radiotherapy##2##3##(2009-11#1)(2011-1#1)
patient received##9##2##(2007-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
patient record##11##2##(1992-4#1)(1993-12#1)(1993-2#1)(1994-2#1)(1997-1#2)(1997-2#1)(2010-4#2)(2012-12#1)(2012-3#1)
patient records in##2##3##(2007-11#1)(2011-2#1)
patient records##15##2##(1994-12#1)(1997-1#2)(1997-4#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#2)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)
patient recovered within##2##3##(1991-8#1)(2011-2#1)
patient recovered##14##2##(1990-12#1)(1991-3#1)(1991-8#1)(1997-2#1)(1997-3#1)(2007-8#2)(2008-5#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
patient recovery##5##2##(1992-1#1)(2008-12#1)(2008-5#1)(2013-8#2)
patient refused##4##2##(2007-8#1)(2008-9#1)(2009-6#2)
patient remained##8##2##(1993-1#1)(1993-2#1)(1997-5#1)(2008-7#1)(2009-4#1)(2011-2#2)(2013-8#1)
patient remains##7##2##(1993-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient reported with##2##3##(2011-1#1)(2013-1#1)
patient reported##8##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
patient reports and ratings##2##4##(1991-3#2)
patient reports##5##2##(1991-3#2)(1994-3#2)(2010-8#1)
patient request##2##2##(2007-8#1)(2010-2#1)
patient required##8##2##(2007-11#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#2)
patient requires##3##2##(1996-8#1)(2008-5#1)(2011-2#1)
patient responded to##3##3##(2007-7#1)(2010-12#1)(2012-2#1)
patient responded##11##2##(1995-8#1)(2007-12#1)(2007-7#5)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
patient response##2##2##(2007-3#1)(2012-3#1)
patient retention##2##2##(2008-6#1)(2012-3#1)
patient returned to##5##3##(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
patient returned##7##2##(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#2)
patient revealed##5##2##(1993-3#1)(1993-6#1)(1994-11#1)(2008-7#1)(2010-11#1)
patient risk##3##2##(1995-9#1)(2008-3#1)(2012-3#1)
patient risks##3##2##(1993-2#3)
patient safety and##4##3##(2007-12#1)(2008-7#1)(2008-9#1)(2013-8#1)
patient safety initiatives##2##3##(2011-2#1)(2013-8#1)
patient safety##29##2##(1992-3#1)(1994-3#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-5#1)(2011-2#5)(2013-1#1)(2013-8#3)
patient samples##4##2##(2008-6#1)(2008-9#1)(2010-12#1)(2013-1#1)
patient satisfaction and##10##3##(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2009-10#1)(2010-8#1)(2013-1#1)
patient satisfaction data##2##3##(1996-1#1)(1997-3#1)
patient satisfaction in##4##3##(1997-1#1)(2008-9#1)(2011-2#2)
patient satisfaction is##2##3##(1994-12#1)(2008-11#1)
patient satisfaction survey##5##3##(1995-12#1)(2008-12#4)
patient satisfaction surveys##3##3##(1996-3#3)
patient satisfaction was##2##3##(1995-3#1)(2007-11#1)
patient satisfaction with##8##3##(1995-12#1)(1996-3#2)(2008-12#1)(2010-10#1)(2010-8#2)(2011-1#1)
patient satisfaction##91##2##(1990-3#1)(1991-3#1)(1993-12#2)(1994-11#1)(1994-12#2)(1994-2#3)(1995-1#3)(1995-12#6)(1995-3#3)(1996-1#4)(1996-2#3)(1996-3#13)(1997-1#3)(1997-2#3)(1997-3#6)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-3#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)(2010-8#5)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
patient scheduling can##2##3##(1996-2#2)
patient scheduling##5##2##(1994-2#1)(1996-2#4)
patient seems to##2##3##(1991-11#1)(2008-1#1)
patient selection and##4##3##(1995-3#1)(2007-12#1)(2008-5#1)(2011-2#1)
patient selection for##2##3##(2011-2#1)(2012-2#1)
patient selection is important##2##4##(2008-7#1)(2011-2#1)
patient selection##23##2##(1991-2#1)(1994-12#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-8#1)
patient sera##4##2##(1992-12#1)(1997-4#2)(2008-8#1)
patient served##2##2##(1992-4#1)(2012-3#1)
patient service##3##2##(1991-3#1)(1995-2#1)(1995-3#1)
patient setup##2##2##(2009-11#1)(2009-2#1)
patient sexual behaviour##2##3##(1996-1#2)
patient should be##9##3##(1991-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1996-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
patient should##10##2##(1991-11#1)(1992-6#1)(1993-6#2)(1994-12#1)(1996-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
patient showed a##4##3##(1993-12#1)(2007-11#1)(2008-7#1)(2010-12#1)
patient showed clinical##3##3##(1990-2#1)(1991-6#1)(1992-11#1)
patient showed##16##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-12#1)(2007-11#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
patient shows##2##2##(1992-6#1)(2011-1#1)
patient specific##6##2##(1993-1#1)(2009-3#4)(2013-1#1)
patient status##3##2##(1997-2#1)(2010-7#1)(2013-1#1)
patient still##3##2##(2006-12#1)(2009-3#1)(2011-2#1)
patient stratification##3##2##(2008-8#2)(2011-2#1)
patient subgroups##4##2##(1996-3#1)(2008-12#1)(2008-3#1)(2011-2#1)
patient subsequently##4##2##(1994-12#1)(2006-10#1)(2007-5#1)(2009-6#1)
patient subtypes##2##2##(1994-2#1)(2010-12#1)
patient suffered a##2##3##(2008-8#1)(2013-1#1)
patient suffered from##9##3##(1990-9#1)(1993-2#1)(1994-7#1)(1995-12#1)(2007-2#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-12#1)
patient suffered##15##2##(1990-9#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-12#1)(1997-6#1)(2007-2#1)(2007-8#1)(2008-12#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
patient suffering from##6##3##(1990-11#2)(1994-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
patient suffering##7##2##(1990-11#2)(1994-12#1)(2007-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
patient support##2##2##(1996-1#1)(2011-2#1)
patient surveys##3##2##(1991-3#1)(1996-3#2)
patient survival of##2##3##(2007-12#1)(2008-1#1)
patient survival was##4##3##(1992-5#1)(1995-2#1)(2008-1#2)
patient survival##19##2##(1992-5#1)(1995-2#1)(2007-12#2)(2008-1#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#3)(2013-1#2)
patient survived##3##2##(1990-9#1)(2008-1#1)(2008-6#1)
patient that##2##2##(1994-12#1)(1996-8#1)
patient the##3##2##(1993-11#1)(1996-6#1)(1996-9#1)
patient therapy##2##2##(2011-2#2)
patient to return##2##3##(1993-12#1)(2012-12#1)
patient to the##3##3##(1992-3#1)(1993-9#1)(2008-9#1)
patient to##28##2##(1990-6#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
patient tolerance##2##2##(2007-12#1)(2011-1#1)
patient transport##2##2##(1994-3#1)(2011-2#1)
patient treated by##2##3##(2007-11#1)(2008-10#1)
patient treated for##3##3##(1991-11#1)(1996-3#1)(2013-8#1)
patient treated in the##2##4##(2007-11#1)(2007-7#1)
patient treated in##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
patient treated with##6##3##(1990-6#1)(1993-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-12#1)
patient treated##15##2##(1990-3#1)(1990-6#1)(1991-11#1)(1993-6#1)(1996-3#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-10#3)(2010-12#1)(2013-8#1)
patient treatment##7##2##(1992-12#1)(1992-2#1)(2007-4#1)(2008-10#1)(2009-11#1)(2011-3#1)(2013-1#1)
patient undergoing##3##2##(2007-8#1)(2010-5#1)(2012-12#1)
patient underwent a##14##3##(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
patient underwent orthotopic liver transplantation##2##5##(1991-11#1)(1992-12#1)
patient underwent radical surgery##2##4##(1992-10#2)
patient underwent##42##2##(1991-11#2)(1992-10#2)(1992-12#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#4)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
patient using##4##2##(2007-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
patient variables and##2##3##(1992-12#1)(2007-12#1)
patient volume and##3##3##(1994-2#1)(1996-12#1)(1996-3#1)
patient volume##6##2##(1994-2#2)(1996-12#1)(1996-3#1)(1997-1#1)(2007-10#1)
patient was a 35-year-old##2##4##(2008-1#1)(2008-7#1)
patient was a##18##3##(1994-11#1)(1994-12#1)(1994-6#1)(1996-6#1)(2006-10#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#4)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
patient was admitted for##2##4##(2007-8#1)(2013-1#1)
patient was admitted to our hospital with##2##7##(1993-6#1)(2011-2#1)
patient was admitted to our##3##5##(1993-6#1)(2011-2#1)(2012-3#1)
patient was admitted to the hospital##2##6##(1993-6#1)(2013-1#1)
patient was admitted to##6##4##(1993-6#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
patient was admitted##14##3##(1991-8#1)(1993-6#2)(2007-8#2)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#5)
patient was asymptomatic##3##3##(1996-3#1)(2011-2#1)(2013-1#1)
patient was brought##2##3##(2010-12#1)(2012-2#1)
patient was diagnosed to have##2##5##(1997-8#1)(2008-6#1)
patient was diagnosed with##5##4##(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
patient was diagnosed##9##3##(1997-8#1)(2008-12#1)(2008-6#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
patient was discharged from the hospital##2##6##(2009-3#1)(2011-2#1)
patient was discharged on day##2##5##(2013-1#1)(2013-8#1)
patient was discharged on##4##4##(2012-12#1)(2013-1#2)(2013-8#1)
patient was discharged##13##3##(1994-9#1)(1995-3#1)(2007-8#2)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
patient was found to have##4##5##(2008-12#1)(2008-6#1)(2011-1#1)(2013-1#1)
patient was found to##5##4##(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
patient was found##6##3##(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
patient was free of##3##4##(2009-1#1)(2011-2#2)
patient was free##4##3##(2009-1#1)(2011-2#2)(2013-8#1)
patient was having##2##3##(2007-7#2)
patient was in##5##3##(1990-5#1)(1993-12#1)(2007-12#1)(2008-4#1)(2013-8#1)
patient was not##2##3##(1997-6#1)(2008-1#1)
patient was on##4##3##(2008-7#1)(2010-12#1)(2013-1#1)(2013-7#1)
patient was operated##2##3##(2013-1#2)
patient was posted for##2##4##(2008-7#1)(2010-5#1)
patient was referred to surgery##2##5##(1994-9#1)(2011-1#1)
patient was referred to##7##4##(1994-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
patient was referred##13##3##(1991-11#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
patient was seen##2##3##(2012-3#1)(2013-1#1)
patient was started on##2##4##(2007-12#1)(2009-11#1)
patient was subjected to##2##4##(2007-7#1)(2008-11#1)
patient was totally##2##3##(2008-10#1)(2012-1#1)
patient was transferred to##4##4##(2011-2#1)(2013-1#2)(2013-8#1)
patient was transfused with two units of##2##7##(1994-6#1)(1994-9#1)
patient was transfused with##3##4##(1994-12#1)(1994-6#1)(1994-9#1)
patient was treated by##3##4##(1990-8#1)(2008-10#1)(2011-2#1)
patient was treated with antibiotics##2##5##(1996-11#1)(2013-1#1)
patient was treated with##24##4##(1992-2#1)(1994-12#1)(1994-6#1)(1996-11#1)(2006-10#3)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#2)
patient was treated##32##3##(1990-8#1)(1992-2#1)(1994-12#1)(1994-6#1)(1996-11#1)(2006-10#3)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#2)
patient was##243##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-11#2)(1994-12#4)(1994-3#1)(1994-6#3)(1994-9#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#2)(1997-8#1)(2006-10#4)(2007-10#2)(2007-12#5)(2007-4#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#10)(2008-10#4)(2008-11#2)(2008-12#9)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#14)(2008-8#1)(2008-9#2)(2009-1#2)(2009-11#3)(2009-3#5)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#5)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#8)(2011-2#24)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#27)(2013-7#1)(2013-8#12)
patient were##5##2##(1992-12#1)(1994-11#1)(2007-11#1)(2007-7#1)(2008-5#1)
patient where##2##2##(2007-11#1)(2011-1#1)
patient while##2##2##(2007-7#1)(2010-12#1)
patient who complained of##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
patient who developed a##4##4##(1993-8#1)(2008-12#1)(2008-8#1)(2009-4#1)
patient who developed##14##3##(1993-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
patient who died##2##3##(1994-11#1)(2008-11#1)
patient who had a##2##4##(2007-10#1)(2008-7#1)
patient who had an##2##4##(1991-3#1)(2008-7#1)
patient who had been##3##4##(1995-11#1)(1997-6#1)(2013-8#1)
patient who had undergone##3##4##(1990-3#1)(2008-12#1)(2009-2#1)
patient who had##17##3##(1990-3#1)(1991-3#1)(1993-8#1)(1995-11#1)(1995-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
patient who has##3##3##(2010-5#1)(2011-1#1)(2012-12#1)
patient who is not##2##4##(2010-12#1)(2010-5#1)
patient who is##3##3##(2010-12#1)(2010-5#1)(2013-1#1)
patient who presented with acute##2##5##(2007-8#1)(2010-8#1)
patient who presented with##10##4##(2007-8#1)(2008-4#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
patient who presented##11##3##(2007-8#1)(2008-4#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
patient who suffered posterior##2##4##(2012-1#1)(2012-2#1)
patient who suffered##3##3##(1990-9#1)(2012-1#1)(2012-2#1)
patient who sustained##2##3##(2009-4#1)(2012-2#1)
patient who underwent##5##3##(2007-8#1)(2008-11#1)(2008-6#1)(2012-12#1)(2013-1#1)
patient who was treated##2##4##(1997-8#1)(2009-5#1)
patient who was##8##3##(1991-11#1)(1997-8#1)(2007-8#3)(2009-5#1)(2012-3#1)(2013-1#1)
patient who##87##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-5#4)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
patient whose##2##2##(1990-9#1)(2008-7#1)
patient will##5##2##(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
patient with HIV##3##3##(1995-12#1)(2010-12#1)(2013-1#1)
patient with a complete##2##4##(1996-2#1)(2011-2#1)
patient with a complex##2##4##(2010-10#1)(2010-3#1)
patient with a history of##5##5##(2009-4#1)(2010-12#1)(2012-3#2)(2013-8#1)
patient with a left lower lobe##2##6##(2008-1#2)
patient with a##56##3##(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-8#4)(2008-1#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#2)
patient with abdominal pain##2##4##(2008-7#1)(2010-12#1)
patient with abdominal##3##3##(2008-7#1)(2010-12#1)(2011-1#1)
patient with acute##10##3##(1994-12#1)(2007-4#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#1)
patient with advanced##4##3##(1990-8#1)(2006-10#1)(2007-11#1)(2012-3#1)
patient with an isolated##2##4##(1994-5#1)(2008-9#1)
patient with an##18##3##(1994-5#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2013-1#4)(2013-8#1)
patient with aortic##2##3##(2011-2#1)(2012-2#1)
patient with arteria lusoria##2##4##(2008-11#2)
patient with bleeding##2##3##(2008-10#2)
patient with chemical corneal burn##2##5##(2010-10#2)
patient with chronic liver disease##2##5##(1991-11#1)(2008-10#1)
patient with chronic##17##3##(1991-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
patient with diabetes##3##3##(2008-1#1)(2008-4#1)(2010-10#1)
patient with dysphagia##2##3##(2008-1#2)
patient with epidural anesthesia##2##4##(2012-3#2)
patient with essential hypertension##2##4##(1992-6#1)(2008-10#1)
patient with essential##3##3##(1992-6#1)(1997-7#1)(2008-10#1)
patient with generalized##2##3##(2012-2#1)(2012-3#1)
patient with hypercalcemia##2##3##(1996-9#1)(2008-6#1)
patient with left atrial##2##4##(2007-8#1)(2008-11#1)
patient with malignant##5##3##(1990-10#1)(1994-12#1)(2011-3#1)(2012-12#1)(2013-7#1)
patient with metastatic renal##2##4##(1990-12#1)(1991-8#1)
patient with metastatic##5##3##(1990-12#1)(1990-9#1)(1991-8#1)(1992-2#1)(2008-11#1)
patient with multiple##8##3##(1992-12#1)(1993-12#1)(1997-8#1)(2007-11#1)(2008-11#1)(2009-4#2)(2011-2#1)
patient with myasthenia gravis##3##4##(2007-8#1)(2012-2#1)(2012-3#1)
patient with neck##2##3##(1991-8#1)(2007-11#1)
patient with neurological##2##3##(1997-6#1)(2008-12#1)
patient with normal##2##3##(2007-8#1)(2010-5#1)
patient with pulmonary##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
patient with radiologically##2##3##(2007-8#1)(2008-7#1)
patient with rheumatoid arthritis##2##4##(2012-12#1)(2013-1#1)
patient with severe##6##3##(1990-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2009-5#1)(2012-12#1)
patient with symptomatic##2##3##(1997-4#1)(2012-3#1)
patient with systemic lupus erythematosus##4##5##(1994-9#1)(2006-10#2)(2007-12#1)
patient with the##4##3##(1991-12#1)(2006-10#2)(2013-1#1)
patient with type I##2##4##(2011-2#1)(2012-3#1)
patient with type II##2##4##(1997-2#1)(2008-7#1)
patient with type##5##3##(1997-2#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
patient with ulcerative colitis##4##4##(2007-10#1)(2010-12#2)(2012-12#1)
patient with##475##2##(1990-10#1)(1990-12#6)(1990-3#4)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#6)(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#11)(2006-12#3)(2007-10#11)(2007-11#4)(2007-12#6)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#8)(2007-8#18)(2008-1#14)(2008-10#17)(2008-11#13)(2008-12#18)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#8)(2008-7#31)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#31)(2011-3#2)(2012-12#15)(2012-2#13)(2012-3#25)(2013-1#37)(2013-7#3)(2013-8#11)
patient without##4##2##(1996-8#1)(2008-1#1)(2009-5#1)(2011-2#1)
patient!##2##1##(1992-1#1)(2008-7#1)
patient##3902##1##(1990-10#4)(1990-11#9)(1990-12#14)(1990-2#12)(1990-3#14)(1990-5#4)(1990-6#12)(1990-7#3)(1990-8#11)(1990-9#14)(1991-1#6)(1991-11#16)(1991-12#21)(1991-2#15)(1991-3#21)(1991-4#3)(1991-5#4)(1991-6#10)(1991-8#9)(1991-9#3)(1992-1#16)(1992-10#5)(1992-11#9)(1992-12#24)(1992-2#17)(1992-3#34)(1992-4#7)(1992-5#7)(1992-6#15)(1992-8#12)(1992-9#9)(1993-1#16)(1993-10#3)(1993-11#19)(1993-12#40)(1993-2#31)(1993-3#15)(1993-5#4)(1993-6#16)(1993-8#4)(1993-9#10)(1994-1#17)(1994-11#15)(1994-12#38)(1994-2#23)(1994-3#34)(1994-5#3)(1994-6#7)(1994-7#3)(1994-8#6)(1994-9#9)(1995-1#11)(1995-11#6)(1995-12#26)(1995-2#31)(1995-3#40)(1995-5#6)(1995-6#4)(1995-8#6)(1995-9#5)(1996-1#23)(1996-11#6)(1996-12#17)(1996-2#35)(1996-3#46)(1996-5#9)(1996-6#19)(1996-7#4)(1996-8#11)(1996-9#16)(1997-1#25)(1997-2#29)(1997-3#31)(1997-4#12)(1997-5#11)(1997-6#13)(1997-7#7)(1997-8#16)(2006-10#27)(2006-12#10)(2006-5#1)(2007-10#57)(2007-11#56)(2007-12#74)(2007-2#11)(2007-3#2)(2007-4#10)(2007-5#5)(2007-6#5)(2007-7#65)(2007-8#112)(2007-9#11)(2008-1#103)(2008-10#102)(2008-11#79)(2008-12#81)(2008-2#15)(2008-3#36)(2008-4#39)(2008-5#31)(2008-6#66)(2008-7#166)(2008-8#54)(2008-9#51)(2009-1#7)(2009-10#15)(2009-11#22)(2009-12#8)(2009-2#6)(2009-3#37)(2009-4#13)(2009-5#15)(2009-6#14)(2009-7#5)(2009-8#21)(2009-9#8)(2010-1#3)(2010-10#20)(2010-11#12)(2010-12#39)(2010-2#9)(2010-3#26)(2010-4#11)(2010-5#44)(2010-6#22)(2010-7#15)(2010-8#60)(2010-9#11)(2011-1#75)(2011-10#1)(2011-2#289)(2011-3#15)(2011-7#2)(2012-1#15)(2012-12#97)(2012-2#87)(2012-3#109)(2013-1#263)(2013-2#1)(2013-7#15)(2013-8#83)
patient's RBCs typed as##2##4##(1994-12#2)
patient's RBCs##4##2##(1994-12#2)(1994-9#2)
patient's adherence##3##2##(2008-3#1)(2011-1#2)
patient's age##10##2##(1996-1#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#1)
patient's best interests##2##3##(1991-2#1)(1997-8#1)
patient's best##5##2##(1991-2#1)(1997-8#2)(2008-10#1)(2012-2#1)
patient's blood##3##2##(2007-7#1)(2008-11#1)(2012-12#1)
patient's body##3##2##(1991-6#1)(2007-12#1)(2011-2#1)
patient's clinical progress##2##3##(2008-6#1)(2008-8#1)
patient's clinical status##2##3##(2009-5#1)(2011-2#1)
patient's clinical##11##2##(2007-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
patient's condition##6##2##(2007-11#3)(2010-5#1)(2012-12#1)(2013-8#1)
patient's daily##2##2##(2007-10#1)(2008-7#1)
patient's data##3##2##(2010-8#2)(2013-1#1)
patient's death##3##2##(1993-5#1)(2008-11#2)
patient's decision to##2##3##(1990-3#1)(1997-1#1)
patient's decision##3##2##(1990-3#1)(1995-9#1)(1997-1#1)
patient's disease##4##2##(1994-11#1)(2010-4#1)(2012-1#1)(2013-8#1)
patient's family##3##2##(1995-3#1)(1996-2#1)(2008-5#1)
patient's functional##4##2##(1991-1#1)(2006-5#1)(2007-12#1)(2010-10#1)
patient's future##2##2##(1990-5#1)(1993-12#1)
patient's general condition##3##3##(2007-11#3)
patient's general##5##2##(1996-6#1)(2007-11#3)(2012-2#1)
patient's health##9##2##(1992-2#1)(1994-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
patient's history##5##2##(1990-6#1)(1997-2#1)(2008-11#1)(2008-8#1)(2013-1#1)
patient's immune system##3##3##(2008-5#1)(2013-8#2)
patient's individual##2##2##(1994-5#1)(2008-10#1)
patient's knowledge about##2##3##(2008-7#1)(2011-1#1)
patient's management##2##2##(2007-11#1)(2012-8#1)
patient's medical and##2##3##(2008-9#1)(2013-1#1)
patient's medical records##2##3##(2007-10#1)(2012-12#1)
patient's medical##6##2##(2007-10#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
patient's outcome##3##2##(1995-6#1)(1995-8#1)(2009-8#1)
patient's own##2##2##(1992-4#1)(2011-3#1)
patient's pain##2##2##(2008-10#1)(2008-7#1)
patient's perspective##7##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#2)(2012-3#1)
patient's physical and mental##3##4##(1996-3#1)(2007-11#1)(2007-8#1)
patient's physical##7##2##(1992-12#1)(1996-3#1)(2007-11#3)(2007-8#2)
patient's presentation##3##2##(2010-8#2)(2011-2#1)
patient's prognosis##2##2##(2008-7#1)(2008-9#1)
patient's qualification##2##2##(2007-11#2)
patient's quality of life##4##4##(2007-8#1)(2009-10#1)(2009-9#1)(2013-1#1)
patient's quality of##6##3##(2007-8#1)(2008-10#2)(2009-10#1)(2009-9#1)(2013-1#1)
patient's right to self-determination##2##4##(1991-2#2)
patient's right to##4##3##(1991-2#2)(1992-12#1)(1993-3#1)
patient's risk of##2##3##(2008-4#1)(2012-3#1)
patient's risk##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
patient's satisfaction and##2##3##(1990-6#1)(2013-1#1)
patient's serum at##2##3##(1992-9#2)
patient's serum##7##2##(1992-6#1)(1992-9#2)(1993-6#1)(1994-6#3)
patient's subjective##2##2##(2011-2#1)(2013-1#1)
patient's symptoms##9##2##(1991-6#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
patient's urine##2##2##(1990-8#1)(2008-10#1)
patient's view##3##2##(1991-1#1)(1996-12#1)(2008-8#1)
patient's with##2##2##(1991-7#1)(2008-1#1)
patient's##371##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#3)(1991-12#4)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#5)(1994-9#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#4)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#8)(2007-11#17)(2007-12#6)(2007-7#3)(2007-8#10)(2008-1#4)(2008-10#13)(2008-11#9)(2008-12#8)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#19)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#7)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#9)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#12)(2012-8#1)(2013-1#21)(2013-7#1)(2013-8#7)
patient) of##2##2##(2007-10#1)(2007-11#1)
patient)##11##1##(1990-2#1)(1992-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
patient- and##4##2##(2008-3#1)(2010-8#1)(2011-2#2)
patient-##5##1##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#2)
patient-associated##2##1##(1993-2#1)(1996-3#1)
patient-based measurement systems##3##3##(1994-3#3)
patient-based##9##1##(1993-12#2)(1993-2#1)(1994-3#4)(2008-3#1)(2011-2#1)
patient-care##2##1##(1993-12#1)(2010-5#1)
patient-centered care##6##2##(1994-3#1)(1997-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
patient-centered or bottom-line?##2##3##(1994-1#2)
patient-centered##14##1##(1992-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-8#2)
patient-centred##3##1##(1995-3#1)(2008-11#1)(2008-7#1)
patient-controlled analgesia##2##2##(2008-11#1)(2009-5#1)
patient-controlled##3##1##(2008-11#1)(2009-5#1)(2012-3#1)
patient-doctor##2##1##(2009-5#1)(2011-2#1)
patient-focused care##10##2##(1993-12#1)(1994-1#3)(1994-12#1)(1996-1#2)(1997-2#1)(1997-3#1)(2011-1#1)
patient-focused hospital##2##2##(1992-12#2)
patient-focused##16##1##(1992-12#2)(1993-12#1)(1994-1#3)(1994-12#1)(1994-2#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#2)(2011-1#1)
patient-friendly drug monitoring##2##3##(2010-11#2)
patient-friendly##9##1##(1996-3#1)(1997-4#1)(2009-5#1)(2010-11#5)(2012-2#1)
patient-level data##2##2##(1993-1#1)(1995-1#1)
patient-level##4##1##(1992-3#1)(1993-1#1)(1995-1#1)(2008-3#1)
patient-months (mean##3##2##(2011-2#3)
patient-oriented##2##1##(1992-12#1)(1997-5#1)
patient-physician communication about##2##3##(2008-10#2)
patient-physician relationship##3##2##(1993-3#1)(1995-12#1)(1997-4#1)
patient-physician##5##1##(1993-3#1)(1995-12#1)(1997-4#1)(2008-10#2)
patient-provider relationship##2##2##(1996-12#1)(2013-1#1)
patient-provider##4##1##(1996-12#1)(2009-5#1)(2013-1#2)
patient-related service time for staff##2##5##(1995-3#2)
patient-related service time for##3##4##(1995-3#3)
patient-related##11##1##(1995-3#4)(1996-3#1)(2007-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
patient-reported outcome##2##2##(2009-11#1)(2013-1#1)
patient-reported outcomes##3##2##(2008-7#1)(2009-9#1)(2010-10#1)
patient-reported pain and disability##2##4##(2008-9#2)
patient-reported##16##1##(1995-2#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
patient-specific##13##1##(1992-3#1)(1994-3#1)(1995-12#2)(2008-12#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)
patient-support##2##1##(2010-12#1)(2011-2#1)
patient-to-patient variation in##2##3##(2010-10#1)(2013-1#1)
patient-years##2##1##(1990-12#1)(2012-2#1)
patient/resident##2##1##(1993-12#1)(1997-1#1)
patient?]##3##1##(1991-11#1)(1993-10#1)(1993-3#1)
patient]##16##1##(1990-10#1)(1990-3#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-5#1)(2007-6#2)(2010-12#1)(2013-1#1)(2013-8#1)
patiente##3##1##(2013-1#3)
patientes##2##1##(2013-1#2)
patients (0##4##2##(1990-2#3)(2010-12#1)
patients (1##5##2##(1990-3#1)(1992-2#1)(2007-11#2)(2008-9#1)
patients (10 male##2##3##(2008-2#1)(2012-3#1)
patients (10##10##2##(1990-9#1)(1991-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2011-3#1)(2012-3#3)
patients (11##3##2##(1992-9#1)(2008-1#1)(2011-2#1)
patients (11%)##2##2##(1990-12#1)(1997-6#1)
patients (12##6##2##(1992-9#1)(1994-7#1)(1997-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
patients (13 men and##2##4##(2011-2#1)(2013-1#1)
patients (13##11##2##(1990-12#1)(1991-11#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#1)
patients (13%)##2##2##(2007-8#1)(2008-9#1)
patients (14 men and##2##4##(1990-8#1)(2011-2#1)
patients (14##6##2##(1990-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
patients (14%) had##2##3##(2011-2#1)(2013-1#1)
patients (14%)##5##2##(1995-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
patients (15##2##2##(2007-8#1)(2008-8#1)
patients (16##6##2##(1990-9#1)(1991-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
patients (16%)##3##2##(1990-9#1)(2008-8#1)(2011-2#1)
patients (18 men##2##3##(1995-3#1)(2008-9#1)
patients (18##8##2##(1992-9#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
patients (18%)##3##2##(1990-9#1)(2007-11#1)(2008-10#1)
patients (19##2##2##(1996-6#1)(2010-3#1)
patients (19%)##3##2##(1996-6#1)(2008-7#1)(2011-2#1)
patients (2##8##2##(1992-8#1)(1993-2#1)(1994-6#1)(1996-7#1)(1997-8#1)(2007-11#2)(2008-7#1)
patients (21 men and 4##2##5##(2007-8#1)(2008-9#1)
patients (21##6##2##(2007-11#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-2#2)
patients (21%) had##2##3##(1996-7#1)(2012-2#1)
patients (21%)##4##2##(1993-11#1)(1996-7#1)(2007-10#1)(2012-2#1)
patients (22 males##2##3##(1990-11#1)(2008-6#1)
patients (22##5##2##(1990-11#1)(1994-3#1)(2007-7#1)(2008-6#1)(2011-2#1)
patients (23##3##2##(1994-12#1)(1997-5#1)(2012-2#1)
patients (23%)##2##2##(2011-2#1)(2013-1#1)
patients (24##2##2##(2007-8#1)(2008-9#1)
patients (25##5##2##(1992-10#1)(1997-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
patients (25%)##3##2##(2007-10#2)(2011-2#1)
patients (26##5##2##(1990-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients (28##3##2##(1991-5#1)(2008-7#1)(2011-2#1)
patients (28%)##2##2##(1993-1#1)(2008-4#1)
patients (29##2##2##(1990-9#1)(2012-3#1)
patients (29%)##4##2##(2008-1#2)(2008-10#2)
patients (3##9##2##(1990-10#1)(1990-3#1)(1993-9#1)(1995-10#1)(2007-11#1)(2007-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
patients (30 women##2##3##(1996-6#1)(2007-8#1)
patients (30%)##3##2##(1996-9#2)(2011-2#1)
patients (31##2##2##(2007-8#1)(2008-7#1)
patients (31%)##4##2##(1992-3#1)(2007-8#1)(2012-3#1)(2013-1#1)
patients (32%)##2##2##(1997-6#1)(2008-7#1)
patients (33##5##2##(1990-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
patients (33%)##3##2##(2007-8#1)(2008-12#1)(2008-7#1)
patients (34##5##2##(1990-2#1)(2008-10#1)(2008-12#2)(2008-6#1)
patients (34%)##3##2##(1991-8#1)(1992-2#1)(2008-8#1)
patients (35%)##5##2##(1994-9#1)(1997-5#1)(2008-1#1)(2008-6#1)(2008-7#1)
patients (37##3##2##(2008-6#1)(2008-7#1)(2008-9#1)
patients (4##6##2##(1990-3#1)(1990-8#1)(1991-2#2)(1996-3#1)(2012-3#1)
patients (40##2##2##(1992-12#1)(2007-8#1)
patients (41##2##2##(2008-4#1)(2008-7#1)
patients (41%)##3##2##(1990-8#1)(2008-1#1)(2011-2#1)
patients (42##2##2##(1990-11#1)(2013-1#1)
patients (42%)##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
patients (43##3##2##(1990-9#1)(2008-4#1)(2011-2#1)
patients (43%)##2##2##(2008-7#2)
patients (44##3##2##(1993-5#1)(2008-1#1)(2008-7#1)
patients (44%)##7##2##(1990-8#1)(1993-8#1)(1996-11#1)(2008-1#2)(2008-6#1)(2011-2#1)
patients (46##2##2##(1990-2#1)(2013-1#1)
patients (46%)##2##2##(2008-1#1)(2008-9#1)
patients (48##2##2##(2007-7#1)(2011-2#1)
patients (48%)##5##2##(1990-6#1)(2007-11#1)(2008-3#2)(2008-7#1)
patients (5##8##2##(1990-8#1)(1992-5#1)(1996-6#1)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
patients (5%)##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
patients (50%)##3##2##(1991-3#1)(2008-11#1)(2008-8#1)
patients (51##2##2##(2007-8#1)(2008-1#1)
patients (52%)##2##2##(2008-3#1)(2011-2#1)
patients (55%)##6##2##(1990-12#1)(1990-9#1)(1996-9#2)(2008-11#1)(2008-6#1)
patients (56##2##2##(2007-11#1)(2008-7#1)
patients (57##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
patients (57%)##2##2##(2008-12#1)(2008-6#1)
patients (58##2##2##(1992-9#1)(2009-6#1)
patients (59%)##4##2##(1990-8#1)(2007-10#1)(2007-7#1)(2007-8#1)
patients (6##6##2##(1991-8#1)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients (6%)##2##2##(1993-8#1)(2007-11#1)
patients (60%)##3##2##(1990-12#1)(1993-9#1)(1995-5#1)
patients (61##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
patients (62##6##2##(1996-11#1)(2007-11#2)(2007-7#1)(2008-10#2)
patients (64##2##2##(2008-7#1)(2013-8#1)
patients (65%)##2##2##(1997-6#1)(2008-7#1)
patients (66##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
patients (67##2##2##(1997-8#1)(2012-2#1)
patients (7##6##2##(1990-3#1)(1994-7#1)(2011-2#2)(2013-1#2)
patients (7%)##2##2##(1991-2#1)(2008-9#1)
patients (70##3##2##(2007-8#1)(2008-4#1)(2013-7#1)
patients (70%)##7##2##(1990-3#1)(1991-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
patients (73##2##2##(1996-11#1)(2013-1#1)
patients (75%)##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
patients (76%)##2##2##(2011-2#2)
patients (77##2##2##(1997-8#1)(2008-1#1)
patients (77%)##2##2##(2008-6#1)(2011-2#1)
patients (78%)##2##2##(2008-4#1)(2011-2#1)
patients (8##9##2##(1990-2#1)(1997-3#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-7#1)(2011-2#1)
patients (8%) had##2##3##(1991-6#1)(2007-7#1)
patients (80%) were##2##3##(2007-8#1)(2010-10#1)
patients (80%)##4##2##(2007-8#1)(2008-1#2)(2010-10#1)
patients (82%)##2##2##(1992-2#1)(2010-5#1)
patients (84%)##2##2##(1991-3#1)(2012-3#1)
patients (87##3##2##(2007-7#1)(2008-11#1)(2012-2#1)
patients (9 women##2##3##(1992-5#1)(2007-11#1)
patients (9##7##2##(1992-5#1)(2007-11#1)(2011-2#3)(2013-1#2)
patients (9%) had##2##3##(2008-10#1)(2011-2#1)
patients (9%)##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
patients (90%)##2##2##(1992-1#1)(2012-2#1)
patients (92##2##2##(1997-7#1)(2012-2#1)
patients (92%)##2##2##(2011-2#2)
patients (93##2##2##(1991-8#1)(2007-8#1)
patients (95%)##3##2##(2008-1#1)(2008-6#1)(2013-1#1)
patients (96##2##2##(2012-2#1)(2012-3#1)
patients (N =##3##3##(1994-2#1)(2011-2#2)
patients (OR =##2##3##(2010-2#1)(2012-1#1)
patients (P =##2##3##(2007-10#1)(2013-1#1)
patients (P##3##2##(1997-8#1)(2007-10#1)(2013-1#1)
patients (a##2##2##(1997-3#1)(2013-8#1)
patients (age 0##2##3##(2011-2#2)
patients (age##8##2##(1993-12#1)(2009-9#1)(2011-2#4)(2012-3#1)(2013-8#1)
patients (aged##2##2##(2007-11#1)(2008-3#1)
patients (all##2##2##(1991-2#1)(1997-8#1)
patients (average age##3##3##(2007-8#2)(2008-7#1)
patients (average##6##2##(2007-8#2)(2008-7#1)(2008-9#3)
patients (group##5##2##(1996-6#1)(2008-1#2)(2009-10#1)(2011-1#1)
patients (i##2##2##(2008-7#1)(2009-10#1)
patients (in##3##2##(1991-6#1)(2008-11#1)(2010-4#1)
patients (mean age##15##3##(1990-5#1)(1991-5#1)(1995-11#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#2)(2009-3#1)(2011-2#2)(2013-1#1)
patients (mean##16##2##(1990-5#1)(1991-5#1)(1995-11#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#2)(2013-1#1)
patients (median##3##2##(1992-12#1)(2011-2#1)(2013-7#1)
patients (n = 18)##2##4##(2007-10#1)(2013-1#1)
patients (n = 27)##2##4##(1996-7#1)(2013-1#1)
patients (n =##23##3##(1990-2#1)(1993-12#1)(1993-8#1)(1994-1#1)(1996-7#4)(2007-10#2)(2008-1#1)(2008-6#2)(2008-7#2)(2010-4#1)(2012-3#3)(2013-1#3)(2013-8#1)
patients (one##2##2##(1995-5#1)(2011-2#1)
patients (p &lt##4##3##(1993-11#1)(1994-6#1)(2011-1#2)
patients (p = 0##2##4##(1993-1#1)(2011-2#1)
patients (p##8##2##(1991-8#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-6#1)(2011-1#2)(2011-2#1)
patients (pts) with##2##3##(1996-3#1)(2010-12#1)
patients (pts)##4##2##(1996-3#1)(2007-7#1)(2010-12#1)(2010-3#1)
patients (range of 1##2##4##(2008-1#2)
patients (range##6##2##(1990-6#1)(1991-8#1)(2008-1#2)(2009-8#2)
patients (the##3##2##(1997-7#1)(2007-11#1)(2008-7#1)
patients (three##3##2##(1990-11#1)(2007-7#1)(2010-3#1)
patients -##6##2##(2007-7#1)(2007-8#3)(2008-7#1)(2011-2#1)
patients 18##2##2##(2009-8#1)(2013-1#1)
patients 3##2##2##(2013-1#2)
patients a##10##2##(1990-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(2007-10#1)(2007-12#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
patients about the##5##3##(1992-5#1)(1997-8#1)(2007-7#1)(2008-8#1)(2011-1#1)
patients about##9##2##(1990-3#1)(1992-12#1)(1992-5#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-8#2)(2011-1#1)
patients above 35 years of age##2##6##(2012-3#2)
patients above##4##2##(2007-7#1)(2008-12#1)(2012-3#2)
patients according to actuarial##2##4##(2011-2#2)
patients according to##10##3##(1994-9#1)(1995-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#2)
patients achieved complete##2##3##(2009-12#1)(2011-2#1)
patients achieved the target reduction##2##5##(2008-3#2)
patients achieved##10##2##(1993-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients achieving##5##2##(2008-3#1)(2008-8#1)(2010-8#2)(2013-1#1)
patients actually##2##2##(1991-12#1)(1993-12#1)
patients admitted for##2##3##(1990-3#1)(2008-3#1)
patients admitted in the##2##4##(2007-10#1)(2008-3#1)
patients admitted in##5##3##(1994-3#1)(2007-10#1)(2008-3#1)(2010-4#1)(2012-3#1)
patients admitted to LSP##2##4##(2006-8#2)
patients admitted to SHR##2##4##(2006-8#2)
patients admitted to a##3##4##(1991-8#1)(2007-10#1)(2008-3#1)
patients admitted to hospital##3##4##(1990-9#1)(2012-12#1)(2013-8#1)
patients admitted to our medical service##2##6##(2008-3#2)
patients admitted to our##3##4##(2008-3#2)(2012-2#1)
patients admitted to the emergency department##2##6##(2011-2#2)
patients admitted to the##7##4##(1991-5#1)(1997-4#1)(2007-10#1)(2009-10#1)(2011-2#2)(2012-3#1)
patients admitted to##24##3##(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1997-4#1)(2006-8#4)(2007-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
patients admitted with acute##3##4##(2007-10#1)(2008-3#2)
patients admitted with##9##3##(1993-9#1)(1995-9#1)(2006-8#1)(2007-10#3)(2008-3#2)(2008-7#1)
patients admitted##45##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1993-9#1)(1994-3#1)(1995-9#1)(1997-4#1)(2006-8#5)(2007-10#8)(2008-12#1)(2008-3#7)(2008-7#2)(2009-10#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
patients affected by diabetes##2##4##(2008-1#1)(2013-1#1)
patients affected by insulin-dependent##2##4##(2013-1#2)
patients affected by systemic##2##4##(1991-5#1)(1993-3#1)
patients affected by##34##3##(1990-6#3)(1990-8#1)(1991-3#1)(1991-5#4)(1991-6#2)(1993-3#2)(1994-9#1)(1995-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-5#2)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#4)
patients affected with##4##3##(1992-2#1)(1993-6#1)(2008-5#1)(2011-3#1)
patients affected##39##2##(1990-6#3)(1990-8#1)(1991-3#1)(1991-5#4)(1991-6#2)(1992-2#1)(1993-3#2)(1993-6#1)(1994-9#1)(1995-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-5#3)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#4)
patients after resection##2##3##(2007-11#1)(2008-6#1)
patients after the##3##3##(1997-8#1)(2008-10#1)(2008-12#1)
patients after total hip replacement##2##5##(2010-10#1)(2013-1#1)
patients after total##3##3##(2007-8#1)(2010-10#1)(2013-1#1)
patients after treatment##2##3##(2007-10#1)(2008-7#1)
patients after##62##2##(1990-11#1)(1990-12#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-4#1)(1996-5#1)(1997-8#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#8)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-3#3)(2013-1#4)(2013-8#2)
patients against##3##2##(1993-9#1)(1996-9#1)(2010-12#1)
patients age 30 years and older##2##5##(2012-2#2)
patients age##4##2##(2007-11#1)(2011-2#1)(2012-2#2)
patients aged 65 years and##2##5##(1994-2#1)(2011-1#1)
patients aged 65##3##3##(1994-2#1)(1994-6#1)(2011-1#1)
patients aged 85 years##2##4##(2007-10#1)(2008-7#1)
patients aged over##3##3##(1990-6#1)(1992-9#1)(2008-10#1)
patients aged##26##2##(1990-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-6#2)(1996-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#6)(2013-8#2)
patients all##2##2##(2008-4#1)(2008-7#1)
patients already##2##2##(2007-7#1)(2008-1#1)
patients also had##3##3##(2007-7#1)(2008-7#1)(2009-1#1)
patients also suffered from##2##4##(1990-3#1)(2010-5#1)
patients also##12##2##(1990-3#1)(1992-6#1)(1996-1#1)(2007-7#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
patients among##3##2##(1992-4#1)(1994-7#1)(2011-2#1)
patients and 13##2##3##(1995-5#1)(2009-6#1)
patients and 20##2##3##(1993-6#1)(2008-11#1)
patients and 23##3##3##(2008-11#1)(2008-6#1)(2011-2#1)
patients and 27##2##3##(2008-1#1)(2008-4#1)
patients and 30##2##3##(2012-3#1)(2013-1#1)
patients and 7##2##3##(1995-5#2)
patients and 77%##2##3##(1992-9#1)(2012-12#1)
patients and a##3##3##(1990-9#1)(2007-8#1)(2008-1#1)
patients and all##2##3##(2007-7#1)(2008-1#1)
patients and also##2##3##(2010-10#1)(2011-2#1)
patients and an##2##3##(1990-11#1)(2007-8#1)
patients and by##5##3##(1992-5#1)(1995-8#1)(2007-8#1)(2012-1#2)
patients and can##3##3##(2010-5#1)(2010-9#1)(2011-2#1)
patients and care##2##3##(2010-5#1)(2013-8#1)
patients and clinicians##3##3##(2007-12#1)(2008-3#1)(2009-5#1)
patients and community##2##3##(1997-3#1)(2008-8#1)
patients and conducted##2##3##(1993-2#1)(2009-10#1)
patients and consisted of##2##4##(1991-3#1)(2008-7#1)
patients and control subjects##4##4##(1995-5#2)(1996-7#2)
patients and controls were##2##4##(1997-5#1)(2008-1#1)
patients and controls##20##3##(1994-8#1)(1995-12#1)(1997-5#3)(2008-1#2)(2008-12#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#6)(2013-8#2)
patients and delayed##2##3##(1992-5#1)(2008-5#1)
patients and distant##2##3##(2008-10#1)(2011-2#1)
patients and elderly##2##3##(2008-7#1)(2013-1#1)
patients and even##2##3##(1992-12#1)(2007-7#1)
patients and families##8##3##(1990-12#1)(1991-2#1)(1994-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)
patients and family members##3##4##(1992-12#1)(1993-1#1)(2008-6#1)
patients and family##4##3##(1992-12#1)(1993-1#1)(1997-8#1)(2008-6#1)
patients and for##2##3##(1992-4#1)(1993-2#1)
patients and from##2##3##(2008-5#2)
patients and good##2##3##(1992-2#1)(2007-10#1)
patients and has##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
patients and health##4##3##(1992-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
patients and healthy controls##3##4##(2007-2#1)(2008-7#1)(2011-2#1)
patients and healthy subjects##5##4##(1994-1#1)(2008-12#2)(2008-7#1)(2011-2#1)
patients and healthy volunteers##2##4##(1996-7#1)(2008-5#1)
patients and healthy##15##3##(1994-1#1)(1996-7#1)(2007-2#1)(2008-12#3)(2008-5#2)(2008-7#2)(2011-2#2)(2012-2#3)
patients and how##2##3##(1992-12#1)(2012-1#1)
patients and in the##2##4##(1992-10#1)(2008-8#1)
patients and in##22##3##(1990-2#1)(1992-10#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#3)(2010-12#1)(2012-12#1)(2013-1#2)
patients and its##9##3##(1991-6#1)(1996-9#1)(2008-1#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
patients and less than##2##4##(1991-2#1)(2008-8#1)
patients and matched controls##2##4##(1997-5#1)(2013-1#1)
patients and may be##3##4##(1990-11#1)(2008-1#1)(2008-7#1)
patients and may##6##3##(1990-11#1)(2007-7#1)(2008-1#2)(2008-7#1)(2010-10#1)
patients and might be##2##4##(2008-7#1)(2011-1#1)
patients and normal controls##2##4##(2008-7#1)(2008-8#1)
patients and normal in##2##4##(2008-7#2)
patients and normal##9##3##(1993-9#1)(1995-5#1)(1996-7#2)(2008-5#1)(2008-7#3)(2008-8#1)
patients and nurses##4##3##(2009-12#2)(2010-10#1)(2010-3#1)
patients and on##3##3##(1993-6#1)(2007-7#1)(2012-12#1)
patients and only##2##3##(1990-6#1)(1994-2#1)
patients and patients with##3##4##(1992-10#1)(1993-8#1)(2011-2#1)
patients and patients##7##3##(1990-11#1)(1992-10#1)(1993-8#1)(2007-5#1)(2011-2#2)(2012-3#1)
patients and physicians##5##3##(1994-2#1)(1996-1#1)(2011-2#1)(2012-1#2)
patients and prevent##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
patients and professionals##2##3##(1996-8#1)(2009-8#1)
patients and providers##7##3##(1991-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-4#1)(2013-1#1)
patients and should be##2##4##(1997-3#1)(2011-3#1)
patients and should##3##3##(1997-3#2)(2011-3#1)
patients and society##2##3##(2007-12#1)(2013-1#1)
patients and staff##4##3##(2010-4#2)(2011-2#1)(2013-8#1)
patients and that##2##3##(2008-12#1)(2008-5#1)
patients and the elderly##2##4##(2008-9#1)(2012-2#1)
patients and the##29##3##(1990-11#1)(1991-11#1)(1991-6#1)(1991-9#1)(1993-12#1)(1996-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)
patients and their families##15##4##(1990-10#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2008-11#4)(2009-9#1)(2011-2#1)(2012-3#1)
patients and their parents##3##4##(1995-12#1)(2008-10#1)(2010-3#1)
patients and their partners##3##4##(2008-7#2)(2011-2#1)
patients and their physicians##4##4##(1996-3#1)(2008-11#2)(2012-3#1)
patients and their relatives##3##4##(1991-6#1)(2007-7#1)(2008-11#1)
patients and their##39##3##(1990-10#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)
patients and therapists##2##3##(1995-12#1)(2013-1#1)
patients and there##3##3##(2007-10#1)(2008-4#1)(2012-2#1)
patients and those with##5##4##(1992-6#1)(1993-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
patients and those##7##3##(1992-6#1)(1993-3#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
patients and to compare##2##4##(2010-10#1)(2013-8#1)
patients and to##10##3##(1990-10#1)(1996-3#1)(2007-7#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#2)
patients and volunteers##3##3##(1992-3#2)(1996-7#1)
patients and was##4##3##(2008-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
patients and with##2##3##(2008-7#1)(2009-9#1)
patients and##547##2##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#3)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#5)(1995-2#5)(1995-3#3)(1995-5#6)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#3)(1996-7#9)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#1)(1997-5#5)(1997-7#1)(1997-8#5)(2006-10#3)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#13)(2007-8#9)(2008-1#19)(2008-10#15)(2008-11#19)(2008-12#11)(2008-3#6)(2008-4#10)(2008-5#8)(2008-6#6)(2008-7#33)(2008-8#9)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#8)(2011-2#37)(2011-3#1)(2011-9#1)(2012-1#7)(2012-12#14)(2012-2#8)(2012-3#14)(2012-4#1)(2012-5#1)(2013-1#31)(2013-7#1)(2013-8#14)
patients and/or##3##2##(1996-3#1)(2008-11#2)
patients appeared##2##2##(1991-6#1)(2008-7#1)
patients appears##3##2##(2008-1#1)(2008-2#1)(2010-1#1)
patients appropriate##2##2##(2008-6#1)(2010-9#1)
patients are able to##2##4##(2007-7#1)(2013-1#1)
patients are advised to##2##4##(1997-4#1)(2012-2#1)
patients are affected##2##3##(2009-4#1)(2011-2#1)
patients are alive and##3##4##(1992-5#1)(2007-8#1)(2011-2#1)
patients are alive##6##3##(1992-5#1)(2007-8#1)(2008-6#2)(2011-2#2)
patients are asymptomatic##3##3##(1993-1#1)(2008-7#1)(2013-1#1)
patients are at greater risk of##2##6##(2008-8#1)(2010-10#1)
patients are at high risk##2##5##(1992-5#1)(2012-12#1)
patients are at##7##3##(1992-5#1)(2008-2#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
patients are available##2##3##(2010-12#1)(2011-2#1)
patients are considered##2##3##(1997-4#1)(2009-11#1)
patients are described##3##3##(1990-2#1)(1991-11#1)(1996-3#1)
patients are diagnosed##2##3##(2008-1#1)(2010-7#1)
patients are discussed in##2##4##(1993-11#1)(2012-12#1)
patients are discussed##5##3##(1993-11#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-2#1)
patients are disease free##2##4##(1990-6#1)(2008-6#1)
patients are generally##2##3##(2007-12#1)(2011-2#1)
patients are healthy##2##3##(1997-3#1)(2007-11#1)
patients are in##2##3##(1997-6#1)(2007-8#1)
patients are more likely to##2##5##(2010-12#1)(2011-2#1)
patients are more##4##3##(2007-8#1)(2010-12#1)(2011-2#2)
patients are not##3##3##(2009-5#1)(2011-2#1)(2013-1#1)
patients are often##4##3##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients are presented##2##3##(2008-8#1)(2013-1#1)
patients are prone to##3##4##(1995-10#1)(2007-11#1)(2008-11#1)
patients are still alive##3##4##(1990-9#1)(1992-9#1)(2011-2#1)
patients are still##5##3##(1990-2#1)(1990-9#1)(1992-9#1)(2008-10#1)(2011-2#1)
patients are treated##3##3##(1997-2#1)(2010-3#1)(2013-8#1)
patients are##145##2##(1990-2#2)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#4)
patients as a##5##3##(1994-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2009-10#1)
patients as compared to##3##4##(1994-10#1)(1997-8#1)(2008-7#1)
patients as compared with##3##4##(1994-2#1)(1995-12#1)(2006-10#1)
patients as compared##6##3##(1994-10#1)(1994-2#1)(1995-12#1)(1997-8#1)(2006-10#1)(2008-7#1)
patients as it##2##3##(2007-7#1)(2012-3#1)
patients as well as##6##4##(1992-8#1)(1996-12#1)(2008-2#1)(2008-7#2)(2011-2#1)
patients as well##8##3##(1992-8#1)(1992-9#1)(1996-12#1)(2008-2#1)(2008-7#2)(2009-3#1)(2011-2#1)
patients as##37##2##(1992-8#1)(1992-9#1)(1993-1#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
patients assigned##2##2##(1995-3#1)(2008-9#1)
patients associated##2##2##(1995-5#1)(2007-8#1)
patients at ICUs of##2##4##(2012-2#2)
patients at a##6##3##(1990-5#1)(1995-5#1)(1997-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
patients at each##2##3##(2013-8#2)
patients at high risk for multidrug resistance##2##7##(2013-1#2)
patients at high risk for##5##5##(2007-8#1)(2008-4#1)(2013-1#3)
patients at high risk of##4##5##(1993-1#1)(2008-5#1)(2008-7#1)(2008-8#1)
patients at high risk##9##4##(1993-1#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#3)
patients at high##10##3##(1993-1#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#3)
patients at higher risk##3##4##(2006-10#1)(2007-11#1)(2010-10#1)
patients at home##2##3##(1993-3#1)(1997-4#1)
patients at relapse##2##3##(1994-5#1)(2011-2#1)
patients at risk for##10##4##(1993-5#1)(1997-3#1)(2006-10#1)(2008-3#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)
patients at risk of developing pressure##2##6##(2012-3#2)
patients at risk of developing##4##5##(1992-12#1)(2008-8#1)(2012-3#2)
patients at risk of##9##4##(1991-9#1)(1992-12#1)(1993-9#1)(2008-8#2)(2010-5#1)(2012-3#2)(2013-1#1)
patients at risk##24##3##(1991-9#1)(1992-12#1)(1993-5#1)(1993-9#1)(1997-3#1)(2006-10#2)(2008-3#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#3)
patients at surgery was 13##2##5##(2007-8#1)(2013-1#1)
patients at the end of##2##5##(2008-1#1)(2012-12#1)
patients at the same##2##4##(1997-8#1)(2010-7#1)
patients at the stage of##2##5##(2008-9#1)(2013-1#1)
patients at the##14##3##(1993-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
patients at two##3##3##(1991-3#1)(2007-1#1)(2008-1#1)
patients at##98##2##(1990-5#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-8#1)(2006-10#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-1#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#8)(2013-8#4)
patients attending a##3##3##(1991-8#2)(2008-3#1)
patients attending the##4##3##(1993-2#1)(2008-11#1)(2010-12#1)(2011-2#1)
patients attending##21##2##(1991-8#2)(1992-12#1)(1993-2#1)(1995-10#1)(2007-7#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
patients available##3##2##(1991-1#1)(2008-5#1)(2012-5#1)
patients away##2##2##(1991-3#1)(2008-6#1)
patients based on##3##3##(1996-12#1)(2007-10#1)(2012-1#1)
patients be##2##2##(1997-3#1)(1997-8#1)
patients became##2##2##(2007-1#1)(2007-7#1)
patients because of the##2##4##(2007-8#1)(2011-2#1)
patients because of##6##3##(2007-8#2)(2008-6#2)(2010-3#1)(2011-2#1)
patients because the##2##3##(1996-3#1)(2010-12#1)
patients because##11##2##(1995-6#1)(1996-3#1)(2007-8#2)(2008-10#1)(2008-6#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
patients become##5##2##(1995-2#1)(1997-6#1)(2008-5#1)(2009-5#1)(2010-9#1)
patients before and after##3##4##(1996-7#1)(2008-7#1)(2013-7#1)
patients before treatment##2##3##(2008-10#2)
patients before##13##2##(1991-2#1)(1994-12#1)(1994-5#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
patients being dialyzed##2##3##(2007-7#2)
patients being##11##2##(1993-2#1)(1995-12#1)(1995-3#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
patients believed that##2##3##(1994-2#1)(1996-2#1)
patients belonging to##3##3##(1997-8#1)(2008-1#1)(2012-12#1)
patients below the age of##3##5##(1997-8#2)(2010-3#1)
patients benefit##3##2##(2008-6#1)(2008-8#1)(2013-1#1)
patients better##2##2##(2006-10#1)(2007-6#1)
patients between##7##2##(1996-9#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
patients both##3##2##(1990-12#1)(2013-1#2)
patients but also##3##3##(1995-9#1)(2010-6#1)(2010-8#1)
patients but##16##2##(1991-1#1)(1991-12#1)(1995-9#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-3#1)
patients by a##7##3##(1990-12#1)(1996-12#1)(2007-11#1)(2007-8#1)(2010-2#1)(2012-1#1)(2013-8#1)
patients by the##2##3##(2011-2#1)(2012-3#1)
patients by##39##2##(1990-12#1)(1990-2#2)(1991-3#2)(1993-8#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
patients came to that of##2##5##(2011-2#2)
patients came##4##2##(2008-7#1)(2011-2#2)(2013-8#1)
patients can be##14##3##(1990-12#1)(1991-3#1)(1992-3#1)(1997-3#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-5#2)(2009-11#1)
patients can make##2##3##(2008-6#1)(2008-7#1)
patients can not##2##3##(1993-1#1)(2010-8#1)
patients can##28##2##(1990-11#1)(1990-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-3#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2010-8#1)(2010-9#1)(2011-2#1)
patients candidate for valvular heart surgery##4##6##(2013-1#4)
patients cared##2##2##(2008-3#1)(2009-3#1)
patients carried the##2##3##(1991-3#1)(2012-12#1)
patients categorized##2##2##(2013-1#1)(2013-7#1)
patients chronically treated with##2##4##(1993-2#1)(1994-8#1)
patients chronically##4##2##(1993-2#1)(1994-8#1)(2008-11#2)
patients clinically##2##2##(2007-11#1)(2008-7#1)
patients combined with##3##3##(2008-6#1)(2012-3#2)
patients come##2##2##(1993-2#1)(2013-1#1)
patients coming to##2##3##(1995-12#1)(2013-1#1)
patients coming##4##2##(1990-9#1)(1995-12#1)(2013-1#2)
patients compared to##10##3##(1993-1#1)(2007-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
patients compared with healthy controls##2##5##(2008-10#1)(2008-6#1)
patients compared with the##3##4##(1993-8#1)(2008-11#1)(2012-3#1)
patients compared with##7##3##(1993-8#1)(1995-11#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
patients compared##17##2##(1993-1#1)(1993-8#1)(1995-11#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#3)
patients complained of severe##2##4##(1990-3#1)(1993-10#1)
patients complained of##6##3##(1990-3#1)(1990-6#1)(1991-11#1)(1993-10#1)(2008-6#1)(2008-8#1)
patients complained##8##2##(1990-3#1)(1990-6#1)(1991-11#1)(1993-10#1)(2008-6#1)(2008-7#2)(2008-8#1)
patients completed the study##3##4##(1992-11#1)(2008-3#1)(2013-1#1)
patients completed the##5##3##(1992-11#1)(2008-3#1)(2010-10#1)(2010-2#1)(2013-1#1)
patients completed##11##2##(1991-3#1)(1992-10#1)(1992-11#1)(1996-7#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-2#2)(2012-12#1)(2013-1#1)
patients confirmed the##2##3##(1994-9#1)(2008-5#1)
patients confirmed##3##2##(1994-9#1)(1997-8#1)(2008-5#1)
patients considering##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
patients continue to##2##3##(1990-3#1)(2008-7#1)
patients continued to##2##3##(1991-3#1)(1997-3#1)
patients correlated with##2##3##(2009-9#1)(2013-8#1)
patients could be##7##3##(1990-12#1)(1990-3#1)(1990-9#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-8#1)
patients could##10##2##(1990-12#1)(1990-3#1)(1990-9#1)(2007-11#2)(2008-1#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-2#1)
patients currently##3##2##(1992-12#1)(2008-8#1)(2012-12#1)
patients decide##2##2##(1994-3#1)(2013-1#1)
patients declared important##2##3##(2007-11#1)(2007-8#1)
patients declared##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
patients delayed##2##2##(1992-5#1)(2013-1#1)
patients delivered##2##2##(1994-9#1)(2013-8#1)
patients demonstrated that##2##3##(2008-11#1)(2011-2#1)
patients demonstrated##7##2##(1991-12#1)(2008-11#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
patients demonstrating##2##2##(2008-7#2)
patients dependent on##2##3##(1991-12#2)
patients despite##2##2##(2007-11#1)(2010-5#1)
patients develop##7##2##(1992-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
patients developed local##2##3##(1991-6#1)(2008-1#1)
patients developed neoplasia among##2##4##(2013-8#2)
patients developed recurrent##2##3##(1996-9#1)(2008-7#1)
patients developed##26##2##(1991-2#1)(1991-6#1)(1994-11#1)(1996-1#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-4#1)(2008-6#1)(2008-7#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-8#2)
patients developing##4##2##(1992-9#1)(1994-3#1)(1996-9#1)(2008-7#1)
patients diagnosed as##3##3##(1997-8#1)(2007-7#1)(2008-11#1)
patients diagnosed to have##2##4##(2007-7#1)(2008-4#1)
patients diagnosed with CF##2##4##(2013-1#2)
patients diagnosed with##24##3##(1991-7#1)(1996-1#1)(2006-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
patients diagnosed##32##2##(1991-7#1)(1991-8#1)(1996-1#1)(1997-8#1)(2006-8#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
patients did not differ significantly from##2##6##(1995-11#1)(2010-12#1)
patients did not differ significantly##3##5##(1993-2#1)(1995-11#1)(2010-12#1)
patients did not have##2##4##(1990-12#1)(2012-12#1)
patients did not##14##3##(1990-11#1)(1990-12#1)(1993-2#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
patients did##18##2##(1990-11#1)(1990-12#1)(1992-12#1)(1993-2#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
patients die##3##2##(2007-11#1)(2008-10#1)(2009-12#1)
patients died (1##2##3##(2013-1#1)(2013-8#1)
patients died during the##2##4##(1993-2#1)(1997-4#1)
patients died from##3##3##(1994-3#1)(1997-4#2)
patients died of the disease##2##5##(1991-6#1)(2008-6#1)
patients died of##12##3##(1990-12#2)(1990-6#1)(1991-4#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-6#3)
patients died##37##2##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-6#1)(1997-4#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-6#5)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
patients differ from##2##3##(2008-3#1)(2011-2#1)
patients differ##3##2##(1995-12#1)(2008-3#1)(2011-2#1)
patients discharged from SHR##2##4##(2006-8#2)
patients discharged from##4##3##(2006-8#3)(2008-9#1)
patients discharged##5##2##(1990-12#1)(2006-8#3)(2008-9#1)
patients discontinued##3##2##(2008-1#1)(2008-7#1)(2012-3#1)
patients displayed##3##2##(2007-10#1)(2007-8#1)(2011-2#1)
patients divided into##2##3##(2008-7#1)(2012-4#1)
patients do not have##2##4##(2008-12#1)(2008-7#1)
patients do not need##2##4##(1996-11#1)(2008-1#1)
patients do not##9##3##(1994-12#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-7#1)
patients do##11##2##(1994-12#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-7#1)
patients does not##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
patients does##4##2##(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
patients dropped out##2##3##(1992-11#1)(2013-1#1)
patients due to##2##3##(2012-12#1)(2012-2#1)
patients during a##4##3##(2008-12#1)(2010-4#1)(2011-2#2)
patients during acute##2##3##(1995-11#1)(2007-7#1)
patients during the first##3##4##(1990-6#1)(2010-8#1)(2011-2#1)
patients during the##7##3##(1990-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
patients during##30##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-6#1)(1993-12#1)(1993-8#1)(1995-11#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
patients each##4##2##(1997-8#1)(2008-1#1)(2008-7#1)(2009-2#1)
patients either##2##2##(2007-2#1)(2011-2#1)
patients eligible for##4##3##(1997-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
patients enrolled in the study##2##5##(2008-11#1)(2012-3#1)
patients enrolled in the##4##4##(2008-11#1)(2010-4#1)(2012-2#1)(2012-3#1)
patients enrolled in##5##3##(2008-11#1)(2010-4#2)(2012-2#1)(2012-3#1)
patients enrolled##9##2##(2008-11#1)(2008-7#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
patients entered the study##3##4##(1991-11#1)(1992-6#1)(2013-1#1)
patients entered##4##2##(1991-11#1)(1992-6#1)(1993-11#1)(2013-1#1)
patients evaluated##5##2##(1992-11#1)(2007-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
patients eventually##3##2##(2010-3#1)(2010-5#1)(2013-8#1)
patients evolving##2##2##(2009-4#1)(2011-2#1)
patients examined##3##2##(2006-10#1)(2008-4#1)(2011-2#1)
patients except one##3##3##(1997-8#1)(2007-8#1)(2008-1#1)
patients except##5##2##(1997-8#1)(2007-8#1)(2008-1#1)(2008-3#2)
patients exhibit##2##2##(2007-8#1)(2008-7#1)
patients exhibited##3##2##(2008-9#1)(2009-9#1)(2013-8#1)
patients experience##4##2##(1992-5#1)(1995-1#1)(2011-2#1)(2012-12#1)
patients experienced a significant##2##4##(1994-1#1)(2008-8#1)
patients experienced a##8##3##(1992-2#1)(1994-1#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
patients experienced##30##2##(1990-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1994-1#1)(1994-3#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-7#4)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-3#3)(2013-1#2)
patients experiencing##8##2##(1994-2#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-3#1)(2012-2#1)
patients expired##2##2##(1997-3#1)(2008-1#1)
patients exposed to##5##3##(1996-9#1)(1997-2#1)(2008-7#1)(2010-5#1)(2013-1#1)
patients fail to##3##3##(1996-1#1)(2009-10#1)(2010-12#1)
patients filled##2##2##(1994-9#1)(2010-2#1)
patients first##2##2##(1993-2#1)(1995-3#1)
patients followed at##2##3##(2008-1#1)(2008-10#1)
patients followed##7##2##(2008-1#2)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)
patients following##9##2##(1991-1#1)(1991-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2011-2#1)(2013-1#3)
patients for the##2##3##(1990-6#1)(2011-2#1)
patients for treatment##3##3##(1992-9#1)(1995-9#1)(1997-3#1)
patients for whom##5##3##(1990-2#1)(1995-11#1)(1996-1#1)(2008-7#1)(2013-1#1)
patients for##56##2##(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-1#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-1#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
patients found##2##2##(1990-2#1)(2008-2#1)
patients frequently##2##2##(1995-11#1)(2011-3#1)
patients from a single##2##4##(2007-7#1)(2010-12#1)
patients from a##7##3##(1996-2#1)(2007-7#1)(2010-12#1)(2010-5#2)(2011-2#1)(2013-1#1)
patients from all##2##3##(2007-12#1)(2010-8#1)
patients from each##2##3##(1991-2#1)(2008-8#1)
patients from endemic areas##2##4##(1993-3#1)(2007-12#1)
patients from group##4##3##(1996-3#2)(2008-3#1)(2008-5#1)
patients from our##2##3##(2008-8#1)(2010-3#1)
patients from the control group##2##5##(2007-10#1)(2011-2#1)
patients from the##9##3##(1995-4#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-3#1)
patients from two##3##3##(2008-8#1)(2011-1#1)(2012-12#1)
patients from##74##2##(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#3)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#9)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)
patients fulfilled the##3##3##(2008-1#1)(2008-6#1)(2008-7#1)
patients fulfilled##4##2##(2008-1#1)(2008-6#1)(2008-7#1)(2009-6#1)
patients fulfilling##2##2##(1995-11#1)(2012-3#1)
patients generally##2##2##(2008-7#1)(2010-3#1)
patients given placebo##2##3##(1995-2#1)(2008-3#1)
patients given##6##2##(1995-2#1)(1996-5#1)(2008-3#2)(2013-1#2)
patients going##2##2##(1990-2#1)(2007-8#1)
patients group##2##2##(2011-2#2)
patients groups##2##2##(1995-12#1)(2007-7#1)
patients had a fistula##2##4##(1991-8#1)(2007-7#1)
patients had a history of##2##5##(2007-7#1)(2010-6#1)
patients had a mean##2##4##(2008-1#1)(2008-7#1)
patients had a normal##2##4##(1992-9#1)(2007-10#1)
patients had a significantly##2##4##(2008-7#1)(2011-2#1)
patients had a similar##2##4##(2010-3#1)(2011-1#1)
patients had a##42##3##(1990-2#1)(1990-9#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-5#1)(1996-12#1)(2007-10#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#3)(2008-8#1)(2009-3#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
patients had an##15##3##(1990-11#1)(1992-2#1)(1993-11#1)(1996-6#1)(2007-10#1)(2007-8#2)(2008-6#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
patients had at least one##2##5##(2008-10#1)(2012-3#1)
patients had at least##3##4##(1994-2#1)(2008-10#1)(2012-3#1)
patients had been diagnosed with the##2##6##(2013-1#2)
patients had been diagnosed with##3##5##(2011-2#1)(2013-1#2)
patients had been previously treated with##2##6##(1992-8#1)(2012-3#1)
patients had been treated##3##4##(1997-6#1)(2008-5#1)(2012-3#1)
patients had been##14##3##(1990-12#1)(1990-3#1)(1992-8#1)(1997-6#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
patients had carcinoma of the##2##5##(1990-9#2)
patients had clinical##2##3##(1991-2#1)(2008-7#1)
patients had complete##6##3##(1995-2#1)(2007-7#1)(2008-3#3)(2012-3#1)
patients had disease##3##3##(1995-12#3)
patients had elevated##3##3##(1991-4#2)(1992-3#1)
patients had excellent results##2##4##(1990-6#1)(2007-8#1)
patients had excellent##3##3##(1990-6#1)(2007-8#1)(2013-1#1)
patients had failed##3##3##(1991-4#1)(2007-11#1)(2012-12#1)
patients had had##6##3##(1991-2#1)(1992-8#1)(1996-6#2)(2008-10#1)(2008-6#1)
patients had higher##3##3##(2008-11#1)(2013-1#2)
patients had history of##3##4##(2007-7#1)(2013-1#2)
patients had low##2##3##(2007-10#1)(2008-4#1)
patients had lower##3##3##(2007-10#1)(2009-3#1)(2013-8#1)
patients had marked##2##3##(2008-7#1)(2012-12#1)
patients had massive##2##3##(1992-9#1)(1994-12#1)
patients had moderate##2##3##(2008-6#1)(2012-3#1)
patients had more##3##3##(1990-5#1)(2007-1#1)(2007-8#1)
patients had no##8##3##(1991-6#1)(1992-10#2)(1995-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
patients had normal##2##3##(1990-3#1)(1991-8#1)
patients had not##2##3##(1991-4#1)(2008-10#1)
patients had occlusive##2##3##(2007-10#2)
patients had one or more##2##5##(2011-1#1)(2011-2#1)
patients had partial##2##3##(1990-2#1)(2007-10#1)
patients had persistent##2##3##(1993-1#1)(1993-3#1)
patients had received##4##3##(1990-2#1)(1992-8#1)(2007-7#1)(2008-7#1)
patients had recurrent##2##3##(1992-6#1)(2011-2#1)
patients had reduced##2##3##(2007-11#1)(2011-2#1)
patients had significantly##5##3##(1996-5#1)(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
patients had sinus node disease##2##5##(1992-4#1)(2008-3#1)
patients had symptoms of##2##4##(1991-2#1)(2008-6#1)
patients had the##3##3##(2006-10#1)(2008-3#1)(2010-4#1)
patients had type##3##3##(1997-8#1)(2012-4#2)
patients had undergone previous##2##4##(2007-8#1)(2011-2#1)
patients had undergone##4##3##(1991-2#1)(2006-8#1)(2007-8#1)(2011-2#1)
patients had vivax malaria##2##4##(2007-2#2)
patients had##317##2##(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#5)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#5)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#4)(1997-3#4)(1997-6#1)(1997-8#4)(2006-10#3)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#11)(2007-11#7)(2007-12#2)(2007-2#2)(2007-7#13)(2007-8#10)(2007-9#2)(2008-1#7)(2008-10#6)(2008-11#6)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#7)(2008-7#24)(2008-8#4)(2008-9#1)(2009-3#5)(2010-1#1)(2010-12#1)(2010-3#5)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#24)(2012-12#4)(2012-2#6)(2012-3#12)(2012-4#2)(2013-1#17)(2013-8#4)
patients harbouring##2##2##(2011-2#1)(2013-1#1)
patients has been##7##3##(1995-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2012-2#1)(2013-1#2)
patients has##20##2##(1990-3#1)(1994-3#1)(1995-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-5#1)(2009-1#1)(2010-11#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
patients have a higher##2##4##(2008-8#1)(2012-2#1)
patients have a##15##3##(1996-11#1)(1997-3#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
patients have an increased##2##4##(1990-12#1)(2008-7#1)
patients have an##3##3##(1990-12#1)(2008-5#1)(2008-7#1)
patients have been described##2##4##(1997-3#1)(2006-10#1)
patients have been reported##2##4##(2007-10#1)(2008-1#1)
patients have been treated##4##4##(1990-5#1)(1991-2#1)(1991-3#1)(1995-2#1)
patients have been##24##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#2)(2008-1#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
patients have contributed to##2##4##(1995-6#1)(2010-7#1)
patients have difficulty##2##3##(2008-4#1)(2012-12#1)
patients have experienced##2##3##(1990-6#1)(1997-6#1)
patients have had##2##3##(2007-8#1)(2008-1#1)
patients have multiple##2##3##(1993-3#1)(2008-7#1)
patients have not##2##3##(1997-3#1)(2008-3#1)
patients have to be##4##4##(1996-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
patients have to##6##3##(1996-2#1)(2007-12#1)(2010-12#2)(2011-1#1)(2011-2#1)
patients have##101##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-3#3)(1997-6#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-12#1)(2010-10#1)(2010-12#4)(2010-3#4)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
patients having a##2##3##(1996-2#1)(2012-3#1)
patients having##18##2##(1991-5#1)(1991-8#1)(1995-12#1)(1996-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-3#3)(2013-8#1)
patients homozygous##2##2##(1995-12#1)(1997-7#1)
patients hospitalised in##2##3##(1991-11#1)(2007-8#1)
patients hospitalised##3##2##(1991-11#1)(2007-8#1)(2013-7#1)
patients hospitalized for acute##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
patients hospitalized for##10##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-3#1)
patients hospitalized in the same##2##5##(1990-3#1)(1993-9#1)
patients hospitalized in##5##3##(1990-3#1)(1993-9#1)(2007-11#1)(2007-8#1)(2012-12#1)
patients hospitalized with##6##3##(1993-2#1)(2008-3#1)(2010-4#1)(2012-12#2)(2013-1#1)
patients hospitalized##23##2##(1990-3#1)(1993-2#2)(1993-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2012-12#4)(2012-3#1)(2013-1#1)
patients identified##4##2##(1996-11#1)(2008-3#1)(2010-11#1)(2010-8#1)
patients if they are##2##4##(1991-5#1)(2008-1#1)
patients if##4##2##(1991-5#1)(2008-1#1)(2010-12#1)(2013-1#1)
patients improved##5##2##(1995-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
patients in Egypt##2##3##(2007-7#2)
patients in Europe##2##3##(2008-1#1)(2008-7#1)
patients in Japan##3##3##(2007-10#1)(2008-1#1)(2008-10#1)
patients in Ontario##3##3##(2007-12#2)(2011-2#1)
patients in a tertiary care hospital in##2##7##(2008-11#1)(2011-2#1)
patients in a##25##3##(1990-5#1)(1991-12#1)(1991-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-9#2)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#4)(2012-3#1)(2013-8#1)
patients in acute##3##3##(1992-1#1)(2011-1#2)
patients in an##5##3##(1991-3#1)(1992-12#1)(1997-1#1)(2008-10#1)(2012-2#1)
patients in both groups were##2##5##(2008-8#1)(2012-3#1)
patients in both groups##7##4##(1994-5#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
patients in classroom teaching##2##4##(2008-11#2)
patients in clinical##2##3##(1995-12#1)(2008-5#1)
patients in community##2##3##(1990-6#1)(1993-2#1)
patients in comparison##2##3##(1995-12#1)(2011-2#1)
patients in critical##3##3##(1991-2#1)(2013-1#2)
patients in different stages of##2##5##(2008-5#1)(2008-7#1)
patients in different##5##3##(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
patients in early##3##3##(1990-11#1)(2012-3#1)(2013-1#1)
patients in either##2##3##(2008-8#1)(2013-1#1)
patients in general##2##3##(1990-6#1)(1994-11#1)
patients in group A##4##4##(1996-6#2)(2007-9#2)
patients in group I##2##4##(2007-7#1)(2013-1#1)
patients in group L##4##4##(1996-3#4)
patients in group S##2##4##(1996-3#1)(2007-8#1)
patients in group##15##3##(1991-3#1)(1996-3#5)(1996-6#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2013-1#1)
patients in long-term##2##3##(1995-3#1)(2008-6#1)
patients in need of##4##4##(1994-6#1)(1995-2#1)(2007-7#1)(2011-2#1)
patients in need##5##3##(1993-12#1)(1994-6#1)(1995-2#1)(2007-7#1)(2011-2#1)
patients in order to detect##2##5##(1990-8#1)(2011-2#1)
patients in order to##5##4##(1990-8#1)(1991-7#1)(2008-4#1)(2010-12#1)(2011-2#1)
patients in other##3##3##(2007-10#1)(2009-8#1)(2013-1#1)
patients in our##2##3##(2007-11#1)(2010-12#1)
patients in primary care##2##4##(2010-4#1)(2013-1#1)
patients in relation to##2##4##(1990-4#1)(2007-10#1)
patients in remission##5##3##(1990-11#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-12#1)
patients in several##2##3##(2010-8#1)(2012-4#1)
patients in the ED##3##4##(2008-11#1)(2012-2#2)
patients in the Jeddah##2##4##(2007-7#2)
patients in the Pacific##2##4##(2008-1#2)
patients in the acute##2##4##(1995-5#1)(1997-5#1)
patients in the control group##4##5##(2007-8#1)(2008-5#1)(2010-4#2)
patients in the experimental##2##4##(1993-12#1)(2010-12#1)
patients in the latter group##2##5##(2008-1#1)(2008-7#1)
patients in the study##2##4##(1994-3#1)(2008-7#1)
patients in the##103##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#2)(1992-2#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#11)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#4)(2010-10#2)(2010-12#1)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
patients in this group##4##4##(1992-9#1)(1995-11#1)(2009-8#1)(2011-2#1)
patients in this series##2##4##(2008-1#1)(2011-2#1)
patients in this study were##2##5##(2007-7#1)(2008-12#1)
patients in this##9##3##(1992-9#1)(1995-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-8#1)(2011-2#2)(2012-2#1)
patients in total##2##3##(2011-2#2)
patients in vitro##2##3##(1994-5#1)(2008-4#1)
patients in which##2##3##(1990-5#1)(2011-2#1)
patients in whom a##2##4##(1990-3#1)(2008-1#1)
patients in whom it##3##4##(1990-3#1)(1991-11#1)(2010-7#1)
patients in whom the##5##4##(1990-12#1)(1991-11#1)(1993-10#1)(2008-7#1)(2013-1#1)
patients in whom##30##3##(1990-12#2)(1990-3#2)(1991-11#4)(1991-2#2)(1991-9#1)(1993-10#1)(1994-12#1)(1994-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
patients in##369##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#5)(1991-12#3)(1991-2#6)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#4)(1995-5#2)(1996-1#1)(1996-11#3)(1996-2#2)(1996-3#6)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#2)(1997-5#2)(1997-7#2)(2006-7#1)(2007-10#5)(2007-11#6)(2007-12#4)(2007-7#15)(2007-8#4)(2007-9#2)(2008-1#19)(2008-10#7)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#18)(2008-8#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#36)(2012-12#4)(2012-2#10)(2012-3#7)(2012-4#1)(2012-6#1)(2013-1#23)(2013-8#8)
patients include##3##2##(2008-1#1)(2008-8#1)(2012-3#1)
patients included##7##2##(1990-9#1)(2007-7#2)(2008-3#1)(2008-8#1)(2011-2#2)
patients including##3##2##(2007-2#1)(2009-8#1)(2013-1#1)
patients increased##4##2##(1990-12#2)(2008-7#1)(2011-2#1)
patients indicate##2##2##(1990-6#1)(2010-7#1)
patients infected by the human immunodeficiency virus (HIV)##2##8##(1996-11#1)(2008-5#1)
patients infected by the##3##4##(1996-11#1)(2008-5#1)(2012-2#1)
patients infected with HIV##2##4##(1991-11#1)(2008-10#1)
patients infected with##5##3##(1991-11#1)(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
patients infected##8##2##(1991-11#1)(1994-11#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
patients initially##2##2##(2010-7#1)(2011-2#1)
patients into three##2##3##(2010-11#1)(2011-2#1)
patients into##10##2##(1997-2#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
patients irradiated due to bone metastases##4##6##(2007-11#4)
patients irradiated##5##2##(2007-11#4)(2013-1#1)
patients is a major##2##4##(2008-6#1)(2010-3#1)
patients is a##10##3##(1991-6#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#1)
patients is an##3##3##(1990-10#1)(1991-4#1)(2011-2#1)
patients is associated with##2##4##(2010-12#1)(2012-2#1)
patients is at##2##3##(1994-5#1)(1995-2#1)
patients is critical to##2##4##(1993-3#1)(1994-12#1)
patients is critical##3##3##(1993-3#1)(1994-12#1)(2009-12#1)
patients is discussed##3##3##(1992-5#1)(1995-11#1)(2010-2#1)
patients is high##2##3##(2008-1#1)(2008-3#1)
patients is less##2##3##(1990-2#1)(2008-1#1)
patients is needed to##2##4##(2006-10#1)(2008-7#1)
patients is not associated with##2##5##(2007-11#1)(2008-7#1)
patients is not##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-10#1)
patients is reported##3##3##(1996-3#1)(2008-10#1)(2008-7#1)
patients is safe and##2##4##(2007-8#1)(2008-1#1)
patients is safe##3##3##(2007-8#1)(2008-1#1)(2008-8#1)
patients is very##2##3##(1993-11#1)(2007-8#1)
patients is##82##2##(1990-10#1)(1990-2#1)(1990-9#2)(1991-4#1)(1991-6#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#7)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
patients it was##3##3##(1994-2#1)(1996-12#1)(2007-11#1)
patients it##4##2##(1994-2#1)(1996-12#1)(2007-11#1)(2007-8#1)
patients known to##3##3##(1996-12#1)(2006-10#1)(2008-7#1)
patients left the hospital##2##4##(1993-6#1)(2012-12#1)
patients left the##3##3##(1993-6#1)(2007-8#1)(2012-12#1)
patients life##2##2##(2007-11#1)(2010-8#1)
patients lived##3##2##(1993-3#1)(2013-1#2)
patients living in##3##3##(1992-1#1)(2011-2#1)(2013-1#1)
patients living##7##2##(1992-1#1)(1995-11#1)(1995-12#1)(2009-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
patients made a##2##3##(2006-12#1)(2009-10#1)
patients made##4##2##(1994-2#1)(1996-5#1)(2006-12#1)(2009-10#1)
patients maintain##2##2##(2006-10#1)(2013-1#1)
patients maintained##4##2##(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
patients make##3##2##(1990-5#1)(2008-12#1)(2011-2#1)
patients managed##3##2##(1995-10#1)(2006-10#1)(2007-11#1)
patients manifested##2##2##(1996-5#1)(2008-7#1)
patients may be##19##3##(1990-7#1)(1991-2#1)(1991-3#1)(1993-3#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)
patients may benefit from##4##4##(1996-6#1)(1996-9#1)(2008-10#1)(2011-2#1)
patients may experience##2##3##(2013-1#1)(2013-8#1)
patients may have a##2##4##(1995-11#1)(1996-7#1)
patients may have##10##3##(1993-9#1)(1995-11#1)(1995-2#1)(1996-7#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
patients may not##2##3##(2012-1#1)(2013-1#1)
patients may require##4##3##(1994-12#1)(2007-12#1)(2013-1#2)
patients may respond##2##3##(2010-1#1)(2012-3#1)
patients may##58##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-11#2)(1995-2#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
patients meeting##2##2##(2007-10#1)(2012-3#1)
patients met the##2##3##(2010-6#1)(2011-2#1)
patients met##3##2##(2010-6#1)(2011-2#1)(2012-12#1)
patients might##3##2##(1996-3#1)(2009-7#1)(2010-8#1)
patients more frequently##2##3##(1990-11#1)(2006-10#1)
patients more than 75 years of age##2##7##(2011-2#2)
patients more##7##2##(1990-11#1)(1990-2#1)(2006-10#1)(2008-3#1)(2011-2#3)
patients most likely to benefit from##2##6##(2007-10#1)(2013-8#1)
patients must be considered##2##4##(1990-8#1)(1997-8#1)
patients must be##4##3##(1990-8#1)(1997-5#1)(1997-8#1)(2012-3#1)
patients must##6##2##(1990-8#1)(1997-5#1)(1997-8#1)(2008-8#1)(2011-2#1)(2012-3#1)
patients need to##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
patients need##10##2##(1996-8#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
patients needed##4##2##(1990-11#1)(1990-2#1)(1992-6#1)(2007-8#1)
patients needing##4##2##(1997-2#1)(2007-8#1)(2008-1#1)(2008-7#1)
patients no##3##2##(1994-11#1)(2008-5#1)(2013-8#1)
patients not receiving##2##3##(1993-12#1)(1994-3#1)
patients not treated with##2##4##(2008-3#1)(2012-3#1)
patients not##20##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(2007-11#1)(2007-8#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
patients observed##3##2##(1990-9#1)(2008-5#1)(2011-2#1)
patients of TA##2##3##(1997-8#2)
patients of a##5##3##(1994-2#1)(1997-3#1)(1997-8#1)(2012-3#1)(2013-8#1)
patients of acute##4##3##(2008-1#1)(2009-11#1)(2010-5#1)(2011-1#1)
patients of all ages##4##4##(1992-3#1)(1993-1#1)(1995-3#1)(2006-10#1)
patients of all##5##3##(1992-3#1)(1993-1#1)(1995-3#1)(2006-10#1)(2007-7#1)
patients of different##3##3##(2008-1#1)(2013-1#2)
patients of group A##2##4##(2007-8#1)(2012-2#1)
patients of group##6##3##(1991-3#1)(2007-8#3)(2012-2#2)
patients of primary##2##3##(2007-7#1)(2013-1#1)
patients of the##13##3##(1991-12#2)(1992-5#1)(1992-6#1)(1995-8#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
patients of this group##2##4##(1993-1#1)(1994-1#1)
patients of this##4##3##(1993-1#1)(1994-1#1)(2008-10#1)(2011-1#1)
patients of whom##2##3##(2008-1#2)
patients of##97##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#3)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#3)(1994-1#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-8#5)(2006-10#1)(2007-10#1)(2007-7#7)(2007-8#5)(2008-1#5)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-11#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#5)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#4)
patients often require##2##3##(2012-2#1)(2013-8#1)
patients often##6##2##(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients older and younger than 65 years##2##7##(2009-8#2)
patients older than 65 years##3##5##(1992-5#1)(2009-1#1)(2011-2#1)
patients older than 65##5##4##(1992-5#1)(2007-11#1)(2007-8#1)(2009-1#1)(2011-2#1)
patients older than##14##3##(1992-5#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
patients older##16##2##(1992-5#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-8#4)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
patients on HD##2##3##(2007-7#2)
patients on a##4##3##(1997-2#1)(2008-10#1)(2010-10#1)(2013-1#1)
patients on chronic dialysis##2##4##(2007-7#1)(2007-8#1)
patients on continuous ambulatory peritoneal dialysis##4##6##(2007-12#4)
patients on dialysis##8##3##(1996-2#1)(2007-7#2)(2008-1#2)(2011-2#3)
patients on hemodialysis in##2##4##(1993-6#1)(2013-1#1)
patients on hemodialysis##8##3##(1991-6#1)(1993-6#1)(2007-7#2)(2008-1#2)(2011-2#1)(2013-1#1)
patients on long-term##2##3##(1993-11#1)(2008-7#1)
patients on maintenance HD##3##4##(2007-7#3)
patients on maintenance hemodialysis##4##4##(2007-7#1)(2008-1#3)
patients on maintenance##7##3##(2007-7#4)(2008-1#3)
patients on peritoneal##2##3##(2007-12#2)
patients on regular##2##3##(2008-1#2)
patients on the##6##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2012-2#1)
patients on##75##2##(1991-11#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-6#1)(1996-2#2)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-7#12)(2007-8#1)(2008-1#10)(2008-10#2)(2008-3#2)(2008-6#3)(2008-7#2)(2008-8#3)(2009-11#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
patients one##2##2##(1990-9#1)(2013-1#1)
patients only##5##2##(1990-2#1)(2007-7#1)(2008-1#1)(2010-3#1)(2010-6#1)
patients ont##2##2##(2011-2#1)(2013-1#1)
patients operated between##2##3##(1993-9#1)(2007-11#1)
patients operated during##2##3##(1990-2#1)(1991-6#1)
patients operated for##7##3##(1991-5#1)(1993-5#1)(1993-9#1)(2007-8#2)(2008-7#1)(2013-8#1)
patients operated in##3##3##(1991-3#2)(1992-6#1)
patients operated on for##4##4##(1990-9#1)(1992-12#2)(2007-8#1)
patients operated on##6##3##(1990-6#1)(1990-9#1)(1992-12#2)(2007-8#2)
patients operated upon##3##3##(1990-11#1)(1992-5#1)(2008-10#1)
patients operated##26##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#3)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-9#2)(2007-11#1)(2007-8#4)(2008-10#1)(2008-7#1)(2013-8#1)
patients or normal##2##3##(1995-11#1)(2011-1#1)
patients or##20##2##(1991-2#1)(1995-11#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-2#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#2)
patients out of 11##2##4##(2008-1#1)(2008-4#1)
patients out of##11##3##(1990-2#1)(1991-8#1)(1993-5#1)(1995-4#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-4#1)(2013-8#1)
patients outside##2##2##(2008-11#1)(2012-3#1)
patients over 1 year of age##2##6##(2011-2#2)
patients over 65 years##3##4##(2007-11#1)(2008-11#1)(2011-2#1)
patients over 65##4##3##(1996-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
patients over 80 years##2##4##(2007-11#1)(2008-9#1)
patients over a##3##3##(1991-5#1)(2008-1#1)(2008-4#1)
patients over the age of##4##5##(2008-3#1)(2011-2#3)
patients over the##5##3##(2007-8#1)(2008-3#1)(2011-2#3)
patients over time##2##3##(1993-12#1)(2008-12#1)
patients over##27##2##(1991-5#1)(1993-12#1)(1996-6#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-2#8)(2012-3#1)
patients participated in##4##3##(1991-1#1)(1991-2#1)(2009-7#1)(2011-1#1)
patients participated##6##2##(1991-1#1)(1991-2#1)(2007-10#1)(2008-12#1)(2009-7#1)(2011-1#1)
patients participating in##2##3##(1996-3#1)(2010-1#1)
patients per year##2##3##(2008-1#1)(2008-7#1)
patients per##7##2##(2007-8#1)(2008-1#4)(2008-7#2)
patients performed##3##2##(1995-11#1)(1996-7#1)(2010-2#1)
patients post##2##2##(2008-1#1)(2009-9#1)
patients prepared##2##2##(2008-8#1)(2012-12#1)
patients present with##5##3##(2008-1#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-1#1)
patients present##7##2##(1994-6#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
patients presented with subarachnoid haemorrhage##2##5##(1997-3#1)(2008-7#1)
patients presented with##13##3##(1991-8#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
patients presented##21##2##(1990-5#1)(1991-8#1)(1992-4#1)(1994-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients presenting for##2##3##(2010-8#2)
patients presenting to the emergency department with chest pain##2##9##(2008-3#2)
patients presenting to the emergency department with##3##7##(2007-10#1)(2008-3#2)
patients presenting to the emergency department##4##6##(2007-10#1)(2008-3#3)
patients presenting to##5##3##(2007-10#1)(2008-3#3)(2012-2#1)
patients presenting with a symptomatic##2##5##(1992-9#1)(2008-8#1)
patients presenting with a##3##4##(1992-9#1)(2008-8#1)(2012-1#1)
patients presenting with acute##7##4##(2007-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-2#1)
patients presenting with##34##3##(1990-12#1)(1992-9#1)(1995-10#1)(1995-5#1)(1997-7#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#2)(2010-1#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)
patients presenting##50##2##(1990-11#1)(1990-12#1)(1992-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1997-7#1)(2007-10#5)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
patients pretreated with##6##3##(1991-6#1)(1992-12#2)(1992-8#2)(1994-8#1)
patients previously treated##2##3##(2008-10#1)(2012-2#1)
patients prior to##8##3##(1991-2#1)(1991-6#1)(1996-1#1)(2008-5#1)(2009-8#1)(2010-3#2)(2010-8#1)
patients prior##9##2##(1991-2#1)(1991-6#1)(1996-1#1)(2008-5#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-2#1)
patients probably##2##2##(1997-6#1)(2011-2#1)
patients produced##2##2##(2009-10#1)(2009-2#1)
patients progressed##2##2##(1991-4#1)(1992-12#1)
patients prone to##2##3##(2008-1#2)
patients quality of##2##3##(2007-11#2)
patients radiosurgery was performed after##2##5##(1996-3#2)
patients randomly divided into##2##4##(2008-6#1)(2010-7#1)
patients ranged from##6##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
patients ranging in age from##2##5##(1993-12#1)(2007-8#1)
patients rated##2##2##(2009-3#1)(2012-3#1)
patients reached##3##2##(1990-10#1)(2007-8#1)(2008-9#1)
patients readmitted within 90 days##2##5##(2011-2#2)
patients receive##4##2##(2007-11#1)(2008-7#1)(2009-8#1)(2010-8#1)
patients received &gt##2##3##(2008-6#1)(2008-7#1)
patients received a total of##2##5##(2008-10#1)(2008-7#1)
patients received a##6##3##(2007-8#1)(2008-10#2)(2008-7#2)(2008-9#1)
patients received an##2##3##(1990-6#1)(2009-9#1)
patients received domperidone##2##3##(2008-7#2)
patients received indinavir##2##3##(2008-5#2)
patients received thrombolytic##2##3##(2007-10#1)(2007-9#1)
patients received##73##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#3)(1990-9#1)(1991-11#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-10#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#10)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
patients receiving Neuprex##2##3##(2008-5#2)
patients receiving a##3##3##(1990-6#1)(1995-3#1)(2007-8#1)
patients receiving chemotherapy##3##3##(1991-4#1)(2008-7#2)
patients receiving dialysis##2##3##(1990-6#1)(2011-1#1)
patients receiving hemodialysis##3##3##(2010-3#1)(2011-1#1)(2013-8#1)
patients receiving high-dose##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
patients receiving low##2##3##(1990-6#1)(2008-8#1)
patients receiving moderately##2##3##(2008-7#1)(2010-12#1)
patients receiving the##2##3##(2008-10#1)(2008-3#1)
patients receiving treatment at the##2##5##(1996-2#1)(2012-2#1)
patients receiving##91##2##(1990-12#1)(1990-3#1)(1990-6#3)(1991-2#1)(1991-4#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#14)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
patients recently##2##2##(1993-6#1)(1997-4#1)
patients recovered##6##2##(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)
patients recovering from##2##3##(2007-8#1)(2008-5#1)
patients recovering##3##2##(2007-8#1)(2008-5#1)(2013-1#1)
patients recruited##6##2##(1992-2#1)(2006-10#1)(2008-1#1)(2008-7#1)(2011-1#2)
patients referred for##13##3##(1992-3#2)(1993-3#1)(1995-11#1)(1996-3#1)(1996-9#1)(2007-8#4)(2011-1#1)(2011-2#1)(2012-2#1)
patients referred to the##5##4##(1992-5#1)(1993-2#1)(2007-11#2)(2008-6#1)
patients referred to##7##3##(1992-5#1)(1993-2#1)(2007-11#2)(2008-12#2)(2008-6#1)
patients referred##22##2##(1992-3#2)(1992-5#1)(1993-2#1)(1993-3#1)(1995-11#1)(1996-3#1)(1996-9#1)(2007-11#2)(2007-8#4)(2008-12#3)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
patients refused##2##2##(1992-9#1)(1994-11#1)
patients regained##3##2##(1996-9#1)(2008-5#1)(2013-1#1)
patients regarding##4##2##(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
patients regardless of##4##3##(1994-12#1)(2007-12#1)(2011-2#2)
patients registered in##2##3##(1997-7#1)(2013-1#1)
patients registered##4##2##(1997-7#2)(2013-1#1)(2013-8#1)
patients rehabilitated##2##2##(2007-8#1)(2010-5#1)
patients relapsed after##2##3##(2007-7#1)(2008-1#1)
patients relapsed##4##2##(1992-6#1)(2007-7#2)(2008-1#1)
patients remain##6##2##(1995-5#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)
patients remained##5##2##(1992-6#1)(2007-7#1)(2008-7#2)(2013-8#1)
patients remains a##2##3##(2007-7#1)(2008-7#1)
patients remains##4##2##(2007-7#1)(2008-7#1)(2011-2#1)(2012-1#1)
patients report##2##2##(2009-5#1)(2011-2#1)
patients reported a##2##3##(1992-5#1)(1993-12#1)
patients reported no##2##3##(2008-6#1)(2010-8#1)
patients reported that##2##3##(2008-7#1)(2012-3#1)
patients reported##21##2##(1991-3#1)(1992-5#2)(1993-12#1)(1993-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-3#1)
patients represent a##2##3##(2009-11#1)(2010-1#1)
patients represents##2##2##(2008-11#1)(2008-4#1)
patients require##4##2##(1994-12#1)(2007-10#1)(2010-11#1)(2012-3#1)
patients required##19##2##(1990-12#1)(1990-3#1)(1992-2#1)(1992-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-6#2)(2008-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
patients requiring hemodialysis##2##3##(2007-7#2)
patients requiring##9##2##(1995-2#1)(1996-9#1)(2007-11#1)(2007-7#2)(2008-6#1)(2011-2#3)
patients respectively##2##2##(1995-11#1)(2007-7#1)
patients respond to##2##3##(1993-2#1)(2012-3#1)
patients responded to treatment##2##4##(1990-2#1)(2010-11#1)
patients responded to##3##3##(1990-2#1)(2008-7#1)(2010-11#1)
patients responded##10##2##(1990-2#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
patients results##2##2##(1996-2#1)(2007-8#1)
patients retained##2##2##(1996-9#1)(2011-2#1)
patients returned to##2##3##(2008-1#1)(2008-7#1)
patients returned##4##2##(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)
patients revealed##4##2##(1990-3#1)(1991-3#1)(1992-3#1)(2013-8#1)
patients reveals##2##2##(1995-2#1)(2010-5#1)
patients scheduled for elective##3##4##(2006-12#1)(2007-8#1)(2011-2#1)
patients scheduled for##9##3##(1994-2#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)
patients scheduled##10##2##(1994-2#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2013-1#1)
patients screened##2##2##(2008-1#1)(2011-2#1)
patients seek##2##2##(2008-3#1)(2012-2#1)
patients seeking treatment##2##3##(2008-12#1)(2008-3#1)
patients seeking##4##2##(2007-11#1)(2008-12#1)(2008-3#1)(2012-3#1)
patients seen in general practice##2##5##(2010-4#2)
patients seen in the##2##4##(1996-3#1)(2008-8#1)
patients seen in##7##3##(1995-2#1)(1996-3#1)(1996-6#1)(2008-8#1)(2010-4#2)(2012-1#1)
patients seen##10##2##(1994-3#1)(1995-2#1)(1996-3#1)(1996-6#1)(2007-7#1)(2008-8#1)(2010-4#2)(2012-1#1)(2012-3#1)
patients selected##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
patients served##2##2##(1995-2#1)(2008-1#1)
patients should be##14##3##(1991-3#1)(1992-3#1)(1993-2#1)(1996-11#1)(1997-1#1)(2008-11#2)(2008-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
patients should have been##2##4##(1992-11#1)(2011-2#1)
patients should include##2##3##(1994-5#1)(2009-12#1)
patients should##26##2##(1991-3#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-11#1)(1997-1#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
patients show##2##2##(2008-4#1)(2008-6#1)
patients showed a higher##2##4##(1990-12#1)(1997-8#1)
patients showed a significant increase##2##5##(1991-6#1)(1994-11#1)
patients showed a significant##4##4##(1991-6#1)(1994-11#1)(2008-10#1)(2011-2#1)
patients showed a##14##3##(1990-12#1)(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#2)
patients showed an improvement in##2##5##(1994-11#1)(2011-2#1)
patients showed an##3##3##(1994-11#1)(2011-2#2)
patients showed complete##2##3##(2012-1#1)(2013-1#1)
patients showed marked##2##3##(2007-2#1)(2008-7#1)
patients showed no##2##3##(1996-7#1)(2013-1#1)
patients showed normal##2##3##(1993-3#1)(2008-7#1)
patients showed significantly##2##3##(2008-7#1)(2010-3#1)
patients showed##57##2##(1990-12#2)(1990-3#1)(1990-9#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2010-3#1)(2011-2#4)(2012-1#1)(2013-1#9)(2013-8#2)
patients showing##7##2##(1990-2#1)(1992-2#1)(1996-1#1)(1996-2#1)(2008-1#2)(2013-1#1)
patients so##2##2##(2010-12#1)(2013-8#1)
patients starting##2##2##(2007-12#1)(2011-2#1)
patients still alive##2##3##(1997-4#1)(2010-8#1)
patients still had##2##3##(1991-9#1)(2008-7#1)
patients still remains##2##3##(2007-10#1)(2009-8#1)
patients still##12##2##(1991-9#1)(1997-4#1)(2007-10#1)(2008-1#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)
patients subjected to the##2##4##(2008-1#1)(2011-2#1)
patients subjected to##6##3##(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#2)(2013-1#1)
patients submitted to biliopancreatic diversion##2##5##(1993-3#1)(1993-5#1)
patients submitted to esophagectomy##2##4##(2013-8#2)
patients submitted to neoadjuvant##2##4##(2013-8#2)
patients submitted to##15##3##(1990-2#1)(1990-3#1)(1991-6#2)(1993-3#1)(1993-5#1)(1993-9#2)(2008-10#1)(2009-11#1)(2013-7#1)(2013-8#4)
patients subsequently underwent##2##3##(1995-11#1)(2008-9#1)
patients subsequently##3##2##(1995-11#1)(2008-7#1)(2008-9#1)
patients succumb to##2##3##(2007-7#1)(2009-5#1)
patients suffer from##2##3##(1993-3#1)(2008-6#1)
patients suffered from##5##3##(1991-8#1)(2007-11#1)(2007-8#2)(2011-3#1)
patients suffered##6##2##(1991-8#2)(2007-11#1)(2007-8#2)(2011-3#1)
patients suffering from a##2##4##(1990-9#1)(2007-11#1)
patients suffering from acute##2##4##(2006-7#1)(2011-2#1)
patients suffering from chronic##5##4##(1991-2#1)(1991-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
patients suffering from coronary heart disease##2##6##(1991-12#1)(2012-3#1)
patients suffering from coxarthrosis##3##4##(2007-11#3)
patients suffering from degenerative##2##4##(2008-7#1)(2011-2#1)
patients suffering from ischemic##2##4##(2008-3#1)(2008-7#1)
patients suffering from moderate to##2##5##(1991-11#1)(2008-12#1)
patients suffering from this##2##4##(2008-6#1)(2010-10#1)
patients suffering from##76##3##(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-6#1)(1994-7#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#3)(2006-7#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#10)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#5)
patients suffering##81##2##(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-6#1)(1994-7#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#3)(2006-7#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#4)(2008-7#10)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#5)
patients surgically treated for##2##4##(1990-9#1)(2012-12#1)
patients surgically treated##3##3##(1990-9#1)(2007-8#1)(2012-12#1)
patients surveyed were##2##3##(1992-5#1)(2008-7#1)
patients survived with##2##3##(1990-12#1)(2008-4#1)
patients survived##9##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-5#1)(1994-3#1)(2008-4#1)(2011-2#2)
patients surviving##3##2##(1992-10#1)(2007-10#1)(2008-7#1)
patients suspected of having##2##4##(2007-7#1)(2011-1#1)
patients suspected of##5##3##(1990-12#1)(1997-8#2)(2007-7#1)(2011-1#1)
patients suspected##6##2##(1990-12#1)(1997-8#2)(2007-7#1)(2008-5#1)(2011-1#1)
patients sustained##3##2##(1996-3#1)(2008-1#1)(2009-3#1)
patients take##2##2##(2010-12#1)(2011-1#1)
patients taking##10##2##(1995-11#1)(2006-10#1)(2008-11#4)(2008-5#2)(2008-8#1)(2009-4#1)
patients tend to##3##3##(1993-11#1)(2011-2#2)
patients tended to be##2##4##(1996-2#1)(2013-8#1)
patients tested##4##2##(2007-7#1)(2008-10#1)(2008-6#1)(2009-3#1)
patients than in controls##8##4##(1992-12#1)(1994-11#1)(1995-12#1)(1996-5#2)(2011-2#2)(2013-8#1)
patients than in the control group##3##6##(1991-12#1)(1993-2#1)(2011-1#1)
patients than in the controls##4##5##(2008-7#2)(2011-1#1)(2011-2#1)
patients than in the##9##4##(1991-12#1)(1993-2#1)(1996-5#1)(2008-1#1)(2008-7#2)(2011-1#2)(2011-2#1)
patients than in##26##3##(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-5#3)(1996-7#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#4)(2012-12#1)(2013-8#2)
patients than##33##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#3)(1996-7#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#4)(2012-12#1)(2013-8#3)
patients that are##2##3##(1995-11#1)(2008-12#1)
patients that do not##2##4##(2008-1#1)(2010-12#1)
patients that had##4##3##(1997-6#1)(2012-2#2)(2013-1#1)
patients that have##3##3##(2011-2#1)(2012-12#1)(2013-7#1)
patients that were##5##3##(1995-12#1)(2008-10#1)(2008-9#1)(2011-2#2)
patients that##38##2##(1995-11#1)(1995-12#1)(1996-7#1)(1997-6#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)
patients the diagnosis##2##3##(1993-5#1)(2013-1#1)
patients the##55##2##(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-9#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-8#3)(2007-10#2)(2007-11#4)(2007-7#1)(2007-8#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#7)
patients themselves##4##2##(1993-2#1)(1995-2#1)(1997-2#1)(2007-12#1)
patients there was##4##3##(1990-2#1)(1993-5#1)(1993-8#1)(2013-1#1)
patients there were##3##3##(1990-11#1)(1990-6#1)(2011-2#1)
patients there##9##2##(1990-11#1)(1990-2#1)(1990-6#1)(1993-5#1)(1993-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
patients these##2##2##(2008-7#1)(2012-12#1)
patients they cared for##2##4##(1991-1#1)(2008-11#1)
patients they##6##2##(1991-1#1)(1991-2#1)(2007-11#1)(2008-11#1)(2009-6#1)(2012-3#1)
patients this##3##2##(2007-8#1)(2008-7#1)(2012-3#1)
patients through##8##2##(1991-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-1#1)(2012-3#1)
patients throughout##3##2##(1994-12#1)(2006-10#1)(2012-2#1)
patients to a new##2##4##(1997-3#1)(2008-4#1)
patients to a##5##3##(1993-9#1)(1995-6#1)(1997-3#1)(2008-4#1)(2008-7#1)
patients to accept##2##3##(1993-11#1)(1995-11#1)
patients to access##2##3##(2007-12#1)(2008-10#1)
patients to achieve##4##3##(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
patients to be treated##2##4##(2008-10#1)(2008-8#1)
patients to be##9##3##(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-3#1)
patients to become##2##3##(1993-9#1)(2007-12#1)
patients to decide on the##2##5##(1995-2#1)(2009-8#1)
patients to goal##2##3##(2009-12#1)(2010-6#1)
patients to help##2##3##(1994-12#1)(2010-9#1)
patients to implement##2##3##(2010-6#1)(2011-1#1)
patients to prevent##2##3##(2011-2#2)
patients to receive##2##3##(1995-12#1)(2008-5#1)
patients to reduce##2##3##(2013-1#1)(2013-8#1)
patients to seek##2##3##(2007-9#1)(2008-11#1)
patients to the##8##3##(1991-11#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
patients to their##2##3##(1994-12#1)(2007-12#1)
patients to use##2##3##(2008-3#1)(2011-1#1)
patients to##126##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-6#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#6)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#5)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
patients took part##3##3##(2008-7#1)(2010-12#1)(2011-7#1)
patients took##6##2##(2007-7#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-3#1)
patients toward##2##2##(2008-12#1)(2012-2#1)
patients towards##2##2##(1993-11#1)(2011-2#1)
patients transplanted##3##2##(1991-9#2)(2010-5#1)
patients treated according to##2##4##(2011-2#2)
patients treated at our##2##4##(2008-7#1)(2011-2#1)
patients treated at the same##2##5##(1990-6#1)(2008-5#1)
patients treated at the##9##4##(1990-6#1)(1993-12#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)
patients treated at##12##3##(1990-6#1)(1993-12#1)(1995-11#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#2)
patients treated by general practitioners##2##5##(1993-2#1)(1994-11#1)
patients treated by radiosurgery##2##4##(2008-7#2)
patients treated by##14##3##(1991-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-6#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-5#1)(2012-2#1)
patients treated for primary##2##4##(1993-8#1)(2008-6#1)
patients treated for##17##3##(1990-2#2)(1990-9#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-8#1)(1997-8#1)(2007-11#2)(2008-6#2)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
patients treated in a##4##4##(1991-6#1)(1996-3#1)(1997-5#1)(2006-10#1)
patients treated in the geriatric assessment unit##3##7##(1990-5#3)
patients treated in the##8##4##(1990-5#3)(2006-10#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
patients treated in##17##3##(1990-5#3)(1991-6#1)(1995-1#1)(1996-3#1)(1997-5#1)(2006-10#2)(2007-11#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
patients treated locally##2##3##(2007-10#1)(2007-11#1)
patients treated over##2##3##(2008-6#1)(2012-2#1)
patients treated surgically for##3##4##(2007-11#1)(2007-8#2)
patients treated surgically##6##3##(2007-11#2)(2007-8#2)(2008-7#1)(2010-11#1)
patients treated using##2##3##(1991-3#1)(2008-8#1)
patients treated with CT only##2##5##(2011-2#2)
patients treated with CT##3##4##(2011-2#3)
patients treated with a##2##4##(2006-10#1)(2008-5#1)
patients treated with band ligation##2##5##(2013-1#2)
patients treated with chemotherapy##2##4##(2008-6#1)(2008-7#1)
patients treated with fibrinolysis##2##4##(2008-3#2)
patients treated with hemodialysis##2##4##(2008-10#1)(2008-7#1)
patients treated with high##2##4##(1990-6#2)
patients treated with low##3##4##(1997-8#1)(2008-5#1)(2008-8#1)
patients treated with placebo##2##4##(1990-6#1)(2008-2#1)
patients treated with the##4##4##(1990-6#1)(1997-3#1)(2007-11#1)(2008-10#1)
patients treated with wedge filters and##2##6##(2007-10#2)
patients treated with##114##3##(1990-11#2)(1990-3#1)(1990-6#4)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#3)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-8#2)(2006-10#2)(2007-10#3)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#11)(2008-8#6)(2008-9#2)(2009-11#1)(2009-4#3)(2009-5#1)(2010-3#2)(2010-8#2)(2011-2#8)(2012-12#3)(2013-1#9)(2013-8#1)
patients treated##202##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#6)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#3)(2006-10#4)(2007-10#6)(2007-11#12)(2007-7#1)(2007-8#6)(2008-1#6)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#10)(2008-7#18)(2008-8#8)(2008-9#2)(2009-11#1)(2009-4#3)(2009-5#3)(2010-11#1)(2010-3#3)(2010-8#2)(2011-1#1)(2011-2#15)(2012-12#4)(2012-2#3)(2013-1#11)(2013-8#1)
patients type##2##2##(1997-8#2)
patients ultimately##2##2##(1990-3#1)(2011-1#1)
patients unable to##2##3##(2010-4#1)(2011-7#1)
patients under tinidazole treatment##2##4##(1996-2#2)
patients under treatment##2##3##(1994-9#1)(2008-10#1)
patients under##20##2##(1990-5#1)(1993-1#1)(1993-2#1)(1994-9#1)(1996-2#2)(1996-3#1)(1996-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#3)(2010-12#1)(2011-2#3)(2013-1#2)
patients undergo##3##2##(1990-3#1)(1997-8#1)(2010-8#1)
patients undergoing a##2##3##(1991-4#1)(2013-1#1)
patients undergoing bilateral##2##3##(2007-8#2)
patients undergoing cardiac surgery##3##4##(2007-8#2)(2008-12#1)
patients undergoing cardiac##5##3##(2007-8#3)(2007-9#1)(2008-12#1)
patients undergoing chemotherapy##3##3##(1990-9#1)(2007-7#1)(2012-2#1)
patients undergoing coronary artery bypass grafting##2##6##(2007-8#1)(2008-12#1)
patients undergoing coronary artery bypass##3##5##(2007-7#1)(2007-8#1)(2008-12#1)
patients undergoing coronary artery##5##4##(1997-3#1)(2007-7#1)(2007-8#1)(2008-12#2)
patients undergoing coronary bypass##2##4##(1991-9#1)(1996-9#1)
patients undergoing coronary##10##3##(1991-9#1)(1996-9#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)
patients undergoing dialysis##2##3##(2007-12#1)(2008-1#1)
patients undergoing either##2##3##(2011-2#1)(2013-1#1)
patients undergoing elective##3##3##(1991-5#1)(2007-8#1)(2012-3#1)
patients undergoing hemodialysis##4##3##(1993-9#1)(2008-7#2)(2010-5#1)
patients undergoing laparoscopic##2##3##(1994-3#1)(2013-8#1)
patients undergoing noncardiac surgery##2##4##(2008-3#1)(2012-3#1)
patients undergoing open thoracotomy##2##4##(2012-12#2)
patients undergoing open##4##3##(1996-9#1)(2007-9#1)(2012-12#2)
patients undergoing oral surgery with##2##5##(1993-1#2)
patients undergoing oral surgery##4##4##(1993-1#4)
patients undergoing orthopedic##2##3##(2008-5#1)(2011-2#1)
patients undergoing percutaneous coronary intervention##3##5##(2008-3#2)(2013-1#1)
patients undergoing primary total##2##4##(2008-8#1)(2011-2#1)
patients undergoing primary##4##3##(2008-8#1)(2011-2#1)(2013-1#2)
patients undergoing surgery##4##3##(2007-8#1)(2008-7#3)
patients undergoing surgical##2##3##(2008-7#1)(2010-11#1)
patients undergoing thoracic surgery##3##4##(2006-10#1)(2012-12#2)
patients undergoing total hip##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
patients undergoing total knee##2##4##(2007-10#1)(2009-3#1)
patients undergoing total##6##3##(2007-10#2)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#1)
patients undergoing treatment##2##3##(2008-10#2)
patients undergoing##147##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-1#4)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-3#2)(1996-9#2)(1997-3#2)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#19)(2007-9#3)(2008-1#3)(2008-10#3)(2008-12#4)(2008-3#4)(2008-5#6)(2008-7#13)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#2)
patients underwent 12##2##3##(2007-10#1)(2008-4#1)
patients underwent a##11##3##(1990-9#1)(1991-9#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#3)(2011-2#1)
patients underwent an##3##3##(1990-5#1)(2007-8#1)(2013-1#1)
patients underwent anterior##2##3##(2007-11#1)(2007-8#1)
patients underwent complete##2##3##(1997-8#1)(2007-8#1)
patients underwent isolated coronary artery bypass grafting##2##7##(2007-8#2)
patients underwent primary##2##3##(2007-11#1)(2008-6#1)
patients underwent radical surgery##2##4##(1990-6#1)(1990-9#1)
patients underwent radical##3##3##(1990-3#1)(1990-6#1)(1990-9#1)
patients underwent surgery due to##2##5##(2007-11#2)
patients underwent surgery##7##3##(1991-6#1)(2007-11#2)(2007-8#1)(2008-6#1)(2012-3#1)(2013-1#1)
patients underwent surgical##2##3##(2007-8#1)(2011-2#1)
patients underwent##104##2##(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-11#1)(1996-3#1)(1997-8#5)(2007-10#5)(2007-11#7)(2007-8#15)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#4)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-3#2)(2013-1#7)
patients unsuitable for##2##3##(2010-6#2)
patients up to##2##3##(2008-7#1)(2010-12#1)
patients use##6##2##(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#1)(2009-3#1)(2009-8#1)
patients used##2##2##(1991-12#1)(1992-2#1)
patients using LMA##2##3##(2008-8#1)(2010-7#1)
patients using a##3##3##(2008-9#1)(2010-3#1)(2013-1#1)
patients using##22##2##(1990-11#1)(1993-12#1)(1995-12#1)(1996-1#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
patients varied##2##2##(1996-7#1)(2008-1#1)
patients via##4##2##(1991-3#1)(1996-3#1)(2007-9#1)(2008-10#1)
patients waiting for##2##3##(1992-1#1)(2009-10#1)
patients was 0##2##3##(2008-8#2)
patients was 1##2##3##(2011-1#1)(2011-2#1)
patients was 33##3##3##(1995-3#1)(2011-1#1)(2012-3#1)
patients was 56 years##2##4##(1995-4#1)(2008-11#1)
patients was 63##2##3##(1993-2#1)(2007-11#1)
patients was 68##2##3##(1991-12#1)(2011-3#1)
patients was also##2##3##(1991-4#1)(1997-7#1)
patients was compared to##2##4##(1990-10#1)(2008-7#1)
patients was detected##2##3##(2008-7#1)(2013-1#1)
patients was evaluated##3##3##(2008-1#1)(2012-1#1)(2012-2#1)
patients was found##3##3##(1993-12#1)(1995-11#1)(1995-12#1)
patients was greater##3##3##(2009-10#1)(2011-2#2)
patients was higher##2##3##(1993-10#1)(2012-2#1)
patients was measured##2##3##(2008-7#1)(2009-6#1)
patients was performed##2##3##(2007-4#1)(2013-1#1)
patients was significantly higher than##2##5##(1991-4#1)(2008-10#1)
patients was significantly##6##3##(1991-4#1)(1991-9#2)(1995-11#1)(2008-10#1)(2011-1#1)
patients was studied##2##3##(1993-11#1)(2008-1#1)
patients was the##2##3##(2008-7#2)
patients was treated with##2##4##(1994-12#1)(2007-11#1)
patients was treated##3##3##(1994-12#1)(2006-12#1)(2007-11#1)
patients was##130##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#3)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#7)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#7)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#3)(2009-10#2)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)
patients we diagnosed incongruence of the##2##6##(2007-8#2)
patients we found##2##3##(1996-9#1)(2008-5#1)
patients we performed##2##3##(2007-8#2)
patients we selected a hybrid##2##5##(1990-12#2)
patients we studied##2##3##(1992-5#1)(2007-11#1)
patients we treated##2##3##(1996-9#1)(2011-2#1)
patients we##17##2##(1990-12#2)(1991-11#1)(1992-5#1)(1996-2#1)(1996-9#2)(2007-11#4)(2007-8#4)(2008-5#1)(2011-2#1)
patients wearing##3##2##(1990-12#1)(2013-1#2)
patients were administered##3##3##(2008-10#1)(2010-7#1)(2011-1#1)
patients were administrated##3##3##(2012-3#3)
patients were admitted to##2##4##(1997-6#1)(2012-3#1)
patients were admitted##5##3##(1996-9#1)(1997-6#1)(1997-8#1)(2011-2#1)(2012-3#1)
patients were affected by##2##4##(1990-5#1)(1990-9#1)
patients were alive and##3##4##(1991-8#2)(2012-12#1)
patients were alive##8##3##(1990-6#1)(1991-2#1)(1991-8#2)(2008-1#1)(2008-6#1)(2012-12#1)(2012-3#1)
patients were also##2##3##(1990-2#1)(1997-8#1)
patients were analysed##4##3##(1990-8#1)(1992-5#1)(1993-8#1)(2008-8#1)
patients were analyzed for##2##4##(1991-3#1)(1992-3#1)
patients were analyzed in##2##4##(1990-2#1)(2008-7#1)
patients were analyzed##10##3##(1990-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-4#1)(2013-8#1)
patients were approached##2##3##(2007-12#1)(2010-12#1)
patients were asked to##3##4##(1996-3#1)(2010-12#1)(2013-1#1)
patients were assessed##7##3##(1990-10#1)(1990-5#1)(1995-3#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-3#1)
patients were at##2##3##(2010-10#1)(2011-2#1)
patients were available for##2##4##(1996-9#1)(2012-3#1)
patients were categorised##2##3##(1997-3#1)(2007-9#1)
patients were classified as a##2##5##(2007-8#1)(2013-1#1)
patients were classified as##5##4##(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
patients were clinically##3##3##(1990-9#1)(2008-12#1)(2011-1#1)
patients were compared##2##3##(2008-11#1)(2008-7#1)
patients were completely##2##3##(2007-7#1)(2008-9#1)
patients were considered##2##3##(1991-3#1)(1996-12#1)
patients were cured##2##3##(1995-11#1)(2008-7#1)
patients were diagnosed with##3##4##(2007-11#1)(2007-8#1)(2008-7#1)
patients were diagnosed##7##3##(1995-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)
patients were divided into two groups##5##6##(1995-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
patients were divided into##10##4##(1995-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)
patients were divided##12##3##(1995-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
patients were enrolled in the study##2##6##(2008-7#1)(2010-4#1)
patients were enrolled in this study##3##6##(2008-1#1)(2008-8#1)(2012-3#1)
patients were enrolled in##7##4##(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
patients were enrolled##19##3##(2007-10#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
patients were entered in##2##4##(1994-7#1)(2008-7#1)
patients were evaluable for response##2##5##(1991-6#1)(2007-10#1)
patients were evaluable for##3##4##(1991-6#1)(2007-10#1)(2008-6#1)
patients were evaluable##4##3##(1990-2#1)(1991-6#1)(2007-10#1)(2008-6#1)
patients were evaluated in##3##4##(2008-3#1)(2008-7#1)(2013-8#1)
patients were evaluated##11##3##(1992-2#1)(1992-5#1)(1993-1#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients were examined at##2##4##(1990-12#1)(2012-2#1)
patients were examined##10##3##(1990-12#1)(1992-9#1)(1993-2#1)(1997-3#1)(2007-2#2)(2007-8#2)(2008-9#1)(2012-2#1)
patients were excluded##2##3##(1997-8#1)(2009-8#1)
patients were exposed to##2##4##(1990-2#1)(2008-8#1)
patients were female and##2##4##(1997-8#1)(2011-2#1)
patients were female##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
patients were first##2##3##(2007-8#1)(2011-2#1)
patients were followed for##2##4##(1996-1#1)(2009-10#1)
patients were followed up at##2##5##(2008-11#1)(2008-2#1)
patients were followed up for##5##5##(1995-5#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-8#1)
patients were followed up##8##4##(1995-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
patients were followed##13##3##(1995-5#1)(1996-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients were followed-up##2##3##(2008-1#1)(2011-2#1)
patients were found to have##7##5##(1995-11#1)(1995-12#1)(2007-10#1)(2008-4#2)(2008-9#2)
patients were found to##9##4##(1990-2#1)(1995-11#1)(1995-12#1)(2007-10#1)(2008-4#2)(2008-9#2)(2012-12#1)
patients were found##10##3##(1990-2#1)(1993-1#1)(1995-11#1)(1995-12#1)(2007-10#1)(2008-4#2)(2008-9#2)(2012-12#1)
patients were given##7##3##(1991-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-12#1)(2013-1#1)
patients were highly##2##3##(1990-9#1)(2013-1#1)
patients were hospitalised##2##3##(2007-11#1)(2007-8#1)
patients were hospitalized##4##3##(1991-6#1)(2007-8#1)(2008-1#1)(2008-11#1)
patients were identified##10##3##(2007-10#2)(2008-6#2)(2008-9#2)(2011-1#1)(2012-3#2)(2013-8#1)
patients were in the age group of##2##7##(2008-11#1)(2010-5#1)
patients were in the age group##3##6##(2008-11#1)(2010-5#1)(2011-1#1)
patients were in the##5##4##(2007-11#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)
patients were in##11##3##(1991-2#1)(1992-9#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
patients were included in the analyses##2##6##(2008-7#1)(2013-8#1)
patients were included in the study##2##6##(2007-7#1)(2007-9#1)
patients were included in the##5##5##(2007-7#1)(2007-9#1)(2008-7#1)(2010-12#1)(2013-8#1)
patients were included in this study##2##6##(2008-7#1)(2012-3#1)
patients were included in##9##4##(1993-2#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-7#2)(2010-12#1)(2012-3#1)(2013-8#1)
patients were included to##2##4##(2007-11#1)(2011-2#1)
patients were included##19##3##(1990-6#1)(1993-2#1)(1997-7#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
patients were induced##2##3##(2010-7#2)
patients were infected in##2##4##(1996-11#1)(2012-3#1)
patients were investigated##3##3##(1996-7#1)(2008-7#1)(2011-2#1)
patients were involved in##2##4##(2006-10#1)(2008-1#1)
patients were less likely to##2##5##(1995-11#1)(1995-12#1)
patients were lost to follow up##2##6##(1993-12#1)(1996-3#1)
patients were lost to##3##4##(1993-12#1)(1996-3#1)(2013-1#1)
patients were made##2##3##(2007-11#1)(2008-5#1)
patients were male##3##3##(1990-9#1)(2007-8#1)(2013-1#1)
patients were managed by##2##4##(1992-8#1)(2007-7#1)
patients were managed##4##3##(1992-8#1)(1994-2#1)(2007-7#1)(2013-1#1)
patients were measured##3##3##(1995-3#1)(2008-4#1)(2011-2#1)
patients were men##3##3##(1990-6#1)(2011-2#1)(2013-8#1)
patients were more likely to have##2##6##(2006-10#1)(2013-8#1)
patients were more likely to##5##5##(1995-12#1)(1996-3#1)(2006-10#1)(2012-3#1)(2013-8#1)
patients were more##9##3##(1994-7#1)(1995-12#1)(1996-3#1)(1996-7#1)(2006-10#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
patients were not##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
patients were observed##3##3##(1991-2#1)(1991-4#1)(2007-11#1)
patients were obtained##3##3##(2012-5#1)(2013-1#2)
patients were older than##2##4##(2008-7#1)(2013-1#1)
patients were on##7##3##(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#1)(2012-5#1)
patients were operated on##3##4##(1991-8#1)(1992-1#1)(1993-3#1)
patients were operated upon##2##4##(1991-6#1)(1992-6#1)
patients were operated##8##3##(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(2007-8#1)
patients were over##2##3##(2008-1#1)(2008-7#1)
patients were prescribed##4##3##(2008-11#1)(2010-12#1)(2012-2#1)(2013-7#1)
patients were prospectively##3##3##(2007-8#1)(2007-9#1)(2013-1#1)
patients were randomized to receive##2##5##(2008-6#1)(2008-7#1)
patients were randomized to##3##4##(2008-6#2)(2008-7#1)
patients were randomized##6##3##(2008-6#2)(2008-7#2)(2009-3#1)(2011-2#1)
patients were randomly allocated##2##4##(2010-12#1)(2012-3#1)
patients were randomly assigned to receive##2##6##(1993-1#1)(2012-2#1)
patients were randomly assigned to##4##5##(1993-1#1)(2008-3#1)(2011-2#1)(2012-2#1)
patients were randomly assigned##5##4##(1993-1#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients were randomly divided into two groups##2##7##(1994-7#1)(2007-8#1)
patients were randomly divided into##4##5##(1994-7#1)(2007-8#1)(2009-7#1)(2010-7#1)
patients were randomly##12##3##(1993-1#1)(1994-7#1)(1997-6#1)(2007-8#1)(2008-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients were receiving##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
patients were recruited##3##3##(2009-2#1)(2011-2#1)(2012-1#1)
patients were referred to##2##4##(2008-4#1)(2011-2#1)
patients were reported##2##3##(2008-2#1)(2008-6#1)
patients were reviewed at##2##4##(2007-8#1)(2010-10#1)
patients were reviewed##4##3##(1996-6#1)(2007-8#1)(2010-10#1)(2011-2#1)
patients were satisfied with the##2##5##(1997-2#1)(2013-1#1)
patients were satisfied with##3##4##(1997-2#1)(2008-9#1)(2013-1#1)
patients were scored for##2##4##(1997-8#1)(2008-7#1)
patients were seen during##3##4##(1992-6#1)(2007-7#1)(2008-1#1)
patients were seen##5##3##(1992-6#1)(1996-1#1)(2007-7#1)(2008-1#1)(2011-1#1)
patients were selected##3##3##(2006-6#1)(2008-1#1)(2008-8#1)
patients were significantly higher than those##2##6##(1994-3#1)(2008-10#1)
patients were significantly##5##3##(1994-3#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#1)
patients were slower than##2##4##(2008-7#2)
patients were started##2##3##(2008-7#1)(2010-8#1)
patients were stratified by##2##4##(2007-7#1)(2011-2#1)
patients were stratified##4##3##(1995-11#1)(2007-7#1)(2011-2#2)
patients were studied by##2##4##(1991-11#1)(2007-7#1)
patients were studied retrospectively and##2##5##(1990-9#1)(1997-8#1)
patients were studied##14##3##(1990-9#1)(1991-11#1)(1991-3#1)(1992-2#1)(1997-8#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-1#1)(2013-1#1)
patients were subjected to##5##4##(1990-11#1)(1995-11#1)(2007-7#1)(2008-12#1)(2012-3#1)
patients were submitted to##4##4##(1990-6#1)(1992-5#1)(2009-4#1)(2011-2#1)
patients were subsequently##2##3##(1997-3#1)(2008-6#1)
patients were taken##2##3##(1991-2#1)(2012-2#1)
patients were then##3##3##(1992-9#1)(2010-8#1)(2011-2#1)
patients were treated as outpatients##2##5##(2007-8#1)(2011-1#1)
patients were treated by laparotomy##2##5##(1991-2#1)(1991-3#1)
patients were treated by##11##4##(1991-2#1)(1991-3#1)(1991-8#2)(1994-12#1)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#1)
patients were treated conservatively##3##4##(2008-7#2)(2012-12#1)
patients were treated for##8##4##(1990-9#1)(1991-8#1)(1992-9#1)(1993-2#1)(1995-11#1)(2006-10#1)(2008-5#1)(2013-7#1)
patients were treated initially##2##4##(1992-12#1)(1996-11#1)
patients were treated surgically##2##4##(2007-7#1)(2008-7#1)
patients were treated with a##3##5##(1992-5#1)(2008-12#1)(2011-2#1)
patients were treated with##33##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
patients were treated##73##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#2)(1992-12#2)(1992-5#1)(1992-9#1)(1993-2#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
patients were with##2##3##(2008-10#1)(2008-11#1)
patients were younger than##2##4##(1990-6#1)(2008-12#1)
patients were##622##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#7)(1990-3#1)(1990-5#3)(1990-6#6)(1990-8#1)(1990-9#9)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#7)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#5)(1992-6#2)(1992-8#3)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#1)(1994-7#3)(1994-9#2)(1995-11#8)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#2)(1996-9#3)(1997-2#3)(1997-3#5)(1997-6#4)(1997-7#1)(1997-8#12)(2006-10#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#8)(2007-11#15)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#25)(2007-8#19)(2007-9#3)(2008-1#23)(2008-10#18)(2008-11#12)(2008-12#8)(2008-2#2)(2008-3#8)(2008-4#11)(2008-5#7)(2008-6#13)(2008-7#40)(2008-8#8)(2008-9#11)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#4)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#4)(2011-1#15)(2011-2#43)(2012-1#2)(2012-12#7)(2012-2#9)(2012-3#33)(2012-5#2)(2013-1#35)(2013-7#3)(2013-8#9)
patients what##2##2##(1996-8#1)(2011-2#1)
patients when compared with##3##4##(2008-3#1)(2008-7#2)
patients when##8##2##(1990-9#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2011-2#1)
patients where extensive##2##3##(1994-8#1)(2008-7#1)
patients where##3##2##(1994-8#1)(2007-8#1)(2008-7#1)
patients which##2##2##(2008-10#1)(2008-12#1)
patients while maintaining a##2##4##(2008-7#1)(2011-2#1)
patients while##5##2##(1992-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
patients who achieved complete##2##4##(1990-12#1)(2007-7#1)
patients who achieved##5##3##(1990-12#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients who appear to##2##4##(1995-2#1)(2008-8#1)
patients who are already##2##4##(2008-6#1)(2011-2#1)
patients who are not candidates for##2##6##(2007-7#1)(2013-1#1)
patients who are not##3##4##(2007-7#1)(2013-1#1)(2013-8#1)
patients who are on##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
patients who are undergoing##2##4##(2008-5#1)(2011-2#1)
patients who are##39##3##(1991-12#1)(1992-5#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
patients who attended the##2##4##(2007-10#1)(2013-8#1)
patients who benefit most from##2##5##(2008-1#1)(2008-7#1)
patients who can##2##3##(2009-8#1)(2010-5#1)
patients who completed##3##3##(2007-7#2)(2008-7#1)
patients who could not be##2##5##(2008-3#1)(2008-6#1)
patients who could##5##3##(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-6#1)
patients who develop##6##3##(1993-11#1)(2006-10#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients who developed dyskinesias##2##4##(2008-7#2)
patients who developed##12##3##(1992-10#1)(1992-3#1)(2007-5#1)(2008-1#1)(2008-6#1)(2008-7#3)(2012-2#1)(2013-1#1)(2013-8#2)
patients who did not have##4##5##(1992-11#1)(2007-10#2)(2013-1#1)
patients who did not receive any treatment##2##7##(2008-7#1)(2012-3#1)
patients who did not receive any##3##6##(2008-1#1)(2008-7#1)(2012-3#1)
patients who did not receive##5##5##(1993-1#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#1)
patients who did not##16##4##(1992-11#2)(1993-1#1)(1994-12#1)(1997-2#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#3)
patients who did##19##3##(1992-11#2)(1993-1#2)(1994-12#1)(1997-2#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
patients who died during##2##4##(1991-7#1)(1997-4#1)
patients who died had##2##4##(2012-12#1)(2012-3#1)
patients who died of cancer##2##5##(2011-2#2)
patients who died##9##3##(1991-7#1)(1991-8#1)(1997-4#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)
patients who do not respond to##3##6##(1993-12#1)(1997-8#1)(2011-2#1)
patients who exhibited##2##3##(2008-9#1)(2011-2#1)
patients who experience##4##3##(1991-11#1)(2008-1#1)(2008-7#1)(2011-2#1)
patients who fail##2##3##(2007-7#1)(2011-3#1)
patients who failed##2##3##(2008-1#1)(2013-8#1)
patients who fall##2##3##(1994-12#1)(2008-7#1)
patients who felt##2##3##(2013-1#1)(2013-7#1)
patients who fulfilled the##2##4##(2008-3#1)(2011-2#1)
patients who had a##6##4##(1990-8#1)(1997-3#1)(2007-10#2)(2010-6#1)(2013-1#1)
patients who had an##2##4##(2007-10#1)(2008-6#1)
patients who had been##6##4##(1991-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
patients who had had##3##4##(2007-10#1)(2008-9#1)(2009-4#1)
patients who had not had##2##5##(1991-2#1)(2010-3#1)
patients who had not##5##4##(1991-2#1)(1997-7#1)(2007-8#1)(2010-3#1)(2012-3#1)
patients who had received##4##4##(1990-2#1)(1993-10#1)(2007-8#1)(2008-6#1)
patients who had undergone THA or TKA##2##7##(1994-3#2)
patients who had undergone THA##3##5##(1994-3#3)
patients who had undergone total##2##5##(1990-9#1)(1994-3#1)
patients who had undergone##12##4##(1990-9#1)(1992-10#1)(1992-6#1)(1994-3#4)(1995-11#1)(2008-11#1)(2008-9#1)(2009-11#1)(2013-1#1)
patients who had##86##3##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-3#4)(1995-11#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2007-10#9)(2007-11#2)(2007-7#4)(2007-8#2)(2008-1#2)(2008-11#5)(2008-6#3)(2008-7#2)(2008-9#3)(2009-11#1)(2009-4#2)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#4)
patients who have a##2##4##(1997-3#1)(2008-1#1)
patients who have been##2##4##(1992-6#1)(2008-12#1)
patients who have had##7##4##(1992-3#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-6#1)(2011-1#1)
patients who have received##3##4##(2008-12#1)(2008-3#1)(2013-8#1)
patients who have undergone##6##4##(1990-9#1)(1996-3#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-8#1)
patients who have##46##3##(1990-5#1)(1990-9#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-5#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#4)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
patients who lack##2##3##(2007-10#1)(2008-10#1)
patients who may##2##3##(1993-12#1)(2013-1#1)
patients who met the inclusion criteria##2##6##(2010-6#1)(2012-3#1)
patients who met the##4##4##(2007-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
patients who met##6##3##(2007-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)
patients who present with##9##4##(2007-7#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)
patients who present##10##3##(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)
patients who presented with##5##4##(1991-12#1)(1992-12#1)(2006-12#1)(2007-10#1)(2007-9#1)
patients who presented##9##3##(1990-3#1)(1991-12#1)(1992-12#1)(2006-12#1)(2007-10#1)(2007-5#1)(2007-9#1)(2011-1#1)(2011-2#1)
patients who progress to##2##4##(2012-2#1)(2013-1#1)
patients who receive##5##3##(1994-5#1)(1997-8#1)(2008-6#1)(2009-11#1)(2013-8#1)
patients who received i##2##4##(2007-7#2)
patients who received renal##2##4##(2008-1#1)(2008-4#1)
patients who received##23##3##(1990-11#1)(1991-5#1)(1992-12#1)(1993-1#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2011-2#2)
patients who relapsed##2##3##(1990-8#1)(2013-7#1)
patients who require##4##3##(2007-8#1)(2008-5#1)(2008-9#1)(2013-8#1)
patients who required##3##3##(1996-3#1)(2008-7#1)(2013-1#1)
patients who scored##3##3##(2008-1#3)
patients who showed##6##3##(1991-11#1)(1994-2#1)(2007-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
patients who subsequently##2##3##(2006-10#1)(2010-6#1)
patients who suffer from##2##4##(2010-5#1)(2012-2#1)
patients who suffer##5##3##(1997-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
patients who survived##3##3##(1992-6#1)(1995-2#1)(2008-11#1)
patients who sustained cardiac##2##4##(2008-1#1)(2008-3#1)
patients who sustained##3##3##(2007-10#1)(2008-1#1)(2008-3#1)
patients who take##2##3##(1990-5#1)(1995-9#1)
patients who took##3##3##(1996-7#2)(2007-7#1)
patients who undergo##4##3##(1993-1#1)(2008-10#1)(2009-5#1)(2013-1#1)
patients who underwent a##4##4##(2007-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
patients who underwent amniocentesis##2##4##(2012-3#2)
patients who underwent biopsy##2##4##(2010-11#1)(2012-3#1)
patients who underwent coronary##2##4##(2007-8#1)(2008-7#1)
patients who underwent endoscopic##2##4##(2011-2#1)(2012-2#1)
patients who underwent renal##2##4##(2008-1#1)(2013-1#1)
patients who underwent surgery for##2##5##(2008-3#1)(2008-8#1)
patients who underwent surgery in##2##5##(2007-11#1)(2008-7#1)
patients who underwent surgery##5##4##(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
patients who underwent surgical##3##4##(1996-3#1)(2007-8#1)(2011-2#1)
patients who underwent total##3##4##(2007-11#1)(2008-8#1)(2011-2#1)
patients who underwent##66##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#1)(1993-9#1)(1996-3#2)(1996-9#2)(2007-10#2)(2007-11#6)(2007-8#6)(2007-9#1)(2008-1#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#7)
patients who use their hand repetitively##2##6##(2008-9#2)
patients who use##3##3##(1992-9#1)(2008-9#2)
patients who utilized##2##3##(1996-2#1)(2012-3#1)
patients who were admitted##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
patients who were discharged##2##4##(2007-10#1)(2008-7#1)
patients who were followed##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
patients who were hospitalized##2##4##(2009-12#1)(2012-2#1)
patients who were operated##3##4##(1996-9#1)(2007-11#1)(2008-1#1)
patients who were overweight##2##4##(2008-10#2)
patients who were selected##2##4##(1994-12#1)(2008-11#1)
patients who were treated with##3##5##(1991-12#1)(2008-7#1)(2011-2#1)
patients who were treated##4##4##(1991-12#1)(1996-11#1)(2008-7#1)(2011-2#1)
patients who were undergoing##2##4##(2011-1#1)(2013-8#1)
patients who were##57##3##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-12#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#1)
patients who will##4##3##(2007-11#1)(2009-4#1)(2010-3#1)(2012-3#1)
patients who would##4##3##(2007-7#1)(2010-3#1)(2010-4#1)(2012-1#1)
patients who##541##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-3#6)(1992-5#2)(1992-6#4)(1992-9#2)(1993-1#6)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-3#5)(1996-6#2)(1996-7#3)(1996-9#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#3)(1997-8#3)(2006-10#3)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#24)(2007-11#11)(2007-12#2)(2007-5#2)(2007-7#20)(2007-8#12)(2007-9#2)(2008-1#24)(2008-10#11)(2008-11#13)(2008-12#4)(2008-3#14)(2008-4#3)(2008-5#4)(2008-6#14)(2008-7#29)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#8)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#42)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#14)(2012-3#22)(2012-5#1)(2013-1#34)(2013-7#2)(2013-8#19)
patients whose tumors##3##3##(1993-1#1)(2012-12#2)
patients whose##26##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
patients will be##10##3##(1993-11#1)(1994-9#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
patients will experience##2##3##(2011-2#1)(2012-2#1)
patients will have##3##3##(2006-10#1)(2008-5#1)(2012-2#1)
patients will##30##2##(1992-2#1)(1993-11#1)(1994-9#1)(2006-10#1)(2007-8#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)
patients with &quot##5##3##(1990-11#1)(1992-4#1)(1992-9#1)(2011-2#1)(2012-12#1)
patients with 1-3 positive nodes##2##5##(1992-12#1)(1993-1#1)
patients with 11##2##3##(2008-1#1)(2013-1#1)
patients with 23##2##3##(2008-9#1)(2011-2#1)
patients with ACS##2##3##(2008-3#2)
patients with AD##3##3##(2011-1#1)(2012-1#1)(2012-2#1)
patients with ADPKD##3##3##(2013-1#3)
patients with AF##2##3##(2007-8#1)(2012-3#1)
patients with AIDS and##3##4##(1996-11#1)(2008-11#1)(2011-2#1)
patients with AIDS##10##3##(1991-2#1)(1991-5#2)(1996-11#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-5#2)(2011-2#1)
patients with ALL##3##3##(2011-2#3)
patients with AMI##2##3##(1990-12#1)(1995-12#1)
patients with AOD##3##3##(2012-12#3)
patients with ARDS##4##3##(1990-2#1)(1991-9#1)(1997-1#2)
patients with ARMD##2##3##(2011-1#1)(2011-2#1)
patients with AVMs##2##3##(2008-7#1)(2012-3#1)
patients with Alport##2##3##(2011-2#2)
patients with Alzheimer disease##2##4##(1990-3#1)(1994-8#1)
patients with Alzheimer's disease (AD)##4##5##(1996-5#1)(2008-7#2)(2012-2#1)
patients with Alzheimer's disease##14##4##(1992-12#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-9#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-6#1)(2009-9#1)(2012-2#1)
patients with BD##3##3##(2013-8#3)
patients with Buerger disease##3##4##(1997-8#3)
patients with CA##2##3##(2011-1#1)(2011-2#1)
patients with CAI##2##3##(2013-1#2)
patients with CCBIP##2##3##(2008-7#2)
patients with CD##3##3##(2008-2#2)(2012-2#1)
patients with CES##2##3##(2012-3#2)
patients with CHF##3##3##(2010-8#1)(2012-3#2)
patients with CKD##2##3##(2009-1#1)(2011-2#1)
patients with CML##2##3##(2007-11#1)(2010-11#1)
patients with CNS##3##3##(2008-7#2)(2011-2#1)
patients with COPD and##2##4##(1997-1#1)(2008-7#1)
patients with COPD in##2##4##(2008-12#1)(2009-1#1)
patients with COPD##15##3##(1997-1#1)(1997-7#2)(2008-12#1)(2008-7#2)(2009-1#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
patients with CRC##2##3##(2012-3#2)
patients with CRF##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
patients with CSX##2##3##(2008-12#1)(2011-2#1)
patients with CTEPH##3##3##(2010-6#3)
patients with CVC occlusions and##2##5##(2008-7#2)
patients with Crohn's disease and ulcerative##2##6##(2010-12#2)
patients with Crohn's disease##7##4##(1994-2#1)(2010-12#4)(2012-2#2)
patients with Crohn's##8##3##(1994-2#1)(2010-12#4)(2012-2#2)(2013-8#1)
patients with Duchenne muscular dystrophy##2##5##(1995-12#1)(2011-2#1)
patients with Dukes'##3##3##(1992-8#2)(2008-10#1)
patients with ER##2##3##(1991-12#1)(2007-10#1)
patients with ESRD##5##3##(2007-7#2)(2008-1#1)(2008-7#1)(2008-8#1)
patients with Forestier's disease##2##4##(2007-8#2)
patients with GHF##2##3##(2011-2#2)
patients with Graves' disease##3##4##(1990-7#1)(1991-12#1)(1994-11#1)
patients with Graves'##4##3##(1990-7#1)(1991-12#1)(1994-11#1)(2008-7#1)
patients with HC##3##3##(2012-3#3)
patients with HCC##3##3##(1992-3#1)(2008-10#2)
patients with HCM##3##3##(2008-7#3)
patients with HCV##10##3##(1994-8#1)(2006-10#3)(2009-8#1)(2012-12#4)(2013-1#1)
patients with HIV and##2##4##(1993-5#1)(2008-10#1)
patients with HIV infection##4##4##(1996-11#1)(1996-3#1)(2008-7#1)(2008-8#1)
patients with HIV##10##3##(1991-11#1)(1993-5#1)(1995-12#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)
patients with HIV-1 infection##5##4##(1990-2#2)(1991-9#1)(2010-11#2)
patients with IP##2##3##(2008-7#2)
patients with IgG##2##3##(1990-2#1)(2007-10#1)
patients with LC##2##3##(2008-10#2)
patients with Laron syndrome##2##4##(2008-1#1)(2008-4#1)
patients with Laron##3##3##(2008-1#2)(2008-4#1)
patients with Luminal##2##3##(2010-12#2)
patients with MG##2##3##(2007-8#2)
patients with MM have##2##4##(2008-1#1)(2010-4#1)
patients with MM##3##3##(2008-1#1)(2008-7#1)(2010-4#1)
patients with MS##9##3##(1995-12#1)(2008-3#1)(2008-5#1)(2010-12#3)(2012-3#3)
patients with MSF##2##3##(2013-8#2)
patients with Marfan syndrome##3##4##(2007-8#1)(2008-8#1)(2009-7#1)
patients with Marfan##4##3##(2007-8#1)(2008-8#2)(2009-7#1)
patients with NCAH##2##3##(2008-1#2)
patients with NSCLC##3##3##(1991-2#1)(2012-3#2)
patients with OA##2##3##(1993-2#1)(2008-9#1)
patients with OSA##2##3##(2012-2#1)(2013-7#1)
patients with PAOD##2##3##(2008-7#2)
patients with PCR##4##3##(1991-4#2)(2008-12#2)
patients with PD##6##3##(2008-10#1)(2008-7#1)(2013-1#3)(2013-8#1)
patients with PDTC##2##3##(2012-3#2)
patients with PHP##2##3##(2010-6#1)(2011-1#1)
patients with PICH and##2##4##(2007-10#2)
patients with PTDM##2##3##(2008-1#2)
patients with Paget's disease##2##4##(1990-6#1)(1991-5#1)
patients with Parkinson disease##2##4##(2013-8#2)
patients with Parkinson disease]##2##4##(2012-12#1)(2013-8#1)
patients with Parkinson##4##3##(2012-12#1)(2013-8#3)
patients with Parkinson's disease (PD)##5##5##(2008-7#5)
patients with Parkinson's disease##13##4##(1991-5#1)(1993-2#1)(2008-7#9)(2013-1#2)
patients with RA were##2##4##(1993-2#1)(2008-7#1)
patients with RA##8##3##(1993-2#1)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#2)
patients with RD##2##3##(1991-4#2)
patients with SAH##4##3##(1995-11#1)(1995-5#1)(2007-10#1)(2008-7#1)
patients with SARS##2##3##(2007-7#2)
patients with SICH##4##3##(2007-10#4)
patients with SLE##2##3##(2006-10#1)(2011-2#1)
patients with SS##6##3##(2007-11#6)
patients with ST-segment elevation myocardial infarction##3##6##(2009-12#1)(2009-5#2)
patients with STEMI##4##3##(2008-3#4)
patients with STS and synchronous metastases##2##6##(2008-6#2)
patients with STS and##3##4##(2008-6#3)
patients with STS##4##3##(2008-6#4)
patients with T1D##3##3##(2007-5#2)(2013-8#1)
patients with TAR##2##3##(2007-8#2)
patients with TSAT&gt##2##3##(2007-7#2)
patients with Takayasu arteritis and severe aortic regurgitation##4##8##(1997-8#4)
patients with Takayasu arteritis##6##4##(1997-8#6)
patients with VDDR##2##3##(2011-1#2)
patients with Werner's syndrome##2##4##(1994-12#2)
patients with a diagnosis of##3##5##(2007-10#1)(2012-2#1)(2013-8#1)
patients with a duration of##2##5##(1997-8#1)(2008-9#1)
patients with a high BSA##2##5##(2011-2#2)
patients with a high##5##4##(1990-3#1)(1997-8#1)(2007-11#1)(2011-2#2)
patients with a history of##13##5##(1990-12#1)(1990-3#1)(1992-5#1)(2007-10#3)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
patients with a mean age of 42##2##7##(2008-1#1)(2008-12#1)
patients with a mean age of##5##6##(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#2)
patients with a mean##8##4##(1991-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
patients with a median##2##4##(2010-8#1)(2013-1#1)
patients with a positive##2##4##(2011-2#1)(2013-1#1)
patients with a previously implanted##2##5##(2008-10#2)
patients with a prior##2##4##(2007-7#1)(2010-12#1)
patients with a superficial##2##4##(2008-6#2)
patients with a tumor##2##4##(1990-12#1)(1994-12#1)
patients with a variety of##5##5##(2006-12#1)(2008-11#2)(2008-2#1)(2008-7#1)
patients with a wrist ganglion##2##5##(2008-9#2)
patients with a##122##3##(1990-10#1)(1990-12#4)(1990-3#3)(1991-11#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#3)(1992-5#2)(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-3#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#6)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#7)(2008-7#4)(2008-9#6)(2009-3#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#3)
patients with abdominal##6##3##(1991-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients with abnormal lower urinary tracts##2##6##(1991-11#2)
patients with abnormal thermograms##4##4##(1993-11#4)
patients with abnormal##12##3##(1990-6#1)(1991-11#2)(1992-12#1)(1993-11#4)(1994-2#1)(1994-9#1)(2008-7#1)(2011-2#1)
patients with achalasia##2##3##(1992-9#1)(2013-1#1)
patients with acne##2##3##(2006-10#1)(2010-8#1)
patients with acquired immunodeficiency syndrome##2##5##(1994-6#1)(2008-2#1)
patients with acquired##4##3##(1994-3#1)(1994-6#1)(2008-2#1)(2011-1#1)
patients with active disease as compared##2##6##(2008-7#2)
patients with active disease##3##4##(1991-5#1)(2008-7#2)
patients with active scars##2##4##(2009-6#2)
patients with active##9##3##(1991-5#1)(2008-7#3)(2009-11#1)(2009-6#2)(2010-12#2)
patients with acute cholecystitis##3##4##(1997-8#1)(2008-5#2)
patients with acute coronary syndrome##11##5##(2008-11#4)(2008-3#5)(2011-2#2)
patients with acute coronary syndromes##9##5##(2008-10#1)(2008-3#6)(2008-7#1)(2009-12#1)
patients with acute coronary##24##4##(2008-10#3)(2008-11#4)(2008-3#11)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#2)(2013-8#1)
patients with acute ischaemic stroke##2##5##(1997-5#1)(2009-11#1)
patients with acute ischemic stroke##8##5##(2007-10#5)(2008-10#1)(2012-12#2)
patients with acute ischemic##9##4##(2007-10#6)(2008-10#1)(2012-12#2)
patients with acute leukemia##3##4##(2008-7#1)(2011-2#2)
patients with acute myeloid leukemia##2##5##(2011-2#2)
patients with acute myeloid##3##4##(2011-2#2)(2012-3#1)
patients with acute myocardial infarction (AMI)##2##6##(1992-3#1)(1995-12#1)
patients with acute myocardial infarction##12##5##(1992-3#1)(1992-9#2)(1995-12#1)(2008-10#1)(2008-3#5)(2010-11#1)(2011-1#1)
patients with acute myocardial##14##4##(1990-12#1)(1992-3#1)(1992-9#2)(1995-12#1)(2008-10#1)(2008-3#6)(2010-11#1)(2011-1#1)
patients with acute necrotizing##2##4##(2012-3#2)
patients with acute pancreatitis##2##4##(1990-3#1)(2009-8#1)
patients with acute renal failure##2##5##(2008-4#2)
patients with acute stroke are##2##5##(2007-10#1)(2008-8#1)
patients with acute stroke##8##4##(1994-6#1)(2007-10#4)(2007-9#1)(2008-8#2)
patients with acute##110##3##(1990-12#1)(1990-2#2)(1990-3#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-9#2)(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-5#1)(1997-8#2)(2007-10#13)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#4)(2008-3#21)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
patients with additional##2##3##(2009-7#1)(2013-1#1)
patients with adult##4##3##(1992-2#1)(1992-8#1)(1993-3#1)(2012-12#1)
patients with advanced breast cancer refractory to##2##7##(1993-12#1)(1997-7#1)
patients with advanced breast cancer##6##5##(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)
patients with advanced breast##7##4##(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2011-2#1)
patients with advanced cancer##3##4##(2008-7#2)(2012-3#1)
patients with advanced colorectal cancer##2##5##(1994-2#1)(2010-9#1)
patients with advanced gastric cancer##2##5##(1990-2#1)(2010-12#1)
patients with advanced malignancies##2##4##(2008-7#1)(2012-3#1)
patients with advanced non-small cell lung##2##6##(1990-2#1)(2012-2#1)
patients with advanced ovarian cancer##2##5##(1991-8#2)
patients with advanced renal##2##4##(1991-6#1)(2013-1#1)
patients with advanced soft tissue##2##5##(2008-6#2)
patients with advanced##50##3##(1990-10#2)(1990-2#2)(1991-4#1)(1991-6#2)(1991-8#3)(1992-10#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#4)(2008-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#3)
patients with affective disorders##3##4##(1996-7#3)
patients with alcohol dependence##3##4##(2008-2#2)(2010-1#1)
patients with alcoholic liver disease##3##5##(1993-12#1)(1994-7#2)
patients with alcoholic##4##3##(1993-12#2)(1994-7#2)
patients with all##3##3##(1992-3#1)(2010-12#1)(2011-2#1)
patients with allergic rhinitis##2##4##(2008-4#1)(2012-12#1)
patients with allergic##5##3##(2007-11#1)(2008-4#1)(2009-6#1)(2010-5#1)(2012-12#1)
patients with ambiguous genitalia##2##4##(2008-10#2)
patients with an acute myocardial infarction##3##6##(2008-11#2)(2008-3#1)
patients with an acute##4##4##(2008-11#2)(2008-3#1)(2008-5#1)
patients with an anorectal##2##4##(2011-2#2)
patients with an asymptomatic##2##4##(2010-6#1)(2012-3#1)
patients with an isolated##2##4##(2008-7#1)(2011-2#1)
patients with an##26##3##(1992-12#1)(1992-5#1)(1996-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2010-6#1)(2011-2#4)(2012-3#1)
patients with and without AIDS##2##5##(2011-2#2)
patients with and without##16##4##(1993-12#1)(1997-7#1)(2007-12#1)(2007-8#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
patients with and##17##3##(1990-3#1)(1993-12#1)(1997-7#1)(2007-12#1)(2007-8#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
patients with aneurysms##2##3##(2011-2#1)(2013-8#1)
patients with angina##4##3##(1992-4#1)(2007-8#2)(2008-3#1)
patients with angiographically##2##3##(1990-8#1)(1994-11#1)
patients with anorexia##2##3##(1996-6#1)(2007-7#1)
patients with aortic##8##3##(1990-12#1)(1995-3#1)(2007-8#2)(2008-8#1)(2012-1#2)(2012-2#1)
patients with arteriovenous##3##3##(1996-9#1)(2008-7#1)(2012-3#1)
patients with arthritis##2##3##(2006-10#1)(2013-8#1)
patients with ascites of##2##4##(1991-4#2)
patients with ascites##6##3##(1991-4#2)(2007-12#3)(2008-10#1)
patients with associated##3##3##(1991-2#1)(2007-8#1)(2008-5#1)
patients with asthma and##4##4##(1996-7#1)(2012-12#3)
patients with asthma##14##3##(1993-1#1)(1996-2#1)(1996-7#2)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#5)(2012-2#1)
patients with asymptomatic##3##3##(1996-3#1)(2008-7#1)(2008-8#1)
patients with at least##2##4##(2012-2#1)(2013-1#1)
patients with atopic dermatitis##4##4##(1992-9#1)(2007-11#1)(2011-1#1)(2012-1#1)
patients with atopic##5##3##(1992-9#1)(2007-11#1)(2008-5#1)(2011-1#1)(2012-1#1)
patients with atrial fibrillation##5##4##(1996-6#1)(2007-8#1)(2008-3#1)(2009-12#1)(2012-12#1)
patients with atrial##6##3##(1996-6#1)(2007-8#1)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
patients with auditory nerve disease (auditory neuropathy)##2##7##(2008-9#2)
patients with auditory##3##3##(2008-9#2)(2012-1#1)
patients with autoimmune##3##3##(1990-3#1)(1994-3#1)(2012-1#1)
patients with autosomal dominant polycystic kidney disease (ADPKD)##3##8##(1997-1#2)(2013-1#1)
patients with autosomal dominant polycystic kidney##4##6##(1997-1#2)(2013-1#2)
patients with bacteremia##3##3##(1990-3#1)(2008-7#1)(2013-1#1)
patients with bacterial##2##3##(2011-1#1)(2013-1#1)
patients with basal##2##3##(2007-7#1)(2012-2#1)
patients with benign prostatic hyperplasia##2##5##(1990-9#2)
patients with benign##14##3##(1990-9#4)(1991-8#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-3#1)(2008-3#2)(2008-4#1)(2011-1#1)(2013-1#1)
patients with bilateral##6##3##(1991-12#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2012-2#1)
patients with biopsy-proven##2##3##(1995-4#1)(1997-3#1)
patients with bipolar disorder##8##4##(2008-6#1)(2009-3#1)(2012-12#1)(2012-3#2)(2013-8#3)
patients with bipolar##10##3##(1995-11#1)(2008-6#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#3)
patients with bladder exstrophy##2##4##(2008-10#2)
patients with bladder##3##3##(2007-9#1)(2008-10#2)
patients with blunt head trauma##3##5##(2011-2#3)
patients with blunt##4##3##(1990-2#1)(2011-2#3)
patients with bone metastases are##2##5##(2007-11#1)(2011-2#1)
patients with bone metastases from##5##5##(2008-10#1)(2008-7#4)
patients with bone metastases treated operatively in our Ward during##2##10##(2007-11#2)
patients with bone metastases##16##4##(1990-2#1)(2007-11#7)(2008-10#2)(2008-7#4)(2011-2#2)
patients with bone sarcomas high grade##2##6##(2011-1#2)
patients with bone sarcomas high##3##5##(2011-1#3)
patients with bone sarcomas##4##4##(2008-6#1)(2011-1#3)
patients with bone##23##3##(1990-2#2)(2007-11#8)(2008-10#2)(2008-6#1)(2008-7#4)(2011-1#4)(2011-2#2)
patients with borderline disorders##2##4##(1992-1#1)(1993-12#1)
patients with both type 1 and type 2 diabetes##2##9##(2008-1#1)(2008-8#1)
patients with both##5##3##(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients with brain##4##3##(1994-3#1)(2008-12#1)(2008-2#1)(2010-8#1)
patients with breast and prostate cancer##2##6##(2007-11#1)(2008-7#1)
patients with breast cancer and##8##5##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(2007-10#1)(2007-11#3)
patients with breast cancer were##2##5##(1994-12#1)(2013-1#1)
patients with breast cancer who##2##5##(2012-3#1)(2013-1#1)
patients with breast cancer##30##4##(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#4)(1994-12#2)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#3)(2008-10#1)(2008-7#4)(2012-3#1)(2013-1#4)
patients with breast##34##3##(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#4)(1994-12#2)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#4)(2008-10#1)(2008-7#7)(2012-3#1)(2013-1#4)
patients with cancer and##3##4##(2008-7#3)
patients with cancer is##4##4##(2007-8#1)(2008-2#1)(2008-7#2)
patients with cancer of the pancreas##6##6##(1990-9#1)(2008-7#5)
patients with cancer of the prostate##2##6##(1990-9#1)(1991-8#1)
patients with cancer of the stomach##11##6##(1991-2#2)(2008-7#9)
patients with cancer of the##22##5##(1990-9#3)(1991-2#2)(1991-8#1)(1992-11#1)(2008-7#15)
patients with cancer of##23##4##(1990-9#3)(1991-12#1)(1991-2#2)(1991-8#1)(1992-11#1)(2008-7#15)
patients with cancer receiving##4##4##(2008-7#4)
patients with cancer who##2##4##(2008-7#2)
patients with cancer##84##3##(1990-6#1)(1990-9#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-11#1)(1992-8#1)(1996-11#1)(1996-9#2)(2007-11#1)(2007-8#1)(2008-2#2)(2008-7#50)(2009-12#1)(2010-11#6)(2010-4#1)(2010-9#2)(2012-1#1)(2012-3#2)(2013-1#3)
patients with candidosis and##2##4##(2008-5#2)
patients with carcinoid tumours##3##4##(1992-11#3)
patients with carcinoid##5##3##(1992-11#4)(2013-1#1)
patients with carcinoma of the##3##5##(1994-3#2)(2009-3#1)
patients with carcinoma##6##3##(1992-5#2)(1994-3#2)(1995-8#1)(2009-3#1)
patients with cardiac injuries##2##4##(2007-8#2)
patients with cardiac##10##3##(1995-11#1)(2007-8#2)(2008-12#2)(2008-3#1)(2008-6#1)(2011-2#2)(2012-2#1)
patients with cardiovascular disease##2##4##(2008-1#1)(2011-2#1)
patients with cardiovascular##7##3##(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients with carotid##2##3##(1991-11#1)(1991-12#1)
patients with carpal##2##3##(2008-9#2)
patients with central##3##3##(1994-9#1)(2008-6#1)(2008-9#1)
patients with cerebral##4##3##(1990-12#1)(1994-9#1)(2007-10#1)(2008-7#1)
patients with cerebrovascular disease##2##4##(2007-10#1)(2008-7#1)
patients with cerebrovascular##6##3##(1990-6#1)(1991-11#1)(2007-10#2)(2008-7#1)(2011-1#1)
patients with certain##2##3##(1992-8#1)(1997-1#1)
patients with cervical intraepithelial neoplasia##2##5##(1991-2#1)(2011-2#1)
patients with cervical##5##3##(1991-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2011-2#1)
patients with chest pain and no ST-segment elevation##2##8##(2008-3#2)
patients with chest pain in the##2##6##(2008-3#2)
patients with chest pain##8##4##(1992-6#1)(2008-3#5)(2012-2#2)
patients with chest##9##3##(1991-12#1)(1992-6#1)(2008-3#5)(2012-2#2)
patients with choledocholithiasis##2##3##(2008-5#2)
patients with chronic HCV##2##4##(2009-4#1)(2009-8#1)
patients with chronic active hepatitis##3##5##(1991-6#1)(2009-8#2)
patients with chronic diseases##2##4##(2009-9#1)(2011-2#1)
patients with chronic heart failure##8##5##(1991-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
patients with chronic heart##10##4##(1991-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-1#2)(2012-2#1)(2013-8#1)
patients with chronic hepatitis B##6##5##(2009-8#3)(2010-8#1)(2011-2#2)
patients with chronic hepatitis C virus infection##2##7##(2011-2#1)(2013-1#1)
patients with chronic hepatitis C##7##5##(1994-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
patients with chronic hepatitis##14##4##(1994-8#1)(2009-10#1)(2009-8#4)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)
patients with chronic inflammatory##2##4##(2008-1#1)(2008-10#1)
patients with chronic kidney disease##4##5##(2008-11#1)(2011-2#3)
patients with chronic kidney##5##4##(2008-11#1)(2011-2#3)(2012-2#1)
patients with chronic liver disease##4##5##(1991-8#1)(2008-1#2)(2009-4#1)
patients with chronic low back pain##3##6##(2008-10#1)(2012-12#2)
patients with chronic neck pain##4##5##(2010-12#4)
patients with chronic obstructive pulmonary disease (COPD)##3##7##(1997-7#1)(2008-7#1)(2011-2#1)
patients with chronic obstructive pulmonary disease##8##6##(1991-9#1)(1997-7#2)(2008-7#2)(2011-2#3)
patients with chronic obstructive pulmonary##9##5##(1991-9#1)(1993-11#1)(1997-7#2)(2008-7#2)(2011-2#3)
patients with chronic obstructive rhinitis##4##5##(2008-4#4)
patients with chronic obstructive##14##4##(1991-9#1)(1993-11#1)(1997-7#2)(2008-1#1)(2008-4#4)(2008-7#2)(2011-2#3)
patients with chronic pain##7##4##(1992-9#1)(1997-6#1)(2008-4#2)(2008-9#1)(2009-7#1)(2012-3#1)
patients with chronic pancreatitis##2##4##(1992-11#2)
patients with chronic periodontitis with##2##5##(2008-12#2)
patients with chronic periodontitis##6##4##(2008-12#3)(2012-3#1)(2013-1#2)
patients with chronic renal disease##2##5##(2008-1#1)(2008-10#1)
patients with chronic renal failure (CRF)##3##6##(2007-7#2)(2011-2#1)
patients with chronic renal failure who##2##6##(1993-2#1)(1994-12#1)
patients with chronic renal failure##12##5##(1991-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2011-2#1)
patients with chronic renal insufficiency or##2##6##(2006-10#2)
patients with chronic renal##17##4##(1991-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-5#1)(2006-10#2)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#1)(2011-2#1)
patients with chronic respiratory##2##4##(2008-1#1)(2013-1#1)
patients with chronic sinusitis who underwent total spheno-ethmoidectomy##2##8##(2008-5#2)
patients with chronic sinusitis##3##4##(1995-8#1)(2008-5#2)
patients with chronic stable hypercapnic respiratory##2##6##(2008-1#2)
patients with chronic stable##3##4##(2008-1#2)(2008-3#1)
patients with chronic venous##2##4##(2010-7#1)(2013-1#1)
patients with chronic wrist pain##3##5##(2008-9#3)
patients with chronic##152##3##(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#11)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#8)(2008-5#3)(2008-7#8)(2008-8#1)(2008-9#4)(2009-10#3)(2009-4#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-12#6)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#11)(2013-8#1)
patients with cirrhosis##8##3##(1994-7#1)(2008-7#1)(2009-4#2)(2011-2#2)(2012-3#1)(2013-1#1)
patients with classical##3##3##(1991-12#2)(1997-5#1)
patients with clear##2##3##(2008-6#2)
patients with cleft lip##2##4##(2013-1#2)
patients with cleft##3##3##(2007-12#1)(2013-1#2)
patients with clinical##7##3##(1991-2#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
patients with clinically evident##2##4##(2008-10#1)(2008-3#1)
patients with clinically##8##3##(1990-2#1)(1992-3#1)(1992-6#1)(1996-11#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)
patients with coagulopathy versus##2##4##(2007-10#2)
patients with cochlear implants##6##4##(2008-9#6)
patients with coexisting##4##3##(2007-11#2)(2008-10#1)(2013-1#1)
patients with cognitive##3##3##(1991-5#1)(2008-7#1)(2010-7#1)
patients with colon##3##3##(1990-8#2)(1991-3#1)
patients with colorectal cancer liver metastases##2##6##(2008-10#2)
patients with colorectal cancer##5##4##(2008-10#2)(2009-12#1)(2011-2#2)
patients with colorectal carcinoma##4##4##(1992-8#4)
patients with colorectal##11##3##(1992-8#4)(2008-10#3)(2009-12#1)(2011-2#2)(2012-2#1)
patients with combined##4##3##(2007-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
patients with communication related impairments in acute##2##7##(2011-1#2)
patients with community-acquired pneumonia and##3##5##(2013-1#3)
patients with community-acquired pneumonia##4##4##(2013-1#4)
patients with compensated##2##3##(2013-1#1)(2013-8#1)
patients with complete##2##3##(1992-4#1)(2012-2#1)
patients with complicated##4##3##(1991-6#1)(2008-3#1)(2010-12#1)(2012-12#1)
patients with concomitant##4##3##(1990-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
patients with confirmed##3##3##(2008-6#1)(2009-11#1)(2012-2#1)
patients with congenital heart disease (CHD)##2##6##(2010-10#1)(2012-2#1)
patients with congenital heart disease##8##5##(2009-10#2)(2009-5#1)(2010-10#2)(2012-2#3)
patients with congenital##12##3##(1994-11#1)(2009-10#2)(2009-5#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-2#4)
patients with congestive heart failure##3##5##(1996-9#1)(2008-5#1)(2012-3#1)
patients with coronary artery disease##10##5##(1990-3#1)(1997-8#1)(2006-10#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)
patients with coronary artery##11##4##(1990-3#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)
patients with coronary heart disease##12##5##(1990-8#2)(1992-5#1)(1993-12#1)(1993-2#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-3#1)
patients with coronary##28##3##(1990-3#1)(1990-8#2)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1995-3#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
patients with cortical deafness##2##4##(2008-9#2)
patients with cortical##3##3##(2007-10#1)(2008-9#2)
patients with craniofacial##2##3##(2007-12#2)
patients with cutaneous##3##3##(1997-4#1)(2008-12#2)
patients with cystic fibrosis were##2##5##(1991-12#1)(2007-8#1)
patients with cystic fibrosis##7##4##(1991-12#2)(1994-12#1)(2007-8#2)(2008-10#1)(2012-1#1)
patients with cystic##8##3##(1991-12#2)(1994-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2012-1#1)
patients with de novo##2##4##(2008-5#1)(2010-1#1)
patients with degenerative disease of the##3##6##(2007-11#2)(2012-12#1)
patients with degenerative##9##3##(2007-11#2)(2007-8#3)(2008-11#1)(2008-8#1)(2009-3#1)(2012-12#1)
patients with delayed##2##3##(2008-5#1)(2011-2#1)
patients with dementia##8##3##(1991-11#1)(1996-11#1)(2008-6#1)(2008-7#4)(2008-8#1)
patients with diabetes and other chronic diseases##2##7##(2013-8#2)
patients with diabetes and other##3##5##(2013-8#3)
patients with diabetes and##4##4##(2013-1#1)(2013-8#3)
patients with diabetes are##2##4##(2008-3#1)(2010-12#1)
patients with diabetes mellitus##11##4##(1992-5#2)(2008-1#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
patients with diabetes##37##3##(1992-5#2)(2007-10#1)(2007-8#1)(2008-1#7)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#3)(2013-1#3)(2013-8#6)
patients with diabetic##3##3##(1994-12#1)(2008-1#1)(2011-1#1)
patients with diarrhoeic type IBS##2##5##(1997-6#2)
patients with diastolic##3##3##(1992-5#1)(2008-7#1)(2012-12#1)
patients with different##13##3##(1991-2#1)(1991-5#2)(1993-11#1)(1993-2#1)(1997-2#1)(2007-2#1)(2008-11#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-3#1)
patients with differentiated##2##3##(1994-11#1)(2013-1#1)
patients with diffuse systemic sclerosis and antitopoisomerase 1 antibodies##2##9##(2009-8#2)
patients with diffuse systemic sclerosis##4##5##(2009-8#4)
patients with diffuse##6##3##(1993-8#1)(1994-11#1)(2009-8#4)
patients with dilated cardiomyopathy##4##4##(1993-2#2)(2011-2#1)(2012-2#1)
patients with disorders of##2##4##(1991-12#1)(1991-5#1)
patients with disseminated neoplasm and##2##5##(1996-12#2)
patients with disseminated neoplasm##4##4##(1996-12#4)
patients with disseminated##5##3##(1996-12#4)(2010-3#1)
patients with distal##3##3##(1991-12#1)(2007-11#1)(2009-12#1)
patients with distant metastases##3##4##(1993-1#1)(2008-6#2)
patients with distant##4##3##(1993-1#1)(1993-8#1)(2008-6#2)
patients with diverse##2##3##(1991-5#1)(1995-3#1)
patients with drug addiction##2##4##(2009-7#2)
patients with duodenal##2##3##(2008-12#2)
patients with dural arteriovenous fistulae##2##5##(1996-9#2)
patients with dysphagia##4##3##(2007-10#2)(2013-8#2)
patients with early breast cancer who##2##6##(1991-8#1)(2011-2#1)
patients with early breast cancer##4##5##(1991-8#2)(1994-12#1)(2011-2#1)
patients with early##14##3##(1991-12#1)(1991-8#2)(1992-6#1)(1994-12#1)(1997-7#1)(2007-10#1)(2007-8#2)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#2)
patients with eating disorders##4##4##(1997-3#1)(2007-7#1)(2008-4#1)(2011-2#1)
patients with elevated##6##3##(1990-2#1)(1990-9#1)(1991-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
patients with end stage renal##2##5##(2007-7#1)(2008-1#1)
patients with end-stage kidney disease##2##5##(2012-12#1)(2013-1#1)
patients with end-stage kidney##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
patients with end-stage renal disease (ESRD)##4##6##(2007-7#3)(2008-1#1)
patients with end-stage renal disease##10##5##(2007-12#1)(2007-7#4)(2008-1#3)(2012-12#1)(2013-1#1)
patients with end-stage renal failure##2##5##(2008-1#1)(2008-4#1)
patients with end-stage renal##13##4##(2007-12#1)(2007-7#4)(2008-1#4)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
patients with end-stage##20##3##(2007-12#1)(2007-7#4)(2008-1#4)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#3)(2013-8#1)
patients with endometriosis##4##3##(1991-11#1)(1995-2#2)(2012-3#1)
patients with epidermolysis bullosa##2##4##(2012-3#2)
patients with epilepsy##3##3##(1997-8#1)(2010-8#1)(2011-2#1)
patients with epileptic##2##3##(2010-11#1)(2010-12#1)
patients with esophageal cancer##2##4##(2007-8#1)(2010-12#1)
patients with essential hypertension##2##4##(2008-5#2)
patients with essential##3##3##(1995-10#1)(2008-5#2)
patients with established coronary artery disease##2##6##(2008-1#1)(2009-12#1)
patients with established coronary##3##4##(2008-1#1)(2008-3#1)(2009-12#1)
patients with established##11##3##(1991-9#1)(1993-11#3)(2007-8#1)(2008-1#1)(2008-3#2)(2009-12#1)(2010-3#1)(2011-2#1)
patients with evidence of##2##4##(2008-5#1)(2009-8#1)
patients with extensive atherosclerosis in the ascending aorta##3##8##(2007-8#3)
patients with extensive atherosclerosis##4##4##(2007-8#4)
patients with extensive##6##3##(1993-8#1)(2007-11#1)(2007-8#4)
patients with extrahepatic cholestasis##2##4##(1993-9#2)
patients with extremity sarcomas##2##4##(2008-6#1)(2010-3#1)
patients with extremity##4##3##(2008-6#1)(2010-3#3)
patients with failed##3##3##(2012-3#2)(2013-1#1)
patients with familial moyamoya disease##2##5##(2007-10#2)
patients with familial##7##3##(1990-2#1)(1996-5#1)(2007-10#2)(2008-12#1)(2009-12#1)(2009-5#1)
patients with femoral##2##3##(2007-11#1)(2007-8#1)
patients with fibromatosis##2##3##(1997-7#1)(2008-6#1)
patients with first##3##3##(2007-10#1)(2008-3#1)(2009-10#1)
patients with focal##4##3##(1997-8#1)(2007-8#1)(2008-11#1)(2011-2#1)
patients with functional tumors##2##4##(2008-3#2)
patients with functional##5##3##(1996-7#1)(2008-10#1)(2008-3#2)(2008-7#1)
patients with gastric cancer##2##4##(2011-2#2)
patients with gastric##7##3##(1990-2#2)(2008-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
patients with gastroenteritis were##2##4##(2008-7#2)
patients with gastroenteritis##4##3##(1990-6#1)(2008-7#3)
patients with gastrointestinal##7##3##(1990-6#1)(1990-8#1)(1997-3#1)(1997-8#1)(2008-3#1)(2013-7#1)(2013-8#1)
patients with genital##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
patients with glioblastoma##2##3##(2008-11#1)(2011-2#1)
patients with good##2##3##(2007-10#1)(2011-2#1)
patients with grade##5##3##(2008-7#5)
patients with hand##2##3##(2008-12#1)(2013-1#1)
patients with head injuries##4##4##(1990-3#1)(1996-8#1)(2008-7#2)
patients with head injury##2##4##(2008-7#2)
patients with head##8##3##(1990-3#1)(1996-8#1)(2008-7#5)(2010-4#1)
patients with heart failure##8##4##(1996-8#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
patients with heart##12##3##(1990-12#1)(1996-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
patients with hematologic malignancies##10##4##(2008-7#9)(2012-12#1)
patients with hematologic##11##3##(2008-7#9)(2012-12#2)
patients with hematological##2##3##(2011-2#1)(2012-2#1)
patients with hemorrhagic fever with renal syndrome without affection of##2##10##(2013-1#2)
patients with hemorrhagic fever with renal syndrome##3##7##(2013-1#3)
patients with hepatic##3##3##(1991-5#1)(2008-1#1)(2009-8#1)
patients with hepatitis C##2##4##(2006-10#1)(2008-1#1)
patients with hepatitis##3##3##(2006-10#1)(2007-12#1)(2008-1#1)
patients with hepatocellular carcinoma##3##4##(1992-3#1)(2008-12#1)(2013-8#1)
patients with hepatosplenic schistosomiasis##2##4##(2013-8#2)
patients with high grade##3##4##(1994-2#1)(2008-6#1)(2010-3#1)
patients with high risk##3##4##(1997-3#1)(2013-1#2)
patients with high##19##3##(1990-12#1)(1990-2#1)(1992-3#1)(1994-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#2)
patients with high-grade##5##3##(1992-6#1)(2008-2#1)(2008-6#1)(2010-3#1)(2013-8#1)
patients with high-risk##7##3##(2008-6#1)(2011-2#5)(2013-1#1)
patients with higher##2##3##(2008-7#1)(2012-1#1)
patients with hip##3##3##(1990-2#1)(1993-11#1)(2008-10#1)
patients with histologically confirmed##2##4##(1994-12#1)(2011-2#1)
patients with histologically proven##5##4##(1990-2#1)(1990-8#1)(1991-2#1)(2007-10#1)(2008-7#1)
patients with histologically##9##3##(1990-2#1)(1990-8#1)(1991-2#1)(1994-12#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients with human immunodeficiency virus infection##2##6##(1993-2#1)(1996-2#1)
patients with human immunodeficiency virus##5##5##(1993-2#1)(1996-11#1)(1996-2#1)(2008-2#1)(2010-11#1)
patients with human##6##3##(1993-2#1)(1996-11#1)(1996-2#1)(2008-2#1)(2010-11#1)(2012-3#1)
patients with hyperlipidaemia and##2##4##(2008-11#1)(2008-3#1)
patients with hyperlipidaemia##4##3##(2008-11#1)(2008-3#3)
patients with hypertrophic##3##3##(2008-7#2)(2010-12#1)
patients with idiopathic PD##2##4##(2008-7#1)(2013-1#1)
patients with idiopathic central DI##2##5##(1997-8#2)
patients with idiopathic pulmonary##2##4##(2009-10#1)(2013-1#1)
patients with idiopathic ulcerative colitis##2##5##(1995-10#2)
patients with idiopathic##17##3##(1991-5#2)(1995-10#2)(1997-8#2)(2008-7#3)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#4)(2013-8#1)
patients with impaired##4##3##(2008-3#1)(2010-4#1)(2011-2#1)(2012-1#1)
patients with incomplete##4##3##(2008-1#1)(2008-9#1)(2012-2#1)(2013-1#1)
patients with increased##5##3##(1993-2#1)(2008-12#2)(2008-4#1)(2011-2#1)
patients with infantile##3##3##(1991-2#1)(2009-4#2)
patients with infectious##2##3##(1990-9#1)(1997-8#1)
patients with inflammatory bowel disease##11##5##(1992-6#1)(2008-10#1)(2010-12#2)(2010-6#1)(2012-12#1)(2013-1#3)(2013-8#2)
patients with inflammatory bowel##13##4##(1992-6#1)(2008-10#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
patients with inflammatory##16##3##(1992-12#1)(1992-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
patients with inherited##3##3##(1994-8#1)(1997-7#1)(2008-10#1)
patients with initial##3##3##(1990-6#1)(2008-1#1)(2008-11#1)
patients with inoperable##4##3##(1991-2#1)(1993-6#2)(2008-6#1)
patients with internal##2##3##(2008-8#1)(2010-12#1)
patients with interstitial##2##3##(1991-2#1)(2007-9#1)
patients with intracerebral hemorrhage##2##4##(2007-10#2)
patients with intracerebral##4##3##(2007-10#2)(2008-7#2)
patients with intracranial##4##3##(1991-2#1)(1995-11#1)(1996-6#1)(2008-7#1)
patients with intractable##2##3##(1993-1#1)(2009-9#1)
patients with invasive##5##3##(1992-8#1)(2008-10#1)(2008-5#2)(2012-2#1)
patients with ipsilateral##2##3##(2008-10#1)(2013-1#1)
patients with ischaemic heart##3##4##(2007-8#1)(2008-7#1)(2012-2#1)
patients with ischaemic##6##3##(2007-8#2)(2008-7#1)(2008-8#2)(2012-2#1)
patients with ischemic heart disease##4##5##(1996-9#3)(2012-3#1)
patients with ischemic stroke who were##2##6##(2007-10#2)
patients with ischemic stroke##6##4##(2007-10#4)(2007-9#1)(2008-8#1)
patients with ischemic##14##3##(1996-9#3)(2006-7#1)(2007-10#4)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
patients with isolated##6##3##(2007-10#2)(2008-1#1)(2011-2#2)(2013-1#1)
patients with kidney##2##3##(1991-3#1)(2013-1#1)
patients with knee##4##3##(2007-8#2)(2013-1#2)
patients with known##5##3##(1996-12#1)(1997-8#1)(2008-1#1)(2010-7#1)(2012-2#1)
patients with lacunar##2##3##(2007-10#2)
patients with large##5##3##(2006-7#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
patients with late##2##3##(2007-11#1)(2012-3#1)
patients with left anterior fascicle block##2##6##(2008-7#2)
patients with left lung cancer##2##5##(2007-8#2)
patients with left unilateral neglect##2##5##(1995-12#1)(2009-10#1)
patients with left ventricular dysfunction##2##5##(2007-8#2)
patients with left ventricular##3##4##(2007-8#2)(2008-7#1)
patients with left##13##3##(1995-12#1)(2007-8#4)(2008-7#4)(2009-10#3)(2012-3#1)
patients with lesions in##2##4##(1990-3#1)(2008-11#1)
patients with lesions##3##3##(1990-3#1)(2007-11#1)(2008-11#1)
patients with less than##2##4##(1997-4#1)(2009-5#1)
patients with less##3##3##(1997-4#1)(2009-5#1)(2012-2#1)
patients with leukemia and lymphoma##2##5##(1992-3#2)
patients with leukemia##4##3##(1992-3#2)(2008-1#1)(2010-11#1)
patients with limited##7##3##(1993-5#1)(1995-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#2)
patients with little##2##3##(2007-12#1)(2010-12#1)
patients with liver cirrhosis##8##4##(1992-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#1)
patients with liver disease##3##4##(1990-8#1)(2013-1#2)
patients with liver metastases##2##4##(1991-4#1)(1995-4#1)
patients with liver##16##3##(1990-8#1)(1991-4#1)(1992-2#1)(1995-4#1)(2008-1#1)(2008-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#5)(2013-8#1)
patients with localized disease##3##4##(2010-3#3)
patients with localized scleroderma##2##4##(2011-2#2)
patients with localized##9##3##(1995-12#1)(2008-7#1)(2010-3#4)(2011-2#2)(2012-12#1)
patients with locally advanced or metastatic##2##6##(2008-6#1)(2009-9#1)
patients with locally advanced prostate cancer##2##6##(1997-7#1)(2008-7#1)
patients with locally advanced##10##4##(1991-4#1)(1997-7#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#1)(2012-2#1)
patients with locally##12##3##(1990-8#1)(1991-4#1)(1997-7#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
patients with long bone metastases##2##5##(2007-11#2)
patients with long##5##3##(2007-11#3)(2010-9#1)(2012-2#1)
patients with long-standing##3##3##(1997-6#1)(2008-7#1)(2008-8#1)
patients with low back pain and##2##6##(2007-11#1)(2008-12#1)
patients with low back pain##6##5##(2007-11#1)(2008-12#4)(2013-1#1)
patients with low##17##3##(1990-2#1)(1992-3#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#2)(2012-2#1)(2013-1#3)
patients with low-grade non-Hodgkin's lymphomas##2##5##(1990-12#1)(1993-6#1)
patients with low-grade##5##3##(1990-12#1)(1993-6#1)(1997-1#2)(2007-10#1)
patients with lower##3##3##(1990-3#1)(2009-2#1)(2011-2#1)
patients with lumbar##5##3##(1992-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
patients with lung cancer##5##4##(1991-2#1)(1991-8#1)(2008-7#1)(2009-11#1)(2012-1#1)
patients with lung##8##3##(1991-2#1)(1991-8#1)(1996-9#1)(2008-7#1)(2009-11#1)(2009-4#1)(2012-1#1)(2012-2#1)
patients with lupus nephritis##2##4##(2006-10#1)(2008-1#1)
patients with lupus##3##3##(2006-10#1)(2008-1#1)(2013-1#1)
patients with lymph node##3##4##(1991-6#1)(2010-8#1)(2013-1#1)
patients with lymphoma##3##3##(1997-8#1)(2007-11#1)(2008-4#1)
patients with major depression##4##4##(1995-11#1)(2008-6#1)(2009-8#2)
patients with major depressive disorder##2##5##(1996-7#1)(2013-7#1)
patients with major##7##3##(1995-11#1)(1996-7#1)(2008-6#1)(2009-8#2)(2011-2#1)(2013-7#1)
patients with malignancies##2##3##(2011-2#1)(2012-3#1)
patients with malignant brain tumors##2##5##(2008-7#1)(2013-8#1)
patients with malignant melanoma##4##4##(1990-6#1)(1993-8#1)(2007-5#1)(2011-2#1)
patients with malignant pleural mesothelioma##2##5##(1990-12#1)(1992-12#1)
patients with malignant tumors##3##4##(1994-12#1)(2007-11#1)(2008-3#1)
patients with malignant tumours##2##4##(1997-2#1)(2008-7#1)
patients with malignant##22##3##(1990-12#1)(1990-2#1)(1990-6#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-2#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
patients with mastectomy##2##3##(1992-12#1)(2013-1#1)
patients with measurable##2##3##(1990-12#1)(2008-6#1)
patients with mechanical jaundice##2##4##(2011-1#2)
patients with mechanical##6##3##(1995-11#1)(2008-12#2)(2011-1#2)(2012-3#1)
patients with mental##2##3##(1995-1#1)(2011-2#1)
patients with mesothelioma##2##3##(1992-11#2)
patients with metabolic##5##3##(1993-8#2)(2008-11#1)(2008-5#1)(2012-2#1)
patients with metachromatic leukodystrophy##2##4##(1997-3#2)
patients with metastases in##3##4##(2007-11#3)
patients with metastases##5##3##(2007-11#5)
patients with metastasis##2##3##(1992-5#1)(2008-6#1)
patients with metastatic breast cancer who##2##6##(1992-10#2)
patients with metastatic breast cancer##4##5##(1992-10#2)(2008-3#1)(2010-8#1)
patients with metastatic colorectal##2##4##(1990-2#1)(1991-4#1)
patients with metastatic disease##7##4##(1990-11#1)(2007-11#1)(2008-6#1)(2010-3#3)(2011-1#1)
patients with metastatic melanoma##2##4##(1990-6#1)(2012-2#1)
patients with metastatic prostate cancer##3##5##(1995-11#1)(2007-5#2)
patients with metastatic##27##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#1)(1991-4#1)(1992-10#2)(1994-10#1)(1994-8#1)(1995-11#1)(2007-11#3)(2007-5#2)(2008-11#1)(2008-3#1)(2008-6#2)(2010-3#3)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
patients with microscopic##2##3##(1990-11#1)(2007-8#1)
patients with mild CHI##2##4##(2013-8#2)
patients with mild OCA##2##4##(1997-4#2)
patients with mild anemia showed##2##5##(2008-7#2)
patients with mild anemia##3##4##(2008-7#3)
patients with mild to moderate##3##5##(1994-11#1)(2008-5#1)(2013-8#1)
patients with mild to##4##4##(1994-11#1)(2008-5#1)(2010-2#1)(2013-8#1)
patients with mild##16##3##(1994-11#1)(1997-4#2)(2008-5#1)(2008-7#3)(2009-5#1)(2010-10#1)(2010-2#1)(2010-7#1)(2013-8#5)
patients with mild-to-moderate hypertension##2##4##(1992-8#2)
patients with mild-to-moderate##4##3##(1991-6#1)(1992-8#3)
patients with minor##2##3##(1992-6#1)(1996-8#1)
patients with moderate and##4##4##(2007-10#1)(2008-7#2)(2011-2#1)
patients with moderate to severe##7##5##(1990-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-2#2)
patients with moderate##11##3##(1990-3#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-2#2)
patients with more than##2##4##(1991-2#1)(2008-11#1)
patients with more##4##3##(1991-2#1)(2007-10#1)(2008-11#1)(2011-2#1)
patients with moyamoya disease has##2##5##(2007-8#1)(2008-7#1)
patients with multimorbidity##2##3##(2011-2#1)(2012-3#1)
patients with multiple bone metastases##3##5##(2007-11#3)
patients with multiple myeloma##6##4##(2008-1#1)(2008-7#3)(2011-1#1)(2011-2#1)
patients with multiple osteoblastic-osteolytic##2##4##(2007-11#2)
patients with multiple sclerosis (MS)##2##5##(2012-3#2)
patients with multiple sclerosis##6##4##(2011-1#1)(2012-12#1)(2012-3#4)
patients with multiple##29##3##(1991-5#1)(1992-6#1)(1994-3#1)(1995-8#1)(1997-1#1)(2007-11#7)(2008-1#1)(2008-11#1)(2008-7#3)(2009-3#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#4)
patients with muscle##2##3##(2008-10#1)(2008-7#1)
patients with myeloma##5##3##(1990-9#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
patients with myocardial infarction and##2##5##(1996-9#1)(2011-1#1)
patients with myocardial infarction##6##4##(1993-9#1)(1996-9#3)(2011-1#1)(2013-1#1)
patients with myocardial##8##3##(1993-9#1)(1996-9#3)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
patients with neck pain##5##4##(2008-11#1)(2008-12#3)(2010-12#1)
patients with necrotizing##2##3##(1991-11#1)(2012-3#1)
patients with neoplasia##2##3##(2011-2#1)(2013-8#1)
patients with neoplastic disease##2##4##(2007-11#2)
patients with neoplastic##3##3##(2007-11#2)(2012-3#1)
patients with neuroendocrine##3##3##(1992-11#2)(2010-9#1)
patients with neurological disorders##2##4##(1990-2#2)
patients with neurological##5##3##(1990-2#2)(1991-8#1)(1993-12#1)(1993-2#1)
patients with neuromuscular diseases##3##4##(2008-7#3)
patients with neuromuscular##4##3##(2008-7#4)
patients with neuropsychomotor disorders##2##4##(2008-12#2)
patients with newly diagnosed##4##4##(1996-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
patients with newly##5##3##(1990-11#1)(1996-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
patients with no evidence of##2##5##(1992-9#1)(2008-5#1)
patients with no##10##3##(1992-9#1)(1993-12#1)(1993-2#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
patients with non-Hodgkin's lymphoma and chemotherapy-induced anemia##2##7##(2008-7#2)
patients with non-Hodgkin's##3##3##(1991-6#1)(2008-7#2)
patients with non-ST##2##3##(2008-3#1)(2013-8#1)
patients with non-insulin dependent diabetes mellitus##2##6##(1994-12#1)(2008-7#1)
patients with non-insulin-dependent diabetes mellitus##2##5##(1992-9#1)(1995-8#1)
patients with non-malignant ovarian##2##4##(1990-2#2)
patients with non-neuroendocrine tumours##2##4##(1992-11#2)
patients with nonrheumatic atrial fibrillation and##2##6##(1995-11#1)(2007-7#1)
patients with nonthyroidal illness##2##4##(2008-7#2)
patients with normal colonoscopy##3##4##(2012-3#3)
patients with normal##15##3##(1991-11#1)(1993-11#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#3)
patients with obsessive-compulsive disorder##2##4##(2008-3#2)
patients with obstructive sleep apnea##2##5##(2012-2#2)
patients with obstructive##4##3##(1997-4#1)(2006-10#1)(2012-2#2)
patients with one or##2##4##(2008-9#1)(2013-1#1)
patients with one##4##3##(1994-11#1)(2008-9#1)(2012-12#1)(2013-1#1)
patients with open angle##2##4##(2011-2#2)
patients with operable breast cancer##2##5##(1991-12#1)(1991-8#1)
patients with operable breast##3##4##(1991-12#1)(1991-8#1)(1994-12#1)
patients with operable##4##3##(1991-12#1)(1991-8#1)(1994-12#1)(1996-9#1)
patients with optic##2##3##(1995-12#1)(2008-7#1)
patients with or without##7##4##(1993-12#1)(1994-7#1)(1997-5#1)(2007-7#1)(2008-3#1)(2012-12#1)(2013-1#1)
patients with oral cancer##2##4##(2013-1#2)
patients with oral##5##3##(2008-1#1)(2008-4#1)(2012-3#1)(2013-1#2)
patients with osteoarthritis##6##3##(1991-5#1)(2007-11#3)(2007-8#1)(2013-1#1)
patients with osteoporosis##8##3##(1997-6#1)(2007-11#3)(2008-4#1)(2008-8#3)
patients with osteoporotic##3##3##(1991-11#1)(2007-11#1)(2007-8#1)
patients with osteosarcoma has##2##4##(2010-3#2)
patients with osteosarcoma##8##3##(2010-3#8)
patients with other etiologies of renal failure##2##7##(2013-1#2)
patients with other##8##3##(1990-3#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-1#1)(2011-2#1)(2013-1#2)
patients with ovarian cancer##2##4##(1991-6#1)(1996-10#1)
patients with ovarian##6##3##(1990-2#1)(1991-4#1)(1991-6#1)(1994-2#1)(1996-1#1)(1996-10#1)
patients with overt##3##3##(2010-6#1)(2010-8#1)(2011-2#1)
patients with pTa##2##3##(2011-2#2)
patients with pain##3##3##(2007-8#1)(2008-7#1)(2009-12#1)
patients with panic disorder##9##4##(1990-11#1)(1993-12#2)(1996-7#1)(2007-1#1)(2013-7#1)(2013-8#3)
patients with parkinsonian##2##3##(1993-11#1)(2008-7#1)
patients with paroxysmal##4##3##(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
patients with partial##3##3##(1992-4#1)(1996-2#1)(2007-11#1)
patients with patellofemoral pain syndrome##3##5##(2008-12#3)
patients with patent##2##3##(1990-3#1)(2011-2#1)
patients with pathological fractures##2##4##(2007-11#2)
patients with pathological##4##3##(1992-5#1)(2007-11#2)(2008-11#1)
patients with pathologically confirmed##2##4##(2008-6#1)(2009-12#1)
patients with penetrating cardiac injuries from##2##6##(2008-1#2)
patients with penetrating##3##3##(2008-1#2)(2010-7#1)
patients with peptic ulcer##2##4##(1995-10#1)(2008-12#1)
patients with peri-implantitis##2##3##(2013-1#2)
patients with peripheral arterial##2##4##(1995-2#1)(2008-7#1)
patients with peripheral##4##3##(1995-2#1)(2007-8#1)(2008-7#1)(2013-1#1)
patients with persistent##7##3##(1991-8#1)(1992-5#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-9#2)
patients with persisting##2##3##(1992-5#1)(2010-12#1)
patients with pheochromocytoma##2##3##(1995-12#1)(2009-1#1)
patients with pituitary##2##3##(2011-2#1)(2013-1#1)
patients with pityriasis versicolor##2##4##(2008-5#2)
patients with plegia##2##3##(2007-11#2)
patients with pneumococcal meningitis##3##4##(2011-2#3)
patients with pneumococcal##4##3##(2011-2#4)
patients with poor##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
patients with poor-grade##2##3##(2012-3#2)
patients with positive##10##3##(1991-4#1)(1993-3#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
patients with posterior##4##3##(2007-8#1)(2008-1#1)(2008-7#1)(2012-3#1)
patients with posttraumatic##2##3##(1996-7#1)(2007-11#1)
patients with pre-existing##2##3##(1990-2#1)(1991-8#1)
patients with preexisting##2##3##(1992-3#1)(1992-8#1)
patients with preoperative##2##3##(2008-7#1)(2013-1#1)
patients with presumed cardioembolic stroke##2##5##(2007-10#2)
patients with presumed##3##3##(2007-10#2)(2008-7#1)
patients with previous##6##3##(1990-11#1)(1992-10#1)(1996-3#1)(2007-8#1)(2010-12#1)(2011-1#1)
patients with previously untreated##3##4##(1991-8#1)(2008-10#1)(2010-11#1)
patients with primary and##2##4##(2013-1#2)
patients with primary biliary cirrhosis##5##5##(1990-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-2#1)
patients with primary breast##3##4##(1990-8#1)(2007-5#1)(2012-2#1)
patients with primary hyperparathyroidism##3##4##(1990-2#1)(1991-12#1)(1991-5#1)
patients with primary immunodeficiency##2##4##(2008-10#1)(2012-12#1)
patients with primary or##2##4##(1993-8#1)(1995-10#1)
patients with primary tumours##2##4##(1997-3#1)(2008-6#1)
patients with primary##32##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-10#1)(1997-3#1)(1997-5#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
patients with proctological symptoms##2##4##(2013-1#2)
patients with progressive##7##3##(1991-3#1)(1992-8#2)(2007-7#1)(2008-6#1)(2008-7#1)(2010-12#1)
patients with prostate cancer##5##4##(2008-1#2)(2008-7#2)(2012-3#1)
patients with prostatic cancer and 14 patients with benign##2##9##(1990-9#2)
patients with prostatic cancer##5##4##(1990-9#2)(1995-11#1)(1995-12#2)
patients with prostatic##7##3##(1990-3#1)(1990-9#2)(1993-6#1)(1995-11#1)(1995-12#2)
patients with proven##3##3##(1997-7#1)(2012-12#1)(2012-2#1)
patients with proximal femur##2##4##(2007-11#1)(2007-8#1)
patients with proximal##4##3##(2007-11#3)(2007-8#1)
patients with psoriatic##2##3##(2006-10#2)
patients with psychiatric disorders##2##4##(2007-8#1)(2012-2#1)
patients with pulmonary hypertension##3##4##(2008-12#1)(2008-7#1)(2010-10#1)
patients with pulmonary tuberculosis##2##4##(2011-1#1)(2013-1#1)
patients with pulmonary##11##3##(1992-2#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
patients with rapid-cycling bipolar disorder##2##5##(1996-7#2)
patients with recent##5##3##(2007-10#2)(2008-8#2)(2012-2#1)
patients with recurrent breast cancer##2##5##(1994-12#2)
patients with recurrent high grade astrocytoma##2##6##(2008-7#2)
patients with recurrent pregnancy loss##2##5##(2011-2#2)
patients with recurrent##25##3##(1991-11#1)(1991-4#1)(1991-6#1)(1993-2#1)(1994-1#1)(1994-12#2)(1996-7#2)(2007-10#1)(2007-7#3)(2008-1#1)(2008-5#2)(2008-7#3)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
patients with reduced##2##3##(2008-4#1)(2008-7#1)
patients with refractory asthma##2##4##(2010-5#2)
patients with refractory##8##3##(2007-10#1)(2008-12#1)(2010-5#2)(2011-1#1)(2011-2#3)
patients with regard to##2##4##(1993-11#1)(2010-11#1)
patients with relapsed##3##3##(2010-11#1)(2010-4#2)
patients with relapsed/refractory##2##3##(2009-12#2)
patients with relapsing-remitting##2##3##(2007-11#1)(2010-12#1)
patients with renal cell carcinoma##3##5##(1995-12#2)(1997-6#1)
patients with renal cell##4##4##(1995-12#2)(1997-6#1)(2011-1#1)
patients with renal##12##3##(1990-12#1)(1995-12#2)(1996-6#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-1#2)(2011-1#1)(2012-3#1)(2013-1#1)
patients with renovascular hypertension##2##4##(2007-7#1)(2008-1#1)
patients with residual##2##3##(2007-8#1)(2011-2#1)
patients with resistant disease##2##4##(2006-10#2)
patients with respiratory##4##3##(1990-3#1)(1994-2#1)(2013-1#2)
patients with retained##2##3##(1991-3#1)(2012-2#1)
patients with retroperitoneal##2##3##(1990-9#1)(1992-12#1)
patients with rheumatic diseases##2##4##(1990-6#1)(2006-10#1)
patients with rheumatic##3##3##(1990-6#1)(2006-10#2)
patients with rheumatoid arthritis##11##4##(1990-2#1)(1993-1#1)(2006-10#2)(2007-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)
patients with rheumatoid##12##3##(1990-2#1)(1993-1#1)(2006-10#2)(2007-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)
patients with right##3##3##(1996-2#1)(1996-5#1)(2007-10#1)
patients with rtN236T##2##3##(2013-1#2)
patients with sarcoma##4##3##(2008-6#4)
patients with schizophrenia and##7##4##(1996-5#1)(1996-7#3)(2010-1#1)(2010-6#1)(2011-1#1)
patients with schizophrenia##33##3##(1995-11#2)(1995-12#4)(1995-5#1)(1996-5#2)(1996-7#10)(2008-11#1)(2009-12#1)(2010-1#2)(2010-6#1)(2011-1#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
patients with schizophrenia]##2##3##(2009-10#1)(2012-12#1)
patients with scleroderma##4##3##(1992-8#1)(2006-10#2)(2008-10#1)
patients with secondary hyperparathyroidism##3##4##(1991-11#2)(1993-3#1)
patients with secondary##7##3##(1991-11#2)(1993-3#1)(2008-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
patients with selective##2##3##(1991-2#1)(2013-1#1)
patients with sensorineural hearing##2##4##(1992-2#1)(2008-9#1)
patients with sepsis##3##3##(1992-2#1)(2007-5#1)(2011-2#1)
patients with septic##2##3##(2011-2#1)(2013-1#1)
patients with serious##4##3##(1990-6#1)(1992-2#1)(2008-10#1)(2010-5#1)
patients with several##2##3##(1994-3#1)(2013-1#1)
patients with severe acute asthma##2##5##(1992-3#1)(1997-1#1)
patients with severe acute pancreatitis##2##5##(2009-8#1)(2013-1#1)
patients with severe acute##4##4##(1992-3#1)(1997-1#1)(2009-8#1)(2013-1#1)
patients with severe coronary##2##4##(2008-12#1)(2011-2#1)
patients with severe sepsis or septic shock##2##7##(2011-2#2)
patients with severe sepsis##8##4##(2007-12#1)(2009-6#5)(2011-2#2)
patients with severe##59##3##(1991-3#3)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#5)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
patients with short##2##3##(2007-11#1)(2013-1#1)
patients with shoulder pain##2##4##(1996-2#1)(2007-11#1)
patients with shoulder##5##3##(1996-2#1)(2007-11#1)(2009-7#1)(2013-1#2)
patients with significant##2##3##(2007-10#1)(2008-1#1)
patients with silent myocardial ischemia##2##5##(1992-6#1)(2008-7#1)
patients with silent##3##3##(1992-6#1)(2008-7#2)
patients with similar##2##3##(1995-12#1)(2007-8#1)
patients with sinusitis##2##3##(1993-2#2)
patients with skeletal metastases##2##4##(2007-11#2)
patients with skin##2##3##(2007-10#1)(2008-12#1)
patients with small##4##3##(2008-8#1)(2009-1#1)(2010-6#1)(2011-1#1)
patients with social##2##3##(2008-4#1)(2008-6#1)
patients with soft tissue sarcoma##3##5##(2008-6#3)
patients with soft tissue sarcomas##6##5##(2008-6#6)
patients with soft tissue##9##4##(2008-6#9)
patients with spinal cord injuries##3##5##(1991-6#2)(2007-8#1)
patients with spinal cord injuries]##2##5##(1991-6#1)(1993-2#1)
patients with spinal cord injury##2##5##(1993-2#1)(2007-11#1)
patients with spinal cord##8##4##(1991-6#4)(1993-2#2)(2007-11#1)(2007-8#1)
patients with spinal metastases##3##4##(2007-11#3)
patients with spinal##17##3##(1991-6#4)(1993-2#2)(2007-11#6)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
patients with spondylolisthesis##2##3##(2007-11#2)
patients with spontaneous##4##3##(1991-6#1)(2011-2#3)
patients with sporadic medullary thyroid carcinoma##2##6##(2008-1#2)
patients with sporadic##3##3##(1990-3#1)(2008-1#2)
patients with stable angina pectoris##2##5##(2008-10#2)
patients with stable angina##3##4##(2008-10#2)(2013-1#1)
patients with stable##9##3##(1992-12#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
patients with stage III##3##4##(1990-9#1)(2008-10#1)(2008-6#1)
patients with stage IIIC##2##4##(2011-2#2)
patients with stage##12##3##(1990-6#1)(1990-9#1)(1992-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
patients with stenosis##2##3##(1993-8#2)
patients with stroke or##2##4##(2007-10#1)(2008-2#1)
patients with stroke##15##3##(2007-10#12)(2008-2#1)(2008-8#1)(2013-1#1)
patients with subarachnoid haemorrhage (SAH)##2##5##(2008-7#2)
patients with subarachnoid##3##3##(1995-11#1)(2008-7#2)
patients with substance##3##3##(1996-5#2)(2008-6#1)
patients with sudden##3##3##(2007-10#1)(2008-4#1)(2009-11#1)
patients with surgical##2##3##(2010-8#1)(2013-1#1)
patients with suspected acute##4##4##(2008-3#2)(2011-2#2)
patients with suspected or##2##4##(2010-7#1)(2012-2#1)
patients with suspected scaphoid fractures##2##5##(2008-9#2)
patients with suspected viral hemorrhagic##2##5##(1995-6#2)
patients with suspected##26##3##(1990-2#1)(1990-6#1)(1995-6#2)(1997-8#1)(2007-10#1)(2008-12#3)(2008-3#2)(2008-8#2)(2008-9#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)
patients with symptomatic internal carotid occlusion##2##6##(2007-10#2)
patients with symptomatic##12##3##(1993-12#1)(1993-2#1)(2007-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2011-2#1)
patients with symptoms of##2##4##(2007-7#1)(2013-8#1)
patients with symptoms##3##3##(1992-9#1)(2007-7#1)(2013-8#1)
patients with systemic lupus erythematosus (SLE)##3##6##(1990-12#1)(2006-10#1)(2011-2#1)
patients with systemic lupus erythematosus##6##5##(1990-12#1)(1992-5#1)(2006-10#3)(2011-2#1)
patients with systemic sclerosis (SSc)##2##5##(2008-8#1)(2010-10#1)
patients with systemic sclerosis##4##4##(2008-8#1)(2009-8#1)(2010-10#1)(2012-2#1)
patients with systemic##12##3##(1990-12#1)(1992-5#1)(2006-10#3)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)
patients with terminal##2##3##(1992-5#1)(1994-12#1)
patients with the diagnosis of##2##5##(2007-10#1)(2008-1#1)
patients with the metabolic syndrome##3##5##(2008-1#1)(2010-4#1)(2011-2#1)
patients with the most##3##4##(2006-10#1)(2008-5#1)(2008-8#1)
patients with the nephrotic syndrome##5##5##(2008-1#5)
patients with the##43##3##(1990-9#1)(1991-12#2)(1992-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(2006-10#3)(2007-10#2)(2007-11#3)(2007-7#1)(2008-1#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-3#2)(2013-1#2)
patients with these lesions##2##4##(2008-7#1)(2012-2#1)
patients with these##7##3##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
patients with this condition##4##4##(2008-12#1)(2008-8#1)(2010-5#1)(2013-8#1)
patients with this disease##7##4##(1990-5#1)(1992-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
patients with this syndrome##2##4##(1991-5#1)(1997-6#1)
patients with this type of##2##5##(1991-11#1)(2010-3#1)
patients with this##24##3##(1990-5#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-9#2)(1997-6#1)(2006-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-3#2)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
patients with thoracic##2##3##(2007-8#1)(2012-12#1)
patients with those of##2##4##(1990-6#1)(1995-3#1)
patients with those##4##3##(1990-6#1)(1995-3#1)(1997-1#1)(2008-8#1)
patients with three##2##3##(1990-9#1)(2009-9#1)
patients with three-vessel##2##3##(2007-8#2)
patients with thyroid dysfunction##2##4##(2013-1#2)
patients with thyroid nodules##3##4##(2011-1#1)(2012-3#2)
patients with thyroid##7##3##(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#2)
patients with transient##2##3##(2007-10#1)(2008-7#1)
patients with transplanted##3##3##(1990-12#1)(1995-8#1)(2012-12#1)
patients with traumatic spinal cord##2##5##(1991-6#1)(2007-11#1)
patients with traumatic##5##3##(1991-6#1)(1992-6#1)(2007-11#1)(2007-8#1)(2011-2#1)
patients with troublesome belching and##4##5##(2013-8#4)
patients with troublesome belching##5##4##(2013-8#5)
patients with tubal##3##3##(1990-10#1)(1990-2#1)(1994-12#1)
patients with tuberculosis##3##3##(1996-3#2)(2009-7#1)
patients with tumors##3##3##(1992-10#1)(2011-2#1)(2013-1#1)
patients with type 1 and type 2 diabetes##3##8##(2008-7#1)(2012-4#2)
patients with type 1 diabetes and##2##6##(2009-9#2)
patients with type 1 diabetes##6##5##(2008-1#1)(2008-8#1)(2009-9#2)(2012-1#1)(2013-8#1)
patients with type 1##9##4##(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#2)(2012-1#1)(2012-4#2)(2013-8#1)
patients with type 2 diabetes in##2##6##(2009-7#1)(2011-1#1)
patients with type 2 diabetes mellitus##6##6##(2008-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#2)
patients with type 2 diabetes##27##5##(2008-1#2)(2008-3#6)(2009-1#1)(2009-7#1)(2010-10#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#2)(2012-5#2)(2013-8#3)
patients with type 2 diabetes?##2##5##(2010-12#1)(2012-5#1)
patients with type 2##29##4##(2008-1#2)(2008-3#6)(2009-1#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#2)(2012-5#3)(2013-8#3)
patients with type I##2##4##(2007-11#1)(2012-3#1)
patients with type II diabetes mellitus##2##6##(1993-12#2)
patients with type II diabetes##5##5##(1993-12#2)(1994-2#1)(1995-8#1)(1996-11#1)
patients with type##46##3##(1993-12#2)(1994-2#1)(1995-8#1)(1996-11#1)(2007-11#1)(2008-1#3)(2008-3#6)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#3)(2012-4#2)(2012-5#3)(2013-8#4)
patients with ulcerative colitis were treated##2##6##(1992-9#1)(1994-2#1)
patients with ulcerative##3##3##(1992-9#1)(1994-2#1)(2010-12#1)
patients with uncomplicated##4##3##(1992-2#2)(2008-3#2)
patients with unexplained##2##3##(2007-5#1)(2008-11#1)
patients with unilateral neglect##2##4##(1996-2#1)(2009-2#1)
patients with unilateral##7##3##(1995-4#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-12#1)(2008-9#1)(2009-2#1)
patients with unrelieved##2##3##(2008-7#1)(2010-8#1)
patients with unresectable##5##3##(1991-2#1)(1995-4#1)(2012-2#1)(2013-1#2)
patients with unstable angina pectoris##3##5##(1990-12#3)
patients with unstable angina##6##4##(1990-12#3)(1991-9#1)(2008-5#1)(2013-1#1)
patients with unstable##9##3##(1990-12#3)(1991-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
patients with untreated or##2##4##(1992-9#1)(2008-7#1)
patients with untreated##4##3##(1992-9#1)(2008-7#1)(2012-3#2)
patients with upper##2##3##(2010-3#1)(2011-2#1)
patients with urinary bladder cancer and##2##6##(1995-12#2)
patients with urinary tract infection and##3##6##(2008-4#3)
patients with urinary##7##3##(1995-12#2)(2008-10#1)(2008-4#3)(2013-8#1)
patients with various##8##3##(1991-3#1)(1992-11#1)(1993-2#1)(1994-9#1)(1997-4#1)(1997-7#1)(2011-1#1)(2012-3#1)
patients with vascular dementia (VD)##2##5##(1996-5#1)(2008-7#1)
patients with vascular dementia##3##4##(1996-5#2)(2008-7#1)
patients with vascular disease##2##4##(1993-2#1)(2010-1#1)
patients with vascular##9##3##(1993-2#1)(1996-5#2)(2007-10#1)(2007-12#1)(2008-7#1)(2010-1#1)(2012-12#1)(2013-1#1)
patients with venous leg##2##4##(1997-3#2)
patients with vertebral##2##3##(2007-11#1)(2008-7#1)
patients with visual loss due to##2##6##(2011-2#1)(2013-1#1)
patients with visual##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
patients with vivax malaria##3##4##(2012-12#2)(2012-2#1)
patients with von##2##3##(2008-1#1)(2008-10#1)
patients with whom##2##3##(1991-8#1)(1995-1#1)
patients with##4040##2##(1990-10#7)(1990-11#9)(1990-12#27)(1990-2#37)(1990-3#25)(1990-5#2)(1990-6#21)(1990-7#1)(1990-8#18)(1990-9#24)(1991-1#2)(1991-11#22)(1991-12#22)(1991-2#22)(1991-3#13)(1991-4#18)(1991-5#23)(1991-6#23)(1991-7#1)(1991-8#19)(1991-9#7)(1992-1#3)(1992-10#7)(1992-11#17)(1992-12#16)(1992-2#18)(1992-3#15)(1992-4#4)(1992-5#20)(1992-6#12)(1992-8#20)(1992-9#17)(1993-1#11)(1993-10#1)(1993-11#21)(1993-12#17)(1993-2#32)(1993-3#6)(1993-5#3)(1993-6#5)(1993-8#11)(1993-9#14)(1994-1#1)(1994-10#2)(1994-11#12)(1994-12#25)(1994-2#12)(1994-3#12)(1994-5#2)(1994-6#4)(1994-7#9)(1994-8#8)(1994-9#6)(1995-1#2)(1995-10#6)(1995-11#17)(1995-12#27)(1995-2#8)(1995-3#15)(1995-4#4)(1995-5#6)(1995-6#5)(1995-8#10)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#13)(1996-12#8)(1996-2#10)(1996-3#7)(1996-5#11)(1996-6#6)(1996-7#32)(1996-8#5)(1996-9#23)(1997-1#13)(1997-2#8)(1997-3#21)(1997-4#10)(1997-5#6)(1997-6#9)(1997-7#21)(1997-8#43)(1997-9#1)(2006-10#42)(2006-12#1)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#118)(2007-11#121)(2007-12#24)(2007-2#4)(2007-4#1)(2007-5#11)(2007-6#1)(2007-7#53)(2007-8#103)(2007-9#10)(2008-1#110)(2008-10#101)(2008-11#46)(2008-12#68)(2008-2#14)(2008-3#97)(2008-4#37)(2008-5#58)(2008-6#77)(2008-7#314)(2008-8#57)(2008-9#62)(2009-1#7)(2009-10#16)(2009-11#9)(2009-12#16)(2009-2#10)(2009-3#15)(2009-4#16)(2009-5#12)(2009-6#13)(2009-7#10)(2009-8#38)(2009-9#12)(2010-1#8)(2010-10#18)(2010-11#22)(2010-12#55)(2010-2#1)(2010-3#37)(2010-4#13)(2010-5#15)(2010-6#20)(2010-7#9)(2010-8#33)(2010-9#6)(2011-1#76)(2011-2#277)(2011-3#4)(2011-7#1)(2012-1#23)(2012-12#79)(2012-2#95)(2012-3#117)(2012-4#2)(2012-5#3)(2012-6#1)(2012-8#1)(2013-1#238)(2013-7#13)(2013-8#103)
patients withdrew##2##2##(2007-11#1)(2008-3#1)
patients within a##2##3##(2008-1#1)(2013-8#1)
patients within the##3##3##(2010-9#1)(2011-2#1)(2012-12#1)
patients within##14##2##(1991-11#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
patients without ADHD##2##3##(2013-8#2)
patients without EPS##2##3##(2011-2#2)
patients without a history of##2##5##(1991-3#1)(2007-7#1)
patients without a##3##3##(1990-9#1)(1991-3#1)(2007-7#1)
patients without cirrhosis##3##3##(1994-7#2)(2006-10#1)
patients without diabetes mellitus##2##4##(1992-5#1)(2011-1#1)
patients without history of##2##4##(1990-9#1)(1992-6#1)
patients without ischemic heart disease##2##5##(2008-7#2)
patients without previous##2##3##(2007-8#1)(2013-1#1)
patients without prior##2##3##(1996-12#1)(2010-12#1)
patients without the##2##3##(2013-1#2)
patients without##87##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#1)(1992-5#2)(1992-6#1)(1994-11#1)(1994-7#3)(1995-12#2)(1996-12#1)(1997-5#1)(2006-10#2)(2007-10#8)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#7)(2012-3#3)(2013-1#8)(2013-3#1)(2013-8#3)
patients worldwide##2##2##(2011-2#1)(2012-2#1)
patients would be##2##3##(1991-11#1)(1994-2#1)
patients would##8##2##(1991-11#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-12#1)(2008-6#1)(2010-3#1)(2012-12#1)
patients younger than 40 years##2##5##(2010-12#2)
patients younger than##8##3##(1993-8#1)(2007-8#2)(2008-9#2)(2010-12#2)(2012-2#1)
patients##14401##1##(1990-10#22)(1990-11#49)(1990-12#90)(1990-2#120)(1990-3#82)(1990-4#2)(1990-5#35)(1990-6#83)(1990-7#2)(1990-8#58)(1990-9#91)(1991-1#27)(1991-11#78)(1991-12#78)(1991-2#101)(1991-3#90)(1991-4#49)(1991-5#60)(1991-6#76)(1991-7#6)(1991-8#76)(1991-9#36)(1992-1#21)(1992-10#20)(1992-11#31)(1992-12#73)(1992-2#56)(1992-3#62)(1992-4#13)(1992-5#65)(1992-6#49)(1992-7#1)(1992-8#51)(1992-9#65)(1993-1#59)(1993-10#16)(1993-11#56)(1993-12#83)(1993-2#90)(1993-3#44)(1993-5#18)(1993-6#21)(1993-8#42)(1993-9#44)(1994-1#17)(1994-10#4)(1994-11#42)(1994-12#91)(1994-2#56)(1994-3#63)(1994-5#23)(1994-6#33)(1994-7#29)(1994-8#20)(1994-9#31)(1995-1#21)(1995-10#14)(1995-11#75)(1995-12#96)(1995-2#60)(1995-3#45)(1995-4#10)(1995-5#33)(1995-6#10)(1995-8#26)(1995-9#13)(1996-1#36)(1996-10#2)(1996-11#48)(1996-12#31)(1996-2#60)(1996-3#68)(1996-5#29)(1996-6#41)(1996-7#83)(1996-8#14)(1996-9#71)(1997-1#34)(1997-2#43)(1997-3#89)(1997-4#39)(1997-5#28)(1997-6#43)(1997-7#47)(1997-8#165)(1997-9#3)(2006-10#106)(2006-12#9)(2006-6#5)(2006-7#8)(2006-8#16)(2007-1#7)(2007-10#312)(2007-11#386)(2007-12#127)(2007-2#35)(2007-4#6)(2007-5#24)(2007-6#9)(2007-7#337)(2007-8#441)(2007-9#45)(2008-1#507)(2008-10#347)(2008-11#240)(2008-12#176)(2008-2#51)(2008-3#280)(2008-4#157)(2008-5#241)(2008-6#266)(2008-7#947)(2008-8#230)(2008-9#197)(2009-1#16)(2009-10#55)(2009-11#36)(2009-12#43)(2009-2#34)(2009-3#57)(2009-4#49)(2009-5#44)(2009-6#27)(2009-7#28)(2009-8#83)(2009-9#28)(2010-1#21)(2010-10#52)(2010-11#55)(2010-12#155)(2010-2#17)(2010-3#130)(2010-4#59)(2010-5#74)(2010-6#46)(2010-7#47)(2010-8#130)(2010-9#21)(2011-1#231)(2011-2#1080)(2011-3#21)(2011-7#6)(2011-9#1)(2012-1#73)(2012-12#248)(2012-2#284)(2012-3#395)(2012-4#8)(2012-5#12)(2012-6#3)(2012-8#1)(2013-1#808)(2013-3#2)(2013-7#34)(2013-8#298)
patients&quot##4##1##(2007-7#1)(2008-4#1)(2010-8#1)(2013-1#1)
patients' ability to##3##3##(2007-7#1)(2008-12#1)(2010-4#1)
patients' adherence to##2##3##(2008-3#1)(2008-8#1)
patients' age and##2##3##(2010-8#1)(2012-2#1)
patients' age##7##2##(1993-2#1)(2007-10#1)(2008-1#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
patients' care##2##2##(1997-2#1)(2008-1#1)
patients' clinical##3##2##(1991-12#1)(2008-4#1)(2012-12#1)
patients' co-occurring##2##2##(2008-6#2)
patients' complaints##2##2##(2008-7#1)(2009-1#1)
patients' compliance##2##2##(2008-1#1)(2008-11#1)
patients' cultural##2##2##(2008-11#1)(2013-1#1)
patients' current##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
patients' data##4##2##(1991-5#1)(2008-10#1)(2010-8#1)(2013-8#1)
patients' expectations##3##2##(1997-8#1)(2007-10#1)(2011-2#1)
patients' experience and knowledge about##2##5##(2011-1#2)
patients' experience##4##2##(2010-10#1)(2011-1#2)(2011-2#1)
patients' medical##3##2##(2007-10#1)(2008-11#1)(2008-7#1)
patients' mobility and##2##3##(2007-11#1)(2012-12#1)
patients' needs##3##2##(1997-3#1)(2008-3#1)(2010-10#1)
patients' organisations##2##2##(2013-1#2)
patients' overall##2##2##(1991-3#1)(1996-3#1)
patients' perception of##3##3##(2008-11#1)(2013-1#2)
patients' perceptions of##2##3##(1996-1#1)(2011-2#1)
patients' performance status##2##3##(2010-2#2)
patients' performance##3##2##(2010-2#2)(2013-1#1)
patients' perspective##2##2##(2008-12#1)(2010-12#1)
patients' problems##3##2##(1993-2#1)(2013-1#2)
patients' quality of life##4##4##(2008-7#1)(2011-2#1)(2013-1#2)
patients' ratings of quality of life##2##6##(2008-7#2)
patients' records##2##2##(2008-1#1)(2010-12#1)
patients' rights were##2##3##(2013-8#2)
patients' rights##10##2##(1994-1#1)(1997-8#1)(2013-8#8)
patients' satisfaction with##4##3##(1997-5#1)(2008-7#1)(2009-12#1)(2013-8#1)
patients' speech##2##2##(2008-9#2)
patients' suffering##2##2##(2008-1#1)(2010-7#1)
patients' views##2##2##(1991-2#1)(2011-1#1)
patients'##230##1##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#3)(1993-5#1)(1994-1#4)(1994-2#3)(1994-3#1)(1994-6#4)(1995-3#3)(1995-4#1)(1996-1#1)(1996-3#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#3)(2006-10#3)(2007-10#6)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#3)(2008-1#9)(2008-10#2)(2008-11#7)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#3)(2009-1#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-2#16)(2012-12#4)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#17)(2013-8#15)
patients(4##4##1##(1991-2#4)
patients) (P=0##2##2##(2007-8#2)
patients) and the elderly##2##4##(2008-11#2)
patients) and##17##2##(1990-8#1)(1990-9#2)(1991-4#1)(1992-2#1)(2007-7#1)(2008-11#2)(2008-6#2)(2008-7#2)(2011-2#2)(2012-12#2)(2012-2#1)
patients) for tonsillitis##2##3##(2011-2#2)
patients) for##4##2##(1995-4#1)(2007-8#1)(2011-2#2)
patients) in the##4##3##(1990-8#1)(1990-9#1)(1997-5#1)(2013-1#1)
patients) in##5##2##(1990-8#1)(1990-9#2)(1997-5#1)(2013-1#1)
patients) of##2##2##(1990-5#1)(2008-5#1)
patients) or##7##2##(1990-9#1)(1991-4#1)(1997-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-12#1)
patients) was##4##2##(1991-8#1)(1992-8#1)(2008-1#1)(2008-6#1)
patients) were##5##2##(1990-12#1)(1992-2#1)(1996-1#1)(2008-9#1)(2011-2#1)
patients) with##5##2##(1990-12#1)(1997-3#1)(2008-7#3)
patients)##118##1##(1990-12#2)(1990-5#1)(1990-8#3)(1990-9#6)(1991-4#3)(1991-8#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#3)(1997-4#3)(1997-5#1)(2007-11#3)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-5#3)(2008-6#4)(2008-7#15)(2008-9#3)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#16)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)
patients--and##2##1##(1995-1#1)(1996-3#1)
patients/families##4##1##(2008-1#2)(2010-2#2)
patients?##11##1##(1992-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-7#1)
patients?]##5##1##(1990-2#1)(1993-11#2)(1994-12#1)(1995-8#1)
patients]##75##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-10#2)(1996-11#3)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2007-1#1)(2007-10#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-5#2)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
patients`##2##1##(2013-1#2)
patientswith##2##1##(2009-8#2)
pations##2##1##(2012-3#2)
patiënt##4##1##(2012-12#4)
patriarchy##3##1##(1991-6#1)(2011-1#1)(2011-2#1)
patrollers##3##1##(2008-8#3)
patrons##6##1##(1992-12#1)(1993-1#2)(1997-3#1)(2009-7#1)(2012-2#1)
pattern analysis of##6##3##(2008-10#5)(2008-2#1)
pattern analysis##13##2##(1994-12#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#3)(2011-2#1)
pattern and a##2##3##(2008-3#1)(2010-8#1)
pattern and the##3##3##(1992-3#1)(2008-12#1)(2008-4#1)
pattern and##48##2##(1991-10#1)(1991-8#2)(1992-2#1)(1992-3#3)(1993-12#1)(1993-9#3)(1994-12#2)(1995-2#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
pattern appears##2##2##(2008-2#1)(2011-2#1)
pattern are##7##2##(1990-3#1)(1990-9#1)(1995-8#1)(2007-12#1)(2008-3#2)(2009-2#1)
pattern as a##3##3##(1991-12#1)(2007-12#1)(2011-2#1)
pattern as the##3##3##(2008-10#2)(2010-1#1)
pattern as well as##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
pattern as##16##2##(1991-12#1)(1994-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#1)
pattern at the##3##3##(1992-3#1)(2008-3#1)(2008-4#1)
pattern at##6##2##(1992-3#1)(1993-12#1)(1993-9#1)(2008-3#2)(2008-4#1)
pattern between the##2##3##(2009-8#1)(2011-2#1)
pattern between##4##2##(1996-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
pattern but##2##2##(1995-2#1)(2007-11#1)
pattern by age##2##3##(1992-2#1)(1997-3#1)
pattern by##6##2##(1992-2#1)(1997-3#1)(2008-3#4)
pattern can be##3##3##(1994-8#1)(2008-11#1)(2008-3#1)
pattern can##4##2##(1994-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
pattern changes##5##2##(1993-1#1)(1994-12#1)(2008-2#2)(2008-5#1)
pattern characteristic of##2##3##(1996-12#1)(2008-6#1)
pattern completion##2##2##(2008-11#2)
pattern consisting##2##2##(1993-2#1)(2008-5#1)
pattern correlated##2##2##(1993-12#1)(2008-3#1)
pattern described##2##2##(1997-8#1)(2012-3#1)
pattern differences##2##2##(2012-7#1)(2013-1#1)
pattern discovery##2##2##(2008-2#2)
pattern during the##3##3##(1991-6#2)(2008-10#1)
pattern during##7##2##(1991-6#2)(1997-4#1)(2008-10#2)(2008-11#2)
pattern dynamics##2##2##(2007-12#1)(2008-11#1)
pattern evolution##2##2##(2008-9#2)
pattern for recording##2##3##(2007-12#2)
pattern for the##4##3##(1993-11#1)(1997-7#1)(2008-10#1)(2008-7#1)
pattern for##15##2##(1991-9#1)(1993-11#1)(1997-7#1)(2007-12#3)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
pattern formation are##2##3##(1997-6#1)(2009-5#1)
pattern formation during##3##3##(1991-5#1)(1997-4#1)(2009-8#1)
pattern formation in doubly resonant##2##5##(2007-12#2)
pattern formation in##5##3##(2007-12#2)(2008-6#1)(2008-7#1)(2009-8#1)
pattern formation##15##2##(1991-5#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#2)(2011-2#1)
pattern formed##2##2##(2007-11#1)(2007-12#1)
pattern from a##3##3##(2008-3#3)
pattern from the##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
pattern from##9##2##(1992-2#1)(1993-8#1)(2008-1#1)(2008-2#2)(2008-3#3)(2011-2#1)
pattern generation##2##2##(1995-11#1)(2008-3#1)
pattern generator##6##2##(2007-12#1)(2008-2#2)(2008-6#1)(2009-6#1)(2013-1#1)
pattern has been##3##3##(1990-9#1)(1996-12#1)(2007-12#1)
pattern has##5##2##(1990-9#1)(1996-12#1)(2007-12#1)(2008-3#1)(2013-1#1)
pattern identification##2##2##(2008-11#1)(2008-4#1)
pattern in a##4##3##(2007-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
pattern in all##2##3##(1993-3#1)(1994-8#1)
pattern in growth##2##3##(2010-8#2)
pattern in liver##2##3##(1991-6#1)(1994-11#1)
pattern in species richness##2##4##(2008-8#2)
pattern in the##14##3##(1993-11#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)(2010-5#1)
pattern in which the##2##4##(2008-3#1)(2012-12#1)
pattern in##58##2##(1991-6#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-8#1)(1996-4#1)(1997-3#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#7)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#6)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
pattern is a##5##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
pattern is also##3##3##(1991-12#1)(2008-3#2)
pattern is compatible with##2##4##(2008-1#1)(2008-5#1)
pattern is very##2##3##(1997-4#1)(2008-11#1)
pattern is##40##2##(1991-12#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#12)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
pattern like##2##2##(1990-5#1)(2007-8#1)
pattern may##4##2##(1994-9#1)(1997-3#1)(2008-10#1)(2009-8#1)
pattern observed##2##2##(1992-3#1)(2008-10#1)
pattern obtained with the##2##4##(2008-10#1)(2008-5#1)
pattern obtained with##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
pattern obtained##5##2##(2008-10#2)(2008-3#2)(2008-5#1)
pattern occurs##2##2##(2008-3#1)(2008-8#1)
pattern of FGF-2##2##3##(1997-4#2)
pattern of a population##2##4##(1990-8#1)(2008-2#1)
pattern of a##9##3##(1990-8#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
pattern of accumulation##2##3##(2008-10#1)(2008-11#1)
pattern of age-related##2##3##(2008-8#1)(2010-8#1)
pattern of blood pressure##2##4##(1992-8#1)(1997-8#1)
pattern of both##2##3##(2007-12#1)(2013-7#1)
pattern of brain##2##3##(2008-11#1)(2008-6#1)
pattern of cerebral asymmetry##2##4##(1992-2#2)
pattern of change in##2##4##(1990-10#1)(2012-2#1)
pattern of change##3##3##(1990-10#1)(2008-10#1)(2012-2#1)
pattern of changes##3##3##(2008-11#2)(2010-8#1)
pattern of childhood##2##3##(2007-7#1)(2010-9#1)
pattern of connections##2##3##(1995-5#1)(1997-3#1)
pattern of distribution of##2##4##(1995-6#1)(2008-10#1)
pattern of distribution##8##3##(1993-6#1)(1995-6#1)(1996-3#1)(2008-10#5)
pattern of evolution##2##3##(1991-3#1)(2008-8#1)
pattern of expression of##5##4##(1994-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-4#1)
pattern of expression##7##3##(1991-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1997-4#1)(2010-6#1)
pattern of failure##2##3##(2008-6#1)(2012-3#1)
pattern of findings##3##3##(2007-7#1)(2008-11#1)(2009-7#1)
pattern of frequency##2##3##(2010-4#1)(2011-2#1)
pattern of gene expression##3##4##(1992-1#1)(2008-10#1)(2008-11#1)
pattern of glomerulonephritis##2##3##(2007-7#2)
pattern of growth##2##3##(2011-2#1)(2013-1#1)
pattern of inheritance##5##3##(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-3#1)
pattern of injury##4##3##(1992-6#1)(1997-6#1)(2012-3#1)(2013-8#1)
pattern of light##2##3##(2008-2#1)(2008-3#1)
pattern of loss##2##3##(2008-8#2)
pattern of presentation##2##3##(1991-8#1)(2010-12#1)
pattern of protein synthesis##2##4##(1993-9#1)(1994-11#1)
pattern of protein##4##3##(1993-9#1)(1994-11#1)(1995-6#1)(2008-5#1)
pattern of reactivity##2##3##(1995-12#1)(2011-2#1)
pattern of responding##2##3##(2008-5#2)
pattern of response to##2##4##(2008-10#1)(2008-4#1)
pattern of response##3##3##(1990-6#1)(2008-10#1)(2008-4#1)
pattern of results##3##3##(1993-12#1)(1994-3#1)(2008-2#1)
pattern of secretion of [125I]IGF-II into milk##2##7##(1992-3#2)
pattern of sexual signalling##2##4##(2009-9#2)
pattern of spread##2##3##(2008-7#1)(2011-2#1)
pattern of the NR2C##2##4##(1996-12#2)
pattern of the##58##3##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1994-5#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-8#1)(2007-12#11)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
pattern of their##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
pattern of these##6##3##(1991-5#1)(1992-11#1)(1993-11#1)(2007-12#1)(2008-5#1)(2010-4#1)
pattern of this##2##3##(1995-2#1)(2007-12#1)
pattern of three##2##3##(1994-11#1)(2008-3#1)
pattern of two##4##3##(1996-5#1)(2007-12#1)(2008-11#1)(2008-12#1)
pattern of##483##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#7)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#6)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#4)(1995-6#5)(1995-8#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#5)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#6)(1997-6#4)(1997-7#3)(1997-8#4)(2007-10#1)(2007-11#4)(2007-12#28)(2007-2#1)(2007-7#8)(2007-8#1)(2008-1#2)(2008-10#59)(2008-11#19)(2008-12#5)(2008-2#11)(2008-3#15)(2008-4#6)(2008-5#16)(2008-6#5)(2008-7#22)(2008-8#19)(2008-9#13)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#9)(2012-8#1)(2013-1#9)(2013-7#4)(2013-8#5)
pattern on the surface of##2##5##(2007-12#1)(2008-3#1)
pattern on the##7##3##(1991-12#1)(2007-12#1)(2008-3#3)(2008-5#1)(2011-2#1)
pattern on##15##2##(1991-11#1)(1991-12#1)(1992-5#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#5)(2008-5#1)(2011-2#1)
pattern onto the##2##3##(2007-11#1)(2007-12#1)
pattern or by##2##3##(2008-3#1)(2010-5#1)
pattern or##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
pattern output from##2##3##(2008-3#2)
pattern over##2##2##(2008-10#1)(2013-8#1)
pattern produced by##4##3##(2007-11#3)(2008-2#1)
pattern recognition (PR)##2##3##(2008-10#2)
pattern recognition and##2##3##(2008-3#2)
pattern recognition by use of##3##5##(2007-12#1)(2008-3#2)
pattern recognition by##4##3##(2007-12#1)(2008-3#3)
pattern recognition in##2##3##(2008-3#2)
pattern recognition is##2##3##(2008-10#1)(2008-3#1)
pattern recognition of##5##3##(2008-10#2)(2008-3#3)
pattern recognition procedures##4##3##(2008-10#3)(2010-5#1)
pattern recognition receptors (PRRs)##2##4##(2009-6#1)(2009-8#1)
pattern recognition receptors that##2##4##(2009-8#1)(2013-1#1)
pattern recognition receptors##5##3##(2009-6#1)(2009-8#2)(2010-8#1)(2013-1#1)
pattern recognition techniques##4##3##(2008-10#4)
pattern recognition that##2##3##(2008-3#1)(2013-8#1)
pattern recognition with##5##3##(2008-3#5)
pattern recognition##64##2##(2007-12#2)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#27)(2009-6#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#3)(2013-1#1)(2013-8#4)
pattern regarding##2##2##(2010-1#1)(2010-3#1)
pattern separation##2##2##(2008-11#1)(2013-8#1)
pattern showed##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2008-7#1)
pattern shows that the##2##4##(2008-10#1)(2013-8#1)
pattern shows##3##2##(2008-10#2)(2013-8#1)
pattern similar to that##3##4##(1991-6#1)(2008-10#2)
pattern similar to##6##3##(1991-6#1)(1996-12#1)(2008-10#3)(2010-9#1)
pattern that is##7##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
pattern that was##2##3##(2008-10#2)
pattern that##21##2##(1994-5#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#3)(2008-6#1)(2008-9#2)(2009-8#1)
pattern through the##2##3##(2008-10#1)(2008-2#1)
pattern through##3##2##(2008-10#1)(2008-2#2)
pattern to a##2##3##(2008-10#1)(2008-3#1)
pattern to that of##2##4##(1990-12#1)(2012-12#1)
pattern to that##3##3##(1990-12#1)(1994-10#1)(2012-12#1)
pattern to the##2##3##(1996-2#1)(2008-3#1)
pattern to##17##2##(1990-10#1)(1990-12#1)(1991-5#1)(1994-10#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2012-12#2)
pattern was evident##2##3##(2008-10#2)
pattern was found to be##2##5##(2008-11#1)(2011-2#1)
pattern was found##4##3##(2007-10#1)(2008-11#2)(2011-2#1)
pattern was observed for##2##4##(1993-12#1)(2008-10#1)
pattern was observed in##3##4##(1994-6#1)(1996-5#1)(2008-10#1)
pattern was observed##10##3##(1993-12#1)(1994-6#1)(1996-5#1)(2007-2#1)(2008-10#4)(2008-11#1)(2010-8#1)
pattern was studied##2##3##(1993-12#2)
pattern was##44##2##(1990-11#1)(1993-12#4)(1993-5#1)(1993-6#1)(1994-6#1)(1996-5#2)(1996-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
pattern which##2##2##(2007-4#1)(2012-3#1)
pattern with a##4##3##(1994-8#1)(2008-10#2)(2008-3#1)
pattern with the##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
pattern with##19##2##(1992-12#1)(1994-8#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#2)
pattern within##2##2##(1994-6#1)(1996-5#1)
pattern##1391##1##(1990-10#3)(1990-11#5)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#4)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#5)(1991-8#3)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#6)(1992-3#11)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#6)(1993-12#17)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#5)(1993-8#5)(1993-9#8)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#2)(1994-3#5)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#14)(1994-9#6)(1995-1#1)(1995-11#4)(1995-12#7)(1995-2#6)(1995-3#1)(1995-5#5)(1995-6#6)(1995-8#5)(1996-12#9)(1996-2#8)(1996-3#4)(1996-4#5)(1996-5#8)(1996-6#7)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#9)(1997-4#10)(1997-6#9)(1997-7#7)(1997-8#9)(2007-10#4)(2007-11#29)(2007-12#65)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#5)(2008-1#11)(2008-10#186)(2008-11#53)(2008-12#10)(2008-2#69)(2008-3#152)(2008-4#13)(2008-5#36)(2008-6#18)(2008-7#49)(2008-8#44)(2008-9#35)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#4)(2009-8#15)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#6)(2010-12#7)(2010-2#3)(2010-3#6)(2010-4#3)(2010-5#6)(2010-6#6)(2010-7#2)(2010-8#17)(2010-9#3)(2011-1#8)(2011-2#39)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#23)(2012-3#16)(2012-7#1)(2012-8#1)(2013-1#23)(2013-7#9)(2013-8#19)
pattern) in##2##2##(2008-11#1)(2012-12#1)
pattern)##8##1##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
pattern-recognition techniques##2##2##(2007-12#1)(2008-10#1)
pattern-recognition##10##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-11#2)
pattern?##2##1##(1990-10#1)(2008-7#1)
patterned by##3##2##(2007-12#2)(2008-10#1)
patterned into##2##2##(2007-11#1)(2008-7#1)
patterned on##2##2##(2009-11#1)(2010-4#1)
patterned surface##2##2##(2008-7#1)(2009-12#1)
patterned with a##2##3##(2008-3#1)(2008-7#1)
patterned with##3##2##(1994-9#1)(2008-3#1)(2008-7#1)
patterned##28##1##(1994-2#1)(1994-9#1)(1997-5#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2012-2#1)
patterning and##4##2##(1997-3#1)(2009-2#1)(2009-6#1)(2012-12#1)
patterning in the##2##3##(1993-12#1)(2007-12#1)
patterning in##5##2##(1990-7#2)(1993-12#1)(2007-12#1)(2008-10#1)
patterning is##2##2##(2009-2#1)(2009-8#1)
patterning of somites##2##3##(1994-12#2)
patterning of the##4##3##(1990-7#2)(1994-9#1)(2009-3#1)
patterning of##20##2##(1990-7#2)(1994-12#2)(1994-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#4)(2009-3#1)(2010-4#1)(2012-1#1)
patterning##58##1##(1990-7#4)(1993-12#1)(1994-12#2)(1994-9#2)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#5)(2009-2#7)(2009-3#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-4#3)(2011-2#1)(2012-1#3)(2012-12#3)
patterns (loss and gain) at AD and PD##2##8##(2011-2#2)
patterns across##6##2##(1991-12#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-8#1)
patterns among the##2##3##(2008-10#1)(2008-8#1)
patterns among##12##2##(1994-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
patterns and processes##2##3##(1996-6#1)(2007-7#1)
patterns and that##2##3##(2008-12#1)(2012-2#1)
patterns and the##5##3##(1991-2#1)(1992-2#1)(2008-10#1)(2008-2#1)(2010-12#1)
patterns and their##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
patterns and##68##2##(1991-2#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#7)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2012-5#1)
patterns are observed##2##3##(2008-3#2)
patterns are the##2##3##(2008-11#1)(2008-9#1)
patterns are##29##2##(1991-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#8)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)
patterns arising from##2##3##(2008-2#2)
patterns as a##3##3##(2007-12#1)(2008-3#1)(2010-9#1)
patterns as##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-9#1)
patterns associated with##2##3##(2008-7#1)(2008-8#1)
patterns at the##2##3##(2008-10#2)
patterns at##8##2##(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
patterns based##2##2##(1995-6#1)(2008-10#1)
patterns because##2##2##(2008-9#1)(2010-4#1)
patterns between the##2##3##(1997-2#1)(2008-3#1)
patterns between##10##2##(1997-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
patterns by##7##2##(1990-2#1)(1991-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2013-1#1)
patterns calculated##2##2##(2008-2#1)(2008-3#1)
patterns can be##10##3##(2008-11#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-12#1)(2013-1#1)
patterns can##11##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-12#1)(2013-1#1)
patterns change##2##2##(1994-12#1)(2008-8#1)
patterns consisting of##2##3##(2008-10#2)
patterns convey##2##2##(2008-2#1)(2011-2#1)
patterns could##3##2##(1990-8#1)(2008-8#2)
patterns did##2##2##(1997-6#1)(2013-1#1)
patterns during the##2##3##(2007-2#1)(2013-1#1)
patterns during##7##2##(2007-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-8#1)(2013-1#1)
patterns for both##3##3##(2008-12#1)(2008-8#1)(2009-9#1)
patterns for the##7##3##(1991-2#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-8#1)(2013-8#1)
patterns for##29##2##(1990-7#1)(1991-12#1)(1991-2#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-2#1)(2008-10#7)(2008-12#2)(2008-3#2)(2008-5#2)(2008-8#2)(2009-8#1)(2009-9#1)(2012-2#2)(2013-8#1)
patterns formed by##2##3##(2008-3#2)
patterns found in##3##3##(2008-2#1)(2009-12#1)(2013-7#1)
patterns from the##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
patterns from##15##2##(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)
patterns generated by the##2##4##(2007-11#1)(2008-3#1)
patterns generated by##4##3##(2007-11#1)(2008-3#2)(2008-9#1)
patterns generated on##2##3##(2008-3#2)
patterns generated##9##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-9#1)
patterns have been##4##3##(1994-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
patterns have##5##2##(1993-3#1)(1994-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
patterns in a##4##3##(2008-2#2)(2012-3#1)(2013-1#1)
patterns in all##2##3##(1995-3#1)(2008-10#1)
patterns in photorefractive##2##3##(2007-11#1)(2008-3#1)
patterns in response to##2##4##(2008-10#1)(2008-11#1)
patterns in the data##2##4##(2008-5#1)(2011-2#1)
patterns in the##31##3##(1990-7#1)(1990-9#1)(1992-12#1)(1993-11#1)(1994-8#1)(2007-11#2)(2007-12#3)(2007-5#2)(2008-10#2)(2008-2#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
patterns in##100##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-6#2)(1994-8#3)(1995-3#1)(1996-2#1)(1997-7#2)(2006-4#1)(2007-11#4)(2007-12#3)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
patterns indicated##3##2##(2008-10#2)(2009-10#1)
patterns into##3##2##(1995-12#1)(2007-12#1)(2009-11#1)
patterns is introduced##2##3##(2007-11#1)(2008-3#1)
patterns is presented##3##3##(2008-3#2)(2008-7#1)
patterns is##13##2##(1992-9#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
patterns may be##3##3##(1990-3#1)(1995-3#1)(2008-10#1)
patterns may##7##2##(1990-3#1)(1994-3#1)(1995-3#1)(1996-4#1)(2008-10#1)(2009-8#1)(2009-9#1)
patterns observed in##2##3##(2008-10#1)(2008-11#1)
patterns observed##5##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)
patterns obtained in##2##3##(2008-2#1)(2008-3#1)
patterns obtained##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
patterns of DNA fragments##2##4##(2008-10#2)
patterns of DNA##6##3##(1992-11#1)(2008-10#3)(2009-4#1)(2010-4#1)
patterns of H##2##3##(2008-10#2)
patterns of S##3##3##(2010-8#1)(2013-7#1)(2013-8#1)
patterns of Staphylococcus##2##3##(2012-3#1)(2013-8#1)
patterns of a##6##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)(2013-1#1)
patterns of activity##5##3##(1990-5#1)(1993-12#1)(1995-2#1)(2008-8#1)(2009-8#1)
patterns of adolescent##2##3##(2009-8#1)(2013-1#1)
patterns of among-island variation in species richness##2##7##(2008-8#2)
patterns of association between##2##4##(1995-2#1)(2008-9#1)
patterns of behavior and##2##4##(2008-9#1)(2013-1#1)
patterns of behavior##3##3##(1990-12#1)(2008-9#1)(2013-1#1)
patterns of both##2##3##(2008-3#1)(2012-3#1)
patterns of care##6##3##(1991-2#1)(1994-3#1)(1995-9#1)(2007-10#1)(2008-7#1)(2012-3#1)
patterns of cortical##2##3##(2012-12#1)(2013-8#1)
patterns of different##2##3##(2007-11#1)(2008-2#1)
patterns of disease##8##3##(2008-1#1)(2008-10#5)(2011-2#1)(2013-1#1)
patterns of disfluency over##2##4##(2008-2#2)
patterns of disfluency##5##3##(2008-2#5)
patterns of distribution that##2##4##(2009-10#1)(2012-2#1)
patterns of distribution##7##3##(1991-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(2008-5#1)(2009-10#1)(2012-2#1)
patterns of diversity and##2##4##(2012-3#2)
patterns of diversity##4##3##(2008-10#1)(2008-8#1)(2012-3#2)
patterns of drug##2##3##(2008-1#1)(2011-1#1)
patterns of echinoderm larvae in La Parguera##2##7##(2011-2#2)
patterns of expression##4##3##(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)
patterns of female##4##3##(2008-7#1)(2009-9#3)
patterns of gene expression##3##4##(2008-7#2)(2008-8#1)
patterns of gene##5##3##(2008-7#4)(2008-8#1)
patterns of genetic##2##3##(2008-10#1)(2008-9#1)
patterns of lactation##2##3##(2008-9#2)
patterns of mitotic##2##3##(2007-12#1)(2008-12#1)
patterns of natural##2##3##(2008-10#1)(2008-9#1)
patterns of noise##2##3##(2008-3#2)
patterns of patch occupancy##4##4##(2008-8#3)(2008-9#1)
patterns of paternity##2##3##(2007-12#1)(2008-9#1)
patterns of plant##2##3##(1996-4#1)(2008-10#1)
patterns of primary##2##3##(2008-10#1)(2011-2#1)
patterns of renal##2##3##(2008-1#2)
patterns of resistance##2##3##(2008-10#1)(2013-8#1)
patterns of response##2##3##(1992-5#1)(2008-7#1)
patterns of rising type 2 diabetes prevalence in the world##2##10##(2010-4#2)
patterns of rt-PA use in##2##5##(2007-10#2)
patterns of rt-PA use##3##4##(2007-10#3)
patterns of selection##2##3##(2008-8#1)(2012-3#1)
patterns of service##2##3##(1994-2#1)(1996-3#1)
patterns of sexual##2##3##(2009-8#1)(2009-9#1)
patterns of skew##2##3##(2008-8#2)
patterns of some##2##3##(2008-10#1)(2008-11#1)
patterns of sperm##2##3##(2007-12#1)(2008-8#1)
patterns of spore deposition were##2##5##(2008-10#2)
patterns of spore deposition##3##4##(2008-10#3)
patterns of the##31##3##(1990-10#1)(1991-8#1)(1993-12#2)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#3)(2009-12#1)(2009-7#1)(2010-3#1)(2013-1#2)
patterns of these##2##3##(2007-12#1)(2008-10#1)
patterns of translation##2##3##(2007-12#2)
patterns of use of##2##4##(2008-11#1)(2013-1#1)
patterns of use##3##3##(2008-11#2)(2013-1#1)
patterns of variation in##2##4##(2009-8#1)(2013-1#1)
patterns of variation##5##3##(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
patterns of##459##2##(1990-10#2)(1990-12#1)(1990-5#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-8#1)(1993-9#3)(1994-2#5)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#4)(1995-9#1)(1996-1#2)(1996-12#6)(1996-3#1)(1996-4#3)(1996-6#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#3)(2007-12#11)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#5)(2008-1#11)(2008-10#68)(2008-11#19)(2008-12#6)(2008-2#14)(2008-3#13)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#20)(2008-8#32)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#11)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#15)(2012-3#10)(2013-1#15)(2013-7#2)(2013-8#10)
patterns on a##2##3##(2008-3#1)(2010-6#1)
patterns on silicon##2##3##(2008-3#1)(2008-7#1)
patterns on the##5##3##(1995-12#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
patterns on##12##2##(1995-12#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2009-11#1)(2010-6#1)
patterns or##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
patterns produced by the##2##4##(2008-10#2)
patterns produced##3##2##(2008-10#2)(2008-9#1)
patterns reconstructed from##2##3##(2008-3#2)
patterns recurrence plots##2##3##(2008-11#2)
patterns related##2##2##(1991-6#1)(1996-1#1)
patterns resulting from##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
patterns should be##2##3##(2008-12#1)(2008-9#1)
patterns show that the##2##4##(2008-10#1)(2008-5#1)
patterns show##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
patterns showed##2##2##(1990-6#1)(2012-2#1)
patterns simulated##2##2##(2008-3#1)(2008-9#1)
patterns such as##5##3##(1997-1#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#1)
patterns suggest that##2##3##(1992-9#1)(2011-2#1)
patterns suggested that##5##3##(2008-10#4)(2008-7#1)
patterns surrounding the translation initiation sites##2##6##(1997-2#2)
patterns surrounding##3##2##(1997-2#3)
patterns that are due to##2##5##(2008-3#2)
patterns that are##3##3##(2008-3#2)(2008-8#1)
patterns that may##2##3##(1996-9#1)(2008-8#1)
patterns that were##3##3##(2008-10#2)(2008-11#1)
patterns that##24##2##(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#5)(2009-9#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
patterns through##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
patterns to those##2##3##(2008-8#1)(2010-4#1)
patterns to##11##2##(1994-2#1)(1995-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-1#1)(2012-3#1)
patterns under##2##2##(2008-2#1)(2008-3#1)
patterns used##2##2##(2008-3#2)
patterns using##2##2##(2008-7#1)(2009-8#1)
patterns was developed and##2##4##(2008-2#1)(2008-8#1)
patterns was performed##2##3##(2008-10#1)(2008-12#1)
patterns was##7##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-8#1)
patterns were analyzed##2##3##(2008-10#1)(2008-11#1)
patterns were consistent##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
patterns were examined##2##3##(2007-11#1)(2008-7#1)
patterns were found##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
patterns were identified##4##3##(1991-1#1)(2007-2#1)(2008-10#2)
patterns were not##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
patterns were noted##2##3##(2008-10#1)(2010-8#1)
patterns were observed in##2##4##(1994-8#1)(2007-12#1)
patterns were observed##4##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
patterns were obtained for##2##4##(2008-10#1)(2013-1#1)
patterns were obtained##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
patterns were produced##2##3##(2008-10#1)(2008-8#1)
patterns were recorded##2##3##(1996-5#1)(2008-10#1)
patterns were seen##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
patterns were studied##2##3##(2008-10#1)(2008-11#1)
patterns were##67##2##(1990-6#1)(1991-1#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
patterns when##4##2##(1993-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
patterns which##2##2##(2008-10#1)(2008-11#1)
patterns will be##2##3##(2008-6#1)(2009-5#1)
patterns will##4##2##(2008-1#1)(2008-6#1)(2009-5#1)(2010-11#1)
patterns with##14##2##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
patterns within the##2##3##(2008-11#1)(2013-8#1)
patterns within##8##2##(1992-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2012-2#1)(2013-8#1)
patterns##1452##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#6)(1993-1#3)(1993-11#3)(1993-12#12)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#5)(1994-1#2)(1994-11#4)(1994-12#7)(1994-2#14)(1994-3#4)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#10)(1995-1#2)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#9)(1995-5#5)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#6)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#4)(1996-5#2)(1996-6#4)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#8)(1997-7#5)(1997-8#4)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#7)(2007-11#25)(2007-12#38)(2007-2#7)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#1)(2008-1#19)(2008-10#202)(2008-11#54)(2008-12#21)(2008-2#77)(2008-3#127)(2008-4#8)(2008-5#33)(2008-6#12)(2008-7#52)(2008-8#85)(2008-9#34)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#4)(2009-4#1)(2009-5#4)(2009-6#7)(2009-7#5)(2009-8#19)(2009-9#13)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#4)(2010-3#4)(2010-4#15)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#14)(2010-9#4)(2011-1#11)(2011-10#1)(2011-2#44)(2011-3#1)(2012-1#6)(2012-12#14)(2012-2#44)(2012-3#23)(2012-5#1)(2012-7#1)(2013-1#45)(2013-7#9)(2013-8#20)
patties increased##2##2##(2010-4#2)
patties were##3##2##(2010-4#3)
patties##12##1##(2010-4#12)
patuletin##2##1##(2008-11#2)
patulin accumulation in##2##3##(2008-10#2)
patulin accumulation##3##2##(2008-10#3)
patulin and##5##2##(2008-10#2)(2010-3#2)(2010-7#1)
patulin##10##1##(2008-10#7)(2010-3#2)(2010-7#1)
paucity of data##5##3##(2008-10#2)(2011-2#1)(2013-1#2)
paucity of information in the##2##5##(2008-1#1)(2013-1#1)
paucity of information##4##3##(2008-1#1)(2009-11#1)(2013-1#2)
paucity of literature##2##3##(2008-11#1)(2012-2#1)
paucity of published data##2##4##(1995-1#1)(2013-1#1)
paucity of##39##2##(1991-8#1)(1995-1#1)(1996-6#1)(1997-2#1)(1997-9#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
pause sites##2##2##(1994-8#1)(1995-3#1)
pause##9##1##(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#2)
pauses##2##1##(1992-2#1)(1996-12#1)
pauvreté##4##1##(2008-11#4)
pave the way for the##2##5##(2011-1#1)(2012-2#1)
pave the way for##3##4##(2009-12#1)(2011-1#1)(2012-2#1)
pave the way##5##3##(2008-7#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-2#1)
paves the way for##2##4##(2008-9#1)(2009-8#1)
paving the##2##2##(2011-1#2)
paving##3##1##(2008-10#1)(2011-1#2)
pavlovskyi##2##1##(2013-1#2)
pavonina##3##1##(2008-11#3)
paw and##2##2##(1994-3#1)(2008-9#1)
paw edema and##2##3##(2011-1#1)(2013-7#1)
paw edema assay##2##3##(2011-1#2)
paw edema##6##2##(2008-10#1)(2011-1#3)(2013-7#2)
paw preference test##2##3##(1994-8#1)(1997-2#1)
paw preference##3##2##(1994-8#2)(1997-2#1)
paw withdrawal threshold##2##3##(1993-12#2)
paw withdrawal thresholds##2##3##(1993-12#2)
paw withdrawal##5##2##(1993-12#4)(1996-5#1)
paw##26##1##(1992-10#1)(1993-12#4)(1994-3#1)(1994-8#2)(1995-12#3)(1996-5#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-9#2)(2011-1#3)(2013-7#2)
paw-licking##2##1##(1992-3#2)
paws##2##1##(1997-2#1)(2008-9#1)
paxillin family of##2##3##(2012-12#2)
paxillin family##3##2##(2012-12#3)
paxillin##6##1##(1996-12#1)(2012-12#5)
pay $120##2##2##(1995-6#2)
pay a cost##2##3##(2008-9#1)(2012-3#1)
pay a##6##2##(1992-12#1)(1996-3#1)(1997-1#1)(2008-9#1)(2009-5#1)(2012-3#1)
pay and##4##2##(1992-2#1)(1997-1#1)(2008-1#1)(2012-12#1)
pay attention to##5##3##(1990-11#1)(2007-11#1)(2008-11#1)(2008-9#1)(2013-1#1)
pay attention##6##2##(1990-11#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
pay dividends##2##2##(1993-2#1)(1994-2#1)
pay for performance##5##3##(1996-3#3)(2008-4#1)(2008-6#1)
pay for the##2##3##(1992-5#1)(2007-7#1)
pay for##29##2##(1990-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#3)(2007-2#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)
pay hospitals for what they##2##5##(1992-12#2)
pay hospitals##3##2##(1992-12#2)(1995-2#1)
pay more attention to the##2##5##(2008-1#2)
pay more attention to##5##4##(1995-1#1)(2008-1#2)(2010-1#1)(2010-4#1)
pay more##6##2##(1994-1#1)(1995-1#1)(2008-1#2)(2010-1#1)(2010-4#1)
pay off##2##2##(2008-6#1)(2010-4#1)
pay##111##1##(1990-11#1)(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1993-2#2)(1993-3#2)(1993-7#1)(1994-1#2)(1994-12#2)(1994-2#4)(1994-3#3)(1995-1#4)(1995-12#5)(1995-2#3)(1995-6#3)(1996-2#1)(1996-3#6)(1996-5#3)(1997-1#4)(1997-2#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#9)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
payback##2##1##(1992-12#1)(1992-2#1)
payed##2##1##(2007-11#1)(2008-11#1)
payer environment##2##2##(1992-11#1)(2008-7#1)
payer##12##1##(1992-11#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(2008-12#3)(2008-7#1)(2013-7#1)(2013-8#1)
payers and##3##2##(1994-12#1)(2008-11#1)(2013-7#1)
payers for##3##2##(1992-1#2)(1994-12#1)
payers use##2##2##(1994-12#2)
payers##34##1##(1991-12#1)(1991-3#1)(1992-1#2)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#8)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#2)(1997-3#2)(1997-6#2)(2007-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2013-7#2)
paying attention to##4##3##(1995-5#1)(1996-8#1)(2008-10#1)(2008-8#1)
paying for##4##2##(1991-12#1)(1992-12#1)(2008-4#1)(2008-7#1)
paying particular attention to##2##4##(1990-9#1)(2008-9#1)
paying special attention to##2##4##(1997-2#1)(2013-1#1)
paying the##2##2##(2008-11#1)(2010-8#1)
paying##20##1##(1990-9#1)(1991-12#1)(1992-12#2)(1992-2#1)(1994-3#1)(1995-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
payload##2##1##(2008-3#2)
payloads##3##1##(2008-12#1)(2013-1#1)(2013-8#1)
payment and cost##2##3##(1992-12#1)(1994-1#1)
payment and##4##2##(1992-12#1)(1993-2#1)(1994-1#1)(1994-2#1)
payment as##2##2##(1992-12#1)(1994-1#1)
payment changes##2##2##(1994-1#1)(2008-4#1)
payment for##10##2##(1991-3#1)(1992-1#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1997-1#1)(2008-11#1)
payment formula##2##2##(1997-1#1)(1997-2#1)
payment levels##2##2##(1992-2#1)(1992-3#1)
payment method##4##2##(1994-12#1)(1997-1#3)
payment methodologies##3##2##(1992-3#1)(1994-12#1)(1995-12#1)
payment methodology##2##2##(1996-3#1)(1997-3#1)
payment methods##4##2##(1992-3#1)(1994-1#1)(1994-12#1)(1995-2#1)
payment model##3##2##(1993-12#2)(1994-3#1)
payment models##2##2##(1997-1#1)(2013-7#1)
payment of##4##2##(1992-2#1)(1992-3#1)(1995-12#1)(2008-11#1)
payment on##2##2##(1994-1#1)(1994-2#1)
payment policies and##2##3##(1997-1#1)(1997-2#1)
payment policies##6##2##(1992-3#1)(1993-3#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-2#1)
payment policy##5##2##(1991-12#1)(1994-1#2)(1995-1#2)
payment rate##2##2##(1991-1#1)(1994-12#1)
payment rates##8##2##(1991-1#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-3#1)
payment reform##14##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-1#4)(1994-12#1)(1995-12#3)(1997-1#1)(2013-1#1)
payment reforms in##2##3##(1997-1#2)
payment reforms##5##2##(1995-12#1)(1997-1#4)
payment system and##3##3##(1991-3#1)(1992-12#1)(1993-3#1)
payment system for##8##3##(1991-1#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#2)
payment system of##2##3##(1993-12#1)(1993-3#1)
payment system that##2##3##(1993-3#1)(1995-2#1)
payment system##56##2##(1991-1#4)(1991-12#1)(1991-2#3)(1991-3#5)(1992-1#4)(1992-12#10)(1992-2#7)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#4)(1994-12#3)(1994-3#2)(1995-2#2)(1995-3#1)(1996-3#1)(1997-1#1)(2008-11#1)(2010-8#1)
payment systems in##2##3##(1992-3#1)(1994-12#1)
payment systems##10##2##(1991-1#1)(1992-3#3)(1993-12#2)(1994-12#2)(1996-1#1)(1996-2#1)
payment to health maintenance organizations##2##5##(1993-1#1)(1993-3#1)
payment to##6##2##(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#2)(1997-5#1)
payment under##2##2##(1991-2#1)(1995-2#1)
payment##238##1##(1991-1#14)(1991-12#5)(1991-2#8)(1991-3#12)(1992-1#14)(1992-12#20)(1992-2#16)(1992-3#11)(1993-1#7)(1993-12#10)(1993-2#2)(1993-3#10)(1994-1#12)(1994-12#16)(1994-2#4)(1994-3#5)(1995-1#4)(1995-12#6)(1995-2#8)(1995-3#4)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#3)(1997-1#15)(1997-2#5)(1997-3#1)(1997-5#3)(2008-11#5)(2008-12#1)(2008-4#3)(2008-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
payments and##4##2##(1992-12#1)(1995-1#1)(1997-2#1)(2012-2#1)
payments are##2##2##(1992-12#1)(1995-2#1)
payments for##12##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1994-12#1)(1997-1#5)(2012-2#1)
payments to health##3##3##(1991-1#2)(1997-1#1)
payments to the##2##3##(1992-12#1)(1994-12#1)
payments to##9##2##(1991-1#2)(1992-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(2008-7#1)
payments##71##1##(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#3)(1992-1#1)(1992-12#10)(1992-2#5)(1992-8#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#2)(1995-1#3)(1995-2#4)(1996-12#1)(1997-1#13)(1997-2#2)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
payoff##5##1##(1992-2#2)(2008-8#2)(2008-9#1)
payoffs of##2##2##(2008-8#1)(2012-3#1)
payoffs##4##1##(2008-8#3)(2012-3#1)
payor net cost savings from a##2##6##(2008-11#2)
payor##8##1##(1992-1#2)(1993-12#1)(1994-1#1)(1996-3#1)(2008-11#3)
payors and##2##2##(1991-1#1)(1994-12#1)
payors##21##1##(1991-1#1)(1991-3#1)(1992-1#2)(1992-12#2)(1992-3#1)(1994-1#6)(1994-12#1)(1995-1#1)(1996-3#1)(2008-11#4)(2012-2#1)
payout##3##1##(1996-3#3)
payroll##2##1##(1995-3#1)(2008-11#1)
pays for##2##2##(2008-5#1)(2009-11#1)
pays off##2##2##(1996-1#1)(1997-3#1)
pays##12##1##(1992-12#1)(1993-3#3)(1996-1#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2013-1#1)
pazopanib and RT##5##3##(2013-1#5)
pazopanib##9##1##(2011-1#1)(2013-1#8)
pb##2##1##(2013-1#2)
pcDNA3 transfectant and##2##3##(2008-9#2)
pcDNA3##8##1##(2008-5#1)(2008-8#4)(2008-9#2)(2012-3#1)
pcDNA3-TPO##2##1##(2008-8#2)
pcXII##2##1##(2008-10#2)
pcbC##2##1##(2011-1#2)
pd 14##3##2##(2008-7#3)
pd##7##1##(2008-7#7)
pePOA##7##1##(1992-3#7)
pea (Pisum sativum)##4##3##(1993-6#1)(2008-1#1)(2008-10#2)
pea DRR206##2##2##(2008-10#2)
pea and lentil##2##3##(1993-8#1)(2008-10#1)
pea and##6##2##(1993-8#1)(2008-10#3)(2008-5#1)(2008-6#1)
pea aphids##3##2##(2008-8#3)
pea cultivars##6##2##(2008-10#6)
pea fields in##2##3##(2008-10#2)
pea is##4##2##(2008-10#1)(2008-5#2)(2009-8#1)
pea lectin and##2##3##(1993-8#2)
pea lectin##4##2##(1993-8#4)
pea lines##4##2##(2008-10#4)
pea plants##3##2##(2008-10#3)
pea production##2##2##(2008-10#2)
pea protein##3##2##(1993-6#3)
pea roots##3##2##(2008-10#3)
pea seeds##2##2##(2008-10#1)(2011-2#1)
pea##91##1##(1993-6#6)(1993-8#5)(2008-1#1)(2008-10#55)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#5)(2009-8#2)(2011-2#6)
pea-size##2##1##(2008-10#2)
peace##5##1##(1990-2#1)(1992-9#1)(2007-7#2)(2008-10#1)
peaceful##2##1##(2007-9#1)(2013-8#1)
peach (Prunus persica)##2##3##(2008-10#2)
peach and##2##2##(2008-10#1)(2011-2#1)
peach fruit##5##2##(2008-10#5)
peach leaves##2##2##(2008-10#2)
peach orchard##2##2##(2008-10#2)
peach orchards##3##2##(2008-10#3)
peach seedlings##4##2##(2008-10#4)
peach tree susceptibility to bacterial canker infection##2##7##(2008-10#2)
peach tree##3##2##(2008-10#3)
peach trees##2##2##(2008-10#2)
peach was##2##2##(2008-10#2)
peach##56##1##(2008-10#55)(2011-2#1)
peak 2##3##2##(1990-5#1)(2008-10#2)
peak BMD and age at peak BMD##2##7##(2010-3#2)
peak BMD##7##2##(2010-3#7)
peak VO2/kg x min(-1)##2##4##(2008-3#2)
peak above##2##2##(2008-3#2)
peak absorption##5##2##(2008-2#1)(2008-3#4)
peak activation occurred between##2##4##(1997-3#2)
peak activation##3##2##(1995-2#1)(1997-3#2)
peak activity##2##2##(1996-6#1)(2011-1#1)
peak age group##2##3##(2007-10#2)
peak age##3##2##(2007-10#2)(2011-1#1)
peak amplitude of##2##3##(1992-11#1)(1995-11#1)
peak and the##4##3##(1995-3#1)(2008-10#2)(2008-8#1)
peak and two##2##3##(2008-10#1)(2008-3#1)
peak and##21##2##(1991-12#1)(1992-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
peak appeared at##2##3##(1995-8#1)(1997-2#1)
peak appeared##4##2##(1995-8#1)(1997-2#1)(2008-10#2)
peak appears in the##2##4##(1990-2#1)(2008-3#1)
peak appears##4##2##(1990-2#1)(2008-10#2)(2008-3#1)
peak are##2##2##(2007-12#1)(2008-10#1)
peak area and peak height##4##5##(2008-10#4)
peak area and##6##3##(2008-10#5)(2011-1#1)
peak area measurement##2##3##(2008-10#2)
peak area measurements##2##3##(2008-10#2)
peak area of the##2##4##(2008-10#2)
peak area of##8##3##(1990-8#1)(2008-10#6)(2011-1#1)
peak area ratio##2##3##(2008-7#1)(2013-8#1)
peak area ratios##3##3##(2008-10#2)(2008-6#1)
peak area was##3##3##(1990-8#1)(2008-10#2)
peak area##42##2##(1990-8#2)(1996-5#1)(2008-10#34)(2008-6#1)(2008-7#1)(2011-1#2)(2013-8#1)
peak areas of##3##3##(2008-10#2)(2011-1#1)
peak areas were##2##3##(2008-10#2)
peak areas##12##2##(1994-9#1)(2008-10#9)(2011-1#1)(2013-1#1)
peak around 1##2##3##(2008-10#2)
peak around##5##2##(2008-10#5)
peak as##3##2##(1992-12#1)(2008-10#2)
peak at -0##6##3##(1990-5#1)(2008-10#4)(2008-8#1)
peak at -1##3##3##(2008-10#3)
peak at 329##2##3##(1992-10#2)
peak at about##5##3##(1992-8#1)(2008-10#4)
peak at around##2##3##(2008-10#1)(2008-5#1)
peak at the##6##3##(1990-5#1)(2007-11#1)(2008-10#3)(2008-3#1)
peak at##54##2##(1990-2#1)(1990-5#2)(1992-10#3)(1992-6#1)(1992-8#1)(1994-6#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#31)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-9#1)(2013-8#1)
peak bone mass##4##3##(1993-11#1)(2007-7#1)(2010-3#2)
peak bone mineral density##2##4##(2010-3#2)
peak bone##6##2##(1993-11#1)(2007-7#1)(2010-3#4)
peak by##4##2##(1994-6#1)(2008-10#3)
peak concentration##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
peak concentrations##2##2##(1990-12#1)(1997-4#1)
peak corresponding to##3##3##(2008-10#3)
peak current and molybdenum concentration is linear##2##7##(2008-10#2)
peak current and the concentration##2##5##(2008-10#2)
peak current and##8##3##(2008-10#8)
peak current at -0##2##4##(2008-10#2)
peak current for##3##3##(2008-10#3)
peak current had##2##3##(2008-10#2)
peak current increased##2##3##(2008-10#2)
peak current is found to be linear##2##7##(2008-10#2)
peak current is proportional to DNA concentration##2##7##(2008-10#2)
peak current is proportional to the concentration of##3##8##(2008-10#3)
peak current is proportional to##6##5##(2008-10#6)
peak current is##10##3##(2008-10#10)
peak current of ARS##2##4##(2008-10#2)
peak current of the##3##4##(2008-10#3)
peak current of##13##3##(2008-10#12)(2012-2#1)
peak current response##2##3##(2008-10#2)
peak current was linear to##2##5##(2008-10#2)
peak current was##5##3##(2008-10#5)
peak current with##2##3##(2008-10#2)
peak current##69##2##(2008-10#67)(2010-6#1)(2012-2#1)
peak currents and##3##3##(2008-10#3)
peak currents of##4##3##(2008-10#3)(2012-2#1)
peak currents were found to be##2##6##(2008-10#2)
peak currents were##4##3##(2008-10#4)
peak currents##26##2##(2008-10#23)(2008-2#1)(2012-2#2)
peak during##5##2##(1991-5#1)(2007-10#2)(2008-11#1)(2010-3#1)
peak efficiency##3##2##(2008-10#1)(2008-3#2)
peak endogenous##2##2##(2008-3#2)
peak enhancement##2##2##(2008-10#1)(2008-7#1)
peak experience##4##2##(2013-8#4)
peak experiences of psilocybin users and non-users##2##7##(2013-8#2)
peak experiences of psilocybin users##3##5##(2013-8#3)
peak experiences##8##2##(2013-8#8)
peak expiratory flow (PEF)##2##4##(2007-2#1)(2008-1#1)
peak expiratory flow rates##2##4##(1996-1#1)(2008-1#1)
peak expiratory flow##8##3##(1990-6#2)(1996-1#1)(2007-2#1)(2008-1#2)(2008-3#1)(2009-6#1)
peak flow meters##2##3##(1991-3#1)(2008-10#1)
peak flow##7##2##(1990-9#1)(1991-3#1)(1996-2#1)(2007-6#1)(2008-10#1)(2008-7#1)(2010-2#1)
peak for##2##2##(1990-3#1)(2008-10#1)
peak frequency##3##2##(2007-11#1)(2008-11#1)(2008-2#1)
peak from##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
peak glucose##3##2##(1994-12#1)(2010-8#1)(2012-2#1)
peak has##2##2##(1992-9#1)(2008-10#1)
peak heart rate##2##3##(2008-7#1)(2013-1#1)
peak height absorbance##2##3##(2008-10#2)
peak height and concentration##2##4##(2008-10#2)
peak height and peak area##3##5##(1996-5#1)(2008-10#2)
peak height and peak##4##4##(1996-5#1)(2008-10#3)
peak height and##12##3##(1996-5#1)(2008-10#11)
peak height by##3##3##(2008-10#3)
peak height of##3##3##(2008-10#3)
peak height values##2##3##(2008-10#2)
peak height was##3##3##(2008-10#3)
peak height##45##2##(1993-8#1)(1996-5#1)(2008-10#42)(2008-3#1)
peak heights##11##2##(2008-10#10)(2008-2#1)
peak hip##2##2##(2011-2#2)
peak identification##2##2##(2008-10#2)
peak in the##14##3##(1990-5#1)(1992-8#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-11#1)
peak in##30##2##(1990-5#1)(1992-8#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-6#1)(2012-3#1)
peak incidence##2##2##(1992-9#1)(1993-9#1)
peak increases##3##2##(1992-3#1)(2007-12#1)(2008-3#1)
peak inspiratory flow##2##3##(1992-3#1)(2012-2#1)
peak inspiratory##3##2##(1992-3#1)(1994-2#1)(2012-2#1)
peak intensities##9##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)
peak intensity at##2##3##(2007-12#1)(2013-8#1)
peak intensity is##3##3##(2007-11#2)(2007-12#1)
peak intensity of##7##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
peak intensity##23##2##(2007-11#3)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#5)(2010-10#1)(2013-8#1)
peak is in##2##3##(2010-3#2)
peak is produced##2##3##(1992-9#1)(2008-10#1)
peak is##15##2##(1990-2#1)(1992-9#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2010-3#2)(2013-8#2)
peak lactation##2##2##(2012-12#2)
peak latency##4##2##(1995-12#3)(2008-7#1)
peak level##3##2##(1994-2#1)(1996-12#2)
peak levels##3##2##(1990-12#1)(2007-10#1)(2011-2#1)
peak located##2##2##(1993-11#1)(2008-10#1)
peak may##2##2##(2008-10#1)(2008-5#1)
peak near##2##2##(1990-8#1)(2008-3#1)
peak of activity##2##3##(1992-9#1)(2013-1#1)
peak of ammonia##2##3##(1992-11#2)
peak of the##17##3##(1990-11#1)(1994-3#1)(1995-11#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#2)
peak of##58##2##(1990-11#1)(1990-8#1)(1991-9#2)(1992-11#2)(1992-9#2)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#3)(2008-10#15)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
peak on##5##2##(1993-11#2)(2007-10#2)(2008-7#1)
peak output power##2##3##(2007-11#2)
peak output##3##2##(2007-11#2)(2008-3#1)
peak overlap##2##2##(2008-10#2)
peak periods##2##2##(1992-8#1)(2008-10#1)
peak plasma concentration of##2##4##(1990-6#1)(1993-1#1)
peak plasma concentration##3##3##(1990-6#1)(1993-1#1)(2012-12#1)
peak plasma##6##2##(1990-6#1)(1992-5#1)(1993-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
peak position at maximum height##3##5##(2008-10#3)
peak position of the##3##4##(2007-11#2)(2008-3#1)
peak position of##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
peak position##9##2##(2007-11#2)(2008-10#6)(2008-3#1)
peak potential is##3##3##(2008-10#3)
peak potential of##5##3##(2008-10#5)
peak potential shifted##2##3##(2008-10#2)
peak potential was##2##3##(2008-10#2)
peak potential##22##2##(2008-10#22)
peak potentials##5##2##(2008-10#5)
peak power and pulse width##2##5##(2008-3#2)
peak power and pulse##3##4##(2008-3#3)
peak power and##8##3##(2007-12#2)(2008-3#6)
peak power density##2##3##(2008-3#1)(2012-2#1)
peak power of the##3##4##(2007-12#1)(2008-3#2)
peak power of##16##3##(2007-11#6)(2007-12#7)(2008-3#3)
peak power##40##2##(2007-11#10)(2007-12#11)(2008-2#1)(2008-3#14)(2008-5#2)(2008-9#1)(2012-2#1)
peak powers of##2##3##(2007-12#1)(2008-2#1)
peak powers##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
peak rate##2##2##(2008-11#1)(2008-9#1)
peak reflectance##3##2##(2008-2#1)(2008-3#2)
peak reflectivity##3##2##(2007-11#1)(2007-12#2)
peak response##2##2##(1995-12#1)(2008-10#1)
peak separation##3##2##(2008-10#2)(2008-3#1)
peak shape##4##2##(2008-10#3)(2008-2#1)
peak shaped##2##2##(2008-10#2)
peak shapes were##2##3##(2007-12#1)(2011-1#1)
peak shapes##4##2##(1994-9#1)(2007-12#1)(2008-10#1)(2011-1#1)
peak sharpness##2##2##(2008-2#1)(2008-3#1)
peak shifted negatively as the##2##5##(2008-10#2)
peak shifts##2##2##(2008-10#2)
peak signal##2##2##(2008-10#2)
peak systolic velocity (PSV)##3##4##(2007-10#1)(2008-1#1)(2013-8#1)
peak systolic velocity in##2##4##(2007-10#1)(2011-2#1)
peak systolic velocity##5##3##(2007-10#2)(2008-1#1)(2011-2#1)(2013-8#1)
peak temperature rise in##2##4##(2008-2#1)(2008-3#1)
peak that is##2##3##(2007-12#1)(2008-3#1)
peak that##5##2##(1992-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-3#1)
peak to peak acceleration of##2##5##(2008-11#2)
peak to peak##3##3##(1992-8#1)(2008-11#2)
peak to##8##2##(1991-12#1)(1992-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#1)
peak transmission##2##2##(2007-11#1)(2008-2#1)
peak value of##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
peak value##6##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
peak values for##3##3##(1990-3#1)(1991-12#1)(2008-10#1)
peak values in##2##3##(2008-5#2)
peak values of##4##3##(2008-2#1)(2008-3#2)(2008-8#1)
peak values##9##2##(1990-3#1)(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)
peak velocity##3##2##(2008-3#1)(2008-4#1)(2010-11#1)
peak was also##2##3##(2008-10#2)
peak was observed at##3##4##(2008-10#3)
peak was observed##8##3##(1992-10#1)(1996-5#1)(2008-10#5)(2009-12#1)
peak was obtained in##2##4##(2008-10#2)
peak was obtained##4##3##(2008-10#4)
peak was##32##2##(1992-10#1)(1992-3#1)(1993-3#2)(1996-5#1)(1997-2#1)(2007-11#3)(2008-10#19)(2008-8#1)(2009-12#1)(2011-2#2)
peak wavelength##6##2##(1995-2#1)(2007-12#1)(2008-3#3)(2013-8#1)
peak were##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
peak when the##2##3##(2008-3#1)(2008-6#1)
peak width##3##2##(2008-10#3)
peak with##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
peak##1001##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#3)(1990-8#4)(1990-9#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-10#5)(1992-11#4)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#5)(1992-8#7)(1992-9#6)(1993-1#1)(1993-11#4)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#7)(1996-2#2)(1996-5#7)(1996-6#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#3)(2007-10#11)(2007-11#35)(2007-12#50)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#434)(2008-11#21)(2008-12#1)(2008-2#42)(2008-3#84)(2008-4#1)(2008-5#12)(2008-6#7)(2008-7#13)(2008-8#13)(2008-9#8)(2009-12#4)(2009-2#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#16)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#14)(2012-12#8)(2012-2#10)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#25)
peak)##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
peak-power##7##1##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
peak-shape##3##1##(2008-10#3)
peak-to-peak amplitude##2##2##(2008-10#1)(2008-2#1)
peak-to-peak resolution##4##2##(2008-10#4)
peak-to-peak##10##1##(1993-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)
peaked approximately##3##2##(1991-12#1)(2008-10#2)
peaked at 2##2##3##(1995-2#1)(2009-8#1)
peaked at##12##2##(1993-11#2)(1993-8#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-6#1)(2009-8#1)(2011-1#1)
peaked between 2 and 3 days##2##6##(2007-10#2)
peaked between##3##2##(2007-10#2)(2008-10#1)
peaked in##4##2##(1992-6#1)(1995-2#1)(1996-11#1)(2008-10#1)
peaked##35##1##(1991-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-8#3)(1995-2#2)(1996-11#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-8#3)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
peaking at##3##2##(1992-9#1)(1993-11#1)(1996-6#1)
peaking##11##1##(1992-11#1)(1992-9#2)(1993-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-3#1)
peaks and the##2##3##(2008-10#2)
peaks and##8##2##(1997-2#1)(2008-10#6)(2009-11#1)
peaks appeared on the##2##4##(2008-10#2)
peaks are observed in the##2##5##(2008-10#1)(2008-3#1)
peaks are observed##4##3##(2008-10#1)(2008-3#2)(2009-5#1)
peaks are separated##2##3##(2008-10#2)
peaks are##13##2##(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-5#1)(2009-6#1)(2013-8#2)
peaks at about##2##3##(2008-10#1)(2013-8#1)
peaks at the##2##3##(2007-11#1)(2008-3#1)
peaks at##18##2##(1990-5#2)(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#2)
peaks can##3##2##(2007-11#1)(2008-10#2)
peaks corresponding to the##3##4##(2008-10#3)
peaks corresponding to##9##3##(2008-10#9)
peaks due to the##3##4##(1996-2#1)(2008-10#2)
peaks for##9##2##(1997-2#1)(2008-10#8)
peaks found##2##2##(1996-5#1)(2008-10#1)
peaks from##3##2##(1990-12#1)(1995-3#1)(2008-10#1)
peaks in a##2##3##(1997-2#1)(2008-10#1)
peaks in the##12##3##(2008-10#3)(2008-3#4)(2008-8#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-7#1)
peaks in##24##2##(1990-7#1)(1997-2#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
peaks is##2##2##(2008-3#2)
peaks located##2##2##(2008-10#1)(2008-3#1)
peaks obtained from##2##3##(1990-8#1)(2008-10#1)
peaks obtained##3##2##(1990-8#1)(2008-10#2)
peaks of dopamine##2##3##(2008-10#2)
peaks of the##13##3##(1990-5#1)(2007-11#1)(2008-10#9)(2013-1#2)
peaks of##43##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1993-6#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#25)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
peaks on the##2##3##(1994-9#1)(2008-8#1)
peaks on##4##2##(1994-9#1)(2008-10#2)(2008-8#1)
peaks produced by##2##3##(2008-10#1)(2008-3#1)
peaks showed##2##2##(2008-10#2)
peaks that##6##2##(2007-11#2)(2008-10#2)(2008-4#1)(2008-8#1)
peaks the##3##2##(1997-4#1)(2008-10#2)
peaks was##4##2##(1995-6#1)(1997-2#1)(2008-10#1)(2013-8#1)
peaks were also observed##2##4##(2008-10#1)(2008-9#1)
peaks were also##4##3##(2008-10#3)(2008-9#1)
peaks were identified##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
peaks were observed for##2##4##(2008-10#2)
peaks were observed##3##3##(2008-10#2)(2008-9#1)
peaks were obtained##3##3##(1991-2#1)(2008-10#2)
peaks were##30##2##(1991-2#1)(1992-12#1)(1996-5#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#4)(2009-12#1)
peaks with an##2##3##(2008-10#1)(2008-3#1)
peaks with##8##2##(1991-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)
peaks##319##1##(1990-12#2)(1990-2#3)(1990-5#6)(1990-7#2)(1990-8#4)(1990-9#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#2)(1992-6#1)(1993-11#2)(1993-6#1)(1994-3#2)(1994-9#2)(1995-11#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#11)(1997-4#1)(2007-1#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-10#157)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#22)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#6)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#7)
peaks)##4##1##(1990-5#1)(2008-10#3)
peanut (Arachis hypogaea L##2##4##(2011-2#2)
peanut (Arachis hypogaea)##4##3##(2008-10#4)
peanut (Arachis##6##2##(2008-10#4)(2011-2#2)
peanut agglutinin##2##2##(1994-8#2)
peanut allergen Ara h1##2##4##(2008-11#2)
peanut allergen##3##2##(2008-10#1)(2008-11#2)
peanut peroxidase##2##2##(2008-10#2)
peanut stunt virus (PSV)##2##4##(2008-10#2)
peanut##41##1##(1994-8#2)(1996-11#4)(1996-8#1)(2008-10#27)(2008-11#2)(2009-2#1)(2010-5#1)(2011-2#3)
peanuts##3##1##(1990-6#1)(1994-3#1)(2008-10#1)
peapods##5##1##(2008-10#5)
pear and apple flowers##2##4##(2008-10#2)
pear and apple fruit##3##4##(2008-10#3)
pear and apple trees##4##4##(2008-10#4)
pear and apple##14##3##(2008-10#14)
pear and##16##2##(2008-10#16)
pear blossoms##5##2##(2008-10#5)
pear cultivars and##2##3##(2008-10#2)
pear cultivars##4##2##(2008-10#4)
pear fruit##5##2##(2008-10#5)
pear in##2##2##(2008-10#2)
pear juice##3##2##(2008-10#3)
pear leaves and##2##3##(2008-10#2)
pear leaves##3##2##(2008-10#3)
pear or apple##2##3##(2008-10#2)
pear orchards##4##2##(2008-10#4)
pear psylla##7##2##(2008-10#7)
pear scab##3##2##(2008-10#3)
pear slices##2##2##(2008-10#2)
pear trees with##2##3##(2008-10#2)
pear trees##4##2##(2008-10#4)
pear##92##1##(2008-10#92)
pear)##2##1##(2008-10#2)
pearl cichlid##2##2##(2008-10#2)
pearl millet##3##2##(2008-10#3)
pearl##9##1##(1997-4#1)(2008-10#5)(2008-5#2)(2008-7#1)
pearls##2##1##(2010-8#2)
pears stored##2##2##(2008-10#2)
pears was##2##2##(2008-10#2)
pears##10##1##(2008-10#10)
peas##7##1##(2008-10#7)
peat and##2##2##(2008-10#2)
peat mix##10##2##(2008-10#10)
peat moss alone##2##3##(2008-10#2)
peat moss##5##2##(2008-10#5)
peat was##3##2##(2008-10#3)
peat##41##1##(1992-3#2)(2008-10#36)(2008-2#1)(2008-8#2)
peat-bound metal species##2##3##(2008-10#2)
peat-bound##3##1##(2008-10#3)
peatlands##7##1##(2008-8#4)(2008-9#3)
pecan##3##1##(2008-10#3)
pecked##2##1##(2008-6#1)(2012-2#1)
pecking behavior of##2##3##(2008-6#2)
pecking behavior##3##2##(2008-6#3)
pecking##9##1##(2008-6#6)(2009-9#2)(2011-2#1)
pecks (habituation)##2##2##(2008-6#2)
pecks##5##1##(2008-6#5)
pectate lyase##6##2##(1993-9#1)(1997-7#1)(2008-10#4)
pectate##8##1##(1993-9#1)(1997-7#1)(2008-10#6)
pecten##5##1##(2008-5#5)
pectic##3##1##(2008-10#2)(2008-5#1)
pectin and##3##2##(2008-10#3)
pectin##30##1##(1990-9#2)(1991-9#2)(1997-2#1)(2008-10#16)(2010-5#4)(2011-10#1)(2011-2#4)
pectin-containing##2##1##(2008-10#1)(2011-1#1)
pectinase##2##1##(2008-10#2)
pectinases##2##1##(2008-10#1)(2008-6#1)
pectinesterase##2##1##(1997-2#2)
pectins##5##1##(2008-10#2)(2011-2#2)(2013-1#1)
pectolytic activity##2##2##(2008-10#2)
pectolytic enzymes##4##2##(1997-2#3)(2008-10#1)
pectolytic##9##1##(1997-2#4)(2008-10#5)
pectoral fin cells##2##3##(2008-11#2)
pectoral fin##3##2##(2008-11#2)(2008-5#1)
pectoral nerve##3##2##(2013-1#3)
pectoral##10##1##(1997-6#1)(2007-12#1)(2008-11#2)(2008-5#1)(2009-6#1)(2009-7#1)(2013-1#3)
pectoralis major##10##2##(1992-6#1)(1992-9#1)(2007-12#1)(2009-1#1)(2010-9#1)(2012-2#4)(2013-1#1)
pectoralis minor muscle##2##3##(2010-9#1)(2013-1#1)
pectoralis minor##9##2##(2010-9#4)(2013-1#5)
pectoralis##19##1##(1992-6#1)(1992-9#1)(2007-12#1)(2009-1#1)(2010-9#5)(2012-2#4)(2013-1#6)
pectoris##27##1##(1990-12#3)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#5)(1992-4#3)(1992-5#1)(1994-11#1)(1995-11#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
pectus deformity in##3##3##(1997-3#1)(2007-8#2)
pectus excavatum in##2##3##(2007-8#2)
pectus excavatum##4##2##(2007-8#4)
pectus##8##1##(1997-3#1)(2007-8#7)
peculiar and##2##2##(1992-8#1)(2007-10#1)
peculiar features##2##2##(2008-7#1)(2011-2#1)
peculiar pattern of##2##3##(2008-6#1)(2012-2#1)
peculiar pattern##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
peculiar to##5##2##(1991-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
peculiar##44##1##(1990-10#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-8#2)(1995-6#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
peculiarities in##4##2##(2007-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
peculiarities of the##4##3##(1991-6#1)(1992-11#1)(2008-10#1)(2008-3#1)
peculiarities of##15##2##(1991-6#1)(1992-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
peculiarities##26##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-11#1)(1993-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
peculiarity of the##3##3##(1990-11#1)(2008-3#1)(2013-7#1)
peculiarity of##5##2##(1990-11#1)(2008-3#1)(2010-1#1)(2011-2#1)(2013-7#1)
pedagogic##4##1##(1991-6#1)(1992-11#1)(1995-6#1)(2011-2#1)
pedagogical##12##1##(1991-1#1)(2008-11#2)(2008-12#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-3#2)(2013-8#1)
pedagogy##3##1##(1994-3#1)(2012-3#1)(2013-8#1)
pedal arteries##2##2##(1997-8#1)(2008-7#1)
pedal bypass##2##2##(2011-3#2)
pedal edema##4##2##(2010-2#4)
pedal##13##1##(1997-8#3)(2008-7#1)(2008-9#1)(2010-2#4)(2011-3#4)
pedaling technique##2##2##(2011-2#2)
pedestal antiresonant reflecting##2##3##(2007-12#2)
pedestal##9##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
pedestal-free pulse##3##2##(2007-11#3)
pedestal-free##6##1##(2007-11#5)(2007-12#1)
pedestrian##3##1##(2011-2#3)
pedestrians##4##1##(2011-2#4)
pediatric HIV##2##2##(1996-1#1)(2012-2#1)
pediatric TBI patients##2##3##(1996-1#2)
pediatric TBI##3##2##(1996-1#3)
pediatric abdominal surgical##3##3##(2011-2#3)
pediatric acute lymphoblastic leukemia##2##4##(2008-11#1)(2008-9#1)
pediatric acute##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
pediatric age group##4##3##(2008-4#1)(2009-3#1)(2012-12#1)(2013-1#1)
pediatric age##5##2##(1992-5#1)(2008-4#1)(2009-3#1)(2012-12#1)(2013-1#1)
pediatric airway##2##2##(2013-8#2)
pediatric and adolescent patients##2##4##(2010-3#2)
pediatric and adolescent##5##3##(2009-11#1)(2010-3#4)
pediatric and adult patients##2##4##(2011-2#1)(2012-3#1)
pediatric and adult##3##3##(1993-12#1)(2011-2#1)(2012-3#1)
pediatric and neonatal##2##3##(2008-9#1)(2011-1#1)
pediatric and##13##2##(1990-6#1)(1993-12#1)(2006-10#1)(2008-9#1)(2009-11#1)(2010-3#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
pediatric asthma##3##2##(2010-5#1)(2010-8#1)(2011-1#1)
pediatric care is##2##3##(2010-9#1)(2012-12#1)
pediatric care##7##2##(1992-3#1)(1996-1#1)(1996-12#1)(2010-9#2)(2012-12#1)(2013-1#1)
pediatric case of##2##3##(2008-10#1)(2013-1#1)
pediatric case##3##2##(2008-10#1)(2013-1#2)
pediatric cases##2##2##(1997-3#1)(2011-2#1)
pediatric craniofacial##4##2##(2007-12#4)
pediatric dental##2##2##(2008-9#1)(2010-3#1)
pediatric dentistry should##2##3##(2010-3#2)
pediatric dentistry##4##2##(2007-12#1)(2010-3#2)(2011-2#1)
pediatric department##2##2##(2007-12#1)(2007-8#1)
pediatric emergency##3##2##(1992-3#1)(2007-5#1)(2012-3#1)
pediatric flexible##2##2##(2012-2#1)(2012-3#1)
pediatric health care##2##3##(2008-11#1)(2010-7#1)
pediatric health##3##2##(2008-11#1)(2009-6#1)(2010-7#1)
pediatric hip fibromatosis with severe joint destruction##2##7##(2011-2#2)
pediatric hip##4##2##(2007-11#2)(2011-2#2)
pediatric hospital in##2##3##(1991-9#1)(2008-9#1)
pediatric hospital##7##2##(1991-9#1)(2008-9#1)(2009-5#1)(2010-10#3)(2011-2#1)
pediatric hospitals and general hospitals##2##5##(1994-1#2)
pediatric hospitals##5##2##(1994-1#3)(2008-10#1)(2008-11#1)
pediatric intensive care##3##3##(2011-2#1)(2012-2#2)
pediatric liver##4##2##(1996-1#1)(2006-10#2)(2013-1#1)
pediatric medical settings##2##3##(2009-6#2)
pediatric medical##4##2##(1994-3#1)(2009-6#2)(2010-6#1)
pediatric nurse practitioners##3##3##(2009-9#2)(2010-10#1)
pediatric nurse##5##2##(2009-9#3)(2010-10#2)
pediatric nurses in##2##3##(2010-5#1)(2011-1#1)
pediatric nurses##6##2##(1992-1#1)(2010-5#1)(2011-1#4)
pediatric nurses'##4##2##(2010-5#1)(2011-1#3)
pediatric nursing##3##2##(1994-1#1)(1997-3#1)(2010-9#1)
pediatric oncologists##2##2##(1992-12#1)(2012-2#1)
pediatric oncology patients and their##2##5##(1992-12#1)(1995-12#1)
pediatric oncology patients##4##3##(1992-12#1)(1994-12#2)(1995-12#1)
pediatric oncology##6##2##(1992-12#1)(1994-12#2)(1995-12#1)(2010-7#1)(2012-2#1)
pediatric overweight##2##2##(2008-11#2)
pediatric pain management##2##3##(1994-1#1)(2006-12#1)
pediatric pain##3##2##(1994-1#2)(2006-12#1)
pediatric patient with##3##3##(2007-8#1)(2011-2#2)
pediatric patient##11##2##(1994-1#2)(2007-8#1)(2008-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)
pediatric patients and##3##3##(1994-2#1)(1995-3#1)(2009-10#1)
pediatric patients with##9##3##(2008-4#1)(2008-5#1)(2010-11#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
pediatric patients##34##2##(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#2)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#3)(2013-8#1)
pediatric population##11##2##(1995-11#1)(2008-10#1)(2008-4#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#2)
pediatric populations##2##2##(2011-1#1)(2012-3#1)
pediatric primary##2##2##(1993-6#1)(1996-12#1)
pediatric pulmonary##2##2##(2010-5#2)
pediatric renal##4##2##(1991-2#1)(2008-10#3)
pediatric surgery##3##2##(1997-8#1)(2007-12#1)(2008-10#1)
pediatric traumatic brain##2##3##(1996-1#1)(2010-5#1)
pediatric trials##2##2##(2008-11#1)(2010-5#1)
pediatric unit##2##2##(1994-12#1)(2010-11#1)
pediatric urologic##2##2##(2008-10#2)
pediatric ward##3##2##(2007-2#1)(2010-5#1)(2011-2#1)
pediatric##329##1##(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1993-12#3)(1993-2#1)(1993-6#2)(1994-1#10)(1994-12#3)(1994-2#3)(1994-3#2)(1995-11#1)(1995-12#6)(1995-3#2)(1995-5#1)(1996-1#9)(1996-12#2)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2006-10#6)(2006-12#1)(2007-11#2)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#6)(2010-10#5)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#9)(2010-5#12)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#17)(2011-2#38)(2012-12#14)(2012-2#13)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#6)
pediatrician##5##1##(1996-2#1)(2007-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
pediatricians##16##1##(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-12#5)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#2)
pediatrics and##3##2##(2007-10#1)(2009-10#2)
pediatrics##16##1##(1991-3#2)(1994-12#1)(1996-9#1)(2007-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2009-10#2)(2011-2#4)(2013-1#1)
pedicel##3##1##(2008-10#3)
pedicle flap##4##2##(2011-2#3)(2013-8#1)
pedicle screw fixation##2##3##(2011-2#2)
pedicle screw placement in##2##4##(2012-12#2)
pedicle screw placement##3##3##(2012-12#3)
pedicle screw##9##2##(2007-11#3)(2009-3#1)(2011-2#2)(2012-12#3)
pedicle screws##2##2##(2008-12#1)(2008-7#1)
pedicle subtraction osteotomy##4##3##(2012-12#3)(2013-8#1)
pedicle##33##1##(1991-4#1)(1996-5#1)(2007-11#5)(2007-12#2)(2008-12#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#6)(2012-12#7)(2012-3#1)(2013-8#2)
pedicled and##2##2##(2010-6#1)(2012-2#1)
pedicled flaps##2##2##(2008-9#1)(2011-2#1)
pedicled##7##1##(2007-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-2#2)
pedicles##4##1##(1996-9#1)(1997-3#1)(1997-6#1)(2008-7#1)
pedicular screw fixation##3##3##(2012-2#3)
pediculosis and scabies##2##3##(2008-12#2)
pediculosis##3##1##(1991-12#1)(2008-12#2)
pediculum##3##1##(2007-11#3)
pedigree analysis##2##2##(1997-5#1)(2008-5#1)
pedigree of##3##2##(2008-2#3)
pedigree##17##1##(1994-12#1)(1997-5#4)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#1)(2010-4#1)
pedigrees##19##1##(1994-8#1)(1995-8#1)(1997-5#7)(2008-1#2)(2008-10#3)(2008-4#2)(2012-3#3)
pedis##4##1##(2010-7#2)(2011-2#2)
peduncle##7##1##(1992-11#1)(1996-5#3)(2008-10#2)(2013-7#1)
pedunculated##9##1##(1992-5#1)(1993-9#2)(2007-8#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
pedunculonigral##2##1##(2008-7#2)
pedunculopontine tegmental nucleus##6##3##(1994-2#2)(1994-3#2)(1995-12#1)(2008-7#1)
pedunculopontine##7##1##(1994-2#2)(1994-3#3)(1995-12#1)(2008-7#1)
peek##2##1##(2009-6#1)(2010-8#1)
peel or##2##2##(2008-10#1)(2008-5#1)
peel tissue##2##2##(2008-10#2)
peel##18##1##(2008-10#7)(2008-5#7)(2010-4#2)(2012-3#2)
peeled##2##1##(1995-4#1)(2008-3#1)
peelii##6##1##(2010-8#6)
peeling of the##2##3##(2011-2#2)
peeling of##3##2##(2011-2#3)
peeling##9##1##(2007-7#2)(2008-11#1)(2008-5#2)(2011-2#4)
peels##4##1##(2007-7#2)(2008-4#1)(2010-8#1)
peer and friend influences##2##4##(2009-7#2)
peer and friend##3##3##(2009-7#3)
peer and##4##2##(2009-7#4)
peer assessment##7##2##(2008-11#6)(2013-1#1)
peer connections##5##2##(2013-1#5)
peer drinking##2##2##(2010-9#2)
peer group control##3##3##(2009-8#3)
peer group processes##2##3##(2009-8#2)
peer group##11##2##(2008-11#2)(2009-5#1)(2009-7#1)(2009-8#6)(2013-7#1)
peer influence##3##2##(2013-1#3)
peer norms##2##2##(2009-7#2)
peer pressure##2##2##(2008-10#1)(2008-9#1)
peer ratings##2##2##(2009-7#2)
peer relationships##3##2##(1996-12#1)(2009-7#1)(2013-1#1)
peer review and##2##3##(1991-1#1)(1994-2#1)
peer review organization##2##3##(1991-1#1)(1996-2#1)
peer review organizations##3##3##(1991-3#1)(1993-2#1)(1995-12#1)
peer review##31##2##(1991-1#4)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#5)(1993-1#4)(1993-2#2)(1994-1#1)(1994-2#2)(1994-6#1)(1995-12#1)(1996-2#1)(1997-3#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
peer review]##2##2##(1990-12#1)(2008-8#1)
peer support##5##2##(1993-3#1)(1995-12#1)(2008-11#2)(2012-12#1)
peer support)##2##2##(2009-7#2)
peer victimization in adolescence##2##4##(2009-7#2)
peer victimization##5##2##(2008-12#2)(2008-4#1)(2009-7#2)
peer##118##1##(1990-12#1)(1990-9#1)(1991-1#4)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#5)(1993-1#4)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#3)(1996-12#1)(1996-2#1)(1997-3#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#12)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#19)(2009-8#6)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#14)(2013-7#1)
peer-group##2##1##(2008-12#1)(2009-7#1)
peer-related belongingness##2##2##(2009-7#2)
peer-reviewed studies##2##2##(2007-11#1)(2012-12#1)
peer-reviewed##12##1##(2007-11#1)(2008-4#1)(2008-7#1)(2010-12#3)(2010-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
peers and the##4##3##(2010-12#3)(2013-1#1)
peers and##8##2##(2010-1#1)(2010-10#1)(2010-12#3)(2013-1#3)
peers is##2##2##(1990-2#1)(2008-9#1)
peers on##2##2##(1993-1#1)(2013-8#1)
peers with##2##2##(1993-3#1)(2008-9#1)
peers##69##1##(1990-2#3)(1991-2#1)(1992-9#1)(1993-1#1)(1993-3#2)(1995-3#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#6)(2008-12#5)(2008-9#3)(2009-7#6)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
pefloxacin and##4##2##(1993-2#4)
pefloxacin##8##1##(1993-2#5)(2007-7#2)(2008-10#1)
peg##10##1##(1993-11#1)(2007-12#2)(2008-10#3)(2008-7#1)(2010-11#3)
pegfilgrastim and##4##2##(2008-7#4)
pegfilgrastim##9##1##(2008-7#9)
peginterferon plus ribavirin for##2##4##(2009-5#1)(2012-12#1)
pegs##5##1##(2007-12#2)(2008-10#2)(2008-7#1)
pegylated interferon and ribavirin##2##4##(2011-2#2)
pegylated interferon and##3##3##(2008-10#1)(2011-2#2)
pegylated interferon##5##2##(2008-10#1)(2009-3#1)(2010-3#1)(2011-2#2)
pegylated##10##1##(2008-10#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#3)(2013-1#1)
pekinensis##2##1##(2008-10#1)(2013-8#1)
pekinensis)##2##1##(1997-2#2)
pelagic larvae##2##2##(2008-8#1)(2013-1#1)
pelagic larval##3##2##(2007-5#1)(2008-8#1)(2008-9#1)
pelagic predator##2##2##(2008-5#2)
pelagic##15##1##(2007-5#1)(2008-5#4)(2008-8#4)(2008-9#3)(2010-3#1)(2013-1#2)
peled##4##1##(2008-12#4)
pellet culture was##2##3##(2008-11#1)(2011-2#1)
pellet culture##3##2##(2008-11#2)(2011-2#1)
pellet form##2##2##(2008-6#2)
pellet reward##2##2##(1993-12#2)
pellet size##3##2##(2008-7#3)
pellet##38##1##(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-3#1)(1995-11#1)(1997-4#1)(2008-10#9)(2008-11#5)(2008-6#5)(2008-7#5)(2011-2#1)(2013-1#3)
pelleted ration##3##2##(2011-1#3)
pelleted##7##1##(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#3)(2012-2#1)
pelleting##2##1##(2008-4#1)(2011-2#1)
pelletized##6##1##(2008-1#3)(2008-10#1)(2008-6#2)
pellets and##2##2##(2008-1#1)(2008-4#1)
pellets is##2##2##(2008-7#2)
pellets of##3##2##(2008-10#3)
pellets results in##2##3##(1993-9#1)(2008-7#1)
pellets with a##2##3##(2008-5#1)(2009-7#1)
pellets with##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
pellets##46##1##(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-8#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#10)(2009-7#1)
pellucida##7##1##(1996-9#1)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#2)
pelt##2##1##(1996-12#1)(1997-5#1)
pelts##2##1##(1996-12#2)
pelvi-ureteric junction obstruction in##3##4##(2008-10#3)
pelvi-ureteric junction##5##2##(2008-10#5)
pelvi-ureteric##6##1##(2008-10#6)
pelvic CS##2##2##(2008-6#2)
pelvic and##4##2##(1990-6#1)(1994-2#1)(1997-7#1)(2011-1#1)
pelvic angiography##2##2##(1994-1#2)
pelvic endometriosis##8##2##(1991-3#3)(1992-1#2)(1995-2#1)(2011-1#1)(2013-1#1)
pelvic examination##2##2##(1991-2#1)(1991-3#1)
pelvic floor muscle##2##3##(2010-12#2)
pelvic floor##13##2##(2008-10#1)(2010-12#2)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#3)
pelvic fracture##3##2##(1997-6#1)(2013-8#2)
pelvic girdle relaxation##6##3##(1990-6#5)(1991-2#1)
pelvic girdle##12##2##(1990-6#6)(1991-2#1)(2008-6#1)(2008-7#1)(2011-2#3)
pelvic inflammatory disease##5##3##(1992-4#1)(1994-3#1)(2007-7#3)
pelvic inflammatory##6##2##(1992-4#1)(1993-2#1)(1994-3#1)(2007-7#3)
pelvic irradiation##6##2##(1990-10#1)(1993-9#1)(2008-6#1)(2009-3#1)(2013-1#2)
pelvic joint syndrome##4##3##(1990-6#3)(1991-2#1)
pelvic joint##5##2##(1990-6#4)(1991-2#1)
pelvic lymph node##4##3##(2013-1#4)
pelvic lymph nodes##2##3##(2011-2#1)(2013-7#1)
pelvic lymph##6##2##(2011-2#1)(2013-1#4)(2013-7#1)
pelvic mass##5##2##(1997-3#1)(1997-8#1)(2008-12#1)(2009-5#1)(2013-1#1)
pelvic masses##2##2##(1992-9#2)
pelvic nerve afferents##2##3##(2008-4#2)
pelvic nerve##6##2##(1992-3#2)(2008-4#4)
pelvic obliquity##2##2##(2009-9#1)(2012-2#1)
pelvic organ prolapse##2##3##(2008-12#2)
pelvic organs##5##2##(1994-3#1)(1996-3#1)(1996-8#1)(2008-12#1)(2011-1#1)
pelvic osteotomy in##3##3##(2008-10#2)(2009-3#1)
pelvic osteotomy##4##2##(2007-8#1)(2008-10#2)(2009-3#1)
pelvic pain##18##2##(1990-6#1)(1991-2#3)(1992-1#3)(1992-2#1)(1994-12#1)(1994-3#3)(2008-10#1)(2008-8#4)(2013-7#1)
pelvic pathology##3##2##(1991-3#2)(1992-3#1)
pelvic schwannoma presenting##2##3##(2008-7#2)
pelvic surgery##4##2##(2010-3#1)(2011-2#2)(2012-2#1)
pelvic tumor##2##2##(2007-8#1)(2013-1#1)
pelvic##188##1##(1990-10#1)(1990-5#2)(1990-6#13)(1991-1#2)(1991-2#7)(1991-3#6)(1992-1#5)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#5)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#5)(2008-4#4)(2008-5#1)(2008-6#10)(2008-7#6)(2008-8#4)(2009-1#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-9#3)(2010-12#2)(2010-3#2)(2011-1#4)(2011-2#14)(2012-1#5)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#3)
pelvic-peritoneal tuberculosis##4##2##(2008-10#4)
pelvic-ureteric stone##2##2##(2008-8#2)
pelvicalyceal##2##1##(2008-1#1)(2012-12#1)
pelvis and femoral##2##3##(1991-11#1)(2012-12#1)
pelvis and##11##2##(1991-11#2)(2007-10#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
pelvis##67##1##(1991-11#2)(1991-12#1)(1991-2#1)(1992-12#2)(1993-9#1)(2007-10#2)(2007-11#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#8)(2008-6#3)(2008-7#1)(2008-8#4)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-3#4)(2011-2#14)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
pemphigus##6##1##(1991-12#1)(2007-7#3)(2007-8#1)(2011-2#1)
pen##11##1##(1995-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-11#5)(2010-2#1)(2012-2#1)
pen2 NahG pmr5##2##3##(2012-2#2)
penalization##2##1##(2008-6#1)(2010-5#1)
penalized log-likelihood##2##2##(2010-5#2)
penalized profile sampler##2##3##(2010-5#2)
penalized regression methods##2##3##(2009-8#2)
penalized regression##3##2##(2009-8#2)(2012-3#1)
penalized##12##1##(1997-8#1)(2008-11#1)(2008-6#1)(2009-8#2)(2010-2#1)(2010-5#4)(2012-3#2)
penalties for##5##2##(1990-3#1)(1996-1#1)(1997-5#1)(2008-11#1)(2013-1#1)
penalties##18##1##(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#4)(1996-1#1)(1997-5#1)(2007-12#1)(2008-11#2)(2009-8#1)(2012-3#1)(2013-1#1)
penalty associated with##2##3##(1993-2#1)(2007-12#1)
penalty for##2##2##(1997-5#1)(2008-2#1)
penalty in##5##2##(2007-11#2)(2008-3#2)(2009-9#1)
penalty##25##1##(1993-2#1)(1996-5#2)(1997-5#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2012-3#3)
pencil beam##5##2##(2008-3#1)(2010-9#2)(2012-12#2)
pencil##11##1##(1991-9#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-9#2)(2012-12#2)(2013-1#1)
pendant alkene group##2##3##(2009-10#2)
pendant drop##3##2##(2007-12#3)
pendant groups##3##2##(1997-7#2)(2008-10#1)
pendant le 2ème##2##3##(2013-1#2)
pendant le##3##2##(2013-1#3)
pendant##23##1##(1992-11#3)(1996-2#1)(1997-7#2)(2007-12#3)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#2)(2009-2#1)(2010-12#1)(2010-2#1)(2013-1#4)
pendants##2##1##(2008-10#2)
pendimethalin##16##1##(2008-10#4)(2008-11#5)(2011-1#7)
pending##11##1##(1990-6#1)(1992-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#2)(2012-12#1)
pendulous##3##1##(2008-10#2)(2008-5#1)
pendulum##5##1##(1995-6#1)(2008-12#1)(2008-2#2)(2008-3#1)
penetrance and##2##2##(2009-12#1)(2009-8#1)
penetrance of C282Y homozygous##2##4##(2008-5#2)
penetrance of the##2##3##(2008-4#1)(2012-3#1)
penetrance of##6##2##(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-3#1)
penetrance##16##1##(1990-9#1)(1997-5#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#6)(2009-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
penetrans##7##1##(2008-10#7)
penetrant inherited##2##2##(2008-12#2)
penetrant##4##1##(1995-12#1)(2008-12#2)(2010-4#1)
penetrate into the##8##3##(1992-4#1)(1994-3#2)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)
penetrate into##12##2##(1992-4#1)(1994-3#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#2)
penetrate the##14##2##(1992-12#1)(1994-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#3)(2012-2#1)(2013-1#1)
penetrate to##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
penetrate##42##1##(1992-12#1)(1992-4#1)(1994-3#2)(1994-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
penetrated by the fungus##2##4##(2008-10#2)
penetrated by the##3##3##(2008-10#3)
penetrated into the##2##3##(2008-10#2)
penetrated into##3##2##(1994-2#1)(2008-10#2)
penetrated the egg##2##3##(2008-10#2)
penetrated the host##2##3##(2008-10#2)
penetrated the##11##2##(1990-5#1)(1991-12#1)(2008-10#7)(2008-5#1)(2011-2#1)
penetrated##29##1##(1990-2#1)(1990-5#3)(1991-12#1)(1994-2#1)(2008-10#17)(2008-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
penetrates into##2##2##(1994-2#1)(2010-11#1)
penetrates the##7##2##(1990-12#1)(1992-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#2)
penetrates##14##1##(1990-12#1)(1990-5#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
penetrating cardiac injuries##4##3##(2008-1#4)
penetrating keratoplasty##3##2##(2010-10#2)(2011-2#1)
penetrating neck##2##2##(2010-12#1)(2010-7#1)
penetrating ocular trauma##3##3##(1991-11#1)(2011-1#2)
penetrating rate##2##2##(2011-3#2)
penetrating the skull base##2##4##(2011-2#2)
penetrating the##8##2##(1990-12#1)(1991-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
penetrating thoracic##2##2##(2007-8#1)(2008-1#1)
penetrating##57##1##(1990-12#1)(1991-11#1)(1991-9#1)(1992-6#2)(1996-8#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#5)
penetration after##2##2##(1997-8#1)(2008-9#1)
penetration and colonization##2##3##(2008-10#2)
penetration and infection##2##3##(2008-10#1)(2011-10#1)
penetration and percent##2##3##(2008-10#2)
penetration and the##2##3##(2008-10#1)(2012-3#1)
penetration and##26##2##(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#1)(2011-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
penetration as##2##2##(2007-8#1)(2008-10#1)
penetration by the##4##3##(2008-10#4)
penetration by##9##2##(1994-9#1)(2008-10#7)(2008-5#1)
penetration depth is##2##3##(2008-2#2)
penetration depth of the##2##4##(2008-3#1)(2008-5#1)
penetration depth of##5##3##(1992-8#1)(2008-3#2)(2008-5#1)(2011-1#1)
penetration depth##11##2##(1992-8#1)(2007-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2011-1#1)
penetration depths##3##2##(2008-3#2)(2012-12#1)
penetration enhancers##2##2##(2008-5#2)
penetration into deeper##2##3##(1993-11#1)(2008-5#1)
penetration into the##7##3##(1992-6#1)(1994-3#1)(1996-5#1)(1997-1#1)(2008-3#1)(2008-5#2)
penetration into##14##2##(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-5#1)(1997-1#1)(2008-3#1)(2008-5#6)(2013-8#1)
penetration of a##3##3##(1992-6#1)(2007-8#1)(2011-2#1)
penetration of host##2##3##(2007-12#1)(2008-10#1)
penetration of the cuticle##2##4##(2008-10#2)
penetration of the##13##3##(1992-1#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)
penetration of##45##2##(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-2#1)(2008-3#2)(2008-5#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2011-2#2)
penetration pore##7##2##(2008-10#7)
penetration process##2##2##(2008-10#2)
penetration properties##2##2##(2008-1#1)(2008-5#1)
penetration rate##2##2##(1991-12#1)(2008-5#1)
penetration significative##2##2##(2008-5#2)
penetration sites##3##2##(2008-10#3)
penetration through the##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
penetration through##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)
penetration via##2##2##(2008-10#1)(2008-5#1)
penetration was##6##2##(1990-5#1)(2007-12#1)(2008-10#4)
penetration##225##1##(1990-2#3)(1990-5#2)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#3)(1997-8#1)(2007-12#5)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#88)(2008-11#3)(2008-2#6)(2008-3#12)(2008-5#43)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2010-10#2)(2011-1#1)(2011-10#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
penetrations##2##1##(2007-12#1)(2008-10#1)
penguins##5##1##(2008-5#4)(2012-1#1)
penicillamine in##2##2##(2008-10#2)
penicillamine##12##1##(1991-8#1)(2006-10#1)(2008-10#10)
penicillatum produced##2##2##(2008-10#2)
penicillatum##11##1##(2008-10#11)
penicillin G and##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
penicillin G benzathine##2##3##(1997-5#2)
penicillin G was##2##3##(1991-8#1)(2013-8#1)
penicillin G##17##2##(1991-8#2)(1992-12#1)(1994-11#1)(1997-5#2)(2007-12#1)(2008-10#4)(2008-12#2)(2008-8#1)(2013-8#3)
penicillin N##2##2##(2011-1#2)
penicillin V##2##2##(1994-9#1)(2008-10#1)
penicillin allergy##2##2##(1995-3#1)(1996-3#1)
penicillin and##5##2##(1990-12#1)(1997-3#1)(2008-10#1)(2008-12#2)
penicillin by##2##2##(1992-12#1)(2011-2#1)
penicillin##65##1##(1990-11#2)(1990-12#2)(1990-8#1)(1991-10#1)(1991-8#2)(1992-12#3)(1992-9#1)(1994-11#1)(1994-9#1)(1995-3#3)(1996-12#1)(1996-3#3)(1997-3#1)(1997-5#2)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#7)(2008-7#3)(2008-8#2)(2011-1#5)(2011-2#6)(2012-12#1)(2013-8#3)
penicillin-allergic##2##1##(1996-3#1)(2006-10#1)
penicillinase##2##1##(2008-10#1)(2013-8#1)
penicillins was##2##2##(2008-10#2)
penicillins##10##1##(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-8#2)
penile cancer##2##2##(2009-2#1)(2013-8#1)
penile fracture##5##2##(2008-10#3)(2008-7#2)
penile length##4##2##(2008-10#1)(2011-1#3)
penile neurons##2##2##(1992-8#2)
penile reconstruction##4##2##(2011-2#4)
penile shaft##4##2##(1991-2#1)(2007-7#1)(2008-10#2)
penile size##3##2##(2009-5#1)(2011-1#2)
penile skin##2##2##(2009-5#1)(2013-8#1)
penile##42##1##(1991-2#3)(1992-8#3)(1994-1#1)(2007-7#1)(2008-10#10)(2008-6#1)(2008-7#3)(2009-2#1)(2009-5#2)(2011-1#8)(2011-2#5)(2012-3#1)(2013-8#3)
peninsula##3##1##(2007-5#1)(2008-10#1)(2008-5#1)
peninsular Malaysia##7##2##(2008-10#1)(2008-12#4)(2008-8#2)
peninsular##8##1##(2008-10#2)(2008-12#4)(2008-8#2)
penis and##3##2##(2007-7#1)(2007-9#1)(2008-10#1)
penis in##3##2##(2008-10#2)(2011-2#1)
penis is a rare##2##4##(1990-12#1)(1991-8#1)
penis is##5##2##(1990-12#1)(1991-8#1)(1992-8#1)(2008-10#1)(2009-5#1)
penis##44##1##(1990-12#2)(1991-2#1)(1991-8#2)(1992-8#4)(1994-1#1)(2007-10#1)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#7)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
penis]##2##1##(1991-8#1)(2008-10#1)
peniscopy##3##1##(1991-2#3)
pennsylvanicus)##2##1##(1994-5#1)(2008-9#1)
penoscrotal hypospadias##2##2##(2008-10#1)(2009-5#1)
penoscrotal transposition##3##2##(2008-10#3)
penoscrotal##7##1##(2008-10#4)(2009-5#1)(2013-1#2)
pens##9##1##(2009-11#2)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)
pension plans##7##2##(1993-3#6)(1994-1#1)
pension##24##1##(1991-11#3)(1992-3#1)(1993-3#7)(1993-6#1)(1994-1#1)(1995-11#1)(1995-5#4)(1997-6#5)(2010-12#1)
pensions##4##1##(1991-3#1)(1993-6#2)(1995-5#1)
pensylvanica##3##1##(2008-10#2)(2008-9#1)
penta- and##3##2##(1996-5#1)(2008-10#2)
pentaacids##2##1##(2008-10#2)
pentaazadentate metal complexes##2##3##(2008-3#2)
pentaazadentate##3##1##(2008-3#3)
pentachloronitrobenzene##2##1##(1997-6#1)(2008-10#1)
pentachlorophenol (PCP) in##2##3##(2008-10#2)
pentachlorophenol (PCP)##3##2##(2008-10#3)
pentachlorophenol and##2##2##(2008-10#2)
pentachlorophenol in##3##2##(2008-10#3)
pentachlorophenol##9##1##(2008-10#8)(2009-3#1)
pentachlorophenolate##3##1##(2008-10#3)
pentacoordinate##2##1##(2008-10#2)
pentadecapeptide BPC 157##2##3##(1997-7#2)
pentadecapeptide##7##1##(1995-2#3)(1997-7#4)
pentaerythritol tetranitrate (PETN)##3##3##(2008-10#2)(2008-3#1)
pentaerythritol tetranitrate##5##2##(2008-10#4)(2008-3#1)
pentaerythritol triacrylate mixture was used##2##5##(2008-9#2)
pentaerythritol triacrylate##14##2##(2008-9#14)
pentaerythritol##25##1##(2008-10#4)(2008-3#1)(2008-9#20)
pentaethylenehexamine##2##1##(2008-10#2)
pentafluorobenzylation##4##1##(2008-10#4)
pentagonal##3##1##(1996-2#1)(2007-12#1)(2008-3#1)
pentahydrate##3##1##(2008-10#3)
pentalenolactone (3)##2##2##(1994-5#2)
pentalenolactone##5##1##(1994-5#5)
pentamer##4##1##(1990-7#2)(1993-11#1)(2009-2#1)
pentamer(+) cell##3##2##(2013-1#3)
pentamer(+) cells##2##2##(2013-1#2)
pentamer(+)##5##1##(2013-1#5)
pentameric##4##1##(1993-9#1)(1995-6#1)(2011-1#1)(2013-1#1)
pentamethylcyclopentadienyl##2##1##(1996-2#2)
pentamidine aerosol##2##2##(1993-2#2)
pentamidine with##2##2##(1993-2#1)(1997-2#1)
pentamidine##16##1##(1990-9#1)(1992-3#1)(1993-2#9)(1996-12#2)(1997-2#1)(2008-10#2)
pentane##8##1##(2008-10#5)(2008-3#3)
pentane-2##3##1##(2007-11#3)
pentanoic acid##3##2##(1990-5#2)(2012-1#1)
pentanol##3##1##(2008-10#3)
pentapeptide yield was##2##3##(2008-7#2)
pentapeptide##10##1##(1990-7#1)(1992-4#1)(1992-5#1)(1995-6#1)(2008-5#2)(2008-7#3)(2012-2#1)
pentasaccharide hapten##2##2##(1992-12#2)
pentasaccharide##7##1##(1992-10#1)(1992-12#3)(1995-11#1)(1995-2#1)(2008-3#1)
pentathia-15-crown-5 and##2##2##(2008-10#2)
pentaurelia##3##1##(2008-12#3)
pentavalent arsenicals##4##2##(2009-6#4)
pentavalent##13##1##(1990-7#1)(2007-7#1)(2008-10#7)(2009-6#4)
pentobarbital##7##1##(1990-7#1)(1995-12#2)(2008-4#3)(2008-6#1)
pentobarbitone##3##1##(1992-10#1)(1995-12#1)(2008-12#1)
pentose phosphate pathway##8##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-5#1)(2010-12#1)
pentose##13##1##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#5)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
pentoxide##3##1##(1996-2#2)(2008-11#1)
pentoxifylline##3##1##(2007-7#1)(2008-10#2)
pentoxyverine##5##1##(2008-10#5)
pentoxyverine-tetraphenylborate##2##1##(2008-10#2)
pentyl rhamnoside##2##2##(2008-5#2)
pentyl##4##1##(1994-8#1)(2008-5#3)
pentylamine##3##1##(1990-5#2)(2008-10#1)
pentylenetetrazole (80 mg/kg)##2##3##(1995-12#1)(2010-3#1)
pentylenetetrazole##5##1##(1992-3#1)(1994-3#1)(1995-12#1)(2010-3#2)
pentylenetetrazole-induced##3##1##(1995-12#2)(2010-2#1)
penultimate leaf##3##2##(2008-10#3)
penultimate##8##1##(1992-6#2)(2008-10#4)(2009-11#2)
penumbra##5##1##(1997-2#2)(2008-10#1)(2008-2#1)(2008-3#1)
peony##3##1##(2011-3#3)
people about##3##2##(1991-3#1)(1997-6#2)
people age##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
people aged 60 years and over##2##6##(2011-1#2)
people aged##12##2##(1995-5#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
people and##25##2##(1990-11#1)(1992-3#1)(1992-5#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
people are still not##2##4##(1996-5#1)(2010-12#1)
people are##23##2##(1993-3#1)(1996-5#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)
people as##9##2##(1992-9#1)(2007-8#1)(2008-7#1)(2009-9#1)(2010-10#3)(2010-8#1)(2012-12#1)
people at highest risk##2##4##(1996-5#1)(2007-10#1)
people at##5##2##(1996-5#1)(2007-10#1)(2008-8#1)(2011-1#2)
people become##2##2##(1993-3#1)(2012-12#1)
people can##2##2##(1994-12#1)(2012-12#1)
people choose##2##2##(2012-3#1)(2013-1#1)
people die##3##2##(1990-6#1)(2009-10#1)(2010-11#1)
people died of##2##3##(1993-6#1)(1997-6#1)
people died##3##2##(1993-6#1)(1996-7#1)(1997-6#1)
people do not##3##3##(1997-6#1)(2008-5#1)(2009-12#1)
people engage in##2##3##(2009-5#1)(2012-1#1)
people following##2##2##(2008-10#1)(2012-3#1)
people for##5##2##(2008-10#2)(2008-5#1)(2010-8#1)(2011-1#1)
people from##10##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#2)(2013-8#1)
people go##2##2##(1993-2#1)(2008-9#1)
people had##2##2##(2011-2#1)(2013-8#1)
people have become##2##3##(2010-9#1)(2012-2#1)
people have##12##2##(1993-3#1)(1995-1#1)(1995-3#1)(1997-6#2)(2008-2#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-2#2)
people in Burkina Faso##2##4##(1990-6#1)(2009-10#1)
people in New Zealand##4##4##(1991-2#1)(1996-12#2)(2008-1#1)
people in Uganda##2##3##(2008-5#2)
people in a##2##3##(1995-1#1)(2007-12#1)
people in an##2##3##(2008-7#1)(2008-8#1)
people in poverty##2##3##(1995-1#1)(2008-11#1)
people in the United States##3##5##(2011-2#1)(2012-3#1)(2013-8#1)
people in the##18##3##(1990-11#1)(1993-3#1)(1995-6#2)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#3)
people in these areas##2##4##(2008-8#1)(2011-1#1)
people in this##2##3##(1995-12#1)(2008-11#1)
people in##67##2##(1990-11#1)(1990-6#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-3#1)(1993-6#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#2)(2007-12#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#4)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
people infected##3##2##(2008-10#1)(2013-1#2)
people is##7##2##(1997-6#1)(2008-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
people living in the##5##4##(1996-6#1)(2008-3#2)(2011-1#1)(2012-12#1)
people living in##8##3##(1996-6#1)(2008-10#1)(2008-3#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
people living with HIV and##3##5##(2010-3#1)(2010-8#1)(2012-12#1)
people living with HIV##5##4##(2009-10#2)(2010-3#1)(2010-8#1)(2012-12#1)
people living with HIV/AIDS##10##4##(2008-12#2)(2011-1#7)(2013-1#1)
people living with##19##3##(2008-12#2)(2008-7#1)(2009-10#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#7)(2011-2#1)(2012-12#1)(2013-1#2)
people living##28##2##(1992-4#1)(1996-6#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#1)(2009-10#2)(2009-5#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-1#8)(2011-2#1)(2012-12#2)(2013-1#2)
people make##3##2##(1997-3#1)(2009-5#1)(2009-6#1)
people need##2##2##(1996-3#1)(2010-10#1)
people not##2##2##(1993-1#1)(1994-2#1)
people now##2##2##(2008-2#1)(2010-8#1)
people of the##2##3##(1993-12#1)(1997-4#1)
people of##12##2##(1993-12#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
people older than 65 years##3##5##(2008-8#1)(2010-4#1)(2011-2#1)
people older than##4##3##(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)
people over the##2##3##(2008-10#1)(2010-4#1)
people over##9##2##(1993-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-4#3)(2012-1#1)
people perceived##2##2##(2008-12#1)(2012-3#1)
people refuse to##2##3##(2009-6#2)
people suffering from##7##3##(1992-3#2)(1992-5#1)(1993-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
people that##3##2##(1996-1#1)(2008-11#1)(2011-2#1)
people the##2##2##(2008-7#1)(2010-8#1)
people to remain living at home##2##6##(2013-1#2)
people to remain##4##3##(2010-10#1)(2013-1#3)
people to seek##2##3##(2010-4#1)(2012-12#1)
people to##29##2##(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-10#3)(2010-4#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
people towards old age homes##2##5##(2008-7#2)
people use##3##2##(2008-1#1)(2013-7#1)(2013-8#1)
people using##2##2##(1994-3#1)(2008-9#1)
people was##2##2##(2013-1#2)
people were##11##2##(1992-9#1)(1995-8#1)(1996-6#2)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
people who are##8##3##(1993-3#2)(1995-1#1)(1996-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
people who had##2##3##(1993-2#1)(2009-6#1)
people who have been##2##4##(1995-1#1)(1995-12#1)
people who have##6##3##(1992-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(2008-7#1)(2012-2#1)
people who may be##2##4##(2008-11#1)(2008-7#1)
people who present##2##3##(2012-12#1)(2013-8#1)
people who use##2##3##(1994-2#1)(1996-3#1)
people who want to##2##4##(1993-12#1)(2012-12#1)
people who were##2##3##(2007-8#1)(2013-8#1)
people who##47##2##(1991-8#1)(1992-3#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#3)(2009-6#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#5)
people whose##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
people will##4##2##(1993-5#1)(1994-8#1)(1996-1#1)(1996-5#1)
people with AIDS##7##3##(1995-12#3)(1995-6#2)(1996-2#1)(1996-3#1)
people with HIV##5##3##(1992-1#1)(1995-12#2)(1995-6#2)
people with a learning disability##2##5##(2008-11#2)
people with a##8##3##(2008-11#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
people with bipolar disorder##2##4##(2009-11#2)
people with chronic illness##3##4##(1997-1#3)
people with chronic##5##3##(1997-1#3)(1997-3#1)(2008-7#1)
people with dementia##9##3##(1991-1#1)(2008-6#1)(2011-1#2)(2013-8#5)
people with diabetes##6##3##(2008-6#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-3#1)
people with disabilities in##2##4##(1995-6#1)(1996-1#1)
people with disabilities##14##3##(1995-12#1)(1995-6#2)(1996-1#6)(1997-1#1)(2009-6#2)(2010-12#1)(2013-1#1)
people with disability##3##3##(1996-12#1)(1997-1#2)
people with greater depressive symptoms##3##5##(2010-4#3)
people with medical##2##3##(1995-6#1)(2011-1#1)
people with mental health problems in the##2##7##(1993-1#1)(2011-1#1)
people with mental health problems##6##5##(1993-1#3)(2008-11#2)(2011-1#1)
people with mental illness##5##4##(2011-1#4)(2011-2#1)
people with mental##16##3##(1990-9#1)(1993-1#3)(1993-3#1)(1997-8#1)(2008-11#2)(2011-1#5)(2011-2#1)(2012-12#1)(2012-3#1)
people with physical disabilities##2##4##(1995-12#2)
people with schizophrenia and##2##4##(2009-7#1)(2013-1#1)
people with schizophrenia##6##3##(2009-6#1)(2009-7#2)(2013-1#3)
people with spinal cord injury (SCI)##2##6##(2008-7#1)(2013-1#1)
people with spinal##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
people with type##2##3##(2008-7#2)
people with##155##2##(1990-9#1)(1991-1#2)(1992-1#1)(1992-12#1)(1993-1#4)(1993-3#2)(1994-2#1)(1995-12#9)(1995-6#7)(1996-1#6)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#8)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-2#1)(2008-11#7)(2008-12#3)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-6#4)(2009-7#2)(2010-10#4)(2010-12#3)(2010-4#4)(2011-1#12)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#9)(2013-1#11)(2013-8#6)
people without##3##2##(2008-2#1)(2008-5#1)(2008-8#1)
people worldwide and is##2##4##(2008-1#2)
people worldwide##7##2##(2008-1#2)(2008-10#3)(2008-5#1)(2009-5#1)
people##846##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-6#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#2)(1993-1#6)(1993-12#3)(1993-2#5)(1993-3#11)(1993-5#2)(1993-6#3)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#8)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#9)(1995-11#1)(1995-12#13)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#10)(1995-8#2)(1996-1#10)(1996-11#5)(1996-12#7)(1996-2#4)(1996-3#5)(1996-5#6)(1996-6#3)(1996-7#1)(1997-1#10)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#7)(1997-8#3)(2006-12#1)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#3)(2007-7#3)(2007-8#3)(2008-1#18)(2008-10#35)(2008-11#32)(2008-12#15)(2008-2#10)(2008-3#14)(2008-4#8)(2008-5#15)(2008-6#7)(2008-7#41)(2008-8#10)(2008-9#8)(2009-10#8)(2009-11#5)(2009-12#4)(2009-3#3)(2009-5#9)(2009-6#12)(2009-7#6)(2009-8#2)(2009-9#1)(2010-10#40)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#6)(2010-4#13)(2010-5#4)(2010-7#3)(2010-8#12)(2010-9#2)(2011-1#43)(2011-2#42)(2012-1#4)(2012-12#37)(2012-2#14)(2012-3#32)(2013-1#46)(2013-7#2)(2013-8#29)
people's health##4##2##(1990-11#1)(2008-8#1)(2010-4#1)(2012-3#1)
people's willingness to##2##3##(1994-3#1)(2013-1#1)
people's##41##1##(1990-11#1)(1992-9#1)(1994-3#1)(1994-7#1)(1996-1#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-10#6)(2010-12#1)(2010-2#6)(2010-4#2)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
people)##3##1##(2011-1#1)(2012-12#1)(2013-8#1)
people]##4##1##(1993-9#1)(1996-6#1)(2008-9#1)(2011-2#1)
peoples in##4##2##(2008-1#1)(2008-12#1)(2008-7#2)
peoples of##3##2##(2008-1#1)(2008-8#1)(2010-4#1)
peoples##17##1##(1997-4#1)(2008-1#3)(2008-12#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-4#1)(2011-1#2)(2012-3#2)(2013-1#2)
peoples'##2##1##(1991-3#1)(2008-11#1)
pepF##4##1##(1994-12#4)
pepo##3##1##(2008-10#2)(2011-2#1)
pepo)##4##1##(2008-10#4)
pepper (Capsicum annuum)##2##3##(2008-10#2)
pepper (Capsicum##3##2##(2008-10#3)
pepper and##4##2##(2008-10#4)
pepper but##2##2##(2008-10#2)
pepper fruit##2##2##(2008-10#2)
pepper genotype##2##2##(2008-10#2)
pepper genotypes carrying##2##3##(2008-10#2)
pepper genotypes##5##2##(2008-10#5)
pepper huasteco virus##2##3##(2008-10#2)
pepper huasteco##3##2##(2008-10#3)
pepper in the##2##3##(2008-10#2)
pepper leaves##2##2##(2008-10#2)
pepper plants##13##2##(2008-10#13)
pepper tissues##3##2##(2008-10#3)
pepper to##3##2##(2008-10#3)
pepper was##2##2##(2008-10#2)
pepper##95##1##(1997-6#5)(2008-10#88)(2008-12#1)(2012-3#1)
pepper)##2##1##(2008-10#2)
peppermint##4##1##(2008-10#3)(2012-2#1)
pepsin and##2##2##(2008-1#1)(2008-10#1)
pepsin##21##1##(1990-2#3)(1990-5#1)(1992-12#1)(1992-8#1)(1995-3#1)(1996-12#1)(1996-5#5)(1997-1#4)(2008-1#1)(2008-10#3)
pepsin-like aspartic##2##2##(1990-5#1)(2008-4#1)
pepsinogen secretion from guinea pig chief cells##3##7##(1995-8#3)
pepsinogen secretion from##5##3##(1995-8#5)
pepsinogen secretion##11##2##(1995-8#10)(1997-1#1)
pepsinogen##16##1##(1993-11#1)(1995-3#4)(1995-8#10)(1997-1#1)
pepstatin A##3##2##(1991-9#1)(1995-6#1)(1995-8#1)
pepstatin##4##1##(1991-9#1)(1995-6#2)(1995-8#1)
pepstatin-agarose##4##1##(1990-8#4)
peptic activity##2##2##(1997-1#2)
peptic ulcer and##2##3##(2008-1#1)(2011-1#1)
peptic ulcer disease patients##5##4##(2007-7#1)(2008-5#4)
peptic ulcer disease##8##3##(1992-9#1)(1997-1#2)(2007-7#1)(2008-5#4)
peptic ulcer patients##2##3##(1992-9#1)(2008-5#1)
peptic ulcer##20##2##(1992-9#2)(1995-10#2)(1997-1#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#6)(2008-7#1)(2011-1#2)(2012-12#1)(2013-1#1)
peptic ulcers##4##2##(1990-3#1)(1990-5#1)(2008-12#1)(2013-1#1)
peptic##28##1##(1990-3#1)(1990-5#2)(1992-9#2)(1995-10#2)(1997-1#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#6)(2008-7#1)(2011-1#2)(2012-12#1)(2013-1#2)
peptidase activity which##2##3##(1990-11#2)
peptidase activity##5##2##(1990-11#5)
peptidase and##2##2##(1995-6#1)(2008-11#1)
peptidase inhibitors##2##2##(1991-3#1)(1997-4#1)
peptidase##35##1##(1990-11#5)(1991-10#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#2)(1995-6#1)(1997-4#1)(1997-7#4)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#4)(2008-9#1)(2012-2#2)(2012-3#1)
peptidases are##2##2##(1996-2#1)(2008-5#1)
peptidases in##5##2##(1992-11#1)(1996-2#1)(2008-4#2)(2010-3#1)
peptidases that##2##2##(1991-3#1)(1996-2#1)
peptidases##16##1##(1991-3#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-8#1)(1996-2#3)(2008-4#4)(2008-5#2)(2008-6#1)(2010-3#1)
peptide (PTHrP)##2##2##(1993-3#1)(2013-7#1)
peptide 1##4##2##(1992-8#1)(1994-11#1)(1995-8#1)(2012-3#1)
peptide 14##3##2##(1993-8#3)
peptide 2##2##2##(1992-8#1)(1994-12#1)
peptide 3##2##2##(1992-8#1)(1995-2#1)
peptide 77-3##2##2##(2008-10#2)
peptide activity##2##2##(1992-4#1)(2008-10#1)
peptide agonist##2##2##(1993-6#1)(1994-6#1)
peptide also##4##2##(1992-5#1)(1992-9#1)(2008-12#1)(2008-3#1)
peptide analogs of the##2##4##(1992-9#1)(2008-10#1)
peptide analogs##3##2##(1992-9#2)(2008-10#1)
peptide analogue##3##2##(1991-9#1)(1992-11#1)(1992-8#1)
peptide and a##4##3##(1992-8#1)(1995-2#1)(2008-11#2)
peptide and azatyrosine##2##3##(1991-12#2)
peptide and its##2##3##(1993-11#1)(1996-12#1)
peptide and protein##2##3##(1992-6#1)(2010-7#1)
peptide and the##7##3##(1990-12#1)(1991-2#1)(1995-5#2)(2008-10#1)(2009-6#1)(2010-6#1)
peptide and##43##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)
peptide antibiotics##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
peptide antibodies raised in two rabbits##2##6##(1991-9#2)
peptide antigen##3##2##(1995-5#1)(2008-11#1)(2008-4#1)
peptide antigenicity##3##2##(1997-6#3)
peptide antigens##3##2##(1990-5#1)(2008-4#2)
peptide appears##2##2##(1995-2#1)(2012-12#1)
peptide as##2##2##(1992-6#1)(2008-10#1)
peptide at the##5##3##(1990-12#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-12#1)
peptide backbone##6##2##(1990-8#1)(1992-6#1)(1993-11#1)(2008-4#3)
peptide binding to##3##3##(1995-5#1)(2007-6#2)
peptide binding##6##2##(1993-11#1)(1995-5#1)(2007-6#3)(2008-7#1)
peptide bond at##2##3##(1995-6#1)(2008-9#1)
peptide bond##17##2##(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-6#2)(1992-8#1)(1993-11#2)(1995-6#1)(2008-10#3)(2008-9#2)
peptide bonds##5##2##(1994-5#1)(2007-11#1)(2008-11#1)(2008-4#2)
peptide by##6##2##(1990-11#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-5#1)(1995-5#1)
peptide can##2##2##(2008-4#1)(2008-8#1)
peptide causes##2##2##(1992-12#1)(1994-9#1)
peptide chain##6##2##(1990-5#2)(1990-8#1)(1993-11#1)(1994-9#1)(1996-12#1)
peptide chains##2##2##(1990-7#1)(2008-4#1)
peptide combinatorial libraries##3##3##(1997-3#2)(2008-4#1)
peptide composed of##3##3##(1990-5#1)(1995-6#1)(2008-10#1)
peptide compounds##2##2##(2008-10#1)(2008-3#1)
peptide concentrations##3##2##(1992-4#1)(2008-10#1)(2009-5#1)
peptide conformation##4##2##(1991-11#1)(1992-6#1)(1995-3#2)
peptide containing##3##2##(1991-9#1)(1995-2#2)
peptide corresponding to residues##3##4##(1991-12#1)(1994-5#1)(1995-2#1)
peptide corresponding to the##4##4##(1990-11#1)(1991-5#1)(1995-2#2)
peptide corresponding to##10##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-2#3)(2010-11#1)
peptide could be##2##3##(1995-5#1)(1996-5#1)
peptide could##3##2##(1991-2#1)(1995-5#1)(1996-5#1)
peptide deltorphin##2##2##(1995-3#2)
peptide derived from the##2##4##(1993-3#1)(1995-2#1)
peptide derived from##3##3##(1993-3#1)(1995-2#1)(2013-1#1)
peptide during##2##2##(1993-12#1)(1997-4#1)
peptide encoded by##4##3##(1990-12#1)(1992-8#1)(1993-8#1)(2008-8#1)
peptide encoding##2##2##(1995-6#1)(2008-4#1)
peptide expression##2##2##(1995-12#1)(2011-2#1)
peptide folding##2##2##(2008-8#1)(2010-5#1)
peptide for##3##2##(1991-12#1)(1994-5#1)(1995-6#1)
peptide found##2##2##(1996-12#1)(2008-6#1)
peptide fragment##10##2##(1992-6#2)(1993-5#1)(1993-8#1)(1994-11#2)(1995-2#1)(1997-8#1)(2008-10#1)(2011-1#1)
peptide fragments of##6##3##(1990-11#1)(1991-2#1)(1993-6#1)(1994-11#2)(1996-5#1)
peptide fragments were##2##3##(1996-5#1)(2008-8#1)
peptide fragments##23##2##(1990-11#1)(1990-12#1)(1991-2#2)(1992-12#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-5#2)(1997-1#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#2)
peptide from the##4##3##(1991-12#2)(1995-2#1)(2008-10#1)
peptide from##15##2##(1990-11#1)(1990-12#2)(1991-12#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-4#1)
peptide growth factors##2##3##(1991-12#1)(1994-8#1)
peptide had##4##2##(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)
peptide has been##3##3##(1990-8#1)(1994-3#1)(2008-1#1)
peptide has##4##2##(1990-8#1)(1994-3#1)(1995-5#1)(2008-1#1)
peptide hormone##8##2##(1992-6#2)(1994-11#1)(1995-12#2)(2008-8#1)(2011-1#1)(2012-3#1)
peptide hormones##7##2##(1993-5#1)(2006-12#1)(2008-4#1)(2010-4#1)(2011-1#2)(2012-12#1)
peptide in rat##2##3##(1991-5#1)(1993-3#1)
peptide in the brain##3##4##(1992-6#2)(2008-6#1)
peptide in the central##2##4##(1992-6#2)
peptide in the regulation of##3##5##(1992-6#3)
peptide in the##16##3##(1992-5#1)(1992-6#10)(1993-3#1)(1994-2#1)(2008-10#2)(2008-6#1)
peptide in##42##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-5#2)(1992-6#14)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-8#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
peptide incorporated##2##2##(1990-5#1)(2008-10#1)
peptide increased##2##2##(2008-5#2)
peptide inhibited the##2##3##(1995-6#1)(1996-12#1)
peptide inhibited##5##2##(1991-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#1)
peptide inhibitor##3##2##(2008-11#1)(2009-6#2)
peptide inhibitors of##2##3##(1990-7#1)(1994-6#1)
peptide inhibitors##3##2##(1990-2#1)(1990-7#1)(1994-6#1)
peptide interactions##2##2##(2008-1#1)(2008-9#1)
peptide is a##3##3##(1992-6#1)(1993-3#1)(2009-6#1)
peptide is able to##2##4##(1994-5#1)(2008-10#1)
peptide is not##2##3##(1990-11#1)(1994-9#1)
peptide is released from##2##4##(1992-6#1)(2008-3#1)
peptide is##28##2##(1990-11#3)(1990-7#1)(1991-5#1)(1992-6#5)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#2)(2009-6#1)
peptide isolated from the##3##4##(1992-9#1)(1993-6#1)(2009-5#1)
peptide isolated from##4##3##(1991-2#1)(1992-9#1)(1993-6#1)(2009-5#1)
peptide isolated##5##2##(1991-2#1)(1992-9#2)(1993-6#1)(2009-5#1)
peptide levels in the##2##4##(1995-5#1)(2008-3#1)
peptide levels##5##2##(1995-5#2)(2008-3#1)(2011-2#1)(2012-2#1)
peptide libraries##3##2##(1994-12#2)(2008-1#1)
peptide library##4##2##(2008-10#2)(2008-8#2)
peptide ligands##5##2##(1994-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)
peptide map of##3##3##(1995-2#2)(1997-6#1)
peptide map##5##2##(1990-11#1)(1990-8#1)(1995-2#2)(1997-6#1)
peptide mapping and##2##3##(1991-5#1)(1994-11#1)
peptide mapping of##2##3##(1990-7#1)(1996-5#1)
peptide mapping##9##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-9#1)(1994-11#1)(1996-5#2)(2008-10#1)
peptide maps##3##2##(1990-8#1)(1996-5#1)(2008-10#1)
peptide mass##3##2##(2008-4#1)(2008-7#2)
peptide may##2##2##(1992-12#1)(2009-5#1)
peptide mixtures##5##2##(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-7#1)
peptide modules##2##2##(1997-6#2)
peptide motif##2##2##(1990-7#2)
peptide motifs##2##2##(2012-2#1)(2013-1#1)
peptide nanotubes##3##2##(2008-10#1)(2008-7#2)
peptide nucleic acid (PNA)##2##4##(2008-1#1)(2008-4#1)
peptide nucleic##4##2##(2008-1#1)(2008-4#3)
peptide of 22##2##3##(1990-7#1)(1993-2#1)
peptide of interest##2##3##(2008-4#1)(2008-9#1)
peptide of the##3##3##(1995-2#1)(2008-10#1)(2010-12#1)
peptide of##29##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#3)(1996-10#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#3)(2008-9#3)(2010-12#1)
peptide on##3##2##(1992-6#1)(1994-12#1)(2008-5#1)
peptide or##5##2##(1995-5#1)(1997-3#1)(2008-7#1)(2008-8#1)(2010-5#1)
peptide pGlu-Glu-ProNH2##2##2##(1991-12#2)
peptide polymorphism was##2##3##(1997-8#2)
peptide polymorphism##3##2##(1997-8#3)
peptide previously isolated from##2##4##(1994-5#1)(2011-2#1)
peptide reacted with##2##3##(1993-11#1)(2008-10#1)
peptide receptor##4##2##(1990-12#1)(2008-11#1)(2010-6#1)(2013-1#1)
peptide receptors##2##2##(1990-12#1)(1994-3#1)
peptide release##3##2##(1992-6#1)(1995-5#1)(2008-7#1)
peptide resulted in##2##3##(1992-5#1)(2008-10#1)
peptide sequence of the##2##4##(1995-2#1)(2008-10#1)
peptide sequence of##3##3##(1995-2#1)(2008-10#2)
peptide sequence was##2##3##(1992-9#1)(2012-12#1)
peptide sequence##27##2##(1992-11#3)(1992-8#1)(1992-9#3)(1995-2#3)(1995-6#1)(1996-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#1)
peptide sequences in##2##3##(1992-6#1)(2008-11#1)
peptide sequences##16##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)
peptide sequencing##3##2##(2008-4#1)(2009-11#2)
peptide sharing##2##2##(1994-8#1)(2012-2#1)
peptide stretch##2##2##(1990-7#2)
peptide structure##2##2##(1995-2#1)(2008-1#1)
peptide substrate##6##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1993-11#1)(1994-8#1)
peptide substrates by##2##3##(1990-8#1)(1994-5#1)
peptide substrates##10##2##(1990-7#1)(1990-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-5#2)(1995-5#1)(1995-6#1)
peptide synthesis##12##2##(1992-11#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#6)
peptide system##2##2##(2008-10#1)(2009-6#1)
peptide that binds##2##3##(2008-3#1)(2008-7#1)
peptide that##17##2##(1990-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-5#1)(1995-6#1)(1996-12#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-7#1)
peptide to##12##2##(1991-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-10#1)(2012-3#1)
peptide toxin##2##2##(1993-9#1)(2008-5#1)
peptide transporter##3##2##(1994-8#3)
peptide vaccines##3##2##(1991-5#1)(1995-5#2)
peptide was able to##2##4##(2008-10#2)
peptide was cloned##2##3##(2008-10#2)
peptide was confirmed by##2##4##(1990-8#1)(1994-8#1)
peptide was determined by##2##4##(1997-8#1)(2008-8#1)
peptide was identified##2##3##(1990-12#1)(2008-8#1)
peptide was isolated##2##3##(1990-12#1)(1991-12#1)
peptide was##32##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#3)(1991-5#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#2)(1997-3#2)(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#3)(2010-6#1)
peptide were##8##2##(1991-12#1)(1991-9#1)(1992-9#1)(1994-5#1)(1995-5#2)(1996-5#1)(2008-10#1)
peptide which##6##2##(1990-2#1)(1992-5#1)(1993-3#2)(1995-2#1)(2008-5#1)
peptide with a##4##3##(1990-8#1)(1991-12#1)(2008-10#1)(2010-1#1)
peptide with##14##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-4#1)(1993-6#1)(1994-6#1)(2008-10#3)(2008-8#2)(2010-1#1)(2010-6#1)
peptide##1098##1##(1990-11#12)(1990-12#22)(1990-2#12)(1990-3#1)(1990-5#15)(1990-7#23)(1990-8#11)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#22)(1991-2#11)(1991-3#1)(1991-5#12)(1991-6#2)(1991-8#3)(1991-9#14)(1992-11#9)(1992-12#11)(1992-3#11)(1992-4#6)(1992-5#12)(1992-6#50)(1992-7#1)(1992-8#19)(1992-9#20)(1993-1#2)(1993-11#25)(1993-12#3)(1993-2#1)(1993-3#15)(1993-5#7)(1993-6#13)(1993-8#15)(1993-9#3)(1994-11#23)(1994-12#20)(1994-2#9)(1994-3#7)(1994-5#23)(1994-6#6)(1994-8#20)(1994-9#13)(1995-11#10)(1995-12#9)(1995-2#32)(1995-3#9)(1995-5#28)(1995-6#18)(1995-8#2)(1996-10#3)(1996-12#12)(1996-2#4)(1996-5#17)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#9)(1997-4#6)(1997-6#9)(1997-7#1)(1997-8#8)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#3)(2008-1#9)(2008-10#64)(2008-11#22)(2008-12#3)(2008-2#4)(2008-3#12)(2008-4#73)(2008-5#21)(2008-6#9)(2008-7#27)(2008-8#25)(2008-9#13)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#8)(2009-6#11)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#6)(2010-6#6)(2010-7#2)(2011-1#6)(2011-2#12)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#8)(2013-7#4)(2013-8#2)
peptide's##2##1##(1993-3#1)(1995-5#1)
peptide)##10##1##(1991-9#2)(1994-11#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#1)(2008-1#1)(2013-8#1)
peptide-(142-155) inhibited APC##2##3##(1993-11#2)
peptide-(142-155) inhibited##3##2##(1993-11#3)
peptide-(142-155)##4##1##(1993-11#4)
peptide-based##2##1##(2008-10#1)(2008-5#1)
peptide-bond##2##1##(1992-8#1)(1993-6#1)
peptide-induced mast cell activation##3##4##(1995-11#3)
peptide-induced##5##1##(1994-5#1)(1995-11#4)
peptide-like##2##1##(1990-5#1)(1994-8#1)
peptide-lipid membranes##3##2##(2008-11#3)
peptide-modified gold electrodes##2##3##(1990-5#2)
peptide-protein##4##1##(1990-5#1)(1992-9#2)(1997-6#1)
peptide-proteosome complexes##2##2##(1990-12#2)
peptide-proteosome##3##1##(1990-12#3)
peptide-specific##2##1##(2011-2#1)(2012-12#1)
peptide-stimulated [35S]GTP gamma S binding##4##5##(1996-2#4)
peptide-stimulated acid secretion##2##3##(1997-1#2)
peptide-stimulated##7##1##(1996-2#5)(1997-1#2)
peptidergic##4##1##(1994-8#1)(1994-9#1)(2008-7#1)(2013-8#1)
peptides (CPPs)##2##2##(2010-10#1)(2011-3#1)
peptides after synthesis##2##3##(2008-4#2)
peptides after##3##2##(1994-5#1)(2008-4#2)
peptides also##2##2##(1992-9#1)(2008-10#1)
peptides and amino acids##3##4##(2008-10#2)(2011-2#1)
peptides and proteins##7##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-7#1)
peptides and small##2##3##(1997-6#1)(2008-2#1)
peptides and##37##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#3)(1991-5#1)(1993-5#1)(1994-8#2)(1995-2#2)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#7)(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)
peptides are##17##2##(1990-5#1)(1991-2#1)(1992-6#1)(1993-8#1)(1994-8#1)(1996-5#1)(2008-1#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-9#1)(2011-2#2)
peptides as well as##2##4##(1995-11#1)(2008-4#1)
peptides as##10##2##(1990-5#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-6#1)(2007-6#1)(2008-4#2)(2008-5#1)(2011-3#1)
peptides at##2##2##(1995-2#1)(2008-10#1)
peptides based on##5##3##(1994-6#1)(2006-12#1)(2008-2#1)(2008-4#2)
peptides bind##2##2##(1990-5#1)(1995-11#1)
peptides bound##2##2##(1995-11#1)(1997-8#1)
peptides by capillary electrophoresis##3##4##(1994-9#1)(1996-5#2)
peptides by capillary##4##3##(1994-9#1)(1996-5#2)(1997-2#1)
peptides by##10##2##(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-5#2)(1997-2#2)(2008-4#2)
peptides can be##3##3##(2008-10#2)(2008-4#1)
peptides can##6##2##(1994-5#1)(2008-10#3)(2008-4#1)(2012-3#1)
peptides coded##2##2##(2008-1#2)
peptides containing the##3##3##(1991-2#2)(2009-6#1)
peptides containing##11##2##(1991-2#4)(1992-11#1)(1995-11#1)(1995-6#2)(2008-11#1)(2009-6#1)(2012-12#1)
peptides corresponding to the##5##4##(1991-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)
peptides corresponding to##8##3##(1991-9#1)(1992-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(2010-11#1)
peptides could##3##2##(1991-3#1)(1996-12#1)(2012-3#1)
peptides covering the##2##3##(2008-11#2)
peptides demonstrated##2##2##(1992-11#1)(1992-8#1)
peptides derived from the##6##4##(1990-5#1)(1992-6#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-1#1)
peptides derived from##10##3##(1990-5#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-1#1)(2010-2#1)
peptides did not##2##3##(1994-11#1)(2006-12#1)
peptides displayed on##2##3##(1995-5#1)(2008-8#1)
peptides do not##2##3##(1994-5#1)(2008-3#1)
peptides either##2##2##(1990-7#1)(2008-4#1)
peptides for##8##2##(1993-5#1)(2008-1#1)(2008-2#1)(2008-4#3)(2010-6#1)(2013-8#1)
peptides from the##10##3##(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-9#1)
peptides from##22##2##(1990-5#1)(1990-7#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#4)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)
peptides had##2##2##(1994-3#1)(1995-12#1)
peptides have been##5##3##(1990-11#1)(1993-5#1)(2008-5#1)(2009-5#1)(2011-2#1)
peptides have##6##2##(1990-11#1)(1993-5#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
peptides having##2##2##(1990-2#1)(2008-7#1)
peptides in a##2##3##(1994-11#1)(2008-9#1)
peptides in bone##2##3##(1990-11#2)
peptides in reversed-phase##2##3##(1992-6#1)(1995-3#1)
peptides in the##5##3##(1991-1#1)(1991-2#1)(1992-9#1)(1993-5#1)(2008-1#1)
peptides in##43##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-7#1)(1991-1#2)(1991-2#1)(1991-5#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-5#6)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)
peptides indicate that##2##3##(1993-3#1)(2008-5#1)
peptides induce##2##2##(1994-5#2)
peptides induced by the hydroxyl radical##2##6##(1990-5#2)
peptides inhibited the##2##3##(1995-11#1)(2012-3#1)
peptides inhibited##3##2##(1990-5#1)(1995-11#1)(2012-3#1)
peptides into##4##2##(1994-12#1)(1994-2#1)(2008-10#1)(2010-5#1)
peptides is not##2##3##(1995-3#1)(2008-4#1)
peptides is##4##2##(1990-12#1)(1995-3#1)(2008-4#2)
peptides may##4##2##(1990-12#1)(1990-2#1)(1990-7#1)(2008-1#1)
peptides might##2##2##(1991-1#1)(1994-2#1)
peptides mixture from tumor cells##2##5##(2008-9#2)
peptides mixture##3##2##(2008-9#3)
peptides obtained##3##2##(1991-12#1)(1992-8#1)(1993-6#1)
peptides of the##6##3##(1993-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(2010-5#1)(2011-2#1)
peptides of##13##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
peptides on the##2##3##(1997-7#1)(2012-1#1)
peptides on##9##2##(1990-7#1)(1991-1#1)(1993-5#1)(1997-7#1)(2008-11#1)(2008-4#2)(2012-1#1)(2012-3#1)
peptides or proteins##2##3##(1995-2#2)
peptides or##6##2##(1995-2#4)(2008-4#1)(2010-5#1)
peptides phosphorylated##2##2##(1996-2#1)(2008-4#1)
peptides present in##2##3##(1994-11#1)(1994-9#1)
peptides presented by##2##3##(1994-12#1)(2012-2#1)
peptides recognized##2##2##(1990-5#1)(2008-4#1)
peptides representing##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
peptides revealed##2##2##(1990-11#1)(1992-8#1)
peptides showed##3##2##(1993-8#1)(2008-10#1)(2008-6#1)
peptides such as##5##3##(1991-5#1)(1994-5#1)(1994-6#1)(2008-3#1)(2008-4#1)
peptides that may##2##3##(2007-11#1)(2012-2#1)
peptides that specifically##2##3##(2008-7#1)(2009-6#1)
peptides that##17##2##(1991-2#1)(1991-5#1)(1993-3#2)(1995-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
peptides to the##7##3##(1995-5#1)(1996-12#1)(1997-4#2)(2008-4#3)
peptides to##17##2##(1994-11#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-4#2)(2008-10#1)(2008-2#1)(2008-4#7)(2011-2#1)
peptides was##5##2##(1994-8#1)(1995-3#1)(1996-2#1)(1997-6#1)(1997-8#1)
peptides were found to##2##4##(1994-8#1)(1997-4#1)
peptides were identified##2##3##(1991-5#1)(1992-12#1)
peptides were separated##2##3##(1996-5#2)
peptides were synthesized##2##3##(1992-6#1)(1997-3#1)
peptides were##30##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#2)
peptides which##5##2##(1992-12#1)(1992-9#1)(1997-3#1)(2008-9#1)(2011-1#1)
peptides with a##2##3##(1994-3#1)(2008-10#1)
peptides with##17##2##(1990-11#1)(1990-12#1)(1993-5#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
peptides within##2##2##(2008-11#1)(2008-3#1)
peptides without##2##2##(2008-10#2)
peptides##683##1##(1990-10#1)(1990-11#12)(1990-12#12)(1990-2#9)(1990-4#2)(1990-5#23)(1990-7#13)(1990-8#2)(1991-1#9)(1991-12#9)(1991-2#9)(1991-3#2)(1991-5#10)(1991-9#2)(1992-11#2)(1992-12#10)(1992-3#1)(1992-4#2)(1992-5#4)(1992-6#11)(1992-8#7)(1992-9#5)(1993-11#6)(1993-3#7)(1993-5#15)(1993-6#5)(1993-8#5)(1994-11#15)(1994-12#8)(1994-2#4)(1994-3#5)(1994-5#12)(1994-6#9)(1994-8#19)(1994-9#12)(1995-11#12)(1995-12#8)(1995-2#20)(1995-3#15)(1995-5#8)(1995-6#9)(1995-8#2)(1996-12#10)(1996-2#4)(1996-5#10)(1997-2#6)(1997-3#3)(1997-4#5)(1997-6#6)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#4)(2007-11#2)(2007-6#2)(2007-7#1)(2008-1#10)(2008-10#36)(2008-11#11)(2008-2#6)(2008-3#3)(2008-4#71)(2008-5#15)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#16)(2009-10#1)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#7)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#19)(2011-3#4)(2012-1#9)(2012-12#1)(2012-2#4)(2012-3#9)(2013-1#2)(2013-7#1)(2013-8#2)
peptides)##4##1##(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
peptides/proteins##3##1##(1997-4#1)(2006-12#2)
peptidic and##3##2##(1992-9#2)(1993-3#1)
peptidic##7##1##(1992-9#3)(1993-3#3)(1997-4#1)
peptidoglycan##13##1##(1990-2#1)(1990-7#3)(1995-2#4)(1997-4#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
peptidolytic reaction of##2##3##(1991-9#2)
peptidolytic reaction##4##2##(1991-9#4)
peptidomimetic##2##1##(1995-2#1)(2013-1#1)
peptidomimetics##2##1##(2013-1#2)
peptidyl-tRNA##4##1##(1992-8#2)(1994-12#2)
peptidylglycine alpha-amidating monooxygenase##2##3##(1994-11#2)
peptone after a preload##2##4##(1997-4#2)
peptone after##4##2##(1997-4#4)
peptone and peptone after##2##4##(1997-4#2)
peptone was found to be##2##5##(2008-10#1)(2012-2#1)
peptone was##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
peptone##18##1##(1992-6#1)(1997-4#8)(2008-10#3)(2008-7#5)(2012-2#1)
peptones##4##1##(2008-11#4)
per 0##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
per 1##23##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-4#3)(1993-1#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
per 10 000##2##3##(2013-8#2)
per 10##7##2##(2007-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
per 100 patients##2##3##(2008-7#1)(2013-1#1)
per 100##26##2##(1991-11#1)(1992-2#1)(1996-3#1)(1996-8#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#5)(2013-1#2)(2013-7#2)
per 1000 live born##2##4##(1995-5#1)(2013-1#1)
per 1000 live##3##3##(1990-9#1)(1995-5#1)(2013-1#1)
per 1000 ml##3##3##(2008-10#3)
per 1000##14##2##(1990-9#1)(1994-2#2)(1994-7#1)(1995-5#1)(1996-9#1)(1997-8#1)(2008-10#4)(2011-2#1)(2012-12#1)(2013-1#1)
per 2##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
per 200 g of soil)##3##5##(2008-10#3)
per 25muL) of Se(IV)##2##4##(2008-10#2)
per 25muL)##3##2##(2008-10#3)
per 50##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
per POPS##2##2##(1990-7#2)
per Sv##5##2##(1996-6#4)(1997-8#1)
per animal##4##2##(1992-8#1)(1996-12#3)
per area##2##2##(2008-10#1)(2008-12#1)
per asymmetric unit##3##3##(1995-2#1)(2008-9#2)
per batch culture##2##3##(2008-11#2)
per billion by##3##3##(2008-10#1)(2008-3#2)
per billion in volume##2##4##(2008-2#1)(2008-3#1)
per billion in##3##3##(2008-2#2)(2008-3#1)
per billion##10##2##(2008-10#2)(2008-2#3)(2008-3#5)
per canker##6##2##(2008-10#6)
per capita costs##3##3##(1991-6#1)(1993-3#1)(1996-3#1)
per capita expenditure##2##3##(1995-12#1)(2011-1#1)
per capita expenditures on##2##4##(2009-3#1)(2013-7#1)
per capita expenditures##4##3##(1994-2#1)(1997-3#1)(2009-3#1)(2013-7#1)
per capita population growth rates##3##5##(2008-8#3)
per capita than##2##3##(1995-1#1)(1996-3#1)
per capita##41##2##(1990-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#4)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-1#3)(1997-3#2)(1997-8#1)(2007-7#1)(2008-7#1)(2008-8#7)(2009-3#1)(2009-4#1)(2010-5#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
per caput effective dose##2##4##(1997-8#2)
per caput##3##2##(1997-8#2)(2012-2#1)
per case##11##2##(1992-12#5)(1996-2#1)(1996-3#3)(1996-9#1)(2012-12#1)
per cell after##2##3##(2008-10#1)(2008-11#1)
per cell and##2##3##(2008-11#1)(2008-9#1)
per cell in##2##3##(2008-11#1)(2008-9#1)
per cell was##2##3##(1994-2#1)(2008-11#1)
per cell with##3##3##(1993-9#1)(1994-6#1)(1995-6#1)
per cell##33##2##(1991-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#12)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#7)
per cent and##6##3##(1990-6#1)(1992-2#1)(1992-5#2)(1994-7#1)(1995-12#1)
per cent for the ELISA and##2##6##(1992-5#2)
per cent for the ELISA##3##5##(1992-5#3)
per cent for the IHA##3##5##(1992-5#3)
per cent for the##6##4##(1992-5#6)
per cent for##11##3##(1992-5#6)(1994-7#1)(1995-12#4)
per cent had##2##3##(2008-10#1)(2011-1#1)
per cent in the first month##2##6##(1996-8#2)
per cent in##4##3##(1992-2#2)(1996-8#2)
per cent of patients##3##4##(1990-6#1)(1992-10#1)(2011-2#1)
per cent of subjects##2##4##(1992-6#2)
per cent of the cases##2##5##(1992-11#1)(1992-9#1)
per cent of the incidence##2##5##(2008-7#2)
per cent of the vaccinated##2##5##(1995-9#1)(2011-2#1)
per cent of the##20##4##(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-7#2)(1995-12#1)(1995-9#3)(1996-3#1)(1997-3#1)(1997-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#1)
per cent of##43##3##(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#3)(1992-9#3)(1993-2#3)(1994-11#1)(1994-7#3)(1995-12#2)(1995-9#3)(1996-3#2)(1997-3#1)(1997-5#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-8#1)(2013-8#1)
per cent reported##2##3##(1991-6#2)
per cent with the##2##4##(1992-5#2)
per cent with##3##3##(1990-6#1)(1992-5#2)
per cent##100##2##(1990-6#7)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#4)(1992-10#1)(1992-11#1)(1992-2#5)(1992-5#14)(1992-6#3)(1992-9#3)(1993-2#3)(1994-11#1)(1994-7#6)(1995-12#10)(1995-9#3)(1996-3#2)(1996-6#2)(1996-8#2)(1997-3#2)(1997-5#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2012-8#1)(2013-8#1)
per cent) and##2##3##(1991-11#1)(1996-8#1)
per cent) of the##10##4##(1990-3#5)(1994-7#1)(1995-9#1)(1997-8#2)(2011-1#1)
per cent) of##11##3##(1990-3#5)(1994-7#1)(1995-9#1)(1997-8#2)(2011-1#2)
per cent)##22##2##(1990-3#5)(1990-9#1)(1991-11#4)(1994-7#1)(1995-9#1)(1996-8#5)(1997-8#2)(2011-1#3)
per channel##9##2##(2007-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2012-3#1)
per chromosome##2##2##(2008-12#2)
per cluster##2##2##(2009-11#1)(2010-10#1)
per cm(2) of##2##3##(2008-10#1)(2008-5#1)
per cm(2))##3##2##(2008-10#3)
per concentration level) overestimated##2##4##(2008-10#2)
per concentration level)##4##3##(2008-10#4)
per concentration##11##2##(2008-10#11)
per cubic centimeter##2##3##(2007-11#1)(2010-7#1)
per cubic##4##2##(2007-11#1)(2008-5#1)(2010-7#1)(2013-8#1)
per cycle##4##2##(1992-2#1)(2008-10#1)(2008-7#2)
per data##2##2##(2008-2#1)(2008-3#1)
per day and##5##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
per day for 3##2##4##(2007-8#1)(2012-3#1)
per day for 5##2##4##(2007-8#1)(2008-12#1)
per day for##11##3##(1990-9#1)(1992-3#2)(1995-3#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
per day in##2##3##(1995-12#1)(2008-12#1)
per day of##6##3##(1994-6#1)(1995-3#2)(2010-12#1)(2011-2#1)(2012-12#1)
per day on the##2##4##(2008-10#1)(2013-8#1)
per day showed##2##3##(2007-12#1)(2011-1#1)
per day was##5##3##(1994-6#1)(1995-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
per day were##2##3##(1991-11#1)(2008-10#1)
per day##90##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-3#5)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-6#4)(1995-11#1)(1995-12#2)(1995-3#9)(1995-8#1)(1996-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#10)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
per day) for##2##3##(1995-2#1)(2009-12#1)
per day)##14##2##(1992-12#1)(1994-2#1)(1994-6#3)(1995-12#1)(1995-2#1)(1997-7#2)(2008-1#1)(2008-10#2)(2009-12#1)(2013-1#1)
per decade and a detection limit of##2##7##(2008-10#2)
per decade and a detection limit##3##6##(2008-10#3)
per decade and a##4##4##(2008-10#4)
per decade and##6##3##(2008-10#6)
per decade for##2##3##(2008-10#2)
per decade of activity##5##4##(2008-10#5)
per decade of##6##3##(2008-10#6)
per decade##40##2##(1996-5#1)(2008-10#39)
per decade)##5##2##(2008-10#5)
per degree of tilt##2##4##(2008-2#2)
per determination and##2##3##(2008-10#2)
per determination were also achieved##2##5##(2008-10#2)
per determination##14##2##(2008-10#14)
per determination)##3##2##(2008-10#3)
per diem cost##2##3##(1991-12#1)(1993-12#1)
per diem##5##2##(1991-12#2)(1993-12#2)(1994-2#1)
per dish)##2##2##(1995-3#1)(2008-10#1)
per dose##5##2##(2007-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
per ear##4##2##(2008-10#1)(2011-2#3)
per enrollee##2##2##(1993-3#1)(1996-1#1)
per enrollee)##2##2##(1991-2#1)(2011-2#1)
per enzyme##6##2##(1992-6#1)(1994-5#2)(1994-6#1)(2008-7#2)
per erythrocyte##2##2##(1990-12#2)
per explant for Mentha##2##4##(2013-1#2)
per female##2##2##(2008-8#1)(2011-2#1)
per field##3##2##(2008-10#2)(2008-6#1)
per flower##6##2##(2008-10#3)(2008-12#1)(2009-12#2)
per fraction##3##2##(1992-10#1)(1993-9#1)(2008-6#1)
per frame##2##2##(2008-3#1)(2011-1#1)
per g liver at##2##4##(1996-12#2)
per g of soil##8##4##(2008-10#8)
per g of tissue##7##4##(1991-8#1)(1995-2#3)(1996-5#1)(2008-10#2)
per g of##24##3##(1991-8#3)(1995-2#3)(1996-5#1)(2008-10#17)
per g##27##2##(1990-8#1)(1991-8#3)(1995-2#3)(1996-12#2)(1996-5#1)(2008-10#17)
per gene##3##2##(1997-6#1)(1997-8#1)(2012-3#1)
per generation##5##2##(2008-10#2)(2008-8#3)
per genome per generation##2##4##(2008-8#2)
per genome##4##2##(2008-10#2)(2008-8#2)
per gram of root##3##4##(2008-10#3)
per gram of soil##9##4##(2008-10#9)
per gram of soil) significantly reduced##2##6##(2008-10#2)
per gram of soil)##6##4##(2008-10#6)
per gram of##30##3##(1993-11#1)(2008-10#25)(2008-11#2)(2011-2#2)
per gram##35##2##(1990-8#1)(1993-11#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-5#1)(2011-2#2)(2013-1#1)
per group##7##2##(1997-3#1)(2008-10#3)(2008-12#1)(2009-8#1)(2010-4#1)
per group)##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
per h##25##2##(1991-5#1)(1992-6#1)(1996-5#1)(2008-10#22)
per h)##3##2##(2008-10#3)
per head##2##2##(2008-10#2)
per heart in the##2##4##(2010-6#2)
per hectare##2##2##(2008-12#2)
per hospital##4##2##(2007-8#1)(2008-11#3)
per hour and is##2##4##(2008-10#2)
per hour and relative standard##3##5##(2008-10#3)
per hour and##10##3##(2008-10#10)
per hour for a##2##4##(2008-10#2)
per hour using##2##3##(2008-10#1)(2011-1#1)
per hour was achieved##4##4##(2008-10#3)(2008-7#1)
per hour was##6##3##(2008-10#5)(2008-7#1)
per hour were achieved##2##4##(2008-10#2)
per hour were##3##3##(2008-10#3)
per hour with a relative standard deviation of##3##8##(2008-10#3)
per hour with a relative standard deviation##5##7##(2008-10#5)
per hour with a relative##6##5##(2008-10#6)
per hour with a##7##4##(2008-10#7)
per hour##90##2##(1993-8#1)(2008-10#81)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#5)
per hundred thousand in##2##4##(2012-3#2)
per hundred thousand##3##3##(2012-12#1)(2012-3#2)
per hundred##8##2##(2008-5#5)(2012-12#1)(2012-3#2)
per infected##2##2##(2008-10#2)
per injection##4##2##(2008-10#3)(2013-8#1)
per inter-spawning interval##2##3##(2010-8#2)
per kg of##3##3##(1995-2#1)(2008-10#1)(2013-1#1)
per kg##8##2##(1991-5#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-6#1)(2013-1#1)
per kilogram of##3##3##(2008-10#2)(2011-3#1)
per kilogram##5##2##(1996-12#1)(1997-8#1)(2008-10#2)(2011-3#1)
per larva##3##2##(2008-12#2)(2008-7#1)
per leaf and##3##3##(2008-10#3)
per leaf##11##2##(2008-10#11)
per leaf)##2##2##(2008-10#2)
per leaflet##4##2##(2008-10#4)
per lesion were##2##3##(2008-10#2)
per lesion##8##2##(2008-10#8)
per liter levels in##3##4##(1997-4#1)(2008-10#2)
per liter levels##4##3##(1997-4#1)(2008-10#3)
per liter of culture##2##4##(1990-12#1)(1997-4#1)
per liter range##3##3##(2008-10#3)
per liter##18##2##(1990-12#1)(1992-8#1)(1997-4#2)(2008-10#12)(2008-5#1)(2008-6#1)
per litre##4##2##(2008-10#4)
per litter##3##2##(1996-12#1)(2008-8#1)(2013-7#1)
per m(2)##3##2##(2008-10#3)
per mL##2##2##(2008-11#1)(2008-8#1)
per mg of membrane protein##3##5##(1990-5#3)
per mg of##4##3##(1990-5#3)(2008-4#1)
per mg protein##16##3##(1990-8#2)(1991-12#1)(1991-5#5)(1994-8#2)(1997-6#6)
per mg##23##2##(1990-5#3)(1990-8#2)(1991-12#1)(1991-5#5)(1994-12#1)(1994-8#2)(1997-6#6)(2008-1#1)(2008-11#1)(2008-4#1)
per milliliter level##2##3##(2008-10#2)
per milliliter levels##2##3##(2008-10#2)
per milliliter##6##2##(2008-1#1)(2008-10#5)
per million in##2##3##(2008-3#1)(2010-3#1)
per million per year##2##4##(1997-5#1)(2013-1#1)
per million persons per##2##4##(2010-3#2)
per million persons##3##3##(2010-3#3)
per million##18##2##(1992-6#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-7#1)(2010-3#4)(2013-1#1)
per million)##2##2##(2010-3#2)
per min per mg protein##8##5##(1991-5#2)(1997-6#6)
per min##21##2##(1991-10#1)(1991-5#4)(1991-6#1)(1992-3#3)(1994-8#2)(1995-12#1)(1997-6#6)(2008-10#2)(2008-11#1)
per min)##2##2##(2007-8#1)(2008-10#1)
per minute##10##2##(1994-11#1)(1994-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-2#2)
per ml of##4##3##(1993-8#1)(2008-10#3)
per ml using##2##3##(2008-10#2)
per ml##25##2##(1993-8#1)(1994-5#2)(2008-10#18)(2008-11#2)(2009-8#1)(2012-3#1)
per ml)##8##2##(2008-10#8)
per mm(2) of pellet at 713 cm(-1)##2##7##(2008-10#2)
per mm(2) of pellet at##4##5##(2008-10#4)
per mol of##4##3##(1990-10#2)(1994-11#1)(2008-10#1)
per mol##7##2##(1990-10#2)(1990-12#1)(1993-8#1)(1994-11#1)(2008-10#2)
per mole of##10##3##(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-5#1)(2008-10#2)(2008-4#1)(2010-11#1)
per mole##11##2##(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-5#1)(1997-4#1)(2008-10#2)(2008-4#1)(2010-11#1)
per molecule of the##2##4##(1991-9#1)(1993-3#1)
per molecule of##3##3##(1991-5#1)(1991-9#1)(1993-3#1)
per molecule##8##2##(1990-12#1)(1991-5#1)(1991-9#2)(1993-3#1)(1995-5#1)(2007-12#1)(2010-2#1)
per monomer##2##2##(1992-4#1)(2008-10#1)
per month and##2##3##(1990-12#1)(1993-9#1)
per month in##2##3##(1995-12#2)
per month##12##2##(1990-12#1)(1993-1#1)(1993-9#1)(1995-12#3)(1997-6#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-12#2)
per month)##2##2##(2008-10#2)
per mouse##7##2##(1990-7#4)(1993-8#1)(1995-2#1)(2008-12#1)
per mug##2##2##(2008-10#1)(2008-11#1)
per mutants##2##2##(1995-9#2)
per nucleus##2##2##(1993-12#1)(2008-5#1)
per one##3##2##(1992-5#1)(2008-1#1)(2011-1#1)
per operation decreased##2##3##(2007-8#2)
per operation##4##2##(1996-9#1)(2007-8#3)
per os##8##2##(1991-3#1)(1993-12#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)
per page##2##2##(2008-3#2)
per paid hour##2##3##(1992-3#2)
per patient and##2##3##(2011-1#1)(2013-7#1)
per patient eligible day##2##4##(1997-2#2)
per patient was##6##3##(1990-9#1)(1991-12#1)(2007-8#2)(2011-2#1)(2013-1#1)
per patient##28##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-6#1)(2008-7#2)(2008-8#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
per patient)##3##2##(2007-10#1)(2007-8#1)(2012-3#1)
per pen##2##2##(2010-2#1)(2012-2#1)
per perithecium##2##2##(2008-10#2)
per person##5##2##(1993-1#1)(1996-3#1)(2008-10#1)(2008-8#1)(2012-2#1)
per petri dish##2##3##(2008-10#1)(2008-6#1)
per pl-carnitine##3##2##(2008-10#3)
per plant were##2##3##(2008-10#1)(2008-5#1)
per plant##19##2##(2008-10#11)(2008-12#4)(2008-5#2)(2008-8#1)(2011-2#1)
per plot##3##2##(2008-10#3)
per plot)##2##2##(2008-10#2)
per population##2##2##(2008-10#1)(2009-5#1)
per porphyrin molecule##2##3##(2008-10#2)
per product)##2##2##(2008-5#2)
per protein##2##2##(1992-6#1)(1994-5#1)
per protocol##3##2##(2008-7#2)(2010-12#1)
per pseudothecium##2##2##(2008-10#2)
per pulse##4##2##(2007-12#2)(2008-2#1)(2010-1#1)
per pycnidium##2##2##(2008-10#2)
per quality-adjusted life year (QALY) gained##2##6##(2007-8#1)(2012-12#1)
per quarter##2##2##(1992-9#1)(2012-2#1)
per replicate##3##2##(2008-10#1)(2008-12#1)(2010-2#1)
per run##2##2##(2008-10#1)(2008-11#1)
per sample of##2##3##(2008-10#1)(2008-5#1)
per sample were##2##3##(2008-10#2)
per sample##16##2##(2008-10#13)(2008-2#1)(2008-5#1)(2011-2#1)
per sample) and##3##3##(2008-10#2)(2010-5#1)
per sampling unit##2##3##(2008-10#1)(2011-2#1)
per scan##2##2##(2007-11#2)
per se and in combination##2##5##(2012-2#2)
per se and##3##3##(2008-1#1)(2012-2#2)
per se is##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
per se##43##2##(1990-2#2)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-7#1)(2006-10#1)(2007-7#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-5#6)(2008-6#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
per season##3##2##(2008-10#2)(2013-7#1)
per second##16##2##(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-6#1)(2008-9#1)
per seedling##2##2##(2008-10#2)
per session##2##2##(2008-1#1)(2012-1#1)
per site##6##2##(1995-2#1)(2007-5#1)(2008-10#2)(2008-6#1)(2013-7#1)
per slide was##2##3##(2008-10#2)
per slide##3##2##(2008-10#2)(2008-11#1)
per spot##4##2##(2008-10#4)
per square centimeter of leaf surface##2##6##(2008-10#2)
per square centimeter of##3##4##(2008-10#3)
per square centimeter##8##3##(2007-12#2)(2008-10#5)(2008-2#1)
per square meter##5##3##(1995-8#1)(2008-10#4)
per square##17##2##(1990-8#1)(1991-2#1)(1992-2#1)(1995-12#1)(1995-8#1)(2007-12#2)(2008-10#9)(2008-2#1)
per subunit##3##2##(1992-8#1)(1994-5#2)
per surface##2##2##(1993-12#1)(1995-8#1)
per testis##3##2##(1992-12#3)
per thousand and##3##3##(1990-12#1)(2008-5#1)(2012-3#1)
per thousand##18##2##(1990-12#1)(1996-2#1)(2008-10#2)(2008-2#3)(2008-5#3)(2008-7#5)(2012-3#2)(2013-1#1)
per thousand)##10##2##(2008-5#6)(2010-3#4)
per time##4##2##(2008-10#2)(2008-11#1)(2009-6#1)
per titration)##2##2##(2008-10#2)
per total##4##2##(1993-8#1)(1994-8#2)(2008-10#1)
per treatment##4##2##(2008-5#1)(2010-2#2)(2013-7#1)
per tree)##2##2##(2008-10#2)
per trillion##6##2##(2008-10#6)
per unit area of##2##4##(2008-10#1)(2008-7#1)
per unit area##8##3##(2008-10#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)
per unit infection##2##3##(2008-10#2)
per unit length of##2##4##(2008-2#1)(2008-5#1)
per unit length##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
per unit mass##2##3##(2008-10#2)
per unit of sporulating##2##4##(2008-10#2)
per unit of time##2##4##(1996-3#1)(2008-9#1)
per unit of##17##3##(1996-3#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)
per unit time##2##3##(1996-4#1)(2008-7#1)
per unit volume##2##3##(1994-3#1)(2008-2#1)
per unit weight)##2##3##(2007-12#2)
per unit##51##2##(1994-3#1)(1996-3#1)(1996-4#1)(2007-11#2)(2007-12#3)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-11#1)
per visit##6##2##(1992-6#1)(1995-12#1)(1995-3#2)(1995-5#1)(2010-8#1)
per volume of##2##3##(2008-11#1)(2008-7#1)
per week and##3##3##(2008-11#1)(2011-2#2)
per week for##33##3##(1995-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#24)(2013-1#3)(2013-8#1)
per week##56##2##(1991-12#1)(1992-6#1)(1994-2#1)(1995-12#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#25)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2013-1#7)(2013-8#1)
per week)##5##2##(1992-10#1)(2008-10#1)(2008-5#1)(2008-7#2)
per well##4##2##(1991-2#1)(2008-10#1)(2008-11#2)
per woman-year##2##2##(2011-3#2)
per worker##3##2##(1994-1#2)(2010-5#1)
per year and##3##3##(1992-1#1)(1997-1#1)(2008-10#1)
per year for##5##3##(1994-12#1)(2007-9#1)(2008-10#1)(2010-8#1)(2012-1#1)
per year in##5##3##(1990-12#2)(1994-6#1)(2010-3#2)
per year or##2##3##(1990-6#1)(1997-3#1)
per year were##2##3##(1994-2#1)(2007-7#1)
per year##73##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2010-3#4)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
per year) and##2##3##(2008-8#1)(2010-3#1)
per year)##6##2##(2007-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-3#1)
per##1898##1##(1990-10#2)(1990-11#3)(1990-12#11)(1990-2#3)(1990-3#7)(1990-5#3)(1990-6#9)(1990-7#8)(1990-8#7)(1990-9#5)(1991-10#1)(1991-11#7)(1991-12#5)(1991-2#8)(1991-3#3)(1991-5#17)(1991-6#6)(1991-8#6)(1991-9#3)(1992-1#6)(1992-10#3)(1992-11#1)(1992-12#9)(1992-2#9)(1992-3#15)(1992-4#4)(1992-5#16)(1992-6#11)(1992-8#3)(1992-9#6)(1993-1#4)(1993-11#3)(1993-12#8)(1993-2#6)(1993-3#9)(1993-6#3)(1993-8#10)(1993-9#7)(1994-1#5)(1994-11#3)(1994-12#8)(1994-2#12)(1994-3#5)(1994-5#9)(1994-6#13)(1994-7#8)(1994-8#10)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#25)(1995-2#15)(1995-3#14)(1995-5#6)(1995-6#2)(1995-8#5)(1995-9#6)(1996-1#2)(1996-11#2)(1996-12#15)(1996-2#5)(1996-3#14)(1996-4#1)(1996-5#5)(1996-6#7)(1996-7#1)(1996-8#9)(1996-9#4)(1997-1#6)(1997-2#9)(1997-3#9)(1997-4#3)(1997-5#4)(1997-6#14)(1997-7#2)(1997-8#10)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#14)(2007-12#23)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#14)(2007-8#17)(2007-9#3)(2008-1#22)(2008-10#602)(2008-11#55)(2008-12#32)(2008-2#33)(2008-3#48)(2008-4#7)(2008-5#53)(2008-6#11)(2008-7#57)(2008-8#33)(2008-9#49)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#4)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#15)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#18)(2011-2#53)(2011-3#4)(2012-1#4)(2012-12#17)(2012-2#17)(2012-3#15)(2012-6#1)(2012-8#1)(2013-1#45)(2013-7#12)(2013-8#16)
per-episode prospective payment##2##3##(1995-3#2)
per-operative##2##1##(2007-11#2)
per-plant##3##1##(2008-10#3)
per-sulfated##2##1##(2008-9#2)
per-wet-pellet volume##2##2##(2008-7#2)
peracute##2##1##(2008-7#2)
perceive and##3##2##(2008-7#1)(2009-8#1)(2011-10#1)
perceive that##3##2##(2008-12#1)(2012-1#1)(2013-1#1)
perceive the##9##2##(1992-11#1)(1994-12#1)(2008-11#1)(2009-5#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
perceive their general##2##3##(1991-11#1)(1996-6#1)
perceive their own health##3##4##(1994-6#1)(1996-6#2)
perceive their own##5##3##(1994-6#1)(1996-6#2)(2012-3#2)
perceive their##12##2##(1991-11#1)(1994-6#1)(1996-6#3)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
perceive themselves as##3##3##(1996-1#1)(2007-12#1)(2008-11#1)
perceive themselves##4##2##(1996-1#1)(1997-7#1)(2007-12#1)(2008-11#1)
perceive##46##1##(1991-11#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-6#3)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#2)
perceived a##4##2##(1994-1#1)(1997-3#1)(2008-9#1)(2012-3#1)
perceived and##5##2##(2008-11#2)(2009-5#1)(2010-3#1)(2011-2#1)
perceived as a##5##3##(1990-11#1)(2010-12#3)(2010-4#1)
perceived as an##2##3##(2007-5#1)(2008-9#1)
perceived as being##2##3##(2011-2#1)(2012-1#1)
perceived as having##2##3##(2008-12#1)(2012-2#1)
perceived as the most##2##4##(2008-11#1)(2013-8#1)
perceived as the##3##3##(2008-11#2)(2013-8#1)
perceived as##31##2##(1990-11#1)(1996-1#1)(1996-12#1)(1996-2#2)(2007-5#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#4)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
perceived barriers to a healthy##2##5##(2011-2#2)
perceived barriers to##5##3##(1997-1#1)(2010-7#1)(2011-2#3)
perceived barriers##6##2##(1995-12#1)(1997-1#1)(2010-7#1)(2011-2#3)
perceived benefits and##2##3##(1994-2#1)(2009-4#1)
perceived benefits##3##2##(1994-2#1)(2008-11#1)(2009-4#1)
perceived by adolescents##2##3##(2009-7#1)(2010-9#1)
perceived by parents##2##3##(1992-2#1)(1995-1#1)
perceived by the patients##2##4##(2009-10#2)
perceived by the##9##3##(1994-1#1)(2008-11#1)(2008-3#1)(2009-10#2)(2009-6#1)(2012-12#1)(2013-1#2)
perceived by##25##2##(1992-2#1)(1993-2#1)(1994-1#2)(1995-1#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
perceived declines in##3##3##(2011-2#3)
perceived degree of##2##3##(2012-2#1)(2013-8#1)
perceived efficacy##3##2##(2008-11#1)(2010-6#1)(2010-9#1)
perceived emotional##2##2##(2013-1#1)(2013-8#1)
perceived exertion##7##2##(2012-3#1)(2013-1#1)(2013-8#5)
perceived family##2##2##(2009-7#1)(2010-10#1)
perceived feelings of being or thinking different##2##7##(2010-10#2)
perceived greater##2##2##(2009-4#1)(2011-1#1)
perceived health status##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
perceived health##8##2##(1997-1#1)(2008-6#4)(2011-2#1)(2012-12#1)(2013-1#1)
perceived high##2##2##(1995-9#1)(2012-3#1)
perceived image##2##2##(2008-2#1)(2008-3#1)
perceived importance of social support##2##5##(2009-7#2)
perceived importance of##3##3##(1994-3#1)(2009-7#2)
perceived improvement##3##2##(1996-3#2)(2007-11#1)
perceived in##4##2##(2008-10#1)(2009-7#1)(2010-11#1)(2010-8#1)
perceived intensity##3##2##(2008-10#3)
perceived lack of##2##3##(2008-10#1)(2013-1#1)
perceived learning outcome##3##3##(2011-2#3)
perceived learning##4##2##(2011-2#4)
perceived level of compliance##2##4##(2007-12#2)
perceived level of##3##3##(2007-11#1)(2007-12#2)
perceived need for##2##3##(1994-12#1)(1995-12#1)
perceived neighborhood##3##2##(2009-7#2)(2011-2#1)
perceived norms regarding##2##3##(2013-1#2)
perceived norms##4##2##(2011-1#1)(2013-1#3)
perceived opportunity##2##2##(1994-3#1)(2009-5#1)
perceived parental##2##2##(2009-11#1)(2009-7#1)
perceived peer##4##2##(2009-7#3)(2010-9#1)
perceived pleasantness##2##2##(2008-5#1)(2012-12#1)
perceived prevalence of##3##3##(1991-12#1)(2013-1#2)
perceived problems with##2##3##(1997-7#1)(2011-2#1)
perceived problems##4##2##(1997-7#1)(2008-11#1)(2008-3#1)(2011-2#1)
perceived quality of##7##3##(1993-12#1)(2008-11#2)(2009-4#1)(2010-4#1)(2011-1#1)(2013-1#1)
perceived quality##11##2##(1993-12#1)(1995-12#1)(1996-3#2)(2008-11#3)(2009-4#1)(2010-4#1)(2011-1#1)(2013-1#1)
perceived realism and subjective SA##2##5##(2011-2#2)
perceived realism##4##2##(2011-2#4)
perceived relationship satisfaction with mothers##2##5##(2009-7#2)
perceived relationship satisfaction##6##3##(2009-7#6)
perceived relationship##7##2##(2007-12#1)(2009-7#6)
perceived risk##6##2##(1990-5#1)(1994-3#4)(2008-11#1)
perceived self-efficacy##2##2##(2009-3#1)(2010-9#1)
perceived service quality##2##3##(1995-2#1)(1996-3#1)
perceived service##3##2##(1993-12#1)(1995-2#1)(1996-3#1)
perceived social support##4##3##(1992-2#1)(2009-7#1)(2010-1#2)
perceived strength##2##2##(2008-9#2)
perceived susceptibility##2##2##(2008-4#2)
perceived that##3##2##(2007-11#1)(2009-7#1)(2011-2#1)
perceived the##6##2##(1992-2#1)(2008-11#1)(2009-5#1)(2010-11#1)(2012-3#2)
perceived their##4##2##(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
perceived themselves as##2##3##(1991-2#1)(1992-2#1)
perceived themselves##3##2##(1991-2#1)(1992-2#1)(2012-2#1)
perceived they##2##2##(2008-11#1)(2010-7#1)
perceived to be##7##3##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(2008-7#1)(2009-4#1)(2010-3#1)
perceived to##10##2##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-3#1)(2013-1#1)
perceived value##3##2##(1994-1#1)(2010-8#1)(2012-2#1)
perceived##336##1##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#4)(1993-12#4)(1993-2#2)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#3)(1994-3#7)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#6)(1996-3#8)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#24)(2008-12#12)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#24)(2009-8#1)(2010-1#6)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#6)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#3)(2011-2#27)(2012-1#3)(2012-12#5)(2012-2#5)(2012-3#10)(2013-1#24)(2013-8#10)
perceiver##2##1##(2009-9#2)
perceivers have##2##2##(2008-11#1)(2013-8#1)
perceivers spontaneously##2##2##(2008-11#2)
perceivers##5##1##(2008-11#4)(2013-8#1)
perceivers' explicit##2##2##(2008-11#2)
perceivers' mental representations of##2##4##(2013-8#2)
perceivers'##5##1##(2008-11#2)(2009-9#1)(2013-8#2)
perceiving oneself as##2##3##(2012-2#2)
perceiving##9##1##(1993-9#1)(2008-11#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
percent (95 percent CI =##3##5##(1996-1#3)
percent (95% C##2##3##(1990-6#2)
percent (95% CI##4##3##(2010-8#4)
percent (95%##7##2##(1990-6#3)(2010-8#4)
percent (all groups##2##3##(2011-1#2)
percent (mol##2##2##(2008-10#2)
percent HCWA##2##2##(2008-10#2)
percent S##2##2##(2008-10#2)
percent accuracy of##2##3##(2008-3#1)(2012-2#1)
percent after##2##2##(1990-5#1)(2012-2#1)
percent and##5##2##(1991-3#1)(1992-5#1)(1992-6#1)(2007-2#1)(2013-1#1)
percent at year-end 2008##3##4##(2011-2#3)
percent at##6##2##(1991-5#1)(1995-6#2)(2011-2#3)
percent between##3##2##(1991-1#1)(1993-1#1)(2008-11#1)
percent body fat##4##3##(2008-11#1)(2008-4#2)(2008-5#1)
percent body##5##2##(2008-11#1)(2008-4#2)(2008-5#1)(2013-1#1)
percent change##2##2##(2010-8#2)
percent confidence##3##2##(1990-5#2)(2008-11#1)
percent control##2##2##(2008-10#2)
percent correct##2##2##(1992-11#2)
percent decrease##2##2##(1993-8#1)(1997-1#1)
percent extraction and##3##3##(2008-10#3)
percent extraction##5##2##(2008-10#5)
percent for##5##2##(1996-3#1)(2008-3#2)(2008-6#2)
percent from the##2##3##(1992-12#1)(2008-11#1)
percent from##5##2##(1992-12#1)(1996-1#1)(1997-3#1)(2008-11#2)
percent had##9##2##(1991-12#2)(1991-3#2)(2008-1#3)(2009-10#1)(2013-1#1)
percent have##2##2##(1995-12#1)(2008-10#1)
percent hull##3##2##(2008-5#3)
percent identity##2##2##(2008-4#2)
percent in 2008##2##3##(2011-2#2)
percent in##11##2##(1992-12#2)(1992-3#1)(1996-9#1)(2008-5#2)(2009-9#1)(2011-2#4)
percent infected spikelets (0##2##4##(2008-10#2)
percent infected##3##2##(2008-10#3)
percent inhibition##3##2##(1992-12#1)(1993-8#1)(2013-1#1)
percent is##2##2##(1992-3#1)(2008-6#1)
percent leaf area##3##3##(2008-10#3)
percent leaf##4##2##(2008-10#4)
percent less##2##2##(1994-2#1)(1996-2#1)
percent nucleotide sequence##2##3##(2008-10#2)
percent of 316##2##3##(2008-12#1)(2012-2#1)
percent of 401(k)##2##3##(2011-2#2)
percent of GDP##2##3##(1993-3#1)(2013-7#1)
percent of Medicaid##2##3##(1994-2#2)
percent of Medicare##2##3##(1994-1#1)(1996-3#1)
percent of adult##2##3##(1996-6#1)(2008-1#1)
percent of all##8##3##(1991-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-6#1)(2008-4#1)(2010-8#1)(2011-2#1)
percent of cases##7##3##(1995-3#1)(1996-3#1)(1997-1#2)(2008-5#1)(2010-2#1)(2013-1#1)
percent of deaths in##2##4##(1997-2#1)(2012-2#1)
percent of health care##2##4##(1993-1#1)(1996-3#1)
percent of health##3##3##(1993-1#1)(1995-1#1)(1996-3#1)
percent of isolates##2##3##(2008-10#2)
percent of office visits##2##4##(2010-8#2)
percent of one's##2##3##(1994-2#2)
percent of patients had##3##4##(1990-2#1)(1994-2#1)(2013-1#1)
percent of patients underwent##2##4##(1992-2#1)(2008-6#1)
percent of patients who##2##4##(2008-3#1)(2011-2#1)
percent of patients##19##3##(1990-2#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)
percent of prescriptions for##2##4##(2009-9#2)
percent of prescriptions##3##3##(2009-9#3)
percent of respondents##6##3##(1990-6#1)(1993-1#1)(1995-3#1)(1996-3#1)(2009-10#2)
percent of the account balances of recently hired participants in their 20s##2##12##(2011-2#2)
percent of the applied MeBr##2##5##(1995-3#2)
percent of the cases##3##4##(1990-3#1)(1991-3#1)(1996-6#1)
percent of the children##2##4##(1996-1#1)(2010-8#1)
percent of the diagnoses were initially##2##6##(2007-12#2)
percent of the nonprofits##2##4##(1994-2#1)(1995-3#1)
percent of the patients were##4##5##(1997-6#1)(2008-1#1)(2012-3#1)(2013-1#1)
percent of the patients##10##4##(1992-5#1)(1994-3#1)(1996-7#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
percent of the population##2##4##(1992-3#1)(1997-2#1)
percent of the sample##2##4##(2008-12#1)(2008-4#1)
percent of the subjects##2##4##(1991-3#1)(2013-1#1)
percent of the total##4##4##(1992-3#2)(1994-3#1)(1994-6#1)
percent of the##95##3##(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-3#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#3)(1992-3#3)(1992-5#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2009-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#1)
percent of their##3##3##(1994-2#1)(1996-3#2)
percent of these patients##2##4##(1995-2#1)(2012-2#1)
percent of these shortcomings##2##4##(2007-12#2)
percent of these##8##3##(1992-1#1)(1995-11#1)(1995-2#1)(1996-6#1)(2007-12#2)(2008-8#1)(2012-2#1)
percent of those##5##3##(1993-2#2)(1996-3#2)(1997-5#1)
percent of total hospital##2##4##(1992-2#1)(1995-1#1)
percent of total##8##3##(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-3#1)(2008-11#1)
percent of women##4##3##(1993-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
percent of##289##2##(1990-11#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#6)(1992-5#5)(1992-6#2)(1993-1#3)(1993-12#2)(1993-2#5)(1993-3#2)(1994-1#3)(1994-12#3)(1994-2#11)(1994-3#8)(1994-6#1)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#7)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#10)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-7#2)(2008-1#3)(2008-10#14)(2008-11#8)(2008-12#6)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-9#7)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#6)(2011-1#2)(2011-2#12)(2012-2#8)(2012-3#4)(2013-1#24)(2013-7#2)(2013-8#2)
percent over the##2##3##(1991-3#1)(2011-2#1)
percent penetration and##2##3##(2008-10#2)
percent per year for##2##4##(1994-12#1)(2007-9#1)
percent per year##4##3##(1994-12#2)(2007-9#2)
percent per##5##2##(1994-12#2)(2007-9#2)(2008-12#1)
percent recovery of copper##3##4##(2008-10#3)
percent recovery of##6##3##(2008-10#6)
percent recovery values were##2##4##(2008-10#2)
percent recovery##10##2##(2008-10#10)
percent reduction in##4##3##(1992-12#1)(1993-12#1)(1997-1#1)(2008-10#1)
percent relative error##3##3##(2008-10#3)
percent relative standard deviation##2##4##(2008-10#2)
percent relative##6##2##(1995-1#1)(2008-10#5)
percent reported##2##2##(1991-12#1)(2008-12#1)
percent stenosis##2##2##(2008-8#1)(2011-2#1)
percent to##9##2##(1992-2#1)(1992-6#1)(1994-12#1)(1995-3#1)(1996-1#3)(1996-12#1)(2008-3#1)
percent visual##2##2##(2008-10#2)
percent was##2##2##(1994-12#1)(2011-2#1)
percent were##12##2##(1991-3#2)(1992-5#1)(1994-12#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-3#1)(2013-1#1)
percent when##2##2##(1992-6#1)(2008-11#1)
percent##664##1##(1990-11#1)(1990-2#9)(1990-3#3)(1990-5#11)(1990-6#5)(1990-8#1)(1990-9#2)(1991-1#7)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#15)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#12)(1992-2#4)(1992-3#10)(1992-5#10)(1992-6#8)(1992-9#1)(1993-1#7)(1993-12#3)(1993-2#6)(1993-3#7)(1993-8#2)(1994-1#6)(1994-12#10)(1994-2#13)(1994-3#11)(1994-6#5)(1994-9#1)(1995-1#8)(1995-11#2)(1995-12#6)(1995-2#5)(1995-3#16)(1995-6#8)(1996-1#13)(1996-12#3)(1996-2#4)(1996-3#17)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#5)(1997-1#8)(1997-2#8)(1997-3#10)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#4)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#87)(2008-11#19)(2008-12#10)(2008-2#1)(2008-3#16)(2008-4#12)(2008-5#10)(2008-6#6)(2008-7#6)(2008-8#8)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-9#10)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#16)(2011-1#5)(2011-2#26)(2012-1#1)(2012-12#3)(2012-2#14)(2012-3#6)(2013-1#38)(2013-7#2)(2013-8#4)
percent) and##2##2##(1994-1#1)(1995-1#1)
percent) favored a##2##3##(1996-1#2)
percent) in##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
percent) of##3##2##(1994-12#1)(1996-1#1)(1996-3#1)
percent) than##2##2##(1994-1#1)(1997-2#1)
percent) were##3##2##(1994-9#1)(2013-1#2)
percent)##36##1##(1991-8#1)(1993-1#3)(1994-1#3)(1994-12#2)(1994-9#1)(1995-1#2)(1995-12#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#5)(1997-3#4)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#2)
percentage agreement##2##2##(2010-5#1)(2011-2#1)
percentage and seedling growth of V##3##6##(2008-12#3)
percentage and##10##2##(1995-12#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#1)
percentage by##2##2##(2008-5#2)
percentage changes of##2##3##(2012-12#2)
percentage content of##3##3##(2008-10#2)(2013-1#1)
percentage cover of##2##3##(2008-9#2)
percentage cover##4##2##(2008-9#4)
percentage ejection fraction##2##3##(2012-2#2)
percentage extraction of##2##3##(2008-10#2)
percentage extraction##3##2##(2008-10#3)
percentage fat##2##2##(2008-7#2)
percentage fractional fiber shortening##2##4##(2012-2#2)
percentage in the##4##3##(1990-11#1)(2008-10#1)(2008-12#1)(2011-1#1)
percentage in##7##2##(1990-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-7#1)
percentage of M##3##3##(2008-10#3)
percentage of adverse##2##3##(1994-6#1)(2010-5#1)
percentage of all##4##3##(1995-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
percentage of apoptotic##2##3##(2008-12#2)
percentage of cells##7##3##(1997-3#1)(2008-10#2)(2008-11#3)(2008-4#1)
percentage of correct answers##2##4##(1993-12#2)
percentage of correct##5##3##(1993-12#2)(2008-10#1)(2008-9#1)(2011-1#1)
percentage of discolored kernels was##2##5##(2011-2#2)
percentage of discolored kernels##3##4##(2011-2#3)
percentage of elderly clients in the practice of mental health professionals##2##11##(1994-1#2)
percentage of emergence##2##3##(2008-6#2)
percentage of energy##2##3##(1997-8#1)(2012-2#1)
percentage of fat##2##3##(2008-7#2)
percentage of field area affected by FCRR##3##7##(2008-10#3)
percentage of germinated conidia with appressoria and##2##7##(2008-10#2)
percentage of germination##3##3##(2008-10#1)(2008-12#2)
percentage of glutaraldehyde##2##3##(2008-10#2)
percentage of health##2##3##(1993-12#1)(2007-7#1)
percentage of infected##7##3##(2007-10#2)(2007-12#1)(2008-10#4)
percentage of larval##2##3##(1996-12#1)(2011-2#1)
percentage of lymphocytes##2##3##(1991-12#1)(2008-1#1)
percentage of m5Cyt in##3##4##(1991-5#3)
percentage of m5Cyt##4##3##(1991-5#4)
percentage of mature##2##3##(2008-10#1)(2008-12#1)
percentage of muscle##2##3##(2010-4#1)(2011-2#1)
percentage of patients##10##3##(1990-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
percentage of polychromatic erythrocytes##2##4##(2008-9#2)
percentage of samples with hemolysis##2##5##(2013-1#2)
percentage of striated myotubes##2##4##(2009-9#2)
percentage of subjects##2##3##(2008-11#1)(2009-8#1)
percentage of the population##2##4##(2008-11#1)(2012-12#1)
percentage of the total##2##4##(2006-6#1)(2009-11#1)
percentage of the##35##3##(1991-3#1)(1992-6#2)(1993-3#3)(1994-2#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(2006-6#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
percentage of total##2##3##(2008-11#1)(2011-1#1)
percentage of tumor##2##3##(2010-3#2)
percentage of##352##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#2)(1993-8#2)(1994-1#2)(1994-11#1)(1994-2#4)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#3)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#5)(2008-1#3)(2008-10#98)(2008-11#15)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#12)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-8#3)(2011-1#8)(2011-2#19)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#7)(2012-4#1)(2013-1#13)(2013-7#1)(2013-8#5)
percentage point##2##2##(2011-2#2)
percentage points##3##2##(1993-1#1)(2013-1#2)
percentage recoveries were##2##3##(2008-10#2)
percentage recoveries##10##2##(2008-10#9)(2010-3#1)
percentage recovery##3##2##(2008-10#3)
percentage turnover rates##2##3##(2007-5#2)
percentage values##2##2##(2007-10#1)(2011-2#1)
percentage was reduced##2##3##(1990-5#1)(2008-10#1)
percentage was significantly##2##3##(2008-10#1)(2009-3#1)
percentage was##16##2##(1990-5#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-3#1)(2009-7#1)(2012-2#1)
percentage with##2##2##(2008-5#1)(2008-7#1)
percentage##520##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#2)(1993-8#2)(1994-1#3)(1994-11#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-12#4)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1997-2#4)(1997-3#2)(1997-7#3)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-5#3)(2007-7#5)(2008-1#4)(2008-10#144)(2008-11#16)(2008-12#20)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#21)(2008-6#8)(2008-7#13)(2008-8#5)(2008-9#11)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#7)(2010-5#3)(2010-8#5)(2011-1#10)(2011-2#26)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#13)(2012-3#9)(2012-4#1)(2012-7#1)(2013-1#22)(2013-7#3)(2013-8#6)
percentage)##4##1##(2007-2#1)(2008-10#1)(2009-6#1)(2009-7#1)
percentages (P &lt##3##3##(2010-2#3)
percentages and##2##2##(1995-12#1)(2011-1#1)
percentages of neutrophils##2##3##(2008-10#2)
percentages of the##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
percentages of women##2##3##(1993-6#1)(2008-11#1)
percentages of##56##2##(1991-12#1)(1991-4#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#3)(2010-4#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
percentages ranging between##2##3##(2008-10#1)(2011-2#1)
percentages ranging##3##2##(2008-10#2)(2011-2#1)
percentages were##5##2##(1990-12#1)(1994-2#1)(2007-10#2)(2010-11#1)
percentages##98##1##(1990-12#2)(1990-2#1)(1991-12#1)(1991-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-8#1)(2006-11#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#38)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-11#1)(2010-2#4)(2010-4#3)(2010-6#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#4)
percentile tables##2##2##(2008-1#2)
percentile##11##1##(1997-3#1)(2008-1#2)(2008-3#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#3)
percentiles##3##1##(2012-3#2)(2013-1#1)
percents##4##1##(2008-10#4)
perceptible##7##1##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-8#1)(2011-2#1)
perception about##2##2##(2009-4#1)(2012-3#1)
perception and interpretation of##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
perception and production##3##3##(2008-11#2)(2008-4#1)
perception and sense of smell##2##5##(2013-1#2)
perception and visuomotor control##2##4##(2007-8#2)
perception and##28##2##(1990-9#1)(1994-12#2)(1997-2#1)(2007-8#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
perception by##5##2##(1995-8#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)
perception during landing##3##3##(2011-2#3)
perception during##4##2##(1996-5#1)(2011-2#3)
perception in a##2##3##(2008-11#1)(2010-5#1)
perception in adult##3##3##(2008-9#3)
perception in children##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
perception in##22##2##(1991-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#7)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
perception is##7##2##(1991-3#1)(1994-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
perception level of nursing activities##2##5##(1991-2#2)
perception level##3##2##(1991-2#3)
perception of a##5##3##(1994-1#1)(2007-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
perception of early TA##3##4##(2013-1#3)
perception of early##4##3##(2013-1#4)
perception of emotional##2##3##(2008-1#1)(2012-2#1)
perception of general health##2##4##(1992-3#2)
perception of health##6##3##(2007-11#2)(2010-10#1)(2011-2#3)
perception of nurses##2##3##(1996-7#1)(2012-3#1)
perception of professional nursing functions##2##5##(1991-2#2)
perception of the disease as cyclical##3##6##(2008-11#3)
perception of the##21##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-6#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#2)
perception of their own##2##4##(2011-1#1)(2013-7#1)
perception of their##7##3##(1991-2#1)(2007-6#1)(2008-11#2)(2008-12#1)(2011-1#1)(2013-7#1)
perception of these##2##3##(2008-11#1)(2011-2#1)
perception of##121##2##(1991-2#5)(1992-11#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-3#2)(1996-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#4)(2007-8#2)(2007-9#4)(2008-1#3)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#10)(2011-7#1)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#9)
perception performance##9##2##(2008-9#7)(2012-2#2)
perception system##2##2##(2008-2#1)(2008-4#1)
perception that they##2##3##(1992-2#1)(2008-7#1)
perception that##9##2##(1992-2#1)(1994-1#1)(1994-12#1)(1994-7#1)(1996-1#1)(1997-1#1)(2008-7#1)(2009-2#1)(2012-12#1)
perception to##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
perception was evaluated##2##3##(2008-7#1)(2013-1#1)
perception was##4##2##(1991-2#1)(2008-6#1)(2008-7#1)(2013-1#1)
perception##315##1##(1990-2#1)(1990-9#1)(1991-12#2)(1991-2#11)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#2)(1993-3#2)(1994-1#3)(1994-12#5)(1994-3#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#4)(2007-8#6)(2007-9#7)(2008-1#3)(2008-10#2)(2008-11#24)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#9)(2008-7#15)(2008-8#2)(2008-9#42)(2009-1#1)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#21)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#16)(2012-3#8)(2013-1#17)(2013-7#2)(2013-8#13)
perceptions about the role##2##4##(2008-11#1)(2011-1#1)
perceptions about the##4##3##(2007-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
perceptions about##5##2##(2007-12#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
perceptions and attitudes##2##3##(2010-6#1)(2011-2#1)
perceptions and behavior##4##3##(2010-7#4)
perceptions and feelings##2##3##(1992-2#1)(1995-12#1)
perceptions and knowledge##2##3##(2008-11#1)(2011-1#1)
perceptions and practices##3##3##(2011-2#1)(2012-2#2)
perceptions and social##3##3##(2007-12#1)(2008-12#1)(2012-3#1)
perceptions and##36##2##(1992-2#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#4)(2009-3#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-6#1)(2010-7#4)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
perceptions are##2##2##(1995-1#1)(1996-3#1)
perceptions in##2##2##(2009-4#1)(2011-1#1)
perceptions of Turkish##2##3##(2008-12#1)(2010-10#1)
perceptions of a##5##3##(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
perceptions of an individual with a laryngectomy##2##7##(2011-1#2)
perceptions of being overweight##2##4##(2007-12#1)(2010-7#1)
perceptions of body weight and##2##5##(2007-12#2)
perceptions of brain death##2##4##(2007-11#2)
perceptions of clinical decision-making##2##4##(2008-11#2)
perceptions of generic medicines##2##4##(2011-1#2)
perceptions of health care##2##4##(1993-12#1)(1994-12#1)
perceptions of health##4##3##(1993-12#1)(1994-12#1)(2008-1#1)(2008-6#1)
perceptions of mental illness##2##4##(2008-12#2)
perceptions of mental##4##3##(2008-12#3)(2008-2#1)
perceptions of nurses##2##3##(1991-2#1)(2012-3#1)
perceptions of nursing##2##3##(1996-1#1)(2008-11#1)
perceptions of quality##4##3##(1991-2#1)(1995-12#1)(1997-3#1)(2010-10#1)
perceptions of risk##2##3##(1997-3#1)(2009-4#1)
perceptions of service providers##2##4##(2012-3#2)
perceptions of service quality##2##4##(1993-12#1)(1994-2#1)
perceptions of service##4##3##(1993-12#1)(1994-2#1)(2012-3#2)
perceptions of support##2##3##(2008-12#1)(2010-1#1)
perceptions of the classroom##3##4##(2008-12#3)
perceptions of the impact of the##2##6##(1996-1#1)(2008-12#1)
perceptions of the quality##2##4##(1995-2#1)(2009-7#1)
perceptions of the##33##3##(1991-1#1)(1991-2#1)(1992-1#1)(1993-1#1)(1995-1#2)(1995-2#2)(1996-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#4)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2013-1#1)
perceptions of their husbands' satisfaction with their bodies##2##8##(2008-9#2)
perceptions of their##12##3##(1992-1#1)(1995-1#1)(2008-11#2)(2008-12#1)(2008-9#2)(2009-9#1)(2010-11#1)(2013-1#3)
perceptions of these##2##3##(1996-1#1)(2011-2#1)
perceptions of##203##2##(1991-1#1)(1991-2#3)(1992-1#3)(1993-1#1)(1993-12#3)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#5)(1995-3#2)(1996-1#6)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#4)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#14)(2008-12#15)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#7)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#14)(2011-2#4)(2012-1#3)(2012-2#2)(2012-3#13)(2013-1#12)(2013-8#2)
perceptions on providing patient decision support##2##6##(2013-1#2)
perceptions on the##2##3##(1995-12#1)(2007-11#1)
perceptions on##4##2##(1995-12#1)(2007-11#1)(2013-1#2)
perceptions regarding##3##2##(2010-10#2)(2011-1#1)
perceptions were##4##2##(1995-1#1)(2007-11#1)(2008-11#1)(2013-1#1)
perceptions##301##1##(1991-1#1)(1991-2#3)(1992-1#3)(1992-2#1)(1993-1#1)(1993-12#4)(1993-2#2)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#6)(1995-12#4)(1995-2#5)(1995-3#2)(1996-1#6)(1996-2#2)(1996-3#3)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#4)(2007-10#1)(2007-11#10)(2007-12#13)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#1)(2008-11#21)(2008-12#24)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#3)(2009-4#7)(2009-5#2)(2009-6#1)(2009-7#10)(2009-9#6)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#6)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#3)(2011-1#24)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#14)(2013-1#22)(2013-8#3)
perceptron##6##1##(2008-10#2)(2008-11#1)(2008-3#2)(2010-8#1)
percepts##4##1##(2008-9#1)(2009-12#2)(2009-9#1)
perceptual and cognitive##2##3##(2007-8#2)
perceptual and##4##2##(2007-8#2)(2008-11#1)(2008-3#1)
perceptual attributes##2##2##(2008-5#2)
perceptual categories##2##2##(1992-11#2)
perceptual error##3##2##(2008-9#2)(2013-8#1)
perceptual grouping##2##2##(2007-8#1)(2008-9#1)
perceptual skill learning##2##3##(2007-8#2)
perceptual##51##1##(1991-12#1)(1992-11#2)(1992-12#1)(1995-5#1)(1997-2#1)(2007-12#1)(2007-8#12)(2007-9#2)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#1)(2008-9#4)(2009-2#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#4)
perceptually##3##1##(2009-9#1)(2012-2#1)(2013-8#1)
perch##2##1##(2009-5#1)(2010-8#1)
perches##4##1##(2008-5#4)
perchlorate and##4##2##(2008-10#4)
perchlorate at##2##2##(2008-10#2)
perchlorate exposure##2##2##(2008-10#2)
perchlorate extraction##2##2##(1994-8#1)(2008-10#1)
perchlorate in drinking water##2##4##(2008-10#2)
perchlorate in##9##2##(2008-10#9)
perchlorate ion##3##2##(2008-10#3)
perchlorate is##2##2##(2008-10#2)
perchlorate salts of##2##3##(2008-10#2)
perchlorate system is##2##3##(2008-10#2)
perchlorate system##3##2##(2008-10#3)
perchlorate than##2##2##(2008-10#2)
perchlorate##66##1##(1994-8#2)(1997-3#2)(2008-10#59)(2008-2#1)(2011-1#1)(2012-2#1)
perchlorates##2##1##(2008-10#2)
perchloric acid or##2##3##(2008-10#2)
perchloric acid##12##2##(2008-10#11)(2008-5#1)
perchloric and hydrofluoric acids##2##4##(2008-10#2)
perchloric and##3##2##(2008-10#3)
perchloric##19##1##(1993-11#1)(2008-10#17)(2008-5#1)
perchloroethylene (PCE)##2##2##(2008-10#1)(2009-2#1)
percolate##2##1##(2007-12#1)(2008-10#1)
percolating##3##1##(2008-10#2)(2010-4#1)
percolation##7##1##(1992-11#1)(2008-10#2)(2008-11#1)(2009-11#2)(2013-8#1)
percussion pistol##2##2##(2011-2#2)
percussion##13##1##(1992-5#1)(1993-12#3)(1995-12#1)(1995-8#1)(2008-12#2)(2008-3#2)(2011-2#3)
percutaneous absorption of##4##3##(2008-5#2)(2011-3#2)
percutaneous absorption##9##2##(2008-11#1)(2008-5#6)(2011-3#2)
percutaneous and##2##2##(2008-10#1)(2008-9#1)
percutaneous angioplasty##2##2##(1990-2#1)(1991-3#1)
percutaneous approach##2##2##(1991-3#1)(2011-2#1)
percutaneous aspiration##3##2##(1991-3#1)(2008-1#1)(2012-2#1)
percutaneous balloon##4##2##(1991-3#1)(2008-7#2)(2011-2#1)
percutaneous biopsy of##2##3##(1995-11#1)(2008-1#1)
percutaneous biopsy##3##2##(1995-11#1)(2007-8#1)(2008-1#1)
percutaneous closure of##3##3##(2010-5#1)(2011-2#1)(2012-12#1)
percutaneous coronary intervention (PCI)##6##4##(2008-11#1)(2008-3#2)(2013-1#2)(2013-8#1)
percutaneous coronary intervention for##3##4##(2009-12#1)(2011-2#1)(2013-8#1)
percutaneous coronary intervention through##2##4##(2011-2#1)(2013-1#1)
percutaneous coronary intervention with##2##4##(2008-3#1)(2009-12#1)
percutaneous coronary intervention##28##3##(2008-11#2)(2008-3#9)(2008-7#1)(2009-10#1)(2009-12#3)(2009-5#3)(2011-2#3)(2013-1#4)(2013-8#2)
percutaneous coronary interventions##7##3##(2008-11#1)(2009-12#1)(2010-8#1)(2011-2#4)
percutaneous coronary revascularization##3##3##(2008-10#1)(2008-12#2)
percutaneous coronary##42##2##(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#9)(2008-7#1)(2009-10#1)(2009-12#4)(2009-5#3)(2010-8#1)(2011-2#11)(2013-1#4)(2013-8#2)
percutaneous device closure##2##3##(2007-8#1)(2008-11#1)
percutaneous dilatational tracheostomy##3##3##(2012-12#3)
percutaneous drainage of##2##3##(2010-12#1)(2010-8#1)
percutaneous drainage through the##2##4##(2009-3#1)(2012-8#1)
percutaneous drainage##8##2##(1991-8#1)(2006-10#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-8#1)
percutaneous enhancers##2##2##(2007-11#2)
percutaneous fixation##3##2##(2008-9#3)
percutaneous injection##2##2##(1993-11#1)(2010-12#1)
percutaneous intervention##2##2##(2008-11#1)(2011-2#1)
percutaneous interventions##2##2##(2008-5#1)(2011-2#1)
percutaneous lumbar##2##2##(1996-6#1)(2011-2#1)
percutaneous mitral valvuloplasty for##2##4##(2011-2#2)
percutaneous needle##2##2##(1990-3#2)
percutaneous nephrolithotomy in children##2##4##(2008-10#2)
percutaneous nephrolithotomy##5##2##(2007-10#1)(2008-10#2)(2011-2#1)(2012-12#1)
percutaneous or##4##2##(1991-3#2)(2008-4#1)(2009-11#1)
percutaneous release of##2##3##(2008-9#2)
percutaneous renal##3##2##(1992-5#1)(1995-11#2)
percutaneous technique##3##2##(2010-5#1)(2012-3#2)
percutaneous tracheostomy##2##2##(2008-2#2)
percutaneous transhepatic##3##2##(2008-5#2)(2010-12#1)
percutaneous transluminal angioplasty (PTA)##3##4##(2008-7#1)(2011-2#2)
percutaneous transluminal angioplasty##7##3##(1991-3#1)(1993-8#1)(1997-3#1)(2008-1#1)(2008-7#1)(2011-2#2)
percutaneous transluminal coronary angioplasty (PTCA)##8##5##(1994-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-5#2)(2008-7#1)(2013-8#1)
percutaneous transluminal coronary angioplasty##15##4##(1994-11#2)(1995-2#1)(1995-8#1)(2006-8#1)(2007-10#2)(2007-8#4)(2008-5#2)(2008-7#1)(2013-8#1)
percutaneous transluminal##22##2##(1991-3#1)(1993-8#1)(1994-11#2)(1995-2#1)(1995-8#1)(1997-3#1)(2006-8#1)(2007-10#2)(2007-8#4)(2008-1#1)(2008-5#2)(2008-7#2)(2011-2#2)(2013-8#1)
percutaneous treatment of##3##3##(1997-8#1)(2008-3#1)(2011-2#1)
percutaneous treatment##4##2##(1997-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
percutaneous trigger finger release##2##4##(2008-9#2)
percutaneous##208##1##(1990-2#3)(1990-3#2)(1990-8#4)(1990-9#1)(1991-2#1)(1991-3#7)(1991-8#1)(1992-5#2)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#2)(1995-11#3)(1995-2#1)(1995-8#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#11)(2008-7#9)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-12#4)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#32)(2011-3#2)(2012-12#6)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#4)(2013-8#6)
percutaneously during##2##2##(2008-10#1)(2008-7#1)
percutaneously in##2##2##(1990-11#1)(2013-7#1)
percutaneously with##2##2##(2007-7#1)(2013-1#1)
percutaneously##15##1##(1990-11#1)(1990-8#1)(1992-4#1)(1993-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
perdeuterated palmitic acid##2##3##(1994-5#1)(2008-10#1)
perdeuterated##3##1##(1994-5#1)(2008-10#2)
peregrina##6##1##(2012-2#6)
perennial allergens##3##2##(2009-6#1)(2011-2#2)
perennial allergic rhinitis (PAR)##2##4##(2008-3#2)
perennial and annual Medicago species##3##5##(2008-5#3)
perennial and winter##2##3##(2012-2#2)
perennial and##6##2##(2008-5#3)(2012-2#2)(2013-1#1)
perennial canker##3##2##(2008-10#3)
perennial crops##2##2##(2008-10#2)
perennial grasses##3##2##(2008-10#2)(2008-9#1)
perennial herb##2##2##(2008-12#1)(2008-9#1)
perennial nature##2##2##(2008-10#1)(2011-2#1)
perennial plants##2##2##(2008-10#1)(2010-1#1)
perennial ryegrass (Lolium perenne)##2##4##(2008-10#2)
perennial ryegrass (Lolium##3##3##(2008-10#3)
perennial ryegrass and tall fescue##2##5##(2008-10#2)
perennial ryegrass and##3##3##(2008-10#3)
perennial ryegrass seed crops##2##4##(2008-10#2)
perennial ryegrass turf##5##3##(2008-10#5)
perennial ryegrass##24##2##(2008-10#24)
perennial##73##1##(2008-10#40)(2008-12#1)(2008-3#2)(2008-5#4)(2008-8#6)(2008-9#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#5)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#1)
perennials##6##1##(2008-9#6)
pereopod##2##1##(2008-6#2)
perfect correlation between##2##3##(2007-8#1)(2008-10#1)
perfect correlation##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
perfect double stranded##2##3##(2008-10#2)
perfect imaging##2##2##(2008-3#2)
perfect odd-periodic autocorrelation##2##3##(2008-2#2)
perfect odd-periodic##3##2##(2008-2#2)(2008-3#1)
perfect sinusoidal fringe##2##3##(2008-3#2)
perfect sinusoidal##3##2##(2008-3#3)
perfect##81##1##(1990-3#1)(1990-5#1)(1993-2#1)(1994-12#3)(1994-3#1)(1995-3#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#7)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#18)(2008-5#2)(2008-7#1)(2008-9#4)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
perfect-match##2##1##(2007-12#2)
perfect-shuffle##2##1##(2008-2#2)
perfection##4##1##(1993-12#1)(2008-4#1)(2013-1#2)
perfectly aligned arrays of##2##4##(2008-7#2)
perfectly aligned##5##2##(1995-3#1)(2008-2#2)(2008-7#2)
perfectly conducting##2##2##(2007-12#1)(2008-3#1)
perfectly linear##2##2##(2008-10#1)(2008-7#1)
perfectly matched layer##4##3##(2008-3#3)(2013-7#1)
perfectly matched##6##2##(1995-12#1)(2008-3#3)(2008-4#1)(2013-7#1)
perfectly periodic##2##2##(1996-4#1)(2007-12#1)
perfectly suited for##2##3##(2007-12#1)(2008-4#1)
perfectly suited##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
perfectly to##2##2##(2008-10#2)
perfectly with##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
perfectly##47##1##(1992-2#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#2)
perfluorinated##2##1##(2008-10#1)(2010-4#1)
perfluoroacylation reagents##2##2##(2008-10#2)
perfluorodecanoic acid##2##2##(1994-8#2)
perforant path in##2##3##(1990-5#1)(1993-12#1)
perforant path##8##2##(1990-5#1)(1990-7#1)(1993-12#6)
perforant##11##1##(1990-5#2)(1990-7#1)(1993-12#6)(1995-12#1)(2009-8#1)
perforata##3##1##(2012-2#3)
perforated duodenal##2##2##(1993-6#1)(2010-4#1)
perforated gastroduodenal ulcer##2##3##(1993-6#1)(2012-3#1)
perforated pyloric ulcer##3##3##(1990-6#3)
perforated with##4##2##(2007-12#2)(2008-7#1)(2012-2#1)
perforated##22##1##(1990-6#4)(1993-6#2)(1993-9#2)(1995-11#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
perforating##3##1##(2011-1#1)(2011-2#1)(2013-1#1)
perforation and##6##2##(1990-6#1)(2007-11#1)(2009-8#1)(2010-8#2)(2011-2#1)
perforation could##2##2##(1993-6#1)(2011-2#1)
perforation during##2##2##(1996-6#1)(1997-2#1)
perforation in##3##2##(1990-12#1)(1991-3#1)(2013-1#1)
perforation of a blind loop##2##5##(1991-9#2)
perforation of a##4##3##(1991-9#2)(1993-6#1)(2008-12#1)
perforation of the rectum by##2##5##(1993-8#2)
perforation of the##7##3##(1991-8#1)(1993-8#2)(2009-4#1)(2011-2#2)(2013-1#1)
perforation of##13##2##(1991-8#1)(1991-9#2)(1993-6#1)(1993-8#2)(2008-10#1)(2008-12#2)(2009-4#1)(2011-2#2)(2013-1#1)
perforation or##2##2##(1990-11#1)(2011-2#1)
perforation with##3##2##(1997-3#1)(2010-12#1)(2010-2#1)
perforation##68##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1993-6#4)(1993-8#2)(1995-10#2)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-2#3)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-2#13)(2013-1#6)(2013-8#2)
perforations are##2##2##(2010-12#2)
perforations##15##1##(1990-2#1)(1990-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#2)(2010-4#1)(2011-2#4)(2012-8#2)(2013-1#1)
perforator flap##3##2##(2011-2#1)(2013-1#2)
perforator flaps##2##2##(2011-2#1)(2012-2#1)
perforator##11##1##(2008-9#2)(2011-2#2)(2012-2#2)(2013-1#5)
perforators##8##1##(2008-9#4)(2011-3#1)(2013-1#3)
perforatum##3##1##(2008-10#1)(2008-8#1)(2009-3#1)
perform a risk##2##3##(2007-9#1)(2012-2#1)
perform a##42##2##(1990-6#1)(1993-11#1)(1996-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
perform accurate##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
perform activities##2##2##(2008-6#1)(2012-2#1)
perform an##13##2##(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
perform any##4##2##(1992-6#1)(2008-2#1)(2009-1#1)(2009-3#1)
perform as well as##3##4##(2008-2#1)(2008-5#1)(2008-9#1)
perform as##4##2##(1996-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
perform better in##2##3##(2012-1#2)
perform better than##2##3##(2008-12#1)(2012-3#1)
perform better##8##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-3#1)(2012-1#2)(2012-3#1)
perform close to##2##3##(2008-1#1)(2008-3#1)
perform complex##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
perform extensive##2##2##(1994-11#1)(2008-6#1)
perform in##7##2##(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)(2010-1#1)(2012-12#1)
perform many##2##2##(2008-11#1)(2008-7#1)
perform measurements at##2##3##(1996-12#1)(2007-12#1)
perform measurements##3##2##(1996-12#1)(2007-12#1)(2008-3#1)
perform more##4##2##(1993-2#1)(2010-7#1)(2010-8#1)(2012-2#1)
perform quantitative##9##2##(1997-2#2)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
perform radical##2##2##(1990-9#1)(1992-6#1)
perform some##2##2##(1993-12#1)(2007-8#1)
perform such##2##2##(2007-11#1)(2010-12#1)
perform tasks##4##2##(2007-9#1)(2008-7#1)(2008-9#1)(2010-12#1)
perform the necessary##2##3##(1994-3#1)(2008-9#1)
perform the operation##2##3##(1993-9#1)(2011-2#1)
perform the same##4##3##(1997-6#1)(2007-12#1)(2008-5#1)(2010-8#1)
perform the sequential##2##3##(2008-10#2)
perform the##55##2##(1991-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
perform their duties##2##3##(1995-1#1)(1996-12#1)
perform their##8##2##(1990-12#1)(1991-3#2)(1995-1#1)(1996-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
perform these##2##2##(2008-3#1)(2009-9#1)
perform this##2##2##(2008-9#1)(2011-2#1)
perform well in##3##3##(1997-3#1)(2008-6#1)(2013-1#1)
perform well##9##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-3#1)(2013-1#1)
perform##395##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#5)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#6)(2007-12#10)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#10)(2008-10#70)(2008-11#9)(2008-12#5)(2008-2#20)(2008-3#39)(2008-4#8)(2008-5#6)(2008-6#9)(2008-7#15)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#15)(2011-3#2)(2012-1#5)(2012-12#3)(2012-2#12)(2012-3#7)(2013-1#14)(2013-7#3)(2013-8#11)
performance across##2##2##(2009-7#1)(2010-3#1)
performance after##6##2##(1991-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)
performance analysis of##5##3##(2008-3#5)
performance analysis##7##2##(2007-12#1)(2008-3#5)(2011-1#1)
performance and a##2##3##(2008-9#1)(2011-1#1)
performance and accountability##2##3##(1996-11#2)
performance and accuracy##2##3##(2008-2#1)(2008-3#1)
performance and cost-effectiveness##2##3##(1995-2#2)
performance and efficiency of##2##4##(2007-12#1)(2009-8#1)
performance and for##3##3##(1996-3#1)(2008-10#1)(2010-8#1)
performance and improve quality##2##4##(1996-3#2)
performance and in##2##3##(2009-12#1)(2013-1#1)
performance and increased##3##3##(1992-11#1)(2008-5#1)(2008-7#1)
performance and quality##2##3##(2008-10#1)(2008-11#1)
performance and the##3##3##(2008-3#1)(2011-1#1)(2013-8#1)
performance and##95##2##(1992-11#1)(1993-12#2)(1994-12#1)(1995-12#1)(1995-2#2)(1996-11#2)(1996-3#3)(1997-2#1)(2007-11#3)(2007-12#4)(2007-2#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#5)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-5#1)(2013-1#3)(2013-8#3)
performance appears to be##2##4##(2008-10#1)(2012-2#1)
performance are discussed##3##3##(2007-11#1)(2008-3#2)
performance are given##2##3##(2007-11#1)(2008-10#1)
performance are##14##2##(1992-12#1)(1996-8#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2010-7#1)(2013-1#1)
performance as a##2##3##(2007-12#1)(2008-3#1)
performance as an##2##3##(2008-10#2)
performance as measured by##3##4##(1993-1#1)(2010-9#1)(2013-1#1)
performance as##15##2##(1993-1#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#5)(2010-9#1)(2013-1#1)
performance assessment##7##2##(1993-12#1)(1994-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(2010-12#1)
performance at a##2##3##(1996-3#1)(2008-11#1)
performance at different temperatures##2##4##(2008-8#2)
performance at##14##2##(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#5)(2011-2#1)(2012-2#1)
performance benefits##2##2##(2008-3#1)(2008-5#1)
performance between the##2##3##(2008-7#1)(2010-8#1)
performance between##4##2##(2008-7#1)(2008-9#2)(2010-8#1)
performance both##2##2##(1993-12#1)(2008-5#1)
performance but##2##2##(1992-11#1)(2008-2#1)
performance by use of##2##4##(2008-2#1)(2008-3#1)
performance by##12##2##(1991-2#1)(1993-3#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2009-11#1)(2011-1#1)(2013-1#1)
performance calculations##2##2##(2008-3#2)
performance can be achieved##2##4##(2007-11#1)(2010-8#1)
performance can be improved##2##4##(1996-3#1)(2008-3#1)
performance can be##11##3##(1996-12#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-8#1)
performance can##14##2##(1996-12#1)(1996-2#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2010-8#1)
performance capillary electrophoresis##3##3##(2008-10#3)
performance characteristics are##3##3##(2008-10#2)(2008-3#1)
performance characteristics in##2##3##(2008-10#2)
performance characteristics of the##6##4##(2008-10#4)(2008-3#1)(2008-5#1)
performance characteristics of##13##3##(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)
performance characteristics were##2##3##(2008-10#2)
performance characteristics##37##2##(1995-2#1)(2008-10#23)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2010-3#1)(2010-4#1)(2011-2#1)
performance compared to##3##3##(2008-1#1)(2008-10#2)
performance compared with##2##3##(2008-11#1)(2008-3#1)
performance compared##5##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
performance conditions##2##2##(2008-10#2)
performance could be##2##3##(1993-3#1)(2008-2#1)
performance criteria such as##2##4##(2008-10#2)
performance criteria##8##2##(2008-10#6)(2008-3#1)(2008-5#1)
performance data##3##2##(1997-3#1)(2008-2#1)(2013-1#1)
performance decreased##2##2##(2008-8#1)(2012-3#1)
performance deficits##4##2##(1992-11#3)(2013-1#1)
performance depends on##2##3##(2008-10#1)(2011-2#1)
performance depends##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
performance deterioration##2##2##(2012-2#2)
performance during##5##2##(1993-3#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-2#1)
performance estimate##2##2##(2008-3#2)
performance evaluation of the##2##4##(2008-10#2)
performance evaluation of##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
performance evaluation##9##2##(1995-1#2)(1996-2#1)(2008-10#3)(2008-2#1)(2008-3#2)
performance factors##2##2##(1993-12#1)(1994-3#1)
performance feedback##5##2##(2007-10#4)(2008-11#1)
performance following##2##2##(2008-5#1)(2008-8#1)
performance for a##2##3##(2008-3#2)
performance for the##5##3##(1996-12#1)(2007-11#1)(2008-3#3)
performance for##28##2##(1996-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
performance from##2##2##(1993-5#1)(2008-3#1)
performance gain##2##2##(2008-2#2)
performance has been compared with##2##5##(2007-11#1)(2010-8#1)
performance has been##6##3##(1994-8#1)(2007-11#1)(2008-2#1)(2009-6#1)(2010-8#2)
performance has##9##2##(1994-8#1)(2007-11#1)(2008-2#2)(2008-7#1)(2009-6#1)(2010-8#2)(2011-2#1)
performance have been studied##2##4##(2008-10#2)
performance have been##4##3##(2008-10#3)(2011-2#1)
performance have##6##2##(1996-3#1)(2008-10#3)(2011-2#1)(2012-3#1)
performance improvement is##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
performance improvement##10##2##(1995-12#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-1#1)
performance improvements of##2##3##(2008-2#1)(2008-3#1)
performance improvements##4##2##(2008-2#1)(2008-3#3)
performance improves##2##2##(1996-3#1)(2008-3#1)
performance in a two-way##2##4##(1996-5#1)(2012-2#1)
performance in a##11##3##(1996-5#2)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#1)(2012-7#1)(2013-8#1)
performance in an##2##3##(1996-1#1)(2008-11#1)
performance in both##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
performance in children and##2##4##(2008-9#2)
performance in children##4##3##(2008-9#3)(2012-1#1)
performance in comparison##2##3##(2008-10#1)(2008-3#1)
performance in high##2##3##(2007-8#1)(2008-10#1)
performance in noise##2##3##(2008-2#1)(2008-9#1)
performance in older##2##3##(2013-1#2)
performance in patients##2##3##(2009-10#1)(2011-2#1)
performance in single-##2##3##(2008-2#1)(2008-3#1)
performance in terms of detection##2##5##(2008-10#1)(2008-3#1)
performance in terms of##7##4##(2008-10#3)(2008-11#1)(2008-3#2)(2010-8#1)
performance in the presence of##2##5##(2008-2#1)(2008-3#1)
performance in the##29##3##(1991-2#1)(1991-3#2)(1992-11#1)(1992-12#2)(1994-1#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#1)
performance in their##2##3##(1993-1#1)(1996-2#1)
performance in these##2##3##(2008-12#1)(2009-9#1)
performance in this##2##3##(1994-6#1)(2008-8#1)
performance in##150##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1992-11#1)(1992-12#2)(1993-1#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-5#3)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#3)(1996-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#15)(2008-11#10)(2008-12#4)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#10)(2009-10#4)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#1)(2012-6#1)(2012-7#1)(2013-1#5)(2013-8#3)
performance index##5##2##(1993-3#1)(2008-12#3)(2011-2#1)
performance indicators for##2##3##(1993-2#1)(1994-2#1)
performance indicators to##2##3##(1994-2#1)(2008-11#1)
performance indicators##12##2##(1992-12#2)(1993-2#2)(1994-2#3)(2007-4#2)(2008-11#2)(2011-2#1)
performance information##6##2##(1996-3#2)(1997-3#1)(2008-7#1)(2013-1#2)
performance is a##2##3##(1995-2#1)(2008-2#1)
performance is achieved##2##3##(2008-10#1)(2008-3#1)
performance is affected##2##3##(1990-11#1)(2008-7#1)
performance is also##3##3##(2008-2#1)(2008-3#2)
performance is compared with##2##4##(1993-2#1)(2008-2#1)
performance is compared##3##3##(1993-2#1)(2008-2#1)(2008-6#1)
performance is evaluated##2##3##(2008-3#1)(2008-8#1)
performance is found to be##2##5##(2008-2#1)(2008-3#1)
performance is investigated##2##3##(2008-3#2)
performance is obtained##3##3##(2008-3#3)
performance is reported##2##3##(1996-12#1)(2008-2#1)
performance is significantly##2##3##(1996-12#1)(2008-2#1)
performance is##46##2##(1990-11#1)(1993-2#1)(1993-5#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-3#1)(2008-10#5)(2008-2#10)(2008-3#16)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-2#1)
performance level##2##2##(1993-3#1)(2008-7#1)
performance limits##2##2##(2008-10#1)(2008-3#1)
performance liquid chromatographic analysis##2##4##(1994-8#1)(2008-10#1)
performance liquid chromatographic determination of##3##5##(1993-2#1)(2008-10#2)
performance liquid chromatographic##17##3##(1993-2#1)(1994-8#1)(2008-10#10)(2010-3#1)(2011-1#2)(2012-1#1)(2012-2#1)
performance liquid chromatography (HPLC) with##7##5##(1997-2#1)(2008-10#4)(2008-5#1)(2010-5#1)
performance liquid chromatography (HPLC)##51##4##(1991-8#1)(1992-8#1)(1997-2#1)(2008-10#35)(2008-11#1)(2008-5#3)(2008-8#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
performance liquid chromatography and##7##4##(1990-2#2)(1990-7#1)(2008-10#4)
performance liquid chromatography coupled##2##4##(2012-1#1)(2012-3#1)
performance liquid chromatography method for##2##5##(2008-10#1)(2008-5#1)
performance liquid chromatography method##3##4##(2008-10#2)(2008-5#1)
performance liquid chromatography of##3##4##(1994-6#1)(2008-10#2)
performance liquid chromatography using##2##4##(2008-10#1)(2011-1#1)
performance liquid chromatography with##17##4##(1993-2#1)(1995-6#1)(2008-10#14)(2008-5#1)
performance liquid chromatography##135##3##(1990-2#3)(1990-7#3)(1990-8#2)(1991-4#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#84)(2008-11#2)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
performance liquid chromatography-electrospray ionization tandem mass##3##6##(2008-10#1)(2011-1#2)
performance liquid chromatography-electrospray ionization##4##4##(2008-10#2)(2011-1#2)
performance liquid chromatography-electrospray##7##3##(2008-10#2)(2008-8#2)(2011-1#2)(2012-3#1)
performance liquid chromatography-tandem mass spectrometry##2##5##(2011-1#2)
performance liquid chromatography-tandem mass##4##4##(2011-1#4)
performance liquid chromatography]##3##3##(2011-1#2)(2011-2#1)
performance liquid##183##2##(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#3)(1990-8#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#108)(2008-11#2)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#17)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
performance loss##2##2##(2007-12#1)(2010-10#1)
performance makes##2##2##(2008-10#1)(2008-11#1)
performance management##5##2##(1995-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
performance may##2##2##(1996-3#1)(1997-3#1)
performance measure##6##2##(1993-3#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#2)
performance measured##2##2##(1994-8#1)(2008-7#1)
performance measurement and##3##3##(1995-3#1)(2008-11#1)(2008-4#1)
performance measurement##18##2##(1993-1#1)(1995-3#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#2)(2007-4#3)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)
performance measures and##4##3##(1996-12#1)(1997-3#1)(2010-8#1)(2013-1#1)
performance measures based on##2##4##(1993-2#1)(1997-3#1)
performance measures##21##2##(1992-11#1)(1993-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#6)(2008-11#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
performance metrics##3##2##(2008-2#2)(2008-3#1)
performance obtained##3##2##(2008-6#1)(2012-12#2)
performance of a joint##2##4##(2008-3#2)
performance of a new##5##4##(2007-7#1)(2008-10#3)(2008-3#1)
performance of a nonlinear##2##4##(2007-11#1)(2008-2#1)
performance of a number of##3##5##(1995-5#1)(2008-3#2)
performance of a spatial##3##4##(1994-3#2)(2008-11#1)
performance of a##88##3##(1992-11#2)(1992-9#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-6#1)(1996-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-2#14)(2008-3#29)(2008-4#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#2)
performance of adaptive##2##3##(2008-3#2)
performance of adult##2##3##(1992-11#1)(2008-9#1)
performance of all##2##3##(2008-10#1)(2008-6#1)
performance of an##15##3##(1993-8#1)(2007-11#3)(2008-10#2)(2008-2#4)(2008-3#3)(2008-5#1)(2009-11#1)
performance of both the##2##4##(2008-10#1)(2008-2#1)
performance of both##8##3##(2008-10#5)(2008-2#1)(2008-3#2)
performance of capillary##2##3##(2008-10#2)
performance of cascaded##3##3##(2008-3#3)
performance of children##3##3##(2008-2#1)(2008-9#1)(2013-1#1)
performance of college students##3##4##(2009-3#1)(2013-8#2)
performance of daily living##2##4##(2007-11#2)
performance of devices##2##3##(2009-11#2)
performance of different##2##3##(2010-2#1)(2013-8#1)
performance of diffractive##2##3##(2008-2#1)(2008-3#1)
performance of direct##2##3##(2009-8#1)(2013-8#1)
performance of electrochemical##3##3##(2008-10#3)
performance of four rapid##2##4##(2007-7#1)(2011-1#1)
performance of four##4##3##(1995-2#1)(2007-7#1)(2008-3#1)(2011-1#1)
performance of fully phase- and amplitude-based encryption##2##7##(2008-3#2)
performance of grating-assisted output couplers of finite extent##2##8##(2007-12#2)
performance of health maintenance organizations##2##5##(1991-3#1)(1994-2#1)
performance of health##5##3##(1991-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)
performance of highly neodymium-doped yttrium aluminum garnet##2##7##(2007-11#2)
performance of individuals##2##3##(2007-8#1)(2008-9#1)
performance of integrated##2##3##(1995-12#1)(2008-3#1)
performance of methods##2##3##(2008-7#1)(2009-5#1)
performance of new##2##3##(1994-3#1)(2008-10#1)
performance of optical##2##3##(2007-12#1)(2008-2#1)
performance of our system##2##4##(2008-2#1)(2008-6#1)
performance of our##6##3##(2008-2#2)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
performance of providers##2##3##(1994-1#1)(1996-1#1)
performance of such a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
performance of such##6##3##(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
performance of the QA-810 V##2##5##(2008-10#2)
performance of the SIA system##2##5##(2008-10#2)
performance of the algorithm##5##4##(1997-3#1)(2008-2#1)(2008-3#3)
performance of the device is##2##5##(2007-11#1)(2008-3#1)
performance of the device##5##4##(2007-11#1)(2008-10#1)(2008-3#2)(2009-7#1)
performance of the different##2##4##(2008-10#1)(2011-1#1)
performance of the filter##2##4##(2007-12#1)(2008-2#1)
performance of the method for##2##5##(2008-10#1)(2008-2#1)
performance of the method has been evaluated##2##7##(2008-10#2)
performance of the method has been##3##6##(2008-10#3)
performance of the method is##3##5##(2008-2#1)(2008-3#2)
performance of the method##15##4##(2008-10#8)(2008-2#2)(2008-3#3)(2010-4#1)(2012-1#1)
performance of the new##3##4##(2008-2#1)(2008-3#2)
performance of the optical##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
performance of the proposed approach##3##5##(2008-10#1)(2011-1#1)(2012-1#1)
performance of the proposed method##9##5##(2008-10#6)(2008-2#1)(2008-3#1)(2010-2#1)
performance of the proposed procedure##2##5##(2008-10#1)(2009-9#1)
performance of the proposed##22##4##(2008-10#11)(2008-2#3)(2008-3#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)
performance of the sensor##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
performance of the sensors##2##4##(2008-10#2)
performance of the system with respect to##2##7##(2008-10#1)(2008-2#1)
performance of the system with##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
performance of the system##12##4##(2008-10#9)(2008-2#1)(2008-3#2)
performance of the test##2##4##(2007-2#1)(2008-11#1)
performance of the three##2##4##(1996-3#1)(2008-5#1)
performance of the two##4##4##(1991-2#1)(2008-12#1)(2008-3#1)(2008-5#1)
performance of the various##2##4##(2007-12#1)(2008-5#1)
performance of the##232##3##(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#10)(2007-12#5)(2007-2#1)(2007-8#2)(2008-10#67)(2008-11#3)(2008-12#3)(2008-2#29)(2008-3#45)(2008-5#6)(2008-6#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
performance of their##3##3##(1994-2#1)(1996-12#1)(2008-4#1)
performance of these electrodes##2##4##(2008-10#2)
performance of these##16##3##(1997-2#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#1)(2010-7#1)
performance of this device##2##4##(2007-11#1)(2008-2#1)
performance of this fungus##2##4##(2008-10#2)
performance of this sensor##2##4##(2008-10#2)
performance of this##28##3##(2007-11#1)(2007-12#3)(2008-10#12)(2008-11#2)(2008-2#5)(2008-3#4)(2012-3#1)
performance of three##4##3##(1993-12#1)(2008-10#2)(2008-2#1)
performance of two##6##3##(1991-2#1)(1994-3#1)(2008-3#3)(2008-5#1)
performance of various##3##3##(2008-10#1)(2008-3#2)
performance of##701##2##(1990-11#2)(1990-3#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#3)(1992-8#1)(1992-9#1)(1993-12#10)(1993-2#1)(1993-3#2)(1993-8#2)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-4#1)(2007-10#1)(2007-11#22)(2007-12#20)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#157)(2008-11#17)(2008-12#9)(2008-2#70)(2008-3#134)(2008-4#4)(2008-5#17)(2008-6#14)(2008-7#12)(2008-8#1)(2008-9#15)(2009-10#1)(2009-11#9)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#4)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#8)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#14)(2013-8#7)
performance on a##4##3##(2008-10#1)(2011-2#1)(2012-3#2)
performance on an attribute##2##4##(1997-3#2)
performance on an##3##3##(1993-12#1)(1997-3#2)
performance on novel##2##3##(2008-8#2)
performance on the##11##3##(1992-11#1)(1996-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
performance on##50##2##(1990-3#1)(1992-11#1)(1993-12#4)(1994-1#1)(1994-3#1)(1995-2#1)(1996-2#2)(1997-3#2)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-3#2)(2011-2#2)(2012-2#3)(2012-3#6)(2013-1#2)(2013-8#1)
performance or##6##2##(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2011-1#2)
performance outcomes##2##2##(1993-2#1)(2008-9#1)
performance over a##2##3##(2008-2#1)(2008-5#1)
performance over time##4##3##(2007-4#1)(2008-12#1)(2009-9#1)(2011-2#1)
performance over##13##2##(2007-4#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
performance parameters##4##2##(1997-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
performance potential##2##2##(2008-3#1)(2008-8#1)
performance profiles##2##2##(1997-2#1)(2012-3#1)
performance regarding##2##2##(2010-8#1)(2012-12#1)
performance related to##3##3##(1996-2#1)(2008-12#1)(2012-2#1)
performance related##4##2##(1996-2#1)(2008-12#1)(2008-7#1)(2012-2#1)
performance relative to##2##3##(2008-8#1)(2008-9#1)
performance report##2##2##(1992-3#1)(1996-3#1)
performance reports##3##2##(1995-3#1)(2013-1#2)
performance requirements##4##2##(2008-2#1)(2008-3#2)(2011-2#1)
performance should be##3##3##(1991-3#1)(2008-3#1)(2012-2#1)
performance similar to##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
performance standard##2##2##(1992-2#1)(2012-2#1)
performance standards##7##2##(1993-12#7)
performance statistics##2##2##(2008-9#2)
performance status (PS)##3##3##(2007-10#1)(2007-11#1)(2008-7#1)
performance status assessment##2##3##(2012-3#2)
performance status##23##2##(1991-2#2)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(2007-10#1)(2007-11#3)(2008-6#1)(2008-7#4)(2010-12#1)(2010-2#3)(2011-2#1)(2012-3#3)
performance such as##2##3##(1992-12#1)(2008-10#1)
performance suggests that##2##3##(1991-2#1)(1992-12#1)
performance testing##2##2##(2008-3#1)(2013-1#1)
performance than the##5##3##(2008-10#1)(2008-11#1)(2008-3#3)
performance than##17##2##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#2)
performance that is##2##3##(2008-2#2)
performance that##6##2##(2008-2#3)(2008-3#2)(2011-2#1)
performance the##3##2##(2008-3#2)(2008-5#1)
performance through##2##2##(2008-10#1)(2010-8#1)
performance to be##2##3##(1990-6#1)(2008-3#1)
performance to the##2##3##(2012-2#1)(2013-1#1)
performance to##19##2##(1990-6#1)(1994-3#2)(1996-12#1)(1996-2#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-8#1)(2009-9#2)(2012-2#1)(2013-1#1)
performance toward##2##2##(2008-10#1)(2013-1#1)
performance under a##2##3##(2008-2#1)(2012-9#1)
performance under##13##2##(1993-1#1)(1993-12#1)(1993-3#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#3)(2012-12#1)(2012-9#1)
performance using##4##2##(1993-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
performance verification##2##2##(2008-2#1)(2008-3#1)
performance voltage##3##2##(2008-10#3)
performance was achieved##3##3##(2008-10#3)
performance was also##4##3##(1993-12#1)(2008-10#2)(2008-7#1)
performance was assessed##2##3##(2008-10#1)(2013-1#1)
performance was evaluated by##7##4##(2008-10#5)(2008-3#1)(2013-1#1)
performance was evaluated using##2##4##(2007-9#1)(2013-1#1)
performance was evaluated with##3##4##(2008-10#3)
performance was evaluated##16##3##(2007-9#1)(2008-10#12)(2008-3#1)(2013-1#2)
performance was found to be##2##5##(2008-10#1)(2008-9#1)
performance was found##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
performance was measured for##2##4##(2008-9#2)
performance was measured##3##3##(2008-10#1)(2008-9#2)
performance was observed##5##3##(2008-10#5)
performance was severely##2##3##(2008-8#1)(2011-2#1)
performance was studied##2##3##(1996-2#1)(2008-11#1)
performance was##71##2##(1990-11#1)(1993-12#3)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-9#2)(2008-10#37)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2010-7#2)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#3)
performance we found in the##2##5##(2008-11#2)
performance were examined##2##3##(2010-7#1)(2011-1#1)
performance were investigated##2##3##(2008-10#1)(2011-1#1)
performance were observed##2##3##(2008-10#1)(2013-1#1)
performance were##15##2##(1996-3#1)(1996-7#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-1#3)(2013-1#2)
performance when##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
performance with that of##3##4##(1997-1#1)(2008-3#1)(2008-5#1)
performance with the##2##3##(2007-11#1)(2008-7#1)
performance with##19##2##(1994-9#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2011-1#1)
performance within##2##2##(1997-1#1)(2008-10#1)
performance without##2##2##(1992-12#1)(2008-5#1)
performance##2425##1##(1990-11#6)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#2)(1991-1#4)(1991-12#3)(1991-2#12)(1991-3#9)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#5)(1992-10#1)(1992-11#15)(1992-12#14)(1992-2#7)(1992-3#2)(1992-8#3)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#44)(1993-2#10)(1993-3#13)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#12)(1994-11#1)(1994-12#10)(1994-2#12)(1994-3#16)(1994-6#5)(1994-8#8)(1994-9#2)(1995-1#8)(1995-11#3)(1995-12#22)(1995-2#11)(1995-3#12)(1995-5#6)(1995-6#3)(1996-1#7)(1996-11#2)(1996-12#19)(1996-2#28)(1996-3#31)(1996-5#7)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#9)(1997-3#22)(1997-5#2)(1997-7#1)(1997-8#1)(2006-4#1)(2007-10#11)(2007-11#45)(2007-12#38)(2007-2#2)(2007-4#6)(2007-7#7)(2007-8#10)(2007-9#4)(2008-1#5)(2008-10#467)(2008-11#78)(2008-12#42)(2008-2#174)(2008-3#322)(2008-4#12)(2008-5#62)(2008-6#37)(2008-7#55)(2008-8#32)(2008-9#56)(2009-1#6)(2009-10#14)(2009-11#10)(2009-12#4)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#16)(2009-8#11)(2009-9#11)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#23)(2010-3#7)(2010-4#7)(2010-5#5)(2010-7#12)(2010-8#32)(2010-9#3)(2011-1#40)(2011-2#60)(2011-3#2)(2011-7#1)(2012-1#12)(2012-12#20)(2012-2#46)(2012-3#33)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#63)(2013-8#29)
performance)##3##1##(1994-8#1)(2008-5#1)(2009-7#1)
performance-based objectives##2##2##(1996-2#2)
performance-based##5##1##(1996-2#2)(2008-10#1)(2011-2#2)
performance-enhancing##2##1##(2008-3#1)(2010-7#1)
performance-measurement system##2##2##(1996-2#2)
performance?##4##1##(1991-11#1)(1992-3#2)(1994-12#1)
performances and##2##2##(1997-7#1)(2013-1#1)
performances are compared##2##3##(2008-10#2)
performances are##5##2##(2008-10#3)(2008-12#1)(2008-3#1)
performances for##6##2##(1997-2#1)(2008-10#1)(2008-3#2)(2009-10#1)(2009-2#1)
performances in the##2##3##(2008-3#1)(2012-2#1)
performances in##7##2##(1997-2#1)(2008-3#2)(2010-8#1)(2012-2#1)(2012-5#1)(2013-1#1)
performances of a##3##3##(1993-3#1)(2008-10#2)
performances of the proposed##2##4##(2008-10#1)(2008-3#1)
performances of the##15##3##(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#3)(2011-2#1)
performances of these##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
performances of two##2##3##(2008-10#1)(2008-3#1)
performances of##38##2##(1991-3#1)(1993-2#1)(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#7)(2008-6#1)(2010-8#1)(2011-2#1)
performances were##3##2##(2008-10#1)(2008-3#1)(2009-2#1)
performances##92##1##(1990-6#1)(1991-3#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#16)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#5)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
performed 12##3##2##(1992-8#1)(2008-12#1)(2013-1#1)
performed 2##2##2##(2008-5#1)(2012-12#1)
performed SMBG##3##2##(2008-8#3)
performed a genome-wide##3##3##(2010-5#1)(2012-3#2)
performed a literature review##2##4##(2008-1#1)(2013-1#1)
performed a pilot study##2##4##(2007-5#1)(2009-12#1)
performed a prospective##3##3##(1994-2#1)(2008-8#1)(2011-2#1)
performed a retrospective##10##3##(2007-10#2)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#5)
performed a semiquantitative##2##3##(2008-7#1)(2013-8#1)
performed a task##2##3##(2008-11#1)(2010-5#1)
performed a##79##2##(1991-3#1)(1992-12#1)(1992-6#1)(1994-2#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#10)(2013-1#5)(2013-8#6)
performed according to a##2##4##(1990-12#1)(2008-6#1)
performed according to the##2##4##(2008-7#1)(2008-9#1)
performed according to##9##3##(1990-12#1)(1991-3#1)(1993-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2012-1#1)
performed after a##4##3##(1990-11#1)(1997-4#1)(2008-10#1)(2011-2#1)
performed after the##2##3##(2012-1#1)(2013-1#1)
performed after##22##2##(1990-11#1)(1990-8#1)(1992-5#1)(1993-11#1)(1993-6#1)(1996-3#2)(1997-4#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-11#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
performed against##2##2##(2008-11#1)(2012-2#1)
performed all##2##2##(2007-8#1)(2008-12#1)
performed along##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
performed also by##2##3##(1991-2#1)(1992-9#1)
performed among##2##2##(2008-10#2)
performed an analysis of##2##4##(2010-2#1)(2011-2#1)
performed an analysis##3##3##(2008-5#1)(2010-2#1)(2011-2#1)
performed an experimental study##2##4##(1993-3#1)(2007-11#1)
performed an experimental##4##3##(1993-3#1)(2007-11#1)(2008-2#1)(2012-2#1)
performed an##18##2##(1991-6#1)(1993-3#1)(1994-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#2)
performed and a##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
performed and compared with##3##4##(1993-9#1)(2008-2#1)(2012-2#1)
performed and replicated##2##3##(2008-10#1)(2010-1#1)
performed and the##18##3##(1990-3#1)(1990-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)(2011-2#3)(2013-1#2)
performed and##53##2##(1990-3#2)(1990-5#1)(1991-2#1)(1992-6#1)(1993-9#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-6#1)(2011-2#4)(2012-2#3)(2013-1#5)(2013-8#1)
performed annually##2##2##(2008-10#1)(2010-11#1)
performed around##2##2##(2009-5#1)(2011-2#1)
performed as a##6##3##(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
performed as an##2##3##(2008-7#1)(2011-2#1)
performed as part of##2##4##(1993-1#1)(2010-3#1)
performed as the##2##3##(1996-5#1)(2008-7#1)
performed as##21##2##(1990-6#1)(1991-2#1)(1993-1#1)(1995-11#2)(1995-2#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
performed at a constant##2##4##(2008-10#2)
performed at a##11##3##(1991-2#1)(1992-12#1)(1993-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)
performed at an##4##3##(1991-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
performed at concentrations##2##3##(1992-3#1)(2008-3#1)
performed at different##6##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)
performed at high##2##3##(1997-8#1)(2008-7#1)
performed at our##2##3##(1995-1#1)(2007-8#1)
performed at the##16##3##(1994-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
performed at this##2##3##(2008-7#1)(2008-8#1)
performed at##94##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#3)(1994-12#2)(1994-3#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-8#2)(2006-8#1)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
performed based on##2##3##(2007-11#1)(2008-10#1)
performed because of##6##3##(1993-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
performed before surgery##2##3##(2007-11#1)(2010-6#1)
performed before the##3##3##(1990-12#1)(1996-11#1)(2008-4#1)
performed before##9##2##(1990-11#1)(1990-12#1)(1996-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-6#1)
performed best on##2##3##(2007-7#1)(2011-2#1)
performed best##5##2##(1993-8#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-3#1)
performed better than##3##3##(2009-3#1)(2009-7#1)(2009-8#1)
performed better when rare variants were collapsed based on genes##2##10##(2012-3#2)
performed better##8##2##(1995-3#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-7#1)(2012-3#2)
performed between##8##2##(1990-6#1)(1994-11#1)(1996-12#1)(2008-10#4)(2010-11#1)
performed both##2##2##(2008-3#1)(2008-4#1)
performed by a##20##3##(1990-6#1)(1993-2#1)(2007-12#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#1)
performed by affinity chromatography##2##4##(1997-2#1)(2008-11#1)
performed by an##3##3##(2008-10#2)(2013-1#1)
performed by comparing##2##3##(1997-6#1)(2008-10#1)
performed by flame atomic absorption##2##5##(2008-10#2)
performed by gas chromatography-mass spectrometry##2##5##(2008-10#2)
performed by gas##3##3##(2008-10#3)
performed by laparoscopy##3##3##(1993-9#1)(1994-9#1)(1996-8#1)
performed by means of a##2##5##(2008-10#1)(2008-2#1)
performed by means of the##2##5##(2008-10#2)
performed by means of##7##4##(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)
performed by measuring the##5##4##(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
performed by minimally-invasive##2##3##(2011-2#1)(2013-8#1)
performed by one##3##3##(2008-10#1)(2008-7#2)
performed by surgeons##2##3##(1996-9#1)(2007-8#1)
performed by the analysis of##2##5##(2008-10#2)
performed by the same##3##4##(1995-1#1)(2008-3#1)(2008-8#1)
performed by the##34##3##(1990-5#1)(1993-12#3)(1995-1#2)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-3#6)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
performed by two##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
performed by use of a##2##5##(2008-3#1)(2008-9#1)
performed by use of##5##4##(2008-3#3)(2008-9#2)
performed by using a##3##4##(2008-10#2)(2011-2#1)
performed by using the##2##4##(2008-5#2)
performed by using##12##3##(1995-12#1)(2008-10#4)(2008-12#1)(2008-5#3)(2011-2#1)(2012-1#1)(2013-1#1)
performed by##243##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#4)(1992-12#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-8#5)(2008-1#2)(2008-10#84)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#16)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
performed clinically##2##2##(2008-2#1)(2012-12#1)
performed data##2##2##(2008-10#1)(2008-6#1)
performed due to##7##3##(2007-11#2)(2008-1#1)(2008-10#2)(2009-9#1)(2011-2#1)
performed during the first##2##4##(1990-8#1)(2008-2#1)
performed during the last##2##4##(1996-9#1)(2008-11#1)
performed during the##12##3##(1990-2#1)(1990-8#1)(1994-8#1)(1996-6#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
performed during##21##2##(1990-2#1)(1990-8#1)(1994-3#1)(1994-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#2)
performed each##2##2##(1990-9#1)(2007-11#1)
performed early##3##2##(1996-11#1)(2007-8#1)(2008-5#1)
performed efficiently##2##2##(2008-1#1)(2009-3#1)
performed endoscopically##2##2##(1997-2#1)(2010-12#1)
performed equally well##2##3##(2008-11#1)(2011-2#1)
performed equally##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
performed experiments with##2##3##(2008-3#2)
performed experiments##4##2##(2008-11#1)(2008-3#3)
performed first##2##2##(2007-11#1)(2008-10#1)
performed followed by##3##3##(2007-12#1)(2008-8#2)
performed following the##2##3##(2012-12#2)
performed following##4##2##(1997-6#1)(2008-10#1)(2012-12#2)
performed for a##8##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#1)
performed for different##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
performed for each##6##3##(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
performed for other reasons##3##4##(1991-8#1)(2008-7#1)(2011-2#1)
performed for the same##2##4##(1995-5#1)(2008-10#1)
performed for the##15##3##(1995-5#1)(2007-11#1)(2008-10#6)(2008-7#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
performed for two##2##3##(2008-2#1)(2008-3#1)
performed for##88##2##(1990-9#2)(1991-8#1)(1995-5#1)(1996-3#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#19)(2008-12#2)(2008-2#4)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
performed four##2##2##(2008-10#2)
performed from##13##2##(1990-5#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
performed immediately##3##2##(1996-3#1)(2009-9#1)(2013-1#1)
performed in 0##3##3##(2008-10#3)
performed in 1##5##3##(2008-10#4)(2009-10#1)
performed in 15##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
performed in 20##3##3##(1990-12#1)(1991-3#1)(2012-12#1)
performed in 4##3##3##(1990-6#1)(2008-10#1)(2009-8#1)
performed in 40##2##3##(1990-8#1)(2013-8#1)
performed in 42 patients##2##4##(1992-6#1)(2013-1#1)
performed in 60 patients##2##4##(1991-6#1)(2007-11#1)
performed in 7##2##3##(2008-10#1)(2013-1#1)
performed in 95##2##3##(1997-8#1)(2008-11#1)
performed in a##37##3##(1990-6#1)(1992-5#1)(1994-5#1)(1996-6#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
performed in all cases##2##4##(2007-8#1)(2008-5#1)
performed in all of##2##4##(2008-9#1)(2011-2#1)
performed in all patients##4##4##(1990-9#1)(1992-5#1)(1993-3#1)(1994-5#1)
performed in all##11##3##(1990-9#1)(1992-5#1)(1993-3#1)(1994-5#1)(1996-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)
performed in an##10##3##(1991-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-11#1)(2013-7#1)
performed in any##2##3##(1996-12#1)(2008-1#1)
performed in both##3##3##(1997-6#1)(2007-12#1)(2008-7#1)
performed in conjunction with##2##4##(2008-10#1)(2012-2#1)
performed in mice##2##3##(2008-10#1)(2013-8#1)
performed in one##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
performed in order to characterize##2##5##(1995-12#1)(2008-7#1)
performed in order to identify##2##5##(1992-12#1)(2008-10#1)
performed in order to obtain##2##5##(2008-10#1)(2008-7#1)
performed in order to##21##4##(1990-2#1)(1990-8#1)(1992-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-7#1)(2013-1#2)
performed in our department##2##4##(2008-9#1)(2013-7#1)
performed in our institution##2##4##(1991-8#1)(2007-11#1)
performed in our##6##3##(1991-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-7#1)
performed in parallel by##2##4##(2008-3#1)(2008-5#1)
performed in parallel##3##3##(2008-3#1)(2008-5#2)
performed in patients with##3##4##(1996-9#1)(2011-2#1)(2012-2#1)
performed in patients##6##3##(1996-3#1)(1996-9#1)(2006-7#1)(2008-1#1)(2011-2#1)(2012-2#1)
performed in situ##2##3##(1996-12#1)(2008-3#1)
performed in the acute##2##4##(1990-12#1)(1997-3#1)
performed in the first##2##4##(2007-11#2)
performed in the hospital##3##4##(1995-2#2)(2008-3#1)
performed in the linear##2##4##(2008-10#1)(2008-5#1)
performed in the period##2##4##(2007-11#2)
performed in the presence of##2##5##(1996-12#1)(2008-10#1)
performed in the range of##3##5##(2008-10#2)(2008-6#1)
performed in the##55##3##(1990-12#1)(1992-3#2)(1995-11#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-11#6)(2007-8#5)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
performed in this##3##3##(2008-10#2)(2008-3#1)
performed in three##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
performed in two##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
performed in vivo##2##3##(1990-2#1)(2008-2#1)
performed in which##3##3##(1997-6#1)(2008-4#1)(2010-3#1)
performed in##376##2##(1990-11#1)(1990-12#3)(1990-2#4)(1990-6#4)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#4)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#16)(2007-12#2)(2007-7#5)(2007-8#16)(2008-1#6)(2008-10#64)(2008-11#14)(2008-12#3)(2008-2#9)(2008-3#17)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#13)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#19)(2011-3#1)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#16)(2013-7#4)(2013-8#5)
performed independently##2##2##(1991-5#1)(1995-4#1)
performed is##2##2##(2008-10#1)(2013-7#1)
performed it##2##2##(2007-12#1)(2007-8#1)
performed laparoscopically##2##2##(2008-10#1)(2013-1#1)
performed less##2##2##(1997-3#1)(2011-1#1)
performed manual##2##2##(2008-8#1)(2011-1#1)
performed monthly##3##2##(2008-12#1)(2009-5#1)(2013-1#1)
performed more##4##2##(1991-6#1)(1995-11#1)(2009-9#1)(2010-8#1)
performed normally in##2##3##(1992-12#1)(2008-11#1)
performed of the##2##3##(2008-10#1)(2012-2#1)
performed of##7##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
performed on a sample of##3##5##(1997-5#1)(2008-10#1)(2010-3#1)
performed on a##31##3##(1990-12#1)(1996-3#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2013-1#1)
performed on admission##3##3##(2007-10#2)(2008-3#1)
performed on all##6##3##(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
performed on an##7##3##(1993-6#1)(2008-10#3)(2008-12#1)(2011-1#2)
performed on blood with##2##4##(1997-4#2)
performed on blood##3##3##(1994-6#1)(1997-4#2)
performed on both##3##3##(2008-10#2)(2008-11#1)
performed on day##7##3##(1993-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-8#2)
performed on different zones of##2##5##(2008-5#2)
performed on different##5##3##(1990-12#1)(1996-5#1)(2008-5#2)(2010-3#1)
performed on fresh##2##3##(2008-5#1)(2008-9#1)
performed on life insurance applicants##3##5##(1995-1#3)
performed on patients##2##3##(2007-11#1)(2012-2#1)
performed on six##2##3##(2008-3#1)(2009-12#1)
performed on the model##3##4##(2008-2#1)(2008-7#1)(2011-2#1)
performed on the same##6##4##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
performed on the##40##3##(1990-2#1)(1991-3#1)(1993-3#1)(1997-2#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
performed on these##2##3##(1995-6#1)(2008-5#1)
performed on this##2##3##(2008-10#2)
performed on two##4##3##(1996-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
performed on##239##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#4)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(2007-10#3)(2007-11#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#45)(2008-11#5)(2008-12#6)(2008-2#5)(2008-3#15)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-6#2)(2011-1#7)(2011-2#8)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#10)(2013-8#6)
performed once##2##2##(2008-10#1)(2011-2#1)
performed one##2##2##(2007-7#1)(2011-2#1)
performed only in##2##3##(2007-11#1)(2012-2#1)
performed only##8##2##(1991-11#1)(1991-6#1)(1994-3#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)
performed or##2##2##(1991-12#1)(2007-11#1)
performed over a wide range of##2##6##(1991-12#1)(2008-10#1)
performed over a wide##3##4##(1991-12#1)(1993-8#1)(2008-10#1)
performed over a##7##3##(1991-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#1)
performed over the##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
performed over##16##2##(1991-12#1)(1993-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#2)
performed per##2##2##(1997-8#1)(2010-12#1)
performed periodically##2##2##(2007-11#1)(2012-2#1)
performed poorly##2##2##(2007-8#1)(2008-10#1)
performed prior to##6##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-1#1)
performed procedure##2##2##(2007-8#1)(2008-7#1)
performed quantitative##2##2##(1994-6#1)(2011-2#1)
performed regularly##3##2##(1997-5#1)(2007-11#1)(2010-10#1)
performed significantly worse than##2##4##(1996-7#1)(2013-1#1)
performed significantly worse##3##3##(1996-7#1)(2012-1#1)(2013-1#1)
performed significantly##6##2##(1996-7#1)(2008-12#1)(2009-9#2)(2012-1#1)(2013-1#1)
performed similarly to##2##3##(2007-8#1)(2009-3#1)
performed similarly##3##2##(1997-3#1)(2007-8#1)(2009-3#1)
performed simulations##2##2##(2008-8#1)(2011-3#1)
performed simultaneously at##2##3##(2008-10#1)(2008-7#1)
performed simultaneously with##3##3##(1992-6#1)(1995-2#1)(2008-3#1)
performed simultaneously##6##2##(1992-6#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
performed six##3##2##(2008-10#1)(2012-8#1)(2013-1#1)
performed successfully##2##2##(2008-11#1)(2008-8#1)
performed surgical##2##2##(2007-8#1)(2013-1#1)
performed that##3##2##(2007-12#1)(2008-2#2)
performed the same##2##3##(2008-11#1)(2008-5#1)
performed the##20##2##(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
performed this##4##2##(1990-8#1)(2008-1#1)(2009-10#1)(2011-2#1)
performed three##3##2##(1991-6#1)(2013-1#1)(2013-8#1)
performed through a##3##3##(2007-8#1)(2008-8#1)(2009-3#1)
performed through an##2##3##(2009-3#1)(2012-12#1)
performed through the##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
performed through##16##2##(1991-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
performed to achieve##2##3##(2008-3#1)(2013-8#1)
performed to assess the##6##4##(1995-11#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
performed to assess##11##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
performed to better understand the##2##5##(2008-10#1)(2011-2#1)
performed to better##3##3##(2008-10#2)(2011-2#1)
performed to compare the##2##4##(2008-7#1)(2013-1#1)
performed to compare##5##3##(1994-9#1)(2008-10#1)(2008-7#2)(2013-1#1)
performed to confirm the##3##4##(2007-10#1)(2008-10#1)(2008-12#1)
performed to confirm##5##3##(1991-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2013-8#1)
performed to demonstrate the##2##4##(2008-3#2)
performed to determine if these##2##5##(1997-3#1)(2008-10#1)
performed to determine if##6##4##(1990-12#1)(1991-9#1)(1997-3#1)(2008-10#3)
performed to determine the##11##4##(1990-9#1)(1993-11#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)
performed to determine whether##4##4##(1994-8#1)(1997-1#1)(2008-7#1)(2012-12#1)
performed to determine##26##3##(1990-12#1)(1990-9#1)(1991-9#1)(1993-11#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)
performed to elucidate the##2##4##(2008-10#1)(2008-4#1)
performed to elucidate##3##3##(2008-10#2)(2008-4#1)
performed to estimate the##4##4##(2008-10#1)(2008-2#1)(2010-11#1)(2013-1#1)
performed to estimate##6##3##(2007-10#1)(2008-10#2)(2008-2#1)(2010-11#1)(2013-1#1)
performed to evaluate the effect of##2##6##(2008-2#1)(2011-2#1)
performed to evaluate the performance of a##2##7##(2008-3#1)(2011-2#1)
performed to evaluate the##13##4##(1992-12#1)(1992-6#1)(1994-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2011-2#2)
performed to evaluate##18##3##(1992-12#1)(1992-3#1)(1992-6#1)(1994-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2011-2#4)(2013-8#1)
performed to examine the##5##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
performed to examine##7##3##(1995-12#1)(1996-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
performed to illustrate the##2##4##(2008-3#1)(2013-8#1)
performed to investigate the##8##4##(1992-8#1)(1995-5#1)(1997-6#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)
performed to obtain information on##2##5##(1991-1#1)(2008-4#1)
performed to obtain##6##3##(1991-1#1)(1994-11#1)(1996-2#1)(2007-8#1)(2008-4#1)(2012-3#1)
performed to reduce the##2##4##(1996-3#1)(2011-1#1)
performed to repair##2##3##(2008-12#1)(2009-10#1)
performed to rule out##3##4##(2007-8#1)(2011-2#1)(2012-12#1)
performed to show the##2##4##(2007-12#1)(2008-10#1)
performed to study the##4##4##(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
performed to validate the##3##4##(2008-10#1)(2008-3#2)
performed to yield##2##3##(1996-12#1)(2008-3#1)
performed to##189##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#6)(2008-2#6)(2008-3#20)(2008-4#4)(2008-5#5)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#8)
performed twice##6##2##(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-12#1)
performed two##5##2##(1995-6#1)(2008-11#3)(2008-5#1)
performed under general anesthesia##2##4##(1994-12#1)(2008-5#1)
performed under general##3##3##(1994-12#1)(1997-6#1)(2008-5#1)
performed under locoregional anesthesia##2##4##(2011-3#2)
performed under regional anaesthesia##2##4##(1992-11#1)(2010-7#1)
performed under##28##2##(1992-11#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#2)(2010-7#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#2)
performed using a##29##3##(1990-3#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-10#2)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
performed using data##2##3##(1993-12#1)(2008-10#1)
performed using sequential##2##3##(1992-9#1)(2008-10#1)
performed using the same##2##4##(1990-12#1)(2008-7#1)
performed using the##26##3##(1990-12#1)(1992-3#3)(1994-3#1)(1997-8#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-7#4)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
performed using##143##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-3#3)(1992-9#2)(1993-1#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-5#2)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#44)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2010-11#2)(2010-8#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
performed via a##3##3##(2008-10#1)(2011-2#2)
performed via the##2##3##(1996-3#1)(2012-12#1)
performed via##7##2##(1996-3#1)(2008-10#1)(2011-2#3)(2012-12#1)(2013-1#1)
performed well for##2##3##(2008-10#2)
performed well in##4##3##(2008-10#1)(2008-3#1)(2009-7#1)(2011-2#1)
performed well##9##2##(1993-12#1)(1995-3#1)(2008-10#4)(2008-3#1)(2009-7#1)(2011-2#1)
performed were##5##2##(1995-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
performed when##4##2##(1990-9#1)(1992-9#1)(2008-12#1)(2010-5#1)
performed which##3##2##(1992-4#1)(1995-12#1)(2008-10#1)
performed with a##41##3##(1990-12#1)(1991-2#1)(1991-9#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#4)(2012-7#1)
performed with an##10##3##(1990-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2012-12#1)
performed with conventional##2##3##(1994-3#1)(2008-7#1)
performed with different##2##3##(1992-11#1)(2011-2#1)
performed with several##3##3##(2008-10#3)
performed with the aid of##2##5##(2008-10#1)(2008-11#1)
performed with the same##2##4##(2009-3#1)(2013-1#1)
performed with the##27##3##(1990-12#1)(1991-3#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
performed with these##2##3##(2008-10#1)(2012-12#1)
performed with##173##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#2)(2008-10#43)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#15)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#6)(2008-9#1)(2009-2#1)(2009-3#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
performed within the##3##3##(1993-11#1)(1997-8#1)(2011-2#1)
performed within##15##2##(1990-12#2)(1990-8#1)(1992-12#1)(1993-11#1)(1995-5#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-3#1)(2009-11#1)(2011-2#2)(2013-1#1)
performed without any##2##3##(1991-3#1)(1992-2#1)
performed without##9##2##(1991-3#1)(1992-2#1)(1993-12#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-12#1)
performed##2739##1##(1990-10#3)(1990-11#4)(1990-12#19)(1990-2#9)(1990-3#8)(1990-5#7)(1990-6#11)(1990-7#1)(1990-8#10)(1990-9#11)(1991-1#3)(1991-11#6)(1991-12#7)(1991-2#8)(1991-3#13)(1991-4#1)(1991-5#6)(1991-6#13)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#5)(1992-11#3)(1992-12#14)(1992-2#5)(1992-3#9)(1992-4#2)(1992-5#7)(1992-6#9)(1992-8#7)(1992-9#6)(1993-1#4)(1993-11#7)(1993-12#10)(1993-2#3)(1993-3#10)(1993-6#6)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#9)(1994-12#8)(1994-2#6)(1994-3#16)(1994-5#8)(1994-6#8)(1994-7#5)(1994-8#5)(1994-9#10)(1995-1#10)(1995-11#10)(1995-12#9)(1995-2#11)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#4)(1996-1#7)(1996-11#5)(1996-12#10)(1996-2#7)(1996-3#14)(1996-4#1)(1996-5#10)(1996-6#7)(1996-7#2)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#10)(1997-3#13)(1997-4#8)(1997-5#8)(1997-6#11)(1997-7#6)(1997-8#17)(1997-9#1)(2006-10#6)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#17)(2007-11#76)(2007-12#28)(2007-2#5)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#17)(2007-8#87)(2007-9#1)(2008-1#37)(2008-10#492)(2008-11#76)(2008-12#52)(2008-2#72)(2008-3#149)(2008-4#36)(2008-5#79)(2008-6#36)(2008-7#103)(2008-8#36)(2008-9#43)(2009-1#3)(2009-10#12)(2009-11#6)(2009-12#7)(2009-2#4)(2009-3#15)(2009-4#8)(2009-5#8)(2009-7#9)(2009-8#11)(2009-9#10)(2010-1#2)(2010-10#6)(2010-11#10)(2010-12#13)(2010-2#4)(2010-3#13)(2010-4#5)(2010-5#10)(2010-6#11)(2010-7#8)(2010-8#15)(2010-9#1)(2011-1#31)(2011-2#152)(2011-3#13)(2011-7#1)(2012-1#16)(2012-12#46)(2012-2#55)(2012-3#53)(2012-5#1)(2012-7#2)(2012-8#3)(2013-1#112)(2013-7#8)(2013-8#50)
performing LM/SL##2##2##(2012-12#2)
performing a controlled##2##3##(1991-3#1)(2008-3#1)
performing a specific##2##3##(2008-4#2)
performing a##26##2##(1991-3#1)(1991-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
performing all##2##2##(1994-1#1)(2008-10#1)
performing an##3##2##(1993-10#1)(2009-3#1)(2009-6#1)
performing any##2##2##(2008-11#1)(2008-4#1)
performing in##2##2##(2007-10#1)(2009-8#1)
performing more complex##2##3##(2008-8#1)(2013-1#1)
performing more##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
performing skin##2##2##(2007-12#1)(2013-1#1)
performing such##2##2##(2008-2#1)(2010-10#1)
performing tasks##3##2##(2008-11#2)(2013-7#1)
performing testing##2##2##(2012-2#2)
performing the##20##2##(1992-6#1)(1994-6#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
performing these##2##2##(2008-11#1)(2011-3#1)
performing this##2##2##(1991-4#1)(2012-3#1)
performing well##2##2##(1993-3#1)(2008-10#1)
performing wrist##2##2##(1991-6#1)(2008-9#1)
performing##216##1##(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#28)(2008-11#11)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#10)(2008-5#4)(2008-7#10)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#2)
performs a##9##2##(1990-6#1)(1992-1#1)(1995-6#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2012-3#1)
performs all##2##2##(2008-10#1)(2013-8#1)
performs an##4##2##(1994-8#1)(2008-10#2)(2010-2#1)
performs as well##2##3##(2008-10#1)(2008-2#1)
performs as##3##2##(2008-10#1)(2008-2#2)
performs at##2##2##(2008-2#2)
performs better than##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
performs in##2##2##(1994-2#1)(2008-10#1)
performs the##7##2##(2008-10#3)(2008-3#3)(2013-1#1)
performs well in##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
performs well##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
performs##61##1##(1990-6#1)(1992-1#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#12)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
perfringens alpha-toxin##2##2##(2010-6#2)
perfringens enterotoxin (CPE)##2##3##(1994-2#1)(2011-2#1)
perfringens enterotoxin##3##2##(1994-2#2)(2011-2#1)
perfringens food poisoning##2##3##(2011-2#2)
perfringens growth in beef-in-sauce products##2##5##(2011-2#2)
perfringens growth##4##2##(2011-2#4)
perfringens in##2##2##(2007-6#2)
perfringens strains##4##2##(2007-6#1)(2011-2#3)
perfringens type A##3##3##(2007-6#1)(2011-2#2)
perfringens type##4##2##(1997-8#1)(2007-6#1)(2011-2#2)
perfringens##33##1##(1990-9#1)(1994-11#1)(1994-2#2)(1997-8#1)(2007-6#5)(2007-7#1)(2010-6#5)(2011-2#17)
perfume diffusion from skin##2##4##(2008-5#2)
perfume##7##1##(2008-5#7)
perfumes##3##1##(2008-5#3)
perfusate and##2##2##(1996-12#1)(2011-3#1)
perfusate was##2##2##(1991-9#1)(2011-2#1)
perfusate##15##1##(1991-9#3)(1992-3#1)(1996-12#6)(1996-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#1)
perfused heart##2##2##(1991-9#1)(1993-11#1)
perfused hearts##2##2##(1993-11#1)(1995-3#1)
perfused liver##5##2##(1990-11#1)(1991-3#1)(1994-6#3)
perfused livers##3##2##(1991-3#2)(1996-12#1)
perfused rat hearts##3##3##(1991-9#1)(1994-12#1)(1995-3#1)
perfused rat liver##7##3##(1990-11#1)(1993-3#1)(1994-6#1)(1996-12#2)(1996-5#1)(2008-11#1)
perfused rat##16##2##(1990-11#1)(1990-12#2)(1991-3#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#2)(1996-12#3)(1996-5#1)(2008-10#1)(2008-11#1)
perfused with##10##2##(1990-7#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-6#1)(1997-2#2)(2008-11#1)(2008-9#2)
perfused##57##1##(1990-11#2)(1990-12#2)(1990-7#1)(1990-8#1)(1991-3#5)(1991-5#1)(1991-9#3)(1992-12#1)(1992-6#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#5)(1995-3#3)(1996-12#5)(1996-5#1)(1997-2#4)(1997-6#1)(1997-7#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-6#1)(2008-9#3)(2009-12#1)(2012-2#1)
perfusing##3##1##(1997-2#1)(2008-10#1)(2008-4#1)
perfusion CT##4##2##(2008-7#2)(2012-3#2)
perfusion MRI and##2##3##(2008-7#2)
perfusion MRI##5##2##(2008-7#4)(2010-12#1)
perfusion after##2##2##(2008-7#2)
perfusion and subsequent##2##3##(1992-1#1)(2008-11#1)
perfusion and##11##2##(1992-1#1)(1996-3#2)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2013-1#1)
perfusion are##2##2##(2008-11#1)(2011-3#1)
perfusion bioreactor##5##2##(2008-11#5)
perfusion bioreactors##3##2##(2008-11#3)
perfusion by##3##2##(1997-8#1)(2008-3#1)(2011-2#1)
perfusion cultivation##4##2##(2008-11#4)
perfusion cultivations##2##2##(2008-11#2)
perfusion culture##9##2##(1994-5#1)(2008-11#8)
perfusion cultures and##3##3##(1994-5#2)(2008-11#1)
perfusion cultures of hybridoma##2##4##(1994-5#1)(2008-11#1)
perfusion cultures of##4##3##(1994-5#1)(2008-11#3)
perfusion cultures##16##2##(1994-5#5)(2008-11#11)
perfusion defects are##2##3##(1996-5#1)(2009-10#1)
perfusion defects##7##2##(1992-5#2)(1996-5#3)(2009-10#1)(2010-6#1)
perfusion during##3##2##(2007-7#2)(2011-3#1)
perfusion following##2##2##(1997-2#1)(2007-8#1)
perfusion images##2##2##(2008-7#2)
perfusion imaging with##3##3##(2007-11#1)(2008-7#2)
perfusion imaging##12##2##(2007-11#1)(2008-7#6)(2009-10#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
perfusion in patients with##2##4##(2006-10#1)(2013-8#1)
perfusion in the##7##3##(1997-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#1)
perfusion in##13##2##(1996-5#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#2)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
perfusion induced##2##2##(1997-2#2)
perfusion is##3##2##(2006-10#1)(2007-10#1)(2011-2#1)
perfusion mode##3##2##(2008-11#3)
perfusion of the##6##3##(1993-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2009-11#1)(2009-12#1)
perfusion of##23##2##(1991-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-6#3)(1996-3#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
perfusion parameters##2##2##(2008-11#1)(2010-12#1)
perfusion pressure and##2##3##(1993-3#1)(2012-4#1)
perfusion pressure##11##2##(1990-8#1)(1993-3#2)(1995-12#1)(2008-7#4)(2008-9#1)(2010-2#1)(2012-4#1)
perfusion rate to##2##3##(2008-11#2)
perfusion rate##12##2##(2008-10#2)(2008-11#10)
perfusion rates##6##2##(2008-11#6)
perfusion system was##2##3##(2008-11#2)
perfusion system##9##2##(1991-12#1)(2008-11#5)(2010-9#1)(2012-1#1)(2012-2#1)
perfusion technique##3##2##(1993-3#1)(2008-4#1)(2008-7#1)
perfusion through##3##2##(1997-1#1)(2008-1#1)(2008-11#1)
perfusion to##2##2##(1993-3#1)(2008-4#1)
perfusion was##4##2##(1996-12#1)(1997-1#1)(2008-11#1)(2008-7#1)
perfusion were##2##2##(1997-2#1)(2011-3#1)
perfusion with##4##2##(1992-5#1)(1996-9#1)(2007-7#1)(2013-7#1)
perfusion##290##1##(1990-11#2)(1990-8#1)(1991-12#2)(1991-8#1)(1992-1#2)(1992-3#1)(1992-5#3)(1992-8#3)(1993-12#1)(1993-3#5)(1994-5#6)(1994-6#1)(1995-12#2)(1995-6#3)(1996-12#1)(1996-3#3)(1996-5#6)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#8)(1997-5#1)(1997-8#4)(2006-10#4)(2007-10#3)(2007-11#2)(2007-7#4)(2007-8#7)(2008-1#2)(2008-10#5)(2008-11#72)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-6#3)(2008-7#37)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#7)(2009-12#2)(2009-4#2)(2009-5#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#6)(2011-3#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#8)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#4)
perfusion-weighted##6##1##(2007-10#4)(2007-9#2)
perfusions##3##1##(1994-12#1)(2008-6#2)
pergolide##7##1##(2008-7#7)
perhaps also##4##2##(1994-3#1)(2007-7#1)(2008-3#1)(2008-9#1)
perhaps because of##2##3##(2009-10#1)(2010-4#1)
perhaps because##4##2##(1993-3#1)(2008-8#1)(2009-10#1)(2010-4#1)
perhaps best##2##2##(1997-2#1)(2008-9#1)
perhaps by##2##2##(1993-12#1)(1995-2#1)
perhaps due to##6##3##(1990-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
perhaps even##3##2##(2008-5#1)(2008-7#1)(2009-4#1)
perhaps implying##2##2##(2009-10#1)(2013-1#1)
perhaps mediated by##2##3##(1993-6#1)(2008-10#1)
perhaps more##2##2##(1995-1#1)(2008-9#1)
perhaps most importantly##2##3##(1997-4#1)(2009-5#1)
perhaps most##4##2##(1997-4#1)(2008-4#1)(2009-5#1)(2012-2#1)
perhaps not##2##2##(2007-11#1)(2007-8#1)
perhaps on##2##2##(2008-10#1)(2013-1#1)
perhaps owing to##2##3##(1994-8#1)(2007-10#1)
perhaps the most##8##3##(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-3#1)
perhaps the##14##2##(1992-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-1#2)(2012-3#2)
perhaps through##2##2##(2008-5#1)(2010-11#1)
perhaps##123##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#6)(2008-8#6)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#3)(2012-3#4)(2013-1#3)
perhydroxyl-cucurbit[6]uril##2##1##(2008-10#2)
peri- and##3##2##(2008-11#1)(2008-9#1)(2010-11#1)
peri-##4##1##(1996-1#1)(2008-11#1)(2008-9#1)(2010-11#1)
peri-implant marginal bone level##2##4##(2013-1#2)
peri-implant marginal bone##3##3##(2013-1#3)
peri-implant soft tissue##2##3##(2007-12#1)(2013-1#1)
peri-implant soft##3##2##(2007-12#1)(2013-1#2)
peri-implant tissues##3##2##(2008-11#2)(2013-1#1)
peri-implant##10##1##(2007-12#1)(2008-11#2)(2013-1#7)
peri-implantitis##14##1##(2007-12#1)(2012-2#1)(2013-1#12)
peri-natal loss##2##2##(2008-12#2)
peri-natal##3##1##(2008-12#3)
peri-operative##7##1##(2007-11#2)(2007-8#2)(2008-11#1)(2012-2#2)
peri-procedural##2##1##(2009-5#2)
peri-urban areas##2##2##(2011-2#2)
peri-urban##6##1##(2009-6#1)(2011-1#1)(2011-2#3)(2013-8#1)
periacetabular osteotomy##3##2##(2007-8#3)
periacetabular##5##1##(2007-8#3)(2008-6#1)(2008-8#1)
periampullary##7##1##(1990-9#1)(1991-3#2)(2013-1#4)
perianal abscesses and fistulas##2##4##(1997-8#2)
perianal and##2##2##(2010-12#2)
perianal area and##2##3##(2010-12#1)(2010-6#1)
perianal surgery##2##2##(2010-12#2)
perianal ulcer##2##2##(2010-8#2)
perianal##16##1##(1994-1#1)(1997-8#4)(2010-12#7)(2010-6#1)(2010-8#3)
periapical lesion##2##2##(2009-8#1)(2013-1#1)
periapical lesions##2##2##(2011-2#1)(2013-1#1)
periapical##9##1##(2008-12#1)(2009-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
periaqueductal gray (PAG)##2##3##(1993-12#1)(2008-7#1)
periaqueductal gray##4##2##(1993-12#3)(2008-7#1)
periaqueductal grey##4##2##(1992-8#3)(2008-7#1)
periaqueductal##8##1##(1992-8#3)(1993-12#3)(2008-7#2)
pericardial aspiration##2##2##(2007-8#2)
pericardial effusion##8##2##(1997-3#1)(1997-4#1)(2007-8#2)(2010-5#3)(2013-8#1)
pericardial patch##2##2##(2007-8#1)(2013-1#1)
pericardial sac was closed##2##4##(2007-8#2)
pericardial sac##3##2##(2007-8#3)
pericardial##29##1##(1991-5#1)(1997-3#1)(1997-4#1)(2007-8#18)(2008-8#1)(2009-10#1)(2010-5#4)(2013-1#1)(2013-8#1)
pericardiectomy##5##1##(2007-8#5)
pericardio-peritoneal shunt##2##2##(2010-5#2)
pericarditis##12##1##(1995-11#1)(1997-4#1)(1997-8#1)(2007-8#4)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#2)
pericardium and a##2##3##(2007-8#1)(2013-1#1)
pericardium and diaphragm##2##3##(2007-8#1)(2008-6#1)
pericardium and##7##2##(2007-8#3)(2008-6#1)(2008-9#1)(2010-8#1)(2013-1#1)
pericardium##15##1##(2007-8#5)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-8#2)(2013-1#2)
pericarp and aleurone tissues##2##4##(2008-10#2)
pericarp and##3##2##(2008-10#3)
pericarp##8##1##(2008-10#8)
pericellular fibrinolytic##2##2##(1993-12#2)
pericellular##5##1##(1993-12#2)(2008-4#2)(2011-2#1)
pericentral##3##1##(2008-7#3)
pericentric##2##1##(1993-12#1)(2010-3#1)
pericentromeric##4##1##(1995-8#1)(1997-5#1)(2008-12#2)
pericystectomies##3##1##(1991-8#3)
pericystectomy##2##1##(1993-6#1)(2008-10#1)
pericyte##4##1##(1993-3#2)(2011-2#1)(2012-4#1)
pericytes##10##1##(1993-3#6)(1993-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
periderm##4##1##(2008-10#4)
peridinin##3##1##(2009-9#3)
perifocal/penumbral##2##1##(1997-2#2)
perifused goldfish pituitary fragments##2##4##(1994-8#2)
perifused##3##1##(1994-8#2)(2008-4#1)
perifusion##3##1##(1996-2#1)(2010-11#2)
periglomerular cells##2##2##(1996-5#2)
perikarya and fibers##4##3##(1992-12#3)(2008-6#1)
perikarya are##2##2##(1992-12#1)(1996-2#1)
perikarya in the##4##3##(1992-12#2)(1996-12#2)
perikarya of##3##2##(1992-3#1)(2007-12#1)(2008-6#1)
perikarya were##3##2##(1993-9#1)(1997-3#1)(2008-6#1)
perikarya##21##1##(1990-5#1)(1991-12#1)(1992-12#6)(1992-3#1)(1993-9#1)(1996-12#3)(1996-2#1)(1997-3#3)(2007-12#1)(2008-6#3)
perikaryal##2##1##(1997-2#1)(2008-7#1)
perilesional##2##1##(2009-9#1)(2013-1#1)
perilous##2##1##(2007-2#1)(2008-9#1)
perimenopausal women with##2##3##(1994-2#1)(1994-9#1)
perimenopausal##4##1##(1993-11#1)(1994-2#1)(1994-9#2)
perimesencephalic hemorrhage##2##2##(2007-10#2)
perimesencephalic##6##1##(2007-10#4)(2008-7#2)
perimeter in##2##2##(2007-8#1)(2012-1#1)
perimeter of the##6##3##(1995-11#1)(1995-6#1)(2007-8#1)(2008-6#2)(2013-7#1)
perimeter of##7##2##(1995-11#1)(1995-6#1)(2007-8#1)(2008-3#1)(2008-6#2)(2013-7#1)
perimeter##13##1##(1995-11#1)(1995-6#1)(2007-8#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2012-1#1)(2012-5#1)(2013-7#1)
perimicrovillar##3##1##(2007-12#3)
perimysium##5##1##(2010-2#3)(2013-1#2)
perinatal and##2##2##(2008-11#2)
perinatal care##9##2##(1995-6#2)(2007-2#1)(2008-11#1)(2013-1#5)
perinatal centres##2##2##(2008-11#2)
perinatal copper deficiency##2##3##(2008-10#2)
perinatal data##2##2##(1991-11#1)(1997-8#1)
perinatal education##4##2##(2007-2#4)
perinatal loss##3##2##(2007-4#3)
perinatal morbidity and mortality##3##4##(1991-6#1)(2007-7#1)(2013-1#1)
perinatal mortality in##2##3##(2007-10#1)(2011-1#1)
perinatal mortality##9##2##(1990-3#1)(1994-3#1)(1995-6#1)(1996-11#1)(2007-10#1)(2008-7#1)(2011-1#2)(2012-12#1)
perinatal outcome##3##2##(2012-12#1)(2012-3#2)
perinatal outcomes##6##2##(2008-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
perinatal period##7##2##(1993-6#1)(1995-6#1)(2007-2#1)(2009-2#1)(2009-9#1)(2011-2#2)
perinatal torsion##2##2##(2008-10#2)
perinatal##93##1##(1990-3#1)(1991-11#1)(1991-6#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-5#2)(1993-6#3)(1994-2#1)(1994-3#3)(1994-6#2)(1995-6#5)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-2#8)(2007-4#3)(2007-7#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#9)(2013-8#1)
perinatally HIV-infected##2##2##(2009-7#2)
perinatally exposed to##2##3##(2009-7#1)(2010-11#1)
perinatally exposed##3##2##(1995-3#1)(2009-7#1)(2010-11#1)
perinatally##10##1##(1992-6#1)(1995-3#1)(1996-2#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-11#1)
perineal urethrostomy##2##2##(2008-10#2)
perineal##17##1##(1992-6#1)(1993-6#1)(1993-9#2)(1994-1#1)(2007-10#1)(2008-10#4)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#2)
perineum and##2##2##(2008-7#1)(2010-12#1)
perineum##9##1##(1993-1#2)(2008-10#3)(2008-7#2)(2010-11#1)(2010-12#1)
perineural##3##1##(2008-1#2)(2013-8#1)
perinuclear distribution##2##2##(1993-11#1)(1995-3#1)
perinuclear translocation##2##2##(1994-6#2)
perinuclear##19##1##(1992-11#1)(1993-11#4)(1994-6#2)(1995-3#1)(2007-12#1)(2008-7#3)(2008-9#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
periocular carboplatin##2##2##(2011-1#2)
periocular##5##1##(1997-3#1)(2011-1#4)
period (1##2##2##(1994-3#1)(2008-7#1)
period (2##2##2##(1993-1#1)(2008-10#1)
period (January##2##2##(2008-5#1)(2011-2#1)
period (P = 0##3##4##(1996-3#1)(2008-10#1)(2010-2#1)
period (from##2##2##(2008-11#1)(2011-2#1)
period (mean##2##2##(1992-9#1)(2008-7#1)
period 1##2##2##(1996-9#1)(2012-12#1)
period 1989-94##2##2##(1995-5#2)
period January 1##2##3##(2007-12#1)(2011-2#1)
period January##5##2##(1990-6#1)(2007-12#1)(2011-2#2)(2013-1#1)
period after the##3##3##(1996-9#1)(2008-10#1)(2008-8#1)
period after##19##2##(1991-12#1)(1992-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-9#1)(2007-11#2)(2007-8#2)(2008-10#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-4#1)(2012-3#1)
period among##2##2##(2012-3#1)(2013-8#1)
period and a##5##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
period and early##3##3##(1997-3#1)(2012-3#2)
period and that##2##3##(1991-9#1)(2009-9#1)
period and the##9##3##(1991-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-7#2)(2013-8#1)
period and was##2##3##(2008-11#1)(2012-2#1)
period and##73##2##(1990-5#1)(1991-12#4)(1991-2#1)(1991-9#1)(1992-3#1)(1994-2#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#2)
period are##7##2##(1993-11#1)(2008-3#3)(2008-7#1)(2010-10#1)(2010-8#1)
period as compared with the##2##5##(2007-9#1)(2008-10#1)
period as the##2##3##(2007-11#1)(2008-10#1)
period as##11##2##(1996-11#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2013-1#2)
period at a##2##3##(2007-2#1)(2012-12#1)
period at##11##2##(1990-7#1)(1995-8#1)(1996-6#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
period before##5##2##(1990-11#1)(1991-3#1)(2007-10#1)(2008-6#1)(2009-10#1)
period between##20##2##(1994-2#1)(1996-5#2)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2011-2#2)
period but##3##2##(1993-3#1)(2008-10#2)
period by##8##2##(1990-8#1)(2007-11#1)(2008-10#3)(2008-11#2)(2011-2#1)
period can be##4##3##(1990-6#1)(2008-2#1)(2008-3#1)(2010-8#1)
period can##5##2##(1990-6#1)(1993-3#1)(2008-2#1)(2008-3#1)(2010-8#1)
period compared with##3##3##(1992-6#1)(2008-11#1)(2011-2#1)
period compared##5##2##(1992-6#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
period due to##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
period during the##4##3##(1993-3#1)(2008-10#2)(2008-7#1)
period during which##4##3##(1991-11#1)(2008-2#1)(2008-7#1)(2010-6#1)
period during##8##2##(1991-11#1)(1993-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2010-6#1)
period even though##2##3##(1997-2#1)(2008-10#1)
period followed by##2##3##(2008-10#2)
period following##12##2##(1991-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
period for the##2##3##(2008-6#1)(2012-2#1)
period for##17##2##(1997-4#1)(2006-8#2)(2007-10#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-2#1)
period from January##4##3##(2007-8#2)(2008-5#1)(2011-2#1)
period from an##2##3##(2008-10#2)
period from the##5##3##(2008-1#1)(2008-10#1)(2008-5#3)
period from##48##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-12#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
period gratings##3##2##(2008-10#1)(2008-3#2)
period had a##3##3##(2008-10#2)(2008-7#1)
period had##4##2##(2007-10#1)(2008-10#2)(2008-7#1)
period have been##3##3##(2007-11#1)(2007-12#1)(2008-6#1)
period have##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#2)
period immediately##2##2##(2008-10#2)
period in a##7##3##(1994-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-1#1)
period in patients##2##3##(2012-3#1)(2013-1#1)
period in question##3##3##(1990-8#1)(2008-9#1)(2011-2#1)
period in the##10##3##(1991-9#1)(1995-4#1)(1996-11#1)(2007-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
period in which##5##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
period in##61##2##(1990-11#1)(1990-8#1)(1991-12#2)(1991-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#3)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
period increased##3##2##(2008-10#2)(2011-2#1)
period is a##2##3##(1991-5#1)(2010-10#1)
period is##20##2##(1991-5#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#2)
period it##2##2##(2008-7#1)(2013-1#1)
period lasted##2##2##(2008-10#1)(2008-8#1)
period length of 26 min##2##5##(2008-7#1)(2009-9#1)
period length of##3##3##(2008-7#2)(2009-9#1)
period length##7##2##(2008-10#2)(2008-5#1)(2008-7#3)(2009-9#1)
period may##2##2##(2008-5#1)(2011-2#1)
period modulation and##2##3##(2008-5#2)
period modulation##4##2##(2008-5#4)
period of 1 year##2##4##(2008-6#1)(2012-12#1)
period of 1##5##3##(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#1)
period of 10 days##2##4##(2006-10#1)(2008-10#1)
period of 10##8##3##(1994-12#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
period of 12##3##3##(2008-10#1)(2008-5#1)(2010-6#1)
period of 16##3##3##(1991-6#1)(1997-8#1)(2008-6#1)
period of 17##2##3##(2007-7#1)(2008-6#1)
period of 2 h##2##4##(2008-10#2)
period of 2 weeks##2##4##(1991-2#1)(2011-2#1)
period of 2##7##3##(1991-2#1)(2008-10#3)(2008-7#2)(2011-2#1)
period of 20 years from##2##5##(1995-11#1)(2008-7#1)
period of 20 years##4##4##(1995-11#1)(1997-8#1)(2008-7#2)
period of 20##6##3##(1995-11#1)(1996-5#1)(1997-8#1)(2008-3#1)(2008-7#2)
period of 21##2##3##(2007-7#1)(2008-7#1)
period of 24##5##3##(1997-2#1)(2008-10#2)(2008-5#1)(2010-11#1)
period of 3 months##4##4##(2008-10#2)(2008-7#1)(2009-8#1)
period of 3 years##4##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)
period of 3##11##3##(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)
period of 30 min##2##4##(1994-8#1)(2008-10#1)
period of 30##5##3##(1994-8#1)(1997-8#1)(2008-10#2)(2013-1#1)
period of 4##5##3##(1991-3#1)(1991-6#1)(2008-10#3)
period of 48##2##3##(1992-5#1)(2011-1#1)
period of 5##7##3##(1991-2#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
period of 6 h##2##4##(2008-11#1)(2008-5#1)
period of 6 weeks##4##4##(2008-11#2)(2008-6#1)(2013-1#1)
period of 6##9##3##(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2009-4#1)(2013-1#1)
period of 7 days##2##4##(1990-2#1)(1992-3#1)
period of 7##4##3##(1990-2#1)(1992-3#1)(1995-3#1)(2008-10#1)
period of 8 months##2##4##(2008-12#1)(2008-5#1)
period of 8##3##3##(2008-1#1)(2008-12#1)(2008-5#1)
period of 9 days##2##4##(1990-6#1)(2011-2#1)
period of 9##3##3##(1990-6#1)(1996-3#1)(2011-2#1)
period of approximately##4##3##(1991-2#1)(2008-11#1)(2008-5#2)
period of at least##6##4##(1990-12#2)(2008-10#2)(2008-5#2)
period of berry susceptibility##2##4##(2008-10#2)
period of berry##3##3##(2008-10#3)
period of decrease##2##3##(1994-3#1)(2009-8#1)
period of development##2##3##(2008-8#1)(2008-9#1)
period of five years##5##4##(1997-5#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)
period of five##6##3##(1995-1#1)(1997-5#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)
period of follow-up##2##3##(1997-4#1)(2007-10#1)
period of four##5##3##(1991-6#1)(1997-5#1)(2007-8#1)(2008-1#1)(2011-2#1)
period of fruit susceptibility##4##4##(2008-10#4)
period of growth##4##3##(1995-3#1)(1996-3#1)(2008-10#1)(2011-2#1)
period of high##2##3##(1996-6#1)(2008-10#1)
period of life##2##3##(1993-2#1)(2008-7#1)
period of maximum##3##3##(2008-10#3)
period of more than##2##4##(2008-10#1)(2008-7#1)
period of nine years##2##4##(1992-5#1)(2011-2#1)
period of nine##4##3##(1992-5#1)(2007-7#1)(2008-9#1)(2011-2#1)
period of observation##2##3##(1990-8#1)(1992-6#1)
period of one year##8##4##(1997-6#1)(2007-5#1)(2007-7#2)(2008-12#1)(2008-3#1)(2012-3#1)(2013-8#1)
period of one##13##3##(1993-6#1)(1997-6#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
period of several##2##3##(2008-10#2)
period of six##8##3##(1990-12#1)(1991-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-7#1)
period of stable disease##3##4##(2008-6#3)
period of storage##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
period of the##27##3##(1991-1#2)(1991-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-12#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2009-9#1)(2013-7#1)
period of these##2##3##(2007-11#1)(2008-6#1)
period of three months##3##4##(1992-11#1)(2008-1#1)(2008-11#1)
period of three##6##3##(1990-6#1)(1992-11#1)(1996-6#1)(2008-1#2)(2008-11#1)
period of time after##3##4##(1992-3#1)(1996-11#1)(2008-10#1)
period of time in##3##4##(1997-2#1)(2008-11#1)(2008-4#1)
period of time than##3##4##(1990-5#1)(1993-3#1)(2008-1#1)
period of time to##4##4##(1996-3#1)(2008-12#1)(2011-1#1)(2013-1#1)
period of time when##2##4##(1993-2#1)(2008-10#1)
period of time##67##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-2#1)(1993-3#3)(1993-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-9#2)(2009-11#2)(2009-12#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
period of treatment##3##3##(1992-3#1)(2007-8#1)(2008-2#1)
period of##473##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#3)(1995-1#2)(1995-11#2)(1995-3#6)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#7)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#3)(2006-10#1)(2007-10#3)(2007-11#12)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#8)(2007-8#12)(2008-1#10)(2008-10#81)(2008-11#26)(2008-12#6)(2008-2#7)(2008-3#9)(2008-4#7)(2008-5#17)(2008-6#16)(2008-7#18)(2008-8#9)(2008-9#8)(2009-11#4)(2009-12#1)(2009-2#2)(2009-4#3)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#15)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#14)(2013-7#3)(2013-8#3)
period on##12##2##(1991-3#1)(2008-10#6)(2008-3#2)(2010-11#1)(2012-12#1)(2013-1#1)
period or##3##2##(2007-10#1)(2007-5#1)(2008-10#1)
period preceding the##2##3##(1996-3#1)(2008-11#1)
period prior to##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
period showed that##2##3##(2008-5#1)(2010-11#1)
period showed##7##2##(1991-5#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-1#1)
period studied##5##2##(1992-12#1)(1995-8#1)(2008-10#2)(2010-11#1)
period than##5##2##(1994-12#1)(1995-11#1)(1996-1#1)(2008-5#1)(2008-9#1)
period that the##2##3##(2008-10#1)(2008-3#1)
period that##6##2##(1994-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-2#1)
period the mean##2##3##(1990-11#1)(2008-4#1)
period the##11##2##(1990-11#1)(1991-6#1)(1995-9#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-3#1)(2012-3#1)
period they##2##2##(1995-5#1)(2008-10#1)
period through##2##2##(2010-5#1)(2011-2#1)
period to assess the##2##4##(2008-5#1)(2009-11#1)
period to##18##2##(1994-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-11#1)(2010-10#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
period using##3##2##(1997-4#1)(2008-3#1)(2009-8#1)
period values##3##2##(2008-10#2)(2008-3#1)
period varied##2##2##(1991-12#1)(2008-11#1)
period via##2##2##(2008-10#2)
period was 19##2##3##(1990-9#1)(2007-8#1)
period was 4##2##3##(1996-8#1)(1997-8#1)
period was calculated##2##3##(2008-9#1)(2011-1#1)
period was followed##2##3##(2008-10#1)(2008-3#1)
period was measured##2##3##(2008-10#1)(2008-5#1)
period was not##2##3##(2008-10#2)
period was observed##2##3##(2007-11#1)(2008-10#1)
period was performed##2##3##(2007-8#1)(2012-5#1)
period was the##2##3##(2008-7#2)
period was uneventful##2##3##(1991-11#1)(2010-7#1)
period was used##2##3##(2011-1#1)(2012-12#1)
period was##64##2##(1990-9#1)(1991-11#1)(1992-12#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#2)(2006-8#2)(2007-11#5)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-3#3)(2008-5#2)(2008-7#4)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#1)
period were calculated##2##3##(2011-1#1)(2011-2#1)
period were studied##2##3##(1994-2#1)(2007-10#1)
period were##23##2##(1991-11#1)(1991-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
period when compared with##2##4##(1990-11#1)(2008-10#1)
period when the##2##3##(1990-12#1)(1996-12#1)
period when##15##2##(1990-11#2)(1990-12#1)(1992-6#1)(1992-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
period where##2##2##(1995-3#1)(2013-8#1)
period which is##2##3##(1991-5#1)(1993-6#1)
period which##3##2##(1991-5#1)(1993-6#1)(2008-11#1)
period who##2##2##(2008-12#1)(2008-7#1)
period with a##2##3##(1991-2#1)(2008-10#1)
period with no##2##3##(1991-8#1)(2008-10#1)
period with the##4##3##(1992-6#1)(1997-6#1)(2011-2#1)(2012-2#1)
period with##18##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-6#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-7#2)(2011-2#2)(2012-2#1)(2013-8#1)
period without##3##2##(1997-8#1)(2008-3#2)
period##2024##1##(1990-10#1)(1990-11#8)(1990-12#5)(1990-2#7)(1990-3#5)(1990-5#7)(1990-6#13)(1990-7#3)(1990-8#10)(1990-9#6)(1991-1#3)(1991-11#6)(1991-12#16)(1991-2#14)(1991-3#4)(1991-4#1)(1991-5#8)(1991-6#14)(1991-8#9)(1991-9#11)(1992-1#5)(1992-10#5)(1992-11#6)(1992-12#9)(1992-2#5)(1992-3#10)(1992-4#1)(1992-5#6)(1992-6#13)(1992-7#1)(1992-8#9)(1992-9#4)(1993-1#5)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#13)(1993-5#2)(1993-6#8)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#3)(1994-12#12)(1994-2#8)(1994-3#9)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#4)(1995-1#5)(1995-11#5)(1995-12#5)(1995-2#1)(1995-3#15)(1995-4#2)(1995-5#11)(1995-6#5)(1995-8#5)(1995-9#4)(1996-1#6)(1996-11#8)(1996-12#9)(1996-2#4)(1996-3#21)(1996-4#1)(1996-5#6)(1996-6#5)(1996-8#3)(1996-9#9)(1997-1#4)(1997-2#16)(1997-3#11)(1997-4#25)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#12)(2006-10#3)(2006-7#1)(2006-8#12)(2007-10#14)(2007-11#41)(2007-12#19)(2007-2#9)(2007-3#1)(2007-4#1)(2007-5#8)(2007-6#2)(2007-7#29)(2007-8#36)(2007-9#4)(2008-1#33)(2008-10#335)(2008-11#77)(2008-12#31)(2008-2#36)(2008-3#59)(2008-4#15)(2008-5#73)(2008-6#40)(2008-7#74)(2008-8#31)(2008-9#33)(2009-1#1)(2009-10#2)(2009-11#9)(2009-12#3)(2009-2#7)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#6)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#9)(2010-12#2)(2010-2#2)(2010-3#9)(2010-4#6)(2010-5#7)(2010-6#6)(2010-7#6)(2010-8#12)(2011-1#39)(2011-2#111)(2011-3#6)(2011-9#1)(2012-1#6)(2012-12#21)(2012-2#44)(2012-3#28)(2012-4#1)(2012-5#4)(2012-7#3)(2013-1#67)(2013-7#11)(2013-8#21)
period&quot##3##1##(1995-12#1)(1997-1#1)(2011-2#1)
period) and##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
period)##26##1##(1991-12#1)(1997-2#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-6#1)(2012-12#2)
period-doubling##3##1##(2007-12#2)(2008-3#1)
period]##10##1##(1991-9#1)(1993-9#1)(1997-3#1)(2008-10#3)(2008-12#1)(2009-5#1)(2012-3#2)
periodate and##6##2##(2008-10#6)
periodate ions##2##2##(2008-10#2)
periodate oxidation##7##2##(1990-8#1)(1992-12#1)(1993-3#1)(2008-10#3)(2008-8#1)
periodate to##2##2##(2008-10#2)
periodate was##2##2##(2008-10#2)
periodate with##3##2##(2008-10#3)
periodate##44##1##(1990-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1996-12#1)(2007-11#1)(2008-10#36)(2008-4#1)(2008-8#1)
periodate-bromate and##4##2##(2008-10#4)
periodic Bragg##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
periodic and##4##2##(2008-2#1)(2008-3#2)(2009-11#1)
periodic array of##2##3##(2007-12#1)(2008-3#1)
periodic autocorrelation functions##2##3##(2008-2#2)
periodic autocorrelation##3##2##(2008-2#3)
periodic changes in##2##3##(1997-4#1)(2008-7#1)
periodic component##2##2##(1997-5#1)(2008-9#1)
periodic domain##2##2##(2008-3#1)(2011-1#1)
periodic fibers##2##2##(2007-12#2)
periodic follow-up##2##2##(2008-12#1)(2008-4#1)
periodic in##2##2##(1990-11#1)(2007-11#1)
periodic length##2##2##(2007-12#1)(2008-2#1)
periodic limb movement##2##3##(2012-3#2)
periodic nonlinearity##4##2##(2008-3#4)
periodic or odd-periodic correlation##2##4##(2008-2#1)(2008-3#1)
periodic or##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
periodic orbits##2##2##(1992-8#1)(2007-12#1)
periodic paralysis is##2##3##(2007-5#2)
periodic paralysis##7##2##(1991-12#2)(2007-5#4)(2008-8#1)
periodic pattern of##2##3##(2007-11#1)(2008-2#1)
periodic pattern##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
periodic phase##2##2##(2007-12#2)
periodic poling of##2##3##(2007-12#2)
periodic solution##2##2##(2007-12#2)
periodic solutions for##2##3##(2013-8#2)
periodic spectral##2##2##(2007-11#1)(2007-12#1)
periodic spin##2##2##(2007-11#2)
periodic structure##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)
periodic structures##9##2##(2007-12#1)(2008-3#6)(2012-2#1)(2013-8#1)
periodic target##3##2##(2008-2#3)
periodic variation##2##2##(2007-12#2)
periodic##193##1##(1990-11#1)(1990-8#3)(1991-12#3)(1992-8#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#3)(1997-4#2)(1997-5#2)(1997-8#1)(2007-11#21)(2007-12#34)(2007-5#4)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#14)(2008-3#43)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#4)
periodical cicadas##5##2##(2008-9#5)
periodical##12##1##(1997-2#1)(2008-3#1)(2008-5#1)(2008-9#5)(2011-2#1)(2012-12#1)(2012-3#2)
periodically coupled microring resonators##2##4##(2007-12#2)
periodically for##2##2##(2007-8#1)(2012-2#1)
periodically in 10 prune orchards##2##5##(2008-10#2)
periodically interrupted amperometric##2##3##(2008-10#2)
periodically interrupted##4##2##(1996-12#1)(2008-10#3)
periodically poled KTP##11##3##(2007-11#6)(2007-12#3)(2008-2#2)
periodically poled KTiOAsO(4)##2##3##(2007-12#2)
periodically poled KTiOPO(4) and its application to spectroscopy##2##8##(2007-12#2)
periodically poled KTiOPO(4)##11##3##(2007-11#3)(2007-12#8)
periodically poled LiNbO(3) (PPLN)##3##4##(2007-12#3)
periodically poled LiNbO(3) crystal in a four-mirror##2##7##(2007-11#1)(2007-12#1)
periodically poled LiNbO(3) crystal##4##4##(2007-11#2)(2007-12#2)
periodically poled LiNbO(3)##17##3##(2007-11#3)(2007-12#13)(2008-2#1)
periodically poled LiTaO(3) crystal##3##4##(2007-11#3)
periodically poled LiTaO(3)##4##3##(2007-11#3)(2007-12#1)
periodically poled RbTiOAsO(4)##3##3##(2007-12#2)(2008-3#1)
periodically poled lithium niobate (PPLN)##5##5##(2007-12#4)(2008-3#1)
periodically poled lithium niobate by##2##5##(2007-11#2)
periodically poled lithium niobate crystal and##2##6##(2007-11#1)(2007-12#1)
periodically poled lithium niobate crystal##6##5##(2007-11#2)(2007-12#3)(2008-3#1)
periodically poled lithium niobate optical parametric oscillator##3##7##(2007-12#1)(2008-3#2)
periodically poled lithium niobate optical parametric##5##6##(2007-12#3)(2008-3#2)
periodically poled lithium niobate##46##4##(2007-11#15)(2007-12#24)(2008-2#1)(2008-3#6)
periodically poled lithium##48##3##(2007-11#15)(2007-12#26)(2008-2#1)(2008-3#6)
periodically poled neodymium-doped lithium niobate##2##5##(2007-11#2)
periodically poled structures##2##3##(2008-3#2)
periodically poled##115##2##(2007-11#35)(2007-12#62)(2008-2#5)(2008-3#13)
periodically segmented waveguides##2##3##(2008-2#1)(2008-3#1)
periodically segmented##3##2##(2008-2#1)(2008-3#2)
periodically updated##2##2##(1993-1#1)(1993-2#1)
periodically##168##1##(1990-8#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-2#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#43)(2007-12#68)(2007-8#1)(2008-10#11)(2008-2#8)(2008-3#19)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-2#2)
periodicals##2##1##(1991-3#1)(1995-12#1)
periodicity and##4##2##(1990-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
periodicity in##2##2##(1996-4#1)(1997-5#1)
periodicity of the##3##3##(2008-2#1)(2008-3#2)
periodicity of##8##2##(1993-3#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-8#1)
periodicity was##2##2##(1993-3#1)(1996-2#1)
periodicity##28##1##(1990-12#1)(1993-3#2)(1996-2#3)(1996-4#1)(1996-6#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
periodontal bone loss measurements##3##4##(2008-12#3)
periodontal bone loss##5##3##(2008-12#5)
periodontal condition##2##2##(2012-12#2)
periodontal conditions##2##2##(1990-12#1)(2008-12#1)
periodontal defects##2##2##(2007-12#1)(2010-5#1)
periodontal disease progression##2##3##(1995-2#2)
periodontal disease##15##2##(1990-3#2)(1990-5#1)(1995-2#2)(1997-4#1)(2008-1#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
periodontal diseases and##2##3##(2008-1#1)(2013-7#1)
periodontal diseases##12##2##(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
periodontal health##5##2##(2008-7#1)(2011-2#1)(2012-3#3)
periodontal ligament (PDL)##3##3##(1995-8#1)(2008-11#1)(2013-1#1)
periodontal ligament cells##3##3##(2012-2#1)(2013-1#2)
periodontal ligament cells]##2##3##(2013-1#1)(2013-8#1)
periodontal ligament fibroblasts##2##3##(1995-8#1)(2013-1#1)
periodontal ligament##10##2##(1995-8#2)(2008-11#1)(2012-2#1)(2013-1#5)(2013-8#1)
periodontal masseteric reflex##2##3##(1996-2#2)
periodontal or##2##2##(2008-7#1)(2011-2#1)
periodontal pockets##4##2##(1990-12#1)(1997-4#1)(2012-12#2)
periodontal regeneration##3##2##(2012-3#3)
periodontal surgery##2##2##(2012-3#2)
periodontal therapy##4##2##(2008-7#1)(2012-2#1)(2012-3#2)
periodontal tissue##4##2##(2012-12#1)(2012-3#1)(2013-1#2)
periodontal tissues##2##2##(2008-1#1)(2008-2#1)
periodontal treatment##4##2##(2008-1#1)(2012-3#3)
periodontal##105##1##(1990-12#2)(1990-3#3)(1990-5#1)(1990-9#1)(1991-2#1)(1995-2#2)(1995-8#2)(1996-2#2)(1997-4#2)(2007-12#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#10)(2008-2#2)(2008-5#2)(2008-7#4)(2008-9#3)(2010-5#1)(2011-2#2)(2012-12#7)(2012-2#3)(2012-3#26)(2013-1#18)(2013-7#1)(2013-8#2)
periodontally healthy##2##2##(2008-12#1)(2013-1#1)
periodontally##4##1##(2008-12#2)(2012-3#1)(2013-1#1)
periodontitis and##5##2##(2012-3#3)(2013-1#2)
periodontitis in##6##2##(1991-6#1)(2008-10#3)(2012-12#1)(2012-3#1)
periodontitis patients and##4##3##(2008-12#3)(2011-2#1)
periodontitis patients##5##2##(2008-12#3)(2011-2#1)(2012-3#1)
periodontitis with##6##2##(2008-12#3)(2012-3#1)(2013-8#2)
periodontitis##45##1##(1991-6#1)(2007-7#3)(2008-10#5)(2008-12#11)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#9)(2013-1#9)(2013-8#3)
periodontium##5##1##(1990-3#1)(2009-8#1)(2010-3#1)(2013-1#2)
periods after##4##2##(1995-4#2)(2007-2#1)(2008-10#1)
periods and##21##2##(1990-11#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
periods as a##2##3##(2008-7#1)(2009-6#1)
periods as long as##2##4##(2007-12#1)(2008-5#1)
periods as##6##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)
periods at##4##2##(1996-12#1)(2007-8#1)(2008-10#2)
periods before##2##2##(2008-10#1)(2008-9#1)
periods between##2##2##(2007-5#1)(2008-10#1)
periods during##2##2##(2008-5#1)(2010-5#1)
periods examined##2##2##(2011-2#1)(2012-3#1)
periods exceeding##2##2##(2008-10#2)
periods for##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
periods in a##2##3##(2008-10#1)(2012-3#1)
periods in all##2##3##(1991-2#1)(2008-10#1)
periods in the##4##3##(1997-4#1)(2007-11#1)(2008-6#1)(2009-7#1)
periods in##15##2##(1991-2#1)(1993-12#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-6#2)(2009-7#1)(2011-2#1)(2012-3#1)
periods is##4##2##(1993-11#1)(1995-6#1)(2008-10#1)(2008-8#1)
periods of 1 to##2##4##(1992-8#1)(2008-10#1)
periods of 1##4##3##(1992-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
periods of 3##2##3##(1991-11#1)(2008-10#1)
periods of 5##2##3##(1993-9#1)(2008-2#1)
periods of both##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
periods of development##2##3##(2007-12#1)(2010-7#1)
periods of high##2##3##(2008-10#1)(2012-12#1)
periods of higher##2##3##(2008-5#1)(2013-7#1)
periods of more than##2##4##(2008-10#1)(2012-12#1)
periods of rapid##2##3##(1990-6#1)(2010-8#1)
periods of temperatures &gt##2##4##(2008-10#2)
periods of temperatures##3##3##(2008-10#3)
periods of the##8##3##(1994-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
periods of time and##2##4##(1991-5#1)(2008-10#1)
periods of time to##2##4##(2008-10#1)(2011-1#1)
periods of time##30##3##(1990-12#1)(1991-5#1)(1992-1#1)(1992-5#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-7#1)(2007-10#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)
periods of treatment##2##3##(2008-10#1)(2012-3#1)
periods of up to##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
periods of##139##2##(1990-12#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-1#2)(1994-3#2)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#40)(2008-11#7)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-3#2)(2013-1#5)(2013-7#1)
periods on##2##2##(2007-6#1)(2008-10#1)
periods over##3##2##(2008-10#3)
periods ranging from##4##3##(1995-8#1)(2008-10#1)(2009-7#1)(2011-2#1)
periods up to##4##3##(1996-12#1)(2008-10#3)
periods using##2##2##(2008-10#2)
periods was##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
periods were##13##2##(2008-10#6)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-4#1)
periods with##4##2##(2008-10#2)(2008-11#1)(2010-1#1)
periods##423##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#3)(1993-11#3)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#4)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2006-8#2)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#3)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#138)(2008-11#14)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#2)(2008-5#14)(2008-6#6)(2008-7#19)(2008-8#7)(2008-9#2)(2009-11#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#19)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#6)(2012-4#1)(2012-7#1)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#3)
periods)##2##1##(2008-3#1)(2008-5#1)
perioperative and early##2##3##(2007-8#1)(2011-2#1)
perioperative blood##3##2##(1991-8#1)(2007-8#2)
perioperative care##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
perioperative complications##10##2##(1991-11#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-8#1)(2009-5#1)(2010-7#1)(2013-1#2)
perioperative context##2##2##(2012-2#1)(2012-3#1)
perioperative deaths##2##2##(1990-2#1)(2008-7#1)
perioperative factors##2##2##(2013-1#2)
perioperative hypothermia##3##2##(2013-8#3)
perioperative management of##6##3##(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
perioperative morbidity and mortality##2##4##(2008-7#1)(2012-12#1)
perioperative morbidity##4##2##(1995-12#1)(2008-7#2)(2012-12#1)
perioperative myocardial##2##2##(2007-8#2)
perioperative setting##2##2##(2012-12#1)(2012-3#1)
perioperative##93##1##(1990-11#1)(1990-2#2)(1991-11#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-9#1)(2006-10#5)(2006-7#3)(2007-8#16)(2007-9#1)(2008-10#2)(2008-3#2)(2008-7#3)(2008-8#4)(2009-4#1)(2009-5#4)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#8)(2013-1#9)(2013-8#4)
perioperatively##8##1##(1994-9#1)(2006-10#1)(2008-6#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
perioral##3##1##(2008-5#2)(2008-7#1)
periorbit##2##1##(2010-8#2)
periorbital area##3##2##(2008-5#2)(2010-8#1)
periorbital lines##2##2##(2008-5#2)
periorbital##9##1##(2008-5#4)(2010-8#3)(2012-8#2)
periosteal cells##5##2##(2008-11#1)(2008-5#4)
periosteal reaction##2##2##(2011-1#2)
periosteal##12##1##(2008-11#1)(2008-5#4)(2008-6#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)
periosteum and##2##2##(1993-8#1)(2008-6#1)
periosteum##6##1##(1993-8#1)(1994-3#1)(2007-12#1)(2008-6#1)(2008-9#2)
periovarian adhesions##2##2##(1992-3#2)
peripancreatic##6##1##(1990-3#1)(1993-3#1)(2008-3#2)(2012-2#2)
peripartum cardiomyopathy##4##2##(2008-11#1)(2011-2#1)(2013-8#2)
peripheral RoDH##2##2##(1995-5#2)
peripheral T##2##2##(1993-12#1)(2009-8#1)
peripheral T-cell lymphomas##2##3##(2009-8#2)
peripheral T-cell##3##2##(2009-8#2)(2013-8#1)
peripheral action##3##2##(1993-12#2)(2011-2#1)
peripheral administration##2##2##(1992-8#1)(2008-3#1)
peripheral and central##4##3##(2007-12#2)(2008-8#1)(2010-1#1)
peripheral and##16##2##(1990-11#1)(1991-12#1)(1991-3#1)(1994-11#1)(1996-1#1)(1996-9#1)(2007-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
peripheral arterial disease##7##3##(1990-11#1)(1995-2#1)(2008-8#2)(2011-2#2)(2012-2#1)
peripheral arterial occlusions##3##3##(2008-7#3)
peripheral arterial##19##2##(1990-11#2)(1990-8#1)(1995-2#2)(2007-10#1)(2008-7#4)(2008-8#3)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
peripheral arteriovenous##2##2##(1990-8#1)(1991-5#1)
peripheral artery disease##4##3##(2008-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
peripheral artery##5##2##(2008-7#1)(2010-4#2)(2012-2#1)(2013-7#1)
peripheral arthritis##3##2##(1990-6#2)(2010-12#1)
peripheral benzodiazepine receptor (PBR)##2##4##(2012-2#2)
peripheral benzodiazepine receptor##4##3##(1995-12#1)(2008-8#1)(2012-2#2)
peripheral benzodiazepine receptors##2##3##(1995-12#1)(2008-6#1)
peripheral benzodiazepine##6##2##(1995-12#2)(2008-6#1)(2008-8#1)(2012-2#2)
peripheral blood T cells##2##4##(1995-2#1)(2013-1#1)
peripheral blood T##4##3##(1992-6#1)(1995-2#2)(2013-1#1)
peripheral blood and##7##3##(1990-5#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-4#2)
peripheral blood cells from pig-tailed macaques and from African green monkeys##2##11##(1995-2#2)
peripheral blood cells##11##3##(1995-2#4)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)
peripheral blood erythrocytes##9##3##(2008-8#1)(2008-9#8)
peripheral blood granulocytes##2##3##(2008-9#2)
peripheral blood leukocytes##3##3##(1992-6#1)(2008-10#1)(2009-6#1)
peripheral blood lymphocyte##3##3##(1992-2#1)(2008-10#1)(2008-7#1)
peripheral blood lymphocytes (PBL)##4##4##(1991-9#1)(1995-12#1)(2008-11#1)(2008-9#1)
peripheral blood lymphocytes and monocytes##2##5##(1990-5#2)
peripheral blood lymphocytes and##5##4##(1990-5#2)(1991-12#1)(1991-9#1)(2007-8#1)
peripheral blood lymphocytes from##4##4##(1991-2#1)(1991-4#1)(1994-6#1)(1997-3#1)
peripheral blood lymphocytes##39##3##(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#3)(1993-8#2)(1994-3#1)(1994-6#1)(1995-12#3)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#8)(2008-4#2)(2008-9#7)(2010-12#2)
peripheral blood monocytes##5##3##(1993-9#2)(2008-4#2)(2008-9#1)
peripheral blood mononuclear cell##3##4##(1995-3#1)(1997-2#1)(2008-7#1)
peripheral blood mononuclear cells (PBMC) to##2##6##(1992-12#1)(2008-10#1)
peripheral blood mononuclear cells (PBMC)##8##5##(1992-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)(2011-3#1)
peripheral blood mononuclear cells (PBMCs)##2##5##(2008-10#1)(2008-9#1)
peripheral blood mononuclear cells from##2##5##(1995-2#1)(1995-3#1)
peripheral blood mononuclear cells in##2##5##(1995-3#1)(2008-7#1)
peripheral blood mononuclear cells##31##4##(1990-2#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-6#2)(1995-2#1)(1995-3#4)(1997-2#1)(2008-10#3)(2008-11#5)(2008-4#3)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2011-3#1)
peripheral blood mononuclear##35##3##(1990-2#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-6#2)(1995-2#1)(1995-3#5)(1997-2#2)(1997-4#1)(2008-10#3)(2008-11#5)(2008-4#3)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#2)(2011-3#1)
peripheral blood neutrophils##2##3##(1990-12#1)(1992-3#1)
peripheral blood of##9##3##(1996-12#2)(1996-9#1)(2007-10#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#2)
peripheral blood or bone marrow##2##5##(2008-4#1)(2008-9#1)
peripheral blood samples##4##3##(2008-9#4)
peripheral blood smear##2##3##(1990-3#1)(2012-3#1)
peripheral blood stem cell transplantation##2##5##(1997-3#1)(2006-10#1)
peripheral blood stem cell##3##4##(1997-3#1)(2006-10#1)(2011-2#1)
peripheral blood stem cells##3##4##(2008-11#1)(2008-5#1)(2010-6#1)
peripheral blood stem##6##3##(1997-3#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
peripheral blood was##2##3##(2011-2#1)(2013-1#1)
peripheral blood##209##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#4)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-3#1)(1994-6#3)(1995-11#1)(1995-12#3)(1995-2#8)(1995-3#5)(1996-12#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(2006-10#1)(2007-10#4)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#19)(2008-4#23)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#31)(2009-6#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
peripheral buttressing bone##2##3##(2013-1#2)
peripheral cells##6##2##(1994-11#1)(1994-8#1)(1997-8#1)(2008-4#1)(2008-5#2)
peripheral circulation##5##2##(1995-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
peripheral conversion of##2##3##(2008-2#1)(2012-3#1)
peripheral disease##2##2##(1996-8#1)(2009-2#1)
peripheral embolism##3##2##(2008-7#1)(2008-8#2)
peripheral erosive##2##2##(2006-10#2)
peripheral facial##2##2##(1991-6#1)(2007-10#1)
peripheral form##2##2##(1995-5#2)
peripheral glial cells##2##3##(2008-7#2)
peripheral glucose##2##2##(1990-8#1)(1992-6#1)
peripheral halo##3##2##(2006-10#2)(2013-1#1)
peripheral inflammation##3##2##(1997-2#3)
peripheral injection of##2##3##(1994-2#1)(1994-8#1)
peripheral insulin sensitivity##2##3##(1992-6#1)(2013-8#1)
peripheral insulin##3##2##(1992-6#1)(1994-11#1)(2013-8#1)
peripheral interventions##2##2##(2011-2#2)
peripheral leukocytes##2##2##(1990-12#2)
peripheral ligands##2##2##(2008-8#2)
peripheral lung cancer##2##3##(2008-1#2)
peripheral lung tumors##2##3##(2007-8#2)
peripheral lung##4##2##(2007-8#2)(2008-1#2)
peripheral lymphadenopathy##2##2##(2008-5#1)(2010-6#1)
peripheral lymphocyte subsets##2##3##(2008-10#2)
peripheral lymphocytes##3##2##(1990-8#1)(2008-8#1)(2012-3#1)
peripheral lymphoid organs##2##3##(2008-4#1)(2011-2#1)
peripheral membrane protein##2##3##(1993-11#1)(2012-2#1)
peripheral membrane##4##2##(1993-11#1)(1995-5#1)(2008-9#1)(2012-2#1)
peripheral nerve injury##7##3##(1993-5#1)(1994-5#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)
peripheral nerve myelin##2##3##(1995-12#1)(1995-5#1)
peripheral nerve regeneration##2##3##(1992-6#1)(2008-7#1)
peripheral nerve sheath tumor arising in##2##6##(1991-2#1)(2009-1#1)
peripheral nerve sheath tumors##2##4##(2008-7#2)
peripheral nerve sheath##5##3##(1991-2#1)(1997-8#1)(2008-7#2)(2009-1#1)
peripheral nerve##41##2##(1990-11#1)(1991-2#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-5#4)(1997-3#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#11)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#1)(2011-2#3)(2012-3#2)(2013-1#1)
peripheral nerves in##2##3##(2008-7#1)(2011-2#1)
peripheral nerves##22##2##(1994-11#2)(1995-12#1)(1997-3#1)(1997-4#1)(2008-7#8)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#5)(2012-3#1)
peripheral nervous system and##2##4##(2008-7#1)(2010-7#1)
peripheral nervous system##22##3##(1992-12#1)(1993-6#2)(1994-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#5)(2009-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
peripheral nervous##27##2##(1992-12#1)(1993-6#2)(1994-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
peripheral neurons##5##2##(1991-12#1)(1996-12#3)(1997-6#1)
peripheral neuropathies##7##2##(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)
peripheral neuropathy and##5##3##(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
peripheral neuropathy in##3##3##(2008-11#2)(2008-7#1)
peripheral neuropathy may##2##3##(2008-3#1)(2011-2#1)
peripheral neuropathy was##2##3##(2008-8#1)(2012-2#1)
peripheral neuropathy##38##2##(1990-2#1)(1990-9#1)(1991-12#1)(1996-2#1)(1996-5#2)(1997-3#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#9)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
peripheral or##4##2##(1990-8#1)(2007-8#1)(2008-4#1)(2008-9#1)
peripheral organs##5##2##(1991-12#1)(1992-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
peripheral pain##2##2##(2008-8#1)(2013-1#1)
peripheral parts##3##2##(1994-12#1)(1996-3#2)
peripheral production##2##2##(1990-8#1)(2008-2#1)
peripheral pulmonary lesions##5##3##(2010-8#5)
peripheral pulmonary##6##2##(2007-8#1)(2010-8#5)
peripheral resistance##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
peripheral retinal##2##2##(2011-1#2)
peripheral round shadow##2##3##(2007-10#2)
peripheral sensory##4##2##(1993-12#1)(1995-8#1)(2008-8#1)(2013-1#1)
peripheral signals##2##2##(2008-10#1)(2009-5#1)
peripheral stem cell##2##3##(2010-3#1)(2012-12#1)
peripheral stimulation##2##2##(1992-3#1)(1996-12#1)
peripheral sudomotor##2##2##(2009-12#2)
peripheral tissue##5##2##(1993-11#4)(2008-7#1)
peripheral tissues is##2##3##(1991-2#1)(1991-7#1)
peripheral tissues##16##2##(1990-11#3)(1991-11#1)(1991-2#2)(1991-7#2)(1991-9#1)(1993-11#1)(1995-12#2)(1997-7#1)(1997-8#1)(2008-3#1)(2012-2#1)
peripheral tolerance##2##2##(1994-11#1)(2008-4#1)
peripheral tumors##2##2##(1990-2#1)(2007-8#1)
peripheral vascular disease##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)
peripheral vascular##10##2##(1990-8#1)(1991-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#1)
peripheral vasculature##2##2##(2008-7#2)
peripheral vein##2##2##(2011-2#2)
peripheral venous catheter##2##3##(1990-8#1)(2013-1#1)
peripheral venous##4##2##(1990-3#1)(1990-8#1)(2013-1#2)
peripheral visual##2##2##(2010-5#1)(2011-2#1)
peripheral zone##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
peripheral##726##1##(1990-11#11)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#10)(1990-9#2)(1991-11#3)(1991-12#7)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#10)(1992-8#3)(1992-9#1)(1993-11#6)(1993-12#5)(1993-3#1)(1993-5#3)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#9)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#14)(1995-2#11)(1995-3#8)(1995-5#10)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#10)(1996-2#3)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-2#5)(1997-3#7)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#3)(2006-10#8)(2007-10#13)(2007-11#1)(2007-12#4)(2007-7#5)(2007-8#10)(2008-1#7)(2008-10#25)(2008-11#28)(2008-12#3)(2008-2#4)(2008-3#17)(2008-4#34)(2008-5#11)(2008-6#6)(2008-7#66)(2008-8#21)(2008-9#42)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#6)(2011-2#40)(2011-3#1)(2012-12#7)(2012-2#18)(2012-3#14)(2013-1#22)(2013-7#2)(2013-8#14)
peripherally administered##2##2##(1994-2#1)(1994-8#1)
peripherally associated with##2##3##(1991-10#1)(2009-10#1)
peripherally inserted central catheter##2##4##(2007-7#1)(2009-4#1)
peripherally inserted central##3##3##(2007-7#1)(2009-4#2)
peripherally inserted##4##2##(2007-7#2)(2009-4#2)
peripherally##14##1##(1990-2#1)(1991-10#1)(1994-2#1)(1994-8#1)(2007-7#2)(2008-10#1)(2008-7#2)(2009-10#1)(2009-4#2)(2012-12#2)
periphery and##4##2##(2008-4#1)(2009-2#1)(2010-1#1)(2010-2#1)
periphery of the##14##3##(1991-11#1)(1991-2#1)(1995-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-7#1)(2011-2#1)
periphery of##22##2##(1990-8#1)(1991-11#1)(1991-2#1)(1995-4#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#2)(2010-7#1)(2011-2#2)
periphery or##3##2##(2008-7#1)(2009-10#1)(2009-11#1)
periphery to##3##2##(1990-2#1)(1996-5#1)(2008-7#1)
periphery##64##1##(1990-2#1)(1990-8#2)(1991-11#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-4#1)(1996-12#2)(1996-5#2)(1997-6#1)(1997-8#1)(2007-12#4)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
periplasm##10##1##(1990-11#1)(1990-12#1)(1991-10#1)(1993-9#1)(1994-2#1)(2008-7#1)(2008-8#1)(2009-6#3)
periplasmic space and##2##3##(1993-6#1)(1997-3#1)
periplasmic space##6##2##(1990-8#1)(1993-6#1)(1994-8#1)(1997-3#2)(2008-4#1)
periplasmic##14##1##(1990-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-4#1)(2009-2#1)(2011-2#2)
periportal and perivenous##2##3##(1991-12#2)
periportal hepatocytes##2##2##(1991-12#1)(2008-8#1)
periportal##5##1##(1991-12#3)(1996-2#1)(2008-8#1)
periprosthetic femoral fracture##2##3##(2013-1#2)
periprosthetic femoral fractures##2##3##(2011-2#1)(2013-1#1)
periprosthetic femoral##4##2##(2011-2#1)(2013-1#3)
periprosthetic fractures##3##2##(2008-7#1)(2011-2#2)
periprosthetic infection##2##2##(2007-11#1)(2012-12#1)
periprosthetic##12##1##(2007-11#1)(2008-7#1)(2008-8#2)(2011-2#4)(2012-12#1)(2013-1#3)
periradicular##3##1##(2008-7#1)(2013-1#2)
perirenal fat were##2##3##(2010-4#1)(2013-1#1)
perirenal fat##9##2##(2010-4#7)(2013-1#2)
perirenal urinoma##2##2##(2011-2#2)
perirenal##11##1##(2010-4#7)(2011-2#2)(2013-1#2)
perirhinal and##2##2##(1992-11#1)(1996-12#1)
perirhinal##3##1##(1992-11#1)(1996-12#1)(1997-2#1)
perishable##2##1##(2009-5#1)(2010-7#1)
peristalsis in##2##2##(2012-2#2)
peristalsis##8##1##(1994-2#1)(2008-12#1)(2008-7#2)(2012-2#3)(2013-8#1)
peristalsis-suppressing effect##2##2##(2012-2#2)
peristaltic of the small##2##4##(2011-2#2)
peristaltic pump##10##2##(2008-10#9)(2008-11#1)
peristaltic pumps##3##2##(2008-10#3)
peristaltic##20##1##(1994-8#1)(1996-3#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
peristomial lip##2##2##(2008-9#2)
perisylvian cortex##2##2##(1996-2#1)(2008-4#1)
perisynaptic##2##1##(2009-8#1)(2013-1#1)
perithecia were##3##2##(2008-10#3)
perithecia##12##1##(2008-10#11)(2008-8#1)
perithecium##3##1##(2008-10#3)
peritoneal Kt/V##3##2##(2007-12#3)
peritoneal and##2##2##(2008-10#1)(2011-2#1)
peritoneal catheter was##2##3##(2007-7#1)(2008-1#1)
peritoneal catheter##7##2##(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#3)(2012-12#1)
peritoneal catheters##2##2##(2011-2#1)(2012-12#1)
peritoneal cavity##15##2##(1990-2#1)(1992-2#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-12#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
peritoneal cells##4##2##(1991-12#2)(2008-10#2)
peritoneal dialysate##3##2##(2007-12#2)(2013-1#1)
peritoneal dialysis (PD) patients##4##4##(2007-12#1)(2011-2#3)
peritoneal dialysis (PD)##16##3##(2007-12#4)(2008-1#2)(2008-4#1)(2011-2#9)
peritoneal dialysis and##7##3##(2007-12#2)(2008-1#2)(2008-10#1)(2008-7#1)(2011-2#1)
peritoneal dialysis catheter##2##3##(2007-7#2)
peritoneal dialysis catheters##2##3##(2007-12#1)(2008-10#1)
peritoneal dialysis in##3##3##(1992-5#1)(2007-12#1)(2008-10#1)
peritoneal dialysis patients##16##3##(2007-12#12)(2011-2#3)(2013-1#1)
peritoneal dialysis solution##2##3##(2011-2#2)
peritoneal dialysis##115##2##(1990-9#1)(1992-5#1)(1994-5#1)(1995-12#2)(1997-5#1)(2007-12#43)(2007-7#8)(2008-1#9)(2008-10#8)(2008-4#2)(2008-5#5)(2008-7#3)(2011-1#1)(2011-2#29)(2013-1#1)
peritoneal dialysis?##2##2##(2007-12#2)
peritoneal exposure##3##2##(2011-2#3)
peritoneal fluid##6##2##(1994-9#3)(2008-1#1)(2008-10#1)(2013-8#1)
peritoneal function in patients##2##4##(2011-2#2)
peritoneal function##5##2##(2011-2#5)
peritoneal inflammation##3##2##(2008-12#3)
peritoneal ligaments##3##2##(2008-1#3)
peritoneal macrophage##3##2##(1997-4#1)(2008-11#2)
peritoneal macrophages were##2##3##(2007-2#1)(2008-11#1)
peritoneal macrophages##20##2##(1990-2#1)(1991-12#1)(1993-6#2)(1994-9#2)(1995-2#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
peritoneal membrane of CAPD patients##2##5##(2007-7#1)(2008-10#1)
peritoneal membrane status##2##3##(2007-7#1)(2011-2#1)
peritoneal membrane##8##2##(2007-12#1)(2007-7#2)(2008-10#3)(2011-2#2)
peritoneal mesothelial##2##2##(2007-12#1)(2013-1#1)
peritoneal mesothelioma##4##2##(1991-12#2)(2010-12#2)
peritoneal penetration##2##2##(1990-2#2)
peritoneal permeability##4##2##(2007-12#1)(2011-2#3)
peritoneal sclerosis (EPS)##4##3##(2007-12#1)(2011-2#3)
peritoneal sclerosis##9##2##(2007-12#2)(2007-7#2)(2011-2#5)
peritoneal transport##4##2##(2011-2#4)
peritoneal##290##1##(1990-2#6)(1990-6#1)(1990-9#1)(1991-12#9)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-5#2)(1993-6#4)(1994-5#1)(1994-8#1)(1994-9#6)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-11#1)(1997-4#1)(1997-5#1)(2007-12#65)(2007-2#1)(2007-7#14)(2008-1#23)(2008-10#21)(2008-11#4)(2008-12#8)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#69)(2012-12#5)(2012-3#5)(2013-1#6)(2013-8#1)
peritoneocele##2##1##(2011-2#2)
peritoneoscopy and##2##2##(2009-8#2)
peritoneoscopy##3##1##(2009-8#3)
peritoneum##12##1##(1990-2#1)(1991-12#1)(1992-8#1)(1993-6#1)(1994-5#1)(2007-7#1)(2008-1#2)(2008-5#2)(2011-2#2)
peritonitis and##8##2##(2007-12#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#4)
peritonitis due to##2##3##(1991-3#1)(2008-10#1)
peritonitis in a##2##3##(2008-5#1)(2013-1#1)
peritonitis in##14##2##(1991-2#1)(1992-5#1)(1995-3#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-12#2)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
peritonitis is##2##2##(1992-5#1)(1993-6#1)
peritonitis rates##6##2##(2011-2#6)
peritonitis remains##2##2##(1992-5#1)(2011-2#1)
peritonitis was##2##2##(1992-5#1)(2009-10#1)
peritonitis were##2##2##(2008-12#1)(2011-2#1)
peritonitis##72##1##(1991-2#3)(1991-3#1)(1992-5#5)(1993-6#2)(1993-9#1)(1995-3#1)(2007-12#4)(2007-7#2)(2008-1#4)(2008-10#1)(2008-12#7)(2008-5#2)(2009-10#1)(2009-8#4)(2010-4#1)(2010-8#1)(2011-2#23)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
peritraumatic dissociation##2##2##(2011-2#2)
peritrochanteric fractures##2##2##(2007-11#2)
peritrochanteric##3##1##(2007-11#3)
peritrophic membrane##4##2##(2007-12#2)(2008-7#2)
peritumorally##2##1##(1990-12#1)(1995-12#1)
periurban##2##1##(2008-6#2)
periureteral fibrosis##2##2##(2008-10#2)
periurethral##5##1##(1997-7#3)(2008-3#1)(2013-8#1)
perivascular##20##1##(1990-12#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-8#3)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
perivenous hepatocytes##3##2##(1990-11#1)(1991-12#2)
perivenous##8##1##(1990-11#3)(1991-12#4)(2008-7#1)
periventricular leucomalacia##2##2##(1996-11#2)
periventricular##9##1##(1992-3#1)(1993-12#1)(1996-11#2)(2007-10#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
periventricularis##2##1##(2008-6#2)
perivitelline##3##1##(1991-5#1)(2008-12#1)(2008-9#1)
periwinkle (Catharanthus##2##2##(2008-10#2)
periwinkle and##2##2##(2008-10#2)
periwinkle##9##1##(2008-10#7)(2008-5#2)
periwinkles##5##1##(2008-10#5)
perm-selective##2##1##(2008-10#2)
permafrost peatlands##2##2##(2008-9#2)
permafrost##4##1##(2008-9#3)(2012-3#1)
permanence##4##1##(1993-1#1)(2008-5#1)(2012-2#1)(2013-7#1)
permanent access##5##2##(2007-7#5)
permanent and transient focal##2##4##(2007-10#1)(2011-2#1)
permanent and##12##2##(1995-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-7#1)
permanent atrial fibrillation##2##3##(2007-8#2)
permanent calves##5##2##(1996-12#5)
permanent cell##2##2##(1991-6#1)(2008-11#1)
permanent changes##2##2##(2008-4#1)(2008-7#1)
permanent chemical modifier##4##3##(2008-10#4)
permanent chemical##5##2##(2008-10#5)
permanent damage##2##2##(1997-2#1)(2012-3#1)
permanent dentition##2##2##(2008-12#1)(2012-2#1)
permanent dipole moments##2##3##(1997-6#2)
permanent focal ischemia##3##3##(1997-2#1)(2007-10#1)(2008-4#1)
permanent growth##2##2##(2008-2#1)(2011-2#1)
permanent hair##2##2##(2008-5#2)
permanent increase##3##2##(1993-2#1)(2008-7#1)(2013-1#1)
permanent magnet attached to the##2##5##(1996-12#1)(2008-10#1)
permanent magnet##5##2##(1996-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
permanent mandibular canines##2##3##(2012-3#2)
permanent modifier##15##2##(2008-10#15)
permanent modifiers for##2##3##(2008-10#2)
permanent modifiers##12##2##(2008-10#12)
permanent reduction##2##2##(1996-7#1)(2007-12#1)
permanent section##4##2##(1995-4#3)(2008-9#1)
permanent sequelae##3##2##(1995-11#1)(2007-7#1)(2011-1#1)
permanent submicrometer##2##2##(2008-3#2)
permanent teeth and##3##3##(2007-12#1)(2008-12#1)(2008-9#1)
permanent teeth##13##2##(2007-12#1)(2008-12#3)(2008-9#4)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
permanent with optimum pyrolysis and atomization temperatures of##2##8##(2008-10#2)
permanent##233##1##(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-4#3)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-4#3)(1996-1#1)(1996-12#6)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-6#5)(2007-10#5)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#9)(2007-8#3)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#11)(2008-7#10)(2008-8#4)(2008-9#6)(2009-3#4)(2009-7#3)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#1)
permanente##2##1##(2010-8#1)(2011-2#1)
permanently after##2##2##(2007-12#1)(2008-3#1)
permanently impair##2##2##(2007-7#1)(2012-3#1)
permanently##25##1##(1991-12#1)(1992-4#1)(1995-12#1)(1996-5#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
permanganate and##5##2##(2008-10#5)
permanganate in sulfuric acid medium##2##5##(2008-10#2)
permanganate in sulphuric acid##2##4##(2008-10#2)
permanganate in##15##2##(2008-10#15)
permanganate solution##2##2##(2008-10#2)
permanganate##48##1##(2008-10#47)(2008-4#1)
permanganates##3##1##(2008-10#3)
permeabilised##3##1##(1990-12#2)(1991-5#1)
permeabilities of##2##2##(1991-5#1)(2008-7#1)
permeabilities##4##1##(1991-5#2)(1994-6#1)(2008-7#1)
permeability (decrease in TER)##2##4##(2008-11#2)
permeability across##2##2##(2008-4#1)(2011-2#1)
permeability and##9##2##(1990-12#2)(1992-3#1)(1992-6#1)(1994-6#1)(1995-6#1)(2008-7#2)(2008-9#1)
permeability barrier##4##2##(1994-5#2)(2008-5#1)(2011-2#1)
permeability changes##2##2##(1994-5#1)(1996-5#1)
permeability coefficients were##2##3##(1992-3#1)(2008-5#1)
permeability coefficients##3##2##(1990-2#1)(1992-3#1)(2008-5#1)
permeability factor (VPF)##2##3##(1991-2#1)(2008-9#1)
permeability factor is##2##3##(1991-9#1)(1994-3#1)
permeability factor##15##2##(1991-2#2)(1991-9#8)(1992-9#1)(1994-12#1)(1994-3#2)(2008-9#1)
permeability for##2##2##(1992-3#1)(1993-3#1)
permeability in the##3##3##(1992-6#1)(2008-1#1)(2008-7#1)
permeability in##8##2##(1992-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#3)
permeability increase by capsaicin##2##4##(2008-11#2)
permeability increase in##2##3##(2008-11#2)
permeability increase##6##2##(1991-5#1)(2008-11#5)
permeability induced by##3##3##(1990-11#1)(1992-12#1)(1994-6#1)
permeability is##3##2##(1992-6#1)(1994-2#1)(1997-1#1)
permeability of bilayers##2##3##(1992-5#2)
permeability of the##16##3##(1990-2#1)(1991-5#1)(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-5#2)(2008-7#1)(2011-1#1)(2013-7#1)
permeability of which is##2##4##(1990-5#1)(1994-2#1)
permeability of##45##2##(1990-2#1)(1990-5#2)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#4)(1992-6#3)(1993-12#1)(1994-2#3)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
permeability to the##2##3##(1992-6#1)(2008-11#1)
permeability to##11##2##(1990-11#1)(1990-5#1)(1992-6#2)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
permeability transition pore##5##3##(2008-7#1)(2010-12#1)(2010-3#1)(2012-2#2)
permeability transition##10##2##(2008-1#2)(2008-11#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#2)
permeability was found to be##2##5##(1990-11#1)(2008-5#1)
permeability was found##3##3##(1990-11#1)(1990-5#1)(2008-5#1)
permeability was##5##2##(1990-11#2)(1990-5#1)(1991-5#1)(2008-5#1)
permeability with##2##2##(2006-10#1)(2008-10#1)
permeability##187##1##(1990-11#8)(1990-12#2)(1990-2#4)(1990-5#4)(1991-11#1)(1991-2#2)(1991-5#4)(1991-8#2)(1991-9#11)(1992-12#2)(1992-3#4)(1992-5#4)(1992-6#10)(1992-9#5)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#6)(2008-10#13)(2008-11#17)(2008-12#1)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#7)(2009-12#1)(2009-9#1)(2010-12#3)(2010-3#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#3)(2013-7#2)(2013-8#1)
permeabilization of the##2##3##(1997-7#1)(2009-11#1)
permeabilization##10##1##(1991-8#1)(1997-7#1)(2006-6#2)(2008-6#1)(2008-9#4)(2009-11#1)
permeabilized cells in##2##3##(1992-12#2)
permeabilized cells##3##2##(1991-8#1)(1992-12#2)
permeabilized rat##4##2##(1991-8#1)(1992-11#2)(1992-12#1)
permeabilized with##3##2##(1992-5#1)(1992-6#1)(1995-12#1)
permeabilized##24##1##(1991-8#2)(1992-11#2)(1992-12#6)(1992-5#1)(1992-6#1)(1993-8#4)(1994-5#2)(1994-9#1)(1995-12#1)(2008-4#1)(2008-7#3)
permeabilizes##3##1##(1990-5#2)(1994-2#1)
permeabilizing the##2##2##(1992-9#1)(2008-9#1)
permeabilizing##5##1##(1992-9#1)(1994-11#3)(2008-9#1)
permeable membrane##5##2##(2006-6#1)(2008-10#3)(2008-11#1)
permeable to##8##2##(1990-11#2)(1994-2#1)(1994-5#1)(1995-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
permeable##21##1##(1990-11#2)(1990-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-8#1)(2010-2#1)(2012-12#1)
permeant penetration##2##2##(2008-5#2)
permeant to##2##2##(1990-7#2)
permeant##13##1##(1990-11#3)(1990-7#2)(1991-5#1)(2008-5#5)(2008-8#1)(2009-11#1)
permease and##3##2##(1990-5#1)(1991-10#2)
permease is##2##2##(1990-5#1)(1991-10#1)
permease##23##1##(1990-5#6)(1991-10#7)(1993-11#6)(1995-11#3)(1996-6#1)
permease)##3##1##(1993-11#1)(1995-11#1)(1997-3#1)
permeases##5##1##(1990-5#3)(1995-11#1)(2013-1#1)
permeate medium##2##2##(2008-7#2)
permeate##14##1##(2007-4#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#1)(2012-3#1)
permeated##6##1##(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
permeates##3##1##(1991-9#1)(2008-7#1)(2012-3#1)
permeating##2##1##(2008-7#1)(2008-8#1)
permeation and##3##2##(1992-8#1)(1994-6#1)(2008-8#1)
permeation chromatography##9##2##(1990-10#1)(1990-8#1)(1996-12#1)(2008-10#3)(2008-5#1)(2009-2#1)(2011-1#1)
permeation experiments##2##2##(2008-10#1)(2008-5#1)
permeation of the UV filters##2##5##(2008-5#2)
permeation of##11##2##(1990-2#1)(2008-10#2)(2008-5#7)(2011-3#1)
permeation pathway##2##2##(2008-8#2)
permeation profile of##3##3##(2008-10#1)(2008-5#2)
permeation through##2##2##(2008-10#2)
permeation##60##1##(1990-10#1)(1990-2#1)(1990-8#1)(1991-5#2)(1992-3#1)(1992-8#1)(1994-6#1)(1995-3#1)(1996-12#1)(2008-10#11)(2008-11#1)(2008-5#23)(2008-7#1)(2008-8#7)(2009-2#1)(2010-5#2)(2011-1#2)(2011-2#1)(2011-3#1)
permed hair##2##2##(2008-5#2)
permet de##2##2##(2011-2#1)(2013-1#1)
permet##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
permethrin##11##1##(1997-5#2)(2007-5#1)(2010-2#1)(2011-2#7)
permettre##2##1##(2013-1#2)
permissible limit##2##2##(2008-10#1)(2008-7#1)
permissible##19##1##(1990-6#1)(1993-3#1)(1993-9#1)(1996-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
permission from the##2##3##(1991-3#1)(1997-5#1)
permission##4##1##(1991-3#1)(1994-3#2)(1997-5#1)
permissive and non-permissive##3##3##(1993-8#1)(1995-11#2)
permissive for##2##2##(1995-2#1)(2008-2#1)
permissive to##2##2##(1995-11#1)(2008-2#1)
permissive##18##1##(1992-2#1)(1993-8#2)(1995-11#3)(1995-2#1)(1995-6#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2012-12#1)(2012-4#1)
permit a more##2##3##(2007-12#1)(2008-10#1)
permit a##8##2##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
permit accurate##2##2##(2008-2#1)(2008-4#1)
permit an##4##2##(1991-11#1)(1992-6#1)(2008-10#2)
permit calculation of the##2##4##(2008-2#1)(2008-9#1)
permit complete##2##2##(1991-5#1)(2007-12#1)
permit direct##2##2##(1990-5#1)(2008-7#1)
permit high##3##2##(2008-10#1)(2008-2#2)
permit in##2##2##(1993-12#1)(2008-10#1)
permit monitoring of##2##3##(1990-12#1)(2008-3#1)
permit more##3##2##(2008-3#2)(2008-9#1)
permit new##2##2##(2007-11#1)(2007-12#1)
permit rapid##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
permit the incorporation of##2##4##(1992-6#1)(2008-4#1)
permit the use of##4##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
permit the##39##2##(1991-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-9#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
permit us to##2##3##(1993-11#1)(2009-4#1)
permit##159##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-6#2)(1992-8#2)(1993-11#4)(1993-12#4)(1993-3#1)(1994-3#1)(1994-9#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#9)(2007-12#13)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#16)(2008-3#21)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#2)(2013-1#3)
permits a direct##5##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)
permits a rapid##2##3##(1995-5#1)(2008-1#1)
permits a##18##2##(1995-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
permits accurate##4##2##(1990-8#1)(2007-11#1)(2007-12#2)
permits additional##2##2##(1997-8#1)(2007-11#1)
permits an##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
permits analysis of##2##3##(2008-10#1)(2008-4#1)
permits assessment of##2##3##(1991-2#1)(2008-7#1)
permits complete##2##2##(2008-10#1)(2008-7#1)
permits determination of##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
permits direct##6##2##(2007-12#3)(2008-1#1)(2008-3#2)
permits efficient##2##2##(2007-12#1)(2008-3#1)
permits fast##3##2##(2008-10#1)(2008-3#2)
permits highly##2##2##(1994-9#1)(2008-2#1)
permits independent control of the##2##5##(2007-12#2)
permits mapping of the##2##4##(2007-12#1)(2008-2#1)
permits measurement of##2##3##(2007-11#1)(2008-3#1)
permits non-invasive##2##2##(1990-3#1)(1993-6#1)
permits not only##2##3##(2008-11#1)(2009-8#1)
permits one to##11##3##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#4)(2008-9#1)
permits precise##2##2##(2007-11#1)(2007-12#1)
permits quantitative##2##2##(2008-3#2)
permits rapid and##3##3##(2008-10#2)(2008-11#1)
permits rapid##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
permits real-time##2##2##(2007-11#1)(2007-12#1)
permits simultaneous##2##2##(2008-2#1)(2012-2#1)
permits sufficient timescale simulations for quantum chemical events such as ATP hydrolysis##2##12##(2013-1#2)
permits sufficient##3##2##(2012-3#1)(2013-1#2)
permits the determination of##8##4##(1990-2#1)(2008-10#6)(2008-2#1)
permits the direct##2##3##(2008-10#1)(2008-3#1)
permits the extraction of##2##4##(2008-2#1)(2008-3#1)
permits the generation of##2##4##(2007-11#1)(2008-2#1)
permits the identification of##2##4##(1992-5#1)(2008-2#1)
permits the measurement of##3##4##(2008-10#1)(2008-3#2)
permits the measurement##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
permits the simultaneous##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
permits the use of a##2##5##(2008-1#1)(2008-3#1)
permits the use of##6##4##(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)
permits the##74##2##(1990-12#1)(1990-2#1)(1992-5#1)(1994-12#2)(1994-3#1)(1995-3#1)(1997-2#1)(2007-11#7)(2007-12#6)(2008-1#1)(2008-10#19)(2008-11#3)(2008-2#9)(2008-3#15)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
permits their##2##2##(2008-10#1)(2010-11#1)
permits to##11##2##(1990-2#1)(2007-11#1)(2008-10#6)(2008-12#1)(2010-6#1)(2013-1#1)
permits us to##7##3##(1995-6#1)(2007-11#1)(2008-2#2)(2008-3#2)(2012-2#1)
permits##275##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-8#2)(2007-11#32)(2007-12#32)(2007-8#1)(2008-1#6)(2008-10#41)(2008-11#6)(2008-12#1)(2008-2#32)(2008-3#44)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
permitted a good##2##3##(2007-8#1)(2008-10#1)
permitted a high##2##3##(2008-10#2)
permitted a##7##2##(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
permitted analysis of##2##3##(1993-9#1)(1994-6#1)
permitted by the##3##3##(1991-12#1)(2008-10#1)(2013-7#1)
permitted identification of##2##3##(2008-10#1)(2012-2#1)
permitted limit##2##2##(2008-10#1)(2011-2#1)
permitted the detection of##2##4##(2008-10#1)(2008-11#1)
permitted the detection##3##3##(2008-10#2)(2008-11#1)
permitted the determination of the##2##5##(1990-8#1)(2008-10#1)
permitted the determination of##4##4##(1990-8#1)(2008-10#3)
permitted the identification of##2##4##(2008-10#1)(2010-2#1)
permitted the##36##2##(1990-12#2)(1990-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-2#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
permitted to##6##2##(2008-10#4)(2013-1#2)
permitted##96##1##(1990-12#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-2#1)(2007-11#5)(2007-12#4)(2007-8#2)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
permitting a##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2009-12#1)
permitting analysis##2##2##(2008-10#1)(2008-9#1)
permitting detection##2##2##(2008-10#1)(2008-2#1)
permitting the##10##2##(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)
permitting##56##1##(1990-12#1)(1990-5#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-3#1)
permittivity at the##3##3##(2008-11#1)(2008-3#2)
permittivity measurements##3##2##(2008-11#3)
permittivity##17##1##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#6)(2008-3#7)(2010-10#1)
permselective##3##1##(2008-10#3)
permselectivity properties##2##2##(2008-10#2)
permselectivity##4##1##(2008-10#4)
permutation network##2##2##(2008-2#1)(2008-3#1)
permutation test##2##2##(2010-8#1)(2012-1#1)
permutation tests##2##2##(2008-12#1)(2008-7#1)
permutation##15##1##(1992-6#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-2#1)(2010-8#1)(2012-1#2)
permutations of##2##2##(2008-3#1)(2012-1#1)
permutations##3##1##(2008-3#2)(2012-1#1)
perniciosa##6##1##(2008-10#6)
perniciosus##4##1##(2008-8#4)
pernicious anemia##5##2##(1997-1#1)(2012-3#1)(2013-1#3)
pernicious##6##1##(1991-9#1)(1997-1#1)(2012-3#1)(2013-1#3)
peroffskyana##3##1##(1994-11#3)
peroneal and posterior tibial##2##4##(2010-5#2)
peroneal##5##1##(2009-3#1)(2010-5#2)(2012-3#1)(2013-8#1)
peroperative##3##1##(1996-8#1)(2008-5#1)(2012-2#1)
peroral##4##1##(1992-3#1)(1996-11#1)(1997-2#1)(2007-2#1)
peroxidase (HRP) and##3##3##(2008-10#3)
peroxidase (HRP) was used##2##4##(2008-10#2)
peroxidase (HRP)##31##2##(1990-5#1)(1995-12#1)(2008-10#27)(2010-5#1)(2012-2#1)
peroxidase (MnP)##2##2##(2008-7#1)(2011-1#1)
peroxidase (POD)##2##2##(2008-10#2)
peroxidase (POD)-like##2##2##(2008-10#2)
peroxidase activities were##2##3##(1992-3#1)(2008-10#1)
peroxidase activities##7##2##(1991-12#2)(1992-3#1)(1994-5#1)(2008-10#3)
peroxidase activity in##4##3##(2008-10#3)(2008-12#1)
peroxidase activity of##3##3##(2008-10#3)
peroxidase activity was##3##3##(2008-2#1)(2008-5#2)
peroxidase activity##22##2##(1990-3#1)(1991-8#3)(1993-8#1)(1994-2#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-5#2)(2009-3#1)
peroxidase and glutathione##2##3##(1994-9#1)(2008-4#1)
peroxidase and##19##2##(1990-12#1)(1991-12#3)(1994-9#2)(2007-12#1)(2008-10#8)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)
peroxidase as##2##2##(2008-10#2)
peroxidase from##4##2##(1991-11#1)(1995-5#1)(2008-10#1)(2008-6#1)
peroxidase gene##4##2##(1990-12#1)(1991-12#1)(2008-10#1)(2011-1#1)
peroxidase in##4##2##(1994-6#2)(2008-10#1)(2008-7#1)
peroxidase is##6##2##(1991-5#1)(2008-10#3)(2008-5#2)
peroxidase on##2##2##(1991-9#1)(1992-12#1)
peroxidase to##2##2##(2008-10#2)
peroxidase was##4##2##(1991-12#1)(2008-10#3)
peroxidase were immobilized##2##3##(2008-10#2)
peroxidase were##6##2##(1990-3#1)(2008-10#3)(2008-5#2)
peroxidase##240##1##(1990-12#3)(1990-3#4)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#9)(1991-2#2)(1991-5#1)(1991-8#3)(1991-9#3)(1992-12#2)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#6)(1993-8#3)(1994-12#1)(1994-2#3)(1994-5#5)(1994-6#3)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#4)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-12#2)(2008-10#113)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#8)(2008-6#7)(2008-7#6)(2008-9#1)(2009-10#1)(2009-3#2)(2009-7#1)(2010-5#2)(2011-1#5)(2011-10#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#1)
peroxidase-labeled bovine lactoferrin##2##3##(1996-12#2)
peroxidase-labeled##3##1##(1996-12#2)(2008-10#1)
peroxidase-like activity##2##2##(2008-5#1)(2008-7#1)
peroxidase-oxidase##2##1##(2008-10#2)
peroxidases in##3##2##(2008-10#2)(2009-7#1)
peroxidases##14##1##(1993-3#1)(1994-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#1)
peroxidation assay##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
peroxidation by##6##2##(1990-3#1)(1993-2#1)(1994-8#1)(1995-6#2)(2008-5#1)
peroxidation in##6##2##(1992-3#1)(1994-6#2)(2008-11#1)(2008-12#1)(2008-5#1)
peroxidation induced by##5##3##(1995-6#2)(2008-10#1)(2008-4#2)
peroxidation induced##6##2##(1995-6#2)(1996-2#1)(2008-10#1)(2008-4#2)
peroxidation more##2##2##(1990-8#1)(2013-1#1)
peroxidation of membrane##2##3##(1991-5#1)(2009-6#1)
peroxidation of membranes##2##3##(1990-12#1)(1991-9#1)
peroxidation of##9##2##(1990-12#1)(1991-5#2)(1991-9#1)(1994-6#1)(1994-8#1)(2008-5#2)(2009-6#1)
peroxidation were##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
peroxidation with##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
peroxidation##136##1##(1990-12#3)(1990-3#3)(1990-5#2)(1990-8#1)(1991-12#2)(1991-5#4)(1991-9#1)(1992-3#2)(1992-8#1)(1993-2#3)(1993-8#2)(1994-11#5)(1994-12#1)(1994-5#3)(1994-6#7)(1994-8#5)(1995-12#4)(1995-3#1)(1995-6#6)(1996-2#7)(1996-9#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#18)(2008-7#8)(2008-8#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#5)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)
peroxidation-resistant membrane composition##3##3##(2009-5#3)
peroxidation-resistant##5##1##(2009-5#5)
peroxidative activity of human Cu##3##5##(1997-2#3)
peroxidative activity##5##2##(1997-2#5)
peroxidative reaction##3##2##(1997-8#3)
peroxidative##11##1##(1997-2#7)(1997-8#3)(2009-5#1)
peroxide (H(2)O(2))##16##2##(2008-10#9)(2008-2#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)
peroxide (H2O2)##10##2##(1990-5#1)(1991-9#1)(1992-3#1)(1995-3#1)(1997-4#2)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
peroxide and the##2##3##(2008-10#2)
peroxide and##37##2##(1991-9#1)(1992-5#1)(1993-12#1)(1996-2#1)(2008-10#23)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2011-2#3)(2013-1#1)
peroxide as##4##2##(2008-10#4)
peroxide concentrations##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
peroxide generation##2##2##(1990-5#1)(2009-9#1)
peroxide in the presence of##3##5##(1996-5#1)(2008-10#2)
peroxide in the##9##3##(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#6)
peroxide in##36##2##(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#32)(2009-5#1)
peroxide is detected##2##3##(2008-10#2)
peroxide is##7##2##(1991-9#1)(1992-11#1)(2008-10#5)
peroxide levels##3##2##(1990-5#1)(2008-11#1)(2008-5#1)
peroxide value##5##2##(2008-10#5)
peroxide values##2##2##(1990-5#2)
peroxide was##7##2##(2008-10#5)(2008-3#1)(2011-2#1)
peroxide##330##1##(1990-5#9)(1990-8#1)(1991-5#3)(1991-9#10)(1992-11#3)(1992-12#2)(1992-3#2)(1992-5#1)(1993-12#2)(1994-5#2)(1994-8#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-4#4)(2008-1#1)(2008-10#219)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-5#3)(2010-8#10)(2011-2#7)(2012-2#1)(2012-3#1)(2012-8#3)(2013-1#3)(2013-8#2)
peroxide)##3##1##(2008-10#3)
peroxide-induced haemolysis##3##2##(1991-12#3)
peroxide-induced##5##1##(1991-12#3)(1997-4#1)(2008-7#1)
peroxides in the##2##3##(2008-10#1)(2013-1#1)
peroxides in##7##2##(1990-5#4)(2008-10#2)(2013-1#1)
peroxides##22##1##(1990-5#5)(1991-9#1)(1992-5#1)(1993-12#2)(2008-10#3)(2008-5#5)(2008-7#3)(2011-2#1)(2013-1#1)
peroxisomal 3-ketoacyl-CoA thiolase##2##3##(1991-12#2)
peroxisomal disorders##3##2##(1990-3#2)(1993-8#1)
peroxisomal enzyme##2##2##(1995-12#1)(2007-12#1)
peroxisomal fatty acid beta-oxidation##2##4##(1992-11#1)(1994-6#1)
peroxisomal protein import##2##3##(2008-1#2)
peroxisomal protein##4##2##(1990-12#1)(1991-9#1)(2008-1#2)
peroxisomal targeting##5##2##(1991-12#2)(2008-1#1)(2009-10#2)
peroxisomal##31##1##(1990-12#1)(1990-3#2)(1990-5#2)(1991-12#5)(1991-9#1)(1992-11#1)(1993-8#4)(1993-9#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-5#1)(2009-10#2)
peroxisome proliferation##8##2##(1992-11#4)(1993-9#1)(1995-3#3)
peroxisome proliferator activated receptor##2##4##(2012-2#1)(2013-8#1)
peroxisome proliferator activated##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
peroxisome proliferator##6##2##(1994-8#2)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
peroxisome proliferator-activated receptor (PPAR)##2##4##(1995-6#1)(2008-5#1)
peroxisome proliferator-activated receptor##10##3##(1994-8#1)(1995-6#2)(2008-5#2)(2010-10#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
peroxisome proliferator-activated receptor-gamma##3##3##(2008-7#2)(2012-12#1)
peroxisome proliferator-activated##14##2##(1994-8#1)(1995-6#2)(2008-5#2)(2008-7#2)(2010-10#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
peroxisome proliferators##4##2##(1990-12#1)(1994-8#2)(1995-6#1)
peroxisome##35##1##(1990-12#1)(1992-11#5)(1993-9#1)(1994-8#5)(1995-3#3)(1995-6#3)(1995-9#1)(2008-10#1)(2008-5#2)(2008-7#3)(2010-10#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
peroxisome-deficient##2##1##(1995-9#2)
peroxisomes and mitochondria##4##3##(2009-10#4)
peroxisomes were##2##2##(1995-9#1)(2008-7#1)
peroxisomes##21##1##(1990-12#1)(1990-5#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-9#4)(2007-12#2)(2008-5#1)(2008-7#2)(2009-10#5)(2009-8#1)(2013-1#1)
peroxodisulfate##5##1##(2008-10#5)
peroxovanadate##2##1##(1997-1#2)
peroxydisulphate##2##1##(2008-10#2)
peroxygenase##4##1##(1990-12#3)(1992-8#1)
peroxyl radical##6##2##(1990-5#2)(1992-9#1)(1993-3#1)(2008-10#1)(2008-7#1)
peroxyl radicals in##2##3##(1992-9#1)(2008-10#1)
peroxyl radicals##4##2##(1992-9#2)(2008-10#2)
peroxyl##11##1##(1990-5#2)(1991-9#1)(1992-9#3)(1993-3#1)(2008-10#3)(2008-7#1)
peroxynitrite (ONOO(-))##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
peroxynitrite in biological samples##2##4##(2008-10#2)
peroxynitrite in##3##2##(2008-10#3)
peroxynitrite##27##1##(1996-5#1)(1997-4#1)(2008-10#19)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#2)
peroxyoxalate chemiluminescence##2##2##(1990-8#2)
peroxyoxalate chemiluminescent##2##2##(2008-10#2)
peroxyoxalate##5##1##(1990-8#2)(2008-10#3)
perpendicular and##2##2##(2007-12#1)(2008-3#1)
perpendicular direction##2##2##(1997-6#1)(2010-4#1)
perpendicular polarized##3##2##(2007-12#2)(2008-3#1)
perpendicular to the c axis##2##5##(1990-4#1)(1996-2#1)
perpendicular to the plane of the##3##6##(1994-12#1)(1995-5#1)(2008-3#1)
perpendicular to the plane of##5##5##(1994-12#1)(1995-5#1)(2008-3#3)
perpendicular to the substrate##2##4##(2008-3#2)
perpendicular to the surface of##2##5##(1995-5#1)(2007-11#1)
perpendicular to the surface##3##4##(1995-5#1)(2007-11#1)(2008-3#1)
perpendicular to the wind##2##4##(2008-10#2)
perpendicular to the##51##3##(1990-4#1)(1994-11#1)(1994-12#1)(1995-5#2)(1996-2#2)(2007-11#6)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#23)(2008-7#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-12#1)
perpendicular to##55##2##(1990-4#1)(1994-11#1)(1994-12#1)(1995-5#2)(1996-2#2)(1997-7#1)(2007-11#6)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#24)(2008-7#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-12#1)
perpendicular##81##1##(1990-2#1)(1990-4#1)(1994-11#1)(1994-12#1)(1995-5#2)(1996-2#2)(1997-6#1)(1997-7#3)(2007-11#8)(2007-12#4)(2008-10#5)(2008-2#5)(2008-3#35)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#3)(2011-2#1)(2012-12#1)
perpendicular)##2##1##(1996-2#1)(2008-10#1)
perpendicularly to the##3##3##(2007-11#1)(2008-3#2)
perpendicularly##8##1##(2007-11#1)(2007-12#3)(2008-3#2)(2008-6#1)(2011-2#1)
perpetrated##3##1##(1991-12#1)(1996-12#1)(2013-1#1)
perpetrating IPV##2##2##(2010-11#1)(2013-1#1)
perpetration of##2##2##(2009-5#1)(2010-11#1)
perpetration##15##1##(2009-5#3)(2009-7#5)(2010-11#2)(2013-1#5)
perpetrator##4##1##(2007-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
perpetrators and##2##2##(2007-2#1)(2008-11#1)
perpetrators##5##1##(2007-2#1)(2008-11#2)(2009-5#1)(2013-1#1)
perpetual##5##1##(1993-11#1)(1995-8#1)(2008-1#1)(2010-3#1)(2012-2#1)
perpetually##3##1##(1995-3#1)(2008-4#1)(2008-7#1)
perpetuate##3##1##(1996-5#1)(2008-7#1)(2008-9#1)
perpetuated by##2##2##(1994-11#1)(2008-7#1)
perpetuated##3##1##(1994-11#1)(2008-7#1)(2010-6#1)
perpetuating##3##1##(1994-2#1)(2010-12#2)
perpetuation of##5##2##(2008-1#1)(2008-12#3)(2013-1#1)
perpetuation##6##1##(1995-3#1)(2008-1#1)(2008-12#3)(2013-1#1)
perphenazine assay##2##2##(2008-10#2)
perphenazine was##2##2##(2008-10#2)
perphenazine##18##1##(1992-12#1)(2008-10#17)
perseverance and##2##2##(2008-11#1)(2008-12#1)
persica##5##1##(2008-10#3)(2008-12#2)
persicae##7##1##(2008-10#6)(2009-8#1)
persicus and##3##2##(2008-12#3)
persicus##10##1##(2008-12#8)(2013-1#2)
persimmon fruits##2##2##(2008-10#2)
persimmon tannin gel##4##3##(2008-10#4)
persimmon##10##1##(2008-10#9)(2008-6#1)
persist at##4##2##(1995-11#1)(2008-8#1)(2011-1#1)(2011-3#1)
persist despite##3##2##(2011-2#1)(2012-2#2)
persist for##4##2##(1991-3#1)(1995-9#1)(1997-8#1)(2011-2#1)
persist in a##2##3##(2008-8#1)(2012-3#1)
persist in large numbers##2##4##(2008-11#1)(2012-2#1)
persist in the##4##3##(1990-5#1)(2008-1#1)(2008-10#1)(2009-8#1)
persist in##14##2##(1990-11#1)(1990-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
persist into adulthood##2##3##(2011-2#1)(2013-7#1)
persist into##3##2##(2008-11#1)(2011-2#1)(2013-7#1)
persist on##2##2##(2008-10#2)
persist##52##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-11#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#1)(2013-7#3)
persist?##2##1##(2008-8#2)
persisted after##2##2##(1991-11#1)(2008-10#1)
persisted and##2##2##(2008-9#1)(2010-12#1)
persisted at##4##2##(1990-5#1)(1991-12#1)(1992-9#1)(1997-2#1)
persisted during##2##2##(1993-5#1)(1995-11#1)
persisted even##2##2##(1992-6#1)(1994-3#1)
persisted for 30 weeks##2##4##(2009-12#2)
persisted for several##2##3##(2008-10#1)(2012-2#1)
persisted for up to##3##4##(2008-10#2)(2008-8#1)
persisted for##17##2##(1993-12#1)(2007-10#2)(2007-6#1)(2008-10#5)(2008-8#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
persisted in the##6##3##(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
persisted in##16##2##(1995-11#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2010-8#1)(2013-1#1)
persisted longer##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
persisted throughout the##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
persisted throughout##4##2##(1997-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
persisted until##2##2##(1993-10#1)(2008-10#1)
persisted when##2##2##(1995-2#1)(1996-5#1)
persisted with##2##2##(1992-6#1)(2008-10#1)
persisted##75##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#2)(1997-2#2)(1997-3#1)(2007-10#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
persistence and dynamics##2##3##(1995-5#2)
persistence and##9##2##(1995-5#4)(2006-6#1)(2007-12#1)(2009-5#1)(2010-11#1)(2010-4#1)
persistence in the##2##3##(1994-6#1)(2011-2#1)
persistence in##9##2##(1994-6#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
persistence of the##11##3##(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#3)(2010-6#1)(2011-2#2)(2013-8#1)
persistence of these##2##3##(1996-4#1)(2008-10#1)
persistence of##51##2##(1993-8#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-4#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#10)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#3)
persistence or##2##2##(2008-7#1)(2012-2#1)
persistence threshold##2##2##(2008-8#2)
persistence##118##1##(1990-9#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#5)(1995-9#1)(1996-4#1)(1997-6#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#27)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#9)(2011-3#5)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#4)
persistent TD##3##2##(2010-12#3)
persistent TGF-beta##2##2##(2008-9#2)
persistent activation of protein kinase C##2##6##(1992-9#2)
persistent activation##3##2##(1992-9#3)
persistent activity of##2##3##(2012-3#2)
persistent activity##3##2##(2008-11#1)(2012-3#2)
persistent allergic rhinitis##2##3##(2008-3#1)(2012-12#1)
persistent alterations in##2##3##(2009-7#1)(2013-8#1)
persistent and chronic##2##3##(1997-3#1)(2012-12#1)
persistent and##7##2##(1994-3#2)(1997-3#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
persistent asthma##7##2##(1990-9#1)(1996-7#1)(2007-11#3)(2010-5#2)
persistent cough and##2##3##(1995-8#1)(2008-12#1)
persistent deficits##2##2##(2011-1#1)(2012-3#1)
persistent disease##2##2##(2009-11#1)(2013-1#1)
persistent elevation of##3##3##(1992-3#1)(1997-3#1)(2010-1#1)
persistent epithelial defect##2##3##(2011-2#2)
persistent hepatitis##2##2##(2008-8#1)(2013-1#1)
persistent hyperparathyroidism##2##2##(1991-5#1)(1993-3#1)
persistent in##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
persistent infection##5##2##(1994-8#1)(2007-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
persistent infections##5##2##(1997-3#1)(1997-6#1)(2010-1#1)(2013-1#2)
persistent left superior vena cava##4##5##(2010-11#1)(2011-2#1)(2012-2#2)
persistent leptokurtosis##2##2##(2008-8#2)
persistent lesions##2##2##(1991-8#1)(2013-1#1)
persistent neutropenia##2##2##(2012-3#2)
persistent occlusion##2##2##(2007-10#2)
persistent or recurrent##4##3##(1991-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
persistent or##6##2##(1991-2#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-2#1)
persistent organochlorine##3##2##(2008-8#3)
persistent otitis media##3##3##(1996-11#2)(2008-9#1)
persistent pain and##2##3##(1996-6#1)(2007-11#1)
persistent pain states##2##3##(2008-7#2)
persistent pain##16##2##(1991-8#1)(1992-6#1)(1996-6#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-7#7)(2011-2#1)(2012-12#1)
persistent pigment darkening##2##3##(2008-5#2)
persistent primitive trigeminal artery##2##4##(2008-7#2)
persistent skin##2##2##(2012-3#1)(2013-8#1)
persistent spectral hole burning##3##4##(2007-12#3)
persistent symptoms##8##2##(1990-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
persistent vegetative state##5##3##(1990-11#1)(1990-9#1)(1991-12#1)(1997-5#1)(2008-2#1)
persistent##281##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#1)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#5)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#6)(2007-11#8)(2007-12#11)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#23)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#16)(2008-8#19)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#9)(2013-1#12)(2013-8#5)
persistently activated form of##2##4##(1992-9#2)
persistently high##3##2##(1990-5#1)(2008-1#1)(2013-1#1)
persistently infected##2##2##(1995-9#1)(1997-5#1)
persistently transmitted##2##2##(2008-10#2)
persistently##20##1##(1990-5#1)(1992-12#1)(1992-9#2)(1995-9#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#2)
persister##2##1##(2012-3#2)
persisting at##3##2##(2008-3#1)(2010-6#1)(2013-1#1)
persisting for##3##2##(1991-3#1)(1994-6#1)(2011-2#1)
persisting symptoms##2##2##(1992-9#1)(2010-12#1)
persisting##29##1##(1991-3#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
persists after##6##2##(1993-12#2)(1994-2#1)(2007-8#1)(2008-5#1)(2008-8#1)
persists in the##4##3##(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)
persists in##12##2##(1994-2#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-10#1)
persists##34##1##(1993-12#2)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-10#2)(2011-2#1)(2011-3#1)(2013-1#2)
person and the##2##3##(1993-6#1)(1995-8#1)
person and##8##2##(1993-6#1)(1994-1#1)(1995-6#1)(1995-8#1)(2008-7#1)(2010-10#1)(2010-6#1)(2013-8#1)
person for##2##2##(2008-10#1)(2008-9#1)
person from##3##2##(2008-11#1)(2008-6#2)
person having##3##2##(1994-12#1)(2007-11#1)(2012-2#1)
person identification##2##2##(2012-1#2)
person information##2##2##(2008-11#2)
person is##5##2##(1996-5#1)(2010-10#2)(2012-12#1)(2012-3#1)
person of##3##2##(1991-8#1)(2008-7#1)(2011-2#1)
person perspective##2##2##(2008-11#2)
person recognition##4##2##(2012-1#4)
person through##2##2##(1994-6#1)(2008-9#1)
person to##12##2##(1990-6#1)(1991-3#1)(1992-6#1)(1994-6#1)(1995-1#1)(1995-6#1)(1997-5#2)(2007-12#2)(2007-6#1)(2010-5#1)
person was##2##2##(1993-8#1)(1995-6#1)
person who##5##2##(1997-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2012-12#1)
person with a##2##3##(1995-11#1)(1996-8#1)
person with##11##2##(1993-6#1)(1995-11#1)(1996-5#1)(1996-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#2)(2013-1#1)
person years##2##2##(1995-9#2)
person##139##1##(1990-11#1)(1990-6#2)(1991-12#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#5)(1995-8#2)(1995-9#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-9#1)(2010-10#6)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#2)(2012-1#7)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#2)
person's##25##1##(1991-6#1)(1992-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
person-centered interactions##2##2##(2007-10#2)
person-centered medicine##2##2##(2013-8#2)
person-centered##4##1##(2007-10#2)(2013-8#2)
person-centred##2##1##(2007-10#1)(2013-1#1)
person-years##6##1##(1993-9#1)(1996-9#1)(2008-7#1)(2009-3#1)(2011-1#2)
personal accomplishment)##2##2##(1996-2#1)(2008-11#1)
personal account of##2##3##(1996-12#1)(2011-2#1)
personal and collective##3##3##(2008-9#2)(2011-3#1)
personal and environmental##3##3##(2008-7#1)(2012-2#2)
personal and organizational growth##2##4##(1993-12#1)(1997-1#1)
personal and organizational##3##3##(1993-12#1)(1997-1#1)(2012-1#1)
personal and professional##13##3##(1993-3#1)(1994-1#1)(1994-3#1)(2008-1#1)(2008-11#5)(2008-12#1)(2011-2#1)(2012-1#2)
personal and public health##2##4##(1994-3#1)(2013-1#1)
personal and social##2##3##(2008-12#1)(2012-3#1)
personal and societal##2##3##(2008-12#1)(2011-2#1)
personal and##34##2##(1991-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#2)(1997-1#1)(2008-1#1)(2008-11#5)(2008-12#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
personal assistance services##2##3##(1996-1#2)
personal bankruptcy filings##2##3##(2008-11#2)
personal bankruptcy##3##2##(2008-11#3)
personal behavior##2##2##(2008-12#1)(2011-2#1)
personal beliefs##2##2##(2007-11#1)(2007-12#1)
personal belongings##2##2##(1992-12#1)(2008-10#1)
personal care applications##3##3##(2008-5#3)
personal care formulations##2##3##(2008-5#2)
personal care products##4##3##(2008-5#4)
personal care##15##2##(1996-2#1)(1997-2#2)(2008-5#12)
personal case series]##2##3##(1992-6#1)(1993-6#1)
personal case##4##2##(1992-6#1)(1993-6#1)(2008-11#1)(2008-4#1)
personal characteristics##8##2##(1995-12#2)(2007-12#2)(2008-7#1)(2009-7#2)(2010-9#1)
personal cleansing products##4##3##(2008-5#4)
personal cleansing##5##2##(2008-5#5)
personal computer (PC)##2##3##(1994-2#1)(2008-11#1)
personal computer##15##2##(1991-1#1)(1991-12#1)(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-3#5)(2010-8#1)
personal computers##4##2##(1993-1#1)(1994-3#1)(2008-3#1)(2010-9#1)
personal considerations##2##2##(2008-1#1)(2013-1#1)
personal contact##2##2##(2007-12#1)(2008-11#1)
personal data##2##2##(2007-10#1)(2010-8#1)
personal development##2##2##(2008-11#2)
personal digital assistant (PDA)##3##4##(2008-10#1)(2008-12#1)(2010-2#1)
personal digital assistant##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)
personal digital assistants##3##3##(2006-10#1)(2008-11#1)(2008-12#1)
personal digital##7##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-2#1)
personal experience and##2##3##(1993-9#1)(1997-3#1)
personal experience in the##2##4##(1991-5#1)(1996-2#1)
personal experience is##2##3##(1991-3#1)(2013-1#1)
personal experience of the##2##4##(1990-3#1)(2008-11#1)
personal experience of##4##3##(1990-3#1)(1990-5#1)(1996-3#1)(2008-11#1)
personal experience on##3##3##(1990-12#1)(1990-9#1)(2008-1#1)
personal experience##22##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#2)(1991-3#1)(1991-5#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-4#1)(2013-1#1)
personal experience]##2##2##(1993-3#1)(1996-8#1)
personal experiences and##4##3##(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
personal experiences of##2##3##(2008-11#1)(2008-12#1)
personal experiences##8##2##(2008-11#1)(2008-12#2)(2010-3#1)(2010-5#2)(2012-12#1)(2012-3#1)
personal exposure to##2##3##(2008-11#2)
personal exposure##7##2##(2008-11#6)(2008-6#1)
personal factors##2##2##(2008-11#1)(2009-7#1)
personal genomics and##2##3##(2009-5#2)
personal genomics##3##2##(2009-5#3)
personal growth##3##2##(1995-1#1)(2008-1#1)(2010-4#1)
personal health care expenditures##2##4##(1996-3#1)(1997-3#1)
personal health care##4##3##(1996-1#1)(1996-3#1)(1997-3#2)
personal health is##2##3##(2008-10#1)(2010-1#1)
personal health##10##2##(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-10#2)(2008-11#2)(2010-1#1)
personal hygiene##2##2##(2007-7#1)(2013-8#1)
personal identification##3##2##(1991-9#1)(1995-6#2)
personal income##2##2##(1993-1#1)(1994-2#1)
personal information##2##2##(1997-4#1)(2008-12#1)
personal interview##2##2##(1993-9#1)(2011-2#1)
personal journey##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
personal life##2##2##(1992-1#1)(2009-10#1)
personal moral dilemmas##3##3##(2008-11#3)
personal moral violations##2##3##(2008-11#2)
personal moral##7##2##(2008-11#7)
personal needs##3##2##(1994-1#1)(1995-3#1)(1996-1#1)
personal opinion##2##2##(2008-11#1)(2008-2#1)
personal or family history of##2##5##(2007-10#1)(2010-6#1)
personal or##4##2##(1991-2#1)(2007-10#1)(2009-7#1)(2010-6#1)
personal perspective##6##2##(1993-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)
personal preferences##2##2##(2012-12#1)(2013-1#1)
personal professional##2##2##(1992-3#1)(2008-10#1)
personal protective equipment##2##3##(2008-12#1)(2008-8#1)
personal protective##6##2##(2007-2#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)
personal qualities##4##2##(1990-12#3)(2011-2#1)
personal reflection##5##2##(1996-12#1)(2008-1#1)(2008-11#2)(2008-12#1)
personal resources##2##2##(2011-3#1)(2012-12#1)
personal responsibility for##2##3##(2009-9#1)(2012-3#1)
personal responsibility##4##2##(1994-1#1)(2008-4#1)(2009-9#1)(2012-3#1)
personal risk##5##2##(1991-3#1)(1997-5#1)(2011-2#2)(2012-12#1)
personal series of##2##3##(1993-6#1)(2008-7#1)
personal stressors##2##2##(2008-1#2)
personal supervision##2##2##(1992-6#2)
personal touch##3##2##(1994-3#1)(1995-1#1)(1996-3#1)
personal tutor role##2##3##(2008-11#2)
personal tutor##4##2##(2008-11#4)
personal view of##4##3##(1994-12#1)(1995-12#2)(1996-1#1)
personal##389##1##(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#3)(1992-6#3)(1993-1#3)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#2)(1993-9#2)(1994-1#4)(1994-12#5)(1994-2#4)(1994-3#5)(1994-6#2)(1995-1#5)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#2)(1996-1#9)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#12)(2008-10#17)(2008-11#54)(2008-12#20)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#22)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#7)(2009-7#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#1)(2011-2#13)(2011-3#2)(2012-1#4)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#9)(2013-8#5)
personalised##3##1##(2007-6#1)(2012-12#1)(2013-1#1)
personalities##6##1##(1992-3#1)(1993-11#1)(1996-7#1)(2008-4#1)(2008-8#1)(2012-2#1)
personality and##15##2##(1991-12#1)(1994-2#5)(2007-11#1)(2008-1#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-1#3)(2012-1#1)
personality assessment##2##2##(1990-2#1)(2008-7#1)
personality changes##3##2##(1996-7#1)(2008-7#1)(2008-9#1)
personality characteristics of##2##3##(2009-5#1)(2011-1#1)
personality characteristics##6##2##(2008-1#1)(2008-11#1)(2009-5#3)(2011-1#1)
personality disorder is##2##3##(2009-10#1)(2011-2#1)
personality disorder##26##2##(1991-1#1)(1993-12#1)(1994-2#3)(1995-11#3)(1996-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-10#4)(2009-9#2)(2010-2#2)(2011-2#3)(2012-12#2)(2013-1#1)
personality disorders in substance abusers##2##5##(1991-1#2)
personality disorders in##6##3##(1991-1#3)(2008-11#1)(2009-10#1)(2012-12#1)
personality disorders##11##2##(1991-1#3)(1992-1#1)(1992-3#1)(1994-2#1)(1997-5#1)(2008-11#1)(2009-10#1)(2012-12#1)(2012-2#1)
personality factors and##2##3##(2008-11#2)
personality factors##4##2##(1994-2#2)(2008-11#2)
personality in##2##2##(2011-2#1)(2013-1#1)
personality inventory##2##2##(2010-1#1)(2011-1#1)
personality of the##2##3##(1995-5#1)(2008-8#1)
personality of##3##2##(1995-5#1)(2008-8#1)(2012-3#1)
personality or##3##2##(1994-2#1)(2008-9#1)(2009-10#1)
personality profiles##3##2##(2011-1#3)
personality trait##7##2##(2007-8#1)(2008-11#2)(2008-5#1)(2010-6#2)(2011-2#1)
personality traits and##3##3##(2008-7#2)(2011-1#1)
personality traits##17##2##(1994-2#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-12#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)
personality variables##2##2##(1994-2#1)(2012-2#1)
personality##140##1##(1990-11#1)(1990-2#1)(1991-1#4)(1991-12#1)(1992-1#1)(1992-3#2)(1993-11#2)(1993-12#1)(1994-2#17)(1995-11#3)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-5#1)(2007-11#3)(2007-8#3)(2008-1#3)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#8)(2009-5#3)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#1)(2010-12#3)(2010-2#2)(2010-6#3)(2011-1#11)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
personalized and##2##2##(1995-3#1)(2011-3#1)
personalized drug##2##2##(2008-8#1)(2010-10#1)
personalized drugs##2##2##(2009-5#1)(2010-4#1)
personalized face##2##2##(2008-6#2)
personalized medicine##11##2##(2008-10#3)(2010-10#2)(2010-4#2)(2010-5#2)(2011-1#1)(2013-8#1)
personalized nutrition##3##2##(2008-10#3)
personalized##40##1##(1991-8#1)(1992-3#1)(1995-3#1)(2008-10#7)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#3)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
personalizing##3##1##(1992-3#1)(2008-11#1)(2013-8#1)
personally and##2##2##(2008-10#1)(2012-1#1)
personally familiar faces##2##3##(2008-1#2)
personally familiar##3##2##(2008-1#3)
personally##16##1##(1995-2#1)(1996-12#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
personata##4##1##(2007-12#2)(2008-10#2)
personatum##3##1##(2008-10#3)
personnel and the##5##3##(1992-12#1)(1993-3#1)(2007-7#1)(2012-12#1)(2013-1#1)
personnel and##24##2##(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
personnel are##3##2##(1993-12#1)(2008-1#1)(2008-10#1)
personnel as##3##2##(1991-2#1)(1995-1#1)(2008-12#1)
personnel at the##2##3##(2007-10#1)(2008-11#1)
personnel costs##2##2##(1995-3#1)(2008-11#1)
personnel employed##2##2##(1991-11#1)(1992-11#1)
personnel from##3##2##(1991-12#1)(2007-2#1)(2008-10#1)
personnel in the##2##3##(1995-2#1)(2008-11#1)
personnel in##5##2##(1990-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
personnel is##2##2##(1997-8#1)(2011-1#1)
personnel must##2##2##(1994-1#1)(2008-8#1)
personnel of the##2##3##(1996-3#1)(2010-9#1)
personnel of##7##2##(1996-3#1)(2008-10#2)(2010-9#1)(2011-1#2)(2012-3#1)
personnel portal##2##2##(2008-10#2)
personnel requirements##2##2##(1990-11#1)(2008-8#1)
personnel should##2##2##(1996-2#1)(2007-7#1)
personnel to##5##2##(1990-11#1)(1992-3#1)(1994-1#1)(2007-4#1)(2008-10#1)
personnel training and##2##3##(2008-10#1)(2008-12#1)
personnel were##4##2##(1990-6#1)(1996-9#1)(2008-10#1)(2008-8#1)
personnel who##2##2##(1991-12#1)(1995-12#1)
personnel working##2##2##(1992-9#1)(2008-10#1)
personnel##175##1##(1990-11#2)(1990-2#3)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#1)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#8)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2007-10#1)(2007-2#4)(2007-4#1)(2007-7#3)(2008-1#2)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-3#1)(2010-1#2)(2010-4#2)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)
personnel's##2##1##(1996-9#1)(2012-12#1)
personnel]##4##1##(1992-2#1)(1992-4#1)(1993-6#1)(1996-3#1)
persons (3)##2##2##(1995-3#1)(2013-8#1)
persons actively##2##2##(2007-11#1)(2007-8#1)
persons aged##4##2##(1991-6#2)(1995-6#1)(2008-7#1)
persons and##8##2##(1990-12#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
persons are##8##2##(1992-11#1)(1993-8#1)(1997-6#1)(2008-10#1)(2011-2#1)(2012-2#3)
persons at high risk##2##4##(1994-11#1)(2007-10#1)
persons at##5##2##(1994-11#1)(1997-3#2)(2007-10#1)(2008-7#1)
persons from the##2##3##(1996-3#1)(2008-5#1)
persons from##4##2##(1995-6#1)(1996-3#1)(2008-5#1)(2012-3#1)
persons had##5##2##(1994-11#1)(1994-9#2)(1996-11#1)(2008-11#1)
persons has##3##2##(1990-3#1)(2009-11#1)(2011-2#1)
persons in Norway##4##3##(1994-2#1)(1994-9#1)(1996-11#1)(1996-6#1)
persons in rehabilitation##2##3##(2007-8#2)
persons in the##4##3##(1995-12#1)(1997-3#1)(2012-2#2)
persons in##24##2##(1992-3#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-9#2)(1995-1#2)(1995-12#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#2)(2010-10#2)(2012-2#2)
persons is##7##2##(1990-11#1)(1993-6#1)(1995-5#1)(2010-5#2)(2012-2#2)
persons living in##2##3##(1992-6#1)(1994-3#1)
persons living near##2##3##(1991-3#1)(2008-8#1)
persons living with##4##3##(2008-6#2)(2009-7#1)(2010-5#1)
persons living##8##2##(1991-3#1)(1992-6#1)(1994-3#1)(2008-6#2)(2008-8#1)(2009-7#1)(2010-5#1)
persons may be##2##3##(1994-9#1)(2008-10#1)
persons may##4##2##(1994-9#1)(2008-10#1)(2010-8#1)(2013-8#1)
persons of interest##2##3##(2008-10#2)
persons of##10##2##(1994-12#2)(1994-2#1)(1995-1#1)(2008-10#3)(2008-7#2)(2010-8#1)
persons over the##2##3##(1996-3#1)(1996-6#1)
persons over##3##2##(1995-2#1)(1996-3#1)(1996-6#1)
persons participated in##2##3##(2010-3#1)(2010-8#1)
persons per##3##2##(2010-3#2)(2011-1#1)
persons recovering from##3##3##(2009-10#2)(2013-1#1)
persons residing in##2##3##(1994-9#1)(1995-12#1)
persons should##3##2##(1994-6#1)(2008-10#1)(2009-6#1)
persons suffering from mental health problems##2##6##(1996-1#2)
persons suffering from##5##3##(1991-3#1)(1992-5#1)(1996-1#2)(2007-8#1)
persons were##9##2##(1991-6#1)(1992-5#1)(1994-11#1)(1994-2#1)(1995-2#1)(2008-1#1)(2008-7#1)(2010-8#1)(2012-3#1)
persons who are##2##3##(2008-1#1)(2012-3#1)
persons who have##2##3##(1993-2#1)(2011-2#1)
persons who inject drugs##2##4##(2013-1#2)
persons who were##3##3##(1994-11#1)(1995-2#1)(2010-10#1)
persons who##24##2##(1991-5#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#3)
persons with AIDS##3##3##(1993-1#1)(1996-1#1)(1996-2#1)
persons with CMT##3##3##(2013-7#3)
persons with HIV/AIDS##2##3##(1995-3#1)(2009-7#1)
persons with Parkinson's disease##2##4##(2008-7#2)
persons with a##4##3##(1992-12#1)(2007-10#1)(2008-6#1)(2011-2#1)
persons with aphasia##3##3##(2012-3#3)
persons with chronic HCV##2##4##(2009-4#2)
persons with chronic hepatitis C##2##5##(2009-4#2)
persons with chronic##9##3##(1993-3#1)(1997-1#1)(2007-10#1)(2008-12#1)(2009-4#4)(2013-1#1)
persons with dementia##3##3##(1991-1#1)(1992-3#1)(2010-11#1)
persons with diabetes##8##3##(1993-6#1)(2007-12#1)(2008-1#3)(2009-11#1)(2011-1#1)(2011-2#1)
persons with diagnosed##2##3##(1993-6#1)(2011-2#1)
persons with disabilities in##2##4##(1996-1#1)(1997-2#1)
persons with disabilities##4##3##(1996-1#1)(1997-2#2)(2009-6#1)
persons with low##2##3##(1994-9#1)(2008-4#1)
persons with psychiatric disabilities in housing programs##2##7##(1997-1#2)
persons with psychiatric disabilities##6##4##(1997-1#3)(2009-6#3)
persons with schizophrenia##5##3##(2008-3#2)(2008-6#2)(2012-12#1)
persons with##120##2##(1991-1#1)(1991-12#3)(1992-12#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-9#2)(1995-3#3)(1995-6#2)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#6)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#4)(2008-9#1)(2009-11#1)(2009-4#4)(2009-6#4)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#5)(2013-7#5)
persons within the##3##3##(1994-1#2)(2009-5#1)
persons without##7##2##(1990-11#1)(1994-12#2)(1994-9#2)(2008-1#1)(2011-1#1)
persons working##2##2##(2008-10#1)(2011-1#1)
persons worldwide##2##2##(1991-5#1)(2012-12#1)
persons##434##1##(1990-11#3)(1990-12#3)(1990-3#2)(1990-7#1)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#4)(1991-5#3)(1991-6#6)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#4)(1992-9#1)(1993-1#5)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#5)(1993-8#2)(1994-1#7)(1994-11#11)(1994-12#6)(1994-2#5)(1994-3#1)(1994-6#2)(1994-9#16)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#6)(1995-5#2)(1995-6#8)(1995-8#3)(1996-1#5)(1996-11#3)(1996-2#1)(1996-3#6)(1996-6#2)(1996-9#4)(1997-1#7)(1997-2#8)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#14)(2008-1#9)(2008-10#17)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#17)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#2)(2009-4#4)(2009-5#1)(2009-6#6)(2009-7#3)(2010-10#7)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#3)(2010-5#6)(2010-8#6)(2011-1#10)(2011-2#17)(2012-1#1)(2012-12#4)(2012-2#15)(2012-3#11)(2013-1#14)(2013-7#5)(2013-8#3)
persons'##2##1##(1996-3#1)(2010-10#1)
persons)##2##1##(1990-12#1)(2008-9#1)
persons]##2##1##(1990-2#1)(2013-7#1)
persoonii group 1##3##3##(2008-10#3)
persoonii group##4##2##(2008-10#4)
persoonii##5##1##(2008-10#5)
perspective and##13##2##(1991-12#1)(1994-5#1)(2007-11#1)(2008-11#3)(2008-6#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2011-2#1)
perspective are##2##2##(1993-3#1)(2009-2#1)
perspective for the##4##3##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
perspective for##9##2##(1992-2#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
perspective from##4##2##(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
perspective have##2##2##(2011-2#1)(2012-3#1)
perspective in order to##3##4##(1994-1#2)(1994-2#1)
perspective in##9##2##(1994-1#2)(1994-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-10#1)
perspective is used to##2##4##(2008-3#1)(2010-4#1)
perspective is##10##2##(1992-3#1)(1995-12#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
perspective of diabetes care##2##4##(2008-7#2)
perspective of health care in the##2##6##(2008-1#2)
perspective of insomnia##2##3##(2008-5#2)
perspective of the##16##3##(1991-12#1)(1992-3#1)(1993-12#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-3#2)(2010-5#1)(2010-6#1)(2012-3#2)
perspective of this##2##3##(2008-7#1)(2009-3#1)
perspective of##87##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#1)(1996-1#2)(1996-2#1)(1996-3#2)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#8)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2010-1#1)(2010-10#4)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#2)
perspective on clinical##2##3##(1995-5#1)(1997-2#1)
perspective on death and dying##3##5##(1994-1#3)
perspective on how##2##3##(1994-3#1)(2010-10#1)
perspective on the##20##3##(1992-1#1)(1994-1#2)(1994-12#1)(1997-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2012-3#1)
perspective on##54##2##(1991-1#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-1#7)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-3#1)(1997-1#1)(1997-2#2)(2007-12#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
perspective projection##2##2##(2008-2#1)(2008-6#1)
perspective so far##2##3##(2007-12#1)(2009-7#1)
perspective taking##2##2##(2008-11#2)
perspective that##4##2##(1994-1#1)(2008-10#1)(2010-3#1)(2012-3#1)
perspective the##3##2##(1990-11#1)(1991-1#1)(2008-3#1)
perspective they##2##2##(1993-1#1)(2008-10#1)
perspective through##2##2##(1997-8#1)(2009-11#1)
perspective to explore##2##3##(2009-7#1)(2010-4#1)
perspective to##9##2##(1993-12#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2012-2#1)
perspective within##3##2##(2008-12#1)(2009-6#1)(2011-2#1)
perspective##500##1##(1990-11#1)(1991-1#3)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#4)(1992-2#4)(1992-3#6)(1993-1#4)(1993-12#9)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#18)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#8)(1994-5#1)(1994-8#1)(1995-12#6)(1995-2#5)(1995-5#3)(1996-1#5)(1996-12#2)(1996-2#4)(1996-3#7)(1996-4#1)(1997-1#2)(1997-2#7)(1997-3#4)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#16)(2008-10#16)(2008-11#40)(2008-12#13)(2008-2#4)(2008-3#8)(2008-4#18)(2008-5#4)(2008-6#22)(2008-7#19)(2008-8#12)(2008-9#15)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#10)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#18)(2012-12#9)(2012-2#11)(2012-3#16)(2013-1#12)(2013-8#15)
perspective)##2##1##(2008-12#1)(2008-9#1)
perspective]##9##1##(1990-9#1)(1993-11#1)(1993-3#1)(1993-6#2)(1995-11#1)(1996-3#1)(2012-12#1)(2012-2#1)
perspectives about##2##2##(2009-12#1)(2011-1#1)
perspectives and##8##2##(1995-1#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#1)
perspectives are##5##2##(1992-1#1)(2008-3#1)(2008-4#1)(2009-4#1)(2012-12#1)
perspectives for the##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)
perspectives for##17##2##(1992-3#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
perspectives from##2##2##(1994-1#1)(2012-2#1)
perspectives imaging##3##2##(2008-3#3)
perspectives in the##5##3##(2007-12#1)(2008-11#2)(2008-5#1)(2010-4#1)
perspectives in##14##2##(1991-12#1)(1991-3#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-5#1)(2013-1#1)
perspectives of##25##2##(1990-12#1)(1993-1#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-10#2)(2007-7#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
perspectives on an##2##3##(1991-2#1)(2008-12#1)
perspectives on health##2##3##(1996-1#1)(2011-2#1)
perspectives on hospital##2##3##(1994-1#1)(2008-11#1)
perspectives on the##6##3##(1992-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
perspectives on their##2##3##(1997-3#1)(2012-12#1)
perspectives on##32##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-8#1)
perspectives to##2##2##(2008-12#1)(2012-12#1)
perspectives##195##1##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#4)(1997-1#1)(1997-3#5)(2007-10#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#11)(2008-12#15)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#3)
perspectives]##3##1##(1990-6#1)(2009-10#1)(2011-2#1)
perspiration##3##1##(1995-5#1)(2008-5#1)(2008-7#1)
perstans##2##1##(1990-8#2)
perstraction system for##2##3##(2008-7#2)
persuasion probability##2##2##(1997-8#2)
persuasion tactics##2##2##(2010-1#2)
persuasion##10##1##(1997-8#2)(2007-4#1)(2009-11#2)(2010-1#5)
persuasive##5##1##(1995-12#1)(1997-2#1)(2008-10#1)(2009-11#2)
persuasively##2##1##(2008-11#1)(2009-10#1)
persufflation##9##1##(2007-8#9)
persulphate##3##1##(2008-10#3)
pertain to##4##2##(1991-3#1)(1997-3#1)(2008-5#1)(2012-12#1)
pertain##5##1##(1991-3#1)(1996-2#1)(1997-3#1)(2008-5#1)(2012-12#1)
pertained to the##2##3##(2007-4#1)(2008-6#1)
pertaining to a##2##3##(2008-4#1)(2012-2#1)
pertaining to different##2##3##(2008-10#1)(2010-8#1)
pertaining to the##16##3##(1993-6#1)(1994-11#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
pertaining to these##2##3##(2008-11#1)(2013-8#1)
pertaining to this##2##3##(2008-2#1)(2009-8#1)
pertaining to##49##2##(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-3#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
pertaining##52##1##(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-3#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
pertains to the##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
pertains to##7##2##(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)
pertechnetate##2##1##(1990-8#1)(2010-7#1)
pertinent because##2##2##(1992-1#1)(1994-5#1)
pertinent information##3##2##(1994-2#1)(1994-3#1)(2008-9#1)
pertinent literature is reviewed##2##4##(2007-12#1)(2012-2#1)
pertinent literature##7##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2012-12#1)(2012-2#2)
pertinent questions##2##2##(2010-12#1)(2012-3#1)
pertinent to the##5##3##(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
pertinent to##16##2##(1991-2#1)(1994-2#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
pertinent##58##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-2#1)(1996-6#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
pertrochanteric##3##1##(2007-11#2)(2011-2#1)
perturb the##7##2##(1990-2#1)(1992-3#1)(1994-5#1)(1995-9#1)(1997-7#1)(2008-3#1)(2010-4#1)
perturb##11##1##(1990-2#2)(1992-3#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-9#1)(1997-7#1)(2008-3#1)(2009-2#1)(2010-4#1)
perturbants##4##1##(1994-3#4)
perturbation and##4##2##(1992-12#1)(2007-12#1)(2008-2#1)(2013-8#1)
perturbation approach##2##2##(2008-2#1)(2008-3#1)
perturbation caused by different amounts of##2##6##(2008-10#2)
perturbation in##2##2##(1994-8#1)(2008-10#1)
perturbation is applied##2##3##(2007-11#1)(2007-12#1)
perturbation is##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
perturbation method##2##2##(2008-2#1)(2008-3#1)
perturbation model to predict the effect of scattering and absorbing inhomogeneities on photon migration##2##14##(2008-3#2)
perturbation of glycolysis##2##3##(1997-6#2)
perturbation of membrane##2##3##(1994-8#1)(1995-12#1)
perturbation of the##8##3##(1992-11#1)(1993-12#1)(1994-5#3)(1996-5#1)(2008-3#1)(2011-2#1)
perturbation of##27##2##(1992-11#1)(1993-12#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-6#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
perturbation solution##2##2##(2008-3#2)
perturbation technique##3##2##(2008-10#2)(2008-2#1)
perturbation techniques##2##2##(1995-8#1)(2009-3#1)
perturbation theories and the##2##4##(2008-2#2)
perturbation theory##14##2##(1992-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)(2009-8#1)(2009-9#1)(2010-10#1)
perturbation to##4##2##(1995-2#1)(2008-10#1)(2008-3#2)
perturbation##115##1##(1990-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-5#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-2#4)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-7#1)(2007-11#4)(2007-12#8)(2008-10#13)(2008-11#1)(2008-2#15)(2008-3#23)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
perturbations and##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
perturbations are##4##2##(2007-12#1)(2008-1#1)(2008-10#2)
perturbations in the##6##3##(1993-11#1)(2008-10#1)(2008-3#4)
perturbations in##17##2##(1991-12#1)(1992-6#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-1#2)(2013-8#1)
perturbations of##7##2##(1992-12#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
perturbations on the##2##3##(1991-9#1)(2008-3#1)
perturbations on##3##2##(1991-9#1)(2008-3#1)(2009-9#1)
perturbations produced by##2##3##(2008-2#1)(2013-1#1)
perturbations that##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
perturbations##75##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-5#2)(1996-12#1)(1996-2#1)(2007-12#4)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
perturbative##3##1##(2007-12#1)(2008-3#2)
perturbed by##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-12#1)
perturbed the##3##2##(1993-9#1)(2008-3#1)(2011-1#1)
perturbed wave##2##2##(2008-3#2)
perturbed with##2##2##(2008-10#1)(2008-3#1)
perturbed##33##1##(1990-7#1)(1990-8#1)(1993-11#1)(1993-9#1)(1995-5#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
perturbing effects##2##2##(1994-1#1)(2008-11#1)
perturbing##6##1##(1994-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2012-2#1)
perturbs the##2##2##(1993-8#1)(2008-10#1)
perturbs##4##1##(1992-6#1)(1993-8#1)(2008-10#1)(2008-12#1)
pertussis antigens##3##2##(1992-2#2)(2007-11#1)
pertussis toxin (PTX)##2##3##(2008-4#2)
pertussis toxin and##2##3##(1990-8#1)(1993-8#1)
pertussis toxin did not##2##4##(1991-12#1)(1992-3#1)
pertussis toxin insensitive##2##3##(1993-9#1)(1997-7#1)
pertussis toxin substrates##2##3##(1991-9#1)(1992-9#1)
pertussis toxin##25##2##(1990-8#1)(1991-1#1)(1991-12#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-9#1)(1996-2#1)(1997-1#3)(1997-2#1)(1997-7#1)(2008-4#3)
pertussis toxin-catalyzed ADP-ribosylation of##2##4##(1992-9#2)
pertussis toxin-sensitive G protein##2##4##(1997-1#2)
pertussis toxin-sensitive G##3##3##(1995-11#1)(1997-1#2)
pertussis toxin-sensitive##5##2##(1990-12#1)(1995-11#1)(1997-1#2)(1997-2#1)
pertussis vaccination##2##2##(1995-5#1)(1997-8#1)
pertussis vaccine##8##2##(1992-2#1)(1993-6#2)(1995-3#1)(1995-5#2)(2013-1#2)
pertussis vaccines with##2##3##(1995-5#1)(1997-8#1)
pertussis vaccines##6##2##(1995-5#4)(1997-8#2)
pertussis##70##1##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-9#1)(1992-2#7)(1992-3#2)(1992-9#3)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#3)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#11)(1996-2#1)(1997-1#5)(1997-2#2)(1997-7#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-4#4)(2008-7#2)(2009-5#1)(2013-1#4)
perutilis##5##1##(2013-7#5)
peruviana##3##1##(2013-1#3)
peruvianus##4##1##(2007-12#3)(2008-10#1)
pervaporation and##2##2##(2008-10#2)
pervaporation flow injection##2##3##(2008-10#2)
pervaporation##8##1##(2008-10#8)
pervasive and##3##2##(2008-5#1)(2010-4#1)(2013-1#1)
pervasive developmental##2##2##(2012-12#1)(2012-2#1)
pervasive##22##1##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
perversum##2##1##(2013-7#2)
perylene##3##1##(2008-10#2)(2009-2#1)
pes planovalgus deformity##3##3##(2009-10#3)
pes##4##1##(2009-10#3)(2010-3#1)
pessimistic##3##1##(2008-7#1)(2013-8#2)
pest and disease##2##3##(2008-10#1)(2008-9#1)
pest control##3##2##(1997-7#1)(2008-11#2)
pest in North America##2##4##(2008-10#1)(2011-2#1)
pest in the##3##3##(2008-10#2)(2008-6#1)
pest in##7##2##(2008-10#3)(2008-6#1)(2011-2#3)
pest insect populations##2##3##(2011-2#1)(2012-12#1)
pest management and##2##3##(2008-10#1)(2011-1#1)
pest management is##2##3##(2008-10#2)
pest management strategies##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
pest management##31##2##(1997-7#1)(2008-10#23)(2008-9#1)(2011-1#1)(2011-2#2)(2013-8#3)
pest of rice##2##3##(2013-8#2)
pest of##6##2##(2008-10#1)(2008-6#2)(2011-2#1)(2013-8#2)
pest should be##2##3##(2008-8#1)(2013-8#1)
pest species##2##2##(2008-10#1)(2008-5#1)
pest##84##1##(1997-7#2)(2008-10#44)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#4)(2008-8#4)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#14)(2012-12#1)(2013-8#7)
pesticide and##2##2##(2008-10#2)
pesticide are##3##2##(2008-10#3)
pesticide dose##3##2##(2008-10#2)(2011-2#1)
pesticide formulations##7##2##(2008-10#7)
pesticide in##3##2##(2008-10#2)(2013-1#1)
pesticide is##2##2##(2008-10#2)
pesticide legislation##2##2##(1996-3#2)
pesticide residue analysis##2##3##(2008-10#1)(2011-1#1)
pesticide residues in stored pollen##2##5##(2011-2#2)
pesticide residues in##12##3##(2008-10#4)(2008-11#1)(2011-1#3)(2011-2#2)(2013-8#2)
pesticide residues were##2##3##(2008-10#1)(2013-8#1)
pesticide residues##17##2##(2008-10#7)(2008-11#1)(2011-1#3)(2011-2#3)(2013-8#3)
pesticide resistance##2##2##(1995-6#1)(2008-10#1)
pesticide use##3##2##(2008-10#2)(2008-12#1)
pesticide##113##1##(1990-9#1)(1995-6#1)(1996-3#3)(2007-10#1)(2007-5#1)(2008-10#72)(2008-11#3)(2008-12#3)(2008-2#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#5)(2011-2#7)(2011-3#1)(2013-1#3)(2013-8#3)
pesticides (OPPs) in##2##3##(2008-10#2)
pesticides (OPPs)##3##2##(2008-10#3)
pesticides and alkylphenols in##3##4##(2008-10#3)
pesticides and their##2##3##(2008-10#2)
pesticides and##19##2##(2008-10#11)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#2)(2010-5#2)(2010-7#1)
pesticides are##7##2##(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#2)
pesticides at##3##2##(2008-10#3)
pesticides from the##2##3##(2008-10#2)
pesticides from##8##2##(2008-10#7)(2011-1#1)
pesticides in soil##2##3##(1990-9#1)(2008-10#1)
pesticides in the##6##3##(2008-10#2)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#1)
pesticides in vegetables##2##3##(2008-10#2)
pesticides in water##7##3##(2008-10#7)
pesticides in##34##2##(1990-9#1)(2008-10#24)(2008-11#2)(2008-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
pesticides is##3##2##(2008-10#2)(2011-1#1)
pesticides may##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
pesticides on##2##2##(2008-12#1)(2011-2#1)
pesticides such as##3##3##(2008-10#3)
pesticides using##3##2##(2008-10#3)
pesticides was##5##2##(2008-10#4)(2008-11#1)
pesticides were##12##2##(1991-6#1)(2008-10#10)(2008-11#1)
pesticides##178##1##(1990-9#3)(1991-6#3)(1992-2#1)(1997-4#1)(2007-5#2)(2008-10#117)(2008-11#13)(2008-12#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-5#6)(2010-7#1)(2011-1#3)(2011-2#3)(2013-1#10)(2013-8#1)
pests and can##2##3##(2008-10#2)
pests and diseases##3##3##(2011-2#3)
pests and##8##2##(1994-3#1)(2008-10#4)(2011-2#3)
pests by##2##2##(2008-10#2)
pests in##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
pests is##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
pests of##4##2##(2008-10#1)(2011-2#3)
pests on##2##2##(2008-10#2)
pests such as##2##3##(1995-6#1)(2008-10#1)
pests##60##1##(1994-3#1)(1995-6#1)(1997-4#1)(2006-12#1)(2008-10#29)(2008-5#7)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#10)(2013-8#1)
pet food##5##2##(2010-4#5)
pet rabbits##2##2##(1995-9#2)
pet##15##1##(1992-2#1)(1993-2#1)(1995-11#1)(1995-9#2)(2010-4#5)(2012-3#1)(2013-1#2)(2013-8#2)
petH gene##2##2##(1992-3#2)
petH##3##1##(1992-3#3)
petal expansion##4##2##(2008-10#4)
petal fall##3##2##(2008-10#3)
petal size##2##2##(2008-8#2)
petal##9##1##(2008-10#7)(2008-8#2)
petals of##3##2##(2008-10#2)(2010-3#1)
petals##16##1##(2007-11#2)(2008-10#11)(2008-12#1)(2008-4#1)(2010-3#1)
petaurista##3##1##(2008-5#3)
pete1 and##2##2##(2009-10#2)
pete1##4##1##(2009-10#4)
pete2 double##2##2##(2009-10#2)
pete2##4##1##(2009-10#4)
pethidine and##2##2##(2008-10#1)(2010-7#1)
pethidine for##2##2##(2010-4#1)(2010-7#1)
pethidine##11##1##(1997-5#1)(2008-10#3)(2009-5#1)(2010-4#1)(2010-7#4)(2012-12#1)
petiole debris##2##2##(2008-10#2)
petiole##7##1##(2008-10#7)
petioles and##3##2##(2008-10#3)
petioles of inoculated leaves##3##4##(2008-10#3)
petioles of##6##2##(2008-10#6)
petioles##14##1##(2008-10#14)
petition##6##1##(1990-11#1)(1993-9#1)(1995-6#1)(2009-8#3)
petits##3##1##(2008-11#1)(2011-2#2)
petrakii##2##1##(2008-10#2)
petri dish##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
petri dishes with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
petri dishes##9##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)
petri plates containing a selective medium##3##6##(2008-10#3)
petri plates##5##2##(2008-10#5)
petri##18##1##(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
petrochemical##7##1##(1991-12#1)(2008-10#4)(2008-7#1)(2010-12#1)
petrol##5##1##(1990-9#1)(1997-6#1)(2008-10#3)
petrolatum##9##1##(2008-5#7)(2012-3#2)
petroleum ether##6##2##(1991-12#1)(2008-12#3)(2013-8#2)
petroleum hydrocarbons##2##2##(2008-11#1)(2008-6#1)
petroleum products##4##2##(1992-10#1)(2008-10#3)
petroleum##36##1##(1991-12#1)(1992-10#1)(1992-3#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
petroporphyrins##3##1##(2008-6#3)
petrous apex cholesteatoma##7##3##(2011-2#7)
petrous apex##11##2##(2008-7#1)(2010-3#1)(2011-2#9)
petrous bone cholesteatoma##4##3##(2011-2#4)
petrous bone##9##2##(2008-7#3)(2008-8#1)(2011-2#5)
petrous temporal bone##2##3##(2011-2#2)
petrous##26##1##(2008-7#5)(2008-8#1)(2010-3#2)(2011-2#17)(2012-12#1)
pets##5##1##(1995-11#4)(2008-5#1)
petunia##5##1##(1993-6#3)(2008-10#2)
peut##6##1##(2008-5#3)(2013-1#3)
peuvent##2##1##(2008-5#1)(2011-2#1)
pf torque##2##2##(1993-12#2)
pfht##3##1##(2010-2#3)
pfu and##2##2##(2008-9#2)
pfu##10##1##(2008-11#2)(2008-9#8)
pfu/cm(2))##2##1##(2012-2#2)
pg (R##2##2##(2008-10#2)
pg (n=20##2##2##(2008-10#2)
pg (recommended of 20 pg)##2##5##(2008-10#2)
pg (recommended of##4##3##(2008-10#4)
pg (recommended##6##2##(2008-10#6)
pg As ml(-1)##2##3##(2008-10#2)
pg Hg/ml##3##2##(2008-10#3)
pg and 0##2##3##(2008-10#2)
pg and the##3##3##(2008-10#3)
pg and##9##2##(1990-8#1)(2008-10#8)
pg cell(-1 )h(-1))##2##3##(2008-11#2)
pg cell(-1) h(-1)##2##3##(2008-11#2)
pg for##7##2##(2008-10#7)
pg mL(-1)##2##2##(2011-3#2)
pg ml(-1) for##2##3##(2008-10#2)
pg ml(-1)##14##2##(2008-10#14)
pg of DNA##2##3##(2008-10#2)
pg of bismuth##2##3##(2008-10#2)
pg of the##2##3##(1997-4#1)(2008-10#1)
pg of##18##2##(1991-8#1)(1994-9#1)(1997-4#1)(2008-10#12)(2008-5#3)
pg per##2##2##(1990-8#1)(2008-10#1)
pg x mL(-1) for##2##4##(2011-3#2)
pg##101##1##(1990-4#1)(1990-8#4)(1991-8#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-12#2)(1997-4#1)(2008-10#75)(2008-11#6)(2008-5#3)(2009-12#1)(2011-3#4)
pg) and##2##2##(1997-2#1)(2008-10#1)
pg)##15##1##(1990-8#1)(1997-2#1)(2008-10#12)(2008-7#1)
pg/mL and##3##2##(2011-1#3)
pg/mL##10##1##(2008-3#3)(2010-5#1)(2011-1#6)
pg/mg creatinine)##2##2##(1990-3#2)
pg/mg##3##1##(1990-3#3)
pg/ml for##4##2##(1992-9#2)(2008-5#2)
pg/ml in##4##2##(1990-5#2)(1994-7#2)
pg/ml##33##1##(1990-11#1)(1990-2#1)(1990-5#3)(1991-2#1)(1992-9#4)(1994-3#1)(1994-7#8)(1995-8#5)(1996-5#1)(2008-5#4)(2011-2#4)
pg/ml)##7##1##(1995-8#1)(1996-5#1)(2008-3#3)(2011-2#2)
pg/mul##3##1##(2008-10#3)
pgi and##2##2##(2008-10#2)
pgi##4##1##(2008-10#4)
pha genes##4##2##(2008-6#4)
phaA##2##1##(2008-6#2)
phaB##2##1##(2008-6#2)
phacoemulsification##3##1##(2010-10#1)(2011-2#1)(2013-1#1)
phacorrhiza##4##1##(2008-10#4)
phaeochromocytoma##3##1##(2011-2#1)(2013-7#2)
phaeohyphomycosis##4##1##(2008-10#2)(2008-5#2)
phage DNA##6##2##(1990-12#1)(1991-9#3)(1992-3#1)(1995-8#1)
phage DNAs##2##2##(1993-11#1)(1994-8#1)
phage T4##3##2##(1995-12#1)(1997-3#1)(2008-10#1)
phage and##4##2##(1993-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
phage antibodies##4##2##(2008-10#2)(2008-4#1)(2010-12#1)
phage application##2##2##(2012-2#2)
phage assay##3##2##(2007-7#3)
phage can##2##2##(2013-1#2)
phage capture##2##2##(1994-12#2)
phage clone##2##2##(1991-9#1)(2008-10#1)
phage concentrations##2##2##(2012-2#2)
phage display antibody##2##3##(2008-10#1)(2008-8#1)
phage display libraries are##2##4##(2008-10#1)(2008-4#1)
phage display libraries##9##3##(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#1)
phage display library##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
phage display method##3##3##(2008-11#2)(2010-12#1)
phage display peptide##2##3##(2008-10#1)(2008-4#1)
phage display system##2##3##(1994-12#1)(2008-10#1)
phage display technique##2##3##(2008-10#1)(2008-8#1)
phage display technology##2##3##(2008-8#1)(2009-5#1)
phage display##38##2##(1993-8#1)(1994-12#2)(2008-10#9)(2008-11#4)(2008-4#6)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#3)(2012-2#1)(2013-8#1)
phage displayed##6##2##(2008-10#3)(2008-8#2)(2013-8#1)
phage lambda##12##2##(1990-5#2)(1991-6#1)(1991-9#1)(1992-4#1)(1994-12#2)(1995-3#3)(1995-8#1)(1997-2#1)
phage libraries##2##2##(1991-6#1)(2008-7#1)
phage monolayer##2##2##(2009-5#2)
phage particles##2##2##(1994-12#1)(2012-2#1)
phage resistance##2##2##(2013-1#2)
phage scFv##3##2##(1993-8#1)(2008-10#2)
phage that##2##2##(1994-12#1)(2013-1#1)
phage therapy##7##2##(2012-2#6)(2013-1#1)
phage use as##2##3##(2012-2#2)
phage vector##2##2##(1990-5#1)(1993-8#1)
phage##180##1##(1990-11#2)(1990-12#1)(1990-5#7)(1990-7#1)(1991-6#2)(1991-9#6)(1992-11#1)(1992-3#2)(1992-4#1)(1993-11#2)(1993-12#1)(1993-8#5)(1993-9#1)(1994-12#15)(1994-8#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-8#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-7#4)(2008-1#1)(2008-10#29)(2008-11#5)(2008-4#11)(2008-7#9)(2008-8#7)(2008-9#3)(2009-5#3)(2009-6#1)(2010-12#4)(2012-2#22)(2013-1#13)(2013-8#3)
phage-IFN variants##2##2##(2008-8#2)
phage-IFN##4##1##(2008-8#4)
phage-based##2##1##(1997-4#1)(2013-1#1)
phage-displayed##3##1##(1994-12#2)(2008-1#1)
phagemid and##2##2##(1994-8#1)(1997-4#1)
phagemid vector##2##2##(1997-6#1)(2008-8#1)
phagemid vectors##2##2##(1994-12#2)
phagemid##12##1##(1994-12#4)(1994-8#3)(1997-4#1)(1997-6#1)(1997-7#2)(2008-8#1)
phages in##2##2##(1994-12#1)(2013-1#1)
phages to##2##2##(1994-12#1)(2012-2#1)
phages was##2##2##(1994-12#1)(2012-2#1)
phages were##2##2##(1994-12#1)(2012-2#1)
phages##24##1##(1993-9#1)(1994-12#8)(1997-3#2)(1997-6#1)(2008-10#1)(2008-4#3)(2012-2#7)(2013-1#1)
phagocyte##3##1##(1995-8#1)(2008-4#1)(2008-9#1)
phagocytes and##3##2##(1991-3#1)(1991-9#2)
phagocytes to##2##2##(2008-8#1)(2009-6#1)
phagocytes##17##1##(1991-11#2)(1991-3#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
phagocytic activity of##2##3##(2008-10#2)
phagocytic activity##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
phagocytic and NK##2##3##(1991-8#2)
phagocytic capacity##2##2##(1994-6#1)(2008-4#1)
phagocytic cell##2##2##(1996-12#1)(2012-2#1)
phagocytic cells##8##2##(1990-2#1)(1992-12#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
phagocytic system##2##2##(2008-10#2)
phagocytic##30##1##(1990-12#2)(1990-2#1)(1991-8#2)(1992-12#1)(1992-5#1)(1994-11#1)(1994-6#2)(1996-12#1)(1997-4#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2012-2#3)(2013-1#1)(2013-8#1)
phagocytized##2##1##(1994-6#1)(2008-8#1)
phagocytophilum is##3##2##(2008-12#1)(2008-9#2)
phagocytophilum##13##1##(2008-12#4)(2008-9#6)(2013-1#3)
phagocytosed##2##1##(1995-5#1)(1996-5#1)
phagocytosis by the hemocytes##2##4##(2008-6#2)
phagocytosis by the##4##3##(2008-10#2)(2008-6#2)
phagocytosis by##11##2##(1993-6#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-6#2)(2008-9#1)
phagocytosis in##5##2##(1993-6#1)(1994-6#3)(2007-10#1)
phagocytosis of the##2##3##(2008-6#1)(2008-9#1)
phagocytosis of##10##2##(1991-5#2)(1993-6#1)(1995-2#1)(2008-4#2)(2008-6#3)(2008-9#1)
phagocytosis or##2##2##(1991-12#1)(2008-4#1)
phagocytosis##53##1##(1990-12#3)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1993-6#6)(1994-6#9)(1995-2#1)(1997-2#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#1)(2008-6#9)(2008-9#3)(2009-9#1)(2012-12#1)
phagosomes##2##1##(1997-6#1)(2008-7#1)
phakic##4##1##(2011-2#3)(2013-1#1)
phalangeal##6##1##(1991-11#1)(1994-6#2)(2006-10#2)(2009-6#1)
phalanges##3##1##(1994-6#1)(1997-3#1)(2011-1#1)
phalanx of##2##2##(1997-5#1)(2010-3#1)
phalanx##7##1##(1997-5#1)(2009-10#2)(2010-3#3)(2012-2#1)
phalloides##3##1##(1991-11#3)
phalloidin microinjection##2##2##(2008-11#2)
phalloidin##12##1##(1990-5#5)(1993-3#1)(1997-7#1)(2007-12#2)(2008-11#2)(2008-7#1)
phalloidin-treated##2##1##(1990-5#2)
phallus##6##1##(2008-1#1)(2008-10#5)
phantom and a##2##3##(2009-11#1)(2012-1#1)
phantom and##8##2##(1993-9#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#1)
phantom by##3##2##(2007-11#1)(2008-3#2)
phantom experiments##2##2##(2007-12#1)(2010-2#1)
phantom for##4##2##(2008-3#3)(2011-1#1)
phantom of##2##2##(2008-10#1)(2008-3#1)
phantom studies##2##2##(1995-5#1)(2008-10#1)
phantom tissue test##2##3##(2009-11#2)
phantom tissue tests##2##3##(2009-11#2)
phantom tissue##5##2##(2009-11#5)
phantom was##4##2##(2008-3#3)(2011-1#1)
phantom were##2##2##(2008-3#1)(2012-1#1)
phantom with##3##2##(2007-12#1)(2010-3#1)(2012-1#1)
phantom##79##1##(1993-9#1)(1994-3#1)(1995-5#1)(1997-8#2)(2007-11#2)(2007-12#7)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#23)(2008-5#4)(2009-11#7)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#3)(2010-3#2)(2011-1#8)(2011-2#1)(2012-1#6)(2012-12#2)(2012-3#1)
phantoms and in##2##3##(2007-11#1)(2013-1#1)
phantoms and##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
phantoms containing##5##2##(1997-8#1)(2007-12#2)(2008-2#1)(2011-1#1)
phantoms is##2##2##(2008-3#1)(2010-12#1)
phantoms show##2##2##(2008-2#1)(2009-8#1)
phantoms which simulate the##2##4##(2008-3#1)(2011-1#1)
phantoms with##3##2##(2007-10#1)(2008-2#1)(2008-3#1)
phantoms##41##1##(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-2#5)(2008-3#18)(2009-8#1)(2010-12#2)(2011-1#3)(2012-1#3)(2012-12#1)(2013-1#1)
pharaonis hR##4##2##(1994-5#4)
pharaonis hRblue##2##2##(1994-5#2)
pharaonis##17##1##(1993-11#2)(1994-5#8)(2007-12#2)(2008-6#1)(2013-7#4)
pharmaceutical agents##2##2##(2007-11#1)(2012-12#1)
pharmaceutical analysis##6##2##(1990-8#1)(2008-10#4)(2013-8#1)
pharmaceutical and biotech industries##2##4##(2008-11#1)(2011-2#1)
pharmaceutical and biotechnology##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
pharmaceutical and medical##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
pharmaceutical and##14##2##(1990-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
pharmaceutical applications##3##2##(1994-3#1)(2012-2#2)
pharmaceutical care##3##2##(2010-3#1)(2011-1#1)(2012-12#1)
pharmaceutical companies and##3##3##(2008-10#1)(2009-5#1)(2010-8#1)
pharmaceutical companies are##3##3##(1994-11#1)(2008-11#1)(2010-8#1)
pharmaceutical companies have##2##3##(2008-5#1)(2011-1#1)
pharmaceutical companies##20##2##(1994-11#1)(1996-5#1)(1997-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#4)(2009-5#1)(2010-8#3)(2011-1#1)
pharmaceutical compounds##3##2##(2008-10#2)(2008-5#1)
pharmaceutical development##5##2##(2008-10#3)(2008-8#2)
pharmaceutical dosage form##4##3##(2008-10#4)
pharmaceutical dosage forms and##3##4##(2008-10#3)
pharmaceutical dosage forms with##3##4##(2008-10#3)
pharmaceutical dosage forms##16##3##(2008-10#14)(2011-1#2)
pharmaceutical dosage##20##2##(2008-10#18)(2011-1#2)
pharmaceutical dosages##2##2##(2008-10#2)
pharmaceutical drug##2##2##(2008-10#2)
pharmaceutical efficacy and safety##2##4##(2012-12#2)
pharmaceutical excipients##2##2##(2008-10#1)(2010-5#1)
pharmaceutical forms##2##2##(2008-10#2)
pharmaceutical formulation##20##2##(1994-3#1)(2008-10#18)(2008-5#1)
pharmaceutical formulations and##7##3##(2008-10#7)
pharmaceutical formulations by##8##3##(2008-10#8)
pharmaceutical formulations containing##2##3##(2008-10#2)
pharmaceutical formulations has##2##3##(2008-10#1)(2010-5#1)
pharmaceutical formulations using##13##3##(2008-10#13)
pharmaceutical formulations were##2##3##(2008-10#2)
pharmaceutical formulations with##3##3##(2008-10#3)
pharmaceutical formulations##103##2##(1991-12#1)(2008-10#100)(2008-5#1)(2010-5#1)
pharmaceutical industries##10##2##(2008-10#3)(2008-11#1)(2008-6#2)(2008-9#2)(2009-3#1)(2010-5#1)
pharmaceutical industry and##3##3##(2009-12#1)(2011-2#1)(2012-3#1)
pharmaceutical industry is a##2##4##(2008-10#1)(2009-11#1)
pharmaceutical industry is##4##3##(1997-4#1)(2008-10#2)(2009-11#1)
pharmaceutical industry##36##2##(1991-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#8)(2008-11#6)(2008-5#4)(2009-11#4)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
pharmaceutical ingredient##2##2##(2011-2#1)(2013-8#1)
pharmaceutical injection samples##2##3##(2008-10#2)
pharmaceutical injections##2##2##(2008-10#2)
pharmaceutical interventions##2##2##(2007-3#1)(2008-6#1)
pharmaceutical lead plasters and painting lead mediums##2##7##(2008-10#2)
pharmaceutical powders##2##2##(2008-10#2)
pharmaceutical practice##2##2##(2008-10#1)(2009-10#1)
pharmaceutical preparation##17##2##(2008-10#17)
pharmaceutical preparations and the results were##2##6##(2008-10#2)
pharmaceutical preparations and the results##3##5##(2008-10#3)
pharmaceutical preparations and##19##3##(2008-10#17)(2010-4#2)
pharmaceutical preparations containing##3##3##(2008-10#2)(2008-11#1)
pharmaceutical preparations in##3##3##(2008-10#3)
pharmaceutical preparations using##7##3##(2008-10#7)
pharmaceutical preparations##114##2##(2008-10#110)(2008-11#1)(2010-4#3)
pharmaceutical processes##4##2##(2008-10#1)(2012-2#3)
pharmaceutical product##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
pharmaceutical production##2##2##(2012-2#2)
pharmaceutical products and##2##3##(2008-10#1)(2008-7#1)
pharmaceutical products using##2##3##(2008-10#2)
pharmaceutical products##34##2##(1995-1#1)(1997-2#1)(2008-10#23)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2012-1#1)(2012-2#1)
pharmaceutical purposes##2##2##(2008-5#2)
pharmaceutical quality##2##2##(1992-5#1)(2008-11#1)
pharmaceutical research##2##2##(1991-3#1)(2008-10#1)
pharmaceutical residues##5##2##(2008-10#5)
pharmaceutical samples and##2##3##(2008-10#2)
pharmaceutical samples##22##2##(2008-10#20)(2012-2#2)
pharmaceutical sciences##2##2##(2011-1#2)
pharmaceutical sector##3##2##(2011-2#1)(2012-1#1)(2012-2#1)
pharmaceutical services at##4##3##(2010-3#3)(2013-8#1)
pharmaceutical tablet##2##2##(2008-10#1)(2013-8#1)
pharmaceutical tablets##4##2##(2008-10#2)(2011-1#2)
pharmaceutical therapy##2##2##(2007-3#1)(2012-12#1)
pharmaceutical use##3##2##(1992-3#1)(1994-5#1)(2007-11#1)
pharmaceutical vitamin tablets##2##3##(2008-10#2)
pharmaceutical##568##1##(1990-8#1)(1990-9#3)(1991-12#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-5#1)(1996-1#2)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#2)(2007-11#2)(2007-3#2)(2008-1#1)(2008-10#388)(2008-11#18)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#17)(2008-6#6)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#3)(2009-5#2)(2009-9#1)(2010-11#2)(2010-3#4)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#7)(2011-3#3)(2012-1#4)(2012-12#5)(2012-2#16)(2012-3#2)(2013-1#1)(2013-8#5)
pharmaceutically relevant##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
pharmaceuticals and##10##2##(2008-10#9)(2013-1#1)
pharmaceuticals by##3##2##(2008-10#3)
pharmaceuticals could##2##2##(2008-10#1)(2010-3#1)
pharmaceuticals in wastewater##2##3##(2008-10#2)
pharmaceuticals in##5##2##(2008-10#4)(2013-1#1)
pharmaceuticals is##2##2##(1997-2#1)(2008-10#1)
pharmaceuticals produced excellent results##2##4##(2008-10#2)
pharmaceuticals using##5##2##(2008-10#5)
pharmaceuticals with##3##2##(2008-10#2)(2009-12#1)
pharmaceuticals##91##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-10#68)(2008-11#1)(2008-7#2)(2009-12#1)(2010-11#1)(2010-3#2)(2010-6#1)(2012-2#4)(2013-1#2)
pharmaceuticals)##2##1##(2011-2#1)(2013-8#1)
pharmacies and##2##2##(1995-1#1)(2008-11#1)
pharmacies in##3##2##(1995-1#1)(2008-11#1)(2012-2#1)
pharmacies since 1985##2##3##(1990-2#2)
pharmacies to##2##2##(1995-1#1)(2009-6#1)
pharmacies##20##1##(1990-2#4)(1995-1#6)(2008-11#3)(2008-3#1)(2008-8#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
pharmacist##14##1##(1991-3#1)(1991-6#1)(1992-4#1)(1992-5#1)(1994-12#1)(1995-11#1)(2008-11#4)(2010-3#2)(2010-5#1)(2013-1#1)
pharmacist's role in##2##3##(1993-2#2)
pharmacist's##3##1##(1993-2#2)(2010-3#1)
pharmacists and nurses##2##3##(1997-8#1)(2008-3#1)
pharmacists and patients##2##3##(1996-1#2)
pharmacists and##5##2##(1996-1#2)(1997-8#1)(2008-3#1)(2008-8#1)
pharmacists can##2##2##(1993-2#1)(1994-12#1)
pharmacists in##5##2##(2008-11#1)(2010-5#1)(2011-1#3)
pharmacists play##2##2##(2011-1#2)
pharmacists to##3##2##(2010-5#2)(2011-1#1)
pharmacists who##2##2##(2011-1#2)
pharmacists##52##1##(1993-2#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-1#3)(1997-8#2)(2008-11#3)(2008-3#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-5#5)(2011-1#23)(2013-1#3)
pharmacists' perceptions##2##2##(2011-1#2)
pharmacists' views##4##2##(2011-1#4)
pharmacists'##10##1##(2008-3#1)(2010-5#1)(2010-9#1)(2011-1#7)
pharmacodynamic and pharmacokinetic##3##3##(1990-6#1)(2008-10#1)(2008-8#1)
pharmacodynamic effect##3##2##(1992-8#1)(2008-5#2)
pharmacodynamic effects##2##2##(1992-8#1)(2013-1#1)
pharmacodynamic interactions##2##2##(2007-11#2)
pharmacodynamic response##3##2##(1996-1#1)(2008-5#1)(2010-8#1)
pharmacodynamic##23##1##(1990-6#1)(1991-12#1)(1991-2#1)(1992-8#2)(1996-1#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
pharmacodynamics of##6##2##(1991-1#1)(1991-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-3#1)
pharmacodynamics##16##1##(1991-1#1)(1991-2#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2010-6#2)(2011-3#2)
pharmacoeconomic##3##1##(2009-11#1)(2011-1#1)(2013-1#1)
pharmacoepidemiologic##3##1##(2008-11#2)(2008-8#1)
pharmacoepidemiological##2##1##(2008-11#1)(2012-3#1)
pharmacogenetic##6##1##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#2)
pharmacogenetics and pharmacogenomics in##3##4##(2008-10#3)
pharmacogenetics##10##1##(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#2)(2012-1#1)
pharmacogenomic biomarker studies##2##3##(2008-8#2)
pharmacogenomic##5##1##(2008-8#3)(2013-8#2)
pharmacogenomics (PGx)##2##2##(2008-10#1)(2010-8#1)
pharmacogenomics in##6##2##(2008-10#5)(2010-8#1)
pharmacogenomics##17##1##(2007-3#1)(2008-10#8)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#2)(2011-1#1)(2013-8#1)
pharmacokinetic and##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
pharmacokinetic behaviour of cytisine##2##4##(2011-1#2)
pharmacokinetic drug interaction##2##3##(2007-11#1)(2011-1#1)
pharmacokinetic drug interactions between##2##4##(2007-11#2)
pharmacokinetic drug##4##2##(2007-11#3)(2011-1#1)
pharmacokinetic interactions between##2##3##(2007-11#1)(2009-7#1)
pharmacokinetic models##2##2##(2008-5#1)(2010-12#1)
pharmacokinetic or##2##2##(1997-1#1)(2011-2#1)
pharmacokinetic parameters of the##4##4##(2008-10#1)(2008-11#1)(2012-2#2)
pharmacokinetic parameters of##5##3##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#2)
pharmacokinetic parameters were##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
pharmacokinetic parameters##11##2##(2008-10#4)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
pharmacokinetic profile##6##2##(2008-10#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
pharmacokinetic profiles##2##2##(2008-8#1)(2011-2#1)
pharmacokinetic properties##3##2##(1991-12#1)(2008-3#1)(2008-7#1)
pharmacokinetic studies have##2##3##(2008-5#1)(2013-1#1)
pharmacokinetic studies of##2##3##(2008-10#2)
pharmacokinetic studies##7##2##(2008-10#4)(2008-5#1)(2009-5#1)(2013-1#1)
pharmacokinetic study of##7##3##(2008-10#5)(2008-5#1)(2011-3#1)
pharmacokinetic study##12##2##(2008-10#7)(2008-5#2)(2008-8#1)(2011-3#2)
pharmacokinetic##82##1##(1990-6#1)(1991-12#1)(1991-2#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-11#5)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#7)(2008-7#3)(2008-8#6)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#2)(2011-1#4)(2011-2#4)(2011-3#2)(2012-2#2)(2013-1#5)(2013-8#2)
pharmacokinetic/pharmacodynamic##2##1##(2008-8#2)
pharmacokinetically##3##1##(2010-11#3)
pharmacokinetics and pharmacodynamics##5##3##(1991-2#1)(2008-3#1)(2008-8#2)(2010-6#1)
pharmacokinetics and##13##2##(1991-2#2)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2010-6#1)(2013-1#1)
pharmacokinetics for##2##2##(2012-3#1)(2013-1#1)
pharmacokinetics in##3##2##(1990-11#1)(2008-10#1)(2008-3#1)
pharmacokinetics of YH439 and its metabolites##3##6##(2008-11#3)
pharmacokinetics of metronidazole##2##3##(2011-2#2)
pharmacokinetics of the##2##3##(1996-1#1)(2006-10#1)
pharmacokinetics of##20##2##(1992-11#1)(1994-3#1)(1996-1#1)(2006-10#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-8#2)(2009-11#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
pharmacokinetics##57##1##(1990-11#1)(1991-1#1)(1991-2#2)(1992-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-4#2)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#9)(2009-11#1)(2009-12#1)(2010-11#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
pharmacologic agents##4##2##(2008-10#1)(2008-12#1)(2008-2#2)
pharmacologic and##2##2##(1991-12#1)(2008-1#1)
pharmacologic ascorbate##2##2##(2012-2#2)
pharmacologic challenge##2##2##(2008-12#1)(2008-4#1)
pharmacologic inhibition of##3##3##(1994-3#1)(2007-10#1)(2012-12#1)
pharmacologic profile##2##2##(2008-8#1)(2012-12#1)
pharmacologic therapies##3##2##(2008-8#1)(2010-11#1)(2011-2#1)
pharmacologic therapy##2##2##(2008-1#1)(2008-10#1)
pharmacologic treatment##6##2##(1991-12#1)(1994-7#1)(1996-9#1)(2007-11#1)(2011-2#1)(2013-8#1)
pharmacologic treatments##2##2##(2006-10#1)(2008-4#1)
pharmacologic##53##1##(1990-2#1)(1991-1#1)(1991-12#3)(1992-8#1)(1993-1#1)(1993-10#1)(1994-3#1)(1994-7#1)(1995-6#2)(1996-7#1)(1996-9#3)(2006-10#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#4)(2008-4#3)(2008-7#3)(2008-8#2)(2009-4#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
pharmacological activation of##3##3##(1993-12#1)(1997-6#1)(2012-2#1)
pharmacological activities##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
pharmacological activity##4##2##(1991-3#1)(1991-8#1)(2008-5#1)(2013-1#1)
pharmacological agent##2##2##(2012-12#1)(2012-2#1)
pharmacological agents with##2##3##(2007-7#1)(2008-1#1)
pharmacological agents##14##2##(1994-10#2)(1995-3#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2012-3#1)
pharmacological aids##2##2##(2009-7#2)
pharmacological and non-pharmacological##4##3##(1993-2#1)(2009-6#1)(2009-7#1)(2011-2#1)
pharmacological and nonpharmacological##2##3##(2008-11#2)
pharmacological and psychological##2##3##(2007-11#1)(2010-12#1)
pharmacological and psychosocial##4##3##(2009-7#1)(2009-8#2)(2009-9#1)
pharmacological and##18##2##(1993-2#1)(1994-3#1)(1994-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
pharmacological approach##3##2##(2008-10#1)(2010-11#1)(2012-2#1)
pharmacological approaches##7##2##(1992-9#1)(1995-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)
pharmacological characteristics##4##2##(1990-3#1)(2008-8#1)(2009-7#2)
pharmacological data##2##2##(1992-6#1)(2008-8#1)
pharmacological effect of##2##3##(1995-12#1)(2008-8#1)
pharmacological effects of the##2##4##(1994-5#1)(2008-5#1)
pharmacological effects of##4##3##(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
pharmacological effects##8##2##(1994-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2013-1#1)
pharmacological evidence for##2##3##(1990-5#1)(2008-12#1)
pharmacological experiments##2##2##(1990-7#1)(2009-8#1)
pharmacological exploitation##2##2##(2008-4#1)(2009-12#1)
pharmacological inhibition of##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
pharmacological inhibition##4##2##(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#1)
pharmacological inhibitors##2##2##(2008-3#1)(2013-1#1)
pharmacological intervention for##2##3##(2008-11#1)(2013-1#1)
pharmacological intervention##6##2##(1991-2#2)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
pharmacological interventions that##2##3##(1996-9#1)(2011-1#1)
pharmacological interventions to##2##3##(2012-12#1)(2013-8#1)
pharmacological interventions##9##2##(1995-3#2)(1996-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
pharmacological management of##6##3##(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)(2012-3#1)
pharmacological manipulation##2##2##(1997-1#1)(2011-1#1)
pharmacological profile for##2##3##(1994-6#1)(1994-8#1)
pharmacological profile of the##2##4##(1995-11#1)(1996-5#1)
pharmacological profile of##3##3##(1995-11#1)(1996-5#1)(2012-12#1)
pharmacological profile##9##2##(1990-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-4#1)(2008-6#1)(2012-12#1)
pharmacological profiles##2##2##(1990-7#1)(1992-3#1)
pharmacological properties of##6##3##(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(2008-4#1)(2008-7#1)
pharmacological properties##12##2##(1990-3#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1997-5#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-12#2)
pharmacological response##2##2##(1993-8#1)(2013-8#1)
pharmacological stimuli##2##2##(1992-6#1)(2009-9#1)
pharmacological strategies for##2##3##(1994-6#2)
pharmacological strategies##3##2##(1994-6#2)(2008-7#1)
pharmacological studies##3##2##(1992-5#1)(2008-4#1)(2008-8#1)
pharmacological study##2##2##(1990-9#1)(2008-4#1)
pharmacological targeting##2##2##(2009-10#1)(2011-2#1)
pharmacological therapies##3##2##(2008-3#1)(2010-10#1)(2011-1#1)
pharmacological therapy##11##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
pharmacological treatment in##2##3##(1997-5#1)(2012-3#1)
pharmacological treatment of##5##3##(1992-6#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-7#1)
pharmacological treatment##23##2##(1991-2#1)(1992-6#1)(1994-6#1)(1996-2#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
pharmacological treatments##4##2##(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
pharmacological##255##1##(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-2#4)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#5)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#3)(1995-6#1)(1996-2#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#14)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#9)(2008-4#15)(2008-5#6)(2008-6#2)(2008-7#17)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#7)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#2)(2011-1#6)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#11)(2013-1#6)(2013-7#2)(2013-8#5)
pharmacologically active##3##2##(1997-8#1)(2008-10#2)
pharmacologically and##2##2##(2008-4#1)(2008-5#1)
pharmacologically from##2##2##(2009-7#1)(2011-2#1)
pharmacologically induced##2##2##(2010-4#1)(2012-2#1)
pharmacologically similar##2##2##(1995-11#1)(1996-2#1)
pharmacologically##28##1##(1992-3#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-2#1)(1997-2#2)(1997-8#1)(2008-10#3)(2008-4#3)(2008-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)
pharmacology and therapeutic##2##3##(1991-2#1)(2012-2#1)
pharmacology and therapeutics##3##3##(2008-11#2)(2008-5#1)
pharmacology and##11##2##(1991-12#1)(1991-2#1)(1994-3#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#2)
pharmacology education for nurses##2##4##(2008-12#2)
pharmacology education##3##2##(2008-12#3)
pharmacology is##2##2##(1995-12#2)
pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors##2##13##(1995-12#2)
pharmacology of the##5##3##(1993-12#1)(1995-11#2)(2008-4#1)(2008-7#1)
pharmacology of these##2##3##(2006-10#1)(2012-12#1)
pharmacology of##14##2##(1993-12#1)(1995-11#3)(1995-12#3)(1996-1#1)(2006-10#1)(2008-4#1)(2008-7#2)(2012-12#1)(2012-2#1)
pharmacology##70##1##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#7)(1995-12#5)(1996-1#2)(1996-12#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#9)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#8)
pharmacopeia##2##1##(2008-10#1)(2013-8#1)
pharmacophore of##2##2##(1996-9#1)(2007-11#1)
pharmacophore##9##1##(1996-9#1)(2007-11#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#2)
pharmacophoric##2##1##(1993-8#1)(2012-2#1)
pharmacopoeia##2##1##(2008-10#1)(2008-5#1)
pharmacopoeial##5##1##(2008-10#3)(2008-5#1)(2010-5#1)
pharmacopoeias##3##1##(2008-10#1)(2012-2#2)
pharmacotherapeutic options for##2##3##(2008-4#1)(2013-1#1)
pharmacotherapeutic##8##1##(1992-2#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-4#3)(2013-1#1)
pharmacotherapies for##2##2##(2008-2#1)(2013-1#1)
pharmacotherapies in##2##2##(2008-2#1)(2008-3#1)
pharmacotherapies##14##1##(2008-11#2)(2008-2#6)(2008-3#1)(2009-6#1)(2011-2#1)(2011-7#1)(2013-1#2)
pharmacotherapy and##5##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-8#1)
pharmacotherapy during##2##2##(2013-1#2)
pharmacotherapy for##3##2##(2008-2#1)(2008-4#1)(2013-1#1)
pharmacotherapy has##2##2##(1993-11#1)(2008-2#1)
pharmacotherapy in##5##2##(2008-2#2)(2008-4#2)(2013-7#1)
pharmacotherapy of##8##2##(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
pharmacotherapy##52##1##(1990-6#1)(1991-2#1)(1993-11#3)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
pharmacotherapy-assisted quit attempts##2##3##(2013-1#2)
pharmacovigilance in##2##2##(2008-11#1)(2008-8#1)
pharmacovigilance practice##2##2##(2008-11#2)
pharmacovigilance study##2##2##(2010-5#2)
pharmacovigilance##22##1##(2007-2#1)(2008-11#13)(2008-8#4)(2010-5#2)(2013-8#2)
pharmacy and##3##2##(2010-3#1)(2010-5#1)(2011-1#1)
pharmacy claims of##2##3##(2008-11#1)(2009-6#1)
pharmacy curriculum##2##2##(2011-1#1)(2011-2#1)
pharmacy department##3##2##(1992-1#1)(2008-1#2)
pharmacy education##3##2##(2010-3#1)(2011-1#1)(2011-2#1)
pharmacy for##2##2##(2010-3#1)(2011-1#1)
pharmacy practice##3##2##(2010-3#1)(2011-1#1)(2013-1#1)
pharmacy students##3##2##(2009-12#1)(2010-4#1)(2011-1#1)
pharmacy##76##1##(1990-9#1)(1991-1#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#2)(1994-12#2)(1995-1#3)(1995-11#1)(1995-2#1)(1997-2#1)(2008-1#4)(2008-11#3)(2008-12#1)(2008-6#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#13)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#15)(2011-2#2)(2013-1#4)
pharmacy's##2##1##(2010-8#2)
pharmacy-based##2##1##(1990-9#1)(2010-3#1)
pharyngeal and laryngeal##2##3##(1990-9#1)(2010-12#1)
pharyngeal muscles##2##2##(2011-1#2)
pharyngeal or##2##2##(2011-2#1)(2012-2#1)
pharyngeal swabs were##2##3##(2008-5#1)(2011-2#1)
pharyngeal swabs##3##2##(2008-5#2)(2011-2#1)
pharyngeal##21##1##(1990-9#1)(1993-2#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
pharyngitis in##2##2##(2012-2#2)
pharyngitis##5##1##(1992-2#1)(2009-5#1)(2012-2#3)
pharynx and##3##2##(1997-7#1)(2008-12#1)(2008-9#1)
pharynx##15##1##(1990-8#2)(1995-5#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#3)(2013-1#1)
phase (7##2##2##(1994-2#1)(2008-10#1)
phase (the##2##2##(2008-3#1)(2012-2#1)
phase 1##2##2##(2007-10#1)(2008-11#1)
phase 2##7##2##(1993-3#1)(1995-12#1)(2007-10#2)(2009-12#1)(2011-2#1)(2013-1#1)
phase 3##3##2##(2008-9#2)(2011-2#1)
phase 3)##2##2##(2008-9#2)
phase C(18) column##5##3##(2008-10#4)(2011-2#1)
phase Doppler anemometry##2##3##(2008-2#1)(2008-3#1)
phase HPLC##7##2##(1990-12#2)(1991-5#1)(1991-8#1)(2008-10#2)(2008-8#1)
phase I Coxiella burnetii##2##4##(1995-12#2)
phase I and II clinical##2##5##(2008-5#2)
phase I and II##5##4##(1995-12#2)(2008-11#1)(2008-5#2)
phase I and phase II##3##5##(1995-12#1)(2008-5#1)(2008-7#1)
phase I and##8##3##(1995-12#3)(2008-11#1)(2008-5#3)(2008-7#1)
phase I clinical trials as##2##5##(2008-5#2)
phase I clinical trials##6##4##(2008-11#1)(2008-5#4)(2012-3#1)
phase I clinical##8##3##(2008-11#1)(2008-5#5)(2011-2#1)(2012-3#1)
phase I studies##2##3##(2006-6#1)(2010-12#1)
phase I study of##2##4##(1992-10#1)(2008-5#1)
phase I study##7##3##(1991-1#1)(1992-10#1)(2008-5#4)(2008-7#1)
phase I trial##5##3##(1994-9#1)(2008-5#3)(2008-6#1)
phase I trials##4##3##(2008-5#3)(2011-2#1)
phase I##51##2##(1991-1#1)(1992-10#1)(1994-9#1)(1995-12#7)(2006-6#1)(2008-1#1)(2008-11#2)(2008-5#21)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-5#2)(2011-2#5)(2011-3#2)(2012-3#1)
phase I-II study##3##3##(1990-12#1)(1991-3#1)(1993-8#1)
phase I/II##2##2##(2008-5#2)
phase II and III studies##2##5##(2008-5#2)
phase II and III##3##4##(2008-5#2)(2012-3#1)
phase II clinical trial##3##4##(1990-12#1)(1997-8#1)(2008-12#1)
phase II clinical trials##6##4##(2008-5#6)
phase II clinical##11##3##(1990-12#1)(1997-8#1)(2008-12#1)(2008-5#7)(2013-1#1)
phase II studies in##2##4##(1990-9#1)(2008-5#1)
phase II studies##5##3##(1990-9#1)(2008-5#2)(2008-6#1)(2008-8#1)
phase II study of##2##4##(1993-2#1)(1995-10#1)
phase II study was##2##4##(2008-10#2)
phase II study##18##3##(1991-2#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(2007-4#2)(2008-10#4)(2008-6#3)(2011-2#1)
phase II trial in##2##4##(2008-5#2)
phase II trial##9##3##(1992-10#1)(2007-7#2)(2008-5#5)(2010-12#1)
phase II trials in##2##4##(2007-7#1)(2008-5#1)
phase II trials##8##3##(2007-7#2)(2008-5#5)(2013-1#1)
phase II##81##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-4#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#6)(1997-8#2)(2007-4#2)(2007-7#5)(2008-10#5)(2008-12#1)(2008-5#27)(2008-6#5)(2008-7#2)(2008-8#5)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
phase II/III trial##3##3##(2007-2#1)(2008-5#2)
phase II/III##7##2##(2007-2#1)(2008-5#4)(2012-2#1)(2012-3#1)
phase IIB##2##2##(2008-8#2)
phase III clinical trial##2##4##(2008-5#1)(2011-3#1)
phase III clinical##5##3##(1994-11#1)(2008-11#1)(2008-5#2)(2011-3#1)
phase III development##2##3##(2008-1#1)(2008-5#1)
phase III studies##2##3##(2008-5#1)(2008-8#1)
phase III study##6##3##(1992-12#1)(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)
phase III trial for##2##4##(2008-5#2)
phase III trial with a clinical##2##6##(2008-8#2)
phase III trial with##3##4##(2008-8#3)
phase III trial##14##3##(2007-12#1)(2008-5#7)(2008-8#3)(2010-12#2)(2012-12#1)
phase III trials are##2##4##(2008-5#2)
phase III trials in##2##4##(2008-5#2)
phase III trials##8##3##(2007-7#1)(2008-5#5)(2010-12#2)
phase III##42##2##(1992-12#1)(1994-11#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#18)(2008-7#1)(2008-8#4)(2010-12#4)(2011-3#1)(2012-12#1)
phase IV##2##2##(2007-7#2)
phase aberrations##3##2##(2007-12#1)(2008-3#2)
phase absorbances at##2##3##(2008-10#2)
phase advance of##2##3##(1991-12#1)(2008-5#1)
phase advance##3##2##(1991-12#1)(1997-6#1)(2008-5#1)
phase after##2##2##(2008-10#1)(2008-3#1)
phase analysis##2##2##(2008-3#2)
phase and 0##2##3##(2008-10#2)
phase and a##6##3##(1993-12#1)(2008-10#5)
phase and amplitude of##2##4##(2008-3#2)
phase and amplitude spatial##2##4##(2008-2#1)(2008-3#1)
phase and amplitude##13##3##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#5)
phase and an##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
phase and decreased##2##3##(1997-2#1)(2008-11#1)
phase and frequency##2##3##(2007-12#1)(2008-3#1)
phase and in##2##3##(2008-10#1)(2008-7#1)
phase and the##24##3##(1990-12#2)(1990-7#1)(1991-5#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#1)
phase and##140##2##(1990-12#3)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-11#7)(2007-12#8)(2008-10#53)(2008-11#8)(2008-2#4)(2008-3#15)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#4)(2011-3#1)(2013-1#3)
phase angle##4##2##(1993-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
phase anisotropy##2##2##(2008-3#2)
phase appeared##2##2##(2008-10#1)(2008-8#1)
phase are##5##2##(1992-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2012-3#1)
phase as a##4##3##(1990-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
phase as an##3##3##(2008-10#3)
phase as the##2##3##(2007-11#1)(2008-10#1)
phase as well as amplitude##2##5##(2008-2#1)(2008-3#1)
phase as well as##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
phase as##14##2##(1990-7#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2012-1#1)
phase at a##5##3##(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#1)
phase at pH 7##2##4##(2008-10#2)
phase at pH##3##3##(2008-10#2)(2008-11#1)
phase at the##4##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
phase at##23##2##(1990-2#1)(1990-9#1)(1992-10#1)(1993-11#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
phase before##2##2##(2008-10#2)
phase behavior at low CBS concentrations##2##6##(1993-8#2)
phase behavior of##3##3##(1990-7#1)(1993-8#2)
phase behavior##10##2##(1990-7#2)(1993-8#5)(1994-5#1)(2008-10#1)(2008-8#1)
phase behaviors##2##2##(2008-10#2)
phase behaviour of##3##3##(1994-3#2)(2012-2#1)
phase behaviour##6##2##(1994-3#2)(2008-5#2)(2012-2#2)
phase between the##4##3##(2007-12#2)(2008-3#1)(2009-7#1)
phase bias##2##2##(2008-3#2)
phase binding##3##2##(1993-2#1)(1996-12#1)(2008-10#1)
phase boundary##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
phase but##4##2##(1992-3#1)(1993-6#1)(2008-10#1)(2008-7#1)
phase by the##2##3##(2008-10#1)(2008-11#1)
phase by##18##2##(2007-11#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#1)(2010-4#1)(2013-8#1)
phase callusing##2##2##(2008-12#2)
phase can be##10##3##(1996-5#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)
phase can##13##2##(1996-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)
phase cannot be##2##3##(2008-10#1)(2008-2#1)
phase cartridges##2##2##(2008-10#2)
phase causes##2##2##(1997-1#1)(2008-7#1)
phase change in each##2##4##(2007-11#1)(2008-3#1)
phase change of the##2##4##(2007-11#1)(2008-10#1)
phase change of##5##3##(2007-11#2)(2008-10#3)
phase change on reflection in##2##5##(2007-11#2)
phase change##19##2##(1994-12#1)(2007-11#7)(2007-12#1)(2008-10#4)(2008-3#6)
phase changes in##4##3##(1995-11#1)(2007-11#1)(2008-3#1)(2008-5#1)
phase changes##12##2##(1995-11#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2008-5#2)
phase characteristics##2##2##(1994-12#1)(2007-12#1)
phase chessboard##2##2##(2008-3#2)
phase chromatographic##4##2##(2008-10#3)(2010-5#1)
phase chromatography##10##2##(1993-9#1)(1994-11#1)(1997-4#1)(2008-10#6)(2008-5#1)
phase code##4##2##(2007-12#1)(2008-3#3)
phase codes located in the##2##5##(2007-12#1)(2008-3#1)
phase codes##11##2##(2007-12#5)(2008-3#6)
phase coding of place information##2##5##(2008-11#2)
phase coding##5##2##(2007-11#1)(2008-11#4)
phase coherence##4##2##(2007-11#4)
phase column##4##2##(1992-8#1)(1992-9#1)(2008-10#2)
phase compensation is##3##3##(2008-3#2)(2013-8#1)
phase compensation##10##2##(2008-2#1)(2008-3#5)(2013-8#4)
phase components##3##2##(2007-12#1)(2008-3#2)
phase composed of##2##3##(2008-10#1)(2008-7#1)
phase composition on the##2##4##(2007-12#1)(2008-10#1)
phase composition##14##2##(1996-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2009-7#3)
phase computer-generated holograms##2##3##(2008-2#1)(2008-3#1)
phase computer-generated##3##2##(2008-2#1)(2008-3#2)
phase conjugation from##2##3##(2008-2#2)
phase conjugation in a photorefractive crystal##2##6##(2008-2#2)
phase conjugation in##4##3##(2008-2#4)
phase conjugation##16##2##(2007-12#4)(2008-2#9)(2008-3#3)
phase conjugator##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
phase consisting of##10##3##(1991-5#1)(2008-10#6)(2010-3#1)(2011-1#1)(2012-12#1)
phase containing a##3##3##(2008-10#2)(2010-3#1)
phase containing##14##2##(1990-8#1)(2008-10#11)(2008-7#1)(2010-3#1)
phase contrast magnetic resonance##2##4##(2012-3#2)
phase contrast microscopy##2##3##(1997-7#1)(2013-7#1)
phase contrast##11##2##(1992-12#1)(1997-7#1)(2007-11#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-3#2)(2013-7#1)(2013-8#1)
phase control of##2##3##(2007-12#1)(2008-3#1)
phase control##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
phase correction method##2##3##(2013-8#2)
phase correction of##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
phase correction##12##2##(2007-11#1)(2007-12#4)(2008-2#1)(2013-8#6)
phase correlation##3##2##(2007-12#3)
phase could be##4##3##(2008-10#2)(2008-11#1)(2009-11#1)
phase could##5##2##(1993-8#1)(2008-10#2)(2008-11#1)(2009-11#1)
phase cyclins) were##2##3##(1997-6#2)
phase data##7##2##(2008-2#1)(2008-3#6)
phase delay is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase delay##7##2##(1997-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
phase delays##3##2##(2007-11#1)(2007-12#2)
phase delivery##2##2##(2008-10#2)
phase demodulation##3##2##(2007-12#2)(2008-3#1)
phase dependent##2##2##(2008-11#1)(2008-5#1)
phase detection##5##2##(1991-12#1)(2007-11#2)(2008-10#1)(2008-2#1)
phase determination##2##2##(1992-8#1)(2008-2#1)
phase diagnostics##2##2##(1994-9#1)(2008-2#1)
phase diagram of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
phase diagram##10##2##(2008-10#4)(2008-3#1)(2008-5#3)(2012-2#2)
phase diagrams were determined##2##4##(2008-5#2)
phase diagrams##6##2##(1991-9#1)(1993-8#1)(2008-10#1)(2008-5#3)
phase difference between the##5##4##(2007-12#1)(2008-3#4)
phase difference between two##4##4##(2007-12#1)(2008-3#3)
phase difference between##13##3##(2007-12#3)(2008-11#1)(2008-3#9)
phase difference in##2##3##(2007-11#1)(2008-3#1)
phase difference is##4##3##(2007-11#3)(2008-2#1)
phase difference of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
phase difference##32##2##(2007-11#6)(2007-12#8)(2008-11#1)(2008-2#3)(2008-3#14)
phase differences in##2##3##(2008-2#1)(2008-9#1)
phase differences pi/2 and 3pi/2##2##5##(2008-3#2)
phase differences##8##2##(2008-2#2)(2008-3#5)(2008-9#1)
phase dislocations##2##2##(2007-11#2)
phase dispersion##6##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
phase dissolution##2##2##(2008-10#2)
phase distortion##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
phase distortions from##2##3##(2007-11#1)(2008-3#1)
phase distortions of##2##3##(2008-2#2)
phase distortions##10##2##(2007-11#1)(2008-2#3)(2008-3#5)(2013-8#1)
phase distribution for the##2##4##(2008-3#2)
phase distribution for##3##3##(2008-2#1)(2008-3#2)
phase distribution is##2##3##(2008-2#2)
phase distribution of the##2##4##(2007-9#1)(2008-2#1)
phase distribution of##4##3##(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)
phase distribution##22##2##(2007-11#2)(2007-9#1)(2008-10#1)(2008-2#11)(2008-3#7)
phase distributions##6##2##(2008-2#4)(2008-3#1)(2011-1#1)
phase disturbance##2##2##(2008-2#2)
phase disturbances##2##2##(1997-6#1)(2008-3#1)
phase diversity##3##2##(2008-3#3)
phase due to##2##3##(1991-5#1)(2008-10#1)
phase duration was##2##3##(2009-9#1)(2011-2#1)
phase duration##5##2##(1997-2#1)(2009-9#2)(2011-2#2)
phase during which##2##3##(1994-2#1)(2012-1#1)
phase during##6##2##(1994-2#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#1)
phase dysphagia##3##2##(1993-2#3)
phase effects##2##2##(2007-11#1)(2008-2#1)
phase element##5##2##(2007-11#1)(2008-3#4)
phase elements##20##2##(2007-11#5)(2007-12#2)(2008-2#3)(2008-3#10)
phase encoded on the##2##4##(2008-2#1)(2008-3#1)
phase encoded##4##2##(2008-2#1)(2008-3#3)
phase encoding in##2##3##(2007-12#1)(2008-3#1)
phase encoding##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#4)
phase encryption technique##2##3##(2007-11#1)(2008-3#1)
phase encryption##5##2##(2007-11#1)(2008-3#4)
phase enhances##2##2##(2008-10#1)(2008-5#1)
phase equilibrium##3##2##(2008-10#2)(2012-3#1)
phase error is##2##3##(2008-2#1)(2008-3#1)
phase error##13##2##(2008-2#8)(2008-3#4)(2013-8#1)
phase errors##11##2##(2007-12#2)(2008-2#4)(2008-3#4)(2011-1#1)
phase estimate##2##2##(2008-2#1)(2008-8#1)
phase estimation##2##2##(2012-2#2)
phase evaluation##3##2##(2008-2#2)(2008-3#1)
phase evolution##2##2##(2007-11#1)(2010-4#1)
phase exchange kinetics##3##3##(2008-10#3)
phase exchange##4##2##(2008-10#4)
phase exists##2##2##(2010-4#1)(2012-12#1)
phase extraction (SPE)##35##3##(2008-10#32)(2008-11#1)(2011-1#1)(2013-1#1)
phase extraction and##9##3##(2008-10#9)
phase extraction of##9##3##(2008-10#9)
phase extraction##98##2##(2007-11#1)(2008-10#90)(2008-11#1)(2008-2#2)(2009-8#1)(2011-1#1)(2013-1#2)
phase extractive preconcentration of##6##4##(2008-10#6)
phase extractive preconcentration##9##3##(2008-10#9)
phase fields##2##2##(2008-2#2)
phase fluctuations##2##2##(2008-3#2)
phase following##4##2##(1995-12#1)(1995-3#1)(2007-8#1)(2010-7#1)
phase for the##7##3##(1990-8#2)(2008-10#4)(2008-5#1)
phase for##21##2##(1990-8#4)(1991-5#2)(2008-10#12)(2008-2#1)(2008-5#1)(2008-7#1)
phase from a##2##3##(2007-12#1)(2008-3#1)
phase from the##3##3##(2007-12#1)(2008-3#1)(2009-7#1)
phase from##13##2##(1990-12#1)(1996-2#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-7#1)(2012-9#1)
phase function and##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
phase function for##3##3##(2008-2#2)(2008-3#1)
phase function of the##2##4##(2008-2#2)
phase function of##3##3##(2008-2#3)
phase function##43##2##(2007-12#2)(2008-2#26)(2008-3#15)
phase functions are##2##3##(2008-3#2)
phase functions with##2##3##(2008-2#1)(2008-3#1)
phase functions##12##2##(2007-11#1)(2008-2#6)(2008-3#5)
phase gradient##6##2##(2008-2#2)(2008-3#4)
phase grating inside a##2##4##(2008-3#2)
phase grating that is##2##4##(2007-11#1)(2007-12#1)
phase grating that##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase grating##17##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#11)
phase gratings were##2##3##(2007-11#1)(2008-3#1)
phase gratings##12##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#8)
phase has been##2##3##(1994-12#1)(2008-10#1)
phase has##4##2##(1994-12#1)(1995-6#1)(2008-10#1)(2009-7#1)
phase have been##2##3##(2008-10#1)(2008-5#1)
phase have##3##2##(2008-10#2)(2008-5#1)
phase high performance liquid chromatography##9##5##(1990-7#1)(1990-8#1)(1994-6#1)(2008-10#4)(2008-5#1)(2011-2#1)
phase high performance liquid##10##4##(1990-7#1)(1990-8#1)(1994-6#1)(2008-10#5)(2008-5#1)(2011-2#1)
phase high-performance liquid chromatography##2##4##(1995-2#1)(2008-10#1)
phase images of##2##3##(1993-8#1)(2007-11#1)
phase images##5##2##(1993-8#1)(2007-11#1)(2012-2#3)
phase imaging of##2##3##(2007-11#1)(2012-1#1)
phase imaging##5##2##(2007-11#2)(2008-3#1)(2008-7#1)(2012-1#1)
phase in a two-dimensional##2##4##(1992-5#1)(2008-2#1)
phase in a##7##3##(1992-5#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-6#1)
phase in space-variant polarization-state manipulations##2##5##(2007-12#2)
phase in the presence of##3##5##(2008-10#1)(2008-5#1)(2008-8#1)
phase in the##24##3##(1990-6#1)(1990-8#1)(1993-8#1)(1996-2#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
phase in which##7##3##(1993-1#1)(1993-8#1)(1994-5#1)(2008-4#1)(2008-6#1)(2011-2#2)
phase in##73##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-5#1)(1992-5#1)(1993-1#1)(1993-8#2)(1994-5#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#25)(2008-11#5)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-6#2)(2010-6#1)(2011-2#5)
phase increased##2##2##(1996-7#1)(2012-1#1)
phase increases with##2##3##(2008-10#1)(2009-7#1)
phase information is##2##3##(2008-3#2)
phase information##12##2##(2007-11#2)(2008-2#1)(2008-3#8)(2008-8#1)
phase insulin response)##2##3##(1994-12#2)
phase insulin##4##2##(1994-12#2)(2010-11#1)(2011-2#1)
phase interaction##2##2##(2008-10#2)
phase interface##2##2##(2008-10#2)
phase interferometry for direct electric-field reconstruction##6##6##(2007-12#6)
phase interferometry for direct##7##4##(2007-11#1)(2007-12#6)
phase into the##2##3##(1991-5#1)(2008-10#1)
phase into##4##2##(1991-5#1)(2008-10#3)
phase inversion morphology##2##3##(2008-10#2)
phase inversion##3##2##(2007-11#1)(2008-10#2)
phase involving##2##2##(1992-12#1)(2008-11#1)
phase ion-pair##2##2##(2008-10#2)
phase is achieved##2##3##(2008-10#1)(2008-7#1)
phase is described##2##3##(2008-10#1)(2008-3#1)
phase is##49##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(2007-11#2)(2007-12#3)(2008-10#19)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-7#5)(2008-9#1)(2009-7#1)(2010-4#1)(2013-8#1)
phase jitter in dispersion-managed soliton systems##2##6##(2007-11#2)
phase jitter in##3##3##(2007-11#3)
phase jump is##2##3##(2008-3#2)
phase jump##6##2##(2008-3#6)
phase jumps##3##2##(2007-12#1)(2008-3#2)
phase key in the Fourier plane##2##6##(2008-3#2)
phase key##5##2##(2008-3#5)
phase lag##2##2##(1994-8#1)(2012-2#1)
phase lasting##2##2##(1991-3#1)(2008-5#1)
phase levels##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
phase liquid chromatography (LC)##2##4##(2008-10#2)
phase liquid chromatography for the##2##5##(2008-10#2)
phase liquid chromatography with##2##4##(2008-10#2)
phase liquid chromatography##18##3##(1990-2#1)(2008-10#17)
phase liquid##19##2##(1990-2#1)(2008-10#17)(2010-3#1)
phase locked to##3##3##(1993-12#1)(2007-12#2)
phase locking and##2##3##(2007-11#2)
phase locking of three independent##2##5##(2007-11#2)
phase locking of##3##3##(2007-11#2)(2007-12#1)
phase locking##12##2##(2007-11#4)(2007-12#6)(2008-11#1)(2008-2#1)
phase map##8##2##(2008-2#4)(2008-3#4)
phase maps is##2##3##(2008-2#1)(2008-3#1)
phase maps that##2##3##(2008-2#1)(2008-3#1)
phase maps##18##2##(2008-2#5)(2008-3#12)(2011-1#1)
phase mask in##4##3##(2007-11#1)(2008-3#3)
phase mask is##3##3##(2008-3#3)
phase mask##22##2##(2007-11#2)(2007-12#1)(2008-2#8)(2008-3#10)(2012-2#1)
phase masks are##3##3##(2008-3#3)
phase masks##9##2##(2008-3#9)
phase matchable for##3##3##(2007-12#1)(2008-2#2)
phase matchable##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
phase matched##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
phase matching and##3##3##(2007-12#2)(2008-3#1)
phase matching by##2##3##(2007-11#1)(2007-12#1)
phase matching can be achieved##2##5##(2007-12#1)(2008-3#1)
phase matching for##2##3##(2007-11#1)(2008-3#1)
phase matching in a##3##4##(2007-11#1)(2007-12#2)
phase matching in##7##3##(2007-11#3)(2007-12#3)(2008-3#1)
phase matching of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
phase matching##40##2##(2007-11#14)(2007-12#16)(2008-2#2)(2008-3#8)
phase matrix##4##2##(2008-2#2)(2008-3#2)
phase measurement by##2##3##(2007-11#1)(2008-2#1)
phase measurement##10##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#3)
phase measurements##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
phase micro extraction##3##3##(2008-10#3)
phase microextraction (SPME)##10##3##(2008-10#8)(2009-8#1)(2012-1#1)
phase microextraction coupled with##2##4##(2008-10#2)
phase microextraction coupled##3##3##(2008-10#3)
phase microextraction##23##2##(2008-10#21)(2009-8#1)(2012-1#1)
phase microscopy##3##2##(2007-11#2)(2011-1#1)
phase mismatch and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
phase mismatch##11##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
phase model##3##2##(1992-1#1)(1995-2#1)(2007-11#1)
phase modulation in##2##3##(2007-12#1)(2008-3#1)
phase modulation is used##2##4##(2007-12#2)
phase modulation is##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
phase modulation of the##6##4##(2007-11#2)(2007-12#1)(2008-3#3)
phase modulation of##10##3##(1993-3#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)
phase modulation##39##2##(1993-3#1)(2007-11#9)(2007-12#11)(2008-2#5)(2008-3#13)
phase modulations##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
phase modulator and##2##3##(2007-12#1)(2008-3#1)
phase modulator in the reference arm of##2##7##(2007-12#1)(2008-3#1)
phase modulator in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase modulator is##2##3##(2007-11#1)(2008-3#1)
phase modulator##16##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#9)
phase modulators in##2##3##(2007-11#1)(2007-12#1)
phase modulators##4##2##(2007-11#2)(2007-12#2)
phase molecular absorption spectrometry##10##4##(2008-10#10)
phase molecular absorption##13##3##(2008-10#13)
phase noise of the##2##4##(2007-12#2)
phase noise of##3##3##(2007-12#3)
phase noise to intensity noise conversion##2##6##(2007-12#2)
phase noise to##3##3##(2007-11#1)(2007-12#2)
phase noise##14##2##(2007-11#8)(2007-12#6)
phase object is placed##2##4##(2008-3#2)
phase object##4##2##(2008-3#4)
phase objects##8##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#3)
phase of HPLC##2##3##(2008-10#2)
phase of a##17##3##(1993-1#1)(1995-3#1)(1997-5#4)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#4)(2012-2#1)
phase of an##4##3##(2007-12#1)(2008-11#1)(2008-7#1)(2010-11#1)
phase of cell##2##3##(1993-3#1)(2008-11#1)
phase of each##2##3##(2008-10#1)(2008-3#1)
phase of fast##2##3##(2008-1#1)(2012-2#1)
phase of gait##2##3##(2010-3#1)(2013-1#1)
phase of growth were##2##4##(2008-11#2)
phase of growth##3##3##(1994-8#1)(2008-11#2)
phase of rehabilitation##3##3##(2007-8#3)
phase of the cell cycle##7##5##(1994-3#1)(1994-8#1)(2008-11#2)(2008-9#1)(2011-1#1)(2013-1#1)
phase of the cell##8##4##(1991-5#1)(1994-3#1)(1994-8#1)(2008-11#2)(2008-9#1)(2011-1#1)(2013-1#1)
phase of the cycle##3##4##(1990-12#1)(1994-9#2)
phase of the disease##5##4##(1997-5#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
phase of the epidemic##2##4##(2008-10#2)
phase of the pulse##3##4##(2007-11#2)(2007-12#1)
phase of the study##3##4##(2008-11#1)(2010-1#1)(2010-9#1)
phase of the##103##3##(1990-12#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1996-2#1)(1997-1#3)(1997-3#1)(1997-4#4)(1997-5#2)(2007-11#9)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-1#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
phase of their##3##3##(1992-6#2)(2012-2#1)
phase of this##4##3##(1995-6#1)(2007-5#1)(2008-12#1)(2010-1#1)
phase of treatment##3##3##(2007-7#1)(2007-9#1)(2013-8#1)
phase of ultrashort##3##3##(2007-12#2)(2008-3#1)
phase of##281##2##(1990-12#2)(1990-6#2)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-12#6)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#7)(2007-11#14)(2007-12#15)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#37)(2008-11#15)(2008-12#5)(2008-2#15)(2008-3#24)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#9)(2012-12#3)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#4)
phase on the##5##3##(1997-1#1)(2008-10#2)(2008-11#1)(2010-11#1)
phase on##12##2##(1997-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2010-11#1)
phase optical##7##2##(2007-11#5)(2008-2#1)(2008-3#1)
phase or##2##2##(2008-10#1)(2008-5#1)
phase out##2##2##(1996-1#2)
phase partitioning##3##2##(1990-5#1)(1995-5#1)(2008-10#1)
phase pattern##2##2##(2008-2#1)(2008-3#1)
phase plate for##2##3##(2007-11#1)(2008-3#1)
phase plate##10##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#3)
phase plates##10##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#6)
phase precession##7##2##(2008-11#7)
phase preconcentration##2##2##(2008-10#2)
phase profile##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
phase profiles of##2##3##(2007-12#1)(2011-1#1)
phase profiles##3##2##(2007-12#1)(2011-1#2)
phase protein##6##2##(1992-12#1)(1994-6#1)(1996-12#2)(1997-3#1)(2008-10#1)
phase provides##2##2##(2008-3#1)(2008-7#1)
phase pulse##3##2##(2008-3#3)
phase quantization##2##2##(2008-3#2)
phase reconstruction from noisy##2##4##(2007-12#2)
phase reconstruction##3##2##(2007-11#1)(2007-12#2)
phase relation##2##2##(2007-11#1)(2011-1#1)
phase relations##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
phase response##6##2##(1992-12#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-12#1)(2008-3#1)
phase retardance##3##2##(2008-3#3)
phase retardation of##2##3##(2008-3#2)
phase retardation##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
phase retarder##5##2##(2007-11#2)(2008-2#1)(2010-4#2)
phase retrieval##8##2##(2007-11#4)(2008-2#2)(2008-3#1)(2008-8#1)
phase screen##10##2##(2008-2#1)(2008-3#8)(2008-8#1)
phase separated##2##2##(2008-10#1)(2008-5#1)
phase separation and##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
phase separation in##5##3##(1992-6#1)(2008-10#1)(2008-3#2)(2008-7#1)
phase separation of##6##3##(1992-6#1)(1997-6#1)(2008-10#3)(2008-7#1)
phase separation was##4##3##(1994-3#1)(2008-10#3)
phase separation##36##2##(1992-6#3)(1994-3#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#18)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2010-4#2)
phase separations##2##2##(1990-2#1)(2008-10#1)
phase separator for##2##3##(2008-10#2)
phase separator with a##2##4##(2008-10#2)
phase separator##10##2##(2008-10#10)
phase shift and##4##3##(2007-12#1)(2008-3#2)(2011-1#1)
phase shift between the s- and the p-polarized##2##8##(2008-3#2)
phase shift between the##4##4##(2007-11#1)(2008-3#3)
phase shift between##9##3##(2007-11#2)(2008-2#2)(2008-3#5)
phase shift in the##2##4##(2008-3#2)
phase shift in##5##3##(2007-11#2)(2008-3#3)
phase shift is##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
phase shift of the fundamental##2##5##(2007-11#1)(2007-12#1)
phase shift of the##6##4##(2007-11#1)(2007-12#2)(2008-3#2)(2009-6#1)
phase shift of##12##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#4)(2009-6#1)
phase shift on reflection for##2##5##(2008-2#2)
phase shift on reflection##3##4##(2008-2#3)
phase shift on##4##3##(2008-2#4)
phase shift produced by a##2##5##(2007-11#2)
phase shift relative to##2##4##(2007-11#1)(2007-12#1)
phase shift##70##2##(1994-2#1)(2007-11#17)(2007-12#14)(2008-2#14)(2008-3#21)(2008-8#1)(2009-6#1)(2011-1#1)
phase shifter##11##2##(2007-11#3)(2008-3#8)
phase shifters##5##2##(2008-2#3)(2008-3#2)
phase shifting in electronic speckle-pattern interferometry##2##6##(2008-3#2)
phase shifting##11##2##(2007-11#1)(2008-2#3)(2008-3#7)
phase shifts in the##2##4##(2007-11#2)
phase shifts induced##2##3##(2007-12#1)(2008-2#1)
phase shifts of##2##3##(1994-2#1)(2008-2#1)
phase shifts produced##2##3##(2007-12#1)(2008-2#1)
phase shifts##29##2##(1994-2#3)(2007-11#5)(2007-12#6)(2008-10#1)(2008-2#5)(2008-3#9)
phase should##2##2##(1994-2#1)(2008-10#1)
phase singularities##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
phase singularity##2##2##(2008-3#2)
phase space beam model to##2##5##(2009-11#2)
phase space beam model##4##4##(2009-11#4)
phase space##8##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#4)(2012-2#1)
phase spectrophotometric determination of vanillin##2##5##(2008-10#2)
phase spectrophotometric determination of##3##4##(2008-10#3)
phase spectrophotometric##5##2##(2008-10#5)
phase stability of##2##3##(2010-12#1)(2010-4#1)
phase stability##4##2##(2008-10#1)(2010-12#1)(2010-4#1)(2012-2#1)
phase step##2##2##(2008-2#1)(2008-3#1)
phase steps##3##2##(2008-2#1)(2008-3#2)
phase structure of the##2##4##(1997-2#1)(2007-9#1)
phase structure##3##2##(1997-2#1)(2007-9#1)(2008-3#1)
phase structures##5##2##(1997-2#1)(2008-3#4)
phase surface##3##2##(2008-10#2)(2008-11#1)
phase synchronization in##2##3##(2007-12#1)(2008-8#1)
phase that is##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
phase that##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
phase the##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
phase through##3##2##(1990-7#1)(2008-7#1)(2010-4#1)
phase to be##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
phase to the##5##3##(1991-5#1)(2008-10#3)(2008-2#1)
phase to##21##2##(1991-5#1)(1994-12#1)(1994-9#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)(2012-2#1)
phase tracing method for fringe pattern analysis##2##7##(2008-3#2)
phase transfer##2##2##(1994-3#1)(2008-5#1)
phase transformation in vanadium dioxide##2##5##(2007-11#2)
phase transformation##5##2##(2007-11#4)(2008-3#1)
phase transition in the##2##4##(1994-11#1)(2007-12#1)
phase transition in##4##3##(1991-9#1)(1994-11#2)(2007-12#1)
phase transition of the##2##4##(1994-3#1)(2007-11#1)
phase transition of##7##3##(1990-2#1)(1992-6#1)(1994-3#1)(2007-11#1)(2008-8#2)(2009-11#1)
phase transition temperature##3##3##(1994-12#1)(1994-3#1)(2008-10#1)
phase transition temperatures of liquid crystals##2##6##(2008-10#2)
phase transition temperatures##3##3##(1994-12#1)(2008-10#2)
phase transition was##2##3##(1990-2#1)(2008-8#1)
phase transition##45##2##(1990-2#5)(1990-7#2)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#2)(1992-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-7#2)(2008-8#3)(2009-11#1)(2009-5#1)
phase transitions in##3##3##(1991-9#2)(1993-5#1)
phase transitions of##2##3##(1990-2#1)(1994-3#1)
phase transitions##8##2##(1990-2#1)(1991-9#2)(1993-5#1)(1994-3#1)(1997-2#1)(2008-10#2)
phase two##2##2##(1994-3#1)(2010-8#1)
phase under##2##2##(2008-10#2)
phase unwrapping algorithm##2##3##(2008-2#1)(2008-3#1)
phase unwrapping in##2##3##(2008-3#2)
phase unwrapping is##2##3##(2008-2#1)(2008-3#1)
phase unwrapping##24##2##(2007-11#1)(2008-2#7)(2008-3#16)
phase used was##9##3##(1997-2#1)(2008-10#5)(2010-5#1)(2012-2#2)
phase using the##2##3##(2008-10#1)(2008-2#1)
phase using##8##2##(2008-10#6)(2008-2#1)(2008-4#1)
phase values##3##2##(2007-11#2)(2008-3#1)
phase variation##6##2##(2008-3#6)
phase velocities##2##2##(2007-11#1)(2007-12#1)
phase velocity##4##2##(2007-11#4)
phase versus##2##2##(2007-11#1)(2008-2#1)
phase volume##2##2##(2008-10#2)
phase was a##2##3##(2008-10#1)(2011-1#1)
phase was also##3##3##(1997-1#1)(2008-10#2)
phase was determined to be##2##5##(1997-2#1)(2008-10#1)
phase was determined##3##3##(1997-2#1)(2008-10#2)
phase was evaluated##2##3##(2008-10#2)
phase was investigated in##2##4##(2008-10#2)
phase was measured at##2##4##(2008-10#2)
phase was used as the##4##5##(2011-1#4)
phase was used as##5##4##(2008-3#1)(2011-1#4)
phase was used##6##3##(2008-10#1)(2008-3#1)(2011-1#4)
phase was##62##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-10#1)(1993-12#1)(1993-6#2)(1994-8#1)(1995-6#1)(1997-1#1)(1997-2#2)(2008-10#33)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#5)(2013-1#1)(2013-8#1)
phase water content##3##3##(2008-10#3)
phase water##4##2##(2008-10#3)(2008-5#1)
phase were optimised##3##3##(2008-10#3)
phase were optimized##2##3##(2008-10#2)
phase were##18##2##(1995-12#1)(1997-2#1)(2008-10#12)(2008-11#2)(2011-2#1)(2013-1#1)
phase when the##2##3##(2008-11#1)(2011-2#1)
phase where##2##2##(2008-10#1)(2008-5#1)
phase which##6##2##(1993-8#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
phase will##2##2##(1996-4#1)(2008-10#1)
phase with 'P' values of P &lt##2##7##(2012-2#2)
phase with a##2##3##(2008-10#1)(2008-3#1)
phase with negatively charged lipids##2##5##(2010-5#2)
phase with no negatively charged lipids##2##6##(2010-5#2)
phase with no##3##3##(2010-5#2)(2010-8#1)
phase with the##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)
phase with##35##2##(1993-11#1)(2007-11#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#4)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
phase within##3##2##(2008-10#2)(2008-3#1)
phase without##3##2##(2008-10#2)(2008-3#1)
phase##3582##1##(1990-12#18)(1990-2#15)(1990-3#1)(1990-5#4)(1990-6#5)(1990-7#11)(1990-8#19)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#7)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#20)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#7)(1992-1#1)(1992-10#5)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#11)(1992-8#4)(1992-9#6)(1993-1#2)(1993-11#6)(1993-12#11)(1993-2#6)(1993-3#6)(1993-5#2)(1993-6#8)(1993-8#22)(1993-9#6)(1994-11#7)(1994-12#9)(1994-2#13)(1994-3#12)(1994-5#8)(1994-6#8)(1994-8#7)(1994-9#9)(1995-10#1)(1995-11#2)(1995-12#25)(1995-2#5)(1995-3#6)(1995-5#1)(1995-6#9)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#9)(1996-3#1)(1996-4#3)(1996-5#7)(1996-7#5)(1997-1#8)(1997-2#18)(1997-3#5)(1997-4#9)(1997-5#7)(1997-6#7)(1997-7#2)(1997-8#5)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#247)(2007-12#218)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#13)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#935)(2008-11#117)(2008-12#13)(2008-2#277)(2008-3#546)(2008-4#18)(2008-5#166)(2008-6#25)(2008-7#77)(2008-8#43)(2008-9#20)(2009-10#3)(2009-11#10)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#6)(2009-7#22)(2009-8#7)(2009-9#4)(2010-1#2)(2010-11#5)(2010-12#9)(2010-3#7)(2010-4#17)(2010-5#15)(2010-6#4)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#45)(2011-2#49)(2011-3#6)(2011-9#1)(2012-1#8)(2012-12#6)(2012-2#39)(2012-3#17)(2012-9#2)(2013-1#30)(2013-3#2)(2013-7#3)(2013-8#28)
phase&quot##2##1##(2008-10#2)
phase) and##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
phase)##24##1##(1991-12#1)(1994-5#1)(1994-8#1)(2008-10#16)(2008-3#1)(2008-5#2)(2008-7#2)
phase- and##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
phase-##7##1##(2007-11#1)(2008-2#1)(2008-3#4)(2008-8#1)
phase-Doppler anemometry##2##2##(2008-3#2)
phase-Doppler interferometry##2##2##(2008-3#2)
phase-Doppler method for##2##3##(2008-3#2)
phase-Doppler##6##1##(2008-3#6)
phase-HPLC##2##1##(2008-10#1)(2011-2#1)
phase-based##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
phase-boundary model##2##2##(2008-10#2)
phase-boundary potential model##2##3##(2008-10#2)
phase-boundary##4##1##(2008-10#4)
phase-calculation algorithms for phase-shifting interferometry##2##5##(2008-3#2)
phase-calculation##3##1##(2008-2#1)(2008-3#2)
phase-change map##2##2##(2008-3#2)
phase-change optical data storage##2##4##(2008-3#2)
phase-change optical disk##3##3##(2007-11#1)(2008-3#2)
phase-change optical disks##2##3##(2008-2#1)(2008-3#1)
phase-change optical recording media##2##4##(2008-3#2)
phase-change optical##9##2##(2007-11#1)(2008-2#1)(2008-3#7)
phase-change readout##2##2##(2008-3#2)
phase-change##25##1##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#15)(2009-11#2)
phase-code multiplexing in##2##3##(2007-12#1)(2008-3#1)
phase-code multiplexing##4##2##(2007-12#3)(2008-3#1)
phase-code##5##1##(2007-12#3)(2008-3#2)
phase-coherent##4##1##(2007-12#2)(2008-2#2)
phase-conjugate beam##3##2##(2008-2#2)(2008-3#1)
phase-conjugate mirror##13##2##(2007-12#1)(2008-2#10)(2008-3#2)
phase-conjugate mirrors during recording##2##4##(2008-2#2)
phase-conjugate mirrors during##3##3##(2008-2#3)
phase-conjugate readout##2##2##(2008-3#2)
phase-conjugate##30##1##(2007-12#4)(2008-2#17)(2008-3#9)
phase-conjugated readout##2##2##(2007-12#1)(2008-3#1)
phase-conjugated##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
phase-conjugation##3##1##(2007-12#1)(2008-2#2)
phase-contrast imaging##4##2##(2006-4#1)(2007-11#1)(2008-3#1)(2010-1#1)
phase-contrast microscopy##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
phase-contrast optical coherence##2##3##(2007-11#2)
phase-contrast technique##2##2##(2007-11#1)(2008-3#1)
phase-contrast##20##1##(1995-11#1)(2006-4#1)(2007-11#8)(2007-12#1)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)
phase-correlated##2##1##(1991-9#1)(2011-2#1)
phase-delay control##3##2##(2007-12#3)
phase-dependent##4##1##(2007-12#3)(2008-2#1)
phase-difference amplification##4##2##(2008-3#4)
phase-dispersion microscopy##2##2##(2007-12#2)
phase-displacement equation##2##2##(2008-3#2)
phase-diversity##2##1##(2008-3#2)
phase-encoded images##5##2##(2008-2#5)
phase-encoded joint transform##2##3##(2008-2#1)(2008-3#1)
phase-encoded optical sampling##2##3##(2007-11#2)
phase-encoded##16##1##(2007-11#3)(2008-2#8)(2008-3#5)
phase-error##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
phase-field##2##1##(2008-2#1)(2008-3#1)
phase-function##3##1##(2008-2#2)(2008-3#1)
phase-gradient##3##1##(2008-2#1)(2008-3#1)(2009-5#1)
phase-iterative algorithm##3##2##(2008-2#1)(2008-3#2)
phase-iterative techniques##2##2##(2008-2#2)
phase-iterative##5##1##(2008-2#3)(2008-3#2)
phase-locked loop##8##2##(2007-11#1)(2007-12#3)(2008-3#4)
phase-locked resonators##2##2##(2008-3#2)
phase-locked##17##1##(2007-11#6)(2007-12#3)(2008-2#1)(2008-3#7)
phase-locking##3##1##(2008-11#2)(2013-8#1)
phase-matched KTP crystal##2##3##(2007-11#1)(2008-3#1)
phase-matched KTP##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
phase-matched optical parametric##2##3##(2007-11#1)(2007-12#1)
phase-matched##31##1##(2007-11#9)(2007-12#16)(2008-2#3)(2008-3#3)
phase-matching angle##2##2##(2007-11#1)(2008-3#1)
phase-matching condition##9##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
phase-matching conditions are##2##3##(2007-12#2)
phase-matching conditions for##2##3##(2007-11#1)(2008-3#1)
phase-matching conditions##9##2##(2007-11#2)(2007-12#4)(2008-3#3)
phase-matching properties of##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
phase-matching temperatures##3##2##(2007-12#1)(2008-3#2)
phase-matching##42##1##(2007-11#6)(2007-12#14)(2008-2#6)(2008-3#16)
phase-matrix elements##2##2##(2008-3#2)
phase-measurement errors##2##2##(2008-3#2)
phase-measurement##4##1##(2008-3#4)
phase-measuring profilometry##4##2##(2008-3#4)
phase-measuring##8##1##(2007-11#1)(2008-2#2)(2008-3#5)
phase-mismatched##2##1##(2007-12#2)
phase-modulated ellipsometry##3##2##(2008-2#1)(2008-3#2)
phase-modulated optical fiber-ring buffer##2##4##(2007-12#2)
phase-modulated optical##3##2##(2007-12#3)
phase-modulated spectroscopic##2##2##(2008-3#2)
phase-modulated##17##1##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#7)(2012-2#1)
phase-modulation##6##1##(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#3)
phase-noise measurement##2##2##(2007-12#2)
phase-noise##6##1##(2007-11#2)(2007-12#4)
phase-only computer-generated##2##2##(2008-3#2)
phase-only domains with##2##3##(2008-3#2)
phase-only elements##2##2##(2008-2#1)(2008-3#1)
phase-only filter##9##2##(2007-11#2)(2007-12#1)(2008-3#6)
phase-only filters##9##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)
phase-only liquid-crystal spatial light modulator##3##5##(2008-3#3)
phase-only spatial light modulator##2##4##(2008-3#2)
phase-only##44##1##(2007-11#3)(2007-12#2)(2008-2#10)(2008-3#29)
phase-resolved digital data processing##2##4##(2008-3#2)
phase-resolved functional optical coherence tomography##3##5##(2007-11#3)
phase-resolved optical Doppler##2##3##(2007-11#1)(2007-12#1)
phase-resolved##10##1##(2007-11#5)(2007-12#1)(2008-3#2)(2011-1#2)
phase-retarding##3##1##(2008-2#1)(2008-3#2)
phase-retrieval algorithm##2##2##(2008-2#1)(2008-3#1)
phase-retrieval procedure##2##2##(2007-12#1)(2008-3#1)
phase-retrieval##9##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
phase-sensitive detection##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
phase-sensitive##11##1##(2007-12#6)(2008-2#2)(2008-3#3)
phase-separated PNIPAM##3##2##(2008-10#3)
phase-separated##8##1##(1994-5#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-4#1)
phase-separation process of##2##3##(2008-10#2)
phase-shift algorithm##2##2##(2007-12#1)(2008-2#1)
phase-shift keying##3##2##(2007-11#3)
phase-shift map##2##2##(2008-3#2)
phase-shift technique##2##2##(2008-3#2)
phase-shift##31##1##(1993-12#1)(2007-11#6)(2007-12#2)(2008-2#4)(2008-3#18)
phase-shifted fringe patterns##2##3##(2007-11#1)(2008-3#1)
phase-shifted images##3##2##(2008-3#3)
phase-shifted##10##1##(2007-11#1)(2008-2#1)(2008-3#8)
phase-shifting Fizeau interferometer##2##3##(2008-3#2)
phase-shifting algorithm##4##2##(2008-2#1)(2008-3#3)
phase-shifting analysis##2##2##(2008-3#2)
phase-shifting digital holographic microscopy##2##4##(2011-1#2)
phase-shifting digital holographic##3##3##(2011-1#3)
phase-shifting digital holography##4##3##(2007-11#2)(2008-3#2)
phase-shifting digital##7##2##(2007-11#2)(2008-3#2)(2011-1#3)
phase-shifting error##2##2##(2007-11#1)(2008-3#1)
phase-shifting interferometer##6##2##(2007-11#1)(2008-3#5)
phase-shifting interferometers##2##2##(2008-3#2)
phase-shifting interferometry algorithms##2##3##(2007-12#1)(2008-2#1)
phase-shifting interferometry##14##2##(2007-12#2)(2008-2#1)(2008-3#11)
phase-shifting joint transform##2##3##(2008-2#1)(2008-3#1)
phase-shifting method##3##2##(2008-2#2)(2008-3#1)
phase-shifting photoelasticity##2##2##(2008-3#2)
phase-shifting point diffraction interferometer##2##4##(2008-2#1)(2008-3#1)
phase-shifting point-diffraction interferometer (PS/PDI)##2##4##(2008-3#2)
phase-shifting point-diffraction interferometer##5##3##(2008-3#5)
phase-shifting speckle interferometry##3##3##(2008-3#3)
phase-shifting speckle##4##2##(2008-3#4)
phase-shifting technique is##3##3##(2008-2#2)(2008-3#1)
phase-shifting technique##6##2##(2008-2#2)(2008-3#4)
phase-shifting##88##1##(1994-2#1)(2007-11#9)(2007-12#2)(2008-2#14)(2008-3#59)(2011-1#3)
phase-space product##3##2##(2007-11#3)
phase-space##8##1##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
phase-step##3##1##(2008-2#1)(2008-3#2)
phase-stepped interferometry##2##2##(2008-3#2)
phase-stepped##4##1##(2008-2#1)(2008-3#3)
phase-stepping interferometer##2##2##(2008-2#1)(2008-3#1)
phase-stepping interferometry##2##2##(2007-12#1)(2008-2#1)
phase-stepping technique##2##2##(2008-3#2)
phase-stepping##15##1##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#7)
phase-transfer catalysts##3##2##(2007-11#2)(2011-2#1)
phase-transfer##4##1##(1994-3#1)(2007-11#2)(2011-2#1)
phase-unwrapping algorithm##5##2##(2008-3#5)
phase-unwrapping method##3##2##(2008-3#3)
phase-unwrapping problems##2##2##(2008-2#1)(2008-3#1)
phase-unwrapping technique##2##2##(2008-2#1)(2008-3#1)
phase-unwrapping##17##1##(2008-2#4)(2008-3#13)
phase]##2##1##(1990-6#1)(2013-1#1)
phased arrays##3##2##(2008-2#1)(2008-3#2)
phased in##2##2##(1992-1#1)(2008-11#1)
phased##17##1##(1992-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)
phased-array antenna##4##2##(2008-3#4)
phased-array antennas##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
phased-array##15##1##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#9)
phaseoli and X##4##3##(2008-10#4)
phaseoli and##5##2##(2008-10#5)
phaseoli in##4##2##(2008-10#4)
phaseoli strains were highly pathogenic on##2##6##(2008-10#2)
phaseoli strains##10##2##(2008-10#10)
phaseoli var##15##2##(2008-10#15)
phaseoli was##2##2##(2008-10#2)
phaseoli##46##1##(2008-10#46)
phaseolicola and glycinea##3##3##(2008-10#3)
phaseolicola and##4##2##(2008-10#4)
phaseolicola was##2##2##(2008-10#2)
phaseolicola##19##1##(2008-10#19)
phaseolina##4##1##(2008-10#4)
phaseolorum and P##2##3##(2008-10#2)
phaseolorum and##6##2##(2008-10#6)
phaseolorum var##40##2##(2008-10#40)
phaseolorum##51##1##(2008-10#51)
phaseolotoxin##2##1##(2008-10#2)
phases IV and II##2##4##(2008-10#2)
phases and the##4##3##(1991-8#1)(2008-10#3)
phases and##15##2##(1991-8#1)(1996-5#1)(2007-12#3)(2007-5#1)(2008-10#7)(2010-11#1)(2013-8#1)
phases are##11##2##(1990-5#1)(1990-7#1)(1991-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2011-2#1)
phases at##4##2##(1993-8#1)(2006-4#1)(2010-4#1)(2011-1#1)
phases bound to the##2##4##(1990-8#2)
phases by##5##2##(1992-9#1)(2008-10#1)(2008-11#2)(2008-12#1)
phases can be##2##3##(2008-10#2)
phases consisted of##2##3##(1990-3#1)(1990-8#1)
phases containing##5##2##(1996-5#3)(2008-10#2)
phases for the##2##3##(2007-12#1)(2008-10#1)
phases for##14##2##(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-11#1)(2011-1#1)
phases have been##2##3##(2008-10#2)
phases in the##7##3##(1996-5#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-7#2)
phases in##13##2##(1992-6#1)(1996-5#2)(2008-10#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#2)
phases involve##2##2##(1996-2#2)
phases is##2##2##(1990-7#1)(2008-3#1)
phases may be##2##3##(1997-2#1)(2008-9#1)
phases of a##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
phases of all##2##3##(1992-2#1)(2008-3#1)
phases of clinical trials##3##4##(2012-12#1)(2012-2#2)
phases of development##2##3##(2008-8#1)(2011-2#1)
phases of different##3##3##(2008-10#2)(2008-3#1)
phases of infection##2##3##(2008-10#1)(2013-1#1)
phases of memory##3##3##(2007-8#3)
phases of menstrual cycle on physical working capacity##2##8##(2012-2#2)
phases of menstrual cycle##3##4##(2012-2#3)
phases of the cell cycle##8##5##(1994-3#1)(2008-11#5)(2008-4#1)(2008-7#1)
phases of the disease##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
phases of the micellar system##3##5##(1990-5#3)
phases of the strategy##3##4##(1996-1#1)(1996-2#1)(2008-11#1)
phases of the##43##3##(1990-2#1)(1990-5#3)(1991-8#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#2)(1996-2#3)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
phases of their##2##3##(1990-5#1)(1992-9#1)
phases of##119##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-2#3)(1996-5#1)(1996-7#1)(2007-11#2)(2007-12#5)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#13)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
phases on the##2##3##(2008-10#1)(2008-3#1)
phases on##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
phases studied##2##2##(1990-12#1)(2008-10#1)
phases that##4##2##(1990-7#1)(1996-5#1)(2008-10#2)
phases to##2##2##(1996-7#1)(2008-10#1)
phases used were##2##3##(1990-8#1)(2008-10#1)
phases was##4##2##(1991-6#1)(2008-10#3)
phases were observed##2##3##(2008-5#1)(2008-7#1)
phases were separated in a##3##5##(2008-10#3)
phases were studied##2##3##(2008-10#2)
phases were used##2##3##(1994-3#1)(2008-10#1)
phases were##19##2##(1993-12#1)(1994-3#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2010-11#1)
phases with high##2##3##(2008-7#1)(2011-1#1)
phases with the##3##3##(2008-10#2)(2008-5#1)
phases with##7##2##(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)
phases##406##1##(1990-12#4)(1990-2#1)(1990-3#5)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#4)(1992-1#2)(1992-2#2)(1992-5#1)(1992-6#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#3)(1994-5#2)(1995-1#1)(1995-12#1)(1995-3#4)(1995-6#1)(1996-1#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#10)(1996-7#2)(1997-2#4)(1997-7#1)(1997-8#1)(2006-4#1)(2007-11#7)(2007-12#14)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#107)(2008-11#30)(2008-12#4)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#19)(2008-6#2)(2008-7#14)(2008-8#7)(2008-9#5)(2009-11#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-11#5)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#8)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#15)(2012-3#2)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#10)
phases'##2##1##(2008-11#2)
phasic inhibition##2##2##(2008-11#1)(2011-2#1)
phasic signals##2##2##(1995-12#2)
phasic##10##1##(1995-12#2)(1997-4#3)(2008-11#1)(2010-8#1)(2011-2#3)
phasing of one-wavelength anomalous-scattering data##2##5##(2006-4#2)
phasing of##5##2##(2006-4#2)(2007-12#1)(2008-9#1)(2012-3#1)
phasing out of##2##3##(1994-1#1)(2007-11#1)
phasing##19##1##(1992-4#1)(1994-1#2)(2006-4#2)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-11#1)(2012-3#1)
phasmid##2##1##(1995-3#2)
phasors##2##1##(2008-2#2)
pheasant flocks##2##2##(2007-6#2)
pheasant##5##1##(1990-6#1)(1992-2#1)(2007-6#3)
pheasants##4##1##(1990-9#1)(1996-8#1)(2007-6#2)
phen and##3##2##(1996-2#1)(2008-10#2)
phen##5##1##(1996-2#2)(2008-10#3)
phenacyl ester##2##2##(2008-10#2)
phenacyl##4##1##(2008-10#3)(2008-11#1)
phenanthrene and##2##2##(2008-10#2)
phenanthrene metabolism##2##2##(1994-5#2)
phenanthrene##21##1##(1994-5#5)(2008-10#12)(2008-11#4)
phenanthrene-9##2##1##(2008-11#2)
phenanthrenes##2##1##(2008-10#2)
phenanthroline##3##1##(1990-2#1)(2012-3#2)
phenazine methosulfate##2##2##(1992-3#1)(2008-11#1)
phenazine methosulphate-linked formate dehydrogenase##2##4##(1992-6#2)
phenazine##5##1##(1992-3#1)(1992-6#2)(2008-10#1)(2008-11#1)
phencyclidine##3##1##(1991-1#2)(1991-9#1)
phenelzine##4##1##(1996-7#4)
phenethyl alcohol and##4##3##(2008-5#4)
phenethyl alcohol in##2##3##(2008-5#2)
phenethyl alcohol##9##2##(2008-5#9)
phenethyl##10##1##(1992-8#1)(2008-5#9)
phenethylamine class##2##2##(1995-11#2)
phenethylamine##5##1##(1991-5#1)(1995-11#2)(2008-10#2)
phenetic##5##1##(2008-10#3)(2008-5#1)(2012-2#1)
phenobarbital and##3##2##(1993-11#1)(2008-10#2)
phenobarbital induced##2##2##(1991-5#1)(2007-8#1)
phenobarbital##15##1##(1990-7#1)(1991-5#1)(1993-11#1)(1995-2#2)(2007-8#2)(2008-10#5)(2008-6#2)(2008-8#1)
phenobarbital-induced##2##1##(1993-11#2)
phenobarbitone##2##1##(1994-8#1)(2008-10#1)
phenogram##4##1##(2008-10#2)(2008-5#2)
phenol and catechol##5##3##(2008-10#5)
phenol and##18##2##(1992-8#1)(1994-12#1)(2008-10#9)(2008-3#3)(2008-8#1)(2012-1#3)
phenol as a##3##3##(1997-2#1)(2008-10#2)
phenol as##5##2##(1997-2#1)(2008-10#4)
phenol compounds##2##2##(2008-10#2)
phenol concentration##3##2##(2008-10#1)(2008-3#2)
phenol degradation##2##2##(1991-7#1)(1994-12#1)
phenol derivatives##4##2##(1990-8#1)(2008-10#2)(2009-12#1)
phenol extraction##3##2##(2008-1#1)(2008-2#2)
phenol in the##2##3##(2008-10#2)
phenol in##9##2##(2008-10#9)
phenol is##3##2##(1996-2#1)(2008-10#2)
phenol ring##2##2##(2008-8#2)
phenol sulphotransferase##3##2##(1994-11#3)
phenol##115##1##(1990-12#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-11#3)(1994-12#4)(1994-5#3)(1996-2#2)(1997-2#3)(2008-1#1)(2008-10#71)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#4)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)
phenolate ligands##3##2##(1996-2#3)
phenolate##10##1##(1990-5#1)(1996-2#7)(1997-7#1)(2008-10#1)
phenolic OH groups##4##3##(2008-10#4)
phenolic OH##5##2##(2008-10#5)
phenolic acid##3##2##(2008-10#1)(2008-5#2)
phenolic acids and##3##3##(2008-10#3)
phenolic acids##14##2##(2008-10#12)(2008-11#1)(2011-2#1)
phenolic antioxidants##4##2##(2008-10#4)
phenolic benzylamines##3##2##(2008-5#3)
phenolic compound##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
phenolic compounds and##4##3##(2008-10#4)
phenolic compounds have##2##3##(2008-10#2)
phenolic compounds in the##2##4##(1994-5#1)(2008-10#1)
phenolic compounds in##11##3##(1994-5#1)(2008-10#7)(2011-1#1)(2011-2#2)
phenolic compounds present in##2##4##(2008-10#2)
phenolic compounds was##2##3##(2008-10#1)(2011-1#1)
phenolic compounds were##3##3##(2008-10#2)(2009-6#1)
phenolic compounds with##3##3##(2008-10#3)
phenolic compounds##63##2##(1991-5#1)(1994-5#3)(2008-10#45)(2008-11#1)(2009-6#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#1)
phenolic content in##2##3##(2010-5#1)(2013-1#1)
phenolic content of##4##3##(2008-10#3)(2008-11#1)
phenolic content was##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
phenolic content##12##2##(2008-10#6)(2008-11#1)(2009-6#1)(2010-5#1)(2013-1#3)
phenolic contents##6##2##(2008-11#1)(2012-2#3)(2013-8#2)
phenolic groups##2##2##(2008-10#2)
phenolic hydroxyl##2##2##(2008-10#1)(2008-9#1)
phenolic monomers##3##2##(2011-1#1)(2011-2#2)
phenolic substance from##2##3##(2008-5#2)
phenolic substance##7##2##(2008-5#7)
phenolic##154##1##(1990-5#2)(1991-5#1)(1992-3#2)(1992-9#1)(1994-5#3)(1996-5#1)(2008-10#91)(2008-11#6)(2008-5#13)(2008-7#1)(2008-9#1)(2009-6#3)(2009-7#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#2)
phenolics and##2##2##(2008-10#2)
phenolics in##3##2##(2008-10#2)(2008-11#1)
phenolics is##2##2##(2008-10#2)
phenolics were##2##2##(2008-10#2)
phenolics##29##1##(1997-4#1)(2008-10#15)(2008-11#3)(2008-4#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)
phenological##9##1##(2008-10#4)(2008-5#2)(2011-2#1)(2012-6#2)
phenology in##2##2##(2008-10#1)(2012-6#1)
phenology of##6##2##(2008-10#3)(2008-5#2)(2012-2#1)
phenology##18##1##(2008-10#10)(2008-5#3)(2008-8#2)(2012-2#1)(2012-6#2)
phenolphthalein##7##1##(2007-12#1)(2008-10#6)
phenols and related compounds##5##4##(2008-10#5)
phenols and##15##2##(1994-9#1)(1996-12#1)(2008-10#13)
phenols by##3##2##(2008-10#3)
phenols from##3##2##(2008-10#3)
phenols in air##3##3##(2008-10#3)
phenols in the##2##3##(2008-10#2)
phenols in##8##2##(2008-10#8)
phenols is##2##2##(1994-5#1)(2011-1#1)
phenols on the##2##3##(2008-10#2)
phenols to##2##2##(2008-10#1)(2011-1#1)
phenols using##4##2##(2008-10#4)
phenols was##2##2##(2008-10#2)
phenols were##4##2##(1990-8#1)(2008-10#2)(2008-6#1)
phenols with##4##2##(2008-10#4)
phenols##85##1##(1990-8#1)(1994-5#2)(1994-9#3)(1996-12#1)(2008-10#71)(2008-11#1)(2008-6#2)(2011-1#4)
phenomena among##2##2##(2008-7#1)(2013-1#1)
phenomena and##11##2##(1995-11#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2013-1#1)
phenomena are involved##2##3##(2008-7#1)(2008-9#1)
phenomena are##7##2##(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)
phenomena as##2##2##(2010-10#1)(2013-8#1)
phenomena being##2##2##(1991-12#1)(2009-7#1)
phenomena between##2##2##(2008-10#1)(2010-12#1)
phenomena by##2##2##(2007-12#1)(2008-2#1)
phenomena can be##2##3##(2008-3#1)(2010-11#1)
phenomena can##3##2##(2008-3#1)(2008-8#1)(2010-11#1)
phenomena discovered in##2##3##(2007-8#1)(2009-8#1)
phenomena due to##3##3##(2009-12#1)(2009-8#1)(2011-2#1)
phenomena have been##2##3##(1991-5#1)(2008-2#1)
phenomena have##3##2##(1991-5#1)(2008-2#1)(2008-7#1)
phenomena in a##2##3##(2008-3#1)(2010-4#1)
phenomena in the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
phenomena in##26##2##(1990-2#1)(1990-8#1)(1994-5#1)(1996-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-7#3)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-2#1)
phenomena including##2##2##(1996-4#1)(2008-3#1)
phenomena is##5##2##(1995-3#1)(2008-1#1)(2008-11#1)(2008-3#2)
phenomena observed##2##2##(2008-11#1)(2008-7#1)
phenomena occurred##2##2##(2008-10#2)
phenomena of##14##2##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-10#1)(2010-11#1)(2012-2#1)
phenomena on##2##2##(2007-8#1)(2008-7#1)
phenomena related to##2##3##(2008-11#1)(2008-2#1)
phenomena should##3##2##(2009-7#1)(2010-11#1)(2012-3#1)
phenomena such as##6##3##(1996-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-2#1)
phenomena that are##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
phenomena that##13##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
phenomena was##4##2##(1991-12#1)(2008-10#1)(2008-3#2)
phenomena we##2##2##(2007-11#1)(2008-7#1)
phenomena were observed##2##3##(2008-10#2)
phenomena were##3##2##(1992-12#1)(2008-10#2)
phenomena which##2##2##(1990-11#1)(2008-10#1)
phenomena##256##1##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#4)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#2)(2007-11#11)(2007-12#7)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#11)(2008-12#1)(2008-2#19)(2008-3#28)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#24)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#5)(2009-8#3)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#4)(2010-7#1)(2011-2#7)(2012-1#1)(2012-2#9)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
phenomena)##2##1##(2008-10#1)(2008-7#1)
phenomenal##3##1##(1991-3#1)(1997-1#1)(2008-12#1)
phenomenographic##2##1##(2008-12#1)(2012-1#1)
phenomenological and##2##2##(2008-3#1)(2008-6#1)
phenomenological approach to##2##3##(2007-11#1)(2010-3#1)
phenomenological approach##8##2##(2007-11#2)(2008-2#2)(2009-9#1)(2010-10#1)(2010-3#1)(2013-1#1)
phenomenological model##3##2##(2008-2#1)(2008-3#2)
phenomenological study investigated the##2##4##(2008-11#1)(2010-11#1)
phenomenological study was##2##3##(2008-11#1)(2009-5#1)
phenomenological study##11##2##(2008-11#4)(2008-12#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
phenomenological##42##1##(1990-8#1)(1995-8#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
phenomenological-hermeneutic##2##1##(2010-10#1)(2013-1#1)
phenomenologically##2##1##(1997-2#1)(2008-3#1)
phenomenology and##2##2##(2008-12#1)(2010-8#1)
phenomenology of the##2##3##(1996-4#1)(2010-6#1)
phenomenology of##3##2##(1996-4#1)(2008-11#1)(2010-6#1)
phenomenology##11##1##(1996-4#1)(2008-11#3)(2008-12#1)(2008-8#1)(2010-6#1)(2010-7#1)(2010-8#2)(2013-8#1)
phenomenon also##2##2##(1997-2#1)(2008-7#1)
phenomenon and the##3##3##(2008-7#1)(2012-12#2)
phenomenon and##12##2##(1992-5#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-7#1)(2012-12#2)(2012-2#1)
phenomenon are##4##2##(1992-1#1)(1997-6#1)(2007-11#1)(2008-11#1)
phenomenon by##3##2##(1992-9#1)(2008-11#1)(2008-2#1)
phenomenon called##4##2##(1994-11#1)(2008-7#1)(2008-9#1)(2009-10#1)
phenomenon can##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
phenomenon commonly##2##2##(2008-12#1)(2010-4#1)
phenomenon could##4##2##(1990-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
phenomenon depends##2##2##(1990-11#1)(2007-11#1)
phenomenon during the##2##3##(2008-10#1)(2008-8#1)
phenomenon enables##2##2##(2008-10#1)(2010-4#1)
phenomenon for##3##2##(2008-11#1)(2008-3#2)
phenomenon has been described in##2##5##(2007-7#1)(2012-2#1)
phenomenon has been##7##3##(2007-11#2)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
phenomenon has##8##2##(2007-11#2)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
phenomenon in humans##2##3##(2008-11#1)(2010-4#1)
phenomenon in the##6##3##(1995-5#1)(1997-4#1)(2008-12#1)(2008-2#1)(2010-10#1)(2013-8#1)
phenomenon in which##3##3##(2008-2#1)(2008-7#1)(2009-10#1)
phenomenon in##29##2##(1992-8#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-7#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
phenomenon is a##3##3##(1994-11#1)(1995-5#1)(2012-2#1)
phenomenon is not##2##3##(2008-10#1)(2008-4#1)
phenomenon is##33##2##(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
phenomenon known as &quot##2##4##(2011-2#1)(2012-2#1)
phenomenon known as##5##3##(1996-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
phenomenon known##6##2##(1996-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
phenomenon may be##7##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#2)
phenomenon may##10##2##(1991-6#1)(1992-12#1)(1992-2#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#2)
phenomenon observed in##2##3##(2007-11#1)(2007-12#1)
phenomenon occurs##4##2##(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)
phenomenon of late-arising##2##3##(2008-9#2)
phenomenon of multiple##2##3##(2007-12#1)(2009-8#1)
phenomenon of the##4##3##(1994-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
phenomenon of##53##2##(1992-7#1)(1993-2#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-4#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)
phenomenon requires##2##2##(2008-12#1)(2013-1#1)
phenomenon that can##2##3##(2008-10#1)(2008-3#1)
phenomenon that may##2##3##(1992-12#1)(1997-3#1)
phenomenon that we##2##3##(2008-5#1)(2012-2#1)
phenomenon that##18##2##(1992-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
phenomenon to##3##2##(1994-5#1)(2007-12#1)(2008-7#1)
phenomenon was observed for##2##4##(2008-10#1)(2008-12#1)
phenomenon was observed##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
phenomenon was present in##2##4##(2007-11#1)(2008-8#1)
phenomenon was##17##2##(1990-5#2)(1995-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#2)(2013-1#1)
phenomenon which##3##2##(1990-6#1)(2008-11#1)(2010-4#1)
phenomenon##396##1##(1990-11#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#4)(1996-2#3)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2007-11#17)(2007-12#12)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#40)(2008-11#18)(2008-12#7)(2008-2#17)(2008-3#18)(2008-4#6)(2008-5#11)(2008-6#6)(2008-7#31)(2008-8#11)(2008-9#17)(2009-10#4)(2009-11#2)(2009-12#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#17)(2011-3#1)(2012-12#4)(2012-2#13)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#4)
phenophases##4##1##(2008-1#1)(2012-6#3)
phenothiazine derivatives in##4##3##(2008-10#4)
phenothiazine derivatives##10##2##(2008-10#10)
phenothiazine drugs##2##2##(2008-10#2)
phenothiazine##15##1##(2008-10#15)
phenothiazines##10##1##(1991-8#1)(2008-10#8)(2011-3#1)
phenotype alterations##2##2##(2008-4#2)
phenotype and a##2##3##(2008-9#1)(2011-2#1)
phenotype and are##2##3##(2008-11#1)(2009-5#1)
phenotype and genotype##2##3##(2008-4#2)
phenotype and the##3##3##(2007-7#1)(2008-3#1)(2011-2#1)
phenotype and##40##2##(1992-9#1)(1994-12#1)(1995-2#3)(1997-3#1)(1997-7#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
phenotype as##3##2##(1992-3#1)(2008-8#2)
phenotype associated with##2##3##(2008-10#1)(2013-8#1)
phenotype between##2##2##(2008-10#1)(2009-8#1)
phenotype but##3##2##(1996-12#1)(2012-3#1)(2013-8#1)
phenotype by##4##2##(1992-9#1)(1995-9#1)(1997-3#1)(2008-5#1)
phenotype can##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
phenotype change##2##2##(2008-10#1)(2013-1#1)
phenotype characterized by##2##3##(2013-1#1)(2013-8#1)
phenotype exhibited##2##2##(2008-10#2)
phenotype expression##3##2##(2012-2#2)(2013-1#1)
phenotype for##2##2##(1995-8#1)(2008-10#1)
phenotype from##2##2##(2008-10#1)(2012-2#1)
phenotype have##2##2##(2008-10#1)(2008-11#1)
phenotype in a##2##3##(1990-11#1)(1993-12#1)
phenotype in the##3##3##(1990-5#1)(1995-8#1)(2008-10#1)
phenotype in this##3##3##(1992-3#1)(2008-10#1)(2011-1#1)
phenotype in##27##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-3#1)(1993-12#2)(1995-11#2)(1995-6#1)(1995-8#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-8#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
phenotype is a##2##3##(2009-3#1)(2012-3#1)
phenotype is##18##2##(1991-12#1)(1991-9#1)(1994-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
phenotype matching##2##2##(2008-8#1)(2012-2#1)
phenotype may be##3##3##(1997-3#1)(2007-7#1)(2011-1#1)
phenotype may##6##2##(1994-11#1)(1997-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-2#1)
phenotype network##3##2##(2011-1#3)
phenotype of LS##2##3##(2008-1#1)(2012-3#1)
phenotype of a##4##3##(1994-12#2)(2008-9#1)(2009-6#1)
phenotype of cells##2##3##(1994-11#1)(1996-5#1)
phenotype of the##12##3##(1993-9#1)(1994-3#1)(1996-12#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#2)
phenotype of their##2##3##(2008-11#1)(2011-1#1)
phenotype of##59##2##(1990-11#1)(1992-9#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#4)(1997-8#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
phenotype or##4##2##(1994-10#1)(2008-10#1)(2008-4#1)(2010-11#1)
phenotype rather than##2##3##(2008-11#1)(2008-12#1)
phenotype should##2##2##(2008-10#1)(2010-7#1)
phenotype similar to that##2##4##(1993-9#1)(2009-10#1)
phenotype that is##2##3##(2009-6#1)(2012-3#1)
phenotype that##4##2##(1994-12#1)(2007-12#1)(2009-6#1)(2012-3#1)
phenotype through##2##2##(2010-4#1)(2013-1#1)
phenotype to the##2##3##(2008-10#1)(2012-2#1)
phenotype to##3##2##(1993-9#1)(2008-10#1)(2012-2#1)
phenotype was also##2##3##(1995-2#1)(1996-12#1)
phenotype was dependent on the##2##5##(1995-2#1)(1997-7#1)
phenotype was due to##2##4##(1997-4#1)(2008-10#1)
phenotype was more##2##3##(2007-2#1)(2008-10#1)
phenotype was not##2##3##(1997-3#1)(2008-10#1)
phenotype was##25##2##(1993-12#1)(1995-2#4)(1996-12#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#2)(2012-3#1)(2013-1#2)
phenotype were##6##2##(1991-6#1)(1993-9#1)(1995-8#1)(2008-10#2)(2012-1#1)
phenotype with##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
phenotype##470##1##(1990-11#2)(1990-12#1)(1990-5#6)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#3)(1992-6#1)(1992-9#3)(1993-12#6)(1993-3#1)(1993-9#5)(1994-10#1)(1994-11#4)(1994-12#11)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#4)(1995-2#10)(1995-3#1)(1995-6#3)(1995-8#9)(1995-9#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#18)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#72)(2008-11#30)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#6)(2008-6#5)(2008-7#10)(2008-8#20)(2008-9#19)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-5#3)(2009-6#4)(2009-8#7)(2009-9#1)(2010-11#4)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#16)(2011-2#10)(2012-1#3)(2012-12#5)(2012-2#15)(2012-3#20)(2012-7#1)(2013-1#20)(2013-8#6)
phenotype) and##2##2##(2008-8#1)(2009-3#1)
phenotype)##3##1##(1992-3#1)(2008-8#1)(2009-3#1)
phenotype/genotype##2##1##(2008-8#1)(2011-1#1)
phenotyped##2##1##(1994-3#1)(2008-10#1)
phenotypes across##2##2##(2008-8#1)(2010-5#1)
phenotypes and present##2##3##(1995-11#1)(2008-9#1)
phenotypes and##15##2##(1993-3#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)
phenotypes are also##2##3##(2008-11#1)(2009-8#1)
phenotypes associated with##2##3##(2008-4#1)(2010-2#1)
phenotypes by the##2##3##(2008-10#2)
phenotypes by##4##2##(1993-11#1)(2008-1#1)(2008-10#2)
phenotypes can be##3##3##(2008-8#1)(2009-5#1)(2011-1#1)
phenotypes can##4##2##(2008-8#2)(2009-5#1)(2011-1#1)
phenotypes exhibited##2##2##(1994-12#1)(1996-12#1)
phenotypes for##4##2##(2010-1#1)(2012-2#1)(2012-3#2)
phenotypes in the##4##3##(2008-10#1)(2009-8#1)(2010-4#1)(2012-3#1)
phenotypes in their##2##3##(2008-8#1)(2008-9#1)
phenotypes in##16##2##(1991-12#1)(2008-10#2)(2008-8#4)(2008-9#1)(2009-8#2)(2010-4#1)(2010-5#2)(2012-2#1)(2012-3#1)(2013-1#1)
phenotypes is##3##2##(2008-8#1)(2009-5#1)(2012-3#1)
phenotypes of V##2##3##(2008-10#2)
phenotypes of the##4##3##(1993-9#1)(1995-8#1)(2008-10#1)(2008-9#1)
phenotypes of##29##2##(1991-9#1)(1993-9#1)(1995-8#1)(1996-2#1)(2008-10#5)(2008-11#5)(2008-4#2)(2008-6#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
phenotypes on##3##2##(2008-10#3)
phenotypes that##7##2##(1995-8#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-1#1)
phenotypes to##3##2##(2008-10#2)(2009-5#1)
phenotypes was##2##2##(1997-8#1)(2008-5#1)
phenotypes were##12##2##(1992-9#1)(1996-12#1)(1997-8#1)(2008-10#7)(2008-5#1)(2008-8#1)
phenotypes will##2##2##(2009-10#1)(2013-1#1)
phenotypes with##2##2##(2008-10#1)(2008-8#1)
phenotypes##250##1##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-11#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#4)(1996-2#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#2)(2007-10#1)(2007-6#1)(2008-1#3)(2008-10#46)(2008-11#16)(2008-3#3)(2008-4#8)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#35)(2008-9#9)(2009-10#2)(2009-3#1)(2009-5#3)(2009-8#9)(2009-9#3)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#3)(2010-7#2)(2011-1#11)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#7)(2013-8#1)
phenotypes)##3##1##(2008-10#3)
phenotypic analyses of##2##3##(2008-10#1)(2008-4#1)
phenotypic analyses##4##2##(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
phenotypic analysis of the##2##4##(2008-10#1)(2008-7#1)
phenotypic analysis of##4##3##(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
phenotypic analysis##7##2##(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)
phenotypic and genetic##4##3##(2008-10#1)(2009-5#1)(2009-8#1)(2011-2#1)
phenotypic and genotypic##5##3##(2008-10#3)(2008-12#1)(2008-8#1)
phenotypic and##14##2##(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#2)(2011-2#1)
phenotypic changes in##3##3##(1991-5#1)(1996-12#1)(2013-1#1)
phenotypic changes##7##2##(1991-5#1)(1996-12#1)(2008-10#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
phenotypic characteristics##5##2##(2007-10#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
phenotypic characterization of##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
phenotypic characters##3##2##(2008-10#2)(2008-8#1)
phenotypic class##2##2##(2008-10#2)
phenotypic consequences##2##2##(2008-8#1)(2010-7#1)
phenotypic correlation##2##2##(2008-10#1)(2008-9#1)
phenotypic data##7##2##(2008-7#1)(2008-8#3)(2010-2#2)(2012-3#1)
phenotypic differences##5##2##(1991-6#1)(2008-10#2)(2008-5#1)(2009-5#1)
phenotypic divergence along##2##3##(2012-3#2)
phenotypic divergence##4##2##(2012-3#3)(2013-1#1)
phenotypic diversity##7##2##(1993-3#1)(2008-10#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#1)
phenotypic effect of##2##3##(2012-3#1)(2013-1#1)
phenotypic effects of the mutation in##2##6##(1993-8#1)(1993-9#1)
phenotypic effects of##3##3##(1993-8#1)(1993-9#1)(2013-1#1)
phenotypic effects##6##2##(1993-8#1)(1993-9#1)(2007-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
phenotypic evolution##2##2##(2010-4#2)
phenotypic expression of##3##3##(1996-12#1)(1996-5#1)(2013-1#1)
phenotypic features##6##2##(2007-7#1)(2008-11#1)(2008-8#1)(2012-3#3)
phenotypic groups##2##2##(2008-10#2)
phenotypic heterogeneity of##3##3##(1992-2#1)(2007-10#1)(2007-7#1)
phenotypic heterogeneity##4##2##(1992-2#1)(2007-10#1)(2007-7#1)(2012-3#1)
phenotypic marker##2##2##(1997-6#1)(2008-10#1)
phenotypic methods##2##2##(2008-8#1)(2011-2#1)
phenotypic plasticity in##4##3##(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)
phenotypic plasticity##14##2##(2008-10#1)(2008-8#4)(2008-9#4)(2009-6#2)(2010-3#2)(2012-12#1)
phenotypic profile##2##2##(1991-2#1)(2008-7#1)
phenotypic ratios##3##2##(2008-10#3)
phenotypic response##2##2##(2008-10#1)(2008-11#1)
phenotypic selection##6##2##(2008-8#5)(2013-1#1)
phenotypic specialization##6##2##(2008-8#5)(2008-9#1)
phenotypic specializations##2##2##(2008-9#2)
phenotypic switching##2##2##(2009-9#2)
phenotypic traits##7##2##(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#3)
phenotypic transformation##4##2##(1991-12#3)(1993-2#1)
phenotypic uniformity##2##2##(2008-10#2)
phenotypic variability##6##2##(2008-10#3)(2008-8#1)(2009-9#1)(2013-8#1)
phenotypic variance of##2##3##(2008-10#1)(2012-3#1)
phenotypic variance##15##2##(2008-10#12)(2008-8#2)(2012-3#1)
phenotypic variation for resistance in##3##5##(2008-10#3)
phenotypic variation for resistance##5##4##(2008-10#5)
phenotypic variation for##9##3##(2008-10#9)
phenotypic variation in##4##3##(1995-2#1)(2008-10#2)(2013-7#1)
phenotypic variation within##2##3##(2009-6#1)(2012-3#1)
phenotypic variation##28##2##(1995-2#1)(2007-7#1)(2008-10#21)(2008-8#1)(2009-6#1)(2012-3#2)(2013-7#1)
phenotypic##264##1##(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1995-2#2)(1995-4#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-12#1)(2007-7#3)(2008-10#79)(2008-11#4)(2008-12#2)(2008-4#5)(2008-5#4)(2008-7#10)(2008-8#37)(2008-9#13)(2009-10#1)(2009-5#4)(2009-6#5)(2009-8#2)(2009-9#3)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#3)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#7)(2012-3#20)(2013-1#14)(2013-7#1)(2013-8#2)
phenotypical##4##1##(1995-8#1)(2008-10#1)(2008-11#1)(2010-3#1)
phenotypically and genotypically##2##3##(1991-6#1)(2008-12#1)
phenotypically and##6##2##(1991-6#1)(2008-10#3)(2008-12#1)(2013-8#1)
phenotypically consistent with Trichophyton rubrum var##2##6##(2009-2#2)
phenotypically diverse endothelial cells##2##4##(1993-3#2)
phenotypically diverse##3##2##(1993-3#2)(2011-1#1)
phenotypically from##2##2##(2008-10#1)(2008-9#1)
phenotypically similar to##2##3##(2008-10#2)
phenotypically##30##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1993-3#2)(1997-3#1)(1997-8#1)(2008-10#10)(2008-12#1)(2008-8#1)(2008-9#4)(2009-2#2)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
phenotyping of##3##2##(2008-4#1)(2008-8#1)(2011-1#1)
phenotyping test##2##2##(2008-2#1)(2008-4#1)
phenotyping##23##1##(1994-3#3)(1995-8#1)(1996-9#1)(2008-10#3)(2008-2#4)(2008-4#2)(2008-8#2)(2008-9#4)(2011-1#1)(2012-2#1)(2012-4#1)
phenoxodiol##4##1##(2009-9#4)
phenoxy##3##1##(2008-10#3)
phenoxy-propionic acid##2##2##(2008-10#2)
phenoxyl free radicals##2##3##(2008-10#2)
phenoxyl free##3##2##(2008-10#3)
phenoxyl radicals are##2##3##(2008-10#2)
phenoxyl radicals generated in##2##4##(2008-10#2)
phenoxyl radicals##7##2##(2008-10#6)(2008-9#1)
phenoxyl##13##1##(2007-11#2)(2008-10#9)(2008-8#1)(2008-9#1)
phenoxypropionic acid##2##2##(2008-10#2)
phenoxythiocarbonyl##2##1##(1996-5#1)(2008-4#1)
phenprocoumon##2##1##(1997-8#1)(2007-8#1)
phentolamine##3##1##(1990-5#1)(1995-12#1)(2013-1#1)
phenyl and##3##2##(2008-10#2)(2010-2#1)
phenyl column##2##2##(2008-10#2)
phenyl group##4##2##(1995-3#1)(2008-10#3)
phenyl ring##6##2##(1994-12#1)(1995-11#1)(1995-5#2)(2008-10#1)(2013-1#1)
phenyl rings##7##2##(1997-7#5)(2008-8#2)
phenyl##47##1##(1994-12#1)(1995-11#1)(1995-3#2)(1995-5#2)(1996-12#2)(1996-5#1)(1997-7#6)(2007-11#2)(2008-10#17)(2008-4#1)(2008-8#2)(2009-11#2)(2009-12#1)(2010-2#3)(2011-1#1)(2012-2#2)(2013-1#1)
phenyl-4##2##1##(2011-1#2)
phenyl-mercury##2##1##(2008-10#2)
phenyl]##2##1##(2008-10#2)
phenylacetic acid##3##2##(1995-3#1)(1996-5#1)(2007-11#1)
phenylalanine ammonia lyase (PAL)##2##4##(2008-10#2)
phenylalanine ammonia lyase activity##2##4##(2008-10#2)
phenylalanine ammonia lyase and##2##4##(2008-10#2)
phenylalanine ammonia lyase##9##3##(2008-10#9)
phenylalanine in##3##2##(1992-9#1)(1993-9#1)(1995-3#1)
phenylalanine residue##2##2##(1990-8#1)(1994-5#1)
phenylalanine was##2##2##(1995-3#1)(2008-10#1)
phenylalanine##40##1##(1990-11#1)(1990-8#1)(1991-2#1)(1992-9#2)(1993-9#1)(1994-5#2)(1994-6#3)(1995-3#2)(1997-7#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#3)
phenylalanine-156##2##1##(1995-2#2)
phenylalanyl##3##1##(1990-2#1)(1993-6#1)(2013-1#1)
phenylalkyl carboxylic acids##3##3##(2011-1#3)
phenylarsine oxide (PhAsO)##2##3##(1994-8#2)
phenylarsine oxide##5##2##(1993-6#2)(1994-8#2)(1995-5#1)
phenylboronate affinity##2##2##(1991-5#1)(2010-2#1)
phenylboronate##3##1##(1991-5#1)(2008-7#1)(2010-2#1)
phenylene diamine##2##2##(2008-10#1)(2008-5#1)
phenylephrine and##2##2##(1991-6#1)(1997-7#1)
phenylephrine in##2##2##(1991-6#1)(2013-8#1)
phenylephrine was##2##2##(1991-3#1)(2011-2#1)
phenylephrine##36##1##(1990-12#1)(1991-3#4)(1991-6#2)(1994-3#5)(1994-6#1)(1995-12#4)(1997-7#2)(2007-10#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
phenylephrine-induced##4##1##(1990-12#1)(1995-12#1)(1997-7#2)
phenylethanolamine N-methyltransferase##3##2##(1991-5#1)(1996-5#1)(2013-1#1)
phenylethanolamine##4##1##(1991-5#2)(1996-5#1)(2013-1#1)
phenylethyl##2##1##(2008-10#1)(2008-9#1)
phenylglycine##2##1##(1995-12#1)(2008-8#1)
phenylglyoxal##2##1##(1990-11#1)(1992-12#1)
phenylhydrazine and##2##2##(2008-10#2)
phenylhydrazine to##2##2##(2008-10#1)(2010-4#1)
phenylhydrazine##15##1##(1991-12#1)(2008-10#12)(2008-11#1)(2010-4#1)
phenylhydrazone##4##1##(1992-6#1)(1993-9#1)(2008-10#2)
phenylmercury##11##1##(2008-10#11)
phenylmethanesulfonyl fluoride##4##2##(1992-8#1)(1994-6#1)(1994-9#1)(1995-5#1)
phenylmethylsulfonyl fluoride##2##2##(1991-12#1)(1996-2#1)
phenylpropanoid glycoside##2##2##(2008-9#2)
phenylpropanoid##4##1##(2008-10#2)(2008-9#2)
phenylpropanolamine and##4##2##(2008-10#4)
phenylpyrroles##2##1##(2008-10#2)
phenylthiohydantoin##2##1##(1994-9#1)(2008-10#1)
phenylurea herbicides##3##2##(2008-10#3)
phenylurea##4##1##(2008-10#4)
phenytoin (20 mg/kg)##2##3##(1995-12#1)(2010-3#1)
phenytoin Na emulsion##2##3##(2008-11#2)
phenytoin Na##3##2##(2008-11#3)
phenytoin and sodium valproate##2##4##(1995-12#2)
phenytoin and##3##2##(1995-12#2)(2008-8#1)
phenytoin in##5##2##(1994-2#1)(2008-10#3)(2008-11#1)
phenytoin suspension##3##2##(2008-11#3)
phenytoin therapy##2##2##(2008-7#2)
phenytoin was##2##2##(1994-2#2)
phenytoin with##2##2##(1994-2#1)(2008-11#1)
phenytoin##54##1##(1990-5#5)(1994-2#8)(1995-12#3)(2007-12#1)(2008-10#9)(2008-11#17)(2008-7#7)(2008-8#2)(2010-3#1)(2011-1#1)
pheochromocytoma (PC12) cells##3##3##(1992-12#1)(2008-4#1)(2013-8#1)
pheochromocytoma and papillary adenocarcinoma of the thyroid in a##2##9##(1992-2#2)
pheochromocytoma and##3##2##(1992-2#2)(2009-1#1)
pheochromocytoma cell line##7##3##(1990-5#1)(1993-8#1)(1994-11#1)(2008-11#4)
pheochromocytoma cells##6##2##(1994-6#1)(1995-2#1)(1997-2#1)(2008-11#2)(2013-8#1)
pheochromocytoma##32##1##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#3)(1993-8#1)(1994-11#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#6)(2008-4#1)(2009-1#4)(2012-12#2)(2012-2#1)(2013-8#2)
pheochromocytomas##2##1##(1995-11#1)(2012-2#1)
pheophytin a##3##2##(2008-11#3)
pheophytin##7##1##(2008-11#3)(2008-8#2)(2008-9#2)
pheophytins##2##1##(2008-9#2)
pheromone biosynthesis activating neuropeptide (PBAN)##2##5##(2007-12#1)(2008-9#1)
pheromone biosynthesis##4##2##(1990-7#1)(2007-12#2)(2008-9#1)
pheromone blend##3##2##(2008-10#3)
pheromone components of##2##3##(2008-10#2)
pheromone components##4##2##(2008-10#4)
pheromone from##2##2##(1990-11#1)(2008-10#1)
pheromone gland##4##2##(2007-12#1)(2008-10#3)
pheromone in the##2##3##(2008-10#1)(2008-6#1)
pheromone in##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
pheromone is##3##2##(1990-8#1)(2008-6#1)(2013-8#1)
pheromone##56##1##(1990-11#3)(1990-7#1)(1990-8#3)(1991-5#3)(1994-12#2)(1996-2#1)(1997-4#2)(2007-12#7)(2008-10#19)(2008-6#5)(2008-8#1)(2008-9#1)(2009-7#3)(2011-2#4)(2013-8#1)
pheromone-baited##2##1##(2011-2#2)
pheromone-binding protein from the silkworm moth##2##6##(2008-10#2)
pheromone-binding protein from##3##3##(2008-10#2)(2009-7#1)
pheromone-binding protein##4##2##(2008-10#3)(2009-7#1)
pheromone-binding##5##1##(2008-10#3)(2009-7#2)
pheromone-producing##2##1##(1990-11#1)(2007-12#1)
pheromones##11##1##(1990-11#1)(1990-8#2)(2008-10#7)(2009-9#1)
phi &gt##3##2##(1996-12#2)(2008-10#1)
phi &lt##4##2##(1996-12#2)(2008-3#2)
phi = 0##3##3##(1991-11#1)(2008-3#2)
phi C3208##2##2##(1993-9#2)
phi X174 DNA##2##3##(1991-5#2)
phi X174##7##2##(1991-5#7)
phi angle##3##2##(1992-4#2)(2008-3#1)
phi coefficient##2##2##(2008-10#1)(2010-1#1)
phi is##2##2##(1995-3#1)(2007-12#1)
phi of##2##2##(1993-3#1)(2008-3#1)
phi values##5##2##(1996-12#3)(2008-11#1)(2008-3#1)
phi was##2##2##(2008-3#2)
phi##58##1##(1991-11#1)(1991-12#1)(1991-5#7)(1992-4#3)(1993-3#2)(1993-9#2)(1994-5#1)(1995-3#3)(1995-5#1)(1996-12#9)(2007-12#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#13)(2010-1#1)(2011-2#1)
phi)##2##1##(1994-11#1)(2011-2#1)
phi-x174##2##1##(1997-6#2)
phi29 DNA packaging motor##2##4##(2010-5#2)
phiNHOH##2##1##(2008-10#2)
philanthotoxin##2##1##(1990-7#1)(2008-8#1)
philanthropic and##2##2##(1995-2#1)(2009-4#1)
philanthropic##7##1##(1992-1#1)(1995-1#1)(1995-2#1)(2008-11#1)(2008-8#1)(2009-4#2)
philanthropy##12##1##(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#3)(1995-3#3)(1997-3#1)
philippensis##3##1##(2008-5#3)
philopatric offspring##2##2##(2008-8#2)
philopatric##4##1##(2008-8#4)
philopatry and altruism##2##3##(2008-8#2)
philopatry and##3##2##(2008-8#3)
philopatry##7##1##(2008-8#7)
philosopher Michel##2##2##(1993-11#1)(2012-3#1)
philosopher##5##1##(1990-8#1)(1993-11#1)(2008-12#1)(2012-12#1)(2012-3#1)
philosophers##9##1##(2008-1#1)(2009-6#1)(2010-12#4)(2011-2#3)
philosophical and##4##2##(2008-10#1)(2008-7#3)
philosophical ideas##2##2##(2008-12#1)(2008-4#1)
philosophical literature##3##2##(1990-12#1)(2012-2#2)
philosophical##24##1##(1990-12#1)(1992-12#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#5)(2010-11#1)(2012-2#5)(2013-8#1)
philosophies and##2##2##(1992-3#1)(1993-1#1)
philosophies##5##1##(1992-3#1)(1993-1#1)(1995-1#1)(1997-3#1)(2008-10#1)
philosophy and##5##2##(1992-2#1)(1994-1#1)(1994-2#1)(2008-11#1)(2008-12#1)
philosophy for##2##2##(1995-1#1)(1996-1#1)
philosophy of##8##2##(1991-1#1)(1991-12#2)(1993-2#1)(1994-12#1)(1997-3#1)(2010-9#1)(2012-2#1)
philosophy##48##1##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-2#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-3#1)(2008-11#3)(2008-12#5)(2008-6#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
phimosis##2##1##(2008-10#2)
phlA'-'lacZ##2##1##(2008-10#2)
phlD##12##1##(2008-10#12)
phlD(+)##3##1##(2008-10#3)
phlD+ pseudomonads in no-till##2##4##(2008-10#2)
phlD+ pseudomonads in##3##3##(2008-10#3)
phlD+ pseudomonads##4##2##(2008-10#4)
phlD+##5##1##(2008-10#5)
phlD-specific PCR-based##2##2##(2008-10#2)
phlD-specific##3##1##(2008-10#3)
phlebitis##4##1##(2010-11#1)(2013-1#3)
phlebothrombosis##2##1##(2007-8#1)(2008-11#1)
phlebotomine##3##1##(2008-8#2)(2013-1#1)
phlebotomy##2##1##(2009-8#1)(2010-8#1)
phlegm##2##1##(1995-8#1)(2013-1#1)
phlegmon##2##1##(2013-1#2)
phlegmonous gastritis##3##2##(2008-12#3)
phloem and xylem##3##3##(2008-11#1)(2012-8#2)
phloem and##6##2##(2008-10#3)(2008-11#1)(2012-8#2)
phloem cells##6##2##(2008-10#5)(2008-11#1)
phloem of##5##2##(2008-10#2)(2008-11#1)(2012-8#2)
phloem remained##2##2##(2012-8#2)
phloem tissue##3##2##(2008-10#2)(2008-9#1)
phloem tissues##4##2##(2008-10#4)
phloem##58##1##(2008-10#40)(2008-11#6)(2008-9#1)(2011-10#1)(2012-2#2)(2012-8#8)
phloem-feeding##2##1##(2007-12#1)(2008-10#1)
phloem-limited##6##1##(2008-10#6)
phloem-restricted##4##1##(2008-10#4)
phloem-specific##2##1##(2006-12#1)(2008-9#1)
phlorglucinol##2##1##(2008-10#2)
phloroglucinol##4##1##(2008-10#4)
pho1##3##1##(1996-10#3)
phoA##7##1##(1990-5#1)(1994-12#3)(2008-8#3)
phoA-kan##2##1##(1994-12#2)
phobia and##3##2##(2008-4#2)(2013-1#1)
phobia##40##1##(2008-1#1)(2008-4#20)(2008-7#1)(2010-2#6)(2012-12#1)(2012-2#8)(2013-1#3)
phobias##2##1##(1991-2#1)(2012-2#1)
phoenicis##3##1##(2008-10#1)(2008-6#2)
phoenicoxanthin##2##1##(2008-12#2)
phonation##3##1##(2009-11#2)(2012-2#1)
phone calls to##2##3##(1991-3#1)(2011-1#1)
phone calls##7##2##(1991-3#1)(2008-3#1)(2009-7#1)(2011-1#1)(2012-3#3)
phone use##2##2##(2013-1#2)
phone##24##1##(1991-3#2)(1994-3#1)(2007-9#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-8#2)(2011-1#5)(2012-2#1)(2012-3#7)(2013-1#2)
phoneme##5##1##(2008-9#5)
phonemic awareness##2##2##(2008-11#1)(2008-9#1)
phonemic##3##1##(2008-11#1)(2008-9#1)(2013-8#1)
phones##6##1##(2008-11#1)(2008-12#3)(2013-1#1)(2013-8#1)
phonetic##8##1##(2008-3#1)(2009-8#1)(2010-2#1)(2012-12#3)(2013-8#2)
phonologic##3##1##(2010-7#3)
phonological awareness and letter naming-decoding fluency##3##6##(2008-12#3)
phonological awareness and##6##3##(2008-12#4)(2011-1#2)
phonological awareness intervention##2##3##(2011-1#2)
phonological awareness##22##2##(2008-11#1)(2008-12#9)(2008-9#1)(2011-1#10)(2011-2#1)
phonological words##3##2##(2008-2#3)
phonological##43##1##(1991-2#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#9)(2008-2#4)(2008-4#5)(2008-7#1)(2008-9#1)(2010-1#2)(2011-1#11)(2011-2#1)(2012-12#2)(2013-8#1)
phonology and##2##2##(2010-1#1)(2010-4#1)
phonology##4##1##(2010-1#1)(2010-4#2)(2013-8#1)
phonon##14##1##(1993-5#2)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#1)(2012-2#1)
phonons in##3##2##(1992-11#1)(1992-8#1)(2012-2#1)
phonons##5##1##(1992-11#1)(1992-8#1)(2007-11#1)(2012-2#2)
phonotaxis##3##1##(2009-5#1)(2009-9#2)
phorbol 12##5##2##(1990-12#2)(1995-11#1)(1995-2#2)
phorbol 12-myristate 13-acetate (PMA)##10##4##(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#2)(2008-5#1)
phorbol 12-myristate 13-acetate##13##3##(1992-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-5#1)
phorbol 12-myristate##17##2##(1990-2#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-11#3)(2008-5#1)(2013-1#1)
phorbol dibutyrate treated##2##3##(1990-11#2)
phorbol dibutyrate##4##2##(1990-11#2)(1990-2#1)(1994-8#1)
phorbol ester and##3##3##(1994-11#3)
phorbol ester binding##4##3##(1994-3#1)(1994-8#2)(1995-8#1)
phorbol ester in##3##3##(1994-6#1)(1996-2#1)(1997-1#1)
phorbol ester stimulation##2##3##(1995-6#2)
phorbol ester treatment##2##3##(1993-8#1)(1995-6#1)
phorbol ester##43##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#4)(1993-6#1)(1993-8#2)(1994-11#7)(1994-3#1)(1994-6#2)(1994-8#4)(1995-11#1)(1995-6#5)(1995-8#1)(1996-2#1)(1997-1#2)(2008-11#2)
phorbol ester-activated##4##2##(1991-12#1)(1991-9#3)
phorbol ester-induced##4##2##(1991-9#1)(1992-11#1)(1994-8#2)
phorbol ester-mediated##2##2##(1991-9#1)(1994-8#1)
phorbol ester-stimulated##3##2##(1991-5#1)(1995-6#1)(1996-12#1)
phorbol esters and##2##3##(1992-12#1)(1994-8#1)
phorbol esters are##2##3##(1994-11#1)(2008-11#1)
phorbol esters##26##2##(1990-12#3)(1991-12#1)(1991-5#2)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-8#3)(1995-6#4)(1996-2#3)(2008-11#1)(2008-7#1)(2010-12#2)
phorbol myristate acetate (PMA)##5##4##(1991-9#1)(1993-6#1)(1994-6#1)(1997-4#1)(2006-6#1)
phorbol myristate acetate##10##3##(1991-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#2)(1997-4#1)(2006-6#1)
phorbol myristate##14##2##(1991-5#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-6#2)(1994-8#2)(1997-4#1)(2006-6#1)(2008-10#1)
phorbol##130##1##(1990-11#2)(1990-12#7)(1990-2#2)(1990-5#1)(1990-8#3)(1991-12#2)(1991-2#1)(1991-5#5)(1991-9#6)(1992-11#2)(1992-12#3)(1992-8#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-11#13)(1994-3#2)(1994-6#5)(1994-8#14)(1994-9#1)(1995-11#8)(1995-2#3)(1995-6#11)(1995-8#1)(1996-12#1)(1996-2#5)(1997-1#3)(1997-4#1)(2006-6#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-7#1)(2010-12#2)(2013-1#1)
phorbol-12-myristate-13-acetate (PMA)##3##2##(1991-9#1)(2008-11#2)
phorids##4##1##(2008-6#4)
phosphatase (AP) and##2##3##(2008-10#2)
phosphatase (AP)##6##2##(1995-12#1)(2008-10#4)(2008-11#1)
phosphatase 2A catalytic subunit##7##4##(1992-9#7)
phosphatase 2A enzyme##2##3##(1992-9#2)
phosphatase 2A##21##2##(1992-9#12)(1994-9#2)(1995-3#5)(1995-8#1)(2008-9#1)
phosphatase activating factor##2##3##(1993-6#2)
phosphatase activities in##2##3##(1994-11#1)(2008-10#1)
phosphatase activities of##2##3##(2008-10#1)(2008-9#1)
phosphatase activities##9##2##(1994-11#1)(2008-10#6)(2008-9#2)
phosphatase activity and##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-4#1)
phosphatase activity in the##2##4##(2008-10#1)(2008-7#1)
phosphatase activity in##6##3##(1993-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
phosphatase activity of##5##3##(2008-10#2)(2008-9#2)(2012-12#1)
phosphatase activity was##3##3##(1992-12#2)(1993-6#1)
phosphatase activity were##2##3##(1994-8#1)(1995-3#1)
phosphatase activity##43##2##(1990-12#1)(1992-12#4)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-2#1)(1997-2#2)(2008-10#6)(2008-11#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-12#1)(2012-4#1)(2013-1#2)
phosphatase and##12##2##(1991-4#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-11#1)(1996-2#1)(2008-10#2)(2008-7#2)(2013-1#1)
phosphatase are##2##2##(1995-2#1)(2012-1#1)
phosphatase as a##3##3##(1995-2#1)(2008-11#2)
phosphatase as##6##2##(1992-11#1)(1995-11#1)(1995-2#2)(2008-11#2)
phosphatase from##5##2##(1991-8#1)(1992-3#1)(1993-6#1)(1994-6#1)(1997-7#1)
phosphatase fusion proteins##2##3##(2008-10#2)
phosphatase fusion##3##2##(1990-11#1)(2008-10#2)
phosphatase has##2##2##(1992-12#1)(1993-8#1)
phosphatase in##10##2##(1991-12#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2012-2#1)
phosphatase inhibition##3##2##(1990-12#1)(1997-4#2)
phosphatase inhibitor okadaic acid##2##4##(1993-8#2)
phosphatase inhibitor##6##2##(1993-8#2)(1994-11#1)(1994-6#1)(1994-9#1)(2008-4#1)
phosphatase inhibitors##10##2##(1992-12#3)(1994-11#1)(1995-2#1)(1997-6#1)(2008-2#2)(2008-4#2)
phosphatase is##2##2##(1992-12#1)(1993-8#1)
phosphatase may be##2##3##(1992-12#1)(1993-6#1)
phosphatase to##2##2##(1991-12#1)(2008-7#1)
phosphatase was##5##2##(1990-8#1)(1993-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
phosphatase##307##1##(1990-11#1)(1990-12#5)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-5#4)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#24)(1992-3#8)(1992-6#2)(1992-9#13)(1993-11#3)(1993-2#1)(1993-3#4)(1993-6#19)(1993-8#11)(1994-11#7)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#11)(1995-3#8)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-2#3)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(2007-12#2)(2008-10#36)(2008-11#19)(2008-12#1)(2008-2#2)(2008-4#9)(2008-5#4)(2008-7#9)(2008-8#4)(2008-9#7)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#9)(2013-8#1)
phosphatase)##2##1##(1996-12#1)(2012-1#1)
phosphatase-1##3##1##(1990-8#1)(1995-8#2)
phosphatases 1 and 2A##5##4##(1991-5#1)(1992-12#2)(1992-8#1)(1994-11#1)
phosphatases 1##6##2##(1991-5#1)(1992-12#2)(1992-8#1)(1994-11#1)(1995-8#1)
phosphatases and##4##2##(1995-11#1)(1996-9#1)(2008-6#1)(2008-7#1)
phosphatases in the##2##3##(1995-8#1)(2012-2#1)
phosphatases that dephosphorylate##2##3##(1995-3#2)
phosphatases##37##1##(1990-12#3)(1991-5#1)(1992-12#2)(1992-8#1)(1992-9#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#5)(1996-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#2)(2012-12#2)(2012-2#1)
phosphate (P)##2##2##(1995-8#1)(2008-10#1)
phosphate (TBP)##4##2##(2008-10#4)
phosphate (beta-TCP)##2##2##(2008-5#2)
phosphate (pH 6##2##3##(1990-11#1)(2008-10#1)
phosphate (pH##4##2##(1990-11#1)(2008-10#2)(2012-12#1)
phosphate accumulation##4##2##(1997-1#2)(2008-4#2)
phosphate activating group on##2##4##(1994-11#2)
phosphate affinity SDS-PAGE##2##3##(2010-12#2)
phosphate and arsenate##2##3##(1991-8#2)
phosphate and silicate##4##3##(2008-10#4)
phosphate and##29##2##(1990-2#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-11#1)(1997-6#1)(2007-11#1)(2008-10#16)(2009-10#2)(2012-12#1)(2013-1#2)
phosphate are##2##2##(2008-10#2)
phosphate as##3##2##(2008-10#3)
phosphate at##3##2##(2008-10#3)
phosphate buffer (0##2##3##(1992-10#1)(1993-12#1)
phosphate buffer (ionic strength)##2##4##(2008-10#2)
phosphate buffer (pH 2##5##4##(1996-5#1)(2008-10#4)
phosphate buffer (pH 6##3##4##(2008-10#2)(2008-4#1)
phosphate buffer (pH 7##16##4##(1995-5#2)(1997-4#1)(2008-10#13)
phosphate buffer (pH 7)##3##4##(2008-10#3)
phosphate buffer (pH 8##2##4##(2008-10#2)
phosphate buffer (pH##32##3##(1995-5#2)(1996-5#2)(1997-4#1)(2008-10#26)(2008-4#1)
phosphate buffer and in the presence of##2##7##(1995-5#1)(2008-10#1)
phosphate buffer and##6##3##(1992-10#1)(1995-5#1)(2008-10#4)
phosphate buffer as##2##3##(2008-10#1)(2008-6#1)
phosphate buffer at pH 3##2##5##(2008-10#2)
phosphate buffer at pH 6##3##5##(2008-10#2)(2008-5#1)
phosphate buffer at pH 7##2##5##(2008-10#2)
phosphate buffer at pH##9##4##(2008-10#8)(2008-5#1)
phosphate buffer at##12##3##(1995-5#1)(2008-10#10)(2008-5#1)
phosphate buffer concentration##2##3##(2008-10#2)
phosphate buffer pH 2##2##4##(1996-5#1)(2008-10#1)
phosphate buffer pH 5##2##4##(2008-10#1)(2011-1#1)
phosphate buffer pH##5##3##(1996-5#1)(2008-10#3)(2011-1#1)
phosphate buffer saline solution##2##4##(2008-10#2)
phosphate buffer saline##3##3##(1992-3#1)(2008-10#2)
phosphate buffer solution (pH 7##3##5##(2008-10#3)
phosphate buffer solution##10##3##(2008-10#9)(2009-7#1)
phosphate buffer solutions##3##3##(2008-10#3)
phosphate buffer##124##2##(1990-12#1)(1990-8#1)(1992-10#2)(1992-3#1)(1992-9#1)(1993-12#1)(1995-5#4)(1996-5#4)(1997-4#1)(2008-10#96)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-7#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)
phosphate buffer)##3##2##(1997-7#1)(2008-10#1)(2010-3#1)
phosphate buffered saline (PBS)##2##4##(2008-10#2)
phosphate buffered saline##5##3##(2008-10#3)(2009-11#1)(2009-9#1)
phosphate buffered##6##2##(2008-10#3)(2009-11#1)(2009-5#1)(2009-9#1)
phosphate buffers##4##2##(2008-10#4)
phosphate chain##2##2##(2008-4#2)
phosphate concentration##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
phosphate concentrations##2##2##(2008-10#1)(2013-1#1)
phosphate dehydrogenase##2##2##(1997-2#1)(2008-10#1)
phosphate determination##3##2##(2008-10#3)
phosphate dibasic##3##2##(2008-10#2)(2009-8#1)
phosphate donor##3##2##(1990-10#1)(1995-11#2)
phosphate esters##4##2##(1993-8#1)(1994-11#1)(2008-10#1)(2008-4#1)
phosphate for preconcentration##2##3##(2008-10#2)
phosphate for##6##2##(2008-10#4)(2008-5#1)(2012-3#1)
phosphate glass##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
phosphate groups of##2##3##(1992-6#1)(2008-10#1)
phosphate groups##5##2##(1991-5#1)(1992-6#2)(2007-11#1)(2008-10#1)
phosphate in the##5##3##(1990-5#1)(2008-10#3)(2013-1#1)
phosphate in##22##2##(1990-5#1)(1993-12#1)(1994-11#1)(1995-11#1)(2008-10#15)(2008-11#1)(2008-5#1)(2013-1#1)
phosphate ion in river water##2##5##(2008-10#2)
phosphate ion in##3##3##(2008-10#3)
phosphate ion##10##2##(2008-10#10)
phosphate ion-selective##2##2##(2008-10#2)
phosphate ions##2##2##(2008-10#2)
phosphate is##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
phosphate isomerase##4##2##(1993-8#1)(1997-6#2)(2008-10#1)
phosphate metabolism##5##2##(1993-5#3)(1994-11#1)(2008-4#1)
phosphate on##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
phosphate or##4##2##(1990-8#1)(1994-3#1)(1996-5#1)(2008-4#1)
phosphate radiolabel specifically to##2##4##(1990-2#2)
phosphate release##2##2##(2008-7#2)
phosphate rock##3##2##(2008-10#3)
phosphate solution##2##2##(1994-3#1)(2008-10#1)
phosphate starvation##2##2##(1994-11#2)
phosphate synthase##2##2##(2011-2#2)
phosphate to the##3##3##(2008-10#3)
phosphate to##4##2##(2008-10#4)
phosphate transfection##3##2##(2008-1#1)(2008-11#1)(2008-2#1)
phosphate using##2##2##(2008-10#2)
phosphate was##5##2##(1991-12#1)(1994-9#1)(2008-10#3)
phosphate were##3##2##(1991-11#1)(1996-6#1)(2008-10#1)
phosphate with##2##2##(1997-7#1)(2008-10#1)
phosphate##568##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#4)(1990-5#2)(1990-6#1)(1990-7#9)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#6)(1991-8#4)(1992-10#2)(1992-12#5)(1992-3#8)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-5#4)(1993-8#4)(1994-11#12)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#4)(1995-12#1)(1995-5#4)(1995-6#1)(1995-8#4)(1996-12#1)(1996-5#6)(1996-6#1)(1997-1#4)(1997-2#2)(1997-4#1)(1997-6#5)(1997-7#5)(2006-4#2)(2007-11#8)(2007-12#4)(2007-3#1)(2008-1#8)(2008-10#283)(2008-11#8)(2008-2#6)(2008-3#5)(2008-4#13)(2008-5#15)(2008-6#6)(2008-7#14)(2008-8#1)(2009-10#4)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#3)(2010-3#3)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#14)
phosphate)##2##1##(2008-10#2)
phosphate-borate##2##1##(1992-12#1)(1996-5#1)
phosphate-buffered saline##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
phosphate-buffered##4##1##(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
phosphate/thiophosphate-protecting group##2##2##(2008-4#2)
phosphated##2##1##(2007-11#2)
phosphates and##5##2##(1997-7#1)(2008-10#2)(2008-4#1)(2012-1#1)
phosphates are##2##2##(1993-5#1)(1994-3#1)
phosphates by##2##2##(2008-10#2)
phosphates in##11##2##(1993-6#2)(1994-11#1)(1996-6#1)(2008-10#5)(2008-4#1)(2008-7#1)
phosphates was##4##2##(1990-12#1)(1993-5#1)(1993-6#1)(2008-10#1)
phosphates with##3##2##(2007-11#1)(2008-10#2)
phosphates##63##1##(1990-12#1)(1990-5#1)(1990-8#3)(1991-5#1)(1992-11#1)(1992-9#1)(1993-5#4)(1993-6#7)(1994-11#2)(1994-3#1)(1994-8#2)(1995-2#1)(1996-6#1)(1997-1#1)(1997-7#2)(2007-11#1)(2008-10#23)(2008-4#3)(2008-7#3)(2010-5#2)(2012-1#2)
phosphatidic acid (PA)##4##3##(1991-5#1)(1995-8#1)(2008-11#1)(2008-8#1)
phosphatidic acid##17##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-3#9)(1994-6#1)(1995-8#1)(2008-11#1)(2008-8#1)
phosphatidyl inositol##3##2##(1991-11#1)(1992-12#1)(1993-8#1)
phosphatidyl##8##1##(1991-11#1)(1992-12#2)(1993-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
phosphatidylcholine (PC) and##3##3##(1994-12#1)(1995-8#1)(2008-8#1)
phosphatidylcholine (PC)##10##2##(1990-11#1)(1991-5#1)(1993-8#1)(1994-12#1)(1995-8#2)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
phosphatidylcholine and deoxycholate##2##3##(2012-1#2)
phosphatidylcholine and phosphatidylethanolamine molecular species composition of##2##7##(1990-2#2)
phosphatidylcholine and phosphatidylethanolamine molecular species##3##5##(1990-2#3)
phosphatidylcholine and phosphatidylethanolamine##6##3##(1990-2#4)(1992-8#1)(2007-11#1)
phosphatidylcholine and##11##2##(1990-2#5)(1990-7#1)(1992-8#1)(1994-6#1)(2007-11#1)(2012-1#2)
phosphatidylcholine bilayers##3##2##(1992-3#3)
phosphatidylcholine breakdown##2##2##(1990-12#2)
phosphatidylcholine component##2##2##(1990-2#1)(1992-6#1)
phosphatidylcholine in##6##2##(1992-9#1)(1995-8#1)(1996-2#1)(2008-10#3)
phosphatidylcholine synthesis##6##2##(1995-3#6)
phosphatidylcholine to##2##2##(1991-12#1)(1992-8#1)
phosphatidylcholine vesicles##7##2##(1990-11#1)(1990-2#1)(1992-3#1)(1997-7#2)(2008-10#2)
phosphatidylcholine##84##1##(1990-11#4)(1990-12#2)(1990-2#8)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-3#4)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#5)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#7)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#1)(1997-2#1)(1997-7#3)(2007-11#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
phosphatidylcholine-selective phospholipase C##2##3##(1997-2#2)
phosphatidylcholines and##3##2##(1990-7#1)(1994-12#1)(1997-2#1)
phosphatidylcholines in##2##2##(1990-7#2)
phosphatidylcholines##22##1##(1990-7#13)(1991-5#2)(1993-11#1)(1994-11#2)(1994-12#1)(1997-2#3)
phosphatidylethanol (PEt)##2##2##(1991-2#1)(1991-5#1)
phosphatidylethanol formation##2##2##(1995-8#2)
phosphatidylethanol##5##1##(1991-2#1)(1991-5#1)(1994-3#1)(1995-8#2)
phosphatidylethanolamine (PE)##8##2##(1992-10#1)(1994-12#1)(1994-3#1)(1995-8#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
phosphatidylethanolamine and##5##2##(1990-5#1)(1990-7#2)(1994-5#1)(2012-2#1)
phosphatidylethanolamine##37##1##(1990-11#2)(1990-2#7)(1990-5#1)(1990-7#2)(1991-11#1)(1992-10#1)(1992-8#2)(1993-11#2)(1994-12#6)(1994-3#2)(1994-5#1)(1995-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#4)
phosphatidylglycerol (PG)##2##2##(2008-8#1)(2012-2#1)
phosphatidylglycerol##6##1##(1994-12#1)(1994-5#1)(1995-8#1)(2008-8#2)(2012-2#1)
phosphatidylinositol (PI)##9##2##(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(2008-4#1)(2009-8#1)(2012-2#1)
phosphatidylinositol 3##4##2##(1993-8#2)(2009-7#1)(2012-2#1)
phosphatidylinositol 3' kinase##2##3##(1996-2#2)
phosphatidylinositol 3'-kinase##2##2##(1992-10#1)(2011-2#1)
phosphatidylinositol 3- and 4-kinases##2##4##(1997-8#2)
phosphatidylinositol 3-kinase (PI 3-kinase)##3##4##(1994-11#1)(1995-8#1)(2008-11#1)
phosphatidylinositol 3-kinase (PI##4##3##(1994-11#1)(1995-8#1)(2008-11#1)(2008-7#1)
phosphatidylinositol 3-kinase (PI3K)##2##3##(2008-11#1)(2011-2#1)
phosphatidylinositol 3-kinase and##2##3##(2008-3#1)(2008-7#1)
phosphatidylinositol 3-kinase##19##2##(1992-12#3)(1994-11#1)(1994-6#1)(1995-6#3)(1995-8#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-7#3)(2011-2#1)
phosphatidylinositol 4##7##2##(1993-3#1)(1993-6#1)(1993-8#2)(1997-1#1)(2008-7#1)(2008-8#1)
phosphatidylinositol 4-kinase##2##2##(1997-8#2)
phosphatidylinositol 4-phosphate##4##2##(1993-8#1)(1997-8#2)(2008-8#1)
phosphatidylinositol bisphosphate (PIP2)##2##3##(2008-8#2)
phosphatidylinositol degradation##3##2##(2008-11#3)
phosphatidylinositol kinase##3##2##(1997-8#3)
phosphatidylinositol metabolism##2##2##(1995-6#2)
phosphatidylinositol turnover##2##2##(1994-3#1)(1997-2#1)
phosphatidylinositol was##2##2##(1991-8#2)
phosphatidylinositol##93##1##(1990-7#1)(1990-8#1)(1991-8#7)(1992-10#2)(1992-11#1)(1992-12#4)(1992-6#2)(1993-3#1)(1993-6#4)(1993-8#5)(1994-11#3)(1994-12#2)(1994-3#1)(1994-6#3)(1994-8#2)(1995-2#1)(1995-6#5)(1995-8#1)(1996-2#4)(1997-1#1)(1997-2#1)(1997-8#10)(2008-1#1)(2008-11#6)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#5)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#2)
phosphatidylinositol-3##2##1##(2008-3#2)
phosphatidylinositol-4##3##1##(1993-6#1)(2009-6#1)(2013-1#1)
phosphatidylinositol-specific phospholipase C##4##3##(1992-3#1)(1993-8#2)(2008-8#1)
phosphatidylserine (PS)##6##2##(1992-10#1)(1995-8#1)(2008-1#1)(2008-11#2)(2009-8#1)
phosphatidylserine and 1##2##3##(1990-10#2)
phosphatidylserine and##5##2##(1990-10#2)(1992-9#1)(1993-8#1)(2008-5#1)
phosphatidylserine asymmetry##2##2##(2008-8#2)
phosphatidylserine at##2##2##(1993-11#1)(2008-8#1)
phosphatidylserine exposure##2##2##(2008-8#2)
phosphatidylserine requirement of the##2##4##(1990-5#2)
phosphatidylserine requirement of##3##3##(1990-5#3)
phosphatidylserine##39##1##(1990-10#2)(1990-5#4)(1990-7#1)(1990-8#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#2)(1995-2#3)(1995-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#5)(2009-8#1)
phosphide##7##1##(2008-11#3)(2008-3#3)(2013-1#1)
phosphine concentrations##2##2##(2011-2#2)
phosphine fumigation at##2##3##(2011-2#2)
phosphine in##3##2##(1996-2#1)(2008-11#1)(2011-2#1)
phosphine oxide##3##2##(2008-10#3)
phosphine##26##1##(1990-8#2)(1996-2#4)(2008-10#6)(2008-11#5)(2010-5#1)(2011-2#8)
phosphines##2##1##(1996-2#1)(1997-7#1)
phosphinothricin##2##1##(1997-1#1)(2006-12#1)
phosphite##14##1##(1991-9#1)(1996-5#1)(2008-10#8)(2008-4#4)
phosphitylation of##2##2##(2008-4#2)
phosphitylation##3##1##(2008-4#3)
phospho-species##2##1##(2010-12#2)
phosphocholine and choline##2##3##(1991-5#1)(1992-12#1)
phosphocholine cytidylyltransferase##3##2##(1995-3#2)(1997-2#1)
phosphocholine##12##1##(1990-12#2)(1991-5#1)(1992-12#2)(1995-2#1)(1995-3#3)(1997-2#3)
phosphocreatine##12##1##(1990-11#2)(1991-5#1)(1993-11#1)(1994-2#1)(1994-8#2)(1995-12#1)(2007-10#1)(2013-1#3)
phosphodiester backbone is replaced by##2##5##(2008-4#2)
phosphodiester backbone##3##2##(1991-5#1)(2008-4#2)
phosphodiester##10##1##(1991-5#2)(1992-8#1)(1993-11#1)(2008-10#1)(2008-4#4)(2008-8#1)
phosphodiesterase 4##2##2##(1997-7#2)
phosphodiesterase activity##3##2##(1992-12#3)
phosphodiesterase inhibition##4##2##(1997-2#1)(2007-8#3)
phosphodiesterase inhibitor##5##2##(1992-3#1)(1994-6#1)(1995-12#1)(2008-5#2)
phosphodiesterase inhibitors##2##2##(1993-6#1)(2007-8#1)
phosphodiesterase isozyme##5##2##(1993-6#2)(1997-2#3)
phosphodiesterase was##2##2##(1994-8#1)(1997-2#1)
phosphodiesterase##43##1##(1992-12#8)(1992-3#2)(1993-6#4)(1994-6#1)(1994-8#1)(1995-12#1)(1997-2#8)(1997-7#3)(2007-8#6)(2008-4#1)(2008-5#4)(2008-7#1)(2009-2#1)(2010-10#2)
phosphodiesterase-5##2##1##(2008-11#1)(2010-6#1)
phosphodiesters##3##1##(1991-9#1)(1993-11#2)
phosphoenolpyruvate carboxykinase (PEPCK)##3##3##(1995-3#1)(1995-6#1)(2010-11#1)
phosphoenolpyruvate carboxykinase##6##2##(1991-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(2010-11#1)(2010-4#1)
phosphoenolpyruvate carboxylase##3##2##(1995-2#2)(2008-7#1)
phosphoenolpyruvate##17##1##(1991-3#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(2008-7#3)(2009-9#1)(2010-11#1)(2010-4#1)
phosphoethanolamine##2##1##(1990-7#2)
phosphofructokinase (PFK)##2##2##(1990-12#1)(1995-5#1)
phosphofructokinase##12##1##(1990-12#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#5)(2008-7#1)
phosphoglucomutase##3##1##(1992-4#3)
phosphoglucose isomerase##3##2##(1990-11#2)(2008-10#1)
phosphoglycerate kinase##3##2##(1990-5#2)(2008-5#1)
phosphoglycerate mutase##5##2##(1990-5#1)(1993-3#1)(2010-12#2)(2012-2#1)
phosphoglycerate##9##1##(1990-5#3)(1992-8#1)(1993-3#1)(2008-5#1)(2010-12#2)(2012-2#1)
phosphohistidine##2##1##(1995-8#2)
phosphohydrolase##2##1##(1994-3#1)(1997-7#1)
phosphoinositide (PI) hydrolysis##2##3##(1997-4#2)
phosphoinositide (PI)##5##2##(1993-11#1)(1994-9#1)(1997-4#2)(2009-6#1)
phosphoinositide hydrolysis##8##2##(1993-3#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#2)
phosphoinositide kinases##2##2##(1996-2#2)
phosphoinositide turnover##3##2##(1991-12#1)(1992-10#1)(1993-11#1)
phosphoinositide##33##1##(1991-12#1)(1992-10#2)(1993-11#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-9#2)(1995-8#1)(1996-12#2)(1996-2#7)(1996-5#2)(1997-1#3)(1997-4#2)(2008-8#1)(2009-6#1)(2013-1#2)(2013-8#1)
phosphoinositides##8##1##(1991-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(2010-9#1)(2011-2#1)
phosphoinositol##2##1##(1994-6#1)(1997-7#1)
phosphokinase##16##1##(1990-11#8)(1995-12#1)(2006-10#1)(2008-1#1)(2008-12#1)(2011-2#2)(2013-1#2)
phospholipase A(2) activity and##2##4##(2008-11#1)(2009-12#1)
phospholipase A(2) and##3##3##(2008-11#3)
phospholipase A(2)##8##2##(2008-11#6)(2009-12#1)(2011-2#1)
phospholipase A2 (IC50##2##3##(1994-11#2)
phospholipase A2 (PLA2)##7##3##(1990-11#1)(1990-8#1)(1991-5#1)(1993-11#1)(1994-6#1)(1996-5#1)(2012-2#1)
phospholipase A2 activation in rabbit platelets was investigated##2##8##(1994-3#1)(1995-11#1)
phospholipase A2 activation in rabbit platelets##3##6##(1994-3#1)(1995-11#2)
phospholipase A2 activation in##5##4##(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#2)
phospholipase A2 activation##6##3##(1994-11#1)(1994-3#2)(1994-6#1)(1995-11#2)
phospholipase A2 activity##3##3##(1990-2#1)(1991-5#1)(1995-11#1)
phospholipase A2 from##4##3##(1990-7#1)(1994-3#1)(2008-8#2)
phospholipase A2 in##2##3##(1990-2#1)(1993-6#1)
phospholipase A2 to##2##3##(1990-2#1)(1995-11#1)
phospholipase A2##62##2##(1990-11#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#2)(1992-8#2)(1993-11#3)(1993-6#2)(1994-11#13)(1994-12#1)(1994-3#5)(1994-5#5)(1994-6#2)(1994-9#1)(1995-11#6)(1995-12#2)(1996-2#2)(1996-5#1)(1997-1#1)(2008-8#2)(2012-2#1)(2013-8#1)
phospholipase A₂##2##2##(2013-1#2)
phospholipase C (PI-PLC)##2##3##(1993-8#1)(1995-8#1)
phospholipase C (PLC)##2##3##(1991-2#1)(2011-2#1)
phospholipase C activation in##2##4##(1990-11#1)(1995-11#1)
phospholipase C activation##6##3##(1990-11#2)(1995-11#1)(1995-2#1)(1995-8#1)(2008-8#1)
phospholipase C activity##4##3##(1990-11#1)(1993-3#1)(1993-6#1)(1994-11#1)
phospholipase C alpha##4##3##(1993-6#4)
phospholipase C and##5##3##(1997-6#1)(2008-11#4)
phospholipase C at##2##3##(1993-3#1)(1994-11#1)
phospholipase C by##2##3##(1992-9#1)(1997-2#1)
phospholipase C in##2##3##(1994-11#1)(2008-11#1)
phospholipase C inhibitor##3##3##(1994-11#2)(2008-10#1)
phospholipase C was##2##3##(1990-11#1)(1993-6#1)
phospholipase C##57##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-3#2)(1992-9#1)(1993-3#2)(1993-6#9)(1993-8#3)(1994-11#6)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#1)(2008-8#3)(2011-2#1)(2012-2#1)
phospholipase C-Ca2+ system through a receptor different from the 53-kDa ATP receptor##2##12##(1993-8#2)
phospholipase C-gamma 1##2##3##(1993-3#1)(1997-4#1)
phospholipase C-gamma##3##2##(1993-3#1)(1997-4#1)(1997-7#1)
phospholipase C-linked agonists##2##3##(1992-5#2)
phospholipase D (PLD) activation##2##4##(1991-2#1)(1993-3#1)
phospholipase D (PLD)##5##3##(1991-2#2)(1993-3#1)(1995-8#1)(2011-2#1)
phospholipase D activation in rat##2##5##(1991-2#1)(1993-3#1)
phospholipase D##23##2##(1991-2#4)(1992-12#1)(1993-3#8)(1994-3#1)(1995-8#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-6#1)(2010-9#1)(2011-2#1)
phospholipase activity and serotype distribution##2##5##(2008-5#2)
phospholipase activity and##4##3##(2008-5#3)(2009-2#1)
phospholipase activity##8##2##(1995-8#2)(2008-5#4)(2009-2#1)(2010-6#1)
phospholipase##177##1##(1990-11#6)(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#5)(1991-5#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-3#11)(1993-6#11)(1993-8#5)(1994-11#19)(1994-12#1)(1994-3#9)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#7)(1995-12#2)(1995-2#3)(1995-8#6)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#1)(2008-10#3)(2008-11#11)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#5)(2009-12#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
phospholipases A2 and C##2##4##(1991-8#1)(1994-11#1)
phospholipases C##3##2##(1990-5#1)(1991-5#1)(1997-4#1)
phospholipases##6##1##(1990-5#1)(1991-5#1)(1991-8#1)(1994-11#1)(1997-4#1)(2008-11#1)
phospholipid (PL)##2##2##(1993-8#1)(2008-7#1)
phospholipid and energy metabolism of##2##5##(2008-8#2)
phospholipid and protein##3##3##(1990-7#2)(1994-5#1)
phospholipid and##10##2##(1990-7#2)(1992-11#2)(1993-6#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-8#2)
phospholipid bilayers##15##2##(1990-11#2)(1990-2#5)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-11#1)(2008-11#2)
phospholipid binding##2##2##(1990-5#1)(1994-12#1)
phospholipid bound##2##2##(1990-5#1)(1994-12#1)
phospholipid composition##5##2##(1992-3#1)(1994-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
phospholipid content##4##2##(1991-12#1)(1995-5#2)(2008-5#1)
phospholipid fatty acid##3##3##(1992-12#1)(1992-8#1)(1996-7#1)
phospholipid fatty##4##2##(1992-12#1)(1992-3#1)(1992-8#1)(1996-7#1)
phospholipid flip-flop in##3##3##(1994-5#3)
phospholipid flip-flop##5##2##(1994-5#5)
phospholipid hydroperoxide glutathione peroxidase mRNA levels were##2##7##(1993-6#2)
phospholipid hydroperoxide glutathione peroxidase##4##4##(1993-6#3)(2009-10#1)
phospholipid in##2##2##(1991-2#1)(1992-6#1)
phospholipid is##2##2##(1990-5#1)(2008-7#1)
phospholipid membranes##4##2##(1990-2#2)(2008-9#2)
phospholipid metabolism as measured by an##2##6##(1994-11#1)(1994-6#1)
phospholipid metabolism##4##2##(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)
phospholipid model##2##2##(1991-8#1)(1997-2#1)
phospholipid molecules##3##2##(1990-5#1)(1993-8#1)(2008-9#1)
phospholipid monolayers##5##2##(1994-3#1)(1994-5#3)(1994-6#1)
phospholipid signaling pathways##2##3##(2008-4#1)(2009-10#1)
phospholipid synthesis##4##2##(1995-6#1)(2011-2#3)
phospholipid vesicles##4##2##(1991-5#1)(1992-3#1)(1994-11#1)(1994-5#1)
phospholipid##168##1##(1990-11#5)(1990-12#1)(1990-2#11)(1990-5#12)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#4)(1991-8#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#9)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#5)(1993-5#1)(1993-6#4)(1993-8#6)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#19)(1994-6#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#4)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)
phospholipid-binding protein##3##2##(2008-9#2)(2009-10#1)
phospholipid-binding##7##1##(1992-9#1)(1995-11#1)(2008-9#2)(2009-10#2)(2010-10#1)
phospholipid-independent##3##1##(1992-9#1)(1994-5#2)
phospholipidic##2##1##(1992-3#1)(2007-8#1)
phospholipids (PL)##2##2##(2008-10#1)(2013-1#1)
phospholipids and##13##2##(1990-2#1)(1990-7#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(2007-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
phospholipids in the##4##3##(1990-11#1)(1991-5#1)(2008-10#1)(2012-12#1)
phospholipids in##12##2##(1990-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-8#1)(1994-12#3)(1994-3#1)(2008-10#1)(2012-12#1)
phospholipids is##2##2##(1994-12#1)(1994-3#1)
phospholipids may##2##2##(1990-7#1)(1992-6#1)
phospholipids of##5##2##(1992-10#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-1#1)
phospholipids on##4##2##(1994-3#1)(1995-8#3)
phospholipids to##3##2##(1992-10#1)(2008-10#1)(2011-2#1)
phospholipids was##3##2##(1992-9#1)(1994-12#1)(2008-11#1)
phospholipids##110##1##(1990-11#3)(1990-2#3)(1990-5#3)(1990-7#5)(1991-12#1)(1991-5#3)(1991-8#1)(1992-10#4)(1992-12#4)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#6)(1994-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#4)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-3#3)(2008-5#3)(2008-7#3)(2009-7#2)(2009-8#3)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)
phosphomolybdate with##2##2##(2008-10#2)
phosphomolybdate##7##1##(2008-10#7)
phosphomolybdenum blue complex by##2##4##(2008-10#2)
phosphomolybdenum blue complex is##2##4##(2008-10#2)
phosphomolybdenum blue complex##5##3##(2008-10#5)
phosphomolybdenum blue##10##2##(2008-10#10)
phosphomolybdenum##11##1##(2008-10#11)
phosphomolybdic acid in##2##3##(2008-10#2)
phosphomolybdic acid##10##2##(2008-10#10)
phosphomolybdic##12##1##(2008-10#12)
phosphomonoester##2##1##(2008-7#1)(2008-8#1)
phosphonate (DBBP)##3##2##(2008-10#3)
phosphonate##15##1##(1992-6#2)(2008-10#13)
phosphonic acid##7##2##(2008-10#7)
phosphonic acids in the##2##4##(1995-11#1)(2008-10#1)
phosphonic acids in##4##3##(1995-11#2)(1996-5#1)(2008-10#1)
phosphonic acids##9##2##(1995-11#5)(1996-5#2)(2008-10#2)
phosphonic group##2##2##(2008-10#2)
phosphonic##20##1##(1995-11#5)(1996-5#2)(2008-10#13)
phosphonoacetate and##2##2##(2008-4#2)
phosphonoacetate##3##1##(2008-4#3)
phosphopeptide mapping##3##2##(1990-11#1)(1993-11#1)(1993-8#1)
phosphopeptide maps##2##2##(1993-11#2)
phosphopeptide##15##1##(1990-11#6)(1992-10#1)(1992-6#1)(1993-11#3)(1993-8#1)(1995-2#1)(1996-2#1)(2011-2#1)
phosphopeptides##12##1##(1993-11#2)(1994-6#2)(1995-12#1)(1995-6#1)(1996-2#4)(2010-7#2)
phosphoprotein of Mr 32##2##4##(1991-10#2)
phosphoprotein substrates##2##2##(1991-9#1)(1994-9#1)
phosphoprotein that is##2##3##(1991-9#1)(2010-11#1)
phosphoprotein that##4##2##(1991-9#1)(1994-12#1)(2010-11#1)(2013-1#1)
phosphoprotein##23##1##(1990-2#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-8#2)(1994-9#1)(1996-2#1)(2008-2#1)(2008-4#2)(2010-11#1)(2012-3#1)(2013-1#1)
phosphoproteins that##2##2##(1992-10#1)(1995-6#1)
phosphoproteins##18##1##(1990-12#1)(1992-10#1)(1994-11#2)(1994-8#1)(1995-6#1)(2008-1#1)(2008-2#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-9#2)(2011-2#1)
phosphoproteomics##2##1##(2012-12#2)
phosphor molecule##2##2##(2008-10#2)
phosphor##15##1##(2008-10#5)(2008-3#3)(2008-4#1)(2011-1#1)(2013-8#5)
phosphoramidates##2##1##(1997-3#1)(2007-11#1)
phosphoramidite and H-phosphonate##2##3##(2008-4#2)
phosphoramidite and##4##2##(2008-4#4)
phosphoramidite building blocks##2##3##(2008-4#2)
phosphoramidite chemistry##2##2##(2008-4#2)
phosphoramidite synthesis##2##2##(2008-4#2)
phosphoramidite##20##1##(2008-4#20)
phosphoramidites and their##2##3##(2008-4#2)
phosphoramidites and##3##2##(2008-4#3)
phosphoramidites are##3##2##(2008-4#3)
phosphoramidites in##2##2##(2008-4#2)
phosphoramidites was##2##2##(2008-4#1)(2012-2#1)
phosphoramidites##19##1##(2008-4#18)(2012-2#1)
phosphorescence (RTP) emission##3##3##(2008-10#3)
phosphorescence (RTP)##10##2##(2008-10#10)
phosphorescence and optical detection of magnetic resonance##2##7##(1993-11#2)
phosphorescence and##4##2##(1993-11#2)(2008-10#1)(2008-3#1)
phosphorescence development##2##2##(2008-10#2)
phosphorescence emission##8##2##(2008-10#8)
phosphorescence enhancers##2##2##(2008-10#2)
phosphorescence in##3##2##(2008-10#1)(2008-3#2)
phosphorescence intensity##3##2##(2008-10#3)
phosphorescence lifetime of##2##3##(2008-10#2)
phosphorescence of the##2##3##(2008-10#1)(2008-3#1)
phosphorescence of##8##2##(2008-10#6)(2008-3#1)(2010-4#1)
phosphorescence quenching##2##2##(1992-12#1)(2008-10#1)
phosphorescence was##2##2##(2008-10#2)
phosphorescence##71##1##(1992-12#3)(1993-11#3)(2008-10#57)(2008-3#7)(2010-4#1)
phosphorescent emission##2##2##(2008-10#2)
phosphorescent##8##1##(2008-10#4)(2008-3#3)(2010-4#1)
phosphoribosyl transferase##3##2##(1997-3#1)(2008-7#1)(2010-12#1)
phosphoric acid (pH 1##2##4##(1996-5#2)
phosphoric acid and##2##3##(2008-10#2)
phosphoric acid as##3##3##(2008-10#3)
phosphoric acid medium##5##3##(2008-10#5)
phosphoric acid##25##2##(1996-5#2)(2008-10#22)(2008-11#1)
phosphoric acid)##2##2##(2008-10#1)(2011-1#1)
phosphoric##32##1##(1994-11#1)(1996-5#2)(2008-10#27)(2008-11#1)(2011-1#1)
phosphorimetric method##3##2##(2008-10#3)
phosphorimetric##7##1##(2008-10#7)
phosphorimetry##5##1##(2008-10#5)
phosphorolysis of##2##2##(1994-8#2)
phosphorolysis##3##1##(1994-8#3)
phosphorothioate ODNs##2##2##(1994-12#2)
phosphorothioate antisense##2##2##(1995-11#1)(1995-12#1)
phosphorothioate linkages##3##2##(2008-4#3)
phosphorothioate oligodeoxynucleotides##3##2##(1993-3#2)(2008-9#1)
phosphorothioate oligonucleotide##2##2##(1994-5#1)(2008-10#1)
phosphorothioate oligonucleotides##2##2##(1993-3#1)(2008-4#1)
phosphorothioate##24##1##(1990-12#1)(1991-9#2)(1993-3#3)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-4#9)(2008-5#1)(2008-9#2)
phosphorothioates##3##1##(2008-10#1)(2008-4#1)(2008-5#1)
phosphorous acid##2##2##(2008-10#1)(2011-2#1)
phosphorous and##2##2##(2008-10#1)(2008-12#1)
phosphorous in##2##2##(2008-10#1)(2013-1#1)
phosphorous##14##1##(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
phosphorus (P) in##2##3##(2008-10#2)
phosphorus (P)##8##2##(2008-10#4)(2011-1#3)(2013-8#1)
phosphorus amount##2##2##(2008-10#2)
phosphorus and nitrate##2##3##(2008-12#2)
phosphorus and nitrogen##2##3##(2008-12#2)
phosphorus and potassium##2##3##(2008-11#1)(2008-12#1)
phosphorus and##8##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#5)
phosphorus availability##2##2##(2008-5#1)(2011-10#1)
phosphorus by spectrophotometry##2##3##(2008-10#2)
phosphorus by##6##2##(2008-10#5)(2008-9#1)
phosphorus chemical shift tensor##2##4##(1997-7#2)
phosphorus compounds in##2##3##(2008-10#2)
phosphorus compounds##4##2##(2008-10#4)
phosphorus concentration##2##2##(2008-12#1)(2013-1#1)
phosphorus concentrations##2##2##(2008-10#1)(2008-12#1)
phosphorus content##3##2##(2008-10#3)
phosphorus determination by##2##3##(2008-10#2)
phosphorus in soil##4##3##(2008-10#4)
phosphorus in soils##2##3##(2008-10#2)
phosphorus in the natural environment##2##5##(2008-10#2)
phosphorus in the##3##3##(2008-10#2)(2013-8#1)
phosphorus in##22##2##(2008-10#17)(2008-11#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
phosphorus is##5##2##(2008-10#5)
phosphorus magnetic resonance spectroscopy##2##4##(2007-10#1)(2008-7#1)
phosphorus occurs##2##2##(1992-6#1)(2008-10#1)
phosphorus ratio##2##2##(2008-9#2)
phosphorus ratios should have several trophic levels simultaneously##2##8##(2008-9#2)
phosphorus removal##3##2##(2013-1#3)
phosphorus speciation##2##2##(2008-10#2)
phosphorus species in##4##3##(2008-10#4)
phosphorus species is##2##3##(2008-10#2)
phosphorus species##9##2##(2008-10#9)
phosphorus to##2##2##(1996-2#1)(2013-1#1)
phosphorus was##2##2##(1994-2#1)(2008-5#1)
phosphorus with##2##2##(2008-10#2)
phosphorus##173##1##(1990-5#1)(1991-11#2)(1992-6#3)(1994-2#3)(1995-11#2)(1995-12#1)(1996-2#1)(1997-5#1)(1997-7#5)(2007-10#1)(2008-1#1)(2008-10#104)(2008-11#3)(2008-12#10)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#8)(2009-7#1)(2010-5#1)(2011-1#3)(2011-10#2)(2011-2#1)(2012-2#1)(2013-1#9)(2013-8#2)
phosphorus-containing molecules##2##2##(1995-11#1)(2008-11#1)
phosphorus-containing##4##1##(1995-11#1)(2008-10#2)(2008-11#1)
phosphorus-doped silica fiber##2##3##(2007-12#2)
phosphoryl##6##1##(1990-8#1)(1995-2#1)(1996-6#3)(2008-10#1)
phosphorylase is##2##2##(1991-11#1)(1997-2#1)
phosphorylase kinase with IC50 values of##2##6##(1990-8#2)
phosphorylase kinase##5##2##(1990-8#5)
phosphorylase phosphatase##2##2##(1990-8#1)(1995-12#1)
phosphorylase##27##1##(1990-8#6)(1991-11#5)(1993-12#2)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-12#1)(2010-4#2)(2012-3#1)
phosphorylate and##2##2##(1995-2#1)(2012-12#1)
phosphorylate the##5##2##(1993-11#1)(1996-2#1)(2010-9#1)(2011-2#2)
phosphorylate##18##1##(1991-2#2)(1992-6#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#2)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-12#1)
phosphorylated anabolites##3##2##(2008-7#3)
phosphorylated and dephosphorylated##4##3##(1996-5#2)(1997-2#2)
phosphorylated and##10##2##(1991-2#1)(1992-3#1)(1994-8#1)(1996-5#2)(1997-2#2)(2008-6#1)(2008-9#1)(2011-2#1)
phosphorylated at##8##2##(1990-11#1)(1994-11#2)(1994-9#1)(1995-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
phosphorylated by TPKI##2##3##(1995-12#2)
phosphorylated by protein kinase C##2##5##(1992-11#1)(1993-6#1)
phosphorylated by protein kinase##3##4##(1991-2#1)(1992-11#1)(1993-6#1)
phosphorylated by##18##2##(1990-11#1)(1991-2#3)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#2)(1997-2#1)(2008-11#1)(2009-8#1)(2010-11#1)
phosphorylated form of##5##3##(1991-2#1)(1992-12#1)(1993-8#1)(1996-12#1)(1997-1#1)
phosphorylated form##6##2##(1991-2#1)(1992-12#1)(1993-8#1)(1995-2#1)(1996-12#1)(1997-1#1)
phosphorylated forms##4##2##(1991-2#1)(1995-2#1)(1997-2#1)(2012-3#1)
phosphorylated in response##2##3##(1996-2#1)(2008-6#1)
phosphorylated in vitro by casein kinase II##2##7##(1990-11#1)(1993-8#1)
phosphorylated in vitro by##5##4##(1990-11#2)(1993-8#1)(1994-6#1)(1995-2#1)
phosphorylated in vitro##7##3##(1990-11#3)(1993-11#1)(1993-8#1)(1994-6#1)(1995-2#1)
phosphorylated in vivo##5##3##(1991-2#1)(1993-11#1)(1995-6#2)(1997-2#1)
phosphorylated in##24##2##(1990-11#3)(1991-12#1)(1991-2#1)(1993-11#3)(1993-3#1)(1993-8#1)(1994-6#2)(1995-2#2)(1995-6#3)(1995-8#1)(1996-2#1)(1997-2#1)(2008-6#1)(2008-8#2)(2012-3#1)
phosphorylated on serine residues##2##4##(1991-5#1)(1993-8#1)
phosphorylated on serine##3##3##(1991-5#1)(1993-8#1)(2008-4#1)
phosphorylated on tyrosine residues##2##4##(1995-8#1)(1996-2#1)
phosphorylated on##7##2##(1991-5#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-4#1)(2008-9#2)
phosphorylated or##2##2##(1992-12#1)(1997-2#1)
phosphorylated peptide##2##2##(2008-8#2)
phosphorylated protein##3##2##(1992-2#1)(1993-11#1)(1994-11#1)
phosphorylated proteins##4##2##(1995-8#1)(2008-5#2)(2008-8#1)
phosphorylated residues##3##2##(1992-6#1)(1994-11#1)(2008-10#1)
phosphorylated species##2##2##(2010-12#2)
phosphorylated state##4##2##(1990-7#1)(1995-2#1)(2008-1#1)(2008-4#1)
phosphorylated the##3##2##(1994-8#1)(1995-6#1)(1996-6#1)
phosphorylated to##3##2##(1994-8#1)(1995-6#1)(2009-5#1)
phosphorylated with##2##2##(2007-11#1)(2008-6#1)
phosphorylated##167##1##(1990-11#5)(1990-7#1)(1990-8#2)(1991-12#3)(1991-2#8)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#4)(1993-11#6)(1993-3#3)(1993-6#2)(1993-8#5)(1994-11#6)(1994-2#1)(1994-6#4)(1994-8#4)(1994-9#4)(1995-12#2)(1995-2#10)(1995-3#1)(1995-5#1)(1995-6#8)(1995-8#3)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#6)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#8)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#2)
phosphorylates c-Jun in vitro##2##4##(1995-2#2)
phosphorylates##8##1##(1991-2#1)(1993-3#1)(1994-6#1)(1995-2#2)(1997-1#1)(2011-1#1)(2011-2#1)
phosphorylating activity##4##2##(1990-8#1)(1994-8#1)(1995-8#1)(2011-1#1)
phosphorylating##16##1##(1990-8#1)(1991-12#4)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-8#1)(2008-4#2)(2011-1#1)
phosphorylation and activation of##3##4##(1992-8#1)(1995-8#1)(1996-2#1)
phosphorylation and activation##4##3##(1992-8#1)(1995-8#1)(1996-2#1)(1997-1#1)
phosphorylation and nuclear exclusion of p53##2##6##(1993-9#2)
phosphorylation and the##3##3##(1992-8#1)(1994-6#1)(2008-11#1)
phosphorylation and##34##2##(1992-3#2)(1992-8#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#8)(1994-9#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
phosphorylation are##2##2##(1991-2#1)(1996-2#1)
phosphorylation as##2##2##(1995-6#1)(1996-12#1)
phosphorylation at##9##2##(1990-8#1)(1994-11#1)(1997-1#1)(2008-11#1)(2008-8#2)(2010-11#1)(2012-2#1)(2013-1#1)
phosphorylation but##4##2##(1993-3#1)(1996-12#1)(2008-2#1)(2008-4#1)
phosphorylation by protein kinase C##2##5##(1990-11#1)(1997-2#1)
phosphorylation by protein kinases##2##4##(1990-8#1)(1995-6#1)
phosphorylation by protein##4##3##(1990-11#1)(1990-8#1)(1995-6#1)(1997-2#1)
phosphorylation by several##2##3##(1995-2#1)(1996-2#1)
phosphorylation by the##2##3##(1995-5#1)(1997-1#1)
phosphorylation by##16##2##(1990-11#1)(1990-8#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2012-12#1)
phosphorylation can##2##2##(2008-8#2)
phosphorylation coupled to electron##2##4##(1991-5#2)
phosphorylation event and##2##3##(1992-8#1)(1995-8#1)
phosphorylation event##4##2##(1992-8#2)(1995-8#1)(2008-8#1)
phosphorylation events##6##2##(1990-12#1)(1993-11#1)(1994-11#1)(1995-11#1)(2008-2#1)(2008-4#1)
phosphorylation in HEK293 and COS-1 cells##2##6##(2008-8#2)
phosphorylation in HEK293##3##3##(2008-8#3)
phosphorylation in response to growth factors##3##6##(1991-5#1)(1993-3#1)(2011-2#1)
phosphorylation in response to##5##4##(1991-5#1)(1992-2#1)(1992-3#1)(1993-3#1)(2011-2#1)
phosphorylation in##30##2##(1990-12#3)(1991-10#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-5#2)(1994-6#1)(1995-6#3)(1996-5#1)(2008-4#3)(2008-6#1)(2008-8#4)(2011-2#1)(2012-3#2)
phosphorylation is##12##2##(1990-11#2)(1995-12#1)(1996-5#2)(2008-2#1)(2008-4#3)(2009-5#1)(2011-1#1)(2012-3#1)
phosphorylation may be##4##3##(1992-3#1)(1995-2#1)(1996-5#1)(1997-1#1)
phosphorylation may##6##2##(1992-3#1)(1992-9#1)(1993-11#1)(1995-2#1)(1996-5#1)(1997-1#1)
phosphorylation mechanisms##2##2##(1992-11#1)(1994-2#1)
phosphorylation of CREB##2##3##(2008-11#2)
phosphorylation of IRS-I##4##3##(1997-1#4)
phosphorylation of PLC-gamma 1##3##4##(1992-7#2)(1993-3#1)
phosphorylation of Tir at##2##4##(2011-2#2)
phosphorylation of a##8##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-8#1)
phosphorylation of alpha##2##3##(1990-11#2)
phosphorylation of both##2##3##(1995-6#2)
phosphorylation of eIF-2##3##3##(1994-5#2)(1994-6#1)
phosphorylation of endogenous substrates in##2##5##(1992-8#1)(1993-12#1)
phosphorylation of endogenous substrates##4##4##(1992-8#1)(1992-9#1)(1993-12#2)
phosphorylation of endogenous##6##3##(1992-8#1)(1992-9#1)(1993-12#3)(2008-8#1)
phosphorylation of epidermal##2##3##(1990-11#1)(2012-3#1)
phosphorylation of mitogen-activated protein kinase##2##5##(1992-8#1)(1994-8#1)
phosphorylation of p53##2##3##(1992-12#1)(1993-9#1)
phosphorylation of procathepsin L##2##4##(1995-6#2)
phosphorylation of protein kinase Akt##2##5##(2011-1#2)
phosphorylation of protein kinase##3##4##(1992-9#1)(2011-1#2)
phosphorylation of signal##2##3##(2009-3#1)(2011-1#1)
phosphorylation of synaptic membranes isolated from##2##6##(1995-12#2)
phosphorylation of tau##2##3##(1995-12#2)
phosphorylation of the enzyme##2##4##(1990-5#1)(1997-2#1)
phosphorylation of the insulin receptor##3##5##(1990-11#1)(1997-6#1)(2008-4#1)
phosphorylation of the postsynaptic protein kinase##2##6##(1997-2#2)
phosphorylation of the receptor##2##4##(1990-11#1)(1992-9#1)
phosphorylation of the##35##3##(1990-10#1)(1990-11#4)(1990-5#2)(1991-12#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-6#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-6#2)(1996-2#1)(1997-2#4)(1997-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
phosphorylation of these##3##3##(1993-8#1)(1994-9#1)(2008-8#1)
phosphorylation of two##2##3##(1991-5#1)(2008-6#1)
phosphorylation of##182##2##(1990-10#4)(1990-11#8)(1990-12#2)(1990-5#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-5#1)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-7#3)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#4)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#10)(1994-9#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-6#10)(1995-8#3)(1996-2#4)(1996-5#1)(1997-1#5)(1997-2#10)(1997-6#1)(1997-7#3)(2008-10#1)(2008-11#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-3#2)(2009-5#3)(2009-6#2)(2010-1#1)(2010-12#1)(2011-1#6)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
phosphorylation on the##2##3##(1997-2#1)(2008-4#1)
phosphorylation on##10##2##(1991-2#1)(1993-3#1)(1993-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
phosphorylation or##2##2##(1994-6#1)(2009-5#1)
phosphorylation rates##3##2##(1992-3#1)(1993-3#1)(1995-6#1)
phosphorylation site##11##2##(1990-12#1)(1991-7#1)(1995-12#1)(1995-2#5)(2008-12#1)(2008-8#1)(2010-12#1)
phosphorylation sites and##4##3##(1995-2#1)(2008-12#1)(2008-8#1)(2008-9#1)
phosphorylation sites are##3##3##(1993-8#1)(1997-9#1)(2008-8#1)
phosphorylation sites of##3##3##(1994-11#1)(2008-8#2)
phosphorylation sites on##3##3##(1995-2#2)(2008-8#1)
phosphorylation sites##34##2##(1991-2#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-9#1)(2008-12#4)(2008-5#1)(2008-8#9)(2008-9#2)(2010-11#1)
phosphorylation state of##7##3##(1991-12#1)(1994-6#1)(1997-2#2)(2008-1#1)(2010-11#2)
phosphorylation state##11##2##(1991-12#1)(1991-9#3)(1994-6#1)(1997-2#2)(2008-1#1)(2010-11#2)(2012-12#1)
phosphorylation status of##2##3##(2008-5#1)(2009-2#1)
phosphorylation status##3##2##(2008-5#1)(2009-2#1)(2010-11#1)
phosphorylation to##4##2##(1994-8#1)(2009-8#1)(2009-9#1)(2011-1#1)
phosphorylation via##2##2##(1993-9#1)(1996-2#1)
phosphorylation was observed in##2##4##(1991-12#1)(1995-6#1)
phosphorylation was observed##3##3##(1991-12#1)(1994-5#1)(1995-6#1)
phosphorylation was##10##2##(1990-10#1)(1990-11#1)(1991-12#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-1#1)(2010-12#1)(2012-3#1)
phosphorylation were##5##2##(1992-9#1)(1993-8#1)(1993-9#1)(1997-6#1)(2012-3#1)
phosphorylation which##2##2##(1995-8#1)(1996-2#1)
phosphorylation with##2##2##(1990-11#1)(1993-11#1)
phosphorylation##548##1##(1990-10#5)(1990-11#19)(1990-12#8)(1990-2#4)(1990-5#3)(1990-8#5)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#13)(1991-5#5)(1991-7#1)(1991-9#6)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#13)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#13)(1992-9#9)(1993-1#1)(1993-11#6)(1993-12#3)(1993-3#12)(1993-6#4)(1993-8#7)(1993-9#7)(1994-11#16)(1994-12#1)(1994-2#1)(1994-5#9)(1994-6#16)(1994-8#12)(1994-9#2)(1995-11#4)(1995-12#9)(1995-2#15)(1995-3#6)(1995-5#4)(1995-6#25)(1995-8#6)(1996-12#7)(1996-2#11)(1996-5#9)(1997-1#13)(1997-2#19)(1997-4#1)(1997-6#3)(1997-7#8)(1997-9#1)(2008-1#2)(2008-10#3)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#1)(2008-4#21)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#30)(2008-9#5)(2009-2#1)(2009-3#2)(2009-5#5)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#5)(2011-1#10)(2011-2#14)(2012-12#5)(2012-2#8)(2012-3#12)(2013-1#7)(2013-7#2)(2013-8#3)
phosphorylation-induced##2##1##(1995-6#2)
phosphorylations of##4##2##(1990-12#1)(2008-10#2)(2012-12#1)
phosphorylations##6##1##(1990-12#1)(1990-5#1)(1993-11#1)(2008-10#2)(2012-12#1)
phosphorylative##2##1##(1990-10#1)(1992-9#1)
phosphorylcholine##6##1##(1993-11#1)(1994-3#1)(2008-11#2)(2010-4#2)
phosphoserine##2##1##(1994-11#1)(2012-2#1)
phosphoseryl##2##1##(1992-6#2)
phosphospecific antibody##2##2##(2010-12#1)(2010-3#1)
phosphotransferase gene##2##2##(2008-10#2)
phosphotransferase##5##1##(1990-10#1)(1991-10#1)(2008-10#2)(2008-7#1)
phosphotriesters##2##1##(2008-4#2)
phosphotungstic acid##2##2##(2008-10#2)
phosphotyrosine phosphatase##2##2##(1992-12#1)(1994-6#1)
phosphotyrosine to##2##2##(2008-4#2)
phosphotyrosine##8##1##(1992-12#1)(1994-11#1)(1994-6#2)(1995-11#1)(1995-6#1)(2008-4#2)
phosvitin at different pH values##2##5##(1994-11#2)
photic##4##1##(1994-2#2)(2008-5#1)(2008-7#1)
photo diode array##4##3##(2008-10#2)(2010-5#1)(2012-3#1)
photo identification system##2##3##(1993-12#1)(2009-4#1)
photo oxidation##2##2##(2008-5#2)
photo standard##5##2##(2008-5#5)
photo##18##1##(1993-12#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#7)(2009-4#1)(2010-5#1)(2012-3#1)
photo-##2##1##(2009-8#2)
photo-Fenton##2##1##(2008-10#2)
photo-assisted electrochemical detection##2##3##(2008-10#2)
photo-degradation product##3##2##(2008-5#3)
photo-induced##3##1##(2008-1#1)(2008-11#1)(2012-2#1)
photo-oxidants##2##1##(1992-3#2)
photo-oxidation and##4##2##(2008-10#4)
photo-oxidation##15##1##(2008-10#12)(2008-5#3)
photo-oxidative##2##1##(2008-5#1)(2008-8#1)
photo-physics##2##1##(2013-8#2)
photo-polymerization##2##1##(2008-10#2)
photo-symbiotic clams##6##2##(2008-5#6)
photo-symbiotic##7##1##(2008-5#7)
photoacoustic (PA)##2##2##(2007-11#1)(2008-10#1)
photoacoustic and##2##2##(2007-12#1)(2008-2#1)
photoacoustic cell##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
photoacoustic cells##2##2##(2008-2#2)
photoacoustic detection##2##2##(2008-3#2)
photoacoustic detector##2##2##(2008-10#1)(2008-2#1)
photoacoustic imaging##6##2##(2008-3#1)(2009-12#1)(2009-5#2)(2011-1#1)(2011-7#1)
photoacoustic microscopy##5##2##(2009-12#2)(2011-1#2)(2011-7#1)
photoacoustic signal##6##2##(2007-11#1)(2008-10#1)(2008-3#3)(2013-8#1)
photoacoustic spectroscopy##10##2##(2007-11#2)(2008-2#1)(2008-3#2)(2013-8#5)
photoacoustic##63##1##(1990-8#2)(1994-11#1)(2007-11#5)(2007-12#4)(2008-10#4)(2008-2#10)(2008-3#19)(2009-12#3)(2009-5#2)(2010-2#1)(2011-1#3)(2011-7#3)(2013-8#6)
photoacoustics##4##1##(2008-2#1)(2008-3#3)
photoactivatable##2##1##(1992-8#1)(1994-5#1)
photoactivated chromotropic acid##2##3##(2008-10#2)
photoactivated##9##1##(1993-8#1)(1995-6#1)(2008-10#4)(2009-6#1)(2012-2#1)(2012-3#1)
photoactivation of##3##2##(1990-12#1)(1992-5#1)(1994-5#1)
photoactivation##7##1##(1990-12#1)(1992-5#1)(1993-8#1)(1994-5#1)(2008-10#2)(2010-2#1)
photoactive protochlorophyllide-protein complex##2##3##(1992-8#2)
photoactive##12##1##(1991-12#1)(1992-8#4)(2007-12#3)(2008-10#3)(2011-1#1)
photoaffinity label##2##2##(1992-5#2)
photoaffinity labeling of##2##3##(1990-11#1)(1990-12#1)
photoaffinity labeling##9##2##(1990-11#3)(1990-12#1)(1991-9#1)(1993-11#1)(1993-8#1)(1995-11#2)
photoaffinity probe##3##2##(1993-8#1)(1994-5#1)(1994-8#1)
photoaffinity##18##1##(1990-11#3)(1990-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-6#1)(1993-8#3)(1994-5#1)(1994-8#1)(1995-11#2)
photoaged skin##2##2##(2011-2#2)
photoaged##4##1##(2008-5#1)(2011-2#2)(2012-2#1)
photoageing##5##1##(2008-5#5)
photoaging##11##1##(1991-6#1)(2008-5#6)(2011-2#4)
photoanode##2##1##(2010-5#2)
photoassimilate##2##1##(2008-12#2)
photobioreactor was##2##2##(2008-6#2)
photobioreactor##4##1##(2008-6#3)(2008-7#1)
photobleached at a##2##3##(2008-1#1)(2008-9#1)
photobleached region is##2##3##(2008-1#2)
photobleached##7##1##(2008-1#6)(2008-9#1)
photobleaching are##2##2##(2008-1#1)(2008-2#1)
photobleaching is##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
photobleaching of##6##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#1)
photobleaching rate##3##2##(2008-3#3)
photobleaching##44##1##(1993-11#1)(2008-1#12)(2008-10#2)(2008-2#6)(2008-3#8)(2008-4#1)(2008-7#2)(2008-9#7)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
photocarcinogenesis##2##1##(2008-5#1)(2011-2#1)
photocatalysis##3##1##(2007-12#1)(2008-10#1)(2013-8#1)
photocatalyst was##2##2##(2008-10#1)(2009-11#1)
photocatalyst##9##1##(2008-10#6)(2009-11#3)
photocatalysts are##2##2##(2008-10#2)
photocatalytic activity##5##2##(2009-11#1)(2013-8#4)
photocatalytic degradation##2##2##(2008-10#2)
photocatalytic disinfection##2##2##(2013-1#2)
photocatalytic oxidation for##2##3##(2008-10#2)
photocatalytic oxidation##6##2##(2008-10#6)
photocatalytic##29##1##(1994-3#3)(2008-10#13)(2009-11#2)(2009-8#4)(2013-1#2)(2013-8#5)
photocathode##7##1##(2007-12#1)(2008-2#5)(2008-3#1)
photochemical activities##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
photochemical cortical##2##2##(2008-4#2)
photochemical degradation of the##2##4##(2008-11#1)(2008-5#1)
photochemical degradation of##3##3##(2008-11#2)(2008-5#1)
photochemical derivatization##2##2##(2008-10#2)
photochemical effects##3##2##(2008-2#2)(2011-1#1)
photochemical ozone destruction##3##3##(2012-2#3)
photochemical processes in the##2##4##(2007-11#1)(2008-11#1)
photochemical processes in##3##3##(2007-11#1)(2008-11#2)
photochemical properties##2##2##(2008-5#1)(2009-8#1)
photochemical reaction of##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
photochemical reaction##17##2##(2008-10#9)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#2)
photochemical reactions of##2##3##(2008-10#2)
photochemical reactions##4##2##(1992-4#1)(1994-5#1)(2008-10#2)
photochemical smog##2##2##(1994-3#1)(2008-5#1)
photochemical stability##4##2##(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)
photochemical##72##1##(1991-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#23)(2008-11#4)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-3#1)(2012-2#3)
photochemically induced fluorescence##7##3##(2008-10#7)
photochemically symmetry-allowed##2##2##(1996-2#2)
photochemically##13##1##(1996-2#2)(1997-6#1)(2008-10#7)(2008-11#3)
photochemically-induced fluorescence##3##2##(2008-10#3)
photochemistry##7##1##(1992-8#1)(2008-1#1)(2010-2#2)(2011-3#1)(2012-7#1)(2012-8#1)
photochromic optical##2##2##(2007-12#2)
photochromic properties##2##2##(2008-1#1)(2009-9#1)
photochromic##17##1##(2007-11#1)(2007-12#3)(2008-1#2)(2008-3#6)(2009-7#1)(2009-8#3)(2009-9#1)
photocoagulation##11##1##(1993-1#1)(1993-6#4)(2011-1#5)(2011-2#1)
photoconducting polymeric layers##2##3##(2008-2#2)
photoconducting##6##1##(2007-11#2)(2007-12#1)(2008-2#3)
photoconductive antennas##4##2##(2008-2#4)
photoconductive switch##2##2##(2007-12#1)(2008-3#1)
photoconductive##15##1##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#6)(2009-5#1)
photoconductivity##2##1##(1990-4#1)(2008-3#1)
photoconductor##4##1##(2007-12#1)(2008-3#3)
photoconductors##7##1##(2007-12#3)(2008-3#4)
photoconversion in##2##2##(2011-1#2)
photoconversion##3##1##(2011-1#3)
photocurable##2##1##(2008-10#1)(2008-9#1)
photocured##2##1##(2008-10#2)
photocurrent and transmittance measurements##2##4##(2008-3#2)
photocurrent for##2##2##(2007-11#1)(2008-2#1)
photocurrent generated by##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
photocurrent in##2##2##(2007-11#1)(2008-2#1)
photocurrent response##2##2##(2008-10#2)
photocurrent##20##1##(2007-11#6)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#3)(2010-5#1)
photocycle##4##1##(1993-11#1)(1994-5#2)(1995-5#1)
photodamage to##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
photodamage##12##1##(1993-8#1)(2008-1#1)(2008-3#1)(2008-5#4)(2008-8#2)(2009-12#1)(2011-2#1)(2012-2#1)
photodamage/photoaging##2##1##(2012-2#2)
photodamaged##3##1##(2008-5#2)(2008-8#1)
photodarkening##2##1##(2008-3#2)
photodecomposition##5##1##(1997-6#1)(2007-11#2)(2008-10#2)
photodegradation and##2##2##(2008-10#2)
photodegradation of the##2##3##(2008-10#1)(2008-3#1)
photodegradation processes##2##2##(2008-10#2)
photodegradation rate##2##2##(2007-12#1)(2008-10#1)
photodegradation were##2##2##(2008-10#1)(2012-3#1)
photodegradation##26##1##(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-3#1)(2008-5#1)(2012-3#1)
photodensitometry##2##1##(2008-5#2)
photodestruction in a solid-state dye laser##2##6##(2008-2#2)
photodestruction##5##1##(1990-11#2)(2008-2#3)
photodestructive##2##1##(1990-11#2)
photodetection##3##1##(2007-11#1)(2008-3#2)
photodetector arrays##2##2##(2007-12#1)(2008-2#1)
photodetector output signal##3##3##(2008-2#3)
photodetector output##4##2##(2008-2#4)
photodetector##38##1##(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#11)(2008-3#17)(2011-1#1)
photodetectors##21##1##(2007-11#4)(2008-2#7)(2008-3#9)(2012-12#1)
photodiagnosis (PD)##3##2##(2009-4#2)(2012-3#1)
photodiode and##3##2##(2007-11#1)(2008-3#2)
photodiode array detector##7##3##(2008-10#7)
photodiode array##12##2##(1997-2#2)(2008-10#10)
photodiode as##2##2##(2008-10#1)(2008-3#1)
photodiode detectors##2##2##(2008-3#2)
photodiode instead of##2##3##(2007-11#1)(2008-10#1)
photodiode is used##2##3##(2007-12#2)
photodiode system##2##2##(2008-11#2)
photodiode that is##2##3##(2008-3#2)
photodiode##49##1##(1997-2#2)(2007-11#6)(2007-12#3)(2008-10#15)(2008-11#2)(2008-2#4)(2008-3#17)
photodiode-array##4##1##(1997-2#1)(2008-10#3)
photodiodes and##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
photodiodes for##3##2##(2008-2#1)(2008-3#2)
photodiodes##23##1##(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#10)
photodissociation of##5##2##(1990-8#1)(2008-2#1)(2008-3#3)
photodissociation##11##1##(1990-8#1)(1995-2#1)(2008-2#3)(2008-3#6)
photodynamic effect of##2##3##(2009-3#1)(2012-3#1)
photodynamic effect##3##2##(1992-1#1)(2009-3#1)(2012-3#1)
photodynamic oxidation rates##3##3##(2008-5#3)
photodynamic oxidation##5##2##(2008-5#5)
photodynamic reactivity##2##2##(2008-5#2)
photodynamic therapy (PDT) of##2##4##(1990-11#1)(2008-7#1)
photodynamic therapy (PDT)##13##3##(1990-11#1)(1992-6#1)(1992-9#1)(2007-8#3)(2008-5#1)(2008-7#1)(2009-4#3)(2012-3#2)
photodynamic therapy and##4##3##(1990-6#1)(2007-8#1)(2009-4#1)(2011-1#1)
photodynamic therapy in##2##3##(2012-3#2)
photodynamic therapy of##4##3##(2008-7#1)(2008-8#1)(2012-3#2)
photodynamic therapy with##3##3##(1992-8#1)(1992-9#1)(1996-8#1)
photodynamic therapy##41##2##(1990-11#1)(1990-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#2)(1994-1#1)(1996-8#1)(2007-8#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#5)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#12)
photodynamic##61##1##(1990-11#2)(1990-6#1)(1991-9#1)(1992-1#2)(1992-6#2)(1992-8#1)(1992-9#2)(1994-1#1)(1996-8#1)(2007-8#5)(2008-3#1)(2008-5#10)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#7)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#13)(2013-1#1)
photoelastic data##2##2##(2008-2#1)(2008-3#1)
photoelastic fringe patterns##4##3##(2008-2#2)(2008-3#2)
photoelastic fringe##6##2##(2008-2#2)(2008-3#4)
photoelastic measurements##2##2##(2008-3#2)
photoelastic tomography##2##2##(2007-11#2)
photoelastic##26##1##(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#17)
photoelasticity##12##1##(2007-7#1)(2008-2#2)(2008-3#9)
photoelectric modulation interferometer##3##3##(2013-8#3)
photoelectric##6##1##(2007-12#1)(2008-5#2)(2013-8#3)
photoelectrochemical##2##1##(2010-5#2)
photoelectron spectroscopy (XPS)##7##3##(2008-10#5)(2008-2#1)(2013-8#1)
photoelectron spectroscopy##23##2##(1996-12#1)(2007-12#1)(2008-10#12)(2008-2#5)(2011-2#2)(2013-8#2)
photoelectron##32##1##(1992-11#1)(1996-12#1)(2007-12#1)(2008-10#17)(2008-2#5)(2009-11#1)(2010-4#1)(2011-2#2)(2013-8#3)
photoellipsometry method##2##2##(2008-2#2)
photoemission from##2##2##(1991-9#1)(1993-5#1)
photoemission##6##1##(1990-4#1)(1991-9#1)(1993-5#2)(2012-2#2)
photoerythema##2##1##(2008-5#2)
photoexcitation##8##1##(2007-1#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-5#1)(2010-7#2)
photoexcited azo##2##2##(2007-12#2)
photoexcited##5##1##(1993-5#1)(2007-12#3)(2008-10#1)
photofilters##2##1##(2008-5#2)
photofragmentation##5##1##(2008-2#4)(2008-3#1)
photofragmentation-fragment detection##2##2##(2008-3#2)
photofragments##5##1##(2008-2#2)(2008-3#3)
photogenerated##4##1##(2007-11#1)(2008-10#2)(2009-11#1)
photograding##3##1##(2008-5#3)
photograph##12##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#2)
photographed##9##1##(1995-6#1)(2008-2#3)(2008-3#3)(2012-12#1)(2013-7#1)
photographic documentation##2##2##(1996-12#1)(2010-9#1)
photographic emulsions##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
photographic plates##3##2##(2008-3#3)
photographic scale##2##2##(2008-5#1)(2011-2#1)
photographic systems##2##2##(2008-3#2)
photographic##35##1##(1996-12#1)(2007-11#1)(2008-10#12)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
photographs and##2##2##(2008-2#1)(2013-1#1)
photographs of the##2##3##(2008-3#1)(2008-5#1)
photographs of##10##2##(1993-11#1)(1995-6#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-10#1)
photographs taken from different angles##2##5##(1995-6#2)
photographs taken from##3##3##(1995-6#2)(2010-12#1)
photographs to##2##2##(2008-11#1)(2008-2#1)
photographs##32##1##(1993-11#2)(1995-6#3)(1995-9#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
photography and##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)
photography for##3##2##(2007-12#1)(2008-1#1)(2008-4#1)
photography to##2##2##(2008-3#2)
photography##44##1##(1995-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-2#4)(2008-3#22)(2008-4#3)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
photoinduced birefringence##3##2##(2007-11#1)(2008-2#2)
photoinduced damage##3##2##(2007-12#3)
photoinduced electron transfer (PET)##2##4##(2008-10#2)
photoinduced refractive-index change##3##3##(2007-12#3)
photoinduced second-harmonic generation##2##3##(2007-11#1)(2008-3#1)
photoinduced##36##1##(1991-12#1)(1995-5#1)(2007-11#8)(2007-12#17)(2008-10#3)(2008-2#2)(2008-3#2)(2010-4#2)
photoinhibition and C(4) pathway##2##4##(2008-9#2)
photoinhibition and##4##2##(2008-9#4)
photoinhibitory##2##1##(1991-12#2)
photoinitiated##2##1##(2008-2#1)(2010-6#1)
photoinitiator##2##1##(2007-11#1)(2010-4#1)
photoirradiation##2##1##(2008-10#1)(2010-4#1)
photoisomerization##3##1##(1992-8#1)(1995-6#1)(2008-10#1)
photolabeled##7##1##(1990-11#2)(1992-12#1)(1992-5#1)(1993-8#3)
photolabeling##3##1##(1993-8#1)(1995-5#1)(2008-1#1)
photolinker##2##1##(2008-10#2)
photolithographic mask##3##2##(2008-2#1)(2008-3#2)
photolithographic technique##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
photolithographic##12##1##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#6)
photolithography and##4##2##(2008-2#1)(2008-3#2)(2009-12#1)
photolithography with##2##2##(2008-3#2)
photolithography##21##1##(2007-11#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#8)(2009-12#1)(2010-2#1)(2012-2#2)
photoluminescence (PL)##3##2##(2008-10#2)(2013-8#1)
photoluminescence intensity##2##2##(2013-8#2)
photoluminescence quenching of##2##3##(2008-10#1)(2009-11#1)
photoluminescence spectra##2##2##(2008-10#1)(2010-4#1)
photoluminescence##21##1##(2007-11#4)(2007-12#2)(2008-10#5)(2008-2#2)(2009-11#2)(2010-2#1)(2010-4#1)(2013-8#4)
photoluminescent##4##1##(2008-10#3)(2009-11#1)
photolysed##2##1##(2008-10#2)
photolysis and##3##2##(2008-10#1)(2008-3#2)
photolysis errors##2##2##(2008-3#2)
photolysis frequencies in the atmosphere##2##5##(2008-3#2)
photolysis frequencies##4##2##(2008-3#4)
photolysis of caged##2##3##(1995-2#1)(2008-4#1)
photolysis of##9##2##(1991-12#1)(1992-8#2)(1995-2#1)(1996-5#2)(2008-11#1)(2008-3#1)(2008-4#1)
photolysis to##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
photolysis##41##1##(1990-11#2)(1990-3#1)(1991-12#1)(1992-3#1)(1992-8#2)(1994-11#2)(1995-2#4)(1995-3#1)(1996-2#1)(1996-5#2)(2008-10#4)(2008-11#2)(2008-3#12)(2008-4#4)(2008-5#1)(2008-8#1)
photolytic##4##1##(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
photolyzed##2##1##(1992-5#1)(2009-12#1)
photometer is##2##2##(2008-10#2)
photometer##11##1##(1992-6#1)(2008-10#7)(2008-2#1)(2008-3#2)
photometers##3##1##(2008-10#2)(2008-5#1)
photometric and##2##2##(2008-10#1)(2008-3#1)
photometric detection at##2##3##(2008-10#2)
photometric detection##13##2##(1994-9#1)(1997-2#1)(2008-10#11)
photometric detector##4##2##(2008-10#4)
photometric determination of iron(II)/iron(III) and nitrite/nitrate##2##6##(2008-10#2)
photometric determination of##4##3##(2008-10#4)
photometric linearity##2##2##(2008-10#2)
photometric measurements##3##2##(2008-10#1)(2008-3#2)
photometric method for##2##3##(2008-10#2)
photometric method with##2##3##(2008-10#2)
photometric method##11##2##(2008-10#11)
photometric system##3##2##(2008-10#3)
photometric titration##3##2##(2008-10#3)
photometric##67##1##(1991-9#1)(1994-9#1)(1995-6#1)(1997-2#1)(2008-10#51)(2008-2#2)(2008-3#10)
photometrically##5##1##(2008-10#4)(2008-5#1)
photometry and##2##2##(2008-10#1)(2008-3#1)
photometry##9##1##(2007-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2011-2#1)
photomorphogenesis##4##1##(1991-9#1)(2009-8#3)
photomultiplier gain modulation##2##3##(2008-2#2)
photomultiplier tube##14##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#6)(2008-7#1)(2011-1#1)
photomultiplier tubes##3##2##(2008-3#3)
photomultiplier##27##1##(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#4)(2008-3#11)(2008-7#1)(2011-1#1)
photomultipliers##2##1##(2008-3#2)
photon absorptiometry##4##2##(1991-11#4)
photon and##4##2##(2008-3#1)(2010-7#1)(2012-1#1)(2012-2#1)
photon beams##6##2##(1993-9#1)(2008-3#1)(2008-6#1)(2012-1#3)
photon concentration##2##2##(2008-3#2)
photon correlation spectroscopy##5##3##(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
photon correlation##7##2##(2008-2#2)(2008-3#3)(2008-5#1)(2013-1#1)
photon counting at##2##3##(2007-11#1)(2008-3#1)
photon counting##9##2##(2007-11#2)(2008-10#1)(2008-3#4)(2011-1#1)(2013-1#1)
photon counts##3##2##(2007-11#1)(2008-3#2)
photon density in##2##3##(2007-11#1)(2008-2#1)
photon density waves are##2##4##(2007-12#1)(2008-3#1)
photon density waves##6##3##(2007-12#2)(2008-3#4)
photon density##16##2##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#7)(2011-1#1)
photon detection##2##2##(1995-6#1)(2007-12#1)
photon detector##4##2##(2007-12#1)(2008-3#3)
photon diffusion##3##2##(2007-11#2)(2008-3#1)
photon echo##3##2##(2007-12#1)(2008-11#1)(2010-2#1)
photon echoes##7##2##(2007-11#2)(2007-12#5)
photon emission computed tomography (SPECT)##7##5##(1994-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2008-8#1)(2009-12#1)(2009-8#1)
photon emission computed tomography##15##4##(1994-1#2)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#2)(2007-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
photon emission computed##16##3##(1994-1#2)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#2)(2007-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
photon emission tomography##2##3##(2008-2#2)
photon emission##21##2##(1994-1#2)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#2)(2007-10#2)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2012-2#1)
photon energies above the##2##4##(2008-3#2)
photon energies of##2##3##(2008-2#1)(2008-3#1)
photon energies##8##2##(2008-2#4)(2008-3#3)(2013-1#1)
photon energy##4##2##(2007-11#2)(2008-3#1)(2012-12#1)
photon flight##2##2##(2008-3#2)
photon flux density##4##3##(2008-10#3)(2010-10#1)
photon flux##10##2##(2008-10#4)(2008-2#1)(2008-3#3)(2010-10#2)
photon in##2##2##(2007-11#1)(2010-11#1)
photon is##2##2##(2008-2#1)(2008-3#1)
photon lifetimes##2##2##(2007-11#1)(2008-3#1)
photon migration (FDPM)##3##3##(2008-3#3)
photon migration in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
photon migration is##2##3##(2008-3#2)
photon migration measurements##2##3##(2008-3#2)
photon migration##20##2##(2007-12#4)(2008-2#2)(2008-3#14)
photon noise in the##2##4##(2008-3#2)
photon noise##6##2##(2008-2#1)(2008-3#5)
photon number##2##2##(1992-11#1)(2007-11#1)
photon pairs generated by spontaneous parametric downconversion##2##7##(2007-12#2)
photon pairs##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
photon paths##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
photon propagation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
photon radiation##2##2##(1990-11#1)(2008-7#1)
photon scanning tunneling microscope##4##4##(2007-11#1)(2007-12#3)
photon trajectories##2##2##(2007-12#1)(2008-2#1)
photon transport in##2##3##(2007-11#1)(2008-3#1)
photon transport through##2##3##(2007-11#1)(2008-3#1)
photon transport##6##2##(2007-11#3)(2008-2#1)(2008-3#2)
photon##222##1##(1990-11#1)(1991-11#4)(1992-11#1)(1993-9#2)(1994-1#2)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-7#2)(2006-4#2)(2007-10#2)(2007-11#30)(2007-12#25)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#23)(2008-3#75)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#3)
photon-conversion##3##1##(2007-11#3)
photon-correlation##4##1##(2008-3#4)
photon-counting avalanche##2##2##(2007-11#2)
photon-counting lock-in##3##2##(2007-11#3)
photon-counting mode##2##2##(2007-12#1)(2008-3#1)
photon-counting receivers##2##2##(2008-3#2)
photon-counting##16##1##(2007-11#6)(2007-12#2)(2008-10#1)(2008-3#7)
photon-echo##7##1##(2007-12#5)(2008-2#2)
photon-gated##2##1##(2007-12#1)(2008-2#1)
photon-migration##3##1##(2007-12#2)(2008-3#1)
photon-number distribution##2##2##(2007-11#1)(2007-12#1)
photon-number statistics of twin beams##2##5##(2007-11#2)
photon-number##6##1##(2007-11#3)(2007-12#3)
photon-pair##3##1##(2007-11#1)(2008-3#2)
photon-scanning tunneling##2##2##(2008-2#1)(2008-3#1)
photon-transport##2##1##(2007-12#1)(2008-3#1)
photonic analog-to-digital##2##2##(2007-12#1)(2008-3#1)
photonic atoms##2##2##(2007-11#2)
photonic backplane##2##2##(2008-2#2)
photonic band##3##2##(2007-11#1)(2007-12#2)
photonic bandgap structures##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2008-7#1)
photonic bandgap##22##2##(2007-11#7)(2007-12#10)(2008-2#2)(2008-3#1)(2008-7#1)(2012-3#1)
photonic circuits##2##2##(2008-3#1)(2012-2#1)
photonic crystal (PC)##4##3##(2007-11#3)(2007-12#1)
photonic crystal and##3##3##(2007-11#2)(2007-12#1)
photonic crystal fiber##5##3##(2007-12#5)
photonic crystal fibers##10##3##(2007-11#5)(2007-12#5)
photonic crystal nanocavities##2##3##(2007-11#2)
photonic crystal slab##3##3##(2007-11#1)(2007-12#2)
photonic crystal waveguide##4##3##(2007-12#4)
photonic crystal waveguides##6##3##(2007-11#3)(2007-12#3)
photonic crystal##61##2##(2007-11#31)(2007-12#25)(2008-3#2)(2009-12#3)
photonic crystals and##2##3##(2007-11#1)(2012-2#1)
photonic crystals by##2##3##(2007-11#1)(2009-12#1)
photonic crystals that##2##3##(2007-11#1)(2008-3#1)
photonic crystals##21##2##(2007-11#15)(2007-12#2)(2008-3#2)(2009-12#1)(2012-2#1)
photonic delay line for phased-array##2##5##(2008-3#2)
photonic delay line is demonstrated##2##5##(2008-2#2)
photonic delay line##7##3##(2008-2#3)(2008-3#4)
photonic delay##8##2##(2008-2#3)(2008-3#5)
photonic device##2##2##(2007-12#1)(2008-3#1)
photonic devices##4##2##(2008-10#1)(2008-2#1)(2008-7#2)
photonic integrated##3##2##(2008-3#3)
photonic lattice##2##2##(2007-11#2)
photonic lattices##2##2##(2007-11#1)(2008-3#1)
photonic sensors##3##2##(2007-11#1)(2007-12#2)
photonic stopgaps##2##2##(2007-11#2)
photonic structures##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
photonic switch##4##2##(2008-3#4)
photonic##177##1##(2007-11#69)(2007-12#48)(2008-10#1)(2008-2#13)(2008-3#32)(2008-7#4)(2009-12#4)(2010-6#1)(2012-2#4)(2012-3#1)
photonic-crystal slab##2##2##(2007-11#1)(2007-12#1)
photonic-crystal waveguide##5##2##(2007-11#5)
photonic-crystal waveguides##2##2##(2007-11#2)
photonic-crystal##20##1##(2007-11#18)(2007-12#2)
photonics applications##3##2##(2008-3#2)(2008-7#1)
photonics##5##1##(2008-10#1)(2008-3#3)(2008-7#1)
photons and##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
photons are##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
photons by##2##2##(2008-10#1)(2008-2#1)
photons emitted##2##2##(2008-3#1)(2012-12#1)
photons for##3##2##(2007-12#1)(2008-2#2)
photons from##2##2##(2008-2#1)(2009-8#1)
photons in a##2##3##(2008-2#1)(2009-11#1)
photons in the##3##3##(2008-2#1)(2008-3#2)
photons in##10##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#3)(2009-11#1)
photons inside##4##2##(2007-12#2)(2008-3#2)
photons per##2##2##(2008-3#1)(2010-2#1)
photons produced##2##2##(2007-12#1)(2008-2#1)
photons scattered##2##2##(2007-11#1)(2007-12#1)
photons that##3##2##(2007-11#1)(2008-3#2)
photons to##2##2##(2008-2#1)(2008-3#1)
photons traversing a turbid medium##2##5##(2008-2#2)
photons with the##2##3##(2008-3#1)(2008-7#1)
photons with##4##2##(2007-12#1)(2008-3#2)(2008-7#1)
photons##81##1##(1992-4#1)(1994-9#1)(2006-4#1)(2007-11#10)(2007-12#11)(2008-10#2)(2008-11#1)(2008-2#20)(2008-3#22)(2008-4#1)(2008-7#2)(2009-11#3)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#3)
photons)##2##1##(2008-3#2)
photons/(s 4pi##2##2##(2007-11#2)
photooxidation##2##1##(2008-10#2)
photooxidative coupling of##2##3##(2008-10#2)
photooxidative##4##1##(2008-10#2)(2008-5#1)(2010-10#1)
photoperiod sensitivity##3##2##(1995-6#2)(2012-3#1)
photoperiod##29##1##(1994-5#1)(1995-6#2)(2007-5#1)(2008-10#1)(2008-11#5)(2008-5#2)(2008-7#5)(2009-6#1)(2010-8#6)(2011-2#3)(2012-3#2)
photoperiodic conditions##2##2##(2008-5#1)(2012-2#1)
photoperiodic##4##1##(1995-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
photoperiods##4##1##(2008-5#1)(2008-7#3)
photophase##3##1##(2007-12#1)(2008-6#1)(2008-9#1)
photophosphorylation##3##1##(1992-3#3)
photophysical dynamics##2##2##(2008-3#2)
photophysical properties of these##2##4##(2009-9#1)(2010-2#1)
photophysical properties##4##2##(2008-10#2)(2009-9#1)(2010-2#1)
photophysical##10##1##(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2009-9#1)(2010-2#1)(2013-8#1)
photopic luminance##2##2##(2011-2#2)
photopic##4##1##(2007-5#1)(2011-2#3)
photoplethysmography##6##1##(1990-5#1)(2008-2#2)(2010-7#2)(2010-8#1)
photopolarimeter##4##1##(1995-6#1)(2008-3#3)
photopolymer and##3##2##(2008-3#1)(2008-9#2)
photopolymer film##3##2##(2007-12#2)(2008-3#1)
photopolymer films##4##2##(2008-2#1)(2008-3#3)
photopolymer storage##2##2##(2007-12#1)(2008-3#1)
photopolymer##24##1##(2007-12#7)(2008-2#2)(2008-3#13)(2008-9#2)
photopolymerizable##5##1##(2007-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
photopolymerization kinetics##2##2##(2008-2#1)(2009-12#1)
photopolymerization of resins##2##3##(2007-12#2)
photopolymerization of##3##2##(2007-12#2)(2008-2#1)
photopolymerization##9##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)(2009-12#1)
photopolymers##3##1##(2008-2#1)(2008-3#2)
photoporation##8##1##(2011-1#8)
photoprobe##2##1##(1990-11#1)(1993-8#1)
photoproduct##2##1##(1990-5#1)(2008-3#1)
photoproducts after##2##2##(2008-10#2)
photoproducts##14##1##(1992-8#3)(2008-10#9)(2008-3#2)
photoprotection##11##1##(2008-5#5)(2011-2#3)(2012-2#3)
photoprotective agent##2##2##(2008-5#2)
photoprotective substance##2##2##(2008-11#2)
photoprotective##10##1##(2008-11#3)(2008-5#4)(2008-7#1)(2010-10#1)(2013-1#1)
photoprotein##3##1##(1990-8#3)
photoradiation##4##1##(1990-6#4)
photoreaction##3##1##(1991-12#1)(2008-3#1)(2008-9#1)
photoreactive##6##1##(1990-11#2)(1993-11#2)(1994-8#1)(2011-2#1)
photoreactivity##2##1##(1997-6#2)
photoreactor##2##1##(2008-10#2)
photoreceptor and##2##2##(1992-8#1)(2012-12#1)
photoreceptor cells##8##2##(1990-11#1)(1990-7#1)(1993-3#1)(1994-12#1)(1994-5#2)(2008-7#1)(2008-9#1)
photoreceptor development##3##2##(1996-2#2)(2007-12#1)
photoreceptor differentiation##2##2##(1996-2#1)(2012-12#1)
photoreceptor regeneration##2##2##(2010-1#2)
photoreceptor##34##1##(1990-11#4)(1990-7#2)(1991-9#1)(1992-8#1)(1993-3#1)(1994-12#2)(1994-5#2)(1996-2#3)(1996-5#1)(2007-12#1)(2007-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-1#4)(2012-12#2)(2012-3#3)
photoreceptors and lateral eyes##2##4##(1993-3#2)
photoreceptors and the##3##3##(1994-5#1)(2008-4#1)(2011-2#1)
photoreceptors and##6##2##(1993-3#2)(1994-5#1)(2008-4#1)(2011-2#2)
photoreceptors are##2##2##(1994-5#1)(2007-11#1)
photoreceptors in the##2##3##(1991-10#1)(2010-1#1)
photoreceptors of the##2##3##(2008-9#1)(2011-1#1)
photoreceptors to##3##2##(2008-7#2)(2011-1#1)
photoreceptors##36##1##(1991-10#1)(1993-3#3)(1994-12#1)(1994-5#5)(1996-2#3)(2007-11#1)(2007-5#2)(2008-10#1)(2008-4#2)(2008-7#3)(2008-9#3)(2009-8#1)(2010-1#4)(2011-1#2)(2011-2#2)(2012-12#2)
photoreduction of##3##2##(2007-12#1)(2008-8#1)(2009-9#1)
photoreduction##8##1##(1992-8#1)(2007-12#1)(2008-10#4)(2008-8#1)(2009-9#1)
photorefractive Bragg gratings##2##3##(2007-12#2)
photorefractive SBN##2##2##(2008-3#2)
photorefractive and##2##2##(2008-3#2)
photorefractive crystal inside the cavity##2##5##(2007-12#2)
photorefractive crystal is##4##3##(2007-12#2)(2008-3#2)
photorefractive crystal##28##2##(2007-11#2)(2007-12#11)(2008-2#4)(2008-3#11)
photorefractive crystals##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
photorefractive damage##2##2##(2007-12#1)(2008-3#1)
photorefractive effect in##2##3##(2008-3#2)
photorefractive effect is##2##3##(2008-3#2)
photorefractive effect##9##2##(2007-12#2)(2008-2#1)(2008-3#6)
photorefractive four-wave mixing##4##3##(2008-2#3)(2008-3#1)
photorefractive grating##4##2##(2007-11#1)(2007-12#3)
photorefractive gratings##2##2##(2007-11#1)(2008-3#1)
photorefractive holograms in##2##3##(2007-12#1)(2008-3#1)
photorefractive holograms##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
photorefractive holographic##2##2##(2007-12#1)(2008-3#1)
photorefractive holography##2##2##(2007-11#2)
photorefractive incoherent-to-coherent optical converter##3##4##(2007-12#2)(2008-2#1)
photorefractive keratectomy##2##2##(2008-3#1)(2013-1#1)
photorefractive material##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
photorefractive materials##2##2##(2007-12#1)(2008-3#1)
photorefractive medium##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
photorefractive phase-conjugate mirror##2##3##(2008-2#2)
photorefractive polymer##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
photorefractive polymers##4##2##(2007-12#2)(2008-3#2)
photorefractive properties##4##2##(2007-11#3)(2007-12#1)
photorefractive response in##4##3##(2007-11#3)(2007-12#1)
photorefractive response of##2##3##(2007-11#1)(2007-12#1)
photorefractive response time of##2##4##(2007-11#2)
photorefractive response##8##2##(2007-11#6)(2007-12#2)
photorefractive solitons##2##2##(2007-12#2)
photorefractive spatial solitons##2##3##(2007-12#2)
photorefractive spatial##3##2##(2007-11#1)(2007-12#2)
photorefractive surface waves in BaTiO(3)##2##5##(2007-12#2)
photorefractive surface##3##2##(2007-12#3)
photorefractive two-beam coupling##3##3##(2007-12#2)(2008-3#1)
photorefractive##175##1##(1990-4#1)(1992-8#1)(2007-11#31)(2007-12#59)(2008-2#28)(2008-3#54)(2013-1#1)
photorefractive-index change##2##2##(2007-11#2)
photorefractive-index##3##1##(2007-11#2)(2008-3#1)
photorelease##3##1##(2008-4#3)
photoresist grating##2##2##(2008-3#2)
photoresist gratings##2##2##(2008-3#2)
photoresist##26##1##(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#14)(2008-7#3)(2009-11#1)
photoresists##3##1##(2008-3#1)(2008-9#2)
photorespiration##5##1##(2008-8#4)(2009-10#1)
photoresponsivity##2##1##(2007-11#2)
photos of##3##2##(2008-5#2)(2011-2#1)
photos##6##1##(2008-2#1)(2008-5#2)(2011-2#1)(2013-1#2)
photosensitising##3##1##(2008-11#3)
photosensitive damage##5##2##(2008-8#5)
photosensitive glass##2##2##(2008-3#2)
photosensitive##25##1##(1991-2#1)(1995-6#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-8#5)
photosensitivity in##5##2##(2007-11#1)(2007-12#3)(2011-2#1)
photosensitivity is##3##2##(2007-12#3)
photosensitivity of##2##2##(2007-12#2)
photosensitivity rashes##2##2##(2008-5#2)
photosensitivity was##2##2##(2008-5#1)(2012-3#1)
photosensitivity##24##1##(1993-11#1)(2006-10#1)(2007-11#2)(2007-12#11)(2008-5#5)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
photosensitization of##4##2##(1992-8#1)(1994-12#1)(2008-8#2)
photosensitization using##2##2##(2012-2#2)
photosensitization##13##1##(1991-5#1)(1992-8#2)(1994-12#3)(2007-8#1)(2008-8#3)(2012-2#3)
photosensitized##6##1##(1994-12#1)(2007-11#1)(2008-2#2)(2008-8#1)(2012-2#1)
photosensitizer and##2##2##(1992-12#1)(2009-4#1)
photosensitizer concentration##2##2##(2008-3#1)(2012-2#1)
photosensitizer for photodynamic therapy##2##4##(2012-3#2)
photosensitizer for##4##2##(1990-11#1)(2012-3#3)
photosensitizer##25##1##(1990-11#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-11#1)(1994-12#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-4#4)(2012-2#1)(2012-3#6)
photosensitizers in##2##2##(1993-11#2)
photosensitizers##13##1##(1991-5#1)(1992-6#1)(1993-11#6)(1993-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-4#1)
photosensitizing concentration of##2##3##(2012-3#2)
photosensitizing drug##3##2##(1993-8#2)(1997-6#1)
photosensitizing##7##1##(1992-9#1)(1993-8#2)(1997-6#1)(2008-5#1)(2012-3#2)
photosensor##3##1##(2008-3#1)(2008-5#1)(2013-8#1)
photospray ionization##2##2##(2008-10#2)
photostabilities of##2##2##(2008-5#2)
photostability of the##2##3##(2008-10#1)(2008-2#1)
photostability of##8##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-2#1)
photostability was##2##2##(2008-5#2)
photostability##20##1##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#9)(2009-2#2)(2009-4#1)
photosynthesis and growth##2##3##(2008-10#1)(2009-10#1)
photosynthesis and##3##2##(2008-10#2)(2009-10#1)
photosynthesis in##3##2##(2008-10#2)(2008-9#1)
photosynthesis was##2##2##(2008-10#2)
photosynthesis##40##1##(1995-6#2)(1996-12#2)(2008-10#16)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#1)(2012-1#1)(2012-5#1)(2012-7#2)(2013-1#2)
photosynthesis-related##2##1##(1996-12#1)(2008-9#1)
photosynthetic active##2##2##(2008-11#1)(2013-7#1)
photosynthetic bacteria##4##2##(1993-8#1)(2008-6#1)(2008-8#2)
photosynthetic bacterium##2##2##(1996-2#1)(2008-6#1)
photosynthetic capacity##4##2##(2008-10#3)(2008-11#1)
photosynthetic electron flow##2##3##(2009-10#2)
photosynthetic electron transport to photorespiration##3##5##(2008-8#3)
photosynthetic electron transport##6##3##(1996-4#1)(2008-8#4)(2011-2#1)
photosynthetic electron##9##2##(1994-3#1)(1996-4#1)(2008-8#4)(2009-10#2)(2011-2#1)
photosynthetic function in##2##3##(2008-9#2)
photosynthetic function##3##2##(2008-9#3)
photosynthetic herbicides##3##2##(2008-10#3)
photosynthetic organisms##5##2##(2008-7#2)(2010-2#2)(2010-6#1)
photosynthetic pigments##3##2##(2008-12#2)(2011-1#1)
photosynthetic rate of##2##3##(2008-10#1)(2008-9#1)
photosynthetic rate##8##2##(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)
photosynthetic rates##2##2##(2008-10#2)
photosynthetic reaction center##2##3##(1992-6#1)(1993-8#1)
photosynthetic reaction##3##2##(1992-6#2)(1993-8#1)
photosynthetic responses of##2##3##(2012-5#1)(2012-7#1)
photosynthetic systems##2##2##(2008-10#2)
photosynthetic##82##1##(1990-7#1)(1992-6#2)(1993-8#2)(1994-3#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#9)(2009-10#3)(2009-6#1)(2009-8#1)(2010-2#5)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#1)(2013-7#1)(2013-8#1)
photosynthetically active##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
photosystem I##2##2##(1991-12#1)(2008-7#1)
photosystem II (PSII)##2##3##(2008-10#1)(2008-8#1)
photosystem II##11##2##(1991-12#1)(1996-10#1)(1996-4#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-8#3)
photosystem##13##1##(1991-12#2)(1996-10#1)(1996-4#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#3)
photosystem-II##6##1##(1990-5#6)
phototactic##2##1##(1993-3#1)(2009-10#1)
phototherapy##9##1##(1992-4#2)(1994-12#1)(1995-5#1)(1997-6#2)(2007-11#1)(2008-11#1)(2010-3#1)
photothermal OCT##3##2##(2011-1#3)
photothermal deflection spectroscopy##3##3##(2008-2#1)(2008-3#2)
photothermal deflection##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
photothermal lens spectroscopy##2##3##(2008-2#2)
photothermal lens##4##2##(2008-2#4)
photothermal method##2##2##(2008-10#1)(2008-3#1)
photothermal signals##2##2##(2008-3#2)
photothermal##35##1##(2007-11#1)(2008-10#2)(2008-2#11)(2008-3#14)(2010-6#1)(2011-1#4)(2012-12#2)
photothermorefractive glass##3##2##(2007-12#2)(2008-2#1)
photothermorefractive##4##1##(2007-12#2)(2008-2#2)
phototoxic##4##1##(1994-8#1)(1997-6#1)(2011-2#1)(2012-3#1)
phototoxicity##5##1##(1993-11#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#1)
phototransduction##3##1##(1991-9#1)(1994-12#1)(1994-5#1)
phototrophic##2##1##(2008-8#1)(2009-4#1)
phototrophs##4##1##(2009-4#2)(2012-2#2)
phototropic##2##1##(2008-9#1)(2011-1#1)
phototropism of rice root##3##4##(2008-9#3)
phototropism##7##1##(2008-9#7)
phototype##9##1##(2008-5#9)
photovoltage##2##1##(2007-11#1)(2008-2#1)
photovoltaic film##3##2##(2008-2#3)
photovoltaic spatial solitons##3##3##(2007-12#3)
photovoltaic spatial##4##2##(2007-12#4)
photovoltaic##13##1##(2007-12#4)(2008-10#1)(2008-2#6)(2008-7#1)(2009-11#1)
phrase &quot##3##2##(1996-2#1)(2007-12#1)(2007-2#1)
phrase##7##1##(1991-9#1)(1996-2#1)(2007-12#2)(2007-2#1)(2011-2#1)(2012-1#1)
phrases##6##1##(1991-2#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
phrenic nerve paresis##5##3##(2013-1#5)
phrenic nerve##10##2##(2008-9#5)(2013-1#5)
phrenic##11##1##(1997-6#1)(2008-9#5)(2013-1#5)
phrenic-musculocutaneous nerve transfer##4##3##(2008-9#4)
phthalate (DBP)##6##2##(2008-10#4)(2008-5#1)(2010-5#1)
phthalate (DEHP)##3##2##(2008-10#2)(2008-5#1)
phthalate (DEP)##2##2##(2008-10#1)(2008-5#1)
phthalate (DOP)##6##2##(2008-10#6)
phthalate acid esters##2##3##(2008-10#2)
phthalate as##3##2##(2008-10#3)
phthalate##45##1##(2008-10#29)(2008-12#1)(2008-5#10)(2010-2#1)(2010-5#3)(2013-8#1)
phthalates##11##1##(2008-10#8)(2008-11#2)(2008-5#1)
phthaleins##3##1##(2008-10#3)
phthalic acid##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
phthalic##8##1##(1994-3#1)(1995-11#1)(2008-10#5)(2008-5#1)
phthalide##2##1##(2008-11#2)
phthalides##2##1##(2008-12#2)
phthalocyanine (FePc)##2##2##(2008-10#2)
phthalocyanine and##2##2##(2008-10#2)
phthalocyanine complex##4##2##(2008-10#4)
phthalocyanine tetrasulfonate##2##2##(1990-11#2)
phthalocyanine##36##1##(1990-11#2)(1992-6#1)(2007-12#2)(2008-10#30)(2008-3#1)
phthirapteran##2##1##(2007-12#2)
phthirapterans##5##1##(2007-12#5)
phycobilisome##3##1##(1993-11#1)(2008-8#2)
phycobilisomes##9##1##(1992-3#3)(1993-11#5)(1997-6#1)
phycocyanin 645##2##2##(1994-5#2)
phycocyanin##7##1##(1994-5#2)(2008-3#1)(2008-8#4)
phycocyanobilins##3##1##(1994-5#3)
phycoerythrin fluorescence##3##2##(2008-10#1)(2008-2#2)
phycoerythrin spectral##3##2##(2008-2#3)
phycoerythrin##19##1##(1996-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-8#6)(2008-9#2)
phycoerythrobilin##3##1##(2008-2#2)(2008-3#1)
phycomycosis##3##1##(2007-7#3)
phycourobilin##4##1##(2008-2#2)(2008-3#1)(2008-8#1)
phyla##10##1##(1992-6#1)(2008-4#2)(2008-9#2)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)
phylactolaemate##2##1##(2011-2#2)
phylla##2##1##(2008-10#1)(2009-8#1)
phyllobacteria##3##1##(2008-10#3)
phyllodes tumor of the breast##4##5##(1994-12#1)(1995-4#3)
phyllodes tumor##8##2##(1992-10#2)(1994-12#1)(1995-4#5)
phyllodes tumour of the seminal vesicle##2##6##(2011-2#2)
phyllodes tumour##3##2##(2011-2#3)
phyllodes##17##1##(1992-10#2)(1994-12#1)(1995-4#5)(2011-2#4)(2011-3#5)
phyllody##3##1##(2008-10#3)
phylloplane##4##1##(2008-10#4)
phyllosilicates##4##1##(2008-6#4)
phyllosphere##2##1##(2008-10#2)
phyllotaxis##2##1##(2009-8#2)
phylogenetic affinity between Plecoptera and the other orders of Polyneoptera##2##10##(2007-12#2)
phylogenetic analyses of the##6##4##(2008-10#4)(2008-8#1)(2010-3#1)
phylogenetic analyses of##8##3##(2008-10#6)(2008-8#1)(2010-3#1)
phylogenetic analyses were##2##3##(2007-6#1)(2008-10#1)
phylogenetic analyses##23##2##(1995-11#1)(2007-6#1)(2008-10#12)(2008-8#2)(2009-5#1)(2009-6#1)(2010-3#2)(2010-6#1)(2013-8#2)
phylogenetic analysis based on the##2##5##(2008-10#1)(2008-5#1)
phylogenetic analysis indicated that##2##4##(2008-10#2)
phylogenetic analysis of the##3##4##(2008-10#2)(2008-8#1)
phylogenetic analysis of##13##3##(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-8#1)(2009-2#1)(2010-6#1)(2011-3#1)
phylogenetic analysis to##2##3##(2008-10#2)
phylogenetic analysis using##3##3##(1996-5#1)(2008-10#2)
phylogenetic analysis was##2##3##(1994-8#1)(2008-10#1)
phylogenetic analysis##40##2##(1993-12#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#22)(2008-5#3)(2008-8#3)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-3#1)(2013-7#1)
phylogenetic and##10##2##(1990-11#1)(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
phylogenetic approach##3##2##(2008-8#1)(2010-3#1)(2010-6#1)
phylogenetic associations##2##2##(2008-8#2)
phylogenetic branch##2##2##(1997-4#1)(2008-10#1)
phylogenetic comparative data##2##3##(2008-8#1)(2012-3#1)
phylogenetic comparative##3##2##(2008-8#1)(2012-3#2)
phylogenetic comparison##2##2##(1991-5#1)(2007-6#1)
phylogenetic comparisons##2##2##(1990-11#1)(2011-2#1)
phylogenetic considerations##2##2##(1990-11#1)(2008-7#1)
phylogenetic correction##2##2##(2008-8#2)
phylogenetic correlation##3##2##(2008-8#3)
phylogenetic coverage##2##2##(2008-10#2)
phylogenetic data##2##2##(2008-9#1)(2013-7#1)
phylogenetic dependence##2##2##(2008-8#2)
phylogenetic distribution##2##2##(2008-7#1)(2008-8#1)
phylogenetic estimation of##2##3##(2010-6#2)
phylogenetic groups using##2##3##(2008-10#1)(2008-8#1)
phylogenetic groups##5##2##(2008-10#4)(2008-8#1)
phylogenetic implications##5##2##(2007-12#4)(2011-2#1)
phylogenetic inference##2##2##(2008-8#2)
phylogenetic information##2##2##(1995-11#1)(2008-8#1)
phylogenetic interest because of the##2##5##(2011-2#2)
phylogenetic interest because of##4##4##(2011-2#4)
phylogenetic interest because##5##3##(2011-2#5)
phylogenetic lineages##3##2##(2008-10#2)(2008-8#1)
phylogenetic methods##2##2##(2008-8#1)(2010-3#1)
phylogenetic networks##2##2##(2008-4#1)(2008-8#1)
phylogenetic origin##2##2##(1993-11#1)(2008-10#1)
phylogenetic origins##2##2##(1995-12#1)(2010-7#1)
phylogenetic position of##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
phylogenetic position##6##2##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#3)
phylogenetic reconstruction and##2##3##(2008-8#2)
phylogenetic reconstruction##5##2##(2008-8#3)(2008-9#1)(2009-6#1)
phylogenetic relationship of##4##3##(1994-11#1)(1996-12#1)(2007-12#1)(2008-8#1)
phylogenetic relationship##9##2##(1994-11#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-10#1)(2013-1#1)
phylogenetic relationships among##6##3##(2008-10#3)(2008-5#2)(2008-6#1)
phylogenetic relationships between##2##3##(2008-10#1)(2008-5#1)
phylogenetic relationships of##4##3##(2008-10#2)(2010-3#1)(2010-6#1)
phylogenetic relationships were detected##2##4##(2008-10#2)
phylogenetic relationships were##3##3##(2008-10#2)(2008-6#1)
phylogenetic relationships within##2##3##(2008-10#2)
phylogenetic relationships##24##2##(1996-4#1)(2007-12#1)(2008-10#11)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)
phylogenetic species##3##2##(2008-10#3)
phylogenetic studies##2##2##(2008-10#1)(2008-7#1)
phylogenetic study##3##2##(2007-12#1)(2008-10#1)(2013-7#1)
phylogenetic tree and##2##3##(2011-1#1)(2013-8#1)
phylogenetic tree based on##3##4##(2008-10#2)(2013-1#1)
phylogenetic tree obtained##2##3##(1997-2#1)(2008-5#1)
phylogenetic tree of the##2##4##(1997-2#1)(1997-7#1)
phylogenetic tree of##4##3##(1997-2#1)(1997-7#1)(2008-8#2)
phylogenetic tree was reconstructed##2##4##(2011-1#1)(2013-8#1)
phylogenetic tree was##4##3##(2010-7#1)(2011-1#1)(2013-8#2)
phylogenetic tree##28##2##(1991-5#1)(1996-5#1)(1997-2#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#3)(2009-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2013-1#1)(2013-8#4)
phylogenetic trees##15##2##(2008-1#3)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2013-8#2)
phylogenetic##289##1##(1990-11#4)(1991-5#2)(1993-11#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#14)(2007-6#2)(2008-1#5)(2008-10#82)(2008-11#1)(2008-12#1)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#39)(2008-9#12)(2009-10#3)(2009-2#2)(2009-5#1)(2009-6#4)(2010-10#1)(2010-3#11)(2010-6#8)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#18)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#8)
phylogenetically based statistical##2##3##(2008-9#2)
phylogenetically closely related##2##3##(2008-10#2)
phylogenetically distant##2##2##(1991-12#1)(2008-10#1)
phylogenetically distinct from the##2##4##(2008-10#1)(2010-3#1)
phylogenetically distinct from##4##3##(2008-10#3)(2010-3#1)
phylogenetically distinct##8##2##(2008-10#7)(2010-3#1)
phylogenetically independent contrasts##3##3##(2008-8#3)
phylogenetically independent##5##2##(2008-8#3)(2009-8#1)(2013-1#1)
phylogenetically related to##3##3##(1997-2#1)(1997-4#1)(2011-2#1)
phylogenetically##39##1##(1991-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-6#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
phylogenetics##2##1##(2009-5#1)(2010-3#1)
phylogenies and##3##2##(2008-8#1)(2010-5#1)(2012-3#1)
phylogenies of##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
phylogenies##16##1##(2008-10#3)(2008-4#2)(2008-8#1)(2008-9#3)(2010-5#1)(2011-2#1)(2012-3#5)
phylogenomic analyses##3##2##(2008-7#1)(2010-3#1)(2013-8#1)
phylogenomic##9##1##(2008-7#2)(2009-10#2)(2010-3#1)(2012-3#2)(2013-8#2)
phylogenomics##2##1##(2010-3#2)
phylogeny and##7##2##(1995-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)
phylogeny inferred from##2##3##(2008-10#1)(2008-9#1)
phylogeny of##11##2##(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)
phylogeny##57##1##(1994-5#2)(1995-3#1)(2007-12#4)(2008-10#12)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#7)(2009-10#1)(2009-5#1)(2009-6#2)(2010-3#5)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
phylogeographic pattern##2##2##(1996-6#2)
phylogeographic##7##1##(1996-6#3)(2010-8#2)(2013-1#1)(2013-7#1)
phylogeography of##2##2##(1996-6#1)(2008-10#1)
phylogeography##3##1##(1996-6#1)(2008-10#1)(2010-8#1)
phylotypes##3##1##(2010-6#2)(2011-2#1)
phylum Planctomycetes##2##2##(2011-1#2)
phylum Synergistetes##3##2##(2011-2#3)
phylum of##2##2##(1994-2#1)(2010-6#1)
phylum##26##1##(1992-6#1)(1994-12#1)(1994-2#1)(1996-5#2)(2008-10#1)(2008-7#1)(2010-6#2)(2011-1#2)(2011-2#9)(2012-2#1)(2013-8#5)
physeal##2##1##(2009-3#1)(2013-1#1)
physical Health Improvement Profile##2##4##(2009-6#2)
physical Health Improvement##3##3##(2009-6#3)
physical UV filter##3##3##(2008-5#3)
physical abuse##7##2##(1995-11#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
physical activities and##2##3##(2010-8#1)(2011-2#1)
physical activities##8##2##(1993-3#1)(1995-6#2)(1996-6#1)(2008-1#1)(2010-8#2)(2011-2#1)
physical activity (PA)##4##3##(2009-3#2)(2011-2#1)(2012-2#1)
physical activity among##3##3##(2008-4#1)(2010-11#1)(2012-12#1)
physical activity and health##2##4##(2010-1#1)(2013-1#1)
physical activity and nutrition##2##4##(2008-7#2)
physical activity and physical##2##4##(2009-6#1)(2013-1#1)
physical activity and the##3##4##(2008-4#1)(2009-6#1)(2012-12#1)
physical activity and##23##3##(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-6#4)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#6)
physical activity at##2##3##(2010-11#1)(2013-1#1)
physical activity counseling##4##3##(2008-4#4)
physical activity during##2##3##(2007-2#1)(2009-9#1)
physical activity for##3##3##(1996-6#1)(2008-12#1)(2011-2#1)
physical activity in an##2##4##(2010-12#1)(2012-12#1)
physical activity in##8##3##(1995-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#3)
physical activity is##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
physical activity level##2##3##(2008-11#1)(2012-12#1)
physical activity levels##5##3##(1996-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
physical activity might##2##3##(2013-1#2)
physical activity of healthcare workers##3##5##(2013-1#3)
physical activity on body##2##4##(2007-12#1)(2008-5#1)
physical activity on##10##3##(2007-12#1)(2008-5#1)(2010-9#1)(2012-12#2)(2013-1#4)(2013-8#1)
physical activity participation##2##3##(2009-6#1)(2012-2#1)
physical activity practice##2##3##(2010-11#1)(2013-1#1)
physical activity than subjects##2##4##(2008-4#1)(2010-11#1)
physical activity##169##2##(1991-12#2)(1993-2#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#5)(2008-4#11)(2008-5#3)(2008-7#4)(2008-9#1)(2009-3#3)(2009-5#1)(2009-6#11)(2009-9#1)(2010-1#3)(2010-11#13)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#11)(2012-2#6)(2013-1#39)(2013-8#12)
physical adsorption##6##2##(2008-10#5)(2013-8#1)
physical aggression in children with attention-deficit/hyperactivity disorder##2##7##(2008-2#2)
physical aggression##8##2##(2008-2#8)
physical algorithm##3##2##(2008-3#3)
physical analysis of the##2##4##(2008-10#1)(2008-7#1)
physical and biological##8##3##(1994-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)
physical and chemical characteristics##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
physical and chemical properties of##5##5##(1992-8#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
physical and chemical properties##15##4##(1990-9#1)(1992-8#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-8#1)
physical and chemical stability##2##4##(2008-7#1)(2011-1#1)
physical and chemical variables##2##4##(2008-10#2)
physical and chemical##37##3##(1990-9#2)(1992-8#1)(1996-12#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#3)(2009-8#2)(2010-2#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2013-8#1)
physical and cognitive##2##3##(1995-3#1)(2013-1#1)
physical and emotional consequences of##2##5##(1997-2#1)(2011-2#1)
physical and emotional##9##3##(1991-8#1)(1997-2#1)(2009-5#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)
physical and functional##3##3##(1990-12#1)(1994-12#1)(2008-11#1)
physical and mental component##2##4##(2012-3#1)(2013-1#1)
physical and mental health and##3##5##(2008-10#1)(2011-2#2)
physical and mental health needs##2##5##(2010-10#1)(2011-2#1)
physical and mental health##17##4##(1994-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#1)
physical and mental quality of life##2##6##(2012-3#2)
physical and mental training combined##2##5##(2009-11#2)
physical and mental##33##3##(1990-6#1)(1991-3#1)(1994-1#1)(1994-3#1)(1995-5#1)(1996-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#3)(2009-3#1)(2010-10#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
physical and psychological##11##3##(1995-2#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-6#2)(2013-8#1)
physical and psychosocial##3##3##(2010-11#1)(2010-3#1)(2012-12#1)
physical and self-assessment tests##2##4##(2008-9#2)
physical and sexual abuse##2##4##(2008-2#1)(2009-7#1)
physical and social##3##3##(2008-11#1)(2010-11#1)(2012-3#1)
physical and structural properties of##2##5##(2010-2#2)
physical and symbolic isolation##2##4##(2009-7#2)
physical and##143##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#8)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#6)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#6)(2013-8#3)
physical appearance##3##2##(1993-1#1)(2007-12#1)(2009-7#1)
physical area##2##2##(2008-4#1)(2011-2#1)
physical assault##2##2##(1996-12#2)
physical attractiveness are##2##3##(2007-12#2)
physical attractiveness in Britain and Malaysia##2##6##(2007-12#2)
physical attractiveness##6##2##(2007-12#6)
physical beam##2##2##(2007-12#2)
physical burden and##2##3##(2008-6#2)
physical burden##3##2##(2008-6#3)
physical capacity##4##2##(1996-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
physical changes##9##2##(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-2#1)
physical characteristics of the##5##4##(1990-9#1)(1996-3#1)(2008-3#1)(2008-5#1)(2013-8#1)
physical characteristics of##11##3##(1990-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
physical characteristics##19##2##(1990-12#1)(1990-9#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
physical characterization and##2##3##(1990-2#1)(2008-5#1)
physical characterization of##2##3##(1995-5#1)(2008-3#1)
physical characterization##6##2##(1990-2#1)(1990-8#1)(1995-5#1)(2008-3#1)(2008-5#2)
physical chemistry of the##2##4##(2008-10#1)(2008-5#1)
physical chemistry##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)
physical competence##2##2##(2009-7#2)
physical component##4##2##(2007-8#1)(2008-5#1)(2008-7#2)
physical concept##2##2##(2008-3#1)(2012-2#1)
physical condition and##3##3##(1994-12#1)(2008-5#1)(2012-12#1)
physical condition##9##2##(1991-6#1)(1994-12#2)(1995-4#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
physical conditions##5##2##(1993-12#1)(1997-5#1)(2008-10#1)(2009-6#1)(2013-8#1)
physical connection##2##2##(2007-12#1)(2011-2#1)
physical contact##4##2##(1993-3#1)(1994-6#1)(2008-9#1)(2009-10#1)
physical damage##2##2##(1995-5#1)(2008-3#1)
physical demands##2##2##(2011-1#2)
physical dependence in##3##3##(1991-1#3)
physical dependence##8##2##(1991-1#4)(1991-12#2)(1996-12#1)(2009-7#1)
physical development##4##2##(2007-11#1)(2007-12#1)(2008-11#1)(2013-1#1)
physical differences##3##2##(1995-5#1)(2007-12#1)(2010-8#1)
physical disabilities##8##2##(1993-9#1)(1995-12#2)(2007-8#1)(2008-7#1)(2010-12#3)
physical disability##7##2##(1992-12#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-6#2)(2012-2#1)
physical discomfort##2##2##(2008-9#1)(2010-6#1)
physical disorder##2##2##(1997-7#1)(2010-12#1)
physical disorders##3##2##(1994-6#1)(1996-7#1)(2013-8#1)
physical distance##3##2##(2008-10#1)(2008-9#2)
physical education and##2##3##(2007-12#1)(2008-12#1)
physical education##6##2##(1993-6#1)(2007-12#1)(2008-12#2)(2009-6#1)(2012-2#1)
physical environment##3##2##(1996-12#1)(2011-2#1)(2012-3#1)
physical environments##2##2##(2008-11#1)(2012-2#1)
physical evidence##4##2##(1997-5#1)(2008-10#3)
physical exam##7##2##(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
physical examination and a##2##4##(1990-6#1)(1993-9#1)
physical examination and##13##3##(1990-12#1)(1990-6#1)(1993-9#1)(1995-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
physical examination are the most##2##5##(2006-10#1)(2013-8#1)
physical examination are the##3##4##(1997-3#1)(2006-10#1)(2013-8#1)
physical examination are##5##3##(1997-3#1)(2006-10#1)(2006-5#1)(2010-1#1)(2013-8#1)
physical examination screening##2##3##(1991-12#1)(2010-8#1)
physical examination##75##2##(1990-10#1)(1990-12#1)(1990-6#2)(1991-12#2)(1993-2#1)(1993-9#1)(1994-7#1)(1995-11#1)(1995-4#4)(1997-3#1)(1997-4#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#2)(2010-1#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
physical examinations and##2##3##(1997-7#1)(2007-8#1)
physical examinations##4##2##(1996-3#1)(1997-7#1)(2007-8#1)(2008-3#1)
physical exercise on##3##3##(1993-6#1)(2008-7#2)
physical exercise##22##2##(1990-3#1)(1993-2#1)(1993-6#2)(1995-6#1)(1996-11#1)(1996-9#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-1#1)(2010-12#1)(2010-6#2)(2011-1#3)(2013-8#3)
physical exercises and##2##3##(2011-1#2)
physical exercises##3##2##(2007-8#1)(2011-1#2)
physical exertion##2##2##(2010-10#2)
physical explanation for##2##3##(1996-12#1)(2007-11#1)
physical explanation##3##2##(1996-12#1)(2007-11#1)(2008-3#1)
physical factors##4##2##(1993-1#1)(2007-11#1)(2008-3#1)(2012-1#1)
physical features of##2##3##(1992-6#1)(2011-2#1)
physical features##3##2##(1992-6#1)(2010-6#1)(2011-2#1)
physical findings##5##2##(1997-8#1)(2008-8#2)(2009-9#1)(2013-1#1)
physical fitness and##3##3##(2012-2#3)
physical fitness##11##2##(1990-8#1)(1991-8#1)(2007-8#1)(2010-4#3)(2012-2#4)(2013-1#1)
physical forces##2##2##(2010-10#1)(2010-9#1)
physical forms##2##2##(2008-6#1)(2010-5#1)
physical function in adults##2##4##(2010-12#1)(2013-1#1)
physical function in##3##3##(2010-11#1)(2010-12#1)(2013-1#1)
physical function##15##2##(1990-5#1)(1996-1#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#2)(2010-12#3)(2010-8#1)(2011-2#1)(2013-1#2)
physical functioning and##2##3##(2007-11#1)(2011-2#1)
physical functioning##11##2##(1995-3#1)(2007-11#3)(2008-1#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
physical health and##3##3##(2008-1#1)(2010-2#2)
physical health care##2##3##(1995-2#1)(1997-2#1)
physical health consequences##2##3##(2010-12#1)(2012-2#1)
physical health of the##3##4##(2008-11#1)(2008-2#1)(2009-6#1)
physical health of##5##3##(1996-9#1)(2008-11#1)(2008-2#1)(2009-6#1)(2012-2#1)
physical health outcomes##2##3##(2009-5#1)(2010-3#1)
physical health problems##2##3##(2008-7#1)(2012-2#1)
physical health##27##2##(1995-2#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-7#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-8#1)
physical illness##4##2##(1992-3#1)(1997-5#1)(1997-7#1)(2010-12#1)
physical impairments##2##2##(2008-3#1)(2008-6#1)
physical inactivity##9##2##(1997-2#1)(2008-11#1)(2008-12#3)(2008-3#1)(2011-2#2)(2013-8#1)
physical injuries##2##2##(1996-3#1)(2009-10#1)
physical injury and##2##3##(1997-7#1)(2011-2#1)
physical injury##5##2##(1995-1#1)(1997-7#1)(2011-10#1)(2011-2#2)
physical insight into the##2##4##(2007-12#2)
physical interactions between##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
physical interactions##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)
physical interpretation##5##2##(1996-4#1)(2008-2#3)(2010-7#1)
physical limit##3##2##(2008-1#2)(2008-7#1)
physical limits##2##2##(2007-12#1)(2008-2#1)
physical linkage##3##2##(2008-8#2)(2008-9#1)
physical map of a##2##4##(1995-6#1)(1996-3#1)
physical map of chromosome##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
physical map of rice chromosome##2##5##(1996-10#2)
physical map of the genome##2##5##(1995-6#1)(2011-2#1)
physical map of the##7##4##(1995-6#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#1)
physical map of##15##3##(1995-6#2)(1996-10#2)(1996-3#1)(1997-2#2)(1997-6#1)(1997-8#3)(2008-10#2)(2008-8#1)(2011-2#1)
physical map##24##2##(1995-6#2)(1996-10#4)(1996-3#1)(1997-2#3)(1997-6#2)(1997-8#3)(1997-9#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-3#1)
physical mapping of##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
physical mapping##12##2##(1995-6#1)(1996-10#1)(1996-12#1)(1997-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#2)
physical maps##7##2##(1994-9#1)(1995-6#2)(1996-10#1)(2008-2#1)(2008-4#1)(2010-10#1)
physical measurements##2##2##(2009-12#1)(2009-5#1)
physical measures##2##2##(2008-12#1)(2011-2#1)
physical mechanism of##2##3##(2007-12#1)(2008-1#1)
physical mechanism##3##2##(2007-12#1)(2008-1#1)(2012-12#1)
physical medicine and##2##3##(2008-12#1)(2012-2#1)
physical medicine##5##2##(1990-6#1)(2008-12#3)(2012-2#1)
physical methods##2##2##(2010-7#2)
physical mixtures were##2##3##(2008-10#2)
physical mixtures##4##2##(2007-11#1)(2008-10#3)
physical mobility##2##2##(2007-11#1)(2010-11#1)
physical model for the##2##4##(2007-12#1)(2008-2#1)
physical model##7##2##(1991-8#1)(1996-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)
physical morbidity in the##2##4##(2012-12#2)
physical morbidity in##3##3##(2012-12#3)
physical movement##2##2##(1996-12#1)(2009-8#1)
physical needs##2##2##(2010-10#1)(2013-8#1)
physical ones##2##2##(1997-1#1)(2008-8#1)
physical or chemical##3##3##(2008-5#2)(2013-1#1)
physical or emotional##2##3##(2009-6#1)(2011-1#1)
physical or occupational therapists##2##4##(2008-4#2)
physical or occupational##3##3##(2008-4#3)
physical or##11##2##(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
physical order of##2##3##(1992-6#2)
physical parameter##2##2##(2008-10#1)(2008-5#1)
physical parameters and##2##3##(2007-11#1)(2008-2#1)
physical parameters of the##2##4##(2008-2#2)
physical parameters of##6##3##(2008-10#1)(2008-2#3)(2008-3#2)
physical parameters that##2##3##(2008-3#1)(2012-2#1)
physical parameters##22##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
physical performance and##2##3##(2008-3#1)(2011-2#1)
physical performance of##2##3##(2008-3#1)(2009-3#1)
physical performance##9##2##(1992-9#1)(1996-3#1)(2008-3#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
physical phenomena##3##2##(2008-10#1)(2008-3#2)
physical picture##3##2##(2007-11#1)(2008-3#1)(2010-7#1)
physical principles of##3##3##(1994-5#1)(2008-1#1)(2008-4#1)
physical principles##6##2##(1994-5#1)(1996-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-2#1)
physical problems##5##2##(1992-5#1)(2007-11#3)(2011-2#1)
physical processes that are##3##4##(2008-2#3)
physical processes that##4##3##(2008-2#3)(2008-3#1)
physical properties and##2##3##(2008-7#1)(2008-8#1)
physical properties of human##2##4##(2008-5#2)
physical properties of the##14##4##(1990-7#1)(1990-8#1)(1990-9#1)(1997-3#1)(2008-5#5)(2008-7#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
physical properties of##32##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1992-11#1)(1992-2#1)(1993-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#10)(2008-7#1)(2009-12#1)(2010-6#1)(2010-7#2)(2012-2#1)(2013-1#1)(2013-7#1)
physical properties##58##2##(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#13)(2008-7#2)(2008-8#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
physical property of the##3##4##(1992-6#2)(2012-2#1)
physical property##6##2##(1992-6#2)(1996-4#1)(2007-11#1)(2008-12#1)(2012-2#1)
physical proximity##2##2##(2008-10#2)
physical quantities##2##2##(2012-2#1)(2013-1#1)
physical rehabilitation##3##2##(1992-3#1)(1994-3#1)(2007-11#1)
physical relationship##2##2##(2008-4#1)(2012-12#1)
physical responses##2##2##(2007-6#1)(2008-11#1)
physical security##3##2##(1992-12#1)(2008-9#1)(2010-8#1)
physical self-perceptions##3##2##(2007-12#3)
physical separation of##2##3##(2008-4#1)(2009-12#1)
physical size##2##2##(2008-11#1)(2008-3#1)
physical stability of##2##3##(2008-5#1)(2013-7#1)
physical stability##5##2##(2008-5#3)(2010-5#1)(2013-7#1)
physical state of##4##3##(1990-12#1)(1990-2#1)(1994-8#1)(2008-4#1)
physical state##7##2##(1990-12#1)(1990-2#1)(1994-8#1)(2008-4#2)(2008-5#1)(2008-8#1)
physical status##4##2##(1993-1#1)(2008-7#1)(2010-7#1)(2012-3#1)
physical steady state##3##3##(2008-10#3)
physical stress##4##2##(2008-5#1)(2008-9#1)(2009-1#1)(2010-2#1)
physical stresses##2##2##(2008-10#1)(2011-2#1)
physical sunscreen films##2##3##(2008-5#2)
physical sunscreen##3##2##(2008-5#3)
physical symptoms and##2##3##(1992-2#1)(2007-5#1)
physical symptoms##5##2##(1992-2#1)(1994-12#1)(2007-5#1)(2009-12#2)
physical systems##6##2##(2007-12#1)(2008-3#1)(2012-2#2)(2013-1#2)
physical testing##2##2##(2012-2#2)
physical therapies##2##2##(2011-1#2)
physical therapist##3##2##(1993-12#1)(2008-12#2)
physical therapists in##3##3##(1992-3#1)(1993-12#2)
physical therapists with##2##3##(1993-12#1)(2008-12#1)
physical therapists##15##2##(1991-3#2)(1992-3#3)(1993-12#6)(2008-12#3)(2011-2#1)
physical therapy following surgery##2##4##(1994-3#2)
physical therapy in##3##3##(1993-3#1)(2008-12#1)(2008-7#1)
physical therapy management##2##3##(2008-12#2)
physical therapy treatment the weekend following##2##6##(1994-3#2)
physical therapy treatment##6##3##(1994-3#3)(2008-12#3)
physical therapy##45##2##(1991-3#1)(1993-12#2)(1993-3#1)(1994-3#6)(1995-2#1)(1995-3#3)(1996-1#4)(1997-6#1)(2008-12#14)(2008-7#4)(2008-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#3)
physical to##2##2##(1996-1#1)(2008-12#1)
physical training##8##2##(2007-6#1)(2008-7#1)(2009-11#1)(2013-1#3)(2013-8#2)
physical treatment##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
physical vapor deposition##2##3##(2009-11#1)(2009-7#1)
physical variables##2##2##(2008-10#1)(2008-9#1)
physical well-being##2##2##(1994-11#1)(2008-7#1)
physical##1344##1##(1990-10#2)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#7)(1990-7#2)(1990-8#5)(1990-9#6)(1991-1#6)(1991-12#6)(1991-2#2)(1991-3#4)(1991-6#3)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#3)(1993-6#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#6)(1994-3#8)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#8)(1995-4#5)(1995-5#5)(1995-6#11)(1996-1#9)(1996-10#6)(1996-11#1)(1996-12#11)(1996-3#6)(1996-4#4)(1996-6#3)(1996-7#2)(1996-9#2)(1997-1#5)(1997-2#11)(1997-3#3)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#5)(1997-9#2)(2006-10#2)(2006-5#2)(2007-10#2)(2007-11#25)(2007-12#32)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#1)(2007-8#12)(2008-1#19)(2008-10#84)(2008-11#33)(2008-12#50)(2008-2#42)(2008-3#63)(2008-4#28)(2008-5#64)(2008-6#17)(2008-7#44)(2008-8#22)(2008-9#21)(2009-1#2)(2009-10#6)(2009-11#13)(2009-12#9)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#8)(2009-6#19)(2009-7#12)(2009-8#7)(2009-9#4)(2010-1#10)(2010-10#10)(2010-11#22)(2010-12#16)(2010-2#11)(2010-3#9)(2010-4#6)(2010-5#5)(2010-6#9)(2010-7#12)(2010-8#13)(2010-9#5)(2011-1#23)(2011-10#1)(2011-2#53)(2011-3#1)(2012-1#8)(2012-12#24)(2012-2#44)(2012-3#18)(2012-5#1)(2013-1#73)(2013-7#2)(2013-8#40)
physical)##2##1##(1995-12#1)(2008-2#1)
physical-##2##1##(2008-5#2)
physical-chemical properties of##2##3##(1992-3#1)(1994-11#1)
physical-chemical properties##3##2##(1992-3#1)(1994-11#1)(2010-11#1)
physical-chemical##5##1##(1992-3#1)(1994-11#1)(2008-1#1)(2008-11#1)(2010-11#1)
physical/chemical##2##1##(2008-10#1)(2008-5#1)
physical/mental health##3##2##(2011-1#3)
physically active##9##2##(1992-5#1)(1994-3#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-1#3)
physically adsorbed##3##2##(1990-12#2)(2008-7#1)
physically aggressive##2##2##(2008-2#1)(2009-9#1)
physically and mentally##3##3##(1990-2#1)(1990-3#1)(1995-11#1)
physically and##7##2##(1990-2#1)(1990-3#1)(1995-11#1)(1997-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
physically assigned P1 clones##2##4##(1997-6#1)(1997-8#1)
physically cross-linked##2##2##(2009-12#2)
physically healthy##3##2##(1995-2#1)(1996-5#1)(1996-7#1)
physically interact##2##2##(1995-12#1)(2008-8#1)
physically interacts with##3##3##(1995-12#1)(2008-9#1)(2013-1#1)
physically interacts##4##2##(1995-12#2)(2008-9#1)(2013-1#1)
physically linked to QCR9##2##4##(1995-6#2)
physically linked to##7##3##(1993-6#1)(1995-5#1)(1995-6#3)(1996-10#1)(2008-4#1)
physically meaningful##2##2##(2008-2#2)
physically realistic##2##2##(1997-2#1)(2008-3#1)
physically remove##2##2##(2008-10#1)(2008-8#1)
physically robust##2##2##(2007-11#1)(2008-10#1)
physically separated##2##2##(2008-10#1)(2008-7#1)
physically##103##1##(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#4)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
physically-based##3##1##(2008-6#3)
physician acceptance##2##2##(1996-1#1)(1997-1#1)
physician access##2##2##(1996-3#2)
physician and patient##7##3##(1992-11#1)(1993-11#2)(1995-2#1)(2007-11#1)(2008-11#1)(2012-3#1)
physician and the##9##3##(1990-9#1)(1993-1#1)(1993-12#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2010-8#1)
physician and##40##2##(1990-9#1)(1992-1#3)(1992-11#1)(1992-4#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-7#2)(2010-8#1)(2012-3#2)(2013-1#1)
physician apologies##2##2##(2012-3#2)
physician arrangements##2##2##(1991-9#1)(1993-3#1)
physician as##6##2##(1992-1#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)
physician assistants##3##2##(1997-3#1)(2008-3#1)(2010-5#1)
physician at##3##2##(1991-12#1)(1996-9#1)(2008-1#1)
physician autonomy##3##2##(1994-1#1)(1996-12#2)
physician behavior##2##2##(1995-1#1)(1995-2#1)
physician centered##2##2##(1997-1#2)
physician charges##2##2##(1993-12#1)(1994-1#1)
physician claims##2##2##(1993-1#1)(1996-3#1)
physician compensation##4##2##(1993-3#1)(1995-12#1)(1996-1#2)
physician education##3##2##(1994-12#1)(1997-1#1)(2008-8#1)
physician fee##3##2##(1993-12#1)(1993-3#1)(2012-3#1)
physician fees are##2##3##(1994-1#2)
physician fees##6##2##(1994-1#4)(1996-3#1)(1997-1#1)
physician for a##2##3##(1993-2#1)(2008-12#1)
physician for##5##2##(1990-6#1)(1991-9#1)(1993-2#1)(1997-2#1)(2008-12#1)
physician groups##6##2##(1994-3#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-4#1)(2013-7#1)
physician health##3##2##(1992-12#2)(1996-12#1)
physician hospital##2##2##(1996-2#1)(1997-3#1)
physician house calls##2##3##(1992-5#1)(2011-2#1)
physician house##3##2##(1992-5#1)(2011-2#2)
physician if the##2##3##(1993-12#1)(2008-8#1)
physician in the##2##3##(1995-2#2)
physician in##12##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1995-11#1)(1995-2#2)(1997-4#1)(2010-12#1)(2010-8#1)
physician is##5##2##(1990-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(2012-12#1)
physician leaders##4##2##(1992-1#1)(1994-1#1)(1996-3#1)(2008-11#1)
physician liability##3##2##(1991-12#1)(1993-2#2)
physician management##2##2##(1997-2#1)(2011-2#1)
physician marketing##2##2##(1993-12#1)(1994-2#1)
physician may##3##2##(1992-1#1)(1993-11#1)(1997-1#1)
physician must##3##2##(1991-3#1)(1992-3#1)(2013-8#1)
physician office##4##2##(1992-1#1)(1994-3#2)(1996-12#1)
physician or##6##2##(1991-3#1)(1992-3#1)(1995-12#2)(2008-11#1)(2008-12#1)
physician order entry and##2##4##(1995-2#1)(2010-8#1)
physician order entry##4##3##(1995-2#3)(2010-8#1)
physician order##5##2##(1995-2#3)(2008-3#1)(2010-8#1)
physician organizations##2##2##(1993-3#1)(1997-2#1)
physician ownership of##2##3##(1993-3#1)(1996-1#1)
physician payment reform##5##3##(1994-1#2)(1995-12#3)
physician payment##18##2##(1991-1#2)(1991-12#1)(1992-1#1)(1993-3#1)(1994-1#6)(1994-12#2)(1995-12#4)(2008-4#1)
physician payments##2##2##(1993-12#1)(1994-1#1)
physician perceptions of##2##3##(1993-12#1)(1996-1#1)
physician performance information##2##3##(2013-1#2)
physician performance##7##2##(1996-3#1)(2010-9#1)(2013-1#5)
physician perspective##2##2##(1994-1#2)
physician practice patterns##2##3##(1992-12#1)(1994-12#1)
physician practice##9##2##(1991-12#1)(1992-12#1)(1994-1#2)(1994-12#2)(1997-3#1)(2010-8#1)(2010-9#1)
physician practices##4##2##(1991-12#1)(1992-12#1)(2011-2#1)(2013-1#1)
physician profiling##2##2##(1995-2#1)(1995-3#1)
physician referral##2##2##(1996-1#1)(2008-12#1)
physician referrals##3##2##(1994-2#1)(1995-1#1)(1995-3#1)
physician reimbursement##2##2##(1991-3#2)
physician relationships##3##2##(1991-12#1)(1995-3#1)(1996-3#1)
physician reports##2##2##(1993-6#1)(1997-3#1)
physician resources##2##2##(1994-12#1)(2008-11#1)
physician satisfaction##3##2##(1993-1#2)(2007-8#1)
physician service##3##2##(1991-3#1)(1992-8#1)(1995-12#1)
physician services##12##2##(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#3)(1994-1#2)(1994-3#2)(1995-12#1)
physician should##4##2##(1993-11#1)(1994-3#1)(2012-1#1)(2012-3#1)
physician staffing##3##2##(1992-8#2)(1993-3#1)
physician supply##3##2##(1993-2#1)(2008-12#1)(2012-3#1)
physician to##11##2##(1991-1#1)(1992-9#1)(1995-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
physician towards##2##2##(1993-12#2)
physician visits##3##2##(1995-1#1)(1995-12#1)(1997-2#1)
physician who##2##2##(1992-12#1)(1997-4#1)
physician with##2##2##(1993-3#1)(2011-1#1)
physician##458##1##(1990-6#5)(1990-9#1)(1991-1#9)(1991-11#1)(1991-12#10)(1991-2#1)(1991-3#5)(1991-6#3)(1991-9#2)(1992-1#12)(1992-11#3)(1992-12#9)(1992-2#5)(1992-3#4)(1992-4#3)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#6)(1993-11#5)(1993-12#19)(1993-2#8)(1993-3#15)(1993-6#1)(1993-8#1)(1994-1#25)(1994-12#9)(1994-2#7)(1994-3#14)(1994-5#1)(1995-1#5)(1995-11#1)(1995-12#19)(1995-2#11)(1995-3#7)(1995-6#1)(1995-9#1)(1996-1#12)(1996-12#9)(1996-2#2)(1996-3#12)(1996-6#1)(1996-9#1)(1997-1#12)(1997-2#10)(1997-3#11)(1997-4#6)(1997-7#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#5)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#10)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#2)
physician's office##6##2##(1990-11#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)
physician's perspective##2##2##(1991-12#1)(1992-12#1)
physician's role##3##2##(1992-6#2)(1993-3#1)
physician's##40##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#3)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#1)(2007-11#1)(2008-4#2)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
physician-based##4##1##(1995-12#2)(1996-11#1)(2013-1#1)
physician-driven marketing##2##2##(1991-1#2)
physician-hospital organizations##2##2##(1994-3#1)(1996-2#1)
physician-hospital##8##1##(1994-1#1)(1994-3#5)(1996-2#2)
physician-nurse collaboration##2##2##(1992-12#2)
physician-patient discussions##2##2##(2009-5#2)
physician-patient relationship##5##2##(1995-2#1)(1996-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
physician-patient##8##1##(1995-2#1)(1996-12#1)(2008-3#1)(2008-4#1)(2009-5#2)(2011-2#1)(2012-3#1)
physician-related factors##2##2##(1995-3#1)(2008-1#1)
physician-scientists##3##1##(1990-5#1)(2007-4#1)(2013-1#1)
physician]##6##1##(1991-3#1)(1993-6#1)(1995-3#1)(1996-8#1)(1996-9#2)
physicians (n =##2##3##(1996-9#2)
physicians about##2##2##(1995-3#1)(2008-10#1)
physicians according to##2##3##(1997-6#1)(2011-2#1)
physicians and general practitioners##2##4##(1995-5#1)(2008-10#1)
physicians and health care##2##4##(1991-2#1)(1996-3#1)
physicians and hospital##3##3##(1992-12#1)(1995-1#1)(1996-9#1)
physicians and hospitals to##3##4##(1992-3#1)(1996-2#2)
physicians and hospitals##10##3##(1991-3#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-1#1)(1996-2#2)(1997-5#1)
physicians and how##2##3##(1992-1#1)(1996-3#1)
physicians and management##2##3##(1991-3#1)(1997-2#1)
physicians and managers##4##3##(1992-2#1)(1995-1#1)(1997-1#2)
physicians and nurses##5##3##(1992-12#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-3#1)
physicians and patients##10##3##(1991-2#2)(1992-8#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-6#1)(2012-12#1)
physicians and payors##2##3##(1992-1#2)
physicians and physician groups##2##4##(1994-3#1)(1996-3#1)
physicians and physician##4##3##(1992-1#1)(1993-3#1)(1994-3#1)(1996-3#1)
physicians and public##3##3##(1997-6#1)(2008-1#1)(2008-8#1)
physicians and support##2##3##(1992-3#1)(1996-1#1)
physicians and surgeons##3##3##(1993-6#1)(2008-4#1)(2013-8#1)
physicians and their##9##3##(1991-1#1)(1991-2#2)(1992-5#1)(1994-3#1)(1995-2#1)(1996-1#1)(2008-11#1)(2011-2#1)
physicians and##104##2##(1990-5#1)(1991-1#1)(1991-2#8)(1991-3#4)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#5)(1996-9#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#3)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
physicians are not##2##3##(1991-1#1)(2010-8#1)
physicians are required to treat a hospital's emergency patients##2##9##(1993-1#1)(1993-2#1)
physicians are##20##2##(1991-1#1)(1991-3#3)(1992-1#3)(1992-5#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-4#1)(2006-12#1)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
physicians as##6##2##(1991-2#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-1#1)(2008-12#1)
physicians at the##2##3##(1996-9#1)(2010-6#1)
physicians at##5##2##(1991-4#1)(1992-4#1)(1996-9#1)(2010-5#1)(2010-6#1)
physicians attending##2##2##(1993-6#1)(2008-4#1)
physicians better##2##2##(1996-3#1)(2008-11#1)
physicians by##2##2##(1993-12#1)(2008-6#1)
physicians can be##3##3##(1992-8#1)(1993-12#1)(1996-1#1)
physicians can##7##2##(1991-3#1)(1992-8#1)(1993-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-6#1)
physicians completed##2##2##(2007-11#1)(2011-1#1)
physicians did not##4##3##(1990-2#1)(1993-6#1)(1995-5#1)(2012-1#1)
physicians during##2##2##(1990-2#1)(1996-3#1)
physicians for rural##3##3##(1994-1#2)(2008-12#1)
physicians for the##2##3##(1991-12#1)(1994-3#1)
physicians for##11##2##(1991-1#1)(1991-12#1)(1991-3#1)(1994-1#2)(1994-3#1)(1995-3#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-3#1)
physicians from##8##2##(1991-6#1)(1992-1#1)(1996-3#1)(2007-4#1)(2008-1#1)(2008-7#1)(2009-3#1)(2013-1#1)
physicians had##3##2##(1990-2#1)(1996-1#1)(1997-6#1)
physicians has##2##2##(1990-6#1)(2008-10#1)
physicians have not##2##3##(1991-1#1)(2011-2#1)
physicians have##8##2##(1991-1#1)(1991-12#1)(1992-2#1)(1994-3#1)(1995-3#1)(2009-3#1)(2010-9#1)(2011-2#1)
physicians in Norway##3##3##(1990-6#1)(1993-6#1)(1996-9#1)
physicians in a##5##3##(1994-12#1)(1996-1#1)(1996-9#1)(1997-6#1)(2008-7#1)
physicians in an##2##3##(1995-1#1)(1995-2#1)
physicians in the##12##3##(1991-8#2)(1992-6#1)(1993-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#1)
physicians in##57##2##(1990-6#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#6)(1995-1#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
physicians is##3##2##(1991-3#1)(2007-5#1)(2011-2#1)
physicians know about##2##3##(1990-2#1)(1994-2#1)
physicians know##3##2##(1990-2#1)(1994-2#1)(2010-10#1)
physicians make##2##2##(1994-2#1)(2007-12#1)
physicians may be##2##3##(1996-3#1)(2008-11#1)
physicians may##3##2##(1996-3#1)(1997-1#1)(2008-11#1)
physicians must be##2##3##(1994-2#1)(1994-3#1)
physicians must##5##2##(1991-3#1)(1994-2#1)(1994-3#1)(2008-8#2)
physicians need to##4##3##(1993-12#1)(1994-2#1)(2008-1#1)(2013-7#1)
physicians of##2##2##(2007-11#1)(2007-8#1)
physicians or##3##2##(1991-3#1)(1994-12#1)(2009-5#1)
physicians per##2##2##(1993-1#1)(1996-3#1)
physicians prescribe##2##2##(1993-12#1)(2011-2#1)
physicians should be aware of##2##5##(2008-10#1)(2011-2#1)
physicians should be##7##3##(1990-6#1)(1991-1#1)(1991-3#2)(1996-8#1)(2008-10#1)(2011-2#1)
physicians should consider##2##3##(2011-2#1)(2013-1#1)
physicians should##14##2##(1990-6#1)(1991-1#1)(1991-3#3)(1994-3#1)(1996-8#1)(2008-10#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
physicians specializing in##2##3##(1996-1#1)(2008-12#1)
physicians than##2##2##(1993-12#1)(1997-6#1)
physicians through the##2##3##(1997-1#1)(2008-1#1)
physicians through##3##2##(1996-3#1)(1997-1#1)(2008-1#1)
physicians to the##2##3##(1997-3#1)(2008-4#1)
physicians to##22##2##(1991-3#1)(1992-1#1)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#2)(1996-3#1)(1997-3#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
physicians towards##2##2##(2008-1#1)(2013-1#1)
physicians under Medicare##2##3##(1991-2#1)(1992-2#1)
physicians under##4##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)
physicians was##3##2##(1997-3#1)(2008-11#2)
physicians were##10##2##(1993-12#1)(1996-11#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-10#1)(2011-2#2)
physicians when##2##2##(1993-3#1)(2012-3#1)
physicians while dealing with##2##4##(2009-5#1)(2013-8#1)
physicians who did not smoke##2##5##(2011-2#2)
physicians who provide##2##3##(1991-2#1)(1993-12#1)
physicians who were##2##3##(2011-2#2)
physicians who##12##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-7#1)(1996-9#1)(2007-7#1)(2008-11#1)(2011-2#5)
physicians will not##2##3##(1994-2#1)(2010-4#1)
physicians will##5##2##(1992-1#1)(1994-2#1)(1995-12#1)(1997-1#1)(2010-4#1)
physicians with the##3##3##(1994-1#1)(2007-5#2)
physicians with##10##2##(1991-3#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-3#1)(2007-5#2)(2008-3#1)(2010-9#1)(2011-2#1)
physicians working in##3##3##(2008-1#1)(2008-7#1)(2009-11#1)
physicians would##2##2##(1992-1#1)(1996-9#1)
physicians##675##1##(1990-10#1)(1990-2#8)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#10)(1991-12#7)(1991-2#21)(1991-3#24)(1991-4#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#14)(1992-11#1)(1992-12#10)(1992-2#12)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#9)(1993-11#3)(1993-12#16)(1993-2#4)(1993-3#16)(1993-5#2)(1993-6#7)(1994-1#16)(1994-11#1)(1994-12#11)(1994-2#13)(1994-3#19)(1994-6#2)(1994-7#1)(1995-1#11)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#6)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#16)(1996-11#4)(1996-12#5)(1996-2#9)(1996-3#18)(1996-6#1)(1996-8#2)(1996-9#10)(1997-1#14)(1997-2#5)(1997-3#13)(1997-4#2)(1997-5#1)(1997-6#8)(1997-8#4)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#7)(2007-7#4)(2007-8#2)(2008-1#14)(2008-10#9)(2008-11#24)(2008-12#8)(2008-3#7)(2008-4#13)(2008-5#1)(2008-6#7)(2008-7#11)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-9#3)(2010-1#3)(2010-10#4)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#8)(2011-1#7)(2011-2#21)(2012-1#7)(2012-12#2)(2012-2#8)(2012-3#11)(2013-1#16)(2013-7#3)(2013-8#6)
physicians' attitudes##2##2##(1997-1#1)(1997-6#1)
physicians' knowledge##3##2##(2008-11#1)(2011-2#2)
physicians' office records and Medicare Part B claims##2##8##(1996-2#2)
physicians' office##3##2##(1992-12#1)(1996-2#2)
physicians' offices##4##2##(1992-1#1)(1994-2#2)(1996-2#1)
physicians' perceptions of##5##3##(1993-12#1)(1997-3#1)(2011-1#3)
physicians' perceptions##6##2##(1993-12#1)(1997-3#1)(2011-1#4)
physicians' services##7##2##(1991-2#5)(1993-2#1)(2009-3#1)
physicians' unawareness of patients'##2##4##(2011-1#2)
physicians' work##2##2##(1995-2#2)
physicians'##58##1##(1990-6#1)(1991-12#2)(1991-2#6)(1991-3#3)(1992-1#1)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-3#1)(2010-8#1)(2011-1#6)(2011-2#3)
physicians/nurses##2##1##(2012-3#2)
physicians?]##4##1##(1990-6#2)(1993-6#1)(1994-3#1)
physicians]##12##1##(1990-6#1)(1991-4#1)(1992-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-4#1)
physicists and##2##2##(2008-10#2)
physicists##13##1##(1990-11#1)(2007-4#7)(2008-10#2)(2008-7#1)(2009-11#1)(2009-5#1)
physico-chemical and structural##2##3##(2008-10#2)
physico-chemical and##5##2##(1992-6#1)(2008-10#2)(2010-4#1)(2013-1#1)
physico-chemical characteristics##2##2##(1994-12#1)(2012-2#1)
physico-chemical parameters##10##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2013-7#2)
physico-chemical properties of the##2##4##(1992-6#2)
physico-chemical properties of##4##3##(1992-6#2)(2008-10#1)(2008-5#1)
physico-chemical properties##17##2##(1990-7#1)(1992-6#2)(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-5#6)(2012-1#1)
physico-chemical stability##2##2##(1992-5#1)(2008-10#1)
physico-chemical##48##1##(1990-7#1)(1992-5#1)(1992-6#3)(1994-12#1)(1994-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-5#8)(2008-6#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
physicochemical and functional##2##3##(2012-2#2)
physicochemical and##5##2##(2008-7#1)(2009-3#1)(2012-2#3)
physicochemical characteristics of##2##3##(2008-10#1)(2008-5#1)
physicochemical characteristics##5##2##(2008-10#2)(2008-5#3)
physicochemical characterization of##2##3##(2008-10#2)
physicochemical conditions##4##2##(2008-10#1)(2008-11#1)(2013-7#2)
physicochemical parameters and##3##3##(1996-5#1)(2008-10#2)
physicochemical parameters on the##2##4##(1996-5#1)(2008-10#1)
physicochemical parameters##9##2##(1996-5#2)(2008-10#6)(2008-5#1)
physicochemical properties and##2##3##(2008-10#1)(2011-2#1)
physicochemical properties of##8##3##(1993-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-4#1)
physicochemical properties##26##2##(1990-7#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-2#1)(1996-5#1)(2008-10#8)(2008-11#2)(2008-5#4)(2008-8#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
physicochemical##72##1##(1990-7#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-5#3)(1997-4#1)(2007-11#1)(2008-10#25)(2008-11#4)(2008-5#9)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#6)(2013-1#2)(2013-7#2)
physics and chemistry##3##3##(2007-11#1)(2008-7#1)(2012-2#1)
physics and##9##2##(2007-11#1)(2008-3#1)(2008-7#1)(2010-9#3)(2011-2#1)(2012-2#2)
physics is##2##2##(1996-4#1)(2007-12#1)
physics of the##2##3##(2008-3#1)(2012-2#1)
physics of##5##2##(2008-2#2)(2008-3#1)(2012-2#1)(2013-1#1)
physics##44##1##(1990-2#1)(1991-5#1)(1994-3#1)(1996-4#2)(1997-6#1)(2007-11#2)(2007-12#3)(2007-4#3)(2008-1#2)(2008-2#2)(2008-3#3)(2008-7#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#4)(2010-9#3)(2011-2#1)(2012-2#6)(2013-1#1)
physics-based##2##1##(2008-10#1)(2008-6#1)
physio-chemical parameters##4##2##(2008-10#4)
physio-chemical##5##1##(2008-10#5)
physiogenomic##2##1##(2012-3#2)
physiologic and metabolic##2##3##(1992-9#1)(2008-5#1)
physiologic and pathologic##4##3##(1990-3#1)(1993-12#1)(2008-9#1)(2010-6#1)
physiologic and##7##2##(1990-3#1)(1992-9#1)(1993-12#1)(1995-2#1)(2008-5#1)(2008-9#1)(2010-6#1)
physiologic concentrations of##2##3##(1991-9#1)(1993-6#1)
physiologic functions##2##2##(2012-1#1)(2013-8#1)
physiologic mechanisms##3##2##(1994-9#1)(2008-3#1)(2010-8#1)
physiologic parameters##2##2##(1991-1#1)(1994-3#1)
physiologic processes in##2##3##(2008-5#1)(2012-12#1)
physiologic processes##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
physiologic regulation##2##2##(1994-11#1)(2008-7#1)
physiologic responsivity##2##2##(1996-7#2)
physiologic role##6##2##(1993-8#1)(1994-12#1)(1995-2#1)(2008-4#2)(2013-7#1)
physiologic saline##2##2##(1993-1#1)(2012-3#1)
physiologic significance##2##2##(1990-3#1)(2013-8#1)
physiologic systems##3##2##(1997-1#1)(2010-7#2)
physiologic##88##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#2)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#3)(1996-3#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#2)(2008-9#3)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#4)(2010-8#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
physiological activity##4##2##(2007-11#1)(2008-10#1)(2009-8#1)(2013-1#1)
physiological adaptation##3##2##(2008-1#1)(2008-11#1)(2010-12#1)
physiological adaptations##4##2##(2011-2#1)(2012-3#1)(2013-8#2)
physiological agonists##2##2##(1992-12#1)(2006-6#1)
physiological alterations##2##2##(2009-11#1)(2012-3#1)
physiological and behavioral##5##3##(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#2)
physiological and biochemical##5##3##(1991-2#1)(2008-11#2)(2012-2#1)(2013-8#1)
physiological and metabolic##2##3##(2010-2#1)(2012-1#1)
physiological and pathological conditions##2##4##(2008-4#1)(2008-8#1)
physiological and pathological##9##3##(1990-9#1)(1992-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-8#1)
physiological and pathophysiological##5##3##(2008-5#1)(2009-12#1)(2010-11#1)(2011-1#2)
physiological and pharmacological##2##3##(1992-6#1)(2008-7#1)
physiological and psychological##2##3##(1992-2#1)(2007-2#1)
physiological and##47##2##(1990-9#1)(1991-2#1)(1992-2#2)(1992-6#1)(1996-9#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#4)(2013-7#1)(2013-8#2)
physiological and/or##3##2##(2008-11#1)(2008-5#1)(2009-9#1)
physiological as well as pathological##2##5##(1990-8#1)(2010-9#1)
physiological basis of##2##3##(2007-12#1)(2008-10#1)
physiological basis##3##2##(1994-11#1)(2007-12#1)(2008-10#1)
physiological changes in##2##3##(2008-12#1)(2008-9#1)
physiological changes##11##2##(1990-11#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-8#2)(2008-9#2)(2009-5#1)(2012-12#1)
physiological characteristics##3##2##(1991-2#1)(1994-5#1)(2008-5#1)
physiological concentration##3##2##(1993-8#1)(2008-10#1)(2008-3#1)
physiological concentrations of##2##3##(1992-3#1)(2013-8#1)
physiological concentrations##7##2##(1992-3#1)(1993-6#1)(1993-9#1)(2008-10#2)(2010-8#1)(2013-8#1)
physiological conditions and after##2##4##(2008-7#2)
physiological conditions and##3##3##(1990-9#1)(2008-7#2)
physiological conditions of##2##3##(1997-2#1)(2008-10#1)
physiological conditions##36##2##(1990-11#1)(1990-12#3)(1990-7#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
physiological constraints##8##2##(2008-7#5)(2008-8#1)(2009-8#1)(2010-8#1)
physiological context##2##2##(2008-7#1)(2009-8#1)
physiological data##5##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)
physiological deterioration##2##2##(2008-7#1)(2008-9#1)
physiological differences between##2##3##(1992-4#1)(2008-10#1)
physiological differences##3##2##(1992-4#1)(1996-12#1)(2008-10#1)
physiological effects of##3##3##(1992-3#1)(1995-3#1)(2008-3#1)
physiological effects##7##2##(1992-3#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)
physiological environments##2##2##(1995-8#1)(2012-2#1)
physiological events##6##2##(2008-2#2)(2008-4#2)(2008-7#1)(2009-8#1)
physiological evolution##2##2##(2008-5#1)(2008-7#1)
physiological factors##5##2##(1995-6#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-12#1)
physiological fluids##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
physiological function of NACP##2##4##(1997-2#2)
physiological function of##8##3##(1994-2#1)(1997-2#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
physiological function##14##2##(1994-2#1)(1995-6#1)(1997-2#3)(1997-6#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#2)(2013-8#1)
physiological functions and##2##3##(1994-12#1)(2008-7#1)
physiological functions in##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
physiological functions##23##2##(1992-9#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2011-2#2)(2013-1#1)(2013-8#2)
physiological gonadal secretions##2##3##(2008-11#2)
physiological growth##4##2##(2008-12#2)(2008-5#1)(2008-9#1)
physiological impact##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
physiological information##2##2##(2008-7#1)(2012-12#1)
physiological interactions##2##2##(1996-12#1)(2008-1#1)
physiological ionic strengths##2##3##(1995-2#2)
physiological ionic##6##2##(1990-7#1)(1994-5#3)(1995-2#2)
physiological leaf spot formation in##2##5##(2008-10#2)
physiological leaf spot##3##3##(2008-10#3)
physiological leaf##4##2##(2008-10#4)
physiological level##2##2##(2008-10#1)(2011-10#1)
physiological levels of##4##3##(1996-5#1)(2008-10#1)(2010-1#1)(2012-6#1)
physiological levels##8##2##(1996-5#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-1#1)(2012-6#1)(2013-1#1)
physiological maturity##3##2##(2008-10#2)(2008-12#1)
physiological meaning of##2##3##(2008-1#1)(2008-7#1)
physiological measures##2##2##(2008-10#1)(2008-5#1)
physiological mechanisms that##4##3##(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
physiological mechanisms##10##2##(1990-11#1)(1990-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)
physiological motion##2##2##(2011-1#1)(2012-2#1)
physiological or pathological##2##3##(1993-3#1)(1996-6#1)
physiological or pharmacological##2##3##(2008-4#1)(2009-9#1)
physiological or##6##2##(1993-3#1)(1996-6#1)(2008-4#2)(2008-9#1)(2009-9#1)
physiological pH##9##2##(1996-12#1)(2008-10#6)(2008-4#1)(2009-11#1)
physiological parameters in##3##3##(2007-12#2)(2008-12#1)
physiological parameters of##2##3##(2008-12#2)
physiological parameters##12##2##(1994-5#1)(2007-12#2)(2008-10#1)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
physiological partners##4##2##(1994-5#1)(1995-2#3)
physiological peptides##2##2##(1990-11#1)(1992-5#1)
physiological process##3##2##(2007-11#1)(2009-3#1)(2010-6#1)
physiological processes such as##4##4##(2008-10#1)(2008-8#1)(2009-12#1)(2009-6#1)
physiological processes##24##2##(1992-5#1)(1992-8#1)(1993-5#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#1)
physiological properties of##8##3##(1997-6#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-1#1)(2013-8#1)
physiological properties##10##2##(1997-6#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2012-1#1)(2013-8#1)
physiological races of D##2##4##(2008-10#2)
physiological races##4##2##(2008-10#4)
physiological range##5##2##(1993-6#1)(1995-5#1)(2007-2#1)(2008-10#2)
physiological ranges of##2##3##(1994-12#1)(2011-2#1)
physiological ranges##3##2##(1994-12#1)(2008-6#1)(2011-2#1)
physiological reactions##2##2##(2011-2#1)(2012-12#1)
physiological redox##2##2##(1994-5#1)(2008-11#1)
physiological regulation of##2##3##(1994-8#1)(1995-11#1)
physiological regulation##4##2##(1994-8#1)(1995-11#1)(2008-9#1)(2012-12#1)
physiological response of##4##3##(2007-7#1)(2008-9#1)(2013-1#2)
physiological response to##3##3##(1990-11#1)(1995-2#1)(2012-2#1)
physiological response##9##2##(1990-11#1)(1995-2#1)(2007-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
physiological responses of##4##3##(1997-8#1)(2008-10#1)(2008-9#1)(2013-7#1)
physiological responses##13##2##(1990-9#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-7#2)(2013-8#2)
physiological role in the regulation of##2##6##(2008-1#1)(2008-4#1)
physiological role in the##4##4##(1997-4#1)(2008-1#1)(2008-4#2)
physiological role in##8##3##(1994-8#1)(1997-4#1)(2008-1#1)(2008-4#2)(2008-6#1)(2009-8#1)(2012-12#1)
physiological role of the##3##4##(1994-6#1)(2008-1#1)(2008-4#1)
physiological role of##17##3##(1990-11#1)(1993-3#1)(1994-6#1)(1995-11#1)(1997-2#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
physiological role##37##2##(1990-11#1)(1990-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#2)(1997-1#1)(1997-2#1)(1997-4#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#1)(2009-11#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
physiological role(s) for##2##3##(1995-3#1)(1995-6#1)
physiological roles of NCKX proteins##2##5##(2008-8#2)
physiological roles of plant##2##4##(1997-4#1)(2009-8#1)
physiological roles of##6##3##(1992-12#1)(1997-4#1)(2008-8#2)(2009-8#1)(2010-12#1)
physiological roles##14##2##(1992-12#1)(1996-2#1)(1997-4#1)(1997-7#2)(2008-4#1)(2008-8#3)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#2)
physiological saline##3##2##(1997-2#1)(2008-5#1)(2011-2#1)
physiological salt##2##2##(2009-12#1)(2010-3#1)
physiological samples##3##2##(2008-10#3)
physiological significance of##5##3##(1991-3#1)(1993-11#1)(1994-5#1)(1994-6#1)(2010-3#1)
physiological situations##2##2##(2009-5#1)(2011-2#1)
physiological stability and##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
physiological state and##2##3##(2008-10#1)(2010-2#1)
physiological state of the cell##2##5##(1995-9#1)(2012-3#1)
physiological state##9##2##(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
physiological states##4##2##(1994-12#1)(2008-3#2)(2008-7#1)
physiological status##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
physiological stimuli##3##2##(2008-2#1)(2008-4#2)
physiological stress##4##2##(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
physiological studies of##2##3##(2008-7#1)(2010-2#1)
physiological studies##4##2##(1996-9#1)(2008-10#1)(2008-7#1)(2010-2#1)
physiological system##2##2##(2008-11#1)(2008-9#1)
physiological systems##3##2##(2006-10#1)(2009-12#1)(2011-2#1)
physiological temperature##5##2##(1995-3#2)(2008-10#1)(2013-8#2)
physiological temperatures##3##2##(1994-3#2)(2008-10#1)
physiological traits##5##2##(2008-10#3)(2008-8#1)(2013-7#1)
physiological understanding##2##2##(2008-11#1)(2012-1#1)
physiological##688##1##(1990-11#10)(1990-12#8)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#10)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#4)(1995-12#1)(1995-2#11)(1995-3#4)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#3)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#5)(1997-6#5)(1997-7#3)(1997-8#2)(2006-10#2)(2006-6#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#80)(2008-11#32)(2008-12#9)(2008-2#6)(2008-3#6)(2008-4#27)(2008-5#24)(2008-6#7)(2008-7#40)(2008-8#19)(2008-9#26)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#7)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#12)(2009-9#6)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#3)(2010-2#12)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#31)(2012-1#3)(2012-12#9)(2012-2#22)(2012-3#9)(2012-4#1)(2012-6#2)(2013-1#18)(2013-7#6)(2013-8#15)
physiological- and product-dependent parameters##2##4##(2008-5#2)
physiologically active compounds##2##3##(2008-10#2)
physiologically active##5##2##(1994-8#1)(2006-12#1)(2008-10#3)
physiologically and##3##2##(2008-3#1)(2009-7#1)(2012-2#1)
physiologically appropriate##2##2##(1992-8#1)(2008-7#1)
physiologically as##2##2##(1992-6#1)(1995-5#1)
physiologically constitutive##2##2##(1990-12#2)
physiologically functional##2##2##(2008-11#1)(2009-7#1)
physiologically important##4##2##(1994-11#1)(2007-12#1)(2008-10#1)(2012-9#1)
physiologically or##2##2##(2008-4#1)(2010-1#1)
physiologically relevant##11##2##(1990-8#1)(1992-5#1)(1994-8#1)(2008-12#1)(2008-7#1)(2009-12#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
physiologically significant##2##2##(2008-10#1)(2008-4#1)
physiologically##66##1##(1990-12#2)(1990-8#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#3)(2009-12#2)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#1)
physiology and disease##2##3##(2008-10#1)(2011-2#1)
physiology and pathology##2##3##(2008-8#1)(2010-10#1)
physiology and the##2##3##(2008-4#1)(2010-7#1)
physiology and##30##2##(1992-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
physiology as##2##2##(2008-12#1)(2010-7#1)
physiology in##5##2##(2008-3#1)(2008-7#1)(2010-3#2)(2012-5#1)
physiology is##4##2##(1990-5#1)(1991-9#1)(2007-8#1)(2008-10#1)
physiology of the gastrointestinal tract##2##5##(2008-7#1)(2011-2#1)
physiology of the##18##3##(1990-5#1)(1993-2#1)(1994-9#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
physiology of these##3##3##(1991-12#1)(2008-7#1)(2008-8#1)
physiology of this##3##3##(2009-9#1)(2010-8#1)(2011-1#1)
physiology of##46##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-6#1)(1993-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
physiology through##2##2##(2011-2#2)
physiology##181##1##(1990-12#1)(1990-2#1)(1990-5#4)(1991-12#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#3)(1994-2#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-1#5)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#6)(2008-7#16)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#6)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#5)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#13)(2012-12#4)(2012-2#7)(2012-3#2)(2012-5#2)(2013-8#4)
physiology)##3##1##(2008-9#1)(2010-3#1)(2010-8#1)
physiome##2##1##(2010-9#2)
physiopathological mechanisms##2##2##(1990-9#1)(1997-3#1)
physiopathological##14##1##(1990-12#1)(1990-9#1)(1992-3#1)(1992-5#1)(1993-6#1)(1997-3#2)(1997-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-6#2)
physiopathology and##2##2##(2008-10#1)(2008-7#1)
physiopathology of the##2##3##(2008-10#1)(2008-5#1)
physiopathology of##12##2##(1990-9#2)(1992-3#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)
physiopathology##21##1##(1990-9#2)(1992-3#2)(1992-5#2)(1994-9#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#2)
physiotherapeutic##4##1##(1991-6#1)(2012-12#3)
physiotherapist##11##1##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-3#2)(2013-1#1)
physiotherapists and##4##2##(1996-1#2)(1996-2#1)(2007-11#1)
physiotherapists can##2##2##(1992-12#1)(2011-2#1)
physiotherapists in##3##2##(1993-1#1)(1994-3#2)
physiotherapists were##3##2##(1993-2#1)(1996-6#1)(2012-12#1)
physiotherapists##35##1##(1991-2#1)(1992-12#2)(1993-1#4)(1993-2#4)(1994-3#3)(1995-12#1)(1996-1#2)(1996-2#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-3#5)(2009-4#1)(2009-7#1)(2011-2#3)(2012-12#2)(2012-3#1)
physiotherapists'##3##1##(1991-6#1)(1993-3#2)
physiotherapy and##2##2##(1993-1#1)(2007-11#1)
physiotherapy assessment##2##2##(1992-12#1)(2011-2#1)
physiotherapy care##2##2##(1992-2#1)(2011-2#1)
physiotherapy clinics##2##2##(1995-2#1)(2008-10#1)
physiotherapy for##4##2##(1997-3#1)(2008-7#1)(2012-12#2)
physiotherapy in prisons##2##3##(1992-2#2)
physiotherapy in##3##2##(1991-2#1)(1992-2#2)
physiotherapy is##3##2##(1994-2#1)(2008-3#1)(2012-12#1)
physiotherapy management##2##2##(2008-3#2)
physiotherapy practice##6##2##(1991-6#1)(1995-12#1)(1996-1#1)(2008-10#1)(2012-1#1)(2012-12#1)
physiotherapy students##12##2##(1996-1#2)(2012-1#2)(2012-12#8)
physiotherapy utilization for##2##3##(2012-2#2)
physiotherapy utilization##3##2##(2012-2#3)
physiotherapy were##2##2##(1993-1#1)(2012-3#1)
physiotherapy##88##1##(1990-6#3)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#3)(1992-5#1)(1993-1#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#3)(1996-2#1)(1997-3#3)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-3#3)(2008-7#1)(2009-3#1)(2011-2#3)(2012-1#5)(2012-12#21)(2012-2#7)(2012-3#3)
physique##2##1##(2009-4#1)(2010-4#1)
physis##3##1##(2007-11#1)(2008-8#1)(2013-1#1)
physisorbed##5##1##(1991-9#1)(2008-10#2)(2010-12#2)
physisorption##2##1##(2008-10#2)
physodes##3##1##(2008-10#3)
physostigmine and pilocarpine##2##3##(2008-10#2)
physostigmine application##2##2##(1991-12#1)(1995-12#1)
physostigmine##5##1##(1991-12#1)(1995-12#1)(2008-10#3)
phytase supplementation in##2##3##(2010-2#2)
phytase supplementation##3##2##(2010-2#3)
phytase##24##1##(1992-12#1)(1993-8#2)(1995-3#1)(2008-11#2)(2008-4#3)(2010-2#15)
phytate##3##1##(2012-12#1)(2012-2#2)
phytate-phosphorus##2##1##(2010-2#2)
phytic acid##4##2##(2008-10#4)
phytoalexin accumulation##2##2##(2008-10#2)
phytoalexin response##3##2##(2008-10#3)
phytoalexin##13##1##(2008-10#13)
phytoalexins in##3##2##(2008-10#3)
phytoalexins##11##1##(2008-10#11)
phytochelatin##3##1##(1994-8#3)
phytochelatins##3##1##(1994-8#1)(2008-10#2)
phytochemical analysis##2##2##(2010-5#1)(2010-6#1)
phytochemical constituents##2##2##(2008-12#1)(2009-11#1)
phytochemical screening of##2##3##(2008-10#2)
phytochemical##10##1##(2008-10#3)(2008-12#1)(2009-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
phytochemicals and##2##2##(2010-1#1)(2013-1#1)
phytochemicals##19##1##(2008-10#2)(2008-7#9)(2008-8#1)(2010-1#2)(2012-2#1)(2013-1#4)
phytochrome##8##1##(1990-5#2)(1995-2#3)(2008-4#1)(2009-8#1)(2012-2#1)
phytoene desaturase##3##2##(1995-2#1)(2010-10#2)
phytoene synthase##5##2##(1995-2#2)(2009-10#2)(2010-10#1)
phytoene##13##1##(1990-7#2)(1995-2#6)(2009-10#2)(2010-10#3)
phytoestrogens in##2##2##(2008-10#2)
phytoestrogens to##2##2##(2008-10#2)
phytoestrogens##16##1##(2008-10#11)(2008-11#2)(2012-2#3)
phytohemagglutinin##3##1##(1992-6#1)(2008-7#1)(2011-2#1)
phytohormones##9##1##(2008-10#5)(2008-7#1)(2009-8#3)
phytomedicine##2##1##(2011-2#2)
phytomyxean species to##2##3##(2012-2#2)
phytomyxean species##4##2##(2012-2#4)
phytopathogenic bacteria##5##2##(2008-10#5)
phytopathogenic fungi##8##2##(1997-4#1)(2008-10#4)(2008-11#1)(2009-8#1)(2011-10#1)
phytopathogenic fungus##6##2##(1997-2#2)(1997-4#1)(2008-10#2)(2009-8#1)
phytopathogenic##33##1##(1997-2#2)(1997-4#2)(2008-10#24)(2008-11#1)(2009-6#1)(2009-8#2)(2011-10#1)
phytopathogens##4##1##(2008-10#2)(2008-7#1)(2009-6#1)
phytopathological literature##2##2##(2008-10#2)
phytopathological significance##2##2##(2008-10#2)
phytopathological##23##1##(2008-10#23)
phytophagous bugs##2##2##(2008-7#2)
phytophagous insects##3##2##(2008-9#3)
phytophagous##9##1##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#5)
phytophthora##3##1##(2008-10#3)
phytoplanktivorous bighead carp (Aristichthys nobilis)##2##5##(2010-5#2)
phytoplankton absorption coefficient##2##3##(2008-2#1)(2008-3#1)
phytoplankton absorption##4##2##(2008-2#1)(2008-3#3)
phytoplankton and zooplankton species##2##4##(2009-8#2)
phytoplankton and##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#2)
phytoplankton blooms##5##2##(1992-8#1)(2008-2#1)(2008-3#1)(2008-8#2)
phytoplankton class##2##2##(2008-10#2)
phytoplankton classes##2##2##(2008-10#2)
phytoplankton growth##2##2##(2013-8#2)
phytoplankton in##2##2##(1994-8#1)(2008-3#1)
phytoplankton populations##2##2##(2008-8#2)
phytoplankton species##5##2##(2008-3#1)(2008-8#3)(2009-8#1)
phytoplankton were##2##2##(2008-10#1)(2009-8#1)
phytoplankton##70##1##(1992-8#1)(1994-8#2)(2008-10#7)(2008-12#1)(2008-2#10)(2008-3#15)(2008-5#1)(2008-8#18)(2008-9#4)(2009-8#8)(2013-8#3)
phytoplasma and##2##2##(2008-10#2)
phytoplasma concentrations in##2##3##(2008-10#2)
phytoplasma concentrations##3##2##(2008-10#3)
phytoplasma could##2##2##(2008-10#2)
phytoplasma extracts##2##2##(2008-10#2)
phytoplasma from##2##2##(2008-10#2)
phytoplasma groups##2##2##(2008-10#2)
phytoplasma in the##3##3##(2008-10#3)
phytoplasma in##9##2##(2008-10#9)
phytoplasma isolates from##3##3##(2008-10#3)
phytoplasma isolates##5##2##(2008-10#5)
phytoplasma strains from##2##3##(2008-10#2)
phytoplasma strains in##2##3##(2008-10#2)
phytoplasma strains were##2##3##(2008-10#2)
phytoplasma strains##10##2##(2008-10#10)
phytoplasma taxa##2##2##(2008-10#2)
phytoplasma was##2##2##(2008-10#2)
phytoplasma were##2##2##(2008-10#2)
phytoplasma##89##1##(2008-10#89)
phytoplasma-infected##2##1##(2008-10#2)
phytoplasma-specific##3##1##(2008-10#3)
phytoplasmas and##2##2##(2008-10#2)
phytoplasmas belonging to##2##3##(2008-10#2)
phytoplasmas from##2##2##(2008-10#2)
phytoplasmas in the##3##3##(2008-10#3)
phytoplasmas in##6##2##(2008-10#6)
phytoplasmas involved in##2##3##(2008-10#2)
phytoplasmas present in##2##3##(2008-10#2)
phytoplasmas were detected in##2##4##(2008-10#2)
phytoplasmas were##4##2##(2008-10#4)
phytoplasmas with##2##2##(2008-10#2)
phytoplasmas##52##1##(2008-10#52)
phytoremediation##6##1##(2008-10#1)(2008-11#4)(2011-1#1)
phytoreovirus##2##1##(2008-10#2)
phytosanitary treatments##2##2##(2011-2#2)
phytosanitary##6##1##(2008-10#3)(2011-2#3)
phytostabilisation of##2##2##(2010-5#2)
phytostabilisation##3##1##(2010-5#3)
phytosterol##3##1##(2007-11#2)(2008-12#1)
phytosterols##3##1##(2008-10#1)(2008-12#1)(2010-12#1)
phytotherapy##2##1##(1992-5#1)(2008-10#1)
phytotoxic activity##2##2##(2008-10#1)(2008-11#1)
phytotoxic effects##2##2##(2008-10#1)(2008-11#1)
phytotoxic protein##2##2##(2008-10#2)
phytotoxic to sugarcane##2##3##(2008-10#2)
phytotoxic to##5##2##(2008-10#5)
phytotoxic##17##1##(2008-10#13)(2008-11#2)(2008-12#1)(2008-8#1)
phytotoxicity##4##1##(2008-10#1)(2008-12#1)(2011-1#2)
phytotoxin produced by##2##3##(2008-10#2)
phytotoxin##5##1##(2008-10#4)(2008-7#1)
phytotoxins in##3##2##(2008-10#3)
phytotoxins##6##1##(2008-10#5)(2008-11#1)
phéochromocytome##3##1##(2011-2#3)
pi centers##2##2##(1996-2#2)
pi phase##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
pi##40##1##(1990-2#2)(1991-12#1)(1992-11#1)(1992-8#2)(1994-2#2)(1996-2#9)(1997-7#4)(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#8)(2008-8#1)(2011-2#1)
pi)##2##1##(1994-2#1)(2007-11#1)
pi-Electron##2##1##(1996-5#1)(2008-10#1)
pi-acceptors##2##1##(2008-10#2)
pi-bond##3##1##(1996-5#2)(2009-5#1)
pi-conjugated##4##1##(1993-11#1)(2007-12#1)(2008-7#1)(2009-11#1)
pi-coordinating##4##1##(2008-10#4)
pi-electron conjugation##2##2##(2007-11#1)(2009-9#1)
pi-electron##6##1##(1996-5#1)(2007-11#2)(2009-9#1)(2010-2#2)
pi-phase##2##1##(2008-2#1)(2008-3#1)
pi-pi interaction##3##2##(2007-11#1)(2008-10#2)
pi-pi##8##1##(1997-7#1)(2007-11#1)(2008-10#5)(2009-11#1)
pi-polarized##2##1##(2008-3#2)
pi-shifted Sagnac interferometer##2##3##(2007-11#2)
pi-system##2##1##(1997-7#1)(2010-2#1)
pi-ta allele##2##2##(2008-10#2)
pi/2##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
piRNA##2##1##(2009-3#1)(2010-5#1)
piRNAs##7##1##(2009-3#7)
pial##2##1##(1995-12#1)(2008-4#1)
piascledine is##2##2##(2007-11#2)
piascledine##3##1##(2007-11#3)
piazselenol##2##1##(2008-10#2)
piceae##6##1##(2008-10#6)
pick of##2##2##(2008-7#2)
pick up##2##2##(2012-12#1)(2012-2#1)
pick##7##1##(1992-2#1)(2008-7#2)(2008-8#2)(2012-12#1)(2012-2#1)
pick-and-place##2##1##(2007-12#2)
picked up##3##2##(1995-3#1)(2007-7#1)(2013-8#1)
picked##7##1##(1992-11#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
picket fence##2##2##(2008-3#2)
picking##2##1##(2008-4#2)
pickle##2##1##(1997-4#1)(2008-10#1)
picks##2##1##(1991-5#1)(1991-9#1)
pickup and display##2##3##(2007-11#1)(2008-3#1)
pickup is##2##2##(2008-2#1)(2008-3#1)
pickup system##2##2##(2008-3#2)
pickup##19##1##(1996-1#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#9)(2008-7#1)
pickups##4##1##(2007-12#1)(2008-3#3)
pico- to##2##2##(1994-6#1)(1997-2#1)
picomolar concentrations##2##2##(2008-10#2)
picomolar##8##1##(1990-7#2)(1994-8#1)(2008-10#3)(2008-7#2)
picomoles/mg/min)##2##1##(1994-11#2)
picornaviruses##2##1##(2008-8#1)(2013-1#1)
picosecond Nd##2##2##(2007-11#2)
picosecond Ti##2##2##(2007-11#1)(2007-12#1)
picosecond and##2##2##(1990-8#1)(2007-12#1)
picosecond laser pulses##2##3##(2007-11#2)
picosecond laser##3##2##(2007-11#2)(2007-12#1)
picosecond lasers##2##2##(2007-11#1)(2008-3#1)
picosecond optical parametric oscillator##2##4##(2007-11#2)
picosecond pulse##4##2##(2007-11#1)(2007-12#3)
picosecond pulsed##3##2##(2007-11#3)
picosecond pulses at##5##3##(2007-11#4)(2007-12#1)
picosecond pulses in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
picosecond pulses##16##2##(2007-11#7)(2007-12#4)(2008-2#2)(2008-3#3)
picosecond temporal resolution##2##3##(2007-11#1)(2007-12#1)
picosecond time##2##2##(2007-12#1)(2008-2#1)
picosecond time-resolved##2##2##(2008-3#2)
picosecond##65##1##(1990-8#1)(1993-5#1)(1995-2#1)(2007-11#29)(2007-12#16)(2008-2#8)(2008-3#9)
picosecond-time-scale##2##1##(2007-12#1)(2008-10#1)
picoseconds to##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
picoseconds##7##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
picotamide on##2##2##(1990-12#1)(2008-7#1)
picotamide##6##1##(1990-12#2)(1990-5#2)(2008-7#2)
picrate 1##2##2##(2008-10#2)
picrate anion##3##2##(2008-10#3)
picrate concentration##3##2##(2008-10#3)
picrate ion##2##2##(2008-10#2)
picrate##19##1##(2008-10#19)
picrates of##2##2##(2008-10#2)
picrates with##6##2##(2008-10#6)
picrates##18##1##(2008-10#18)
picric acid in##2##3##(2008-10#2)
picric acid##8##2##(2008-10#8)
picroliv##2##1##(2008-8#2)
picrotoxin (PTX)##2##2##(2008-8#1)(2008-9#1)
picrotoxin##7##1##(1990-5#2)(1995-12#2)(1995-5#1)(2008-8#1)(2008-9#1)
pictorial essay##10##2##(1997-8#2)(2012-2#8)
pictorial review is##3##3##(2012-2#3)
pictorial review##10##2##(2011-2#1)(2012-2#9)
pictorial##30##1##(1992-3#1)(1997-8#2)(2008-10#4)(2008-12#1)(2008-4#1)(2009-9#1)(2011-2#2)(2012-2#17)(2012-3#1)
picture and##5##2##(1995-6#1)(1997-7#1)(2007-10#1)(2008-3#1)(2011-2#1)
picture archiving and##2##3##(1996-2#1)(1997-8#1)
picture does not##2##3##(1997-4#1)(2012-2#1)
picture in the##2##3##(2007-11#1)(2008-3#1)
picture in which##2##3##(2008-3#1)(2012-2#1)
picture in##7##2##(1990-3#1)(2007-11#1)(2008-3#2)(2008-4#1)(2012-2#1)(2013-1#1)
picture is further complicated by the##2##6##(2008-1#1)(2008-4#1)
picture is made##2##3##(1993-2#1)(2008-3#1)
picture is##12##2##(1990-6#1)(1990-8#2)(1993-2#1)(1994-6#1)(1995-11#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-9#1)(2012-3#1)
picture naming##2##2##(1994-3#2)
picture of a##2##3##(1995-4#1)(2012-3#1)
picture of how these##2##4##(1995-9#1)(2008-8#1)
picture of how##3##3##(1995-9#1)(2007-12#1)(2008-8#1)
picture of the quality##2##4##(2008-10#1)(2009-11#1)
picture of the##26##3##(1992-2#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#1)
picture of##57##2##(1990-3#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-8#1)
picture should be##2##3##(2008-4#1)(2008-7#1)
picture should##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
picture similar to##2##3##(2009-3#1)(2012-2#1)
picture that##3##2##(2009-6#1)(2009-8#1)(2012-2#1)
picture was##3##2##(1990-2#1)(2009-5#1)(2011-2#1)
picture with##2##2##(1996-6#1)(2010-1#1)
picture##176##1##(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#4)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-7#2)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#2)(2013-8#3)
pictures and##4##2##(1994-2#1)(2009-8#1)(2011-2#1)(2012-12#1)
pictures of##5##2##(2007-11#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
pictures##29##1##(1990-8#1)(1994-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-8#2)
piece are##2##2##(2008-3#1)(2008-4#1)
piece in##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
piece of information##2##3##(1993-6#1)(2011-2#1)
piece of the##3##3##(1992-3#1)(2008-10#1)(2009-3#1)
piece of tubing##3##3##(1997-3#3)
piece of##22##2##(1992-3#1)(1993-6#1)(1995-11#1)(1997-3#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#3)
piece to##2##2##(2008-10#2)
piece##42##1##(1992-3#1)(1993-6#1)(1995-11#1)(1997-3#5)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
piecemeal##3##1##(1997-8#1)(2011-2#1)(2013-8#1)
pieces and##2##2##(2008-10#2)
pieces in a##2##3##(1996-3#1)(2008-10#1)
pieces of the##3##3##(1997-2#1)(2008-6#1)(2013-1#1)
pieces of##23##2##(1992-8#1)(1994-3#1)(1995-3#2)(1996-6#1)(1997-2#1)(1997-7#1)(2006-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
pieces placed##2##2##(2008-10#2)
pieces were##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
pieces##53##1##(1992-5#1)(1992-8#1)(1994-3#1)(1995-3#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-4#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
pieces)##2##1##(2007-8#1)(2008-10#1)
piecewise direct standardization (PDS)##3##4##(2008-10#3)
piecewise linear##3##2##(1991-5#1)(2007-11#1)(2013-1#1)
piecewise models##2##2##(2007-11#2)
piecewise##14##1##(1991-5#1)(1992-6#1)(1995-12#1)(2007-11#5)(2008-10#3)(2008-6#2)(2013-1#1)
pier##3##1##(1994-3#1)(2008-3#2)
piercing##3##1##(2008-11#1)(2011-2#1)(2013-8#1)
piety##3##1##(2008-11#1)(2008-12#2)
piezoelectric chemical sensor array##2##4##(2008-10#2)
piezoelectric crystal##4##2##(2008-10#4)
piezoelectric crystals##2##2##(2008-10#2)
piezoelectric immunosensor##3##2##(2008-10#3)
piezoelectric quartz crystal (PQC)##5##4##(2008-10#5)
piezoelectric quartz crystal impedance (PQCI)##2##5##(2008-10#2)
piezoelectric quartz crystal impedance##3##4##(2008-10#3)
piezoelectric quartz crystal##18##3##(2008-10#18)
piezoelectric quartz##21##2##(1990-8#1)(2008-10#20)
piezoelectric response model##2##3##(2008-10#2)
piezoelectric sensor##2##2##(2008-10#2)
piezoelectric transducer and##2##3##(2007-12#1)(2008-3#1)
piezoelectric transducer##10##2##(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#4)
piezoelectric##87##1##(1990-8#5)(1992-3#1)(2007-11#1)(2007-12#4)(2008-10#52)(2008-2#4)(2008-3#12)(2008-8#1)(2009-5#5)(2012-12#1)(2013-1#1)
piezoresistive##2##1##(2008-7#1)(2010-2#1)
piezosurgery##4##1##(2012-12#4)
pig and cow##2##3##(1994-12#1)(1994-5#1)
pig and##12##2##(1990-2#2)(1990-5#2)(1993-11#1)(1994-12#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-3#2)(2012-2#1)
pig aorta##2##2##(1991-12#1)(1993-3#1)
pig blastocyst cDNA##2##3##(1993-6#2)
pig blood##2##2##(2006-6#1)(2008-12#1)
pig breeds##3##2##(2008-8#3)
pig farms##2##2##(1997-6#1)(2013-1#1)
pig had##2##2##(2012-3#2)
pig handling##2##2##(2011-1#2)
pig heart##3##2##(1992-3#1)(1996-9#1)(2008-11#1)
pig industry##4##2##(2008-7#2)(2011-2#2)
pig liver by##2##3##(1990-2#1)(1992-11#1)
pig liver##9##2##(1990-11#2)(1990-2#2)(1992-11#2)(1992-8#3)
pig management in##2##3##(1996-12#2)
pig manure##2##2##(2007-12#1)(2008-10#1)
pig meat##3##2##(2008-10#1)(2013-1#2)
pig model##2##2##(1995-2#1)(2007-8#1)
pig muscle##3##2##(1994-5#1)(1994-9#1)(2008-11#1)
pig oocytes##2##2##(1990-12#1)(2013-1#1)
pig phosphoglucose isomerase##2##3##(1990-11#2)
pig pulmonary##2##2##(1993-3#2)
pig slurry##2##2##(2008-10#2)
pig small intestine##3##3##(1990-11#2)(2008-5#1)
pig stomach##3##2##(1995-6#3)
pig that##2##2##(2008-3#1)(2012-3#1)
pig##184##1##(1990-11#8)(1990-12#2)(1990-2#4)(1990-5#2)(1990-7#1)(1990-9#4)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#1)(1992-11#4)(1992-12#3)(1992-3#6)(1992-6#4)(1992-8#5)(1992-9#3)(1993-11#2)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#5)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#2)(1997-3#3)(1997-6#1)(1997-7#1)(2006-6#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#6)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#4)(2011-2#6)(2012-2#2)(2012-3#6)(2013-1#6)(2013-8#2)
pig)##2##1##(1994-11#1)(1995-5#1)
pig-tailed macaques##5##2##(1995-2#4)(1997-3#1)
pigeon pea pollen##2##3##(2008-6#2)
pigeon pea##6##2##(2008-10#2)(2008-6#4)
pigeon##15##1##(1991-6#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#4)(2008-8#2)
pigeonpea (Cajanus##2##2##(2008-10#1)(2010-10#1)
pigeonpea and##3##2##(2008-10#1)(2010-10#2)
pigeonpea plants##5##2##(2008-10#5)
pigeonpea##18##1##(2008-10#9)(2010-10#9)
pigeons (Columba##2##2##(1995-12#1)(2008-5#1)
pigeons free of##2##3##(2008-5#2)
pigeons in the##2##3##(1990-11#1)(1997-3#1)
pigeons to##2##2##(1990-11#1)(2012-12#1)
pigeons were##4##2##(1997-3#1)(2008-5#1)(2011-2#2)
pigeons##28##1##(1990-11#5)(1995-12#1)(1997-3#2)(1997-6#1)(2008-5#7)(2008-8#2)(2009-2#1)(2011-2#8)(2012-12#1)
piglet##3##1##(2010-2#2)(2011-2#1)
piglets (n = 12)##2##4##(1994-2#2)
piglets (n =##3##3##(1990-5#1)(1994-2#2)
piglets and##2##2##(2011-2#2)
piglets from##5##2##(1990-5#2)(1996-8#1)(2013-1#2)
piglets##27##1##(1990-11#1)(1990-5#4)(1994-2#5)(1996-12#4)(1996-3#1)(1996-8#2)(2008-8#1)(2010-2#1)(2011-2#3)(2013-1#5)
pigment concentration##3##2##(2008-2#1)(2008-3#2)
pigment concentrations##2##2##(2008-10#1)(2008-3#1)
pigment dispersion##3##2##(2008-8#3)
pigment elaboration##2##2##(2008-8#2)
pigment epithelium##10##2##(1990-3#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-7#3)(2012-3#1)
pigment epithelium-derived factor##2##3##(2008-7#1)(2012-5#1)
pigment granules in##2##3##(1992-3#2)
pigment granules##3##2##(1992-3#2)(2007-12#1)
pigment in##3##2##(2008-11#1)(2008-5#1)(2010-6#1)
pigment layers were found##2##4##(2008-10#2)
pigment levels in##2##3##(2007-11#2)
pigment levels##3##2##(2007-11#2)(2011-1#1)
pigment metals##2##2##(2008-10#2)
pigment particles##3##2##(2008-3#3)
pigment production##5##2##(1991-5#1)(2007-7#1)(2008-10#3)
pigment substitution##5##2##(2008-8#5)
pigment was##2##2##(1990-12#1)(2010-6#1)
pigment##114##1##(1990-12#6)(1990-3#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#4)(1992-8#1)(1993-3#7)(1993-6#1)(1996-5#2)(1997-4#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#19)(2010-10#2)(2010-6#2)(2011-1#1)(2011-2#1)(2011-7#3)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#1)
pigment-protein complexes##6##2##(2010-2#6)
pigment-protein##7##1##(2010-2#7)
pigment-to-volume concentration##2##2##(2008-3#2)
pigmentary disorders##2##2##(1994-12#1)(2008-5#1)
pigmentary##7##1##(1994-12#1)(2008-5#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
pigmentation and##6##2##(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)
pigmentation in##2##2##(1995-2#1)(1997-3#1)
pigmentation of##2##2##(2008-6#1)(2012-3#1)
pigmentation##51##1##(1991-6#2)(1995-2#2)(1997-3#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#5)(2009-4#1)(2009-5#3)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
pigmented Bowen's disease##2##3##(2010-6#2)
pigmented and##3##2##(2008-10#2)(2008-8#1)
pigmented cells##3##2##(1992-8#1)(2008-1#1)(2008-8#1)
pigmented epidermis##2##2##(2008-5#2)
pigmented medaka##4##2##(2008-11#4)
pigmented melanoma cells##2##3##(1992-3#2)
pigmented melanoma##3##2##(1992-3#3)
pigmented skin lesions##3##3##(2007-10#1)(2011-2#2)
pigmented skin##6##2##(1997-5#1)(2007-10#3)(2011-2#2)
pigmented##49##1##(1992-3#3)(1992-8#1)(1997-3#1)(1997-5#1)(2007-10#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-4#2)(2008-5#7)(2008-8#2)(2010-12#1)(2010-6#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
pigmenti and##2##2##(2012-3#2)
pigmenti##3##1##(2012-3#3)
pigments and water##2##3##(2008-10#1)(2008-12#1)
pigments and##7##2##(2008-10#5)(2008-12#1)(2008-3#1)
pigments from##2##2##(2008-10#2)
pigments in a liquid matrix##2##5##(2008-3#2)
pigments in a##3##3##(2008-3#3)
pigments in the##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
pigments in##7##2##(2007-11#1)(2008-10#2)(2008-3#3)(2012-2#1)
pigments were##6##2##(2008-10#3)(2008-12#1)(2008-5#2)
pigments##57##1##(1990-12#2)(1991-9#1)(2007-11#3)(2008-10#25)(2008-12#2)(2008-2#1)(2008-3#12)(2008-5#3)(2008-8#2)(2009-10#2)(2010-4#1)(2011-1#2)(2012-2#1)
pigs and##7##2##(1990-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2009-6#1)(2011-1#2)
pigs at##3##2##(1990-3#2)(2011-1#1)
pigs by##2##2##(1992-2#1)(1995-12#1)
pigs fed##2##2##(2010-2#1)(2012-2#1)
pigs had##2##2##(2011-2#1)(2012-3#1)
pigs in the##2##3##(1990-3#1)(2013-1#1)
pigs in##9##2##(1990-3#1)(1994-11#1)(2009-5#1)(2011-2#3)(2013-1#2)(2013-8#1)
pigs to study the##2##4##(2008-11#1)(2010-4#1)
pigs was##2##2##(2010-2#1)(2011-1#1)
pigs were inoculated with##2##4##(2012-3#2)
pigs were used##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
pigs were##13##2##(1990-3#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
pigs with HGR##3##3##(2012-2#3)
pigs with##15##2##(1990-3#3)(1995-12#1)(1996-9#1)(2007-8#1)(2010-4#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-8#1)
pigs##148##1##(1990-11#1)(1990-3#10)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#8)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#6)(2008-5#2)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#11)(2010-4#2)(2011-1#10)(2011-2#12)(2012-2#16)(2012-3#9)(2013-1#7)(2013-7#1)(2013-8#7)
pigs)##2##1##(1996-12#1)(2012-3#1)
pigus virgo##2##2##(2008-10#2)
pigweed##2##1##(2011-2#1)(2013-8#1)
pika##3##1##(2008-9#3)
pilE transcription##2##2##(1993-12#2)
pilE##8##1##(1993-12#8)
pile driving and other##3##4##(2010-8#3)
pile##6##1##(1992-11#1)(2008-10#1)(2010-8#3)(2012-12#1)
piles##6##1##(2007-5#1)(2008-10#5)
pili##2##1##(1990-11#1)(2008-8#1)
pilin##2##1##(1993-12#2)
piling##2##1##(2007-12#2)
pill containing##2##2##(2008-5#1)(2013-8#1)
pill##24##1##(1991-3#1)(1991-6#2)(1992-12#1)(1993-2#5)(1995-11#1)(1997-6#3)(2007-12#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
pill-induced esophagitis##3##2##(2008-5#3)
pillar cells##3##2##(1993-9#1)(2008-7#2)
pillar##9##1##(1993-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2012-2#1)
pillars##10##1##(1996-1#1)(2007-12#1)(2008-11#1)(2008-2#7)
pillow##10##1##(2007-11#1)(2007-8#9)
pills on##2##2##(2008-10#1)(2012-3#1)
pills##12##1##(1993-2#3)(1994-9#1)(1996-8#1)(2007-11#1)(2008-10#3)(2011-1#1)(2012-3#1)(2013-1#1)
pilocarpine##9##1##(1991-7#1)(2006-10#4)(2008-10#3)(2008-7#1)
pilocytic astrocytoma##4##2##(2013-1#4)
pilomatrix carcinoma##2##2##(1994-8#2)
pilomatrix##3##1##(1994-8#2)(2013-7#1)
pilomatrixoma##3##1##(1994-8#2)(2013-7#1)
pilonidal sinus##2##2##(2009-1#1)(2013-8#1)
pilonidal##3##1##(2009-1#1)(2010-11#1)(2013-8#1)
pilosa##6##1##(2008-10#1)(2008-12#5)
pilot data##2##2##(2013-1#2)
pilot phase of##3##3##(2008-12#1)(2010-9#1)(2012-3#1)
pilot phase##4##2##(1990-12#1)(2008-12#1)(2010-9#1)(2012-3#1)
pilot plant##5##2##(1995-3#1)(2008-10#2)(2012-2#2)
pilot program##4##2##(2007-5#3)(2012-2#1)
pilot programs##2##2##(1994-12#1)(2008-12#1)
pilot project##14##2##(1993-3#1)(1994-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)
pilot projects##2##2##(1996-3#2)
pilot sample##2##2##(2008-10#2)
pilot scale##13##2##(1992-5#1)(1994-5#3)(2008-11#7)(2008-7#1)(2010-4#1)
pilot screening##2##2##(2013-1#2)
pilot series##2##2##(2007-8#2)
pilot sites were##2##3##(2008-11#2)
pilot sites##3##2##(2008-11#3)
pilot studies##5##2##(2007-7#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-12#1)
pilot study assessed the##2##4##(2008-7#1)(2011-2#1)
pilot study has##2##3##(2008-10#1)(2009-5#1)
pilot study in##6##3##(2007-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2013-1#1)
pilot study of##18##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1993-3#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-5#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#2)
pilot study on##2##3##(1990-8#1)(2013-8#1)
pilot study to evaluate##2##4##(2008-7#2)
pilot study to##5##3##(2008-12#1)(2008-7#2)(2009-12#1)(2009-5#1)
pilot study was conducted in##2##5##(1992-2#1)(2012-3#1)
pilot study was to determine the##2##6##(2007-10#1)(2008-12#1)
pilot study was to##11##4##(1995-3#1)(2007-10#1)(2008-11#1)(2008-12#4)(2010-3#1)(2011-2#1)(2013-1#2)
pilot study was##19##3##(1991-12#1)(1992-2#1)(1995-3#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#1)(2010-10#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
pilot study##148##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(2007-10#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#4)(2008-12#12)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#10)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#9)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#1)
pilot study]##2##2##(2010-12#1)(2013-7#1)
pilot survey##2##2##(1993-1#1)(2009-5#1)
pilot test##5##2##(1994-3#1)(1996-2#1)(2010-4#2)(2010-5#1)
pilot tested##5##2##(2008-1#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
pilot testing##2##2##(1996-2#1)(2010-3#1)
pilot trial was##2##3##(1992-12#1)(2008-7#1)
pilot trial##6##2##(1992-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
pilot##281##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#5)(1993-2#1)(1993-3#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-3#9)(1994-5#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#4)(1996-3#3)(1997-1#2)(1997-2#2)(1997-5#3)(1997-8#1)(2007-10#3)(2007-2#1)(2007-5#4)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#13)(2008-11#25)(2008-12#15)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#15)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#11)(2010-4#8)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#12)(2011-3#1)(2011-9#1)(2012-1#4)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#18)(2013-7#2)(2013-8#3)
pilot&quot##2##1##(1994-3#2)
pilot-scale##2##1##(2008-11#1)(2008-6#1)
pilot-tested##3##1##(2010-3#1)(2011-2#1)(2012-12#1)
piloted##7##1##(2008-11#1)(2008-12#1)(2008-3#2)(2012-12#1)(2012-2#2)
piloting##2##1##(2008-11#1)(2013-1#1)
pilots##7##1##(1997-5#3)(2011-2#2)(2012-2#2)
pim-1##2##1##(1991-5#2)
pim1##3##1##(1995-2#3)
pimozide##6##1##(1995-12#5)(2010-8#1)
pin track##2##2##(2010-12#2)
pin tracts##2##2##(2009-4#2)
pin##12##1##(2007-8#1)(2008-10#2)(2008-12#1)(2009-3#1)(2009-4#3)(2010-12#2)(2012-2#1)(2012-3#1)
pinaverium bromure and##2##3##(2013-1#2)
pinch plasma is##2##3##(2008-3#2)
pinch plasma##3##2##(2007-12#1)(2008-3#2)
pinch##8##1##(1992-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#2)
pinching##3##1##(1996-8#1)(1997-2#1)(2008-5#1)
pindolol and##4##2##(1995-12#1)(1995-6#1)(2008-10#2)
pindolol in##2##2##(1997-5#1)(2008-10#1)
pindolol##18##1##(1992-11#1)(1995-11#1)(1995-12#1)(1995-6#3)(1997-5#1)(2008-10#11)
pine (P##8##2##(2008-10#8)
pine (Pinus##12##2##(2008-10#11)(2013-1#1)
pine and##2##2##(2008-10#2)
pine bark##3##2##(2008-10#3)
pine blister rust in##3##4##(2008-10#3)
pine blister rust##18##3##(2008-10#18)
pine blister##19##2##(2008-10#19)
pine in##4##2##(2008-10#3)(2013-1#1)
pine needles##2##2##(2008-10#1)(2008-12#1)
pine plantations##3##2##(2008-10#3)
pine seedlings##2##2##(2008-10#1)(2008-7#1)
pine species##4##2##(2008-10#3)(2008-8#1)
pine stem rusts##2##3##(2008-10#2)
pine stem##3##2##(2008-10#3)
pine trees##2##2##(2008-10#1)(2011-2#1)
pine were##2##2##(2008-10#2)
pine with##2##2##(2008-10#1)(2008-7#1)
pine##106##1##(2008-10#89)(2008-12#1)(2008-7#4)(2008-8#3)(2011-10#2)(2011-2#1)(2013-1#5)(2013-7#1)
pineal cysts##4##2##(2012-2#4)
pineal gland and the##2##4##(2008-10#1)(2013-7#1)
pineal gland and##4##3##(1994-5#1)(2008-10#2)(2013-7#1)
pineal gland hormone##2##3##(2008-12#2)
pineal gland##25##2##(1994-2#2)(1994-5#7)(1995-11#1)(1995-12#2)(1995-3#2)(2008-10#2)(2008-12#3)(2008-5#1)(2008-9#1)(2012-1#2)(2013-7#2)
pineal hormone melatonin (MLT)##3##4##(1992-12#1)(1995-9#1)(2013-7#1)
pineal hormone melatonin##8##3##(1990-2#2)(1990-5#1)(1991-6#1)(1992-12#2)(1995-9#1)(2013-7#1)
pineal hormone##10##2##(1990-2#3)(1990-5#1)(1991-6#1)(1992-12#2)(1995-9#1)(2008-5#1)(2013-7#1)
pineal melatonin##2##2##(1994-5#2)
pineal organ via##2##3##(1994-5#2)
pineal organ##11##2##(1994-5#11)
pineal##91##1##(1990-2#3)(1990-5#1)(1991-6#1)(1992-12#2)(1994-2#3)(1994-5#36)(1995-11#1)(1995-12#8)(1995-3#9)(1995-9#1)(2008-10#2)(2008-12#4)(2008-5#3)(2008-7#5)(2008-9#1)(2012-1#2)(2012-2#4)(2013-7#5)
pinealectomized##2##1##(1994-5#1)(2008-5#1)
pinealocyte##2##1##(2012-1#2)
pinealocytes##2##1##(1994-5#2)
pineals of##3##2##(1994-5#3)
pineals##5##1##(1994-5#5)
pineapple mealybug##3##2##(2008-10#3)
pineapple plants##2##2##(2008-10#2)
pineapple skin##2##2##(2012-2#2)
pineapple##18##1##(2008-10#13)(2008-8#1)(2012-2#3)(2013-1#1)
pines and##3##2##(2008-10#2)(2008-12#1)
pines in##2##2##(2008-10#2)
pines##14##1##(2008-10#11)(2008-12#1)(2008-7#1)(2008-8#1)
pinewood nematode##2##2##(2008-10#2)
ping-pong##2##1##(1992-3#1)(1994-5#1)
pinhole array##2##2##(2008-3#2)
pinhole camera##2##2##(2007-11#1)(2008-2#1)
pinhole size##2##2##(2008-3#2)
pinhole##24##1##(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#11)(2009-8#2)(2012-2#1)
pinholes and##2##2##(2008-3#1)(2012-2#1)
pinholes is##2##2##(2008-2#2)
pinholes##14##1##(2007-11#1)(2008-2#3)(2008-3#4)(2009-8#1)(2012-2#5)
pini and##3##2##(2008-10#2)(2011-2#1)
pini##8##1##(2008-10#5)(2011-2#3)
pink coloured##2##2##(2008-10#2)
pink##27##1##(1990-12#1)(1993-8#1)(2008-10#16)(2008-5#4)(2008-9#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
pinless navigation group##2##3##(2013-1#2)
pinless navigation##3##2##(2013-1#3)
pinless##4##1##(2013-1#4)
pinnae##5##1##(2008-5#5)
pinning##3##1##(2008-8#2)(2012-5#1)
pinniped lactation##2##2##(2008-9#2)
pinnipeds by##2##2##(2008-9#2)
pinnipeds##8##1##(2008-9#6)(2009-2#1)(2012-3#1)
pinocytosis##2##1##(1990-11#1)(1991-12#1)
pinocytotic##3##1##(2007-12#2)(2012-1#1)
pinodes##2##1##(2008-10#2)
pinpointed##6##1##(1993-8#1)(1997-2#1)(2006-8#1)(2008-10#1)(2012-2#1)(2013-7#1)
pinpointing##3##1##(2009-10#1)(2009-12#1)(2013-1#1)
pinpoints##4##1##(2008-5#1)(2009-10#1)(2012-2#1)(2012-3#1)
pins##7##1##(1997-3#2)(2007-8#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
pinwheel centers##3##2##(2008-11#2)(2012-2#1)
pioglitazone##2##1##(2010-10#1)(2013-1#1)
pioneer of##6##2##(1997-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2009-1#1)
pioneer##20##1##(1991-5#1)(1991-6#1)(1992-9#1)(1994-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#3)(2013-1#1)
pioneered the##2##2##(2010-10#1)(2011-7#1)
pioneered##7##1##(1994-9#1)(1996-3#1)(2007-12#1)(2007-4#1)(2010-10#1)(2011-7#1)(2013-1#1)
pioneering work in##2##3##(2007-4#1)(2011-2#1)
pioneering work##3##2##(2007-4#1)(2010-8#1)(2011-2#1)
pioneering##15##1##(1992-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
pioneers in the##2##3##(1997-4#1)(2008-5#1)
pioneers of##3##2##(2007-12#1)(2010-5#1)(2012-2#1)
pioneers##14##1##(1993-6#1)(1994-2#1)(1997-4#1)(2007-12#6)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#2)
pipe is##2##2##(2008-3#2)
pipe##17##1##(1991-5#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#6)(2010-3#1)
pipeline and##2##2##(2008-10#1)(2013-1#1)
pipeline model##2##2##(2008-12#2)
pipeline programs##3##2##(2012-3#3)
pipeline##18##1##(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#5)(2013-1#1)
piperacillin##4##1##(1990-2#2)(2008-7#1)(2013-8#1)
piperacillin-tazobactam##3##1##(2013-8#3)
piperazine##3##1##(1995-11#1)(1995-3#1)(2008-10#1)
piperazine-1##2##1##(2008-10#2)
piperidine treatment##2##2##(1993-8#2)
piperidine##17##1##(1990-5#1)(1990-8#2)(1992-3#1)(1992-8#1)(1993-8#2)(1994-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#2)
piperidine-2##2##1##(2008-10#2)
piperita L##6##2##(2008-10#3)(2013-1#3)
piperita##7##1##(2008-10#3)(2013-1#4)
pipes##9##1##(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#2)
pipet##2##1##(2008-4#1)(2013-1#1)
pipette solution##2##2##(2009-12#2)
pipette was##3##2##(1993-12#1)(1995-12#1)(2013-1#1)
pipette##12##1##(1993-12#1)(1995-11#2)(1995-12#1)(2008-10#2)(2008-8#1)(2009-12#3)(2013-1#2)
pipettes##2##1##(1993-12#1)(2013-1#1)
pipetting##4##1##(2008-10#2)(2008-8#1)(2008-9#1)
pipiens##5##1##(2013-1#5)
piping##2##1##(1992-11#1)(2013-8#1)
piracy##3##1##(2011-2#1)(2012-2#2)
pirenzepine##2##1##(1993-9#2)
pirica##3##1##(2012-12#3)
piriform cortex##9##2##(1990-5#2)(1994-3#3)(2012-1#1)(2013-1#3)
piriform##10##1##(1990-5#2)(1994-3#3)(1996-12#1)(2012-1#1)(2013-1#3)
pirina on##2##2##(2008-10#2)
pirina##9##1##(2008-10#9)
piroctone olamine and salicylic acid##2##5##(2008-5#2)
piroctone olamine and##3##3##(2008-5#3)
piroctone olamine##7##2##(2008-5#7)
piroxicam##10##1##(1990-9#4)(1994-2#1)(2008-10#5)
pisi and##2##2##(2008-10#2)
pisi##22##1##(1995-3#1)(2008-10#19)(2008-7#2)
pistachio and##5##2##(2008-10#5)
pistachio in##6##2##(2008-10#6)
pistachio isolates##4##2##(2008-10#4)
pistachio orchards##7##2##(2008-10#7)
pistachio##44##1##(2008-10#44)
piston pump##2##2##(2008-10#2)
piston##8##1##(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#2)
pisum##7##1##(1996-12#1)(2007-12#1)(2008-10#4)(2008-5#1)
pit cell##3##2##(1995-2#1)(1995-6#2)
pit cells##2##2##(1995-6#2)
pit hardening stage##3##3##(2008-10#3)
pit on the##2##3##(2009-3#1)(2011-2#1)
pit##21##1##(1994-6#1)(1995-2#3)(1995-6#4)(2008-10#7)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2011-2#1)
pit-and-fissure sealants##2##2##(2013-1#2)
pit-and-fissure##3##1##(2013-1#3)
pit-lining##2##1##(1997-1#2)
pitch accent##3##2##(2013-8#3)
pitch accents##2##2##(2013-8#2)
pitch and##6##2##(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#2)
pitch blende##2##2##(2008-10#2)
pitch canker##3##2##(2008-10#3)
pitch height##2##2##(2013-8#2)
pitch in##2##2##(1997-2#2)
pitch of the##4##3##(2008-2#2)(2008-3#2)
pitch of##8##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
pitch scaling##2##2##(2013-8#2)
pitch##59##1##(1992-9#2)(1993-9#1)(1997-2#4)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-2#13)(2008-3#11)(2008-9#4)(2009-9#1)(2011-1#2)(2013-8#11)
pitches of##2##2##(1995-5#1)(2008-3#1)
pitches##5##1##(1993-9#1)(1995-5#1)(2008-3#3)
pitfall in##3##2##(1991-12#1)(2011-2#1)(2012-12#1)
pitfall of##5##2##(1994-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)
pitfall##13##1##(1991-12#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
pitfalls and##7##2##(1994-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
pitfalls associated with##2##3##(1993-1#1)(2010-5#1)
pitfalls in the##2##3##(2008-4#1)(2011-2#1)
pitfalls in##10##2##(1992-1#1)(1993-1#1)(1993-12#1)(1995-2#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-2#1)
pitfalls of a##2##3##(2007-4#1)(2008-10#1)
pitfalls of##9##2##(1994-6#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
pitfalls such as##2##3##(2008-6#1)(2011-2#1)
pitfalls that##2##2##(1992-1#1)(2009-8#1)
pitfalls##55##1##(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#4)(2012-2#6)(2013-8#1)
pits and##3##2##(1997-3#1)(2007-12#1)(2008-3#1)
pits or##2##2##(2008-3#2)
pits was##2##2##(2008-10#1)(2013-1#1)
pits##19##1##(1995-1#1)(1995-6#2)(1997-1#1)(1997-3#4)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-7#1)(2009-3#1)(2013-1#2)
pitted##2##1##(2008-10#1)(2008-11#1)
pitting##10##1##(1994-9#1)(2008-10#6)(2008-8#1)(2009-10#1)(2011-2#1)
pituitaries##3##1##(1990-12#2)(2008-4#1)
pituitary PRL##2##2##(1994-3#1)(2011-2#1)
pituitary abnormalities##2##2##(1997-3#1)(2008-6#1)
pituitary adenoma##2##2##(2006-12#1)(2013-1#1)
pituitary adenoma]##2##2##(1990-6#1)(1991-6#1)
pituitary adenomas##14##2##(1990-12#3)(1991-2#1)(1994-5#1)(1995-9#1)(1996-11#1)(2008-7#1)(2011-2#4)(2013-1#2)
pituitary adenylate cyclase activating polypeptide##3##5##(1990-12#2)(1990-7#1)
pituitary adenylate cyclase##4##3##(1990-12#2)(1990-7#2)
pituitary adenylate##5##2##(1990-12#2)(1990-7#2)(1995-11#1)
pituitary and the##2##3##(1993-5#2)
pituitary and##10##2##(1992-12#1)(1993-3#2)(1993-5#3)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
pituitary apoplexy##3##2##(2011-2#2)(2012-2#1)
pituitary cell line##3##3##(1993-3#1)(1996-2#2)
pituitary cell##5##2##(1990-7#1)(1992-9#1)(1993-3#1)(1996-2#2)
pituitary cells##27##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#2)(1991-6#1)(1992-6#3)(1992-8#1)(1993-8#1)(1994-9#2)(1996-2#5)(1996-5#1)(1997-2#1)(2008-4#4)
pituitary corticotrope tumor##2##3##(1992-12#2)
pituitary gland##24##2##(1990-11#1)(1990-8#1)(1992-3#2)(1992-6#2)(1993-3#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)
pituitary glands##2##2##(2008-11#1)(2011-2#1)
pituitary gonadotropes##3##2##(1993-11#1)(1997-2#2)
pituitary hormone deficiencies##2##3##(2013-1#2)
pituitary hormone##5##2##(1992-8#1)(1993-11#1)(2011-1#1)(2013-1#2)
pituitary is##2##2##(1992-12#1)(2008-7#1)
pituitary macroadenoma##6##2##(1991-6#1)(2008-8#3)(2011-2#2)
pituitary melanotrophs##4##2##(1993-5#4)
pituitary of the##3##3##(1993-5#3)
pituitary stalk##4##2##(1997-3#1)(2013-8#3)
pituitary tumor cell line##4##4##(1990-12#1)(1993-3#1)(1994-12#1)(1997-7#1)
pituitary tumor##6##2##(1990-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1997-7#1)
pituitary tumors##2##2##(2011-2#1)(2013-1#1)
pituitary##237##1##(1990-11#4)(1990-12#14)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-6#3)(1992-10#2)(1992-12#11)(1992-3#4)(1992-6#6)(1992-8#2)(1992-9#1)(1993-11#4)(1993-2#1)(1993-3#6)(1993-5#21)(1993-8#1)(1993-9#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#7)(1994-8#3)(1994-9#4)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#5)(1996-2#9)(1996-5#3)(1997-2#4)(1997-3#2)(1997-7#1)(1997-8#4)(2006-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#14)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2009-1#1)(2009-4#1)(2010-2#1)(2010-5#2)(2011-1#3)(2011-2#17)(2012-1#5)(2012-2#3)(2012-3#2)(2013-1#13)(2013-8#3)
pituitary-reproductive tract##2##2##(2008-3#2)
pityocampa larvae##3##2##(2008-12#3)
pityocampa##5##1##(2008-12#5)
pityriasis versicolor and dermatitis seborrhoeica##2##5##(2008-5#2)
pityriasis versicolor##9##2##(2007-7#3)(2008-5#6)
pityriasis##10##1##(2007-7#4)(2008-5#6)
pivot point##2##2##(2008-3#2)
pivot##11##1##(1992-3#1)(1995-2#1)(2008-11#1)(2008-3#5)(2009-5#1)(2010-12#1)(2013-1#1)
pivotal for##2##2##(2012-2#1)(2012-3#1)
pivotal in the##3##3##(2006-10#2)(2010-12#1)
pivotal in##6##2##(2006-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)
pivotal link##2##2##(1994-3#1)(2009-10#1)
pivotal phase##2##2##(2008-5#2)
pivotal point##2##2##(1994-1#1)(2006-10#1)
pivotal position##3##2##(2006-10#1)(2010-10#1)(2010-3#1)
pivotal role in##35##3##(1991-2#1)(1991-9#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
pivotal role##46##2##(1991-2#1)(1991-9#1)(1992-9#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(1997-8#2)(2008-1#3)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#2)
pivotal roles of##2##3##(2009-10#1)(2009-6#1)
pivotal roles##5##2##(2007-12#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
pivotal studies##2##2##(1996-1#1)(2013-1#1)
pivotal to##5##2##(1995-11#1)(1995-2#1)(2008-1#1)(2008-8#1)(2010-5#1)
pivotal trial for the##2##4##(2008-5#2)
pivotal trial##3##2##(2008-5#2)(2010-4#1)
pivotal##99##1##(1990-3#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#2)(1997-8#3)(2006-10#4)(2007-12#1)(2008-1#5)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#2)(2009-12#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#4)
pixel area##2##2##(2008-3#1)(2008-7#1)
pixel array##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
pixel by pixel##2##3##(2008-3#1)(2011-1#1)
pixel columns##2##2##(2008-3#2)
pixel geometries##2##2##(2008-2#2)
pixel in the##5##3##(2008-2#2)(2008-3#2)(2011-1#1)
pixel intensities##2##2##(2010-2#1)(2011-2#1)
pixel is##4##2##(2008-10#1)(2008-3#3)
pixel misregistration in##2##3##(2007-11#1)(2007-12#1)
pixel misregistration##3##2##(2007-11#2)(2007-12#1)
pixel of the##2##3##(2008-10#1)(2008-3#1)
pixel pitch and##2##3##(2011-1#2)
pixel pitch of##2##3##(2007-11#1)(2008-3#1)
pixel pitch##5##2##(2007-11#2)(2008-3#1)(2011-1#2)
pixel resolution##2##2##(2008-3#1)(2012-12#1)
pixel sensor##2##2##(2008-10#1)(2008-3#1)
pixel size of##2##3##(2007-11#1)(2011-1#1)
pixel size##4##2##(2007-11#2)(2011-1#1)(2012-1#1)
pixel##90##1##(1991-2#1)(2007-11#8)(2007-12#6)(2008-10#4)(2008-11#1)(2008-2#12)(2008-3#44)(2008-6#1)(2008-7#1)(2010-2#3)(2011-1#6)(2011-2#1)(2012-1#1)(2012-12#1)
pixel-matched holographic##2##2##(2007-12#2)
pixel-matched volume holographic data storage##2##5##(2008-3#2)
pixel-matched##6##1##(2007-11#2)(2007-12#2)(2008-3#2)
pixel-pitch reflective liquid-crystal display by use of a light-emitting diode reference light##2##12##(2007-11#2)
pixelated lens##4##2##(2008-3#4)
pixelated##13##1##(2007-11#2)(2008-2#4)(2008-3#7)
pixels and##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
pixels as##2##2##(2008-3#2)
pixels by##2##2##(2007-11#1)(2007-12#1)
pixels for##2##2##(2008-3#2)
pixels from##2##2##(2007-11#1)(2008-2#1)
pixels in the##4##3##(2008-2#1)(2008-3#3)
pixels in##6##2##(2008-2#1)(2008-3#4)(2012-2#1)
pixels of the##2##3##(2008-10#1)(2013-8#1)
pixels of##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
pixels that##4##2##(2007-11#1)(2008-3#2)(2008-8#1)
pixels to be##2##3##(2008-3#1)(2013-8#1)
pixels with##5##2##(2007-11#1)(2008-3#2)(2011-1#2)
pixels##70##1##(2007-10#1)(2007-11#11)(2007-12#3)(2008-10#3)(2008-2#7)(2008-3#36)(2008-8#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#3)
pixels)##3##1##(2008-10#2)(2008-2#1)
pk(a(1))=2##2##1##(2008-10#2)
pk(a(1))=7##3##1##(2008-10#3)
pk(a(2))=6##2##1##(2008-10#2)
pka1 gene##2##2##(1994-12#2)
pka1##3##1##(1994-12#3)
pkc1##2##1##(1996-6#1)(1997-3#1)
pl##3##1##(2008-7#1)(2008-8#2)
place a##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
place after##4##2##(1995-5#1)(2006-12#1)(2010-8#1)(2011-2#1)
place among##2##2##(2008-10#1)(2013-1#1)
place an##2##2##(2007-11#1)(2008-8#1)
place and head direction##2##4##(2013-8#2)
place and route##2##3##(1996-11#1)(2008-2#1)
place and##12##2##(1996-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#2)
place as##5##2##(1991-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
place at a##2##3##(2008-1#1)(2008-10#1)
place at the##11##3##(1991-2#1)(1994-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
place at##24##2##(1990-11#1)(1991-2#1)(1993-12#1)(1994-2#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-8#1)(2012-12#1)
place before##2##2##(1997-5#1)(2011-2#1)
place between##6##2##(1997-3#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
place cell##3##2##(2007-8#1)(2008-11#2)
place cells##4##2##(2007-8#3)(2008-11#1)
place during the enzymatic reaction##2##5##(2008-10#2)
place during the##4##3##(1991-12#1)(1994-3#1)(2008-10#2)
place during##9##2##(1991-12#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2012-12#1)
place for the##2##3##(2008-11#1)(2012-1#1)
place for##28##2##(1991-12#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-2#1)(1996-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
place from##6##2##(1991-9#1)(2008-10#2)(2009-6#1)(2012-12#1)(2012-3#1)
place greater emphasis on##3##4##(1994-2#2)(2008-12#1)
place in a##12##3##(1991-6#1)(1993-12#1)(1995-3#1)(1996-11#1)(2008-10#4)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
place in all##2##3##(2011-2#1)(2012-8#1)
place in an##2##3##(2008-11#1)(2010-7#1)
place in basic##2##3##(2008-10#1)(2011-1#1)
place in society##2##3##(2007-8#1)(2012-12#1)
place in the history##2##4##(2008-7#1)(2008-8#1)
place in the##39##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
place in this area##2##4##(2008-2#2)
place in##99##2##(1990-10#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#2)
place is##3##2##(1996-3#1)(2008-9#1)(2009-10#1)
place it##2##2##(1996-11#1)(2009-7#1)
place learning deficits##2##3##(1993-3#2)
place learning##5##2##(1993-12#2)(1993-3#3)
place like##2##2##(1997-1#1)(2008-1#1)
place of birth##5##3##(1990-6#1)(2013-1#4)
place of death##3##3##(1991-12#1)(1991-3#1)(2011-2#1)
place of diagnosis##3##3##(2012-12#3)
place of origin##2##3##(2008-10#1)(2012-12#1)
place of residence##4##3##(1994-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
place of the##13##3##(1990-6#1)(1995-2#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
place of##69##2##(1990-6#3)(1991-12#1)(1991-3#1)(1992-12#1)(1992-6#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#4)(2009-12#1)(2009-6#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
place on the##6##3##(1992-4#1)(2008-10#2)(2008-8#1)(2010-8#1)(2013-1#1)
place on##7##2##(1992-4#1)(1995-2#1)(2008-10#2)(2008-8#1)(2010-8#1)(2013-1#1)
place or##2##2##(2008-12#1)(2008-9#1)
place preference is##2##3##(1993-6#1)(2008-4#1)
place preference##5##2##(1993-6#2)(1994-2#1)(2008-4#2)
place such##2##2##(2008-7#1)(2009-7#1)
place the##11##2##(1992-11#1)(1992-8#1)(1993-3#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#2)(2012-3#1)
place them at risk##2##4##(2007-4#1)(2012-12#1)
place them##6##2##(1993-9#1)(1995-1#1)(2007-4#1)(2008-12#1)(2010-7#1)(2012-12#1)
place these##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
place this##2##2##(2008-11#1)(2008-7#1)
place through the##2##3##(2007-12#1)(2008-10#1)
place through##3##2##(1990-11#1)(2007-12#1)(2008-10#1)
place to##19##2##(1991-3#1)(1993-8#2)(1994-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
place under##5##2##(2008-10#3)(2011-2#2)
place were##2##2##(1995-12#1)(2011-1#1)
place when##4##2##(1994-12#1)(2008-10#2)(2008-7#1)
place with##4##2##(1992-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
place within the##3##3##(1991-2#1)(1997-1#1)(2008-11#1)
place within##6##2##(1990-10#1)(1991-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
place##568##1##(1990-10#3)(1990-11#3)(1990-2#1)(1990-6#4)(1990-8#1)(1991-1#2)(1991-12#10)(1991-2#3)(1991-3#5)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#3)(1993-3#6)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-12#7)(1995-2#7)(1995-3#5)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#6)(1996-3#2)(1996-4#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-5#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#9)(2008-10#67)(2008-11#41)(2008-12#14)(2008-2#8)(2008-3#7)(2008-4#7)(2008-5#11)(2008-6#8)(2008-7#14)(2008-8#11)(2008-9#19)(2009-10#3)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#4)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#20)(2012-2#12)(2012-3#9)(2012-8#1)(2013-1#19)(2013-7#1)(2013-8#9)
placebo (P##2##2##(1992-5#1)(2008-7#1)
placebo (P)##2##2##(2008-5#2)
placebo administered once a day##2##5##(2008-7#2)
placebo and##3##2##(2008-6#1)(2008-7#1)(2009-8#1)
placebo at##3##2##(2008-10#1)(2012-2#2)
placebo control##2##2##(2008-5#1)(2010-11#1)
placebo controlled studies##2##3##(2008-11#1)(2008-5#1)
placebo controlled study with##2##4##(1990-3#1)(2008-5#1)
placebo controlled study##4##3##(1990-3#1)(2007-7#1)(2007-9#1)(2008-5#1)
placebo controlled##14##2##(1990-3#1)(1993-3#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#4)(2012-3#1)
placebo effect##5##2##(1990-3#1)(2008-10#1)(2008-12#3)
placebo effects##3##2##(1990-3#1)(2008-10#2)
placebo for##10##2##(1990-5#1)(1992-8#1)(2008-10#2)(2008-5#4)(2012-2#1)(2013-1#1)
placebo group and##2##3##(2008-7#1)(2012-2#1)
placebo group##27##2##(1990-3#1)(1991-11#1)(1992-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-8#1)(2011-1#2)(2012-2#4)(2013-1#2)
placebo groups##6##2##(1990-3#1)(1995-12#1)(2008-5#2)(2008-8#1)(2012-2#1)
placebo in short##2##3##(2011-2#1)(2013-1#1)
placebo in##10##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-7#1)(2011-2#1)(2013-1#2)
placebo on##2##2##(2008-5#1)(2011-2#1)
placebo or##13##2##(1992-8#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
placebo treated##2##2##(2008-5#1)(2009-7#1)
placebo treatment##7##2##(1990-3#2)(1991-11#1)(2013-1#4)
placebo was##3##2##(1992-5#1)(2008-7#1)(2011-1#1)
placebo were##3##2##(1990-5#1)(2008-10#1)(2011-2#1)
placebo##220##1##(1990-3#8)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-3#2)(1992-2#1)(1992-5#5)(1992-8#3)(1993-3#2)(1994-11#6)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#6)(2008-5#51)(2008-6#7)(2008-7#17)(2008-8#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-2#17)(2012-3#2)(2013-1#16)(2013-8#4)
placebo)##5##1##(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
placebo-controlled clinical trial##2##3##(2008-3#1)(2011-2#1)
placebo-controlled clinical trials##4##3##(1991-9#1)(2008-2#1)(2008-7#1)(2012-3#1)
placebo-controlled clinical##8##2##(1991-9#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
placebo-controlled double-blind study##2##3##(1992-5#1)(2008-7#1)
placebo-controlled double-blind##3##2##(1992-5#1)(1994-8#1)(2008-7#1)
placebo-controlled studies in##2##3##(2008-1#1)(2011-2#1)
placebo-controlled study of##2##3##(1996-3#1)(2008-7#1)
placebo-controlled study was conducted##2##4##(2011-1#1)(2011-2#1)
placebo-controlled study was##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
placebo-controlled study##11##2##(1996-3#1)(2006-10#1)(2008-5#4)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
placebo-controlled trial of##3##3##(1991-2#1)(1997-5#1)(2008-8#1)
placebo-controlled trial##11##2##(1991-2#1)(1997-5#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2013-1#2)
placebo-controlled trials of##4##3##(2008-2#1)(2008-7#1)(2009-12#1)(2010-2#1)
placebo-controlled trials##12##2##(2008-2#2)(2008-7#5)(2008-9#2)(2009-12#1)(2010-2#1)(2010-8#1)
placebo-controlled##66##1##(1991-2#1)(1991-9#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
placebo-related##2##1##(2006-10#1)(2011-1#1)
placebo-treated patients##2##2##(1991-11#1)(2008-5#1)
placebo-treated##4##1##(1991-11#1)(2008-5#2)(2011-2#1)
placebos##2##1##(1995-9#1)(1996-2#1)
placed a##6##2##(2007-11#1)(2008-11#1)(2010-5#1)(2012-12#1)(2013-1#2)
placed after##2##2##(2007-12#1)(2011-2#1)
placed all##2##2##(2008-10#1)(2009-10#1)
placed along the##2##3##(1995-3#1)(2009-2#1)
placed along##3##2##(1995-3#1)(2008-10#1)(2009-2#1)
placed around the##2##3##(1995-12#1)(2008-12#1)
placed at a##2##3##(2007-12#1)(2008-3#1)
placed at the detection point##2##5##(2008-10#2)
placed at the##10##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
placed at##20##2##(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-3#4)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
placed before##2##2##(2008-2#1)(2013-1#1)
placed between a##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
placed between crossed polarizers##2##4##(2008-2#1)(2008-3#1)
placed between the##4##3##(2008-3#2)(2008-5#1)(2009-5#1)
placed between##13##2##(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-9#1)(2009-5#1)(2012-1#1)
placed by##3##2##(1996-7#1)(2008-11#1)(2009-2#1)
placed directly on the##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
placed directly on##4##3##(2008-10#2)(2008-3#1)(2008-6#1)
placed directly##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)
placed either##2##2##(1994-1#1)(2008-9#1)
placed for##5##2##(2008-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2013-1#1)
placed in a cell##2##4##(2008-10#1)(2008-3#1)
placed in a flow##2##4##(2008-10#2)
placed in a large volume##2##5##(2008-10#1)(2008-8#1)
placed in a##31##3##(1996-3#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
placed in an##8##3##(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)
placed in close##2##3##(2008-10#1)(2009-12#1)
placed in contact with##4##4##(2007-11#1)(2008-10#2)(2009-5#1)
placed in each##2##3##(2008-10#1)(2008-5#1)
placed in front of##2##4##(2007-12#1)(2008-2#1)
placed in one##2##3##(2008-10#1)(2013-7#1)
placed in the chamber##2##4##(2008-1#1)(2008-10#1)
placed in the same group##2##5##(1997-6#1)(2008-10#1)
placed in the same##5##4##(1997-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
placed in the sample##2##4##(2008-10#1)(2008-11#1)
placed in the##54##3##(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-7#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)
placed in##153##2##(1991-3#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-7#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#58)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#11)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#2)
placed inside a##5##3##(2008-10#2)(2008-3#2)(2011-2#1)
placed inside##9##2##(1997-6#1)(2008-10#4)(2008-3#2)(2009-3#1)(2011-2#1)
placed into the##2##3##(1990-10#1)(2011-2#1)
placed into##10##2##(1990-10#1)(1996-5#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
placed just##2##2##(1997-4#1)(2008-10#1)
placed more##2##2##(2008-12#1)(2008-3#1)
placed new##2##2##(1991-2#1)(1992-12#1)
placed on a gluten-free diet for##2##6##(2007-5#2)
placed on a##8##3##(1996-3#1)(2007-11#2)(2007-5#2)(2008-10#2)(2008-7#1)
placed on how these##2##4##(2006-10#1)(2013-8#1)
placed on radiology reports##2##4##(2012-2#2)
placed on the##34##3##(1993-2#1)(1993-3#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
placed on##94##2##(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1995-9#1)(1996-3#2)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#2)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
placed over the##2##3##(2008-12#1)(2008-3#1)
placed over##3##2##(2008-12#1)(2008-3#1)(2012-2#1)
placed the##4##2##(1992-3#1)(1995-3#1)(1995-9#1)(1996-6#1)
placed them##2##2##(1992-1#1)(2008-5#1)
placed to##7##2##(2007-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
placed together##2##2##(2008-10#1)(2008-3#1)
placed under the##5##3##(1994-11#1)(1995-2#1)(1997-4#2)(2012-2#1)
placed under##9##2##(1994-11#1)(1995-2#1)(1997-4#2)(1997-6#1)(2008-1#1)(2008-10#2)(2012-2#1)
placed upstream##2##2##(1993-3#1)(2008-11#1)
placed with##5##2##(1994-3#2)(2007-10#1)(2008-8#1)(2013-1#1)
placed within a##2##3##(1993-11#1)(2008-3#1)
placed within the##2##3##(2008-10#1)(2008-9#1)
placed within##5##2##(1993-11#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
placed##443##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-7#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(2006-10#1)(2007-10#3)(2007-11#9)(2007-12#8)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#113)(2008-11#16)(2008-12#7)(2008-2#11)(2008-3#36)(2008-4#4)(2008-5#12)(2008-6#7)(2008-7#14)(2008-8#11)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#3)(2011-2#15)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#19)(2013-7#3)(2013-8#5)
placement and is##2##3##(2008-1#1)(2010-7#1)
placement and##15##2##(1993-3#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2009-4#1)(2010-7#2)(2012-2#1)
placement areas##2##2##(2008-11#1)(2013-8#1)
placement for the##2##3##(2008-10#1)(2008-8#1)
placement for##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
placement in a##2##3##(1995-1#1)(2011-2#1)
placement in an Irish##2##4##(2008-11#1)(2008-12#1)
placement in the treatment of##2##5##(2009-1#1)(2010-7#1)
placement in the##10##3##(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#1)(2010-7#2)(2012-12#2)
placement in##22##2##(1995-1#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#3)(2013-1#1)
placement of a##11##3##(1993-11#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
placement of an##3##3##(1990-2#1)(2007-7#1)(2008-10#1)
placement of dental implants##3##4##(2007-12#2)(2012-12#1)
placement of the##13##3##(1992-6#1)(1994-5#1)(1996-5#1)(2007-7#2)(2007-8#3)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
placement of##67##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#10)(2007-8#5)(2008-1#2)(2008-10#8)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-10#2)(2009-2#4)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
placement on##2##2##(2008-10#1)(2013-1#1)
placement provided##2##2##(2008-12#1)(2012-12#1)
placement rather than##2##3##(2007-12#1)(2010-7#1)
placement using##2##2##(2013-1#2)
placement was##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2010-7#1)
placement were##3##2##(1990-5#1)(2007-7#1)(2012-3#1)
placement while##2##2##(2008-12#1)(2008-8#1)
placement will be##2##3##(2008-5#1)(2009-10#1)
placement within##2##2##(2008-3#1)(2008-4#1)
placement##243##1##(1990-2#1)(1990-5#6)(1991-1#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-5#1)(1995-1#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#5)(2007-12#10)(2007-7#20)(2007-8#7)(2008-1#3)(2008-10#14)(2008-11#30)(2008-12#22)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#3)(2009-2#4)(2009-4#2)(2009-5#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#9)(2010-8#1)(2011-2#12)(2012-12#15)(2012-2#1)(2012-3#6)(2013-1#18)(2013-8#2)
placements and##2##2##(1994-3#1)(2008-12#1)
placements can be##2##3##(2008-11#1)(2013-8#1)
placements in##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
placements to##2##2##(2008-11#2)
placements##50##1##(1991-1#1)(1994-3#2)(1995-3#2)(2008-11#21)(2008-12#11)(2010-3#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#7)
placenta and fetal##2##3##(1990-5#1)(2008-9#1)
placenta and##13##2##(1990-2#2)(1990-5#1)(1991-12#1)(1992-10#1)(1996-11#2)(1996-12#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
placenta by##2##2##(1993-11#1)(1995-12#1)
placenta in##3##2##(1990-2#1)(1995-12#1)(2013-1#1)
placenta##81##1##(1990-11#3)(1990-12#2)(1990-2#5)(1990-5#5)(1990-9#1)(1991-1#1)(1991-12#3)(1991-7#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-8#1)(1996-11#4)(1996-12#1)(1997-1#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
placenta-derived multipotent cells##2##3##(2008-9#2)
placental AP##4##2##(1992-3#1)(2008-11#3)
placental P-450arom isoform##2##3##(1995-8#2)
placental P-450arom##3##2##(1995-8#3)
placental alkaline phosphatase##4##3##(2008-11#4)
placental and##2##2##(1995-8#2)
placental cells##2##2##(1996-12#1)(2008-9#1)
placental development##2##2##(1992-6#1)(1994-9#1)
placental glycoprotein##2##2##(1990-4#1)(1992-8#1)
placental insufficiency##3##2##(1991-9#1)(1996-11#2)
placental mammals##4##2##(1995-11#1)(2008-9#2)(2010-4#1)
placental nutrient transport##2##3##(2013-1#2)
placental nutrient##3##2##(2013-1#3)
placental tissue##2##2##(1990-12#1)(2008-9#1)
placental##64##1##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#2)(1994-3#1)(1994-6#3)(1994-9#2)(1995-11#3)(1995-12#2)(1995-6#1)(1995-8#6)(1996-11#2)(1996-12#2)(2008-10#1)(2008-11#9)(2008-4#2)(2008-8#2)(2008-9#4)(2009-7#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#4)
placentas of##5##2##(2011-1#4)(2013-1#1)
placentas##7##1##(1994-9#1)(2011-1#5)(2013-1#1)
places a##2##2##(1994-8#1)(2011-2#1)
places emphasis on##2##3##(2009-8#1)(2010-8#1)
places high demands##2##3##(2008-10#1)(2008-12#1)
places in the##2##3##(2008-10#1)(2008-3#1)
places in##4##2##(2008-10#3)(2008-3#1)
places of the##2##3##(1991-6#1)(2007-10#1)
places of##10##2##(1991-6#2)(1995-6#1)(2007-10#1)(2008-10#3)(2010-10#1)(2013-1#2)
places on##3##2##(2008-11#1)(2008-2#1)(2009-9#1)
places rectangles where they do not overlap each other and where the##2##12##(2008-6#2)
places rectangles##3##2##(2008-6#3)
places where##4##2##(2007-12#1)(2008-10#1)(2008-12#2)
places with##2##2##(2008-4#1)(2013-1#1)
places##77##1##(1991-5#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#3)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
placing a##5##2##(1997-5#1)(2008-10#1)(2008-3#2)(2010-3#1)
placing an##2##2##(1996-2#1)(2008-10#1)
placing of the##2##3##(2007-12#1)(2008-3#1)
placing of##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
placing the##13##2##(1992-1#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)
placing##57##1##(1992-1#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#3)(2011-1#1)(2012-2#1)(2013-1#2)
plagiarism##3##1##(2008-12#1)(2013-1#2)
plagiocephaly##6##1##(2007-12#6)
plague##12##1##(1990-6#4)(1991-11#1)(1997-6#1)(2010-2#1)(2013-1#5)
plagued by significant##2##3##(2008-3#1)(2011-2#1)
plagued by##6##2##(1994-3#1)(1995-3#1)(2007-9#1)(2008-3#2)(2011-2#1)
plagued##8##1##(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(2007-9#1)(2008-3#2)(2011-2#1)
plagues##3##1##(1990-6#1)(1994-2#1)(2010-1#1)
plaguing##2##1##(1991-2#1)(2013-8#1)
plain CT##2##2##(2012-12#2)
plain X-ray##2##2##(1990-6#1)(2007-11#1)
plain abdominal##3##2##(1991-8#1)(2008-10#1)(2012-2#1)
plain bupivacaine plus##2##3##(2011-2#2)
plain bupivacaine##3##2##(2011-2#3)
plain clindamycin##2##2##(2007-7#2)
plain film##3##2##(2007-11#2)(2008-12#1)
plain radiography##3##2##(2010-6#1)(2011-2#2)
plain##44##1##(1990-6#1)(1991-8#1)(1992-6#1)(1993-1#2)(1994-2#1)(2007-11#5)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
plainly##2##1##(2008-4#1)(2008-5#1)
plains##4##1##(2008-10#3)(2013-7#1)
plaintiff##8##1##(1991-7#5)(1997-5#3)
plaintiffs in the##2##3##(1995-6#2)
plaintiffs who##2##2##(1997-5#2)
plaintiffs##9##1##(1992-2#1)(1994-1#1)(1995-12#1)(1995-6#3)(1996-5#1)(1997-5#2)
plan a##2##2##(1995-11#1)(2012-3#1)
plan aims##2##2##(1993-8#1)(2008-7#1)
plan an##2##2##(2008-10#1)(2008-9#1)
plan and implement##6##3##(1996-3#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-7#1)
plan and provider##2##3##(1991-2#1)(1992-3#1)
plan and##25##2##(1991-2#2)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#4)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
plan are##4##2##(1991-2#1)(1992-3#1)(1993-3#1)(2008-3#1)
plan as##2##2##(1992-3#1)(2008-3#1)
plan choices##3##2##(1997-3#3)
plan development and##2##3##(1994-2#1)(1994-3#1)
plan development##4##2##(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)
plan for health care##2##4##(1992-12#1)(2008-4#1)
plan for neuronal##2##3##(2007-12#2)
plan for the future##2##4##(1992-12#1)(1992-2#1)
plan for the##9##3##(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-5#1)
plan for their##2##3##(1992-1#1)(2008-11#1)
plan for this##2##3##(2008-9#1)(2011-2#1)
plan for##43##2##(1990-11#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-2#1)(1994-1#3)(1994-2#2)(1995-2#1)(1996-2#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-3#1)
plan in##5##2##(1991-1#1)(1993-12#1)(2007-9#1)(2008-11#1)(2013-1#1)
plan included##2##2##(2011-2#1)(2013-1#1)
plan is##11##2##(1991-2#1)(1992-11#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-2#1)(2008-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
plan managers##2##2##(1994-2#1)(1996-12#1)
plan of action##3##3##(1991-1#1)(1991-3#1)(2008-10#1)
plan of care##5##3##(2008-11#1)(2008-2#2)(2013-1#2)
plan of the##2##3##(1996-12#1)(1996-2#1)
plan of##12##2##(1991-1#1)(1991-3#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-8#1)(2013-1#2)
plan on##2##2##(1997-2#1)(2011-1#1)
plan or##2##2##(1994-3#1)(2008-11#1)
plan performance##7##2##(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#3)(1997-3#1)
plan report cards##2##3##(1996-3#1)(1997-2#1)
plan selections##2##2##(1997-3#2)
plan that##6##2##(1991-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#2)
plan the##5##2##(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2013-8#1)
plan their##3##2##(1992-4#1)(1995-12#1)(2013-8#1)
plan to##32##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#3)(1995-6#3)(1997-2#1)(1997-6#1)(2008-1#2)(2008-11#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#3)
plan was developed##2##3##(2008-10#1)(2010-7#1)
plan was##6##2##(1992-12#1)(1996-3#1)(2008-10#1)(2009-10#1)(2010-7#1)(2012-2#1)
plan which##2##2##(1991-1#1)(1992-1#1)
plan will##4##2##(1992-2#1)(1994-3#2)(2008-7#1)
plan with##3##2##(1992-3#1)(2008-11#1)(2011-1#1)
plan would##2##2##(1991-9#1)(2008-10#1)
plan##381##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#4)(1991-12#3)(1991-2#7)(1991-3#6)(1991-8#1)(1991-9#1)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#6)(1992-3#10)(1992-4#2)(1992-5#1)(1993-1#4)(1993-12#3)(1993-2#6)(1993-3#6)(1993-5#2)(1993-8#1)(1994-1#11)(1994-12#4)(1994-2#15)(1994-3#8)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#9)(1995-2#9)(1995-3#4)(1995-6#8)(1996-1#7)(1996-12#5)(1996-2#6)(1996-3#17)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#17)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#17)(2008-12#3)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#12)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#8)
plan's##4##1##(1993-8#1)(1995-12#1)(1995-6#1)(2008-6#1)
plana vitrectomy##2##2##(2011-2#1)(2013-1#1)
plana##3##1##(2011-1#1)(2011-2#1)(2013-1#1)
planar BLM##4##2##(1997-7#4)
planar and##3##2##(2008-2#1)(2008-3#2)
planar bilayers##4##2##(2008-4#4)
planar cell##2##2##(2007-12#2)
planar geometry##6##2##(1996-2#1)(2008-2#3)(2008-3#2)
planar guided-wave##2##2##(2007-12#2)
planar holographic optical elements##2##4##(2008-2#2)
planar holographic##3##2##(2008-2#3)
planar imaging##3##2##(1992-3#2)(1994-1#1)
planar laser##2##2##(2008-3#2)
planar laser-induced fluorescence (PLIF)##2##4##(2008-2#1)(2008-3#1)
planar laser-induced fluorescence##5##3##(2008-2#3)(2008-3#2)
planar light waveguide-type##2##3##(2007-12#2)
planar lipid bilayer##2##3##(1993-3#1)(2008-8#1)
planar lipid##3##2##(1993-3#2)(2008-8#1)
planar membranes##3##2##(1990-12#1)(1994-2#2)
planar micro-optics##2##2##(2007-12#2)
planar microcavities##2##2##(2008-3#2)
planar microlenses##2##2##(2008-3#2)
planar optical waveguide##3##3##(2007-12#2)(2008-10#1)
planar optical##6##2##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
planar phospholipid bilayers##2##3##(1990-11#1)(1990-2#1)
planar structure##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
planar waveguide and##2##3##(2007-12#1)(2008-3#1)
planar waveguide gratings##4##3##(2008-3#4)
planar waveguide laser##3##3##(2007-11#3)
planar waveguide was##2##3##(2007-12#2)
planar waveguide##29##2##(2007-11#11)(2007-12#4)(2008-2#5)(2008-3#7)(2010-5#2)
planar waveguides by ultraviolet##2##4##(2007-12#1)(2008-3#1)
planar waveguides by##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
planar waveguides in##2##3##(2007-12#1)(2008-3#1)
planar waveguides##18##2##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#9)
planar##185##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-3#2)(1992-5#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#3)(1995-2#1)(1996-2#3)(1996-5#1)(1997-7#7)(2007-11#19)(2007-12#28)(2008-10#11)(2008-11#1)(2008-2#28)(2008-3#53)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2010-5#2)(2012-2#5)(2012-3#2)
planar-apertured probe array##2##3##(2008-3#2)
planar-integrated##6##1##(2007-11#2)(2008-3#4)
planarian CNS##3##2##(2008-5#3)
planarian##5##1##(2008-5#5)
planarians##2##1##(2008-5#1)(2013-8#1)
planarity##3##1##(1996-5#1)(2008-3#2)
plane and the##2##3##(2008-3#1)(2011-2#1)
plane and##14##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2011-2#2)
plane are##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
plane as##2##2##(2008-9#1)(2011-2#1)
plane at##2##2##(2008-2#1)(2008-3#1)
plane between the##2##3##(2008-3#1)(2012-12#1)
plane by##2##2##(2007-11#1)(2008-3#1)
plane containing the##2##3##(2007-11#1)(2008-2#1)
plane for##4##2##(2008-2#2)(2008-3#2)
plane from##3##2##(2007-11#2)(2008-2#1)
plane image##2##2##(2008-3#2)
plane in a##2##3##(2008-3#1)(2012-2#1)
plane in the##2##3##(2007-12#1)(2008-3#1)
plane in##6##2##(2007-12#1)(2008-3#2)(2009-11#1)(2010-8#1)(2012-2#1)
plane is##15##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#7)(2008-5#1)(2011-1#1)(2012-2#1)
plane located in the Fresnel diffraction region##2##7##(2007-12#1)(2008-3#1)
plane mirror##2##2##(2008-2#2)
plane nonlinear filtering##2##3##(2008-2#2)
plane of a##6##3##(2008-2#2)(2008-3#3)(2008-9#1)
plane of incidence##9##3##(2007-12#1)(2008-2#2)(2008-3#6)
plane of polarization##2##3##(2007-12#1)(2008-2#1)
plane of the correlator##2##4##(2008-3#2)
plane of the grating##3##4##(2008-3#3)
plane of the##28##3##(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-5#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#12)(2010-6#1)(2010-8#1)
plane of##56##2##(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-2#8)(2008-3#26)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2013-8#1)
plane or##3##2##(1990-3#1)(2008-3#2)
plane perpendicular to the##3##4##(2008-3#2)(2012-12#1)
plane polariscope##2##2##(2008-3#2)
plane surface of a##2##4##(2008-2#1)(2008-3#1)
plane surface of##3##3##(2008-2#1)(2008-3#2)
plane surface##4##2##(2008-2#1)(2008-3#3)
plane that##2##2##(2007-12#1)(2008-3#1)
plane to##3##2##(2008-2#1)(2008-3#2)
plane warts##4##2##(2013-1#4)
plane wave or##2##3##(2007-12#1)(2008-3#1)
plane wave with##2##3##(2008-2#1)(2008-3#1)
plane wave##21##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#14)
plane waves in##2##3##(2007-11#1)(2008-3#1)
plane waves##12##2##(2007-11#4)(2008-3#8)
plane were##4##2##(1996-5#1)(2008-3#1)(2008-7#1)(2012-3#1)
plane when##2##2##(2007-12#1)(2008-3#1)
plane with##4##2##(2008-2#1)(2008-3#3)
plane without##2##2##(2007-11#2)
plane##357##1##(1990-3#1)(1991-5#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#4)(2006-12#1)(2007-10#4)(2007-11#26)(2007-12#19)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#57)(2008-3#156)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#5)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
plane)##2##1##(2007-11#1)(2008-3#1)
plane-parallel plate##3##2##(2008-2#3)
plane-parallel resonator##3##2##(2008-3#3)
plane-parallel##18##1##(2008-2#9)(2008-3#8)(2012-1#1)
plane-polarized##2##1##(2007-12#1)(2008-4#1)
plane-symmetric##2##1##(2008-3#2)
plane-wave holograms##3##2##(2007-12#3)
plane-wave##15##1##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#6)(2013-1#2)
planes and##4##2##(1990-11#1)(2008-2#1)(2008-3#1)(2009-10#1)
planes are##3##2##(2008-3#3)
planes in##10##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
planes is##2##2##(2008-3#2)
planes of the##3##3##(1992-11#1)(2007-8#1)(2008-6#1)
planes of##9##2##(1992-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)
planes##77##1##(1990-11#2)(1992-11#1)(1992-8#1)(1993-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#38)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
planet detection##2##2##(2008-3#2)
planet##8##1##(1991-8#1)(1992-7#1)(1996-6#1)(2008-3#3)(2010-5#1)(2013-8#1)
planetary##10##1##(1997-5#1)(2008-2#3)(2008-3#6)
planets##6##1##(1995-6#1)(1997-5#1)(2008-2#2)(2008-3#1)(2012-2#1)
planing##2##1##(1996-1#1)(2012-3#1)
plankton##5##1##(2008-3#1)(2009-8#2)(2010-6#1)(2010-8#1)
planktonic systems##2##2##(2009-8#2)
planktonic##9##1##(2007-5#1)(2008-3#4)(2009-6#2)(2009-8#2)
planned a##2##2##(1995-1#1)(2008-12#1)
planned action##2##2##(2008-11#1)(2013-1#1)
planned and executed##2##3##(1990-3#1)(2012-12#1)
planned and##10##2##(1990-3#1)(1992-3#2)(1995-1#1)(2008-1#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
planned as a##4##3##(2008-5#1)(2010-6#1)(2010-7#1)(2013-8#1)
planned as##5##2##(1990-6#1)(2008-5#1)(2010-6#1)(2010-7#1)(2013-8#1)
planned cholecystectomy##2##2##(1997-8#2)
planned for the##3##3##(1991-3#1)(2008-2#1)(2012-3#1)
planned for##8##2##(1991-3#1)(2007-12#1)(2007-7#1)(2008-2#3)(2008-5#1)(2012-3#1)
planned gifts##2##2##(1991-1#1)(1992-3#1)
planned giving##5##2##(1991-3#2)(1992-3#1)(1994-1#2)
planned in order to##2##4##(2008-12#1)(2013-1#1)
planned in##5##2##(1991-9#1)(2008-12#1)(2008-7#2)(2013-1#1)
planned studies##2##2##(1990-6#1)(2011-1#1)
planned suicide##3##2##(1992-1#3)
planned surgery##2##2##(1991-8#1)(1994-11#1)
planned to breastfeed##2##3##(2007-2#2)
planned to evaluate the##2##4##(2007-10#1)(2011-1#1)
planned to##21##2##(1992-4#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(2007-10#1)(2007-2#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
planned##147##1##(1990-3#2)(1990-6#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-3#7)(1992-4#1)(1992-9#2)(1993-1#1)(1993-3#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#7)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-2#2)(2009-6#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#3)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#3)
planners and##2##2##(2011-2#2)
planners##15##1##(1991-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1996-1#1)(1996-3#2)(2008-10#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)
planning a##5##2##(1991-2#1)(2007-11#1)(2007-7#1)(2010-12#1)(2011-1#1)
planning actions##2##2##(2008-9#2)
planning activities##2##2##(1996-12#1)(2008-2#1)
planning after##2##2##(1992-2#1)(1992-4#1)
planning among##3##2##(1996-2#1)(2007-2#1)(2008-11#1)
planning and development##4##3##(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)
planning and execution##3##3##(2007-8#1)(2008-2#1)(2009-8#1)
planning and implementation of a##2##5##(1991-2#1)(2008-1#1)
planning and implementation of the##2##5##(1993-3#1)(2008-9#1)
planning and implementation of##8##4##(1991-2#1)(1993-3#1)(1995-3#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-12#1)
planning and implementation##12##3##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-3#2)(1996-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-12#1)
planning and implementing##2##3##(1994-2#1)(1995-1#1)
planning and improving##2##3##(1997-1#1)(2007-11#1)
planning and management##3##3##(1993-12#1)(1993-2#1)(1994-1#1)
planning and monitoring##2##3##(1996-2#1)(2012-2#1)
planning and the##3##3##(1994-2#1)(1996-3#1)(2013-1#1)
planning and##91##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#2)(1994-7#1)(1995-1#3)(1995-12#1)(1995-3#3)(1995-5#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
planning are discussed##3##3##(1994-1#2)(2008-7#1)
planning are##6##2##(1991-12#1)(1993-3#1)(1994-1#2)(1996-2#1)(2008-7#1)
planning at the##2##3##(1991-2#1)(1994-2#1)
planning child##2##2##(1990-12#1)(2009-10#1)
planning complications and surgical miscues##2##5##(2008-11#2)
planning disturbances in children who clutter##2##6##(2011-1#2)
planning document##2##2##(1992-2#1)(2013-8#1)
planning effort##2##2##(1992-1#1)(2012-2#1)
planning efforts##4##2##(1994-1#1)(1997-1#2)(2008-11#1)
planning experiments##2##2##(2008-6#1)(2013-1#1)
planning for a##2##3##(1991-3#1)(2007-7#1)
planning for cancer##3##3##(1997-1#1)(2008-7#1)(2009-11#1)
planning for data collection##5##4##(1994-12#3)(1995-2#1)(1995-3#1)
planning for the##5##3##(1992-2#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-7#1)
planning for##38##2##(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-2#3)(2007-4#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-7#3)(2009-11#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
planning from the##2##3##(1992-4#1)(1994-2#1)
planning from##4##2##(1991-1#1)(1992-4#1)(1993-12#1)(1994-2#1)
planning future##2##2##(1995-1#1)(2008-8#1)
planning have##2##2##(1994-1#1)(1996-12#1)
planning in Canada##2##3##(1991-1#1)(1994-1#1)
planning in health care##2##4##(1994-2#1)(1995-1#1)
planning in the##6##3##(1994-1#1)(1994-2#1)(1996-12#1)(2008-11#1)(2011-2#1)(2011-3#1)
planning in##22##2##(1991-1#1)(1992-1#1)(1992-12#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-7#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)
planning is a##3##3##(1994-2#1)(1994-7#1)(1997-1#1)
planning is becoming##2##3##(1993-3#2)
planning is##16##2##(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-7#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-2#2)(2008-7#1)(2009-11#1)(2009-2#1)(2012-2#1)
planning methods##4##2##(1994-2#3)(2008-7#1)
planning model##5##2##(1991-1#2)(1991-3#1)(1993-12#1)(1996-2#1)
planning new##2##2##(1996-1#1)(1996-6#1)
planning of health care##2##4##(1992-12#1)(2008-8#1)
planning of health##5##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(2008-8#1)
planning of the##2##3##(2008-1#1)(2008-10#1)
planning of##23##2##(1990-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-8#1)(2013-1#1)
planning or##3##2##(1997-3#1)(2008-2#1)(2012-12#1)
planning process and##4##3##(1992-2#1)(1994-2#1)(1996-1#1)(2008-11#1)
planning process##28##2##(1991-2#2)(1991-3#2)(1991-9#1)(1992-2#4)(1993-3#2)(1994-2#8)(1994-3#1)(1995-1#1)(1996-1#3)(1997-1#2)(2008-11#1)(2008-2#1)
planning processes##4##2##(1994-2#1)(1995-2#1)(1996-2#1)(2008-2#1)
planning programs##5##2##(1997-2#2)(2008-7#2)(2013-1#1)
planning should##2##2##(1991-3#1)(2007-12#1)
planning strategies##5##2##(1992-1#1)(1993-2#1)(1996-3#2)(2009-4#1)
planning system##4##2##(1996-1#2)(2009-11#2)
planning the##7##2##(1994-2#1)(1995-1#1)(1995-2#1)(2007-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
planning to improve##2##3##(1992-1#1)(2010-4#1)
planning to return##2##3##(1993-1#2)
planning to##12##2##(1990-2#1)(1991-1#1)(1992-1#1)(1993-1#2)(1996-1#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)
planning tool##4##2##(1991-2#1)(1997-1#1)(1997-3#1)(2008-7#1)
planning tools##7##2##(1994-1#2)(1994-2#2)(2007-12#1)(2009-11#1)(2009-5#1)
planning treatment##2##2##(2008-11#1)(2013-8#1)
planning using##3##2##(1995-9#1)(1997-3#1)(2012-2#1)
planning was##9##2##(1992-4#3)(1994-12#1)(1994-2#1)(2008-7#1)(2009-2#2)(2013-1#1)
planning with##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
planning within the##2##3##(2008-11#1)(2010-10#1)
planning work##2##2##(2008-11#1)(2012-3#1)
planning##607##1##(1990-12#4)(1990-2#1)(1990-3#1)(1991-1#13)(1991-11#1)(1991-12#4)(1991-2#10)(1991-3#8)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#7)(1992-2#8)(1992-3#4)(1992-4#9)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#6)(1993-2#8)(1993-3#10)(1993-6#3)(1994-1#18)(1994-11#1)(1994-12#8)(1994-2#33)(1994-3#20)(1994-6#2)(1994-7#2)(1994-8#10)(1994-9#2)(1995-1#12)(1995-12#1)(1995-2#6)(1995-3#5)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#12)(1996-12#8)(1996-2#9)(1996-3#8)(1996-4#2)(1996-6#2)(1997-1#17)(1997-2#13)(1997-3#10)(1997-5#1)(1997-6#1)(2006-12#1)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#3)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#8)(2008-11#26)(2008-12#9)(2008-2#18)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#21)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#14)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#10)(2012-3#8)(2013-1#31)(2013-7#2)(2013-8#4)
planning&quot##2##1##(1992-3#1)(2008-11#1)
planning]##2##1##(1994-3#1)(1996-6#1)
plano-concave##2##1##(2008-2#2)
plano-convex##3##1##(2007-12#1)(2008-2#2)
plans and providers##3##3##(1996-3#2)(2008-6#1)
plans and##16##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#2)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-6#2)
plans are##4##2##(1991-3#1)(1993-3#1)(1997-3#2)
plans can be##2##3##(1997-1#1)(2008-8#1)
plans can##5##2##(1997-1#1)(1997-2#3)(2008-8#1)
plans for the future##2##4##(1990-3#1)(2013-7#1)
plans for the##4##3##(1990-3#1)(1995-12#1)(1996-5#1)(2013-7#1)
plans for their##2##3##(1993-3#1)(1996-3#1)
plans for##24##2##(1990-3#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-7#1)(1995-12#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)(2010-8#1)(2013-1#2)(2013-7#1)
plans has##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
plans have##4##2##(1996-12#1)(1997-2#1)(2007-9#1)(2008-12#1)
plans in the##2##3##(1994-3#1)(2008-11#1)
plans in##12##2##(1993-3#1)(1993-5#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2008-11#1)
plans must##3##2##(1996-1#1)(1997-1#1)(2011-2#1)
plans of the##2##3##(2007-11#2)
plans of##7##2##(1993-3#1)(2007-11#2)(2008-2#2)(2010-12#1)(2013-7#1)
plans or##3##2##(1991-2#1)(1994-3#1)(1995-12#1)
plans that##8##2##(1994-1#1)(1995-1#1)(1997-1#2)(1997-3#2)(2007-12#1)(2008-2#1)
plans to open##2##3##(1994-3#2)
plans to##22##2##(1991-11#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#2)
plans were##6##2##(1997-3#1)(2008-11#1)(2012-1#1)(2013-1#3)
plans##253##1##(1990-3#2)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#7)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#8)(1993-5#1)(1993-9#1)(1994-1#9)(1994-12#3)(1994-2#9)(1994-3#14)(1994-7#1)(1995-1#3)(1995-12#10)(1995-3#3)(1996-1#2)(1996-12#7)(1996-2#10)(1996-3#14)(1996-5#1)(1997-1#15)(1997-2#11)(1997-3#13)(1997-5#5)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#6)(2008-6#4)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#2)
plans&quot##3##1##(1993-12#1)(2012-1#2)
plant AChEs##3##2##(2009-8#3)
plant Arabidopsis thaliana##8##3##(1996-10#1)(2008-7#1)(2008-9#3)(2009-3#1)(2011-1#1)(2011-2#1)
plant Arabidopsis##9##2##(1996-10#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
plant DNA##6##2##(2008-10#3)(2008-9#1)(2012-2#2)
plant RNA##4##2##(2008-10#3)(2008-9#1)
plant activators##5##2##(2008-10#5)
plant age and##2##3##(2008-10#2)
plant age at##2##3##(2008-10#2)
plant age##10##2##(2008-10#8)(2011-2#2)
plant alkaloid##3##2##(1993-8#1)(1994-8#1)(2011-1#1)
plant and a##3##3##(2008-10#2)(2012-2#1)
plant and algal systems##2##4##(2009-8#2)
plant and algal##3##3##(1990-12#1)(2009-8#2)
plant and animal cells##3##4##(1994-12#1)(2008-2#1)(2008-4#1)
plant and animal##10##3##(1994-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)
plant and bacterial##2##3##(2008-7#2)
plant and fungal##2##3##(2008-10#2)
plant and insect##2##3##(2008-10#2)
plant and pathogen##2##3##(2011-10#2)
plant and the##4##3##(2008-10#2)(2012-2#2)
plant and##44##2##(1990-12#1)(1994-12#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#2)(2011-10#2)(2011-2#1)(2012-2#3)(2012-3#1)
plant as a##2##3##(2008-10#2)
plant as##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
plant assays##2##2##(2008-10#2)
plant associations##2##2##(2008-10#1)(2008-5#1)
plant at##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
plant availability##3##2##(1992-3#2)(2008-10#1)
plant bioinformatics##2##2##(2008-7#2)
plant biology##4##2##(2007-12#1)(2008-9#2)(2012-1#1)
plant biomass reductions were##2##4##(2008-10#2)
plant biomass##7##2##(2008-10#2)(2008-8#5)
plant biotechnology##3##2##(2008-7#1)(2009-6#1)(2009-8#1)
plant breeding##5##2##(2008-10#3)(2008-8#1)(2013-8#1)
plant by##4##2##(2008-10#3)(2008-9#1)
plant can##2##2##(2008-10#1)(2008-11#1)
plant canopy##3##2##(1993-3#1)(2008-10#2)
plant carbon/nitrogen ratio##2##3##(2008-10#2)
plant carbon/nitrogen##3##2##(2008-10#3)
plant cell death##2##3##(2009-8#2)
plant cell wall##2##3##(2009-10#1)(2010-2#1)
plant cell walls##5##3##(2008-9#1)(2009-10#1)(2013-8#3)
plant cell##18##2##(1994-11#1)(1995-2#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-8#3)(2010-2#1)(2010-3#1)(2012-1#1)(2013-8#4)
plant cells and tissues##2##4##(2008-4#1)(2010-11#1)
plant cells and##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)
plant cells is##2##3##(2008-9#1)(2009-8#1)
plant cells to##2##3##(1997-8#1)(2008-8#1)
plant cells##41##2##(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#3)(2009-6#1)(2009-8#10)(2010-11#1)(2011-2#1)
plant chloroplasts##2##2##(1995-8#1)(1997-6#1)
plant communities in##3##3##(2008-5#1)(2008-8#1)(2013-7#1)
plant communities##9##2##(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-6#1)(2013-7#3)
plant community##3##2##(2008-11#1)(2008-8#2)
plant compartments##2##2##(2010-11#2)
plant competition##2##2##(2008-10#1)(2008-8#1)
plant complex##6##2##(2008-5#6)
plant constituents##2##2##(2008-10#1)(2009-6#1)
plant cover##4##2##(2008-8#4)
plant damage##5##2##(2008-10#2)(2008-8#3)
plant defense reactions##4##3##(2008-10#4)
plant defense response##2##3##(2008-10#2)
plant defense##19##2##(1990-12#1)(2008-10#14)(2008-8#3)(2008-9#1)
plant defenses##2##2##(2008-9#1)(2009-8#1)
plant density##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
plant derived##2##2##(2008-10#1)(2011-3#1)
plant development and##6##3##(2008-10#2)(2008-9#1)(2009-8#1)(2010-2#1)(2012-3#1)
plant development##16##2##(2008-10#7)(2008-9#1)(2009-10#1)(2009-8#5)(2010-2#1)(2012-3#1)
plant digests##2##2##(2008-10#2)
plant disease and##2##3##(2008-10#2)
plant disease control##2##3##(2008-10#2)
plant disease epidemics##6##3##(2008-10#6)
plant disease epidemiology##3##3##(2008-10#3)
plant disease forecasting##2##3##(2008-10#2)
plant disease incidence##2##3##(2008-10#2)
plant disease management##2##3##(2008-10#2)
plant disease resistance##4##3##(2008-10#4)
plant disease suppression##3##3##(2008-10#3)
plant disease##38##2##(2008-10#37)(2008-8#1)
plant diseases in##2##3##(2008-10#2)
plant diseases##18##2##(2008-10#17)(2012-2#1)
plant diversification##2##2##(2010-5#1)(2012-3#1)
plant diversity##8##2##(2008-5#1)(2008-8#2)(2008-9#5)
plant ecology##2##2##(2008-8#2)
plant evolution##3##2##(1996-4#1)(2009-6#2)
plant expression vectors were constructed##2##5##(2008-9#2)
plant expression vectors##3##3##(2008-8#1)(2008-9#2)
plant expression##5##2##(1997-6#1)(2008-8#1)(2008-9#3)
plant extract##5##2##(2008-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
plant extracts were##2##3##(2008-5#1)(2011-1#1)
plant extracts with a##2##4##(2008-10#1)(2008-5#1)
plant extracts##31##2##(2008-10#10)(2008-11#1)(2008-12#3)(2008-5#13)(2011-1#3)(2013-1#1)
plant families##4##2##(2008-10#3)(2008-8#1)
plant fitness##4##2##(2008-8#4)
plant folate##2##2##(2011-2#2)
plant foods##2##2##(2012-12#1)(2013-1#1)
plant for##3##2##(1996-12#1)(2008-8#1)(2011-3#1)
plant from##5##2##(1994-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
plant functional group richness##5##4##(2008-8#5)
plant functional group##6##3##(2008-8#6)
plant functional##7##2##(2008-8#6)(2008-9#1)
plant gene encoding a##2##4##(1993-2#1)(1995-6#1)
plant gene##4##2##(1993-2#1)(1995-2#1)(1995-6#1)(2008-9#1)
plant genes##4##2##(2008-10#3)(2012-2#1)
plant genetic##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
plant genome##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
plant genotype##3##2##(2008-10#3)
plant growth and development##4##4##(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#1)
plant growth and nutrient##2##4##(2008-10#1)(2013-8#1)
plant growth and##12##3##(2008-10#5)(2008-9#1)(2009-6#1)(2009-8#3)(2011-1#1)(2013-8#1)
plant growth in##2##3##(2008-10#1)(2008-8#1)
plant growth parameters##3##3##(2008-10#3)
plant growth promotion##7##3##(2008-10#4)(2013-8#3)
plant growth regulator##2##3##(2008-10#1)(2011-1#1)
plant growth regulators##4##3##(2008-10#3)(2008-12#1)
plant growth stage was##2##4##(2008-10#2)
plant growth stage##4##3##(2008-10#2)(2011-2#2)
plant growth stages##3##3##(2008-10#2)(2011-2#1)
plant growth##62##2##(2007-11#1)(2008-10#35)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#5)(2011-1#2)(2011-2#4)(2012-7#1)(2013-8#5)
plant growth-promoting rhizobacteria##5##3##(2008-10#5)
plant growth-promoting##6##2##(2008-10#6)
plant habit##2##2##(2008-10#1)(2009-10#1)
plant height and##3##3##(2008-10#1)(2008-12#2)
plant height was##2##3##(2008-12#2)
plant height##21##2##(2008-10#12)(2008-12#6)(2008-9#1)(2013-7#2)
plant hormone##5##2##(2009-6#3)(2009-8#1)(2011-10#1)
plant hormones##5##2##(1994-8#1)(2008-10#1)(2008-9#1)(2009-8#2)
plant host##6##2##(2008-10#5)(2008-9#1)
plant hosts##7##2##(2008-10#7)
plant hydrolysates##3##2##(2008-11#3)
plant immune responses##2##3##(2009-8#2)
plant immunity##4##2##(2009-6#1)(2009-8#2)(2011-2#1)
plant in a##2##3##(2008-10#2)
plant in##8##2##(2008-10#5)(2008-6#1)(2010-5#1)(2012-1#1)
plant infected##3##2##(2008-10#2)(2008-9#1)
plant infection by##3##3##(2008-10#3)
plant infection##4##2##(2008-10#4)
plant introduction (PI)##2##3##(2008-10#2)
plant is##7##2##(2008-10#4)(2008-12#1)(2008-8#1)(2013-8#1)
plant isolates##3##2##(2008-10#3)
plant keratin intermediate filaments##3##4##(2008-8#3)
plant keratin intermediate##4##3##(2008-8#4)
plant leaves##9##2##(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
plant lectins##2##2##(1990-7#1)(2008-9#1)
plant level##2##2##(2008-10#1)(2009-8#1)
plant lineage##3##2##(2009-10#1)(2011-2#2)
plant lineages##3##2##(2009-8#2)(2011-2#1)
plant lipids##2##2##(2008-11#2)
plant mass##2##2##(2008-10#1)(2008-9#1)
plant material and##2##3##(2008-10#1)(2008-9#1)
plant material from##2##3##(2008-10#1)(2008-9#1)
plant material is##3##3##(2008-10#2)(2008-11#1)
plant material##30##2##(2008-10#20)(2008-11#3)(2008-7#1)(2008-9#5)(2012-2#1)
plant materials from##2##3##(2008-10#2)
plant materials in##2##3##(2008-10#1)(2010-5#1)
plant materials##11##2##(2008-10#10)(2010-5#1)
plant matrices##2##2##(2008-10#2)
plant maturity##3##2##(2008-10#3)
plant metabolism##5##2##(2008-10#1)(2008-11#1)(2009-8#1)(2012-1#2)
plant mortality##4##2##(2011-1#2)(2013-1#2)
plant names##2##2##(2008-5#1)(2012-2#1)
plant nutrition##2##2##(2009-10#1)(2011-2#1)
plant odors##2##2##(1990-11#1)(2007-12#1)
plant of##2##2##(2008-10#1)(2008-12#1)
plant on##2##2##(2008-10#2)
plant orders##3##2##(2008-10#3)
plant organs##4##2##(1994-11#1)(2008-10#2)(2008-11#1)
plant origin##7##2##(1994-5#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-8#3)
plant parasites##3##2##(2008-10#1)(2008-8#2)
plant parts##8##2##(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#1)
plant pathogen that##2##3##(2008-10#2)
plant pathogen##16##2##(2008-10#13)(2008-8#1)(2008-9#1)(2010-10#1)
plant pathogenic bacteria##3##3##(2008-10#2)(2009-6#1)
plant pathogenic##5##2##(2008-10#3)(2008-11#1)(2009-6#1)
plant pathogens and##4##3##(2008-10#3)(2009-8#1)
plant pathogens by##4##3##(2008-10#4)
plant pathogens in##4##3##(2008-10#4)
plant pathogens is##2##3##(2008-10#2)
plant pathogens##52##2##(2008-10#50)(2009-2#1)(2009-8#1)
plant pathologists##5##2##(2008-10#5)
plant pathology##14##2##(1992-9#1)(2008-10#13)
plant penetration##2##2##(2007-12#1)(2008-10#1)
plant performance##3##2##(2008-8#1)(2012-5#1)(2012-7#1)
plant pheophytin##2##2##(2008-8#1)(2008-9#1)
plant photosynthesis##2##2##(2008-10#1)(2008-8#1)
plant physiological##2##2##(2008-10#1)(2008-4#1)
plant physiologist##3##2##(2008-7#2)(2012-1#1)
plant physiology##4##2##(2008-10#1)(2008-7#2)(2012-5#1)
plant population##10##2##(2008-10#2)(2008-12#7)(2008-9#1)
plant populations##18##2##(2008-10#2)(2008-12#2)(2008-8#9)(2008-9#5)
plant processes##3##2##(1990-9#2)(2008-10#1)
plant production system##2##3##(2008-7#2)
plant production##5##2##(2008-10#2)(2008-7#2)(2008-8#1)
plant products##3##2##(1993-11#1)(2008-5#1)(2012-2#1)
plant protection##6##2##(2008-10#1)(2008-11#3)(2011-10#1)(2013-8#1)
plant protein##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
plant protoplasts##5##2##(2008-1#1)(2008-2#1)(2008-9#3)
plant quality##2##2##(2009-10#1)(2012-3#1)
plant regulatory##2##2##(2008-10#1)(2009-8#1)
plant reproduction##2##2##(2008-8#1)(2008-9#1)
plant research##3##2##(2008-9#1)(2009-10#1)(2013-8#1)
plant resistance (R) genes##2##4##(2008-8#1)(2009-6#1)
plant resistance genes##2##3##(2008-10#2)
plant resistance to##7##3##(2008-10#5)(2008-8#1)(2011-2#1)
plant resistance##22##2##(2008-10#13)(2008-6#1)(2008-8#5)(2008-9#1)(2009-6#1)(2011-2#1)
plant resources##2##2##(2008-8#2)
plant response to##3##3##(2008-10#2)(2009-8#1)
plant response##4##2##(2008-10#3)(2009-8#1)
plant responses to herbivory##2##4##(2008-8#2)
plant responses to insect feeding##2##5##(2009-8#2)
plant responses to##8##3##(2008-10#1)(2008-8#3)(2009-8#4)
plant responses##9##2##(2008-10#2)(2008-8#3)(2009-8#4)
plant revealed##3##2##(1996-3#1)(2008-10#2)
plant richness and##2##3##(2008-8#1)(2013-7#1)
plant richness##3##2##(2008-8#1)(2013-7#2)
plant root##3##2##(2008-7#1)(2010-10#1)(2012-1#1)
plant roots##8##2##(1992-3#1)(2008-10#5)(2008-12#1)(2009-8#1)
plant sPLA₂s##2##2##(2013-1#2)
plant samples was##2##3##(2008-10#2)
plant samples##30##2##(2008-10#27)(2008-11#1)(2008-9#1)(2013-7#1)
plant scale##2##2##(1995-3#1)(2008-10#1)
plant scales##2##2##(2008-10#2)
plant sciences##3##2##(1994-11#1)(2008-7#1)(2011-10#1)
plant scientists##2##2##(2008-4#1)(2009-6#1)
plant seeds##2##2##(2008-9#1)(2012-2#1)
plant showed##2##2##(2008-10#1)(2008-9#1)
plant size##3##2##(2008-5#1)(2008-8#2)
plant spacing##4##2##(2008-12#4)
plant species and##5##3##(2008-10#3)(2008-11#1)(2009-8#1)
plant species are##2##3##(2008-10#1)(2008-8#1)
plant species belonging to##2##4##(2008-10#2)
plant species in##3##3##(2008-10#2)(2010-3#1)
plant species richness and plant functional group richness##2##8##(2008-8#2)
plant species richness and plant functional##3##6##(2008-8#2)(2008-9#1)
plant species richness##7##3##(2008-8#5)(2008-9#2)
plant species tested were##2##4##(2008-10#1)(2008-6#1)
plant species tested##5##3##(2008-10#3)(2008-12#1)(2008-6#1)
plant species that##2##3##(2013-7#2)
plant species to##2##3##(2008-8#1)(2009-8#1)
plant species was##3##3##(2008-10#3)
plant species were screened for their##2##6##(2008-10#1)(2008-8#1)
plant species were##3##3##(2008-10#1)(2008-8#1)(2012-6#1)
plant species##95##2##(2008-10#48)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#18)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-3#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-7#4)(2013-8#1)
plant species/cultivars##2##2##(2008-10#2)
plant stem##3##2##(2008-10#2)(2012-5#1)
plant sterols##2##2##(1992-6#1)(2008-12#1)
plant stress##3##2##(2008-9#1)(2009-10#1)(2011-2#1)
plant surfaces##4##2##(2008-10#2)(2008-6#1)(2009-8#1)
plant system##6##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
plant systems##2##2##(2008-11#1)(2008-8#1)
plant than##3##2##(2008-10#3)
plant that##2##2##(2008-10#1)(2009-8#1)
plant tissue and##3##3##(2008-10#3)
plant tissue homogenate##2##3##(2008-10#2)
plant tissue in##2##3##(2008-10#1)(2011-2#1)
plant tissue##27##2##(1996-12#1)(2008-10#22)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
plant tissues and##2##3##(2008-10#1)(2009-8#1)
plant tissues##20##2##(1990-5#1)(1997-2#2)(2008-10#8)(2008-4#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-7#1)
plant to the##2##3##(2008-10#2)
plant to##9##2##(2008-10#5)(2008-8#1)(2009-8#2)(2012-2#1)
plant tolerance to##3##3##(2008-12#1)(2009-8#2)
plant traits##2##2##(2008-10#1)(2009-2#1)
plant transformation##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
plant under##3##2##(2008-10#1)(2008-8#2)
plant uptake##2##2##(1992-3#1)(2008-9#1)
plant vigor##3##2##(2008-10#3)
plant virus disease epidemics##2##4##(2008-10#2)
plant virus##10##2##(2008-10#8)(2008-7#1)(2008-8#1)
plant viruses by##3##3##(2008-10#3)
plant viruses##29##2##(2008-10#21)(2008-9#7)(2010-10#1)
plant volatiles##2##2##(2007-12#1)(2009-8#1)
plant was significantly##2##3##(2008-10#2)
plant was##15##2##(2008-10#6)(2008-12#3)(2008-9#3)(2009-10#1)(2012-1#1)(2013-7#1)
plant were##5##2##(2008-10#3)(2008-5#1)(2012-12#1)
plant with##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
plant##1735##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#2)(1992-3#6)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#8)(1994-12#1)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#4)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#3)(1996-10#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-9#1)(1997-2#4)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2007-11#3)(2007-12#9)(2008-1#5)(2008-10#808)(2008-11#53)(2008-12#62)(2008-2#2)(2008-4#10)(2008-5#51)(2008-6#13)(2008-7#47)(2008-8#139)(2008-9#110)(2009-10#20)(2009-12#2)(2009-2#2)(2009-3#3)(2009-6#24)(2009-8#88)(2010-10#3)(2010-11#7)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#6)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#13)(2011-10#7)(2011-2#42)(2011-3#3)(2012-1#12)(2012-12#3)(2012-2#25)(2012-3#6)(2012-5#3)(2012-6#4)(2012-7#3)(2013-1#15)(2013-7#17)(2013-8#21)
plant's##5##1##(2008-10#1)(2008-8#1)(2009-10#1)(2009-8#2)
plant(-1)##9##1##(2008-12#9)
plant(-1))##2##1##(2008-12#2)
plant)##4##1##(2008-10#3)(2011-2#1)
plant-associated bacteria##3##2##(2008-10#3)
plant-associated microbes##3##2##(2008-10#3)
plant-associated##8##1##(2008-10#8)
plant-based##2##1##(2008-11#1)(2008-7#1)
plant-derived##7##1##(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
plant-herbivore##4##1##(2008-8#3)(2008-9#1)
plant-microbe##2##1##(2008-10#1)(2012-2#1)
plant-parasitic nematode##3##2##(1994-12#2)(2008-10#1)
plant-parasitic nematodes##4##2##(2008-10#4)
plant-parasitic##7##1##(1994-12#2)(2008-10#5)
plant-pathogen interactions##2##2##(2008-10#1)(2011-10#1)
plant-pathogen##4##1##(2008-10#3)(2011-10#1)
plant-pathogenic fungi##3##2##(2008-10#3)
plant-pathogenic##14##1##(2008-10#14)
plant-pollinator interactions##3##2##(2008-8#1)(2009-6#1)(2012-6#1)
plant-pollinator##4##1##(2008-8#2)(2009-6#1)(2012-6#1)
plant-specific##2##1##(2009-10#1)(2009-8#1)
plant-to-plant##3##1##(2008-10#1)(2009-8#2)
planta growth##2##2##(2008-10#2)
planta##53##1##(1997-3#1)(2008-10#44)(2008-9#2)(2009-12#4)(2010-11#1)(2011-2#1)
plantain##2##1##(2008-1#1)(2008-10#1)
plantains##2##1##(2008-10#2)
plantar flexion##4##2##(2010-3#1)(2011-1#2)(2013-8#1)
plantar pressure measurements##3##3##(2012-2#3)
plantar pressure##5##2##(2011-2#1)(2012-2#4)
plantar pressures and##2##3##(2011-2#2)
plantar pressures##5##2##(2011-2#5)
plantar##28##1##(1990-8#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-3#2)(2011-1#2)(2011-2#10)(2012-2#4)(2012-3#1)(2013-8#2)
plantarflexion##2##1##(1993-12#2)
plantaris muscle##5##2##(2012-2#5)
plantaris##8##1##(2011-2#1)(2012-2#7)
plantarum TF103##2##2##(2008-6#2)
plantarum##6##1##(2008-6#4)(2012-2#2)
plantation of##3##2##(2008-10#2)(2008-5#1)
plantation##13##1##(2008-10#7)(2008-5#3)(2008-6#1)(2008-8#1)(2012-2#1)
plantations and##6##2##(2008-10#5)(2012-2#1)
plantations in the##2##3##(2008-10#2)
plantations in##5##2##(2008-10#4)(2011-2#1)
plantations##27##1##(2008-10#25)(2011-2#1)(2012-2#1)
planted at##2##2##(2008-10#1)(2011-2#1)
planted in##18##2##(2008-10#14)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
planted to a##2##3##(2008-10#2)
planted to corn##3##3##(2008-10#1)(2011-2#2)
planted to snap##2##3##(2008-10#2)
planted to##17##2##(2008-10#14)(2011-2#3)
planted with cotton##2##3##(2008-10#2)
planted with##12##2##(2008-10#11)(2008-12#1)
planted##65##1##(2008-10#53)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#4)(2011-2#4)
planthopper##3##1##(2006-12#1)(2008-10#2)
planthoppers##5##1##(2008-10#5)
planting area##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
planting date##2##2##(2008-10#2)
planting densities##2##2##(2008-10#2)
planting density and the##2##4##(2008-10#2)
planting density##9##2##(2008-10#9)
planting in##2##2##(2008-10#2)
planting material##3##2##(2008-10#3)
planting of the##2##3##(2008-10#2)
planting of##4##2##(2008-10#4)
planting##59##1##(1995-6#1)(2008-10#51)(2008-12#1)(2008-9#1)(2011-2#5)
plantings and##2##2##(2008-10#2)
plantings##12##1##(2008-10#12)
plantlet##2##1##(2008-10#1)(2011-10#1)
plantlets from##4##2##(2008-10#1)(2008-12#3)
plantlets were##2##2##(2008-10#1)(2008-9#1)
plantlets##15##1##(2008-10#5)(2008-12#4)(2008-9#4)(2009-8#1)(2013-1#1)
plants (cv##2##2##(2008-10#2)
plants (plants##2##2##(2008-10#2)
plants -##2##2##(2008-5#2)
plants a##2##2##(2008-10#1)(2008-11#1)
plants after##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
plants against##4##2##(1992-8#1)(2008-7#1)(2009-10#1)(2009-6#1)
plants also##5##2##(2008-10#3)(2010-4#1)(2012-7#1)
plants although##2##2##(2008-10#1)(2012-2#1)
plants and a##2##3##(2008-10#1)(2008-8#1)
plants and algae##4##3##(2008-7#1)(2012-2#3)
plants and animals##12##3##(1995-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#2)(2010-4#1)(2013-8#1)
plants and in the##3##4##(2008-6#1)(2008-8#1)(2012-2#1)
plants and in##13##3##(2008-10#7)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)
plants and insect vectors##2##4##(2008-10#2)
plants and insects##2##3##(2008-10#1)(2009-8#1)
plants and is##3##3##(2008-10#2)(2013-8#1)
plants and resistance to##2##4##(2008-10#1)(2011-10#1)
plants and resistance##3##3##(2008-10#2)(2011-10#1)
plants and some##2##3##(2008-7#1)(2010-1#1)
plants and the##10##3##(1997-3#1)(2008-10#3)(2008-5#1)(2008-9#2)(2009-8#1)(2010-2#1)(2011-2#1)
plants and their##6##3##(2008-10#2)(2008-5#1)(2008-8#2)(2013-1#1)
plants and##124##2##(1995-8#1)(1997-3#2)(1997-6#1)(2008-10#57)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#13)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-10#2)(2011-2#1)(2012-2#5)(2013-1#1)(2013-8#2)
plants and/or##2##2##(2008-10#1)(2012-3#1)
plants appear##2##2##(2008-10#2)
plants appeared to##2##3##(2008-10#2)
plants are vernalized##2##3##(2009-8#2)
plants are##21##2##(1991-11#1)(2008-10#8)(2008-11#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
plants as well##2##3##(1997-8#1)(2008-10#1)
plants as##8##2##(1997-3#1)(1997-8#1)(2008-10#4)(2008-8#1)(2013-7#1)
plants at 96 h after inoculation##2##6##(2008-10#2)
plants at the##2##3##(2008-10#1)(2008-12#1)
plants at various##2##3##(2008-10#2)
plants at##16##2##(2008-10#15)(2008-12#1)
plants became infected with##2##4##(2008-10#2)
plants became infected##3##3##(2008-10#3)
plants became##6##2##(2008-10#6)
plants belonging to##2##3##(2008-10#1)(2008-5#1)
plants between##2##2##(2008-11#1)(2011-2#1)
plants but not in##2##4##(2008-10#2)
plants but##5##2##(2008-10#4)(2009-8#1)
plants by GC/MS##2##3##(2008-10#2)
plants by Southern blot hybridization##2##5##(2008-10#2)
plants by Southern##3##3##(2008-10#2)(2008-9#1)
plants by##26##2##(1997-2#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-8#1)(2008-9#4)(2011-2#2)
plants can be##4##3##(1994-11#1)(2008-10#1)(2009-8#2)
plants can##11##2##(1994-11#1)(2008-10#5)(2008-4#1)(2008-9#1)(2009-8#3)
plants carrying cognate resistance proteins##2##5##(2009-8#2)
plants carrying##7##2##(1997-4#1)(2008-10#3)(2009-8#2)(2010-9#1)
plants collected from##2##3##(2008-10#2)
plants collected##3##2##(2008-10#3)
plants colonized by##2##3##(2008-10#1)(2008-12#1)
plants compared with##2##3##(2008-10#2)
plants contained##3##2##(2008-10#3)
plants containing the##3##3##(2008-10#1)(2008-9#2)
plants containing##10##2##(2008-10#5)(2008-5#1)(2008-9#3)(2009-8#1)
plants could be##4##3##(2008-10#2)(2008-8#1)(2011-10#1)
plants cultivated in##2##3##(2008-10#2)
plants developed##2##2##(2008-10#2)
plants did not differ##2##4##(2008-10#1)(2013-7#1)
plants did not##8##3##(2008-10#5)(2008-8#1)(2010-10#1)(2013-7#1)
plants display##2##2##(2008-10#1)(2008-11#1)
plants displayed##2##2##(2008-10#2)
plants displaying##5##2##(2008-10#5)
plants do not##3##3##(1995-2#1)(2008-10#1)(2009-10#1)
plants due to the##2##4##(2008-12#1)(2012-2#1)
plants during##3##2##(2008-10#2)(2009-10#1)
plants either##2##2##(2008-10#2)
plants exhibit##2##2##(1996-2#1)(2008-4#1)
plants exhibited##5##2##(1997-6#1)(2008-10#3)(2013-1#1)
plants exhibiting##4##2##(2008-10#4)
plants exposed to##5##3##(2008-10#2)(2008-7#1)(2013-8#2)
plants expressing a##4##3##(2008-10#4)
plants expressing the coat protein##2##5##(1997-6#1)(2008-10#1)
plants expressing the##7##3##(1997-6#2)(1997-8#1)(2008-10#3)(2011-10#1)
plants expressing##19##2##(1995-2#1)(1997-6#2)(1997-8#1)(2008-10#11)(2008-8#1)(2009-8#1)(2011-10#2)
plants for the##3##3##(2008-10#2)(2008-5#1)
plants for##11##2##(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
plants from five##2##3##(2008-10#2)
plants from powdery mildew##2##4##(2008-10#2)
plants from the same##2##4##(2008-10#2)
plants from the##9##3##(2008-10#6)(2012-7#3)
plants from##31##2##(2008-10#22)(2008-5#2)(2009-12#1)(2009-2#1)(2012-2#1)(2012-7#4)
plants growing in field soil##2##5##(2008-10#2)
plants growing in##7##3##(2008-10#7)
plants growing##8##2##(2008-10#7)(2008-8#1)
plants grown in either mix##2##5##(2008-10#2)
plants grown in soil##3##4##(2008-10#3)
plants grown in the compost mix##2##6##(2008-10#2)
plants grown in the compost##3##5##(2008-10#3)
plants grown in the##7##4##(2008-10#7)
plants grown in##27##3##(1996-10#1)(2008-10#22)(2008-11#1)(2012-7#3)
plants grown##30##2##(1996-10#1)(2008-10#23)(2008-11#1)(2008-5#2)(2012-7#3)
plants had##12##2##(2008-10#7)(2008-8#4)(2008-9#1)
plants has##4##2##(1992-3#1)(2008-11#1)(2008-8#1)(2012-2#1)
plants have a##2##3##(2008-10#1)(2011-1#1)
plants have been##5##3##(2008-11#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
plants have on average##2##4##(2008-11#1)(2009-8#1)
plants have the##2##3##(2008-10#1)(2009-12#1)
plants have##15##2##(2008-10#2)(2008-11#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2011-3#1)(2012-2#1)
plants homozygous for the##2##4##(2012-3#2)
plants in F(2)##2##3##(2008-10#1)(2008-8#1)
plants in a greenhouse##2##4##(2008-10#2)
plants in a##12##3##(1997-6#1)(2008-10#11)
plants in dry##2##3##(2008-5#1)(2012-5#1)
plants in each##3##3##(2008-10#3)
plants in greenhouse##2##3##(2008-10#2)
plants in response to##2##4##(2008-10#2)
plants in some families##2##4##(2008-8#2)
plants in terms of##3##4##(1997-4#1)(2008-10#2)
plants in the absence of##2##5##(1997-3#1)(2009-8#1)
plants in the family Brassicaceae##2##5##(2008-10#2)
plants in the field##4##4##(2008-10#2)(2008-11#1)(2008-8#1)
plants in the greenhouse##3##4##(2008-10#3)
plants in the##33##3##(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)
plants in##98##2##(1997-3#1)(1997-4#3)(1997-6#1)(2008-1#1)(2008-10#66)(2008-11#2)(2008-12#4)(2008-5#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-5#1)(2012-9#1)(2013-8#1)
plants increased##4##2##(2008-10#4)
plants incubated##2##2##(2008-10#2)
plants indicate that##2##3##(2008-10#2)
plants indicated that##5##3##(2008-10#5)
plants indicated##7##2##(2008-10#7)
plants infected with F##2##4##(2008-10#2)
plants infected with PVX##2##4##(2008-10#2)
plants infected with the##4##4##(2008-10#4)
plants infected with##16##3##(2008-10#16)
plants infected##18##2##(2008-10#18)
plants inoculated with the higher zoospore concentration##2##7##(2008-10#2)
plants inoculated with the##4##4##(2008-10#4)
plants inoculated with##25##3##(2008-10#24)(2008-12#1)
plants inoculated##28##2##(2008-10#27)(2008-12#1)
plants is a##2##3##(2008-10#1)(2008-2#1)
plants is##13##2##(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2012-3#1)
plants maintained##2##2##(2008-10#2)
plants may##4##2##(2008-10#3)(2008-11#1)
plants not receiving SA##2##4##(2008-10#2)
plants not##4##2##(2008-10#4)
plants obtained from##2##3##(2008-10#2)
plants occurred##2##2##(2008-10#2)
plants of a##2##3##(1997-6#1)(2008-10#1)
plants of both cultivars##2##4##(2008-10#2)
plants of each##2##3##(2008-10#2)
plants of the resistant##2##4##(2008-10#2)
plants of the##8##3##(2008-10#6)(2008-11#2)
plants of two##2##3##(2008-10#1)(2013-1#1)
plants of##40##2##(1996-4#1)(1997-2#1)(1997-6#2)(2007-1#1)(2008-10#27)(2008-11#3)(2008-5#2)(2008-8#1)(2009-5#1)(2013-1#1)
plants on##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
plants or in##2##3##(2006-12#1)(2008-10#1)
plants or##14##2##(2006-12#1)(2008-10#10)(2011-2#1)(2013-1#1)(2013-7#1)
plants over time##2##3##(2008-10#1)(2008-9#1)
plants per plot at##2##4##(2008-10#2)
plants per##5##2##(2008-10#5)
plants produced more##2##3##(2008-10#1)(2008-8#1)
plants produced##3##2##(2008-10#2)(2008-8#1)
plants protected##2##2##(2008-10#2)
plants remain##2##2##(2008-10#1)(2012-2#1)
plants representing##2##2##(2008-10#1)(2008-5#1)
plants represents a##2##3##(2009-6#2)
plants revealed that the##2##4##(2008-10#2)
plants revealed##4##2##(2008-10#3)(2008-8#1)
plants sampled at##2##3##(2008-10#2)
plants sampled##4##2##(2008-10#4)
plants shed##2##2##(2008-10#2)
plants showed a##2##3##(1997-6#1)(2008-10#1)
plants showed that##3##3##(2008-10#3)
plants showed##10##2##(1997-6#1)(2008-10#8)(2013-1#1)
plants showing##6##2##(2008-10#5)(2008-5#1)
plants species##2##2##(2008-10#1)(2008-12#1)
plants suggests that##4##3##(2008-10#4)
plants suggests##5##2##(1996-10#1)(2008-10#4)
plants than in##4##3##(2008-10#3)(2009-10#1)
plants than on##2##3##(2008-10#1)(2012-2#1)
plants than##10##2##(1991-12#1)(2008-10#7)(2009-10#1)(2012-2#1)
plants that are##2##3##(2008-10#2)
plants that expressed##2##3##(2008-10#2)
plants that were##7##3##(2008-10#6)(2008-5#1)
plants that##19##2##(2008-10#14)(2008-5#2)(2009-3#1)(2013-7#1)(2013-8#1)
plants through##2##2##(2008-5#1)(2008-8#1)
plants to a##3##3##(2008-10#3)
plants to adapt to##2##4##(2008-8#1)(2009-6#1)
plants to the##4##3##(2008-10#2)(2009-6#1)(2011-10#1)
plants to##41##2##(2008-10#22)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-2#1)(2009-6#2)(2009-8#3)(2011-10#1)(2011-2#1)(2012-5#1)
plants transformed with##4##3##(1997-2#1)(2008-10#3)
plants treated with##5##3##(2008-10#5)
plants treated##6##2##(2008-10#6)
plants under the control of the##2##6##(1997-4#1)(2008-10#1)
plants under##8##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2013-8#1)
plants used in##3##3##(2008-10#2)(2010-3#1)
plants using##8##2##(1991-7#1)(2008-10#4)(2008-9#2)(2010-10#1)
plants was analyzed##2##3##(2008-10#1)(2008-9#1)
plants was demonstrated##2##3##(2008-10#2)
plants was higher##2##3##(2008-10#1)(2008-12#1)
plants was mainly##2##3##(2008-10#2)
plants was studied##2##3##(2008-10#1)(2008-12#1)
plants was##34##2##(1995-2#1)(2008-10#25)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#2)(2008-9#1)
plants were aggregated##2##3##(2008-10#2)
plants were also##2##3##(2008-10#2)
plants were analyzed##2##3##(1995-2#1)(2008-5#1)
plants were at##2##3##(2008-12#1)(2011-2#1)
plants were challenged with##3##4##(2008-10#3)
plants were classified##2##3##(2013-7#1)(2013-8#1)
plants were collected##2##3##(2008-10#1)(2008-6#1)
plants were evaluated for##3##4##(2008-10#3)
plants were evaluated##6##3##(2008-10#6)
plants were examined by##2##4##(2008-10#2)
plants were examined with##2##4##(2008-10#2)
plants were examined##4##3##(2008-10#4)
plants were exposed to##2##4##(2008-10#1)(2011-1#1)
plants were grown in##2##4##(2008-10#1)(2010-11#1)
plants were grown##4##3##(2008-10#2)(2008-12#1)(2010-11#1)
plants were infected with##2##4##(2008-10#2)
plants were infected##4##3##(2008-10#4)
plants were inoculated with##4##4##(1997-6#1)(2008-10#3)
plants were inoculated##9##3##(1997-6#1)(2008-10#7)(2008-5#1)
plants were investigated##2##3##(2008-10#1)(2010-3#1)
plants were kept in##2##4##(2008-10#1)(2008-5#1)
plants were measured##3##3##(2008-10#2)(2008-12#1)
plants were more##3##3##(2008-10#1)(2008-8#2)
plants were observed##2##3##(2008-10#2)
plants were regenerated##3##3##(2008-9#2)(2013-1#1)
plants were screened for##2##4##(2008-10#1)(2008-5#1)
plants were sprayed with##2##4##(2008-10#1)(2008-8#1)
plants were subjected to##3##4##(1995-2#1)(2008-12#1)(2012-2#1)
plants were transformed with the##2##5##(2008-10#2)
plants were used##2##3##(2008-10#2)
plants were##117##2##(1995-2#2)(1997-3#1)(1997-6#1)(2008-10#79)(2008-11#1)(2008-12#7)(2008-5#4)(2008-6#1)(2008-8#9)(2008-9#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
plants when##3##2##(2008-10#2)(2008-9#1)
plants where##2##2##(2008-10#1)(2008-8#1)
plants which were##2##3##(2008-10#2)
plants which##5##2##(2008-10#3)(2008-12#1)(2013-1#1)
plants while##2##2##(1995-2#1)(2009-8#1)
plants with a##3##3##(2008-10#2)(2009-10#1)
plants with an##2##3##(2008-10#2)
plants with greater##2##3##(2008-10#1)(2008-8#1)
plants with the same##2##4##(2008-10#1)(2008-8#1)
plants with the##5##3##(2008-10#4)(2008-8#1)
plants with##46##2##(2008-10#37)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#1)
plants within##5##2##(2008-10#4)(2008-5#1)
plants without##3##2##(2008-10#3)
plants##1896##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#2)(1992-3#2)(1992-8#1)(1993-2#1)(1993-6#2)(1994-11#4)(1994-8#1)(1995-11#1)(1995-2#13)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#6)(1997-3#11)(1997-4#5)(1997-6#14)(1997-8#2)(2006-12#3)(2007-1#1)(2007-12#2)(2008-1#2)(2008-10#1176)(2008-11#39)(2008-12#46)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#36)(2008-6#6)(2008-7#30)(2008-8#102)(2008-9#70)(2009-10#24)(2009-11#1)(2009-12#10)(2009-2#5)(2009-3#4)(2009-5#2)(2009-6#23)(2009-8#53)(2010-1#2)(2010-10#3)(2010-11#3)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#3)(2010-9#1)(2011-1#13)(2011-10#8)(2011-2#30)(2011-3#1)(2012-1#4)(2012-2#19)(2012-3#5)(2012-5#2)(2012-7#9)(2012-9#2)(2013-1#19)(2013-7#10)(2013-8#15)
plants) is##2##2##(2008-10#1)(2008-8#1)
plants) showed##2##2##(2006-12#1)(2008-10#1)
plants)##19##1##(2006-12#1)(2008-10#13)(2008-5#2)(2008-8#1)(2010-3#1)(2010-6#1)
plants/m2##3##1##(2008-5#3)
plants]##2##1##(2007-3#1)(2011-3#1)
planus and##6##2##(1991-2#1)(2007-7#1)(2008-4#1)(2009-6#2)(2013-1#1)
planus is##3##2##(1991-2#2)(2007-7#1)
planus##31##1##(1990-5#1)(1991-2#4)(1991-3#1)(1996-2#1)(2007-7#5)(2008-4#6)(2009-6#5)(2011-2#3)(2013-1#5)
plaque accumulation##2##2##(2008-1#1)(2008-7#1)
plaque and##8##2##(1991-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2012-3#1)(2013-1#2)
plaque assay##6##2##(1995-12#2)(2008-2#1)(2008-4#1)(2012-2#2)
plaque composition##2##2##(2008-7#1)(2010-9#1)
plaque control##2##2##(2012-12#1)(2012-3#1)
plaque development and##2##3##(2008-10#1)(2008-5#1)
plaque formation##4##2##(1994-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
plaque forming units (PFU)##2##4##(1997-3#1)(2010-5#1)
plaque forming##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
plaque imaging##7##2##(2008-7#3)(2010-9#4)
plaque in##4##2##(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#1)
plaque index##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
plaque of##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
plaque on##2##2##(1993-9#1)(2007-7#1)
plaque psoriasis##3##2##(2007-11#1)(2008-5#1)(2008-6#1)
plaque purification##2##2##(2008-2#1)(2013-8#1)
plaque rupture and##2##3##(2006-10#1)(2008-3#1)
plaque samples from 61 patients##2##5##(2008-12#2)
plaque scores##2##2##(2008-1#1)(2012-3#1)
plaque size##2##2##(2010-9#2)
plaque ulcerations##2##2##(2007-10#2)
plaque volume##3##2##(2008-6#1)(2008-8#1)(2009-1#1)
plaque vulnerability##3##2##(2008-8#2)(2012-2#1)
plaque with##5##2##(2007-7#1)(2008-5#1)(2010-6#2)(2012-3#1)
plaque##139##1##(1991-10#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-7#3)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#17)(2008-9#2)(2009-1#1)(2009-5#4)(2010-12#4)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#16)(2011-2#5)(2012-12#1)(2012-2#11)(2012-3#8)(2013-1#4)(2013-8#2)
plaque-forming cell (PFC) assay##2##4##(2008-10#1)(2008-4#1)
plaque-forming cell (PFC) assays##2##4##(2008-4#2)
plaque-forming cell (PFC)##5##3##(1993-12#1)(2008-10#1)(2008-4#3)
plaque-forming##6##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#3)
plaque-purified##2##1##(1991-6#1)(1997-4#1)
plaques also##2##2##(1991-10#1)(2008-8#1)
plaques and neurofibrillary tangles##3##4##(1991-1#1)(2008-5#1)(2008-7#1)
plaques and##15##2##(1991-1#1)(1991-12#3)(1991-9#1)(1992-12#1)(1993-6#1)(2008-5#1)(2008-7#5)(2012-2#2)
plaques as##2##2##(2012-2#1)(2013-8#1)
plaques in the##2##3##(1991-1#1)(1991-12#1)
plaques in##6##2##(1991-1#2)(1991-12#1)(1993-3#1)(1997-3#1)(2008-7#1)
plaques is##2##2##(1997-8#1)(2008-5#1)
plaques of the##2##3##(2007-7#1)(2012-3#1)
plaques of##3##2##(1990-5#1)(2007-7#1)(2012-3#1)
plaques that##2##2##(2010-12#1)(2010-9#1)
plaques were##3##2##(1991-10#1)(1992-11#1)(1995-12#1)
plaques with##5##2##(1991-12#1)(2007-7#2)(2010-12#1)(2012-3#1)
plaques##99##1##(1990-5#1)(1990-6#1)(1991-1#5)(1991-10#6)(1991-12#9)(1991-3#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#2)(2007-11#4)(2007-7#3)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#4)(2009-4#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#7)(2012-3#6)(2013-1#1)(2013-8#3)
plasm##29##1##(2008-10#27)(2009-3#1)(2009-7#1)
plasma (0##2##2##(2008-10#1)(2011-2#1)
plasma (PRP)##5##2##(1997-7#1)(2007-9#2)(2008-7#1)(2013-1#1)
plasma ACTH in##2##3##(1992-8#2)
plasma ACTH##3##2##(1992-8#3)
plasma ADAMTS13##2##2##(2009-7#2)
plasma Bragg mirror##2##3##(2007-12#2)
plasma C-reactive protein (CRP)##2##4##(1990-12#1)(1997-7#1)
plasma CCK levels##2##3##(2008-7#2)
plasma CCK##4##2##(2008-7#4)
plasma Cardiac Troponin I##2##4##(2008-12#2)
plasma DBH activity##2##3##(1995-11#2)
plasma DBH##3##2##(1995-11#3)
plasma GABA levels##2##3##(1995-11#1)(1996-7#1)
plasma GABA##5##2##(1995-11#2)(1996-7#3)
plasma GH##2##2##(1991-12#1)(1997-2#1)
plasma IL-6 levels in##2##4##(2011-2#2)
plasma IL-6 levels##4##3##(1997-7#1)(2011-2#3)
plasma IL-6##5##2##(1997-7#2)(2011-2#3)
plasma IgM##2##2##(2008-7#2)
plasma LDL##3##2##(1990-11#1)(1991-5#1)(2010-12#1)
plasma NO##2##2##(2007-10#1)(2010-4#1)
plasma PAF acetylhydrolase##2##3##(1997-7#2)
plasma PC##5##2##(1995-8#5)
plasma TG levels alone##3##4##(2008-3#3)
plasma TSH levels##2##3##(1994-6#2)
plasma V level and V loss##3##6##(2011-2#3)
plasma V level and##4##4##(2011-2#4)
plasma V level##5##3##(2011-2#5)
plasma Zn alpha 2gp##2##4##(1994-6#2)
plasma activity##3##2##(1993-11#2)(1997-7#1)
plasma after##4##2##(1992-6#1)(2007-11#1)(2008-10#2)
plasma albumin concentration and indices of glycaemic control##2##8##(1992-9#2)
plasma albumin concentration##5##3##(1992-9#5)
plasma albumin##6##2##(1992-9#5)(2008-7#1)
plasma amino acids##2##3##(1992-12#1)(1992-8#1)
plasma and blood##2##3##(1993-9#1)(2008-4#1)
plasma and erythrocytes##5##3##(1990-7#2)(1991-12#1)(1993-2#1)(2008-7#1)
plasma and granule membranes##2##4##(1992-6#2)
plasma and in##4##3##(1990-12#1)(1990-8#1)(1993-2#1)(2008-10#1)
plasma and its##2##3##(1994-12#1)(2008-10#1)
plasma and lipoprotein lipid peroxidation in##2##6##(1994-6#2)
plasma and red cell glutathione##2##5##(1991-9#2)
plasma and saliva##4##3##(2008-10#3)(2013-8#1)
plasma and spinal cord##2##4##(1991-5#2)
plasma and the##3##3##(1991-9#1)(1992-12#1)(2008-1#1)
plasma and tissue##4##3##(1996-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
plasma and urine samples##2##4##(2008-10#2)
plasma and urine##7##3##(1991-12#1)(1993-9#1)(2008-10#2)(2008-11#1)(2013-1#2)
plasma and##85##2##(1990-12#3)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#5)(1991-2#1)(1991-5#2)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#2)(1993-2#2)(1993-9#2)(1994-12#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
plasma apolipoprotein##2##2##(1991-8#1)(1995-2#1)
plasma are often##2##3##(1992-3#1)(2008-8#1)
plasma are##7##2##(1992-3#2)(1994-12#1)(1995-2#1)(2008-2#1)(2008-8#1)(2012-3#1)
plasma as well as##2##4##(1993-11#1)(2008-7#1)
plasma as##5##2##(1992-3#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
plasma at##3##2##(1990-12#1)(1994-2#1)(2008-10#1)
plasma atomic emission spectrometry (ICP-AES)##14##5##(2008-10#14)
plasma atomic emission spectrometry##55##4##(1992-3#1)(2008-10#54)
plasma atomic emission##68##3##(1992-3#1)(2008-10#67)
plasma atomic##70##2##(1992-3#1)(2008-10#69)
plasma balls##2##2##(2008-2#2)
plasma beta2M##2##2##(2008-1#2)
plasma by a##3##3##(1990-8#1)(1992-10#1)(2011-3#1)
plasma by high-performance liquid chromatography and##2##6##(2008-10#2)
plasma by high-performance liquid chromatography##4##5##(2008-10#4)
plasma by##25##2##(1990-2#1)(1990-8#3)(1992-10#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-9#1)(2011-2#2)(2011-3#3)(2012-1#1)(2012-2#1)
plasma calcitonin##2##2##(1990-12#1)(1993-6#1)
plasma can##2##2##(2008-2#1)(2012-12#1)
plasma catecholamines and heart##2##4##(1994-3#2)
plasma catecholamines##3##2##(1994-3#2)(2008-7#1)
plasma cell granuloma##2##3##(1991-9#2)
plasma cell##10##2##(1991-9#2)(1993-8#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
plasma cells and##3##3##(1997-8#1)(2012-12#1)(2013-8#1)
plasma cells##14##2##(1997-8#1)(2006-10#1)(2008-5#1)(2008-9#4)(2009-4#1)(2010-12#2)(2012-12#2)(2013-1#1)(2013-8#1)
plasma cholesterol levels##3##3##(1990-3#1)(1994-8#1)(1995-2#1)
plasma cholesterol##13##2##(1990-3#2)(1991-4#1)(1994-8#2)(1995-2#1)(1996-8#1)(1997-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)
plasma cholesteryl ester transfer protein activity##3##6##(2008-12#3)
plasma coagulation##5##2##(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#2)
plasma column##2##2##(2007-11#1)(2007-12#1)
plasma components##3##2##(1990-11#1)(2008-11#1)(2008-8#1)
plasma concentration of the##2##4##(1993-1#1)(1994-12#1)
plasma concentration of##17##3##(1990-5#1)(1990-6#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-5#1)(2008-1#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#3)
plasma concentration profiles##2##3##(2008-11#2)
plasma concentration versus time profile##2##5##(2010-11#2)
plasma concentration versus time##3##4##(2008-11#1)(2010-11#2)
plasma concentration##32##2##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-7#4)(2008-9#1)(2010-11#2)(2010-12#1)(2012-12#3)(2012-2#1)(2013-8#3)
plasma concentrations are##2##3##(2008-7#1)(2012-2#1)
plasma concentrations in##2##3##(1990-12#1)(2012-2#1)
plasma concentrations of##13##3##(1990-12#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-3#1)
plasma concentrations##28##2##(1990-12#2)(1990-6#1)(1991-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
plasma cortisol levels##2##3##(2008-6#2)
plasma cortisol##5##2##(2008-6#4)(2013-1#1)
plasma creatinine##2##2##(2008-4#1)(2009-12#1)
plasma digoxin level##8##3##(1994-6#8)
plasma during##3##2##(1991-3#1)(1992-6#1)(1995-11#1)
plasma emission spectrometer##2##3##(2008-10#2)
plasma emission##5##2##(2008-10#4)(2008-5#1)
plasma enhanced chemical vapor deposition##2##5##(2008-10#1)(2009-11#1)
plasma enzyme activity##2##3##(1997-7#2)
plasma enzyme##3##2##(1997-7#3)
plasma exchange and##2##3##(1993-2#1)(2012-3#1)
plasma exchange##10##2##(1990-12#1)(1993-2#1)(1995-3#1)(1995-5#1)(2011-2#4)(2012-3#2)
plasma exchanges synchronized with##2##4##(1993-2#2)
plasma extraction rate##2##3##(2011-2#2)
plasma fatty acids##2##3##(2012-2#2)
plasma fibrinogen##7##2##(1996-2#1)(2008-10#5)(2008-7#1)
plasma fibronectin##6##2##(1990-7#2)(1995-5#1)(2008-7#3)
plasma for##8##2##(1995-8#1)(1997-2#1)(2008-10#5)(2008-11#1)
plasma formation in##3##3##(2007-12#1)(2008-3#2)
plasma formation##6##2##(2007-12#3)(2008-3#3)
plasma free T4 concentrations##2##4##(1994-6#2)
plasma free##3##2##(1990-5#1)(1994-6#2)
plasma from a##2##3##(2008-10#1)(2011-2#1)
plasma from healthy individuals##2##4##(2008-10#1)(2010-12#1)
plasma from healthy##4##3##(1992-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
plasma from the##4##3##(1990-5#2)(2008-2#1)(2013-8#1)
plasma from##17##2##(1990-5#2)(1992-3#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
plasma fructosamine concentration##3##3##(1992-9#3)
plasma glucagon##3##2##(1991-8#1)(2010-11#2)
plasma glucose concentration in##2##4##(1991-12#1)(1992-9#1)
plasma glucose concentration##8##3##(1991-12#1)(1991-7#1)(1991-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(2010-10#2)
plasma glucose levels##3##3##(1990-5#1)(1991-12#1)(2008-7#1)
plasma glucose##32##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#3)(1992-9#1)(1994-12#2)(1994-2#1)(2008-3#2)(2008-7#2)(2009-3#1)(2010-10#3)(2010-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2012-7#3)
plasma glycoprotein##2##2##(1994-8#1)(2008-11#1)
plasma glycosaminoglycans##2##2##(1992-3#2)
plasma half-life and##2##3##(1993-8#1)(2008-10#1)
plasma half-life##7##2##(1993-8#2)(2008-10#1)(2008-3#1)(2008-5#2)(2012-2#1)
plasma high##2##2##(1994-8#1)(2010-12#1)
plasma homocyst(e)ine##3##2##(1995-2#3)
plasma homocysteine concentrations##4##3##(2008-3#3)(2008-7#1)
plasma homocysteine levels##2##3##(1992-9#1)(2007-9#1)
plasma homocysteine##13##2##(1991-12#1)(1992-9#2)(2007-10#1)(2007-9#1)(2008-3#6)(2008-7#2)
plasma igniter##2##2##(2013-8#2)
plasma in##5##2##(1991-3#1)(1994-2#1)(2007-8#1)(2008-3#1)(2011-2#1)
plasma insulin and corticosterone##2##4##(1996-12#2)
plasma insulin and##3##3##(1996-12#2)(2010-10#1)
plasma insulin concentration##2##3##(2010-10#1)(2012-2#1)
plasma insulin levels were##3##4##(1990-5#2)(2008-5#1)
plasma insulin levels##7##3##(1990-5#3)(1991-7#1)(1994-8#1)(2008-5#2)
plasma insulin##16##2##(1990-5#3)(1991-7#1)(1994-8#1)(1996-12#2)(2008-5#2)(2008-7#2)(2010-10#2)(2011-1#2)(2012-2#1)
plasma interferograms##2##2##(2008-3#2)
plasma is presented##2##3##(2008-10#1)(2008-3#1)
plasma is reported##2##3##(2008-10#1)(2010-3#1)
plasma is##20##2##(1990-12#2)(1990-5#1)(1991-12#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-9#1)(2010-3#1)
plasma jet##4##2##(1992-11#1)(2013-8#3)
plasma kernel##2##2##(2008-2#2)
plasma leptin##4##2##(2011-2#2)(2013-1#2)
plasma level during##2##3##(1990-9#1)(2008-12#1)
plasma level of##6##3##(1990-8#1)(1992-6#1)(1997-4#1)(2008-12#2)(2011-2#1)
plasma level##11##2##(1990-8#1)(1990-9#1)(1992-6#1)(1997-4#1)(2008-12#5)(2011-2#1)(2012-2#1)
plasma levels and##3##3##(2008-7#1)(2011-2#2)
plasma levels below 400 copies/ml##2##5##(2008-5#2)
plasma levels in##2##3##(2011-2#2)
plasma levels of##21##3##(1990-12#2)(1992-11#1)(1992-5#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
plasma levels were##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
plasma levels##42##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2010-12#1)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#2)
plasma lipid concentrations##2##3##(2012-2#2)
plasma lipid levels##3##3##(1993-9#1)(1997-8#1)(2009-5#1)
plasma lipid peroxidation and##2##4##(2008-7#2)
plasma lipid profiles##2##3##(1991-12#1)(2011-1#1)
plasma lipid##12##2##(1991-12#1)(1993-9#1)(1997-8#1)(2008-7#2)(2009-5#1)(2011-1#2)(2012-2#4)
plasma lipids and enzymes of lipid metabolism##2##7##(2008-7#2)
plasma lipids and##6##3##(1993-1#1)(1996-8#1)(2008-7#3)(2012-2#1)
plasma lipids##12##2##(1990-2#1)(1992-11#1)(1993-1#1)(1996-11#1)(1996-8#2)(1997-8#1)(2008-7#4)(2012-2#1)
plasma lipoprotein##4##2##(1995-6#1)(2008-1#1)(2008-7#1)(2012-2#1)
plasma lipoproteins and##3##3##(1993-6#1)(1995-5#1)(2012-2#1)
plasma lipoproteins##9##2##(1992-12#1)(1993-6#3)(1995-5#1)(2012-2#4)
plasma low density##2##3##(1994-3#1)(2010-12#1)
plasma low-density lipoproteins##2##3##(1991-9#2)
plasma mass spectrometry and Raman##2##5##(2013-8#2)
plasma mass spectrometry##77##3##(1993-9#1)(2008-10#69)(2010-11#3)(2013-8#4)
plasma mass##84##2##(1993-9#1)(2008-10#74)(2010-11#3)(2013-8#6)
plasma materials##2##2##(2008-10#2)
plasma membrane NTPDases##2##3##(2008-4#2)
plasma membrane and the##7##4##(1990-12#1)(1991-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)
plasma membrane and##21##3##(1990-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1997-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-3#1)
plasma membrane are##2##3##(1990-5#1)(2008-11#1)
plasma membrane depolarization##2##3##(2008-4#1)(2010-11#1)
plasma membrane electron transport and##2##5##(2009-9#2)
plasma membrane electron transport##3##4##(2009-9#3)
plasma membrane fractions##2##3##(1990-5#1)(1994-11#1)
plasma membrane hyperpolarization##2##3##(2008-4#2)
plasma membrane in##6##3##(1990-11#2)(1992-12#1)(1994-3#1)(2008-7#1)(2009-10#1)
plasma membrane localization of##2##4##(2009-10#1)(2010-12#1)
plasma membrane marker##3##3##(1990-11#1)(1990-5#1)(2008-11#1)
plasma membrane of Mycobacterium tuberculosis##2##5##(2008-7#2)
plasma membrane of##24##3##(1990-12#3)(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#4)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
plasma membrane permeability of##2##4##(1994-2#2)
plasma membrane potential variations##2##4##(2008-4#2)
plasma membrane potential##3##3##(1994-12#1)(2008-4#2)
plasma membrane protein##6##3##(1990-11#2)(1995-2#2)(2008-11#1)(2008-5#1)
plasma membrane proteins and##2##4##(1995-12#1)(2008-7#1)
plasma membrane proteins by##2##4##(1995-12#1)(2008-11#1)
plasma membrane proteins of##2##4##(1995-12#2)
plasma membrane proteins##8##3##(1995-12#4)(1995-2#1)(2008-11#1)(2008-7#1)(2010-12#1)
plasma membrane receptors##3##3##(1992-12#1)(2008-4#2)
plasma membrane vesicles##2##3##(1994-12#2)
plasma membrane was##2##3##(1994-11#1)(2008-11#1)
plasma membrane were##2##3##(1993-3#1)(2012-3#1)
plasma membrane##211##2##(1990-11#8)(1990-12#7)(1990-2#1)(1990-5#7)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-3#4)(1993-8#2)(1994-10#1)(1994-11#7)(1994-12#10)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#8)(1995-6#3)(1996-3#1)(1996-5#1)(1996-7#2)(1997-3#1)(1997-6#3)(2008-1#3)(2008-10#8)(2008-11#13)(2008-4#15)(2008-5#1)(2008-7#8)(2008-8#8)(2008-9#1)(2009-10#6)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#8)(2010-11#4)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)
plasma membrane-bound##2##2##(2009-10#2)
plasma membranes and##2##3##(1990-11#1)(1997-1#1)
plasma membranes by##2##3##(1990-11#1)(2008-11#1)
plasma membranes from##4##3##(1990-11#1)(1992-12#1)(1993-6#1)(1997-1#1)
plasma membranes in the##2##4##(1994-5#1)(1995-8#1)
plasma membranes in##7##3##(1990-11#1)(1992-3#1)(1994-5#1)(1995-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
plasma membranes of##5##3##(1991-12#1)(1993-6#1)(1995-2#1)(2008-10#1)(2010-10#1)
plasma membranes##51##2##(1990-11#7)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#3)(1993-6#2)(1994-11#1)(1994-2#5)(1994-5#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#5)(1996-5#1)(1997-1#4)(2008-10#3)(2008-11#4)(2008-6#1)(2008-7#2)(2010-10#1)(2012-12#1)(2012-2#1)
plasma near a high-power antenna##2##5##(2013-8#2)
plasma obtained##2##2##(2008-10#1)(2010-11#1)
plasma of patients##3##3##(1992-9#1)(2008-10#1)(2008-8#1)
plasma of the##3##3##(1992-6#1)(1993-3#1)(1994-11#1)
plasma of##25##2##(1990-2#1)(1990-7#1)(1992-6#4)(1992-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2012-2#2)(2013-1#3)(2013-8#1)
plasma on##2##2##(2008-10#2)
plasma or erythrocyte##2##3##(1991-12#1)(2008-7#1)
plasma or##8##2##(1990-8#2)(1991-12#1)(1992-3#1)(2008-4#1)(2008-7#1)(2010-11#2)
plasma phospholipids##2##2##(1994-12#1)(2008-7#1)
plasma potassium##3##2##(1993-1#3)
plasma protein##9##2##(1990-8#1)(1992-11#1)(1994-3#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-1#2)
plasma proteins##16##2##(1990-8#1)(1992-3#2)(1993-9#1)(1995-2#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#2)(2011-2#1)
plasma proteome of##2##3##(2010-12#2)
plasma proteome##5##2##(2010-12#5)
plasma renin activity##2##3##(1997-3#1)(2008-7#1)
plasma renin##3##2##(1997-3#1)(2008-1#1)(2008-7#1)
plasma replacement##2##2##(1995-3#1)(2011-2#1)
plasma sample was##3##3##(1990-8#2)(2008-10#1)
plasma sample##5##2##(1990-8#2)(2008-10#2)(2012-1#1)
plasma samples (n =##2##4##(2012-3#2)
plasma samples and##2##3##(2008-10#2)
plasma samples from##3##3##(1992-11#1)(2008-10#1)(2008-8#1)
plasma samples obtained from##2##4##(1997-3#1)(2008-10#1)
plasma samples of##3##3##(2008-10#2)(2013-1#1)
plasma samples spiked with##2##4##(1993-9#1)(2008-10#1)
plasma samples using##3##3##(1996-5#1)(2008-10#2)
plasma samples were extracted##2##4##(1996-5#1)(2011-3#1)
plasma samples were##9##3##(1990-12#1)(1995-12#1)(1996-5#1)(2008-10#4)(2011-2#1)(2011-3#1)
plasma samples##46##2##(1990-12#2)(1991-12#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-10#23)(2008-4#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
plasma separator##4##2##(2011-1#4)
plasma source mass spectrometry##3##4##(2008-10#3)
plasma spectrometer##2##2##(2008-10#2)
plasma spectrometric##2##2##(2008-10#2)
plasma spectrometry##8##2##(2007-12#2)(2008-10#5)(2008-7#1)
plasma spiked with##2##3##(2008-10#1)(2012-1#1)
plasma spray##2##2##(2008-11#2)
plasma that##2##2##(2008-10#1)(2008-2#1)
plasma to##4##2##(1996-5#1)(1997-7#1)(2008-5#1)(2008-9#1)
plasma torch##9##2##(2008-10#9)
plasma total##7##2##(1993-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
plasma treatment##4##2##(2008-5#2)(2008-6#1)(2008-7#1)
plasma triglyceride (TG) levels##2##4##(2010-8#2)
plasma triglyceride (TG)##3##3##(2008-7#1)(2010-8#2)
plasma triglyceride##6##2##(1993-3#1)(1994-11#1)(2008-3#1)(2008-7#1)(2010-8#2)
plasma using##10##2##(1991-5#1)(1994-2#1)(2008-10#8)
plasma vitamin E##3##3##(1990-8#2)(2008-7#1)
plasma vitamin##4##2##(1990-8#2)(1993-12#1)(2008-7#1)
plasma volume##4##2##(1992-8#1)(1995-2#1)(2011-2#2)
plasma was determined##2##3##(1990-8#1)(2013-1#1)
plasma was##10##2##(1990-8#1)(1991-3#1)(1991-5#1)(2008-10#4)(2008-2#1)(2008-9#1)(2013-1#1)
plasma water##4##2##(1993-2#4)
plasma waves##2##2##(2007-11#2)
plasma were##12##2##(1990-8#2)(1996-5#1)(2008-10#9)
plasma with##10##2##(1993-11#1)(1994-8#1)(2006-6#1)(2007-12#2)(2008-10#5)
plasma##1751##1##(1990-11#20)(1990-12#32)(1990-2#9)(1990-3#6)(1990-5#22)(1990-6#3)(1990-7#8)(1990-8#23)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#17)(1991-2#7)(1991-3#9)(1991-4#2)(1991-5#10)(1991-7#2)(1991-8#5)(1991-9#17)(1992-10#1)(1992-11#12)(1992-12#16)(1992-2#1)(1992-3#30)(1992-5#3)(1992-6#14)(1992-8#7)(1992-9#27)(1993-1#6)(1993-11#9)(1993-12#5)(1993-2#16)(1993-3#7)(1993-5#1)(1993-6#6)(1993-8#5)(1993-9#11)(1994-10#1)(1994-11#15)(1994-12#25)(1994-2#19)(1994-3#8)(1994-5#3)(1994-6#21)(1994-7#2)(1994-8#19)(1994-9#3)(1995-11#13)(1995-12#16)(1995-2#19)(1995-3#6)(1995-5#4)(1995-6#6)(1995-8#15)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#13)(1996-7#7)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#10)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#17)(1997-8#5)(2006-10#1)(2006-6#2)(2007-10#9)(2007-11#13)(2007-12#25)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#19)(2008-10#404)(2008-11#32)(2008-12#14)(2008-2#16)(2008-3#41)(2008-4#30)(2008-5#21)(2008-6#16)(2008-7#79)(2008-8#24)(2008-9#16)(2009-10#11)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#5)(2009-8#4)(2009-9#8)(2010-10#6)(2010-11#16)(2010-12#23)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#21)(2011-2#59)(2011-3#6)(2012-1#6)(2012-12#16)(2012-2#42)(2012-3#15)(2012-7#3)(2013-1#26)(2013-7#1)(2013-8#30)
plasma's electron temperature##2##3##(2008-3#2)
plasma) was##2##2##(1990-5#1)(2008-8#1)
plasma)##7##1##(1990-5#1)(1992-3#1)(1995-2#1)(2008-10#2)(2008-8#1)(2010-7#1)
plasma-atomic emission spectroscopy (ICP-AES)##3##4##(2008-10#3)
plasma-atomic emission spectroscopy##4##3##(1995-2#1)(2008-10#3)
plasma-atomic emission##20##2##(1995-2#1)(2008-10#19)
plasma-based##2##1##(1996-5#1)(2008-10#1)
plasma-deposited##3##1##(2008-2#2)(2008-3#1)
plasma-derived##4##1##(1990-7#1)(1997-7#1)(2010-11#1)(2012-12#1)
plasma-enhanced chemical vapor deposition of##2##5##(2008-3#2)
plasma-enhanced chemical vapor deposition##6##4##(2008-2#1)(2008-3#5)
plasma-enhanced chemical vapor##7##3##(2008-2#2)(2008-3#5)
plasma-enhanced##9##1##(2007-11#1)(2008-2#2)(2008-3#6)
plasma-mass spectrometer (ICP-MS)##2##3##(2008-10#2)
plasma-mass spectrometer##3##2##(2008-10#3)
plasma-mass##20##1##(2008-10#20)
plasma-membrane##3##1##(1990-11#2)(1995-11#1)
plasma-polymerized##2##1##(2008-10#2)
plasma]##3##1##(1992-5#1)(2011-3#1)(2012-2#1)
plasmacytoma of the##3##3##(2009-3#2)(2012-12#1)
plasmacytoma##11##1##(2008-4#1)(2009-3#3)(2009-8#1)(2011-2#2)(2012-12#4)
plasmalemma and##2##2##(2008-7#1)(2008-8#1)
plasmalemma of the##3##3##(2008-10#2)(2008-7#1)
plasmalemma of##5##2##(1995-2#1)(2008-10#3)(2008-7#1)
plasmalemma##17##1##(1994-11#1)(1995-2#1)(1997-7#2)(2007-12#1)(2008-10#7)(2008-7#2)(2008-8#3)
plasmalemmal##2##1##(1995-2#2)
plasmalogen-PE##3##1##(1994-12#3)
plasmapheresis##14##1##(1993-2#1)(1995-3#4)(2007-7#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
plasmas are##2##2##(2008-2#1)(2008-3#1)
plasmas were##3##2##(1990-12#2)(2008-10#1)
plasmas##16##1##(1990-12#3)(1991-9#1)(1992-6#1)(1992-8#1)(1993-5#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#4)
plasmatic and##2##2##(2008-7#1)(2013-1#1)
plasmatic concentration##3##2##(1991-11#1)(1992-9#2)
plasmatic##6##1##(1991-11#1)(1992-9#2)(2008-7#1)(2012-2#1)(2013-1#1)
plasmepsin 2##2##2##(2008-4#2)
plasmepsin##3##1##(2008-4#3)
plasmepsins##3##1##(2008-4#3)
plasmid DNA (pDNA)##2##3##(2013-1#2)
plasmid DNA and##2##3##(2008-10#1)(2008-11#1)
plasmid DNA from##3##3##(2008-10#1)(2008-11#2)
plasmid DNA has##2##3##(2008-10#1)(2010-8#1)
plasmid DNA into##3##3##(2008-2#1)(2008-4#2)
plasmid DNA is introduced to monolayer cell cultures via a precipitate that adheres to the cell surface##2##17##(2008-1#1)(2008-2#1)
plasmid DNA is##5##3##(1995-2#1)(1997-8#1)(2008-1#1)(2008-2#1)(2013-1#1)
plasmid DNA replication##4##3##(1994-11#3)(1994-8#1)
plasmid DNA##54##2##(1990-11#4)(1991-6#1)(1994-11#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-8#2)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#9)(2008-2#3)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
plasmid and chromosomal##2##3##(1996-6#1)(2008-10#1)
plasmid and phagemid##2##3##(1994-12#1)(1994-8#1)
plasmid and##15##2##(1990-5#1)(1991-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
plasmid by##2##2##(2008-10#1)(2008-8#1)
plasmid can##2##2##(1991-9#1)(1995-2#1)
plasmid clone##2##2##(1990-5#1)(1994-12#1)
plasmid constructs##3##2##(1993-3#1)(1994-8#1)(1995-8#1)
plasmid containing a##6##3##(1990-12#1)(1990-5#1)(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
plasmid containing the##4##3##(1993-9#1)(1994-11#1)(1996-3#1)(2008-2#1)
plasmid containing##13##2##(1990-12#1)(1990-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)
plasmid content##2##2##(2008-7#1)(2012-3#1)
plasmid copy number and##2##4##(1994-12#1)(2008-11#1)
plasmid copy number##3##3##(1994-12#1)(2008-11#1)(2008-12#1)
plasmid encoding the##3##3##(1990-5#1)(2010-6#2)
plasmid encoding##9##2##(1990-5#1)(1991-3#1)(1994-8#1)(1997-4#1)(2008-2#1)(2010-11#1)(2010-6#2)(2012-2#1)
plasmid expressing##4##2##(2008-11#1)(2008-2#1)(2008-9#2)
plasmid expression vector##2##3##(1991-9#1)(1995-2#1)
plasmid harboring##3##2##(1992-9#1)(1994-3#1)(2008-10#1)
plasmid in the##2##3##(1995-8#1)(2008-10#1)
plasmid in##3##2##(1995-8#1)(2008-10#2)
plasmid integration##2##2##(2008-10#2)
plasmid is##5##2##(1990-11#1)(1997-2#1)(1997-3#1)(2008-8#1)(2011-1#1)
plasmid molecules##2##2##(1990-11#1)(1995-8#1)
plasmid of approximately 70 kb##2##5##(2008-10#2)
plasmid of##7##2##(1995-6#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-9#1)
plasmid or##6##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)
plasmid pI9789##2##2##(1995-8#2)
plasmid pKYM is##2##3##(1997-6#2)
plasmid pKYM##4##2##(1997-6#4)
plasmid pRL-rhTNF##2##2##(2008-8#2)
plasmid profile##6##2##(1997-8#1)(2007-7#1)(2008-12#4)
plasmid profiles##4##2##(1997-3#1)(2008-10#2)(2008-12#1)
plasmid replication and##2##3##(2008-11#1)(2008-12#1)
plasmid replication##4##2##(1994-11#2)(2008-11#1)(2008-12#1)
plasmid series##3##2##(1994-12#3)
plasmid stability and protein##2##4##(2008-7#2)
plasmid stability and##3##3##(1994-3#1)(2008-7#2)
plasmid system##4##2##(1993-9#2)(1995-8#1)(2011-1#1)
plasmid that carries##2##3##(1995-2#1)(1997-6#1)
plasmid that##8##2##(1993-3#2)(1995-2#2)(1997-6#2)(2008-10#1)(2008-6#1)
plasmid to##2##2##(1996-12#1)(2008-5#1)
plasmid vector##13##2##(1990-5#3)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#1)
plasmid vectors##8##2##(1990-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-5#2)(2008-11#1)
plasmid was introduced into##2##4##(1990-8#1)(1994-8#1)
plasmid was stably maintained##2##4##(1994-3#1)(2008-7#1)
plasmid was##13##2##(1990-8#1)(1991-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
plasmid which##2##2##(1993-9#1)(2008-11#1)
plasmid with a##2##3##(1993-9#1)(2008-10#1)
plasmid with an##2##3##(1991-7#1)(1993-3#1)
plasmid with##6##2##(1991-7#1)(1993-3#1)(1993-9#1)(1995-2#2)(2008-10#1)
plasmid##383##1##(1990-11#17)(1990-12#1)(1990-5#14)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-9#4)(1992-12#4)(1992-3#1)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#12)(1994-11#6)(1994-12#13)(1994-3#4)(1994-8#10)(1994-9#3)(1995-11#1)(1995-2#12)(1995-5#4)(1995-6#2)(1995-8#14)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#5)(1997-2#7)(1997-3#8)(1997-4#3)(1997-6#8)(1997-8#4)(2006-12#1)(2007-7#3)(2008-1#3)(2008-10#45)(2008-11#33)(2008-12#8)(2008-2#10)(2008-3#1)(2008-4#9)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#24)(2008-9#14)(2009-2#1)(2010-11#1)(2010-6#2)(2010-8#2)(2011-1#6)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#5)
plasmid)##2##1##(2008-10#1)(2008-11#1)
plasmid-based##4##1##(1994-12#2)(1996-8#1)(1997-7#1)
plasmid-borne cpe-carrying C##2##3##(2011-2#2)
plasmid-borne cpe-carrying##3##2##(2011-2#3)
plasmid-borne##6##1##(1995-11#1)(2008-8#1)(2011-2#4)
plasmid-carrying cells##4##2##(2008-7#4)
plasmid-carrying##5##1##(2008-7#5)
plasmid-encoded##6##1##(1991-10#2)(1994-12#1)(1994-5#1)(1997-6#1)(2011-2#1)
plasmid/liposomes and##2##2##(2008-8#2)
plasmid/liposomes##3##1##(2008-8#3)
plasmids F and R6-5##2##4##(1991-7#2)
plasmids and##5##2##(1993-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#1)
plasmids are##3##2##(1997-6#1)(2008-5#1)(2011-2#1)
plasmids carrying##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
plasmids contained##2##2##(1992-12#1)(2008-8#1)
plasmids containing the##3##3##(1994-12#1)(1995-6#1)(2008-8#1)
plasmids containing##6##2##(1994-12#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-8#1)(2013-8#1)
plasmids efficiently##2##2##(2008-8#2)
plasmids encoding the##3##3##(1993-6#1)(1995-2#1)(2008-2#1)
plasmids for the##2##3##(1993-9#1)(1997-8#1)
plasmids for##3##2##(1993-9#1)(1997-8#1)(2008-9#1)
plasmids from##2##2##(1997-3#1)(2012-3#1)
plasmids had##2##2##(1995-6#1)(2008-8#1)
plasmids in##4##2##(1995-8#1)(1997-6#1)(1997-7#1)(2008-1#1)
plasmids into##3##2##(1992-11#1)(2008-11#1)(2012-3#1)
plasmids of size##2##3##(2011-2#2)
plasmids of##5##2##(2008-10#2)(2011-2#3)
plasmids to##2##2##(2008-10#1)(2008-5#1)
plasmids was compared##2##3##(1990-11#1)(1997-8#1)
plasmids was##3##2##(1990-11#1)(1995-8#1)(1997-8#1)
plasmids were constructed##2##3##(1990-5#1)(2008-8#1)
plasmids were##16##2##(1990-5#2)(1994-3#1)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-6#2)(2012-3#1)
plasmids which##2##2##(1990-5#1)(1991-5#1)
plasmids##140##1##(1990-11#4)(1990-5#4)(1991-12#1)(1991-5#1)(1991-7#7)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#7)(1996-12#1)(1996-5#1)(1996-6#3)(1997-2#1)(1997-3#5)(1997-6#4)(1997-7#2)(1997-8#3)(2008-1#2)(2008-10#13)(2008-11#4)(2008-2#3)(2008-5#5)(2008-8#11)(2008-9#8)(2010-1#1)(2010-6#2)(2011-2#7)(2012-2#1)(2012-3#10)(2013-8#2)
plasmin and MMP-2 activity##2##4##(2011-2#2)
plasmin in##2##2##(1995-2#1)(2013-1#1)
plasmin##16##1##(1990-7#1)(1992-12#1)(1993-8#2)(1994-3#3)(1995-2#1)(1995-6#3)(2011-2#4)(2013-1#1)
plasminogen activation##7##2##(1995-6#1)(1997-2#6)
plasminogen activator (t-PA)##4##3##(1995-8#1)(2007-10#1)(2008-11#2)
plasminogen activator (tPA)##2##3##(2008-11#1)(2008-8#1)
plasminogen activator (u-PA)##3##3##(1993-12#1)(1994-3#1)(2008-11#1)
plasminogen activator (uPA)##3##3##(1990-12#1)(1997-4#1)(2008-11#1)
plasminogen activator activity in##4##4##(2008-11#3)(2010-3#1)
plasminogen activator activity##7##3##(2008-11#5)(2008-8#1)(2010-3#1)
plasminogen activator inhibitor##3##3##(1992-7#1)(1994-9#1)(2010-6#1)
plasminogen activator inhibitor-1 (PAI-1)##5##4##(1993-12#1)(1994-9#1)(2008-3#1)(2008-4#1)(2013-1#1)
plasminogen activator inhibitor-1##9##3##(1993-12#1)(1994-9#1)(1997-1#1)(2008-3#1)(2008-4#2)(2011-2#1)(2013-1#2)
plasminogen activator is##2##3##(2006-7#1)(2007-10#1)
plasminogen activator was##2##3##(1995-6#1)(2008-7#1)
plasminogen activator##73##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#2)(1992-12#2)(1992-7#1)(1993-12#2)(1994-3#4)(1994-5#1)(1994-9#2)(1995-6#2)(1995-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(2006-7#1)(2007-10#6)(2007-5#1)(2007-9#2)(2008-11#13)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#4)(2013-8#1)
plasminogen activators##5##2##(1990-11#1)(1992-12#1)(1992-6#2)(1995-6#1)
plasminogen and##8##2##(1992-3#2)(1993-8#1)(1994-11#2)(1995-6#1)(1997-2#2)
plasminogen gene##3##2##(1990-12#1)(1992-3#1)(1995-6#1)
plasminogen is##2##2##(1995-6#1)(1997-2#1)
plasminogen##134##1##(1990-11#1)(1990-12#5)(1990-5#3)(1990-8#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-12#3)(1992-3#6)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#3)(1993-8#5)(1994-11#2)(1994-3#4)(1994-5#2)(1994-9#2)(1995-2#3)(1995-6#10)(1995-8#2)(1996-8#1)(1997-1#2)(1997-2#13)(1997-4#2)(2006-7#1)(2007-10#6)(2007-5#1)(2007-9#2)(2008-11#14)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#2)(2010-6#1)(2011-2#1)(2013-1#6)(2013-8#2)
plasminogen-related genes##2##2##(1992-3#2)
plasmocytoma##2##1##(1991-3#1)(2007-11#1)
plasmodesmata##2##1##(1997-3#1)(2008-10#1)
plasmodia##2##1##(2008-10#2)
plasmon absorbance##2##2##(2009-11#1)(2011-2#1)
plasmon resonance (SPR)##20##3##(2008-10#16)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
plasmon resonance in##2##3##(2007-11#2)
plasmon resonance##62##2##(1992-11#1)(1995-12#1)(2007-11#4)(2007-12#2)(2008-10#39)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2013-1#2)
plasmon resonances of##2##3##(2008-3#1)(2010-2#1)
plasmon resonances##6##2##(2007-12#1)(2008-3#1)(2008-6#2)(2010-2#2)
plasmon##86##1##(1992-11#1)(1995-12#1)(2007-11#6)(2007-12#10)(2008-10#39)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#3)(2010-1#1)(2010-2#2)(2011-2#1)(2013-1#2)
plasmonic metamaterials##3##2##(2008-7#3)
plasmonic##6##1##(2007-11#1)(2008-7#4)(2012-2#1)
plasmons##11##1##(2007-12#4)(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#3)
plaster cast##6##2##(2007-12#2)(2007-8#3)(2012-2#1)
plaster##10##1##(1991-12#1)(2007-12#3)(2007-8#4)(2011-2#1)(2012-2#1)
plastic and reconstructive surgery##2##4##(2008-11#2)
plastic and##9##2##(1991-3#1)(1995-9#1)(2007-7#1)(2008-10#1)(2008-11#5)
plastic bag##4##2##(1991-12#1)(1991-3#2)(2007-12#1)
plastic bags##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
plastic beads##3##2##(2008-10#2)(2008-8#1)
plastic chip##2##2##(2007-11#1)(2008-10#1)
plastic corrector##2##2##(2013-1#2)
plastic cover##2##2##(2008-10#2)
plastic deformation of##3##3##(2008-7#2)(2009-7#1)
plastic deformation##8##2##(2008-7#7)(2009-7#1)
plastic device and ceramic knives##2##5##(2008-10#2)
plastic embedded##2##2##(1994-10#2)
plastic foils##3##2##(1997-6#1)(2008-1#2)
plastic graded-index##2##2##(2007-12#2)
plastic material##2##2##(2008-3#2)
plastic objective lenses##2##3##(2008-3#2)
plastic objective##4##2##(2008-3#4)
plastic optical fibers (POF's)##2##4##(2008-3#2)
plastic optical fibers##4##3##(2008-3#4)
plastic optical##8##2##(2008-2#1)(2008-3#5)(2010-4#2)
plastic pigments##3##2##(2008-3#3)
plastic pins##2##2##(1997-3#1)(2008-4#1)
plastic products for food use##2##5##(2008-10#2)
plastic responses##2##2##(2009-6#2)
plastic strain was##2##3##(2009-7#2)
plastic strain##7##2##(2009-7#7)
plastic substrates##4##2##(1990-8#1)(2008-3#1)(2008-7#2)
plastic surgeon##5##2##(2007-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
plastic surgeons to##2##3##(2010-8#2)
plastic surgeons##7##2##(2007-12#1)(2010-8#5)(2013-1#1)
plastic surgery for##2##3##(1990-9#1)(2012-1#1)
plastic surgery##21##2##(1990-3#1)(1990-9#2)(1993-9#2)(2007-12#1)(2010-8#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#9)
plastic type##4##2##(2008-8#4)
plastic##191##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-3#3)(1992-2#2)(1992-3#1)(1993-6#1)(1993-9#2)(1994-10#2)(1994-8#4)(1995-3#1)(1995-4#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#10)(2008-2#5)(2008-3#19)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#10)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#8)(2009-8#1)(2010-4#2)(2010-8#8)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2012-4#1)(2013-1#16)(2013-7#1)
plastically bent##2##2##(2008-3#2)
plastically##4##1##(2008-3#2)(2008-7#2)
plasticised PVC##4##2##(2008-10#4)
plasticised##5##1##(2008-10#5)
plasticiser##2##1##(2008-10#2)
plasticising##2##1##(2008-10#1)(2008-5#1)
plasticity after##2##2##(1995-11#1)(2008-11#1)
plasticity and cellular resilience##2##4##(2008-7#2)
plasticity and may##2##3##(1996-2#1)(2008-9#1)
plasticity and their##3##3##(2008-4#1)(2008-8#1)(2009-8#1)
plasticity and##22##2##(1996-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#3)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#1)
plasticity are##2##2##(2008-8#1)(2009-9#1)
plasticity as##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
plasticity between##2##2##(2009-6#1)(2012-2#1)
plasticity by##2##2##(2009-8#1)(2013-1#1)
plasticity has been##2##3##(1994-8#1)(2010-3#1)
plasticity has##6##2##(1994-8#1)(1996-5#1)(2008-8#1)(2010-3#1)(2012-2#2)
plasticity in hippocampus and##2##4##(1995-2#1)(2013-1#1)
plasticity in maternal selection##2##4##(2008-8#2)
plasticity in response to the##2##5##(2008-9#1)(2010-12#1)
plasticity in the hippocampal##2##4##(2008-4#1)(2008-7#1)
plasticity in the hippocampus##2##4##(1993-12#1)(2008-7#1)
plasticity in the##11##3##(1993-12#1)(1996-12#2)(2008-11#2)(2008-4#1)(2008-7#4)(2012-2#1)
plasticity in their##2##3##(2010-3#2)
plasticity in##36##2##(1993-12#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#2)(2008-11#2)(2008-4#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-6#1)(2010-12#1)(2010-3#3)(2012-2#2)(2012-9#1)(2013-1#1)(2013-7#1)
plasticity is##6##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)
plasticity may##2##2##(2008-8#1)(2009-6#1)
plasticity of nigrostriatal DAergic neurons##2##5##(2013-7#2)
plasticity of the##4##3##(2008-7#1)(2008-9#1)(2012-2#1)(2013-7#1)
plasticity of this##2##3##(2007-8#1)(2008-9#1)
plasticity of##17##2##(1995-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-9#3)(2012-12#1)(2012-2#2)(2013-7#3)
plasticity##196##1##(1993-12#4)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#2)(1996-12#3)(1996-2#1)(1996-5#3)(1997-7#3)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#14)(2008-2#2)(2008-4#8)(2008-7#25)(2008-8#29)(2008-9#10)(2009-3#6)(2009-6#6)(2009-8#16)(2009-9#2)(2010-12#1)(2010-3#5)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#18)(2012-5#1)(2012-9#2)(2013-1#5)(2013-7#5)(2013-8#2)
plasticity-related##2##1##(2008-11#2)
plasticization##2##1##(2010-4#1)(2012-2#1)
plasticized PVC membranes##5##3##(2008-10#5)
plasticized PVC##10##2##(2008-10#10)
plasticized cellulose triacetate membranes##2##4##(2008-10#2)
plasticized poly (vinyl chloride) (PVC)##2##5##(2008-10#2)
plasticized poly##3##2##(2008-10#3)
plasticized poly(vinyl chloride) (PVC) membrane##2##5##(2008-10#2)
plasticized poly(vinyl chloride) (PVC) membranes##2##5##(2008-10#2)
plasticized poly(vinyl chloride) (PVC)##5##4##(2008-10#5)
plasticized poly(vinyl chloride) membrane##4##4##(2008-10#4)
plasticized poly(vinyl chloride)##12##3##(2008-10#12)
plasticized polymer##2##2##(2008-10#2)
plasticized polymeric##2##2##(2008-10#2)
plasticized with o-NPOE##2##3##(2008-10#2)
plasticized with##8##2##(2008-10#8)
plasticized##46##1##(1995-3#1)(2008-10#45)
plasticizer admixtures##5##2##(2008-10#5)
plasticizer and molecular weight of cyanocopolymers##2##6##(2008-10#2)
plasticizer and the##2##3##(2008-10#2)
plasticizer and##11##2##(2008-10#11)
plasticizer in##3##2##(2008-10#3)
plasticizer nature##3##2##(2008-10#3)
plasticizer##46##1##(1996-8#2)(2008-10#44)
plasticizers in plastic##2##3##(2008-10#2)
plasticizers##23##1##(2008-10#17)(2008-5#4)(2010-5#2)
plastics and##3##2##(2008-10#1)(2008-6#1)(2010-9#1)
plastics in packaging and disposable products##2##6##(2008-6#2)
plastics in##3##2##(2008-6#2)(2013-1#1)
plastics##16##1##(2008-1#1)(2008-10#6)(2008-3#2)(2008-6#4)(2008-7#1)(2010-9#1)(2013-1#1)
plastid envelope##2##2##(1997-6#1)(2009-10#1)
plastid gene expression##2##3##(2011-2#2)
plastid##17##1##(1995-8#1)(1997-6#4)(2008-1#1)(2009-10#2)(2010-10#1)(2011-2#7)(2013-1#1)
plastidic##4##1##(1995-8#4)
plastids in##2##2##(1997-6#1)(2011-2#1)
plastids##10##1##(1997-6#3)(2008-10#1)(2008-9#3)(2011-2#2)(2012-2#1)
plastocyanin has been##2##3##(1994-5#1)(2009-10#1)
plastocyanin isoforms##3##2##(2009-10#3)
plastocyanin##19##1##(1990-5#2)(1993-11#1)(1994-5#6)(2009-10#10)
plastocyanins##3##1##(1994-5#3)
plastoquinone synthesis##2##2##(1994-11#2)
plastoquinone##4##1##(1994-11#3)(2010-10#1)
plasty with##2##2##(2007-11#1)(2012-1#1)
plasty##5##1##(2007-11#3)(2008-10#1)(2012-1#1)
platanus leaves##4##2##(2013-8#4)
platanus##5##1##(2013-8#5)
plate -##2##2##(2013-1#2)
plate allows##2##2##(2008-10#1)(2008-3#1)
plate and a##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
plate and screw fixation##2##4##(2007-8#1)(2008-9#1)
plate and screws##2##3##(2008-9#1)(2012-2#1)
plate and the##6##3##(2008-10#3)(2008-3#3)
plate and##38##2##(1991-12#1)(1991-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2007-11#4)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#2)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
plate as a##3##3##(2008-2#1)(2008-3#2)
plate as##4##2##(2008-2#1)(2008-3#3)
plate assay##2##2##(2008-11#1)(2008-9#1)
plate assays##4##2##(2007-11#1)(2008-10#3)
plate at##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
plate by##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
plate coated with##3##3##(1994-6#1)(2008-11#2)
plate containing##2##2##(2008-11#1)(2008-8#1)
plate count##4##2##(1997-4#2)(2008-10#2)
plate counts##5##2##(2007-3#1)(2008-10#4)
plate diagram sheet##6##3##(2013-1#6)
plate diagram##7##2##(2013-1#7)
plate fixation##5##2##(2009-10#3)(2009-3#1)(2011-2#1)
plate for##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
plate has##3##2##(1997-4#1)(2008-10#2)
plate imaging##2##2##(2007-11#1)(2007-12#1)
plate in the##2##3##(1997-7#1)(2007-11#1)
plate in##9##2##(1997-7#1)(2007-11#4)(2007-8#1)(2008-11#1)(2009-5#1)(2012-1#1)
plate is##18##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)
plate lysis##2##2##(2009-6#2)
plate method##7##2##(2008-10#3)(2008-5#1)(2010-3#2)(2011-1#1)
plate numbers##4##2##(1994-9#1)(2008-10#3)
plate of the##4##3##(1993-9#1)(2007-11#2)(2008-3#1)
plate of##9##2##(1993-9#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-8#2)
plate reader##2##2##(2008-10#2)
plate separation##2##2##(1991-8#1)(2007-11#1)
plate stabilisation##3##2##(2007-11#3)
plate surface##3##2##(2008-10#1)(2008-8#2)
plate technique##2##2##(2007-11#2)
plate test##4##2##(1992-3#1)(1996-2#2)(2011-2#1)
plate tests##3##2##(1994-3#1)(2008-10#2)
plate that##6##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
plate to##3##2##(2007-12#1)(2008-2#1)(2010-11#1)
plate was used to##2##4##(2008-10#1)(2010-9#1)
plate was used##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-9#1)
plate was##12##2##(1997-7#1)(2007-11#6)(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)(2012-1#1)
plate with a##3##3##(2008-10#1)(2008-3#2)
plate with the##2##3##(2008-3#2)
plate with##12##2##(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2009-5#1)
plate##398##1##(1991-12#2)(1991-8#2)(1991-9#3)(1992-3#1)(1992-8#2)(1993-12#2)(1993-9#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-4#4)(1997-7#2)(2007-11#42)(2007-12#15)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#70)(2008-11#16)(2008-12#2)(2008-2#35)(2008-3#51)(2008-4#1)(2008-5#5)(2008-7#12)(2008-8#12)(2008-9#16)(2009-10#8)(2009-12#1)(2009-3#1)(2009-5#11)(2009-6#2)(2010-11#1)(2010-12#2)(2010-3#6)(2010-5#4)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#16)
plate)##2##1##(2008-10#1)(2008-11#1)
plate-oriented##3##1##(2008-2#3)
plateau level##3##2##(1994-6#2)(1997-1#1)
plateau of##2##2##(2010-3#1)(2011-1#1)
plateau phase##3##2##(1990-7#1)(1994-6#1)(1997-2#1)
plateau stresses and elastic moduli##2##5##(2009-7#2)
plateau##55##1##(1990-12#1)(1990-7#3)(1992-3#2)(1992-9#1)(1994-11#1)(1994-6#5)(1995-4#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#2)(2010-3#3)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#6)
plateaued##3##1##(2007-9#1)(2008-6#1)(2010-5#1)
plateaus##2##1##(2008-10#1)(2012-2#1)
plateaux##2##1##(2008-5#2)
plated in situ##2##3##(2008-10#2)
plated in##8##2##(1994-6#1)(2008-10#4)(2008-12#1)(2013-1#2)
plated on a##3##3##(2008-10#2)(2012-4#1)
plated on capsules extended##2##4##(1997-3#2)
plated on##13##2##(1992-6#1)(1994-6#1)(1997-3#3)(2008-10#4)(2008-11#1)(2008-5#1)(2012-4#2)
plated##30##1##(1990-3#1)(1992-6#1)(1994-6#2)(1997-3#4)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#1)(2012-4#2)(2013-1#2)
platelet MAO activity##3##3##(1995-11#1)(2008-3#2)
platelet MAO##4##2##(1995-11#2)(2008-3#2)
platelet actin [beta##2##3##(1990-5#2)
platelet activating factor##4##3##(1995-2#2)(1995-3#1)(2008-1#1)
platelet activation and aggregation##2##4##(2006-6#2)
platelet activation and##6##3##(1992-6#1)(2006-6#2)(2008-7#1)(2008-9#1)(2011-2#1)
platelet activation by##2##3##(1994-6#1)(2008-9#1)
platelet activation of##2##3##(2006-6#1)(2008-4#1)
platelet activation##34##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-6#3)(1992-8#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-7#4)(2006-6#5)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#3)(2011-2#5)
platelet activity and##2##3##(1997-7#1)(2011-2#1)
platelet activity##3##2##(1997-7#2)(2011-2#1)
platelet aggregability in##2##3##(1991-12#1)(2008-7#1)
platelet aggregability##5##2##(1991-12#3)(2008-7#1)(2011-1#1)
platelet aggregation and##13##3##(1990-12#2)(1990-8#1)(1991-12#1)(1991-9#3)(1992-4#1)(1992-8#1)(1996-7#2)(1997-7#1)(2011-1#1)
platelet aggregation by##3##3##(1997-7#1)(2008-11#1)(2008-5#1)
platelet aggregation in response to##2##5##(1992-4#1)(2008-5#1)
platelet aggregation in vitro and##3##5##(2006-6#3)
platelet aggregation in vitro##5##4##(1990-5#1)(2006-6#4)
platelet aggregation in##11##3##(1990-5#1)(1991-11#2)(1992-4#1)(1995-5#1)(2006-6#4)(2008-5#1)(2011-2#1)
platelet aggregation induced by##2##4##(1997-6#1)(1997-7#1)
platelet aggregation induced##4##3##(1992-8#1)(1997-6#1)(1997-7#2)
platelet aggregation was##3##3##(1991-11#1)(1991-12#1)(1997-2#1)
platelet aggregation##67##2##(1990-12#2)(1990-5#4)(1990-8#1)(1991-11#3)(1991-12#5)(1991-8#1)(1991-9#4)(1992-4#2)(1992-8#3)(1993-3#2)(1993-8#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#4)(2006-6#8)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#2)
platelet alpha-granule protein##2##3##(1991-2#1)(1992-8#1)
platelet alpha-granules##4##2##(1997-7#3)(2010-3#1)
platelet and leukocyte activation##2##4##(2006-6#2)
platelet and##8##2##(1992-8#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-7#2)
platelet cAMP##3##2##(1993-3#3)
platelet cholesterol content##2##3##(1997-7#2)
platelet cholesterol##3##2##(1992-12#1)(1997-7#2)
platelet count &lt##2##3##(2007-10#1)(2009-8#1)
platelet count (PC)##2##3##(2008-10#1)(2008-7#1)
platelet count and##5##3##(2007-10#3)(2008-10#1)(2013-8#1)
platelet count in##2##3##(2006-6#1)(2007-10#1)
platelet count##22##2##(1990-12#1)(1990-3#1)(1993-6#1)(2006-6#2)(2007-10#7)(2007-12#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#2)
platelet counts and##3##3##(2007-10#1)(2008-10#1)(2010-3#1)
platelet counts in##2##3##(2007-10#1)(2008-10#1)
platelet counts##15##2##(1990-10#2)(2007-10#3)(2008-10#3)(2008-7#1)(2008-8#1)(2010-3#3)(2010-5#1)(2011-2#1)
platelet cross-matching##4##2##(2011-2#4)
platelet degranulation##2##2##(1992-12#2)
platelet deposition##4##2##(1992-9#1)(2006-6#3)
platelet derived##3##2##(1991-12#1)(2008-11#1)(2013-1#1)
platelet destruction##2##2##(1993-6#2)
platelet disorder##2##2##(1997-7#1)(2006-6#1)
platelet dysfunction##5##2##(2007-10#4)(2008-10#1)
platelet factor 4 was##2##4##(1990-5#1)(1992-8#1)
platelet factor 4##6##3##(1990-5#1)(1992-8#4)(2013-1#1)
platelet factor##8##2##(1990-5#2)(1992-8#5)(2013-1#1)
platelet fatty##2##2##(1991-12#2)
platelet fibrinogen receptor##5##3##(1993-8#1)(1997-7#1)(2006-6#3)
platelet free##2##2##(1992-12#1)(1997-7#1)
platelet function##19##2##(1991-11#2)(1991-12#3)(1992-9#1)(1993-8#1)(1997-4#1)(2006-6#2)(2007-10#3)(2008-1#2)(2008-11#1)(2008-7#1)(2009-5#1)(2012-12#1)
platelet glycoprotein##3##2##(1993-3#1)(2008-11#1)(2009-12#1)
platelet homogenates##2##2##(1994-8#2)
platelet hyperactivity##2##2##(1997-7#2)
platelet hyperaggregability##2##2##(1991-11#1)(1997-6#1)
platelet inhibition##2##2##(2009-5#2)
platelet lysate medium##2##3##(2008-11#2)
platelet lysate was##3##3##(2008-11#3)
platelet lysate##9##2##(2008-11#9)
platelet lysates##2##2##(2012-6#2)
platelet mRNA##2##2##(1994-12#1)(2006-6#1)
platelet magnesium##3##2##(2008-7#3)
platelet membrane##2##2##(1995-11#1)(2006-6#1)
platelet membranes with##2##3##(1992-3#1)(1995-11#1)
platelet membranes##10##2##(1992-3#2)(1992-6#3)(1993-6#1)(1995-11#1)(1997-7#1)(2008-11#1)(2008-6#1)
platelet monoamine oxidase##4##3##(1995-11#1)(1995-8#1)(2008-3#2)
platelet production##2##2##(2006-6#1)(2008-8#1)
platelet protein##2##2##(1990-5#1)(1991-2#1)
platelet reactivity##6##2##(2008-4#1)(2008-9#1)(2009-5#4)
platelet response##2##2##(1990-5#1)(2011-2#1)
platelet rich plasma (PRP)##3##4##(2007-9#2)(2013-1#1)
platelet rich plasma##4##3##(1992-12#1)(2007-9#2)(2013-1#1)
platelet stimulation with##3##3##(1992-6#2)(2008-9#1)
platelet sulphate conjugated NA##2##4##(1997-7#2)
platelet sulphate conjugated##3##3##(1997-7#3)
platelet surface##5##2##(1990-5#1)(1994-12#1)(2006-6#1)(2008-9#2)
platelet syndrome##3##2##(1997-6#2)(1997-7#1)
platelet thrombus formation##4##3##(2006-6#4)
platelet transfusion##5##2##(1991-3#1)(2006-6#1)(2011-2#3)
platelet transfusions associated with##2##4##(2011-2#2)
platelet transfusions##6##2##(2006-10#1)(2008-11#1)(2011-2#4)
platelet volume##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
platelet##401##1##(1990-10#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#12)(1990-7#1)(1990-8#2)(1991-11#8)(1991-12#15)(1991-2#3)(1991-3#1)(1991-8#4)(1991-9#5)(1992-11#2)(1992-12#9)(1992-3#2)(1992-4#4)(1992-6#8)(1992-8#11)(1992-9#2)(1993-11#1)(1993-3#7)(1993-6#7)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-7#6)(1997-2#1)(1997-4#1)(1997-6#6)(1997-7#29)(2006-10#1)(2006-6#43)(2007-10#17)(2007-12#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#20)(2008-2#1)(2008-3#6)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#14)(2008-8#9)(2008-9#10)(2009-12#2)(2009-5#7)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#5)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#30)(2012-12#2)(2012-6#2)(2013-1#3)(2013-7#1)(2013-8#2)
platelet-activating factor (PAF)##4##3##(1991-5#1)(1997-7#2)(2009-3#1)
platelet-activating factor##10##2##(1990-5#1)(1991-5#2)(1992-3#1)(1997-7#3)(2008-10#1)(2008-3#1)(2009-3#1)
platelet-activating factor-induced##2##2##(1991-8#1)(1992-3#1)
platelet-activating##13##1##(1990-5#1)(1991-5#2)(1991-8#1)(1992-3#2)(1994-5#1)(1997-7#3)(2008-10#1)(2008-3#1)(2009-3#1)
platelet-aggregating enzyme##2##2##(1995-5#2)
platelet-aggregating##4##1##(1995-5#4)
platelet-derived growth factor (PDGF)##4##4##(1995-11#2)(1997-6#1)(2008-11#1)
platelet-derived growth factor receptor##2##4##(2013-1#1)(2013-8#1)
platelet-derived growth factor##16##3##(1990-7#1)(1993-8#1)(1994-9#1)(1995-11#3)(1995-2#1)(1996-5#1)(1997-6#2)(1997-7#1)(2008-11#1)(2009-3#1)(2013-1#2)(2013-8#1)
platelet-derived growth factor-AA##2##3##(1991-12#1)(1995-11#1)
platelet-derived growth##20##2##(1990-7#1)(1991-12#1)(1993-8#1)(1994-9#1)(1995-11#5)(1995-2#2)(1996-5#1)(1997-6#2)(1997-7#1)(2008-11#1)(2009-3#1)(2013-1#2)(2013-8#1)
platelet-derived##22##1##(1990-7#1)(1991-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#5)(1995-2#2)(1996-5#1)(1997-6#2)(1997-7#1)(2008-11#2)(2009-3#1)(2013-1#2)(2013-8#1)
platelet-leukocyte conjugate formation in whole blood##3##6##(2006-6#3)
platelet-leukocyte##4##1##(2006-6#4)
platelet-monocyte##2##1##(2006-6#2)
platelet-rich plasma##10##2##(1991-12#1)(1991-9#1)(1995-5#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-7#1)(2012-12#3)
platelet-specific##3##1##(1991-2#1)(2008-9#2)
plateletpheresis##4##1##(2007-9#3)(2011-2#1)
platelets after##2##2##(1990-8#1)(1997-6#1)
platelets aggregate with##2##3##(2008-1#1)(2008-9#1)
platelets also##2##2##(2006-6#2)
platelets and endothelial cells##2##4##(1991-12#1)(2009-3#1)
platelets and its##3##3##(1992-12#1)(1992-6#1)(1995-11#1)
platelets and monocytes##2##3##(2006-6#1)(2008-9#1)
platelets and##25##2##(1991-12#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(2006-6#5)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-3#2)(2011-2#1)
platelets are##4##2##(1992-12#1)(2006-6#1)(2008-11#1)(2011-2#1)
platelets as##2##2##(1990-5#1)(1995-8#1)
platelets at##3##2##(1991-8#1)(1992-6#1)(2008-1#1)
platelets by##8##2##(1991-8#1)(1992-12#1)(1992-4#1)(2006-6#2)(2008-7#1)(2008-9#1)(2011-1#1)
platelets can##3##2##(1991-2#1)(2006-6#1)(2008-9#1)
platelets from##4##2##(1991-12#1)(1992-12#1)(1996-7#1)(2006-6#1)
platelets had##2##2##(2006-6#2)
platelets has been##2##3##(1992-12#1)(1994-12#1)
platelets has##3##2##(1992-12#1)(1994-12#1)(2006-6#1)
platelets in plasma##2##3##(1990-5#1)(2008-8#1)
platelets in the##2##3##(1993-6#1)(2011-2#1)
platelets in vitro##2##3##(1990-5#1)(2008-9#1)
platelets in##15##2##(1990-5#2)(1991-12#1)(1991-4#1)(1993-6#1)(1995-11#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#1)
platelets is##4##2##(1992-12#1)(1993-8#1)(2006-6#1)(2008-9#1)
platelets may serve as##2##4##(1992-12#1)(2008-3#1)
platelets may##3##2##(1992-12#1)(2006-6#1)(2008-3#1)
platelets of##4##2##(1995-11#1)(1996-7#1)(2008-3#2)
platelets on##5##2##(2006-6#3)(2008-11#1)(2010-3#1)
platelets stimulated with##2##3##(1995-11#1)(1997-7#1)
platelets to fibrinogen##3##3##(1997-7#3)
platelets to##10##2##(1991-12#1)(1997-7#6)(2006-6#1)(2008-11#1)(2008-5#1)
platelets was##8##2##(1992-6#2)(1994-3#1)(1995-11#1)(2006-6#1)(2008-3#1)(2008-5#1)(2011-1#1)
platelets were examined##2##3##(1991-9#1)(1993-8#1)
platelets were treated with##2##4##(1994-3#1)(1995-11#1)
platelets were##12##2##(1991-9#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#2)(1997-7#1)(2006-6#3)(2011-2#1)
platelets with##5##2##(1992-12#1)(1992-8#1)(1993-11#1)(1997-7#1)(2008-9#1)
platelets##243##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#6)(1990-8#8)(1991-12#5)(1991-2#2)(1991-4#2)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#14)(1992-4#1)(1992-6#11)(1992-8#3)(1992-9#3)(1993-11#4)(1993-3#1)(1993-6#1)(1993-8#10)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#9)(1995-12#1)(1995-6#1)(1995-8#1)(1996-7#3)(1997-2#1)(1997-6#1)(1997-7#15)(2006-6#46)(2007-12#1)(2008-1#7)(2008-11#5)(2008-3#7)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#16)(2009-11#1)(2009-12#1)(2009-3#3)(2010-3#2)(2011-1#3)(2011-2#7)(2012-3#1)(2013-8#1)
platelets) and##2##2##(2008-4#2)
platelets)##3##1##(2008-4#2)(2013-8#1)
platelike##2##1##(2008-3#2)
platensis##5##1##(2008-10#1)(2008-8#4)
plates after##2##2##(1990-5#1)(2010-6#1)
plates and a##2##3##(1990-12#1)(2008-10#1)
plates and photoresists##2##3##(2008-9#2)
plates and##16##2##(1990-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#3)(2011-2#3)(2013-1#1)(2013-7#1)
plates are also##2##3##(1997-4#1)(2008-2#1)
plates are##7##2##(1990-12#1)(1997-4#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
plates at##2##2##(2008-3#1)(2008-7#1)
plates by the##2##3##(1991-9#1)(2008-2#1)
plates by##4##2##(1991-9#1)(2007-11#1)(2007-12#1)(2008-2#1)
plates containing##6##2##(1997-6#1)(2007-11#1)(2008-10#3)(2008-5#1)
plates for distal radius fractures##2##5##(2008-9#2)
plates for##11##2##(1994-9#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-9#2)(2010-11#1)(2010-6#1)
plates from##2##2##(1996-11#1)(2008-9#1)
plates have been##2##3##(2007-11#1)(2008-5#1)
plates have##5##2##(1996-11#1)(2007-11#1)(2008-3#2)(2008-5#1)
plates in##7##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
plates indicated##2##2##(1997-3#1)(2008-10#1)
plates is##7##2##(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#3)(2011-1#1)
plates of each type were##2##5##(2008-9#2)
plates of the##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
plates of##11##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)
plates on##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
plates or##6##2##(1997-3#1)(2007-11#1)(2008-12#1)(2008-4#2)(2008-7#1)
plates per meter##2##3##(2008-10#2)
plates precoated with##3##3##(2008-10#1)(2008-11#2)
plates showed##2##2##(2008-11#1)(2011-2#1)
plates that##2##2##(2008-3#2)
plates to##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
plates using##2##2##(2010-4#2)
plates was##5##2##(2008-10#4)(2008-3#1)
plates were##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
plates with##8##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-5#1)
plates##241##1##(1990-11#1)(1990-12#4)(1990-5#1)(1991-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-11#3)(1996-2#1)(1996-5#2)(1997-3#2)(1997-4#3)(1997-6#1)(2007-11#16)(2007-12#9)(2007-8#1)(2008-10#50)(2008-11#16)(2008-12#4)(2008-2#12)(2008-3#40)(2008-4#4)(2008-5#7)(2008-7#8)(2008-8#2)(2008-9#14)(2009-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#9)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)
plates)##2##1##(2008-10#1)(2008-11#1)
platform and##7##2##(1995-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2013-8#1)
platform as a##2##3##(2009-12#1)(2009-7#1)
platform as##3##2##(2008-4#1)(2009-12#1)(2009-7#1)
platform based on##3##3##(2008-10#2)(2011-1#1)
platform can be##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
platform for a##2##3##(2008-10#1)(2008-11#1)
platform for future##2##3##(2012-2#2)
platform for the##10##3##(1994-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2010-12#1)(2011-2#1)(2012-12#1)
platform for##47##2##(1994-12#2)(1994-6#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-4#2)(2008-5#1)(2008-7#3)(2009-5#1)(2010-10#1)(2010-12#5)(2010-5#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
platform has been##2##3##(2008-10#2)
platform has##3##2##(2008-10#2)(2012-2#1)
platform in##3##2##(1995-5#1)(2007-11#1)(2010-5#1)
platform may##2##2##(2008-5#1)(2012-12#1)
platform of##6##2##(1995-12#1)(2008-10#4)(2009-12#1)
platform provides##2##2##(2012-12#1)(2013-8#1)
platform surface##2##2##(2008-10#2)
platform that##5##2##(2008-10#2)(2008-11#1)(2009-12#1)(2012-2#1)
platform to the##2##3##(2009-3#1)(2012-3#1)
platform to##16##2##(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
platform upon which##2##3##(2010-12#1)(2012-2#1)
platform was##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-1#1)
platform with##3##2##(2008-4#1)(2010-5#1)(2012-2#1)
platform##183##1##(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#40)(2008-11#17)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-7#8)(2008-9#6)(2009-12#5)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#3)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-12#6)(2012-2#12)(2012-3#4)(2013-1#7)(2013-8#3)
platform-independent##2##1##(2008-4#1)(2011-3#1)
platforms and##5##2##(1995-12#1)(2008-2#1)(2008-8#1)(2010-7#1)(2013-8#1)
platforms are not##2##3##(2008-4#1)(2008-7#1)
platforms are##4##2##(2008-10#1)(2008-4#1)(2008-7#2)
platforms for##6##2##(1994-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
platforms to##3##2##(2008-7#1)(2010-7#1)(2012-2#1)
platforms##47##1##(1990-11#2)(1994-8#1)(1995-12#1)(2008-10#8)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#2)(2010-7#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
platination##2##1##(1991-9#1)(1993-8#1)
plating and##3##2##(1994-3#1)(2008-10#2)
plating assay##2##2##(2008-1#1)(2008-10#1)
plating assays##2##2##(2008-10#2)
plating density##4##2##(1990-7#1)(1994-2#1)(1996-5#1)(2008-11#1)
plating of##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
plating on##3##2##(2008-10#2)(2008-8#1)
plating onto##2##2##(2008-10#2)
plating systems##2##2##(2008-9#1)(2012-2#1)
plating techniques##4##2##(2008-10#1)(2008-3#1)(2011-1#2)
plating##52##1##(1990-7#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-5#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-6#2)(2011-1#2)(2012-12#2)(2012-2#2)
platinised carbon##2##2##(2008-10#2)
platinum (Pt)##5##2##(1993-9#1)(2008-10#3)(2008-11#1)
platinum and paclitaxel##2##3##(2007-7#2)
platinum and palladium##9##3##(2008-10#9)
platinum and##19##2##(2007-7#2)(2008-10#17)
platinum black##2##2##(2008-10#2)
platinum coil##2##2##(2008-7#2)
platinum complexes##2##2##(2010-11#1)(2013-1#1)
platinum concentrations##2##2##(2008-10#2)
platinum dish##2##2##(2008-10#2)
platinum disk electrode##3##3##(2008-10#3)
platinum disk##4##2##(2008-10#4)
platinum electrode in the##2##4##(2008-10#2)
platinum electrode in##3##3##(2008-10#3)
platinum electrode were##2##3##(2008-10#2)
platinum electrode##18##2##(1991-5#2)(2008-10#16)
platinum electrodes##7##2##(2008-10#7)
platinum group elements (PGEs)##2##4##(2008-10#2)
platinum group elements##7##3##(2008-10#5)(2008-11#2)
platinum group metals##7##3##(2008-10#7)
platinum group##15##2##(2008-10#13)(2008-11#2)
platinum in##3##2##(2008-10#2)(2008-11#1)
platinum nanoparticles##5##2##(2008-7#1)(2010-12#1)(2010-4#3)
platinum wire as the##2##4##(2008-10#2)
platinum wire##5##2##(2008-10#5)
platinum##153##1##(1991-5#2)(1993-11#1)(1993-8#1)(1993-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-7#3)(2008-10#113)(2008-11#5)(2008-3#2)(2008-4#4)(2008-7#3)(2008-9#1)(2009-4#2)(2010-11#3)(2010-12#2)(2010-4#4)(2011-1#1)(2013-1#1)
platinum(II) and palladium(II) chlorido complexes##2##5##(2013-1#2)
platinum(II) complexes##2##2##(2012-3#1)(2013-1#1)
platinum(II)##16##1##(2008-10#11)(2012-3#2)(2013-1#3)
platinum(IV)##9##1##(2008-10#9)
platinum-based chemotherapy##6##2##(2007-10#2)(2010-8#3)(2012-1#1)
platinum-based##11##1##(1990-6#1)(2007-10#2)(2007-5#1)(2008-10#2)(2008-11#1)(2010-8#3)(2012-1#1)
platycephala from Suriname##2##3##(2010-3#2)
platycephala##3##1##(2010-3#3)
platyfish (Xiphophorus##2##2##(2008-12#2)
platyfish##4##1##(2008-12#4)
platyhelminth##3##1##(1993-6#3)
plausibility of##4##2##(2008-7#2)(2008-9#1)(2012-2#1)
plausibility##6##1##(1991-12#1)(1995-6#1)(2008-7#2)(2008-9#1)(2012-2#1)
plausible and##3##2##(2008-3#1)(2009-2#1)(2012-12#1)
plausible candidate##2##2##(1990-12#1)(2008-4#1)
plausible explanation##2##2##(2008-10#1)(2008-3#1)
plausible mechanism##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
plausible mechanisms##3##2##(1994-3#1)(2010-4#1)(2010-6#1)
plausible##60##1##(1990-12#1)(1990-3#1)(1990-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-4#2)(2010-5#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
plausibly##2##1##(1995-11#1)(2007-11#1)
play a causal role in##3##5##(1991-12#1)(1995-12#1)(2008-6#1)
play a central role in determining##2##6##(2009-10#1)(2013-1#1)
play a central role in the##3##6##(1991-9#1)(1996-5#1)(2008-10#1)
play a central role in##15##5##(1991-9#1)(1992-9#1)(1995-5#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2011-3#1)(2013-1#1)(2013-8#1)
play a certain role in##3##5##(2008-8#3)
play a complementary role##2##4##(2008-10#1)(2010-6#1)
play a critical role in the##5##6##(1990-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
play a critical role in this##2##6##(2009-6#1)(2011-2#1)
play a critical role in##25##5##(1990-11#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
play a critical role##27##4##(1990-11#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
play a critical##29##3##(1990-11#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#2)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)
play a crucial role in the pathogenesis of##2##8##(2008-1#1)(2011-2#1)
play a crucial role in the##8##6##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-9#1)(2011-2#1)
play a crucial role in##17##5##(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
play a crucial role##20##4##(1992-10#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
play a crucial##21##3##(1992-10#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
play a dominant role in##2##5##(2008-1#1)(2011-2#1)
play a dominant role##3##4##(2008-1#1)(2008-2#1)(2011-2#1)
play a key role for##2##5##(1990-2#1)(2010-8#1)
play a key role in the development of##3##8##(1996-1#1)(2008-1#1)(2010-11#1)
play a key role in the development##4##7##(1991-12#1)(1996-1#1)(2008-1#1)(2010-11#1)
play a key role in the natural##2##7##(2008-10#2)
play a key role in the pathogenesis of##2##8##(2008-3#1)(2009-8#1)
play a key role in the##22##6##(1991-12#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#3)
play a key role in##40##5##(1990-2#1)(1991-12#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#2)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#1)
play a key role##44##4##(1990-2#2)(1991-12#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#1)
play a major role as##2##5##(2008-5#1)(2009-11#1)
play a major role in determining##3##6##(1997-2#1)(2008-6#1)(2010-8#1)
play a major role in regulating##2##6##(2008-4#1)(2009-8#1)
play a major role in the regulation of##2##8##(1991-6#1)(1992-8#1)
play a major role in the##7##6##(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#1)(2009-7#1)
play a major role in##32##5##(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#2)(2009-8#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#2)
play a major role##38##4##(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-12#2)(1995-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
play a major##39##3##(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-12#2)(1995-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
play a minor role##2##4##(2008-10#2)
play a more important role##2##5##(1994-8#1)(1995-6#1)
play a more##4##3##(1994-8#1)(1995-6#1)(2008-5#1)(2011-1#1)
play a part in the##3##5##(1994-2#1)(1997-1#1)(1997-3#1)
play a part in##5##4##(1994-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2013-8#1)
play a part##6##3##(1994-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(2007-12#1)(2013-8#1)
play a physiological role##2##4##(1994-8#1)(2009-11#1)
play a pivotal role in the control of##2##8##(1994-2#1)(2009-5#1)
play a pivotal role in the##8##6##(1994-2#1)(1995-12#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-5#1)
play a pivotal role in##19##5##(1991-2#1)(1991-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
play a pivotal role##23##4##(1991-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
play a pivotal##24##3##(1991-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
play a positive##2##3##(1995-12#1)(2008-8#1)
play a primary##2##3##(2008-12#1)(2009-3#1)
play a prominent role in##2##5##(1990-5#1)(1995-3#1)
play a prominent role##3##4##(1990-5#1)(1995-3#1)(2008-9#1)
play a prominent##5##3##(1990-5#1)(1995-3#1)(2007-12#1)(2008-8#1)(2008-9#1)
play a regulatory role in##3##5##(1991-12#1)(1994-12#1)(2008-4#1)
play a regulatory role##4##4##(1991-12#1)(1993-3#1)(1994-12#1)(2008-4#1)
play a relevant##2##3##(1993-9#1)(2012-8#1)
play a role as##2##4##(1992-9#1)(2011-2#1)
play a role in a##3##5##(1994-11#1)(1994-6#1)(2007-8#1)
play a role in ammonia##2##5##(2008-10#1)(2008-7#1)
play a role in controlling##2##5##(2008-10#2)
play a role in disease##2##5##(1995-3#1)(2008-10#1)
play a role in health##2##5##(1994-3#1)(2011-2#1)
play a role in inflammatory##2##5##(1995-12#1)(2007-12#1)
play a role in its##2##5##(1994-8#1)(2008-10#1)
play a role in local##2##5##(1992-6#1)(1994-6#1)
play a role in normal##2##5##(2008-5#1)(2009-10#1)
play a role in regulating##2##5##(1995-12#1)(2010-2#1)
play a role in the development and progression of##2##9##(2010-3#1)(2012-3#1)
play a role in the development##6##6##(2008-1#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-10#1)(2012-3#1)
play a role in the early##2##6##(1994-11#1)(1997-3#1)
play a role in the etiology##2##6##(1990-11#1)(2008-5#1)
play a role in the evolution of##2##7##(2008-8#1)(2010-3#1)
play a role in the modulation of##2##7##(2012-2#1)(2013-8#1)
play a role in the pathogenesis of##7##7##(1991-5#1)(1992-6#1)(1993-12#1)(1994-2#1)(2008-3#2)(2009-1#1)
play a role in the pathophysiology of##2##7##(2008-4#1)(2011-1#1)
play a role in the regulation of##5##7##(1990-5#1)(1992-12#1)(1992-6#1)(2008-1#1)(2008-4#1)
play a role in the survival##2##6##(2008-10#2)
play a role in the##67##5##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-6#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-3#2)(1997-6#1)(1997-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
play a role in this##3##5##(1994-11#1)(2008-1#1)(2009-7#1)
play a role in##170##4##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-6#4)(1992-8#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#7)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#3)(1997-3#2)(1997-6#1)(1997-7#3)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#3)(2009-1#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#2)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#3)
play a role##187##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#3)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#12)(2008-8#2)(2008-9#3)(2009-1#2)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#2)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#3)
play a significant role in the##8##6##(1995-6#1)(2008-10#3)(2008-4#1)(2012-2#2)(2013-8#1)
play a significant role in##20##5##(1993-1#1)(1995-6#1)(2008-10#8)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#2)(2013-8#2)
play a significant role##21##4##(1993-1#1)(1995-6#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#2)(2013-8#2)
play a significant##22##3##(1993-1#1)(1995-6#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#2)(2013-8#2)
play a similar role##2##4##(1997-7#1)(2008-7#1)
play a small role in##2##5##(2008-9#1)(2011-1#1)
play a substantial role in##2##5##(1990-2#1)(2008-9#1)
play a substantial##3##3##(1990-2#1)(2008-11#1)(2008-9#1)
play a valuable role in the##2##6##(2008-11#1)(2008-5#1)
play a very important role in##2##6##(2009-2#1)(2010-5#1)
play a very##3##3##(2009-2#1)(2009-6#1)(2010-5#1)
play a vital role in the##2##6##(2008-4#1)(2008-7#1)
play a vital role in##6##5##(1990-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#2)
play a vital role##8##4##(1990-11#1)(1990-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#2)
play a wide range of##2##5##(2008-7#1)(2010-11#1)
play a##471##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-5#3)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#5)(1994-3#1)(1994-6#3)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#12)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#5)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#12)(2008-10#43)(2008-11#16)(2008-12#2)(2008-2#4)(2008-3#11)(2008-4#16)(2008-5#10)(2008-6#7)(2008-7#27)(2008-8#12)(2008-9#11)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#10)(2011-10#2)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#12)(2012-3#4)(2012-7#1)(2012-8#1)(2013-1#7)(2013-7#2)(2013-8#8)
play an active role in##3##5##(1996-3#1)(2008-5#1)(2010-11#1)
play an active role##4##4##(1996-3#1)(2008-11#1)(2008-5#1)(2010-11#1)
play an essential role as##2##5##(1995-6#1)(1997-7#1)
play an essential role in the##3##6##(1990-5#1)(1992-11#1)(2008-11#1)
play an essential role in##7##5##(1990-5#1)(1992-11#1)(1995-2#1)(1995-5#1)(2008-11#3)
play an essential role##10##4##(1990-5#1)(1992-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(2008-11#3)(2011-2#1)
play an important part in the##2##6##(1993-9#1)(2012-12#1)
play an important part in##4##5##(1993-9#1)(1995-5#2)(2012-12#1)
play an important role during##2##5##(2008-8#1)(2008-9#1)
play an important role for##2##5##(1997-1#1)(2012-2#1)
play an important role in controlling##3##6##(1997-1#1)(2008-10#1)(2008-9#1)
play an important role in determining##2##6##(2009-2#1)(2011-1#1)
play an important role in human##3##6##(2008-10#1)(2011-1#1)(2011-2#1)
play an important role in many##2##6##(1996-6#1)(2008-5#1)
play an important role in mediating##3##6##(1990-12#1)(1995-12#1)(2008-4#1)
play an important role in promoting##2##6##(2008-4#1)(2011-1#1)
play an important role in reducing##3##6##(2009-3#1)(2011-2#1)(2012-2#1)
play an important role in regulating the##3##7##(1991-3#1)(1994-11#1)(2008-11#1)
play an important role in resistance##2##6##(2008-10#2)
play an important role in the binding##2##7##(2008-10#2)
play an important role in the development of##4##8##(2006-6#1)(2008-3#1)(2010-5#1)(2011-2#1)
play an important role in the future##2##7##(1996-2#1)(1996-3#1)
play an important role in the pathogenesis of##3##8##(2008-2#1)(2011-2#1)(2012-12#1)
play an important role in the pathogenesis##4##7##(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#1)
play an important role in the regulation of##4##8##(1993-11#1)(1995-2#1)(2008-8#1)(2012-2#1)
play an important role in the treatment of##3##8##(1995-11#1)(2011-1#1)(2011-3#1)
play an important role in the##59##6##(1991-12#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
play an important role in this##3##6##(2008-7#1)(2008-9#1)(2010-8#1)
play an important role in##150##5##(1990-12#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
play an important role on##2##5##(1992-3#1)(2008-6#1)
play an important role##164##4##(1990-12#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
play an important##174##3##(1990-12#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
play an integral role in the##2##6##(1992-2#1)(2008-11#1)
play an##197##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#9)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-11#5)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
play and##7##2##(1991-3#1)(1992-3#3)(2007-11#1)(2008-11#1)(2008-9#1)
play any role##2##3##(2008-10#1)(2008-2#1)
play any##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
play as a##4##3##(1993-6#1)(1994-11#1)(1996-3#1)(2008-9#1)
play as##6##2##(1992-3#1)(1993-6#1)(1994-11#1)(1996-3#1)(2008-9#2)
play back##2##2##(2008-3#2)
play behaviors##4##2##(1993-12#2)(2012-12#2)
play critical roles in##5##4##(2008-1#1)(2008-10#1)(2009-4#1)(2009-9#1)(2011-1#1)
play crucial roles in the##2##5##(2008-10#1)(2008-4#1)
play crucial roles in##6##4##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-8#1)
play different roles in##2##4##(1995-11#1)(2008-11#1)
play different roles##3##3##(1995-11#1)(2008-11#1)(2012-2#1)
play different##4##2##(1995-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
play distinct roles in##2##4##(1995-2#1)(1997-7#1)
play essential roles in##3##4##(1994-8#1)(2008-11#1)(2008-2#1)
play essential roles##5##3##(1994-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-8#1)
play important role in##2##4##(2013-1#2)
play important role##3##3##(2013-1#2)(2013-8#1)
play important roles in both the formation of flower meristem and the determination of floral organ identity##2##17##(1997-2#1)(1997-8#1)
play important roles in both##3##5##(1997-2#1)(1997-8#1)(2009-6#1)
play important roles in plant development and##2##7##(2008-9#1)(2012-3#1)
play important roles in plant##3##5##(2008-9#2)(2012-3#1)
play important roles in the regulation of##2##7##(2009-8#1)(2013-1#1)
play important roles in the##10##5##(1994-12#1)(1995-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
play important roles in##39##4##(1991-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
play important roles##41##3##(1991-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
play important##46##2##(1991-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
play in determining##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
play in the development of##2##5##(2008-11#1)(2008-5#1)
play in the##17##3##(1990-5#1)(1992-3#1)(1993-1#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-3#1)(2012-12#2)(2013-8#1)
play in this##2##3##(1997-2#1)(2007-11#1)
play in##52##2##(1990-5#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#2)(2007-11#1)(2007-12#2)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
play key roles in##10##4##(1996-10#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
play key roles##11##3##(1996-10#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
play key##12##2##(1991-9#1)(1996-10#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
play major roles in##2##4##(1994-11#1)(2008-7#1)
play major roles##3##3##(1994-11#1)(2008-7#2)
play only a minor role##2##5##(2008-5#1)(2008-9#1)
play only a##3##3##(2008-5#1)(2008-6#1)(2008-9#1)
play pivotal roles in##2##4##(2007-12#1)(2011-2#1)
play pivotal roles##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
play roles as##2##3##(1991-2#1)(1995-6#1)
play roles in the##2##4##(2008-8#1)(2010-8#1)
play roles in##11##3##(1992-12#1)(1994-8#1)(1997-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#2)(2011-2#2)(2012-3#1)
play roles##13##2##(1991-2#1)(1992-12#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#2)(2011-2#2)(2012-3#1)
play several roles in##2##4##(2008-1#1)(2009-8#1)
play several##3##2##(2008-1#1)(2009-8#1)(2012-2#1)
play significant roles in##4##4##(1990-8#1)(1995-2#1)(1997-6#1)(2008-9#1)
play some role in##2##4##(2008-7#1)(2008-8#1)
play some##3##2##(1993-8#1)(2008-7#1)(2008-8#1)
play such##2##2##(1995-2#1)(2007-4#1)
play the most important role##2##5##(1996-5#1)(2008-10#1)
play the role of##4##4##(1990-12#1)(1993-12#1)(2008-10#2)
play the##9##2##(1990-12#1)(1993-12#1)(1996-5#1)(1997-4#1)(1997-9#1)(2008-10#3)(2008-4#1)
play very##2##2##(2008-11#1)(2008-8#1)
play vital roles in##2##4##(2010-9#1)(2012-12#1)
play with##2##2##(2008-12#1)(2008-7#1)
play##943##1##(1990-11#5)(1990-12#4)(1990-2#3)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#9)(1992-6#4)(1992-8#5)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#14)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#11)(1994-12#8)(1994-2#7)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#18)(1995-2#11)(1995-3#3)(1995-5#5)(1995-6#6)(1995-8#4)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#7)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#1)(1997-1#5)(1997-2#6)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#6)(1997-9#2)(2006-6#2)(2007-11#6)(2007-12#13)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#18)(2008-10#68)(2008-11#42)(2008-12#4)(2008-2#11)(2008-3#20)(2008-4#29)(2008-5#21)(2008-6#10)(2008-7#48)(2008-8#25)(2008-9#39)(2009-1#2)(2009-10#8)(2009-11#5)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#6)(2009-7#7)(2009-8#8)(2009-9#3)(2010-1#6)(2010-10#6)(2010-11#12)(2010-12#7)(2010-2#5)(2010-3#8)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#3)(2011-1#18)(2011-10#2)(2011-2#42)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#22)(2012-2#25)(2012-3#12)(2012-7#1)(2012-8#1)(2013-1#29)(2013-7#3)(2013-8#15)
playa##3##1##(2007-10#1)(2008-10#1)(2013-7#1)
playback systems##2##2##(2008-10#1)(2008-3#1)
playback##8##1##(2008-10#1)(2008-3#1)(2008-8#4)(2009-8#2)
played a central role in the##2##6##(1997-1#1)(2008-8#1)
played a crucial role in##3##5##(2007-8#1)(2008-10#1)(2008-8#1)
played a key role in the##2##6##(2008-6#1)(2009-4#1)
played a key role in##4##5##(2008-11#2)(2008-6#1)(2009-4#1)
played a major role in the##2##6##(1991-1#1)(1996-12#1)
played a major role##3##4##(1991-1#1)(1996-12#1)(2011-2#1)
played a minor role##2##4##(1995-6#1)(2008-10#1)
played a part##2##3##(1990-6#1)(1990-9#1)
played a role in##9##4##(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#2)
played a significant role in##2##5##(2010-3#1)(2011-2#1)
played a##40##2##(1990-6#1)(1990-9#1)(1991-1#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#3)
played an important role in the##4##6##(1993-3#1)(1996-1#1)(2008-8#1)(2012-2#1)
played an important role in##15##5##(1991-6#1)(1992-12#1)(1993-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
played an important role##16##4##(1991-6#1)(1992-12#1)(1993-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
played an important##17##3##(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
played an##18##2##(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
played by the##11##3##(1995-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
played by these##2##3##(1997-5#1)(2009-8#1)
played by this##2##3##(1993-12#1)(1997-7#1)
played by##49##2##(1990-9#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#2)(2009-8#2)(2010-10#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
played important roles in the##2##5##(1995-4#1)(2008-11#1)
played important roles in##3##4##(1995-4#1)(2008-11#1)(2012-12#1)
played important roles##4##3##(1995-4#1)(2008-11#2)(2012-12#1)
played in the##2##3##(1993-6#1)(2008-1#1)
played in##7##2##(1993-1#1)(1993-6#1)(1995-12#1)(2008-1#1)(2008-12#1)(2008-6#1)(2013-1#1)
played the##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
played##139##1##(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#6)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-5#2)(1997-7#1)(2006-10#1)(2007-12#3)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#15)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#7)(2013-8#1)
player in the##6##3##(1994-12#1)(2008-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
player in##12##2##(1994-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-8#1)
player##18##1##(1994-12#1)(1995-3#1)(1996-2#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-2#5)(2013-8#1)
players in the##10##3##(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-4#1)(2009-10#2)(2009-5#1)(2011-1#1)(2011-2#1)
players in##22##2##(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-3#1)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#2)(2013-7#2)
players of##2##2##(2009-3#1)(2011-2#1)
players under##2##2##(2008-5#1)(2011-2#1)
players were##2##2##(2008-5#1)(2011-2#1)
players who##2##2##(1997-3#1)(2010-1#1)
players with##2##2##(2009-10#1)(2010-1#1)
players##50##1##(1991-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-1#1)(2009-10#3)(2009-3#2)(2009-5#2)(2009-6#1)(2010-1#3)(2010-3#2)(2011-1#1)(2011-2#5)(2012-3#3)(2013-1#1)(2013-7#3)
players'##4##1##(2008-8#2)(2011-2#1)(2012-3#1)
playground##2##1##(2009-10#1)(2012-2#1)
playgrounds##2##1##(2008-11#1)(2012-2#1)
playgroups##2##1##(2008-12#2)
playing a key role in##2##5##(1994-8#1)(2013-1#1)
playing a major role in##3##5##(1990-11#1)(2008-10#1)(2013-1#1)
playing a role in the##3##5##(1993-11#1)(1993-3#1)(1997-7#1)
playing a role in##5##4##(1993-11#1)(1993-3#1)(1997-7#1)(2008-7#1)(2009-1#1)
playing a role##7##3##(1990-11#1)(1993-11#1)(1993-3#1)(1997-7#1)(2008-7#1)(2009-1#1)(2009-9#1)
playing a##24##2##(1990-11#2)(1993-11#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-1#2)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#2)(2013-1#2)
playing an important role in##6##5##(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
playing an important##7##3##(2007-10#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
playing an##11##2##(1992-6#1)(2007-10#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
playing at##2##2##(1990-6#1)(1993-1#1)
playing field##2##2##(2009-8#1)(2010-7#1)
playing surfaces##4##2##(2013-1#4)
playing##63##1##(1990-11#2)(1990-6#7)(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-8#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#2)(1997-7#1)(2007-10#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#9)
plays a central role in the##6##6##(1990-11#1)(1993-3#1)(1994-12#1)(1995-6#1)(2009-10#1)(2011-2#1)
plays a central role in##11##5##(1990-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-6#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-2#1)
plays a central role##13##4##(1990-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)
plays a critical role in the development of##2##8##(2008-7#1)(2008-9#1)
plays a critical role in the##11##6##(1990-5#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#3)(2013-1#1)
plays a critical role in##24##5##(1990-5#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#3)
plays a critical role##27##4##(1990-5#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#3)
plays a critical##30##3##(1990-5#1)(1991-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#3)
plays a crucial role in the##6##6##(1994-10#1)(2008-11#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
plays a crucial role in##20##5##(1994-10#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
plays a crucial##21##3##(1994-10#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
plays a functional role##2##4##(2008-11#1)(2009-12#1)
plays a greater role than the##2##6##(1991-11#1)(2008-10#1)
plays a key regulatory role in##2##6##(2008-7#1)(2013-1#1)
plays a key role in the##13##6##(1991-5#1)(1994-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
plays a key role in##26##5##(1991-5#1)(1994-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)
plays a key role##30##4##(1991-5#1)(1992-9#1)(1994-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#4)
plays a key##34##3##(1991-5#1)(1992-9#1)(1994-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#5)
plays a major part in##2##5##(1993-9#1)(2011-2#1)
plays a major role in characterizing quasi-monochromatic##2##7##(2007-12#1)(2008-3#1)
plays a major role in determining##2##6##(2008-10#1)(2008-7#1)
plays a major role in regulating##2##6##(2012-12#1)(2012-3#1)
plays a major role in the##11##6##(1992-10#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-4#1)
plays a major role in##20##5##(1992-10#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
plays a major role##21##4##(1992-10#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
plays a major##23##3##(1992-10#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
plays a modulatory##2##3##(1993-6#1)(2008-5#1)
plays a pivotal role in the##3##6##(1997-8#1)(2012-2#1)(2013-7#1)
plays a pivotal role in##9##5##(1994-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-7#1)
plays a pivotal role##11##4##(1994-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
plays a positive role in##2##5##(2009-8#1)(2011-2#1)
plays a positive role##3##4##(1995-2#1)(2009-8#1)(2011-2#1)
plays a predominant role in##2##5##(2008-11#1)(2008-5#1)
plays a primary role in##3##5##(1995-5#1)(2008-7#1)(2008-8#1)
plays a prominent role in##4##5##(1996-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
plays a role in encoding##2##5##(1995-12#1)(1996-5#1)
plays a role in regulating##2##5##(1995-12#1)(2012-12#1)
plays a role in the development of##4##7##(1994-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
plays a role in the maintenance of##2##7##(1996-5#1)(1997-1#1)
plays a role in the##19##5##(1991-8#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#2)
plays a role in##50##4##(1991-2#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
plays a role##52##3##(1990-8#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
plays a significant role in regulating##2##6##(2009-10#1)(2012-12#1)
plays a significant role in the##4##6##(2006-10#1)(2008-1#1)(2008-4#1)(2013-1#1)
plays a significant role in##10##5##(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
plays a significant##12##3##(1993-8#1)(1995-2#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
plays a substantial role in##2##5##(2007-10#1)(2010-3#1)
plays a substantial##3##3##(2007-10#1)(2010-3#1)(2013-1#1)
plays a very important##2##4##(2008-5#1)(2008-9#1)
plays a vital role in the##2##6##(2008-1#1)(2012-12#1)
plays a vital role in##5##5##(1990-12#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-12#1)
plays a vital##6##3##(1990-12#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-12#2)
plays a##247##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#2)(1996-5#5)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#19)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#11)(2008-7#9)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#15)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#4)
plays an essential role in the##2##6##(2012-2#1)(2013-1#1)
plays an essential role in##10##5##(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
plays an essential##11##3##(1992-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
plays an important role as##2##5##(1991-9#1)(2008-4#1)
plays an important role for##2##5##(1997-6#1)(2008-5#1)
plays an important role in a##2##6##(1990-2#1)(2008-5#1)
plays an important role in cell##2##6##(2008-9#1)(2011-2#1)
plays an important role in its##3##6##(2007-5#1)(2008-10#1)(2008-8#1)
plays an important role in pain##2##6##(1996-12#1)(2008-8#1)
plays an important role in regulating##3##6##(1991-12#1)(2008-4#1)(2008-8#1)
plays an important role in the daily##2##7##(1991-12#1)(2008-11#1)
plays an important role in the development of##4##8##(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
plays an important role in the development##5##7##(2008-10#1)(2008-11#1)(2009-5#1)(2010-10#1)(2012-3#1)
plays an important role in the functioning of##2##8##(2012-12#1)(2013-8#1)
plays an important role in the pathophysiology of##2##8##(2008-7#1)(2009-8#1)
plays an important role in the regulation of##4##8##(1991-5#1)(1993-12#1)(1995-11#1)(2008-8#1)
plays an important role in the##52##6##(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-6#1)(2012-1#1)(2012-12#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-3#1)(2013-7#1)(2013-8#1)
plays an important role in this##3##6##(1992-3#1)(1993-11#1)(2010-2#1)
plays an important role in tumor##2##6##(2008-8#1)(2009-3#1)
plays an important role in##104##5##(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-3#1)(2013-7#3)(2013-8#1)
plays an important role##117##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-6#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#9)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)(2013-3#1)(2013-7#3)(2013-8#2)
plays an important##122##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)(2013-3#1)(2013-7#3)(2013-8#2)
plays an integral role in the##2##6##(1993-3#1)(2007-4#1)
plays an integral role in##3##5##(1993-3#1)(2007-4#1)(2010-10#1)
plays an integral##5##3##(1993-3#1)(1996-12#1)(2007-4#1)(2010-10#1)(2010-8#1)
plays an##144##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#5)(2013-3#1)(2013-7#3)(2013-8#2)
plays important roles in the##3##5##(2008-10#2)(2008-5#1)
plays important roles in##6##4##(1993-8#1)(1996-12#1)(2008-10#2)(2008-5#1)(2009-9#1)
plays important roles##7##3##(1993-8#1)(1996-12#1)(2008-10#3)(2008-5#1)(2009-9#1)
plays important##10##2##(1993-8#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)
plays in the##7##3##(1993-12#1)(1994-3#1)(2007-7#2)(2008-3#1)(2013-1#2)
plays in##17##2##(1992-10#1)(1992-6#1)(1993-12#2)(1994-3#1)(1995-1#1)(1996-6#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#1)(2013-1#2)
plays key roles in##2##4##(2007-10#1)(2012-12#1)
plays key##3##2##(2007-10#1)(2009-6#1)(2012-12#1)
plays no role in##2##4##(2007-8#1)(2010-7#1)
plays no role##3##3##(2007-8#1)(2008-7#1)(2010-7#1)
plays no##4##2##(2007-8#1)(2008-6#1)(2008-7#1)(2010-7#1)
plays the##5##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
plays to##2##2##(2008-7#1)(2009-12#1)
plays##458##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#3)(1993-3#8)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#7)(1995-8#4)(1996-1#1)(1996-12#5)(1996-3#1)(1996-5#5)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#7)(2008-10#36)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#12)(2008-5#18)(2008-6#3)(2008-7#13)(2008-8#17)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#8)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#23)(2012-1#2)(2012-12#11)(2012-2#18)(2012-3#8)(2012-7#1)(2013-1#22)(2013-3#1)(2013-7#4)(2013-8#6)
plc)##2##1##(2008-5#2)
plea to##2##2##(2007-2#1)(2007-6#1)
plea##3##1##(2007-2#1)(2007-6#1)(2007-8#1)
pleading##2##1##(2008-10#1)(2011-1#1)
pleasant##7##1##(1991-12#1)(1997-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#1)
pleasantness##13##1##(2007-6#1)(2008-11#1)(2008-5#2)(2012-12#8)(2012-2#1)
please##3##1##(1994-3#1)(1996-3#1)(2008-12#1)
pleased with the##2##3##(1992-3#1)(2011-2#1)
pleased##4##1##(1991-1#1)(1992-3#1)(1995-3#1)(2011-2#1)
pleasing##2##1##(2008-6#1)(2010-8#1)
pleasurable##6##1##(1992-3#1)(2009-6#1)(2011-2#1)(2012-2#3)
pleasure for##2##2##(2008-7#1)(2009-5#1)
pleasure##8##1##(1990-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#2)(2011-2#1)
pleckstrin homology##3##2##(1994-11#2)(2009-7#1)
pleiotrophic mutations##2##2##(1997-4#2)
pleiotrophic##3##1##(1997-4#2)(2008-9#1)
pleiotropic effects##2##2##(2008-1#1)(2008-4#1)
pleiotropic phenotypes of##2##3##(1995-8#1)(2011-2#1)
pleiotropic phenotypes##3##2##(1995-8#1)(2009-8#1)(2011-2#1)
pleiotropic##14##1##(1993-8#1)(1995-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
pleiotropy##7##1##(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#2)
plenary sessions##3##2##(2008-5#3)
plenary##5##1##(2008-5#3)(2008-7#1)(2009-6#1)
plentiful##5##1##(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)
plenty of room for improvement##2##5##(2008-6#1)(2012-12#1)
plenty of##6##2##(1997-4#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-12#1)
plenty##7##1##(1997-4#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-12#1)
pleocytosis##2##1##(1992-11#1)(1997-8#1)
pleomorphic liposarcoma##2##2##(2008-6#2)
pleomorphic xanthoastrocytoma##4##2##(2008-7#3)(2013-8#1)
pleomorphic##19##1##(1991-12#2)(1997-2#1)(1997-7#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#5)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#1)(2013-8#1)
pleomorphism##4##1##(1991-12#1)(2008-11#1)(2009-1#1)(2011-2#1)
plesiomorphic##3##1##(2007-12#3)
plethora of##22##2##(1991-1#1)(1993-11#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
plethysmographic##2##1##(1990-3#1)(2009-5#1)
plethysmography##2##1##(2007-8#1)(2013-1#1)
pleura and the##2##3##(1991-12#1)(2007-8#1)
pleura##20##1##(1991-12#2)(2007-10#1)(2007-5#4)(2007-8#8)(2008-6#1)(2010-5#1)(2010-8#1)(2011-1#2)
pleural and peritoneal mesothelioma tissues##2##5##(1991-12#2)
pleural and##4##2##(1991-12#2)(2007-12#2)
pleural biopsy##3##2##(1997-4#1)(2007-8#2)
pleural cavities##3##2##(2007-8#1)(2008-10#2)
pleural cavity##6##2##(1990-5#1)(1991-8#1)(1995-6#1)(2007-12#2)(2007-8#1)
pleural disease##2##2##(1991-12#2)
pleural drainage and##2##3##(2007-8#1)(2008-1#1)
pleural drainage##5##2##(2007-8#3)(2008-1#1)(2008-10#1)
pleural effusion and##4##3##(2007-12#1)(2007-8#1)(2010-5#1)(2012-3#1)
pleural effusion in four##2##4##(2008-5#2)
pleural effusion in##7##3##(2008-5#2)(2008-7#2)(2010-12#1)(2013-8#2)
pleural effusion is##2##3##(1991-6#1)(2013-8#1)
pleural effusion were##3##3##(1991-12#1)(1997-4#1)(2013-1#1)
pleural effusion##45##2##(1991-12#4)(1991-6#1)(1992-2#1)(1997-4#2)(1997-8#1)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#3)(2008-5#2)(2008-6#1)(2008-7#4)(2010-11#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#8)(2013-8#6)
pleural effusions##6##2##(1991-6#2)(2007-12#1)(2008-9#1)(2010-3#1)(2012-2#1)
pleural fibrosis is##2##3##(1991-12#2)
pleural fibrosis##5##2##(1991-12#5)
pleural fluid and##2##3##(1991-3#1)(2007-12#1)
pleural fluid##7##2##(1991-3#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2011-2#1)
pleural mesothelioma in##4##3##(1991-12#1)(1995-2#1)(1997-5#1)(2011-2#1)
pleural mesothelioma was##2##3##(1991-12#1)(1997-5#1)
pleural mesothelioma##22##2##(1990-12#2)(1991-12#2)(1992-12#3)(1995-2#2)(1997-5#4)(2007-8#6)(2008-10#1)(2010-5#1)(2011-2#1)
pleural plaques and diffuse pleural thickening##2##6##(1991-12#2)
pleural plaques and##3##3##(1991-12#3)
pleural plaques##6##2##(1991-12#6)
pleural space##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
pleural thickening##3##2##(1991-12#3)
pleural tuberculosis##2##2##(1991-3#1)(1997-3#1)
pleural##144##1##(1990-12#2)(1990-3#1)(1990-5#2)(1991-12#25)(1991-3#2)(1991-6#3)(1991-8#1)(1992-11#2)(1992-12#3)(1992-2#1)(1995-2#2)(1995-6#1)(1996-11#1)(1997-3#1)(1997-4#3)(1997-5#4)(1997-8#1)(2007-12#11)(2007-6#2)(2007-7#4)(2007-8#21)(2008-1#6)(2008-10#5)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#6)
pleurectomy##4##1##(1991-6#1)(2007-8#1)(2008-10#2)
pleurisy and##2##2##(2011-2#1)(2012-2#1)
pleurisy##6##1##(2011-2#4)(2012-2#1)(2013-1#1)
pleuritic chest pain##2##3##(2007-12#1)(2012-2#1)
pleuritis##5##1##(1997-4#1)(2007-12#3)(2010-1#1)
pleuro-pulmonary##2##1##(2007-8#1)(2012-3#1)
pleurodesis##5##1##(1990-9#1)(2006-10#2)(2007-8#1)(2008-1#1)
pleuropneumoniae##4##1##(1996-12#4)
plexiform fibrohistiocytic tumor##2##3##(2007-8#2)
plexiform layer##2##2##(1991-10#1)(2008-4#1)
plexiform##7##1##(1991-10#1)(1996-5#1)(2007-8#4)(2008-4#1)
plexiglass plate##2##2##(1991-12#2)
plexiglass##3##1##(1991-12#3)
plexopathy##4##1##(2008-12#3)(2012-12#1)
plexus and##9##2##(1993-12#2)(1995-12#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2011-2#2)
plexus block##7##2##(2008-7#1)(2009-4#1)(2010-7#2)(2012-2#2)(2012-3#1)
plexus in the##2##3##(1992-3#1)(1996-12#1)
plexus in##6##2##(1992-3#1)(1996-12#1)(2008-9#2)(2009-6#1)(2013-1#1)
plexus injury##5##2##(2008-9#2)(2011-2#2)(2013-1#1)
plexus is##2##2##(1992-3#2)
plexus nerve##2##2##(2008-8#1)(2008-9#1)
plexus neuroma##2##2##(2009-3#2)
plexus of the##2##3##(1996-5#1)(2008-4#1)
plexus of##5##2##(1996-5#1)(1997-1#1)(1997-3#1)(2008-4#1)(2011-2#1)
plexus preparation##2##2##(1990-5#1)(1995-12#1)
plexus were##2##2##(1996-5#1)(2013-8#1)
plexus##109##1##(1990-11#1)(1990-5#2)(1992-3#5)(1993-12#4)(1994-2#1)(1995-12#3)(1996-12#4)(1996-5#6)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#4)(2008-8#5)(2008-9#20)(2009-3#7)(2009-4#1)(2009-6#2)(2010-7#3)(2010-9#1)(2011-2#13)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
plexuses##6##1##(1990-5#1)(2011-2#3)(2013-8#2)
pliability and##2##2##(2008-5#2)
pliability##3##1##(2008-5#2)(2009-9#1)
pliable##2##1##(2007-12#1)(2009-9#1)
plicata##2##1##(2008-6#2)
plicatilis##4##1##(2008-9#2)(2010-3#2)
plication##6##1##(2008-8#1)(2013-1#5)
ploidy analysis##2##2##(2008-6#1)(2008-9#1)
ploidy and##5##2##(1993-1#1)(2007-11#1)(2008-9#3)
ploidy in##3##2##(2008-6#1)(2008-9#1)(2009-2#1)
ploidy level##5##2##(2008-11#1)(2008-5#2)(2008-9#1)(2009-12#1)
ploidy levels##2##2##(2008-5#1)(2010-3#1)
ploidy status##2##2##(1993-1#1)(2008-6#1)
ploidy##36##1##(1991-6#1)(1993-1#2)(1994-11#1)(2007-11#2)(2008-11#1)(2008-5#3)(2008-6#7)(2008-9#10)(2009-12#1)(2009-2#2)(2010-3#5)(2011-1#1)
plot analysis##3##2##(1990-11#1)(1996-12#1)(2008-10#1)
plot and##6##2##(2008-10#3)(2008-12#1)(2010-4#1)(2013-8#1)
plot are##2##2##(1995-5#1)(2008-10#1)
plot at##4##2##(2008-10#3)(2013-7#1)
plot between the##2##3##(2008-10#2)
plot calibration##3##2##(2008-10#2)(2008-3#1)
plot for##4##2##(1992-11#1)(2008-10#2)(2008-6#1)
plot in the fall of##2##5##(2008-10#2)
plot in the##3##3##(2008-10#3)
plot in##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
plot is not##2##3##(1992-5#1)(2008-10#1)
plot is##4##2##(1992-5#1)(2008-10#3)
plot of deltaT versus (1 - RT(-1))##2##7##(2008-3#2)
plot of the##6##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)
plot of##23##2##(1991-5#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2009-11#1)(2012-1#1)
plot revealed that##2##3##(1990-2#1)(2008-11#1)
plot revealed##3##2##(1990-2#1)(2008-11#2)
plot showed##3##2##(2008-10#2)(2011-1#1)
plot to##2##2##(2008-10#2)
plot was linear over the range##2##6##(2008-10#2)
plot was linear##3##3##(2008-10#3)
plot was##12##2##(1990-9#1)(2008-10#8)(2008-12#2)(2013-7#1)
plot with##2##2##(1991-5#1)(2008-10#1)
plot##141##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#82)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#4)(2012-1#1)(2012-7#1)(2013-7#2)(2013-8#2)
plot) for##2##2##(2008-10#2)
plot)##6##1##(2008-10#6)
plots also##2##2##(2008-10#1)(2008-12#1)
plots amended with##4##3##(2008-10#4)
plots and##10##2##(2008-10#6)(2008-12#1)(2008-7#1)(2012-1#1)(2013-1#1)
plots are presented##2##3##(2008-3#1)(2008-8#1)
plots are##7##2##(1992-3#1)(1995-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)
plots at##3##2##(2008-10#2)(2008-12#1)
plots based on##2##3##(2008-8#1)(2013-8#1)
plots by##3##2##(2008-10#3)
plots during##2##2##(2008-10#2)
plots for each##2##3##(1995-3#1)(2008-10#1)
plots for the##2##3##(1995-9#1)(2008-10#1)
plots for##13##2##(1995-3#1)(1995-9#2)(2008-10#8)(2008-3#2)
plots from##2##2##(2007-5#1)(2008-10#1)
plots in the##5##3##(1995-9#1)(2008-10#3)(2008-11#1)
plots in##14##2##(1995-9#1)(2008-10#11)(2008-11#1)(2013-7#1)
plots increased##2##2##(2008-10#2)
plots infected##2##2##(2008-10#2)
plots obtained##2##2##(2008-10#2)
plots of the##12##3##(1994-12#1)(1995-9#1)(2008-10#6)(2008-3#2)(2008-5#1)(2010-12#1)
plots of##33##2##(1990-8#1)(1994-12#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2010-12#1)(2011-3#1)
plots planted with##3##3##(2008-10#3)
plots protected by##2##3##(2008-10#2)
plots provide##2##2##(2008-10#1)(2010-12#1)
plots ranged from##2##3##(2008-10#1)(2011-2#1)
plots ranging from##2##3##(2008-10#2)
plots received##2##2##(2008-10#1)(2008-9#1)
plots showed good##3##3##(2008-10#3)
plots showed##4##2##(2008-10#3)(2010-11#1)
plots sown with##2##3##(2008-10#1)(2008-12#1)
plots than##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
plots that##3##2##(2008-10#3)
plots to determine the##2##4##(2008-10#2)
plots to##5##2##(2008-10#4)(2011-2#1)
plots was##6##2##(2008-10#5)(2011-2#1)
plots were##27##2##(2008-10#23)(2008-12#1)(2008-5#2)(2011-2#1)
plots when##2##2##(2008-10#2)
plots where##6##2##(2008-10#5)(2008-12#1)
plots with four replications##2##4##(2008-10#1)(2008-12#1)
plots with two##2##3##(2008-10#2)
plots with##13##2##(1990-11#1)(2008-10#11)(2008-12#1)
plots##319##1##(1990-11#1)(1990-8#2)(1991-5#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-3#2)(1995-9#7)(1996-5#1)(1997-2#3)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#224)(2008-11#4)(2008-12#16)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-8#1)(2010-11#2)(2010-12#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
plots)##3##1##(2008-10#3)
plotted against the##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
plotted against##8##2##(1990-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
plotted as a##2##3##(1997-6#1)(2008-2#1)
plotted by##2##2##(2008-10#1)(2013-8#1)
plotted##22##1##(1990-7#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
plotting and##2##2##(2008-2#1)(2009-11#1)
plotting of##2##2##(2008-10#1)(2008-5#1)
plotting the##6##2##(2008-10#5)(2010-8#1)
plotting##14##1##(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-8#1)
plow##5##1##(2008-12#5)
plowing depth##4##2##(2008-12#4)
plowing##8##1##(2008-10#1)(2008-12#7)
plucking as##2##2##(1990-3#1)(2008-5#1)
plucking##7##1##(1990-3#1)(1990-9#3)(2008-5#3)
plug and##5##2##(2008-10#2)(2008-3#1)(2009-6#1)(2013-1#1)
plug flow##3##2##(2008-7#2)(2008-9#1)
plug length##2##2##(2009-6#2)
plug of##4##2##(2008-10#2)(2008-4#1)(2013-1#1)
plug speed decreases##2##3##(2009-6#2)
plug test during anoscopy##2##4##(2013-1#2)
plug test##6##2##(2013-1#6)
plug was##5##2##(2008-10#1)(2010-5#1)(2013-1#3)
plug##59##1##(1994-3#1)(2007-10#1)(2007-12#2)(2008-10#16)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#16)(2010-5#3)(2011-2#2)(2013-1#13)
plug-in##2##1##(2008-10#1)(2009-10#1)
plugging##5##1##(1990-10#1)(2008-10#4)
plugs and##3##2##(2008-10#3)
plugs of##2##2##(2008-4#1)(2008-9#1)
plugs were##2##2##(1995-2#1)(2008-11#1)
plugs##15##1##(1995-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#2)(2011-2#1)
plum and peach##2##3##(2008-10#2)
plum ingredient##2##2##(2010-4#2)
plum juice concentrate##2##3##(2010-4#2)
plum##27##1##(2008-10#16)(2010-4#6)(2011-2#5)
plumage##7##1##(1997-3#1)(2008-8#6)
plume is##2##2##(2008-3#2)
plume protection problems##2##3##(1993-3#2)
plume spacing and##2##3##(2008-6#2)
plume spacing##3##2##(2008-6#3)
plume with##2##2##(1996-12#1)(2008-2#1)
plume##24##1##(1993-3#2)(1996-12#1)(2007-12#1)(2008-2#6)(2008-3#11)(2008-6#3)
plumes##14##1##(2007-5#1)(2008-11#1)(2008-2#2)(2008-3#8)(2008-6#1)(2009-6#1)
plumierii##2##1##(2013-7#2)
plump##2##1##(2010-6#2)
plural##2##1##(1994-2#1)(2011-2#1)
pluralism##4##1##(2009-8#4)
pluralistic##4##1##(1994-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
pluripotency##5##1##(2008-11#2)(2008-9#1)(2010-7#1)(2013-1#1)
pluripotent cells##2##2##(2008-11#1)(2010-2#1)
pluripotent stem cell##2##3##(2008-11#1)(2009-3#1)
pluripotent stem cells has##2##4##(2009-3#2)
pluripotent stem cells##14##3##(2008-9#1)(2009-3#7)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-5#1)
pluripotent stem##16##2##(2008-11#1)(2008-9#1)(2009-3#8)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-5#1)
pluripotent##29##1##(1990-5#1)(1992-12#1)(1992-5#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-9#3)(2009-3#8)(2010-10#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-5#2)(2013-1#1)
plus 0##6##2##(1995-12#1)(1996-5#1)(2008-10#4)
plus 1##3##2##(1993-1#1)(1997-1#1)(2008-10#1)
plus 2##7##2##(1990-5#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#2)
plus 35##2##2##(1997-8#1)(2011-2#1)
plus 36##2##2##(1992-4#1)(2008-10#1)
plus 50##2##2##(1995-5#1)(2008-1#1)
plus 7##2##2##(2008-10#1)(2008-5#1)
plus C##4##2##(2008-6#1)(2013-1#3)
plus MPA##4##2##(1995-4#4)
plus P##2##2##(2008-10#2)
plus a signal peptide of##2##5##(1990-2#1)(2008-8#1)
plus a##19##2##(1990-2#1)(1991-2#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-2#2)
plus alemtuzumab##3##2##(2008-12#3)
plus alpha##2##2##(1993-6#1)(2008-7#1)
plus an##5##2##(1993-8#1)(2008-3#1)(2009-10#1)(2009-4#1)(2011-2#1)
plus ascorbate##2##2##(2011-1#2)
plus canola oil##4##3##(2008-10#4)
plus chemotherapy##2##2##(2008-10#1)(2008-11#1)
plus clopidogrel##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
plus endocervical brush##2##3##(2009-6#2)
plus esophagectomy##2##2##(2013-8#2)
plus etoposide##4##2##(1993-8#4)
plus glucose##4##2##(2008-10#3)(2008-7#1)
plus heparin##5##2##(1992-1#4)(1994-6#1)
plus ifosfamide##2##2##(1992-6#1)(2010-3#1)
plus medication##2##2##(2008-3#1)(2012-3#1)
plus other##4##2##(1991-9#1)(2008-12#1)(2008-6#1)(2012-3#1)
plus radiotherapy##2##2##(1991-4#1)(1993-8#1)
plus ribavirin##5##2##(2009-5#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
plus several##2##2##(1991-8#1)(2008-10#1)
plus standard##2##2##(2008-3#1)(2010-8#1)
plus the##11##2##(1993-12#1)(1993-9#1)(1994-5#1)(2008-10#4)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
plus##375##1##(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#6)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#6)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#8)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#4)(1995-3#3)(1995-4#6)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#80)(2008-11#11)(2008-12#7)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#10)(2008-6#10)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#7)(2010-4#3)(2010-8#2)(2011-1#5)(2011-2#25)(2012-12#5)(2012-2#4)(2012-3#8)(2012-6#1)(2013-1#11)(2013-8#4)
plus- and minus-strand##2##3##(2008-9#2)
plus-maze and##3##2##(1993-3#3)
plus-maze experience##3##2##(1992-7#3)
plus-maze test and##2##3##(1994-2#1)(2013-1#1)
plus-maze test##7##2##(1993-3#2)(1994-2#1)(2008-11#2)(2013-1#2)
plus-maze##19##1##(1992-7#6)(1993-3#5)(1994-2#1)(2008-11#5)(2013-1#2)
plus-strand##2##1##(2008-8#2)
pluton##3##1##(2013-8#3)
plutonium##4##1##(2008-10#4)
pluvialis##3##1##(2010-10#3)
plymuthica##3##1##(2008-10#3)
plywood##3##1##(2008-7#3)
pm and 6##2##3##(2008-12#1)(2008-5#1)
pm for##5##2##(1996-2#4)(2007-11#1)
pm##27##1##(1996-2#16)(2007-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2011-2#1)
pm/V was##2##2##(2007-12#2)
pm/V##4##1##(2007-11#1)(2007-12#3)
pmMC##2##1##(2013-8#2)
pmol 3-hydroxyanthranilic acid formed per mg protein per min##2##9##(1991-5#2)
pmol 32P/min/mg##2##2##(1997-6#2)
pmol cm(-2)##2##2##(2008-10#2)
pmol cm-2 s-1##2##3##(1991-5#2)
pmol for##13##2##(1990-8#4)(2008-10#7)(2009-7#2)
pmol l(-1)##4##2##(2008-10#3)(2008-11#1)
pmol of##3##2##(1991-8#2)(2008-10#1)
pmol x h/10(6) PBMC##2##4##(2008-7#2)
pmol x##3##2##(2008-7#2)(2011-3#1)
pmol##47##1##(1990-8#5)(1991-5#5)(1991-8#2)(1993-8#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#4)(2008-10#16)(2008-11#2)(2008-7#3)(2009-7#2)(2010-4#1)(2011-3#1)
pmol)##4##1##(1992-6#1)(1992-8#1)(1994-11#1)(2008-10#1)
pmol/A(260)##2##1##(2008-4#2)
pmol/L##3##1##(2008-1#1)(2008-4#1)(2008-8#1)
pmol/injection##2##1##(2008-10#2)
pmol/l##3##1##(1993-12#2)(2008-7#1)
pmol/l)##3##1##(1992-8#1)(2007-8#1)(2012-12#1)
pmol/mg protein and##2##3##(1990-7#1)(1995-11#1)
pmol/mg protein per min##2##4##(1992-3#2)
pmol/mg protein##8##2##(1990-2#1)(1990-7#1)(1991-12#2)(1992-3#2)(1995-11#2)
pmol/mg protein)##3##2##(1993-11#2)(1994-12#1)
pmol/mg##14##1##(1990-2#1)(1990-7#1)(1991-12#2)(1992-3#3)(1993-11#2)(1994-12#1)(1995-11#2)(2008-8#2)
pmol/min##2##1##(1990-2#1)(1994-12#1)
pmol/ml of##3##2##(1990-8#3)
pmol/ml##4##1##(1990-8#3)(1995-12#1)
pmole/mg protein)##4##2##(2008-11#4)
pmoles of radioligandY mg(-1) protein##2##5##(2008-11#2)
pmoles per mg of membrane protein##2##6##(1990-5#2)
pmoles##4##1##(1990-5#2)(2008-11#2)
pmol·l-1##2##1##(2013-1#2)
pmp##3##1##(2008-4#3)
pnbA gene##2##2##(1994-12#2)
pnbA##4##1##(1994-12#4)
pneumatic dilatation##2##2##(1992-9#2)
pneumatic nebulization##3##2##(2008-10#3)
pneumatic nebulizer##3##2##(2008-10#3)
pneumatic##16##1##(1992-9#3)(2008-10#10)(2012-3#3)
pneumatization in##2##2##(2011-2#2)
pneumatization##4##1##(2011-2#4)
pneumatosis intestinalis##5##2##(2007-5#2)(2012-2#3)
pneumatosis##7##1##(2007-5#2)(2008-12#1)(2012-2#4)
pneumocephalus##8##1##(2008-7#4)(2008-9#1)(2009-6#2)(2011-2#1)
pneumococcal disease in##2##3##(2007-12#1)(2008-10#1)
pneumococcal disease##6##2##(1994-9#4)(2007-12#1)(2008-10#1)
pneumococcal endocarditis##4##2##(1997-2#4)
pneumococcal infections##2##2##(1995-3#1)(1997-2#1)
pneumococcal meningitis##6##2##(1996-3#1)(2007-2#1)(2011-2#4)
pneumococcal polysaccharide vaccine##2##3##(1994-9#2)
pneumococcal vaccination##2##2##(1995-3#1)(2008-9#1)
pneumococcal vaccine##5##2##(1990-9#1)(1994-9#2)(1997-2#1)(2012-12#1)
pneumococcal vaccine]##2##2##(1994-9#1)(2007-6#1)
pneumococcal##46##1##(1990-9#1)(1994-9#11)(1995-3#4)(1996-11#1)(1996-3#1)(1997-2#6)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#7)(2012-12#1)
pneumococci##5##1##(1990-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2009-5#1)
pneumocoele##3##1##(2012-2#3)
pneumocoeles##9##1##(2012-2#9)
pneumocystis##2##1##(1990-6#1)(2007-8#1)
pneumocytes##7##1##(1990-7#2)(1992-11#1)(1994-5#3)(1996-9#1)
pneumolysin##5##1##(2008-10#5)
pneumomediastinum##2##1##(2011-2#1)(2013-8#1)
pneumonectomies##2##1##(2007-8#1)(2008-10#1)
pneumonectomy for##2##2##(2007-10#1)(2008-1#1)
pneumonectomy is##2##2##(1995-11#1)(2007-8#1)
pneumonectomy with##2##2##(2007-8#1)(2009-3#1)
pneumonectomy##17##1##(1990-8#1)(1995-11#1)(2007-10#1)(2007-8#10)(2008-1#2)(2008-6#1)(2009-3#1)
pneumonia (OP)##2##2##(2010-12#1)(2011-2#1)
pneumonia among##2##2##(2013-1#2)
pneumonia and hemorrhagic##3##3##(2010-6#2)(2013-1#1)
pneumonia and##14##2##(1991-12#2)(1991-8#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#2)(2013-1#4)
pneumonia associated with##2##3##(2006-10#1)(2008-5#1)
pneumonia by##2##2##(1990-6#1)(1991-12#1)
pneumonia cases##2##2##(2008-1#1)(2009-5#1)
pneumonia caused by##3##3##(1992-2#1)(2008-5#1)(2011-2#1)
pneumonia complicated by##4##3##(2008-1#4)
pneumonia during##2##2##(1991-9#1)(2008-10#1)
pneumonia in a##2##3##(2008-10#1)(2010-12#1)
pneumonia in adults##2##3##(2010-5#1)(2013-1#1)
pneumonia in##17##2##(1991-12#1)(1991-3#2)(1992-2#1)(1992-5#1)(1996-9#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
pneumonia that##2##2##(2007-7#1)(2013-1#1)
pneumonia with##2##2##(1993-2#1)(2011-2#1)
pneumonia##123##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-3#2)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#3)(1992-6#1)(1993-2#1)(1994-5#1)(1994-6#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2006-10#2)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#12)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#2)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#16)(2013-8#5)
pneumonia)##3##1##(2011-2#2)(2011-3#1)
pneumonia]##3##1##(1992-5#1)(1992-6#1)(1996-9#1)
pneumoniae BLSE##2##2##(2010-4#2)
pneumoniae MGH 78578##2##3##(2010-10#2)
pneumoniae and##14##2##(1992-5#2)(1995-5#1)(1995-8#1)(1997-4#2)(2007-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
pneumoniae fldA gene##2##3##(1997-7#2)
pneumoniae fldA##3##2##(1997-7#3)
pneumoniae gene##2##2##(1997-7#2)
pneumoniae has been##3##3##(2007-10#1)(2007-12#1)(2011-2#1)
pneumoniae has##4##2##(1997-2#1)(2007-10#1)(2007-12#1)(2011-2#1)
pneumoniae in##2##2##(2007-7#1)(2012-12#1)
pneumoniae infection##5##2##(2007-10#2)(2007-11#1)(2007-12#1)(2013-1#1)
pneumoniae is a##2##3##(2007-10#1)(2012-12#1)
pneumoniae is##5##2##(1997-7#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
pneumoniae or##2##2##(1995-5#1)(2007-11#1)
pneumoniae to cefepime##2##3##(2008-7#2)
pneumoniae to##3##2##(2008-7#2)(2013-8#1)
pneumoniae was##3##2##(1995-3#1)(1997-7#1)(2007-10#1)
pneumoniae were##2##2##(2008-8#1)(2012-12#1)
pneumoniae##121##1##(1992-5#5)(1994-11#1)(1994-5#1)(1994-9#4)(1995-3#1)(1995-5#4)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#13)(2006-10#1)(2007-10#6)(2007-11#5)(2007-12#4)(2007-7#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#11)(2008-8#2)(2008-9#3)(2010-10#3)(2010-12#2)(2010-3#2)(2010-4#3)(2010-6#2)(2011-1#1)(2011-2#15)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
pneumoniae)##3##1##(2011-2#2)(2012-3#1)
pneumonic consolidation##2##2##(1997-8#1)(2008-5#1)
pneumonic plague##2##2##(1990-6#2)
pneumonic##7##1##(1990-6#2)(1991-3#1)(1997-8#1)(2008-5#3)
pneumonie varicelleuse du nouveau-né##2##4##(2013-1#2)
pneumonie varicelleuse##3##2##(2013-1#3)
pneumonitis in##2##2##(1990-11#1)(2010-12#1)
pneumonitis##12##1##(1990-11#1)(1991-9#2)(1995-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2010-12#2)(2011-2#1)(2012-12#1)
pneumopathy##2##1##(1996-3#1)(2010-12#1)
pneumoperitoneum with##2##2##(1991-12#1)(2009-8#1)
pneumoperitoneum##11##1##(1991-12#1)(1993-6#3)(2007-5#3)(2009-4#1)(2009-8#1)(2010-5#1)(2011-2#1)
pneumorrhachis##3##1##(2008-12#2)(2009-4#1)
pneumostasis##2##1##(2007-8#2)
pneumothoraces and##2##2##(2010-9#1)(2011-2#1)
pneumothoraces##5##1##(2008-7#1)(2010-9#1)(2011-2#3)
pneumothorax in silicosis##2##3##(2008-7#2)
pneumothorax in##6##2##(2006-10#1)(2007-8#2)(2008-7#2)(2012-3#1)
pneumothorax or##2##2##(2007-11#1)(2013-1#1)
pneumothorax##51##1##(1990-3#1)(1990-5#2)(1991-3#3)(1991-6#3)(2006-10#6)(2007-11#1)(2007-8#11)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#10)(2010-12#1)(2010-8#2)(2012-3#4)(2013-1#2)
pneumothorax]##3##1##(1991-3#1)(2008-1#1)(2008-10#1)
pneumotoxicity##4##1##(1994-5#3)(1995-3#1)
pnp1-1##2##1##(2012-3#2)
poae##2##1##(2008-10#2)
pockels##3##1##(2008-2#2)(2008-3#1)
pocket and##2##2##(1990-8#1)(2007-12#1)
pocket cards##2##2##(2008-3#2)
pocket depth##2##2##(2008-10#1)(2013-1#1)
pocket for##2##2##(1991-2#1)(2007-11#1)
pocket formed by##2##3##(1991-12#1)(1992-4#1)
pocket in##2##2##(2008-8#1)(2008-9#1)
pocket of the##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
pocket of##6##2##(1991-12#1)(1991-8#1)(1995-5#1)(1996-5#1)(2008-10#1)(2013-7#1)
pocket that##2##2##(2010-10#1)(2013-1#1)
pocket##53##1##(1990-8#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-4#2)(1992-8#2)(1994-5#4)(1994-8#1)(1995-11#1)(1995-2#5)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-3#2)(2008-8#6)(2008-9#2)(2010-10#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
pocket-sized##2##1##(1996-2#1)(2008-11#1)
pockets adjacent to##3##3##(2012-12#3)
pockets##15##1##(1990-12#1)(1995-3#1)(1997-4#1)(2007-6#2)(2007-7#1)(2008-10#4)(2008-12#1)(2012-12#4)
pod mottle virus (BPMV)##2##4##(1992-8#1)(2008-10#1)
pod mottle virus##7##3##(1992-8#2)(2008-10#5)
pod mottle##8##2##(1992-8#2)(2008-10#6)
pod yields##4##2##(2008-10#2)(2008-12#2)
pod##21##1##(1992-8#2)(2008-10#12)(2008-12#4)(2010-11#2)(2013-8#1)
podocyte##7##1##(2008-1#2)(2011-2#5)
podocytes##7##1##(2008-1#5)(2008-7#2)
podophyllotoxin from##2##2##(2008-11#2)
podophyllotoxin##12##1##(1991-9#6)(1992-9#1)(2008-11#5)
podophyllum##2##1##(2008-10#2)
podoplanin expression##3##2##(2013-1#3)
podoplanin##8##1##(2013-1#8)
podospirone##2##1##(2008-11#2)
pods (12##2##2##(2008-12#2)
pods ha(-1)##2##2##(2008-12#2)
pods of##2##2##(2008-10#1)(2011-2#1)
pods plant(-1)##3##2##(2008-12#3)
pods was##2##2##(2008-10#1)(2008-12#1)
pods were##2##2##(2008-10#2)
pods##27##1##(2008-10#15)(2008-12#9)(2011-2#2)(2013-8#1)
poinsettia##6##1##(2008-10#5)(2011-2#1)
point (control##2##2##(2008-7#2)
point (the##2##2##(2008-3#1)(2008-9#1)
point 1##2##2##(2008-9#2)
point along the##4##3##(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
point along##5##2##(2007-12#1)(2008-10#2)(2010-12#1)(2011-2#1)
point and interval estimates##2##4##(1994-9#1)(2008-11#1)
point and the##4##3##(2008-10#2)(2008-3#2)
point and##27##2##(1994-9#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
point at the##2##3##(2007-12#1)(2008-10#1)
point at which##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
point at##11##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#1)
point by##4##2##(1995-11#1)(2008-11#2)(2012-12#1)
point can be##3##3##(2007-12#2)(2008-2#1)
point charge##4##2##(1991-9#1)(1996-2#1)(2010-12#2)
point counting##2##2##(2008-4#1)(2011-2#1)
point defects##2##2##(2007-11#1)(2012-2#1)
point diffraction interferometer##4##3##(2008-2#1)(2008-3#3)
point during##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
point estimate of##3##3##(2008-11#1)(2012-3#2)
point estimate##6##2##(2008-11#2)(2012-12#2)(2012-3#2)
point estimates##2##2##(1994-2#1)(1994-9#1)
point extraction (CPE)##3##3##(2008-10#3)
point extraction of lead##2##4##(2008-10#2)
point extraction of##6##3##(2008-10#6)
point extraction was applied##2##4##(2008-10#2)
point extraction was##4##3##(2008-10#4)
point extraction##25##2##(2008-10#25)
point for the##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
point for##34##2##(1992-12#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
point from##2##2##(1991-6#1)(1991-9#1)
point greater##2##2##(1992-6#1)(1995-1#1)
point group##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
point illumination##2##2##(2007-11#1)(2008-3#1)
point image approximation##2##3##(2010-12#2)
point image##3##2##(2010-12#3)
point images##3##2##(2008-3#3)
point in a##2##3##(2008-2#2)
point in the##21##3##(1992-2#1)(1992-4#1)(1994-1#1)(1994-2#1)(1995-11#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-6#1)(2012-2#1)(2013-8#1)
point in their##3##3##(2008-4#1)(2008-9#1)(2009-5#1)
point in time##7##3##(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-9#1)
point in##52##2##(1992-2#1)(1992-4#1)(1993-11#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
point inoculation##3##2##(2008-10#3)
point inside##2##2##(2008-3#1)(2008-7#1)
point into##2##2##(2007-12#1)(2012-2#1)
point is a##2##3##(2007-11#1)(2008-6#1)
point is the##3##3##(1996-3#1)(2008-11#1)(2008-4#1)
point is##28##2##(1994-12#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#2)(2010-6#1)
point mutants##2##2##(1991-10#1)(1995-6#1)
point mutation in the##7##4##(1990-12#1)(1991-2#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-10#2)
point mutation in##9##3##(1990-12#1)(1991-2#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#3)
point mutation of##3##3##(1992-8#1)(1994-12#1)(1995-8#1)
point mutation was##2##3##(1990-8#1)(1992-8#1)
point mutation##30##2##(1990-12#1)(1990-8#1)(1991-2#2)(1991-8#1)(1992-2#1)(1992-8#5)(1993-11#1)(1993-9#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#2)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)
point mutations and inversions##2##4##(2011-2#2)
point mutations and##5##3##(2008-7#1)(2011-1#2)(2011-2#2)
point mutations found in##2##4##(1991-5#1)(1997-6#1)
point mutations in the##6##4##(1991-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(2011-2#1)
point mutations in##10##3##(1991-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
point mutations of the##2##4##(1994-11#1)(2008-10#1)
point mutations of##3##3##(1991-5#1)(1994-11#1)(2008-10#1)
point mutations that##2##3##(1993-11#1)(2010-8#1)
point mutations##39##2##(1991-12#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-8#1)(2011-1#5)(2011-2#3)
point of 2##2##3##(1997-2#1)(2012-2#1)
point of a##8##3##(1992-12#1)(2007-12#1)(2008-3#3)(2008-6#1)(2011-2#1)(2012-2#1)
point of care##5##3##(1997-2#1)(1997-3#1)(2008-11#1)(2009-5#1)(2010-8#1)
point of departure for##4##4##(1991-12#1)(2007-7#1)(2008-11#1)(2012-2#1)
point of interest##2##3##(2008-3#2)
point of no return&quot##2##4##(2008-11#2)
point of no##3##3##(2008-11#3)
point of service##2##3##(1996-1#1)(1996-3#1)
point of the##36##3##(1990-10#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
point of this##2##3##(2007-8#1)(2008-10#1)
point of view and##4##4##(1992-6#1)(2007-10#1)(2007-8#1)(2010-12#1)
point of view of##22##4##(1990-3#1)(1991-2#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-12#1)(2009-9#1)(2013-8#2)
point of view##84##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#4)(2013-8#6)
point of##209##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#36)(2008-11#12)(2008-12#1)(2008-2#7)(2008-3#15)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#9)(2013-1#6)(2013-8#11)
point on the##11##3##(1991-5#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#2)
point on##13##2##(1991-5#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-7#2)(2011-1#1)
point or##3##2##(1991-12#1)(2008-6#1)(2011-2#1)
point out that the##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
point out that##8##3##(1990-2#1)(1992-5#1)(2007-11#2)(2008-10#1)(2008-2#2)(2012-2#1)
point out the need for##2##5##(2007-10#1)(2012-3#1)
point out the need##3##4##(1991-8#1)(2007-10#1)(2012-3#1)
point out the##8##3##(1991-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
point out to##2##3##(2008-10#1)(2010-4#1)
point out##28##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-5#1)(1996-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)
point patterns##2##2##(2008-10#2)
point prevalence of##2##3##(1990-6#1)(2011-1#1)
point prevalence##4##2##(1990-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
point source and##2##3##(2007-12#1)(2008-3#1)
point source is##3##3##(2008-3#3)
point source##23##2##(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#11)
point sources##5##2##(2008-3#3)(2011-2#2)
point spread function##2##3##(2008-6#1)(2011-1#1)
point temperature##4##2##(2008-10#3)(2008-2#1)
point the way##2##3##(2008-1#1)(2010-3#1)
point the##6##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-3#1)
point to a correlation between##2##5##(2008-10#1)(2008-7#1)
point to a##9##3##(1991-5#1)(1993-12#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-3#1)(2013-8#1)
point to an##5##3##(1991-11#1)(1991-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
point to be##2##3##(2008-12#1)(2008-2#1)
point to new##2##3##(2008-6#1)(2012-2#1)
point to the importance of##3##5##(1991-6#1)(1995-2#1)(2008-5#1)
point to the necessity of##2##5##(1997-4#1)(2007-12#1)
point to the need for a##2##6##(2008-2#1)(2011-2#1)
point to the need for##6##5##(1991-3#1)(1994-2#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)
point to the need##7##4##(1991-3#1)(1994-2#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-3#1)
point to the##22##3##(1990-6#1)(1991-3#1)(1991-6#2)(1992-11#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#3)(2012-3#1)
point to##67##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-3#2)(1996-2#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-5#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
point two##2##2##(2013-1#2)
point was 6##2##3##(2009-2#1)(2011-1#1)
point was the##2##3##(2008-10#1)(2008-2#1)
point was##15##2##(1991-6#1)(1992-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
point were##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
point where the##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-9#1)
point where they##2##3##(2007-12#1)(2010-3#1)
point where##12##2##(1992-3#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-9#1)(2011-1#1)
point which##2##2##(2008-12#1)(2011-2#1)
point with the##2##3##(2008-10#1)(2012-2#1)
point with##5##2##(2008-10#2)(2008-3#1)(2012-2#1)(2013-7#1)
point within##2##2##(2008-6#1)(2012-2#1)
point##999##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#2)(1991-5#5)(1991-6#7)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#6)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#8)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#7)(1996-5#5)(1996-6#1)(1997-2#3)(1997-3#6)(1997-4#4)(1997-6#5)(1997-7#2)(2006-10#1)(2006-4#1)(2007-10#7)(2007-11#24)(2007-12#28)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#179)(2008-11#41)(2008-12#9)(2008-2#51)(2008-3#91)(2008-4#11)(2008-5#15)(2008-6#17)(2008-7#29)(2008-8#15)(2008-9#16)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#10)(2009-3#3)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#10)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#9)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#15)(2011-10#1)(2011-2#33)(2011-3#2)(2012-1#2)(2012-12#11)(2012-2#26)(2012-3#10)(2012-8#1)(2013-1#29)(2013-7#7)(2013-8#20)
point&quot##2##1##(1991-4#1)(2008-8#1)
point)##5##1##(2008-10#1)(2008-2#1)(2009-8#1)(2010-5#1)(2011-2#1)
point-by-point##2##1##(2007-12#1)(2008-3#1)
point-diffraction interferometer##10##2##(2007-12#2)(2008-3#8)
point-diffraction interferometry##3##2##(2008-3#3)
point-diffraction##13##1##(2007-12#2)(2008-3#11)
point-of-care##10##1##(1996-1#1)(2008-12#1)(2008-6#3)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
point-of-service##5##1##(1991-3#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-10#1)
point-prevalence##2##1##(1992-2#1)(2013-8#1)
point-source##4##1##(2008-2#1)(2008-3#3)
point-spread function (PSF) of##2##4##(2008-3#2)
point-spread function (PSF)##6##3##(2008-2#1)(2008-3#5)
point-spread function and##4##3##(2007-12#1)(2008-3#3)
point-spread function by##2##3##(2007-12#1)(2008-2#1)
point-spread function in##3##3##(2007-11#1)(2008-3#2)
point-spread function is##5##3##(2008-3#5)
point-spread function##28##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#20)
point-spread functions##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
point-spread##35##1##(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#25)
point-to-point##9##1##(1997-3#1)(2007-10#1)(2008-2#1)(2008-3#6)
pointed at##2##2##(2008-10#1)(2008-3#1)
pointed in##2##2##(1990-7#1)(2008-6#1)
pointed out as##2##3##(2008-10#1)(2008-12#1)
pointed out that the##2##4##(2008-10#2)
pointed out that##7##3##(1995-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)
pointed out##31##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-6#1)(1991-8#1)(1995-4#1)(1996-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
pointed to a##2##3##(2008-2#1)(2009-10#1)
pointed to the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
pointed to##8##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2011-1#1)(2012-2#1)
pointed toward the##2##3##(1996-2#1)(2012-2#1)
pointed##51##1##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-6#1)(1991-8#1)(1994-1#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
pointing by captive##2##3##(2007-12#2)
pointing by##3##2##(2007-12#3)
pointing errors##3##2##(1990-11#1)(2008-3#2)
pointing jitter##3##2##(2008-2#3)
pointing out the##2##3##(2009-10#1)(2011-2#1)
pointing out##5##2##(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
pointing system##2##2##(2008-2#2)
pointing to a role##2##4##(1991-9#1)(2008-4#1)
pointing to a##3##3##(1991-9#1)(2008-4#1)(2012-12#1)
pointing to the##4##3##(1994-5#1)(2008-10#1)(2009-8#1)(2010-2#1)
pointing to##17##2##(1990-8#1)(1991-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-12#2)(2012-2#1)
pointing toward##2##2##(1994-5#1)(2009-11#1)
pointing##56##1##(1990-11#3)(1990-8#1)(1991-9#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-12#6)(2008-10#1)(2008-2#10)(2008-3#11)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
pointlike##6##1##(2007-12#1)(2008-3#5)
points (p##2##2##(2008-3#1)(2008-9#1)
points about the##2##3##(2008-10#1)(2008-3#1)
points after##3##2##(2007-11#1)(2011-3#1)(2012-1#1)
points along a##2##3##(2007-11#1)(2008-10#1)
points along the##3##3##(2008-10#1)(2009-2#1)(2011-2#1)
points along##7##2##(2007-11#2)(2008-10#2)(2009-2#1)(2011-2#2)
points and in##2##3##(1997-3#1)(2011-2#1)
points and##24##2##(1997-3#2)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-9#1)(2010-2#3)(2011-2#3)(2012-1#1)(2012-4#1)(2013-1#3)
points are##10##2##(1990-7#1)(1996-6#1)(2007-10#1)(2008-2#2)(2008-3#2)(2008-6#2)(2009-9#1)
points at##2##2##(2008-10#1)(2010-8#1)
points between##3##2##(2008-11#1)(2008-3#1)(2010-10#1)
points by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
points can be##2##3##(2009-11#1)(2009-7#1)
points during the##3##3##(2010-2#1)(2011-2#1)(2012-1#1)
points during##4##2##(2007-2#1)(2010-2#1)(2011-2#1)(2012-1#1)
points evaluated##3##2##(2007-11#2)(2008-5#1)
points for a##2##3##(2007-11#1)(2008-4#1)
points for the##5##3##(1990-11#1)(2007-12#1)(2007-8#1)(2009-2#1)(2011-2#1)
points for##19##2##(1990-11#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#2)(2010-8#1)(2011-2#3)
points from##6##2##(1992-2#1)(2007-12#1)(2008-4#1)(2010-11#1)(2012-1#1)(2013-1#1)
points in a##7##3##(1990-11#1)(1991-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
points in the phase##2##4##(2007-12#1)(2008-3#1)
points in the##19##3##(1992-2#1)(1992-6#1)(1994-12#1)(1995-6#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)(2010-1#1)(2011-1#1)(2013-1#1)
points in time##6##3##(1992-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)
points in##55##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-6#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-8#1)(1997-3#2)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#5)(2008-6#4)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#2)(2013-1#5)(2013-7#1)
points is presented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
points is the##2##3##(1990-8#1)(2008-10#1)
points is##13##2##(1990-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2012-2#1)
points more##3##2##(2008-10#1)(2013-1#2)
points of a##2##3##(2007-11#1)(2008-3#1)
points of contact between##2##4##(2010-12#2)
points of contact##3##3##(2009-5#1)(2010-12#2)
points of the##16##3##(1993-6#1)(1995-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-3#1)(2009-8#1)
points of these##2##3##(2008-10#1)(2008-9#1)
points of view and##2##4##(2008-7#1)(2011-2#1)
points of view##19##3##(1990-11#1)(1990-2#1)(1991-6#1)(1993-11#1)(1993-2#1)(1996-1#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#3)
points of##85##2##(1990-11#1)(1990-2#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#2)(2006-4#1)(2007-1#1)(2007-11#6)(2007-12#3)(2007-6#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#6)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#8)
points on a##3##3##(2008-3#1)(2008-6#2)
points on the##4##3##(2008-12#1)(2008-3#3)
points on##11##2##(2008-12#1)(2008-3#4)(2008-6#2)(2009-11#1)(2009-2#1)(2012-12#2)
points only##2##2##(2007-12#1)(2009-2#1)
points out some##2##3##(1995-2#1)(2007-11#1)
points out that the##2##4##(2008-7#1)(2011-2#1)
points out that##6##3##(1994-12#1)(1996-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
points out the##11##3##(1991-9#1)(1992-1#1)(1993-6#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
points out##23##2##(1991-9#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#2)
points postoperatively##3##2##(2008-3#1)(2013-1#2)
points regarding the##2##3##(1995-1#1)(2010-10#1)
points showed that##2##3##(1997-6#1)(2007-5#1)
points showed##3##2##(1997-6#1)(2007-5#1)(2011-2#1)
points that are##3##3##(2008-3#3)
points that##8##2##(1991-2#1)(2007-11#1)(2008-11#1)(2008-3#3)(2009-8#1)(2012-1#1)
points the##2##2##(2007-11#1)(2012-12#1)
points to a##7##3##(1990-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)
points to consider in##2##4##(2008-4#1)(2012-12#1)
points to consider##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
points to the existence of a##2##6##(1993-9#1)(1994-6#1)
points to the existence of##3##5##(1993-9#1)(1994-6#1)(2009-8#1)
points to the image##2##4##(2008-12#1)(2010-5#1)
points to the involvement of##3##5##(2008-11#1)(2008-4#1)(2013-8#1)
points to the need for##3##5##(1991-6#1)(1995-5#1)(2006-10#1)
points to the need##4##4##(1991-6#1)(1995-5#1)(1997-2#1)(2006-10#1)
points to the possibility##2##4##(1996-12#1)(2008-10#1)
points to the##19##3##(1991-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
points to##44##2##(1990-5#1)(1990-8#1)(1991-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
points towards##3##2##(1995-12#1)(2007-7#1)(2008-7#1)
points was##8##2##(1996-7#1)(2008-10#2)(2009-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
points were##15##2##(1994-11#1)(1995-5#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
points where##2##2##(2008-3#1)(2010-4#1)
points with##9##2##(1993-2#1)(2008-10#2)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
points##612##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#4)(1992-2#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#37)(2007-12#15)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#72)(2008-11#14)(2008-12#9)(2008-2#29)(2008-3#58)(2008-4#23)(2008-5#12)(2008-6#18)(2008-7#14)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#12)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-10#1)(2011-2#26)(2011-3#1)(2012-1#9)(2012-12#8)(2012-2#10)(2012-3#7)(2012-4#2)(2013-1#39)(2013-7#6)(2013-8#6)
points'##2##1##(2008-10#1)(2009-10#1)
points)##18##1##(1996-3#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#7)(2009-11#1)(2009-2#1)
points]##2##1##(1997-8#1)(2013-8#1)
pointwise detector##2##2##(2008-2#2)
pointwise##3##1##(2008-2#3)
poised at##2##2##(2008-10#2)
poised##6##1##(1994-12#1)(1996-2#1)(1996-3#1)(2008-10#2)(2013-8#1)
poison glands##2##2##(2007-12#2)
poison##11##1##(1995-11#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-12#1)
poisoned by##3##2##(1991-11#1)(1997-3#1)(2008-10#1)
poisoned##5##1##(1991-11#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)
poisoning and##3##2##(1992-5#1)(2012-2#2)
poisoning as##3##2##(1995-3#1)(1997-4#1)(2010-5#1)
poisoning by##5##2##(1990-9#1)(1993-2#1)(1995-11#1)(1997-3#1)(2008-10#1)
poisoning in a##3##3##(1995-11#1)(2010-11#1)(2011-2#1)
poisoning in children##2##3##(1990-3#1)(1991-8#1)
poisoning in the##2##3##(1997-4#1)(2011-2#1)
poisoning in##12##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1995-11#1)(1997-4#1)(2008-11#1)(2010-11#1)(2011-2#2)(2012-12#1)
poisoning is##4##2##(1991-9#2)(1997-6#1)(2009-11#1)
poisoning of the##2##3##(1997-3#1)(2008-10#1)
poisoning of##5##2##(1990-9#1)(1997-3#1)(1997-4#2)(2008-10#1)
poisoning treated with##2##3##(2008-1#1)(2012-2#1)
poisoning with organophosphate##2##3##(1997-7#1)(2013-1#1)
poisoning with the most common##2##5##(2011-2#2)
poisoning with##6##2##(1991-11#1)(1997-7#1)(2008-1#1)(2011-2#2)(2013-1#1)
poisoning##101##1##(1990-3#2)(1990-5#6)(1990-6#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-5#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-11#2)(1995-3#2)(1995-9#1)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#3)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2009-11#3)(2009-2#1)(2010-11#1)(2010-12#1)(2010-5#3)(2011-2#11)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
poisoning]##6##1##(1990-9#1)(1991-11#1)(1996-3#1)(1997-5#1)(2009-5#1)(2013-8#1)
poisonings##6##1##(1996-3#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
poisonous##6##1##(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
poisons##3##1##(1990-9#1)(1996-2#1)(2008-10#1)
poisson##2##1##(1997-8#1)(2008-8#1)
pokeweed antiviral protein (PAP)##2##4##(2008-10#1)(2008-8#1)
pokeweed antiviral protein##3##3##(2008-10#1)(2008-8#2)
pokeweed mitogen##2##2##(1997-6#1)(2011-2#1)
pokeweed##6##1##(1997-6#1)(2008-10#2)(2008-8#2)(2011-2#1)
pol I##4##2##(1992-6#1)(1997-8#2)(2010-2#1)
pol alpha##4##2##(1995-2#4)
pol delta##2##2##(1995-2#2)
pol##15##1##(1992-6#1)(1994-12#1)(1995-2#7)(1997-8#2)(2008-11#2)(2009-8#1)(2010-2#1)
polar I-compounds##2##2##(1992-11#2)
polar PIN##2##2##(2009-10#2)
polar and non-polar##2##3##(2008-10#2)
polar and nonpolar##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
polar and##11##2##(1992-6#1)(2008-10#5)(2008-11#1)(2009-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
polar bear##4##2##(1996-12#1)(2008-2#3)
polar cave##2##2##(1992-3#2)
polar compounds##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
polar coordinate system##2##3##(2008-3#2)
polar environment##4##2##(1992-3#1)(1994-5#1)(1995-2#1)(2012-2#1)
polar groups##2##2##(2008-10#1)(2008-5#1)
polar growth##3##2##(2008-10#1)(2009-8#2)
polar head groups##2##3##(1994-3#1)(2008-11#1)
polar head##4##2##(1990-2#1)(1990-5#1)(1994-3#1)(2008-11#1)
polar headgroups##2##2##(1990-11#1)(1990-7#1)
polar inner-layer##2##2##(2008-10#2)
polar interactions##3##2##(1991-9#1)(2008-10#2)
polar lipid##3##2##(1992-10#1)(1995-2#1)(2008-5#1)
polar lipids##7##2##(1992-10#1)(2008-11#3)(2008-5#1)(2011-2#1)(2013-1#1)
polar nephelometer##3##2##(2007-11#1)(2008-3#2)
polar nucleus##2##2##(2009-12#2)
polar oils##2##2##(2008-5#2)
polar organic##2##2##(2007-11#1)(2008-10#1)
polar orientation##2##2##(2007-11#2)
polar segment##2##2##(2008-3#2)
polar solvents##5##2##(1997-7#2)(2008-10#3)
polar stationary##2##2##(2008-10#1)(2008-5#1)
polar stratosphere##4##2##(1991-5#3)(2008-2#1)
polar stratospheric clouds on##2##4##(2008-3#2)
polar stratospheric clouds##5##3##(1991-5#2)(2008-3#3)
polar surface area##3##3##(1992-5#3)
polar surface##7##2##(1992-5#6)(2008-10#1)
polar targeting##2##2##(2009-10#2)
polar vortex##2##2##(1991-5#2)
polar##184##1##(1990-11#3)(1990-2#4)(1990-5#1)(1990-7#1)(1991-5#11)(1991-9#1)(1992-10#3)(1992-11#3)(1992-3#3)(1992-5#6)(1992-6#4)(1993-11#1)(1994-3#1)(1994-5#2)(1995-2#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#6)(2007-12#7)(2008-10#40)(2008-11#9)(2008-2#8)(2008-3#12)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#7)(2009-12#6)(2009-2#1)(2009-6#1)(2009-8#3)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
polarimeter are##2##2##(2008-3#2)
polarimeter for##3##2##(2008-2#1)(2008-3#2)
polarimeter is##3##2##(2008-2#1)(2008-3#2)
polarimeter was set up##2##4##(2008-2#1)(2008-3#1)
polarimeter was##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polarimeter with##2##2##(2008-3#2)
polarimeter##30##1##(2007-11#1)(2007-12#2)(2008-2#10)(2008-3#17)
polarimeters##6##1##(2007-12#1)(2008-3#5)
polarimetric detection##2##2##(2008-10#2)
polarimetric fiber laser##2##3##(2007-12#2)
polarimetric images##2##2##(2008-6#2)
polarimetric information##2##2##(2008-3#2)
polarimetric pressure##3##2##(2008-2#2)(2010-4#1)
polarimetric strain sensor##2##3##(2007-12#2)
polarimetric##33##1##(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#4)(2008-3#12)(2008-6#3)(2010-4#2)
polarimetry and##2##2##(2008-2#1)(2008-3#1)
polarimetry##17##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#14)
polarisation##4##1##(1996-12#1)(2008-10#3)
polariscope##6##1##(2008-2#1)(2008-3#5)
polariscopes##2##1##(2008-3#2)
polarised Ca(2+)-dependence of the paracellular barrier##2##6##(1994-6#2)
polarised##8##1##(1994-6#5)(2008-10#1)(2008-11#1)(2010-5#1)
polarities##4##1##(1992-10#2)(2008-10#2)
polariton##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
polarity and##8##2##(1990-5#1)(2007-12#1)(2008-10#4)(2010-2#1)(2011-2#1)
polarity are##2##2##(2008-10#1)(2008-7#1)
polarity establishment##2##2##(2009-8#2)
polarity in the##2##3##(1994-6#1)(2009-8#1)
polarity in##5##2##(1990-5#1)(1994-6#1)(2008-9#1)(2009-10#1)(2009-8#1)
polarity is##3##2##(2008-1#1)(2008-9#1)(2009-5#1)
polarity of the##7##3##(1991-5#2)(2007-12#1)(2008-10#3)(2008-5#1)
polarity of this##2##3##(2008-10#1)(2008-7#1)
polarity of##11##2##(1991-5#2)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
polarity proteins##3##2##(2008-9#1)(2012-2#2)
polarity to##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
polarity##95##1##(1990-5#4)(1991-5#3)(1993-12#3)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#9)(2008-1#1)(2008-10#27)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#6)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)
polarizability of##4##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
polarizability##10##1##(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2010-5#1)
polarizable##2##1##(1995-5#1)(2011-3#1)
polarization Sagnac interferometer##2##3##(2007-12#2)
polarization amplitude and the phase##2##5##(2008-2#2)
polarization analysis##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
polarization and anisotropy##4##3##(2008-10#4)
polarization and the##2##3##(2008-2#2)
polarization and##22##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
polarization angle of the##2##4##(2007-12#1)(2008-3#1)
polarization angle##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
polarization angles##2##2##(2008-3#2)
polarization anisotropy##3##2##(1991-3#1)(2007-12#1)(2008-3#1)
polarization are##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2012-1#1)
polarization as well as##2##4##(2008-3#2)
polarization at the zenith##2##4##(2008-2#2)
polarization at the##4##3##(2008-2#4)
polarization at##9##2##(1994-3#1)(1997-6#1)(2007-12#1)(2008-2#4)(2008-3#2)
polarization beam splitter and quarter-wave plates##2##6##(2008-3#2)
polarization beam splitter##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
polarization can be##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
polarization can##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
polarization changing##3##2##(2008-2#3)
polarization characteristics of a##2##4##(2008-2#1)(2008-3#1)
polarization characteristics of##6##3##(2007-11#1)(2008-2#4)(2008-3#1)
polarization characteristics##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
polarization components that are##2##4##(2007-12#2)
polarization components##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
polarization configurations##4##2##(2007-12#1)(2008-3#1)(2013-8#2)
polarization controller##3##2##(2007-12#2)(2008-3#1)
polarization conversion##2##2##(2007-12#1)(2008-3#1)
polarization converter##4##2##(2008-2#2)(2008-3#2)
polarization correlations##2##2##(2007-11#1)(2008-3#1)
polarization data##4##2##(1995-5#1)(2008-2#1)(2008-3#2)
polarization dependence of the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
polarization dependence of##8##3##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#2)
polarization dependence##11##2##(2007-11#5)(2007-12#2)(2008-2#2)(2008-3#2)
polarization detection##2##2##(2008-2#1)(2008-4#1)
polarization difference##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
polarization direction of the##2##4##(2008-2#1)(2008-3#1)
polarization direction of##4##3##(2008-2#2)(2008-3#2)
polarization direction##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
polarization directions##3##2##(2007-11#2)(2008-2#1)
polarization discrimination##3##2##(2007-12#1)(2008-3#2)
polarization effects in##2##3##(2007-12#1)(2008-2#1)
polarization effects##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
polarization eigenmodes##3##2##(2008-2#3)
polarization eigenstates is##2##3##(2008-3#2)
polarization eigenstates##4##2##(2008-3#4)
polarization evolution##2##2##(2007-12#2)
polarization extinction ratio##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
polarization for##5##2##(2008-2#1)(2008-3#4)
polarization gating##2##2##(2007-11#2)
polarization gratings##2##2##(2008-3#2)
polarization holography##4##2##(2007-11#1)(2008-3#3)
polarization imaging##6##2##(2008-3#2)(2009-10#1)(2011-1#3)
polarization in spectral##3##3##(2008-3#3)
polarization in##7##2##(2008-2#2)(2008-3#5)
polarization insensitive##2##2##(2007-11#1)(2008-2#1)
polarization interferometric##2##2##(2007-11#1)(2008-3#1)
polarization interferometry##2##2##(2007-11#1)(2008-3#1)
polarization is##13##2##(2008-2#4)(2008-3#9)
polarization length##2##2##(1997-6#2)
polarization lidar and##2##3##(2008-2#1)(2008-3#1)
polarization lidar##7##2##(2008-2#2)(2008-3#5)
polarization may##2##2##(2007-12#1)(2011-2#1)
polarization measurement is##2##3##(2007-11#1)(2007-12#1)
polarization measurement##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
polarization measurements##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
polarization microscopy##4##2##(2008-1#1)(2008-3#2)(2012-3#1)
polarization mode dispersion (PMD)##7##4##(2007-11#5)(2007-12#2)
polarization mode dispersion in##2##4##(2007-12#2)
polarization mode dispersion of##2##4##(2007-11#2)
polarization mode dispersion##22##3##(2007-11#13)(2007-12#9)
polarization mode##24##2##(2007-11#14)(2007-12#10)
polarization modes##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
polarization modulation##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
polarization modulators##2##2##(2008-2#1)(2008-3#1)
polarization multiplexing##3##2##(2007-12#1)(2008-3#2)
polarization noise##2##2##(2008-2#2)
polarization of light##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
polarization of the incident laser beam##2##6##(2008-3#2)
polarization of the incident##3##4##(2007-11#1)(2008-3#2)
polarization of the##20##3##(2007-11#2)(2008-2#6)(2008-3#11)(2008-8#1)
polarization of##49##2##(1990-2#1)(1991-5#1)(1993-5#1)(1995-8#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#11)(2008-3#19)(2008-4#1)(2008-8#1)(2008-9#3)(2012-2#2)
polarization on the##2##3##(2007-12#1)(2008-3#1)
polarization on##3##2##(2007-12#1)(2008-3#2)
polarization or##2##2##(2008-3#1)(2008-4#1)
polarization orientation of the reference beam##2##6##(2008-3#2)
polarization orientation of the##3##4##(2008-3#3)
polarization orientation)##2##2##(2008-2#2)
polarization over a##2##3##(2008-3#2)
polarization over##3##2##(2008-2#1)(2008-3#2)
polarization parallel##2##2##(2007-12#1)(2008-2#1)
polarization patterns from##2##3##(2008-2#1)(2008-3#1)
polarization patterns##4##2##(2008-2#3)(2008-3#1)
polarization preservation of##2##3##(2008-2#2)
polarization properties of##13##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#6)(2011-1#1)
polarization properties##17##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#7)(2011-1#1)
polarization pulse shaping##2##3##(2007-11#2)
polarization pulse##4##2##(2007-11#4)
polarization purity##2##2##(2007-11#1)(2008-2#1)
polarization rotation##10##2##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#3)
polarization rotator##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
polarization self-modulation in vertical-cavity surface-emitting lasers##3##6##(2007-11#3)
polarization self-modulation##6##2##(2007-11#5)(2007-12#1)
polarization sensitivity on the##2##4##(2008-2#2)
polarization sensitivity##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
polarization signature##3##2##(2007-11#2)(2008-3#1)
polarization spectroscopy of##2##3##(2008-3#2)
polarization spectroscopy##5##2##(1994-6#1)(2007-12#1)(2008-3#3)
polarization state in##2##3##(2008-2#1)(2008-3#1)
polarization state is##2##3##(2007-12#1)(2008-3#1)
polarization state of the##7##4##(2007-12#1)(2008-2#2)(2008-3#4)
polarization state of##16##3##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#8)
polarization state##26##2##(2007-11#4)(2007-12#6)(2008-2#6)(2008-3#10)
polarization states and##2##3##(2008-3#2)
polarization states during##2##3##(2007-11#1)(2007-12#1)
polarization states in##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
polarization states##19##2##(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#8)(2013-7#1)
polarization switching in##2##3##(2007-12#2)
polarization switching is##2##3##(2007-12#2)
polarization switching##5##2##(2007-12#5)
polarization techniques##4##2##(1991-5#1)(2008-10#2)(2008-3#1)
polarization that##2##2##(2008-3#2)
polarization the##3##2##(2007-11#2)(2008-3#1)
polarization to##4##2##(1990-12#1)(2008-3#3)
polarization was##2##2##(2008-3#1)(2008-7#1)
polarization were##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
polarization with##2##2##(2007-12#1)(2008-2#1)
polarization##642##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#2)(1993-5#1)(1993-8#3)(1994-3#1)(1994-6#1)(1995-5#3)(1995-8#1)(1996-2#1)(1997-6#3)(2007-11#97)(2007-12#103)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#133)(2008-3#230)(2008-4#6)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#6)
polarization-channel and the scattering-angle dependence##2##5##(2008-3#2)
polarization-conversion bands##2##2##(2007-11#2)
polarization-conversion##3##1##(2007-11#3)
polarization-coupled##3##1##(2007-11#2)(2007-12#1)
polarization-dependent gain##2##2##(2008-3#2)
polarization-dependent loss of##2##3##(2007-11#1)(2008-3#1)
polarization-dependent loss##6##2##(2007-11#4)(2008-3#2)
polarization-dependent losses##3##2##(2007-11#1)(2007-12#2)
polarization-dependent##24##1##(2007-11#8)(2007-12#4)(2008-2#1)(2008-3#11)
polarization-division multiplexing##2##2##(2007-12#2)
polarization-insensitive##9##1##(2007-12#4)(2008-2#4)(2008-3#1)
polarization-maintaining fiber##2##2##(2007-11#2)
polarization-maintaining fibers##2##2##(2007-11#1)(2008-3#1)
polarization-maintaining##10##1##(2007-11#6)(2008-3#4)
polarization-mode dispersion (PMD)##2##3##(2007-11#1)(2008-3#1)
polarization-mode dispersion##5##2##(2007-11#1)(2008-3#4)
polarization-mode##6##1##(2007-11#1)(2007-12#1)(2008-3#4)
polarization-modulated grating##2##2##(2007-12#2)
polarization-modulated##5##1##(2007-12#3)(2008-3#2)
polarization-preserving##3##1##(2007-11#3)
polarization-resolved##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
polarization-selective diffractive phase elements##5##4##(2008-3#5)
polarization-selective diffractive##6##2##(2008-2#1)(2008-3#5)
polarization-selective##8##1##(2008-2#1)(2008-3#7)
polarization-sensitive detection##2##2##(2007-11#1)(2007-12#1)
polarization-sensitive optical coherence tomography (OCT) system##2##6##(2007-12#1)(2008-3#1)
polarization-sensitive optical coherence tomography##10##4##(2007-11#3)(2007-12#5)(2008-3#2)
polarization-sensitive optical##12##2##(2007-11#4)(2007-12#6)(2008-3#2)
polarization-sensitive##18##1##(2007-11#5)(2007-12#9)(2008-2#2)(2008-3#2)
polarization-state##7##1##(2007-11#2)(2007-12#2)(2008-3#3)
polarizations and##3##2##(2007-12#1)(2008-3#2)
polarizations are##2##2##(2007-12#1)(2008-10#1)
polarizations is##2##2##(2008-2#1)(2008-3#1)
polarizations of the##6##3##(2007-11#1)(2007-12#2)(2008-3#2)(2008-4#1)
polarizations of##11##2##(2007-11#2)(2007-12#3)(2008-3#4)(2008-4#1)(2008-9#1)
polarizations##30##1##(2007-11#6)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-9#1)
polarize the##2##2##(2008-10#1)(2009-10#1)
polarized Caco-2 cell monolayers##2##4##(2007-12#2)
polarized Gaussian beam##3##3##(2007-12#2)(2008-3#1)
polarized Gaussian##4##2##(2007-12#2)(2008-3#2)
polarized absorption spectra##2##3##(2008-10#1)(2008-3#1)
polarized and##6##2##(2007-11#3)(2008-2#2)(2010-8#1)
polarized at##5##2##(2008-10#4)(2008-3#1)
polarized beam of##2##3##(2007-12#1)(2008-10#1)
polarized beam##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
polarized beams##9##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#4)
polarized by##2##2##(2008-10#1)(2008-3#1)
polarized component##2##2##(2007-11#1)(2008-3#1)
polarized components of##2##3##(2007-11#1)(2008-2#1)
polarized components##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
polarized field##2##2##(2007-12#2)
polarized fluorescence##4##2##(2007-11#3)(2008-3#1)
polarized fundamental##2##2##(2007-12#2)
polarized growth in##2##3##(2009-8#2)
polarized growth##4##2##(2009-8#4)
polarized incident light##3##3##(2008-2#2)(2008-3#1)
polarized laser beam##4##3##(2008-2#1)(2008-3#3)
polarized laser##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
polarized lidar technique##2##3##(2008-3#2)
polarized lidar##4##2##(2008-3#4)
polarized light and##3##3##(2007-11#1)(2008-3#2)
polarized light by##2##3##(2007-12#2)
polarized light in##2##3##(2008-2#1)(2008-3#1)
polarized light is##2##3##(2007-12#1)(2008-3#1)
polarized light propagation in##2##4##(2008-3#2)
polarized light to##2##3##(2007-11#1)(2008-2#1)
polarized light with##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
polarized light##50##2##(2007-11#5)(2007-12#9)(2008-2#9)(2008-3#24)(2008-5#1)(2010-12#2)
polarized object beam##2##3##(2007-12#2)
polarized optical##2##2##(2008-10#1)(2008-3#1)
polarized output##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
polarized perpendicular##2##2##(2008-2#1)(2008-3#1)
polarized pump##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
polarized radiance##3##2##(2008-2#1)(2008-3#2)
polarized radiation at##2##3##(2007-11#1)(2007-12#1)
polarized radiation##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
polarized secretion##2##2##(2008-10#1)(2008-11#1)
polarized signal##2##2##(2008-2#1)(2008-3#1)
polarized sky##2##2##(2008-2#1)(2008-3#1)
polarized technique##2##2##(2008-3#2)
polarized to the##3##3##(2007-11#2)(2008-3#1)
polarized wave##2##2##(2007-11#1)(2008-2#1)
polarized with the##2##3##(1992-10#1)(2008-2#1)
polarized with##3##2##(1992-10#1)(2007-11#1)(2008-2#1)
polarized##243##1##(1990-11#1)(1991-12#1)(1992-10#1)(1993-11#1)(1994-9#2)(1997-3#1)(1997-7#1)(2006-4#1)(2007-11#31)(2007-12#47)(2008-1#3)(2008-10#14)(2008-11#1)(2008-2#39)(2008-3#80)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-8#5)(2010-12#2)(2010-8#1)(2012-12#2)(2012-2#1)(2013-8#1)
polarized-light##2##1##(2008-3#2)
polarizer and a##3##3##(2008-2#2)(2008-3#1)
polarizer and analyzer##2##3##(2008-3#2)
polarizer and##5##2##(2008-2#2)(2008-3#3)
polarizer for the##2##3##(2008-2#1)(2008-3#1)
polarizer for##3##2##(2008-2#2)(2008-3#1)
polarizer##39##1##(2007-12#6)(2008-2#12)(2008-3#21)
polarizer)##2##1##(2008-3#2)
polarizers and##3##2##(2007-11#2)(2007-12#1)
polarizers are##2##2##(2008-3#1)(2011-1#1)
polarizers in##2##2##(2008-2#1)(2008-3#1)
polarizers##21##1##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#12)(2011-1#1)
polarizing activity##5##2##(1991-5#1)(1993-12#4)
polarizing and phase-retarding##2##3##(2008-2#1)(2008-3#1)
polarizing beam splitter (PBS)##2##4##(2008-2#1)(2008-3#1)
polarizing beam splitter##10##3##(2008-10#1)(2008-2#3)(2008-3#6)
polarizing beam##11##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)
polarizing films##5##2##(2008-3#5)
polarizing glass##2##2##(2007-11#2)
polarizing##44##1##(1991-5#1)(1993-12#6)(1993-6#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#10)(2008-3#20)
polarogram of##2##2##(2008-10#2)
polarogram##3##1##(2008-10#3)
polarograms and##2##2##(1990-5#1)(2008-10#1)
polarograms##6##1##(1990-5#1)(2008-10#5)
polarographic determination of##13##3##(2008-10#13)
polarographic determination##14##2##(2008-10#14)
polarographic method for the determination of##2##6##(2008-10#2)
polarographic method##8##2##(2008-10#8)
polarographic peak##2##2##(2008-10#2)
polarographic signal##2##2##(2008-10#2)
polarographic studies##2##2##(1990-5#1)(2008-10#1)
polarographic study##2##2##(2008-10#2)
polarographic wave##4##2##(2008-10#4)
polarographic##47##1##(1990-5#1)(2008-10#46)
polarography##39##1##(2008-10#39)
polaronic##2##1##(2008-3#2)
pole and##2##2##(2011-2#1)(2012-1#1)
pole is##2##2##(2012-1#1)(2013-1#1)
pole of the##10##3##(1990-9#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-12#1)(2008-7#2)(2008-9#2)(2011-2#1)
pole of##11##2##(1990-9#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)
pole##37##1##(1990-9#1)(1991-5#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-7#1)(2007-10#1)(2007-12#4)(2008-10#2)(2008-12#1)(2008-7#3)(2008-9#3)(2009-6#1)(2009-7#2)(2010-5#1)(2011-2#5)(2012-1#3)(2013-1#3)
polecat M##2##2##(2008-6#2)
poled KTiOPO(4) was##2##3##(2007-11#1)(2008-3#1)
poled KTiOPO(4)##13##2##(2007-11#3)(2007-12#9)(2008-3#1)
poled crystal##2##2##(2007-11#1)(2007-12#1)
poled films##2##2##(2008-2#1)(2008-3#1)
poled glass##2##2##(2007-11#1)(2007-12#1)
poled nonlinear##3##2##(2007-11#2)(2008-2#1)
poled polymer and silica films##2##5##(2008-2#2)
poled polymer films is##2##4##(2007-11#1)(2008-3#1)
poled polymer##6##2##(2007-11#3)(2008-2#2)(2008-3#1)
poled potassium##2##2##(2007-12#2)
poled silica##2##2##(2007-12#2)
poled##150##1##(2006-4#1)(2007-11#46)(2007-12#76)(2008-2#10)(2008-3#17)
poles in##2##2##(2008-3#1)(2011-2#1)
poles##18##1##(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#4)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#1)
polh or p10##2##3##(1997-4#2)
polh promoter##4##2##(1997-4#4)
polh##10##1##(1997-4#10)
police and##2##2##(1992-12#1)(1993-2#1)
police chiefs##2##2##(1993-2#2)
police investigation##2##2##(1997-8#1)(2008-10#1)
police officers##2##2##(1994-2#1)(2008-7#1)
police reports##3##2##(1991-8#1)(1992-11#1)(2012-3#1)
police##33##1##(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-2#4)(1993-3#1)(1994-2#2)(1997-5#2)(1997-8#4)(2008-10#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-1#4)(2012-2#2)(2012-3#2)
policies affect##2##2##(1995-2#1)(2009-8#1)
policies affecting##2##2##(1995-1#1)(1995-3#1)
policies aimed at##3##3##(1993-1#1)(2007-7#1)(2010-5#1)
policies and guidelines##3##3##(1996-11#1)(1996-12#1)(2010-5#1)
policies and practices##3##3##(1991-3#1)(2008-11#1)(2010-7#1)
policies and procedures for##3##4##(1993-1#1)(1994-2#1)(2008-12#1)
policies and procedures##9##3##(1993-1#1)(1994-2#2)(1995-12#1)(2007-11#1)(2008-1#1)(2008-12#2)(2009-11#1)
policies and programs to##2##4##(1997-3#1)(2008-11#1)
policies and programs##3##3##(1997-3#1)(2008-11#1)(2008-9#1)
policies and their##2##3##(1995-2#1)(2011-1#1)
policies and##35##2##(1991-3#1)(1991-5#1)(1992-2#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
policies are##7##2##(1993-3#2)(1995-6#1)(1997-2#1)(2008-12#1)(2008-7#1)(2012-3#1)
policies at the##3##3##(1994-2#1)(2008-10#1)(2010-11#1)
policies developed##2##2##(1994-5#1)(2008-7#1)
policies directed at##3##3##(2011-2#1)(2012-2#2)
policies for controlling##2##3##(1995-1#1)(2013-1#1)
policies for the##2##3##(2007-5#1)(2008-11#1)
policies for volunteer programs##2##4##(1994-2#2)
policies for##19##2##(1992-3#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#1)(1996-8#1)(2007-2#1)(2007-5#1)(2008-11#3)(2012-12#1)(2013-1#4)
policies have been##2##3##(2008-1#1)(2008-10#1)
policies have##6##2##(1995-1#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
policies in health##2##3##(2008-7#1)(2012-12#1)
policies in place##2##3##(2007-2#1)(2011-2#1)
policies in the field##2##4##(1997-7#1)(2010-10#1)
policies in the##4##3##(1997-7#1)(2008-7#1)(2010-1#1)(2010-10#1)
policies in##18##2##(1991-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-7#1)(2007-2#2)(2007-3#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#2)
policies may##2##2##(1996-1#1)(2008-10#1)
policies of##6##2##(1994-1#1)(1995-1#1)(2010-1#1)(2012-2#2)(2012-3#1)
policies on##7##2##(1991-11#1)(1995-1#1)(1995-2#1)(2008-7#1)(2009-3#2)(2012-2#1)
policies or##4##2##(1992-1#1)(1996-3#1)(2008-12#1)(2012-3#1)
policies relating to##2##3##(1991-12#1)(1993-3#1)
policies resulting in##2##3##(1996-12#1)(2007-6#1)
policies should##2##2##(1996-3#1)(2008-1#1)
policies that##12##2##(1993-11#1)(1993-3#1)(1995-1#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
policies to##10##2##(1993-2#2)(1994-3#1)(2008-1#1)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#2)
policies was##2##2##(1993-12#1)(1996-12#1)
policies will##4##2##(1993-11#1)(1994-2#1)(1995-1#1)(2008-12#1)
policies with##2##2##(1992-3#1)(1995-1#1)
policies##244##1##(1990-12#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#8)(1994-1#3)(1994-12#4)(1994-2#7)(1994-3#4)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#11)(1995-12#1)(1995-2#6)(1995-3#5)(1995-6#3)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#6)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-7#1)(2007-11#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#7)(2008-10#3)(2008-11#14)(2008-12#8)(2008-3#1)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#10)(2012-2#9)(2012-3#6)(2013-1#10)(2013-8#2)
policing in##2##2##(2008-8#1)(2013-8#1)
policing of male production##2##4##(2008-8#2)
policing##9##1##(2008-8#7)(2010-8#1)(2013-8#1)
policy agenda##3##2##(1996-3#1)(2008-11#1)(2008-7#1)
policy allowed##2##2##(1996-5#1)(2008-7#1)
policy analysis##6##2##(1991-2#1)(1996-2#2)(1996-3#1)(1997-1#1)(2010-8#1)
policy analysts##2##2##(1996-2#1)(1996-3#1)
policy and environmental strategies##3##4##(2011-1#3)
policy and management##2##3##(1993-12#1)(1994-2#1)
policy and operational##2##3##(1992-1#1)(1992-12#1)
policy and politics##2##3##(1995-1#1)(2008-7#1)
policy and practice##7##3##(1993-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-8#1)
policy and procedure manual##2##4##(2013-8#2)
policy and procedure manuals##2##4##(2013-8#2)
policy and procedure##4##3##(2013-8#4)
policy and procedures##2##3##(2013-8#2)
policy and the##2##3##(1991-1#1)(2010-2#1)
policy and##49##2##(1990-6#1)(1991-1#1)(1991-3#1)(1992-1#2)(1992-12#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#3)(1994-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#7)
policy are discussed##3##3##(1995-1#1)(2012-1#1)(2013-1#1)
policy are##4##2##(1995-1#1)(1996-1#1)(2012-1#1)(2013-1#1)
policy as a##3##3##(1997-2#1)(2008-11#2)
policy as well as##2##4##(1993-3#1)(1994-1#1)
policy as##5##2##(1993-3#1)(1994-1#1)(1997-2#1)(2008-11#2)
policy brief##2##2##(2007-7#1)(2012-12#1)
policy change##2##2##(1991-1#1)(1992-12#1)
policy changes##3##2##(1992-12#1)(1995-3#1)(2012-2#1)
policy context##3##2##(1994-2#1)(2008-11#1)(2008-7#1)
policy criteria##2##2##(1991-1#1)(1991-12#1)
policy decisions##6##2##(1991-3#1)(1996-1#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
policy design and##2##3##(1993-3#1)(2008-7#1)
policy design##3##2##(1993-3#1)(2008-7#2)
policy designers##2##2##(1995-2#2)
policy development and##3##3##(1992-1#1)(1995-2#1)(1996-12#1)
policy development##16##2##(1992-1#1)(1994-1#1)(1994-2#3)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2012-3#1)
policy directives##2##2##(2008-12#2)
policy documents##2##2##(2008-11#2)
policy for the##2##3##(1991-1#1)(2007-5#1)
policy for##14##2##(1990-11#1)(1990-2#1)(1991-1#2)(1991-12#1)(1995-3#1)(1996-3#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
policy has##3##2##(1994-1#1)(1996-3#1)(2008-7#1)
policy implications and##2##3##(1996-2#1)(2012-12#1)
policy implications for the##2##4##(1992-12#1)(1993-12#1)
policy implications for##3##3##(1992-12#1)(1993-12#1)(1994-12#1)
policy implications of##6##3##(1995-12#1)(1996-1#1)(2008-11#1)(2008-7#2)(2011-1#1)
policy implications that##2##3##(1991-12#1)(1992-1#1)
policy implications##24##2##(1991-1#1)(1991-12#4)(1992-1#1)(1992-12#2)(1993-12#2)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-7#3)(2010-8#2)(2011-1#1)(2012-12#1)
policy in the##4##3##(1990-3#1)(1992-1#1)(2008-10#1)(2010-4#1)
policy in##15##2##(1990-3#2)(1991-6#1)(1992-1#2)(2008-10#2)(2008-7#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2013-1#1)
policy initiatives in##2##3##(1993-2#1)(2011-1#1)
policy initiatives##4##2##(1992-12#1)(1993-2#1)(2011-1#1)(2012-3#1)
policy instruments##2##2##(1991-1#2)
policy is the##2##3##(1997-5#1)(2012-12#1)
policy is to##2##3##(1992-11#1)(1997-3#1)
policy is##11##2##(1990-12#1)(1991-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1997-3#1)(1997-5#1)(2011-2#1)(2012-12#3)
policy issue##3##2##(1991-12#1)(1994-2#1)(2008-7#1)
policy issues related to##2##4##(1991-5#1)(1996-12#1)
policy issues that##2##3##(1991-1#1)(1994-2#1)
policy issues##15##2##(1991-1#1)(1991-5#1)(1993-2#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2010-4#1)(2011-1#2)(2012-12#2)
policy makers and##9##3##(1992-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
policy makers must##2##3##(1993-12#1)(2011-1#1)
policy makers to##3##3##(2008-7#1)(2008-8#1)(2010-8#1)
policy makers##33##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-1#3)(1994-12#1)(1995-3#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-3#1)(2008-11#1)(2008-7#4)(2008-8#2)(2009-7#1)(2010-10#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
policy making##2##2##(2008-7#1)(2009-3#1)
policy of##7##2##(1993-11#1)(1993-3#1)(2008-1#1)(2008-7#1)(2012-2#2)(2013-1#1)
policy on##9##2##(1991-12#1)(1992-1#1)(1992-2#2)(1995-6#1)(2007-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
policy options##7##2##(1992-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(2012-12#1)
policy or##2##2##(1992-2#1)(2012-12#1)
policy perspective##3##2##(1994-2#1)(2010-4#1)(2011-1#1)
policy planning##3##2##(1991-1#1)(1997-2#1)(2008-1#1)
policy process##6##2##(1993-1#1)(1995-1#1)(1995-2#2)(1996-12#1)(2008-7#1)
policy recommendations##3##2##(1996-1#1)(1996-3#1)(2009-4#1)
policy reform##4##2##(1994-1#1)(1997-2#2)(1997-3#1)
policy reforms##2##2##(1994-7#1)(2009-6#1)
policy regarding##2##2##(2008-12#1)(2013-1#1)
policy relevant##2##2##(1992-3#1)(1993-3#1)
policy research##3##2##(1994-1#1)(1995-3#1)(2009-3#1)
policy review##3##2##(1991-1#1)(1994-12#1)(2009-4#1)
policy should be##2##3##(1992-12#1)(1994-1#1)
policy statement##2##2##(1996-3#1)(2008-11#1)
policy that##5##2##(1995-3#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
policy to reduce##2##3##(2007-8#1)(2011-1#1)
policy to##10##2##(1994-11#1)(1997-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
policy toward##4##2##(1993-1#1)(1994-3#1)(1996-5#1)(2008-10#1)
policy was##2##2##(1997-1#1)(2008-6#1)
policy which##2##2##(1994-12#1)(2007-12#1)
policy with##2##2##(1993-3#1)(2011-1#1)
policy would##2##2##(1997-1#1)(2012-12#1)
policy##570##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#2)(1991-1#19)(1991-12#12)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#2)(1992-1#12)(1992-11#2)(1992-12#16)(1992-2#4)(1992-3#11)(1992-8#2)(1993-1#4)(1993-11#1)(1993-12#9)(1993-2#4)(1993-3#14)(1993-9#1)(1994-1#12)(1994-11#1)(1994-12#7)(1994-2#15)(1994-3#2)(1994-7#3)(1995-1#12)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#11)(1995-6#4)(1995-8#1)(1996-1#16)(1996-12#8)(1996-2#13)(1996-3#20)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#10)(1997-2#11)(1997-3#11)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#5)(2007-3#1)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#1)(2008-1#9)(2008-10#8)(2008-11#28)(2008-12#8)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#33)(2008-8#3)(2008-9#1)(2009-11#2)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#6)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#5)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#15)(2011-2#11)(2012-1#1)(2012-12#28)(2012-2#15)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#8)
policy-makers have##2##2##(1995-3#1)(1996-1#1)
policy-makers in##2##2##(1996-1#1)(2010-8#1)
policy-makers##11##1##(1995-3#2)(1996-1#2)(2008-11#1)(2008-7#1)(2010-8#2)(2011-2#2)(2013-1#1)
policy-making##7##1##(1996-1#1)(1997-2#1)(1997-3#1)(2008-7#1)(2011-1#2)(2013-1#1)
policy]##2##1##(1991-6#1)(1997-6#1)
policymakers and##2##2##(2007-7#1)(2010-4#1)
policymakers##16##1##(1992-3#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-4#1)(2009-4#2)(2010-4#4)
policymaking and##2##2##(1995-2#1)(1995-3#1)
policymaking##5##1##(1991-1#1)(1995-2#1)(1995-3#1)(2007-3#1)(2010-4#1)
poling duty cycle##2##3##(2007-12#2)
poling in##2##2##(2007-11#1)(2007-12#1)
poling of##5##2##(2007-11#2)(2007-12#3)
poling temperature##4##2##(2007-12#4)
poling##34##1##(2007-11#10)(2007-12#23)(2008-3#1)
polio has##2##2##(1994-9#1)(2008-4#1)
polio in##3##2##(1994-9#3)
polio vaccine##6##2##(1994-9#2)(2007-10#2)(2008-4#1)(2013-8#1)
polio virus##3##2##(2007-10#1)(2008-4#1)(2011-1#1)
polio##30##1##(1994-9#14)(1995-3#1)(2007-10#5)(2008-11#2)(2008-4#4)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
poliomyelitis in##2##2##(1991-11#1)(1997-5#1)
poliomyelitis is an##2##3##(2009-3#2)
poliomyelitis##18##1##(1991-11#1)(1993-12#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-5#1)(2009-3#6)(2009-5#1)
poliovirus in##2##2##(1994-12#1)(2011-1#1)
poliovirus vaccination##2##2##(1990-3#1)(1995-5#1)
poliovirus vaccine##4##2##(1995-3#2)(2007-10#2)
poliovirus vaccines##2##2##(1995-5#2)
poliovirus##23##1##(1990-3#1)(1993-6#1)(1994-12#1)(1995-3#3)(1995-5#9)(2007-10#2)(2008-10#2)(2008-11#1)(2011-1#3)
polish orthopedists##2##2##(2007-8#2)
polish##16##1##(2007-8#14)(2008-10#1)(2008-3#1)
polished optical##2##2##(2007-11#1)(2008-3#1)
polished surface##3##2##(2008-3#2)(2013-1#1)
polished to##2##2##(2008-3#1)(2009-5#1)
polished##18##1##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)(2008-8#2)(2009-5#1)(2013-1#2)
polishers##3##1##(2008-2#3)
polishing and##3##2##(2008-10#2)(2013-1#1)
polishing is##2##2##(2008-10#1)(2008-3#1)
polishing methods##2##2##(2008-10#1)(2013-1#1)
polishing of##2##2##(2008-2#1)(2008-3#1)
polishing on an alumina paper##3##5##(2008-10#3)
polishing on##7##2##(2008-10#7)
polishing the##2##2##(2008-10#2)
polishing##44##1##(2008-10#21)(2008-11#1)(2008-2#4)(2008-3#10)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-7#1)(2013-1#3)
polisomnography##2##1##(2010-8#2)
polistine wasps##2##2##(2008-8#2)
political activity##3##2##(1996-3#1)(2008-4#1)(2012-2#1)
political and##10##2##(1994-3#1)(1995-2#2)(1996-2#2)(1997-1#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
political aspects##2##2##(1996-1#1)(2009-10#1)
political at##2##2##(1996-1#1)(2008-1#1)
political climate##2##2##(2008-11#1)(2008-4#1)
political commitment and##2##3##(2012-12#2)
political commitment to##2##3##(1992-1#1)(2008-11#1)
political commitment##5##2##(1992-1#1)(2008-11#1)(2010-12#1)(2012-12#2)
political conflict##2##2##(1996-3#1)(2008-7#1)
political consensus##2##2##(1996-2#1)(2008-10#1)
political culture##3##2##(1995-1#1)(1996-12#1)(2008-11#1)
political ecology##2##2##(2008-1#2)
political forces##2##2##(1995-12#1)(1997-2#1)
political influence of##2##3##(2008-7#1)(2011-1#1)
political participation##5##2##(1994-2#1)(2007-7#1)(2011-2#2)(2012-2#1)
political parties##2##2##(2008-7#1)(2010-4#1)
political science##3##2##(1995-1#1)(2008-2#1)(2011-1#1)
political structure##2##2##(1994-2#1)(1996-12#1)
political will##4##2##(1993-6#1)(1994-7#1)(1997-1#1)(2013-8#1)
political##148##1##(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-2#3)(1994-3#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#5)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(2007-7#1)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#12)(2008-12#3)(2008-2#2)(2008-4#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#10)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#2)
politically and##2##2##(2010-9#1)(2011-2#1)
politically viable##2##2##(1993-3#1)(1995-3#1)
politically##9##1##(1993-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
politicians##5##1##(1992-2#1)(1993-11#1)(1995-1#1)(1995-6#2)
politicized##2##1##(1996-12#1)(2008-5#1)
politics and policy##2##3##(1995-1#2)
politics and the##2##3##(1994-12#1)(2012-3#1)
politics and##12##2##(1991-2#1)(1994-12#1)(1994-3#2)(1995-1#4)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
politics in##5##2##(1990-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)
politics of##12##2##(1991-2#1)(1992-1#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2013-7#1)
politics##44##1##(1990-10#1)(1991-2#2)(1992-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#6)(1995-9#1)(1996-12#1)(1996-3#2)(2007-10#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
poll##8##1##(1991-3#1)(1994-1#1)(1995-2#1)(1996-1#1)(1997-5#1)(2009-4#1)(2011-2#1)(2012-2#1)
pollen abortion##2##2##(2008-8#2)
pollen allergens##7##2##(1996-5#2)(2009-10#2)(2011-2#3)
pollen allergy##3##2##(2011-2#1)(2013-8#2)
pollen and ovule##2##3##(2008-8#2)
pollen and##9##2##(2008-10#2)(2008-6#1)(2008-8#2)(2009-10#2)(2011-2#1)(2013-1#1)
pollen but##3##2##(2008-6#1)(2009-10#1)(2012-12#1)
pollen discounting and its##2##4##(2008-9#2)
pollen discounting and##3##3##(2008-9#3)
pollen discounting##4##2##(2008-9#4)
pollen export##2##2##(2008-9#2)
pollen fertility##3##2##(2009-10#3)
pollen from##3##2##(2008-10#2)(2011-2#1)
pollen germination and pollen tube##2##5##(2008-8#1)(2009-10#1)
pollen germination##5##2##(2008-8#1)(2009-10#4)
pollen grains and##4##3##(2008-10#1)(2008-5#1)(2008-8#2)
pollen grains##14##2##(2008-10#5)(2008-2#2)(2008-5#2)(2008-8#2)(2009-10#1)(2013-1#1)(2013-8#1)
pollen in##4##2##(2008-2#1)(2008-6#1)(2012-12#1)(2012-7#1)
pollen mediated gene##2##3##(2011-2#2)
pollen mother cells##2##3##(2008-10#1)(2009-12#1)
pollen of##6##2##(1996-5#1)(2008-11#2)(2008-6#1)(2009-12#1)(2012-7#1)
pollen plus honey##3##3##(2008-6#3)
pollen production has##2##3##(2012-7#2)
pollen samples##3##2##(2011-2#3)
pollen season##3##2##(2012-12#1)(2012-7#2)
pollen species##2##2##(2008-6#2)
pollen to##3##2##(1992-3#1)(2008-10#2)
pollen transfer##5##2##(2008-8#5)
pollen tube growth##4##3##(2008-11#1)(2009-10#1)(2009-12#2)
pollen tube##14##2##(2008-10#1)(2008-11#3)(2008-8#1)(2009-10#2)(2009-12#3)(2009-8#4)
pollen tubes##13##2##(1997-2#1)(2008-10#3)(2008-8#3)(2009-10#4)(2009-12#2)
pollen was##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-7#1)
pollen wasps (Masarinae##2##3##(2007-12#2)
pollen wasps##4##2##(2007-12#4)
pollen were##2##2##(2008-10#1)(2012-7#1)
pollen##205##1##(1992-3#5)(1996-5#3)(1997-2#1)(2007-12#6)(2007-2#1)(2008-10#38)(2008-11#6)(2008-2#3)(2008-5#6)(2008-6#11)(2008-7#1)(2008-8#27)(2008-9#9)(2009-10#29)(2009-12#9)(2009-8#4)(2011-2#16)(2012-1#1)(2012-12#5)(2012-2#3)(2012-7#14)(2013-1#2)(2013-8#5)
pollen-mediated gene flow##2##3##(2011-2#2)
pollen-specific##4##1##(1997-2#3)(2009-10#1)
pollenizer##2##1##(2008-10#2)
pollens and##2##2##(2008-8#1)(2013-1#1)
pollens##9##1##(1991-2#1)(1997-2#1)(2008-6#2)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
pollicis longus tendon##3##3##(2008-9#3)
pollicis longus##7##2##(2007-11#2)(2008-7#2)(2008-9#3)
pollicis##9##1##(1996-5#1)(2007-11#2)(2008-7#2)(2008-9#4)
pollicus longus##2##2##(2008-9#2)
pollinating##2##1##(2008-2#1)(2008-8#1)
pollination and seed dispersal##3##4##(2008-9#3)
pollination and##6##2##(2008-10#2)(2008-9#3)(2009-10#1)
pollination conditions##2##2##(2008-9#2)
pollination is##2##2##(2012-7#1)(2013-8#1)
pollination occurs##2##2##(2008-10#1)(2012-7#1)
pollination systems##3##2##(2009-8#3)
pollination##44##1##(2008-10#12)(2008-11#3)(2008-8#1)(2008-9#14)(2009-10#2)(2009-12#1)(2009-6#2)(2009-8#4)(2011-2#2)(2012-7#2)(2013-8#1)
pollinator abundance in crop fields##2##5##(2012-2#2)
pollinator abundance in##3##3##(2008-8#1)(2012-2#2)
pollinator abundance##5##2##(2008-8#1)(2012-2#4)
pollinator visitation##3##2##(2008-8#3)
pollinator##18##1##(2008-10#3)(2008-8#8)(2008-9#1)(2009-8#2)(2012-2#4)
pollinators##8##1##(2008-10#2)(2008-8#3)(2008-9#3)
pollinators' learning##2##2##(2008-9#2)
pollinosis##12##1##(2008-11#2)(2012-12#10)
pollutant detection##2##2##(2007-11#1)(2008-3#1)
pollutant producers##2##2##(2011-2#2)
pollutant##29##1##(1990-8#2)(1991-9#1)(1992-3#1)(2007-11#1)(2008-10#12)(2008-11#5)(2008-3#1)(2009-3#1)(2011-2#2)(2013-1#3)
pollutants and##4##2##(1992-9#1)(1994-3#1)(1997-4#1)(2008-3#1)
pollutants at##4##2##(2008-10#3)(2008-3#1)
pollutants by##3##2##(2008-10#3)
pollutants contained in##2##3##(2008-10#2)
pollutants from##2##2##(2007-5#1)(2008-10#1)
pollutants in a##4##3##(2008-10#4)
pollutants in soils##2##3##(2008-10#1)(2008-7#1)
pollutants in the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
pollutants in##15##2##(1996-3#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-7#1)(2011-1#1)
pollutants is##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
pollutants such as##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
pollutants that##5##2##(1994-3#1)(2008-10#2)(2008-11#2)
pollutants##110##1##(1991-3#1)(1992-3#1)(1992-9#1)(1994-3#3)(1995-11#1)(1996-3#2)(1997-4#1)(2006-10#1)(2007-5#1)(2008-10#56)(2008-11#18)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
polluted air##2##2##(1991-4#1)(2008-3#1)
polluted river##3##2##(2008-10#3)
polluted sites##2##2##(2008-11#1)(2010-5#1)
polluted water##3##2##(2008-10#3)
polluted waters##3##2##(2008-10#3)
polluted##32##1##(1991-4#1)(1992-3#1)(1996-3#1)(2006-10#1)(2008-10#14)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#3)(2010-5#3)
polluting##2##1##(2008-12#1)(2011-2#1)
pollution and its##2##3##(1992-9#1)(1993-6#1)
pollution and##15##2##(1992-9#1)(1993-6#1)(1994-3#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
pollution by##2##2##(2008-11#1)(2008-12#1)
pollution can##2##2##(1994-9#1)(1997-1#1)
pollution from##2##2##(2008-11#2)
pollution in Shizuoka##2##3##(2008-10#2)
pollution in the##6##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
pollution in##21##2##(1991-12#1)(1992-9#2)(1993-3#1)(1994-11#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#2)
pollution is##3##2##(1992-9#1)(2008-10#2)
pollution levels##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
pollution of indoor##2##3##(1994-9#2)
pollution of the##2##3##(1994-3#1)(2008-8#1)
pollution of##7##2##(1994-3#1)(1994-9#2)(2008-10#2)(2008-8#1)(2010-5#1)
pollution sources##2##2##(2008-10#2)
pollution was##2##2##(2008-10#2)
pollution with##2##2##(2008-11#1)(2011-2#1)
pollution##128##1##(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#2)(1992-3#1)(1992-9#8)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-9#4)(1995-6#1)(1997-1#4)(1997-4#1)(1997-5#1)(1997-6#1)(2007-5#5)(2007-7#1)(2008-10#29)(2008-11#22)(2008-12#3)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
polonica in##2##2##(2008-10#2)
polonica##5##1##(2008-10#5)
polonium-210##2##1##(2008-7#2)
poly (A)##4##2##(2008-11#1)(2010-4#3)
poly (A)(+) RNA##2##3##(2008-8#1)(2008-9#1)
poly (lactic-co-glycolic acid) (PLGA)##2##4##(2009-11#1)(2009-7#1)
poly (lactic-co-glycolic acid)##3##3##(2009-11#2)(2009-7#1)
poly (vinyl chloride) (PVC)##3##4##(2008-10#3)
poly (vinyl chloride) carboxylate##2##4##(2008-10#2)
poly (vinyl chloride)##7##3##(2008-10#7)
poly (vinyl##10##2##(2008-10#10)
poly A tail##2##3##(1992-9#1)(1994-11#1)
poly A##3##2##(1990-12#1)(1992-9#1)(1994-11#1)
poly vinyl##2##2##(2008-10#2)
poly##50##1##(1990-12#2)(1991-12#1)(1992-9#1)(1994-11#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-10#26)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-7#1)(2010-4#3)(2011-2#1)
poly(-caprolactone)##2##1##(2010-4#2)
poly(1##6##1##(2008-10#5)(2008-3#1)
poly(2-acrylamido-2-methylpropane sulfonate)##3##2##(2008-10#3)
poly(2-hydroxyethyl methacrylate)##2##2##(2008-10#2)
poly(3##4##1##(2008-10#3)(2009-11#1)
poly(3-hydroxyalkanoic##2##1##(2008-6#2)
poly(3-methylthiophene)##5##1##(2008-10#5)
poly(4-BCMU)##2##1##(2007-12#2)
poly(A##2##1##(1991-12#1)(1993-11#1)
poly(A) polymerase##2##2##(2013-1#2)
poly(A) tail##7##2##(1991-2#1)(1991-9#1)(1997-2#1)(2008-10#4)
poly(A) tail)##2##2##(1994-11#2)
poly(A)##14##1##(1990-11#1)(1991-2#1)(1991-9#1)(1994-11#4)(1997-2#1)(2008-10#4)(2013-1#2)
poly(A)+ RNA from##2##3##(1994-8#1)(2008-2#1)
poly(A)+ RNA##5##2##(1992-6#2)(1994-8#1)(1995-12#1)(2008-2#1)
poly(A)+##7##1##(1992-6#2)(1992-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-2#1)
poly(A)+RNA##2##1##(1991-6#1)(1997-7#1)
poly(A+)RNA##2##1##(1990-7#1)(1990-8#1)
poly(ADP-ribose) polymerase##7##2##(1992-3#1)(1993-12#1)(1994-10#1)(2008-1#2)(2008-10#1)(2011-2#1)
poly(ADP-ribose) synthesis##2##2##(2008-1#2)
poly(ADP-ribose) synthetase##6##2##(1991-6#2)(1993-6#4)
poly(ADP-ribose)##20##1##(1991-6#2)(1992-3#1)(1993-12#2)(1993-6#4)(1994-10#1)(2008-1#8)(2008-10#1)(2011-2#1)
poly(L-lysine) to##2##2##(1992-6#2)
poly(L-lysine)##7##1##(1991-5#1)(1992-6#5)(2008-10#1)
poly(N-isopropylacrylamide) (PNIPAAm)##2##2##(2008-10#1)(2008-11#1)
poly(N-isopropylacrylamide)##3##1##(2008-10#2)(2008-11#1)
poly(Pu/Py) sequences##2##2##(1997-4#2)
poly(Pu/Py)##3##1##(1997-4#3)
poly(acrylic acid) (PAA)##2##3##(2008-10#1)(2009-12#1)
poly(acrylic acid)##4##2##(2008-10#1)(2009-12#1)(2013-1#2)
poly(acrylic acids)##5##2##(2008-10#5)
poly(acrylic##9##1##(2008-10#6)(2009-12#1)(2013-1#2)
poly(amphiphilic pyrrole)##2##2##(2008-10#2)
poly(beta-hydroxybutyrate)##5##1##(2008-7#5)
poly(butylene##2##1##(2008-10#2)
poly(dA-dT)##2##1##(1995-2#2)
poly(dAdT)##3##1##(1995-2#3)
poly(dG-dC)##2##1##(1995-2#2)
poly(dT)##3##1##(1995-5#1)(1997-2#2)
poly(dimethylsiloxane) (PDMS)##3##2##(2009-11#2)(2009-2#1)
poly(dimethylsiloxane)##7##1##(2008-10#3)(2009-11#2)(2009-2#1)(2010-4#1)
poly(ether ether ketone)##2##3##(2010-4#2)
poly(ethylene glycol) (PEG) chains##2##4##(2008-8#1)(2009-9#1)
poly(ethylene glycol) (PEG)##6##3##(2008-6#1)(2008-8#1)(2009-9#1)(2010-5#1)(2013-1#2)
poly(ethylene glycol)##16##2##(1993-6#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2013-1#2)
poly(ethylene oxide)##4##2##(2008-10#4)
poly(ethylene terephthalate) (PET)##2##3##(2008-10#1)(2010-5#1)
poly(ethylene terephthalate) (PET)-toner##2##3##(2008-10#2)
poly(ethylene terephthalate)##7##2##(2007-12#1)(2008-10#5)(2010-5#1)
poly(ethylene##31##1##(1993-6#1)(1993-8#1)(1995-2#1)(2007-12#1)(2008-10#14)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2013-1#2)
poly(ethyleneglycol)##2##1##(1990-7#1)(2008-10#1)
poly(ethylenimine)##4##1##(2008-10#4)
poly(gamma-benzyl-L-glutamate) and##3##2##(2008-11#3)
poly(hydromethylsiloxane)##2##1##(2008-10#2)
poly(lactic-co-glycolic acid) (PLGA)##2##3##(2009-11#1)(2009-7#1)
poly(lactic-co-glycolic acid)##3##2##(2009-11#1)(2009-7#2)
poly(maleic##2##1##(2008-10#2)
poly(methyl methacrylate) (PMMA) films##2##4##(2007-12#1)(2010-4#1)
poly(methyl methacrylate) (PMMA)##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#2)
poly(methyl methacrylate)##26##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#10)(2010-4#2)
poly(methyl##27##1##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#7)(2008-3#10)(2010-4#2)
poly(p-phenylenevinylene)##2##1##(1995-3#1)(2007-11#1)
poly(propylene##2##1##(2008-10#2)
poly(pyrrolylalkylammonium) films containing an enzyme##2##5##(2008-10#2)
poly(rA)##3##1##(1990-7#3)
poly(sodium 4-styrenesulfonate) (PSS)##2##3##(2008-10#1)(2009-11#1)
poly(sodium 4-styrenesulfonate) coatings##3##3##(2008-10#3)
poly(sodium 4-styrenesulfonate)##5##2##(2008-10#4)(2009-11#1)
poly(sodium 4-styrenesulfonate)-coated thin mercury film electrodes##2##6##(2008-10#2)
poly(sodium##7##1##(2008-10#6)(2009-11#1)
poly(sulfonylpiperidinylmethylene hydroxide)##2##2##(2008-10#2)
poly(tetrafluoroethylene) (PTFE)##2##2##(2008-10#1)(2008-3#1)
poly(vinyl acetate)##2##2##(2008-3#2)
poly(vinyl alcohol) (PVA)##4##3##(2008-10#2)(2008-5#1)(2009-12#1)
poly(vinyl alcohol)##11##2##(1990-8#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-5#1)(2009-12#1)
poly(vinyl chloride) (PVC) matrix##2##4##(2008-10#2)
poly(vinyl chloride) (PVC) membrane electrode##2##5##(2008-10#2)
poly(vinyl chloride) (PVC) membrane##5##4##(2008-10#5)
poly(vinyl chloride) (PVC) membranes##4##4##(2008-10#4)
poly(vinyl chloride) (PVC)##13##3##(2008-10#13)
poly(vinyl chloride) (PVC)-based##2##3##(2008-10#2)
poly(vinyl chloride) matrix membrane##2##4##(2008-10#2)
poly(vinyl chloride) membrane electrode##2##4##(2008-10#2)
poly(vinyl chloride) membrane electrodes##3##4##(2008-10#3)
poly(vinyl chloride) membrane##11##3##(2008-10#11)
poly(vinyl chloride)##32##2##(2008-10#32)
poly(vinyl##48##1##(1990-8#1)(2007-12#2)(2008-10#38)(2008-3#4)(2008-5#1)(2009-12#1)(2010-5#1)
poly(vinylchloride)##2##1##(2008-10#2)
poly(vinylpyridine) (PVP)##2##2##(2008-10#1)(2010-4#1)
poly(vinylpyrrolidone)##2##1##(2008-10#1)(2008-5#1)
poly-1-naphthylamine##2##1##(2008-10#2)
poly-3-methylthiophene##2##1##(2008-10#2)
poly-L-glutamic acid and##2##3##(1993-8#2)
poly-L-lysine (PL)##2##2##(1990-8#1)(2008-8#1)
poly-L-lysine##6##1##(1990-8#1)(2008-10#2)(2008-11#2)(2008-8#1)
poly-N-acetyllactosamine##3##1##(1990-12#2)(1994-6#1)
poly-alanine lengths##2##2##(2012-2#2)
poly-alanine repeat##2##2##(2012-2#2)
poly-alanine##6##1##(2012-2#6)
poly-beta-hydroxybutyric acid##2##2##(2008-7#2)
poly-drug users of##2##3##(2013-8#2)
poly-drug users who used##3##4##(2013-8#3)
poly-drug users##5##2##(2013-8#5)
poly-glutamic##2##1##(2008-11#2)
poly-l-aspartic acid##3##2##(2009-8#3)
poly-l-lysine (PLL) film##2##3##(2008-10#2)
poly-l-lysine (PLL)##3##2##(2008-10#3)
poly-lysine(5)##2##1##(2008-10#2)
poly-m-aminophenol##2##1##(2008-10#2)
polyA##3##1##(1992-3#1)(1993-8#1)(1997-3#1)
polyacetylene##2##1##(2009-11#2)
polyacrylamide gel and##2##3##(1996-12#1)(2008-10#1)
polyacrylamide gel electrophoresis (PAGE)##3##4##(1990-11#1)(1995-12#1)(2010-3#1)
polyacrylamide gel electrophoresis and##2##4##(1992-3#1)(2008-10#1)
polyacrylamide gel electrophoresis in##2##4##(1992-12#1)(1992-3#1)
polyacrylamide gel electrophoresis showed that##3##5##(1996-9#1)(2008-10#1)(2008-11#1)
polyacrylamide gel electrophoresis was##2##4##(1991-12#1)(2008-8#1)
polyacrylamide gel electrophoresis##35##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-6#1)(1995-12#2)(1996-5#1)(1996-9#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
polyacrylamide gel electrophoretic##2##3##(1991-12#1)(1992-8#1)
polyacrylamide gel##48##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-6#1)(1993-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
polyacrylamide gels and##2##3##(1992-2#1)(2008-2#1)
polyacrylamide gels##13##2##(1992-2#2)(1993-8#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-2#3)(2008-4#1)
polyacrylamide gradient gel electrophoresis##2##4##(1991-12#1)(2008-3#1)
polyacrylamide gradient##4##2##(1991-12#1)(2008-10#2)(2008-3#1)
polyacrylamide##78##1##(1990-10#1)(1990-11#2)(1990-7#1)(1991-12#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#3)(1993-6#1)(1993-8#2)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#2)(2008-10#19)(2008-11#3)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#1)
polyacrylaminoimidazole chelating fiber##2##3##(2008-10#2)
polyacrylate nanoparticles##2##2##(2008-8#2)
polyacrylate##9##1##(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#2)
polyacrylates##2##1##(2008-10#2)
polyacrylic acid##9##2##(2008-10#4)(2008-5#5)
polyacrylic##11##1##(2008-10#6)(2008-5#5)
polyacrylonitrile fiber##2##2##(2008-10#2)
polyacrylonitrile##5##1##(2008-10#5)
polyadenylate##2##1##(1994-8#1)(2008-10#1)
polyadenylated##11##1##(1991-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2010-4#3)
polyadenylation at the##2##3##(1997-7#1)(2007-12#1)
polyadenylation at##3##2##(1997-4#1)(1997-7#1)(2007-12#1)
polyadenylation of##5##2##(1995-6#1)(1997-2#1)(1997-7#1)(2010-4#2)
polyadenylation signal was found in the##2##6##(1993-12#1)(1997-2#1)
polyadenylation signal##7##2##(1991-2#1)(1992-12#1)(1993-12#2)(1997-2#2)(2008-8#1)
polyadenylation signals##3##2##(1993-3#1)(1994-11#1)(2008-7#1)
polyadenylation site##4##2##(1990-2#2)(1991-9#1)(1994-11#1)
polyadenylation sites##5##2##(1993-2#1)(1997-4#1)(2008-8#1)(2010-4#2)
polyadenylation##33##1##(1990-2#2)(1991-2#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#5)(1995-6#1)(1997-2#3)(1997-4#3)(1997-7#2)(2007-12#1)(2008-7#1)(2008-8#2)(2010-4#6)
polyamide##4##1##(2007-7#1)(2008-7#1)(2012-1#2)
polyamidoamine##3##1##(2008-10#2)(2008-12#1)
polyamine Metalfix-Chelamine resin##2##3##(2008-10#2)
polyamine binding##2##2##(1990-7#1)(2008-8#1)
polyamine biosynthesis##3##2##(1992-9#1)(2008-10#2)
polyamine conjugates##2##2##(1997-3#2)
polyamine depletion##2##2##(1992-8#2)
polyamine linkers##2##2##(1997-3#2)
polyamine metabolism##3##2##(1991-9#1)(2009-8#1)(2013-8#1)
polyamine##39##1##(1990-12#1)(1990-5#3)(1990-7#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-2#3)(1997-3#5)(1997-7#2)(2008-10#7)(2008-12#2)(2008-8#3)(2009-8#1)(2013-8#1)
polyamine-deficient##3##1##(2009-6#3)
polyamines (putrescine##3##2##(1991-5#1)(1994-9#1)(2009-8#1)
polyamines and methonium ions##2##4##(1991-8#2)
polyamines and##9##2##(1991-8#3)(2008-10#3)(2008-7#1)(2008-8#1)(2010-11#1)
polyamines are##4##2##(2009-10#4)
polyamines in##2##2##(1995-2#1)(2008-10#1)
polyamines to##2##2##(1995-2#2)
polyamines were##3##2##(2008-10#3)
polyamines with##2##2##(1991-8#1)(2008-10#1)
polyamines##56##1##(1991-5#1)(1991-8#6)(1991-9#1)(1992-11#2)(1992-8#1)(1993-8#2)(1994-9#1)(1995-2#3)(1997-3#2)(2008-10#14)(2008-12#5)(2008-7#2)(2008-8#3)(2009-10#9)(2009-8#2)(2010-11#1)(2010-4#1)
polyammonium cation##2##2##(2008-10#2)
polyammonium cations##5##2##(2008-10#5)
polyammonium##8##1##(2008-10#8)
polyamorphic##2##1##(1995-3#2)
polyandrous mating##2##2##(2008-8#2)
polyandrous##3##1##(2008-8#3)
polyandry##4##1##(2008-8#1)(2008-9#3)
polyangiitis##5##1##(2008-4#1)(2012-12#3)(2013-8#1)
polyaniline and##3##2##(2008-10#3)
polyaniline##23##1##(2008-10#20)(2008-7#2)(2010-4#1)
polyanion complexes##2##2##(2008-10#2)
polyanion##5##1##(2008-10#5)
polyanions by##4##2##(2008-10#4)
polyanions##11##1##(1991-11#2)(2008-10#9)
polyaromatic hydrocarbons (PAHs)##5##3##(2008-10#5)
polyaromatic hydrocarbons##9##2##(1993-8#1)(2008-10#8)
polyaromatic##10##1##(1993-8#1)(2008-10#9)
polyarteritis nodosa##3##2##(1997-8#1)(2006-10#2)
polyarteritis##6##1##(1990-8#1)(1990-9#1)(1997-8#1)(2006-10#2)(2008-11#1)
polyarthritis##7##1##(1990-6#1)(1993-6#1)(2006-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
polyatomic interferences##2##2##(2008-10#2)
polyatomic ions##2##2##(2008-10#2)
polyatomic##5##1##(2008-10#5)
polybrominated diphenyl ethers (PBDEs) in##2##5##(2008-10#2)
polybrominated diphenyl ethers (PBDEs)##4##4##(2008-10#3)(2008-7#1)
polybrominated diphenyl ethers##7##3##(2008-10#6)(2008-7#1)
polybrominated##9##1##(2008-10#8)(2008-7#1)
polybutadiene##2##1##(2008-10#2)
polycarbonate and##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
polycarbonate at##2##2##(2008-10#1)(2009-11#1)
polycarbonate filters##2##2##(1990-12#1)(1990-5#1)
polycarbonate surface##3##2##(2008-10#3)
polycarbonate##24##1##(1990-12#1)(1990-5#1)(2008-10#12)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2009-11#2)
polycation##2##1##(2008-10#1)(2010-4#1)
polycationic proteins##3##2##(1994-9#3)
polycationic##10##1##(1994-9#6)(1995-11#1)(2008-11#1)(2008-8#1)(2009-10#1)
polycations##3##1##(2008-11#1)(2010-4#2)
polycentric##2##1##(1990-3#2)
polychaete abundance and species##2##4##(2008-5#2)
polychaete##6##1##(1990-5#1)(1992-6#1)(2008-5#3)(2010-2#1)
polychaetes##7##1##(2007-5#1)(2008-5#5)(2008-7#1)
polychemotherapy for##2##2##(1990-6#1)(2008-1#1)
polychemotherapy##3##1##(1990-6#1)(2008-1#1)(2012-12#1)
polychlorinated biphenyl (PCB)##2##3##(2008-10#1)(2012-1#1)
polychlorinated biphenyl##4##2##(2008-10#3)(2012-1#1)
polychlorinated biphenyls (PCBs) and polychlorinated##2##5##(2008-10#2)
polychlorinated biphenyls (PCBs) and##3##4##(1994-3#1)(2008-10#2)
polychlorinated biphenyls (PCBs) from##2##4##(2008-10#2)
polychlorinated biphenyls (PCBs) have##2##4##(1995-3#1)(2008-7#1)
polychlorinated biphenyls (PCBs) in##3##4##(2008-10#3)
polychlorinated biphenyls (PCBs)##12##3##(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#8)(2008-7#1)
polychlorinated biphenyls in##3##3##(2008-10#3)
polychlorinated biphenyls##24##2##(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#14)(2008-11#3)(2008-7#2)
polychlorinated dibenzo-p-dioxins and dibenzo-furans##2##4##(2008-10#2)
polychlorinated dibenzo-p-dioxins and dibenzofurans##2##4##(2008-10#1)(2008-11#1)
polychlorinated dibenzo-p-dioxins and##5##3##(2008-10#4)(2008-11#1)
polychlorinated dibenzo-p-dioxins##7##2##(2008-10#6)(2008-11#1)
polychlorinated##43##1##(1993-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#28)(2008-11#4)(2008-3#1)(2008-7#3)(2012-1#1)
polychromatic erythrocytes was##2##3##(2008-8#1)(2008-9#1)
polychromatic erythrocytes##5##2##(1993-8#1)(2008-8#1)(2008-9#2)(2011-2#1)
polychromatic flow##2##2##(2008-4#1)(2008-9#1)
polychromatic illumination##2##2##(2008-2#1)(2008-3#1)
polychromatic##17##1##(1993-8#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-8#1)(2008-9#3)(2011-2#1)(2012-1#1)
polychromator##3##1##(2008-3#3)
polycistronic##5##1##(2007-12#1)(2008-7#1)(2008-8#2)(2012-2#1)
polyclonal T cell##2##3##(1992-6#1)(2008-4#1)
polyclonal and monoclonal antibodies##2##4##(1993-9#1)(2009-11#1)
polyclonal and monoclonal##5##3##(1993-9#1)(2008-4#3)(2009-11#1)
polyclonal and##8##2##(1991-2#1)(1993-9#1)(2008-10#1)(2008-4#4)(2009-11#1)
polyclonal antibodies against##5##3##(1990-5#1)(1994-11#1)(2008-10#2)(2008-5#1)
polyclonal antibodies and##2##3##(1992-6#1)(1995-12#1)
polyclonal antibodies directed##2##3##(1996-5#1)(2008-9#1)
polyclonal antibodies for##4##3##(1992-8#1)(1993-2#1)(1995-12#1)(2008-1#1)
polyclonal antibodies raised against the##2##5##(1992-8#1)(1996-12#1)
polyclonal antibodies raised against##6##4##(1990-8#1)(1991-5#1)(1992-8#2)(1995-5#1)(1996-12#1)
polyclonal antibodies to##4##3##(1990-5#1)(1991-8#1)(1992-6#1)(1995-6#1)
polyclonal antibodies were##2##3##(1995-12#1)(2008-10#1)
polyclonal antibodies##41##2##(1990-5#3)(1990-8#1)(1991-5#1)(1991-8#1)(1992-6#3)(1992-8#3)(1993-2#1)(1993-6#2)(1994-11#1)(1994-3#1)(1995-12#4)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)
polyclonal antibody against##4##3##(1994-6#1)(1996-2#1)(1997-4#1)(2008-10#1)
polyclonal antibody preparation##2##3##(2008-10#2)
polyclonal antibody raised against the##2##5##(2007-12#2)
polyclonal antibody raised against##5##4##(1992-11#1)(1995-2#1)(1997-6#1)(2007-12#2)
polyclonal antibody to##2##3##(1993-6#1)(2008-10#1)
polyclonal antibody was produced against##2##5##(2008-10#2)
polyclonal antibody was##5##3##(1993-12#1)(2008-10#4)
polyclonal antibody##37##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#2)(1992-11#2)(1993-12#2)(1993-6#1)(1993-9#2)(1994-6#1)(1995-2#1)(1996-2#2)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#14)(2012-2#1)(2013-8#1)
polyclonal antisera against##2##3##(1990-8#1)(2008-10#1)
polyclonal antisera in##2##3##(2008-10#2)
polyclonal antisera##11##2##(1990-8#2)(1997-6#2)(2008-10#7)
polyclonal antiserum##11##2##(1993-12#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#7)
polyclonal human##2##2##(1992-12#1)(2008-11#1)
polyclonal rabbit##4##2##(1992-9#1)(1996-12#1)(2008-10#2)
polyclonal##150##1##(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-6#4)(1992-8#4)(1992-9#2)(1993-12#4)(1993-2#1)(1993-6#3)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#2)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#41)(2008-11#2)(2008-2#1)(2008-4#16)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
polycondensation##3##1##(1992-12#2)(2007-11#1)
polycrystalline fibers##2##2##(1991-1#1)(2007-12#1)
polycrystalline##17##1##(1991-1#1)(1996-2#2)(1997-4#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)
polycyclic aromatic compounds (PACs) in##2##5##(2008-10#2)
polycyclic aromatic compounds##7##3##(2008-10#6)(2012-2#1)
polycyclic aromatic hydrocarbon (PAH)##2##4##(2008-10#1)(2011-1#1)
polycyclic aromatic hydrocarbon##6##3##(1994-6#1)(2008-10#3)(2011-1#2)
polycyclic aromatic hydrocarbons (PAH)##2##4##(1995-11#1)(2008-10#1)
polycyclic aromatic hydrocarbons (PAHs) dissolved in aqueous micellar cetyltrimethylammonium chloride##2##10##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs) in a##2##6##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs) in##10##5##(2008-10#9)(2010-5#1)
polycyclic aromatic hydrocarbons (PAHs) is##2##5##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs)##28##4##(1990-7#1)(1992-3#1)(2008-10#23)(2010-5#3)
polycyclic aromatic hydrocarbons and##6##4##(1995-11#1)(2008-10#3)(2008-11#1)(2010-7#1)
polycyclic aromatic hydrocarbons from##3##4##(2008-10#3)
polycyclic aromatic hydrocarbons in water samples##5##6##(2008-10#5)
polycyclic aromatic hydrocarbons in water##6##5##(2008-10#6)
polycyclic aromatic hydrocarbons in##11##4##(2008-10#11)
polycyclic aromatic hydrocarbons were##2##4##(2008-10#2)
polycyclic aromatic hydrocarbons##69##3##(1990-7#2)(1992-3#2)(1995-11#2)(2008-10#56)(2008-11#2)(2010-5#3)(2010-7#1)(2011-1#1)
polycyclic aromatic##82##2##(1990-7#2)(1992-3#2)(1994-6#1)(1995-11#2)(2008-10#65)(2008-11#2)(2010-5#3)(2010-7#1)(2011-1#3)(2012-2#1)
polycyclic epidemics##2##2##(2008-10#2)
polycyclic##88##1##(1990-7#2)(1992-3#2)(1994-6#1)(1995-11#2)(2008-10#70)(2008-11#2)(2010-5#3)(2010-7#1)(2011-1#3)(2012-2#1)(2013-7#1)
polycylic aromatic hydrocarbons##2##3##(2008-10#2)
polycylic aromatic##3##2##(2008-10#3)
polycystic kidney disease##9##3##(1997-1#2)(2007-7#2)(2008-1#1)(2008-4#1)(2010-6#1)(2013-1#2)
polycystic kidney##11##2##(1997-1#2)(2007-7#2)(2008-1#1)(2008-4#1)(2010-6#1)(2011-1#1)(2013-1#3)
polycystic ovarian syndrome##6##3##(2007-7#1)(2008-1#1)(2008-3#2)(2010-11#1)(2011-1#1)
polycystic ovarian##9##2##(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
polycystic ovary syndrome (PCOS) is##2##5##(2008-4#2)
polycystic ovary syndrome (PCOS)##9##4##(2008-3#1)(2008-4#7)(2013-8#1)
polycystic ovary syndrome##22##3##(2007-7#1)(2008-1#1)(2008-3#5)(2008-4#11)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
polycystic ovary##23##2##(2007-7#2)(2008-1#1)(2008-3#5)(2008-4#11)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
polycystic##47##1##(1995-2#1)(1997-1#3)(2007-7#5)(2008-1#3)(2008-11#1)(2008-3#7)(2008-4#12)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
polycythemia vera##2##2##(1993-9#1)(2009-7#1)
polycythemia##6##1##(1990-12#1)(1993-9#1)(2008-1#1)(2008-10#2)(2009-7#1)
polycythemic##2##1##(1990-12#2)
polydactyly##5##1##(1997-3#1)(2008-7#1)(2010-4#3)
polydiacetylene##4##1##(2007-11#1)(2007-12#1)(2008-10#2)
polydimethyl siloxane##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
polydimethylsiloxane (PDMS)##4##2##(2008-10#3)(2010-8#1)
polydimethylsiloxane##8##1##(2008-10#6)(2009-9#1)(2010-8#1)
polydimethylsiloxane/divinylbenzene##2##1##(2008-10#2)
polydioxanone##2##1##(1992-1#1)(2008-5#1)
polydipsia##5##1##(1993-6#2)(1996-12#1)(1997-3#2)
polydipsic##2##1##(1993-6#1)(1996-7#1)
polydisperse##9##1##(1993-8#1)(1995-2#1)(2008-10#2)(2008-2#3)(2008-3#2)
polydispersities##2##1##(2009-10#1)(2010-12#1)
polydispersity##8##1##(1995-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)(2013-8#2)
polydithiocarbamate resin##2##2##(2008-10#2)
polydrug use##4##2##(1996-11#1)(2009-11#1)(2013-1#2)
polyelectrolyte coatings on##2##3##(2008-10#2)
polyelectrolyte coatings##4##2##(2008-10#4)
polyelectrolyte layer##2##2##(2008-10#2)
polyelectrolyte multilayer##2##2##(2008-10#2)
polyelectrolyte##27##1##(1991-11#1)(2008-10#16)(2008-12#1)(2008-7#5)(2009-12#2)(2010-4#1)(2013-1#1)
polyelectrolyte-ELISA##4##1##(2008-10#4)
polyelectrolytes and##2##2##(2008-10#1)(2009-11#1)
polyelectrolytes such as##3##3##(2008-10#3)
polyelectrolytes using##2##2##(2008-10#2)
polyelectrolytes##15##1##(1997-2#1)(2008-10#10)(2008-7#1)(2009-11#2)(2010-4#1)
polyene##3##1##(1990-5#1)(2010-2#2)
polyenes##2##1##(2008-11#1)(2008-5#1)
polyenzyme formulation##2##2##(2008-8#2)
polyenzyme##3##1##(2008-8#3)
polyester and##2##2##(2008-3#1)(2008-9#1)
polyester##16##1##(2007-12#2)(2008-10#4)(2008-11#3)(2008-3#3)(2008-9#1)(2010-4#2)(2010-8#1)
polyether##7##1##(2008-10#6)(2009-10#1)
polyethers##5##1##(2008-10#5)
polyethoxylate##2##1##(2008-10#2)
polyethoxylated##3##1##(2008-10#3)
polyethylene (HDPE)##2##2##(2008-3#1)(2009-3#1)
polyethylene glycol (PEG)##8##3##(1990-12#1)(2008-10#3)(2008-7#2)(2012-1#1)(2012-3#1)
polyethylene glycol additives##2##3##(1994-3#2)
polyethylene glycol##26##2##(1990-12#2)(1992-11#1)(1993-11#2)(1994-3#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-3#1)
polyethylene liner##2##2##(2008-5#1)(2008-8#1)
polyethylene oxide##2##2##(2008-10#2)
polyethylene wear##5##2##(2008-8#5)
polyethylene##63##1##(1990-12#2)(1990-4#1)(1992-11#1)(1993-11#2)(1994-3#3)(1997-3#2)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#2)(2009-3#4)(2011-2#3)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#2)
polyethyleneglycol (PEG) 6000##2##3##(2008-12#2)
polyethyleneglycol (PEG)##3##2##(2008-10#1)(2008-12#2)
polyethyleneglycol##6##1##(1992-12#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-12#2)
polyethyleneimide and##2##2##(1990-11#2)
polyethyleneimine (PEI)##5##2##(1994-5#1)(1996-5#1)(2008-10#2)(2009-11#1)
polyethyleneimine##10##1##(1992-8#1)(1994-5#1)(1996-5#2)(2008-10#5)(2009-11#1)
polyethylenimine (PEI)##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
polyethylenimine##7##1##(2008-10#4)(2008-11#2)(2010-4#1)
polyfluorene##2##1##(2009-2#2)
polyfluorooctanol as##2##2##(2007-11#2)
polygalacturonase activity##2##2##(2008-10#2)
polygalacturonase##6##1##(1997-2#2)(2008-10#4)
polygalacturonase-inhibiting protein##3##2##(2008-10#3)
polygalacturonase-inhibiting proteins##3##2##(2008-10#1)(2011-10#2)
polygalacturonase-inhibiting##6##1##(2008-10#4)(2011-10#2)
polygalacturonases (PGs)##2##2##(2008-10#1)(2011-10#1)
polygamy##2##1##(2011-1#1)(2012-2#1)
polygenic hypercholesterolemia##2##2##(1991-2#1)(1991-6#1)
polygenic hypercholesterolemic patients##2##3##(1991-2#2)
polygenic##23##1##(1991-2#3)(1991-6#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#2)(2009-12#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#1)
polyglandular syndrome type 3 with##2##5##(2013-1#2)
polyglandular syndrome type##4##3##(2009-5#1)(2012-3#1)(2013-1#2)
polyglandular syndrome##5##2##(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
polyglandular##9##1##(1997-2#2)(2009-5#1)(2012-2#2)(2012-3#2)(2013-1#2)
polyglutamine##2##1##(2008-6#2)
polyglycolic acid##2##2##(2011-2#2)
polygon##6##1##(2007-11#1)(2008-2#3)(2008-3#2)
polygonal shape##2##2##(2008-11#1)(2008-7#1)
polygonal##13##1##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)(2012-1#2)
polygoni##2##1##(2012-3#1)(2013-8#1)
polygons##3##1##(2008-6#2)(2009-12#1)
polygynous##10##1##(1995-6#1)(1996-6#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-2#1)
polygyny and##2##2##(1995-6#1)(2011-2#1)
polygyny##3##1##(1995-6#1)(2008-6#1)(2011-2#1)
polyhedra or GFP##2##3##(2008-11#2)
polyhedra##9##1##(1993-12#1)(1995-12#1)(2008-11#6)(2009-12#1)
polyhedral prisms##2##2##(2008-3#2)
polyhedral##9##1##(1996-2#1)(1996-5#1)(2008-3#3)(2008-4#1)(2008-6#1)(2013-1#1)(2013-7#1)
polyhedrin gene##4##2##(1995-12#1)(2008-11#2)(2008-8#1)
polyhedrin promoter##7##2##(1994-11#1)(1997-4#3)(2008-11#2)(2008-7#1)
polyhedrin##13##1##(1994-11#1)(1995-12#1)(1997-4#5)(2008-11#4)(2008-7#1)(2008-8#1)
polyhydramnios##4##1##(2010-4#1)(2012-12#2)(2012-3#1)
polyhydric phenols##3##2##(2008-10#3)
polyhydroxy phenols##3##2##(2008-10#3)
polyhydroxy##4##1##(1992-12#1)(2008-10#3)
polyhydroxyalkanoates##2##1##(2011-1#2)
polyhydroxylbenzenes##2##1##(2008-10#2)
polyimide and poly(vinyl alcohol)##2##4##(2007-12#2)
polyimide waveguide##2##2##(2008-2#1)(2008-3#1)
polyimide##16##1##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#5)(2009-7#4)
polyinosinic and polycytidylic acids##2##4##(2008-11#2)
polyketide synthase gene##2##3##(2008-10#1)(2008-8#1)
polyketide synthase##5##2##(1994-12#2)(2008-10#2)(2008-8#1)
polyketide##8##1##(1994-12#2)(2008-10#3)(2008-8#1)(2013-1#2)
polylactic acid##3##2##(2008-10#3)
polylactic##4##1##(2008-10#3)(2009-7#1)
polylactide##3##1##(2008-6#2)(2009-12#1)
polylinker##4##1##(1991-7#1)(1991-9#1)(2008-11#1)(2008-2#1)
polylysine##9##1##(1992-3#4)(1995-6#4)(2008-11#1)
polylysines##4##1##(1991-5#2)(2008-10#2)
polymer (CP) films##2##3##(2008-10#2)
polymer (CP)##3##2##(2008-10#3)
polymer (IIP)##3##2##(2008-10#3)
polymer analysis##2##2##(2008-10#2)
polymer and silica films##3##4##(2008-2#3)
polymer and the##5##3##(1995-6#1)(2008-10#2)(2008-7#1)(2010-12#1)
polymer and##22##2##(1995-11#1)(1995-6#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)
polymer as a##3##3##(1996-5#1)(2008-10#2)
polymer at##2##2##(2008-12#1)(2008-3#1)
polymer backbone##4##2##(2007-12#1)(2008-10#1)(2009-10#2)
polymer backbones##2##2##(1995-3#1)(2009-9#1)
polymer beads##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#2)(2011-1#1)
polymer blend microparticles##2##3##(2007-12#2)
polymer blend##4##2##(2007-12#2)(2008-3#1)(2008-7#1)
polymer brush##2##2##(2009-5#2)
polymer brushes##2##2##(2009-5#1)(2010-7#1)
polymer by use of##2##4##(2007-11#1)(2007-12#1)
polymer by##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
polymer capsules##2##2##(2008-10#2)
polymer chain##2##2##(2008-10#1)(2009-9#1)
polymer coated##4##2##(2008-10#4)
polymer coating##4##2##(2007-12#1)(2008-10#3)
polymer coatings##3##2##(2008-10#2)(2009-11#1)
polymer composite##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#2)
polymer composites##3##2##(2008-10#2)(2008-2#1)
polymer composition##5##2##(2008-10#1)(2010-4#1)(2010-5#1)(2013-1#2)
polymer degradation##2##2##(2008-11#1)(2009-12#1)
polymer dielectric##2##2##(2007-12#1)(2008-2#1)
polymer dispersion##2##2##(2008-10#2)
polymer dye##2##2##(2007-12#1)(2008-3#1)
polymer electrode##4##2##(2008-10#4)
polymer electrodes##2##2##(2008-10#2)
polymer electrolytes by volumetric Karl Fischer##2##6##(2008-10#2)
polymer electrolytes by##3##3##(2008-10#3)
polymer electrolytes##5##2##(2008-10#5)
polymer extrusion processes##2##3##(2008-10#2)
polymer extrusion##3##2##(2008-10#3)
polymer fiber##2##2##(2008-10#1)(2008-3#1)
polymer fibers##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polymer film are##2##3##(2008-10#1)(2008-3#1)
polymer film were##2##3##(2008-10#2)
polymer film##21##2##(2007-12#3)(2008-10#12)(2008-3#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-5#1)
polymer films are##2##3##(2008-10#1)(2008-3#1)
polymer films containing##2##3##(2008-10#1)(2008-2#1)
polymer films for##2##3##(2008-10#2)
polymer films is##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
polymer films was##2##3##(2008-10#2)
polymer films##28##2##(1990-8#1)(1993-11#1)(2007-11#3)(2007-12#2)(2008-10#12)(2008-2#2)(2008-3#5)(2008-5#1)(2010-4#1)
polymer for##6##2##(2007-11#2)(2008-10#4)
polymer host##3##2##(2007-12#2)(2008-3#1)
polymer in a##2##3##(2008-2#1)(2008-3#1)
polymer in##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)
polymer is described##2##3##(2008-10#1)(2008-2#1)
polymer is##7##2##(2008-10#5)(2008-2#1)(2008-5#1)
polymer laser##3##2##(2007-12#3)
polymer layer##6##2##(2008-10#5)(2010-2#1)
polymer materials##6##2##(1995-3#1)(1996-12#2)(2008-10#2)(2010-10#1)
polymer matrices##5##2##(2008-3#4)(2010-10#1)
polymer matrix and##6##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-4#1)
polymer matrix during##3##3##(2008-10#2)(2009-12#1)
polymer matrix##19##2##(2007-12#1)(2008-10#5)(2008-3#3)(2008-7#4)(2009-11#1)(2009-12#3)(2010-4#1)(2012-2#1)
polymer membrane##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
polymer membranes##3##2##(2008-10#3)
polymer micelle##2##2##(2008-7#1)(2010-2#1)
polymer microlens arrays##3##3##(2008-3#3)
polymer microring resonators##3##3##(2009-5#3)
polymer microspheres##2##2##(2008-10#1)(2008-3#1)
polymer modified electrode obtained##2##4##(2008-10#2)
polymer modified electrode##5##3##(2008-10#5)
polymer modified electrodes##6##3##(2008-10#6)
polymer modified##11##2##(2008-10#11)
polymer molecules##2##2##(2008-10#1)(2008-7#1)
polymer nanoparticles##2##2##(2009-2#2)
polymer network##2##2##(2007-12#1)(2008-5#1)
polymer obtained##2##2##(2008-10#1)(2011-1#1)
polymer of##5##2##(1990-2#1)(1992-12#1)(1995-3#1)(2008-10#2)
polymer on##3##2##(2008-10#2)(2008-12#1)
polymer optical fiber##2##3##(2007-12#2)
polymer optical##3##2##(2007-12#2)(2008-2#1)
polymer particles##9##2##(2007-12#1)(2008-10#8)
polymer phase##3##2##(2008-10#3)
polymer properties##3##2##(2008-6#1)(2009-10#1)(2009-12#1)
polymer resin##2##2##(2008-10#1)(2009-7#1)
polymer sample##2##2##(1996-12#1)(2010-5#1)
polymer solar cells##2##3##(2011-2#2)
polymer solutions##3##2##(2008-10#2)(2008-3#1)
polymer structure to##2##3##(2008-8#1)(2009-7#1)
polymer surface##4##2##(2008-10#2)(2008-5#1)(2009-11#1)
polymer synthesis##3##2##(1992-11#1)(2009-12#2)
polymer systems##2##2##(2008-3#1)(2010-4#1)
polymer that has##2##3##(2007-11#1)(2008-10#1)
polymer that##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)
polymer thin films##3##3##(2007-12#2)(2008-3#1)
polymer to the##2##3##(2008-11#1)(2009-2#1)
polymer to##7##2##(1995-11#1)(2008-10#3)(2008-11#1)(2009-2#1)(2010-4#1)
polymer was prepared##2##3##(2008-10#2)
polymer was synthesized##2##3##(2008-10#1)(2008-3#1)
polymer was used##2##3##(2008-10#1)(2008-3#1)
polymer was##11##2##(2008-10#7)(2008-3#3)(2008-5#1)
polymer waveguide##6##2##(2007-11#3)(2007-12#1)(2008-3#2)
polymer waveguides##3##2##(2007-11#1)(2008-2#2)
polymer were##4##2##(2008-10#4)
polymer with##6##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
polymer##623##1##(1990-2#1)(1990-4#1)(1990-8#1)(1992-11#3)(1992-12#1)(1993-11#2)(1995-11#5)(1995-2#1)(1995-3#4)(1995-6#3)(1996-12#3)(1996-5#3)(1997-7#2)(2007-11#22)(2007-12#40)(2008-10#253)(2008-11#19)(2008-12#7)(2008-2#23)(2008-3#58)(2008-5#24)(2008-6#4)(2008-7#27)(2008-8#2)(2008-9#6)(2009-10#5)(2009-11#10)(2009-12#9)(2009-2#4)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#2)(2010-12#3)(2010-2#5)(2010-4#17)(2010-5#10)(2010-6#1)(2010-7#3)(2011-1#5)(2011-2#4)(2011-3#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)
polymer's##3##1##(2007-11#1)(2007-12#1)(2008-5#1)
polymer)##2##1##(2008-12#1)(2008-5#1)
polymer-blend##2##1##(2007-11#2)
polymer-bound##2##1##(2008-4#2)
polymer-coated##7##1##(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
polymer-dispersed liquid crystals##2##3##(2008-2#1)(2008-3#1)
polymer-dispersed liquid##3##2##(2008-2#2)(2008-3#1)
polymer-dispersed liquid-crystal (PDLC)##2##3##(2007-11#1)(2008-3#1)
polymer-dispersed liquid-crystal##7##2##(2007-11#5)(2008-3#2)
polymer-dispersed##10##1##(2007-11#5)(2008-2#2)(2008-3#3)
polymer-impregnated concrete##2##2##(2008-9#2)
polymer-modified electrode##2##2##(2008-10#2)
polymer-modified##3##1##(2008-10#3)
polymer-network liquid##3##2##(2008-3#3)
polymer-solvent##3##1##(2007-12#3)
polymer-supported##5##1##(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#2)
polymerase (PARP)##3##2##(2008-12#1)(2011-2#2)
polymerase III##9##2##(1992-3#3)(1994-12#3)(1995-6#1)(1997-7#1)(2012-12#1)
polymerase accessory protein##3##3##(1997-3#3)
polymerase activity in##2##3##(1993-8#1)(2012-3#1)
polymerase activity##8##2##(1991-5#1)(1993-8#2)(1994-8#2)(1997-4#1)(2012-2#1)(2012-3#1)
polymerase alpha##10##2##(1990-7#1)(1994-8#1)(1995-4#5)(1995-6#3)
polymerase alpha-primase complex##3##3##(1990-7#2)(1994-8#1)
polymerase alpha-primase holoenzyme##2##3##(1994-8#2)
polymerase alpha-primase##6##2##(1990-7#2)(1994-8#4)
polymerase and##6##2##(1993-8#1)(1994-10#1)(1995-2#1)(1997-3#1)(2008-10#1)(2012-3#1)
polymerase by##4##2##(1993-8#1)(1995-2#1)(1997-6#1)(2011-1#1)
polymerase chain reaction (PCR) amplification and##2##6##(2008-10#2)
polymerase chain reaction (PCR) amplification of the##2##7##(2008-10#2)
polymerase chain reaction (PCR) amplification##6##5##(1996-10#1)(2008-10#5)
polymerase chain reaction (PCR) amplified##2##5##(1995-12#1)(2008-10#1)
polymerase chain reaction (PCR) analysis##3##5##(1991-9#1)(2008-10#2)
polymerase chain reaction (PCR) and##14##5##(2008-10#10)(2008-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
polymerase chain reaction (PCR) approach##2##5##(2008-10#2)
polymerase chain reaction (PCR) assay for##2##6##(2008-10#2)
polymerase chain reaction (PCR) assay using a##2##7##(2008-10#2)
polymerase chain reaction (PCR) assay##11##5##(2008-10#10)(2011-2#1)
polymerase chain reaction (PCR) assays##8##5##(2008-10#5)(2012-2#2)(2012-3#1)
polymerase chain reaction (PCR) detection method for##2##7##(2008-10#2)
polymerase chain reaction (PCR) has become##2##6##(2008-4#1)(2012-3#1)
polymerase chain reaction (PCR) has##3##5##(2008-10#1)(2008-4#1)(2012-3#1)
polymerase chain reaction (PCR) in##4##5##(1994-1#1)(1995-8#1)(2008-10#2)
polymerase chain reaction (PCR) method##2##5##(1996-12#1)(2008-10#1)
polymerase chain reaction (PCR) methods##2##5##(2008-10#1)(2011-2#1)
polymerase chain reaction (PCR) of genomic DNA##2##7##(1992-8#2)
polymerase chain reaction (PCR) primers were##2##6##(2008-10#2)
polymerase chain reaction (PCR) primers##3##5##(2008-10#3)
polymerase chain reaction (PCR) technique##2##5##(2008-10#1)(2013-1#1)
polymerase chain reaction (PCR) testing##2##5##(1991-1#1)(2008-10#1)
polymerase chain reaction (PCR) to##4##5##(1992-3#1)(2008-11#1)(2008-2#1)(2008-4#1)
polymerase chain reaction (PCR) using TaqMan chemistry##2##7##(2008-10#2)
polymerase chain reaction (PCR) using##6##5##(1996-12#1)(1996-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
polymerase chain reaction (PCR) with##3##5##(2008-10#3)
polymerase chain reaction (PCR)##136##4##(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-8#2)(1996-10#2)(1996-12#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#77)(2008-11#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
polymerase chain reaction (PCR)-amplified##2##4##(1992-8#1)(2008-10#1)
polymerase chain reaction (PCR)-based assay##2##5##(2008-10#2)
polymerase chain reaction (PCR)-based detection method##2##6##(2008-1#1)(2008-10#1)
polymerase chain reaction (PCR)-based##8##4##(2008-1#1)(2008-10#7)
polymerase chain reaction (RT-PCR) and##5##5##(1994-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
polymerase chain reaction (RT-PCR) in##3##5##(1995-12#1)(2007-10#1)(2008-7#1)
polymerase chain reaction (RT-PCR) technique##2##5##(1996-12#1)(2008-10#1)
polymerase chain reaction (RT-PCR) was performed##2##6##(1994-11#1)(2008-10#1)
polymerase chain reaction (RT-PCR) was##3##5##(1993-8#1)(1994-11#1)(2008-10#1)
polymerase chain reaction (RT-PCR)##27##4##(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-4#1)(2007-10#1)(2007-6#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#2)
polymerase chain reaction (qPCR)##3##4##(2009-6#2)(2012-3#1)
polymerase chain reaction (rep-PCR) and##2##5##(2008-10#2)
polymerase chain reaction (rep-PCR) with##2##5##(2008-10#2)
polymerase chain reaction (rep-PCR)##9##4##(2008-10#9)
polymerase chain reaction amplification of the##2##6##(1993-8#1)(2008-10#1)
polymerase chain reaction amplification of##4##5##(1993-8#1)(2008-10#3)
polymerase chain reaction amplification##9##4##(1993-8#1)(1995-12#1)(2008-10#7)
polymerase chain reaction amplified##3##4##(2008-10#1)(2009-5#1)(2012-3#1)
polymerase chain reaction analysis##2##4##(2008-10#2)
polymerase chain reaction and Southern blot##2##6##(2008-10#1)(2008-6#1)
polymerase chain reaction and##20##4##(1990-8#1)(1991-9#1)(1994-12#1)(1997-3#1)(2007-10#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#2)(2013-1#1)
polymerase chain reaction assay##5##4##(1996-12#1)(2007-6#1)(2008-10#2)(2012-2#1)
polymerase chain reaction assays for##3##5##(2008-10#3)
polymerase chain reaction assays##7##4##(2008-10#7)
polymerase chain reaction detection##2##4##(2007-12#2)
polymerase chain reaction employing##2##4##(2008-2#1)(2008-5#1)
polymerase chain reaction following##2##4##(1992-12#1)(2008-5#1)
polymerase chain reaction for the##3##5##(1996-11#1)(2012-3#1)(2013-8#1)
polymerase chain reaction for##6##4##(1996-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
polymerase chain reaction from##5##4##(1995-12#1)(2008-10#3)(2008-4#1)
polymerase chain reaction in real-time operation mode##3##7##(2013-1#3)
polymerase chain reaction in##9##4##(1994-7#1)(1996-3#1)(1997-7#1)(2008-10#3)(2013-1#3)
polymerase chain reaction is##2##4##(1990-8#1)(1997-7#1)
polymerase chain reaction markers##3##4##(2008-10#1)(2011-2#2)
polymerase chain reaction of the##2##5##(2008-10#1)(2011-2#1)
polymerase chain reaction of##7##4##(1993-8#1)(2008-10#5)(2011-2#1)
polymerase chain reaction primers designed##2##5##(2008-10#1)(2008-5#1)
polymerase chain reaction primers##4##4##(2008-10#3)(2008-5#1)
polymerase chain reaction product##3##4##(1995-12#1)(1997-3#1)(2008-10#1)
polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis of##2##10##(2008-10#2)
polymerase chain reaction restriction fragment length##3##6##(2008-10#3)
polymerase chain reaction showed##2##4##(2008-10#1)(2009-8#1)
polymerase chain reaction technique##3##4##(1990-12#1)(1991-9#1)(2010-4#1)
polymerase chain reaction techniques##2##4##(1991-8#1)(2008-10#1)
polymerase chain reaction using primers based on the##2##8##(1993-2#1)(2008-10#1)
polymerase chain reaction using primers##3##5##(1992-6#1)(1993-2#1)(2008-10#1)
polymerase chain reaction using##7##4##(1992-6#1)(1993-2#1)(1993-9#1)(1997-7#1)(2008-10#2)(2012-12#1)
polymerase chain reaction was used to##5##6##(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(2007-6#1)
polymerase chain reaction was##8##4##(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1995-6#1)(1996-5#1)(2007-6#1)(2008-10#1)
polymerase chain reaction with degenerate##2##5##(1993-2#1)(1997-4#1)
polymerase chain reaction with##5##4##(1992-2#1)(1993-2#1)(1994-11#1)(1997-4#1)(2008-10#1)
polymerase chain reaction##434##3##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#7)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#4)(1992-8#5)(1992-9#2)(1993-12#2)(1993-2#5)(1993-3#1)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#6)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#4)(1997-8#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#205)(2008-11#6)(2008-12#2)(2008-2#5)(2008-4#7)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-8#4)(2010-2#1)(2010-4#1)(2010-6#4)(2011-1#1)(2011-2#17)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#9)(2013-1#11)(2013-8#3)
polymerase chain reaction-allele specific oligonucleotide##2##5##(1997-8#2)
polymerase chain reaction-amplified##5##3##(2008-10#5)
polymerase chain reaction-based markers##3##4##(2008-10#3)
polymerase chain reaction-based##12##3##(1993-8#1)(2008-10#11)
polymerase chain reaction-restriction fragment length polymorphism##6##6##(1997-8#1)(2008-10#4)(2011-2#1)
polymerase chain reaction-restriction fragment length##7##5##(1997-8#1)(2008-10#5)(2011-2#1)
polymerase chain reaction-sequence-specific##2##3##(1997-8#1)(2012-2#1)
polymerase chain reaction-single##2##3##(1992-2#1)(2009-7#1)
polymerase chain reactions (PCR)##2##4##(1993-8#1)(2008-10#1)
polymerase chain reactions##4##3##(1993-8#1)(1997-4#1)(2008-10#2)
polymerase chain##478##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#7)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#5)(1992-8#5)(1992-9#2)(1993-12#2)(1993-2#5)(1993-3#1)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#7)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-6#4)(1997-7#4)(1997-8#6)(2006-8#1)(2007-10#3)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#229)(2008-11#6)(2008-12#2)(2008-2#5)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-2#1)(2010-4#1)(2010-6#4)(2011-1#1)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#11)(2013-8#3)
polymerase from Thermus##3##3##(1990-7#1)(1997-6#1)(1997-8#1)
polymerase from the##3##3##(1990-7#1)(1994-8#1)(1997-6#1)
polymerase from##7##2##(1990-7#2)(1994-8#1)(1995-6#1)(1997-6#2)(1997-8#1)
polymerase gene##8##2##(1991-9#1)(1993-8#2)(1997-4#2)(2008-10#2)(2013-1#1)
polymerase has been##3##3##(1990-5#1)(1993-9#1)(1995-8#1)
polymerase has##6##2##(1990-5#1)(1993-9#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-1#1)
polymerase in a##2##3##(1995-2#1)(2008-4#1)
polymerase in##6##2##(1990-12#1)(1994-11#1)(1995-2#1)(1997-4#1)(2008-4#1)(2011-1#1)
polymerase incorporation of##2##3##(2008-4#2)
polymerase is##5##2##(1990-7#1)(1991-9#1)(1994-12#1)(1997-6#1)(1997-8#1)
polymerase mutations##2##2##(2013-1#2)
polymerase of##2##2##(1991-9#1)(2008-10#1)
polymerase reaction##2##2##(1990-8#1)(1997-8#1)
polymerase to##3##2##(1993-8#1)(1995-2#1)(1997-6#1)
polymerase was##7##2##(1991-12#1)(1993-12#1)(1993-8#1)(1994-5#1)(1997-4#2)(1997-6#1)
polymerase##720##1##(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#6)(1990-7#10)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#15)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-6#5)(1992-8#5)(1992-9#2)(1993-11#1)(1993-12#7)(1993-2#5)(1993-3#1)(1993-8#16)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#14)(1994-2#1)(1994-3#9)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#19)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#10)(1995-3#1)(1995-4#5)(1995-6#10)(1995-8#6)(1996-10#2)(1996-11#1)(1996-12#7)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#8)(1997-4#19)(1997-6#18)(1997-7#7)(1997-8#12)(1997-9#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#246)(2008-11#7)(2008-12#3)(2008-2#6)(2008-4#12)(2008-5#13)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#4)(2011-1#5)(2011-2#23)(2012-1#2)(2012-12#5)(2012-2#12)(2012-3#14)(2013-1#17)(2013-8#5)
polymerase)##2##1##(2008-10#1)(2013-1#1)
polymerase-encoding##2##1##(1993-12#1)(1997-4#1)
polymerases by##2##2##(1992-6#1)(2010-7#1)
polymerases##30##1##(1990-7#4)(1992-6#2)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#2)(1997-4#2)(1997-6#2)(1997-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-7#3)(2012-2#1)(2012-3#1)(2013-8#1)
polymeric CTA membrane##2##3##(2008-10#2)
polymeric MB##2##2##(2008-10#2)
polymeric and##2##2##(2008-5#1)(2012-12#1)
polymeric coatings##2##2##(2007-11#1)(2009-11#1)
polymeric composites##2##2##(2010-4#2)
polymeric dye##2##2##(2008-3#1)(2011-1#1)
polymeric emulsifier##2##2##(2008-5#2)
polymeric film##7##2##(2008-10#7)
polymeric films##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
polymeric gain medium##3##3##(2008-2#3)
polymeric gels##2##2##(2008-8#2)
polymeric layers##3##2##(2008-2#2)(2013-1#1)
polymeric materials##10##2##(1996-12#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-10#1)(2010-4#2)
polymeric matrices##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
polymeric matrix##13##2##(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
polymeric membrane electrode based on##2##5##(2008-10#2)
polymeric membrane electrode##5##3##(2008-10#5)
polymeric membrane electrodes based on##2##5##(2008-10#2)
polymeric membrane electrodes##8##3##(2008-10#8)
polymeric membrane sensor##3##3##(2008-10#3)
polymeric membrane##20##2##(2008-10#20)
polymeric membranes for the effective batch pre-concentration and determination of zinc traces with flame atomic absorption spectrometry##2##17##(2008-10#2)
polymeric membranes##10##2##(2008-10#10)
polymeric nanoparticles##3##2##(2013-1#3)
polymeric optical##2##2##(2007-12#1)(2008-3#1)
polymeric reagent##2##2##(1990-8#2)
polymeric resin beads##2##3##(2008-10#2)
polymeric resin##8##2##(2008-10#8)
polymeric scattering gain media##2##4##(2007-12#1)(2008-3#1)
polymeric sorbent was##2##3##(2008-10#2)
polymeric sorbent##6##2##(2008-10#6)
polymeric supports and##2##3##(1997-4#1)(2008-10#1)
polymeric supports##3##2##(1997-4#1)(2008-10#2)
polymeric systems##2##2##(2008-11#1)(2010-5#1)
polymeric##188##1##(1990-2#3)(1990-7#1)(1990-8#3)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#4)(2008-10#101)(2008-11#5)(2008-2#10)(2008-3#6)(2008-5#10)(2008-6#1)(2008-8#3)(2009-11#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#5)(2010-5#4)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#7)
polymerisation of##2##2##(2008-10#2)
polymerisation##5##1##(1990-7#1)(1992-12#1)(2008-10#3)
polymerised##2##1##(2008-10#2)
polymerizable carbon double bonds##2##4##(2009-7#2)
polymerizable##6##1##(1990-2#2)(2007-12#1)(2009-7#2)(2011-2#1)
polymerization (ATRP)##3##2##(2008-10#2)(2010-4#1)
polymerization and##11##2##(1990-2#1)(1992-9#1)(1993-8#1)(2008-10#3)(2008-7#2)(2011-2#2)(2012-2#1)
polymerization assays##2##2##(2008-1#1)(2008-8#1)
polymerization behavior##2##2##(2009-10#2)
polymerization by##2##2##(1990-11#1)(1997-6#1)
polymerization contraction force through##2##4##(2008-12#2)
polymerization contraction force##4##3##(2008-12#4)
polymerization for##2##2##(2008-10#1)(2010-4#1)
polymerization from##2##2##(2008-10#1)(2008-2#1)
polymerization in tris(hydroxymethyl)-aminomethane##2##3##(2008-10#2)
polymerization in##8##2##(1997-6#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-10#1)(2009-9#1)
polymerization induced by##2##3##(1995-6#1)(1997-6#1)
polymerization method##2##2##(2008-10#1)(2010-2#1)
polymerization of phenothiazine derivatives##2##4##(2008-10#2)
polymerization of tert-butyl acrylate##2##4##(2008-12#2)
polymerization of the##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
polymerization of##31##2##(1990-7#1)(1992-4#1)(1995-2#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#6)(2008-2#1)(2008-3#2)(2009-10#1)(2010-4#2)(2011-1#3)(2012-2#1)
polymerization on##2##2##(1993-8#1)(2012-2#1)
polymerization process##5##2##(2008-12#1)(2008-3#2)(2009-12#1)(2010-10#1)
polymerization system##2##2##(2008-10#1)(2010-4#1)
polymerization that##2##2##(2008-7#1)(2012-12#1)
polymerization was##4##2##(1990-7#1)(1997-6#1)(2008-10#1)(2010-2#1)
polymerization##150##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#4)(1992-4#1)(1992-9#1)(1993-8#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#7)(2007-11#6)(2007-12#1)(2008-1#1)(2008-10#37)(2008-12#12)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#5)(2009-10#8)(2009-11#3)(2009-12#2)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#7)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#5)(2013-1#4)
polymerization-induced##2##1##(2008-10#1)(2010-4#1)
polymerizations##2##1##(1994-9#1)(2008-12#1)
polymerize##4##1##(1995-2#1)(2008-3#1)(2012-1#1)(2013-1#1)
polymerized bovine hemoglobin##2##3##(1997-6#2)
polymerized##14##1##(1991-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-6#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#2)(2010-10#1)
polymerizing##3##1##(1991-12#1)(2008-10#2)
polymers and##19##2##(1991-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#1)(2010-8#1)
polymers are##9##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-11#1)(2009-12#1)(2009-7#1)
polymers as##4##2##(2008-10#2)(2008-11#1)(2010-10#1)
polymers by##2##2##(2008-10#2)
polymers can##2##2##(2008-10#1)(2008-5#1)
polymers could##2##2##(1997-7#1)(2011-1#1)
polymers demonstrated##2##2##(2008-10#1)(2010-8#1)
polymers for the##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
polymers for##10##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
polymers from##3##2##(1995-3#1)(2008-12#1)(2009-9#1)
polymers have been##3##3##(2008-11#1)(2008-2#1)(2009-2#1)
polymers have##5##2##(1995-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)
polymers in soil##2##3##(2008-11#2)
polymers in##11##2##(1997-6#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
polymers is##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
polymers like##3##2##(2008-7#1)(2011-1#2)
polymers offer##2##2##(2008-10#2)
polymers or##2##2##(1995-6#1)(2007-12#1)
polymers such as##2##3##(2008-10#1)(2012-2#1)
polymers that are##3##3##(2007-12#1)(2008-5#1)(2010-5#1)
polymers that##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)
polymers to##3##2##(1995-11#1)(2008-9#1)(2013-1#1)
polymers under##2##2##(2008-10#1)(2008-5#1)
polymers were##10##2##(2008-10#7)(2008-11#1)(2008-5#1)(2010-5#1)
polymers with a##2##3##(2008-10#1)(2008-5#1)
polymers with##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
polymers##249##1##(1990-8#1)(1991-7#1)(1993-11#1)(1994-11#1)(1995-11#3)(1995-3#6)(1995-6#2)(1996-5#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#7)(2007-12#8)(2008-10#79)(2008-11#13)(2008-12#6)(2008-2#12)(2008-3#12)(2008-4#1)(2008-5#25)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#5)(2009-11#3)(2009-12#3)(2009-2#1)(2009-7#2)(2009-9#2)(2010-10#4)(2010-12#2)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#2)(2011-3#1)(2012-2#5)(2013-1#5)
polymetalates##2##1##(2009-11#2)
polymetallic##3##1##(2008-10#1)(2013-8#2)
polymethacrylate##2##1##(2009-8#2)
polymethacrylates##3##1##(2008-10#2)(2009-8#1)
polymethacrylic acid##2##2##(1990-12#1)(2008-10#1)
polymethacrylic-acid-co-vinyl-acetate (PMAVA)##2##2##(2008-10#2)
polymethine dyes##2##2##(2009-12#2)
polymethine##3##1##(2008-10#1)(2009-12#2)
polymethyl methacrylate##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
polymethylene linker##2##2##(1992-11#1)(2008-10#1)
polymethylene##3##1##(1991-12#1)(1992-11#1)(2008-10#1)
polymethylmethacrylate (PMMA)##2##2##(2008-5#1)(2009-11#1)
polymethylmethacrylate##4##1##(2007-11#1)(2008-5#1)(2009-11#1)(2010-6#1)
polymicrobial##5##1##(2007-7#2)(2008-10#1)(2010-12#1)(2012-3#1)
polymodal##4##1##(1993-12#1)(1995-12#1)(2008-4#1)(2008-8#1)
polymorph##4##1##(1992-7#1)(2008-12#1)(2011-3#2)
polymorpha##7##1##(1995-8#1)(1995-9#2)(1997-4#2)(2008-11#1)(2013-1#1)
polymorphic AFLP markers were##2##4##(2008-10#2)
polymorphic AFLP markers##3##3##(2008-10#3)
polymorphic AFLP##4##2##(2008-10#4)
polymorphic DNA fingerprints##2##3##(2008-10#2)
polymorphic DNA##83##2##(1995-6#1)(1996-10#1)(1997-8#1)(2007-10#1)(2008-10#72)(2008-5#4)(2011-2#1)(2012-3#1)(2013-7#1)
polymorphic among##2##2##(1996-8#1)(2008-5#1)
polymorphic and##5##2##(2008-10#3)(2008-4#1)(2008-5#1)
polymorphic bands##6##2##(2008-10#3)(2008-12#1)(2008-8#2)
polymorphic disease##2##2##(1990-6#1)(2008-4#1)
polymorphic for##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
polymorphic fragments##3##2##(1995-6#2)(2008-10#1)
polymorphic in##3##2##(1995-3#1)(1997-5#1)(2008-10#1)
polymorphic individuals##2##2##(2008-5#2)
polymorphic loci in##4##3##(2008-10#1)(2008-5#1)(2008-9#2)
polymorphic loci##13##2##(2008-10#7)(2008-12#1)(2008-5#2)(2008-9#3)
polymorphic markers##13##2##(1994-12#1)(1997-5#1)(1997-8#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
polymorphic microsatellite loci##3##3##(2008-10#1)(2008-9#1)(2009-2#1)
polymorphic microsatellite##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-8#1)
polymorphic microsatellites##2##2##(1994-3#2)
polymorphic probes were##3##3##(2008-10#3)
polymorphic promoter##2##2##(2009-10#1)(2010-8#1)
polymorphic sites##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
polymorphic ventricular tachycardia##4##3##(2008-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
polymorphic ventricular##5##2##(2008-12#1)(2008-7#1)(2009-5#1)(2013-1#2)
polymorphic##226##1##(1990-12#2)(1990-6#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-6#4)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-10#1)(1996-8#2)(1997-5#4)(1997-8#2)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#118)(2008-12#8)(2008-4#8)(2008-5#16)(2008-7#2)(2008-8#5)(2008-9#8)(2009-10#1)(2009-2#1)(2009-5#3)(2010-6#1)(2010-8#2)(2011-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
polymorphism (PCR-SSCP)##2##2##(1995-6#1)(2009-7#1)
polymorphism (SNP)##10##2##(2008-10#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
polymorphism analysis and##2##3##(1992-8#1)(2008-4#1)
polymorphism analysis for##2##3##(2008-10#2)
polymorphism analysis of the amplified##2##5##(2008-10#1)(2011-2#1)
polymorphism analysis of the##5##4##(2008-10#4)(2011-2#1)
polymorphism analysis of##11##3##(2008-10#10)(2011-2#1)
polymorphism analysis was##2##3##(2008-10#1)(2011-2#1)
polymorphism analysis##34##2##(1991-12#1)(1992-2#1)(1992-8#2)(2008-10#21)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#2)
polymorphism and risk of##2##4##(2011-2#1)(2013-1#1)
polymorphism and the##4##3##(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
polymorphism and##40##2##(1992-2#1)(1996-6#6)(2008-10#15)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
polymorphism as a##3##3##(1994-5#1)(1995-6#1)(2008-12#1)
polymorphism as##4##2##(1994-5#1)(1995-6#1)(2008-11#1)(2008-12#1)
polymorphism at##3##2##(2006-6#1)(2008-9#1)(2011-2#1)
polymorphism between the##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
polymorphism between##5##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
polymorphism can##2##2##(2008-9#2)
polymorphism could be##2##3##(2008-1#1)(2013-1#1)
polymorphism could##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
polymorphism data##2##2##(2008-10#1)(2008-7#1)
polymorphism detected in this##2##4##(2008-10#1)(2008-5#1)
polymorphism detected##3##2##(2008-10#2)(2008-5#1)
polymorphism for##6##2##(1995-12#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-9#1)
polymorphism has been##2##3##(1990-2#1)(2012-1#1)
polymorphism has##4##2##(1990-2#1)(1997-9#1)(2006-6#1)(2012-1#1)
polymorphism in a##2##3##(1995-3#1)(2008-9#1)
polymorphism in the promoter##2##4##(2008-7#1)(2011-2#1)
polymorphism in the signal sequence of apolipoprotein B##2##8##(1993-9#2)
polymorphism in the##12##3##(1991-8#1)(1993-6#1)(1993-9#2)(1995-12#1)(1997-5#1)(1997-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
polymorphism in two##2##3##(1993-9#1)(1995-3#1)
polymorphism in##45##2##(1991-8#1)(1993-6#1)(1993-9#3)(1995-12#2)(1995-3#3)(1995-9#1)(1996-6#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-6#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
polymorphism is associated with##2##4##(2008-6#1)(2012-2#1)
polymorphism is##6##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-2#1)
polymorphism markers##13##2##(2008-10#13)
polymorphism of CYP450 2C9 and##2##5##(2011-1#2)
polymorphism of DNA##2##3##(2008-10#1)(2008-5#1)
polymorphism of cholesteryl ester transfer protein gene##2##7##(2008-12#2)
polymorphism of the##9##3##(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#2)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
polymorphism of##38##2##(1992-3#1)(1993-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#8)(2008-12#4)(2008-5#2)(2008-8#2)(2009-5#1)(2011-1#7)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
polymorphism on the##3##3##(2006-6#1)(2012-3#1)(2013-8#1)
polymorphism on##8##2##(2006-6#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
polymorphism or##2##2##(2008-10#1)(2012-2#1)
polymorphism that##3##2##(1992-8#1)(2008-10#2)
polymorphism was associated with##2##4##(2010-8#1)(2013-7#1)
polymorphism was detected##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
polymorphism was found##2##3##(2008-10#1)(2008-3#1)
polymorphism was observed between##2##4##(1995-12#1)(2008-10#1)
polymorphism was observed##4##3##(1995-12#1)(2008-10#2)(2008-12#1)
polymorphism was##16##2##(1995-12#1)(1997-8#3)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-7#1)
polymorphism were##2##2##(2008-12#1)(2008-5#1)
polymorphism with the##2##3##(2008-9#1)(2011-1#1)
polymorphism with##9##2##(2008-10#2)(2008-8#1)(2008-9#3)(2011-1#1)(2012-1#1)(2013-1#1)
polymorphism##492##1##(1990-2#2)(1990-3#1)(1991-12#1)(1991-8#1)(1992-2#2)(1992-3#3)(1992-8#4)(1993-2#2)(1993-6#1)(1993-9#3)(1994-12#2)(1994-5#1)(1995-12#5)(1995-3#3)(1995-6#4)(1995-9#1)(1996-10#2)(1996-12#1)(1996-6#7)(1996-8#2)(1997-3#1)(1997-5#4)(1997-7#2)(1997-8#6)(1997-9#2)(2006-10#1)(2006-6#7)(2006-8#1)(2007-10#1)(2008-1#4)(2008-10#229)(2008-11#3)(2008-12#21)(2008-3#2)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#19)(2009-10#1)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#18)(2011-2#15)(2011-3#2)(2012-1#5)(2012-12#1)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#6)
polymorphism)##3##1##(1992-8#1)(2010-10#1)(2012-12#1)
polymorphisms (RFLP)##2##2##(2008-10#2)
polymorphisms (SNPs) were detected##2##4##(2008-8#1)(2009-7#1)
polymorphisms (SNPs)##22##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
polymorphisms among##4##2##(2008-10#1)(2008-12#1)(2011-1#1)(2012-12#1)
polymorphisms and mutations##2##3##(2008-7#2)
polymorphisms and their##2##3##(2008-11#1)(2013-8#1)
polymorphisms and##22##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
polymorphisms are##7##2##(2008-10#2)(2008-8#1)(2012-12#2)(2012-3#2)
polymorphisms at the##3##3##(1996-12#1)(1997-7#1)(2008-10#1)
polymorphisms at##5##2##(1996-12#1)(1997-7#1)(2008-10#1)(2011-1#2)
polymorphisms between the##2##3##(2008-10#2)
polymorphisms between##5##2##(1991-8#1)(2008-10#4)
polymorphisms have been##2##3##(2008-5#1)(2009-5#1)
polymorphisms have##3##2##(2008-4#1)(2008-5#1)(2009-5#1)
polymorphisms in a##2##3##(2008-10#2)
polymorphisms in the IL4##2##4##(2008-7#2)
polymorphisms in the human##3##4##(1997-5#1)(1997-9#1)(2008-7#1)
polymorphisms in the##12##3##(1997-5#1)(1997-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2012-12#1)(2013-8#1)
polymorphisms in##37##2##(1991-8#1)(1992-3#2)(1997-5#1)(1997-9#1)(2006-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
polymorphisms is##4##2##(1994-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
polymorphisms linked to the##2##4##(1990-3#1)(2011-2#1)
polymorphisms of Y chromosome at YAP locus##2##7##(2008-9#2)
polymorphisms of the##2##3##(2008-2#1)(2011-2#1)
polymorphisms of##20##2##(1994-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-1#1)
polymorphisms on##4##2##(2008-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
polymorphisms rs1410996 CFH and rs10490924 ARMS2##2##6##(2013-1#2)
polymorphisms that##3##2##(2008-10#1)(2008-6#1)(2009-5#1)
polymorphisms to##2##2##(2008-10#1)(2012-3#1)
polymorphisms using##3##2##(2008-10#2)(2008-8#1)
polymorphisms were detected##2##3##(2008-10#1)(2008-5#1)
polymorphisms were observed##2##3##(2008-10#2)
polymorphisms were useful##2##3##(2010-8#2)
polymorphisms were##13##2##(1996-12#1)(1997-5#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-8#4)
polymorphisms will##2##2##(2007-3#1)(2012-2#1)
polymorphisms with the##2##3##(2008-10#1)(2012-12#1)
polymorphisms with##6##2##(1996-12#1)(2008-10#1)(2009-12#1)(2009-7#1)(2010-4#1)(2012-12#1)
polymorphisms within##2##2##(1997-9#1)(2008-10#1)
polymorphisms##271##1##(1990-3#1)(1991-8#2)(1992-3#2)(1994-11#2)(1994-12#2)(1994-9#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-5#3)(1997-7#1)(1997-8#2)(1997-9#3)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#72)(2008-11#3)(2008-12#8)(2008-2#4)(2008-3#3)(2008-4#11)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#7)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#7)(2011-1#16)(2011-2#9)(2012-1#5)(2012-12#13)(2012-2#7)(2012-3#17)(2013-1#14)(2013-8#3)
polymorphonuclear cells (PMNs)##2##3##(2008-12#1)(2008-4#1)
polymorphonuclear leucocytes##3##2##(1991-11#3)
polymorphonuclear leukocyte##3##2##(1992-12#1)(1993-6#1)(1993-8#1)
polymorphonuclear leukocytes (PMN)##3##3##(1993-11#1)(2008-4#2)
polymorphonuclear leukocytes (PMNs)##3##3##(1991-9#1)(1995-6#1)(2008-12#1)
polymorphonuclear leukocytes were##2##3##(1990-3#1)(1992-12#1)
polymorphonuclear leukocytes##19##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-6#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-1#1)(2008-12#1)(2008-4#3)(2008-8#1)(2010-1#1)
polymorphonuclear neutrophils (PMNs)##2##3##(1993-6#1)(2009-10#1)
polymorphonuclear neutrophils##4##2##(1990-12#1)(1992-10#1)(1993-6#1)(2009-10#1)
polymorphonuclear##34##1##(1990-12#2)(1990-3#1)(1991-11#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-5#1)(1993-11#2)(1993-6#3)(1993-8#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-1#1)(2008-10#1)(2008-12#2)(2008-4#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)
polymorphous##5##1##(1997-7#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-6#1)
polymorphs##6##1##(2007-7#1)(2008-10#2)(2009-11#1)(2011-3#2)
polymyalgia rheumatica and temporal arteritis##7##5##(1994-9#2)(1997-8#5)
polymyalgia rheumatica##14##2##(1994-11#2)(1994-9#4)(1997-8#5)(2006-10#1)(2008-7#2)
polymyalgia##15##1##(1994-11#2)(1994-9#4)(1997-8#5)(2006-10#1)(2008-7#3)
polymyositis##7##1##(1993-2#1)(1995-5#1)(1997-8#1)(2008-7#4)
polymyxin B##2##2##(1996-12#1)(2008-10#1)
polymyxins##3##1##(2008-10#3)
polyneuropathies##2##1##(1995-5#1)(2012-3#1)
polyneuropathy and##2##2##(1990-3#1)(2012-3#1)
polyneuropathy in##4##2##(1990-5#2)(1994-6#1)(2008-7#1)
polyneuropathy##32##1##(1990-3#2)(1990-5#2)(1992-12#1)(1992-8#2)(1994-6#1)(1995-5#1)(2006-12#2)(2007-7#1)(2008-1#5)(2008-2#1)(2008-7#4)(2010-11#1)(2011-1#1)(2012-3#5)(2013-1#3)
polynitroaromatic##3##1##(2008-10#3)
polynomial approximation##3##2##(2007-11#2)(2008-10#1)
polynomial expansion##2##2##(2007-12#1)(2008-3#1)
polynomial in##2##2##(1990-8#1)(2008-6#1)
polynomial model##7##2##(2008-10#2)(2008-6#3)(2009-9#1)(2010-3#1)
polynomial regression##3##2##(2008-3#2)(2012-2#1)
polynomial##46##1##(1990-8#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#9)(2008-6#8)(2009-3#3)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#4)(2011-1#1)(2012-2#1)(2013-8#1)
polynomially decreasing##2##2##(2008-10#2)
polynomials are##2##2##(2008-6#1)(2009-12#1)
polynomials##19##1##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#12)(2008-6#2)(2009-12#1)
polynuclear aromatic hydrocarbons (PAH)##2##4##(2008-10#1)(2008-11#1)
polynuclear aromatic hydrocarbons in##3##4##(2008-10#3)
polynuclear aromatic hydrocarbons##9##3##(1994-9#2)(2008-10#6)(2008-11#1)
polynuclear##18##1##(1994-9#3)(2007-11#1)(2008-10#13)(2008-11#1)
polynucleated##3##1##(1993-8#2)(1994-11#1)
polynucleotide phosphorylase##3##2##(1997-2#2)(2012-3#1)
polynucleotide treated##2##2##(1991-2#2)
polynucleotide##8##1##(1991-2#3)(1997-2#2)(2007-6#1)(2008-4#1)(2012-3#1)
polynucleotides##3##1##(1994-8#1)(1995-5#1)(2008-10#1)
polyol pathway##2##2##(2008-1#1)(2011-2#1)
polyol##7##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)
polyoma large##2##2##(1995-2#2)
polyoma##7##1##(1994-8#1)(1995-2#6)
polyomavirus##2##1##(2009-3#1)(2013-1#1)
polyoxometalate##6##1##(2007-11#1)(2008-10#2)(2008-7#3)
polyoxometalates##6##1##(2008-10#5)(2010-5#1)
polyoxyalkylene systems##2##2##(2008-10#2)
polyoxyalkylene##3##1##(2008-10#3)
polyoxyethylene##5##1##(2008-10#5)
polyp has##2##2##(2009-12#2)
polyp of the##2##3##(2009-5#2)
polyp of##3##2##(2009-5#2)(2013-8#1)
polyp##28##1##(1993-3#1)(1993-9#3)(1994-2#1)(2008-1#1)(2008-11#4)(2008-7#1)(2009-12#5)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#2)(2011-2#2)(2012-12#1)(2013-8#2)
polyparasitism##4##1##(2009-10#2)(2012-12#2)
polypectomy of##2##2##(1990-6#1)(2009-12#1)
polypectomy##12##1##(1990-6#2)(1993-9#1)(1994-2#1)(2009-12#5)(2011-2#3)
polypeptide and##4##2##(1990-5#1)(1993-2#1)(1994-11#1)(1994-5#1)
polypeptide backbones##3##2##(1995-3#1)(2008-10#1)(2009-2#1)
polypeptide chain of##3##3##(1994-2#1)(1994-6#1)(1997-7#1)
polypeptide chain##19##2##(1990-8#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-2#2)(1994-6#1)(1995-5#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-8#2)(2012-1#1)
polypeptide chains##7##2##(1990-5#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#2)(1996-12#1)
polypeptide composition##2##2##(1992-12#1)(1992-6#1)
polypeptide containing##3##2##(1990-11#1)(1995-2#1)(1997-4#1)
polypeptide designated##3##2##(1991-2#1)(1992-3#1)(1993-11#1)
polypeptide for##2##2##(1994-5#1)(2008-4#1)
polypeptide has##3##2##(1994-5#2)(1995-5#1)
polypeptide hormone##2##2##(1991-6#1)(2008-4#1)
polypeptide in the##2##3##(1992-6#1)(1993-8#1)
polypeptide in##4##2##(1991-9#1)(1992-6#1)(1993-8#1)(1995-6#1)
polypeptide is##5##2##(1990-5#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-10#1)
polypeptide of 33##2##3##(1992-8#1)(2008-10#1)
polypeptide of approximately##5##3##(1992-10#1)(1996-2#1)(1997-7#1)(2008-10#2)
polypeptide of##28##2##(1990-11#2)(1990-5#2)(1991-12#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
polypeptide predicted from the##2##4##(1991-9#1)(1992-8#1)
polypeptide recognized by a monoclonal antibody##2##6##(1995-3#2)
polypeptide segment##2##2##(1990-12#1)(1995-3#1)
polypeptide signal in plants##2##4##(2008-8#2)
polypeptide signal in##3##3##(2008-8#3)
polypeptide to##3##2##(1990-5#1)(1993-8#1)(2012-1#1)
polypeptide was##6##2##(1993-1#1)(1993-3#1)(1997-6#1)(2008-8#2)(2008-9#1)
polypeptide whose##2##2##(1992-8#1)(1995-5#1)
polypeptide with a##3##3##(1991-12#1)(1993-2#1)(2008-10#1)
polypeptide with##7##2##(1990-2#1)(1990-7#1)(1991-12#1)(1993-2#1)(1994-6#1)(1995-9#1)(2008-10#1)
polypeptide##212##1##(1990-11#6)(1990-12#4)(1990-2#1)(1990-5#13)(1990-7#3)(1990-8#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-6#5)(1992-8#7)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#1)(1993-8#7)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#2)(1994-5#5)(1994-6#2)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#4)(1995-5#5)(1995-6#5)(1995-8#2)(1995-9#1)(1996-10#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#11)(2008-9#3)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-1#2)(2013-1#2)(2013-8#1)
polypeptides and##4##2##(1991-2#1)(1991-5#1)(1995-2#1)(2009-2#1)
polypeptides are##7##2##(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#2)(2007-12#1)(2012-1#1)
polypeptides containing##2##2##(1994-11#1)(2008-4#1)
polypeptides from##3##2##(1997-4#1)(2008-5#1)(2008-7#1)
polypeptides in the##2##3##(1993-11#1)(2008-9#1)
polypeptides in##8##2##(1993-11#1)(1993-6#1)(1995-5#1)(2008-4#3)(2008-9#2)
polypeptides of the##2##3##(1990-5#1)(1997-4#1)
polypeptides of##8##2##(1990-5#1)(1991-8#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-9#1)
polypeptides that##2##2##(1994-11#1)(1995-5#1)
polypeptides was##4##2##(1991-12#1)(1994-11#1)(1995-5#1)(2008-4#1)
polypeptides were##6##2##(1993-11#3)(1994-12#1)(1994-5#1)(2008-7#1)
polypeptides with##2##2##(1990-7#1)(2011-2#1)
polypeptides##91##1##(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#9)(1993-12#1)(1993-2#1)(1993-6#4)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-5#6)(1994-8#1)(1995-12#1)(1995-2#6)(1995-5#3)(1995-6#2)(1997-4#3)(2007-11#3)(2007-12#1)(2008-11#2)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-8#1)
polypeptidic##2##1##(1993-3#1)(2008-5#1)
polyphagous##3##1##(2008-5#1)(2008-8#1)(2011-2#1)
polypharmacotherapy strategy##2##2##(2009-4#2)
polypharmacotherapy##3##1##(2009-4#3)
polypharmacy##8##1##(1991-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
polyphenol index##3##2##(2008-10#3)
polyphenol oxidase (PPO)##5##3##(2008-10#5)
polyphenol oxidase into##2##3##(2008-10#2)
polyphenol oxidase##14##2##(2008-10#14)
polyphenol##25##1##(1995-9#2)(2008-10#18)(2009-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
polyphenolic compounds in wastewater##2##4##(2008-10#2)
polyphenolic compounds##8##2##(1992-9#3)(2008-10#4)(2013-1#1)
polyphenolic constituents##2##2##(2008-10#1)(2012-2#1)
polyphenolic##14##1##(1992-9#3)(2008-10#6)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
polyphenolics##2##1##(1992-9#1)(2008-10#1)
polyphenoloxidase##2##1##(2008-10#2)
polyphenols and##3##2##(2009-8#1)(2012-2#1)(2013-1#1)
polyphenols can##2##2##(2009-3#2)
polyphenols extraction##2##2##(2009-6#1)(2013-1#1)
polyphenols have been##2##3##(2008-10#1)(2012-12#1)
polyphenols in##6##2##(2008-10#2)(2009-12#1)(2009-3#1)(2009-8#2)
polyphenols may##4##2##(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)
polyphenols with##2##2##(2008-10#1)(2009-6#1)
polyphenols##47##1##(2008-10#11)(2008-5#3)(2008-7#2)(2009-12#6)(2009-3#6)(2009-6#2)(2009-8#6)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
polyphenols-rich foods##2##2##(2012-12#2)
polyphenylalanine synthesis##2##2##(1996-2#2)
polyphosphate##9##1##(1994-11#3)(2008-10#2)(2009-2#4)
polyphosphates in##3##2##(1994-11#2)(2008-10#1)
polyphosphates##12##1##(1994-11#3)(1996-5#1)(1997-7#2)(2008-10#3)(2008-4#2)(2009-2#1)
polyphosphoinositide##2##1##(2008-8#1)(2012-2#1)
polyphosphoinositides##4##1##(1993-11#1)(1993-6#1)(2012-2#2)
polyphyletic##4##1##(2008-10#4)
polyphylla var##3##2##(2012-3#1)(2013-1#2)
polyploid hybrid##2##2##(2008-9#1)(2009-2#1)
polyploid##13##1##(1993-3#1)(2008-10#1)(2008-5#1)(2008-9#3)(2009-12#1)(2009-2#1)(2010-3#2)(2012-3#2)(2013-1#1)
polyploidization by##2##2##(1994-11#1)(2009-12#1)
polyploidization was##2##2##(1994-11#2)
polyploidization##10##1##(1994-11#5)(2007-12#1)(2008-7#2)(2009-12#1)(2013-1#1)
polyploids##5##1##(2007-12#2)(2008-9#1)(2009-2#2)
polyploidy##4##1##(2007-12#1)(2008-9#2)(2009-2#1)
polypoid granulation##3##2##(2008-1#3)
polypoid lesion##4##2##(1993-9#2)(2009-2#1)(2013-1#1)
polypoid lesions##7##2##(2013-1#7)
polypoid tumor with##2##3##(1997-8#1)(2008-11#1)
polypoid tumor##4##2##(1991-12#1)(1997-8#1)(2008-11#1)(2013-8#1)
polypoid##22##1##(1991-12#1)(1992-6#1)(1993-9#2)(1997-8#1)(2008-1#3)(2008-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#8)(2013-8#1)
polyposis and##3##2##(1990-6#1)(1991-6#1)(2012-3#1)
polyposis coli##5##2##(1990-3#1)(2007-4#1)(2009-12#1)(2012-1#2)
polyposis##31##1##(1990-3#1)(1990-6#3)(1991-6#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-12#13)(2011-2#4)(2012-1#3)(2012-3#1)
polypropylene and human hair##3##4##(2012-3#3)
polypropylene and##4##2##(2008-10#1)(2012-3#3)
polypropylene fiber##3##2##(2012-3#3)
polypropylene glycol##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
polypropylene mesh##4##2##(1996-9#1)(2008-12#1)(2008-7#1)(2010-4#1)
polypropylene##32##1##(1996-12#1)(1996-9#1)(2007-12#3)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-4#1)(2012-3#9)
polyprotein of 3##2##3##(2008-10#2)
polyprotein of##4##2##(2008-10#3)(2008-8#1)
polyprotein##20##1##(1991-9#1)(1992-6#1)(1994-11#2)(2008-10#9)(2008-8#2)(2008-9#2)(2009-7#1)(2012-2#1)(2013-8#1)
polyproteins##2##1##(1993-6#1)(2008-10#1)
polyps and allergic##2##3##(2010-6#1)(2012-1#1)
polyps and##10##2##(2009-1#1)(2009-12#1)(2009-8#2)(2010-6#3)(2012-1#1)(2012-3#1)(2013-1#1)
polyps are##7##2##(1997-8#1)(2006-8#1)(2009-12#4)(2011-2#1)
polyps at##2##2##(1990-11#1)(1997-8#1)
polyps in the##2##3##(2011-2#1)(2012-1#1)
polyps in##5##2##(2007-4#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
polyps of##3##2##(1993-9#2)(2010-2#1)
polyps or##2##2##(2009-12#1)(2013-1#1)
polyps the##2##2##(1993-9#1)(1996-12#1)
polyps was##2##2##(1993-9#1)(2010-2#1)
polyps were##2##2##(2012-1#1)(2013-1#1)
polyps##81##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-5#1)(1993-9#6)(1994-2#2)(1996-12#1)(1997-8#5)(2006-8#1)(2007-4#1)(2008-1#2)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-12#19)(2009-8#3)(2010-2#4)(2010-6#3)(2011-2#6)(2012-1#4)(2012-3#4)(2013-1#5)(2013-8#1)
polypurine tract##2##2##(1995-8#1)(2012-3#1)
polypurine##3##1##(1994-2#1)(1995-8#1)(2012-3#1)
polypyrimidine tract binding protein##2##4##(2008-1#1)(2008-9#1)
polypyrimidine##3##1##(1993-6#1)(2008-1#1)(2008-9#1)
polypyrrole (PPY)##2##2##(2008-10#2)
polypyrrole (PPy)##3##2##(2008-10#3)
polypyrrole and##3##2##(2008-10#3)
polypyrrole electrode modified with a##2##5##(2008-10#2)
polypyrrole electrode modified##3##3##(2008-10#3)
polypyrrole electrode##4##2##(2008-10#4)
polypyrrole film##7##2##(2008-10#7)
polypyrrole##39##1##(2008-10#36)(2008-5#3)
polypyrrole/beta-cyclodextrin (Ppy/beta-CD) film##2##3##(2008-10#2)
polyradiculoneuropathy##7##1##(1995-5#2)(2007-8#2)(2008-2#2)(2008-7#1)
polyrhiza accumulated##2##2##(2011-1#2)
polyrhiza##8##1##(2011-1#8)
polysaccharide conjugate vaccine##2##3##(1994-9#1)(1997-3#1)
polysaccharide is##3##2##(1995-11#2)(2012-3#1)
polysaccharide of##3##2##(1990-12#1)(1995-6#1)(2007-10#1)
polysaccharide##49##1##(1990-12#1)(1991-3#1)(1992-3#1)(1994-9#4)(1995-11#6)(1995-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(2007-10#2)(2007-2#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-3#5)(2013-8#1)
polysaccharides and##3##2##(2008-10#1)(2008-2#1)(2012-6#1)
polysaccharides are##2##2##(1994-9#1)(1995-6#1)
polysaccharides at##2##2##(2008-10#2)
polysaccharides from the##2##3##(1995-11#1)(2008-10#1)
polysaccharides from##3##2##(1994-9#1)(1995-11#1)(2008-10#1)
polysaccharides in##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
polysaccharides of##2##2##(1992-12#1)(1995-11#1)
polysaccharides that##2##2##(1992-12#1)(2008-10#1)
polysaccharides were##2##2##(2013-1#2)
polysaccharides with##2##2##(2008-10#2)
polysaccharides##52##1##(1992-12#3)(1994-9#4)(1995-11#3)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#16)(2008-2#2)(2008-5#4)(2008-6#3)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#4)(2012-3#1)(2012-6#1)(2013-1#3)
polysialic acid##3##2##(1994-11#1)(2009-8#2)
polysialic##4##1##(1994-11#1)(2009-8#3)
polysilazane nanocoating and##2##3##(2010-5#2)
polysomal mRNA##4##2##(1991-12#1)(2012-2#3)
polysomal##8##1##(1991-12#3)(1991-2#1)(2012-2#4)
polysomes were##2##2##(1991-12#1)(2008-7#1)
polysomes##15##1##(1991-12#1)(1992-8#2)(1997-7#1)(2008-11#3)(2008-12#1)(2008-7#1)(2012-2#6)
polysorbate 80##3##2##(2008-10#2)(2008-5#1)
polysorbate##4##1##(2008-10#2)(2008-5#2)
polyspermy under sperm-limited conditions##2##4##(2008-8#2)
polyspermy##9##1##(2008-8#9)
polystyrene (PS)##3##2##(1990-12#1)(2008-10#1)(2009-11#1)
polystyrene and glass##2##3##(2008-3#2)
polystyrene and##5##2##(2008-11#2)(2008-3#3)
polystyrene beads and##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
polystyrene beads loaded with##2##4##(2008-10#2)
polystyrene beads##13##2##(1990-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2009-5#1)(2011-2#1)
polystyrene divinyl benzene##2##3##(2008-10#2)
polystyrene latex spheres##5##3##(2008-3#5)
polystyrene latex##8##2##(2008-3#6)(2010-6#2)
polystyrene microbeads##2##2##(2007-11#1)(2008-10#1)
polystyrene microspheres##8##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
polystyrene microtiter plates##2##3##(1997-3#1)(2008-10#1)
polystyrene particles##5##2##(2008-10#3)(2008-2#2)
polystyrene plate##4##2##(2008-11#4)
polystyrene plates##2##2##(2008-4#1)(2012-5#1)
polystyrene resin##3##2##(2007-12#2)(2008-10#1)
polystyrene spheres are##2##3##(2007-11#1)(2008-3#1)
polystyrene spheres##9##2##(2007-11#2)(2008-2#3)(2008-3#4)
polystyrene##105##1##(1990-12#2)(1995-11#1)(1996-12#1)(1997-3#1)(2007-11#6)(2007-12#8)(2008-10#30)(2008-11#16)(2008-2#9)(2008-3#19)(2008-4#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-5#1)
polystyrene-divinylbenzene reversed-phase HPLC##2##3##(1997-2#2)
polystyrene-divinylbenzene##5##1##(1997-2#3)(2008-10#2)
polystyrenesulfonate##3##1##(2008-10#3)
polysulfone##8##1##(2007-7#2)(2008-1#2)(2008-5#2)(2008-7#1)(2010-5#1)
polysynaptic##4##1##(1993-12#1)(1996-2#2)(2013-1#1)
polytene region##2##2##(1995-8#1)(2008-9#1)
polytene##4##1##(1995-8#2)(1996-6#1)(2008-9#1)
polytetrafluoroethylene (PTFE) graft##3##3##(2007-7#2)(2007-8#1)
polytetrafluoroethylene (PTFE) grafts##2##3##(2007-7#1)(2008-1#1)
polytetrafluoroethylene (PTFE) turnings##2##3##(2008-10#2)
polytetrafluoroethylene (PTFE)##14##2##(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2011-2#1)
polytetrafluoroethylene##19##1##(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#1)(2011-2#1)(2011-3#1)
polythiophene##3##1##(2008-10#3)
polytopic##3##1##(1990-5#1)(1990-6#1)(2011-2#1)
polyunsaturated Fatty acids##2##3##(2012-2#1)(2013-1#1)
polyunsaturated Fatty##3##2##(2010-1#1)(2012-2#1)(2013-1#1)
polyunsaturated fat##2##2##(1993-9#1)(2011-1#1)
polyunsaturated fatty acid##7##3##(1995-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-2#1)
polyunsaturated fatty acids (PUFAs) in##4##5##(2008-10#1)(2010-4#1)(2010-6#1)(2012-2#1)
polyunsaturated fatty acids (PUFAs)##7##4##(2008-10#2)(2008-5#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
polyunsaturated fatty acids and iron##4##5##(2012-2#4)
polyunsaturated fatty acids in##3##4##(1991-12#1)(1992-3#1)(2008-5#1)
polyunsaturated fatty acids##32##3##(1990-2#1)(1990-3#1)(1991-12#2)(1992-3#1)(1994-11#2)(1994-12#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-5#3)(2008-7#1)(2010-1#1)(2010-4#2)(2010-6#1)(2012-2#8)(2013-1#3)
polyunsaturated fatty##40##2##(1990-2#1)(1990-3#1)(1991-12#2)(1992-3#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#2)(2010-1#2)(2010-2#1)(2010-4#2)(2010-6#1)(2012-12#1)(2012-2#8)(2013-1#3)
polyunsaturated##51##1##(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1992-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#2)(2009-5#1)(2010-1#3)(2010-2#1)(2010-4#4)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#9)(2013-1#5)
polyurethane coating##5##2##(2013-8#5)
polyurethane film##2##2##(2008-10#1)(2008-9#1)
polyurethane foam (PUF) were##2##4##(2008-10#1)(2008-11#1)
polyurethane foam (PUF)##6##3##(2008-10#4)(2008-11#2)
polyurethane foam column##2##3##(2008-10#2)
polyurethane foam loaded with##4##4##(2008-10#4)
polyurethane foam mini-column##2##3##(2008-10#2)
polyurethane foam##36##2##(2008-10#29)(2008-11#3)(2008-6#1)(2008-7#2)(2010-5#1)
polyurethane foams##2##2##(2008-10#2)
polyurethane membrane has been investigated##2##5##(2008-10#2)
polyurethane membrane has been##3##4##(2008-10#3)
polyurethane membrane##13##2##(2008-10#13)
polyurethane##80##1##(1996-12#1)(1996-6#1)(2007-7#2)(2008-10#55)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#2)(2009-9#1)(2010-5#1)(2013-8#7)
polyuria with low urine osmolality##2##5##(2013-1#2)
polyuria##5##1##(1997-3#1)(2007-7#1)(2009-7#1)(2013-1#2)
polyvalent cations##2##2##(1990-7#2)
polyvalent##12##1##(1990-7#2)(1994-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2009-10#3)(2012-12#1)(2012-2#1)
polyvinyl alcohol (PVA)##3##3##(2008-10#1)(2009-11#1)(2012-3#1)
polyvinyl alcohol##11##2##(2008-10#6)(2008-2#1)(2008-3#1)(2009-11#1)(2012-3#2)
polyvinyl chloride (PVC) matrix##2##4##(2008-10#2)
polyvinyl chloride (PVC) membrane##3##4##(2008-10#3)
polyvinyl chloride (PVC)##8##3##(2008-10#8)
polyvinyl chloride and##2##3##(1996-8#1)(2012-1#1)
polyvinyl chloride##15##2##(1996-8#1)(2008-10#13)(2012-1#1)
polyvinyl pyrrolidine##2##2##(2012-2#2)
polyvinyl pyrrolidone##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
polyvinyl##37##1##(1990-12#1)(1996-8#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
polyvinylalcohol##2##1##(1991-2#1)(2008-10#1)
polyvinylchloride##2##1##(1992-1#1)(2008-10#1)
polyvinylidene difluoride##3##2##(1992-8#1)(2008-11#1)(2012-2#1)
polyvinylidene##4##1##(1992-8#1)(2008-11#1)(2009-5#1)(2012-2#1)
polyvinylpyrollidone##2##1##(2008-10#1)(2010-5#1)
pomaceous flowers##2##2##(2008-10#2)
pomatia agglutinin (HPA)##2##3##(1990-7#1)(2011-2#1)
pomatia agglutinin##3##2##(1990-7#1)(2011-2#2)
pomatia##4##1##(1990-7#1)(1991-8#1)(2011-2#2)
pombe##45##1##(1994-12#7)(1995-2#4)(1995-8#3)(1995-9#1)(1996-7#2)(1997-2#1)(1997-3#5)(1997-4#1)(2008-2#8)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#5)
pome fruit##5##2##(2008-10#3)(2011-2#2)
pome##7##1##(2008-10#5)(2011-2#2)
pomegranate antioxidants##2##2##(2013-8#2)
pomegranate##9##1##(2012-12#3)(2013-8#6)
ponceau 4R##2##2##(2008-10#2)
pond culture##2##2##(2013-7#2)
pond water##6##2##(2008-10#2)(2008-5#3)(2012-2#1)
pond##18##1##(1991-2#1)(2008-10#3)(2008-5#5)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-7#2)
pondering##2##1##(2012-1#2)
ponderomotive##2##1##(2007-11#1)(2008-3#1)
ponds##7##1##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
ponies##2##1##(1990-6#2)
pons and medulla##4##3##(1997-2#4)
pons##12##1##(1992-8#1)(1993-3#2)(1995-2#1)(1996-5#1)(1997-2#4)(2007-10#2)(2011-1#1)
ponticum##5##1##(2008-10#5)
pontine infarction##3##2##(2007-10#1)(2008-7#1)(2013-8#1)
pontine reticular formation of##2##4##(1990-7#2)
pontine reticular formation##6##3##(1990-7#6)
pontine##25##1##(1990-12#1)(1990-7#6)(1993-12#1)(1997-8#1)(2007-10#3)(2008-11#6)(2008-7#3)(2008-8#1)(2011-2#2)(2013-8#1)
pontomedullary##2##1##(1990-9#1)(1992-8#1)
pontomesencephalic tegmentum##2##2##(1995-12#2)
pontomesencephalic##5##1##(1995-12#2)(1997-3#2)(2008-2#1)
pool and that##2##3##(1995-8#1)(2008-10#1)
pool and##9##2##(1991-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-10#1)
pool composition##2##2##(1995-6#1)(2008-8#1)
pool for##3##2##(1992-12#1)(1993-12#1)(1993-3#1)
pool in the##2##3##(2008-10#1)(2008-8#1)
pool in##5##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
pool is##2##2##(1993-12#1)(2008-11#1)
pool may##2##2##(1992-3#1)(2011-2#1)
pool of IBV strains##2##4##(1997-6#2)
pool of docked granules##2##4##(1997-7#2)
pool of intracellular##2##3##(1991-6#1)(1994-12#1)
pool of##49##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-6#2)(1997-7#3)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
pool to be##2##3##(2008-4#1)(2008-8#1)
pool to##5##2##(1991-8#1)(1992-8#1)(2008-3#1)(2008-4#1)(2008-8#1)
pool was##2##2##(1995-6#1)(2013-1#1)
pool##142##1##(1990-11#1)(1990-12#3)(1990-5#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-6#3)(1995-8#2)(1996-1#1)(1997-2#1)(1997-6#3)(1997-7#6)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#13)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#11)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
pooled analysis of##2##3##(2012-3#2)
pooled analysis##4##2##(2009-2#1)(2012-3#2)(2013-8#1)
pooled data##5##2##(2008-10#2)(2008-12#1)(2009-11#1)(2012-2#1)
pooled for##2##2##(2008-10#1)(2011-2#1)
pooled from##2##2##(1990-6#1)(1991-12#1)
pooled normal##2##2##(1990-8#2)
pooled samples##2##2##(2012-2#1)(2013-8#1)
pooled serum##2##2##(1990-12#1)(2008-10#1)
pooled##50##1##(1990-12#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-9#1)(1993-12#1)(1995-8#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#4)(2009-11#1)(2009-2#1)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#3)
pooling##8##1##(1994-11#2)(1994-9#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
pools and##3##2##(1995-6#1)(2008-11#2)
pools are##2##2##(1994-3#1)(1995-6#1)
pools as##2##2##(1995-6#1)(2008-7#1)
pools in##2##2##(1991-6#1)(2008-11#1)
pools of##15##2##(1990-5#1)(1992-7#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-3#1)
pools were##2##2##(1995-6#1)(2011-2#1)
pools##57##1##(1990-5#1)(1991-6#3)(1992-1#1)(1992-11#1)(1992-7#1)(1993-12#2)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#5)(1996-8#1)(2008-10#12)(2008-11#10)(2008-5#1)(2008-7#4)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#3)(2012-3#1)
poor PE##2##2##(2008-8#2)
poor QOL##2##2##(2010-5#2)
poor adaptation##2##2##(2008-11#2)
poor and the##3##3##(1993-3#1)(2008-1#1)(2008-10#1)
poor and##15##2##(1993-3#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2011-1#1)(2013-1#2)
poor appetite and##2##3##(2007-11#1)(2007-12#1)
poor appetite##3##2##(1990-10#1)(2007-11#1)(2007-12#1)
poor are not##2##3##(2008-11#2)
poor are##3##2##(1992-5#1)(2008-11#2)
poor bioavailability##2##2##(2011-3#1)(2012-2#1)
poor bone quality##2##3##(1995-9#1)(2011-7#1)
poor children##3##2##(1992-2#1)(2007-9#1)(2008-11#1)
poor clinical outcome##2##3##(2008-8#1)(2012-12#1)
poor clinical##5##2##(1990-5#1)(1991-3#1)(2008-8#1)(2009-7#1)(2012-12#1)
poor compliance##3##2##(1992-5#1)(1993-11#2)
poor condition##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
poor control##2##2##(2008-7#1)(2011-2#1)
poor countries##2##2##(2008-5#1)(2013-1#1)
poor crop##2##2##(2008-12#1)(2010-10#1)
poor data##2##2##(2008-11#1)(2012-12#1)
poor despite##2##2##(2008-7#1)(2011-2#1)
poor differentiation (P &lt##2##4##(2012-3#2)
poor differentiation##7##2##(1992-2#1)(1993-9#1)(2009-12#1)(2011-2#1)(2012-3#3)
poor family##2##2##(2007-9#1)(2013-8#1)
poor for##4##2##(1990-2#1)(2007-4#1)(2008-10#1)(2010-4#1)
poor functional##3##2##(2008-1#1)(2008-5#1)(2008-7#1)
poor general##2##2##(2008-7#2)
poor glycemic control##5##3##(2007-7#1)(2008-1#2)(2008-7#1)(2013-7#1)
poor growth##2##2##(2008-5#1)(2008-6#1)
poor health status##2##3##(2009-5#2)
poor health##11##2##(1990-2#1)(1993-12#1)(1997-2#1)(2008-11#2)(2008-7#1)(2009-5#2)(2010-4#1)(2011-2#2)
poor households##2##2##(2012-12#2)
poor hygiene##3##2##(1991-12#1)(1993-3#1)(2008-2#1)
poor in##12##2##(1991-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2013-8#1)
poor long-term results##2##3##(2008-11#1)(2010-12#1)
poor long-term##3##2##(2008-11#1)(2009-11#1)(2010-12#1)
poor mechanical##2##2##(2007-11#1)(2009-7#1)
poor mental health##2##3##(2009-5#2)
poor mental##3##2##(2009-5#3)
poor neurological status##2##3##(2013-1#2)
poor nutrition##2##2##(1991-2#1)(2010-6#1)
poor or##4##2##(1992-2#1)(2007-8#1)(2008-1#1)(2013-1#1)
poor oral health##2##3##(2008-1#1)(2008-7#1)
poor oral##3##2##(2008-1#1)(2008-5#1)(2008-7#1)
poor outcome in##6##3##(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
poor outcome##28##2##(1990-9#1)(1994-12#2)(2007-10#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#5)(2012-12#4)(2012-3#3)
poor outcomes##7##2##(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
poor overall##2##2##(1995-3#1)(2008-6#1)
poor patient##2##2##(1996-11#1)(2009-11#1)
poor performance in##2##3##(2008-10#1)(2012-12#1)
poor performance##6##2##(1993-12#1)(1997-5#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
poor physical health##2##3##(2008-11#1)(2011-1#1)
poor physical##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
poor precision and##2##3##(2008-10#2)
poor precision##3##2##(2008-10#3)
poor predictors##2##2##(1994-3#2)
poor prognosis and##4##3##(2009-5#1)(2009-8#2)(2010-6#1)
poor prognosis because##3##3##(1993-5#1)(1996-11#1)(2012-1#1)
poor prognosis in patients with##2##5##(2011-2#1)(2013-1#1)
poor prognosis in##6##3##(2007-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
poor prognosis##64##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-5#2)(1997-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#5)(2008-7#1)(2009-10#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
poor prognostic factors##3##3##(2008-1#1)(2008-6#2)
poor psychological adjustment##2##3##(2009-11#2)
poor quality of life##2##4##(2011-2#1)(2013-1#1)
poor quality of the##2##4##(1995-9#1)(2008-5#1)
poor quality of##7##3##(1991-9#1)(1995-9#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
poor quality##15##2##(1991-9#1)(1993-12#1)(1995-5#1)(1995-9#3)(1997-6#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
poor recovery##5##2##(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
poor relief in##2##3##(2008-11#2)
poor responders to##2##3##(2010-3#1)(2012-2#1)
poor responders##6##2##(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#2)
poor response of##2##3##(2008-10#1)(2013-1#1)
poor response to##5##3##(1990-10#1)(2010-12#2)(2010-6#1)(2013-8#1)
poor response##13##2##(1990-10#1)(2008-10#3)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#1)
poor results in##3##3##(2007-11#3)
poor results##7##2##(1990-10#1)(1990-6#1)(2007-11#4)(2008-9#1)
poor school##3##2##(2008-11#1)(2008-12#1)(2009-7#1)
poor self-rated health##2##3##(2011-2#1)(2013-1#1)
poor sensitivity of##2##3##(2008-10#2)
poor sensitivity##3##2##(2008-10#2)(2012-1#1)
poor stability##2##2##(2008-10#1)(2008-5#1)
poor substrate for##4##3##(1991-5#1)(1992-3#1)(1994-11#1)(1997-3#1)
poor substrate##6##2##(1991-5#2)(1992-12#1)(1992-3#1)(1994-11#1)(1997-3#1)
poor substrates for##2##3##(1993-8#1)(1995-8#1)
poor substrates##4##2##(1990-11#1)(1993-8#1)(1994-9#1)(1995-8#1)
poor survival##4##2##(1991-2#1)(1991-4#1)(2008-7#1)(2009-10#1)
poor vision##2##2##(1993-11#1)(2010-8#1)
poor visualization of##2##3##(2007-10#1)(2012-2#1)
poor with##2##2##(1996-9#1)(2007-10#1)
poor wound healing##2##3##(2012-3#2)
poor##637##1##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#4)(1991-9#2)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#6)(1993-2#1)(1993-3#5)(1993-5#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-6#2)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#4)(1995-9#7)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#7)(2007-11#11)(2007-12#5)(2007-2#6)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#11)(2008-10#48)(2008-11#27)(2008-12#11)(2008-2#5)(2008-3#12)(2008-4#3)(2008-5#13)(2008-6#20)(2008-7#31)(2008-8#11)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#14)(2009-6#2)(2009-7#5)(2009-8#5)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#11)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#33)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#19)(2012-2#14)(2012-3#19)(2012-8#1)(2013-1#31)(2013-7#2)(2013-8#19)
poor&quot##3##1##(2007-10#1)(2011-2#2)
poor-quality##2##1##(2008-1#1)(2008-3#1)
poor-risk##2##1##(1994-12#1)(2010-11#1)
poorer academic achievement##2##3##(2007-8#1)(2012-2#1)
poorer child social development##2##4##(2009-9#2)
poorer health status##2##3##(1996-2#1)(1997-2#1)
poorer health##7##2##(1993-1#1)(1995-12#2)(1996-2#1)(1997-2#1)(2008-1#1)(2008-11#1)
poorer outcomes##2##2##(1991-12#1)(2011-1#1)
poorer perceived health##2##3##(2008-6#2)
poorer performance in##4##3##(1996-5#1)(2008-11#1)(2008-12#1)(2012-1#1)
poorer performance##7##2##(1996-5#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-1#1)
poorer physical##2##2##(1994-1#1)(2013-8#1)
poorer prognosis##5##2##(1991-2#1)(1992-5#1)(1993-11#1)(1994-12#1)(2009-2#1)
poorer social##2##2##(2009-10#1)(2013-1#1)
poorer spatial##2##2##(1994-3#1)(2008-3#1)
poorer than that##3##3##(2006-10#1)(2008-2#1)(2011-2#1)
poorer than##4##2##(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
poorer##83##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#2)(1996-2#2)(1996-5#2)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
poorest##14##1##(1990-2#1)(1992-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2012-12#1)
poorly active##2##2##(1991-3#1)(1995-2#1)
poorly and##3##2##(1995-2#1)(2008-2#1)(2013-1#1)
poorly characterized##4##2##(1993-3#1)(2007-7#1)(2008-11#1)(2008-4#1)
poorly controlled##9##2##(2007-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
poorly defined##12##2##(1993-2#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
poorly demonstrated##2##2##(2008-5#1)(2008-7#1)
poorly developed##8##2##(1990-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2013-1#1)
poorly differentiated carcinoma##2##3##(1990-3#1)(2011-2#1)
poorly differentiated##20##2##(1990-2#1)(1990-3#1)(1992-2#1)(1993-9#2)(2006-8#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-3#3)(2013-7#3)
poorly documented##5##2##(1990-12#1)(1995-5#1)(2012-1#1)(2012-2#1)(2013-7#1)
poorly expressed in##2##3##(2011-2#1)(2013-8#1)
poorly expressed##3##2##(1992-9#1)(2011-2#1)(2013-8#1)
poorly immunogenic##3##2##(1994-5#1)(1997-4#1)(2007-11#1)
poorly in##2##2##(1996-12#1)(2009-10#1)
poorly informed about##2##3##(1991-6#1)(1995-1#1)
poorly informed##3##2##(1991-6#1)(1992-2#1)(1995-1#1)
poorly known##6##2##(1997-5#1)(2008-10#1)(2008-5#2)(2013-7#2)
poorly on##3##2##(1995-11#1)(2012-3#2)
poorly protected##2##2##(1997-3#2)
poorly quantified##2##2##(2007-8#1)(2008-10#1)
poorly resolved##2##2##(2008-10#2)
poorly soluble in water##2##4##(1994-3#1)(2010-3#1)
poorly soluble in##3##3##(1994-3#1)(2008-10#1)(2010-3#1)
poorly soluble##4##2##(1994-3#1)(2008-10#1)(2008-7#1)(2010-3#1)
poorly studied##10##2##(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#3)
poorly to##8##2##(1992-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
poorly tolerated##2##2##(1995-3#1)(2008-7#1)
poorly understood and##8##3##(1990-5#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2013-8#2)
poorly understood##74##2##(1990-5#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-1#1)(1996-11#1)(1996-2#1)(2007-10#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
poorly water-soluble drugs##2##3##(2012-2#2)
poorly water-soluble##3##2##(2010-5#1)(2012-2#2)
poorly with the##2##3##(1992-11#1)(1995-12#1)
poorly with##8##2##(1992-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
poorly##266##1##(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-4#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#14)(2008-8#4)(2008-9#7)(2009-10#3)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#11)(2013-1#8)(2013-7#10)(2013-8#6)
poorly-controlled##2##1##(1993-12#1)(2013-7#1)
pop##5##1##(2008-12#4)(2008-9#1)
poplar clones##5##2##(2008-10#1)(2011-2#4)
poplar##26##1##(2008-10#16)(2008-6#3)(2011-2#6)(2013-1#1)
popliteal artery##5##2##(1991-3#4)(2006-10#1)
popliteal lymph node assay##3##4##(2008-10#3)
popliteal lymph node##4##3##(2008-10#3)(2008-5#1)
popliteal lymph##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
popliteal##12##1##(1991-3#6)(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#1)
poppy (Papaver somniferum)##2##3##(2008-10#2)
poppy leaves##2##2##(2008-10#2)
poppy##16##1##(2008-10#16)
pops##9##1##(2008-12#8)(2008-9#1)
popular and##5##2##(1995-12#1)(1995-2#1)(1995-3#1)(2008-11#1)(2011-1#1)
popular belief##5##2##(1993-1#1)(1997-3#1)(2008-5#1)(2008-7#1)(2009-9#1)
popular choice for##2##3##(2008-10#1)(2010-8#1)
popular culture##2##2##(2008-11#1)(2008-5#1)
popular for##5##2##(1994-9#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-2#1)
popular free##2##2##(2010-9#1)(2013-8#1)
popular in the##6##3##(1993-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
popular in##14##2##(1993-1#1)(1995-2#2)(1997-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
popular method##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2011-2#1)
popular methods##2##2##(2008-4#1)(2008-6#1)
popular music of today##2##4##(1992-3#2)
popular music##4##2##(1992-3#3)(2007-6#1)
popular romances##2##2##(2011-2#2)
popular strategy##2##2##(1996-3#1)(2012-2#1)
popular techniques for##3##3##(2008-10#2)(2010-3#1)
popular techniques##4##2##(2008-1#1)(2008-10#2)(2010-3#1)
popular tool for##2##3##(2008-8#1)(2009-6#1)
popular tool##4##2##(1994-2#1)(2008-8#1)(2009-3#1)(2009-6#1)
popular with##2##2##(2007-2#1)(2008-10#1)
popular##146##1##(1992-2#1)(1992-3#4)(1992-8#1)(1993-1#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#3)(1996-1#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
popular&quot##2##1##(2009-7#2)
popularity as a##2##3##(2012-12#1)(2012-3#1)
popularity as##5##2##(2010-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
popularity for##2##2##(1992-11#1)(2008-12#1)
popularity in##5##2##(1992-12#1)(1994-2#1)(2008-11#1)(2010-1#1)(2010-7#1)
popularity motivations##3##2##(2009-8#3)
popularity of##11##2##(1993-2#1)(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)
popularity was##2##2##(2010-1#2)
popularity with##2##2##(2007-5#1)(2009-11#1)
popularity##43##1##(1992-11#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#4)(2010-1#7)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)
popularization of##2##2##(1993-2#1)(2007-5#1)
popularization##3##1##(1993-2#1)(2007-5#1)(2013-1#1)
popularized##3##1##(1997-1#1)(2010-8#1)(2011-1#1)
populate##3##1##(1991-6#1)(1995-2#1)(2012-1#1)
populated areas##2##2##(1994-8#1)(2008-2#1)
populated by##3##2##(1997-5#1)(2008-5#2)
populated in##2##2##(1996-2#1)(2007-11#1)
populated##16##1##(1991-1#1)(1993-11#1)(1994-8#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#2)(2013-1#1)
populating##2##1##(2007-11#1)(2008-7#1)
population about##2##2##(1990-5#1)(1991-9#1)
population adapted to##2##3##(2008-8#2)
population after##3##2##(1992-2#1)(1992-6#1)(2008-10#1)
population ageing##2##2##(2008-7#2)
population ages##5##2##(1996-2#1)(2008-1#1)(2008-7#2)(2012-3#1)
population aging##4##2##(2008-7#1)(2010-5#2)(2013-1#1)
population also##2##2##(2008-10#2)
population analysis##2##2##(2008-1#1)(2012-12#1)
population and a##3##3##(1992-1#1)(2007-8#1)(2012-12#1)
population and for##2##3##(1991-1#1)(1995-12#1)
population and its##4##3##(1990-3#1)(1991-12#1)(1993-5#1)(2008-9#1)
population and may be##2##4##(2007-7#1)(2008-10#1)
population and more##2##3##(1997-1#1)(1997-2#1)
population and reproductive##2##3##(2010-8#1)(2013-7#1)
population and should##2##3##(2011-2#1)(2013-1#1)
population and the##12##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
population and their##2##3##(1991-3#1)(2011-1#1)
population and to##2##3##(1990-3#1)(2008-10#1)
population and##102##2##(1990-3#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#12)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
population appears to##2##3##(2008-10#1)(2011-2#1)
population appears##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
population approach##2##2##(1991-6#1)(2008-10#1)
population are##12##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
population as a whole##7##4##(2008-11#2)(2008-8#2)(2010-8#1)(2011-1#1)(2012-12#1)
population as a##8##3##(1996-12#1)(2008-11#2)(2008-8#2)(2010-8#1)(2011-1#1)(2012-12#1)
population as well as the##2##5##(1995-9#1)(2011-1#1)
population as well as##6##4##(1992-2#1)(1994-2#1)(1995-9#1)(2009-10#1)(2011-1#1)(2011-2#1)
population as##16##2##(1992-2#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-8#1)(2008-11#2)(2008-12#1)(2008-8#2)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
population at high risk of##2##5##(1993-11#1)(2008-1#1)
population at high##3##3##(1993-11#1)(2008-1#1)(2008-10#1)
population at large##4##3##(1992-2#2)(2008-4#1)(2012-2#1)
population at risk##3##3##(1997-6#1)(2012-12#2)
population at##16##2##(1991-1#1)(1992-2#2)(1993-11#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-4#2)(2009-6#1)(2012-12#2)(2012-2#1)
population based##6##2##(1996-11#1)(1996-2#1)(2008-11#1)(2009-10#1)(2011-3#1)(2013-1#1)
population being##8##2##(1994-9#1)(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#2)
population between 2000 and 2010##6##5##(2013-8#6)
population between##10##2##(1990-8#1)(1994-6#1)(2008-10#1)(2008-9#1)(2013-8#6)
population biology and##2##3##(2008-6#1)(2008-8#1)
population biology in##2##3##(2008-8#2)
population biology##11##2##(2008-10#3)(2008-6#1)(2008-8#6)(2008-9#1)
population bottleneck##3##2##(2008-10#1)(2008-9#2)
population bottlenecks##3##2##(1995-2#2)(2010-8#1)
population but in##2##3##(2009-11#1)(2010-8#1)
population but##6##2##(2007-1#1)(2007-7#1)(2008-10#1)(2009-11#2)(2010-8#1)
population by##13##2##(1991-3#1)(1994-11#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
population can be##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2012-3#1)
population can##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
population carrying Rcm##2##3##(2008-10#2)
population census##3##2##(1991-11#1)(1994-2#1)(2013-1#1)
population change##2##2##(2008-8#1)(2008-9#1)
population characteristics##3##2##(2009-9#1)(2010-8#1)(2011-2#1)
population composition##2##2##(2008-10#2)
population comprising##3##2##(1990-6#1)(2010-2#1)(2011-2#1)
population consisted of##9##3##(1996-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
population consists of##2##3##(1997-6#1)(2008-1#1)
population control##5##2##(1993-9#1)(1994-8#1)(1994-9#1)(2007-7#1)(2011-2#1)
population crashes##2##2##(1995-2#1)(1996-6#1)
population cultured##3##2##(2008-11#2)(2008-9#1)
population data from##2##3##(2008-12#1)(2012-12#1)
population data##13##2##(1996-2#1)(2008-10#3)(2008-12#7)(2008-7#1)(2012-12#1)
population database##2##2##(2008-12#1)(2010-5#1)
population decline##6##2##(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#2)
population declines##2##2##(1995-2#1)(2009-2#1)
population demographics##2##2##(1992-1#1)(1994-3#1)
population demography##3##2##(2008-8#2)(2010-8#1)
population densities at##2##3##(2008-10#2)
population densities in the##2##4##(2008-10#2)
population densities in##3##3##(2008-10#3)
population densities of H##5##4##(2008-10#5)
population densities of the##3##4##(2008-10#2)(2008-7#1)
population densities of##19##3##(2007-5#1)(2008-10#17)(2008-7#1)
population densities than the##2##4##(2008-10#2)
population densities were##2##3##(2008-10#2)
population densities##54##2##(2007-5#1)(2008-10#42)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-8#1)
population density and##9##3##(1993-1#1)(2008-10#4)(2008-8#2)(2008-9#2)
population density in the##2##4##(1990-11#1)(2008-10#1)
population density in##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
population density of strain##2##4##(2008-10#2)
population density of the##4##4##(2008-10#4)
population density of##13##3##(2008-10#12)(2008-3#1)
population density or##3##3##(2008-8#1)(2010-8#1)(2012-2#1)
population density when##2##3##(2008-8#1)(2008-9#1)
population density##59##2##(1990-11#1)(1993-1#1)(1994-5#1)(1996-3#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-3#3)(2008-8#7)(2008-9#9)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-8#1)
population derived from a cross between##3##6##(2008-10#3)
population derived from a cross##4##5##(2008-10#4)
population derived from a##5##4##(2008-10#5)
population derived from anther culture of##2##6##(2008-4#1)(2008-8#1)
population derived from the cross##2##5##(2008-10#2)
population derived from##12##3##(2008-10#9)(2008-4#1)(2008-8#1)(2009-10#1)
population development##3##2##(2008-10#3)
population did not##3##3##(2008-10#2)(2008-11#1)
population differences##2##2##(2008-10#1)(2008-8#1)
population differentiation at##3##3##(2012-3#3)
population differentiation was detected##2##4##(2008-10#2)
population differentiation was##4##3##(2008-10#4)
population differentiation##18##2##(2008-10#13)(2008-8#1)(2012-3#4)
population distribution##3##2##(1995-12#1)(1997-2#1)(2008-2#1)
population distributions##3##2##(2008-8#2)(2008-9#1)
population diversity of##2##3##(2008-10#1)(2008-5#1)
population diversity##3##2##(2008-10#2)(2008-5#1)
population does##2##2##(1997-3#1)(2008-10#1)
population doubling##6##2##(1993-6#1)(2008-11#3)(2011-1#2)
population doublings##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
population during a##2##3##(2008-10#1)(2008-7#1)
population during##9##2##(1990-6#1)(1993-6#1)(1996-3#1)(2008-10#2)(2008-7#1)(2011-2#2)(2013-1#1)
population dynamics and##5##3##(2008-10#2)(2008-8#1)(2008-9#1)(2013-7#1)
population dynamics in##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
population dynamics of each##2##4##(2008-10#2)
population dynamics of the##7##4##(2007-12#1)(2008-10#5)(2008-5#1)
population dynamics of##24##3##(1994-8#1)(2007-12#1)(2008-10#14)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
population dynamics##61##2##(1994-8#2)(1997-6#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-5#2)(2008-8#13)(2008-9#9)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
population enjoys##2##2##(2012-1#2)
population estimates for##2##3##(2010-11#1)(2011-2#1)
population estimates##4##2##(1994-2#1)(2010-11#2)(2011-2#1)
population exhibited##3##2##(2008-10#2)(2013-8#1)
population expansion##2##2##(2010-8#1)(2011-2#1)
population experienced a##2##3##(2008-7#1)(2008-8#1)
population exposed to##2##3##(1995-5#1)(2008-7#1)
population features##2##2##(2008-8#1)(2008-9#1)
population for##13##2##(1994-6#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-8#1)(2013-1#1)
population from Real de Salinas##3##5##(2008-5#3)
population from a##3##3##(2008-10#2)(2012-3#1)
population from the cross##2##4##(2008-10#2)
population from the##7##3##(1991-12#1)(2008-10#2)(2009-7#1)(2011-1#3)
population from##32##2##(1991-11#1)(1991-12#1)(2008-1#1)(2008-10#15)(2008-12#3)(2008-5#3)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#4)(2012-3#1)
population genetic models##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
population genetic structure and##2##4##(2010-8#2)
population genetic structure of##8##4##(2008-10#5)(2008-8#1)(2011-2#1)(2013-8#1)
population genetic structure##14##3##(2008-10#7)(2008-8#3)(2010-8#2)(2011-2#1)(2013-8#1)
population genetic studies of##2##4##(2008-10#1)(2012-3#1)
population genetic studies##4##3##(1995-11#1)(2008-10#2)(2012-3#1)
population genetic##27##2##(1995-11#1)(2008-10#13)(2008-12#3)(2008-8#4)(2008-9#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
population genetics of##3##3##(2008-10#2)(2013-1#1)
population genetics##16##2##(2008-10#6)(2008-12#1)(2008-6#1)(2008-8#4)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
population grating##2##2##(2007-12#2)
population groups##8##2##(1990-12#1)(1997-8#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
population growth and##3##3##(1994-3#1)(2008-11#2)
population growth is##2##3##(2008-9#2)
population growth of##4##3##(2008-10#2)(2008-6#1)(2011-2#1)
population growth rate##7##3##(2008-8#4)(2008-9#2)(2010-8#1)
population growth rates and##3##4##(2008-8#3)
population growth rates##8##3##(2008-8#6)(2008-9#1)(2010-8#1)
population growth##44##2##(1991-3#1)(1994-2#1)(1994-3#1)(1994-7#2)(1994-9#1)(2008-10#5)(2008-11#5)(2008-5#1)(2008-6#1)(2008-8#12)(2008-9#7)(2009-4#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)
population had a##4##3##(1992-5#1)(2008-10#2)(2008-8#1)
population had##12##2##(1990-2#1)(1990-5#1)(1992-5#1)(1992-8#1)(2008-10#2)(2008-8#2)(2012-7#1)(2013-1#1)(2013-8#2)
population has a##4##3##(2007-10#1)(2008-1#1)(2008-10#2)
population has been##5##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
population has not##3##3##(1997-5#1)(2008-3#1)(2012-12#1)
population has##21##2##(1991-2#1)(1992-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
population have##10##2##(1991-8#1)(1994-6#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#1)
population health##12##2##(1996-12#3)(1997-2#1)(2008-7#1)(2009-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2013-8#1)
population heterogeneity##2##2##(2008-8#1)(2012-2#1)
population identified##2##2##(2008-10#2)
population in Israel##2##3##(2008-1#1)(2008-10#1)
population in Japan##3##3##(2007-1#1)(2012-2#2)
population in Nepal##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
population in a##4##3##(1997-2#1)(2008-8#1)(2011-1#1)(2012-12#1)
population in the North Fiji Basin##2##6##(2008-6#2)
population in the##29##3##(1992-3#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
population in this##2##3##(2008-10#2)
population in which##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
population in##94##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#1)(1995-9#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-12#2)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#2)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#2)(2009-4#1)(2010-11#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#11)(2012-12#5)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#2)
population included##2##2##(1996-9#1)(2012-12#1)
population increase##4##2##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
population increases##3##2##(2008-10#2)(2008-8#1)
population indicated that the##2##4##(2008-10#1)(2012-3#1)
population interactions##2##2##(2008-10#1)(2008-8#1)
population into a##2##3##(1997-6#1)(2008-8#1)
population into##3##2##(1997-6#1)(2008-10#1)(2008-8#1)
population inversion##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
population inversions##2##2##(2007-12#1)(2008-3#1)
population is a##3##3##(1990-3#1)(2008-10#1)(2010-6#1)
population is affected by##2##4##(2008-9#1)(2012-2#1)
population is affected##3##3##(2008-9#1)(2010-7#1)(2012-2#1)
population is also##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
population is at##2##3##(2012-12#1)(2012-2#1)
population is capable of##2##4##(2008-10#1)(2010-1#1)
population is dependent on##2##4##(2008-7#1)(2011-2#1)
population is increasing##2##3##(1992-11#1)(1997-8#1)
population is##76##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#3)(1991-9#1)(1992-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-10#1)(2007-12#4)(2008-10#7)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-2#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#2)
population isolated from##2##3##(2008-10#2)
population it##2##2##(1994-3#1)(2011-1#1)
population level##15##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-8#4)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#1)
population levels of##2##3##(2008-10#2)
population levels##11##2##(2008-10#9)(2010-5#1)(2012-2#1)
population life##2##2##(1993-1#1)(2013-1#1)
population located in##2##3##(2008-10#1)(2008-12#1)
population makes##2##2##(2011-2#1)(2013-8#1)
population may be##2##3##(2008-10#1)(2010-8#1)
population may##8##2##(1995-12#1)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
population membership##2##2##(2008-11#1)(2012-3#1)
population might##3##2##(1994-3#1)(2008-10#2)
population model##2##2##(2008-10#1)(2008-8#1)
population models##2##2##(2008-9#1)(2010-10#1)
population movements##2##2##(2008-8#1)(2013-1#1)
population needs##3##2##(1994-3#1)(2008-9#1)(2009-4#1)
population norms##3##2##(2008-6#1)(2010-10#1)(2013-1#1)
population now##2##2##(1994-12#1)(2012-2#1)
population of &gt##2##3##(1995-6#1)(2008-10#1)
population of 1##5##3##(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#1)(2012-2#1)
population of 128##2##3##(2007-9#1)(2008-10#1)
population of 2##2##3##(2008-10#1)(2008-7#1)
population of 330##2##3##(1991-11#2)
population of B##2##3##(1993-6#1)(2008-4#1)
population of C##2##3##(2008-10#1)(2008-8#1)
population of P##2##3##(2008-10#2)
population of Phytophthora##3##3##(2008-10#3)
population of R##2##3##(2008-10#2)
population of a cross##2##4##(2008-10#2)
population of a##8##3##(1993-5#1)(1995-9#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-8#1)
population of adolescent##2##3##(2011-1#2)
population of any##2##3##(1995-5#1)(2008-5#1)
population of approximately##3##3##(1995-11#1)(2008-1#1)(2008-4#1)
population of axon terminals with##2##5##(1997-2#2)
population of bacteria##3##3##(1996-6#1)(2008-7#1)(2011-2#1)
population of cells##5##3##(1995-5#1)(1996-5#1)(2008-11#1)(2008-9#1)(2010-10#1)
population of children who##2##4##(1992-1#1)(2008-11#1)
population of children##5##3##(1991-12#1)(1992-1#1)(2008-11#1)(2008-2#1)(2009-5#1)
population of each##2##3##(2008-10#1)(2013-1#1)
population of elderly##2##3##(2007-12#1)(2008-7#1)
population of healthy##2##3##(1990-12#1)(2008-11#1)
population of immature##2##3##(2008-11#1)(2008-5#1)
population of immunocompromised##2##3##(2011-2#2)
population of interest##2##3##(1994-1#1)(2008-9#1)
population of isolates##2##3##(2008-10#2)
population of neurons##5##3##(1991-2#2)(1996-12#1)(2007-8#1)(2009-10#1)
population of normal##2##3##(1992-6#1)(2011-2#1)
population of patients##8##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
population of recombinant inbred lines (RILs) was##2##7##(2008-10#2)
population of recombinant inbred lines##3##5##(2008-10#3)
population of sequence variants##2##4##(2008-10#2)
population of the United States##2##5##(2010-10#1)(2010-8#1)
population of the city of##2##5##(2008-7#1)(2013-1#1)
population of the##31##3##(1991-2#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-5#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
population of these##3##3##(1990-6#1)(2008-12#1)(2012-1#1)
population of this##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
population of young adults##3##4##(1991-1#1)(2010-5#1)(2012-12#1)
population of young##4##3##(1991-1#1)(2010-5#1)(2012-12#1)(2012-2#1)
population of##347##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#2)(1991-4#1)(1992-1#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#2)(1993-6#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#2)(2007-1#1)(2007-10#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#80)(2008-11#15)(2008-12#10)(2008-2#7)(2008-3#6)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#16)(2008-8#4)(2008-9#11)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#8)
population often##2##2##(2008-8#1)(2012-12#1)
population on the##2##3##(2008-10#1)(2011-2#1)
population on##6##2##(1995-2#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-3#1)
population only##2##2##(2008-10#1)(2008-8#1)
population or##4##2##(1992-11#1)(2008-11#1)(2010-3#1)(2012-12#1)
population over##6##2##(1990-6#1)(2008-10#2)(2011-2#3)
population parameters##5##2##(2008-8#3)(2008-9#1)(2012-2#1)
population per year##2##3##(2008-10#1)(2011-2#1)
population persistence##5##2##(2008-8#5)
population present##2##2##(2008-4#1)(2008-5#1)
population pressure##2##2##(1995-9#1)(2013-8#1)
population pressures##2##2##(2008-10#1)(2008-5#1)
population projections##2##2##(2012-12#2)
population redistribution##3##2##(2011-2#3)
population regulation##5##2##(2008-8#5)
population relaxation##2##2##(2007-11#2)
population requiring##3##2##(2008-3#1)(2009-9#1)(2013-1#1)
population sample from##3##3##(2008-12#3)
population sample of##6##3##(1990-8#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#2)
population sample##16##2##(1990-8#1)(1992-2#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-9#1)(2009-2#1)(2012-12#1)(2013-1#2)
population samples##5##2##(1995-12#1)(2008-11#1)(2008-12#2)(2009-5#1)
population sampling##2##2##(2008-1#1)(2008-10#1)
population segregated##2##2##(2008-10#2)
population sex ratio##2##3##(2008-8#1)(2010-8#1)
population showed a##2##3##(2008-5#1)(2008-8#1)
population showed that##3##3##(2008-10#2)(2008-9#1)
population showed##6##2##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
population size and##7##3##(1991-3#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)
population size below##3##3##(2008-10#1)(2008-8#2)
population size in##4##3##(1997-5#1)(2008-1#1)(2008-8#1)(2008-9#1)
population size is##3##3##(2008-8#2)(2010-7#1)
population size of the##3##4##(2008-10#3)
population size of##14##3##(2008-10#11)(2008-9#1)(2010-8#1)(2012-5#1)
population size was##3##3##(2008-10#1)(2008-8#2)
population size##75##2##(1991-3#1)(1992-12#1)(1992-2#1)(1996-3#1)(1996-6#2)(1997-5#1)(2008-1#3)(2008-10#24)(2008-12#1)(2008-5#2)(2008-8#21)(2008-9#10)(2010-7#1)(2010-8#1)(2011-2#1)(2012-5#1)(2013-1#3)
population sizes and##3##3##(2008-10#2)(2010-6#1)
population sizes in##3##3##(2008-10#2)(2008-9#1)
population sizes of the##2##4##(2008-10#2)
population sizes of##5##3##(2008-10#5)
population sizes##25##2##(2007-9#1)(2008-10#13)(2008-8#7)(2008-9#2)(2010-6#1)(2013-1#1)
population spike amplitude##2##3##(1996-5#1)(2008-7#1)
population spike##11##2##(1990-7#1)(1991-12#3)(1995-12#4)(1996-5#1)(1997-2#1)(2008-7#1)
population spikes in##2##3##(2008-11#1)(2008-2#1)
population spikes##7##2##(1996-5#1)(1997-2#2)(2008-11#3)(2008-2#1)
population spread##3##2##(2008-8#3)
population strategy##2##2##(1991-6#2)
population stratification##2##2##(2011-2#1)(2012-3#1)
population structure and##9##3##(2008-10#3)(2008-9#3)(2010-5#1)(2011-1#1)(2013-7#1)
population structure can##2##3##(2008-8#1)(2008-9#1)
population structure in##2##3##(2008-10#1)(2008-8#1)
population structure of S##2##4##(2008-10#2)
population structure of##21##3##(2008-10#15)(2008-5#1)(2011-2#4)(2013-8#1)
population structure was##2##3##(2008-10#1)(2008-5#1)
population structure##61##2##(2008-10#35)(2008-5#2)(2008-8#5)(2008-9#6)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-7#1)(2013-8#1)
population studied##3##2##(1997-4#1)(2007-10#1)(2013-1#1)
population studies to##2##3##(2008-10#1)(2008-4#1)
population studies##10##2##(1991-12#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)
population study in##2##3##(1993-11#1)(2013-1#1)
population study of##2##3##(2008-11#1)(2008-12#1)
population study##6##2##(1993-11#1)(1993-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
population subdivision##4##2##(2008-10#1)(2008-8#1)(2009-2#2)
population suffer from##2##3##(1994-11#1)(1997-2#1)
population surveillance##3##2##(1991-12#2)(1991-3#1)
population survey##2##2##(2007-11#1)(2008-7#1)
population tested##2##2##(2007-7#1)(2008-12#1)
population than in the##2##4##(2008-10#1)(2011-1#1)
population than##3##2##(2008-10#2)(2011-1#1)
population that is##5##3##(1996-2#1)(2007-12#1)(2008-10#2)(2008-12#1)
population that was##4##3##(1997-5#1)(2008-10#3)
population that will##2##3##(1995-2#1)(2008-10#1)
population that##23##2##(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2012-12#1)(2012-3#1)
population the##4##2##(1994-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
population through##3##2##(2008-11#1)(2009-2#1)(2011-2#1)
population to be##4##3##(1997-2#1)(2008-10#2)(2008-9#1)
population to##16##2##(1996-7#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#4)(2011-2#1)
population trapping##6##2##(2007-11#3)(2007-12#3)
population trends##4##2##(1997-2#1)(2008-8#1)(2008-9#2)
population turnover##3##2##(2008-8#2)(2008-9#1)
population under##5##2##(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-5#1)
population using both##2##3##(2009-3#1)(2010-11#1)
population using##6##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-11#1)
population viability##2##2##(2008-9#2)
population was compared##2##3##(2008-10#1)(2012-3#1)
population was composed of##3##4##(2008-10#2)(2010-1#1)
population was composed##4##3##(2008-10#2)(2010-1#1)(2011-2#1)
population was created from##2##4##(2008-10#2)
population was evaluated for##2##4##(2008-10#2)
population was lower than##2##4##(1996-3#1)(2008-9#1)
population was more##2##3##(2008-10#1)(2010-11#1)
population was reduced##2##3##(1995-2#1)(2008-11#1)
population was##75##2##(1991-6#1)(1993-3#1)(1995-2#1)(1995-9#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#35)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
population we found##2##3##(2007-8#1)(2008-8#1)
population we##3##2##(2007-8#1)(2008-8#1)(2011-1#1)
population were significantly##2##3##(2011-1#1)(2012-3#1)
population were studied##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
population were##28##2##(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2011-1#5)(2011-2#1)(2012-12#3)(2012-3#1)(2012-4#1)(2013-7#2)(2013-8#1)
population when##2##2##(2008-10#1)(2011-2#1)
population which##3##2##(1990-3#1)(1995-12#1)(2010-3#1)
population while##3##2##(2008-11#1)(2010-3#1)(2010-9#1)
population who##4##2##(1996-8#1)(1997-1#1)(2010-9#1)(2013-1#1)
population will be##3##3##(1994-7#1)(1994-9#1)(2008-8#1)
population will##5##2##(1994-7#1)(1994-9#1)(2008-7#1)(2008-8#1)(2010-8#1)
population with a##3##3##(1994-12#1)(2008-10#2)
population with##22##2##(1990-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
population within##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2010-8#1)
population without##4##2##(1996-9#1)(2008-10#2)(2008-8#1)
population##3045##1##(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#12)(1990-5#2)(1990-6#13)(1990-7#2)(1990-8#6)(1990-9#4)(1991-1#9)(1991-11#5)(1991-12#28)(1991-2#9)(1991-3#15)(1991-4#1)(1991-5#1)(1991-6#7)(1991-8#3)(1991-9#2)(1992-1#5)(1992-11#3)(1992-12#4)(1992-2#13)(1992-3#5)(1992-5#3)(1992-6#7)(1992-8#3)(1992-9#5)(1993-1#5)(1993-10#1)(1993-11#6)(1993-12#12)(1993-2#4)(1993-3#7)(1993-5#4)(1993-6#8)(1993-8#2)(1993-9#7)(1994-1#1)(1994-11#5)(1994-12#10)(1994-2#17)(1994-3#9)(1994-5#6)(1994-6#5)(1994-7#5)(1994-8#6)(1994-9#13)(1995-1#6)(1995-11#9)(1995-12#26)(1995-2#19)(1995-3#5)(1995-5#9)(1995-6#2)(1995-9#7)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#13)(1996-2#7)(1996-3#19)(1996-5#7)(1996-6#13)(1996-7#5)(1996-8#3)(1996-9#6)(1997-1#9)(1997-2#20)(1997-3#16)(1997-4#6)(1997-5#10)(1997-6#11)(1997-7#6)(1997-8#11)(2006-10#2)(2006-6#1)(2007-1#4)(2007-10#21)(2007-11#9)(2007-12#34)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#6)(2007-9#2)(2008-1#48)(2008-10#659)(2008-11#111)(2008-12#79)(2008-2#22)(2008-3#36)(2008-4#27)(2008-5#65)(2008-6#17)(2008-7#99)(2008-8#234)(2008-9#151)(2009-1#1)(2009-10#7)(2009-11#9)(2009-12#4)(2009-2#11)(2009-3#8)(2009-4#8)(2009-5#12)(2009-6#6)(2009-7#10)(2009-8#6)(2009-9#5)(2010-1#6)(2010-10#16)(2010-11#17)(2010-12#9)(2010-2#6)(2010-3#8)(2010-4#7)(2010-5#16)(2010-6#18)(2010-7#6)(2010-8#56)(2010-9#3)(2011-1#53)(2011-2#144)(2011-3#5)(2011-7#1)(2012-1#5)(2012-12#71)(2012-2#41)(2012-3#57)(2012-4#2)(2012-5#1)(2012-7#2)(2013-1#108)(2013-3#1)(2013-7#16)(2013-8#72)
population's health##2##2##(2010-8#1)(2011-1#1)
population's##11##1##(1994-6#1)(1996-1#1)(1997-7#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-7#1)
population) and##2##2##(1993-6#1)(2008-12#1)
population)##12##1##(1990-12#1)(1993-6#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-8#2)(2011-1#1)(2013-1#1)(2013-8#1)
population-averaged##3##1##(1995-2#3)
population-based and##4##2##(1994-3#1)(1997-6#1)(2012-12#1)(2012-3#1)
population-based case-control##4##2##(1992-10#3)(2007-10#1)
population-based cohort study##2##3##(2008-6#1)(2013-1#1)
population-based cohort##6##2##(2007-10#1)(2008-6#1)(2010-6#1)(2013-1#3)
population-based data##4##2##(1996-12#1)(1997-2#1)(2007-10#1)(2008-3#1)
population-based estimates of##2##3##(1993-9#1)(2013-1#1)
population-based health datasets - part##2##5##(2012-2#2)
population-based model##3##2##(2009-8#3)
population-based services##2##2##(1995-12#1)(1996-2#1)
population-based stroke##2##2##(2007-10#1)(2008-8#1)
population-based studies of##2##3##(2007-12#1)(2008-1#1)
population-based studies##7##2##(2007-10#1)(2007-12#1)(2008-1#2)(2008-7#1)(2013-1#1)(2013-8#1)
population-based study of##3##3##(2007-12#1)(2008-12#1)(2008-7#1)
population-based study##11##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
population-based survey##2##2##(1994-8#1)(2013-8#1)
population-based surveys##2##2##(2008-12#2)
population-based##102##1##(1991-6#2)(1991-8#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-6#1)(1993-9#5)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-10#5)(2007-12#3)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#3)(2008-6#1)(2008-7#5)(2008-8#3)(2009-8#3)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#5)
population-genetic structure##2##2##(2008-9#1)(2011-2#1)
population-genetic##3##1##(2008-9#2)(2011-2#1)
population-groups##2##1##(2008-12#2)
population-level and individual-level##2##3##(1994-9#1)(2008-8#1)
population-level##16##1##(1994-9#1)(2007-12#2)(2008-10#1)(2008-8#2)(2008-9#4)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
population-specific##6##1##(1995-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-3#1)
population-wide##5##1##(2008-8#3)(2011-2#1)(2012-12#1)
population]##8##1##(1993-11#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
populational##2##1##(2008-6#1)(2008-9#1)
populations (&gt##2##2##(2008-10#2)
populations (from##2##2##(2008-10#2)
populations 881-WT and 882-WT on##2##5##(2008-10#2)
populations 881-WT and 882-WT##3##4##(2008-10#3)
populations adapted to##3##3##(2008-10#1)(2012-3#2)
populations after##3##2##(1991-9#1)(2008-10#1)(2008-9#1)
populations almost##2##2##(2008-5#1)(2009-3#1)
populations along the##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
populations along##4##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
populations also##2##2##(2008-10#1)(2010-5#1)
populations among##2##2##(2008-7#1)(2010-5#1)
populations and 10##2##3##(2008-10#1)(2008-7#1)
populations and in##4##3##(1994-1#1)(2008-10#1)(2009-4#1)(2012-3#1)
populations and root##2##3##(2008-10#2)
populations and species##2##3##(2008-8#1)(2013-7#1)
populations and that##2##3##(2008-10#1)(2008-8#1)
populations and the##6##3##(1995-6#1)(2007-5#1)(2008-10#1)(2008-8#2)(2011-2#1)
populations and##75##2##(1991-12#1)(1993-12#1)(1994-1#2)(1995-12#1)(1995-6#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#7)(2009-4#1)(2009-8#1)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#5)(2012-3#3)(2012-4#1)(2012-7#1)(2013-1#3)(2013-7#2)
populations are at##2##3##(2008-7#1)(2012-1#1)
populations are not##2##3##(2008-10#1)(2008-5#1)
populations are##34##2##(1994-3#1)(1995-12#1)(1995-3#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2010-5#1)(2011-1#1)(2012-1#1)
populations as well as##2##4##(2008-10#1)(2008-8#1)
populations as##5##2##(1995-12#2)(2008-10#2)(2008-8#1)
populations associated with##3##3##(2008-10#2)(2008-4#1)
populations at risk##3##3##(2007-11#1)(2008-6#2)
populations at the##4##3##(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)
populations at##14##2##(1997-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-6#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
populations based on##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
populations belong to##2##3##(2008-10#1)(2013-7#1)
populations but##2##2##(1994-3#1)(2011-2#1)
populations by##11##2##(1996-11#1)(2008-10#4)(2008-4#1)(2008-9#2)(2009-8#1)(2011-2#2)
populations can be##7##3##(1994-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#1)
populations can##13##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#4)(2008-9#1)(2012-1#1)(2013-1#1)
populations changed##4##2##(2008-10#4)
populations collected from three##2##4##(2008-10#1)(2011-2#1)
populations collected from##10##3##(2008-10#9)(2011-2#1)
populations collected##12##2##(2008-10#11)(2011-2#1)
populations compared with the##2##4##(2008-10#2)
populations containing##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
populations could be##3##3##(2008-10#2)(2010-8#1)
populations could##4##2##(2008-10#3)(2010-8#1)
populations decreased##2##2##(2008-10#2)
populations derived from an##2##4##(2008-5#1)(2008-8#1)
populations derived from crosses##2##4##(2008-10#2)
populations derived from##12##3##(2008-10#7)(2008-4#2)(2008-5#1)(2008-8#2)
populations differed##2##2##(1994-6#1)(2009-9#1)
populations displayed##2##2##(2008-10#1)(2013-1#1)
populations due to##2##3##(2008-10#1)(2011-2#1)
populations during the##2##3##(2008-10#2)
populations during##4##2##(1994-9#1)(2008-10#3)
populations even when##2##3##(2008-7#1)(2008-9#1)
populations even##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
populations exposed to##2##3##(2008-10#1)(2008-9#1)
populations following 30 passages##2##4##(2013-1#2)
populations for##7##2##(1992-3#1)(1995-11#1)(1997-5#1)(1997-6#1)(2007-1#1)(2008-10#1)(2011-2#1)
populations from P##2##3##(2008-10#2)
populations from a##2##3##(2008-8#1)(2011-2#1)
populations from component pure stands##2##5##(2008-10#2)
populations from cultivated##2##3##(2008-10#2)
populations from different locations##2##4##(2008-10#2)
populations from different##5##3##(2008-10#4)(2012-7#1)
populations from four host genotypes##3##5##(2008-10#3)
populations from the##9##3##(2008-10#7)(2008-8#1)(2011-2#1)
populations from##75##2##(2007-1#1)(2008-1#1)(2008-10#48)(2008-4#2)(2008-5#3)(2008-8#7)(2008-9#1)(2009-6#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-7#1)(2013-1#5)
populations generally##2##2##(2008-10#1)(2008-9#1)
populations had##3##2##(2008-10#1)(2009-9#1)(2011-2#1)
populations has##4##2##(1996-3#1)(2009-4#1)(2010-11#1)(2010-8#1)
populations have been##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
populations have not##2##3##(2008-10#1)(2008-8#1)
populations have##9##2##(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
populations having##2##2##(1996-12#1)(2008-8#1)
populations in a##4##3##(1997-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
populations in one##2##3##(2011-2#1)(2013-7#1)
populations in sympatry##2##3##(2008-10#2)
populations in the field##2##4##(2008-10#1)(2008-9#1)
populations in the greenhouse##2##4##(2008-10#2)
populations in the##24##3##(1992-8#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-1#2)
populations in their##2##3##(2008-10#1)(2008-12#1)
populations in which##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
populations in##92##2##(1992-2#1)(1992-3#1)(1992-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-3#1)(1997-4#2)(2008-1#1)(2008-10#41)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
populations include##2##2##(2008-11#2)
populations including the##2##3##(2010-11#1)(2010-3#1)
populations increased##2##2##(2008-10#1)(2008-8#1)
populations indicated that##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
populations indicated##4##2##(2008-10#2)(2010-8#1)(2011-2#1)
populations interact with##2##3##(1995-2#1)(2011-2#1)
populations into##2##2##(2008-10#1)(2008-8#1)
populations involved in##2##3##(2008-10#1)(2008-11#1)
populations is a##3##3##(2008-9#2)(2009-2#1)
populations is##16##2##(1991-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-9#4)(2009-2#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
populations isolated from##2##3##(2008-10#2)
populations living in##5##3##(1994-5#1)(2007-5#1)(2008-12#1)(2008-7#1)(2013-7#1)
populations living##9##2##(1991-3#2)(1994-5#1)(1996-6#2)(2007-5#1)(2008-12#1)(2008-7#1)(2013-7#1)
populations located##2##2##(2008-10#1)(2012-7#1)
populations may##3##2##(2008-8#1)(2009-9#1)(2010-5#1)
populations occur##2##2##(1996-6#1)(2008-10#1)
populations of 2##2##3##(2008-10#2)
populations of A##2##3##(2008-10#2)
populations of Aedes aegypti##2##4##(2007-10#2)
populations of B##5##3##(2008-10#5)
populations of C##7##3##(2008-10#7)
populations of CMV and its satRNA##2##6##(2008-10#2)
populations of CMV##3##3##(2008-10#3)
populations of D##3##3##(2008-5#1)(2013-8#2)
populations of Drosophila##2##3##(2008-9#1)(2012-3#1)
populations of Erwinia amylovora##2##4##(2008-10#2)
populations of F##3##3##(2008-10#3)
populations of G##5##3##(2008-10#4)(2010-3#1)
populations of H##4##3##(2008-10#2)(2011-2#2)
populations of Heterodera glycines##2##4##(2008-10#2)
populations of L##3##3##(2008-10#2)(2010-8#1)
populations of M##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
populations of Mycosphaerella graminicola##2##4##(2008-10#2)
populations of P##15##3##(2008-10#14)(2009-5#1)
populations of Phytophthora capsici##2##4##(2008-10#2)
populations of Phytophthora infestans in the United States##2##8##(2008-10#2)
populations of Phytophthora parasitica were significantly reduced in##2##8##(2008-10#2)
populations of Phytophthora parasitica##4##4##(2008-10#4)
populations of Phytophthora##9##3##(2008-10#9)
populations of Pseudomonas putida 06909-rif/nal##2##5##(2008-10#2)
populations of Pseudomonas##4##3##(2008-10#4)
populations of R##2##3##(2008-10#2)
populations of S##4##3##(2008-10#3)(2011-2#1)
populations of T##2##3##(2008-10#2)
populations of V##3##3##(2008-10#3)
populations of Venturia inaequalis was##2##5##(2008-10#2)
populations of Venturia inaequalis##3##4##(2008-10#3)
populations of Western##2##3##(2008-10#1)(2011-2#1)
populations of a##9##3##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)(2012-3#1)(2012-7#1)
populations of bacteria##3##3##(2008-10#2)(2012-3#1)
populations of birds##2##3##(2008-8#1)(2008-9#1)
populations of cells from##2##4##(2008-11#1)(2008-4#1)
populations of cells##8##3##(1992-8#2)(1995-2#1)(2008-11#1)(2008-4#1)(2009-2#1)(2012-3#1)(2013-1#1)
populations of culturable bacteria##3##4##(2008-10#3)
populations of different sizes##3##4##(2008-9#2)(2011-2#1)
populations of different##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
populations of each##3##3##(2008-10#3)
populations of hybrids between##2##4##(2008-9#2)
populations of hybrids##4##3##(2008-10#2)(2008-9#2)
populations of neurons and##2##4##(1993-12#1)(2008-4#1)
populations of neurons##7##3##(1993-12#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-1#1)
populations of strain##2##3##(2008-10#2)
populations of the pathogen##4##4##(2008-10#4)
populations of the##37##3##(1990-8#2)(1991-4#1)(1994-9#1)(1997-7#1)(2008-1#1)(2008-10#19)(2008-8#6)(2008-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
populations of these two##2##4##(2008-10#2)
populations of this##3##3##(1992-8#1)(2008-11#2)
populations of three##2##3##(2008-10#2)
populations of wild##2##3##(2008-10#1)(2013-7#1)
populations of##328##2##(1990-5#3)(1990-8#2)(1991-4#1)(1992-12#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#173)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#17)(2008-9#13)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#4)(2010-8#2)(2011-1#1)(2011-2#14)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#8)(2012-7#2)(2013-1#10)(2013-7#1)(2013-8#3)
populations on a##2##3##(2008-10#1)(2008-9#1)
populations on different##2##3##(2008-10#2)
populations on pear##2##3##(2008-10#2)
populations on the##4##3##(1993-6#1)(2007-5#1)(2010-8#1)(2012-9#1)
populations on##22##2##(1993-6#1)(2007-5#1)(2008-10#14)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-9#1)(2013-7#1)
populations or##10##2##(1996-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
populations over the##2##3##(2008-10#2)
populations over##3##2##(2008-10#3)
populations present##2##2##(2008-10#2)
populations prior to##2##3##(2008-10#1)(2008-11#1)
populations probably##2##2##(2008-10#2)
populations ranged from##3##3##(2008-10#3)
populations remained##2##2##(2008-10#1)(2008-8#1)
populations requires##2##2##(2008-7#1)(2008-9#1)
populations resistant to##2##3##(2008-10#2)
populations respond to##2##3##(2008-8#2)
populations revealed that##4##3##(1993-11#1)(2008-10#2)(2008-8#1)
populations revealed##7##2##(1993-11#1)(2008-10#4)(2008-12#1)(2008-8#1)
populations sampled from the##2##4##(2008-10#2)
populations sampled from##4##3##(2008-10#4)
populations sampled in##3##3##(2008-10#3)
populations sampled##10##2##(2008-10#9)(2008-9#1)
populations should be##2##3##(2008-8#1)(2008-9#1)
populations show##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
populations showed a##2##3##(2008-9#1)(2011-1#1)
populations showed##4##2##(2008-9#2)(2011-1#1)(2011-2#1)
populations significantly##3##2##(2008-2#1)(2008-5#1)(2013-1#1)
populations so##2##2##(2008-10#1)(2008-9#1)
populations studied##11##2##(1992-10#1)(1996-12#1)(2008-1#1)(2008-10#4)(2008-9#2)(2013-7#1)(2013-8#1)
populations such as##2##3##(1997-2#1)(2012-12#1)
populations suggests that##2##3##(2008-10#1)(2010-5#1)
populations targeted##2##2##(1993-9#1)(1994-3#1)
populations than##3##2##(2008-10#2)(2008-11#1)
populations that are##6##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#2)(2013-7#1)
populations that can be##2##4##(2008-10#1)(2008-4#1)
populations that had been##2##4##(2008-10#1)(2008-8#1)
populations that##25##2##(1991-6#1)(2007-11#1)(2008-10#8)(2008-4#2)(2008-8#3)(2008-9#4)(2009-12#1)(2009-6#1)(2010-10#1)(2010-6#1)(2013-1#1)(2013-7#1)
populations through##4##2##(2008-10#2)(2008-8#2)
populations to be##2##3##(2008-11#1)(2009-6#1)
populations to the##3##3##(2008-10#2)(2008-8#1)
populations to##25##2##(1995-2#1)(1997-8#1)(2008-10#10)(2008-11#1)(2008-8#3)(2008-9#3)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-7#1)(2013-1#1)
populations under##4##2##(2007-10#1)(2008-10#1)(2008-8#1)(2010-10#1)
populations using the##2##3##(2008-10#2)
populations using##6##2##(2008-10#3)(2008-11#1)(2009-7#1)(2012-3#1)
populations was 0##2##3##(2008-10#2)
populations was observed##2##3##(2008-10#1)(2012-3#1)
populations was significantly##2##3##(2008-10#2)
populations was studied##2##3##(2008-10#2)
populations was##28##2##(2008-10#23)(2008-11#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
populations were at##2##3##(2008-10#2)
populations were compared##2##3##(1990-6#1)(1995-12#1)
populations were developed by crossing##2##5##(2008-10#2)
populations were evaluated##2##3##(2008-10#2)
populations were genotyped##2##3##(2008-10#1)(2013-8#1)
populations were highly diverse##2##4##(2008-10#2)
populations were highly##5##3##(2008-10#5)
populations were monitored##2##3##(2008-10#2)
populations were more aggressive on##2##5##(2008-10#2)
populations were more##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
populations were not##2##3##(2008-10#2)
populations were reduced##2##3##(2008-10#2)
populations were sampled from##2##4##(2008-10#2)
populations were sampled##3##3##(2008-10#3)
populations were##71##2##(1990-6#1)(1995-11#1)(1995-12#3)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#45)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#6)(2013-1#1)(2013-7#1)(2013-8#2)
populations where##3##2##(1996-11#1)(2008-8#1)(2008-9#1)
populations who##4##2##(1995-12#1)(2008-1#1)(2010-1#1)(2012-3#1)
populations will##4##2##(1995-3#1)(2008-10#1)(2010-2#1)(2012-2#1)
populations with a##5##3##(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-3#1)
populations with##24##2##(1990-8#1)(1992-2#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
populations within the##6##3##(1991-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)
populations within##14##2##(1991-12#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)
populations##1856##1##(1990-12#1)(1990-5#4)(1990-6#2)(1990-8#7)(1991-1#1)(1991-12#8)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#5)(1993-11#2)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-9#1)(1994-1#2)(1994-11#1)(1994-3#8)(1994-5#3)(1994-6#3)(1994-9#4)(1995-11#4)(1995-12#14)(1995-2#9)(1995-3#6)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#5)(1996-11#4)(1996-12#6)(1996-2#5)(1996-3#9)(1996-4#1)(1996-5#1)(1996-6#7)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#2)(2006-10#3)(2007-1#4)(2007-10#8)(2007-11#4)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#6)(2007-7#3)(2007-8#1)(2008-1#18)(2008-10#748)(2008-11#38)(2008-12#35)(2008-2#6)(2008-3#6)(2008-4#25)(2008-5#37)(2008-6#9)(2008-7#21)(2008-8#141)(2008-9#102)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#9)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#9)(2009-9#14)(2010-1#3)(2010-10#10)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#9)(2010-4#2)(2010-5#12)(2010-6#2)(2010-8#23)(2011-1#24)(2011-2#80)(2012-1#8)(2012-12#12)(2012-2#30)(2012-3#40)(2012-4#1)(2012-7#8)(2012-9#1)(2013-1#61)(2013-7#16)(2013-8#17)
populations'##2##1##(2008-5#1)(2008-8#1)
populations)##7##1##(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2011-1#1)
populations?##2##1##(2008-5#1)(2008-9#1)
porA from##2##2##(1993-12#2)
porA##6##1##(1993-12#5)(2008-11#1)
porcelain gallbladder##2##2##(1992-6#1)(1994-6#1)
porcelain##3##1##(1992-6#1)(1994-6#1)(2010-12#1)
porcine AF cells##2##3##(2012-2#2)
porcine DOs##2##2##(2013-1#2)
porcine FGF-2 mRNA##2##3##(1996-12#2)
porcine FGF-2##3##2##(1996-12#3)
porcine Leydig##2##2##(1992-3#2)
porcine MCP-1##2##2##(1994-11#2)
porcine Serpulina##3##2##(1996-11#3)
porcine Tex11 is##2##3##(2012-2#2)
porcine Tex11##4##2##(2012-2#4)
porcine and human##2##3##(1991-8#1)(2008-3#1)
porcine and##4##2##(1991-2#1)(1991-8#2)(2008-3#1)
porcine aortic endothelial cells##5##4##(1990-2#2)(1992-12#1)(1993-3#1)(2008-8#1)
porcine aortic smooth muscle cells##2##5##(1990-7#1)(1992-8#1)
porcine aortic tissue##2##3##(2009-7#2)
porcine aortic##10##2##(1990-2#2)(1990-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(2008-8#1)(2009-7#2)(2010-8#1)
porcine big endothelin-1##2##3##(1990-12#2)
porcine big##4##2##(1990-12#2)(1990-2#2)
porcine bone##2##2##(2008-12#1)(2012-3#1)
porcine brain##10##2##(1990-7#5)(1994-5#2)(1994-8#1)(1996-12#1)(1996-5#1)
porcine ciliary##2##2##(1992-8#2)
porcine coronary arteries with##2##4##(1994-11#2)
porcine coronary arteries##4##3##(1994-11#3)(1997-8#1)
porcine coronary artery##5##3##(1990-8#1)(1992-9#2)(2008-11#2)
porcine coronary##10##2##(1990-8#1)(1992-9#2)(1994-11#4)(1997-8#1)(2008-11#2)
porcine endogenous##2##2##(2010-10#1)(2011-2#1)
porcine granulosa cells##2##3##(1995-12#2)
porcine hepatocyte spheroids##2##3##(2008-11#2)
porcine hepatocyte##3##2##(2008-11#3)
porcine hepatocytes was##2##3##(2008-11#2)
porcine hepatocytes##6##2##(2008-11#5)(2011-2#1)
porcine intestinal##2##2##(1995-2#1)(2008-10#1)
porcine kidney##4##2##(1990-11#1)(1992-11#1)(2008-10#2)
porcine leukocyte 12-lipoxygenase##2##3##(1994-11#2)
porcine luteal cells##2##3##(1994-11#2)
porcine model of##2##3##(2007-7#1)(2012-2#1)
porcine model##9##2##(2007-7#1)(2007-8#1)(2008-4#1)(2009-2#1)(2011-2#3)(2012-2#1)(2013-1#1)
porcine models##2##2##(2009-2#1)(2012-2#1)
porcine oocytes##5##2##(2013-1#5)
porcine pancreas##3##2##(1990-12#1)(2008-10#1)(2010-11#1)
porcine pancreatic elastase (PPE)##4##4##(1991-3#1)(2008-5#3)
porcine pancreatic elastase##5##3##(1991-3#2)(2008-5#3)
porcine pancreatic##12##2##(1990-7#1)(1990-8#1)(1990-9#2)(1991-3#2)(1992-12#2)(2008-5#3)(2010-11#1)
porcine pepsinogen##3##2##(1995-3#3)
porcine placental##2##2##(1995-8#2)
porcine platelet lysate##2##3##(2008-11#2)
porcine renal##2##2##(1991-12#1)(2008-11#1)
porcine serum##4##2##(1991-12#4)
porcine skin model##2##3##(2008-5#2)
porcine skin##7##2##(2008-5#7)
porcine thyroid gland##4##3##(1993-3#4)
porcine tumor necrosis factor-encoding genes##2##5##(1991-6#2)
porcine##214##1##(1990-11#3)(1990-12#5)(1990-2#6)(1990-7#7)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#9)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#6)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#2)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#3)(1993-3#6)(1993-6#1)(1994-11#13)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#4)(1996-11#3)(1996-12#6)(1996-5#1)(1996-8#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#11)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-7#4)(2010-10#1)(2010-11#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#9)(2012-3#1)(2013-1#14)(2013-7#1)
pore and the##2##3##(2008-10#1)(2011-2#1)
pore and##5##2##(2008-10#1)(2010-11#1)(2011-2#2)(2012-2#1)
pore complex##8##2##(1994-11#3)(1995-2#2)(2011-2#3)
pore complexes##2##2##(2011-2#2)
pore diameter of##2##3##(1990-8#1)(2008-10#1)
pore diameter##4##2##(1990-8#2)(2008-10#1)(2008-5#1)
pore diameters##2##2##(1990-8#1)(2008-3#1)
pore distribution##2##2##(2007-12#1)(2013-1#1)
pore formation##9##2##(1990-11#1)(1994-2#5)(1994-5#1)(2008-10#1)(2008-11#1)
pore forming##2##2##(2008-10#1)(2008-8#1)
pore glass##8##2##(2008-10#8)
pore in##2##2##(2008-5#1)(2010-12#1)
pore network##2##2##(2008-6#1)(2009-7#1)
pore of the##2##3##(1991-9#2)
pore of##3##2##(1991-9#2)(2008-10#1)
pore size and##4##3##(2008-10#2)(2008-2#1)(2010-9#1)
pore size distribution##4##3##(2008-10#1)(2008-7#1)(2009-11#2)
pore size of the##2##4##(2008-5#2)
pore size of##3##3##(2008-10#1)(2008-5#2)
pore size##20##2##(1990-8#1)(1994-5#3)(2008-10#6)(2008-2#2)(2008-5#2)(2008-7#3)(2009-11#2)(2010-9#1)
pore sizes##8##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2012-2#1)(2013-1#1)
pore water##5##2##(2008-10#3)(2011-1#1)(2013-8#1)
pore waters##4##2##(2008-10#4)
pore##159##1##(1990-11#3)(1990-2#5)(1990-8#5)(1991-9#2)(1992-6#1)(1994-11#3)(1994-2#7)(1994-5#6)(1995-11#1)(1995-2#2)(2007-12#8)(2008-10#41)(2008-11#9)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#10)(2009-11#2)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-2#7)(2013-1#3)(2013-8#1)
pore-forming loop##2##2##(2012-12#2)
pore-forming##8##1##(1994-2#3)(2008-8#2)(2011-2#1)(2012-12#2)
pore-size distributions##2##2##(2008-3#1)(2008-7#1)
pored##2##1##(2007-12#1)(2013-7#1)
porencephaly##3##1##(1997-3#3)
pores and##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
pores are##4##2##(1994-2#2)(2007-12#1)(2009-11#1)
pores in the##5##3##(1994-2#2)(1997-6#1)(2008-10#1)(2008-8#1)
pores in##9##2##(1994-2#2)(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
pores is##2##2##(2008-7#1)(2011-2#1)
pores of the##7##3##(2008-10#4)(2008-5#1)(2010-2#1)(2011-1#1)
pores of##11##2##(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-1#1)
pores size##2##2##(2008-5#1)(2013-8#1)
pores that##2##2##(2008-7#1)(2009-11#1)
pores was##2##2##(2008-10#1)(2008-3#1)
pores with a diameter of##2##5##(1994-2#1)(2008-10#1)
pores with##3##2##(1994-2#1)(2008-10#2)
pores##65##1##(1990-2#1)(1994-2#7)(1997-6#1)(2007-12#4)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#3)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#2)
porgy##5##1##(2008-7#5)
porin##7##1##(1993-12#1)(1994-8#1)(2008-8#3)(2012-3#1)(2013-8#1)
porins##13##1##(1992-12#1)(1997-8#2)(2008-10#3)(2008-8#2)(2013-1#5)
pork and##4##2##(1997-2#1)(1997-4#1)(2008-10#1)(2010-4#1)
pork freshness using potentiometric##2##4##(2008-10#2)
pork freshness##3##2##(2008-10#3)
pork meat##6##2##(1990-8#1)(1997-4#2)(2010-4#3)
pork products##2##2##(1997-4#1)(2010-4#1)
pork quality##5##2##(2010-4#3)(2011-1#1)(2013-1#1)
pork##45##1##(1990-8#1)(1995-12#1)(1997-2#1)(1997-4#4)(2007-12#2)(2008-10#8)(2008-7#1)(2009-4#1)(2010-2#7)(2010-4#15)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
poroelastic##2##1##(2011-2#2)
porogen##2##1##(2008-10#1)(2008-7#1)
porogens##4##1##(2008-10#4)
porokeratosis##8##1##(2007-7#6)(2010-6#2)
porosities##3##1##(2009-12#1)(2009-7#2)
porosity and##6##2##(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#2)(2010-5#1)
porosity in##2##2##(2008-10#1)(2008-12#1)
porosity of the##2##3##(2008-10#2)
porosity of##3##2##(2008-10#2)(2008-7#1)
porosity##28##1##(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-7#8)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)
porosus##2##1##(2010-3#2)
porous Vycor glass##2##3##(2008-3#2)
porous beads (CPB##2##3##(2008-11#2)
porous beta-TCP##2##2##(2008-5#2)
porous bioceramic##2##2##(2008-5#2)
porous carrier##2##2##(1994-5#1)(2008-11#1)
porous carriers was investigated in order##2##6##(2008-11#2)
porous carriers##5##2##(1994-5#1)(2008-11#4)
porous cellulose##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
porous collagen##2##2##(2008-11#1)(2009-7#1)
porous core##4##2##(2008-10#4)
porous crystals##2##2##(2010-12#2)
porous glass##5##2##(2008-10#4)(2008-11#1)
porous graphitic carbon##5##3##(1990-8#2)(1995-6#1)(2008-10#2)
porous media##2##2##(2008-7#1)(2013-1#1)
porous metal##2##2##(2008-11#2)
porous microcarrier Cytopore##2##3##(2008-11#2)
porous microcarrier##3##2##(2008-11#3)
porous microcarriers##2##2##(2008-11#2)
porous scaffold##2##2##(2008-5#1)(2012-2#1)
porous silica##5##2##(1990-8#1)(2007-11#1)(2008-10#3)
porous silicon samples##2##3##(2008-10#2)
porous silicon##15##2##(1992-11#1)(2007-11#2)(2008-10#7)(2008-2#3)(2008-3#2)
porous structure##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)
porous##124##1##(1990-8#5)(1992-11#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-5#2)(1997-5#3)(2007-11#3)(2008-1#2)(2008-10#32)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#9)(2008-7#4)(2009-11#3)(2009-12#2)(2009-7#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#6)(2012-4#1)(2013-1#2)
porphyria##8##1##(1990-2#5)(1991-2#1)(1991-5#1)(2011-2#1)
porphyrin (TAPP)##2##2##(2008-10#2)
porphyrin and its##3##3##(2008-10#3)
porphyrin and##8##2##(2008-10#8)
porphyrin catalysts##2##2##(2008-7#2)
porphyrin compounds##3##2##(1994-5#1)(2008-10#2)
porphyrin film##3##2##(2008-10#3)
porphyrin fluorescence##4##2##(1991-5#2)(1993-11#1)(2008-10#1)
porphyrin in##2##2##(1992-8#1)(2008-10#1)
porphyrin is##2##2##(2008-10#2)
porphyrin molecules##2##2##(2008-10#2)
porphyrin pi-cation##2##2##(1994-5#2)
porphyrin to##5##2##(1997-7#1)(2008-10#3)(2010-6#1)
porphyrin with##3##2##(2008-10#3)
porphyrin##84##1##(1991-5#3)(1992-8#1)(1993-11#2)(1994-5#3)(1996-5#1)(1997-7#2)(2007-11#2)(2007-12#2)(2008-10#59)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-6#3)
porphyrinic##2##1##(1993-6#1)(1995-3#1)
porphyrinogen##3##1##(1991-5#1)(1996-5#2)
porphyrins can##2##2##(2008-10#2)
porphyrins have been##2##3##(1996-2#1)(2009-12#1)
porphyrins in##6##2##(1991-5#1)(1992-9#3)(1996-5#2)
porphyrins was##3##2##(1992-9#2)(2008-10#1)
porphyrins with##2##2##(2008-10#2)
porphyrins##30##1##(1991-5#1)(1992-9#8)(1993-8#1)(1994-12#1)(1996-2#1)(1996-5#3)(2008-10#11)(2008-6#1)(2009-12#2)(2010-6#1)
porri##2##1##(2008-10#2)
port access surgery##2##3##(2008-11#1)(2012-12#1)
port access##5##2##(2007-8#1)(2008-11#2)(2012-12#2)
port and the##2##3##(2007-11#1)(2008-10#1)
port and##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
port implantation##2##2##(2007-7#1)(2012-12#1)
port in##2##2##(2007-7#2)
port is##2##2##(2007-7#1)(2008-3#1)
port of a##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
port of the##4##3##(2007-12#2)(2008-10#2)
port of##11##2##(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)
port was##2##2##(2007-7#1)(2008-10#1)
port wine stain##2##3##(2007-11#1)(2009-4#1)
port wine##3##2##(1996-11#1)(2007-11#1)(2009-4#1)
port##78##1##(1995-5#1)(1996-11#1)(1997-1#1)(1997-6#2)(2007-11#4)(2007-12#4)(2007-7#15)(2007-8#2)(2008-10#20)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#3)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-12#4)(2013-1#1)
port-wine##2##1##(1996-3#1)(2007-12#1)
porta-caval anastomosis##5##2##(1993-3#5)
portability and##5##2##(2008-10#4)(2010-9#1)
portability##10##1##(1996-12#1)(2008-10#6)(2009-12#1)(2010-9#1)(2011-1#1)
portable analytical##2##2##(2008-10#2)
portable analyzer for##2##3##(2008-10#2)
portable analyzer##3##2##(2008-10#3)
portable and easily##2##3##(2008-4#1)(2012-12#1)
portable and##9##2##(1997-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#1)
portable devices##3##2##(2008-10#2)(2008-11#1)
portable gait rhythmogram##2##3##(2013-1#2)
portable gas chromatography-microflame ionization##2##4##(2008-10#2)
portable gas##3##2##(2008-10#3)
portable micro-XRF##2##2##(2008-10#2)
portable optical##2##2##(2008-10#2)
portable pumps##2##2##(1992-5#2)
portable ventilators##3##2##(2011-1#2)(2011-2#1)
portable##88##1##(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-9#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#43)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-10#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#2)
portacaval##2##1##(1991-11#1)(1993-3#1)
portal and cardiac##2##3##(1991-5#2)
portal and##4##2##(1991-5#2)(2010-12#1)(2012-3#1)
portal for##2##2##(2008-4#1)(2008-9#1)
portal hypertension are##2##3##(2006-10#1)(2013-8#1)
portal hypertension##25##2##(1991-11#1)(1991-5#2)(1991-6#1)(2006-10#5)(2009-8#5)(2009-9#3)(2010-10#1)(2011-2#1)(2013-1#3)(2013-8#3)
portal hypertensive colopathy##3##3##(2013-8#3)
portal hypertensive##5##2##(2009-8#2)(2013-8#3)
portal images##2##2##(2008-2#1)(2009-2#1)
portal infusion of hypertonic saline##4##5##(1993-12#4)
portal infusion of##5##3##(1993-12#5)
portal pressure by##2##3##(1991-5#1)(2009-9#1)
portal pressure##4##2##(1991-5#1)(1993-3#1)(2009-8#1)(2009-9#1)
portal technology##2##2##(2008-10#2)
portal thrombosis##4##2##(1990-3#1)(1990-8#3)
portal vein##8##2##(1995-2#1)(1997-4#1)(1997-8#1)(2009-11#2)(2009-9#1)(2012-2#1)(2012-3#1)
portal venous embolization##3##3##(1997-8#2)(2012-12#1)
portal venous##7##2##(1994-7#1)(1997-8#2)(2008-7#1)(2010-12#2)(2012-12#1)
portal##89##1##(1990-3#1)(1990-8#3)(1991-11#2)(1991-5#5)(1991-6#1)(1993-12#5)(1993-3#2)(1993-9#2)(1994-7#2)(1995-2#1)(1997-4#1)(1997-8#3)(2006-10#5)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#3)(2009-8#8)(2009-9#5)(2010-10#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#6)
portals in##2##2##(1995-8#1)(2010-3#1)
portals##14##1##(1991-8#1)(1995-8#1)(2008-10#7)(2008-9#1)(2009-2#2)(2010-3#1)(2011-2#1)
portfolio development##3##2##(2008-11#2)(2008-12#1)
portfolio is##2##2##(2008-12#2)
portfolio learning##2##2##(2008-12#1)(2013-1#1)
portfolio selection##4##2##(2012-12#2)(2013-1#2)
portfolio##27##1##(1996-1#1)(2008-11#3)(2008-12#15)(2008-5#1)(2012-12#3)(2013-1#4)
portfolios in##2##2##(2008-11#2)
portfolios##11##1##(1997-1#1)(2008-11#6)(2008-12#1)(2012-12#1)(2013-1#2)
portion and##3##2##(1997-4#1)(2008-7#1)(2011-2#1)
portion consists of##2##3##(2008-10#2)
portion from##2##2##(2011-1#1)(2013-8#1)
portion has##2##2##(1991-6#1)(2008-5#1)
portion in##3##2##(2007-11#1)(2009-10#1)(2011-1#1)
portion is##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
portion of a##6##3##(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2011-1#1)
portion of an##3##3##(1991-9#2)(2008-4#1)
portion of that##2##3##(1994-8#1)(2008-4#1)
portion of the Golgi complex##2##5##(2008-7#2)
portion of the duodenum##2##4##(1990-10#1)(2011-2#1)
portion of the gene##2##4##(1994-12#1)(2010-5#1)
portion of the genome##3##4##(2008-10#2)(2010-8#1)
portion of the large##2##4##(1993-8#1)(1996-5#1)
portion of the lateral##2##4##(1991-8#1)(2007-12#1)
portion of the mature##2##4##(1992-3#1)(1994-6#1)
portion of the spectrum##2##4##(2007-12#1)(2008-2#1)
portion of the##139##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-3#7)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-9#1)(2006-12#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-1#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#2)
portion of these##3##3##(1993-9#1)(1995-9#1)(2008-3#1)
portion of this##2##3##(1997-2#1)(2007-6#1)
portion of##210##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#5)(1992-3#8)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#4)(1995-12#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-9#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#5)(2008-7#13)(2008-8#2)(2008-9#6)(2009-1#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-2#3)(2012-3#6)(2013-1#3)
portion##261##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#5)(1992-3#8)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#4)(1995-12#2)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#1)(1997-9#2)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#17)(2008-8#2)(2008-9#8)(2009-1#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#13)(2012-2#4)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#1)
portion)##2##1##(2008-10#1)(2008-7#1)
portions and##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
portions of a##2##3##(2008-10#1)(2008-4#1)
portions of the facial skin##2##5##(2008-5#2)
portions of the##23##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#3)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#1)
portions of their##2##3##(1994-1#1)(1995-6#1)
portions of these##2##3##(1993-2#1)(2008-6#1)
portions of##49##2##(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
portions##76##1##(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-12#2)(1992-6#1)(1993-2#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#6)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2012-8#1)
porto-systemic shunt vessels##2##3##(2011-2#2)
porto-systemic shunt##3##2##(2011-2#3)
portocaval##2##1##(1990-3#2)
portoenterostomy##3##1##(1994-6#3)
portosystemic##5##1##(2006-10#2)(2009-8#1)(2009-9#2)
portrait of##7##2##(1992-1#1)(2008-12#1)(2008-2#1)(2009-1#1)(2009-7#2)(2012-2#1)
portrait##9##1##(1992-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-1#1)(2009-7#2)(2012-2#1)
portray##7##1##(1993-2#1)(1995-1#1)(1996-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)
portrayal of the##2##3##(2009-9#1)(2012-3#1)
portrayal of##3##2##(2009-9#1)(2012-2#1)(2012-3#1)
portrayed##3##1##(1996-6#1)(2008-11#1)(2010-5#1)
portrays##2##1##(2011-2#1)(2012-12#1)
ports in##2##2##(2007-11#1)(2011-2#1)
ports is##2##2##(2007-8#1)(2011-2#1)
ports##22##1##(2007-11#2)(2007-7#1)(2007-8#4)(2008-2#1)(2008-3#2)(2008-6#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#7)
portuguese##2##1##(2013-1#2)
posatirelin##4##1##(2008-7#4)
pose a challenge to##3##4##(2009-10#1)(2013-1#2)
pose a challenge##5##3##(2007-8#1)(2009-10#1)(2010-9#1)(2013-1#2)
pose a diagnostic##2##3##(2011-1#1)(2013-1#1)
pose a risk of##2##4##(2010-3#1)(2011-2#1)
pose a risk##3##3##(2008-12#1)(2010-3#1)(2011-2#1)
pose a serious##3##3##(2008-1#1)(2009-4#1)(2011-2#1)
pose a##28##2##(1992-2#1)(1994-7#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#4)(2013-8#1)
pose an##3##2##(2008-10#2)(2013-1#1)
pose any##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
pose challenges##2##2##(1993-3#1)(2008-11#1)
pose the##2##2##(2008-9#1)(2013-1#1)
pose un problème##2##3##(2011-2#1)(2013-1#1)
pose##65##1##(1991-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-7#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#6)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#8)(2013-8#2)
posed a##4##2##(1990-6#1)(2009-4#1)(2011-2#1)(2013-8#1)
posed by the##4##3##(1995-11#1)(2008-9#1)(2010-3#1)(2012-3#1)
posed by##18##2##(1991-3#2)(1992-2#1)(1995-1#1)(1995-11#2)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
posed to the##2##3##(2008-11#1)(2008-12#1)
posed to##4##2##(2007-12#1)(2008-11#2)(2008-12#1)
posed##39##1##(1990-6#1)(1991-3#2)(1992-2#2)(1995-1#1)(1995-11#2)(1995-8#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#4)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
poses a challenge to##6##4##(1994-12#1)(1995-2#1)(2010-12#1)(2010-3#2)(2012-2#1)
poses a challenge##7##3##(1994-12#1)(1995-2#1)(2010-12#1)(2010-3#2)(2010-5#1)(2012-2#1)
poses a major##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
poses a serious##2##3##(2008-7#1)(2011-2#1)
poses a##26##2##(1992-1#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#1)
poses an##3##2##(2007-12#1)(2008-4#1)(2009-2#1)
poses challenges##2##2##(1996-2#1)(2013-1#1)
poses new##2##2##(2008-10#1)(2008-7#1)
poses several challenges##2##3##(2011-2#1)(2012-12#1)
poses some problems##2##3##(2008-10#1)(2012-2#1)
poses the##2##2##(2008-11#1)(2008-8#1)
poses##53##1##(1990-3#1)(1992-1#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
posing a risk of shocks##2##5##(2011-1#1)(2011-2#1)
posing a##5##2##(1994-1#1)(2011-1#1)(2011-2#2)(2012-2#1)
posing the##2##2##(2008-11#1)(2008-12#1)
posing##9##1##(1994-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
posit that##2##2##(1994-12#1)(2013-1#1)
posited that##2##2##(2008-12#1)(2012-12#1)
posited##4##1##(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#1)
position (P &lt##2##3##(1993-10#2)
position -11377C &gt##3##3##(2011-1#3)
position 147##2##2##(2008-8#1)(2012-2#1)
position 2##4##2##(1991-2#1)(1992-6#1)(1993-11#1)(1994-3#1)
position 3##2##2##(1992-9#1)(1993-6#1)
position 30##3##2##(1992-8#3)
position 33##2##2##(1991-11#1)(1993-8#1)
position 4##4##2##(1990-8#1)(1995-3#1)(1996-5#1)(2013-8#1)
position a##5##2##(1992-6#3)(1994-3#1)(2008-2#1)
position accuracy of##2##3##(2008-2#1)(2008-3#1)
position accuracy##3##2##(1994-3#1)(2008-2#1)(2008-3#1)
position along the##2##3##(1997-4#1)(2008-6#1)
position along##3##2##(1997-4#1)(2008-10#1)(2008-6#1)
position among##4##2##(1992-11#1)(1995-6#1)(2008-11#1)(2009-8#1)
position and extent##2##3##(2008-2#1)(2011-2#1)
position and orientation##2##3##(1993-6#1)(2008-3#1)
position and shape##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
position and the##7##3##(1990-6#1)(2007-12#1)(2008-2#3)(2008-3#1)(2011-1#1)
position and velocity##2##3##(2008-3#2)
position and##64##2##(1990-12#1)(1990-6#1)(1992-11#2)(1992-4#3)(1993-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-12#2)(2008-2#6)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2011-1#4)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)
position are##4##2##(2008-1#1)(2008-2#1)(2013-1#1)(2013-8#1)
position as a##2##3##(2009-11#1)(2009-4#1)
position as compared with##3##4##(1992-11#1)(1993-1#1)(2008-6#1)
position as##13##2##(1990-2#1)(1992-11#2)(1993-1#1)(1993-2#1)(1996-3#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-3#1)
position at##5##2##(1993-8#1)(2008-10#3)(2011-2#1)
position between the##2##3##(1990-3#1)(2008-3#1)
position between##5##2##(1990-3#1)(1992-4#1)(1997-6#1)(2008-3#2)
position by##6##2##(1992-11#2)(1997-2#1)(2008-3#1)(2009-11#2)
position changes##3##2##(1993-1#1)(2007-12#1)(2009-4#1)
position control##3##2##(1994-2#1)(2010-3#1)(2011-1#1)
position corresponding to##4##3##(1990-2#1)(1991-12#1)(1993-3#1)(1996-5#1)
position cues##2##2##(1993-9#2)
position during##7##2##(1992-11#1)(1993-1#1)(2008-10#2)(2008-9#1)(2009-2#2)
position for the##2##3##(1995-5#1)(2011-2#1)
position for##13##2##(1992-4#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-9#1)(2011-2#3)
position from the##3##3##(1990-2#1)(1992-4#1)(1994-11#1)
position from##4##2##(1990-2#1)(1992-4#1)(1994-11#1)(2012-3#1)
position has##2##2##(1994-11#1)(1997-4#1)
position in a##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
position in relation to the##4##5##(1995-5#2)(2008-10#1)(2008-9#1)
position in the##28##3##(1990-8#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
position in##57##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#2)
position information##2##2##(1993-9#1)(2012-2#1)
position is##12##2##(1990-11#1)(1993-1#1)(1993-6#1)(1996-9#1)(2007-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2010-3#1)
position may be##3##3##(1992-4#1)(2008-12#1)(2008-4#1)
position may##5##2##(1992-4#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-4#1)
position measurement##3##2##(1993-5#1)(2007-11#1)(2008-3#1)
position of a##5##3##(1995-5#1)(1997-7#1)(2008-2#1)(2008-3#2)
position of adenosine##2##3##(2008-4#2)
position of amino acid##2##4##(1990-12#1)(2008-8#1)
position of each##2##3##(1994-5#1)(2007-11#1)
position of nurse cell nuclei##2##5##(2007-12#2)
position of the central##2##4##(1992-3#1)(2008-8#1)
position of the phenyl ring##2##5##(1995-11#1)(2013-1#1)
position of the sun and associated celestial##2##7##(1994-3#2)
position of the##105##3##(1990-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#7)(2008-3#23)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
position of##173##2##(1990-12#5)(1990-2#1)(1990-5#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#3)(2007-11#8)(2007-12#10)(2008-1#1)(2008-10#15)(2008-12#2)(2008-2#10)(2008-3#29)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-2#2)(2013-1#2)(2013-8#2)
position on the##11##3##(1992-11#1)(1995-12#1)(1995-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
position on##17##2##(1992-11#1)(1993-12#1)(1995-12#1)(1995-9#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#2)
position or##2##2##(2008-10#1)(2008-12#1)
position paper##3##2##(1996-1#1)(2007-12#1)(2012-2#1)
position papers##3##2##(1996-1#3)
position sense##2##2##(2012-3#2)
position sensitive detector##3##3##(2008-10#3)
position sensitive##4##2##(2008-10#4)
position sensors##2##2##(2008-3#1)(2009-9#1)
position shifting of##2##3##(2008-2#1)(2008-3#1)
position specific##2##2##(1997-7#1)(2008-11#1)
position that the##2##3##(1993-3#1)(2008-12#1)
position that##3##2##(1993-3#1)(2007-12#1)(2008-12#1)
position their##3##2##(1994-3#1)(1996-3#1)(1997-1#1)
position themselves##3##2##(1994-12#1)(1994-8#1)(1997-1#1)
position to provide##2##3##(1996-1#1)(2008-12#1)
position to the##2##3##(1993-1#1)(1996-12#1)
position to##26##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-11#1)(2010-4#1)(2011-1#1)
position was##13##2##(1992-11#1)(1993-1#1)(1993-10#1)(1993-11#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-8#1)
position were##4##2##(1990-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
position which##3##2##(2011-2#1)(2012-12#2)
position with respect to the##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
position with the##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
position with##9##2##(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2011-2#1)(2012-3#1)
position within the##8##3##(1990-11#1)(1993-11#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
position within##11##2##(1990-11#1)(1993-11#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#2)
position##894##1##(1990-11#3)(1990-12#10)(1990-2#6)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#19)(1992-12#1)(1992-3#7)(1992-4#12)(1992-6#12)(1992-8#7)(1992-9#2)(1993-1#10)(1993-10#6)(1993-11#6)(1993-12#8)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#6)(1993-8#6)(1993-9#4)(1994-1#1)(1994-11#7)(1994-12#6)(1994-2#2)(1994-3#12)(1994-5#7)(1994-8#8)(1995-11#5)(1995-12#8)(1995-2#9)(1995-3#4)(1995-5#10)(1995-6#7)(1995-8#7)(1995-9#2)(1996-1#9)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#7)(1997-7#11)(1997-8#4)(2006-10#2)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#22)(2007-12#32)(2007-6#1)(2007-8#8)(2008-1#7)(2008-10#63)(2008-11#18)(2008-12#24)(2008-2#37)(2008-3#78)(2008-4#8)(2008-5#16)(2008-6#8)(2008-7#16)(2008-8#22)(2008-9#17)(2009-10#6)(2009-11#8)(2009-12#4)(2009-2#4)(2009-3#6)(2009-4#4)(2009-5#4)(2009-6#1)(2009-8#4)(2009-9#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#12)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#17)(2011-2#30)(2012-1#1)(2012-12#6)(2012-2#19)(2012-3#13)(2013-1#13)(2013-8#6)
position)##4##1##(1997-2#1)(2007-7#1)(2008-10#1)(2008-3#1)
position-sensing##3##1##(2007-12#1)(2008-3#1)(2009-6#1)
position-sensitive detectors##3##2##(2008-3#3)
position-sensitive##7##1##(2007-11#2)(2008-2#1)(2008-3#4)
positional and##2##2##(2008-10#1)(2008-2#1)
positional atrial##3##2##(2009-4#3)
positional cloning approach##2##3##(1995-6#1)(2008-2#1)
positional cloning of the##3##4##(2008-10#2)(2008-7#1)
positional cloning of##5##3##(2008-1#1)(2008-10#3)(2008-7#1)
positional cloning##10##2##(1995-6#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-7#1)(2008-9#1)
positional effects##3##2##(1995-5#1)(2008-3#1)(2008-4#1)
positional enrichment##3##2##(2009-5#3)
positional isomers of##3##3##(1992-8#1)(1995-11#1)(1997-2#1)
positional isomers##8##2##(1992-8#1)(1995-11#1)(1997-2#1)(2008-10#4)(2011-1#1)
positional plagiocephaly##2##2##(2007-12#2)
positional vertigo##8##2##(2008-4#5)(2012-12#1)(2012-2#2)
positional##66##1##(1992-11#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-1#1)(2007-12#4)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#9)(2008-7#2)(2008-9#1)(2009-4#3)(2009-5#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
positioned and##3##2##(2007-7#1)(2008-10#1)(2012-12#1)
positioned as##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
positioned at a##2##3##(1993-11#1)(2008-3#1)
positioned at the##5##3##(1994-12#1)(1995-8#1)(2008-10#3)
positioned at##11##2##(1992-8#1)(1993-11#1)(1994-12#1)(1995-8#1)(2008-10#4)(2008-3#3)
positioned between##2##2##(1994-11#1)(1997-7#1)
positioned in a##2##3##(2007-11#1)(2011-2#1)
positioned in the##6##3##(1991-2#1)(2008-10#4)(2013-1#1)
positioned in##11##2##(1991-2#1)(2007-11#1)(2008-10#5)(2011-1#1)(2011-2#2)(2013-1#1)
positioned on the##3##3##(1997-9#1)(2007-12#1)(2008-10#1)
positioned on##6##2##(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#3)
positioned to##10##2##(1992-1#1)(1993-8#1)(1994-12#1)(2007-4#1)(2007-5#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)
positioned within##3##2##(1993-8#1)(2008-8#1)(2012-12#1)
positioned##84##1##(1991-12#1)(1991-2#1)(1992-1#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#18)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#4)(2013-1#3)
positioner##2##1##(2008-9#2)
positioners and##2##2##(2010-8#2)
positioners##4##1##(2008-2#1)(2010-8#3)
positioning a##5##2##(1993-11#1)(1993-9#1)(1994-12#1)(2008-6#1)(2013-1#1)
positioning and##5##2##(2008-11#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
positioning in##2##2##(2008-3#1)(2011-2#1)
positioning is##3##2##(2008-3#1)(2009-4#1)(2010-3#1)
positioning of the stimulating electrode##2##5##(2008-9#2)
positioning of the##23##3##(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1996-2#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
positioning of##33##2##(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
positioning strategies and##2##3##(1993-12#2)
positioning strategies##3##2##(1993-12#3)
positioning systems##2##2##(2008-10#1)(2008-7#1)
positioning the##2##2##(2008-10#1)(2008-3#1)
positioning to##2##2##(1995-8#1)(2009-10#1)
positioning with##2##2##(2008-10#1)(2008-4#1)
positioning##111##1##(1991-5#1)(1991-9#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-6#1)(1993-9#2)(1994-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#16)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#5)(2009-10#5)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-3#4)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)
positions 2##3##2##(1992-3#1)(1994-3#1)(2012-3#1)
positions and profiles##2##3##(2008-3#2)
positions and##28##2##(1992-11#2)(1993-1#1)(1994-1#2)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-2#2)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#7)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
positions are##3##2##(1995-2#1)(2007-12#1)(2008-3#1)
positions as##4##2##(1993-6#1)(1994-1#1)(2008-8#1)(2009-6#1)
positions by##3##2##(1991-7#1)(2008-3#1)(2008-7#1)
positions during##2##2##(2007-2#1)(2008-1#1)
positions for##3##2##(1990-6#1)(2008-3#1)(2008-6#1)
positions from##2##2##(1990-2#1)(1994-12#1)
positions in a##2##3##(2008-10#1)(2008-3#1)
positions in the waveguide##2##4##(2008-3#2)
positions in the##13##3##(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1997-3#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)
positions in##26##2##(1990-6#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-9#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)
positions is##2##2##(2007-8#1)(2008-6#1)
positions of the##27##3##(1990-2#1)(1990-5#2)(1992-3#1)(1992-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-8#1)(2012-1#1)(2013-1#1)
positions of##70##2##(1990-12#1)(1990-2#1)(1990-5#3)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-8#3)(1997-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
positions on##4##2##(1996-10#1)(2008-10#1)(2008-5#1)(2009-4#1)
positions reported##2##2##(1992-11#1)(1995-2#1)
positions was##3##2##(1991-11#1)(1993-8#1)(2013-1#1)
positions were##7##2##(1990-6#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)
positions with##2##2##(1992-11#1)(2012-3#1)
positions within the##2##3##(1997-9#1)(2008-3#1)
positions within##5##2##(1994-5#1)(1995-5#1)(1997-9#1)(2008-3#1)(2008-7#1)
positions##317##1##(1990-12#1)(1990-2#4)(1990-5#3)(1990-6#4)(1990-7#1)(1991-11#2)(1991-12#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#9)(1992-12#1)(1992-3#7)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#5)(1993-2#2)(1993-3#3)(1993-6#7)(1993-8#2)(1994-1#5)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#8)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#4)(1997-9#4)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#4)(2008-2#9)(2008-3#35)(2008-4#10)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
positions)##2##1##(1993-12#1)(1997-7#1)
positive (CD4+##2##2##(1997-7#2)
positive IgA antibody titer##2##4##(2007-10#2)
positive Kerr##2##2##(2007-12#2)
positive Kleihauer tests##2##3##(2009-3#2)
positive Kleihauer##3##2##(2009-3#3)
positive LLNA##2##2##(2008-10#2)
positive OCT##4##2##(2011-2#4)
positive P##2##2##(2008-10#2)
positive V(P) shift##2##3##(2009-6#2)
positive adjustment##2##2##(2009-7#2)
positive affect##6##2##(2007-8#1)(2008-11#2)(2008-7#1)(2009-7#1)(2012-12#1)
positive after##2##2##(1990-8#1)(1993-11#1)
positive airway pressure (CPAP)##2##4##(2010-7#1)(2011-1#1)
positive airway pressure for##2##4##(2007-8#1)(2010-5#1)
positive airway pressure##11##3##(2007-12#1)(2007-8#6)(2010-5#2)(2010-7#1)(2011-1#1)
positive airway##12##2##(2007-12#1)(2007-8#7)(2010-5#2)(2010-7#1)(2011-1#1)
positive allometry##3##2##(1993-12#1)(2011-2#2)
positive and negative aspects of the##2##6##(2008-11#2)
positive and negative aspects of##5##5##(1990-5#1)(1993-1#1)(2008-11#2)(2009-12#1)
positive and negative aspects##6##4##(1990-5#1)(1993-1#1)(1995-11#1)(2008-11#2)(2009-12#1)
positive and negative cases##2##4##(2008-10#2)
positive and negative correlations with##2##5##(2008-10#1)(2008-2#1)
positive and negative correlations##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
positive and negative index changes##2##5##(2008-2#2)
positive and negative index##3##4##(2007-12#1)(2008-2#2)
positive and negative information##2##4##(1993-12#2)
positive and negative predictive value of##3##6##(2007-5#1)(2011-2#1)(2013-1#1)
positive and negative predictive value##4##5##(2007-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
positive and negative predictive values of##2##6##(1991-6#1)(2008-11#1)
positive and negative predictive values were##2##6##(1991-4#1)(2008-12#1)
positive and negative predictive values##4##5##(1991-4#1)(1991-6#1)(2008-11#1)(2008-12#1)
positive and negative predictive##9##4##(1991-4#1)(1991-6#1)(1992-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
positive and negative social events##2##5##(2010-2#1)(2010-4#1)
positive and negative symptoms##2##4##(2008-12#1)(2012-2#1)
positive and negative values##2##4##(2008-3#1)(2012-2#1)
positive and negative##69##3##(1990-5#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#3)
positive and the##5##3##(1994-12#1)(1995-5#1)(1996-12#1)(2008-11#1)(2013-1#1)
positive and##110##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-4#1)(1991-6#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#1)(2008-6#3)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
positive antibody##2##2##(2011-2#1)(2013-8#1)
positive approach##2##2##(1994-12#1)(2008-11#1)
positive as well as##2##4##(2008-8#1)(2009-8#1)
positive as##3##2##(1990-6#1)(2008-8#1)(2009-8#1)
positive aspects##3##2##(1990-9#1)(2010-3#1)(2011-2#1)
positive association between##11##3##(1990-8#1)(1992-4#1)(1993-12#1)(1994-2#2)(2008-11#1)(2009-7#1)(2010-1#1)(2010-6#1)(2012-2#1)(2013-1#1)
positive association of##2##3##(2008-1#1)(2008-7#1)
positive association with##4##3##(2008-8#1)(2012-2#2)(2013-1#1)
positive association##20##2##(1990-8#1)(1992-4#1)(1993-12#1)(1994-2#3)(1995-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-6#1)(2012-2#3)(2013-1#3)
positive associations between##2##3##(2008-11#1)(2009-2#1)
positive associations of##2##3##(1997-8#2)
positive associations##6##2##(1997-8#2)(2007-12#1)(2008-11#1)(2009-2#1)(2009-8#1)
positive assortment##4##2##(2008-8#4)
positive at##4##2##(1994-7#1)(1997-2#1)(2007-7#1)(2008-5#1)
positive attitude toward##2##3##(1996-11#1)(2009-5#1)
positive attitude towards##2##3##(1993-3#1)(2013-1#1)
positive attitude##7##2##(1993-3#1)(1996-11#1)(2007-8#1)(2009-5#1)(2011-1#1)(2013-1#2)
positive attitudes that##2##3##(1994-3#1)(2010-3#1)
positive attitudes to##2##3##(2008-12#1)(2013-1#1)
positive attitudes towards##3##3##(1995-6#1)(2008-9#1)(2013-1#1)
positive attitudes##9##2##(1994-3#1)(1995-6#1)(2008-12#1)(2008-9#1)(2010-3#1)(2010-5#1)(2013-1#3)
positive axillary nodes##2##3##(1994-7#1)(1997-7#1)
positive axillary##3##2##(1993-2#1)(1994-7#1)(1997-7#1)
positive bacteria##7##2##(1997-8#1)(2007-7#1)(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
positive biopsy##2##2##(1994-12#1)(1994-9#1)
positive birefringence##2##2##(1990-7#1)(2008-3#1)
positive blood culture##2##3##(2010-12#1)(2010-6#1)
positive blood cultures##2##3##(2010-6#1)(2011-1#1)
positive blood##5##2##(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)
positive body image##2##3##(2007-12#2)
positive breast cancer##2##3##(2012-3#1)(2013-1#1)
positive breast##4##2##(2011-2#2)(2012-3#1)(2013-1#1)
positive but##3##2##(1997-6#1)(2009-7#1)(2013-7#1)
positive by the##2##3##(1992-6#2)
positive by##8##2##(1991-8#1)(1992-6#2)(1995-4#1)(2007-7#2)(2008-10#1)(2013-8#1)
positive cases##12##2##(1990-6#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-8#2)
positive cavity##2##2##(2007-12#2)
positive cell lines##2##3##(1992-12#1)(1993-3#1)
positive cell##3##2##(1992-12#1)(1993-3#1)(1995-8#1)
positive cells in##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
positive cells of##2##3##(1995-8#2)
positive cells were##3##3##(1996-5#1)(2007-10#1)(2007-8#1)
positive cells##17##2##(1990-12#1)(1991-5#1)(1994-7#1)(1995-8#3)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2013-1#1)
positive change in##2##3##(2008-5#1)(2011-2#1)
positive changes in##2##3##(2008-5#1)(2012-3#1)
positive changes##5##2##(1992-3#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-7#1)
positive charge of##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
positive charge##9##2##(1990-8#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
positive charges##4##2##(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)
positive chemical ionization##4##3##(2008-10#3)(2013-8#1)
positive clinical outcomes##2##3##(1995-1#1)(2011-2#1)
positive clinical##5##2##(1995-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
positive clone was##2##3##(2008-8#1)(2008-9#1)
positive clone##3##2##(1997-6#1)(2008-8#1)(2008-9#1)
positive clones were isolated from##2##5##(1991-1#1)(2008-8#1)
positive clones were obtained##2##4##(2008-9#2)
positive clones were##6##3##(1991-1#1)(1997-4#1)(2008-8#2)(2008-9#2)
positive clones##12##2##(1990-8#1)(1991-1#1)(1993-6#1)(1993-8#1)(1994-8#1)(1997-4#2)(2008-8#3)(2008-9#2)
positive cocci##3##2##(2007-7#1)(2010-12#1)(2013-8#1)
positive control group##4##3##(1992-2#1)(2008-10#1)(2010-1#1)(2013-1#1)
positive control in##3##3##(2008-10#2)(2008-5#1)
positive control##29##2##(1992-12#1)(1992-2#1)(1992-8#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-9#1)(2010-1#1)(2010-2#1)(2010-5#2)(2010-7#1)(2013-1#3)
positive controls##9##2##(2008-10#3)(2008-4#1)(2008-9#4)(2013-1#1)
positive cooperativity in the##2##4##(1997-2#2)
positive cooperativity##6##2##(1994-5#2)(1997-2#4)
positive coping##2##2##(1995-9#1)(2012-1#1)
positive correlation between expression##2##4##(2012-3#1)(2013-8#1)
positive correlation between the##7##4##(1990-10#1)(1993-11#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
positive correlation between##22##3##(1990-10#1)(1990-7#1)(1993-11#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-7#1)(2013-8#3)
positive correlation of##6##3##(1995-9#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#2)
positive correlation was found between the##2##6##(1992-10#1)(2008-10#1)
positive correlation was found between##5##5##(1992-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)
positive correlation was##9##3##(1992-10#1)(1995-12#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)
positive correlation with the##3##4##(1991-11#1)(1991-12#1)(2008-12#1)
positive correlation with##7##3##(1991-11#1)(1991-12#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-8#1)(2013-1#1)
positive correlation##50##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-10#1)(1993-11#1)(1995-12#1)(1995-9#1)(1997-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
positive correlations among##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
positive correlations between size at maturity and asymptotic size##3##9##(2008-9#3)
positive correlations between##8##3##(2007-6#1)(2008-8#1)(2008-9#4)(2010-8#2)
positive correlations were##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)
positive correlations with##4##3##(2008-8#1)(2010-10#1)(2011-1#2)
positive correlations##21##2##(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2010-10#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)
positive cultures##2##2##(2007-7#1)(2011-2#1)
positive cytology##2##2##(1994-7#1)(2011-1#1)
positive diagnosis of##2##3##(2008-7#1)(2008-9#1)
positive diagnosis##4##2##(1997-2#2)(2008-7#1)(2008-9#1)
positive direct antiglobulin test##4##4##(1992-3#1)(1992-9#1)(1994-3#1)(1994-9#1)
positive direct antiglobulin##5##3##(1992-3#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)
positive direction##2##2##(2008-10#2)
positive discography##9##2##(2012-12#9)
positive dispersion##2##2##(2007-11#1)(2008-3#1)
positive displacement##3##2##(2007-12#1)(2008-10#2)
positive due##2##2##(1995-4#1)(2008-1#1)
positive dynamics##2##2##(1996-3#1)(2011-1#1)
positive effect in##2##3##(2011-2#1)(2012-3#1)
positive effect of##6##3##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
positive effect on##17##3##(1990-9#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
positive effect##31##2##(1990-9#1)(1993-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
positive effects in##2##3##(2008-10#1)(2010-8#1)
positive effects of##5##3##(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
positive effects on##9##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
positive effects##24##2##(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#4)(2009-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
positive electrode##3##2##(2009-12#1)(2009-5#1)(2013-8#1)
positive electrospray ionization##2##3##(2010-11#1)(2011-1#1)
positive elements##2##2##(1991-6#1)(1996-2#1)
positive emotions##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
positive errors##2##2##(2008-10#2)
positive events##2##2##(2008-6#1)(2010-2#1)
positive experiences of##2##3##(2008-10#1)(2013-1#1)
positive experiences##5##2##(1993-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
positive expiratory pressure##2##3##(1991-2#1)(1997-3#1)
positive expression##2##2##(2009-4#1)(2012-2#1)
positive factor##3##2##(1993-6#1)(1993-8#1)(1995-2#1)
positive factors##2##2##(2009-12#1)(2009-8#1)
positive family history##7##3##(1997-5#1)(1997-6#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
positive family##8##2##(1997-5#1)(1997-6#1)(2008-3#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
positive features##3##2##(2008-2#2)(2008-5#1)
positive feedback and##2##3##(2008-11#1)(2009-9#1)
positive feedback in##2##3##(2009-8#1)(2009-9#1)
positive feedback loop##2##3##(1991-5#2)
positive feedback##12##2##(1990-8#1)(1991-5#2)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-10#1)
positive feelings##3##2##(2009-6#1)(2010-3#1)(2012-3#1)
positive findings are##2##3##(1995-1#1)(2008-8#1)
positive findings##7##2##(1994-12#1)(1995-1#1)(2008-10#1)(2008-8#2)(2012-2#2)
positive for ACA##2##3##(2011-2#2)
positive for CD34##2##3##(2009-11#2)
positive for H##2##3##(2008-1#1)(2008-5#1)
positive for HBsAg##2##3##(2008-7#1)(2013-8#1)
positive for HIV##2##3##(1995-6#1)(1996-5#1)
positive for PE##3##3##(2011-2#1)(2012-2#2)
positive for anti-HCV##2##3##(2008-1#1)(2013-8#1)
positive for both##4##3##(2011-2#4)
positive for epithelial membrane antigen##2##5##(2006-12#1)(2011-2#1)
positive for hepatitis##2##3##(2008-1#1)(2008-12#1)
positive for human immunodeficiency virus (HIV)##2##6##(1990-6#1)(2007-7#1)
positive for one##4##3##(1990-12#1)(2007-7#1)(2011-2#2)
positive for the##14##3##(1991-6#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-12#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#3)(2012-12#1)(2013-8#1)
positive for##123##2##(1990-12#2)(1990-3#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#14)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#2)(2008-12#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-11#2)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#17)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#6)
positive group##2##2##(2008-1#1)(2008-3#1)
positive health##2##2##(2008-10#1)(2008-11#1)
positive history of##4##3##(1991-4#1)(2008-12#1)(2008-9#1)(2013-7#1)
positive identification##3##2##(1995-3#1)(1995-6#1)(2008-10#1)
positive immunoreactivity##2##2##(1993-9#1)(2008-10#1)
positive impact of##2##3##(2008-11#1)(2008-6#1)
positive impact on the ability of##2##6##(1996-12#1)(2013-8#1)
positive impact on the##9##4##(1995-5#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#2)
positive impact on##15##3##(1994-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#3)(2013-1#1)(2013-8#2)
positive impact##18##2##(1994-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#4)(2013-1#1)(2013-8#2)
positive in NLE##2##3##(1993-5#2)
positive in all##4##3##(1991-3#1)(1995-11#1)(1996-8#1)(2012-12#1)
positive in media alone##2##4##(1995-12#2)
positive in the##5##3##(1994-7#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
positive in##44##2##(1990-2#1)(1990-3#1)(1991-3#1)(1993-5#3)(1994-1#1)(1994-7#1)(1995-11#1)(1995-12#2)(1996-8#1)(1997-2#1)(2007-11#1)(2007-7#5)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
positive influence of##7##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
positive influence on their##2##4##(2008-11#1)(2009-7#1)
positive influence on##6##3##(1994-3#1)(2008-11#1)(2008-7#2)(2009-7#1)(2013-8#1)
positive influence##13##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
positive inotropic effect of##2##4##(1995-12#2)
positive inotropic effect##3##3##(1995-12#2)(2008-5#1)
positive inotropic##9##2##(1995-12#2)(1997-7#6)(2008-5#1)
positive ion mode##4##3##(2008-10#2)(2011-3#2)
positive ion##5##2##(2008-10#3)(2011-3#2)
positive ionization##2##2##(2008-10#1)(2011-2#1)
positive levels##2##2##(2006-10#1)(2011-2#1)
positive likelihood##2##2##(2008-11#1)(2008-12#1)
positive linear##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
positive long-term##3##2##(1993-1#1)(2011-1#1)(2013-1#1)
positive lymph nodes##2##3##(1990-8#1)(2011-2#1)
positive male##2##2##(2009-5#1)(2013-1#1)
positive margins##4##2##(2008-6#2)(2012-2#2)
positive mental health##3##3##(2011-2#3)
positive messages##2##2##(2008-11#1)(2010-11#1)
positive modulators##3##2##(1992-3#3)
positive net##3##2##(1995-3#1)(2008-10#2)
positive neurones##2##2##(1993-9#2)
positive nodes##4##2##(1992-12#1)(1993-1#1)(2011-2#1)(2012-3#1)
positive on##4##2##(1997-4#1)(2008-10#1)(2009-7#2)
positive one##2##2##(2008-12#1)(2010-1#1)
positive or negative control##2##4##(2008-7#1)(2008-8#1)
positive or negative##20##3##(1990-8#1)(1993-5#1)(1994-7#1)(1995-11#2)(1995-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
positive or neutral##3##3##(1992-6#1)(1994-1#1)(2009-4#1)
positive or suspicious##2##3##(1995-4#2)
positive or##28##2##(1990-8#1)(1992-6#1)(1993-11#1)(1993-5#1)(1994-1#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-4#2)(1997-8#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-8#1)
positive outcome##2##2##(2008-12#1)(2008-6#1)
positive outcomes for patients with##2##5##(2012-3#1)(2013-8#1)
positive outcomes for patients##3##4##(2011-1#1)(2012-3#1)(2013-8#1)
positive outcomes for##5##3##(2008-11#2)(2011-1#1)(2012-3#1)(2013-8#1)
positive outcomes##11##2##(1995-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
positive patient##7##2##(1997-8#1)(2006-5#1)(2007-7#2)(2008-10#1)(2010-12#2)
positive patients is##3##3##(2007-7#1)(2008-1#1)(2008-5#1)
positive patients with##2##3##(1991-4#1)(2007-11#1)
positive patients##18##2##(1990-8#1)(1991-4#1)(1993-11#1)(1994-10#1)(2007-11#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-5#6)(2010-12#1)
positive performance##2##2##(1997-3#2)
positive persons##3##2##(1990-11#1)(1993-8#1)(2010-8#1)
positive physical##3##2##(2007-6#1)(2008-8#1)(2009-11#1)
positive polymerase chain reaction##3##4##(2008-12#1)(2011-2#2)
positive population##3##2##(1995-2#1)(2008-8#1)(2008-9#1)
positive potential to##2##3##(2008-10#2)
positive potential##9##2##(1993-12#1)(1994-8#1)(2008-10#7)
positive potentials##4##2##(1990-5#2)(2008-10#2)
positive predictive value and##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
positive predictive value of##3##4##(1992-10#1)(1993-2#1)(1993-5#1)
positive predictive value##18##3##(1992-10#1)(1992-11#1)(1993-2#1)(1993-5#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)
positive predictive values##4##3##(1994-3#1)(2007-10#1)(2011-1#1)(2012-12#1)
positive predictive##24##2##(1992-10#1)(1992-11#1)(1993-2#1)(1993-5#1)(1994-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)
positive pressure ventilation##3##3##(2008-1#1)(2008-8#1)(2013-7#1)
positive pressure##5##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-7#1)
positive proliferative responses to##2##4##(2011-2#2)
positive psychological##2##2##(2008-12#1)(2011-2#1)
positive rate of##3##3##(1994-12#1)(2011-1#1)(2012-3#1)
positive rate was 9##2##4##(2011-3#1)(2013-8#1)
positive rate was##3##3##(2011-3#1)(2013-8#2)
positive rate##10##2##(1992-3#1)(1993-1#1)(1994-12#1)(1997-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#3)
positive rates##3##2##(1996-12#1)(2011-1#1)(2012-3#1)
positive ratings of##2##3##(2012-2#2)
positive ratings##3##2##(2009-5#1)(2012-2#2)
positive reaction to##5##3##(1990-6#1)(1997-6#1)(2011-2#1)(2012-1#2)
positive reaction##7##2##(1990-6#1)(1997-6#1)(2007-12#1)(2010-4#1)(2011-2#1)(2012-1#2)
positive reactions##6##2##(1997-6#1)(2007-10#1)(2007-7#1)(2008-5#1)(2009-12#1)(2011-2#1)
positive regulation##2##2##(2008-4#1)(2008-8#1)
positive regulator of##4##3##(1996-2#1)(2010-11#1)(2011-1#1)(2013-1#1)
positive regulator##6##2##(1995-8#1)(1996-2#1)(2008-11#1)(2010-11#1)(2011-1#1)(2013-1#1)
positive regulatory##4##2##(1997-1#1)(1997-7#1)(1997-8#1)(2011-1#1)
positive reinforcement##3##2##(1993-6#1)(1994-2#1)(2008-2#1)
positive relation between##3##3##(1990-8#1)(2008-12#1)(2009-10#1)
positive relationship between the##2##4##(2008-10#1)(2011-1#1)
positive relationship between##9##3##(1995-3#1)(1996-12#1)(2008-10#3)(2010-10#1)(2010-11#1)(2011-1#1)(2013-7#1)
positive relationship of##2##3##(2008-1#1)(2013-1#1)
positive relationship##14##2##(1995-2#1)(1995-3#1)(1996-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
positive relationships##2##2##(1993-2#1)(2008-8#1)
positive religious coping##3##3##(2008-12#2)(2008-4#1)
positive resection##2##2##(2007-8#1)(2009-12#1)
positive residue##2##2##(2008-8#2)
positive residues in##3##3##(2008-8#3)
positive respectively##2##2##(2007-7#1)(2011-2#1)
positive response##7##2##(1993-12#1)(1993-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2010-4#1)
positive responses to##5##3##(1992-12#1)(2008-10#1)(2011-2#2)(2012-3#1)
positive responses##7##2##(1992-12#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-3#1)
positive result##3##2##(2007-7#1)(2010-3#1)(2012-3#1)
positive results and##2##3##(1990-3#1)(1997-5#1)
positive results in the##3##4##(1996-2#2)(1997-4#1)
positive results in##8##3##(1996-2#2)(1997-4#1)(2007-7#1)(2008-5#2)(2011-1#1)(2011-3#1)
positive results observed##3##3##(1992-12#1)(1997-4#1)(2007-7#1)
positive results obtained##2##3##(1997-4#1)(2011-2#1)
positive results of##4##3##(1990-10#1)(1997-6#1)(2011-1#1)(2012-2#1)
positive results on##2##3##(1993-3#1)(2010-8#1)
positive results were##3##3##(1990-12#1)(1993-3#1)(1997-4#1)
positive results with the##2##4##(2008-9#1)(2011-2#1)
positive results##47##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#1)(1992-12#2)(1993-3#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-4#7)(1997-5#3)(1997-6#1)(1997-8#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-5#4)(2008-9#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#2)
positive returns##2##2##(1997-3#1)(2008-1#1)
positive role in##5##3##(1993-6#1)(1995-12#1)(2009-8#1)(2010-2#1)(2011-2#1)
positive role##8##2##(1993-6#1)(1995-12#1)(1995-2#1)(2008-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
positive samples of##2##3##(1996-12#1)(2008-10#1)
positive samples were##2##3##(2007-7#1)(2008-1#1)
positive samples##17##2##(1996-12#2)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-12#1)(2010-6#3)(2011-1#1)(2011-2#2)(2012-12#1)
positive selection operates on##2##4##(1994-8#2)
positive selection##7##2##(1994-8#2)(2008-9#2)(2010-7#1)(2012-2#1)(2012-3#1)
positive sensory phenomena##4##3##(2012-2#4)
positive sensory symptoms##2##3##(2008-7#1)(2012-2#1)
positive sensory##6##2##(2008-7#1)(2012-2#5)
positive sera (dot-blot##2##3##(1990-8#2)
positive sera##7##2##(1990-8#4)(1997-5#1)(2007-2#1)(2007-7#1)
positive shift##3##2##(1995-5#1)(2008-8#1)(2012-3#1)
positive side##2##2##(1992-6#1)(2013-7#1)
positive signal##2##2##(1997-4#1)(2008-10#1)
positive signals##3##2##(2008-11#1)(2008-5#2)
positive single##2##2##(1992-11#1)(2009-12#1)
positive social##3##2##(2010-10#1)(2010-4#1)(2011-2#1)
positive staining for CD-117##2##4##(2012-12#2)
positive staining for##3##3##(2012-12#3)
positive staining of##2##3##(1993-9#1)(2008-8#1)
positive staining##6##2##(1993-9#1)(1997-7#1)(2008-8#1)(2012-12#3)
positive steady state##2##3##(2013-8#2)
positive strand##4##2##(1990-11#1)(1994-8#2)(2008-10#1)
positive strands##2##2##(1994-8#2)
positive subjects##2##2##(1990-6#1)(2008-10#1)
positive surgical margins##2##3##(2011-2#2)
positive surgical##5##2##(2007-12#1)(2008-6#1)(2011-2#3)
positive symptoms##3##2##(1996-7#1)(2008-6#1)(2008-8#1)
positive test results##2##3##(1996-12#1)(2008-10#1)
positive test##8##2##(1990-2#1)(1990-5#1)(1991-12#1)(1994-1#1)(1994-2#1)(1996-12#1)(2008-10#1)(2011-1#1)
positive tests##2##2##(2008-1#1)(2011-2#1)
positive than##7##2##(1993-3#1)(1994-7#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2009-8#1)
positive tits were##2##3##(2008-5#2)
positive to negative##2##3##(1992-6#1)(1996-2#1)
positive to##10##2##(1990-2#1)(1990-3#1)(1991-8#1)(1992-6#1)(1995-5#1)(1996-2#1)(1996-6#1)(2008-10#1)(2013-8#2)
positive transcription##2##2##(2011-1#1)(2012-12#1)
positive treatment##2##2##(2008-11#1)(2011-1#1)
positive using##3##2##(1996-12#1)(2007-8#1)(2012-12#1)
positive valence##2##2##(2008-5#2)
positive values in the##2##4##(2008-10#2)
positive values##8##2##(1990-11#1)(1990-8#1)(1993-12#1)(2008-10#5)
positive viral##2##2##(1992-11#1)(2013-8#1)
positive well-being##3##2##(2010-6#3)
positive were##2##2##(2008-1#1)(2011-1#1)
positive with C##2##3##(2008-10#2)
positive with##8##2##(1991-2#1)(1994-12#1)(1995-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
positive working##3##2##(1993-1#2)(1994-12#1)
positive##1782##1##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#8)(1990-3#9)(1990-5#5)(1990-6#13)(1990-7#2)(1990-8#17)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#5)(1991-5#3)(1991-6#5)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#12)(1992-2#7)(1992-3#16)(1992-4#2)(1992-5#8)(1992-6#9)(1992-8#4)(1992-9#5)(1993-1#8)(1993-11#7)(1993-12#10)(1993-2#6)(1993-3#10)(1993-5#5)(1993-6#4)(1993-8#5)(1993-9#8)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#15)(1994-2#8)(1994-3#9)(1994-5#5)(1994-6#4)(1994-7#9)(1994-8#12)(1994-9#3)(1995-1#3)(1995-11#7)(1995-12#10)(1995-2#6)(1995-3#5)(1995-4#6)(1995-5#7)(1995-6#7)(1995-8#10)(1995-9#2)(1996-11#1)(1996-12#13)(1996-2#12)(1996-3#3)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#16)(1997-3#6)(1997-4#17)(1997-5#6)(1997-6#11)(1997-7#20)(1997-8#10)(2006-10#3)(2006-12#1)(2006-5#1)(2007-10#12)(2007-11#12)(2007-12#22)(2007-2#6)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#52)(2007-8#23)(2008-1#33)(2008-10#159)(2008-11#61)(2008-12#41)(2008-2#9)(2008-3#17)(2008-4#10)(2008-5#73)(2008-6#20)(2008-7#35)(2008-8#62)(2008-9#36)(2009-1#1)(2009-10#3)(2009-11#10)(2009-12#8)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#8)(2009-6#9)(2009-7#12)(2009-8#16)(2009-9#7)(2010-1#6)(2010-10#10)(2010-11#12)(2010-12#14)(2010-2#6)(2010-3#7)(2010-4#12)(2010-5#9)(2010-6#10)(2010-7#3)(2010-8#13)(2010-9#1)(2011-1#55)(2011-2#105)(2011-3#6)(2012-1#10)(2012-12#32)(2012-2#40)(2012-3#33)(2013-1#66)(2013-7#8)(2013-8#39)
positive&quot##2##1##(1991-8#1)(1992-5#1)
positive)##3##1##(2008-11#1)(2008-6#2)
positive- and##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
positive-branch unstable##2##2##(2008-3#2)
positive-branch##4##1##(2007-11#1)(2008-3#3)
positive-ion mode##3##2##(2008-10#2)(2011-1#1)
positive-ion##7##1##(2008-10#5)(2009-6#1)(2011-1#1)
positive-sense##3##1##(2008-10#1)(2008-9#2)
positive-side shift##2##2##(1992-6#2)
positive-strand##2##1##(2008-4#1)(2008-9#1)
positive/negative##2##1##(2009-11#1)(2011-2#1)
positively affected##2##2##(1990-11#1)(2008-10#1)
positively and negatively##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
positively and##9##2##(1996-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
positively associated with age##2##4##(2011-2#1)(2013-1#1)
positively associated with the##5##4##(1995-8#1)(2008-11#1)(2008-8#2)(2009-11#1)
positively associated with##24##3##(1993-6#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)
positively associated##26##2##(1993-6#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#4)
positively by the##2##3##(1996-12#1)(2011-2#1)
positively by##3##2##(1996-12#1)(1996-3#1)(2011-2#1)
positively charged amino acids##4##4##(1995-5#3)(2008-8#1)
positively charged complexes##2##3##(2008-10#2)
positively charged histidine##2##3##(1991-8#1)(2008-10#1)
positively charged protein##2##3##(1990-5#1)(1994-9#1)
positively charged residue##2##3##(1992-8#1)(1997-7#1)
positively charged residues##5##3##(1997-8#2)(2008-8#2)(2011-1#1)
positively charged##43##2##(1990-5#3)(1991-8#2)(1992-8#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#3)(1997-7#1)(1997-8#3)(2006-12#1)(2008-10#14)(2008-11#3)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2011-1#1)
positively correlated to host##2##4##(2008-10#2)
positively correlated to##6##3##(2006-10#1)(2008-10#3)(2008-7#1)(2011-2#1)
positively correlated with a##2##4##(2008-10#1)(2009-6#1)
positively correlated with children's##3##4##(2010-11#3)
positively correlated with primary##2##4##(2008-8#1)(2012-1#1)
positively correlated with the degree of##2##6##(1991-7#1)(2008-6#1)
positively correlated with the##14##4##(1990-7#1)(1991-12#1)(1991-7#1)(1996-6#1)(2008-10#4)(2008-5#1)(2008-6#2)(2009-7#1)(2010-1#1)(2012-12#1)
positively correlated with##73##3##(1990-7#1)(1991-12#2)(1991-7#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#30)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
positively correlated##87##2##(1990-7#1)(1991-12#2)(1991-7#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#34)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
positively correlates with##2##3##(2008-4#1)(2013-1#1)
positively for##4##2##(2008-4#1)(2008-7#1)(2010-11#1)(2013-8#1)
positively identified as##3##3##(1995-6#1)(2008-10#2)
positively identified##7##2##(1995-11#1)(1995-6#1)(2008-10#5)
positively impact##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
positively influenced##2##2##(1993-12#1)(2011-1#1)
positively on##3##2##(1990-2#1)(1992-5#1)(2010-3#1)
positively predicted##2##2##(2011-2#2)
positively regulates##3##2##(1992-5#1)(1995-11#1)(2013-1#1)
positively related to adolescents'##2##4##(2009-11#1)(2009-7#1)
positively related to the##6##4##(1992-2#1)(1995-2#1)(1996-12#1)(2009-8#2)(2011-2#1)
positively related to##32##3##(1990-8#1)(1991-12#1)(1992-2#2)(1995-12#1)(1995-2#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#3)(2009-8#2)(2010-2#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
positively related with##3##3##(2010-12#2)(2010-8#1)
positively related##36##2##(1990-8#1)(1991-12#1)(1992-2#2)(1995-12#1)(1995-2#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#3)(2009-8#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
positively selected##4##2##(2008-10#1)(2008-4#1)(2010-8#2)
positively stained##2##2##(1992-3#1)(1997-2#1)
positively to##10##2##(1992-3#1)(1994-12#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2013-1#1)
positively with the##5##3##(1995-8#1)(2008-10#2)(2013-8#2)
positively with##23##2##(1990-2#1)(1995-8#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-8#2)(2011-10#1)(2011-2#3)(2012-1#1)(2013-1#3)(2013-8#2)
positively##302##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-7#1)(1991-8#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-8#1)(1993-12#1)(1993-6#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#3)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#65)(2008-11#12)(2008-12#4)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#14)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#6)(2011-1#6)(2011-10#3)(2011-2#21)(2012-1#4)(2012-12#2)(2012-3#5)(2013-1#16)(2013-8#5)
positives and false negatives##2##4##(2008-7#1)(2011-2#1)
positives and##7##2##(1995-3#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)
positives##18##1##(1995-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#3)(2012-3#1)
positivism##2##1##(1993-2#1)(2013-1#1)
positivist##3##1##(2008-11#1)(2009-10#1)(2009-7#1)
positivistic##3##1##(1993-2#2)(1993-6#1)
positivity by##3##2##(1994-1#1)(2007-7#1)(2011-2#1)
positivity constraint##3##2##(2013-1#3)
positivity for##6##2##(1991-12#1)(1992-8#1)(1995-12#1)(2008-12#1)(2010-6#1)(2013-8#1)
positivity in##3##2##(2008-4#1)(2012-3#2)
positivity of the##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
positivity of##6##2##(1991-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
positivity rate##2##2##(2007-7#2)
positivity was seen in##2##4##(2007-7#2)
positivity was##9##2##(1994-10#1)(1994-9#1)(1996-12#1)(1996-3#1)(2007-7#4)(2008-10#1)
positivity##52##1##(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-8#2)(1992-6#1)(1992-8#1)(1994-1#1)(1994-10#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-8#1)(2007-7#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
positron emission tomographic##3##3##(1995-8#1)(2007-10#1)(2009-10#1)
positron emission tomography (PET) and##3##5##(1996-5#2)(2008-8#1)
positron emission tomography (PET) have##2##5##(1995-2#1)(2008-8#1)
positron emission tomography (PET) in##3##5##(1996-2#1)(2008-7#1)(2010-3#1)
positron emission tomography (PET) to##2##5##(1995-11#1)(1995-12#1)
positron emission tomography (PET)##15##4##(1990-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#3)(1996-7#1)(2008-1#1)(2008-7#1)(2008-8#2)(2010-3#1)(2012-2#1)
positron emission tomography and functional magnetic resonance imaging##2##8##(1994-3#1)(2008-2#1)
positron emission tomography and##3##4##(1994-3#1)(2008-2#1)(2010-12#1)
positron emission tomography in##2##4##(1996-2#1)(2008-12#1)
positron emission tomography##35##3##(1990-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#3)(1996-5#5)(1996-7#1)(2008-1#3)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#2)(2009-11#1)(2010-12#2)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
positron emission##41##2##(1990-8#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#3)(1996-5#5)(1996-7#1)(2007-10#1)(2008-1#3)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
positron##43##1##(1990-8#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#3)(1996-5#5)(1996-7#1)(2007-10#1)(2008-1#3)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
positron-emission##2##1##(2011-2#2)
posits a##2##2##(1995-1#1)(2009-7#1)
posits that the##3##3##(1994-3#1)(2008-11#2)
posits that##5##2##(1994-3#1)(2008-11#2)(2009-11#1)(2010-1#1)
posits the##2##2##(2008-12#1)(2012-2#1)
posits##11##1##(1994-3#1)(1995-1#1)(2008-11#2)(2008-12#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-2#1)
posses a##3##2##(2008-10#2)(2008-11#1)
posses##10##1##(1994-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-8#1)(2010-8#1)(2013-7#1)
possess a similar##2##3##(1996-2#1)(2008-5#1)
possess a unique##2##3##(1995-6#1)(1995-8#1)
possess a##28##2##(1990-7#1)(1991-6#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-5#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2013-1#1)
possess an##8##2##(1990-3#1)(2007-12#1)(2008-10#1)(2008-7#3)(2008-9#1)(2012-1#1)
possess both##4##2##(1990-5#1)(1993-6#1)(1995-8#1)(2008-10#1)
possess four##2##2##(1995-11#1)(2008-2#1)
possess good##2##2##(2008-10#1)(2008-4#1)
possess immunomodulatory##2##2##(1993-12#1)(2012-2#1)
possess in##3##2##(1992-2#1)(1995-11#1)(1997-4#1)
possess inhibitory##2##2##(2008-11#1)(2008-7#1)
possess many##2##2##(2008-4#1)(2010-11#1)
possess potent##3##2##(2008-5#1)(2010-5#1)(2011-1#1)
possess significant##3##2##(2007-5#1)(2008-3#1)(2008-9#1)
possess some##2##2##(2007-11#1)(2008-10#1)
possess specific##2##2##(1991-2#1)(2008-7#1)
possess the ability to differentiate into##2##6##(2008-9#2)
possess the ability to##3##4##(2008-10#1)(2008-9#2)
possess the same##3##3##(1993-9#1)(2008-10#1)(2008-9#1)
possess the##21##2##(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-9#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
possess two##4##2##(1992-3#1)(1994-11#1)(2008-11#1)(2010-11#1)
possess unique##2##2##(2008-11#1)(2008-3#1)
possess##200##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-5#3)(2008-1#2)(2008-10#32)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#10)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)
possessed a##7##2##(1993-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)
possessed by the##2##3##(2008-10#1)(2008-8#1)
possessed by##4##2##(2008-10#3)(2008-8#1)
possessed high##3##2##(2008-10#1)(2010-6#1)(2013-8#1)
possessed only##2##2##(1995-1#1)(2008-10#1)
possessed similar##2##2##(1991-8#1)(1997-4#1)
possessed the##8##2##(1993-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-8#1)
possessed##65##1##(1990-12#2)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-8#2)(1993-9#2)(1994-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-4#2)(1997-6#1)(2007-7#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2012-12#2)(2013-1#1)(2013-8#2)
possesses a high##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
possesses a higher##2##3##(1992-8#1)(2008-10#1)
possesses a unique##2##3##(1991-8#1)(1993-6#1)
possesses a##31##2##(1990-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-6#2)(2007-11#2)(2007-12#3)(2008-10#5)(2008-3#4)(2008-7#1)(2009-5#1)(2009-8#1)
possesses all##2##2##(2007-11#1)(2008-7#1)
possesses an##6##2##(1992-8#2)(1993-1#1)(1997-4#1)(2008-4#1)(2008-9#1)
possesses both##3##2##(1994-5#1)(1995-6#1)(2007-11#1)
possesses some##3##2##(1995-5#1)(2008-10#1)(2013-1#1)
possesses the##6##2##(1993-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-1#1)
possesses##93##1##(1990-10#1)(1990-7#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-9#1)(1997-3#1)(1997-4#1)(2007-11#4)(2007-12#4)(2008-10#13)(2008-11#3)(2008-3#7)(2008-4#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
possessing a##9##2##(1991-7#1)(1993-12#1)(2008-10#2)(2008-7#3)(2009-2#1)(2012-3#1)
possessing an##3##2##(1994-6#1)(2011-1#1)(2012-2#1)
possessing different##2##2##(1990-8#1)(2008-10#1)
possessing high##2##2##(2008-10#1)(2008-5#1)
possessing inhibition##2##2##(2008-10#1)(2008-7#1)
possessing specific##2##2##(1990-11#1)(2007-2#1)
possessing the##7##2##(1992-10#1)(1994-11#1)(2008-10#2)(2008-11#2)(2012-2#1)
possessing various##2##2##(2008-10#2)
possessing very##2##2##(1990-12#1)(2008-4#1)
possessing##64##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#3)(1991-2#1)(1991-7#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-6#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
possession of a##2##3##(1996-5#1)(2008-6#1)
possession of##4##2##(1991-12#1)(1996-5#1)(2008-1#1)(2008-6#1)
possession##10##1##(1991-12#1)(1992-4#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-2#1)(2012-12#2)
possibilistic##2##1##(2009-10#2)
possibilities and limitations##3##3##(1991-11#1)(1992-3#1)(2008-3#1)
possibilities and limits##2##3##(1997-4#1)(2012-2#1)
possibilities and##14##2##(1991-11#1)(1992-1#1)(1992-3#1)(1994-2#1)(1994-5#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
possibilities are##2##2##(1994-9#1)(2007-12#1)
possibilities for the##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
possibilities for their##2##3##(1992-5#1)(2008-8#1)
possibilities for therapeutic##2##3##(1990-3#1)(1997-7#1)
possibilities for##33##2##(1990-3#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
possibilities in the##3##3##(1997-3#2)(2008-10#1)
possibilities in##14##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#2)(1997-3#2)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
possibilities of controlling##2##3##(1990-11#1)(2007-12#1)
possibilities of inductively coupled plasma##2##5##(2008-10#2)
possibilities of the##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)
possibilities of these##2##3##(2007-12#1)(2008-10#1)
possibilities of treatment##2##3##(1993-11#1)(2012-12#1)
possibilities of##45##2##(1990-10#1)(1990-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-9#1)(2007-11#8)(2007-12#2)(2007-8#1)(2008-10#9)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
possibilities offered by##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
possibilities to##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-1#1)
possibilities##150##1##(1990-10#1)(1990-11#3)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2007-11#9)(2007-12#6)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
possibilities]##5##1##(1991-3#2)(1991-8#1)(1993-6#1)(2008-10#1)
possibility and##2##2##(2011-2#1)(2012-3#1)
possibility exists that##4##3##(1994-8#1)(1996-4#1)(1996-9#1)(2011-2#1)
possibility for the##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
possibility for##18##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-12#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
possibility has been explored##2##4##(1990-8#1)(2007-8#1)
possibility in the##3##3##(1991-3#1)(1992-2#1)(2010-10#1)
possibility in##5##2##(1991-3#1)(1992-2#1)(2008-8#1)(2010-10#1)(2013-1#1)
possibility is that##4##3##(1993-9#1)(2008-6#2)(2008-9#1)
possibility is##8##2##(1991-3#1)(1993-9#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-12#1)(2011-2#1)
possibility of a##29##3##(1990-6#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
possibility of achieving##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
possibility of an##9##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1997-8#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-8#1)
possibility of biliary##2##3##(2011-2#1)(2012-12#1)
possibility of carrying out##2##4##(2008-2#1)(2008-7#1)
possibility of designing##2##3##(1990-5#1)(2012-2#1)
possibility of determining##2##3##(2008-10#1)(2008-2#1)
possibility of developing##7##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
possibility of direct##3##3##(1990-5#1)(1992-12#1)(2008-10#1)
possibility of generating##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
possibility of improving##2##3##(1990-2#1)(1995-12#1)
possibility of increasing the##2##4##(2007-11#1)(2008-10#1)
possibility of infection##2##3##(2008-12#2)
possibility of measuring the##2##4##(1997-3#1)(2008-7#1)
possibility of measuring##4##3##(1990-8#1)(1997-3#1)(2008-2#1)(2008-7#1)
possibility of obtaining##4##3##(1990-12#1)(1991-12#1)(2008-3#1)(2008-7#1)
possibility of on-line##2##3##(2008-10#2)
possibility of the##12##3##(1990-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#2)
possibility of these##3##3##(1990-9#1)(1995-12#1)(2008-10#1)
possibility of using this##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
possibility of using##31##3##(1991-1#1)(1991-8#1)(1993-3#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#4)(2011-1#1)(2012-2#1)(2013-1#2)
possibility of##351##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-3#2)(1993-11#2)(1993-12#3)(1993-3#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#18)(2007-12#11)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#57)(2008-11#14)(2008-12#7)(2008-2#13)(2008-3#22)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#10)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#3)(2010-8#2)(2011-1#6)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#13)(2013-8#4)
possibility that such##3##3##(1991-4#1)(1994-5#1)(2008-11#1)
possibility that the##18##3##(1990-12#1)(1991-5#1)(1992-7#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-9#1)(2008-10#3)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-2#2)(2013-1#1)
possibility that these##6##3##(1996-12#1)(1997-8#2)(2008-10#1)(2008-11#1)(2011-2#1)
possibility that this##3##3##(1992-9#1)(1994-8#1)(2008-11#1)
possibility that##116##2##(1990-11#1)(1990-12#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-11#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-8#2)(2006-10#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#4)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
possibility to apply##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
possibility to be##2##3##(2008-10#1)(2012-3#1)
possibility to develop##2##3##(2008-11#1)(2011-2#1)
possibility to perform##3##3##(1993-9#1)(1996-12#1)(2013-1#1)
possibility to use##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
possibility to##53##2##(1990-10#1)(1990-2#1)(1993-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
possibility##591##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#2)(1992-12#3)(1992-2#6)(1992-3#3)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#6)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#7)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#19)(2007-12#12)(2007-2#4)(2007-5#1)(2007-6#1)(2007-8#5)(2008-1#6)(2008-10#93)(2008-11#23)(2008-12#8)(2008-2#18)(2008-3#28)(2008-4#8)(2008-5#11)(2008-6#4)(2008-7#17)(2008-8#19)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#6)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-8#3)(2011-1#7)(2011-2#35)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#11)(2012-3#13)(2013-1#24)(2013-7#1)(2013-8#6)
possible &quot##3##2##(1994-11#1)(2008-6#1)(2009-3#1)
possible a##7##2##(1993-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
possible action##3##2##(1992-3#1)(1993-3#1)(2013-1#1)
possible activation of##3##3##(1993-3#1)(2010-10#1)(2012-3#1)
possible active##2##2##(2008-8#1)(2008-9#1)
possible additional##2##2##(2006-10#1)(2012-2#1)
possible adulteration##2##2##(2008-10#1)(2010-4#1)
possible advantages##2##2##(1993-2#1)(2011-2#1)
possible adverse effects of##3##4##(2008-8#2)(2012-2#1)
possible adverse effects on##2##4##(2012-3#1)(2013-1#1)
possible adverse effects##5##3##(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
possible adverse##8##2##(1991-2#1)(1992-11#1)(2008-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
possible after##3##2##(1990-12#1)(2007-10#1)(2007-11#1)
possible alterations of##2##3##(2010-6#1)(2012-2#1)
possible alterations##3##2##(2008-5#1)(2010-6#1)(2012-2#1)
possible alternative##4##2##(1997-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
possible alternatives##2##2##(1992-3#1)(1993-1#1)
possible and easy##2##3##(1997-3#1)(2008-10#1)
possible and that##2##3##(2008-3#1)(2008-8#1)
possible and the##4##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)
possible and##30##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
possible application in##3##3##(1994-8#1)(2008-2#1)(2008-3#1)
possible application of##2##3##(1991-2#1)(2008-10#1)
possible application to##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
possible application##9##2##(1991-2#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
possible applications are##2##3##(2008-7#2)
possible applications in##2##3##(1993-1#1)(2007-12#1)
possible applications of the##2##4##(2008-11#1)(2008-2#1)
possible applications of##6##3##(2007-12#2)(2008-11#1)(2008-2#2)(2011-1#1)
possible applications##13##2##(1993-1#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#2)(2008-8#1)(2011-1#1)
possible approach to##3##3##(1992-5#1)(2008-10#1)(2010-5#1)
possible approach##4##2##(1992-5#1)(2008-10#1)(2010-5#1)(2011-2#1)
possible approaches##2##2##(1994-3#1)(2013-1#1)
possible areas##2##2##(1997-2#1)(2013-1#1)
possible as##6##2##(1991-12#1)(1997-3#1)(2007-11#1)(2008-5#2)(2011-2#1)
possible association between##7##3##(2006-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
possible association of##5##3##(1992-12#1)(1997-3#1)(2011-2#3)
possible association with##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
possible association##16##2##(1992-12#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-5#1)(2013-1#1)(2013-8#1)
possible associations between##3##3##(1994-12#1)(2008-7#1)(2011-1#1)
possible associations##5##2##(1994-12#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)
possible at##6##2##(2008-10#3)(2008-11#1)(2008-2#1)(2011-1#1)
possible because of##5##3##(1991-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
possible because##6##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
possible benefits of##2##3##(2008-10#1)(2013-1#1)
possible benefits##5##2##(2007-11#1)(2008-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
possible between##2##2##(2008-10#1)(2008-8#1)
possible but##2##2##(1996-1#1)(2013-1#1)
possible by a##5##3##(1994-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)
possible by means of##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
possible by the##8##3##(1994-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2011-2#1)
possible by use of a##2##5##(2008-2#1)(2008-3#1)
possible by use of the##2##5##(2008-2#1)(2008-3#1)
possible by use of##6##4##(2007-11#1)(2008-2#2)(2008-3#3)
possible by using##2##3##(1996-12#1)(2008-10#1)
possible by##48##2##(1990-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(2007-11#4)(2007-12#5)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
possible candidates for##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
possible candidates##4##2##(2008-3#1)(2008-7#2)(2013-1#1)
possible causal##2##2##(1992-5#1)(2009-4#1)
possible cause of##6##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
possible cause##11##2##(1992-11#1)(1992-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#2)
possible causes and##2##3##(2008-5#1)(2010-8#1)
possible causes of##6##3##(1993-10#1)(2007-7#1)(2008-7#2)(2008-8#1)(2008-9#1)
possible causes##13##2##(1993-10#1)(1993-9#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)
possible cellular##4##2##(2008-10#1)(2009-8#2)(2011-2#1)
possible changes in the##2##4##(2009-12#1)(2010-8#1)
possible changes in##5##3##(1996-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)
possible changes of##2##3##(2008-7#1)(2011-1#1)
possible changes##8##2##(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)
possible chiral##2##2##(1990-8#1)(2008-10#1)
possible clinical scenarios##2##3##(2008-3#1)(2012-3#1)
possible clinical##5##2##(2008-3#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
possible coexistence of##2##3##(1993-3#1)(2012-2#1)
possible combination of##2##3##(2008-10#1)(2012-2#1)
possible combinations of##5##3##(2008-10#2)(2008-12#1)(2008-3#2)
possible combinations##7##2##(2008-10#4)(2008-12#1)(2008-3#2)
possible common##2##2##(1991-5#1)(2008-10#1)
possible complication##4##2##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
possible complications of##6##3##(1990-11#1)(1993-8#1)(1993-9#1)(2007-11#1)(2007-8#1)(2012-3#1)
possible complications##16##2##(1990-11#1)(1991-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
possible configurations##3##2##(2008-10#1)(2008-3#2)
possible confounding##2##2##(1991-3#1)(2008-2#1)
possible connection between##3##3##(1992-11#1)(2006-10#1)(2011-2#1)
possible connection##4##2##(1992-11#1)(2006-10#1)(2008-10#1)(2011-2#1)
possible consequence of##2##3##(2013-1#1)(2013-8#1)
possible consequences of##2##3##(2008-10#1)(2011-2#1)
possible consequences##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
possible contributing factors##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
possible contributing##4##2##(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
possible contribution##2##2##(2009-6#1)(2012-2#1)
possible correlation between##4##3##(1997-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
possible damage##2##2##(1996-3#1)(2008-10#1)
possible dependence##2##2##(1997-4#1)(2008-8#1)
possible diagnosis##4##2##(2007-2#1)(2010-12#1)(2010-3#1)(2012-12#1)
possible diagnostic##2##2##(1996-12#1)(2008-3#1)
possible differences between##2##3##(1990-5#1)(2008-1#1)
possible differences in##3##3##(1997-6#1)(2008-3#1)(2008-4#1)
possible differences##6##2##(1990-5#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2012-3#1)
possible differential##4##2##(1995-11#1)(2008-4#1)(2012-3#1)(2012-8#1)
possible disadvantages##2##2##(2008-11#1)(2012-2#1)
possible disease##2##2##(2010-12#1)(2013-7#1)
possible dose##2##2##(2007-10#1)(2008-10#1)
possible drug interactions##2##3##(1992-8#1)(1994-5#1)
possible drug##3##2##(1992-8#1)(1994-5#1)(2008-5#1)
possible effect of##5##3##(1994-8#1)(1996-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
possible effect on##3##3##(1995-1#1)(2008-2#1)(2008-3#1)
possible effect##8##2##(1994-8#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
possible effects of##7##3##(1990-6#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-7#1)
possible effects on##3##3##(2008-10#1)(2011-1#1)(2013-7#1)
possible effects##13##2##(1990-6#1)(1994-12#1)(1995-12#1)(1996-2#2)(1996-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-1#1)(2013-7#2)
possible efficacy##2##2##(2009-10#1)(2013-1#1)
possible endemic area##2##3##(1996-11#2)
possible environmental factors##2##3##(2006-10#1)(2008-5#1)
possible environmental##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
possible errors##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
possible etiologies##2##2##(2008-8#1)(2011-1#1)
possible etiology##6##2##(1990-2#1)(1991-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
possible even##3##2##(1990-11#1)(1992-11#1)(2008-10#1)
possible existence of##6##3##(1992-3#1)(1992-9#1)(1997-1#1)(2007-8#1)(2010-11#1)(2012-2#1)
possible experimental##2##2##(2008-10#1)(2008-6#1)
possible explanation for##7##3##(1992-3#1)(1995-8#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
possible explanation is##4##3##(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
possible explanation of##2##3##(1993-1#1)(1996-12#1)
possible explanation##14##2##(1992-3#1)(1993-1#1)(1995-8#1)(1996-12#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-2#1)
possible explanations for this##2##4##(1993-11#1)(2008-8#1)
possible explanations for##5##3##(1992-3#1)(1993-11#1)(2008-7#1)(2008-8#1)(2009-11#1)
possible explanations##6##2##(1991-11#1)(1992-3#1)(1993-11#1)(2008-7#1)(2008-8#1)(2009-11#1)
possible extension of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
possible extension##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
possible factors##3##2##(1993-12#1)(2009-4#1)(2013-1#1)
possible for a##4##3##(1994-9#1)(1996-9#1)(2008-3#1)(2010-12#1)
possible for the first time to##2##6##(1992-9#1)(1994-3#1)
possible for the##6##3##(1990-5#1)(1991-12#1)(1992-9#1)(1994-3#1)(2007-12#1)(2007-8#1)
possible for these##2##3##(2008-9#2)
possible for us to##3##4##(2008-3#1)(2010-6#1)(2011-2#1)
possible for##38##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-9#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
possible formation of##3##3##(1993-11#1)(1994-5#1)(2011-2#1)
possible from the##4##3##(1991-12#1)(1994-6#2)(2013-1#1)
possible from##6##2##(1991-12#1)(1994-6#2)(2008-11#2)(2013-1#1)
possible functional role##3##3##(1990-8#1)(2009-10#1)(2013-1#1)
possible functional##5##2##(1990-8#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
possible functions of##3##3##(2008-6#1)(2010-8#1)(2012-12#1)
possible functions##5##2##(2008-11#1)(2008-6#1)(2009-10#1)(2010-8#1)(2012-12#1)
possible further##2##2##(1995-5#1)(1997-3#1)
possible future directions##3##3##(1996-12#1)(2008-11#1)(2011-2#1)
possible future##7##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-8#1)
possible genetic##5##2##(1993-8#1)(1994-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
possible harmful##2##2##(2011-2#2)
possible health effects##2##3##(1994-9#1)(2013-8#1)
possible health##5##2##(1994-12#1)(1994-9#1)(1996-3#1)(2008-11#1)(2013-8#1)
possible if the##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
possible if##10##2##(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2013-8#1)
possible impact of##6##3##(1991-2#1)(1993-9#1)(1995-12#1)(2008-11#1)(2008-8#1)(2013-8#1)
possible impact on the##2##4##(2011-1#1)(2011-2#1)
possible impact on##6##3##(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
possible impact##12##2##(1991-2#1)(1993-9#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
possible implementation##2##2##(2008-11#1)(2011-2#1)
possible implications for##4##3##(2007-2#1)(2008-1#1)(2009-9#1)(2012-1#1)
possible implications of##3##3##(1991-5#1)(1991-6#1)(2009-8#1)
possible implications##10##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(2007-2#1)(2008-1#1)(2009-8#2)(2009-9#1)(2012-1#1)
possible importance##2##2##(2008-10#1)(2008-9#1)
possible in a##5##3##(1996-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
possible in all##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
possible in many##2##3##(2008-6#1)(2008-9#1)
possible in the future to##2##5##(1994-6#1)(2008-1#1)
possible in the##10##3##(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
possible in##50##2##(1990-12#1)(1991-11#1)(1991-6#2)(1992-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)
possible indications##2##2##(1993-8#1)(1994-12#1)
possible influence of##6##3##(2006-6#2)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
possible influence##7##2##(2006-6#2)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
possible inhibition##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
possible inhibitory##4##2##(1994-5#1)(1995-11#1)(2008-6#1)(2008-7#1)
possible injury##2##2##(2008-7#1)(2008-9#1)
possible interaction between##3##3##(1993-12#1)(2008-4#1)(2013-7#1)
possible interaction of##4##3##(1993-5#1)(1993-6#1)(1994-11#1)(2012-8#1)
possible interaction##8##2##(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(2008-4#1)(2008-8#1)(2012-8#1)(2013-7#1)
possible interactions between##2##3##(1993-9#1)(1996-2#1)
possible interactions##9##2##(1991-3#1)(1993-9#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-3#1)
possible interference##3##2##(1994-6#1)(2007-12#1)(2008-10#1)
possible interferences of##3##3##(2008-10#2)(2008-2#1)
possible interferences were##2##3##(2008-10#2)
possible interferences##9##2##(2008-10#8)(2008-2#1)
possible interferents##3##2##(2008-10#3)
possible interfering##5##2##(2008-10#5)
possible intermediate##2##2##(1991-12#1)(1992-6#1)
possible involvement in these##2##4##(1997-5#1)(2008-5#1)
possible involvement in##4##3##(1995-12#1)(1997-5#1)(2008-5#1)(2010-10#1)
possible involvement of cAMP##2##4##(1997-2#2)
possible involvement of##17##3##(1991-9#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-12#2)(1997-2#3)(1997-6#1)(2008-10#2)(2008-11#2)(2008-6#1)(2013-7#1)
possible involvement##22##2##(1991-9#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#2)(1997-2#3)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2010-10#1)(2013-7#1)
possible is##3##2##(1990-3#1)(1997-3#1)(2008-2#1)
possible late##2##2##(1996-6#1)(2008-1#1)
possible link between##3##3##(2009-12#1)(2013-1#1)(2013-7#1)
possible link##4##2##(2008-10#1)(2009-12#1)(2013-1#1)(2013-7#1)
possible linkage##3##2##(1997-5#1)(1997-7#1)(2008-3#1)
possible loss or##2##3##(1994-3#1)(2008-10#1)
possible matrix##2##2##(2008-10#2)
possible mean##2##2##(2007-12#1)(2008-8#1)
possible means for##2##3##(2008-10#1)(2012-3#1)
possible means##4##2##(2008-10#2)(2012-3#1)(2013-1#1)
possible mechanism by which##3##4##(1993-6#1)(1995-3#1)(2008-5#1)
possible mechanism for the##8##4##(1993-6#1)(2008-10#6)(2010-6#1)
possible mechanism for##16##3##(1990-3#1)(1993-6#1)(1994-8#1)(1997-4#1)(2007-11#1)(2008-10#7)(2010-4#2)(2010-6#1)(2011-2#1)
possible mechanism is##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
possible mechanism of extraction##2##4##(2008-10#1)(2008-5#1)
possible mechanism of the##6##4##(2008-10#5)(2011-3#1)
possible mechanism of##22##3##(1993-6#1)(2008-10#14)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-1#1)
possible mechanism##51##2##(1990-3#1)(1992-4#1)(1993-6#3)(1994-8#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#24)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-4#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)
possible mechanisms by which##3##4##(2007-12#1)(2008-10#1)(2010-7#1)
possible mechanisms for the##3##4##(1991-5#1)(1992-8#1)(2008-10#1)
possible mechanisms for##6##3##(1991-12#1)(1991-5#1)(1992-8#1)(2007-10#1)(2008-10#1)(2009-8#1)
possible mechanisms involved in##2##4##(2008-10#1)(2008-9#1)
possible mechanisms of action##2##4##(2007-11#1)(2013-1#1)
possible mechanisms of##9##3##(1992-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)(2013-1#1)
possible mechanisms##31##2##(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-7#1)(2012-12#2)(2013-1#1)(2013-7#1)
possible mediator##2##2##(1996-2#1)(2013-1#1)
possible metabolic##2##2##(1990-11#1)(2008-10#1)
possible method of##3##3##(2009-7#1)(2010-12#1)(2011-2#1)
possible methods##2##2##(1995-12#1)(2008-1#1)
possible misinterpretations##2##2##(1991-12#1)(1994-5#1)
possible mode of##4##3##(2007-7#1)(2008-3#2)(2013-1#1)
possible mode(s) of action##2##4##(2008-7#2)
possible models##3##2##(1993-8#1)(2008-11#1)(2009-10#1)
possible molecular##5##2##(1994-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2010-7#1)
possible neural##3##2##(1992-11#1)(1992-8#1)(2013-1#1)
possible neuropsychological##2##2##(2008-11#1)(2013-8#1)
possible new mechanism of##2##4##(1990-8#1)(2008-10#1)
possible new##8##2##(1990-8#2)(1992-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)
possible novel##3##2##(2008-10#1)(2008-7#1)(2010-3#1)
possible occurrence##4##2##(1991-3#1)(1994-6#1)(2010-5#1)(2011-2#1)
possible only by##2##3##(1993-6#1)(2008-1#1)
possible only##6##2##(1991-6#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
possible options##3##2##(1992-3#1)(2008-9#1)(2011-2#1)
possible or##2##2##(1994-12#1)(1997-4#1)
possible origin of##2##3##(2008-3#1)(2009-7#1)
possible origin##4##2##(2006-12#1)(2008-3#1)(2008-5#1)(2009-7#1)
possible pairwise##2##2##(2008-10#2)
possible pathogenic##4##2##(1991-6#1)(2008-1#1)(2008-2#1)(2008-7#1)
possible pathological##3##2##(2008-7#1)(2009-10#1)(2010-12#1)
possible pathways for##2##3##(1990-11#1)(2010-7#1)
possible physiological roles##2##3##(2009-10#1)(2009-8#1)
possible physiological##4##2##(1994-11#1)(2009-10#1)(2009-8#1)(2011-1#1)
possible pitfalls##2##2##(2008-10#1)(2009-3#1)
possible points of##2##3##(2008-7#1)(2013-1#1)
possible predisposing##2##2##(2010-12#1)(2012-2#1)
possible preventive measures are discussed##2##5##(1990-8#1)(2013-1#1)
possible problems##2##2##(1991-2#1)(2008-9#1)
possible prognostic##2##2##(2008-7#1)(2013-1#1)
possible protective role of##2##4##(2008-1#1)(2012-4#1)
possible protective##5##2##(2007-2#1)(2008-1#1)(2011-2#1)(2012-4#1)(2013-1#1)
possible reaction mechanism##5##3##(1990-5#1)(2008-10#3)(2009-11#1)
possible reaction##7##2##(1990-5#1)(2008-10#4)(2009-11#2)
possible reason for##3##3##(2008-2#1)(2012-12#2)
possible reason##4##2##(2008-2#1)(2008-9#1)(2012-12#2)
possible reasons for the##3##4##(1996-12#1)(1996-5#1)(2011-2#1)
possible reasons for##9##3##(1996-12#1)(1996-5#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)
possible recurrence##2##2##(1992-6#1)(2007-12#1)
possible regulation of##2##3##(1995-12#1)(1995-2#1)
possible relation between##2##3##(1994-7#1)(2013-1#1)
possible relation##4##2##(1990-6#1)(1994-7#1)(2007-10#1)(2013-1#1)
possible relationship between##7##3##(1992-2#1)(1993-12#1)(1993-2#1)(2007-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
possible relationship of##2##3##(1990-6#1)(2008-10#1)
possible relationship##11##2##(1990-6#1)(1992-2#1)(1993-12#1)(1993-2#1)(2007-10#1)(2008-10#2)(2008-9#1)(2012-2#1)(2013-1#2)
possible relationships between fluctuations in##2##5##(2008-7#2)
possible relationships between##4##3##(2008-10#1)(2008-4#1)(2008-7#2)
possible relationships##5##2##(2008-10#2)(2008-4#1)(2008-7#2)
possible relevance of##5##3##(1992-12#1)(1992-9#1)(1995-3#1)(2008-10#1)(2008-9#1)
possible relevance##7##2##(1992-12#1)(1992-9#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)
possible resistance##2##2##(2007-6#1)(2008-11#1)
possible risk factors##3##3##(1992-11#2)(2008-1#1)
possible risk of##2##3##(1995-8#1)(2012-2#1)
possible risk##6##2##(1992-11#2)(1995-8#1)(2008-1#1)(2011-2#1)(2012-2#1)
possible risks##2##2##(1994-1#1)(2011-3#1)
possible role for##10##3##(1991-1#1)(1992-3#1)(1993-12#1)(1994-8#1)(2006-12#1)(2008-10#2)(2009-12#1)(2011-2#1)(2012-2#1)
possible role in the##5##4##(1993-9#1)(1995-12#1)(1996-3#1)(2008-12#1)(2008-7#1)
possible role in##10##3##(1990-5#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
possible role of genetic##2##4##(1992-3#1)(2009-4#1)
possible role of the##5##4##(1992-6#1)(1997-4#1)(2007-12#1)(2011-2#1)(2013-8#1)
possible role of##37##3##(1990-10#1)(1990-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-8#1)
possible role##60##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-1#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-12#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
possible role(s)##2##2##(1991-5#1)(2008-11#1)
possible roles in##4##3##(1991-1#1)(1993-12#1)(2008-7#1)(2009-6#1)
possible roles of##11##3##(1991-11#1)(1991-9#1)(1993-9#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-8#1)(2012-3#1)
possible roles##15##2##(1991-1#1)(1991-11#1)(1991-9#1)(1993-12#1)(1993-9#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#3)(2009-6#1)(2010-8#1)(2012-3#1)
possible route##2##2##(2011-1#1)(2012-2#1)
possible routes of##2##3##(2008-11#1)(2008-4#1)
possible selves (and##2##3##(2010-6#2)
possible selves focused on##2##4##(2010-6#2)
possible selves of low-income mothers##2##5##(2010-6#2)
possible selves##8##2##(2010-6#8)
possible sensitivity##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
possible sequence##2##2##(1997-6#1)(2008-12#1)
possible side effects##5##3##(1995-1#1)(2007-11#2)(2008-5#1)(2010-3#1)
possible side##6##2##(1995-1#1)(2007-11#2)(2008-5#1)(2010-3#2)
possible signal##2##2##(2010-7#1)(2012-1#1)
possible significance##2##2##(2008-10#1)(2011-2#1)
possible single##2##2##(1991-9#1)(2009-9#1)
possible sites##2##2##(1990-8#1)(1994-5#1)
possible situations##3##2##(1990-12#1)(2008-8#2)
possible solution##6##2##(1991-9#1)(1992-1#1)(1993-3#1)(2007-5#1)(2008-10#1)(2009-10#1)
possible solutions for##2##3##(2008-6#1)(2008-7#1)
possible solutions to##4##3##(2008-2#1)(2008-6#1)(2009-6#1)(2013-1#1)
possible solutions##13##2##(1994-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-6#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
possible source of##2##3##(2006-10#1)(2011-2#1)
possible sources of##4##3##(1995-3#1)(2008-10#2)(2008-3#1)
possible strategies for##2##3##(2007-6#1)(2012-2#1)
possible synergistic##2##2##(2008-10#1)(2008-8#1)
possible target##2##2##(1992-12#1)(1994-8#1)
possible targets##2##2##(2008-11#1)(2013-7#1)
possible techniques to##2##3##(2008-10#1)(2008-3#1)
possible techniques##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2010-11#1)
possible that the##14##3##(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#3)
possible that this##4##3##(1995-5#1)(1997-1#1)(1997-5#1)(2008-9#1)
possible that##65##2##(1990-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-5#1)(1997-7#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
possible the##15##2##(1991-5#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
possible therapeutic##5##2##(1990-5#2)(1991-1#1)(2008-7#1)(2010-10#1)
possible through##2##2##(2007-11#1)(2008-10#1)
possible time##5##2##(1997-3#1)(2007-8#1)(2008-10#2)(2013-1#1)
possible to achieve a high##2##5##(2008-2#1)(2008-7#1)
possible to achieve a##3##4##(2008-2#2)(2008-7#1)
possible to achieve##6##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-7#1)
possible to adopt a##2##4##(2008-10#2)
possible to analyse##3##3##(2008-10#2)(2008-7#1)
possible to analyze##2##3##(2008-10#1)(2012-2#1)
possible to anticipate##2##3##(2007-8#1)(2013-1#1)
possible to apply##2##3##(2008-10#1)(2011-1#1)
possible to assess the##3##4##(1993-6#1)(2008-10#2)
possible to avoid the##2##4##(1992-5#1)(2007-11#1)
possible to avoid##7##3##(1990-8#1)(1992-5#1)(1996-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-2#1)
possible to build##2##3##(2008-2#1)(2008-3#1)
possible to carry out##3##4##(1993-11#1)(1996-3#1)(1997-6#1)
possible to combine##4##3##(1995-5#1)(2007-12#1)(2008-7#1)(2013-1#1)
possible to compare the##4##4##(1994-6#1)(2008-10#1)(2008-7#1)(2009-2#1)
possible to compare##6##3##(1994-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-2#1)
possible to conclude that##3##4##(1991-3#1)(1993-9#1)(2008-5#1)
possible to conduct##2##3##(2010-3#1)(2011-2#1)
possible to confirm##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
possible to consider##2##3##(2008-10#1)(2008-3#1)
possible to construct##4##3##(2006-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
possible to control the##4##4##(2008-2#1)(2008-3#2)(2008-7#1)
possible to control##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
possible to create##2##3##(2008-7#1)(2009-7#1)
possible to define##2##3##(1996-11#1)(2011-2#1)
possible to deliver##2##3##(1997-4#1)(2010-5#1)
possible to derive##2##3##(2008-2#1)(2008-3#1)
possible to design##8##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
possible to detect and##2##4##(1991-6#1)(2008-10#1)
possible to detect the##2##4##(2008-10#1)(2010-9#1)
possible to detect##14##3##(1990-3#1)(1991-6#1)(1994-6#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-9#1)
possible to determine the##9##4##(1993-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
possible to determine##18##3##(1990-8#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2013-1#1)
possible to develop##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
possible to diagnose##2##3##(1990-6#1)(2007-11#1)
possible to differentiate##2##3##(1994-9#1)(2008-10#1)
possible to distinguish the##2##4##(2007-12#1)(2008-10#1)
possible to distinguish##6##3##(1996-5#1)(2007-12#1)(2008-10#2)(2010-4#1)(2013-7#1)
possible to eliminate##2##3##(2008-10#1)(2013-1#1)
possible to employ##4##3##(1990-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
possible to establish a##3##4##(1990-3#1)(2008-10#1)(2008-5#1)
possible to establish##5##3##(1990-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
possible to estimate the##4##4##(1996-12#1)(2008-10#2)(2008-3#1)
possible to estimate##8##3##(1991-3#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2012-12#1)
possible to evaluate##3##3##(1990-3#1)(2008-2#1)(2010-12#1)
possible to examine##2##3##(2008-9#1)(2013-8#1)
possible to extend the##3##4##(1995-3#1)(2007-11#1)(2008-10#1)
possible to extract##8##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)
possible to follow the##2##4##(1995-9#1)(2008-10#1)
possible to follow##4##3##(1994-6#1)(1995-9#1)(1997-6#1)(2008-10#1)
possible to generate##3##3##(1993-12#1)(1994-12#1)(2007-12#1)
possible to identify and##2##4##(2006-4#1)(2008-4#1)
possible to identify some##2##4##(2008-10#2)
possible to identify the##4##4##(2008-10#1)(2008-11#2)(2012-3#1)
possible to identify##12##3##(1996-3#1)(2006-4#1)(2008-10#4)(2008-11#3)(2008-4#2)(2012-3#1)
possible to improve the##2##4##(2008-11#1)(2008-2#1)
possible to improve##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
possible to increase the##2##4##(1997-3#1)(2009-4#1)
possible to increase##3##3##(1997-3#1)(2008-10#1)(2009-4#1)
possible to introduce##4##3##(1993-8#1)(2006-12#1)(2007-11#1)(2008-10#1)
possible to investigate the##3##4##(1997-8#1)(2007-11#1)(2008-8#1)
possible to investigate##4##3##(1997-8#1)(2007-11#1)(2008-7#1)(2008-8#1)
possible to measure the##3##4##(1997-4#1)(2008-4#1)(2009-12#1)
possible to measure##7##3##(1990-12#1)(1997-4#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-12#1)
possible to monitor the##3##4##(2008-10#3)
possible to monitor##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
possible to observe##5##3##(1992-6#1)(1995-2#1)(1997-2#1)(2007-12#1)(2010-12#1)
possible to obtain a model##3##5##(2008-10#3)
possible to obtain a##6##4##(2008-10#4)(2010-7#1)(2013-1#1)
possible to obtain the##2##4##(2008-10#1)(2008-3#1)
possible to obtain##24##3##(1990-12#1)(2007-12#2)(2008-10#12)(2008-3#3)(2008-4#1)(2008-7#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#1)
possible to optimize the##2##4##(2007-12#1)(2011-2#1)
possible to perform the##2##4##(2008-10#2)
possible to perform##8##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-7#1)(2012-2#1)
possible to place##4##3##(2008-6#1)(2008-7#1)(2010-6#1)(2013-1#1)
possible to predict##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
possible to prepare##2##3##(1990-12#1)(1995-8#1)
possible to prioritize##2##3##(1994-3#1)(2010-9#1)
possible to produce##6##3##(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-11#1)
possible to quantify the##3##4##(2008-7#2)(2010-3#1)
possible to reduce the##3##4##(1997-8#1)(2007-12#1)(2008-3#1)
possible to reduce##4##3##(1997-8#1)(2007-12#1)(2008-3#1)(2012-12#1)
possible to resolve##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
possible to select##3##3##(1997-2#1)(2008-10#2)
possible to study##4##3##(1995-5#1)(2006-12#1)(2008-2#1)(2008-9#1)
possible to use##6##3##(1991-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)
possible to##460##2##(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-8#3)(2006-10#1)(2006-12#3)(2006-4#1)(2007-11#15)(2007-12#16)(2007-2#1)(2007-8#5)(2008-1#4)(2008-10#111)(2008-11#23)(2008-12#3)(2008-2#25)(2008-3#39)(2008-4#11)(2008-5#12)(2008-6#2)(2008-7#19)(2008-8#7)(2008-9#17)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#3)
possible treatment of##2##3##(2008-6#1)(2010-12#1)
possible treatment##8##2##(1990-8#1)(1995-12#1)(2008-6#2)(2008-7#2)(2010-12#1)(2011-1#1)
possible treatments##2##2##(2012-3#1)(2013-8#1)
possible underlying mechanisms for##2##4##(2008-11#1)(2013-1#1)
possible underlying mechanisms##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
possible underlying##11##2##(1995-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#2)(2013-1#1)
possible use for##2##3##(2008-10#1)(2008-5#1)
possible use in##4##3##(2007-5#1)(2008-5#2)(2013-1#1)
possible use of the##2##4##(2008-10#2)
possible use of##13##3##(1991-9#1)(1992-3#1)(1992-9#1)(2008-1#1)(2008-10#4)(2008-5#2)(2009-8#2)(2013-1#1)
possible use##20##2##(1991-9#1)(1992-3#1)(1992-9#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#5)(2009-8#2)(2013-1#2)
possible using a##3##3##(2008-10#3)
possible using##9##2##(2008-10#7)(2008-2#1)(2011-1#1)
possible values##3##2##(1992-4#1)(2008-10#1)(2008-2#1)
possible variation##2##2##(2008-3#2)
possible way to##3##3##(2007-11#1)(2008-12#1)(2012-1#1)
possible ways in which##2##4##(2008-3#1)(2008-7#1)
possible ways of##4##3##(1992-11#1)(1992-9#1)(2008-11#1)(2008-6#1)
possible ways to##2##3##(2008-10#1)(2008-3#1)
possible ways##11##2##(1990-11#1)(1992-11#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-2#1)(2013-1#1)
possible when the##2##3##(2008-10#1)(2008-2#1)
possible when##6##2##(1996-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
possible with a limit of detection of##2##7##(2008-10#2)
possible with a##7##3##(2007-11#2)(2008-10#4)(2008-3#1)
possible with other##2##3##(2007-11#1)(2011-2#1)
possible with standard##2##3##(2008-3#1)(2011-1#1)
possible with the##8##3##(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
possible with this##2##3##(2007-12#1)(2009-12#1)
possible with##42##2##(1993-3#1)(1993-6#1)(1994-3#1)(1995-6#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#2)
possible within##2##2##(2008-10#1)(2010-2#1)
possible without##5##2##(1997-3#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)
possible##2467##1##(1990-10#1)(1990-11#11)(1990-12#8)(1990-2#6)(1990-3#6)(1990-5#11)(1990-6#6)(1990-7#1)(1990-8#15)(1990-9#8)(1991-1#5)(1991-11#6)(1991-12#12)(1991-2#8)(1991-3#7)(1991-4#1)(1991-5#6)(1991-6#12)(1991-8#3)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#9)(1992-12#9)(1992-2#6)(1992-3#20)(1992-4#2)(1992-5#7)(1992-6#9)(1992-8#12)(1992-9#10)(1993-1#5)(1993-10#1)(1993-11#5)(1993-12#15)(1993-2#5)(1993-3#10)(1993-5#2)(1993-6#11)(1993-8#7)(1993-9#11)(1994-1#3)(1994-11#7)(1994-12#11)(1994-2#6)(1994-3#17)(1994-5#13)(1994-6#11)(1994-7#1)(1994-8#12)(1994-9#9)(1995-1#6)(1995-11#7)(1995-12#10)(1995-2#11)(1995-3#6)(1995-5#14)(1995-6#8)(1995-8#6)(1995-9#3)(1996-1#4)(1996-11#6)(1996-12#13)(1996-2#7)(1996-3#12)(1996-4#1)(1996-5#7)(1996-6#5)(1996-8#3)(1996-9#3)(1997-1#7)(1997-2#10)(1997-3#13)(1997-4#12)(1997-5#12)(1997-6#10)(1997-7#8)(1997-8#7)(2006-10#12)(2006-12#5)(2006-4#2)(2006-6#2)(2007-10#11)(2007-11#56)(2007-12#69)(2007-2#7)(2007-4#3)(2007-5#8)(2007-6#2)(2007-7#13)(2007-8#18)(2008-1#31)(2008-10#420)(2008-11#90)(2008-12#26)(2008-2#68)(2008-3#121)(2008-4#46)(2008-5#56)(2008-6#24)(2008-7#103)(2008-8#58)(2008-9#49)(2009-1#2)(2009-10#9)(2009-11#8)(2009-12#10)(2009-2#2)(2009-3#4)(2009-4#8)(2009-5#3)(2009-6#4)(2009-7#10)(2009-8#14)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#18)(2010-2#6)(2010-3#9)(2010-4#11)(2010-5#8)(2010-6#17)(2010-7#9)(2010-8#11)(2010-9#3)(2011-1#26)(2011-2#104)(2011-3#5)(2011-7#1)(2012-1#12)(2012-12#27)(2012-2#49)(2012-3#31)(2012-4#1)(2012-5#2)(2012-8#2)(2013-1#80)(2013-7#10)(2013-8#30)
possible&quot##2##1##(2008-2#1)(2013-1#1)
possible?##4##1##(2007-10#1)(2010-12#1)(2010-5#1)(2011-7#1)
possibly a##7##2##(1994-12#2)(1994-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2011-1#1)
possibly also##8##2##(1993-12#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-2#1)(2008-4#1)(2010-2#1)
possibly as a##3##3##(1991-1#1)(1993-12#1)(2008-10#1)
possibly as##4##2##(1991-1#1)(1993-12#1)(1995-8#1)(2008-10#1)
possibly associated with##2##3##(1997-7#1)(2010-10#1)
possibly be used##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
possibly be##13##2##(1990-12#1)(1990-5#1)(1991-1#1)(1993-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)
possibly because of the##3##4##(1994-2#1)(2007-11#1)(2008-11#1)
possibly because of##4##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-11#1)
possibly because##11##2##(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2012-3#1)
possibly being##2##2##(2008-11#1)(2011-2#1)
possibly by##7##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
possibly caused by the##2##4##(2008-10#1)(2011-1#1)
possibly caused by##4##3##(2008-10#1)(2011-1#1)(2011-2#2)
possibly due to a##2##4##(1991-2#1)(2013-1#1)
possibly due to the##3##4##(1993-6#1)(1995-12#1)(2008-11#1)
possibly due to##18##3##(1991-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
possibly even##2##2##(2008-6#1)(2011-2#1)
possibly for##4##2##(2007-2#1)(2008-1#1)(2013-1#1)(2013-8#1)
possibly in combination with##2##4##(1993-6#1)(2012-2#1)
possibly in##6##2##(1990-5#1)(1992-8#1)(1993-6#1)(2008-10#1)(2009-8#1)(2012-2#1)
possibly indicating a##2##3##(2008-10#1)(2012-5#1)
possibly indicating##5##2##(1996-3#1)(1997-5#1)(2008-10#2)(2012-5#1)
possibly involved in the##3##4##(1990-8#1)(2008-10#1)(2010-11#1)
possibly involved in##4##3##(1990-8#1)(1995-5#1)(2008-10#1)(2010-11#1)
possibly involving the##2##3##(1997-3#1)(2008-10#1)
possibly less than##2##3##(2008-5#1)(2012-3#1)
possibly less##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
possibly linked##2##2##(2008-9#1)(2011-2#1)
possibly mediated by##2##3##(1994-11#1)(2009-8#1)
possibly more##2##2##(1992-3#1)(2008-9#1)
possibly of##2##2##(1990-11#1)(1991-12#1)
possibly other##10##2##(1995-12#2)(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)
possibly playing a##2##3##(1990-11#2)
possibly playing##3##2##(1990-11#2)(2009-7#1)
possibly reflecting##4##2##(1996-2#1)(1997-1#1)(2010-7#1)(2012-5#1)
possibly related to the##2##4##(2009-11#1)(2010-12#1)
possibly related to##6##3##(1994-3#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-12#1)
possibly related##7##2##(1994-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-12#1)
possibly relevant##2##2##(2008-10#1)(2008-12#1)
possibly representing##2##2##(1991-2#1)(2011-2#1)
possibly result from##2##3##(2009-9#1)(2012-3#1)
possibly resulting in##2##3##(2008-10#1)(2009-5#1)
possibly several##2##2##(2007-8#1)(2008-10#1)
possibly the main##2##3##(2006-6#1)(2008-5#1)
possibly the##9##2##(1992-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-7#1)
possibly through##4##2##(1993-6#2)(2008-8#1)(2009-11#1)
possibly to##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
possibly via a##3##3##(1995-12#1)(1997-1#1)(2007-12#1)
possibly via##8##2##(1994-9#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
possibly with##3##2##(1993-11#1)(1994-8#1)(2008-7#1)
possibly##318##1##(1990-11#3)(1990-12#3)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#3)(1993-3#1)(1993-6#6)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#2)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#37)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#11)(2008-9#7)(2009-11#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#16)(2012-12#2)(2012-2#4)(2012-3#5)(2012-5#2)(2013-1#10)(2013-8#1)
possums (Trichosurus vulpecula)##2##3##(1997-8#2)
possums##3##1##(1997-8#3)
post dialysis##6##2##(2007-7#1)(2008-12#1)(2008-4#4)
post exercise##3##2##(2013-1#3)
post exposure prophylaxis##2##3##(2013-1#2)
post exposure##4##2##(1996-12#2)(2013-1#2)
post genomic##2##2##(2008-7#1)(2010-5#1)
post germinative growth and productivity of##2##6##(2008-12#2)
post hoc analysis##3##3##(2008-9#1)(2010-9#1)(2011-2#1)
post hoc test##3##3##(2009-8#1)(2010-3#1)(2012-2#1)
post hoc##10##2##(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
post in##2##2##(2013-1#1)(2013-8#1)
post incubation##3##2##(2008-12#3)
post infection##9##2##(1995-12#1)(1997-4#2)(2008-11#4)(2013-1#2)
post injection##4##2##(1994-5#1)(1997-2#1)(2007-11#2)
post inoculation##4##2##(1994-5#1)(2008-10#2)(2008-5#1)
post intervention##2##2##(2013-1#2)
post marketing surveys##2##3##(2008-8#2)
post mortem examination##2##3##(2010-10#1)(2011-1#1)
post mortem human##2##3##(1991-9#1)(2009-7#1)
post mortem##12##2##(1991-11#1)(1991-9#1)(1995-9#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-3#1)
post natal##2##2##(1990-11#1)(2008-4#1)
post operative period##2##3##(2010-7#1)(2012-3#1)
post operative##9##2##(1996-6#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-7#2)(2012-2#1)(2012-3#2)
post operatively##5##2##(2007-11#1)(2007-8#1)(2010-5#1)(2013-1#2)
post parathyroidectomy##2##2##(2011-2#2)
post partum care##2##3##(2008-11#2)
post partum##12##2##(1990-3#1)(1990-6#2)(1993-10#1)(1994-7#1)(2008-11#2)(2011-2#3)(2013-1#1)(2013-8#1)
post registration##4##2##(2008-11#3)(2008-12#1)
post surgery##2##2##(2008-6#1)(2009-9#1)
post surgical##2##2##(1990-5#1)(2011-1#1)
post transplant##6##2##(2008-1#5)(2009-2#1)
post traumatic stress disorder##2##4##(1991-2#1)(2013-8#1)
post treatment##5##2##(1996-12#1)(2010-12#2)(2010-9#1)(2013-1#1)
post##212##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#3)(1991-11#1)(1991-2#2)(1991-5#1)(1991-9#1)(1993-10#1)(1993-9#1)(1994-5#3)(1994-7#2)(1995-12#1)(1995-9#1)(1996-12#4)(1996-3#1)(1996-6#2)(1996-8#3)(1997-2#2)(1997-4#2)(2006-10#1)(2007-10#2)(2007-11#11)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#8)(2008-10#11)(2008-11#21)(2008-12#9)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#5)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#18)(2013-8#5)
post)##2##1##(1996-2#1)(2010-7#1)
post-##9##1##(2008-10#1)(2008-11#2)(2012-12#4)(2013-1#2)
post-1991##2##1##(2007-7#1)(2009-3#1)
post-ESD##4##1##(2012-2#4)
post-I group##5##2##(2009-3#5)
post-Katrina##5##1##(2012-2#5)
post-PCR##2##1##(2008-10#2)
post-PTCA##2##1##(1992-9#2)
post-QQc cells compared with##2##4##(2012-12#2)
post-QQc cells##5##2##(2012-12#5)
post-abortion##2##1##(1991-6#1)(2011-2#1)
post-acute care##3##2##(1991-1#2)(1994-2#1)
post-acute rehabilitation##4##2##(1991-12#1)(1992-3#1)(1993-3#1)(1995-3#1)
post-acute##10##1##(1991-1#2)(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-3#1)
post-adolescent acne##5##2##(2008-5#5)
post-adolescent##6##1##(2008-5#6)
post-annealing##2##1##(2013-8#2)
post-binding##2##1##(1994-11#1)(1995-11#1)
post-burn##2##1##(2008-12#2)
post-cataract surgery optical images##2##4##(2010-8#2)
post-cataract surgery##3##2##(2010-8#3)
post-cessation weight gain##3##3##(2013-1#3)
post-cessation weight##4##2##(2013-1#4)
post-cessation##5##1##(2007-12#1)(2013-1#4)
post-challenge##4##1##(1997-3#1)(2009-6#2)(2011-2#1)
post-chromatographic##2##1##(2008-10#2)
post-column derivatization with##4##3##(1990-8#1)(1991-5#1)(2008-10#2)
post-column derivatization##5##2##(1990-8#1)(1991-5#1)(2008-10#3)
post-column reaction##5##2##(1990-8#1)(1991-5#1)(2008-10#3)
post-column##23##1##(1990-8#4)(1991-5#3)(2008-10#15)(2008-7#1)
post-copulation##2##1##(2012-12#1)(2013-8#1)
post-crash##4##1##(1996-12#4)
post-delivery##3##1##(2007-7#2)(2011-1#1)
post-dialysis##6##1##(2007-7#1)(2008-1#3)(2008-4#1)(2013-1#1)
post-diffusion samples##2##2##(2008-11#2)
post-disaster##3##1##(2008-2#1)(2012-2#2)
post-discharge complications##2##2##(2011-2#2)
post-discharge##4##1##(2008-11#1)(2009-6#1)(2011-2#2)
post-dispersal agents##3##2##(2008-5#3)
post-dispersal##4##1##(2008-5#4)
post-dose##2##1##(1995-11#1)(2008-6#1)
post-embedding##4##1##(1990-8#3)(1994-2#1)
post-embryonic##2##1##(2007-12#1)(2009-8#1)
post-experience hour##2##2##(2008-11#2)
post-exposure prophylaxis##3##2##(2007-2#1)(2008-10#1)(2012-12#1)
post-exposure##4##1##(2007-12#1)(2007-2#1)(2008-10#1)(2012-12#1)
post-fertilization##2##1##(1997-9#1)(2013-1#1)
post-genome##3##1##(2008-7#3)
post-genomic biology##2##2##(2009-5#1)(2009-7#1)
post-genomic era##7##2##(2008-7#3)(2010-4#1)(2011-2#1)(2012-3#2)
post-genomic##11##1##(2008-7#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#3)
post-glucose##2##1##(2010-10#1)(2012-7#1)
post-graduate##4##1##(1994-12#2)(2007-4#1)(2008-1#1)
post-harvest##2##1##(2008-10#2)
post-hatch and##2##2##(2008-12#1)(2008-7#1)
post-hatch##5##1##(2008-12#1)(2008-7#2)(2010-8#2)
post-hemodialysis##3##1##(2008-10#3)
post-herpetic##2##1##(2008-5#1)(2008-7#1)
post-hoc analysis##2##2##(2009-3#1)(2012-2#1)
post-hoc##8##1##(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)
post-hospital##2##1##(1995-3#1)(2008-1#1)
post-hybridization washes##2##2##(2008-1#1)(2008-9#1)
post-ictal##5##1##(1995-12#5)
post-immunization##5##1##(2008-10#1)(2009-5#4)
post-implant##7##1##(2008-9#6)(2012-2#1)
post-implantation##11##1##(1996-12#2)(2008-10#1)(2008-5#4)(2008-9#1)(2011-1#2)(2013-1#1)
post-incident##2##1##(2012-1#2)
post-infection (p##2##2##(1997-6#1)(2007-6#1)
post-infection in##4##2##(1996-12#3)(2012-12#1)
post-infection##24##1##(1992-8#1)(1996-12#4)(1997-4#2)(1997-6#1)(2007-6#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-12#2)
post-infectious##2##1##(2007-7#1)(2008-1#1)
post-infusion F-DOPA##2##2##(2008-7#2)
post-infusion##3##1##(2008-7#3)
post-initiation##3##1##(1992-5#3)
post-injection##6##1##(1993-8#1)(1994-5#1)(2008-10#3)(2011-1#1)
post-injury##8##1##(1991-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-2#3)
post-inoculation##8##1##(2008-5#5)(2010-10#2)(2012-2#1)
post-intervention##11##1##(2007-12#1)(2008-12#8)(2011-2#1)(2013-1#1)
post-irradiation##3##1##(2008-9#1)(2011-2#1)(2013-1#1)
post-ischemic hyperemia##2##2##(2008-4#2)
post-ischemic##4##1##(1994-2#1)(2008-4#2)(2009-12#1)
post-lingually deaf adults using##2##4##(2008-9#2)
post-lingually deaf adults##4##3##(2008-9#4)
post-lingually deaf##5##2##(2008-9#5)
post-lingually deafened##2##2##(2008-9#2)
post-lingually##7##1##(2008-9#7)
post-market##4##1##(2011-2#3)(2012-3#1)
post-marketing surveillance##2##2##(2007-7#1)(2008-8#1)
post-marketing##6##1##(1990-9#1)(2007-7#1)(2008-10#1)(2008-8#2)(2011-2#1)
post-meiotic##2##1##(2008-5#1)(2012-2#1)
post-meningitic deafness##3##2##(2008-9#3)
post-meningitic##4##1##(2008-9#4)
post-menopausal breast cancer##3##3##(1993-1#2)(2012-12#1)
post-menopausal women##11##2##(2008-11#3)(2008-5#2)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
post-menopausal##19##1##(1993-1#2)(1994-7#1)(2008-10#1)(2008-11#5)(2008-5#2)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
post-mitotic##2##1##(2008-5#1)(2009-8#1)
post-mortem cerebral cortex##2##3##(1996-12#2)
post-mortem examination##4##2##(1997-3#3)(2008-7#1)
post-mortem human brain tissue##2##4##(1996-12#2)
post-mortem interval##4##2##(1993-12#1)(2008-6#1)(2008-7#1)(2009-3#1)
post-mortem samples##2##2##(1992-3#1)(2009-12#1)
post-mortem tissues of##2##3##(2008-7#2)
post-mortem with##3##2##(2008-7#3)
post-mortem##40##1##(1991-11#1)(1992-3#3)(1993-12#1)(1996-12#4)(1997-3#4)(2008-10#1)(2008-6#2)(2008-7#13)(2009-12#2)(2009-3#5)(2009-5#1)(2011-2#1)(2013-1#2)
post-natal##9##1##(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-3#3)(2012-2#1)
post-obturation##2##1##(2012-3#2)
post-op##4##1##(2007-8#1)(2012-2#1)(2013-1#2)
post-operation##2##1##(2008-7#1)(2008-9#1)
post-operative blood loss##2##3##(2007-8#1)(2013-1#1)
post-operative cardiac surgical patients##2##4##(2008-12#2)
post-operative care##2##2##(2007-11#2)
post-operative complications##4##2##(1990-9#1)(2007-8#1)(2012-2#2)
post-operative course##2##2##(1993-5#1)(2011-2#1)
post-operative hearing##2##2##(2012-2#1)(2012-8#1)
post-operative lung function##3##3##(2007-8#3)
post-operative mortality##2##2##(1992-9#1)(2011-2#1)
post-operative pain##4##2##(2008-11#2)(2009-3#2)
post-operative period##5##2##(2007-11#1)(2008-11#1)(2012-2#2)(2013-1#1)
post-operative##76##1##(1990-9#2)(1991-5#2)(1992-9#1)(1993-5#2)(1997-7#1)(2007-11#6)(2007-7#6)(2007-8#9)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-3#5)(2010-10#1)(2010-11#2)(2010-12#2)(2011-2#5)(2012-2#13)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#1)
post-operatively and remains##2##3##(2008-6#1)(2011-2#1)
post-operatively and##4##2##(2008-6#2)(2011-2#1)(2012-2#1)
post-operatively##13##1##(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
post-oxidation##2##1##(2012-12#2)
post-partum period##2##2##(1994-3#1)(2010-11#1)
post-partum##9##1##(1993-10#2)(1994-3#2)(1996-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)
post-penetration##2##1##(2008-10#1)(2012-2#1)
post-polymerization treatments on the flexural strength and Vickers hardness of##2##10##(2008-12#2)
post-polymerization treatments##3##2##(2008-12#3)
post-prandial##7##1##(1994-12#1)(2008-1#1)(2008-6#5)
post-prandially##4##1##(1991-8#3)(1994-11#1)
post-processing##4##1##(2009-10#1)(2009-5#1)(2010-6#1)(2012-2#1)
post-radioiodine hypothyroidism##2##2##(2008-11#2)
post-receptor##4##1##(1994-12#2)(1996-2#1)(2009-7#1)
post-registration students##2##2##(2008-11#1)(2008-12#1)
post-registration##9##1##(2008-11#8)(2008-12#1)
post-reproductive phase of the experiment##3##5##(1997-4#3)
post-reproductive##9##1##(1997-4#9)
post-residency##2##1##(2011-2#2)
post-resuscitation##2##1##(2008-7#1)(2012-3#1)
post-revolutionary Mexico##2##2##(2009-7#2)
post-session##2##1##(2013-1#2)
post-settlement##3##1##(2007-5#2)(2010-8#1)
post-spike##2##1##(1990-12#1)(1996-2#1)
post-stimulus##5##1##(1990-5#1)(1995-12#1)(1996-2#3)
post-stress##2##1##(2010-3#1)(2012-2#1)
post-stressed vowels more than their##2##5##(2009-11#2)
post-stressed vowels##4##2##(2009-11#4)
post-stressed##6##1##(2009-11#6)
post-stroke##8##1##(2007-10#4)(2008-11#1)(2008-7#1)(2009-10#2)
post-surgery##7##1##(2007-11#4)(2008-12#1)(2011-2#1)(2013-1#1)
post-surgical##9##1##(1991-1#1)(1993-12#1)(2007-8#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
post-synaptic##8##1##(1995-12#2)(1996-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
post-synthesis##3##1##(2008-1#2)(2008-10#1)
post-target mechanisms##2##2##(2008-11#2)
post-test and##2##2##(2008-12#2)
post-test##17##1##(1992-1#1)(1993-1#1)(1994-1#3)(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-12#1)(2013-1#3)
post-thaw##2##1##(2008-11#1)(2012-3#1)
post-thrombotic syndrome##5##2##(2011-2#5)
post-training inactivation##2##2##(1993-12#2)
post-training##7##1##(1991-2#2)(1992-8#1)(1993-12#2)(2008-12#1)(2008-6#1)
post-transcriptional gene regulation##2##3##(1993-12#1)(2009-2#1)
post-transcriptional gene silencing##2##3##(2008-10#1)(2008-9#1)
post-transcriptional gene##5##2##(1993-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2013-8#1)
post-transcriptional level##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
post-transcriptional mechanisms##3##2##(1990-11#1)(1995-6#1)(2008-4#1)
post-transcriptional processing##2##2##(1993-6#2)
post-transcriptional regulation of##3##3##(1991-12#1)(1996-12#1)(2009-2#1)
post-transcriptional regulation##4##2##(1991-12#2)(1996-12#1)(2009-2#1)
post-transcriptional##30##1##(1990-11#1)(1991-12#2)(1991-6#1)(1992-1#2)(1992-12#2)(1993-12#1)(1993-6#2)(1995-6#1)(1996-12#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#3)(2009-2#3)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
post-transcriptionally by##2##2##(1994-11#1)(2011-2#1)
post-transcriptionally##5##1##(1994-11#1)(2009-5#1)(2010-7#1)(2011-2#2)
post-translation##2##1##(2008-11#1)(2011-1#1)
post-translational incorporation of##2##3##(1995-12#2)
post-translational modification of##2##3##(1997-1#1)(2013-1#1)
post-translational modification##12##2##(1990-8#1)(1997-1#1)(2008-1#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-1#2)
post-translational modifications (PTMs)##2##3##(2008-7#1)(2009-5#1)
post-translational modifications of the##2##4##(1994-8#1)(2008-11#1)
post-translational modifications of##3##3##(1994-8#1)(2008-11#1)(2011-2#1)
post-translational modifications on##2##3##(2008-11#1)(2008-4#1)
post-translational modifications##21##2##(1992-12#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-8#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#2)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
post-translational processing in##2##3##(1991-5#1)(1991-8#1)
post-translational processing##5##2##(1991-5#1)(1991-8#1)(1995-8#3)
post-translational##63##1##(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#3)(1997-1#1)(2008-1#4)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
post-translationally modified##6##2##(1993-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)
post-translationally##9##1##(1993-3#1)(1994-12#1)(1996-12#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)
post-transplant erythrocytosis##2##2##(2008-4#2)
post-transplant lymphoproliferative disease##2##3##(2007-12#1)(2012-2#1)
post-transplant lymphoproliferative##3##2##(2007-12#1)(2011-3#1)(2012-2#1)
post-transplant##17##1##(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#4)(2010-11#1)(2010-6#1)(2011-3#1)(2012-2#1)
post-transplantation##4##1##(2008-4#1)(2010-11#1)(2012-2#1)(2013-1#1)
post-traumatic stress disorder (PTSD)##6##4##(2008-6#2)(2012-1#1)(2012-12#2)(2013-8#1)
post-traumatic stress disorder##12##3##(2008-6#5)(2009-6#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
post-traumatic stress disorder&quot##2##3##(1993-6#2)
post-traumatic stress symptoms##2##3##(2009-7#1)(2012-12#1)
post-traumatic stress##20##2##(1991-2#1)(1992-9#1)(1993-6#2)(2008-6#5)(2009-6#1)(2009-7#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-8#2)
post-traumatic ventricular##2##2##(2007-8#2)
post-traumatic##35##1##(1990-9#1)(1991-2#1)(1992-9#1)(1993-6#2)(1997-3#1)(2007-8#4)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#2)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#2)
post-travel##2##1##(2007-2#1)(2011-2#1)
post-treatment follow-up time##2##3##(2008-6#2)
post-treatment follow-up##3##2##(2008-5#1)(2008-6#2)
post-treatment platelet reactivity##2##3##(2009-5#2)
post-treatment##47##1##(1992-9#2)(1994-8#1)(1996-12#1)(1997-4#3)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#4)(2012-12#1)(2013-1#12)
post-vaccination##6##1##(1997-6#1)(2007-2#1)(2008-5#1)(2009-12#1)(2012-12#2)
post-war##4##1##(1994-11#1)(1996-8#1)(2007-7#1)(2013-8#1)
post-work##2##1##(2012-1#2)
postablation##2##1##(2008-3#2)
postacrosomal##2##1##(2008-4#1)(2008-8#1)
postadmission##3##1##(2008-3#2)(2010-11#1)
postal questionnaire was##3##3##(1995-5#1)(2007-2#1)(2011-1#1)
postal questionnaire##8##2##(1993-10#1)(1995-5#1)(2007-2#2)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
postal questionnaires and##2##3##(2008-11#1)(2009-6#1)
postal survey##6##2##(1997-4#1)(1997-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
postal##18##1##(1993-10#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
postalveolar fricatives##2##2##(2009-12#2)
postalveolar##5##1##(2009-12#5)
postamplifier##2##1##(2008-3#2)
postanthesis##2##1##(2008-10#2)
postattack##3##1##(2007-12#3)
postbloom##9##1##(2008-10#9)
postburn##3##1##(1994-5#1)(2008-8#2)
postcardiotomy phrenic nerve paresis##4##4##(2013-1#4)
postcardiotomy##5##1##(2013-1#5)
postcastration syndrome##2##2##(2008-11#2)
postcentral##2##1##(2008-7#1)(2013-8#1)
postcoital contraceptive##2##2##(1993-2#2)
postcoital##8##1##(1993-2#7)(1994-2#1)
postconceptional age##4##2##(1992-2#1)(1995-8#1)(2007-11#2)
postconcussion syndrome##3##2##(2008-7#2)(2013-1#1)
postconcussive symptoms##3##2##(2008-6#1)(2013-1#2)
postconcussive syndrome##2##2##(2008-6#2)
postconcussive##6##1##(2008-6#4)(2013-1#2)
postconditioning##6##1##(2013-1#3)(2013-7#3)
postcontrast##3##1##(2007-10#1)(2008-7#1)(2013-8#1)
postcrash##2##1##(1996-12#2)
postdeposition##3##1##(2008-2#1)(2008-3#1)(2010-4#1)
postdiapause embryos##2##2##(2013-1#2)
postdiapause##3##1##(2013-1#3)
postdischarge##3##1##(2007-10#1)(2008-11#2)
postdoctoral fellows##2##2##(1997-2#1)(2008-5#1)
postdoctoral##3##1##(1994-12#1)(1997-2#1)(2008-5#1)
postdonation platelet##2##2##(2011-2#2)
postdural puncture headache in##2##4##(1993-10#2)
postdural puncture headache##3##3##(1993-10#3)
posted for##6##2##(1994-1#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#2)
posted##8##1##(1994-1#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#2)(2012-3#1)
postembedding##2##1##(1994-8#1)(1995-12#1)
postembryonic development of##2##3##(1996-5#1)(2007-12#1)
postembryonic development##4##2##(1996-5#1)(2007-12#3)
postembryonic##5##1##(1996-5#1)(2007-12#4)
postemergence##2##1##(2008-10#2)
poster presentations##2##2##(2008-5#2)
poster sessions##4##2##(2008-5#3)(2010-11#1)
poster##9##1##(2008-12#1)(2008-5#6)(2010-11#1)(2011-2#1)
posterior VSD##2##2##(2012-1#2)
posterior and anterior##3##3##(1994-8#1)(2008-6#1)(2011-7#1)
posterior and##5##2##(1994-8#1)(1994-9#1)(2008-12#1)(2008-6#1)(2011-7#1)
posterior approach##6##2##(2007-11#2)(2008-9#1)(2011-2#3)
posterior canal wall during##2##4##(2008-9#2)
posterior canal wall##5##3##(2008-9#5)
posterior canal##6##2##(2008-9#5)(2012-12#1)
posterior capsule##2##2##(2011-2#2)
posterior cerebral artery (PCA)##2##4##(1997-6#1)(2008-7#1)
posterior cerebral##3##2##(1997-6#2)(2008-7#1)
posterior cervical space##2##3##(1997-6#2)
posterior cervical##5##2##(1997-6#2)(2011-2#1)(2012-3#2)
posterior chamber##3##2##(1991-2#1)(2008-4#1)(2011-2#1)
posterior cingulate##8##2##(1993-12#2)(2008-11#1)(2008-6#4)(2013-8#1)
posterior circulation##9##2##(1993-3#1)(2008-7#4)(2012-2#1)(2012-3#2)(2013-8#1)
posterior column##2##2##(1990-3#1)(2008-7#1)
posterior communicating artery##2##3##(2008-7#2)
posterior communicating##3##2##(2008-7#3)
posterior composites##6##2##(2009-2#6)
posterior cruciate ligament (PCL)##2##4##(2009-7#1)(2013-1#1)
posterior cruciate ligament retaining##2##4##(2013-1#2)
posterior cruciate ligament##4##3##(2009-7#1)(2013-1#3)
posterior dislocation of##3##3##(2009-3#1)(2012-12#2)
posterior dislocations##2##2##(2008-12#1)(2009-3#1)
posterior distribution##2##2##(2010-2#1)(2010-5#1)
posterior elements of the upper##2##5##(2013-1#2)
posterior elements of the##3##4##(2012-3#1)(2013-1#2)
posterior end of the##2##4##(2007-12#1)(2009-10#1)
posterior epidural##2##2##(2011-2#2)
posterior epithelium##2##2##(2007-12#2)
posterior facets##2##2##(2011-2#2)
posterior fossa and##2##3##(1996-6#1)(2008-7#1)
posterior fossa##19##2##(1993-1#1)(1996-6#2)(1996-9#1)(2008-12#2)(2008-7#7)(2009-9#1)(2011-2#4)(2012-12#1)
posterior hypothalamic##2##2##(1991-5#1)(1995-12#1)
posterior hypothalamus##2##2##(1991-5#1)(1995-12#1)
posterior instrumentation to the##2##4##(2008-8#2)
posterior instrumentation##3##2##(2008-8#3)
posterior interosseous##4##2##(2008-9#4)
posterior leaflet##4##2##(2007-8#3)(2008-10#1)
posterior left##2##2##(2008-11#1)(2009-7#1)
posterior lobe##5##2##(1992-9#2)(1997-8#1)(2012-3#2)
posterior location##2##2##(2009-4#1)(2011-2#1)
posterior lumbar interbody fusion##2##4##(2008-11#2)
posterior maxilla##3##2##(2007-12#2)(2010-5#1)
posterior maxillary##2##2##(2007-12#1)(2011-2#1)
posterior medial##2##2##(1991-2#1)(2008-6#1)
posterior mediastinal##5##2##(2007-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
posterior mediastinum##7##2##(2007-8#2)(2010-12#2)(2011-2#3)
posterior mitral##2##2##(2007-12#1)(2008-10#1)
posterior neck##2##2##(1990-12#1)(2007-5#1)
posterior only##2##2##(2008-8#2)
posterior or##2##2##(2007-11#1)(2011-2#1)
posterior parietal cortex##4##3##(1994-3#2)(1997-2#2)
posterior parietal##12##2##(1994-3#3)(1996-2#1)(1997-2#3)(2007-10#1)(2007-8#1)(2008-11#1)(2009-10#1)(2012-1#1)
posterior part of the##5##4##(2007-12#1)(2008-2#1)(2009-4#2)(2011-2#1)
posterior part of##6##3##(2007-12#1)(2008-2#1)(2009-4#2)(2011-2#2)
posterior pituitary gland##2##3##(1997-8#1)(2013-1#1)
posterior pituitary##8##2##(1993-5#1)(1997-8#4)(2007-10#1)(2008-4#1)(2013-1#1)
posterior probabilities##2##2##(2008-10#1)(2011-2#1)
posterior probability calculations##2##3##(1995-2#2)
posterior probability that the##2##4##(1994-11#1)(1997-8#1)
posterior probability##5##2##(1994-11#1)(1995-2#2)(1997-8#1)(2010-4#1)
posterior quadrants##3##2##(1996-7#1)(2009-8#2)
posterior region##2##2##(2007-12#2)
posterior regions##2##2##(2008-3#1)(2011-7#1)
posterior sigmoid##2##2##(2011-2#2)
posterior stabilization##3##2##(2007-11#3)
posterior surface of the neck were##2##6##(2012-1#2)
posterior surface of the##3##4##(2007-8#1)(2012-1#2)
posterior surface##4##2##(2007-8#1)(2012-1#2)(2013-8#1)
posterior surgery##3##2##(2008-8#2)(2011-2#1)
posterior tibial artery##2##3##(2013-1#2)
posterior tibial tendon##3##3##(1990-9#2)(2008-8#1)
posterior tibial##9##2##(1990-11#1)(1990-9#2)(2007-2#1)(2008-8#1)(2010-5#2)(2013-1#2)
posterior to the##2##3##(2008-7#1)(2011-2#1)
posterior to##5##2##(1997-8#1)(2008-10#1)(2008-7#2)(2011-2#1)
posterior trunk##2##2##(2012-2#2)
posterior tympanotomy##2##2##(2008-9#2)
posterior urethra##4##2##(2008-10#4)
posterior urethral valve##5##3##(2008-10#2)(2011-2#3)
posterior urethral valves##7##3##(1991-11#1)(2008-1#1)(2008-10#5)
posterior urethral##14##2##(1991-11#1)(2008-1#1)(2008-10#7)(2011-2#3)(2013-8#2)
posterior uterine##2##2##(1993-1#1)(2011-2#1)
posterior wall of the##3##4##(1997-8#1)(2006-12#1)(2008-7#1)
posterior wall##6##2##(1997-8#1)(2006-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
posterior walls##3##2##(1991-6#2)(1993-12#1)
posterior##427##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#2)(1991-11#2)(1991-2#3)(1991-5#2)(1991-6#5)(1992-9#2)(1993-1#2)(1993-12#7)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#3)(1994-8#2)(1994-9#3)(1995-12#2)(1995-2#3)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-9#2)(1997-2#5)(1997-3#9)(1997-6#4)(1997-7#2)(1997-8#12)(2006-12#1)(2007-10#4)(2007-11#10)(2007-12#26)(2007-2#1)(2007-5#1)(2007-8#14)(2008-1#1)(2008-10#17)(2008-11#12)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#37)(2008-8#23)(2008-9#13)(2009-10#2)(2009-11#1)(2009-2#7)(2009-3#6)(2009-4#5)(2009-7#2)(2009-8#3)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#48)(2011-7#2)(2012-1#7)(2012-12#6)(2012-2#8)(2012-3#13)(2013-1#21)(2013-8#6)
posterior-only##4##1##(2008-8#2)(2009-3#1)(2012-3#1)
posterioris##3##1##(2008-6#3)
posteriorly##9##1##(1995-11#1)(1995-5#2)(2007-12#1)(2008-5#3)(2008-7#1)(2009-3#1)
postero-lateral spondylodesis##4##2##(2007-11#4)
postero-lateral##6##1##(2007-11#4)(2007-8#1)(2008-12#1)
postero-medial##5##1##(1993-6#3)(2008-2#1)(2009-7#1)
posterolateral corner injuries##2##3##(2012-2#2)
posterolateral corner##4##2##(2011-2#1)(2012-2#3)
posterolateral fusion##3##2##(2008-8#1)(2012-12#2)
posterolateral instrumentation##2##2##(2011-2#1)(2012-12#1)
posterolateral knee pain##2##3##(2011-2#2)
posterolateral structures##2##2##(2013-1#2)
posterolateral thalamic##2##2##(2008-7#2)
posterolateral thoracotomy##5##2##(2007-12#1)(2007-8#3)(2010-12#1)
posterolateral##29##1##(2007-12#1)(2007-8#3)(2008-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)
posterolateral-subcostal thoracotomy##3##2##(2007-8#3)
posterolateral-subcostal##4##1##(2007-8#4)
posteromedial fragment##2##2##(2013-1#2)
posteromedial##11##1##(2007-10#2)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#2)(2013-1#4)
posteroventral##2##1##(2008-7#2)
posters and##2##2##(2008-10#1)(2008-7#1)
posters were##4##2##(2008-5#3)(2008-7#1)
posters##17##1##(1996-2#1)(2008-10#3)(2008-3#1)(2008-5#7)(2008-7#2)(2010-11#1)(2013-1#2)
postexercise##5##1##(1992-5#1)(2013-1#1)(2013-8#3)
postexposure prophylaxis##2##2##(2012-3#2)
postexposure##7##1##(1992-3#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#2)
postflame region of##2##3##(2008-2#1)(2008-3#1)
postflame region##4##2##(2008-2#2)(2008-3#2)
postflame##6##1##(2008-2#2)(2008-3#4)
postganglionic##2##1##(1990-7#1)(2012-1#1)
postgenomic##2##1##(2008-7#2)
postgermination##3##1##(2008-10#3)
postgraduate and##2##2##(2007-11#1)(2008-1#1)
postgraduate dental##3##2##(2013-1#3)
postgraduate education##3##2##(1993-6#1)(1994-12#1)(2011-2#1)
postgraduate medical##2##2##(1994-3#1)(2008-8#1)
postgraduate students in India##2##4##(2013-1#2)
postgraduate students##3##2##(2008-11#1)(2013-1#2)
postgraduate training in##2##3##(1992-5#1)(1997-6#1)
postgraduate training##7##2##(1992-5#1)(1993-11#1)(1994-12#1)(1997-5#1)(1997-6#1)(2008-7#1)(2012-1#1)
postgraduate##46##1##(1991-2#1)(1992-1#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#8)(1994-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#9)(2013-8#1)
postgrowth##2##1##(2007-11#1)(2008-2#1)
postharvest biocontrol##2##2##(2008-10#2)
postharvest blue mold##2##3##(2008-10#2)
postharvest decay##3##2##(2008-10#3)
postharvest fungal##2##2##(2008-10#2)
postharvest pathogen##4##2##(2008-10#4)
postharvest pathogens##4##2##(2008-10#4)
postharvest##37##1##(2008-10#37)
posthaustorial##2##1##(2008-10#2)
postherpetic neuralgia (PHN)##2##3##(1996-6#1)(2008-9#1)
postherpetic neuralgia##3##2##(1996-6#2)(2008-9#1)
postherpetic##4##1##(1994-3#1)(1996-6#2)(2008-9#1)
posthospital adjustment##2##2##(1992-3#1)(1993-1#1)
posthospital##3##1##(1992-3#1)(1993-1#1)(2013-1#1)
postictal behavioral depression##2##3##(1992-12#2)
postimmunization##4##1##(2009-4#2)(2009-5#1)(2013-7#1)
postimplantation##2##1##(1993-12#1)(1995-2#1)
postinfarction##7##1##(1993-12#2)(1996-3#1)(2007-8#2)(2009-10#1)(2012-1#1)
postinfection##13##1##(2008-10#7)(2008-5#1)(2009-2#1)(2009-8#2)(2012-3#2)
postinfectious##7##1##(1993-3#1)(2007-8#2)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
postinjection##4##1##(1991-9#1)(1992-11#1)(1993-1#1)(1996-2#1)
postinjury##2##1##(2008-7#2)
postinoculation (dpi)##4##2##(2008-10#4)
postinoculation and##2##2##(2008-10#2)
postinoculation##27##1##(2008-10#27)
postinstitutionalized Romanian##2##2##(2008-11#2)
postinstitutionalized##3##1##(2008-11#3)
postintervention##7##1##(2007-10#1)(2007-8#1)(2010-7#1)(2013-1#4)
postirradiation##2##1##(1995-8#1)(2011-2#1)
postischemic reperfusion##2##2##(1991-9#2)
postischemic##8##1##(1991-9#2)(1993-3#1)(1995-12#2)(1996-9#1)(2013-1#2)
postlabeling assay of AAF modified##2##5##(1991-5#2)
postlabeling assay##3##2##(1991-5#3)
postlabeling##7##1##(1991-5#6)(1994-8#1)
postlesion##13##1##(1993-6#1)(1997-3#12)
postlingual patients with cochlear implants##2##5##(2008-9#2)
postlingual##6##1##(2008-9#5)(2011-1#1)
postlingually and prelingually deafened##2##4##(2008-9#2)
postlingually deafened adult##2##3##(2008-9#2)
postlingually deafened adults##3##3##(2008-9#3)
postlingually deafened##7##2##(2008-9#7)
postlingually##10##1##(2008-9#10)
postmarketing##6##1##(2006-10#1)(2008-11#3)(2010-5#1)(2013-1#1)
postmastectomy##2##1##(2013-1#2)
postmating barriers##3##2##(2008-6#1)(2012-3#2)
postmating##6##1##(2008-6#1)(2008-9#2)(2012-12#1)(2012-3#2)
postmenopausal HRT##2##2##(2008-3#2)
postmenopausal or climacteric bleeding##2##4##(1992-12#2)
postmenopausal osteoporosis##10##2##(1993-11#1)(1995-11#2)(2007-7#1)(2008-4#1)(2012-2#5)
postmenopausal patients##9##2##(1991-12#1)(1991-4#2)(1993-12#1)(1994-12#2)(1994-2#1)(2007-5#1)(2010-7#1)
postmenopausal subjects who were and were not on HRT and##2##10##(2008-5#2)
postmenopausal women were##3##3##(1992-1#1)(1992-3#1)(1994-12#1)
postmenopausal women who had##2##4##(1993-2#1)(2008-7#1)
postmenopausal women who##3##3##(1993-2#1)(2008-5#1)(2008-7#1)
postmenopausal women with##2##3##(2011-1#1)(2013-1#1)
postmenopausal women##33##2##(1992-1#3)(1992-3#3)(1993-2#1)(1994-12#1)(1994-9#1)(2008-11#2)(2008-3#4)(2008-5#3)(2008-7#3)(2010-12#1)(2011-1#5)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
postmenopausal##73##1##(1991-12#1)(1991-4#3)(1992-1#4)(1992-12#2)(1992-3#3)(1993-11#4)(1993-12#2)(1993-2#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-11#2)(2007-5#1)(2007-7#1)(2008-11#3)(2008-3#8)(2008-4#1)(2008-5#5)(2008-7#3)(2010-12#1)(2010-7#1)(2011-1#5)(2011-2#1)(2012-2#8)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#1)
postmitotic cells##2##2##(1994-5#1)(2007-12#1)
postmitotic##6##1##(1994-5#3)(1995-5#1)(2007-12#1)(2013-1#1)
postmodern##2##1##(2008-1#1)(2008-12#1)
postmortem brain##2##2##(2008-7#1)(2011-1#1)
postmortem examination of the##2##4##(1997-3#1)(2013-1#1)
postmortem examination##5##2##(1997-3#1)(2007-10#1)(2013-1#2)(2013-8#1)
postmortem human##4##2##(1992-8#1)(1995-12#1)(2008-7#2)
postmortem studies have##2##3##(2008-7#1)(2013-1#1)
postmortem##32##1##(1990-11#1)(1991-3#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-3#2)(1996-12#2)(1997-3#2)(1997-8#2)(2007-10#1)(2007-12#1)(2008-12#1)(2008-7#6)(2008-9#2)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
postmortem)##2##1##(2010-4#2)
postnatal and adult##2##3##(1996-5#1)(2008-7#1)
postnatal brain development##3##3##(1994-6#2)(2008-4#1)
postnatal brain##4##2##(1994-6#2)(2008-4#1)(2009-8#1)
postnatal care##2##2##(1993-3#1)(2013-8#1)
postnatal day 1##2##3##(1990-11#1)(1996-12#1)
postnatal day 2##2##3##(1993-5#1)(1996-5#1)
postnatal day##17##2##(1990-11#1)(1991-2#1)(1993-12#2)(1993-3#2)(1993-5#1)(1995-6#1)(1996-12#3)(1996-5#3)(2008-10#1)(2008-7#1)(2012-12#1)
postnatal days##5##2##(1993-12#1)(1995-8#1)(1996-5#2)(1997-2#1)
postnatal depression##2##2##(2011-2#1)(2013-1#1)
postnatal development of##9##3##(1991-6#1)(1992-6#1)(1993-12#2)(1996-5#2)(2009-8#1)(2011-2#2)
postnatal development##16##2##(1990-7#1)(1991-6#1)(1992-6#2)(1993-12#2)(1994-5#1)(1996-1#1)(1996-5#3)(1997-2#1)(2009-8#2)(2011-2#2)
postnatal follow-up##3##2##(1992-2#1)(2007-8#1)(2008-7#1)
postnatal growth##2##2##(2009-3#1)(2011-1#1)
postnatal period##9##2##(1990-5#1)(1991-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-1#1)
postnatal retina##2##2##(2010-1#1)(2012-12#1)
postnatal treatment##2##2##(1996-5#1)(2013-1#1)
postnatal week##6##2##(1993-12#2)(1997-2#4)
postnatal##143##1##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#3)(1993-12#14)(1993-3#4)(1993-5#2)(1994-11#3)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#5)(1996-5#14)(1997-2#7)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-7#4)(2009-3#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#11)(2012-3#2)(2013-1#4)(2013-8#2)
postnatally to##2##2##(1996-2#1)(1997-3#1)
postnatally##9##1##(1992-10#1)(1992-11#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(2009-3#1)(2012-1#1)(2012-3#1)
postnonlinearity compensation##2##2##(2007-11#2)
postoperative CSF leak and wound dehiscence##2##6##(2008-7#2)
postoperative LOS##2##2##(1994-3#2)
postoperative adhesion formation or reproductive##2##5##(1992-3#2)
postoperative adhesion formation##4##3##(1992-3#4)
postoperative adhesions##4##2##(1992-3#2)(1995-2#2)
postoperative adjuvant therapy##2##3##(1997-7#1)(2013-1#1)
postoperative adjuvant##3##2##(1994-7#1)(1997-7#1)(2013-1#1)
postoperative analgesia##4##2##(1993-2#1)(2007-11#2)(2007-12#1)
postoperative angiogram##2##2##(2007-8#1)(2008-7#1)
postoperative bleeding##4##2##(1990-3#1)(2007-8#1)(2008-7#1)(2011-3#1)
postoperative cardiorespiratory##2##2##(2007-8#2)
postoperative care##8##2##(1990-9#1)(1991-3#1)(2007-11#1)(2009-5#2)(2010-5#1)(2010-7#2)
postoperative chemotherapy##3##2##(1990-12#1)(1990-8#1)(1996-6#1)
postoperative complication occurrence##2##3##(2010-8#2)
postoperative complication##7##2##(1991-3#1)(2008-9#1)(2009-3#1)(2010-8#2)(2011-2#2)
postoperative complications and##2##3##(2008-10#1)(2009-2#1)
postoperative complications of##3##3##(2009-5#1)(2011-3#1)(2013-8#1)
postoperative complications were observed##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
postoperative complications were##6##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#2)
postoperative complications##35##2##(1992-2#1)(1994-2#2)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
postoperative course of##2##3##(1992-6#1)(2007-8#1)
postoperative course was uneventful and##3##5##(2008-10#1)(2008-12#1)(2012-3#1)
postoperative course was uneventful##12##4##(1996-8#1)(2006-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
postoperative course was##16##3##(1992-9#1)(1996-8#1)(2006-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
postoperative course##26##2##(1991-9#1)(1992-6#1)(1992-9#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-8#7)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
postoperative day##24##2##(1990-2#1)(1993-1#1)(1994-6#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#3)
postoperative days##3##2##(2007-10#1)(2011-2#1)(2013-1#1)
postoperative death##3##2##(1992-5#1)(2007-8#1)(2010-6#1)
postoperative deficits##2##2##(1991-2#1)(2008-9#1)
postoperative evaluation of##2##3##(1994-3#1)(2008-7#1)
postoperative evaluation##3##2##(1994-3#1)(2008-7#1)(2013-8#1)
postoperative extubation##3##2##(2007-8#3)
postoperative follow-up##3##2##(1992-6#1)(2008-9#1)(2011-2#1)
postoperative hospital mortality and morbidity after##2##6##(2011-2#2)
postoperative hospital##3##2##(2007-8#1)(2011-2#2)
postoperative hours##2##2##(1991-2#1)(2007-8#1)
postoperative hypoxemia in OSA patients##2##5##(2012-2#2)
postoperative ileus##3##2##(2010-4#2)(2013-1#1)
postoperative immobilization##3##2##(2009-3#3)
postoperative increase##3##2##(1990-6#2)(2012-2#1)
postoperative infection##4##2##(1992-6#1)(2008-8#2)(2011-2#1)
postoperative infections##11##2##(1990-11#1)(1991-5#2)(1995-11#3)(2007-12#1)(2008-9#1)(2012-1#3)
postoperative irradiation is##2##3##(1990-9#1)(2007-11#1)
postoperative irradiation##3##2##(1990-9#1)(1994-8#1)(2007-11#1)
postoperative management and##2##3##(2007-11#1)(2011-3#1)
postoperative management##4##2##(2007-11#1)(2007-12#1)(2011-3#1)(2013-1#1)
postoperative meningitis##2##2##(2008-9#2)
postoperative monitoring##3##2##(1993-1#1)(2007-11#1)(2012-2#1)
postoperative morbidity##13##2##(1991-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(2008-10#3)(2008-7#3)(2011-2#1)(2012-3#1)
postoperative mortality rate##2##3##(1993-5#1)(2012-1#1)
postoperative mortality was##4##3##(1992-11#1)(2008-10#1)(2008-7#1)(2011-3#1)
postoperative mortality##7##2##(1992-11#1)(1993-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)
postoperative mortality/morbidity##2##2##(2008-7#2)
postoperative nausea and vomiting##2##4##(1995-9#1)(2010-7#1)
postoperative neurological deficit##2##3##(2008-7#1)(2011-2#1)
postoperative neurological##4##2##(1992-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
postoperative outcomes##3##2##(2009-10#2)(2013-1#1)
postoperative pain and##4##3##(2009-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
postoperative pain characteristics##2##3##(2010-6#2)
postoperative pain in patients##2##4##(2007-11#1)(2010-7#1)
postoperative pain management##3##3##(1992-8#1)(2010-6#1)(2012-3#1)
postoperative pain relief##2##3##(2010-11#2)
postoperative pain##34##2##(1992-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#8)(2010-6#4)(2010-7#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
postoperative patients with ARM##2##4##(2011-2#2)
postoperative patients with##3##3##(2010-4#1)(2011-2#2)
postoperative patients##8##2##(1993-12#2)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#3)
postoperative period of##2##3##(2009-4#1)(2013-1#1)
postoperative period##34##2##(1990-2#1)(1990-3#2)(1991-11#1)(1991-2#1)(1991-5#2)(1994-3#1)(1995-4#1)(1995-5#1)(2007-11#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#2)
postoperative pulmonary complications##3##3##(2006-10#2)(2011-2#1)
postoperative pulmonary##6##2##(2006-10#2)(2011-2#1)(2012-12#2)(2012-2#1)
postoperative radiotherapy for##2##3##(1994-8#1)(2009-3#1)
postoperative radiotherapy was##2##3##(2007-5#1)(2012-2#1)
postoperative radiotherapy##9##2##(1990-10#1)(1990-12#1)(1991-4#1)(1994-2#1)(1994-8#1)(2007-5#1)(2008-7#1)(2009-3#1)(2012-2#1)
postoperative range of motion##2##4##(2008-9#1)(2013-1#1)
postoperative recovery##6##2##(1996-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
postoperative rehabilitation and##3##3##(2008-8#1)(2013-1#2)
postoperative rehabilitation##4##2##(2008-8#1)(2010-10#1)(2013-1#2)
postoperative results##5##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
postoperative sanguineous wound drainage##2##4##(1996-9#2)
postoperative scar##5##2##(2007-11#3)(2011-2#2)
postoperative shivering##6##2##(2010-7#6)
postoperative sinonasal##2##2##(2012-1#2)
postoperative speech##2##2##(2008-9#2)
postoperative survival##3##2##(1992-9#1)(1993-5#1)(2007-11#1)
postoperative symptoms##2##2##(2009-2#1)(2013-1#1)
postoperative time##4##2##(2007-8#1)(2008-5#1)(2011-2#2)
postoperative treatment##8##2##(1990-12#1)(1990-9#1)(1992-6#1)(1992-9#1)(1993-5#1)(2007-11#2)(2013-1#1)
postoperative wound##2##2##(2007-12#1)(2008-5#1)
postoperative##533##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#5)(1990-6#3)(1990-8#1)(1990-9#6)(1991-11#4)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#6)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#3)(1993-1#3)(1993-12#7)(1993-2#2)(1993-5#4)(1993-6#1)(1994-12#1)(1994-2#5)(1994-3#10)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#7)(2006-12#2)(2007-10#2)(2007-11#20)(2007-12#7)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#43)(2007-9#4)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#30)(2008-8#14)(2008-9#19)(2009-10#4)(2009-2#4)(2009-3#10)(2009-4#2)(2009-5#6)(2010-10#3)(2010-11#9)(2010-12#4)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#9)(2010-7#13)(2010-8#9)(2011-1#3)(2011-2#34)(2011-3#7)(2011-7#1)(2012-1#9)(2012-12#13)(2012-2#11)(2012-3#14)(2013-1#35)(2013-8#10)
postoperatively and##7##2##(1990-6#1)(1990-8#1)(2007-8#2)(2008-9#1)(2009-10#1)(2012-2#1)
postoperatively in##4##2##(1993-12#2)(2007-8#1)(2011-2#1)
postoperatively using##2##2##(2009-10#1)(2013-1#1)
postoperatively##93##1##(1990-2#2)(1990-6#2)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#4)(1993-12#3)(1994-1#1)(1994-2#2)(1994-3#3)(2007-11#1)(2007-12#1)(2007-8#9)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#10)(2009-10#4)(2009-3#1)(2010-12#1)(2010-8#2)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
postoral##2##1##(2007-12#2)
postpandemic season##2##2##(2013-1#2)
postpandemic##3##1##(2013-1#3)
postpartum checkup##4##2##(2013-1#4)
postpartum contraceptive use##2##3##(2013-1#2)
postpartum depression##6##2##(2007-2#1)(2012-2#1)(2013-1#4)
postpartum depressive##2##2##(2010-6#1)(2013-1#1)
postpartum fistula##2##2##(1996-12#2)
postpartum hemorrhage##3##2##(2012-12#1)(2013-1#2)
postpartum hysterectomy##3##2##(1995-12#3)
postpartum length of hospital stay##2##5##(2007-2#2)
postpartum period##7##2##(1995-8#1)(1996-3#1)(2007-2#1)(2009-3#1)(2011-2#1)(2012-2#2)
postpartum women##4##2##(1996-12#1)(1996-8#1)(2007-2#1)(2013-1#1)
postpartum##62##1##(1995-12#3)(1995-8#1)(1996-11#1)(1996-12#5)(1996-3#2)(1996-8#1)(2007-10#2)(2007-11#2)(2007-2#11)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#4)(2009-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#17)(2013-8#1)
postplanting environment##4##2##(2008-10#4)
postpone##7##1##(1990-11#1)(1996-11#1)(2009-12#2)(2011-2#2)(2012-12#1)
postponed##9##1##(1991-11#1)(1994-2#1)(1994-5#1)(1995-6#1)(2009-7#1)(2010-5#1)(2013-1#2)(2013-8#1)
postponement##4##1##(1991-6#1)(1992-2#1)(2008-11#1)(2012-12#1)
postprandial blood##2##2##(1994-12#1)(2012-3#1)
postprandial lipemia##2##2##(2008-1#1)(2008-12#1)
postprandial state##2##2##(2008-3#2)
postprandial##21##1##(1994-12#1)(1997-1#1)(1997-4#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#2)(2010-10#1)(2010-8#2)(2011-1#3)(2012-3#3)(2012-4#1)
postprocessed##2##1##(2008-3#1)(2008-7#1)
postprocessing algorithm##2##2##(2007-11#2)
postprocessing##13##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#7)
postproduction##2##1##(1993-2#1)(2010-4#1)
postpubertal patient##2##2##(2008-10#2)
postpubertal##4##1##(2008-10#3)(2008-5#1)
postradiation##2##1##(1993-2#1)(2007-12#1)
postreproductive lifespan##2##2##(2009-12#2)
postreproductive##4##1##(2009-12#4)
postresection##2##1##(2007-11#1)(2011-2#1)
posts and##2##2##(2008-11#1)(2008-3#1)
posts##8##1##(1996-11#1)(1996-8#1)(2008-11#4)(2008-3#1)(2012-2#1)
postsecondary education##4##2##(1992-3#1)(1995-3#1)(2007-12#1)(2008-11#1)
postsecondary##7##1##(1992-3#2)(1995-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-12#1)
postspawning mass##3##2##(2010-8#3)
postspawning##5##1##(2008-5#1)(2010-8#4)
poststroke functional##2##2##(2012-12#1)(2013-1#1)
poststroke patients##4##2##(2008-2#1)(2013-1#3)
poststroke##10##1##(2007-10#1)(2008-2#2)(2009-11#1)(2012-12#2)(2013-1#4)
postsupplementation##4##1##(2013-8#4)
postsurgery##4##1##(1991-3#1)(1992-12#1)(2008-1#1)(2008-12#1)
postsurgical##12##1##(1990-2#1)(1995-12#3)(2007-12#1)(2007-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-3#1)
postsynaptic cells##2##2##(2012-12#2)
postsynaptic currents##2##2##(1995-2#1)(2009-12#1)
postsynaptic densities##4##2##(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)
postsynaptic density##6##2##(1996-12#3)(2008-11#1)(2012-2#1)(2012-3#1)
postsynaptic differentiation at the##2##4##(2009-8#2)
postsynaptic differentiation##3##2##(2009-8#3)
postsynaptic dopamine##2##2##(1993-11#1)(1995-12#1)
postsynaptic inhibition##2##2##(1997-3#1)(2008-1#1)
postsynaptic neurons##3##2##(2008-11#2)(2009-8#1)
postsynaptic potential##4##2##(1992-3#1)(1997-2#2)(2011-2#1)
postsynaptic potentials##4##2##(1995-12#1)(1995-5#1)(1996-5#1)(2007-12#1)
postsynaptic proteins##2##2##(1992-8#2)
postsynaptic targets of##3##3##(1992-3#2)(1995-12#1)
postsynaptic##79##1##(1990-12#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-3#3)(1992-8#3)(1993-11#1)(1994-8#1)(1995-12#4)(1995-2#3)(1995-5#4)(1995-6#1)(1996-12#9)(1996-5#1)(1996-6#1)(1997-2#7)(1997-3#2)(1997-7#3)(2007-12#1)(2008-1#1)(2008-11#6)(2008-4#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-8#6)(2009-9#3)(2010-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#3)
postsynaptically##3##1##(1992-3#1)(1992-8#1)(2012-3#1)
posttest##10##1##(2008-12#2)(2008-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-1#1)
posttraining##7##1##(1993-5#5)(1994-8#1)(2008-5#1)
posttranscriptional gene silencing (PTGS)##3##4##(2008-10#3)
posttranscriptional gene silencing##5##3##(2008-10#4)(2012-3#1)
posttranscriptional gene##6##2##(2008-10#4)(2012-3#1)(2013-1#1)
posttranscriptional##19##1##(1990-11#1)(1991-5#2)(1994-11#1)(1994-8#2)(1995-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
posttransfection##2##1##(2008-2#2)
posttransfusion##4##1##(1994-9#3)(2011-2#1)
posttranslation##2##1##(1996-9#1)(2008-7#1)
posttranslational modification##3##2##(1992-6#2)(2010-4#1)
posttranslational modifications##6##2##(1991-6#1)(1995-2#1)(2008-2#1)(2009-3#1)(2012-2#1)(2013-1#1)
posttranslational processing of the##2##4##(1991-7#1)(1993-8#1)
posttranslational processing of##4##3##(1991-7#1)(1992-10#1)(1993-8#1)(1994-11#1)
posttranslational processing##5##2##(1991-7#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-11#1)
posttranslational translocation##2##2##(2012-1#2)
posttranslational##22##1##(1991-12#1)(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-4#1)(2012-1#2)(2012-2#1)(2013-1#1)
posttransplant (median##2##2##(2011-2#2)
posttransplant##7##1##(1991-9#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-8#2)
posttransplantation diabetes mellitus##2##3##(2008-1#2)
posttransplantation hepatitis B##2##3##(2006-10#1)(2013-8#1)
posttransplantation##5##1##(2006-10#1)(2008-1#2)(2008-7#1)(2013-8#1)
posttraumatic cerebrospinal fluid##2##3##(2008-12#2)
posttraumatic stress disorder (PTSD)##5##4##(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
posttraumatic stress disorder and##2##4##(2009-9#1)(2013-8#1)
posttraumatic stress disorder##16##3##(1996-5#2)(1996-7#1)(2008-8#1)(2009-11#3)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
posttraumatic stress symptoms##2##3##(2009-11#2)
posttraumatic stress##21##2##(1996-5#2)(1996-7#1)(2008-8#1)(2009-11#6)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
posttraumatic##41##1##(1996-5#2)(1996-7#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-12#3)(2008-8#2)(2008-9#2)(2009-11#6)(2009-3#2)(2009-9#1)(2010-10#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
posttreatment follow-up##2##2##(1991-1#1)(2008-7#1)
posttreatment##12##1##(1991-1#1)(1994-11#1)(1996-5#3)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#1)
postulate a##2##2##(1990-8#1)(1996-4#1)
postulate that the##9##3##(1990-2#1)(1992-3#1)(1994-8#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
postulate that##24##2##(1990-2#1)(1992-12#2)(1992-3#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-2#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
postulate the##2##2##(1995-3#1)(2009-10#1)
postulate##35##1##(1990-2#1)(1990-8#3)(1992-12#2)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
postulated and##2##2##(2008-8#1)(2010-10#1)
postulated as##3##2##(1990-3#1)(2008-1#1)(2008-7#1)
postulated for##2##2##(2008-7#1)(2009-5#1)
postulated in##4##2##(1992-11#1)(1994-8#1)(1996-2#1)(2008-9#1)
postulated that the##6##3##(1992-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#1)
postulated that##24##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-10#1)(2013-1#1)
postulated the##2##2##(2008-7#1)(2008-8#1)
postulated to be a##6##4##(1994-2#1)(1995-8#1)(2008-5#1)(2008-7#2)(2012-2#1)
postulated to be in##2##4##(1994-5#1)(2008-10#1)
postulated to be##14##3##(1994-2#1)(1994-5#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#3)(2011-1#1)(2012-2#1)
postulated to##22##2##(1990-5#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#3)(2011-1#1)(2012-2#1)
postulated##88##1##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
postulates the##3##2##(1995-11#1)(2007-12#1)(2008-5#1)
postulates##18##1##(1993-12#1)(1995-11#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-5#2)(2009-6#1)
postulation##2##1##(1997-3#1)(2008-5#1)
postural and movement##3##3##(2008-12#3)
postural and##6##2##(1991-2#1)(2008-12#3)(2008-7#2)
postural changes##4##2##(2008-12#2)(2010-12#1)(2011-2#1)
postural drainage##2##2##(1991-2#1)(1992-9#1)
postural hypotension##3##2##(2008-1#1)(2008-7#2)
postural instability and gait abnormalities##2##5##(2008-7#2)
postural instability##3##2##(2008-7#3)
postural perturbations##2##2##(2013-1#2)
postural reflexes##4##2##(1996-7#3)(2008-7#1)
postural righting##2##2##(1992-11#2)
postural stability##4##2##(2008-7#2)(2010-12#1)(2010-9#1)
postural##51##1##(1990-6#1)(1991-2#2)(1992-11#2)(1992-9#1)(1994-3#1)(1995-8#1)(1996-7#3)(2007-6#1)(2008-1#1)(2008-12#7)(2008-3#1)(2008-6#1)(2008-7#12)(2009-11#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#1)
posture after##3##2##(1991-2#2)(2008-5#1)
posture and locomotion##2##3##(1991-2#1)(2007-12#1)
posture and##5##2##(1991-2#1)(2007-12#2)(2008-12#1)(2012-12#1)
posture in##4##2##(1993-5#1)(2007-12#1)(2008-7#1)(2010-9#1)
posture on##2##2##(2010-9#1)(2012-3#1)
posture was##2##2##(1991-2#1)(1993-3#1)
posture##43##1##(1991-2#6)(1992-5#1)(1993-3#1)(1993-5#1)(1994-3#2)(1995-3#1)(2007-11#1)(2007-12#4)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-8#4)(2010-9#7)(2012-1#1)(2012-12#1)(2012-3#4)(2013-8#1)
postures##7##1##(2008-12#1)(2008-6#3)(2010-12#1)(2011-2#2)
postwar appraisals##6##2##(2013-1#6)
postwar##8##1##(2013-1#8)
postzygotic##6##1##(2008-10#2)(2009-2#1)(2012-3#3)
pot experiments##4##2##(1992-3#1)(2008-10#3)
pot##15##1##(1992-3#1)(1996-12#1)(1996-5#1)(2008-10#11)(2009-10#1)
pot(-1) and##2##2##(2008-10#1)(2008-12#1)
pot(-1)##4##1##(2008-10#3)(2008-12#1)
potable water##4##2##(2008-10#4)
potable##5##1##(2008-10#5)
potassium and calcium##2##3##(2008-10#2)
potassium and chloride##2##3##(2008-8#1)(2012-2#1)
potassium and magnesium##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
potassium and silver##2##3##(2008-2#2)
potassium and sodium##2##3##(2008-10#2)
potassium and##18##2##(1993-1#2)(1997-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2012-2#1)
potassium are##2##2##(2007-12#1)(2008-10#1)
potassium bromate##8##2##(2008-10#7)(2008-9#1)
potassium bromide##6##2##(2008-10#6)
potassium channel##19##2##(1991-9#3)(1994-11#3)(1994-12#2)(1996-10#1)(1996-2#2)(1997-2#3)(2007-7#1)(2008-3#1)(2008-5#2)(2008-8#1)
potassium channels##17##2##(1990-8#1)(1992-3#1)(1992-6#2)(1994-12#1)(1994-6#1)(1995-5#1)(1996-2#2)(2007-10#1)(2008-5#2)(2008-8#3)(2009-8#1)(2010-12#1)
potassium chlorate##3##2##(2008-10#3)
potassium chloride and##5##3##(1996-6#1)(2008-10#4)
potassium chloride solution##2##3##(1992-3#1)(2008-10#1)
potassium chloride##11##2##(1992-3#1)(1996-6#1)(2008-10#9)
potassium citrate##3##2##(1992-9#1)(1997-7#1)(2007-7#1)
potassium concentration##2##2##(1993-1#1)(2009-8#1)
potassium concentrations##3##2##(1995-8#2)(2008-10#1)
potassium currents in##3##3##(1993-3#1)(2008-8#1)(2010-12#1)
potassium currents##6##2##(1993-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-8#1)(2010-12#1)
potassium cyanide##2##2##(2008-10#1)(2008-7#1)
potassium dichromate##3##2##(2008-10#3)
potassium dihydrogen phosphate buffer##2##4##(2008-10#1)(2010-3#1)
potassium dihydrogen phosphate##7##3##(2008-10#3)(2008-3#1)(2008-5#1)(2010-3#1)(2012-12#1)
potassium ferricyanide##10##2##(2008-10#8)(2009-9#1)(2010-2#1)
potassium ferrocyanide##2##2##(2008-10#2)
potassium hexacyanoferrate(III)##6##2##(2008-10#6)
potassium hydrogen phthalate##4##3##(2008-10#4)
potassium hydrogen##5##2##(2008-10#5)
potassium hydrogenphthalate##2##2##(1994-9#1)(2008-10#1)
potassium hydroxide (KOH)##3##3##(2007-7#2)(2008-10#1)
potassium hydroxide and##2##3##(2008-10#2)
potassium hydroxide solution##3##3##(2008-10#3)
potassium hydroxide##13##2##(1996-2#1)(2007-7#2)(2008-10#8)(2008-6#2)
potassium in##7##2##(2008-10#4)(2008-12#1)(2008-9#2)
potassium iodate and##2##3##(2008-10#2)
potassium iodide (KI)##2##3##(2008-10#2)
potassium iodide and##3##3##(2008-10#3)
potassium iodide##16##2##(2007-7#3)(2008-10#11)(2008-2#1)(2010-12#1)
potassium ion in##3##3##(2008-10#3)
potassium ion##14##2##(1994-12#1)(2008-10#10)(2008-3#1)(2008-6#1)(2011-2#1)
potassium ion-exchanged waveguides##2##3##(2008-2#1)(2008-3#1)
potassium ions in the##2##4##(1994-12#1)(2008-10#1)
potassium ions in##3##3##(1994-12#1)(2008-10#2)
potassium ions##6##2##(1994-12#1)(2008-10#5)
potassium is##2##2##(2008-2#1)(2008-9#1)
potassium level##3##2##(1994-6#1)(2007-5#1)(2011-2#1)
potassium lithium tantalate niobate##2##4##(2007-11#1)(2007-12#1)
potassium loss##2##2##(1990-2#2)
potassium niobate##5##2##(2007-12#4)(2008-3#1)
potassium nitrate##4##2##(2008-10#3)(2008-5#1)
potassium periodate##6##2##(2008-10#6)
potassium permanganate and##3##3##(2008-10#3)
potassium permanganate in dilute sulphuric acid##2##6##(2008-10#2)
potassium permanganate in##10##3##(2008-10#10)
potassium permanganate##23##2##(2008-10#22)(2008-4#1)
potassium permanganate-sodium sulfite##2##3##(2008-10#2)
potassium phosphate buffer (pH##3##4##(2008-10#3)
potassium phosphate buffer##5##3##(2008-10#5)
potassium phosphate##13##2##(2007-11#1)(2008-10#9)(2008-5#1)(2008-7#2)
potassium poly (vinyl sulfate) (PVSK)##2##5##(2008-10#2)
potassium salt##2##2##(1995-11#1)(2007-11#1)
potassium tetrakis##3##2##(2008-10#3)
potassium tetrakis(4-chlorophenyl)borate as##2##3##(2008-10#2)
potassium tetrakis(4-chlorophenyl)borate##3##2##(2008-10#3)
potassium tetrakis(p-chlorophenyl)borate (KTpClPB)##2##3##(2008-10#2)
potassium tetrakis(p-chlorophenyl)borate##3##2##(2008-10#3)
potassium titanyl phosphate (KTP)##3##4##(2008-10#1)(2008-3#2)
potassium titanyl phosphate##11##3##(2006-4#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#2)
potassium to##2##2##(1990-12#1)(1995-8#1)
potassium vapor##2##2##(2007-11#1)(2008-2#1)
potassium was##4##2##(1993-1#1)(2008-10#2)(2008-9#1)
potassium##418##1##(1990-12#3)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#3)(1991-9#3)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#5)(1993-3#1)(1994-11#3)(1994-12#5)(1994-6#2)(1994-9#1)(1995-11#3)(1995-5#1)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#6)(1996-5#3)(1996-6#1)(1997-2#6)(1997-7#1)(1997-8#3)(2006-10#1)(2006-4#2)(2007-10#2)(2007-11#8)(2007-12#10)(2007-5#2)(2007-7#8)(2007-8#1)(2008-1#2)(2008-10#215)(2008-11#1)(2008-12#6)(2008-2#7)(2008-3#13)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#16)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)
potassium-selective electrode##3##2##(2008-10#3)
potassium-selective##5##1##(2008-10#5)
potato and tomato production##2##4##(2008-10#2)
potato and tomato##16##3##(2008-10#16)
potato and##26##2##(2008-10#26)
potato based ready-to-eat food products##3##5##(2011-2#3)
potato brown rot##2##3##(2008-10#2)
potato collected##2##2##(2008-10#2)
potato crops in##2##3##(2008-10#2)
potato crops##8##2##(2008-10#8)
potato cultivar##3##2##(2008-10#3)
potato cultivars##14##2##(2008-10#14)
potato cv##6##2##(2008-10#6)
potato cvs##3##2##(2008-10#3)
potato cyst nematode##2##3##(2008-10#2)
potato cyst##3##2##(2008-10#3)
potato dextrose agar##13##3##(2008-10#13)
potato dextrose##16##2##(2008-10#16)
potato differentials##4##2##(2008-10#4)
potato feathery mottle##5##3##(2008-10#5)
potato fields in##4##3##(2008-10#4)
potato fields##10##2##(2008-10#10)
potato growers##2##2##(2008-10#2)
potato had a##2##3##(2008-10#2)
potato in##5##2##(2008-10#4)(2011-2#1)
potato isolate##2##2##(2008-10#2)
potato isolates collected in##2##4##(2008-10#2)
potato isolates##7##2##(2008-10#7)
potato late blight epidemics##2##4##(2008-10#2)
potato late blight##15##3##(2008-10#15)
potato leafroll virus##3##3##(2008-10#3)
potato leaves##4##2##(2008-10#4)
potato mixtures##2##2##(2008-10#2)
potato or tomato##4##3##(2008-10#4)
potato or##6##2##(2008-10#5)(2008-5#1)
potato plants were##2##3##(2008-10#1)(2008-8#1)
potato plants##11##2##(1997-4#1)(2008-10#8)(2008-8#1)(2009-6#1)
potato production##6##2##(2008-10#5)(2008-12#1)
potato proteins##2##2##(2008-5#1)(2010-4#1)
potato samples##3##2##(2008-10#3)
potato scab##3##2##(2008-10#3)
potato seed tubers##3##3##(2008-10#3)
potato seed##4##2##(2008-10#4)
potato stems##2##2##(2008-10#2)
potato stocks##2##2##(2008-10#2)
potato tissue##2##2##(2008-10#2)
potato tuber discs##2##3##(2008-10#2)
potato tuber##8##2##(2008-10#8)
potato tubers##11##2##(1992-12#2)(2008-10#7)(2008-12#2)
potato virus X (PVX)##2##4##(1997-3#1)(2008-10#1)
potato virus X##3##3##(1997-3#1)(2008-10#1)(2010-9#1)
potato virus Y##5##3##(2008-10#5)
potato virus##11##2##(1997-3#1)(2008-10#9)(2010-9#1)
potato was##2##2##(2008-10#2)
potato yield##2##2##(2008-10#1)(2008-12#1)
potato##349##1##(1992-12#2)(1993-12#2)(1997-3#1)(1997-4#2)(2008-10#306)(2008-12#6)(2008-5#6)(2008-6#3)(2008-8#4)(2008-9#2)(2009-6#4)(2010-4#2)(2010-9#1)(2011-2#8)
potatoes and##6##2##(2008-10#6)
potatoes in the##3##3##(2008-10#3)
potatoes in##6##2##(2008-10#6)
potatoes##19##1##(1990-8#1)(2008-10#17)(2008-9#1)
potencies and##5##2##(1993-11#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-12#1)
potencies in##3##2##(1992-3#3)
potencies of the##2##3##(1995-11#1)(2007-11#1)
potencies of##8##2##(1991-3#2)(1992-9#1)(1994-6#1)(1995-11#2)(2007-11#1)(2008-10#1)
potencies to induce##2##3##(1993-12#1)(1995-5#1)
potencies to##4##2##(1993-12#1)(1995-11#1)(1995-5#1)(1997-7#1)
potencies were##3##2##(1990-5#1)(1993-3#1)(1995-8#1)
potencies##31##1##(1990-12#1)(1990-5#1)(1991-3#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#1)
potency against##2##2##(1995-3#1)(2013-1#1)
potency and##11##2##(1991-1#1)(1992-3#1)(1993-8#2)(1994-6#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
potency as##3##2##(1997-4#1)(2008-12#1)(2013-1#1)
potency but##2##2##(1995-12#1)(2009-8#1)
potency comparable to that of##3##5##(1995-3#2)(2008-5#1)
potency for the##2##3##(1995-12#2)
potency for##7##2##(1995-11#1)(1995-12#4)(2008-10#1)(2008-3#1)
potency in human##2##3##(1994-3#1)(1997-4#1)
potency in inhibiting##2##3##(1990-12#1)(1990-5#1)
potency in the aerosol##2##4##(1991-1#2)
potency in the##5##3##(1991-1#3)(2008-7#1)(2013-1#1)
potency in##18##2##(1990-12#1)(1990-5#1)(1991-1#3)(1991-3#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-7#3)(2013-1#2)
potency may##2##2##(1991-12#1)(2008-10#1)
potency of 5-HT to##2##4##(1993-9#2)
potency of a##2##3##(1991-12#1)(2008-5#1)
potency of iloprost but##2##4##(2008-7#2)
potency of iloprost##3##3##(2008-7#3)
potency of the peptides##2##4##(1994-8#1)(1995-12#1)
potency of the##17##3##(1991-1#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-12#3)(1995-5#2)(1996-12#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-5#1)(2013-1#1)
potency of these compounds##2##4##(1990-12#1)(2008-11#1)
potency of these##5##3##(1990-12#1)(1992-12#1)(1995-3#1)(2008-11#1)(2008-7#1)
potency of##75##2##(1990-12#2)(1990-2#2)(1991-1#2)(1991-12#3)(1991-2#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-8#5)(1995-11#2)(1995-12#3)(1995-3#3)(1995-5#2)(1996-12#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-4#3)(2008-5#7)(2008-7#6)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#3)
potency than##2##2##(1991-5#1)(2008-10#1)
potency to##10##2##(1993-12#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#2)
potency was##2##2##(1994-6#1)(1995-3#1)
potency when##2##2##(2008-8#1)(2012-3#1)
potency##207##1##(1990-12#6)(1990-2#2)(1990-5#3)(1991-1#7)(1991-12#5)(1991-2#1)(1991-3#3)(1991-5#2)(1991-8#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#4)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#7)(1995-11#5)(1995-12#10)(1995-2#1)(1995-3#10)(1995-5#4)(1995-8#1)(1996-12#5)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#16)(2008-7#10)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#11)
potency)##4##1##(1992-3#1)(2008-10#3)
potent CYP26 inhibitors##2##3##(2008-8#2)
potent activator of##5##3##(1990-2#1)(1992-9#1)(1994-11#1)(2008-4#1)(2010-6#1)
potent activator##6##2##(1990-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(2008-4#1)(2010-6#1)
potent activity against##2##3##(2011-2#1)(2011-3#1)
potent activity with##2##3##(2008-11#1)(2011-2#1)
potent activity##8##2##(1993-3#1)(1994-12#1)(2008-11#1)(2008-5#1)(2011-2#3)(2011-3#1)
potent agonist##2##2##(1995-11#1)(1997-7#1)
potent analgesic##2##2##(1993-11#1)(2008-12#1)
potent and selective human A(3) adenosine##2##6##(2008-4#2)
potent and selective##9##3##(1990-8#1)(1992-8#1)(1994-2#1)(1995-3#1)(2008-4#3)(2008-5#2)
potent and##21##2##(1990-8#1)(1991-12#2)(1991-9#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#3)(2011-2#1)
potent antagonist of##2##3##(1992-11#1)(2008-8#1)
potent antagonist##4##2##(1992-11#1)(1995-3#1)(1996-2#1)(2008-8#1)
potent anti-HIV activities##3##3##(2011-3#3)
potent anti-HIV agent##2##3##(1991-3#1)(1992-9#1)
potent anti-HIV##6##2##(1991-3#1)(1992-9#1)(2011-3#4)
potent anti-inflammatory and##2##3##(2007-11#1)(2013-1#1)
potent anti-inflammatory effects##2##3##(2009-8#1)(2013-1#1)
potent anti-inflammatory##5##2##(2007-11#1)(2008-5#1)(2009-8#1)(2013-1#2)
potent anticancer##2##2##(2009-7#1)(2011-2#1)
potent antifungal##2##2##(2008-11#2)
potent antigen-presenting cells##3##3##(2006-10#1)(2008-4#1)(2008-5#1)
potent antitumor activity##3##3##(1994-5#1)(2008-5#2)
potent antitumor##5##2##(1994-5#1)(1997-4#1)(2008-5#3)
potent antiviral activity##2##3##(1994-11#1)(2012-2#1)
potent antiviral##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
potent as##6##2##(1990-2#1)(1991-12#1)(1992-12#1)(1995-12#1)(1995-3#1)(2008-5#1)
potent at##4##2##(1991-9#1)(1992-3#1)(1994-8#1)(1996-2#1)
potent bacterial##2##2##(2008-5#1)(2011-2#1)
potent carcinogens##2##2##(1992-9#1)(2008-10#1)
potent cryoprotective activity##2##3##(1992-3#2)
potent cytotoxic##3##2##(1996-3#1)(2008-8#2)
potent drugs##2##2##(1995-3#1)(2011-2#1)
potent free radical scavenger##4##4##(1994-6#1)(1995-8#1)(2012-2#2)
potent immunosuppressive##4##2##(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#1)
potent in inhibiting the tail-flick response evoked by##2##8##(1992-3#2)
potent in inhibiting the##3##4##(1992-3#3)
potent in inhibiting##4##3##(1992-3#3)(2008-4#1)
potent in vitro##4##3##(1995-3#1)(2008-8#1)(2010-2#1)(2010-5#1)
potent in##23##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#5)(1992-5#1)(1993-1#1)(1995-12#1)(1995-3#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
potent inhibition of##3##3##(1992-8#1)(2008-5#1)(2012-3#1)
potent inhibition##4##2##(1992-8#1)(2008-5#1)(2011-1#1)(2012-3#1)
potent inhibitor of insulin##2##4##(1994-11#1)(1995-6#1)
potent inhibitor of nitric oxide##2##5##(1995-12#1)(1995-2#1)
potent inhibitor of the##3##4##(1991-8#1)(2008-11#1)(2012-12#1)
potent inhibitor of##35##3##(1990-5#1)(1991-12#2)(1991-8#1)(1992-12#2)(1993-8#2)(1994-11#4)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-4#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
potent inhibitors of human##2##4##(1994-8#1)(1995-3#1)
potent inhibitors of protein##2##4##(1993-8#1)(2012-2#1)
potent inhibitors of the##6##4##(1990-12#1)(1992-12#1)(1994-11#1)(2008-5#1)(2009-9#1)(2010-12#1)
potent inhibitors of##23##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-9#2)(2010-12#1)(2012-2#1)
potent inhibitors##27##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2009-9#2)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#1)
potent inhibitory activity##4##3##(1991-1#1)(1995-3#1)(2008-8#1)(2011-1#1)
potent inhibitory##7##2##(1991-1#1)(1993-1#1)(1995-3#1)(1997-7#1)(2008-4#1)(2008-8#1)(2011-1#1)
potent ligand for##3##3##(1991-9#2)(1992-12#1)
potent lipid##3##2##(1991-12#1)(1991-5#1)(1993-9#1)
potent mitogen for##2##3##(1993-8#1)(1997-1#1)
potent mitogen##4##2##(1993-8#1)(1995-6#1)(1997-1#1)(2009-2#1)
potent neuroprotective##2##2##(2008-7#1)(2008-8#1)
potent oxidant##2##2##(1992-10#1)(2008-10#1)
potent quenching effect on##2##4##(2008-4#2)
potent than the##5##3##(1990-12#1)(1992-4#1)(1994-5#1)(1994-6#1)(1995-12#1)
potent than##28##2##(1990-12#2)(1991-1#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#5)(1995-5#1)(1996-2#1)(1996-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
potent therapeutic##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
potent tumor##3##2##(1990-7#1)(1993-8#1)(2013-1#1)
potent vasodilator##2##2##(1991-3#1)(2008-3#1)
potent with##2##2##(1994-6#1)(2013-1#1)
potent##491##1##(1990-11#1)(1990-12#4)(1990-2#5)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#3)(1991-12#14)(1991-2#1)(1991-3#4)(1991-5#8)(1991-6#1)(1991-8#2)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#9)(1992-3#12)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#8)(1992-9#9)(1993-1#3)(1993-11#5)(1993-12#2)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#11)(1993-9#1)(1994-11#19)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#6)(1994-8#9)(1994-9#2)(1995-11#7)(1995-12#17)(1995-2#4)(1995-3#15)(1995-5#7)(1995-6#4)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#2)(1997-1#3)(1997-4#5)(1997-6#1)(1997-7#5)(2006-10#3)(2007-11#5)(2007-12#1)(2008-10#22)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#14)(2008-5#23)(2008-6#3)(2008-7#12)(2008-8#20)(2008-9#1)(2009-10#3)(2009-12#4)(2009-2#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#13)(2011-3#6)(2012-12#3)(2012-2#10)(2012-3#9)(2013-1#10)(2013-7#2)(2013-8#3)
potential (0##2##2##(2008-10#2)
potential (EPSP)##2##2##(1995-12#1)(1997-2#1)
potential (ERP)##3##2##(1995-5#1)(1996-5#1)(2013-8#1)
potential (MEP)##2##2##(2008-7#1)(2011-2#1)
potential (versus##2##2##(2008-10#2)
potential 0##3##2##(2008-10#2)(2009-10#1)
potential B-cell epitopes##2##3##(2008-10#2)
potential E##2##2##(2008-10#2)
potential EF-hand##2##2##(1995-6#2)
potential N-glycosylation site##2##3##(1993-8#1)(2008-10#1)
potential N-glycosylation##3##2##(1991-12#1)(1993-8#1)(2008-10#1)
potential ORFs##2##2##(1995-8#2)
potential Sp1 binding##2##3##(1991-7#1)(1992-3#1)
potential ability of##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
potential activity##2##2##(1995-2#1)(2008-5#1)
potential adaptation##2##2##(2008-10#1)(2008-5#1)
potential additional##2##2##(2008-10#1)(2008-11#1)
potential advantages of this##2##4##(1995-2#1)(2008-3#1)
potential advantages of##9##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-2#1)
potential advantages over##4##3##(2008-1#1)(2008-2#1)(2012-12#1)(2013-1#1)
potential advantages##19##2##(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2010-8#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
potential adverse drug reactions##2##4##(1994-6#1)(2008-8#1)
potential adverse drug##3##3##(1994-6#1)(2008-8#1)(2011-3#1)
potential adverse effects##6##3##(1994-6#1)(2008-10#2)(2008-8#1)(2009-5#1)(2013-1#1)
potential adverse##11##2##(1994-6#2)(2008-10#2)(2008-12#1)(2008-8#2)(2009-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
potential after##3##2##(1990-7#1)(1992-2#1)(2008-11#1)
potential against##4##2##(1992-6#1)(2008-10#1)(2008-5#1)(2008-6#1)
potential agent##2##2##(2008-10#1)(2008-5#1)
potential along##2##2##(2008-10#1)(2008-2#1)
potential alternative##10##2##(1996-1#1)(2006-10#1)(2008-10#3)(2008-2#1)(2011-2#2)(2012-8#1)(2013-1#1)
potential amplitude##3##2##(2008-4#2)(2012-2#1)
potential analytical##2##2##(2008-10#2)
potential and cytosolic free##2##4##(1997-1#2)
potential and deposition time##2##4##(2008-10#2)
potential and persistence##2##3##(2008-11#2)
potential and practical##2##3##(2007-8#1)(2008-10#1)
potential and the##8##3##(1993-11#1)(2007-10#2)(2008-10#4)(2008-3#1)
potential and##75##2##(1991-1#1)(1992-3#2)(1993-11#2)(1993-12#2)(1994-11#2)(1994-5#1)(1997-1#3)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#7)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
potential antagonist##3##2##(2008-10#3)
potential anti-inflammatory##2##2##(1994-11#1)(2009-1#1)
potential anticancer##7##2##(1991-2#1)(1995-3#1)(1997-3#1)(2008-5#1)(2010-7#1)(2013-1#2)
potential applicability##4##2##(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
potential application as##5##3##(2008-10#3)(2013-1#2)
potential application for##2##3##(2008-3#2)
potential application in the fields of##2##6##(2008-7#1)(2013-1#1)
potential application in##12##3##(1994-6#1)(1996-3#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
potential application of the##4##4##(1990-12#1)(2007-8#1)(2008-10#2)
potential application of##15##3##(1990-12#1)(1995-9#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
potential application to the##2##4##(2008-7#1)(2012-4#1)
potential application to##9##3##(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-4#1)
potential application##44##2##(1990-12#1)(1994-6#1)(1995-9#1)(1996-3#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-10#14)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#1)
potential applications are suggested##2##4##(2008-2#1)(2008-3#1)
potential applications are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
potential applications for##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)
potential applications in medicine##2##4##(2008-7#1)(2010-4#1)
potential applications in##19##3##(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
potential applications of##7##3##(2008-10#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-11#1)(2013-1#1)
potential applications to##6##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#2)
potential applications##52##2##(1995-2#1)(1996-12#2)(1997-4#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#4)
potential approaches##2##2##(2008-10#1)(2009-12#1)
potential are##4##2##(1993-11#1)(2008-11#1)(2008-9#2)
potential as a function of##2##5##(2008-10#1)(2009-9#1)
potential as a rapid##2##4##(1997-4#1)(2008-10#1)
potential as a##24##3##(1994-5#1)(1997-4#2)(2007-11#2)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)
potential as an alternative##2##4##(2008-10#1)(2008-12#1)
potential as an effective##2##4##(2008-10#1)(2008-7#1)
potential as an##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
potential as therapeutic##2##3##(2011-2#1)(2013-1#1)
potential as##39##2##(1992-3#2)(1994-5#1)(1997-1#1)(1997-4#2)(2007-11#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#2)
potential ascospore dose (PAD)##2##4##(2008-10#2)
potential at pH##2##3##(1990-5#1)(2008-10#1)
potential at the##2##3##(1991-6#1)(1997-6#1)
potential at##14##2##(1990-5#1)(1991-3#1)(1991-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-8#1)
potential atypical antipsychotic##3##3##(1992-12#2)(1995-3#1)
potential barrier to##2##3##(2007-12#1)(2009-4#1)
potential barriers to##2##3##(2008-1#1)(2013-1#1)
potential beneficial effects of##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
potential beneficial effects##5##3##(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
potential beneficial##6##2##(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
potential benefit for##2##3##(1993-3#1)(2008-3#1)
potential benefit of this##3##4##(2007-8#1)(2008-6#1)(2009-11#1)
potential benefit of##9##3##(2007-8#1)(2008-10#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)
potential benefit##16##2##(1993-3#1)(1994-3#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#1)
potential benefits and limitations of##2##5##(1996-11#1)(2008-7#1)
potential benefits and limitations##3##4##(1996-11#1)(2008-7#1)(2013-1#1)
potential benefits and risks##3##4##(1992-3#1)(2008-10#1)(2010-4#1)
potential benefits and##8##3##(1992-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
potential benefits for##2##3##(2011-1#1)(2013-1#1)
potential benefits in##2##3##(1995-12#1)(2010-12#1)
potential benefits of##12##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-1#1)(2013-7#1)
potential benefits##29##2##(1992-3#1)(1994-3#1)(1995-12#2)(1996-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
potential between different##3##3##(1994-12#2)(1995-11#1)
potential between##8##2##(1994-12#2)(1995-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)
potential bias##2##2##(2008-12#1)(2011-2#1)
potential binding sites for##3##4##(1993-2#1)(1994-11#1)(1995-8#1)
potential bioavailability##2##2##(2008-10#1)(2008-11#1)
potential biocontrol agents##2##3##(2008-10#2)
potential biological activity##3##3##(2007-11#2)(2008-10#1)
potential biological##6##2##(2007-11#3)(2007-12#1)(2008-10#1)(2012-3#1)
potential biomarker for##2##3##(2008-10#2)
potential biomarker##3##2##(2008-10#2)(2011-2#1)
potential biomarkers for##2##3##(2010-12#1)(2011-2#1)
potential biomarkers##6##2##(2010-12#1)(2010-5#2)(2011-2#2)(2013-1#1)
potential biotechnological##2##2##(2011-1#2)
potential bleeding##2##2##(2011-2#1)(2013-1#1)
potential buffer from 10(-3) to 10(-5) M##2##7##(2008-10#2)
potential buffer solution containing##2##4##(2008-10#2)
potential buffer solution##5##3##(2008-10#5)
potential buffer##12##2##(2008-10#12)
potential by##7##2##(1997-7#1)(2008-10#2)(2008-9#2)(2009-11#1)(2012-2#1)
potential can be##2##3##(1990-12#1)(2013-8#1)
potential candidate for##4##3##(1994-6#1)(1996-9#1)(2008-5#1)(2012-2#1)
potential candidate##6##2##(1994-12#1)(1994-6#1)(1996-9#1)(1997-5#1)(2008-5#1)(2012-2#1)
potential candidates as##2##3##(2008-10#1)(2011-1#1)
potential candidates for##5##3##(2008-10#1)(2009-10#2)(2009-4#1)(2010-12#1)
potential candidates##10##2##(1993-2#1)(1994-1#2)(2008-10#2)(2009-10#2)(2009-4#1)(2010-12#1)(2011-1#1)
potential catastrophic##2##2##(2006-10#1)(2008-9#1)
potential cause of##3##3##(1997-6#1)(2008-4#1)(2008-7#1)
potential cause##4##2##(1997-6#1)(2008-4#1)(2008-7#1)(2010-3#1)
potential causes of##5##3##(2008-10#1)(2008-7#2)(2011-1#1)(2013-1#1)
potential causes##6##2##(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)
potential cellular##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
potential challenges##4##2##(1996-1#1)(1997-3#1)(2007-12#1)(2009-9#1)
potential change (electro-olfactogram##2##3##(2008-5#1)(2008-6#1)
potential change of the##2##4##(2008-10#2)
potential change##13##2##(2008-10#11)(2008-5#1)(2008-6#1)
potential changes (OSC)##2##3##(2008-5#1)(2008-6#1)
potential changes in##2##3##(1993-3#1)(2010-6#1)
potential changes##8##2##(1990-12#1)(1993-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)
potential chemical##2##2##(1994-5#1)(2012-2#1)
potential chemotherapeutic##2##2##(1990-7#1)(2013-1#1)
potential clinical applications of##2##4##(1997-4#1)(2008-7#1)
potential clinical applications##4##3##(1994-11#1)(1997-4#1)(2008-7#1)(2011-7#1)
potential clinical implications##2##3##(1991-6#1)(2010-4#1)
potential clinical use##2##3##(2008-11#1)(2010-8#1)
potential clinical##16##2##(1991-6#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
potential complication##2##2##(1993-10#1)(2012-12#1)
potential complications##6##2##(1994-5#1)(2011-1#1)(2012-12#3)(2013-8#1)
potential conditions##3##2##(2008-10#3)
potential confounders##6##2##(2008-3#1)(2009-3#1)(2011-1#1)(2013-1#3)
potential confounding factors##7##3##(2008-6#1)(2008-7#1)(2010-1#3)(2010-11#1)(2013-1#1)
potential confounding##8##2##(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#3)(2010-11#1)(2013-1#1)
potential consequences##4##2##(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
potential contaminants##2##2##(2008-5#1)(2008-9#1)
potential contamination##2##2##(2008-11#1)(2012-2#1)
potential contributions to##3##3##(1990-12#1)(1993-6#1)(2012-12#1)
potential contributions##4##2##(1990-12#1)(1993-6#1)(2009-11#1)(2012-12#1)
potential control##2##2##(2008-10#2)
potential correlates of##2##3##(1995-5#1)(2009-12#1)
potential cosmetic odourants##2##3##(2008-5#2)
potential cosmetic##3##2##(2008-5#3)
potential curative##2##2##(1993-11#1)(1997-8#1)
potential curves##2##2##(2008-10#2)
potential customers##2##2##(1994-2#1)(1994-3#1)
potential cycling in##2##3##(2008-10#2)
potential cytostatic drug##2##3##(1996-5#2)
potential damage to##2##3##(2008-2#1)(2008-9#1)
potential deleterious effects##2##3##(2008-10#1)(2008-11#1)
potential dermal##2##2##(2008-10#1)(2008-5#1)
potential detrimental effects of##3##4##(2010-1#1)(2011-2#1)(2012-1#1)
potential detrimental##4##2##(1995-5#1)(2010-1#1)(2011-2#1)(2012-1#1)
potential diagnostic##6##2##(1992-11#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-8#1)
potential difference (PD) and##2##4##(2008-12#1)(2008-5#1)
potential difference between the two electrodes##2##6##(2008-10#2)
potential difference##10##2##(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)
potential differences in##2##3##(1995-3#1)(2008-11#1)
potential differences##3##2##(1994-12#1)(1995-3#1)(2008-11#1)
potential difficulties##2##2##(2008-8#1)(2013-1#1)
potential direct effects of##2##4##(2008-7#1)(2013-1#1)
potential directions##2##2##(2010-12#1)(2012-1#1)
potential disease##4##2##(2008-10#2)(2008-12#1)(2009-12#1)
potential donor##3##2##(2011-2#2)(2013-1#1)
potential donors##2##2##(2008-12#1)(2011-2#1)
potential drawback##2##2##(2008-3#1)(2009-2#1)
potential drawbacks##2##2##(2010-8#1)(2012-3#1)
potential drug##6##2##(1994-5#1)(2008-11#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
potential drugs##2##2##(1994-8#1)(2007-2#1)
potential due to##3##3##(2008-10#2)(2008-5#1)
potential during##2##2##(1993-12#1)(2008-10#1)
potential effect of##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
potential effect on##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
potential effect##7##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
potential effectiveness of##4##3##(2008-11#1)(2010-12#2)(2010-8#1)
potential effectiveness##5##2##(1992-12#1)(2008-11#1)(2010-12#2)(2010-8#1)
potential effects of the##2##4##(2008-10#1)(2008-11#1)
potential effects of##7##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-8#1)(2013-1#1)
potential effects on the##2##4##(1991-12#1)(1997-5#1)
potential effects on##5##3##(1991-12#1)(1997-5#1)(2008-10#1)(2008-3#2)
potential effects##13##2##(1991-12#1)(1991-5#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2010-8#1)(2011-2#1)(2013-1#1)
potential efficacy and##2##3##(2008-7#1)(2013-8#1)
potential efficacy of##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
potential efficacy##8##2##(1995-3#1)(2008-11#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-8#2)
potential energy##8##2##(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-12#2)
potential estrogenic##2##2##(2008-10#2)
potential ethical and practical##2##4##(2010-3#2)
potential ethical##3##2##(2010-3#2)(2013-8#1)
potential exists for##2##3##(1995-5#1)(2008-5#1)
potential exists##3##2##(1991-9#1)(1995-5#1)(2008-5#1)
potential explanation for##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
potential explanations for##2##3##(2008-8#1)(2012-12#1)
potential exposure to##2##3##(1990-8#1)(1997-4#1)
potential exposure##4##2##(1990-8#1)(1997-4#1)(2007-2#1)(2012-3#1)
potential factors##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
potential for a##7##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
potential for adaptation##2##3##(1990-2#1)(2010-3#1)
potential for an##2##3##(1996-12#1)(2013-1#1)
potential for application##2##3##(1994-11#1)(2008-10#1)
potential for clinical application##2##4##(1996-9#1)(2010-11#1)
potential for clinical##3##3##(1996-9#1)(2008-5#1)(2010-11#1)
potential for decreasing in##4##4##(2008-10#4)
potential for development of##2##4##(2008-10#1)(2010-3#1)
potential for distant##2##3##(1997-7#1)(2008-5#1)
potential for enhancing##2##3##(2007-12#1)(2009-1#1)
potential for further development##2##4##(2008-10#1)(2011-2#1)
potential for further##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
potential for future##3##3##(2007-11#1)(2008-8#1)(2011-2#1)
potential for high##2##3##(2008-11#1)(2010-2#1)
potential for improved##5##3##(1994-3#1)(2008-3#2)(2008-9#2)
potential for improving the##2##4##(2008-3#1)(2012-1#1)
potential for improving##7##3##(1993-12#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-2#1)
potential for myocardial regeneration##2##4##(2010-10#1)(2010-6#1)
potential for other##2##3##(2008-11#1)(2010-12#1)
potential for outcrossing in##2##4##(2008-10#2)
potential for outcrossing##4##3##(2008-10#4)
potential for preventing##2##3##(2008-11#1)(2008-5#1)
potential for producing##2##3##(1990-8#1)(2011-1#1)
potential for recovery##2##3##(2008-7#2)
potential for regeneration##2##3##(2008-11#1)(2013-1#1)
potential for sensing applications##2##4##(2008-2#2)
potential for studying##2##3##(2008-8#1)(2010-11#1)
potential for successful##2##3##(2007-1#1)(2008-10#1)
potential for the development of##2##5##(2008-10#1)(2008-11#1)
potential for the study of the##2##6##(2008-3#1)(2009-10#1)
potential for the treatment of##3##5##(2008-5#2)(2008-7#1)
potential for the##21##3##(1991-1#1)(1992-1#1)(1995-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
potential for treating##2##3##(2009-3#1)(2012-12#1)
potential for use as an##2##5##(2008-11#1)(2008-5#1)
potential for use as##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
potential for use in##2##4##(2008-10#2)
potential for use##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
potential for using##3##3##(2008-11#2)(2011-1#1)
potential for##285##2##(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1993-10#2)(1993-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-9#1)(1997-1#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#41)(2008-11#19)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#5)(2008-5#17)(2008-6#4)(2008-7#7)(2008-8#9)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#16)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#12)(2013-8#3)
potential from##6##2##(2008-10#5)(2008-12#1)
potential function##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
potential functional##2##2##(2008-11#1)(2008-4#1)
potential functions of##2##3##(2008-7#1)(2009-8#1)
potential future##6##2##(1997-8#1)(2008-11#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-12#1)
potential gains and##2##3##(2011-7#1)(2013-1#1)
potential gains##3##2##(2010-8#1)(2011-7#1)(2013-1#1)
potential genetic biomarkers##2##3##(2011-2#2)
potential genetic##5##2##(1997-5#1)(2008-7#1)(2011-2#3)
potential glycosylation sites at##2##4##(1992-12#1)(2013-8#1)
potential glycosylation sites##3##3##(1990-5#1)(1992-12#1)(2013-8#1)
potential habitats of Oncomelania hupensis##2##5##(2008-8#2)
potential has been##2##3##(1994-12#1)(2008-10#1)
potential has not##2##3##(1995-6#1)(2008-3#1)
potential has##10##2##(1994-12#1)(1995-6#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)
potential have##3##2##(1994-2#1)(2008-11#1)(2008-9#1)
potential hazard to##2##3##(2007-5#1)(2008-5#1)
potential hazard##4##2##(1994-11#1)(2007-5#1)(2007-7#1)(2008-5#1)
potential hazards of##2##3##(2008-10#1)(2008-9#1)
potential hazards##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
potential health benefits##2##3##(2007-11#1)(2011-1#1)
potential health effects##2##3##(2008-9#2)
potential health##13##2##(2007-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-4#1)(2011-1#2)
potential high##2##2##(2010-10#1)(2012-12#1)
potential host##2##2##(2008-10#1)(2008-9#1)
potential imaging##2##2##(1993-5#1)(1994-1#1)
potential immunomodulatory##2##2##(2008-10#2)
potential immunotoxicity of chemicals##2##4##(2008-10#2)
potential immunotoxicity##4##2##(2008-10#4)
potential impact of these##2##4##(2008-10#1)(2008-7#1)
potential impact of##11##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)(2012-12#1)(2013-8#2)
potential impact on##11##3##(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
potential impact##26##2##(1992-3#1)(1993-2#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#2)
potential implications for##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
potential implications##5##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
potential importance##9##2##(1995-11#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-7#1)
potential improvement##2##2##(1997-1#1)(2012-2#1)
potential in a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
potential in comparison to##2##4##(2008-10#2)
potential in developing##2##3##(2008-1#1)(2008-10#1)
potential in intact##2##3##(1993-11#1)(2008-11#1)
potential in rat##2##3##(1992-3#1)(1996-5#1)
potential in rats##2##3##(1995-12#1)(1996-1#1)
potential in response to##2##4##(1996-8#1)(2008-10#1)
potential in the##10##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-9#1)
potential in##61##2##(1992-3#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
potential indicator##3##2##(1993-3#1)(2008-10#1)(2011-1#1)
potential indicators of##2##3##(2008-10#1)(2012-3#1)
potential industrial##2##2##(2008-11#1)(2013-1#1)
potential infection##2##2##(2008-11#1)(2008-8#1)
potential influence of the##3##4##(2009-9#1)(2011-1#1)(2012-12#1)
potential influence of##6##3##(1997-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
potential inhibitors of##2##3##(2008-11#1)(2011-2#1)
potential inhibitors##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
potential inhibitory##3##2##(1992-12#1)(2009-12#1)(2011-3#1)
potential initiation##2##2##(1993-12#1)(1997-6#1)
potential inoculum sources##2##3##(2008-10#2)
potential inoculum##4##2##(2008-10#4)
potential interaction##3##2##(1990-6#1)(1995-6#1)(2009-9#1)
potential interest##3##2##(2008-3#1)(2008-5#2)
potential interference##5##2##(2008-10#5)
potential interferences were##2##3##(2008-10#1)(2010-5#1)
potential interferences##7##2##(2008-10#6)(2010-5#1)
potential interferents##4##2##(2008-10#4)
potential interfering species##2##3##(2008-10#2)
potential interfering##8##2##(1992-6#1)(2008-10#7)
potential into##2##2##(2007-12#1)(2008-11#1)
potential involvement of##4##3##(1994-11#1)(1995-12#1)(1996-5#1)(2010-3#1)
potential involvement##5##2##(1994-11#1)(1995-12#1)(1996-5#1)(2010-3#1)(2011-2#1)
potential is a##2##3##(2007-8#1)(2008-11#1)
potential is the##2##3##(2007-11#1)(2007-12#1)
potential is##25##2##(1992-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#2)(2009-3#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
potential latency##4##2##(2008-7#3)(2011-2#1)
potential liability of##3##3##(1991-12#2)(1992-1#1)
potential liability##4##2##(1991-12#2)(1992-1#1)(1993-2#1)
potential ligands##3##2##(1991-12#1)(1991-7#1)(2008-9#1)
potential link between##2##3##(2008-10#1)(2009-10#1)
potential link##3##2##(2008-10#1)(2009-10#1)(2009-12#1)
potential links between##2##3##(2009-7#1)(2012-3#1)
potential major##2##2##(1994-8#1)(2010-12#1)
potential male##2##2##(2008-9#1)(2012-2#1)
potential management##3##2##(2008-10#2)(2008-3#1)
potential markers of##2##3##(2008-8#1)(2010-12#1)
potential markers##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2012-3#1)
potential market##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
potential mates##8##2##(2008-8#8)
potential may be##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
potential means##2##2##(2007-11#1)(2008-10#1)
potential mechanism for##2##3##(1991-3#1)(2008-10#1)
potential mechanism of##6##3##(2007-8#1)(2008-10#3)(2011-2#2)
potential mechanism##12##2##(1990-8#1)(1991-3#1)(2007-8#1)(2008-10#4)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
potential mechanisms are##2##3##(2008-4#1)(2008-7#1)
potential mechanisms by which##4##4##(1994-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
potential mechanisms of action of the##2##6##(2008-7#1)(2011-1#1)
potential mechanisms of##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
potential mechanisms##16##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
potential mediators of##2##3##(2009-7#1)(2012-2#1)
potential medical##5##2##(1993-3#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
potential method (MPM)##4##3##(2008-10#4)
potential method##8##2##(2008-10#8)
potential methods##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
potential model##6##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2013-1#1)
potential moderators of the effect of##2##6##(2008-12#1)(2013-1#1)
potential moderators##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
potential modifiers##3##2##(1991-3#2)(2010-12#1)
potential molecular mechanisms##2##3##(2008-11#1)(2008-3#1)
potential molecular targets##2##3##(2008-7#1)(2009-12#1)
potential molecular##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-3#1)
potential monitoring##2##2##(2008-9#1)(2011-2#1)
potential movement##2##2##(1990-9#1)(2008-12#1)
potential negative##4##2##(1995-12#1)(2008-10#1)(2010-11#1)(2012-2#1)
potential neural##2##2##(2008-11#1)(2013-1#1)
potential new##8##2##(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-11#1)(2011-2#1)
potential novel##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
potential of +0##6##3##(1995-12#1)(2008-10#5)
potential of +1##2##3##(2008-10#2)
potential of -0##18##3##(2008-10#18)
potential of -1##2##3##(2008-10#2)
potential of -300 mV##2##4##(2008-10#2)
potential of 0##8##3##(2008-10#8)
potential of 10V##2##3##(2013-1#2)
potential of AA##2##3##(2008-10#2)
potential of Hb##2##3##(2008-10#1)(2008-7#1)
potential of Uf at##2##4##(1991-8#2)
potential of Uf##5##3##(1991-8#5)
potential of a##18##3##(1992-2#1)(1993-9#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
potential of biotechnology##2##3##(2008-11#2)
potential of cancer cells##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
potential of combining solid-phase optosensing and multicommutation principles##2##8##(2008-10#2)
potential of different##2##3##(2008-10#1)(2013-8#1)
potential of drugs##2##3##(2008-10#2)
potential of each##3##3##(2008-10#1)(2008-5#2)
potential of human##3##3##(2008-11#1)(2008-9#1)(2009-3#1)
potential of mean##2##3##(2008-10#2)
potential of personal cleansing products##2##5##(2008-5#2)
potential of smooth muscle cells##2##5##(1996-5#1)(2008-7#1)
potential of solid-phase extraction and##2##5##(2008-10#2)
potential of stem cells##3##4##(2008-11#2)(2012-2#1)
potential of stem##4##3##(2008-11#3)(2012-2#1)
potential of such##3##3##(1994-5#1)(2011-2#1)(2013-1#1)
potential of sunflower stem##2##4##(2008-10#2)
potential of terahertz imaging##2##4##(2012-12#2)
potential of terahertz##3##3##(2010-5#1)(2012-12#2)
potential of the technique##3##4##(2007-12#2)(2009-12#1)
potential of the working electrode##2##5##(2008-10#2)
potential of the##55##3##(1993-11#1)(1993-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(2007-12#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)
potential of these chiral amines to catalyze two organic reactions##2##10##(2009-10#2)
potential of these##13##3##(1990-5#1)(1997-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2011-2#1)(2013-1#1)
potential of this technique for##2##5##(2007-12#1)(2008-3#1)
potential of this technique##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
potential of this##20##3##(1995-8#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-3#3)(2008-5#3)(2011-1#1)(2012-12#1)(2013-1#1)
potential of using##3##3##(2008-10#3)
potential of working electrode##3##4##(2008-10#3)
potential of##449##2##(1990-5#3)(1990-7#2)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#6)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-6#1)(2008-1#1)(2008-10#158)(2008-11#27)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#6)(2008-5#23)(2008-6#1)(2008-7#14)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#16)(2011-3#1)(2012-1#6)(2012-12#9)(2012-2#12)(2012-3#2)(2012-7#1)(2013-1#15)(2013-8#4)
potential on the##2##3##(1994-8#1)(2008-10#1)
potential on##9##2##(1990-8#1)(1990-9#1)(1994-8#1)(1997-8#1)(2008-10#5)
potential open reading frames##3##4##(1996-12#2)(1996-6#1)
potential opportunities##2##2##(2008-11#1)(2010-11#1)
potential or##2##2##(2008-10#2)
potential participants##5##2##(1994-1#1)(1996-11#1)(2009-4#1)(2009-6#1)(2012-2#1)
potential partners##2##2##(1995-12#1)(1996-1#1)
potential pathogens##4##2##(1994-6#1)(2007-12#1)(2009-4#1)(2009-6#1)
potential pathways##2##2##(2008-1#1)(2011-2#1)
potential patients##4##2##(1996-2#2)(2007-12#1)(2010-8#1)
potential pharmacotherapeutic agents##2##3##(2008-4#2)
potential phosphorylation sites##2##3##(1997-7#1)(2008-5#1)
potential physiological##3##2##(1993-3#1)(2008-5#1)(2012-12#1)
potential pitfalls for##2##3##(1992-12#1)(2008-1#1)
potential pitfalls in##2##3##(2008-4#1)(2011-2#1)
potential pitfalls##7##2##(1992-12#1)(1992-3#1)(1994-3#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-2#1)
potential positive##4##2##(1991-5#1)(1995-5#1)(2007-12#1)(2008-5#1)
potential prevention##2##2##(2008-10#1)(2010-7#1)
potential prey##2##2##(2008-5#1)(2012-3#1)
potential probe##3##2##(1992-6#1)(1992-9#1)(1995-12#1)
potential problem##4##2##(2007-12#2)(2008-10#1)(2008-4#1)
potential problems##9##2##(1991-3#1)(1993-2#1)(1995-9#1)(1997-2#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-9#2)
potential promising##2##2##(2008-10#1)(2009-7#1)
potential protective##7##2##(1990-12#1)(1993-2#1)(1994-5#1)(2008-10#1)(2008-12#1)(2009-11#1)(2011-1#1)
potential protein genes##3##3##(1996-6#3)
potential protein##4##2##(1993-3#1)(1996-6#3)
potential protein-coding genes and/or gene segments with known or predicted functions were identified##2##13##(1997-6#1)(1997-8#1)
potential protein-coding regions##3##3##(1996-6#3)
potential protein-coding##5##2##(1996-6#3)(1997-6#1)(1997-8#1)
potential public health##3##3##(1991-3#1)(2012-12#1)(2012-3#1)
potential public##4##2##(1991-3#1)(1992-3#1)(2012-12#1)(2012-3#1)
potential pulse##4##2##(2008-10#4)
potential pulses##2##2##(1995-6#2)
potential quantitative trait loci (QTL)##2##5##(2008-10#2)
potential range##7##2##(2007-12#1)(2008-10#6)
potential reasons for##3##3##(2008-10#1)(2010-9#1)(2012-2#1)
potential reasons##4##2##(2008-10#2)(2010-9#1)(2012-2#1)
potential recipients##2##2##(2008-7#1)(2010-12#1)
potential regulatory##5##2##(1991-7#1)(1993-2#1)(1994-9#1)(2008-10#1)(2012-3#1)
potential release##2##2##(2008-10#2)
potential reproductive##3##2##(2008-8#1)(2012-12#1)(2012-3#1)
potential research##6##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#1)
potential resistance of##2##3##(2011-2#1)(2013-8#1)
potential response of##5##3##(2008-10#5)
potential response##10##2##(1996-3#1)(2008-10#9)
potential restriction##2##2##(2010-4#1)(2012-2#1)
potential risk factors##4##3##(1994-12#1)(2011-2#2)(2013-1#1)
potential risk for##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
potential risk of##12##3##(1992-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
potential risk##27##2##(1992-6#1)(1994-12#2)(1995-5#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-1#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
potential risks and##2##3##(2008-10#1)(2013-1#1)
potential risks for##3##3##(2006-12#1)(2008-10#1)(2010-9#1)
potential risks##14##2##(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2010-9#1)(2013-1#2)
potential role for##12##3##(1992-3#2)(1993-3#1)(1993-9#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
potential role in the##2##4##(2008-7#1)(2011-2#1)
potential role in##12##3##(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#2)
potential role of the##4##4##(1994-11#1)(2008-7#1)(2012-12#1)(2013-7#1)
potential role of these##2##4##(1992-12#1)(2011-2#1)
potential role of##30##3##(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
potential role##56##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2009-1#1)(2009-11#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
potential roles of##4##3##(2009-9#1)(2010-2#1)(2010-3#1)(2013-1#1)
potential roles##8##2##(2006-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
potential scan rate##2##3##(2008-10#2)
potential scan##4##2##(2008-10#4)
potential scans##2##2##(2008-10#2)
potential selection pressures##2##3##(2012-3#2)
potential service##2##2##(1993-12#1)(1995-3#1)
potential shift##5##2##(1995-5#2)(1996-5#2)(2008-10#1)
potential shifts##4##2##(1995-5#1)(2008-10#3)
potential side effects##2##3##(1996-3#1)(2010-5#1)
potential side##4##2##(1996-3#1)(2008-3#1)(2008-4#1)(2010-5#1)
potential significance##4##2##(2008-10#1)(2008-2#1)(2008-9#2)
potential site of##2##3##(1997-2#1)(2008-10#1)
potential sites for##2##3##(1992-1#1)(1993-2#1)
potential sites##3##2##(1992-1#1)(1993-2#1)(2008-2#1)
potential solid phase##2##3##(2008-10#2)
potential solution to##2##3##(1990-11#1)(2008-8#1)
potential solution##5##2##(1990-11#1)(1992-12#1)(2008-2#1)(2008-8#2)
potential solutions##3##2##(1996-12#1)(2007-8#1)(2010-6#1)
potential source of##7##3##(1991-12#1)(2008-10#4)(2008-5#2)
potential source##9##2##(1991-12#1)(2008-10#4)(2008-5#2)(2011-2#1)(2012-2#1)
potential sources of contamination##2##4##(2008-10#1)(2012-2#1)
potential sources of inoculum##2##4##(2008-10#2)
potential sources of##15##3##(1992-11#1)(1996-5#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
potential stability and reproducibility##2##4##(2008-10#2)
potential stability and##3##3##(2008-10#3)
potential stability##6##2##(2008-10#6)
potential strength of##2##3##(2008-10#1)(2008-9#1)
potential subgroups##2##2##(2008-12#2)
potential substrates and/or inhibitors of##2##5##(2009-2#2)
potential substrates##4##2##(1994-5#1)(2008-11#1)(2009-2#2)
potential sweep##2##2##(2008-10#2)
potential synergistic##2##2##(2008-10#1)(2008-5#1)
potential target##16##2##(1993-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
potential targeting##2##2##(2008-10#1)(2011-2#1)
potential targets for##7##3##(1995-6#1)(1997-7#1)(2008-4#2)(2008-6#1)(2011-1#1)(2011-2#1)
potential targets##9##2##(1995-6#1)(1997-7#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
potential than##4##2##(1994-6#1)(2008-5#2)(2012-7#1)
potential that##7##2##(1992-12#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)
potential therapeutic applications##4##3##(1997-4#1)(2008-4#2)(2013-1#1)
potential therapeutic benefit##2##3##(2008-11#1)(2009-4#1)
potential therapeutic drugs for cognitive impairments##2##6##(2011-1#2)
potential therapeutic drugs for##3##4##(2011-1#3)
potential therapeutic drugs##4##3##(2008-4#1)(2011-1#3)
potential therapeutic roles##2##3##(2011-2#1)(2012-2#1)
potential therapeutic target##5##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
potential therapeutic targets to##2##4##(2008-4#1)(2013-7#1)
potential therapeutic targets##7##3##(2008-4#1)(2008-7#1)(2010-12#2)(2011-1#1)(2013-7#1)(2013-8#1)
potential therapeutic use##3##3##(1992-9#1)(1993-8#1)(2012-2#1)
potential therapeutic##42##2##(1992-9#1)(1993-8#1)(1994-6#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#2)(2013-8#1)
potential therapies for##2##3##(2008-5#1)(2012-3#1)
potential therapies##4##2##(2008-4#2)(2008-5#1)(2012-3#1)
potential therapy for##3##3##(1994-5#1)(2007-11#1)(2012-12#1)
potential therapy of##2##3##(1994-5#1)(2008-5#1)
potential therapy##5##2##(1994-5#2)(2007-11#1)(2008-5#1)(2012-12#1)
potential threat to the##2##4##(2008-7#1)(2012-2#1)
potential threat to##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
potential threat##7##2##(1990-12#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
potential threshold##2##2##(2008-10#2)
potential titration##2##2##(2008-10#2)
potential to affect##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
potential to alter the##2##4##(2008-10#1)(2012-2#1)
potential to be a useful##2##5##(2006-12#1)(2008-10#1)
potential to be a##3##4##(2006-12#1)(2008-10#1)(2012-2#1)
potential to be applied##2##4##(2008-3#1)(2008-8#1)
potential to be used as##2##5##(1991-9#1)(2009-3#1)
potential to be used in##3##5##(2008-10#1)(2008-6#1)(2012-2#1)
potential to be used##8##4##(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2012-2#1)
potential to be##26##3##(1991-9#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2012-2#4)
potential to become a##2##4##(2008-10#1)(2008-9#1)
potential to become##5##3##(2008-10#1)(2008-9#1)(2011-7#1)(2012-12#1)(2012-3#1)
potential to cause##4##3##(2006-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
potential to control##2##3##(1994-6#1)(2008-10#1)
potential to damage##2##3##(1996-1#1)(2008-10#1)
potential to detect##4##3##(1996-3#1)(1996-4#1)(2008-2#1)(2008-7#1)
potential to differentiate into##4##4##(2008-11#3)(2008-8#1)
potential to enhance the##2##4##(2008-1#1)(2008-9#1)
potential to enhance##7##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
potential to form all types of cells##2##7##(2008-9#2)
potential to generate##2##3##(1990-5#1)(2010-10#1)
potential to improve##6##3##(1994-12#1)(1994-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)
potential to increase##4##3##(1995-3#1)(1996-11#2)(2008-3#1)
potential to induce##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
potential to infect##2##3##(2008-10#2)
potential to make a##2##4##(1994-11#1)(2013-8#1)
potential to make##3##3##(1994-11#1)(1996-11#1)(2013-8#1)
potential to mature##2##3##(2008-5#2)
potential to offer##2##3##(2008-12#1)(2012-2#1)
potential to overcome##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
potential to provide a##4##4##(2008-10#1)(2008-11#1)(2011-7#1)(2012-2#1)
potential to provide##12##3##(1991-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
potential to replace##2##3##(2007-11#1)(2008-3#1)
potential to serve##2##3##(2008-5#2)
potential to support##2##3##(2008-1#1)(2013-1#1)
potential to##240##2##(1990-5#1)(1991-3#2)(1991-9#1)(1992-12#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#4)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#39)(2008-11#13)(2008-12#3)(2008-2#10)(2008-3#12)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#6)(2011-7#4)(2012-1#2)(2012-12#4)(2012-2#13)(2012-3#5)(2012-6#1)(2013-1#9)(2013-8#3)
potential toxic##3##2##(2008-10#3)
potential toxicity##7##2##(2008-10#1)(2008-8#3)(2008-9#1)(2010-10#1)(2013-1#1)
potential transmembrane##3##2##(1994-12#1)(1996-12#1)(1996-6#1)
potential treatment of##9##3##(2008-5#8)(2008-8#1)
potential treatment options##2##3##(2011-2#1)(2012-2#1)
potential treatment##25##2##(1997-1#1)(2008-2#1)(2008-5#16)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
potential use as a biodegradable implant material##2##7##(2012-2#2)
potential use as a##3##4##(2009-11#1)(2012-2#2)
potential use as an##4##4##(1990-8#1)(1993-12#1)(1995-2#1)(1996-5#1)
potential use as##8##3##(1990-8#1)(1993-12#1)(1995-2#1)(1996-5#1)(2009-11#1)(2009-8#1)(2012-2#2)
potential use for##6##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#1)
potential use in human gene therapy##2##6##(1993-2#1)(1997-4#1)
potential use in human##3##4##(1993-2#1)(1997-4#1)(2008-5#1)
potential use in the##3##4##(2008-3#1)(2008-5#1)(2008-9#1)
potential use in##15##3##(1993-2#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#4)(2008-9#1)(2010-4#1)
potential use of##21##3##(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-12#1)(2011-1#1)(2012-2#1)
potential use##52##2##(1990-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#3)
potential usefulness##6##2##(1990-2#1)(2008-10#3)(2008-7#1)(2009-7#1)
potential users##2##2##(1991-3#1)(2013-8#1)
potential uses of the##3##4##(1991-12#1)(2008-3#1)(2008-4#1)
potential uses of##7##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-5#1)
potential uses##10##2##(1991-12#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-5#1)
potential using the##2##3##(1993-11#1)(2008-9#1)
potential using##4##2##(1993-11#1)(2008-9#3)
potential utility as a##2##4##(2008-6#1)(2010-8#1)
potential utility for##2##3##(2008-5#1)(2008-9#1)
potential utility of the##2##4##(1996-2#1)(2008-10#1)
potential utility of##9##3##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
potential utility##14##2##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
potential vaccine##2##2##(2008-7#1)(2009-5#1)
potential value for##2##3##(2008-10#1)(2012-3#1)
potential value of##6##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
potential value##13##2##(1995-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
potential values##4##2##(2007-11#1)(2008-10#2)(2012-2#1)
potential variations##3##2##(2008-4#2)(2013-1#1)
potential versus##3##2##(2008-10#3)
potential vulnerability##2##2##(1997-5#1)(2011-2#1)
potential was +0##2##3##(2008-10#2)
potential was investigated##2##3##(2008-10#1)(2009-6#1)
potential was observed##2##3##(1992-8#1)(2008-10#1)
potential was##24##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-2#1)(2008-10#14)(2009-12#1)(2009-6#1)(2012-4#1)
potential waveform##2##2##(2008-10#2)
potential well##3##2##(1996-2#3)
potential were##3##2##(1990-8#1)(1991-5#1)(2008-10#1)
potential window was##2##3##(2008-10#2)
potential window##5##2##(2008-10#5)
potential with##7##2##(1992-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-5#1)
potential within the##2##3##(2009-5#1)(2012-2#1)
potential within##4##2##(2008-10#1)(2008-4#1)(2009-5#1)(2012-2#1)
potential zinc##2##2##(1991-9#1)(1997-7#1)
potential##3629##1##(1990-11#3)(1990-12#9)(1990-2#3)(1990-3#3)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#13)(1990-9#4)(1991-1#9)(1991-10#1)(1991-12#12)(1991-2#3)(1991-3#12)(1991-5#8)(1991-6#5)(1991-7#5)(1991-8#7)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#5)(1992-12#16)(1992-2#6)(1992-3#24)(1992-5#1)(1992-6#7)(1992-8#5)(1992-9#8)(1993-1#3)(1993-10#3)(1993-11#13)(1993-12#23)(1993-2#15)(1993-3#9)(1993-5#2)(1993-6#3)(1993-8#7)(1993-9#6)(1994-1#10)(1994-11#20)(1994-12#20)(1994-2#7)(1994-3#11)(1994-5#14)(1994-6#15)(1994-7#1)(1994-8#10)(1994-9#5)(1995-1#4)(1995-11#3)(1995-12#23)(1995-2#14)(1995-3#11)(1995-5#18)(1995-6#13)(1995-8#6)(1995-9#4)(1996-1#11)(1996-10#2)(1996-11#6)(1996-12#16)(1996-2#21)(1996-3#11)(1996-4#3)(1996-5#16)(1996-6#8)(1996-8#1)(1996-9#5)(1997-1#11)(1997-2#13)(1997-3#10)(1997-4#11)(1997-5#4)(1997-6#10)(1997-7#12)(1997-8#16)(2006-10#7)(2006-12#6)(2006-6#1)(2007-1#1)(2007-10#14)(2007-11#37)(2007-12#54)(2007-2#5)(2007-5#8)(2007-6#5)(2007-7#4)(2007-8#14)(2007-9#1)(2008-1#29)(2008-10#857)(2008-11#167)(2008-12#43)(2008-2#48)(2008-3#87)(2008-4#60)(2008-5#155)(2008-6#33)(2008-7#139)(2008-8#110)(2008-9#100)(2009-1#7)(2009-10#16)(2009-11#19)(2009-12#23)(2009-2#11)(2009-3#16)(2009-4#16)(2009-5#18)(2009-6#12)(2009-7#9)(2009-8#14)(2009-9#14)(2010-1#7)(2010-10#6)(2010-11#14)(2010-12#35)(2010-2#7)(2010-3#18)(2010-4#20)(2010-5#21)(2010-6#14)(2010-7#6)(2010-8#16)(2010-9#6)(2011-1#60)(2011-2#133)(2011-3#5)(2011-7#7)(2012-1#21)(2012-12#62)(2012-2#100)(2012-3#50)(2012-4#2)(2012-6#2)(2012-7#3)(2012-8#1)(2013-1#120)(2013-7#11)(2013-8#45)
potential)##8##1##(1990-7#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-1#3)
potential-dependent##4##1##(2007-12#3)(2008-10#1)
potentialities of the##3##3##(2008-10#2)(2008-3#1)
potentialities of##6##2##(2008-10#4)(2008-3#1)(2008-7#1)
potentialities##14##1##(1990-6#1)(1991-11#1)(1995-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#2)(2013-1#1)
potentiality of##7##2##(2008-10#3)(2008-8#1)(2010-3#1)(2013-1#2)
potentiality##10##1##(1990-10#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-3#1)(2013-1#2)
potentially anti-atherogenic##2##2##(2008-3#2)
potentially applicable##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
potentially at risk##3##3##(1991-12#1)(2013-1#2)
potentially be used in##2##4##(2007-12#1)(2009-12#1)
potentially be used to##3##4##(2008-2#1)(2008-8#1)(2009-4#1)
potentially be used##7##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-4#1)(2012-3#1)
potentially be##20##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#2)(2011-2#1)(2012-3#1)(2013-1#2)
potentially beneficial##4##2##(2007-10#1)(2008-10#1)(2010-1#2)
potentially can be##2##3##(2007-11#1)(2008-10#1)
potentially causal##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
potentially causing##2##2##(2008-12#1)(2008-8#1)
potentially compromise the##2##3##(2008-1#1)(2011-2#1)
potentially contributing to##2##3##(1991-5#1)(2009-6#1)
potentially could##3##2##(2008-10#2)(2008-3#1)
potentially curable##5##2##(1990-8#1)(2008-7#2)(2008-9#1)(2012-3#1)
potentially curative##6##2##(1992-12#1)(1993-9#1)(1996-11#1)(1997-8#1)(2006-10#1)(2013-1#1)
potentially dangerous##10##2##(1992-3#1)(1995-3#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#1)(2012-3#1)
potentially deadly##2##2##(1992-2#1)(2008-9#1)
potentially decrease##2##2##(1993-1#1)(2009-9#1)
potentially deleterious##2##2##(1992-9#1)(2008-11#1)
potentially devastating##2##2##(2007-2#1)(2011-2#1)
potentially effective##2##2##(1993-11#1)(2010-8#1)
potentially enabling##2##2##(2008-3#1)(2011-1#1)
potentially encodes a polypeptide##2##4##(1996-6#1)(2008-10#1)
potentially encodes##3##2##(1996-6#1)(2008-10#2)
potentially fatal complication##2##3##(2007-8#1)(2012-3#1)
potentially fatal##14##2##(1991-8#1)(1996-12#1)(2006-10#1)(2007-8#2)(2008-1#1)(2009-11#1)(2011-2#3)(2012-12#2)(2012-3#2)
potentially forming a##2##3##(1991-5#1)(2008-10#1)
potentially from##2##2##(2008-10#1)(2008-3#1)
potentially greater##2##2##(2008-11#2)
potentially harmful to##2##3##(1994-3#1)(2008-11#1)
potentially harmful##9##2##(1990-8#1)(1994-3#1)(2007-8#1)(2008-11#1)(2008-5#3)(2010-1#1)(2012-12#1)
potentially hazardous##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
potentially hepatotoxic drugs##2##3##(2008-11#2)
potentially high##4##2##(1995-2#1)(2008-12#1)(2008-4#1)(2008-9#1)
potentially important##16##2##(1993-11#2)(1993-8#1)(1995-11#1)(1995-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2013-8#1)
potentially improved##2##2##(2012-2#2)
potentially increasing the##2##3##(2008-5#1)(2010-2#1)
potentially influence##2##2##(1991-6#1)(2007-12#1)
potentially involved in##3##3##(2008-10#2)(2011-1#1)
potentially lead to##3##3##(2008-7#1)(2009-9#2)
potentially leading to##5##3##(2007-4#1)(2008-5#1)(2009-9#1)(2012-2#1)(2012-3#1)
potentially lethal##10##2##(2007-10#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
potentially life threatening##2##3##(2012-2#1)(2013-1#1)
potentially life-threatening condition##3##3##(2009-12#1)(2013-1#1)(2013-8#1)
potentially life-threatening##13##2##(1995-8#1)(1997-5#1)(2007-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-8#1)(2013-1#3)(2013-8#2)
potentially modifiable risk factors##2##4##(2008-8#1)(2009-5#1)
potentially modifiable##3##2##(2008-8#1)(2009-5#1)(2012-3#1)
potentially modulate##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
potentially more##2##2##(2008-11#1)(2012-2#1)
potentially negative##2##2##(1994-3#1)(2009-12#1)
potentially new##2##2##(1996-12#1)(2013-1#1)
potentially novel##2##2##(1990-2#1)(2008-5#1)
potentially other##2##2##(1995-6#1)(2011-2#1)
potentially play##2##2##(2008-10#1)(2012-2#1)
potentially powerful##3##2##(1993-3#1)(2008-7#1)(2008-9#1)
potentially provide a##2##3##(2008-10#1)(2012-3#1)
potentially provide##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
potentially providing##2##2##(1997-3#1)(2008-10#1)
potentially related to##3##3##(1992-6#1)(1996-1#1)(2008-4#1)
potentially related##4##2##(1992-6#1)(1996-1#1)(2008-4#1)(2011-2#1)
potentially relevant##3##2##(2012-12#2)(2013-8#1)
potentially resistant##2##2##(2008-7#1)(2011-2#1)
potentially responsive to##2##3##(1993-9#1)(2011-2#1)
potentially responsive##3##2##(1993-9#1)(1994-1#1)(2011-2#1)
potentially resulting in##4##3##(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
potentially reversible##4##2##(1992-3#1)(2008-1#1)(2008-7#2)
potentially risky##2##2##(2007-12#1)(2012-2#1)
potentially serious##10##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#2)
potentially serve as##3##3##(1991-12#1)(2008-5#1)(2009-7#1)
potentially severe##3##2##(1995-3#1)(2008-11#1)(2011-3#1)
potentially significant##2##2##(2008-10#1)(2008-3#1)
potentially successful##2##2##(1991-12#1)(2008-1#1)
potentially susceptible to##2##3##(2008-7#1)(2011-1#1)
potentially susceptible##3##2##(2008-7#2)(2011-1#1)
potentially the##2##2##(1996-1#1)(2008-9#1)
potentially therapeutic##3##2##(1994-5#1)(1995-12#2)
potentially toxic accumulation of##2##4##(1990-5#1)(2008-4#1)
potentially toxic##6##2##(1990-5#1)(2008-10#1)(2008-4#1)(2008-7#2)(2013-8#1)
potentially useful diagnostic##2##3##(1997-4#1)(2008-12#1)
potentially useful for studying##2##4##(1993-9#1)(1995-11#1)
potentially useful for##13##3##(1993-9#2)(1995-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
potentially useful in##4##3##(1990-8#1)(1992-12#1)(1994-11#1)(2013-7#1)
potentially useful##34##2##(1990-8#1)(1992-12#1)(1992-3#1)(1993-9#2)(1994-11#1)(1995-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
potentially valuable##5##2##(1996-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-2#1)
potentially violent##2##2##(2008-7#2)
potentially vulnerable##2##2##(2009-4#1)(2012-1#1)
potentially##518##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#3)(1991-10#1)(1991-12#4)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#4)(2007-10#4)(2007-11#5)(2007-12#9)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#57)(2008-11#25)(2008-12#13)(2008-2#10)(2008-3#16)(2008-4#10)(2008-5#15)(2008-6#2)(2008-7#21)(2008-8#13)(2008-9#15)(2009-10#2)(2009-11#6)(2009-12#5)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#6)(2010-1#6)(2010-10#2)(2010-11#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#9)(2011-2#30)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#20)(2012-3#17)(2012-8#1)(2013-1#22)(2013-7#1)(2013-8#6)
potentials (0##2##2##(2008-10#2)
potentials (ERPs)##3##2##(1995-2#1)(2008-11#1)(2008-8#1)
potentials and##14##2##(1990-7#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-12#1)(2013-8#1)
potentials are##4##2##(1992-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
potentials evoked by##2##3##(2008-11#1)(2008-7#1)
potentials for further##2##3##(2008-10#2)
potentials for##7##2##(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)
potentials from##2##2##(2008-7#1)(2013-1#1)
potentials have##2##2##(2008-10#1)(2013-1#1)
potentials in response to##2##4##(2011-2#1)(2013-1#1)
potentials in the##7##3##(1992-12#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)
potentials in##20##2##(1991-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-5#1)(1996-6#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#2)
potentials mediated by##2##3##(2008-7#2)
potentials more negative than##3##4##(1993-3#1)(1996-5#1)(1997-2#1)
potentials more positive than##3##4##(1993-3#1)(1996-5#1)(1997-2#1)
potentials more##7##2##(1993-3#2)(1996-5#2)(1997-2#2)(2012-2#1)
potentials obtained##2##2##(2008-10#1)(2012-1#1)
potentials of -1##2##3##(2008-10#1)(2012-7#1)
potentials of hMSCs##3##3##(2008-11#3)
potentials of the##5##3##(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
potentials of##35##2##(1991-11#1)(1991-8#1)(1995-8#1)(1997-8#2)(2008-10#14)(2008-11#7)(2008-12#2)(2008-5#2)(2008-8#1)(2010-5#1)(2012-3#1)(2012-7#1)(2013-8#1)
potentials on##3##2##(2008-10#3)
potentials or##3##2##(1997-6#1)(2008-10#1)(2009-12#1)
potentials recorded in##2##3##(1993-12#1)(2008-9#1)
potentials recorded##4##2##(1993-12#1)(1996-6#1)(2008-4#1)(2008-9#1)
potentials that##5##2##(1990-5#1)(2008-11#1)(2008-4#1)(2009-12#1)(2012-2#1)
potentials to##4##2##(1995-8#1)(1996-5#1)(1996-6#1)(2008-10#1)
potentials was##2##2##(2012-1#1)(2013-1#1)
potentials were recorded##3##3##(1996-6#1)(2008-11#1)(2008-7#1)
potentials were##15##2##(1990-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
potentials which##2##2##(2008-7#1)(2012-2#1)
potentials with##6##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-7#1)
potentials##269##1##(1990-3#1)(1990-5#6)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#4)(1993-12#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1995-1#1)(1995-12#6)(1995-2#2)(1995-5#3)(1995-8#3)(1996-2#2)(1996-5#7)(1996-6#5)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#85)(2008-11#29)(2008-12#4)(2008-2#1)(2008-4#8)(2008-5#4)(2008-7#12)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#4)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#7)(2013-8#2)
potentiate diacylglycerol-activated protein kinase C##2##5##(1990-5#2)
potentiate excitatory##2##2##(1990-7#1)(1992-8#1)
potentiate the effects of##3##4##(1996-2#1)(2008-5#1)(2010-4#1)
potentiate the##12##2##(1990-12#1)(1990-8#2)(1992-3#1)(1993-3#1)(1993-6#1)(1996-2#3)(2008-11#1)(2008-5#1)(2010-4#1)
potentiate##35##1##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-8#1)(1995-11#1)(1995-5#1)(1996-2#3)(1997-7#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-6#1)
potentiated by adenosine##2##3##(1994-11#1)(2008-5#1)
potentiated by the##2##3##(2007-10#1)(2008-4#1)
potentiated by##14##2##(1990-5#1)(1990-7#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
potentiated fear##2##2##(2008-11#2)
potentiated in##3##2##(1990-8#1)(1996-2#2)
potentiated insulin secretion in##2##4##(1990-8#1)(1995-8#1)
potentiated insulin##3##2##(1990-8#2)(1995-8#1)
potentiated the responses##2##3##(1990-7#1)(2008-8#1)
potentiated the##22##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-8#2)
potentiated##67##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-12#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-11#4)(1995-12#2)(1995-8#2)(1996-2#5)(1997-1#2)(1997-4#2)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#6)(2008-4#5)(2008-5#2)(2008-8#3)(2009-4#2)(2013-1#2)(2013-8#1)
potentiates its##2##2##(1991-5#1)(2008-5#1)
potentiates the##5##2##(1990-2#1)(1997-2#1)(1997-4#1)(2008-5#1)(2010-12#1)
potentiates##25##1##(1990-12#1)(1990-2#2)(1991-1#1)(1991-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#3)(2007-11#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-12#1)(2013-1#1)
potentiating effect of CGRP##3##4##(1997-4#3)
potentiating effect of##7##3##(1990-5#1)(1997-4#4)(2008-4#2)
potentiating effect##10##2##(1990-5#1)(1995-11#1)(1996-12#1)(1997-4#4)(2008-4#2)(2008-8#1)
potentiating effects##2##2##(1995-11#2)
potentiating the##3##2##(1995-3#1)(2008-1#1)(2013-7#1)
potentiating##17##1##(1990-5#1)(1995-11#4)(1995-3#1)(1996-12#1)(1997-4#4)(2008-1#1)(2008-4#2)(2008-8#1)(2010-11#1)(2013-7#1)
potentiation (LTP) was##3##3##(1995-12#2)(2008-7#1)
potentiation (LTP)##19##2##(1990-5#1)(1992-12#1)(1993-12#2)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-8#2)(2012-3#1)
potentiation by methamphetamine##2##3##(1995-3#2)
potentiation by##4##2##(1993-6#1)(1995-3#2)(2008-7#1)
potentiation in the dentate gyrus##2##5##(1995-12#2)
potentiation in the##7##3##(1990-5#1)(1995-12#5)(2008-7#1)
potentiation in##11##2##(1990-5#1)(1993-12#1)(1995-12#5)(1996-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
potentiation is##2##2##(1995-12#1)(1995-3#1)
potentiation of carbon tetrachloride hepatotoxicity##3##5##(1995-3#3)
potentiation of carbon##4##3##(1995-3#4)
potentiation of field##2##3##(1995-12#2)
potentiation of ileal contractions##2##4##(1992-8#2)
potentiation of insulin secretion##2##4##(1990-12#1)(1996-5#1)
potentiation of phagocytosis##4##3##(1993-6#4)
potentiation of synaptic transmission##2##4##(1995-2#1)(1996-5#1)
potentiation of the population spike##3##5##(1991-12#2)(1995-12#1)
potentiation of the##15##3##(1990-5#1)(1991-12#2)(1993-6#2)(1994-2#1)(1995-11#1)(1995-12#2)(1997-4#2)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)
potentiation of##55##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-5#1)(1993-6#7)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1996-2#1)(1996-5#2)(1997-4#3)(1997-7#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2012-2#1)
potentiation was##3##2##(1993-6#1)(1995-12#1)(1995-3#1)
potentiation##125##1##(1990-12#1)(1990-5#4)(1990-8#1)(1991-12#7)(1991-9#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#4)(1993-5#1)(1993-6#9)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#22)(1995-2#2)(1995-3#8)(1996-2#4)(1996-5#5)(1997-2#2)(1997-4#3)(1997-7#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#10)(2008-9#2)(2009-1#2)(2009-3#1)(2009-8#4)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
potentiometer##4##1##(2008-10#4)
potentiometric and spectrophotometric##2##3##(2008-10#2)
potentiometric and##8##2##(2008-10#8)
potentiometric anion##2##2##(2008-10#2)
potentiometric back-titration##2##2##(2008-10#2)
potentiometric biosensor for##2##3##(2008-10#2)
potentiometric biosensor##3##2##(2008-10#3)
potentiometric clinical analyser##2##3##(2008-10#2)
potentiometric detection of##5##3##(2008-10#3)(2010-5#2)
potentiometric detection##9##2##(2008-10#7)(2010-5#2)
potentiometric detector##2##2##(2008-10#2)
potentiometric detectors##2##2##(2008-10#2)
potentiometric determination of nitrite ion##2##5##(2008-10#2)
potentiometric determination of##21##3##(2008-10#21)
potentiometric electronic tongue##2##3##(2008-10#2)
potentiometric end-point detection##2##3##(2008-10#2)
potentiometric flow injection determination##3##4##(2008-10#3)
potentiometric flow injection##6##3##(2008-10#6)
potentiometric flow titration##2##3##(2008-10#2)
potentiometric flow##9##2##(2008-10#9)
potentiometric indicator##3##2##(2008-10#3)
potentiometric ion##2##2##(2008-10#2)
potentiometric measurements and##2##3##(2008-10#2)
potentiometric measurements##5##2##(2008-10#5)
potentiometric membrane electrode##2##3##(2008-10#2)
potentiometric membrane electrodes (EPMEs) based on##3##6##(2008-10#3)
potentiometric membrane electrodes based on alpha-##2##6##(2008-10#2)
potentiometric membrane electrodes based on maltodextrins##2##6##(2008-10#2)
potentiometric membrane electrodes based on##8##5##(2008-10#8)
potentiometric membrane electrodes for the##2##5##(2008-10#2)
potentiometric membrane electrodes##15##3##(2008-10#15)
potentiometric membrane##18##2##(2008-10#18)
potentiometric method based on##2##4##(2008-10#2)
potentiometric method for the##2##4##(2008-10#2)
potentiometric method for##3##3##(2008-10#3)
potentiometric method##13##2##(2008-10#13)
potentiometric pH-sensitive field-effect transistors##2##4##(2008-10#2)
potentiometric response characteristics of##4##4##(2008-10#4)
potentiometric response characteristics##6##3##(2008-10#6)
potentiometric response was##2##3##(2008-10#2)
potentiometric response##19##2##(2008-10#19)
potentiometric responses##3##2##(2008-10#3)
potentiometric selectivity coefficient##4##3##(2008-10#4)
potentiometric selectivity coefficients of ion-selective##2##5##(2008-10#2)
potentiometric selectivity coefficients of##4##4##(2008-10#4)
potentiometric selectivity coefficients##6##3##(2008-10#6)
potentiometric selectivity##20##2##(2008-10#20)
potentiometric sensor based on##3##4##(2008-10#3)
potentiometric sensor for ascorbic acid based on cobalt phthalocyanine nanoparticles##2##10##(2008-10#2)
potentiometric sensor for##7##3##(2008-10#7)
potentiometric sensor##24##2##(2008-10#24)
potentiometric sensors based on##2##4##(2008-10#2)
potentiometric sensors for##4##3##(2008-10#4)
potentiometric sensors##14##2##(2008-10#14)
potentiometric stripping analysis##2##3##(2008-10#2)
potentiometric study##3##2##(2008-10#3)
potentiometric technique##2##2##(2008-10#2)
potentiometric titration is##2##3##(2008-10#2)
potentiometric titration method##4##3##(2008-10#4)
potentiometric titration of Mg(2+)##2##4##(2008-10#2)
potentiometric titration of##32##3##(2008-10#32)
potentiometric titration was##2##3##(2008-10#2)
potentiometric titration with##2##3##(2008-10#2)
potentiometric titration##55##2##(2008-10#55)
potentiometric titrations of##5##3##(2008-10#5)
potentiometric titrations##19##2##(2008-10#19)
potentiometric##308##1##(2008-10#305)(2010-5#3)
potentiometrically in##5##2##(2008-10#5)
potentiometrically using a##2##3##(2008-10#1)(2008-11#1)
potentiometrically with##3##2##(2007-11#1)(2008-10#2)
potentiometrically##21##1##(2007-11#1)(2008-10#19)(2008-11#1)
potentiometry and##6##2##(2008-10#6)
potentiometry as##2##2##(2008-10#2)
potentiometry by##3##2##(2008-10#3)
potentiometry for##2##2##(2008-10#2)
potentiometry in##2##2##(2008-10#2)
potentiometry with##2##2##(2008-10#1)(2008-5#1)
potentiometry##41##1##(1997-2#1)(2008-10#38)(2008-5#1)(2010-5#1)
potentiostat and##2##2##(2008-10#2)
potentiostat##4##1##(2008-10#4)
potentiostatic##2##1##(2008-10#2)
potently inhibited##5##2##(1993-11#1)(1993-3#1)(1994-8#1)(1995-12#1)(2011-2#1)
potently inhibits##4##2##(1993-3#1)(1995-12#1)(2008-8#1)(2009-7#1)
potently suppress##2##2##(1994-6#1)(2010-7#1)
potently##20##1##(1991-12#1)(1993-11#2)(1993-3#3)(1993-6#1)(1994-6#1)(1994-8#2)(1995-12#2)(1996-2#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)
potexviruses##2##1##(1997-2#1)(2008-10#1)
potocytosis and##2##2##(1995-2#1)(1995-6#1)
potocytosis##5##1##(1994-6#1)(1995-2#2)(1995-6#2)
potomac division meeting##7##3##(2008-11#7)
potomac##9##1##(2008-11#9)
pots and##2##2##(2008-10#2)
pots containing##2##2##(2008-10#2)
pots##10##1##(2008-10#9)(2008-12#1)
potted plants##4##2##(2008-10#3)(2008-12#1)
potted##12##1##(2008-10#10)(2008-12#2)
pottery##2##1##(2008-10#2)
potting media##3##2##(2008-10#3)
potting medium##4##2##(2008-10#4)
potting mix was##2##3##(2008-10#2)
potting mix were##2##3##(2008-10#2)
potting mix##23##2##(2008-10#22)(2013-1#1)
potting mixes##3##2##(2008-10#3)
potting mixture##2##2##(2008-10#2)
potting mixtures##3##2##(2008-10#3)
potting##41##1##(2008-10#40)(2013-1#1)
potyvirus HC-Pro##4##2##(2008-10#4)
potyvirus##28##1##(2008-10#27)(2008-9#1)
potyviruses##17##1##(2008-10#16)(2008-9#1)
pouch II##2##2##(1996-3#2)
pouch of##2##2##(1994-9#1)(2011-1#1)
pouch polyps##2##2##(2009-12#2)
pouch##22##1##(1991-6#1)(1994-9#1)(1995-12#1)(1996-3#2)(2008-10#5)(2009-12#7)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
pouches##5##1##(1994-3#1)(2008-10#2)(2008-5#1)(2012-12#1)
poultry farmers##2##2##(2011-2#2)
poultry farms in##2##3##(2011-2#1)(2011-3#1)
poultry farms##3##2##(1997-5#1)(2011-2#1)(2011-3#1)
poultry houses##3##2##(2007-6#2)(2008-10#1)
poultry in##2##2##(2008-5#1)(2011-2#1)
poultry intake##2##2##(2011-2#2)
poultry production##2##2##(1990-3#1)(2011-3#1)
poultry products##2##2##(1990-3#1)(1990-6#1)
poultry##38##1##(1990-3#2)(1990-6#1)(1990-8#1)(1995-8#1)(1995-9#1)(1997-5#3)(2007-6#4)(2008-10#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#8)(2011-3#2)(2013-7#1)
poultry)##2##1##(2008-10#1)(2011-2#1)
poults from flock A##2##4##(1997-3#2)
poults were##4##2##(1997-3#1)(1997-6#2)(2008-5#1)
poults##27##1##(1990-6#1)(1992-2#1)(1997-3#6)(1997-6#10)(2008-5#9)
poumons##2##1##(2011-2#1)(2013-1#1)
pound 13 billion##2##3##(2012-12#2)
pound##4##1##(1997-3#1)(2010-4#1)(2012-12#2)
pounds##3##1##(1992-8#1)(1996-8#1)(2008-1#1)
pour des##2##2##(2008-5#1)(2013-1#1)
pour l'Observation de la Terre##2##5##(2008-2#1)(2008-3#1)
pour la##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
pour les##2##2##(2008-5#1)(2011-2#1)
pour plate##2##2##(2008-10#1)(2008-5#1)
pour##25##1##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#10)(2008-7#1)(2009-7#1)(2011-2#3)(2013-1#5)
pour-on##3##1##(1996-12#3)
poured##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
pouring##2##1##(1992-8#1)(2009-7#1)
pourrait##2##1##(2011-2#1)(2013-1#1)
poverty and##6##2##(2008-1#1)(2008-11#3)(2009-8#1)(2012-12#1)
poverty in##2##2##(2008-11#2)
poverty is##2##2##(2008-11#2)
poverty on the##2##3##(2008-11#1)(2009-8#1)
poverty on##3##2##(2008-11#2)(2009-8#1)
poverty rates##2##2##(2008-11#1)(2013-8#1)
poverty reduction##2##2##(2007-7#1)(2009-4#1)
poverty##78##1##(1990-6#2)(1992-1#1)(1992-5#1)(1995-1#1)(1995-9#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#39)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#4)(2010-3#5)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
poverty-reduction strategy##2##2##(2008-11#2)
povidone##2##1##(1990-3#1)(2008-10#1)
powder X-ray diffraction##5##3##(1997-7#1)(2008-10#1)(2008-7#1)(2010-4#1)(2013-8#1)
powder and infant##2##3##(2008-10#2)
powder and then##2##3##(2008-10#1)(2013-1#1)
powder and##13##2##(1996-2#1)(1997-7#1)(2008-10#7)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
powder as##3##2##(1994-11#1)(2011-2#2)
powder by##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
powder catalysts##3##2##(2008-10#3)
powder diffraction (XRD)##3##3##(2008-10#2)(2012-2#1)
powder diffraction data##2##3##(1997-7#1)(2006-4#1)
powder diffraction##9##2##(1996-2#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2011-3#1)(2012-2#1)
powder form##3##2##(2008-10#2)(2012-2#1)
powder has##2##2##(2008-10#1)(2011-2#1)
powder in##6##2##(2008-10#3)(2008-5#1)(2009-7#1)(2013-1#1)
powder inhaler (DPI)##3##3##(1997-1#1)(1997-2#2)
powder inhaler##11##2##(1994-2#3)(1996-2#5)(1997-1#1)(1997-2#2)
powder inhalers (DPI's)##2##3##(1992-3#2)
powder inhalers##6##2##(1992-3#4)(1996-1#2)
powder metallurgy##3##2##(2009-7#3)
powder of##2##2##(2008-10#1)(2008-12#1)
powder pattern##2##2##(1997-7#1)(2008-10#1)
powder patterns##2##2##(1997-7#2)
powder samples##6##2##(2008-10#2)(2012-2#2)(2013-8#2)
powder spray containing##2##3##(2008-5#2)
powder spray##3##2##(2008-5#3)
powder to##4##2##(2010-5#2)(2011-2#1)(2012-2#1)
powder was##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
powder##177##1##(1991-5#1)(1992-3#6)(1992-8#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-11#2)(1995-3#2)(1996-1#2)(1996-2#9)(1996-9#1)(1997-1#2)(1997-2#2)(1997-7#6)(2006-4#1)(2007-11#5)(2008-1#1)(2008-10#70)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#1)(2009-7#5)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#12)(2011-3#3)(2012-1#1)(2012-2#5)(2013-1#5)(2013-8#9)
powder)##6##1##(2008-10#6)
powdered milk##3##2##(2008-10#1)(2009-8#2)
powdered##20##1##(1990-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2009-8#2)(2013-1#1)
powders may##2##2##(1995-3#1)(2008-10#1)
powders of##2##2##(2008-10#1)(2010-4#1)
powders with##2##2##(2008-10#2)
powders##26##1##(1995-3#3)(2008-10#17)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#2)(2010-5#1)
powdery mildew (Podosphaera##2##3##(2008-10#2)
powdery mildew (Uncinula##2##3##(2008-10#2)
powdery mildew and##4##3##(2008-10#4)
powdery mildew development on##2##4##(2008-10#2)
powdery mildew fungi##2##3##(2008-10#2)
powdery mildew fungus##3##3##(2008-10#3)
powdery mildew in the##2##4##(2008-10#2)
powdery mildew in##7##3##(2008-10#7)
powdery mildew of##2##3##(2008-10#2)
powdery mildew resistance gene in Suwon 92##2##7##(2008-10#2)
powdery mildew resistance gene in##3##5##(2008-10#3)
powdery mildew resistance in NC96BGTA5##2##5##(2008-10#2)
powdery mildew resistance in Suwon 92##2##6##(2008-10#2)
powdery mildew resistance in the##2##5##(2008-10#2)
powdery mildew resistance in##8##4##(2008-10#8)
powdery mildew resistance##15##3##(2008-10#15)
powdery mildew was evaluated##2##4##(2008-10#2)
powdery mildew was##4##3##(2008-10#4)
powdery mildew were##2##3##(2008-10#2)
powdery mildew##91##2##(2008-10#91)
powdery mildews##3##2##(2008-10#3)
powdery##96##1##(2008-10#95)(2008-5#1)
power (relative##2##2##(2008-7#1)(2009-7#1)
power absorption in##2##3##(1992-3#2)
power absorption##4##2##(1992-3#2)(1992-8#1)(2008-3#1)
power amplifier##9##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#1)(2009-10#1)
power analysis##7##2##(2007-7#3)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
power and a##3##3##(2007-11#2)(2008-10#1)
power and an##2##3##(2008-2#1)(2008-3#1)
power and in##2##3##(2008-11#1)(2008-3#1)
power and potential of##2##4##(2008-11#1)(2010-7#1)
power and resolution##3##3##(2008-10#2)(2012-3#1)
power and the##11##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2010-4#1)(2012-3#1)
power and wavelength tuning##2##4##(2007-11#1)(2008-9#1)
power and wavelength##4##3##(2007-11#1)(2007-12#2)(2008-9#1)
power and##95##2##(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-1#1)(1995-2#1)(2007-11#8)(2007-12#10)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#7)(2008-3#19)(2008-6#1)(2008-8#2)(2008-9#4)(2009-11#2)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
power are##4##2##(1995-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
power as a function of##2##5##(1996-3#1)(2008-2#1)
power as##6##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
power at 1##2##3##(2007-11#1)(2008-2#1)
power at 532 nm##2##4##(2007-12#1)(2008-2#1)
power at a wavelength of##2##5##(2007-12#2)
power at a##5##3##(2007-12#5)
power at the##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
power at##33##2##(2007-11#4)(2007-12#14)(2008-10#1)(2008-2#6)(2008-3#4)(2008-8#1)(2008-9#1)(2010-3#1)(2013-8#1)
power between##2##2##(1997-3#1)(2011-2#1)
power budget##2##2##(2007-11#1)(2008-2#1)
power buildup##2##2##(2008-3#2)
power by##9##2##(2007-11#2)(2007-12#4)(2008-3#3)
power can be##2##3##(1995-12#1)(2012-12#1)
power can##7##2##(1991-12#1)(1995-12#1)(2008-3#3)(2010-9#1)(2012-12#1)
power carried##2##2##(2008-3#2)
power characteristics##2##2##(2008-2#2)
power consumption and##3##3##(2009-5#1)(2010-11#1)(2011-1#1)
power consumption##11##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-5#1)(2010-11#2)(2011-1#1)(2013-1#1)
power conversion efficiencies##2##3##(2008-3#1)(2011-2#1)
power conversion##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
power cords from service##2##4##(2011-1#1)(2011-2#1)
power cords from##3##3##(2011-1#1)(2011-2#2)
power cords##7##2##(2011-1#2)(2011-2#5)
power corresponding to##2##3##(2008-2#1)(2008-3#1)
power coupling##3##2##(2008-2#2)(2008-3#1)
power densities##2##2##(2008-2#1)(2013-7#1)
power density at the##2##4##(1992-12#2)
power density at##3##3##(1992-12#2)(1995-2#1)
power density##12##2##(1992-1#1)(1992-12#2)(1995-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#4)(2012-2#1)
power deposition##3##2##(1992-3#1)(2008-2#2)
power dissipation##3##2##(2010-8#2)(2011-1#1)
power distribution##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
power distributions##2##2##(2008-2#2)
power efficiency of##2##3##(1995-3#1)(2007-12#1)
power efficiency##4##2##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
power extraction##2##2##(2008-3#2)
power fluctuation##2##2##(2008-2#1)(2008-3#1)
power fluctuations##2##2##(2008-10#1)(2008-2#1)
power for a##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
power for detecting a##2##4##(1995-2#2)
power for detecting##3##3##(1994-2#1)(1995-2#2)
power for self-focusing in##2##4##(2007-12#2)
power for self-focusing##3##3##(2007-12#3)
power for the##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
power for##30##2##(1994-2#1)(1995-2#2)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2010-12#1)(2010-3#1)
power frequency##3##2##(2010-12#1)(2012-2#2)
power from a##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
power from the##2##3##(2007-12#1)(2008-3#1)
power from##13##2##(2007-11#5)(2007-12#3)(2008-3#3)(2013-1#2)
power function##8##2##(1992-6#3)(1994-8#1)(1995-8#1)(1997-7#1)(2008-6#1)(2008-7#1)
power has been##7##3##(2007-11#2)(2008-2#1)(2008-3#3)(2008-5#1)
power has##10##2##(1992-3#1)(1993-2#1)(2007-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-5#1)
power imbalances##2##2##(1997-3#2)
power in a##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
power in health##2##3##(1993-2#1)(1997-2#1)
power in the##17##3##(1991-3#1)(1995-2#1)(1995-8#2)(2007-11#4)(2007-12#2)(2008-3#5)(2008-7#1)(2009-7#1)
power in this##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
power in##44##2##(1991-3#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-8#2)(1997-2#1)(2007-11#7)(2007-12#8)(2008-2#2)(2008-3#7)(2008-7#4)(2008-9#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
power into the##2##3##(2008-3#2)
power into##5##2##(2008-2#2)(2008-3#3)
power is increased##2##3##(1992-12#1)(2007-12#1)
power is presented##2##3##(2007-11#1)(2008-3#1)
power is the##2##3##(2008-2#1)(2008-3#1)
power is##31##2##(1992-1#1)(1992-12#1)(1997-3#1)(2007-11#5)(2007-12#7)(2008-11#1)(2008-2#4)(2008-3#7)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
power law and##2##3##(2008-10#2)
power law was used to##2##5##(2008-10#2)
power law with##3##3##(2008-10#2)(2008-8#1)
power law##34##2##(2007-12#1)(2008-10#23)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#2)(2010-5#1)(2011-2#1)
power level of##2##3##(2007-12#2)
power level##5##2##(2007-12#4)(2008-3#1)
power levels##11##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)
power loss##4##2##(1992-12#1)(2008-2#2)(2008-3#1)
power maps##2##2##(2008-2#1)(2009-7#1)
power microwave##2##2##(2008-10#1)(2011-2#1)
power monitoring##2##2##(2007-9#2)
power near##3##2##(2008-2#1)(2008-3#2)
power of &gt##4##3##(2007-11#1)(2007-12#2)(2010-4#1)
power of 0##7##3##(2007-11#2)(2007-12#4)(2008-2#1)
power of 1 W##5##4##(2007-11#1)(2007-12#2)(2008-3#2)
power of 1 mW##2##4##(2008-3#2)
power of 1##15##3##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#7)
power of 10 mW and a##2##6##(2008-2#1)(2008-3#1)
power of 10 mW##4##4##(2008-2#3)(2008-3#1)
power of 10##5##3##(1996-12#1)(2008-2#3)(2008-3#1)
power of 2##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
power of 200 mW##3##4##(2007-12#2)(2008-3#1)
power of 3##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
power of 60##2##3##(1991-3#1)(2007-11#1)
power of 68##2##3##(2007-12#1)(2008-2#1)
power of 7##2##3##(2007-11#1)(2008-3#1)
power of IMT##2##3##(2012-3#2)
power of a##13##3##(1993-5#1)(1995-9#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-8#1)(2012-2#1)
power of an##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
power of approximately##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
power of as much as##2##5##(2007-12#1)(2008-3#1)
power of attorney##2##3##(1992-1#1)(1997-1#1)
power of flow cytometry##2##4##(2008-9#2)
power of only##3##3##(2007-12#1)(2008-2#2)
power of the input##2##4##(2007-11#2)
power of the method##2##4##(2008-3#1)(2012-12#1)
power of the models##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
power of the system##2##4##(1995-11#1)(2008-11#1)
power of the test##2##4##(1992-9#1)(1996-3#1)
power of the##59##3##(1992-9#3)(1993-12#1)(1994-2#1)(1995-11#1)(1996-3#3)(1997-3#1)(1997-6#1)(2007-11#4)(2007-12#4)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#14)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
power of these##4##3##(2008-10#1)(2008-12#1)(2009-3#1)(2013-1#1)
power of this methodology##2##4##(2008-2#1)(2012-2#1)
power of this##4##3##(2007-11#1)(2008-2#2)(2012-2#1)
power of##266##2##(1991-3#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#2)(1995-11#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#4)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(2007-11#27)(2007-12#43)(2008-10#19)(2008-11#3)(2008-12#4)(2008-2#32)(2008-3#44)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#1)(2013-8#2)
power on the##6##3##(2007-11#1)(2007-12#2)(2008-3#2)(2008-9#1)
power on##9##2##(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-9#1)
power or##2##2##(2008-3#1)(2008-7#1)
power output##5##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
power over the range##3##4##(2007-11#1)(2008-3#2)
power over the##4##3##(2007-11#1)(2008-3#3)
power over##6##2##(2007-11#1)(2008-11#1)(2008-3#3)(2013-1#1)
power penalty##2##2##(2007-11#1)(2007-12#1)
power performance reported to date from##2##6##(2008-2#2)
power performance##4##2##(2008-2#4)
power plant##8##2##(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#2)(2010-8#1)(2011-2#1)
power poles##2##2##(2011-2#2)
power range##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
power ratio##2##2##(2007-11#1)(2007-12#1)
power relative to the##2##4##(1995-8#1)(2007-11#1)
power required to##2##3##(2008-3#2)
power required##3##2##(2008-3#2)(2013-1#1)
power requirements##5##2##(2007-11#2)(2008-10#3)
power scaling##2##2##(2008-3#2)
power spectra of the##2##4##(2008-3#2)
power spectra##9##2##(2007-11#1)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)
power spectral densities##2##3##(2008-3#2)
power spectral density (PSD)##2##4##(2008-3#1)(2010-8#1)
power spectral density functions##2##4##(2008-2#2)
power spectral density of##3##4##(2007-12#1)(2008-3#2)
power spectral density##12##3##(2007-12#2)(2008-2#3)(2008-3#5)(2010-8#1)(2012-2#1)
power spectral##14##2##(2007-12#2)(2008-2#3)(2008-3#7)(2010-8#1)(2012-2#1)
power spectrum broadens##2##3##(2008-3#2)
power spectrum from##2##3##(2007-12#1)(2008-3#1)
power spectrum is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
power spectrum of the spontaneous Brillouin backscattered light##2##8##(2008-3#2)
power spectrum of the spontaneous##3##5##(2008-3#3)
power spectrum of the##7##4##(2007-12#1)(2008-3#6)
power spectrum of##10##3##(1990-4#1)(2007-12#1)(2008-3#8)
power spectrum that##2##3##(2008-3#2)
power spectrum##33##2##(1990-4#1)(1990-8#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#2)(2008-3#21)
power stability of##2##3##(2008-3#2)
power stabilization##2##2##(2008-3#2)
power station##2##2##(2008-10#1)(2012-2#1)
power stations##7##2##(2008-10#6)(2008-3#1)
power supply##9##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-10#1)(2011-1#1)(2011-2#1)
power than the##2##3##(1997-7#1)(2008-10#1)
power than##7##2##(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-3#1)
power that is##2##3##(2008-2#2)
power that##7##2##(1997-3#1)(2007-12#1)(2008-2#2)(2008-3#3)
power to a prosthetic knee##2##5##(2013-1#2)
power to detect rare variants##3##5##(2012-3#3)
power to detect##8##3##(1997-5#1)(2008-4#1)(2008-8#1)(2012-3#5)
power to the##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
power to##34##2##(1992-1#1)(1992-2#1)(1993-3#1)(1994-9#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#7)(2013-1#3)
power transfer##8##2##(2007-11#1)(2007-12#2)(2008-3#2)(2010-10#3)
power transmission and thermal##2##4##(2008-3#2)
power transmission and##3##3##(2008-3#3)
power transmission##8##2##(2008-10#1)(2008-2#1)(2008-3#5)(2010-10#1)
power under##2##2##(1994-9#1)(1995-2#1)
power up to##2##3##(2007-12#1)(2008-3#1)
power variation##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
power variations##3##2##(2007-11#1)(2008-2#2)
power was also##2##3##(2007-11#1)(2008-2#1)
power was measured##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
power was obtained##2##3##(2007-12#1)(2008-2#1)
power was reduced by##2##4##(2008-2#1)(2008-3#1)
power was##28##2##(1991-10#1)(2007-11#5)(2007-12#1)(2008-10#3)(2008-2#7)(2008-3#7)(2008-7#1)(2009-7#1)(2011-2#2)
power were generated##2##3##(2008-10#1)(2008-3#1)
power were##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
power with a##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
power with respect to the##2##5##(2008-2#1)(2008-5#1)
power with respect to##3##4##(1992-10#1)(2008-2#1)(2008-5#1)
power with the##2##3##(2008-3#1)(2013-8#1)
power with##14##2##(1992-10#1)(1996-3#1)(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2011-1#1)(2013-8#1)
power within##2##2##(2008-3#1)(2010-8#1)
power##1352##1##(1990-4#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#3)(1992-1#7)(1992-10#1)(1992-12#9)(1992-2#2)(1992-3#6)(1992-6#3)(1992-8#2)(1992-9#5)(1993-12#1)(1993-2#5)(1993-3#3)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-5#1)(1995-8#8)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#8)(1997-1#6)(1997-2#4)(1997-3#15)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(2007-10#1)(2007-11#136)(2007-12#166)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#132)(2008-11#19)(2008-12#7)(2008-2#166)(2008-3#284)(2008-4#5)(2008-5#16)(2008-6#7)(2008-7#33)(2008-8#15)(2008-9#18)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#4)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#9)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#5)(2010-7#3)(2010-8#10)(2010-9#3)(2011-1#16)(2011-2#29)(2012-1#2)(2012-12#5)(2012-2#20)(2012-3#28)(2013-1#17)(2013-7#2)(2013-8#7)
power)##8##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-6#1)
power-amplifier system##3##2##(2007-12#2)(2008-2#1)
power-amplifier##5##1##(2007-12#3)(2008-2#1)(2008-3#1)
power-conversion efficiency##2##2##(2007-12#1)(2008-10#1)
power-delivery system##2##2##(2008-3#2)
power-delivery##4##1##(2008-3#4)
power-dependent lens##2##2##(2008-2#2)
power-dependent##3##1##(2008-2#2)(2008-3#1)
power-efficient##2##1##(2008-2#1)(2009-5#1)
power-gap law##2##2##(2008-2#2)
power-law model##2##2##(2008-10#2)
power-law##12##1##(1990-4#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#3)
power-limiting##2##1##(2007-11#2)
power-series method##2##2##(2008-3#2)
power]##2##1##(1997-8#1)(2012-12#1)
powered by##2##2##(1996-12#1)(2008-8#1)
powered to##3##2##(2008-5#1)(2010-10#1)(2012-3#1)
powered##14##1##(1996-12#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-10#3)(2012-1#1)(2012-3#1)(2013-1#1)
powerful alternative##5##2##(1991-5#1)(2008-10#2)(2008-3#2)
powerful analytical tool##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
powerful analytical tools##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
powerful analytical##9##2##(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
powerful and##12##2##(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
powerful anti-oxidants##2##2##(2008-5#2)
powerful approach##2##2##(2008-10#1)(2008-9#1)
powerful approaches##2##2##(2010-6#1)(2011-2#1)
powerful but##2##2##(2008-12#1)(2008-3#1)
powerful computers##2##2##(1993-12#1)(2013-1#1)
powerful effect##2##2##(2008-8#1)(2012-3#1)
powerful evolutionary##2##2##(2010-4#1)(2013-1#1)
powerful experimental##2##2##(2007-11#1)(2012-3#1)
powerful for##4##2##(2008-10#1)(2008-4#2)(2008-7#1)
powerful in##3##2##(2008-10#2)(2012-3#1)
powerful means for##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
powerful means##4##2##(2008-11#2)(2008-3#1)(2008-8#1)
powerful method for##3##3##(1993-8#1)(1995-2#1)(2008-3#1)
powerful method##6##2##(1993-8#1)(1995-2#2)(2008-3#2)(2013-1#1)
powerful methodology##3##2##(1997-3#1)(2008-10#1)(2008-2#1)
powerful model##2##2##(2008-2#1)(2008-4#1)
powerful multidimensional##2##2##(2008-3#1)(2008-4#1)
powerful new##3##2##(2008-10#2)(2008-8#1)
powerful predictor of##5##3##(1994-2#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-5#1)
powerful predictor##7##2##(1994-2#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
powerful roles##2##2##(1995-2#1)(2012-2#1)
powerful technique for##7##3##(1993-3#1)(1994-2#1)(1994-9#1)(2008-2#2)(2008-6#1)(2008-7#1)
powerful technique##12##2##(1991-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
powerful techniques##2##2##(2008-10#2)
powerful technologies##2##2##(2009-4#1)(2010-7#1)
powerful to##2##2##(1995-12#1)(1997-5#1)
powerful tool for##38##3##(1991-8#1)(1996-10#2)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)
powerful tool in##16##3##(1993-11#1)(1994-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2013-8#1)
powerful tool to##16##3##(1995-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2011-1#2)(2012-2#1)(2012-3#1)
powerful tool##79##2##(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-10#2)(1997-3#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
powerful tools for the##2##4##(2008-4#1)(2011-2#1)
powerful tools for##5##3##(1997-6#1)(2007-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
powerful tools in##3##3##(1993-3#1)(2007-11#1)(2012-3#1)
powerful tools that can##2##4##(2008-10#1)(2008-4#1)
powerful tools##11##2##(1993-3#1)(1997-6#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-9#1)(2011-2#1)(2012-3#1)
powerful##306##1##(1990-5#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#38)(2008-11#12)(2008-12#6)(2008-2#10)(2008-3#14)(2008-4#28)(2008-5#9)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#8)(2011-2#13)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#7)(2013-8#1)
powerfully inhibited##2##2##(1990-11#1)(1991-12#1)
powerfully##6##1##(1990-11#1)(1991-12#1)(1995-8#1)(1996-5#1)(2008-10#1)(2009-2#1)
powerless##2##1##(1995-1#1)(2008-1#1)
powers and##3##2##(2008-2#2)(2008-3#1)
powers are##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
powers as great as##2##4##(2007-12#2)
powers as high as 1##2##5##(2007-12#1)(2008-3#1)
powers as high as##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
powers as##7##2##(2007-12#4)(2008-2#1)(2008-3#2)
powers exceeding##2##2##(2007-11#1)(2007-12#1)
powers for##2##2##(2007-12#1)(2008-3#1)
powers from##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
powers greater than##2##3##(2007-12#2)
powers in excess of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
powers in##5##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
powers of 1##3##3##(2007-11#2)(2007-12#1)
powers of 600##2##3##(2007-11#1)(2007-12#1)
powers of approximately##2##3##(2007-12#1)(2008-2#1)
powers of as much as##3##5##(2007-11#2)(2007-12#1)
powers of several##3##3##(2007-11#3)
powers of the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-7#1)
powers of##32##2##(1994-1#1)(2007-11#14)(2007-12#8)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-7#1)
powers that##2##2##(2008-2#2)
powers to##3##2##(2007-11#1)(2008-3#2)
powers were##2##2##(1992-2#1)(2012-3#1)
powers##94##1##(1992-2#1)(1993-8#1)(1994-1#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#24)(2007-12#21)(2008-10#3)(2008-2#17)(2008-3#16)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#2)(2012-3#1)
pox potyvirus##2##2##(2008-10#2)
pox virus Strain##2##3##(2008-10#2)
pox virus##12##2##(1997-6#1)(2008-10#11)
pox##19##1##(1992-2#1)(1997-3#2)(1997-6#1)(2008-10#14)(2008-4#1)
poxvirus##3##1##(1997-3#2)(2008-11#1)
poxviruses##3##1##(1995-5#1)(2008-11#2)
pp##37##1##(1990-11#6)(1990-3#4)(1990-8#4)(1993-8#4)(1997-6#4)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
pp15##3##1##(1991-5#3)
pp185##6##1##(1991-12#1)(1992-10#5)
pp33 and pp15##2##3##(1991-5#2)
pp60c-src##4##1##(1990-12#4)
ppb (parts in##2##3##(2008-3#2)
ppb (parts##3##2##(2008-10#1)(2008-3#2)
ppb (signal to noise ratio##2##5##(2008-10#2)
ppb aflatoxin##3##2##(2008-12#3)
ppb and higher##3##3##(2008-10#1)(2008-12#2)
ppb and##5##2##(2008-10#3)(2008-12#2)
ppb at##2##2##(2008-10#2)
ppb for the##2##3##(2008-10#2)
ppb for##12##2##(2008-10#10)(2008-2#1)(2008-3#1)
ppb in dimethylformamide solution##2##4##(2008-10#2)
ppb in the##3##3##(2008-10#2)(2008-5#1)
ppb in##6##2##(2008-10#5)(2008-5#1)
ppb is##2##2##(2008-10#2)
ppb level##4##2##(2008-10#4)
ppb levels##6##2##(2008-10#6)
ppb of##2##2##(2008-10#2)
ppb were##2##2##(2008-10#1)(2008-5#1)
ppb##89##1##(1996-5#1)(2008-10#70)(2008-12#5)(2008-2#4)(2008-3#7)(2008-5#2)
ppb) were##2##2##(2008-10#2)
ppb)##10##1##(2008-10#8)(2008-5#1)(2008-6#1)
ppbV for##2##2##(2008-10#2)
ppbV##3##1##(2008-10#3)
ppbv##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
pph(3) and the##2##3##(2013-1#2)
pph(3)##6##1##(2013-1#6)
ppm (5##2##2##(1997-7#1)(2008-3#1)
ppm (parts in 10(6))##2##4##(2008-3#2)
ppm and##6##2##(1990-5#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
ppm at##3##2##(2008-10#3)
ppm detection##2##2##(2008-10#2)
ppm enrofloxacin##2##2##(2008-5#2)
ppm for molybdenum##2##3##(2008-10#2)
ppm for##18##2##(1991-8#1)(1995-5#1)(2008-10#14)(2008-3#2)
ppm in the##2##3##(1995-11#1)(2008-10#1)
ppm in##7##2##(1995-11#2)(2008-10#2)(2008-3#1)(2010-1#2)
ppm level was##3##3##(2008-10#3)
ppm level##4##2##(2008-10#4)
ppm levels of##2##3##(2008-10#2)
ppm levels##3##2##(2008-10#3)
ppm m##2##2##(2008-3#2)
ppm of gold##3##3##(2008-10#3)
ppm of##22##2##(1991-9#2)(1997-2#1)(2008-10#18)(2008-3#1)
ppm or 0##2##3##(2008-10#2)
ppm or##3##2##(2008-10#3)
ppm per unit IND and##2##5##(2008-10#2)
ppm per unit IND##3##4##(2008-10#3)
ppm respectively##2##2##(2013-8#2)
ppm to##3##2##(1995-11#1)(2008-10#2)
ppm was##5##2##(2008-10#4)(2008-5#1)
ppm with a correlation coefficient##2##5##(2008-10#2)
ppm with a##5##3##(2008-10#5)
ppm with##10##2##(2008-10#10)
ppm##217##1##(1990-3#1)(1990-5#3)(1990-8#2)(1991-8#2)(1991-9#2)(1993-1#2)(1993-6#3)(1995-11#3)(1995-5#2)(1996-12#3)(1997-2#2)(1997-4#9)(1997-6#1)(1997-7#4)(2008-1#2)(2008-10#127)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#9)(2008-7#1)(2008-8#8)(2009-12#1)(2010-1#3)(2011-1#1)(2011-2#5)(2012-12#1)(2013-8#2)
ppm) and the##2##3##(2008-10#2)
ppm) and##4##2##(2008-10#4)
ppm) were##4##2##(2008-10#4)
ppm)##27##1##(1992-9#1)(1993-11#1)(1993-6#1)(2008-10#21)(2008-5#3)
ppm-hr##2##1##(1993-1#2)
ppm/yr for##2##2##(2008-3#2)
ppmv##2##1##(2008-3#2)
ppoFEV1 calculated##2##2##(2007-8#2)
ppoFEV1##5##1##(2007-8#5)
pps##4##1##(2008-9#4)
ppt##3##1##(2008-10#3)
pptv##3##1##(2008-11#1)(2008-2#2)
pr actice##2##2##(2008-11#2)
pr-10##2##1##(2008-10#2)
prC4##4##1##(1997-8#4)
pra1##3##1##(2008-10#3)
practicability in##2##2##(2008-10#1)(2008-2#1)
practicability##6##1##(2008-10#4)(2008-2#1)(2012-3#1)
practicable for##2##2##(2011-2#1)(2012-2#1)
practicable##11##1##(1990-5#1)(1994-7#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
practical advantages##5##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
practical advice and##2##3##(2008-12#1)(2012-2#1)
practical advice##5##2##(1992-12#1)(2008-1#1)(2008-12#1)(2009-5#1)(2012-2#1)
practical analytical##3##2##(1997-2#1)(2008-10#2)
practical and economic##3##3##(1997-2#1)(2008-8#1)(2013-1#1)
practical and economical##2##3##(2008-7#1)(2013-1#1)
practical and ethical##2##3##(1991-11#1)(2008-11#1)
practical and useful##2##3##(2008-12#1)(2008-9#1)
practical and##30##2##(1991-11#1)(1992-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#2)
practical applicability of the developed resin##2##6##(2008-10#2)
practical applicability of the##5##4##(2008-10#5)
practical applicability of##6##3##(2008-10#6)
practical application are##2##3##(2010-12#1)(2010-9#1)
practical application in##2##3##(1991-11#1)(1994-12#1)
practical application of the##2##4##(1992-3#1)(2008-3#1)
practical application of##9##3##(1992-3#1)(1996-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2011-2#1)
practical application##22##2##(1991-11#1)(1992-3#1)(1994-12#1)(1996-8#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
practical applications for##2##3##(1997-7#1)(2008-5#1)
practical applications in##2##3##(2008-10#1)(2011-1#1)
practical applications of##5##3##(1997-2#1)(2008-10#3)(2012-2#1)
practical applications##27##2##(1995-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
practical approach for##3##3##(1990-5#1)(2008-11#1)(2012-2#1)
practical approach to##6##3##(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
practical approach using##2##3##(1997-2#1)(2010-8#1)
practical approach##14##2##(1990-5#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#2)
practical approaches for##2##3##(2008-10#1)(2011-2#1)
practical approaches##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
practical aspects of##8##3##(1991-12#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-3#1)
practical aspects##11##2##(1991-12#1)(1993-12#1)(1994-12#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-3#1)
practical assessment##2##2##(2008-11#2)
practical benefits##2##2##(1997-7#1)(2008-11#1)
practical case##3##2##(2008-2#2)(2013-1#1)
practical cases##3##2##(1995-2#1)(1995-6#1)(2007-11#1)
practical clinical skills##2##3##(1995-6#2)
practical clinical##6##2##(1991-6#1)(1992-3#1)(1995-6#2)(2008-4#1)(2008-6#1)
practical consequences##2##2##(1991-11#1)(1991-6#1)
practical considerations for##2##3##(2008-1#1)(2008-4#1)
practical considerations##9##2##(1993-1#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2009-12#1)
practical detection##5##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
practical determination of##2##3##(2008-10#1)(2008-2#1)
practical diagnostic##2##2##(2008-10#1)(2008-7#1)
practical difficulties of##2##3##(2008-11#2)
practical difficulties##5##2##(1992-3#1)(2008-11#2)(2008-4#1)(2011-2#1)
practical examples of##3##3##(1993-2#1)(1996-5#1)(2013-1#1)
practical examples##5##2##(1993-2#1)(1996-5#1)(2008-10#1)(2012-12#1)(2013-1#1)
practical experience to##2##3##(1994-3#1)(2008-10#1)
practical experience##4##2##(1991-3#1)(1994-3#1)(1997-2#1)(2008-10#1)
practical experiences##3##2##(1995-12#1)(1995-6#1)(2007-10#1)
practical features##2##2##(2007-7#1)(2008-9#1)
practical for##9##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-9#1)(2013-1#1)
practical framework##2##2##(1996-3#1)(2008-12#1)
practical guidance for##2##3##(1992-2#1)(2011-2#1)
practical guidance##5##2##(1992-2#1)(1995-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
practical guide for##6##3##(1991-2#1)(1993-12#1)(1993-6#1)(2008-10#2)(2012-12#1)
practical guide to##3##3##(1994-3#1)(2007-11#1)(2008-3#1)
practical guide##11##2##(1991-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-12#1)
practical implementation##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2013-1#1)
practical implications for##4##3##(1996-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
practical implications of##5##3##(1990-9#1)(1992-3#1)(2008-11#2)(2008-4#1)
practical implications##13##2##(1990-9#1)(1992-3#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2013-1#1)
practical importance for the##2##4##(2008-7#1)(2009-9#1)
practical importance to##2##3##(1990-12#1)(2013-1#1)
practical importance##11##2##(1990-12#1)(1992-5#1)(1995-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-7#1)(2013-1#1)
practical in##2##2##(2008-11#1)(2008-3#1)
practical information on##2##3##(2008-10#1)(2008-7#1)
practical information##4##2##(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
practical interest for##2##3##(2008-10#1)(2008-3#1)
practical interest##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
practical issues in##2##3##(1992-9#1)(2009-9#1)
practical issues##7##2##(1992-9#1)(1996-6#1)(2008-10#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)
practical measurements##2##2##(2008-2#1)(2008-3#1)
practical method for the##3##4##(2008-10#2)(2008-3#1)
practical method for##5##3##(1993-8#1)(2007-11#1)(2008-10#2)(2008-3#1)
practical method is developed to##2##5##(2008-3#2)
practical method of##2##3##(1991-12#1)(2008-10#1)
practical method to##2##3##(2008-11#1)(2008-5#1)
practical method##11##2##(1991-12#1)(1993-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)
practical piety##2##2##(2008-12#2)
practical problem of##2##3##(1997-7#1)(2008-12#1)
practical problem##4##2##(1993-3#1)(1997-2#1)(1997-7#1)(2008-12#1)
practical problems encountered##2##3##(1994-2#1)(2008-2#1)
practical problems##7##2##(1994-2#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2012-2#1)
practical procedure##2##2##(1997-5#1)(1997-8#1)
practical reasons##3##2##(2008-12#1)(2008-3#1)(2012-2#1)
practical recommendations for##2##3##(1994-12#1)(2010-12#1)
practical recommendations##4##2##(1992-9#1)(1994-12#1)(2010-12#1)(2012-12#1)
practical requirements##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
practical research##2##2##(1997-3#1)(2010-3#1)
practical samples##5##2##(2008-10#5)
practical scheme for##2##3##(2007-12#1)(2008-2#1)
practical significance##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
practical situation##2##2##(2008-3#2)
practical situations##2##2##(2008-2#1)(2008-3#1)
practical skills and performance indicators##2##5##(2008-11#2)
practical skills and##3##3##(1992-11#1)(2008-11#2)
practical skills of##2##3##(1997-4#1)(2008-11#1)
practical skills##9##2##(1992-11#1)(1995-6#1)(1996-1#1)(1997-4#1)(2008-11#4)(2008-12#1)
practical solution to##2##3##(2008-10#1)(2012-3#1)
practical solution##4##2##(1994-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
practical solutions to##2##3##(1996-1#1)(2013-1#1)
practical strategies##4##2##(1994-12#2)(2009-5#1)(2013-1#1)
practical suggestions for##3##3##(1992-2#1)(1993-1#1)(2008-12#1)
practical test##2##2##(2008-5#1)(2008-9#1)
practical to##2##2##(2008-10#1)(2008-3#1)
practical use of the##2##4##(2008-10#1)(2008-3#1)
practical use of##7##3##(2008-10#2)(2008-2#1)(2008-3#3)(2011-1#1)
practical use##14##2##(1992-5#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)
practical utility of the##4##4##(2008-10#3)(2008-7#1)
practical utility##6##2##(2008-10#4)(2008-7#1)(2011-1#1)
practical value##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
practical way##6##2##(2007-12#1)(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
practical ways to##2##3##(2007-11#1)(2008-1#1)
practical##555##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#2)(1992-9#2)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#3)(1994-12#11)(1994-2#2)(1994-3#4)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#6)(1995-8#1)(1996-1#3)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#10)(1997-3#2)(1997-4#4)(1997-5#2)(1997-7#4)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#12)(2007-12#13)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#87)(2008-11#37)(2008-12#16)(2008-2#30)(2008-3#67)(2008-4#9)(2008-5#9)(2008-6#5)(2008-7#17)(2008-8#7)(2008-9#15)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#6)(2010-4#1)(2010-5#6)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#6)(2012-12#3)(2012-2#11)(2012-3#9)(2012-5#1)(2013-1#13)(2013-8#3)
practicality##7##1##(1990-2#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-7#2)
practically absent##3##2##(1996-5#1)(2008-7#1)(2011-1#1)
practically all##4##2##(1990-6#1)(1991-11#1)(2008-3#1)(2010-9#1)
practically constant##3##2##(2008-10#2)(2008-6#1)
practically identical##3##2##(1995-2#1)(1997-2#1)(2008-3#1)
practically linear function of##2##4##(2008-3#2)
practically no##3##2##(2008-10#2)(2012-2#1)
practically non-existent##2##2##(2008-10#1)(2011-1#1)
practically relevant##5##2##(1994-12#1)(2008-10#3)(2008-5#1)
practically the##2##2##(1990-12#1)(2010-8#1)
practically##68##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#1)(1993-11#1)(1993-3#1)(1994-12#3)(1995-2#2)(1995-5#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-7#1)
practice -##3##2##(2008-11#2)(2011-2#1)
practice BSE##2##2##(1990-6#2)
practice a##3##2##(2008-10#2)(2008-12#1)
practice across##3##2##(2008-11#1)(2010-3#1)(2011-1#1)
practice activity##3##2##(1990-3#3)
practice among##7##2##(1991-6#1)(1992-3#1)(1996-11#1)(2008-11#1)(2008-8#1)(2010-11#1)(2013-1#1)
practice and a##3##3##(1991-3#1)(2008-11#1)(2012-3#1)
practice and academia##2##3##(1993-2#1)(2012-3#1)
practice and attitude##3##3##(2013-1#3)
practice and education##3##3##(2008-11#3)
practice and future##2##3##(2007-12#1)(2011-2#1)
practice and higher education##3##4##(1991-1#1)(2008-12#2)
practice and its##2##3##(1995-1#1)(2008-11#1)
practice and presents##2##3##(2008-10#1)(2008-11#1)
practice and public health##2##4##(1996-1#1)(2008-3#1)
practice and research##9##3##(2008-6#3)(2010-10#1)(2010-11#1)(2011-2#3)(2012-2#1)
practice and that##2##3##(2008-12#1)(2011-2#1)
practice and the##9##3##(1997-1#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2013-1#1)
practice and theory##5##3##(1996-2#1)(2008-11#3)(2008-8#1)
practice and to##4##3##(1996-12#1)(1996-3#1)(1997-2#1)(2010-10#1)
practice and##115##2##(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-11#16)(2008-12#10)(2008-3#2)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2009-4#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#1)
practice are discussed##5##3##(1994-12#1)(1994-3#1)(2008-11#1)(2008-12#1)(2009-8#1)
practice are##19##2##(1992-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2008-11#4)(2008-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
practice areas##3##2##(2008-1#1)(2008-11#2)
practice as a##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
practice as##12##2##(1994-11#1)(1996-1#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#2)(2013-1#1)
practice association##4##2##(1993-12#1)(1993-2#1)(1996-3#1)(1997-3#1)
practice at##5##2##(1990-6#2)(2008-11#2)(2011-2#1)
practice by##8##2##(2007-10#1)(2008-10#1)(2008-11#3)(2008-2#1)(2011-1#1)(2012-1#1)
practice can be defined##2##4##(1995-12#1)(1996-2#1)
practice can be##3##3##(1995-12#1)(1996-2#1)(2008-12#1)
practice can##5##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2011-2#1)
practice change##4##2##(2007-10#1)(2008-11#3)
practice conditions##2##2##(2010-9#1)(2012-12#1)
practice context##4##2##(1993-1#1)(2008-11#2)(2010-9#1)
practice cost##2##2##(1994-1#2)
practice could##2##2##(1990-2#1)(2008-8#1)
practice development##4##2##(2008-11#4)
practice during##3##2##(2008-10#1)(2012-12#2)
practice environment##3##2##(1992-2#1)(1996-3#1)(2008-12#1)
practice especially##2##2##(2008-6#1)(2009-11#1)
practice evaluation at##2##3##(1997-2#2)
practice evaluation##4##2##(1996-7#1)(1997-2#3)
practice expense component##2##3##(1996-1#2)
practice expense##6##2##(1994-1#4)(1996-1#2)
practice expenses##2##2##(1994-1#2)
practice experience##2##2##(2008-11#1)(2008-12#1)
practice for the##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
practice for##20##2##(1993-10#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
practice from##4##2##(1996-12#1)(1996-3#1)(2008-11#1)(2013-7#1)
practice function costs##2##3##(1996-1#2)
practice group##2##2##(2008-12#1)(2008-9#1)
practice guideline##11##2##(1992-8#1)(2008-6#5)(2009-7#1)(2010-10#2)(2010-8#1)(2012-3#1)
practice guidelines for##4##3##(1993-12#1)(1994-3#1)(2008-9#1)(2013-8#1)
practice guidelines in##3##3##(1996-2#1)(2008-8#1)(2009-7#1)
practice guidelines##35##2##(1992-8#1)(1993-12#5)(1994-12#1)(1994-3#6)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
practice has been##4##3##(2008-1#1)(2008-11#2)(2008-3#1)
practice has##10##2##(1996-3#1)(1997-4#1)(2008-1#1)(2008-11#3)(2008-3#1)(2013-1#2)(2013-8#1)
practice have been##2##3##(1990-5#1)(2011-1#1)
practice have##4##2##(1990-5#1)(2008-11#2)(2011-1#1)
practice in a##6##3##(1993-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2012-12#2)
practice in an##3##3##(2012-12#2)(2012-3#1)
practice in clinical##2##3##(2006-6#1)(2008-11#1)
practice in order to##2##4##(2008-11#1)(2011-2#1)
practice in the United##2##4##(1996-11#1)(1997-3#1)
practice in the field of##2##5##(2008-11#1)(2012-12#1)
practice in the future##2##4##(2007-10#1)(2010-11#1)
practice in the##24##3##(1991-3#1)(1992-1#1)(1992-3#1)(1995-12#1)(1996-11#1)(1997-3#1)(2007-10#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#2)
practice in this##4##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-12#1)
practice in##98##2##(1990-5#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-3#1)(1993-3#2)(1994-9#1)(1995-12#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-6#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#17)(2008-12#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
practice into##3##2##(2008-11#2)(2010-10#1)
practice is an##2##3##(2008-12#1)(2008-4#1)
practice is at##2##3##(1996-8#1)(2008-9#1)
practice is inadequate and##2##4##(2012-2#1)(2013-8#1)
practice is not##3##3##(1993-2#1)(1996-3#1)(1997-8#1)
practice is often##2##3##(1997-3#1)(2008-12#1)
practice is presented##2##3##(2008-11#1)(2008-12#1)
practice is the##2##3##(1992-3#1)(2008-11#1)
practice is##42##2##(1992-3#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-11#9)(2008-12#9)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
practice issues##2##2##(2008-11#1)(2008-9#1)
practice it##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
practice knowledge##2##2##(2008-12#1)(2010-10#1)
practice learning in##2##3##(2008-11#2)
practice learning##8##2##(2008-11#8)
practice location##2##2##(1994-3#1)(2008-12#1)
practice management skills##2##3##(1993-1#1)(1994-3#1)
practice management##8##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-3#2)(1997-3#1)(2008-1#1)(2011-2#1)
practice may be##2##3##(1997-4#1)(2008-11#1)
practice may##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
practice medical##2##2##(2008-10#1)(2008-8#1)
practice model##5##2##(1991-1#3)(1993-1#1)(1997-3#1)
practice module##2##2##(2008-11#2)
practice more##2##2##(2008-12#2)
practice moves##2##2##(1997-4#1)(2008-11#1)
practice nurse##2##2##(1997-4#1)(2012-3#1)
practice nurses##5##2##(2008-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
practice of a##3##3##(1991-6#1)(2008-11#1)(2008-9#1)
practice of anesthesia##2##3##(2008-8#1)(2010-5#1)
practice of community involvement in health programmes##2##7##(2010-3#2)
practice of dietetics##2##3##(1992-2#1)(1994-2#1)
practice of medicine##6##3##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-1#1)
practice of nursing##2##3##(2008-1#1)(2008-12#1)
practice of physical activity##5##4##(2010-11#5)
practice of primary##2##3##(1990-9#1)(1997-3#1)
practice of public health##4##4##(1996-2#1)(1997-3#1)(2010-8#1)(2013-1#1)
practice of public##5##3##(1996-2#1)(1997-3#1)(2008-12#1)(2010-8#1)(2013-1#1)
practice of sedation##3##3##(2008-8#3)
practice of the##6##3##(1993-11#1)(1994-6#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
practice of##136##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#4)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#2)(1997-3#6)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#9)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#1)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#6)
practice often##2##2##(1996-1#1)(2011-2#1)
practice on##4##2##(1996-2#1)(2008-12#1)(2008-7#1)(2013-1#1)
practice or##7##2##(1992-11#1)(1994-3#1)(1995-1#1)(2009-10#1)(2010-9#1)(2012-12#1)(2013-8#1)
practice outcomes##2##2##(2008-11#1)(2008-8#1)
practice outside##2##2##(2008-11#1)(2008-8#1)
practice over the past##3##4##(1996-8#1)(2010-8#1)(2012-2#1)
practice over##4##2##(1990-9#1)(1996-8#1)(2010-8#1)(2012-2#1)
practice parameters##8##2##(1993-3#5)(1994-3#2)(1995-1#1)
practice pattern##3##2##(1994-12#2)(1995-12#1)
practice patterns and##2##3##(1993-2#1)(2010-9#1)
practice patterns are##2##3##(1994-12#1)(2008-11#1)
practice patterns of##2##3##(2011-2#1)(2012-1#1)
practice patterns##21##2##(1990-6#2)(1992-12#1)(1993-2#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-12#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
practice performance##5##2##(1993-12#1)(1996-2#3)(2007-4#1)
practice placement##10##2##(2008-11#10)
practice placements##5##2##(2008-11#5)
practice places##2##2##(2008-12#1)(2009-5#1)
practice policies##2##2##(1991-12#1)(1996-12#1)
practice relating to care of the older person##2##8##(2010-10#2)
practice relevant##2##2##(2007-3#1)(2010-10#1)
practice remains##3##2##(2010-10#1)(2010-5#1)(2012-3#1)
practice setting##11##2##(1993-2#1)(1994-3#2)(1995-3#1)(1996-1#1)(1996-3#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-3#1)
practice settings##12##2##(1992-1#1)(1996-7#1)(2008-1#2)(2008-11#5)(2008-5#1)(2010-7#1)(2010-8#1)
practice should be##2##3##(1993-3#1)(2010-8#1)
practice should##5##2##(1993-3#1)(1994-12#1)(2008-11#1)(2008-4#1)(2010-8#1)
practice skills##2##2##(2008-11#1)(2008-12#1)
practice staff and##2##3##(2007-2#1)(2011-2#1)
practice staff##5##2##(2007-2#4)(2011-2#1)
practice standards##2##2##(1993-2#1)(1997-7#1)
practice than##3##2##(1994-12#1)(2009-11#1)(2013-1#1)
practice that##11##2##(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-10#1)(2013-8#2)
practice the##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
practice through##8##2##(1991-3#1)(1997-2#1)(2008-11#3)(2008-12#3)
practice to##21##2##(1993-3#1)(1994-1#1)(1994-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
practice type##2##2##(1997-2#1)(2007-10#1)
practice using##4##2##(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
practice was##12##2##(1990-5#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)(2012-1#1)(2013-8#1)
practice we##2##2##(2008-1#1)(2008-5#1)
practice were##6##2##(1991-11#1)(1994-6#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-12#1)
practice when##2##2##(2008-11#1)(2013-1#1)
practice which##3##2##(2007-7#1)(2008-11#1)(2008-5#1)
practice who had##2##3##(1996-2#1)(2008-12#1)
practice will##3##2##(2007-4#1)(2008-10#1)(2010-10#1)
practice with##10##2##(2008-11#2)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
practice within##4##2##(1996-8#1)(2007-10#1)(2008-10#1)(2013-8#1)
practice would be##2##3##(2008-10#1)(2008-11#1)
practice##1771##1##(1990-2#5)(1990-3#11)(1990-5#3)(1990-6#10)(1990-8#1)(1990-9#7)(1991-1#10)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#13)(1991-6#13)(1991-8#4)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#9)(1992-3#8)(1992-5#4)(1992-6#4)(1992-8#4)(1993-1#6)(1993-10#2)(1993-11#5)(1993-12#25)(1993-2#16)(1993-3#14)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#23)(1994-11#1)(1994-12#17)(1994-2#7)(1994-3#18)(1994-5#3)(1994-6#6)(1994-7#1)(1994-9#3)(1995-1#11)(1995-11#2)(1995-12#11)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#5)(1996-1#22)(1996-11#9)(1996-12#14)(1996-2#24)(1996-3#16)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#6)(1997-1#6)(1997-2#13)(1997-3#25)(1997-4#12)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#6)(2006-10#5)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#23)(2007-11#20)(2007-12#8)(2007-2#8)(2007-3#1)(2007-4#6)(2007-5#6)(2007-6#1)(2007-7#4)(2007-8#7)(2008-1#30)(2008-10#54)(2008-11#290)(2008-12#99)(2008-2#8)(2008-3#31)(2008-4#20)(2008-5#9)(2008-6#18)(2008-7#28)(2008-8#30)(2008-9#24)(2009-10#7)(2009-11#11)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#7)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#4)(2010-1#4)(2010-10#47)(2010-11#15)(2010-12#14)(2010-2#1)(2010-3#13)(2010-4#8)(2010-5#5)(2010-7#6)(2010-8#14)(2010-9#12)(2011-1#35)(2011-2#76)(2011-3#2)(2011-7#1)(2012-1#14)(2012-12#36)(2012-2#31)(2012-3#41)(2013-1#67)(2013-7#4)(2013-8#29)
practice&quot##4##1##(1991-12#1)(1995-1#1)(2008-10#2)
practice'##8##1##(2007-10#1)(2008-11#4)(2008-12#2)(2012-12#1)
practice's##4##1##(1995-1#1)(1996-12#1)(2007-4#1)(2008-4#1)
practice--a##2##1##(1992-3#1)(1993-2#1)
practice-based research in clinical nutrition##2##5##(1993-2#2)
practice-based research##4##2##(1993-2#3)(2007-12#1)
practice-based teaching##4##2##(2008-11#4)
practice-based##14##1##(1993-2#3)(2007-12#1)(2008-11#7)(2008-12#2)(2008-7#1)
practice?##5##1##(1992-12#1)(2007-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
practice?]##4##1##(1991-6#1)(1994-5#1)(1995-8#2)
practice]##35##1##(1990-11#2)(1991-3#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
practiced by the##2##3##(1994-12#1)(2008-7#1)
practiced by##4##2##(1994-12#1)(1995-1#1)(2008-10#1)(2008-7#1)
practiced in the##3##3##(1991-8#1)(1994-3#1)(2008-2#1)
practiced in##4##2##(1991-8#1)(1994-3#1)(2008-2#1)(2008-3#1)
practiced##24##1##(1990-2#1)(1991-2#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
practices after the##2##3##(1992-5#1)(2008-9#1)
practices among##8##2##(1993-12#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
practices and a##2##3##(1992-2#1)(2008-10#1)
practices and policies##3##3##(1996-12#1)(2010-1#1)(2012-12#1)
practices and social##2##3##(2008-12#1)(2013-1#1)
practices and the##2##3##(2008-11#1)(2011-2#1)
practices and training##2##3##(2008-11#1)(2011-2#1)
practices and##65##2##(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-12#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
practices are described##2##3##(2008-4#1)(2010-11#1)
practices are##11##2##(1993-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-3#1)
practices associated with##4##3##(1996-3#1)(1996-9#1)(2008-9#1)(2010-9#1)
practices at##3##2##(2010-5#1)(2011-2#1)(2013-1#1)
practices based on##2##3##(1992-2#1)(2012-3#1)
practices between##2##2##(1990-2#1)(1996-1#1)
practices by##2##2##(2008-5#1)(2011-2#1)
practices can##4##2##(1992-12#1)(1994-2#1)(2008-10#1)(2010-5#1)
practices designed to##2##3##(2008-9#1)(2010-4#1)
practices for the##5##3##(1994-3#1)(2007-10#1)(2009-5#1)(2010-11#1)(2011-2#1)
practices for##17##2##(1994-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
practices have been##2##3##(1991-12#1)(2008-10#1)
practices have##8##2##(1991-12#1)(1992-3#1)(1993-3#1)(2008-10#2)(2008-11#1)(2010-9#1)(2012-3#1)
practices in a##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
practices in the United States##2##5##(1993-3#1)(2012-2#1)
practices in the United##3##4##(1993-3#1)(2008-11#1)(2012-2#1)
practices in the field##2##4##(2008-12#1)(2011-2#1)
practices in the home##2##4##(2012-2#2)
practices in the##19##3##(1993-3#1)(1994-1#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)
practices in##56##2##(1990-2#1)(1991-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#2)(2008-5#2)(2008-7#4)(2009-5#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
practices include##3##2##(2008-12#1)(2011-2#2)
practices involved##2##2##(2008-12#1)(2008-4#1)
practices is needed##2##3##(2009-11#1)(2010-11#1)
practices is##7##2##(1997-3#1)(2008-4#3)(2009-11#1)(2009-9#1)(2010-11#1)
practices must be##2##3##(1992-12#1)(2008-10#1)
practices of health care##3##4##(1993-12#1)(2008-1#1)(2013-7#1)
practices of the##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
practices of##32##2##(1990-6#1)(1990-8#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#3)(2013-7#2)
practices often##2##2##(1991-3#1)(1997-7#1)
practices on the##2##3##(2008-10#2)
practices on##6##2##(2008-10#4)(2008-5#1)(2009-6#1)
practices regarding##5##2##(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#1)
practices related to##2##3##(2010-7#1)(2011-2#1)
practices such as##5##3##(1994-2#1)(2008-10#3)(2012-12#1)
practices that may##2##3##(1995-3#1)(2008-5#1)
practices that reduce##3##3##(2008-10#3)
practices that##17##2##(1993-1#1)(1995-3#2)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#2)(2010-7#1)
practices to be##2##3##(1990-9#1)(2013-8#1)
practices to children's perceptions and##2##5##(2008-12#2)
practices to the##2##3##(2008-12#1)(2012-3#1)
practices to##16##2##(1990-9#1)(1993-3#2)(2008-10#1)(2008-12#3)(2008-4#1)(2008-6#2)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
practices used##3##2##(1991-12#1)(2008-10#1)(2010-11#1)
practices was##2##2##(1994-12#1)(2011-1#1)
practices were##4##2##(2008-4#2)(2008-7#1)(2010-4#1)
practices with##3##2##(1991-12#1)(2007-10#1)(2008-6#1)
practices within##2##2##(1994-2#1)(1996-12#1)
practices##537##1##(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#9)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-5#1)(1993-1#2)(1993-12#14)(1993-2#1)(1993-3#11)(1993-5#1)(1994-1#2)(1994-12#6)(1994-2#8)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#4)(1995-2#2)(1995-3#5)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#3)(1996-2#4)(1996-3#4)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-6#2)(1997-7#7)(1997-8#1)(2007-10#6)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#6)(2007-5#2)(2007-7#1)(2008-1#10)(2008-10#41)(2008-11#30)(2008-12#24)(2008-2#2)(2008-3#4)(2008-4#19)(2008-5#9)(2008-6#6)(2008-7#15)(2008-8#1)(2008-9#15)(2009-11#2)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#8)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#14)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#7)(2010-6#5)(2010-7#3)(2010-8#2)(2010-9#8)(2011-1#9)(2011-2#28)(2012-12#11)(2012-2#14)(2012-3#11)(2013-1#19)(2013-7#8)(2013-8#7)
practices--the##2##1##(1996-5#1)(2008-1#1)
practices]##2##1##(1993-6#1)(2008-9#1)
practicing community pharmacists##3##3##(2010-5#3)
practicing health care##2##3##(1995-2#1)(1996-1#1)
practicing in##2##2##(2013-7#1)(2013-8#1)
practicing physician##2##2##(1996-3#1)(2010-9#1)
practicing physicians##3##2##(1992-12#1)(1996-1#1)(2008-6#1)
practicing##35##1##(1990-6#1)(1992-1#2)(1992-12#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
practicum##9##1##(1992-2#2)(1995-12#2)(1996-1#5)
practicums##3##1##(1995-12#1)(1997-3#1)(2008-12#1)
practise##10##1##(1994-12#1)(1994-2#1)(1997-5#1)(2007-11#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
practised by##2##2##(1994-12#2)
practised in##2##2##(2009-10#1)(2013-8#1)
practised##12##1##(1991-8#2)(1993-11#1)(1994-12#2)(1997-6#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-6#1)(2010-6#1)(2013-8#1)
practises##3##1##(1996-1#2)(2010-6#1)
practising physicians##2##2##(1995-11#1)(1996-9#1)
practising##16##1##(1993-1#5)(1993-12#1)(1995-11#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-5#1)(2012-1#1)(2013-1#1)
practitioner and the##2##3##(1995-3#1)(1996-3#1)
practitioner and##13##2##(1991-1#1)(1992-3#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-1#2)(2008-11#4)(2008-12#1)
practitioner has##2##2##(1995-11#1)(2008-7#1)
practitioner in##13##2##(1990-2#1)(1992-12#1)(1993-11#1)(1993-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-9#1)(2010-10#1)
practitioner is##3##2##(1994-1#1)(1995-11#1)(2008-11#1)
practitioner more##2##2##(1992-5#1)(2008-7#1)
practitioner to##2##2##(1994-2#1)(2008-11#1)
practitioner##104##1##(1990-11#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#4)(1996-8#2)(1996-9#1)(1997-4#5)(1997-7#1)(2007-11#5)(2008-1#5)(2008-10#2)(2008-11#17)(2008-12#9)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
practitioner's perspective of##2##3##(1991-1#1)(2008-7#1)
practitioner's perspective##3##2##(1991-1#1)(1996-3#1)(2008-7#1)
practitioner's role##3##2##(1990-10#1)(1997-1#1)(2008-1#1)
practitioner's##14##1##(1990-10#1)(1990-9#1)(1991-1#2)(1991-4#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-7#1)
practitioner-teacher model##3##2##(1991-12#3)
practitioners (GPs)##6##2##(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
practitioners and a##3##3##(1997-4#2)(2013-8#1)
practitioners and educationalists##3##3##(2008-11#3)
practitioners and other##2##3##(2007-12#1)(2010-7#1)
practitioners and the##4##3##(1991-8#1)(1997-4#1)(2007-12#1)(2010-10#1)
practitioners and those##2##3##(2008-7#1)(2010-10#1)
practitioners and##38##2##(1991-1#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#2)(1994-11#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#4)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-10#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
practitioners are required##2##3##(1993-3#1)(2010-8#1)
practitioners are##9##2##(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
practitioners can##3##2##(1991-12#1)(1995-9#1)(2008-11#1)
practitioners consider##2##2##(1993-2#1)(2008-10#1)
practitioners do##2##2##(1994-6#1)(2008-12#1)
practitioners during##2##2##(1991-12#1)(2008-11#1)
practitioners for##3##2##(2007-2#2)(2009-6#1)
practitioners from##4##2##(1993-3#1)(1994-6#1)(2008-1#1)(2008-9#1)
practitioners had##3##2##(1993-2#1)(2008-10#1)(2011-1#1)
practitioners have##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
practitioners in the health##2##4##(1994-3#1)(2008-12#1)
practitioners in the##11##3##(1994-2#1)(1994-3#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2013-1#1)
practitioners in##31##2##(1991-9#1)(1993-2#1)(1994-2#1)(1994-3#4)(1994-6#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2012-12#1)(2013-1#3)
practitioners involved##3##2##(1995-8#1)(2008-9#1)(2013-8#1)
practitioners may be##2##3##(2008-5#1)(2011-1#1)
practitioners must##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
practitioners of##9##2##(1996-3#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2012-12#2)
practitioners on the##2##3##(1994-11#1)(2008-9#1)
practitioners on##3##2##(1994-11#1)(2008-9#2)
practitioners regarding##2##2##(2010-5#1)(2011-2#1)
practitioners should##2##2##(2012-3#1)(2013-8#1)
practitioners to develop##2##3##(2008-12#1)(2010-9#1)
practitioners to understand##3##3##(2009-9#1)(2010-10#1)(2010-4#1)
practitioners to##23##2##(1992-4#1)(1993-12#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-8#1)
practitioners were willing to##2##4##(2008-1#1)(2008-8#1)
practitioners were##6##2##(1993-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
practitioners who##4##2##(1996-9#1)(1997-8#1)(2008-11#1)(2010-12#1)
practitioners with the##2##3##(2008-1#1)(2011-2#1)
practitioners with##4##2##(1993-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
practitioners##316##1##(1990-2#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#14)(1993-3#2)(1993-6#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#5)(1994-6#4)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-3#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#7)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#10)(1997-5#2)(1997-6#4)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#6)(2007-4#2)(2007-5#1)(2008-1#12)(2008-10#19)(2008-11#33)(2008-12#22)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#2)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#12)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#4)
practitioners' knowledge##2##2##(2008-8#1)(2009-6#1)
practitioners'##12##1##(1990-11#1)(1996-9#1)(1997-3#1)(1997-8#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-6#1)
practitioners?##2##1##(1991-11#1)(2013-1#1)
pragmatic and explanatory##2##3##(2008-7#1)(2009-3#1)
pragmatic and##3##2##(2008-7#1)(2009-3#1)(2010-1#1)
pragmatic approach to##2##3##(1994-2#1)(2012-3#1)
pragmatic approach##3##2##(1994-2#1)(2011-2#1)(2012-3#1)
pragmatic way##2##2##(2008-3#1)(2012-3#1)
pragmatic##25##1##(1993-3#1)(1994-2#1)(1995-1#1)(2008-11#2)(2008-12#4)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#2)(2011-2#2)(2012-3#3)(2013-1#2)
pragmatics##3##1##(2008-11#1)(2008-9#1)(2010-4#1)
prairie and aspen forest##2##4##(2008-9#2)
prairie and forest##3##3##(2008-8#1)(2008-9#2)
prairie and##6##2##(2008-8#2)(2008-9#4)
prairie voles did##2##3##(2008-9#2)
prairie voles##4##2##(2008-9#4)
prairie##17##1##(2008-8#3)(2008-9#14)
praise##2##1##(1992-12#1)(2013-8#1)
praised##2##1##(2008-11#1)(2013-1#1)
prajmaline##3##1##(1996-3#3)
praseodymium (Pr)##2##2##(2007-12#1)(2012-2#1)
praseodymium in the##2##3##(2008-10#2)
praseodymium in##4##2##(2008-10#4)
praseodymium##11##1##(2007-12#1)(2008-10#8)(2008-2#1)(2012-2#1)
prasinoviruses##3##1##(2013-1#3)
pratensis##4##1##(2008-5#4)
pratissolii##6##1##(2008-6#6)
pravastatin and gemfibrozil##2##3##(2011-1#2)
pravastatin and##3##2##(1991-6#1)(2011-1#2)
pravastatin##5##1##(1991-6#1)(2008-5#2)(2011-1#2)
prawn##4##1##(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
prawns##2##1##(2008-5#1)(2008-8#1)
praxis of##2##2##(2008-11#2)
praxis##8##1##(2008-11#2)(2009-6#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#1)
prayer##5##1##(2008-1#1)(2008-12#3)(2010-10#1)
praying##4##1##(2008-12#4)
prazepam##5##1##(2008-10#5)
praziquantel or oxamniquine##4##3##(2010-12#4)
praziquantel##14##1##(1995-12#1)(1996-12#2)(2010-12#5)(2012-3#6)
prazosin and##2##2##(2008-4#1)(2013-1#1)
prazosin##7##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(2008-4#1)(2013-1#1)
pre and post##9##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-3#1)(2012-3#1)
pre and##13##2##(1994-12#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-3#1)(2012-3#1)
pre malignant##2##2##(2008-7#1)(2009-6#1)
pre or##2##2##(2007-5#1)(2012-3#1)
pre##23##1##(1990-8#1)(1994-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-8#1)
pre- and post##2##3##(1990-5#1)(1996-3#1)
pre- and post-dialysis##3##3##(2008-1#3)
pre- and post-emergence##3##3##(2008-10#2)(2013-8#1)
pre- and post-intervention##6##3##(2007-12#1)(2008-12#3)(2011-2#1)(2013-1#1)
pre- and post-operative##4##3##(1990-9#1)(1991-5#1)(2007-11#2)
pre- and post-test##4##3##(1993-1#1)(1994-1#1)(1996-5#1)(2013-1#1)
pre- and post-treatment##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
pre- and postintervention##3##3##(2010-7#1)(2013-1#2)
pre- and postnatal##6##3##(1991-9#1)(1993-3#1)(1996-5#1)(2008-2#1)(2012-2#2)
pre- and postoperative##5##3##(1994-2#1)(2008-7#2)(2012-12#2)
pre- and postoperatively##2##3##(2007-8#1)(2008-9#1)
pre- and postsynaptic##8##3##(1990-12#1)(1995-12#1)(2009-5#1)(2009-8#2)(2009-9#2)(2012-12#1)
pre- and##86##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#2)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#2)
pre- and/or##2##2##(1990-6#1)(2008-6#1)
pre- or post-QQc cells##2##4##(2012-12#2)
pre- or##5##2##(1993-11#1)(1997-7#1)(2008-4#1)(2012-12#2)
pre- to post-intervention##3##3##(2008-12#3)
pre- to##10##2##(1992-12#1)(1994-2#1)(2007-8#1)(2008-12#6)(2012-2#1)
pre-##113##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#2)(2009-9#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#14)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#2)
pre-B cell##3##2##(1991-2#1)(1991-5#1)(2008-4#1)
pre-B##5##1##(1991-2#2)(1991-5#1)(1994-10#1)(2008-4#1)
pre-Columbian##2##1##(2008-7#1)(2012-3#1)
pre-EVAR iliac artery embolisation##2##4##(2012-2#2)
pre-I group##3##2##(2009-3#3)
pre-LT##3##1##(2011-3#3)
pre-PPS##2##1##(1991-2#1)(1992-2#1)
pre-QQc cells##2##2##(2012-12#2)
pre-activated##3##1##(2008-10#2)(2008-8#1)
pre-aligned with the##2##3##(2008-10#2)
pre-aligned##4##1##(2008-10#4)
pre-analytical##3##1##(2007-7#1)(2010-9#1)(2013-1#1)
pre-and post-treatment regimens##2##3##(2013-1#2)
pre-arthritic deformities##2##2##(1997-6#2)
pre-beta-lactamase##4##1##(1992-3#4)
pre-case biosurveillance##2##2##(2010-8#2)
pre-certification##2##1##(1991-2#1)(2009-4#1)
pre-clinical and clinical##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
pre-clinical and##4##2##(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
pre-clinical models of##3##3##(2008-8#1)(2009-4#2)
pre-clinical models##4##2##(2008-8#1)(2009-4#2)(2011-2#1)
pre-clinical studies##4##2##(1994-11#1)(2008-1#1)(2008-5#1)(2011-2#1)
pre-clinical validation##2##2##(2009-7#2)
pre-clinical##25##1##(1994-11#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-7#2)(2009-9#1)(2011-2#2)(2013-1#4)(2013-8#1)
pre-coating##3##1##(2008-10#1)(2013-1#2)
pre-column and##2##2##(2008-10#2)
pre-column chelating reagent for##2##4##(2008-10#2)
pre-column chelating##3##2##(2008-10#3)
pre-column derivatization with##2##3##(2008-10#1)(2011-1#1)
pre-column derivatization##8##2##(2008-10#6)(2011-1#2)
pre-column fluorescence derivatization##3##3##(1997-2#1)(2008-10#2)
pre-column##22##1##(1997-2#1)(2008-10#19)(2011-1#2)
pre-competitive season##2##2##(2008-5#2)
pre-concentrated##2##1##(2008-10#2)
pre-concentrating##3##1##(2008-10#3)
pre-concentration and##12##2##(2008-10#12)
pre-concentration factor of##2##3##(2008-10#2)
pre-concentration factor##6##2##(2008-10#6)
pre-concentration in##3##2##(2008-10#3)
pre-concentration of mercury##2##3##(2008-10#2)
pre-concentration of selenite##2##3##(2008-10#2)
pre-concentration of the##3##3##(2008-10#3)
pre-concentration of##19##2##(2008-10#19)
pre-concentration procedure##3##2##(2008-10#3)
pre-concentration step##3##2##(2008-10#3)
pre-concentration time##2##2##(2008-10#2)
pre-concentration with##2##2##(2008-10#2)
pre-concentration##73##1##(2008-10#72)(2010-5#1)
pre-condition for##2##2##(2007-8#1)(2012-2#1)
pre-contact##2##1##(2009-9#2)
pre-contrast##2##1##(1997-8#1)(2012-2#1)
pre-curved elastic tubes##2##3##(2012-1#1)(2012-2#1)
pre-defined##3##1##(2008-3#1)(2011-2#1)(2012-1#1)
pre-denuded group##3##2##(2013-1#3)
pre-denuded##4##1##(2013-1#4)
pre-departure##2##1##(2007-2#1)(2011-2#1)
pre-determined##6##1##(1995-6#1)(1995-9#1)(2007-6#1)(2008-5#1)(2010-6#1)(2011-2#1)
pre-dialysis##2##1##(2011-2#2)
pre-dialytic##4##1##(2011-2#4)
pre-ecdysis##4##1##(2008-7#4)
pre-eclampsia is##3##2##(2008-4#1)(2008-6#1)(2011-2#1)
pre-eclampsia##24##1##(1995-2#1)(1997-3#1)(2008-4#1)(2008-6#1)(2011-2#18)(2013-1#1)(2013-8#1)
pre-embedding##3##1##(1990-8#2)(1994-2#1)
pre-emergence##2##1##(2008-10#1)(2013-8#1)
pre-employment testing##3##2##(1996-2#1)(1997-1#2)
pre-employment##4##1##(1996-2#1)(1997-1#2)(2011-2#1)
pre-emptive culling##2##2##(2011-3#2)
pre-emptive services that##2##3##(2009-6#2)
pre-emptive treatment with##2##3##(1993-12#1)(2009-7#1)
pre-emptive##11##1##(1993-12#1)(2008-7#1)(2009-6#2)(2009-7#1)(2011-2#2)(2011-3#2)(2012-2#2)
pre-end stage renal disease##3##4##(2008-1#3)
pre-end stage renal##4##3##(2008-1#4)
pre-established##2##1##(2008-11#1)(2013-1#1)
pre-exercise##2##1##(1991-12#1)(2008-5#1)
pre-existent##2##1##(1991-4#1)(2011-2#1)
pre-existing and##2##2##(1996-3#1)(2011-2#1)
pre-existing##43##1##(1990-2#1)(1991-5#1)(1991-8#1)(1992-12#2)(1993-12#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-11#3)(2010-12#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#3)
pre-experimental values##2##2##(2011-2#2)
pre-experimental##3##1##(2011-2#3)
pre-exponential##2##1##(1996-7#1)(2008-4#1)
pre-exposed to##2##2##(1995-12#1)(2008-1#1)
pre-exposure prophylaxis##3##2##(2012-2#1)(2013-1#2)
pre-exposure##8##1##(1990-7#1)(1992-11#1)(1996-2#1)(2007-12#2)(2012-2#1)(2013-1#2)
pre-harvest application of##2##3##(2011-2#2)
pre-heated##2##1##(2008-10#1)(2008-5#1)
pre-hospital##2##1##(1991-2#1)(2008-1#1)
pre-implant##3##1##(2008-9#2)(2012-2#1)
pre-implantation##3##1##(1996-12#1)(2008-8#1)(2008-9#1)
pre-incubated##3##1##(1990-12#1)(2008-4#1)(2009-7#1)
pre-incubation of the cells with##2##5##(1993-9#2)
pre-incubation of##3##2##(1993-9#2)(2008-12#1)
pre-incubation with##3##2##(1993-9#1)(2008-4#2)
pre-incubation##7##1##(1993-9#3)(1995-11#1)(2008-12#1)(2008-4#2)
pre-infection##2##1##(2008-10#1)(2008-11#1)
pre-injection baseline##2##2##(1995-12#1)(1995-5#1)
pre-injection##4##1##(1995-12#1)(1995-5#1)(2010-12#2)
pre-intervention AROM##2##2##(2008-12#2)
pre-ischemic##2##1##(2008-12#1)(2009-12#1)
pre-karyote##7##1##(2009-6#7)
pre-karyotes##2##1##(2009-6#2)
pre-lingual##2##1##(2008-9#2)
pre-lingually deaf children##2##3##(2008-9#2)
pre-lingually##3##1##(2008-9#3)
pre-load##2##1##(1991-5#1)(2012-2#1)
pre-loading##2##1##(1995-8#1)(2010-2#1)
pre-mRNA splicing##4##2##(1991-9#1)(2008-4#1)(2008-8#1)(2009-7#1)
pre-mRNA##15##1##(1991-9#5)(1993-8#3)(1995-6#2)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
pre-mRNAs containing##2##2##(1993-6#2)
pre-mRNAs##4##1##(1993-6#2)(2007-12#2)
pre-malignant##5##1##(1994-2#3)(2008-2#1)(2011-2#1)
pre-maxilla##2##1##(2013-1#2)
pre-migration environmental stress##2##3##(2011-2#2)
pre-mix##3##1##(2008-10#3)
pre-mixed##2##1##(2012-2#1)(2013-8#1)
pre-morbid##3##1##(2008-7#1)(2009-2#2)
pre-natal##2##1##(2008-1#1)(2012-3#1)
pre-normative research##2##2##(2008-10#2)
pre-op discharge planning and pre-emptive pain and nausea management##2##9##(2012-2#2)
pre-operative chemotherapy##3##2##(2008-6#1)(2008-8#1)(2013-1#1)
pre-operative radiotherapy and##2##3##(2008-12#2)
pre-operative##29##1##(1991-3#1)(1995-12#1)(1997-6#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-8#2)(2008-9#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#3)(2013-1#3)
pre-operatively and##2##2##(1996-3#1)(2008-1#1)
pre-operatively##9##1##(1996-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
pre-ovulatory##4##1##(1991-9#3)(2011-1#1)
pre-oxidized##2##1##(2008-10#2)
pre-parietal##5##1##(1995-6#5)
pre-peritoneal##5##1##(1992-5#2)(1993-9#1)(2012-12#2)
pre-plant##5##1##(2008-10#5)
pre-post##2##1##(2008-6#1)(2011-2#1)
pre-pregnancy##3##1##(1990-9#1)(1997-7#1)(2011-1#1)
pre-procedure##2##1##(1993-3#1)(2011-2#1)
pre-processing##4##1##(2008-10#2)(2008-7#1)(2013-8#1)
pre-prosthetic##3##1##(1990-5#1)(2013-1#2)
pre-pyloric site gastric cancer after PPG##2##6##(2008-12#2)
pre-qualification##2##1##(2008-11#2)
pre-reduced##4##1##(2008-10#4)
pre-reducing##4##1##(2008-10#4)
pre-reduction coil##2##2##(2008-10#1)(2009-6#1)
pre-reduction of pentavalent arsenicals##3##4##(2009-6#3)
pre-reduction of##7##2##(2008-10#4)(2009-6#3)
pre-reduction step##2##2##(2008-10#2)
pre-reduction##17##1##(2008-10#10)(2009-6#7)
pre-reflective self##5##2##(2008-11#5)
pre-registration diploma##2##2##(2008-11#1)(2008-12#1)
pre-registration education##2##2##(2008-11#2)
pre-registration nursing programmes##2##3##(2008-11#2)
pre-registration nursing student##2##3##(2008-11#1)(2008-12#1)
pre-registration nursing students##3##3##(2008-11#3)
pre-registration nursing students'##4##3##(2008-11#3)(2008-12#1)
pre-registration nursing##15##2##(2008-11#13)(2008-12#2)
pre-registration programmes##2##2##(2008-11#2)
pre-registration student##2##2##(2008-11#2)
pre-registration##37##1##(2008-11#31)(2008-12#5)(2012-3#1)
pre-ruminant##2##1##(2012-2#2)
pre-school children##3##2##(2008-9#1)(2011-2#2)
pre-school##5##1##(1996-1#1)(2008-1#1)(2008-9#1)(2011-2#2)
pre-selected##4##1##(1992-1#1)(1997-3#1)(2008-10#1)(2008-5#1)
pre-separation##6##1##(1996-5#1)(2008-10#5)
pre-slaughter handling##2##2##(2011-1#2)
pre-slaughter##3##1##(2011-1#3)
pre-stage salivary##2##2##(2013-8#2)
pre-stimulated with##2##2##(2008-11#2)
pre-stimulated##3##1##(1990-12#1)(2008-11#2)
pre-surgical##2##1##(2011-2#1)(2013-1#1)
pre-term infants could##2##3##(1995-8#2)
pre-term infants##6##2##(1995-8#6)
pre-term##7##1##(1995-8#6)(2011-1#1)
pre-test and##2##2##(1996-1#1)(2008-11#1)
pre-test##7##1##(1996-1#2)(1996-5#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
pre-tested##4##1##(2008-11#1)(2011-1#2)(2013-8#1)
pre-training##3##1##(2008-6#1)(2010-8#2)
pre-transplant##3##1##(2008-10#1)(2012-2#2)
pre-travel##6##1##(2007-2#4)(2011-2#2)
pre-treated with 2##2##3##(2008-10#2)
pre-treated with##11##2##(1993-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-12#1)(2012-2#1)
pre-treated##16##1##(1990-6#1)(1993-12#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#1)
pre-treatment and##5##2##(2008-10#5)
pre-treatment baseline##2##2##(2010-9#1)(2012-3#1)
pre-treatment by##2##2##(2008-10#2)
pre-treatment for##2##2##(2008-10#1)(2010-5#1)
pre-treatment measurements##3##2##(2012-1#3)
pre-treatment methods##2##2##(2008-10#1)(2013-1#1)
pre-treatment of the sample##3##4##(2008-10#3)
pre-treatment of the samples##2##4##(2008-10#2)
pre-treatment of the##7##3##(1996-12#1)(2008-10#6)
pre-treatment of##8##2##(1996-12#1)(2008-10#6)(2008-4#1)
pre-treatment or##2##2##(2008-10#2)
pre-treatment process##2##2##(2008-10#1)(2008-6#1)
pre-treatment regimen##2##2##(2008-7#1)(2013-1#1)
pre-treatment was##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
pre-treatment with ozone##2##3##(2008-10#2)
pre-treatment with##12##2##(1991-9#1)(1996-12#1)(2008-10#7)(2009-6#1)(2011-2#2)
pre-treatment##83##1##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-9#1)(1996-12#2)(2008-1#1)(2008-10#44)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-5#2)(2010-9#1)(2011-2#4)(2012-1#4)(2012-3#1)(2013-1#8)
pre-treatments of##2##2##(2008-10#1)(2013-1#1)
pre-treatments##7##1##(2008-10#4)(2013-1#3)
pre-warmed##2##1##(2008-8#2)
pre-zymogenic##2##1##(1995-6#2)
preAD##3##1##(2009-10#3)
preS##2##1##(1993-8#2)
preS1 peptide##3##2##(1994-8#3)
preS1##8##1##(1993-8#3)(1994-8#4)(2008-8#1)
preS2##9##1##(1993-8#3)(1997-6#4)(2008-8#2)
preZad##4##1##(1991-10#4)
preabsorbed with##2##2##(1995-12#1)(1996-12#1)
preabsorbed##3##1##(1995-12#1)(1996-12#1)(2008-4#1)
preactivated conidia##2##2##(2008-10#2)
preactivated##5##1##(1990-5#1)(2008-10#4)
preadapted##3##1##(2008-11#3)
preadipocyte##3##1##(1990-12#1)(2008-11#1)(2008-3#1)
preadipocytes and adipocytes##3##3##(1993-6#2)(2008-3#1)
preadipocytes and##5##2##(1993-6#2)(2008-3#1)(2008-5#2)
preadipocytes##15##1##(1990-12#1)(1992-9#1)(1993-6#2)(2008-11#1)(2008-3#3)(2008-5#7)
preadipose cells##2##2##(1992-9#2)
preadipose##4##1##(1992-9#4)
preadmission telephone call on the day before surgery to initiate##2##10##(2008-8#2)
preadmission telephone call on the day before surgery##3##8##(2008-8#3)
preadmission telephone call##4##3##(2008-8#4)
preadmission##5##1##(1997-2#1)(2008-8#4)
preadult##2##1##(2008-8#1)(2008-9#1)
prealbumin##3##1##(2008-5#2)(2011-2#1)
prealignment##2##1##(2007-12#1)(2008-2#1)
preamplification (PEP)##2##2##(2008-4#2)
preamplification##4##1##(2007-12#2)(2008-4#2)
preamplifier##3##1##(2007-12#1)(2010-8#2)
preamplifiers##2##1##(2007-11#1)(2010-8#1)
preantral and antral follicles##2##4##(2008-8#2)
preantral and##3##2##(2008-8#3)
preantral##4##1##(2008-8#3)(2008-9#1)
preapheresis##2##1##(1994-12#1)(2011-2#1)
prebiotic ingredients##2##2##(2012-2#2)
prebiotic##4##1##(1995-11#2)(2012-2#2)
prebiotics##2##1##(2008-8#1)(2011-2#1)
prebleaching##2##1##(2008-6#2)
prebloom##6##1##(2008-10#6)
prebottleneck##2##1##(2008-9#2)
prebypass##3##1##(1990-2#1)(2007-8#2)
precancer and cancer of the##2##5##(2008-11#2)
precancer and##3##2##(2008-11#2)(2011-1#1)
precancer##5##1##(2008-11#2)(2011-1#2)(2013-1#1)
precancerous and cancerous##2##3##(1990-6#1)(2008-5#1)
precancerous cervical lesions##2##3##(2008-4#1)(2012-2#1)
precancerous lesions and##3##3##(2011-2#2)(2012-3#1)
precancerous lesions##13##2##(1994-5#1)(2008-2#1)(2011-2#3)(2011-3#7)(2012-3#1)
precancerous##21##1##(1990-6#1)(1994-2#1)(1994-5#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#4)(2011-3#7)(2012-2#1)(2012-3#1)
precarious##10##1##(1991-12#1)(2008-6#1)(2008-9#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
precariousness##2##1##(2013-1#2)
precaution##2##1##(1996-3#1)(2012-3#1)
precautionary measures##4##2##(1991-1#1)(1992-2#1)(2012-3#1)(2013-1#1)
precautionary##5##1##(1991-1#1)(1992-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
precautions and##3##2##(1992-3#1)(2007-7#1)(2008-7#1)
precautions are taken##3##3##(2008-10#1)(2009-11#1)(2013-1#1)
precautions are##6##2##(1993-2#1)(1995-2#1)(2008-10#1)(2009-11#1)(2010-3#1)(2013-1#1)
precautions for##3##2##(2007-2#1)(2009-5#1)(2010-8#1)
precautions must be taken to##2##5##(1992-3#1)(2008-9#1)
precautions must be##3##3##(1992-3#1)(2008-9#1)(2010-3#1)
precautions needed to##2##3##(2008-10#1)(2008-12#1)
precautions should##2##2##(1992-2#1)(1993-2#1)
precautions with##2##2##(2007-2#1)(2008-3#1)
precautions##49##1##(1991-12#3)(1991-5#2)(1991-8#1)(1992-2#1)(1992-3#2)(1993-2#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#2)(2007-2#3)(2007-7#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#7)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
precede the development of##3##4##(2008-1#1)(2008-10#2)
precede the onset of##2##4##(2006-10#1)(2013-8#1)
precede the##9##2##(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-1#1)(2013-8#1)
precede##27##1##(1991-5#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
preceded by a period of##2##5##(2008-10#1)(2010-8#1)
preceded by a##14##3##(1990-2#1)(1991-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
preceded by an##2##3##(1995-8#1)(2011-2#1)
preceded by the##5##3##(1991-9#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-8#1)
preceded by##38##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#2)(1996-4#1)(1997-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
preceded the admission of##2##4##(1991-2#2)
preceded the##14##2##(1990-7#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-11#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-3#1)(2009-8#1)
preceded those##2##2##(1991-5#1)(2008-11#1)
preceded##69##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#2)(1997-1#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-8#2)
precedence##5##1##(1994-1#1)(2008-8#2)(2008-9#1)(2012-12#1)
precedent##4##1##(1995-12#1)(1995-5#1)(2008-12#1)(2013-1#1)
precedents##2##1##(1996-3#1)(2007-11#1)
precedes and##2##2##(2008-10#1)(2008-7#1)
precedes the##8##2##(1990-11#1)(1990-12#1)(1992-11#1)(1993-2#1)(1995-3#1)(2008-2#1)(2011-2#2)
precedes##22##1##(1990-11#1)(1990-12#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#3)(2011-2#4)(2012-12#1)(2012-3#1)
preceding a##4##2##(1993-12#1)(2008-10#1)(2009-12#1)(2012-12#1)
preceding and following##3##3##(1997-4#1)(2008-2#1)(2008-5#1)
preceding and##4##2##(1992-6#1)(1997-4#1)(2008-2#1)(2008-5#1)
preceding article##3##2##(1992-1#2)(1992-3#1)
preceding paper##2##2##(1993-12#1)(1995-11#1)
preceding the posttreatment PET study##2##5##(1996-5#2)
preceding the##17##2##(1990-11#1)(1990-3#1)(1991-6#1)(1991-9#1)(1992-5#2)(1995-6#1)(1996-3#1)(1996-5#2)(1996-8#1)(2007-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
preceding##83##1##(1990-11#2)(1990-3#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#4)(1992-9#1)(1993-12#2)(1993-2#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#4)(1996-6#2)(1996-8#1)(1997-4#3)(1997-5#1)(1997-6#1)(2007-10#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
preceeding##2##1##(1993-3#1)(1994-12#1)
preceeds##2##1##(1996-2#1)(1996-5#1)
preceptors##4##1##(1994-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
preceptorship within the workplace##2##4##(2008-11#2)
preceptorship##4##1##(2008-11#4)
precession##9##1##(2008-11#7)(2008-3#1)(2010-8#1)
prechecklist##2##1##(2013-1#2)
prechirped##2##1##(2007-11#1)(2007-12#1)
precious metal ions##2##3##(2008-10#2)
precious metal##6##2##(2008-10#6)
precious metals in##2##3##(2008-10#2)
precious metals##5##2##(2008-10#5)
precious##18##1##(1990-6#1)(1994-8#1)(2008-10#14)(2008-6#1)(2009-2#1)
precipitable##3##1##(1994-6#1)(2008-2#2)
precipitant##8##1##(2008-10#3)(2008-3#2)(2008-8#2)(2011-1#1)
precipitate and##2##2##(2008-10#1)(2008-9#1)
precipitate by##2##2##(2008-10#1)(2013-1#1)
precipitate formation##2##2##(2008-10#2)
precipitate is##5##2##(2008-10#4)(2008-4#1)
precipitate of##4##2##(2008-10#3)(2008-11#1)
precipitate that##4##2##(2008-1#2)(2008-2#2)
precipitate was##7##2##(2008-10#7)
precipitate with##3##2##(2008-10#3)
precipitate##67##1##(1991-11#1)(1993-2#1)(1993-8#1)(1996-2#2)(1996-3#1)(2008-1#3)(2008-10#36)(2008-11#2)(2008-2#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
precipitated and##3##2##(2008-10#2)(2008-6#1)
precipitated at##2##2##(1997-4#1)(2008-10#1)
precipitated by a##3##3##(1993-6#1)(2008-5#1)(2013-8#1)
precipitated by the##2##3##(1996-12#1)(2008-9#1)
precipitated by##14##2##(1990-12#1)(1991-3#1)(1993-6#1)(1994-1#2)(1996-12#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#2)(2012-2#1)(2013-8#1)
precipitated from the##2##3##(2008-10#1)(2008-4#1)
precipitated from##3##2##(1990-11#1)(2008-10#1)(2008-4#1)
precipitated in##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
precipitated polysaccharides##2##2##(2013-1#2)
precipitated with##5##2##(1991-5#1)(2007-11#1)(2008-10#2)(2008-11#1)
precipitated##55##1##(1990-11#2)(1990-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-6#1)(1994-1#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-4#2)(2012-2#1)(2013-1#6)(2013-8#1)
precipitates and##3##2##(2008-10#2)(2013-8#1)
precipitates were##5##2##(2008-10#5)
precipitates##33##1##(1994-11#1)(1996-12#1)(2007-11#2)(2008-10#26)(2012-1#1)(2013-1#1)(2013-8#1)
precipitating agents##2##2##(2008-6#2)
precipitating factor##2##2##(2009-11#1)(2012-3#1)
precipitating factors##6##2##(1990-11#1)(2008-1#1)(2010-10#3)(2011-2#1)
precipitating the##2##2##(2008-10#1)(2008-4#1)
precipitating##27##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-6#3)(2008-9#1)(2009-11#1)(2010-10#3)(2010-11#1)(2011-2#1)(2012-3#1)
precipitation F(ab')2 anti-C3 ELISA##2##4##(1990-12#2)
precipitation and##21##2##(1991-9#1)(1993-3#1)(2008-10#10)(2008-3#1)(2008-4#2)(2008-8#4)(2010-4#1)(2011-3#1)
precipitation at##2##2##(2007-7#1)(2008-10#1)
precipitation events##5##2##(2008-10#5)
precipitation from##3##2##(1997-6#1)(2008-10#2)
precipitation is##4##2##(1997-6#1)(2008-10#2)(2008-7#1)
precipitation of alpha-lactalbumin##2##3##(2008-7#2)
precipitation of the##6##3##(1994-6#1)(2008-10#3)(2008-2#1)(2008-5#1)
precipitation of##33##2##(1990-2#1)(1994-6#1)(1995-5#2)(1996-2#1)(2008-1#1)(2008-10#18)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-7#1)(2012-5#1)(2013-1#1)
precipitation patterns##2##2##(2008-10#1)(2012-5#1)
precipitation reaction of##3##3##(2008-10#3)
precipitation reaction##4##2##(2008-10#4)
precipitation step##2##2##(1994-6#1)(2008-7#1)
precipitation to##2##2##(2008-11#1)(2008-9#1)
precipitation using ethanol##2##3##(2008-6#1)(2008-8#1)
precipitation using##4##2##(2008-10#2)(2008-6#1)(2008-8#1)
precipitation was##2##2##(2008-10#1)(2008-11#1)
precipitation were##4##2##(2008-10#3)(2009-7#1)
precipitation with ammonium##2##3##(1990-11#1)(1992-8#1)
precipitation with##8##2##(1990-11#1)(1992-8#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
precipitation##184##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-7#2)(1991-9#1)(1992-11#1)(1992-8#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-3#1)(1997-6#2)(2007-7#1)(2008-1#1)(2008-10#90)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#6)(2008-7#9)(2008-8#10)(2008-9#2)(2009-11#2)(2009-7#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-5#2)(2013-1#3)(2013-7#1)
precipitation-dissolution##4##1##(2008-10#4)
precipitation/dissolution##4##1##(2008-10#4)
precipitations##3##1##(1992-12#1)(2008-10#1)(2008-6#1)
precipitator##5##1##(2008-10#5)
precipitous decrease in##2##3##(1995-2#1)(2007-9#1)
precipitous##4##1##(1995-2#2)(2007-9#1)(2013-1#1)
precise alignment##2##2##(2007-11#1)(2008-2#1)
precise and accurate##12##3##(2008-10#11)(2012-2#1)
precise and rapid##2##3##(2008-10#1)(2010-5#1)
precise and reproducible##3##3##(1994-2#1)(2008-10#1)(2010-5#1)
precise and##37##2##(1992-12#1)(1994-2#1)(1995-2#1)(1997-5#1)(1997-7#1)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
precise assessment of##2##3##(1994-2#1)(2008-10#1)
precise clinical##2##2##(2007-11#1)(2008-7#1)
precise control of the##2##4##(2008-7#1)(2008-9#1)
precise control of##4##3##(1995-1#1)(2008-7#1)(2008-9#1)(2012-12#1)
precise control##8##2##(1995-1#1)(2008-7#4)(2008-9#1)(2010-5#1)(2012-12#1)
precise criteria##2##2##(2008-2#1)(2008-9#1)
precise delivery##3##2##(2008-10#2)(2010-5#1)
precise description of##2##3##(2008-10#1)(2013-8#1)
precise determination of the##4##4##(2007-11#1)(2008-10#1)(2008-2#2)
precise determination of##11##3##(1990-8#1)(2007-11#2)(2008-10#6)(2008-2#2)
precise determination##12##2##(1990-8#1)(2007-11#2)(2008-10#6)(2008-2#2)(2012-3#1)
precise diagnosis and##3##3##(1992-5#1)(2007-11#1)(2013-1#1)
precise diagnosis##8##2##(1992-5#1)(1993-9#1)(2007-11#1)(2007-7#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)
precise estimates##2##2##(1994-11#1)(2012-3#1)
precise etiology of##2##3##(2008-7#1)(2009-12#1)
precise etiology##3##2##(2008-7#1)(2009-12#1)(2012-3#1)
precise evaluation of##4##3##(1994-12#1)(2007-11#1)(2008-2#1)(2011-7#1)
precise for##2##2##(2008-10#1)(2012-2#1)
precise function##4##2##(1994-5#1)(1995-8#1)(1997-3#2)
precise functional role##2##3##(1994-8#1)(2012-2#1)
precise identification##2##2##(2007-8#1)(2010-7#1)
precise imaging in regions where the##2##6##(2008-3#2)
precise imaging##4##2##(2008-3#3)(2012-2#1)
precise individual##3##2##(1996-2#1)(2008-10#2)
precise knowledge of the##2##4##(2008-2#1)(2008-3#1)
precise localisation##2##2##(1991-3#1)(2011-2#1)
precise localization of##4##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
precise localization##5##2##(1993-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
precise manner##2##2##(2008-11#1)(2008-3#1)
precise map##2##2##(1993-9#2)
precise measurement of the##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
precise measurement of##6##3##(1991-8#1)(2007-11#2)(2007-12#1)(2008-3#2)
precise measurement##8##2##(1991-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2010-7#1)
precise measurements##4##2##(1990-11#1)(2008-11#1)(2008-3#1)(2008-6#1)
precise mechanism of action##2##4##(2008-1#1)(2008-10#1)
precise mechanism of##3##3##(2008-1#1)(2008-10#1)(2010-8#1)
precise mechanism##5##2##(2008-1#1)(2008-10#1)(2008-9#2)(2010-8#1)
precise mechanisms##4##2##(2008-9#1)(2010-7#1)(2012-12#2)
precise method for##2##3##(2008-10#1)(2008-2#1)
precise method##3##2##(2008-10#2)(2008-2#1)
precise methods##2##2##(2008-10#1)(2013-8#1)
precise molecular mechanisms##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
precise molecular##5##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
precise phase compensation formulas##2##4##(2008-2#1)(2008-3#1)
precise quantification of##2##3##(1993-2#1)(2008-10#1)
precise quantification##3##2##(1993-2#1)(2008-10#2)
precise results##8##2##(2008-10#7)(2010-3#1)
precise submicrometer##2##2##(2007-11#1)(2008-2#1)
precise three-dimensional##2##2##(2007-11#1)(2008-10#1)
precise timing and##2##3##(2008-7#2)
precise timing##5##2##(1994-9#1)(2008-10#1)(2008-7#2)(2009-12#1)
precise tuning##2##2##(2007-12#1)(2011-2#1)
precise values of##2##3##(2008-11#1)(2008-3#1)
precise##361##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#2)(1992-10#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#14)(2007-12#8)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#113)(2008-11#10)(2008-2#15)(2008-3#21)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#21)(2008-8#1)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#6)(2013-1#2)(2013-8#7)
precisely analyzed by##2##3##(1997-2#1)(2008-10#1)
precisely at the##2##3##(1996-10#1)(2008-10#1)
precisely at##3##2##(1996-10#1)(2008-10#2)
precisely control##2##2##(2008-2#1)(2009-8#1)
precisely controlled##2##2##(2008-10#1)(2008-7#1)
precisely defined##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
precisely determined##3##2##(2008-10#2)(2008-9#1)
precisely in##3##2##(2008-3#1)(2009-9#1)(2010-8#1)
precisely known##5##2##(1993-6#1)(1994-5#1)(1997-8#1)(2008-7#1)(2010-6#1)
precisely mapped##2##2##(1997-3#1)(2012-3#1)
precisely measured##2##2##(2007-12#1)(2008-3#1)
precisely predict the##2##3##(2008-10#1)(2008-2#1)
precisely the time##2##3##(1996-5#1)(2008-5#1)
precisely the##10##2##(1990-3#1)(1990-8#1)(1996-5#1)(2008-10#2)(2008-5#1)(2009-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
precisely to the##2##3##(1991-10#1)(2007-12#1)
precisely to##3##2##(1991-10#1)(2007-12#1)(2012-12#1)
precisely##107##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#4)(2008-2#4)(2008-3#8)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)
precision (CV##3##2##(2008-10#3)
precision (R##18##2##(1992-11#1)(2008-10#17)
precision (RSD##5##2##(2008-10#5)
precision (assessed as the relative standard deviation)##2##7##(2008-10#2)
precision (n=8)##2##2##(2008-10#2)
precision (relative standard deviation)##2##4##(2008-10#2)
precision (relative standard##3##3##(2008-10#2)(2013-1#1)
precision and accuracy of the method##2##6##(2008-10#2)
precision and accuracy of the##11##5##(1991-5#1)(2008-10#9)(2008-3#1)
precision and accuracy of##18##4##(1991-5#1)(2008-10#13)(2008-3#2)(2009-8#1)(2010-11#1)
precision and accuracy##37##3##(1991-5#1)(1997-2#1)(2008-10#31)(2008-3#2)(2009-8#1)(2010-11#1)
precision and efficiency##2##3##(2008-10#1)(2008-3#1)
precision and linearity##3##3##(2008-10#3)
precision and reproducibility##3##3##(2008-10#3)
precision and selectivity##2##3##(2008-10#2)
precision and sensitivity##5##3##(2008-10#4)(2008-5#1)
precision and specificity##2##3##(2008-10#1)(2012-2#1)
precision and##81##2##(1991-5#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-10#58)(2008-11#1)(2008-3#9)(2008-5#1)(2008-7#1)(2009-11#2)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
precision as##3##2##(2008-10#2)(2008-3#1)
precision at the##3##3##(2008-10#3)
precision at##4##2##(2008-10#4)
precision better than##3##3##(2008-10#2)(2008-2#1)
precision between##2##2##(2008-10#2)
precision by##3##2##(2008-10#2)(2008-2#1)
precision characteristics##3##2##(2008-10#3)
precision expressed as relative standard deviation (RSD)##2##7##(2008-10#1)(2009-8#1)
precision expressed as relative standard deviation was##2##7##(2008-10#2)
precision expressed as relative standard deviation##8##6##(2008-10#7)(2009-8#1)
precision expressed as##10##3##(2008-10#8)(2009-4#1)(2009-8#1)
precision filter radiometer##2##3##(2008-3#2)
precision for all##2##3##(2008-10#2)
precision for the##4##3##(2008-10#3)(2011-2#1)
precision for##21##2##(2008-10#15)(2008-3#3)(2010-8#1)(2011-2#2)
precision grip##2##2##(1996-2#2)
precision in the##9##3##(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2011-2#1)
precision in##25##2##(1993-9#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-3#5)(2008-7#1)(2008-8#2)(2011-2#2)
precision is##10##2##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-4#1)(2012-2#1)
precision laser##2##2##(2008-2#2)
precision of &lt##2##3##(2007-12#1)(2008-10#1)
precision of 0##2##3##(2008-10#1)(2008-3#1)
precision of 1##7##3##(2008-10#7)
precision of approximately##4##3##(2008-3#4)
precision of direct analyses##2##4##(2008-10#2)
precision of less than##2##4##(2008-10#2)
precision of measurement##3##3##(2008-10#2)(2008-3#1)
precision of the calibrator##2##4##(2008-10#2)
precision of the determination##3##4##(2008-10#3)
precision of the measurement##2##4##(2008-10#2)
precision of the method was estimated by##2##7##(2008-10#2)
precision of the method was estimated##3##6##(2008-10#3)
precision of the method was##8##5##(2008-10#8)
precision of the method were##2##5##(1990-8#1)(2008-10#1)
precision of the method##25##4##(1990-8#1)(2008-10#24)
precision of the proposed method was##3##6##(2008-10#3)
precision of the proposed method##5##5##(2008-10#5)
precision of the proposed##6##4##(2008-10#6)
precision of the results##3##4##(2008-10#2)(2008-2#1)
precision of the technique##2##4##(2008-10#2)
precision of the##70##3##(1990-8#1)(1992-11#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(2008-10#54)(2008-2#2)(2008-3#4)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
precision of these##2##3##(2008-10#2)
precision of this##5##3##(2008-10#2)(2008-2#2)(2011-1#1)
precision of##145##2##(1990-8#1)(1991-3#1)(1992-11#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#98)(2008-11#1)(2008-2#8)(2008-3#18)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
precision on the##2##3##(2008-10#2)
precision on##4##2##(1990-2#1)(2008-10#2)(2008-3#1)
precision or##3##2##(2008-10#3)
precision ranged##2##2##(2008-10#2)
precision spectral pyranometer##2##3##(2008-3#2)
precision spectral##3##2##(2007-11#1)(2008-3#2)
precision than##2##2##(2008-10#2)
precision that##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
precision to the##2##3##(2008-10#1)(2008-5#1)
precision values##2##2##(2008-10#2)
precision was better##2##3##(1995-2#1)(2008-10#1)
precision was between##2##3##(1990-2#1)(2008-10#1)
precision was found to be##2##5##(2008-10#2)
precision was less than##2##4##(2008-10#1)(2011-3#1)
precision was obtained##2##3##(2008-10#2)
precision was studied##2##3##(2008-10#2)
precision was##30##2##(1990-2#1)(1990-8#1)(1993-2#1)(1995-2#1)(2008-10#24)(2008-3#1)(2011-3#1)
precision were also##2##3##(2008-10#1)(2009-8#1)
precision were studied##2##3##(2008-10#2)
precision were##9##2##(1990-2#1)(2008-10#5)(2009-8#1)(2011-2#1)(2011-3#1)
precision##624##1##(1990-2#4)(1990-5#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-5#1)(1992-11#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-2#3)(1997-3#1)(2007-11#7)(2007-12#6)(2007-3#1)(2007-8#2)(2008-10#416)(2008-11#4)(2008-12#1)(2008-2#24)(2008-3#61)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2009-11#3)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#3)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#7)(2013-1#6)(2013-7#1)(2013-8#5)
precision)##5##1##(2008-10#3)(2008-3#1)(2013-7#1)
precisions (RSD##2##2##(2008-10#2)
precisions and##2##2##(2008-10#2)
precisions of##4##2##(2008-10#4)
precisions##18##1##(2008-10#17)(2008-3#1)
preclinical AD##2##2##(2011-2#2)
preclinical CS##2##2##(2011-2#2)
preclinical and clinical research##3##4##(1995-5#1)(2008-5#1)(2008-7#1)
preclinical and clinical##12##3##(1993-11#1)(1995-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
preclinical and early##2##3##(2008-8#1)(2013-1#1)
preclinical and##16##2##(1993-11#1)(1995-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
preclinical animal studies##2##3##(2012-12#2)
preclinical data##3##2##(2008-8#2)(2010-4#1)
preclinical development##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
preclinical drug##2##2##(1994-12#1)(2010-3#1)
preclinical evaluation##3##2##(1991-9#1)(1992-5#1)(2008-10#1)
preclinical evidence for##2##3##(2008-6#1)(2012-12#1)
preclinical models##3##2##(1996-9#1)(2009-3#1)(2010-11#1)
preclinical phase##2##2##(2008-10#2)
preclinical research##3##2##(2008-7#2)(2012-3#1)
preclinical results##2##2##(2008-5#1)(2013-8#1)
preclinical studies##9##2##(1997-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2012-12#3)
preclinical testing of##2##3##(2008-9#1)(2010-6#1)
preclinical##82##1##(1991-9#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-9#2)(1997-6#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#7)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#3)(2010-11#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2011-2#8)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
preclinically##2##1##(2008-11#1)(2010-10#1)
preclude the##3##2##(1997-5#1)(2008-10#1)(2013-8#1)
preclude##18##1##(1992-11#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#2)(2013-8#1)
precluded by##2##2##(1995-12#1)(2009-2#1)
precluded the##2##2##(1997-3#1)(2010-12#1)
precluded##12##1##(1990-12#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#3)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)
precludes its use##2##3##(1990-3#1)(1990-6#1)
precludes their##2##2##(2008-7#1)(2008-8#1)
precludes##13##1##(1990-3#1)(1990-6#1)(1994-8#1)(1995-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#2)
precluding the##2##2##(1991-5#1)(2009-9#1)
precluding##8##1##(1991-5#1)(1994-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
precoated with##5##2##(2008-10#2)(2008-11#3)
precoated##6##1##(2008-10#3)(2008-11#3)
precocious puberty##3##2##(2011-1#2)(2012-2#1)
precocious##5##1##(2008-1#1)(2010-5#1)(2011-1#2)(2012-2#1)
precolumn derivatisation##2##2##(1990-12#1)(1996-5#1)
precolumn derivatization with##3##3##(1990-8#1)(1991-12#1)(2008-5#1)
precolumn derivatization##5##2##(1990-8#1)(1991-12#1)(1991-5#1)(2008-10#1)(2008-5#1)
precolumn enzymatic##2##2##(2008-10#2)
precolumn system##2##2##(2008-10#2)
precolumn with##2##2##(1990-8#1)(2008-10#1)
precolumn##34##1##(1990-12#1)(1990-8#3)(1991-12#1)(1991-5#1)(1996-5#1)(2008-10#26)(2008-5#1)
precolumns##2##1##(1992-11#1)(2008-10#1)
precompensation##2##1##(2007-11#1)(2007-12#1)
precompetitive distribution##2##2##(2008-8#2)
precompetitive distributions##3##2##(2008-8#3)
precompetitive##5##1##(2008-8#5)
preconcentrate the##2##2##(2008-10#2)
preconcentrate##10##1##(2008-10#10)
preconcentrated and##3##2##(2008-10#3)
preconcentrated by##4##2##(2008-10#4)
preconcentrated from##2##2##(2008-10#2)
preconcentrated in a membrane cell and##2##6##(2008-10#2)
preconcentrated in a membrane cell using##2##6##(2008-10#2)
preconcentrated in a membrane cell##4##5##(2008-10#4)
preconcentrated in a##6##3##(2008-10#6)
preconcentrated in the##2##3##(2008-10#2)
preconcentrated in##10##2##(2008-10#10)
preconcentrated on a##3##3##(2008-10#3)
preconcentrated on the##5##3##(2008-10#5)
preconcentrated on##11##2##(2008-10#11)
preconcentrated onto the##4##3##(2008-10#4)
preconcentrated onto##6##2##(2008-10#6)
preconcentrated with##3##2##(2008-10#3)
preconcentrated##52##1##(2008-10#51)(2009-8#1)
preconcentrates the##3##2##(2008-10#3)
preconcentrating##8##1##(2008-10#8)
preconcentration and determination by##3##4##(2008-10#3)
preconcentration and determination in##3##4##(2008-10#3)
preconcentration and determination of Cr(III)##2##5##(2008-10#2)
preconcentration and determination of cobalt##2##5##(2008-10#2)
preconcentration and determination of copper by flame##2##7##(2008-10#2)
preconcentration and determination of copper##7##5##(2008-10#7)
preconcentration and determination of lead in##2##6##(2008-10#2)
preconcentration and determination of lead##4##5##(2008-10#4)
preconcentration and determination of trace amounts of##2##7##(2008-10#2)
preconcentration and determination of trace##3##5##(2008-10#3)
preconcentration and determination of##25##4##(2008-10#25)
preconcentration and determination system implemented with##2##6##(2008-10#2)
preconcentration and determination##36##3##(2008-10#36)
preconcentration and elution##2##3##(2008-10#2)
preconcentration and separation of trace##4##5##(2008-10#4)
preconcentration and separation of##10##4##(2008-10#9)(2009-6#1)
preconcentration and separation##15##3##(2008-10#14)(2009-6#1)
preconcentration and speciation of chromium##2##5##(2008-10#2)
preconcentration and speciation of##5##4##(2008-10#5)
preconcentration and speciation##6##3##(2008-10#6)
preconcentration and spectrophotometric##3##3##(2008-10#3)
preconcentration and##92##2##(2008-10#91)(2009-6#1)
preconcentration at##2##2##(2008-10#2)
preconcentration by complexation##2##3##(2008-10#2)
preconcentration by##10##2##(2008-10#10)
preconcentration column##4##2##(2008-10#4)
preconcentration coupled with##2##3##(2008-10#2)
preconcentration efficiency##2##2##(2008-10#2)
preconcentration factor of##11##3##(2008-10#11)
preconcentration factor was##4##3##(2008-10#4)
preconcentration factor##27##2##(2008-10#27)
preconcentration factors of##3##3##(2008-10#3)
preconcentration factors##9##2##(2008-10#9)
preconcentration followed by##2##3##(2008-10#2)
preconcentration for##4##2##(2008-10#4)
preconcentration from##2##2##(2008-10#2)
preconcentration in a##4##3##(2008-10#4)
preconcentration in##7##2##(2008-10#7)
preconcentration is##2##2##(2008-10#2)
preconcentration method and##2##3##(2008-10#2)
preconcentration method for the determination of trace##2##7##(2008-10#2)
preconcentration method for the determination of##4##6##(2008-10#4)
preconcentration method for##7##3##(2008-10#7)
preconcentration method in conjunction with##2##5##(2008-10#2)
preconcentration method is described for the determination of##2##8##(2008-10#2)
preconcentration method is##4##3##(2008-10#4)
preconcentration method was##3##3##(2008-10#3)
preconcentration method##25##2##(2008-10#25)
preconcentration of 100 ml of##2##5##(2008-10#2)
preconcentration of Cd##3##3##(2008-10#3)
preconcentration of Cd(II)##2##3##(2008-10#2)
preconcentration of U(VI)##5##3##(2008-10#5)
preconcentration of both##2##3##(2008-10#2)
preconcentration of cadmium and lead from##2##6##(2008-10#2)
preconcentration of cadmium and##3##4##(2008-10#3)
preconcentration of cobalt and nickel##2##5##(2008-10#2)
preconcentration of cobalt##5##3##(2008-10#5)
preconcentration of copper##4##3##(2008-10#4)
preconcentration of fulvic and humic acids##2##6##(2008-10#2)
preconcentration of inorganic and##2##4##(2008-10#2)
preconcentration of inorganic##4##3##(2008-10#4)
preconcentration of iron##3##3##(2008-10#3)
preconcentration of its##4##3##(2008-10#4)
preconcentration of lead and##2##4##(2008-10#2)
preconcentration of lead by##2##4##(2008-10#1)(2013-8#1)
preconcentration of lead##6##3##(2008-10#5)(2013-8#1)
preconcentration of mercury##2##3##(2008-10#2)
preconcentration of metal ions##4##4##(2008-10#4)
preconcentration of metal##6##3##(2008-10#6)
preconcentration of palladium(II)##2##3##(2008-10#2)
preconcentration of platinum##2##3##(2008-10#2)
preconcentration of the##5##3##(2008-10#5)
preconcentration of thorium##3##3##(2008-10#3)
preconcentration of trace amounts of##3##5##(2008-10#3)
preconcentration of trace and ultratrace amounts of lanthanides##2##8##(2008-10#2)
preconcentration of trace and ultratrace amounts of##3##7##(2008-10#3)
preconcentration of trace elements##2##4##(2008-10#2)
preconcentration of trace mercury##2##4##(2008-10#2)
preconcentration of trace##19##3##(2008-10#19)
preconcentration of ultra trace##2##4##(2008-10#2)
preconcentration of uranium(VI)##4##3##(2008-10#4)
preconcentration of##149##2##(2008-10#148)(2013-8#1)
preconcentration on a##5##3##(2008-10#5)
preconcentration on##10##2##(2008-10#10)
preconcentration onto the##2##3##(2008-10#2)
preconcentration onto##5##2##(2008-10#5)
preconcentration procedure based on##2##4##(2008-10#2)
preconcentration procedure for lead determination##2##5##(2008-10#2)
preconcentration procedure for##4##3##(2008-10#4)
preconcentration procedure##10##2##(2008-10#10)
preconcentration procedures for##2##3##(2008-10#2)
preconcentration procedures##5##2##(2008-10#5)
preconcentration step by##2##3##(2008-10#2)
preconcentration step##15##2##(2008-10#15)
preconcentration system for bismuth##2##4##(2008-10#2)
preconcentration system for palladium##2##4##(2008-10#2)
preconcentration system for the##2##4##(2008-10#2)
preconcentration system for##15##3##(2008-10#15)
preconcentration system using##2##3##(2008-10#2)
preconcentration system##32##2##(2008-10#32)
preconcentration systems##3##2##(2008-10#3)
preconcentration technique was examined##2##4##(2008-10#2)
preconcentration technique##5##2##(2008-10#4)(2013-1#1)
preconcentration techniques##4##2##(2008-10#3)(2010-7#1)
preconcentration time and##2##3##(2008-10#2)
preconcentration time of 120 s and a sample flow rate of##2##11##(2008-10#2)
preconcentration time of 120 s##5##5##(2008-10#5)
preconcentration time of 5 min##2##5##(2008-10#2)
preconcentration time of##20##3##(2008-10#20)
preconcentration time##48##2##(2008-10#48)
preconcentration time)##3##2##(2008-10#3)
preconcentration using the##2##3##(2008-10#2)
preconcentration using##9##2##(2008-10#9)
preconcentration was##8##2##(2008-10#8)
preconcentration were##3##2##(2008-10#3)
preconcentration with the##3##3##(2008-10#3)
preconcentration with##10##2##(2008-10#10)
preconcentration##588##1##(2008-10#582)(2008-11#1)(2009-6#1)(2010-7#2)(2013-1#1)(2013-8#1)
preconcentration)##4##1##(2008-10#4)
preconcentration/separation of##2##2##(2008-10#2)
preconcentration/separation##9##1##(2008-10#9)
preconcentrative separation of##2##3##(2008-10#2)
precondition for##2##2##(1993-2#1)(1994-3#1)
precondition##3##1##(1993-2#1)(1994-3#1)(1997-3#1)
preconditioned in##2##2##(1996-9#1)(2009-12#1)
preconditioned with##4##2##(1996-9#1)(2008-10#2)(2013-1#1)
preconditioned##19##1##(1996-9#4)(2008-10#3)(2008-2#3)(2008-3#3)(2008-7#2)(2009-12#1)(2013-1#1)(2013-7#2)
preconditioning in##5##2##(1996-9#3)(2013-7#2)
preconditioning is##2##2##(1994-11#1)(1996-9#1)
preconditioning of##2##2##(2007-8#1)(2011-1#1)
preconditioning or##2##2##(2007-8#2)
preconditioning##35##1##(1994-11#1)(1996-5#1)(1996-9#15)(2007-8#7)(2008-10#2)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-1#1)(2013-7#3)
preconditions are##2##2##(1990-2#1)(2008-8#1)
preconditions##4##1##(1990-2#1)(1992-5#1)(1994-7#1)(2008-8#1)
precontemplation##2##1##(2008-4#1)(2010-2#1)
precontracted##2##1##(2007-10#1)(2008-11#1)
precontrast##2##1##(2007-10#1)(2011-2#1)
precooled##3##1##(2008-9#3)
precooling##4##1##(1992-3#4)
precopulatory expenditure##2##2##(2013-1#2)
precopulatory male-male##2##2##(2013-1#2)
precopulatory##5##1##(2013-1#5)
precordial pain##4##2##(2008-10#1)(2008-7#3)
precordial##5##1##(2008-10#1)(2008-7#3)(2012-12#1)
precore##2##1##(2006-10#1)(2013-1#1)
precorneous layers##2##2##(2011-2#2)
precovalent##2##1##(1995-2#2)
precue##3##1##(2008-7#3)
precuneus and##2##2##(2008-11#1)(2010-2#1)
precuneus##4##1##(2008-11#3)(2010-2#1)
precursor (APP)##10##2##(1991-2#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-9#1)
precursor and the##4##3##(1993-12#2)(1994-11#2)
precursor and##10##2##(1992-6#1)(1993-12#3)(1994-11#2)(1994-6#1)(1995-2#1)(1995-6#1)(2008-6#1)
precursor as##2##2##(1992-12#1)(1995-6#1)
precursor by##2##2##(1995-2#1)(2008-4#1)
precursor cDNA##2##2##(2010-5#2)
precursor cell lines##4##3##(1995-2#1)(2008-11#3)
precursor cell##9##2##(1992-9#1)(1994-12#1)(1995-2#1)(2007-12#3)(2008-11#3)
precursor cells are##2##3##(2008-4#1)(2008-9#1)
precursor cells from##3##3##(1992-12#1)(2007-12#1)(2008-11#1)
precursor cells of##2##3##(1996-2#1)(2007-12#1)
precursor cells to##3##3##(1995-8#1)(2007-12#1)(2010-8#1)
precursor cells##46##2##(1990-11#3)(1992-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-8#5)(1996-2#1)(2007-12#5)(2007-8#1)(2008-11#14)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#2)(2010-8#1)(2012-2#1)(2013-1#1)
precursor chemicals##2##2##(2013-8#2)
precursor cleavage##3##2##(2008-11#3)
precursor film thickness##2##3##(2009-6#2)
precursor film##5##2##(2009-6#5)
precursor for##9##2##(1993-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-1#2)
precursor form##2##2##(1991-9#1)(2008-4#1)
precursor from##2##2##(2008-7#1)(2008-8#1)
precursor in##6##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-9#1)(2008-6#1)
precursor is##5##2##(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1996-5#1)
precursor lesion of colorectal cancer##2##5##(1997-8#1)(2010-12#1)
precursor lesion of##3##3##(1997-8#1)(2010-12#1)(2013-8#1)
precursor lesion##4##2##(1997-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
precursor mRNA##3##2##(1996-12#1)(2009-2#2)
precursor molecule##3##2##(1992-12#1)(1994-8#1)(1995-2#1)
precursor molecules by##2##3##(1993-11#1)(2008-11#1)
precursor molecules##4##2##(1993-11#1)(1995-8#1)(2008-10#1)(2008-11#1)
precursor of 23-kDa polypeptide of##2##5##(1996-10#2)
precursor of dehydroalanine in the active site of##2##8##(1994-5#2)
precursor of human sperm protamines HP2 and HP3##2##8##(1990-7#2)
precursor of the##9##3##(1991-11#1)(1994-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
precursor of##42##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-5#3)(1994-6#1)(1996-10#2)(1997-1#1)(1997-2#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
precursor processing##5##2##(1993-6#1)(1994-8#3)(2008-11#1)
precursor produced##2##2##(1994-11#1)(2008-3#1)
precursor protein (APP)##6##3##(1992-12#1)(1993-11#1)(1993-8#1)(1995-12#1)(1996-12#2)
precursor protein (beta APP)##3##4##(1991-10#1)(1991-11#1)(1992-8#1)
precursor protein expression in##2##4##(1991-10#1)(2009-12#1)
precursor protein in##3##3##(1994-8#1)(1997-4#1)(2008-11#1)
precursor protein of##2##3##(1997-2#2)
precursor protein##46##2##(1990-12#2)(1991-10#2)(1991-11#3)(1991-9#1)(1992-12#8)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-3#1)(1993-8#4)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#3)(1996-12#2)(1996-5#1)(1997-2#2)(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2012-3#1)
precursor proteins##8##2##(1991-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-1#1)
precursor that##2##2##(1993-12#1)(2008-4#1)
precursor to a##3##3##(1996-4#1)(2010-4#1)(2011-2#1)
precursor to the##4##3##(1992-6#1)(1994-11#1)(2009-8#1)(2013-1#1)
precursor to##19##2##(1990-7#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
precursor was##3##2##(1991-9#1)(1995-2#1)(2008-5#1)
precursor were##2##2##(1992-12#1)(1994-8#1)
precursor with##3##2##(1991-12#1)(1992-6#1)(2008-7#1)
precursor##355##1##(1990-11#4)(1990-12#4)(1990-5#1)(1990-7#6)(1990-8#2)(1991-10#2)(1991-11#6)(1991-12#3)(1991-2#3)(1991-6#2)(1991-7#2)(1991-9#7)(1992-10#2)(1992-11#1)(1992-12#19)(1992-3#1)(1992-6#9)(1992-8#7)(1992-9#8)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#5)(1994-11#10)(1994-12#1)(1994-2#3)(1994-5#6)(1994-6#4)(1994-8#9)(1994-9#3)(1995-12#1)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#8)(1996-10#2)(1996-12#3)(1996-2#3)(1996-4#2)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#5)(1997-4#2)(1997-7#4)(1997-8#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#27)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#6)(2008-6#6)(2008-7#9)(2008-8#3)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#6)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
precursor-derived peptides##2##2##(1994-8#2)
precursor-like##3##1##(1996-12#2)(1996-5#1)
precursors and##8##2##(2008-10#2)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
precursors for the##3##3##(2008-10#1)(2010-12#1)(2010-5#1)
precursors for##5##2##(1995-3#1)(2008-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
precursors from##2##2##(2007-12#1)(2008-11#1)
precursors in a##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
precursors in the##2##3##(1994-11#1)(2013-1#1)
precursors in##11##2##(1990-5#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#1)
precursors of the##2##3##(1992-6#1)(1994-8#1)
precursors of##24##2##(1990-12#1)(1990-3#1)(1990-5#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-8#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
precursors present in##2##3##(2008-5#2)
precursors to##9##2##(1992-6#1)(1993-12#1)(1995-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
precursors were##2##2##(2008-5#1)(2008-7#1)
precursors with##4##2##(1991-9#1)(1992-9#1)(2007-10#1)(2008-4#1)
precursors##125##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-6#1)(1991-9#1)(1992-12#4)(1992-6#4)(1992-8#2)(1992-9#6)(1993-12#3)(1993-6#1)(1994-1#1)(1994-11#3)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#8)(2008-10#12)(2008-11#6)(2008-2#1)(2008-4#7)(2008-5#5)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#3)(2011-3#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
precursors)##2##1##(2008-10#1)(2008-3#1)
precursory changes##2##2##(1996-4#2)
precursory seismicity##2##2##(1996-4#2)
precursory##7##1##(1996-4#7)
pred##2##1##(1993-2#2)
predate##4##1##(1994-2#1)(2012-12#2)(2012-3#1)
predated##2##1##(1996-2#1)(2010-6#1)
predates##2##1##(1997-1#1)(2009-6#1)
predation and##7##2##(1995-3#1)(2007-7#1)(2008-6#1)(2008-8#2)(2008-9#2)
predation as##2##2##(2007-7#1)(2008-9#1)
predation increased##2##2##(2008-9#1)(2013-1#1)
predation on##6##2##(2008-8#3)(2008-9#3)
predation pressure##2##2##(2007-12#1)(2008-9#1)
predation risk is##2##3##(2008-8#1)(2012-12#1)
predation risk##8##2##(2008-8#1)(2008-9#3)(2010-8#1)(2012-12#1)(2012-3#2)
predation##65##1##(1995-3#1)(2007-12#1)(2007-7#3)(2008-5#3)(2008-6#1)(2008-8#20)(2008-9#24)(2010-8#2)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#1)
predation)##2##1##(2008-9#1)(2012-3#1)
predator and##5##2##(2008-8#2)(2009-8#1)(2010-8#1)(2012-3#1)
predator cues##2##2##(2012-3#2)
predator density##2##2##(2012-3#2)
predator effectiveness##2##2##(2008-6#2)
predator feeding strategy##2##3##(2008-5#2)
predator in##4##2##(2008-8#1)(2008-9#1)(2010-8#2)
predator is##2##2##(2008-6#1)(2008-8#1)
predator odors##5##2##(2008-4#5)
predator species##3##2##(2008-8#1)(2008-9#2)
predator##70##1##(1994-8#1)(2008-12#1)(2008-4#7)(2008-5#4)(2008-6#7)(2008-8#21)(2008-9#12)(2009-10#1)(2009-8#1)(2010-8#6)(2012-3#8)(2013-1#1)
predator-induced##5##1##(2008-4#1)(2008-8#3)(2012-12#1)
predator-prey system##3##2##(2008-8#2)(2008-9#1)
predator-prey##10##1##(1997-6#1)(2008-10#1)(2008-8#5)(2008-9#3)
predators and prey##3##3##(2008-8#3)
predators and##8##2##(1997-7#1)(2008-4#2)(2008-8#5)
predators but##2##2##(2008-8#1)(2008-9#1)
predators in##4##2##(2008-6#1)(2008-8#3)
predators may##2##2##(2008-6#1)(2008-8#1)
predators with##2##2##(2008-8#1)(2012-2#1)
predators##63##1##(1997-7#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#32)(2008-9#8)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#6)(2013-1#4)
predatory behaviour##2##2##(2012-2#2)
predatory mite##2##2##(2011-2#2)
predatory##15##1##(2007-12#1)(2008-5#3)(2008-6#4)(2008-8#1)(2011-2#3)(2012-2#3)
predefined criteria##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
predefined##19##1##(1993-1#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-12#2)
predeposit##2##1##(1996-9#2)
predetermined##23##1##(1993-12#2)(1994-3#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#4)(2008-4#1)(2009-1#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
prediabetes##2##1##(2008-5#1)(2011-2#1)
prediabetic##4##1##(2007-5#3)(2010-11#1)
predialysis and##2##2##(2008-1#2)
predialysis patients##3##2##(2008-1#3)
predialysis##13##1##(1994-5#1)(2007-12#1)(2008-1#5)(2008-12#2)(2008-4#1)(2008-7#3)
predicament##3##1##(1994-2#1)(2009-11#1)(2013-1#1)
predicated on##6##2##(1997-1#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-4#1)(2013-8#1)
predicated##8##1##(1997-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-4#1)(2013-8#1)
predict a##9##2##(1990-8#2)(1993-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-2#1)
predict an##5##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
predict and##9##2##(1996-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
predict binding##2##2##(1992-9#1)(2010-7#1)
predict disease severity##3##3##(2008-10#2)(2013-1#1)
predict disease##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
predict either##2##2##(2008-6#1)(2008-9#1)
predict future##4##2##(2008-1#1)(2008-11#1)(2012-2#1)(2013-7#1)
predict internal conversion rates roughly double those of the all-trans species##2##11##(2010-2#2)
predict its##2##2##(1996-2#1)(1997-2#1)
predict mortality##3##2##(2008-3#1)(2009-4#1)(2013-1#1)
predict postoperative##2##2##(2007-8#1)(2010-8#1)
predict protein##2##2##(2008-7#2)
predict readmission##2##2##(2011-2#2)
predict response to therapy##2##4##(2008-7#1)(2012-12#1)
predict response##3##2##(1992-3#1)(2008-7#1)(2012-12#1)
predict risk##4##2##(2009-12#1)(2010-7#1)(2012-1#1)(2013-1#1)
predict stem cell##2##3##(2008-11#2)
predict that it##2##3##(2008-10#1)(2008-5#1)
predict that the##5##3##(1992-11#1)(2007-11#1)(2008-5#1)(2010-10#1)(2010-4#1)
predict that##32##2##(1992-11#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#4)(2009-11#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
predict the binding##2##3##(1992-9#1)(2013-7#1)
predict the effects of##3##4##(2007-12#1)(2008-2#1)(2010-9#1)
predict the enantiomeric composition##2##4##(2008-10#2)
predict the existence of a##2##5##(1997-9#1)(2007-12#1)
predict the existence of##5##4##(1997-9#1)(2007-11#1)(2007-12#2)(2008-3#1)
predict the formation of##2##4##(2007-12#1)(2008-7#1)
predict the function of newly discovered proteins##2##7##(2009-5#1)(2011-2#1)
predict the function of##4##4##(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)
predict the level of##2##4##(2011-2#1)(2013-1#1)
predict the likelihood of##3##4##(2009-6#2)(2012-12#1)
predict the number##2##3##(2008-11#1)(2008-6#1)
predict the outcome of##2##4##(1990-8#1)(2008-7#1)
predict the potential##3##3##(1996-6#1)(2011-3#1)(2013-8#1)
predict the prognosis of##2##4##(2010-8#1)(2011-2#1)
predict the rate of##2##4##(2007-12#1)(2008-3#1)
predict the results of##2##4##(2008-2#1)(2008-7#1)
predict the stability of##2##4##(2007-11#1)(2008-6#1)
predict the##162##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-9#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#27)(2008-11#5)(2008-2#10)(2008-3#15)(2008-5#3)(2008-6#2)(2008-7#13)(2008-8#10)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
predict their##5##2##(1991-11#1)(2007-11#1)(2008-11#1)(2009-9#1)(2013-1#1)
predict this##3##2##(1995-4#1)(2007-11#1)(2012-1#1)
predict who##3##2##(2007-10#1)(2008-3#1)(2008-7#1)
predict with##2##2##(2008-7#1)(2010-3#1)
predict##494##1##(1990-12#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#3)(2007-11#12)(2007-12#15)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#65)(2008-11#15)(2008-12#6)(2008-2#20)(2008-3#29)(2008-4#1)(2008-5#11)(2008-6#4)(2008-7#29)(2008-8#34)(2008-9#14)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#6)(2010-7#4)(2010-8#10)(2010-9#2)(2011-1#1)(2011-2#20)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#9)(2013-1#14)(2013-7#2)(2013-8#8)
predictability of##9##2##(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2011-7#1)
predictability##18##1##(1994-3#2)(1995-12#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#2)(2011-7#1)(2013-1#1)
predictable and##5##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2013-1#1)
predictable from##2##2##(2008-9#1)(2009-2#1)
predictable or##2##2##(1994-3#1)(2008-3#1)
predictable##50##1##(1993-3#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
predictably##6##1##(1994-3#1)(1996-9#1)(1997-1#1)(2007-12#2)(2010-4#1)
predicted M(r)##4##2##(1994-12#2)(1994-8#2)
predicted SWB##3##2##(2013-1#3)
predicted a##7##2##(1996-12#1)(1997-2#1)(2008-11#1)(2008-7#3)(2008-9#1)
predicted amino acid (aa) sequences##3##5##(1991-9#1)(1993-6#1)(1993-9#1)
predicted amino acid sequence from RT-PCR amplified cDNA and its expression##2##11##(1993-11#1)(1993-9#1)
predicted amino acid sequence of##5##5##(1992-3#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-6#1)
predicted amino acid sequence##16##4##(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-6#2)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#1)(2008-9#1)
predicted amino acid sequences##4##4##(1991-9#1)(1997-2#1)(2008-10#1)(2008-7#1)
predicted amino acid##25##3##(1991-9#3)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-6#2)(1995-6#2)(1995-8#1)(1997-2#2)(2008-10#3)(2008-7#1)(2008-9#1)
predicted amino##26##2##(1991-9#3)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-6#2)(1995-6#2)(1995-8#1)(1997-2#2)(2008-10#4)(2008-7#1)(2008-9#1)
predicted and experimental##3##3##(2008-10#3)
predicted and observed##2##3##(2008-10#1)(2008-3#1)
predicted and the measured##4##4##(2007-12#1)(2008-3#2)(2013-1#1)
predicted and the##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2010-6#1)(2013-1#1)
predicted and##19##2##(1990-5#1)(2007-12#1)(2008-10#7)(2008-3#6)(2008-8#1)(2009-5#1)(2010-6#1)(2013-1#1)
predicted as##6##2##(1990-12#1)(1990-7#1)(2008-10#2)(2008-8#1)(2013-1#1)
predicted based on##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
predicted body##2##2##(2007-12#2)
predicted by a recently##2##4##(1997-7#1)(2008-2#1)
predicted by a##7##3##(1990-7#1)(1997-7#1)(2008-10#1)(2008-2#3)(2013-8#1)
predicted by model##2##3##(2008-10#2)
predicted by models of##3##4##(2008-8#2)(2008-9#1)
predicted by the model##7##4##(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-10#1)(2012-1#1)
predicted by the##42##3##(1991-10#1)(1991-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-1#2)(2012-3#1)
predicted by theory##3##3##(2007-12#2)(2008-9#1)
predicted by this##2##3##(2008-3#2)
predicted by use of##2##4##(2007-12#1)(2008-3#1)
predicted by##110##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#16)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#13)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-2#1)(2012-3#3)(2013-8#1)
predicted change in##2##3##(1992-3#1)(2007-12#1)
predicted concentration##2##2##(2008-10#2)
predicted concentrations##3##2##(2008-10#2)(2008-3#1)
predicted distribution##2##2##(1996-4#1)(2008-10#1)
predicted for a##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
predicted for different##2##3##(2008-3#1)(2008-9#1)
predicted for the##4##3##(1993-11#1)(2008-10#2)(2012-5#1)
predicted for##17##2##(1990-12#1)(1990-5#1)(1992-2#1)(1993-11#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-5#1)(2013-1#1)
predicted from a##2##3##(1996-2#1)(2008-3#1)
predicted from the cDNA sequence##2##5##(1991-2#1)(1992-8#1)
predicted from the nucleotide sequence of the##2##7##(1991-5#1)(1991-9#1)
predicted from the##16##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1994-8#1)(1996-4#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-3#1)(2010-5#1)
predicted from their##2##3##(1993-6#1)(1994-11#1)
predicted from##32##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-2#2)(1996-4#1)(1997-2#2)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)
predicted generally##2##2##(2008-10#1)(2008-3#1)
predicted genes##3##2##(1997-6#1)(1997-8#1)(2008-10#1)
predicted growth##2##2##(2011-1#1)(2011-2#1)
predicted higher##2##2##(2007-10#1)(2009-7#1)
predicted in the##5##3##(1996-4#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-8#1)
predicted in##10##2##(1992-3#1)(1996-4#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
predicted increase in##2##3##(1992-3#1)(2008-3#1)
predicted increase##3##2##(1991-2#1)(1992-3#1)(2008-3#1)
predicted initial levels##2##3##(2009-7#1)(2011-2#1)
predicted lower levels of##3##4##(2009-7#2)(2011-2#1)
predicted lower##5##2##(2007-10#2)(2009-7#2)(2011-2#1)
predicted molecular mass##5##3##(1992-3#1)(1994-12#2)(2008-10#2)
predicted molecular##7##2##(1992-3#1)(1994-12#2)(2008-10#3)(2008-8#1)
predicted most##2##2##(2008-10#1)(2009-9#1)
predicted on the basis of##2##5##(2008-3#1)(2008-8#1)
predicted on the##3##3##(1994-2#1)(2008-3#1)(2008-8#1)
predicted only##3##2##(2008-10#2)(2012-3#1)
predicted open reading frames##2##4##(1994-11#1)(2008-10#1)
predicted open reading##3##3##(1994-11#2)(2008-10#1)
predicted optimal##2##2##(2008-7#1)(2013-1#1)
predicted or##2##2##(1991-12#1)(1994-9#1)
predicted polypeptide##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
predicted postoperative forced expiratory##3##4##(2007-8#3)
predicted primary##2##2##(1994-11#1)(2012-1#1)
predicted product##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
predicted products##2##2##(1991-5#1)(1994-12#1)
predicted protein of##3##3##(1993-2#1)(1996-6#1)(1997-4#1)
predicted protein##9##2##(1993-12#2)(1993-2#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#1)
predicted proteins##2##2##(1992-12#1)(2009-8#1)
predicted rates##2##2##(2008-7#2)
predicted response##4##2##(2008-10#1)(2008-7#1)(2012-2#2)
predicted results##3##2##(2008-10#2)(2008-8#1)
predicted secondary structure##2##3##(1990-4#1)(2008-7#1)
predicted secondary##4##2##(1990-4#1)(1993-3#1)(2008-7#1)(2012-1#1)
predicted sequence of##2##3##(1990-11#1)(1994-12#1)
predicted sequence##3##2##(1990-11#1)(1993-12#1)(1994-12#1)
predicted slopes of##3##3##(2008-8#3)
predicted snail##3##2##(2008-8#3)
predicted solely from##2##3##(1994-8#1)(2011-2#1)
predicted subsequent##2##2##(2008-8#1)(2009-9#1)
predicted that a##3##3##(1995-12#1)(2008-7#1)(2008-9#1)
predicted that the##5##3##(2007-12#1)(2008-7#2)(2008-8#2)
predicted that##18##2##(1990-2#1)(1990-3#1)(1995-12#1)(1995-3#1)(1996-8#1)(2007-12#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)
predicted the severity of##2##4##(1996-5#1)(2011-2#1)
predicted the##16##2##(1991-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(2008-10#4)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
predicted their##2##2##(2009-9#1)(2012-12#1)
predicted theoretically##6##2##(1994-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)
predicted to be##22##3##(1990-11#1)(1990-12#1)(1991-2#1)(1993-12#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
predicted to encode a##8##4##(1990-8#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
predicted to encode##11##3##(1990-8#1)(1994-9#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
predicted to form a##2##4##(1991-12#1)(1994-12#1)
predicted to form##3##3##(1991-12#1)(1994-12#1)(2008-8#1)
predicted to increase##4##3##(1995-12#1)(1995-3#1)(2008-7#1)(2008-9#1)
predicted to occur##2##3##(1992-12#1)(2013-8#1)
predicted to produce##2##3##(2008-9#1)(2011-2#1)
predicted to##60##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#2)
predicted translation product##2##3##(1991-5#1)(1997-8#1)
predicted transmembrane##3##2##(1992-12#1)(1995-2#1)(1996-3#1)
predicted using an##2##3##(2008-10#2)
predicted using##8##2##(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)
predicted values##7##2##(1992-3#1)(2007-11#1)(2008-10#4)(2013-8#1)
predicted versus##2##2##(1994-3#2)
predicted with a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
predicted with##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
predicted##695##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#8)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#6)(1991-5#4)(1991-6#1)(1991-9#8)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#8)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#7)(1997-4#3)(1997-6#5)(1997-7#6)(1997-8#4)(2007-10#3)(2007-11#12)(2007-12#27)(2007-8#7)(2008-10#110)(2008-11#9)(2008-12#10)(2008-2#15)(2008-3#42)(2008-4#4)(2008-5#8)(2008-6#6)(2008-7#32)(2008-8#53)(2008-9#23)(2009-10#2)(2009-5#8)(2009-6#3)(2009-7#9)(2009-8#8)(2009-9#10)(2010-1#1)(2010-10#4)(2010-11#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#8)(2011-2#22)(2011-3#2)(2012-1#8)(2012-12#1)(2012-2#8)(2012-3#6)(2012-5#1)(2012-7#1)(2013-1#16)(2013-8#10)
predicted)##3##1##(2007-8#1)(2008-3#1)(2008-8#1)
predicting HIV##2##2##(2010-8#1)(2012-2#1)
predicting RNA##3##2##(1992-3#1)(2008-4#1)(2011-3#1)
predicting a##3##2##(1994-11#1)(2008-6#1)(2009-5#1)
predicting an##2##2##(2008-10#1)(2012-3#1)
predicting future##3##2##(1992-3#1)(1996-6#1)(2008-8#1)
predicting how##3##2##(2008-8#1)(2009-2#1)(2012-1#1)
predicting mortality in##2##3##(2007-8#1)(2011-2#1)
predicting outcomes##3##2##(2008-9#1)(2013-1#2)
predicting the results of##2##4##(2007-12#1)(2008-4#1)
predicting the risk of##4##4##(1994-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
predicting the severity of##2##4##(2011-2#1)(2013-1#1)
predicting the structure of simple transmembrane##2##6##(2008-4#2)
predicting the##60##2##(1990-9#1)(1991-4#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
predicting these##2##2##(2008-11#1)(2008-2#1)
predicting treatment##2##2##(2008-6#1)(2013-1#1)
predicting##191##1##(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-3#3)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#8)(2008-12#7)(2008-2#5)(2008-3#10)(2008-4#9)(2008-5#2)(2008-6#5)(2008-7#6)(2008-8#6)(2008-9#5)(2009-11#4)(2009-2#2)(2009-3#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#6)(2011-1#3)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#3)
prediction ability and its##2##4##(2008-10#1)(2013-8#1)
prediction ability and##3##3##(2008-10#2)(2013-8#1)
prediction ability##12##2##(2008-10#10)(2010-4#1)(2013-8#1)
prediction accuracy##8##2##(2008-10#4)(2008-2#1)(2008-3#1)(2010-7#1)(2011-1#1)
prediction and experimental##2##3##(1993-6#1)(2008-7#1)
prediction and principal component analysis##2##5##(2010-8#2)
prediction and real samples data##2##5##(2008-10#2)
prediction and the##2##3##(2009-7#1)(2013-8#1)
prediction and##16##2##(1993-6#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-8#2)(2013-8#2)
prediction are##3##2##(2008-10#1)(2008-11#2)
prediction by##6##2##(2008-10#1)(2008-8#3)(2009-2#1)(2010-12#1)
prediction error of the##2##4##(2008-10#1)(2008-3#1)
prediction error of##3##3##(2008-10#2)(2008-3#1)
prediction error##15##2##(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2013-8#1)
prediction errors of the##2##4##(2008-10#2)
prediction errors of##3##3##(2008-10#2)(2008-3#1)
prediction errors##7##2##(2008-10#5)(2008-3#1)(2011-1#1)
prediction for##7##2##(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#1)
prediction from##2##2##(1991-6#1)(2008-10#1)
prediction has been##2##3##(2008-2#1)(2008-3#1)
prediction in##6##2##(1991-12#1)(1996-4#1)(2008-11#1)(2010-12#3)
prediction is##11##2##(1996-4#2)(2007-12#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)
prediction methods##4##2##(1996-4#2)(2008-10#1)(2008-4#1)
prediction model for##3##3##(2008-10#2)(2012-2#1)
prediction model##8##2##(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2012-2#1)
prediction models were##2##3##(2008-10#2)
prediction models##5##2##(2008-10#2)(2008-8#1)(2010-5#1)(2012-3#1)
prediction of a##4##3##(1996-4#1)(2007-11#1)(2008-2#1)(2009-8#1)
prediction of all-cause mortality##2##4##(2008-7#2)
prediction of gene##2##3##(1997-8#1)(2012-2#1)
prediction of gray leaf spot of##2##6##(2008-10#2)
prediction of light##2##3##(2008-3#2)
prediction of long term##2##4##(2013-1#2)
prediction of long-term##2##3##(1992-12#1)(2008-9#1)
prediction of moisture##2##3##(2008-10#2)
prediction of polymers##2##3##(2008-9#2)
prediction of pregnancy-induced hypertension##2##4##(1994-3#1)(2012-2#1)
prediction of risk##4##3##(1990-5#1)(1993-11#1)(2007-8#1)(2010-8#1)
prediction of the retention##2##4##(2008-10#2)
prediction of the##30##3##(1990-5#1)(1993-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#1)(2009-6#2)(2010-8#2)(2012-3#1)
prediction of their##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
prediction of therapeutic##2##3##(1995-11#1)(1996-7#1)
prediction of##154##2##(1990-2#1)(1990-3#1)(1990-5#3)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-11#6)(2007-12#5)(2007-8#2)(2008-10#33)(2008-11#4)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#7)(2009-12#1)(2009-4#3)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#5)(2013-8#1)
prediction performance of the##2##4##(2008-10#1)(2013-1#1)
prediction performance##4##2##(2008-10#3)(2013-1#1)
prediction programs##2##2##(2008-8#1)(2008-9#1)
prediction rate of##2##3##(1997-6#1)(2010-8#1)
prediction rate##3##2##(1997-6#1)(2010-8#2)
prediction results##4##2##(2008-10#4)
prediction rules##2##2##(1993-12#1)(2008-12#1)
prediction samples##2##2##(2008-10#2)
prediction server##3##2##(2007-6#3)
prediction that##8##2##(1990-7#1)(2008-5#1)(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#1)
prediction using##3##2##(2008-4#2)(2008-7#1)
prediction was##4##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
prediction##426##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-12#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-4#21)(1996-6#1)(1996-7#1)(1997-3#1)(1997-6#3)(1997-8#1)(2007-11#11)(2007-12#11)(2007-5#2)(2007-6#4)(2007-8#4)(2008-10#124)(2008-11#13)(2008-12#3)(2008-2#10)(2008-3#21)(2008-4#13)(2008-5#8)(2008-6#2)(2008-7#20)(2008-8#21)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-6#3)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#6)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#9)(2012-3#5)(2012-7#1)(2013-1#10)(2013-8#8)
prediction)##2##1##(1992-9#1)(2007-12#1)
predictions about the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
predictions about##9##2##(1992-1#1)(1994-3#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)
predictions and##12##2##(1991-5#1)(1994-3#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#2)
predictions are based on##4##4##(2007-11#1)(2008-8#1)(2009-5#2)
predictions are consistent with##2##4##(1995-2#1)(2007-11#1)
predictions are given##2##3##(1991-12#1)(2008-8#1)
predictions are##20##2##(1991-12#1)(1995-2#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-5#2)(2012-2#1)(2013-8#1)
predictions as to##2##3##(1991-1#1)(2012-3#1)
predictions as##3##2##(1991-1#1)(2008-7#1)(2012-3#1)
predictions based on the##2##4##(2007-11#1)(2008-2#1)
predictions based on##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
predictions based upon##2##3##(1992-6#1)(1995-9#1)
predictions based##7##2##(1992-6#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
predictions by##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
predictions for the##4##3##(1990-12#1)(2007-12#2)(2008-11#1)
predictions for##18##2##(1990-12#1)(1992-6#1)(1992-9#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#1)
predictions from the model##2##4##(2007-12#1)(2008-11#1)
predictions from the##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
predictions from##12##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#3)
predictions have been##2##3##(2008-10#1)(2008-11#1)
predictions in the light of##2##5##(2008-8#1)(2008-9#1)
predictions in the##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
predictions in##8##2##(1993-12#1)(1997-3#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-2#1)
predictions made##4##2##(1994-3#1)(2008-1#1)(2008-3#1)(2008-8#1)
predictions match##2##2##(2008-11#1)(2008-8#1)
predictions obtained##2##2##(2008-2#2)
predictions of a##6##3##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
predictions of future##2##3##(2008-11#1)(2009-9#1)
predictions of the model##4##4##(1990-8#1)(1992-3#1)(2008-3#1)(2008-8#1)
predictions of the##25##3##(1990-8#1)(1992-3#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#6)(2008-9#3)(2009-5#1)(2009-7#1)
predictions of this##2##3##(2007-11#1)(2008-2#1)
predictions of##70##2##(1990-8#1)(1992-3#2)(1994-3#2)(1995-3#1)(1996-4#1)(2007-11#7)(2007-12#2)(2008-10#9)(2008-11#2)(2008-2#6)(2008-3#10)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#7)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-8#1)
predictions provide##2##2##(2008-3#1)(2008-8#1)
predictions that##7##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#3)(2013-8#1)
predictions using##5##2##(2008-10#1)(2008-11#1)(2008-8#3)
predictions was##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
predictions were compared with##2##4##(1994-3#1)(2008-8#1)
predictions were made##2##3##(2008-10#1)(2008-7#1)
predictions were then##2##3##(2008-7#2)
predictions were##17##2##(1990-2#1)(1993-12#1)(1994-3#2)(2008-10#5)(2008-7#3)(2008-8#3)(2009-7#1)(2013-1#1)
predictions with##4##2##(1996-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
predictions##337##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#3)(1992-6#3)(1992-9#2)(1993-12#2)(1994-3#7)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#5)(1997-3#3)(1997-5#1)(1997-7#1)(2007-11#17)(2007-12#16)(2008-1#1)(2008-10#34)(2008-11#15)(2008-2#26)(2008-3#48)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#24)(2008-8#44)(2008-9#19)(2009-11#2)(2009-4#1)(2009-5#4)(2009-7#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#6)
predictive ability of the##7##4##(2008-10#4)(2008-8#1)(2009-3#1)(2012-3#1)
predictive ability of##11##3##(2008-10#7)(2008-8#1)(2009-3#1)(2012-12#1)(2012-3#1)
predictive ability##17##2##(2007-11#1)(2008-10#10)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#2)
predictive accuracy for##2##3##(2012-3#2)
predictive accuracy##5##2##(1993-3#1)(2008-9#1)(2012-3#2)(2013-1#1)
predictive and prognostic##2##3##(2008-7#1)(2011-3#1)
predictive and##6##2##(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-3#1)(2012-2#1)
predictive control##3##2##(2007-12#2)(2013-1#1)
predictive factors for##3##3##(2007-7#1)(2009-5#1)(2012-3#1)
predictive factors of recurrent bleeding##3##5##(2007-8#3)
predictive factors of##5##3##(2007-8#3)(2008-10#1)(2010-7#1)
predictive factors##13##2##(2007-7#1)(2007-8#3)(2008-10#1)(2009-4#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
predictive for a substitution of##2##5##(1994-11#2)
predictive for##5##2##(1994-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
predictive in##2##2##(1993-11#1)(2007-2#1)
predictive information##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
predictive marker##3##2##(2010-12#2)(2010-8#1)
predictive markers##3##2##(2008-1#1)(2013-1#2)
predictive microbiology##2##2##(2011-2#2)
predictive model for##4##3##(2008-10#3)(2008-5#1)
predictive model with##2##3##(2010-8#1)(2012-12#1)
predictive model##11##2##(2008-10#4)(2008-11#2)(2008-5#1)(2009-3#1)(2010-7#1)(2010-8#1)(2012-12#1)
predictive models of##7##3##(2007-11#2)(2008-11#1)(2008-7#1)(2010-4#2)(2012-2#1)
predictive models##12##2##(2007-11#2)(2008-11#1)(2008-7#2)(2008-8#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)
predictive of a##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
predictive of clinical##2##3##(2008-5#1)(2010-11#1)
predictive of early##2##3##(2008-8#1)(2012-12#1)
predictive of increased##3##3##(2008-10#1)(2012-3#2)
predictive of poor outcome##2##4##(2012-12#1)(2012-3#1)
predictive of the##4##3##(1996-6#1)(2008-11#1)(2008-5#1)(2008-6#1)
predictive of##52##2##(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#2)(2010-11#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#2)
predictive performance##4##2##(2008-7#2)(2009-7#1)(2012-3#1)
predictive power and##2##3##(2008-8#1)(2013-8#1)
predictive power of the models##2##5##(2008-5#1)(2009-8#1)
predictive power of the##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
predictive power of##9##3##(1992-12#1)(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-2#1)
predictive power##13##2##(1992-10#1)(1992-12#1)(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
predictive process models for##2##4##(2009-9#2)
predictive process##3##2##(2009-9#3)
predictive risk##2##2##(2008-10#1)(2008-11#1)
predictive role in the##2##4##(2008-3#1)(2011-2#1)
predictive role##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
predictive test##3##2##(1992-3#1)(1997-6#1)(2013-8#1)
predictive validity and effects of using the##2##7##(2013-1#2)
predictive validity##11##2##(1994-2#3)(1994-3#1)(2008-6#2)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
predictive value and##5##3##(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
predictive value for##5##3##(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
predictive value of 0##2##4##(1993-2#2)
predictive value of a positive##3##5##(1990-3#1)(1992-5#1)(1994-2#1)
predictive value of a##6##4##(1990-3#1)(1992-10#1)(1992-5#2)(1994-2#1)(2011-2#1)
predictive value of the test##2##5##(1991-12#2)
predictive value of the##6##4##(1990-2#1)(1991-12#2)(1992-10#1)(2008-10#1)(2009-7#1)
predictive value of##36##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#3)(1992-10#2)(1992-5#3)(1993-2#3)(1993-5#1)(1994-2#1)(1994-7#1)(1995-3#2)(1996-1#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#2)
predictive value##78##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#4)(1991-2#1)(1992-10#2)(1992-11#2)(1992-5#3)(1993-2#3)(1993-5#1)(1994-2#1)(1994-7#2)(1995-3#2)(1996-1#1)(1997-4#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#17)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
predictive values for the##2##4##(1992-5#1)(2007-10#1)
predictive values for##3##3##(1992-5#1)(1993-2#1)(2007-10#1)
predictive values of##3##3##(1991-6#1)(2008-11#1)(2012-12#1)
predictive values were##4##3##(1991-4#1)(1994-3#1)(2008-12#1)(2008-3#1)
predictive values##15##2##(1991-4#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-2#1)(1994-3#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#2)(2012-12#2)
predictive##318##1##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#4)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#5)(1994-3#2)(1994-7#2)(1994-8#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#44)(2008-11#7)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#14)(2008-8#10)(2008-9#5)(2009-11#4)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#4)(2010-8#4)(2011-1#6)(2011-2#26)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#7)(2012-3#15)(2013-1#12)(2013-8#7)
predictor for the##2##3##(2009-8#1)(2013-1#1)
predictor for##18##2##(1994-11#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#3)
predictor in##2##2##(1991-2#1)(1995-4#1)
predictor is##2##2##(2008-10#1)(2008-6#1)
predictor of acute coronary##2##4##(2008-3#2)
predictor of acute##3##3##(2008-3#2)(2013-1#1)
predictor of clinical outcome##2##4##(2010-8#1)(2013-1#1)
predictor of depression##2##3##(2007-12#1)(2013-1#1)
predictor of later##3##3##(2008-12#1)(2012-2#1)(2013-7#1)
predictor of long-term##2##3##(2008-5#1)(2009-8#1)
predictor of outcome##3##3##(2007-10#2)(2009-11#1)
predictor of overall##2##3##(2011-2#1)(2013-1#1)
predictor of poor outcome##2##4##(2008-3#1)(2012-12#1)
predictor of the##8##3##(1995-2#1)(2008-10#3)(2008-7#1)(2008-9#2)(2012-3#1)
predictor of##89##2##(1990-2#1)(1991-3#1)(1992-4#1)(1993-1#2)(1993-11#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#3)(1996-7#1)(1996-8#1)(2006-10#1)(2007-10#3)(2007-12#3)(2007-7#2)(2008-10#3)(2008-12#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#9)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#9)(2013-7#2)
predictor variables were##3##3##(2008-10#2)(2008-9#1)
predictor variables##11##2##(2008-10#6)(2008-2#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-2#1)
predictor##138##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-1#3)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-3#3)(1996-7#1)(1996-8#1)(2006-10#1)(2007-10#4)(2007-12#4)(2007-7#2)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#11)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#9)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#14)(2013-7#3)
predictors and##4##2##(2008-6#1)(2011-2#2)(2012-12#1)
predictors for##9##2##(1994-3#1)(2007-10#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
predictors in##2##2##(2007-10#1)(2008-6#1)
predictors of and##2##3##(2012-3#1)(2013-1#1)
predictors of apple scab##2##4##(2008-10#2)
predictors of body dissatisfaction##2##4##(2007-12#2)
predictors of body##3##3##(2007-12#3)
predictors of children's##2##3##(1993-1#1)(2008-2#1)
predictors of depression##4##3##(2007-10#1)(2009-5#1)(2011-2#2)
predictors of disease class##2##4##(2008-7#2)
predictors of disease##3##3##(2008-7#2)(2012-2#1)
predictors of end-stage##2##3##(2013-1#2)
predictors of hypertension##3##3##(2008-11#3)
predictors of low##2##3##(1995-12#1)(2012-2#1)
predictors of memory performance in##2##5##(2008-12#1)(2008-7#1)
predictors of mortality in##5##4##(1993-9#1)(2011-2#4)
predictors of mortality##9##3##(1993-9#1)(2008-7#3)(2011-2#5)
predictors of peripheral neuropathy occurrence in HIV-1 infected##2##8##(2008-11#2)
predictors of poor##2##3##(2008-3#1)(2011-2#1)
predictors of response to##4##4##(2008-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
predictors of survival##2##3##(2008-7#1)(2011-1#1)
predictors of the##6##3##(1992-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-3#1)(2012-12#1)
predictors of these##2##3##(2012-3#1)(2013-1#1)
predictors of##124##2##(1992-3#1)(1992-4#1)(1993-1#2)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#2)(1996-1#1)(1996-3#1)(2006-10#2)(2007-10#5)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#14)(2011-3#1)(2012-12#7)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#6)(2013-3#1)(2013-8#2)
predictors that##2##2##(1994-3#1)(2008-11#1)
predictors were##2##2##(2008-10#1)(2009-9#1)
predictors##173##1##(1992-12#2)(1992-3#2)(1992-4#1)(1993-1#2)(1993-9#1)(1994-2#2)(1994-3#3)(1995-12#4)(1996-1#1)(1996-3#1)(1996-8#1)(2006-10#2)(2007-10#8)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#21)(2011-3#1)(2012-12#9)(2012-2#9)(2012-3#5)(2012-5#1)(2013-1#10)(2013-3#1)(2013-8#2)
predicts a##12##2##(1990-5#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
predicts an##3##2##(1995-9#1)(2008-1#1)(2008-3#1)
predicts mortality##2##2##(1990-5#1)(1997-7#1)
predicts other##2##2##(2007-11#1)(2010-7#1)
predicts some##2##2##(2008-11#1)(2008-3#1)
predicts that a##2##3##(1997-6#1)(2008-8#1)
predicts that cooperation can##2##4##(2008-8#2)
predicts that the##11##3##(1992-12#1)(1993-9#1)(1997-8#1)(2008-2#1)(2008-7#1)(2008-8#4)(2010-10#1)(2012-3#1)
predicts that this##2##3##(1995-8#1)(2008-10#1)
predicts that##52##2##(1992-12#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-9#1)(1995-8#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#14)(2008-9#8)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
predicts the##29##2##(1991-5#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-7#2)(2008-8#2)(2013-1#1)
predicts two##2##2##(1991-12#1)(1995-6#1)
predicts well the##2##3##(1997-2#1)(2008-9#1)
predicts well##3##2##(1992-5#1)(1997-2#1)(2008-9#1)
predicts##154##1##(1990-5#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#16)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#22)(2008-9#11)(2009-2#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
predilection for the head and neck##2##6##(2008-7#1)(2013-1#1)
predilection for the##4##3##(2008-7#1)(2013-1#3)
predilection for##9##2##(1991-8#1)(1994-2#1)(1997-1#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#3)
predispose for##2##2##(1993-2#1)(1997-4#1)
predispose some##2##2##(2008-10#1)(2009-12#1)
predispose to platelet aggregation##2##4##(1991-8#1)(1991-9#1)
predispose to the development of##5##5##(2006-10#1)(2008-11#1)(2011-2#2)(2012-2#1)
predispose to##21##2##(1991-8#1)(1991-9#1)(1992-2#2)(1997-8#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-2#2)
predispose##36##1##(1990-9#2)(1991-8#1)(1991-9#1)(1992-2#3)(1993-10#1)(1993-2#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2011-2#3)(2012-2#2)(2013-8#1)
predisposed to memorize##2##3##(2008-6#2)
predisposed to##8##2##(1992-6#1)(2008-6#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
predisposed##17##1##(1992-6#1)(1994-3#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-6#2)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
predisposes for##2##2##(1992-12#1)(2010-4#1)
predisposes to##7##2##(1990-2#1)(1995-12#1)(1996-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2013-1#1)
predisposes##11##1##(1990-2#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-4#1)(2013-1#1)
predisposing factor for##3##3##(1991-8#1)(2008-7#1)(2010-12#1)
predisposing factor##8##2##(1991-8#1)(1992-4#1)(1994-5#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-12#2)
predisposing factors and##2##3##(2008-1#1)(2008-5#1)
predisposing factors##21##2##(1990-11#1)(1992-1#1)(1997-3#1)(1997-9#1)(2006-10#1)(2008-1#2)(2008-5#4)(2008-7#1)(2009-3#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
predisposing gene##2##2##(1993-1#1)(2008-8#1)
predisposing lung conditions##2##3##(2007-12#2)
predisposing them to##2##3##(2008-1#1)(2008-4#1)
predisposing to##8##2##(1992-2#1)(1996-8#1)(1997-8#1)(2007-7#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
predisposing##56##1##(1990-11#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(1997-9#1)(2006-10#2)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
predisposition and environmental influences##2##4##(1995-2#1)(2008-10#1)
predisposition and environmental##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
predisposition and##5##2##(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
predisposition is##3##2##(1997-3#1)(2008-11#1)(2011-2#1)
predisposition of##3##2##(1991-12#1)(1994-5#1)(2008-4#1)
predisposition to LDL oxidation during copper-catalyzed oxidative modification##2##8##(1991-12#2)
predisposition to catalepsy##2##3##(2013-1#2)
predisposition to##24##2##(1990-5#1)(1991-12#2)(1993-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#3)
predisposition##50##1##(1990-5#2)(1991-12#3)(1993-6#1)(1994-5#1)(1995-2#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#3)(2008-4#1)(2008-7#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)
predispositions##2##1##(2008-10#1)(2008-12#1)
prednisolone and##2##2##(2008-1#1)(2008-4#1)
prednisolone for##2##2##(1994-3#1)(2008-1#1)
prednisolone in##2##2##(1995-5#1)(2011-1#1)
prednisolone##27##1##(1991-5#1)(1992-2#2)(1994-3#1)(1995-5#2)(1997-8#1)(2007-12#1)(2007-7#5)(2008-1#5)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#3)(2013-1#1)(2013-8#2)
prednisone and##3##2##(1991-5#1)(1994-12#1)(2013-1#1)
prednisone for##2##2##(1997-3#1)(2013-8#1)
prednisone##29##1##(1990-11#4)(1990-12#1)(1991-5#1)(1992-2#1)(1993-6#1)(1994-12#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-7#3)(2009-3#2)(2010-12#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
predominance in the##3##3##(1994-12#2)(2013-8#1)
predominance in##6##2##(1991-9#1)(1994-12#2)(2008-10#1)(2012-3#1)(2013-8#1)
predominance is##2##2##(1991-9#1)(1996-2#1)
predominance of a##3##3##(1990-12#1)(1993-2#1)(2013-8#1)
predominance of the##3##3##(2008-10#2)(2012-3#1)
predominance of##36##2##(1990-12#1)(1990-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-6#1)(1994-11#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-3#5)(2013-8#1)
predominance##53##1##(1990-12#1)(1990-8#1)(1991-9#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-12#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#6)(2013-8#2)
predominant among##2##2##(2008-10#1)(2008-11#1)
predominant and##2##2##(1994-2#1)(2013-8#1)
predominant clinical##3##2##(2007-10#1)(2008-9#2)
predominant component##2##2##(2008-10#1)(2008-12#1)
predominant for##2##2##(1997-1#1)(2007-11#1)
predominant genotype in##2##3##(2009-3#1)(2013-8#1)
predominant glucose transporter##2##3##(1993-6#2)
predominant in the##7##3##(1990-5#2)(2007-5#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
predominant in##24##2##(1990-5#2)(1991-4#2)(1994-2#3)(1995-3#1)(1996-6#1)(2007-5#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
predominant mode of##3##3##(2008-10#2)(2011-2#1)
predominant mode##5##2##(2008-10#4)(2011-2#1)
predominant mutations##2##2##(2008-4#2)
predominant pattern##2##2##(2011-2#1)(2012-3#1)
predominant serotype##2##2##(2008-5#1)(2013-8#1)
predominant species was##2##3##(2008-5#1)(2013-8#1)
predominant species##9##2##(1994-11#1)(1996-12#1)(2008-10#4)(2008-5#1)(2013-8#2)
predominant##202##1##(1990-11#1)(1990-5#2)(1990-6#1)(1991-11#2)(1991-4#3)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#5)(1994-6#1)(1994-8#4)(1995-11#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#6)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#42)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#10)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#10)
predominantly a##3##2##(1991-2#1)(2008-7#1)(2009-7#1)
predominantly as##2##2##(1993-6#1)(2008-2#1)
predominantly associated with##2##3##(1997-1#1)(2012-2#1)
predominantly at##2##2##(1993-11#1)(2008-10#1)
predominantly bound##2##2##(1992-12#1)(2010-6#1)
predominantly by##4##2##(1995-5#1)(2008-10#1)(2009-5#1)(2011-2#1)
predominantly detected in##2##3##(2008-10#2)
predominantly detected##3##2##(1992-3#1)(2008-10#2)
predominantly during##2##2##(1994-8#1)(1995-8#1)
predominantly expressed in the##6##4##(1994-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-7#1)
predominantly expressed in##9##3##(1992-8#1)(1994-2#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-7#1)(2009-8#1)
predominantly expressed##12##2##(1990-12#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
predominantly extracellular##2##2##(1992-8#1)(1996-12#1)
predominantly found in##2##3##(2008-10#1)(2008-7#1)
predominantly from##2##2##(2008-10#1)(2012-3#1)
predominantly in the posterior fossa##2##5##(2008-7#2)
predominantly in the##21##3##(1991-12#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
predominantly in##28##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
predominantly male##2##2##(2012-12#1)(2012-2#1)
predominantly mediated by##2##3##(1992-3#1)(2008-8#1)
predominantly nuclear##3##2##(1991-5#1)(2009-7#1)(2012-12#1)
predominantly of##2##2##(2008-5#1)(2012-2#1)
predominantly on the##2##3##(2008-10#1)(2008-5#1)
predominantly on##6##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
predominantly seen in##2##3##(1995-8#1)(2012-3#1)
predominantly the##4##2##(1991-12#2)(1993-11#1)(1994-8#1)
predominantly through##2##2##(1993-11#1)(2008-10#1)
predominantly to##5##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
predominantly##224##1##(1990-11#2)(1990-12#2)(1990-9#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#4)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#5)(1995-12#2)(1995-5#2)(1995-8#4)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#1)
predominate in the##3##3##(1997-3#1)(2008-10#1)(2013-7#1)
predominate in##6##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-7#1)
predominate##17##1##(1994-9#1)(1995-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
predominated in the##2##3##(2008-10#1)(2011-2#1)
predominated in##9##2##(1991-11#2)(2008-10#5)(2011-2#1)(2013-1#1)
predominated over the other##2##4##(2008-10#2)
predominated over##3##2##(2008-10#2)(2012-12#1)
predominated##28##1##(1990-11#1)(1990-6#1)(1991-11#2)(1991-5#1)(1993-6#1)(1994-11#2)(1994-9#1)(1996-6#1)(2008-10#8)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
predominately##12##1##(1993-2#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
predominates in##3##2##(1992-12#1)(1992-6#1)(2008-5#1)
predominates over##2##2##(1993-9#1)(2008-12#1)
predominates##9##1##(1990-6#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-11#1)(1997-1#1)(2008-12#1)(2008-5#1)(2013-8#1)
predominating in##2##2##(2008-5#1)(2013-1#1)
predominating##12##1##(1990-11#1)(1991-2#1)(2008-1#1)(2008-10#6)(2008-5#1)(2013-1#1)(2013-8#1)
predonation hemoglobin##2##2##(1996-9#2)
predonation##4##1##(1996-9#3)(2011-2#1)
predorsal##2##1##(1993-3#1)(2013-7#1)
preeclampsia and##6##2##(1996-11#1)(2007-10#2)(2008-10#1)(2008-11#2)
preeclampsia complicated with HELLP##2##4##(2008-4#2)
preeclampsia##28##1##(1996-11#1)(1997-8#1)(2007-10#3)(2008-10#1)(2008-11#7)(2008-4#3)(2009-1#1)(2009-8#3)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)
preeclampsia]##3##1##(1995-11#1)(2008-11#1)(2013-1#1)
preeclamptic##3##1##(2008-10#2)(2009-8#1)
preemptive##7##1##(2008-10#2)(2008-8#1)(2011-2#3)(2012-1#1)
preening##3##1##(2011-2#3)
preexisting pigmented skin lesion##2##4##(2007-10#2)
preexisting pigmented skin##3##3##(2007-10#3)
preexisting##21##1##(1992-3#1)(1992-8#1)(1994-2#1)(1996-11#1)(1996-3#1)(2007-10#3)(2007-7#1)(2008-10#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-3#1)
preexposure to##2##2##(1994-6#1)(2008-10#1)
preexposure##6##1##(1994-6#1)(2007-12#1)(2008-10#3)(2008-4#1)
prefabricated##3##1##(2007-11#1)(2008-4#1)(2013-1#1)
preface##3##1##(2009-11#1)(2009-4#1)(2010-5#1)
prefatigue values##2##2##(2013-8#2)
prefatory##2##1##(2008-10#1)(2010-7#1)
prefecture compared with##3##3##(1994-6#3)
prefecture##9##1##(1994-6#5)(2008-10#2)(2013-1#2)
prefectures##5##1##(1994-6#2)(1997-3#1)(2008-10#1)(2011-2#1)
prefer males with##2##3##(2008-8#1)(2008-9#1)
prefer to know the fetal sex as part of invasive##2##10##(2013-1#2)
prefer to##6##2##(1997-3#1)(2008-10#1)(2009-11#1)(2012-2#1)(2013-1#2)
prefer##20##1##(1992-5#1)(1993-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
preferable for the##3##3##(2007-8#1)(2008-10#2)
preferable for##4##2##(2007-8#1)(2008-10#3)
preferable to use##3##3##(2008-10#2)(2011-2#1)
preferable to##18##2##(1990-6#1)(1993-3#2)(1994-8#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
preferable##48##1##(1990-6#1)(1991-9#1)(1993-3#3)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#4)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#3)(2013-8#1)
preferably by##3##2##(1990-9#2)(1993-1#1)
preferably with##2##2##(1990-3#1)(2008-2#1)
preferably##40##1##(1990-3#1)(1990-9#2)(1991-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-12#3)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
preference &quot##2##2##(1996-3#1)(2008-9#1)
preference and the##2##3##(2008-2#1)(2008-8#1)
preference and##12##2##(1992-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#4)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
preference between##2##2##(1993-6#1)(2010-2#1)
preference for Spanish language were associated with##2##7##(2009-5#2)
preference for an##2##3##(1996-12#1)(2007-2#1)
preference for the benzoyl peroxide foaming cloth##2##7##(2010-8#2)
preference for the##10##3##(1990-11#1)(1992-3#2)(1995-6#1)(1996-2#2)(2008-4#1)(2008-9#1)(2010-8#2)
preference for##45##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-2#1)(1992-3#3)(1992-6#1)(1993-11#1)(1994-12#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(2007-12#1)(2007-2#2)(2007-5#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-9#2)(2010-3#1)(2010-8#2)(2012-3#2)(2013-7#1)
preference given to##2##3##(1993-6#1)(2008-8#1)
preference in a##2##3##(1994-8#1)(2012-2#1)
preference in##9##2##(1990-11#2)(1991-1#1)(1992-6#1)(1994-8#1)(1997-5#1)(2007-12#1)(2008-4#1)(2012-2#1)
preference is##6##2##(1992-3#1)(1992-6#1)(1993-6#1)(2008-3#1)(2008-4#1)(2008-8#1)
preference occurs##2##2##(2008-8#1)(2012-12#1)
preference of##15##2##(1990-11#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-9#1)(1995-2#1)(1996-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-8#1)
preference on##2##2##(2009-11#2)
preference test and operant conditioning##2##5##(2010-2#2)
preference test and##3##3##(1994-8#1)(2010-2#2)
preference test in##2##3##(1997-2#1)(2008-4#1)
preference test##6##2##(1992-3#1)(1994-8#1)(1997-2#1)(2008-4#1)(2010-2#2)
preference tests##3##2##(2008-10#1)(2008-5#2)
preference to##8##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-9#4)(2012-12#1)
preference was##3##2##(1995-5#1)(2008-10#1)(2013-8#1)
preference were##3##2##(1992-3#1)(2007-12#2)
preference##183##1##(1990-11#4)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-3#8)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#4)(1994-12#4)(1994-2#1)(1994-7#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#10)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#5)(2008-6#1)(2008-8#17)(2008-9#11)(2009-11#4)(2009-12#1)(2009-5#3)(2009-8#3)(2009-9#3)(2010-10#1)(2010-2#5)(2010-3#2)(2010-8#5)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#2)
preference)##2##1##(2008-8#2)
preferences among##2##2##(2008-2#1)(2011-2#1)
preferences and##9##2##(1992-2#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-2#1)(2013-1#1)
preferences are##4##2##(2008-8#1)(2008-9#1)(2009-9#2)
preferences between##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
preferences by##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
preferences for body##3##3##(2007-12#3)
preferences for different##3##3##(2008-5#1)(2009-9#1)(2010-8#1)
preferences for the##4##3##(1992-3#1)(2008-8#2)(2013-1#1)
preferences for##39##2##(1990-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#2)(2007-12#5)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#3)(2009-11#2)(2009-9#6)(2010-1#2)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#3)
preferences have##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
preferences in the##2##3##(2009-6#1)(2010-8#1)
preferences in##17##2##(1994-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-9#3)(2010-8#1)(2011-2#1)(2012-2#1)
preferences of##18##2##(1995-5#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
preferences on##2##2##(2008-5#1)(2010-3#1)
preferences than##2##2##(2012-12#1)(2012-3#1)
preferences to##3##2##(2008-8#1)(2010-1#1)(2012-12#1)
preferences were##3##2##(1993-12#1)(2010-3#1)(2012-12#1)
preferences##147##1##(1990-3#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#3)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1997-2#1)(2006-10#1)(2007-12#9)(2007-2#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#14)(2008-9#11)(2009-11#5)(2009-12#1)(2009-6#3)(2009-8#1)(2009-9#11)(2010-1#3)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#5)(2011-1#1)(2011-10#1)(2011-2#7)(2012-12#10)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#3)
preferential accumulation of##3##3##(1995-3#1)(2008-11#1)(2012-2#1)
preferential binding to##2##3##(1995-8#1)(1997-2#1)
preferential binding##3##2##(1995-8#1)(1997-2#2)
preferential interaction##2##2##(1995-5#1)(1997-2#1)
preferential site of##2##3##(1992-3#1)(1993-8#1)
preferential solvation##2##2##(2008-10#1)(2010-7#1)
preferential uptake of##2##3##(1997-1#1)(2008-10#1)
preferential##59##1##(1990-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
preferential-order volume grating waveguide##2##4##(2008-3#2)
preferentially activated by##2##3##(2008-11#1)(2008-4#1)
preferentially at##2##2##(2008-4#1)(2011-1#1)
preferentially attached##2##2##(1994-6#1)(2008-1#1)
preferentially binds##3##2##(1995-11#1)(2007-11#1)(2008-11#1)
preferentially by##2##2##(1990-12#1)(1993-11#1)
preferentially expressed in##5##3##(1997-2#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)
preferentially expressed##6##2##(1995-8#1)(1997-2#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)
preferentially in##5##2##(1995-5#1)(1997-2#2)(2008-10#1)(2008-8#1)
preferentially induced##2##2##(2008-10#1)(2008-5#1)
preferentially inhibit##2##2##(1990-2#1)(2013-1#1)
preferentially inhibited##2##2##(1995-2#1)(2008-10#1)
preferentially oriented##2##2##(2008-2#1)(2008-3#1)
preferentially to the##7##3##(1992-3#1)(1993-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-8#1)(2009-8#1)
preferentially to##11##2##(1990-12#2)(1992-3#1)(1993-9#1)(1994-5#1)(1996-2#1)(1997-2#2)(2007-11#1)(2008-8#1)(2009-8#1)
preferentially with the##2##3##(1990-5#1)(1995-5#1)
preferentially with##3##2##(1990-5#1)(1995-5#1)(2008-10#1)
preferentially##108##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#2)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-2#2)(1997-1#2)(1997-2#5)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-4#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
preferred alternative to##2##3##(2008-2#1)(2013-1#1)
preferred alternative##3##2##(1997-6#1)(2008-2#1)(2013-1#1)
preferred an average-length call over##2##5##(2009-9#2)
preferred and##2##2##(2008-3#1)(2008-9#1)
preferred by##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
preferred drug##2##2##(2011-10#1)(2013-1#1)
preferred for##4##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
preferred host##2##2##(2008-9#1)(2011-2#1)
preferred in##5##2##(1992-4#1)(1997-3#1)(2008-3#2)(2010-5#1)
preferred method for##2##3##(2007-12#1)(2011-1#1)
preferred method of##3##3##(1994-1#1)(2008-7#1)(2010-7#1)
preferred method##7##2##(1994-1#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)
preferred music##2##2##(2007-6#2)
preferred orientation##7##2##(1995-6#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)
preferred over##6##2##(1991-11#1)(1995-2#2)(2010-8#1)(2011-2#1)(2012-12#1)
preferred procedure for##2##3##(2011-2#2)
preferred provider organizations (PPOs)##2##4##(1991-3#1)(1994-1#1)
preferred provider organizations##4##3##(1991-3#1)(1992-2#1)(1993-12#1)(1994-1#1)
preferred provider##6##2##(1991-3#2)(1992-2#1)(1993-12#1)(1994-1#1)(2008-4#1)
preferred resources##2##2##(2008-9#2)
preferred strategy for##2##3##(1996-12#1)(2012-3#1)
preferred strategy##5##2##(1996-12#1)(2008-5#1)(2012-3#3)
preferred target##2##2##(2010-12#1)(2011-2#1)
preferred technique##2##2##(2007-8#1)(2008-10#1)
preferred temperature##2##2##(2011-2#2)
preferred the##6##2##(1992-3#1)(1995-12#1)(1995-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
preferred to use##2##3##(1993-12#1)(2013-8#1)
preferred to visit##2##3##(2008-8#2)
preferred to##16##2##(1993-12#1)(1994-6#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-9#1)(2013-1#2)(2013-8#2)
preferred treatment##4##2##(1996-3#1)(2007-7#1)(2008-10#1)(2010-3#1)
preferred using##2##2##(1993-2#1)(2013-8#1)
preferred##196##1##(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1994-1#2)(1994-11#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#7)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#15)(2008-11#6)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#10)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#5)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#14)
preferring##11##1##(1994-5#2)(1995-6#1)(2007-12#1)(2008-9#1)(2009-9#5)(2010-12#1)
prefers the##2##2##(2008-8#1)(2009-10#1)
prefers##3##1##(2008-4#1)(2008-8#1)(2009-10#1)
prefixes##2##1##(1993-12#1)(2008-9#1)
preflexion##3##1##(2008-5#3)
preflight##2##1##(2008-2#1)(2008-3#1)
preform was##2##2##(1990-8#1)(2008-2#1)
preform##7##1##(1990-8#1)(2007-12#1)(2008-2#3)(2008-3#2)
preformed DAPs in##2##3##(2010-5#2)
preformed DAPs##4##2##(2010-5#4)
preformed antifungal diene##2##3##(2008-10#2)
preformed antifungal##3##2##(2008-10#3)
preformed in the##2##3##(1990-12#1)(2008-10#1)
preformed in##4##2##(1990-12#1)(2008-10#2)(2008-11#1)
preformed metal##2##2##(2013-1#2)
preformed##31##1##(1990-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#3)(2009-5#1)(2010-5#4)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
preformulated##2##1##(2007-10#1)(2008-4#1)
prefractionation is##2##2##(2008-4#2)
prefractionation##4##1##(2008-4#4)
prefrontal activity##2##2##(2008-11#2)
prefrontal and##3##2##(1993-12#1)(1997-2#1)(2008-11#1)
prefrontal cortex (PFC)##6##3##(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)(2013-8#2)
prefrontal cortex and the##2##4##(1994-8#1)(2008-7#1)
prefrontal cortex and##8##3##(1991-12#1)(1994-3#1)(1994-8#1)(2008-11#3)(2008-7#1)(2013-8#1)
prefrontal cortex in##2##3##(1997-2#1)(2010-7#1)
prefrontal cortex induced by##2##4##(1994-8#1)(1997-2#1)
prefrontal cortex is##3##3##(2008-11#1)(2008-6#2)
prefrontal cortex of##5##3##(1994-3#1)(1995-12#1)(2008-10#1)(2009-12#2)
prefrontal cortex##60##2##(1991-12#1)(1991-4#1)(1991-5#1)(1993-6#1)(1994-2#1)(1994-3#4)(1994-8#5)(1995-12#1)(1996-2#4)(1996-5#3)(1997-2#3)(2007-8#3)(2008-10#2)(2008-11#13)(2008-6#4)(2008-7#3)(2009-12#2)(2010-7#2)(2012-1#1)(2013-1#2)(2013-8#3)
prefrontal cortical##4##2##(1991-2#2)(1995-12#1)(2008-6#1)
prefrontal lesions##3##2##(1993-3#3)
prefrontal sulcal prominence##5##3##(1996-7#5)
prefrontal##98##1##(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1993-12#1)(1993-3#4)(1993-6#1)(1994-2#1)(1994-3#4)(1994-8#7)(1995-12#3)(1996-2#5)(1996-5#4)(1996-7#5)(1997-2#6)(1997-8#1)(2007-8#4)(2008-10#2)(2008-11#22)(2008-6#5)(2008-7#3)(2009-12#2)(2010-7#2)(2011-2#2)(2012-1#2)(2013-1#2)(2013-8#4)
preganglionic sympathetic neurones##2##3##(1995-12#2)
preganglionic##5##1##(1995-12#3)(2008-9#2)
preglobular##2##1##(2011-2#2)
pregnancies after in vitro fertilization##2##5##(1995-6#2)
pregnancies after##3##2##(1994-12#1)(1995-6#2)
pregnancies and lactations##2##3##(1992-5#2)
pregnancies and##15##2##(1991-3#1)(1992-4#1)(1992-5#2)(1993-3#1)(1997-2#1)(2007-11#1)(2008-1#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)
pregnancies are##3##2##(1991-6#1)(2008-11#1)(2008-7#1)
pregnancies by##2##2##(1992-6#1)(2013-1#1)
pregnancies complicated by##2##3##(2011-2#1)(2013-1#1)
pregnancies has##2##2##(1992-4#1)(2008-11#1)
pregnancies have##2##2##(1991-1#1)(1993-1#1)
pregnancies in##6##2##(1990-9#1)(1991-3#1)(1992-4#1)(1994-3#1)(2008-3#1)(2011-1#1)
pregnancies is##3##2##(1994-2#1)(2010-8#1)(2013-1#1)
pregnancies of##2##2##(1994-9#1)(1997-3#1)
pregnancies resulted in##2##3##(2008-3#1)(2013-1#1)
pregnancies were##6##2##(1990-10#1)(1990-8#1)(2007-7#1)(2008-11#1)(2008-9#1)(2011-2#1)
pregnancies with fetal##2##3##(1995-8#1)(2008-3#1)
pregnancies with##5##2##(1995-8#1)(1996-12#1)(2008-3#1)(2012-12#2)
pregnancies##109##1##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-4#4)(1992-5#2)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#4)(1995-8#2)(1996-11#1)(1996-12#3)(1996-3#2)(1997-2#3)(1997-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#5)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#9)
pregnancy a##3##2##(1990-6#1)(2007-11#1)(2013-1#1)
pregnancy after##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
pregnancy and a##2##3##(1992-10#1)(1997-7#1)
pregnancy and birth outcomes##2##4##(1997-7#1)(2013-1#1)
pregnancy and birth rate was##2##5##(1994-9#2)
pregnancy and birth##6##3##(1994-9#2)(1997-7#1)(2007-2#1)(2009-10#1)(2013-1#1)
pregnancy and childbearing##2##3##(1995-1#1)(2012-12#1)
pregnancy and fecundity rates##2##4##(2008-12#2)
pregnancy and in##3##3##(1990-9#1)(1995-12#1)(2012-2#1)
pregnancy and its effect on perinatal##2##6##(2012-3#2)
pregnancy and its##4##3##(1995-12#1)(2012-3#3)
pregnancy and labour##2##3##(1990-11#1)(1992-4#1)
pregnancy and lactation##6##3##(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)
pregnancy and lactation]##2##3##(1991-6#1)(2008-11#1)
pregnancy and postpartum##3##3##(2008-9#3)
pregnancy and pregnancy##2##3##(1994-9#1)(1996-12#1)
pregnancy and to##2##3##(1990-6#1)(2013-8#1)
pregnancy and##80##2##(1990-11#2)(1990-6#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-8#1)(1996-12#1)(1996-9#1)(1997-7#2)(2007-11#1)(2007-2#3)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#3)(2013-8#1)
pregnancy are discussed##2##3##(1995-6#1)(2008-4#1)
pregnancy are##8##2##(1991-3#1)(1995-6#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-6#1)(2012-12#2)
pregnancy as##3##2##(1995-6#1)(1996-9#1)(2009-5#1)
pregnancy at the##2##3##(1990-8#1)(1995-8#1)
pregnancy at##4##2##(1990-8#1)(1994-8#1)(1995-8#1)(2013-1#1)
pregnancy because##2##2##(2009-1#1)(2013-1#1)
pregnancy but##3##2##(1994-9#1)(2008-7#1)(2010-6#1)
pregnancy can##5##2##(1992-5#1)(2008-2#1)(2008-4#1)(2009-1#1)(2009-3#1)
pregnancy complicated by fetal##2##4##(1990-9#1)(2012-3#1)
pregnancy complicated by##4##3##(1990-9#1)(2006-10#1)(2012-3#1)(2013-1#1)
pregnancy complications##6##2##(1994-12#1)(2008-11#2)(2012-3#1)(2013-1#2)
pregnancy failure##2##2##(1996-12#2)
pregnancy for##2##2##(2008-7#1)(2010-12#1)
pregnancy had a##2##3##(1994-12#1)(2010-11#1)
pregnancy had##3##2##(1992-6#1)(1994-12#1)(2010-11#1)
pregnancy has been reported in##2##5##(1990-6#1)(1994-3#1)
pregnancy has been##3##3##(1990-6#1)(1994-3#1)(1995-6#1)
pregnancy has to be##2##4##(1990-9#1)(2008-7#1)
pregnancy has##8##2##(1990-6#1)(1990-9#1)(1992-5#1)(1994-3#1)(1995-6#1)(2008-11#1)(2008-7#2)
pregnancy have been##2##3##(1993-3#1)(2011-1#1)
pregnancy in a##6##3##(1992-12#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
pregnancy in group##2##3##(1991-3#1)(2012-2#1)
pregnancy in the next year##2##5##(2011-1#2)
pregnancy in the##7##3##(1990-2#1)(1992-6#1)(1996-6#1)(2007-11#1)(2008-9#1)(2011-1#2)
pregnancy in##27##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-6#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnancy induced##3##2##(2008-1#1)(2008-4#2)
pregnancy is a##8##3##(1997-2#1)(2008-2#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#2)
pregnancy is rare##2##3##(1992-10#1)(2009-3#1)
pregnancy is##21##2##(1990-9#1)(1992-10#1)(1994-3#1)(1994-7#1)(1997-2#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#5)
pregnancy loss in##2##3##(1994-9#1)(2012-3#1)
pregnancy loss##10##2##(1994-9#3)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)
pregnancy may be##2##3##(1994-8#1)(2012-3#1)
pregnancy may##6##2##(1992-4#1)(1994-8#1)(2009-3#1)(2012-3#1)(2013-1#2)
pregnancy might be##2##3##(1992-2#1)(2008-11#1)
pregnancy occurred in##2##3##(1991-12#1)(1991-3#1)
pregnancy of##4##2##(1994-9#1)(1995-8#1)(2010-11#1)(2011-1#1)
pregnancy on##5##2##(1995-12#1)(1996-12#1)(1997-7#2)(2013-1#1)
pregnancy or##11##2##(1991-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#2)(2012-3#1)(2013-8#1)
pregnancy outcome in##4##3##(1991-12#1)(1992-2#1)(2011-1#2)
pregnancy outcome##14##2##(1991-12#1)(1992-2#2)(1992-9#1)(1996-12#1)(2008-11#2)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)
pregnancy outcomes##7##2##(2007-12#1)(2008-11#1)(2009-9#1)(2011-2#2)(2013-1#2)
pregnancy rate in##2##3##(2007-10#2)
pregnancy rate##6##2##(1991-11#1)(1992-1#1)(1994-12#1)(2007-10#2)(2008-10#1)
pregnancy rates to those##2##4##(1991-3#1)(1992-2#1)
pregnancy rates##12##2##(1991-12#2)(1991-3#3)(1992-2#3)(1994-12#2)(1996-9#1)(2011-1#1)
pregnancy serum##2##2##(1991-6#1)(2008-10#1)
pregnancy significantly##2##2##(2008-9#1)(2009-9#1)
pregnancy termination##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
pregnancy tests##2##2##(2011-2#1)(2013-1#1)
pregnancy the##3##2##(1990-12#1)(1991-12#1)(1994-8#1)
pregnancy to##6##2##(1990-8#1)(1995-8#1)(1996-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
pregnancy was##9##2##(1992-11#1)(1993-3#2)(1995-6#1)(2008-4#1)(2011-1#2)(2012-3#1)(2013-1#1)
pregnancy were##6##2##(1990-9#1)(1995-12#3)(2011-2#1)(2013-1#1)
pregnancy when##2##2##(1993-12#1)(1994-3#1)
pregnancy with##8##2##(1996-12#1)(2008-1#1)(2008-3#1)(2009-1#1)(2010-8#2)(2011-2#1)(2012-2#1)
pregnancy##631##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#4)(1990-6#7)(1990-8#5)(1990-9#8)(1991-1#1)(1991-11#5)(1991-12#9)(1991-2#3)(1991-3#14)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#5)(1992-11#1)(1992-12#7)(1992-2#8)(1992-4#3)(1992-5#8)(1992-6#2)(1992-9#1)(1993-10#1)(1993-12#4)(1993-2#3)(1993-3#4)(1994-12#7)(1994-2#1)(1994-3#13)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#13)(1995-1#1)(1995-12#12)(1995-3#1)(1995-6#12)(1995-8#12)(1996-11#7)(1996-12#15)(1996-3#3)(1996-6#2)(1996-8#3)(1996-9#4)(1997-2#4)(1997-4#3)(1997-5#1)(1997-7#5)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#8)(2007-12#5)(2007-2#7)(2007-7#9)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#9)(2008-11#22)(2008-12#9)(2008-2#8)(2008-3#2)(2008-4#22)(2008-5#2)(2008-7#13)(2008-8#3)(2008-9#8)(2009-1#7)(2009-10#2)(2009-12#2)(2009-3#11)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-6#6)(2010-8#5)(2011-1#31)(2011-2#22)(2012-1#3)(2012-12#21)(2012-2#11)(2012-3#34)(2012-8#3)(2013-1#56)(2013-7#1)(2013-8#7)
pregnancy-associated diseases with abnormal fetal growth##2##6##(2008-10#2)
pregnancy-associated##9##1##(1994-8#1)(1994-9#1)(2008-10#2)(2012-3#1)(2013-1#4)
pregnancy-induced hypertension##14##2##(1990-3#5)(1994-3#1)(2010-10#1)(2011-2#4)(2012-2#2)(2013-1#1)
pregnancy-induced hypertensive##2##2##(1994-3#1)(2011-2#1)
pregnancy-induced##16##1##(1990-3#5)(1994-3#2)(2010-10#1)(2011-2#5)(2012-2#2)(2013-1#1)
pregnancy?##4##1##(1995-6#1)(2008-11#1)(2008-3#1)(2013-1#1)
pregnancy]##21##1##(1990-2#1)(1991-11#1)(1991-3#1)(1992-4#1)(1992-5#2)(1993-9#1)(1994-6#1)(1996-11#4)(1997-2#1)(1997-8#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
pregnanediol##2##1##(1990-2#1)(1990-8#1)
pregnant adolescents##2##2##(2007-2#2)
pregnant and non-pregnant##2##3##(1994-8#1)(2010-6#1)
pregnant and puerperal women##3##4##(1995-6#3)
pregnant and##15##2##(1990-11#2)(1994-8#1)(1995-6#3)(1996-8#1)(2009-9#1)(2010-6#2)(2011-2#3)(2013-1#2)
pregnant cows##2##2##(1991-3#2)
pregnant female##4##2##(1990-11#1)(2008-7#1)(2009-4#1)(2012-1#1)
pregnant females in##2##3##(2013-7#2)
pregnant females##7##2##(2008-10#2)(2008-7#1)(2010-11#1)(2013-7#3)
pregnant group##2##2##(1990-11#1)(1990-3#1)
pregnant lady##3##2##(2011-1#3)
pregnant mare serum##2##3##(2008-5#1)(2008-8#1)
pregnant mice##2##2##(1991-12#1)(2008-9#1)
pregnant mother##2##2##(1990-9#1)(2012-3#1)
pregnant mothers##2##2##(2007-7#1)(2008-10#1)
pregnant or##2##2##(2007-2#1)(2008-3#1)
pregnant patients were##3##3##(1993-10#2)(2008-11#1)
pregnant patients##9##2##(1993-10#4)(1993-12#1)(2007-7#1)(2008-11#1)(2009-1#1)(2013-1#1)
pregnant personnel##2##2##(1993-12#2)
pregnant rats##5##2##(1990-11#2)(1993-12#1)(2008-11#1)(2012-1#1)
pregnant uterus##4##2##(2008-7#2)(2008-8#2)
pregnant woman##9##2##(1990-6#1)(1991-9#1)(1992-9#1)(1997-7#1)(1997-8#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-8#1)
pregnant women and their##3##4##(2007-12#1)(2011-1#1)(2012-2#1)
pregnant women and women with##2##5##(1992-12#1)(2013-1#1)
pregnant women and##8##3##(1992-12#1)(1994-3#1)(2007-12#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
pregnant women are##4##3##(1993-3#1)(2008-12#1)(2009-4#1)(2012-3#1)
pregnant women at##4##3##(1990-3#1)(1990-9#1)(2010-8#2)
pregnant women attending##2##3##(2010-8#1)(2013-1#1)
pregnant women from##4##3##(1995-8#1)(2007-12#1)(2008-7#1)(2011-2#1)
pregnant women had##3##3##(1990-8#1)(1997-4#1)(2012-12#1)
pregnant women in the##5##4##(1994-6#1)(2007-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
pregnant women in##21##3##(1990-2#1)(1990-6#3)(1994-6#2)(1995-2#1)(1997-6#1)(2007-12#1)(2009-7#1)(2010-6#3)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnant women is##4##3##(1992-11#1)(2007-7#1)(2010-8#1)(2013-1#1)
pregnant women living in##2##4##(1991-8#1)(2012-12#1)
pregnant women still##2##3##(1991-11#1)(1995-6#1)
pregnant women to##3##3##(1992-4#1)(2007-2#2)
pregnant women were##5##3##(2008-10#1)(2010-8#2)(2011-2#1)(2012-3#1)
pregnant women who##4##3##(1990-6#1)(1995-6#1)(2008-3#1)(2010-8#1)
pregnant women whose##2##3##(2008-10#1)(2011-1#1)
pregnant women with risk factors##2##5##(2012-2#2)
pregnant women with symptoms of##2##5##(2008-11#2)
pregnant women with##10##3##(1996-11#1)(2008-1#1)(2008-11#3)(2011-1#2)(2012-2#2)(2013-8#1)
pregnant women##155##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#4)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#6)(1995-8#3)(1996-11#3)(1996-12#1)(1996-3#1)(1997-3#2)(1997-4#3)(1997-6#1)(2006-10#1)(2007-12#6)(2007-2#7)(2007-7#4)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-4#5)(2009-7#1)(2010-6#4)(2010-7#1)(2010-8#7)(2011-1#12)(2011-2#5)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#12)(2013-8#2)
pregnant women's##3##2##(1995-6#2)(2008-10#1)
pregnant women]##2##2##(1991-9#1)(1992-4#1)
pregnant##269##1##(1990-11#6)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#3)(1992-9#1)(1993-10#4)(1993-12#6)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#13)(1995-8#3)(1996-11#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#6)(2007-2#14)(2007-7#6)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#8)(2008-8#6)(2008-9#1)(2009-1#2)(2009-10#1)(2009-4#6)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-6#6)(2010-7#1)(2010-8#8)(2011-1#17)(2011-2#11)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#8)(2013-1#16)(2013-7#4)(2013-8#2)
pregnenolone fatty acid esters##2##4##(1991-9#2)
pregnenolone production##4##2##(2012-2#4)
pregnenolone production&quot##5##2##(2012-2#5)
pregnenolone sulfate##7##2##(1996-2#7)
pregnenolone##22##1##(1990-11#1)(1991-9#3)(1996-2#9)(2012-2#9)
pregomisin##2##1##(2008-11#2)
preharvest##5##1##(2008-10#5)
prehaustorial resistance to P##2##4##(2008-10#2)
prehaustorial resistance to##3##3##(2008-10#3)
prehaustorial resistance##4##2##(2008-10#4)
prehaustorial##8##1##(2008-10#8)
preheated glassy carbon electrode modified with##2##6##(2008-10#2)
preheated glassy carbon electrode##3##4##(2008-10#3)
preheated##5##1##(1994-11#1)(2008-10#3)(2008-2#1)
prehension##6##1##(1996-2#4)(2008-7#2)
prehistoric##2##1##(2008-9#1)(2013-1#1)
prehospital adjustment##3##2##(1993-1#3)
prehospital cardiac arrest##2##3##(1990-12#2)
prehospital phase of##2##3##(2007-9#2)
prehospital##15##1##(1990-12#2)(1991-2#2)(1993-1#3)(1994-3#1)(2007-9#3)(2008-3#2)(2008-7#1)(2008-9#1)
prehospitalization##3##1##(1993-1#1)(2008-7#2)
prehydrolysate##2##1##(2008-6#2)
preimmune serum and##2##3##(1991-9#1)(1996-12#1)
preimmune serum##5##2##(1990-11#1)(1991-9#2)(1994-9#1)(1996-12#1)
preimplantation embryo##2##2##(2008-4#1)(2008-5#1)
preimplantation embryos##2##2##(1995-2#2)
preimplantation genetic diagnosis##3##3##(2008-4#2)(2012-3#1)
preimplantation##14##1##(1991-2#1)(1995-2#3)(2008-4#3)(2008-5#4)(2008-8#1)(2012-3#1)(2013-1#1)
preincubated with##9##2##(1992-12#1)(1993-6#1)(1994-8#4)(1995-12#1)(1995-6#2)
preincubated##11##1##(1992-12#1)(1993-6#1)(1994-3#1)(1994-8#4)(1995-12#1)(1995-6#2)(2008-8#1)
preincubating the##2##2##(1993-8#1)(1994-6#1)
preincubating##3##1##(1993-8#1)(1994-6#1)(2008-8#1)
preincubation of the Latex beads with##2##6##(2008-6#2)
preincubation of the##5##3##(1992-8#1)(1997-1#1)(2008-5#1)(2008-6#2)
preincubation of##12##2##(1991-12#1)(1991-9#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#1)
preincubation time##2##2##(1991-8#1)(1992-12#1)
preincubation with##6##2##(1990-5#1)(1991-9#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-11#1)
preincubation##26##1##(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-9#1)
preinoculated with##2##2##(2008-10#2)
preinoculated##5##1##(2008-10#5)
preinoculation with##2##2##(2008-10#2)
preinoculation##4##1##(2008-10#4)
preintegration complex##2##2##(1997-3#1)(2009-11#1)
preintensification time##2##2##(2008-10#2)
preirrigated with##2##2##(2008-10#2)
prejudice and hate crimes##2##4##(2008-12#2)
prejudice##15##1##(1994-3#1)(2008-11#2)(2008-12#7)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
prejudiced##2##1##(1993-11#1)(1997-7#1)
prejudices##6##1##(1992-6#1)(1994-1#1)(2008-5#1)(2009-7#1)(2013-1#2)
prejudicial##2##1##(1990-2#1)(2008-9#1)
prelabeled with##4##2##(1990-12#1)(1991-12#1)(1997-2#1)(2008-7#1)
prelabelled with##4##2##(1990-12#3)(1990-2#1)
prelabelled##6##1##(1990-12#4)(1990-2#1)(1993-6#1)
prelamin A##2##2##(2011-2#2)
prelaunch calibration##2##2##(2008-3#2)
prelaunch##5##1##(2008-3#5)
preleptotene##3##1##(2009-10#2)(2012-2#1)
prelicensure##2##1##(2008-10#2)
prelimbic cortex##2##2##(1993-6#2)
prelimbic##3##1##(1993-6#2)(1995-12#1)
preliminarily##4##1##(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
preliminary advances in##2##3##(2009-2#2)
preliminary analysis##6##2##(2008-3#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
preliminary assessment of##3##3##(1992-2#1)(1993-9#1)(2008-3#1)
preliminary assessment##4##2##(1992-2#1)(1993-9#1)(2008-3#1)(2013-1#1)
preliminary conclusion##2##2##(2008-5#1)(2009-6#1)
preliminary data from the##2##4##(1994-1#1)(2008-4#1)
preliminary data from##3##3##(1994-1#1)(2008-11#1)(2008-4#1)
preliminary data on the##3##4##(1995-12#1)(2008-9#1)(2009-5#1)
preliminary data on##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2009-5#1)
preliminary data that##2##3##(2008-7#1)(2008-8#1)
preliminary data##20##2##(1992-12#2)(1994-1#1)(1995-12#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
preliminary definitions##2##2##(2011-1#2)
preliminary diagnosis##3##2##(1995-11#1)(2008-6#1)(2012-3#1)
preliminary evaluation of##6##3##(1990-5#1)(1991-12#1)(2008-10#2)(2008-12#1)(2012-12#1)
preliminary evaluation##8##2##(1990-5#1)(1991-12#1)(1993-1#1)(2008-10#3)(2008-12#1)(2012-12#1)
preliminary evidence for the##3##4##(2008-12#2)(2012-2#1)
preliminary evidence of##2##3##(1995-3#1)(1995-5#1)
preliminary evidence that##2##3##(2008-12#2)
preliminary evidence##10##2##(1993-3#1)(1995-3#1)(1995-5#1)(2008-12#4)(2008-4#1)(2010-5#1)(2012-2#1)
preliminary experience##5##2##(1990-8#1)(2007-8#4)
preliminary experiment##2##2##(2008-2#1)(2008-5#1)
preliminary experimental results##3##3##(2007-11#1)(2008-3#1)(2012-12#1)
preliminary experimental##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2012-12#1)
preliminary experiments were##2##3##(2008-10#1)(2008-3#1)
preliminary experiments##10##2##(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#1)
preliminary findings from##3##3##(2012-2#1)(2013-1#2)
preliminary findings of##3##3##(1990-3#1)(1995-6#1)(2011-2#1)
preliminary findings suggest that##2##4##(1994-11#1)(2013-1#1)
preliminary findings##14##2##(1990-3#1)(1991-1#3)(1992-1#1)(1994-11#1)(1995-6#1)(1996-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
preliminary genetic##2##2##(2008-10#1)(2011-2#1)
preliminary identification of##2##3##(2008-8#1)(2009-7#1)
preliminary in nature##2##3##(2008-6#1)(2010-11#1)
preliminary in##3##2##(2008-5#1)(2008-6#1)(2010-11#1)
preliminary investigation##13##2##(1990-2#1)(1990-6#1)(1991-1#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#4)(2010-3#1)(2011-2#1)
preliminary molecular##2##2##(2008-11#1)(2013-7#1)
preliminary multivariate##2##2##(1994-6#1)(2008-10#1)
preliminary nutrient##2##2##(2008-10#1)(2008-8#1)
preliminary observations##2##2##(2006-10#1)(2008-6#1)
preliminary report from##2##3##(1994-3#1)(2007-7#1)
preliminary report on##2##3##(1993-2#1)(2007-7#1)
preliminary report##16##2##(1990-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(1997-5#1)(2007-7#5)(2008-10#2)(2008-9#1)(2009-5#1)
preliminary research on the##2##4##(2010-3#1)(2013-8#1)
preliminary result##2##2##(2010-12#1)(2011-2#1)
preliminary results and##3##3##(1992-8#1)(2009-3#1)(2010-12#1)
preliminary results demonstrated the##2##4##(2008-8#1)(2010-12#1)
preliminary results from##3##3##(1997-3#1)(2007-8#1)(2012-1#1)
preliminary results indicate that##4##4##(2007-8#1)(2008-1#1)(2008-10#2)
preliminary results of##12##3##(1996-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#3)(2011-1#1)(2011-2#1)(2013-8#1)
preliminary results on the##2##4##(2008-3#1)(2008-8#1)
preliminary results on##3##3##(2008-3#1)(2008-8#1)(2013-1#1)
preliminary results show that##3##4##(1990-2#1)(2007-8#1)(2008-10#1)
preliminary results show##4##3##(1990-2#1)(2007-8#1)(2008-10#1)(2008-5#1)
preliminary results suggest that##6##4##(1990-12#1)(1990-5#1)(1992-12#1)(1995-4#1)(1997-4#1)(2011-2#1)
preliminary results suggest##7##3##(1990-12#1)(1990-5#1)(1992-12#1)(1995-4#1)(1997-4#1)(2011-2#1)(2012-2#1)
preliminary results support the##2##4##(1992-6#1)(2010-10#1)
preliminary results that##2##3##(1995-12#1)(2008-3#1)
preliminary results##66##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-8#5)(2008-1#3)(2008-10#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
preliminary results]##3##2##(1993-6#1)(2007-8#1)(2011-2#1)
preliminary screening of##2##3##(2008-10#1)(2009-10#1)
preliminary stages##2##2##(2007-12#2)
preliminary studies##3##2##(2008-10#1)(2010-11#1)(2011-2#1)
preliminary study of##5##3##(2008-2#1)(2010-10#1)(2010-7#1)(2013-8#2)
preliminary study on the##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
preliminary study on##4##3##(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
preliminary study was conducted##2##4##(2007-7#1)(2011-2#1)
preliminary study was##4##3##(1993-12#1)(2007-7#1)(2008-5#1)(2011-2#1)
preliminary study##41##2##(1991-9#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
preliminary survey##2##2##(2008-10#2)
preliminary targets##2##2##(1991-2#2)
preliminary tests##4##2##(2008-10#4)
preliminary##380##1##(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-1#6)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-7#6)(2007-8#12)(2008-1#4)(2008-10#57)(2008-11#8)(2008-12#11)(2008-2#6)(2008-3#18)(2008-4#8)(2008-5#9)(2008-6#6)(2008-7#6)(2008-8#11)(2008-9#12)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#9)(2013-1#14)(2013-7#2)(2013-8#6)
prelingual##3##1##(2008-9#2)(2011-1#1)
prelingually deaf##2##2##(2008-9#2)
prelingually deafened##7##2##(2008-9#7)
prelingually##11##1##(2008-9#11)
preload##8##1##(1996-3#1)(1997-4#4)(2011-2#3)
preloaded##3##1##(1990-2#1)(1995-12#1)(2011-2#1)
prelude to##3##2##(2007-3#1)(2008-10#1)(2008-9#1)
prelude##4##1##(2007-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
premalignant##5##1##(2007-12#1)(2009-12#1)(2011-2#1)(2013-1#2)
premammillary nucleus##2##2##(1994-2#2)
premammillary##4##1##(1994-2#4)
premating barriers##4##2##(2008-8#2)(2012-3#2)
premating isolation##7##2##(2008-8#3)(2008-9#4)
premating reproductive isolation##3##3##(2008-9#3)
premating##19##1##(2008-8#7)(2008-9#8)(2012-3#4)
premature activation of HIV-1##2##4##(2011-3#2)
premature adrenarche##6##2##(2008-4#6)
premature ageing##3##2##(2008-5#1)(2009-12#2)
premature aging and##2##3##(1994-12#1)(2008-11#1)
premature aging disorder##2##3##(2010-2#2)
premature aging syndromes##2##3##(2007-7#1)(2011-2#1)
premature aging##10##2##(1992-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-2#2)(2011-2#1)
premature and low birth weight##2##5##(1991-12#1)(2008-10#1)
premature and newborn##2##3##(1990-8#2)
premature and##5##2##(1990-8#2)(1991-12#1)(2008-10#1)(2010-10#1)
premature atherosclerosis##2##2##(1994-8#1)(2007-10#1)
premature atherosclerotic##2##2##(1992-9#1)(2008-1#1)
premature babies##3##2##(1994-3#1)(1994-6#1)(1996-11#1)
premature birth##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
premature cardiovascular##2##2##(1992-9#1)(2008-11#1)
premature children##2##2##(2011-2#2)
premature death in##3##3##(1990-7#1)(2011-2#1)(2012-12#1)
premature death##8##2##(1990-7#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#4)
premature delivery##4##2##(1996-2#1)(2008-11#1)(2012-3#2)
premature discharge##2##2##(1991-12#1)(1996-1#1)
premature infant##5##2##(1994-3#1)(1997-2#1)(2007-12#1)(2011-2#2)
premature infants and##2##3##(2010-10#1)(2013-1#1)
premature infants are##2##3##(1996-11#1)(2007-11#1)
premature infants during##2##3##(2010-10#1)(2011-2#1)
premature infants with##2##3##(1990-11#1)(1996-6#1)
premature infants##26##2##(1990-11#4)(1994-3#1)(1995-8#2)(1996-11#1)(1996-6#1)(2007-11#9)(2008-11#1)(2008-9#1)(2010-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
premature infants]##3##2##(1990-11#1)(1996-11#1)(2013-1#1)
premature mortality##3##2##(1990-9#1)(1995-9#1)(1997-8#1)
premature myocardial infarction##2##3##(1991-6#2)
premature newborn##4##2##(1996-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
premature newborns##5##2##(2008-11#1)(2009-5#3)(2009-9#1)
premature ovarian failure##6##3##(1996-2#2)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
premature rupture of##5##3##(2008-10#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
premature senescence##3##2##(2008-11#3)
premature stop codon##2##3##(1994-11#1)(2008-4#1)
premature termination##3##2##(1990-8#1)(1997-6#1)(2008-10#1)
premature to##4##2##(1994-2#1)(2008-11#1)(2008-6#1)(2013-1#1)
premature ventricular contraction##2##3##(2007-8#2)
premature ventricular##4##2##(1993-1#1)(2007-8#2)(2013-8#1)
premature##167##1##(1990-11#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-6#2)(1992-6#1)(1992-9#3)(1993-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#12)(2008-3#1)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#3)(2009-12#2)(2009-3#1)(2009-5#3)(2009-9#3)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#5)(2011-2#14)(2011-3#3)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#3)
prematurely##16##1##(1990-8#1)(1994-1#1)(1994-3#1)(1996-11#1)(2007-2#1)(2008-10#5)(2008-9#1)(2009-6#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
prematurity was##2##2##(1992-2#1)(2007-12#1)
prematurity##16##1##(1991-9#1)(1992-2#1)(1993-2#1)(1994-3#1)(2007-12#1)(2008-11#2)(2011-1#7)(2012-12#1)(2012-3#1)
premedicated##4##1##(1990-3#2)(1996-6#1)(2012-3#1)
premedication with##2##2##(1996-12#1)(1997-6#1)
premedication##8##1##(1990-3#1)(1996-12#3)(1997-6#1)(2012-2#2)(2012-3#1)
premeiotic and meiotic periods##2##4##(2008-7#2)
premeiotic##3##1##(2008-5#1)(2008-7#2)
premenopausal and postmenopausal patients##2##4##(1993-12#1)(1994-2#1)
premenopausal and##3##2##(1993-12#1)(1994-12#1)(1994-2#1)
premenopausal breast cancer patients##2##4##(1992-12#1)(2007-5#1)
premenopausal breast cancer##3##3##(1991-4#1)(1992-12#1)(2007-5#1)
premenopausal patients##3##2##(1997-7#1)(2007-5#1)(2010-7#1)
premenopausal women##5##2##(1990-12#1)(1994-9#1)(2009-8#1)(2010-6#1)(2010-8#1)
premenopausal##20##1##(1990-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#2)(1994-2#2)(1994-9#1)(1997-7#1)(2007-5#3)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
premenstrual dysphoric##2##2##(2009-10#2)
premenstrual syndrome##3##2##(2008-10#2)(2008-8#1)
premenstrual##6##1##(1994-9#1)(2008-10#2)(2008-8#1)(2009-10#2)
premicellar aggregates##3##2##(2008-10#3)
premier##4##1##(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
premise is that the##2##4##(1991-3#1)(1994-12#1)
premise is that##4##3##(1991-3#1)(1994-12#1)(2008-1#1)(2008-4#1)
premise of##2##2##(1997-3#1)(2008-7#1)
premise that##15##2##(1990-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
premise##29##1##(1990-8#1)(1991-3#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#1)(2013-1#1)
premises and##2##2##(1990-2#1)(2010-4#1)
premises##17##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1992-4#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-4#2)(2012-12#1)
premium and##2##2##(1997-1#1)(2008-7#1)
premium costs##2##2##(1996-3#1)(1997-2#1)
premium increases##2##2##(2007-3#1)(2008-11#1)
premium rate restrictions and open enrolment##2##6##(2008-7#2)
premium##19##1##(1993-3#1)(1994-12#2)(1995-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-7#5)(2009-11#2)
premiums for##2##2##(1992-12#1)(1996-3#1)
premiums may##2##2##(1992-12#1)(1993-3#1)
premiums##26##1##(1991-12#1)(1991-3#1)(1992-12#2)(1993-3#3)(1994-12#1)(1994-3#2)(1996-1#1)(1996-3#3)(1996-5#1)(1997-1#5)(1997-3#1)(2008-12#1)(2008-7#4)
premixed ethylene-air##2##2##(2008-3#2)
premixed flames##3##2##(2008-3#3)
premixed twin flames stabilized in##2##5##(2008-2#1)(2008-3#1)
premixed##16##1##(2008-10#1)(2008-2#6)(2008-3#9)
premolar##5##1##(2008-12#1)(2010-3#1)(2012-12#1)(2013-8#2)
premolars##7##1##(2009-2#3)(2010-3#1)(2013-1#3)
premolt##2##1##(2008-6#2)
premorbid##4##1##(1995-2#1)(2007-11#1)(2013-8#2)
premotor area##2##2##(1995-5#1)(1996-2#1)
premotor cortex##7##2##(1995-5#1)(1995-8#1)(2007-10#1)(2010-7#2)(2013-1#1)(2013-8#1)
premotor##11##1##(1995-5#2)(1995-8#1)(1996-2#1)(2007-10#1)(2008-11#1)(2010-7#2)(2012-1#1)(2013-1#1)(2013-8#1)
prenalterol##4##1##(2008-10#4)
prenatal DES-exposure##2##2##(2008-10#2)
prenatal DEX##2##2##(1995-12#2)
prenatal GC##2##2##(1995-12#2)
prenatal WIC##3##2##(1993-3#3)
prenatal alcohol consumption##2##3##(2008-11#2)
prenatal alcohol use##3##3##(2008-11#3)
prenatal alcohol##7##2##(2008-11#6)(2011-2#1)
prenatal and neonatal##2##3##(2008-10#1)(2008-12#1)
prenatal and postnatal##5##3##(1993-3#1)(1995-1#1)(2008-4#2)(2012-3#1)
prenatal and##7##2##(1993-3#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2012-3#1)
prenatal care and##8##3##(1992-2#2)(1993-3#1)(1993-6#1)(1995-2#2)(2008-11#1)(2011-1#1)
prenatal care at a##3##4##(1993-10#1)(1993-3#1)(1995-12#1)
prenatal care in the##2##4##(1994-3#1)(2008-10#1)
prenatal care in##4##3##(1994-3#2)(2008-10#2)
prenatal care was associated with##2##5##(1993-3#2)
prenatal care was##4##3##(1993-3#2)(1995-2#1)(2008-1#1)
prenatal care##48##2##(1992-2#3)(1993-10#1)(1993-3#6)(1993-6#2)(1994-3#6)(1995-12#2)(1995-2#5)(1996-12#1)(1996-8#1)(2008-1#8)(2008-10#4)(2008-11#2)(2009-7#2)(2011-1#1)(2011-2#2)(2013-1#2)
prenatal classes##2##2##(1995-1#1)(2007-2#1)
prenatal cytogenetic diagnosis##3##3##(2008-11#1)(2012-3#2)
prenatal detection of##2##3##(1993-12#1)(2012-3#1)
prenatal development of##2##3##(2007-11#1)(2012-3#1)
prenatal development##4##2##(2007-11#2)(2012-3#2)
prenatal diagnosis in##2##3##(2011-2#1)(2012-3#1)
prenatal diagnosis is##2##3##(1990-9#1)(2013-1#1)
prenatal diagnosis of fetal##3##4##(1996-12#2)(2012-3#1)
prenatal diagnosis of##7##3##(1992-6#1)(1996-12#2)(2008-4#1)(2012-2#2)(2012-3#1)
prenatal diagnosis##18##2##(1990-9#1)(1992-6#2)(1996-12#4)(1997-3#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
prenatal exposure to DEX##2##4##(1995-12#2)
prenatal exposure to##3##3##(1995-12#2)(2008-10#1)
prenatal famine and adult##2##4##(2011-1#2)
prenatal famine and##3##3##(2011-1#3)
prenatal life##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
prenatal malnutrition##2##2##(2008-11#2)
prenatal or##2##2##(1995-6#1)(2008-4#1)
prenatal period##6##2##(1995-5#1)(1996-5#1)(2007-2#1)(2010-5#1)(2012-2#1)(2013-7#1)
prenatal programming##2##2##(2013-1#2)
prenatal stress##4##2##(1996-5#1)(2008-2#3)
prenatal testing##3##2##(1992-9#1)(2008-1#1)(2013-1#1)
prenatal treatment of congenital##2##4##(1990-3#1)(2008-4#1)
prenatal treatment##3##2##(1990-3#1)(1992-2#1)(2008-4#1)
prenatal vascular disruptions##3##3##(1997-3#3)
prenatal##187##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-2#7)(1992-6#2)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#11)(1993-6#2)(1994-12#1)(1994-3#6)(1995-1#2)(1995-12#8)(1995-2#5)(1995-5#1)(1995-6#1)(1996-12#7)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-3#4)(2007-11#3)(2007-2#4)(2007-7#1)(2008-1#10)(2008-10#14)(2008-11#13)(2008-12#3)(2008-2#7)(2008-4#7)(2008-7#2)(2009-7#2)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#4)(2011-5#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#11)(2013-1#12)(2013-7#1)
prenatally androgenized female rhesus monkeys##2##5##(2008-4#2)
prenatally detected##2##2##(2008-10#1)(2008-7#1)
prenatally diagnosed##2##2##(1990-8#1)(1997-3#1)
prenatally exposed to DES##2##4##(2008-10#2)
prenatally exposed to##3##3##(2008-10#3)
prenatally to##2##2##(1990-8#1)(1995-12#1)
prenatally##18##1##(1990-5#1)(1990-8#3)(1995-12#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#1)(2013-1#1)
preneoplastic lesions in##2##3##(1991-6#1)(1991-9#1)
preneoplastic transformation##2##2##(1991-12#1)(1995-9#1)
preneoplastic##7##1##(1991-12#1)(1991-6#1)(1991-9#1)(1995-9#1)(2008-6#1)(2011-1#1)(2013-7#1)
prenols and sterols##2##3##(1994-11#2)
prenyl group##2##2##(2009-11#2)
prenyl##5##1##(1994-8#1)(2009-11#4)
prenylated##4##1##(2008-5#1)(2011-2#3)
prenyltransferase##3##1##(2011-2#3)
prenyltransferases##3##1##(2008-8#1)(2011-2#1)(2012-2#1)
preoccupation of the##2##3##(1994-3#1)(2008-5#1)
preoccupation of##3##2##(1994-3#1)(2008-12#1)(2008-5#1)
preoccupation with##2##2##(1993-6#1)(2010-6#1)
preoccupation##7##1##(1993-2#1)(1993-6#1)(1994-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-6#1)
preoccupied with##3##2##(2007-7#1)(2008-11#1)(2008-7#1)
preoperative and postoperative##7##3##(1994-3#1)(1996-2#1)(2007-8#1)(2009-10#1)(2011-7#1)(2012-12#1)(2013-8#1)
preoperative and##10##2##(1994-3#1)(1996-2#1)(2007-8#1)(2007-9#1)(2009-10#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
preoperative angiography##3##2##(1996-9#1)(2008-12#1)(2012-3#1)
preoperative assessment of##2##3##(2012-1#1)(2012-3#1)
preoperative assessment##7##2##(2006-10#1)(2009-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
preoperative chemotherapy was##3##3##(2010-3#3)
preoperative chemotherapy##9##2##(1992-6#2)(1994-8#1)(2010-3#4)(2012-3#2)
preoperative clinical##5##2##(1993-5#1)(1997-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
preoperative counseling##3##2##(2011-2#1)(2012-12#2)
preoperative diagnosis and##2##3##(1996-8#1)(2011-2#1)
preoperative diagnosis##10##2##(1991-3#1)(1992-9#2)(1996-8#1)(1997-8#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
preoperative differentiation##2##2##(1993-9#1)(2008-12#1)
preoperative disinfection of hands##2##4##(1994-11#2)
preoperative disinfection of##3##3##(1994-11#3)
preoperative embolization of##2##3##(2008-7#2)
preoperative embolization##9##2##(2008-7#8)(2012-3#1)
preoperative evaluation##7##2##(1990-9#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2012-12#1)
preoperative examination##2##2##(1994-12#1)(2012-2#1)
preoperative feeding##3##2##(2011-2#3)
preoperative hemoglobin##2##2##(1994-3#1)(2009-3#1)
preoperative imaging##4##2##(1993-5#1)(2006-12#1)(2012-1#1)(2013-8#1)
preoperative investigation##2##2##(1990-11#2)
preoperative levels by 6##2##4##(2013-1#2)
preoperative levels##3##2##(1990-9#1)(2013-1#2)
preoperative magnetic resonance##2##3##(2008-9#1)(2011-2#1)
preoperative period##2##2##(2011-2#1)(2012-3#1)
preoperative planning and##4##3##(1997-6#1)(2007-11#1)(2007-12#2)
preoperative planning##8##2##(1997-6#1)(2007-11#1)(2007-12#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
preoperative preparation##4##2##(1992-9#1)(2008-10#1)(2011-2#2)
preoperative pulmonary##2##2##(2006-10#1)(2010-6#1)
preoperative radiation##2##2##(1992-11#1)(2010-3#1)
preoperative selective embolization##2##3##(1996-8#2)
preoperative staging##2##2##(1990-9#2)
preoperative status##2##2##(2011-2#1)(2013-1#1)
preoperative teaching program##2##3##(1995-1#2)
preoperative teaching##3##2##(1995-1#3)
preoperative therapy##2##2##(2006-10#1)(2010-3#1)
preoperative treatment##3##2##(1990-12#1)(1993-8#1)(2010-7#1)
preoperative values##3##2##(1991-2#2)(2009-10#1)
preoperative weight##3##2##(2010-8#3)
preoperative##232##1##(1990-11#4)(1990-12#1)(1990-6#1)(1990-9#8)(1991-2#3)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#4)(1993-1#1)(1993-12#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#3)(1994-7#1)(1994-8#2)(1995-1#3)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#4)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#5)(2006-12#1)(2007-11#3)(2007-12#3)(2007-8#10)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#19)(2008-8#2)(2008-9#6)(2009-10#6)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-8#1)(2010-3#7)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#29)(2011-7#1)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#15)(2013-1#18)(2013-8#5)
preoperatively and at 6-month follow-up##3##5##(2008-9#3)
preoperatively and at##4##3##(2008-9#4)
preoperatively and postoperatively##2##3##(2009-10#2)
preoperatively and##9##2##(2007-8#2)(2008-9#4)(2009-10#2)(2013-1#1)
preoperatively by##3##2##(1990-3#1)(2010-8#1)(2013-7#1)
preoperatively to##3##2##(1994-9#1)(2009-3#1)(2013-1#1)
preoperatively with##2##2##(2008-7#1)(2011-2#1)
preoperatively##60##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-1#2)(1994-9#1)(1996-1#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#6)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#3)(2009-3#1)(2009-9#1)(2010-8#4)(2011-2#3)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
preoptic and##2##2##(1991-5#1)(1993-12#1)
preoptic area of the##2##4##(1992-3#1)(1994-2#1)
preoptic area##13##2##(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1994-2#1)(1997-3#2)(2008-8#1)(2008-9#1)
preoptic##19##1##(1991-5#4)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#3)(1993-12#1)(1994-2#1)(1997-3#2)(2008-8#2)(2008-9#2)
preovulatory follicles##8##2##(1994-7#1)(2008-12#4)(2008-8#3)
preowned imaging equipment##2##3##(1995-1#2)
preowned##3##1##(1995-1#3)
prepaid health plans##2##3##(1994-2#2)
prepaid plans##3##2##(1991-2#2)(1994-2#1)
prepaid##8##1##(1991-2#2)(1991-3#1)(1994-2#3)(1994-3#1)(1997-1#1)
preparation (e##2##2##(1994-12#1)(2010-4#1)
preparation against##2##2##(2008-11#1)(2008-4#1)
preparation and analysis##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
preparation and application times##2##4##(2012-3#2)
preparation and application##3##3##(2008-5#1)(2012-3#2)
preparation and bacteriological tools##2##4##(2008-2#1)(2008-9#1)
preparation and handling##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
preparation and storage##2##3##(2008-9#1)(2012-2#1)
preparation and use of##3##4##(1991-9#1)(2008-10#1)(2008-2#1)
preparation and##65##2##(1990-8#1)(1991-5#1)(1991-9#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#11)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
preparation are##5##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)
preparation as##4##2##(1990-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
preparation at##2##2##(2008-10#1)(2012-2#1)
preparation before##4##2##(2011-2#1)(2012-1#1)(2012-3#2)
preparation by##9##2##(1990-12#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-11#1)(2012-12#1)(2013-1#1)
preparation conditions##3##2##(1994-11#1)(2008-10#2)
preparation for a##2##3##(1994-12#1)(2008-11#1)
preparation for colonoscopy##2##3##(2011-2#2)
preparation for future##2##3##(1997-6#1)(2012-1#1)
preparation for the##7##3##(1994-1#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-2#1)
preparation for their##2##3##(2008-12#1)(2011-2#1)
preparation for##45##2##(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-2#2)(2013-1#1)
preparation from##11##2##(1991-5#2)(1992-12#1)(1992-3#1)(1994-2#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)
preparation had a##2##3##(1991-12#1)(2011-1#1)
preparation has been##3##3##(1994-6#1)(1996-1#1)(2008-8#1)
preparation has##4##2##(1994-6#1)(1996-1#1)(2008-8#1)(2010-5#1)
preparation have##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
preparation in a##2##3##(2008-10#1)(2012-2#1)
preparation in the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
preparation in##11##2##(1990-12#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)(2013-1#1)
preparation into##2##2##(2008-10#1)(2013-1#1)
preparation is rapid and simple##2##5##(2008-10#2)
preparation is##14##2##(1990-11#1)(1994-12#1)(1995-5#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-7#1)
preparation method based on##4##4##(2008-10#3)(2010-5#1)
preparation method for the##2##4##(1994-12#1)(2008-10#1)
preparation method is##2##3##(2008-10#1)(2008-9#1)
preparation method##13##2##(1994-11#1)(1994-12#1)(2008-10#8)(2008-9#1)(2010-5#1)(2012-2#1)
preparation methods##7##2##(2008-10#4)(2008-11#2)(2008-5#1)
preparation must##2##2##(1992-5#1)(1997-2#1)
preparation of a new##2##4##(2008-10#2)
preparation of a##19##3##(1995-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#4)(2008-9#2)(2009-3#1)(2010-4#1)(2011-1#1)
preparation of an##3##3##(1994-5#1)(2008-10#2)
preparation of chromosome##2##3##(2008-4#1)(2008-9#1)
preparation of deoxyribonucleoside phosphoramidites##2##4##(2008-4#2)
preparation of intact##2##3##(2008-4#1)(2008-9#1)
preparation of mouse##2##3##(2008-4#2)
preparation of other##2##3##(2008-4#1)(2010-12#1)
preparation of phage##2##3##(1995-12#1)(2008-9#1)
preparation of phosphoramidites##2##3##(2008-4#2)
preparation of plasmid##2##3##(2008-11#1)(2008-2#1)
preparation of purified##2##3##(2008-11#1)(2008-4#1)
preparation of solid##2##3##(2008-10#2)
preparation of staff##2##3##(2008-11#1)(2008-12#1)
preparation of suitable##2##3##(2008-4#2)
preparation of the retina##3##4##(2008-8#3)
preparation of the samples##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
preparation of the##33##3##(1990-5#2)(1990-6#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2009-5#1)(2011-2#1)
preparation of tissue##2##3##(2008-4#1)(2010-10#1)
preparation of two##2##3##(2008-4#1)(2011-1#1)
preparation of##247##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#4)(1997-2#2)(1997-3#2)(2006-12#2)(2007-11#6)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#46)(2008-11#13)(2008-12#4)(2008-2#8)(2008-3#2)(2008-4#57)(2008-5#3)(2008-7#6)(2008-8#6)(2008-9#21)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
preparation on the##3##3##(2008-10#2)(2009-4#1)
preparation on##4##2##(2008-10#2)(2009-4#1)(2011-1#1)
preparation or##3##2##(1990-12#1)(1993-2#1)(2008-10#1)
preparation prior to analysis##3##4##(2008-10#2)(2010-5#1)
preparation procedure for##4##3##(2008-10#4)
preparation procedure##12##2##(2008-10#12)
preparation procedures were##2##3##(2008-10#2)
preparation procedures##4##2##(2008-10#4)
preparation process was##2##3##(2008-10#1)(2008-11#1)
preparation process##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
preparation processes##2##2##(2008-10#1)(2008-7#1)
preparation programs##2##2##(1992-1#1)(1994-2#1)
preparation recipes##2##2##(2008-10#2)
preparation required##2##2##(1994-6#1)(2008-10#1)
preparation steps##3##2##(2008-10#3)
preparation technique for the##2##4##(2008-10#2)
preparation technique##5##2##(2008-10#3)(2008-9#1)(2012-12#1)
preparation techniques##3##2##(2008-3#1)(2008-9#1)(2012-12#1)
preparation that##4##2##(1993-1#1)(2008-4#1)(2009-9#2)
preparation time##2##2##(2008-10#1)(2012-3#1)
preparation to the##2##3##(1990-5#1)(2008-7#1)
preparation to##9##2##(1990-5#3)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-2#1)
preparation used##2##2##(2007-12#1)(2008-12#1)
preparation using##4##2##(1991-2#1)(1994-12#1)(1995-5#1)(2008-9#1)
preparation was developed##2##3##(2008-10#2)
preparation was performed by##2##4##(1991-5#1)(2008-10#1)
preparation was##18##2##(1990-7#1)(1991-2#1)(1991-5#2)(1993-6#1)(1995-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-7#1)(2013-8#1)
preparation were##3##2##(1990-11#1)(2008-10#2)
preparation will##2##2##(1997-2#1)(2008-9#1)
preparation with##2##2##(1995-6#1)(1996-2#1)
preparation##783##1##(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#8)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-12#3)(1991-2#2)(1991-5#9)(1991-6#1)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#8)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#8)(1994-2#6)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1996-1#3)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#5)(1997-2#9)(1997-3#2)(1997-6#1)(1997-7#1)(2006-12#2)(2007-10#1)(2007-11#8)(2007-12#10)(2007-2#1)(2007-7#6)(2008-1#11)(2008-10#220)(2008-11#33)(2008-12#13)(2008-2#16)(2008-3#5)(2008-4#82)(2008-5#14)(2008-7#25)(2008-8#11)(2008-9#45)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#5)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#6)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#13)(2012-3#13)(2013-1#13)(2013-7#1)(2013-8#2)
preparation)##4##1##(1990-2#1)(1995-2#1)(2008-10#1)(2008-6#1)
preparations agreed with those##2##4##(2008-10#2)
preparations and in##2##3##(1990-7#1)(1996-12#1)
preparations and the##4##3##(1991-5#1)(2008-10#3)
preparations and##36##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-8#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#20)(2008-7#1)(2010-4#2)(2013-1#1)
preparations are##12##2##(1991-8#1)(1992-8#1)(1994-2#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-9#2)(2011-2#1)
preparations by capillary electrophoresis##2##4##(2008-10#2)
preparations by using##2##3##(2008-10#2)
preparations by##16##2##(1990-12#1)(2008-10#15)
preparations can be##4##3##(2008-10#1)(2008-4#3)
preparations can##5##2##(1997-6#1)(2008-10#1)(2008-4#3)
preparations contained##2##2##(2008-10#1)(2008-5#1)
preparations containing##8##2##(1994-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)
preparations could##2##2##(1992-12#1)(1993-11#1)
preparations from both##2##3##(1994-8#1)(2008-10#1)
preparations from##17##2##(1990-11#1)(1990-5#1)(1990-8#1)(1993-1#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)
preparations has##3##2##(1992-11#1)(1994-12#1)(2008-10#1)
preparations in the##4##3##(1992-3#1)(2008-10#2)(2011-1#1)
preparations in vitro##2##3##(1990-12#1)(2008-7#1)
preparations in##13##2##(1990-12#1)(1992-3#1)(1994-6#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
preparations of the##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
preparations of##30##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(1992-9#1)(1995-6#2)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#4)(2008-5#2)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
preparations on##2##2##(2008-10#1)(2008-5#1)
preparations to##2##2##(2008-4#1)(2008-5#1)
preparations using 1##2##3##(2008-10#2)
preparations using##11##2##(2008-10#9)(2008-4#1)(2011-2#1)
preparations was##2##2##(1993-9#1)(2008-10#1)
preparations were incubated with##2##4##(1994-9#1)(1995-6#1)
preparations were used to produce##2##5##(2008-10#2)
preparations were##10##2##(1992-11#1)(1994-9#1)(1995-6#2)(1996-2#1)(2008-10#5)
preparations with##10##2##(1990-12#1)(1990-5#1)(1991-12#1)(1993-5#1)(1995-5#1)(2008-10#3)(2009-8#1)(2011-2#1)
preparations##378##1##(1990-11#3)(1990-12#6)(1990-3#2)(1990-5#5)(1990-7#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#4)(1995-6#4)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#5)(1997-3#5)(1997-6#5)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#5)(2008-10#167)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#21)(2008-5#25)(2008-7#5)(2008-8#3)(2008-9#7)(2009-8#2)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
preparations]##3##1##(1991-2#1)(1995-8#1)(1996-2#1)
preparative HPLC##2##2##(1992-8#1)(2006-12#1)
preparative SEC##2##2##(1997-2#2)
preparative anion-exchange high-performance liquid chromatography##2##5##(1991-5#1)(1994-12#1)
preparative column##2##2##(2008-10#2)
preparative gel electrophoresis##2##3##(1991-9#1)(1995-6#1)
preparative gel##3##2##(1991-9#1)(1994-6#1)(1995-6#1)
preparative procedures##2##2##(2008-9#2)
preparative scale##3##2##(2008-10#1)(2011-1#2)
preparative techniques##3##2##(1990-7#1)(2008-9#2)
preparative thin layer chromatography and##2##5##(2008-10#1)(2012-2#1)
preparative thin layer chromatography##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
preparative##37##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#3)(1996-12#1)(1997-2#2)(1997-7#1)(2006-12#1)(2007-4#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-9#4)(2011-1#2)(2012-2#1)
preparatory grief##4##2##(2010-2#4)
preparatory work##4##2##(2010-12#3)(2010-7#1)
preparatory##23##1##(1995-12#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-6#2)(2010-7#1)(2013-1#1)(2013-8#3)
prepare a##11##2##(1990-11#1)(1993-12#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#2)(2010-7#1)
prepare and##8##2##(1993-11#1)(1997-6#1)(2008-10#3)(2008-4#1)(2010-7#1)(2011-1#1)
prepare for the future should##2##5##(2007-12#1)(2008-11#1)
prepare for the##5##3##(2007-12#1)(2008-11#2)(2010-4#1)(2012-3#1)
prepare for##9##2##(1993-2#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-11#3)(2010-4#1)(2012-3#1)
prepare nurses to##2##3##(2008-11#1)(2008-12#1)
prepare nurses##3##2##(2008-11#2)(2008-12#1)
prepare the##18##2##(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-7#1)
prepare them for##3##3##(2008-12#1)(2009-9#1)(2010-3#1)
prepare them##4##2##(2008-12#1)(2008-4#1)(2009-9#1)(2010-3#1)
prepare##122##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#27)(2008-11#9)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#4)(2009-12#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#4)(2011-1#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#1)
prepared a##5##2##(1991-9#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-9#1)
prepared against##8##2##(1990-11#1)(1990-8#1)(1993-6#2)(1994-11#1)(1996-2#2)(2008-5#1)
prepared and characterized##3##3##(2008-10#2)(2009-11#1)
prepared and demonstrated##2##3##(2008-10#2)
prepared and evaluated##7##3##(1992-12#1)(1993-9#1)(1995-3#1)(2008-10#2)(2008-5#1)(2009-6#1)
prepared and investigated as##5##4##(2008-10#5)
prepared and investigated##6##3##(2007-12#1)(2008-10#5)
prepared and its##6##3##(2008-10#4)(2008-5#1)(2013-1#1)
prepared and studied##2##3##(2008-10#1)(2009-9#1)
prepared and tested for##3##4##(1993-11#1)(2007-11#1)(2008-10#1)
prepared and tested##4##3##(1993-11#1)(2007-11#2)(2008-10#1)
prepared and used as an##2##5##(1992-3#1)(2008-10#1)
prepared and used as##3##4##(1992-3#1)(2008-10#2)
prepared and used for##3##4##(2007-8#1)(2008-10#2)
prepared and used##10##3##(1992-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)
prepared and##76##2##(1992-12#1)(1992-3#1)(1993-11#2)(1993-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-2#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#37)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-9#1)(2011-3#1)(2012-8#1)(2013-1#1)(2013-7#1)
prepared as a##2##3##(2008-10#1)(2012-2#1)
prepared as described##2##3##(2008-4#2)
prepared as##15##2##(1991-12#1)(1991-8#1)(1994-9#1)(1995-3#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
prepared at##7##2##(2008-10#2)(2008-2#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
prepared batches##3##2##(2010-3#2)(2012-2#1)
prepared by a sol-gel##2##4##(2008-10#1)(2008-5#1)
prepared by a##11##3##(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
prepared by an##2##3##(2008-10#2)
prepared by blending##2##3##(2008-1#1)(2009-7#1)
prepared by coupling Amberlite XAD-2 with##2##6##(2008-10#2)
prepared by coupling##3##3##(2008-10#3)
prepared by different methods##2##4##(1990-7#1)(2008-11#1)
prepared by different##3##3##(1990-7#1)(2008-11#1)(2008-3#1)
prepared by direct##2##3##(2008-10#1)(2010-5#1)
prepared by dissolving in##2##4##(2008-10#1)(2008-5#1)
prepared by dissolving##6##3##(2008-10#4)(2008-5#1)(2010-4#1)
prepared by electropolymerization of##2##4##(2008-10#2)
prepared by entrapping##2##3##(2008-10#2)
prepared by fusing##2##3##(1994-12#1)(1994-2#1)
prepared by immobilizing##2##3##(2008-10#2)
prepared by in situ##2##4##(2008-10#2)
prepared by incorporating##3##3##(2008-10#3)
prepared by mixing##7##3##(2008-10#6)(2008-2#1)
prepared by packing##2##3##(2008-10#2)
prepared by reacting##2##3##(2008-10#2)
prepared by reaction of##2##4##(1996-2#1)(1997-7#1)
prepared by reactive ion-assisted##2##4##(2008-3#2)
prepared by sol-gel method and##2##5##(2008-10#2)
prepared by sol-gel##4##3##(2008-10#4)
prepared by solid-phase synthesis##2##4##(1993-11#1)(2008-4#1)
prepared by the##25##3##(1990-7#1)(1992-11#1)(1992-6#1)(1994-7#1)(1996-5#2)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-8#1)
prepared by this##3##3##(1997-1#1)(2008-6#1)(2009-9#1)
prepared by use of##2##4##(2007-12#1)(2008-3#1)
prepared by using##10##3##(2008-10#6)(2008-2#1)(2008-9#1)(2010-5#1)(2013-8#1)
prepared by weighing##3##3##(2008-10#3)
prepared by##204##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-7#2)(1997-9#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#95)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-5#1)(2009-7#2)(2009-9#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#4)(2013-1#4)(2013-8#4)
prepared can##2##2##(2008-10#2)
prepared compounds##2##2##(2007-11#1)(2008-11#1)
prepared for analysis##2##3##(2008-10#1)(2008-12#1)
prepared for or##2##3##(1992-2#2)
prepared for the##4##3##(1992-1#1)(1997-1#1)(2008-10#1)(2008-11#1)
prepared for##28##2##(1992-1#1)(1992-2#3)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-7#1)(2012-12#1)(2012-3#1)
prepared from a##6##3##(1990-7#1)(2008-10#3)(2008-5#2)
prepared from cells##2##3##(1994-6#1)(2008-10#1)
prepared from control##2##3##(2008-11#1)(2008-5#1)
prepared from embryonic day##2##4##(1994-2#1)(2008-7#1)
prepared from purified##2##3##(1991-5#1)(2008-10#1)
prepared from rat##2##3##(1991-5#1)(2008-7#1)
prepared from the isolated##2##4##(2008-11#1)(2008-2#1)
prepared from the same##3##4##(1991-12#1)(1994-6#1)(2008-1#1)
prepared from the##21##3##(1990-7#2)(1991-12#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-5#4)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)(2011-2#1)
prepared from tumor##2##3##(2008-4#1)(2008-9#1)
prepared from##117##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#3)(1991-12#3)(1991-5#4)(1991-7#1)(1991-8#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#11)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#4)(2008-1#1)(2008-10#15)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
prepared in a##5##3##(1992-11#1)(2008-10#3)(2008-4#1)
prepared in acetonitrile##2##3##(2008-10#1)(2013-1#1)
prepared in aqueous phase##3##4##(2008-10#3)
prepared in aqueous solutions##2##4##(2008-10#2)
prepared in aqueous##6##3##(2008-10#6)
prepared in good##2##3##(1996-5#1)(2009-5#1)
prepared in order to##2##4##(2007-11#1)(2008-10#1)
prepared in situ##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
prepared in the laboratory##2##4##(2008-10#2)
prepared in the presence of##2##5##(1990-11#1)(1990-8#1)
prepared in the##6##3##(1990-11#1)(1990-8#1)(2008-10#4)
prepared in this study##2##4##(2008-10#2)
prepared in this##3##3##(1994-12#1)(2008-10#2)
prepared in tissue culture##2##4##(2008-9#1)(2011-2#1)
prepared in two different##2##4##(1992-11#1)(2008-10#1)
prepared in water##3##3##(2008-10#3)
prepared in##69##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-11#3)(1992-2#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#34)(2008-11#5)(2008-4#4)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)
prepared of##3##2##(1991-3#1)(2008-5#1)(2011-1#1)
prepared on the basis of##2##5##(1992-9#1)(2008-10#1)
prepared on the##5##3##(1990-6#1)(1992-9#1)(1997-3#1)(2008-10#1)(2008-5#1)
prepared on##9##2##(1990-6#1)(1992-9#1)(1993-1#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-5#1)
prepared prior##2##2##(2008-10#1)(2010-11#1)
prepared resin##2##2##(2008-10#2)
prepared samples##2##2##(1997-2#1)(2008-10#1)
prepared serum group was##2##4##(2008-10#2)
prepared serum group##3##3##(2008-10#3)
prepared tablets were##3##3##(2012-2#3)
prepared three##2##2##(2008-11#1)(2008-9#1)
prepared through##5##2##(2007-11#2)(2008-11#2)(2008-5#1)
prepared to deal with##2##4##(2006-10#1)(2013-8#1)
prepared to meet the##2##4##(1994-1#1)(2011-1#1)
prepared to study the##2##4##(1997-3#1)(2007-11#1)
prepared to##31##2##(1991-1#1)(1991-8#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
prepared under##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2009-12#1)
prepared using a##6##3##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
prepared using the following##2##4##(2008-5#2)
prepared using the##7##3##(1995-2#1)(2008-5#4)(2008-6#1)(2011-2#1)
prepared using these##2##3##(2008-10#1)(2008-4#1)
prepared using various##2##3##(2008-7#1)(2011-2#1)
prepared using##37##2##(1990-2#1)(1993-9#1)(1995-2#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#2)
prepared via a##2##3##(1996-5#1)(2008-10#1)
prepared via##4##2##(1996-5#1)(2008-10#2)(2008-4#1)
prepared were##6##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
prepared with a##6##3##(2008-10#4)(2008-3#1)(2008-5#1)
prepared with different##2##3##(2008-10#2)
prepared with iodoacetamide##3##3##(1994-6#3)
prepared with the##5##3##(2008-10#3)(2011-3#1)(2013-8#1)
prepared with##54##2##(1990-5#1)(1993-6#1)(1994-2#2)(1994-6#3)(1995-3#1)(1996-6#1)(2008-10#30)(2008-11#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-12#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
prepared within##2##2##(2008-10#2)
prepared without##4##2##(1994-6#2)(1996-2#1)(2008-10#1)
prepared##902##1##(1990-11#3)(1990-12#5)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#8)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#6)(1994-12#4)(1994-2#6)(1994-5#1)(1994-6#9)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#10)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#12)(1996-3#1)(1996-5#17)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#21)(2007-12#8)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#331)(2008-11#47)(2008-12#12)(2008-2#13)(2008-3#20)(2008-4#18)(2008-5#44)(2008-6#4)(2008-7#13)(2008-8#14)(2008-9#19)(2009-11#9)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#6)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#4)(2010-5#7)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#16)(2012-3#3)(2012-8#1)(2013-1#15)(2013-7#3)(2013-8#10)
preparedness and##3##2##(2009-12#1)(2011-2#1)(2012-12#1)
preparedness for##2##2##(2008-11#1)(2013-1#1)
preparedness is##2##2##(1992-1#1)(2010-8#1)
preparedness to manage##2##3##(2007-12#1)(2007-2#1)
preparedness##26##1##(1990-2#2)(1992-1#1)(1995-2#1)(1996-1#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-8#5)(2011-2#1)(2012-12#1)(2013-1#4)
prepares##6##1##(1992-8#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
preparing DNA##2##2##(1994-11#1)(2008-9#1)
preparing a##9##2##(2008-10#3)(2008-12#1)(2008-4#3)(2008-9#2)
preparing an abstract##2##3##(2010-4#2)
preparing an##3##2##(1991-5#1)(2010-4#2)
preparing and##6##2##(1993-12#1)(1994-1#1)(2008-11#1)(2008-4#2)(2008-9#1)
preparing for the##6##3##(1992-1#1)(1992-2#1)(1996-12#1)(1996-5#1)(2007-2#1)(2011-1#1)
preparing for##9##2##(1992-1#1)(1992-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(2007-2#1)(2008-1#1)(2011-1#1)(2012-3#1)
preparing the##18##2##(2006-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
preparing##108##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#6)(2008-2#5)(2008-4#26)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#11)(2009-12#1)(2009-4#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
prepayment and##2##2##(1994-2#2)
prepayment##3##1##(1994-2#2)(1997-1#1)
prepenetration development##2##2##(2008-10#2)
prepenetration morphogenesis in C##2##4##(2008-10#2)
prepenetration morphogenesis##3##2##(2008-10#3)
prepenetration##5##1##(2008-10#5)
preperitoneal##4##1##(1992-5#1)(1993-9#1)(1996-9#1)(2011-2#1)
preplanned##2##1##(1995-5#1)(2013-1#1)
preplant##3##1##(2008-10#3)
preplanting##2##1##(2008-10#2)
preplated##3##1##(2008-10#3)
preponderance of males##2##3##(1990-2#1)(2007-7#1)
preponderance of##10##2##(1990-2#1)(1993-2#1)(1996-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)
preponderance##12##1##(1990-2#1)(1993-2#1)(1996-5#1)(1996-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
preponderant##3##1##(2007-12#1)(2008-8#1)(2008-9#1)
prepositions##3##1##(2008-10#1)(2008-4#2)
prepositus hypoglossal##2##2##(1991-12#1)(1993-12#1)
prepregnancy weight##3##2##(2010-4#1)(2013-1#2)
prepregnancy##5##1##(2010-4#1)(2013-1#4)
prepro##2##1##(1994-12#1)(1995-6#1)
prepro-EGF##2##1##(1991-12#2)
preproET-1##3##1##(1991-2#3)
preproET-2##2##1##(1993-6#2)
preprocarboxypeptidase A##3##2##(1991-2#3)
preprocarboxypeptidase##4##1##(1991-2#4)
preprocecropinA##2##1##(1994-11#2)
preprocessed joint transform correlation##3##4##(2008-3#3)
preprocessed##7##1##(2008-3#5)(2008-7#1)(2010-8#1)
preprocessing and##3##2##(2008-2#1)(2008-3#2)
preprocessing method for partial least squares##2##6##(2008-10#2)
preprocessing##16##1##(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-6#2)(2008-7#1)
preprocholecystokinin##2##1##(1992-8#2)
preprodynorphin (PPD)##2##2##(1996-12#2)
preprodynorphin##3##1##(1996-12#3)
preproenkephalin (PPE)##2##2##(1996-12#2)
preproenkephalin##4##1##(1996-12#3)(2013-8#1)
preprogrammed##3##1##(1992-4#1)(2007-11#1)(2007-12#1)
preproinsulin##3##1##(2008-11#2)(2010-11#1)
prepromelittin##2##1##(1994-11#2)
preprosthetic##2##1##(2007-12#2)
preprotachykinin##3##1##(1992-9#2)(1993-8#1)
preproteins##3##1##(1996-10#1)(2008-1#2)
prepubertal male calves##3##3##(2013-1#3)
prepubertal##12##1##(2008-10#1)(2008-4#2)(2011-1#4)(2012-2#1)(2012-3#1)(2013-1#3)
prepubescent Latino children##2##3##(2009-9#2)
prepubescent##3##1##(2009-9#2)(2013-8#1)
prepulse inhibition##2##2##(2008-4#2)
prepulse##4##1##(2007-11#1)(2008-2#1)(2008-4#2)
prepupa##2##1##(2007-12#2)
preputial##6##1##(2008-10#4)(2011-1#2)
prerecorded##2##1##(2007-11#1)(2008-3#1)
prereduction##3##1##(2007-10#1)(2008-10#2)
preregistration house officers##3##3##(1995-6#3)
preregistration internship consists of 12 months##2##6##(1995-6#2)
preregistration internship##3##2##(1995-6#3)
preregistration##8##1##(1995-6#6)(1996-12#1)(2013-8#1)
prerequisite for a##2##3##(2008-10#1)(2012-3#1)
prerequisite for the##6##3##(1990-2#1)(1996-5#1)(2008-10#2)(2008-8#1)(2008-9#1)
prerequisite for##35##2##(1990-2#1)(1991-11#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-5#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
prerequisite of the##2##3##(2008-8#1)(2009-2#1)
prerequisite of##3##2##(1991-9#1)(2008-8#1)(2009-2#1)
prerequisite to##8##2##(1990-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-11#1)(2008-5#1)(2013-7#1)
prerequisite##52##1##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
prerequisites for the##2##3##(1991-3#1)(1995-5#1)
prerequisites for##6##2##(1991-3#1)(1994-1#1)(1995-5#1)(2007-8#1)(2008-11#1)(2010-10#1)
prerequisites of##2##2##(1995-5#1)(2010-10#1)
prerequisites##13##1##(1991-2#1)(1991-3#1)(1994-1#1)(1995-5#3)(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#2)
presacral neurectomy##4##2##(1994-3#4)
presacral##7##1##(1994-3#6)(2009-3#1)
presampled##2##1##(2008-10#1)(2011-1#1)
presbyopia treatment##3##2##(2011-2#3)
presbyopia##4##1##(2011-2#4)
preschool children in##2##3##(2012-12#1)(2013-1#1)
preschool children##11##2##(1993-3#1)(1996-12#1)(2007-11#1)(2008-11#2)(2008-4#1)(2009-9#1)(2011-1#2)(2012-12#1)(2013-1#1)
preschool children's##2##2##(2009-9#1)(2012-12#1)
preschool##19##1##(1993-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-4#2)(2009-9#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
preschoolers##3##1##(1992-9#1)(2013-7#1)(2013-8#1)
prescribe a##2##2##(1996-11#1)(2011-2#1)
prescribe##21##1##(1990-2#1)(1991-6#1)(1993-12#1)(1993-2#2)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
prescribed a##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
prescribed and##4##2##(1996-4#1)(2008-7#1)(2010-4#1)(2010-5#1)
prescribed as##2##2##(1991-6#1)(2008-10#1)
prescribed at##2##2##(2008-11#1)(2010-5#1)
prescribed by a##3##3##(1996-4#1)(2009-9#1)(2011-1#1)
prescribed by##6##2##(1996-4#1)(1997-6#1)(2006-12#1)(2008-11#1)(2009-9#1)(2011-1#1)
prescribed drug##2##2##(2008-11#1)(2010-5#1)
prescribed drugs##5##2##(2008-11#4)(2008-3#1)
prescribed for the##2##3##(2008-10#1)(2012-12#1)
prescribed for##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-12#1)
prescribed in the##4##3##(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
prescribed in##12##2##(1991-11#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
prescribed medication##5##2##(1993-11#1)(1995-2#1)(2008-11#1)(2010-1#2)
prescribed to##7##2##(1991-2#1)(2007-11#1)(2008-11#3)(2011-2#2)
prescribed was##2##2##(2008-11#1)(2010-5#1)
prescribed##131##1##(1990-2#1)(1990-6#2)(1991-11#3)(1991-2#1)(1991-6#1)(1993-11#2)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#2)(1996-4#2)(1997-6#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#23)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#2)(2009-9#3)(2010-1#3)(2010-12#4)(2010-4#1)(2010-5#9)(2010-6#2)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
prescriber##3##1##(2008-11#1)(2010-5#1)(2013-1#1)
prescribers in##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
prescribers of##2##2##(2008-8#2)
prescribers##11##1##(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#4)(2009-3#1)(2012-12#1)
prescribes##2##1##(1993-11#1)(1993-7#1)
prescribing and##6##2##(1992-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)
prescribing drugs##2##2##(2008-10#1)(2009-10#1)
prescribing for##3##2##(2008-11#1)(2010-4#1)(2013-1#1)
prescribing habits##2##2##(1995-11#1)(1996-11#1)
prescribing in##4##2##(1996-11#1)(2008-11#2)(2012-2#1)
prescribing of cotrimoxazole##2##3##(2008-11#2)
prescribing of##8##2##(1993-12#1)(2008-11#3)(2008-7#1)(2009-3#1)(2010-3#1)(2010-5#1)
prescribing patterns##6##2##(2008-11#5)(2013-1#1)
prescribing practices##5##2##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
prescribing preventive medication##2##3##(2008-11#2)
prescribing rates for##2##3##(2008-11#1)(2008-3#1)
prescribing rates##3##2##(2008-11#2)(2008-3#1)
prescribing##81##1##(1992-2#1)(1993-12#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#36)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-3#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
prescription and##10##2##(1991-1#1)(1993-1#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
prescription data##4##2##(2008-11#1)(2008-3#1)(2008-8#2)
prescription databases##2##2##(2008-3#2)
prescription drug benefit##4##3##(1995-1#2)(2007-9#1)(2008-11#1)
prescription drug benefits##3##3##(1995-1#3)
prescription drug coverage##2##3##(1992-1#1)(1995-1#1)
prescription drug expenditures##3##3##(1995-1#2)(1997-1#1)
prescription drug plan##2##3##(1995-6#1)(2008-11#1)
prescription drug spending##2##3##(1995-1#2)
prescription drug use##4##3##(1992-1#1)(1995-1#1)(2013-1#2)
prescription drug##30##2##(1992-1#2)(1993-1#1)(1995-1#13)(1995-6#1)(1997-1#3)(2007-9#1)(2008-11#2)(2012-1#1)(2013-1#3)(2013-8#3)
prescription drugs and##3##3##(1993-1#2)(2013-1#1)
prescription drugs in##2##3##(1997-1#1)(2008-11#1)
prescription drugs##24##2##(1993-1#3)(1993-3#1)(1994-3#1)(1995-1#3)(1996-1#1)(1997-1#2)(1997-2#1)(2008-11#3)(2008-12#3)(2008-4#1)(2010-4#1)(2010-5#1)(2013-1#2)(2013-8#1)
prescription for##11##2##(1991-3#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-4#1)(2009-6#1)(2010-1#1)
prescription in##4##2##(1994-3#1)(1996-11#1)(1997-5#1)(2007-11#1)
prescription medications##3##2##(1996-1#1)(2008-12#1)(2008-3#1)
prescription of##12##2##(1991-11#1)(1995-11#1)(1996-9#2)(2008-11#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)
prescription or##2##2##(1994-6#2)
prescription pads##2##2##(1996-2#1)(2008-3#1)
prescription patterns##2##2##(2008-11#1)(2013-8#1)
prescription##158##1##(1990-2#2)(1991-1#1)(1991-11#1)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#1)(1993-1#5)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-1#21)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#4)(1996-2#1)(1996-9#3)(1997-1#5)(1997-2#2)(1997-4#2)(1997-5#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#6)
prescription]##5##1##(1990-9#1)(1993-11#1)(1995-5#1)(1996-10#1)(1997-6#1)
prescriptions and##2##2##(1995-6#1)(2013-1#1)
prescriptions for##8##2##(1991-1#1)(1993-11#1)(1995-11#1)(1996-3#1)(2008-8#2)(2009-9#2)
prescriptions in general##2##3##(1995-3#1)(1996-9#1)
prescriptions in##5##2##(1995-11#1)(1995-3#1)(1995-8#1)(1996-9#1)(2008-11#1)
prescriptions were##7##2##(1995-8#1)(1996-9#1)(2008-11#3)(2009-9#1)(2010-12#1)
prescriptions##52##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-11#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-3#1)(1996-9#3)(2007-9#1)(2008-10#2)(2008-11#8)(2008-8#2)(2009-9#7)(2010-12#1)(2010-5#8)(2013-1#1)
prescriptions]##3##1##(1991-6#1)(1993-11#1)(1993-6#1)
prescriptive incrementalism##2##2##(1996-12#2)
prescriptive##3##1##(1996-12#2)(2008-3#1)
presecretory proteins##3##2##(1994-11#3)
presecretory##4##1##(1994-11#4)
preseizure##4##1##(2013-8#4)
preselected##6##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
preselection##2##1##(2008-10#1)(2008-5#1)
presence and absence of##46##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#12)(2008-11#4)(2008-7#1)(2008-8#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
presence and location of##2##4##(1992-12#1)(2008-10#1)
presence and severity of##4##4##(1991-8#1)(1997-1#1)(1997-8#1)(2008-3#1)
presence and shape of the##2##5##(2008-3#1)(2008-5#1)
presence and the##6##3##(2007-5#1)(2008-10#3)(2011-2#1)(2013-8#1)
presence and##88##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#3)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#20)(2008-11#5)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
presence are##2##2##(2008-8#2)
presence as##2##2##(2008-10#1)(2011-1#1)
presence during##3##2##(1996-2#1)(2008-9#1)(2011-2#1)
presence has been##2##3##(2012-1#1)(2012-2#1)
presence in some##2##3##(2008-10#1)(2008-11#1)
presence in the##10##3##(1993-8#1)(1994-12#1)(1995-11#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-8#1)
presence in##42##2##(1990-5#1)(1991-8#2)(1992-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
presence is##4##2##(2008-1#1)(2008-10#2)(2013-8#1)
presence of &quot##4##3##(1990-3#1)(2008-10#1)(2008-5#1)(2009-7#1)
presence of 0##21##3##(1990-11#1)(1990-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-2#1)(2008-10#5)(2008-11#2)(2011-2#2)
presence of 1 mM##3##4##(1992-12#1)(1993-6#1)(1995-12#1)
presence of 1##20##3##(1990-12#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#7)(2009-12#1)(2009-2#1)
presence of 1%##3##3##(2008-10#3)
presence of 10 mM##3##4##(1995-11#1)(1997-2#1)(2008-11#1)
presence of 10##6##3##(1995-11#1)(1997-2#1)(1997-3#1)(2008-11#1)(2010-11#1)(2012-12#1)
presence of 10(-3) M##2##4##(2008-10#2)
presence of 18-crown-6##2##3##(2008-10#2)
presence of 2##11##3##(1990-8#2)(1992-6#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#4)(2013-1#1)
presence of 5 microM##3##4##(1994-11#1)(1995-11#1)(1995-12#1)
presence of 5##8##3##(1992-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-7#1)
presence of B##4##3##(1992-3#1)(2008-10#2)(2013-7#1)
presence of Co(III)##2##3##(2008-10#2)
presence of E2##2##3##(1997-6#1)(2008-11#1)
presence of EDTA##5##3##(1995-6#1)(2008-10#4)
presence of EGTA##6##3##(1990-10#2)(1990-2#1)(1990-8#1)(1994-6#1)(1995-8#1)
presence of Fusarium##3##3##(2008-10#3)
presence of GAP-43##2##3##(2008-9#2)
presence of HBV##2##3##(1997-4#1)(2009-3#1)
presence of HNO(3)##2##3##(2008-10#2)
presence of L-histidine##2##3##(1995-8#2)
presence of NO##4##3##(1995-11#1)(2008-10#3)
presence of Na(+)##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
presence of O2##2##3##(1995-6#2)
presence of P##4##3##(2008-10#4)
presence of PAP in##2##4##(2008-12#2)
presence of S9##2##3##(1996-2#1)(1997-4#1)
presence of T##4##3##(1997-8#1)(2008-10#1)(2008-8#2)
presence of T22##3##3##(2008-10#3)
presence of Zn2+##2##3##(1997-4#2)
presence of a cationic surfactant##3##5##(2008-10#3)
presence of a conserved##2##4##(1994-2#1)(2008-10#1)
presence of a metabolic syndrome##2##5##(2008-10#2)
presence of a neutral surfactant##2##5##(2008-10#2)
presence of a non-ionic##2##4##(1997-7#1)(2008-10#1)
presence of a relatively##2##4##(1992-6#1)(2008-9#1)
presence of a significant##2##4##(1997-7#1)(2008-10#1)
presence of a single##11##4##(1990-11#1)(1990-2#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-6#1)(2010-3#1)
presence of a susceptibility locus##2##5##(1997-5#2)
presence of a##236##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#10)(2007-2#1)(2007-7#1)(2008-10#55)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
presence of abnormal##4##3##(1990-12#1)(2008-10#1)(2009-12#1)(2011-2#1)
presence of acanthosis##2##3##(2013-1#2)
presence of active##7##3##(1993-12#1)(1994-5#1)(1994-6#1)(2008-11#2)(2008-7#1)(2008-8#1)
presence of acute##2##3##(2008-2#1)(2008-3#1)
presence of additional##4##3##(1994-8#1)(1997-3#1)(2008-10#1)(2008-6#1)
presence of aerosols##2##3##(2008-3#2)
presence of agonists##2##3##(1992-11#1)(2012-2#1)
presence of air##4##3##(1991-3#1)(2008-10#1)(2008-6#1)(2013-1#1)
presence of alkyl##2##3##(2008-10#1)(2012-2#1)
presence of an electron##2##4##(2008-10#2)
presence of an##75##3##(1990-11#2)(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
presence of antibodies##2##3##(2008-10#2)
presence of any##9##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#1)(2013-1#1)
presence of ascorbic acid (AA)##2##5##(2008-10#2)
presence of ascorbic acid##10##4##(2008-10#9)(2011-1#1)
presence of autoantibodies##2##3##(1991-4#1)(2011-2#1)
presence of beta-CD##7##3##(1994-3#2)(2008-10#5)
presence of bilateral##2##3##(2013-1#2)
presence of bone metastases##2##4##(1991-8#2)
presence of bone##4##3##(1991-8#2)(2011-1#2)
presence of both##17##3##(1991-12#2)(1991-8#1)(1992-5#1)(2007-2#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)
presence of bovine serum albumin##7##5##(1993-8#1)(1995-12#4)(2008-10#2)
presence of cagA##2##3##(1997-8#2)
presence of cancer##2##3##(2012-12#1)(2013-1#1)
presence of carbonate##2##3##(2008-10#2)
presence of catalase in##2##4##(2008-10#2)
presence of catalase##3##3##(1991-9#1)(2008-10#2)
presence of central##2##3##(1997-8#1)(2008-1#1)
presence of chloride ions##3##4##(1991-9#1)(2008-10#2)
presence of chloride##4##3##(1991-9#1)(2008-10#3)
presence of chronic##4##3##(1992-5#1)(2008-1#1)(2008-4#1)(2008-7#1)
presence of circulating##4##3##(1991-2#1)(1992-3#1)(2006-6#1)(2008-10#1)
presence of concomitant##3##3##(2008-10#1)(2009-9#1)(2012-12#1)
presence of copper(II)##2##3##(2008-10#2)
presence of different percentages of##2##5##(2008-10#2)
presence of different##13##3##(1990-5#1)(1991-5#1)(1992-5#1)(2008-10#6)(2008-2#1)(2008-5#2)(2010-4#1)
presence of disease##6##3##(1994-11#1)(1996-2#1)(2008-10#3)(2012-2#1)
presence of distant metastases##2##4##(1991-8#1)(2011-2#1)
presence of distracters##2##3##(2009-2#2)
presence of each of the##3##5##(1994-12#1)(1996-5#1)(2011-2#1)
presence of each##6##3##(1994-12#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
presence of either##8##3##(1991-8#1)(1995-11#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
presence of elevated##2##3##(2008-11#1)(2012-3#1)
presence of ethanol##4##3##(1991-5#1)(2008-10#3)
presence of fish##2##3##(2008-2#1)(2008-9#1)
presence of free##3##3##(1993-8#1)(2008-10#2)
presence of fructose 6-phosphate##3##4##(1990-7#3)
presence of gas##2##3##(2012-12#1)(2012-2#1)
presence of glucose oxidase##2##4##(2008-10#2)
presence of glucose##6##3##(1990-2#1)(1995-8#2)(2008-10#3)
presence of great##2##3##(2008-10#2)
presence of guanidine hydrochloride##2##4##(1992-6#1)(1995-5#1)
presence of guanidine##3##3##(1992-6#1)(1995-5#1)(2008-4#1)
presence of guanine##2##3##(1993-6#1)(2008-10#1)
presence of heparin##4##3##(1990-12#1)(1992-5#1)(2008-4#1)(2010-8#1)
presence of high concentrations of##7##5##(1990-12#2)(1994-9#1)(2008-10#2)(2008-11#1)(2008-4#1)
presence of high##23##3##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2012-5#1)
presence of higher##5##3##(1993-11#1)(2008-10#1)(2009-9#1)(2010-8#1)(2011-1#1)
presence of higher-order##3##3##(1994-8#1)(2007-12#1)(2008-2#1)
presence of human##6##3##(1990-12#1)(1991-2#1)(2008-10#1)(2009-4#1)(2009-9#1)(2011-2#1)
presence of hydrogen peroxide catalyses the oxidation of hydroquinone to##2##10##(2008-10#2)
presence of hydrogen peroxide catalyses the oxidation of##3##8##(2008-10#3)
presence of hydrogen peroxide##10##4##(2008-10#10)
presence of hydrogen##12##3##(2007-12#1)(2008-10#11)
presence of imidazole##3##3##(1994-5#2)(2008-10#1)
presence of infection##2##3##(2008-12#1)(2010-8#1)
presence of insulin##5##3##(1991-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
presence of interfering ions##3##4##(2008-10#3)
presence of interfering##5##3##(2008-10#4)(2013-1#1)
presence of internal##2##3##(2010-4#1)(2013-1#1)
presence of ions and##2##4##(2008-10#1)(2010-5#1)
presence of iron##7##3##(1991-5#1)(1995-3#1)(2008-10#3)(2013-1#1)(2013-8#1)
presence of its##7##3##(1993-8#1)(2008-10#4)(2011-2#1)(2013-7#1)
presence of known##2##3##(2008-1#1)(2008-10#1)
presence of large number of cations and anions##2##8##(2008-10#2)
presence of large##14##3##(2007-11#3)(2007-12#1)(2008-10#9)(2011-2#1)
presence of ligand##2##3##(2008-10#1)(2008-4#1)
presence of low##10##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
presence of magnesium##3##3##(1997-3#1)(2007-11#1)(2008-4#1)
presence of metabolic syndrome##2##4##(2008-1#1)(2012-12#1)
presence of metastases at##2##4##(2007-8#1)(2010-3#1)
presence of metastases##5##3##(1990-12#1)(1990-6#1)(2007-8#1)(2010-3#2)
presence of microorganisms##2##3##(2008-11#2)
presence of more than##3##4##(1990-12#1)(2008-10#1)(2008-5#1)
presence of more##4##3##(1990-12#1)(1991-3#1)(2008-10#1)(2008-5#1)
presence of multiple forms of##2##5##(1990-7#1)(1991-5#1)
presence of multiple##11##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-4#1)(2012-2#1)(2013-8#1)
presence of necrosis##3##3##(2011-2#2)(2012-3#1)
presence of negatively charged##3##4##(1992-12#1)(1995-8#1)(2008-1#1)
presence of nitrate##5##3##(1992-6#1)(2008-10#2)(2008-11#2)
presence of normal##3##3##(2006-6#1)(2008-1#1)(2011-2#1)
presence of numerous##2##3##(2008-10#1)(2008-2#1)
presence of one##7##3##(1991-9#1)(1994-6#1)(2008-10#4)(2008-8#1)
presence of open##2##3##(1992-3#1)(2007-12#1)
presence of osteophytes##2##3##(1994-11#1)(2007-11#1)
presence of other##23##3##(1991-5#1)(1991-8#1)(1993-8#1)(1997-4#1)(2008-10#13)(2008-4#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
presence of oxygen##12##3##(1991-2#1)(1991-9#1)(1993-6#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-9#1)(2009-3#1)
presence of peroxidase##2##3##(1991-8#1)(2008-10#1)
presence of phytoplasma in##2##4##(2008-10#2)
presence of possible##2##3##(2007-11#1)(2008-7#1)
presence of predators##3##3##(2008-8#3)
presence of protein kinase C##2##5##(1990-7#1)(2008-4#1)
presence of protein kinase##3##4##(1990-7#1)(1994-11#1)(2008-4#1)
presence of proteins##5##3##(1992-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#1)
presence of putative##2##3##(1992-8#1)(2008-7#1)
presence of relatively##4##3##(1990-12#1)(1991-9#1)(2008-10#2)
presence of residual##5##3##(1992-10#1)(2008-10#1)(2009-11#1)(2009-7#1)(2013-8#1)
presence of selenium##2##3##(2008-10#2)
presence of serum##11##3##(1991-5#1)(1992-11#1)(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#4)(2011-2#1)(2013-1#1)
presence of several cations##2##4##(2008-10#2)
presence of several##20##3##(1991-6#1)(1991-9#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#13)(2008-12#1)(2008-8#1)
presence of sodium##24##3##(1990-11#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)
presence of soluble##2##3##(2008-11#2)
presence of squamous##2##3##(1991-2#1)(2011-2#1)
presence of substantial amounts of##2##5##(1991-12#1)(1992-11#1)
presence of such##8##3##(1991-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
presence of surfactant##3##3##(2008-10#3)
presence of testosterone##3##3##(1995-2#2)(2012-2#1)
presence of the additional##2##4##(2006-12#1)(2008-10#1)
presence of the pathogen##3##4##(2008-10#3)
presence of the polymer##2##4##(1995-2#1)(2008-10#1)
presence of the two##4##4##(1990-7#1)(1994-11#2)(2008-11#1)
presence of the##184##3##(1990-11#3)(1990-2#1)(1990-5#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#60)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#8)(2009-11#2)(2009-9#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#4)(2013-1#2)(2013-7#1)(2013-8#1)
presence of these receptors##2##4##(1991-5#1)(1995-12#1)
presence of these##16##3##(1991-1#1)(1991-5#1)(1991-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
presence of this##15##3##(1990-12#1)(1990-5#1)(1991-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-8#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-9#1)(2013-7#1)
presence of trace##2##3##(2008-10#2)
presence of tremor##2##3##(2008-7#2)
presence of two##43##3##(1990-5#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-2#1)(1996-10#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#11)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
presence of type##2##3##(1990-8#1)(1993-11#1)
presence of underlying##2##3##(2011-2#1)(2012-12#1)
presence of urea##3##3##(1995-5#1)(2008-10#2)
presence of various##10##3##(1990-8#1)(1994-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2008-10#2)(2012-3#1)(2013-8#1)
presence of viable##2##3##(2007-8#2)
presence of water##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
presence of##3010##2##(1990-10#7)(1990-11#18)(1990-12#25)(1990-2#20)(1990-3#3)(1990-5#28)(1990-6#1)(1990-7#12)(1990-8#23)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#27)(1991-2#16)(1991-3#6)(1991-4#2)(1991-5#24)(1991-6#2)(1991-7#1)(1991-8#16)(1991-9#15)(1992-1#1)(1992-10#1)(1992-11#10)(1992-12#18)(1992-2#4)(1992-3#25)(1992-4#1)(1992-5#8)(1992-6#21)(1992-7#1)(1992-8#13)(1992-9#12)(1993-1#1)(1993-11#18)(1993-12#7)(1993-2#5)(1993-3#11)(1993-5#1)(1993-6#22)(1993-8#31)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#27)(1994-12#15)(1994-2#9)(1994-3#10)(1994-5#21)(1994-6#19)(1994-7#3)(1994-8#22)(1994-9#10)(1995-11#22)(1995-12#23)(1995-2#34)(1995-3#16)(1995-4#1)(1995-5#16)(1995-6#20)(1995-8#19)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#13)(1996-2#15)(1996-3#6)(1996-4#2)(1996-5#24)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#19)(1997-3#13)(1997-4#21)(1997-5#4)(1997-6#4)(1997-7#15)(1997-8#10)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#2)(2007-10#15)(2007-11#30)(2007-12#43)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#10)(2007-8#8)(2007-9#2)(2008-1#21)(2008-10#926)(2008-11#105)(2008-12#34)(2008-2#42)(2008-3#80)(2008-4#49)(2008-5#60)(2008-6#31)(2008-7#59)(2008-8#50)(2008-9#37)(2009-1#2)(2009-10#6)(2009-11#7)(2009-12#5)(2009-2#5)(2009-3#4)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#6)(2009-8#18)(2009-9#16)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#6)(2010-2#3)(2010-3#12)(2010-4#13)(2010-5#11)(2010-6#13)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#21)(2011-2#82)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#33)(2012-2#28)(2012-3#30)(2012-5#1)(2013-1#60)(2013-7#11)(2013-8#26)
presence on the##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
presence on##6##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
presence or absence of a##6##5##(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
presence or absence of light##2##5##(1991-9#1)(2008-10#1)
presence or absence of the##10##5##(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#5)(2008-5#1)(2008-6#1)
presence or absence of##72##4##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#27)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2009-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)
presence or absence##75##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)
presence or##79##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)
presence suggests##2##2##(1994-2#1)(2013-1#1)
presence versus absence##2##3##(1996-2#1)(2011-2#1)
presence was##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
presence##3305##1##(1990-10#7)(1990-11#20)(1990-12#26)(1990-2#21)(1990-3#3)(1990-5#32)(1990-6#2)(1990-7#15)(1990-8#23)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#29)(1991-2#16)(1991-3#7)(1991-4#2)(1991-5#26)(1991-6#3)(1991-7#1)(1991-8#19)(1991-9#16)(1992-1#2)(1992-10#1)(1992-11#10)(1992-12#20)(1992-2#4)(1992-3#29)(1992-4#2)(1992-5#8)(1992-6#23)(1992-7#1)(1992-8#13)(1992-9#13)(1993-1#1)(1993-11#20)(1993-12#8)(1993-2#6)(1993-3#15)(1993-5#1)(1993-6#23)(1993-8#34)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#30)(1994-12#17)(1994-2#11)(1994-3#11)(1994-5#22)(1994-6#20)(1994-7#3)(1994-8#24)(1994-9#10)(1995-11#25)(1995-12#23)(1995-2#35)(1995-3#18)(1995-4#1)(1995-5#16)(1995-6#22)(1995-8#20)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#13)(1996-2#17)(1996-3#6)(1996-4#2)(1996-5#25)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#10)(1997-2#19)(1997-3#14)(1997-4#21)(1997-5#4)(1997-6#4)(1997-7#15)(1997-8#12)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#2)(2007-10#16)(2007-11#32)(2007-12#44)(2007-2#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#9)(2007-9#2)(2008-1#24)(2008-10#1000)(2008-11#119)(2008-12#40)(2008-2#44)(2008-3#86)(2008-4#51)(2008-5#73)(2008-6#33)(2008-7#67)(2008-8#61)(2008-9#39)(2009-1#2)(2009-10#8)(2009-11#7)(2009-12#5)(2009-2#6)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#6)(2009-7#6)(2009-8#19)(2009-9#20)(2010-1#3)(2010-10#3)(2010-11#9)(2010-12#6)(2010-2#3)(2010-3#15)(2010-4#14)(2010-5#12)(2010-6#14)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#24)(2011-2#97)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#35)(2012-2#35)(2012-3#33)(2012-5#1)(2013-1#67)(2013-7#13)(2013-8#33)
presence/absence data##2##2##(2008-10#1)(2013-7#1)
presence/absence of##2##2##(1993-2#1)(2008-11#1)
presence/absence##4##1##(1993-2#1)(2008-10#1)(2008-11#1)(2013-7#1)
presences##2##1##(2008-10#1)(2008-8#1)
presenilin 1 gene##2##3##(1996-2#2)
presenilin##3##1##(1996-2#3)
presensitized##6##1##(1991-3#1)(2007-12#5)
present 2 cases of##2##4##(2009-1#1)(2012-3#1)
present 3 cases of##2##4##(2011-2#1)(2012-12#1)
present 3 cases##3##3##(2007-4#1)(2011-2#1)(2012-12#1)
present 3##4##2##(2007-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
present SPE/LC method##2##3##(2008-10#2)
present a case in which##4##5##(2008-11#1)(2008-7#1)(2010-7#1)(2012-12#1)
present a case of a giant##2##6##(2008-12#1)(2012-12#1)
present a case of a##25##5##(2007-5#2)(2007-8#5)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#4)
present a case of an##5##5##(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
present a case of multiple##2##5##(2008-10#1)(2013-1#1)
present a case of secondary##2##5##(2008-12#1)(2010-3#1)
present a case of##100##4##(1991-3#1)(1991-6#2)(1993-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-5#4)(2007-7#1)(2007-8#6)(2008-10#4)(2008-11#1)(2008-12#7)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#9)(2012-2#5)(2012-3#1)(2013-1#14)(2013-8#3)
present a case report of a##6##6##(2007-10#1)(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
present a case report of##7##5##(2007-10#1)(2007-8#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
present a case report##9##4##(1990-3#1)(2007-10#1)(2007-8#1)(2008-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
present a case study of a##2##6##(2010-6#1)(2013-1#1)
present a case study##3##4##(2008-6#1)(2010-6#1)(2013-1#1)
present a case that##2##4##(2008-7#1)(2010-5#1)
present a case where##3##4##(2007-8#2)(2012-12#1)
present a case with##2##4##(2008-12#1)(2011-1#1)
present a case##128##3##(1990-3#1)(1991-3#1)(1991-6#2)(1993-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-5#4)(2007-7#1)(2007-8#9)(2008-10#4)(2008-11#2)(2008-12#9)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#1)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#13)(2012-2#7)(2012-3#1)(2013-1#16)(2013-8#3)
present a challenge##2##3##(2009-6#1)(2012-2#1)
present a clinical case of##2##5##(2010-12#1)(2013-1#1)
present a clinical##3##3##(2008-6#1)(2010-12#1)(2013-1#1)
present a comparative study of##3##5##(2008-3#1)(2010-2#2)
present a comprehensive##3##3##(2008-3#2)(2012-2#1)
present a computer##2##3##(2008-10#1)(2008-2#1)
present a conceptual##3##3##(2008-2#1)(2013-1#2)
present a critical##2##3##(2008-3#1)(2012-3#1)
present a design##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
present a detailed##8##3##(2008-2#2)(2008-3#5)(2010-3#1)
present a discussion of##2##4##(1994-3#1)(2007-12#1)
present a generic##2##3##(2008-6#1)(2008-9#1)
present a high##2##3##(2009-7#1)(2013-7#1)
present a major##3##3##(2007-12#1)(2008-10#1)(2010-1#1)
present a market##2##3##(1994-2#1)(2008-5#1)
present a mathematical model to##2##5##(1991-11#1)(2013-7#1)
present a mathematical model##4##4##(1991-11#1)(2008-2#1)(2008-7#1)(2013-7#1)
present a mathematical##6##3##(1991-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-7#1)
present a method for##13##4##(1992-6#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)(2008-8#1)(2011-2#1)
present a method of##9##4##(2007-11#5)(2007-12#1)(2008-3#2)(2009-11#1)
present a method to##2##4##(2008-3#1)(2012-3#1)
present a method##29##3##(1992-6#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#7)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#1)
present a methodology##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
present a model of##2##4##(2007-11#1)(2007-12#1)
present a model##12##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-8#2)(2008-9#3)(2012-2#1)
present a modified##2##3##(2007-11#1)(2007-8#1)
present a more##2##3##(2008-3#1)(2012-7#1)
present a new analytical method##2##5##(2008-10#1)(2008-3#1)
present a new method for##3##5##(2008-2#1)(2008-3#1)(2008-9#1)
present a new method##8##4##(1994-9#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
present a new technique to##2##5##(1997-3#1)(2008-3#1)
present a new technique##7##4##(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
present a new##53##3##(1990-12#1)(1994-9#1)(1997-3#1)(2007-11#6)(2007-12#7)(2008-10#2)(2008-2#5)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
present a novel method for##2##5##(2007-11#1)(2008-5#1)
present a novel method##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
present a novel##30##3##(1992-3#1)(1994-12#1)(2007-11#12)(2007-12#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)
present a patient who developed##2##5##(2008-1#1)(2011-1#1)
present a patient who##4##4##(1990-9#1)(2008-1#1)(2011-1#1)(2013-1#1)
present a patient with##10##4##(1993-8#1)(2007-8#2)(2008-12#2)(2008-9#2)(2009-11#1)(2009-8#1)(2013-1#1)
present a patient##14##3##(1990-9#1)(1993-8#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-9#2)(2009-11#1)(2009-8#1)(2011-1#1)(2013-1#2)
present a perspective##2##3##(2008-12#1)(2011-2#1)
present a preliminary##2##3##(2012-2#1)(2013-8#1)
present a problem for##2##4##(2008-10#1)(2011-2#1)
present a problem##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
present a project##2##3##(1990-3#1)(2012-12#1)
present a rare case of##7##5##(2008-10#2)(2008-6#1)(2008-9#2)(2011-2#1)(2012-12#1)
present a rare##9##3##(2008-10#2)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
present a regularized##2##3##(2008-2#1)(2010-1#1)
present a review of the literature and##2##7##(2008-4#1)(2008-9#1)
present a review of the literature##3##6##(2008-2#1)(2008-4#1)(2008-9#1)
present a review of the##4##5##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
present a review of##5##4##(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
present a series of##6##4##(1990-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)
present a serious##2##3##(2008-11#1)(2008-7#1)
present a simple and##2##4##(2008-8#1)(2009-5#1)
present a simple approach##2##4##(2008-9#1)(2011-1#1)
present a simple technique for##2##5##(2007-11#1)(2008-3#1)
present a simple##21##3##(2007-11#4)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#2)(2011-1#1)(2012-2#1)
present a strategy##4##3##(2008-11#1)(2008-2#2)(2008-4#1)
present a study##4##3##(1990-3#1)(2008-8#1)(2012-3#2)
present a summary of the##2##5##(1992-6#1)(2009-12#1)
present a systematic##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
present a technique for measuring##2##5##(2007-11#2)
present a technique for##8##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
present a technique##10##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2013-1#1)
present a two-step##2##3##(2008-2#1)(2009-5#1)
present a typology##2##3##(2010-12#1)(2012-12#1)
present a unified##2##3##(2008-3#1)(2009-5#1)
present a variety of##2##4##(2008-7#1)(2010-11#1)
present a##616##2##(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#3)(1992-3#2)(1992-6#3)(1993-1#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#4)(2007-11#52)(2007-12#42)(2007-2#1)(2007-5#6)(2007-7#1)(2007-8#19)(2008-1#3)(2008-10#25)(2008-11#11)(2008-12#15)(2008-2#47)(2008-3#97)(2008-4#2)(2008-5#5)(2008-6#10)(2008-7#23)(2008-8#17)(2008-9#19)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#23)(2012-1#1)(2012-12#20)(2012-2#17)(2012-3#7)(2012-7#1)(2013-1#25)(2013-7#5)(2013-8#8)
present after##4##2##(1990-7#1)(1992-3#1)(1993-12#1)(2013-1#1)
present alone##2##2##(2008-10#2)
present also in##2##3##(1991-9#1)(1994-8#1)
present also##3##2##(1991-9#1)(1994-8#1)(2008-1#1)
present among##6##2##(2008-10#3)(2008-5#1)(2008-9#1)(2009-5#1)
present an algorithm for##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
present an algorithm##7##3##(2008-2#3)(2008-3#3)(2013-1#1)
present an alternative derivation##2##4##(2008-2#1)(2008-3#1)
present an alternative method##2##4##(2007-11#1)(2008-9#1)
present an alternative##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
present an analysis of the##4##5##(1995-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
present an analysis of##6##4##(1995-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)
present an application##2##3##(2008-2#1)(2013-1#1)
present an approach##7##3##(1997-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2011-1#1)
present an efficient##2##3##(2007-11#1)(2008-6#1)
present an example of##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
present an experimental##7##3##(2007-11#1)(2007-12#3)(2008-2#2)(2012-2#1)
present an extremely##2##3##(1993-8#1)(2013-1#1)
present an improved##2##3##(2008-2#1)(2008-3#1)
present an interferometric##2##3##(2007-11#1)(2008-2#1)
present an inversion##2##3##(2008-3#2)
present an investigation of the##2##5##(2008-2#1)(2009-5#1)
present an investigation##3##3##(2007-11#1)(2008-2#1)(2009-5#1)
present an optical##7##3##(2007-12#1)(2008-2#3)(2008-3#3)
present an overview of the##8##5##(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-3#1)
present an overview of##13##4##(2007-5#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
present an overview##14##3##(2007-5#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
present an unusual case##4##4##(2008-10#1)(2008-9#1)(2011-1#2)
present an##126##2##(1993-8#1)(1994-12#1)(1995-8#1)(1997-1#1)(1997-3#2)(2006-10#1)(2007-11#8)(2007-12#8)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#21)(2008-3#24)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#2)(2009-5#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)
present analysis is##2##3##(1991-5#1)(2012-3#1)
present analysis##5##2##(1991-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
present analytical##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
present and discuss##3##3##(2008-3#2)(2013-1#1)
present and future of##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
present and future##18##3##(1992-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
present and##52##2##(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
present apparatus##2##2##(2008-10#1)(2008-2#1)
present application##2##2##(2008-10#2)
present approach##5##2##(1995-8#1)(2007-11#1)(2008-10#3)
present are##2##2##(2008-10#2)
present article highlights##3##3##(2008-10#1)(2008-11#2)
present article is##4##3##(1994-6#1)(2008-11#2)(2012-2#1)
present article provides a##2##4##(2008-11#1)(2013-8#1)
present article provides##5##3##(2008-11#2)(2009-2#1)(2011-2#1)(2013-8#1)
present article reports##5##3##(1992-1#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-7#1)
present article##63##2##(1990-12#1)(1990-6#1)(1992-1#1)(1994-6#1)(1995-8#2)(1996-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#22)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
present as a minor##2##4##(2008-10#1)(2012-1#1)
present as a single copy##3##5##(1993-2#1)(1997-4#1)(2008-8#1)
present as a##18##3##(1992-11#1)(1992-2#1)(1992-9#1)(1993-2#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
present as an##4##3##(1992-2#1)(2007-8#1)(2012-12#1)(2013-1#1)
present as multiple##3##3##(2011-2#1)(2012-1#1)(2012-12#1)
present as##53##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-2#4)(1992-9#1)(1993-2#1)(1994-11#1)(1995-2#1)(1996-2#3)(1997-4#1)(1997-6#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)
present at a frequency of##2##5##(2008-10#1)(2011-2#1)
present at a level##2##4##(1991-12#1)(2008-10#1)
present at a##9##3##(1990-5#1)(1991-12#1)(1994-3#1)(2008-10#4)(2008-12#1)(2011-2#1)
present at birth##4##3##(2008-1#1)(2008-11#1)(2011-1#1)(2012-3#1)
present at concentrations##2##3##(2008-10#1)(2012-12#1)
present at high concentrations##2##4##(2008-10#1)(2008-8#1)
present at high##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
present at low concentrations##2##4##(1991-9#1)(2007-12#1)
present at low##7##3##(1991-9#1)(1993-9#1)(1994-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
present at the##18##3##(1991-5#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
present at##81##2##(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#3)(2013-8#1)
present before##2##2##(1990-2#1)(2009-3#1)
present between the##2##3##(2008-5#1)(2008-7#1)
present between##4##2##(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
present both in##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
present both##9##2##(1992-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
present but##6##2##(1991-12#1)(1994-8#1)(2007-12#1)(2008-11#1)(2011-1#1)(2013-7#1)
present case report##8##3##(1990-8#1)(1994-7#1)(2007-12#2)(2008-7#1)(2009-8#1)(2013-1#2)
present case reports of three patients who successfully underwent##2##9##(2008-11#2)
present case was##2##3##(1997-7#1)(2008-5#1)
present case##39##2##(1990-5#1)(1990-8#1)(1994-2#1)(1994-7#1)(1995-4#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
present cases##2##2##(1994-6#1)(1997-3#1)
present challenges##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
present clear evidence##2##3##(2007-12#1)(2013-1#1)
present clinical##6##2##(1990-10#1)(1990-5#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
present communication##4##2##(1990-12#1)(1991-12#1)(1993-8#1)(2012-3#1)
present data from##3##3##(1992-11#1)(2008-7#1)(2013-8#1)
present data indicate that##2##4##(1993-8#1)(1995-12#1)
present data indicate##4##3##(1990-7#1)(1993-8#1)(1995-12#1)(2008-8#1)
present data on##2##3##(1994-9#1)(2011-2#1)
present data suggest##4##3##(1992-3#1)(1994-3#1)(2008-12#1)(2008-7#1)
present data that##5##3##(1992-7#1)(2008-11#1)(2008-2#1)(2008-3#2)
present data##36##2##(1990-12#1)(1990-7#2)(1991-6#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-8#2)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
present day##6##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
present design##2##2##(2008-2#1)(2009-10#1)
present detailed##3##2##(1994-3#1)(2008-2#1)(2008-6#1)
present different##4##2##(2007-11#1)(2008-5#1)(2009-8#1)(2010-12#1)
present difficulties in##2##3##(1993-9#1)(2010-8#1)
present during the##2##3##(1994-2#1)(2008-10#1)
present during##13##2##(1990-11#1)(1991-5#1)(1994-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-3#1)(2013-8#1)
present early##2##2##(2011-2#1)(2013-1#1)
present epidemiological##3##2##(1990-6#1)(1992-5#1)(2009-5#1)
present estimates##2##2##(1992-12#1)(2010-11#1)
present evidence for##3##3##(2007-8#1)(2008-6#1)(2008-9#1)
present evidence that the##2##4##(1994-11#1)(2008-6#1)
present evidence that##8##3##(1991-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
present evidence##20##2##(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)
present examples of##2##3##(2007-11#1)(2009-5#1)
present examples##3##2##(1990-8#1)(2007-11#1)(2009-5#1)
present experiment showed that##2##4##(2008-12#1)(2008-9#1)
present experiment was##3##3##(1992-7#1)(1997-8#1)(2008-11#1)
present experiment##13##2##(1992-7#1)(1993-11#1)(1994-3#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2009-11#1)(2011-2#2)
present experimental data##5##3##(1990-8#1)(1995-3#1)(2008-2#1)(2008-3#1)(2009-3#1)
present experimental evidence that##2##4##(2008-2#1)(2008-9#1)
present experimental evidence##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
present experimental results of##3##4##(2007-11#2)(2007-12#1)
present experimental results that demonstrate the##2##6##(2008-2#1)(2008-3#1)
present experimental results##15##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#7)(2008-6#1)(2013-1#1)
present experimental##35##2##(1990-8#1)(1993-1#1)(1995-3#1)(2007-11#4)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#11)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-4#1)(2013-1#1)
present experiments were designed to##2##5##(1993-3#1)(1993-6#1)
present experiments were##3##3##(1993-3#1)(1993-6#1)(1994-2#1)
present experiments##16##2##(1990-5#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-2#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
present finding##2##2##(1994-11#1)(1996-7#1)
present findings demonstrate##2##3##(1993-3#1)(2008-5#1)
present findings suggest that##4##4##(1994-5#1)(1995-5#1)(1996-12#1)(1997-2#1)
present findings##13##2##(1991-5#1)(1993-3#2)(1994-5#1)(1995-5#1)(1996-12#1)(1997-2#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
present first##2##2##(2007-11#1)(2008-10#1)
present for a##2##3##(1990-3#1)(2011-2#1)
present for the##3##3##(2008-10#2)(2013-1#1)
present for##16##2##(1990-3#1)(1992-6#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
present four##4##2##(1996-1#1)(1997-3#1)(2008-3#1)(2012-2#1)
present from##2##2##(1996-12#1)(2008-9#1)
present fundamental##2##2##(2007-11#1)(2013-1#1)
present general##2##2##(2008-1#1)(2010-8#1)
present guidelines##3##2##(1996-9#1)(2008-1#1)(2008-10#1)
present here an overview of##2##5##(2008-7#1)(2011-2#1)
present here the##10##3##(1990-3#1)(1993-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-7#1)(2013-1#1)
present here##35##2##(1990-11#1)(1990-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
present higher##3##2##(2008-10#2)(2008-5#1)
present in 1##3##3##(2008-10#2)(2008-12#1)
present in 25%##2##3##(2007-10#1)(2009-5#1)
present in 3 cases##2##4##(1991-3#1)(1993-2#1)
present in 46%##2##3##(1990-9#1)(2010-4#1)
present in 8##2##3##(1991-5#1)(2008-11#1)
present in C##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
present in Drosophila##2##3##(1991-5#1)(1997-6#1)
present in Europe##2##3##(2007-8#1)(2008-10#1)
present in L1##3##3##(1993-12#2)(2008-10#1)
present in S##2##3##(1995-6#1)(2008-11#1)
present in a complex##2##4##(1992-11#1)(1994-8#1)
present in a number of##3##5##(1995-2#1)(1996-12#1)(2008-5#1)
present in a single copy##2##5##(1992-11#1)(1993-6#1)
present in a single##3##4##(1992-11#1)(1993-6#1)(2012-12#1)
present in a variety of##2##5##(1992-6#1)(2012-3#1)
present in a##42##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#2)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#9)(2008-2#2)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
present in about##5##3##(2008-1#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
present in all the##2##4##(2008-1#1)(2008-10#1)
present in all three##2##4##(2007-12#1)(2008-10#1)
present in all##33##3##(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-9#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#4)(2012-3#1)(2013-8#1)
present in an##3##3##(1993-8#1)(2006-10#1)(2007-12#1)
present in aqueous##3##3##(1992-9#1)(2008-10#2)
present in biological fluids##3##4##(1996-12#1)(1997-7#1)(2010-11#1)
present in biological##4##3##(1996-12#1)(1997-7#1)(2008-10#1)(2010-11#1)
present in blood##2##3##(2007-11#1)(2008-10#1)
present in both the##5##4##(1990-8#1)(1997-4#1)(2010-4#1)(2012-3#1)(2013-7#1)
present in both##8##3##(1990-8#1)(1997-4#1)(2006-6#1)(2008-10#2)(2010-4#1)(2012-3#1)(2013-7#1)
present in brain and##2##4##(1990-7#1)(1996-12#1)
present in carrot##2##3##(2008-10#1)(2008-9#1)
present in cell extracts##2##4##(1994-11#1)(2008-4#1)
present in cells##3##3##(1991-5#1)(1995-12#1)(2008-1#1)
present in columns##2##3##(2013-1#2)
present in cornea##2##3##(2008-4#2)
present in cytosol##2##3##(1994-6#1)(2013-1#1)
present in databases##2##3##(1997-3#2)
present in different##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
present in each of the##2##5##(2007-6#1)(2008-10#1)
present in each##7##3##(1990-2#1)(1996-2#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2012-3#1)
present in early##2##3##(2008-7#1)(2010-6#1)
present in either##2##3##(2008-10#1)(2008-5#1)
present in equal##2##3##(2008-10#1)(2008-11#1)
present in excess##2##3##(1994-11#1)(2008-10#1)
present in five##2##3##(2008-10#1)(2008-5#1)
present in food##2##3##(2010-5#1)(2011-2#1)
present in high##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
present in higher##2##3##(2007-11#1)(2008-7#1)
present in human##8##3##(1992-3#2)(1993-11#1)(2008-10#1)(2008-6#1)(2009-4#1)(2013-1#1)(2013-8#1)
present in individuals##2##3##(2008-10#1)(2008-8#1)
present in infancy or early childhood with##2##7##(2008-11#1)(2011-1#1)
present in infancy##3##3##(1995-11#1)(2008-11#1)(2011-1#1)
present in irrigation water##2##4##(2008-10#2)
present in isolates##2##3##(2008-10#2)
present in large##3##3##(1992-6#1)(1994-8#1)(2008-10#1)
present in layers II##2##4##(1994-2#2)
present in leaves##2##3##(2008-10#1)(2013-1#1)
present in liquid##2##3##(2007-12#1)(2008-10#1)
present in low##2##3##(1994-2#1)(2008-10#1)
present in many##3##3##(1997-2#1)(2008-12#1)(2008-5#1)
present in more than##2##4##(1997-6#1)(2008-3#1)
present in more##4##3##(1997-6#1)(2007-12#1)(2008-3#1)(2010-8#1)
present in most##10##3##(1990-6#1)(1992-12#1)(1993-11#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-2#1)(2010-6#1)
present in multiple##2##3##(2008-10#1)(2009-10#1)
present in native##2##3##(1993-8#1)(2008-8#1)
present in natural waters##4##4##(2008-10#4)
present in natural##6##3##(1991-5#1)(2008-10#5)
present in nearly all##2##4##(2008-10#1)(2008-2#1)
present in nearly##4##3##(1990-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
present in necrotic##2##3##(2008-10#1)(2008-7#1)
present in one##2##3##(2007-6#1)(2010-10#1)
present in only one##2##4##(2008-10#1)(2010-4#1)
present in only##5##3##(1990-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
present in other##8##3##(1992-8#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)
present in patients with##4##4##(1995-2#1)(1996-5#1)(2008-5#1)(2013-8#1)
present in patients##7##3##(1995-2#1)(1996-5#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-8#1)
present in petrochemical##2##3##(2008-10#2)
present in pharmaceutical##2##3##(2008-10#1)(2012-2#1)
present in plant##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
present in plants##3##3##(2008-10#2)(2011-2#1)
present in rat##2##3##(1992-8#1)(1993-8#1)
present in real samples##4##4##(2008-10#4)
present in samples##2##3##(2008-10#2)
present in secretory##2##3##(1995-8#1)(2008-11#1)
present in serum##2##3##(1991-8#1)(1996-12#1)
present in several##6##3##(1992-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
present in solution##3##3##(2008-10#3)
present in some##6##3##(1990-5#1)(1994-9#1)(2008-10#2)(2008-7#1)(2011-2#1)
present in surrounding##2##3##(1992-12#1)(2012-12#1)
present in the C##2##4##(1990-5#1)(1996-3#1)
present in the cell##4##4##(1990-11#1)(1992-9#1)(2008-7#1)(2013-8#1)
present in the central nervous system##2##6##(1992-12#1)(1997-8#1)
present in the central##4##4##(1992-12#1)(1995-12#1)(1997-8#1)(2008-10#1)
present in the coding##2##4##(1993-2#1)(1997-7#1)
present in the cytoplasm as##2##5##(1994-11#1)(2008-11#1)
present in the data##2##4##(2008-10#1)(2008-2#1)
present in the different##2##4##(2008-10#1)(2013-7#1)
present in the dust that##2##5##(2008-10#2)
present in the dust##3##4##(2008-10#3)
present in the environmental##2##4##(2008-10#2)
present in the female##2##4##(1996-12#1)(2008-7#1)
present in the form of##3##5##(1994-9#1)(2008-10#2)
present in the host##2##4##(1993-6#1)(2008-10#1)
present in the human genome##2##5##(1991-6#1)(2012-2#1)
present in the human##5##4##(1991-6#1)(1993-11#1)(1993-9#1)(2008-5#1)(2012-2#1)
present in the intracellular##2##4##(2008-4#1)(2008-7#1)
present in the laser##3##4##(2008-3#3)
present in the liver##2##4##(1992-12#1)(2008-11#1)
present in the majority of##3##5##(1994-12#1)(1995-12#1)(2010-3#1)
present in the material##2##4##(2008-10#1)(2009-7#1)
present in the medium##3##4##(2008-10#1)(2008-11#1)(2012-7#1)
present in the parents##2##4##(2008-10#2)
present in the pePOA of the male##2##7##(1992-3#2)
present in the plasma##2##4##(1994-6#1)(2008-10#1)
present in the previous##2##4##(2007-12#1)(2008-10#1)
present in the rat##4##4##(1991-12#1)(1992-12#2)(1993-12#1)
present in the reaction##2##4##(2008-10#2)
present in the same##3##4##(2008-10#3)
present in the sample solution##2##5##(2008-10#2)
present in the sample##12##4##(2008-10#10)(2008-4#2)
present in the samples##6##4##(2008-10#5)(2012-2#1)
present in the sediments##2##4##(2008-10#1)(2008-5#1)
present in the solution##3##4##(1994-2#1)(2008-10#2)
present in the urine##2##4##(1990-12#2)
present in the water##2##4##(2008-10#1)(2008-3#1)
present in the wine##2##4##(2008-10#2)
present in the##325##3##(1990-11#3)(1990-12#4)(1990-5#2)(1991-11#1)(1991-12#7)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#5)(1992-3#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#4)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-12#7)(2007-8#2)(2008-1#5)(2008-10#99)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#1)
present in these cells##3##4##(1990-2#1)(2009-12#1)(2010-2#1)
present in these##19##3##(1990-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-4#1)
present in this##10##3##(1995-2#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
present in trace amounts##2##4##(2008-11#1)(2008-5#1)
present in urine##2##3##(1990-12#1)(2008-12#1)
present in various##4##3##(1993-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
present in vitro##2##3##(1995-9#1)(2008-3#1)
present in women##2##3##(2008-7#1)(2012-12#1)
present in##941##2##(1990-11#7)(1990-12#11)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#5)(1991-12#11)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#8)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#6)(1992-10#1)(1992-11#4)(1992-12#11)(1992-2#1)(1992-3#8)(1992-5#2)(1992-6#8)(1992-8#7)(1992-9#5)(1993-11#7)(1993-12#6)(1993-2#2)(1993-3#7)(1993-6#9)(1993-8#9)(1993-9#4)(1994-1#1)(1994-11#6)(1994-12#5)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#13)(1994-9#7)(1995-11#4)(1995-12#6)(1995-2#8)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#7)(1995-9#2)(1996-12#10)(1996-2#1)(1996-3#1)(1996-5#5)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#9)(1997-4#1)(1997-6#5)(1997-7#4)(1997-8#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#5)(2007-12#19)(2007-2#1)(2007-6#2)(2007-7#4)(2007-8#6)(2008-1#11)(2008-10#268)(2008-11#25)(2008-12#16)(2008-2#9)(2008-3#16)(2008-4#22)(2008-5#26)(2008-6#9)(2008-7#32)(2008-8#16)(2008-9#12)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#7)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#5)(2010-4#8)(2010-5#5)(2010-6#2)(2010-8#4)(2011-1#3)(2011-2#22)(2012-12#4)(2012-2#10)(2012-3#14)(2012-7#1)(2012-9#1)(2013-1#18)(2013-7#3)(2013-8#7)
present initial##2##2##(2008-12#1)(2008-3#1)
present initially##2##2##(1992-3#1)(2011-1#1)
present investigation was##4##3##(1992-3#1)(1995-12#1)(2008-4#2)
present investigation##27##2##(1990-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2009-3#1)(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#4)(2013-8#1)
present is##4##2##(2007-12#1)(2008-10#2)(2009-10#1)
present it##2##2##(2008-10#1)(2009-3#1)
present knowledge about##2##3##(1993-11#1)(1995-2#1)
present knowledge of the##3##4##(2008-10#2)(2008-4#1)
present knowledge of##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
present knowledge##9##2##(1991-6#1)(1993-11#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)
present laboratory##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
present late for##2##3##(2008-1#1)(2013-1#1)
present literature##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
present mainly as##3##3##(1993-11#1)(2008-10#1)(2009-3#1)
present mainly in the##2##4##(1991-5#1)(2008-10#1)
present mainly in##4##3##(1991-5#1)(2008-10#2)(2008-4#1)
present mainly##7##2##(1991-5#1)(1993-11#1)(2008-10#3)(2008-4#1)(2009-3#1)
present management##3##2##(2008-1#1)(2008-5#1)(2008-8#1)
present matrix##2##2##(2008-10#2)
present meta-analysis##3##2##(2008-12#2)(2008-2#1)
present method has##2##3##(2008-10#2)
present method is##4##3##(1990-7#1)(2008-10#3)
present method showed a##2##4##(2008-10#2)
present method was##8##3##(2008-10#8)
present method##59##2##(1990-7#1)(1991-3#1)(1993-8#2)(1994-8#1)(1995-3#1)(1996-5#2)(2008-10#48)(2008-4#2)(2009-9#1)
present methods for##6##3##(1997-3#1)(1997-7#1)(2008-2#1)(2008-4#2)(2008-9#1)
present methods##10##2##(1997-3#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-9#1)(2010-12#1)
present modeling##2##2##(2008-3#1)(2008-9#1)
present models##2##2##(1992-4#1)(2008-2#1)
present molecular##2##2##(2008-8#1)(2008-9#1)
present more##4##2##(1992-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
present new data##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
present new##11##2##(1990-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-2#1)
present novel##4##2##(1996-12#1)(2008-1#1)(2008-2#1)(2012-2#1)
present numerical simulations##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2011-1#1)
present numerical##7##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
present observations##3##2##(1995-3#1)(2008-3#1)(2013-8#1)
present on all##2##3##(1997-8#1)(2008-4#1)
present on only one side of the membrane##2##8##(1990-11#1)(1991-5#1)
present on the surface of##2##5##(1994-11#1)(2010-12#1)
present on the surface##3##4##(1994-11#1)(2010-12#1)(2013-8#1)
present on the##18##3##(1991-6#1)(1992-3#1)(1992-6#2)(1994-11#1)(1994-8#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
present on##49##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
present one such##2##3##(2011-1#1)(2012-3#1)
present one##6##2##(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-3#1)
present only in a##2##4##(1993-12#1)(1997-6#1)
present only in##10##3##(1991-12#1)(1993-12#1)(1993-3#1)(1997-6#1)(2008-10#3)(2008-6#2)(2008-7#1)
present only##14##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-6#3)(2008-7#1)
present or absent##2##3##(1991-11#1)(2008-3#1)
present or##7##2##(1990-6#1)(1991-11#1)(1992-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
present our experience of##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
present our experience with##3##4##(2007-5#1)(2012-3#1)(2013-8#1)
present our experience##9##3##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
present our experimental##2##3##(2007-11#1)(2011-1#1)
present our preliminary results##2##4##(2008-3#1)(2010-4#1)
present our preliminary##3##3##(2007-8#1)(2008-3#1)(2010-4#1)
present our protocol##2##3##(1992-6#1)(2008-8#1)
present our results##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
present our##30##2##(1992-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
present over the##3##3##(2007-7#1)(2008-2#1)(2011-1#1)
present paper is##4##3##(1990-7#1)(2007-12#1)(2008-10#2)
present paper##103##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-4#1)(2007-12#6)(2007-4#1)(2008-10#35)(2008-11#10)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#8)
present population##2##2##(1994-2#1)(2013-7#1)
present predominantly##2##2##(2008-10#2)
present preliminary data##2##3##(2007-10#1)(2008-4#1)
present preliminary##3##2##(2007-10#1)(2007-8#1)(2008-4#1)
present report describes the##5##4##(1990-2#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
present report describes##18##3##(1990-12#1)(1990-2#1)(1994-12#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#2)
present report we##2##3##(2007-11#1)(2011-2#1)
present report##38##2##(1990-12#1)(1990-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#4)(2008-11#5)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#5)(2013-1#2)(2013-7#1)
present research was##2##3##(2008-12#1)(2013-8#1)
present research##14##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-3#1)(2009-9#1)(2010-8#1)(2013-8#3)
present result of##2##3##(2007-11#2)
present result##3##2##(2007-11#2)(2008-8#1)
present results and##2##3##(1991-5#1)(2008-7#1)
present results demonstrate that##4##4##(1991-12#1)(1995-11#1)(2008-8#1)(2013-1#1)
present results demonstrate##5##3##(1991-12#1)(1995-11#1)(1997-4#1)(2008-8#1)(2013-1#1)
present results for##2##3##(2007-12#1)(2008-3#1)
present results from a##4##4##(1995-6#1)(2008-3#2)(2008-8#1)
present results from##8##3##(1990-11#1)(1995-5#1)(1995-6#1)(2008-12#1)(2008-3#3)(2008-8#1)
present results indicate that##4##4##(1990-8#1)(1991-5#1)(1993-11#1)(2010-1#1)
present results of a simulation##2##5##(1996-3#1)(2008-3#1)
present results of a##4##4##(1996-3#1)(2008-3#1)(2008-5#1)(2009-11#1)
present results of measurements##2##4##(2008-2#1)(2011-2#1)
present results of##14##3##(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-11#1)(2011-2#1)(2012-1#1)
present results on##2##3##(2007-11#1)(2008-3#1)
present results suggest that the##5##5##(1990-2#1)(1997-2#1)(2008-10#2)(2008-6#1)
present results suggest that##15##4##(1990-2#1)(1991-12#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
present results that demonstrate##3##4##(2008-2#1)(2008-3#2)
present results that##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
present results##89##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-5#1)(1995-11#1)(1995-12#4)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-11#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
present review article##3##3##(1993-12#1)(2008-3#1)(2012-12#1)
present review is##5##3##(1992-6#1)(2008-10#2)(2009-7#1)(2010-1#1)
present review##54##2##(1992-6#1)(1993-12#1)(1994-8#1)(1995-8#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#2)
present series of experiments##2##4##(1996-2#1)(2011-2#1)
present series##4##2##(1990-12#1)(1996-2#1)(2008-7#1)(2011-2#1)
present several##6##2##(1992-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-3#1)
present short review##2##3##(2008-10#1)(2008-7#1)
present significant differences##2##3##(2008-10#1)(2008-3#1)
present significant##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
present single-molecule fluorescence data##2##4##(2007-12#1)(2009-4#1)
present situation##5##2##(1991-3#1)(1991-6#1)(2008-1#1)(2008-10#2)
present some examples of##2##4##(2008-8#1)(2010-8#1)
present some##9##2##(1990-2#1)(1994-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)
present state of knowledge##2##4##(1990-8#1)(1991-3#1)
present state of##6##3##(1990-8#1)(1991-3#1)(2008-11#1)(2009-12#1)(2011-3#1)(2013-8#1)
present status of##5##3##(1990-11#1)(1997-4#1)(2008-3#1)(2008-7#1)(2011-2#1)
present status##6##2##(1990-11#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
present studies of##2##3##(2007-12#1)(2008-7#1)
present studies were##4##3##(1991-3#1)(1994-6#1)(1995-11#1)(1997-7#1)
present studies##15##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-10#1)(1994-6#2)(1995-11#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
present study a##6##3##(1990-12#1)(2008-10#2)(2008-12#1)(2010-3#1)(2013-1#1)
present study assessed##2##3##(1996-7#1)(2008-8#1)
present study attempts to##2##4##(1993-12#1)(1994-6#1)
present study clearly##2##3##(1992-9#1)(2012-2#1)
present study different##2##3##(2007-2#1)(2009-7#1)
present study employed a##2##4##(2008-12#1)(2008-9#1)
present study evaluated the##8##4##(1991-2#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
present study evaluated##9##3##(1991-2#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
present study examined the influence of##2##6##(1994-3#1)(1994-8#1)
present study examined the##15##4##(1991-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-1#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
present study examined##29##3##(1991-8#1)(1992-12#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
present study has##6##3##(1997-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2013-1#2)
present study indicated that the##2##5##(2008-10#1)(2008-9#1)
present study indicated that##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
present study indicates that##4##4##(1993-9#1)(1996-9#1)(2008-5#1)(2011-2#1)
present study indicates##5##3##(1993-9#1)(1996-9#1)(2008-5#1)(2009-8#1)(2011-2#1)
present study investigated##11##3##(1991-7#1)(1991-9#1)(1995-12#2)(1996-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
present study is the first to##3##6##(2009-12#2)(2013-3#1)
present study is the first##4##5##(1997-7#1)(2009-12#2)(2013-3#1)
present study is the##5##4##(1997-7#1)(2009-12#2)(2012-5#1)(2013-3#1)
present study is to discuss##2##5##(2008-12#1)(2011-2#1)
present study is to##16##4##(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
present study is##35##3##(1990-8#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#1)
present study provides##2##3##(2010-4#1)(2011-2#1)
present study revealed that##4##4##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
present study revealed##7##3##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-7#1)
present study sought to##2##4##(2008-11#1)(2008-9#1)
present study suggests that##4##4##(1995-12#2)(2008-10#1)(2011-2#1)
present study suggests##5##3##(1992-12#1)(1995-12#2)(2008-10#1)(2011-2#1)
present study the##8##3##(1991-6#1)(1991-8#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-6#2)
present study used a##2##4##(1993-12#1)(2009-4#1)
present study used##3##3##(1993-12#1)(2008-12#1)(2009-4#1)
present study was aimed to##5##5##(2008-12#1)(2009-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
present study was aimed##9##4##(1990-6#1)(1994-2#1)(1995-5#1)(2008-12#1)(2009-12#1)(2010-5#1)(2012-12#2)(2012-3#1)
present study was to determine the##3##6##(2008-10#1)(2008-12#1)(2011-1#1)
present study was to determine##8##5##(1995-12#1)(1996-5#1)(2008-10#2)(2008-12#2)(2011-1#1)(2011-2#1)
present study was to investigate the relationship between##2##8##(2008-8#1)(2013-8#1)
present study was to investigate the##17##6##(1990-9#1)(1995-12#1)(1997-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-1#1)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
present study was to investigate##23##5##(1990-9#1)(1995-12#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
present study was to##90##4##(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#5)(2008-5#7)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#5)
present study was undertaken to##13##5##(1992-3#1)(1993-6#1)(1994-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#3)(2013-7#1)
present study was undertaken##14##4##(1992-3#2)(1993-6#1)(1994-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#3)(2013-7#1)
present study was##175##3##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-1#1)(1993-12#3)(1993-6#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#11)(2008-11#4)(2008-12#9)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#1)(2009-1#1)(2009-12#2)(2009-2#1)(2009-8#2)(2010-10#2)(2010-2#2)(2010-3#2)(2010-5#7)(2010-6#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#7)
present study we have##14##4##(1991-2#1)(1992-12#1)(1994-11#1)(1994-2#1)(1995-12#2)(1996-12#1)(1997-2#1)(2007-7#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
present study we##48##3##(1991-2#1)(1992-12#2)(1993-12#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
present study##803##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#2)(1991-12#4)(1991-2#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#5)(1992-9#1)(1993-1#4)(1993-12#12)(1993-3#6)(1993-5#1)(1993-6#8)(1993-8#2)(1993-9#3)(1994-11#8)(1994-12#3)(1994-2#14)(1994-3#7)(1994-5#1)(1994-6#8)(1994-8#8)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#18)(1995-2#5)(1995-3#3)(1995-5#1)(1995-8#5)(1996-12#6)(1996-2#9)(1996-3#1)(1996-5#9)(1996-6#1)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#8)(1997-6#4)(1997-7#4)(1997-8#1)(2007-10#6)(2007-11#6)(2007-12#9)(2007-2#2)(2007-5#1)(2007-7#8)(2007-8#8)(2008-1#3)(2008-10#73)(2008-11#31)(2008-12#32)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#36)(2008-6#11)(2008-7#24)(2008-8#9)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#5)(2010-3#8)(2010-4#4)(2010-5#11)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#8)(2011-2#41)(2011-3#1)(2011-7#1)(2012-1#7)(2012-12#7)(2012-2#35)(2012-3#15)(2012-5#4)(2012-6#1)(2013-1#39)(2013-3#1)(2013-7#10)(2013-8#18)
present such##2##2##(2008-11#1)(2012-2#1)
present survey##3##2##(1994-1#1)(2013-1#1)(2013-8#1)
present system##13##2##(1992-4#1)(1994-1#1)(1995-6#1)(2008-10#7)(2008-2#1)(2008-8#2)
present systematic##2##2##(1996-11#1)(2009-11#1)
present tense/agreement morphology##2##3##(2012-1#2)
present tense/agreement##4##2##(2012-1#4)
present that##2##2##(1991-6#1)(2008-4#1)
present the application of##2##4##(2008-3#2)
present the case of a patient who##2##7##(2008-10#1)(2008-5#1)
present the case of a patient##5##6##(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-5#1)
present the case of a##28##5##(1991-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
present the case of##34##4##(1991-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#4)
present the case report of##2##5##(2012-2#1)(2013-1#1)
present the case##37##3##(1991-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
present the clinical##2##3##(2008-7#1)(2009-12#1)
present the current##2##3##(2008-5#1)(2010-12#1)
present the design##7##3##(2007-11#1)(2008-2#2)(2008-3#3)(2013-1#1)
present the first experimental##2##4##(2007-12#1)(2008-7#1)
present the first##12##3##(1993-2#1)(1993-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
present the history##2##3##(2007-8#1)(2008-2#1)
present the major##2##3##(2007-5#1)(2008-3#1)
present the most##6##3##(1993-2#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-1#1)
present the possibility that##2##4##(2008-11#1)(2008-9#1)
present the possibility##3##3##(1992-2#1)(2008-11#1)(2008-9#1)
present the results obtained##3##4##(1995-11#1)(2008-10#1)(2013-8#1)
present the results of a##6##5##(1990-5#1)(1991-12#1)(1996-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
present the results of an##5##5##(1993-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
present the results of the##3##5##(2008-2#1)(2008-3#1)(2010-9#1)
present the results of##28##4##(1990-5#1)(1990-6#1)(1991-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(2007-11#4)(2007-12#1)(2008-2#5)(2008-3#7)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)
present the results##34##3##(1990-5#1)(1990-6#1)(1991-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-7#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#7)(2008-7#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-8#1)
present the technique of##3##4##(2008-3#2)(2012-2#1)
present the technique##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
present the treatment results of##2##5##(2007-11#1)(2011-2#1)
present the##208##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-12#3)(1994-3#2)(1995-11#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#12)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#14)(2008-3#28)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
present their##5##2##(1990-5#1)(1993-3#1)(1995-5#1)(2008-9#1)(2012-2#1)
present there##4##2##(1991-12#1)(2008-11#1)(2008-5#1)(2013-8#1)
present this case##3##3##(2008-5#1)(2009-3#1)(2012-3#1)
present this##10##2##(1992-3#2)(2007-7#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
present three cases of##2##4##(1997-8#1)(2011-1#1)
present three##4##2##(1991-11#1)(1997-8#1)(2008-2#1)(2011-1#1)
present throughout the##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
present throughout##7##2##(1994-2#1)(1997-2#2)(2008-10#2)(2008-7#1)(2011-2#1)
present time##20##2##(1991-6#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2012-3#1)
present to a##2##3##(1991-8#1)(2008-10#1)
present to the##3##3##(2007-5#1)(2008-4#1)(2013-1#1)
present to##19##2##(1991-8#1)(1994-5#1)(1996-6#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
present two case##2##3##(2008-6#1)(2009-6#1)
present two cases of##15##4##(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#3)(2013-1#1)(2013-8#1)
present two cases##17##3##(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
present two examples##2##3##(1992-9#1)(2008-1#1)
present two novel##2##3##(2008-2#1)(2008-3#1)
present two##33##2##(1992-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
present under##2##2##(2008-10#1)(2008-8#1)
present unique##2##2##(1997-2#1)(2009-10#1)
present various##3##2##(2007-8#1)(2008-2#1)(2013-1#1)
present was##2##2##(2007-12#1)(2008-10#1)
present were##4##2##(1994-2#1)(2008-10#2)(2013-8#1)
present what to our knowledge is a novel##2##8##(2008-2#1)(2008-3#1)
present what to our knowledge is a##3##7##(2008-2#1)(2008-3#2)
present what we believe is##4##5##(2008-3#4)
present what we believe to be##4##6##(2007-11#1)(2007-12#1)(2008-3#2)
present what we believe##9##4##(2007-11#1)(2007-12#2)(2008-3#6)
present what##21##2##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#10)
present when##5##2##(1991-11#1)(2008-10#3)(2011-2#1)
present which##3##2##(1996-3#1)(2008-10#1)(2010-12#1)
present with a##10##3##(1990-8#1)(2007-2#1)(2008-10#1)(2008-7#2)(2009-3#2)(2010-9#2)(2011-1#1)
present with abdominal pain##2##4##(2010-12#1)(2013-1#1)
present with abdominal##3##3##(2010-12#1)(2013-1#2)
present with secondary##2##3##(1997-2#1)(2011-1#1)
present with severe##3##3##(2009-6#1)(2010-1#1)(2011-2#1)
present with symptoms##4##3##(2007-2#1)(2008-11#1)(2008-9#1)(2013-8#1)
present with the##2##3##(2009-3#1)(2010-6#1)
present with this##2##3##(2007-6#1)(2008-10#1)
present with##75##2##(1990-8#1)(1990-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#7)(2011-2#6)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
present within the##8##3##(1991-9#1)(1992-12#1)(1992-3#1)(1994-6#1)(2008-10#2)(2008-5#1)(2010-3#1)
present within##14##2##(1990-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-6#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)
present without##2##2##(2008-2#1)(2012-1#1)
present work is##9##3##(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)
present work was##17##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(2008-10#3)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#3)
present work##130##2##(1990-11#1)(1990-12#2)(1990-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#55)(2008-11#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
present##5056##1##(1990-10#2)(1990-11#20)(1990-12#31)(1990-2#11)(1990-3#12)(1990-5#22)(1990-6#13)(1990-7#15)(1990-8#18)(1990-9#8)(1991-1#1)(1991-11#13)(1991-12#33)(1991-2#13)(1991-3#11)(1991-4#3)(1991-5#26)(1991-6#21)(1991-7#3)(1991-8#12)(1991-9#15)(1992-1#3)(1992-10#5)(1992-11#10)(1992-12#28)(1992-2#9)(1992-3#36)(1992-4#3)(1992-5#5)(1992-6#24)(1992-7#2)(1992-8#17)(1992-9#13)(1993-1#7)(1993-11#20)(1993-12#32)(1993-2#12)(1993-3#28)(1993-5#2)(1993-6#25)(1993-8#20)(1993-9#16)(1994-1#4)(1994-10#1)(1994-11#21)(1994-12#26)(1994-2#35)(1994-3#24)(1994-5#12)(1994-6#26)(1994-7#3)(1994-8#31)(1994-9#18)(1995-1#1)(1995-10#1)(1995-11#12)(1995-12#34)(1995-2#26)(1995-3#14)(1995-4#1)(1995-5#15)(1995-6#9)(1995-8#18)(1995-9#4)(1996-1#6)(1996-11#1)(1996-12#31)(1996-2#19)(1996-3#11)(1996-4#1)(1996-5#24)(1996-6#3)(1996-7#8)(1996-8#1)(1996-9#6)(1997-1#9)(1997-2#29)(1997-3#26)(1997-4#22)(1997-5#1)(1997-6#16)(1997-7#17)(1997-8#15)(1997-9#1)(2006-10#8)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#20)(2007-11#120)(2007-12#148)(2007-2#9)(2007-4#4)(2007-5#16)(2007-6#5)(2007-7#30)(2007-8#63)(2008-1#48)(2008-10#793)(2008-11#174)(2008-12#96)(2008-2#166)(2008-3#282)(2008-4#62)(2008-5#121)(2008-6#62)(2008-7#177)(2008-8#100)(2008-9#98)(2009-1#7)(2009-10#24)(2009-11#18)(2009-12#25)(2009-2#9)(2009-3#19)(2009-4#11)(2009-5#18)(2009-6#14)(2009-7#22)(2009-8#34)(2009-9#11)(2010-1#14)(2010-10#16)(2010-11#12)(2010-12#23)(2010-2#11)(2010-3#28)(2010-4#22)(2010-5#31)(2010-6#18)(2010-7#7)(2010-8#25)(2010-9#9)(2011-1#59)(2011-10#2)(2011-2#184)(2011-3#4)(2011-7#1)(2012-1#30)(2012-12#66)(2012-2#117)(2012-3#78)(2012-5#4)(2012-6#1)(2012-7#4)(2012-9#3)(2013-1#159)(2013-3#1)(2013-7#25)(2013-8#81)
present)##6##1##(1990-12#2)(1995-2#1)(2008-10#2)(2008-8#1)
present-day##9##1##(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#2)
presentation after##2##2##(2008-1#1)(2013-1#1)
presentation and advanced HIV disease were##2##6##(2013-1#2)
presentation and diagnostic##3##3##(1991-8#1)(2008-7#1)(2010-8#1)
presentation and discussion##2##3##(1991-6#1)(2012-2#1)
presentation and management##2##3##(2010-3#1)(2011-2#1)
presentation and the##2##3##(2008-9#1)(2012-3#1)
presentation and##46##2##(1991-2#1)(1991-6#1)(1991-8#1)(1992-8#1)(1995-10#1)(1995-11#2)(1996-2#1)(1997-2#1)(2007-7#1)(2008-1#3)(2008-12#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
presentation at a conference##2##4##(2008-10#1)(2008-12#1)
presentation because of##2##3##(2008-11#1)(2012-3#1)
presentation by##4##2##(1995-5#1)(2007-12#1)(2008-11#2)
presentation can##2##2##(2010-8#1)(2012-12#1)
presentation focuses on##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
presentation for##6##2##(1995-5#1)(2008-10#1)(2010-10#1)(2010-6#1)(2013-1#2)
presentation from##2##2##(2008-10#1)(2008-7#1)
presentation in order to##2##4##(1993-8#1)(2011-2#1)
presentation in the##2##3##(2008-7#1)(2009-4#1)
presentation in##14##2##(1991-11#1)(1992-3#1)(1993-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
presentation is very##2##3##(1997-8#1)(2008-9#1)
presentation is##13##2##(1995-1#1)(1996-1#1)(1997-4#1)(1997-8#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#3)
presentation may be##3##3##(2008-1#1)(2008-12#1)(2012-3#1)
presentation may##4##2##(2007-8#1)(2008-1#1)(2008-12#1)(2012-3#1)
presentation of a rare##2##4##(1997-3#1)(2012-3#1)
presentation of a##12##3##(1996-12#1)(1997-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
presentation of acute##2##3##(1990-8#1)(2009-3#1)
presentation of metastatic##3##3##(1990-12#1)(2007-10#1)(2009-3#1)
presentation of primary hyperparathyroidism##2##4##(2008-12#1)(2012-12#1)
presentation of primary##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
presentation of the disease##2##4##(2007-4#1)(2010-12#1)
presentation of the##21##3##(1992-11#1)(1993-6#1)(1994-2#1)(1997-6#1)(2007-11#3)(2007-4#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-7#1)
presentation of this##5##3##(1990-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2011-2#1)
presentation of tuberculosis##2##3##(2011-2#2)
presentation of two clinical##2##4##(1992-6#1)(2013-8#1)
presentation of two##4##3##(1992-6#1)(2008-4#1)(2011-2#1)(2013-8#1)
presentation of type 2 diabetes##2##5##(2008-11#1)(2008-3#1)
presentation of words##2##3##(1990-8#2)
presentation of##151##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#5)(2008-10#3)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
presentation on##3##2##(1992-12#1)(2008-10#1)(2008-4#1)
presentation order##2##2##(2008-12#2)
presentation skills##3##2##(1995-12#1)(1997-4#1)(2008-11#1)
presentation status##3##2##(2008-6#1)(2013-1#2)
presentation that##4##2##(1993-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
presentation the##2##2##(2009-3#1)(2010-3#1)
presentation to the emergency department##2##5##(2007-10#1)(2012-2#1)
presentation to the##4##3##(2007-10#1)(2008-10#1)(2009-8#1)(2012-2#1)
presentation to##8##2##(1990-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
presentation was##7##2##(1996-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-7#1)(2013-1#2)
presentation will##3##2##(2008-10#1)(2008-7#2)
presentation with a##3##3##(1997-3#1)(2008-7#1)(2009-8#1)
presentation with the##2##3##(2008-4#1)(2012-2#1)
presentation with##8##2##(1997-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
presentation##472##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#6)(2006-10#1)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#8)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#14)(2007-8#5)(2008-1#18)(2008-10#22)(2008-11#21)(2008-12#14)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#6)(2008-6#13)(2008-7#22)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-6#1)(2009-8#15)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#6)(2010-3#5)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#28)(2012-1#2)(2012-12#14)(2012-2#14)(2012-3#14)(2013-1#28)(2013-7#4)(2013-8#8)
presentations and##11##2##(1996-9#1)(2008-5#2)(2008-7#2)(2010-11#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-7#1)
presentations are##2##2##(2008-12#1)(2008-5#1)
presentations at the 2003##7##4##(2008-11#6)(2008-7#1)
presentations at the##49##3##(2008-11#45)(2008-5#1)(2008-7#1)(2010-11#1)(2012-12#1)
presentations at##51##2##(2008-11#45)(2008-5#2)(2008-7#1)(2010-11#1)(2010-4#1)(2012-12#1)
presentations during##3##2##(1994-9#1)(2007-8#1)(2008-4#1)
presentations from##2##2##(2008-10#1)(2011-2#1)
presentations have been##2##3##(2010-12#1)(2011-2#1)
presentations in##2##2##(2008-5#1)(2008-7#1)
presentations of tropical diseases in travelers##2##6##(2011-2#2)
presentations of##10##2##(1991-3#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#3)
presentations on##2##2##(1996-3#1)(2011-2#1)
presentations that##3##2##(2008-12#1)(2008-7#1)(2010-6#1)
presentations##126##1##(1991-3#1)(1993-1#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#47)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#14)(2008-6#4)(2008-7#7)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
presented a good##3##3##(2008-10#3)
presented a high##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
presented a higher##2##3##(2008-12#1)(2008-5#1)
presented a more##2##3##(1992-4#1)(2011-2#1)
presented a##52##2##(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-8#1)(1997-4#1)(1997-8#1)(2007-6#1)(2007-8#4)(2008-10#11)(2008-12#2)(2008-2#2)(2008-5#5)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
presented again##2##2##(2007-10#1)(2008-6#1)
presented along with a##2##4##(2007-5#1)(2008-2#1)
presented along with the##2##4##(2007-12#1)(2008-10#1)
presented along with##7##3##(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
presented alteration##2##2##(2008-10#1)(2013-1#1)
presented an analytical##4##3##(2008-10#3)(2008-3#1)
presented an increased##2##3##(1991-3#1)(2008-10#1)
presented an##13##2##(1991-3#1)(1994-5#1)(2008-10#7)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#1)
presented and a##4##3##(1991-12#1)(1995-12#1)(2008-10#1)(2011-1#1)
presented and analyzed##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
presented and compared to##2##4##(1993-6#1)(2008-11#1)
presented and compared with##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
presented and compared##8##3##(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
presented and discussed##20##3##(1990-5#1)(1990-8#1)(1991-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2009-3#1)
presented and explained##2##3##(2008-10#2)
presented and the##9##3##(1990-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-7#1)
presented and used to##3##4##(1993-3#1)(1994-5#1)(2008-12#1)
presented and##82##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#2)(1992-11#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#18)(2008-4#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-1#3)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
presented are##11##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-9#1)
presented as a new##4##4##(2007-12#1)(2008-10#2)(2012-2#1)
presented as a working hypothesis in Part 1##2##8##(2008-12#2)
presented as a##31##3##(1991-12#2)(1993-1#1)(1993-12#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#2)
presented as an example##4##4##(1997-8#1)(2008-2#1)(2009-8#1)(2013-8#1)
presented as an##20##3##(1993-9#2)(1994-2#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2009-11#1)(2009-8#1)(2013-1#3)(2013-8#1)
presented as mean##2##3##(2008-5#1)(2011-2#1)
presented as powerful analytical tools for##2##6##(2008-10#2)
presented as the##2##3##(2008-10#1)(2011-2#1)
presented as##82##2##(1991-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#2)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#17)(2008-12#4)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
presented at a##5##3##(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-6#1)
presented at least one##2##4##(2007-10#1)(2013-1#1)
presented at least##3##3##(2007-10#1)(2008-7#1)(2013-1#1)
presented at the American##2##4##(1995-2#1)(2008-5#1)
presented at the Optical Society of America Topical Meeting on##3##10##(2008-2#2)(2008-3#1)
presented at the age of##4##5##(2007-7#2)(2008-7#2)
presented at the symposium##2##4##(2008-5#2)
presented at the##37##3##(1992-1#1)(1995-2#1)(2007-5#1)(2007-7#2)(2008-10#13)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#4)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
presented at##55##2##(1992-1#1)(1994-12#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#6)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
presented based on the##2##4##(2008-10#1)(2008-4#1)
presented based on##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
presented better performance##2##3##(2008-10#2)
presented briefly##2##2##(1994-6#1)(2010-5#1)
presented by patients with##2##4##(2010-5#1)(2012-3#1)
presented by the##7##3##(1991-6#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2011-2#1)
presented by##33##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-4#1)(2007-11#3)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
presented can be##2##3##(2008-3#1)(2008-7#1)
presented case##5##2##(1990-9#1)(2008-10#1)(2012-12#2)(2013-8#1)
presented data on##2##3##(1990-9#1)(2009-6#1)
presented data##4##2##(1990-9#1)(1991-12#1)(2008-5#1)(2009-6#1)
presented different##5##2##(1996-12#1)(2008-10#2)(2013-1#2)
presented during##4##2##(1992-4#1)(1994-9#1)(2008-4#1)(2013-8#1)
presented earlier##2##2##(2008-2#1)(2012-3#1)
presented elsewhere##2##2##(2008-4#1)(2008-8#1)
presented evidence that##2##3##(2008-10#1)(2011-2#1)
presented evidence##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
presented for a##10##3##(2007-11#1)(2008-11#1)(2008-3#3)(2009-10#1)(2010-1#1)(2011-1#2)(2011-2#1)
presented for determination of##3##4##(2008-10#3)
presented for each##2##3##(1993-3#1)(2008-3#1)
presented for the case##2##4##(2008-2#1)(2008-3#1)
presented for the detection##2##4##(2008-10#1)(2008-3#1)
presented for the determination of the##2##6##(2008-10#2)
presented for the determination of##9##5##(2008-10#8)(2008-3#1)
presented for the first time to our knowledge##2##8##(2008-3#2)
presented for the first time##4##5##(1993-3#1)(2008-3#2)(2008-4#1)
presented for the##58##3##(1990-8#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#19)(2008-2#4)(2008-3#15)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)
presented for three##2##3##(2007-11#1)(2008-2#1)
presented for##160##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-7#1)(1996-4#1)(1997-4#1)(1997-7#2)(2007-11#4)(2007-12#8)(2008-1#2)(2008-10#32)(2008-11#3)(2008-12#2)(2008-2#16)(2008-3#38)(2008-4#11)(2008-5#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
presented from a##5##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
presented from##10##2##(1993-6#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2011-2#1)
presented good##4##2##(2008-10#3)(2012-3#1)
presented here and##2##3##(1994-2#1)(2011-2#1)
presented here are##9##3##(1993-6#1)(1996-1#1)(2007-11#1)(2008-3#4)(2008-4#1)(2013-8#1)
presented here can be used##2##5##(2007-8#1)(2008-7#1)
presented here can##4##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
presented here for##4##3##(1990-8#1)(1992-2#1)(2008-3#1)(2011-3#1)
presented here has been##2##4##(2008-3#1)(2008-4#1)
presented here is a##2##4##(2008-3#2)
presented here is capable of##2##5##(2008-10#1)(2008-11#1)
presented here is##14##3##(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
presented here provide##3##3##(1995-3#1)(2008-11#1)(2009-10#1)
presented here provides a##3##4##(2008-12#1)(2008-4#1)(2013-8#1)
presented here show that##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
presented here show##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
presented here suggest that##4##4##(1996-6#1)(2008-10#1)(2008-7#1)(2010-8#1)
presented here suggests that differential##2##5##(2008-7#1)(2008-8#1)
presented here support a##2##4##(2008-10#1)(2010-8#1)
presented here support##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
presented here##105##2##(1990-5#1)(1990-8#1)(1992-2#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#12)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#3)(2008-7#8)(2008-8#5)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
presented herein##8##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
presented higher##6##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#1)
presented in Part I##2##4##(1993-2#1)(2008-3#1)
presented in a##10##3##(1990-9#1)(1992-11#1)(1993-3#1)(1994-2#1)(2008-10#2)(2008-3#2)(2009-2#1)(2009-8#1)
presented in addition to##2##4##(2008-3#1)(2010-8#1)
presented in an##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
presented in detail##5##3##(1992-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
presented in part##2##3##(2008-3#2)
presented in terms of##2##4##(2008-10#1)(2009-7#1)
presented in the article##3##4##(2008-6#1)(2010-11#1)(2012-3#1)
presented in the literature##3##4##(2008-6#1)(2008-9#1)(2010-9#1)
presented in the main theme##3##5##(2010-10#3)
presented in the##37##3##(1990-3#1)(1991-3#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-5#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2010-10#3)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
presented in this appendix##2##4##(2008-4#1)(2008-9#1)
presented in this article##14##4##(1991-2#1)(1992-2#1)(1992-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
presented in this issue##3##4##(1995-1#2)(1997-3#1)
presented in this paper show that##2##6##(1991-9#1)(1993-3#1)
presented in this paper##30##4##(1991-12#1)(1991-9#1)(1993-3#1)(1993-6#1)(1996-5#1)(2007-11#3)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
presented in this report##3##4##(1993-3#1)(2008-10#1)(2010-8#1)
presented in this review##2##4##(2008-11#1)(2008-8#1)
presented in this study##8##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2012-2#1)
presented in this unit##11##4##(2008-4#6)(2008-9#5)
presented in this##84##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
presented in various##2##3##(1994-8#1)(2008-3#1)
presented in which the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
presented in which##13##3##(1990-2#1)(1991-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2012-1#1)
presented in##203##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-3#1)(1996-5#3)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#35)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#17)(2008-4#13)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#5)
presented individually##2##2##(2008-3#1)(2010-7#1)
presented information##2##2##(1995-3#1)(2013-1#1)
presented initially with##3##3##(2007-10#1)(2008-8#1)(2009-10#1)
presented initially##5##2##(2006-10#1)(2007-10#1)(2007-8#1)(2008-8#1)(2009-10#1)
presented is a##2##3##(1990-8#1)(2010-11#1)
presented is the##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
presented is##12##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)
presented itself##2##2##(1990-9#1)(2008-8#1)
presented late##2##2##(2007-8#1)(2013-1#1)
presented low##2##2##(2008-5#2)
presented lower##2##2##(2008-10#1)(2010-4#1)
presented method of##2##3##(2008-11#2)
presented method##8##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2011-2#1)
presented methods##2##2##(2008-3#1)(2008-5#1)
presented more##2##2##(2008-7#1)(2011-2#1)
presented new challenges##2##3##(2008-10#1)(2008-7#1)
presented new##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
presented of the##4##3##(1992-3#1)(2007-12#1)(2008-2#2)
presented of##16##2##(1990-8#1)(1992-2#2)(1992-3#1)(1993-2#1)(1996-4#1)(1996-7#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)(2013-7#1)
presented on the basis of the##2##6##(2007-11#1)(2007-8#1)
presented on the##9##3##(1992-1#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
presented on##17##2##(1991-3#1)(1992-1#1)(1993-2#2)(1994-8#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)
presented one##4##2##(1994-9#1)(2008-7#1)(2009-5#1)(2013-7#1)
presented only##2##2##(2006-6#1)(2009-9#1)
presented paper##2##2##(2008-10#2)
presented positive##2##2##(2008-5#1)(2008-6#1)
presented provides##2##2##(2008-10#1)(2008-2#1)
presented recoveries##2##2##(2008-10#2)
presented results##5##2##(1991-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2011-1#1)
presented severe##2##2##(2008-9#1)(2013-1#1)
presented show##2##2##(1992-3#1)(2007-12#1)
presented showing that##3##3##(1995-6#1)(2008-2#1)(2008-9#1)
presented showing##5##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
presented significant##2##2##(2008-7#1)(2012-2#1)
presented significantly##2##2##(2008-5#1)(2013-1#1)
presented similar##3##2##(2008-10#1)(2013-1#2)
presented some##3##2##(1997-3#1)(2008-10#2)
presented such##2##2##(2008-10#1)(2012-3#1)
presented symptoms##3##2##(1991-11#1)(1992-4#1)(2007-8#1)
presented that have##2##3##(2007-11#1)(2010-11#1)
presented that relate##2##3##(2008-3#2)
presented that##74##2##(1990-2#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#10)(2008-10#3)(2008-11#1)(2008-2#12)(2008-3#24)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#1)
presented the best evidence to answer the clinical question##7##9##(2007-8#7)
presented the highest##6##3##(2009-7#1)(2011-2#1)(2013-1#4)
presented the same##3##3##(2007-10#1)(2008-10#2)
presented the##32##2##(2007-10#2)(2007-11#3)(2007-8#8)(2008-10#2)(2009-7#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
presented three##3##2##(1997-2#1)(2008-12#1)(2012-12#1)
presented to a##3##3##(2008-3#1)(2008-5#1)(2013-8#1)
presented to attendees##2##3##(2008-10#1)(2010-5#1)
presented to demonstrate the##4##4##(1995-2#1)(2008-3#1)(2009-12#1)(2011-2#1)
presented to demonstrate##8##3##(1990-8#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
presented to describe the##2##4##(2008-10#1)(2008-7#1)
presented to describe##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
presented to determine##3##3##(1990-9#1)(2008-2#1)(2008-3#1)
presented to explain##3##3##(2008-2#1)(2008-3#1)(2009-2#1)
presented to his##2##3##(1996-2#1)(2011-1#1)
presented to hospital with##2##4##(2011-2#1)(2012-12#1)
presented to illustrate the##6##4##(1996-12#1)(1996-9#1)(2008-1#1)(2008-3#3)
presented to illustrate##8##3##(1996-12#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-3#3)
presented to our facility with##2##5##(1992-6#1)(2013-8#1)
presented to our hospital##2##4##(2011-2#1)(2012-12#1)
presented to our institution with##2##5##(2008-8#1)(2013-1#1)
presented to our##9##3##(1992-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
presented to show that##2##4##(1996-5#1)(2008-3#1)
presented to show the##4##4##(1992-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
presented to show##8##3##(1992-1#1)(1996-5#1)(2008-10#1)(2008-3#3)(2008-5#1)(2013-1#1)
presented to the Radiation Oncology and##2##6##(2008-10#2)
presented to the emergency department with##2##6##(2007-5#1)(2013-1#1)
presented to the emergency department##3##5##(2007-10#1)(2007-5#1)(2013-1#1)
presented to the emergency room##2##5##(2007-12#2)
presented to the emergency##5##4##(2007-10#1)(2007-12#2)(2007-5#1)(2013-1#1)
presented to the##18##3##(1993-12#2)(1993-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-10#1)(2007-12#2)(2007-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#2)
presented to us with##3##4##(2013-1#2)(2013-8#1)
presented to us##7##3##(2007-8#1)(2008-1#1)(2008-8#1)(2010-5#1)(2013-1#2)(2013-8#1)
presented to verify the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
presented to##127##2##(1990-12#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-3#1)(1995-2#2)(1995-5#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#7)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#21)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#3)(2013-1#9)(2013-8#3)
presented together with a##4##4##(2008-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
presented together with##11##3##(1990-2#1)(2008-10#2)(2008-2#2)(2008-3#4)(2011-2#1)(2013-7#1)
presented together##13##2##(1990-2#1)(2008-10#3)(2008-2#2)(2008-3#4)(2011-2#1)(2013-1#1)(2013-7#1)
presented two##2##2##(2008-10#1)(2010-10#1)
presented using##4##2##(1991-5#1)(1993-3#1)(2008-4#1)(2008-7#1)
presented was##2##2##(1994-8#1)(2008-7#1)
presented which##14##2##(1991-5#1)(1992-6#1)(1993-1#1)(1997-4#1)(1997-6#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)
presented will##2##2##(1997-2#1)(1997-4#1)
presented with a 4-year history of a##2##7##(2010-6#1)(2012-3#1)
presented with a giant##2##4##(2006-12#1)(2010-6#1)
presented with a history of intermittent##2##6##(2011-2#1)(2012-2#1)
presented with a history of##8##5##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-7#1)
presented with a large##2##4##(2008-8#1)(2012-3#1)
presented with a neurological##2##4##(1996-8#1)(2010-12#1)
presented with a one year history of##2##7##(2008-12#1)(2008-7#1)
presented with a one##3##4##(1996-9#1)(2008-12#1)(2008-7#1)
presented with a painless##4##4##(2007-7#1)(2008-7#2)(2011-2#1)
presented with a rapidly##2##4##(2009-3#1)(2011-1#1)
presented with a solitary##3##4##(2008-6#1)(2010-6#2)
presented with a subarachnoid haemorrhage##2##5##(1996-9#1)(2008-7#1)
presented with a subarachnoid##3##4##(1996-9#1)(2008-7#1)(2013-8#1)
presented with a swelling##2##4##(2008-6#1)(2008-7#1)
presented with a##80##3##(1990-2#1)(1991-12#1)(1991-8#1)(1992-10#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#4)(2008-7#12)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#7)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#5)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#3)
presented with abdominal pain##3##4##(1997-8#1)(2009-10#1)(2013-1#1)
presented with acute onset of##2##5##(1997-3#1)(2012-2#1)
presented with acute##8##3##(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
presented with an acute##2##4##(2009-9#1)(2011-1#1)
presented with an impalpable right testis##2##6##(2008-10#2)
presented with an##15##3##(1991-8#1)(1992-2#1)(2007-7#2)(2008-10#2)(2008-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
presented with bilateral##7##3##(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
presented with chest##2##3##(2007-8#2)
presented with chyluria##2##3##(2008-1#1)(2008-4#1)
presented with complaints of##3##4##(2007-7#1)(2013-7#1)(2013-8#1)
presented with complex##2##3##(2008-6#1)(2009-5#1)
presented with cough##2##3##(2007-12#1)(2007-8#1)
presented with different##2##3##(1997-3#1)(2008-11#1)
presented with diffuse##2##3##(2008-9#1)(2012-12#1)
presented with diplopia##2##3##(1996-9#1)(2011-1#1)
presented with dyspnoea and##3##4##(2009-4#1)(2011-2#2)
presented with fever##3##3##(2009-11#2)(2013-8#1)
presented with headaches and##3##4##(2006-10#1)(2009-1#1)(2011-2#1)
presented with hearing loss##2##4##(2008-1#1)(2011-2#1)
presented with hemorrhage##2##3##(2008-12#1)(2008-7#1)
presented with increased##2##3##(2008-12#1)(2011-2#1)
presented with intermittent##2##3##(2008-10#1)(2012-2#1)
presented with long##2##3##(2008-7#1)(2012-2#1)
presented with lower##2##3##(2008-8#1)(2011-2#1)
presented with multiple##4##3##(2007-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
presented with neck##2##3##(1991-8#1)(2009-3#1)
presented with orbital swelling##2##4##(2013-1#2)
presented with painless##2##3##(2010-11#1)(2012-12#1)
presented with paraparesis##2##3##(2008-6#1)(2013-1#1)
presented with persistent##2##3##(2007-7#1)(2012-3#1)
presented with progressive##4##3##(2007-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
presented with recurrent urinary tract infections##2##6##(2008-10#1)(2013-1#1)
presented with recurrent##10##3##(2007-8#2)(2008-10#2)(2008-11#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-1#1)
presented with secondary##2##3##(1996-3#1)(2011-1#1)
presented with severe##12##3##(1990-9#1)(1996-6#1)(2007-10#1)(2007-7#1)(2008-7#2)(2009-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
presented with subarachnoid haemorrhage (SAH)##2##5##(2008-7#2)
presented with subarachnoid haemorrhage##5##4##(1997-3#1)(2008-7#4)
presented with subarachnoid##6##3##(1997-3#1)(2008-7#4)(2011-2#1)
presented with sudden onset of coma##2##6##(2008-7#2)
presented with sudden onset of##4##5##(2008-10#1)(2008-7#3)
presented with sudden onset##5##4##(2008-10#1)(2008-7#3)(2013-1#1)
presented with sudden##9##3##(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#3)(2010-10#1)(2011-2#1)(2013-1#1)
presented with swelling##2##3##(2008-7#1)(2013-1#1)
presented with symptoms and##2##4##(2007-7#1)(2008-12#1)
presented with symptoms of##3##4##(2008-7#2)(2012-12#1)
presented with symptoms##5##3##(2007-7#1)(2008-12#1)(2008-7#2)(2012-12#1)
presented with the##9##3##(1990-6#1)(1992-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-11#1)(2012-2#1)(2013-8#1)
presented with two##3##3##(2007-10#1)(2010-11#1)(2011-2#1)
presented with##383##2##(1990-2#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#4)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-12#2)(2007-10#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#17)(2007-8#13)(2007-9#1)(2008-1#9)(2008-10#24)(2008-11#7)(2008-12#17)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#8)(2008-7#34)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#4)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#9)(2010-6#10)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#29)(2012-12#10)(2012-2#12)(2012-3#12)(2012-8#1)(2013-1#29)(2013-7#4)(2013-8#10)
presented within the##3##3##(1991-10#1)(1992-1#1)(2008-7#1)
presented within##6##2##(1991-10#1)(1992-1#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-11#1)
presented without##2##2##(1990-3#1)(1994-3#1)
presented##2961##1##(1990-12#4)(1990-2#6)(1990-3#6)(1990-5#7)(1990-6#7)(1990-7#3)(1990-8#10)(1990-9#8)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#12)(1991-3#8)(1991-4#1)(1991-5#8)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#10)(1992-10#1)(1992-11#6)(1992-12#10)(1992-2#16)(1992-3#10)(1992-4#4)(1992-6#7)(1992-8#3)(1992-9#2)(1993-1#6)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#7)(1993-3#10)(1993-5#1)(1993-6#11)(1993-8#2)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#13)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#7)(1995-11#6)(1995-12#5)(1995-2#11)(1995-3#6)(1995-5#8)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#5)(1996-12#5)(1996-2#13)(1996-3#9)(1996-4#4)(1996-5#10)(1996-6#8)(1996-7#2)(1996-8#2)(1996-9#6)(1997-1#2)(1997-2#8)(1997-3#11)(1997-4#6)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#8)(2006-10#6)(2006-12#5)(2006-4#1)(2006-6#1)(2007-10#14)(2007-11#94)(2007-12#90)(2007-2#4)(2007-5#5)(2007-6#3)(2007-7#21)(2007-8#52)(2007-9#3)(2008-1#21)(2008-10#432)(2008-11#68)(2008-12#52)(2008-2#203)(2008-3#475)(2008-4#83)(2008-5#71)(2008-6#37)(2008-7#112)(2008-8#35)(2008-9#38)(2009-1#1)(2009-10#11)(2009-11#10)(2009-12#2)(2009-2#4)(2009-3#13)(2009-4#2)(2009-5#11)(2009-6#5)(2009-7#13)(2009-8#5)(2009-9#10)(2010-1#5)(2010-10#9)(2010-11#16)(2010-12#8)(2010-2#3)(2010-3#10)(2010-4#5)(2010-5#18)(2010-6#14)(2010-7#4)(2010-8#14)(2010-9#9)(2011-1#34)(2011-10#1)(2011-2#96)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#30)(2012-2#41)(2012-3#34)(2012-8#2)(2013-1#98)(2013-7#12)(2013-8#38)
presented)##2##1##(1995-5#1)(2008-4#1)
presenting a method##2##3##(1992-11#1)(2008-3#1)
presenting a##21##2##(1991-6#1)(1992-11#1)(1993-2#1)(1996-1#1)(1996-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
presenting an##3##2##(1992-3#1)(2013-1#2)
presenting and##3##2##(1995-11#1)(2007-7#1)(2008-1#1)
presenting as a##11##3##(1990-2#1)(1992-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
presenting as acute##4##3##(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
presenting as an acute##2##4##(2008-11#1)(2013-1#1)
presenting as an isolated##2##4##(2008-7#2)
presenting as an obstructive colon mass##2##6##(2008-11#2)
presenting as an##8##3##(2008-11#3)(2008-7#2)(2009-4#1)(2012-1#1)(2013-1#1)
presenting as massive##2##3##(2008-12#2)
presenting as multiple##4##3##(1990-2#1)(2008-1#1)(2008-3#1)(2010-6#1)
presenting as##68##2##(1990-2#2)(1992-9#1)(1995-11#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#5)(2008-3#1)(2008-4#1)(2008-7#10)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
presenting at a##2##3##(2008-3#1)(2013-8#1)
presenting clinical features were##2##4##(2008-1#1)(2008-4#1)
presenting clinical features##3##3##(2007-2#1)(2008-1#1)(2008-4#1)
presenting clinical##4##2##(2007-2#1)(2008-1#1)(2008-4#1)(2009-10#1)
presenting complaints##2##2##(2009-11#1)(2013-1#1)
presenting data on##2##3##(1996-3#1)(2011-2#1)
presenting feature of##8##3##(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-9#2)(2010-6#1)
presenting feature##10##2##(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#2)(2010-6#1)(2011-1#1)
presenting for##8##2##(1991-12#1)(2008-1#1)(2008-6#1)(2009-10#1)(2010-8#2)(2012-2#1)(2012-3#1)
presenting in a##3##3##(2008-10#1)(2008-7#1)(2009-1#1)
presenting in the##3##3##(2010-12#1)(2012-2#1)(2013-8#1)
presenting in##10##2##(2007-10#1)(2008-10#2)(2008-7#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
presenting information##2##2##(1992-3#1)(2008-10#1)
presenting metabolism in the context of##2##6##(2008-3#2)
presenting much higher peak currents than those##2##7##(2008-10#2)
presenting relative##2##2##(2008-10#2)
presenting sign of##7##3##(2007-2#1)(2008-1#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
presenting sign##8##2##(2007-2#1)(2008-1#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
presenting signs were##2##3##(1993-2#1)(2012-3#1)
presenting symptom##4##2##(1993-6#1)(1995-10#1)(2008-7#1)(2013-7#1)
presenting symptoms were##2##3##(2011-2#1)(2012-3#1)
presenting symptoms##10##2##(1990-6#1)(1991-11#1)(1992-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
presenting syndrome of HIV disease##2##5##(2011-2#2)
presenting the first case of##2##5##(2011-1#1)(2013-1#1)
presenting the risk##2##3##(2011-2#2)
presenting the##20##2##(1990-9#1)(1995-12#1)(1997-3#1)(2007-4#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-6#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#2)
presenting this##2##2##(2008-12#2)
presenting to a##4##3##(2007-2#1)(2012-2#3)
presenting to the emergency department with chest pain##3##8##(2008-3#3)
presenting to the emergency department with##6##6##(2007-10#1)(2008-3#3)(2009-9#2)
presenting to the emergency department##10##5##(2007-10#2)(2008-11#1)(2008-3#4)(2009-9#2)(2012-3#1)
presenting to the emergency##11##4##(2007-10#2)(2008-11#1)(2008-3#4)(2009-9#2)(2012-3#1)(2013-1#1)
presenting to the##13##3##(2007-10#2)(2008-1#1)(2008-11#1)(2008-3#4)(2009-8#1)(2009-9#2)(2012-3#1)(2013-1#1)
presenting to##22##2##(2006-5#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-7#1)(2009-8#1)(2009-9#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
presenting unique##2##2##(2008-5#1)(2013-8#1)
presenting with ALI due to##2##5##(2011-2#2)
presenting with a history of##2##5##(2012-1#1)(2013-1#1)
presenting with a palpable##2##4##(2013-1#1)(2013-7#1)
presenting with a##14##3##(1990-6#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-1#1)(2013-1#3)(2013-7#1)
presenting with abdominal pain##3##4##(2011-2#1)(2013-1#2)
presenting with acute coronary syndrome##2##5##(2008-11#1)(2008-7#1)
presenting with acute##13##3##(2006-12#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-2#2)
presenting with an##3##3##(2008-11#1)(2010-10#1)(2013-1#1)
presenting with atypical##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
presenting with features of##2##4##(2008-6#1)(2013-1#1)
presenting with gross hematuria##3##4##(2008-11#3)
presenting with hematuria##2##3##(2008-1#1)(2008-10#1)
presenting with metastatic##2##3##(1997-8#1)(2010-3#1)
presenting with multiple##2##3##(2008-12#1)(2010-12#1)
presenting with recurrent##4##3##(2007-8#1)(2008-1#1)(2008-6#1)(2013-7#1)
presenting with severe##4##3##(2007-12#1)(2007-8#1)(2009-4#1)(2013-8#1)
presenting with spontaneous pneumothorax##2##4##(2008-1#1)(2008-7#1)
presenting with spontaneous##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
presenting with subarachnoid haemorrhage##2##4##(1996-9#1)(2008-7#1)
presenting with sudden##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
presenting with symptoms of##2##4##(1995-5#1)(2008-4#1)
presenting with symptoms##3##3##(1995-5#1)(2008-4#1)(2011-1#1)
presenting with this condition##2##4##(2008-10#1)(2008-12#1)
presenting with##141##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-9#1)(1995-10#1)(1995-5#1)(1996-9#1)(1997-7#1)(1997-8#4)(2006-10#1)(2006-12#1)(2007-10#3)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#7)(2008-11#5)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#19)(2008-8#3)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#3)
presenting within##3##2##(2007-10#3)
presenting##443##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#5)(2006-10#2)(2006-12#2)(2006-5#1)(2007-10#11)(2007-12#3)(2007-2#7)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#10)(2008-1#16)(2008-10#23)(2008-11#18)(2008-12#17)(2008-2#1)(2008-3#12)(2008-4#10)(2008-5#9)(2008-6#9)(2008-7#36)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#9)(2011-2#31)(2012-1#7)(2012-12#13)(2012-2#16)(2012-3#13)(2013-1#27)(2013-7#4)(2013-8#14)
presently available##4##2##(1990-3#1)(1991-2#1)(2008-10#1)(2008-11#1)
presently being##3##2##(1993-2#1)(1997-1#1)(2008-11#1)
presently described##2##2##(1994-3#1)(1995-12#1)
presently unclear##3##2##(1993-11#1)(1993-6#1)(2008-8#1)
presently under##4##2##(1997-3#1)(2008-9#1)(2010-6#1)(2012-2#1)
presently used##3##2##(1990-12#1)(1991-2#1)(2008-10#1)
presently##45##1##(1990-12#1)(1990-3#1)(1991-2#2)(1992-1#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
presents a brief overview##2##4##(2006-10#1)(2008-9#1)
presents a brief review of the##2##6##(1990-12#1)(2008-5#1)
presents a brief##7##3##(1990-12#1)(1991-9#1)(1992-1#1)(2006-10#1)(2006-4#1)(2008-5#1)(2008-9#1)
presents a case of a##9##5##(2007-4#1)(2009-3#6)(2010-12#1)(2013-1#1)
presents a case of##14##4##(2007-4#1)(2008-11#1)(2009-10#1)(2009-3#8)(2010-12#1)(2011-2#1)(2013-1#1)
presents a case study in##3##5##(1993-12#1)(1996-2#1)(2012-2#1)
presents a case study of##2##5##(1997-2#2)
presents a case study##6##4##(1993-12#1)(1996-2#1)(1997-2#2)(2009-5#1)(2012-2#1)
presents a case##23##3##(1993-12#1)(1996-2#1)(1997-2#2)(2007-4#1)(2008-11#1)(2009-10#1)(2009-3#8)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
presents a challenge to##2##4##(1993-3#1)(2008-10#1)
presents a challenge##4##3##(1993-3#1)(2008-10#1)(2010-5#1)(2013-8#1)
presents a comprehensive overview of the##3##6##(1992-12#1)(1993-12#1)(2013-1#1)
presents a detailed description of##2##5##(1996-1#1)(2010-3#1)
presents a detailed##4##3##(1994-1#1)(1996-1#1)(2010-3#1)(2010-5#1)
presents a different##2##3##(2007-11#1)(2008-5#1)
presents a discussion of##3##4##(2008-4#1)(2008-9#1)(2010-10#1)
presents a flow injection##2##4##(2008-10#2)
presents a general##5##3##(1995-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
presents a major##2##3##(2008-1#1)(2010-6#1)
presents a method for##3##4##(2008-10#2)(2008-6#1)
presents a method##6##3##(2008-10#4)(2008-6#1)(2008-9#1)
presents a methodology for##3##4##(1992-3#1)(1995-12#2)
presents a methodology##5##3##(1992-3#1)(1993-2#1)(1995-12#2)(2008-10#1)
presents a new and##2##4##(2009-3#1)(2012-3#1)
presents a new##7##3##(1996-12#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-3#1)(2012-3#1)(2013-1#1)
presents a novel##4##3##(1995-11#1)(2008-10#1)(2008-6#1)(2009-5#1)
presents a number of##2##4##(1995-12#1)(2008-7#1)
presents a problem in##2##4##(1995-11#1)(2011-2#1)
presents a problem##4##3##(1993-6#1)(1995-11#1)(2008-9#1)(2011-2#1)
presents a procedure##3##3##(2009-8#1)(2010-8#1)(2013-1#1)
presents a retrospective##2##3##(2008-11#1)(2013-1#1)
presents a review of the literature##2##6##(2008-1#1)(2013-8#1)
presents a review of the##4##5##(2008-1#1)(2010-1#1)(2010-12#1)(2013-8#1)
presents a review of##8##4##(2007-11#1)(2008-1#1)(2008-2#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-7#1)(2013-8#1)
presents a short##4##3##(2008-7#1)(2008-9#1)(2012-2#2)
presents a significant##2##3##(2007-12#1)(2012-2#1)
presents a simple and##2##4##(2008-4#2)
presents a simple##7##3##(1997-3#1)(2008-10#3)(2008-4#2)(2009-8#1)
presents a solution to these##2##5##(2008-6#1)(2008-9#1)
presents a study of##2##4##(2008-10#2)
presents a study##3##3##(2008-10#2)(2010-8#1)
presents a summary of the##3##5##(2009-10#1)(2011-3#1)(2013-1#1)
presents a system##2##3##(1994-12#1)(2008-6#1)
presents a systematic##2##3##(1995-1#1)(2007-7#1)
presents a technique##2##3##(2008-6#1)(2008-9#1)
presents a unique challenge to##2##5##(1997-2#1)(2008-10#1)
presents a unique##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
presents a variety of##4##4##(1991-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
presents a##230##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#1)(1997-2#3)(1997-3#2)(1997-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#32)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#15)(2008-5#4)(2008-6#6)(2008-7#5)(2008-8#1)(2008-9#13)(2009-10#5)(2009-11#1)(2009-3#9)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#7)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#10)(2012-3#3)(2013-1#11)(2013-8#2)
presents an alternative##5##3##(2008-2#4)(2008-7#1)
presents an analysis of##5##4##(1993-6#1)(1996-2#1)(2007-8#1)(2008-11#1)(2011-1#1)
presents an investigation on##2##4##(2008-10#2)
presents an overview of the##8##5##(1997-2#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
presents an overview of##16##4##(1991-12#1)(1997-2#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-9#2)(2011-2#1)(2013-8#1)
presents an update of##2##4##(2008-11#1)(2008-9#1)
presents an##61##2##(1991-12#2)(1992-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#5)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
presents as a##5##3##(1990-9#1)(2008-7#1)(2009-12#1)(2010-8#1)(2012-3#1)
presents as##10##2##(1990-6#1)(1990-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#2)
presents basic##3##2##(2008-2#1)(2008-9#1)(2010-4#1)
presents both##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
presents certain##2##2##(2008-10#1)(2008-5#1)
presents challenges##2##2##(2008-10#1)(2008-11#1)
presents clinical##2##2##(1993-1#1)(2008-4#1)
presents concise##2##2##(2008-9#1)(2010-5#1)
presents data on##7##3##(1991-6#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)
presents data that##2##3##(2008-3#1)(2008-4#1)
presents data##13##2##(1991-6#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
presents diagnostic##3##2##(2007-11#1)(2010-11#1)(2013-1#1)
presents evidence##2##2##(1994-8#1)(1995-11#1)
presents extensive##2##2##(2008-9#2)
presents findings from##2##3##(1994-1#1)(2008-11#1)
presents findings##3##2##(1994-1#1)(2008-11#1)(2008-12#1)
presents for the first time##2##5##(2007-8#1)(2008-7#1)
presents his##3##2##(1995-1#1)(1997-2#1)(2008-2#1)
presents in a##2##3##(2008-1#1)(2013-1#1)
presents in##9##2##(1993-8#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-1#2)(2011-2#1)(2013-1#1)
presents information on##2##3##(1991-12#1)(2008-9#1)
presents information##4##2##(1991-12#1)(1995-3#1)(2008-2#1)(2008-9#1)
presents itself as a##2##4##(1994-2#1)(2008-11#1)
presents itself##3##2##(1994-2#1)(2008-11#1)(2012-3#1)
presents key##2##2##(1992-2#1)(1994-2#1)
presents many challenges##5##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)
presents many##8##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
presents methods for##4##3##(2008-4#2)(2008-9#2)
presents methods##5##2##(2008-4#2)(2008-9#3)
presents new challenges##2##3##(2007-4#1)(2008-12#1)
presents new##3##2##(2007-4#1)(2008-12#1)(2009-8#1)
presents no##3##2##(1990-6#1)(1994-8#1)(2008-3#1)
presents numerous##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
presents practical##2##2##(2008-9#1)(2012-2#1)
presents procedures for##5##3##(2008-4#3)(2008-9#1)(2010-2#1)
presents recent research##2##3##(1991-2#1)(2008-10#1)
presents recent##3##2##(1991-2#1)(1997-7#1)(2008-10#1)
presents results of a##4##4##(1997-3#1)(2008-2#2)(2008-9#1)
presents results of##7##3##(1997-3#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-8#1)
presents results##9##2##(1992-5#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-8#1)
presents several##2##2##(2008-9#1)(2010-4#1)
presents significant##2##2##(1997-2#1)(2007-12#1)
presents some of the##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
presents some##10##2##(1991-12#1)(1993-2#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-12#1)
presents tables of##2##3##(2008-2#1)(2008-9#1)
presents the case of a##4##5##(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
presents the case of##6##4##(1992-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
presents the case##7##3##(1992-1#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
presents the findings of a##3##5##(1991-12#1)(1997-7#1)(2013-8#1)
presents the findings of##5##4##(1991-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2013-8#1)
presents the findings##6##3##(1991-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2013-8#1)
presents the first##3##3##(1990-6#1)(1992-12#1)(1996-2#1)
presents the historical##2##3##(1996-2#1)(2008-9#1)
presents the history of##2##4##(2007-8#1)(2009-10#1)
presents the main##3##3##(1991-2#1)(1991-6#1)(2008-10#1)
presents the most##3##3##(2008-9#1)(2011-1#1)(2013-8#1)
presents the principles##2##3##(2007-11#1)(2007-8#1)
presents the results of a survey##2##6##(1994-3#1)(2008-11#1)
presents the results of a##11##5##(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
presents the results of the first##2##6##(1995-3#1)(2013-8#1)
presents the results of the##3##5##(1995-3#1)(2008-10#1)(2013-8#1)
presents the results of##22##4##(1993-1#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#1)(2009-10#1)(2009-4#2)(2011-2#2)(2013-1#2)(2013-8#1)
presents the results##23##3##(1993-1#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#1)(2009-10#1)(2009-4#2)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
presents the treatment##2##3##(1993-8#1)(2011-2#1)
presents the validation##2##3##(2008-10#1)(2008-5#1)
presents the##122##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#10)(2007-12#2)(2007-8#6)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-9#5)(2009-10#3)(2009-4#2)(2009-5#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-8#4)(2011-1#2)(2011-2#6)(2011-7#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#8)
presents three##3##2##(1991-1#1)(1994-1#1)(2007-2#1)
presents to the emergency room with##2##6##(2008-3#1)(2009-3#1)
presents two##14##2##(1994-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)
presents unique challenges##3##3##(1991-3#1)(2011-2#1)(2012-2#1)
presents unique##4##2##(1991-3#1)(1995-1#1)(2011-2#1)(2012-2#1)
presents with a##4##3##(1997-3#1)(2007-12#1)(2007-2#1)(2007-8#1)
presents with multiple##2##3##(1997-1#1)(2008-10#1)
presents with##32##2##(1997-1#1)(1997-3#1)(2006-10#1)(2006-5#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
presents##732##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#6)(1991-6#3)(1991-9#2)(1992-1#4)(1992-12#4)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#3)(1993-2#7)(1993-3#2)(1993-6#4)(1993-8#2)(1994-1#6)(1994-12#2)(1994-2#8)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#13)(1997-3#9)(1997-4#1)(1997-6#1)(1997-7#4)(2006-10#2)(2006-4#1)(2006-5#6)(2007-10#2)(2007-11#23)(2007-12#8)(2007-2#2)(2007-4#2)(2007-5#3)(2007-7#2)(2007-8#14)(2008-1#9)(2008-10#73)(2008-11#23)(2008-12#11)(2008-2#26)(2008-3#6)(2008-4#49)(2008-5#15)(2008-6#12)(2008-7#17)(2008-8#5)(2008-9#60)(2009-1#3)(2009-10#10)(2009-11#3)(2009-12#1)(2009-3#11)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#11)(2011-1#8)(2011-10#1)(2011-2#23)(2011-3#1)(2011-7#3)(2012-12#11)(2012-2#17)(2012-3#8)(2013-1#24)(2013-7#2)(2013-8#13)
preseparation##2##1##(1993-12#1)(2008-10#1)
presequence of the##2##3##(1991-12#2)
presequence of##4##2##(1991-12#4)
presequence##7##1##(1991-12#5)(1995-11#1)(1996-10#1)
presequences of##3##2##(1995-11#1)(1995-2#1)(1996-10#1)
presequences##5##1##(1995-11#2)(1995-2#1)(1996-10#2)
preservation and##13##2##(1991-3#1)(1995-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#1)(2010-9#1)(2011-2#1)
preservation at##2##2##(2008-10#1)(2008-11#1)
preservation following##2##2##(2007-12#2)
preservation in the##3##3##(1997-2#2)(2008-10#1)
preservation in##9##2##(1996-3#1)(1997-2#2)(2008-10#1)(2008-5#1)(2009-10#1)(2010-4#2)(2012-2#1)
preservation is##6##2##(1996-3#1)(2008-10#1)(2009-4#1)(2010-4#2)(2011-2#1)
preservation medium was##2##3##(2008-10#2)
preservation medium##3##2##(2008-10#3)
preservation method##3##2##(2008-10#2)(2008-5#1)
preservation of a##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
preservation of arsenic species in##2##5##(2008-10#2)
preservation of bronchial##2##3##(2010-8#2)
preservation of normal tissue##3##4##(2007-12#2)(2010-8#1)
preservation of renal function##2##4##(2008-3#1)(2011-2#1)
preservation of renal##3##3##(1992-8#1)(2008-3#1)(2011-2#1)
preservation of residual##2##3##(2007-12#1)(2008-9#1)
preservation of soft tissue##2##4##(2008-12#2)
preservation of the##19##3##(1990-5#1)(1990-9#1)(1992-9#1)(1995-12#1)(1997-6#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
preservation of these##2##3##(2008-10#1)(2011-2#1)
preservation of##69##2##(1990-5#1)(1990-9#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-3#1)(2010-8#3)(2010-9#2)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#5)
preservation time##2##2##(2007-8#2)
preservation with##2##2##(1996-12#1)(2008-7#1)
preservation##143##1##(1990-5#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#2)(1996-9#2)(1997-2#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-5#1)(2007-8#7)(2008-1#2)(2008-10#25)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#5)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-4#4)(2010-7#2)(2010-8#4)(2010-9#3)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
preservative efficacy##3##2##(2008-5#3)
preservative in##3##2##(1990-2#1)(1995-5#1)(2008-5#1)
preservative system##7##2##(2008-5#7)
preservative was##2##2##(2008-5#1)(2008-8#1)
preservative##28##1##(1990-2#1)(1995-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#15)(2008-6#1)(2008-8#4)(2011-2#2)
preservative-free##2##1##(1990-12#1)(2008-5#1)
preservatives in cosmetic##3##3##(2008-10#2)(2008-5#1)
preservatives##15##1##(2008-10#2)(2008-5#11)(2008-8#1)(2010-4#1)
preserve a##4##2##(1996-8#1)(2008-2#1)(2008-3#1)(2009-8#1)
preserve or##2##2##(2008-5#1)(2010-7#1)
preserve renal##2##2##(2007-7#1)(2008-10#1)
preserve the##27##2##(1994-1#1)(1994-3#1)(1996-9#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
preserve their##6##2##(2007-11#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
preserve these##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
preserve##73##1##(1992-3#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
preserved after##3##2##(1994-3#1)(2008-9#1)(2012-3#1)
preserved and##3##2##(1991-10#1)(2008-10#1)(2012-3#1)
preserved at##2##2##(1993-2#2)
preserved by##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
preserved cells##3##2##(2008-11#3)
preserved for##4##2##(2007-7#1)(2008-10#2)(2008-3#1)
preserved in the##6##3##(1994-3#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-4#1)
preserved in##20##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-7#1)
preserved performances##2##2##(2009-2#2)
preserved the##3##2##(1995-6#1)(2008-11#1)(2012-6#1)
preserved through the##2##3##(1997-6#1)(2009-12#1)
preserved with the##2##3##(2008-10#2)
preserved with thymol##2##3##(1997-2#1)(2008-10#1)
preserved with##9##2##(1996-12#1)(1997-2#1)(2008-10#4)(2008-5#3)
preserved##109##1##(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#2)(1993-12#1)(1993-2#3)(1994-11#1)(1994-12#1)(1994-3#3)(1995-11#1)(1995-6#3)(1995-8#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#8)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#6)(2012-6#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
preserves the##11##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
preserves##30##1##(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
preserving function##2##2##(2008-7#1)(2008-8#1)
preserving the##20##2##(1991-3#1)(1994-12#1)(1994-9#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
preserving treatment##2##2##(2011-1#1)(2012-3#1)
preserving##59##1##(1991-1#1)(1991-3#2)(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
preset##9##1##(1995-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2013-8#1)
presided over the##2##3##(2008-2#1)(2009-5#1)
president of##4##2##(1993-12#1)(1994-1#1)(1994-9#1)(2008-5#1)
president##14##1##(1991-3#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)
president's##3##1##(1991-12#1)(1992-3#1)(1995-6#1)
presidential##5##1##(1991-3#1)(1996-2#1)(1997-2#1)(2008-4#1)(2012-2#1)
presidents##5##1##(1994-12#2)(1995-3#2)(1997-3#1)
prespecified##8##1##(1995-2#1)(1995-5#1)(1996-9#1)(2008-3#2)(2008-7#1)(2009-9#1)(2012-3#1)
press 1 RM##2##3##(2008-5#2)
press in##5##2##(1990-12#1)(2006-10#1)(2009-1#1)(2009-10#2)
press releases##3##2##(1996-2#1)(2008-7#1)(2009-4#1)
press##44##1##(1990-12#3)(1991-6#1)(1992-11#1)(1992-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-6#2)(2006-10#1)(2007-11#1)(2008-10#4)(2008-12#2)(2008-5#8)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#4)(2009-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
press]##4##1##(1990-5#1)(2006-4#1)(2008-10#2)
pressed##11##1##(1991-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-3#1)(2013-8#1)
presses##3##1##(1993-5#2)(2013-8#1)
pressing##16##1##(1990-9#1)(1995-1#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
pressor and bradycardic responses to##2##5##(1991-12#1)(1997-2#1)
pressor and bradycardic responses##4##4##(1991-12#3)(1997-2#1)
pressor and##5##2##(1991-12#3)(1995-12#1)(1997-2#1)
pressor effects##2##2##(1991-1#1)(1995-11#1)
pressor response to i##2##4##(1992-8#2)
pressor response to##7##3##(1992-8#3)(1994-3#1)(1995-12#1)(1997-2#2)
pressor response##10##2##(1991-2#1)(1992-8#5)(1994-3#1)(1995-12#1)(1997-2#2)
pressor responses##3##2##(1992-8#3)
pressor##26##1##(1990-5#2)(1991-1#1)(1991-12#3)(1991-2#1)(1992-8#8)(1994-3#1)(1995-11#1)(1995-12#2)(1997-2#4)(2007-9#1)(2008-4#1)(2012-2#1)
pressure &gt##3##2##(2008-1#1)(2008-7#2)
pressure &lt##3##2##(2008-1#2)(2008-3#1)
pressure (25##2##2##(2010-7#1)(2012-3#1)
pressure (ICP)##8##2##(1993-1#1)(2006-7#1)(2008-12#1)(2008-7#3)(2010-5#1)(2011-2#1)
pressure (MAP)##6##2##(1991-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#2)
pressure (PAP)##2##2##(2008-11#1)(2010-8#1)
pressure (PPA##2##2##(1991-6#2)
pressure (odds ratio##2##3##(1994-3#2)
pressure above##2##2##(1992-6#1)(2008-7#1)
pressure after##6##2##(1991-5#1)(1995-11#1)(2007-8#2)(2008-3#1)(2010-10#1)
pressure and a significant##2##4##(2007-9#1)(2008-7#1)
pressure and cerebral blood flow##2##5##(1996-5#1)(2007-10#1)
pressure and flow signals##2##4##(2008-3#2)
pressure and flow##3##3##(1997-1#1)(2008-3#2)
pressure and heart rate##6##4##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1995-12#2)
pressure and heart##7##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1995-12#2)(1997-8#1)
pressure and high##2##3##(1995-6#1)(2008-2#1)
pressure and its##2##3##(1990-2#1)(2009-6#1)
pressure and low##2##3##(2008-10#1)(2013-8#1)
pressure and temperature measurements##2##4##(2008-3#2)
pressure and temperature##11##3##(1995-6#1)(2008-10#1)(2008-2#2)(2008-3#5)(2009-11#1)(2012-2#1)
pressure and that##3##3##(2008-10#1)(2012-1#1)(2013-1#1)
pressure and the##10##3##(1990-5#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-5#1)(2010-8#1)(2012-3#1)
pressure and##117##2##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-11#1)(1993-1#1)(1993-10#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-3#1)(1997-8#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#7)(2008-3#9)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#4)(2013-8#3)
pressure are##6##2##(1992-11#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-7#1)
pressure as##6##2##(2008-1#1)(2008-10#3)(2008-6#1)(2012-12#1)
pressure at the##2##3##(2008-10#1)(2012-3#1)
pressure at which the##2##4##(1994-6#1)(2007-11#1)
pressure at##15##2##(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#2)(2012-1#1)(2012-3#2)(2013-7#1)
pressure below##2##2##(1990-11#1)(2008-1#1)
pressure between##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
pressure by##12##2##(1991-5#2)(1993-2#1)(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#1)
pressure can##2##2##(2008-10#1)(2008-2#1)
pressure changes##6##2##(1991-8#1)(1995-12#2)(2007-8#1)(2008-3#1)(2008-8#1)
pressure chemical##2##2##(2008-10#2)
pressure chromatographic##2##2##(2008-10#2)
pressure conditions##5##2##(2008-11#3)(2008-2#1)(2011-1#1)
pressure control##15##2##(1992-8#1)(1996-2#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2013-1#1)(2013-8#2)
pressure decreased##3##2##(1990-11#1)(1991-6#1)(2010-4#1)
pressure denaturation##3##2##(1995-2#1)(1997-7#2)
pressure dependence of##3##3##(2008-2#2)(2008-3#1)
pressure difference##5##2##(1994-9#1)(2008-8#3)(2010-10#1)
pressure differences##2##2##(1994-9#1)(2007-12#1)
pressure distributions##2##2##(2008-3#2)
pressure drop across the plug##2##5##(2009-6#2)
pressure drop##9##2##(1990-11#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#2)
pressure due to##2##3##(2007-8#1)(2008-10#1)
pressure during the##2##3##(2008-10#1)(2013-1#1)
pressure during##15##2##(1990-6#1)(1993-1#1)(1993-10#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-11#1)(2009-12#1)(2012-1#1)(2013-1#1)
pressure exerted by##3##3##(1991-12#1)(2008-10#1)(2010-2#1)
pressure exerted##4##2##(1991-12#1)(2007-12#1)(2008-10#1)(2010-2#1)
pressure fell##3##2##(1991-5#1)(1992-5#1)(1995-12#1)
pressure flow##2##2##(2008-10#2)
pressure for the##4##3##(2008-10#1)(2009-12#1)(2009-8#1)(2010-7#1)
pressure for##16##2##(1993-12#1)(1996-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#2)
pressure from the##2##3##(2007-9#1)(2008-11#1)
pressure from##12##2##(1990-11#1)(1993-10#1)(1993-2#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-8#1)
pressure gradient##7##2##(1991-5#2)(2007-8#3)(2009-6#2)
pressure gradients##2##2##(1992-9#1)(2008-7#1)
pressure has been##2##3##(1994-3#1)(2009-11#1)
pressure has##5##2##(1994-3#1)(2008-10#1)(2009-11#1)(2010-4#1)(2012-3#1)
pressure in men##3##3##(1991-6#1)(2008-3#1)(2013-1#1)
pressure in patients with##2##4##(1992-8#1)(2008-7#1)
pressure in the left##2##4##(1993-10#1)(2009-12#1)
pressure in the##18##3##(1990-4#1)(1993-10#1)(1996-4#1)(1997-5#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
pressure in##58##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-6#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#2)(1994-3#1)(1995-12#1)(1996-1#1)(1996-4#1)(1997-5#3)(1997-8#2)(2007-10#2)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-5#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
pressure increase##3##2##(1997-7#3)
pressure increased##2##2##(1993-3#1)(1997-2#1)
pressure increases##2##2##(1995-5#1)(2010-9#1)
pressure index##6##2##(1990-6#1)(1993-12#4)(2008-8#1)
pressure inside the##2##3##(2008-10#2)
pressure inside##3##2##(2008-10#2)(2008-3#1)
pressure is##18##2##(1993-11#1)(1993-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-6#1)
pressure level##4##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
pressure liquid chromatography (HPLC)##5##4##(1995-12#1)(2008-10#3)(2011-1#1)
pressure liquid chromatography##8##3##(1995-12#1)(1995-3#1)(2008-10#3)(2008-5#1)(2011-1#2)
pressure liquid##11##2##(1995-12#1)(1995-3#1)(2008-10#6)(2008-5#1)(2011-1#2)
pressure loss##2##2##(2010-4#2)
pressure losses##2##2##(2010-4#2)
pressure may##3##2##(1992-8#1)(1997-5#1)(2008-7#1)
pressure measurement and the##2##4##(1990-8#1)(2013-8#1)
pressure measurement and##3##3##(1990-8#1)(1996-6#1)(2013-8#1)
pressure measurement##14##2##(1990-8#1)(1991-6#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-8#1)(2010-4#1)(2010-8#2)(2013-8#1)
pressure measurements##12##2##(1990-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-1#1)(2012-2#3)
pressure might##3##2##(1996-11#1)(2007-10#1)(2013-8#1)
pressure monitoring is##2##3##(2008-9#1)(2009-11#1)
pressure monitoring##19##2##(1990-11#2)(1992-8#1)(1994-9#1)(1997-8#1)(2007-10#1)(2008-1#4)(2008-7#1)(2008-9#1)(2009-11#3)(2010-1#3)(2012-3#1)
pressure occurred##2##2##(1994-3#1)(2012-2#1)
pressure of &lt##3##3##(1997-5#2)(2008-3#1)
pressure of 0##2##3##(2009-5#1)(2011-2#1)
pressure of 30##2##3##(1997-2#1)(2007-8#1)
pressure of a##5##3##(1991-12#1)(2007-12#2)(2008-2#1)(2008-5#1)
pressure of the##8##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#3)(2009-11#1)(2010-7#1)
pressure of##60##2##(1991-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-5#2)(2007-10#1)(2007-12#5)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-7#2)(2011-2#2)(2013-8#2)
pressure on physicians and hospitals to##2##6##(1992-3#1)(1996-2#1)
pressure on the##9##3##(1992-6#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-1#1)(2010-4#1)
pressure on##34##2##(1990-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
pressure or##4##2##(1993-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
pressure oxygen##2##2##(2008-10#1)(2012-2#1)
pressure pain threshold##2##3##(2010-12#2)
pressure profile is##2##3##(2008-3#2)
pressure profiles##3##2##(2008-3#2)(2008-8#1)
pressure range from##3##3##(2008-10#1)(2008-3#2)
pressure range##8##2##(2008-10#3)(2008-3#4)(2008-7#1)
pressure reduction##3##2##(1992-8#1)(2013-1#1)(2013-8#1)
pressure relief##2##2##(1991-3#1)(2010-11#1)
pressure reservoir##2##2##(1990-9#1)(1996-3#1)
pressure response during##2##3##(1990-5#2)
pressure response##6##2##(1990-5#2)(2008-1#2)(2008-7#2)
pressure secondary to##2##3##(2008-7#1)(2010-10#1)
pressure sensing##2##2##(2008-2#2)
pressure sensitivity of##2##3##(2008-3#1)(2010-9#1)
pressure sensitivity##5##2##(2008-2#1)(2008-3#3)(2010-9#1)
pressure sensor with##2##3##(2008-2#2)
pressure sensor##7##2##(2008-10#1)(2008-2#5)(2008-3#1)
pressure sensors##4##2##(2008-3#2)(2009-1#1)(2010-2#1)
pressure should##6##2##(1990-3#1)(1992-6#1)(1993-2#1)(1994-6#1)(1996-6#2)
pressure signal##5##2##(2008-10#4)(2012-3#1)
pressure signals##2##2##(2008-10#2)
pressure significantly##2##2##(1994-11#1)(2010-2#1)
pressure sore##2##2##(2006-10#1)(2008-12#1)
pressure symptoms##2##2##(2008-6#1)(2011-2#1)
pressure tactics##4##2##(2010-1#4)
pressure that##2##2##(1995-11#1)(2007-11#1)
pressure to a##4##3##(2008-11#1)(2008-5#1)(2009-6#1)(2009-7#1)
pressure to be##2##3##(2007-12#1)(2009-7#1)
pressure to reduce the##2##4##(1994-3#1)(2008-9#1)
pressure to reduce##3##3##(1994-3#1)(2008-9#1)(2011-2#1)
pressure to the##2##3##(1991-3#1)(2013-8#1)
pressure to##30##2##(1991-2#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
pressure transducer##3##2##(2008-2#1)(2010-2#2)
pressure ulcer##4##2##(2007-7#1)(2012-3#3)
pressure ulcers##2##2##(1992-8#1)(2013-8#1)
pressure using##2##2##(2008-10#2)
pressure was achieved##2##3##(2007-12#1)(2008-1#1)
pressure was low##2##3##(1997-7#1)(2008-10#1)
pressure was maintained##2##3##(1995-12#1)(2012-12#1)
pressure was measured##4##3##(1993-10#2)(2008-11#1)(2013-7#1)
pressure was not##2##3##(1991-5#1)(1993-10#1)
pressure was observed in##2##4##(2010-4#1)(2012-12#1)
pressure was observed##3##3##(1990-7#1)(2010-4#1)(2012-12#1)
pressure was significantly##2##3##(1997-8#1)(2007-10#1)
pressure was##40##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-10#5)(1993-3#1)(1995-12#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2010-4#2)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
pressure wave by a rigid body##2##6##(2009-10#2)
pressure wave##3##2##(1996-3#1)(2009-10#2)
pressure waves##2##2##(2008-3#1)(2008-8#1)
pressure were measured##2##3##(2008-3#1)(2013-1#1)
pressure were observed##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
pressure were##16##2##(1992-8#1)(1993-12#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
pressure which##3##2##(1992-3#1)(1997-3#1)(2008-1#1)
pressure with##11##2##(1990-9#1)(1992-2#1)(1994-3#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)
pressure within##2##2##(2008-10#1)(2009-6#1)
pressure without alerting##2##3##(2011-2#2)
pressure without##4##2##(2007-10#2)(2011-2#2)
pressure##1396##1##(1990-11#9)(1990-12#1)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#4)(1990-8#10)(1990-9#6)(1991-10#5)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#6)(1991-5#9)(1991-6#14)(1991-8#3)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#4)(1992-5#2)(1992-6#8)(1992-8#14)(1992-9#3)(1993-1#10)(1993-10#12)(1993-11#1)(1993-12#11)(1993-2#9)(1993-3#4)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#14)(1994-6#4)(1994-8#1)(1994-9#4)(1995-11#3)(1995-12#18)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#6)(1996-3#7)(1996-4#3)(1996-5#4)(1996-6#6)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#9)(1997-4#1)(1997-5#8)(1997-6#4)(1997-7#16)(1997-8#10)(2006-10#1)(2006-7#1)(2007-10#21)(2007-11#6)(2007-12#28)(2007-5#1)(2007-7#9)(2007-8#28)(2007-9#5)(2008-1#56)(2008-10#175)(2008-11#58)(2008-12#10)(2008-2#51)(2008-3#92)(2008-4#3)(2008-5#31)(2008-6#10)(2008-7#82)(2008-8#22)(2008-9#13)(2009-1#8)(2009-10#3)(2009-11#12)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#8)(2009-6#14)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#8)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#19)(2010-5#14)(2010-6#4)(2010-7#13)(2010-8#9)(2010-9#4)(2011-1#19)(2011-2#36)(2012-1#9)(2012-12#13)(2012-2#24)(2012-3#27)(2012-4#1)(2012-6#1)(2013-1#25)(2013-7#8)(2013-8#30)
pressure) and##2##2##(1993-3#1)(1994-11#1)
pressure)##7##1##(1993-3#1)(1994-11#1)(1996-2#1)(2008-5#1)(2008-6#1)(2012-3#2)
pressure-broadened wings of strong O(3) lines##2##6##(2008-2#2)
pressure-dependent##2##1##(2008-3#1)(2008-7#1)
pressure-driven##2##1##(2008-12#1)(2013-1#1)
pressure-induced##2##1##(2008-3#1)(2010-1#1)
pressure-temperature##2##1##(2008-10#1)(2012-2#1)
pressure/displacement curves##2##2##(2008-5#2)
pressure]##5##1##(1990-8#1)(1991-11#1)(1991-9#1)(2010-12#2)
pressured to participate##2##3##(2008-8#1)(2012-1#1)
pressured##3##1##(2008-8#1)(2011-1#1)(2012-1#1)
pressures and##16##2##(1995-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#1)
pressures are##4##2##(2008-10#2)(2010-3#1)(2011-2#1)
pressures as##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
pressures at the##2##3##(1990-8#1)(2011-2#1)
pressures at##3##2##(1990-8#1)(2010-4#1)(2011-2#1)
pressures for##8##2##(1990-8#1)(1993-3#2)(1995-1#1)(1996-3#1)(1997-3#1)(2007-12#2)
pressures from##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
pressures have##2##2##(1995-3#1)(2008-5#1)
pressures in##2##2##(1997-9#1)(2008-10#1)
pressures is##2##2##(2007-12#1)(2008-2#1)
pressures of phenethyl alcohol and limonene in##2##7##(2008-5#2)
pressures of##13##2##(1990-2#1)(1995-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#2)
pressures on##4##2##(1992-12#1)(2010-12#1)(2011-7#1)(2012-3#1)
pressures that may##3##3##(2008-8#1)(2010-8#1)(2012-3#1)
pressures that##6##2##(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
pressures to##4##2##(1992-2#1)(2008-11#1)(2008-3#1)(2010-4#1)
pressures were higher##2##3##(1991-12#1)(2008-10#1)
pressures were##10##2##(1991-12#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2013-8#1)
pressures##155##1##(1990-2#1)(1990-8#4)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-3#2)(1997-8#1)(1997-9#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-2#7)(2008-3#17)(2008-5#5)(2008-7#4)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#10)(2011-7#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
pressurised##3##1##(1997-1#1)(2008-10#1)(2012-1#1)
pressurized hot water extraction##2##4##(2008-10#2)
pressurized liquid extraction (PLE)##3##4##(2008-10#3)
pressurized liquid extraction##4##3##(2008-10#4)
pressurized metered dose##3##3##(1992-3#2)(1996-2#1)
pressurized microwave digestion##2##3##(2008-10#2)
pressurized##20##1##(1992-3#4)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#12)(2008-4#1)
pressurizing##2##1##(1992-3#1)(2008-10#1)
presternal catheters##3##2##(2011-2#3)
presternal##4##1##(2011-2#4)
prestige of diseases and##3##4##(1991-11#1)(1991-6#2)
prestige##12##1##(1991-11#1)(1991-2#1)(1991-6#6)(1993-6#1)(1995-1#1)(2008-10#2)
prestimulatory levels##2##2##(1993-3#2)
prestress##3##1##(2009-7#3)
prestriate cortex##3##2##(1993-12#3)
presumably as a result of##3##5##(1990-3#1)(1992-9#1)(2008-10#1)
presumably as##4##2##(1990-3#1)(1992-9#1)(1997-3#1)(2008-10#1)
presumably associated##2##2##(2012-2#1)(2013-7#1)
presumably because of the##2##4##(2008-3#1)(2013-1#1)
presumably because##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
presumably by##5##2##(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#2)
presumably caused by##2##3##(1991-3#1)(2009-7#1)
presumably due to an##2##4##(1993-5#1)(1994-6#1)
presumably due to differences in the##2##6##(1997-2#1)(2009-12#1)
presumably due to##9##3##(1993-5#1)(1994-6#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-6#1)(2009-12#1)(2011-1#1)
presumably involved in##2##3##(1993-6#1)(1995-6#1)
presumably involved##3##2##(1993-6#1)(1995-6#1)(2008-7#1)
presumably reflecting##4##2##(1991-9#1)(1993-2#1)(1994-2#1)(2010-3#1)
presumably through##3##2##(1992-5#1)(1995-2#1)(2008-10#1)
presumably to##2##2##(2008-11#1)(2009-8#1)
presumably via the##2##3##(1991-10#1)(1991-12#1)
presumably via##7##2##(1991-10#1)(1991-12#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
presumably##98##1##(1990-3#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-11#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#3)(2007-12#3)(2008-10#13)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
presume that##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
presume##6##1##(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#1)
presumed that the##5##3##(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-2#1)
presumed that##8##2##(1993-8#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
presumed to be##11##3##(1992-6#1)(1994-5#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-5#1)
presumed to have a##2##4##(1993-6#1)(2007-10#1)
presumed to have##3##3##(1993-6#1)(2007-10#1)(2009-10#1)
presumed to work##2##3##(2009-9#1)(2012-1#1)
presumed to##25##2##(1990-7#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2012-1#1)
presumed vascular##2##2##(1997-3#1)(2008-4#1)
presumed##80##1##(1990-7#1)(1991-12#2)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-10#5)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)
presumptive diagnosis##2##2##(1997-7#1)(2008-7#1)
presumptive p53-dependent##2##2##(2008-7#2)
presumptive##24##1##(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#3)(1995-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#6)
presupplementation resting##2##2##(2013-8#2)
presupposes##4##1##(2008-11#1)(2009-10#1)(2010-10#1)(2012-2#1)
presuppositions##2##1##(2008-10#2)
presurgical##6##1##(1991-1#1)(1994-3#1)(2008-7#1)(2009-9#1)(2010-8#1)(2013-1#1)
presymptomatic diagnosis and##2##3##(1991-8#1)(2008-11#1)
presymptomatic##6##1##(1991-8#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2013-7#1)
presynaptic and postsynaptic##2##3##(2008-11#1)(2008-7#1)
presynaptic function##3##2##(1995-11#1)(1997-7#1)(2012-2#1)
presynaptic inhibition##4##2##(1995-11#4)
presynaptic membrane##2##2##(1997-7#1)(2008-7#1)
presynaptic nerve terminal protein##2##4##(1995-6#1)(1996-12#1)
presynaptic nerve terminal##3##3##(1993-3#1)(1995-6#1)(1996-12#1)
presynaptic nerve terminals##2##3##(1993-12#1)(1997-2#1)
presynaptic nerve##5##2##(1993-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(1997-2#1)
presynaptic plasma membrane##2##3##(1995-2#1)(2008-7#1)
presynaptic terminal##2##2##(1994-8#1)(1995-12#1)
presynaptic terminals##4##2##(1992-12#1)(2008-4#1)(2012-2#2)
presynaptic##60##1##(1990-12#1)(1992-11#1)(1992-12#2)(1993-12#1)(1993-3#2)(1994-8#3)(1995-11#5)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#5)(1996-2#2)(1996-5#1)(1997-2#5)(1997-7#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-5#1)(2009-9#1)(2012-2#3)
presynaptically##2##1##(1995-11#1)(1997-3#1)
preteen and##4##2##(2013-1#4)
pretends##2##1##(2008-10#1)(2013-1#1)
preterm and low birth weight##2##5##(1991-12#1)(2008-12#1)
preterm and low##3##3##(1991-12#1)(2007-2#1)(2008-12#1)
preterm and##6##2##(1991-12#1)(1993-12#1)(2007-2#1)(2008-12#2)(2011-2#1)
preterm babies with respiratory distress syndrome##2##6##(1990-12#2)
preterm babies##5##2##(1990-11#1)(1990-12#3)(1997-5#1)
preterm birth and cerebral palsy##2##5##(2011-2#2)
preterm birth in##2##3##(2007-2#1)(2013-8#1)
preterm birth##13##2##(1995-6#1)(2007-2#4)(2008-11#1)(2008-9#1)(2011-2#4)(2012-2#1)(2013-8#1)
preterm deliveries##2##2##(2011-2#1)(2013-1#1)
preterm delivery##6##2##(1992-2#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(2012-3#1)
preterm infant is##2##3##(1993-12#1)(2012-2#1)
preterm infant##13##2##(1993-12#3)(1993-3#1)(1994-3#2)(2007-9#1)(2008-11#3)(2010-11#2)(2012-2#1)
preterm infants with##4##3##(1990-12#1)(2010-5#2)(2013-1#1)
preterm infants##23##2##(1990-12#1)(1990-3#1)(1991-1#1)(1992-2#1)(1993-12#4)(1993-2#3)(1994-1#1)(1997-2#1)(2007-11#1)(2008-12#2)(2009-6#1)(2010-5#2)(2011-2#2)(2012-12#1)(2013-1#1)
preterm labor##8##2##(1994-9#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-3#1)
preterm labour##2##2##(1994-3#2)
preterm neonates##5##2##(2007-11#4)(2012-2#1)
preterm newborn##4##2##(2008-11#2)(2011-2#1)(2012-12#1)
preterm or##2##2##(2008-11#1)(2013-1#1)
preterm##104##1##(1990-11#1)(1990-12#5)(1990-3#1)(1991-1#1)(1991-12#1)(1992-2#2)(1992-4#1)(1993-12#8)(1993-2#3)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#6)(1994-9#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#6)(2007-2#6)(2007-9#1)(2008-11#7)(2008-12#4)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-5#2)(2011-1#1)(2011-2#15)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
pretest##5##1##(1993-2#1)(2008-10#1)(2010-10#2)(2011-1#1)
pretest-posttest design study##2##3##(2010-7#2)
pretest-posttest design##3##2##(2010-7#2)(2013-1#1)
pretest-posttest##4##1##(2010-7#2)(2013-1#2)
pretransfusion testing during the##2##4##(2011-1#2)
pretransfusion testing##4##2##(2011-1#4)
pretransfusion tests (with##2##3##(2011-1#2)
pretransfusion##8##1##(1992-6#1)(1994-9#1)(2011-1#6)
pretransplant##4##1##(1994-5#1)(2010-11#1)(2011-2#1)(2012-12#1)
pretreated advanced breast cancer##3##4##(1992-2#1)(1993-2#1)(1994-8#1)
pretreated at 200°C##2##3##(2013-1#2)
pretreated at##4##2##(2013-1#4)
pretreated breast cancer##2##3##(1992-2#1)(1992-8#1)
pretreated by##5##2##(2008-10#2)(2013-1#3)
pretreated materials##2##2##(2008-6#1)(2013-1#1)
pretreated patients with advanced breast cancer##2##6##(1992-2#1)(1994-8#1)
pretreated patients##3##2##(1992-2#1)(1994-8#1)(2007-12#1)
pretreated plants##2##2##(2008-10#2)
pretreated platinum electrode##2##3##(2008-10#2)
pretreated rats##2##2##(1993-12#1)(1993-3#1)
pretreated samples##3##2##(1993-2#1)(2008-10#2)
pretreated straw was##2##3##(2013-1#2)
pretreated teflon membrane served as##2##5##(2008-10#2)
pretreated teflon membrane##3##3##(2008-10#3)
pretreated with ASM##3##3##(2008-10#3)
pretreated with a##2##3##(1995-3#1)(2008-5#1)
pretreated with aDON the##2##4##(1995-12#2)
pretreated with an##2##3##(1992-6#1)(2013-1#1)
pretreated with doxifluridine##2##3##(1992-8#2)
pretreated with saline##3##3##(1993-3#1)(1994-8#1)(1994-9#1)
pretreated with the##6##3##(1992-3#1)(1993-12#1)(1995-11#1)(1995-12#2)(2008-10#1)
pretreated with##60##2##(1990-11#3)(1991-12#1)(1991-6#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#2)(1992-8#4)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2013-1#1)
pretreated##107##1##(1990-11#3)(1991-12#1)(1991-6#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#5)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#2)(1994-8#6)(1994-9#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-8#2)(1996-12#1)(1996-9#2)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-5#1)(2008-6#6)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#13)
pretreating the cells with##2##4##(1992-6#1)(1996-5#1)
pretreating the##4##2##(1992-6#1)(1995-12#1)(1996-5#1)(2008-5#1)
pretreatment and##14##2##(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#6)
pretreatment by##3##2##(1990-12#1)(2008-10#2)
pretreatment conditions##2##2##(2013-1#2)
pretreatment factors on##2##3##(2013-1#2)
pretreatment followed by##2##3##(2008-11#1)(2013-1#1)
pretreatment for##5##2##(1990-2#1)(2008-10#4)
pretreatment glassy carbon electrode##2##4##(2008-10#2)
pretreatment in the##2##3##(1996-2#1)(2008-10#1)
pretreatment in##7##2##(1992-6#1)(1996-2#1)(2008-10#4)(2012-3#1)
pretreatment increased myocardial##2##3##(1991-9#2)
pretreatment increased##3##2##(1991-9#2)(2013-1#1)
pretreatment is##2##2##(1994-9#1)(2008-10#1)
pretreatment method##2##2##(2008-10#2)
pretreatment methods for the##3##4##(2008-10#2)(2013-1#1)
pretreatment of a lignocellulosic biomass##2##5##(2013-1#2)
pretreatment of a##3##3##(2008-8#1)(2013-1#2)
pretreatment of cells with##4##4##(2008-11#1)(2008-4#1)(2011-2#2)
pretreatment of cells##5##3##(1990-11#1)(2008-11#1)(2008-4#1)(2011-2#2)
pretreatment of sugarcane##2##3##(2013-1#2)
pretreatment of the samples##2##4##(2008-10#1)(2008-11#1)
pretreatment of the##13##3##(1995-11#1)(1995-2#1)(1997-1#2)(2008-10#7)(2008-11#1)(2013-8#1)
pretreatment of##52##2##(1990-11#1)(1991-12#1)(1991-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#3)(2012-12#1)(2013-1#7)(2013-8#2)
pretreatment on##5##2##(1993-12#2)(2008-10#1)(2012-12#1)(2013-8#1)
pretreatment procedure##4##2##(2008-10#4)
pretreatment regimen##2##2##(1995-3#1)(2011-2#1)
pretreatment temperatures##2##2##(1993-9#1)(2013-1#1)
pretreatment using a##2##3##(2008-10#1)(2013-1#1)
pretreatment using##4##2##(2008-10#2)(2009-6#1)(2013-1#1)
pretreatment was##5##2##(2008-10#1)(2008-6#1)(2013-1#3)
pretreatment were##4##2##(1995-12#1)(1996-5#1)(2008-10#1)(2013-1#1)
pretreatment with rimalkalim##3##3##(1997-7#3)
pretreatment with the##5##3##(1990-5#1)(1993-12#1)(1996-5#1)(2013-1#2)
pretreatment with##40##2##(1990-11#2)(1990-12#1)(1990-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#5)(1996-5#2)(1997-1#1)(1997-6#1)(1997-7#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#3)
pretreatment##266##1##(1990-11#5)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#6)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-9#2)(1997-1#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#3)(2007-10#3)(2007-2#1)(2008-1#2)(2008-10#84)(2008-11#10)(2008-12#1)(2008-4#6)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#41)(2013-8#4)
pretreatment)##2##1##(1997-7#1)(2008-10#1)
pretreatments led to##2##3##(2008-10#1)(2013-1#1)
pretreatments##11##1##(2008-10#5)(2013-1#6)
pretty##4##1##(1991-1#1)(1993-2#1)(2009-4#1)(2010-12#1)
prevail in##2##2##(2008-9#1)(2009-8#1)
prevail over##2##2##(1991-3#1)(1991-8#1)
prevail##11##1##(1991-3#1)(1991-8#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
prevailed in the##2##3##(2011-1#1)(2012-12#1)
prevailed in##6##2##(1991-8#1)(2008-12#2)(2011-1#1)(2011-2#1)(2012-12#1)
prevailed under##2##2##(1990-7#1)(2009-7#1)
prevailed##15##1##(1990-7#1)(1991-8#1)(1992-3#1)(1997-5#1)(2008-1#1)(2008-12#2)(2009-7#2)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#1)
prevailing in##5##2##(1991-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
prevailing##41##1##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-9#1)(2012-2#3)(2013-8#1)
prevails over##2##2##(1994-2#1)(2008-10#1)
prevails##6##1##(1994-2#1)(2008-10#3)(2008-3#1)(2012-3#1)
prevalant in##2##2##(2008-1#1)(2008-3#1)
prevalence =##2##2##(2008-6#2)
prevalence among young##2##3##(1995-9#1)(2008-5#1)
prevalence among##7##2##(1990-2#1)(1990-6#1)(1993-6#1)(1995-9#1)(2008-1#1)(2008-4#1)(2008-5#1)
prevalence and distribution of##2##4##(2006-8#1)(2012-12#1)
prevalence and incidence##2##3##(2009-5#1)(2011-2#1)
prevalence and predictors of##2##4##(2011-1#1)(2012-2#1)
prevalence and risk factors in##2##5##(2012-12#1)(2013-8#1)
prevalence and severity of##5##4##(2007-7#1)(2008-1#1)(2008-2#1)(2010-6#1)(2011-2#1)
prevalence and the number of##2##5##(1992-2#1)(2008-6#1)
prevalence and the##4##3##(1992-2#1)(2008-6#1)(2010-12#1)(2011-7#1)
prevalence and##74##2##(1991-1#1)(1992-1#1)(1992-2#1)(1992-9#2)(1994-11#2)(1994-6#1)(1995-3#2)(1997-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-7#1)(2012-12#4)(2012-2#6)(2013-1#2)(2013-8#6)
prevalence as##2##2##(2008-1#1)(2011-1#1)
prevalence between##5##2##(1994-6#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-8#1)
prevalence data##5##2##(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
prevalence differences##2##2##(1990-6#1)(2013-1#1)
prevalence estimates##2##2##(2011-2#1)(2012-12#1)
prevalence for##3##2##(2012-12#2)(2013-1#1)
prevalence has increased##2##3##(1992-2#1)(2009-4#1)
prevalence has##5##2##(1992-2#1)(2007-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
prevalence in Iranian##2##3##(2008-12#1)(2012-12#1)
prevalence in a##4##3##(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#1)
prevalence in different##2##3##(2008-10#1)(2013-8#1)
prevalence in females##2##3##(2008-3#1)(2010-8#1)
prevalence in the north-central region of the United States##2##9##(2008-10#2)
prevalence in the##14##3##(1990-6#1)(2008-10#3)(2008-8#3)(2009-7#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
prevalence in women##2##3##(2009-10#1)(2013-8#1)
prevalence in##50##2##(1990-6#3)(1992-2#1)(1994-11#1)(1994-6#1)(1995-9#1)(1996-3#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
prevalence increased with age##2##4##(2008-3#1)(2008-7#1)
prevalence is in##2##3##(1996-7#1)(2012-12#1)
prevalence is##10##2##(1991-12#1)(1996-7#1)(1997-3#1)(2007-7#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-12#2)
prevalence occurred##2##2##(1996-12#1)(2008-7#1)
prevalence of 26##2##3##(1990-6#1)(1994-6#1)
prevalence of 5##4##3##(1997-3#3)(2008-8#1)
prevalence of 6##2##3##(1995-11#1)(2008-12#1)
prevalence of AB in children##2##5##(1996-7#2)
prevalence of AB##3##3##(1996-7#3)
prevalence of AD##2##3##(2008-7#1)(2012-2#1)
prevalence of CCSVI##2##3##(2012-3#2)
prevalence of CSDS##3##3##(2013-8#3)
prevalence of CVD risks##2##4##(2011-1#2)
prevalence of CVD##3##3##(2010-12#1)(2011-1#2)
prevalence of Chlamydia trachomatis##2##4##(2007-7#1)(2008-12#1)
prevalence of Chlamydia##3##3##(2007-7#1)(2008-12#2)
prevalence of GDM##2##3##(2009-3#1)(2011-2#1)
prevalence of H##3##3##(2008-1#1)(2008-8#1)(2011-1#1)
prevalence of HBV##2##3##(2008-10#2)
prevalence of HBsAg##2##3##(2008-10#1)(2013-1#1)
prevalence of HCV##2##3##(2008-1#1)(2009-8#1)
prevalence of HIV infection among the drug addicts##2##8##(2007-7#2)
prevalence of HIV infection among##3##5##(2007-7#2)(2011-2#1)
prevalence of HIV infection in##2##5##(1993-11#1)(1996-11#1)
prevalence of HIV infection##6##4##(1993-11#1)(1996-11#1)(2007-7#2)(2011-2#2)
prevalence of HIV seropositivity##2##4##(2007-7#2)
prevalence of HIV##8##3##(1993-11#1)(1996-11#1)(2007-7#4)(2011-2#2)
prevalence of Helicobacter##2##3##(1990-2#1)(2011-2#1)
prevalence of MDD##2##3##(2011-1#1)(2013-8#1)
prevalence of PAD was##2##4##(2008-8#2)
prevalence of PNE##2##3##(2007-7#2)
prevalence of S##3##3##(1997-3#1)(2008-8#2)
prevalence of T(2)##2##3##(2010-8#2)
prevalence of a##4##3##(1997-7#1)(2008-7#1)(2010-5#1)(2012-2#1)
prevalence of abdominal##3##3##(1992-5#1)(2008-3#1)(2013-8#1)
prevalence of abnormal##5##3##(1991-12#1)(2007-2#1)(2011-2#1)(2012-12#2)
prevalence of about##2##3##(2008-11#1)(2008-6#1)
prevalence of active##2##3##(2008-12#1)(2009-12#1)
prevalence of acute##2##3##(2008-3#1)(2013-8#1)
prevalence of and risk factors for##2##6##(2009-2#1)(2009-8#1)
prevalence of and##4##3##(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)
prevalence of anemia##2##3##(2007-11#1)(2011-2#1)
prevalence of anti-HCV antibodies##2##4##(2008-1#2)
prevalence of anti-HCV##4##3##(2007-7#2)(2008-1#2)
prevalence of antibodies to##3##4##(1991-11#2)(2008-12#1)
prevalence of antibodies##4##3##(1991-11#2)(1994-7#1)(2008-12#1)
prevalence of asthma and##2##4##(2012-3#2)
prevalence of asthma##3##3##(2008-3#1)(2012-3#2)
prevalence of asymptomatic##2##3##(2007-9#1)(2008-12#1)
prevalence of autoimmune diseases##2##4##(2008-10#1)(2011-2#1)
prevalence of bipolar##2##3##(2007-8#1)(2008-8#1)
prevalence of both##2##3##(2008-4#1)(2013-8#1)
prevalence of bronchial asthma##2##4##(1996-7#2)
prevalence of brown stem rot##4##5##(2008-10#4)
prevalence of cardiovascular disease##2##4##(2008-3#1)(2009-11#1)
prevalence of cardiovascular##5##3##(2008-3#1)(2009-11#2)(2009-9#1)(2012-2#1)
prevalence of cavities##3##3##(2008-9#3)
prevalence of chronic##4##3##(1997-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
prevalence of cigarette##3##3##(2013-1#1)(2013-8#2)
prevalence of circumportal pancreas##3##4##(2012-2#3)
prevalence of delirium in##2##4##(2010-10#1)(2012-12#1)
prevalence of dementia##5##3##(1991-11#1)(1991-9#1)(2008-7#3)
prevalence of dental caries##2##4##(1991-6#1)(2011-1#1)
prevalence of depression##4##3##(2007-10#2)(2009-10#1)(2013-8#1)
prevalence of depressive symptoms in Brazil##2##6##(2013-8#2)
prevalence of depressive symptoms in##3##5##(2013-8#3)
prevalence of depressive symptoms was##2##5##(2013-1#1)(2013-8#1)
prevalence of depressive symptoms##6##4##(2013-1#2)(2013-8#4)
prevalence of depressive##9##3##(2009-10#1)(2013-1#2)(2013-8#6)
prevalence of diabetes among##2##4##(2008-7#1)(2013-8#1)
prevalence of diabetes and##2##4##(2008-7#1)(2010-10#1)
prevalence of diabetes mellitus is##2##5##(2008-7#1)(2011-2#1)
prevalence of diabetes mellitus##5##4##(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
prevalence of diabetes##15##3##(2007-12#1)(2008-1#1)(2008-7#5)(2010-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
prevalence of diabetic##2##3##(2007-12#1)(2008-7#1)
prevalence of disturbed eating attitudes in##2##6##(2007-7#2)
prevalence of drug##2##3##(2012-3#1)(2013-8#1)
prevalence of elevated blood lead (PbB) levels in##2##8##(1997-4#2)
prevalence of elevated blood##3##4##(1997-4#2)(2008-5#1)
prevalence of elevated##4##3##(1997-4#2)(2007-7#1)(2008-5#1)
prevalence of end-stage renal disease##2##5##(2007-7#1)(2008-1#1)
prevalence of ergot##2##3##(2008-10#2)
prevalence of genital##2##3##(2007-12#2)
prevalence of hepatitis A##2##4##(2007-12#2)
prevalence of hepatitis B##2##4##(1996-3#2)
prevalence of hepatitis C##2##4##(2008-1#2)
prevalence of hepatitis##6##3##(1996-3#2)(2007-12#2)(2008-1#2)
prevalence of hypertension in##3##4##(2008-1#3)
prevalence of hypertension was##2##4##(2008-11#1)(2008-7#1)
prevalence of hypertension##13##3##(2008-1#6)(2008-11#5)(2008-7#2)
prevalence of infection##7##3##(1990-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#3)
prevalence of infectious##2##3##(2007-7#1)(2008-10#1)
prevalence of influenza##2##3##(2011-2#2)
prevalence of intestinal parasitism in##2##5##(2012-12#2)
prevalence of intestinal##4##3##(2009-10#1)(2012-12#2)(2012-3#1)
prevalence of low vision##2##4##(2010-8#2)
prevalence of low##5##3##(1997-5#1)(2010-1#1)(2010-8#2)(2011-2#1)
prevalence of lymphadenopathy##2##3##(2011-1#2)
prevalence of major##2##3##(2011-1#1)(2013-8#1)
prevalence of mental##3##3##(1993-5#1)(2008-11#1)(2008-12#1)
prevalence of metabolic syndrome##5##4##(2008-3#3)(2010-10#1)(2012-12#1)
prevalence of metabolic##6##3##(2007-12#1)(2008-3#3)(2010-10#1)(2012-12#1)
prevalence of migraine headache among depressed##2##6##(2010-2#2)
prevalence of migraine##6##3##(2008-9#1)(2010-2#5)
prevalence of morbidity##2##3##(2009-12#1)(2011-1#1)
prevalence of musculoskeletal pain and discomfort##2##6##(2008-12#2)
prevalence of obesity has##2##4##(2010-6#1)(2011-1#1)
prevalence of obesity in##2##4##(1993-11#1)(2013-1#1)
prevalence of obesity##11##3##(1993-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
prevalence of occult##2##3##(1990-6#2)
prevalence of oocysts##2##3##(1996-12#2)
prevalence of oral##3##3##(2008-1#1)(2008-5#2)
prevalence of osteoporosis##5##3##(1996-11#1)(2010-3#4)
prevalence of overweight and obesity among##2##6##(2011-1#1)(2012-12#1)
prevalence of overweight and obesity##6##5##(2008-3#1)(2011-1#1)(2012-12#4)
prevalence of overweight and##8##4##(2008-3#2)(2011-1#1)(2012-12#4)(2013-8#1)
prevalence of overweight##9##3##(2008-3#3)(2011-1#1)(2012-12#4)(2013-8#1)
prevalence of pain in##2##4##(2008-5#1)(2010-12#1)
prevalence of pain##4##3##(2008-12#1)(2008-5#1)(2010-12#1)(2012-12#1)
prevalence of pediatric##2##3##(2008-10#1)(2008-11#1)
prevalence of peripheral##2##3##(2008-8#2)
prevalence of positive##3##3##(2007-7#1)(2008-12#1)(2013-1#1)
prevalence of psychiatric##2##3##(1993-5#1)(2011-1#1)
prevalence of radiographic##2##3##(1991-12#1)(2012-3#1)
prevalence of respiratory symptoms##2##4##(1995-8#2)
prevalence of rheumatoid factor##2##4##(2011-2#2)
prevalence of secondary##2##3##(2008-1#1)(2008-12#1)
prevalence of smoking among##3##4##(1991-11#1)(1991-4#1)(2009-7#1)
prevalence of smoking##6##3##(1991-11#1)(1991-4#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
prevalence of soybean##2##3##(2008-10#2)
prevalence of suicidal##2##3##(1992-1#1)(2013-1#1)
prevalence of systemic##2##3##(2006-10#1)(2007-12#1)
prevalence of the MS is##2##5##(2008-3#2)
prevalence of the MS##4##4##(2008-3#4)
prevalence of the disease was##2##5##(2008-10#2)
prevalence of the disease##5##4##(2007-11#1)(2008-10#3)(2008-9#1)
prevalence of the illness##2##4##(1990-9#1)(2008-7#1)
prevalence of the infection in##2##5##(1990-9#1)(2008-1#1)
prevalence of the metabolic syndrome##2##5##(2008-1#1)(2008-3#1)
prevalence of the most##2##4##(2007-7#1)(2011-1#1)
prevalence of the##35##3##(1990-9#2)(1993-2#1)(1993-6#1)(2007-11#1)(2007-7#2)(2008-1#3)(2008-10#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
prevalence of these##6##3##(1990-9#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)
prevalence of this disease##2##4##(2010-5#1)(2013-8#1)
prevalence of this mutation##3##4##(1991-8#1)(2008-2#2)
prevalence of this##9##3##(1991-8#1)(1991-9#1)(1996-12#1)(2008-12#1)(2008-2#2)(2008-7#1)(2010-5#1)(2013-8#1)
prevalence of thrombocytosis##3##3##(1990-12#3)
prevalence of transmitted##2##3##(2013-1#2)
prevalence of treatment##2##3##(1992-9#1)(2008-11#1)
prevalence of tuberculosis##4##3##(1995-10#1)(2011-1#2)(2012-3#1)
prevalence of type 2 diabetes##2##5##(2008-12#1)(2008-3#1)
prevalence of use##2##3##(1991-12#1)(2008-1#1)
prevalence of viral##2##3##(2008-1#1)(2008-10#1)
prevalence of##671##2##(1990-12#5)(1990-2#3)(1990-3#2)(1990-6#7)(1990-9#5)(1991-11#6)(1991-12#5)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#2)(1992-9#3)(1993-11#2)(1993-2#3)(1993-5#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#6)(1994-7#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-7#5)(1996-9#1)(1997-3#7)(1997-4#3)(1997-5#3)(1997-7#3)(2006-10#3)(2007-10#7)(2007-11#3)(2007-12#16)(2007-2#2)(2007-7#31)(2007-8#3)(2007-9#1)(2008-1#34)(2008-10#31)(2008-11#16)(2008-12#28)(2008-2#5)(2008-3#24)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#23)(2008-8#22)(2008-9#10)(2009-10#8)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#5)(2010-12#4)(2010-2#6)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#4)(2010-8#9)(2010-9#1)(2011-1#31)(2011-2#38)(2011-7#1)(2012-1#2)(2012-12#26)(2012-2#21)(2012-3#22)(2012-5#1)(2013-1#28)(2013-7#1)(2013-8#32)
prevalence ranging from##2##3##(2008-1#2)
prevalence rate for##2##3##(2008-7#1)(2013-8#1)
prevalence rate of##15##3##(1994-6#1)(2006-10#2)(2008-1#2)(2008-12#1)(2008-3#2)(2008-7#2)(2010-4#1)(2013-8#4)
prevalence rate##24##2##(1990-6#1)(1991-12#2)(1994-6#1)(2006-10#2)(2008-1#4)(2008-12#1)(2008-3#2)(2008-7#4)(2010-4#1)(2011-1#1)(2013-8#5)
prevalence rates of probable##2##4##(2012-1#2)
prevalence rates of##9##3##(2007-12#1)(2007-7#1)(2008-7#1)(2011-1#4)(2012-1#2)
prevalence rates were##2##3##(2011-1#1)(2012-3#1)
prevalence rates##21##2##(2007-12#2)(2007-7#1)(2008-1#2)(2008-7#2)(2011-1#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
prevalence studies##2##2##(2008-1#1)(2011-2#1)
prevalence study##4##2##(1990-6#1)(1993-6#1)(2008-7#1)(2009-7#1)
prevalence surveillance project##2##3##(2007-12#2)
prevalence survey##3##2##(2008-12#1)(2013-8#2)
prevalence that##2##2##(2008-7#1)(2012-2#1)
prevalence to be##2##3##(2011-2#1)(2013-8#1)
prevalence varies##2##2##(2008-1#1)(2013-1#1)
prevalence was 0##2##3##(2008-10#1)(2013-1#1)
prevalence was significantly higher in##2##5##(1996-12#1)(2008-3#1)
prevalence was significantly higher##3##4##(1996-12#1)(2008-3#1)(2008-5#1)
prevalence was significantly##4##3##(1996-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
prevalence was##24##2##(1990-2#1)(1990-3#1)(1990-6#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
prevalence were##6##2##(1990-3#1)(1994-6#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)
prevalence with##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
prevalence##1043##1##(1990-12#5)(1990-2#5)(1990-3#4)(1990-6#15)(1990-9#5)(1991-1#1)(1991-11#6)(1991-12#9)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#3)(1992-8#2)(1992-9#6)(1993-11#2)(1993-2#3)(1993-5#2)(1993-6#5)(1994-11#4)(1994-12#1)(1994-2#2)(1994-6#12)(1994-7#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#4)(1995-9#4)(1996-1#2)(1996-11#3)(1996-12#7)(1996-2#1)(1996-3#6)(1996-7#6)(1996-9#1)(1997-3#8)(1997-4#5)(1997-5#3)(1997-7#5)(2006-10#6)(2006-8#1)(2007-10#8)(2007-11#4)(2007-12#22)(2007-2#3)(2007-5#1)(2007-7#48)(2007-8#3)(2007-9#1)(2008-1#59)(2008-10#52)(2008-11#21)(2008-12#36)(2008-2#7)(2008-3#30)(2008-4#3)(2008-5#16)(2008-6#9)(2008-7#39)(2008-8#36)(2008-9#13)(2009-10#9)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#6)(2010-3#6)(2010-4#7)(2010-5#8)(2010-6#7)(2010-8#13)(2010-9#1)(2011-1#51)(2011-2#64)(2011-7#2)(2012-1#4)(2012-12#49)(2012-2#32)(2012-3#32)(2012-5#1)(2013-1#44)(2013-7#3)(2013-8#58)
prevalences of##5##2##(1990-12#1)(1991-12#1)(1995-11#1)(2008-10#1)(2011-2#1)
prevalences##10##1##(1990-12#1)(1990-6#1)(1991-12#1)(1995-11#1)(2007-10#1)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)
prevalent among T##2##3##(2012-3#2)
prevalent among the general population##2##5##(2012-12#1)(2012-3#1)
prevalent among the##3##3##(2012-12#2)(2012-3#1)
prevalent among##8##2##(2007-12#1)(2007-7#1)(2008-9#1)(2012-12#2)(2012-3#3)
prevalent and##6##2##(2008-1#1)(2008-10#3)(2012-12#1)(2012-3#1)
prevalent chronic##2##2##(2008-1#1)(2011-1#1)
prevalent disease##3##2##(2009-5#1)(2012-3#1)(2013-8#1)
prevalent forms of##2##3##(1992-1#1)(1994-12#1)
prevalent in both##2##3##(1991-1#1)(2009-11#1)
prevalent in cattle##2##3##(2012-3#1)(2013-1#1)
prevalent in many##2##3##(2008-10#1)(2013-8#1)
prevalent in our##2##3##(2007-7#1)(2010-8#1)
prevalent in patients with##2##4##(2008-7#1)(2010-6#1)
prevalent in the United States##2##5##(2007-2#1)(2013-8#1)
prevalent in the##10##3##(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)(2013-1#1)(2013-8#1)
prevalent in##62##2##(1991-1#1)(1991-2#1)(1994-3#1)(1996-12#2)(1997-8#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
prevalent is##2##2##(2007-12#1)(2012-3#1)
prevalent metabolic##2##2##(2008-3#1)(2010-10#1)
prevalent of##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
prevalent than##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
prevalent throughout##2##2##(2008-10#1)(2011-2#1)
prevalent when##2##2##(2008-10#2)
prevalent wind##3##2##(2008-5#3)
prevalent##211##1##(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-7#5)(2007-8#1)(2008-1#12)(2008-10#36)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#11)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#4)(2009-6#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#14)(2012-12#8)(2012-2#2)(2012-3#12)(2013-1#13)(2013-8#7)
prevalently##4##1##(2008-10#2)(2008-8#1)(2010-8#1)
prevalidation##2##1##(2008-10#1)(2008-5#1)
prevent a##9##2##(1990-6#1)(1993-1#1)(1993-2#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-5#1)(2013-8#1)
prevent against##3##2##(2009-8#2)(2010-2#1)
prevent age-related##2##2##(2008-5#1)(2009-8#1)
prevent amyloid##2##2##(1992-9#1)(1994-8#1)
prevent and control##7##3##(2007-12#1)(2008-1#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
prevent and manage##2##3##(2007-12#1)(2012-3#1)
prevent and reverse##2##3##(2012-2#2)
prevent and##28##2##(1992-2#1)(1993-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
prevent any##2##2##(2008-11#1)(2008-4#1)
prevent apoptosis##2##2##(1994-10#1)(1995-2#1)
prevent bleeding in##2##3##(1992-11#1)(2011-2#1)
prevent bone loss##2##3##(2008-7#1)(2008-8#1)
prevent bone##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
prevent cardiovascular##4##2##(1993-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
prevent cell##2##2##(1994-10#1)(1994-9#1)
prevent chronic disease and##2##4##(2010-1#1)(2011-2#1)
prevent chronic##3##2##(2009-5#1)(2010-1#1)(2011-2#1)
prevent clinical##2##2##(2008-8#1)(2012-3#1)
prevent complications##4##2##(1991-2#1)(2007-8#1)(2011-1#1)(2011-2#1)
prevent conversion##2##2##(2008-6#1)(2011-1#1)
prevent development of##4##3##(1991-6#1)(1996-3#1)(1996-7#1)(1997-7#1)
prevent disease##6##2##(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-7#2)
prevent further bone##2##3##(1993-11#1)(2008-10#1)
prevent further##5##2##(1993-11#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
prevent growth##2##2##(1990-12#1)(2011-2#1)
prevent infection##2##2##(2008-10#1)(2008-5#1)
prevent infections##8##2##(2008-11#1)(2008-5#1)(2011-2#6)
prevent interference from##3##3##(2008-10#2)(2008-3#1)
prevent interference##4##2##(2008-10#3)(2008-3#1)
prevent invasive##2##2##(2013-1#1)(2013-8#1)
prevent it##6##2##(1995-5#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
prevent its##2##2##(2008-3#1)(2009-5#1)
prevent leakage##2##2##(2008-3#1)(2008-5#1)
prevent life-threatening##2##2##(1991-8#1)(2010-8#1)
prevent long-term##4##2##(1993-2#1)(2008-1#2)(2013-1#1)
prevent myocardial##2##2##(1993-2#1)(2008-12#1)
prevent obesity##2##2##(2011-2#1)(2012-2#1)
prevent or##24##2##(1991-9#1)(1993-11#1)(1994-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
prevent overfitting##2##2##(1995-9#1)(2008-10#1)
prevent pathogen ingress##2##3##(2008-10#2)
prevent patient##2##2##(1994-1#1)(2011-2#1)
prevent progression of##2##3##(2007-2#1)(2011-2#1)
prevent relapse##2##2##(1991-1#1)(2012-12#1)
prevent repetitive##2##2##(2009-3#1)(2011-1#1)
prevent restenosis##2##2##(1992-9#1)(1996-8#1)
prevent severe##3##2##(2007-8#1)(2010-1#1)(2011-2#1)
prevent skin cancer in##2##4##(1991-11#1)(2008-8#1)
prevent skin##3##2##(1991-11#1)(2008-5#1)(2008-8#1)
prevent such##5##2##(1991-2#1)(2007-12#1)(2008-5#1)(2009-3#1)(2013-8#1)
prevent the development of##9##4##(1991-9#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
prevent the growth of##2##4##(2008-12#1)(2012-1#1)
prevent the growth##3##3##(2008-1#1)(2008-12#1)(2012-1#1)
prevent the in##2##3##(1991-9#1)(2008-10#1)
prevent the increase in##3##4##(1994-2#1)(2008-1#1)(2008-10#1)
prevent the onset of##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
prevent the onset##4##3##(2008-1#1)(2008-7#1)(2009-7#1)(2013-1#1)
prevent the progression of##2##4##(2008-7#1)(2010-12#1)
prevent the recurrence of##2##4##(2010-6#1)(2012-2#1)
prevent the spread of##6##4##(1993-8#1)(1997-6#2)(2007-7#1)(2008-10#1)(2010-3#1)
prevent the##87##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
prevent their##8##2##(1991-5#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
prevent these##4##2##(2008-5#2)(2008-7#1)(2013-8#1)
prevent this##6##2##(1993-11#1)(1995-6#1)(1995-8#1)(2007-8#1)(2009-10#1)(2013-1#1)
prevent trabecular bone loss##2##4##(1993-11#2)
prevent tumor##2##2##(2011-1#1)(2013-1#1)
prevent##595##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#5)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#7)(1993-12#2)(1993-2#5)(1993-3#4)(1993-8#2)(1994-1#2)(1994-10#2)(1994-12#2)(1994-2#3)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#5)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#1)(2006-10#1)(2006-6#2)(2007-10#3)(2007-11#2)(2007-12#9)(2007-2#1)(2007-7#6)(2007-8#12)(2008-1#19)(2008-10#61)(2008-11#19)(2008-12#9)(2008-2#4)(2008-3#15)(2008-4#5)(2008-5#18)(2008-6#6)(2008-7#20)(2008-8#18)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#6)(2009-2#1)(2009-3#4)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#5)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#9)(2011-2#38)(2011-3#2)(2012-1#5)(2012-12#7)(2012-2#18)(2012-3#10)(2013-1#24)(2013-7#4)(2013-8#13)
preventable cause of##2##3##(2008-1#1)(2008-8#1)
preventable causes##3##2##(1990-2#1)(1997-2#1)(2011-1#1)
preventable diseases##4##2##(1994-9#1)(2007-2#1)(2008-7#1)(2013-1#1)
preventable in##3##2##(1992-2#1)(1993-2#1)(2013-8#1)
preventable##32##1##(1990-2#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#3)
preventative measures are##2##3##(1995-9#1)(2008-7#1)
preventative measures##3##2##(1995-9#1)(2008-7#1)(2011-2#1)
preventative##17##1##(1995-9#1)(2007-12#4)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2011-1#2)(2011-2#2)(2012-2#2)
prevented (range##2##2##(2009-8#2)
prevented by GroE##2##3##(1992-3#2)
prevented by a##5##3##(1991-3#1)(1994-3#1)(1997-3#1)(2007-7#1)(2007-8#1)
prevented by the addition of##2##5##(1997-1#1)(1997-4#1)
prevented by the##8##3##(1993-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-1#1)(1997-4#1)(2008-11#1)
prevented by##65##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-3#2)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
prevented cytotoxicity##2##2##(1994-8#2)
prevented disease##2##2##(2008-10#2)
prevented from##3##2##(1995-2#1)(2008-9#1)(2012-12#1)
prevented if##2##2##(1992-4#1)(1992-8#1)
prevented in cirrhotics##2##3##(2009-8#2)
prevented in the##2##3##(1997-1#1)(2008-5#1)
prevented in##10##2##(1991-9#1)(1992-5#1)(1994-2#1)(1995-2#1)(1997-1#2)(2008-5#1)(2009-8#2)(2013-8#1)
prevented increases in the urinary excretion of protein##3##8##(1994-5#2)(1995-3#1)
prevented infection##3##2##(1996-12#1)(2008-10#2)
prevented its##2##2##(1995-12#1)(2012-12#1)
prevented or treated##2##3##(2008-12#1)(2008-9#1)
prevented or##5##2##(1996-12#1)(2008-12#1)(2008-5#2)(2008-9#1)
prevented spontaneous##2##2##(1995-5#1)(2013-1#1)
prevented the development of##2##4##(2008-1#1)(2008-10#1)
prevented the formation of##2##4##(1990-12#1)(1993-8#1)
prevented the generation of##2##4##(2008-11#2)
prevented the growth##2##3##(1991-12#1)(2008-7#1)
prevented the increase in##3##4##(1995-3#1)(1997-2#1)(2013-1#1)
prevented the increase##4##3##(1992-12#1)(1995-3#1)(1997-2#1)(2013-1#1)
prevented the inhibitory##2##3##(1994-2#1)(1994-8#1)
prevented the occurrence of##2##4##(1995-12#1)(2013-1#1)
prevented the use of##2##4##(2008-10#1)(2011-10#1)
prevented the##49##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#3)(1997-2#1)(1997-7#2)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#2)(2010-12#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
prevented these##2##2##(2008-10#1)(2009-8#1)
prevented this##3##2##(1992-3#1)(1995-2#1)(2007-12#1)
prevented with##2##2##(1994-2#1)(2008-7#1)
prevented##252##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#6)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#7)(1996-2#6)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#5)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#24)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#4)(2009-2#1)(2009-6#1)(2009-8#6)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#16)(2013-8#2)
preventer medication##3##2##(2008-3#3)
preventer##4##1##(2008-3#4)
preventing HIV##2##2##(1992-12#1)(2012-2#1)
preventing a##2##2##(1992-3#1)(2008-10#1)
preventing acute##3##2##(1990-6#1)(2008-12#1)(2008-3#1)
preventing an##2##2##(2013-1#2)
preventing and treating##5##3##(2007-10#1)(2007-11#1)(2008-5#1)(2013-1#1)(2013-7#1)
preventing and##11##2##(1994-2#1)(2007-10#1)(2007-11#1)(2008-5#3)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#2)
preventing any##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
preventing cardiovascular##3##2##(1993-2#1)(2008-8#1)(2011-2#1)
preventing harm##2##2##(2008-9#1)(2009-11#1)
preventing its##4##2##(1990-7#1)(2008-12#1)(2008-9#1)(2010-11#1)
preventing new##2##2##(1990-6#1)(2007-12#1)
preventing or delaying##2##3##(2008-10#1)(2010-6#1)
preventing or##5##2##(1993-1#1)(2008-10#2)(2010-6#1)(2013-1#1)
preventing premature##2##2##(1990-11#1)(1994-12#1)
preventing progression##3##2##(1994-8#1)(1997-3#1)(2007-7#1)
preventing the formation of##2##4##(1990-7#1)(1991-9#1)
preventing the##37##2##(1990-7#1)(1991-12#1)(1991-9#2)(1992-12#2)(1992-2#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
preventing their##3##2##(1991-9#1)(2008-10#1)(2013-1#1)
preventing##232##1##(1990-11#1)(1990-5#1)(1990-6#3)(1990-7#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-12#5)(1992-2#2)(1992-3#2)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#23)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#21)(2013-7#2)(2013-8#1)
prevention among##4##2##(1990-2#1)(2008-12#1)(2009-5#1)(2013-8#1)
prevention and adequate treatment of##2##5##(1996-12#1)(2011-2#1)
prevention and adequate##3##3##(1994-12#1)(1996-12#1)(2011-2#1)
prevention and care##3##3##(1997-3#1)(2008-4#1)(2012-1#1)
prevention and control in##2##4##(2010-5#1)(2011-1#1)
prevention and control measures##2##4##(1996-1#1)(2008-10#1)
prevention and control of##13##4##(1991-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#2)(2011-2#3)(2012-3#1)(2013-8#2)
prevention and control##30##3##(1991-5#1)(1996-1#1)(1996-2#1)(1997-1#4)(2007-12#1)(2008-1#2)(2008-10#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-8#3)
prevention and early treatment##2##4##(2007-11#1)(2010-11#1)
prevention and early##4##3##(1993-2#1)(2007-11#1)(2007-7#1)(2010-11#1)
prevention and health##2##3##(1995-3#1)(1996-3#1)
prevention and intervention##7##3##(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#2)
prevention and management##7##3##(1990-2#1)(1995-12#1)(2007-7#1)(2008-7#2)(2011-1#2)
prevention and proper management of OP poisoning##2##7##(2013-1#2)
prevention and rehabilitation for patients with##2##6##(2012-3#2)
prevention and the##3##3##(1993-11#1)(2007-8#1)(2009-6#1)
prevention and therapy of##5##4##(1990-5#1)(1991-9#1)(1997-2#1)(2008-7#1)(2009-9#1)
prevention and therapy##8##3##(1990-5#1)(1991-12#1)(1991-9#1)(1997-2#1)(2007-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
prevention and transmission##3##3##(2011-2#1)(2012-12#2)
prevention and treatment of osteoporosis##7##5##(1993-11#4)(1997-6#2)(2008-7#1)
prevention and treatment of various##2##5##(1997-2#1)(2013-7#1)
prevention and treatment of##35##4##(1993-11#4)(1997-2#1)(1997-6#2)(1997-8#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#4)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
prevention and treatment##59##3##(1990-12#1)(1992-5#1)(1993-11#5)(1995-1#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#2)(2007-11#3)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
prevention and##168##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-11#7)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-7#5)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#13)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#6)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#6)
prevention approaches##2##2##(2009-4#1)(2012-2#1)
prevention are##6##2##(1996-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2012-2#2)
prevention as well as treatment of##2##6##(2008-12#1)(2010-12#1)
prevention awareness##2##2##(1995-2#1)(2009-6#1)
prevention behavior##2##2##(2008-1#2)
prevention by##4##2##(1990-11#1)(1991-9#1)(2008-5#1)(2010-6#1)
prevention campaign##3##2##(1990-3#1)(2008-1#1)(2008-9#1)
prevention concentrations##2##2##(2011-2#2)
prevention education##6##2##(2008-10#2)(2009-5#3)(2010-7#1)
prevention efforts and##2##3##(2008-8#1)(2012-2#1)
prevention efforts##10##2##(1996-9#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-2#2)
prevention for##2##2##(1992-5#1)(2013-8#1)
prevention have been##2##3##(1994-2#1)(2008-3#1)
prevention have##4##2##(1994-2#1)(2007-9#1)(2008-3#1)(2011-2#1)
prevention in##19##2##(1990-6#1)(1991-1#1)(1993-12#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-5#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
prevention initiative##3##2##(1995-12#1)(1995-3#1)(2008-7#1)
prevention initiatives##3##2##(1995-12#1)(1995-3#1)(2009-5#1)
prevention interventions##3##2##(2008-12#1)(2008-4#1)(2010-10#1)
prevention is better than cure##2##5##(2008-3#1)(2013-7#1)
prevention is##12##2##(1993-6#1)(1994-8#1)(1996-6#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#3)(2013-7#1)
prevention knowledge##2##2##(2007-7#1)(2012-12#1)
prevention measures##7##2##(2007-12#2)(2011-2#4)(2013-1#1)
prevention of AMD##2##3##(2011-2#2)
prevention of CVD##2##3##(2009-4#1)(2011-1#1)
prevention of TB##4##3##(2007-2#1)(2009-4#1)(2010-5#1)(2013-1#1)
prevention of cancer##3##3##(2009-4#2)(2011-2#1)
prevention of cardiac##3##3##(2008-8#1)(2010-8#1)(2013-8#1)
prevention of cardiovascular disease (CVD)##2##5##(2011-1#1)(2013-1#1)
prevention of cardiovascular disease##5##4##(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
prevention of cardiovascular diseases##2##4##(1990-2#1)(2008-7#1)
prevention of cardiovascular events##2##4##(2008-10#1)(2010-1#1)
prevention of cardiovascular##9##3##(1990-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#2)
prevention of cervical cancer##5##4##(2008-11#1)(2010-8#1)(2011-1#3)
prevention of chronic##2##3##(1991-3#1)(1997-2#1)
prevention of coronary heart disease in##2##6##(1995-11#1)(1996-8#1)
prevention of coronary heart disease##4##5##(1991-6#1)(1995-11#1)(1996-8#1)(2010-6#1)
prevention of coronary##5##3##(1991-6#1)(1995-11#1)(1996-8#1)(2010-2#1)(2010-6#1)
prevention of dental caries##3##4##(2008-7#2)(2013-7#1)
prevention of dental##4##3##(2008-5#1)(2008-7#2)(2013-7#1)
prevention of depression##3##3##(2008-12#1)(2011-2#2)
prevention of diabetes##2##3##(2008-1#1)(2010-4#1)
prevention of disease##3##3##(1991-11#1)(2008-1#1)(2008-9#1)
prevention of falls##2##3##(1993-11#1)(2007-11#1)
prevention of heterotopic ossification##3##4##(1994-8#2)(2007-11#1)
prevention of hip fractures##2##4##(1993-11#2)
prevention of infection of##2##4##(2008-10#1)(2009-6#1)
prevention of infection##4##3##(1991-2#1)(2008-10#1)(2009-6#1)(2011-2#1)
prevention of influenza##2##3##(2008-5#1)(2011-2#1)
prevention of its##3##3##(1990-12#1)(2008-8#1)(2012-2#1)
prevention of mother-to-child transmission of HIV##5##6##(2009-4#3)(2009-7#1)(2012-2#1)
prevention of mother-to-child transmission of##6##5##(2009-4#4)(2009-7#1)(2012-2#1)
prevention of mother-to-child transmission##8##4##(2009-4#6)(2009-7#1)(2012-2#1)
prevention of obesity##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
prevention of postoperative##4##3##(2007-12#1)(2010-7#1)(2012-3#2)
prevention of recurrence##2##3##(2009-7#1)(2010-12#1)
prevention of recurrences##4##3##(1996-12#1)(2007-7#1)(2008-1#1)(2008-7#1)
prevention of restenosis##2##3##(1995-8#1)(2008-12#1)
prevention of sexually##2##3##(1996-8#1)(2013-8#1)
prevention of stroke##6##3##(1991-11#1)(1995-5#1)(2007-10#3)(2012-12#1)
prevention of the##8##3##(1991-9#1)(1993-11#1)(1996-3#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
prevention of these##2##3##(1995-3#1)(2008-7#1)
prevention of this disease##2##4##(1996-6#1)(2009-5#1)
prevention of this##6##3##(1990-3#1)(1995-5#1)(1996-6#1)(2007-10#1)(2007-4#1)(2009-5#1)
prevention of thromboembolism in##2##4##(2007-8#2)
prevention of thromboembolism##4##3##(2007-8#4)
prevention of transmission##3##3##(1993-3#1)(2008-10#1)(2010-5#1)
prevention of venous##3##3##(1994-9#1)(2007-10#1)(2010-11#1)
prevention of##297##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-5#1)(1992-9#2)(1993-11#9)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#4)(2006-10#1)(2007-10#10)(2007-11#9)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#10)(2008-1#8)(2008-10#12)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#10)(2008-7#14)(2008-8#2)(2008-9#1)(2009-10#3)(2009-3#2)(2009-4#13)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#9)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#3)
prevention or treatment of##3##4##(2007-5#1)(2008-7#1)(2010-2#1)
prevention or##6##2##(1991-2#1)(1991-9#1)(1997-1#1)(2007-5#1)(2008-7#1)(2010-2#1)
prevention policy##2##2##(1995-3#1)(2008-11#1)
prevention program for##3##3##(1995-3#1)(2008-1#1)(2008-12#1)
prevention program on##3##3##(1990-3#1)(2010-7#2)
prevention program##15##2##(1990-3#2)(1991-1#2)(1992-2#1)(1993-2#1)(1994-2#1)(1995-3#2)(2008-1#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-7#2)
prevention programme in##2##3##(2008-7#1)(2013-8#1)
prevention programme##4##2##(1991-6#2)(2008-7#1)(2013-8#1)
prevention programmes##3##2##(2007-7#1)(2008-10#1)(2009-7#1)
prevention programs and##2##3##(1993-3#1)(2009-9#1)
prevention programs are##2##3##(1997-2#1)(2013-1#1)
prevention programs for##3##3##(1995-12#1)(2008-11#1)(2013-1#1)
prevention programs may##2##3##(2008-12#1)(2012-12#1)
prevention programs that##3##3##(1997-1#1)(2009-6#1)(2009-7#1)
prevention programs##33##2##(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-11#2)(2008-12#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#5)
prevention project##3##2##(1995-3#3)
prevention remains##2##2##(2007-7#1)(2013-7#1)
prevention services##3##2##(2008-6#1)(2009-5#1)(2012-12#1)
prevention should be##2##3##(1993-6#1)(1997-8#1)
prevention should##3##2##(1993-6#1)(1997-8#1)(2010-10#1)
prevention strategies for##4##3##(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)
prevention strategies##18##2##(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2009-5#3)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
prevention strategy##6##2##(1995-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-1#2)
prevention study##3##2##(1997-3#1)(2008-4#2)
prevention to##4##2##(1993-12#1)(1997-4#1)(2011-1#1)(2011-2#1)
prevention trial##2##2##(1997-8#1)(2009-7#1)
prevention trials##5##2##(1993-2#1)(1994-9#2)(2008-8#1)(2013-1#1)
prevention were##2##2##(2007-8#1)(2010-1#1)
prevention with##7##2##(1991-9#1)(1993-10#1)(1993-2#1)(1995-12#1)(2008-8#1)(2009-5#1)(2012-12#1)
prevention##906##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#6)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#4)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#3)(1991-5#2)(1991-6#6)(1991-9#5)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#18)(1993-12#2)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#6)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-8#4)(1994-9#6)(1995-1#5)(1995-11#2)(1995-12#13)(1995-2#3)(1995-3#17)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#5)(1996-3#8)(1996-4#3)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#9)(1997-2#13)(1997-3#6)(1997-4#4)(1997-5#3)(1997-6#3)(1997-8#7)(2006-10#3)(2006-7#1)(2007-10#12)(2007-11#17)(2007-12#18)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#16)(2007-8#14)(2007-9#1)(2008-1#17)(2008-10#27)(2008-11#29)(2008-12#18)(2008-2#3)(2008-3#15)(2008-4#9)(2008-5#18)(2008-6#6)(2008-7#36)(2008-8#17)(2008-9#10)(2009-10#5)(2009-11#3)(2009-12#3)(2009-3#3)(2009-4#21)(2009-5#23)(2009-6#7)(2009-7#11)(2009-8#5)(2009-9#3)(2010-1#6)(2010-10#5)(2010-11#6)(2010-12#14)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#6)(2010-6#6)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#21)(2011-2#57)(2011-3#4)(2012-1#4)(2012-12#29)(2012-2#19)(2012-3#13)(2013-1#29)(2013-7#5)(2013-8#14)
prevention)##2##1##(2008-7#1)(2010-6#1)
prevention?]##2##1##(1990-6#1)(2011-2#1)
prevention]##6##1##(1992-11#1)(1994-5#1)(1996-6#1)(1997-8#1)(2008-2#1)(2009-5#1)
preventive and control measures##2##4##(2011-2#1)(2012-12#1)
preventive and educational interventions##3##4##(2012-2#3)
preventive and primary care for children with chronic##2##8##(1997-2#2)
preventive and therapeutic##6##3##(1990-6#1)(2008-11#3)(2009-3#1)(2011-2#1)
preventive and##20##2##(1990-6#1)(1990-9#1)(1994-11#1)(1996-2#1)(1997-2#2)(2007-12#2)(2008-11#3)(2009-3#1)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#3)
preventive applications##2##2##(2008-10#1)(2008-5#1)
preventive care and##2##3##(1994-2#1)(1996-1#1)
preventive care as##3##3##(1996-3#1)(2013-1#2)
preventive care for##2##3##(2010-9#1)(2011-2#1)
preventive care##23##2##(1994-12#1)(1994-2#5)(1994-3#1)(1994-8#1)(1996-1#2)(1996-12#1)(1996-3#1)(2007-7#1)(2008-11#2)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
preventive effect of black tea##2##5##(2009-8#2)
preventive effect of##7##3##(1992-10#1)(2008-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2013-8#1)
preventive effect##11##2##(1992-10#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2013-8#1)
preventive efforts##2##2##(1996-6#1)(2011-1#1)
preventive health care##11##3##(1995-2#1)(2008-11#2)(2008-4#2)(2009-5#1)(2010-8#5)
preventive health services##2##3##(1993-12#1)(1995-12#1)
preventive health##17##2##(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-11#2)(2008-4#3)(2009-5#2)(2010-8#5)
preventive in##2##2##(1992-5#1)(2008-11#1)
preventive ingredients##2##2##(2008-5#2)
preventive intervention##3##2##(2008-1#1)(2008-12#2)
preventive interventions##3##2##(1992-3#1)(2008-5#1)(2011-1#1)
preventive management##2##2##(2008-10#1)(2008-9#1)
preventive measures and##2##3##(1993-9#1)(2010-1#1)
preventive measures in##2##3##(1992-9#1)(2008-8#1)
preventive measures to be##2##4##(1995-3#1)(2011-1#1)
preventive measures to##4##3##(1995-3#1)(2011-1#2)(2013-8#1)
preventive measures##31##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-9#1)(1993-9#1)(1995-3#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
preventive medication was##2##3##(2008-11#2)
preventive medication##3##2##(2008-11#3)
preventive medications##4##2##(2008-10#1)(2008-11#2)(2010-9#1)
preventive medicine##2##2##(1995-6#1)(2008-3#1)
preventive or##2##2##(2008-8#1)(2011-2#1)
preventive services for##2##3##(1995-2#1)(2008-1#1)
preventive services to##2##3##(1995-12#2)
preventive services##21##2##(1994-2#8)(1995-12#4)(1995-2#2)(1996-12#1)(1996-2#1)(2008-1#3)(2009-5#1)(2010-8#1)
preventive strategies##11##2##(1993-11#2)(1996-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
preventive therapy of##2##3##(1990-3#1)(1995-11#1)
preventive therapy##10##2##(1990-3#1)(1995-11#1)(1996-3#1)(1997-2#4)(2007-2#2)(2011-1#1)
preventive treatment##7##2##(1990-6#1)(1994-5#1)(1997-2#1)(2008-8#1)(2011-2#2)(2012-3#1)
preventive##242##1##(1990-12#1)(1990-3#1)(1990-6#5)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#15)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#5)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#3)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#4)(2007-7#1)(2008-1#4)(2008-10#11)(2008-11#16)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#3)(2010-12#2)(2010-6#1)(2010-8#7)(2010-9#2)(2011-1#6)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#4)
prevents an##2##2##(1994-8#1)(2008-10#1)
prevents development of##4##3##(1993-12#1)(2007-11#1)(2008-12#1)(2008-7#1)
prevents oxidation of##2##3##(1991-5#1)(1991-9#1)
prevents pregnancy##3##2##(1994-8#1)(1996-9#2)
prevents the degeneration of##2##4##(1990-5#2)
prevents the formation of##3##4##(1994-8#1)(1995-5#1)(1997-7#1)
prevents the use of##2##4##(1994-5#1)(2007-5#1)
prevents the##40##2##(1990-11#1)(1990-5#3)(1991-12#2)(1991-2#1)(1991-5#1)(1992-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#2)(2007-11#3)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-6#1)(2011-10#1)(2012-2#1)(2013-1#1)
prevents this##2##2##(1991-9#1)(1995-6#1)
prevents transformation##2##2##(2008-10#1)(2008-11#1)
prevents tumor##2##2##(2013-1#2)
prevents##133##1##(1990-11#3)(1990-12#2)(1990-5#3)(1990-7#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-9#2)(1992-3#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#6)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#6)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2009-8#3)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#2)
preverbal child##2##2##(2008-9#2)
preverbal children##3##2##(2008-9#3)
preverbal##5##1##(2008-9#5)
preview##3##1##(1992-2#1)(2011-1#2)
previous &quot##2##2##(2008-6#1)(2008-8#1)
previous Caesarean##2##2##(1991-9#1)(2011-1#1)
previous adenovirus (pre-Ad)##2##3##(2008-9#2)
previous aggressive##2##2##(1992-10#1)(2008-8#1)
previous analyses of##2##3##(2008-9#1)(2010-3#1)
previous analyses##6##2##(1995-2#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)
previous analysis##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
previous and##2##2##(2007-11#1)(2008-10#1)
previous approaches to##2##3##(2008-6#1)(2013-1#1)
previous approaches##4##2##(2008-6#1)(2009-7#1)(2011-3#1)(2013-1#1)
previous article##3##2##(1992-3#1)(1996-12#1)(2008-11#1)
previous cardiac##2##2##(2007-8#1)(2013-8#1)
previous case##4##2##(2008-6#1)(2009-1#1)(2012-2#1)(2013-8#1)
previous cases##2##2##(1996-12#1)(2008-10#1)
previous chemotherapy##4##2##(1991-2#1)(1992-10#1)(2007-10#1)(2008-6#1)
previous clinical##2##2##(2008-6#1)(2009-10#1)
previous comparisons##2##2##(1994-9#1)(2011-2#1)
previous contact with##2##3##(1996-9#2)
previous data on##2##3##(2008-10#1)(2009-8#1)
previous data##8##2##(2008-10#3)(2008-2#2)(2008-5#1)(2009-8#1)(2010-11#1)
previous decade##4##2##(2008-11#1)(2008-5#1)(2013-1#2)
previous derivatization##2##2##(2008-10#2)
previous designs##3##2##(2008-2#2)(2008-3#1)
previous diagnosis of##4##3##(2007-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
previous educational and##2##3##(2008-11#1)(2011-2#1)
previous educational##3##2##(2008-11#2)(2011-2#1)
previous electrophysiological##2##2##(1993-12#1)(1997-7#1)
previous established##2##2##(2011-2#1)(2013-7#1)
previous estimates##6##2##(1993-3#1)(1996-12#1)(2008-10#3)(2008-9#1)
previous evaluation##2##2##(1995-1#2)
previous experience with##2##3##(2008-12#1)(2008-7#1)
previous experience##5##2##(1996-2#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-1#1)
previous experimental observations of##2##4##(2008-3#2)
previous experimental observations##3##3##(2008-3#2)(2009-9#1)
previous experimental##5##2##(2008-3#2)(2008-7#1)(2009-9#1)(2013-1#1)
previous experiments##5##2##(1994-5#1)(1995-12#1)(2008-10#2)(2008-7#1)
previous exposure to##5##3##(1992-10#1)(1992-7#1)(1995-2#1)(1997-3#1)(2009-8#1)
previous exposure##6##2##(1992-10#1)(1992-7#1)(1995-2#1)(1996-12#1)(1997-3#1)(2009-8#1)
previous extraction##5##2##(1990-12#1)(2007-12#1)(2008-10#3)
previous field##3##2##(2008-10#1)(2008-9#1)(2011-10#1)
previous finding##4##2##(1990-8#1)(1993-8#1)(1996-12#1)(2008-9#1)
previous findings for##2##3##(1994-8#1)(1996-5#1)
previous findings in##3##3##(1993-5#1)(1995-12#1)(2008-7#1)
previous findings of##4##3##(2008-10#2)(2008-6#1)(2009-5#1)
previous findings on the##2##4##(1994-8#1)(2009-10#1)
previous findings that##6##3##(1994-2#1)(1994-5#1)(1996-12#1)(1996-5#1)(2008-7#1)(2008-8#1)
previous findings##38##2##(1993-1#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#1)(1996-12#1)(1996-5#4)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
previous generation##2##2##(2010-6#1)(2011-2#1)
previous generations##2##2##(2008-9#1)(2013-8#1)
previous history of##12##3##(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
previous history or##2##3##(2007-12#1)(2013-1#1)
previous history##15##2##(1992-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
previous hospitalization##4##2##(1992-2#1)(1995-1#1)(2010-10#1)(2013-8#1)
previous hospitalizations##3##2##(1991-2#2)(1992-2#1)
previous investigations##8##2##(1990-8#1)(1993-11#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#2)
previous knowledge##2##2##(2008-11#1)(2012-12#1)
previous learning##2##2##(2008-11#1)(2008-5#1)
previous literature##4##2##(2008-11#1)(2008-6#1)(2011-2#1)(2013-2#1)
previous management##2##2##(2007-12#1)(2008-10#1)
previous measurements of##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
previous measurements##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
previous medication##2##2##(1993-2#1)(2008-3#1)
previous method of##2##3##(1995-2#1)(2008-3#1)
previous method##4##2##(1995-2#1)(1996-5#1)(2008-11#1)(2008-3#1)
previous methods##4##2##(1990-8#1)(2008-10#2)(2008-2#1)
previous models of##2##3##(2008-8#1)(2008-9#1)
previous models##8##2##(1997-7#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2013-1#2)
previous myocardial infarction##4##3##(1990-11#1)(2007-8#1)(2008-11#1)(2010-11#1)
previous observation##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
previous observations and##2##3##(1995-12#1)(2008-5#1)
previous observations that##5##3##(1991-12#1)(1993-12#1)(1995-2#1)(2008-10#1)(2010-8#1)
previous observations##13##2##(1991-12#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
previous ones##2##2##(1990-7#1)(2008-10#1)
previous paper##10##2##(1991-12#1)(1994-5#1)(2008-10#4)(2008-2#3)(2008-3#1)
previous papers we##2##3##(1994-6#1)(2008-2#1)
previous papers##5##2##(1994-6#1)(2008-10#1)(2008-2#2)(2008-3#1)
previous pelvic surgery##2##3##(2011-2#2)
previous pelvic##3##2##(1990-6#1)(2011-2#2)
previous percutaneous transluminal coronary angioplasty##2##5##(2007-8#1)(2008-7#1)
previous period##2##2##(1990-8#1)(1996-11#1)
previous preconcentration##3##2##(2008-10#3)
previous pregnancy##2##2##(1992-12#1)(2011-1#1)
previous procedures##2##2##(2008-8#1)(2009-9#1)
previous publication##2##2##(2007-11#1)(2008-5#1)
previous published##2##2##(2008-10#2)
previous report of this##2##4##(1996-9#1)(2012-12#1)
previous report of##4##3##(1996-9#1)(2008-6#1)(2008-7#1)(2012-12#1)
previous report##17##2##(1990-4#1)(1990-5#1)(1990-7#1)(1994-8#1)(1995-2#2)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2012-12#2)(2012-3#1)(2013-1#1)
previous reports have##2##3##(1991-3#1)(2011-2#1)
previous reports of##7##3##(1991-8#1)(1994-3#1)(1995-12#1)(1997-5#1)(2008-10#2)(2008-8#1)
previous reports on the##2##4##(1991-9#1)(2008-10#1)
previous reports on##4##3##(1991-9#1)(1992-2#1)(1993-6#1)(2008-10#1)
previous reports that##2##3##(1994-8#1)(2008-10#1)
previous reports##32##2##(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#2)(1997-5#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
previous research by demonstrating that##2##5##(2009-4#1)(2009-7#1)
previous research examining##2##3##(1996-2#1)(2013-1#1)
previous research has##2##3##(1991-3#1)(2007-12#1)
previous research in##3##3##(1996-11#1)(2008-12#1)(2013-8#1)
previous research of##2##3##(1994-3#1)(2008-2#1)
previous research on##2##3##(1993-11#1)(2012-2#1)
previous research that##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
previous research##31##2##(1991-3#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
previous results for##2##3##(1991-8#1)(2007-11#1)
previous results##18##2##(1990-8#1)(1991-8#1)(1995-11#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
previous reviews##2##2##(2012-12#1)(2012-3#1)
previous sample##3##2##(2008-10#3)
previous separation##7##2##(2008-10#7)
previous separations##3##2##(2008-10#3)
previous spectroscopic and##2##3##(1991-8#1)(2008-5#1)
previous spectroscopic##3##2##(1991-8#1)(1992-3#1)(2008-5#1)
previous step##3##2##(1992-3#1)(1995-3#1)(2008-10#1)
previous strategies##2##2##(2008-3#1)(2008-4#1)
previous stroke##2##2##(2007-10#1)(2009-4#1)
previous studies and##4##3##(1994-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
previous studies by##2##3##(1994-12#1)(2008-3#1)
previous studies have reported##2##4##(2008-11#1)(2008-3#1)
previous studies have shown that##2##5##(1995-8#1)(2013-1#1)
previous studies have shown##3##4##(1992-9#1)(1995-8#1)(2013-1#1)
previous studies have##16##3##(1992-8#1)(1992-9#1)(1994-5#1)(1995-12#1)(1995-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#2)(2009-9#1)(2010-5#1)(2010-8#2)(2013-1#1)
previous studies in##5##3##(1997-7#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-1#1)
previous studies indicating that##2##4##(1994-5#1)(1995-6#1)
previous studies of##8##3##(1997-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
previous studies on the##5##4##(1994-12#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-9#1)
previous studies on##8##3##(1994-12#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-6#1)
previous studies that##3##3##(2008-10#1)(2008-8#1)(2010-11#1)
previous studies using##2##3##(1994-3#1)(1995-11#1)
previous studies with##4##3##(1993-12#1)(2008-10#1)(2008-4#1)(2009-8#1)
previous studies##117##2##(1990-12#1)(1991-11#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-12#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
previous study of##3##3##(1992-6#1)(2008-10#2)
previous study on##2##3##(1990-2#1)(1991-2#1)
previous study to##2##3##(2008-10#1)(2010-8#1)
previous study with##3##3##(1991-2#1)(1993-12#1)(1994-5#1)
previous study##48##2##(1990-2#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-6#1)(1993-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1997-2#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
previous study)##3##2##(2008-10#1)(2008-9#2)
previous successful PTCA##2##3##(2007-8#2)
previous successful##3##2##(2007-8#3)
previous surgery##2##2##(2010-6#1)(2013-1#1)
previous surgical##2##2##(1994-5#1)(2012-2#1)
previous survey##2##2##(2008-10#1)(2013-1#1)
previous system##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
previous techniques##2##2##(2008-3#2)
previous theoretical##6##2##(2008-11#1)(2008-3#3)(2008-9#1)(2010-2#1)
previous theory##3##2##(2008-3#1)(2008-8#2)
previous thoracic##2##2##(2007-12#1)(2012-2#1)
previous to the##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
previous to##5##2##(1991-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-4#1)
previous transfection##2##2##(1996-5#1)(2008-11#1)
previous trauma##2##2##(1992-2#1)(2011-2#1)
previous treatment declined from##2##4##(2013-8#2)
previous treatment of the##2##4##(2008-10#2)
previous treatment of##4##3##(2008-10#2)(2010-10#2)
previous treatment with##2##3##(1992-2#1)(2007-8#1)
previous treatment##18##2##(1992-2#1)(1992-3#1)(1992-8#1)(2007-8#1)(2008-10#5)(2008-7#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
previous treatments##4##2##(1993-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
previous trials##7##2##(1996-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-1#1)(2013-8#1)
previous work and##2##3##(2008-10#1)(2008-12#1)
previous work has##3##3##(1993-6#1)(2008-7#1)(2011-2#1)
previous work in##4##3##(2009-2#1)(2010-5#1)(2010-8#1)(2013-8#1)
previous work on##6##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)
previous work that##2##3##(2008-10#2)
previous work to##2##3##(1992-10#1)(2008-10#1)
previous work##42##2##(1992-10#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
previous works##7##2##(2007-11#3)(2008-10#1)(2010-8#1)(2011-1#1)(2013-7#1)
previous year's##3##2##(2008-10#2)(2011-2#1)
previous years##6##2##(1990-12#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
previous##1090##1##(1990-11#4)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#5)(1991-11#1)(1991-12#6)(1991-2#8)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#6)(1992-10#6)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#9)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#10)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#8)(1994-2#8)(1994-3#9)(1994-5#8)(1994-6#2)(1994-8#8)(1994-9#4)(1995-1#4)(1995-11#3)(1995-12#10)(1995-2#7)(1995-3#5)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#12)(1996-2#5)(1996-3#6)(1996-5#10)(1996-6#2)(1996-7#3)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#2)(2006-10#4)(2007-10#4)(2007-11#9)(2007-12#19)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#12)(2008-1#12)(2008-10#162)(2008-11#40)(2008-12#21)(2008-2#30)(2008-3#46)(2008-4#7)(2008-5#20)(2008-6#21)(2008-7#39)(2008-8#38)(2008-9#37)(2009-1#2)(2009-10#7)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#5)(2009-9#8)(2010-10#7)(2010-11#7)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#16)(2010-9#3)(2011-1#21)(2011-10#1)(2011-2#50)(2011-3#4)(2012-1#6)(2012-12#18)(2012-2#17)(2012-3#15)(2012-7#1)(2013-1#30)(2013-2#1)(2013-7#3)(2013-8#18)
previously acidified##2##2##(2008-10#2)
previously acquired##2##2##(2008-11#1)(2009-6#1)
previously amplified##2##2##(2008-10#1)(2011-2#1)
previously and##8##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#2)(2013-8#1)
previously are reviewed##2##3##(2007-2#1)(2008-10#1)
previously as a##2##3##(1992-12#1)(2008-7#1)
previously as##6##2##(1990-7#1)(1992-12#1)(1995-8#1)(2008-5#1)(2008-7#1)(2008-8#1)
previously ascribed to##2##3##(2008-10#1)(2011-1#1)
previously assigned ORFs##2##3##(1995-12#2)
previously assigned##5##2##(1995-12#4)(1995-6#1)
previously associated with##2##3##(2008-10#1)(2009-8#1)
previously attributed to##2##3##(2007-12#1)(2008-4#1)
previously baited hole##2##3##(1992-8#2)
previously been demonstrated##2##3##(1993-1#1)(1997-2#1)
previously been described in##3##4##(1992-6#1)(2008-10#1)(2009-3#1)
previously been described##7##3##(1990-6#1)(1992-10#1)(1992-6#1)(2008-10#2)(2008-12#1)(2009-3#1)
previously been found##3##3##(2008-5#1)(2008-8#1)(2012-12#1)
previously been implicated in##2##4##(1993-12#1)(1994-5#1)
previously been reported##12##3##(1990-7#1)(1992-5#1)(1993-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-8#1)(2013-8#1)
previously been shown to be##5##5##(1993-12#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-8#1)
previously been shown to##18##4##(1990-12#1)(1990-5#1)(1990-7#1)(1993-12#2)(1993-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
previously been shown##21##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-12#2)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#3)
previously been used##5##3##(1990-8#1)(2008-10#2)(2008-4#1)(2008-6#1)
previously been##93##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#1)(2012-8#2)(2013-1#4)(2013-8#2)
previously bound##2##2##(1992-12#1)(1995-5#1)
previously by##10##2##(1991-12#1)(1991-2#1)(1993-12#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-3#1)(2009-4#1)
previously called##2##2##(1993-12#1)(2008-10#1)
previously characterized in##2##3##(1997-3#1)(2008-10#1)
previously characterized##20##2##(1990-5#1)(1991-9#1)(1994-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-7#1)(2013-1#1)
previously checked for the absence of##3##6##(2008-10#3)
previously cloned##5##2##(1991-9#1)(1992-3#1)(1993-6#1)(1995-11#1)(2008-6#1)
previously collected##3##2##(2008-10#2)(2010-6#1)
previously considered to be##2##4##(1990-11#1)(2008-10#1)
previously considered##8##2##(1990-11#1)(1992-6#1)(1997-3#1)(2008-10#3)(2008-8#1)(2011-1#1)
previously constructed##4##2##(1995-6#1)(1996-12#1)(2008-10#1)(2008-7#1)
previously defined##5##2##(1990-11#1)(1993-6#1)(1995-2#1)(2008-10#2)
previously demonstrated a##2##3##(2010-6#1)(2013-1#1)
previously demonstrated that the##5##4##(1992-12#1)(1993-6#1)(1994-11#1)(2008-11#1)(2008-8#1)
previously demonstrated that##18##3##(1990-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
previously demonstrated the##2##3##(1993-11#1)(2009-3#1)
previously demonstrated to##2##3##(1993-9#1)(2008-8#1)
previously demonstrated##32##2##(1990-12#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-2#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
previously derived##6##2##(1996-5#1)(2007-12#2)(2008-10#2)(2008-3#1)
previously described EC-2##3##3##(2008-10#3)
previously described and##2##3##(1994-2#1)(2008-10#1)
previously described as a##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
previously described as##5##3##(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)
previously described for the##2##4##(1991-9#1)(2008-10#1)
previously described for##7##3##(1991-9#1)(2007-12#1)(2008-10#3)(2010-6#1)(2011-1#1)
previously described genes##2##3##(1995-9#1)(1996-3#1)
previously described in##7##3##(1991-5#1)(1991-6#1)(1992-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
previously described methods##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
previously described##103##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#35)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
previously designated##3##2##(1991-8#1)(1991-9#1)(2008-10#1)
previously designed##2##2##(2008-5#1)(2008-7#1)
previously detected##4##2##(1997-2#1)(2008-10#3)
previously determined by##2##3##(2007-12#1)(2008-10#1)
previously determined##11##2##(1991-11#1)(1993-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-8#2)
previously developed for##4##3##(2008-10#3)(2008-3#1)
previously developed##21##2##(1990-8#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2009-11#2)(2012-12#1)(2012-2#1)
previously diagnosed with##2##3##(2011-2#1)(2013-8#1)
previously diagnosed##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
previously discussed##2##2##(2008-10#1)(2011-2#1)
previously diseased plants##2##3##(2008-10#2)
previously documented##5##2##(1994-11#1)(1995-2#1)(2008-2#1)(2008-3#1)(2012-2#1)
previously dominant##3##2##(2008-10#2)(2008-8#1)
previously established##10##2##(1991-6#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)
previously estimated##3##2##(1996-5#1)(1996-8#1)(2008-8#1)
previously examined##5##2##(1991-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
previously existing##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
previously expressed##2##2##(2008-8#1)(2011-2#1)
previously for the##3##3##(1992-3#1)(2007-12#1)(2008-10#1)
previously for##13##2##(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
previously found in the##2##4##(1993-3#1)(1994-11#1)
previously found in##7##3##(1991-12#1)(1993-3#1)(1994-11#2)(2008-10#1)(2010-2#1)(2012-2#1)
previously found that##2##3##(1995-11#1)(2012-2#1)
previously found to be associated with##2##6##(2008-10#1)(2013-1#1)
previously found to be##7##4##(1994-11#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
previously found##19##2##(1991-12#1)(1993-3#1)(1993-6#1)(1994-11#3)(1995-11#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#2)(2013-1#1)
previously frozen##2##2##(2010-4#2)
previously generated##3##2##(1995-6#1)(2011-1#1)(2011-2#1)
previously had##2##2##(1992-8#1)(2008-10#1)
previously has not been##2##4##(1992-11#1)(2008-10#1)
previously has##3##2##(1992-11#1)(2008-10#2)
previously have##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
previously having##2##2##(1996-12#1)(2007-12#1)
previously healthy##10##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#2)(2009-8#3)(2011-2#2)
previously heated##2##2##(2008-10#2)
previously hypothesized##2##2##(1993-3#1)(2008-4#1)
previously identified an##2##3##(1995-2#1)(2010-11#1)
previously identified as the##2##4##(2008-10#1)(2008-4#1)
previously identified as##7##3##(1991-8#1)(1992-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-3#1)
previously identified by##3##3##(1994-12#1)(1995-2#1)(2010-3#1)
previously identified genes##3##3##(1996-3#1)(1997-8#1)(2008-10#1)
previously identified in rat##2##4##(1990-12#1)(1991-11#1)
previously identified in##8##3##(1990-12#1)(1991-11#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#1)
previously identified resistance##2##3##(2008-10#1)(2008-9#1)
previously identified##55##2##(1990-12#1)(1991-11#1)(1991-8#1)(1992-8#2)(1992-9#2)(1993-6#3)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#12)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-3#2)(2011-2#1)(2012-2#2)(2012-3#2)
previously immunized with##2##3##(1995-5#2)
previously implanted##5##2##(1993-12#1)(2007-7#1)(2008-10#2)(2009-12#1)
previously implicated in the##3##4##(1991-9#1)(2008-10#1)(2008-11#1)
previously implicated in##8##3##(1991-9#1)(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)
previously implicated##9##2##(1991-9#1)(1993-12#1)(1995-2#1)(1995-6#1)(1997-5#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)
previously in a##2##3##(2007-12#1)(2008-9#1)
previously in the literature##2##4##(2007-11#1)(2008-3#1)
previously in the##5##3##(1992-12#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-3#1)
previously in##21##2##(1992-12#1)(1993-3#1)(1993-9#1)(1995-12#2)(1995-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-3#1)(2008-9#1)(2011-1#1)
previously incorporated##2##2##(1995-3#1)(2008-5#1)
previously infected with##2##3##(2008-10#1)(2011-2#1)
previously infected##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
previously inoculated with highly virulent infectious bursal disease virus##2##9##(2008-5#2)
previously interpreted as##2##3##(2008-7#1)(2008-8#1)
previously investigated##2##2##(2008-8#1)(2009-8#1)
previously isolated from rat##2##4##(1991-12#1)(1993-8#1)
previously isolated from the##2##4##(2008-5#1)(2011-2#1)
previously isolated from##9##3##(1991-12#2)(1992-8#1)(1993-8#1)(1994-5#2)(2008-10#1)(2008-5#1)(2011-2#1)
previously isolated##19##2##(1990-12#1)(1991-12#3)(1992-12#1)(1992-8#1)(1993-8#1)(1994-5#2)(1995-2#1)(1996-10#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
previously known as##2##3##(2008-7#1)(2012-2#1)
previously known genes##2##3##(1996-6#1)(1997-3#1)
previously known only##2##3##(2007-11#1)(2008-10#1)
previously known to##3##3##(1993-12#1)(1994-11#1)(2008-10#1)
previously known##21##2##(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
previously learned##4##2##(1993-5#1)(1994-8#2)(2007-8#1)
previously mapped##7##2##(1993-12#1)(1994-12#1)(2008-10#3)(2012-3#2)
previously non-endemic##2##2##(2007-7#1)(2008-8#1)
previously not been##2##3##(1993-2#1)(2009-6#1)
previously not##3##2##(1993-2#1)(2009-6#1)(2010-10#1)
previously noted##2##2##(1994-3#1)(1995-3#1)
previously observed during##2##3##(1991-9#1)(1993-8#1)
previously observed in##7##3##(1992-3#1)(1992-9#2)(1994-11#1)(1995-11#1)(2008-3#1)(2010-8#1)
previously observed##13##2##(1991-9#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)
previously obtained by##2##3##(2008-10#2)
previously obtained##7##2##(1990-2#1)(2007-11#1)(2008-10#4)(2013-1#1)
previously on##4##2##(1995-2#1)(2008-10#2)(2011-2#1)
previously only##2##2##(2008-11#1)(2010-12#1)
previously operated##3##2##(1992-9#1)(2008-10#1)(2008-11#1)
previously partially characterized##2##3##(2008-10#2)
previously partially##3##2##(1990-8#1)(2008-10#2)
previously postulated##4##2##(1992-8#1)(1995-8#1)(2008-7#1)(2012-3#1)
previously predicted##2##2##(1996-12#1)(2007-11#1)
previously presented by##2##3##(1991-6#1)(2008-12#1)
previously presented##6##2##(1991-6#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
previously proposed to##3##3##(2008-2#2)(2011-2#1)
previously proposed##17##2##(1992-6#1)(1994-3#1)(1996-8#1)(1997-7#1)(2008-10#4)(2008-2#2)(2008-3#3)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
previously provided by##2##3##(2007-11#1)(2008-10#1)
previously published cases##2##3##(2008-10#1)(2013-8#1)
previously published data##4##3##(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)
previously published findings in##2##4##(2007-12#2)
previously published findings##3##3##(2007-12#3)
previously published models##2##3##(2008-10#1)(2008-2#1)
previously published report##2##3##(1992-11#1)(2008-9#1)
previously published reports##2##3##(2008-2#1)(2010-2#1)
previously published research##2##3##(2008-10#1)(2008-3#1)
previously published results##5##3##(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#2)
previously published studies##2##3##(1993-11#1)(2008-9#1)
previously published study##2##3##(2008-5#1)(2008-8#1)
previously published##56##2##(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-5#2)(2007-11#1)(2007-12#4)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-2#3)(2010-7#1)(2011-1#1)(2013-8#1)
previously purified##3##2##(1990-11#1)(1995-5#1)(2009-8#1)
previously received##2##2##(2008-7#1)(2011-2#1)
previously recognized that##2##3##(1996-2#1)(2011-2#1)
previously recognized##8##2##(1990-8#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)
previously regarded as##3##3##(1996-12#1)(2007-12#1)(2009-6#1)
previously reported a##2##3##(1992-6#1)(2011-1#1)
previously reported as##5##3##(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
previously reported case##3##3##(2012-3#2)(2013-1#1)
previously reported cases of##2##4##(1990-6#1)(2006-10#1)
previously reported cases##8##3##(1990-6#1)(1993-8#1)(2006-10#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
previously reported data##2##3##(2008-10#1)(2008-4#1)
previously reported experimental results##2##4##(2008-10#1)(2008-2#1)
previously reported for##8##3##(1993-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-8#2)(2009-9#1)
previously reported human##2##3##(1992-10#1)(1993-8#1)
previously reported in the literature##9##5##(1995-9#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)
previously reported in the##12##4##(1995-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)
previously reported in vitro##2##4##(1995-12#1)(2008-9#1)
previously reported in##27##3##(1991-3#1)(1995-12#2)(1995-9#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)
previously reported ones##2##3##(2008-10#1)(2008-9#1)
previously reported studies##2##3##(1997-4#1)(2008-3#1)
previously reported that##17##3##(1990-11#1)(1990-7#1)(1992-8#1)(1994-11#1)(1994-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#2)(2011-2#1)(2013-1#2)
previously reported the##5##3##(1994-8#1)(1997-8#1)(2008-10#2)(2010-3#1)
previously reported to be##2##4##(1992-6#1)(2008-10#1)
previously reported to##4##3##(1992-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
previously reported values##3##3##(2007-11#1)(2008-10#2)
previously reported with##2##3##(1993-1#1)(2008-10#1)
previously reported##222##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-11#9)(2007-8#2)(2008-1#1)(2008-10#52)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-1#2)(2009-12#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#4)(2013-8#2)
previously seen##4##2##(1991-2#1)(1995-12#1)(2008-8#1)(2009-10#1)
previously selected##3##2##(2008-10#2)(2008-6#1)
previously sequenced##7##2##(1991-2#1)(1991-6#1)(1994-12#1)(1995-11#1)(1996-6#1)(1997-8#1)(2008-10#1)
previously shocked animals##2##3##(2008-6#2)
previously shown that this##2##4##(1991-12#1)(2009-7#1)
previously shown that##27##3##(1990-12#1)(1991-12#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
previously shown to be essential for##2##6##(1993-12#1)(2008-11#1)
previously shown to be##15##4##(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-9#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-1#1)
previously shown to##35##3##(1990-12#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-12#3)(2012-2#1)
previously shown##69##2##(1990-11#1)(1990-12#3)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
previously spiked with different amounts of##2##6##(2008-10#2)
previously standardized##2##2##(1992-1#1)(2008-10#1)
previously studied##14##2##(1994-2#1)(1995-12#1)(1996-7#1)(2007-11#2)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)
previously suggested##13##2##(1990-11#1)(1992-6#1)(1993-11#1)(1993-9#1)(1995-5#1)(2008-10#5)(2008-2#1)(2008-9#1)(2012-12#1)
previously suspected##2##2##(1991-12#1)(2008-5#1)
previously synthesized##3##2##(1995-11#2)(2008-10#1)
previously tested##4##2##(1992-5#1)(2008-10#2)(2008-7#1)
previously that the##5##3##(1994-8#1)(1995-5#1)(2008-2#1)(2008-5#1)(2008-7#1)
previously that##16##2##(1990-11#1)(1992-12#1)(1992-9#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
previously thought to be##2##4##(1996-2#1)(2008-10#1)
previously thought to##3##3##(1995-6#1)(1996-2#1)(2008-10#1)
previously thought##16##2##(1990-5#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
previously to##14##2##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(2007-6#1)(2008-10#1)(2009-10#1)
previously transferred to##2##3##(2008-10#2)
previously treated patients##2##3##(1991-6#1)(1993-6#1)
previously treated with##9##3##(1991-6#1)(1992-12#1)(1992-8#1)(2008-10#3)(2008-6#1)(2012-2#1)(2012-3#1)
previously treated##14##2##(1991-6#2)(1992-12#1)(1992-8#1)(1993-6#1)(2008-10#5)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
previously uncharacterized##5##2##(2008-10#3)(2009-8#1)(2012-3#1)
previously underappreciated##2##2##(2011-2#1)(2012-3#1)
previously undescribed species of##2##4##(2008-10#2)
previously undescribed##11##2##(2007-11#1)(2008-10#7)(2011-1#2)(2012-3#1)
previously undetected##3##2##(1997-7#1)(2008-10#2)
previously undiagnosed sickle cell##3##4##(2013-8#3)
previously undiagnosed##5##2##(2006-10#1)(2010-5#1)(2013-8#3)
previously unidentified##6##2##(1992-4#1)(1993-8#1)(1997-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
previously unknown##21##2##(1991-12#1)(1992-8#1)(1993-2#1)(1995-2#1)(1997-7#1)(2008-10#5)(2008-3#2)(2008-7#2)(2009-10#2)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
previously unrecognised adverse drug reactions##2##5##(2008-8#2)
previously unrecognised adverse##3##3##(2008-8#3)
previously unrecognised##6##2##(1994-3#1)(1996-6#1)(2008-8#4)
previously unrecognized##16##2##(1995-2#1)(1995-5#2)(1996-2#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-8#2)(2009-12#1)(2009-9#1)(2012-2#1)
previously unreported##15##2##(1990-9#1)(1994-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2013-8#1)
previously unsuspected##4##2##(1992-3#1)(1994-3#1)(2012-2#1)(2012-3#1)
previously untreated patients with##3##4##(1990-12#1)(1991-4#1)(2008-7#1)
previously untreated patients##6##3##(1990-12#1)(1990-6#2)(1991-4#1)(2007-7#1)(2008-7#1)
previously untreated##13##2##(1990-12#1)(1990-6#2)(1991-4#1)(1991-8#1)(2007-7#1)(2008-10#1)(2008-7#3)(2010-11#1)(2011-2#1)(2013-1#1)
previously used for##2##3##(2008-3#1)(2008-8#1)
previously used to##4##3##(2008-10#3)(2008-3#1)
previously used##15##2##(1991-5#1)(1993-9#1)(1997-4#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
previously using##3##2##(2008-10#3)
previously validated##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
previously was thought##2##3##(2008-10#2)
previously was##6##2##(2008-10#6)
previously well##2##2##(2009-5#1)(2012-2#1)
previously well-characterized##2##2##(1990-7#1)(1994-8#1)
previously were##6##2##(2007-10#1)(2008-10#4)(2008-3#1)
previously with##8##2##(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)
previously##1606##1##(1990-10#1)(1990-11#14)(1990-12#11)(1990-2#3)(1990-5#7)(1990-6#4)(1990-7#8)(1990-8#8)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#11)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#10)(1991-6#9)(1991-8#6)(1991-9#9)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#10)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#8)(1992-8#18)(1992-9#7)(1993-1#4)(1993-11#8)(1993-12#20)(1993-2#3)(1993-3#7)(1993-5#2)(1993-6#12)(1993-8#14)(1993-9#6)(1994-1#1)(1994-11#18)(1994-12#13)(1994-2#10)(1994-3#7)(1994-5#6)(1994-6#4)(1994-8#15)(1994-9#3)(1995-11#10)(1995-12#18)(1995-2#17)(1995-3#6)(1995-5#16)(1995-6#15)(1995-8#4)(1995-9#4)(1996-1#3)(1996-10#2)(1996-12#16)(1996-2#13)(1996-3#4)(1996-5#9)(1996-6#7)(1996-7#1)(1996-8#3)(1997-2#6)(1997-3#12)(1997-4#7)(1997-5#5)(1997-6#3)(1997-7#12)(1997-8#5)(2006-10#6)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#30)(2007-12#21)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2008-1#5)(2008-10#386)(2008-11#34)(2008-12#14)(2008-2#27)(2008-3#47)(2008-4#15)(2008-5#32)(2008-6#13)(2008-7#50)(2008-8#37)(2008-9#19)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#6)(2009-2#4)(2009-3#5)(2009-4#5)(2009-5#6)(2009-6#5)(2009-7#2)(2009-8#12)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#5)(2010-3#9)(2010-4#12)(2010-5#3)(2010-6#11)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#27)(2011-2#45)(2011-3#1)(2012-1#3)(2012-12#13)(2012-2#26)(2012-3#31)(2012-7#1)(2012-8#2)(2013-1#29)(2013-8#15)
previtellogenesis##4##1##(2007-12#3)(2008-7#1)
previtellogenic oocytes (phase I oocytes)##2##5##(2008-8#2)
previtellogenic oocytes##5##2##(2007-12#2)(2008-8#3)
previtellogenic##8##1##(2007-12#3)(2008-8#4)(2010-5#1)
prewarming and##2##2##(1994-9#2)
prewarming##3##1##(1994-9#3)
prey and##3##2##(2008-8#2)(2008-9#1)
prey as##2##2##(2008-5#1)(2012-3#1)
prey by##3##2##(2007-12#1)(2008-8#1)(2008-9#1)
prey can##2##2##(2008-8#1)(2008-9#1)
prey consumption##2##2##(2008-8#2)
prey density##4##2##(2008-12#1)(2008-8#2)(2008-9#1)
prey in the##2##3##(2008-9#1)(2010-8#1)
prey in##3##2##(2007-12#1)(2008-9#1)(2010-8#1)
prey item##3##2##(2008-5#3)
prey productivity##2##2##(2008-9#2)
prey resource##2##2##(2008-9#2)
prey selection of##2##3##(2010-8#2)
prey selection##6##2##(2010-8#6)
prey size##3##2##(2010-8#3)
prey species##10##2##(2008-8#7)(2008-9#1)(2012-12#1)(2012-3#1)
prey to##2##2##(2008-8#1)(2012-3#1)
prey were##2##2##(2008-8#1)(2010-8#1)
prey##115##1##(1994-6#1)(1995-12#2)(2007-12#5)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#14)(2008-6#1)(2008-8#36)(2008-9#23)(2010-8#22)(2012-12#1)(2012-2#1)(2012-3#4)
preys##3##1##(2008-12#2)(2008-5#1)
prezygotic isolation##2##2##(2008-8#2)
prezygotic##5##1##(2008-10#1)(2008-8#3)(2012-3#1)
prg##12##1##(2008-10#12)
priB##2##1##(1991-7#2)
priapism in a##2##3##(2008-10#2)
priapism in##4##2##(2008-10#4)
priapism##8##1##(2008-10#7)(2013-8#1)
price and##2##2##(1995-1#1)(1996-3#1)
price changes##2##2##(1994-1#1)(1994-12#1)
price competition among providers##2##4##(1994-1#1)(1994-12#1)
price competition##3##2##(1994-1#1)(1994-12#1)(1994-3#1)
price controls##5##2##(1994-12#4)(1994-2#1)
price index##5##2##(1992-2#1)(1993-1#3)(1993-3#1)
price indexes##2##2##(1992-1#1)(1993-3#1)
price of the##2##3##(1990-9#1)(2008-12#1)
price of these##2##3##(1994-2#1)(2008-10#1)
price of##18##2##(1990-9#1)(1991-1#1)(1991-4#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2010-5#1)(2011-2#1)
price setting##4##2##(1993-2#4)
price to##2##2##(2008-11#1)(2008-12#1)
price trends##2##2##(1993-3#2)
price volatility is##2##3##(2012-12#2)
price volatility##5##2##(2012-12#5)
price without##2##2##(1992-1#1)(1993-2#1)
price##86##1##(1990-9#1)(1991-1#2)(1991-12#1)(1991-4#1)(1992-1#4)(1992-12#1)(1992-2#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#4)(1994-1#4)(1994-12#7)(1994-2#3)(1994-3#1)(1994-7#1)(1995-1#3)(1995-12#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#6)(2012-2#2)(2013-1#1)
price-fixing##2##1##(1991-1#2)
priced##2##1##(1992-5#1)(2008-11#1)
prices are##2##2##(1992-2#1)(1993-1#1)
prices for##6##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-6#1)
prices in##2##2##(1992-5#1)(1994-12#1)
prices of##2##2##(2008-11#1)(2013-8#1)
prices##46##1##(1991-1#1)(1991-12#3)(1991-2#2)(1992-1#2)(1992-11#1)(1992-2#3)(1992-5#2)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#4)(1994-12#4)(1994-2#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
pricing and fair##2##3##(2008-11#2)
pricing and##5##2##(1995-12#1)(2008-11#3)(2008-12#1)
pricing##27##1##(1990-4#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#2)(2008-11#8)(2008-12#1)(2008-7#1)
prick test##3##2##(1992-9#1)(2008-10#1)(2012-3#1)
prick##14##1##(1990-11#1)(1992-9#2)(1996-8#1)(1997-6#1)(2007-2#1)(2008-10#3)(2012-12#1)(2012-3#2)(2013-1#2)
prickle trichomes##3##2##(2008-5#3)
pride##8##1##(1996-1#1)(1997-1#1)(2009-10#1)(2009-4#1)(2009-7#2)(2013-8#2)
priest##2##1##(1991-11#1)(1993-3#1)
prilocaine##2##1##(1993-1#1)(2008-10#1)
primacy of##3##2##(2009-8#1)(2011-1#1)(2013-8#1)
primacy##4##1##(2009-10#1)(2009-8#1)(2011-1#1)(2013-8#1)
primarily a##8##2##(1990-2#1)(1992-3#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
primarily about##2##2##(1995-2#1)(2008-11#1)
primarily affecting##2##2##(2010-12#1)(2013-1#1)
primarily affects the##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
primarily affects##4##2##(2007-7#1)(2008-1#1)(2010-8#1)(2012-2#1)
primarily among##3##2##(1992-6#1)(1994-2#1)(2011-2#1)
primarily an##3##2##(1993-12#1)(1996-5#1)(2009-9#1)
primarily as##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-9#1)
primarily associated with##2##3##(1997-7#1)(2008-9#1)
primarily at the##5##3##(1990-12#1)(1995-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
primarily at##7##2##(1990-12#1)(1990-5#1)(1994-12#1)(1995-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
primarily be##2##2##(1992-2#1)(2008-10#1)
primarily because of slow##2##4##(1991-3#1)(1997-3#1)
primarily because of##6##3##(1991-12#1)(1991-3#1)(1997-3#1)(2010-7#1)(2013-1#2)
primarily because##8##2##(1991-12#1)(1991-3#1)(1992-6#1)(1997-3#1)(2008-5#1)(2010-7#1)(2013-1#2)
primarily by its##2##3##(1990-12#1)(2008-8#1)
primarily by oxidation##2##3##(2008-8#1)(2013-7#1)
primarily by the##11##3##(1993-11#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-9#1)
primarily by##53##2##(1990-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-10#15)(2008-11#3)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
primarily caused by##2##3##(1994-11#1)(2008-8#1)
primarily characterized by##3##3##(1994-8#1)(2008-10#2)
primarily consists of##2##3##(2008-3#1)(2011-2#1)
primarily cultured scar##2##3##(2008-9#2)
primarily cultured##3##2##(2008-2#1)(2008-9#2)
primarily dependent on##2##3##(2007-11#1)(2008-11#1)
primarily determined by##2##3##(2009-12#1)(2009-7#1)
primarily determined##4##2##(2009-12#1)(2009-7#1)(2013-1#2)
primarily diagnosed##2##2##(2012-12#1)(2013-1#1)
primarily driven by##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
primarily due to the##4##4##(1997-7#1)(2008-4#1)(2011-1#1)(2012-12#1)
primarily due to##10##3##(1993-11#1)(1997-7#1)(2007-7#1)(2008-3#2)(2008-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
primarily during##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
primarily female##2##2##(2010-11#1)(2011-2#1)
primarily focused on the##3##4##(2011-1#1)(2011-2#1)(2012-3#1)
primarily focused on##4##3##(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
primarily for##5##2##(2008-1#1)(2008-10#2)(2008-3#1)(2012-3#1)
primarily form##2##2##(2008-10#1)(2008-6#1)
primarily from the##6##3##(1994-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
primarily from##13##2##(1994-3#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#2)
primarily in the form of##2##5##(1995-3#1)(2008-7#1)
primarily in the##20##3##(1991-5#1)(1992-10#1)(1994-9#1)(1995-3#1)(1997-1#2)(1997-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#2)(2010-11#1)(2011-2#2)(2012-2#1)
primarily in##28##2##(1991-5#1)(1992-10#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-1#2)(1997-8#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#2)(2008-9#4)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
primarily influenced by the##2##4##(2008-3#1)(2010-8#1)
primarily influenced by##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
primarily into##2##2##(2008-10#1)(2009-5#1)
primarily involve##2##2##(2008-11#1)(2008-5#1)
primarily involved in##3##3##(1997-8#1)(2012-12#1)(2013-1#1)
primarily located##2##2##(2013-1#1)(2013-7#1)
primarily of##7##2##(1997-5#1)(2007-11#1)(2008-10#1)(2009-1#1)(2009-11#1)(2009-7#1)(2012-3#1)
primarily on a##2##3##(1992-12#1)(2008-2#1)
primarily on the##13##3##(1995-12#1)(1996-1#1)(1997-5#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-12#1)
primarily on their##2##3##(1990-12#1)(2011-2#1)
primarily on##37##2##(1990-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-1#2)(1995-12#2)(1996-1#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
primarily provider expertise##2##3##(1994-1#2)
primarily recognized##2##2##(1995-2#1)(2007-7#1)
primarily related to##2##3##(2011-2#1)(2012-1#1)
primarily responsible for the##6##4##(1990-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)
primarily responsible for##8##3##(1990-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-6#1)
primarily the##6##2##(1990-5#1)(1991-8#1)(1994-11#1)(1996-5#1)(2010-8#1)(2012-2#1)
primarily through the##2##3##(1993-12#1)(2010-5#1)
primarily through##6##2##(1993-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#2)
primarily to the##4##3##(1994-5#1)(2008-10#1)(2008-4#1)(2008-8#1)
primarily to##35##2##(1990-12#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#7)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-3#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
primarily treated with##2##3##(1991-6#1)(2008-11#1)
primarily upon##3##2##(1990-11#1)(1993-6#1)(2008-10#1)
primarily used##2##2##(2008-11#1)(2013-8#1)
primarily via##2##2##(2008-7#1)(2008-9#1)
primarily when these##2##3##(1991-12#1)(2008-2#1)
primarily with respect to the##2##5##(1996-5#1)(2011-1#1)
primarily with##5##2##(1996-5#1)(2008-3#1)(2008-6#1)(2010-2#1)(2011-1#1)
primarily##440##1##(1990-11#1)(1990-12#7)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#3)(1991-8#3)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#1)(1993-11#6)(1993-12#4)(1993-6#2)(1993-8#1)(1994-1#4)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#4)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#5)(2006-10#3)(2006-12#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#6)(2007-8#1)(2008-1#4)(2008-10#53)(2008-11#19)(2008-12#2)(2008-2#12)(2008-3#23)(2008-4#9)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#17)(2008-9#19)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#11)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#3)
primary ACC##2##2##(2013-8#2)
primary B##4##2##(1991-2#3)(2008-9#1)
primary HIV infection##2##3##(1992-4#2)
primary IgM##2##2##(2008-10#2)
primary PCI##3##2##(2008-3#3)
primary T##2##2##(2008-4#2)
primary access##3##2##(2007-7#2)(2008-1#1)
primary adult##3##2##(1995-8#1)(2011-2#1)(2013-1#1)
primary afferent fibers in##2##4##(1997-2#2)
primary afferent fibers##6##3##(1990-7#1)(1994-8#1)(1995-12#1)(1997-2#2)(2008-4#1)
primary afferent fibres##2##3##(1997-3#1)(2008-7#1)
primary afferent neurons##4##3##(1995-12#2)(1996-5#1)(2008-4#1)
primary afferent terminal##2##3##(1990-5#1)(1994-8#1)
primary afferent terminals of##2##4##(1990-5#1)(1993-12#1)
primary afferent terminals##5##3##(1990-5#2)(1993-12#1)(1997-3#1)(2008-8#1)
primary afferent##26##2##(1990-5#3)(1990-7#1)(1993-12#1)(1994-8#2)(1995-12#4)(1995-5#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#1)(2008-4#2)(2008-7#2)(2008-8#1)
primary afferents##7##2##(1992-6#1)(1993-12#2)(1997-3#4)
primary aim of##4##3##(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
primary aim##5##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
primary aldosteronism##3##2##(1990-11#3)
primary aliphatic##3##2##(2008-10#3)
primary amenorrhoea##2##2##(2007-7#1)(2012-3#1)
primary amine##8##2##(2008-10#7)(2011-1#1)
primary amines##5##2##(1996-2#1)(1996-5#1)(2007-11#1)(2010-8#1)(2012-3#1)
primary amino acid sequence##2##4##(1996-12#1)(2012-2#1)
primary amino groups##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
primary amino##8##2##(1995-2#2)(1996-12#1)(2008-10#3)(2008-5#1)(2012-2#1)
primary analysis of##2##3##(1997-4#1)(2008-8#1)
primary and a##2##3##(1990-6#1)(2008-9#1)
primary and interfering ions##2##4##(2008-10#2)
primary and interfering##3##3##(2008-10#3)
primary and metastatic lung##2##4##(2012-2#1)(2012-3#1)
primary and metastatic tumors##2##4##(2009-9#1)(2010-9#1)
primary and metastatic##9##3##(1992-6#3)(1994-7#1)(2009-9#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
primary and permanent##3##3##(2008-12#1)(2008-9#1)(2012-2#1)
primary and preventive care##3##4##(1994-12#1)(2013-1#2)
primary and recurrent bladder##2##4##(1991-6#2)
primary and recurrent##7##3##(1990-9#1)(1991-6#4)(2008-6#1)(2012-1#1)
primary and secondary amines##2##4##(1996-5#1)(2008-10#1)
primary and secondary education##2##4##(2009-10#1)(2011-2#1)
primary and secondary foci##2##4##(2007-11#1)(2008-10#1)
primary and secondary infection##10##4##(2008-10#10)
primary and secondary patency of pedal bypasses##2##7##(2011-3#2)
primary and secondary patency##4##4##(2007-7#2)(2011-3#2)
primary and secondary prevention have##2##5##(1994-2#1)(2011-2#1)
primary and secondary prevention of##4##5##(2008-11#1)(2010-2#1)(2010-8#1)(2011-1#1)
primary and secondary prevention##11##4##(1990-12#1)(1994-2#1)(1996-12#1)(2008-11#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
primary and secondary sexual characters##2##5##(1995-2#2)
primary and secondary##64##3##(1990-12#1)(1990-8#1)(1992-6#2)(1992-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#3)
primary and##119##2##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#4)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#5)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#1)
primary angioplasty##3##2##(2008-3#3)
primary antibodies##2##2##(1990-12#1)(2008-8#1)
primary antibody followed by##2##4##(2008-9#1)(2012-3#1)
primary antibody##13##2##(2007-2#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-9#1)(2012-3#1)
primary antiphospholipid syndrome##3##3##(2006-10#3)
primary appraisals##2##2##(2012-1#2)
primary auditory cortex##7##3##(1996-2#2)(2008-11#3)(2012-2#1)(2013-8#1)
primary auditory##8##2##(1995-5#1)(1996-2#2)(2008-11#3)(2012-2#1)(2013-8#1)
primary axon scaffold of the##2##5##(2007-12#2)
primary beam##2##2##(2008-2#1)(2009-11#1)
primary biliary cirrhosis##13##3##(1990-3#1)(1990-9#1)(1991-5#1)(1992-12#3)(1992-6#1)(1992-9#2)(1993-5#1)(1994-2#1)(2006-10#2)
primary biliary##14##2##(1990-3#1)(1990-9#1)(1991-5#1)(1992-12#4)(1992-6#1)(1992-9#2)(1993-5#1)(1994-2#1)(2006-10#2)
primary binding site##2##3##(1997-3#1)(2008-10#1)
primary bone lymphoma##3##3##(2007-5#3)
primary bone tumors##5##3##(2008-2#3)(2009-3#1)(2012-12#1)
primary bone##14##2##(1990-11#1)(2007-5#3)(2008-2#3)(2008-6#3)(2008-7#1)(2009-3#1)(2010-3#1)(2012-12#1)
primary brain tumor##3##3##(2007-10#1)(2008-11#1)(2008-5#1)
primary brain tumours##3##3##(2007-10#1)(2013-1#2)
primary brain##7##2##(2007-10#2)(2008-11#1)(2008-5#1)(2013-1#2)(2013-8#1)
primary breast cancer (n =##2##5##(1993-1#2)
primary breast cancer##16##3##(1990-8#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#2)(1994-12#1)(1994-7#1)(1997-7#1)(2007-5#2)
primary breast##22##2##(1990-8#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#2)(1994-12#1)(1994-7#1)(1994-8#1)(1997-7#2)(2007-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
primary cancer site##2##3##(2008-7#1)(2013-8#1)
primary cancer##11##2##(1990-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
primary cancers##2##2##(1991-6#1)(2009-9#1)
primary carbon##3##2##(1994-5#1)(2008-3#1)(2008-7#1)
primary carcinoma of the##2##4##(1992-9#1)(1993-8#1)
primary cardiac##2##2##(1994-6#1)(2007-8#1)
primary cardiomyopathies##2##2##(1995-12#2)
primary care and##8##3##(1993-2#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-3#2)(2012-1#2)
primary care case##2##3##(1991-2#1)(1994-3#1)
primary care clinic##5##3##(1993-12#1)(1996-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
primary care health##3##3##(1993-6#1)(1994-9#1)(2011-2#1)
primary care in the##3##4##(1995-3#1)(1996-9#1)(1997-5#1)
primary care in##4##3##(1995-3#1)(1996-9#1)(1997-5#1)(2013-1#1)
primary care management##3##3##(1994-6#2)(1995-6#1)
primary care medical practices##2##4##(2008-4#2)
primary care physician as##2##4##(1997-2#1)(2008-10#1)
primary care physician in##2##4##(1995-2#1)(2010-8#1)
primary care physician##9##3##(1995-2#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-12#1)(2009-9#1)(2010-8#1)(2011-1#1)
primary care physicians##13##3##(1994-12#1)(1995-3#2)(1996-11#2)(1996-9#1)(1997-1#1)(2007-12#1)(2008-9#1)(2009-9#2)(2011-1#1)(2012-2#1)
primary care practice##3##3##(1993-10#1)(1995-2#1)(2011-2#1)
primary care practices##2##3##(2008-11#1)(2013-1#1)
primary care practitioners##3##3##(1996-1#1)(2011-1#2)
primary care professionals##2##3##(2013-1#2)
primary care providers to##3##4##(1994-2#1)(2011-1#1)(2011-2#1)
primary care providers##7##3##(1994-2#1)(1996-1#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
primary care services##3##3##(1995-12#1)(1997-8#1)(2011-2#1)
primary care setting##10##3##(2008-11#2)(2008-4#1)(2008-8#2)(2010-1#2)(2010-2#1)(2013-1#2)
primary care settings##5##3##(1996-12#1)(2008-11#2)(2009-12#1)(2009-9#1)
primary care sites)##2##3##(1996-2#2)
primary care to##3##3##(1995-12#1)(1996-9#1)(2008-11#1)
primary care training##5##3##(1995-2#1)(1996-1#3)(2008-1#1)
primary care##212##2##(1990-10#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-5#2)(1993-6#3)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#5)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#5)(1995-5#1)(1995-6#2)(1996-1#8)(1996-11#5)(1996-12#3)(1996-2#6)(1996-3#5)(1996-6#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#5)(1997-3#10)(1997-5#4)(1997-8#4)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#13)(2008-12#3)(2008-2#2)(2008-4#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-7#1)(2009-9#6)(2010-1#2)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#10)(2011-2#14)(2012-1#2)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#3)
primary care]##33##2##(1993-10#1)(1993-11#2)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-3#2)(1995-6#2)(1996-11#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-3#1)(1997-5#1)
primary caregivers##4##2##(1991-3#1)(1995-12#1)(2010-7#1)(2010-8#1)
primary cause for##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
primary cause of##7##3##(1996-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
primary cause##12##2##(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
primary cell cultures from Indian water snake (Natrix piscator) and Indian mugger (Crocodylus palustris) embryos##2##15##(2010-3#2)
primary cell cultures from##3##4##(2008-11#1)(2010-3#2)
primary cell cultures of rat##3##5##(1990-5#1)(2008-10#1)(2008-7#1)
primary cell cultures of##4##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-7#1)
primary cell cultures##10##3##(1990-5#2)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#2)
primary cell##13##2##(1990-5#2)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2010-3#3)
primary cells and##2##3##(2008-11#1)(2008-4#1)
primary cells##11##2##(1997-2#1)(1997-4#1)(2008-11#4)(2008-4#2)(2008-9#1)(2010-3#1)(2011-2#1)
primary central nervous system lymphoma##3##5##(1991-6#1)(1996-11#1)(2008-7#1)
primary central nervous system##4##4##(1991-6#1)(1996-11#1)(2008-7#1)(2010-5#1)
primary cerebral##2##2##(1991-6#1)(2009-3#1)
primary chicken##3##2##(1991-3#1)(1994-8#1)(2008-11#1)
primary cilium##3##2##(2013-1#3)
primary clinical##3##2##(2008-3#1)(2008-5#1)(2013-8#1)
primary closure##4##2##(2006-12#1)(2007-12#1)(2012-3#1)(2013-1#1)
primary component##3##2##(2007-12#1)(2008-10#1)(2009-4#1)
primary components##2##2##(2008-9#1)(2013-8#1)
primary concern was##2##3##(1997-2#1)(2011-2#1)
primary concern##6##2##(1992-8#1)(1994-2#1)(1997-2#1)(2008-11#1)(2010-8#1)(2011-2#1)
primary consideration##2##2##(2012-12#1)(2013-1#1)
primary coronary##2##2##(2008-11#1)(2008-3#1)
primary cortical##4##2##(1995-5#1)(2008-4#2)(2008-7#1)
primary culture of rat##2##4##(1992-3#2)
primary culture of##7##3##(1992-3#2)(1993-8#2)(2008-11#1)(2013-1#2)
primary culture##21##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#2)(1993-3#1)(1993-8#3)(1994-12#1)(1994-8#3)(1995-11#1)(2008-11#2)(2008-6#1)(2013-1#3)
primary cultured human##3##3##(2008-5#3)
primary cultured rat hepatocytes##2##4##(1993-6#2)
primary cultured##7##2##(1993-6#2)(1996-2#1)(2008-5#4)
primary cultures from##2##3##(1991-12#1)(1996-5#1)
primary cultures of fetal##2##4##(1994-3#1)(1996-5#1)
primary cultures of human pancreatic##2##5##(2010-11#2)
primary cultures of human##5##4##(1993-3#2)(2008-11#1)(2010-11#2)
primary cultures of rat##5##4##(1995-11#1)(1997-6#2)(2008-11#1)(2008-4#1)
primary cultures of the##2##4##(1996-2#1)(2011-2#1)
primary cultures of##33##3##(1990-12#1)(1990-5#1)(1991-5#2)(1992-9#1)(1993-3#2)(1994-2#2)(1994-3#1)(1995-11#3)(1995-12#3)(1995-8#1)(1996-2#1)(1996-5#2)(1997-6#2)(2008-11#2)(2008-4#2)(2009-9#1)(2010-11#3)(2011-2#1)(2012-12#1)(2012-3#1)
primary cultures##38##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-2#1)(1992-9#1)(1993-3#2)(1994-2#2)(1994-3#1)(1995-11#3)(1995-12#3)(1995-8#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-6#2)(2008-11#3)(2008-4#2)(2009-9#1)(2010-11#3)(2011-2#1)(2012-12#1)(2012-3#1)
primary cutaneous histoplasmosis##2##3##(2007-7#2)
primary cutaneous##9##2##(1991-6#1)(2007-7#3)(2009-4#2)(2010-8#2)(2011-1#1)
primary cytoreductive surgery##2##3##(2011-2#2)
primary data source##2##3##(2008-1#1)(2008-9#1)
primary data##4##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
primary defect in##2##3##(2008-1#1)(2008-10#1)
primary defense##3##2##(1997-2#2)(2008-7#1)
primary deficit in##2##3##(2008-11#1)(2008-2#1)
primary deficit##3##2##(2007-8#1)(2008-11#1)(2008-2#1)
primary degradation##2##2##(2008-10#2)
primary diagnosis in##3##3##(1992-1#2)(2010-3#1)
primary diagnosis##12##2##(1991-1#1)(1992-1#2)(1994-2#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-3#2)
primary diagnostic##4##2##(1990-6#1)(2008-2#1)(2008-6#1)(2012-12#1)
primary disease gradients##2##3##(2008-10#2)
primary disease##9##2##(1991-3#1)(2007-12#1)(2008-10#4)(2008-6#1)(2011-1#1)(2013-1#1)
primary diseases of##2##3##(1997-6#1)(2012-3#1)
primary diseases##3##2##(1997-6#1)(2012-12#1)(2012-3#1)
primary dysmenorrhoea##2##2##(1994-9#2)
primary education##3##2##(2013-1#3)
primary effect of##3##3##(1994-8#1)(2008-11#1)(2010-1#1)
primary efficacy endpoint##2##3##(2008-7#2)
primary efficacy measure##2##3##(2008-7#1)(2012-2#1)
primary efficacy##6##2##(2007-10#1)(2008-7#4)(2012-2#1)
primary electron donor is##3##4##(2008-8#3)
primary electron donor##8##3##(1992-6#2)(1993-11#2)(2008-8#4)
primary emulsifier##3##2##(2008-5#3)
primary endosperm##5##2##(2008-9#5)
primary endpoint of##3##3##(1997-4#1)(2008-5#1)(2010-4#1)
primary endpoint##8##2##(1997-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)
primary endpoints##2##2##(2008-1#1)(2012-1#1)
primary esophageal carcinomas##2##3##(1992-8#2)
primary esophageal##4##2##(1992-8#2)(2011-1#1)(2012-2#1)
primary experimental##2##2##(2007-11#1)(2008-2#1)
primary factor responsible for##2##4##(2008-3#1)(2010-3#1)
primary factor##7##2##(2007-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-3#1)
primary failure##2##2##(1993-2#1)(2012-3#1)
primary focus of this##3##4##(2008-1#1)(2008-11#1)(2008-7#1)
primary focus of##6##3##(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)
primary focus##9##2##(1990-3#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
primary function of##4##3##(1997-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
primary gastric carcinoma##2##3##(2008-9#1)(2012-2#1)
primary gastric lymphoma##2##3##(2013-1#2)
primary gastric lymphomas##2##3##(1992-8#1)(2009-8#1)
primary gastric##7##2##(1992-8#2)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#2)
primary gastrointestinal##2##2##(1990-2#1)(1997-3#1)
primary generated##2##2##(1995-3#2)
primary germinoma originating in the basal ganglia##2##7##(2008-7#2)
primary glomerular disease##2##3##(2007-7#2)
primary glomerular diseases##3##3##(2008-1#3)
primary glomerular##5##2##(2007-7#2)(2008-1#3)
primary glomerulonephritidis##2##2##(2008-1#2)
primary glomerulonephritis##2##2##(2007-7#1)(2008-1#1)
primary goal in##5##3##(2007-11#1)(2008-3#1)(2008-6#1)(2008-9#2)
primary goal##11##2##(1995-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#2)(2010-2#1)(2013-1#1)
primary health care and##4##4##(1991-6#1)(1992-1#1)(1995-11#1)(2008-6#1)
primary health care centers in##3##5##(2007-8#1)(2011-2#2)
primary health care centers##7##4##(1995-8#1)(2007-2#1)(2007-8#1)(2011-2#4)
primary health care for##4##4##(1996-12#1)(2010-10#3)
primary health care in the##2##5##(1990-9#1)(2011-1#1)
primary health care programme##2##4##(2008-1#2)
primary health care services##4##4##(1991-6#1)(1991-8#1)(1993-6#1)(2008-1#1)
primary health care setting##2##4##(2011-2#1)(2013-8#1)
primary health care staff##2##4##(2011-2#2)
primary health care##59##3##(1990-9#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#5)(1993-11#1)(1993-6#2)(1994-3#3)(1995-11#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#5)(2008-6#1)(2008-7#1)(2010-10#3)(2011-1#2)(2011-2#9)(2012-3#1)(2013-8#1)
primary health care]##9##3##(1991-9#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1997-5#1)(1997-8#1)
primary health services##6##3##(1991-6#1)(1992-11#3)(1994-6#1)(1995-6#1)
primary health##78##2##(1990-9#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#9)(1993-11#1)(1993-3#1)(1993-6#2)(1994-3#4)(1994-6#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#6)(2008-6#1)(2008-7#1)(2010-10#3)(2011-1#2)(2011-2#9)(2012-3#1)(2013-1#1)(2013-8#2)
primary health-care centres##2##3##(2008-10#2)
primary health-care##3##2##(2008-10#2)(2012-12#1)
primary healthcare##10##2##(2008-10#1)(2009-3#3)(2009-6#2)(2011-2#3)(2012-12#1)
primary hepatocellular carcinoma##3##3##(2008-8#1)(2010-12#1)(2010-7#1)
primary hepatocyte cultures##2##3##(1990-5#1)(1992-11#1)
primary hepatocyte##4##2##(1990-5#1)(1992-11#1)(2008-11#2)
primary hepatocytes##5##2##(2008-11#4)(2008-9#1)
primary host##2##2##(2008-10#2)
primary human cells##4##3##(2008-11#4)
primary human##21##2##(1991-6#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-11#8)(2008-9#1)(2009-12#1)(2012-12#1)(2012-5#1)(2013-1#2)
primary hydroxyl groups##4##3##(1990-9#2)(1996-5#1)(2008-7#1)
primary hypercholesterolaemia##2##2##(1992-11#2)
primary hypercholesterolemia##3##2##(1991-6#2)(1992-11#1)
primary hyperoxaluria type 1##4##4##(1993-9#2)(2007-12#1)(2009-3#1)
primary hyperoxaluria type##6##3##(1993-9#2)(1995-12#2)(2007-12#1)(2009-3#1)
primary hyperoxaluria##9##2##(1992-6#1)(1993-9#3)(1995-12#2)(2007-12#1)(2009-3#1)(2011-2#1)
primary hyperparathyroidism and##2##3##(1990-2#2)
primary hyperparathyroidism##17##2##(1990-2#5)(1991-12#1)(1991-5#1)(1995-11#1)(1996-9#1)(2008-10#2)(2008-12#2)(2011-1#1)(2011-2#1)(2012-12#2)
primary hypertriglyceridemia##2##2##(2008-12#2)
primary hypertriglyceridemic##2##2##(2008-12#2)
primary hyphae##4##2##(2008-10#4)
primary hypothyroidism##7##2##(1991-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2012-2#3)
primary immune##4##2##(2008-10#3)(2008-11#1)
primary immunodeficiency diseases##2##3##(2012-12#2)
primary immunodeficiency##6##2##(1990-10#1)(2008-10#1)(2012-12#3)(2013-1#1)
primary importance##5##2##(1992-3#1)(1994-11#1)(2008-2#1)(2008-9#1)(2012-3#1)
primary in##3##2##(2008-12#1)(2010-2#1)(2013-1#1)
primary infection##16##2##(1990-3#1)(1997-5#1)(2007-10#1)(2008-10#12)(2008-8#1)
primary infections##3##2##(2008-10#3)
primary information##2##2##(1996-1#1)(2013-1#1)
primary inoculum in##2##3##(2008-10#2)
primary inoculum##21##2##(2008-10#20)(2008-12#1)
primary intracerebral hemorrhage (PICH)##2##4##(2007-10#2)
primary intracerebral hemorrhage##4##3##(2007-10#4)
primary intracerebral##5##2##(2007-10#4)(2008-8#1)
primary isolation##3##2##(1992-2#1)(2008-12#1)(2008-9#1)
primary keratinocyte##2##2##(2008-4#2)
primary kernel percent hull##2##4##(2008-5#2)
primary kernel##3##2##(2008-5#3)
primary leiomyoma of the ureter##2##5##(2013-7#2)
primary lesion in##2##3##(1997-7#1)(2013-8#1)
primary lesion##6##2##(1991-5#1)(1992-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
primary lesions##3##2##(2008-10#2)(2011-1#1)
primary ligand and##2##3##(2008-10#2)
primary liver##3##2##(1991-11#1)(2011-1#1)(2013-1#1)
primary localised cutaneous amyloidosis##3##4##(2007-7#3)
primary lung cancer in##2##4##(1992-3#1)(2013-7#1)
primary lung cancer##5##3##(1992-3#1)(1993-8#1)(2008-11#1)(2008-2#1)(2013-7#1)
primary lung cancers##2##3##(1992-3#1)(2011-1#1)
primary lung##11##2##(1992-3#2)(1993-2#1)(1993-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
primary lymphocytes##2##2##(2008-2#1)(2011-3#1)
primary malignancies and##2##3##(1990-12#1)(2011-2#1)
primary malignancies of##2##3##(2011-2#2)
primary malignancies##11##2##(1990-12#3)(1991-8#3)(2011-2#5)
primary malignant bone##3##3##(2008-6#1)(2010-3#1)(2011-2#1)
primary malignant tumor of the bone##2##6##(2008-6#1)(2010-3#1)
primary malignant tumours##2##3##(1990-12#1)(2012-2#1)
primary malignant##13##2##(1990-12#1)(1992-11#1)(2008-10#1)(2008-3#1)(2008-6#3)(2010-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
primary maxillary##2##2##(2008-12#2)
primary means for##2##3##(2008-10#1)(2012-12#1)
primary means##5##2##(2008-10#3)(2008-5#1)(2012-12#1)
primary mechanism of##2##3##(2008-10#2)
primary mechanism##4##2##(1997-3#1)(2008-10#2)(2012-12#1)
primary mediastinal##3##2##(2007-8#2)(2010-12#1)
primary medical care##2##3##(1993-11#1)(1997-4#1)
primary medical##3##2##(1993-11#1)(1997-2#1)(1997-4#1)
primary melanoma##7##2##(2008-9#1)(2009-4#1)(2011-2#5)
primary melanomas##4##2##(1993-8#1)(2008-9#1)(2011-2#2)
primary mesangial cells##2##3##(2011-2#2)
primary metabolite of##2##3##(1993-8#1)(1994-11#1)
primary method for##2##3##(2008-11#1)(2011-2#1)
primary methods of##2##3##(2008-10#1)(2008-4#1)
primary methods##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
primary mirror##9##2##(2008-2#2)(2008-3#7)
primary mode of##2##3##(2007-12#1)(2008-11#1)
primary model##2##2##(2008-5#1)(2008-7#1)
primary molars##3##2##(2008-12#3)
primary motor area##4##3##(2008-11#2)(2008-9#1)(2009-6#1)
primary motor cortex##3##3##(2010-7#1)(2011-2#1)(2012-2#1)
primary motor##7##2##(2008-11#2)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
primary musical cues##2##3##(2013-8#2)
primary neoplasm##2##2##(1991-6#1)(2013-1#1)
primary nephropathies##2##2##(2008-1#2)
primary neuronal cultures##2##3##(1995-12#1)(1995-5#1)
primary neurotransmitter##2##2##(1997-3#1)(2009-12#1)
primary nevoid melanoma##2##3##(2011-2#2)
primary nocturnal enuresis?##2##3##(1994-8#1)(2008-10#1)
primary nocturnal##3##2##(1994-8#1)(2007-7#1)(2008-10#1)
primary objective of this study##3##5##(1991-2#1)(2008-10#2)
primary objective of this##5##4##(1991-2#1)(2008-10#2)(2010-4#1)(2011-1#1)
primary objective of##8##3##(1991-2#1)(1996-9#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
primary objective##9##2##(1991-2#1)(1996-9#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
primary ocular##3##2##(2012-3#3)
primary ones##2##2##(1990-8#1)(2008-5#1)
primary open angle glaucoma##3##4##(2011-2#2)(2012-2#1)
primary open angle##4##3##(2011-2#3)(2012-2#1)
primary operable breast cancer##2##4##(1991-8#1)(2007-5#1)
primary operation##3##2##(1994-6#1)(2007-8#1)(2008-6#1)
primary or secondary##12##3##(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-2#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
primary or##16##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-10#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
primary orbital##2##2##(2010-11#2)
primary origin of##2##3##(2007-11#1)(2008-10#1)
primary osteogenic sarcoma of the breast##2##6##(1992-2#2)
primary osteosarcoma##3##2##(2008-6#2)(2010-3#1)
primary outcome was##4##3##(2007-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
primary outcome##9##2##(1991-11#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
primary outcomes##3##2##(2008-7#1)(2010-1#1)(2010-4#1)
primary outpatient care##2##3##(2011-1#2)
primary ovarian##2##2##(2011-1#1)(2013-1#1)
primary oxalosis##2##2##(1991-11#2)
primary ozonides##3##2##(1996-5#3)
primary parenchymatous##2##2##(1997-8#2)
primary particle size##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
primary particle##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
primary particles##7##2##(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)
primary patency rate##2##3##(2007-7#2)
primary patency##3##2##(2007-7#3)
primary patients##3##2##(2012-3#1)(2013-1#2)
primary pattern##2##2##(2008-2#1)(2008-6#1)
primary percutaneous coronary intervention (PCI)##2##5##(2008-3#2)
primary percutaneous coronary intervention##5##4##(2008-3#2)(2009-12#1)(2013-1#2)
primary pests##2##2##(2008-5#2)
primary photochemical##3##2##(1991-12#1)(2008-8#1)(2011-1#1)
primary porcine hepatocytes##4##3##(2008-11#3)(2011-2#1)
primary predecessors##3##2##(2013-1#3)
primary prevention and##3##3##(2007-8#1)(2008-12#1)(2013-1#1)
primary prevention groups that##2##4##(2010-12#2)
primary prevention groups##3##3##(2010-12#3)
primary prevention of cardiovascular disease##3##5##(2009-4#1)(2011-2#1)(2013-1#1)
primary prevention of##12##3##(1995-5#1)(2007-10#3)(2007-8#2)(2009-4#2)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
primary prevention strategies##2##3##(2008-3#1)(2011-2#1)
primary prevention##38##2##(1992-5#1)(1995-3#7)(1995-5#2)(1996-12#2)(1996-3#2)(1997-1#1)(1997-8#1)(2007-10#3)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#2)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-8#1)
primary preventive##2##2##(1996-12#2)
primary processes##2##2##(2008-10#1)(2008-8#1)
primary producers##3##2##(2008-8#1)(2009-4#1)(2012-2#1)
primary production in##2##3##(2008-8#1)(2012-2#1)
primary production##6##2##(2008-3#1)(2008-8#3)(2009-8#1)(2012-2#1)
primary productivity##3##2##(2008-8#2)(2011-2#1)
primary purpose of##3##3##(1992-11#1)(2009-5#1)(2010-3#1)
primary radiotherapy##4##2##(1990-10#1)(1992-3#1)(1993-11#2)
primary rainbow##2##2##(2008-2#1)(2008-3#1)
primary rat hepatocyte cultures##2##4##(1993-3#1)(2008-4#1)
primary rat hepatocytes##7##3##(1993-8#2)(2008-11#2)(2008-9#3)
primary rat##13##2##(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#2)(1996-12#1)(1996-2#1)(2008-11#2)(2008-4#1)(2008-9#3)
primary reaction##3##2##(2008-8#3)
primary reasons##2##2##(1994-5#1)(2012-1#1)
primary repair##4##2##(2010-12#2)(2010-8#1)(2011-2#1)
primary research##5##2##(1993-2#3)(2008-9#1)(2013-8#1)
primary resection##2##2##(1990-9#1)(2008-11#1)
primary resistance to HER2-targeted therapies##2##5##(2013-1#2)
primary resistance##3##2##(2010-5#1)(2013-1#2)
primary resistant##2##2##(1990-12#1)(2010-4#1)
primary response##3##2##(1992-7#1)(1994-2#1)(1995-2#1)
primary responsibility##2##2##(1993-3#1)(1995-1#1)
primary retroperitoneal##7##2##(2008-10#2)(2008-6#2)(2009-5#3)
primary risk##2##2##(2007-8#1)(2008-12#1)
primary rodent##2##2##(2008-10#1)(2008-7#1)
primary role of##2##3##(1990-11#1)(2008-7#1)
primary role##9##2##(1990-11#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)
primary school children##4##3##(2008-10#2)(2008-12#1)(2010-8#1)
primary school##9##2##(1993-6#1)(2007-5#1)(2008-10#2)(2008-12#2)(2009-12#1)(2010-8#1)(2013-8#1)
primary schools##8##2##(2007-5#2)(2007-7#1)(2008-10#3)(2008-7#1)(2013-8#1)
primary sclerosing cholangitis##3##3##(2006-10#1)(2009-8#1)(2010-12#1)
primary sensory neurons##3##3##(2008-4#1)(2008-5#1)(2008-6#1)
primary sensory##4##2##(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
primary sequence homology##2##3##(1992-3#1)(1994-8#1)
primary sequence of##2##3##(1991-8#1)(1993-9#1)
primary sequence##11##2##(1991-8#1)(1992-3#2)(1992-6#1)(1993-2#2)(1993-9#1)(1994-8#1)(1995-3#1)(1997-9#1)(2008-9#1)
primary shape##2##2##(2011-1#2)
primary site of cancer##3##4##(1997-8#1)(2007-11#2)
primary site of##11##3##(1991-2#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-3#1)
primary site was##2##3##(2013-8#2)
primary site with##2##3##(1992-12#1)(1992-2#1)
primary site##20##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#2)(1997-6#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
primary sites##8##2##(1990-8#1)(1993-3#1)(1994-7#3)(2008-10#1)(2008-6#2)
primary sleep disorders##2##3##(2012-2#1)(2013-7#1)
primary somatosensory##2##2##(1995-12#1)(1996-2#1)
primary source of##8##3##(1995-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)
primary sources##4##2##(1992-6#1)(2008-2#1)(2008-3#1)(2013-1#1)
primary specialization courses##2##3##(1994-12#2)
primary spontaneous pneumothorax##2##3##(2008-10#1)(2008-7#1)
primary spontaneous##3##2##(2008-10#2)(2008-7#1)
primary stage##3##2##(1997-3#1)(2007-11#1)(2013-1#1)
primary stem##2##2##(2009-6#1)(2010-11#1)
primary step##3##2##(2008-5#1)(2008-6#1)(2009-10#1)
primary stroke##2##2##(2007-10#1)(2013-8#1)
primary structure and##2##3##(1992-8#1)(1995-3#1)
primary structure of African catfish GnRH##2##6##(1992-8#2)
primary structure of goat Mb##3##5##(2010-4#3)
primary structure of the##15##4##(1990-12#1)(1990-7#1)(1991-6#1)(1992-3#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#2)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
primary structure of this##2##4##(1991-9#1)(1992-3#1)
primary structure of##36##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-6#2)(1991-9#1)(1992-3#4)(1992-8#3)(1992-9#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-9#2)(1995-3#1)(1997-4#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#3)(2011-2#2)
primary structure##49##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#2)(1991-6#2)(1991-9#1)(1992-3#5)(1992-6#2)(1992-8#5)(1992-9#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-2#1)(1994-9#2)(1995-3#2)(1995-6#2)(1997-4#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#3)(2011-2#2)
primary structures of##4##3##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#1)
primary structures##8##2##(1990-5#1)(1990-7#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-3#1)(1997-2#1)
primary success rate of##2##4##(1991-3#1)(2008-11#1)
primary success rate##4##3##(1991-3#1)(2008-11#1)(2008-12#2)
primary surgery##7##2##(1990-6#1)(1991-8#1)(1993-9#1)(2007-11#1)(2008-6#1)(2008-9#2)
primary suture repair##2##3##(2011-2#2)
primary synovial##2##2##(2010-5#1)(2013-1#1)
primary systemic##2##2##(1995-5#1)(2011-2#1)
primary target cell##2##3##(1992-11#1)(2012-2#1)
primary target of##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
primary target##7##2##(1992-11#1)(1993-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
primary targets##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
primary teaching##2##2##(2008-11#2)
primary teeth with##2##3##(2011-2#2)
primary teeth##12##2##(2008-9#1)(2010-3#3)(2011-1#1)(2011-2#6)(2013-1#1)
primary telescope##2##2##(2008-3#2)
primary teratoma of the penis##2##5##(2008-10#2)
primary therapy##5##2##(1990-11#1)(2008-1#1)(2010-12#1)(2011-2#2)
primary total hip arthroplasty##6##4##(2008-8#5)(2011-2#1)
primary total hip##9##3##(1996-11#1)(1996-9#1)(2008-8#5)(2011-2#1)(2013-1#1)
primary total##10##2##(1996-11#1)(1996-9#1)(2008-8#5)(2011-2#2)(2013-1#1)
primary treatment for##2##3##(2008-7#1)(2011-2#1)
primary treatment of##5##3##(1994-2#1)(1997-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
primary treatment##10##2##(1991-6#1)(1994-2#1)(1997-3#2)(2007-10#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
primary trisomics##4##2##(2009-12#4)
primary tumor in the##2##4##(2008-1#1)(2011-2#1)
primary tumor in##3##3##(2008-1#1)(2010-3#1)(2011-2#1)
primary tumor of##2##3##(2013-1#1)(2013-8#1)
primary tumor was##6##3##(1990-6#1)(1992-6#2)(1992-8#1)(2008-6#2)
primary tumor##54##2##(1990-12#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-3#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-10#3)(2008-6#3)(2009-10#1)(2010-3#8)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
primary tumors and##5##3##(1992-12#1)(1993-8#1)(1994-12#1)(2011-2#1)(2012-12#1)
primary tumors in##2##3##(1992-8#1)(2012-2#1)
primary tumors##19##2##(1992-12#1)(1992-8#1)(1993-8#2)(1994-12#2)(1997-7#1)(2008-6#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
primary tumour in##2##3##(2007-11#1)(2013-7#1)
primary tumour##14##2##(1991-6#1)(1995-8#3)(1997-3#1)(2007-11#2)(2008-1#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
primary tumours of the##4##4##(2008-6#3)(2012-2#1)
primary tumours of##5##3##(2008-6#4)(2012-2#1)
primary tumours##8##2##(1991-8#1)(1997-3#1)(2008-6#5)(2012-2#1)
primary uncomplicated##2##2##(2011-1#2)
primary value##2##2##(2008-1#1)(2013-1#1)
primary varicella zoster infection##3##4##(2008-7#2)(2010-8#1)
primary varicella##4##2##(2008-7#2)(2010-8#2)
primary versus secondary##2##3##(1994-2#1)(2012-2#1)
primary visual cortex (V1)##5##4##(1995-11#1)(2008-11#2)(2008-8#1)(2012-2#1)
primary visual cortex of##4##4##(1992-10#1)(1993-12#1)(2008-11#1)(2008-8#1)
primary visual cortex##18##3##(1992-10#1)(1993-12#1)(1995-11#3)(1995-12#3)(2007-9#1)(2008-1#1)(2008-11#3)(2008-7#2)(2008-8#2)(2012-2#1)
primary visual##19##2##(1992-10#1)(1993-12#1)(1995-11#3)(1995-12#3)(2007-9#1)(2008-1#1)(2008-11#3)(2008-7#2)(2008-8#3)(2012-2#1)
primary##2453##1##(1990-10#3)(1990-11#8)(1990-12#18)(1990-2#13)(1990-3#4)(1990-4#2)(1990-5#17)(1990-6#5)(1990-7#5)(1990-8#11)(1990-9#10)(1991-1#5)(1991-11#6)(1991-12#9)(1991-2#12)(1991-3#7)(1991-4#2)(1991-5#7)(1991-6#26)(1991-8#11)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#20)(1992-12#11)(1992-2#13)(1992-3#19)(1992-4#2)(1992-5#3)(1992-6#22)(1992-7#2)(1992-8#16)(1992-9#8)(1993-1#6)(1993-10#3)(1993-11#10)(1993-12#17)(1993-2#18)(1993-3#14)(1993-5#4)(1993-6#22)(1993-8#14)(1993-9#12)(1994-10#1)(1994-11#7)(1994-12#12)(1994-2#16)(1994-3#11)(1994-5#9)(1994-6#10)(1994-7#5)(1994-8#13)(1994-9#13)(1995-1#4)(1995-10#1)(1995-11#17)(1995-12#28)(1995-2#18)(1995-3#26)(1995-4#1)(1995-5#13)(1995-6#11)(1995-8#9)(1996-1#11)(1996-11#13)(1996-12#17)(1996-2#15)(1996-3#14)(1996-4#1)(1996-5#15)(1996-6#7)(1996-8#2)(1996-9#15)(1997-1#6)(1997-2#16)(1997-3#33)(1997-4#14)(1997-5#8)(1997-6#6)(1997-7#9)(1997-8#15)(1997-9#2)(2006-10#8)(2006-12#2)(2007-1#1)(2007-10#19)(2007-11#26)(2007-12#27)(2007-2#5)(2007-5#11)(2007-6#1)(2007-7#27)(2007-8#18)(2007-9#2)(2008-1#44)(2008-10#223)(2008-11#103)(2008-12#30)(2008-2#32)(2008-3#55)(2008-4#36)(2008-5#47)(2008-6#43)(2008-7#61)(2008-8#47)(2008-9#52)(2009-1#1)(2009-10#12)(2009-11#5)(2009-12#11)(2009-2#1)(2009-3#8)(2009-4#9)(2009-5#11)(2009-6#5)(2009-7#4)(2009-8#8)(2009-9#18)(2010-1#5)(2010-10#5)(2010-11#12)(2010-12#14)(2010-2#5)(2010-3#31)(2010-4#11)(2010-5#7)(2010-6#7)(2010-7#4)(2010-8#18)(2010-9#2)(2011-1#41)(2011-2#126)(2011-3#6)(2012-1#9)(2012-12#25)(2012-2#55)(2012-3#34)(2012-5#1)(2013-1#98)(2013-7#10)(2013-8#43)
primary&quot##2##1##(2006-10#1)(2008-5#1)
primary-care providers##2##2##(1992-8#1)(1996-3#1)
primary-care##11##1##(1992-8#2)(1996-2#2)(1996-3#2)(1997-2#4)(2011-2#1)
primary-cultured##3##1##(2008-11#3)
primary-growth##2##1##(2008-10#2)
primary-tertiary##3##1##(2008-10#3)
primase##5##1##(1992-3#1)(1994-12#2)(1995-2#2)
primase-synthesized##2##1##(1995-2#2)
primate ES cells##2##3##(2008-9#2)
primate and##2##2##(1990-8#1)(1994-12#1)
primate brain##4##2##(1992-12#1)(1997-2#2)(2012-3#1)
primate embryonic stem##2##3##(2008-9#1)(2009-12#1)
primate models of##2##3##(1993-5#1)(2008-9#1)
primate species##5##2##(1994-12#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-8#1)
primate##37##1##(1990-8#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#6)(1997-2#3)(1997-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#4)(2009-12#1)(2010-3#1)(2011-2#1)(2012-3#2)
primates and##2##2##(1996-6#1)(2008-10#1)
primates with##2##2##(1993-8#1)(1993-9#1)
primates##53##1##(1990-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-2#2)(1994-8#3)(1996-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-3#2)(2009-8#1)(2010-3#2)(2011-2#3)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
primaurelia##4##1##(2008-12#4)
prime and##2##2##(2008-2#1)(2010-8#1)
prime candidate for##2##3##(1991-9#1)(2008-7#1)
prime candidate##3##2##(1991-9#1)(2008-7#2)
prime code##3##2##(2008-3#3)
prime importance##5##2##(1992-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
prime naïve CD4(+) T cells##2##5##(2008-11#2)
prime the##2##2##(1993-9#1)(1994-11#1)
prime time##2##2##(2008-8#1)(2010-4#1)
prime##63##1##(1990-4#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#7)(2008-3#4)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
primed for apoptosis##2##3##(1995-2#2)
primed for##3##2##(1995-2#2)(2007-12#1)
primed polymerase chain reaction##6##4##(2008-10#5)(2008-11#1)
primed with##4##2##(1992-1#1)(1995-2#1)(2008-10#1)(2010-8#1)
primed##26##1##(1990-11#1)(1991-6#1)(1992-1#1)(1994-6#1)(1995-12#1)(1995-2#4)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#2)
primer analysis##3##2##(2008-10#3)
primer and the##2##3##(1994-12#1)(1997-7#1)
primer and##10##2##(1990-11#1)(1992-6#1)(1994-12#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)
primer binding site##3##3##(1995-8#1)(2008-12#1)(2012-3#1)
primer binding##5##2##(1992-3#1)(1995-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
primer combination##2##2##(2008-10#2)
primer complementary to##2##3##(1997-7#1)(2008-5#1)
primer concentration##2##2##(1994-12#1)(2008-10#1)
primer designed##2##2##(2007-6#1)(2008-4#1)
primer extension analysis of##3##4##(1993-2#1)(1993-8#1)(2008-10#1)
primer extension analysis##4##3##(1990-11#1)(1993-2#1)(1993-8#1)(2008-10#1)
primer extension and##3##3##(1990-11#1)(1990-12#1)(1991-9#1)
primer extension assay##2##3##(2008-4#2)
primer extension##21##2##(1990-11#3)(1990-12#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-9#1)
primer for##4##2##(1996-2#1)(2008-11#1)(2008-4#1)(2010-1#1)
primer have##2##2##(2008-10#1)(2008-8#1)
primer hybridization##2##2##(2008-2#2)
primer in##3##2##(2008-5#1)(2008-7#1)(2009-3#1)
primer is##5##2##(1990-12#1)(1994-12#1)(2008-11#1)(2008-2#1)(2009-7#1)
primer loop of##3##3##(2009-7#3)
primer loop##4##2##(2009-7#4)
primer of##2##2##(2008-11#1)(2008-8#1)
primer on##6##2##(1993-12#2)(1994-3#1)(1996-3#1)(2011-2#1)(2013-1#1)
primer pair amplified##2##3##(1992-2#1)(2008-10#1)
primer pair##22##2##(1992-2#2)(1995-12#1)(2008-10#18)(2008-5#1)
primer pairs and##3##3##(1995-6#1)(2008-11#1)(2008-5#1)
primer pairs derived from##2##4##(1995-12#1)(2008-10#1)
primer pairs for##2##3##(2008-10#1)(2013-8#1)
primer pairs used##2##3##(2008-10#2)
primer pairs were used##2##4##(2008-10#2)
primer pairs were##3##3##(2008-10#3)
primer pairs##29##2##(1995-12#1)(1995-6#1)(2008-10#21)(2008-11#1)(2008-5#3)(2011-2#1)(2013-8#1)
primer set is##2##3##(2008-10#2)
primer set was##3##3##(2008-10#3)
primer set##15##2##(2008-10#13)(2008-4#1)(2011-1#1)
primer sets for##2##3##(2008-10#2)
primer sets##15##2##(1997-2#1)(1997-4#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
primer##212##1##(1990-11#4)(1990-12#2)(1991-3#1)(1991-9#2)(1992-2#2)(1992-3#3)(1992-6#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(2007-6#1)(2008-10#95)(2008-11#4)(2008-12#3)(2008-2#6)(2008-4#9)(2008-5#9)(2008-7#1)(2008-8#6)(2008-9#6)(2009-3#1)(2009-7#5)(2010-1#1)(2011-1#4)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
primer-probe systems##2##2##(2008-10#1)(2010-4#1)
primer-probe##5##1##(2008-10#3)(2010-4#2)
primer/probe sets were##3##3##(2008-10#3)
primer/probe sets##4##2##(2008-10#4)
primer/probe##6##1##(2008-10#6)
primers also were##2##3##(2008-10#2)
primers also##3##2##(2008-10#3)
primers amplified the##2##3##(2008-10#2)
primers amplified##7##2##(2008-10#7)
primers and TaqMan probes##3##4##(2008-10#2)(2010-4#1)
primers and probes##2##3##(2008-10#2)
primers and the polymerase chain reaction##2##6##(1994-12#2)
primers and the##3##3##(1994-12#2)(2008-8#1)
primers and##19##2##(1992-3#1)(1994-12#2)(2008-10#13)(2008-8#1)(2008-9#1)(2010-4#1)
primers based on the##3##4##(1993-2#1)(2008-10#2)
primers based on##6##3##(1993-2#1)(1993-3#1)(2008-10#3)(2008-5#1)
primers confirmed##2##2##(2008-10#1)(2012-12#1)
primers corresponding to##2##3##(1992-6#1)(1997-2#1)
primers could##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
primers derived from##3##3##(1997-6#1)(2008-10#2)
primers designed according to##2##4##(2008-8#1)(2008-9#1)
primers designed for##2##3##(2008-10#1)(2008-5#1)
primers designed from the##4##4##(1997-7#1)(2008-10#3)
primers designed from##5##3##(1994-12#1)(1997-7#1)(2008-10#3)
primers designed in this##2##4##(2008-10#1)(2010-4#1)
primers designed to##3##3##(1995-11#1)(2008-10#2)
primers designed##15##2##(1994-12#1)(1995-11#1)(1997-7#1)(2007-6#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
primers detected##2##2##(2008-10#2)
primers flanking the##6##3##(1990-11#1)(1990-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
primers for C##2##3##(2008-10#2)
primers for polymerase chain reaction##2##5##(2008-10#2)
primers for the##2##3##(2008-10#2)
primers for##19##2##(1990-11#1)(1994-11#1)(1995-6#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)
primers from##6##2##(1994-11#1)(2008-10#4)(2008-9#1)
primers identified##2##2##(2008-10#1)(2008-5#1)
primers in a##2##3##(2008-10#2)
primers in##7##2##(1990-7#1)(2008-10#5)(2008-12#1)
primers is##3##2##(2008-10#3)
primers on##2##2##(2008-10#1)(2011-2#1)
primers produced##2##2##(1997-4#1)(2013-7#1)
primers resulted in##2##3##(2008-10#2)
primers revealed##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
primers specific for the##4##4##(1992-3#1)(2008-10#2)(2008-5#1)
primers specific for##8##3##(1992-3#1)(2007-12#1)(2008-10#5)(2008-5#1)
primers specific##9##2##(1992-3#1)(2007-12#1)(2008-10#6)(2008-5#1)
primers targeting the conserved##2##4##(2008-10#2)
primers that amplified##2##3##(1993-12#1)(2008-10#1)
primers that amplify##3##3##(2008-10#3)
primers that specifically amplified##2##4##(1993-12#1)(2008-10#1)
primers that were##2##3##(2008-10#2)
primers that##11##2##(1993-12#2)(1993-6#1)(2008-10#8)
primers to##9##2##(1991-5#1)(1996-2#1)(2008-10#6)(2008-5#1)
primers used##4##2##(1997-7#1)(2008-10#2)(2008-5#1)
primers was found to be##2##5##(2008-10#1)(2008-12#1)
primers was##7##2##(1993-2#1)(1997-4#1)(2008-10#4)(2008-12#1)
primers were designed and used to##2##6##(2008-10#2)
primers were designed and##4##4##(2008-10#3)(2008-8#1)
primers were designed for##2##4##(2008-10#2)
primers were designed to##2##4##(2008-10#1)(2012-12#1)
primers were designed##12##3##(2008-10#8)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
primers were developed##2##3##(2008-10#2)
primers were screened##3##3##(2008-10#3)
primers were used in##2##4##(2008-10#2)
primers were used to amplify##2##5##(2007-6#1)(2008-10#1)
primers were used to##7##4##(1993-6#1)(1993-9#1)(2007-6#1)(2008-10#3)(2008-8#1)
primers were used##10##3##(1993-6#1)(1993-9#1)(2007-6#1)(2008-10#6)(2008-8#1)
primers were##38##2##(1993-6#1)(1993-9#1)(1994-12#1)(2007-6#1)(2008-10#29)(2008-8#2)(2011-2#1)(2012-12#1)(2013-8#1)
primers with sequences##2##3##(1994-12#1)(2008-10#1)
primers with##3##2##(1994-12#1)(2008-10#1)(2010-4#1)
primers##324##1##(1990-11#4)(1990-12#1)(1990-5#2)(1990-7#2)(1991-5#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#9)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-2#3)(1997-4#5)(1997-6#2)(1997-7#6)(1997-8#1)(2007-12#1)(2007-6#2)(2008-10#191)(2008-11#5)(2008-12#9)(2008-2#2)(2008-4#1)(2008-5#15)(2008-7#2)(2008-8#7)(2008-9#7)(2010-4#4)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
primes##6##1##(1992-3#1)(1992-8#2)(1995-2#1)(1995-5#1)(2012-3#1)
primexine##2##1##(2011-2#2)
primigravid##2##1##(1992-5#2)
priming doses##2##2##(2008-7#2)
priming effect of extracellular##2##4##(2008-4#2)
priming effect##3##2##(2008-2#1)(2008-4#2)
priming for##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
priming in##2##2##(2008-4#1)(2010-7#1)
priming is##2##2##(1992-3#1)(2013-8#1)
priming may##4##2##(2013-8#4)
priming of alveolar macrophages##2##4##(1992-8#2)
priming of##8##2##(1992-8#3)(2008-10#3)(2008-2#1)(2008-4#1)
priming to##3##2##(2009-11#1)(2010-7#2)
priming with 1 nM neuropeptide##2##5##(1995-12#2)
priming with##3##2##(1992-3#1)(1995-12#2)
priming##65##1##(1992-3#4)(1992-6#1)(1992-8#5)(1995-12#2)(1995-2#3)(1995-5#2)(1997-4#1)(2008-10#9)(2008-11#1)(2008-2#5)(2008-4#5)(2008-7#4)(2009-11#1)(2010-7#4)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#1)(2013-8#9)
priming&quot##2##1##(1992-3#2)
primipara##4##1##(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
primiparas##5##1##(1996-12#1)(2008-4#1)(2011-2#3)
primiparous mothers##3##2##(1992-5#3)
primiparous##6##1##(1992-5#3)(2011-1#1)(2011-2#1)(2012-3#1)
primitive and##2##2##(1992-2#1)(2007-2#1)
primitive cells##2##2##(2008-1#1)(2011-1#1)
primitive neuroectodermal tumour of the chest wall##2##7##(2008-6#2)
primitive neuroectodermal tumour##3##3##(2008-6#2)(2008-7#1)
primitive neuroectodermal##8##2##(2008-6#2)(2008-7#1)(2009-1#3)(2012-12#2)
primitive stem##2##2##(2008-9#1)(2010-11#1)
primitive##47##1##(1990-10#1)(1990-3#1)(1990-5#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#3)(2009-10#1)(2009-12#1)(2010-11#3)(2010-3#2)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
primitive&quot##2##1##(2010-11#2)
primitives##6##1##(2008-11#2)(2008-3#2)(2008-6#2)
primordia##6##1##(2008-8#2)(2009-8#4)
primordial and primary follicles##2##4##(1995-12#2)
primordial endoblast##2##2##(2007-12#2)
primordial germ cells (PGCs)##2##4##(2008-11#2)
primordial germ cells between chicken##2##5##(2008-11#2)
primordial germ cells##9##3##(2008-11#4)(2010-5#5)
primordial germ##11##2##(2007-12#1)(2008-11#4)(2008-12#1)(2010-5#5)
primordial mesoteloblast##2##2##(2007-12#2)
primordial##30##1##(1995-12#2)(1996-2#1)(2007-12#7)(2008-11#5)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#5)(2012-12#1)(2013-1#2)
primordium##2##1##(2008-5#1)(2008-8#1)
primosome##2##1##(1991-7#1)(1992-3#1)
principal A beta##2##3##(1994-8#2)
principal axes##3##2##(2007-11#2)(2008-3#1)
principal axis##2##2##(2008-3#1)(2009-5#1)
principal cause of##2##3##(2007-10#1)(2008-2#1)
principal cause##3##2##(2007-10#1)(2008-2#1)(2008-7#1)
principal causes##2##2##(2008-10#1)(2012-2#1)
principal component analysis (PCA) and partial least##2##7##(2008-10#2)
principal component analysis (PCA) and##11##5##(2008-10#11)
principal component analysis (PCA) for##2##5##(2008-10#1)(2010-5#1)
principal component analysis (PCA) method##2##5##(2008-10#1)(2013-8#1)
principal component analysis (PCA) of##3##5##(1996-5#1)(2008-10#1)(2011-2#1)
principal component analysis (PCA)##36##4##(1996-5#1)(2008-1#1)(2008-10#28)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
principal component analysis and cluster analysis##2##6##(2008-10#2)
principal component analysis and improved BP##2##6##(2013-8#2)
principal component analysis and##7##4##(2008-10#4)(2011-2#1)(2013-8#2)
principal component analysis is##2##4##(2013-1#2)
principal component analysis on the##2##5##(2010-8#1)(2011-2#1)
principal component analysis or##2##4##(2008-2#1)(2010-10#1)
principal component analysis to##2##4##(2008-10#1)(2010-8#1)
principal component analysis was##2##4##(2008-1#1)(2010-5#1)
principal component analysis##79##3##(1996-5#1)(2008-1#2)(2008-10#46)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2010-5#3)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#4)
principal component and##2##3##(2008-10#2)
principal component artificial neural network##2##5##(2008-10#2)
principal component of##4##3##(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#1)
principal component regression (PCR) and partial least squares (PLS)##2##9##(2008-10#1)(2013-8#1)
principal component regression (PCR) and partial##3##6##(2008-10#2)(2013-8#1)
principal component regression (PCR)##11##4##(2008-10#10)(2013-8#1)
principal component regression##16##3##(2008-10#15)(2013-8#1)
principal component##114##2##(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#2)(2008-1#3)(2008-10#71)(2008-11#2)(2008-2#1)(2008-9#1)(2010-10#1)(2010-5#3)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#5)
principal components (PCs)##5##3##(2008-10#5)
principal components analysis (PCA)##5##4##(2008-10#5)
principal components analysis and##2##4##(1992-2#1)(2008-10#1)
principal components analysis##18##3##(1992-2#1)(1992-6#2)(2008-10#11)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
principal components and cluster##2##4##(2008-10#2)
principal components of the##4##4##(1993-11#1)(1997-7#1)(2008-2#1)(2008-9#1)
principal components of##5##3##(1993-11#1)(1997-7#1)(2008-2#1)(2008-6#1)(2008-9#1)
principal components scores##2##3##(2008-10#1)(2010-7#1)
principal components##44##2##(1992-2#1)(1992-6#2)(1993-11#1)(1997-7#1)(2008-10#24)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-7#1)(2010-8#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
principal cortical##2##2##(1991-3#1)(2008-11#1)
principal curve algorithm##2##3##(2009-12#2)
principal determinants##2##2##(1990-7#1)(2009-11#1)
principal direction##2##2##(2008-6#2)
principal findings of##3##3##(1992-8#1)(2008-7#1)(2011-1#1)
principal findings were as follows##2##5##(1997-2#1)(2008-7#1)
principal findings##5##2##(1992-8#1)(1997-2#1)(2008-7#2)(2011-1#1)
principal food##2##2##(2008-1#1)(2008-5#1)
principal frequency##2##2##(2008-8#1)(2008-9#1)
principal investigator##2##2##(2010-11#1)(2012-3#1)
principal map##2##2##(2008-11#2)
principal parts##2##2##(2008-3#1)(2013-8#1)
principal peak##2##2##(1992-12#2)
principal plane##5##2##(2008-2#1)(2008-3#4)
principal refractive indices and##4##4##(2008-2#4)
principal refractive indices##7##3##(2008-2#5)(2008-3#2)
principal source of##4##3##(1991-8#1)(1996-4#1)(2007-12#1)(2008-10#1)
principal states of polarization##3##4##(2007-11#1)(2007-12#2)
principal strain##2##2##(2013-1#2)
principal stratification##4##2##(2009-9#4)
principal transmittance##2##2##(2007-11#2)
principal##339##1##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#9)(2007-12#6)(2007-2#1)(2008-1#6)(2008-10#112)(2008-11#9)(2008-12#1)(2008-2#9)(2008-3#23)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#2)(2010-5#3)(2010-7#5)(2010-8#6)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#9)
principal-component analysis##4##2##(2008-10#3)(2008-2#1)
principal-component##6##1##(2008-10#3)(2008-2#3)
principalement##2##1##(2008-5#1)(2011-2#1)
principally due to##3##3##(1991-12#1)(2008-7#1)(2013-1#1)
principally from the##2##3##(1995-11#1)(2013-7#1)
principally from##3##2##(1993-2#1)(1995-11#1)(2013-7#1)
principally in the##3##3##(1994-2#1)(1996-12#1)(2008-12#1)
principally in##6##2##(1994-2#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
principally on##4##2##(2008-10#1)(2008-5#1)(2010-3#1)(2010-4#1)
principally responsible for##2##3##(1996-12#1)(1996-2#1)
principally through##3##2##(2008-10#2)(2008-4#1)
principally##40##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-4#1)(1996-12#2)(1996-2#1)(2006-10#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#5)(2009-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
principle and the##3##3##(2007-11#1)(2008-2#1)(2009-5#1)
principle and##11##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
principle applicable to reflected##2##4##(2008-3#2)
principle are##3##2##(2008-3#1)(2009-5#1)(2012-2#1)
principle behind##3##2##(2008-2#1)(2008-9#1)(2011-7#1)
principle by##2##2##(2008-10#1)(2008-2#1)
principle component analysis##2##3##(2008-10#2)
principle component##4##2##(2007-12#1)(2008-10#3)
principle for the##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
principle for##14##2##(1993-11#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-4#1)(2010-5#1)(2013-1#1)
principle from##2##2##(1992-9#1)(1993-3#1)
principle in massage##2##3##(2009-3#2)
principle in##7##2##(1992-1#1)(1995-8#1)(1997-6#1)(2008-10#1)(2009-3#2)(2012-2#1)
principle involves##2##2##(2008-10#1)(2012-2#1)
principle is based on the##2##5##(2008-10#1)(2010-7#1)
principle is based on##3##4##(2008-10#1)(2010-7#1)(2011-1#1)
principle is presented##2##3##(2008-3#2)
principle is to##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
principle is##22##2##(1992-3#1)(1995-3#1)(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2010-7#2)(2011-1#1)
principle of a##2##3##(2008-10#1)(2008-3#1)
principle of cost-effectiveness##2##3##(2008-7#2)
principle of early##2##3##(2008-11#2)
principle of the method##3##4##(2008-10#1)(2008-2#2)
principle of the technique##2##4##(2008-2#1)(2008-3#1)
principle of the##15##3##(1997-6#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)
principle of this##5##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
principle of##85##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#4)(1992-4#1)(1993-9#1)(1995-9#3)(1996-3#1)(1997-6#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#3)
principle that the##3##3##(1992-2#1)(2008-3#1)(2011-2#1)
principle that##9##2##(1992-2#1)(1994-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
principle to emulsions##2##3##(2008-5#2)
principle to estimate the##2##4##(2007-11#1)(2008-3#1)
principle to##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
principle using a##2##3##(2008-10#2)
principle using##4##2##(2008-10#4)
principle was used to##2##4##(2008-12#1)(2008-9#1)
principle was##5##2##(2008-10#3)(2008-12#1)(2008-9#1)
principle with##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
principle##307##1##(1990-3#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#3)(1992-2#1)(1992-3#10)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#3)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(2007-11#10)(2007-12#11)(2007-8#2)(2008-1#3)(2008-10#62)(2008-11#9)(2008-12#5)(2008-2#23)(2008-3#51)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#6)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#5)(2011-2#3)(2011-7#2)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#4)
principle)##3##1##(1992-8#1)(2008-10#1)(2008-5#1)
principled##4##1##(1993-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
principles and a##2##3##(1996-2#1)(2008-3#1)
principles and applications##3##3##(2008-10#2)(2013-8#1)
principles and clinical##2##3##(2009-11#1)(2013-8#1)
principles and methods##2##3##(1995-3#1)(2010-8#1)
principles and models##2##3##(2008-2#1)(2008-9#1)
principles and practice of##3##4##(1993-12#1)(1994-5#1)(1997-3#1)
principles and practice##7##3##(1993-12#1)(1994-5#1)(1997-3#1)(2008-4#3)(2008-5#1)
principles and practices##3##3##(2008-6#1)(2008-9#2)
principles and strategies##2##3##(2010-1#1)(2013-1#1)
principles and techniques##4##3##(1990-12#1)(1995-1#1)(1997-3#1)(2007-12#1)
principles and the##2##3##(2008-11#1)(2008-2#1)
principles and##62##2##(1990-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#4)(1995-6#2)(1996-2#3)(1996-4#1)(1997-3#3)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#6)(2009-11#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
principles are addressed##2##3##(2008-12#1)(2010-8#1)
principles are discussed##2##3##(2008-2#1)(2008-3#1)
principles are##16##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
principles as##2##2##(2008-1#1)(2008-10#1)
principles based on##3##3##(2008-1#1)(2008-5#1)(2008-8#1)
principles by##2##2##(1994-3#1)(2008-8#1)
principles discussed##3##2##(2007-5#1)(2008-4#1)(2010-8#1)
principles for clinical##2##3##(1996-2#1)(2012-2#1)
principles for the##6##3##(1991-9#1)(1994-1#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-1#1)
principles for treating##2##3##(1993-6#1)(2007-11#1)
principles for##28##2##(1991-9#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2010-6#2)(2012-12#1)(2012-2#1)(2013-1#1)
principles from the##2##3##(2008-10#1)(2008-12#1)
principles from##3##2##(1992-3#1)(2008-10#1)(2008-12#1)
principles governing##3##2##(1994-2#1)(2007-11#1)(2008-11#1)
principles have been##2##3##(2008-10#1)(2008-3#1)
principles have##5##2##(1992-2#1)(2008-10#1)(2008-3#1)(2009-4#1)(2013-1#1)
principles in the##4##3##(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
principles in##11##2##(1992-1#1)(1992-2#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
principles is##2##2##(2008-7#1)(2008-9#1)
principles of a##2##3##(1992-6#1)(2007-12#1)
principles of action##2##3##(2010-6#1)(2010-7#1)
principles of adult learning##2##4##(1992-1#1)(2007-5#1)
principles of adult##3##3##(1992-1#1)(2007-5#1)(2008-12#1)
principles of an##3##3##(2008-3#2)(2008-9#1)
principles of beneficence##2##3##(1991-2#1)(2008-1#1)
principles of care##2##3##(2008-11#1)(2008-8#1)
principles of continuous quality improvement##2##5##(1992-12#1)(1993-2#1)
principles of diagnosis##2##3##(2007-8#1)(2011-2#1)
principles of general##2##3##(2008-10#1)(2008-11#1)
principles of justice##2##3##(2009-6#1)(2011-2#1)
principles of management of##3##4##(2011-2#1)(2012-2#2)
principles of optical design and linear measurement##2##7##(2008-3#2)
principles of optical##3##3##(2008-3#2)(2012-2#1)
principles of pharmacology and therapeutics##2##5##(2008-11#2)
principles of statistical##2##3##(2008-10#1)(2008-3#1)
principles of the##14##3##(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-6#1)(2010-9#1)(2011-1#1)(2011-7#1)
principles of this##4##3##(1993-6#1)(1997-4#1)(2007-12#1)(2008-3#1)
principles of treatment##2##3##(1992-4#1)(1996-3#1)
principles of##170##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#13)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2010-11#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#7)(2011-7#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
principles that##6##2##(2008-1#1)(2008-2#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-2#1)
principles to avoid##2##3##(1991-1#1)(2007-12#1)
principles to the##2##3##(1992-1#1)(1996-2#1)
principles to##10##2##(1991-1#1)(1992-1#1)(1992-2#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
principles underlying the##6##3##(1992-12#1)(2007-12#1)(2008-9#1)(2010-8#1)(2012-2#2)
principles underlying##9##2##(1992-12#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#2)
principles used##3##2##(2008-7#1)(2011-1#1)(2013-8#1)
principles were##2##2##(2008-10#1)(2012-3#1)
principles with##2##2##(1994-11#1)(2008-10#1)
principles##442##1##(1990-11#1)(1990-12#3)(1990-5#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#5)(1992-4#2)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#2)(1994-1#5)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#6)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(2007-11#9)(2007-12#13)(2007-2#1)(2007-5#4)(2007-8#2)(2008-1#10)(2008-10#31)(2008-11#20)(2008-12#10)(2008-2#10)(2008-3#23)(2008-4#19)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#14)(2008-9#29)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#5)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#7)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#20)(2012-3#3)(2013-1#16)(2013-8#11)
principles]##2##1##(1994-9#1)(1995-2#1)
print awareness##2##2##(2009-9#2)
print##14##1##(1991-12#1)(1993-1#1)(1997-2#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-9#3)(2011-2#1)(2012-2#1)(2013-1#2)
printed circuit boards##3##3##(2008-10#1)(2008-2#2)
printed circuit##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
printed in##2##2##(2008-10#1)(2008-2#1)
printed on##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
printed standards of care##2##4##(2008-3#2)
printed upon##2##2##(2008-2#2)
printed##30##1##(1991-1#1)(1991-5#1)(1992-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#11)(2008-7#1)(2011-3#1)(2013-1#1)
printing and##2##2##(2008-10#1)(2008-7#1)
printing of##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
printing##17##1##(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#4)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#1)
prion disease##3##2##(2010-12#3)
prion diseases in animals and man##2##6##(1996-3#2)
prion diseases##3##2##(1996-3#2)(1997-3#1)
prion protein##8##2##(1996-5#2)(1997-3#1)(1997-5#1)(2008-11#2)(2008-5#2)
prion transmission##2##2##(2008-10#1)(2010-11#1)
prion##23##1##(1996-3#5)(1996-5#2)(1997-3#2)(1997-5#1)(2008-10#1)(2008-11#6)(2008-5#2)(2010-11#1)(2010-12#3)
prions##3##1##(2010-4#3)
prior addition of##2##3##(1993-3#2)
prior antigenic exposure##2##3##(2008-4#1)(2012-2#1)
prior can##2##2##(2008-6#1)(2011-1#1)
prior conditions##2##2##(2010-11#2)
prior depression##3##2##(2013-1#3)
prior diagnosis of##2##3##(1997-3#1)(2008-12#1)
prior distributions on##2##3##(2009-10#1)(2009-4#1)
prior distributions##5##2##(1995-12#1)(2009-10#3)(2009-4#1)
prior drug##2##2##(1992-9#1)(1996-9#1)
prior experience##6##2##(1992-12#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#1)
prior exposure to##5##3##(1993-12#1)(1994-9#1)(1997-1#1)(2006-10#1)(2008-10#1)
prior exposure##6##2##(1993-12#2)(1994-9#1)(1997-1#1)(2006-10#1)(2008-10#1)
prior extraction##4##2##(1990-8#1)(2008-10#3)
prior findings##4##2##(1996-5#1)(2007-9#1)(2008-9#1)(2009-11#1)
prior for##2##2##(2008-6#1)(2010-5#1)
prior history of##7##3##(1996-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
prior history##9##2##(1992-7#1)(1996-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
prior hypotheses of##2##3##(2010-6#1)(2013-7#1)
prior i##3##2##(1990-11#1)(1996-2#1)(1997-4#1)
prior immunity##2##2##(2009-12#1)(2011-2#1)
prior incubation with##2##3##(1992-3#1)(1994-8#1)
prior induction of##2##3##(1994-11#1)(1995-2#1)
prior information on the##2##4##(2008-10#1)(2008-3#1)
prior information on##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
prior information##7##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-2#1)(2012-2#1)
prior knowledge about the##3##4##(2008-2#1)(2008-4#1)(2010-11#1)
prior knowledge about##4##3##(2008-2#1)(2008-4#1)(2010-11#1)(2012-1#1)
prior knowledge of the##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)
prior knowledge of##8##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
prior knowledge##15##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-1#1)
prior myocardial infarction##2##3##(2008-3#1)(2011-2#1)
prior removal of##2##3##(1995-2#1)(2008-10#1)
prior reports##2##2##(2008-1#1)(2008-7#1)
prior research##3##2##(2008-10#1)(2008-9#1)(2009-11#1)
prior separation##9##2##(2008-10#9)
prior stimulation of##2##3##(2008-11#2)
prior stimulation##3##2##(2008-11#3)
prior studies##4##2##(1993-1#1)(1996-5#1)(2011-2#1)(2012-3#1)
prior the##2##2##(2008-10#1)(2011-2#1)
prior to 1990/91##2##3##(2008-5#2)
prior to 37##2##3##(2011-2#2)
prior to FAST##2##3##(2012-12#2)
prior to HSG##2##3##(2011-2#2)
prior to PCR##2##3##(1996-12#1)(2008-10#1)
prior to a##8##3##(1990-12#1)(1991-6#1)(1993-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#2)
prior to activity##2##3##(1993-6#1)(2013-1#1)
prior to addition of##2##4##(1994-6#1)(2008-11#1)
prior to an##2##3##(2008-12#1)(2008-3#1)
prior to analysis by##3##4##(2008-10#3)
prior to analysis of##2##4##(1993-12#1)(2008-4#1)
prior to analysis##16##3##(1993-12#1)(2008-10#11)(2008-4#2)(2010-5#1)(2012-12#1)
prior to and after##4##4##(1995-12#1)(1997-2#2)(2008-5#1)
prior to and##9##3##(1990-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#2)(2008-5#1)(2008-7#1)
prior to any##3##3##(1993-12#1)(2008-11#1)(2008-4#1)
prior to application of the##2##5##(1990-7#1)(2008-10#1)
prior to application of##3##4##(1990-7#1)(2008-10#2)
prior to application##4##3##(1990-7#1)(2008-10#3)
prior to commitment##2##3##(1994-12#2)
prior to contact with##3##4##(2008-10#2)(2008-8#1)
prior to death##2##3##(1991-12#1)(1995-1#1)
prior to detection##2##3##(2008-10#2)
prior to determination##2##3##(2008-10#2)
prior to diagnosis##3##3##(1990-6#1)(1992-8#1)(2008-1#1)
prior to differentiation##2##3##(2011-2#2)
prior to discharge##3##3##(1994-2#1)(2007-10#2)
prior to disease##2##3##(2008-10#2)
prior to drug##2##3##(2008-4#1)(2008-8#1)
prior to each##5##3##(1990-12#1)(1994-2#1)(1997-2#1)(2008-10#2)
prior to entering##4##3##(1993-1#1)(1994-12#1)(1994-3#1)(2008-11#1)
prior to exposure to##2##4##(2008-10#2)
prior to exposure##3##3##(2008-10#2)(2008-11#1)
prior to final##2##3##(1992-9#1)(1997-4#1)
prior to flame atomic absorption##2##5##(2008-10#2)
prior to gastric##2##3##(1996-12#1)(2012-5#1)
prior to harvest##4##3##(2007-8#1)(2008-10#3)
prior to heading##2##3##(2008-10#2)
prior to her##2##3##(1994-6#1)(1995-12#1)
prior to high##3##3##(2008-10#2)(2008-11#1)
prior to implantation##2##3##(2008-9#1)(2012-1#1)
prior to implementation##2##3##(1994-3#1)(2008-6#1)
prior to incubation##2##3##(1990-12#1)(2008-5#1)
prior to infestation with##2##4##(2008-10#2)
prior to initiating##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
prior to initiation of##2##4##(2008-10#1)(2008-11#1)
prior to injection##2##3##(1995-5#1)(2007-11#1)
prior to inoculation with the pathogen##2##6##(2008-10#2)
prior to inoculation with the##3##5##(2008-10#3)
prior to inoculation with##6##4##(2008-10#6)
prior to inoculation##12##3##(2008-10#12)
prior to introduction##2##3##(2009-2#1)(2011-1#1)
prior to ion##2##3##(1991-2#1)(2008-10#1)
prior to irradiation##3##3##(1994-12#1)(1997-4#1)(2008-7#1)
prior to ischemia##4##3##(1996-9#3)(2011-2#1)
prior to its determination by inductively coupled plasma##2##8##(2008-10#2)
prior to its determination by##3##5##(2008-10#3)
prior to its##9##3##(2007-12#1)(2008-10#6)(2008-11#1)(2013-8#1)
prior to making##2##3##(2008-11#1)(2011-2#1)
prior to obliteration##2##3##(2008-7#2)
prior to onset of##2##4##(1997-2#1)(2008-10#1)
prior to pathogen##2##3##(2008-10#2)
prior to petal expansion##2##4##(2008-10#2)
prior to photoaffinity labeling##2##4##(1990-11#2)
prior to placement##3##3##(2007-7#2)(2008-10#1)
prior to planting of##2##4##(2008-10#2)
prior to planting##5##3##(2008-10#5)
prior to pregnancy##2##3##(2007-12#1)(2008-10#1)
prior to radial artery harvest for##2##6##(2007-8#2)
prior to radial artery harvest##3##5##(2007-8#3)
prior to referral##2##3##(2006-10#1)(2008-6#1)
prior to sacrifice##3##3##(1992-11#1)(1996-2#1)(2008-10#1)
prior to sampling##3##3##(1996-12#2)(2008-10#1)
prior to separation##2##3##(1997-2#1)(2010-5#1)
prior to stimulation##2##3##(1992-12#1)(2008-7#1)
prior to structural##3##3##(1997-2#1)(2008-4#1)(2009-9#1)
prior to surgery and##2##4##(1991-2#1)(1997-2#1)
prior to surgery or radiosurgery##2##5##(2008-7#2)
prior to surgery or##3##4##(2008-10#1)(2008-7#2)
prior to surgery##16##3##(1991-2#1)(1991-3#1)(1992-10#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)
prior to surgical##3##3##(1997-6#1)(2011-2#1)(2012-12#1)
prior to testing##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
prior to the addition of##2##5##(1996-1#1)(2008-10#1)
prior to the administration of##2##5##(1995-12#1)(2007-10#1)
prior to the analysis##4##4##(1994-6#1)(2008-10#3)
prior to the appearance of##2##5##(1992-12#1)(2012-3#1)
prior to the determination by##2##5##(2008-10#2)
prior to the determination of##4##5##(2008-10#4)
prior to the determination##6##4##(2008-10#6)
prior to the development of##3##5##(2008-10#1)(2009-3#1)(2010-1#1)
prior to the divergence of##2##5##(1994-11#1)(2011-1#1)
prior to the extraction##2##4##(2008-10#1)(2012-1#1)
prior to the formation of##2##5##(2008-10#2)
prior to the introduction of CsA##2##6##(2007-7#2)
prior to the introduction of##3##5##(2007-7#2)(2010-3#1)
prior to the onset of##6##5##(1991-1#1)(1994-2#1)(2008-10#1)(2009-10#1)(2010-10#1)(2012-2#1)
prior to the pathogen##2##4##(2008-10#2)
prior to the radiation##2##4##(2007-12#1)(2008-3#1)
prior to the retention##2##4##(1994-8#1)(1995-12#1)
prior to the start of the##2##6##(2008-10#1)(2010-11#1)
prior to the third injection##2##5##(2013-8#2)
prior to the##106##3##(1991-1#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#2)(1996-4#2)(1996-9#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#30)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-8#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
prior to their baby's discharge##2##5##(1994-2#2)
prior to their determination by flame atomic absorption spectrometry##5##9##(2008-10#5)
prior to their determination by graphite furnace atomic absorption spectrometry##2##10##(2008-10#2)
prior to their determination by inductively coupled plasma atomic emission spectrometry##2##11##(2008-10#2)
prior to their determination by inductively coupled##3##7##(2008-10#3)
prior to their determination by##13##5##(2008-10#13)
prior to their##32##3##(1990-2#1)(1991-2#1)(1994-2#2)(1995-1#1)(2008-10#23)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
prior to this##3##3##(1992-6#1)(2008-10#2)
prior to transfection##2##3##(2008-11#2)
prior to treatment##8##3##(1991-3#1)(1992-6#2)(1997-4#1)(2008-5#2)(2011-2#1)(2012-2#1)
prior to wound closure##3##4##(2008-7#3)
prior to##612##2##(1990-11#4)(1990-12#5)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-6#4)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#3)(1994-11#1)(1994-12#8)(1994-2#6)(1994-3#6)(1994-6#5)(1994-8#7)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#6)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#2)(1996-9#5)(1997-2#7)(1997-3#3)(1997-4#6)(1997-6#5)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#7)(2008-1#3)(2008-10#188)(2008-11#19)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#13)(2008-5#17)(2008-6#7)(2008-7#23)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-5#2)(2010-6#1)(2010-8#8)(2011-1#13)(2011-2#16)(2012-1#2)(2012-12#11)(2012-2#5)(2012-3#6)(2012-5#2)(2013-1#8)(2013-7#1)(2013-8#3)
prior training##2##2##(2008-10#2)
prior treatment with##2##3##(1991-4#1)(2009-8#1)
prior treatment##8##2##(1991-2#1)(1991-4#1)(2008-10#3)(2009-8#1)(2012-3#2)
prior use of##2##3##(2008-12#1)(2008-5#1)
prior use##3##2##(1994-3#1)(2008-12#1)(2008-5#1)
prior work##3##2##(2008-10#1)(2009-9#1)(2013-8#1)
prior##887##1##(1990-11#6)(1990-12#5)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-4#1)(1991-6#4)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#8)(1992-6#6)(1992-7#5)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#6)(1993-6#3)(1994-1#1)(1994-11#3)(1994-12#9)(1994-2#7)(1994-3#7)(1994-6#5)(1994-8#8)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#11)(1995-2#7)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#3)(1996-12#8)(1996-2#5)(1996-3#4)(1996-4#4)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#7)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#8)(1997-6#5)(1997-7#1)(1997-8#4)(2006-10#3)(2007-10#7)(2007-11#4)(2007-12#9)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#12)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#238)(2008-11#26)(2008-12#7)(2008-2#12)(2008-3#11)(2008-4#19)(2008-5#20)(2008-6#10)(2008-7#28)(2008-8#13)(2008-9#16)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#7)(2010-2#2)(2010-3#8)(2010-4#1)(2010-5#5)(2010-6#5)(2010-8#11)(2011-1#17)(2011-2#25)(2012-1#4)(2012-12#14)(2012-2#8)(2012-3#11)(2012-5#2)(2013-1#18)(2013-7#4)(2013-8#7)
priori##55##1##(1990-8#2)(1991-12#1)(1997-6#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#10)(2008-3#17)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
priorities and##7##2##(1991-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-7#1)(2013-1#1)
priorities are##2##2##(1994-2#1)(2013-1#1)
priorities for Australian critical care nurses##3##6##(2007-11#3)
priorities for the##4##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
priorities for##20##2##(1992-2#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#6)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)
priorities in##6##2##(1991-1#1)(1991-6#1)(1992-2#1)(1994-2#1)(2008-10#1)(2010-10#1)
priorities include##2##2##(1994-2#1)(2011-1#1)
priorities of calls and##2##4##(2010-3#2)
priorities of calls##3##3##(2010-3#3)
priorities of##7##2##(1996-1#1)(2008-7#2)(2010-3#3)(2011-2#1)
priorities##77##1##(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-2#2)(1992-6#1)(1992-8#1)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#6)(2007-10#1)(2007-11#9)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#2)
priorities)##2##1##(1993-12#1)(2008-1#1)
prioritised##2##1##(2009-4#1)(2011-2#1)
prioritization of##3##2##(1992-11#1)(1995-8#1)(1996-2#1)
prioritization##13##1##(1992-11#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(2010-8#3)(2011-2#3)(2013-7#1)
prioritize##9##1##(1994-3#1)(2008-10#2)(2008-8#2)(2010-12#1)(2010-9#2)(2011-2#1)
prioritized##12##1##(1994-3#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#3)
prioritizing##8##1##(1994-12#1)(1994-9#1)(2008-11#2)(2010-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
priority and##3##2##(1992-5#1)(2012-12#2)
priority area##2##2##(2008-1#1)(2008-7#1)
priority by##2##2##(2007-6#1)(2009-5#1)
priority for the##2##3##(1994-2#1)(2013-7#1)
priority for##11##2##(1994-2#1)(1994-3#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
priority in the##2##3##(1997-8#1)(2008-7#1)
priority in##14##2##(1992-12#1)(1993-11#1)(1994-3#1)(1996-12#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)
priority issues and problems to be addressed for the administrative##3##10##(2013-8#3)
priority issues and problems##4##4##(2013-8#4)
priority issues and##5##3##(2013-8#5)
priority of##4##2##(1991-11#1)(1993-3#1)(2008-12#1)(2010-3#1)
priority on##3##2##(1996-1#1)(2008-8#1)(2010-10#1)
priority pollutants##2##2##(2008-10#2)
priority setting##2##2##(1992-2#1)(2008-7#1)
priority to##5##2##(1997-1#1)(2007-11#1)(2008-9#1)(2009-3#1)(2013-7#1)
priority##106##1##(1990-3#1)(1991-11#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-5#1)(1993-11#2)(1993-3#2)(1994-2#2)(1994-3#3)(1994-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-8#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#3)(2013-8#5)
priority-setting##6##1##(1992-2#1)(2008-10#1)(2008-7#4)
priors##2##1##(1995-2#1)(2008-6#1)
prise en charge##6##3##(2011-2#2)(2013-1#4)
prism and##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
prism can be##2##3##(2008-2#1)(2008-3#1)
prism can##3##2##(2008-2#1)(2008-3#2)
prism coupler##2##2##(2008-3#2)
prism faces##2##2##(2008-2#1)(2008-3#1)
prism for##3##2##(2007-12#1)(2008-3#2)
prism in##2##2##(2007-12#1)(2008-3#1)
prism is##4##2##(2007-12#1)(2008-3#3)
prism pair##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
prism with##2##2##(2007-12#1)(2008-3#1)
prism##68##1##(1994-11#1)(1996-2#1)(2007-11#6)(2007-12#8)(2008-10#1)(2008-2#8)(2008-3#38)(2008-6#1)(2008-9#1)(2013-8#3)
prismatic or##2##2##(2007-12#1)(2008-10#1)
prismatic##8##1##(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)
prisms after the##2##3##(2008-3#2)
prisms that##2##2##(2007-11#1)(2008-3#1)
prisms to##2##2##(2007-11#1)(2008-2#1)
prisms##25##1##(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#18)(2013-8#1)
prison and##2##2##(2008-7#1)(2009-11#1)
prison inmates are##2##3##(1992-2#1)(2009-11#1)
prison##23##1##(1990-2#1)(1992-2#4)(1996-5#4)(1997-5#3)(2007-1#1)(2008-7#1)(2009-11#7)(2009-5#1)(2012-1#1)
prisoner's dilemma##6##2##(1995-2#1)(2008-8#5)
prisoner's##7##1##(1995-2#1)(1996-12#1)(2008-8#5)
prisoners##10##1##(1996-2#1)(1996-7#1)(1997-5#3)(2008-12#4)(2013-1#1)
prisons##4##1##(1992-2#2)(2009-7#1)(2010-5#1)
pristinamycin resistance##2##2##(2010-2#2)
pristinamycin##4##1##(2010-2#4)
pristine##7##1##(2007-11#1)(2007-12#1)(2008-10#2)(2009-11#1)(2010-4#1)(2012-2#1)
privacy in##2##2##(1996-9#1)(1997-5#1)
privacy interest##2##2##(1991-7#1)(1995-12#1)
privacy of##4##2##(1996-5#1)(1997-5#2)(2010-8#1)
privacy rule and##2##3##(2007-12#1)(2010-9#1)
privacy rule requirements##3##3##(2007-12#3)
privacy rule##7##2##(2007-12#6)(2010-9#1)
privacy##48##1##(1991-7#1)(1992-3#2)(1992-4#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-6#2)(1996-1#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-5#4)(2007-12#9)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-12#2)
private accreditation##2##2##(1995-3#2)
private and public health##2##4##(1997-3#1)(1997-4#1)
private and public##9##3##(1991-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2010-11#1)
private and##11##2##(1991-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2010-11#1)(2011-1#1)(2011-2#1)
private enterprise##2##2##(1995-12#1)(1997-5#1)
private fee-for-service##3##2##(2006-10#2)(2009-8#1)
private fees##5##2##(1994-1#5)
private funders##2##2##(1994-12#1)(1997-5#1)
private health care providers##2##4##(1996-2#1)(1996-3#1)
private health care##4##3##(1990-6#1)(1996-2#1)(1996-3#1)(2012-1#1)
private health insurance##13##3##(1992-2#1)(1993-1#1)(1993-3#3)(1994-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
private health##21##2##(1990-6#1)(1991-2#1)(1992-2#2)(1993-1#1)(1993-3#4)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2012-1#1)(2013-1#1)
private hospital employees##2##3##(2011-1#2)
private hospitals in##2##3##(2008-12#1)(2012-2#1)
private hospitals##5##2##(1992-2#1)(2007-7#2)(2008-12#1)(2012-2#1)
private houses##2##2##(2008-6#2)
private insurance coverage##3##3##(1991-12#1)(1992-2#1)(1994-3#1)
private insurance##11##2##(1991-12#1)(1992-2#2)(1994-1#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-3#2)(1997-2#1)
private insurers##4##2##(1993-1#1)(1994-1#1)(1994-2#1)(1997-5#1)
private laboratories##4##2##(1991-6#1)(1997-4#2)(1997-5#1)
private laboratory##4##2##(1994-12#1)(1997-4#2)(2010-4#1)
private medical##5##2##(1992-3#1)(1996-1#1)(2010-4#1)(2012-2#1)(2013-7#1)
private or##3##2##(1992-3#1)(1993-2#1)(2008-11#1)
private payers##3##2##(1997-1#1)(2008-12#1)(2008-7#1)
private physician##2##2##(1990-6#1)(1995-12#1)
private practice or##2##3##(1994-3#1)(2009-10#1)
private practice##18##2##(1992-10#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-1#1)(2011-2#1)(2012-1#1)
private practitioners##2##2##(1993-2#1)(1995-12#1)
private psychiatric hospital##3##3##(1991-2#1)(1992-3#1)(1993-12#1)
private psychiatric hospitals##5##3##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)
private psychiatric##9##2##(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(2012-2#1)
private schools##8##2##(2008-9#7)(2011-2#1)
private sector employment##3##3##(1994-12#1)(1996-1#1)(1996-2#1)
private sector participation##2##3##(2008-6#2)
private sector##34##2##(1991-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#5)(2006-10#1)(2008-1#1)(2008-6#4)(2008-7#1)(2012-2#1)(2012-3#1)
private supplementary##3##2##(1991-2#1)(1996-3#2)
private supply##2##2##(2008-7#2)
private treatment##2##2##(1996-11#2)
private##260##1##(1990-6#3)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#7)(1992-3#5)(1993-1#3)(1993-12#4)(1993-2#8)(1993-3#6)(1993-6#1)(1994-1#10)(1994-12#4)(1994-2#5)(1994-3#5)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#8)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#10)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#5)(1997-5#11)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#14)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-2#7)(2012-1#4)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
private-public mix##2##2##(2008-7#2)
private-sector##4##1##(1996-2#2)(1997-3#1)(2007-4#1)
privately funded abortions at military facilities##2##6##(1996-5#2)
privately funded abortions at##3##4##(1995-6#1)(1996-5#2)
privately funded##4##2##(1995-6#1)(1996-5#2)(2013-1#1)
privately insured##4##2##(1997-3#3)(2012-2#1)
privately##8##1##(1995-6#1)(1996-5#2)(1997-3#3)(2012-2#1)(2013-1#1)
privatization of public##2##3##(1997-1#1)(2008-11#1)
privatization of##4##2##(1993-2#1)(1997-1#1)(2008-11#1)(2013-1#1)
privatization##8##1##(1993-2#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
privilege##9##1##(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-1#5)
privileged##7##1##(2008-1#2)(2008-4#1)(2009-10#3)(2010-8#1)
privileges and##3##2##(1993-1#2)(2013-8#1)
privileges without##3##2##(1992-12#1)(1993-1#1)(1993-3#1)
privileges##19##1##(1991-12#3)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#3)(1993-3#3)(1994-1#2)(1996-1#1)(1996-9#1)(2008-7#1)(2013-8#1)
privileging##3##1##(1992-2#1)(1994-3#2)
prize##2##1##(2009-5#1)(2010-1#1)
prized##3##1##(1996-2#1)(2008-11#1)(2010-4#1)
prmt5##5##1##(2009-7#5)
pro##5##1##(1995-6#2)(1996-3#1)(2010-11#1)(2010-7#1)
pro- and anti-apoptotic##4##3##(2009-12#2)(2010-10#1)(2012-2#1)
pro- and anti-inflammatory##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2013-7#1)
pro- and##11##2##(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-10#1)(2011-1#1)(2012-2#2)(2013-7#1)
pro-##12##1##(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-7#1)
pro-C3 and proalbumin##2##3##(1990-8#2)
pro-C3##7##1##(1990-8#4)(1992-12#3)
pro-EGF##3##1##(1990-12#3)
pro-HGF##4##1##(1992-12#4)
pro-PO##4##1##(1997-2#4)
pro-Urokinase##2##1##(2008-7#2)
pro-active approach##2##2##(1991-1#1)(1994-1#1)
pro-active##5##1##(1991-1#1)(1994-1#1)(2008-11#3)
pro-angiogenic factors##2##2##(2008-8#1)(2013-1#1)
pro-angiogenic##5##1##(2008-10#1)(2008-8#1)(2010-9#1)(2013-1#2)
pro-apoptotic protein##3##2##(2009-12#1)(2010-6#1)(2013-1#1)
pro-apoptotic proteins##2##2##(2009-12#2)
pro-apoptotic##17##1##(1995-6#1)(2008-11#1)(2008-8#1)(2009-12#3)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
pro-atherogenic##3##1##(2008-10#1)(2008-3#2)
pro-domain##4##1##(2008-4#4)
pro-drug##3##1##(1996-3#1)(2012-2#2)
pro-enzyme##2##1##(1992-12#2)
pro-estrus and##2##2##(1992-9#2)
pro-inflammatory cytokine##2##2##(2008-10#1)(2009-3#1)
pro-inflammatory cytokines##9##2##(2008-10#4)(2008-5#3)(2009-12#1)(2010-1#1)
pro-inflammatory mediators##5##2##(2008-11#1)(2008-5#3)(2012-2#1)
pro-inflammatory##33##1##(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#7)(2008-7#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-1#2)(2012-2#4)(2013-1#1)(2013-7#1)
pro-opiomelanocortin (POMC)##2##2##(1995-12#1)(2009-8#1)
pro-opiomelanocortin mRNA expression in##2##4##(2012-1#2)
pro-opiomelanocortin mRNA##4##2##(2012-1#4)
pro-opiomelanocortin##8##1##(1991-5#1)(1992-10#1)(1995-12#1)(2009-8#1)(2012-1#4)
pro-oxidant##4##1##(1991-9#1)(2008-1#1)(2008-7#1)(2009-6#1)
pro-oxidants##4##1##(1991-9#4)
pro-peptide##5##1##(1990-5#4)(2012-12#1)
pro-region##2##1##(1992-8#1)(1993-12#1)
pro-tPA derivative##2##2##(1991-9#2)
pro-urokinase##3##1##(1990-8#3)
pro-vitamins##2##1##(2008-5#2)
proANF 1-98##2##2##(1990-12#2)
proANF 31-67##3##2##(1990-12#3)
proANF##6##1##(1990-12#6)
proTRH contents##2##2##(1994-6#2)
proTRH##3##1##(1994-6#3)
proU##6##1##(1994-12#6)
proactive LVs##2##2##(2008-11#2)
proactive approach##2##2##(2008-10#1)(2008-11#1)
proactive in##2##2##(1995-12#1)(2013-8#1)
proactive##27##1##(1991-12#1)(1991-3#1)(1992-2#1)(1994-2#3)(1995-12#2)(1996-1#2)(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
proactively##6##1##(1991-12#1)(1992-1#1)(1993-1#1)(1996-12#1)(1996-2#1)(2010-10#1)
proactivity##3##1##(2007-12#3)
proalbumin and##2##2##(1992-12#2)
proalbumin associated with a second##2##5##(1993-2#2)
proalbumin convertase##2##2##(1992-12#1)(1993-2#1)
proalbumin##11##1##(1990-8#3)(1992-12#3)(1993-2#5)
proangiogenic##4##1##(2008-7#1)(2011-2#2)(2013-1#1)
proanthocyanidins (100 mg/kg/day##2##3##(2011-2#2)
proanthocyanidins can##2##2##(2011-2#2)
proanthocyanidins##9##1##(2010-12#1)(2011-2#8)
proapoptotic proteins##2##2##(2008-11#1)(2013-1#1)
proapoptotic##8##1##(2008-11#1)(2009-4#1)(2010-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
probabilistic description##2##2##(2008-7#2)
probabilistic neural network (PNN)##2##4##(2008-10#1)(2010-8#1)
probabilistic neural networks (PNNs)##2##4##(2008-10#1)(2010-8#1)
probabilistic neural networks##3##3##(2008-10#1)(2010-8#2)
probabilistic neural##5##2##(2008-10#2)(2010-8#3)
probabilistic risk##2##2##(2008-7#1)(2012-12#1)
probabilistic##32##1##(1990-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#3)(2009-12#1)(2009-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
probabilities and##9##2##(2008-5#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
probabilities are##7##2##(1992-9#1)(1994-12#2)(2008-2#1)(2008-8#3)
probabilities at##2##2##(1997-8#1)(2012-3#1)
probabilities based on the##2##4##(1992-9#1)(2012-3#1)
probabilities for##7##2##(1992-9#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)
probabilities of##12##2##(1991-4#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2012-2#1)
probabilities to##3##2##(1992-6#1)(2008-10#1)(2008-8#1)
probabilities##71##1##(1991-4#1)(1992-6#2)(1992-9#3)(1994-11#1)(1994-12#2)(1995-2#1)(1996-4#2)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#17)(2008-9#4)(2009-10#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)
probability and the##4##3##(2007-10#1)(2008-10#1)(2008-6#1)(2010-4#1)
probability and##6##2##(1992-6#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)
probability both##2##2##(2008-7#1)(2011-1#1)
probability density function of the##3##5##(2008-2#1)(2008-3#2)
probability density function of##4##4##(2008-2#2)(2008-3#2)
probability density function##5##3##(2008-2#2)(2008-3#3)
probability density functions##5##3##(2008-10#2)(2008-3#2)(2012-3#1)
probability density##12##2##(2008-10#2)(2008-2#3)(2008-3#5)(2008-7#1)(2012-3#1)
probability distribution of##2##3##(2008-6#1)(2012-1#1)
probability distribution##9##2##(2008-10#4)(2008-3#1)(2008-6#1)(2009-9#1)(2010-5#1)(2012-1#1)
probability distributions for##2##3##(2008-10#2)
probability distributions of##2##3##(2008-10#1)(2008-2#1)
probability distributions##9##2##(1994-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)
probability equal to##2##3##(1995-9#1)(2013-8#1)
probability for##5##2##(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)
probability in##3##2##(1994-10#1)(2011-2#2)
probability is##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
probability model##3##2##(2008-10#2)(2008-8#1)
probability models##5##2##(2008-8#2)(2010-10#3)
probability of 0##2##3##(2007-12#1)(2009-4#1)
probability of ASD##2##3##(2012-3#2)
probability of a##11##3##(1990-6#1)(1993-8#1)(1996-3#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
probability of achieving##2##3##(2008-10#1)(2012-3#1)
probability of an##2##3##(1995-12#1)(2012-3#1)
probability of being##5##3##(1996-7#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)
probability of conducting HIV test##2##5##(2011-1#2)
probability of death##2##3##(1995-2#1)(2008-11#1)
probability of detecting##2##3##(2008-4#1)(2012-12#1)
probability of detection##2##3##(2008-10#2)
probability of developing##5##3##(1992-9#2)(2008-4#1)(2012-3#1)(2013-8#1)
probability of divorce##2##3##(2011-2#2)
probability of each##3##3##(2008-7#1)(2009-10#1)(2010-11#1)
probability of entry##2##3##(2008-10#2)
probability of having##2##3##(2009-6#1)(2012-12#1)
probability of limb salvage##2##4##(2011-3#2)
probability of success##2##3##(2008-11#1)(2010-8#1)
probability of survival##2##3##(2007-8#1)(2008-7#1)
probability of the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
probability of##181##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#4)(1996-7#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#28)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#12)(2008-9#5)(2009-10#4)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#10)(2011-3#4)(2012-12#3)(2012-2#1)(2012-3#11)(2013-1#1)(2013-8#1)
probability p of type I error##2##6##(2008-10#2)
probability sample of##5##3##(1996-2#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
probability that the##4##3##(1990-5#1)(1994-11#1)(1997-8#1)(2008-9#1)
probability that##24##2##(1990-5#1)(1991-12#2)(1994-11#2)(1994-3#1)(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2013-1#2)(2013-8#2)
probability to##8##2##(1990-11#1)(1990-12#1)(1991-4#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#2)
probability##361##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#4)(1991-4#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-10#3)(1994-11#4)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#6)(1995-2#7)(1995-5#1)(1995-6#1)(1995-9#2)(1996-2#2)(1996-3#1)(1996-4#4)(1996-6#5)(1996-7#1)(1997-3#3)(1997-4#4)(1997-6#1)(1997-8#4)(1997-9#1)(2007-10#5)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#63)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#17)(2008-4#4)(2008-5#2)(2008-6#6)(2008-7#19)(2008-8#25)(2008-9#6)(2009-10#5)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#4)(2011-1#6)(2011-2#21)(2011-3#5)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#13)(2012-7#1)(2013-1#4)(2013-8#6)
probable Alzheimer's disease##2##3##(1994-5#1)(2008-7#1)
probable Alzheimer's##3##2##(1994-5#1)(1995-11#1)(2008-7#1)
probable cases##3##2##(2006-10#2)(2007-7#1)
probable cause of##2##3##(2008-10#1)(2009-11#1)
probable cause##3##2##(1995-12#1)(2008-10#1)(2009-11#1)
probable diagnosis of##2##3##(2012-2#1)(2013-1#1)
probable effects of microwave exposure##2##5##(2008-12#2)
probable effects of##3##3##(2008-12#2)(2013-1#1)
probable ligands##2##2##(1992-4#1)(1993-11#1)
probable number##3##2##(2008-10#2)(2012-1#1)
probable or possible##2##3##(1996-11#1)(2008-7#1)
probable role##2##2##(1992-6#1)(2008-7#1)
probable that##6##2##(1991-1#1)(1995-8#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-2#1)
probable##109##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-5#2)(1994-7#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
probably a major##3##3##(2008-10#2)(2012-12#1)
probably a##14##2##(1990-6#1)(1992-12#1)(1995-11#1)(1995-5#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
probably accounts for the##2##4##(1991-8#1)(1993-6#1)
probably acts##3##2##(1990-5#1)(1990-7#1)(2008-7#1)
probably after##2##2##(2008-5#1)(2008-6#1)
probably allelic##2##2##(2008-10#2)
probably also##12##2##(1991-11#1)(1991-6#1)(1992-6#1)(1993-11#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)
probably an important##2##3##(2008-10#1)(2009-7#1)
probably an##8##2##(1992-4#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)
probably analogous to the##2##4##(1990-11#1)(2008-5#1)
probably as a result of##6##5##(1997-5#1)(1997-7#1)(2008-10#3)(2012-5#1)
probably as a##9##3##(1990-2#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-5#1)(2009-2#1)(2012-5#1)
probably as##12##2##(1990-2#1)(1990-6#1)(1995-6#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-5#2)(2009-2#1)(2012-5#1)
probably associated with##4##3##(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)
probably attributable to##2##3##(1997-2#1)(2011-2#1)
probably be##19##2##(1990-9#1)(1992-2#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-1#1)
probably because it is##2##4##(1994-2#1)(1994-8#1)
probably because of the##3##4##(2007-7#1)(2008-5#1)(2010-4#1)
probably because of##13##3##(1991-6#1)(1994-3#2)(1996-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-4#1)(2013-7#1)
probably because##23##2##(1990-3#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-3#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2013-7#1)
probably been##3##2##(1995-12#1)(1996-12#1)(2010-1#1)
probably by the##2##3##(2008-7#2)
probably by##5##2##(1995-5#1)(2008-10#2)(2008-7#2)
probably can be##2##3##(1997-6#1)(2008-10#1)
probably caused by##6##3##(1991-7#1)(1992-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
probably contribute to the##2##4##(2008-10#1)(2008-11#1)
probably dependent##2##2##(1992-9#1)(1995-12#1)
probably did not##2##3##(1990-7#1)(2008-10#1)
probably differs##2##2##(1992-12#1)(2011-2#1)
probably do not##4##3##(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#1)
probably does not##3##3##(1995-2#1)(1996-5#1)(2011-3#1)
probably due to a##6##4##(1991-11#1)(1991-3#1)(1992-6#1)(1994-5#1)(2008-5#1)(2012-12#1)
probably due to enhanced##2##4##(1992-8#1)(2012-5#1)
probably due to increased##2##4##(1990-6#1)(2009-5#1)
probably due to the formation of##3##6##(1994-11#1)(2008-10#2)
probably due to the##16##4##(1993-11#1)(1994-11#1)(1994-2#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-3#1)
probably due to##50##3##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)
probably even##2##2##(2008-10#1)(2013-1#1)
probably formed##3##2##(1990-5#1)(1994-3#1)(2011-1#1)
probably forms##2##2##(1993-11#1)(2007-7#1)
probably from##2##2##(1996-12#1)(2013-1#1)
probably functions##2##2##(2007-12#1)(2008-10#1)
probably had##3##2##(2008-10#3)
probably has##4##2##(1996-3#1)(1996-6#1)(2008-10#1)(2008-9#1)
probably have a##2##3##(1993-2#1)(2008-4#1)
probably have##6##2##(1992-6#1)(1993-2#1)(1994-6#1)(2008-10#2)(2008-4#1)
probably having##2##2##(1992-12#1)(2008-10#1)
probably highly##2##2##(1991-2#1)(1997-4#1)
probably in##6##2##(1991-2#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-1#1)
probably indicating##2##2##(2008-1#1)(2008-11#1)
probably induced##2##2##(2008-10#1)(2009-3#1)
probably interact with##2##3##(1990-8#1)(1995-5#1)
probably interact##3##2##(1990-8#1)(1992-10#1)(1995-5#1)
probably involved in the##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
probably involved in##8##3##(1990-5#1)(1992-9#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)
probably involved##9##2##(1990-5#1)(1992-9#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)
probably involves##3##2##(1991-12#1)(1997-7#1)(2008-10#1)
probably involving##3##2##(1991-11#1)(1997-4#1)(2008-10#1)
probably is##6##2##(1993-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
probably largely##2##2##(1991-12#1)(2008-7#1)
probably lead to##2##3##(1994-3#1)(2008-11#1)
probably lead##3##2##(1994-3#1)(1996-3#1)(2008-11#1)
probably linked to##2##3##(1996-8#1)(2008-10#1)
probably located##2##2##(1992-11#1)(1992-6#1)
probably mediated by##3##3##(1994-11#1)(1996-2#1)(1997-2#1)
probably mediated##5##2##(1994-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2013-1#1)
probably need more##2##3##(2011-2#1)(2012-2#1)
probably not##12##2##(1990-12#1)(1991-11#1)(1992-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1997-6#1)(2008-10#3)(2010-3#1)
probably occurred as the result of##2##6##(2008-10#1)(2008-2#1)
probably of##2##2##(1997-4#1)(2008-11#1)
probably play a##5##3##(1993-9#1)(1994-2#1)(1995-6#1)(2008-12#1)(2008-7#1)
probably plays an important role in##3##6##(1992-9#1)(1994-3#1)(1995-6#1)
probably plays an important##4##4##(1992-9#1)(1994-3#1)(1995-6#1)(1996-3#1)
probably produce##2##2##(2007-12#1)(2010-5#1)
probably reflected##2##2##(2008-10#1)(2008-8#1)
probably related to the##6##4##(1991-11#1)(1997-2#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
probably related to##11##3##(1991-11#1)(1992-11#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
probably related##12##2##(1991-11#1)(1992-11#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
probably remain##2##2##(2009-1#1)(2011-2#1)
probably represent a##2##3##(1990-6#1)(2012-2#1)
probably represent##4##2##(1990-6#1)(1995-3#1)(2008-7#1)(2012-2#1)
probably representative##2##2##(1991-11#1)(1995-2#1)
probably representing##2##2##(1993-3#1)(1997-4#1)
probably responsible for the displacement of##2##6##(1997-1#1)(2008-10#1)
probably responsible for the##4##4##(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)
probably responsible for##5##3##(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#2)
probably resulted##2##2##(2008-10#1)(2012-3#1)
probably resulting in##2##3##(2008-10#1)(2008-11#1)
probably resulting##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
probably results from##3##3##(2010-6#1)(2011-2#1)(2013-8#1)
probably results##4##2##(2008-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
probably slightly##2##2##(2008-1#1)(2008-5#1)
probably the first##4##3##(1996-5#1)(2008-2#1)(2008-5#1)(2009-5#1)
probably the most important##2##4##(1993-11#1)(2007-11#1)
probably the most widely used##2##5##(2008-4#1)(2008-9#1)
probably the most##10##3##(1993-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
probably the reason for##3##4##(2008-3#1)(2008-5#1)(2009-8#1)
probably the##39##2##(1991-12#2)(1992-8#3)(1993-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-8#1)(2011-2#2)(2013-1#1)
probably through##8##2##(1991-5#1)(1993-11#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
probably to##3##2##(2008-5#1)(2008-8#1)(2009-3#1)
probably uncommon##2##2##(1990-12#1)(2007-2#1)
probably via P2Y(1) receptor stimulation##2##5##(2008-4#2)
probably via the A1 type of P1 receptor##2##8##(1994-11#1)(1994-6#1)
probably via##4##2##(1994-11#1)(1994-6#1)(2008-4#2)
probably was##3##2##(1991-6#1)(2008-10#2)
probably will be##2##3##(1991-11#1)(1992-9#1)
probably will##3##2##(1991-11#1)(1992-9#1)(1996-2#1)
probably with##3##2##(1995-3#1)(2011-2#2)
probably would##2##2##(1995-12#1)(2008-10#1)
probably##556##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#3)(1991-11#7)(1991-12#8)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#6)(1992-8#5)(1992-9#7)(1993-11#7)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#6)(1994-3#7)(1994-5#4)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#1)(1996-1#1)(1996-12#6)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#5)(1996-6#4)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#3)(1997-8#2)(2006-10#1)(2006-6#3)(2007-11#4)(2007-12#6)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#5)(2008-10#92)(2008-11#14)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#27)(2008-6#6)(2008-7#17)(2008-8#17)(2008-9#11)(2009-1#1)(2009-10#7)(2009-11#1)(2009-2#2)(2009-3#3)(2009-5#2)(2009-7#2)(2009-8#3)(2010-1#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#4)(2011-2#23)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-5#2)(2013-1#10)(2013-7#2)(2013-8#3)
proband and##2##2##(1997-5#1)(2011-1#1)
proband diagnosed with##2##3##(2008-8#1)(2010-3#1)
proband##12##1##(1993-3#1)(1997-5#5)(2008-11#1)(2008-8#1)(2010-3#2)(2011-1#1)(2012-3#1)
probands and##2##2##(1991-11#1)(1991-12#1)
probands of##3##2##(1991-11#1)(2007-10#1)(2008-9#1)
probands with##3##2##(1992-9#1)(1997-5#2)
probands##19##1##(1991-11#3)(1991-12#4)(1992-9#3)(1994-2#1)(1997-5#4)(1997-8#1)(2007-10#1)(2008-7#1)(2008-9#1)
probation##2##1##(1997-5#1)(2009-11#1)
probative##2##1##(2008-10#1)(2008-12#1)
probe DNA molecules##2##3##(2008-5#2)
probe DNA##7##2##(1992-4#1)(2008-10#4)(2008-5#2)
probe RG57##7##2##(2008-10#7)
probe a##6##2##(1990-2#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-3#2)
probe and by##2##3##(2008-10#2)
probe and target##2##3##(2008-10#2)
probe and the##7##3##(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-5#1)
probe and##24##2##(1990-2#1)(1993-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)
probe angle##3##2##(1994-5#3)
probe are##3##2##(2007-12#1)(2008-10#2)
probe array with##2##3##(2007-12#1)(2008-3#1)
probe array##9##2##(2007-12#3)(2008-3#6)
probe as a##2##3##(2008-2#1)(2008-3#1)
probe as##4##2##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
probe based on##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
probe beam that##2##3##(2007-11#1)(2008-3#1)
probe beam##16##2##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#6)
probe beam)##3##2##(2008-3#3)
probe concentration##2##2##(1994-5#1)(2008-9#1)
probe confirmed##2##2##(2008-3#1)(2008-8#1)
probe containing the##2##3##(2008-10#1)(2008-5#1)
probe containing##5##2##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-5#1)
probe demonstrated##2##2##(1991-5#1)(1995-11#1)
probe derived from##4##3##(1991-1#1)(1991-9#1)(2008-10#1)(2008-8#1)
probe design for##3##3##(2011-1#2)(2012-2#1)
probe design##5##2##(2011-1#4)(2012-2#1)
probe designed from a highly conserved##2##6##(1993-12#1)(1994-12#1)
probe designed##3##2##(1992-9#1)(1993-12#1)(1994-12#1)
probe encoding##2##2##(1993-3#1)(1993-5#1)
probe for measuring##2##3##(2008-9#2)
probe for noninvasive##2##3##(2008-3#2)
probe for protein##2##3##(1994-8#1)(2008-8#1)
probe for the##11##3##(1990-2#1)(1990-8#1)(1991-5#1)(1994-5#1)(1995-11#1)(1995-5#1)(1997-7#1)(2008-10#4)
probe for##47##2##(1990-12#2)(1990-2#2)(1990-8#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2011-1#1)
probe frequency detuning##2##3##(2007-11#2)
probe hybridized##2##2##(1997-7#1)(2008-10#1)
probe in the##7##3##(1991-5#1)(1992-6#2)(1994-5#1)(1994-8#1)(2008-2#1)(2012-2#1)
probe in##16##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
probe indicated that the##2##4##(1997-2#1)(2008-8#1)
probe indicated that##4##3##(1995-6#1)(1997-2#1)(2008-8#1)(2008-9#1)
probe into the##2##3##(2008-10#1)(2008-8#1)
probe is a##2##3##(1991-2#1)(2008-2#1)
probe is introduced for##2##4##(1994-8#1)(2008-3#1)
probe is##19##2##(1991-2#1)(1992-11#1)(1994-8#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-9#1)(2010-5#1)(2013-1#1)
probe labeling##3##2##(2008-9#3)
probe laser beam##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
probe laser##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
probe may be##2##3##(2008-4#1)(2011-2#1)
probe methods##2##2##(1991-2#1)(2012-2#1)
probe modified CPE##2##3##(2008-10#2)
probe modified##3##2##(2008-10#2)(2009-3#1)
probe molecule##2##2##(2008-7#1)(2013-1#1)
probe molecules##2##2##(2008-10#1)(2011-1#1)
probe of the##5##3##(1990-2#1)(1991-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
probe of two-dimensional##2##3##(2007-12#2)
probe of##18##2##(1990-2#1)(1991-6#1)(1992-4#1)(1995-12#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-5#1)(2011-1#1)
probe on the##5##3##(1997-6#1)(2008-10#3)(2008-3#1)
probe on##8##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)
probe or##2##2##(1992-6#2)
probe orientation##2##2##(2008-2#2)
probe prepared from##2##3##(1993-6#1)(2008-10#1)
probe pulse and##2##3##(2007-11#1)(2007-12#1)
probe pulse##10##2##(2007-11#5)(2007-12#5)
probe pulses##3##2##(2007-11#1)(2007-12#2)
probe revealed a##2##3##(1996-12#1)(2008-5#1)
probe revealed##7##2##(1991-2#1)(1994-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
probe sequences##4##2##(2008-10#2)(2010-5#1)(2012-3#1)
probe sets##5##2##(2012-3#5)
probe showed##3##2##(1992-6#1)(1993-8#1)(1997-2#1)
probe shows##2##2##(2008-3#1)(2010-8#1)
probe sonication##4##2##(2008-10#4)
probe specific for##3##3##(1993-8#1)(2008-10#2)
probe synthesis##2##2##(2008-9#2)
probe that##4##2##(1992-11#1)(1997-7#1)(2008-3#2)
probe the molecular##2##3##(1995-2#1)(2008-10#1)
probe the##27##2##(1990-7#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-12#1)
probe tip##4##2##(2007-12#1)(2008-3#2)(2011-1#1)
probe to determine##2##3##(2008-10#2)
probe to monitor##2##3##(1992-6#1)(2012-3#1)
probe to the##5##3##(1992-6#2)(1992-8#1)(2008-4#1)(2010-4#1)
probe to##30##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-6#4)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
probe volume##7##2##(2008-3#7)
probe was immobilized##2##3##(2008-10#1)(2008-12#1)
probe was performed##2##3##(2008-8#1)(2008-9#1)
probe was studied##2##3##(1990-3#1)(2013-8#1)
probe was used to##3##4##(1996-12#1)(2008-10#1)(2009-3#1)
probe was##25##2##(1990-3#1)(1993-8#1)(1994-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-3#1)(2013-8#2)
probe were##6##2##(1992-3#1)(1996-2#1)(1997-6#2)(2007-12#1)(2008-10#1)
probe with an##2##3##(2007-12#1)(2008-3#1)
probe with the##2##3##(2008-10#1)(2013-8#1)
probe with##6##2##(2007-12#1)(2008-10#2)(2008-3#2)(2013-8#1)
probe##776##1##(1990-11#5)(1990-12#5)(1990-2#7)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#7)(1991-3#1)(1991-5#7)(1991-6#5)(1991-9#3)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#10)(1992-4#2)(1992-6#16)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#7)(1993-3#4)(1993-5#2)(1993-6#6)(1993-8#4)(1993-9#4)(1994-11#3)(1994-12#6)(1994-3#2)(1994-5#9)(1994-7#1)(1994-8#10)(1994-9#3)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#6)(1995-8#2)(1996-10#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#3)(1997-1#1)(1997-2#9)(1997-3#2)(1997-4#7)(1997-6#5)(1997-7#5)(1997-8#2)(2007-11#22)(2007-12#42)(2007-9#2)(2008-1#2)(2008-10#183)(2008-11#7)(2008-12#5)(2008-2#29)(2008-3#79)(2008-4#14)(2008-5#10)(2008-7#13)(2008-8#24)(2008-9#28)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#3)(2010-5#8)(2010-7#1)(2010-8#2)(2011-1#13)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#9)(2013-1#3)(2013-8#8)
probe)##4##1##(2008-10#3)(2008-3#1)
probe-enzyme combinations##2##2##(2008-10#2)
probe-to-probe##2##1##(2007-12#1)(2008-10#1)
probe-type##2##1##(2008-10#1)(2008-3#1)
probed at##2##2##(2008-10#1)(2008-3#1)
probed by##10##2##(1990-12#1)(1992-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
probed for##2##2##(1991-2#1)(2008-4#1)
probed in##2##2##(1990-5#1)(2010-4#1)
probed with a##4##3##(1993-8#1)(1997-3#1)(2008-10#1)(2008-4#1)
probed with the##4##3##(1991-5#1)(1991-6#1)(1993-6#1)(2008-10#1)
probed with##14##2##(1991-5#1)(1991-6#1)(1993-6#1)(1993-8#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)
probed##43##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#6)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-4#1)(2012-2#1)
probenecid-sensitive folate transporter##2##3##(1994-6#2)
probes and##21##2##(1991-6#1)(1993-11#1)(1996-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2012-3#1)
probes are##14##2##(1992-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-9#3)(2010-5#1)
probes at##3##2##(1997-8#1)(2008-10#2)
probes based on##2##3##(1992-3#1)(2008-10#1)
probes can be##2##3##(2009-11#1)(2012-3#1)
probes can##3##2##(2008-4#1)(2009-11#1)(2012-3#1)
probes demonstrated that##2##3##(1990-12#1)(2008-8#1)
probes derived from the##2##4##(1991-9#1)(2008-10#1)
probes derived from##5##3##(1991-9#1)(1997-2#1)(2008-10#2)(2012-3#1)
probes designed to##3##3##(2008-10#2)(2008-4#1)
probes encapsulated by biologically localized embedding (PEBBLEs)##2##7##(2008-10#2)
probes for chromosome##2##3##(2008-9#1)(2012-3#1)
probes for molecular##2##3##(1994-8#1)(2008-9#1)
probes for physical##2##3##(1992-6#1)(2010-3#1)
probes for the##2##3##(2008-10#1)(2008-4#1)
probes for##31##2##(1990-12#1)(1992-6#1)(1994-5#1)(1994-8#2)(2008-1#2)(2008-10#6)(2008-4#2)(2008-7#1)(2008-9#6)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#4)(2011-1#1)(2012-3#1)
probes from##7##2##(1991-5#1)(1992-3#1)(2008-10#3)(2008-4#2)
probes generated from##2##3##(1992-6#1)(2008-10#1)
probes have been designed##2##4##(1992-3#1)(2008-10#1)
probes have been##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
probes have##6##2##(1992-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-5#1)
probes hybridized##2##2##(1997-6#1)(2008-10#1)
probes in the##3##3##(1990-4#1)(1995-5#1)(2012-3#1)
probes in##14##2##(1990-2#1)(1990-4#1)(1993-1#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-12#2)(2012-3#1)(2013-8#1)
probes indicated that##2##3##(1993-6#1)(2008-5#1)
probes is also included##2##4##(2008-4#2)
probes is based on##2##4##(2008-10#2)
probes is##4##2##(2008-10#2)(2008-4#2)
probes labeled with##2##3##(2008-10#1)(2008-4#1)
probes may be##2##3##(2008-4#2)
probes might##2##2##(1996-3#1)(2008-10#1)
probes obtained by##2##3##(2008-10#1)(2008-2#1)
probes of the##2##3##(1991-5#2)
probes of##14##2##(1991-3#1)(1991-5#2)(1994-12#1)(1994-8#1)(1996-3#1)(1996-6#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)
probes on a##2##3##(2008-12#1)(2010-9#1)
probes on##4##2##(1990-5#1)(2008-12#1)(2008-2#1)(2010-9#1)
probes or##4##2##(1997-4#1)(1997-7#1)(2008-4#1)(2008-7#1)
probes representing##2##2##(2008-10#1)(2009-4#1)
probes revealed##2##2##(2008-10#1)(2008-5#1)
probes should##2##2##(1994-9#1)(2008-10#1)
probes specific for##2##3##(1994-11#1)(1997-6#1)
probes such as##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
probes targeted##2##2##(2008-10#1)(2008-9#1)
probes that are##4##3##(2007-11#1)(2008-10#2)(2012-2#1)
probes that recognize##2##3##(1996-12#2)
probes that##13##2##(1996-12#2)(2007-11#1)(2008-10#6)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
probes the##2##2##(2007-12#1)(2008-10#1)
probes to detect##2##3##(1990-5#1)(1994-11#1)
probes to investigate the##2##4##(1993-2#1)(2008-10#1)
probes to investigate##3##3##(1993-2#1)(2008-10#1)(2012-2#1)
probes to##15##2##(1990-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(2008-10#9)(2008-9#1)(2012-2#1)
probes used in##2##3##(2008-4#1)(2008-9#1)
probes was##3##2##(1991-2#1)(2008-3#1)(2010-5#1)
probes were applied##2##3##(2008-10#2)
probes were selected##2##3##(2008-5#1)(2008-7#1)
probes were tested##2##3##(2008-10#2)
probes were then used to analyze##2##6##(2008-10#2)
probes were used in##2##4##(2008-10#2)
probes were used to##2##4##(2008-10#2)
probes were used##5##3##(2008-10#5)
probes were##26##2##(1992-6#1)(1997-7#1)(2008-10#18)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)
probes which##2##2##(2008-10#1)(2008-9#1)
probes with##3##2##(2008-10#1)(2008-12#1)(2009-7#1)
probes##391##1##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#4)(1992-8#1)(1993-1#2)(1993-11#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#4)(1996-3#2)(1996-6#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#3)(2008-1#5)(2008-10#122)(2008-11#1)(2008-12#6)(2008-2#15)(2008-3#12)(2008-4#37)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#40)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#9)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#1)(2013-8#3)
probing a##2##2##(1991-9#1)(2007-11#1)
probing and##2##2##(2008-12#1)(2013-8#1)
probing beam##3##2##(2007-11#2)(2008-3#1)
probing depth (PD)##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
probing depth and##2##3##(2008-12#1)(2013-1#1)
probing depth##9##2##(2008-12#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
probing for##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
probing in##2##2##(2008-10#1)(2010-5#1)
probing of##10##2##(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)
probing the##10##2##(1990-3#1)(1990-8#1)(1993-6#1)(1994-5#1)(1994-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
probing with##4##2##(1990-5#1)(1996-8#1)(2008-4#2)
probing##73##1##(1990-3#1)(1990-5#2)(1990-8#1)(1991-9#1)(1993-6#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-8#1)(2007-11#5)(2007-12#4)(2008-10#9)(2008-12#4)(2008-2#4)(2008-3#9)(2008-4#2)(2008-6#3)(2008-7#4)(2008-8#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
probiotic E##2##2##(2011-2#2)
probiotic bacteria##3##2##(2010-10#1)(2013-1#2)
probiotic effects##2##2##(2010-10#1)(2011-2#1)
probiotic microorganisms##3##2##(2009-11#3)
probiotic potential##2##2##(2009-11#1)(2012-1#1)
probiotic strains##4##2##(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
probiotic##44##1##(2008-12#1)(2008-5#4)(2009-11#8)(2009-12#2)(2010-10#5)(2011-2#9)(2012-1#4)(2012-2#1)(2013-1#7)(2013-8#3)
probiotics and##2##2##(2008-10#1)(2010-12#1)
probiotics are##2##2##(2009-12#1)(2010-10#1)
probiotics for##2##2##(2011-2#1)(2013-1#1)
probiotics have##2##2##(2011-2#1)(2013-7#1)
probiotics in##8##2##(2008-10#1)(2009-11#1)(2009-12#1)(2012-1#2)(2013-7#3)
probiotics is##3##2##(2011-2#2)(2013-7#1)
probiotics##47##1##(2008-10#6)(2009-11#1)(2009-12#2)(2009-5#1)(2010-10#3)(2010-12#2)(2011-2#12)(2012-1#7)(2012-2#2)(2013-1#3)(2013-7#7)(2013-8#1)
probit model for##2##3##(1997-4#1)(2008-7#1)
probit model##5##2##(1997-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
probit##9##1##(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#4)(2011-2#1)
problem affecting##2##2##(2008-5#1)(2013-8#1)
problem among##5##2##(1996-12#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
problem and a##2##3##(1995-9#1)(2008-11#1)
problem and an##2##3##(2008-10#1)(2008-3#1)
problem and is##3##3##(1993-11#1)(1994-8#1)(2012-12#1)
problem and its##3##3##(2008-6#1)(2009-6#1)(2011-1#1)
problem and the##3##3##(1995-1#2)(2012-12#1)
problem and##37##2##(1992-12#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-9#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-8#1)
problem are needed##2##3##(2008-1#1)(2011-2#1)
problem are##6##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-11#1)(2011-2#1)
problem areas and##2##3##(2007-8#1)(2008-2#1)
problem areas##4##2##(1992-12#1)(2007-8#1)(2008-2#1)(2010-11#1)
problem as##4##2##(1995-5#1)(1997-6#1)(2008-10#1)(2008-9#1)
problem associated with##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2010-6#1)
problem at the##2##3##(2006-6#1)(2008-12#1)
problem at##4##2##(2006-6#1)(2008-12#1)(2008-4#1)(2009-4#1)
problem based learning##5##3##(2008-11#3)(2008-12#2)
problem based##8##2##(2008-11#5)(2008-12#3)
problem because##2##2##(2007-11#1)(2008-5#1)
problem behavior and##2##3##(2008-12#1)(2013-7#1)
problem behavior in##2##3##(2008-12#1)(2009-9#1)
problem behavior##10##2##(2008-12#3)(2009-7#1)(2009-9#4)(2013-7#2)
problem behaviors were##3##3##(2008-12#2)(2008-9#1)
problem behaviors##7##2##(1994-2#1)(2008-12#4)(2008-9#2)
problem by solving##2##3##(2010-10#1)(2010-7#1)
problem by using##2##3##(2008-3#1)(2008-8#1)
problem by##15##2##(1990-12#1)(1991-9#1)(1992-9#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
problem can be solved##2##4##(2008-3#1)(2009-12#1)
problem can be##6##3##(1996-5#1)(1997-4#1)(2008-3#2)(2009-12#1)(2011-2#1)
problem could##3##2##(1993-9#1)(2006-8#1)(2008-3#1)
problem drinkers##3##2##(1994-2#1)(1995-5#1)(2013-8#1)
problem drinking in##2##3##(1994-2#2)
problem drinking##7##2##(1994-2#7)
problem due to##2##3##(2010-11#1)(2013-1#1)
problem during##5##2##(2007-11#2)(2007-7#1)(2008-12#1)(2010-9#1)
problem facing##2##2##(1991-3#1)(2007-7#1)
problem for a##2##3##(2008-2#2)
problem for many##3##3##(1997-4#1)(2008-11#1)(2008-5#1)
problem for most##2##3##(2008-5#1)(2010-8#1)
problem for the##12##3##(1993-3#1)(1996-8#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
problem for##52##2##(1990-10#1)(1991-12#1)(1991-2#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
problem from##3##2##(2008-10#2)(2008-3#1)
problem gamblers##2##2##(2012-12#2)
problem gambling##2##2##(2008-11#2)
problem has been##4##3##(1997-4#1)(2008-6#2)(2008-9#1)
problem has##9##2##(1995-5#1)(1997-4#1)(2007-11#2)(2008-3#1)(2008-6#2)(2008-9#1)(2013-1#1)
problem have##3##2##(1994-6#1)(2008-6#1)(2010-1#1)
problem identification##3##2##(1993-1#1)(2008-12#1)(2013-1#1)
problem in Europe##2##3##(1992-9#1)(2008-10#1)
problem in a##3##3##(2008-2#1)(2008-7#1)(2010-4#1)
problem in analytical chemistry##3##4##(2008-10#3)
problem in children##2##3##(1996-8#1)(2008-10#1)
problem in endemic##3##3##(2007-2#1)(2010-12#1)(2011-2#1)
problem in industrialized countries##2##4##(1990-6#1)(2007-11#1)
problem in many##3##3##(1991-6#1)(2008-1#1)(2008-11#1)
problem in older##2##3##(2013-1#1)(2013-8#1)
problem in our##2##3##(2008-9#1)(2011-2#1)
problem in patients with##2##4##(2008-7#2)
problem in some##3##3##(1993-3#1)(2011-2#1)(2013-1#1)
problem in the United States##2##5##(2008-11#1)(2013-8#1)
problem in the developing world##2##5##(2008-5#1)(2013-8#1)
problem in the treatment of##2##5##(1991-9#1)(2013-8#1)
problem in the treatment##3##4##(1991-9#1)(2007-2#1)(2013-8#1)
problem in the##31##3##(1991-3#1)(1991-9#1)(1995-5#1)(1997-1#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
problem in which the##2##4##(2008-3#1)(2008-6#1)
problem in women##2##3##(1993-11#1)(2011-1#1)
problem in##120##2##(1990-6#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#3)(1997-4#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-7#2)(2008-1#4)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#4)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#4)
problem into a##2##3##(2008-6#1)(2009-4#1)
problem involving##2##2##(2008-2#1)(2008-5#1)
problem is considered##2##3##(2008-2#1)(2010-11#1)
problem is discussed##2##3##(1994-2#1)(2008-3#1)
problem is not##4##3##(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
problem is presented##4##3##(2008-10#1)(2008-3#2)(2008-6#1)
problem is that##3##3##(1993-11#1)(1996-2#1)(2008-8#1)
problem is the##4##3##(1997-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
problem is to##5##3##(1993-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
problem is##53##2##(1991-8#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#7)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)
problem may##2##2##(2011-1#1)(2011-2#1)
problem of computing the##2##4##(2008-3#1)(2011-3#1)
problem of detecting##3##3##(1997-7#2)(2007-12#1)
problem of estimating##2##3##(2008-2#1)(2008-3#1)
problem of how to##2##4##(1994-2#1)(2008-12#1)
problem of identifying##2##3##(2008-7#1)(2011-2#1)
problem of male##2##3##(2011-2#1)(2013-1#1)
problem of multivariate classification##2##4##(2008-10#2)
problem of our##2##3##(1995-11#1)(2011-2#1)
problem of phase##2##3##(2007-11#1)(2008-3#1)
problem of the##22##3##(1990-12#1)(1990-6#1)(1993-2#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
problem of##193##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#1)(2007-11#9)(2007-12#7)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#13)(2008-3#17)(2008-4#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#3)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#4)
problem on##3##2##(2007-2#1)(2008-10#2)
problem or##2##2##(1994-2#1)(2008-7#1)
problem pre-definition##2##2##(2008-12#2)
problem resolution##2##2##(1995-12#2)
problem should##3##2##(1997-8#1)(2007-12#1)(2011-2#1)
problem situations##3##2##(1996-1#3)
problem solve##2##2##(2008-11#1)(2010-11#1)
problem solving and##3##3##(1994-2#1)(2008-11#1)(2010-10#1)
problem solving##19##2##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
problem than##2##2##(1995-3#1)(2013-8#1)
problem that can##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
problem that is##5##3##(1997-3#1)(2008-2#1)(2009-12#1)(2010-6#1)(2011-2#1)
problem that##24##2##(1990-11#1)(1992-8#1)(1993-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-8#1)
problem through##2##2##(1997-8#1)(2012-12#1)
problem to be##4##3##(1990-2#1)(1991-2#1)(1997-5#1)(2008-3#1)
problem to find##2##3##(1990-12#1)(1992-6#1)
problem to the##2##3##(2008-10#1)(2010-3#1)
problem to##14##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-6#1)(1993-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-12#1)(2010-3#1)
problem under##3##2##(1997-7#1)(2008-3#1)(2013-8#1)
problem use##5##2##(2009-6#1)(2013-1#4)
problem using##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
problem was identified##2##3##(2011-2#1)(2012-12#1)
problem was to##2##3##(2008-10#2)
problem was##11##2##(1990-11#1)(1992-3#1)(2008-10#7)(2011-2#1)(2012-12#1)
problem we##2##2##(1996-5#1)(2008-2#1)
problem when##4##2##(1997-8#1)(2007-11#1)(2008-3#1)(2011-1#1)
problem which##2##2##(1991-9#1)(2008-7#1)
problem with a##4##3##(1995-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
problem with an##2##3##(1997-3#1)(2008-10#1)
problem with many##2##3##(2008-3#2)
problem with the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
problem with##24##2##(1991-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#4)
problem within##2##2##(2007-12#1)(2012-1#1)
problem worldwide##3##2##(2008-7#1)(2010-5#1)(2013-8#1)
problem would##2##2##(1992-3#1)(2008-11#1)
problem##1088##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-6#3)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#3)(1991-4#1)(1991-6#4)(1991-8#1)(1991-9#7)(1992-1#4)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#6)(1993-1#2)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#7)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#4)(1994-11#2)(1994-12#3)(1994-2#16)(1994-3#7)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#3)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#5)(1997-2#2)(1997-3#7)(1997-4#10)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#7)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#41)(2007-12#22)(2007-2#5)(2007-4#1)(2007-7#13)(2007-8#7)(2007-9#2)(2008-1#9)(2008-10#88)(2008-11#45)(2008-12#28)(2008-2#56)(2008-3#82)(2008-4#11)(2008-5#11)(2008-6#27)(2008-7#38)(2008-8#14)(2008-9#19)(2009-10#5)(2009-11#4)(2009-12#4)(2009-3#6)(2009-4#8)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#2)(2009-9#7)(2010-1#6)(2010-10#5)(2010-11#10)(2010-12#8)(2010-2#3)(2010-3#8)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#10)(2010-9#4)(2011-1#19)(2011-2#57)(2011-3#2)(2012-1#4)(2012-12#28)(2012-2#17)(2012-3#10)(2013-1#43)(2013-7#3)(2013-8#24)
problem&quot##5##1##(1993-1#1)(1994-12#1)(1995-1#1)(2008-4#1)(2008-9#1)
problem'##3##1##(1991-1#1)(2009-5#1)(2009-9#1)
problem-based learning (PBL) in##2##4##(2008-12#2)
problem-based learning (PBL)##6##3##(2008-10#1)(2008-11#1)(2008-12#3)(2013-8#1)
problem-based learning curriculum##2##3##(2008-10#1)(2011-1#1)
problem-based learning in a##2##4##(2008-11#1)(2008-12#1)
problem-based learning is##2##3##(1995-2#2)
problem-based learning##21##2##(1995-2#3)(2008-10#2)(2008-11#7)(2008-12#5)(2011-1#1)(2012-3#1)(2013-8#2)
problem-based##23##1##(1995-2#3)(2008-10#2)(2008-11#8)(2008-12#6)(2011-1#1)(2012-3#1)(2013-8#2)
problem-focused coping strategies##3##3##(1991-1#1)(2008-1#1)(2008-11#1)
problem-focused coping##6##2##(1991-1#1)(2008-1#1)(2008-11#1)(2011-2#3)
problem-focused##7##1##(1991-1#2)(2008-1#1)(2008-11#1)(2011-2#3)
problem-oriented##3##1##(1994-6#1)(2010-5#2)
problem-solving approach to##2##3##(1993-2#1)(2010-10#1)
problem-solving approach##4##2##(1993-2#2)(2010-10#2)
problem-solving skills and##2##3##(2008-12#1)(2009-10#1)
problem-solving skills##8##2##(1993-12#1)(1995-2#1)(2008-12#1)(2009-10#4)(2010-11#1)
problem-solving##34##1##(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#4)(1994-1#1)(1994-3#2)(1995-2#2)(1996-2#2)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2009-10#4)(2009-7#1)(2010-10#2)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
problem?##8##1##(1991-3#1)(1992-12#1)(1994-2#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-3#2)
problem]##8##1##(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-6#1)(2012-1#1)(2013-1#1)
problematic adverse##2##2##(1993-6#1)(2008-3#1)
problematic alcohol use##2##3##(2008-11#1)(2010-7#1)
problematic area##2##2##(2008-10#1)(2011-2#1)
problematic considering##2##2##(2013-1#1)(2013-7#1)
problematic in##5##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
problematic issues##2##2##(1991-3#1)(2012-1#1)
problematic of##2##2##(2008-12#1)(2011-3#1)
problematic with##2##2##(1991-12#1)(2008-1#1)
problematic##69##1##(1991-12#1)(1991-3#1)(1992-12#1)(1993-3#2)(1993-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#2)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)
problematic)##2##1##(2012-2#2)
problematical##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
problems -##3##2##(2007-11#3)
problems affecting##2##2##(1996-3#1)(2008-9#1)
problems among adolescents##2##3##(2008-2#1)(2012-12#1)
problems among##10##2##(1992-4#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(2008-11#2)(2008-2#1)(2012-12#1)(2013-1#1)
problems and are##2##3##(2008-3#1)(2011-2#1)
problems and family##2##3##(2009-7#1)(2011-2#1)
problems and issues##4##3##(1995-3#1)(1997-2#1)(2013-8#2)
problems and new##2##3##(1995-1#1)(2008-10#1)
problems and other##2##3##(1993-1#1)(1994-1#1)
problems and perspectives##2##3##(1990-12#1)(2007-2#1)
problems and prospects##3##3##(1992-3#1)(2008-8#1)(2009-10#1)
problems and solutions##4##3##(1991-12#1)(1992-2#2)(1996-2#1)
problems and the##6##3##(1993-2#1)(1995-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2011-2#1)
problems and their##2##3##(2008-9#1)(2013-1#1)
problems and to##3##3##(1995-11#1)(2009-5#1)(2010-10#1)
problems and##97##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#4)(1994-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#3)(2013-1#3)(2013-7#1)(2013-8#4)
problems are also##2##3##(1993-6#1)(2008-3#1)
problems are being##2##3##(1994-6#1)(2007-5#1)
problems are discussed in an interactive case presentation##2##8##(2007-12#1)(2008-1#1)
problems are discussed##4##3##(1997-4#1)(2007-12#1)(2008-1#1)(2008-9#1)
problems are well known##2##4##(1990-2#1)(1996-3#1)
problems are##36##2##(1990-2#2)(1991-12#1)(1992-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-2#2)(2013-8#1)
problems arise from##2##3##(2010-11#1)(2011-2#1)
problems arise##5##2##(2007-8#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)
problems arising from##4##3##(1990-6#1)(2007-5#1)(2008-10#1)(2013-1#1)
problems arising##5##2##(1990-6#1)(2007-5#1)(2008-10#2)(2013-1#1)
problems as##3##2##(1996-3#1)(2009-7#1)(2011-2#1)
problems associated with the use of##3##6##(2008-1#1)(2008-11#1)(2008-3#1)
problems associated with the##11##4##(1993-1#1)(1996-2#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2013-1#1)
problems associated with their##2##4##(2011-2#1)(2011-3#1)
problems associated with this##2##4##(1991-3#1)(2008-4#1)
problems associated with using##2##4##(2008-10#1)(2009-5#1)
problems associated with##44##3##(1991-3#2)(1993-1#2)(1993-11#1)(1994-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
problems at the##4##3##(1997-2#1)(2008-12#1)(2011-1#1)(2012-2#1)
problems at##7##2##(1997-2#1)(2008-12#1)(2008-2#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
problems between##2##2##(1997-6#1)(2008-3#1)
problems by##7##2##(1991-3#1)(1992-12#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-12#1)
problems can be avoided##2##4##(1993-2#1)(2008-7#1)
problems can be##8##3##(1992-11#1)(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
problems can##10##2##(1992-11#1)(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)
problems caused by##5##3##(1991-1#1)(1992-3#1)(1996-3#1)(2009-3#1)(2011-2#1)
problems concerning##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
problems confronting the##2##3##(1990-10#2)
problems connected to##5##3##(1993-6#1)(1994-11#1)(1994-6#1)(2008-11#1)(2009-7#1)
problems connected with##2##3##(1997-6#1)(2008-10#1)
problems connected##7##2##(1993-6#1)(1994-11#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
problems currently##2##2##(1995-12#1)(2008-7#1)
problems detected##2##2##(1993-5#1)(2011-2#1)
problems due to the##3##4##(2008-10#2)(2012-3#1)
problems due to##8##3##(1990-3#1)(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
problems during##2##2##(1990-3#1)(2011-2#1)
problems encountered and##2##3##(1990-9#1)(2010-10#1)
problems encountered by##2##3##(2008-12#1)(2012-12#1)
problems encountered during##2##3##(2008-7#1)(2010-12#1)
problems encountered in the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
problems encountered in##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2011-1#1)
problems encountered when##2##3##(1994-2#1)(2008-4#1)
problems encountered with##4##3##(2007-10#1)(2008-3#1)(2008-7#1)(2009-6#1)
problems encountered##24##2##(1990-9#1)(1994-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
problems experienced by patients in the postoperative period##2##8##(2010-10#2)
problems experienced##4##2##(2007-11#1)(2008-11#1)(2010-10#2)
problems faced by the##3##4##(2007-11#1)(2008-11#1)(2012-2#1)
problems faced by##6##3##(1993-12#1)(2007-11#1)(2008-11#1)(2010-1#1)(2012-2#1)(2013-8#1)
problems facing##5##2##(1991-2#2)(1992-2#1)(2008-3#1)(2010-7#1)
problems for the##3##3##(1994-11#1)(2007-11#1)(2008-9#1)
problems for##14##2##(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)
problems found in##2##3##(2009-12#1)(2010-2#1)
problems found##3##2##(2008-1#1)(2009-12#1)(2010-2#1)
problems from the##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
problems has##2##2##(1992-8#1)(2008-7#1)
problems have been##3##3##(2008-10#2)(2008-11#1)
problems in a##3##3##(1997-7#1)(2008-8#1)(2010-11#1)
problems in analytical chemistry##3##4##(2008-10#3)
problems in children with##2##4##(1992-2#1)(2011-1#1)
problems in children##5##3##(1992-2#1)(1995-3#1)(1996-1#1)(2008-11#1)(2011-1#1)
problems in clinical##2##3##(2008-12#1)(2010-11#1)
problems in defining##2##3##(1996-1#1)(2008-10#1)
problems in health care##2##4##(2008-7#1)(2010-8#1)
problems in health##3##3##(1994-2#1)(2008-7#1)(2010-8#1)
problems in modern##2##3##(2010-7#1)(2013-8#1)
problems in patients##5##3##(2007-7#2)(2008-7#2)(2009-11#1)
problems in primary##2##3##(1997-5#1)(2008-10#1)
problems in some##2##3##(2008-10#1)(2011-2#1)
problems in the first##2##4##(2007-11#1)(2013-1#1)
problems in the health care system##2##6##(1993-6#1)(1994-2#1)
problems in the health care##3##5##(1993-3#1)(1993-6#1)(1994-2#1)
problems in the health##4##4##(1992-11#1)(1993-3#1)(1993-6#1)(1994-2#1)
problems in the treatment of##2##5##(1992-8#1)(1993-6#1)
problems in the##29##3##(1991-11#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-2#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
problems in this##3##3##(1994-2#1)(1997-8#1)(2009-7#1)
problems in##156##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#4)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#2)
problems including##2##2##(2012-12#1)(2012-3#1)
problems inherent##3##2##(1993-3#1)(2008-10#1)(2008-6#1)
problems involve##2##2##(2008-7#1)(2009-9#1)
problems involved in##4##3##(1994-8#1)(1997-2#1)(2007-11#1)(2008-12#1)
problems involved##5##2##(1994-8#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-12#1)
problems involving the##2##3##(1990-3#1)(2008-1#1)
problems involving##4##2##(1990-3#1)(2008-1#1)(2008-3#1)(2011-2#1)
problems is##8##2##(1992-1#1)(1993-11#1)(1993-12#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-3#1)(2011-2#1)
problems linked to##2##3##(2008-10#1)(2010-11#1)
problems may occur##2##3##(1993-6#1)(2009-5#1)
problems may##6##2##(1992-2#1)(1993-12#1)(1993-6#1)(1996-3#1)(1996-5#1)(2009-5#1)
problems must be##2##3##(1994-2#1)(2008-12#1)
problems now##2##2##(1992-2#1)(1993-3#1)
problems occur##2##2##(2009-10#1)(2013-1#1)
problems occurred##3##2##(1993-3#1)(1994-3#1)(2012-12#1)
problems of availability##2##3##(2010-8#2)
problems of bias##2##3##(1994-11#1)(2008-3#1)
problems of clinical##2##3##(1990-2#1)(2008-10#1)
problems of health care##2##4##(1994-2#2)
problems of overuse##2##3##(1994-3#2)
problems of the##11##3##(1990-5#1)(1990-8#1)(1991-3#1)(1993-12#1)(1994-2#2)(1995-3#1)(2007-5#2)(2011-1#1)(2013-1#1)
problems of##100##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
problems often##5##2##(1997-2#1)(2007-9#1)(2008-4#1)(2009-10#1)(2013-7#1)
problems on##2##2##(1994-2#1)(2011-2#1)
problems or##12##2##(1990-6#1)(1993-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-2#2)(2013-1#2)
problems over##2##2##(2008-10#1)(2009-7#1)
problems posed by##2##3##(2007-8#1)(2010-11#1)
problems presented##2##2##(1992-12#1)(2010-11#1)
problems provides##2##2##(1994-2#1)(2008-7#1)
problems regarding the##2##3##(1990-3#1)(1997-8#1)
problems regarding##4##2##(1990-3#1)(1997-8#2)(2008-6#1)
problems related to the##4##4##(1996-12#1)(2008-10#2)(2011-2#1)
problems related to##14##3##(1991-3#1)(1992-12#1)(1996-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)
problems related with##2##3##(2008-10#2)
problems related##16##2##(1991-3#1)(1992-12#1)(1996-12#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)
problems relating to the##2##4##(1992-5#1)(1993-6#1)
problems remain##3##2##(1994-5#1)(2008-11#2)
problems reported by##2##3##(2008-3#1)(2013-1#1)
problems seen##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
problems should be##2##3##(2008-1#1)(2008-6#1)
problems such as##10##3##(1995-9#1)(1996-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-6#1)(2011-7#1)(2013-1#1)
problems such##11##2##(1995-9#1)(1996-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-6#1)(2011-7#1)(2013-1#1)
problems surrounding##2##2##(1993-2#1)(2009-7#1)
problems than##7##2##(1992-1#1)(1994-3#1)(1996-6#1)(2008-7#2)(2008-9#1)(2009-9#1)
problems that are encountered in##2##5##(2008-3#1)(2008-4#1)
problems that are##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2012-3#1)
problems that can##2##3##(2008-7#1)(2011-2#1)
problems that could##2##3##(2008-10#1)(2010-3#1)
problems that may##2##3##(1993-2#1)(2008-9#1)
problems that need##3##3##(2011-1#1)(2012-12#1)(2013-8#1)
problems that##33##2##(1990-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#5)(2008-9#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
problems these##2##2##(1991-12#1)(2008-5#1)
problems they##2##2##(2008-4#1)(2010-10#1)
problems to be##4##3##(2012-2#1)(2013-8#3)
problems to##12##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#1)(1995-5#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
problems under##2##2##(1991-2#1)(2010-11#1)
problems underlying##2##2##(2011-2#1)(2013-1#1)
problems unique to##2##3##(1992-2#1)(2013-1#1)
problems was##4##2##(1996-1#1)(1996-6#1)(2010-7#1)(2013-1#1)
problems were found##2##3##(2007-2#1)(2008-3#1)
problems were observed##2##3##(2008-1#1)(2008-10#1)
problems were solved##2##3##(2007-9#1)(2008-10#1)
problems were##26##2##(1990-2#1)(1991-2#1)(1992-5#1)(1994-3#1)(1994-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#1)(2011-1#2)(2013-1#2)(2013-8#1)
problems when##4##2##(1996-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
problems where##2##2##(2009-9#1)(2010-11#1)
problems which are##2##3##(1996-12#1)(2010-3#1)
problems which##4##2##(1990-12#1)(1996-12#1)(2007-8#1)(2010-3#1)
problems will##2##2##(1993-1#1)(2008-12#1)
problems with a##2##3##(2010-2#1)(2010-7#1)
problems with computationally##2##3##(2007-9#2)
problems with the##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
problems with this##2##3##(2008-10#1)(2008-9#1)
problems with##56##2##(1990-11#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1995-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-9#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
problems##1349##1##(1990-10#2)(1990-11#7)(1990-12#7)(1990-2#7)(1990-3#6)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#5)(1991-12#8)(1991-2#9)(1991-3#11)(1991-5#1)(1991-6#4)(1992-1#13)(1992-11#4)(1992-12#3)(1992-2#11)(1992-3#11)(1992-4#2)(1992-5#7)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#10)(1993-11#2)(1993-12#11)(1993-2#11)(1993-3#12)(1993-5#1)(1993-6#9)(1993-9#4)(1994-1#8)(1994-11#4)(1994-12#4)(1994-2#19)(1994-3#9)(1994-5#2)(1994-6#6)(1994-8#1)(1994-9#4)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#10)(1995-5#5)(1995-6#4)(1995-8#1)(1995-9#6)(1996-1#9)(1996-11#4)(1996-12#9)(1996-2#6)(1996-3#11)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#10)(1997-3#9)(1997-4#6)(1997-5#7)(1997-6#3)(1997-7#3)(1997-8#10)(2006-10#4)(2006-12#1)(2007-10#2)(2007-11#35)(2007-12#28)(2007-2#5)(2007-4#2)(2007-5#7)(2007-6#2)(2007-7#14)(2007-8#11)(2007-9#8)(2008-1#20)(2008-10#97)(2008-11#67)(2008-12#28)(2008-2#27)(2008-3#45)(2008-4#15)(2008-5#17)(2008-6#18)(2008-7#60)(2008-8#26)(2008-9#34)(2009-1#1)(2009-10#11)(2009-11#8)(2009-12#11)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#10)(2009-6#5)(2009-7#20)(2009-8#4)(2009-9#9)(2010-1#3)(2010-10#8)(2010-11#18)(2010-12#8)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#7)(2010-6#2)(2010-7#9)(2010-8#12)(2010-9#7)(2011-1#22)(2011-2#50)(2011-3#3)(2011-7#1)(2012-1#6)(2012-12#23)(2012-2#21)(2012-3#11)(2013-1#43)(2013-7#7)(2013-8#21)
problems&quot##2##1##(1992-1#1)(1996-9#1)
problems)##4##1##(1993-11#1)(2008-11#1)(2008-7#1)(2009-11#1)
problems?##2##1##(2011-1#1)(2012-3#1)
problems?]##2##1##(1990-6#1)(1995-8#1)
problems]##13##1##(1990-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2012-3#1)
proboscis in##3##2##(2007-12#3)
proboscis##6##1##(1994-8#1)(2007-12#5)
probucol##2##1##(1991-5#1)(2008-11#1)
procainamide##3##1##(1992-9#1)(2007-8#1)(2008-5#1)
procaine hydrochloride##12##2##(1992-5#2)(2008-10#10)
procaine##22##1##(1990-2#1)(1991-1#1)(1992-5#2)(1993-9#4)(2008-10#14)
procalcitonin level was##2##3##(2013-1#2)
procalcitonin level##5##2##(2013-1#5)
procalcitonin##13##1##(2008-5#3)(2011-2#1)(2013-1#9)
procarcinogenic##2##1##(1994-6#1)(2013-1#1)
procathepsin E to##3##3##(1991-2#3)
procathepsin E##5##2##(1991-2#5)
procathepsin L##9##2##(1995-6#9)
procathepsin##14##1##(1991-2#5)(1995-6#9)
procede de##2##2##(2008-5#2)
procedes##2##1##(2008-5#2)
procedural and declarative##2##3##(2008-2#2)
procedural and sensory information##2##4##(1995-1#2)
procedural and##6##2##(1995-1#2)(2008-10#1)(2008-2#2)(2012-2#1)
procedural model##2##2##(2007-11#2)
procedural pain##8##2##(1993-2#1)(2008-10#2)(2009-12#2)(2011-1#1)(2011-2#2)
procedural parameters##2##2##(2008-10#1)(2009-5#1)
procedural success rates##2##3##(2008-11#1)(2008-12#1)
procedural##47##1##(1991-12#1)(1991-3#1)(1992-9#1)(1993-2#2)(1995-1#2)(1996-1#1)(1996-2#2)(2007-11#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#6)(2012-2#3)
procedure DROPCORA##2##2##(2008-10#2)
procedure Part##3##2##(2008-10#3)
procedure a##4##2##(2008-10#2)(2008-4#2)
procedure after##2##2##(1994-5#1)(2012-12#1)
procedure agree##2##2##(2008-10#2)
procedure aimed at##2##3##(2008-4#1)(2009-8#1)
procedure aimed##3##2##(2008-1#1)(2008-4#1)(2009-8#1)
procedure allowed the##5##3##(1992-6#1)(1993-9#1)(2008-10#3)
procedure allowed##7##2##(1992-6#1)(1993-9#1)(2007-12#1)(2008-10#4)
procedure allows determination of##2##4##(2008-10#2)
procedure allows the##6##3##(2008-10#6)
procedure allows##13##2##(1994-12#1)(2008-10#12)
procedure also##2##2##(1990-2#1)(2008-10#1)
procedure an##2##2##(2008-4#1)(2011-2#1)
procedure and a##2##3##(1994-11#1)(2011-1#1)
procedure and an##2##3##(2008-10#1)(2008-6#1)
procedure and no##2##3##(1993-1#1)(2008-10#1)
procedure and results##3##3##(1994-9#1)(2008-4#1)(2009-5#1)
procedure and show that the##2##5##(2008-3#2)
procedure and the use of##2##5##(2008-10#1)(2011-1#1)
procedure and the##15##3##(2008-10#8)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
procedure and to##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
procedure and##76##2##(1990-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#4)(2013-1#4)(2013-8#1)
procedure applied##2##2##(2008-10#2)
procedure are presented##2##3##(1990-9#1)(2008-3#1)
procedure are the##2##3##(1991-6#1)(1997-5#1)
procedure are##19##2##(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-9#1)(1996-8#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
procedure as an alternative to##2##5##(1990-9#1)(2008-11#1)
procedure as well as##2##4##(2012-1#1)(2013-1#1)
procedure as##6##2##(1990-9#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-1#1)(2013-1#1)
procedure at the##4##3##(1990-9#1)(2008-10#2)(2008-11#1)
procedure at##6##2##(1990-9#1)(2008-10#4)(2008-11#1)
procedure based on a##2##4##(2008-10#1)(2008-3#1)
procedure based on the total dissolution of the samples##2##9##(2008-10#2)
procedure based on the##10##4##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#1)
procedure based on##27##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-3#3)(2008-5#1)(2012-2#1)(2012-3#1)
procedure before##2##2##(1993-3#1)(2008-10#1)
procedure but##3##2##(2008-10#2)(2008-3#1)
procedure by the##2##3##(2008-10#1)(2008-12#1)
procedure by##10##2##(1992-6#1)(1994-8#1)(2007-11#2)(2008-10#5)(2008-12#1)
procedure can be applied##2##4##(2008-3#1)(2009-9#1)
procedure can be used##3##4##(2008-10#2)(2008-8#1)
procedure can be##18##3##(1993-9#1)(1994-8#2)(1995-1#1)(2006-6#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)
procedure can##26##2##(1993-9#1)(1994-8#2)(1995-1#1)(2006-6#1)(2007-11#2)(2008-10#8)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)
procedure codes##3##2##(1991-3#1)(1995-8#2)
procedure combined##2##2##(2008-10#2)
procedure compared##2##2##(2008-10#1)(2011-2#1)
procedure consisting of##3##3##(1991-12#1)(1992-6#1)(2008-10#1)
procedure consists in the##2##4##(1991-11#1)(2008-10#1)
procedure consists of##4##3##(2008-10#3)(2008-3#1)
procedure consists##6##2##(1991-11#1)(2008-10#4)(2008-3#1)
procedure controls the##2##3##(2009-9#1)(2012-2#1)
procedure could also be used##2##5##(2008-10#1)(2008-11#1)
procedure could also be##3##4##(2008-10#2)(2008-11#1)
procedure could be##3##3##(1996-9#1)(2008-10#1)(2009-8#1)
procedure could##6##2##(1996-9#1)(2008-10#3)(2008-11#1)(2009-8#1)
procedure described for##2##3##(2008-10#1)(2008-3#1)
procedure described##4##2##(2008-10#3)(2008-3#1)
procedure designed to##2##3##(2008-10#1)(2008-3#1)
procedure developed by##3##3##(1994-12#1)(2008-3#1)(2008-9#1)
procedure developed##13##2##(1994-12#1)(2008-10#10)(2008-3#1)(2008-9#1)
procedure did not##3##3##(1996-5#1)(2007-12#1)(2010-8#1)
procedure due to##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
procedure duration was##2##3##(2013-8#2)
procedure eliminates##2##2##(2007-7#1)(2008-10#1)
procedure followed by##2##3##(2008-10#1)(2011-1#1)
procedure for Saccharomyces cerevisiae##2##4##(2008-2#2)
procedure for a##9##3##(2008-10#3)(2008-11#2)(2008-3#2)(2009-10#1)(2013-1#1)
procedure for acid##2##3##(2008-10#1)(2008-4#1)
procedure for analysis of##2##4##(2008-10#2)
procedure for analyzing##2##3##(2008-2#1)(2008-3#1)
procedure for arsenic##3##3##(2008-10#3)
procedure for assessing##2##3##(2008-4#1)(2008-9#1)
procedure for bovine##2##3##(2008-10#2)
procedure for calculating the##2##4##(2008-2#1)(2008-3#1)
procedure for casting a solid##2##5##(2008-5#2)
procedure for determination of##6##4##(2008-10#5)(2008-2#1)
procedure for determining##4##3##(2008-10#3)(2008-2#1)
procedure for estimating##3##3##(1996-12#1)(2008-3#2)
procedure for fabricating##3##3##(2008-10#1)(2008-3#2)
procedure for handling and##2##4##(2008-10#1)(2008-4#1)
procedure for iron##2##3##(2008-10#2)
procedure for lead determination##3##4##(2008-10#3)
procedure for lead##4##3##(2008-10#4)
procedure for measuring the##4##4##(2008-10#2)(2008-3#2)
procedure for obtaining##2##3##(2008-3#1)(2008-4#1)
procedure for organotin##2##3##(2008-10#2)
procedure for preparing##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
procedure for rapid##2##3##(1994-12#1)(2008-10#1)
procedure for selecting the##2##4##(2008-2#1)(2008-3#1)
procedure for separating##4##3##(2008-10#3)(2008-4#1)
procedure for separation##2##3##(2008-10#2)
procedure for simultaneous##2##3##(2008-10#2)
procedure for solid phase microextraction-gas chromatographic##2##6##(2008-10#2)
procedure for spectrophotometric determination of##3##5##(2008-10#3)
procedure for testing##2##3##(1997-8#1)(2008-10#1)
procedure for the analysis of polycyclic aromatic hydrocarbons (PAHs)##2##9##(2008-10#2)
procedure for the analysis of##4##5##(2008-10#4)
procedure for the determination of the##2##6##(2008-10#2)
procedure for the determination of trace levels of##2##8##(2008-10#2)
procedure for the determination of trace##4##6##(2008-10#4)
procedure for the determination of##36##5##(1990-12#2)(1996-5#1)(2008-10#32)(2008-5#1)
procedure for the isolation##2##4##(2008-11#2)
procedure for the separation##2##4##(1996-5#1)(2008-10#1)
procedure for the simultaneous determination of##4##6##(2008-10#4)
procedure for the simultaneous##5##4##(2008-10#5)
procedure for the speciation of antimony##2##6##(2008-10#2)
procedure for the spectrophotometric determination of##4##6##(2008-10#3)(2010-5#1)
procedure for the synthesis of##2##5##(2008-12#1)(2008-5#1)
procedure for the##97##3##(1990-12#2)(1991-12#1)(1995-9#1)(1996-5#2)(2007-8#1)(2008-10#66)(2008-11#2)(2008-12#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
procedure for this##2##3##(1995-8#1)(2008-2#1)
procedure for treating##2##3##(2013-1#2)
procedure for##326##2##(1990-12#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#3)(1992-3#1)(1992-5#2)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#4)(2008-10#157)(2008-11#9)(2008-12#2)(2008-2#16)(2008-3#24)(2008-4#25)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#9)(2009-10#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#9)(2012-12#3)(2012-3#1)(2013-1#6)
procedure gave##2##2##(2008-10#1)(2009-8#1)
procedure had##3##2##(2008-10#2)(2008-6#1)
procedure has a##4##3##(1994-12#1)(2008-10#1)(2008-12#1)(2009-5#1)
procedure has been applied##2##4##(1991-5#1)(2008-10#1)
procedure has been developed for the determination of##2##8##(2008-10#2)
procedure has been developed for the direct##2##7##(2008-10#2)
procedure has been developed for the##6##6##(2008-10#5)(2009-5#1)
procedure has been developed for##12##5##(2008-10#11)(2009-5#1)
procedure has been developed to##2##5##(2008-2#2)
procedure has been developed##14##4##(2008-10#11)(2008-2#2)(2009-5#1)
procedure has been performed##4##4##(2008-2#1)(2008-4#2)(2009-9#1)
procedure has been successfully##6##4##(2008-10#6)
procedure has been##45##3##(1991-5#1)(1993-12#1)(2008-10#33)(2008-11#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)
procedure has to be##2##4##(2008-10#1)(2008-11#1)
procedure has##59##2##(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#2)(1994-12#1)(2007-7#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#4)(2009-9#1)
procedure have been##3##3##(2008-10#3)
procedure have##4##2##(2008-10#4)
procedure in a##2##3##(1995-1#1)(2008-10#1)
procedure in deep##2##3##(1993-9#1)(2007-11#1)
procedure in preteen and teen patients with brachial plexus birth palsy##2##11##(2013-1#2)
procedure in terms of##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
procedure in the diagnosis of##2##5##(1990-11#1)(2007-11#1)
procedure in the##16##3##(1990-11#1)(1990-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
procedure in##66##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-9#1)(1992-11#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-9#1)(1997-3#2)(2007-11#6)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-3#4)(2013-1#5)
procedure includes##3##2##(2008-10#2)(2008-7#1)
procedure involved the##2##3##(2008-10#2)
procedure involved##7##2##(1996-5#1)(2008-10#4)(2008-12#1)(2008-8#1)
procedure involves the##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
procedure involves##6##2##(1990-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
procedure involving the##3##3##(2008-10#3)
procedure involving##11##2##(1990-7#1)(1994-8#1)(1996-5#1)(2008-10#8)
procedure is a safe and##2##5##(2008-10#1)(2008-9#1)
procedure is a##6##3##(1990-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
procedure is also##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
procedure is applicable##2##3##(2008-10#1)(2008-3#1)
procedure is applied##2##3##(2008-10#1)(2008-6#1)
procedure is based on a##2##5##(2008-10#1)(2013-1#1)
procedure is based on the##12##5##(2008-10#12)
procedure is based on##17##4##(2008-10#14)(2008-2#1)(2008-3#1)(2013-1#1)
procedure is carried out##3##4##(1996-5#1)(2008-10#1)(2008-7#1)
procedure is demonstrated##3##3##(2008-10#2)(2008-3#1)
procedure is described for the determination of##3##7##(2008-10#3)
procedure is described for the##5##5##(1993-11#1)(2008-10#4)
procedure is described for##9##4##(1993-11#1)(2008-10#4)(2008-4#3)(2008-8#1)
procedure is described in detail##2##5##(2007-8#1)(2008-10#1)
procedure is described in##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
procedure is described##17##3##(1990-8#1)(1993-11#1)(1994-5#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-4#3)(2008-8#1)(2011-2#1)
procedure is developed for##2##4##(2008-10#2)
procedure is developed to##2##4##(2008-3#2)
procedure is developed##4##3##(2008-10#2)(2008-3#2)
procedure is effective##2##3##(2007-8#1)(2008-2#1)
procedure is employed##2##3##(2007-11#1)(2008-10#1)
procedure is illustrated for##2##4##(2008-3#1)(2010-5#1)
procedure is illustrated##5##3##(2008-10#3)(2008-3#1)(2010-5#1)
procedure is investigated##2##3##(2008-2#1)(2008-3#1)
procedure is not affected by##2##5##(2008-10#2)
procedure is not##7##3##(2008-10#5)(2008-3#1)(2011-1#1)
procedure is only##2##3##(1996-8#1)(2011-2#1)
procedure is particularly useful##2##4##(2008-2#1)(2008-4#1)
procedure is performed##2##3##(1996-3#1)(2008-10#1)
procedure is presented for the##4##5##(1994-12#1)(2008-10#2)(2008-4#1)
procedure is presented for##6##4##(1994-12#1)(2008-10#2)(2008-3#1)(2008-4#2)
procedure is presented##10##3##(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2011-2#1)
procedure is proposed for the##5##5##(2008-10#5)
procedure is proposed for##8##4##(2008-10#7)(2010-11#1)
procedure is proposed##11##3##(2008-10#9)(2008-3#1)(2010-11#1)
procedure is provided##2##3##(2007-12#1)(2008-4#1)
procedure is rapid##2##3##(2008-10#1)(2008-9#1)
procedure is safe##2##3##(2009-2#1)(2010-6#1)
procedure is shown##2##3##(2008-2#1)(2010-7#1)
procedure is the##4##3##(2007-8#1)(2008-10#1)(2008-11#2)
procedure is to##3##3##(2008-3#1)(2008-4#1)(2009-9#1)
procedure is used to##2##4##(2008-10#1)(2008-3#1)
procedure is used##5##3##(2008-10#1)(2008-3#3)(2013-1#1)
procedure is##189##2##(1990-11#1)(1990-8#2)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2007-11#5)(2007-12#3)(2007-8#4)(2008-10#77)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#22)(2008-4#14)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-2#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#4)
procedure it is possible to##2##5##(2008-10#1)(2008-2#1)
procedure itself##3##2##(1990-11#1)(1994-12#1)(2012-1#1)
procedure leads to##2##3##(2008-10#1)(2008-3#1)
procedure makes use of##2##4##(1991-5#1)(2008-8#1)
procedure may be##5##3##(1996-12#1)(1997-8#1)(2011-1#2)(2011-2#1)
procedure may##9##2##(1996-12#1)(1997-8#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
procedure might##2##2##(2009-5#1)(2012-12#1)
procedure not##2##2##(2008-10#1)(2008-2#1)
procedure of 0##2##3##(2008-10#2)
procedure of an##2##3##(2008-10#1)(2008-3#1)
procedure of choice##8##3##(2007-11#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
procedure of the##8##3##(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
procedure of##47##2##(1990-8#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-3#1)(2010-8#3)(2011-2#3)(2013-1#2)(2013-8#1)
procedure offers high selectivity##2##4##(2008-10#2)
procedure offers##5##2##(2008-10#4)(2011-2#1)
procedure on##5##2##(2007-8#1)(2008-10#3)(2012-2#1)
procedure only##2##2##(1990-12#1)(2008-10#1)
procedure or##5##2##(1992-5#1)(1993-9#1)(1995-3#1)(2008-1#1)(2008-11#1)
procedure over##2##2##(1991-8#1)(2008-7#1)
procedure performed##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
procedure permits the##2##3##(2008-10#1)(2008-4#1)
procedure permits##4##2##(2008-10#3)(2008-4#1)
procedure presents##2##2##(2008-10#1)(2008-4#1)
procedure previously reported##2##3##(2008-10#2)
procedure previously##3##2##(1993-9#1)(2008-10#2)
procedure prior to##3##3##(1994-12#1)(2012-12#1)(2012-3#1)
procedure proposed##6##2##(2008-10#6)
procedure provided##5##2##(2008-10#4)(2009-3#1)
procedure provides a##6##3##(2008-10#2)(2008-3#1)(2008-5#2)(2009-7#1)
procedure provides##9##2##(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#1)
procedure reduces##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
procedure requested##2##2##(2010-8#2)
procedure requires##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
procedure resulted in a##2##4##(1993-12#1)(2008-10#1)
procedure resulted in##4##3##(1991-2#1)(1993-12#1)(1995-11#1)(2008-10#1)
procedure reveals##2##2##(1996-3#1)(2010-6#1)
procedure should be##4##3##(1990-5#1)(1994-3#1)(2008-1#1)(2008-9#1)
procedure should##6##2##(1990-5#1)(1994-3#1)(2008-1#2)(2008-11#1)(2008-9#1)
procedure shows##3##2##(1991-2#1)(2008-10#2)
procedure similar to##3##3##(2008-10#2)(2008-5#1)
procedure such as##2##3##(1990-11#1)(2008-10#1)
procedure than##7##2##(1993-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
procedure that allows##2##3##(2008-10#1)(2011-2#1)
procedure that can be##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
procedure that can##4##3##(1994-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
procedure that is##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
procedure that may##3##3##(1994-9#1)(2008-10#1)(2010-8#1)
procedure that was##2##3##(2008-2#1)(2008-3#1)
procedure that##34##2##(1990-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#3)
procedure the##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
procedure through##2##2##(1992-9#1)(2008-10#1)
procedure to be used##2##4##(2008-4#1)(2008-7#1)
procedure to be##5##3##(1993-6#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
procedure to determine##3##3##(2007-12#1)(2008-3#2)
procedure to evaluate the##2##4##(2008-10#1)(2008-5#1)
procedure to isolate##2##3##(1990-12#1)(1997-2#1)
procedure to measure the##2##4##(2008-10#1)(2008-5#1)
procedure to measure##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
procedure to obtain##2##3##(1990-10#1)(1990-8#1)
procedure to reduce the number of##2##6##(2008-10#1)(2008-3#1)
procedure to the##4##3##(2008-10#3)(2012-12#1)
procedure to##65##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-6#2)(1994-12#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
procedure until##2##2##(2008-10#1)(2012-2#1)
procedure used in this##2##4##(1996-8#1)(2008-10#1)
procedure used##9##2##(1991-4#1)(1992-6#1)(1996-5#1)(1996-8#1)(2008-10#4)(2008-11#1)
procedure using a##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
procedure using the##3##3##(2008-10#2)(2008-9#1)
procedure using##20##2##(1992-9#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
procedure via##2##2##(2009-6#1)(2011-2#1)
procedure volume##4##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)
procedure was achieved##2##3##(2008-10#2)
procedure was also##4##3##(1990-8#1)(2008-10#3)
procedure was applied for copper determination##2##6##(2008-10#2)
procedure was applied for the determination of##2##7##(2008-10#2)
procedure was applied for##6##4##(2008-10#6)
procedure was applied successfully##3##4##(2008-10#3)
procedure was applied to determination of##2##6##(2008-10#2)
procedure was applied to the analysis of##4##7##(2008-10#4)
procedure was applied to the determination of##6##7##(2008-10#6)
procedure was applied to the speciation of##2##7##(2008-10#2)
procedure was applied to the##13##5##(2008-10#13)
procedure was applied to##29##4##(1996-12#1)(2008-10#27)(2008-3#1)
procedure was applied##39##3##(1996-12#1)(2008-10#37)(2008-3#1)
procedure was based on the##5##5##(2008-10#5)
procedure was based on##8##4##(1995-12#1)(2007-8#1)(2008-10#6)
procedure was carried out##5##4##(1991-8#1)(1993-12#1)(2008-10#2)(2008-11#1)
procedure was checked by the##2##5##(2008-10#2)
procedure was checked by##3##4##(2008-10#3)
procedure was checked##5##3##(2008-10#5)
procedure was completed##2##3##(1996-11#1)(2011-2#1)
procedure was confirmed by##3##4##(2008-10#3)
procedure was developed for simultaneous determination of##3##7##(2008-10#3)
procedure was developed for the determination of##4##7##(2008-10#3)(2012-1#1)
procedure was developed for the##7##5##(2008-10#6)(2012-1#1)
procedure was developed for##14##4##(1995-12#1)(2008-10#12)(2012-1#1)
procedure was developed in##2##4##(2008-10#2)
procedure was developed to##2##4##(2008-10#1)(2008-6#1)
procedure was developed##25##3##(1990-5#1)(1993-12#1)(1995-12#1)(2008-10#20)(2008-6#1)(2012-1#1)
procedure was devised##2##3##(1990-8#1)(2008-10#1)
procedure was done##2##3##(2007-8#1)(2008-7#1)
procedure was evaluated by##3##4##(2008-10#3)
procedure was evaluated##4##3##(2008-10#4)
procedure was not##2##3##(2008-10#1)(2008-7#1)
procedure was optimized by##2##4##(2008-10#2)
procedure was optimized##4##3##(2008-10#4)
procedure was performed in##2##4##(2007-8#1)(2008-10#1)
procedure was performed to##2##4##(2007-12#1)(2009-10#1)
procedure was performed##9##3##(1991-2#1)(1995-12#1)(2007-12#1)(2007-8#2)(2008-10#3)(2009-10#1)
procedure was repeated##4##3##(1990-8#1)(1993-3#1)(1997-6#1)(2011-3#1)
procedure was successfully applied for the determination of##2##8##(2008-10#2)
procedure was successfully applied for the##3##6##(2008-10#3)
procedure was successfully applied to the determination of##5##8##(2008-10#5)
procedure was successfully applied to the extraction and determination of##2##10##(2008-10#2)
procedure was successfully applied to the##8##6##(2008-10#8)
procedure was successfully applied to##9##5##(2008-10#9)
procedure was successfully applied##12##4##(2008-10#12)
procedure was successfully##13##3##(2008-10#13)
procedure was tested by analyzing##3##5##(2008-10#3)
procedure was tested by##4##4##(2008-10#4)
procedure was tested##7##3##(2008-10#7)
procedure was then##2##3##(2008-10#1)(2008-7#1)
procedure was used for##3##4##(2008-10#3)
procedure was used to##6##4##(2008-10#3)(2008-3#1)(2008-9#1)(2009-11#1)
procedure was used##12##3##(2008-10#8)(2008-3#1)(2008-9#1)(2009-11#1)(2010-5#1)
procedure was validated by##5##4##(2008-10#4)(2013-8#1)
procedure was validated##6##3##(2008-10#5)(2013-8#1)
procedure was##209##2##(1990-5#1)(1990-7#1)(1990-8#3)(1991-2#2)(1991-8#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-12#4)(1996-11#1)(1996-12#2)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#5)(2008-10#149)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
procedure we##2##2##(1993-11#1)(2008-3#1)
procedure well##2##2##(2012-12#1)(2013-1#1)
procedure were evaluated##2##3##(2008-10#2)
procedure were in good agreement with those obtained by##2##9##(2008-10#2)
procedure were in##4##3##(2008-10#4)
procedure were studied##3##3##(2008-10#3)
procedure were##26##2##(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#18)(2010-3#1)(2010-7#1)(2011-2#3)
procedure when##3##2##(1992-12#1)(2008-5#2)
procedure which is##2##3##(2008-12#1)(2012-3#1)
procedure which##9##2##(2008-10#3)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
procedure will##3##2##(1997-3#1)(1997-7#1)(2007-12#1)
procedure with a high##2##4##(1994-3#1)(2008-10#1)
procedure with a##9##3##(1994-3#1)(1995-2#1)(2008-10#4)(2008-7#1)(2010-12#1)(2012-3#1)
procedure with ethyl##2##3##(2008-10#2)
procedure with the##3##3##(1997-3#1)(2008-10#2)
procedure with##37##2##(1990-6#1)(1991-12#1)(1991-3#1)(1993-3#1)(1994-3#1)(1995-2#1)(1997-3#2)(2007-11#2)(2008-10#17)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)
procedure without##5##2##(2008-10#4)(2009-6#1)
procedure works well##2##3##(2008-10#1)(2008-2#1)
procedure yielded##3##2##(1992-11#1)(1993-8#1)(2008-10#1)
procedure yields##3##2##(2008-4#1)(2012-2#1)(2012-3#1)
procedure##2256##1##(1990-10#2)(1990-11#9)(1990-12#8)(1990-2#3)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#9)(1990-9#11)(1991-11#1)(1991-12#6)(1991-2#9)(1991-3#7)(1991-4#2)(1991-5#6)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#13)(1992-3#3)(1992-5#3)(1992-6#6)(1992-8#1)(1992-9#7)(1993-1#1)(1993-11#5)(1993-12#12)(1993-2#1)(1993-3#5)(1993-6#4)(1993-8#1)(1993-9#7)(1994-1#2)(1994-11#5)(1994-12#14)(1994-2#3)(1994-3#6)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#9)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#10)(1995-2#5)(1995-3#2)(1995-6#2)(1995-8#6)(1995-9#2)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#9)(1996-6#2)(1996-8#4)(1996-9#6)(1997-2#6)(1997-3#9)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#10)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#40)(2007-12#20)(2007-2#2)(2007-7#10)(2007-8#44)(2008-1#7)(2008-10#970)(2008-11#47)(2008-12#14)(2008-2#66)(2008-3#111)(2008-4#69)(2008-5#34)(2008-6#15)(2008-7#38)(2008-8#19)(2008-9#41)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#10)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#9)(2010-1#3)(2010-10#2)(2010-11#6)(2010-12#4)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#8)(2010-6#5)(2010-7#10)(2010-8#18)(2011-1#22)(2011-2#80)(2011-3#5)(2012-1#5)(2012-12#25)(2012-2#30)(2012-3#21)(2013-1#46)(2013-7#4)(2013-8#20)
procedure)##9##1##(1990-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
procedure-related pain in##2##3##(2008-11#2)
procedure-related stress##2##2##(1994-12#2)
procedure-related##6##1##(1994-12#2)(1996-2#1)(2008-11#2)(2013-1#1)
procedure?##5##1##(2008-11#3)(2008-7#1)(2009-4#1)
procedures (e##2##2##(2008-10#1)(2011-2#1)
procedures (i##3##2##(1990-11#1)(2008-4#2)
procedures -##2##2##(2007-11#1)(2008-10#1)
procedures a##2##2##(2007-11#1)(2008-10#1)
procedures after##2##2##(1995-8#1)(2008-9#1)
procedures allow for the study of a variety of drug properties##2##11##(2008-4#1)(2012-3#1)
procedures also##3##2##(2008-10#2)(2008-4#1)
procedures among##2##2##(1994-11#1)(2010-8#1)
procedures and an##2##3##(1997-5#1)(2008-7#1)
procedures and in##2##3##(2008-10#1)(2011-2#1)
procedures and remarkable stability in##2##5##(2008-10#2)
procedures and results##2##3##(2008-9#1)(2012-1#1)
procedures and surgical##2##3##(1993-6#1)(2012-2#1)
procedures and the##4##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-6#1)
procedures and their##3##3##(1994-3#1)(2012-2#2)
procedures and treatment##2##3##(1996-3#1)(2011-1#1)
procedures and##84##2##(1990-8#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-3#3)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-8#4)(2011-1#2)(2011-2#9)(2012-1#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
procedures appear to be##2##4##(2008-1#1)(2011-2#1)
procedures appeared##2##2##(1993-5#1)(1994-3#1)
procedures are also##2##3##(2008-2#1)(2008-4#1)
procedures are currently##2##3##(2008-10#1)(2009-9#1)
procedures are described in##4##4##(2008-3#1)(2008-4#2)(2008-9#1)
procedures are described##11##3##(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#3)(2008-9#3)(2010-6#1)
procedures are discussed##2##3##(2008-10#1)(2008-4#1)
procedures are less##2##3##(1996-3#1)(2008-10#1)
procedures are not##4##3##(1996-2#1)(1996-3#1)(2008-5#1)(2008-7#1)
procedures are presented##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
procedures are provided##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
procedures are time consuming##2##4##(2008-10#2)
procedures are used to##2##4##(2008-4#1)(2012-3#1)
procedures are used##3##3##(2008-4#2)(2012-3#1)
procedures are##88##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#12)(2008-5#1)(2008-7#1)(2008-9#6)(2009-11#1)(2009-12#1)(2009-9#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)
procedures as##8##2##(1991-3#2)(1994-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
procedures associated with##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
procedures at##3##2##(1996-1#1)(2006-8#1)(2012-12#1)
procedures available for##2##3##(2008-7#1)(2010-9#1)
procedures based on##7##3##(1994-9#1)(1995-5#1)(2008-10#3)(2009-11#1)(2012-3#1)
procedures before##2##2##(1995-12#1)(2007-12#1)
procedures by##3##2##(2008-10#2)(2008-7#1)
procedures can also be##2##4##(2008-4#1)(2012-3#1)
procedures can be used##2##4##(1996-5#1)(2008-2#1)
procedures can be##7##3##(1991-6#1)(1993-3#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
procedures can##11##2##(1991-6#1)(1993-3#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#2)
procedures carried out##4##3##(1991-8#1)(2007-8#1)(2008-3#1)(2008-7#1)
procedures combined with##2##3##(2009-6#1)(2010-3#1)
procedures could##4##2##(1993-2#1)(1996-12#1)(2008-10#2)
procedures currently##2##2##(2008-10#1)(2010-11#1)
procedures described in##2##3##(2008-10#1)(2008-4#1)
procedures described##3##2##(2008-10#1)(2008-4#2)
procedures designed to##2##3##(2008-4#2)
procedures developed for##3##3##(2008-10#2)(2008-11#1)
procedures developed##5##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
procedures do##2##2##(2008-10#1)(2008-11#1)
procedures during##4##2##(2007-8#1)(2008-2#1)(2010-8#1)(2012-1#1)
procedures effectively##2##2##(2008-2#1)(2010-8#1)
procedures employed##2##2##(1992-2#1)(2008-5#1)
procedures for a##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
procedures for analyzing the##2##4##(2008-2#1)(2008-4#1)
procedures for measuring the##3##4##(2008-4#2)(2008-9#1)
procedures for measuring##4##3##(2008-4#3)(2008-9#1)
procedures for simultaneous##2##3##(2008-10#2)
procedures for testing##2##3##(2008-4#1)(2008-9#1)
procedures for the determination of##7##5##(2008-10#7)
procedures for the preparation of##3##5##(2008-4#2)(2008-9#1)
procedures for the preparation##4##4##(2008-10#1)(2008-4#2)(2008-9#1)
procedures for the qualitative and quantitative assessment of mRNA abundance are important##2##12##(2008-2#1)(2008-4#1)
procedures for the##29##3##(1994-2#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#7)(2008-9#2)(2010-8#1)(2012-3#1)(2013-8#1)
procedures for which##3##3##(1995-2#1)(1996-9#1)(2008-6#1)
procedures for##145##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#3)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#32)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#11)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-7#2)(2010-8#2)(2012-2#1)(2012-3#3)(2013-8#1)
procedures from##2##2##(1990-3#1)(1991-2#1)
procedures give##2##2##(1994-12#1)(2013-8#1)
procedures has##5##2##(2007-8#2)(2008-10#2)(2011-2#1)
procedures have been applied to the##2##6##(2008-10#2)
procedures have been applied##3##4##(2008-10#3)
procedures have been developed to##2##5##(1994-12#1)(2008-10#1)
procedures have been developed##4##4##(1991-3#1)(1994-12#1)(2008-10#1)(2010-1#1)
procedures have been proposed##2##4##(2011-2#1)(2011-7#1)
procedures have been reported##2##4##(2008-5#1)(2010-7#1)
procedures have been used##2##4##(2008-10#1)(2008-4#1)
procedures have been##22##3##(1991-3#1)(1991-5#1)(1994-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#2)(2010-1#2)(2010-7#1)(2011-2#3)(2011-7#1)
procedures have##34##2##(1991-11#1)(1991-3#1)(1991-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-1#2)(2010-7#1)(2011-2#4)(2011-7#1)(2012-2#1)
procedures in a##3##3##(2008-5#1)(2008-7#2)
procedures in an##2##3##(2010-11#1)(2011-2#1)
procedures in infants##2##3##(2008-10#1)(2012-2#1)
procedures in patients##2##3##(1995-8#1)(2010-3#1)
procedures in the treatment of##2##5##(2007-11#1)(2011-3#1)
procedures in the##12##3##(1994-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-8#1)(2011-3#1)(2012-12#1)
procedures in this##2##3##(2009-9#1)(2011-2#1)
procedures in##54##2##(1990-9#1)(1994-2#1)(1995-8#2)(1996-9#1)(1997-3#1)(1997-6#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2009-12#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
procedures included##3##2##(1992-2#1)(1993-2#1)(2007-8#1)
procedures including##5##2##(2006-10#1)(2008-10#2)(2010-8#1)(2012-3#1)
procedures involve##2##2##(2007-12#1)(2008-10#1)
procedures involved in##2##3##(2008-11#1)(2008-2#1)
procedures involved##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
procedures involving the##2##3##(1990-9#1)(2008-10#1)
procedures involving##5##2##(1990-9#1)(2007-11#1)(2008-10#3)
procedures is an##2##3##(2010-7#1)(2011-2#1)
procedures is the##2##3##(1997-6#1)(2009-2#1)
procedures is##19##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-4#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-2#2)
procedures led to##2##3##(1992-12#1)(1992-3#1)
procedures like##2##2##(2008-10#1)(2008-11#1)
procedures may be##2##3##(1997-5#1)(2011-1#1)
procedures may##7##2##(1997-5#1)(2007-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
procedures might be##2##3##(2008-9#1)(2011-2#1)
procedures must be##2##3##(1996-3#1)(2007-7#1)
procedures must##4##2##(1996-3#1)(1996-6#1)(2007-7#1)(2008-10#1)
procedures now##2##2##(1992-2#1)(1994-12#1)
procedures occurred in##2##3##(1996-9#1)(2008-7#1)
procedures of a##2##3##(2008-3#1)(2011-1#1)
procedures of the##5##3##(2007-12#1)(2008-10#1)(2009-5#1)(2009-6#1)(2013-7#1)
procedures of##28##2##(1991-3#1)(1992-3#1)(1992-9#2)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#2)(2009-6#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
procedures on the##5##3##(1996-9#2)(2007-8#1)(2008-10#1)(2008-9#1)
procedures on##7##2##(1996-9#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
procedures or##4##2##(1993-3#1)(1995-9#1)(1997-8#1)(2011-2#1)
procedures performed in the hospital##2##5##(1995-2#2)
procedures performed in the##3##4##(1995-2#2)(2011-2#1)
procedures performed in##5##3##(1995-2#3)(2010-8#1)(2011-2#1)
procedures performed##15##2##(1992-12#1)(1993-1#1)(1995-1#1)(1995-2#3)(1995-3#1)(1997-3#1)(2006-10#1)(2008-3#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
procedures present##2##2##(2008-10#1)(2012-2#1)
procedures presented##2##2##(2008-4#1)(2008-9#1)
procedures related to##2##3##(2008-12#2)
procedures require##4##2##(2007-12#1)(2007-8#1)(2009-10#1)(2012-1#1)
procedures required to##2##3##(1993-12#1)(2008-4#1)
procedures required##3##2##(1993-12#1)(2008-4#2)
procedures retrospectively##2##2##(2010-8#2)
procedures should be##6##3##(2007-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-6#1)
procedures should##9##2##(1995-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-6#1)
procedures such as##14##3##(1993-2#1)(1996-5#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-8#1)(2012-3#1)
procedures that allow##2##3##(2008-4#1)(2010-6#1)
procedures that are##6##3##(2008-1#1)(2008-2#1)(2008-4#3)(2013-8#1)
procedures that can be used##2##5##(1997-3#1)(2008-2#1)
procedures that can##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
procedures that have##2##3##(2008-12#1)(2008-7#1)
procedures that were##2##3##(1995-3#1)(2007-8#1)
procedures that##27##2##(1992-5#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#2)(2008-2#2)(2008-4#6)(2008-7#1)(2010-6#1)(2012-3#1)(2013-8#1)
procedures the##4##2##(1990-3#1)(1996-3#1)(2007-11#1)(2008-4#1)
procedures to a minimum##2##4##(1992-12#1)(2008-7#1)
procedures to a##3##3##(1992-12#1)(2008-3#1)(2008-7#1)
procedures to achieve##2##3##(2008-11#1)(2008-3#1)
procedures to assess##2##3##(2008-10#1)(2010-8#1)
procedures to be##2##3##(1996-6#1)(2008-10#1)
procedures to correct##2##3##(1990-9#1)(2008-9#1)
procedures to determine##3##3##(2008-10#2)(2008-4#1)
procedures to identify##3##3##(2008-12#1)(2008-5#1)(2009-12#1)
procedures to the##2##3##(2008-10#1)(2008-3#1)
procedures to##50##2##(1990-11#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
procedures used by the##2##4##(1991-12#1)(2008-7#1)
procedures used by##3##3##(1991-12#1)(1993-5#1)(2008-7#1)
procedures used for##3##3##(2008-10#2)(2012-3#1)
procedures used in the##2##4##(1992-3#1)(2008-3#1)
procedures used in##5##3##(1992-3#1)(1996-12#1)(2007-11#1)(2008-3#1)(2008-7#1)
procedures used to##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
procedures used##17##2##(1991-12#1)(1992-3#1)(1993-5#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#3)(2010-6#1)(2012-2#1)(2012-3#1)
procedures using##13##2##(1990-12#1)(1993-1#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#2)
procedures was##11##2##(1990-12#1)(1990-7#1)(2007-8#2)(2008-10#6)(2008-5#1)
procedures were also carried out##2##5##(2008-10#1)(2008-5#1)
procedures were applied to the##2##5##(1991-8#1)(2008-10#1)
procedures were applied to##4##4##(1991-8#1)(2008-10#3)
procedures were applied##5##3##(1991-8#1)(2008-10#4)
procedures were compared##2##3##(2008-10#1)(2011-2#1)
procedures were developed##2##3##(2008-10#1)(2008-8#1)
procedures were evaluated##2##3##(2008-10#2)
procedures were investigated##2##3##(2008-10#2)
procedures were performed on##2##4##(2007-7#1)(2007-8#1)
procedures were performed##9##3##(1991-8#1)(1992-6#1)(2007-7#1)(2007-8#2)(2009-4#1)(2011-3#3)
procedures were used to##2##4##(2011-2#1)(2012-2#1)
procedures were used##4##3##(2007-11#1)(2007-7#1)(2011-2#1)(2012-2#1)
procedures were##53##2##(1991-8#2)(1992-6#2)(1993-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#21)(2008-5#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#2)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#1)
procedures which##5##2##(1992-6#1)(1992-9#1)(1996-12#1)(2008-11#1)(2013-1#1)
procedures with the##2##3##(2007-11#1)(2012-3#1)
procedures with##13##2##(1990-5#1)(1995-8#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#1)
procedures within##3##2##(2007-10#1)(2008-5#1)(2008-9#1)
procedures without##3##2##(2008-7#1)(2012-12#1)(2012-3#1)
procedures##1387##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#7)(1991-1#4)(1991-11#4)(1991-12#6)(1991-2#5)(1991-3#6)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#4)(1992-2#7)(1992-3#12)(1992-4#1)(1992-5#1)(1992-6#6)(1992-9#5)(1993-1#4)(1993-11#2)(1993-12#9)(1993-2#8)(1993-3#8)(1993-5#2)(1993-6#2)(1993-9#1)(1994-1#4)(1994-11#2)(1994-12#7)(1994-2#5)(1994-3#7)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#12)(1995-2#10)(1995-3#5)(1995-5#4)(1995-6#2)(1995-8#6)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#11)(1996-3#14)(1996-5#3)(1996-6#4)(1996-8#1)(1996-9#9)(1997-1#2)(1997-2#1)(1997-3#7)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#6)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#32)(2007-12#22)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#12)(2007-8#32)(2007-9#1)(2008-1#15)(2008-10#304)(2008-11#33)(2008-12#21)(2008-2#23)(2008-3#27)(2008-4#92)(2008-5#21)(2008-6#3)(2008-7#42)(2008-8#11)(2008-9#48)(2009-10#2)(2009-11#5)(2009-12#8)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#7)(2009-6#4)(2009-8#4)(2009-9#16)(2010-1#3)(2010-11#6)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#1)(2010-5#5)(2010-6#5)(2010-7#4)(2010-8#23)(2010-9#1)(2011-1#12)(2011-2#70)(2011-3#6)(2011-7#1)(2012-1#8)(2012-12#20)(2012-2#26)(2012-3#26)(2013-1#33)(2013-7#3)(2013-8#8)
procedures)##6##1##(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-9#1)(2011-2#1)
procedures]##5##1##(1991-11#2)(1991-3#1)(1994-11#1)(2011-2#1)
proceed by##3##2##(1993-8#1)(1996-2#1)(2008-2#1)
proceed to a##2##3##(2008-11#1)(2011-2#1)
proceed to##7##2##(1991-5#1)(1992-12#1)(1992-2#1)(2008-1#1)(2008-11#1)(2011-2#2)
proceed via##2##2##(1995-3#1)(2008-10#1)
proceed with##8##2##(1990-5#1)(1990-8#1)(1993-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
proceed##37##1##(1990-5#1)(1990-8#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
proceeded at##2##2##(2008-10#1)(2008-5#1)
proceeded from a##2##3##(2008-10#1)(2010-8#1)
proceeded from##3##2##(1996-2#1)(2008-10#1)(2010-8#1)
proceeded in##6##2##(1992-12#1)(1996-5#1)(1997-1#1)(2008-10#2)(2013-1#1)
proceeded to##5##2##(1995-6#1)(2007-8#1)(2008-10#1)(2008-7#2)
proceeded with##2##2##(2008-10#1)(2009-6#1)
proceeded##28##1##(1992-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
proceeding in##2##2##(1990-5#1)(1995-2#1)
proceeding to##2##2##(2008-10#1)(2008-7#1)
proceeding##11##1##(1990-5#1)(1992-2#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-7#1)(2010-3#1)
proceedings in##4##2##(1996-12#1)(2007-11#3)
proceedings##27##1##(1993-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-6#1)(1997-8#2)(2007-11#5)(2008-12#1)(2008-8#2)(2010-1#1)(2010-9#1)(2011-2#4)
proceeds along##2##2##(2009-8#1)(2012-2#1)
proceeds at##2##2##(1991-12#1)(2008-10#1)
proceeds by##3##2##(1990-12#1)(1995-8#1)(2008-10#1)
proceeds in##2##2##(1995-8#1)(2008-10#1)
proceeds more rapidly##2##3##(1992-3#1)(2010-8#1)
proceeds through a process that##2##5##(2008-10#2)
proceeds through a##4##3##(1993-11#1)(2008-10#2)(2008-11#1)
proceeds through##6##2##(1992-8#1)(1993-11#1)(2008-10#2)(2008-11#1)(2009-10#1)
proceeds via a##3##3##(1996-2#1)(2008-7#1)(2010-2#1)
proceeds via##6##2##(1996-2#2)(2008-11#1)(2008-7#1)(2009-2#1)(2010-2#1)
proceeds with##8##2##(1991-2#1)(1996-2#2)(1996-5#3)(2008-10#1)(2008-7#1)
proceeds##41##1##(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1995-8#2)(1996-2#4)(1996-5#3)(1997-4#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-7#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#2)(2012-2#2)
procera##4##1##(2008-10#1)(2013-1#3)
process a special##2##3##(2008-10#1)(2008-5#1)
process a##6##2##(2008-10#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)
process about##2##2##(1997-1#1)(2011-2#1)
process achieved##2##2##(1997-5#1)(2008-11#1)
process after##3##2##(1995-5#1)(2008-7#1)(2010-10#1)
process aimed at##3##3##(1993-9#1)(2008-11#1)(2012-3#1)
process allows##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
process also##4##2##(2008-10#2)(2008-2#1)(2008-6#1)
process among##2##2##(2008-10#1)(2013-1#1)
process analysis on baseline data##2##5##(2008-3#2)
process analysis##5##2##(1995-3#1)(2008-3#2)(2013-8#2)
process and are##2##3##(1995-2#1)(2013-1#1)
process and can##2##3##(2007-12#1)(2013-8#1)
process and characterized by##3##4##(2008-3#1)(2009-7#1)(2012-2#1)
process and how##3##3##(1993-3#1)(1994-2#1)(1996-1#1)
process and is##3##3##(1996-8#1)(2007-12#1)(2012-1#1)
process and its##5##3##(1990-11#1)(1990-4#1)(1991-1#1)(1992-2#1)(2008-1#1)
process and may##2##3##(1991-12#1)(2008-10#1)
process and outcome of##2##4##(1991-1#1)(2008-12#1)
process and outcome##3##3##(1991-1#1)(2008-12#1)(2013-1#1)
process and present##2##3##(1995-12#1)(2012-1#1)
process and presentation##3##3##(2008-8#3)
process and that##2##3##(2008-10#2)
process and the##28##3##(1990-9#1)(1993-3#1)(1994-2#1)(1994-3#3)(1996-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#1)
process and thereby##3##3##(1994-3#1)(2008-7#1)(2012-2#1)
process and to determine the##2##5##(1991-9#1)(2008-10#1)
process and to##3##3##(1991-9#1)(2008-10#2)
process and##155##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-9#1)(1992-2#3)(1992-3#1)(1993-11#2)(1993-3#2)(1994-1#1)(1994-2#5)(1994-3#5)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#19)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
process and/or##2##2##(2008-7#1)(2009-2#1)
process appears to##2##3##(1993-1#1)(2008-7#1)
process are##22##2##(1990-5#1)(1993-6#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-2#1)
process as a##3##3##(1992-3#1)(1992-9#1)(2006-12#1)
process as well as the##2##5##(1996-12#1)(2008-3#1)
process as well as##7##4##(1996-12#1)(2008-10#3)(2008-3#1)(2010-9#1)(2012-2#1)
process as well##8##3##(1996-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-9#1)(2012-2#1)
process as##17##2##(1991-4#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-5#1)(1996-12#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#2)(2010-9#1)(2012-2#2)
process associated with##6##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)
process at a##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
process at the##2##3##(2008-10#1)(2008-3#1)
process at##18##2##(1993-12#1)(1993-3#2)(1994-2#1)(1995-5#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-8#1)(2009-11#1)
process based on##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
process because##2##2##(1995-3#1)(2008-12#1)
process becomes##2##2##(1994-5#1)(2008-10#1)
process before##2##2##(1991-12#1)(2008-10#1)
process between the##2##3##(1993-1#1)(2011-1#1)
process between##6##2##(1991-3#1)(1993-1#1)(2008-10#1)(2010-3#1)(2011-1#2)
process blank##2##2##(2008-10#2)
process but also##2##3##(1993-3#1)(1995-5#1)
process but##5##2##(1993-3#1)(1995-5#1)(2008-12#1)(2008-3#1)(2011-2#1)
process by eliminating##2##3##(1996-1#1)(2008-6#1)
process by the##4##3##(1993-8#1)(2008-10#2)(2008-5#1)
process by using##2##3##(2008-10#2)
process by which##19##3##(1992-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
process by##46##2##(1992-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
process called##4##2##(2007-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
process can be altered##2##4##(1991-6#1)(2008-6#1)
process can be successfully##2##4##(1993-3#1)(2010-4#1)
process can be used##2##4##(2010-8#1)(2013-1#1)
process can be##21##3##(1991-2#1)(1991-5#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
process can##28##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
process catalysed by##2##3##(1995-11#1)(2008-5#1)
process change##4##2##(1993-2#1)(1995-2#1)(2008-10#1)(2013-8#1)
process changes##2##2##(2008-10#1)(2008-8#1)
process conditions##2##2##(2008-2#1)(2008-6#1)
process consisting of a##2##4##(1997-4#1)(2008-10#1)
process consisting of##4##3##(1997-4#1)(2008-10#2)(2009-11#1)
process continues##2##2##(2010-10#1)(2010-7#1)
process control (SPC)##3##3##(1995-2#1)(1996-1#1)(2008-10#1)
process control in##3##3##(1995-2#1)(2008-10#1)(2010-2#1)
process control of##2##3##(1996-5#1)(2008-2#1)
process control##14##2##(1995-2#2)(1996-1#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-3#3)(2010-2#1)
process could be##6##3##(1994-6#1)(1995-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
process could##11##2##(1994-2#1)(1994-6#1)(1995-8#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)
process described here##2##3##(2008-11#2)
process described##6##2##(1991-1#1)(1992-3#1)(2008-11#3)(2008-12#1)
process design and##2##3##(1994-5#1)(2008-7#1)
process design##8##2##(1994-5#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
process despite##2##2##(2008-11#1)(2009-10#1)
process developed##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
process development##13##2##(1997-2#1)(2008-11#5)(2008-6#1)(2010-11#1)(2011-2#5)
process does not##7##3##(1995-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
process does##8##2##(1995-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
process dominates##2##2##(2008-11#1)(2008-3#1)
process during the##3##3##(2008-10#3)
process during which##2##3##(1991-5#1)(1997-6#1)
process during##8##2##(1991-5#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-3#1)
process effectively##2##2##(2007-7#1)(2013-1#1)
process enabled the##2##3##(2010-12#1)(2011-1#1)
process enables the##2##3##(2008-2#1)(2008-7#1)
process entails##2##2##(1995-12#1)(2008-7#1)
process factors##2##2##(1996-1#1)(2010-9#1)
process flow##2##2##(2008-2#1)(2010-1#1)
process for a##4##3##(1993-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
process for biological##2##3##(2007-12#1)(2008-10#1)
process for in vitro##2##4##(2008-11#1)(2008-7#1)
process for patients##2##3##(1994-12#1)(2008-12#1)
process for the continuous production of##2##6##(2008-6#1)(2008-7#1)
process for the synthesis of##3##5##(1992-11#1)(2008-11#1)(2011-2#1)
process for the##18##3##(1992-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#5)(2008-6#2)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
process for##80##2##(1992-11#1)(1992-2#2)(1992-3#2)(1993-1#2)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#2)(2008-3#5)(2008-5#1)(2008-6#6)(2008-7#3)(2008-8#4)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
process from the##4##3##(1994-1#1)(1994-3#1)(2010-3#1)(2012-2#1)
process from##19##2##(1994-1#1)(1994-3#2)(1996-1#1)(1996-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-2#2)
process has a##2##3##(1996-12#1)(2008-8#1)
process has become##2##3##(1991-1#1)(1996-1#1)
process has been##13##3##(1991-12#1)(1992-11#1)(1995-1#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#2)(2009-10#1)(2011-2#2)(2012-12#1)
process has not been##3##4##(1995-8#1)(2008-11#1)(2008-7#1)
process has##33##2##(1991-1#1)(1991-12#1)(1992-11#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-6#5)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
process have been##2##3##(2007-12#1)(2008-9#1)
process have##4##2##(2007-12#1)(2008-9#1)(2010-12#1)(2013-1#1)
process improvement##15##2##(1994-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#2)
process improvements##2##2##(1996-1#1)(2008-3#1)
process in a##7##3##(1993-3#1)(1995-12#1)(1996-1#1)(2007-12#2)(2008-11#1)(2013-1#1)
process in an##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
process in order to##3##4##(2008-10#2)(2008-6#1)
process in social##2##3##(2010-4#1)(2013-8#1)
process in terms of##2##4##(1996-4#1)(2008-3#1)
process in the##20##3##(1991-12#1)(1992-6#1)(1993-1#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
process in vitro##2##3##(1990-8#1)(1994-9#1)
process in which an##2##4##(2008-10#1)(2011-8#1)
process in which the##5##4##(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
process in which##23##3##(1990-6#1)(1991-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
process in##112##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#5)(2008-1#4)(2008-10#19)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
process included the##2##3##(1996-3#1)(2013-1#1)
process included##6##2##(1996-3#2)(2008-10#3)(2013-1#1)
process includes##2##2##(2008-10#1)(2008-11#1)
process increased the##2##3##(2008-5#1)(2013-1#1)
process induces a##2##3##(2008-10#1)(2009-9#1)
process information##2##2##(2008-4#1)(2008-7#1)
process instead of##2##3##(2008-2#1)(2008-3#1)
process into##2##2##(1993-12#1)(2008-10#1)
process involved in##3##3##(1991-5#1)(2008-7#1)(2009-6#1)
process involves a##3##3##(1993-8#1)(1996-5#1)(2008-9#1)
process involves the##3##3##(2008-11#1)(2009-10#1)(2009-3#1)
process involves##11##2##(1993-8#1)(1994-3#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2011-8#1)
process involving##15##2##(1991-2#1)(1992-3#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2012-2#2)
process is a##4##3##(1991-2#1)(1996-1#1)(2008-10#2)
process is achieved##2##3##(2008-10#1)(2008-3#1)
process is also##5##3##(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)
process is attributed to##2##4##(2008-10#1)(2008-7#1)
process is based on the##2##5##(2008-3#1)(2013-1#1)
process is based on##4##4##(1991-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
process is called##2##3##(2008-3#1)(2011-2#1)
process is characterized by##2##4##(2008-10#1)(2009-12#1)
process is considered##2##3##(1991-11#1)(2007-12#1)
process is described##3##3##(1991-2#1)(2008-12#1)(2008-4#1)
process is discussed##2##3##(2008-10#1)(2008-7#1)
process is entirely##2##3##(2008-3#1)(2011-1#1)
process is initiated##2##3##(2008-6#1)(2008-9#1)
process is introduced##2##3##(2008-3#1)(2013-1#1)
process is made##2##3##(1996-1#1)(2008-10#1)
process is mediated##2##3##(2008-8#1)(2009-8#1)
process is more efficient##2##4##(2007-11#1)(2013-1#1)
process is needed##2##3##(1994-3#1)(2008-7#1)
process is not##5##3##(1991-3#1)(1993-2#1)(1994-12#1)(1995-2#1)(2007-12#1)
process is presented##3##3##(1993-6#1)(2007-11#1)(2008-7#1)
process is that##3##3##(1993-12#1)(2008-3#1)(2010-1#1)
process is the##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
process is##143##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-8#1)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)
process itself##4##2##(1996-4#1)(1997-1#1)(2008-3#1)(2012-2#1)
process knowledge##2##2##(2008-11#1)(2013-1#1)
process leading to the##2##4##(2008-5#1)(2013-1#1)
process leading to##7##3##(1990-11#1)(1990-5#1)(1994-2#1)(1996-8#1)(2008-5#1)(2009-3#1)(2013-1#1)
process leads##2##2##(2007-11#1)(2008-2#1)
process led to##2##3##(2007-11#1)(2008-11#1)
process makes##2##2##(2008-3#1)(2008-8#1)
process marked by##2##3##(1995-1#1)(2012-3#1)
process may be##5##3##(1992-3#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-12#1)
process may##11##2##(1992-3#1)(1992-9#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)
process measures##5##2##(1994-12#1)(2008-7#2)(2013-1#2)
process model for##2##3##(2008-2#1)(2013-1#1)
process model##5##2##(2008-10#1)(2008-2#1)(2009-9#1)(2010-10#1)(2013-1#1)
process models are##2##3##(2009-9#1)(2013-1#1)
process models for##3##3##(2009-9#3)
process models##5##2##(2009-9#4)(2013-1#1)
process monitoring##7##2##(1994-9#1)(2008-10#3)(2008-11#3)
process more##3##2##(1991-9#1)(1996-3#1)(2008-10#1)
process not##2##2##(2008-6#1)(2008-7#1)
process occurs##2##2##(2007-12#1)(2009-3#1)
process of DNA##3##3##(2008-10#3)
process of a new##2##4##(1992-5#1)(2009-7#1)
process of a##8##3##(1992-5#1)(1994-2#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
process of aging##4##3##(1992-9#1)(1993-12#1)(2008-5#1)(2008-7#1)
process of an##2##3##(1990-3#1)(2008-10#1)
process of beer##2##3##(1991-5#1)(2008-10#1)
process of bone##3##3##(1996-3#1)(2007-8#1)(2011-2#1)
process of carcinogenesis##2##3##(2008-12#1)(2009-3#1)
process of care##9##3##(1994-12#2)(1996-3#2)(1997-1#1)(2008-3#3)(2008-6#1)
process of change##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
process of chromosomal##2##3##(1993-6#1)(2010-3#1)
process of chronic##2##3##(2012-2#2)
process of collecting##4##3##(1996-3#1)(1997-1#1)(1997-6#2)
process of degradation of##2##4##(2008-8#1)(2013-1#1)
process of delayed neuronal cell death##2##6##(1995-5#1)(2008-2#1)
process of disease##2##3##(2008-8#1)(2009-6#1)
process of drug##3##3##(1997-4#1)(2008-4#1)(2008-8#1)
process of dye##2##3##(2008-2#2)
process of establishing##3##3##(1995-3#1)(2008-10#1)(2011-1#1)
process of exposure##2##3##(2008-2#1)(2011-2#1)
process of getting##2##3##(2009-9#1)(2010-4#1)
process of glucose##2##3##(2008-7#1)(2009-9#1)
process of grating regeneration##2##4##(2013-8#2)
process of group##2##3##(2008-11#1)(2013-1#1)
process of implementation##2##3##(1992-2#1)(1996-1#1)
process of in##2##3##(2008-11#1)(2009-12#1)
process of informed consent##2##4##(2012-1#2)
process of post-testicular maturation##2##4##(2008-8#2)
process of producing##2##3##(1992-3#1)(2008-11#1)
process of programmed cell death##2##5##(2008-8#1)(2011-2#1)
process of selecting##3##3##(1995-12#1)(2008-7#1)(2009-1#1)
process of sperm maturation##2##4##(2011-1#2)
process of spermatogenesis##2##3##(2009-10#1)(2011-1#1)
process of systems##2##3##(2008-10#1)(2008-7#1)
process of the subjects##2##4##(1990-10#2)
process of the##37##3##(1990-10#2)(1992-1#1)(1993-1#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#2)
process of this##3##3##(1990-5#1)(2008-11#1)(2013-1#1)
process of tumorigenesis##2##3##(1995-9#1)(2008-7#1)
process of##476##2##(1990-10#3)(1990-11#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#4)(2007-11#5)(2007-12#5)(2007-4#1)(2007-8#2)(2008-1#8)(2008-10#59)(2008-11#33)(2008-12#17)(2008-2#15)(2008-3#20)(2008-4#5)(2008-5#20)(2008-6#5)(2008-7#15)(2008-8#20)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#2)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#15)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#17)(2012-8#1)(2013-1#9)(2013-7#4)(2013-8#7)
process often##2##2##(1997-1#1)(2008-10#1)
process on a##3##3##(1994-2#1)(1995-3#1)(2008-10#1)
process on the##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
process on##15##2##(1994-2#1)(1995-3#1)(1996-10#1)(1996-4#1)(2007-12#1)(2008-10#4)(2008-8#1)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
process optimization##2##2##(2008-10#2)
process or outcome##2##3##(1995-12#1)(2011-2#1)
process or##13##2##(1990-12#1)(1992-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
process over##2##2##(1995-2#1)(2012-2#1)
process parameters and##2##3##(2008-11#1)(2010-4#1)
process parameters for##2##3##(2008-10#1)(2008-7#1)
process parameters##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)
process performance##5##2##(1993-12#1)(1996-3#1)(2008-11#1)(2008-6#1)(2011-2#1)
process proceeds##3##2##(2008-10#1)(2008-2#1)(2010-2#1)
process produces a##2##3##(2007-12#1)(2008-6#1)
process produces##3##2##(1993-12#1)(2007-12#1)(2008-6#1)
process producing##3##2##(1995-2#1)(1996-4#1)(2010-12#1)
process provided##3##2##(1996-3#1)(2008-10#2)
process quality##2##2##(2008-11#1)(2008-2#1)
process redesign##3##2##(1993-12#1)(1993-3#2)
process remained##2##2##(2008-3#1)(2008-5#1)
process requires the##2##3##(2007-11#1)(2008-4#1)
process requires##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-9#1)
process requiring##2##2##(1992-7#1)(2009-6#1)
process results in##2##3##(2008-10#1)(2008-2#1)
process samples##2##2##(2008-10#2)
process should be##2##3##(1990-8#1)(2008-3#1)
process should##7##2##(1990-8#1)(1995-5#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
process startup##4##2##(2008-11#4)
process step##2##2##(2008-2#1)(2008-3#1)
process such as##2##3##(2008-10#1)(2009-5#1)
process temperature##2##2##(2007-11#1)(2008-3#1)
process termed##3##2##(2008-4#1)(2010-5#1)(2011-2#1)
process that can be used##2##5##(2008-10#1)(2008-4#1)
process that can be##6##4##(2008-10#1)(2008-11#1)(2008-4#3)(2013-1#1)
process that can##8##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2010-11#1)(2013-1#1)
process that could##2##3##(2008-10#1)(2012-3#1)
process that has##2##3##(1997-3#1)(2008-5#1)
process that includes##2##3##(2008-7#1)(2011-1#1)
process that involves a##2##4##(2008-7#1)(2011-2#1)
process that involves##8##3##(1997-3#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#2)
process that is##10##3##(1991-6#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)
process that may be##3##4##(1996-12#1)(2008-1#1)(2010-10#1)
process that may##5##3##(1996-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-10#1)
process that requires##2##3##(1994-2#1)(2008-2#1)
process that uses##2##3##(2008-3#1)(2008-6#1)
process that was##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
process that##77##2##(1991-1#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#3)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#2)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
process the acquired##2##3##(2008-10#1)(2008-2#1)
process the##20##2##(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#7)(2008-8#1)(2010-10#1)(2012-12#1)
process theory##3##2##(2007-6#1)(2008-9#1)(2009-11#1)
process there is##2##3##(1994-2#1)(2008-5#1)
process there##3##2##(1994-2#1)(2008-5#1)(2008-8#1)
process they##2##2##(1994-3#1)(1997-2#1)
process through the##2##3##(1993-2#1)(2008-2#1)
process through##8##2##(1993-12#2)(1993-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-8#1)
process to be##4##3##(1990-7#1)(2007-11#1)(2008-2#1)(2008-5#1)
process to improve##3##3##(1993-12#1)(2008-11#1)(2008-2#1)
process to make##2##3##(2008-5#1)(2008-8#1)
process to produce##2##3##(2008-11#1)(2008-6#1)
process to remove##2##3##(2008-3#1)(2013-1#1)
process to##41##2##(1990-7#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-12#2)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
process used by##3##3##(1991-2#1)(1992-2#1)(2012-3#1)
process used in##2##3##(1996-2#1)(2008-7#1)
process used to identify##2##4##(1995-1#1)(2008-11#1)
process used to##10##3##(1994-1#1)(1994-2#1)(1995-1#1)(1996-2#2)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
process used##18##2##(1991-2#1)(1992-2#2)(1994-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-2#3)(2007-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
process uses##2##2##(2008-11#1)(2008-3#1)
process using F(2) and KrF excimer lasers##2##7##(2007-11#2)
process using the##3##3##(1995-2#1)(2008-9#1)(2009-4#1)
process using##18##2##(1991-5#1)(1992-3#1)(1995-2#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
process variables##3##2##(1993-12#1)(2008-3#1)(2013-1#1)
process via##2##2##(1992-6#1)(2009-7#1)
process was also##3##3##(1991-5#1)(2008-10#1)(2009-11#1)
process was applied##2##3##(2008-10#1)(2009-11#1)
process was based on##2##4##(2008-10#1)(2008-11#1)
process was carried out in two steps##2##7##(2007-11#1)(2008-10#1)
process was carried out using##2##5##(2008-10#2)
process was carried out##5##4##(2007-11#1)(2008-10#3)(2008-6#1)
process was developed for##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
process was developed##5##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)
process was implemented in a##2##5##(2008-10#1)(2008-3#1)
process was implemented##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
process was investigated##2##3##(2008-10#2)
process was not##2##3##(1993-12#1)(2008-10#1)
process was observed##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
process was studied##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
process was then##2##3##(1993-2#1)(2008-10#1)
process was used##2##3##(2008-10#1)(2013-1#1)
process was##75##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#2)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#29)(2008-11#8)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#2)(2009-11#2)(2009-9#1)(2010-4#1)(2010-8#2)(2012-12#1)(2013-1#3)
process were##19##2##(1991-3#1)(1995-3#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#2)
process when##2##2##(1992-2#1)(2008-12#1)
process where##2##2##(2011-2#1)(2012-12#1)
process whereby the##2##3##(2007-12#1)(2007-7#1)
process whereby##6##2##(1996-1#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-9#1)(2013-8#1)
process which allows##2##3##(2008-12#1)(2008-7#1)
process which can be##2##4##(1994-3#1)(1995-2#1)
process which is##4##3##(1991-12#2)(1996-2#1)(2008-7#1)
process which##23##2##(1990-2#1)(1991-12#2)(1993-1#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-4#1)(2011-2#2)
process while##2##2##(1992-5#1)(2008-10#1)
process will be##2##3##(1996-1#1)(2008-6#1)
process will##7##2##(1992-12#1)(1996-1#1)(1997-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
process with a##7##3##(1997-4#1)(2008-1#1)(2008-10#3)(2008-7#2)
process with only##2##3##(2008-3#1)(2008-5#1)
process with the##3##3##(2008-10#2)(2008-7#1)
process with##37##2##(1990-11#1)(1992-1#1)(1992-11#1)(1994-9#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#5)(2011-2#2)(2012-2#2)(2012-3#1)
process within the##3##3##(2008-10#2)(2008-3#1)
process within##7##2##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
process without##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
process would##2##2##(2008-6#1)(2008-7#1)
process yield##2##2##(2008-6#1)(2008-7#1)
process##3197##1##(1990-10#9)(1990-11#11)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#7)(1990-6#4)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#7)(1991-11#2)(1991-12#14)(1991-2#18)(1991-3#9)(1991-4#1)(1991-5#9)(1991-6#8)(1991-7#1)(1991-8#3)(1991-9#11)(1992-1#7)(1992-11#5)(1992-12#8)(1992-2#23)(1992-3#20)(1992-5#3)(1992-6#10)(1992-7#2)(1992-8#5)(1992-9#9)(1993-1#14)(1993-11#8)(1993-12#27)(1993-2#10)(1993-3#23)(1993-6#8)(1993-8#7)(1993-9#3)(1994-1#16)(1994-11#7)(1994-12#23)(1994-2#33)(1994-3#32)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#8)(1995-1#14)(1995-11#3)(1995-12#24)(1995-2#31)(1995-3#28)(1995-5#12)(1995-6#11)(1995-8#5)(1995-9#3)(1996-1#31)(1996-10#1)(1996-11#2)(1996-12#18)(1996-2#30)(1996-3#27)(1996-4#8)(1996-5#7)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#26)(1997-2#32)(1997-3#18)(1997-4#10)(1997-5#1)(1997-6#7)(1997-7#5)(1997-8#2)(2006-10#2)(2006-12#2)(2007-10#8)(2007-11#58)(2007-12#75)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#33)(2008-10#476)(2008-11#190)(2008-12#58)(2008-2#97)(2008-3#181)(2008-4#45)(2008-5#94)(2008-6#86)(2008-7#136)(2008-8#61)(2008-9#64)(2009-1#3)(2009-10#18)(2009-11#22)(2009-12#19)(2009-2#1)(2009-3#14)(2009-4#7)(2009-5#6)(2009-6#12)(2009-7#18)(2009-8#17)(2009-9#14)(2010-1#4)(2010-10#17)(2010-11#9)(2010-12#11)(2010-2#7)(2010-3#15)(2010-4#19)(2010-5#11)(2010-6#6)(2010-7#4)(2010-8#19)(2010-9#7)(2011-1#29)(2011-10#2)(2011-2#95)(2011-3#4)(2011-8#2)(2012-1#11)(2012-12#25)(2012-2#72)(2012-3#49)(2012-8#1)(2013-1#75)(2013-7#7)(2013-8#31)
process(es)##3##1##(1992-11#1)(2008-4#1)(2008-5#1)
process)##5##1##(2008-10#2)(2008-7#2)(2012-2#1)
process-dependent##3##1##(2008-2#3)
process-oriented##2##1##(1996-2#1)(2008-11#1)
process]##2##1##(1997-4#1)(2013-8#1)
processed according to##2##3##(2008-7#1)(2012-12#1)
processed and##6##2##(1992-3#1)(1995-5#1)(1997-2#1)(2007-10#1)(2010-12#1)(2013-8#1)
processed at##2##2##(2008-10#1)(2012-1#1)
processed by a##3##3##(2008-10#2)(2008-2#1)
processed by the##5##3##(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
processed by using##2##3##(2007-7#1)(2008-10#1)
processed by##27##2##(1995-6#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-2#1)(2008-3#3)(2010-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
processed food##2##2##(2008-10#1)(2011-2#1)
processed foods##4##2##(1991-6#1)(2008-10#1)(2011-2#1)(2012-1#1)
processed for light microscopy##2##4##(2008-1#1)(2008-5#1)
processed for##14##2##(1996-5#3)(2007-7#2)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
processed from##6##2##(1994-11#1)(1996-5#1)(2007-7#1)(2007-8#1)(2009-11#1)(2010-7#1)
processed in a##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
processed in such a way that##2##6##(1997-5#1)(2008-3#1)
processed in the##4##3##(1991-9#1)(2008-12#1)(2013-1#1)(2013-8#1)
processed in##16##2##(1991-9#2)(1995-12#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
processed into the##2##3##(1990-8#2)
processed into##4##2##(1990-5#1)(1990-8#2)(2012-2#1)
processed protein##3##2##(1995-6#3)
processed pseudogene##7##2##(1990-8#2)(1991-6#1)(1993-2#1)(1994-11#1)(1997-4#2)
processed pseudogenes##2##2##(1993-2#1)(1997-4#1)
processed recombinant##2##2##(1990-12#1)(1997-4#1)
processed to a##3##3##(1990-5#1)(1992-12#1)(1995-8#1)
processed to generate##2##3##(1997-7#1)(2009-8#1)
processed to the mature##2##4##(1995-2#1)(1997-1#1)
processed to##24##2##(1990-5#2)(1991-9#1)(1992-12#3)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
processed using partial least squares##2##5##(2008-10#2)
processed using##6##2##(2008-10#2)(2008-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
processed with a##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
processed with##8##2##(1990-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)
processed##199##1##(1990-11#1)(1990-12#4)(1990-5#3)(1990-6#1)(1990-8#4)(1991-2#1)(1991-6#2)(1991-9#4)(1992-12#5)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#3)(1993-6#2)(1993-8#2)(1994-11#3)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#8)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#6)
processes a##2##2##(2007-11#1)(2008-5#1)
processes also##2##2##(2008-10#2)
processes and activation of the##2##5##(2008-11#1)(2011-1#1)
processes and in##2##3##(2008-10#1)(2009-12#1)
processes and mechanisms##3##3##(2008-7#1)(2009-8#1)(2010-3#1)
processes and outcomes##4##3##(1993-3#1)(2008-12#1)(2008-8#1)(2009-8#1)
processes and systems##3##3##(1995-1#1)(2012-2#2)
processes and that##2##3##(1996-12#1)(2008-8#1)
processes and the##15##3##(1994-1#1)(1995-2#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
processes and their##2##3##(1994-3#1)(2010-10#1)
processes and thus##2##3##(2008-2#1)(2011-1#1)
processes and to##3##3##(1993-5#1)(2008-11#1)(2009-2#1)
processes and##105##2##(1993-3#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#3)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
processes are critical for##2##4##(1997-7#1)(2012-2#1)
processes are described##2##3##(2008-10#1)(2008-11#1)
processes are discussed##2##3##(1996-2#1)(2008-10#1)
processes are effective and##2##4##(1990-8#1)(2013-8#1)
processes are generally##2##3##(2008-8#1)(2012-3#1)
processes are in##2##3##(2007-12#1)(2010-9#1)
processes are involved in##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
processes are of##2##3##(2008-5#1)(2013-8#1)
processes are regulated##2##3##(2010-2#1)(2013-1#1)
processes are the##4##3##(1995-2#1)(2007-11#1)(2011-2#1)(2013-7#1)
processes are used##2##3##(2008-10#1)(2008-2#1)
processes are##73##2##(1990-12#1)(1990-8#2)(1992-3#1)(1993-12#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
processes arise##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
processes as well as the##2##5##(2008-11#2)
processes as well as##7##4##(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#1)
processes as##16##2##(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2013-1#1)
processes associated with##7##3##(1992-12#1)(1992-8#1)(1993-2#1)(1995-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
processes at the##4##3##(2007-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
processes at##10##2##(1992-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
processes behind the##2##3##(2010-12#1)(2013-7#1)
processes behind##3##2##(2010-12#1)(2012-2#1)(2013-7#1)
processes being##2##2##(2008-11#1)(2011-2#1)
processes believed to##2##3##(2009-11#1)(2012-2#1)
processes between the##2##3##(2008-11#1)(2008-12#1)
processes but also##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
processes but##5##2##(2007-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
processes by which##4##3##(1996-5#1)(2007-12#1)(2008-10#1)(2009-5#1)
processes by##11##2##(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-8#1)
processes can be##4##3##(1990-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
processes can##8##2##(1990-8#1)(1991-6#2)(2008-10#2)(2008-8#1)(2009-8#1)(2012-3#1)
processes caused by##2##3##(2008-10#1)(2008-12#1)
processes could##3##2##(1994-3#1)(2008-10#1)(2012-3#1)
processes described##2##2##(1996-5#1)(2008-11#1)
processes due to##2##3##(1994-11#1)(2007-12#1)
processes during##3##2##(2007-8#1)(2008-11#2)
processes for the determination of##2##5##(2008-10#2)
processes for the##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
processes for##20##2##(1992-2#1)(1995-5#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#3)
processes from the##2##3##(2007-11#1)(2008-11#1)
processes from##4##2##(1993-12#1)(2007-11#1)(2008-11#1)(2008-6#1)
processes generated##2##2##(2008-10#1)(2009-11#1)
processes has been##2##3##(2008-10#1)(2008-7#1)
processes has##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
processes have been identified##2##4##(1996-6#1)(2012-2#1)
processes have been##10##3##(1994-2#1)(1995-12#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
processes have##12##2##(1994-2#1)(1995-12#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
processes in a##5##3##(2007-12#2)(2008-2#1)(2008-7#1)(2008-9#1)
processes in many##2##3##(2008-10#1)(2008-11#1)
processes in order to##2##4##(2008-10#1)(2013-1#1)
processes in response to low doses##2##6##(2008-7#2)
processes in response to##3##4##(2008-7#2)(2009-6#1)
processes in the##28##3##(1991-6#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-2#2)(2013-8#1)
processes in this##2##3##(2008-10#1)(2009-11#1)
processes in which##4##3##(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)
processes in##103##2##(1991-6#1)(1992-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-2#8)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
processes include##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
processes including cell##2##3##(2007-12#1)(2010-10#1)
processes including the##2##3##(2008-10#1)(2013-8#1)
processes including##11##2##(1995-11#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-11#1)(2010-10#1)(2011-9#1)(2013-8#1)
processes induced##2##2##(2008-11#1)(2012-12#1)
processes into##2##2##(2007-12#1)(2008-11#1)
processes involved in the##9##4##(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)
processes involved in this##2##4##(2010-12#1)(2011-2#1)
processes involved in##22##3##(1994-11#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#2)
processes involved##25##2##(1994-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#2)
processes involving##8##2##(1991-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)
processes is discussed##2##3##(1996-4#1)(2008-10#1)
processes is unknown##2##3##(1990-3#1)(1995-2#1)
processes is##18##2##(1990-3#1)(1991-12#1)(1995-2#1)(1996-4#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
processes leading to##6##3##(1992-6#2)(2008-10#1)(2009-4#1)(2010-11#1)(2012-12#1)
processes linked to##2##3##(2008-10#2)
processes may be##2##3##(2008-5#1)(2008-7#1)
processes may##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
processes might##2##2##(2008-7#1)(2008-9#1)
processes must##2##2##(1994-3#1)(2008-11#1)
processes not##5##2##(2008-10#1)(2008-12#1)(2009-2#1)(2009-4#1)(2012-2#1)
processes occurring at##2##3##(2008-7#2)
processes occurring during##2##3##(1994-3#1)(1997-3#1)
processes occurring in the##2##4##(2008-10#1)(2010-2#1)
processes occurring within##2##3##(2008-11#1)(2008-8#1)
processes occurring##9##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)
processes of bone##4##3##(1992-8#1)(2007-8#2)(2008-7#1)
processes of interest##2##3##(1990-8#1)(2008-7#1)
processes of molecular##2##3##(2008-2#1)(2010-4#1)
processes of the two##2##4##(2008-10#2)
processes of the##15##3##(1990-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2010-9#1)(2011-2#1)
processes of##121##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1995-2#1)(1996-9#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#4)(2007-8#5)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#1)
processes on the##2##3##(2008-3#1)(2008-9#1)
processes on##8##2##(1996-3#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-5#1)
processes or to##3##3##(2007-12#1)(2010-10#1)(2012-2#1)
processes or##5##2##(1994-11#1)(2007-12#1)(2010-10#1)(2011-1#1)(2012-2#1)
processes present##2##2##(1997-2#1)(2013-1#1)
processes provide##3##2##(2008-11#1)(2008-7#1)(2009-7#1)
processes related to##4##3##(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
processes relevant to##2##3##(2008-10#1)(2010-6#1)
processes required to##2##3##(2008-11#1)(2012-2#1)
processes responsible for the##2##4##(1996-6#1)(2008-4#1)
processes responsible for##9##3##(1996-4#1)(1996-6#2)(2007-12#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
processes seems##2##2##(2008-10#1)(2009-2#1)
processes should be##4##3##(1990-9#1)(2007-11#1)(2007-4#1)(2009-10#1)
processes should##5##2##(1990-9#1)(2007-11#1)(2007-4#1)(2008-8#1)(2009-10#1)
processes such as cell proliferation##2##5##(2008-8#1)(2012-12#1)
processes such as cell##3##4##(2008-8#1)(2009-6#1)(2012-12#1)
processes such as##25##3##(1993-5#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
processes taking place in##3##4##(2007-11#1)(2008-12#1)(2010-12#1)
processes taking place##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-1#1)
processes that are linked to##2##5##(2008-10#1)(2008-3#1)
processes that are##11##3##(1994-1#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2013-8#1)
processes that have##3##3##(1991-3#1)(2010-12#1)(2012-3#1)
processes that influence##2##3##(2008-2#1)(2012-3#1)
processes that involve##3##3##(1992-5#1)(2008-10#1)(2009-8#1)
processes that lead to this##2##5##(2008-11#1)(2011-2#1)
processes that may##3##3##(2009-10#1)(2011-2#1)(2012-1#1)
processes that regulate##2##3##(1992-2#1)(2013-8#1)
processes that shape##2##3##(2007-12#1)(2008-10#1)
processes that##62##2##(1990-9#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-1#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#2)
processes the##2##2##(2008-2#1)(2008-7#1)
processes they##2##2##(1991-3#1)(2008-7#1)
processes to be##2##3##(2011-2#1)(2013-8#1)
processes to eliminate##2##3##(1996-1#1)(2013-1#1)
processes to health##2##3##(1996-1#1)(2013-1#1)
processes to the##3##3##(1991-10#1)(2008-10#1)(2012-12#1)
processes to##23##2##(1991-10#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-10#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
processes underlying the##2##3##(2008-4#1)(2008-5#1)
processes underlying##8##2##(2007-12#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-8#1)
processes used in##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2010-3#1)
processes used##6##2##(1993-12#1)(1994-3#1)(2008-11#2)(2008-8#1)(2010-3#1)
processes was##5##2##(2008-10#3)(2008-7#1)(2008-8#1)
processes we##2##2##(2009-12#1)(2012-2#1)
processes were hypothesized to relate to##2##6##(2009-8#2)
processes were inhibited by##2##4##(2008-11#2)
processes were##22##2##(1992-3#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-3#1)
processes where##3##2##(2008-11#2)(2013-1#1)
processes which may##2##3##(2008-7#1)(2009-10#1)
processes which##8##2##(1993-2#1)(1995-12#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)
processes will##4##2##(1995-1#1)(2008-11#1)(2008-3#1)(2011-2#1)
processes with##15##2##(1991-6#1)(1995-3#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
processes within##4##2##(1993-3#1)(2007-10#1)(2008-2#1)(2008-3#1)
processes##1494##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#5)(1990-9#3)(1991-10#2)(1991-12#2)(1991-3#2)(1991-5#4)(1991-6#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#6)(1992-8#6)(1992-9#2)(1993-12#7)(1993-2#5)(1993-3#8)(1993-5#6)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#4)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#15)(1994-5#3)(1994-6#2)(1994-8#12)(1995-1#7)(1995-11#3)(1995-12#19)(1995-2#13)(1995-3#7)(1995-5#5)(1995-6#2)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#10)(1996-3#5)(1996-4#4)(1996-5#4)(1996-6#6)(1996-9#1)(1997-1#7)(1997-2#4)(1997-3#13)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#4)(2007-11#26)(2007-12#43)(2007-4#3)(2007-5#4)(2007-7#1)(2007-8#16)(2007-9#1)(2008-1#7)(2008-10#175)(2008-11#101)(2008-12#21)(2008-2#41)(2008-3#42)(2008-4#32)(2008-5#36)(2008-6#15)(2008-7#87)(2008-8#49)(2008-9#35)(2009-10#12)(2009-11#7)(2009-12#8)(2009-2#8)(2009-3#5)(2009-4#8)(2009-5#14)(2009-6#3)(2009-7#10)(2009-8#33)(2009-9#5)(2010-10#11)(2010-11#3)(2010-12#18)(2010-2#4)(2010-3#13)(2010-4#6)(2010-5#12)(2010-6#3)(2010-7#6)(2010-8#9)(2010-9#6)(2011-1#13)(2011-2#53)(2011-3#1)(2011-9#1)(2012-1#10)(2012-12#21)(2012-2#54)(2012-3#23)(2012-5#1)(2012-7#1)(2013-1#48)(2013-7#8)(2013-8#27)
processes)##5##1##(1994-2#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-4#1)
processing ability##3##2##(1994-11#1)(1994-6#1)(2010-10#1)
processing activity##3##2##(1991-12#1)(1992-12#1)(1995-6#1)
processing algorithms##3##2##(2007-12#1)(2008-2#1)(2010-9#1)
processing and analysis##2##3##(2008-9#1)(2009-12#1)
processing and joining##3##3##(1997-3#2)(1997-7#1)
processing and presentation of##3##4##(1994-11#2)(2008-11#1)
processing and secretion##2##3##(1993-11#2)
processing and the##7##3##(1992-12#1)(1992-6#1)(1993-11#1)(1994-8#1)(1997-4#1)(2009-6#1)(2012-3#1)
processing and##58##2##(1992-12#1)(1992-6#1)(1993-11#3)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
processing applications##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
processing approach##2##2##(2008-10#1)(2008-3#1)
processing architecture##3##2##(1997-1#2)(2008-3#1)
processing are##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
processing as##3##2##(2008-7#1)(2010-8#1)(2013-1#1)
processing at the##2##3##(1995-8#1)(2008-4#1)
processing at##6##2##(1995-8#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)
processing based##2##2##(2008-11#1)(2008-3#1)
processing be##2##2##(1992-12#1)(2008-3#1)
processing between##2##2##(1996-5#1)(2008-11#1)
processing by##13##2##(1991-11#1)(1991-9#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2009-3#2)(2011-2#1)
processing can be##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
processing can##5##2##(2008-10#1)(2008-3#2)(2013-8#2)
processing chain##5##2##(2008-12#3)(2009-12#1)(2011-2#1)
processing chains##2##2##(2008-12#2)
processing characteristics of##2##3##(2010-4#2)
processing conditions##6##2##(2008-2#1)(2008-5#2)(2009-11#1)(2010-4#2)
processing devices##2##2##(2007-11#1)(2012-2#1)
processing efficiency##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
processing enzymes in##2##3##(1993-5#1)(2008-4#1)
processing enzymes##4##2##(1993-5#3)(2008-4#1)
processing event##2##2##(1993-12#1)(2007-12#1)
processing events##2##2##(1992-6#1)(1997-7#1)
processing for##9##2##(1991-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-9#2)
processing has recently##2##3##(2008-1#1)(2008-2#1)
processing has##5##2##(1990-8#1)(1991-2#1)(1994-3#1)(2008-1#1)(2008-2#1)
processing history##2##2##(2008-10#1)(2010-4#1)
processing in a##2##3##(2008-11#1)(2008-6#1)
processing in the brain##2##4##(2008-8#1)(2010-9#1)
processing in the##11##3##(1993-5#1)(1993-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
processing in##39##2##(1990-11#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-5#1)(1993-6#2)(1994-3#1)(1995-11#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-4#2)(2010-9#1)(2012-1#1)(2012-2#2)(2013-8#2)
processing industries##2##2##(2008-10#2)
processing into##2##2##(1995-12#1)(2008-10#1)
processing is discussed##2##3##(1997-4#1)(2008-10#1)
processing is used to##3##4##(2007-11#1)(2008-2#1)(2008-9#1)
processing is used##4##3##(2007-11#2)(2008-2#1)(2008-9#1)
processing is##21##2##(1996-5#1)(1997-1#1)(1997-4#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-9#2)(2010-7#1)
processing may be##2##3##(1993-6#1)(2009-10#1)
processing may##5##2##(1993-11#1)(1993-6#1)(2008-11#2)(2009-10#1)
processing mechanisms##2##2##(1996-5#1)(2009-12#1)
processing method##4##2##(1994-12#1)(2008-3#1)(2009-6#1)(2012-3#1)
processing methods##5##2##(1990-12#1)(2008-3#2)(2008-5#1)(2008-9#1)
processing mode##2##2##(2010-10#2)
processing of a##5##3##(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-2#1)
processing of amyloid##2##3##(1992-6#1)(2012-3#1)
processing of an##3##3##(2007-11#1)(2008-1#1)(2010-5#1)
processing of angry##2##3##(2008-11#2)
processing of beta APP##2##4##(1991-10#1)(1992-9#1)
processing of both##2##3##(1990-8#1)(2008-2#1)
processing of data##2##3##(2008-10#1)(2008-3#1)
processing of emotional##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
processing of faces##2##3##(2007-8#1)(2008-11#1)
processing of human##2##3##(1991-2#1)(1991-9#1)
processing of irrelevant stimuli##2##4##(1995-5#2)
processing of prorenin##2##3##(1991-9#2)
processing of temporal##4##3##(1992-11#1)(2008-2#3)
processing of the Alzheimer##2##4##(1992-12#1)(1992-9#1)
processing of the amyloid##2##4##(1992-12#2)
processing of the internal and##2##5##(2008-1#2)
processing of the precursor##3##4##(1991-7#1)(1992-12#1)(1997-1#1)
processing of the##31##3##(1990-11#1)(1991-7#1)(1991-9#2)(1992-12#6)(1992-9#1)(1993-8#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-3#1)(2013-8#1)
processing of these##2##3##(2008-2#1)(2013-8#1)
processing of this##3##3##(1991-10#1)(1992-10#1)(2009-12#1)
processing of wh-questions is##2##4##(2011-1#2)
processing of##171##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-8#5)(1991-10#2)(1991-2#3)(1991-5#1)(1991-7#1)(1991-9#6)(1992-10#2)(1992-11#1)(1992-12#7)(1992-6#4)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#4)(1995-5#2)(1995-8#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#5)(2008-10#10)(2008-11#12)(2008-12#1)(2008-2#12)(2008-3#11)(2008-4#5)(2008-6#4)(2008-7#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
processing on the##2##3##(2007-12#1)(2013-8#1)
processing on##6##2##(1991-5#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2013-8#1)
processing or##3##2##(1993-12#1)(2008-4#1)(2008-5#1)
processing over a##2##3##(2008-2#1)(2008-3#1)
processing pathways##2##2##(1992-12#1)(2008-4#1)
processing procedure##2##2##(2008-11#1)(2008-9#1)
processing products##2##2##(1992-8#1)(2013-8#1)
processing rate##2##2##(2008-12#2)
processing required##3##2##(2008-11#1)(2008-2#1)(2010-3#1)
processing shows that##2##3##(2008-2#1)(2008-3#1)
processing site##6##2##(1991-10#2)(1994-11#2)(1995-6#1)(1996-10#1)
processing sites##2##2##(1990-12#1)(1997-4#1)
processing software##2##2##(2008-11#1)(2011-7#1)
processing speed and executive function##2##5##(2012-1#1)(2012-2#1)
processing speed of##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
processing speed##11##2##(2007-12#1)(2007-7#1)(2008-2#3)(2008-3#2)(2012-1#1)(2012-12#1)(2012-2#2)
processing step##2##2##(2008-10#1)(2008-2#1)
processing steps##4##2##(1990-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
processing strategies in children##2##4##(2008-9#2)
processing strategies##4##2##(2008-9#4)
processing system is##2##3##(2008-3#2)
processing system that##2##3##(1994-12#1)(2008-3#1)
processing system##6##2##(1994-12#1)(2008-11#1)(2008-3#4)
processing systems##3##2##(2008-2#2)(2008-4#1)
processing technique##3##2##(2008-3#3)
processing techniques##11##2##(1992-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-8#1)(2012-1#1)(2012-2#1)
processing than##2##2##(1993-6#1)(2009-5#1)
processing that##3##2##(1991-9#1)(1995-2#1)(2007-12#1)
processing the##6##2##(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)
processing time##3##2##(1997-3#1)(2008-2#1)(2008-3#1)
processing to##9##2##(1995-2#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-12#1)
processing tomato production##2##3##(2008-10#2)
processing tomato##5##2##(2008-10#5)
processing unit##6##2##(1995-6#1)(2008-3#1)(2009-6#1)(2011-1#2)(2012-2#1)
processing was##8##2##(1991-10#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)
processing were##3##2##(1990-8#1)(2010-10#1)(2011-2#1)
processing with##5##2##(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)
processing##911##1##(1990-11#5)(1990-12#4)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#9)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#6)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#9)(1992-10#3)(1992-11#1)(1992-12#14)(1992-3#1)(1992-6#9)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#2)(1993-5#9)(1993-6#9)(1993-8#6)(1993-9#1)(1994-11#12)(1994-12#4)(1994-3#6)(1994-5#1)(1994-6#3)(1994-8#6)(1995-11#1)(1995-12#5)(1995-2#11)(1995-5#6)(1995-6#7)(1995-8#4)(1996-10#1)(1996-12#2)(1996-2#7)(1996-5#6)(1997-1#5)(1997-3#5)(1997-4#7)(1997-6#2)(1997-7#3)(2007-10#1)(2007-11#18)(2007-12#29)(2007-7#3)(2007-8#7)(2008-1#12)(2008-10#72)(2008-11#75)(2008-12#13)(2008-2#59)(2008-3#132)(2008-4#18)(2008-5#11)(2008-6#14)(2008-7#16)(2008-8#10)(2008-9#31)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#6)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#5)(2009-8#2)(2009-9#2)(2010-10#6)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#6)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#5)(2012-2#19)(2012-3#10)(2013-1#9)(2013-7#1)(2013-8#18)
processivity and##2##2##(2008-1#1)(2009-2#1)
processivity factor##4##2##(1994-12#2)(1995-2#1)(1995-6#1)
processivity##9##1##(1994-12#2)(1994-8#1)(1995-2#2)(1995-6#1)(2008-1#1)(2009-2#1)(2010-12#1)
processor and the##2##3##(2008-5#1)(2009-5#1)
processor and##7##2##(1991-5#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)
processor for##6##2##(2007-12#2)(2008-3#3)(2008-9#1)
processor has##2##2##(2008-3#1)(2008-9#1)
processor is proposed##2##3##(2007-12#1)(2008-3#1)
processor is##8##2##(2007-12#1)(2008-3#7)
processor that##2##2##(2008-3#2)
processor to##2##2##(2008-10#1)(2008-3#1)
processor with##6##2##(2008-2#3)(2008-3#2)(2008-9#1)
processor##73##1##(1991-5#1)(1995-6#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-10#1)(2008-2#8)(2008-3#28)(2008-5#1)(2008-6#2)(2008-9#19)(2009-5#1)(2010-8#1)
processors are interconnected with##2##4##(2008-3#1)(2010-8#1)
processors are##3##2##(2007-9#1)(2008-3#1)(2010-8#1)
processors in##3##2##(2008-2#1)(2008-3#2)
processors to##2##2##(2008-3#2)
processors##29##1##(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#5)(2008-3#11)(2008-9#5)(2010-8#4)
procholecystokinin##2##1##(1991-8#1)(1992-8#1)
procidentia in##2##2##(2008-10#2)
procoagulant##3##1##(2008-7#1)(2008-9#1)(2009-3#1)
procolipase##10##1##(1995-5#10)
procollagen C-proteinase enhancer##2##3##(1990-11#2)
procollagen##9##1##(1990-11#3)(1992-5#2)(1993-6#1)(2008-7#1)(2008-9#2)
procreate##2##1##(2008-1#1)(2012-3#1)
procrustes discriminant analysis##2##3##(2008-10#2)
proctectomy##3##1##(2007-8#2)(2011-2#1)
proctocolectomy##4##1##(1990-6#1)(1991-6#2)(2009-12#1)
procured##6##1##(2007-7#1)(2008-4#2)(2008-6#1)(2008-7#2)
procurement and##2##2##(2007-12#1)(2012-12#1)
procurement##19##1##(1992-3#1)(1995-2#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#6)(2013-7#1)
procuring##3##1##(1992-12#2)(1996-2#1)
procyanidins##5##1##(2008-5#5)
procymidone and##2##2##(2008-10#2)
procymidone##3##1##(2008-10#3)
prodigal son##2##2##(2008-12#2)
prodigious##2##1##(2008-10#1)(2008-11#1)
prodromal##5##1##(1992-12#1)(1994-2#1)(2011-8#2)(2012-12#1)
prodrome of##2##2##(2010-5#1)(2011-1#1)
prodrome##3##1##(2010-12#1)(2010-5#1)(2011-1#1)
prodrug of##4##2##(1995-6#2)(2008-5#1)(2012-12#1)
prodrug##11##1##(1991-8#1)(1994-5#1)(1995-3#2)(1995-6#2)(2008-1#1)(2008-4#1)(2008-5#1)(2011-3#1)(2012-12#1)
prodrugs for##3##2##(1995-3#3)
prodrugs of##2##2##(1995-3#2)
prodrugs##11##1##(1991-6#1)(1991-9#1)(1992-3#1)(1995-3#7)(2008-4#1)
produce 2##4##2##(1993-6#1)(2008-10#3)
produce IAA##3##2##(2008-10#3)
produce a better##2##3##(1992-9#1)(2008-3#1)
produce a functional##2##3##(2008-4#1)(2008-8#1)
produce a greater##2##3##(2008-12#1)(2008-3#1)
produce a more##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
produce a new##2##3##(1994-1#1)(2010-12#1)
produce a range of##2##4##(2012-12#1)(2013-1#1)
produce a variety of##2##4##(2007-10#1)(2013-7#1)
produce a##137##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-9#4)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#2)(2008-10#28)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#2)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
produce about##2##2##(1990-2#1)(2008-7#1)
produce accurate##3##2##(2008-3#2)(2013-1#1)
produce aflatoxin##2##2##(2008-10#2)
produce an increase in##3##4##(1992-9#1)(1993-11#1)(2008-10#1)
produce an##31##2##(1990-8#1)(1991-7#1)(1992-9#1)(1993-11#1)(1995-9#1)(1996-5#2)(1996-6#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)
produce and secrete##4##3##(1995-2#1)(2008-10#1)(2013-1#2)
produce and##9##2##(1995-2#2)(1997-4#1)(2008-1#2)(2008-10#1)(2012-2#1)(2013-1#2)
produce better##3##2##(2008-5#1)(2009-4#1)(2012-12#1)
produce both##8##2##(1991-1#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
produce competent##2##2##(1995-2#1)(2008-11#1)
produce compounds that##2##3##(2008-10#2)
produce different##5##2##(1992-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
produce either##2##2##(1993-9#1)(2008-8#1)
produce ethanol##2##2##(2008-6#1)(2012-3#1)
produce free radicals##2##3##(1993-11#1)(1995-3#1)
produce fumonisin##2##2##(2008-10#1)(2013-1#1)
produce functional##2##2##(2007-11#1)(2008-7#1)
produce good##3##2##(1996-3#1)(2008-3#1)(2008-4#1)
produce greater quantities of aflatoxins than##2##6##(2008-10#2)
produce greater##4##2##(2008-10#2)(2009-8#1)(2012-3#1)
produce high levels of##4##4##(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#1)
produce high##6##2##(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2009-5#1)(2011-1#1)
produce high-resolution##2##2##(2008-2#1)(2008-7#1)
produce higher##3##2##(1993-2#1)(2007-11#1)(2008-10#1)
produce holes##2##2##(2008-10#1)(2008-3#1)
produce identical##2##2##(1997-9#1)(2008-7#1)
produce images##3##2##(2008-2#2)(2008-3#1)
produce information##2##2##(1995-12#1)(2012-12#1)
produce interpretable##2##2##(2009-8#1)(2013-1#1)
produce large amounts of##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
produce large offspring##2##3##(2008-8#2)
produce large quantities of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
produce large##14##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)
produce larger##2##2##(2008-8#1)(2012-3#1)
produce less##2##2##(2008-10#1)(2008-9#1)
produce many##2##2##(1993-1#1)(2008-8#1)
produce material for##2##3##(2008-11#2)
produce meaningful##2##2##(2008-2#1)(2009-8#1)
produce more than##2##3##(1991-1#1)(2007-12#1)
produce more##9##2##(1991-1#1)(1993-11#1)(1994-2#1)(2007-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
produce multiple##2##2##(1995-12#1)(2010-10#1)
produce mycotoxins##2##2##(2008-10#1)(2010-3#1)
produce new##4##2##(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)
produce novel##3##2##(2008-7#1)(2009-11#1)(2013-8#1)
produce only##3##2##(1990-7#1)(1993-8#1)(2008-6#1)
produce oospores in##4##3##(2008-10#4)
produce oospores##8##2##(2008-10#8)
produce or##2##2##(2008-10#1)(2009-5#1)
produce positive##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
produce results in##2##3##(2008-3#1)(2010-8#1)
produce results##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
produce secondary##4##2##(2007-12#1)(2008-10#3)
produce severe##2##2##(1990-9#1)(1994-3#1)
produce side effects##2##3##(1993-11#1)(2008-7#1)
produce significant##9##2##(1994-11#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
produce similar##5##2##(1991-12#1)(1992-10#1)(2008-12#2)(2013-1#1)
produce sound##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
produce specific##3##2##(2008-10#2)(2008-11#1)
produce strong##2##2##(2008-10#1)(2008-3#1)
produce such##2##2##(2008-3#1)(2008-5#1)
produce sufficient amounts of##2##4##(2008-11#1)(2011-2#1)
produce sufficient##3##2##(1997-7#1)(2008-11#1)(2011-2#1)
produce sustainable##2##2##(1995-1#1)(2008-12#1)
produce sustained##2##2##(1992-6#1)(1994-2#1)
produce the most##2##3##(2008-12#1)(2010-4#1)
produce the same##2##3##(1990-12#1)(2012-12#1)
produce the##52##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
produce their##3##2##(2008-4#1)(2008-5#1)(2010-5#1)
produce them##2##2##(2008-5#2)
produce these##4##2##(1990-12#1)(1992-9#1)(1993-8#1)(2011-1#1)
produce this##5##2##(1991-1#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-3#1)
produce two##4##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)
produce valid##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
produce various##2##2##(2008-10#1)(2008-7#1)
produce very##2##2##(2008-5#1)(2012-2#1)
produce##925##1##(1990-12#6)(1990-2#6)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#10)(1991-12#7)(1991-2#4)(1991-3#5)(1991-7#1)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#9)(1993-1#1)(1993-11#7)(1993-12#6)(1993-2#2)(1993-3#3)(1993-5#4)(1993-6#6)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#11)(1995-3#4)(1995-5#4)(1995-6#2)(1995-9#1)(1996-11#3)(1996-12#9)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2006-12#1)(2007-10#1)(2007-11#25)(2007-12#27)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#177)(2008-11#41)(2008-12#15)(2008-2#45)(2008-3#52)(2008-4#23)(2008-5#31)(2008-6#21)(2008-7#30)(2008-8#37)(2008-9#20)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#6)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#7)(2010-4#9)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#10)(2011-2#14)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#18)(2012-3#12)(2013-1#19)(2013-7#3)(2013-8#5)
produced BHV-1##2##2##(2008-11#2)
produced DNA products##2##3##(2008-10#2)
produced DNA##3##2##(2008-10#3)
produced IgG##3##2##(1990-12#1)(2008-11#2)
produced a concentration-dependent##6##3##(1992-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#2)
produced a consistent##2##3##(2007-7#1)(2008-10#1)
produced a decrease in motor activity and an##2##8##(1991-2#2)
produced a decrease in##3##4##(1991-2#2)(2008-10#1)
produced a dose-dependent increase##2##4##(1993-12#1)(2009-12#1)
produced a dose-dependent reduction in##2##5##(1991-12#1)(1997-2#1)
produced a dose-dependent##8##3##(1991-12#1)(1992-5#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(2009-12#1)
produced a gradual##3##3##(1993-6#1)(1994-11#1)(1995-12#1)
produced a higher##2##3##(1992-12#1)(1997-7#1)
produced a large##2##3##(1993-12#1)(2007-12#1)
produced a marked##4##3##(1992-11#1)(1995-11#1)(1995-12#1)(1996-12#1)
produced a partial##2##3##(1990-2#1)(1991-5#1)
produced a protein##2##3##(1993-8#1)(2008-9#1)
produced a significant enhancement##2##4##(2008-10#1)(2008-12#1)
produced a significant increase in##2##5##(2008-10#1)(2013-1#1)
produced a significant reduction##2##4##(1995-12#1)(2008-3#1)
produced a significant##15##3##(1992-2#1)(1992-8#1)(1995-12#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2010-5#1)(2010-8#1)(2013-1#1)
produced a similar##2##3##(1993-12#1)(2008-10#1)
produced a single##2##3##(1991-5#1)(1993-8#1)
produced a strong##2##3##(1992-2#1)(2008-4#1)
produced a##126##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-2#3)(1991-5#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#2)(1993-12#4)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#2)(1995-11#2)(1995-12#6)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#5)(1997-7#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#25)(2008-11#3)(2008-12#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)
produced aflatoxin in##3##3##(2008-10#3)
produced aflatoxin##4##2##(2008-10#4)
produced after##4##2##(1995-5#1)(2008-12#1)(2008-6#1)(2009-7#1)
produced against a##2##3##(1992-3#1)(1996-12#1)
produced against the##2##3##(2008-10#2)
produced against##9##2##(1992-3#1)(1996-12#2)(2008-10#5)(2008-11#1)
produced almost##2##2##(1994-8#1)(2008-10#1)
produced ammonia##2##2##(2008-10#2)
produced an average##2##3##(2007-11#1)(2008-10#1)
produced an increase in##3##4##(1996-12#1)(2008-5#1)(2012-3#1)
produced an increase##4##3##(1996-12#1)(2008-11#1)(2008-5#1)(2012-3#1)
produced an##23##2##(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
produced and characterized##2##3##(1996-12#1)(2008-5#1)
produced and purified##2##3##(1993-8#1)(1994-5#1)
produced and released##2##3##(1994-5#1)(2007-12#1)
produced and secreted by##2##4##(1993-3#1)(2008-5#1)
produced and##27##2##(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#3)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2011-3#1)
produced antibody##2##2##(2008-11#2)
produced are##2##2##(2008-10#1)(2008-3#1)
produced as a##5##3##(1992-2#1)(1993-12#1)(2008-10#1)(2010-5#1)(2010-8#1)
produced as an##2##3##(1990-5#1)(1994-9#1)
produced as one of the##2##5##(2008-10#1)(2009-5#1)
produced as##14##2##(1990-5#1)(1992-2#1)(1993-12#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2010-5#2)(2010-8#1)
produced at 10°C and 30°C##3##5##(2011-2#3)
produced at 10°C##4##3##(2011-2#4)
produced at 30°C##2##3##(2011-2#2)
produced at least##2##3##(2008-10#2)
produced at the##6##3##(1993-12#1)(2007-11#1)(2008-10#2)(2008-3#2)
produced at##27##2##(1992-8#1)(1993-12#1)(1994-9#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2011-2#6)(2012-5#1)
produced better##2##2##(2008-10#1)(2011-2#1)
produced between##2##2##(2007-11#1)(2008-11#1)
produced by 8-OH-DPAT##2##3##(1991-2#2)
produced by A##2##3##(1991-9#1)(2013-8#1)
produced by CHO cells##3##4##(1992-10#1)(2008-11#2)
produced by Chinese hamster ovary##5##5##(2008-11#4)(2008-7#1)
produced by Fusarium##2##3##(2008-10#2)
produced by P##3##3##(2008-10#3)
produced by PCR##2##3##(1997-3#1)(2010-5#1)
produced by Penicillium##2##3##(2008-10#1)(2008-6#1)
produced by Pseudomonas##4##3##(1995-2#1)(2008-10#2)(2008-6#1)
produced by T cells##2##4##(2007-11#1)(2008-9#1)
produced by U##2##3##(2008-10#2)
produced by a single##2##4##(2007-11#1)(2008-10#1)
produced by a variety of cells##2##6##(2008-4#1)(2009-3#1)
produced by a##41##3##(1991-2#1)(1993-12#1)(1995-6#1)(1996-3#1)(2007-11#5)(2007-12#3)(2008-10#6)(2008-2#6)(2008-3#8)(2008-4#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
produced by alkali treatment of##2##5##(1992-6#2)
produced by all##5##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
produced by an##8##3##(1993-6#1)(1997-2#1)(2008-3#3)(2008-8#1)(2013-1#1)(2013-8#1)
produced by bile-pancreatic juice diversion##2##5##(2008-7#2)
produced by both##3##3##(1993-1#1)(2008-10#1)(2008-3#1)
produced by chronic##2##3##(1991-5#1)(1996-5#1)
produced by combining##2##3##(1996-1#1)(2008-4#1)
produced by conidial##2##3##(2008-10#2)
produced by different##8##3##(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)
produced by digestion with##2##4##(2008-1#2)
produced by each strain##2##4##(2008-10#2)
produced by each##3##3##(2008-10#3)
produced by enzyme##2##3##(2008-10#2)
produced by fusing splenocytes##2##4##(2008-11#2)
produced by fusing##4##3##(2008-11#4)
produced by human##2##3##(2008-11#1)(2008-8#1)
produced by ion exchange in##2##5##(2008-2#2)
produced by irradiation of##2##4##(2007-11#2)
produced by its##2##3##(2008-5#1)(2009-10#1)
produced by jet nebulizers##2##4##(1995-3#2)
produced by jet##3##3##(1991-1#1)(1995-3#2)
produced by laser ablation##2##4##(1991-2#1)(2008-3#1)
produced by less##2##3##(2008-10#1)(2011-2#1)
produced by means of##2##4##(2008-2#1)(2008-7#1)
produced by mobile phones on the##2##6##(2008-12#2)
produced by mobile phones##3##4##(2008-12#3)
produced by morphine##2##3##(1993-12#1)(1994-2#1)
produced by multiple##4##3##(1992-6#1)(2008-2#1)(2008-9#1)(2010-10#1)
produced by one##2##3##(2007-12#1)(2011-1#1)
produced by our##2##3##(2008-3#1)(2013-1#1)
produced by recombinant##2##3##(1991-2#1)(2007-11#1)
produced by several##3##3##(2008-10#2)(2008-4#1)
produced by simple##2##3##(2008-10#1)(2010-7#1)
produced by strain##2##3##(2008-10#2)
produced by systemic##2##3##(1993-12#1)(1994-2#1)
produced by the different##2##4##(2008-10#2)
produced by the immobilized-enzyme##2##4##(2008-10#2)
produced by the reaction between##3##5##(2008-10#3)
produced by the##98##3##(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-3#1)(1996-2#2)(1997-2#2)(2007-11#2)(2007-12#2)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
produced by these cells##4##4##(1992-9#1)(2008-11#2)(2008-9#1)
produced by these##9##3##(1990-12#1)(1992-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-9#1)
produced by this##5##3##(1992-8#1)(1996-4#1)(2008-6#1)(2011-1#1)(2013-8#1)
produced by two##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
produced by use of##2##4##(2007-11#1)(2008-2#1)
produced by using a##2##4##(1995-12#1)(2008-6#1)
produced by using##3##3##(1995-12#1)(2008-5#1)(2008-6#1)
produced by##547##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#4)(1990-8#3)(1991-1#3)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#3)(1991-9#3)(1992-10#3)(1992-11#3)(1992-12#3)(1992-3#1)(1992-6#5)(1992-8#3)(1992-9#6)(1993-1#1)(1993-12#13)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#1)(1994-6#2)(1994-9#3)(1995-11#6)(1995-12#7)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#7)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#2)(2007-11#15)(2007-12#13)(2007-8#1)(2008-1#2)(2008-10#120)(2008-11#35)(2008-12#8)(2008-2#21)(2008-3#43)(2008-4#9)(2008-5#9)(2008-6#14)(2008-7#17)(2008-8#11)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#2)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#4)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#5)
produced characteristic##2##2##(2008-10#2)
produced conidia##2##2##(2008-10#2)
produced consistent##2##2##(2008-10#1)(2008-12#1)
produced cytopathic##2##2##(2006-10#1)(2008-5#1)
produced directly from##2##3##(1994-2#1)(2007-12#1)
produced distinct##2##2##(2008-10#2)
produced dose-dependent##2##2##(1996-2#1)(2011-1#1)
produced dose-related##2##2##(1994-11#1)(1994-2#1)
produced during the##4##3##(2007-11#2)(2008-10#1)(2008-4#1)
produced during##10##2##(1993-2#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-4#1)(2009-3#1)(2013-1#1)
produced early in the##2##4##(2008-10#1)(2008-8#1)
produced either##2##2##(1997-7#1)(2008-8#1)
produced equivocal results##2##3##(1997-5#1)(2012-12#1)
produced ethylene at##2##3##(2008-10#2)
produced ethylene##3##2##(2008-10#3)
produced exclusively##2##2##(2008-3#1)(2009-7#1)
produced fewer##2##2##(2008-10#1)(2008-4#1)
produced for the##4##3##(1990-12#1)(2008-10#1)(2008-3#2)
produced for##7##2##(1990-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
produced from a##5##3##(1991-2#1)(1993-5#1)(2007-12#1)(2008-2#2)
produced from an##2##3##(2008-3#1)(2011-2#1)
produced from the enzymatic reaction##2##5##(2008-10#2)
produced from the reaction##2##4##(2008-10#2)
produced from the##14##3##(1990-7#1)(1994-11#2)(1997-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2013-1#1)
produced from##57##2##(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#23)(2008-11#5)(2008-2#4)(2008-3#2)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#1)
produced good##2##2##(1990-9#1)(2008-10#1)
produced greater##3##2##(2008-10#3)
produced high amounts##3##3##(2008-10#2)(2010-11#1)
produced high levels of##2##4##(2008-10#2)
produced high##5##2##(2008-10#4)(2010-11#1)
produced higher##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
produced hydrogen peroxide##4##3##(2008-10#3)(2009-8#1)
produced in E##3##3##(1990-11#1)(1990-5#1)(1990-8#1)
produced in Escherichia coli##7##4##(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-12#1)(2008-4#1)(2010-6#1)
produced in a baculovirus##2##4##(1994-8#1)(2008-11#1)
produced in a##14##3##(1990-5#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-11#1)(2009-7#1)
produced in an##7##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)
produced in bacteria and##2##4##(1993-12#1)(2013-8#1)
produced in bacteria##4##3##(1993-12#1)(2008-4#1)(2009-6#1)(2013-8#1)
produced in its##2##3##(2008-10#2)
produced in large##2##3##(2008-11#1)(2011-1#1)
produced in less than##3##4##(2008-11#2)(2008-6#1)
produced in less##4##3##(2008-11#2)(2008-6#1)(2008-9#1)
produced in mice##2##3##(1992-3#1)(2008-10#1)
produced in response to##2##4##(2007-11#1)(2008-9#1)
produced in the different##2##4##(2008-11#1)(2012-2#1)
produced in the reaction##2##4##(2008-10#2)
produced in the##31##3##(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-5#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#1)(2010-2#1)(2012-2#1)
produced in this##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
produced in vitro and##2##4##(1996-5#1)(2008-10#1)
produced in vitro by##4##4##(1990-11#1)(2008-10#2)(2008-7#1)
produced in vitro##10##3##(1990-11#1)(1991-3#1)(1996-5#1)(2008-10#6)(2008-7#1)
produced in yeast##2##3##(1996-12#2)
produced in##168##2##(1990-11#3)(1990-5#3)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-5#1)(1997-4#2)(1997-6#1)(2007-11#2)(2007-12#4)(2008-10#46)(2008-11#18)(2008-2#3)(2008-3#11)(2008-4#4)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
produced increased##3##2##(2008-10#2)(2008-11#1)
produced interesting results##2##3##(2008-10#1)(2008-3#1)
produced is##3##2##(1993-6#1)(2008-10#1)(2008-7#1)
produced large amounts of ethanol##2##5##(2013-1#2)
produced large amounts of##5##4##(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
produced large##6##2##(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
produced less##7##2##(1993-1#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
produced little or no##3##4##(1994-12#1)(2008-10#1)(2008-11#1)
produced live##2##2##(1991-3#1)(2008-11#1)
produced long##2##2##(2008-10#1)(2008-8#1)
produced mainly by##4##3##(1992-5#1)(2008-1#1)(2008-10#2)
produced males and oviparae##2##4##(2008-9#2)
produced many##2##2##(1996-5#1)(2008-11#1)
produced maps##2##2##(1993-12#1)(2007-5#1)
produced mixtures of##2##3##(2007-11#1)(2008-10#1)
produced more##17##2##(1991-9#1)(1992-11#1)(1996-12#1)(2008-10#8)(2008-12#1)(2008-6#2)(2008-8#2)(2011-2#1)
produced mostly##2##2##(2008-10#1)(2012-3#1)
produced multiple##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
produced near-identical effects on reaction time##3##6##(2009-2#3)
produced no change in##2##4##(1991-6#1)(1995-11#1)
produced no change##3##3##(1991-6#1)(1995-11#1)(2011-2#1)
produced no significant##3##3##(1993-1#1)(2007-11#1)(2008-7#1)
produced no##12##2##(1991-6#1)(1993-1#1)(1995-11#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)
produced on infected plants##2##4##(2008-10#2)
produced on leaves##2##3##(2008-10#2)
produced on the##4##3##(2008-10#3)(2012-3#1)
produced on##26##2##(2008-10#22)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
produced one##2##2##(2008-10#1)(2009-5#1)
produced only a##2##3##(2008-10#1)(2008-11#1)
produced only modest##2##3##(2008-10#1)(2009-7#1)
produced only##10##2##(1990-11#1)(1992-6#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2009-7#1)
produced oospores when grown on##2##5##(2008-10#2)
produced over the##2##3##(2008-1#1)(2008-10#1)
produced per cotyledon##2##3##(2008-10#2)
produced per##7##2##(2008-10#5)(2008-11#1)(2009-12#1)
produced positive results in the##2##5##(1996-2#2)
produced protein##2##2##(1994-12#1)(2008-11#1)
produced proteins##2##2##(2008-4#1)(2008-7#1)
produced pycnidia on##2##3##(2008-10#2)
produced quick##2##2##(2007-11#1)(2012-2#1)
produced results##3##2##(2008-10#2)(2013-1#1)
produced robust##2##2##(1993-3#1)(2012-2#1)
produced satisfactory##2##2##(2007-8#1)(2008-10#1)
produced several##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
produced significant changes##2##3##(1993-6#1)(2008-10#1)
produced significant##19##2##(1991-8#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1995-12#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
produced significantly more##8##3##(1990-12#1)(1990-5#1)(1990-8#1)(2008-10#2)(2009-10#1)(2012-12#1)(2013-1#1)
produced significantly smaller##2##3##(1991-12#1)(2008-10#1)
produced significantly##14##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-1#1)(2008-10#6)(2009-10#1)(2012-12#1)(2013-1#1)
produced similar symptoms##2##3##(1997-3#1)(2008-10#1)
produced similar##10##2##(1990-5#1)(1992-2#1)(1997-3#1)(2008-10#6)(2008-8#1)
produced small##3##2##(1992-11#1)(1995-2#1)(2008-6#1)
produced some##3##2##(1991-8#1)(2008-10#1)(2008-5#1)
produced structures##2##2##(1997-4#1)(2007-11#1)
produced symptoms##3##2##(2008-10#2)(2008-12#1)
produced that##4##2##(1995-6#1)(2007-7#1)(2008-10#2)
produced the best results##2##4##(1990-11#1)(2008-10#1)
produced the best##5##3##(1990-11#1)(2008-10#1)(2008-5#1)(2010-4#2)
produced the following##2##3##(2008-6#1)(2008-7#1)
produced the highest##6##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
produced the largest##3##3##(1995-11#1)(2008-10#1)(2010-2#1)
produced the##29##2##(1990-11#1)(1990-5#1)(1994-9#1)(1995-11#2)(1996-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-1#1)(2013-1#1)
produced through the##4##3##(1992-8#1)(2008-2#1)(2008-4#2)
produced through##12##2##(1992-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-8#1)
produced to##4##2##(1995-8#1)(2007-5#1)(2008-10#1)(2009-5#1)
produced too##3##2##(1995-12#1)(2008-10#2)
produced transgenic mice##2##3##(1990-8#1)(1992-11#1)
produced two##9##2##(1990-5#1)(1994-8#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-1#1)
produced typical##2##2##(2008-10#2)
produced under##2##2##(2008-11#1)(2008-9#1)
produced using a##2##3##(2008-10#2)
produced using##5##2##(1997-4#1)(2008-10#2)(2008-11#2)
produced various##2##2##(2008-10#2)
produced via the##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
produced via##5##2##(1990-2#1)(1995-12#2)(2008-10#1)(2008-7#1)
produced was##5##2##(1990-11#1)(1995-3#1)(2008-10#2)(2008-12#1)
produced water samples##2##3##(2008-10#2)
produced water was##2##3##(1994-3#1)(2013-1#1)
produced water##12##2##(1994-3#1)(2008-10#2)(2008-7#2)(2013-1#7)
produced waters##3##2##(2008-10#3)
produced were##2##2##(1994-2#1)(2008-10#1)
produced when the##2##3##(2007-11#1)(2008-10#1)
produced when##6##2##(1994-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
produced with a##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)
produced with the##2##3##(2008-10#1)(2008-6#1)
produced with##21##2##(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#2)(2010-4#2)
produced within##2##2##(2007-11#1)(2012-2#1)
produced##1815##1##(1990-10#1)(1990-11#8)(1990-12#8)(1990-2#4)(1990-5#13)(1990-7#6)(1990-8#7)(1990-9#2)(1991-1#3)(1991-12#18)(1991-2#12)(1991-3#7)(1991-5#13)(1991-6#3)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#9)(1992-12#7)(1992-2#4)(1992-3#5)(1992-5#4)(1992-6#12)(1992-7#1)(1992-8#8)(1992-9#10)(1993-1#5)(1993-10#1)(1993-11#2)(1993-12#24)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#13)(1993-8#9)(1993-9#3)(1994-11#14)(1994-12#9)(1994-2#11)(1994-3#7)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#8)(1995-1#1)(1995-11#13)(1995-12#23)(1995-2#14)(1995-3#5)(1995-5#9)(1995-6#8)(1995-8#3)(1995-9#1)(1996-1#3)(1996-12#19)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#1)(1997-1#1)(1997-2#13)(1997-3#2)(1997-4#21)(1997-5#3)(1997-6#5)(1997-7#6)(1997-8#1)(2006-10#2)(2007-11#40)(2007-12#34)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#514)(2008-11#113)(2008-12#24)(2008-2#40)(2008-3#109)(2008-4#24)(2008-5#40)(2008-6#40)(2008-7#49)(2008-8#37)(2008-9#29)(2009-10#7)(2009-11#5)(2009-12#8)(2009-2#4)(2009-3#5)(2009-5#3)(2009-6#1)(2009-7#9)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-2#3)(2010-3#3)(2010-4#10)(2010-5#8)(2010-6#2)(2010-7#4)(2010-8#4)(2011-1#14)(2011-2#32)(2011-3#2)(2012-1#3)(2012-12#13)(2012-2#14)(2012-3#8)(2012-5#1)(2012-6#1)(2013-1#34)(2013-7#3)(2013-8#12)
produced)##2##1##(2008-9#1)(2009-12#1)
producer cell line##3##3##(1990-5#1)(2008-11#2)
producer cell##5##2##(1990-5#1)(2008-11#4)
producer cells##3##2##(2008-11#3)
producer from##2##2##(2008-10#2)
producer of##5##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
producer##30##1##(1990-5#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
producers and##8##2##(1997-4#1)(2008-10#4)(2008-9#1)(2012-12#1)(2012-2#1)
producers have##2##2##(1997-6#1)(2008-10#1)
producers in the##4##3##(2008-10#2)(2010-6#1)(2012-2#1)
producers in##6##2##(2008-10#4)(2010-6#1)(2012-2#1)
producers of##6##2##(2008-11#1)(2008-7#2)(2008-8#1)(2012-12#2)
producers to##2##2##(2008-10#1)(2013-8#1)
producers##55##1##(1996-2#2)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#22)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-8#2)
produces a decrease in##2##4##(1994-2#1)(2008-5#1)
produces a decrease##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
produces a marked##2##3##(1990-5#1)(1993-6#1)
produces a mixture of##2##4##(2008-10#1)(2008-6#1)
produces a range of##2##4##(2007-4#1)(2008-5#1)
produces a single##2##3##(2008-10#1)(2008-8#1)
produces a toxin##2##3##(2008-10#2)
produces a##85##2##(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-5#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)
produces an enzyme##2##3##(2008-10#1)(2009-11#1)
produces an output##2##3##(2008-2#1)(2008-3#1)
produces an##26##2##(1992-11#1)(1992-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
produces and##3##2##(1997-4#1)(2009-6#1)(2010-10#1)
produces dose-related##2##2##(1991-1#1)(1992-6#1)
produces fewer##2##2##(2008-3#1)(2011-1#1)
produces good##3##2##(1991-3#1)(2008-4#1)(2008-7#1)
produces high##2##2##(1990-5#1)(2008-11#1)
produces large##2##2##(1996-4#1)(2010-10#1)
produces multiple##3##2##(2008-10#2)(2008-3#1)
produces only##2##2##(1992-5#1)(2008-8#1)
produces optically pure##2##3##(2008-6#2)
produces pseudothecia and ascospores##2##4##(2008-10#2)
produces pseudothecia##3##2##(2008-10#3)
produces pulses##2##2##(2007-11#1)(2007-12#1)
produces quantitative##2##2##(2008-2#1)(2012-2#1)
produces the##19##2##(1990-8#1)(1993-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-8#1)(2010-10#1)(2010-3#1)
produces tunable##2##2##(2007-12#1)(2008-2#1)
produces two different##2##3##(1992-5#1)(2011-2#1)
produces two##4##2##(1990-2#1)(1992-5#1)(2008-8#1)(2011-2#1)
produces unique##2##2##(2008-3#1)(2009-4#1)
produces##331##1##(1990-2#2)(1990-5#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#5)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#21)(2007-12#22)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#57)(2008-11#4)(2008-12#2)(2008-2#15)(2008-3#32)(2008-4#9)(2008-5#8)(2008-6#12)(2008-7#5)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#4)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
producing Escherichia coli##3##3##(2012-2#2)(2013-1#1)
producing a##49##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
producing an##9##2##(1994-5#1)(1994-8#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)
producing and##3##2##(1994-5#1)(2008-2#1)(2009-10#1)
producing area of##2##3##(2008-10#1)(2012-3#1)
producing autocrine##2##2##(1992-9#1)(2008-11#1)
producing cell lines##3##3##(2008-11#3)
producing cell##4##2##(2008-11#4)
producing cells##10##2##(1992-9#2)(1994-12#1)(2008-11#4)(2008-12#1)(2008-7#1)(2010-11#1)
producing either##2##2##(1992-12#1)(2008-11#1)
producing human##3##2##(1995-6#1)(2008-11#2)
producing large##5##2##(1990-8#1)(1994-6#1)(2008-10#1)(2009-12#1)(2009-5#1)
producing light##2##2##(1991-2#1)(2008-3#1)
producing monoclonal antibody##2##3##(1994-2#1)(1994-5#1)
producing monoclonal##3##2##(1994-2#1)(1994-5#1)(1994-9#1)
producing new##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
producing optical##2##2##(2008-2#1)(2008-3#1)
producing recombinant human##3##3##(2008-11#3)
producing recombinant##9##2##(2008-11#6)(2008-5#1)(2008-8#2)
producing relatively##2##2##(2008-11#2)
producing reliable##2##2##(2008-9#1)(2010-10#1)
producing severe##2##2##(2008-10#1)(2008-6#1)
producing strain##3##2##(1994-2#1)(2008-8#2)
producing strains were##2##3##(2008-10#1)(2008-11#1)
producing strains##4##2##(2008-10#1)(2008-11#1)(2012-2#2)
producing the antibiotic 2##2##4##(2008-10#2)
producing the##22##2##(1990-11#1)(1990-8#1)(1992-1#1)(1992-6#1)(1993-2#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-8#1)(2013-7#1)
producing this##4##2##(2008-11#1)(2009-2#1)(2011-2#2)
producing##368##1##(1990-11#3)(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#5)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#10)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#3)(2008-10#52)(2008-11#48)(2008-12#8)(2008-2#9)(2008-3#19)(2008-4#8)(2008-5#8)(2008-6#7)(2008-7#15)(2008-8#13)(2008-9#6)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#2)(2009-5#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#1)
product 2##2##2##(2008-10#2)
product CL##2##2##(2008-3#2)
product after##2##2##(1997-2#1)(2008-10#1)
product analysis##2##2##(2008-10#1)(2008-4#1)
product and service##2##3##(1995-12#1)(1995-3#1)
product and the##2##3##(1994-8#1)(2008-10#1)
product and##22##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#6)(2008-3#2)(2008-5#2)(2008-7#1)
product and/or##2##2##(2012-2#2)
product application##4##2##(2008-5#4)
product are##5##2##(2008-1#1)(2008-10#2)(2008-5#1)(2009-5#1)
product as a##2##3##(1995-2#1)(2010-4#1)
product as##4##2##(1991-9#1)(1995-2#1)(1997-7#1)(2010-4#1)
product associates with##3##3##(1994-11#2)(1994-8#1)
product at##5##2##(2008-10#3)(2008-5#1)(2010-5#1)
product by##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2009-9#1)
product called##3##2##(1991-9#1)(2008-5#1)(2010-5#1)
product can be##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
product can##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
product characteristics##4##2##(2008-5#2)(2012-3#2)
product contained##3##2##(1990-7#1)(1995-2#1)(2008-10#1)
product containing 5%##2##3##(2008-5#2)
product containing##7##2##(2008-10#2)(2008-5#5)
product contains##4##2##(1990-11#1)(1990-5#1)(1995-3#1)(1995-8#1)
product could be##3##3##(1993-3#1)(1994-5#1)(2009-12#1)
product could##5##2##(1993-3#1)(1994-5#1)(2008-10#1)(2008-12#1)(2009-12#1)
product design##3##2##(2009-7#3)
product development##6##2##(1994-12#1)(2008-10#1)(2008-5#4)
product did not show any##2##5##(1997-2#1)(2012-2#1)
product during##2##2##(2008-10#1)(2008-7#1)
product efficacy##2##2##(2008-10#1)(2008-5#1)
product expression##2##2##(1995-6#1)(2008-11#1)
product flow##3##2##(2008-2#2)(2012-2#1)
product flux##2##2##(2008-7#1)(2010-10#1)
product for##9##2##(1993-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
product formation in##3##3##(1991-5#1)(1994-3#2)
product formation##11##2##(1991-5#3)(1994-3#2)(1994-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#2)
product formed##2##2##(1992-12#1)(2008-10#1)
product from a##2##3##(2008-10#1)(2008-6#1)
product from all##2##3##(2008-10#2)
product from##8##2##(1993-3#1)(1994-12#1)(2008-10#4)(2008-6#1)(2012-3#1)
product has a##3##3##(1993-2#1)(1995-8#1)(2013-1#1)
product has been##3##3##(2008-10#2)(2008-11#1)
product has##8##2##(1990-11#1)(1993-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-1#1)
product in the##5##3##(1990-7#1)(2008-10#2)(2008-5#1)(2013-1#1)
product in##19##2##(1990-7#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2013-1#1)
product indicated##2##2##(1990-8#1)(2008-5#1)
product information##2##2##(2008-1#1)(2010-4#1)
product inhibition##5##2##(1991-9#1)(1993-8#1)(1994-8#1)(2008-7#2)
product into##2##2##(1991-9#1)(2008-9#1)
product ion##4##2##(2008-10#4)
product is a##7##3##(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-9#1)(2008-11#1)(2013-1#1)
product is not##2##3##(1994-11#1)(2008-11#1)
product is required for##2##4##(1995-6#1)(1996-3#1)
product is##46##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#2)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#4)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
product lines##3##2##(1993-12#1)(1995-2#1)(2008-1#1)
product may be##2##3##(1990-12#1)(2008-9#1)
product may##5##2##(1990-12#1)(2008-5#2)(2008-6#1)(2008-9#1)
product must be##2##3##(2008-8#1)(2012-2#1)
product obtained##4##2##(1990-7#1)(1993-12#1)(2008-10#1)(2009-12#1)
product of Cr(VI)##2##3##(2008-10#2)
product of a##4##3##(1993-3#1)(1995-8#1)(1997-4#1)(2008-3#1)
product of heme##2##3##(1992-3#1)(1992-4#1)
product of its##2##3##(1990-5#1)(1996-5#1)
product of lipoxygenase##2##3##(1992-12#2)
product of organic nitrate##2##4##(1991-9#2)
product of reaction between##2##4##(2008-10#2)
product of reaction##5##3##(2008-10#5)
product of the enzymatic reaction##5##5##(1990-8#1)(2008-10#4)
product of the enzymatic##6##4##(1990-8#1)(2008-10#5)
product of the enzyme reaction##3##5##(1997-6#1)(2008-10#2)
product of the enzyme##5##4##(1994-8#1)(1995-2#1)(1997-6#1)(2008-10#2)
product of the reaction##2##4##(2008-10#1)(2008-2#1)
product of the##67##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-8#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-2#3)(1995-6#2)(1995-8#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#16)(2008-2#6)(2008-3#10)(2008-9#2)(2009-10#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-7#1)(2013-1#1)
product of this gene##4##4##(1993-8#1)(1994-5#1)(1995-6#1)(2008-6#1)
product of this##6##3##(1993-8#1)(1994-5#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-6#1)
product of two##5##3##(1990-11#1)(2007-12#1)(2008-3#2)(2011-2#1)
product of##171##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#2)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1994-12#3)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#3)(1996-12#1)(1996-5#2)(1996-8#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#4)(2008-10#53)(2008-11#2)(2008-2#8)(2008-3#15)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
product on##2##2##(2008-5#2)
product or##5##2##(1994-12#1)(1997-3#1)(2008-10#2)(2008-4#1)
product over##2##2##(1997-4#1)(2013-8#1)
product per##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
product performance##3##2##(2008-5#3)
product profile##2##2##(2008-10#1)(2011-2#1)
product quality and##2##3##(2011-2#2)
product quality##14##2##(2008-10#5)(2008-11#2)(2008-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
product ratios##2##2##(1996-5#1)(2007-11#1)
product release##5##2##(1990-8#1)(1991-9#1)(2008-5#1)(2008-7#2)
product should be##2##3##(2008-5#1)(2010-11#1)
product showed##3##2##(2008-10#2)(2008-5#1)
product shows##2##2##(1997-3#1)(2008-10#1)
product specifically##2##2##(2008-10#1)(2013-1#1)
product specification##2##2##(1994-3#2)
product spoilage##2##2##(2011-2#2)
product stability##2##2##(1992-3#1)(2008-5#1)
product synthesis##3##2##(1996-5#1)(2008-11#2)
product terms##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
product testing##2##2##(2008-10#1)(2008-5#1)
product that##9##2##(1990-5#1)(1991-10#1)(1996-12#2)(1997-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-5#1)
product titre##3##2##(2008-11#3)
product to be##2##3##(1991-12#1)(2011-2#1)
product to##11##2##(1991-12#1)(1992-6#1)(1995-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#2)(2013-8#1)
product types##2##2##(2008-5#2)
product use##5##2##(2008-10#3)(2008-5#2)
product used##2##2##(2008-6#1)(2008-7#1)
product using##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
product via##2##2##(1996-8#1)(2008-4#1)
product was detected##3##3##(1990-11#1)(1991-12#1)(2008-10#1)
product was found to##2##4##(1996-8#1)(2010-5#1)
product was used##2##3##(2008-10#2)
product was##44##2##(1990-11#2)(1991-12#2)(1992-3#2)(1992-6#2)(1994-12#1)(1994-3#2)(1995-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-8#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-12#1)(2012-2#2)
product we##2##2##(2008-3#1)(2008-5#1)
product were determined##2##3##(1992-6#1)(1994-3#1)
product were##12##2##(1992-6#1)(1994-3#1)(1996-1#1)(2008-10#6)(2008-6#3)
product when##2##2##(2008-10#1)(2008-5#1)
product which is##2##3##(1990-7#1)(2008-11#1)
product which##7##2##(1990-7#1)(1994-11#1)(2008-10#1)(2008-11#3)(2012-3#1)
product with##11##2##(1990-12#1)(1990-8#1)(1994-11#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#1)
product world##2##2##(2008-5#2)
product worlds##3##2##(2008-5#3)
product yield##7##2##(1990-7#1)(1997-6#1)(2008-11#2)(2008-7#3)
product yields##4##2##(1996-5#1)(2008-11#1)(2008-6#1)(2008-7#1)
product##1091##1##(1990-11#12)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#10)(1990-6#3)(1990-7#10)(1990-8#6)(1991-10#2)(1991-12#7)(1991-2#5)(1991-3#4)(1991-5#14)(1991-7#2)(1991-8#2)(1991-9#13)(1992-1#2)(1992-11#6)(1992-12#8)(1992-2#2)(1992-3#13)(1992-4#1)(1992-6#8)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#5)(1993-8#4)(1993-9#3)(1994-1#3)(1994-10#3)(1994-11#11)(1994-12#17)(1994-3#10)(1994-5#4)(1994-6#2)(1994-8#16)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#20)(1995-3#8)(1995-5#9)(1995-6#11)(1995-8#8)(1996-1#1)(1996-12#7)(1996-2#3)(1996-3#3)(1996-5#9)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#7)(1997-4#8)(1997-6#3)(1997-7#9)(1997-8#3)(1997-9#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#12)(2007-3#1)(2007-5#2)(2007-7#2)(2008-1#5)(2008-10#257)(2008-11#48)(2008-12#3)(2008-2#12)(2008-3#27)(2008-4#13)(2008-5#105)(2008-6#17)(2008-7#32)(2008-8#8)(2008-9#12)(2009-10#4)(2009-11#3)(2009-12#4)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#8)(2010-5#8)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#31)(2012-12#5)(2012-2#26)(2012-3#4)(2012-7#1)(2013-1#14)(2013-8#6)
product(s)##4##1##(1990-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
product) in##2##2##(2008-10#1)(2008-3#1)
product)##12##1##(1991-11#1)(1993-11#1)(1994-12#1)(2007-5#1)(2008-10#4)(2008-3#1)(2008-5#3)
product-attribute##2##1##(2010-8#2)
product-free##2##1##(1994-5#1)(2008-11#1)
product-line management##5##2##(1994-3#5)
production and a##2##3##(1995-2#1)(2008-11#1)
production and cell##3##3##(1994-2#1)(2008-10#1)(2012-2#1)
production and characterization of##3##4##(1992-2#1)(1996-5#1)(2011-2#1)
production and collection##3##3##(2008-10#2)(2008-8#1)
production and consumption##2##3##(2008-7#1)(2013-1#1)
production and dissemination##2##3##(1992-12#1)(2008-10#1)
production and export##2##3##(2008-7#1)(2011-2#1)
production and glycosylation##3##3##(2008-11#2)(2011-2#1)
production and increased##3##3##(2008-10#2)(2008-6#1)
production and oxygen##2##3##(1996-5#2)
production and protein##2##3##(1990-12#1)(2012-7#1)
production and purification##2##3##(1991-2#1)(2008-4#1)
production and quality##2##3##(2008-10#1)(2008-7#1)
production and recovery##2##3##(2008-11#2)
production and release##2##3##(1996-2#1)(2008-10#1)
production and the##7##3##(1990-5#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-4#1)
production and their##2##3##(2008-10#2)
production and to##2##3##(2008-1#1)(2008-3#1)
production and use##2##3##(1991-12#1)(2008-11#1)
production and##158##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#3)(1992-1#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#4)(1997-1#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#35)(2008-11#18)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-12#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#10)(2013-8#1)
production and/or##4##2##(1994-8#1)(1997-3#1)(2008-1#1)(2010-10#1)
production are##5##2##(2008-10#2)(2008-4#1)(2012-2#1)(2012-3#1)
production area##3##2##(2008-10#3)
production areas and##2##3##(2008-10#2)
production areas in Canada##2##4##(2008-10#2)
production areas in##3##3##(2008-10#2)(2011-2#1)
production areas of the world##2##5##(2008-10#2)
production areas of the##4##4##(2008-10#4)
production areas of##5##3##(2008-10#4)(2008-12#1)
production areas##16##2##(2008-10#14)(2008-12#1)(2011-2#1)
production as a result of##2##5##(1991-12#1)(2011-2#1)
production as a##5##3##(1991-12#1)(1991-5#1)(2006-10#1)(2011-2#2)
production as an##2##3##(1992-2#1)(2009-3#1)
production as evidenced##2##3##(1994-5#1)(2008-10#1)
production as##14##2##(1991-12#1)(1991-5#1)(1992-2#1)(1994-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-3#1)(2011-2#2)
production assay##4##2##(2008-11#4)
production assays##2##2##(2008-11#2)
production at a##2##3##(1993-6#1)(2008-11#1)
production at the##2##3##(1996-5#1)(2008-11#1)
production at##10##2##(1990-12#1)(1993-6#1)(1996-5#1)(2008-11#5)(2008-3#1)(2008-7#1)
production between##2##2##(2008-10#1)(2008-12#1)
production but##2##2##(2008-11#1)(2011-2#1)
production by A##2##3##(2008-10#2)
production by Saccharomyces##2##3##(1995-6#1)(2012-3#1)
production by a##5##3##(1993-9#1)(1994-9#1)(2008-6#1)(2008-7#1)(2012-2#1)
production by human##6##3##(1994-12#1)(2008-10#1)(2008-11#3)(2008-5#1)
production by in##4##3##(2008-11#4)
production by the##9##3##(1993-11#1)(2008-10#5)(2008-11#1)(2008-6#1)(2011-1#1)
production by##104##2##(1990-5#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#3)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#2)(2007-12#1)(2007-2#3)(2008-10#18)(2008-11#22)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#4)(2008-8#3)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
production can be##2##3##(2008-11#1)(2013-8#1)
production capacity##4##2##(2008-11#3)(2008-6#1)
production cell lines##2##3##(2008-11#2)
production chain##2##2##(2008-10#2)
production conditions##2##2##(2008-11#1)(2012-1#1)
production constraints##3##2##(2008-10#1)(2011-1#2)
production control##2##2##(1994-8#1)(2008-5#1)
production cost##3##2##(2008-2#1)(2008-6#1)(2013-8#1)
production costs and their##2##4##(2008-12#2)
production costs and##3##3##(1995-2#1)(2008-12#2)
production costs##5##2##(1994-5#1)(1995-2#1)(2008-11#1)(2008-12#2)
production could##3##2##(1992-3#1)(1995-3#1)(2008-11#1)
production data##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
production decreased##3##2##(2008-10#1)(2008-11#2)
production depend##2##2##(1991-2#1)(1995-5#1)
production does not##2##3##(1993-11#1)(2008-11#1)
production during the##3##3##(1996-9#1)(2008-5#1)(2013-1#1)
production during##4##2##(1995-5#1)(1996-9#1)(2008-5#1)(2013-1#1)
production efficiency and##3##3##(2008-11#2)(2008-6#1)
production efficiency##4##2##(2008-11#3)(2008-6#1)
production field##2##2##(2011-2#2)
production fields in##2##3##(2008-10#2)
production fields##10##2##(2008-10#10)
production following##3##2##(1996-9#1)(2008-11#2)
production food safety##2##3##(2011-2#2)
production for##9##2##(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)
production from a##3##3##(2008-11#3)
production from glucose##4##3##(1990-11#2)(1995-3#1)(2012-3#1)
production from the##5##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#2)
production from##48##2##(1990-11#2)(1991-12#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-6#1)(2008-10#4)(2008-11#11)(2008-3#1)(2008-4#1)(2008-6#8)(2008-7#1)(2011-1#1)(2011-3#1)(2012-3#3)(2013-1#7)
production has been observed in##2##5##(1990-2#1)(2007-2#1)
production has been##3##3##(1990-2#1)(2007-2#1)(2008-5#1)
production has not been##3##4##(2008-10#1)(2008-11#1)(2012-7#1)
production has##10##2##(1990-2#1)(1991-3#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-7#2)
production have##2##2##(1992-9#1)(2008-12#1)
production in Bacillus megaterium##2##4##(2011-1#2)
production in Bacillus##3##3##(2011-1#2)(2011-2#1)
production in CHO cells##2##4##(2008-11#2)
production in Canada##2##3##(2008-10#2)
production in China##2##3##(1997-4#1)(2008-4#1)
production in Escherichia coli##2##4##(1993-9#1)(2008-7#1)
production in a dose-dependent manner##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
production in a##9##3##(1990-4#1)(1993-3#1)(1993-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)
production in all##3##3##(2008-10#2)(2008-11#1)
production in batch##2##3##(1994-8#1)(2008-11#1)
production in both##2##3##(2010-12#1)(2013-8#1)
production in cattle vaccinated with Brucella abortus strain RB51##2##9##(2010-4#2)
production in cultured##3##3##(1990-11#1)(2008-10#1)(2013-1#1)
production in human##2##3##(2008-10#2)
production in insulin-secreting##2##3##(1997-1#2)
production in mice##3##3##(1997-7#2)(2008-10#1)
production in perfusion culture##2##4##(1994-5#1)(2008-11#1)
production in rat##2##3##(1991-12#1)(2012-2#1)
production in recombinant Chinese hamster ovary##2##6##(2008-11#2)
production in recombinant##4##3##(2008-11#2)(2008-7#2)
production in response to##5##4##(1990-11#1)(1992-3#1)(1993-11#1)(2008-10#1)(2012-2#1)
production in serum-free##2##3##(2008-11#2)
production in suspension##2##3##(2008-11#2)
production in the United States##2##5##(2008-10#2)
production in the brain##3##4##(1994-2#1)(1995-12#1)(2012-2#1)
production in the presence of cell walls from##2##8##(2008-10#2)
production in the##32##3##(1990-5#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
production in these##2##3##(2008-10#1)(2013-1#1)
production in this##2##3##(1997-4#1)(2009-8#1)
production in three##2##3##(2008-12#1)(2011-2#1)
production in various##3##3##(1992-8#1)(2006-6#1)(2011-2#1)
production in vitro and##2##4##(1991-8#1)(2008-10#1)
production in vitro##7##3##(1991-8#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)
production in vivo##3##3##(1990-2#1)(1991-8#2)
production in##214##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-12#4)(1991-5#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#2)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-4#2)(1997-7#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#52)(2008-11#28)(2008-12#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#5)(2009-12#3)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#9)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
production increased with increasing##2##4##(2008-10#2)
production increased##6##2##(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
production induced by##6##3##(1990-12#1)(1991-5#1)(1996-2#1)(2008-10#2)(2008-4#1)
production induced##7##2##(1990-12#1)(1991-5#1)(1996-2#1)(2008-10#2)(2008-4#2)
production is discussed##2##3##(2008-6#1)(2008-7#1)
production is not##3##3##(1993-5#1)(1994-8#1)(2008-11#1)
production is proposed##2##3##(2008-10#1)(2008-8#1)
production is##37##2##(1990-2#1)(1991-3#2)(1991-7#1)(1991-9#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-6#1)(2006-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)
production level of##3##3##(1993-6#1)(2008-11#1)(2008-7#1)
production level##5##2##(1993-6#1)(2008-11#3)(2008-7#1)
production line and##2##3##(2012-2#2)
production line##4##2##(2008-10#1)(2012-2#2)(2013-8#1)
production made##2##2##(2007-10#1)(2008-11#1)
production may##2##2##(2008-3#1)(2008-7#1)
production medium##3##2##(2008-10#1)(2012-2#2)
production method##2##2##(1994-6#1)(2008-3#1)
production methods##4##2##(1992-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
production obtained##2##2##(2008-10#1)(2008-11#1)
production occurred##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
production occurs##4##2##(1996-5#1)(1997-1#1)(2008-11#1)(2008-7#1)
production of 6-APA##3##3##(2008-12#3)
production of A##2##3##(2008-10#2)
production of Anticarsia gemmatalis##3##4##(2008-11#3)
production of CEA per cell##2##5##(2008-11#2)
production of CEA##3##3##(2008-11#3)
production of IFN-beta##3##3##(2008-11#3)
production of IL-10##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
production of IL-4##2##3##(2008-10#1)(2009-5#1)
production of IL-6##2##3##(1990-5#1)(2008-10#1)
production of L-lactic acid##3##4##(2008-6#2)(2008-7#1)
production of MAb##2##3##(2008-11#2)
production of P##2##3##(2008-10#2)
production of ROS##6##3##(1994-11#1)(1994-5#3)(2008-10#1)(2008-11#1)
production of a highly##2##4##(1997-3#1)(2008-10#1)
production of a mature##2##4##(2011-3#2)
production of a murine##2##4##(1994-12#1)(2008-4#1)
production of a recombinant##3##4##(1994-12#1)(2008-11#2)
production of a##42##3##(1990-12#1)(1990-7#2)(1993-8#1)(1994-12#2)(1994-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
production of abnormal##2##3##(1992-12#1)(2008-10#1)
production of an##7##3##(1991-6#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
production of antibodies against##3##4##(1993-3#1)(2008-4#1)(2011-2#1)
production of antibodies##13##3##(1990-12#1)(1993-3#2)(1995-11#1)(1995-5#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2011-2#1)
production of antibody##2##3##(2008-11#1)(2011-2#1)
production of apothecia##3##3##(2008-10#3)
production of ascospores##3##3##(2008-10#3)
production of bacterial##2##3##(1995-8#1)(2008-6#1)
production of beta-galactosidase##2##3##(2008-11#1)(2008-7#1)
production of beta-lactamases##2##3##(2008-12#2)
production of biodiesel##2##3##(2008-6#2)
production of biologically active##4##4##(1993-6#2)(1997-4#1)(2008-11#1)
production of biopharmaceuticals##3##3##(2008-11#2)(2011-2#1)
production of conidia##2##3##(2008-10#2)
production of corn##2##3##(1997-4#1)(2008-10#1)
production of cytokines##3##3##(1992-2#1)(2008-11#1)(2013-1#1)
production of endothelin##2##3##(1994-11#2)
production of estrogens##2##3##(2010-2#1)(2012-3#1)
production of ethanol from##2##4##(2008-6#2)
production of ethanol##4##3##(2008-6#2)(2008-7#1)(2008-8#1)
production of extracellular##3##3##(2008-10#2)(2011-2#1)
production of functional##3##3##(1990-5#1)(1993-9#1)(1994-11#1)
production of glucose from##2##4##(1991-9#1)(1997-7#1)
production of glucose##3##3##(1991-9#1)(1997-7#1)(2008-10#1)
production of glycoproteins##2##3##(2008-4#1)(2008-7#1)
production of growth factors##2##4##(1993-11#1)(2013-8#1)
production of high levels of##2##5##(2008-10#1)(2008-11#1)
production of high##5##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-7#1)
production of human monoclonal antibodies##2##5##(2008-11#2)
production of human umbilical vein endothelial cells##2##7##(1994-9#2)
production of human##6##3##(1994-9#3)(2008-11#3)
production of hydrogen##2##3##(2008-10#1)(2008-4#1)
production of industrially##2##3##(2008-7#1)(2011-1#1)
production of infectious##2##3##(2008-9#1)(2012-2#1)
production of inflammatory mediators##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
production of inflammatory##4##3##(1997-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
production of inositol trisphosphate##3##4##(1990-8#2)(1991-12#1)
production of inositol##7##3##(1990-8#5)(1991-12#1)(1997-1#1)
production of inositol(1##2##3##(1990-12#1)(1994-11#1)
production of interferon-beta per unit cell##2##6##(2008-11#2)
production of interferon-beta##5##3##(2008-11#5)
production of lactic acid##4##4##(2008-6#3)(2008-7#1)
production of large quantities of##3##5##(2008-11#2)(2008-7#1)
production of lignin##2##3##(2008-11#1)(2008-6#1)
production of local##2##3##(2008-10#1)(2008-8#1)
production of mRNA##2##3##(1997-8#1)(2009-10#1)
production of methane##2##3##(2008-6#2)
production of monoclonal antibodies##4##4##(2008-11#2)(2008-9#1)(2011-2#1)
production of monoclonal antibody##3##4##(2008-11#3)
production of monoclonal##7##3##(2008-11#5)(2008-9#1)(2011-2#1)
production of nisin##2##3##(2008-6#2)
production of nitric oxide (NO)##2##5##(1991-9#1)(1997-7#1)
production of nitric oxide##5##4##(1991-9#1)(1997-7#1)(2008-11#1)(2008-7#1)(2009-9#1)
production of phosphate from 5'AMP##2##5##(2008-4#2)
production of podophyllotoxin##2##3##(2008-11#2)
production of poly-beta-hydroxybutyrate##2##3##(2008-7#2)
production of progeny##2##3##(1994-11#1)(1997-3#1)
production of proinflammatory cytokines##2##4##(2007-11#1)(2008-1#1)
production of proteins##2##3##(2008-11#1)(2011-1#1)
production of pseudothecia##2##3##(2008-10#2)
production of reactive oxygen species (ROS)##4##6##(1994-5#1)(2008-11#1)(2009-8#1)(2011-2#1)
production of reactive oxygen species##10##5##(1994-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#2)
production of reactive oxygen##11##4##(1994-5#2)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#2)
production of recombinant protein##2##4##(2008-11#2)
production of recombinant proteins by##2##5##(2008-11#2)
production of recombinant proteins for##3##5##(1997-4#1)(2008-11#2)
production of recombinant proteins##14##4##(1997-3#1)(1997-4#1)(2008-11#11)(2009-8#1)
production of recombinant##28##3##(1997-3#1)(1997-4#1)(1997-7#1)(2008-11#22)(2008-7#1)(2009-8#1)(2010-5#1)
production of secondary##4##3##(2008-10#4)
production of secreted##3##3##(1992-9#1)(1997-3#1)(1997-4#1)
production of sorbitol and gluconic acid##2##6##(2008-6#2)
production of specific##2##3##(1995-2#1)(1997-6#1)
production of sporangia and zoospores##2##5##(2008-10#2)
production of sporangia##3##3##(2008-10#3)
production of superoxide anion##2##4##(1994-8#1)(2012-2#1)
production of superoxide##5##3##(1994-8#1)(1995-6#1)(2007-10#1)(2009-9#1)(2012-2#1)
production of the cyclic lipopeptide##2##5##(2008-10#2)
production of the##41##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1997-4#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
production of these##2##3##(1994-11#1)(1994-8#1)
production of this##2##3##(2008-10#1)(2008-11#1)
production of three##2##3##(2008-12#1)(2011-1#1)
production of toxic##2##3##(2008-10#1)(2008-11#1)
production of transgenic##4##3##(1995-2#1)(2008-2#1)(2010-5#1)(2011-2#1)
production of tumor necrosis factor##2##5##(1992-3#1)(1994-8#1)
production of various viruses##2##4##(2008-11#2)
production of various##8##3##(1991-12#1)(1994-9#1)(2008-11#4)(2008-4#2)
production of viral##3##3##(1994-11#1)(2008-11#1)(2011-3#1)
production of xylitol from##2##4##(2008-6#2)
production of##767##2##(1990-11#1)(1990-12#4)(1990-2#4)(1990-5#3)(1990-7#3)(1990-8#6)(1991-1#1)(1991-11#1)(1991-12#10)(1991-3#2)(1991-5#3)(1991-6#1)(1991-9#5)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#1)(1992-8#3)(1992-9#6)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#14)(1994-12#8)(1994-2#6)(1994-3#2)(1994-5#6)(1994-6#5)(1994-8#6)(1994-9#4)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#13)(1997-6#2)(1997-7#4)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#127)(2008-11#137)(2008-12#18)(2008-2#13)(2008-3#6)(2008-4#22)(2008-5#15)(2008-6#40)(2008-7#32)(2008-8#12)(2008-9#9)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#22)(2011-3#4)(2012-1#1)(2012-12#2)(2012-2#15)(2012-3#9)(2012-7#1)(2013-1#14)(2013-7#1)(2013-8#9)
production ofinterferon-beta##2##2##(2008-11#2)
production on the##3##3##(2008-10#3)
production on##10##2##(2008-10#5)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-3#1)
production only##2##2##(2008-11#1)(2008-6#1)
production or to##2##3##(1994-9#1)(2008-3#1)
production or##11##2##(1992-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)
production over##2##2##(2008-7#1)(2010-10#1)
production per cell##2##3##(1994-2#1)(2008-9#1)
production per lesion##3##3##(2008-10#3)
production per##11##2##(1992-12#1)(1994-2#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-9#1)
production period##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
production phase##9##2##(2008-11#7)(2008-7#2)
production plant and the##2##4##(2012-2#2)
production plant##8##2##(2008-10#4)(2012-1#1)(2012-2#3)
production plants##2##2##(2008-10#1)(2012-2#1)
production platform for##2##3##(2008-11#2)
production procedures##2##2##(2008-10#1)(2008-5#1)
production process was##2##3##(2008-11#2)
production process##24##2##(1993-3#1)(2008-10#2)(2008-11#7)(2008-5#1)(2008-6#3)(2008-7#1)(2011-2#1)(2012-2#6)(2012-3#1)(2013-8#1)
production processes and the##2##4##(2008-11#1)(2008-5#1)
production processes and##4##3##(1996-2#1)(2008-11#1)(2008-5#1)(2012-2#1)
production processes are##2##3##(2008-11#2)
production processes##12##2##(1996-2#1)(2008-10#2)(2008-11#5)(2008-5#1)(2012-2#2)(2013-8#1)
production rate and egg number##2##5##(2008-12#2)
production rate and##4##3##(2008-11#1)(2008-12#2)(2008-8#1)
production rate from##2##3##(2008-11#1)(2008-6#1)
production rate in the##2##4##(2008-11#2)
production rate increased##2##3##(2008-11#1)(2013-1#1)
production rate of the##2##4##(1994-3#1)(2008-11#1)
production rate of##6##3##(1994-3#1)(1997-5#1)(2008-11#2)(2008-6#1)(2011-2#1)
production rate per cell##2##4##(2008-11#2)
production rate per##3##3##(2008-10#1)(2008-11#2)
production rate was##5##3##(1994-3#1)(2008-11#3)(2013-1#1)
production rate##37##2##(1994-3#2)(1994-8#1)(1997-5#1)(2008-10#1)(2008-11#19)(2008-12#2)(2008-6#4)(2008-7#2)(2008-8#2)(2011-2#1)(2013-1#2)
production rates of##2##3##(2008-11#2)
production rates were##5##3##(1994-3#1)(2008-11#2)(2008-7#1)(2013-1#1)
production rates##15##2##(1994-2#1)(1994-3#1)(2008-11#8)(2008-12#1)(2008-7#2)(2008-8#1)(2013-1#1)
production reached##2##2##(2008-12#1)(2008-6#1)
production region##2##2##(2008-10#2)
production requires##2##2##(2008-11#2)
production samples##3##2##(2008-10#3)
production significantly##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)
production situations and##2##3##(2008-10#2)
production situations##4##2##(2008-10#4)
production system as well as##2##5##(1991-12#1)(2008-11#1)
production system for##3##3##(2008-11#1)(2008-9#2)
production system##22##2##(1991-12#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#3)(2011-2#1)(2012-1#3)(2013-1#1)
production systems for##2##3##(1997-4#1)(2008-11#1)
production systems##19##2##(1997-4#1)(2008-10#11)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#3)
production techniques##4##2##(2008-10#3)(2011-2#1)
production through##3##2##(1995-11#1)(2008-11#1)(2010-10#1)
production to control##2##3##(2008-10#2)
production to the##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
production to##9##2##(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)
production trial##5##2##(2013-8#5)
production under##5##2##(1992-9#1)(1994-11#1)(2008-12#1)(2009-10#1)(2011-1#1)
production using the##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
production using##16##2##(1994-8#1)(1995-11#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2011-2#1)(2013-1#1)
production via the##2##3##(1991-3#1)(2008-4#1)
production via##9##2##(1991-3#2)(1993-11#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-11#1)(2013-1#1)
production was achieved##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
production was also##3##3##(2008-10#2)(2008-7#1)
production was determined##2##3##(2008-11#1)(2008-6#1)
production was enhanced by##2##4##(1995-3#1)(1996-12#1)
production was enhanced##3##3##(1995-3#1)(1996-12#1)(2008-11#1)
production was found##3##3##(1991-12#1)(1994-5#1)(2008-8#1)
production was highest##2##3##(2007-7#1)(2008-10#1)
production was measured using##2##4##(2008-10#1)(2008-11#1)
production was measured##5##3##(1991-9#1)(2008-10#2)(2008-11#1)(2008-12#1)
production was not affected##2##4##(1996-2#1)(2008-11#1)
production was not##6##3##(1996-2#1)(2008-10#1)(2008-11#4)
production was observed##4##3##(2008-10#1)(2008-11#2)(2008-6#1)
production was reduced by##3##4##(1997-1#1)(2008-10#2)
production was reduced##4##3##(1997-1#1)(1997-6#1)(2008-10#2)
production was seen##2##3##(1994-5#1)(2008-5#1)
production was similar##3##3##(2008-10#2)(2008-11#1)
production was##97##2##(1990-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#2)(1995-3#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-5#1)(2007-7#3)(2008-10#29)(2008-11#22)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#4)
production were evaluated##2##3##(2008-10#2)
production were investigated##3##3##(1997-1#1)(2008-11#1)(2013-1#1)
production were obtained by##2##4##(2008-10#2)
production were obtained##3##3##(2008-10#2)(2008-11#1)
production were studied##2##3##(1993-3#1)(1997-2#1)
production were##28##2##(1991-3#1)(1993-3#1)(1997-1#1)(1997-2#1)(2008-10#14)(2008-11#4)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
production when##4##2##(1996-12#1)(1997-2#1)(2008-6#1)(2011-2#1)
production while##2##2##(2008-11#2)
production with Candida boidinii##2##4##(2008-7#2)
production with##15##2##(1991-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
production without##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
production yield##5##2##(2008-11#2)(2008-6#1)(2013-1#2)
production yields##2##2##(1993-12#1)(2013-1#1)
production##2556##1##(1990-11#7)(1990-12#9)(1990-2#10)(1990-3#2)(1990-4#1)(1990-5#7)(1990-7#3)(1990-8#8)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#21)(1991-2#4)(1991-3#12)(1991-5#14)(1991-6#1)(1991-7#2)(1991-8#11)(1991-9#12)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#17)(1992-2#6)(1992-3#7)(1992-5#4)(1992-6#3)(1992-8#8)(1992-9#16)(1993-11#9)(1993-12#4)(1993-2#1)(1993-3#9)(1993-5#1)(1993-6#10)(1993-8#5)(1993-9#9)(1994-11#32)(1994-12#10)(1994-2#11)(1994-3#13)(1994-5#18)(1994-6#9)(1994-8#17)(1994-9#9)(1995-11#8)(1995-12#9)(1995-2#11)(1995-3#8)(1995-5#7)(1995-6#6)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#13)(1996-2#17)(1996-5#15)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#5)(1997-1#9)(1997-2#5)(1997-3#7)(1997-4#23)(1997-5#1)(1997-6#6)(1997-7#8)(1997-8#2)(2006-10#4)(2006-6#3)(2007-10#2)(2007-11#9)(2007-12#17)(2007-2#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#14)(2008-10#518)(2008-11#449)(2008-12#53)(2008-2#23)(2008-3#21)(2008-4#66)(2008-5#63)(2008-6#109)(2008-7#102)(2008-8#49)(2008-9#31)(2009-10#6)(2009-12#6)(2009-2#4)(2009-3#7)(2009-4#4)(2009-5#6)(2009-6#12)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#7)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#9)(2010-5#8)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#33)(2011-10#2)(2011-2#81)(2011-3#7)(2012-1#10)(2012-12#7)(2012-2#62)(2012-3#25)(2012-4#1)(2012-7#4)(2013-1#88)(2013-7#2)(2013-8#36)
production)##7##1##(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2012-3#1)
productions##8##1##(1992-12#1)(2008-11#3)(2010-10#1)(2011-2#1)(2012-3#2)
productive and##4##2##(1996-1#1)(2008-5#1)(2010-7#1)(2013-1#1)
productive areas##2##2##(2008-10#1)(2008-9#1)
productive binding mode##2##3##(1990-7#1)(1994-5#1)
productive binding modes##2##3##(1990-7#2)
productive binding of##2##3##(1992-6#1)(1993-8#1)
productive binding##6##2##(1990-7#3)(1992-6#1)(1993-8#1)(1994-5#1)
productive cell##2##2##(1992-8#1)(2008-11#1)
productive cough##3##2##(1991-8#1)(2008-1#2)
productive patches##3##2##(2008-9#3)
productive substrate binding##2##3##(1991-5#1)(1994-8#1)
productive tree holes##2##3##(2008-9#2)
productive##65##1##(1990-7#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-8#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-1#2)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#3)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#8)(2010-12#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#3)
productively##4##1##(1994-2#1)(1996-6#1)(1997-9#1)(2010-3#1)
productivities in##2##2##(2008-11#1)(2008-7#1)
productivities of##2##2##(1997-4#1)(2008-6#1)
productivities##15##1##(1997-4#1)(2008-11#4)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)
productivity and efficiency##2##3##(1993-3#1)(2007-9#1)
productivity and the##3##3##(2008-11#2)(2008-8#1)
productivity and turnover rate##2##4##(2008-5#2)
productivity and##30##2##(1990-9#1)(1991-2#1)(1993-3#1)(1994-12#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#8)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-5#1)
productivity as##4##2##(2008-11#2)(2008-6#2)
productivity because##2##2##(2008-11#1)(2008-9#1)
productivity but##2##2##(2008-8#2)
productivity by##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
productivity compared to##2##3##(2008-12#1)(2013-1#1)
productivity during##2##2##(2008-11#1)(2008-7#1)
productivity for##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
productivity from##3##2##(2008-6#1)(2008-9#1)(2010-6#1)
productivity gradient##4##2##(2008-8#1)(2008-9#3)
productivity in CHO##2##3##(2008-11#2)
productivity in terms of##2##4##(2008-11#1)(2009-4#1)
productivity in the##5##3##(1991-12#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
productivity in##27##2##(1990-11#1)(1991-12#1)(1992-2#1)(1992-6#1)(1997-1#2)(2007-5#1)(2008-11#11)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#2)
productivity increased##2##2##(2008-11#2)
productivity is##7##2##(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#1)
productivity of 0##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
productivity of 2##2##3##(2008-11#1)(2013-1#1)
productivity of 293##2##3##(2008-11#2)
productivity of hybridoma##2##3##(2008-11#2)
productivity of recombinant##5##3##(2008-11#5)
productivity of the##8##3##(2007-5#2)(2008-10#1)(2008-11#3)(2008-7#1)(2010-8#1)
productivity of##56##2##(1991-3#1)(1995-3#1)(1997-4#1)(2007-5#2)(2008-10#3)(2008-11#27)(2008-12#2)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#2)(2010-8#1)(2012-1#1)(2012-9#1)(2013-1#2)
productivity or##3##2##(1992-3#1)(2008-11#1)(2013-1#1)
productivity rate of##3##3##(2008-11#3)
productivity rate##6##2##(2008-11#6)
productivity was##13##2##(1993-2#1)(2008-11#6)(2008-6#4)(2008-7#1)(2011-2#1)
productivity while##2##2##(1995-1#1)(2008-10#1)
productivity##315##1##(1990-11#1)(1990-9#1)(1991-12#4)(1991-2#4)(1991-3#2)(1992-2#3)(1992-3#4)(1992-6#1)(1993-1#1)(1993-2#4)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-2#2)(1997-1#2)(1997-4#1)(1997-6#1)(2007-4#3)(2007-5#6)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#110)(2008-12#6)(2008-4#1)(2008-5#4)(2008-6#18)(2008-7#18)(2008-8#22)(2008-9#22)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#17)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-9#1)(2013-1#7)
productivity)##3##1##(1993-2#1)(2008-8#1)(2008-9#1)
products (p &lt##2##3##(2008-12#2)
products (p##3##2##(2008-12#2)(2011-2#1)
products against##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
products and in the##3##4##(1990-6#1)(2008-10#1)(2009-10#1)
products and services##5##3##(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#2)
products and the##9##3##(1993-11#2)(1994-2#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-3#1)
products and their##6##3##(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-5#2)
products and##73##2##(1990-6#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#19)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
products are also##2##3##(2008-2#1)(2010-7#1)
products are applied in##2##4##(2008-10#1)(2008-5#1)
products are being##2##3##(2007-12#1)(2011-2#1)
products are in good agreement with those obtained by##2##9##(2008-10#2)
products are in##4##3##(1991-12#1)(2008-10#3)
products are known to##2##4##(2007-12#1)(2008-5#1)
products are needed for##2##4##(2007-12#1)(2012-2#1)
products are to##2##3##(2008-10#1)(2012-2#1)
products are used##2##3##(1990-2#1)(2011-2#1)
products are##61##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-8#3)(1994-9#1)(1996-12#2)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#5)
products arising from##2##3##(1994-12#1)(2008-10#1)
products as a##2##3##(1997-2#1)(2008-6#1)
products as well##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
products as##11##2##(1994-8#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#2)(2013-7#1)
products at the##2##3##(2008-8#1)(2013-1#1)
products at##7##2##(1996-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
products based on##2##3##(2008-5#2)
products become##2##2##(2007-12#1)(2012-2#1)
products before##2##2##(1995-5#1)(2008-2#1)
products by HPLC##2##3##(1994-11#1)(2008-10#1)
products by high-performance liquid chromatography##2##5##(1992-11#1)(2008-5#1)
products by##25##2##(1990-11#1)(1990-9#1)(1992-11#2)(1992-5#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2010-4#1)
products can be##6##3##(1992-5#1)(2008-2#2)(2008-5#3)
products can##9##2##(1992-5#1)(1995-2#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)
products confirmed##2##2##(2008-5#1)(2009-11#1)
products consisting of##2##3##(2008-10#1)(2012-2#1)
products consumption (p = 0##2##5##(2011-2#2)
products contained##2##2##(1994-8#1)(2009-5#1)
products containing##8##2##(1991-12#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
products could be##2##3##(2008-11#1)(2009-12#1)
products derived from##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
products during##4##2##(1997-6#1)(2007-12#1)(2008-10#1)(2013-1#1)
products except##2##2##(2007-6#2)
products faster##2##2##(2008-11#1)(2008-5#1)
products for a##2##3##(2008-11#1)(2008-5#1)
products for the##4##3##(1992-3#1)(1996-7#1)(2008-11#1)(2008-5#1)
products for##24##2##(1990-12#1)(1992-3#1)(1993-12#1)(1996-7#1)(1997-4#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#1)(2010-5#1)(2012-2#1)
products formed##5##2##(1990-7#1)(1992-2#1)(2008-10#2)(2008-7#1)
products from a##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
products from different##2##3##(1997-8#1)(2008-8#1)
products from the##9##3##(1990-11#1)(1992-3#1)(1994-9#1)(1997-6#1)(2008-10#3)(2008-11#1)(2009-10#1)
products from##34##2##(1990-11#2)(1990-8#1)(1991-9#2)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-8#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
products generated by##2##3##(2008-10#2)
products generated##4##2##(1995-3#1)(2008-10#3)
products had a##3##3##(1997-2#1)(2008-5#1)(2011-2#1)
products has been##2##3##(1996-5#1)(2008-10#1)
products has##3##2##(1996-5#1)(2008-1#1)(2008-10#1)
products have a##4##3##(1991-6#1)(2008-12#1)(2008-3#1)(2008-5#1)
products have been identified##2##4##(2008-10#1)(2008-8#1)
products have been##9##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#2)
products have##20##2##(1991-6#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-7#2)(2012-2#2)
products having##2##2##(1995-9#1)(2008-5#1)
products in a##2##3##(2008-10#1)(2008-5#1)
products in an##2##3##(1996-12#1)(2008-3#1)
products in the##18##3##(1990-5#1)(1993-5#1)(1994-5#1)(1997-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)(2013-8#2)
products in##64##2##(1990-5#1)(1991-3#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#15)(2008-11#4)(2008-3#2)(2008-5#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#3)
products including##4##2##(2008-10#3)(2008-5#1)
products involved in the##2##4##(1996-3#1)(2009-5#1)
products involved in##4##3##(1995-9#1)(1996-3#1)(2008-10#1)(2009-5#1)
products is##20##2##(1990-7#1)(1992-2#1)(1993-11#1)(1994-11#1)(1995-9#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-11#1)
products it##2##2##(1996-3#1)(2008-5#1)
products like##3##2##(2008-10#2)(2010-4#1)
products may be##2##3##(1990-5#1)(2007-11#1)
products may not##2##3##(2008-6#1)(2009-6#1)
products may##8##2##(1990-5#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-6#1)(2009-5#1)(2009-6#1)
products more##3##2##(1996-5#1)(2008-10#1)(2012-2#1)
products must##2##2##(1995-5#1)(2013-1#1)
products observed during##2##3##(1993-8#2)
products observed##3##2##(1993-8#2)(2008-10#1)
products of an##3##3##(1993-12#1)(1997-8#1)(2008-4#1)
products of incomplete combustion are##2##5##(1996-12#2)
products of incomplete combustion##3##4##(1996-12#3)
products of organophosphorous##2##3##(2010-5#2)
products of the reaction##2##4##(2008-10#2)
products of the##31##3##(1990-7#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(2008-10#11)(2008-11#2)(2008-7#2)(2009-5#1)
products of these##2##3##(1991-12#1)(1994-8#1)
products of two##3##3##(1995-8#1)(2008-10#1)(2008-2#1)
products of##124##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#5)(1991-3#2)(1991-5#1)(1991-9#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#4)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#2)(1996-12#5)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#1)(2012-1#1)(2013-8#2)
products on a##3##3##(2006-12#1)(2008-10#1)(2008-8#1)
products on the basis of##2##5##(2008-10#1)(2008-5#1)
products on the market##2##4##(2008-11#1)(2013-8#1)
products on the##7##3##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
products on##14##2##(1994-3#1)(1995-2#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-8#1)
products or services##2##3##(1994-3#1)(1995-3#1)
products or##15##2##(1993-6#1)(1994-3#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
products provide##2##2##(2008-3#1)(2008-5#1)
products quality##2##2##(2008-12#1)(2012-2#1)
products released##3##2##(1994-12#1)(2008-10#2)
products resulting from##2##3##(2007-12#1)(2008-10#1)
products revealed##4##2##(1993-11#1)(1995-12#1)(1996-5#1)(2009-8#1)
products should##2##2##(1996-5#1)(2011-2#1)
products showed##3##2##(2007-6#1)(2008-12#1)(2011-2#1)
products such as##9##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)
products suggests##2##2##(1993-12#1)(1995-2#1)
products tested##3##2##(1997-2#1)(2007-6#2)
products than##2##2##(2008-6#1)(2008-7#1)
products that are##5##3##(1990-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
products that were##3##3##(1995-12#1)(2008-10#2)
products that##20##2##(1990-5#1)(1992-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2009-6#1)(2010-12#1)
products to be##2##3##(1996-3#1)(2011-2#1)
products to the##2##3##(2008-11#1)(2008-9#1)
products to##13##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
products typically##2##2##(2008-5#1)(2008-7#1)
products using##10##2##(1994-6#1)(1996-2#1)(2008-10#4)(2008-5#4)
products varied##2##2##(2008-10#1)(2008-6#1)
products was##12##2##(1992-9#1)(1996-12#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-5#3)(2011-2#1)(2013-1#1)
products were analyzed##2##3##(1991-2#1)(2008-10#1)
products were detected by##2##4##(2008-12#1)(2008-4#1)
products were detected##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
products were determined##2##3##(1992-5#1)(2011-2#1)
products were found##2##3##(1990-12#1)(1997-3#1)
products were identified as##2##4##(1994-6#1)(1995-6#1)
products were identified by##3##4##(1991-2#1)(2008-10#1)(2008-7#1)
products were identified##6##3##(1991-2#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-7#1)
products were observed##5##3##(1990-7#1)(1992-10#1)(2008-10#2)(2010-4#1)
products were obtained##2##3##(1995-6#1)(2007-11#1)
products were separated and##2##4##(1991-5#1)(2008-10#1)
products were separated on##2##4##(2007-7#1)(2011-1#1)
products were separated##5##3##(1991-5#1)(2007-7#1)(2008-10#2)(2011-1#1)
products were used to##2##4##(1992-8#1)(2008-10#1)
products were##71##2##(1990-12#1)(1990-7#2)(1991-2#2)(1991-5#1)(1992-10#1)(1992-5#2)(1992-8#2)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#3)(1996-1#1)(1997-3#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
products which##6##2##(1994-11#1)(1994-8#1)(1996-6#1)(1997-4#1)(2008-5#2)
products whose##4##2##(1994-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
products with a new##2##4##(2008-10#2)
products with a##5##3##(1996-12#1)(2008-10#3)(2013-1#1)
products with restriction enzymes##2##4##(1990-3#1)(2008-5#1)
products with the##3##3##(1996-1#1)(2008-10#2)
products with##24##2##(1990-2#1)(1990-3#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#4)(2009-10#1)(2009-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
products within##2##2##(2008-4#1)(2008-7#1)
products without##2##2##(2008-1#1)(2008-10#1)
products would##2##2##(1995-12#1)(2008-10#1)
products##1401##1##(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#10)(1991-2#3)(1991-3#5)(1991-5#4)(1991-6#1)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#6)(1992-2#6)(1992-3#5)(1992-4#1)(1992-5#7)(1992-6#5)(1992-7#1)(1992-8#10)(1992-9#1)(1993-11#10)(1993-12#6)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#5)(1994-1#2)(1994-11#8)(1994-12#11)(1994-2#3)(1994-3#6)(1994-5#4)(1994-6#5)(1994-8#16)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#13)(1995-3#7)(1995-5#5)(1995-6#9)(1995-8#5)(1995-9#3)(1996-1#2)(1996-12#19)(1996-2#2)(1996-3#5)(1996-5#22)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#13)(1997-3#8)(1997-4#8)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#4)(2007-10#1)(2007-11#8)(2007-12#18)(2007-4#1)(2007-6#10)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#9)(2008-10#339)(2008-11#57)(2008-12#11)(2008-2#17)(2008-3#22)(2008-4#30)(2008-5#155)(2008-6#22)(2008-7#34)(2008-8#21)(2008-9#11)(2009-10#5)(2009-11#10)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#6)(2010-3#3)(2010-4#19)(2010-5#6)(2010-6#1)(2010-7#9)(2010-8#5)(2010-9#3)(2011-1#19)(2011-2#48)(2011-3#3)(2012-1#5)(2012-12#7)(2012-2#41)(2012-3#8)(2013-1#23)(2013-7#1)(2013-8#9)
products'##2##1##(2008-5#2)
products) were##2##2##(2008-10#1)(2008-2#1)
products)##5##1##(2006-10#1)(2008-10#3)(2008-2#1)
products]##3##1##(1991-2#1)(1993-11#1)(2010-3#1)
producís##2##1##(2013-8#2)
produits secondaires##2##2##(2008-5#2)
produits##9##1##(2008-5#9)
proefferalgan##2##1##(2007-11#2)
proenzyme##3##1##(1992-11#1)(1992-12#1)(1997-2#1)
proenzymes##3##1##(1994-5#1)(1995-6#1)(2013-1#1)
profession and the##2##3##(2009-10#1)(2012-3#1)
profession and##8##2##(1991-3#1)(1992-2#1)(1993-1#1)(1994-12#1)(2007-12#1)(2008-12#1)(2009-10#1)(2012-3#1)
profession as##2##2##(1995-1#1)(2008-11#1)
profession for##2##2##(1993-1#1)(2011-2#1)
profession has##3##2##(1991-3#2)(2007-10#1)
profession in##2##2##(1993-2#1)(2008-1#1)
profession is##5##2##(1994-12#2)(1996-3#1)(2011-1#1)(2012-3#1)
profession needs to##2##3##(2008-7#1)(2013-1#1)
profession of##4##2##(1994-12#1)(1996-1#1)(2008-10#1)(2008-12#1)
profession that##2##2##(1993-12#1)(2008-1#1)
profession##106##1##(1990-2#1)(1991-11#1)(1991-2#3)(1991-3#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#9)(1994-2#1)(1994-3#1)(1995-1#4)(1995-11#1)(1995-2#2)(1996-1#4)(1996-11#1)(1996-2#1)(1996-3#3)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#10)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#8)(2013-1#3)
profession's##5##1##(1992-12#2)(1993-2#1)(2008-12#1)(2008-4#1)
profession]##2##1##(1990-8#1)(1995-8#1)
professional and legal issues in nursing##2##6##(2008-11#2)
professional and personal##3##3##(1994-1#1)(2012-1#1)(2013-8#1)
professional and##24##2##(1991-12#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
professional antigen presenting cells##2##4##(2010-8#1)(2013-1#1)
professional associations and private training and development corporations##2##8##(1993-3#1)(1997-3#1)
professional associations##7##2##(1993-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-12#1)(2011-1#1)
professional attitude##6##2##(1990-2#5)(2008-10#1)
professional backgrounds##2##2##(1996-12#1)(2008-11#1)
professional bodies##3##2##(1994-2#1)(2007-2#1)(2008-11#1)
professional boundaries##3##2##(2008-11#2)(2008-12#1)
professional bullfighters##2##2##(2008-3#2)
professional challenge##3##2##(1992-3#1)(1996-1#1)(1997-1#1)
professional characteristics##2##2##(1992-3#1)(1994-3#1)
professional competence##2##2##(1993-3#1)(2008-12#1)
professional confidence as perceived by##2##5##(2008-11#1)(2008-12#1)
professional confidence as##3##3##(2008-11#1)(2008-12#2)
professional confidence in nursing##2##4##(2008-11#1)(2008-12#1)
professional confidence is##2##3##(2008-11#2)
professional confidence##11##2##(2008-11#7)(2008-12#4)
professional development and##3##3##(2008-11#1)(2012-1#1)(2013-8#1)
professional development in##2##3##(2008-11#1)(2010-9#1)
professional development of the##2##4##(2008-12#2)
professional development of##5##3##(2007-10#1)(2008-12#2)(2010-9#1)(2013-1#1)
professional development programs##2##3##(2010-5#2)
professional development##32##2##(1993-1#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-11#12)(2008-12#2)(2008-6#1)(2009-10#1)(2010-10#1)(2010-5#3)(2010-9#2)(2012-1#1)(2013-1#2)(2013-8#2)
professional doctorates##3##2##(2013-8#3)
professional education in##4##3##(1996-1#1)(1997-3#1)(2008-12#1)(2008-3#1)
professional education##15##2##(1993-1#1)(1994-12#2)(1996-1#2)(1997-3#2)(2007-11#1)(2008-11#1)(2008-12#3)(2008-3#1)(2010-3#1)(2010-5#1)
professional experience##3##2##(1994-3#1)(2008-9#1)(2010-5#1)
professional factors##2##2##(1991-4#1)(2009-7#1)
professional group##2##2##(1993-6#1)(2011-2#1)
professional groups##2##2##(1994-3#1)(1996-2#1)
professional health##2##2##(1994-1#1)(2008-2#1)
professional history##2##2##(2008-11#1)(2008-12#1)
professional image##2##2##(1993-3#2)
professional journals##2##2##(1995-12#1)(2011-2#1)
professional knowledge and##3##3##(1993-3#1)(1997-3#1)(2010-10#1)
professional knowledge##8##2##(1993-3#1)(1997-3#1)(2008-11#2)(2009-10#2)(2010-10#1)(2010-5#1)
professional learning##4##2##(2008-11#1)(2008-12#3)
professional liability insurance policy##2##4##(1993-3#2)
professional liability insurance##4##3##(1992-2#1)(1993-1#1)(1993-3#2)
professional liability##13##2##(1991-3#4)(1992-2#1)(1993-1#3)(1993-3#3)(1994-1#1)(1997-3#1)
professional life##2##2##(2008-2#1)(2012-3#1)
professional literature##2##2##(1995-12#1)(2007-11#1)
professional lives##2##2##(2008-11#2)
professional management##2##2##(1993-3#1)(1997-2#1)
professional misconduct##2##2##(2008-12#2)
professional norms##2##2##(1993-3#1)(2008-12#1)
professional nurses in##2##3##(2008-10#1)(2008-12#1)
professional nurses##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
professional nursing journals##2##3##(2010-11#2)
professional nursing##8##2##(1991-2#2)(2008-11#1)(2010-10#1)(2010-11#2)(2013-1#2)
professional opinion##2##2##(1994-3#1)(1996-9#1)
professional organizations##10##2##(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-2#1)
professional paper##26##2##(1991-1#2)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#4)(1994-3#9)(1996-1#2)(1996-3#2)(1997-1#4)
professional practice and##2##3##(2008-1#1)(2008-8#1)
professional practice##21##2##(1991-3#1)(1997-7#1)(2008-1#3)(2008-10#1)(2008-11#7)(2008-12#3)(2008-8#3)(2013-1#2)
professional practices and##2##3##(2008-11#2)
professional practices##5##2##(2007-10#1)(2008-11#3)(2009-6#1)
professional profile##9##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1995-12#1)(2008-10#1)(2012-2#1)
professional public##2##2##(1991-3#1)(2010-8#1)
professional qualifications##2##2##(1990-12#2)
professional relationships##5##2##(2007-5#1)(2008-7#2)(2008-8#1)(2010-1#1)
professional resources##2##2##(1996-1#1)(2012-1#1)
professional role##4##2##(1996-2#1)(2008-11#2)(2010-10#1)
professional satisfaction##2##2##(2010-2#1)(2010-5#1)
professional self-esteem##2##2##(2008-11#2)
professional service firms##2##3##(1993-1#2)
professional service##3##2##(1993-1#2)(1994-12#1)
professional should##2##2##(1993-1#1)(2008-7#1)
professional skill##3##2##(2008-12#1)(2010-4#1)(2012-3#1)
professional skills##6##2##(1993-6#2)(2007-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
professional society##3##2##(2008-5#1)(2012-1#1)(2012-2#1)
professional staff time##2##3##(1995-3#2)
professional staff##12##2##(1991-12#2)(1993-2#1)(1994-2#1)(1995-3#2)(2008-7#1)(2008-8#3)(2012-12#1)(2012-3#1)
professional support##5##2##(1992-3#2)(1993-2#1)(2013-1#2)
professional to##4##2##(1992-1#1)(1992-3#1)(1997-1#1)(2008-3#1)
professional training##3##2##(1990-12#1)(1992-3#1)(1995-1#1)
professional uncertainty##2##2##(1993-3#2)
professional who##2##2##(1992-1#1)(2012-3#1)
professional work hours##2##3##(2011-2#2)
professional work##10##2##(1990-6#1)(2007-11#1)(2008-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
professional##509##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#8)(1990-3#1)(1990-6#3)(1990-9#1)(1991-1#4)(1991-12#4)(1991-2#5)(1991-3#6)(1991-4#2)(1991-6#2)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#11)(1992-5#2)(1993-1#10)(1993-12#1)(1993-2#4)(1993-3#19)(1993-6#4)(1994-1#10)(1994-12#8)(1994-2#6)(1994-3#17)(1995-1#5)(1995-12#5)(1995-2#2)(1995-3#6)(1996-1#13)(1996-11#1)(1996-12#8)(1996-2#5)(1996-3#9)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#2)(1997-3#5)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#9)(2007-2#2)(2007-5#1)(2007-8#3)(2008-1#13)(2008-10#9)(2008-11#64)(2008-12#39)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#5)(2009-10#6)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#9)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#15)(2012-1#7)(2012-12#8)(2012-2#9)(2012-3#7)(2012-6#1)(2013-1#20)(2013-8#8)
professional's approach##2##2##(2011-2#2)
professional's##5##1##(1991-6#1)(2011-2#3)(2012-3#1)
professionalism within dental education##2##4##(2012-1#2)
professionalism##13##1##(1993-12#1)(1993-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2012-1#3)(2013-1#4)
professionalization##4##1##(1990-12#1)(1994-3#2)(2012-2#1)
professionally active##2##2##(1992-12#1)(2007-12#1)
professionally led##2##2##(1996-3#1)(2008-11#1)
professionally##9##1##(1991-3#1)(1992-12#1)(1993-3#1)(1996-3#1)(2007-12#1)(2008-11#1)(2011-1#1)(2013-8#2)
professionals &quot##2##2##(1993-2#2)
professionals about the##2##3##(1991-2#1)(2013-1#1)
professionals about##3##2##(1991-2#1)(2008-12#1)(2013-1#1)
professionals and##23##2##(1991-6#1)(1992-3#3)(1993-2#1)(1994-1#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)
professionals are##8##2##(1990-6#1)(1996-1#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-3#1)
professionals as##2##2##(1993-1#1)(2007-12#1)
professionals but##2##2##(1995-1#1)(1996-2#1)
professionals by##3##2##(1996-2#1)(2007-12#1)(2011-2#1)
professionals can##3##2##(1992-3#1)(2007-12#1)(2013-8#1)
professionals caring for##2##3##(1992-3#1)(2008-11#1)
professionals entering the##2##3##(2007-12#1)(2008-12#1)
professionals face##2##2##(1992-3#1)(1997-2#1)
professionals from##5##2##(1992-3#1)(1995-3#1)(2008-12#1)(2013-1#2)
professionals have##2##2##(1991-12#1)(1996-2#1)
professionals in health##2##3##(1996-1#1)(2010-2#1)
professionals in providing##2##3##(1993-12#1)(2008-4#1)
professionals in the##2##3##(2008-1#1)(2012-12#1)
professionals in##20##2##(1991-1#1)(1991-2#2)(1993-12#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(2008-1#2)(2008-12#1)(2008-4#2)(2008-7#2)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
professionals involved##2##2##(1992-1#1)(2008-2#1)
professionals is##7##2##(1992-3#1)(1994-1#1)(1996-1#1)(2008-12#1)(2013-1#3)
professionals may be##2##3##(1995-3#1)(1996-3#1)
professionals may##3##2##(1995-3#1)(1996-3#1)(2013-1#1)
professionals must##2##2##(1996-2#1)(2013-1#1)
professionals need to know##2##4##(1996-3#1)(2007-12#1)
professionals need to##5##3##(1994-3#1)(1996-3#1)(2007-12#1)(2008-9#1)(2010-4#1)
professionals need##6##2##(1993-1#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-9#1)(2010-4#1)
professionals of##4##2##(1994-1#2)(2008-12#1)(2009-10#1)
professionals or##2##2##(1996-1#1)(2011-2#1)
professionals should be aware##3##4##(2010-1#1)(2013-1#2)
professionals should##11##2##(1991-12#1)(1993-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-9#1)(2013-1#2)
professionals that##3##2##(1994-2#1)(2008-12#1)(2012-3#1)
professionals through##2##2##(2008-12#1)(2012-2#1)
professionals to adopt##2##3##(2008-11#1)(2013-1#1)
professionals to be##2##3##(2009-9#1)(2013-8#1)
professionals to use##2##3##(2007-4#1)(2008-11#1)
professionals to work##2##3##(2007-12#1)(2011-2#1)
professionals to##18##2##(1993-2#1)(1994-1#1)(1995-3#1)(1995-6#1)(2007-12#1)(2007-4#1)(2008-11#4)(2008-12#2)(2009-9#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
professionals towards##2##2##(2008-11#1)(2008-12#1)
professionals view their##2##3##(1993-2#1)(1994-3#1)
professionals was##2##2##(1994-1#1)(2009-5#1)
professionals who##10##2##(1991-12#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-4#1)(2010-1#2)(2011-2#1)
professionals with a##4##3##(1991-1#1)(1994-12#1)(2008-12#1)(2013-8#1)
professionals with the##2##3##(2007-12#1)(2011-2#1)
professionals with##6##2##(1991-1#1)(1994-12#1)(2007-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
professionals within##2##2##(1993-2#1)(2013-1#1)
professionals working in##4##3##(1991-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
professionals working with##6##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
professionals working##10##2##(1991-2#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
professionals##313##1##(1990-10#1)(1990-6#1)(1991-1#3)(1991-12#6)(1991-2#6)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#11)(1992-6#1)(1993-1#4)(1993-12#6)(1993-2#8)(1993-3#1)(1993-6#1)(1994-1#9)(1994-12#6)(1994-2#1)(1994-3#4)(1994-6#1)(1995-1#4)(1995-2#1)(1995-3#8)(1995-5#2)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-8#1)(2007-12#12)(2007-2#3)(2007-4#1)(2007-7#1)(2008-1#8)(2008-10#3)(2008-11#30)(2008-12#19)(2008-2#4)(2008-3#6)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#6)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#8)(2013-1#26)(2013-8#7)
professionals' approach towards them##5##4##(2011-2#5)
professionals' approach##7##2##(2011-2#7)
professionals' attitudes##2##2##(1994-3#1)(2010-10#1)
professionals'##15##1##(1993-12#1)(1994-1#1)(1994-3#1)(2007-11#1)(2007-2#1)(2010-10#1)(2011-2#7)(2012-12#1)(2013-1#1)
professions to##2##2##(1995-1#1)(2013-1#1)
professions##33##1##(1991-6#2)(1992-1#2)(1992-3#1)(1995-1#2)(1995-2#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-12#4)(2009-10#1)(2009-5#1)(2010-3#1)(2012-2#2)(2012-3#4)(2013-1#1)
professor of clinical##2##3##(1997-5#1)(2007-5#1)
professor of##8##2##(1993-3#1)(1997-5#1)(2007-12#2)(2007-5#3)(2010-7#1)
professor##17##1##(1993-2#1)(1993-3#1)(1997-5#1)(2007-12#2)(2007-5#4)(2008-10#2)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
professors of##3##2##(1990-12#1)(1993-6#1)(2010-1#1)
professors##10##1##(1990-12#1)(1993-6#1)(1995-2#1)(2007-8#1)(2010-1#1)(2012-2#2)(2012-3#3)
proficiency and##2##2##(2008-12#1)(2010-9#1)
proficiency of##2##2##(1992-12#1)(1996-6#1)
proficiency testing##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2012-2#1)
proficiency##21##1##(1992-12#1)(1994-3#1)(1995-3#2)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
proficient mentor##4##2##(2008-7#4)
proficient##10##1##(1992-3#1)(2007-12#1)(2008-3#1)(2008-7#6)(2009-5#1)
profile allows##2##2##(1996-1#1)(2007-12#1)
profile and a##2##3##(2008-10#1)(2008-2#1)
profile and clinical##2##3##(1996-8#1)(2013-1#1)
profile and for##2##3##(2008-10#1)(2011-2#1)
profile and its##3##3##(2008-7#2)(2010-11#1)
profile and the##10##3##(1990-8#1)(1995-11#1)(1995-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2013-1#1)
profile and##59##2##(1990-8#1)(1992-2#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
profile are##2##2##(2008-2#1)(2008-3#1)
profile as a##2##3##(2009-10#1)(2013-1#1)
profile as##5##2##(1995-5#1)(2008-10#1)(2008-3#1)(2009-10#1)(2013-1#1)
profile at a##2##3##(2007-11#1)(2008-2#1)
profile at##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
profile beam##3##2##(2008-3#3)
profile by##6##2##(1993-11#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#2)
profile can be determined##2##4##(2007-11#1)(2008-3#1)
profile can be##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
profile can##6##2##(1991-2#1)(1993-8#1)(1996-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
profile characteristics##3##2##(1996-2#1)(2008-10#1)(2008-3#1)
profile compared##2##2##(2008-10#1)(2012-12#1)
profile comparisons##3##2##(2008-10#1)(2008-4#2)
profile during the##3##3##(2008-1#1)(2010-10#2)
profile during##4##2##(2008-1#1)(2008-7#1)(2010-10#2)
profile for each##3##3##(1994-6#1)(2008-10#1)(2008-12#1)
profile for##14##2##(1990-2#1)(1992-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-6#1)
profile from an##2##3##(2008-10#1)(2008-3#1)
profile from the##2##3##(2008-3#2)
profile from##9##2##(1990-11#1)(2008-10#2)(2008-3#4)(2009-5#1)(2011-1#1)
profile if the##2##3##(2008-12#1)(2008-2#1)
profile if##3##2##(2008-12#1)(2008-2#2)
profile in a##4##3##(2007-12#1)(2008-3#2)(2009-1#1)
profile in patients with##2##4##(2007-10#1)(2011-2#1)
profile in the transverse and the longitudinal direction##2##8##(2008-3#2)
profile in the##15##3##(1996-12#1)(2007-12#1)(2008-2#6)(2008-3#5)(2012-2#1)(2013-8#1)
profile in##48##2##(1993-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#10)(2008-7#1)(2009-1#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
profile indicates##2##2##(1994-3#1)(2008-10#1)
profile is a##2##3##(2007-11#1)(2008-11#1)
profile is also##2##3##(2008-2#2)
profile is not##2##3##(1996-1#1)(2010-5#1)
profile is obtained##2##3##(2007-11#1)(2008-3#1)
profile is##33##2##(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#14)(2008-5#1)(2010-5#1)(2012-3#1)
profile likelihood##2##2##(1994-11#1)(2011-2#1)
profile may##2##2##(2008-5#1)(2008-8#1)
profile measurement##3##2##(2008-3#3)
profile measurements##5##2##(2008-2#2)(2008-3#3)
profile observed##2##2##(1996-7#1)(2008-3#1)
profile obtained##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
profile of a laser##2##4##(2007-12#1)(2008-3#1)
profile of a##18##3##(1993-2#1)(1994-8#1)(1995-2#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#7)
profile of acute##2##3##(1992-3#1)(2009-12#1)
profile of an elderly population in Tabasco##2##7##(2012-12#2)
profile of an##5##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#2)
profile of different##2##3##(2008-10#1)(2008-2#1)
profile of high##2##3##(1995-3#1)(2008-3#1)
profile of patients with##2##4##(2009-5#1)(2012-3#1)
profile of patients##3##3##(2009-5#1)(2010-5#1)(2012-3#1)
profile of public##2##3##(1993-1#1)(2008-9#1)
profile of salivary gland tumours presenting to a##2##8##(2012-2#2)
profile of the drug##2##4##(1996-7#1)(2008-10#1)
profile of the##45##3##(1991-12#1)(1992-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
profile of these##2##3##(2007-11#1)(2008-11#1)
profile of this##3##3##(1991-6#1)(1993-12#1)(2008-8#1)
profile of tuberculosis in##2##4##(2012-3#1)(2013-1#1)
profile of tuberculosis##3##3##(2012-3#1)(2013-1#2)
profile of##239##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-12#2)(1993-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1997-3#1)(2006-4#2)(2007-11#8)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#23)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#8)(2012-4#1)(2013-1#8)(2013-8#6)
profile on the##2##3##(2008-3#2)
profile on##3##2##(2008-3#2)(2008-7#1)
profile or##2##2##(2007-12#1)(2010-11#1)
profile retrieval##3##2##(2008-3#3)
profile sampler##3##2##(2010-5#3)
profile show##2##2##(2008-2#1)(2008-5#1)
profile showed##2##2##(2010-5#1)(2011-2#1)
profile shows##2##2##(1992-9#1)(2008-11#1)
profile similar to that##2##4##(2008-4#1)(2008-7#1)
profile similar to##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
profile than##3##2##(2008-11#1)(2008-12#1)(2012-12#1)
profile that is##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-11#1)
profile that##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-11#1)(2013-1#1)
profile the##2##2##(1994-12#1)(2009-6#1)
profile to a##2##3##(2008-10#1)(2008-7#1)
profile to##9##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-3#2)
profile was determined##2##3##(1997-4#1)(2009-3#1)
profile was studied##2##3##(2008-10#2)
profile was used##3##3##(2008-10#2)(2008-3#1)
profile was##24##2##(1990-7#1)(1990-8#1)(1992-3#1)(1993-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)
profile with a##2##3##(2007-11#1)(2008-2#1)
profile with an##3##3##(2008-2#2)(2008-3#1)
profile with the##6##3##(1990-12#1)(1996-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#1)
profile with##19##2##(1990-12#1)(1996-10#1)(1996-2#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-6#1)(2011-2#1)
profile within the##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
profile within##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
profile##845##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#6)(1991-6#3)(1991-8#2)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-8#5)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#6)(1995-5#2)(1995-8#3)(1996-1#5)(1996-10#3)(1996-12#6)(1996-2#6)(1996-3#5)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#5)(2006-4#2)(2006-9#1)(2007-10#1)(2007-11#29)(2007-12#28)(2007-2#2)(2007-5#1)(2007-7#5)(2007-8#5)(2008-1#5)(2008-10#70)(2008-11#21)(2008-12#13)(2008-2#63)(2008-3#149)(2008-4#12)(2008-5#23)(2008-6#6)(2008-7#34)(2008-8#11)(2008-9#10)(2009-1#2)(2009-10#9)(2009-11#4)(2009-12#2)(2009-3#3)(2009-5#4)(2009-6#3)(2009-7#2)(2009-9#1)(2010-10#4)(2010-11#8)(2010-12#4)(2010-3#3)(2010-4#8)(2010-5#13)(2010-6#3)(2010-7#2)(2011-1#10)(2011-2#25)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#18)(2012-3#16)(2012-4#2)(2012-6#1)(2013-1#30)(2013-7#1)(2013-8#8)
profiled##6##1##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)
profiler and##2##2##(2008-3#1)(2013-8#1)
profiler##7##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
profiles along##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
profiles among##2##2##(2008-10#1)(2011-2#1)
profiles and polarization characteristics of airborne lidar return signals##2##9##(2008-2#2)
profiles and the##6##3##(1994-8#1)(2008-10#2)(2008-2#2)(2008-8#1)
profiles and##39##2##(1990-8#1)(1994-6#1)(1994-8#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#7)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
profiles are analyzed##2##3##(1996-2#1)(2011-1#1)
profiles are consistent with##2##4##(1992-4#1)(1997-7#1)
profiles are obtained##2##3##(2008-2#1)(2008-3#1)
profiles are presented##2##3##(2008-3#2)
profiles are##33##2##(1990-12#1)(1992-4#1)(1994-2#3)(1996-2#2)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-7#3)(2008-8#1)(2011-1#2)(2012-3#1)
profiles as##2##2##(2008-10#1)(2011-1#1)
profiles at an##2##3##(2008-3#1)(2010-12#1)
profiles at##7##2##(2008-2#1)(2008-3#4)(2009-11#1)(2010-12#1)
profiles between the##2##3##(2008-10#1)(2008-3#1)
profiles between##5##2##(2008-10#3)(2008-3#2)
profiles by a##2##3##(2008-10#1)(2008-3#1)
profiles by use of##2##4##(2007-12#1)(2008-3#1)
profiles by##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
profiles can be##7##3##(1997-2#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-12#1)
profiles can##8##2##(1997-2#1)(2008-2#1)(2008-3#4)(2008-4#1)(2010-12#1)
profiles could##2##2##(2008-12#1)(2011-3#1)
profiles derived from##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
profiles did not##2##3##(2008-10#2)
profiles due to##2##3##(1992-8#1)(2012-3#1)
profiles for the##5##3##(1991-9#1)(2008-2#1)(2008-3#2)(2008-8#1)
profiles for##29##2##(1990-7#1)(1991-9#1)(1992-3#1)(1994-3#1)(1996-2#1)(1997-1#1)(2007-12#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#4)(2008-7#2)(2008-8#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#2)
profiles from other##2##3##(1996-2#1)(2010-11#1)
profiles from the##2##3##(2008-2#1)(2008-3#1)
profiles from##17##2##(1996-2#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2010-11#1)
profiles generated by##2##3##(1997-3#1)(2008-10#1)
profiles generated##3##2##(1997-3#1)(2008-10#1)(2008-3#1)
profiles have been##5##3##(1990-5#1)(1991-5#1)(2008-3#1)(2008-8#1)(2009-12#1)
profiles in a##3##3##(2008-2#1)(2008-3#2)
profiles in the##9##3##(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)
profiles in##36##2##(1991-12#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#12)(2008-5#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
profiles indicated that##2##3##(1990-12#1)(2008-10#1)
profiles is##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
profiles may##3##2##(2009-5#1)(2011-2#1)(2013-8#1)
profiles measured by the##2##4##(1996-7#1)(2008-2#1)
profiles measured by##3##3##(1996-7#1)(2008-10#1)(2008-2#1)
profiles measured##4##2##(1996-7#1)(2008-10#1)(2008-2#2)
profiles obtained by##8##3##(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#1)
profiles obtained were##2##3##(2008-5#1)(2010-5#1)
profiles obtained with##2##3##(2008-3#2)
profiles obtained##18##2##(1995-5#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2010-5#2)
profiles of a##4##3##(1995-8#1)(2008-7#1)(2008-8#1)(2009-6#1)
profiles of aerosol##2##3##(2008-3#2)
profiles of all##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
profiles of atmospheric##3##3##(2008-2#1)(2008-3#2)
profiles of cell##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
profiles of fiber gratings##2##4##(2008-3#2)
profiles of fragrance##2##3##(2008-5#2)
profiles of multiple##2##3##(1996-10#1)(2008-3#1)
profiles of pressure##3##3##(2008-3#3)
profiles of skeletal muscles##2##4##(2012-1#2)
profiles of the aerosol backscattering coefficient at 355 and 723##2##10##(2008-3#2)
profiles of the bacterial##2##4##(2008-10#1)(2008-7#1)
profiles of the lidar##2##4##(2008-2#2)
profiles of the scattering coefficient##2##5##(2008-3#2)
profiles of the two##3##4##(1992-8#1)(2008-11#1)(2009-6#1)
profiles of the various##2##4##(2008-5#1)(2008-9#1)
profiles of the##51##3##(1992-3#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-10#1)(2007-12#4)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#12)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)
profiles of these##2##3##(2008-12#1)(2012-2#1)
profiles of three different##2##4##(2008-10#1)(2008-11#1)
profiles of various##3##3##(2008-10#3)
profiles of##181##2##(1990-7#2)(1990-8#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#1)(1996-8#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#34)(2008-11#9)(2008-12#4)(2008-2#20)(2008-3#34)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#3)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#4)(2011-10#2)(2011-2#4)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)
profiles on the##2##3##(1993-1#1)(2008-10#1)
profiles on##5##2##(1993-1#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-1#1)
profiles presented##2##2##(2007-12#1)(2010-1#1)
profiles resulting from##2##3##(1997-7#1)(2008-2#1)
profiles retrieved##2##2##(2008-3#2)
profiles revealed##3##2##(2008-10#2)(2012-2#1)
profiles show that##2##3##(1994-9#1)(2008-3#1)
profiles showed that##5##3##(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)
profiles showed##7##2##(2008-10#3)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
profiles that were##4##3##(2008-10#1)(2008-12#2)(2008-7#1)
profiles that##8##2##(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-7#1)(2011-2#1)
profiles the##3##2##(2008-3#1)(2008-7#2)
profiles to##3##2##(1997-2#1)(2008-10#1)(2008-2#1)
profiles under##2##2##(2008-5#1)(2008-7#1)
profiles using a##2##3##(1992-1#1)(2007-12#1)
profiles using##5##2##(1991-9#1)(1992-1#1)(2007-12#1)(2008-10#1)(2012-3#1)
profiles was##5##2##(1991-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
profiles were also obtained##2##4##(2008-2#1)(2010-5#1)
profiles were also##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
profiles were found to be##3##5##(2008-10#2)(2010-3#1)
profiles were found to##4##4##(2008-10#3)(2010-3#1)
profiles were generated from##2##4##(2008-10#1)(2008-12#1)
profiles were generated##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
profiles were measured##4##3##(2008-11#1)(2008-3#1)(2008-7#2)
profiles were obtained for##3##4##(2008-10#2)(2008-12#1)
profiles were obtained##7##3##(2008-10#5)(2008-12#1)(2008-3#1)
profiles were seen##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
profiles were similar##2##3##(1996-12#1)(2011-10#1)
profiles were##52##2##(1990-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-3#4)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#2)(2011-10#1)(2013-1#1)
profiles with##8##2##(2008-2#2)(2008-3#4)(2011-1#1)(2011-2#1)
profiles##772##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#4)(1991-12#6)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-11#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#5)(1995-6#1)(1995-8#1)(1996-10#4)(1996-12#6)(1996-2#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#5)(1997-7#2)(1997-8#1)(2007-11#15)(2007-12#26)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#151)(2008-11#22)(2008-12#19)(2008-2#76)(2008-3#145)(2008-4#7)(2008-5#14)(2008-6#2)(2008-7#30)(2008-8#10)(2008-9#4)(2009-10#3)(2009-11#5)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#1)(2010-7#1)(2011-1#11)(2011-10#6)(2011-2#20)(2011-3#5)(2012-1#4)(2012-12#6)(2012-2#14)(2012-3#11)(2012-6#1)(2013-1#10)(2013-7#2)(2013-8#4)
profiles) and##2##2##(2008-4#1)(2012-3#1)
profiles)##3##1##(2008-10#1)(2008-4#1)(2012-3#1)
profiles]##2##1##(1990-2#1)(2011-3#1)
profilin II##2##2##(1994-8#2)
profilin##11##1##(1990-7#3)(1994-8#5)(2008-1#1)(2009-10#1)(2010-12#1)
profiling analysis##2##2##(2008-10#1)(2008-7#1)
profiling and its##2##3##(1995-11#1)(2008-7#1)
profiling and##6##2##(1995-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)
profiling by##3##2##(2008-3#1)(2008-4#1)(2010-3#1)
profiling can##2##2##(2008-12#1)(2012-12#1)
profiling data##5##2##(2008-2#1)(2008-7#3)(2009-10#1)
profiling has been##2##3##(1995-11#1)(2008-7#1)
profiling has##6##2##(1995-11#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-3#1)
profiling in the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
profiling in##8##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
profiling is##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
profiling method##2##2##(2008-10#1)(2008-3#1)
profiling of biological samples##2##4##(2008-4#1)(2008-7#1)
profiling of biological##3##3##(2008-4#1)(2008-7#1)(2010-5#1)
profiling of human##2##3##(2008-7#1)(2011-2#1)
profiling of optical fibers##2##4##(2007-11#2)
profiling of ultrafiltration was##2##4##(2008-1#2)
profiling of ultrafiltration##4##3##(2008-1#4)
profiling of##36##2##(2007-11#2)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
profiling studies##3##2##(2008-2#1)(2008-4#1)(2009-4#1)
profiling system##3##2##(1995-3#1)(2008-12#2)
profiling systems for##2##3##(2008-12#2)
profiling systems##6##2##(1996-1#2)(2008-12#4)
profiling techniques##3##2##(1997-2#1)(2008-7#2)
profiling that##2##2##(2008-10#1)(2008-4#1)
profiling to##2##2##(2008-12#1)(2008-7#1)
profiling using##5##2##(2008-1#1)(2008-10#1)(2008-4#2)(2009-6#1)
profiling was##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
profiling with##2##2##(2008-2#1)(2008-3#1)
profiling##148##1##(1993-3#1)(1995-11#2)(1995-2#1)(1995-3#2)(1996-1#2)(1997-2#1)(2007-11#2)(2008-1#5)(2008-10#19)(2008-11#6)(2008-12#11)(2008-2#12)(2008-3#8)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#22)(2008-8#1)(2009-10#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#7)(2010-3#2)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
profilins##3##1##(1990-7#1)(1994-8#2)
profilometer##10##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2009-7#1)
profilometric measurement##2##2##(2008-3#2)
profilometric##4##1##(2007-11#1)(2008-3#3)
profilometry (DDSP) are##2##3##(2008-3#2)
profilometry and##2##2##(2008-2#1)(2008-3#1)
profilometry based on##3##3##(2008-3#3)
profilometry by##3##2##(2007-12#1)(2008-3#2)
profilometry is##4##2##(2008-3#4)
profilometry##39##1##(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#30)
profit and##4##2##(1996-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
profit from##4##2##(1993-2#1)(1994-3#1)(2008-3#1)(2008-8#1)
profit per unit area##2##4##(2008-12#2)
profit rates##2##2##(1993-12#1)(1993-3#1)
profit##29##1##(1991-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-11#2)(1997-2#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#3)
profitability of##7##2##(1991-1#1)(1994-3#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-6#1)
profitability##18##1##(1991-1#2)(1992-3#1)(1994-3#1)(1995-1#2)(1995-3#3)(2008-11#7)(2008-12#1)(2008-6#1)
profitable features such as a##2##5##(2008-10#2)
profitable features such as##5##4##(2008-10#5)
profitable##13##1##(1994-3#1)(2007-11#1)(2008-10#10)(2008-9#1)
profitably##3##1##(1996-2#1)(2008-10#1)(2008-3#1)
profited from a##2##3##(2011-2#2)
profited from##3##2##(2011-2#2)(2012-2#1)
profits are##2##2##(1996-12#1)(1996-2#1)
profits in the##3##3##(1992-2#1)(1993-3#1)(2008-11#1)
profits##26##1##(1991-1#1)(1991-3#2)(1992-2#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(2007-4#1)(2008-11#3)(2008-7#2)(2010-5#2)(2013-1#1)
proflavine##4##1##(1991-12#2)(2008-10#2)
proform##2##1##(1995-6#1)(2008-4#1)
proforma##2##1##(1996-2#1)(2009-9#1)
profound and##5##2##(1992-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
profound changes in the##3##4##(1994-12#3)
profound changes in##4##3##(1994-12#3)(1994-3#1)
profound changes##6##2##(1994-12#3)(1994-3#1)(2008-5#2)
profound deafness##3##2##(2008-9#3)
profound effect on##7##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-6#1)
profound effects on the##4##4##(2008-8#1)(2010-1#1)(2010-3#1)(2010-8#1)
profound effects on##8##3##(1995-2#1)(2008-5#1)(2008-8#3)(2010-1#1)(2010-3#1)(2010-8#1)
profound effects##9##2##(1995-11#1)(1995-2#1)(2008-5#1)(2008-8#3)(2010-1#1)(2010-3#1)(2010-8#1)
profound hearing loss##8##3##(2008-9#7)(2012-2#1)
profound immune##2##2##(2008-4#1)(2011-2#1)
profound impact on the##2##4##(2008-11#1)(2010-11#1)
profound impact on##4##3##(1994-12#1)(2008-11#1)(2010-11#1)(2011-1#1)
profound implications for##2##3##(2008-8#1)(2009-9#1)
profound implications##3##2##(2008-11#1)(2008-8#1)(2009-9#1)
profound influence on##4##3##(2008-11#2)(2008-5#1)(2010-7#1)
profound sensorineural hearing loss##3##4##(2008-9#3)
profound##90##1##(1990-8#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#5)(2008-9#15)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
profoundly affect the##3##3##(1995-5#1)(1995-9#1)(1997-6#1)
profoundly affect##5##2##(1995-5#1)(1995-9#1)(1997-5#1)(1997-6#1)(2008-8#1)
profoundly affects##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
profoundly decreased##2##2##(2008-5#1)(2008-7#1)
profoundly hearing-impaired children##3##3##(2008-9#3)
profoundly suppress FN expression##2##4##(1994-9#2)
profoundly##34##1##(1990-8#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-12#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-9#1)(1997-5#1)(1997-6#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#6)(2010-2#1)(2011-2#5)
profunda arteries##2##2##(2008-7#2)
profunda##3##1##(2008-7#3)
profundal##2##1##(2008-5#2)
profundus##6##1##(2010-6#1)(2011-2#2)(2013-1#3)
profuse diarrhoea##2##2##(2008-5#2)
profuse##7##1##(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
profusion of##2##2##(2008-7#1)(2008-9#1)
progabide##2##1##(1997-8#2)
progelatinase A##3##2##(1994-5#3)
progenies from##2##2##(2008-10#2)
progenies of crosses##2##3##(2008-10#2)
progenies of##8##2##(2007-1#1)(2008-10#5)(2008-8#1)(2008-9#1)
progenies were##4##2##(2008-10#4)
progenies##33##1##(1996-6#1)(2006-12#1)(2007-1#2)(2008-10#18)(2008-11#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-8#1)(2012-3#1)
progenitor cell differentiation##2##3##(2008-10#1)(2012-8#1)
progenitor cell populations##3##3##(1995-6#1)(2008-4#1)(2008-9#1)
progenitor cell##14##2##(1992-5#1)(1994-10#1)(1995-6#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2012-12#1)(2012-8#1)(2013-1#1)
progenitor cells and##6##3##(1996-5#1)(2008-1#1)(2008-11#2)(2008-9#1)(2010-6#1)
progenitor cells are##4##3##(2008-11#1)(2008-9#1)(2009-12#1)(2012-12#1)
progenitor cells derived from##2##4##(2008-11#1)(2008-7#1)
progenitor cells from##4##3##(1996-5#2)(2008-11#2)
progenitor cells have##2##3##(2012-2#1)(2013-1#1)
progenitor cells in the##2##4##(2010-11#1)(2012-3#1)
progenitor cells in##5##3##(2010-1#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
progenitor cells of the##4##4##(2008-11#2)(2008-7#1)(2013-1#1)
progenitor cells of##6##3##(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
progenitor cells that##4##3##(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#1)
progenitor cells to##2##3##(2009-9#1)(2012-2#1)
progenitor cells were##2##3##(1991-5#1)(1994-5#1)
progenitor cells##83##2##(1990-12#1)(1991-5#2)(1994-5#4)(1996-5#4)(1997-4#1)(1997-7#2)(2008-1#1)(2008-11#18)(2008-4#1)(2008-7#7)(2008-8#2)(2008-9#9)(2009-11#1)(2009-12#3)(2009-6#2)(2009-9#2)(2010-1#2)(2010-11#3)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)
progenitor differentiation##2##2##(2008-7#1)(2009-12#1)
progenitor of##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
progenitor##129##1##(1990-12#1)(1990-5#1)(1991-5#3)(1992-3#2)(1992-5#1)(1994-10#2)(1994-5#5)(1994-8#1)(1995-6#4)(1996-5#4)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#21)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#10)(2008-8#3)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#1)(2009-6#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#6)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#9)
progenitors and##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
progenitors expressing##2##2##(2008-4#1)(2008-7#1)
progenitors from##4##2##(2008-4#2)(2008-8#1)(2009-3#1)
progenitors in##6##2##(2008-10#2)(2008-4#4)
progenitors into##2##2##(2011-2#2)
progenitors of##4##2##(2007-12#2)(2008-4#1)(2008-5#1)
progenitors or##2##2##(1995-6#1)(2008-5#1)
progenitors were##2##2##(1993-9#1)(2009-12#1)
progenitors##58##1##(1990-5#2)(1991-6#1)(1993-9#2)(1995-6#1)(1996-12#2)(2007-12#3)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#15)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#2)(2009-3#1)(2010-1#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-7#1)(2013-1#3)
progeny and##3##2##(2008-10#2)(2008-9#1)
progeny cells##4##2##(1997-4#1)(2008-7#2)(2012-2#1)
progeny derived from the cross between##3##6##(2008-10#3)
progeny derived from##7##3##(2008-10#6)(2013-8#1)
progeny from a cross##2##4##(2008-10#2)
progeny from a##3##3##(2008-10#3)
progeny from crosses between##2##4##(2008-10#1)(2012-3#1)
progeny from crosses##3##3##(2008-10#2)(2012-3#1)
progeny from the##4##3##(2008-10#3)(2008-9#1)
progeny from##17##2##(2008-10#13)(2008-11#1)(2008-9#1)(2012-1#1)(2012-3#1)
progeny in##2##2##(2008-10#1)(2012-3#1)
progeny indicated that a##2##4##(2008-10#1)(2008-5#1)
progeny isolates were##2##3##(2008-10#2)
progeny isolates##4##2##(2008-10#4)
progeny lines##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
progeny of a cross between##2##5##(2008-10#1)(2008-9#1)
progeny of line##3##3##(2008-10#3)
progeny of matings between##2##4##(2008-10#2)
progeny of the##9##3##(1994-5#1)(2008-10#6)(2012-2#2)
progeny of two##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
progeny of##34##2##(1994-5#1)(2007-12#1)(2008-10#21)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-8#1)(2012-2#3)
progeny segregated##2##2##(2008-10#2)
progeny testing##3##2##(1997-3#1)(2008-10#2)
progeny that##2##2##(2008-10#1)(2009-9#1)
progeny virus derived from cloned DNA##2##6##(2008-10#2)
progeny virus derived from##4##4##(2008-10#4)
progeny virus##9##2##(1995-12#1)(1997-3#1)(2008-10#7)
progeny was##3##2##(2008-10#3)
progeny were examined for virulence##2##5##(2008-10#2)
progeny were##13##2##(2008-10#11)(2008-11#1)(2008-5#1)
progeny##169##1##(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1997-3#4)(1997-4#1)(2007-12#1)(2008-10#107)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#9)(2008-7#4)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-8#1)
progeria##6##1##(2007-8#2)(2009-12#3)(2011-2#1)
progeroid-related##2##1##(2008-7#2)
progesteron##4##1##(2008-11#4)
progesterone (P)##3##2##(1994-9#1)(1995-11#1)(2008-10#1)
progesterone action##2##2##(1995-11#1)(1996-5#1)
progesterone and##8##2##(1991-12#1)(1994-9#2)(1995-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
progesterone as##2##2##(2008-7#1)(2012-2#1)
progesterone in the##3##3##(1995-11#1)(2008-4#1)(2008-6#1)
progesterone in##5##2##(1990-5#2)(1995-11#1)(2008-4#1)(2008-6#1)
progesterone production##3##2##(1991-9#1)(1994-9#1)(1996-5#1)
progesterone receptor (PR)##2##3##(1996-5#1)(1997-7#1)
progesterone receptor and##3##3##(1994-12#1)(2008-11#1)(2009-12#1)
progesterone receptor level as well as plasminogen activator activity in MCF-7 cells##2##12##(2008-11#2)
progesterone receptor##15##2##(1992-2#2)(1993-11#1)(1994-12#1)(1996-5#1)(1997-7#1)(2008-11#3)(2008-4#3)(2009-12#2)(2011-2#1)
progesterone receptors (PR)##2##3##(1993-9#1)(2013-8#1)
progesterone receptors##10##2##(1990-11#2)(1991-12#1)(1993-8#1)(1993-9#2)(1994-2#1)(2013-8#3)
progesterone to##3##2##(1990-11#1)(1990-5#1)(1995-12#1)
progesterone was##2##2##(1993-11#1)(2007-2#1)
progesterone##87##1##(1990-11#6)(1990-5#3)(1991-11#1)(1991-12#4)(1991-3#2)(1991-9#1)(1992-2#2)(1992-5#1)(1993-11#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#6)(1995-11#4)(1995-12#3)(1996-2#1)(1996-5#4)(1997-7#1)(2007-10#2)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
progestin were##2##2##(1992-2#1)(1994-9#1)
progestin##20##1##(1990-11#1)(1991-9#2)(1992-2#7)(1993-11#1)(1994-5#1)(1994-9#3)(2008-12#4)(2011-2#1)
progestins##7##1##(1990-11#1)(1991-9#2)(1993-11#1)(1994-9#1)(2008-11#1)(2008-2#1)
progestogen therapy is##2##3##(1994-9#2)
progestogen##8##1##(1994-9#5)(2008-5#1)(2011-2#2)
progestrone receptor##2##2##(2008-11#2)
prognoses##5##1##(1996-11#1)(2007-10#1)(2007-7#1)(2011-2#1)(2012-3#1)
prognosis after treatment##2##3##(2008-7#2)
prognosis after##6##2##(1991-2#1)(2006-8#1)(2007-10#1)(2008-7#2)(2008-8#1)
prognosis and outcome##3##3##(2009-8#2)(2013-1#1)
prognosis and response to##2##4##(2008-7#1)(2012-3#1)
prognosis and the##2##3##(2008-4#1)(2013-1#1)
prognosis and therapeutic##2##3##(2010-11#2)
prognosis and therapies##2##3##(2013-1#2)
prognosis and therapy##2##3##(2010-12#2)
prognosis and treatment##6##3##(1994-7#1)(2006-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
prognosis and##49##2##(1990-2#1)(1990-3#1)(1991-3#2)(1991-8#1)(1994-7#1)(1994-9#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#2)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#10)
prognosis as##2##2##(1991-5#1)(1992-8#1)
prognosis associated with##2##3##(1993-1#1)(1997-7#1)
prognosis because the##2##3##(1993-5#1)(2011-2#1)
prognosis because##4##2##(1993-5#1)(1996-11#1)(2011-2#1)(2012-1#1)
prognosis by##2##2##(1991-4#1)(2010-8#1)
prognosis for patients with##2##4##(2010-3#1)(2013-1#1)
prognosis for patients##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
prognosis for##21##2##(1992-5#1)(1993-11#1)(1995-8#1)(2007-10#1)(2008-5#1)(2008-6#3)(2008-7#4)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
prognosis in breast##2##3##(1990-12#1)(2012-2#1)
prognosis in patients with##4##4##(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
prognosis in stage##2##3##(2013-1#2)
prognosis in##24##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1996-11#1)(2007-7#1)(2007-8#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
prognosis is generally##2##3##(2010-7#1)(2013-1#1)
prognosis is good if the##2##5##(1996-9#1)(2008-4#1)
prognosis is good if##3##4##(1996-8#1)(1996-9#1)(2008-4#1)
prognosis is##15##2##(1990-8#1)(1990-9#1)(1996-8#1)(1996-9#3)(1997-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
prognosis of ARF##2##3##(2008-4#2)
prognosis of RCC##2##3##(2012-3#2)
prognosis of breast cancer##3##4##(1993-9#1)(2008-4#1)(2010-8#1)
prognosis of course##2##3##(2013-1#2)
prognosis of patients##6##3##(2006-10#1)(2006-8#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
prognosis of the disease##2##4##(1992-2#1)(2012-2#1)
prognosis of the##10##3##(1990-2#1)(1992-2#1)(1993-12#1)(1993-2#1)(2007-8#1)(2008-1#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
prognosis of these patients##2##4##(2009-5#1)(2010-8#1)
prognosis of these##5##3##(1994-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-8#1)
prognosis of this rare##3##4##(1993-8#1)(2008-10#1)(2008-6#1)
prognosis of this##6##3##(1992-5#1)(1993-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
prognosis of##86##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-3#2)(2006-10#1)(2006-8#1)(2007-10#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#5)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#4)(2011-1#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#2)
prognosis than the##2##3##(2009-5#1)(2012-2#1)
prognosis than##6##2##(1991-6#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
prognosis was##10##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1994-12#1)(1995-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-6#1)
prognosis were##2##2##(1993-11#1)(2008-12#1)
prognosis when##4##2##(1993-1#1)(1997-6#1)(2006-10#1)(2008-6#1)
prognosis with##5##2##(1990-12#1)(2007-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
prognosis##449##1##(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#9)(1990-9#5)(1991-11#3)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#6)(1991-8#6)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#3)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#4)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-6#4)(1994-7#1)(1994-9#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-8#4)(1995-9#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#5)(1997-1#1)(1997-3#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#5)(2006-12#2)(2006-8#2)(2007-10#8)(2007-11#4)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#7)(2008-10#19)(2008-11#6)(2008-12#5)(2008-3#10)(2008-4#9)(2008-5#3)(2008-6#15)(2008-7#19)(2008-8#5)(2008-9#4)(2009-1#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#5)(2009-6#2)(2009-8#4)(2010-1#2)(2010-11#6)(2010-12#4)(2010-3#6)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#6)(2011-1#6)(2011-2#35)(2011-3#5)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#13)(2012-3#16)(2013-1#36)(2013-8#6)
prognosis)##2##1##(1994-10#1)(2012-2#1)
prognosis]##2##1##(2007-10#1)(2011-1#1)
prognostic and predictive##2##3##(2008-7#1)(2013-8#1)
prognostic and therapeutic targets##2##4##(2010-12#1)(2012-12#1)
prognostic and therapeutic##4##3##(2007-8#1)(2008-7#1)(2010-12#1)(2012-12#1)
prognostic and##9##2##(2007-8#1)(2008-2#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
prognostic assessment##5##2##(1991-6#1)(1993-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
prognostic biomarker##2##2##(2010-5#1)(2013-1#1)
prognostic biomarkers##3##2##(2007-10#1)(2008-7#1)(2011-3#1)
prognostic conclusions##2##2##(1990-9#2)
prognostic criteria##2##2##(2011-2#1)(2012-3#1)
prognostic effect of##2##3##(2007-8#1)(2013-1#1)
prognostic effect##5##2##(1990-6#1)(2007-8#1)(2009-11#1)(2013-1#2)
prognostic effects of##2##3##(2007-8#1)(2009-4#1)
prognostic factor for##5##3##(1993-11#1)(1994-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
prognostic factor in patients with Hodgkin's##2##6##(2008-7#2)
prognostic factor in##8##3##(1995-4#1)(1996-8#1)(2007-5#1)(2008-7#2)(2011-2#2)(2012-3#1)
prognostic factor##27##2##(1993-11#1)(1994-5#1)(1995-4#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-8#1)
prognostic factors and##8##3##(1994-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
prognostic factors are##4##3##(1990-9#1)(1996-12#1)(2011-2#2)
prognostic factors by##2##3##(1994-7#2)
prognostic factors for##3##3##(1991-9#1)(2006-10#1)(2011-2#1)
prognostic factors in##4##3##(1991-11#1)(1995-8#1)(2008-7#1)(2011-2#1)
prognostic factors included##2##3##(1990-6#1)(2008-1#1)
prognostic factors of##3##3##(1990-9#1)(1991-11#1)(2007-10#1)
prognostic factors were evaluated##2##4##(2008-6#1)(2012-3#1)
prognostic factors##51##2##(1990-6#2)(1990-9#2)(1991-11#2)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#2)(1994-7#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#6)(2008-7#2)(2010-11#2)(2011-2#8)(2012-2#1)(2012-3#2)
prognostic factors]##2##2##(1990-9#1)(1997-5#1)
prognostic features##5##2##(1992-2#1)(2008-6#1)(2008-9#1)(2011-1#2)
prognostic for##2##2##(2008-6#1)(2012-3#1)
prognostic impact##3##2##(2010-3#1)(2011-2#1)(2012-3#1)
prognostic implication and##2##3##(2007-8#1)(2012-2#1)
prognostic implication##3##2##(2007-8#2)(2012-2#1)
prognostic implications##5##2##(2007-8#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)
prognostic importance of##2##3##(1990-6#1)(2007-8#1)
prognostic indicator##9##2##(1993-11#2)(1994-10#1)(1994-12#1)(1997-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2013-1#1)
prognostic indicators for##2##3##(1991-8#1)(2012-2#1)
prognostic indicators##10##2##(1991-8#1)(1993-11#1)(1994-7#1)(2007-12#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
prognostic information for##4##3##(1994-7#1)(2008-1#2)(2008-7#1)
prognostic information in##3##3##(2010-11#1)(2010-4#1)(2011-2#1)
prognostic information##11##2##(1991-2#1)(1994-7#1)(2008-1#2)(2008-7#1)(2009-4#1)(2010-11#2)(2010-4#1)(2011-2#2)
prognostic marker##3##2##(2011-2#2)(2012-2#1)
prognostic markers and##2##3##(2008-3#1)(2008-7#1)
prognostic markers in##2##3##(2007-10#1)(2009-5#1)
prognostic markers##9##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)
prognostic model##3##2##(1995-9#3)
prognostic parameters##2##2##(1997-8#1)(2011-2#1)
prognostic relevance##4##2##(1991-2#1)(2007-11#1)(2011-1#1)(2013-8#1)
prognostic significance in##4##3##(1990-6#1)(1997-7#1)(2008-7#1)(2013-1#1)
prognostic significance of cathepsin-D expression##2##5##(1993-9#2)
prognostic significance of##12##3##(1990-9#1)(1991-12#1)(1993-1#1)(1993-9#2)(1996-9#1)(2007-8#1)(2008-11#2)(2008-7#2)(2012-3#1)
prognostic significance##24##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-12#1)(1993-1#1)(1993-9#2)(1994-8#1)(1996-9#2)(1997-7#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#3)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
prognostic signs##2##2##(1990-3#2)
prognostic value for##3##3##(2011-1#1)(2012-12#2)
prognostic value in##3##3##(1994-11#1)(2009-4#1)(2011-2#1)
prognostic value of##14##3##(1991-6#2)(1996-9#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
prognostic value##31##2##(1990-5#1)(1990-8#1)(1991-6#2)(1994-11#1)(1994-12#1)(1994-7#1)(1996-9#3)(1997-7#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)
prognostic variables and##2##3##(1994-6#1)(2012-3#1)
prognostic variables##6##2##(1991-3#1)(1991-4#1)(1994-6#1)(2009-8#1)(2012-3#2)
prognostic##286##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#7)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#5)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#1)(1994-7#5)(1994-8#1)(1995-4#3)(1995-5#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-8#2)(1996-9#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#5)(2006-10#1)(2007-10#7)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#3)(2007-8#11)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#14)(2008-7#17)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#9)(2010-12#3)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#31)(2011-3#2)(2011-8#1)(2012-12#5)(2012-2#7)(2012-3#15)(2013-1#8)(2013-8#3)
prognostically##3##1##(1995-5#1)(2011-2#1)(2012-3#1)
prognostication of##3##2##(2010-3#1)(2011-2#2)
prognostication##7##1##(1994-12#1)(2008-11#1)(2010-11#1)(2010-3#1)(2011-2#3)
prognosticators##3##1##(1990-10#2)(1995-1#1)
program according to##2##3##(2008-10#1)(2008-8#1)
program aimed at##2##3##(1990-6#1)(2013-1#1)
program aimed##3##2##(1990-6#1)(2013-1#2)
program and an##2##3##(1994-12#1)(1995-3#1)
program and are##2##3##(1993-12#1)(2008-3#1)
program and its##2##3##(1991-2#2)
program and the##6##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)
program and to##2##3##(1995-1#1)(1997-1#1)
program and##40##2##(1990-10#1)(1991-1#1)(1991-2#2)(1992-1#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#4)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
program appears to##2##3##(1994-2#1)(1997-2#1)
program are##6##2##(1993-5#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-4#1)
program as a##2##3##(1992-3#1)(2012-1#1)
program as##3##2##(1991-12#1)(1992-3#1)(2012-1#1)
program at a##4##3##(1992-2#1)(1995-1#1)(1997-4#1)(2012-3#1)
program at his hospital##2##4##(1991-1#1)(1994-2#1)
program at his##4##3##(1991-1#2)(1994-2#1)(1995-2#1)
program at the##4##3##(1991-12#1)(1994-12#1)(2009-3#1)(2013-1#1)
program at##20##2##(1991-1#2)(1991-12#1)(1992-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#2)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
program based on the##2##4##(1996-12#2)
program based on##8##3##(1995-6#2)(1996-12#2)(2007-12#1)(2008-10#2)(2009-11#1)
program based##9##2##(1995-6#2)(1996-12#2)(2007-12#1)(2008-10#2)(2009-11#1)(2013-8#1)
program because##3##2##(1991-1#1)(1994-3#1)(2012-2#1)
program began##2##2##(2008-11#1)(2008-12#1)
program by##2##2##(1991-1#1)(1991-12#1)
program called##6##2##(1996-3#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-12#1)
program can be##2##3##(1991-5#1)(2008-11#1)
program can##6##2##(1991-5#1)(1994-12#1)(1996-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
program changes##2##2##(1995-2#1)(2008-11#1)
program components##2##2##(1992-1#1)(1993-3#1)
program cost##3##2##(1992-3#2)(1995-3#1)
program costs##2##2##(1993-3#1)(2010-12#1)
program could be##2##3##(2008-10#2)
program could##4##2##(1992-12#1)(2007-2#1)(2008-10#2)
program covering##2##2##(1995-1#1)(2008-10#1)
program demonstrated##2##2##(1991-2#1)(1995-1#1)
program design and##3##3##(1991-2#1)(1995-1#1)(1997-3#1)
program design##5##2##(1991-2#1)(1995-1#1)(1997-2#1)(1997-3#1)(2008-1#1)
program designed to improve##2##4##(1997-2#1)(2008-12#1)
program designed to##9##3##(1994-12#1)(1994-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-12#1)(2013-1#1)
program developed##4##2##(1991-2#1)(1995-2#1)(1996-1#1)(1996-2#1)
program development and##2##3##(1995-1#1)(1997-1#1)
program development##7##2##(1991-2#1)(1992-2#1)(1995-1#1)(1997-1#1)(2008-11#1)(2009-9#1)(2010-7#1)
program directors##5##2##(1994-3#1)(2007-4#1)(2009-8#2)(2012-3#1)
program during the##2##3##(1992-3#1)(1993-3#1)
program during##3##2##(1992-3#1)(1993-3#1)(1997-2#1)
program effectiveness and##2##3##(1996-2#1)(1997-2#1)
program effectiveness##3##2##(1996-2#1)(1997-2#1)(2008-4#1)
program emphasizes##2##2##(1992-1#1)(1993-3#1)
program enrollment##2##2##(1991-3#1)(1997-2#1)
program evaluation are##2##3##(1993-12#1)(1993-2#1)
program evaluation is##2##3##(1992-1#1)(1993-12#1)
program evaluation##11##2##(1992-1#1)(1993-12#4)(1993-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-12#1)(2013-8#1)
program expenditures##3##2##(1992-1#1)(1993-1#1)(1993-3#1)
program focus##2##2##(1993-12#2)
program for a##6##3##(1991-1#1)(1992-2#1)(1994-12#1)(1996-3#2)(2008-11#1)
program for children and##2##4##(1992-1#1)(1995-3#1)
program for children##4##3##(1992-1#1)(1993-12#2)(1995-3#1)
program for diabetes mellitus##2##4##(1993-2#1)(2012-3#1)
program for hospitals##2##3##(1992-2#1)(2009-11#1)
program for older adults##2##4##(1992-1#1)(2008-3#1)
program for patients with##2##4##(1990-2#1)(2012-1#1)
program for persons with##2##4##(1993-1#1)(1993-3#1)
program for prevention##2##3##(1995-3#2)
program for rural##3##3##(1992-12#1)(1996-2#1)(2013-1#1)
program for the##6##3##(1991-12#1)(1992-1#1)(1993-6#1)(1995-3#1)(1996-9#1)(2007-2#1)
program for##95##2##(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#3)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-3#6)(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#3)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#6)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
program from##5##2##(1993-1#1)(1994-1#1)(1994-9#1)(1995-12#1)(2008-10#1)
program funded by the##2##4##(2008-7#1)(2009-5#1)
program funded by##3##3##(2008-1#1)(2008-7#1)(2009-5#1)
program graduates##2##2##(1993-2#1)(2011-2#1)
program has also been##3##4##(1993-3#1)(2008-3#2)
program has been##9##3##(1991-2#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2011-3#1)(2013-1#1)
program has made##2##3##(1992-3#1)(1996-2#1)
program has##26##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-3#2)(1995-12#2)(1996-2#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#6)(2008-4#2)(2008-7#1)(2011-3#1)(2013-1#1)
program have##2##2##(1994-9#1)(2011-2#1)
program impact##2##2##(2007-11#2)
program implementation##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
program in Finnmark]##3##3##(1993-11#1)(1995-6#2)
program in Japan##2##3##(1993-2#1)(1996-4#1)
program in an##3##3##(1996-3#1)(1997-1#1)(2008-7#1)
program in health##2##3##(1993-12#2)
program in the##14##3##(1990-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-1#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(2009-8#1)(2013-1#1)
program in which##3##3##(1994-3#1)(2007-5#1)(2008-7#1)
program in##67##2##(1990-11#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#3)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#2)
program included##2##2##(2007-8#1)(2012-12#1)
program includes##3##2##(1992-1#1)(2008-12#1)(2012-3#1)
program into##2##2##(2008-11#2)
program is a##4##3##(1991-1#2)(1996-3#1)(1996-6#1)
program is also##2##3##(2008-4#1)(2011-1#1)
program is an##3##3##(1993-1#1)(1993-12#1)(2007-7#1)
program is arranged with##2##4##(1993-1#2)
program is designed to##2##4##(1997-3#1)(2013-1#1)
program is the##4##3##(1992-2#1)(1993-3#1)(1996-12#1)(2007-11#1)
program is to##4##3##(1993-12#1)(2008-11#2)(2008-4#1)
program is##46##2##(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#4)(1993-12#2)(1993-3#2)(1994-2#1)(1995-1#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#4)(2008-4#3)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
program location and program reputation##2##5##(1996-1#2)
program location and##3##3##(1996-1#3)
program management in##2##3##(1995-2#2)
program management##10##2##(1994-12#2)(1994-3#3)(1995-2#3)(1996-2#1)(1996-3#1)
program managers##2##2##(1994-12#1)(1996-12#1)
program may be##3##3##(1995-2#1)(2008-12#1)(2012-1#1)
program may have##2##3##(1996-1#1)(2013-8#1)
program may##7##2##(1993-3#1)(1995-2#1)(1996-1#1)(2008-12#1)(2008-4#1)(2012-1#1)(2013-8#1)
program mission##2##2##(1992-12#1)(2009-8#1)
program of care##2##3##(1992-1#1)(2008-1#1)
program of instruction in operative laparoscopy##2##6##(1993-12#2)
program of rehabilitation##2##3##(2007-8#2)
program of research##3##3##(1995-4#1)(2008-11#1)(2012-3#1)
program of the##4##3##(1993-12#1)(1995-12#1)(1997-5#1)(2008-1#1)
program of##46##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1994-12#3)(1994-2#2)(1995-12#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
program on the##4##3##(1990-3#1)(1992-1#1)(1995-1#1)(2008-10#1)
program on##17##2##(1990-3#1)(1991-2#1)(1992-1#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)
program or by##2##3##(1993-2#1)(2008-4#1)
program or##3##2##(1993-2#1)(2008-12#1)(2008-4#1)
program over the##3##3##(1992-1#1)(2008-4#1)(2011-2#1)
program participants##2##2##(1996-3#1)(2010-12#1)
program participation##4##2##(1995-12#1)(2008-12#3)
program payments##3##2##(1991-2#1)(1991-3#2)
program performance##3##2##(1995-1#2)(1995-3#1)
program planning and##2##3##(1994-7#1)(1995-1#1)
program planning##4##2##(1991-1#1)(1994-7#1)(1995-1#1)(2011-1#1)
program providers##3##2##(1994-2#1)(2008-11#1)(2008-12#1)
program provides##5##2##(1993-12#1)(2007-4#1)(2008-10#2)(2008-11#1)
program providing##3##2##(1996-3#1)(2008-10#1)(2008-6#1)
program reputation##3##2##(1996-1#3)
program requires##3##2##(1993-2#1)(1997-6#1)(2008-3#1)
program resulted in##2##3##(2008-10#2)
program should be##3##3##(1995-12#1)(1995-2#1)(2009-4#1)
program should##4##2##(1995-12#1)(1995-2#1)(2009-4#1)(2011-2#1)
program showed##2##2##(2007-12#1)(2010-7#1)
program staff##3##2##(1995-12#1)(1996-2#1)(1996-3#1)
program statement##4##2##(1996-2#4)
program that addresses##2##3##(1991-12#1)(2012-3#1)
program that creates##2##3##(2008-11#1)(2008-9#1)
program that includes##2##3##(2007-12#1)(2008-11#1)
program that is##4##3##(1993-2#1)(1997-1#1)(1997-3#1)(2012-3#1)
program that uses##2##3##(2008-3#1)(2008-7#1)
program that was##3##3##(1990-3#1)(1996-1#1)(2009-12#1)
program that##38##2##(1990-3#1)(1991-12#1)(1992-12#3)(1993-1#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-3#2)(1997-1#2)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
program the##2##2##(2008-11#1)(2011-2#1)
program through##2##2##(1997-2#1)(2012-3#1)
program to address##2##3##(1997-2#1)(2008-12#1)
program to be##2##3##(1995-12#1)(2012-2#1)
program to determine##5##3##(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)
program to ensure the##2##4##(1996-2#1)(2008-4#1)
program to ensure##3##3##(1996-2#1)(2008-4#1)(2008-9#1)
program to improve##3##3##(2008-3#1)(2013-1#2)
program to prevent##2##3##(1997-7#1)(2013-8#1)
program to the##2##3##(1991-2#1)(1996-1#1)
program to##49##2##(1991-1#2)(1991-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-2#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
program used##2##2##(1993-12#1)(1995-3#1)
program using##2##2##(2008-11#1)(2011-2#1)
program was carried out by employing a heating cycle in four steps##2##12##(2008-10#2)
program was carried out##3##4##(2008-10#2)(2008-11#1)
program was designed to##2##4##(1997-4#1)(2007-11#1)
program was developed and##2##4##(1997-2#1)(2008-11#1)
program was developed##6##3##(1991-5#1)(1992-2#1)(1997-2#1)(2008-11#2)(2008-12#1)
program was established in##2##4##(1993-3#1)(1996-1#1)
program was successful##2##3##(2007-5#1)(2008-4#1)
program was to develop##2##4##(1993-12#1)(1997-4#1)
program was to##3##3##(1992-1#1)(1993-12#1)(1997-4#1)
program was used to##4##4##(1992-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
program was used##6##3##(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
program was##48##2##(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#2)(1997-2#2)(1997-4#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-10#2)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
program were##9##2##(1991-12#1)(1991-2#1)(1994-1#1)(2008-10#3)(2012-1#1)(2012-12#1)(2012-3#1)
program which##6##2##(1992-1#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-10#2)
program will be##2##3##(1993-12#1)(2010-11#1)
program will##6##2##(1993-12#1)(1994-2#2)(1995-12#1)(2008-5#1)(2010-11#1)
program with a graphical##2##4##(2008-3#1)(2011-3#1)
program with a##3##3##(1997-1#1)(2008-3#1)(2011-3#1)
program with##12##2##(1992-12#1)(1995-1#1)(1997-1#2)(2008-11#1)(2008-3#2)(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
program within the##2##3##(1991-1#1)(2008-7#1)
program within##4##2##(1991-1#1)(1991-2#1)(1995-12#1)(2008-7#1)
program without##2##2##(1997-2#1)(2007-8#1)
program would be##2##3##(1997-6#1)(2012-12#1)
program would##6##2##(1992-12#1)(1995-1#1)(1997-6#1)(2008-11#1)(2012-12#1)(2013-1#1)
program written##4##2##(1992-2#1)(2008-10#3)
program##1379##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-6#2)(1991-1#26)(1991-12#19)(1991-2#27)(1991-3#13)(1991-5#2)(1991-6#3)(1991-9#3)(1992-1#28)(1992-10#2)(1992-12#19)(1992-2#23)(1992-3#12)(1992-6#1)(1993-1#18)(1993-11#7)(1993-12#29)(1993-2#25)(1993-3#25)(1993-5#1)(1993-6#2)(1994-1#5)(1994-12#30)(1994-2#17)(1994-3#25)(1994-5#2)(1994-6#2)(1994-7#2)(1994-9#10)(1995-1#27)(1995-12#25)(1995-2#24)(1995-3#20)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#3)(1996-1#31)(1996-10#1)(1996-11#1)(1996-12#24)(1996-2#26)(1996-3#23)(1996-4#1)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#18)(1997-2#37)(1997-3#10)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#1)(2006-12#2)(2006-4#2)(2006-5#1)(2007-10#2)(2007-11#17)(2007-12#18)(2007-2#3)(2007-4#3)(2007-5#6)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#14)(2008-10#100)(2008-11#46)(2008-12#47)(2008-2#16)(2008-3#45)(2008-4#38)(2008-5#11)(2008-6#16)(2008-7#21)(2008-8#11)(2008-9#18)(2009-11#4)(2009-12#5)(2009-3#3)(2009-4#3)(2009-5#5)(2009-8#6)(2009-9#2)(2010-10#6)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#8)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#30)(2011-3#3)(2011-7#1)(2012-1#9)(2012-12#24)(2012-2#13)(2012-3#24)(2013-1#43)(2013-7#6)(2013-8#12)
program's experience##2##2##(1994-3#1)(1995-3#1)
program's success##2##2##(1993-2#1)(2007-2#1)
program's##13##1##(1993-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-6#3)(2012-12#2)
program)##4##1##(1992-2#1)(2011-2#3)
program?##3##1##(1993-3#1)(2011-2#2)
program]##3##1##(1995-6#1)(1997-4#1)(1997-5#1)
programmable array##2##2##(2008-3#1)(2008-9#1)
programmable digital##2##2##(2008-2#1)(2008-3#1)
programmable logic##2##2##(2008-3#2)
programmable pulse shaper##3##3##(2007-12#3)
programmable pulse##4##2##(2007-12#4)
programmable temperature vaporizer (PTV-LV) injection##2##5##(2008-10#2)
programmable##38##1##(2007-11#7)(2007-12#5)(2007-7#1)(2008-10#6)(2008-2#3)(2008-3#10)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#1)(2013-1#1)
programmatic areas##3##2##(2013-1#3)
programmatic##11##1##(1996-12#1)(1997-3#2)(2008-10#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#3)(2013-8#1)
programme and##14##2##(1991-5#1)(1995-11#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#3)(2012-12#1)(2012-3#1)(2013-8#1)
programme as##2##2##(2012-12#1)(2012-3#1)
programme directors##2##2##(2011-2#2)
programme for nurses##2##3##(2008-11#1)(2008-12#1)
programme for the##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
programme for##18##2##(1990-12#1)(1991-2#1)(1993-6#1)(1995-2#1)(2008-11#4)(2008-12#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
programme has been##3##3##(1995-9#1)(2010-4#1)(2012-3#1)
programme has##6##2##(1993-6#1)(1995-9#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)
programme in our##2##3##(2010-7#1)(2012-2#1)
programme in the##3##3##(1994-11#1)(2008-7#1)(2008-9#1)
programme in##20##2##(1990-11#1)(1994-11#1)(1995-9#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#3)(2009-7#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
programme is##6##2##(1994-12#1)(2008-11#2)(2008-12#2)(2008-3#1)
programme of##7##2##(1990-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-7#2)(2012-2#1)
programme on##9##2##(1990-8#1)(1995-3#1)(2008-11#1)(2008-12#2)(2008-7#4)
programme provides##2##2##(2008-12#2)
programme reduced##2##2##(1995-5#1)(2013-1#1)
programme should##2##2##(2008-11#1)(2010-10#1)
programme that##4##2##(2007-11#1)(2008-11#1)(2008-12#1)(2012-3#1)
programme the##2##2##(1990-11#1)(2008-11#1)
programme to##5##2##(1990-2#1)(1995-9#1)(2008-11#1)(2011-1#1)(2012-2#1)
programme was applied to##2##4##(2008-10#1)(2008-8#1)
programme was applied##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
programme was optimized##2##3##(2008-10#1)(2010-1#1)
programme was##15##2##(1990-2#1)(1995-11#1)(2007-2#1)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#2)(2012-12#1)(2013-8#1)
programme which##2##2##(1991-6#1)(1997-3#1)
programme##252##1##(1990-11#4)(1990-12#1)(1990-2#4)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#4)(1991-8#3)(1992-5#1)(1993-6#5)(1994-11#3)(1994-12#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#5)(1996-11#1)(1996-2#1)(1997-3#4)(1997-7#3)(1997-8#1)(2007-11#4)(2007-2#1)(2007-7#2)(2008-1#6)(2008-10#17)(2008-11#33)(2008-12#20)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#13)(2008-8#7)(2008-9#19)(2009-1#2)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#10)(2012-2#6)(2012-3#7)(2013-1#9)(2013-8#9)
programme's##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
programmed cell death (PCD)##3##4##(2008-10#1)(2009-8#2)
programmed cell death (apoptosis)##2##4##(1994-9#1)(2006-10#1)
programmed cell death during##2##4##(1994-8#1)(2008-4#1)
programmed cell death in##6##4##(1991-12#1)(1994-8#2)(1995-8#1)(2008-8#1)(2009-10#1)
programmed cell death or##2##4##(1996-12#1)(2008-11#1)
programmed cell death##36##3##(1991-12#3)(1993-9#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2011-2#2)
programmed cell##38##2##(1991-12#3)(1992-9#1)(1993-9#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2011-2#2)
programmed death##2##2##(2010-5#1)(2012-3#1)
programmed decomposition (TPDE) of [Mo(CO)(6)]##2##5##(2008-10#2)
programmed diode array photometric detection##2##5##(2008-10#2)
programmed electrical stimulation##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
programmed electrical##4##2##(1992-3#1)(2007-8#1)(2008-12#1)(2011-2#1)
programmed flow systems##2##3##(2008-10#2)
programmed flow##3##2##(2008-10#3)
programmed sequence##3##2##(2008-10#3)
programmed to##5##2##(1992-3#1)(2008-11#1)(2008-3#2)(2011-2#1)
programmed##86##1##(1991-12#3)(1992-3#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)
programmes and##7##2##(1996-11#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-12#1)
programmes are##5##2##(1997-8#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)
programmes as well as##2##4##(1991-6#1)(2012-2#1)
programmes as##3##2##(1991-6#1)(1993-6#1)(2012-2#1)
programmes can##2##2##(2008-11#1)(2012-1#1)
programmes do##2##2##(2008-12#1)(2011-2#1)
programmes for the##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
programmes for##24##2##(1990-6#1)(1991-12#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
programmes have##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
programmes in the##2##3##(2010-3#1)(2012-1#1)
programmes in##10##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#2)(2011-2#1)(2012-1#1)(2013-7#1)
programmes is##4##2##(1991-6#2)(1997-7#1)(2013-1#1)
programmes must##2##2##(2011-2#1)(2013-1#1)
programmes of##3##2##(1991-6#1)(2007-6#1)(2008-11#1)
programmes that can be##2##4##(2008-11#1)(2008-12#1)
programmes that##8##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-8#2)(2012-1#1)
programmes to##3##2##(2010-3#1)(2012-12#1)(2013-8#1)
programmes were##3##2##(2008-10#2)(2011-2#1)
programmes##150##1##(1990-6#1)(1991-12#1)(1991-6#5)(1991-8#1)(1992-6#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-6#1)(2007-7#4)(2008-1#3)(2008-10#12)(2008-11#24)(2008-12#11)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#7)(2009-10#1)(2009-2#1)(2009-7#2)(2010-3#6)(2010-4#3)(2010-8#2)(2011-1#3)(2011-2#13)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#2)
programming (LP)##2##2##(2008-11#1)(2008-7#1)
programming and##9##2##(1994-3#1)(1995-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-3#1)(2010-12#1)
programming by##2##2##(1996-5#1)(2008-10#1)
programming can be used##2##4##(2008-11#1)(2008-7#1)
programming for##4##2##(1992-3#1)(2007-11#1)(2008-7#1)(2012-12#1)
programming in##2##2##(2009-10#1)(2009-9#1)
programming is##2##2##(2008-11#1)(2008-4#1)
programming language##3##2##(2008-10#2)(2008-3#1)
programming of the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
programming of##8##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2012-2#1)(2013-1#1)
programming pulses##3##2##(2007-12#3)
programming the speech processor of##2##5##(2008-9#2)
programming the##3##2##(2008-9#3)
programming to##2##2##(2008-11#1)(2009-5#1)
programming##88##1##(1990-3#1)(1991-6#1)(1992-3#1)(1994-3#2)(1995-1#1)(1996-5#2)(2007-11#2)(2007-12#6)(2008-10#11)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#6)(2008-8#1)(2008-9#13)(2009-10#1)(2009-11#3)(2009-3#3)(2009-5#2)(2009-9#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#2)
programs across##3##2##(2012-12#2)(2012-3#1)
programs addressing##3##2##(1996-3#1)(2008-9#1)(2009-5#1)
programs aimed at##6##3##(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
programs and for##2##3##(1994-2#1)(2008-10#1)
programs and in##2##3##(1993-2#1)(2008-8#1)
programs and policies##2##3##(1993-3#1)(2008-7#1)
programs and services that##2##4##(1994-12#1)(1994-3#1)
programs and services##8##3##(1991-2#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(2010-12#1)
programs and the##5##3##(1995-1#1)(1996-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
programs and to##5##3##(1991-1#1)(1993-6#1)(1996-1#1)(2007-4#1)(2008-6#1)
programs and what##2##3##(1991-1#1)(2013-1#1)
programs and##58##2##(1991-1#4)(1991-2#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-12#2)(1996-4#2)(1997-1#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
programs are also##2##3##(1995-2#1)(2008-9#1)
programs are based on##2##4##(2008-3#1)(2011-3#1)
programs are being##2##3##(1991-12#1)(1992-1#1)
programs are described##2##3##(1995-1#1)(2008-4#1)
programs are discussed##2##3##(1995-12#1)(2008-10#1)
programs are implemented##2##3##(1991-12#1)(2012-12#1)
programs are in##2##3##(2012-12#1)(2012-2#1)
programs are presented##3##3##(1995-1#1)(1997-2#1)(2008-4#1)
programs are the##2##3##(1997-2#1)(2010-5#1)
programs are##46##2##(1991-1#1)(1991-12#2)(1992-1#3)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-1#2)(1996-3#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
programs around##2##2##(1995-1#1)(1997-2#1)
programs as well as##2##4##(1994-12#1)(2008-8#1)
programs as##5##2##(1994-12#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
programs at##3##2##(1992-12#1)(2008-3#1)(2013-1#1)
programs available##2##2##(1995-2#1)(2008-4#1)
programs by##2##2##(1996-1#1)(2008-4#1)
programs can be##4##3##(1993-1#1)(1995-3#1)(2008-10#1)(2012-2#1)
programs can##13##2##(1991-1#2)(1992-1#1)(1992-3#1)(1993-1#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2012-2#1)(2013-8#1)
programs dealing with##2##3##(1995-12#1)(2008-10#1)
programs designed to##6##3##(1993-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)
programs designed##7##2##(1993-1#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-1#1)
programs do##2##2##(1993-1#1)(2008-9#1)
programs focusing on##2##3##(2008-5#1)(2010-11#1)
programs for clinical##3##3##(1994-12#2)(2008-12#1)
programs for infants##2##3##(1995-12#1)(2010-10#1)
programs for the##9##3##(1992-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
programs for##61##2##(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)
programs has##5##2##(1991-12#1)(1992-1#1)(2007-11#1)(2013-1#2)
programs have a##2##3##(1995-1#1)(2008-12#1)
programs have been##8##3##(1991-12#1)(1994-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
programs have the potential to##2##5##(1997-2#1)(2008-7#1)
programs have##32##2##(1991-1#1)(1991-12#2)(1992-1#1)(1992-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-1#1)(2012-2#2)(2013-1#2)
programs implemented##2##2##(2008-7#1)(2010-4#1)
programs in Canada##2##3##(1991-3#1)(2008-11#1)
programs in TRM##3##3##(2008-1#3)
programs in health administration##10##4##(1991-1#1)(1994-1#1)(1995-1#2)(1996-1#3)(1996-2#1)(1996-3#2)
programs in health care administration##3##5##(1995-1#2)(1996-2#1)
programs in health services administration##2##5##(1996-2#1)(1996-3#1)
programs in health services##3##4##(1992-1#1)(1996-2#1)(1996-3#1)
programs in health##16##3##(1991-1#1)(1992-1#1)(1994-1#1)(1995-1#4)(1996-1#3)(1996-2#3)(1996-3#3)
programs in order to##2##4##(2008-10#1)(2012-12#1)
programs in the United States##3##5##(1993-1#1)(1997-2#1)(2012-12#1)
programs in the##15##3##(1991-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-12#2)(2011-1#1)(2012-12#1)(2013-7#1)
programs in their##3##3##(1995-3#1)(1996-3#1)(2008-11#1)
programs in this##2##3##(1995-1#1)(2008-7#1)
programs in##78##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#5)(1995-12#2)(1995-3#1)(1996-1#5)(1996-12#1)(1996-2#3)(1996-3#5)(1997-1#2)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
programs into##2##2##(2007-11#1)(2008-11#1)
programs is##10##2##(1991-12#1)(1992-12#1)(1994-2#2)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)(2011-3#1)
programs like the##2##3##(1994-2#1)(2010-5#1)
programs located in##2##3##(1996-3#1)(2013-1#1)
programs may be##3##3##(2007-11#1)(2008-9#1)(2012-12#1)
programs may##9##2##(1992-12#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
programs must be##2##3##(1997-2#1)(2013-1#1)
programs must##7##2##(1991-1#1)(1993-12#1)(1997-2#3)(2011-2#1)(2013-1#1)
programs of the##3##3##(1995-6#1)(1997-2#1)(2013-1#1)
programs of##8##2##(1991-3#1)(1992-3#1)(1995-2#2)(1995-6#1)(1997-2#1)(2008-12#1)(2013-1#1)
programs on##7##2##(1994-3#1)(2007-11#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
programs operating in##2##3##(1991-12#1)(1995-3#1)
programs or##2##2##(1992-3#1)(1995-1#1)
programs provide##4##2##(1995-1#2)(2008-11#2)
programs require##2##2##(2012-12#1)(2013-1#1)
programs requires##2##2##(1994-12#1)(1995-2#1)
programs run##2##2##(1996-5#1)(2008-9#1)
programs serve as##2##3##(1997-3#1)(2011-2#1)
programs should##7##2##(1992-1#1)(1997-2#1)(1997-3#1)(2008-12#1)(2009-12#1)(2009-7#1)(2011-1#1)
programs such as##7##3##(1992-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-3#1)
programs targeting##3##2##(1996-2#1)(2008-11#1)(2008-12#1)
programs that are##5##3##(1994-1#1)(1994-2#1)(2008-4#1)(2009-7#1)(2012-3#1)
programs that encourage##2##3##(2010-4#1)(2012-2#1)
programs that have proven##2##4##(1996-12#1)(1996-2#1)
programs that provide##2##3##(1995-1#1)(2008-11#1)
programs that will##2##3##(1997-1#1)(2012-12#1)
programs that##37##2##(1991-1#2)(1993-1#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
programs they##3##2##(1991-2#1)(1995-1#1)(1995-3#1)
programs to be##3##3##(1992-12#1)(2008-10#1)(2010-9#1)
programs to improve##5##3##(1994-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#1)
programs to reduce##4##3##(1993-2#1)(2008-11#1)(2013-1#2)
programs to##44##2##(1990-4#1)(1991-2#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#3)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#3)
programs under##2##2##(1994-1#1)(1995-3#1)
programs using##2##2##(1995-2#1)(2007-11#1)
programs was##4##2##(1992-2#1)(1995-12#1)(1997-5#1)(2008-10#1)
programs were examined##2##3##(2008-10#2)
programs were identified as##2##4##(1996-1#2)
programs were##13##2##(1992-12#1)(1995-1#1)(1996-1#2)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-9#1)(2012-12#1)
programs which##2##2##(1991-12#1)(1996-1#1)
programs will be##2##3##(1994-1#1)(1994-12#1)
programs will##3##2##(1994-1#1)(1994-12#1)(1996-12#1)
programs with the##2##3##(2008-10#1)(2010-9#1)
programs with##6##2##(1992-1#1)(1992-3#1)(2008-10#1)(2009-12#1)(2010-5#1)(2010-9#1)
programs within the##2##3##(2008-7#1)(2012-3#1)
programs within##6##2##(1991-12#1)(1995-1#1)(1997-2#1)(2007-11#1)(2008-7#1)(2012-3#1)
programs would help##2##3##(1990-2#1)(2010-8#1)
programs would##5##2##(1990-2#1)(1992-12#1)(1994-3#1)(1995-2#1)(2010-8#1)
programs##1004##1##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1991-1#23)(1991-12#17)(1991-2#7)(1991-3#5)(1991-8#1)(1992-1#27)(1992-12#16)(1992-2#12)(1992-3#11)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#14)(1993-11#2)(1993-12#4)(1993-2#16)(1993-3#7)(1993-6#2)(1994-1#13)(1994-12#15)(1994-2#24)(1994-3#18)(1994-9#1)(1995-1#35)(1995-12#16)(1995-2#15)(1995-3#21)(1995-5#1)(1995-6#3)(1995-9#2)(1996-1#29)(1996-12#17)(1996-2#15)(1996-3#23)(1996-4#2)(1996-5#5)(1997-1#11)(1997-2#30)(1997-3#16)(1997-5#7)(1997-6#3)(1997-8#1)(2007-10#3)(2007-11#26)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#3)(2008-1#8)(2008-10#69)(2008-11#39)(2008-12#19)(2008-2#1)(2008-3#8)(2008-4#27)(2008-5#4)(2008-6#17)(2008-7#14)(2008-8#10)(2008-9#22)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#8)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#4)(2010-3#5)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#4)(2011-2#24)(2011-3#7)(2012-1#5)(2012-12#29)(2012-2#25)(2012-3#11)(2013-1#46)(2013-7#3)(2013-8#5)
programs'##2##1##(1997-3#1)(2012-3#1)
programs)##3##1##(1994-1#1)(2009-1#1)(2011-2#1)
programs]##2##1##(2007-6#1)(2011-3#1)
progress and people##2##3##(2008-10#2)
progress and problems##2##3##(2007-2#1)(2010-12#1)
progress and##18##2##(1991-5#1)(1994-12#1)(1996-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-7#3)(2008-8#1)(2010-12#2)(2011-1#1)(2012-1#1)
progress are##4##2##(1997-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
progress as##2##2##(2010-12#1)(2012-2#1)
progress at##2##2##(1991-2#1)(2012-2#1)
progress based on the##2##4##(2008-10#2)
progress can be made##2##4##(2008-8#1)(2011-1#1)
progress can be##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
progress continues to be made##2##5##(2008-9#1)(2010-4#1)
progress could##2##2##(2008-11#1)(2012-2#1)
progress curve##36##2##(2008-10#36)
progress curves and##3##3##(2008-10#3)
progress curves were##3##3##(2008-10#3)
progress curves##15##2##(1990-5#1)(1992-6#1)(1992-8#1)(2008-10#12)
progress during the##2##3##(2008-5#1)(2008-9#1)
progress during##3##2##(1992-3#1)(2008-5#1)(2008-9#1)
progress feedback##3##2##(2012-2#3)
progress for##3##2##(2008-10#2)(2008-5#1)
progress from##2##2##(2008-10#1)(2010-3#1)
progress has been achieved in the##3##6##(1997-7#1)(2008-12#1)(2008-7#1)
progress has been achieved in##4##5##(1997-6#1)(1997-7#1)(2008-12#1)(2008-7#1)
progress has been achieved##5##4##(1995-5#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-7#1)
progress has been made in the understanding of##3##8##(2008-11#2)(2008-7#1)
progress has been made in the##7##6##(2008-11#3)(2008-7#2)(2008-9#1)(2009-12#1)
progress has been made in understanding##2##6##(2008-5#1)(2011-2#1)
progress has been made in##17##5##(1997-1#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
progress has been made over the##2##6##(2008-1#1)(2008-7#1)
progress has been made toward the##2##6##(2008-3#1)(2010-9#1)
progress has been made##28##4##(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
progress has been##35##3##(1990-9#1)(1995-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#7)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
progress has##39##2##(1990-9#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#8)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
progress have been##2##3##(2008-5#1)(2011-2#1)
progress in determining##2##3##(1995-2#1)(2008-11#1)
progress in development##2##3##(2010-10#1)(2011-2#1)
progress in early##2##3##(1990-2#1)(2010-12#1)
progress in elucidating##2##3##(2008-8#1)(2009-7#1)
progress in identifying##2##3##(2008-10#1)(2009-5#1)
progress in learning##2##3##(2008-11#2)
progress in our##3##3##(1994-9#1)(2008-11#1)(2009-3#1)
progress in recent##2##3##(2012-3#1)(2013-8#1)
progress in rehabilitation##2##3##(2007-11#2)
progress in researches of##2##4##(2013-8#2)
progress in the area of##2##5##(1997-6#1)(2012-12#1)
progress in the development of HIV-1 fusion##2##7##(2011-3#2)
progress in the development of##9##5##(2007-8#1)(2008-10#4)(2011-2#1)(2011-3#2)(2013-1#1)
progress in the development##11##4##(1994-3#1)(2007-8#1)(2008-10#4)(2011-2#1)(2011-3#2)(2013-1#2)
progress in the field of##2##5##(2009-10#1)(2009-4#1)
progress in the field##3##4##(2009-10#1)(2009-4#1)(2012-2#1)
progress in the treatment of##3##5##(1996-6#1)(1997-4#1)(2010-3#1)
progress in the understanding of the##2##6##(1991-2#1)(2009-4#1)
progress in the use of##3##5##(2007-8#1)(2008-11#1)(2010-10#1)
progress in the##36##3##(1991-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-4#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
progress in this field##2##4##(2008-10#1)(2013-8#1)
progress in this##5##3##(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
progress in understanding the##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
progress in understanding##4##3##(2007-12#1)(2008-11#1)(2012-2#2)
progress in##113##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-5#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#3)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#7)
progress into##2##2##(2008-9#1)(2011-1#1)
progress is being made##2##4##(1993-2#1)(2012-12#1)
progress is##4##2##(1993-2#1)(1994-2#1)(2008-10#1)(2012-12#1)
progress made in the##4##4##(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
progress made in understanding##3##4##(2009-2#1)(2011-1#1)(2012-2#1)
progress made in##9##3##(2008-10#1)(2008-5#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
progress made##13##2##(2006-10#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
progress monitoring##8##2##(2008-12#1)(2011-2#7)
progress of maturity##2##3##(2008-10#1)(2009-9#1)
progress of research##2##3##(2008-10#1)(2010-10#1)
progress of the disease##3##4##(1993-5#1)(2008-7#1)(2011-1#1)
progress of the##9##3##(1991-9#1)(1993-5#1)(1996-4#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-2#1)
progress of##49##2##(1991-9#1)(1993-3#1)(1993-5#1)(1994-5#1)(1996-4#1)(1996-5#1)(2008-10#18)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-8#1)
progress on the##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
progress on##11##2##(1995-1#1)(1996-1#1)(2007-11#2)(2008-10#2)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
progress over the##2##3##(1996-11#1)(2012-2#1)
progress over##3##2##(1996-11#1)(2008-10#1)(2012-2#1)
progress recently##2##2##(2007-7#1)(2011-1#1)
progress report##2##2##(2008-7#1)(2010-10#1)
progress signal##2##2##(2008-11#2)
progress so##2##2##(2008-7#1)(2011-2#1)
progress that has been made in##3##6##(2007-6#1)(2008-11#1)(2008-8#1)
progress that has been made##4##5##(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
progress that has been##5##4##(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
progress that##6##2##(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
progress through the##2##3##(1993-12#1)(2011-1#1)
progress through##6##2##(1993-12#1)(2008-11#1)(2009-10#1)(2010-10#1)(2010-9#1)(2011-1#1)
progress to AIDS##2##3##(1997-3#1)(2012-2#1)
progress to a##2##3##(2009-10#1)(2013-1#1)
progress to develop##2##3##(2008-10#1)(2009-8#1)
progress to##24##2##(1992-5#1)(1994-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
progress toward##8##2##(1996-2#1)(1996-3#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-3#1)
progress towards##5##2##(1993-9#1)(1996-1#1)(2008-11#1)(2008-5#1)(2008-8#1)
progress was##6##2##(2008-10#3)(2010-1#1)(2012-2#1)(2013-8#1)
progress##511##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-11#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#3)(2007-11#7)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#116)(2008-11#30)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#18)(2008-6#4)(2008-7#28)(2008-8#14)(2008-9#14)(2009-10#8)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#6)(2010-3#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#14)(2011-2#23)(2011-3#3)(2012-1#2)(2012-12#7)(2012-2#25)(2012-3#9)(2013-1#9)(2013-8#13)
progress)##3##1##(2008-10#1)(2008-4#1)(2012-3#1)
progress?##2##1##(2008-9#1)(2012-1#1)
progressed for##2##2##(1992-5#1)(2008-10#1)
progressed from##6##2##(1993-2#1)(2008-10#1)(2010-6#1)(2012-1#2)(2013-1#1)
progressed in the##2##3##(1992-3#1)(2008-10#1)
progressed in##3##2##(1992-3#1)(1997-3#1)(2008-10#1)
progressed through##4##2##(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
progressed to a##2##3##(1995-2#1)(2010-3#1)
progressed to##12##2##(1994-12#1)(1995-2#1)(1997-3#2)(2008-1#3)(2008-10#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-1#1)
progressed with##2##2##(2008-12#1)(2011-2#1)
progressed##60##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-3#4)(2007-11#1)(2007-5#1)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#3)(2008-7#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
progresses in##3##2##(2008-8#1)(2009-12#1)(2011-2#1)
progresses through##2##2##(1997-1#1)(2013-1#1)
progresses towards##2##2##(2013-1#1)(2013-8#1)
progresses##24##1##(1996-1#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
progressing to##10##2##(1993-1#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
progressing##31##1##(1990-8#2)(1991-1#1)(1993-1#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
progression (TTP)##2##2##(2008-10#1)(2009-4#1)
progression after##3##2##(1991-6#1)(1994-8#1)(2013-8#1)
progression and axial eye growth##2##5##(2010-1#2)
progression and##50##2##(1991-4#1)(1991-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
progression are##2##2##(2008-8#1)(2009-3#1)
progression as well as##3##4##(2008-9#1)(2010-12#1)(2013-8#1)
progression at 5 years##2##4##(1991-4#1)(2013-1#1)
progression at##5##2##(1991-4#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
progression by##4##2##(1997-7#1)(2008-4#1)(2009-3#1)(2011-2#1)
progression during##2##2##(2010-3#1)(2012-3#1)
progression factors##2##2##(1994-3#1)(2008-6#1)
progression for##4##2##(2008-6#1)(2012-3#2)(2013-8#1)
progression free survival##3##3##(2008-10#3)
progression from G0##2##3##(1990-11#1)(1995-2#1)
progression from##9##2##(1990-11#1)(1995-2#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
progression in the##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
progression in##30##2##(1992-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#3)(2013-1#3)
progression is##4##2##(2008-1#1)(2008-11#1)(2011-7#1)(2013-8#1)
progression may##3##2##(2008-1#1)(2009-4#1)(2010-4#1)
progression of ARM in##2##4##(2011-2#2)
progression of ARM##3##3##(2011-2#3)
progression of a##5##3##(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
progression of atherosclerosis in##2##4##(2008-1#2)
progression of atherosclerosis##8##3##(1995-12#1)(1995-6#1)(2008-1#4)(2008-7#1)(2013-7#1)
progression of cancer##2##3##(1993-9#1)(2013-1#1)
progression of chronic renal disease##2##5##(1994-3#1)(2008-1#1)
progression of chronic renal##4##4##(1994-3#1)(2008-1#3)
progression of chronic##5##3##(1994-3#1)(2008-1#3)(2009-8#1)
progression of coronary artery disease##2##5##(1996-3#1)(2007-8#1)
progression of coronary atherosclerosis##2##4##(1995-12#2)
progression of coronary##4##3##(1995-12#2)(1996-3#1)(2007-8#1)
progression of diabetic##2##3##(2008-1#1)(2011-2#1)
progression of disease during##2##4##(1991-2#1)(1994-8#1)
progression of disease##13##3##(1990-10#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#2)
progression of his##2##3##(2010-6#1)(2011-2#1)
progression of insulin resistance##2##4##(2008-1#2)
progression of liver##2##3##(2012-3#1)(2013-8#1)
progression of nephropathy##3##3##(2008-1#3)
progression of prostate cancer##2##4##(2011-2#2)
progression of renal##5##3##(1990-5#1)(1990-9#1)(2007-7#1)(2008-1#1)(2011-1#1)
progression of spine curve##2##4##(2007-8#2)
progression of symptoms##2##3##(2011-2#1)(2013-1#1)
progression of the disease in##2##5##(1992-6#1)(2012-3#1)
progression of the disease##12##4##(1990-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-5#1)(1996-6#1)(2008-12#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-3#1)
progression of the neurological##2##4##(1991-11#1)(1997-5#1)
progression of the##29##3##(1990-11#2)(1990-2#1)(1990-8#1)(1991-11#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-3#1)(2010-10#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
progression of various##2##3##(2009-5#1)(2010-3#1)
progression of vascular##3##3##(2007-10#1)(2012-12#2)
progression of##200##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#5)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#16)(2008-10#8)(2008-11#1)(2008-12#2)(2008-7#15)(2008-8#5)(2008-9#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-3#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#25)(2011-3#3)(2012-12#9)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#5)
progression or##9##2##(1994-8#1)(2008-10#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-3#1)(2013-1#1)
progression remains##2##2##(1991-2#1)(2010-4#1)
progression through the cell cycle##2##5##(1993-8#1)(2008-9#1)
progression through##9##2##(1993-6#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#1)
progression to AIDS##3##3##(2008-12#1)(2010-8#1)(2012-2#1)
progression to a##2##3##(1994-8#1)(2013-1#1)
progression to acute##2##3##(2011-2#1)(2012-12#1)
progression to cirrhosis##2##3##(2006-10#1)(2008-5#1)
progression to disease##2##3##(2007-2#1)(2013-8#1)
progression to##29##2##(1994-5#1)(1994-8#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
progression was observed##2##3##(1991-8#1)(2008-6#1)
progression was##12##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(2008-10#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-1#2)
progression were##5##2##(1993-8#1)(1994-11#1)(2007-2#1)(2008-10#2)
progression with##2##2##(2012-12#2)
progression##564##1##(1990-10#2)(1990-11#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#4)(1993-8#4)(1993-9#4)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#11)(1995-11#1)(1995-12#6)(1995-2#5)(1995-6#2)(1995-9#3)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#27)(2008-10#32)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#26)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#7)(2009-4#7)(2009-5#11)(2009-6#6)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#13)(2010-10#3)(2010-11#6)(2010-12#5)(2010-3#7)(2010-4#3)(2010-5#2)(2010-6#5)(2010-8#6)(2010-9#1)(2011-1#10)(2011-2#42)(2011-3#6)(2011-7#3)(2012-1#2)(2012-12#30)(2012-2#13)(2012-3#19)(2012-8#3)(2013-1#42)(2013-7#2)(2013-8#15)
progression-free and overall survival##2##4##(2008-6#2)
progression-free survival##5##2##(1990-6#2)(2011-2#1)(2013-1#2)
progression-free##8##1##(1990-6#2)(2008-6#2)(2011-2#1)(2012-1#1)(2013-1#2)
progressions##3##1##(1991-2#1)(1991-8#1)(2010-1#1)
progressive MS##2##2##(2010-12#2)
progressive accumulation##2##2##(2008-7#1)(2008-9#1)
progressive and##4##2##(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
progressive aphasia and##2##3##(2008-4#1)(2008-9#1)
progressive brain##3##2##(2008-7#1)(2009-10#2)
progressive changes in##2##3##(2008-7#1)(2013-8#1)
progressive changes##3##2##(1992-11#1)(2008-7#1)(2013-8#1)
progressive cholestasis##2##2##(1996-3#2)
progressive decline in##4##3##(2009-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
progressive decline##6##2##(1993-2#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
progressive decrease in the##2##4##(1996-5#1)(2008-5#1)
progressive decrease in##3##3##(1991-2#1)(1996-5#1)(2008-5#1)
progressive decrease##5##2##(1991-2#1)(1995-8#1)(1996-5#1)(2008-5#1)(2011-2#1)
progressive degeneration of##2##3##(2007-11#1)(2008-9#1)
progressive destruction of##2##3##(1994-8#1)(2011-2#1)
progressive deterioration of##5##3##(1991-2#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-7#1)
progressive deterioration##8##2##(1991-2#1)(2006-7#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
progressive development of##4##3##(1991-6#1)(2008-4#1)(2010-11#1)(2010-12#1)
progressive disease##15##2##(1990-12#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-9#1)(1994-8#1)(1995-5#1)(2007-7#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
progressive enlargement of the##2##4##(2007-10#1)(2007-12#1)
progressive glomerulonephritis##5##2##(2007-7#2)(2008-1#2)(2008-7#1)
progressive hearing loss##3##3##(2012-2#3)
progressive impairment of##2##3##(2009-10#1)(2011-2#1)
progressive increase in##8##3##(1990-7#1)(1991-9#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)
progressive increase##9##2##(1990-7#1)(1991-9#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-1#1)
progressive infection##2##2##(2007-7#1)(2013-1#1)
progressive liver disease##2##3##(2009-5#1)(2009-8#1)
progressive liver##3##2##(2009-5#1)(2009-8#1)(2012-2#1)
progressive loss of##12##3##(1990-3#1)(1990-7#1)(1992-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
progressive loss##13##2##(1990-3#1)(1990-7#1)(1992-8#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
progressive multiple##2##2##(2010-12#1)(2011-2#1)
progressive neurological##9##2##(2008-4#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#2)(2013-8#1)
progressive nonfluent aphasia (PNFA)##2##4##(2008-4#1)(2009-9#1)
progressive nonfluent aphasia##3##3##(2008-4#1)(2009-9#2)
progressive occlusion of the##2##4##(2008-3#1)(2012-3#1)
progressive reduction in##2##3##(2008-10#1)(2010-11#1)
progressive reduction##3##2##(2008-10#2)(2010-11#1)
progressive renal failure##2##3##(1990-9#1)(2008-1#1)
progressive renal insufficiency##2##3##(2007-7#1)(2008-1#1)
progressive renal##5##2##(1990-9#1)(2007-7#1)(2008-1#3)
progressive replacement of##2##3##(1992-12#1)(2008-8#1)
progressive resistance training##2##3##(2007-12#1)(2012-12#1)
progressive supranuclear palsy##4##3##(1992-8#2)(2008-7#1)(2012-12#1)
progressive systemic##2##2##(1991-3#2)
progressive vascular remodelling##2##3##(2010-10#1)(2010-6#1)
progressive weakness##2##2##(2012-2#2)
progressive##304##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#2)(2006-7#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-7#8)(2007-8#2)(2008-1#10)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#10)(2008-6#5)(2008-7#28)(2008-8#2)(2008-9#11)(2009-10#6)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#12)(2011-7#1)(2012-1#1)(2012-12#9)(2012-2#11)(2012-3#14)(2013-1#17)(2013-7#3)(2013-8#6)
progressive)##2##1##(1995-11#1)(2012-3#1)
progressively as##2##2##(1993-3#1)(2008-10#1)
progressively decline##2##2##(1995-8#1)(2009-12#1)
progressively decreased##2##2##(1990-3#1)(1997-4#1)
progressively decreases##2##2##(2008-10#1)(2008-5#1)
progressively from##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)
progressively higher##2##2##(1995-5#1)(1995-9#1)
progressively increased##4##2##(1990-9#1)(1993-12#1)(1993-2#1)(2011-2#1)
progressively increasing the##2##3##(1997-2#1)(2010-7#1)
progressively increasing##6##2##(1993-8#1)(1997-2#1)(2007-7#1)(2008-9#1)(2010-7#1)(2013-1#1)
progressively less##2##2##(1992-8#1)(2009-8#1)
progressively lost##2##2##(1990-11#1)(2008-5#1)
progressively more##9##2##(1990-3#1)(1992-10#1)(1993-12#2)(1994-2#2)(2010-7#1)(2011-2#1)(2012-2#1)
progressively over##2##2##(2008-10#1)(2011-2#1)
progressively reduced with##2##3##(2008-3#2)
progressively reduced##5##2##(1997-2#1)(2008-1#1)(2008-3#2)(2012-3#1)
progressively smaller##2##2##(2008-2#1)(2008-6#1)
progressively with increasing##3##3##(1990-9#1)(1994-12#1)(2008-3#1)
progressively with##6##2##(1990-9#1)(1994-12#1)(2008-10#2)(2008-3#1)(2010-2#1)
progressively##112##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#2)(1991-12#1)(1992-10#1)(1992-12#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-8#2)(1994-12#1)(1994-2#3)(1994-5#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#4)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
prohemostatic##2##1##(2013-1#2)
prohibit or##2##2##(2008-10#1)(2009-7#1)
prohibit the##4##2##(1990-2#2)(2007-12#1)(2008-3#1)
prohibit##11##1##(1990-2#3)(1996-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-7#1)(2013-8#1)
prohibited in##2##2##(1995-2#1)(2008-10#1)
prohibited the##2##2##(1996-5#1)(2012-12#1)
prohibited##15##1##(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-11#2)(2010-2#1)(2010-7#1)(2012-12#1)
prohibitin##2##1##(1994-12#1)(2010-12#1)
prohibiting##2##1##(1996-5#1)(2009-6#1)
prohibition on##2##2##(1995-6#1)(1996-5#1)
prohibition##3##1##(1995-6#1)(1996-5#1)(2008-8#1)
prohibitive##5##1##(1996-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
prohibits discrimination##2##2##(1994-1#1)(1995-6#1)
prohibits##4##1##(1994-1#1)(1995-6#2)(2007-12#1)
prohormone##7##1##(1990-12#3)(1992-12#1)(1993-5#1)(2008-4#2)
prohormones##8##1##(1992-6#1)(1993-5#1)(2008-4#5)(2008-6#1)
proinflammatory and prothrombotic##2##3##(2008-3#1)(2013-1#1)
proinflammatory cytokine##4##2##(1995-12#1)(2008-6#1)(2009-10#1)(2009-8#1)
proinflammatory cytokines##14##2##(1995-12#1)(2007-11#3)(2008-1#2)(2008-11#4)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
proinflammatory mediator##2##2##(2008-10#1)(2008-7#1)
proinflammatory mediators and##2##3##(2008-7#1)(2012-2#1)
proinflammatory mediators##6##2##(1992-6#1)(1994-8#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
proinflammatory##42##1##(1992-6#1)(1994-8#1)(1995-12#2)(2007-11#3)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
proinsulin secretion##2##2##(2008-11#2)
proinsulin##8##1##(1995-5#1)(1995-6#1)(1995-8#1)(2008-11#4)(2008-4#1)
project aimed at##3##3##(1997-7#1)(2008-10#2)
project aimed to##3##3##(2008-11#2)(2012-12#1)
project aimed##6##2##(1997-7#1)(2008-10#2)(2008-11#2)(2012-12#1)
project aims##2##2##(2008-7#1)(2011-2#1)
project and##4##2##(1992-2#1)(2008-1#1)(2008-12#1)(2009-8#1)
project are##5##2##(1993-3#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-6#1)
project as##2##2##(2008-11#1)(2008-12#1)
project at##2##2##(1993-3#1)(2008-7#1)
project can be##2##3##(1992-3#2)
project concerned##2##2##(2009-5#1)(2013-1#1)
project contributed to##2##3##(2008-1#1)(2011-2#1)
project could have##2##3##(1997-3#2)
project designed##2##2##(1991-12#1)(2007-11#1)
project explored the##2##3##(2008-9#1)(2012-12#1)
project for the##3##3##(1995-12#1)(2008-12#1)(2012-12#1)
project for##5##2##(1993-1#1)(1995-12#1)(1997-8#1)(2008-12#1)(2012-12#1)
project from##2##2##(1992-11#1)(2008-4#1)
project in the##4##3##(1991-1#1)(1993-3#1)(2008-9#1)(2013-1#1)
project in##11##2##(1991-1#1)(1993-3#1)(1994-1#1)(1996-3#1)(1996-8#1)(2008-1#1)(2008-12#3)(2008-9#1)(2013-1#1)
project included##2##2##(2008-1#1)(2008-11#1)
project into##2##2##(2007-12#2)
project involving##3##2##(1995-1#1)(2008-11#1)(2008-7#1)
project is to##2##3##(1996-2#1)(2010-7#1)
project is##13##2##(1991-1#1)(1994-3#1)(1995-12#1)(1996-2#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-7#1)
project itself##2##2##(1993-12#1)(2010-10#1)
project management##2##2##(1994-1#1)(2010-6#1)
project of##10##2##(1990-3#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-7#2)(2012-12#1)(2012-2#2)(2013-1#1)
project offers##2##2##(1995-12#1)(2010-5#1)
project on##4##2##(1992-3#1)(2008-7#2)(2009-7#1)
project plan##3##2##(1995-12#1)(1995-2#1)(2008-7#1)
project plane##2##2##(2009-7#2)
project team##4##2##(1995-3#3)(2008-7#1)
project teams##2##2##(1993-12#1)(2008-10#1)
project that##11##2##(1991-9#1)(1996-2#1)(2008-11#3)(2008-12#3)(2008-8#1)(2010-10#1)(2010-11#1)
project to the##7##3##(1996-5#2)(1997-3#1)(2007-12#1)(2008-4#1)(2012-12#1)(2013-8#1)
project to##26##2##(1991-6#1)(1991-9#1)(1993-3#1)(1995-2#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(2007-12#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-10#2)(2012-12#1)(2013-8#1)
project was carried out##2##4##(1994-6#1)(2013-1#1)
project was conducted##3##3##(1996-2#1)(2008-11#1)(2012-3#1)
project was designed to##2##4##(1996-2#1)(2008-11#1)
project was initiated##3##3##(1993-3#1)(2008-12#1)(2009-4#1)
project was to examine the##2##5##(1995-3#1)(2011-2#1)
project was to examine##3##4##(1995-3#1)(2007-4#1)(2011-2#1)
project was to##13##3##(1991-9#1)(1994-3#1)(1995-3#2)(1997-4#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
project was undertaken in##2##4##(1992-2#1)(1993-12#1)
project was undertaken##5##3##(1992-2#1)(1993-12#1)(2007-5#1)(2008-10#1)(2008-11#1)
project was##47##2##(1991-9#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-3#3)(1995-6#1)(1996-2#2)(1997-4#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-9#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
project we##2##2##(2011-1#2)
project which##2##2##(1995-3#2)
project whose purpose is to##2##5##(1994-12#1)(2010-8#1)
project whose##3##2##(1992-1#1)(1994-12#1)(2010-8#1)
project will be##3##3##(1996-9#1)(2009-10#1)(2010-5#1)
project will provide##2##3##(2008-7#1)(2012-12#1)
project will##7##2##(1996-1#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-12#1)
project with##3##2##(1992-12#1)(1997-3#1)(2012-12#1)
project within the##3##3##(1995-6#2)(2012-2#1)
project##436##1##(1990-3#1)(1991-1#2)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#3)(1992-6#1)(1993-1#2)(1993-12#5)(1993-3#5)(1994-1#5)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#20)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#9)(1996-3#3)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#2)(2006-5#1)(2007-11#4)(2007-12#9)(2007-4#2)(2007-5#3)(2007-7#2)(2008-1#8)(2008-10#19)(2008-11#32)(2008-12#22)(2008-2#4)(2008-3#6)(2008-4#9)(2008-5#1)(2008-6#3)(2008-7#18)(2008-8#4)(2008-9#9)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#6)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#1)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#47)(2011-9#5)(2012-1#2)(2012-12#15)(2012-2#11)(2012-3#6)(2013-1#16)(2013-8#7)
project]##4##1##(1991-2#1)(1994-3#1)(1997-2#1)(2007-3#1)
projected for the##2##3##(2007-12#1)(2007-7#1)
projected for##5##2##(1995-12#1)(2007-12#2)(2007-7#1)(2012-2#1)
projected increase in##2##3##(2008-6#1)(2013-1#1)
projected increases in##2##3##(1996-12#1)(2008-8#1)
projected into##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
projected on a##2##3##(2008-12#1)(2009-5#1)
projected onto a##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-7#1)
projected onto the object##3##4##(2008-3#3)
projected onto the##4##3##(2008-2#1)(2008-3#3)
projected onto##11##2##(2007-12#1)(2008-2#2)(2008-3#6)(2011-2#1)(2011-7#1)
projected over the##2##3##(1993-11#1)(2012-12#1)
projected random patterns##2##3##(2008-3#2)
projected to become the##2##4##(1994-9#1)(2010-8#1)
projected to the##4##3##(1993-12#4)
projected to##13##2##(1993-12#5)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-3#1)(2010-8#1)(2012-12#1)
projected##77##1##(1991-1#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#5)(1994-12#1)(1994-2#1)(1994-3#4)(1994-9#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#1)(2007-11#4)(2007-12#7)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#17)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
projectile##6##1##(1990-9#1)(1997-5#2)(2009-10#2)(2010-2#1)
projecting from the medial##2##4##(1997-3#1)(2012-2#1)
projecting from the##3##3##(1997-3#1)(2012-2#2)
projecting to##3##2##(1996-5#3)
projecting##16##1##(1992-9#1)(1993-2#1)(1994-2#2)(1995-11#1)(1996-5#3)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-9#1)(2012-2#2)(2013-8#1)
projection algorithm##4##2##(2008-3#4)
projection and the##2##3##(2008-3#1)(2012-1#1)
projection and##4##2##(1997-7#1)(2008-3#1)(2010-8#1)(2012-1#1)
projection area##4##2##(1993-12#1)(1996-2#1)(2008-5#2)
projection areas##5##2##(1993-6#1)(1995-12#1)(1997-2#1)(2008-7#1)(2008-8#1)
projection data##3##2##(2010-12#1)(2012-1#2)
projection display##2##2##(2008-2#1)(2008-3#1)
projection displays##2##2##(2008-2#1)(2008-3#1)
projection for##2##2##(1990-11#1)(2008-10#1)
projection from##3##2##(1993-9#1)(1996-5#1)(2008-11#1)
projection grating##2##2##(2008-3#2)
projection image data##2##3##(2008-5#2)
projection image##3##2##(2008-5#3)
projection images##6##2##(2008-5#5)(2011-1#1)
projection in##2##2##(1990-5#1)(2008-7#1)
projection lens##3##2##(2008-3#3)
projection lithography##2##2##(2008-2#1)(2008-3#1)
projection neurons in the##2##4##(1994-2#1)(2008-7#1)
projection neurons##11##2##(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#3)(2008-7#3)(2009-12#1)(2013-8#1)
projection of##11##2##(1993-12#1)(1994-2#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#1)
projection onto##2##2##(2008-2#1)(2008-3#1)
projection optical##2##2##(2008-3#2)
projection optics##3##2##(2008-3#3)
projection patterns of##2##3##(2007-12#1)(2008-11#1)
projection system##6##2##(2008-2#1)(2008-3#5)
projection systems##4##2##(2008-3#4)
projection that##2##2##(2008-3#1)(2011-1#1)
projection to the##5##3##(1990-5#2)(1993-12#1)(1996-5#1)(2011-2#1)
projection to##6##2##(1990-5#2)(1993-12#1)(1996-5#1)(2008-2#1)(2011-2#1)
projection view##2##2##(2008-5#2)
projection was##2##2##(2008-6#1)(2008-7#1)
projection##162##1##(1990-11#1)(1990-5#3)(1991-5#1)(1992-10#2)(1992-6#1)(1993-12#4)(1993-6#1)(1993-9#1)(1994-2#3)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#12)(2008-3#53)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#1)(2013-8#2)
projectional##3##1##(2008-7#1)(2010-12#2)
projections and##3##2##(1991-5#1)(1994-2#1)(2013-8#1)
projections are##3##2##(1994-5#2)(2008-2#1)
projections for##2##2##(1991-9#1)(2008-11#1)
projections from the medial##2##4##(1997-3#1)(2013-8#1)
projections from the##6##3##(1992-10#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-8#1)
projections from##9##2##(1992-10#1)(1994-2#1)(1997-3#1)(2008-11#2)(2008-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
projections in a##2##3##(2008-2#1)(2010-12#1)
projections in##3##2##(2008-2#1)(2010-12#1)(2011-2#1)
projections into##2##2##(1991-12#1)(2008-7#1)
projections of the##4##3##(1994-9#1)(2008-2#1)(2008-3#1)(2008-7#1)
projections of##10##2##(1992-9#1)(1994-9#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)
projections to the##8##3##(1993-6#1)(1995-12#2)(1995-8#1)(1996-5#1)(1997-2#1)(2009-10#1)(2011-2#1)
projections to##9##2##(1993-6#1)(1995-12#2)(1995-8#1)(1996-5#1)(1997-2#1)(2009-10#1)(2009-5#1)(2011-2#1)
projections##85##1##(1991-1#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#3)(1993-6#2)(1994-2#3)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-2#2)(1996-5#4)(1997-2#1)(1997-3#2)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#3)(2009-5#3)(2009-8#2)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
projective displays##2##2##(2008-3#2)
projective##4##1##(2008-3#2)(2008-6#1)(2009-10#1)
projective-introjective identification##2##2##(2009-11#2)
projector and##2##2##(2008-2#1)(2008-3#1)
projector with a##2##3##(2008-3#2)
projector with##3##2##(2008-2#1)(2008-3#2)
projector##21##1##(2007-11#2)(2008-10#2)(2008-2#4)(2008-3#10)(2008-6#3)
projectors##2##1##(2008-3#1)(2008-6#1)
projects and##7##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
projects are##3##2##(1996-2#1)(2008-12#1)(2008-7#1)
projects for##2##2##(1994-3#1)(2011-2#1)
projects from the##2##3##(1991-5#1)(2008-10#1)
projects have##2##2##(1991-12#1)(2010-3#1)
projects in the##2##3##(1991-12#1)(2009-6#1)
projects in##10##2##(1991-12#1)(2007-7#2)(2008-4#1)(2008-7#2)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#1)
projects is##2##2##(2008-7#2)
projects of##6##2##(1990-6#1)(1996-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-12#1)
projects presented##2##2##(1995-6#1)(2012-2#1)
projects should be##2##3##(1992-12#1)(2013-1#1)
projects that##7##2##(1993-12#1)(1993-3#1)(1994-7#1)(1997-1#1)(2008-6#1)(2008-9#1)(2012-3#1)
projects to##4##2##(1993-3#1)(1994-2#1)(2008-9#1)(2011-2#1)
projects undertaken in##2##3##(2008-10#1)(2008-11#1)
projects were##3##2##(1996-12#1)(2008-8#1)(2012-3#1)
projects which##4##2##(1992-3#1)(1996-3#2)(2013-1#1)
projects within##4##2##(1993-2#1)(1995-3#1)(2012-12#1)(2012-3#1)
projects##144##1##(1990-6#1)(1991-1#1)(1991-12#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#6)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#2)(2009-6#2)(2010-10#2)(2010-3#5)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#12)(2013-1#4)
prokaryote##9##1##(1996-12#1)(2008-1#2)(2008-10#4)(2008-8#1)(2008-9#1)
prokaryotes and eukaryotes##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
prokaryotes and##4##2##(1996-12#1)(1997-7#1)(2011-2#1)(2012-3#1)
prokaryotes##16##1##(1996-12#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
prokaryotic DNA##2##2##(1994-12#1)(2008-10#1)
prokaryotic and eukaryotic expression##2##4##(1997-4#1)(2009-9#1)
prokaryotic and eukaryotic organisms##2##4##(2008-11#1)(2008-7#1)
prokaryotic and eukaryotic##11##3##(1990-5#1)(1995-6#1)(1997-4#2)(1997-7#2)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)
prokaryotic and##13##2##(1990-5#1)(1993-9#1)(1995-6#1)(1997-4#2)(1997-7#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-9#1)
prokaryotic as well as##2##4##(1996-2#1)(2011-2#1)
prokaryotic cells##3##2##(1992-12#1)(1997-4#1)(2008-11#1)
prokaryotic counterparts##2##2##(2009-2#2)
prokaryotic expression##3##2##(1995-11#1)(2008-4#1)(2011-1#1)
prokaryotic organisms##2##2##(1995-2#1)(2011-2#1)
prokaryotic vector##2##2##(2008-11#2)
prokaryotic##54##1##(1990-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-4#3)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-2#3)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#2)
prokinetic drugs##2##2##(1994-2#2)
prokinetic##3##1##(1994-2#2)(2011-2#1)
prokineticins##2##1##(2008-7#2)
prolactin (PRL)##4##2##(1990-7#1)(1991-12#1)(1994-8#1)(2008-6#1)
prolactin and##5##2##(1991-12#1)(1994-11#1)(2008-1#1)(2008-12#1)(2008-4#1)
prolactin in##4##2##(1992-9#1)(1993-2#1)(2008-12#1)(2008-4#1)
prolactin levels were##2##3##(1990-11#1)(1992-5#1)
prolactin levels##7##2##(1990-11#4)(1992-5#1)(1993-2#1)(1995-3#1)
prolactin receptor gene##2##3##(2008-4#2)
prolactin receptor##6##2##(1995-11#2)(2008-4#3)(2011-2#1)
prolactin release##3##2##(1991-3#1)(1994-6#1)(2008-4#1)
prolactin secretion##7##2##(1990-7#1)(1993-11#1)(1994-3#1)(1996-2#4)
prolactin##66##1##(1990-11#5)(1990-2#1)(1990-7#2)(1991-12#3)(1991-3#3)(1992-5#2)(1992-9#1)(1993-11#1)(1993-2#4)(1994-11#8)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#3)(1995-3#1)(1996-2#4)(2008-1#1)(2008-11#2)(2008-12#6)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)
prolactine##2##1##(2008-7#2)
prolactinoma##2##1##(1993-2#1)(2009-4#1)
prolapse and##7##2##(1997-2#1)(2008-12#1)(2013-1#5)
prolapse in##2##2##(1992-5#1)(2011-2#1)
prolapse stage##2##2##(2008-12#2)
prolapse was##6##2##(2008-12#2)(2013-1#4)
prolapse##51##1##(1992-11#1)(1992-5#2)(1997-2#2)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#8)(2008-7#1)(2011-2#7)(2012-3#1)(2013-1#23)
prolapsed##2##1##(1993-9#1)(2013-1#1)
prolapsing##2##1##(2007-8#1)(2008-11#1)
prolate##4##1##(2008-2#1)(2008-3#3)
prolene mesh##2##2##(2008-12#1)(2008-7#1)
prolidase##2##1##(2013-1#1)(2013-7#1)
proliferate and differentiate##3##3##(1995-12#1)(2008-4#1)(2010-3#1)
proliferate and mature into##2##4##(2008-11#1)(2008-4#1)
proliferate and##10##2##(1995-12#1)(1997-6#1)(2008-11#3)(2008-4#2)(2008-7#1)(2009-5#1)(2010-3#1)
proliferate in##9##2##(1990-12#1)(1992-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2013-8#1)
proliferate to form##2##3##(1995-2#1)(2012-12#1)
proliferate to##3##2##(1995-2#1)(2011-1#1)(2012-12#1)
proliferate##40##1##(1990-12#2)(1992-2#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-11#9)(2008-4#4)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#3)(2013-8#2)
proliferated in##5##2##(1993-8#1)(2008-10#1)(2008-11#2)(2012-1#1)
proliferated more##2##2##(2008-11#2)
proliferated##20##1##(1993-8#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#7)(2008-3#1)(2009-10#1)(2012-1#2)(2012-4#1)
proliferates in the##2##3##(1994-12#1)(2011-2#1)
proliferating HeLa interphase cells##2##4##(1992-6#2)
proliferating and##6##2##(1992-3#2)(1992-9#1)(1993-11#1)(2008-8#1)(2008-9#1)
proliferating cell nuclear antigen (PCNA)##8##5##(1994-12#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2011-2#1)(2012-1#1)
proliferating cell nuclear antigen##11##4##(1992-10#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
proliferating cell##12##2##(1992-10#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
proliferating cells with##2##3##(1995-12#1)(1996-5#1)
proliferating cells##12##2##(1992-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-5#2)(2008-8#1)(2008-9#3)(2010-3#2)
proliferating##56##1##(1991-11#2)(1992-10#1)(1992-3#2)(1992-6#3)(1992-9#2)(1993-11#2)(1993-2#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
proliferation ability##2##2##(2008-11#1)(2013-1#1)
proliferation after##7##2##(1997-8#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#2)
proliferation and a##3##3##(1993-11#1)(2008-11#1)(2012-3#1)
proliferation and apoptosis in##3##4##(2008-11#1)(2011-2#2)
proliferation and apoptosis of##3##4##(2011-2#2)(2013-1#1)
proliferation and apoptosis##9##3##(2008-11#2)(2008-7#1)(2011-2#4)(2012-1#1)(2013-1#1)
proliferation and cell death##3##4##(2008-11#3)
proliferation and cell##7##3##(2008-11#3)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)
proliferation and differentiation during##2##4##(1994-9#1)(2010-9#1)
proliferation and differentiation of human##2##5##(1994-6#1)(2008-11#1)
proliferation and differentiation of##7##4##(1993-3#1)(1994-6#1)(2008-11#2)(2008-5#3)
proliferation and differentiation##23##3##(1991-2#1)(1991-5#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-10#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-9#2)(2010-9#1)(2012-2#2)
proliferation and growth of##3##4##(1994-11#1)(2008-1#1)(2011-2#1)
proliferation and increased##4##3##(2009-12#1)(2012-4#1)(2013-1#2)
proliferation and induction of##2##4##(1995-11#1)(2008-10#1)
proliferation and invasion of##8##4##(2008-11#6)(2011-2#1)(2013-1#1)
proliferation and invasion##10##3##(2008-11#7)(2011-2#1)(2012-12#1)(2013-1#1)
proliferation and migration of##3##4##(1991-12#1)(2008-4#2)
proliferation and migration##5##3##(1991-12#1)(2008-10#2)(2008-4#2)
proliferation and neuronal differentiation of human fetal##2##7##(2009-10#2)
proliferation and recombinant##2##3##(2008-11#2)
proliferation and survival##5##3##(2012-12#1)(2013-1#3)(2013-8#1)
proliferation and the##7##3##(1990-11#1)(1991-12#1)(1992-3#1)(1993-3#1)(2008-11#2)(2008-4#1)
proliferation and to##3##3##(1993-12#1)(1995-2#1)(2012-2#1)
proliferation and##150##2##(1990-11#1)(1990-12#1)(1991-12#3)(1991-2#1)(1991-5#2)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#25)(2008-12#1)(2008-3#1)(2008-4#8)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#15)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#10)(2013-8#4)
proliferation as##2##2##(1991-5#1)(2009-9#1)
proliferation assay##10##2##(1993-8#1)(1995-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2011-2#2)(2013-1#2)
proliferation assays##8##2##(1991-9#1)(1993-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)(2012-12#1)
proliferation at##4##2##(1991-12#1)(1992-5#1)(2008-11#1)(2013-1#1)
proliferation by##12##2##(1992-11#1)(1992-2#1)(1992-5#1)(1993-9#2)(1995-2#3)(2008-5#1)(2008-6#1)(2008-9#2)
proliferation can##2##2##(1990-8#1)(2008-6#1)
proliferation control in##2##3##(2008-11#1)(2009-5#1)
proliferation control##4##2##(2008-11#2)(2009-5#2)
proliferation during##3##2##(1994-3#1)(2008-11#1)(2012-12#1)
proliferation for##2##2##(2006-6#1)(2008-11#1)
proliferation in a##3##3##(1992-5#1)(1995-11#1)(2008-11#1)
proliferation in both##4##3##(1991-5#1)(1993-8#1)(2007-8#1)(2008-11#1)
proliferation in breast##2##3##(2008-10#1)(2008-4#1)
proliferation in different##2##3##(2012-3#1)(2013-7#1)
proliferation in response to##3##4##(1992-12#1)(2010-11#1)(2012-12#1)
proliferation in the##8##3##(1990-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-7#1)(2010-6#1)(2013-1#1)
proliferation in vitro##6##3##(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-3#1)
proliferation in##62##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#2)(1991-5#3)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
proliferation index##2##2##(2011-1#1)(2013-8#1)
proliferation inhibition##2##2##(1992-2#1)(2012-12#1)
proliferation is a##2##3##(2008-1#1)(2008-6#1)
proliferation is##9##2##(1995-6#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-1#1)
proliferation kinetics of adapted strain##2##5##(2013-8#2)
proliferation kinetics of adapted##3##4##(2013-8#3)
proliferation kinetics##5##2##(2009-12#1)(2013-8#4)
proliferation marker##2##2##(2011-2#1)(2013-8#1)
proliferation markers##4##2##(1997-7#1)(2011-2#1)(2012-1#2)
proliferation occurred##3##2##(1991-8#1)(2008-9#1)(2013-1#1)
proliferation of CHO cells##2##4##(1995-2#1)(1997-1#1)
proliferation of MCF-7 human breast cancer cells that contained high levels of estrogen receptor (1##2##15##(2008-11#2)
proliferation of MCF-7##4##3##(2008-11#4)
proliferation of RPMI 1788 cells##2##5##(1990-12#2)
proliferation of RPMI 1788##3##4##(1990-12#3)
proliferation of T##2##3##(1993-3#1)(2008-10#1)
proliferation of a murine##2##4##(1994-5#1)(2008-4#1)
proliferation of a##3##3##(1994-5#1)(2008-4#1)(2010-6#1)
proliferation of activated##2##3##(1991-3#1)(2011-2#1)
proliferation of cells##2##3##(1990-7#1)(2008-11#1)
proliferation of gastric cancer##2##4##(2008-11#2)
proliferation of gastric##3##3##(2008-11#2)(2008-9#1)
proliferation of human cells##2##4##(1997-3#2)
proliferation of human##9##3##(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#2)(2008-11#2)(2008-5#1)(2008-8#1)
proliferation of individual##2##3##(2008-4#1)(2011-2#1)
proliferation of mammalian cells##2##4##(1997-1#1)(2008-11#1)
proliferation of mature##2##3##(2010-6#1)(2013-7#1)
proliferation of mouse##5##3##(1992-5#1)(2008-11#1)(2008-6#1)(2008-9#2)
proliferation of neural stem cells##2##5##(1994-11#2)
proliferation of nontransformed cells##2##4##(1995-2#2)
proliferation of normal##2##3##(1991-3#2)
proliferation of pre-existing β-cells##2##4##(2010-11#2)
proliferation of primary##2##3##(1993-6#1)(1994-3#1)
proliferation of quiescent##2##3##(1997-3#2)
proliferation of rat PASMCs##3##4##(2011-3#3)
proliferation of rat##6##3##(1992-3#1)(2011-3#5)
proliferation of smooth muscle cells##4##5##(1992-9#1)(1993-8#1)(1996-3#1)(2008-11#1)
proliferation of spindle##2##3##(2007-8#1)(2012-2#1)
proliferation of the human##3##4##(1994-6#1)(2007-11#1)(2008-4#1)
proliferation of the##25##3##(1993-11#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-2#1)(2006-6#1)(2007-11#1)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-1#1)
proliferation of these cells##2##4##(1994-2#1)(1995-3#1)
proliferation of these##3##3##(1994-2#1)(1995-3#1)(2008-10#1)
proliferation of vascular smooth muscle##2##5##(1990-12#1)(2010-12#1)
proliferation of vascular##4##3##(1990-12#1)(1993-3#1)(1997-1#1)(2010-12#1)
proliferation of##206##2##(1990-12#4)(1990-5#2)(1990-7#3)(1991-12#2)(1991-3#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1997-1#4)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#34)(2008-4#6)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-11#5)(2010-12#3)(2010-3#1)(2010-6#3)(2011-1#1)(2011-2#8)(2011-3#6)(2012-1#4)(2012-2#3)(2012-3#2)(2012-4#1)(2012-6#1)(2013-1#2)(2013-7#2)(2013-8#3)
proliferation or##8##2##(1992-5#2)(1992-8#1)(1992-9#1)(2008-11#1)(2012-3#1)(2013-8#2)
proliferation over that of control##2##5##(2008-11#2)
proliferation potential##2##2##(2008-11#2)
proliferation rate##10##2##(1991-8#1)(1994-10#1)(1995-4#1)(2007-11#1)(2008-11#3)(2008-5#1)(2008-7#1)(2012-3#1)
proliferation regulation##2##2##(2008-4#1)(2012-1#1)
proliferation than##2##2##(2008-5#1)(2010-3#1)
proliferation through##2##2##(1991-9#1)(1995-2#1)
proliferation to##2##2##(1997-2#1)(2008-5#1)
proliferation was investigated##2##3##(1996-12#1)(2008-11#1)
proliferation was reduced##2##3##(1997-2#1)(2008-11#1)
proliferation was##21##2##(1991-12#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-2#3)(2007-2#1)(2008-11#6)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
proliferation were##8##2##(2008-11#5)(2008-5#2)(2008-9#1)
proliferation with##6##2##(1991-9#1)(2007-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-5#1)
proliferation##824##1##(1990-11#6)(1990-12#10)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#5)(1991-12#10)(1991-2#2)(1991-3#5)(1991-5#8)(1991-8#3)(1991-9#6)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#7)(1992-8#9)(1992-9#6)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#8)(1993-6#2)(1993-8#8)(1993-9#11)(1994-10#5)(1994-11#12)(1994-2#5)(1994-3#9)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#6)(1995-11#7)(1995-12#9)(1995-2#20)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#4)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#5)(1996-5#3)(1996-6#1)(1997-1#5)(1997-2#7)(1997-3#5)(1997-6#4)(1997-7#6)(1997-8#1)(2006-10#1)(2006-6#6)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#4)(2007-8#2)(2008-1#4)(2008-10#37)(2008-11#120)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#36)(2008-5#25)(2008-6#10)(2008-7#23)(2008-8#10)(2008-9#25)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-11#11)(2010-12#5)(2010-3#9)(2010-6#5)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#39)(2011-3#6)(2012-1#15)(2012-12#15)(2012-2#16)(2012-3#10)(2012-4#3)(2012-5#2)(2012-6#1)(2012-8#1)(2013-1#25)(2013-7#6)(2013-8#17)
proliferation-associated proteins##2##2##(1994-7#1)(2008-9#1)
proliferation-associated##5##1##(1990-11#2)(1993-11#1)(1994-7#1)(2008-9#1)
proliferation-controlled cell lines##2##3##(2008-11#2)
proliferation-controlled##3##1##(2008-11#3)
proliferation-related##2##1##(1995-9#1)(2008-3#1)
proliferation/apoptosis##2##1##(2011-2#1)(2012-4#1)
proliferations are##2##2##(2010-1#1)(2011-2#1)
proliferations in##2##2##(2010-12#1)(2011-2#1)
proliferations##10##1##(1993-11#1)(2008-11#1)(2010-1#1)(2010-12#1)(2011-2#4)(2013-1#2)
proliferative GN##2##2##(2008-1#2)
proliferative activation##2##2##(1990-12#2)
proliferative activity in##3##3##(1995-12#2)(2008-6#1)
proliferative activity of breast##2##4##(1993-11#1)(1997-7#1)
proliferative activity of##6##3##(1993-11#1)(1994-9#1)(1997-7#2)(2008-11#1)(2012-1#1)
proliferative activity##15##2##(1990-8#1)(1993-11#2)(1994-9#2)(1995-12#2)(1995-4#2)(1997-7#2)(2008-11#1)(2008-6#1)(2010-11#1)(2012-1#1)
proliferative and##2##2##(2008-11#1)(2010-12#1)
proliferative capacity##2##2##(2008-11#1)(2008-7#1)
proliferative changes##2##2##(1994-5#1)(2009-1#1)
proliferative diabetic retinopathy and coronary##2##5##(2013-1#2)
proliferative diabetic retinopathy in the##2##5##(2013-1#2)
proliferative diabetic retinopathy##6##3##(2011-1#1)(2013-1#5)
proliferative diseases##2##2##(1993-5#1)(2013-1#1)
proliferative disorder of##2##3##(1990-12#1)(2010-3#1)
proliferative disorders##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
proliferative effect##2##2##(1992-8#1)(2012-1#1)
proliferative effects##2##2##(2008-4#1)(2011-2#1)
proliferative endometrium##2##2##(2011-2#2)
proliferative function##2##2##(2008-11#1)(2008-7#1)
proliferative glomerulonephritis##4##2##(2007-7#3)(2008-1#1)
proliferative index##8##2##(1993-11#1)(1997-7#1)(2008-10#1)(2008-6#2)(2011-2#1)(2012-2#1)(2012-3#1)
proliferative lesions##3##2##(1992-9#1)(1994-12#1)(2008-1#1)
proliferative response of##8##3##(1991-1#1)(1991-12#1)(1994-8#2)(1995-12#1)(1995-8#1)(2008-7#2)
proliferative response to##3##3##(1992-5#1)(2008-7#1)(2012-3#1)
proliferative response##13##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-5#1)(1994-8#2)(1995-12#1)(1995-8#1)(2008-7#4)(2012-3#1)
proliferative responses in##2##3##(1995-5#1)(2008-11#1)
proliferative responses of##3##3##(1991-12#1)(2008-4#2)
proliferative responses##10##2##(1991-12#1)(1995-5#1)(2008-11#1)(2008-4#2)(2008-7#3)(2011-2#2)
proliferative state##2##2##(1995-11#1)(2009-12#1)
proliferative stimulation##2##2##(1994-5#2)
proliferative vitreoretinopathy##3##2##(1991-2#3)
proliferative##136##1##(1990-12#4)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#1)(1993-5#1)(1994-12#2)(1994-5#4)(1994-8#3)(1994-9#3)(1995-11#2)(1995-12#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(2006-10#2)(2007-5#1)(2007-7#4)(2008-1#4)(2008-10#1)(2008-11#13)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#12)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#1)
proliferatively##2##1##(1994-6#1)(2012-2#1)
proliferator activated receptor##3##3##(2006-8#1)(2012-2#1)(2013-8#1)
proliferator activated##4##2##(2006-8#1)(2008-10#1)(2012-2#1)(2013-8#1)
proliferator##7##1##(1994-8#2)(2006-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
proliferator-activated receptor##13##2##(1994-12#1)(1994-8#1)(1995-6#2)(2008-1#1)(2008-3#1)(2008-5#2)(2010-10#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
proliferator-activated receptors##5##2##(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-7#1)
proliferator-activated##22##1##(1994-12#1)(1994-8#1)(1995-6#2)(2008-1#2)(2008-3#2)(2008-5#4)(2008-7#2)(2010-10#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
proliferators##5##1##(1990-12#2)(1994-8#2)(1995-6#1)
proliferatum##13##1##(2008-10#13)
proliferin gene##2##2##(1992-5#2)
proliferin##3##1##(1992-5#3)
prolific##3##1##(1994-3#1)(2008-11#1)(2009-9#1)
prolificans pneumonia##2##2##(2008-5#2)
prolificans##6##1##(2008-5#6)
proline analogue with##2##3##(2008-8#2)
proline analogue##3##2##(1990-5#1)(2008-8#2)
proline at##3##2##(1994-11#1)(1994-3#1)(2008-10#1)
proline in the##2##3##(1991-12#2)
proline in##5##2##(1991-12#2)(2008-10#3)
proline or##2##2##(1994-5#1)(2013-1#1)
proline residue##3##2##(1991-5#1)(1992-6#1)(1994-5#1)
proline residues##3##2##(1990-5#1)(1992-6#1)(1995-6#1)
proline were##3##2##(2008-10#2)(2008-12#1)
proline with##3##2##(1990-5#2)(1994-11#1)
proline##57##1##(1990-5#6)(1990-9#1)(1991-12#7)(1991-5#2)(1992-4#1)(1992-6#3)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-6#1)(2006-6#2)(2008-1#1)(2008-10#8)(2008-12#5)(2008-5#2)(2008-8#2)(2010-4#1)(2011-1#1)(2012-7#1)(2013-1#1)
proline-rich domain##2##2##(2008-8#1)(2013-8#1)
proline-rich region##3##2##(1991-6#2)(1997-7#1)
proline-rich##6##1##(1991-10#1)(1991-6#2)(1997-7#1)(2008-8#1)(2013-8#1)
prolines##2##1##(1992-6#1)(1995-6#1)
prolixus showed a##2##3##(2008-8#2)
prolixus##4##1##(2008-8#4)
prolong lifespan##2##2##(2009-12#1)(2012-3#1)
prolong survival##3##2##(1990-12#1)(2007-8#1)(2013-1#1)
prolong the cardiac QT(c) interval##2##5##(2007-11#2)
prolong the duration of##2##4##(2010-5#1)(2010-7#1)
prolong the survival##2##3##(1990-3#1)(1992-3#1)
prolong the##13##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-3#1)(1996-5#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2010-5#1)(2010-7#1)(2013-8#1)
prolong##31##1##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1995-1#1)(1996-5#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#3)(2009-11#1)(2009-12#1)(2010-5#2)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
prolongation of cell##2##3##(2008-11#2)
prolongation of the##12##3##(1991-3#1)(1994-8#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#2)
prolongation of##24##2##(1990-11#1)(1991-3#1)(1994-8#1)(1996-3#1)(1996-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#4)(2008-7#3)(2008-8#1)(2009-12#1)(2010-1#1)(2010-6#1)(2011-2#2)(2013-1#3)
prolongation##33##1##(1990-11#1)(1991-3#1)(1994-8#1)(1995-8#1)(1996-3#1)(1996-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#4)(2008-7#3)(2008-8#3)(2009-12#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#2)
prolonged (p &lt##2##3##(2008-12#1)(2008-9#1)
prolonged CPB##2##2##(2007-9#2)
prolonged action##2##2##(1992-3#1)(2010-5#1)
prolonged administration of##3##3##(1994-6#1)(1995-6#1)(2008-4#1)
prolonged administration##4##2##(1994-6#1)(1995-6#1)(1997-1#1)(2008-4#1)
prolonged and##7##2##(1992-3#1)(1994-5#1)(1994-6#1)(1997-2#1)(2008-9#1)(2010-6#1)(2011-2#1)
prolonged brain retraction##2##3##(2008-7#2)
prolonged by##2##2##(1992-6#1)(1995-12#1)
prolonged cardiopulmonary##2##2##(2007-8#1)(2010-12#1)
prolonged course##2##2##(1997-5#1)(2008-1#1)
prolonged courses of##2##3##(2007-11#1)(2011-2#1)
prolonged cultivation##2##2##(1994-3#1)(2008-11#1)
prolonged due to##2##3##(1996-3#1)(2007-8#1)
prolonged duration of##2##3##(2007-8#1)(2008-10#1)
prolonged duration##3##2##(2007-7#1)(2007-8#1)(2008-10#1)
prolonged elevation##2##2##(2008-5#1)(2008-8#1)
prolonged exposure of##2##3##(1995-12#1)(2013-1#1)
prolonged exposure to##9##3##(1991-12#2)(1991-4#1)(1995-12#1)(1997-1#1)(2008-10#3)(2013-1#1)
prolonged exposure##11##2##(1991-12#2)(1991-4#1)(1995-12#2)(1997-1#1)(2008-10#3)(2013-1#2)
prolonged fever##4##2##(2008-11#1)(2011-2#3)
prolonged food deprivation##2##3##(1997-2#2)
prolonged group##2##2##(2011-2#2)
prolonged heat##2##2##(1995-6#1)(2008-5#1)
prolonged heating##2##2##(2008-10#1)(2013-1#1)
prolonged hypothermic storage##2##3##(2007-8#2)
prolonged in##4##2##(1994-6#1)(1997-3#1)(2007-11#1)(2008-10#1)
prolonged latency of##2##3##(2011-2#1)(2013-8#1)
prolonged local##2##2##(2008-5#1)(2010-3#1)
prolonged mechanical ventilation##2##3##(2006-10#1)(2007-11#1)
prolonged neutropenia##2##2##(2007-12#1)(2008-7#1)
prolonged operation##2##2##(1997-2#1)(2007-8#1)
prolonged period of##4##3##(2008-8#1)(2008-9#2)(2011-2#1)
prolonged period##6##2##(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)
prolonged periods of##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)
prolonged periods##12##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
prolonged response to sunitinib##2##4##(2013-1#2)
prolonged response##4##2##(2008-11#1)(2013-1#3)
prolonged significantly##2##2##(2008-7#1)(2011-3#1)
prolonged stays##2##2##(1996-3#2)
prolonged storage##2##2##(2008-10#1)(2008-12#1)
prolonged survival in##2##3##(1995-2#1)(2011-2#1)
prolonged survival of##2##3##(1993-8#1)(2008-5#1)
prolonged survival##7##2##(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)
prolonged the culture period by##2##5##(2008-11#2)
prolonged the survival##2##3##(2008-5#1)(2008-8#1)
prolonged the##11##2##(1993-8#1)(1994-9#1)(1996-2#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-2#1)
prolonged time##4##2##(2007-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
prolonged to##2##2##(1997-3#1)(2008-11#1)
prolonged treatment with##6##3##(1990-12#1)(1991-12#1)(1994-6#1)(1995-3#1)(2008-3#1)(2008-5#1)
prolonged treatment##10##2##(1990-12#1)(1991-12#2)(1994-6#2)(1995-3#1)(2007-7#1)(2008-3#1)(2008-5#2)
prolonged tumor##2##2##(2009-2#1)(2010-6#1)
prolonged use of##3##3##(2008-1#1)(2010-1#1)(2012-3#1)
prolonged##295##1##(1990-12#1)(1990-3#2)(1990-9#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-8#2)(1992-12#3)(1992-3#4)(1992-6#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#10)(1994-8#1)(1994-9#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#13)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#16)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#18)(2008-8#8)(2008-9#11)(2009-1#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#3)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#17)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#18)(2013-8#2)
prolonging drugs##2##2##(1994-6#1)(2010-8#1)
prolonging the##8##2##(1994-2#1)(1994-7#1)(1995-6#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
prolonging##19##1##(1994-2#1)(1994-6#1)(1994-7#2)(1995-6#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
prolongs survival in##2##3##(2008-7#1)(2009-9#1)
prolongs survival##4##2##(2007-5#1)(2008-10#1)(2008-7#1)(2009-9#1)
prolongs the##5##2##(2007-11#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
prolongs##13##1##(1992-3#1)(1994-5#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#2)
prolyl peptides##4##2##(1990-5#4)
prolyl##11##1##(1990-2#1)(1990-5#4)(1992-3#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
prolymphocytes##3##1##(2008-4#2)(2009-2#1)
promastigote##5##1##(2008-9#2)(2012-2#2)(2013-1#1)
promastigotes##2##1##(2008-9#1)(2012-2#1)
promazines in bovine##2##3##(2008-10#2)
prometaphase##2##1##(1992-12#1)(2008-4#1)
promethazine hydrochloride##5##2##(2008-10#5)
promethazine##9##1##(1990-6#1)(1995-6#1)(2008-10#6)(2010-5#1)
promethazine-HCl##4##1##(2008-10#4)
prometryne##2##1##(2008-10#2)
prominence in##3##2##(1996-7#2)(2010-12#1)
prominence of##2##2##(1992-8#1)(2009-5#1)
prominence##16##1##(1992-8#1)(1994-2#1)(1996-7#6)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#2)
prominent and##5##2##(2007-12#1)(2008-11#1)(2008-7#2)(2012-3#1)
prominent at the##2##3##(2008-7#1)(2012-3#1)
prominent at##4##2##(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
prominent feature##5##2##(1990-5#1)(1994-11#2)(1996-11#1)(1997-3#1)
prominent in##8##2##(1992-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#2)
prominent of##3##2##(1993-1#1)(2008-4#1)(2009-7#1)
prominent part of the##2##4##(1991-8#1)(2008-9#1)
prominent part##3##2##(1991-8#1)(2007-12#1)(2008-9#1)
prominent pathological##2##2##(2008-7#2)
prominent position in##2##3##(2007-12#1)(2008-9#1)
prominent position##3##2##(2007-12#1)(2008-9#1)(2009-8#1)
prominent protein##2##2##(1990-11#1)(2008-10#1)
prominent role in the##3##4##(1990-5#1)(2008-9#1)(2011-2#1)
prominent role in##9##3##(1990-5#1)(1992-6#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
prominent role##14##2##(1990-5#1)(1990-8#1)(1992-6#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#2)(2011-1#2)(2011-2#1)
prominent toxicity##2##2##(2008-6#1)(2011-1#1)
prominent when##3##2##(1995-2#1)(2008-5#2)
prominent with##2##2##(2008-7#1)(2008-9#1)
prominent##169##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-8#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#4)
prominently in the##2##3##(1996-5#1)(2012-3#1)
prominently in##3##2##(1996-5#1)(2008-7#1)(2012-3#1)
prominently##9##1##(1996-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
promiscuity##5##1##(2008-5#1)(2008-9#1)(2009-3#2)(2009-5#1)
promiscuous##5##1##(1990-3#1)(1997-4#1)(2011-3#1)(2012-12#2)
promise and##3##2##(1994-12#1)(1996-12#1)(1997-3#1)
promise as a##7##3##(1995-3#1)(2007-11#1)(2008-11#2)(2008-5#1)(2010-5#1)(2013-1#1)
promise as an##2##3##(2007-10#1)(2008-7#1)
promise as##10##2##(1995-3#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2013-1#1)
promise for a##2##3##(2008-10#1)(2008-7#1)
promise for future##2##3##(2007-10#1)(2008-7#1)
promise for improving##3##3##(1991-3#1)(2008-3#1)(2011-2#1)
promise for such##2##3##(2008-10#1)(2012-12#1)
promise for the##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
promise for##45##2##(1991-2#1)(1991-3#1)(1993-11#1)(1996-12#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
promise in animal models##2##4##(1994-5#1)(2008-8#1)
promise in controlling##2##3##(2010-10#1)(2011-2#1)
promise in the treatment of##2##5##(2006-10#1)(2008-8#1)
promise in the treatment##3##4##(2006-10#1)(2008-8#1)(2010-6#1)
promise in the##4##3##(1994-3#1)(2006-10#1)(2008-8#1)(2010-6#1)
promise in##17##2##(1994-3#1)(1994-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#4)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
promise into##2##2##(2008-11#1)(2010-5#1)
promise of enhanced##2##3##(1997-3#1)(2008-5#1)
promise of pharmacogenomics##2##3##(2008-10#1)(2008-8#1)
promise of##20##2##(1993-2#1)(1994-3#1)(1996-12#1)(1996-3#2)(1997-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
promise to##12##2##(1991-3#1)(1993-12#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)
promise##125##1##(1991-2#1)(1991-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-12#3)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#7)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#1)
promised the##2##2##(1996-4#1)(2008-4#1)
promised##6##1##(1995-1#1)(1995-12#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-4#1)
promisekeeping##2##1##(1996-12#2)
promises a##4##2##(1991-9#1)(2008-2#1)(2010-8#1)(2011-2#1)
promises and##4##2##(1991-11#1)(1991-3#1)(2007-4#1)(2010-7#1)
promises new##2##2##(2008-4#1)(2009-8#1)
promises of##4##2##(1996-3#1)(2008-11#1)(2008-7#1)(2010-9#1)
promises to be a powerful##2##5##(2007-12#1)(2008-11#1)
promises to be a##5##4##(1994-1#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-8#1)
promises to be an##2##4##(1996-2#1)(2012-2#1)
promises to be##8##3##(1994-1#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-2#1)
promises to##16##2##(1994-1#1)(1996-2#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2009-12#2)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#1)
promises##46##1##(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1994-1#1)(1996-2#1)(1996-3#2)(1997-5#1)(1997-8#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)
promising agent##3##2##(1992-5#1)(2008-10#1)(2008-3#1)
promising alternative to##3##3##(2008-10#2)(2010-8#1)
promising alternative##5##2##(2008-10#2)(2009-5#1)(2010-11#1)(2010-8#1)
promising and valuable##2##3##(2008-10#1)(2011-2#1)
promising and##12##2##(1996-3#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
promising application##3##2##(2007-12#1)(2008-10#1)(2010-7#1)
promising applications##2##2##(1994-5#1)(2008-10#1)
promising approach for the##6##4##(1992-8#1)(1993-11#1)(2010-4#1)(2010-5#1)(2012-2#2)
promising approach for##11##3##(1992-8#1)(1993-11#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-7#1)
promising approach to##4##3##(2008-8#1)(2009-10#1)(2010-5#1)(2012-2#1)
promising approach towards##2##3##(2007-12#1)(2008-10#1)
promising approach##19##2##(1992-8#1)(1993-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#3)(2012-7#1)
promising but##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
promising candidates and##2##3##(2008-3#1)(2013-1#1)
promising candidates for##6##3##(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
promising candidates##9##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
promising clinical##2##2##(2008-12#1)(2008-7#1)
promising evidence##3##2##(1990-3#1)(2008-6#1)(2008-8#1)
promising field of##2##3##(2008-10#1)(2012-3#1)
promising for the##6##3##(1991-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-7#1)
promising for##26##2##(1991-9#1)(1995-2#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-1#1)
promising in the##2##3##(2008-10#1)(2012-2#1)
promising in##10##2##(1991-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
promising instrument##2##2##(1996-12#1)(2008-8#1)
promising materials##2##2##(1995-6#1)(2010-7#1)
promising means##3##2##(1991-2#1)(1997-3#1)(2009-10#1)
promising method for the##4##4##(1990-9#1)(2008-10#1)(2008-3#1)(2010-10#1)
promising method for##10##3##(1990-9#1)(2008-10#4)(2008-3#2)(2010-10#1)(2012-3#1)(2013-1#1)
promising method##15##2##(1990-9#1)(1991-9#1)(2008-10#4)(2008-3#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-3#1)(2013-1#2)
promising new##8##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-8#1)(2013-8#2)
promising novel##5##2##(1994-12#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-7#1)
promising option for##2##3##(2009-7#1)(2012-3#1)
promising option##3##2##(2009-7#1)(2011-2#1)(2012-3#1)
promising options##2##2##(2008-10#1)(2008-3#1)
promising platform##2##2##(2009-5#1)(2012-2#1)
promising potential##4##2##(2008-5#1)(2008-9#1)(2009-3#1)(2012-1#1)
promising research##2##2##(2007-10#1)(2012-1#1)
promising result##3##2##(2008-9#2)(2011-3#1)
promising results in vitro##2##4##(2007-11#1)(2011-2#1)
promising results in##14##3##(1992-10#1)(1992-3#1)(1993-3#1)(2007-11#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
promising results obtained##2##3##(2008-10#2)
promising results##26##2##(1992-10#1)(1992-3#1)(1993-3#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
promising source##2##2##(2007-12#1)(2009-6#1)
promising strategy to##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2013-8#1)
promising strategy##7##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
promising therapeutic approach##3##3##(1997-5#1)(2008-5#1)(2013-1#1)
promising therapeutic##9##2##(1994-6#1)(1995-2#1)(1997-5#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
promising to##4##2##(1992-12#1)(2007-12#1)(2013-1#1)(2013-8#1)
promising tool##10##2##(1994-12#1)(1997-4#1)(2008-10#6)(2008-3#1)(2009-11#1)
promising tools for##2##3##(2008-10#2)
promising tools##4##2##(2008-10#2)(2008-4#1)(2012-3#1)
promising treatment of##2##3##(2008-11#1)(2011-2#1)
promising treatment##4##2##(2006-7#1)(2008-11#1)(2011-2#1)(2012-3#1)
promising way##4##2##(2007-11#1)(2008-10#1)(2009-10#1)(2012-1#1)
promising##399##1##(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#4)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#10)(2007-8#3)(2008-1#3)(2008-10#52)(2008-11#15)(2008-12#1)(2008-2#5)(2008-3#19)(2008-4#8)(2008-5#13)(2008-6#4)(2008-7#17)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#6)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#3)(2010-7#5)(2010-8#9)(2011-1#10)(2011-2#24)(2011-3#3)(2011-7#1)(2012-1#5)(2012-12#3)(2012-2#22)(2012-3#11)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#19)(2013-7#1)(2013-8#7)
promontory##5##1##(2008-9#5)
promote a##12##2##(1992-12#1)(1993-1#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)
promote adherence##2##2##(1992-6#1)(2013-1#1)
promote an##2##2##(1991-2#1)(1992-6#1)
promote and##9##2##(1993-1#1)(1996-2#1)(2007-2#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-6#1)(2012-3#1)
promote autoimmunity was##2##3##(2008-10#2)
promote better##2##2##(2009-11#1)(2013-1#1)
promote cellular##2##2##(2008-5#1)(2008-9#1)
promote coexistence between##2##3##(2008-9#2)
promote differentiation##2##2##(2008-11#1)(2011-2#1)
promote functional recovery##2##3##(1994-8#1)(2008-7#1)
promote genetic##2##2##(2009-8#1)(2012-3#1)
promote growth##4##2##(1995-11#1)(2008-9#2)(2013-8#1)
promote healing##3##2##(2008-10#1)(2010-10#1)(2010-12#1)
promote health##9##2##(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-12#2)(2012-1#1)(2012-3#1)
promote healthy##2##2##(2008-12#1)(2009-5#1)
promote learning##3##2##(2008-11#1)(2008-3#1)(2012-12#1)
promote lifestyle##2##2##(2008-8#2)
promote mental health##2##3##(1996-1#1)(2009-10#1)
promote more##4##2##(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
promote or##3##2##(2008-12#1)(2013-1#2)
promote plant##2##2##(2008-9#1)(2013-8#1)
promote professional##2##2##(2008-11#1)(2008-12#1)
promote quality##4##2##(1996-2#2)(1997-1#1)(2008-3#1)
promote research into##2##3##(2008-10#1)(2013-1#1)
promote research##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
promote student##2##2##(2007-5#1)(2008-11#1)
promote the creation of##2##4##(2008-11#1)(2008-7#1)
promote the development of##4##4##(2008-11#2)(2008-2#1)(2011-2#1)
promote the differentiation of##2##4##(1994-12#1)(2008-11#1)
promote the formation of the##2##5##(1990-2#1)(1995-6#1)
promote the formation of##6##4##(1990-2#1)(1995-2#2)(1995-5#1)(1995-6#1)(2008-9#1)
promote the growth and##3##4##(2008-8#1)(2013-1#2)
promote the growth of##2##4##(2013-1#2)
promote the growth##5##3##(2008-8#1)(2013-1#4)
promote the health of##2##4##(2010-8#1)(2012-2#1)
promote the practice##2##3##(2008-8#1)(2010-11#1)
promote the understanding##2##3##(2008-8#1)(2011-1#1)
promote the##80##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1994-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-1#4)(2008-10#7)(2008-11#5)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
promote tumor cell migration##2##4##(2011-2#2)
promote tumor##5##2##(1991-5#1)(2009-3#2)(2011-2#2)
promote tumour##2##2##(2011-2#1)(2013-1#1)
promote wider use of##2##4##(1997-2#1)(2012-3#1)
promote wound##2##2##(2010-3#1)(2012-3#1)
promote##371##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#3)(1992-6#3)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-8#3)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#3)(1996-11#1)(1996-2#5)(1996-3#2)(1996-5#4)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#1)(2007-10#5)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#30)(2008-11#19)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#8)(2008-6#7)(2008-7#12)(2008-8#19)(2008-9#11)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#5)(2010-10#5)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#11)(2013-1#24)(2013-7#5)(2013-8#7)
promoted a significant##2##3##(2008-12#2)
promoted a##3##2##(2008-12#2)(2008-5#1)
promoted an increase in##2##4##(1994-3#1)(2008-12#1)
promoted as##2##2##(1996-12#1)(2008-11#1)
promoted by a##3##3##(1995-6#1)(2008-8#1)(2010-12#1)
promoted by an##2##3##(1992-6#1)(1993-12#1)
promoted by increasing##2##3##(2008-12#1)(2008-9#1)
promoted by the##7##3##(1993-12#1)(1994-3#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)
promoted by##27##2##(1990-2#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#3)(2013-1#1)
promoted cell##2##2##(1990-11#1)(2008-10#1)
promoted cell-attachment of##2##3##(1997-1#2)
promoted growth and##3##3##(1995-11#2)(2008-6#1)
promoted in##3##2##(2010-10#1)(2011-1#1)(2011-2#1)
promoted platelet thrombus formation##2##4##(2006-6#2)
promoted rearrangement##2##2##(2009-11#2)
promoted seed germination##2##3##(2006-11#1)(2008-5#1)
promoted the##18##2##(1991-2#1)(1991-9#1)(1994-11#2)(1995-11#1)(1996-4#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
promoted to##2##2##(2008-1#1)(2012-3#1)
promoted##120##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-7#1)(2006-11#2)(2006-6#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#7)(2008-11#8)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#7)(2008-9#4)(2009-11#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#3)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#7)(2013-8#1)
promoter CpG##3##2##(2007-11#2)(2008-7#1)
promoter DNA##5##2##(1994-3#2)(2008-10#1)(2008-8#1)(2008-9#1)
promoter activation##3##2##(2008-11#3)
promoter activities##2##2##(1992-9#2)
promoter activity and##3##3##(1994-11#1)(1994-12#1)(2007-12#1)
promoter activity in##9##3##(1991-9#2)(1994-11#2)(1995-6#2)(1996-5#2)(2008-9#1)
promoter activity is##5##3##(1993-3#1)(1994-9#2)(1995-6#1)(1996-5#1)
promoter activity of the##3##4##(1995-2#1)(1997-7#1)(1997-8#1)
promoter activity of##4##3##(1993-8#1)(1995-2#1)(1997-7#1)(1997-8#1)
promoter activity was##4##3##(1994-12#1)(1994-8#1)(1996-5#1)(2009-8#1)
promoter activity when##2##3##(1993-3#1)(2008-9#1)
promoter activity##57##2##(1990-5#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-6#4)(1995-8#1)(1996-5#4)(1997-2#4)(1997-7#3)(1997-8#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-8#1)(2010-11#3)(2010-8#1)(2013-1#1)
promoter and 3'##2##3##(1992-12#1)(1997-6#1)
promoter and coding region##2##4##(1990-11#1)(1997-3#1)
promoter and enhancer##6##3##(1992-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#2)
promoter and introduced##2##3##(1993-12#1)(1997-3#1)
promoter and terminator##4##3##(2008-10#1)(2008-8#3)
promoter and the##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
promoter and##53##2##(1990-11#2)(1990-8#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
promoter and/or##2##2##(1992-6#1)(2011-2#1)
promoter as##5##2##(1994-8#1)(2008-10#1)(2008-8#1)(2008-9#2)
promoter at the##2##3##(1993-12#1)(2007-12#1)
promoter at##4##2##(1991-5#1)(1993-12#1)(1993-3#1)(2007-12#1)
promoter based##2##2##(1991-9#1)(1997-4#1)
promoter but not##2##3##(1990-5#1)(1995-2#1)
promoter but##3##2##(1990-5#1)(1992-2#1)(1995-2#1)
promoter by##8##2##(1994-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)
promoter constructs##3##2##(1994-12#1)(1995-6#2)
promoter contains a##2##3##(1994-11#1)(1994-12#1)
promoter contains##5##2##(1994-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(2008-7#1)
promoter control##2##2##(2008-4#1)(2008-7#1)
promoter element##9##2##(1992-12#1)(1993-6#1)(1994-12#1)(1995-6#4)(2008-9#1)(2010-8#1)
promoter elements that##2##3##(1994-11#1)(2008-11#1)
promoter elements##8##2##(1990-5#1)(1991-9#1)(1994-11#1)(1995-6#1)(1996-10#1)(2008-11#1)(2008-9#2)
promoter for the##7##3##(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)
promoter for##11##2##(1991-6#2)(1991-9#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#1)
promoter from##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
promoter function##4##2##(1992-12#1)(1993-6#1)(1996-5#1)(1997-2#1)
promoter fused with##2##3##(1997-2#1)(2008-10#1)
promoter has been##4##3##(1991-5#1)(1996-3#1)(2008-5#1)(2008-9#1)
promoter in a##3##3##(1994-11#1)(1997-2#1)(1997-8#1)
promoter in the##6##3##(1991-6#1)(1992-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)
promoter in##32##2##(1990-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1995-9#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#3)(2012-12#1)
promoter is active in##2##4##(1991-9#1)(1997-4#1)
promoter is active##4##3##(1990-12#1)(1991-9#1)(1997-4#1)(2008-2#1)
promoter is reduced##2##3##(1994-11#1)(1995-8#1)
promoter is regulated##2##3##(1997-7#1)(2008-11#1)
promoter is similar to##2##4##(1990-11#1)(1996-5#1)
promoter is##22##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-9#5)(1993-12#1)(1993-6#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
promoter methylation##4##2##(2008-7#2)(2009-8#1)(2013-1#1)
promoter of chronic diseases of Western societies##2##7##(2009-2#2)
promoter of the gene##2##4##(1993-3#1)(1996-12#1)
promoter of the human##2##4##(1990-11#1)(1997-7#1)
promoter of the##16##3##(1990-11#1)(1991-9#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-7#2)(2011-2#1)(2012-12#1)
promoter of##37##2##(1990-11#2)(1991-9#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#5)(2009-2#2)(2009-7#3)(2011-2#1)(2012-12#2)(2013-1#1)
promoter on a##2##3##(1997-3#1)(1997-4#1)
promoter or##8##2##(1996-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#2)
promoter polymorphism##2##2##(2008-6#1)(2013-8#1)
promoter polymorphisms and##4##3##(2012-12#1)(2013-1#3)
promoter polymorphisms##5##2##(2009-12#1)(2012-12#1)(2013-1#3)
promoter region contains##2##3##(1993-3#1)(1993-6#1)
promoter region has##2##3##(2008-9#1)(2011-1#1)
promoter region is##2##3##(1991-6#1)(1993-12#1)
promoter region of the##12##4##(1991-6#1)(1992-11#1)(1992-12#1)(1993-3#2)(1994-6#2)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-4#1)
promoter region of##22##3##(1991-6#2)(1992-11#1)(1992-12#2)(1993-2#1)(1993-3#2)(1994-6#2)(1995-11#1)(1995-2#2)(1997-2#1)(1997-7#2)(2008-4#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
promoter region was##4##3##(1990-11#1)(1991-6#1)(1994-12#1)(1997-2#1)
promoter region##57##2##(1990-11#2)(1991-6#7)(1991-7#1)(1992-11#1)(1992-12#4)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1994-12#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-6#2)(1997-7#3)(1997-9#1)(2008-4#1)(2008-9#1)(2009-8#3)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#2)
promoter regions of the##2##4##(1993-3#1)(2009-10#1)
promoter regions of##5##3##(1993-3#1)(1997-2#3)(2009-10#1)
promoter regions were##2##3##(1992-9#1)(1997-2#1)
promoter regions##16##2##(1991-9#1)(1992-9#1)(1993-3#1)(1994-11#1)(1996-10#1)(1997-2#4)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-3#2)
promoter resulted in##2##3##(1996-3#1)(1996-5#1)
promoter sequence##9##2##(1991-9#1)(1993-12#1)(1993-3#1)(1997-7#2)(2008-10#1)(2008-9#1)(2011-1#2)
promoter sequences of the##2##4##(2010-7#2)
promoter sequences of##3##3##(2010-7#3)
promoter sequences##10##2##(1991-2#1)(1992-12#1)(1993-12#1)(1996-5#3)(1997-4#1)(2010-7#3)
promoter showed##2##2##(2008-8#1)(2011-2#1)
promoter structure##2##2##(1995-8#1)(1996-12#1)
promoter that is##3##3##(1990-12#1)(1993-12#1)(1994-2#1)
promoter that##5##2##(1990-12#1)(1993-12#1)(1994-2#1)(2008-2#1)(2010-11#1)
promoter to##3##2##(1994-5#1)(1997-8#1)(2012-12#1)
promoter together##2##2##(1992-5#1)(2011-1#1)
promoter vectors##2##2##(1991-12#1)(1993-12#1)
promoter was constructed##2##3##(2008-8#1)(2008-9#1)
promoter was inserted into##2##4##(2008-11#1)(2010-5#1)
promoter was then##2##3##(1996-6#1)(2010-5#1)
promoter was used to##2##4##(2008-8#1)(2010-5#1)
promoter was##23##2##(1990-12#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-11#2)(2008-8#2)(2008-9#5)(2009-8#1)(2010-5#3)(2012-2#1)
promoter were##3##2##(1992-5#1)(2008-10#1)(2008-9#1)
promoter when##2##2##(1991-6#1)(2008-9#1)
promoter which is##3##3##(1990-11#2)(1993-3#1)
promoter which was##2##3##(1997-3#1)(2008-11#1)
promoter which##5##2##(1990-11#2)(1993-3#1)(1997-3#1)(2008-11#1)
promoter##703##1##(1990-11#16)(1990-12#6)(1990-5#11)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#12)(1991-6#12)(1991-7#2)(1991-9#24)(1992-10#1)(1992-11#1)(1992-12#12)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#8)(1993-12#14)(1993-2#1)(1993-3#14)(1993-6#11)(1993-8#4)(1993-9#5)(1994-11#20)(1994-12#15)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#7)(1994-8#9)(1994-9#4)(1995-11#1)(1995-12#3)(1995-2#21)(1995-6#30)(1995-8#8)(1995-9#2)(1996-10#4)(1996-12#9)(1996-3#3)(1996-5#17)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#20)(1997-3#10)(1997-4#20)(1997-6#6)(1997-7#14)(1997-8#8)(1997-9#1)(2006-12#2)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#31)(2008-11#48)(2008-12#1)(2008-2#3)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#14)(2008-8#25)(2008-9#48)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#3)(2009-8#11)(2010-1#1)(2010-11#5)(2010-2#1)(2010-3#1)(2010-5#5)(2010-7#3)(2010-8#2)(2011-1#10)(2011-10#1)(2011-2#13)(2012-12#6)(2012-2#7)(2012-3#8)(2013-1#10)(2013-8#2)
promoter)##3##1##(2008-10#1)(2008-9#2)
promoter-activated production##2##2##(2008-11#2)
promoter-containing segment##2##2##(2008-10#1)(2011-1#1)
promoter-enhancer##2##1##(1990-12#1)(2008-11#1)
promoter-lacZ##2##1##(1995-6#1)(1997-6#1)
promoter-reporter##3##1##(1993-3#1)(1994-2#1)(2011-1#1)
promoter/enhancer activity##2##2##(1994-2#2)
promoter/enhancer##3##1##(1994-2#2)(2008-4#1)
promoter/operator##2##1##(1993-12#1)(1994-12#1)
promoterless##8##1##(1990-5#1)(1993-12#1)(1994-12#3)(1997-4#1)(1997-8#1)(2008-10#1)
promoters and##9##2##(1990-11#1)(1990-12#1)(1993-8#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)
promoters by the##2##3##(1995-2#1)(1997-4#1)
promoters by##3##2##(1995-2#1)(1997-4#2)
promoters for##4##2##(1990-5#2)(1994-11#1)(1994-12#1)
promoters in##8##2##(1990-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(2008-11#1)(2008-4#1)(2008-5#1)
promoters including##2##2##(1992-3#1)(1997-8#1)
promoters is##4##2##(1995-2#1)(1997-4#1)(2008-4#2)
promoters of genes##2##3##(2008-4#1)(2012-12#1)
promoters of the##2##3##(1997-4#1)(1997-8#1)
promoters of these genes##2##4##(2008-7#1)(2009-8#1)
promoters of these##3##3##(2008-7#2)(2009-8#1)
promoters of##16##2##(1991-5#1)(1994-6#1)(1997-2#1)(1997-4#2)(1997-8#2)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#3)(2012-12#1)
promoters to##2##2##(1997-4#1)(2008-7#1)
promoters was##3##2##(1996-3#1)(1997-8#1)(2008-8#1)
promoters##133##1##(1990-11#4)(1990-12#3)(1990-5#4)(1991-2#2)(1991-5#3)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-6#4)(1992-9#8)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#8)(1995-6#1)(1995-8#2)(1996-3#1)(1997-2#2)(1997-4#12)(1997-8#5)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-4#7)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-8#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#1)
promotes a##5##2##(1991-12#1)(1995-3#1)(2008-10#2)(2009-8#1)
promotes adherence##2##2##(1991-3#1)(2013-8#1)
promotes an##4##2##(1991-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
promotes apoptotic cell death##2##4##(2011-2#1)(2013-1#1)
promotes cell##2##2##(2008-11#1)(2009-3#1)
promotes fusion##2##2##(1994-12#1)(1997-2#1)
promotes growth##2##2##(2008-9#1)(2012-1#1)
promotes high##2##2##(2008-4#1)(2008-9#1)
promotes hippocampal##2##2##(2009-3#1)(2013-8#1)
promotes its##2##2##(1990-7#1)(2009-2#1)
promotes neurite outgrowth and##2##4##(1996-12#1)(2008-11#1)
promotes or##2##2##(2007-6#1)(2013-1#1)
promotes processes##2##2##(2008-7#1)(2009-10#1)
promotes survival##2##2##(1991-6#1)(2009-10#1)
promotes the binding##2##3##(1994-11#1)(1995-2#1)
promotes the formation of##2##4##(1994-12#1)(2010-6#1)
promotes the growth of##2##4##(1994-11#1)(2008-5#1)
promotes the proliferation##2##3##(2008-9#1)(2013-1#1)
promotes the##24##2##(1990-7#1)(1992-11#1)(1994-11#2)(1994-12#2)(1995-1#1)(1995-2#1)(1995-9#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-6#1)(2013-1#3)
promotes##118##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-3#3)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#8)(2009-10#5)(2009-11#1)(2009-2#1)(2009-3#3)(2009-7#1)(2009-8#2)(2010-6#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
promoting a##7##2##(1992-9#1)(1994-8#1)(2008-11#2)(2008-8#1)(2010-10#1)(2013-8#1)
promoting activity of##4##3##(1993-9#1)(1994-11#1)(2008-11#1)(2008-7#1)
promoting activity##8##2##(1992-3#1)(1993-9#1)(1994-11#1)(1996-5#1)(2008-11#3)(2008-7#1)
promoting adipocyte differentiation##2##3##(2008-3#2)
promoting and##4##2##(1992-1#1)(2008-5#1)(2009-8#1)(2011-1#1)
promoting better##2##2##(2008-10#1)(2010-10#1)
promoting blood##2##2##(2008-10#1)(2013-8#1)
promoting breastfeeding##2##2##(1993-6#2)
promoting cell##3##2##(2008-11#2)(2008-7#1)
promoting coexistence##2##2##(2008-8#1)(2012-2#1)
promoting differentiation of##2##3##(2008-8#1)(2009-3#1)
promoting effect##4##2##(1992-2#1)(1996-5#1)(1996-8#1)(2008-11#1)
promoting effects of##4##3##(1992-9#4)
promoting growth##2##2##(2008-11#1)(2013-1#1)
promoting health##2##2##(2011-1#1)(2013-1#1)
promoting phorbol##3##2##(1994-11#3)
promoting physical activity##2##3##(2008-4#1)(2008-7#1)
promoting play in hospitals##2##4##(2008-9#2)
promoting positive##2##2##(2010-10#1)(2012-1#1)
promoting proliferation##2##2##(1994-10#1)(2013-1#1)
promoting the##21##2##(1992-2#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
promoting##188##1##(1990-2#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#5)(1992-3#2)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#5)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#23)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#3)(2010-10#5)(2010-3#3)(2010-5#1)(2011-1#10)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#8)(2013-8#2)
promotion activity##2##2##(1992-2#1)(2008-11#1)
promotion and disease##6##3##(1995-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
promotion and prevention##2##3##(1991-1#1)(2013-1#1)
promotion and##21##2##(1991-1#1)(1993-12#1)(1995-12#2)(1995-9#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#2)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
promotion campaigns##2##2##(2008-11#1)(2009-7#1)
promotion during##2##2##(1992-9#1)(2012-3#1)
promotion for##2##2##(2008-10#1)(2013-1#1)
promotion in a##2##3##(2008-11#1)(2008-12#1)
promotion in the##4##3##(1994-9#1)(2008-11#2)(2013-8#1)
promotion in##13##2##(1992-8#2)(1993-8#1)(1994-9#1)(2007-8#1)(2008-11#5)(2008-12#1)(2013-8#2)
promotion is##3##2##(1995-12#1)(2011-2#2)
promotion of health##3##3##(1991-2#1)(1995-3#1)(2008-1#1)
promotion of morphological transformation##2##4##(1992-5#2)
promotion of the##5##3##(1994-3#1)(1995-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
promotion of##48##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-5#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-9#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
promotion to##2##2##(1992-3#1)(2008-9#1)
promotion##190##1##(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#23)(2008-12#17)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#7)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-5#3)(2010-6#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#8)
promotion'##3##1##(2008-11#3)
promotion-focused##2##1##(2009-6#2)
promotional practices##2##2##(2008-7#2)
promotional##10##1##(1991-1#1)(1993-12#1)(1994-12#1)(1996-5#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
promotor##3##1##(1994-8#1)(1997-8#1)(2008-8#1)
promotors##2##1##(1994-11#1)(1997-4#1)
prompt and proper treatment##2##4##(2011-1#1)(2011-2#1)
prompt and proper##3##3##(2010-8#1)(2011-1#1)(2011-2#1)
prompt and##8##2##(1991-12#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#3)
prompt diagnosis and treatment is##3##5##(2008-7#1)(2011-1#1)(2012-12#1)
prompt diagnosis and##4##3##(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
prompt diagnosis may##2##3##(2008-7#1)(2011-2#1)
prompt diagnosis##9##2##(1991-8#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
prompt recognition and##4##3##(2008-1#1)(2012-3#2)(2013-1#1)
prompt recognition##5##2##(2008-1#1)(2008-3#1)(2012-3#2)(2013-1#1)
prompt referral##2##2##(2008-11#1)(2011-1#1)
prompt response to##2##3##(1996-3#1)(2010-11#1)
prompt surgical##3##2##(2008-12#1)(2011-2#2)
prompt the##3##2##(1993-8#1)(2009-5#1)(2013-1#1)
prompt treatment and##2##3##(2008-9#1)(2013-1#1)
prompt treatment##8##2##(1993-12#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#2)
prompt##76##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
prompt&quot##2##1##(1994-11#2)
prompted a##6##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2013-1#1)
prompted an investigation##2##3##(1990-11#1)(2012-8#1)
prompted an##4##2##(1990-11#1)(2008-7#1)(2009-12#1)(2012-8#1)
prompted the development of##2##4##(1994-12#1)(2012-12#1)
prompted the##13##2##(1994-11#1)(1994-12#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-12#1)
prompted this##2##2##(2008-11#1)(2010-8#1)
prompted to##3##2##(1994-2#1)(2007-12#1)(2009-5#1)
prompted us to initiate##2##4##(1995-12#1)(2008-10#1)
prompted us to##10##3##(1995-11#1)(1995-12#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-3#1)
prompted##57##1##(1990-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-3#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#1)
prompting a need to educate underwriters about this technology##2##9##(1993-12#2)
prompting##9##1##(1992-12#1)(1993-12#2)(1996-1#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-5#1)(2012-2#1)
promptly report the results of##2##5##(2010-6#2)
promptly##21##1##(1990-3#1)(1993-12#3)(1994-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
prompts##4##1##(1995-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
promulgate##2##1##(1991-3#1)(2008-3#1)
promulgated##3##1##(1993-3#1)(1994-12#1)(2010-1#1)
promulgation##2##1##(1996-12#1)(1996-2#1)
promyelocytic leukemia cell line##2##4##(1991-12#1)(2008-11#1)
promyelocytic leukemia cells##2##3##(1991-9#1)(2008-11#1)
promyelocytic leukemia##12##2##(1991-12#1)(1991-9#3)(2007-12#1)(2007-4#2)(2008-11#2)(2008-8#2)(2011-2#1)
promyelocytic##17##1##(1991-12#1)(1991-9#3)(1993-3#1)(1993-6#1)(1994-6#1)(2007-12#1)(2007-4#2)(2008-11#2)(2008-8#3)(2011-2#1)(2013-1#1)
pronase##5##1##(1991-5#2)(1992-9#1)(2008-10#2)
pronase-treated##2##1##(1992-6#2)
prone position and##2##3##(1992-11#1)(1992-4#1)
prone position as##2##3##(1992-11#2)
prone position##16##2##(1992-11#8)(1992-4#4)(1993-1#1)(1996-9#1)(2008-7#1)(2013-1#1)
prone sleeping position##4##3##(1992-11#2)(1992-4#1)(2008-1#1)
prone to cardiovascular##2##3##(2008-3#1)(2012-1#1)
prone to develop##2##3##(2007-11#1)(2007-7#1)
prone to the##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
prone to##41##2##(1993-12#1)(1994-11#1)(1995-10#1)(1995-9#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
prone##79##1##(1992-11#11)(1992-4#8)(1993-1#1)(1993-12#1)(1994-11#1)(1995-10#2)(1995-9#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
proneness##3##1##(2007-12#2)(2013-8#1)
pronephros##4##1##(1997-9#3)(2012-12#1)
proneural##3##1##(2007-12#1)(2009-5#2)
prongs##4##1##(1992-11#1)(2008-7#3)
pronounced after##3##2##(2008-10#1)(2008-7#2)
pronounced and##3##2##(1993-12#1)(2008-11#1)(2012-2#1)
pronounced at##13##2##(1991-2#1)(1992-11#1)(1994-11#1)(1994-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#2)
pronounced differences in##2##3##(1992-9#1)(2008-4#1)
pronounced differences##3##2##(1992-9#1)(2008-4#1)(2008-5#1)
pronounced effect on the##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
pronounced effect on##5##3##(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
pronounced effect##6##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
pronounced effects on##2##3##(1996-12#1)(2009-9#1)
pronounced in the##12##3##(1990-7#1)(1993-3#1)(1994-2#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)
pronounced in##39##2##(1990-7#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-6#1)
pronounced increase in##2##3##(1997-7#1)(2008-5#1)
pronounced increase##3##2##(1997-7#1)(2008-5#1)(2008-7#1)
pronounced on##2##2##(1994-5#1)(2008-3#1)
pronounced reduction in##2##3##(1991-9#1)(2008-7#1)
pronounced reduction##3##2##(1991-9#1)(1996-12#1)(2008-7#1)
pronounced than##7##2##(1990-2#1)(1992-11#1)(2006-6#1)(2008-10#2)(2008-7#1)(2012-1#1)
pronounced when##5##2##(1991-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
pronounced with##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
pronounced##180##1##(1990-11#1)(1990-2#4)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-11#2)(1992-5#1)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#3)(1996-2#2)(1996-5#4)(1997-1#1)(1997-6#1)(1997-7#2)(2006-6#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-10#31)(2008-11#5)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#11)(2008-7#12)(2008-8#5)(2008-9#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#2)
pronouncedly##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
pronuclear formation##2##2##(2008-9#1)(2013-1#1)
pronuclear##4##1##(2008-2#1)(2008-9#2)(2013-1#1)
pronucleus##3##1##(2008-7#1)(2008-9#2)
proof for the##4##3##(1990-7#1)(1994-2#1)(2012-2#1)(2012-3#1)
proof for##11##2##(1990-7#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#2)(2012-3#1)
proof of concept of##2##4##(1996-6#1)(2012-12#1)
proof of concept##11##3##(1996-6#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
proof of efficacy##2##3##(1996-12#1)(2011-2#1)
proof of principle##5##3##(2008-10#2)(2008-8#1)(2009-4#1)(2010-4#1)
proof of synergy##2##3##(2008-10#2)
proof of the##6##3##(2007-11#2)(2007-7#1)(2008-3#2)(2009-10#1)
proof of##35##2##(1992-3#1)(1996-12#1)(1996-6#1)(1997-4#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-3#5)(2008-5#1)(2008-8#3)(2009-10#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
proof that the##2##3##(1990-6#1)(2008-9#1)
proof that##6##2##(1990-6#1)(1990-7#1)(1993-3#1)(1996-11#1)(2008-9#1)(2009-12#1)
proof##58##1##(1990-6#1)(1990-7#2)(1992-3#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-4#2)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
proof-of-concept study##2##2##(2008-10#1)(2011-1#1)
proof-of-concept##8##1##(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
proof-of-principle##4##1##(2007-12#1)(2008-2#1)(2010-12#1)(2011-1#1)
proof-testing##2##1##(2008-3#2)
proofreading##4##1##(1991-9#1)(2008-7#1)(2009-5#2)
proofs of##2##2##(2008-8#1)(2010-1#1)
proofs##5##1##(1993-11#1)(2007-11#1)(2008-8#1)(2010-1#1)(2010-10#1)
proopiomelanocortin (POMC)##4##2##(1993-5#1)(1996-12#1)(2008-4#2)
proopiomelanocortin gene##2##2##(1993-5#2)
proopiomelanocortin##9##1##(1993-5#6)(1996-12#1)(2008-4#2)
prop roots##2##2##(2008-5#2)
prop##3##1##(2007-5#1)(2008-5#2)
propagate along the##2##3##(2008-11#1)(2008-3#1)
propagate along##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
propagate in the##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
propagate in##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-9#1)
propagate through##6##2##(2007-11#3)(2008-3#2)(2009-7#1)
propagate to##2##2##(2008-3#1)(2013-1#1)
propagate##34##1##(1997-7#1)(2007-11#6)(2007-12#4)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
propagated and##2##2##(1997-3#1)(2008-8#1)
propagated as##2##2##(2008-10#1)(2008-8#1)
propagated by##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
propagated from the##2##3##(1992-8#1)(1993-3#1)
propagated in the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
propagated in##7##2##(1991-5#1)(2008-10#2)(2008-11#2)(2011-1#1)(2012-2#1)
propagated on##2##2##(2008-10#1)(2008-11#1)
propagated to##2##2##(1995-6#1)(2009-3#1)
propagated##33##1##(1991-5#1)(1992-8#1)(1993-3#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#5)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
propagates from##2##2##(2007-11#1)(2008-3#1)
propagates in the##2##3##(2007-12#1)(2008-3#1)
propagates in##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
propagates throughout the##2##3##(1997-7#1)(2008-3#1)
propagates toward##2##2##(2008-3#2)
propagates##21##1##(1997-2#1)(1997-7#2)(2007-11#5)(2007-12#1)(2008-11#1)(2008-3#7)(2009-6#3)(2009-7#1)
propagating along the longitudinal##2##4##(2008-9#2)
propagating along the##3##3##(2007-12#1)(2008-9#2)
propagating along##4##2##(2007-12#1)(2008-2#1)(2008-9#2)
propagating and evanescent waves##2##4##(2008-3#2)
propagating and evanescent##3##3##(2007-11#1)(2008-3#2)
propagating and##4##2##(2007-11#1)(2008-3#2)(2008-9#1)
propagating between##3##2##(2007-11#2)(2009-8#1)
propagating in a##6##3##(2007-11#2)(2008-3#4)
propagating in air##5##3##(2007-11#3)(2007-12#2)
propagating in the##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
propagating in##26##2##(2007-11#10)(2007-12#4)(2008-2#2)(2008-3#10)
propagating light in##2##3##(2008-3#2)
propagating light##3##2##(2008-2#1)(2008-3#2)
propagating pulse##3##2##(2007-11#2)(2007-12#1)
propagating surface##2##2##(2008-3#1)(2012-2#1)
propagating terahertz##2##2##(2007-12#1)(2008-2#1)
propagating through a##2##3##(2007-11#1)(2007-12#1)
propagating through##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
propagating wave##2##2##(2008-2#1)(2008-3#1)
propagating##89##1##(1996-4#1)(1997-4#1)(2007-11#23)(2007-12#15)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#26)(2008-4#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-2#1)
propagation along##2##2##(2007-11#1)(2008-3#1)
propagation and##16##2##(2007-11#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-9#3)
propagation angles##2##2##(2008-2#1)(2008-3#1)
propagation axis##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
propagation behavior of##2##3##(2007-12#1)(2008-3#1)
propagation behavior##3##2##(2007-12#2)(2008-3#1)
propagation by use of##2##4##(2008-3#2)
propagation by##4##2##(2007-11#1)(2008-3#2)(2008-5#1)
propagation can be##2##3##(2007-11#1)(2008-3#1)
propagation can##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
propagation characteristics of##2##3##(2007-11#1)(2008-1#1)
propagation code##2##2##(2007-12#2)
propagation constant##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
propagation constants of##2##3##(2007-12#1)(2008-3#1)
propagation constants##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
propagation direction##5##2##(2007-11#2)(2008-3#3)
propagation distance of##2##3##(2007-11#1)(2007-12#1)
propagation distance##5##2##(2007-11#2)(2007-12#3)
propagation dynamics of intense light##2##5##(2007-12#2)
propagation dynamics of##4##3##(2007-12#4)
propagation effects in an##2##4##(2007-12#2)
propagation effects##3##2##(2007-12#2)(2008-2#1)
propagation for##2##2##(2007-12#1)(2008-3#1)
propagation from##2##2##(2007-9#1)(2008-8#1)
propagation in a normal-dispersion##2##4##(2007-12#2)
propagation in a##7##3##(1993-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
propagation in fused silica##2##4##(2007-11#1)(2008-3#1)
propagation in the atmosphere##3##4##(2008-3#3)
propagation in the##11##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#6)(2009-5#1)
propagation in##49##2##(1993-5#1)(1996-4#1)(2007-11#6)(2007-12#6)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#21)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2013-1#1)
propagation inside the##2##3##(2008-3#2)
propagation is##7##2##(2007-11#2)(2007-12#1)(2008-3#3)(2008-7#1)
propagation law##2##2##(2007-11#2)
propagation lengths##2##2##(2008-2#1)(2008-3#1)
propagation loss##3##2##(2007-11#2)(2008-3#1)
propagation method##13##2##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#6)
propagation mode##3##2##(2007-11#2)(2008-2#1)
propagation model##2##2##(2008-3#1)(2013-8#1)
propagation modes and##2##3##(2007-12#1)(2008-3#1)
propagation modes##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
propagation of a liquid plug##2##5##(2009-6#2)
propagation of a##8##3##(2007-11#2)(2008-3#3)(2008-4#1)(2009-6#2)
propagation of action potentials##2##4##(2009-12#1)(2009-8#1)
propagation of an off-axis Gaussian wave##2##6##(2008-3#2)
propagation of an optical##2##4##(2007-11#2)
propagation of an##5##3##(2007-11#2)(2008-3#3)
propagation of depression to##2##4##(1997-7#2)
propagation of error##3##3##(2008-10#2)(2008-3#1)
propagation of highly##2##3##(2007-11#1)(2007-12#1)
propagation of light##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
propagation of optical##2##3##(2007-12#1)(2008-2#1)
propagation of subpicosecond##2##3##(2007-11#1)(2007-12#1)
propagation of the photon##2##4##(2008-3#2)
propagation of the##11##3##(1994-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#4)(2009-5#1)(2011-1#1)
propagation of##78##2##(1990-5#1)(1994-3#1)(1995-2#1)(1997-7#2)(2007-11#10)(2007-12#16)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#20)(2008-4#2)(2008-5#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
propagation over##5##2##(2007-11#1)(2007-12#3)(2012-2#1)
propagation parameter##3##2##(1993-11#2)(2007-12#1)
propagation path##2##2##(2008-3#2)
propagation phase##2##2##(2008-11#2)
propagation speed##2##2##(2008-5#1)(2009-6#1)
propagation step##2##2##(2008-3#1)(2012-12#1)
propagation through a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
propagation through atmospheric turbulence##2##4##(2008-2#1)(2008-3#1)
propagation through large-core##2##3##(2007-11#1)(2008-3#1)
propagation through##18##2##(2007-11#3)(2007-12#8)(2008-2#1)(2008-3#6)
propagation time delay##2##3##(2008-2#2)
propagation time##3##2##(2007-11#1)(2008-2#2)
propagation with##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
propagation within the##5##3##(2008-10#2)(2008-7#2)(2009-6#1)
propagation within##6##2##(2008-10#2)(2008-3#1)(2008-7#2)(2009-6#1)
propagation##397##1##(1990-5#2)(1991-12#3)(1991-8#1)(1993-11#2)(1993-12#2)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-4#1)(1997-3#1)(1997-7#3)(2007-11#62)(2007-12#73)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#34)(2008-3#117)(2008-4#3)(2008-5#5)(2008-7#7)(2008-8#2)(2008-9#15)(2009-12#2)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#2)(2010-8#6)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
propagation-invariant##2##1##(2007-11#1)(2007-12#1)
propagule germination##2##2##(2008-10#2)
propagule production##2##2##(2008-10#1)(2008-8#1)
propagule size##9##2##(2008-8#9)
propagule##21##1##(2008-10#7)(2008-8#12)(2008-9#2)
propagules and##2##2##(2008-10#1)(2008-8#1)
propagules in the##3##3##(2008-10#3)
propagules in##6##2##(2008-10#6)
propagules of F##4##3##(2008-10#4)
propagules of the pathogen##2##4##(2008-10#2)
propagules of##9##2##(2008-10#7)(2008-8#2)
propagules were##2##2##(2008-10#2)
propagules##44##1##(2008-10#33)(2008-8#11)
propamocarb##3##1##(2008-10#3)
propan-2-ol##3##1##(1990-2#1)(2008-10#2)
propane##8##1##(2008-10#3)(2008-3#2)(2008-7#2)(2011-2#1)
propane-air##2##1##(2008-2#2)
propanil##3##1##(2008-10#3)
propanoic##2##1##(2008-10#1)(2008-5#1)
propanol and##2##2##(2008-10#1)(2008-3#1)
propanol vapor##3##2##(2008-3#3)
propanol##10##1##(1990-12#1)(2008-10#3)(2008-3#6)
propargyl##3##1##(1992-11#1)(1997-7#1)(2008-10#1)
propargylic esters##2##2##(2010-2#2)
propargylic##3##1##(2010-2#2)(2013-7#1)
propel the##2##2##(2008-10#2)
propellant HFA134a##2##2##(1996-1#2)
propellant and##2##2##(1992-3#1)(1996-1#1)
propellant compositions##2##2##(2008-10#1)(2012-2#1)
propellant##19##1##(1991-12#1)(1992-3#2)(1996-1#9)(1996-2#1)(2008-10#5)(2012-2#1)
propellants in metered dose inhalers (MDIs)##2##6##(1992-3#1)(1996-1#1)
propellants in##4##2##(1992-3#3)(1996-1#1)
propellants##28##1##(1991-12#1)(1992-3#9)(1996-1#13)(1996-2#1)(2008-10#4)
propelled##5##1##(2008-1#1)(2008-10#2)(2012-1#1)(2013-1#1)
propelling##3##1##(2008-10#3)
propensities of the##2##3##(1993-11#1)(1997-2#1)
propensities of##3##2##(1993-11#1)(1997-2#1)(2008-11#1)
propensities##6##1##(1993-11#1)(1997-2#1)(2008-11#3)(2008-9#1)
propensity for##14##2##(1992-12#1)(1993-6#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
propensity of the##2##3##(1993-11#1)(2008-8#1)
propensity of##13##2##(1991-9#1)(1993-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
propensity score weighting method##2##4##(2011-1#2)
propensity score weighting##4##3##(2011-1#4)
propensity score##7##2##(2008-8#1)(2010-3#1)(2011-1#5)
propensity scores##5##2##(2008-11#2)(2008-12#1)(2008-8#2)
propensity to##14##2##(1993-6#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-11#2)(2012-3#1)(2013-1#1)
propensity##61##1##(1991-9#1)(1992-12#1)(1993-11#2)(1993-6#2)(1994-2#1)(1995-2#1)(1997-2#2)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#4)(2010-11#2)(2010-3#1)(2011-1#6)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
propeptide and##2##2##(1991-9#1)(1995-2#1)
propeptide is##2##2##(1995-3#2)
propeptide of type##3##3##(1993-6#1)(1997-1#2)
propeptide processing##2##2##(1991-9#2)
propeptide sequence##2##2##(1991-9#2)
propeptide which##2##2##(1993-12#1)(1995-3#1)
propeptide##29##1##(1990-5#2)(1991-11#1)(1991-9#7)(1993-12#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-3#5)(1995-6#4)(1997-1#2)(2008-11#1)(2008-7#1)(2009-10#2)
proper adjustment of the##2##4##(2007-12#1)(2008-2#1)
proper adjustment##3##2##(2007-12#1)(2008-2#1)(2010-12#1)
proper amount of##2##3##(1993-12#1)(2008-5#1)
proper and##3##2##(1992-2#1)(2007-12#1)(2013-1#1)
proper approach for##2##3##(2008-12#1)(2009-12#1)
proper approaches##2##2##(1993-12#1)(2008-3#1)
proper attention##2##2##(1996-6#1)(1997-6#1)
proper balance##3##2##(1991-12#1)(1997-2#1)(2008-5#1)
proper care and##2##3##(1995-2#1)(2008-10#1)
proper care##3##2##(1994-1#1)(1995-2#1)(2008-10#1)
proper choice of##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
proper choice##5##2##(1990-2#1)(2007-12#1)(2008-2#1)(2008-9#2)
proper classification##2##2##(2007-8#1)(2008-10#1)
proper clinical management##2##3##(2007-8#1)(2008-3#1)
proper combination of##2##3##(1994-9#1)(2012-2#1)
proper conditions##2##2##(2008-10#1)(2008-3#1)
proper diagnosis and treatment##2##4##(2012-12#1)(2013-7#1)
proper diagnosis##8##2##(2007-11#5)(2012-12#2)(2013-7#1)
proper dosage##2##2##(2011-2#2)
proper evaluation of the##2##4##(2007-11#1)(2011-2#1)
proper evaluation of##3##3##(2007-11#1)(2010-8#1)(2011-2#1)
proper execution of##2##3##(2008-10#1)(2008-4#1)
proper execution##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
proper function of the##2##4##(2008-7#1)(2011-2#1)
proper function##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
proper genetic##2##2##(1995-12#1)(2008-1#1)
proper guidance##2##2##(2008-3#1)(2013-1#1)
proper identification of##2##3##(2007-11#1)(2013-8#1)
proper identification##3##2##(1991-3#1)(2007-11#1)(2013-8#1)
proper initial##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
proper interpretation of##3##3##(1996-12#1)(2008-4#1)(2011-3#1)
proper management of##5##3##(2007-7#1)(2010-6#1)(2010-8#1)(2013-1#2)
proper management##9##2##(1991-6#1)(2007-7#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-8#2)(2013-1#2)
proper membrane##2##2##(2008-7#2)
proper model##3##2##(1993-12#1)(2009-12#1)(2013-1#1)
proper names##2##2##(1991-2#1)(2008-11#1)
proper patient selection##3##3##(2008-7#1)(2011-2#2)
proper place##2##2##(1994-9#1)(2007-7#1)
proper positioning of the##2##4##(1993-6#1)(2010-8#1)
proper positioning of##3##3##(1993-6#1)(2010-8#1)(2013-1#1)
proper prior##2##2##(1995-12#1)(1997-8#1)
proper processing##2##2##(2008-9#1)(2012-3#1)
proper regulation of##2##3##(2009-8#1)(2011-2#1)
proper selection of the##3##4##(2008-11#1)(2008-3#2)
proper selection of##9##3##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#1)
proper surgical technique##2##3##(2007-11#1)(2007-8#1)
proper surgical##3##2##(2007-11#1)(2007-8#1)(2012-3#1)
proper timing##2##2##(2008-2#1)(2009-8#1)
proper training##3##2##(1993-3#1)(1996-2#1)(2008-12#1)
proper treatment##11##2##(1993-2#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
proper use of##6##3##(1991-11#1)(1993-12#1)(1997-2#1)(2007-11#2)(2010-9#1)
proper##323##1##(1990-2#1)(1990-3#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-1#3)(1994-2#2)(1994-6#1)(1994-9#4)(1995-11#1)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#18)(2007-12#13)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#4)(2008-10#30)(2008-11#9)(2008-12#6)(2008-2#8)(2008-3#20)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#4)(2009-12#5)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#4)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#5)(2011-2#24)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#8)
properly accounted for##2##3##(2008-2#1)(2008-4#1)
properly adjusted##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
properly aligned##2##2##(2008-2#1)(2008-3#1)
properly applied##3##2##(1994-3#1)(2008-2#1)(2012-12#1)
properly chosen##2##2##(2008-2#2)
properly controlled##3##2##(2008-10#2)(2013-1#1)
properly designed##3##2##(1991-12#1)(2007-7#1)(2008-3#1)
properly evaluated##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
properly folded##2##2##(1997-4#1)(2012-2#1)
properly in##3##2##(1990-12#1)(1993-3#1)(2008-9#1)
properly managed##2##2##(1995-12#1)(2008-10#1)
properly normalized##2##2##(1997-4#1)(2008-2#1)
properly prepared##2##2##(1991-12#1)(2009-4#1)
properly selected##4##2##(2007-12#1)(2007-8#1)(2010-8#1)(2011-2#1)
properly structured##2##2##(1993-12#1)(1996-3#1)
properly the##3##2##(1991-12#1)(2008-10#2)
properly to##2##2##(2008-1#1)(2011-2#1)
properly##125##1##(1990-11#1)(1990-12#1)(1991-12#5)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-5#1)(1995-6#2)(1996-3#2)(1996-4#1)(1997-2#1)(1997-4#5)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
properties (i##2##2##(2008-3#1)(2008-5#1)
properties after##4##2##(1992-2#1)(2008-5#2)(2009-7#1)
properties against##2##2##(1993-5#1)(2008-5#1)
properties and amino acid##2##4##(1992-8#1)(2008-7#1)
properties and analytical##2##3##(2008-10#1)(2011-3#1)
properties and applications of##3##4##(1996-3#1)(2008-10#1)(2008-11#1)
properties and applications##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
properties and can##3##3##(2008-11#1)(2010-10#1)(2011-2#1)
properties and clinical##2##3##(2008-7#1)(2011-1#1)
properties and diagnostic##2##3##(2013-1#2)
properties and for##2##3##(2008-3#2)
properties and its##3##3##(1990-5#1)(1990-8#1)(2008-10#1)
properties and mechanical stability##2##4##(2008-11#1)(2008-3#1)
properties and mechanical##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
properties and size distribution of##2##5##(2008-2#2)
properties and size##3##3##(2008-2#2)(2008-3#1)
properties and structural##2##3##(1990-7#1)(2011-1#1)
properties and study##2##3##(2010-3#1)(2012-3#1)
properties and surface##2##3##(1997-2#1)(2008-10#1)
properties and that##2##3##(2007-11#1)(2008-10#1)
properties and the optical##2##4##(2008-2#1)(2008-3#1)
properties and the##16##3##(1991-2#1)(1992-3#1)(1992-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2009-2#1)(2009-7#1)
properties and their##4##3##(1991-6#1)(2008-5#1)(2008-7#1)(2010-5#1)
properties and thermal##2##3##(1993-8#1)(2009-9#1)
properties and##159##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#3)(1997-7#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#3)(2008-2#10)(2008-3#15)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#5)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
properties are also discussed##2##4##(2008-10#1)(2008-4#1)
properties are also##3##3##(1992-8#1)(2008-10#1)(2008-4#1)
properties are derived##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
properties are described##2##3##(2007-11#1)(2007-12#1)
properties are determined by the##2##5##(2008-1#1)(2008-5#1)
properties are expressed##2##3##(1996-2#1)(2008-3#1)
properties are likely##2##3##(1996-2#1)(2008-10#1)
properties are reported##2##3##(2008-3#1)(2009-11#1)
properties are##60##2##(1990-2#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-2#4)(2007-11#5)(2007-12#7)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-7#1)(2012-1#1)(2012-2#2)(2013-1#1)
properties as a function of anatomical position##2##7##(2012-2#2)
properties as a function of##4##5##(2008-5#1)(2009-9#1)(2012-2#2)
properties as a##5##3##(1993-11#1)(2008-5#1)(2009-9#1)(2012-2#2)
properties as well as##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
properties as well##4##3##(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
properties as##20##2##(1992-10#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#2)
properties associated with##3##3##(1997-3#1)(2009-11#1)(2012-3#1)
properties at the##2##3##(2008-3#1)(2008-9#1)
properties at##13##2##(1993-8#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-2#1)
properties between##7##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)
properties both##2##2##(1991-9#1)(1993-8#1)
properties but##7##2##(1996-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2011-2#1)
properties by means of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
properties by##11##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-6#1)(2012-2#2)
properties can be##8##3##(2007-11#1)(2008-10#1)(2008-3#3)(2009-12#1)(2009-5#1)(2010-11#1)
properties can##9##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#3)(2009-12#1)(2009-5#1)(2010-11#1)
properties close to##2##3##(2008-3#1)(2009-7#1)
properties common to##2##3##(1990-7#1)(2009-10#1)
properties compared with##4##3##(2007-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
properties could##2##2##(2008-1#1)(2009-7#1)
properties decreased##2##2##(2008-5#1)(2013-8#1)
properties depend##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
properties different from##2##3##(2008-10#1)(2009-7#1)
properties due to##3##3##(2008-1#1)(2008-11#1)(2009-7#1)
properties during##2##2##(2008-3#1)(2011-2#1)
properties for the##7##3##(1990-3#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-2#1)
properties for##29##2##(1990-3#1)(1993-8#1)(1994-5#1)(1996-4#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
properties from downwelling##2##3##(2008-3#2)
properties from the##2##3##(2008-2#1)(2008-3#1)
properties from##22##2##(1993-6#1)(2008-10#1)(2008-2#4)(2008-3#15)(2011-1#1)
properties has been##2##3##(1994-9#1)(2013-1#1)
properties has##3##2##(1994-9#1)(2008-5#1)(2013-1#1)
properties have been##8##3##(1992-1#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-2#1)(2012-3#1)
properties have##10##2##(1992-1#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-2#1)(2010-7#1)(2012-3#1)
properties in both##2##3##(1992-6#1)(2008-2#1)
properties in several##2##3##(2008-10#1)(2008-7#1)
properties in terms of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
properties in the context of##2##5##(2007-12#1)(2008-11#1)
properties in the##18##3##(1990-5#1)(1991-8#1)(1992-8#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2011-2#1)
properties in vitro##3##3##(1992-9#1)(2008-6#1)(2009-3#1)
properties in vivo##2##3##(1995-11#1)(2010-11#1)
properties in##61##2##(1990-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-11#1)(2007-11#3)(2007-12#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#11)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
properties including##3##2##(2008-7#1)(2013-1#2)
properties induced by##2##3##(2008-4#1)(2008-5#1)
properties is##5##2##(1993-11#1)(2007-12#1)(2008-10#3)
properties like##5##2##(1994-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)
properties may##4##2##(1996-5#1)(2008-10#1)(2009-12#1)(2012-2#1)
properties measured##2##2##(2008-2#1)(2008-7#1)
properties might##2##2##(2008-2#1)(2011-2#1)
properties observed##2##2##(2008-10#1)(2012-2#1)
properties obtained##3##2##(2008-2#2)(2008-3#1)
properties of 1##2##3##(1993-11#1)(1997-7#1)
properties of 1-phenyl-1##2##3##(2008-10#2)
properties of 2##2##3##(2008-10#1)(2009-3#1)
properties of 5##2##3##(2008-10#2)
properties of DAST##2##3##(2007-12#2)
properties of NO##2##3##(2008-10#1)(2010-6#1)
properties of Nd##2##3##(2008-3#2)
properties of Rhodobacter sphaeroides##3##4##(1993-11#1)(2008-8#2)
properties of a mutant##2##4##(1995-8#1)(2008-11#1)
properties of a new##5##4##(1991-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
properties of a novel##2##4##(1990-7#1)(1997-7#1)
properties of a series of##2##5##(2007-11#1)(2011-1#1)
properties of a spherical##2##4##(2008-3#2)
properties of a##64##3##(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#6)(2008-11#3)(2008-2#11)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
properties of aerosols##2##3##(2008-2#1)(2008-3#1)
properties of an##19##3##(1992-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2008-8#2)(2009-7#1)
properties of atmospheric transmission##2##4##(2008-2#2)
properties of atmospheric##4##3##(2008-2#2)(2008-3#2)
properties of bacteriorhodopsin##2##3##(2007-12#1)(2008-2#1)
properties of biological samples##2##4##(2007-12#1)(2008-4#1)
properties of biological##6##3##(1997-6#1)(2007-12#1)(2008-3#2)(2008-4#1)(2012-2#1)
properties of both##7##3##(1995-5#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-8#1)
properties of brain##2##3##(1991-1#1)(1991-4#1)
properties of cat AMLS##2##4##(2008-9#2)
properties of cathepsin D##2##4##(1994-5#2)
properties of collagen##2##3##(2008-5#2)
properties of connective tissue##2##4##(2013-1#2)
properties of dendritic##2##3##(2012-2#2)
properties of dexmedetomidine##2##3##(2011-2#2)
properties of different##2##3##(2008-10#1)(2008-8#1)
properties of distributed##3##3##(2008-3#2)(2008-8#1)
properties of each##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
properties of fac-Re(CO)(3)(dpknph)Cl##3##3##(2008-10#3)
properties of fiber lasers with twist-induced##2##6##(2008-2#2)
properties of fiber lasers##3##4##(2008-2#3)
properties of gel##2##3##(2008-7#2)
properties of hemoglobin##2##3##(1990-8#1)(1993-8#1)
properties of highly##6##3##(1992-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-7#1)
properties of human skin in vivo##2##6##(2008-5#2)
properties of human##7##3##(1990-8#1)(2008-4#1)(2008-5#4)(2012-1#1)
properties of hydrazine##2##3##(2010-5#2)
properties of ice##2##3##(2007-11#1)(2008-3#1)
properties of individual##3##3##(1990-8#1)(2007-11#1)(2012-2#1)
properties of large##4##3##(1994-11#1)(2008-3#1)(2010-4#1)(2013-7#1)
properties of light##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
properties of local##2##3##(2008-3#1)(2008-8#1)
properties of mammalian##2##3##(2008-2#1)(2008-5#1)
properties of materials##2##3##(2008-3#1)(2008-7#1)
properties of medium-chain##2##3##(1995-5#2)
properties of melittin##2##3##(1992-6#2)
properties of molecules##2##3##(1991-5#1)(2010-7#1)
properties of natural##2##3##(2008-11#1)(2008-3#1)
properties of new##4##3##(1990-11#1)(2008-10#3)
properties of normal##2##3##(2007-11#1)(2010-8#1)
properties of novel##2##3##(1992-8#1)(2008-11#1)
properties of objects##2##3##(2007-11#1)(2009-8#1)
properties of optical##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
properties of organic##2##3##(2008-10#1)(2008-3#1)
properties of other##2##3##(2008-10#1)(2008-2#1)
properties of our##2##3##(2008-6#1)(2010-1#1)
properties of particles##4##3##(1990-12#1)(1997-2#1)(2008-3#2)
properties of polarization mode dispersion##3##5##(2007-11#2)(2007-12#1)
properties of polymer##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
properties of proteins##2##3##(2008-1#1)(2012-1#1)
properties of randomly oriented hexagonal ice columns##2##7##(2008-3#2)
properties of randomly##3##3##(2008-3#3)
properties of rat##2##3##(2010-12#1)(2013-8#1)
properties of retinol in primary cultured##2##6##(2008-5#2)
properties of scattering##2##3##(2008-3#2)
properties of seawater##4##3##(2008-2#2)(2008-3#2)
properties of selected##2##3##(1991-5#1)(2009-7#1)
properties of several##2##3##(2007-12#1)(2008-5#1)
properties of silica##2##3##(2008-10#1)(2010-4#1)
properties of single##4##3##(1994-12#1)(1995-2#1)(1995-5#1)(2008-5#1)
properties of six##3##3##(1994-2#1)(1997-7#1)(2008-10#1)
properties of skin##7##3##(1990-3#2)(2008-5#5)
properties of soft##2##3##(2008-2#1)(2010-4#1)
properties of solid##2##3##(2008-10#2)
properties of some##3##3##(1995-6#1)(2008-10#1)(2009-9#1)
properties of substances##2##3##(1993-12#1)(2008-3#1)
properties of such##4##3##(1996-12#1)(2008-10#2)(2008-3#1)
properties of supercritical fluids##2##4##(2008-10#1)(2012-2#1)
properties of synaptic##2##3##(1996-2#1)(2009-9#1)
properties of the C-terminal region of##2##6##(1992-6#1)(1993-8#1)
properties of the TiNi##2##4##(2009-7#2)
properties of the active site##2##5##(1990-5#1)(1992-6#1)
properties of the aerosol##3##4##(1992-3#1)(2008-2#1)(2008-3#1)
properties of the atmosphere##2##4##(2008-2#2)
properties of the biosensors##2##4##(2008-10#2)
properties of the cell##3##4##(1991-6#1)(2008-11#1)(2009-8#1)
properties of the cells##2##4##(2008-11#1)(2012-1#1)
properties of the compounds##2##4##(1996-5#1)(2008-3#1)
properties of the dye##3##4##(2008-10#1)(2008-9#1)(2010-4#1)
properties of the dyes##2##4##(2008-10#1)(2008-3#1)
properties of the electrode##3##4##(2008-10#3)
properties of the enzyme##2##4##(1990-12#1)(1991-6#1)
properties of the films were##2##5##(2008-10#1)(2008-3#1)
properties of the films##4##4##(2008-10#2)(2008-3#1)(2009-11#1)
properties of the flow##2##4##(2008-3#1)(2008-6#1)
properties of the flower##2##4##(2009-12#2)
properties of the glass##2##4##(2008-3#2)
properties of the hair##3##4##(2008-5#3)
properties of the medium##2##4##(1996-4#1)(2008-3#1)
properties of the membrane##6##4##(1992-6#1)(1993-8#1)(2008-10#2)(2009-5#1)(2012-2#1)
properties of the model##2##4##(1994-12#1)(1997-8#1)
properties of the molecule##2##4##(1990-9#1)(2008-11#1)
properties of the native##3##4##(1993-8#1)(1994-11#1)(2008-10#1)
properties of the newly##2##4##(2008-10#1)(2010-11#1)
properties of the proposed##3##4##(2008-3#1)(2010-11#1)(2012-3#1)
properties of the resin##2##4##(2008-10#2)
properties of the resulting##3##4##(2007-11#1)(2008-10#1)(2009-6#1)
properties of the scaffolds##3##4##(2009-7#3)
properties of the silica##2##4##(2008-10#2)
properties of the stratum corneum##3##5##(2008-5#3)
properties of the three##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
properties of the two##4##4##(1992-8#1)(1996-1#1)(1997-2#1)(2008-10#1)
properties of the whole##2##4##(2008-5#1)(2009-4#1)
properties of the wild-type##2##4##(1990-8#1)(2008-6#1)
properties of the yeast##3##4##(1993-8#1)(1996-2#1)(1996-3#1)
properties of the##363##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-3#3)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#1)(1993-8#7)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#15)(2007-12#11)(2007-8#1)(2008-1#2)(2008-10#51)(2008-11#10)(2008-2#22)(2008-3#47)(2008-4#4)(2008-5#19)(2008-6#7)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#9)(2009-8#4)(2009-9#2)(2010-1#2)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#8)(2013-8#2)
properties of their##3##3##(1997-4#1)(2008-5#1)(2013-7#1)
properties of these compounds##4##4##(1990-7#1)(1992-3#1)(1993-6#1)(2009-5#1)
properties of these systems##2##4##(2008-3#1)(2008-8#1)
properties of these two types of##2##6##(2008-4#1)(2008-5#1)
properties of these two##3##4##(2008-4#1)(2008-5#2)
properties of these##32##3##(1990-7#1)(1991-9#1)(1992-3#1)(1993-6#1)(1996-2#1)(1996-5#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-2#1)
properties of thin##2##3##(2008-10#1)(2008-3#1)
properties of this##18##3##(1992-11#1)(1992-3#1)(1993-3#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#2)
properties of three##4##3##(1992-5#1)(2008-10#2)(2008-3#1)
properties of tissue##2##3##(2008-3#2)
properties of tissues##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
properties of titanium##2##3##(2009-7#2)
properties of transmission##2##3##(2007-11#1)(2008-3#1)
properties of trypsin immobilized on##2##5##(1997-2#2)
properties of two##9##3##(1994-6#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2011-1#1)
properties of two-layer turbid media##2##5##(2008-3#2)
properties of two-layer##4##3##(2008-3#4)
properties of vertebrate##2##3##(1993-11#1)(2012-3#1)
properties of water##2##3##(1992-9#1)(2008-2#1)
properties of waterborne##2##3##(2010-4#2)
properties of##1222##2##(1990-11#2)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#12)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#11)(1992-5#3)(1992-6#10)(1992-7#1)(1992-8#7)(1992-9#3)(1993-1#1)(1993-11#10)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#9)(1993-9#1)(1994-11#6)(1994-12#7)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#8)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#2)(1995-5#11)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#6)(1996-3#7)(1996-4#3)(1996-5#4)(1996-8#1)(1997-1#3)(1997-2#8)(1997-3#2)(1997-4#2)(1997-6#5)(1997-7#8)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#60)(2007-12#40)(2007-8#5)(2008-1#7)(2008-10#162)(2008-11#26)(2008-12#2)(2008-2#89)(2008-3#179)(2008-4#16)(2008-5#66)(2008-6#14)(2008-7#28)(2008-8#22)(2008-9#17)(2009-10#3)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#24)(2009-8#11)(2009-9#6)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#6)(2010-3#3)(2010-4#17)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#21)(2012-1#9)(2012-12#5)(2012-2#27)(2012-3#6)(2012-8#1)(2013-1#18)(2013-7#6)(2013-8#17)
properties on the##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
properties on##12##2##(1996-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2011-2#1)
properties or##2##2##(2008-11#1)(2008-4#1)
properties over##2##2##(2008-11#1)(2008-2#1)
properties provide##3##2##(1994-11#1)(1997-7#1)(2012-2#1)
properties related to the##2##4##(2008-10#1)(2010-4#1)
properties related to##5##3##(2008-10#2)(2008-7#1)(2009-2#1)(2010-4#1)
properties relevant for##2##3##(2008-5#1)(2011-2#1)
properties relevant##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
properties show##2##2##(2010-4#1)(2012-2#1)
properties similar to those of the##2##6##(1991-5#1)(2007-12#1)
properties similar to those of##6##5##(1990-7#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#2)
properties similar to those##7##4##(1990-7#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-12#1)
properties similar to##12##3##(1990-7#1)(1991-5#1)(1991-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-11#1)(2009-12#1)(2010-9#1)
properties such as##10##3##(1995-2#1)(1997-6#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
properties suggest that##2##3##(1993-8#1)(2011-2#1)
properties suitable for##2##3##(2008-10#2)
properties than##2##2##(2008-10#1)(2008-11#1)
properties that are unique and##2##5##(2008-8#1)(2009-10#1)
properties that are##10##3##(1995-3#1)(1997-6#1)(1997-7#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)
properties that have been##2##4##(2008-3#1)(2008-9#1)
properties that may##2##3##(1994-8#1)(2008-7#1)
properties that##31##2##(1991-6#1)(1994-8#1)(1995-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#3)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-1#2)(2012-2#3)
properties this##2##2##(2008-11#1)(2008-2#1)
properties through the##2##3##(1993-11#1)(2008-10#1)
properties to be##4##3##(1990-9#1)(1991-9#1)(2008-10#1)(2008-3#1)
properties to the##3##3##(2008-5#1)(2010-4#1)(2011-2#1)
properties to##20##2##(1990-9#1)(1991-9#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
properties towards##4##2##(1990-2#1)(2008-10#3)
properties typical of##3##3##(2008-3#2)(2012-2#1)
properties using##5##2##(1994-12#1)(1996-5#1)(2008-2#1)(2008-8#1)(2009-11#1)
properties was##6##2##(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-2#1)
properties were also##2##3##(2008-10#1)(2010-11#1)
properties were compared##2##3##(2008-8#1)(2010-4#1)
properties were determined##3##3##(2008-5#1)(2010-4#1)(2012-2#1)
properties were established##2##3##(2008-10#2)
properties were evaluated by##2##4##(2008-10#1)(2011-2#1)
properties were evaluated##3##3##(2008-10#2)(2011-2#1)
properties were found##2##3##(2008-3#1)(2011-2#1)
properties were measured using##2##4##(2009-7#1)(2010-4#1)
properties were measured##5##3##(1995-3#1)(2008-3#1)(2009-7#1)(2010-10#1)(2010-4#1)
properties were observed##2##3##(1995-3#1)(2010-4#1)
properties were##42##2##(1993-3#1)(1995-3#2)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-4#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
properties when##3##2##(1993-6#1)(2008-6#1)(2009-11#1)
properties which may##2##3##(2008-5#1)(2010-4#1)
properties which##7##2##(1994-8#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-4#1)(2010-6#1)
properties with a##2##3##(2008-10#2)
properties with respect to##4##4##(1990-12#1)(1995-9#1)(2008-2#1)(2008-3#1)
properties with the##5##3##(1993-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
properties with##25##2##(1990-12#1)(1990-7#1)(1993-11#1)(1995-9#1)(1997-6#1)(2007-11#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
properties##2527##1##(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#11)(1990-8#19)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#8)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#9)(1991-6#6)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#14)(1992-5#4)(1992-6#15)(1992-7#1)(1992-8#12)(1992-9#8)(1993-1#2)(1993-11#17)(1993-12#8)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#4)(1993-8#23)(1993-9#1)(1994-11#8)(1994-12#10)(1994-2#4)(1994-3#6)(1994-5#10)(1994-6#4)(1994-8#18)(1994-9#4)(1995-11#8)(1995-12#7)(1995-2#14)(1995-3#10)(1995-5#15)(1995-6#11)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#8)(1996-2#15)(1996-3#9)(1996-4#4)(1996-5#7)(1996-8#1)(1997-1#4)(1997-2#13)(1997-3#7)(1997-4#3)(1997-5#2)(1997-6#12)(1997-7#13)(1997-8#3)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#94)(2007-12#68)(2007-8#6)(2008-1#14)(2008-10#326)(2008-11#70)(2008-12#11)(2008-2#172)(2008-3#343)(2008-4#29)(2008-5#144)(2008-6#32)(2008-7#79)(2008-8#45)(2008-9#33)(2009-10#9)(2009-11#18)(2009-12#26)(2009-2#3)(2009-3#9)(2009-4#7)(2009-5#15)(2009-6#6)(2009-7#52)(2009-8#28)(2009-9#8)(2010-1#7)(2010-10#7)(2010-11#9)(2010-12#8)(2010-2#8)(2010-3#6)(2010-4#39)(2010-5#9)(2010-6#7)(2010-7#14)(2010-8#6)(2010-9#9)(2011-1#21)(2011-2#55)(2011-3#3)(2012-1#17)(2012-12#12)(2012-2#69)(2012-3#13)(2012-8#1)(2012-9#1)(2013-1#52)(2013-7#7)(2013-8#23)
properties)##4##1##(2007-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
properties/activities##2##1##(2007-11#2)
property and##7##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2013-8#1)
property can be##2##3##(2011-2#1)(2012-2#1)
property changes of##2##3##(2008-2#1)(2008-5#1)
property changes##3##2##(2008-2#1)(2008-5#1)(2009-10#1)
property for##2##2##(2008-10#2)
property has led to the development of##2##7##(2008-12#1)(2008-2#1)
property has##3##2##(1990-8#1)(2008-12#1)(2008-2#1)
property in the##2##3##(2011-2#1)(2012-3#1)
property in##5##2##(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
property is##7##2##(1990-12#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-1#1)
property loss up to##2##4##(2011-1#2)
property may##2##2##(2008-12#1)(2008-5#1)
property means that##2##3##(2008-3#1)(2010-1#1)
property measurements##3##2##(2008-2#1)(2008-3#2)
property of MT##2##3##(1996-12#2)
property of a##5##3##(2008-2#2)(2008-3#3)
property of an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
property of dopamine##2##3##(2008-10#2)
property of the##32##3##(1990-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-9#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2009-1#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
property of these##4##3##(2007-12#1)(2008-10#2)(2009-10#1)
property of##90##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#9)(2008-11#6)(2008-2#5)(2008-3#13)(2008-5#3)(2008-7#2)(2009-1#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
property rights##4##2##(2007-7#1)(2012-3#3)
property that##5##2##(1990-8#1)(1995-12#1)(1995-3#1)(2007-11#1)(2012-2#1)
property to##6##2##(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2012-2#1)
property was##4##2##(1990-2#1)(2008-10#2)(2008-11#1)
property##236##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-1#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-11#9)(2007-12#6)(2007-7#1)(2008-1#4)(2008-10#26)(2008-11#15)(2008-12#4)(2008-2#13)(2008-3#28)(2008-4#1)(2008-5#13)(2008-7#7)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-2#9)(2012-3#6)(2013-1#3)(2013-8#2)
prophage excision and##2##3##(2011-1#2)
prophage excision##3##2##(2011-1#3)
prophage##6##1##(1993-9#1)(1996-12#1)(2011-1#4)
prophages##3##1##(1993-9#1)(1997-3#1)(2011-1#1)
prophase I##5##2##(2008-5#2)(2011-2#3)
prophase and##2##2##(2007-12#1)(2008-5#1)
prophase spindle##3##2##(2009-10#3)
prophase##22##1##(1991-5#1)(1992-11#1)(1997-3#1)(2007-12#2)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#6)(2011-2#3)
prophenoloxidase##2##1##(1997-2#2)
prophylactic administration of##3##3##(2008-7#1)(2012-1#2)
prophylactic analgesic##2##2##(2011-2#2)
prophylactic and therapeutic##2##3##(1993-5#1)(1995-5#1)
prophylactic and##3##2##(1993-5#1)(1995-5#1)(2008-10#1)
prophylactic antibiotics for the prevention of##2##6##(2007-12#1)(2009-5#1)
prophylactic antibiotics##8##2##(2007-12#1)(2007-2#1)(2008-7#2)(2009-5#3)(2009-8#1)
prophylactic antimicrobials##2##2##(1990-6#1)(2012-3#1)
prophylactic cholecystectomy##3##2##(1993-3#3)
prophylactic cranial irradiation##2##3##(1995-8#1)(1995-9#1)
prophylactic efficacy of##2##3##(2009-12#1)(2010-4#1)
prophylactic efficacy##3##2##(2009-12#1)(2010-4#1)(2013-1#1)
prophylactic infusion of saline into the epidural space##2##8##(1993-10#2)
prophylactic measures##3##2##(1991-11#1)(2009-10#1)(2010-4#1)
prophylactic therapy##4##2##(1990-2#1)(2007-2#1)(2008-3#1)(2009-5#1)
prophylactic treatment of##2##3##(2007-10#1)(2008-7#1)
prophylactic treatment##5##2##(1990-3#1)(2007-10#2)(2008-7#1)(2011-1#1)
prophylactic treatments##2##2##(1996-11#1)(2011-2#1)
prophylactic use of dexamethasone##2##4##(1992-11#2)
prophylactic use of##4##3##(1990-5#1)(1992-11#2)(2010-7#1)
prophylactic vaccines##2##2##(1994-2#1)(2011-1#1)
prophylactic##96##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-2#2)(1992-11#2)(1993-10#2)(1993-3#4)(1993-5#1)(1994-2#4)(1994-6#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-1#2)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-4#2)(2010-7#2)(2011-1#4)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
prophylactically and##2##2##(1997-7#1)(2008-10#1)
prophylactically##12##1##(1990-3#1)(1993-3#1)(1994-3#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
prophylaxis after total##2##3##(2008-8#1)(2011-2#1)
prophylaxis after##7##2##(1990-2#1)(1990-9#1)(1991-11#2)(2008-7#1)(2008-8#1)(2011-2#1)
prophylaxis against##9##2##(1990-9#2)(1993-10#1)(1995-5#1)(2007-2#1)(2007-7#1)(2008-7#2)(2009-8#1)
prophylaxis and therapy of candidiasis##3##5##(2008-5#3)
prophylaxis and therapy##5##3##(2008-5#3)(2013-1#2)
prophylaxis and treatment of##4##4##(1990-6#1)(1992-2#1)(1993-2#1)(2007-12#1)
prophylaxis and treatment##8##3##(1990-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1996-11#1)(2007-12#1)(2007-2#1)(2013-1#1)
prophylaxis and##15##2##(1990-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1996-11#1)(2007-12#1)(2007-2#1)(2008-5#3)(2008-7#1)(2010-8#1)(2013-1#3)
prophylaxis can be##2##3##(2008-7#1)(2011-2#1)
prophylaxis following##2##2##(2012-12#1)(2012-3#1)
prophylaxis for##3##2##(1997-4#1)(2006-10#1)(2012-1#1)
prophylaxis in orthopedic##2##3##(2011-2#2)
prophylaxis in surgery##2##3##(1990-6#1)(1992-6#1)
prophylaxis in##16##2##(1990-3#1)(1990-5#1)(1990-6#2)(1991-3#1)(1992-6#2)(1993-10#1)(2007-12#1)(2008-7#1)(2009-5#2)(2011-2#2)(2012-12#1)(2013-1#1)
prophylaxis of diarrhea##2##3##(1991-3#1)(1991-8#1)
prophylaxis of##15##2##(1990-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(2007-11#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-6#1)
prophylaxis was##4##2##(1993-10#1)(2007-8#1)(2011-2#2)
prophylaxis which##2##2##(1990-3#1)(1992-6#1)
prophylaxis with##10##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-11#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)
prophylaxis##156##1##(1990-11#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#4)(1990-9#5)(1991-11#2)(1991-3#3)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#4)(1992-9#2)(1993-10#4)(1993-11#1)(1993-2#1)(1993-5#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-11#5)(2007-12#3)(2007-2#5)(2007-7#2)(2007-8#3)(2008-10#3)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#2)(2009-12#1)(2009-5#6)(2009-7#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#2)
propiconazole resistance##2##2##(2008-10#2)
propiconazole sensitivity##3##2##(2008-10#3)
propiconazole##14##1##(2008-10#14)
propidium iodide (PI)##5##3##(2008-4#1)(2008-9#4)
propidium iodide staining##2##3##(2008-9#1)(2013-1#1)
propidium iodide##15##2##(1994-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#6)(2009-6#1)(2011-1#1)(2012-1#1)(2013-1#1)
propidium with RNA##3##3##(1992-3#3)
propidium##22##1##(1992-3#5)(1994-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#6)(2009-6#1)(2011-1#1)(2012-1#1)(2013-1#1)
propiolate##3##1##(2007-11#1)(2008-4#2)
propionate##14##1##(1990-11#1)(1991-12#1)(1995-2#1)(1996-1#1)(1996-2#2)(2007-11#2)(2008-10#2)(2008-7#1)(2008-8#1)(2013-8#2)
propionic acid##8##2##(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#3)
propionic##13##1##(1991-5#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-7#3)
propionyl-CoA##5##1##(1991-12#4)(1992-9#1)
propiverine and##5##2##(2008-10#5)
propiverine##8##1##(2008-10#8)
propofol and##4##2##(2011-2#3)(2012-12#1)
propofol is##2##2##(2010-8#1)(2011-2#1)
propofol##26##1##(1990-3#1)(1993-1#2)(1995-12#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-7#3)(2010-8#1)(2011-2#9)(2012-12#3)(2012-3#1)
propolis and##2##2##(2008-10#2)
propolis in##2##2##(2008-10#2)
propolis is##2##2##(2008-10#2)
propolis on##2##2##(2008-10#1)(2008-11#1)
propolis##22##1##(2008-10#16)(2008-11#5)(2013-1#1)
propolis's##2##1##(2008-10#2)
proponents of##2##2##(2008-6#1)(2012-3#1)
proponents##5##1##(1992-2#1)(1994-1#1)(1996-5#1)(2008-6#1)(2012-3#1)
proportion and##2##2##(2008-10#1)(2013-1#1)
proportion as##2##2##(1991-2#1)(2011-2#1)
proportion in##3##2##(2008-10#2)(2012-3#1)
proportion of 0##2##3##(2008-10#2)
proportion of HIV##2##3##(1995-12#1)(2007-7#1)
proportion of P##4##3##(2008-10#3)(2010-8#1)
proportion of affected##4##3##(1992-9#2)(2008-2#1)(2008-5#1)
proportion of beta-structure##2##3##(1991-9#1)(2008-7#1)
proportion of blossoms##2##3##(2008-10#2)
proportion of breast cancer##2##4##(1994-9#1)(2009-2#1)
proportion of cases##8##3##(1991-11#1)(1996-5#1)(2010-12#1)(2011-2#3)(2013-8#2)
proportion of cells in the S and##2##7##(1994-3#1)(2008-11#1)
proportion of cells in##3##4##(1993-11#1)(1994-3#1)(2008-11#1)
proportion of cells##6##3##(1993-11#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
proportion of chicks##2##3##(1990-3#1)(2008-6#1)
proportion of children##4##3##(1996-11#1)(2008-2#2)(2012-2#1)
proportion of correct know responses##2##5##(2008-9#2)
proportion of correct remember responses and##2##6##(2008-9#2)
proportion of correct##4##3##(2008-9#4)
proportion of deaths##2##3##(1991-3#1)(2008-9#1)
proportion of disease##3##3##(2008-10#3)
proportion of diseased##5##3##(2008-10#5)
proportion of errors in##2##4##(1995-8#1)(1996-2#1)
proportion of individuals##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
proportion of infants##2##3##(1992-4#1)(1995-6#1)
proportion of isolates##3##3##(2008-10#3)
proportion of mummy berries##2##4##(2008-10#2)
proportion of older##2##3##(2008-1#1)(2012-12#1)
proportion of other clinically relevant findings##2##6##(2011-2#2)
proportion of patients with##13##4##(1997-6#1)(1997-7#1)(2007-7#3)(2008-7#2)(2008-9#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
proportion of patients##26##3##(1997-6#1)(1997-7#1)(2007-7#3)(2008-1#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-8#5)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
proportion of pseudosclerotia##3##3##(2008-10#3)
proportion of recombinant offspring##2##4##(2012-3#2)
proportion of seed##2##3##(2008-10#1)(2013-8#1)
proportion of sink habitat##2##4##(2008-8#2)
proportion of subjects##4##3##(1997-1#1)(2010-12#1)(2012-2#2)
proportion of susceptible host##2##4##(2008-10#2)
proportion of the population##4##4##(1997-1#1)(2007-12#1)(2008-10#1)(2009-4#1)
proportion of the total##9##4##(1994-1#1)(1994-8#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
proportion of the##69##3##(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-2#1)(1993-3#2)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-9#2)(1997-1#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#1)
proportion of their##2##3##(1992-12#2)
proportion of them##2##3##(2008-11#1)(2011-2#1)
proportion of those##3##3##(1990-6#1)(1997-6#1)(2008-6#1)
proportion of time spent##4##4##(2008-8#1)(2011-2#1)(2012-2#2)
proportion of total##9##3##(1990-5#1)(1995-3#1)(2008-10#3)(2008-8#2)(2010-12#1)(2012-2#1)
proportion of true##2##3##(1991-6#1)(1996-12#1)
proportion of women##5##3##(1991-8#1)(1994-2#1)(2007-12#1)(2009-7#1)(2012-3#1)
proportion of##441##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#5)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#2)(1992-9#3)(1993-11#1)(1993-3#5)(1993-8#1)(1994-1#1)(1994-2#4)(1994-3#2)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2006-8#1)(2007-10#1)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#5)(2008-1#5)(2008-10#89)(2008-11#19)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#11)(2008-6#7)(2008-7#18)(2008-8#23)(2008-9#14)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#23)(2012-12#4)(2012-2#11)(2012-3#12)(2013-1#15)(2013-7#4)(2013-8#7)
proportion to the##18##3##(1990-8#1)(1992-6#1)(1994-8#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#3)(2010-3#1)
proportion to##23##2##(1990-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2010-3#1)
proportion who##2##2##(1996-8#1)(2012-12#1)
proportion with##2##2##(1996-8#1)(2008-10#1)
proportion##516##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-3#5)(1993-8#1)(1994-1#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2006-8#1)(2007-10#1)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#7)(2008-1#6)(2008-10#105)(2008-11#23)(2008-12#7)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#14)(2008-6#8)(2008-7#23)(2008-8#25)(2008-9#15)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#9)(2010-9#1)(2011-1#5)(2011-2#25)(2012-1#1)(2012-12#5)(2012-2#12)(2012-3#13)(2012-6#1)(2013-1#18)(2013-7#4)(2013-8#10)
proportional equations##3##2##(2008-10#3)
proportional hazard model##5##3##(2010-8#1)(2011-1#1)(2012-2#3)
proportional hazard##9##2##(1997-3#4)(2010-8#1)(2011-1#1)(2012-2#3)
proportional hazards model##6##3##(1994-2#2)(1997-4#1)(1997-8#2)(2008-10#1)
proportional hazards##16##2##(1994-2#2)(1997-3#2)(1997-4#1)(1997-8#3)(2008-10#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
proportional increase in##2##3##(2008-11#1)(2008-9#1)
proportional systematic error##2##3##(2008-10#2)
proportional to a##3##3##(2007-11#1)(2008-5#1)(2011-1#1)
proportional to logarithm of##2##4##(2008-10#2)
proportional to scan##2##3##(2007-11#1)(2008-10#1)
proportional to that of##3##4##(1992-12#1)(1992-9#1)(2008-10#1)
proportional to the absorption##3##4##(2008-10#1)(2008-3#2)
proportional to the amount of##3##5##(2008-10#3)
proportional to the concentration of nucleic acids##2##7##(2008-10#2)
proportional to the concentration of the##4##6##(1996-12#1)(2008-10#3)
proportional to the concentration of##33##5##(1990-8#1)(1991-2#1)(1996-12#1)(2008-10#29)(2008-12#1)
proportional to the concentration##35##4##(1990-8#1)(1991-2#1)(1996-12#1)(2008-10#31)(2008-12#1)
proportional to the degree of##3##5##(1991-9#1)(2008-11#1)(2010-11#1)
proportional to the distance##2##4##(2008-2#1)(2008-3#1)
proportional to the external##2##4##(2008-11#1)(2008-2#1)
proportional to the intensity of##2##5##(1997-3#1)(2007-12#1)
proportional to the level of##2##5##(2008-11#1)(2012-2#1)
proportional to the number of##6##5##(2008-10#2)(2008-2#1)(2008-3#3)
proportional to the specific energy dissipation rate##2##7##(2008-7#2)
proportional to the specific##3##4##(1994-3#1)(2008-7#2)
proportional to the square of the##6##6##(2007-11#1)(2008-3#5)
proportional to the square##8##4##(2007-11#1)(2007-12#1)(2008-3#6)
proportional to the total##2##4##(2012-2#2)
proportional to the##147##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-10#68)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#28)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
proportional to their##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
proportional to viable##3##3##(2008-11#3)
proportional to##197##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-7#1)(2008-10#85)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#30)(2008-5#2)(2008-7#8)(2008-8#3)(2008-9#3)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
proportional##258##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#7)(1997-4#1)(1997-7#1)(1997-8#4)(2007-10#1)(2007-11#7)(2007-12#8)(2007-7#1)(2008-10#99)(2008-11#9)(2008-12#4)(2008-2#8)(2008-3#31)(2008-5#2)(2008-7#9)(2008-8#6)(2008-9#4)(2009-11#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#1)(2013-8#1)
proportionality in punitive damages awards##2##5##(1992-3#2)
proportionality##5##1##(1992-3#2)(1997-8#1)(2008-2#1)(2013-1#1)
proportionally to the##6##3##(1995-12#1)(2007-12#1)(2008-10#3)(2008-2#1)
proportionally to##8##2##(1995-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-9#1)(2012-2#1)
proportionally with the##2##3##(2008-10#1)(2008-3#1)
proportionally##15##1##(1990-7#1)(1991-12#1)(1991-6#1)(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
proportionate to the##2##3##(1993-1#1)(2008-7#1)
proportionate##3##1##(1993-1#1)(2008-11#1)(2008-7#1)
proportionately with##2##2##(1994-3#1)(2008-10#1)
proportionately##7##1##(1990-12#1)(1991-5#1)(1992-3#1)(1994-3#1)(2008-10#2)(2008-6#1)
proportions among##2##2##(2008-1#1)(2013-7#1)
proportions and##6##2##(1995-12#1)(2006-12#1)(2008-10#2)(2013-1#2)
proportions by##2##2##(2008-10#2)
proportions in the##3##3##(2008-5#1)(2010-10#1)(2010-4#1)
proportions in##5##2##(2008-10#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-4#1)
proportions of 0##2##3##(2008-10#2)
proportions of affected relatives##2##4##(1992-9#2)
proportions of affected##3##3##(1992-9#3)
proportions of cholestanol##2##3##(1992-6#2)
proportions of the##9##3##(1992-2#1)(1992-6#1)(2008-10#4)(2008-7#2)(2013-8#1)
proportions of##54##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-7#1)(2010-4#2)(2010-5#1)(2012-2#3)(2012-3#4)(2013-8#3)
proportions to##3##2##(1990-12#1)(1996-12#1)(2013-8#1)
proportions were##3##2##(2008-10#2)(2011-2#1)
proportions with##2##2##(2008-10#1)(2011-1#1)
proportions##115##1##(1990-11#1)(1990-12#2)(1990-3#1)(1991-10#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#6)(1992-9#3)(1994-12#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#3)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#5)
proposal and##2##2##(1992-2#1)(2012-2#1)
proposal for a##8##3##(1993-11#1)(1994-6#1)(1996-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
proposal for the##2##3##(1991-12#1)(2007-8#1)
proposal for##14##2##(1991-12#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-6#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-8#1)
proposal in##2##2##(1995-6#1)(2008-10#1)
proposal includes##2##2##(1992-2#1)(2008-10#1)
proposal is##4##2##(1992-2#1)(1992-5#1)(1993-12#1)(1997-8#1)
proposal of a##2##3##(2006-10#1)(2008-5#1)
proposal of##6##2##(1990-5#1)(1991-9#1)(2006-10#1)(2007-12#1)(2008-5#1)(2010-4#1)
proposal that the##3##3##(1990-10#1)(1991-5#1)(1997-2#1)
proposal that##10##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#1)(1994-11#1)(1997-2#2)(2009-4#1)(2009-5#1)(2013-8#1)
proposal to change the##2##4##(2008-10#1)(2011-2#1)
proposal to##8##2##(1995-5#1)(1995-6#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
proposal##85##1##(1990-10#1)(1990-11#2)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#8)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#3)
proposals and##2##2##(1993-12#1)(2012-2#1)
proposals for health system reform##2##5##(1993-3#1)(1996-12#1)
proposals for health##3##3##(1993-3#1)(1996-12#1)(2010-9#1)
proposals for##16##2##(1991-2#1)(1992-12#1)(1993-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-5#1)(2010-9#1)(2013-1#1)
proposals in the##3##3##(1992-1#1)(1993-3#1)(1994-9#1)
proposals on##2##2##(1993-12#1)(1995-1#1)
proposals that##2##2##(1996-12#1)(2008-8#1)
proposals##44##1##(1991-2#1)(1992-1#1)(1992-12#1)(1993-12#4)(1993-3#2)(1994-9#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#3)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
propose a &quot##2##3##(1995-2#1)(2009-3#1)
propose a comprehensive##2##3##(1992-9#1)(2007-4#1)
propose a mechanism##3##3##(1995-11#1)(2008-7#1)(2012-2#1)
propose a method for the##2##5##(2008-10#1)(2010-8#1)
propose a method for##15##4##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2010-3#1)(2010-6#1)(2010-8#1)
propose a method of##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
propose a method to improve##2##5##(2008-3#2)
propose a method to##4##4##(2007-11#1)(2008-3#3)
propose a method##27##3##(1994-9#1)(2007-11#5)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#10)(2010-3#1)(2010-6#1)(2010-8#1)
propose a model for the##2##5##(2009-3#1)(2009-8#1)
propose a model for##5##4##(1991-5#1)(1996-2#1)(2008-7#1)(2009-3#1)(2009-8#1)
propose a model of##2##4##(2008-10#1)(2008-11#1)
propose a model##10##3##(1991-5#1)(1993-11#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#2)
propose a modified version of##2##5##(1997-3#1)(2012-2#1)
propose a modified##3##3##(1997-3#1)(2008-3#1)(2012-2#1)
propose a more##2##3##(2007-12#1)(2012-3#1)
propose a new approach to the##2##6##(2008-3#1)(2012-3#1)
propose a new approach to##5##5##(1997-8#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
propose a new approach##7##4##(1997-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-3#1)(2013-8#1)
propose a new technique##3##4##(2008-2#2)(2008-3#1)
propose a new##44##3##(1993-9#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
propose a novel approach for##2##5##(2010-10#1)(2013-1#1)
propose a novel approach##3##4##(2008-3#1)(2010-10#1)(2013-1#1)
propose a novel method##2##4##(2007-12#1)(2010-8#1)
propose a novel##21##3##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#8)(2010-10#2)(2010-8#1)(2012-1#1)(2013-1#1)
propose a robust##3##3##(2008-3#2)(2013-1#1)
propose a simple##10##3##(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2013-1#1)
propose a system##2##3##(2008-10#1)(2008-7#1)
propose a##217##2##(1990-10#1)(1990-7#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#18)(2007-12#18)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#7)(2008-2#18)(2008-3#55)(2008-4#3)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#6)(2013-1#10)(2013-8#4)
propose an algorithm##3##3##(1995-2#1)(2008-3#1)(2013-1#1)
propose an alternative##8##3##(1997-8#1)(2007-11#2)(2008-11#1)(2009-2#1)(2010-11#1)(2012-2#1)(2012-3#1)
propose an##46##2##(1995-2#1)(1997-8#1)(2007-11#3)(2007-12#7)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#9)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#4)(2012-3#3)(2013-1#2)
propose and##21##2##(1991-3#1)(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#7)(2010-8#1)(2013-8#1)
propose better##2##2##(1991-2#1)(2009-8#1)
propose experiments##2##2##(2008-11#1)(2008-7#1)
propose guidelines for the##2##4##(2007-11#1)(2012-2#1)
propose here##3##2##(1995-11#1)(2008-11#1)(2010-8#1)
propose recommendations for##3##3##(1995-2#1)(2011-1#2)
propose separate##2##2##(1996-3#1)(2008-10#1)
propose that a##7##3##(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)
propose that an##2##3##(1995-2#1)(1996-2#1)
propose that the##45##3##(1990-7#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
propose that these##7##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-3#1)
propose that this##10##3##(1992-3#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#1)
propose that##142##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#4)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#7)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#5)(2013-8#1)
propose the following##2##3##(2008-10#1)(2008-7#1)
propose the name##2##3##(2008-10#2)
propose the use of##12##4##(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
propose the##33##2##(1990-3#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
propose therefore that##2##3##(1990-5#1)(1990-9#1)
propose to use the##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
propose to use##13##3##(1992-5#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#6)(2008-7#1)
propose to##35##2##(1990-11#1)(1991-2#1)(1992-5#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#1)(2013-7#1)
propose two##9##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-12#1)
propose using##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
propose what we believe is a new##2##7##(2008-3#2)
propose what we believe##4##4##(2008-3#4)
propose what##7##2##(2007-12#1)(2008-3#6)
propose##600##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#11)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-11#39)(2007-12#44)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#50)(2008-11#15)(2008-12#2)(2008-2#37)(2008-3#105)(2008-4#9)(2008-5#6)(2008-6#6)(2008-7#20)(2008-8#9)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#5)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#5)(2012-12#9)(2012-2#12)(2012-3#14)(2012-7#1)(2013-1#23)(2013-7#1)(2013-8#9)
proposed Bayesian##2##2##(1994-9#1)(2009-10#1)
proposed FI system##2##3##(2008-10#2)
proposed FI##5##2##(2008-10#5)
proposed FIA##2##2##(2008-10#2)
proposed HPLC##2##2##(1990-8#1)(2008-10#1)
proposed SIA##3##2##(2008-10#3)
proposed a method##2##3##(2009-8#1)(2013-1#1)
proposed a new##5##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
proposed a novel##2##3##(1990-5#1)(2010-3#1)
proposed a##34##2##(1990-5#1)(1995-6#1)(1996-5#1)(1997-8#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#2)(2010-3#1)(2010-8#3)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
proposed active##2##2##(1994-5#1)(2008-8#1)
proposed algorithm can be##2##4##(2008-2#1)(2012-2#1)
proposed algorithm is##8##3##(2008-10#2)(2008-3#3)(2008-6#1)(2011-3#1)(2012-1#1)
proposed algorithm##13##2##(2008-10#2)(2008-2#2)(2008-3#3)(2008-6#1)(2009-12#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-2#1)
proposed an##2##2##(1996-1#1)(2008-10#1)
proposed and analyzed##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
proposed and applied to the##2##5##(2008-10#1)(2008-3#1)
proposed and applied to##5##4##(2008-10#3)(2008-3#1)(2012-1#1)
proposed and applied##6##3##(2008-10#4)(2008-3#1)(2012-1#1)
proposed and compared##2##3##(2008-10#1)(2010-6#1)
proposed and demonstrated for measuring the##2##6##(2007-12#2)
proposed and demonstrated##17##3##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#8)
proposed and discussed##4##3##(1994-9#1)(2008-10#2)(2008-3#1)
proposed and experimentally##8##3##(1997-2#1)(2007-12#5)(2008-2#1)(2008-3#1)
proposed and it##2##3##(2008-10#1)(2008-2#1)
proposed and tested##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
proposed and the results##2##4##(2008-10#2)
proposed and the##5##3##(2008-10#4)(2011-1#1)
proposed and##82##2##(1993-1#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#4)(2007-12#11)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#7)(2008-3#18)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
proposed application##3##2##(1993-2#1)(2009-3#2)
proposed approach is##4##3##(2008-10#1)(2008-2#1)(2009-7#1)(2011-2#1)
proposed approach##25##2##(1994-11#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#1)(2013-1#1)(2013-8#1)
proposed are##2##2##(1996-8#1)(2008-10#1)
proposed as a measure##2##4##(2008-10#1)(2008-8#1)
proposed as a possible##2##4##(2008-10#1)(2012-12#1)
proposed as a simple##2##4##(2008-10#1)(2008-11#1)
proposed as a threshold##2##4##(1994-5#1)(2012-1#1)
proposed as a##36##3##(1990-5#2)(1990-7#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1997-2#1)(2006-7#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
proposed as an alternative to##3##5##(1994-2#1)(1995-1#1)(2013-1#1)
proposed as an alternative##5##4##(1994-2#1)(1995-1#1)(2008-10#1)(2013-1#1)(2013-7#1)
proposed as an important##2##4##(2008-10#1)(2012-2#1)
proposed as an##15##3##(1991-5#1)(1992-6#1)(1994-2#1)(1995-1#1)(1995-12#1)(2008-10#3)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
proposed as the##7##3##(1990-11#1)(1991-2#1)(2008-2#2)(2008-5#2)(2013-1#1)
proposed as##73##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#2)(2006-7#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#1)
proposed based on a##2##4##(1990-8#1)(2008-10#1)
proposed based on the##6##4##(2008-10#5)(2013-1#1)
proposed based on##13##3##(1990-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2009-5#1)(2013-1#1)
proposed before##2##2##(1994-8#1)(2008-11#1)
proposed biosensor##4##2##(2008-10#3)(2010-5#1)
proposed by Enneking##2##3##(2007-11#2)
proposed by the authors##3##4##(2008-10#2)(2008-3#1)
proposed by the##15##3##(1992-12#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
proposed by using##2##3##(2008-10#2)
proposed by##69##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-11#5)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#1)(2013-8#1)
proposed can be##2##3##(1993-6#1)(2008-10#1)
proposed changes in##2##3##(2008-10#1)(2010-8#1)
proposed changes##5##2##(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
proposed circuit uses##2##3##(2010-8#2)
proposed concept##2##2##(2008-3#1)(2008-6#1)
proposed definition of##2##3##(2007-6#1)(2012-1#1)
proposed design##4##2##(2008-3#2)(2010-8#1)(2011-2#1)
proposed developments##2##2##(2007-5#1)(2008-11#1)
proposed device##3##2##(2007-12#1)(2008-3#2)
proposed diagnostic##2##2##(2008-10#1)(2011-1#1)
proposed electrochemical method##2##3##(2008-10#2)
proposed electrode has##2##3##(2008-10#2)
proposed electrode was##3##3##(2008-10#3)
proposed electrode##17##2##(2008-10#17)
proposed electrodes could be reliably##2##5##(2008-10#2)
proposed electrodes could be##3##4##(2008-10#3)
proposed electrodes##8##2##(2008-10#8)
proposed extraction##2##2##(2008-10#2)
proposed filter##2##2##(2008-3#2)
proposed flow system##2##3##(2008-10#2)
proposed flow##5##2##(2008-10#5)
proposed flow-injection##3##2##(2008-10#3)
proposed for assessment of##2##4##(2008-10#1)(2009-5#1)
proposed for control##2##3##(2008-1#1)(2010-8#1)
proposed for determination of##3##4##(2007-11#1)(2008-10#2)
proposed for explaining##2##3##(1990-8#1)(2009-12#1)
proposed for genomic sequencing##2##4##(2008-10#2)
proposed for measuring the##4##4##(2008-3#3)(2012-2#1)
proposed for measuring##5##3##(2008-3#4)(2012-2#1)
proposed for simultaneous##4##3##(2008-10#4)
proposed for the determination of ascorbic acid##2##7##(2008-10#2)
proposed for the determination of trace##6##6##(2008-10#5)(2013-8#1)
proposed for the determination of##44##5##(2008-10#43)(2013-8#1)
proposed for the speciation##2##4##(2008-10#2)
proposed for the##118##3##(1990-5#1)(1991-5#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#92)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-6#1)(2012-12#2)(2012-6#1)(2013-8#1)
proposed for these##2##3##(1992-8#1)(1995-2#1)
proposed for this##2##3##(1996-5#1)(2008-10#1)
proposed for use in##2##4##(2007-11#1)(2007-12#1)
proposed for##228##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#126)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#20)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#1)
proposed framework##4##2##(2008-7#2)(2012-2#2)
proposed funding##2##2##(1996-1#2)
proposed government##2##2##(1993-3#2)
proposed here is##3##3##(1991-5#1)(2008-10#2)
proposed here##11##2##(1991-5#1)(1993-11#1)(1994-1#1)(1997-1#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-7#1)
proposed how##2##2##(2007-8#1)(2010-8#1)
proposed hypothesis##2##2##(2007-12#1)(2008-3#1)
proposed immunosensor##3##2##(2008-10#3)
proposed in a##3##3##(1994-6#1)(1994-9#1)(2008-3#1)
proposed in order to##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
proposed in the literature##7##4##(1996-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-9#1)(2013-1#1)
proposed in the present##2##4##(2013-8#2)
proposed in the##15##3##(1996-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
proposed in this article##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
proposed in this paper##12##4##(2008-10#9)(2008-2#1)(2008-6#1)(2013-8#1)
proposed in this work for the determination of##2##8##(2008-10#2)
proposed in this##18##3##(2008-10#12)(2008-2#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-8#2)
proposed in which##6##3##(1991-5#1)(1991-9#1)(2007-12#1)(2008-3#2)(2008-9#1)
proposed in##56##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-11#2)(1997-8#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-3#2)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#4)
proposed including##2##2##(1996-2#1)(2010-11#1)
proposed is##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
proposed iterative##2##2##(2008-10#1)(2012-3#1)
proposed joint spatial encodings##2##4##(2008-2#2)
proposed managed care##3##3##(1994-2#2)(1994-3#1)
proposed mechanism for##4##3##(2007-6#1)(2008-10#1)(2008-3#1)(2013-1#1)
proposed mechanism of##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
proposed mechanism##13##2##(2007-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#2)
proposed method allows the determination of##3##6##(2008-10#3)
proposed method allows the##4##4##(2008-10#4)
proposed method allows##7##3##(2008-10#7)
proposed method can be used##4##5##(2008-10#4)
proposed method can be##9##4##(2008-10#4)(2008-3#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
proposed method can##11##3##(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
proposed method could be##3##4##(2008-10#2)(2008-5#1)
proposed method could##5##3##(2008-10#4)(2008-5#1)
proposed method exhibited##2##3##(2008-10#2)
proposed method for the##3##4##(2008-10#2)(2010-8#1)
proposed method for##14##3##(2008-10#11)(2008-7#2)(2010-8#1)
proposed method had been successfully applied to##2##7##(2008-10#2)
proposed method had been##3##4##(2008-10#3)
proposed method had##5##3##(1992-11#1)(2008-10#4)
proposed method has a##5##4##(2007-12#1)(2008-10#4)
proposed method has been applied to determine##2##7##(2008-10#2)
proposed method has been applied to the determination of##15##9##(2008-10#15)
proposed method has been applied to the##19##7##(2008-10#19)
proposed method has been applied to##24##6##(2008-10#24)
proposed method has been applied##27##5##(2008-10#27)
proposed method has been successfully applied to the determination of##3##10##(2008-10#3)
proposed method has been successfully applied to the##6##8##(2008-10#6)
proposed method has been successfully applied to##9##7##(2008-10#9)
proposed method has been successfully applied##10##6##(2008-10#10)
proposed method has been##45##4##(2008-10#45)
proposed method has##53##3##(2007-12#2)(2008-10#51)
proposed method is applied to##4##5##(2008-10#4)
proposed method is evaluated##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
proposed method is promising for##2##5##(2008-10#2)
proposed method is simple##13##4##(2008-10#13)
proposed method is##79##3##(2008-10#66)(2008-2#4)(2008-3#7)(2012-3#2)
proposed method may##2##3##(2007-11#1)(2013-8#1)
proposed method of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
proposed method offers the##2##4##(2008-10#1)(2008-2#1)
proposed method was applied to the analysis of##4##8##(2008-10#3)(2010-4#1)
proposed method was applied to the##26##6##(2008-10#25)(2010-4#1)
proposed method was applied to##38##5##(2008-10#37)(2010-4#1)
proposed method was applied##46##4##(2008-10#45)(2010-4#1)
proposed method was compared with##4##5##(2008-10#4)
proposed method was evaluated by analyzing certified reference##2##8##(2008-10#2)
proposed method was evaluated by analyzing##4##6##(2008-10#4)
proposed method was evaluated by##6##5##(2008-10#6)
proposed method was evaluated##7##4##(2008-10#7)
proposed method was successfully applied to the simultaneous determination of##8##10##(2008-10#8)
proposed method was successfully applied to the##23##7##(2008-10#22)(2012-1#1)
proposed method was successfully applied to##26##6##(2008-10#25)(2012-1#1)
proposed method was successfully applied##34##5##(2008-10#33)(2012-1#1)
proposed method was successfully##38##4##(2008-10#37)(2012-1#1)
proposed method was validated by##2##5##(2008-10#1)(2012-1#1)
proposed method was validated##3##4##(2008-10#1)(2011-1#1)(2012-1#1)
proposed method was##134##3##(2008-10#127)(2008-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#3)
proposed method##472##2##(1992-11#1)(2007-11#5)(2007-12#5)(2008-10#400)(2008-2#7)(2008-3#25)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#3)(2010-2#1)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#3)(2013-8#2)
proposed methodologies##2##2##(2008-10#2)
proposed methodology has been##3##4##(2008-10#3)
proposed methodology was applied##2##4##(2008-10#2)
proposed methodology was##6##3##(2008-10#6)
proposed methodology##19##2##(2008-10#18)(2008-2#1)
proposed methods have been applied##2##5##(2008-10#2)
proposed methods have been##3##4##(2008-10#3)
proposed methods have##4##3##(2008-10#4)
proposed methods to##2##3##(2008-10#2)
proposed methods were selective and##2##5##(2008-10#2)
proposed methods were successfully applied to the determination of##2##9##(2008-10#2)
proposed methods were successfully applied to the##3##7##(2008-10#3)
proposed methods were validated by using##2##6##(2008-10#2)
proposed methods were##9##3##(2008-10#9)
proposed methods##30##2##(1994-11#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-11#1)(2012-3#1)
proposed model and##3##3##(2008-10#1)(2009-8#1)(2010-11#1)
proposed model for##4##3##(1996-12#1)(2010-8#2)(2013-1#1)
proposed model has##2##3##(1994-2#1)(2010-8#1)
proposed model of##2##3##(1991-5#1)(2009-9#1)
proposed model was##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
proposed model##32##2##(1991-5#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
proposed models##7##2##(1992-6#1)(1996-3#1)(2008-10#3)(2009-5#1)(2009-8#1)
proposed modified##2##2##(2008-10#1)(2008-2#1)
proposed new##6##2##(1991-2#1)(2008-10#1)(2008-3#3)(2011-2#1)
proposed nonparametric##2##2##(2010-9#2)
proposed nutrition delivery##2##3##(1996-1#2)
proposed nutrition##3##2##(1996-1#3)
proposed of##3##2##(1996-6#1)(2008-10#1)(2008-3#1)
proposed on the##2##3##(2007-11#1)(2007-12#1)
proposed optical##7##2##(2008-10#1)(2008-2#4)(2008-3#2)
proposed over##2##2##(2008-10#1)(2013-8#1)
proposed previously##4##2##(1994-11#1)(2008-10#2)(2009-10#1)
proposed principle##2##2##(2008-10#1)(2008-3#1)
proposed procedure can be##2##4##(2008-10#2)
proposed procedure can##3##3##(2008-10#3)
proposed procedure for##3##3##(2008-10#2)(2010-5#1)
proposed procedure has been##7##4##(2008-10#7)
proposed procedure has##8##3##(2008-10#8)
proposed procedure is##6##3##(1997-8#1)(2007-12#1)(2008-10#4)
proposed procedure was##12##3##(2008-10#12)
proposed procedure##57##2##(1997-8#1)(2007-12#1)(2008-10#50)(2008-3#1)(2008-6#1)(2009-9#1)(2010-1#1)(2010-5#1)
proposed procedures##9##2##(2007-11#1)(2008-10#6)(2009-10#1)(2013-1#1)
proposed reagent-injection FI method##2##4##(2008-10#2)
proposed recording##2##2##(2007-12#2)
proposed reforms##2##2##(1996-12#1)(2008-6#1)
proposed refractive-index##2##2##(2008-2#2)
proposed regulations##3##2##(1991-12#1)(1991-2#1)(1993-3#1)
proposed robust##2##2##(2008-10#1)(2012-3#1)
proposed role##2##2##(1991-12#1)(1996-9#1)
proposed sensor has##2##3##(2008-10#1)(2008-3#1)
proposed sensor##23##2##(2008-10#21)(2008-2#1)(2008-3#1)
proposed sensors##3##2##(2008-10#3)
proposed separation##2##2##(2008-10#2)
proposed sequential##2##2##(2008-10#2)
proposed setup##2##2##(2008-2#1)(2008-3#1)
proposed solutions##2##2##(1995-2#1)(2011-2#1)
proposed strategy of##3##3##(2008-10#2)(2011-2#1)
proposed structure##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
proposed system can##3##3##(2008-3#2)(2010-8#1)
proposed system handles about##2##4##(2008-10#2)
proposed system is##9##3##(2008-10#4)(2008-2#2)(2008-3#3)
proposed system was evaluated by##2##5##(2008-10#2)
proposed system was##8##3##(2008-10#8)
proposed system##41##2##(1994-2#2)(2007-11#3)(2008-10#23)(2008-2#2)(2008-3#9)(2010-8#2)
proposed technique can##2##3##(2008-10#1)(2008-3#1)
proposed technique is##7##3##(2008-10#5)(2008-3#1)(2008-6#1)
proposed technique##31##2##(2007-11#3)(2007-12#1)(2008-10#14)(2008-2#2)(2008-3#10)(2008-6#1)
proposed techniques##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-7#1)
proposed test##4##2##(1997-7#2)(2012-3#1)(2013-1#1)
proposed that has##2##3##(2007-11#1)(2010-4#1)
proposed that is based on##3##5##(2008-3#3)
proposed that is##4##3##(2008-3#3)(2008-6#1)
proposed that the##35##3##(1990-5#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#3)(1996-5#1)(1997-7#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#2)(2013-8#3)
proposed that this##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
proposed that two##2##3##(2008-7#1)(2009-5#1)
proposed that##117##2##(1990-12#2)(1990-5#1)(1990-7#1)(1991-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#5)(2010-10#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#4)
proposed the##10##2##(1991-12#1)(1995-12#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#2)
proposed to account for the##2##5##(1996-5#1)(2008-3#1)
proposed to account for##5##4##(1990-8#2)(1996-5#1)(2008-3#1)(2008-9#1)
proposed to arise##2##3##(1992-6#1)(2012-2#1)
proposed to be a##3##4##(1991-10#1)(1995-2#1)(2013-1#1)
proposed to be involved in##3##5##(1994-6#1)(1997-7#1)(2011-2#1)
proposed to be the##3##4##(2008-4#1)(2008-6#1)(2008-9#1)
proposed to be##21##3##(1990-12#1)(1991-10#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-5#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
proposed to carry out##2##4##(1992-5#1)(2008-2#1)
proposed to describe the##3##4##(2008-10#2)(2008-3#1)
proposed to describe##5##3##(1991-12#1)(2008-10#3)(2008-3#1)
proposed to evaluate##2##3##(2008-10#1)(2008-2#1)
proposed to explain the##10##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
proposed to explain##12##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2012-3#1)
proposed to improve the##2##4##(2008-3#1)(2011-2#1)
proposed to improve##3##3##(2008-3#2)(2011-2#1)
proposed to model the##2##4##(2008-3#1)(2011-2#1)
proposed to play a##6##4##(1990-11#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-8#2)
proposed to predict the##2##4##(2008-11#1)(2008-7#1)
proposed to predict##4##3##(2008-11#1)(2008-2#2)(2008-7#1)
proposed to reduce##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2013-1#1)
proposed to regulate##3##3##(1990-8#1)(1993-6#1)(2012-2#1)
proposed to study the##2##4##(2008-10#2)
proposed to study##3##3##(2008-10#3)
proposed to take##2##3##(1995-12#1)(1996-2#1)
proposed to the##2##3##(2008-10#1)(2013-1#1)
proposed to##135##2##(1990-11#1)(1990-12#1)(1990-8#3)(1991-10#1)(1991-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-7#2)(2006-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#11)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
proposed treatment##7##2##(1993-2#1)(1997-8#5)(2008-10#1)
proposed using a##2##3##(2008-10#2)
proposed using the##2##3##(1993-11#1)(2008-10#1)
proposed using##7##2##(1993-11#1)(2008-10#5)(2010-8#1)
proposed was##8##2##(2008-10#8)
proposed were##4##2##(2008-10#4)
proposed when##3##2##(1991-2#2)(2008-10#1)
proposed where##2##2##(1993-6#1)(2008-10#1)
proposed which##4##2##(1990-2#1)(1995-6#1)(2008-11#1)(2009-12#1)
proposed with the##2##3##(1991-5#1)(2011-1#1)
proposed with##7##2##(1991-5#1)(2007-12#1)(2008-10#4)(2011-1#1)
proposed##2666##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#9)(1990-6#2)(1990-7#3)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#8)(1991-2#8)(1991-5#10)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#3)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#6)(1993-6#5)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#6)(1994-12#2)(1994-2#11)(1994-3#6)(1994-5#5)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#5)(1995-2#14)(1995-3#2)(1995-5#8)(1995-6#5)(1995-9#2)(1996-1#9)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#8)(1996-6#1)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#2)(1997-6#1)(1997-7#10)(1997-8#12)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#54)(2007-12#68)(2007-2#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#13)(2008-10#1251)(2008-11#44)(2008-12#7)(2008-2#120)(2008-3#268)(2008-4#13)(2008-5#21)(2008-6#31)(2008-7#40)(2008-8#31)(2008-9#24)(2009-1#1)(2009-10#13)(2009-11#3)(2009-12#6)(2009-3#2)(2009-4#5)(2009-5#11)(2009-6#3)(2009-7#4)(2009-8#13)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#11)(2010-12#2)(2010-2#3)(2010-3#7)(2010-4#7)(2010-5#9)(2010-6#4)(2010-7#2)(2010-8#31)(2010-9#4)(2011-1#22)(2011-2#34)(2011-3#2)(2011-7#2)(2012-1#16)(2012-12#24)(2012-2#26)(2012-3#29)(2012-6#1)(2012-8#1)(2013-1#35)(2013-7#2)(2013-8#28)
proposes a clinical##2##3##(1997-2#1)(2013-1#1)
proposes a new method to##2##5##(2008-10#1)(2008-5#1)
proposes a new##9##3##(1997-3#1)(2008-10#2)(2008-5#2)(2008-6#1)(2010-8#1)(2011-3#1)(2012-3#1)
proposes a set of##2##4##(2008-1#1)(2008-7#1)
proposes a##37##2##(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
proposes an##6##2##(1995-1#1)(2007-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
proposes possible##3##2##(1991-12#1)(1992-2#1)(2008-11#1)
proposes that##12##2##(1991-1#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-3#2)
proposes the##2##2##(1996-12#1)(2012-1#1)
proposes to##2##2##(1995-2#1)(2010-8#1)
proposes##76##1##(1991-1#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)
proposing a##3##2##(1997-1#1)(2008-9#1)(2010-7#1)
proposing that##3##2##(1995-12#1)(1996-3#1)(2012-12#1)
proposing##13##1##(1995-12#1)(1996-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-9#3)(2009-10#1)(2010-7#1)(2012-12#1)(2013-1#1)
proposita##7##1##(1992-12#6)(1997-3#1)
proposition that##11##2##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-11#3)(2012-2#1)
proposition##18##1##(1991-5#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-6#1)(2007-11#2)(2008-10#3)(2008-7#1)(2008-8#1)(2009-11#3)(2011-2#1)(2012-2#1)(2013-8#1)
propositions that##2##2##(1996-12#1)(2009-8#1)
propositions##8##1##(1993-11#1)(1996-12#1)(1996-2#1)(2007-12#1)(2009-11#1)(2009-8#1)(2010-8#1)(2013-1#1)
propranolol and pindolol##4##3##(2008-10#4)
propranolol and##7##2##(1994-5#2)(2008-10#5)
propranolol for##2##2##(1994-9#1)(2013-1#1)
propranolol has##2##2##(2009-8#1)(2011-2#1)
propranolol in##4##2##(1993-5#1)(2008-10#1)(2009-8#2)
propranolol treatment##2##2##(1995-3#2)
propranolol##41##1##(1990-5#1)(1992-8#1)(1993-5#1)(1994-3#1)(1994-5#4)(1994-9#2)(1995-12#1)(1995-3#3)(1995-6#1)(1996-2#1)(2008-10#11)(2008-2#1)(2008-7#2)(2009-8#7)(2011-2#3)(2013-1#1)
propria of##4##2##(2008-11#1)(2009-1#1)(2011-2#2)
propria##17##1##(1997-1#1)(1997-8#1)(2008-11#4)(2008-4#3)(2008-5#1)(2009-1#1)(2009-10#3)(2011-2#3)
propria)##3##1##(2011-2#1)(2013-1#2)
proprietary security##2##2##(1992-12#2)
proprietary##12##1##(1992-12#2)(1993-3#1)(1994-3#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)
proprietes##4##1##(2008-5#4)
proprieties##4##1##(2007-11#2)(2012-1#1)(2013-1#1)
propriety##3##1##(1994-3#1)(1995-5#1)(1997-8#1)
proprioception of the##2##3##(2007-11#1)(2010-12#1)
proprioception##8##1##(1996-5#1)(2007-11#3)(2009-8#1)(2010-12#3)
proprioceptive stimulation##2##2##(1996-5#2)
proprioceptive##10##1##(1990-6#1)(1993-12#2)(1994-8#1)(1995-12#1)(1996-5#2)(2009-1#2)(2013-1#1)
proprioceptors##3##1##(1997-3#1)(2007-11#1)(2009-1#1)
proprotein convertase subtilisin/kexin##2##3##(2008-6#1)(2013-1#1)
proprotein convertase##3##2##(1993-2#1)(2008-6#1)(2013-1#1)
proprotein##4##1##(1993-2#1)(1994-9#1)(2008-6#1)(2013-1#1)
proproteins##2##1##(1992-12#1)(1993-5#1)
proptosis with##2##2##(2011-1#1)(2013-8#1)
proptosis##12##1##(2008-7#3)(2008-8#2)(2010-11#1)(2011-1#3)(2011-2#1)(2013-7#1)(2013-8#1)
propulsion##6##1##(2007-12#2)(2008-10#4)
propulsive##2##1##(2007-12#1)(2010-8#1)
propyl gallate##2##2##(1992-9#1)(1996-2#1)
propyl##12##1##(1992-9#1)(1996-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-1#1)
propylene glycol and isopropanol##2##4##(1991-5#2)
propylene glycol and triethyl phosphate##2##5##(2008-11#2)
propylene glycol and##5##3##(1991-5#2)(2008-11#3)
propylene glycol##17##2##(1991-5#6)(2007-7#1)(2008-10#1)(2008-11#4)(2008-5#5)
propylene oxide production rate##2##4##(2008-6#2)
propylene oxide production##4##3##(2008-6#4)
propylene oxide##10##2##(1993-8#2)(2008-6#8)
propylene##31##1##(1991-5#6)(1993-8#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-5#6)(2008-6#8)
propylparaben and##3##2##(2008-10#3)
propylparaben##4##1##(2008-10#4)
prorenin to renin in vitro##2##5##(1990-8#2)
prorenin##12##1##(1990-5#2)(1990-8#3)(1991-9#3)(1996-5#4)
proreninR-4 was##2##2##(1991-9#2)
proreninR-4##4##1##(1991-9#4)
pros and cons of##15##4##(1992-1#1)(1996-6#1)(2008-11#2)(2008-3#1)(2008-4#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
pros and cons##20##3##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
pros of changing##2##3##(2008-11#2)
pros##22##1##(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
prosaikogenin##3##1##(2008-11#3)
prosecution##4##1##(1990-6#1)(1994-3#1)(2008-10#1)(2012-1#1)
prosecutor##2##1##(1995-12#2)
prosequence##3##1##(1995-6#1)(1996-5#2)
prosimians##2##1##(2007-12#1)(2009-8#1)
prosocial behavior##6##2##(2008-12#1)(2012-12#3)(2013-1#2)
prosocial norms##4##2##(2013-1#4)
prosocial##14##1##(2008-12#2)(2012-12#4)(2013-1#7)(2013-8#1)
prosodic##7##1##(2009-10#2)(2010-9#3)(2013-8#2)
prosody in##2##2##(2009-10#1)(2010-9#1)
prosody##10##1##(2008-9#1)(2009-10#4)(2010-9#5)
prosomatostatin##6##1##(1994-11#6)
prosomes##2##1##(2012-2#2)
prosopagnosia##4##1##(1991-11#3)(1996-11#1)
prosopagnosics##4##1##(2008-11#4)
prospect for a##2##3##(2010-12#1)(2012-2#1)
prospect for##3##2##(2008-9#1)(2010-12#1)(2012-2#1)
prospect in##3##2##(2011-3#1)(2013-8#2)
prospect of the##2##3##(1991-12#1)(2013-8#1)
prospect of##14##2##(1991-12#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
prospect##26##1##(1991-12#1)(1993-12#1)(1994-12#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#3)
prospective analysis of##3##3##(2011-1#2)(2011-2#1)
prospective analysis##5##2##(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
prospective and retrospective##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
prospective and##8##2##(2007-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
prospective case series we investigated the##2##6##(2011-2#2)
prospective case-based system##2##3##(1992-12#2)
prospective clinical trial##4##3##(1990-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
prospective clinical##7##2##(1990-9#1)(2009-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
prospective cohort of##6##3##(2008-8#1)(2008-9#1)(2012-12#1)(2012-6#1)(2013-1#2)
prospective cohort studies##2##3##(2008-11#1)(2008-8#1)
prospective cohort study of##3##4##(2008-7#1)(2009-5#1)(2012-1#1)
prospective cohort study on##2##4##(2011-1#1)(2013-1#1)
prospective cohort study##16##3##(1992-11#1)(1996-11#1)(2007-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
prospective cohort##26##2##(1992-11#1)(1996-11#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-6#1)(2013-1#5)(2013-8#1)
prospective controlled studies##3##3##(1991-2#1)(2008-1#1)(2010-5#1)
prospective controlled##6##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-5#1)
prospective design##2##2##(1995-1#1)(2013-1#1)
prospective evaluation of##2##3##(1992-12#1)(2008-8#1)
prospective evaluation##4##2##(1992-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
prospective investigations##2##2##(1993-12#1)(2006-10#1)
prospective longitudinal study##3##3##(2008-8#1)(2010-4#1)(2012-12#1)
prospective longitudinal##5##2##(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
prospective memory##7##2##(2008-1#2)(2013-7#5)
prospective multicenter##3##2##(2009-10#1)(2011-2#1)(2012-12#1)
prospective observational studies##2##3##(1990-3#2)
prospective observational study was##2##4##(2011-2#1)(2012-5#1)
prospective observational study##8##3##(2008-3#1)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
prospective observational##11##2##(1990-3#2)(2008-11#1)(2008-3#1)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
prospective payment by##2##3##(1991-3#1)(1992-1#1)
prospective payment rates##2##3##(1991-1#2)
prospective payment system (PPS) for##4##5##(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)
prospective payment system (PPS)##17##4##(1991-2#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-3#1)
prospective payment system for hospitals##2##5##(1992-2#2)
prospective payment system for##4##4##(1991-1#2)(1992-2#2)
prospective payment system##40##3##(1991-1#4)(1991-2#3)(1991-3#3)(1992-1#2)(1992-12#8)(1992-2#6)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-3#1)(1996-3#1)(2008-11#1)(2010-8#1)
prospective payment##60##2##(1991-1#8)(1991-12#1)(1991-2#4)(1991-3#6)(1992-1#4)(1992-12#10)(1992-2#7)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#1)(2008-11#1)(2010-8#1)
prospective phase II study##3##4##(2008-10#3)
prospective phase##4##2##(2008-10#4)
prospective pilot study was##2##4##(2007-10#1)(2012-3#1)
prospective pilot study##4##3##(1994-1#1)(2007-10#1)(2012-3#1)(2013-1#1)
prospective randomized controlled##3##3##(2008-7#2)(2011-2#1)
prospective randomized double blind##3##4##(2009-8#1)(2010-7#1)(2012-12#1)
prospective randomized study##5##3##(2007-12#1)(2007-8#1)(2011-2#1)(2012-3#2)
prospective randomized trial of##2##4##(1993-9#1)(2008-10#1)
prospective randomized trial##4##3##(1993-9#1)(2008-10#1)(2008-6#1)(2010-10#1)
prospective randomized trials##3##3##(1997-4#1)(2008-6#1)(2010-8#1)
prospective randomized##21##2##(1991-2#1)(1993-9#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#3)(2008-7#2)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)
prospective registration of##2##3##(1990-6#1)(2010-5#1)
prospective review of##3##3##(1992-3#1)(2008-7#1)(2008-8#1)
prospective studies are##4##3##(1995-8#1)(2007-10#2)(2007-12#1)
prospective studies have##4##3##(1997-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
prospective studies in##2##3##(2009-5#1)(2011-1#1)
prospective studies to##2##3##(1997-5#1)(2013-1#1)
prospective studies##26##2##(1990-6#1)(1993-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-6#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2011-1#1)(2012-3#1)(2013-1#3)
prospective study at##2##3##(1990-11#1)(2008-1#1)
prospective study in##4##3##(1990-9#1)(2008-9#1)(2009-8#1)(2010-12#1)
prospective study of a##2##4##(1995-5#1)(2012-12#1)
prospective study of the##2##4##(1994-2#1)(2007-11#1)
prospective study of##17##3##(1990-2#2)(1990-3#1)(1990-5#1)(1992-6#2)(1994-2#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#3)(2009-8#1)(2012-12#1)
prospective study to##2##3##(2010-2#1)(2010-5#1)
prospective study was conducted##7##4##(2007-10#1)(2007-11#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
prospective study was done on##2##5##(2013-8#2)
prospective study was##18##3##(1992-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
prospective study##93##2##(1990-11#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-9#2)(1992-12#2)(1992-6#2)(1993-2#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#6)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#5)
prospective study]##4##2##(1990-3#1)(1990-6#1)(1991-3#1)(2009-5#1)
prospective surveys##3##2##(2008-10#3)
prospective systems##2##2##(1994-2#2)
prospective trial was conducted##2##4##(1991-2#1)(1997-2#1)
prospective trial##5##2##(1990-10#1)(1991-2#1)(1997-2#1)(2009-5#1)(2011-2#1)
prospective trials##4##2##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
prospective triple-blind randomized##2##3##(1997-3#2)
prospective##453##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#6)(1990-4#1)(1990-5#1)(1990-6#3)(1990-9#3)(1991-1#9)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#8)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#16)(1992-2#7)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#5)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#10)(2007-11#4)(2007-12#4)(2007-2#2)(2007-7#9)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#17)(2008-11#9)(2008-12#5)(2008-3#7)(2008-4#3)(2008-6#6)(2008-7#24)(2008-8#13)(2008-9#9)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#5)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#7)(2011-2#28)(2012-1#1)(2012-12#15)(2012-2#7)(2012-3#18)(2012-5#2)(2012-6#1)(2013-1#28)(2013-7#5)(2013-8#8)
prospectively and##2##2##(2007-8#1)(2010-3#1)
prospectively assessed##4##2##(1994-12#1)(1995-4#1)(2013-1#2)
prospectively collected##2##2##(2007-8#1)(2010-11#1)
prospectively evaluated##5##2##(2007-7#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
prospectively followed patients##2##3##(2008-6#2)
prospectively followed##3##2##(2008-6#2)(2011-2#1)
prospectively gathered##2##2##(2008-6#1)(2012-2#1)
prospectively in##5##2##(1990-11#1)(1990-9#1)(1991-4#1)(1994-3#1)(2013-1#1)
prospectively included##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
prospectively performed##2##2##(1997-8#1)(2013-7#1)
prospectively recruited##2##2##(1992-2#1)(2008-3#1)
prospectively studied##9##2##(1994-12#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#3)(2013-8#1)
prospectively the##3##2##(1990-3#1)(2007-10#1)(2007-12#1)
prospectively to##3##2##(1992-2#1)(2006-10#1)(2007-10#1)
prospectively with##2##2##(1990-9#1)(1994-1#1)
prospectively##76##1##(1990-11#1)(1990-3#1)(1990-9#3)(1991-4#1)(1992-2#2)(1994-1#1)(1994-12#2)(1994-3#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1997-8#3)(2006-10#1)(2007-10#3)(2007-12#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#4)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
prospects and##2##2##(1995-2#1)(2009-10#1)
prospects for further##4##3##(1990-11#1)(2007-11#2)(2008-3#1)
prospects for the future##3##4##(1997-7#1)(2009-4#1)(2010-3#1)
prospects for the##7##3##(1991-2#1)(1997-7#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)
prospects for##43##2##(1990-11#1)(1991-2#2)(1992-12#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#4)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)
prospects in##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
prospects of##8##2##(1993-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2011-2#1)(2011-7#1)(2013-1#1)
prospects##81##1##(1990-11#1)(1990-2#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#3)(1997-6#1)(1997-7#2)(2006-9#1)(2007-11#4)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#4)(2011-7#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
prospects]##5##1##(1990-12#1)(1990-3#1)(1991-3#1)(1992-3#1)(1997-3#1)
prosperous##2##1##(1994-9#1)(2008-5#1)
prostacyclin (PGI2)##3##2##(1994-5#1)(1995-11#1)(2008-3#1)
prostacyclin analogues##3##2##(1994-6#2)(2010-10#1)
prostacyclin production##5##2##(1994-5#1)(1994-9#4)
prostacyclin release from##3##3##(1991-5#2)(1995-11#1)
prostacyclin release##4##2##(1991-5#3)(1995-11#1)
prostacyclin synthase##2##2##(1995-11#2)
prostacyclin##30##1##(1991-12#1)(1991-5#5)(1992-6#1)(1994-5#4)(1994-6#2)(1994-9#5)(1995-11#4)(1996-2#2)(1996-8#1)(1997-7#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-6#1)
prostaglandin D2##3##2##(1992-3#2)(1996-2#1)
prostaglandin E##3##2##(1993-12#1)(1994-6#1)(2012-2#1)
prostaglandin E(2) (PGE(2))##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
prostaglandin E1 (PGE1)##4##3##(1993-12#1)(1993-8#1)(1994-2#1)(1997-7#1)
prostaglandin E1##7##2##(1993-12#1)(1993-8#1)(1994-2#1)(1997-7#1)(2007-8#3)
prostaglandin E2 (PGE2) and##4##4##(1991-8#1)(1993-12#1)(2007-11#1)(2013-8#1)
prostaglandin E2 (PGE2)##8##3##(1990-2#1)(1991-8#1)(1993-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2013-8#1)
prostaglandin E2 and##2##3##(1993-8#1)(1996-2#1)
prostaglandin E2 production##2##3##(1991-8#1)(1995-6#1)
prostaglandin E2 synthesis by##3##4##(1997-1#3)
prostaglandin E2##32##2##(1990-2#2)(1991-8#2)(1993-11#1)(1993-12#2)(1993-8#1)(1994-9#1)(1995-12#4)(1995-3#1)(1995-6#2)(1996-2#2)(1997-1#7)(1997-2#2)(2007-11#1)(2008-7#1)(2011-2#2)(2013-8#1)
prostaglandin F synthase##4##3##(1992-3#4)
prostaglandin H synthase##9##3##(1992-8#2)(1994-5#5)(2008-4#2)
prostaglandin H synthase-1##2##3##(2008-4#2)
prostaglandin H synthase-2 in##2##4##(1993-3#2)
prostaglandin H synthase-2##8##3##(1993-3#5)(2008-4#3)
prostaglandin H##21##2##(1991-8#1)(1992-8#2)(1993-3#5)(1994-5#6)(2008-4#7)
prostaglandin H2##2##2##(1992-3#2)
prostaglandin endoperoxide H##2##3##(1995-5#2)
prostaglandin endoperoxide##4##2##(1992-3#2)(1995-5#2)
prostaglandin formation##2##2##(2008-5#2)
prostaglandin production##2##2##(1996-2#2)
prostaglandin synthesis in##3##3##(1990-12#2)(1997-1#1)
prostaglandin synthesis was##2##3##(1997-1#2)
prostaglandin synthesis##8##2##(1990-12#2)(1991-3#1)(1995-5#1)(1996-6#1)(1997-1#3)
prostaglandin##108##1##(1990-12#3)(1990-2#2)(1990-8#1)(1991-3#1)(1991-8#3)(1992-3#10)(1992-8#2)(1993-11#1)(1993-12#4)(1993-3#5)(1993-8#3)(1994-11#1)(1994-2#1)(1994-5#6)(1994-6#1)(1994-9#2)(1995-12#4)(1995-3#1)(1995-5#3)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-6#1)(1997-1#12)(1997-2#2)(1997-7#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-4#7)(2008-5#2)(2008-7#3)(2010-9#1)(2011-2#2)(2012-2#2)(2013-8#2)
prostaglandin-independent##2##1##(1992-8#1)(1993-11#1)
prostaglandins (PGs)##3##2##(2008-11#2)(2008-7#1)
prostaglandins##29##1##(1990-3#1)(1992-8#1)(1993-6#1)(1994-11#4)(1994-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(2008-10#2)(2008-11#4)(2008-4#2)(2008-7#4)(2010-1#2)(2011-2#1)
prostanoid synthesis##5##2##(1994-3#4)(2008-5#1)
prostanoid##7##1##(1993-3#1)(1994-3#4)(2008-5#1)(2010-10#1)
prostanoids##8##1##(1992-8#3)(1993-3#1)(1995-12#1)(2010-10#2)(2010-5#1)
prostate -##2##2##(2007-11#2)
prostate adenocarcinoma##2##2##(2011-2#1)(2013-1#1)
prostate and##5##2##(1990-8#1)(2007-11#1)(2008-2#1)(2010-10#1)(2013-1#1)
prostate biopsy##2##2##(2011-2#1)(2012-3#1)
prostate cancer (PCa)##2##3##(2013-1#2)
prostate cancer account for##2##4##(2007-11#1)(2008-7#1)
prostate cancer and##7##3##(2007-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
prostate cancer are##2##3##(2008-4#1)(2009-5#1)
prostate cancer bone metastases##3##4##(2007-11#2)(2011-2#1)
prostate cancer cell line##3##4##(1990-12#1)(2008-9#2)
prostate cancer cell##5##3##(1990-12#1)(2008-8#1)(2008-9#2)(2010-1#1)
prostate cancer cells and##3##4##(2011-2#2)(2012-3#1)
prostate cancer cells is##2##4##(2011-2#2)
prostate cancer cells##10##3##(2008-6#1)(2011-2#7)(2012-3#2)
prostate cancer diagnosis##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
prostate cancer has##2##3##(2008-7#1)(2009-5#1)
prostate cancer in the United States##2##6##(1995-9#1)(2009-5#1)
prostate cancer in the##3##4##(1995-9#1)(2009-5#2)
prostate cancer in##9##3##(1994-12#1)(1995-9#1)(2008-8#1)(2009-5#2)(2010-1#1)(2011-2#2)(2012-3#1)
prostate cancer incidence and mortality##2##5##(2009-5#2)
prostate cancer is##8##3##(1992-2#1)(2007-5#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
prostate cancer may##2##3##(2010-11#1)(2013-1#1)
prostate cancer pathogenesis##2##3##(2011-2#2)
prostate cancer patients with##2##4##(2007-11#1)(2011-2#1)
prostate cancer patients##7##3##(1994-8#1)(2007-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
prostate cancer screening##6##3##(2009-5#6)
prostate cancer should##2##3##(2008-1#1)(2008-4#1)
prostate cancer support groups##2##4##(2009-5#2)
prostate cancer survivors##2##3##(2012-3#2)
prostate cancer survivorship care##2##4##(2012-3#2)
prostate cancer survivorship##3##3##(2012-3#3)
prostate cancer treatment##2##3##(2008-7#1)(2009-5#1)
prostate cancer using##3##3##(1995-11#1)(2008-6#1)(2009-12#1)
prostate cancer was##2##3##(2011-2#1)(2012-12#1)
prostate cancer##213##2##(1990-12#1)(1990-2#2)(1991-8#1)(1992-2#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-8#3)(1995-9#3)(1997-7#1)(2007-11#10)(2007-5#5)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#26)(2008-8#6)(2008-9#2)(2009-12#1)(2009-5#24)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#4)(2010-6#1)(2011-1#1)(2011-2#41)(2012-12#10)(2012-3#12)(2013-1#13)(2013-8#7)
prostate cancers##6##2##(2011-2#5)(2012-12#1)
prostate carcinoma##11##2##(1990-12#1)(1994-12#2)(2007-11#1)(2008-9#2)(2011-2#1)(2013-1#4)
prostate cell##3##2##(2008-11#1)(2008-9#1)(2012-12#1)
prostate cells##3##2##(1995-11#2)(2010-1#1)
prostate disease and##2##3##(2008-1#2)
prostate epithelial cells##2##3##(2008-11#1)(2011-2#1)
prostate gland of##2##3##(2008-7#2)
prostate gland##6##2##(2008-11#1)(2008-12#1)(2008-7#2)(2012-3#2)
prostate health##5##2##(2008-1#4)(2008-4#1)
prostate in##3##2##(1993-8#1)(2012-3#2)
prostate specific antigen (PSA)##2##4##(1994-12#1)(2011-2#1)
prostate specific antigen##4##3##(1994-12#2)(2011-2#1)(2013-8#1)
prostate specific##5##2##(1994-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
prostate specimens##2##2##(2008-6#1)(2011-2#1)
prostate tumor cells##2##3##(2008-4#1)(2012-12#1)
prostate tumor##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
prostate tumors##5##2##(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#1)
prostate were##3##2##(1992-12#1)(1995-3#1)(2011-2#1)
prostate##353##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-2#1)(1991-5#2)(1991-8#4)(1992-12#1)(1992-2#1)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#6)(1994-2#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-8#7)(1995-9#3)(1997-7#1)(2007-10#1)(2007-11#14)(2007-5#5)(2007-9#1)(2008-1#9)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#19)(2008-5#4)(2008-6#8)(2008-7#28)(2008-8#6)(2008-9#5)(2009-11#2)(2009-12#2)(2009-5#24)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#5)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#57)(2012-12#19)(2012-2#5)(2012-3#17)(2013-1#23)(2013-8#8)
prostate-specific antigen (PSA)##4##3##(2008-9#1)(2009-5#1)(2010-12#1)(2012-12#1)
prostate-specific antigen##11##2##(1994-3#1)(1996-9#1)(2007-4#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
prostate-specific membrane##2##2##(1995-11#1)(2008-4#1)
prostate-specific##13##1##(1994-3#1)(1995-11#1)(1996-9#1)(2007-4#1)(2008-4#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
prostatectomies##3##1##(1996-9#1)(2008-10#1)(2010-11#1)
prostatectomy##23##1##(1990-9#1)(1994-12#1)(1995-11#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-5#3)(2010-10#2)(2010-11#2)(2011-2#2)(2012-2#1)(2013-1#4)
prostatic Zn##2##2##(2008-10#2)
prostatic adenocarcinoma##3##2##(1990-3#1)(2007-10#1)(2009-5#1)
prostatic adenoma##3##2##(1990-3#1)(1991-6#1)(1994-3#1)
prostatic biopsy##2##2##(2010-11#1)(2011-1#1)
prostatic cancer##20##2##(1990-12#2)(1990-9#3)(1991-2#2)(1991-7#6)(1991-9#1)(1993-8#1)(1995-11#1)(1995-12#2)(2009-5#1)(2013-8#1)
prostatic cancer]##2##2##(1993-6#1)(1995-11#1)
prostatic carcinoma##12##2##(1990-12#1)(1991-2#5)(1993-8#3)(1994-11#1)(2008-4#2)
prostatic cell##2##2##(1990-7#1)(1991-2#1)
prostatic epithelial cells from##2##4##(1990-7#2)
prostatic epithelial cells##4##3##(1990-7#2)(1993-8#1)(1995-11#1)
prostatic epithelial##5##2##(1990-7#2)(1993-8#1)(1995-11#1)(2008-11#1)
prostatic hyperthermia##2##2##(1990-3#2)
prostatic hypertrophy##4##2##(1990-11#1)(1990-3#2)(2008-5#1)
prostatic urethra##2##2##(1997-8#1)(2012-3#1)
prostatic##86##1##(1990-11#2)(1990-12#3)(1990-3#7)(1990-7#4)(1990-9#6)(1991-2#12)(1991-6#1)(1991-7#6)(1991-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1993-8#5)(1994-11#3)(1994-12#1)(1994-3#1)(1995-11#3)(1995-12#2)(1997-8#1)(2007-10#2)(2008-10#5)(2008-11#2)(2008-4#4)(2008-5#3)(2008-7#1)(2009-5#3)(2010-11#1)(2011-1#2)(2012-3#1)(2013-8#1)
prostatitis due to Trichomonas vaginalis##2##5##(2008-10#2)
prostatitis syndrome##3##2##(2008-10#3)
prostatitis##22##1##(1990-3#1)(2008-10#14)(2008-12#1)(2008-8#1)(2010-11#1)(2011-1#3)(2011-2#1)
prostheses and other##2##3##(1991-3#1)(2011-2#1)
prostheses and##7##2##(1991-3#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
prostheses are##4##2##(1991-3#1)(2009-12#1)(2010-8#1)(2012-2#1)
prostheses for##2##2##(2008-8#1)(2011-7#1)
prostheses have##3##2##(2009-1#1)(2010-8#2)
prostheses in the treatment of##3##5##(1992-3#1)(2007-8#1)(2009-4#1)
prostheses in the##4##3##(1992-3#1)(1993-9#1)(2007-8#1)(2009-4#1)
prostheses in##5##2##(1992-3#1)(1993-9#1)(2007-8#1)(2009-4#1)(2012-2#1)
prostheses may##2##2##(2011-2#1)(2013-1#1)
prostheses were##3##2##(2007-11#1)(2009-1#1)(2011-2#1)
prostheses##69##1##(1990-12#2)(1990-8#1)(1991-3#2)(1992-3#2)(1993-9#1)(2007-11#4)(2007-8#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-1#9)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#4)(2009-8#1)(2010-3#3)(2010-8#5)(2011-2#6)(2011-3#2)(2011-7#1)(2012-2#2)(2013-1#13)
prostheses]##4##1##(1990-12#1)(1994-11#1)(2010-8#1)(2012-2#1)
prosthesis after##2##2##(2009-4#1)(2013-1#1)
prosthesis and##5##2##(1993-6#1)(2007-8#2)(2012-2#1)(2013-1#1)
prosthesis can be##2##3##(2009-3#2)
prosthesis can##3##2##(2009-3#2)(2011-3#1)
prosthesis during##2##2##(2011-7#1)(2013-1#1)
prosthesis for##2##2##(2011-3#1)(2013-8#1)
prosthesis has been##2##3##(1993-3#1)(2009-4#1)
prosthesis has##4##2##(1993-3#1)(2007-8#2)(2009-4#1)
prosthesis implantation##4##2##(2007-11#1)(2007-8#2)(2013-8#1)
prosthesis in##4##2##(1992-9#1)(2008-6#1)(2009-12#1)(2009-3#1)
prosthesis infection##2##2##(2008-1#1)(2011-3#1)
prosthesis insertion##5##2##(1993-6#1)(2008-10#1)(2013-8#3)
prosthesis is##3##2##(2010-5#1)(2013-1#2)
prosthesis that##2##2##(2013-1#2)
prosthesis was implanted##2##3##(2007-8#1)(2009-4#1)
prosthesis was##7##2##(2007-8#3)(2009-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
prosthesis with##2##2##(2010-5#1)(2010-8#1)
prosthesis##113##1##(1991-2#3)(1992-9#1)(1993-11#3)(1993-3#2)(1993-6#3)(1994-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-7#1)(2007-8#25)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-6#2)(2008-9#2)(2009-1#1)(2009-12#5)(2009-3#7)(2009-4#5)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#5)(2011-3#5)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#14)(2013-8#6)
prosthesis)##2##1##(1992-5#2)
prosthesis]##4##1##(1990-3#1)(1996-6#1)(2011-2#1)(2013-1#1)
prosthetic complications were##2##3##(2013-1#2)
prosthetic components##2##2##(2013-1#2)
prosthetic finite element modeling##2##4##(2007-7#2)
prosthetic graft##3##2##(2007-7#1)(2011-3#2)
prosthetic grafts##3##2##(1991-3#1)(2007-7#2)
prosthetic group##8##2##(1990-12#1)(1992-10#1)(1992-8#2)(1993-8#1)(1995-3#1)(2007-11#1)(2008-12#1)
prosthetic groups##5##2##(2008-11#1)(2008-7#3)(2011-2#1)
prosthetic implants##2##2##(2008-9#1)(2011-2#1)
prosthetic joint infection##2##3##(2007-12#1)(2012-12#1)
prosthetic joint##4##2##(2006-10#1)(2007-12#2)(2012-12#1)
prosthetic knee##3##2##(2013-1#3)
prosthetic material##2##2##(2011-2#1)(2012-2#1)
prosthetic mesh##2##2##(2011-2#2)
prosthetic meshes##3##2##(2011-2#3)
prosthetic replacement##4##2##(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)
prosthetic valve dysfunction##3##3##(2008-4#2)(2012-2#1)
prosthetic valve##5##2##(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
prosthetic##89##1##(1990-12#1)(1990-5#3)(1990-6#1)(1991-3#2)(1992-10#1)(1992-5#3)(1992-8#2)(1993-2#1)(1993-8#1)(1994-8#1)(1995-3#1)(2006-10#2)(2007-11#3)(2007-12#4)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-3#4)(2010-6#1)(2011-2#12)(2011-3#3)(2012-12#1)(2012-2#2)(2013-1#13)(2013-8#1)
prosthetics##3##1##(2007-12#1)(2010-3#1)(2012-3#1)
prosthetist##2##1##(2010-3#1)(2013-1#1)
prosthodontic##4##1##(2007-12#1)(2008-11#1)(2012-7#1)(2013-1#1)
prosthodontics##3##1##(1990-3#1)(2013-1#2)
prostitute##4##1##(1992-9#2)(1996-5#1)(2008-5#1)
prostitutes who##2##2##(1990-3#2)
prostitutes##9##1##(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#1)(1993-3#1)(1993-8#1)(1995-12#1)
prostitution##7##1##(1990-2#1)(1997-5#1)(1997-6#1)(2008-1#1)(2009-7#2)(2011-2#1)
prostomial##2##1##(2008-5#1)(2011-2#1)
prosurvival##2##1##(2013-1#1)(2013-7#1)
protagonists##2##1##(2007-4#1)(2012-1#1)
protamine##11##1##(1990-7#1)(1994-6#2)(1994-9#2)(1996-6#1)(2008-10#1)(2008-6#2)(2008-8#1)(2011-1#1)
protamine-DNA##2##1##(1994-6#2)
protamines##8##1##(1990-7#2)(1993-6#1)(1994-6#5)
protean manifestations##2##2##(2010-12#1)(2011-2#1)
protean##4##1##(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
protease activation##2##2##(2008-4#1)(2008-5#1)
protease activity and##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
protease activity in##3##3##(1991-12#1)(2008-11#1)(2008-4#1)
protease activity##16##2##(1991-12#2)(1995-8#2)(1997-4#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#4)
protease and##9##2##(1991-5#1)(1991-9#2)(1994-12#1)(2008-2#1)(2009-9#1)(2011-2#1)(2011-3#2)
protease as##2##2##(1991-5#1)(1991-9#1)
protease cleavage##2##2##(2008-10#1)(2008-11#1)
protease digestion##3##2##(1995-3#1)(2008-4#1)(2008-5#1)
protease domain##3##2##(1995-6#3)
protease from##4##2##(1990-8#2)(1992-6#1)(1992-8#1)
protease has been##2##3##(1991-9#2)
protease has##3##2##(1991-12#1)(1991-9#2)
protease in the##3##3##(1992-6#2)(2011-3#1)
protease in##8##2##(1991-12#1)(1991-9#1)(1992-6#2)(1997-1#1)(2008-10#1)(2011-3#2)
protease inhibitor (KPI)##3##3##(1992-12#1)(1996-12#2)
protease inhibitor domain##4##3##(1991-11#1)(1991-2#1)(1994-11#2)
protease inhibitor##18##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#2)(1994-11#2)(1994-9#1)(1996-12#2)(2008-10#2)(2008-7#1)(2008-8#2)(2013-1#1)
protease inhibitors and##2##3##(1997-7#1)(2008-3#1)
protease inhibitors to##2##3##(1991-2#1)(2013-1#1)
protease inhibitors##34##2##(1990-11#1)(1990-2#1)(1991-2#6)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#2)(1994-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-6#1)(2008-1#2)(2008-3#1)(2008-5#2)(2009-8#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#2)
protease inhibitors)##2##2##(1992-3#1)(2008-4#1)
protease inhibitory##2##2##(1991-12#1)(1995-6#1)
protease is##8##2##(1990-2#1)(1991-9#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)
protease nexin-2 (PN-2)##2##3##(1991-2#1)(1992-12#1)
protease of##4##2##(1991-5#1)(1993-12#1)(2008-4#1)(2012-3#1)
protease production##3##2##(1992-6#2)(2008-10#1)
protease resistant##2##2##(1994-6#1)(1997-3#1)
protease to##2##2##(1990-8#1)(1991-10#1)
protease treatment##2##2##(1990-11#1)(2008-10#1)
protease was not##2##3##(2008-10#2)
protease was##5##2##(1990-8#1)(2008-10#4)
protease with##4##2##(1992-12#1)(1992-8#2)(1993-11#1)
protease##247##1##(1990-11#2)(1990-2#5)(1990-5#1)(1990-8#4)(1991-10#1)(1991-11#1)(1991-12#11)(1991-2#11)(1991-5#4)(1991-6#1)(1991-9#14)(1992-11#6)(1992-12#9)(1992-3#2)(1992-6#17)(1992-8#9)(1992-9#3)(1993-11#4)(1993-12#7)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#5)(1995-6#6)(1995-8#5)(1996-12#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(2006-6#1)(2008-1#3)(2008-10#20)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#10)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#8)(2011-3#7)(2012-12#4)(2012-3#2)(2013-1#5)
protease)##2##1##(1992-6#1)(2009-8#1)
protease-activated##2##1##(2008-5#1)(2009-3#1)
protease-resistant##4##1##(1992-12#1)(1995-2#1)(1995-6#1)(1996-5#1)
protease-sensitive##2##1##(1992-4#1)(1992-9#1)
protease-treated##2##1##(2008-10#2)
proteases and protease inhibitors in##2##5##(2009-8#2)
proteases and protease inhibitors##3##4##(1997-4#1)(2009-8#2)
proteases and their##4##3##(2008-4#3)(2010-3#1)
proteases and##8##2##(1997-4#1)(2008-10#1)(2008-4#3)(2009-8#2)(2010-3#1)
proteases based on##2##3##(1994-6#1)(1996-12#1)
proteases constitute a##2##3##(2008-1#1)(2012-3#1)
proteases from##4##2##(1990-8#1)(1992-6#1)(1994-6#1)(2011-2#1)
proteases in the##5##3##(1990-11#1)(2008-1#3)(2008-11#1)
proteases in##8##2##(1990-11#1)(1991-9#1)(2008-1#3)(2008-11#1)(2008-4#1)(2013-1#1)
proteases involved in##3##3##(1991-6#1)(2008-4#1)(2010-11#1)
proteases was##2##2##(1992-6#1)(1994-6#1)
proteases with##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
proteases##96##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-8#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-6#4)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#5)(1996-12#1)(1997-1#2)(1997-4#2)(2008-1#7)(2008-10#5)(2008-11#5)(2008-4#13)(2008-5#7)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2010-3#1)(2011-2#3)(2012-3#3)(2013-1#2)
proteasomal degradation##6##2##(2008-8#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
proteasomal##10##1##(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#3)(2011-2#1)(2012-2#1)(2013-1#1)
proteasome inhibitor##4##2##(2008-8#1)(2010-7#1)(2010-8#1)(2012-12#1)
proteasome is##3##2##(2008-4#3)
proteasome subunit##2##2##(2008-8#1)(2010-12#1)
proteasome##28##1##(1993-9#1)(2008-4#11)(2008-5#2)(2008-8#5)(2009-7#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
proteasomes from Saccharomyces cerevisiae##2##4##(2008-4#2)
protect a##2##2##(2008-11#1)(2011-2#1)
protect against the development of##3##5##(1991-6#1)(1991-8#1)(1993-11#1)
protect against the##6##3##(1991-6#1)(1991-8#1)(1993-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
protect against##39##2##(1990-11#1)(1991-6#4)(1991-8#1)(1992-2#1)(1993-11#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#6)(2008-7#3)(2010-2#1)(2010-8#1)(2011-2#6)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
protect and##5##2##(1995-6#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
protect cells from##3##3##(1996-12#1)(2008-11#1)(2008-5#1)
protect cells##5##2##(1994-11#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-5#1)
protect from##5##2##(1994-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2012-12#1)
protect health##2##2##(1997-1#1)(2013-1#1)
protect human subjects##2##3##(2009-4#2)
protect immunodeficient mice from candidiasis##2##5##(2008-5#2)
protect immunodeficient##4##2##(2008-5#4)
protect in##2##2##(1995-11#2)
protect mice from##2##3##(1990-11#1)(1995-5#1)
protect mice##3##2##(1990-11#1)(1995-5#1)(2009-6#1)
protect neurons from##2##3##(2008-7#2)
protect other##2##2##(2008-11#1)(2011-2#1)
protect the cells##3##3##(1992-11#1)(2008-11#1)(2008-7#1)
protect the health of the##2##5##(2008-10#1)(2010-6#1)
protect the health of##3##4##(2008-10#1)(2008-11#1)(2010-6#1)
protect the patients##2##3##(1996-2#1)(2008-1#1)
protect the##49##2##(1990-11#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-5#7)(2008-7#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
protect them against##3##3##(1994-3#1)(2008-5#1)(2013-1#1)
protect them from##3##3##(1993-12#1)(2009-9#1)(2011-2#1)
protect them##6##2##(1993-12#1)(1994-3#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
protect themselves from##2##3##(2007-7#1)(2012-2#1)
protect themselves##4##2##(2007-7#1)(2008-12#1)(2010-3#1)(2012-2#1)
protect wheat##3##2##(2008-10#2)(2011-2#1)
protect your##2##2##(1996-12#1)(2008-10#1)
protect##228##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#7)(1994-5#2)(1994-6#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#3)(2007-11#2)(2007-2#4)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#12)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#24)(2008-7#10)(2008-8#2)(2009-10#1)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#16)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#1)
protectant fungicide##2##2##(2008-10#2)
protectant fungicides##2##2##(2008-10#2)
protectant##8##1##(1994-2#1)(2007-8#1)(2008-10#5)(2013-8#1)
protected against the##6##3##(1991-5#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
protected against##14##2##(1991-5#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
protected and##3##2##(2008-3#2)(2008-5#1)
protected area##4##2##(2013-7#4)
protected by the##2##3##(1991-9#1)(2010-1#1)
protected by##11##2##(1991-9#1)(1994-3#1)(1995-5#1)(2008-10#5)(2008-7#1)(2010-1#1)(2011-2#1)
protected cells##2##2##(2008-7#1)(2012-12#1)
protected for##2##2##(2007-3#1)(2008-11#1)
protected fragments of##2##3##(1996-2#2)
protected from the##4##3##(1993-9#1)(2008-10#1)(2009-3#1)(2013-1#1)
protected from##22##2##(1990-11#1)(1993-6#1)(1993-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
protected maleimide##2##2##(2008-6#2)
protected mice against##2##3##(1994-8#1)(2009-6#1)
protected mice##3##2##(1994-8#1)(2009-6#1)(2012-12#1)
protected river##2##2##(2013-7#2)
protected the##7##2##(1992-8#1)(1994-12#1)(1996-3#1)(1997-8#1)(2008-11#2)(2008-7#1)
protected their##2##2##(1991-7#1)(2008-4#1)
protected with##4##2##(1996-9#1)(2008-10#1)(2008-3#1)(2010-12#1)
protected##161##1##(1990-11#3)(1990-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#7)(1995-6#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#1)(2007-11#3)(2007-3#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#10)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#8)(2013-8#2)
protecting against##11##2##(1992-5#1)(1993-5#1)(1994-1#1)(1994-5#1)(1994-9#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
protecting and##5##2##(1993-1#1)(2007-2#1)(2008-9#2)(2010-8#1)
protecting cells from##2##3##(1992-7#1)(1995-2#1)
protecting cells##4##2##(1992-7#1)(1995-2#1)(2008-11#1)(2011-2#1)
protecting group for the##3##4##(2008-4#2)(2010-6#1)
protecting group##5##2##(2008-4#4)(2010-6#1)
protecting groups and##3##3##(1997-4#2)(2008-7#1)
protecting groups was##2##3##(1996-5#1)(2010-2#1)
protecting groups##10##2##(1994-12#1)(1995-11#1)(1996-5#1)(1997-4#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)
protecting instruments##2##2##(1991-6#2)
protecting it##2##2##(1994-2#1)(2008-7#1)
protecting mice against##2##3##(1992-8#1)(2008-7#1)
protecting neurons against##2##3##(1995-12#1)(2009-12#1)
protecting patients##3##2##(1997-5#1)(2011-2#2)
protecting the rights of##2##4##(2008-7#2)
protecting the rights##3##3##(1992-3#1)(2008-7#2)
protecting the##19##2##(1992-3#2)(1992-8#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
protecting##103##1##(1991-12#1)(1991-6#2)(1992-1#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#3)(2009-2#1)(2009-9#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
protection afforded by##3##3##(1996-12#1)(2008-5#2)
protection afforded##4##2##(1994-3#1)(1996-12#1)(2008-5#2)
protection against FMDV##2##3##(2013-1#2)
protection against HIV##2##3##(1990-6#2)
protection against a##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
protection against both##4##3##(2008-10#3)(2008-5#1)
protection against carbon##2##3##(1996-12#1)(2008-11#1)
protection against infection by##2##4##(2008-10#1)(2008-9#1)
protection against infection with##3##4##(1991-6#1)(2009-6#1)(2011-2#1)
protection against infection##5##3##(1991-6#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
protection against oxidative##2##3##(2008-10#1)(2008-2#1)
protection against pulmonary tuberculosis##2##4##(2013-1#2)
protection against sensitisation##2##3##(1990-11#2)
protection against the development of##2##5##(1991-2#1)(2009-6#1)
protection against the disease##2##4##(2008-10#1)(2011-2#1)
protection against the##18##3##(1991-2#1)(1991-6#2)(1993-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
protection against this##2##3##(1995-12#2)
protection against typical##2##3##(1995-5#2)
protection against##130##2##(1990-11#5)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-12#4)(1995-2#2)(1995-5#12)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#2)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-6#2)(2010-1#2)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#4)
protection analysis##4##2##(1992-3#1)(1993-3#1)(1994-6#1)(2008-2#1)
protection and enhancement of the##2##5##(1994-1#1)(1997-1#1)
protection and in##2##3##(1995-2#1)(2008-1#1)
protection and promotion##3##3##(2008-9#2)(2011-2#1)
protection and the##2##3##(1994-2#1)(2008-9#1)
protection and##33##2##(1990-2#1)(1992-2#1)(1992-6#1)(1994-1#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-1#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-12#2)(2009-5#2)(2010-11#1)(2011-2#4)(2013-1#1)(2013-7#1)
protection are##4##2##(1990-6#1)(1993-3#1)(1994-12#1)(2008-7#1)
protection assay enables##2##3##(1996-12#1)(2008-4#1)
protection assay for##2##3##(1996-12#1)(2008-4#1)
protection assay using##2##3##(1993-3#1)(1997-7#1)
protection assay##16##2##(1991-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1996-12#4)(1997-7#1)(2008-10#2)(2008-4#5)
protection assays were used to##2##5##(2008-4#1)(2009-5#1)
protection assays were##3##3##(1995-5#1)(2008-4#1)(2009-5#1)
protection assays##11##2##(1992-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-4#3)(2009-5#1)
protection at##2##2##(1995-5#1)(2011-2#1)
protection by##12##2##(1990-12#1)(1992-9#1)(1995-2#1)(2008-10#2)(2008-5#3)(2008-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
protection compared to##2##3##(1990-6#1)(2008-12#1)
protection devices##4##2##(1994-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
protection during##3##2##(1991-3#1)(1996-6#1)(2007-8#1)
protection elicited by##2##3##(2008-10#2)
protection even when##2##3##(2008-10#2)
protection experiments##2##2##(1991-11#1)(1991-7#1)
protection factor (SPF) of##2##4##(2008-5#2)
protection factor (SPF)##4##3##(2008-5#4)
protection factor##10##2##(1991-6#1)(2008-5#7)(2008-7#1)(2011-2#1)
protection factors##11##2##(1995-3#1)(2008-5#9)(2008-9#1)
protection for nurses##2##3##(2013-8#2)
protection for the##4##3##(2008-10#1)(2008-7#1)(2012-2#1)(2013-7#1)
protection for##14##2##(1991-9#1)(1993-12#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
protection from##32##2##(1990-6#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-10#2)(1994-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-9#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
protection in the##6##3##(1990-12#1)(1990-9#1)(1994-2#1)(1996-9#1)(2008-10#1)(2008-5#1)
protection in this##2##3##(1992-6#1)(1995-5#1)
protection in various##2##3##(1994-11#1)(1996-9#1)
protection in##32##2##(1990-12#1)(1990-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#3)(1995-5#3)(1996-9#2)(1997-4#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#4)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
protection is##12##2##(1990-12#1)(1990-4#1)(1993-10#1)(1995-5#3)(2008-4#2)(2008-5#3)(2008-7#1)
protection measures##3##2##(2008-8#1)(2011-2#2)
protection occurs##2##2##(1994-11#1)(2008-10#1)
protection of children##2##3##(1996-12#1)(2011-2#1)
protection of target mRNA##2##4##(2008-4#2)
protection of the skin against##2##5##(2008-5#1)(2009-6#1)
protection of the skin##3##4##(2008-5#2)(2009-6#1)
protection of the##23##3##(1990-5#1)(1995-5#1)(1996-1#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-7#1)
protection of wheat##2##3##(2011-2#2)
protection of##71##2##(1990-12#2)(1990-2#2)(1990-5#2)(1991-3#1)(1991-9#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#8)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)
protection policy##3##2##(1996-6#1)(2008-9#1)(2013-1#1)
protection program##3##2##(1995-1#1)(2008-12#2)
protection programs##3##2##(2008-11#1)(2008-12#2)
protection provided by##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
protection services##2##2##(1996-12#1)(1997-2#1)
protection should be##2##3##(2007-11#1)(2010-5#1)
protection should##3##2##(2007-11#1)(2010-5#1)(2011-2#1)
protection strategies##2##2##(2007-2#1)(2011-10#1)
protection studies##4##2##(1992-8#2)(1995-5#2)
protection systems##2##2##(1990-5#1)(2012-2#1)
protection to the##4##3##(1995-11#1)(2008-10#1)(2010-7#1)(2013-1#1)
protection to##11##2##(1992-6#1)(1992-7#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
protection under the##3##3##(1997-5#1)(2008-12#1)(2012-12#1)
protection using##2##2##(2008-2#1)(2008-4#1)
protection value##2##2##(2008-10#1)(2011-1#1)
protection was not##3##3##(1992-5#1)(2008-10#1)(2009-5#1)
protection was observed##2##3##(2008-10#1)(2013-1#1)
protection was##22##2##(1990-6#1)(1991-12#1)(1992-5#1)(1992-9#1)(1994-8#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-5#1)(2009-5#1)(2010-4#1)(2013-1#2)
protection were##2##2##(2008-2#1)(2008-5#1)
protection when##3##2##(1996-6#1)(2008-10#2)
protection with##7##2##(1995-12#1)(2007-8#1)(2008-10#3)(2008-5#2)
protection##668##1##(1990-11#5)(1990-12#5)(1990-2#4)(1990-4#1)(1990-5#5)(1990-6#7)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#5)(1991-7#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#8)(1993-6#3)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#10)(1995-2#8)(1995-3#3)(1995-5#26)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#13)(1996-2#1)(1996-5#2)(1996-6#6)(1996-8#2)(1996-9#8)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#7)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#96)(2008-11#22)(2008-12#15)(2008-2#5)(2008-3#1)(2008-4#28)(2008-5#73)(2008-6#1)(2008-7#20)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#6)(2009-5#6)(2009-6#5)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#5)(2011-1#8)(2011-10#1)(2011-2#31)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#12)(2012-7#1)(2013-1#23)(2013-7#6)(2013-8#11)
protection)##5##1##(1995-5#2)(2008-10#1)(2008-4#1)(2010-1#1)
protection]##6##1##(1990-12#1)(1990-9#1)(1996-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
protections##3##1##(1992-12#1)(2008-4#1)(2009-4#1)
protective action of adenosine##2##4##(1996-2#2)
protective action of##4##3##(1996-2#2)(1997-7#1)(2008-11#1)
protective action##5##2##(1993-5#1)(1996-2#2)(1997-7#1)(2008-11#1)
protective activity against##2##3##(1995-12#1)(2008-10#1)
protective activity of##2##3##(2008-11#1)(2013-1#1)
protective activity##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
protective against the##2##3##(2008-8#1)(2011-2#1)
protective against##12##2##(1990-12#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-5#2)(1997-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
protective agent##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
protective agents##5##2##(1995-11#1)(1996-9#1)(2008-4#1)(2008-5#2)
protective and##7##2##(1992-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-12#1)(2012-3#1)
protective apoptosis-mediated##2##2##(2008-7#2)
protective behavior##2##2##(2012-12#2)
protective behaviors##3##2##(2010-2#2)(2013-1#1)
protective coating##2##2##(2008-3#2)
protective devices##2##2##(1993-12#1)(2009-12#1)
protective effect against##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
protective effect for##2##3##(1997-3#1)(2010-3#1)
protective effect in##3##3##(1990-3#1)(1995-11#1)(2011-1#1)
protective effect of the##5##4##(1995-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
protective effect of##37##3##(1992-10#1)(1993-2#2)(1994-9#1)(1995-12#5)(1996-12#1)(1996-3#1)(2007-2#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
protective effect on##7##3##(1992-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
protective effect##72##2##(1990-3#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-2#4)(1993-6#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#1)(1996-12#2)(1996-3#1)(1997-3#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
protective effects against##2##3##(1994-5#1)(2009-11#1)
protective effects in##2##3##(1994-11#1)(2008-11#1)
protective effects of the##2##4##(1995-12#1)(2008-10#1)
protective effects of##18##3##(1992-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-9#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
protective effects on the##2##4##(2008-7#1)(2008-9#1)
protective effects on##9##3##(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#1)(2011-3#1)
protective effects##36##2##(1992-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-9#2)(1997-4#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#7)(2008-9#1)(2009-11#1)(2009-7#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
protective efficacy of##3##3##(1995-12#1)(1995-5#1)(2008-3#1)
protective efficacy##7##2##(1995-12#1)(1995-5#3)(2008-3#1)(2008-5#2)
protective enzyme activities##2##3##(2008-12#2)
protective enzymes##2##2##(2008-12#2)
protective equipment##6##2##(2008-12#4)(2008-8#1)(2011-2#1)
protective factor against doping##2##4##(2009-11#2)
protective factor against##6##3##(1995-12#1)(2009-11#2)(2009-7#1)(2011-1#1)(2013-1#1)
protective factor in##4##3##(2009-11#1)(2009-7#2)(2011-1#1)
protective factor##18##2##(1994-12#1)(1994-2#1)(1995-12#1)(2009-11#3)(2009-12#1)(2009-7#5)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
protective factors##12##2##(2008-2#1)(2008-5#1)(2009-7#4)(2010-5#1)(2011-1#3)(2013-1#2)
protective film##2##2##(2008-10#2)
protective function of##2##3##(2008-11#1)(2013-1#1)
protective function##5##2##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
protective functions##2##2##(2012-1#1)(2012-3#1)
protective immunity##8##2##(1995-2#1)(1997-3#1)(2008-4#2)(2011-2#4)
protective in##2##2##(2008-7#1)(2009-5#1)
protective influence##2##2##(2008-10#1)(2008-7#1)
protective layer##2##2##(2008-10#1)(2008-3#1)
protective measures are##2##3##(2007-2#1)(2009-10#1)
protective measures##4##2##(2007-2#2)(2008-12#1)(2009-10#1)
protective mechanism##4##2##(1994-6#1)(2010-5#1)(2013-1#1)(2013-8#1)
protective mechanisms of##2##3##(2011-2#1)(2013-7#1)
protective mechanisms##7##2##(2008-3#1)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-7#1)
protective potential##3##2##(1992-12#1)(1994-2#1)(2008-5#1)
protective process##2##2##(2008-7#2)
protective properties##3##2##(1993-5#1)(2011-2#1)(2013-1#1)
protective protein##7##2##(1994-11#7)
protective response to##2##3##(2008-5#1)(2008-7#1)
protective responses##2##2##(1997-4#1)(2012-12#1)
protective role in##3##3##(2008-12#1)(2011-2#2)
protective role of##14##3##(1991-9#1)(1995-12#1)(1996-12#1)(2008-1#1)(2009-6#1)(2010-11#1)(2012-4#1)(2013-1#7)
protective role##22##2##(1991-9#1)(1993-5#1)(1995-12#1)(1996-12#2)(1997-2#1)(2008-1#1)(2008-12#1)(2009-6#2)(2010-11#1)(2011-2#3)(2012-4#1)(2013-1#7)
protective services##3##2##(1991-1#2)(2012-3#1)
protective substances##2##2##(2008-5#1)(2008-7#1)
protective than##2##2##(1992-2#1)(2011-2#1)
protective values against##2##3##(2008-10#1)(2008-12#1)
protective##389##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-5#3)(1993-6#1)(1993-9#3)(1994-11#9)(1994-12#1)(1994-2#6)(1994-5#3)(1994-6#2)(1994-9#2)(1995-11#2)(1995-12#13)(1995-2#3)(1995-5#8)(1995-6#1)(1996-1#1)(1996-12#7)(1996-2#2)(1996-3#1)(1996-9#6)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#2)(2007-11#1)(2007-12#2)(2007-2#3)(2008-1#2)(2008-10#28)(2008-11#7)(2008-12#18)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#27)(2008-6#2)(2008-7#31)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#4)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#12)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#14)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#27)(2013-7#2)(2013-8#5)
protector of##2##2##(1992-8#1)(2011-2#1)
protector##7##1##(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(2007-8#2)(2011-2#1)
protects actin against##2##3##(1997-7#2)
protects against experimental##2##3##(1993-5#1)(1995-2#1)
protects against the##2##3##(1992-9#1)(1993-3#1)
protects against##23##2##(1991-5#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
protects and##2##2##(1995-6#2)
protects cells from##4##3##(1992-7#1)(2008-5#1)(2008-9#1)(2009-12#1)
protects cells##6##2##(1991-5#1)(1992-7#1)(1994-11#1)(2008-5#1)(2008-9#1)(2009-12#1)
protects it from##2##3##(2008-5#1)(2008-8#1)
protects it##3##2##(2008-5#2)(2008-8#1)
protects neurons##2##2##(1995-12#1)(2008-11#1)
protects the##16##2##(1990-12#1)(1991-12#1)(1994-6#1)(1995-2#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)
protects##82##1##(1990-12#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#5)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-9#2)(1997-6#1)(1997-7#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#5)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
protein (A##4##2##(1994-8#1)(1995-12#1)(1995-6#1)(1996-5#1)
protein (AFP)##2##2##(1994-9#1)(2008-10#1)
protein (CP) gene##14##3##(1997-6#1)(2008-10#12)(2008-8#1)
protein (CP)##32##2##(1997-6#1)(2008-10#29)(2008-8#1)(2010-2#1)
protein (CREB) in##2##3##(1996-12#1)(2008-10#1)
protein (CREB)##5##2##(1996-12#2)(2008-10#1)(2008-7#1)(2009-3#1)
protein (CRP)##17##2##(1990-12#1)(1994-12#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
protein (FABP)##2##2##(1994-8#1)(2013-1#1)
protein (G protein)##2##3##(1993-8#1)(2008-3#1)
protein (GAP)##4##2##(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#1)
protein (GFP)##26##2##(1996-6#1)(1997-4#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#1)(2011-3#1)(2013-8#1)
protein (Gs)##2##2##(1992-3#1)(1993-9#1)
protein (HSP##2##2##(1991-2#1)(2008-10#1)
protein (HSP)##5##2##(1993-8#1)(1994-11#1)(1994-12#1)(2008-7#1)(2013-1#1)
protein (MAP) kinase##6##3##(1992-8#1)(1994-11#1)(1996-2#1)(2008-4#2)(2008-7#1)
protein (MAP) kinases##2##3##(1993-8#1)(1995-8#1)
protein (MAP)##8##2##(1992-8#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-2#1)(2008-4#2)(2008-7#1)
protein (MBP) fusion##2##3##(1995-12#2)
protein (MBP)##9##2##(1992-11#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-12#3)(1996-5#1)(2008-8#1)
protein (MRP)##3##2##(1997-4#1)(2008-11#2)
protein (Mr =##3##3##(1990-11#1)(1992-3#2)
protein (P50)##2##2##(2008-10#2)
protein (TSPO) is a##3##4##(2012-2#3)
protein (TSPO)##6##2##(2012-2#6)
protein (domain) evolution##2##3##(2009-5#2)
protein (hsCRP) levels##2##3##(2008-3#1)(2010-12#1)
protein (hsCRP)##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
protein (r = 0##2##4##(2010-4#1)(2011-2#1)
protein (r =##3##3##(1993-2#1)(2010-4#1)(2011-2#1)
protein (the FRET &quot##2##4##(2008-9#2)
protein (the##3##2##(1992-3#1)(2008-9#2)
protein 1 (CaBP1)##2##3##(2009-7#2)
protein 1##20##2##(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#2)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
protein 2##5##2##(1996-12#2)(2008-10#1)(2012-1#1)(2012-3#1)
protein 3##6##2##(2008-10#1)(2008-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
protein 4##14##2##(1994-12#9)(2009-7#1)(2010-5#1)(2012-2#2)(2013-1#1)
protein 5##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
protein 56##3##2##(1992-11#1)(1993-8#1)(2007-12#1)
protein 7##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
protein 70##13##2##(1993-11#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-10#3)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-8#1)
protein 90##3##2##(1994-12#1)(2012-1#1)(2012-12#1)
protein A (SPA)##2##3##(1994-12#1)(2008-10#1)
protein A and##2##3##(1990-12#1)(1990-8#1)
protein A containing##2##3##(1994-6#2)
protein A in human plasma##2##5##(1990-12#2)
protein A in##5##3##(1990-12#4)(1990-8#1)
protein A or##2##3##(1990-11#1)(2008-4#1)
protein A##42##2##(1990-11#1)(1990-12#8)(1990-8#4)(1991-5#1)(1994-12#3)(1994-3#2)(1994-6#2)(1995-5#1)(1996-12#5)(1996-6#1)(1997-4#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)
protein B##2##2##(1993-2#2)
protein C (APC)##2##3##(1993-11#1)(2007-12#1)
protein C and##5##3##(1996-6#3)(2008-1#1)(2011-2#1)
protein C deficiency##5##3##(1991-8#1)(2008-12#3)(2013-1#1)
protein C##29##2##(1990-5#1)(1991-8#1)(1991-9#1)(1993-11#2)(1995-2#2)(1996-6#3)(1997-2#2)(1997-3#2)(1997-4#1)(2007-12#2)(2008-1#1)(2008-12#7)(2008-3#1)(2011-2#2)(2013-1#1)
protein D cDNA##2##3##(1992-3#1)(1992-8#1)
protein D##11##2##(1992-3#6)(1992-8#5)
protein G and##2##3##(1990-12#2)
protein G##14##2##(1990-12#5)(1995-5#1)(2008-10#7)(2008-4#1)
protein G-binding antibodies##2##3##(1990-12#2)
protein G-liposomal nanovesicles##8##3##(2008-10#8)
protein G-sepharose##2##2##(2008-10#2)
protein G-tagged##2##2##(2008-10#2)
protein HPI1##3##2##(1990-7#3)
protein I##2##2##(1993-11#1)(2008-10#1)
protein L##2##2##(1990-12#2)
protein L3##3##2##(1992-8#3)
protein LRP##2##2##(2008-11#2)
protein QUAD##2##2##(1994-11#2)
protein S17##2##2##(1993-11#2)
protein SNAP-25 (synaptosome-associated protein##2##4##(1995-2#1)(1997-7#1)
protein SNAP-25##4##2##(1995-2#1)(1996-12#1)(1997-7#2)
protein X##2##2##(1995-3#2)
protein abundance##3##2##(1990-5#1)(2008-7#1)(2010-11#1)
protein accumulated##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
protein accumulation##6##2##(1994-11#1)(1995-6#2)(2008-10#1)(2008-7#1)(2009-12#1)
protein activation##3##2##(1991-12#1)(2008-8#1)(2009-12#1)
protein activities##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
protein activity by##2##3##(1990-8#1)(2011-2#1)
protein activity##7##2##(1990-8#1)(1992-8#1)(2008-12#3)(2009-7#1)(2011-2#1)
protein adducts##2##2##(1991-2#1)(1995-6#1)
protein adopts##2##2##(1991-5#1)(2009-7#1)
protein adsorption##14##2##(2008-10#4)(2008-6#3)(2008-7#2)(2009-11#2)(2010-7#1)(2013-1#2)
protein aerosols##2##2##(1996-1#2)
protein after##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
protein aggregates##4##2##(1990-12#2)(1994-11#1)(2008-1#1)
protein aggregation##5##2##(1990-12#1)(2008-4#1)(2008-7#3)
protein allowed the##2##3##(1995-2#1)(1997-6#1)
protein alone##3##2##(1995-3#1)(2008-4#1)(2008-5#1)
protein along##2##2##(1991-12#1)(2010-6#1)
protein also binds##2##3##(1994-11#1)(1994-6#1)
protein also##7##2##(1990-11#1)(1991-10#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-6#1)
protein alterations##2##2##(1995-12#1)(2012-1#1)
protein amino acid##2##3##(2008-10#1)(2012-2#1)
protein analysis using##2##3##(2008-10#1)(2008-4#1)
protein analysis##8##2##(1990-5#1)(1997-2#1)(2008-10#3)(2008-4#2)(2010-7#1)
protein anchors##2##2##(1994-12#2)
protein and DNA sequences##4##4##(2008-4#4)
protein and DNA##8##3##(1993-12#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-4#4)
protein and RNA##3##3##(1990-5#1)(2010-12#1)(2011-2#1)
protein and a##9##3##(1990-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-8#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-7#1)
protein and are##2##3##(1994-5#1)(1995-2#1)
protein and asialo-orosomucoid were##2##4##(1995-6#2)
protein and asialo-orosomucoid##4##3##(1995-6#4)
protein and calorie##2##3##(2007-12#2)
protein and have##2##3##(1995-6#1)(2010-11#1)
protein and is##2##3##(1994-8#1)(1996-6#1)
protein and its associated##2##4##(1994-9#1)(2009-3#1)
protein and its##7##3##(1990-7#1)(1993-11#1)(1994-9#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-1#1)
protein and lipid##6##3##(1993-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
protein and low##2##3##(2010-4#1)(2013-7#1)
protein and mRNA levels##3##4##(1991-12#1)(1993-3#1)(2010-1#1)
protein and mRNA##7##3##(1991-12#1)(1992-3#1)(1993-3#1)(1994-9#2)(2010-1#1)(2013-1#1)
protein and membrane##2##3##(2008-11#2)
protein and nucleic acid##2##4##(1995-2#1)(2008-11#1)
protein and peptide##2##3##(1995-5#2)
protein and that the##2##4##(1992-6#1)(1994-3#1)
protein and the cell##2##4##(2008-11#1)(2008-2#1)
protein and the##18##3##(1991-5#1)(1991-7#1)(1992-6#1)(1992-9#1)(1994-3#1)(1997-2#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#2)(2010-10#1)(2013-8#1)
protein and to##4##3##(1994-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
protein and was##3##3##(1990-2#1)(1992-6#1)(1992-9#1)
protein and##204##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#5)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#3)(1994-7#2)(1994-8#5)(1994-9#3)(1995-11#3)(1995-12#1)(1995-2#5)(1995-5#2)(1995-6#6)(1995-8#3)(1995-9#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#11)(2008-5#4)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#2)
protein and/or activity##2##3##(2012-3#2)
protein and/or##3##2##(1993-12#1)(2012-3#2)
protein antigens##4##2##(1995-5#1)(2008-11#1)(2008-4#2)
protein appeared to be##3##4##(1995-2#1)(2008-7#1)(2008-8#1)
protein appears to be##2##4##(1991-6#1)(1993-2#1)
protein appears##3##2##(1990-11#1)(1991-6#1)(1993-2#1)
protein are discussed##2##3##(1992-12#1)(2008-10#1)
protein are essential for##2##4##(1993-2#1)(2009-7#1)
protein are##18##2##(1991-5#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#2)(2009-7#1)
protein array##2##2##(2008-4#2)
protein arrays##3##2##(2008-7#2)(2011-2#1)
protein as a##10##3##(1991-12#1)(1991-6#1)(1993-1#1)(1994-11#1)(1994-12#1)(1996-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
protein as an antigen##2##4##(1997-4#1)(2008-8#1)
protein as determined by##3##4##(1990-5#1)(1993-3#1)(1997-4#1)
protein as well as##4##4##(1990-8#1)(1991-12#1)(2008-11#1)(2011-2#1)
protein as##30##2##(1990-5#3)(1990-8#1)(1991-12#2)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-6#1)(1997-4#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-8#1)
protein assay##6##2##(1992-5#1)(2008-10#4)(2008-12#1)
protein assays such as##2##4##(2007-2#1)(2008-10#1)
protein assemblies##2##2##(2008-4#1)(2008-7#1)
protein assembly##2##2##(2008-4#1)(2011-2#1)
protein associated with##3##3##(1991-2#1)(1995-6#1)(2009-7#1)
protein at a##3##3##(1992-6#1)(1995-2#1)(2008-11#1)
protein at the##2##3##(1993-8#1)(1996-5#1)
protein at##16##2##(1990-12#1)(1991-12#1)(1992-6#1)(1993-8#1)(1995-2#2)(1996-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#2)(2010-7#1)(2012-3#1)
protein balance##5##2##(2008-5#5)
protein band in##2##3##(2008-9#1)(2009-8#1)
protein band of##3##3##(1990-5#1)(1993-8#1)(1994-5#1)
protein band was##2##3##(1992-12#1)(2011-3#1)
protein band with##3##3##(1995-5#1)(2009-9#1)(2010-3#1)
protein band##15##2##(1990-5#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-3#1)
protein bands of##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
protein bands that##2##3##(2008-10#2)
protein bands##19##2##(1990-2#1)(1990-5#1)(1992-11#1)(1993-3#1)(1994-9#3)(2008-10#6)(2008-11#3)(2008-7#1)(2010-11#1)(2010-3#1)
protein based on##3##3##(2008-10#3)
protein based##5##2##(2008-10#3)(2008-5#1)(2012-12#1)
protein before##2##2##(1995-12#1)(2008-10#1)
protein behavior##2##2##(2008-1#1)(2008-6#1)
protein being analyzed##2##3##(2008-10#2)
protein being##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
protein belonging to the##2##4##(2008-11#1)(2010-10#1)
protein between##4##2##(1991-9#1)(1994-8#1)(1997-2#1)(2008-8#1)
protein binding assay for activin A/EDF##2##6##(1992-6#2)
protein binding assay##4##3##(1990-12#2)(1992-6#2)
protein binding sites##4##3##(1991-5#2)(1994-12#1)(2013-1#1)
protein binding to the##2##4##(1992-11#1)(1992-12#1)
protein binding to##4##3##(1990-11#1)(1992-11#2)(1992-12#1)
protein binding##29##2##(1990-11#1)(1990-12#2)(1991-5#2)(1992-11#2)(1992-12#1)(1992-6#3)(1993-12#1)(1993-8#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2013-1#1)
protein binds##5##2##(1994-12#2)(2008-9#1)(2011-2#1)(2012-2#1)
protein bioavailability##2##2##(2011-2#1)(2012-2#1)
protein biomarkers##7##2##(2008-10#2)(2010-11#2)(2010-9#3)
protein biopharmaceuticals##2##2##(2011-2#2)
protein biosynthesis##5##2##(1992-8#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-7#1)
protein blot##3##2##(2008-10#3)
protein bound to the##2##4##(1992-12#1)(1997-6#1)
protein bound to##4##3##(1992-12#1)(1993-6#1)(1997-6#1)(2008-1#1)
protein bound##6##2##(1992-12#1)(1993-6#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
protein bovine serum##2##3##(2008-10#1)(2008-2#1)
protein breakdown##2##2##(2008-5#2)
protein but not##4##3##(1992-8#2)(1993-11#1)(1995-6#1)
protein but##5##2##(1992-11#1)(1992-8#2)(1993-11#1)(1995-6#1)
protein by means of##2##4##(1993-9#1)(1996-3#1)
protein by the##2##3##(1991-5#1)(1994-5#1)
protein by##31##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)
protein can be detected##2##4##(1995-2#1)(2008-1#1)
protein can be##7##3##(1994-8#1)(1995-2#1)(1997-4#1)(2008-1#2)(2008-2#1)(2008-8#1)
protein can##14##2##(1990-11#1)(1994-8#2)(1995-2#1)(1997-4#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
protein carbonyl##3##2##(2008-3#2)(2011-2#1)
protein catabolism##2##2##(1990-2#1)(1991-5#1)
protein chain##2##2##(1990-5#1)(2012-2#1)
protein changes##3##2##(2010-11#2)(2010-9#1)
protein charge##2##2##(2008-2#1)(2009-12#1)
protein cleavage##2##2##(1993-11#1)(2007-6#1)
protein co-localized##2##2##(1995-6#1)(2008-10#1)
protein co-purified with##2##3##(1995-5#1)(1997-4#1)
protein coding region##2##3##(1990-7#1)(1997-4#1)
protein coding regions##5##3##(1993-6#1)(1996-12#2)(1997-2#1)(2010-7#1)
protein coding sequence##2##3##(1991-7#1)(2011-2#1)
protein coding sequences##2##3##(2008-7#1)(2008-9#1)
protein coding##16##2##(1990-7#1)(1991-7#1)(1993-6#1)(1994-12#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-7#2)(2011-2#1)
protein complex involved in##2##4##(1997-1#1)(1997-7#1)
protein complex of##2##3##(1992-6#1)(2009-9#1)
protein complex that is required##2##5##(1995-2#1)(2008-5#1)
protein complex that##3##3##(1995-2#1)(2007-12#1)(2008-5#1)
protein complex##28##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-6#1)(1994-8#3)(1995-2#2)(1997-1#1)(1997-7#1)(2007-12#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-7#1)(2009-8#3)(2009-9#1)(2011-2#2)(2012-2#1)
protein complexes formed##2##3##(1995-6#1)(1997-3#1)
protein complexes in the##2##4##(1994-5#1)(2008-4#1)
protein complexes in##4##3##(1994-5#1)(1995-8#1)(2008-4#1)(2010-9#1)
protein complexes that##2##3##(2008-4#1)(2010-10#1)
protein complexes##26##2##(1993-8#2)(1994-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-2#3)(2008-4#5)(2008-7#5)(2010-10#2)(2010-9#1)(2011-2#2)(2013-8#1)
protein component of##4##3##(1993-6#1)(1995-6#1)(1997-8#1)(2008-5#1)
protein component##8##2##(1992-3#1)(1993-6#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
protein components in##2##3##(2008-12#1)(2008-7#1)
protein components of nucleolar skeleton##2##5##(2008-8#2)
protein components of##6##3##(1990-5#1)(1995-2#1)(2008-2#1)(2008-8#2)(2010-11#1)
protein components##13##2##(1990-5#1)(1991-12#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-2#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2010-11#1)(2013-8#1)
protein composition and##3##3##(2008-5#1)(2010-11#1)(2012-2#1)
protein composition of the nucleolar skeleton of HeLa cells##2##9##(2008-8#2)
protein composition of the##4##4##(1990-7#1)(1991-2#1)(2008-8#2)
protein composition of##7##3##(1990-7#1)(1991-2#1)(2008-8#3)(2008-9#1)(2009-6#1)
protein composition##15##2##(1990-7#1)(1991-2#1)(1994-9#1)(1995-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-11#1)(2012-2#1)
protein comprised##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
protein concentrates##2##2##(2010-4#2)
protein concentration and##3##3##(1990-7#1)(2009-7#2)
protein concentration in the##3##4##(1990-7#2)(1991-11#1)
protein concentration in##5##3##(1990-7#2)(1991-11#1)(2008-10#1)(2008-4#1)
protein concentration##30##2##(1990-12#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(1997-6#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-7#2)(2010-11#1)(2011-1#1)(2011-2#1)
protein concentrations and##2##3##(1991-12#1)(2008-10#1)
protein concentrations were##2##3##(1997-4#1)(2013-1#1)
protein concentrations##11##2##(1990-8#1)(1991-12#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
protein conformation and##2##3##(1994-8#1)(2008-6#1)
protein conformation##6##2##(1994-8#1)(1995-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-4#1)
protein conformational change##2##3##(1995-6#2)
protein conformational##3##2##(1995-6#2)(2008-10#1)
protein consisting of##3##3##(1994-11#1)(1995-8#1)(2008-9#1)
protein consists of two##2##4##(1991-5#1)(1992-6#1)
protein consists of##5##3##(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)
protein consumption##3##2##(2007-12#1)(2008-5#1)(2013-7#1)
protein contained a##2##3##(1990-12#1)(1993-12#1)
protein contained##5##2##(1990-11#1)(1990-12#1)(1992-3#1)(1992-8#1)(1993-12#1)
protein containing a##5##3##(1994-12#1)(1994-5#1)(1995-12#1)(1997-7#1)(2009-9#1)
protein containing the##6##3##(1990-8#1)(1994-12#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-4#1)
protein containing two##2##3##(1993-8#1)(1995-8#1)
protein containing##18##2##(1990-12#1)(1990-8#1)(1993-8#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-4#1)(2008-8#1)(2009-9#1)
protein contains a##4##3##(1991-11#1)(1993-12#1)(1994-12#1)(2008-8#1)
protein contains two##2##3##(1993-2#1)(2008-10#1)
protein contains##15##2##(1991-11#2)(1992-10#1)(1992-12#1)(1993-12#1)(1993-2#2)(1994-12#1)(1995-2#2)(1995-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
protein content and##4##3##(1990-5#1)(1991-12#1)(1995-12#1)(2011-3#1)
protein content in##5##3##(1993-6#1)(2008-10#1)(2008-12#1)(2013-1#2)
protein content of the##3##4##(1992-9#1)(2008-4#1)(2013-1#1)
protein content of##8##3##(1992-9#1)(1995-9#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-11#1)(2013-1#1)
protein content were##2##3##(2008-12#1)(2010-11#1)
protein content##32##2##(1990-5#1)(1990-7#2)(1991-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-9#2)(1997-4#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-11#2)(2010-4#1)(2011-3#1)(2012-7#1)(2013-1#4)
protein contents of##2##3##(1994-5#1)(2008-10#1)
protein contents##7##2##(1994-11#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-12#1)
protein controlled##2##2##(1990-8#2)
protein core##4##2##(1993-2#2)(1995-5#1)(2009-8#1)
protein corresponding to##2##3##(1992-3#1)(1995-2#1)
protein could be##10##3##(1990-11#2)(1994-5#2)(1994-6#1)(1997-4#1)(2008-4#1)(2008-8#2)(2013-8#1)
protein could not##2##3##(1996-5#1)(2008-9#1)
protein could##16##2##(1990-11#2)(1994-5#2)(1994-6#2)(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
protein coupled receptors##2##3##(2008-4#1)(2008-7#1)
protein coupled##3##2##(1997-2#1)(2008-4#1)(2008-7#1)
protein coupling during maturation##2##4##(2008-3#2)
protein coupling##6##2##(1990-2#1)(1993-8#1)(2008-3#4)
protein crystallization##3##2##(2007-5#1)(2008-10#1)(2009-11#1)
protein crystals##3##2##(1996-12#2)(2008-4#1)
protein cytolysins##2##2##(1994-2#2)
protein data##2##2##(1995-6#1)(2008-4#1)
protein database##4##2##(1994-12#1)(1997-2#1)(2008-7#1)(2010-4#1)
protein databases##6##2##(2008-2#2)(2008-4#2)(2008-9#1)(2010-4#1)
protein deficiency##2##2##(1993-12#1)(1994-11#1)
protein degradation and##2##3##(1990-5#1)(1992-12#1)
protein degradation in the##2##4##(1995-2#1)(2008-7#1)
protein degradation were##2##3##(2011-2#1)(2011-3#1)
protein degradation##18##2##(1990-5#3)(1992-12#1)(1992-8#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2011-3#1)(2013-1#1)
protein delivery to##2##3##(2009-10#1)(2010-10#1)
protein delivery##7##2##(2008-11#4)(2009-10#1)(2010-10#1)(2012-6#1)
protein demonstrated##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
protein denaturation##3##2##(1991-5#1)(1995-6#1)(2013-1#1)
protein derivative##4##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-7#1)
protein detected in the##2##4##(2008-5#1)(2012-2#1)
protein detected##4##2##(1994-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
protein determination##5##2##(2007-2#1)(2008-10#3)(2008-9#1)
protein digestion within the phagocytic vacuole of##2##7##(1990-12#2)
protein digestion##8##2##(1990-12#2)(2008-10#2)(2012-3#4)
protein discovered##2##2##(2008-5#1)(2008-9#1)
protein displayed##2##2##(1993-8#1)(2008-11#1)
protein distribution##2##2##(1994-6#2)
protein disulfide isomerase (PDI)##3##4##(1990-7#1)(2008-7#1)(2013-1#1)
protein disulfide isomerase gene expression##2##5##(1990-7#2)
protein disulfide isomerase##13##3##(1990-7#3)(1993-6#6)(1995-3#1)(2008-7#1)(2013-1#2)
protein disulfide##16##2##(1990-7#3)(1993-6#6)(1995-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
protein disulfide-thiol interchange##2##3##(2009-9#2)
protein domain##7##2##(1997-2#1)(2008-4#2)(2009-10#1)(2009-7#1)(2011-2#2)
protein domains##8##2##(1995-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#3)
protein driven by##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
protein drug##2##2##(2008-10#1)(2009-12#1)
protein during##4##2##(1990-7#1)(1992-3#1)(1993-8#1)(2008-11#1)
protein dynamics##2##2##(2008-4#1)(2010-10#1)
protein encoded by a##2##4##(1996-3#1)(2009-7#1)
protein encoded by the small RNA##2##6##(2008-10#2)
protein encoded by the##6##4##(1993-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(2008-10#2)
protein encoded by##11##3##(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-10#2)(2009-7#1)
protein encoded##15##2##(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-11#1)(2009-7#1)
protein energy malnutrition##2##3##(1991-8#1)(2007-8#1)
protein engineering##16##2##(1991-6#2)(1992-11#3)(1994-8#4)(1997-6#2)(2008-9#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)
protein evolution##8##2##(1991-12#1)(1996-10#1)(1997-6#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-1#1)
protein excretion##4##2##(1993-12#1)(1997-8#1)(2008-1#1)(2011-3#1)
protein exhibited##3##2##(1991-9#1)(1994-6#1)(1997-4#1)
protein exhibiting##2##2##(1994-11#1)(1996-6#1)
protein exists as a dimer##2##5##(1992-3#1)(1994-8#1)
protein exists##3##2##(1992-3#1)(1994-8#1)(2010-5#1)
protein exposure##2##2##(2011-2#1)(2013-1#1)
protein expressed from##2##3##(2008-8#1)(2010-10#1)
protein expressed in the##2##4##(1996-12#1)(1997-7#1)
protein expressed in##4##3##(1996-12#1)(1997-7#1)(2008-9#1)(2009-9#1)
protein expressed##8##2##(1990-8#1)(1996-12#1)(1997-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)
protein expression analysis##2##3##(2008-11#1)(2010-12#1)
protein expression and##6##3##(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#1)
protein expression are##2##3##(2008-4#1)(2010-8#1)
protein expression in the##5##4##(1993-11#1)(1994-2#1)(2008-11#1)(2009-12#1)(2013-1#1)
protein expression in##26##3##(1990-8#1)(1991-10#1)(1993-11#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#8)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
protein expression is##5##3##(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#1)
protein expression levels##3##3##(2008-11#2)(2013-1#1)
protein expression of##10##3##(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
protein expression patterns##2##3##(2010-12#2)
protein expression was##2##3##(2012-3#1)(2013-1#1)
protein expression were##2##3##(2008-7#1)(2013-1#1)
protein expression##101##2##(1990-8#1)(1991-10#1)(1993-11#2)(1993-5#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-4#2)(2008-1#3)(2008-10#2)(2008-11#24)(2008-12#1)(2008-2#3)(2008-4#9)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#10)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#2)
protein expressions##3##2##(2008-12#1)(2012-3#2)
protein extract##4##2##(1993-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
protein extracted from##2##3##(1994-8#1)(2008-9#1)
protein extraction and##2##3##(2008-11#2)
protein extraction##4##2##(2008-10#1)(2008-11#2)(2010-4#1)
protein extracts from##3##3##(1991-12#1)(2008-10#1)(2010-12#1)
protein extracts##8##2##(1991-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2010-12#1)
protein factor##3##2##(1990-11#1)(1991-2#1)(2008-9#1)
protein factors##5##2##(1994-5#1)(2008-11#2)(2008-9#1)(2012-2#1)
protein families##12##2##(1992-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)
protein family are##2##3##(1995-2#1)(2009-8#1)
protein family of##2##3##(1994-11#1)(2008-4#1)
protein family that##2##3##(2008-8#1)(2012-3#1)
protein family##25##2##(1992-12#1)(1994-11#2)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
protein farnesyltransferase##3##2##(1993-11#1)(1993-9#1)(1995-2#1)
protein films##3##2##(2008-10#1)(2008-12#2)
protein fingerprints##2##2##(2008-10#1)(2013-1#1)
protein fluorescence##3##2##(1990-5#1)(1992-12#1)(1995-8#1)
protein folding and assembly##2##4##(1994-11#1)(1994-8#1)
protein folding and##7##3##(1991-6#1)(1991-9#1)(1994-11#2)(1994-8#1)(2008-1#1)(2009-9#1)
protein folding machinery##2##3##(1994-12#2)
protein folding to##2##3##(2010-4#1)(2012-2#1)
protein folding##25##2##(1991-6#2)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#3)(2010-4#3)(2011-2#1)(2012-2#1)
protein folds##3##2##(1992-6#1)(2008-4#1)(2012-1#1)
protein following##2##2##(1992-8#1)(1994-10#1)
protein footprinting##2##2##(2008-4#2)
protein for Rab3A##4##3##(1994-11#1)(1994-9#3)
protein for the##6##3##(1991-2#1)(1991-9#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-8#1)
protein for##27##2##(1990-11#5)(1991-2#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-11#1)(1995-2#1)(1996-5#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-8#1)(2012-2#1)
protein found in##2##3##(1990-5#1)(2007-12#1)
protein found##5##2##(1990-5#1)(1996-5#1)(2007-12#1)(2013-7#1)(2013-8#1)
protein fraction derived##2##3##(2008-10#1)(2010-4#1)
protein fraction##16##2##(1990-5#1)(1991-12#1)(1991-5#1)(1993-6#1)(1994-11#3)(1995-5#1)(1996-2#1)(2008-10#3)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
protein fractions and##2##3##(2011-2#1)(2012-2#1)
protein fractions##9##2##(1991-12#3)(1991-6#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
protein from a##3##3##(1994-8#1)(1997-3#1)(2008-11#1)
protein from an##2##3##(2008-4#2)
protein from flax seeds##2##4##(1992-8#2)
protein from human##2##3##(1990-12#1)(1992-12#1)
protein from rat##3##3##(1993-11#1)(1994-12#1)(1995-9#1)
protein from the##16##3##(1990-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1995-8#1)(1997-4#1)(2008-1#1)(2008-10#2)(2009-12#2)(2009-7#2)(2009-8#1)(2010-2#1)(2012-2#1)
protein from##75##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-8#2)(1993-11#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-8#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-4#4)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#5)(2008-8#2)(2008-9#1)(2009-12#2)(2009-7#7)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
protein function and##4##3##(2008-9#1)(2009-5#1)(2011-2#2)
protein function specificity##2##3##(2011-2#2)
protein function##11##2##(1997-3#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-11#1)(2011-2#4)
protein functional##3##2##(1997-2#1)(1997-6#1)(2008-8#1)
protein functions##2##2##(2008-7#1)(2011-2#1)
protein gene and##5##3##(1997-2#1)(2008-10#2)(2008-8#2)
protein gene expression##2##3##(2008-8#1)(2011-10#1)
protein gene in##8##3##(1993-3#1)(1993-8#1)(1997-2#2)(2008-12#1)(2008-8#2)(2013-1#1)
protein gene of##7##3##(1991-8#1)(1997-2#1)(1997-6#1)(2008-10#3)(2009-5#1)
protein gene sequences##2##3##(2008-10#2)
protein gene was##3##3##(1997-4#1)(2008-12#1)(2009-5#1)
protein gene##53##2##(1991-8#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#8)(2008-9#1)(2009-5#2)(2011-1#1)(2011-10#1)(2013-1#1)
protein gene)##2##2##(2008-9#1)(2013-1#1)
protein genes and##2##3##(2008-10#1)(2008-8#1)
protein genes##18##2##(1994-8#1)(1996-3#1)(1996-6#3)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)
protein glycosylation and##2##3##(2008-11#1)(2010-12#1)
protein glycosylation in##2##3##(1992-6#1)(2010-11#1)
protein glycosylation##8##2##(1992-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2011-1#1)
protein growth factor##2##3##(1996-12#1)(2008-5#1)
protein had a##2##3##(2008-10#2)
protein had an apparent molecular mass of##2##7##(1993-6#1)(1993-8#1)
protein had an##4##3##(1993-6#1)(1993-8#1)(1996-10#1)(2008-10#1)
protein had been##2##3##(1992-6#1)(1995-2#1)
protein had##10##2##(1991-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-10#1)(2008-10#3)(2008-8#1)
protein half-life##2##2##(1995-12#1)(2008-11#1)
protein has a##3##3##(1990-11#1)(1991-5#1)(1992-8#1)
protein has been found in##2##5##(2008-7#1)(2008-8#1)
protein has been implicated in##3##5##(1992-12#1)(1992-3#1)(1993-3#1)
protein has been studied using##2##5##(1992-8#1)(2008-10#1)
protein has been##12##3##(1990-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
protein has##28##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
protein have been##4##3##(1992-11#1)(2008-11#1)(2011-1#1)(2012-8#1)
protein have##6##2##(1992-11#1)(1992-8#1)(1995-6#1)(2008-11#1)(2011-1#1)(2012-8#1)
protein highly homologous to##2##4##(1990-12#1)(1994-11#1)
protein highly##3##2##(1990-12#1)(1994-11#1)(2008-11#1)
protein homeostasis##2##2##(2008-7#1)(2010-4#1)
protein homologous to##3##3##(1990-5#1)(1994-12#1)(2013-1#1)
protein hydrolysate##4##2##(2008-10#1)(2008-11#2)(2010-2#1)
protein hydrolysates##10##2##(2008-10#1)(2008-11#6)(2008-5#3)
protein hydrolyzates##3##2##(1997-2#3)
protein hyper-producing cell lines##2##4##(2008-11#2)
protein hyper-producing##4##2##(2008-11#4)
protein identification##8##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)
protein immobilization and##2##3##(2008-10#1)(2010-7#1)
protein immunoreactivity##2##2##(1992-2#1)(2009-1#1)
protein implicated in##3##3##(1994-11#1)(1995-2#1)(2009-7#1)
protein import##6##2##(1994-8#1)(1995-2#1)(2008-1#3)(2012-2#1)
protein in Bacillus subtilis##2##4##(1994-12#1)(2009-7#1)
protein in a short period##2##5##(2008-11#1)(2008-2#1)
protein in a##9##3##(1993-3#1)(1994-8#1)(2008-11#3)(2008-2#2)(2008-4#1)(2009-11#1)
protein in an##3##3##(1993-6#1)(2008-10#1)(2009-12#1)
protein in both##2##3##(1994-10#1)(2008-5#1)
protein in crude##2##3##(1991-12#1)(2008-1#1)
protein in human serum##7##4##(1993-6#1)(1995-8#1)(2008-10#5)
protein in human##15##3##(1990-12#1)(1992-11#1)(1993-6#1)(1994-11#1)(1995-8#2)(1996-2#1)(2008-10#6)(2008-11#1)(2013-8#1)
protein in insect larvae##2##4##(2008-7#2)
protein in mammalian cells##3##4##(1997-7#2)(2008-11#1)
protein in mammalian##4##3##(1993-11#1)(1997-7#2)(2008-11#1)
protein in patients with##2##4##(1990-12#1)(2007-5#1)
protein in patients##3##3##(1990-12#1)(2007-5#1)(2010-4#1)
protein in plants##2##3##(1993-6#1)(2008-10#1)
protein in rat##2##3##(1995-12#1)(1997-4#1)
protein in solution##3##3##(2008-1#1)(2008-4#1)(2009-7#1)
protein in synaptic##2##3##(1995-6#1)(2008-7#1)
protein in the absence of##2##5##(1995-2#1)(2007-8#1)
protein in the cytoplasm##3##4##(1995-8#1)(1997-4#1)(2008-10#1)
protein in the cytosol##2##4##(1990-5#1)(1997-4#1)
protein in the tissue##2##4##(1995-12#1)(2013-1#1)
protein in the##57##3##(1990-12#2)(1990-5#2)(1990-8#1)(1991-2#3)(1991-5#1)(1991-9#4)(1992-11#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
protein in vitro##2##3##(1993-11#1)(2008-8#1)
protein in vivo##5##3##(1990-8#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
protein in which##2##3##(1992-3#1)(1995-5#1)
protein in yeast##2##3##(1992-8#1)(1995-2#1)
protein in##216##2##(1990-12#6)(1990-5#5)(1990-8#2)(1991-12#2)(1991-2#5)(1991-5#2)(1991-9#5)(1992-11#2)(1992-12#2)(1992-3#1)(1992-7#2)(1992-8#1)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#7)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#6)(1997-6#2)(1997-7#3)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#19)(2008-11#18)(2008-12#1)(2008-2#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
protein including##2##2##(2008-10#1)(2008-8#1)
protein increased##3##2##(1990-12#1)(1993-8#1)(2013-8#1)
protein indicated that it##2##4##(1992-8#1)(1994-8#1)
protein indicated that##3##3##(1992-8#1)(1993-11#1)(1994-8#1)
protein indicated##5##2##(1990-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)
protein induced by##2##3##(1994-12#1)(2013-8#1)
protein induced##4##2##(1994-12#1)(1997-6#1)(2013-1#1)(2013-8#1)
protein induction##5##2##(2008-10#4)(2008-11#1)
protein ingestion##2##2##(2008-1#1)(2008-5#1)
protein inhibitor##5##2##(1991-5#1)(1993-3#1)(1994-6#1)(2008-4#1)(2008-7#1)
protein inhibits##3##2##(1990-7#1)(1997-3#2)
protein intake and##5##3##(2008-1#1)(2008-5#1)(2013-8#3)
protein intake in healthy adults##2##5##(2013-8#2)
protein intake in##4##3##(2008-5#1)(2013-1#1)(2013-8#2)
protein intake on##2##3##(2008-5#2)
protein intake was##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
protein intake##24##2##(2008-1#2)(2008-5#7)(2011-2#2)(2013-1#2)(2013-8#11)
protein intakes##5##2##(2008-5#2)(2013-1#3)
protein interacting with##2##3##(1992-11#1)(1994-11#1)
protein interaction information##2##3##(2008-4#1)(2012-2#1)
protein interaction networks##2##3##(2008-7#1)(2011-2#1)
protein interaction##10##2##(2008-4#1)(2008-7#4)(2009-11#1)(2009-8#1)(2011-2#2)(2012-2#1)
protein interactions and##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
protein interactions by##2##3##(2008-4#2)
protein interactions in##6##3##(2008-4#4)(2008-9#1)(2012-2#1)
protein interactions that##2##3##(1993-11#1)(2012-2#1)
protein interactions with##2##3##(1997-2#1)(2011-2#1)
protein interactions##26##2##(1991-9#1)(1993-11#1)(1997-2#1)(1997-7#1)(2008-4#13)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-8#1)
protein interacts with##3##3##(1997-3#1)(2008-8#1)(2008-9#1)
protein interacts##4##2##(1992-11#1)(1997-3#1)(2008-8#1)(2008-9#1)
protein into the cytoplasm##2##4##(1994-11#1)(2008-11#1)
protein into the##4##3##(1990-11#1)(1991-5#1)(1994-11#1)(2008-11#1)
protein into##9##2##(1990-11#1)(1991-5#1)(1994-11#1)(1997-1#1)(1997-8#2)(2008-11#1)(2008-8#1)(2009-12#1)
protein involved in##9##3##(1992-6#1)(1992-9#1)(2008-5#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
protein involved##10##2##(1992-6#1)(1992-9#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
protein is a major##2##4##(1990-2#1)(2008-7#1)
protein is a##12##3##(1990-2#1)(1991-6#1)(1991-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-7#1)(2008-9#1)(2012-3#1)
protein is able to##2##4##(1993-9#1)(2009-8#1)
protein is an essential##2##4##(1994-3#1)(2013-1#1)
protein is an##7##3##(1993-6#1)(1994-3#1)(1995-2#1)(2008-7#1)(2009-6#1)(2010-5#1)(2013-1#1)
protein is capable of##2##4##(1995-6#1)(2008-9#1)
protein is characterized by its##2##5##(2008-4#1)(2013-1#1)
protein is composed of##2##4##(1995-2#1)(2011-2#1)
protein is described##2##3##(1997-2#1)(2008-2#1)
protein is expressed##2##3##(2008-5#1)(2010-11#1)
protein is highly conserved##2##4##(1991-6#1)(1993-12#1)
protein is induced by##2##4##(1992-7#1)(1995-12#1)
protein is involved in##2##4##(1991-12#1)(1995-6#1)
protein is known to##3##4##(1991-12#2)(1995-2#1)
protein is less##2##3##(2008-9#2)
protein is not##6##3##(1990-11#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1997-4#1)
protein is overexpressed##2##3##(1992-9#1)(1994-7#1)
protein is precipitated##2##3##(2008-4#2)
protein is present in##3##4##(1992-6#1)(2008-10#1)(2009-8#1)
protein is present##4##3##(1992-6#1)(2008-10#2)(2009-8#1)
protein is the##8##3##(1990-8#1)(1996-2#1)(1997-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)
protein is then##2##3##(2008-4#2)
protein is##155##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#3)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#2)(1994-8#4)(1995-11#1)(1995-12#3)(1995-2#6)(1995-6#6)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#7)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#11)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
protein isoforms##4##2##(1995-2#1)(2008-7#2)(2010-8#1)
protein isolate##4##2##(2011-2#2)(2013-1#2)
protein isolated from the##3##4##(1991-9#1)(1994-11#1)(2008-9#1)
protein isolated from##11##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-9#2)(1992-3#1)(1994-11#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-9#1)
protein isolated##12##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-9#2)(1992-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-9#1)
protein isolates##4##2##(2010-4#2)(2011-2#2)
protein it##2##2##(1995-2#1)(2011-2#1)
protein itself##4##2##(1995-12#1)(1997-2#1)(2009-8#1)(2009-9#1)
protein kinase (AMPK)##2##3##(2010-11#1)(2011-2#1)
protein kinase (MAPK) cascade##3##4##(1995-2#2)(2009-8#1)
protein kinase (MAPK)##14##3##(1995-2#2)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-7#2)
protein kinase (PK)##3##3##(1993-2#2)(1993-9#1)
protein kinase (PKA)##7##3##(1992-3#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-8#1)
protein kinase (PKC)##2##3##(1993-12#1)(1997-2#1)
protein kinase (protein kinase##3##4##(1993-8#2)(1994-9#1)
protein kinase A (PKA) and##2##5##(2008-10#1)(2008-5#1)
protein kinase A (PKA)##9##4##(1990-12#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)
protein kinase A (PKA)-mediated##2##4##(2008-1#1)(2011-2#1)
protein kinase A activity)##2##4##(1993-8#2)
protein kinase A can##2##4##(1992-12#2)
protein kinase A may##2##4##(1993-8#1)(1994-6#1)
protein kinase A phosphorylation##3##4##(1991-2#3)
protein kinase A##36##3##(1990-12#2)(1991-2#4)(1992-12#3)(1993-8#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
protein kinase B##3##3##(2008-10#1)(2008-3#2)
protein kinase C (PK-C)##2##4##(1991-2#1)(1993-6#1)
protein kinase C (PKC) activator##2##5##(1994-11#1)(1997-1#1)
protein kinase C (PKC) activity##3##5##(1997-4#1)(1997-7#1)(2008-10#1)
protein kinase C (PKC) and##6##5##(1992-9#1)(1993-3#1)(1993-8#1)(1995-3#1)(1997-6#1)(2008-11#1)
protein kinase C (PKC) family##2##5##(1992-9#1)(1996-5#1)
protein kinase C (PKC) in the##2##6##(1993-8#1)(1996-5#1)
protein kinase C (PKC) in##5##5##(1991-2#1)(1993-8#1)(1995-11#1)(1996-5#1)(2008-4#1)
protein kinase C (PKC) inhibitor##2##5##(2008-4#1)(2013-1#1)
protein kinase C (PKC) pathway##2##5##(1993-6#1)(1997-1#1)
protein kinase C (PKC)##47##4##(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-8#2)(1995-11#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#2)
protein kinase C activation##14##4##(1990-12#1)(1992-6#3)(1992-8#1)(1993-3#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
protein kinase C activators##4##4##(1993-3#3)(1995-11#1)
protein kinase C activity and##3##5##(1990-2#1)(1993-12#1)(2008-11#1)
protein kinase C activity in##5##5##(1990-8#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-11#1)
protein kinase C activity##13##4##(1990-2#1)(1990-5#1)(1990-8#2)(1992-11#1)(1993-12#3)(1993-8#1)(1994-11#1)(1997-6#1)(2008-11#1)(2008-3#1)
protein kinase C and protein kinase A##2##7##(1995-6#1)(2008-11#1)
protein kinase C and protein kinase##3##6##(1995-6#1)(2008-11#1)(2008-3#1)
protein kinase C and the##2##5##(1991-2#1)(1997-2#1)
protein kinase C and##17##4##(1991-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#2)(2008-11#3)(2008-3#1)
protein kinase C by##8##4##(1990-12#1)(1990-2#1)(1990-5#1)(1993-8#1)(1994-9#1)(2008-3#2)(2008-8#1)
protein kinase C in the##4##5##(1994-11#1)(1996-9#1)(1997-1#2)
protein kinase C in##18##4##(1990-11#2)(1990-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-9#2)(1997-1#2)(2008-11#3)
protein kinase C inhibitor##6##4##(1990-2#1)(1990-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(2008-11#1)
protein kinase C is##3##4##(1992-6#1)(1994-3#1)(1994-5#1)
protein kinase C isoforms##2##4##(2010-12#1)(2011-2#1)
protein kinase C pathway##3##4##(1990-11#1)(1995-12#1)(2008-1#1)
protein kinase C phosphorylation sites and##2##6##(2008-12#1)(2008-8#1)
protein kinase C phosphorylation sites##4##5##(1993-3#1)(2008-12#2)(2008-8#1)
protein kinase C phosphorylation##5##4##(1991-7#1)(1993-3#1)(2008-12#2)(2008-8#1)
protein kinase C was##3##4##(1990-11#1)(1990-5#1)(2008-11#1)
protein kinase C with##3##4##(1992-9#1)(1994-5#1)(1995-2#1)
protein kinase C##257##3##(1990-11#9)(1990-12#4)(1990-2#6)(1990-5#11)(1990-7#2)(1990-8#8)(1991-12#2)(1991-2#5)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#5)(1992-12#3)(1992-3#2)(1992-6#7)(1992-8#8)(1992-9#13)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#10)(1993-6#6)(1993-8#9)(1994-11#12)(1994-2#1)(1994-3#4)(1994-5#10)(1994-6#3)(1994-8#3)(1994-9#1)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#4)(1996-12#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(2008-1#3)(2008-10#1)(2008-11#20)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
protein kinase C's##2##3##(1994-5#2)
protein kinase C-epsilon##2##3##(1990-7#2)
protein kinase C-mediated phosphorylation of endogenous substrates##2##7##(1993-12#2)
protein kinase D##2##3##(1994-8#2)
protein kinase II (CaMKII)##2##4##(2008-8#1)(2012-2#1)
protein kinase II##18##3##(1990-5#1)(1993-6#3)(1995-2#4)(1995-8#2)(1996-2#3)(1997-2#1)(2008-10#1)(2008-8#2)(2012-2#1)
protein kinase activation##2##3##(1994-11#1)(1995-6#1)
protein kinase activities##2##3##(1993-11#1)(1997-2#1)
protein kinase activity in##2##4##(1992-3#1)(1993-8#1)
protein kinase activity with##2##4##(1991-11#1)(1993-11#1)
protein kinase activity##11##3##(1991-11#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-8#1)(1997-2#1)(2008-4#1)
protein kinase and##4##3##(1990-8#1)(1993-3#1)(1993-6#1)(2012-3#1)
protein kinase family##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
protein kinase in the##2##4##(1993-3#1)(2010-10#1)
protein kinase in##6##3##(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(2010-10#1)(2013-1#1)
protein kinase inhibitor##11##3##(1990-12#3)(1991-11#1)(1994-2#1)(1995-12#1)(1995-2#2)(1997-2#1)(2008-10#1)(2010-6#1)
protein kinase inhibitors##3##3##(1990-8#2)(1994-11#1)
protein kinase is a##2##4##(1994-8#1)(1996-2#1)
protein kinase is##3##3##(1990-5#1)(1994-8#1)(1996-2#1)
protein kinase phosphorylation sites##2##4##(2008-12#1)(2008-9#1)
protein kinase phosphorylation##3##3##(2008-12#2)(2008-9#1)
protein kinase that##4##3##(1991-2#1)(1992-6#1)(1994-8#1)(2009-7#1)
protein kinase##498##2##(1990-10#1)(1990-11#9)(1990-12#11)(1990-2#8)(1990-5#13)(1990-7#4)(1990-8#13)(1991-11#5)(1991-12#3)(1991-2#12)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#5)(1992-12#8)(1992-2#1)(1992-3#8)(1992-6#9)(1992-8#9)(1992-9#14)(1993-11#6)(1993-12#8)(1993-2#4)(1993-3#17)(1993-6#10)(1993-8#17)(1993-9#1)(1994-11#19)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#12)(1994-6#9)(1994-8#13)(1994-9#5)(1995-11#9)(1995-12#7)(1995-2#18)(1995-3#3)(1995-5#3)(1995-6#11)(1995-8#6)(1996-12#2)(1996-2#6)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#4)(1997-2#13)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2008-1#4)(2008-10#15)(2008-11#24)(2008-12#4)(2008-3#7)(2008-4#8)(2008-5#2)(2008-7#5)(2008-8#10)(2008-9#6)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-10#3)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#3)
protein kinases A and C##2##5##(1990-8#1)(1995-6#1)
protein kinases and protein phosphatases##2##5##(2008-5#2)
protein kinases and##4##3##(1990-8#1)(1997-2#1)(2008-5#2)
protein kinases in the##3##4##(1994-9#1)(2008-11#1)(2012-3#1)
protein kinases in##4##3##(1994-9#1)(1997-1#1)(2008-11#1)(2012-3#1)
protein kinases##51##2##(1990-8#4)(1991-11#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#3)(1995-6#4)(1996-2#4)(1997-1#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
protein known to be##2##4##(2007-12#1)(2008-10#1)
protein known to##5##3##(1992-2#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-10#1)
protein lacking##3##2##(1992-6#1)(1993-6#1)(2012-2#1)
protein layer##3##2##(2008-10#1)(2008-2#2)
protein leads to##2##3##(1994-11#1)(2011-1#1)
protein level in##2##3##(2008-7#1)(2012-2#1)
protein level of##3##3##(1997-1#1)(2008-4#1)(2008-9#1)
protein level was##2##3##(1993-1#1)(2012-3#1)
protein level##29##2##(1990-5#1)(1992-8#1)(1993-1#2)(1994-11#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#5)(2008-7#3)(2008-9#1)(2009-5#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
protein levels and##7##3##(1995-5#1)(2008-10#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
protein levels are##2##3##(1996-12#1)(2008-8#1)
protein levels as##2##3##(1997-7#1)(2011-2#1)
protein levels in##12##3##(1995-12#1)(1995-5#1)(2008-11#2)(2008-5#1)(2011-2#2)(2013-8#5)
protein levels of##7##3##(2008-11#1)(2008-4#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-8#1)
protein levels were##3##3##(1991-12#1)(2008-6#1)(2009-6#1)
protein levels##50##2##(1990-5#2)(1991-12#1)(1993-6#3)(1995-12#1)(1995-5#4)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-11#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#6)
protein ligase##2##2##(1995-6#1)(1997-3#1)
protein liquid##3##2##(2008-10#3)
protein localization##2##2##(2008-7#1)(2008-9#1)
protein localized##2##2##(1993-6#1)(2008-8#1)
protein loss##4##2##(2007-12#2)(2008-11#1)(2008-5#1)
protein losses##2##2##(2011-2#2)
protein mRNA##4##2##(1991-11#1)(1994-8#1)(1995-8#1)(1996-12#1)
protein maize##2##2##(2012-2#2)
protein malnutrition##2##2##(2008-11#1)(2012-2#1)
protein marker##5##2##(2008-10#2)(2008-4#1)(2009-6#1)(2010-12#1)
protein markers##7##2##(2008-10#2)(2009-6#2)(2012-3#1)(2012-7#1)(2012-8#1)
protein mass recovery##2##3##(2008-10#1)(2008-6#1)
protein mass##7##2##(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#3)
protein matrix##6##2##(1990-8#1)(1994-5#1)(2007-11#1)(2008-10#1)(2009-6#2)
protein may be an##2##4##(1991-9#1)(1997-3#1)
protein may be important in##3##5##(1992-11#1)(1992-9#1)(2008-10#1)
protein may be##11##3##(1991-2#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-9#1)
protein may play a role in the##2##7##(1997-6#1)(2009-4#1)
protein may play a role in##3##6##(1997-6#1)(2009-4#1)(2009-7#1)
protein may play a##4##4##(1992-11#1)(1997-6#1)(2009-4#1)(2009-7#1)
protein may play an important role in##2##7##(2008-8#1)(2008-9#1)
protein may play##6##3##(1992-11#1)(1997-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)
protein may##23##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#2)(1992-11#2)(1992-8#1)(1992-9#1)(1993-8#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)
protein medium##2##2##(1994-3#1)(2008-11#1)
protein metabolism##3##2##(2008-10#2)(2009-10#1)
protein methyltransferase##4##2##(1991-2#1)(1993-8#2)(1994-9#1)
protein microarray##3##2##(2008-10#2)(2010-2#1)
protein microarrays##3##2##(2008-4#1)(2009-12#1)(2010-7#1)
protein might be##2##3##(1990-7#1)(1996-12#1)
protein might##5##2##(1990-7#1)(1994-10#1)(1996-12#1)(2008-10#1)(2008-9#1)
protein mixture##3##2##(2008-1#1)(2008-10#2)
protein mixtures followed by##2##4##(2008-4#1)(2010-12#1)
protein mixtures##5##2##(2008-11#1)(2008-4#3)(2010-12#1)
protein modification##5##2##(1993-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)
protein modifications##2##2##(2008-11#1)(2010-12#1)
protein moiety##4##2##(1992-3#3)(1993-2#1)
protein molecular##2##2##(2009-12#1)(2012-3#1)
protein molecule##3##2##(1990-5#1)(2008-4#1)(2013-8#1)
protein molecules in##2##3##(1990-11#1)(2008-9#1)
protein molecules##9##2##(1990-11#1)(1990-12#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-12#1)(2010-10#1)
protein monomers##2##2##(1997-6#1)(2008-10#1)
protein motifs##2##2##(1995-8#1)(1996-10#1)
protein myristoylation##2##2##(2009-8#2)
protein nanolithography##2##2##(2008-7#2)
protein not only##2##3##(2008-10#1)(2012-2#1)
protein not##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
protein occurred in##2##3##(1994-11#1)(2009-8#1)
protein of 1##3##3##(1990-8#1)(2008-10#1)(2010-5#1)
protein of 294 amino acids##2##5##(1990-11#1)(1996-6#1)
protein of Escherichia coli##2##4##(1991-12#1)(1991-7#1)
protein of M(r)##2##3##(1993-9#1)(2010-4#1)
protein of S##2##3##(1995-6#1)(2008-10#1)
protein of about##2##3##(1993-12#1)(1994-8#1)
protein of apparent##2##3##(1990-7#1)(1991-5#1)
protein of approximately##3##3##(1993-6#1)(1995-2#1)(1996-10#1)
protein of human##3##3##(1990-5#2)(1994-8#1)
protein of interest is expressed as a fusion to the DNA binding protein##2##13##(2008-2#2)
protein of interest is##3##4##(2008-2#2)(2008-4#1)
protein of interest##11##3##(1992-5#1)(2008-1#2)(2008-2#2)(2008-4#4)(2008-9#1)(2012-2#1)
protein of ribonucleotide reductase##3##4##(1991-5#2)(1993-11#1)
protein of the central nervous system##2##6##(1996-12#1)(1997-2#1)
protein of the inner##2##4##(1993-6#1)(2011-2#1)
protein of the##23##3##(1990-5#1)(1991-2#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
protein of unknown function##2##4##(2008-10#2)
protein of unknown##3##3##(1994-12#1)(2008-10#2)
protein of##213##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#6)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-5#4)(1991-7#2)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#5)(1993-6#4)(1993-8#2)(1993-9#5)(1994-11#7)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#7)(1995-12#3)(1995-2#4)(1995-6#5)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#8)(1996-6#5)(1997-2#7)(1997-3#4)(1997-4#4)(1997-6#1)(1997-7#4)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-6#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
protein oligomers##2##2##(2010-8#1)(2011-2#1)
protein on a##4##3##(1991-5#1)(1994-6#1)(1997-4#1)(2008-4#1)
protein on immunoblots of##2##4##(1991-9#1)(1995-6#1)
protein on the surface of##2##5##(1992-9#1)(2008-9#1)
protein on the##8##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
protein on##25##2##(1990-2#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)
protein only##4##2##(1993-6#1)(1994-3#1)(1997-7#1)(2008-4#1)
protein or peptide##2##3##(1995-5#1)(2008-11#1)
protein or##18##2##(1991-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1995-2#1)(1995-5#2)(1997-4#1)(2008-11#1)(2008-4#6)(2008-9#1)(2009-9#1)
protein organization##2##2##(2008-7#2)
protein overexpression##4##2##(2008-2#1)(2011-1#3)
protein oxidation##7##2##(1994-11#1)(2008-1#1)(2010-4#4)(2011-1#1)
protein p20##3##2##(2008-9#3)
protein part of##2##3##(2009-8#2)
protein part##3##2##(2009-8#3)
protein particles##2##2##(1996-1#1)(2008-11#1)
protein pattern##2##2##(1992-12#1)(1994-9#1)
protein patterns##4##2##(1994-9#1)(2008-1#2)(2010-4#1)
protein peaks##2##2##(2008-10#2)
protein per min##8##3##(1991-5#2)(1992-3#3)(2008-10#2)(2008-11#1)
protein per##10##2##(1991-5#2)(1992-3#3)(2008-10#2)(2008-11#2)(2010-7#1)
protein permeability##2##2##(2011-1#1)(2011-2#1)
protein pharmaceuticals##2##2##(1997-2#1)(2008-11#1)
protein phosphatase 1##6##3##(1995-6#2)(1995-8#2)(1997-4#1)(2008-10#1)
protein phosphatase 1/2A##3##3##(1993-8#2)(1994-11#1)
protein phosphatase 2A##4##3##(1994-9#2)(1995-8#1)(2008-9#1)
protein phosphatase activator##2##3##(1993-6#2)
protein phosphatase and##4##3##(1993-6#2)(1994-11#1)(1996-2#1)
protein phosphatase inhibition##2##3##(1997-4#2)
protein phosphatase inhibitors##5##3##(1992-12#2)(1997-6#1)(2008-2#1)(2008-4#1)
protein phosphatase one##2##3##(2012-12#2)
protein phosphatase##38##2##(1992-12#3)(1993-6#7)(1993-8#5)(1994-11#2)(1994-9#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-2#2)(1997-4#3)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#2)
protein phosphatases 1 and 2A##3##5##(1991-5#1)(1992-12#2)
protein phosphatases 1##4##3##(1991-5#1)(1992-12#2)(1995-8#1)
protein phosphatases type 1 and##2##5##(1990-12#1)(1994-11#1)
protein phosphatases##13##2##(1990-12#2)(1991-5#1)(1992-12#2)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#2)(2008-5#2)(2012-12#1)
protein phosphorylation events##3##3##(1990-12#1)(2008-2#1)(2008-4#1)
protein phosphorylation in##5##3##(1990-12#3)(1992-2#2)
protein phosphorylation is##3##3##(1995-12#1)(2008-2#1)(2008-4#1)
protein phosphorylation##28##2##(1990-12#5)(1992-2#2)(1992-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#3)(1996-2#1)(2008-2#3)(2008-4#3)(2008-8#2)
protein plugs##3##2##(2008-10#1)(2009-7#2)
protein plus##2##2##(1994-11#1)(2008-10#1)
protein precipitation##3##2##(2008-7#1)(2011-2#1)(2011-3#1)
protein precursor (APP)##7##3##(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)
protein precursor is##2##3##(1992-6#1)(1992-9#1)
protein precursor##21##2##(1991-9#3)(1992-12#2)(1992-6#3)(1992-8#1)(1992-9#4)(1993-12#2)(1993-3#1)(1994-11#2)(2008-11#1)(2008-7#1)(2010-12#1)
protein predicted##2##2##(1997-2#1)(2008-10#1)
protein preparations##3##2##(1990-11#1)(1990-12#1)(2011-2#1)
protein present in##4##3##(1992-11#1)(1995-8#1)(2007-7#1)(2008-10#1)
protein previously##2##2##(1991-8#1)(2008-7#1)
protein processing##2##2##(1996-10#1)(2008-4#1)
protein produced##6##2##(1993-12#1)(1997-4#1)(2008-11#3)(2011-2#1)
protein product of##4##3##(1990-5#1)(1993-11#1)(1993-12#1)(1997-9#1)
protein product##13##2##(1990-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(1995-6#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
protein production and##5##3##(2008-11#3)(2012-2#2)
protein production in##10##3##(1997-4#1)(2008-11#3)(2008-7#4)(2011-2#2)
protein production is##2##3##(2008-7#1)(2011-2#1)
protein production of##3##3##(2008-11#3)
protein production was##2##3##(2008-11#2)
protein production##58##2##(1992-12#1)(1992-8#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#27)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#10)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)
protein productivity of##2##3##(2008-11#2)
protein productivity##7##2##(2008-11#5)(2008-7#2)
protein products are##2##3##(1992-12#1)(2011-2#1)
protein products##7##2##(1991-12#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
protein profile comparisons##2##3##(2008-4#2)
protein profile##8##2##(1997-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#2)(2011-2#1)(2013-1#1)
protein profiles##7##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#2)
protein profiling##4##2##(2008-4#4)
protein promoter##4##2##(1996-12#1)(1997-4#2)(2008-12#1)
protein protects##3##2##(1992-7#1)(1995-6#1)(2008-8#1)
protein purification and##2##3##(1996-12#1)(2008-4#1)
protein purification##7##2##(1996-12#1)(2008-4#3)(2008-7#2)(2013-1#1)
protein purified##4##2##(1990-5#1)(1995-6#2)(2008-10#1)
protein quality##2##2##(2008-11#1)(2008-7#1)
protein rather than##2##3##(2008-10#2)
protein reacted##2##2##(1993-11#1)(1995-6#1)
protein recently##2##2##(1993-3#1)(2010-5#1)
protein receptor##3##2##(1994-2#2)(2009-8#1)
protein refolded##2##2##(1995-11#1)(1995-2#1)
protein refolding##3##2##(2011-1#1)(2011-2#2)
protein regulation##4##2##(1991-5#1)(1994-12#1)(2009-6#2)
protein relative to##3##3##(2008-4#2)(2011-2#1)
protein release##2##2##(1995-2#1)(2012-6#1)
protein required for##4##3##(1993-9#1)(2008-9#2)(2009-8#1)
protein required##5##2##(1991-3#1)(1993-9#1)(2008-9#2)(2009-8#1)
protein requirements##4##2##(2008-5#3)(2012-2#1)
protein requires##2##2##(1994-11#1)(2008-4#1)
protein responses##2##2##(2008-7#1)(2013-8#1)
protein responsible for##2##3##(1990-2#1)(1991-2#1)
protein revealed that the##2##4##(1993-2#1)(2008-10#1)
protein revealed that##3##3##(1991-12#1)(1993-2#1)(2008-10#1)
protein revealed##4##2##(1991-12#1)(1993-2#1)(2008-10#1)(2008-11#1)
protein samples and##2##3##(2008-1#1)(2008-8#1)
protein samples##10##2##(1997-2#1)(2008-1#2)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)
protein science##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
protein secondary##3##2##(1991-11#1)(2008-10#1)(2008-4#1)
protein secreted by##5##3##(1993-2#1)(1994-5#1)(1997-4#1)(2008-4#1)(2008-7#1)
protein secretion in##2##3##(1993-8#1)(1997-3#1)
protein secretion machinery##2##3##(1997-3#1)(2012-2#1)
protein secretion##16##2##(1992-9#1)(1993-8#1)(1994-9#2)(1996-12#1)(1997-3#2)(1997-4#1)(2008-11#2)(2008-7#2)(2009-8#1)(2012-2#2)(2013-1#1)
protein separation##3##2##(1996-12#1)(2008-10#2)
protein sequence comparisons##2##3##(2008-9#2)
protein sequence data##2##3##(1995-2#1)(2008-4#1)
protein sequence database##2##3##(2008-4#1)(2008-9#1)
protein sequence databases##2##3##(2008-7#1)(2009-6#1)
protein sequence from##2##3##(1994-8#1)(2008-4#1)
protein sequence had a##2##4##(1993-6#1)(2013-1#1)
protein sequence homology##2##3##(1997-3#1)(2011-2#1)
protein sequence is##2##3##(1996-12#1)(2008-4#1)
protein sequence##40##2##(1992-8#3)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-4#12)(2008-7#4)(2008-9#6)(2009-6#2)(2010-11#1)(2011-2#1)(2013-1#1)
protein sequences are##2##3##(1996-10#1)(2009-3#1)
protein sequences of##2##3##(1992-8#1)(2008-10#1)
protein sequences that##2##3##(1995-2#1)(2008-4#1)
protein sequences using##2##3##(2008-4#1)(2008-9#1)
protein sequences##22##2##(1991-12#1)(1992-8#1)(1994-6#1)(1995-2#2)(1996-10#1)(1997-2#1)(2008-10#2)(2008-4#6)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
protein sequencing##5##2##(1991-6#1)(1993-9#1)(1995-6#1)(1996-8#1)(1997-2#1)
protein serine-threonine kinases##2##3##(1990-5#2)
protein serine/threonine phosphatases##2##3##(1994-11#1)(1995-8#1)
protein serine/threonine##3##2##(1994-11#1)(1995-8#2)
protein serum-free medium##2##3##(2008-11#2)
protein share##2##2##(1995-8#1)(2008-10#1)
protein shared##3##2##(1994-12#1)(1995-6#1)(2008-10#1)
protein shares##2##2##(2008-10#1)(2009-5#1)
protein should##2##2##(1992-12#1)(1994-11#1)
protein showed a##2##3##(1993-11#1)(1997-4#1)
protein showed high homology##2##4##(1990-5#1)(1993-8#1)
protein showed that##3##3##(1994-8#1)(1995-12#1)(1995-5#1)
protein showed##14##2##(1990-5#1)(1991-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-9#1)(2010-12#1)
protein shows a##2##3##(1993-6#1)(2009-5#1)
protein shows that##2##3##(1991-2#1)(1992-3#1)
protein shows##9##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-6#2)(2007-12#1)(2008-8#1)(2009-5#1)
protein signal##2##2##(1992-8#1)(1995-11#1)
protein signaling##2##2##(2008-4#1)(2012-1#1)
protein significantly##3##2##(1994-8#1)(2008-12#1)(2008-9#1)
protein similar to##2##3##(1992-9#1)(2008-8#1)
protein sites##2##2##(2008-4#1)(2010-11#1)
protein solders##4##2##(2008-3#4)
protein solubility##2##2##(1993-8#1)(2008-6#1)
protein solubilization##2##2##(2008-4#2)
protein solution##3##2##(2008-6#1)(2008-7#1)(2011-2#1)
protein solutions##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
protein source##3##2##(2011-2#1)(2012-2#1)(2013-7#1)
protein sources##7##2##(2008-10#2)(2008-12#1)(2008-5#2)(2013-7#2)
protein space##3##2##(1997-8#1)(2008-7#2)
protein species of approximately##2##4##(2008-10#2)
protein species##7##2##(1993-8#1)(2008-10#3)(2008-4#1)(2008-7#2)
protein splicing##4##2##(1993-12#3)(2011-3#1)
protein spots were##3##3##(1996-8#1)(2008-10#1)(2010-12#1)
protein spots##7##2##(1996-8#1)(2008-10#3)(2010-12#2)(2011-3#1)
protein stability and##2##3##(1995-5#1)(2013-1#1)
protein stability##9##2##(1992-5#1)(1993-11#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-8#2)(2011-1#1)(2013-1#1)
protein stabilization##3##2##(1991-5#1)(1997-2#1)(2008-8#1)
protein stimulates##2##2##(1991-2#1)(1994-5#1)
protein strongly##2##2##(1992-8#1)(2012-2#1)
protein structural##2##2##(1990-8#1)(2008-10#1)
protein structure and dynamics##3##4##(2008-4#2)(2012-3#1)
protein structure and function##2##4##(2008-7#1)(2010-12#1)
protein structure and##6##3##(2008-4#2)(2008-7#2)(2010-12#1)(2012-3#1)
protein structure is##4##3##(1994-12#1)(1994-8#1)(2008-4#1)(2008-7#1)
protein structure##36##2##(1991-11#1)(1991-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-4#9)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
protein structures and##2##3##(2008-7#1)(2013-1#1)
protein structures##16##2##(1990-11#1)(1992-4#1)(1992-8#1)(1994-8#2)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#3)(2009-5#1)(2012-2#1)(2013-1#1)
protein substrate##8##2##(1992-11#2)(1995-2#3)(2008-4#1)(2010-9#1)(2011-2#1)
protein substrates##6##2##(1990-5#1)(1992-6#2)(1992-8#1)(2008-4#1)(2011-2#1)
protein subunit##4##2##(1990-5#1)(1993-8#2)(1994-11#1)
protein subunits##2##2##(1995-2#1)(2009-9#1)
protein such as##3##3##(1993-11#1)(2008-10#1)(2008-7#1)
protein suggests that the##2##4##(1993-11#1)(2008-10#1)
protein suggests that##3##3##(1991-12#1)(1993-11#1)(2008-10#1)
protein sumoylation##2##2##(2008-4#2)
protein superfamily##2##2##(1997-6#1)(2008-9#1)
protein supplement##2##2##(2008-11#1)(2008-6#1)
protein supplementation##5##2##(2013-1#5)
protein surface##7##2##(1990-5#1)(1995-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)
protein surfaces##2##2##(2012-1#1)(2012-5#1)
protein symbol##2##2##(2008-7#2)
protein synthesis and##8##3##(1991-12#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-2#1)(2008-5#1)(2008-7#1)
protein synthesis as well as##2##5##(2008-5#2)
protein synthesis at##2##3##(1991-2#1)(2008-10#1)
protein synthesis by##6##3##(1990-11#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-6#1)(2013-8#1)
protein synthesis in L6 myotubes##3##5##(2008-11#3)
protein synthesis in RLC-16##2##4##(2008-11#2)
protein synthesis in a##2##4##(1995-11#1)(1995-12#1)
protein synthesis in both##2##4##(1994-6#1)(1995-11#1)
protein synthesis in the##3##4##(1994-5#1)(2008-12#1)(2008-9#1)
protein synthesis in##16##3##(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(2008-11#6)(2008-12#1)(2008-9#1)(2011-3#1)
protein synthesis inhibitor)##2##3##(1994-5#2)
protein synthesis inhibitors##5##3##(1991-2#1)(1991-5#3)(1994-9#1)
protein synthesis may##2##3##(1990-12#1)(1997-1#1)
protein synthesis or##2##3##(1994-2#1)(2008-7#1)
protein synthesis was inhibited##2##4##(1993-12#1)(1994-11#1)
protein synthesis was##4##3##(1992-11#1)(1993-12#1)(1994-11#1)(2008-7#1)
protein synthesis were##3##3##(1991-9#1)(2008-11#2)
protein synthesis##115##2##(1990-11#2)(1990-12#3)(1991-12#2)(1991-2#3)(1991-5#3)(1991-9#1)(1992-11#2)(1992-12#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-5#4)(1994-6#4)(1994-8#4)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#21)(2008-12#1)(2008-2#2)(2008-5#8)(2008-7#5)(2008-8#1)(2008-9#4)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2013-8#1)
protein synthesized in##2##3##(1993-12#1)(1994-8#1)
protein synthesized##3##2##(1993-12#1)(1994-8#1)(2008-9#1)
protein target##2##2##(2008-1#1)(2008-7#1)
protein termed##5##2##(1992-6#2)(2007-2#1)(2008-10#1)(2009-8#1)
protein than##2##2##(1990-12#1)(1997-2#1)
protein that are##2##3##(1993-12#1)(2008-10#1)
protein that binds##2##3##(1991-10#1)(1995-2#1)
protein that can##3##3##(1991-5#1)(2008-9#1)(2012-2#1)
protein that contains##2##3##(1992-8#1)(1997-4#1)
protein that has##3##3##(1990-11#1)(1992-4#1)(2011-2#1)
protein that is expressed##3##4##(2008-1#1)(2008-11#1)(2008-4#1)
protein that is highly##2##4##(1992-12#1)(2011-2#1)
protein that is induced by##2##5##(1990-11#1)(2010-3#1)
protein that is required for##3##5##(1995-12#1)(2009-10#2)
protein that is##24##3##(1990-11#1)(1990-5#2)(1991-7#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-6#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)
protein that may##2##3##(1990-5#1)(1991-12#1)
protein that mediates##2##3##(1993-12#1)(2012-2#1)
protein that serves as##2##4##(1991-5#1)(2008-7#1)
protein that was##5##3##(1990-12#1)(1993-8#1)(1995-6#1)(2007-7#1)(2009-12#1)
protein that we##2##3##(1992-3#1)(1992-8#1)
protein that##72##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#1)(1991-10#1)(1991-12#2)(1991-5#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-12#3)(1993-6#3)(1993-8#1)(1993-9#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#4)(1997-4#1)(2007-7#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)
protein therapeutics##4##2##(2008-10#3)(2012-3#1)
protein thiols##3##2##(1992-11#3)
protein through##3##2##(1992-8#1)(1996-5#1)(2013-1#1)
protein throughout##2##2##(1993-12#1)(2008-5#1)
protein to be##4##3##(1990-2#1)(1991-5#1)(2008-10#1)(2008-11#1)
protein to its##2##3##(1993-6#1)(1995-2#1)
protein to the##12##3##(1990-11#1)(1990-5#2)(1991-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
protein to##51##2##(1990-11#2)(1990-2#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
protein toxin##3##2##(2008-10#3)
protein toxins##2##2##(1994-5#1)(2011-1#1)
protein trafficking##4##2##(2008-1#1)(2008-9#1)(2009-7#1)(2012-2#1)
protein translation##3##2##(2011-2#1)(2012-2#2)
protein translocation into##2##3##(1991-2#1)(1997-8#1)
protein translocation##4##2##(1991-2#1)(1991-5#1)(1997-8#2)
protein transport##2##2##(1992-12#1)(1995-3#1)
protein turnover##6##2##(1990-2#1)(1992-12#2)(2008-3#2)(2013-1#1)
protein types##2##2##(2009-12#1)(2013-1#1)
protein tyrosine kinase (PTK)##4##4##(1994-6#1)(1994-8#1)(1997-6#1)(2008-8#1)
protein tyrosine kinase that##2##4##(1997-7#1)(2008-7#1)
protein tyrosine kinase##15##3##(1992-3#2)(1993-3#1)(1993-8#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-8#1)
protein tyrosine kinases (PTKs)##2##4##(1993-3#1)(1995-11#1)
protein tyrosine kinases##8##3##(1992-3#1)(1993-3#2)(1995-11#2)(1996-2#2)(2012-2#1)
protein tyrosine phosphatase (PTPase)##2##4##(1993-3#1)(2008-8#1)
protein tyrosine phosphatase activity##2##4##(1992-12#1)(1993-3#1)
protein tyrosine phosphatase##10##3##(1992-12#1)(1993-11#1)(1993-3#2)(1994-6#1)(1995-9#1)(1997-7#1)(2008-8#1)(2009-6#1)(2009-7#1)
protein tyrosine phosphorylation and phospholipase A2##2##6##(1994-6#2)
protein tyrosine phosphorylation and##3##4##(1994-6#2)(1996-5#1)
protein tyrosine phosphorylation in##2##4##(1994-6#1)(2012-3#1)
protein tyrosine phosphorylation##9##3##(1993-3#1)(1994-6#3)(1996-5#2)(2012-3#3)
protein tyrosine##45##2##(1992-12#1)(1992-3#3)(1993-11#1)(1993-3#6)(1993-8#2)(1994-6#5)(1994-8#2)(1995-11#3)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#2)(1997-6#1)(1997-7#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#3)
protein tyrosyl##3##2##(1992-12#2)(1993-3#1)
protein under##2##2##(1996-12#1)(2008-11#1)
protein undergoes##3##2##(1991-5#1)(1994-11#1)(1994-8#1)
protein using##8##2##(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-6#1)
protein vaccine antigens##2##3##(2008-7#2)
protein vaccine##6##2##(1991-5#2)(2007-2#1)(2008-4#1)(2008-7#2)
protein variants##3##2##(1997-2#1)(2008-8#1)(2011-1#1)
protein was also##5##3##(1991-11#1)(1992-11#1)(1993-6#1)(1994-5#1)(1996-12#1)
protein was approximately##2##3##(1995-2#1)(2008-8#1)
protein was blocked##2##3##(1990-11#1)(1994-8#1)
protein was deduced##2##3##(1993-9#1)(2009-2#1)
protein was detected in##5##4##(1991-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
protein was detected on##2##4##(1991-2#1)(1994-11#1)
protein was detected##8##3##(1991-2#1)(1991-9#1)(1994-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
protein was expressed in##4##4##(1990-11#1)(1993-11#1)(2008-9#2)
protein was expressed##7##3##(1990-11#1)(1993-11#1)(1993-6#1)(2008-5#1)(2008-8#1)(2008-9#2)
protein was extracted##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
protein was found in##2##4##(1994-6#1)(2008-5#1)
protein was found to##3##4##(1991-7#1)(1994-5#1)(2009-9#1)
protein was found##5##3##(1991-7#1)(1994-5#1)(1994-6#1)(2008-5#1)(2009-9#1)
protein was highly##3##3##(1994-8#1)(1997-4#1)(2008-8#1)
protein was identified as the##2##5##(1997-3#1)(2008-10#1)
protein was identified in##2##4##(1990-11#1)(1990-8#1)
protein was identified##7##3##(1990-11#1)(1990-8#1)(1997-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
protein was localized in##2##4##(1992-3#1)(2009-10#1)
protein was located in##2##4##(1990-5#1)(2008-9#1)
protein was measured by##2##4##(2008-11#1)(2011-2#1)
protein was measured in##2##4##(1992-6#1)(1993-1#1)
protein was measured##7##3##(1992-6#1)(1993-1#1)(1994-8#1)(2008-11#3)(2011-2#1)
protein was named##2##3##(2007-8#1)(2011-2#1)
protein was not##4##3##(1993-11#1)(2008-11#2)(2008-8#1)
protein was observed in##3##4##(1991-5#1)(1995-6#1)(2008-10#1)
protein was observed##6##3##(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#1)
protein was obtained##3##3##(1994-3#1)(2008-9#1)(2011-1#1)
protein was produced in##2##4##(1993-12#1)(2008-11#1)
protein was produced##4##3##(1993-12#1)(2008-11#3)
protein was purified to homogeneity by##2##6##(1990-8#1)(2009-3#1)
protein was purified to homogeneity##3##5##(1990-8#1)(1995-12#1)(2009-3#1)
protein was purified to##5##4##(1990-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(2009-3#1)
protein was purified##10##3##(1990-8#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)
protein was reported##2##3##(1996-12#1)(2011-2#1)
protein was secreted into the##2##5##(1991-9#1)(1997-4#1)
protein was significantly##2##3##(2008-8#1)(2011-2#1)
protein was synthesized##2##3##(1990-5#2)
protein was the most##3##4##(1993-2#1)(2008-10#1)(2013-7#1)
protein was the##4##3##(1993-2#1)(1994-8#1)(2008-10#1)(2013-7#1)
protein was upregulated in##2##4##(2010-12#2)
protein was used to##3##4##(1990-11#1)(1992-9#1)(1997-6#1)
protein was used##4##3##(1990-11#1)(1992-9#1)(1997-6#1)(2013-7#1)
protein was##195##2##(1990-11#8)(1990-12#1)(1990-2#1)(1990-5#7)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#7)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-12#3)(1997-2#5)(1997-3#1)(1997-4#9)(1997-6#1)(2007-8#1)(2008-10#19)(2008-11#16)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#10)(2008-9#6)(2009-10#1)(2009-2#2)(2009-3#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#10)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
protein we##2##2##(1994-12#1)(2011-2#1)
protein were found##2##3##(1992-2#1)(2012-2#1)
protein were not##2##3##(1990-5#1)(1993-3#1)
protein were observed##3##3##(1994-10#1)(1995-3#1)(1995-8#1)
protein were produced##2##3##(1990-5#1)(1996-1#1)
protein were similar##2##3##(2008-10#2)
protein were studied##2##3##(2008-10#2)
protein were##39##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
protein when##5##2##(1990-5#1)(1992-11#1)(1993-6#1)(1995-2#1)(2008-4#1)
protein which binds##2##3##(1992-12#1)(2009-7#1)
protein which is temperature-sensitive for nuclear transport##2##7##(1991-2#2)
protein which is##8##3##(1991-2#3)(1994-11#1)(1994-12#1)(1995-6#1)(1997-3#1)(2008-11#1)
protein which was##4##3##(1991-2#1)(1993-6#1)(1994-11#1)(1995-6#1)
protein which##32##2##(1990-7#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
protein whose tyrosine phosphorylation is##2##5##(1996-5#2)
protein whose##7##2##(1990-5#1)(1991-2#1)(1994-2#1)(1995-6#1)(1996-5#2)(2008-4#1)
protein with GARS##2##3##(1993-12#2)
protein with a molecular mass of about##2##7##(1993-11#1)(1994-8#1)
protein with a molecular mass of##5##6##(1993-11#1)(1993-6#1)(1994-8#1)(1997-7#1)(2008-10#1)
protein with a molecular weight of##5##6##(1990-7#1)(1993-6#1)(2012-1#3)
protein with a molecular##10##4##(1990-7#1)(1993-11#1)(1993-6#2)(1994-8#1)(1997-7#1)(2008-10#1)(2012-1#3)
protein with a predicted Mr of##2##6##(1990-12#1)(2008-10#1)
protein with a predicted##3##4##(1990-12#1)(1994-8#1)(2008-10#1)
protein with a##27##3##(1990-12#1)(1990-7#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-6#4)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2012-1#3)(2012-2#1)
protein with an##9##3##(1991-2#1)(1992-11#1)(1992-12#1)(1994-12#1)(1995-5#1)(2008-11#2)(2008-6#1)(2010-4#1)
protein with both##2##3##(2010-2#1)(2012-12#1)
protein with high##2##3##(1991-5#1)(1994-8#1)
protein with respect to##2##4##(1990-11#1)(2011-2#1)
protein with some##2##3##(1993-8#1)(2008-9#1)
protein with strong##2##3##(2008-8#2)
protein with the same##2##4##(1996-3#1)(2009-10#1)
protein with the##6##3##(1993-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-9#1)(2009-10#1)
protein with##93##2##(1990-11#3)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-2#1)(1991-5#3)(1992-11#2)(1992-12#2)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#3)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#4)(1997-8#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#8)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)
protein within##2##2##(1991-9#1)(2008-4#1)
protein yield##4##2##(2008-11#2)(2011-2#2)
protein##6943##1##(1990-10#3)(1990-11#89)(1990-12#87)(1990-2#32)(1990-5#110)(1990-6#1)(1990-7#57)(1990-8#69)(1990-9#2)(1991-10#12)(1991-11#23)(1991-12#58)(1991-2#63)(1991-3#4)(1991-5#77)(1991-6#22)(1991-7#14)(1991-8#9)(1991-9#52)(1992-1#2)(1992-10#3)(1992-11#49)(1992-12#73)(1992-2#10)(1992-3#84)(1992-4#6)(1992-5#5)(1992-6#54)(1992-7#10)(1992-8#82)(1992-9#42)(1993-1#9)(1993-11#94)(1993-12#74)(1993-2#45)(1993-3#60)(1993-5#1)(1993-6#105)(1993-8#100)(1993-9#44)(1994-10#5)(1994-11#133)(1994-12#92)(1994-2#27)(1994-3#25)(1994-5#67)(1994-6#58)(1994-7#5)(1994-8#132)(1994-9#40)(1995-11#47)(1995-12#65)(1995-2#124)(1995-3#26)(1995-5#53)(1995-6#120)(1995-8#62)(1995-9#7)(1996-1#6)(1996-10#9)(1996-11#1)(1996-12#64)(1996-2#35)(1996-3#9)(1996-5#28)(1996-6#28)(1996-8#6)(1996-9#6)(1997-1#16)(1997-2#101)(1997-3#57)(1997-4#92)(1997-5#1)(1997-6#44)(1997-7#53)(1997-8#19)(1997-9#2)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#9)(2007-12#28)(2007-2#9)(2007-5#2)(2007-6#6)(2007-7#6)(2007-8#10)(2008-1#78)(2008-10#592)(2008-11#378)(2008-12#41)(2008-2#80)(2008-3#43)(2008-4#296)(2008-5#115)(2008-6#41)(2008-7#242)(2008-8#184)(2008-9#195)(2009-1#1)(2009-10#18)(2009-11#13)(2009-12#25)(2009-2#12)(2009-3#15)(2009-4#6)(2009-5#23)(2009-6#26)(2009-7#58)(2009-8#61)(2009-9#33)(2010-1#3)(2010-10#24)(2010-11#30)(2010-12#50)(2010-2#16)(2010-3#6)(2010-4#42)(2010-5#11)(2010-6#11)(2010-7#12)(2010-8#7)(2010-9#11)(2011-1#46)(2011-10#3)(2011-2#176)(2011-3#20)(2011-9#1)(2012-1#23)(2012-12#33)(2012-2#110)(2012-3#49)(2012-5#2)(2012-6#3)(2012-7#3)(2012-8#2)(2012-9#1)(2013-1#114)(2013-7#25)(2013-8#56)
protein's quadratic indices##2##3##(2007-11#2)
protein's##18##1##(1994-11#2)(1995-11#2)(1995-2#2)(1997-2#1)(2007-11#3)(2008-2#2)(2008-8#2)(2008-9#2)(2010-10#1)(2011-1#1)
protein(s) and##2##2##(1991-11#1)(1994-6#1)
protein(s) is involved in##2##4##(1992-11#1)(1995-12#1)
protein(s) that##2##2##(1992-12#1)(1992-8#1)
protein(s)##15##1##(1991-11#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
protein) and##11##2##(1990-11#1)(1993-11#1)(1995-11#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#1)
protein) family##3##2##(2008-7#1)(2012-12#1)(2013-8#1)
protein) in##2##2##(2008-11#1)(2008-4#1)
protein) was##2##2##(1996-2#1)(2008-7#1)
protein) were##3##2##(1994-8#1)(1997-7#1)(2010-6#1)
protein)##70##1##(1990-11#2)(1990-8#1)(1991-12#1)(1992-11#3)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#4)(1996-5#2)(1996-9#5)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#8)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
protein-##2##1##(1996-6#1)(2008-11#1)
protein-1 (MCP-1)##3##2##(1994-9#1)(2011-2#1)(2013-1#1)
protein-1 and##3##2##(1994-6#2)(2011-2#1)
protein-1 in##2##2##(2012-2#2)
protein-1##18##1##(1994-12#2)(1994-6#5)(1994-9#1)(1995-8#1)(2008-5#1)(2009-7#1)(2011-2#3)(2012-2#2)(2013-1#2)
protein-1)##2##1##(1991-3#1)(2008-9#1)
protein-2##13##1##(1991-1#1)(1993-2#2)(1994-11#4)(2008-7#1)(2008-8#2)(2011-2#2)(2013-8#1)
protein-3##3##1##(2008-11#1)(2010-6#1)(2011-1#1)
protein-7##4##1##(2011-2#2)(2012-2#2)
protein-89##2##1##(2010-8#2)
protein-DNA complex##4##2##(1995-2#2)(1995-5#1)(1997-7#1)
protein-DNA complexes##3##2##(1993-11#2)(2008-10#1)
protein-DNA interaction##2##2##(2008-7#1)(2008-8#1)
protein-DNA interactions##6##2##(1990-7#1)(1991-11#1)(1992-8#1)(2008-2#1)(2008-4#1)(2008-8#1)
protein-DNA##19##1##(1990-7#1)(1991-11#1)(1992-8#1)(1993-11#3)(1995-2#2)(1995-5#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)
protein-RNA##2##1##(2008-2#1)(2011-3#1)
protein-based##2##1##(2008-4#1)(2010-4#1)
protein-binding##5##1##(1993-6#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
protein-bound toxins##2##2##(2008-5#2)
protein-bound urinary##2##2##(1991-12#2)
protein-bound##17##1##(1990-3#2)(1991-12#4)(1991-9#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-9#1)(2010-6#1)
protein-calorie malnutrition##2##2##(1990-9#1)(2007-12#1)
protein-coated##2##1##(1990-12#1)(2008-10#1)
protein-coding and 47 RNA genes is##2##6##(2011-2#2)
protein-coding and 52 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 52 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 52 RNA genes is##5##6##(2011-2#5)
protein-coding and 53 RNA genes is##2##6##(2011-2#2)
protein-coding and 55 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 55 RNA genes is##4##6##(2011-2#4)
protein-coding and 56 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 57 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 58 RNA genes is##2##6##(2011-2#2)
protein-coding and 60 RNA genes##2##5##(2011-2#2)
protein-coding and 63 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 63 RNA genes is##3##6##(2011-2#3)
protein-coding and##42##2##(2011-2#41)(2012-3#1)
protein-coding gene-containing##2##2##(2008-7#2)
protein-coding genes and##3##3##(2011-2#2)(2012-12#1)
protein-coding genes in wild-type##2##4##(2008-7#2)
protein-coding genes in##3##3##(2008-7#2)(2011-2#1)
protein-coding genes##13##2##(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#4)(2011-2#5)(2012-12#1)
protein-coding regions##4##2##(1996-6#3)(2010-9#1)
protein-coding##66##1##(1996-6#4)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-7#6)(2010-9#1)(2011-2#47)(2012-12#1)(2012-3#1)
protein-coupled##23##1##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#4)(1995-6#1)(1997-2#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)
protein-dependent##4##1##(1993-8#1)(1995-6#1)(2008-4#1)(2008-8#1)
protein-dye##2##1##(1996-12#1)(2008-10#1)
protein-encoding gene##2##2##(1993-12#1)(1994-12#1)
protein-encoding genes##5##2##(1991-6#2)(1993-12#1)(1993-9#1)(1994-12#1)
protein-encoding##9##1##(1991-6#2)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#2)(2008-10#1)
protein-free and##2##2##(2008-11#2)
protein-free cell culture media##2##4##(2008-11#1)(2011-2#1)
protein-free conditions##4##2##(1993-9#3)(2008-11#1)
protein-free culture##5##2##(1993-9#1)(2008-11#4)
protein-free diet##3##2##(1993-12#3)
protein-free media##6##2##(2008-11#6)
protein-free medium and to be##2##5##(2008-11#2)
protein-free medium in##3##3##(2008-11#2)(2011-2#1)
protein-free medium##16##2##(2008-11#15)(2011-2#1)
protein-free##43##1##(1991-5#1)(1993-12#3)(1993-9#4)(2008-11#32)(2011-2#3)
protein-freeculture##3##1##(2008-11#3)
protein-ligand interactions##2##2##(1997-2#1)(2008-4#1)
protein-ligand##6##1##(1995-11#1)(1997-2#2)(2008-4#1)(2008-7#1)(2011-3#1)
protein-lipid interactions##2##2##(2008-9#1)(2011-3#1)
protein-mediated activation of##2##3##(1992-6#1)(1995-11#1)
protein-mediated##6##1##(1992-6#3)(1995-11#1)(2008-10#1)(2011-2#1)
protein-profiling technologies##2##2##(2008-4#2)
protein-profiling##4##1##(2008-4#4)
protein-protein and peptide-protein interactions##2##4##(1992-9#2)
protein-protein and protein-DNA##3##3##(2008-2#2)(2008-7#1)
protein-protein and##6##2##(1992-9#2)(1993-9#1)(2008-2#2)(2008-7#1)
protein-protein interaction data##4##3##(2008-4#4)
protein-protein interaction networks##3##3##(2008-4#3)
protein-protein interaction##22##2##(1993-6#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-4#10)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#2)(2012-2#2)(2013-1#1)
protein-protein interactions and##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
protein-protein interactions are##2##3##(2008-6#1)(2008-7#1)
protein-protein interactions by##4##3##(2008-4#2)(2008-7#2)
protein-protein interactions in living cells by##2##6##(2008-1#1)(2008-4#1)
protein-protein interactions in##5##3##(1993-9#1)(2008-1#1)(2008-4#3)
protein-protein interactions of##2##3##(2008-10#1)(2008-4#1)
protein-protein interactions with##2##3##(2008-1#1)(2008-9#1)
protein-protein interactions##56##2##(1992-3#1)(1992-8#1)(1993-9#1)(1995-6#1)(1995-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#20)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
protein-protein interfaces##2##2##(2008-4#2)
protein-protein##95##1##(1992-3#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#4)(2008-4#34)(2008-6#1)(2008-7#13)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
protein-sorting##2##1##(1993-3#1)(2008-11#1)
protein-specific##2##1##(1995-5#1)(2013-8#1)
protein-sugar binding##2##2##(2008-10#2)
protein-tyrosine kinase##5##2##(1992-6#2)(1992-8#2)(1995-6#1)
protein-tyrosine phosphorylation##4##2##(1992-8#3)(1993-11#1)
protein-tyrosine##11##1##(1992-6#2)(1992-8#6)(1993-11#1)(1995-6#1)(1996-2#1)
protein/peptide##2##1##(2008-4#1)(2011-2#1)
protein1##2##1##(2010-11#1)(2013-8#1)
proteinaceous binding media##4##3##(2008-10#4)
proteinaceous components##2##2##(2008-5#2)
proteinaceous compounds##2##2##(2008-10#2)
proteinaceous metabolites##2##2##(2008-10#2)
proteinaceous##30##1##(1991-11#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)
proteinase K treatment##2##3##(1996-12#1)(2008-10#1)
proteinase K##11##2##(1990-5#1)(1996-12#2)(2008-10#5)(2008-4#1)(2012-3#2)
proteinase cDNA fragment##2##3##(1997-6#2)
proteinase cDNA##3##2##(1997-6#3)
proteinase concentrations##2##2##(1990-5#2)
proteinase from##3##2##(1990-8#1)(1995-6#1)(2008-10#1)
proteinase inhibitor##7##2##(1991-9#2)(1992-2#1)(1995-2#2)(1995-6#1)(2008-11#1)
proteinase inhibitors and##2##3##(1990-12#2)
proteinase inhibitors##9##2##(1990-12#2)(1992-8#1)(1994-3#1)(1996-12#2)(1996-2#2)(2008-5#1)
proteinase of##2##2##(1990-5#1)(1992-9#1)
proteinase##79##1##(1990-12#4)(1990-2#1)(1990-5#11)(1990-8#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#6)(1993-3#3)(1994-12#2)(1994-3#1)(1994-5#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#4)(1996-2#2)(1997-6#5)(2008-10#10)(2008-11#5)(2008-4#1)(2008-5#2)(2012-3#3)
proteinase-inhibitory##2##1##(1995-6#2)
proteinases and their##2##3##(2008-4#1)(2012-12#1)
proteinases and##4##2##(1997-6#1)(2008-11#1)(2008-4#1)(2012-12#1)
proteinases can##3##2##(1993-11#1)(2012-12#2)
proteinases in the##2##3##(1993-11#1)(1996-2#1)
proteinases in##5##2##(1993-11#1)(1996-2#2)(2007-11#1)(2012-3#1)
proteinases is##2##2##(1990-8#1)(1992-6#1)
proteinases was##3##2##(1990-5#2)(1996-12#1)
proteinases##48##1##(1990-12#2)(1990-5#7)(1990-7#1)(1990-8#2)(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#7)(1993-3#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2012-12#4)(2012-3#2)
proteinogenic amino acids##3##3##(2006-12#3)
proteinogenic##5##1##(1992-11#1)(2006-12#4)
proteinosis##5##1##(2007-2#1)(2007-8#2)(2010-7#2)
proteins (30##2##2##(2008-10#1)(2011-2#1)
proteins (43##2##2##(2008-11#2)
proteins (G proteins)##2##3##(1993-6#1)(1997-7#1)
proteins (G##3##2##(1993-6#1)(1995-8#1)(1997-7#1)
proteins (HSP)##2##2##(1994-11#2)
proteins (HSPs)##3##2##(1991-9#1)(2008-4#1)(2008-7#1)
proteins (IGFBPs)##4##2##(1993-3#1)(2008-4#2)(2008-5#1)
proteins (MAPs)##2##2##(2009-8#1)(2011-2#1)
proteins (MPs)##2##2##(1997-3#1)(2008-7#1)
proteins (P##2##2##(1996-12#1)(2008-10#1)
proteins (PGIPs)##2##2##(2008-10#1)(2011-10#1)
proteins (RIPs)##4##2##(1990-11#1)(1990-12#1)(2008-10#2)
proteins (e##5##2##(2008-11#2)(2008-2#1)(2012-1#1)(2012-2#1)
proteins (including##2##2##(1994-8#2)
proteins (such as##2##3##(2008-10#1)(2009-10#1)
proteins 1 and 2##2##4##(1994-9#1)(2008-10#1)
proteins 1##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
proteins across and##2##3##(1992-12#1)(2012-1#1)
proteins across##3##2##(1991-5#1)(1992-12#1)(2012-1#1)
proteins act##2##2##(2012-12#1)(2012-3#1)
proteins also##5##2##(1992-5#1)(1994-9#1)(1997-3#1)(2009-6#1)(2010-12#1)
proteins and DNA##3##3##(1996-9#1)(2008-4#1)(2008-5#1)
proteins and are##2##3##(1990-5#1)(2011-2#1)
proteins and as##2##3##(1990-7#1)(2008-10#1)
proteins and by##2##3##(1992-8#1)(2008-10#1)
proteins and endogenous##2##3##(2008-10#2)
proteins and formation and##2##4##(2008-10#1)(2011-2#1)
proteins and found##2##3##(2008-5#1)(2009-8#1)
proteins and functions##2##3##(2008-9#1)(2013-1#1)
proteins and identified##2##3##(2008-10#1)(2008-7#1)
proteins and in##3##3##(2008-7#1)(2009-6#1)(2009-8#1)
proteins and its function##2##4##(2008-9#1)(2011-3#1)
proteins and its modulation by##2##5##(1990-3#2)
proteins and its##6##3##(1990-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2011-3#1)
proteins and lipids##10##3##(1990-2#1)(1993-11#1)(1995-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2012-2#1)
proteins and membrane##2##3##(2008-7#1)(2008-8#1)
proteins and nucleic acids##4##4##(1995-2#1)(2007-11#1)(2008-6#1)(2012-3#1)
proteins and of##2##3##(1990-7#1)(1991-12#1)
proteins and peptides##7##3##(1995-2#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-11#1)(2011-3#1)
proteins and play##2##3##(1992-11#1)(1997-8#1)
proteins and small##2##3##(2008-10#1)(2012-2#1)
proteins and the##15##3##(1990-7#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
proteins and their##5##3##(1990-5#1)(1993-9#1)(1995-2#1)(2008-4#1)(2012-1#1)
proteins and transcription factors##2##4##(2008-10#1)(2008-8#1)
proteins and various##2##3##(1994-12#1)(1996-12#1)
proteins and##203##2##(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#2)(1996-12#3)(1996-2#1)(1996-5#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#24)(2008-11#11)(2008-2#3)(2008-4#11)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2011-2#5)(2011-3#3)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#4)
proteins and/or##2##2##(1997-3#1)(2013-1#1)
proteins appear to##2##3##(1994-11#1)(2008-4#1)
proteins appear##3##2##(1994-11#1)(2008-4#1)(2009-9#1)
proteins are a##2##3##(1993-3#1)(2010-3#1)
proteins are also##5##3##(1994-6#1)(2008-4#2)(2012-12#2)
proteins are associated with##2##4##(1997-3#1)(2011-2#1)
proteins are essential##2##3##(1992-5#1)(2012-12#1)
proteins are expressed##2##3##(2008-1#1)(2008-7#1)
proteins are found##2##3##(1991-9#1)(1994-6#1)
proteins are glycosylated##2##3##(1992-6#1)(2010-12#1)
proteins are highly##3##3##(1993-2#1)(2008-4#1)(2012-2#1)
proteins are important##2##3##(1992-12#1)(2009-2#1)
proteins are involved in the##2##5##(1992-12#1)(2008-9#1)
proteins are involved in##4##4##(1992-12#1)(1996-12#1)(2008-7#1)(2008-9#1)
proteins are involved##5##3##(1992-12#1)(1996-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
proteins are known to##3##4##(1995-8#1)(2010-11#1)(2013-1#1)
proteins are not##4##3##(1994-11#1)(1997-7#1)(2008-4#1)(2009-8#1)
proteins are often##2##3##(2008-2#1)(2008-8#1)
proteins are phosphorylated##2##3##(1994-11#1)(1997-2#1)
proteins are present in##3##4##(1992-8#1)(1993-11#1)(2013-1#1)
proteins are present##4##3##(1992-8#1)(1993-11#1)(2008-4#1)(2013-1#1)
proteins are required for the##2##5##(1993-12#1)(2012-3#1)
proteins are separated##3##3##(2008-10#1)(2008-4#2)
proteins are shed##2##3##(2009-9#2)
proteins are synthesized##3##3##(1994-5#1)(1996-9#1)(2008-1#1)
proteins are well##2##3##(2008-1#1)(2008-4#1)
proteins are##124##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-10#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#18)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
proteins as well##2##3##(2007-12#1)(2008-4#1)
proteins as##19##2##(1990-5#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#1)
proteins associated with##7##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)
proteins at the apical##2##4##(2012-2#2)
proteins at the##10##3##(1993-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
proteins at##24##2##(1990-12#1)(1990-5#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2009-9#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
proteins based on the interaction##2##5##(2008-10#2)
proteins based on the##4##4##(2008-10#3)(2008-7#1)
proteins based on##6##3##(2008-10#3)(2008-7#1)(2011-3#1)(2012-2#1)
proteins belonging to the##3##4##(1992-6#1)(1997-6#1)(2009-12#1)
proteins belonging to##5##3##(1992-6#1)(1995-12#1)(1997-6#1)(2008-7#1)(2009-12#1)
proteins between##2##2##(2008-4#1)(2009-5#1)
proteins bind##2##2##(1996-12#1)(2008-9#1)
proteins binding to the##2##4##(1992-11#1)(1996-12#1)
proteins both##2##2##(2008-10#1)(2008-7#1)
proteins bound to the##2##4##(1993-8#1)(2012-2#1)
proteins bound to##3##3##(1993-8#1)(1994-12#1)(2012-2#1)
proteins but##2##2##(2008-11#1)(2008-5#1)
proteins by SDS-PAGE##2##3##(1993-2#1)(1993-8#1)
proteins by a##3##3##(1995-11#1)(1996-12#1)(2008-11#1)
proteins by electrophoresis##2##3##(2009-12#1)(2013-8#1)
proteins by high##2##3##(1995-8#1)(2008-8#1)
proteins by the##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
proteins by##51##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#3)(1997-2#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#3)(2008-4#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#1)
proteins can be##20##3##(1990-11#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#6)(2009-5#1)(2012-2#1)
proteins can##28##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#7)(2009-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
proteins consist of##2##3##(1992-6#1)(2009-7#1)
proteins contain a##2##3##(1993-6#1)(1995-6#1)
proteins contain##4##2##(1993-6#1)(1995-6#1)(1997-7#1)(2013-1#1)
proteins contained##2##2##(1990-11#1)(2011-1#1)
proteins containing##13##2##(1992-12#1)(1995-2#2)(1996-2#1)(2008-10#1)(2008-4#3)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
proteins content##4##2##(2008-10#2)(2008-12#2)
proteins contribute to the##2##4##(2008-6#1)(2013-1#1)
proteins could be##4##3##(1994-11#1)(1995-8#1)(2008-6#1)(2009-2#1)
proteins could##7##2##(1993-8#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-9#1)(2008-6#1)(2009-2#1)
proteins directly from##2##3##(2008-4#2)
proteins directly##4##2##(2008-4#3)(2008-9#1)
proteins do not##2##3##(1997-3#1)(2013-1#1)
proteins during##5##2##(2006-6#1)(2008-10#1)(2010-5#1)(2012-1#1)(2012-12#1)
proteins encoded by the##2##4##(1990-8#1)(2008-10#1)
proteins encoded by##8##3##(1990-8#1)(1993-6#1)(1994-12#1)(2008-10#3)(2009-8#1)(2012-3#1)
proteins encoded in the##3##4##(1995-8#1)(2008-4#2)
proteins encoded##11##2##(1990-8#1)(1993-6#1)(1994-12#1)(1995-8#1)(2008-10#3)(2008-4#2)(2009-8#1)(2012-3#1)
proteins examined##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
proteins exhibit##2##2##(1995-2#1)(2008-10#1)
proteins exhibited##3##2##(1990-7#1)(2008-1#1)(2008-10#1)
proteins exhibiting##2##2##(1992-8#1)(2008-11#1)
proteins expressed by##2##3##(1991-5#1)(2009-3#1)
proteins expressed in E##2##4##(1992-8#1)(2008-4#1)
proteins expressed##5##2##(1991-5#1)(1992-8#1)(2008-4#1)(2009-3#1)(2011-2#1)
proteins extracted from the##2##4##(1994-5#1)(1996-8#1)
proteins extracted from##4##3##(1994-5#1)(1996-8#1)(2008-10#1)(2008-9#1)
proteins extracted##6##2##(1990-2#1)(1994-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-9#1)
proteins following##2##2##(1994-9#1)(1996-9#1)
proteins for diagnosis##2##3##(2008-1#2)
proteins for the##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
proteins for use in##2##4##(1995-5#1)(2008-2#1)
proteins for which##2##3##(1992-8#1)(2008-4#1)
proteins for##35##2##(1992-11#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
proteins form##5##2##(2008-11#1)(2008-7#2)(2011-2#2)
proteins found in##2##3##(1995-2#1)(1997-3#1)
proteins found##3##2##(1995-2#1)(1997-3#1)(2008-1#1)
proteins from E##2##3##(2008-4#2)
proteins from Escherichia coli##2##4##(2008-4#2)
proteins from a##3##3##(1990-12#1)(1995-8#1)(2008-1#1)
proteins from bovine##2##3##(1993-8#1)(1994-9#1)
proteins from different##2##3##(1993-6#1)(2008-9#1)
proteins from each of##2##4##(1995-5#1)(2008-10#1)
proteins from maize##2##3##(1995-2#1)(2008-10#1)
proteins from mammalian##2##3##(1993-6#1)(1995-2#1)
proteins from other##4##3##(1991-12#1)(1992-8#1)(1995-9#1)(1997-2#1)
proteins from the##17##3##(1991-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2009-10#2)(2009-7#1)
proteins from whole-cell extracts##2##4##(2008-4#2)
proteins from whole-cell lysates##2##4##(2008-4#2)
proteins from whole-cell##4##3##(2008-4#4)
proteins from##80##2##(1990-12#1)(1990-7#1)(1991-12#2)(1991-8#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#11)(2008-5#1)(2008-6#2)(2008-9#3)(2009-10#2)(2009-7#2)(2010-12#1)(2010-4#2)(2011-2#1)(2011-3#1)(2013-1#1)
proteins function##2##2##(1994-11#1)(2012-12#1)
proteins fused to##2##3##(2008-4#2)
proteins had##2##2##(1991-12#1)(2008-10#1)
proteins has been developed##2##4##(2008-10#2)
proteins has been##9##3##(1996-11#1)(1997-6#3)(2008-10#2)(2008-8#1)(2009-3#1)(2013-1#1)
proteins has##14##2##(1996-11#1)(1997-6#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
proteins have a##2##3##(1991-6#1)(1995-11#1)
proteins have been found to##2##5##(1996-2#1)(2011-2#1)
proteins have been identified##3##4##(1992-12#1)(2008-7#1)(2011-2#1)
proteins have been shown to be##2##6##(1992-3#1)(2009-8#1)
proteins have been##15##3##(1992-12#1)(1992-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#2)(2009-8#1)(2011-2#2)
proteins have the same##2##4##(2008-7#1)(2009-10#1)
proteins have the##3##3##(2008-7#2)(2009-10#1)
proteins have##31##2##(1990-11#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
proteins identified##4##2##(1991-12#1)(1997-4#1)(2008-10#1)(2011-3#1)
proteins immunoreactivity##2##2##(1995-8#2)
proteins implicated in##3##3##(1995-11#1)(1996-12#1)(2010-2#1)
proteins in Arabidopsis##2##3##(2009-8#1)(2011-10#1)
proteins in BCG##2##3##(1995-5#2)
proteins in E##2##3##(1991-12#1)(1995-11#1)
proteins in Escherichia coli##6##4##(1990-11#1)(1991-12#1)(1991-5#1)(1994-12#1)(1994-5#1)(2008-4#1)
proteins in a single##2##4##(2008-4#1)(2010-12#1)
proteins in a##9##3##(1992-12#1)(1992-3#1)(1997-4#1)(2006-12#1)(2008-12#1)(2008-4#3)(2010-12#1)
proteins in an##2##3##(1990-12#1)(1997-6#1)
proteins in animal##2##3##(1993-2#1)(2009-8#1)
proteins in cancer##4##3##(2011-2#1)(2012-12#3)
proteins in cells##3##3##(2008-1#1)(2008-9#1)(2010-10#1)
proteins in complex mixtures##2##4##(2008-1#1)(2008-4#1)
proteins in complex samples##2##4##(2008-4#1)(2010-11#1)
proteins in complex##5##3##(2008-1#1)(2008-4#3)(2010-11#1)
proteins in gels##3##3##(2008-2#1)(2008-4#2)
proteins in human serum##3##4##(2008-10#2)(2008-4#1)
proteins in human##9##3##(1994-7#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
proteins in infected##2##3##(2008-10#1)(2009-8#1)
proteins in live##2##3##(2008-1#1)(2008-3#1)
proteins in melanogenesis##2##3##(1996-9#2)
proteins in mouse peritoneal macrophages##2##5##(1993-6#2)
proteins in other##2##3##(1992-9#1)(2008-8#1)
proteins in rat skeletal muscle##2##5##(2008-8#2)
proteins in rat##3##3##(1996-2#1)(2008-8#2)
proteins in response to##2##4##(1993-9#1)(1997-2#1)
proteins in solution##4##3##(2008-10#1)(2008-4#3)
proteins in the cells##2##4##(1990-2#1)(2008-8#1)
proteins in the control of##2##5##(1994-11#1)(1996-5#1)
proteins in the development of##2##5##(1995-6#1)(2008-11#1)
proteins in the presence of##3##5##(1995-5#1)(2008-10#2)
proteins in the##56##3##(1990-11#2)(1990-12#1)(1990-2#2)(1991-2#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-3#1)(2012-6#1)(2013-8#1)
proteins in their##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
proteins in these##3##3##(1997-2#1)(2009-7#1)(2010-11#1)
proteins in tissue##2##3##(1996-12#1)(2012-12#1)
proteins in##277##2##(1990-11#6)(1990-12#3)(1990-2#2)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#4)(1992-12#3)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-6#6)(1993-9#2)(1994-11#7)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(1997-6#2)(2006-12#1)(2007-12#1)(2008-1#6)(2008-10#28)(2008-11#10)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#18)(2008-5#2)(2008-6#4)(2008-7#13)(2008-8#16)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#7)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#2)(2010-6#1)(2011-10#1)(2011-2#7)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2012-6#1)(2013-7#1)(2013-8#4)
proteins include##3##2##(2008-4#1)(2008-6#2)
proteins including##12##2##(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1997-2#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
proteins increased##2##2##(1990-12#1)(2011-2#1)
proteins indicate that##2##3##(1993-9#1)(1995-3#1)
proteins indicated that##2##3##(2008-10#2)
proteins induce##2##2##(2008-10#1)(2008-9#1)
proteins induced by##2##3##(1995-6#1)(2011-2#1)
proteins interact##3##2##(1993-8#1)(2008-4#1)(2011-1#1)
proteins interacting with##3##3##(1997-6#1)(2008-7#1)(2008-8#1)
proteins into the##6##3##(1990-12#1)(1991-2#1)(1992-12#1)(1994-11#1)(2012-1#2)
proteins into##15##2##(1990-12#1)(1990-5#1)(1991-2#2)(1992-12#1)(1994-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
proteins involved in a##2##4##(2008-4#1)(2008-7#1)
proteins involved in cell##2##4##(2011-3#1)(2013-7#1)
proteins involved in the regulation of##2##6##(1996-2#1)(2008-4#1)
proteins involved in the##6##4##(1994-8#1)(1996-2#1)(2008-4#2)(2008-7#1)(2012-2#1)
proteins involved in##28##3##(1991-2#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#4)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
proteins involved##29##2##(1991-2#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#5)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
proteins is a##5##3##(1992-9#1)(2008-1#1)(2008-11#1)(2008-4#2)
proteins is described##2##3##(2008-4#1)(2008-7#1)
proteins is presented##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
proteins is##48##2##(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-4#7)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2012-3#1)
proteins isolated from##3##3##(1992-6#1)(1996-5#1)(1997-2#1)
proteins isolated##5##2##(1992-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-9#1)
proteins known as##4##3##(1993-9#1)(1995-2#1)(2008-5#1)(2008-9#1)
proteins known to##2##3##(2012-7#1)(2013-1#1)
proteins known##6##2##(1993-9#1)(1995-2#1)(2008-5#1)(2008-9#1)(2012-7#1)(2013-1#1)
proteins localize##2##2##(1995-2#1)(2011-2#1)
proteins localized to##2##3##(1997-7#1)(2008-7#1)
proteins localized##5##2##(1994-8#1)(1997-7#1)(2008-7#2)(2008-9#1)
proteins made by##2##3##(2008-1#1)(2010-5#1)
proteins may be involved in##2##5##(1997-7#1)(2008-8#1)
proteins may be##12##3##(1990-8#1)(1992-12#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2011-2#1)
proteins may play##4##3##(1994-8#1)(1996-12#1)(2008-8#2)
proteins may##23##2##(1990-3#1)(1990-8#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-2#1)(2010-11#2)(2011-2#1)
proteins mediate##2##2##(2008-10#1)(2009-10#1)
proteins might be##2##3##(1994-5#1)(2008-9#1)
proteins might##5##2##(1994-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)
proteins migrate##2##2##(2008-2#1)(2008-4#1)
proteins modified by O-GlcNAc##2##4##(2008-11#1)(2008-2#1)
proteins modified by##6##3##(2008-11#1)(2008-2#2)(2008-4#1)(2009-6#1)(2010-12#1)
proteins must##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
proteins named##2##2##(2008-8#1)(2011-2#1)
proteins obtained##3##2##(1990-5#1)(1991-5#1)(1994-8#1)
proteins of M##3##3##(1995-2#2)(2008-7#1)
proteins of cyclins##2##3##(1997-6#2)
proteins of human##2##3##(1992-3#1)(1992-8#1)
proteins of interest##8##3##(1994-5#1)(2008-4#4)(2008-7#1)(2008-9#1)(2012-2#1)
proteins of known##2##3##(1994-9#1)(2008-4#1)
proteins of other##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
proteins of rat##3##3##(1991-8#1)(1994-6#1)(1995-12#1)
proteins of the Mre11 complex in irradiated##2##7##(2011-2#2)
proteins of the Mre11 complex##3##5##(2011-2#3)
proteins of the cell surface##2##5##(2009-9#2)
proteins of the##21##3##(1991-5#1)(1992-12#1)(1992-6#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#2)(2011-1#1)(2011-2#3)(2013-1#1)
proteins of these##2##3##(1994-12#1)(2008-10#1)
proteins of unknown function##2##4##(2008-10#1)(2008-7#1)
proteins of##107##2##(1990-11#1)(1990-12#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#21)(2008-12#3)(2008-4#5)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#5)(2009-12#1)(2009-9#2)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#1)
proteins on a##2##3##(2008-2#1)(2008-4#1)
proteins on the basis of##3##5##(1995-2#1)(2008-10#1)(2013-8#1)
proteins on the surface of##2##5##(1995-2#2)
proteins on the##10##3##(1994-12#1)(1995-12#1)(1995-2#3)(2008-10#2)(2008-11#1)(2012-5#1)(2013-8#1)
proteins on##24##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-12#2)(1995-2#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2012-5#1)(2013-1#1)(2013-8#1)
proteins only##3##2##(1992-9#1)(1997-7#1)(2008-10#1)
proteins onto##2##2##(2012-2#1)(2013-8#1)
proteins or DNA##3##3##(1996-2#1)(2008-12#1)(2008-4#1)
proteins or peptides##4##3##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)
proteins or##18##2##(1990-12#1)(1995-5#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)
proteins play a central role in##2##6##(2008-7#1)(2009-7#1)
proteins play a##4##3##(2008-7#2)(2009-7#1)(2011-2#1)
proteins play##9##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)
proteins plays##2##2##(1994-12#1)(2008-1#1)
proteins possessed##2##2##(1994-12#1)(2008-9#1)
proteins present in the##6##4##(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#2)
proteins present in##13##3##(1991-5#1)(1993-8#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
proteins present##14##2##(1991-5#1)(1993-8#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)
proteins prior to##2##3##(1996-1#1)(2008-10#1)
proteins produced by##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
proteins produced##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
proteins ranged from##2##3##(2008-10#2)
proteins recognized by##2##3##(1992-3#1)(2008-7#1)
proteins recognized##3##2##(1992-3#1)(1995-6#1)(2008-7#1)
proteins regulate the##2##3##(2008-11#1)(2008-4#1)
proteins related to##4##3##(2008-10#1)(2009-6#1)(2010-11#1)(2010-2#1)
proteins released##3##2##(1991-2#1)(1992-3#1)(2010-3#1)
proteins remains##2##2##(1997-7#1)(2009-7#1)
proteins required for##4##3##(1993-9#1)(2008-4#1)(2009-6#1)(2011-2#1)
proteins responsible for a##2##4##(1992-3#1)(2008-10#1)
proteins responsible for##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
proteins results in##2##3##(2008-10#1)(2008-9#1)
proteins revealed the##2##3##(2008-10#1)(2008-11#1)
proteins revealed##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
proteins secreted by##2##3##(1997-1#1)(2008-10#1)
proteins share##4##2##(1991-5#1)(1994-12#2)(1995-5#1)
proteins shared by##2##3##(2008-9#2)
proteins should be##2##3##(1993-8#1)(2008-10#1)
proteins show##3##2##(1994-11#1)(2009-10#1)(2012-3#1)
proteins showed a##2##3##(1995-2#1)(2010-12#1)
proteins showed the##2##3##(1994-8#1)(2012-12#1)
proteins showed##7##2##(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(2010-12#1)(2010-3#1)(2012-12#1)
proteins so##2##2##(1990-7#1)(1992-7#1)
proteins specifically##4##2##(1997-7#1)(2008-10#1)(2009-5#1)(2012-2#1)
proteins such as the##2##4##(2008-1#1)(2011-2#1)
proteins such as##13##3##(1993-8#1)(1994-5#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
proteins suggests##2##2##(1993-3#1)(1994-8#1)
proteins synthesized##4##2##(1995-9#1)(2008-10#1)(2008-6#1)(2010-12#1)
proteins that are associated with##2##5##(1992-3#1)(2008-11#1)
proteins that are similar to##2##5##(1993-12#1)(1994-9#1)
proteins that are##23##3##(1991-2#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#2)(2008-9#1)(2010-11#2)(2010-12#1)(2011-3#1)(2013-1#1)
proteins that bind to##3##4##(1993-6#1)(1994-8#1)(2013-8#1)
proteins that bind##4##3##(1993-6#1)(1994-8#2)(2013-8#1)
proteins that contain a##2##4##(2008-9#1)(2010-10#1)
proteins that contain##3##3##(2008-4#1)(2008-9#1)(2010-10#1)
proteins that could##3##3##(2008-7#1)(2010-12#1)(2010-3#1)
proteins that have been##4##4##(1994-6#1)(1995-2#1)(2008-4#1)(2010-11#1)
proteins that have##8##3##(1994-6#1)(1995-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-2#1)
proteins that induce##2##3##(2008-10#1)(2008-4#1)
proteins that interact with##2##4##(2008-7#1)(2008-8#1)
proteins that interact##3##3##(1992-8#1)(2008-7#1)(2008-8#1)
proteins that lack##2##3##(1992-8#1)(2009-8#1)
proteins that play##2##3##(1995-8#1)(2008-11#1)
proteins that produce##2##3##(2008-10#1)(2008-4#1)
proteins that##93##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-6#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#5)(2010-3#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
proteins through##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2013-7#1)
proteins to a##2##3##(2008-1#1)(2012-2#1)
proteins to form##2##3##(1995-5#1)(2008-7#1)
proteins to give##2##3##(1992-3#1)(2010-7#1)
proteins to specific##3##3##(2008-4#1)(2009-5#1)(2012-7#1)
proteins to the cell##2##4##(2008-1#1)(2008-9#1)
proteins to the##14##3##(1991-2#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-12#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)
proteins to##46##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-4#3)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#3)
proteins under the##2##3##(1995-5#1)(2008-11#1)
proteins under##6##2##(1995-5#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
proteins undergo##2##2##(2008-10#1)(2010-9#1)
proteins unique to a given##2##5##(2008-9#2)
proteins using a##2##3##(1997-4#1)(2008-9#1)
proteins using the##5##3##(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#1)
proteins using##15##2##(1997-4#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
proteins usually##2##2##(1997-6#1)(2008-2#1)
proteins via##3##2##(2008-4#1)(2008-9#1)(2010-7#1)
proteins was estimated to be##2##5##(1992-12#1)(1997-6#1)
proteins was found##2##3##(1995-12#1)(2011-2#1)
proteins was investigated by##2##4##(1994-6#1)(1995-11#1)
proteins was observed##3##3##(1994-6#1)(1995-8#1)(2008-10#1)
proteins was##30##2##(1990-11#1)(1990-12#2)(1990-5#1)(1992-12#3)(1993-6#3)(1994-11#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
proteins were analyzed##4##3##(1997-2#1)(1997-4#1)(2008-4#1)(2010-12#1)
proteins were completely##2##3##(2008-10#1)(2008-12#1)
proteins were degraded##2##3##(1992-12#2)
proteins were detected in the##2##5##(1997-3#1)(2008-10#1)
proteins were detected in##4##4##(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)
proteins were detected##6##3##(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
proteins were determined##2##3##(1992-3#1)(1997-2#1)
proteins were downregulated##3##3##(2010-12#3)
proteins were examined##2##3##(1997-3#1)(2008-10#1)
proteins were excluded from##2##4##(1995-2#1)(2009-8#1)
proteins were expressed##2##3##(1997-4#1)(2009-3#1)
proteins were found to bind##2##5##(1990-11#1)(1995-6#1)
proteins were found to##3##4##(1990-11#1)(1995-6#1)(2009-10#1)
proteins were identified as##3##4##(1993-11#1)(2008-10#1)(2010-12#1)
proteins were identified##4##3##(1993-11#1)(2008-10#2)(2010-12#1)
proteins were isolated##3##3##(1990-11#1)(1996-12#1)(2008-9#1)
proteins were made##2##3##(1995-12#1)(1995-5#1)
proteins were not##2##3##(1997-4#1)(2008-10#1)
proteins were observed##3##3##(1992-2#1)(1997-2#1)(2008-11#1)
proteins were obtained##2##3##(2008-10#2)
proteins were present##2##3##(1994-12#1)(2007-12#1)
proteins were purified##2##3##(1994-8#1)(1997-4#1)
proteins were separated by##3##4##(1990-10#1)(2008-10#1)(2008-11#1)
proteins were separated##4##3##(1990-10#1)(1992-8#1)(2008-10#1)(2008-11#1)
proteins were studied##2##3##(2008-10#1)(2008-8#1)
proteins were synthesized##2##3##(1994-6#1)(2009-3#1)
proteins were tested##2##3##(2008-10#1)(2010-3#1)
proteins were the##2##3##(1991-6#1)(2010-11#1)
proteins were##107##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#20)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#3)(2009-8#2)(2010-11#3)(2010-12#7)(2010-3#2)(2011-2#1)(2011-3#1)
proteins where##2##2##(2008-4#1)(2012-2#1)
proteins which are##7##3##(1991-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(1996-9#1)(2008-8#1)
proteins which have been##2##4##(1992-3#1)(2013-7#1)
proteins which regulate##2##3##(1991-2#1)(2008-11#1)
proteins which##26##2##(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-6#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-11#2)(2008-5#1)(2008-8#2)(2010-12#1)(2013-7#1)
proteins while##2##2##(1992-12#1)(2009-5#1)
proteins whose##6##2##(1992-4#1)(1996-6#1)(2008-10#1)(2008-7#2)(2012-3#1)
proteins with a variety of##2##5##(2008-4#1)(2008-7#1)
proteins with a##7##3##(1993-8#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-9#1)
proteins with an##6##3##(1992-6#3)(1994-11#2)(2009-9#1)
proteins with different##2##3##(1990-5#1)(1994-6#1)
proteins with high##2##3##(2008-4#1)(2008-7#1)
proteins with important##2##3##(1994-6#1)(2008-7#1)
proteins with molecular masses of##2##5##(2008-10#1)(2008-8#1)
proteins with molecular masses##3##4##(2008-10#2)(2008-8#1)
proteins with molecular##5##3##(1990-11#2)(2008-10#2)(2008-8#1)
proteins with specific genomic##2##4##(2008-2#2)
proteins with specific##4##3##(2008-2#3)(2011-1#1)
proteins with the##4##3##(1995-6#1)(1996-3#1)(2008-11#1)(2008-4#1)
proteins with##79##2##(1990-11#3)(1990-5#1)(1991-10#1)(1992-6#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#3)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-4#2)(2008-10#14)(2008-11#2)(2008-2#4)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#2)(2009-1#1)(2009-3#1)(2009-8#1)(2009-9#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
proteins within a##3##3##(2008-2#1)(2008-4#1)(2010-11#1)
proteins within the##2##3##(2008-1#1)(2011-2#1)
proteins within##8##2##(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#1)
proteins without##2##2##(2008-2#1)(2008-9#1)
proteins work##2##2##(2008-4#1)(2009-8#1)
proteins##3180##1##(1990-10#2)(1990-11#28)(1990-12#21)(1990-2#10)(1990-3#3)(1990-5#27)(1990-7#11)(1990-8#12)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#22)(1991-2#22)(1991-4#1)(1991-5#23)(1991-6#10)(1991-7#1)(1991-8#2)(1991-9#16)(1992-10#2)(1992-11#8)(1992-12#36)(1992-2#2)(1992-3#21)(1992-4#2)(1992-5#8)(1992-6#21)(1992-7#2)(1992-8#30)(1992-9#6)(1993-1#2)(1993-11#29)(1993-12#15)(1993-2#12)(1993-3#19)(1993-5#2)(1993-6#44)(1993-8#24)(1993-9#15)(1994-11#38)(1994-12#39)(1994-2#7)(1994-3#3)(1994-5#29)(1994-6#27)(1994-7#1)(1994-8#29)(1994-9#22)(1995-11#16)(1995-12#21)(1995-2#69)(1995-3#12)(1995-5#24)(1995-6#35)(1995-8#29)(1995-9#7)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#35)(1996-2#16)(1996-3#4)(1996-5#18)(1996-6#3)(1996-8#6)(1996-9#10)(1997-1#6)(1997-2#40)(1997-3#27)(1997-4#40)(1997-5#1)(1997-6#20)(1997-7#29)(1997-8#3)(1997-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#15)(2007-2#1)(2007-7#2)(2008-1#65)(2008-10#340)(2008-11#130)(2008-12#17)(2008-2#57)(2008-3#6)(2008-4#235)(2008-5#55)(2008-6#29)(2008-7#167)(2008-8#76)(2008-9#92)(2009-1#1)(2009-10#29)(2009-11#2)(2009-12#16)(2009-2#12)(2009-3#11)(2009-4#5)(2009-5#22)(2009-6#16)(2009-7#15)(2009-8#48)(2009-9#23)(2010-10#8)(2010-11#23)(2010-12#45)(2010-2#7)(2010-3#9)(2010-4#15)(2010-5#11)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#4)(2011-1#20)(2011-10#2)(2011-2#105)(2011-3#13)(2011-9#1)(2012-1#22)(2012-12#45)(2012-2#53)(2012-3#24)(2012-5#1)(2012-6#3)(2012-7#2)(2013-1#36)(2013-7#9)(2013-8#30)
proteins'##3##1##(1995-5#1)(2008-7#1)(2008-9#1)
proteins) and##2##2##(2008-10#1)(2008-5#1)
proteins)##15##1##(1990-2#1)(1993-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#5)
proteins?##2##1##(2008-11#1)(2009-8#1)
proteinuria and leukocyturia##4##3##(1996-12#4)
proteinuria and##15##2##(1996-12#4)(2007-7#3)(2008-1#3)(2008-4#1)(2011-2#2)(2012-2#2)
proteinuria in##3##2##(1997-7#1)(2008-1#2)
proteinuria of##3##2##(2008-1#2)(2013-8#1)
proteinuria##58##1##(1990-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1996-12#4)(1996-6#1)(1997-7#1)(2007-7#9)(2008-1#24)(2008-4#1)(2008-7#1)(2008-8#3)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#2)
proteinuric##2##1##(2007-7#1)(2008-1#1)
proteobacteria##2##1##(2008-7#1)(2008-9#1)
proteoglycan core protein##2##3##(1991-5#1)(2008-11#1)
proteoglycan core##3##2##(1990-5#1)(1991-5#1)(2008-11#1)
proteoglycan##17##1##(1990-5#1)(1991-5#2)(1992-1#2)(1992-11#1)(1993-2#1)(1993-9#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-7#2)(2008-9#1)(2012-12#1)
proteoglycans (PG)##2##2##(1994-8#1)(1994-9#1)
proteoglycans and##4##2##(1991-9#2)(1995-6#1)(2007-11#1)
proteoglycans are##2##2##(1991-9#1)(2012-12#1)
proteoglycans##21##1##(1990-2#2)(1991-5#1)(1991-9#5)(1992-12#2)(1993-2#1)(1994-8#1)(1994-9#1)(1995-6#2)(2007-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)
proteolipid protein gene##2##3##(1996-12#1)(2008-7#1)
proteolipid protein##7##2##(1993-6#4)(1996-12#1)(2008-7#2)
proteolipid##9##1##(1993-6#4)(1996-12#1)(2008-7#2)(2009-6#2)
proteoliposomes with##2##2##(1995-8#2)
proteoliposomes##11##1##(1990-11#3)(1990-12#1)(1995-8#7)
proteolysis and##9##2##(1992-9#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-12#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
proteolysis by##3##2##(1990-12#1)(1992-11#1)(1993-8#1)
proteolysis can##2##2##(1995-6#1)(2008-5#1)
proteolysis in##5##2##(1991-5#1)(1995-11#1)(2011-2#1)(2013-1#2)
proteolysis of the##2##3##(1990-5#1)(2009-8#1)
proteolysis of##8##2##(1990-5#2)(1993-11#1)(1995-6#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-3#1)
proteolysis plays an important role##2##5##(1990-11#1)(2012-3#1)
proteolysis was##4##2##(1990-5#1)(1991-5#1)(1992-11#1)(1995-6#1)
proteolysis with##2##2##(1990-5#1)(1991-12#1)
proteolysis##77##1##(1990-11#1)(1990-12#3)(1990-5#5)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-8#3)(1994-11#1)(1995-11#2)(1995-2#1)(1995-6#5)(1995-8#1)(1997-2#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#3)(2009-7#1)(2009-8#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#7)(2013-1#5)
proteolytic activities##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
proteolytic activity against##3##3##(1992-8#1)(1994-5#1)(1994-6#1)
proteolytic activity and##2##3##(1993-12#1)(2013-1#1)
proteolytic activity of##3##3##(1992-11#1)(2008-10#1)(2010-12#1)
proteolytic activity to##2##3##(1991-12#1)(2008-11#1)
proteolytic activity was##2##3##(1992-9#1)(2010-4#1)
proteolytic activity##28##2##(1990-2#4)(1991-12#2)(1991-2#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-5#1)(1994-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#2)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
proteolytic and##3##2##(1997-4#1)(2008-6#1)(2009-8#1)
proteolytic cleavage of##4##3##(1990-5#1)(1991-9#1)(1994-11#1)(1994-12#1)
proteolytic cleavage##9##2##(1990-5#1)(1991-9#1)(1994-11#3)(1994-12#2)(1996-5#1)(2008-10#1)
proteolytic degradation of##2##3##(2008-11#1)(2011-2#1)
proteolytic degradation##7##2##(1992-3#1)(1997-4#1)(2008-11#3)(2008-4#1)(2011-2#1)
proteolytic digestion of##2##3##(1992-3#1)(2008-6#1)
proteolytic digestion##5##2##(1992-3#1)(1992-6#1)(1993-8#1)(1994-8#1)(2008-6#1)
proteolytic enzyme##4##2##(1990-11#1)(1990-5#1)(2008-10#1)(2008-9#1)
proteolytic enzymes and##2##3##(2006-6#1)(2010-2#1)
proteolytic enzymes##17##2##(1990-11#1)(1991-5#1)(1994-11#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-1#1)
proteolytic fragments of##2##3##(1992-12#1)(1992-3#1)
proteolytic fragments##5##2##(1992-12#1)(1992-3#1)(1992-6#1)(2008-1#1)(2008-8#1)
proteolytic genes##2##2##(2013-1#2)
proteolytic pathway##4##2##(1992-12#1)(1994-11#1)(1994-9#1)(1995-6#1)
proteolytic patterns##2##2##(1991-2#1)(1991-9#1)
proteolytic processing in##2##3##(1992-8#1)(2008-11#1)
proteolytic processing of##7##3##(1990-8#1)(1991-9#2)(1992-12#1)(2008-11#1)(2008-6#2)
proteolytic processing##14##2##(1990-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-8#1)(1993-6#1)(1995-8#1)(2007-12#2)(2008-11#2)(2008-6#2)
proteolytic##129##1##(1990-11#2)(1990-2#4)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#6)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-6#2)(1995-8#1)(1996-5#1)(1997-4#2)(2006-12#1)(2006-6#1)(2007-12#2)(2008-1#3)(2008-10#8)(2008-11#8)(2008-4#8)(2008-5#6)(2008-6#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#5)(2012-12#1)(2013-1#5)(2013-8#1)
proteolytically processed to##3##3##(1992-12#1)(1995-6#1)(1997-7#1)
proteolytically##9##1##(1992-12#2)(1992-6#2)(1995-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2009-7#1)
proteolyzed##2##1##(1995-11#2)
proteome analyses##2##2##(2008-7#1)(2011-1#1)
proteome analysis of##3##3##(2008-7#1)(2009-2#1)(2010-12#1)
proteome analysis##10##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)
proteome as##2##2##(2008-4#1)(2008-7#1)
proteome catalog##3##2##(2008-9#3)
proteome comparisons##2##2##(2008-4#1)(2008-9#1)
proteome database##3##2##(2008-7#2)(2008-9#1)
proteome of##9##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#3)(2010-6#2)(2011-3#1)
proteome research##2##2##(2012-3#2)
proteome that##2##2##(2010-12#2)
proteome##66##1##(2008-10#2)(2008-11#4)(2008-12#3)(2008-4#6)(2008-7#11)(2008-9#13)(2009-2#1)(2009-6#2)(2009-7#1)(2010-12#11)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
proteomes of##2##2##(2008-4#1)(2008-7#1)
proteomes##16##1##(2008-4#5)(2008-7#2)(2008-9#5)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)
proteomic analysis of##7##3##(2008-10#1)(2008-7#2)(2009-7#1)(2010-12#2)(2013-8#1)
proteomic analysis##16##2##(2008-10#2)(2008-7#2)(2008-9#2)(2009-7#1)(2010-12#7)(2013-8#2)
proteomic and##2##2##(2008-10#1)(2008-7#1)
proteomic approaches##4##2##(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)
proteomic data analysis##2##3##(2008-7#2)
proteomic data##9##2##(2008-11#1)(2008-4#1)(2008-7#4)(2010-12#2)(2010-2#1)
proteomic methodologies##2##2##(2008-4#1)(2012-2#1)
proteomic profiling##2##2##(2008-7#1)(2010-12#1)
proteomic studies##8##2##(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#4)(2010-2#1)
proteomic technologies to##2##3##(2008-11#1)(2012-2#1)
proteomic technologies##3##2##(2008-11#1)(2010-12#1)(2012-2#1)
proteomic technology##2##2##(2009-7#1)(2010-12#1)
proteomic##78##1##(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#1)(2008-4#7)(2008-7#11)(2008-9#4)(2009-11#1)(2009-3#1)(2009-7#2)(2010-11#5)(2010-12#23)(2010-2#3)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
proteomics analysis##2##2##(2008-7#1)(2010-12#1)
proteomics and##7##2##(2008-7#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)
proteomics approach##4##2##(2008-10#1)(2009-9#1)(2010-12#2)
proteomics data##5##2##(2008-11#1)(2008-7#4)
proteomics in##4##2##(2009-1#1)(2009-6#2)(2012-2#1)
proteomics of##4##2##(2008-7#2)(2010-2#1)(2010-5#1)
proteomics##67##1##(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#7)(2008-5#1)(2008-7#19)(2008-9#4)(2009-1#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#8)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-2#3)(2013-8#1)
protest##2##1##(1991-1#1)(1993-9#1)
protested##2##1##(1994-9#1)(2009-10#1)
protexin##5##1##(2010-4#5)
prothoracic gland##2##2##(1995-11#2)
prothoracic glands##4##2##(1995-11#3)(2008-6#1)
prothoracic##9##1##(1995-11#6)(2007-12#2)(2008-6#1)
prothoracicotropic hormone##2##2##(1995-11#2)
prothoracicotropic##3##1##(1995-11#3)
prothrombin time##5##2##(1991-11#1)(1991-6#1)(2008-10#1)(2008-7#1)(2010-3#1)
prothrombin##6##1##(1991-11#1)(1991-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2013-1#1)
prothrombinase##3##1##(1993-11#1)(1993-3#1)(1994-5#1)
prothrombotic state##4##2##(1997-7#2)(2012-2#1)(2013-1#1)
prothrombotic##7##1##(1997-7#2)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
protic and aprotic##2##3##(2008-10#1)(2009-9#1)
protic solvents##5##2##(1994-8#1)(2007-11#1)(2008-10#3)
protic##8##1##(1994-8#1)(2007-11#1)(2008-10#4)(2009-9#2)
protist##2##1##(1997-6#1)(2008-7#1)
protists on bacterial density##2##4##(2008-8#2)
protists##5##1##(2008-7#1)(2008-8#4)
proto-oncogene expression##3##2##(1990-12#2)(1994-6#1)
proto-oncogene induction##3##2##(1991-5#2)(1996-12#1)
proto-oncogene mRNA##3##2##(1990-12#3)
proto-oncogene##32##1##(1990-12#5)(1991-5#2)(1991-9#3)(1992-2#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2008-9#4)(2010-6#1)(2011-2#1)(2011-3#2)(2012-1#1)
proto-oncogenes##9##1##(1991-12#1)(1992-9#1)(1993-8#1)(2008-7#2)(2009-4#1)(2010-3#2)(2011-2#1)
protocatechuic acid##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
protocerebral commissure##5##2##(2007-12#5)
protocerebral##7##1##(2007-12#7)
protocerebrum##10##1##(2007-12#9)(2008-9#1)
protocol (group##2##2##(2011-2#1)(2012-3#1)
protocol A was##3##3##(2008-4#3)
protocol A##8##2##(2008-4#8)
protocol B##5##2##(2008-4#5)
protocol DIN 6800-2##2##3##(2012-1#2)
protocol also describes##2##3##(2008-4#2)
protocol also##3##2##(2008-4#3)
protocol and a##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
protocol and the##3##3##(1996-12#1)(2012-1#1)(2013-1#1)
protocol and##20##2##(1996-12#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-3#1)(2012-1#2)(2012-3#2)(2013-1#4)
protocol are##2##2##(2008-8#1)(2013-1#1)
protocol based on##6##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)
protocol based##7##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)
protocol can be performed##2##4##(2008-4#1)(2008-9#1)
protocol can be##4##3##(2008-4#2)(2008-8#1)(2008-9#1)
protocol combining##2##2##(2008-10#1)(2008-5#1)
protocol consisted of##2##3##(1990-3#1)(2008-10#1)
protocol described in this unit is##2##6##(2008-2#1)(2008-4#1)
protocol described in this unit##3##5##(2008-2#1)(2008-4#2)
protocol described in this##4##4##(1994-9#1)(2008-2#1)(2008-4#2)
protocol described in##5##3##(1994-9#1)(2008-2#1)(2008-4#3)
protocol described##7##2##(1994-9#1)(2008-2#2)(2008-4#4)
protocol describes a method for##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
protocol describes a method##5##4##(2008-2#1)(2008-4#3)(2008-9#1)
protocol describes a##11##3##(2008-11#1)(2008-2#1)(2008-4#8)(2008-9#1)
protocol describes an##3##3##(2008-4#3)
protocol describes how to##6##4##(2008-2#1)(2008-4#5)
protocol describes how##7##3##(2008-2#1)(2008-4#6)
protocol describes the##16##3##(2008-1#1)(2008-2#1)(2008-4#12)(2008-9#2)
protocol describes##48##2##(2008-1#1)(2008-11#1)(2008-2#5)(2008-4#36)(2008-9#5)
protocol details the##3##3##(2008-4#3)
protocol details##9##2##(2008-2#1)(2008-4#8)
protocol detected##3##2##(2008-10#3)
protocol developed##2##2##(2008-10#1)(2008-11#1)
protocol during##2##2##(2007-11#1)(2013-8#1)
protocol for a##4##3##(2007-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
protocol for flow cytometric##2##4##(2008-4#1)(2008-9#1)
protocol for flow##3##3##(2008-4#2)(2008-9#1)
protocol for isolating##2##3##(2008-1#1)(2008-4#1)
protocol for the analysis of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
protocol for the evaluation of##2##5##(1990-12#1)(2008-10#1)
protocol for the study of##2##5##(1991-9#1)(2008-4#1)
protocol for the use of##2##5##(2007-7#1)(2008-7#1)
protocol for the##25##3##(1990-12#1)(1991-9#1)(1993-6#1)(1997-2#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#4)(2008-7#1)(2008-8#1)(2010-7#1)
protocol for##106##2##(1990-12#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#3)(1997-6#1)(2007-10#2)(2007-7#3)(2007-8#3)(2008-1#9)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#25)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
protocol has##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2012-1#1)
protocol implementation##2##2##(2007-11#1)(2013-1#1)
protocol in this unit describes the##3##6##(2008-2#2)(2008-4#1)
protocol in this unit describes##4##5##(2008-2#2)(2008-4#2)
protocol in this unit is##2##5##(2008-4#2)
protocol in this unit##7##4##(2008-2#2)(2008-4#5)
protocol in which the##2##4##(2008-10#1)(2008-4#1)
protocol in which##7##3##(1993-11#1)(2008-1#1)(2008-10#2)(2008-4#3)
protocol in##25##2##(1993-11#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#8)(2008-6#1)(2008-7#2)(2009-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
protocol includes##2##2##(2008-2#1)(2008-4#1)
protocol is a##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
protocol is also##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
protocol is based on the##4##5##(2008-10#1)(2008-4#2)(2008-9#1)
protocol is based on##7##4##(2008-10#1)(2008-4#4)(2008-9#2)
protocol is described for##3##4##(2008-4#3)
protocol is described##4##3##(2008-4#3)(2010-11#1)
protocol is designed##2##3##(2008-4#2)
protocol is included for##2##4##(2008-4#1)(2008-9#1)
protocol is its##2##3##(2008-4#2)
protocol is presented##2##3##(2008-4#1)(2009-10#1)
protocol is provided for##5##4##(2008-4#5)
protocol is provided##6##3##(2008-4#6)
protocol is##54##2##(1994-2#1)(1994-5#1)(1997-2#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#29)(2008-5#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2012-2#1)
protocol may##3##2##(1992-9#1)(2008-2#1)(2008-4#1)
protocol of##13##2##(1992-6#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-9#2)(2009-5#1)(2012-1#1)
protocol offers##3##2##(2008-10#1)(2008-4#2)
protocol on##6##2##(1994-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-2#1)
protocol outlines##4##2##(2008-1#1)(2008-2#1)(2008-4#2)
protocol presented##2##2##(2008-9#2)
protocol presents##2##2##(2008-4#2)
protocol produced##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
protocol provides##6##2##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#3)
protocol results in##2##3##(2007-7#1)(2008-11#1)
protocol should##3##2##(1997-5#1)(2008-10#1)(2008-4#1)
protocol that describes##2##3##(2008-4#2)
protocol that##14##2##(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#7)(2008-9#1)(2009-8#1)(2012-12#1)
protocol therapy##2##2##(2011-2#2)
protocol to examine##2##3##(2008-10#1)(2008-11#1)
protocol to investigate##2##3##(2008-11#2)
protocol to perform##2##3##(2008-4#1)(2008-7#1)
protocol to the##2##3##(2008-10#1)(2010-5#1)
protocol to##19##2##(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
protocol used for##2##3##(2008-11#1)(2008-7#1)
protocol used##4##2##(2008-11#1)(2008-7#1)(2010-3#1)(2012-3#1)
protocol uses a##2##3##(2008-4#2)
protocol uses##4##2##(2008-4#3)(2008-9#1)
protocol using the##2##3##(2008-11#1)(2008-9#1)
protocol using##4##2##(1995-12#1)(2008-11#1)(2008-9#1)(2009-1#1)
protocol was applied##2##3##(2008-10#1)(2011-2#1)
protocol was designed##2##3##(2008-10#1)(2010-10#1)
protocol was developed##2##3##(2008-10#2)
protocol was used to##2##4##(2008-10#1)(2008-7#1)
protocol was used##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
protocol was##27##2##(1996-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2010-10#3)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
protocol were##3##2##(2008-10#1)(2011-2#2)
protocol which##2##2##(2008-4#1)(2013-1#1)
protocol will##6##2##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)
protocol with##12##2##(1994-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-3#2)
protocol without##2##2##(2007-7#1)(2011-2#1)
protocol##686##1##(1990-12#1)(1990-3#1)(1990-6#2)(1991-4#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#2)(1994-5#4)(1994-9#1)(1995-12#5)(1995-6#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#1)(2007-7#8)(2007-8#18)(2007-9#2)(2008-1#20)(2008-10#78)(2008-11#29)(2008-12#7)(2008-2#27)(2008-3#10)(2008-4#188)(2008-5#12)(2008-6#4)(2008-7#19)(2008-8#13)(2008-9#48)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#29)(2012-1#7)(2012-12#5)(2012-2#9)(2012-3#12)(2013-1#15)(2013-7#1)(2013-8#12)
protocol)##4##1##(2008-2#4)
protocols and##16##2##(1991-12#1)(1992-12#1)(1994-3#2)(2006-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
protocols are accompanied by##2##4##(2008-4#1)(2008-9#1)
protocols are also##2##3##(2008-4#2)
protocols are available##2##3##(2008-8#2)
protocols are described##3##3##(2008-4#2)(2008-9#1)
protocols are designed##2##3##(2008-2#1)(2008-9#1)
protocols are discussed##2##3##(1994-2#1)(2009-4#1)
protocols are given for##2##4##(2008-4#2)
protocols are included##2##3##(2008-2#1)(2008-9#1)
protocols are presented##2##3##(2008-4#2)
protocols are provided for the##2##5##(2008-4#2)
protocols are provided for##9##4##(2008-2#1)(2008-4#6)(2008-9#2)
protocols are provided to##2##4##(2008-4#2)
protocols are provided##15##3##(2008-2#1)(2008-4#11)(2008-9#3)
protocols are##52##2##(1991-12#1)(1994-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-2#5)(2008-4#25)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#10)(2009-4#1)(2011-1#1)(2013-1#1)
protocols based on##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
protocols by##3##2##(1992-3#1)(2008-10#2)
protocols can be used##5##4##(2007-10#1)(2008-1#1)(2008-4#1)(2008-9#2)
protocols can be##7##3##(1994-3#1)(2007-10#1)(2008-1#1)(2008-4#2)(2008-9#2)
protocols can##8##2##(1994-3#1)(2007-10#1)(2008-1#1)(2008-4#3)(2008-9#2)
protocols cover##5##2##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#2)
protocols describe how to##5##4##(2008-4#4)(2008-9#1)
protocols describe methods for preparing##2##5##(2008-4#2)
protocols describe methods for##4##4##(2008-4#4)
protocols describe preparation of##2##4##(2008-4#2)
protocols describe the preparation of##2##5##(2008-4#2)
protocols describe the##8##3##(2008-4#8)
protocols describe##37##2##(2008-2#2)(2008-4#30)(2008-9#5)
protocols described herein##3##3##(2008-4#2)(2008-9#1)
protocols described in this unit##3##5##(2008-1#1)(2008-4#2)
protocols described##9##2##(2008-1#1)(2008-4#7)(2008-9#1)
protocols describes##2##2##(2008-2#1)(2008-4#1)
protocols detail##4##2##(2008-4#3)(2008-9#1)
protocols discuss##3##2##(2008-4#3)
protocols employ##2##2##(2008-4#2)
protocols for all##2##3##(2008-4#1)(2008-8#1)
protocols for assessment of##2##4##(2008-9#2)
protocols for both##2##3##(2008-4#1)(2008-9#1)
protocols for cell##2##3##(2008-10#1)(2010-6#1)
protocols for isolating##2##3##(2008-1#1)(2008-4#1)
protocols for measuring##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
protocols for more##2##3##(2008-4#1)(2008-9#1)
protocols for performing##2##3##(2008-9#2)
protocols for preparing##5##3##(2008-4#4)(2008-9#1)
protocols for probe labeling##2##4##(2008-9#2)
protocols for the in##2##4##(2008-11#1)(2008-4#1)
protocols for the isolation of##2##5##(2008-4#1)(2008-9#1)
protocols for the##26##3##(1994-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#10)(2008-6#1)(2008-9#8)
protocols for these##2##3##(2007-8#1)(2008-9#1)
protocols for this##2##3##(2008-4#1)(2008-9#1)
protocols for training##2##3##(1993-12#1)(2011-2#1)
protocols for##157##2##(1993-12#1)(1994-5#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#11)(2008-10#8)(2008-11#3)(2008-2#8)(2008-3#1)(2008-4#53)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#45)(2009-8#1)(2010-6#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#2)
protocols from the##2##3##(1991-9#1)(2008-9#1)
protocols from##3##2##(1991-9#1)(1995-3#1)(2008-9#1)
protocols have been##4##3##(2008-4#1)(2008-9#2)(2011-2#1)
protocols have##6##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2011-2#1)
protocols in a##2##3##(2008-9#1)(2013-1#1)
protocols in the##2##3##(2008-3#1)(2013-8#1)
protocols in this unit are##2##5##(2008-4#1)(2008-9#1)
protocols in this unit cover##2##5##(2008-2#1)(2008-9#1)
protocols in this unit outline the##2##6##(2008-4#2)
protocols in this unit##13##4##(2008-2#2)(2008-4#6)(2008-9#5)
protocols in this##14##3##(2008-2#2)(2008-4#6)(2008-9#6)
protocols in##27##2##(1990-12#1)(1991-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#7)(2008-9#7)(2010-10#1)(2011-1#2)(2013-1#1)(2013-8#1)
protocols is##9##2##(1994-3#1)(2008-11#3)(2008-9#2)(2011-2#1)(2013-1#1)(2013-7#1)
protocols may be##2##3##(2008-10#1)(2008-4#1)
protocols may##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
protocols needed for##2##3##(2008-4#1)(2008-9#1)
protocols of##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)
protocols on##2##2##(2008-4#1)(2008-9#1)
protocols outlining##2##2##(2008-2#1)(2008-9#1)
protocols present methods for##3##4##(2008-4#2)(2008-9#1)
protocols present##4##2##(2008-4#3)(2008-9#1)
protocols presented##2##2##(2008-4#2)
protocols provide##4##2##(1992-3#1)(2008-4#2)(2008-9#1)
protocols that can be used to##5##6##(2008-1#1)(2008-4#4)
protocols that##15##2##(1995-8#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#7)(2008-9#1)
protocols to##13##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#4)(2010-12#1)
protocols used for##2##3##(2008-10#1)(2008-4#1)
protocols used##6##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
protocols using##2##2##(2008-4#1)(2008-9#1)
protocols was##3##2##(2008-10#2)(2009-4#1)
protocols were used##2##3##(1990-10#1)(2011-2#1)
protocols were##8##2##(1990-10#2)(2008-10#2)(2008-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
protocols which##2##2##(1997-1#1)(2008-4#1)
protocols will##2##2##(1994-3#1)(2008-9#1)
protocols with##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
protocols##614##1##(1990-10#2)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#3)(1993-11#2)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#8)(1994-5#1)(1995-3#3)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#3)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#20)(2008-10#45)(2008-11#18)(2008-12#2)(2008-2#34)(2008-3#6)(2008-4#194)(2008-5#7)(2008-6#4)(2008-7#18)(2008-8#7)(2008-9#115)(2009-11#1)(2009-3#1)(2009-4#3)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#19)(2012-1#4)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#5)(2013-8#9)
protogynous##2##1##(2010-5#2)
protoheme IX farnesyltransferase##2##3##(1992-12#2)
protoheme IX##7##2##(1992-12#4)(1994-8#1)(2009-2#2)
protoheme##11##1##(1990-8#2)(1992-12#4)(1994-8#1)(1995-2#2)(2009-2#2)
protolytic constants from##2##3##(2008-10#2)
protolytic constants of 4-(2-pyridylazo)##2##4##(2008-10#2)
protolytic constants##6##2##(2008-10#6)
protolytic equilibrium##3##2##(2008-10#3)
protolytic##11##1##(1996-5#1)(2008-10#10)
protomer##2##1##(1992-5#1)(1994-8#1)
proton NMR##13##2##(1992-3#1)(1992-7#1)(1993-11#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)
proton abstraction##2##2##(1993-8#1)(2008-10#1)
proton and##3##2##(2008-10#3)
proton channel##2##2##(1997-7#1)(2011-1#1)
proton concentration##2##2##(1990-8#1)(2008-10#1)
proton ejection##2##2##(1994-11#2)
proton exchange##4##2##(2007-11#2)(2008-4#2)
proton from##3##2##(1992-10#1)(1995-5#1)(2008-10#1)
proton gradient is##2##3##(1990-2#1)(1994-8#1)
proton gradient##6##2##(1990-2#2)(1994-8#1)(1995-2#1)(1996-4#1)(2008-11#1)
proton in##2##2##(2008-10#1)(2008-9#1)
proton ionophore##2##2##(1990-2#1)(2008-9#1)
proton magnetic resonance spectra##2##4##(2008-6#2)
proton magnetic resonance spectroscopy in##2##5##(2008-6#1)(2008-7#1)
proton magnetic resonance spectroscopy##7##4##(1991-1#1)(1992-3#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-12#1)
proton magnetic resonance##10##3##(1991-1#1)(1992-3#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#2)(2010-12#1)
proton nuclear magnetic resonance##3##4##(1990-12#1)(2008-5#2)
proton pump inhibitor (omeprazole)##2##4##(1996-3#1)(2012-2#1)
proton pump inhibitor##9##3##(1996-3#2)(2008-11#1)(2009-11#1)(2010-12#1)(2012-2#4)
proton pump inhibitors##6##3##(2011-2#1)(2012-2#5)
proton pump##17##2##(1992-12#1)(1994-6#1)(1996-3#2)(2008-11#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#9)
proton pumping##3##2##(1995-2#2)(2008-7#1)
proton reactions##2##2##(2008-10#2)
proton release##6##2##(1990-8#3)(1993-11#1)(1994-3#2)
proton resonances##2##2##(1991-8#1)(2008-9#1)
proton therapy##2##2##(2010-3#1)(2012-12#1)
proton transfer in the##2##4##(2008-10#2)
proton transfer reaction##2##3##(2008-10#1)(2009-6#1)
proton transfer##12##2##(1992-3#1)(1994-8#1)(2008-10#3)(2009-6#1)(2009-8#1)(2010-2#1)(2012-12#4)
proton translocation activity of##3##4##(2008-8#3)
proton translocation activity##4##3##(2008-8#4)
proton translocation##6##2##(1990-5#1)(2008-8#5)
proton uptake##2##2##(1995-5#2)
proton##162##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#1)(1993-11#5)(1993-8#2)(1994-11#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#5)(1995-2#9)(1995-5#6)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-7#1)(2007-11#4)(2008-10#20)(2008-11#2)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#7)(2008-9#5)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-9#4)(2011-1#2)(2011-2#1)(2012-12#9)(2012-2#9)(2013-1#2)
proton-activated##3##1##(1990-7#3)
proton-coupled##5##1##(1994-8#1)(1997-7#2)(2008-10#2)
proton-exchanged##3##1##(2008-2#3)
proton-transfer##2##1##(1994-8#1)(2009-9#1)
protonated bititanate##2##2##(2009-11#2)
protonated bradykinin##2##2##(1996-7#2)
protonated form of##2##3##(2008-10#2)
protonated form##5##2##(1991-5#1)(2008-10#4)
protonated ions##3##2##(1996-7#3)
protonated methyl ester of bradykinin##2##5##(1996-7#2)
protonated molecular ion##4##3##(2008-10#4)
protonated species##3##2##(2008-10#3)
protonated##56##1##(1991-5#1)(1991-9#4)(1992-6#2)(1994-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-7#8)(2008-10#30)(2009-11#2)(2011-2#1)(2012-12#2)
protonation and##2##2##(2008-10#2)
protonation constant of##2##3##(2008-10#2)
protonation constant##3##2##(2008-10#3)
protonation constants and##3##3##(2008-10#3)
protonation constants for##2##3##(2008-10#2)
protonation constants of##5##3##(2008-10#5)
protonation constants##15##2##(2008-10#15)
protonation of a##2##3##(1991-8#1)(1991-9#1)
protonation of the amine##2##4##(2008-10#2)
protonation of the internal##2##4##(1991-8#1)(1992-6#1)
protonation of the##7##3##(1991-8#1)(1992-6#1)(2008-10#4)(2012-2#1)
protonation of##15##2##(1991-8#2)(1991-9#1)(1992-6#1)(1995-2#1)(2008-10#9)(2012-2#1)
protonation sites of the##2##4##(2009-9#2)
protonation##46##1##(1990-8#1)(1991-8#2)(1991-9#1)(1992-6#1)(1993-8#1)(1995-2#2)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#32)(2009-9#2)(2012-2#1)
protonic##3##1##(1992-12#1)(2008-5#1)(2010-4#1)
protonizable nitrogen##2##2##(1993-12#2)
protonophores##7##1##(1994-6#1)(1996-4#6)
protons and##4##2##(2008-3#1)(2008-7#2)(2008-9#1)
protons from##2##2##(2008-10#1)(2008-4#1)
protons in##3##2##(1990-2#1)(1991-9#1)(2010-12#1)
protons of##2##2##(1993-8#1)(2012-12#1)
protons##32##1##(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-8#2)(1991-9#1)(1992-3#1)(1993-11#2)(1993-8#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
protonymphal##2##1##(2007-12#2)
protooncogene##6##1##(1992-8#1)(1993-3#1)(1994-8#2)(1995-2#2)
protooncogenes##2##1##(1991-12#1)(2007-5#1)
protoplasm##3##1##(2008-10#3)
protoplasmic##3##1##(2008-12#2)(2008-7#1)
protoplast culture##3##2##(2008-8#3)
protoplast fusion between##2##3##(2008-11#1)(2008-8#1)
protoplast fusion##4##2##(2008-11#1)(2008-8#2)(2010-2#1)
protoplast preparation##2##2##(2008-9#2)
protoplast##17##1##(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#8)(2008-9#2)(2009-10#1)(2010-2#1)
protoplasts are##2##2##(2008-8#1)(2008-9#1)
protoplasts derived from##3##3##(2008-11#1)(2008-9#2)
protoplasts from##3##2##(2008-9#3)
protoplasts inoculated with##2##3##(2008-10#2)
protoplasts of##7##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-2#1)
protoplasts or##3##2##(1997-3#1)(2008-10#2)
protoplasts were##4##2##(1997-3#2)(2008-8#2)
protoplasts##61##1##(1994-11#1)(1997-3#7)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#17)(2008-9#17)(2009-8#2)(2010-2#2)
protoporphyrin IX and##2##3##(1993-8#1)(1995-12#1)
protoporphyrin IX in the##2##4##(1993-8#1)(2012-3#1)
protoporphyrin IX were##2##3##(1993-8#1)(1995-12#1)
protoporphyrin IX##16##2##(1991-5#2)(1992-8#1)(1993-8#4)(1995-12#5)(1996-8#1)(2012-2#1)(2012-3#2)
protoporphyrin##21##1##(1991-5#4)(1992-8#1)(1993-8#4)(1994-5#1)(1995-12#5)(1995-2#2)(1996-8#1)(2012-2#1)(2012-3#2)
protoporphyrine IX##4##2##(2008-11#4)
protoporphyrinogen oxidase##5##2##(1991-5#4)(2008-10#1)
protoporphyrinogen##6##1##(1991-5#5)(2008-10#1)
protostomes and deuterostomes##3##3##(2007-12#3)
protostomes##6##1##(2007-12#4)(2008-7#1)(2010-4#1)
prototergal glands##3##2##(2007-12#3)
prototrophic##4##1##(2008-10#4)
prototrophy##2##1##(1991-7#1)(2008-10#1)
prototype and##2##2##(2007-12#1)(2012-12#1)
prototype device##3##2##(2008-2#2)(2008-3#1)
prototype fiber##2##2##(2008-3#2)
prototype for##6##2##(1992-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-11#1)
prototype interferometer with##2##3##(2008-3#2)
prototype is##2##2##(2007-11#1)(2008-8#1)
prototype of a new##2##4##(1996-7#1)(2008-10#1)
prototype of a##7##3##(1994-9#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
prototype of the##4##3##(2008-2#2)(2008-3#1)(2008-9#1)
prototype of##18##2##(1991-12#1)(1994-9#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2011-2#2)
prototype system##3##2##(1994-5#1)(2008-3#1)(2008-6#1)
prototype was##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
prototype were##2##2##(2008-10#1)(2008-5#1)
prototype##122##1##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-3#1)(2007-11#5)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#29)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#3)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
prototypes of##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
prototypes were##2##2##(2008-10#1)(2008-5#1)
prototypes##6##1##(2008-10#2)(2008-5#2)(2010-12#1)(2010-8#1)
prototypic member of##2##3##(2008-4#1)(2011-2#1)
prototypic##6##1##(1990-7#1)(2008-10#1)(2008-4#2)(2011-2#1)(2012-12#1)
prototypical##12##1##(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2010-12#1)(2012-2#2)
prototyping and##2##2##(2008-3#1)(2009-12#1)
prototyping of##2##2##(2008-3#1)(2008-8#1)
prototyping##8##1##(2008-3#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-9#2)(2012-2#1)
protozoa and##3##2##(2009-10#1)(2011-2#1)(2012-12#1)
protozoa isolates##3##2##(2008-12#3)
protozoa species in##2##3##(2009-10#2)
protozoa species##3##2##(2009-10#3)
protozoa##25##1##(1990-7#1)(1994-11#1)(2007-12#1)(2008-12#5)(2008-5#1)(2008-9#2)(2009-10#8)(2011-2#1)(2012-12#2)(2013-1#3)
protozoal##6##1##(1995-5#1)(1996-2#1)(1997-7#1)(2007-7#1)(2009-10#1)(2012-3#1)
protozoan parasite##4##2##(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)
protozoan parasites##3##2##(2011-1#2)(2013-1#1)
protozoan##21##1##(1990-7#1)(1992-2#1)(1993-9#2)(1994-12#1)(1996-3#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
protozoans##4##1##(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
protozoon##3##1##(2009-10#2)(2012-12#1)
protracted and##3##2##(1995-12#1)(2008-10#1)(2009-7#1)
protracted##15##1##(1992-4#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#2)(2009-7#2)(2011-2#1)(2013-1#1)
protrude through##2##2##(2008-5#1)(2011-2#1)
protrude##4##1##(1995-12#1)(2008-5#1)(2009-8#1)(2011-2#1)
protruded into the##2##3##(1991-12#1)(2012-12#1)
protruded##4##1##(1991-12#1)(2007-12#1)(2012-12#1)(2013-1#1)
protrudes##2##1##(1996-5#1)(2012-3#1)
protruding nictitating membranes and diarrhoea##3##5##(1990-9#3)
protruding##18##1##(1990-9#3)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
protrusion at the##3##3##(2008-12#2)(2012-2#1)
protrusion of the##9##3##(2007-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
protrusion of##10##2##(2007-8#2)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
protrusion##23##1##(1990-2#1)(2007-8#3)(2008-10#1)(2008-12#2)(2008-3#3)(2008-7#3)(2008-9#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
protrusions##10##1##(1991-5#1)(2007-12#3)(2008-7#2)(2009-9#2)(2011-2#2)
protuberance##3##1##(1993-11#1)(2007-12#1)(2012-2#1)
protuberances##2##1##(2008-10#1)(2008-5#1)
protuberans##5##1##(1992-2#2)(2008-6#3)
proud##4##1##(1990-2#1)(1992-3#1)(1996-3#1)(2011-2#1)
prourokinase and##2##2##(2008-11#2)
prourokinase##4##1##(2008-11#4)
prove a##5##2##(1992-3#1)(2008-1#1)(2008-10#2)(2008-3#1)
prove beneficial##2##2##(2009-6#1)(2011-2#1)
prove helpful in##2##3##(1996-5#1)(2008-3#1)
prove helpful##4##2##(1993-9#1)(1996-5#1)(1997-3#1)(2008-3#1)
prove important##2##2##(2007-5#1)(2010-3#1)
prove more##2##2##(2008-1#1)(2008-10#1)
prove that the##8##3##(1992-8#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-7#1)
prove that this method##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
prove that this##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
prove that##29##2##(1990-11#1)(1991-7#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2013-8#1)
prove the##17##2##(1991-3#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#1)
prove to be a useful##3##5##(1994-3#1)(1994-6#1)(2008-1#1)
prove to be a##6##4##(1994-3#1)(1994-6#2)(1996-12#1)(2008-1#1)(2008-11#1)
prove to be instrumental##2##4##(1993-11#1)(2008-10#1)
prove to be the##3##4##(1995-6#1)(1996-3#1)(2008-8#1)
prove to be very##2##4##(1994-2#1)(2008-10#1)
prove to be##31##3##(1991-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
prove to##34##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
prove useful as a##3##4##(1997-4#1)(2008-10#2)
prove useful as##4##3##(1997-4#1)(2008-10#2)(2009-5#1)
prove useful for the##2##4##(2007-12#1)(2012-2#1)
prove useful for##9##3##(1991-6#1)(2007-12#3)(2008-10#2)(2008-8#1)(2012-2#1)(2012-3#1)
prove useful in the##2##4##(2008-5#1)(2012-2#1)
prove useful in##9##3##(1990-5#1)(1994-8#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
prove useful to##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
prove useful##26##2##(1990-5#1)(1991-6#1)(1992-12#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#4)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
prove valuable##2##2##(2008-10#1)(2010-8#1)
prove##168##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-11#6)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
proved a##6##2##(1991-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
proved also that##4##3##(2007-11#2)(2008-10#2)
proved as##3##2##(2010-5#1)(2010-8#1)(2012-3#1)
proved by the##5##3##(2008-10#5)
proved by##18##2##(1990-5#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)
proved difficult to##4##3##(1997-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
proved difficult##5##2##(1997-7#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
proved effective in##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
proved effective##8##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
proved experimentally##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
proved for##2##2##(2008-10#1)(2008-9#1)
proved in##2##2##(1990-11#1)(2013-8#1)
proved less##2##2##(1992-8#1)(2008-11#1)
proved lethal##2##2##(1993-12#1)(2008-10#1)
proved more##2##2##(1995-5#1)(2012-1#1)
proved necessary##2##2##(2008-6#1)(2010-3#1)
proved not to##2##3##(2007-11#1)(2008-10#1)
proved possible##2##2##(2008-10#1)(2008-7#1)
proved relatively##2##2##(1991-3#1)(2008-11#1)
proved successful##3##2##(1990-9#1)(2008-10#1)(2008-3#1)
proved superior##3##2##(2008-10#2)(2012-2#1)
proved that both##2##3##(2008-10#2)
proved that the method##3##4##(2008-10#1)(2013-8#2)
proved that the##23##3##(1990-12#1)(1992-2#1)(1992-5#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
proved that there##2##3##(2008-10#1)(2008-8#1)
proved that these##2##3##(1995-3#1)(2011-2#1)
proved that##55##2##(1990-12#1)(1990-8#1)(1992-2#1)(1992-5#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
proved the presence of##2##4##(2007-7#1)(2008-11#1)
proved the##17##2##(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
proved to be a characteristic##2##5##(2008-10#2)
proved to be a rapid##3##5##(2008-10#2)(2008-11#1)
proved to be a reliable##2##5##(1996-6#1)(2008-10#1)
proved to be a very##2##5##(1993-12#1)(2008-10#1)
proved to be a##29##4##(1990-2#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-8#1)(1996-6#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-8#2)
proved to be advantageous over##2##5##(2008-10#1)(2008-4#1)
proved to be an adequate##2##5##(2008-11#1)(2008-3#1)
proved to be an effective treatment##2##6##(1992-8#1)(1997-6#1)
proved to be an effective##4##5##(1992-8#1)(1997-6#1)(2008-10#1)(2010-8#1)
proved to be an excellent##2##5##(2008-10#1)(2013-1#1)
proved to be an##13##4##(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
proved to be applicable##2##4##(2008-10#2)
proved to be colonized by##2##5##(1991-3#1)(1997-3#1)
proved to be effective in##7##5##(1992-12#1)(1992-9#1)(1994-7#1)(2008-1#1)(2011-2#2)(2013-1#1)
proved to be effective##12##4##(1990-5#2)(1992-12#1)(1992-9#1)(1994-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-6#1)(2013-1#1)
proved to be good substrates##2##5##(1992-11#1)(2008-10#1)
proved to be good##3##4##(1992-11#1)(2008-10#2)
proved to be highly##6##4##(1995-11#1)(2008-10#2)(2008-6#1)(2013-8#2)
proved to be less important##2##5##(2008-10#1)(2008-7#1)
proved to be less##3##4##(2008-10#1)(2008-7#2)
proved to be linear##2##4##(2008-10#2)
proved to be more sensitive##2##5##(2007-10#1)(2008-10#1)
proved to be more##4##4##(2007-10#1)(2008-10#2)(2008-3#1)
proved to be much##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
proved to be of##2##4##(1991-2#1)(1991-6#1)
proved to be reliable##2##4##(2007-12#1)(2008-10#1)
proved to be safe and##2##5##(1991-12#1)(2008-8#1)
proved to be safe##3##4##(1991-12#1)(2008-8#1)(2013-1#1)
proved to be stable##2##4##(2008-11#1)(2008-3#1)
proved to be suitable##3##4##(2008-10#2)(2008-3#1)
proved to be superior##2##4##(1992-8#1)(2008-10#1)
proved to be the best##3##5##(1995-3#1)(2008-10#1)(2008-6#1)
proved to be the main##2##5##(2008-10#1)(2008-11#1)
proved to be the most effective##2##6##(2008-10#2)
proved to be the most##8##5##(1995-12#1)(2008-10#5)(2008-4#1)(2008-9#1)
proved to be the##19##4##(1991-2#1)(1995-12#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)
proved to be useful for##3##5##(2008-10#3)
proved to be useful##7##4##(1990-10#1)(1990-6#1)(2008-10#4)(2011-2#1)
proved to be very effective##2##5##(2007-11#1)(2013-1#1)
proved to be very##6##4##(2007-11#1)(2008-10#4)(2013-1#1)
proved to be##191##3##(1990-10#1)(1990-2#1)(1990-5#3)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#3)(1996-2#2)(1996-6#1)(1997-1#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#56)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#4)
proved to have##7##3##(1991-6#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
proved to##212##2##(1990-10#1)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#3)(1996-2#2)(1996-6#1)(1997-1#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#63)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#4)
proved useful for the##2##4##(2008-10#1)(2008-9#1)
proved useful for##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
proved useful in the##2##4##(1991-5#1)(2008-10#1)
proved useful in##4##3##(1991-5#1)(1992-9#1)(2008-10#1)(2008-5#1)
proved useful##10##2##(1991-12#1)(1991-5#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)
proved valuable in##2##3##(1992-1#1)(2008-7#1)
proved very##4##2##(1990-5#1)(1995-5#1)(1997-3#1)(1997-7#1)
proved with##2##2##(1996-3#1)(2007-5#1)
proved##438##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#4)(1995-5#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-3#3)(1997-6#1)(1997-7#4)(2006-12#1)(2006-8#1)(2007-10#6)(2007-11#9)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#121)(2008-11#17)(2008-12#5)(2008-2#6)(2008-3#17)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#11)(2008-8#14)(2008-9#12)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#19)(2011-7#2)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#8)(2013-8#9)
proven benefits##2##2##(2007-2#1)(2012-12#1)
proven by##7##2##(1990-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)
proven effective in##5##3##(1992-6#1)(1992-8#1)(1994-10#1)(2008-2#1)(2008-6#1)
proven effective##8##2##(1992-6#1)(1992-8#1)(1993-6#1)(1994-10#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-1#1)
proven efficacy in##4##3##(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
proven efficacy##5##2##(2008-3#1)(2008-9#1)(2011-2#2)(2012-12#1)
proven for##4##2##(1993-3#1)(1996-5#1)(2011-2#1)(2013-8#1)
proven strategies to##2##3##(1994-2#1)(2010-12#1)
proven strategies##3##2##(1994-2#2)(2010-12#1)
proven that the##2##3##(2008-10#2)
proven that##6##2##(2008-1#1)(2008-10#2)(2008-11#2)(2010-5#1)
proven the##4##2##(1993-12#1)(1996-12#1)(2008-10#1)(2011-1#1)
proven to be a very##2##5##(2008-10#2)
proven to be a viable##2##5##(2008-10#1)(2008-11#1)
proven to be a##15##4##(1992-1#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-2#1)
proven to be an extremely useful##2##6##(1991-5#1)(2008-4#1)
proven to be an##6##4##(1991-5#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-8#1)
proven to be effective in##2##5##(2008-4#1)(2011-2#1)
proven to be effective##3##4##(1996-2#1)(2008-4#1)(2011-2#1)
proven to be more clinically##2##5##(2008-11#1)(2008-6#1)
proven to be more##4##4##(2008-11#1)(2008-6#1)(2012-2#2)
proven to be safe##2##4##(1996-2#1)(2009-1#1)
proven to be useful in##2##5##(2008-9#1)(2009-10#1)
proven to be very powerful##2##5##(1995-12#1)(2008-10#1)
proven to be very##6##4##(1995-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-9#1)
proven to be##61##3##(1991-5#1)(1992-1#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#2)(1997-2#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
proven to have##2##3##(2008-8#1)(2011-2#1)
proven to##70##2##(1991-5#1)(1992-1#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#2)
proven treatment##3##2##(2008-1#1)(2008-3#1)(2010-12#1)
proven useful in a##2##4##(2008-12#1)(2008-5#1)
proven useful in##6##3##(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2011-7#1)
proven useful##8##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-7#1)(2011-7#1)
proven very##3##2##(2008-4#2)(2008-9#1)
proven with##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
proven##212##1##(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#5)(2008-10#19)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#10)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#17)(2011-7#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#3)
provenance##13##1##(2008-10#6)(2008-11#3)(2008-2#1)(2012-5#1)(2012-9#1)(2013-1#1)
provenance)##3##1##(2008-10#1)(2011-10#2)
provenances of##2##2##(2012-5#1)(2012-9#1)
provenances or species##2##3##(2012-9#2)
provenances##16##1##(2008-10#1)(2011-10#2)(2012-5#7)(2012-9#6)
proventriculus##2##1##(1997-3#1)(2008-5#1)
proves a##3##2##(1993-9#1)(2012-3#1)(2013-1#1)
proves inadequate##2##2##(1994-6#1)(2013-1#1)
proves that the##3##3##(2008-10#2)(2008-6#1)
proves that##12##2##(1990-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
proves the##8##2##(1991-12#1)(1995-1#1)(2007-11#1)(2008-10#3)(2009-7#1)(2011-2#1)
proves to be a##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
proves to be an##2##4##(2007-11#1)(2008-11#1)
proves to be##8##3##(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
proves##41##1##(1990-6#1)(1991-12#1)(1991-6#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-11#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)
provide &quot##2##2##(1992-4#1)(2008-7#1)
provide a baseline##2##3##(2011-1#1)(2012-12#1)
provide a basis for further##2##5##(2008-4#1)(2010-7#1)
provide a basis for the development of##2##7##(2009-5#1)(2010-12#1)
provide a basis for understanding##2##5##(2008-10#1)(2010-12#1)
provide a basis for##12##4##(1991-11#1)(1992-3#1)(1996-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#3)(2010-7#1)(2013-8#1)
provide a basis##13##3##(1991-11#1)(1992-3#1)(1996-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#3)(2010-7#1)(2013-8#1)
provide a better understanding of the##2##6##(1997-2#1)(2008-10#1)
provide a better##7##3##(1994-6#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-5#1)
provide a brief overview of##2##5##(2008-11#1)(2011-2#1)
provide a brief overview##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
provide a brief##9##3##(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
provide a broad##3##3##(2008-7#1)(2011-1#1)(2012-3#1)
provide a case##2##3##(1993-12#1)(2011-1#1)
provide a clear##2##3##(2007-11#1)(2012-12#1)
provide a clinically##2##3##(1996-2#1)(2011-2#1)
provide a clue to##2##4##(2008-10#1)(2008-8#1)
provide a common##2##3##(1996-3#1)(2012-12#1)
provide a complete##3##3##(2008-3#2)(2009-11#1)
provide a comprehensive assessment of##2##5##(2011-2#2)
provide a comprehensive overview of the##2##6##(2008-11#1)(2013-8#1)
provide a comprehensive overview of##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
provide a comprehensive##12##3##(1993-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#4)(2013-8#1)
provide a concise##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
provide a critical review##2##4##(2009-10#1)(2012-2#1)
provide a critical##4##3##(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
provide a description of the##3##5##(1993-12#1)(2008-12#1)(2009-7#1)
provide a description of##4##4##(1991-12#1)(1993-12#1)(2008-12#1)(2009-7#1)
provide a detailed##5##3##(1992-6#1)(1995-3#1)(2008-11#1)(2010-8#1)(2011-1#1)
provide a direct##2##3##(1994-8#1)(1995-3#1)
provide a first##2##3##(2010-6#1)(2011-2#1)
provide a flexible##2##3##(2008-4#1)(2010-10#1)
provide a foundation for##5##4##(1996-2#1)(2008-10#1)(2009-5#1)(2010-3#1)(2013-1#1)
provide a foundation##7##3##(1996-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-3#1)(2013-1#2)
provide a framework for the##3##5##(1993-3#1)(2008-7#1)(2012-12#1)
provide a framework for##5##4##(1992-6#1)(1993-3#1)(2008-7#1)(2010-10#1)(2012-12#1)
provide a functional##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
provide a further##2##3##(2008-3#1)(2008-4#1)
provide a general overview of##2##5##(2008-7#1)(2012-2#1)
provide a general##9##3##(1997-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-2#1)
provide a good##9##3##(1990-3#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-1#1)
provide a great##2##3##(2012-2#1)(2012-3#1)
provide a high degree of protection for##2##7##(2012-2#2)
provide a high##5##3##(2008-11#1)(2010-2#2)(2012-2#2)
provide a hydrophobic##2##3##(1994-2#1)(2008-10#1)
provide a link between##2##4##(1994-11#1)(2008-9#1)
provide a means for##4##4##(1991-12#1)(1996-2#1)(1997-8#1)(2008-10#1)
provide a means of##3##4##(1990-5#1)(2009-10#1)(2011-2#1)
provide a means##8##3##(1990-5#1)(1991-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
provide a measure of##2##4##(1990-8#1)(1994-8#1)
provide a measure##3##3##(1990-8#1)(1994-8#1)(2012-2#1)
provide a mechanism for##2##4##(1995-8#1)(2008-3#1)
provide a mechanism to##2##4##(1995-8#1)(1996-12#1)
provide a mechanism##4##3##(1995-8#2)(1996-12#1)(2008-3#1)
provide a mechanistic##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
provide a method for##3##4##(2007-12#1)(2008-6#1)(2012-1#1)
provide a method##4##3##(2007-12#1)(2008-3#1)(2008-6#1)(2012-1#1)
provide a model##4##3##(1992-6#1)(1993-3#1)(2008-9#1)(2011-10#1)
provide a more accurate identification of microorganisms##2##7##(2012-2#2)
provide a more accurate##4##4##(2008-5#1)(2012-2#2)(2012-3#1)
provide a more##12##3##(1992-6#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
provide a new method##2##4##(2012-2#1)(2013-8#1)
provide a new##13##3##(1991-8#1)(1993-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#2)(2012-2#2)(2013-8#1)
provide a non-invasive##2##3##(1997-2#1)(2010-8#1)
provide a novel##8##3##(1991-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
provide a numerical##2##3##(1992-6#1)(2008-3#1)
provide a partial##2##3##(1992-9#1)(2008-7#1)
provide a perspective##2##3##(2010-11#1)(2010-3#1)
provide a picture of##2##4##(1996-3#1)(2013-8#1)
provide a potential##4##3##(2008-7#2)(2009-10#1)(2011-1#1)
provide a powerful tool for##2##5##(1991-8#1)(2007-11#1)
provide a powerful tool##3##4##(1991-8#1)(1993-11#1)(2007-11#1)
provide a powerful##6##3##(1991-8#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
provide a practical##5##3##(2006-10#1)(2008-11#1)(2008-6#1)(2012-5#1)(2013-8#1)
provide a principled##2##3##(2008-5#1)(2013-8#1)
provide a promising##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
provide a quantitative description of the##2##6##(2010-5#1)(2011-1#1)
provide a rapid##5##3##(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)
provide a rationale for the##2##5##(1990-3#1)(1994-6#1)
provide a reliable##6##3##(2008-3#2)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
provide a review of##4##4##(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
provide a rich##2##3##(2008-11#1)(2010-3#1)
provide a robust method for##2##5##(2008-1#1)(2008-10#1)
provide a robust##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
provide a safe and effective##2##5##(1990-8#1)(2007-11#1)
provide a safe and##3##4##(1990-8#1)(1995-2#1)(2007-11#1)
provide a safe##5##3##(1990-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
provide a second##2##3##(2008-4#1)(2011-2#1)
provide a set of##2##4##(2008-6#1)(2008-9#1)
provide a significant##4##3##(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#1)
provide a simple and##2##4##(2008-10#1)(2010-11#1)
provide a simple##9##3##(1995-12#1)(1995-3#1)(2008-10#3)(2008-3#1)(2010-11#1)(2010-7#1)(2012-3#1)
provide a skin##2##3##(2008-5#2)
provide a small##2##3##(2008-3#2)
provide a solid foundation for##2##5##(1995-1#1)(2008-4#1)
provide a solution to the##2##5##(2008-1#1)(2008-10#1)
provide a solution##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
provide a source of##2##4##(2007-12#1)(2008-10#1)
provide a stable##4##3##(2008-4#2)(2009-11#1)(2011-2#1)
provide a starting point for##2##5##(2008-10#1)(2013-1#1)
provide a step-by-step##2##3##(1997-1#1)(2008-9#1)
provide a strong rationale for##2##5##(2008-5#1)(2009-4#1)
provide a structural basis for the##2##6##(1993-11#2)
provide a structural##3##3##(1993-11#2)(2008-2#1)
provide a supportive##2##3##(2010-9#1)(2013-1#1)
provide a theoretical framework##3##4##(1992-3#1)(2008-8#2)
provide a theoretical##4##3##(1992-3#1)(2008-8#2)(2013-8#1)
provide a unique opportunity to##3##5##(2009-10#1)(2009-5#1)(2013-8#1)
provide a unique##5##3##(2007-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2013-8#1)
provide a useful tool##2##4##(1996-4#1)(2010-3#1)
provide a useful##17##3##(1990-5#1)(1992-2#1)(1994-3#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-3#1)(2012-3#2)
provide a valuable tool for the study of##2##8##(2007-11#1)(2008-11#1)
provide a valuable tool for##3##5##(2007-11#1)(2008-11#1)(2009-12#1)
provide a valuable tool##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2009-12#1)
provide a valuable##9##3##(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)
provide a very##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
provide a viable##2##3##(2008-10#1)(2008-7#1)
provide a way to##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
provide a##545##2##(1990-3#3)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#4)(1993-3#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#7)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#6)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#6)(1996-3#7)(1996-4#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#3)(2006-10#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#46)(2008-11#27)(2008-12#5)(2008-2#13)(2008-3#30)(2008-4#20)(2008-5#12)(2008-6#4)(2008-7#21)(2008-8#11)(2008-9#16)(2009-10#5)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#13)(2011-10#1)(2011-2#18)(2011-7#2)(2012-1#2)(2012-12#10)(2012-2#26)(2012-3#15)(2012-5#1)(2012-9#1)(2013-1#14)(2013-8#11)
provide acceptable##3##2##(2008-10#1)(2010-10#1)(2010-8#1)
provide access to##4##3##(1991-12#1)(1993-1#1)(2008-11#1)(2008-4#1)
provide access##5##2##(1991-12#1)(1993-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
provide accurate##7##2##(2007-5#1)(2008-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
provide additional evidence for##2##4##(1992-3#2)
provide additional information to##2##4##(2007-10#1)(2008-4#1)
provide additional information##4##3##(2007-10#1)(2008-10#1)(2008-4#1)(2010-12#1)
provide additional insight into##2##4##(1991-10#1)(2012-3#1)
provide additional insights into the##2##5##(1992-11#1)(2012-2#1)
provide additional support to##2##4##(2008-12#1)(2013-1#1)
provide additional support##4##3##(2008-12#1)(2011-1#1)(2013-1#2)
provide additional tools for##2##4##(1995-1#1)(2008-11#1)
provide additional##29##2##(1991-10#1)(1992-11#1)(1992-3#2)(1995-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
provide adequate protection##2##3##(2007-2#1)(2008-2#1)
provide adequate##21##2##(1991-12#1)(1991-6#1)(1992-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
provide advantages##2##2##(1997-1#1)(2009-7#1)
provide an additional##4##3##(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
provide an alternative to##4##4##(2008-4#1)(2008-9#2)(2009-9#1)
provide an alternative##10##3##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#5)(2009-9#1)
provide an analysis##2##3##(2008-2#1)(2008-7#1)
provide an attractive##4##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-9#1)
provide an economical##2##3##(2008-1#1)(2008-9#1)
provide an effective means##2##4##(2008-10#1)(2008-3#1)
provide an effective tool##2##4##(2008-11#1)(2013-8#1)
provide an effective##8##3##(1993-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2013-8#1)
provide an efficient##5##3##(1994-2#1)(1997-4#1)(2007-11#1)(2008-3#1)(2011-2#1)
provide an estimate of##3##4##(1992-12#1)(2008-3#1)(2008-4#1)
provide an evidence-based##2##3##(2011-2#1)(2011-7#1)
provide an example##2##3##(1996-3#1)(2010-11#1)
provide an excellent##7##3##(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
provide an explanation##2##3##(2008-3#2)
provide an ideal##2##3##(2007-11#1)(2009-2#1)
provide an important##8##3##(1996-1#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-11#1)(2011-2#1)(2013-8#1)
provide an improved##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
provide an initial##3##3##(2008-3#1)(2010-8#1)(2013-1#1)
provide an insight into the##2##5##(2008-10#1)(2012-3#1)
provide an insight##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
provide an interesting##2##3##(2012-2#1)(2012-3#1)
provide an opportunity to##3##4##(2011-1#1)(2011-2#1)(2013-1#1)
provide an opportunity##4##3##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
provide an optimal##5##3##(2008-10#2)(2008-3#2)(2010-10#1)
provide an outline of the##2##5##(1997-8#1)(2010-3#1)
provide an overview of the##14##5##(1991-1#1)(2008-10#1)(2008-6#2)(2008-9#1)(2009-4#1)(2009-6#2)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
provide an overview of##29##4##(1991-1#1)(1995-1#1)(1995-3#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
provide an overview##31##3##(1991-1#1)(1995-1#1)(1995-3#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
provide an update on the##2##5##(2008-8#1)(2012-2#1)
provide an update on##3##4##(2006-7#1)(2008-8#1)(2012-2#1)
provide an update##4##3##(2006-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
provide an updated##2##3##(2010-6#1)(2011-1#1)
provide an##182##2##(1990-3#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#3)(2008-10#22)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#9)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-9#1)(2010-10#3)(2010-11#5)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#10)(2012-3#4)(2013-1#3)(2013-8#3)
provide anatomical##2##2##(2008-1#1)(2013-1#1)
provide and##6##2##(1996-2#1)(1997-3#1)(2009-5#1)(2012-2#2)(2013-1#1)
provide any protection##3##3##(1995-11#2)(2008-10#1)
provide any##7##2##(1991-2#1)(1995-11#2)(2008-10#1)(2008-12#1)(2009-4#1)(2013-1#1)
provide appropriate##5##2##(1993-3#1)(1995-9#1)(1997-7#1)(2007-8#1)(2012-12#1)
provide assistance##2##2##(1996-3#1)(2007-12#1)
provide at##2##2##(2008-1#1)(2008-12#1)
provide avenues for##2##3##(2008-10#1)(2008-2#1)
provide baseline##2##2##(1992-2#1)(2008-10#1)
provide basic##2##2##(2008-7#1)(2010-8#1)
provide benefit##3##2##(2008-3#1)(2010-12#1)(2012-12#1)
provide benefits in##2##3##(2012-2#2)
provide benefits##3##2##(2009-11#1)(2012-2#2)
provide better habitats##2##3##(2008-8#2)
provide better long-term patency##2##4##(1997-3#1)(2007-8#1)
provide better long-term##3##3##(1997-3#1)(2007-8#1)(2011-2#1)
provide better##15##2##(1993-12#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
provide both a##2##3##(2009-11#1)(2010-4#1)
provide both the##2##3##(2008-3#1)(2011-2#1)
provide both##7##2##(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#2)
provide breeders##2##2##(2008-10#1)(2011-2#1)
provide broadband controlled dispersion##2##4##(2007-11#1)(2007-12#1)
provide care to##3##3##(1997-2#1)(2008-11#1)(2008-9#1)
provide care##11##2##(1991-2#1)(1993-12#1)(1994-3#1)(1997-2#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)
provide clinical and##2##3##(2007-10#1)(2008-11#1)
provide clinical##6##2##(2007-10#2)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
provide clinically##2##2##(2008-10#1)(2008-7#1)
provide clues about the##2##4##(2010-10#1)(2012-12#1)
provide clues about##3##3##(2008-7#1)(2010-10#1)(2012-12#1)
provide clues for##2##3##(1997-6#1)(2009-2#1)
provide clues on the##2##4##(2008-7#1)(2008-8#1)
provide clues on##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
provide clues to##3##3##(2008-11#1)(2010-6#1)(2012-3#1)
provide clues##13##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)
provide compelling evidence that##2##4##(2009-8#1)(2011-2#1)
provide compelling##3##2##(2009-8#1)(2011-2#1)(2012-3#1)
provide complementary information##2##3##(2008-1#1)(2012-2#1)
provide complete##4##2##(1992-8#1)(2008-10#2)(2008-8#1)
provide comprehensive##5##2##(1993-2#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#1)
provide consistent##2##2##(2008-5#1)(2009-7#1)
provide continuous##4##2##(1995-12#1)(2008-10#1)(2011-1#1)(2013-1#1)
provide critical##2##2##(2007-12#1)(2008-12#1)
provide data for##3##3##(1990-2#1)(2007-4#1)(2010-7#1)
provide data on##2##3##(2011-2#1)(2013-1#1)
provide data##8##2##(1990-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
provide decision##2##2##(2007-12#1)(2008-10#1)
provide decision-makers with##2##3##(2008-10#1)(2011-2#1)
provide detailed##5##2##(1991-1#1)(2007-12#1)(2008-9#2)(2011-1#1)
provide details on the##2##4##(2008-10#1)(2008-11#1)
provide details##6##2##(1990-11#1)(1992-3#1)(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
provide diagnostic information##2##3##(2007-4#1)(2008-11#1)
provide different##2##2##(2008-12#1)(2013-1#1)
provide direct evidence for##2##4##(1990-7#1)(2008-7#1)
provide direct evidence that##3##4##(1994-8#1)(2008-10#1)(2009-8#1)
provide direct evidence##5##3##(1990-7#1)(1994-8#1)(2008-10#1)(2008-7#1)(2009-8#1)
provide direct experimental##2##3##(2007-11#1)(2008-10#1)
provide direct##15##2##(1990-7#1)(1991-5#1)(1994-3#1)(1994-8#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-3#1)
provide direction for##2##3##(1994-3#1)(2011-1#1)
provide documentation##2##2##(1991-12#1)(1992-12#1)
provide durable##2##2##(2008-10#2)
provide education##2##2##(1991-12#1)(2008-11#1)
provide effective control##2##3##(1991-8#1)(2011-2#1)
provide effective protection##2##3##(2008-10#1)(2011-2#1)
provide effective##8##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#2)(2012-3#1)
provide enhanced##2##2##(1991-9#1)(2008-3#1)
provide enough##4##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
provide equivalent##4##2##(1993-11#1)(1996-1#1)(1996-2#1)(2008-3#1)
provide essential information##3##3##(1993-2#1)(2008-11#1)(2012-2#1)
provide estimates of##5##3##(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-8#1)
provide evidence for a##4##4##(1993-12#1)(1994-12#1)(1997-2#1)(2013-1#1)
provide evidence for the existence of##2##6##(1990-7#1)(1997-6#1)
provide evidence for the##6##4##(1990-7#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
provide evidence for##18##3##(1990-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
provide evidence of an##2##4##(1991-12#1)(2010-12#1)
provide evidence of the existence of##2##6##(1995-8#1)(2008-3#1)
provide evidence of the##3##4##(1995-8#1)(2008-3#1)(2009-7#1)
provide evidence of##9##3##(1991-12#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#1)
provide evidence on##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
provide evidence that a##3##4##(1992-3#1)(1993-6#1)(2008-7#1)
provide evidence that although##2##4##(1990-7#1)(1995-3#1)
provide evidence that the##5##4##(1992-9#1)(1993-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
provide evidence that##42##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-3#2)(2008-10#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
provide evidence to##2##3##(2012-12#1)(2013-1#1)
provide evidence##82##2##(1990-11#1)(1990-7#2)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
provide evidence-based##2##2##(2007-12#1)(2013-1#1)
provide examples of##2##3##(2008-11#1)(2008-7#1)
provide excellent##4##2##(2008-10#1)(2009-3#1)(2012-2#1)(2012-3#1)
provide experimental evidence##2##3##(1996-7#1)(2007-12#1)
provide experimental##3##2##(1996-7#1)(2007-12#1)(2008-3#1)
provide extensive##4##2##(2008-7#1)(2008-9#2)(2011-2#1)
provide fast##2##2##(2008-10#1)(2012-3#1)
provide for more##2##3##(2008-8#1)(2013-1#1)
provide for the##3##3##(1995-1#1)(2008-11#1)(2008-7#1)
provide for##18##2##(1990-2#1)(1991-3#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#3)
provide free##2##2##(1993-2#1)(2011-2#1)
provide fundamental##2##2##(1994-8#1)(1996-2#1)
provide further evidence for##2##4##(1991-8#1)(1996-2#1)
provide further evidence of a##2##5##(1994-8#1)(2008-4#1)
provide further evidence that##3##4##(1990-8#1)(1997-8#1)(2008-3#1)
provide further evidence##7##3##(1990-8#1)(1991-8#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-3#1)(2008-4#1)
provide further insight into the##3##5##(1993-12#1)(1995-3#1)(2007-12#1)
provide further insight##5##3##(1993-12#1)(1993-9#1)(1995-3#1)(2007-12#1)(2008-8#1)
provide further##22##2##(1990-8#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
provide general##3##2##(1994-2#1)(1995-2#1)(2010-12#1)
provide genetic##5##2##(2008-10#1)(2008-4#2)(2010-2#1)(2011-2#1)
provide good##11##2##(1990-12#1)(1991-6#1)(1993-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2013-1#1)
provide greater insight into the##2##5##(2008-10#1)(2010-6#1)
provide greater##7##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)
provide guidance for##7##3##(2007-2#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
provide guidance on how##2##4##(2008-11#1)(2009-10#1)
provide guidance to##3##3##(1993-12#1)(2007-4#1)(2008-11#1)
provide guidance##17##2##(1993-12#1)(1996-3#1)(2007-2#1)(2007-4#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
provide guidelines for##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
provide guidelines##5##2##(1992-3#1)(2008-10#1)(2009-11#1)(2009-9#1)(2011-2#1)
provide health care##3##3##(1994-12#1)(1995-3#1)(1997-3#1)
provide health##6##2##(1994-12#1)(1995-3#1)(1997-3#1)(2007-5#1)(2008-11#1)(2010-12#1)
provide high quality##3##3##(1991-12#1)(1997-2#1)(2008-11#1)
provide high##11##2##(1991-12#1)(1994-6#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-7#2)
provide high-resolution##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
provide higher##5##2##(1993-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2012-3#1)
provide important diagnostic##2##3##(1991-2#1)(1992-4#1)
provide important information for##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
provide important information on##3##4##(1991-2#1)(2008-3#1)(2013-1#1)
provide important information##8##3##(1990-8#1)(1991-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-6#1)(2013-1#2)
provide important insights##3##3##(1993-3#1)(2008-7#1)(2012-12#1)
provide important##23##2##(1990-8#1)(1991-2#2)(1992-4#1)(1993-3#2)(1995-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)
provide improved##2##2##(2008-3#1)(2012-2#1)
provide in##3##2##(1996-2#1)(2009-7#1)(2010-10#1)
provide incentives for##2##3##(1997-2#1)(2008-12#1)
provide incentives##3##2##(1994-2#1)(1997-2#1)(2008-12#1)
provide increased##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
provide independent##6##2##(1990-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-4#1)
provide indications##2##2##(2008-12#1)(2008-2#1)
provide indicators of the##2##4##(1992-2#1)(2012-3#1)
provide information about the##7##4##(1992-12#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
provide information about##15##3##(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-3#1)(2013-1#1)(2013-8#1)
provide information and##2##3##(2007-2#1)(2009-5#1)
provide information for the##2##4##(2008-11#1)(2011-1#1)
provide information for##8##3##(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)
provide information on cell##2##4##(2008-9#2)
provide information on the##8##4##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2011-1#1)
provide information on##14##3##(1995-3#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)
provide information to##8##3##(1990-6#1)(1991-2#1)(1993-2#1)(1996-2#2)(2009-9#1)(2010-8#1)(2012-1#1)
provide information##55##2##(1990-6#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
provide insight as##2##3##(1991-2#1)(2013-1#1)
provide insight into how##2##4##(1997-7#1)(2008-11#1)
provide insight into the mechanisms of##2##6##(2007-8#1)(2008-4#1)
provide insight into the mechanisms##3##5##(2007-8#1)(2008-4#1)(2008-9#1)
provide insight into the##12##4##(1994-3#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-12#2)
provide insight into##26##3##(1992-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
provide insight##30##2##(1991-2#1)(1992-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-4#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
provide insights into the##9##4##(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
provide insights into##16##3##(1993-12#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
provide insights##19##2##(1993-12#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
provide invaluable##3##2##(2008-11#1)(2008-6#1)(2012-3#1)
provide limited##2##2##(2008-10#1)(2012-2#1)
provide little##3##2##(1996-11#1)(2008-10#1)(2010-4#1)
provide long-term##5##2##(1991-4#1)(2008-11#1)(2008-3#2)(2010-5#1)
provide many##3##2##(1995-2#1)(2008-2#1)(2012-1#1)
provide mechanistic##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
provide medical##2##2##(1996-3#1)(2007-7#1)
provide moderate##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
provide more accurate##3##3##(1990-3#1)(1991-11#1)(2012-12#1)
provide more##16##2##(1990-3#1)(1991-1#1)(1991-11#1)(1992-3#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2009-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
provide most##2##2##(2009-11#1)(2011-2#1)
provide multiple##2##2##(2008-11#1)(2013-1#1)
provide necessary##2##2##(1993-12#1)(2008-7#1)
provide new and##2##3##(2010-3#1)(2011-1#1)
provide new information about the##2##5##(1997-7#1)(2012-2#1)
provide new information##5##3##(1997-7#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
provide new insight into the##2##5##(2007-7#1)(2008-10#1)
provide new insight into##4##4##(1991-5#1)(2007-7#1)(2008-10#1)(2012-1#1)
provide new insights into the##5##5##(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)
provide new insights into##7##4##(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)
provide new insights on the##2##5##(2008-10#1)(2008-7#1)
provide new insights##9##3##(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)
provide new##39##2##(1991-5#1)(1993-2#1)(1996-1#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
provide no evidence that##2##4##(1993-6#1)(2010-4#1)
provide no support for the##2##5##(2008-5#1)(2009-2#1)
provide no##6##2##(1992-6#1)(1993-6#1)(1997-3#1)(2008-5#1)(2009-2#1)(2010-4#1)
provide not only##4##3##(1991-2#1)(2008-10#1)(2010-12#1)(2010-3#1)
provide novel insights into the##2##5##(2010-12#1)(2013-8#1)
provide novel insights into##3##4##(2010-11#1)(2010-12#1)(2013-8#1)
provide novel##7##2##(2008-4#2)(2009-6#1)(2010-11#1)(2010-12#1)(2013-8#2)
provide objective##3##2##(1995-12#1)(2008-3#1)(2013-8#1)
provide one of the##4##4##(1992-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
provide one##5##2##(1992-1#1)(1994-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
provide only##5##2##(1990-8#1)(1994-2#1)(2008-3#1)(2010-1#1)(2012-2#1)
provide opportunities for##6##3##(1993-6#1)(2007-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)
provide opportunities to##3##3##(2007-12#1)(2008-10#1)(2009-9#1)
provide opportunities##9##2##(1993-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)
provide optimal##6##2##(1993-11#1)(2007-11#1)(2008-2#1)(2010-11#1)(2011-3#1)(2012-1#1)
provide optimum##2##2##(1996-12#1)(2008-8#1)
provide other##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
provide parental care##2##3##(2008-8#2)
provide part of the##2##4##(2008-3#1)(2008-5#1)
provide partial support for##2##4##(1995-2#1)(2009-8#1)
provide patients with##4##3##(1993-2#1)(2008-1#1)(2008-7#1)(2010-12#1)
provide personal##2##2##(1996-1#1)(2010-8#1)
provide potential##4##2##(1996-1#1)(2008-2#1)(2008-4#1)(2010-11#1)
provide powerful##3##2##(2008-11#1)(2008-7#1)(2010-6#1)
provide practical##4##2##(1993-1#1)(1997-7#1)(2008-10#1)(2008-12#1)
provide preliminary evidence##2##3##(2008-12#2)
provide preliminary##3##2##(2008-12#2)(2011-1#1)
provide promising##2##2##(2008-6#1)(2010-6#1)
provide protection against##5##3##(1990-11#1)(1995-12#1)(2008-10#2)(2008-9#1)
provide protection##10##2##(1990-11#1)(1993-3#1)(1995-12#1)(1996-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
provide quality##7##2##(1994-3#1)(1995-3#1)(1997-1#1)(2008-11#2)(2010-9#1)(2011-1#1)
provide quantitative##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
provide quick##2##2##(2008-3#1)(2012-2#1)
provide real##2##2##(1995-6#1)(2008-10#1)
provide reasonable##2##2##(1996-2#1)(2008-3#1)
provide recommendations for future##2##4##(2008-11#1)(2008-8#1)
provide recommendations for##6##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
provide recommendations##7##2##(1992-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
provide relevant information on the##2##5##(2008-7#1)(2013-1#1)
provide reliable data##2##3##(1993-9#1)(2008-10#1)
provide reliable##7##2##(1990-6#1)(1993-9#1)(1997-3#1)(2008-10#2)(2012-1#1)(2012-2#1)
provide reproducible##2##2##(2008-11#1)(2008-9#1)
provide resistance to##2##3##(1997-6#1)(2008-10#1)
provide results##2##2##(2008-7#1)(2008-8#1)
provide robust##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
provide safe##4##2##(1994-3#1)(2008-10#1)(2008-6#1)(2009-2#1)
provide satisfactory results##2##3##(2008-10#2)
provide satisfactory##5##2##(1993-2#1)(1996-12#1)(2008-10#2)(2008-3#1)
provide services that##2##3##(2008-11#1)(2010-3#1)
provide services##6##2##(1993-12#1)(1994-1#2)(2008-11#2)(2010-3#1)
provide short-term##2##2##(2010-11#1)(2013-1#1)
provide significant##7##2##(1991-2#1)(1992-6#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
provide similar##5##2##(1996-6#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-2#1)
provide some basic information about##2##5##(2008-1#1)(2010-5#1)
provide some form of##2##4##(1991-3#1)(2012-3#1)
provide some##20##2##(1991-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-5#1)(2012-3#2)
provide spatial##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
provide specific##4##2##(1991-2#1)(1996-12#1)(2008-4#1)(2013-1#1)
provide stable##2##2##(2008-4#1)(2009-1#1)
provide strong support for##2##4##(1992-2#1)(2008-11#1)
provide strong##4##2##(1992-2#1)(1996-8#1)(2008-11#1)(2008-8#1)
provide structural##2##2##(2008-8#1)(2010-10#1)
provide students with##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
provide students##4##2##(1995-1#1)(2008-11#1)(2008-12#1)(2011-1#1)
provide substantial##5##2##(1990-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
provide such##6##2##(1994-3#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
provide sufficient information##2##3##(2007-10#1)(2013-8#1)
provide sufficient##7##2##(1994-12#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
provide superior##3##2##(1994-1#2)(2008-10#1)
provide support for the hypothesis##3##5##(1994-8#1)(2008-10#1)(2013-8#1)
provide support for the##5##4##(1994-8#1)(2008-10#1)(2008-6#1)(2010-3#1)(2013-8#1)
provide support for##10##3##(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
provide support to##3##3##(1994-12#1)(2008-8#1)(2013-8#1)
provide support##15##2##(1994-12#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#2)(2011-2#1)(2013-8#2)
provide systemic##2##2##(2008-10#1)(2012-2#1)
provide that##3##2##(1990-2#1)(1996-1#1)(1996-3#1)
provide the appropriate##2##3##(2012-12#1)(2013-1#1)
provide the basic##3##3##(1990-12#1)(2008-7#1)(2011-1#1)
provide the basis for##11##4##(1990-2#1)(1991-1#1)(1992-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-6#1)
provide the best##10##3##(2008-10#5)(2008-4#1)(2008-8#1)(2010-11#1)(2012-1#1)(2013-1#1)
provide the cells with a##2##5##(1994-8#1)(2008-11#1)
provide the desired##2##3##(2009-9#1)(2010-8#1)
provide the evidence for##2##4##(2012-3#2)
provide the evidence##3##3##(2008-12#1)(2012-3#2)
provide the first direct evidence that##2##6##(2007-7#1)(2008-10#1)
provide the first evidence that##4##5##(1994-5#1)(2008-5#1)(2010-11#1)(2013-1#1)
provide the first evidence##5##4##(1994-5#1)(2008-1#1)(2008-5#1)(2010-11#1)(2013-1#1)
provide the first##19##3##(1994-5#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#2)(2010-4#1)(2013-1#1)
provide the foundation for a##2##5##(2007-11#1)(2009-10#1)
provide the foundation for##4##4##(2007-11#1)(2008-9#1)(2009-10#1)(2012-2#1)
provide the foundation necessary##2##4##(1991-1#1)(2008-1#1)
provide the foundation##6##3##(1991-1#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-10#1)(2012-2#1)
provide the framework for##3##4##(2007-4#1)(2008-5#1)(2011-2#1)
provide the greatest##4##3##(1995-12#1)(1996-3#1)(2008-10#1)(2008-4#1)
provide the highest sensitivity##2##4##(2008-10#1)(2008-3#1)
provide the highest##7##3##(1990-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
provide the information##2##3##(1997-8#1)(2008-9#1)
provide the means for##3##4##(1992-6#1)(1994-2#1)(2008-3#1)
provide the means to##4##4##(1990-11#1)(2008-10#1)(2008-11#1)(2010-10#1)
provide the means##7##3##(1990-11#1)(1992-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
provide the most effective##2##4##(1996-3#1)(2008-11#1)
provide the most##10##3##(1994-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#3)(2012-2#1)
provide the necessary##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
provide the only##2##3##(1991-5#1)(2008-4#1)
provide the opportunity##2##3##(1995-9#1)(2011-2#1)
provide the reader with an##4##5##(1997-3#1)(2007-7#1)(2008-10#1)(2009-12#1)
provide the reader with##8##4##(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-9#1)(2013-8#1)
provide the same##2##3##(2008-10#1)(2008-2#1)
provide the substrate for##2##4##(2008-4#1)(2011-2#1)
provide the##191##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-8#1)(1995-9#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#21)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#6)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#4)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#10)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#1)
provide their##4##2##(1997-2#1)(2008-9#1)(2010-8#1)(2013-1#1)
provide them with##2##3##(2007-7#1)(2011-2#1)
provide them##3##2##(1992-12#1)(2007-7#1)(2011-2#1)
provide therapeutic##2##2##(2010-3#1)(2013-1#1)
provide these##4##2##(1995-1#1)(1997-1#1)(2011-2#1)(2013-8#1)
provide timely##4##2##(1992-12#1)(1997-3#1)(2008-8#1)(2012-12#1)
provide to##3##2##(1997-1#1)(2010-8#1)(2013-1#1)
provide training##3##2##(2011-2#2)(2012-12#1)
provide unequivocal##2##2##(2011-2#1)(2012-3#1)
provide unique##3##2##(2008-1#1)(2008-3#1)(2008-9#1)
provide us with##2##3##(2008-9#1)(2013-1#1)
provide us##3##2##(2007-11#1)(2008-9#1)(2013-1#1)
provide useful data##2##3##(1994-5#1)(2008-4#1)
provide useful information for the##2##5##(2008-10#1)(2010-5#1)
provide useful information for##5##4##(1996-3#1)(2008-10#2)(2008-2#1)(2010-5#1)
provide useful information on##3##4##(2008-6#1)(2008-7#1)(2009-5#1)
provide useful information##10##3##(1991-2#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-5#1)
provide useful tools##2##3##(2008-5#1)(2008-7#1)
provide useful##26##2##(1991-2#1)(1994-5#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2012-2#2)(2012-3#1)
provide valid##2##2##(1994-2#1)(1995-2#1)
provide valuable information about##2##4##(2008-11#1)(2008-4#1)
provide valuable information for##3##4##(1996-8#1)(1997-4#1)(2008-8#1)
provide valuable information to##2##4##(2012-12#1)(2013-8#1)
provide valuable information##10##3##(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
provide valuable##18##2##(1995-1#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
provide very##2##2##(2008-4#1)(2011-2#1)
provide visual##2##2##(2008-10#1)(2009-12#1)
provide##2390##1##(1990-10#1)(1990-11#10)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#7)(1991-1#9)(1991-10#1)(1991-11#2)(1991-12#17)(1991-2#14)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#5)(1991-8#4)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#11)(1992-3#21)(1992-4#3)(1992-5#1)(1992-6#11)(1992-8#4)(1992-9#7)(1993-1#5)(1993-11#9)(1993-12#20)(1993-2#12)(1993-3#10)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#2)(1994-1#6)(1994-11#6)(1994-12#15)(1994-2#12)(1994-3#22)(1994-5#3)(1994-6#4)(1994-8#13)(1994-9#3)(1995-1#12)(1995-11#3)(1995-12#14)(1995-2#22)(1995-3#16)(1995-5#4)(1995-6#5)(1995-8#5)(1995-9#4)(1996-1#11)(1996-11#1)(1996-12#12)(1996-2#19)(1996-3#21)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#11)(1997-2#15)(1997-3#16)(1997-4#11)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#7)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#1)(2007-10#9)(2007-11#30)(2007-12#39)(2007-2#6)(2007-3#1)(2007-4#6)(2007-5#8)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#24)(2008-10#213)(2008-11#125)(2008-12#38)(2008-2#51)(2008-3#128)(2008-4#68)(2008-5#43)(2008-6#24)(2008-7#109)(2008-8#55)(2008-9#75)(2009-1#1)(2009-10#13)(2009-11#15)(2009-12#7)(2009-2#6)(2009-3#7)(2009-4#6)(2009-5#18)(2009-6#11)(2009-7#11)(2009-8#13)(2009-9#18)(2010-1#4)(2010-10#22)(2010-11#22)(2010-12#25)(2010-2#7)(2010-3#16)(2010-4#12)(2010-5#12)(2010-6#12)(2010-7#5)(2010-8#21)(2010-9#5)(2011-1#39)(2011-10#2)(2011-2#93)(2011-3#4)(2011-7#3)(2012-1#11)(2012-12#37)(2012-2#92)(2012-3#53)(2012-5#1)(2012-9#1)(2013-1#73)(2013-3#1)(2013-7#3)(2013-8#45)
provided a better##5##3##(2008-1#1)(2008-10#2)(2009-8#1)(2012-2#1)
provided a direct##2##3##(1995-3#1)(2009-12#1)
provided a good##3##3##(2008-10#2)(2008-7#1)
provided a linear##3##3##(2008-10#3)
provided a more##2##3##(2008-1#1)(2008-10#1)
provided a picture of##2##4##(2008-7#2)
provided a rapid##2##3##(2007-12#1)(2008-10#1)
provided a sensitive##2##3##(2008-10#2)
provided a significant##2##3##(2008-10#2)
provided a source of##2##4##(2008-10#1)(2010-4#1)
provided a useful##3##3##(2008-3#1)(2009-9#1)(2012-3#1)
provided a variety of##3##4##(2008-12#1)(2011-1#1)(2013-8#1)
provided a##104##2##(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
provided accurate predictions of##2##4##(2008-10#2)
provided additional evidence##2##3##(1994-7#1)(2008-11#1)
provided additional information##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
provided additional##6##2##(1994-7#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
provided along with##2##3##(2008-11#1)(2008-4#1)
provided an excellent##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
provided an indication of##2##4##(2007-6#1)(2008-10#1)
provided an opportunity for##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2010-9#1)
provided an opportunity to##4##4##(1991-8#1)(2008-10#1)(2008-11#1)(2010-8#1)
provided an opportunity##8##3##(1991-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)
provided an##30##2##(1991-8#1)(1994-6#1)(1995-6#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
provided and##10##2##(2007-12#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
provided as a##2##3##(2007-11#1)(2008-4#1)
provided as##5##2##(1991-12#1)(2007-11#1)(2008-4#2)(2010-2#1)
provided at the##2##3##(2009-8#1)(2013-1#1)
provided at##8##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
provided based on##2##3##(2007-4#1)(2008-10#1)
provided baseline##2##2##(2008-4#1)(2009-4#1)
provided better##5##2##(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
provided by Trichoderma spp##2##4##(2008-10#2)
provided by a##18##3##(1993-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-10#1)(2009-2#1)
provided by an##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
provided by both##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
provided by either##3##3##(1992-6#1)(2007-12#1)(2007-9#1)
provided by its##2##3##(1997-2#1)(2008-10#1)
provided by synchrotron##2##3##(2008-10#1)(2008-3#1)
provided by the National##2##4##(2012-1#1)(2013-8#1)
provided by the identification of##2##5##(2007-7#1)(2012-3#1)
provided by the##83##3##(1990-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-8#2)(1995-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-9#1)(2007-11#4)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
provided by their##2##3##(2008-8#1)(2013-8#1)
provided by these##3##3##(1992-1#1)(1994-3#1)(2013-1#1)
provided by this##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)
provided by##231##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#3)(1994-3#3)(1994-8#3)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#5)(1997-6#1)(1997-7#1)(1997-9#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#41)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#4)
provided care##2##2##(1990-11#1)(2008-7#1)
provided clear##2##2##(2007-12#1)(2008-10#1)
provided complete##2##2##(2008-5#1)(2010-3#1)
provided continuous##2##2##(2008-3#1)(2009-8#1)
provided data##6##2##(2007-2#1)(2008-3#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
provided direct evidence for the##2##5##(2008-9#1)(2013-8#1)
provided direct##4##2##(2008-9#1)(2009-9#1)(2010-11#1)(2013-8#1)
provided during##4##2##(1992-12#1)(1993-2#1)(2007-7#1)(2008-10#1)
provided each##2##2##(1995-2#1)(2008-5#1)
provided either##2##2##(2008-4#1)(2008-5#1)
provided encouraging results##2##3##(1992-9#1)(2010-2#1)
provided estimates##2##2##(1991-5#1)(2008-9#1)
provided evidence for##4##3##(1991-2#1)(1994-5#1)(1996-5#1)(2009-11#1)
provided evidence of##10##3##(1994-1#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
provided evidence supporting the##2##4##(2008-12#1)(2008-8#1)
provided evidence that the##5##4##(1992-3#1)(2007-6#1)(2008-10#1)(2009-11#1)(2010-11#1)
provided evidence that##10##3##(1992-12#1)(1992-3#1)(2007-6#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#1)
provided evidence##26##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-11#2)(2009-6#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
provided examples##2##2##(2009-10#1)(2010-10#1)
provided excellent##5##2##(1995-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
provided experimental evidence of##2##4##(2008-9#1)(2011-1#1)
provided experimental##3##2##(2008-3#1)(2008-9#1)(2011-1#1)
provided facilities to##2##3##(2008-10#2)
provided facilities##3##2##(1992-5#1)(2008-10#2)
provided for a##6##3##(1992-2#1)(1993-1#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
provided for both##4##3##(2007-9#1)(2008-4#2)(2008-7#1)
provided for determining the##2##4##(2008-4#2)
provided for determining##3##3##(2008-4#3)
provided for each##3##3##(2007-7#1)(2008-2#1)(2008-4#1)
provided for preparation of##2##4##(2008-4#1)(2008-9#1)
provided for the##7##3##(1997-3#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)
provided for##84##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#31)(2008-5#2)(2008-7#3)(2008-9#7)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
provided from##2##2##(2008-11#1)(2008-12#1)
provided further evidence##4##3##(2008-10#2)(2009-9#1)(2011-2#1)
provided further##8##2##(1990-7#1)(2006-10#1)(2008-10#2)(2008-12#1)(2009-9#1)(2011-2#2)
provided good##7##2##(2007-8#1)(2008-10#3)(2009-11#1)(2009-3#1)(2012-1#1)
provided greater##2##2##(1996-3#1)(2008-6#1)
provided herein##3##2##(1992-1#1)(2008-5#1)(2008-7#1)
provided high sensitivity##2##3##(2008-10#2)
provided high##3##2##(2008-10#2)(2008-3#1)
provided highly##2##2##(2008-10#1)(2012-3#1)
provided important clues##2##3##(1991-2#1)(2008-9#1)
provided important##4##2##(1991-2#1)(1996-3#1)(1997-3#1)(2008-9#1)
provided in other##2##3##(1996-2#1)(2009-8#1)
provided in the##12##3##(1994-3#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#1)
provided in this unit##4##4##(2008-2#1)(2008-4#3)
provided in this##8##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)
provided in##37##2##(1994-12#1)(1994-3#2)(1996-2#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-4#6)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
provided including##2##2##(2008-11#2)
provided information about##3##3##(2006-12#1)(2008-11#1)(2013-8#1)
provided information on the##3##4##(2007-10#1)(2008-10#2)
provided information on##4##3##(1994-2#1)(2007-10#1)(2008-10#2)
provided information##9##2##(1994-2#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2013-1#1)(2013-8#1)
provided insight into##3##3##(1995-5#1)(2008-10#1)(2008-4#1)
provided insight##4##2##(1995-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
provided insights into the##3##4##(2008-4#1)(2013-1#2)
provided insights into##5##3##(2007-8#1)(2008-4#1)(2008-9#1)(2013-1#2)
provided insights##8##2##(2007-8#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#3)
provided is##4##2##(1995-12#1)(2008-4#2)(2008-9#1)
provided it is##2##3##(1994-2#1)(2011-2#1)
provided limited##2##2##(1992-3#1)(2011-2#1)
provided more##8##2##(1994-1#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#2)
provided new insight into the##2##5##(1993-2#1)(2010-8#1)
provided new insight into##3##4##(1993-2#1)(2010-4#1)(2010-8#1)
provided new insight##4##3##(1993-2#1)(1996-8#1)(2010-4#1)(2010-8#1)
provided new insights into the##4##5##(1997-8#1)(2007-7#1)(2008-10#2)
provided new insights##6##3##(1997-8#1)(2007-7#1)(2008-10#2)(2010-8#1)(2011-2#1)
provided new##15##2##(1993-2#2)(1996-8#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-2#1)
provided no##7##2##(1991-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
provided of##5##2##(1997-2#1)(1997-7#1)(2007-12#1)(2010-11#1)(2013-8#1)
provided on a##2##3##(1994-3#1)(2012-12#1)
provided on the##3##3##(2008-4#1)(2008-7#1)(2010-8#1)
provided on##6##2##(1994-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)
provided one of##2##3##(1995-6#1)(2008-5#1)
provided only##5##2##(2008-10#4)(2008-11#1)
provided over##2##2##(2008-12#1)(2013-1#1)
provided physiotherapy for##2##3##(2012-12#2)
provided physiotherapy students##2##3##(2012-12#2)
provided physiotherapy##6##2##(2012-12#6)
provided quantitative##2##2##(2010-10#1)(2012-1#1)
provided regarding##3##2##(2008-4#3)
provided reliable and##2##3##(2008-12#1)(2013-8#1)
provided reliable##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
provided results between##2##3##(2008-10#2)
provided results##6##2##(2008-10#4)(2011-2#1)(2012-2#1)
provided satisfactory results##4##3##(2008-10#3)(2013-1#1)
provided satisfactory##6##2##(2007-7#1)(2008-10#3)(2011-2#1)(2013-1#1)
provided services##2##2##(1992-12#1)(2008-6#1)
provided significant improvement##2##3##(2008-5#1)(2013-1#1)
provided significant protection against##2##4##(1995-12#1)(2008-10#1)
provided significant protection##4##3##(1992-6#1)(1995-12#1)(2008-10#2)
provided significant##10##2##(1992-6#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2013-1#1)
provided similar##2##2##(2008-7#1)(2009-3#1)
provided some##4##2##(1994-1#1)(1994-11#1)(2008-2#1)(2008-9#1)
provided support to##3##3##(2008-12#1)(2008-7#1)(2010-3#1)
provided support##4##2##(2008-12#1)(2008-7#1)(2010-3#1)(2010-4#1)
provided that a##4##3##(1991-6#1)(1994-5#1)(2008-3#1)(2008-9#1)
provided that adequate##2##3##(1992-2#1)(1994-2#1)
provided that all##2##3##(2008-3#1)(2008-4#1)
provided that species##2##3##(2008-8#2)
provided that the##17##3##(1990-11#1)(1990-7#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#7)(2008-8#2)(2009-11#1)(2012-2#1)
provided that##58##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#12)(2008-4#3)(2008-7#2)(2008-8#6)(2008-9#3)(2009-11#2)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
provided the basis for##3##4##(2008-4#1)(2008-8#1)(2010-5#1)
provided the best fit##3##4##(2008-10#3)
provided the best##11##3##(1996-8#1)(2008-10#7)(2011-2#2)(2013-1#1)
provided the evidence##2##3##(2008-10#1)(2008-8#1)
provided the flexibility##2##3##(2008-10#1)(2009-9#1)
provided the highest##2##3##(2009-8#1)(2012-3#1)
provided the impetus for##2##4##(1997-1#1)(1997-7#1)
provided the means##2##3##(2008-11#1)(2008-4#1)
provided the most##2##3##(2008-10#2)
provided the opportunity for##3##4##(1994-12#1)(2008-11#1)(2012-12#1)
provided the opportunity to##3##4##(1992-4#1)(1994-8#1)(2008-2#1)
provided the opportunity##6##3##(1992-4#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-2#1)(2012-12#1)
provided the scientific##2##3##(2008-10#2)
provided the##80##2##(1992-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-8#2)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#7)(2008-9#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
provided them with##2##3##(2007-12#1)(2007-7#1)
provided there##2##2##(1991-8#1)(2012-12#1)
provided they##2##2##(1994-12#1)(2010-8#1)
provided through##5##2##(1994-12#1)(1995-1#1)(1995-2#1)(2012-12#1)(2012-3#1)
provided to Medicare##2##3##(1991-3#1)(1996-2#1)
provided to a##3##3##(1995-12#1)(1995-3#1)(2012-3#1)
provided to illustrate the##2##4##(2008-11#2)
provided to inpatients##2##3##(1992-1#1)(1993-12#1)
provided to people with disabilities##2##5##(1996-1#1)(2009-6#1)
provided to the patients##2##4##(2007-9#1)(2008-10#1)
provided to the##6##3##(1991-3#1)(1992-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-1#1)
provided to##55##2##(1990-11#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#2)(1997-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
provided training##2##2##(2008-1#1)(2008-12#1)
provided unique information##2##3##(2009-9#1)(2010-8#1)
provided unsatisfactory##2##2##(2008-12#1)(2008-7#1)
provided us with##4##3##(1995-12#1)(1997-3#1)(2008-11#1)(2008-9#1)
provided useful##2##2##(2008-10#1)(2008-7#1)
provided using##2##2##(2008-10#1)(2010-4#1)
provided valuable information##4##3##(2008-1#1)(2008-10#1)(2010-4#1)(2012-12#1)
provided valuable##7##2##(2007-10#1)(2008-1#1)(2008-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)
provided values##2##2##(2008-10#1)(2013-7#1)
provided very good##2##3##(1995-2#1)(2008-7#1)
provided very##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
provided with a##2##3##(1996-1#1)(2013-7#1)
provided with an##2##3##(2008-10#1)(2008-11#1)
provided with continuous##2##3##(1992-1#1)(2007-8#1)
provided with the##2##3##(1992-3#1)(2009-2#1)
provided with##31##2##(1992-1#1)(1992-3#1)(1994-6#1)(1995-12#1)(1996-1#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
provided within the##2##3##(2008-12#1)(2008-2#1)
provided##1374##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#7)(1991-2#6)(1991-3#2)(1991-5#3)(1991-6#3)(1991-8#4)(1992-1#7)(1992-10#1)(1992-12#7)(1992-2#7)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#2)(1993-12#3)(1993-2#6)(1993-3#5)(1993-8#2)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#10)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1995-1#3)(1995-11#3)(1995-12#10)(1995-2#7)(1995-3#6)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#6)(1996-12#3)(1996-2#6)(1996-3#7)(1996-5#6)(1996-8#2)(1996-9#1)(1997-1#8)(1997-2#8)(1997-3#8)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(1997-9#1)(2006-10#1)(2006-12#2)(2007-10#8)(2007-11#13)(2007-12#26)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#16)(2008-10#237)(2008-11#63)(2008-12#29)(2008-2#35)(2008-3#63)(2008-4#95)(2008-5#33)(2008-6#11)(2008-7#47)(2008-8#35)(2008-9#49)(2009-10#4)(2009-11#6)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#10)(2009-9#8)(2010-1#4)(2010-10#5)(2010-11#8)(2010-12#4)(2010-2#3)(2010-3#6)(2010-4#10)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#21)(2010-9#2)(2011-1#15)(2011-2#36)(2011-3#1)(2011-7#1)(2012-1#7)(2012-12#30)(2012-2#19)(2012-3#22)(2013-1#38)(2013-7#8)(2013-8#24)
provider analysis and##5##3##(1991-12#1)(1993-12#2)(1994-12#1)(1995-2#1)
provider analysis##6##2##(1991-12#1)(1992-12#1)(1993-12#2)(1994-12#1)(1995-2#1)
provider and patient##2##3##(1996-12#1)(1997-2#1)
provider and##10##2##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-2#2)(2008-10#1)(2008-7#1)(2009-3#1)
provider choice##2##2##(1991-3#1)(1997-2#1)
provider control##3##2##(1995-3#1)(1996-11#2)
provider expertise##4##2##(1994-1#4)
provider for##2##2##(1996-5#1)(2009-3#1)
provider groups##3##2##(1996-12#1)(1996-2#1)(1997-3#1)
provider in##2##2##(1996-3#1)(2013-1#1)
provider information systems##2##3##(1996-12#2)
provider network##3##2##(1996-12#1)(1996-3#1)(2007-12#1)
provider networks##3##2##(1994-2#2)(1994-3#1)
provider obligations##2##2##(1991-2#1)(1994-1#1)
provider of##5##2##(1995-12#1)(1995-3#1)(1997-3#1)(2008-4#1)(2012-12#1)
provider organizations (PPOs)##3##3##(1991-3#1)(1994-1#1)(1997-1#1)
provider organizations##8##2##(1991-3#2)(1992-2#1)(1993-12#1)(1994-1#2)(1997-1#2)
provider payment##3##2##(1995-2#2)(1997-1#1)
provider performance##4##2##(1994-3#1)(1995-3#1)(2010-12#1)(2013-1#1)
provider practices##2##2##(1996-1#1)(2013-1#1)
provider profiling systems##2##3##(1996-1#2)
provider profiling##3##2##(1993-3#1)(1996-1#2)
provider relationship##2##2##(1993-12#1)(2013-8#1)
provider roles##2##2##(1996-3#1)(1997-1#1)
provider selection##2##2##(1994-1#1)(1996-2#1)
provider to##7##2##(1992-2#1)(1994-2#2)(2008-1#2)(2008-11#1)(2013-7#1)
provider were##2##2##(2011-1#1)(2013-7#1)
provider##171##1##(1991-12#2)(1991-2#3)(1991-3#4)(1992-12#3)(1992-2#2)(1992-3#2)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#3)(1994-1#12)(1994-12#6)(1994-2#8)(1994-3#5)(1995-1#1)(1995-12#3)(1995-2#6)(1995-3#8)(1995-6#1)(1996-1#4)(1996-11#3)(1996-12#7)(1996-2#5)(1996-3#3)(1996-5#2)(1997-1#7)(1997-2#7)(1997-3#5)(2007-12#4)(2007-2#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#3)(2009-3#2)(2010-1#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#11)(2013-7#5)(2013-8#2)
provider's##9##1##(1991-12#1)(1992-3#1)(1994-1#2)(1994-3#1)(2007-2#1)(2008-11#2)(2013-8#1)
provider-patient communication##2##2##(1995-12#1)(2013-8#1)
provider-patient relationship##5##2##(2013-8#5)
provider-patient##7##1##(1995-12#1)(2013-8#6)
provider-specific##2##1##(1996-1#2)
providers (physicians##2##2##(1994-3#1)(2012-3#1)
providers and consumers##2##3##(1993-1#1)(1997-3#1)
providers and the##7##3##(1995-1#2)(1996-1#1)(1996-2#1)(2007-2#1)(2008-12#1)(2010-12#1)
providers and##41##2##(1992-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#4)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#3)(2007-2#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-7#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
providers are##11##2##(1991-3#1)(1992-8#1)(1994-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-2#1)
providers at##2##2##(2008-6#1)(2011-1#1)
providers but##3##2##(1996-12#1)(2008-12#1)(2013-8#1)
providers can##4##2##(1994-12#1)(1994-3#1)(1996-3#1)(2013-1#1)
providers coded##2##2##(2011-2#2)
providers for##4##2##(1993-12#1)(1996-1#1)(1996-2#1)(2010-9#1)
providers has##2##2##(1992-1#1)(1996-3#1)
providers have##7##2##(1992-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1997-5#1)(2008-11#1)(2008-12#1)
providers in order to##2##4##(1994-12#1)(1995-1#1)
providers in the##8##3##(1994-1#1)(1995-3#1)(2008-1#1)(2008-11#1)(2009-9#1)(2012-12#1)(2012-3#2)
providers in##22##2##(1992-2#1)(1994-1#2)(1994-12#1)(1995-1#2)(1995-3#2)(1996-11#1)(1996-3#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#2)
providers into##2##2##(1993-3#2)
providers is to##3##3##(1992-12#1)(2008-11#1)(2008-6#1)
providers is##8##2##(1992-12#2)(1994-12#2)(2008-11#1)(2008-6#2)(2011-1#1)
providers may be##2##3##(2008-10#1)(2012-3#1)
providers must##3##2##(1991-12#1)(1995-12#1)(2008-6#1)
providers need to understand##2##4##(2007-10#1)(2008-3#1)
providers need to##7##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-3#1)
providers need##8##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-3#1)
providers of health care##3##4##(1995-1#1)(1997-1#1)(2008-7#1)
providers of health##4##3##(1995-1#1)(1997-1#1)(2008-7#2)
providers of##12##2##(1991-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-7#2)(2010-10#1)(2012-2#1)
providers on##2##2##(1993-1#1)(1996-12#1)
providers should be aware of##2##5##(2010-3#1)(2013-1#1)
providers should be##3##3##(1994-3#1)(2010-3#1)(2013-1#1)
providers should##6##2##(1994-3#1)(2007-10#1)(2008-3#1)(2010-3#1)(2011-1#1)(2013-1#1)
providers that##4##2##(1993-12#2)(1995-1#1)(2013-1#1)
providers to work##2##3##(2008-11#1)(2011-2#1)
providers to##28##2##(1991-2#1)(1992-12#1)(1993-12#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-6#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
providers under##2##2##(1991-2#1)(1995-12#1)
providers were##4##2##(1991-3#1)(1992-3#1)(1993-3#1)(1996-8#1)
providers who##8##2##(1992-12#1)(1992-2#1)(1993-12#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-12#1)(2012-12#1)
providers will##4##2##(1994-12#1)(1995-1#1)(1995-12#1)(1996-12#1)
providers would##2##2##(1996-5#1)(1997-2#1)
providers##392##1##(1991-1#1)(1991-12#3)(1991-2#5)(1991-3#5)(1992-1#1)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#2)(1992-8#1)(1993-1#5)(1993-12#16)(1993-2#1)(1993-3#6)(1993-5#2)(1994-1#12)(1994-12#15)(1994-2#6)(1994-3#9)(1994-8#1)(1995-1#13)(1995-12#9)(1995-2#2)(1995-3#4)(1995-6#1)(1996-1#7)(1996-11#1)(1996-12#13)(1996-2#9)(1996-3#19)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#15)(1997-3#11)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-12#3)(2007-2#4)(2007-9#1)(2008-1#8)(2008-10#3)(2008-11#22)(2008-12#7)(2008-3#5)(2008-4#1)(2008-6#9)(2008-7#6)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#15)(2013-1#18)(2013-8#15)
providers'##13##1##(1994-1#1)(1994-2#2)(1994-3#1)(1996-11#1)(1996-2#1)(2008-11#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
providers) in##2##2##(1995-2#1)(1995-3#1)
providers)##4##1##(1995-2#1)(1995-3#1)(2009-10#1)(2012-1#1)
providers?##3##1##(1993-12#2)(2008-4#1)
provides &quot##2##2##(1992-3#1)(2013-1#1)
provides a basis for##6##4##(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-8#1)
provides a better##4##3##(1993-3#1)(1995-12#1)(2008-10#1)(2008-9#1)
provides a brief background on##2##5##(2007-5#1)(2009-11#1)
provides a brief description of the##3##6##(2008-11#1)(2008-7#1)(2010-5#1)
provides a brief overview of the##6##6##(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)
provides a brief overview of##7##5##(1993-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)
provides a brief overview##8##4##(1993-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)
provides a brief##21##3##(1993-2#1)(1996-9#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-1#1)
provides a case study##3##4##(1995-6#1)(2009-3#1)(2012-12#1)
provides a case##4##3##(1994-12#1)(1995-6#1)(2009-3#1)(2012-12#1)
provides a clear##3##3##(1992-8#1)(2008-2#1)(2008-9#1)
provides a complete##2##3##(2008-9#1)(2011-2#1)
provides a comprehensive##6##3##(2008-11#1)(2008-4#4)(2011-3#1)
provides a conceptual##4##3##(1997-2#1)(2008-11#1)(2008-8#1)(2013-8#1)
provides a concise##2##3##(2008-11#1)(2012-12#1)
provides a constructive##2##3##(1996-1#1)(2008-3#1)
provides a convenient##2##3##(2008-9#1)(2012-12#1)
provides a cost-effective##3##3##(1994-3#2)(2008-10#1)
provides a critical##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
provides a description of the##2##5##(1996-12#1)(1997-1#1)
provides a description of##4##4##(1996-12#1)(1997-1#1)(2008-12#2)
provides a descriptive##2##3##(1996-1#1)(2008-4#1)
provides a detailed method for##2##5##(2008-4#1)(2008-9#1)
provides a detailed##7##3##(2008-10#1)(2008-4#1)(2008-9#4)(2011-1#1)
provides a fast##2##3##(2008-10#2)
provides a flexible##2##3##(2008-3#1)(2008-9#1)
provides a framework for##5##4##(1997-8#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-8#1)
provides a framework to##2##4##(2007-12#1)(2012-2#1)
provides a framework##10##3##(1997-8#1)(2007-12#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
provides a general guideline##2##4##(2008-10#1)(2010-5#1)
provides a general##8##3##(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-5#1)
provides a good##6##3##(1991-2#1)(1992-11#1)(1997-6#1)(2008-5#1)(2010-10#1)(2012-2#1)
provides a guide for##3##4##(2008-4#1)(2011-2#1)(2012-12#1)
provides a guide##5##3##(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
provides a high##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
provides a higher##2##3##(2007-11#1)(2011-1#1)
provides a highly##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
provides a limit of detection##2##5##(2008-10#2)
provides a link between the##2##5##(2007-12#1)(2009-7#1)
provides a map of##2##4##(2008-3#2)
provides a means of##5##4##(1992-5#1)(2007-4#1)(2008-10#1)(2008-2#1)(2010-11#1)
provides a means to##3##4##(1997-2#1)(2008-12#1)(2009-10#1)
provides a means##10##3##(1992-5#1)(1995-12#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2010-11#1)
provides a measure of the##3##5##(1997-2#1)(2008-2#1)(2008-9#1)
provides a measure of##5##4##(1996-2#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-9#1)
provides a mechanism for the##2##5##(2008-11#1)(2013-1#1)
provides a mechanism for##4##4##(2008-11#1)(2009-5#1)(2013-1#2)
provides a mechanism##5##3##(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#2)
provides a method for##3##4##(2008-3#1)(2008-4#2)
provides a method##5##3##(1992-9#1)(2008-3#1)(2008-4#2)(2010-6#1)
provides a minimum##2##3##(1990-8#1)(2008-3#1)
provides a model for##4##4##(1992-6#1)(1992-8#1)(2008-1#1)(2008-10#1)
provides a model of##2##4##(2008-4#1)(2008-7#1)
provides a model##7##3##(1991-1#1)(1992-6#1)(1992-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
provides a more##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
provides a near##2##3##(2010-5#1)(2010-7#1)
provides a new and##2##4##(1996-5#1)(2013-8#1)
provides a new tool##2##4##(1996-12#2)
provides a new##22##3##(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-6#1)(2012-2#2)(2013-8#3)
provides a perspective##3##3##(2008-1#1)(2010-10#1)(2012-12#1)
provides a physical##2##3##(2008-11#1)(2008-3#1)
provides a plausible##2##3##(2008-10#2)
provides a possible explanation for the##2##6##(1992-3#1)(1997-1#1)
provides a possible##5##3##(1992-3#1)(1997-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
provides a potent##2##3##(1992-8#1)(2008-10#1)
provides a potential##2##3##(2008-10#1)(2008-9#1)
provides a powerful tool for##5##5##(1996-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
provides a powerful tool to##2##5##(2008-2#1)(2012-3#1)
provides a powerful tool##7##4##(1996-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-3#1)
provides a powerful##9##3##(1996-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-12#1)(2012-3#1)
provides a practical approach##2##4##(2010-12#1)(2012-2#1)
provides a practical##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
provides a promising##3##3##(2009-5#1)(2010-5#1)(2013-1#1)
provides a quantitative##3##3##(2008-9#1)(2009-9#1)(2013-7#1)
provides a quick##3##3##(2008-10#1)(2008-4#2)
provides a rapid and sensitive##3##5##(1993-8#1)(2008-10#2)
provides a rapid and##6##4##(1993-8#1)(2008-10#5)
provides a reference##2##3##(2007-7#1)(2008-3#1)
provides a reliable and##2##4##(1990-12#1)(2013-1#1)
provides a reliable##4##3##(1990-12#1)(2007-12#1)(2011-2#1)(2013-1#1)
provides a review of the current##2##6##(2010-12#1)(2011-7#1)
provides a review of the##5##5##(2008-10#1)(2008-8#1)(2010-12#2)(2011-7#1)
provides a review of##8##4##(1995-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#2)(2011-7#1)(2013-1#1)
provides a review##9##3##(1995-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#2)(2011-7#1)(2013-1#1)
provides a series of##2##4##(1992-6#1)(2008-9#1)
provides a set of##3##4##(1994-3#1)(2008-4#2)
provides a significant##3##3##(1990-5#1)(2008-1#1)(2010-11#1)
provides a simple and##3##4##(1995-12#1)(2008-10#1)(2008-9#1)
provides a simple way to##5##5##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
provides a simple##13##3##(1995-12#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#2)
provides a source of##2##4##(1990-8#1)(2013-1#1)
provides a source##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
provides a strong##2##3##(2008-5#1)(2010-4#1)
provides a suitable##3##3##(1995-12#1)(2008-11#1)(2012-2#1)
provides a summary of the##2##5##(1992-3#1)(2008-7#1)
provides a summary of##8##4##(1992-3#1)(1996-1#1)(2008-4#3)(2008-7#1)(2010-3#1)(2011-2#1)
provides a systematic##2##3##(2008-11#1)(2008-4#1)
provides a testable##2##3##(2008-8#1)(2008-9#1)
provides a tool##2##3##(2008-2#1)(2008-7#1)
provides a unique opportunity to##3##5##(2007-12#1)(2008-1#1)(2008-12#1)
provides a unique way to##2##5##(2007-11#1)(2007-12#1)
provides a unique way##3##4##(1993-1#1)(2007-11#1)(2007-12#1)
provides a unique##11##3##(1992-6#1)(1993-1#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#1)(2011-7#1)
provides a useful tool to##2##5##(2008-4#1)(2008-5#1)
provides a useful tool##3##4##(2008-4#2)(2008-5#1)
provides a useful##14##3##(1993-3#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)
provides a valuable##5##3##(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2011-2#1)
provides a versatile##2##3##(2008-8#1)(2009-8#1)
provides a very##6##3##(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)
provides a way##2##3##(1995-2#1)(2009-11#1)
provides a##480##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-6#3)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#12)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#10)(2008-10#60)(2008-11#19)(2008-12#14)(2008-2#16)(2008-3#24)(2008-4#41)(2008-5#9)(2008-6#2)(2008-7#17)(2008-8#12)(2008-9#29)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#13)(2011-3#1)(2011-7#2)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#7)
provides access to##4##3##(1992-2#1)(1994-12#1)(2008-8#1)(2009-12#1)
provides accurate##3##2##(1994-6#2)(2008-2#1)
provides additional evidence##3##3##(1997-6#1)(2009-8#1)(2013-1#1)
provides additional##11##2##(1993-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-8#1)(2013-1#1)
provides adequate##2##2##(1992-1#1)(1992-12#1)
provides advantages##2##2##(1992-11#1)(2008-1#1)
provides all the##2##3##(2007-12#1)(2008-9#1)
provides ample##2##2##(2008-12#1)(2011-1#1)
provides an acceptable##2##3##(2008-10#1)(2013-8#1)
provides an alternative and##2##4##(2008-10#2)
provides an alternative##7##3##(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)
provides an analysis of the##2##5##(2008-8#1)(2010-8#1)
provides an analysis of##3##4##(2008-8#1)(2010-10#1)(2010-8#1)
provides an analysis##4##3##(2008-1#1)(2008-8#1)(2010-10#1)(2010-8#1)
provides an analytical##2##3##(1991-5#1)(2008-3#1)
provides an attractive##4##3##(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)
provides an easy##2##3##(2007-12#1)(2008-10#1)
provides an effective and##2##4##(2008-2#1)(2013-1#1)
provides an effective##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)(2013-1#1)
provides an efficient means to##2##5##(1997-2#1)(2008-10#1)
provides an efficient method of##2##5##(2008-11#1)(2008-4#1)
provides an efficient##8##3##(1995-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)
provides an estimate of the##2##5##(2008-10#2)
provides an estimate of##3##4##(2008-10#2)(2011-1#1)
provides an excellent example##2##4##(1993-12#1)(2008-2#1)
provides an excellent platform##2##4##(2008-10#1)(2009-12#1)
provides an excellent##15##3##(1990-8#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#5)(2009-12#1)(2009-9#1)(2011-2#1)
provides an explanation for the##3##5##(1994-8#1)(1997-2#1)(2013-1#1)
provides an explanation for##4##4##(1994-8#1)(1997-2#1)(2010-3#1)(2013-1#1)
provides an important##8##3##(1991-9#1)(1993-1#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-12#1)
provides an indication of##2##4##(2009-8#1)(2010-9#1)
provides an indirect measure of the##2##6##(2008-9#1)(2010-5#1)
provides an introduction to the##2##5##(2008-10#1)(2008-4#1)
provides an introduction to##11##4##(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-7#1)(2012-12#1)
provides an opportunity for##2##4##(1996-12#1)(2008-10#1)
provides an opportunity to review##2##5##(2007-2#1)(2008-4#1)
provides an opportunity to##9##4##(1994-2#1)(1995-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#1)(2013-1#2)
provides an opportunity##12##3##(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-4#1)(2013-1#2)
provides an overview of the current##2##6##(2009-2#1)(2013-1#1)
provides an overview of the field of##3##7##(2007-12#1)(2008-4#2)
provides an overview of the types of##2##7##(1997-2#1)(2008-2#1)
provides an overview of the various##2##6##(2010-12#1)(2011-1#1)
provides an overview of the##35##5##(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2009-1#1)(2009-2#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
provides an overview of various##2##5##(1991-1#1)(2008-4#1)
provides an overview of##65##4##(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-2#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#12)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
provides an update##2##3##(2011-1#1)(2012-1#1)
provides an##198##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#3)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#22)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#9)(2009-1#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#11)(2013-8#3)
provides analytical##2##2##(2007-11#1)(2008-8#1)
provides and##3##2##(1996-12#1)(2008-4#1)(2012-2#1)
provides another##2##2##(1992-8#1)(2010-8#1)
provides background##4##2##(1991-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
provides basic information##2##3##(2008-10#1)(2008-4#1)
provides basic##3##2##(2008-10#1)(2008-4#2)
provides better##9##2##(2007-8#2)(2008-2#2)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
provides both an##2##3##(1993-12#1)(1996-12#1)
provides both##8##2##(1993-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-11#1)
provides brief##2##2##(1993-12#1)(1996-12#1)
provides clear##2##2##(2008-9#1)(2013-8#1)
provides commonly used abbreviations for many terms used in##2##9##(2008-4#1)(2008-9#1)
provides compelling evidence##3##3##(1995-3#1)(2008-2#1)(2010-8#1)
provides compelling##4##2##(1995-2#1)(1995-3#1)(2008-2#1)(2010-8#1)
provides complete##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
provides considerable detail##2##3##(1995-1#1)(2008-9#1)
provides considerable##3##2##(1995-1#1)(2008-10#1)(2008-9#1)
provides current##2##2##(2010-11#1)(2011-1#1)
provides data##2##2##(2008-9#1)(2011-2#1)
provides details##2##2##(1990-8#1)(1995-11#1)
provides direct evidence##2##3##(2011-2#1)(2012-2#1)
provides direct##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
provides efficient##2##2##(2008-10#1)(2008-3#1)
provides enhanced##3##2##(2007-12#1)(2008-10#1)(2009-11#1)
provides essential##2##2##(2008-1#1)(2008-9#1)
provides even##2##2##(2008-2#1)(2008-3#1)
provides evidence for the##3##4##(1994-8#1)(1996-5#1)(1997-4#1)
provides evidence for##14##3##(1990-11#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
provides evidence of the##2##4##(2008-10#1)(2010-5#1)
provides evidence of##7##3##(1992-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
provides evidence that the##2##4##(2008-10#1)(2010-2#1)
provides evidence that##7##3##(1993-11#1)(1994-6#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-2#1)
provides evidence##30##2##(1990-11#1)(1990-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
provides examples from the##2##4##(1993-12#1)(2008-7#1)
provides examples of##5##3##(1997-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2012-2#1)
provides examples##8##2##(1993-12#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
provides excellent##11##2##(1991-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2011-7#1)(2012-2#1)
provides flexibility##2##2##(2008-3#1)(2008-8#1)
provides for a##4##3##(1996-2#1)(1996-3#1)(2008-9#1)(2012-2#1)
provides for older adults and researchers##2##6##(2013-1#2)
provides for the##8##3##(1994-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#1)
provides for##18##2##(1994-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#3)(2011-2#2)(2012-2#2)(2013-1#2)
provides full##2##2##(2007-12#1)(2008-9#1)
provides further evidence for the##2##5##(2008-10#2)
provides further evidence for##3##4##(2008-10#2)(2008-7#1)
provides further evidence that##3##4##(1994-2#1)(1994-8#1)(1995-12#1)
provides further evidence##6##3##(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-7#1)
provides further support for##2##4##(1990-11#1)(2008-10#1)
provides further##10##2##(1990-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#3)(2008-7#2)(2008-8#1)
provides good results##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
provides good##12##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
provides guidance for##4##3##(2008-4#3)(2008-9#1)
provides guidance##6##2##(1993-1#1)(1997-2#1)(2008-4#3)(2008-9#1)
provides guidelines##3##2##(1991-1#1)(2008-1#1)(2008-4#1)
provides health care##2##3##(1991-4#1)(2008-12#1)
provides high resolution##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
provides high sensitivity and##2##4##(2007-11#1)(2008-3#1)
provides high spectral resolution and high-throughput capabilities that##2##8##(2008-2#2)
provides high##15##2##(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-6#1)(2009-10#1)(2011-1#1)
provides high-resolution##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
provides higher##5##2##(2008-10#1)(2008-3#2)(2008-4#2)
provides important##5##2##(2008-3#3)(2008-7#1)(2009-11#1)
provides improved##2##2##(2008-3#1)(2012-12#1)
provides in##3##2##(1992-10#1)(1995-12#1)(2012-2#1)
provides increased##2##2##(2007-12#1)(2008-3#1)
provides indications##2##2##(1991-6#1)(2008-10#1)
provides indirect##2##2##(1990-3#1)(2012-3#1)
provides information about the##11##4##(1996-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)
provides information about##13##3##(1996-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
provides information concerning the##3##4##(1992-8#1)(1994-5#1)(2008-10#1)
provides information concerning##4##3##(1992-8#1)(1994-5#1)(1997-6#1)(2008-10#1)
provides information on the##6##4##(1991-6#1)(1995-11#1)(1997-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
provides information on##12##3##(1991-5#1)(1991-6#1)(1992-3#1)(1995-11#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)
provides information##38##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-11#2)(1996-1#1)(1997-4#1)(1997-6#2)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2010-7#1)(2010-8#1)(2011-2#1)
provides insight in##2##3##(2008-10#1)(2008-12#1)
provides insight into the potential of##2##6##(2012-2#1)(2013-1#1)
provides insight into the##8##4##(1994-1#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#2)
provides insight into##13##3##(1994-1#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#2)
provides insight##15##2##(1994-1#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#2)
provides insights into the##6##4##(2008-4#2)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
provides insights into##10##3##(2008-4#3)(2008-5#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
provides instructions for##2##3##(2008-4#2)
provides little##2##2##(1991-5#1)(1996-2#1)
provides managers with##2##3##(1993-12#1)(2009-3#1)
provides many##2##2##(2007-8#1)(2008-3#1)
provides maximum##2##2##(2008-2#2)
provides methods for the##3##4##(2008-2#1)(2008-4#2)
provides methods for##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
provides minimal##3##2##(1993-2#1)(1996-12#1)(2008-9#1)
provides molecular##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
provides more##3##2##(1990-8#1)(2011-7#2)
provides much more##2##3##(2007-7#1)(2008-3#1)
provides much##3##2##(2007-7#1)(2008-3#1)(2012-12#1)
provides multiple##2##2##(2008-5#1)(2008-9#1)
provides new information that##2##4##(2009-8#1)(2010-8#1)
provides new insights into the##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
provides new insights into##6##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-8#1)
provides new insights##7##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
provides new opportunities##2##3##(2007-7#1)(2011-2#1)
provides new##17##2##(1993-8#1)(1995-5#1)(1996-2#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
provides no information##2##3##(2008-4#1)(2008-8#1)
provides no##4##2##(1990-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
provides novel##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
provides numerous##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
provides only##5##2##(1993-9#1)(2008-1#1)(2008-10#3)
provides opportunities for##3##3##(1995-1#1)(1995-12#1)(2008-12#1)
provides physiological##2##2##(1996-5#1)(2012-12#1)
provides practical##3##2##(1995-12#1)(2010-12#1)(2012-12#1)
provides precise##2##2##(2008-3#1)(2008-7#1)
provides preliminary##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
provides protocols for##9##3##(2008-1#1)(2008-4#4)(2008-9#4)
provides protocols##11##2##(2008-1#1)(2008-4#5)(2008-9#5)
provides quantitative information##2##3##(2008-10#2)
provides quantitative##5##2##(2007-11#1)(2008-10#3)(2008-7#1)
provides rapid##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
provides reasonable##2##2##(2008-3#1)(2010-8#1)
provides recommendations for##2##3##(2007-12#1)(2008-3#1)
provides recommendations##4##2##(2007-12#1)(2008-3#1)(2010-10#1)(2011-2#1)
provides relatively##2##2##(2008-2#1)(2008-3#1)
provides reliable data in the 320-420-nm region##2##7##(2008-2#1)(2008-3#1)
provides reliable data##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
provides reliable information on##2##4##(1991-2#1)(2011-1#1)
provides reliable##7##2##(1991-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
provides resistance to##2##3##(2008-10#2)
provides results##2##2##(2008-10#1)(2008-11#1)
provides services##2##2##(1994-1#1)(1995-3#1)
provides several##2##2##(2008-8#1)(2013-1#1)
provides significant##4##2##(1996-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
provides significantly##2##2##(2007-12#1)(2008-3#1)
provides similar##2##2##(2008-10#1)(2013-1#1)
provides simultaneous##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
provides some##13##2##(1992-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
provides spatial##2##2##(2007-12#1)(2008-10#1)
provides spectra##2##2##(2007-12#1)(2008-2#1)
provides statistically##2##2##(2008-10#1)(2011-2#1)
provides step-by-step##2##2##(1993-3#1)(2008-12#1)
provides strong evidence##2##3##(1995-12#1)(2012-3#1)
provides strong support##2##3##(2012-3#2)
provides strong##4##2##(1995-12#1)(2012-3#3)
provides substantial##3##2##(2007-11#1)(2009-11#1)(2010-3#1)
provides such##2##2##(1997-1#1)(2012-3#1)
provides sufficient##2##2##(1993-9#1)(2008-9#1)
provides support for the##2##4##(2007-12#1)(2011-1#1)
provides support for##3##3##(1994-3#1)(2007-12#1)(2011-1#1)
provides the advantages of##2##4##(2008-3#1)(2012-2#1)
provides the basic biosafety information needed to perform the procedures detailed in this manual##2##14##(2008-4#1)(2008-9#1)
provides the basic##3##3##(2008-4#1)(2008-9#1)(2009-12#1)
provides the basis for the##2##5##(2008-10#1)(2012-1#1)
provides the basis for##7##4##(1992-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
provides the best##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
provides the first##7##3##(1990-2#1)(1990-7#1)(1993-3#1)(1995-2#1)(2008-10#2)(2009-2#1)
provides the foundation for further##2##5##(2010-10#1)(2013-1#1)
provides the latest##2##3##(1997-2#1)(2008-9#1)
provides the means to##4##4##(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
provides the most##3##3##(1995-2#1)(1997-2#1)(2013-8#1)
provides the opportunity to##8##4##(1994-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-3#1)
provides the optimal##2##3##(2007-12#1)(2008-3#1)
provides the possibility of##2##4##(2008-1#1)(2008-11#1)
provides the possibility##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
provides the potential to##2##4##(1994-8#1)(2008-10#1)
provides the required##4##3##(2008-3#2)(2008-5#1)(2008-7#1)
provides the results##2##3##(1994-2#1)(2010-9#1)
provides the same##4##3##(2008-10#2)(2008-5#1)(2009-8#1)
provides the##119##2##(1990-2#1)(1990-7#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#2)(1995-2#2)(1995-5#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-6#1)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#2)
provides these##2##2##(2007-6#1)(2008-9#1)
provides treatment##2##2##(2011-2#1)(2013-1#1)
provides two##4##2##(1990-12#1)(2008-3#1)(2008-9#1)(2009-10#1)
provides unique##2##2##(2010-11#1)(2012-2#1)
provides us with a##3##4##(1992-1#1)(2008-6#1)(2008-9#1)
provides us with##5##3##(1992-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
provides useful information and##2##4##(2008-4#1)(2009-12#1)
provides useful information##5##3##(1992-10#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-12#1)
provides useful##9##2##(1992-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-3#1)
provides valuable information##2##3##(2006-10#1)(2007-12#1)
provides valuable##6##2##(1994-7#1)(2006-10#1)(2007-12#1)(2008-4#1)(2010-11#1)(2013-1#1)
provides very##5##2##(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#2)
provides##1542##1##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#6)(1991-1#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#1)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#9)(1992-4#1)(1992-5#4)(1992-6#7)(1992-8#7)(1992-9#1)(1993-1#5)(1993-11#2)(1993-12#11)(1993-2#6)(1993-3#9)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#5)(1994-12#8)(1994-2#8)(1994-3#11)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#7)(1995-1#4)(1995-11#4)(1995-12#19)(1995-2#8)(1995-3#5)(1995-5#3)(1995-6#7)(1995-9#1)(1996-1#6)(1996-10#1)(1996-12#11)(1996-2#11)(1996-3#5)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#12)(1997-3#8)(1997-4#7)(1997-6#7)(1997-7#2)(1997-8#3)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#3)(2007-11#29)(2007-12#48)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#11)(2008-1#29)(2008-10#182)(2008-11#43)(2008-12#33)(2008-2#57)(2008-3#102)(2008-4#112)(2008-5#23)(2008-6#11)(2008-7#51)(2008-8#22)(2008-9#89)(2009-1#1)(2009-10#7)(2009-11#9)(2009-12#7)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#6)(2009-7#4)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#8)(2010-11#7)(2010-12#12)(2010-2#1)(2010-3#8)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#12)(2010-9#4)(2011-1#20)(2011-2#50)(2011-3#2)(2011-7#5)(2011-8#1)(2012-1#4)(2012-12#23)(2012-2#40)(2012-3#17)(2013-1#42)(2013-7#4)(2013-8#25)
providing a balanced##2##3##(1995-12#1)(2013-1#1)
providing a comprehensive##2##3##(1991-11#1)(2008-4#1)
providing a differential##2##3##(1990-6#1)(2008-3#1)
providing a direct##2##3##(2007-11#1)(2008-11#1)
providing a framework for##4##4##(1994-1#2)(2008-3#1)(2009-6#1)
providing a major##2##3##(2008-10#2)
providing a mean level of disease reduction of##2##8##(2008-10#2)
providing a method##2##3##(1997-2#1)(2008-10#1)
providing a molecular##2##3##(2012-12#1)(2013-8#1)
providing a new##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
providing a possible##3##3##(1993-1#1)(2008-10#1)(2011-2#1)
providing a potential##3##3##(2008-10#3)
providing a rationale for##2##4##(2008-11#1)(2008-4#1)
providing a ready source of##2##5##(2008-10#1)(2010-12#1)
providing a solid##3##3##(2007-12#1)(2008-9#1)(2012-2#1)
providing a suitable##2##3##(2008-10#2)
providing a tool##2##3##(2008-7#1)(2008-8#1)
providing a##110##2##(1990-6#1)(1991-11#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-6#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#21)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
providing abortions##3##2##(1994-2#2)(1997-2#1)
providing access to##4##3##(1994-2#1)(2007-12#1)(2008-4#1)(2008-8#1)
providing access##6##2##(1992-12#1)(1994-2#1)(2007-12#1)(2008-4#2)(2008-8#1)
providing additional##5##2##(2008-10#3)(2013-1#2)
providing adequate##3##2##(1991-2#1)(2007-8#1)(2012-12#1)
providing all##2##2##(1995-12#1)(2009-10#1)
providing an adequate##2##3##(1992-1#1)(2009-5#1)
providing an effective##2##3##(2008-10#1)(2008-3#1)
providing an estimate of the##2##5##(1992-1#1)(2008-11#1)
providing an estimate##3##3##(1992-1#1)(1996-3#1)(2008-11#1)
providing an overview of##2##4##(2008-4#1)(2011-2#1)
providing an##22##2##(1992-1#2)(1993-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
providing and##3##2##(1997-2#1)(2008-10#1)(2010-8#1)
providing appropriate##3##2##(1996-2#2)(2008-11#1)
providing benefits to the##2##4##(1997-3#1)(2008-12#1)
providing better##6##2##(1991-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)
providing both##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
providing care for##3##3##(1996-2#1)(2007-6#1)(2011-2#1)
providing care to a##2##4##(2009-5#1)(2010-9#1)
providing care to people with mental illness##2##7##(2011-1#2)
providing care to##11##3##(2007-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#3)(2010-4#1)(2010-9#1)(2011-1#2)
providing care##21##2##(1995-12#1)(1996-2#2)(1996-3#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#3)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#1)
providing clear##3##2##(1993-12#1)(2007-11#1)(2008-11#1)
providing clinical##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
providing consumer health information##2##4##(1993-1#1)(1997-3#1)
providing data on the##2##4##(2007-12#1)(2010-6#1)
providing data on##4##3##(2007-12#1)(2008-3#1)(2010-6#1)(2010-9#1)
providing detailed##2##2##(1996-3#1)(2008-5#1)
providing direct##2##2##(1995-2#1)(1996-2#1)
providing education##2##2##(2008-7#1)(2010-10#1)
providing evidence for##5##3##(1991-5#1)(1992-12#1)(1992-6#1)(2008-4#1)(2009-10#1)
providing evidence of##2##3##(1994-11#1)(2009-12#1)
providing evidence that the##3##4##(2008-10#2)(2013-8#1)
providing evidence that##5##3##(2008-10#3)(2008-11#1)(2013-8#1)
providing evidence##13##2##(1991-5#1)(1992-12#1)(1992-6#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2011-1#1)(2013-8#1)
providing examples of##2##3##(1996-3#1)(2013-8#1)
providing examples##3##2##(1996-3#1)(2010-7#1)(2013-8#1)
providing excellent##2##2##(1993-12#1)(2012-3#1)
providing financial##2##2##(1993-1#1)(1993-12#1)
providing for the##2##3##(1992-12#1)(2010-10#1)
providing for##4##2##(1992-12#1)(2008-1#1)(2008-2#1)(2010-10#1)
providing further evidence that##2##4##(1991-12#1)(1993-6#1)
providing further evidence##3##3##(1991-12#1)(1993-6#1)(2009-10#1)
providing further##5##2##(1991-12#1)(1993-6#1)(2008-11#2)(2009-10#1)
providing general##2##2##(1993-3#1)(2007-7#1)
providing guidance##2##2##(2007-10#1)(2008-8#1)
providing health care services##2##4##(1996-12#1)(1996-2#1)
providing health care##3##3##(1996-12#1)(1996-2#1)(2008-12#1)
providing health services##2##3##(2011-1#1)(2011-2#1)
providing health##6##2##(1996-12#1)(1996-2#1)(2008-12#1)(2011-1#1)(2011-2#2)
providing high##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
providing home care##2##3##(1991-1#1)(1993-1#1)
providing home##3##2##(1991-1#1)(1993-1#1)(1995-3#1)
providing immediate##2##2##(2008-4#1)(2008-8#1)
providing improved##2##2##(1997-2#1)(2008-10#1)
providing information about##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
providing information on the##3##4##(1997-3#1)(2008-10#1)(2013-1#1)
providing information on##8##3##(1994-1#1)(1994-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)
providing information##17##2##(1994-1#1)(1994-9#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
providing insights##2##2##(2008-7#1)(2013-8#1)
providing integrated treatment##2##3##(2008-6#1)(2012-12#1)
providing it##2##2##(1993-3#1)(2008-10#1)
providing its##2##2##(1991-9#1)(2011-1#1)
providing more accurate##2##3##(2008-3#1)(2012-3#1)
providing more##6##2##(2008-3#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-3#2)
providing new##7##2##(2008-5#1)(2009-12#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
providing no##4##2##(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
providing optimal##3##2##(1995-5#1)(2008-11#1)(2008-9#1)
providing primary##2##2##(1997-4#1)(2008-1#1)
providing quality##3##2##(1991-1#1)(2008-11#1)(2012-12#1)
providing relief##2##2##(2007-8#1)(2008-11#1)
providing resources##2##2##(2008-6#1)(2010-4#1)
providing responses##2##2##(2008-1#1)(2010-11#1)
providing services##4##2##(1997-3#1)(2007-5#1)(2011-2#1)(2012-2#1)
providing some##4##2##(2008-6#1)(2008-9#1)(2010-1#1)(2011-3#1)
providing spiritual care##4##3##(2009-11#1)(2011-1#3)
providing strong##2##2##(2008-2#1)(2011-1#1)
providing such##3##2##(1994-12#1)(1997-3#1)(2007-11#1)
providing sufficient##2##2##(2008-10#1)(2010-8#1)
providing support for the##3##4##(1993-1#1)(2012-12#1)(2012-3#1)
providing support for##5##3##(1993-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
providing support to##2##3##(2007-12#1)(2010-12#1)
providing support##9##2##(1993-1#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
providing temporary##2##2##(2010-10#1)(2011-2#1)
providing that##3##2##(1990-12#1)(1997-4#1)(2010-10#1)
providing the appropriate##2##3##(2010-7#1)(2013-8#1)
providing the basis for##2##4##(1994-11#1)(2009-7#1)
providing the best##2##3##(2008-10#2)
providing the information##2##3##(1995-12#1)(1997-1#1)
providing the necessary##3##3##(1995-2#1)(2010-12#1)(2012-12#1)
providing the##35##2##(1993-12#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-2#2)(1997-1#2)(2006-5#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
providing this##3##2##(1993-12#1)(1994-2#1)(2008-9#1)
providing timely##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
providing treatment##2##2##(2010-12#1)(2013-8#1)
providing##613##1##(1990-12#1)(1990-3#1)(1990-6#2)(1990-7#1)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#2)(1992-3#3)(1992-6#1)(1993-1#7)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#4)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#4)(1994-9#2)(1995-1#6)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#4)(1996-2#7)(1996-3#8)(1997-1#3)(1997-2#6)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#6)(2007-11#11)(2007-12#15)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#11)(2008-10#67)(2008-11#40)(2008-12#11)(2008-2#10)(2008-3#20)(2008-4#18)(2008-5#7)(2008-6#10)(2008-7#20)(2008-8#14)(2008-9#16)(2009-10#3)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#1)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#21)(2011-2#18)(2011-3#2)(2012-12#10)(2012-2#10)(2012-3#10)(2013-1#15)(2013-7#3)(2013-8#10)
province during##2##2##(2012-12#1)(2013-1#1)
province in eastern##2##3##(2008-8#1)(2009-6#1)
province in the##2##3##(1997-3#1)(2008-5#1)
province in##11##2##(1996-1#1)(1997-3#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2013-1#2)
province of Varese##2##3##(1992-10#1)(1992-8#1)
province of##37##2##(1992-10#1)(1992-8#1)(1993-2#1)(1994-9#2)(1995-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#1)(2008-8#2)(2009-10#2)(2009-7#3)(2011-1#2)(2012-12#1)(2013-1#2)
province##116##1##(1990-9#1)(1992-1#1)(1992-10#6)(1992-8#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-12#19)(2008-5#6)(2008-6#1)(2008-8#5)(2009-10#2)(2009-6#1)(2009-7#4)(2010-5#1)(2011-1#16)(2011-2#1)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#9)
province-wide##3##1##(1991-2#1)(1994-1#1)(1996-1#1)
province]##6##1##(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
provinces are##2##2##(2008-10#1)(2010-12#1)
provinces for##2##2##(2007-12#1)(2008-8#1)
provinces have##2##2##(1993-3#1)(2008-12#1)
provinces in##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
provinces of##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2013-1#1)
provinces to##2##2##(1996-12#1)(2012-12#1)
provinces##51##1##(1992-12#1)(1993-3#2)(1994-2#1)(1996-12#1)(2007-12#4)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-7#1)(2008-8#8)(2008-9#2)(2009-7#1)(2010-12#1)(2010-8#2)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
provincial and##5##2##(1992-1#1)(1993-1#1)(1993-2#1)(1997-5#1)(2009-5#1)
provincial government##3##2##(1992-2#1)(1995-2#1)(2012-12#1)
provincial governments##3##2##(2007-12#1)(2008-12#1)(2012-12#1)
provincial health directors##2##3##(2012-12#2)
provincial health##5##2##(1996-1#1)(2012-12#4)
provincial##40##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-5#1)(2010-8#2)(2012-12#9)
provincially##2##1##(2008-10#1)(2008-12#1)
proving a##2##2##(2008-10#1)(2013-8#1)
proving that the##2##3##(2008-10#2)
proving that##5##2##(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
proving the##8##2##(1991-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-4#1)(2012-12#1)
proving to be##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
proving##23##1##(1990-12#1)(1991-3#1)(1994-12#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
proviral DNA##5##2##(1991-9#1)(1992-12#1)(1997-3#1)(2008-5#1)(2008-9#1)
proviral cell line##2##3##(2008-9#2)
proviral integration##2##2##(1994-8#1)(2008-2#1)
proviral##15##1##(1991-5#1)(1991-9#2)(1992-12#1)(1994-12#1)(1994-7#2)(1994-8#1)(1997-3#1)(2008-2#1)(2008-5#1)(2008-9#3)(2012-12#1)
provirus tagging##3##2##(1991-5#3)
provirus##10##1##(1990-2#2)(1991-5#4)(1994-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
proviruses##4##1##(1991-5#2)(1995-2#1)(1995-8#1)
provision and##5##2##(1996-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
provision during##3##2##(1996-5#1)(2009-9#1)(2013-8#1)
provision for##11##2##(1994-1#2)(1995-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-12#2)
provision in##4##2##(1995-11#1)(2007-2#1)(2008-11#1)(2012-2#1)
provision is##2##2##(2012-1#1)(2012-12#1)
provision of a public good##2##5##(1993-2#1)(2008-10#1)
provision of a##6##3##(1993-2#1)(1994-12#1)(1994-2#1)(2008-10#2)(2011-1#1)
provision of adequate##4##3##(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
provision of care##3##3##(1995-3#1)(1997-8#1)(2011-1#1)
provision of family-centered##2##3##(1993-12#1)(2010-9#1)
provision of health##6##3##(1992-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-5#1)(2012-12#1)
provision of information##3##3##(1996-1#1)(1997-3#1)(2007-7#1)
provision of medical##2##3##(1996-2#1)(2011-2#1)
provision of quality##3##3##(1992-2#1)(1994-2#2)
provision of safe and##2##4##(2008-12#1)(2010-10#1)
provision of services##6##3##(1990-2#1)(1992-12#1)(1993-2#1)(1996-3#1)(2007-12#1)(2008-10#1)
provision of the##3##3##(1995-1#1)(1995-12#1)(2012-3#1)
provision of this##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
provision of##111##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#3)(1994-1#2)(1994-12#1)(1994-2#4)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-5#3)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#3)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#4)(2008-5#2)(2008-7#2)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)
provision##171##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#3)(1993-3#1)(1994-1#4)(1994-12#1)(1994-2#4)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#3)(1997-1#1)(1997-2#4)(1997-3#4)(1997-5#3)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2008-1#4)(2008-10#7)(2008-11#12)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#7)(2011-2#4)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#6)
provisional diagnosis of##2##3##(2007-7#1)(2011-1#1)
provisional##15##1##(1990-5#1)(1992-12#1)(1992-6#1)(1995-3#1)(1995-6#1)(2007-1#1)(2007-7#1)(2008-10#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-7#1)(2013-1#3)
provisionally##4##1##(1990-8#1)(1994-6#1)(2008-10#2)
provisioning##3##1##(2008-6#1)(2008-9#2)
provisions for##5##2##(1994-1#1)(1995-1#1)(2008-7#1)(2012-12#1)(2012-3#1)
provisions of the##5##3##(1991-1#1)(1992-1#1)(1993-2#1)(1994-3#1)(2010-5#1)
provisions of##8##2##(1991-1#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-3#1)(1996-1#1)(2010-5#1)
provisions that##2##2##(1991-3#1)(1993-1#1)
provisions##39##1##(1991-1#1)(1991-12#1)(1991-3#3)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#3)(1993-2#1)(1993-3#3)(1994-1#1)(1994-3#2)(1995-1#3)(1995-2#1)(1996-1#1)(1997-1#1)(1997-8#1)(2007-4#2)(2007-9#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#2)
provocation of pain by##2##4##(1990-6#2)
provocation of##3##2##(1990-6#2)(1991-3#1)
provocation test##4##2##(2010-6#2)(2012-3#1)(2013-1#1)
provocation tests are##2##3##(1997-1#1)(2010-8#1)
provocation tests##5##2##(1990-6#1)(1997-1#1)(2007-7#1)(2010-8#1)(2013-1#1)
provocation##20##1##(1990-6#3)(1991-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-6#2)(2010-8#1)(2012-3#2)(2013-1#2)
provocative##9##1##(1994-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2008-4#2)(2008-7#1)(2012-3#1)(2013-1#1)
provoke a##4##2##(1991-1#1)(1993-3#1)(2010-4#1)(2011-1#1)
provoke##12##1##(1991-1#1)(1992-2#1)(1993-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)
provoked a##5##2##(1993-11#1)(1994-8#1)(1994-9#1)(2008-6#1)(2011-2#1)
provoked by the##3##3##(1993-11#1)(2008-10#1)(2009-7#1)
provoked by##5##2##(1993-11#1)(2008-10#2)(2009-7#1)(2012-2#1)
provoked##23##1##(1991-2#1)(1992-1#1)(1993-11#2)(1994-8#1)(1994-9#1)(1996-3#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
provokes a##2##2##(2012-2#1)(2012-3#1)
provokes the development of##2##4##(2009-7#1)(2011-1#1)
provokes##9##1##(1994-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
provoking and##2##2##(2008-11#1)(2008-7#1)
provoking##9##1##(1993-5#1)(1993-6#1)(1997-5#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2013-1#1)
prowazekii##3##1##(1994-12#2)(1995-12#1)
proxies for the##2##3##(1992-1#1)(2008-7#1)
proxies for##3##2##(1992-1#1)(2008-7#1)(2011-1#1)
proxies##11##1##(1992-1#1)(1992-12#3)(2008-7#5)(2008-8#1)(2011-1#1)
proximal VS cells and##2##4##(2008-11#2)
proximal VS cells##3##3##(2008-11#3)
proximal anastomosis##3##2##(2007-8#3)
proximal anastomotic devices##3##3##(2010-8#3)
proximal anastomotic##5##2##(2007-8#1)(2010-8#4)
proximal and distal##11##3##(1993-1#2)(1997-8#1)(2007-12#2)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
proximal and##16##2##(1992-5#1)(1993-1#2)(1997-8#1)(2007-12#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
proximal bond##2##2##(1994-5#2)
proximal caries##2##2##(2008-12#1)(2010-3#1)
proximal colon##3##2##(1994-12#1)(1997-4#1)(2008-12#1)
proximal contact##2##2##(1990-9#1)(2010-12#1)
proximal cortical##2##2##(2013-8#2)
proximal end in##2##3##(2007-11#1)(2008-12#1)
proximal end of the femur##5##5##(2007-11#5)
proximal end of the##9##4##(1995-6#1)(2007-11#6)(2007-8#1)(2008-6#1)
proximal end of##10##3##(1995-6#1)(2007-11#6)(2007-8#1)(2008-6#1)(2013-8#1)
proximal end##13##2##(1995-6#1)(2007-11#7)(2007-8#1)(2008-12#1)(2008-6#1)(2011-2#1)(2013-8#1)
proximal ends##3##2##(2007-11#1)(2008-5#1)(2011-1#1)
proximal femoral growth plate in children with unilateral Perthes disease##2##10##(2007-11#2)
proximal femoral growth plate##3##4##(2007-11#3)
proximal femoral##8##2##(2007-11#3)(2008-6#2)(2012-2#1)(2013-1#1)(2013-7#1)
proximal femur fractures##3##3##(2007-11#1)(2007-8#2)
proximal femur using the##2##4##(2009-3#1)(2011-2#1)
proximal femur##29##2##(2006-10#1)(2007-11#18)(2007-8#3)(2008-6#3)(2009-3#1)(2011-2#2)(2013-1#1)
proximal gastric##2##2##(1993-2#1)(2013-1#1)
proximal heme##2##2##(1990-8#1)(1991-9#1)
proximal histidine##4##2##(1994-5#1)(1995-2#2)(2007-11#1)
proximal humeral plate can provide##2##5##(2013-1#2)
proximal humeral plate##3##3##(2013-1#3)
proximal humeral##5##2##(2007-11#1)(2009-3#1)(2013-1#3)
proximal humerus fractures are##2##4##(2007-8#2)
proximal humerus fractures##7##3##(2007-11#1)(2007-8#6)
proximal humerus of a dog##2##5##(2012-3#2)
proximal humerus of##3##3##(1996-11#1)(2012-3#2)
proximal humerus##17##2##(1996-11#1)(2007-11#1)(2007-8#8)(2008-6#4)(2009-4#1)(2012-3#2)
proximal hypospadias##4##2##(2008-10#1)(2009-5#3)
proximal interphalangeal joint##2##3##(2008-9#2)
proximal interphalangeal##8##2##(2008-9#6)(2011-2#1)(2012-3#1)
proximal jejunum##3##2##(2008-10#1)(2010-12#1)(2013-7#1)
proximal ligand of sperm whale##2##5##(1994-5#2)
proximal ligand##4##2##(1994-5#4)
proximal obstruction##2##2##(1993-1#1)(1997-8#1)
proximal occlusion##2##2##(1997-3#2)
proximal one##2##2##(2008-7#1)(2009-3#1)
proximal part of the##3##4##(1991-5#1)(1993-12#1)(2008-7#1)
proximal part of##5##3##(1991-5#1)(1993-12#1)(2007-11#1)(2008-7#1)(2012-2#1)
proximal part##7##2##(1991-5#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-3#1)(2012-2#1)
proximal patency##2##2##(1993-1#2)
proximal phalanx##4##2##(2010-3#3)(2012-2#1)
proximal promoter##2##2##(1990-11#1)(1997-7#1)
proximal region of the##2##4##(1994-11#1)(2008-10#1)
proximal region of##3##3##(1993-2#1)(1994-11#1)(2008-10#1)
proximal segment##2##2##(1991-9#1)(2007-12#1)
proximal tibia##4##2##(2009-3#1)(2012-1#2)(2012-12#1)
proximal to the##12##3##(1990-11#1)(1990-8#1)(1993-3#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)
proximal to##15##2##(1990-11#1)(1990-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)
proximal tubular epithelium##2##3##(1994-5#2)
proximal tubular##9##2##(1993-3#1)(1994-5#4)(1995-11#2)(2007-12#1)(2011-2#1)
proximal tubule cells##5##3##(1991-5#1)(1992-8#3)(2008-11#1)
proximal tubule##11##2##(1991-5#1)(1992-8#3)(1994-5#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-9#1)(2013-8#1)
proximal tubules##5##2##(1996-5#1)(1997-1#4)
proximal##337##1##(1990-11#2)(1990-8#3)(1990-9#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#8)(1993-12#1)(1993-2#2)(1993-3#3)(1993-8#4)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#13)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#5)(1997-2#1)(1997-3#5)(1997-4#3)(1997-7#3)(1997-8#3)(1997-9#1)(2006-10#2)(2006-12#1)(2007-11#39)(2007-12#8)(2007-5#1)(2007-8#22)(2008-1#1)(2008-10#11)(2008-11#9)(2008-12#10)(2008-3#1)(2008-5#4)(2008-6#12)(2008-7#7)(2008-8#1)(2008-9#13)(2009-1#1)(2009-2#1)(2009-3#6)(2009-4#2)(2009-5#8)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#6)(2010-4#1)(2010-8#6)(2011-1#2)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#11)(2013-3#1)(2013-7#5)(2013-8#10)
proximal-to-distal##4##1##(1995-2#1)(2011-2#3)
proximally to##2##2##(1997-3#1)(2008-4#1)
proximally##13##1##(1992-11#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2013-8#1)
proximate analysis##2##2##(2010-2#1)(2010-4#1)
proximate composition and##2##3##(2011-2#1)(2012-2#1)
proximate composition##4##2##(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
proximate##20##1##(1991-5#2)(1992-11#1)(1995-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2010-11#2)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
proximities of##2##2##(1995-6#1)(2012-3#1)
proximities##3##1##(1995-6#1)(2008-5#1)(2012-3#1)
proximity and##4##2##(1994-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
proximity assay##6##2##(2008-11#1)(2008-4#4)(2013-1#1)
proximity between##2##2##(1995-2#1)(2008-7#1)
proximity in##4##2##(1993-11#1)(2008-2#1)(2008-9#2)
proximity of the##4##3##(1994-5#1)(2008-11#1)(2008-3#1)(2011-2#1)
proximity of##14##2##(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
proximity patterns##5##2##(2008-10#5)
proximity searching##2##2##(1997-1#1)(1997-3#1)
proximity that##2##2##(1997-6#1)(2008-4#1)
proximity to the##10##3##(1992-9#1)(1993-6#1)(1994-5#1)(1996-4#1)(1996-7#1)(1997-5#1)(2007-11#1)(2008-10#2)(2010-5#1)
proximity to##21##2##(1992-9#1)(1993-6#2)(1994-5#1)(1996-4#1)(1996-7#1)(1997-5#1)(2007-11#1)(2008-10#6)(2008-6#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
proximity was##3##2##(2008-7#1)(2008-9#1)(2009-4#1)
proximity##88##1##(1992-9#1)(1993-11#1)(1993-6#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#7)(2009-12#1)(2009-4#4)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
proxy for##7##2##(2008-10#1)(2008-2#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
proxy informants##2##2##(2010-12#2)
proxy##27##1##(1992-12#1)(1993-3#1)(1994-12#1)(1995-5#2)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#1)(2013-1#1)
prudent exploitation##2##2##(2008-8#2)
prudent for##2##2##(1991-12#1)(1995-1#1)
prudent that##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
prudent to recommend##2##3##(2008-7#1)(2010-5#1)
prudent to##5##2##(1991-12#1)(1997-3#1)(2008-7#1)(2010-5#1)(2013-1#1)
prudent##19##1##(1991-12#2)(1995-1#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-5#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
prune (Prunus##2##2##(2008-10#2)
prune belly syndrome##3##3##(2008-7#3)
prune orchards in##3##3##(2008-10#3)
prune orchards##7##2##(2008-10#7)
prune##16##1##(2008-10#12)(2008-7#3)(2008-8#1)
pruned##2##1##(2008-10#1)(2008-3#1)
pruni##4##1##(2008-10#4)
pruning##3##1##(2008-10#3)
pruritic papular##2##2##(2007-2#1)(2010-6#1)
pruritic##10##1##(2007-2#4)(2010-6#5)(2012-3#1)
pruritis##2##1##(2010-1#1)(2013-1#1)
pruritus in##2##2##(1993-3#1)(2008-4#1)
pruritus##12##1##(1991-2#1)(1993-3#1)(2007-7#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-6#1)(2013-1#2)(2013-7#2)
ps and##4##2##(2007-1#1)(2008-2#1)(2008-8#1)(2013-8#1)
ps in##2##2##(2008-2#1)(2009-9#1)
ps is##2##2##(2007-11#1)(2008-3#1)
ps with##2##2##(2007-12#2)
ps##63##1##(1992-6#1)(1993-11#1)(1995-5#1)(1996-2#1)(2007-1#5)(2007-11#14)(2007-12#9)(2008-2#8)(2008-3#17)(2008-8#4)(2009-9#1)(2013-8#1)
ps)##6##1##(1991-12#1)(1995-3#1)(2008-2#1)(2008-3#3)
ps/(nm##2##1##(2007-12#2)
psbA-trnH intergenic##2##2##(2011-2#2)
psbA-trnH sequences##2##2##(2011-2#2)
psbA-trnH##6##1##(2011-2#6)
psbP gene encoding##2##3##(1996-10#2)
psbP gene##4##2##(1996-10#4)
psbP##6##1##(1996-10#6)
pseudarthrosis##2##1##(2009-3#1)(2012-2#1)
pseudo first-order kinetics##2##3##(2008-10#1)(2008-11#1)
pseudo first-order##3##2##(2008-10#2)(2008-11#1)
pseudo##13##1##(1997-7#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)
pseudo-atomic##2##1##(2008-4#1)(2009-8#1)
pseudo-digestion of##3##2##(2008-10#3)
pseudo-digestion were as follows##2##4##(2008-10#2)
pseudo-digestion##9##1##(2008-10#9)
pseudo-first order##6##2##(1990-11#1)(1991-5#1)(2008-10#4)
pseudo-first-order##5##1##(1992-5#2)(1993-8#1)(1994-8#1)(2008-10#1)
pseudo-obstruction##2##1##(1991-5#1)(2011-2#1)
pseudo-pneumatosis##2##1##(2012-2#2)
pseudo-second-order##2##1##(2013-1#1)(2013-8#1)
pseudo-steady state##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
pseudo-syringae##2##1##(2008-10#2)
pseudoanalog true-time-delay##2##2##(2008-3#2)
pseudoaneurysm formation##2##2##(2008-7#1)(2012-2#1)
pseudoaneurysm of the MMA##2##4##(2008-12#2)
pseudoaneurysm of the ascending aorta##2##5##(2007-8#2)
pseudoaneurysm of the##6##3##(2007-8#3)(2008-12#3)
pseudoaneurysm which was##2##3##(2007-8#1)(2012-2#1)
pseudoaneurysm##31##1##(1991-3#1)(2007-8#9)(2008-12#6)(2008-7#3)(2009-7#1)(2011-2#1)(2012-12#3)(2012-2#7)
pseudoaneurysms are##2##2##(2011-2#2)
pseudoaneurysms##11##1##(2007-7#1)(2007-8#1)(2008-12#2)(2008-7#4)(2011-2#2)(2012-2#1)
pseudoarthroses##2##1##(2009-3#2)
pseudoarthrosis##4##1##(1997-6#1)(2007-2#1)(2009-3#2)
pseudobactin production##3##2##(2008-10#3)
pseudobactin##5##1##(2008-10#5)
pseudocatenulatum##2##1##(2008-11#2)
pseudocyst of the##3##3##(1991-6#2)(2011-2#1)
pseudocyst##13##1##(1990-12#1)(1991-6#2)(2009-2#1)(2011-2#4)(2013-1#5)
pseudocysts##9##1##(1991-6#1)(1991-8#6)(2013-1#2)
pseudodata##2##1##(2008-2#2)
pseudodipeptides##3##1##(2008-5#3)
pseudoephedrine##9##1##(1995-2#2)(2007-10#1)(2008-10#6)
pseudoexfoliation glaucoma##3##2##(2011-2#3)
pseudoexfoliation##4##1##(2011-2#4)
pseudoexfoliative glaucoma in Primorsko-Goranska County##2##5##(2011-2#2)
pseudoexfoliative glaucoma##6##2##(2011-2#6)
pseudoflava##5##1##(1997-6#5)
pseudogamous parthenogenetic##3##2##(2008-5#3)
pseudogamous##5##1##(2008-5#5)
pseudogene and##3##2##(1991-6#1)(1993-6#1)(1997-4#1)
pseudogene from Bos taurus##2##4##(1993-2#2)
pseudogene is##3##2##(1993-12#1)(1993-2#1)(1994-11#1)
pseudogene was##3##2##(1990-8#1)(1994-11#1)(1997-4#1)
pseudogene##38##1##(1990-8#5)(1991-6#3)(1993-12#5)(1993-2#5)(1993-6#4)(1994-11#2)(1994-6#1)(1995-11#2)(1997-4#8)(2008-1#1)(2008-10#1)(2008-11#1)
pseudogenes for##3##2##(1991-6#3)
pseudogenes##18##1##(1990-8#3)(1991-6#7)(1993-2#1)(1993-8#1)(1995-11#2)(1997-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
pseudograph's##4##1##(2007-11#4)
pseudoguiding##2##1##(2008-3#2)
pseudoislets formation##3##2##(2010-11#3)
pseudoislets##12##1##(2010-11#12)
pseudoknot##2##1##(2008-10#2)
pseudoknots##2##1##(2009-11#2)
pseudomembranous##2##1##(2008-5#1)(2009-5#1)
pseudomolecular ions##3##2##(1994-3#3)
pseudomonad##9##1##(2008-10#9)
pseudomonad-based##2##1##(2008-10#2)
pseudomonads and xanthomonads##2##3##(2008-10#2)
pseudomonads and##3##2##(2008-10#3)
pseudomonads in##4##2##(2008-10#4)
pseudomonads##23##1##(2008-10#23)
pseudomyxoma peritonei##4##2##(2007-2#1)(2009-1#1)(2009-5#2)
pseudonondiffracting beams##2##2##(2008-3#2)
pseudonygamai##3##1##(2008-10#3)
pseudophakic##6##1##(1991-2#1)(2011-2#4)(2013-1#1)
pseudophases##2##1##(1990-5#1)(2008-10#1)
pseudopregnancy##2##1##(1992-9#2)
pseudopregnant rat##3##2##(1997-6#1)(2008-8#1)(2008-9#1)
pseudopregnant##5##1##(1997-6#2)(2008-8#2)(2008-9#1)
pseudopseudohypoparathyroidism##2##1##(2010-6#2)
pseudorandom code##3##2##(2007-12#2)(2008-3#1)
pseudorandom##11##1##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#5)
pseudorecombinant##2##1##(2008-10#2)
pseudorecombinants##2##1##(2008-10#2)
pseudorotation##2##1##(1993-11#1)(1996-2#1)
pseudosarcomatous polyp##2##2##(2008-11#2)
pseudosarcomatous##3##1##(2008-11#3)
pseudosclerotia and##2##2##(2008-10#2)
pseudosclerotia of##2##2##(2008-10#2)
pseudosclerotia or##2##2##(2008-10#2)
pseudosclerotia that##2##2##(2008-10#2)
pseudosclerotia##19##1##(2008-10#19)
pseudostationary phase##2##2##(2008-10#2)
pseudostationary##3##1##(2008-10#3)
pseudosubstrate domain of##3##3##(1992-9#2)(1993-11#1)
pseudosubstrate##5##1##(1992-9#3)(1993-11#1)(1996-6#1)
pseudosyringae##4##1##(2008-10#4)
pseudothecia and ascospores##5##3##(2008-10#5)
pseudothecia and pycnidia##2##3##(2008-10#2)
pseudothecia and##9##2##(2008-10#9)
pseudothecia development##3##2##(2008-10#3)
pseudothecia formed##3##2##(2008-10#3)
pseudothecia matured##2##2##(2008-10#2)
pseudothecia maturity##6##2##(2008-10#6)
pseudothecia were##4##2##(2008-10#4)
pseudothecia##44##1##(2008-10#44)
pseudothecial density and##2##3##(2008-10#2)
pseudothecial initials##2##2##(2008-10#2)
pseudothecial##6##1##(2008-10#6)
pseudothecium##6##1##(2008-10#6)
pseudotumor of the##5##3##(1990-10#2)(2008-12#2)(2010-12#1)
pseudotumor##12##1##(1990-10#2)(1991-9#1)(2007-8#2)(2008-12#2)(2008-4#1)(2009-3#1)(2010-12#3)
pseudotumour of the lung##4##4##(2008-7#1)(2013-1#3)
pseudotumour of the##5##3##(2008-7#1)(2012-12#1)(2013-1#3)
pseudotumour syndrome##2##2##(2008-7#2)
pseudotumour##8##1##(2008-7#4)(2012-12#1)(2013-1#3)
pseudotumoural lesions##2##2##(2012-2#2)
pseudotumoural##4##1##(2010-10#1)(2012-2#3)
pseudotype##2##1##(1990-5#2)
pseudouridine (psi)##2##2##(1990-8#1)(1993-8#1)
pseudouridine and 1-methyladenosine##6##3##(1992-3#5)(1993-8#1)
pseudouridine##14##1##(1990-8#5)(1992-3#5)(1993-8#2)(1997-2#2)
pseudowords##5##1##(1990-8#2)(2008-4#1)(2010-7#1)(2013-8#1)
psi --&gt##2##2##(1992-8#1)(2008-3#1)
psi =##3##2##(2008-2#2)(2008-3#1)
psi COX6b-1##3##2##(1991-6#3)
psi COX6b-2 and psi COX6b-3##2##5##(1991-6#2)
psi##53##1##(1990-11#2)(1990-8#1)(1991-6#7)(1992-8#18)(1993-2#3)(1993-8#2)(1994-2#1)(2008-10#2)(2008-2#3)(2008-3#9)(2008-6#4)(2008-7#1)
psilocin and psilocybin##4##3##(2008-10#4)
psilocin##5##1##(2008-10#5)
psilocybin##22##1##(2008-10#9)(2013-8#13)
psittaci and##2##2##(1992-5#1)(2012-12#1)
psittaci was##2##2##(2012-12#2)
psittaci##13##1##(1990-5#1)(1992-5#1)(1993-2#2)(1993-9#2)(2012-12#6)(2013-1#1)
psittacine birds##2##2##(1997-6#1)(2008-5#1)
psittacine circovirus (PsCV)##2##3##(2008-5#2)
psittacine##6##1##(1997-6#1)(2008-5#5)
psittacines##3##1##(1992-2#2)(1997-3#1)
psoas hitch procedure##2##3##(2008-10#2)
psoas hitch##3##2##(2008-10#3)
psoas major muscle##3##3##(2011-2#3)
psoas major##4##2##(2008-7#1)(2011-2#3)
psoas muscle##4##2##(1995-2#1)(2008-10#1)(2009-2#1)(2009-4#1)
psoas##19##1##(1991-3#1)(1995-2#1)(1996-11#1)(1996-6#1)(2008-10#5)(2008-7#1)(2009-2#1)(2009-4#5)(2011-2#3)
psoralen was##2##2##(2008-11#2)
psoralen##8##1##(1995-2#1)(2008-11#7)
psoriasis and##4##2##(2008-6#1)(2013-1#3)
psoriasis in##4##2##(1997-8#1)(2007-11#1)(2008-6#1)(2011-2#1)
psoriasis that##2##2##(1997-8#1)(2008-6#1)
psoriasis with##2##2##(1993-11#1)(2008-8#1)
psoriasis##48##1##(1993-11#4)(1993-8#1)(1995-5#2)(1996-2#1)(1997-8#3)(2007-11#8)(2007-7#1)(2008-3#1)(2008-5#3)(2008-6#8)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#8)
psoriatic arthritis##4##2##(1990-6#2)(2006-10#1)(2010-5#1)
psoriatic plaques##3##2##(2012-2#3)
psoriatic spondyloarthropathy##3##2##(2006-10#3)
psoriatic##12##1##(1990-6#2)(2006-10#4)(2007-11#1)(2010-5#1)(2012-2#4)
psu##2##1##(2008-4#1)(2008-7#1)
psychiatric admission##2##2##(1996-9#1)(2008-6#1)
psychiatric adverse##2##2##(2009-7#2)
psychiatric and neurological##2##3##(1993-1#1)(2011-2#1)
psychiatric and##14##2##(1990-6#1)(1991-2#1)(1993-1#3)(1995-1#1)(1996-7#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
psychiatric assessment##2##2##(2010-12#2)
psychiatric care##6##2##(1990-6#1)(1992-3#1)(1993-12#1)(2011-2#1)(2012-12#2)
psychiatric clinic##2##2##(2008-2#2)
psychiatric clinics##2##2##(1997-8#1)(2008-2#1)
psychiatric comorbidities##3##2##(2008-6#1)(2009-4#1)(2013-1#1)
psychiatric comorbidity and##2##3##(2008-4#1)(2013-1#1)
psychiatric comorbidity in##2##3##(1991-1#1)(2009-10#1)
psychiatric comorbidity##6##2##(1991-1#1)(2008-4#1)(2008-6#1)(2009-10#1)(2013-1#2)
psychiatric condition##3##2##(2008-4#2)(2011-1#1)
psychiatric conditions and##2##3##(1995-5#1)(2009-9#1)
psychiatric conditions##4##2##(1995-5#1)(2008-7#1)(2009-9#1)(2012-3#1)
psychiatric consultation##2##2##(1992-11#1)(2008-4#1)
psychiatric diagnoses##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
psychiatric disease in##2##3##(2008-9#1)(2011-1#1)
psychiatric disease##3##2##(1991-12#1)(2008-9#1)(2011-1#1)
psychiatric diseases were##2##3##(1993-8#1)(2013-8#1)
psychiatric diseases##5##2##(1993-8#1)(1996-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
psychiatric disorder that##2##3##(2008-4#1)(2012-12#1)
psychiatric disorder##5##2##(1994-2#1)(2008-12#1)(2008-2#1)(2008-4#1)(2012-12#1)
psychiatric disorders and##5##3##(1996-8#1)(2008-4#1)(2008-9#1)(2011-1#2)
psychiatric disorders in##2##3##(2007-1#1)(2008-1#1)
psychiatric disorders##62##2##(1991-1#3)(1996-11#3)(1996-6#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#6)(2009-10#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#6)(2011-2#2)(2012-2#6)(2013-1#2)(2013-7#2)(2013-8#1)
psychiatric facilities##6##2##(1991-2#1)(1993-2#1)(1993-3#1)(1996-1#1)(1997-5#1)(2010-4#1)
psychiatric facility##3##2##(1991-2#1)(1992-12#1)(1993-2#1)
psychiatric healthcare##6##2##(1991-2#2)(2011-2#4)
psychiatric hospital##20##2##(1991-12#1)(1991-2#3)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#5)(2008-11#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
psychiatric hospital]##2##2##(2008-9#1)(2009-10#1)
psychiatric hospitalization on##2##3##(1991-2#1)(1993-1#1)
psychiatric hospitalization##5##2##(1991-2#2)(1993-1#1)(1995-1#1)(2012-3#1)
psychiatric hospitals are##2##3##(1992-1#1)(1992-12#1)
psychiatric hospitals is##2##3##(1991-12#1)(1993-2#1)
psychiatric hospitals##17##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1993-12#4)(1993-2#1)
psychiatric illness##4##2##(1993-12#1)(1994-2#2)(2008-4#1)
psychiatric illnesses##3##2##(1993-12#1)(2008-11#1)(2008-4#1)
psychiatric inpatient unit##2##3##(1993-2#1)(2009-9#1)
psychiatric inpatient##4##2##(1991-2#1)(1992-3#1)(1993-2#1)(2009-9#1)
psychiatric inpatients##3##2##(1993-2#1)(2008-11#1)(2013-1#1)
psychiatric intervention##2##2##(1992-1#1)(1996-1#1)
psychiatric mental health##3##3##(2008-1#1)(2008-12#2)
psychiatric morbidity##5##2##(1993-2#1)(1993-5#1)(2008-11#1)(2012-3#2)
psychiatric nurse##2##2##(2008-11#2)
psychiatric nurses##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
psychiatric nurses'##3##2##(2008-11#2)(2008-12#1)
psychiatric nursing students##4##3##(2008-11#3)(2008-12#1)
psychiatric nursing##7##2##(2008-11#6)(2008-12#1)
psychiatric occupational therapy##8##3##(2012-1#8)
psychiatric or medical##2##3##(2009-4#1)(2009-9#1)
psychiatric or##4##2##(1995-1#1)(2009-11#1)(2009-4#1)(2009-9#1)
psychiatric outcome##2##2##(1994-2#1)(2009-9#1)
psychiatric outpatients##3##2##(2007-2#1)(2008-6#1)(2011-2#1)
psychiatric patients who##2##3##(1992-3#1)(2008-1#1)
psychiatric patients##16##2##(1992-1#1)(1992-3#1)(1993-12#2)(1995-11#2)(1996-7#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-9#1)(2013-1#1)
psychiatric patients]##2##2##(1996-11#1)(2007-1#1)
psychiatric population##2##2##(1991-2#1)(2008-3#1)
psychiatric practice in an##2##4##(2012-12#2)
psychiatric practice in##4##3##(1992-1#1)(2012-12#3)
psychiatric practice##9##2##(1991-3#1)(1992-1#1)(2006-9#1)(2008-6#1)(2012-12#4)(2012-2#1)
psychiatric presentation of##2##3##(2008-11#1)(2010-3#1)
psychiatric problems##2##2##(2008-6#1)(2012-12#1)
psychiatric services##4##2##(1991-1#1)(1991-3#1)(1991-6#1)(2008-2#1)
psychiatric setting##3##2##(1992-2#2)(2009-6#1)
psychiatric subjects##2##2##(2009-4#2)
psychiatric symptom##2##2##(2012-1#2)
psychiatric symptomatology##2##2##(2008-4#1)(2012-1#1)
psychiatric symptoms and##2##3##(2012-1#1)(2013-8#1)
psychiatric symptoms are##2##3##(2009-5#1)(2012-1#1)
psychiatric symptoms##15##2##(1996-5#1)(2009-5#2)(2009-9#2)(2011-2#1)(2012-1#6)(2013-8#3)
psychiatric terms##2##2##(1996-9#1)(2009-10#1)
psychiatric treatment are##2##3##(1992-2#1)(1993-2#1)
psychiatric treatment##15##2##(1991-2#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1997-3#2)(2007-1#1)(2008-11#1)(2009-7#1)(2010-11#1)(2010-5#1)(2013-1#1)
psychiatric unit##3##2##(1993-1#1)(1993-12#1)(1995-1#1)
psychiatric units in##2##3##(1993-12#2)
psychiatric wandering##2##2##(1996-5#2)
psychiatric ward of##2##3##(1993-2#1)(2008-2#1)
psychiatric ward##5##2##(1993-2#1)(1996-2#1)(2008-2#1)(2011-2#1)(2012-3#1)
psychiatric wards##2##2##(2008-2#1)(2013-1#1)
psychiatric##427##1##(1990-6#2)(1991-1#6)(1991-11#1)(1991-12#3)(1991-2#17)(1991-3#3)(1991-6#1)(1992-1#4)(1992-11#2)(1992-12#4)(1992-2#9)(1992-3#9)(1992-5#1)(1992-6#1)(1993-1#9)(1993-12#16)(1993-2#14)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#5)(1994-5#1)(1994-6#1)(1995-1#5)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#7)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#3)(1997-3#3)(1997-5#3)(1997-8#3)(2006-10#1)(2006-9#3)(2007-1#4)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#13)(2008-10#2)(2008-11#20)(2008-12#7)(2008-2#12)(2008-3#2)(2008-4#17)(2008-5#2)(2008-6#10)(2008-7#6)(2008-8#2)(2008-9#13)(2009-10#6)(2009-11#2)(2009-4#4)(2009-5#2)(2009-6#6)(2009-7#9)(2009-8#1)(2009-9#9)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#8)(2011-2#15)(2011-3#1)(2011-4#2)(2012-1#17)(2012-12#14)(2012-2#10)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#7)
psychiatrically hospitalized##2##2##(1993-12#1)(1995-1#1)
psychiatrically##6##1##(1993-12#1)(1993-3#1)(1995-1#1)(1995-8#1)(1997-5#1)(2012-12#1)
psychiatrist##8##1##(1995-11#1)(1996-11#1)(2009-9#2)(2012-12#3)(2013-1#1)
psychiatrist's##2##1##(1992-12#1)(2012-12#1)
psychiatrists and neurologists##2##3##(2008-4#1)(2008-6#1)
psychiatrists and psychologists in##2##4##(1996-11#1)(2010-12#1)
psychiatrists and psychologists##4##3##(1996-11#1)(2008-12#2)(2010-12#1)
psychiatrists and##9##2##(1995-11#1)(1996-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-3#1)
psychiatrists##28##1##(1993-12#1)(1993-6#2)(1995-11#1)(1996-1#2)(1996-11#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2009-9#3)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
psychiatrists'##3##1##(2008-2#1)(2008-7#1)(2013-8#1)
psychiatry and neurology##3##3##(2008-1#1)(2008-4#1)(2008-6#1)
psychiatry and##14##2##(1990-8#1)(1991-3#1)(1993-3#1)(1994-3#1)(1996-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-8#1)(2009-9#2)(2011-2#1)(2011-3#1)(2013-1#1)
psychiatry are##2##2##(1992-9#1)(2013-8#1)
psychiatry because##2##2##(2008-1#1)(2008-9#1)
psychiatry in##7##2##(1992-6#1)(1995-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-7#1)
psychiatry was##2##2##(1992-6#1)(2009-10#1)
psychiatry##83##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-8#1)(2006-9#2)(2008-1#2)(2008-11#5)(2008-2#5)(2008-4#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#5)
psychiatry]##6##1##(1992-11#1)(1996-9#1)(2009-10#1)(2011-3#1)(2012-1#1)(2013-8#1)
psychic##7##1##(1990-3#1)(1993-11#1)(1994-6#1)(1995-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
psycho-educational##2##1##(2010-7#2)
psycho-organic##2##1##(1991-5#1)(1992-5#1)
psycho-physical##2##1##(1992-11#1)(2010-6#1)
psychoactive drugs##8##2##(1990-3#1)(1994-2#1)(2008-1#2)(2008-6#1)(2012-3#3)
psychoactive substance##2##2##(2013-1#1)(2013-7#1)
psychoactive substances and##2##3##(2008-1#1)(2011-1#1)
psychoactive substances##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
psychoactive##20##1##(1990-3#1)(1994-2#1)(1996-5#1)(2008-1#3)(2008-6#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#5)(2013-1#2)(2013-7#1)
psychoanalysis##5##1##(2008-10#1)(2011-2#4)
psychoanalytic process##2##2##(2008-4#1)(2011-2#1)
psychoanalytic##5##1##(2008-4#2)(2008-6#1)(2009-10#1)(2011-2#1)
psychoanalytical##5##1##(1991-2#2)(2008-12#1)(2010-6#1)(2012-12#1)
psychobiological model##2##2##(2009-9#2)
psychobiological##5##1##(1993-12#1)(2008-1#1)(2008-4#1)(2009-9#2)
psychodynamic##4##1##(1993-1#1)(2008-11#1)(2008-4#1)(2012-12#1)
psychoeducation##7##1##(2007-12#2)(2009-11#1)(2012-12#3)(2012-2#1)
psychoeducational interventions##2##2##(2009-11#2)
psychoeducational##3##1##(2008-8#1)(2009-11#2)
psychogenetically selected lines##2##3##(1993-5#1)(1994-2#1)
psychogenic and neurogenic stressors##2##4##(2008-11#2)
psychogenic causes##2##2##(2009-3#1)(2010-11#1)
psychogenic##9##1##(1994-2#1)(1994-9#1)(2008-11#4)(2009-3#2)(2010-11#1)
psychogeriatric##2##1##(1994-6#1)(2013-1#1)
psychol##2##1##(1991-1#2)
psychologic and##2##2##(1991-12#1)(2008-10#1)
psychologic##5##1##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
psychological adjustment and##5##3##(2009-11#2)(2010-2#1)(2013-1#2)
psychological adjustment of##2##3##(2010-2#1)(2012-3#1)
psychological adjustment##19##2##(1996-3#1)(2007-12#2)(2009-11#7)(2009-7#1)(2010-2#3)(2012-3#1)(2013-1#4)
psychological and biological##3##3##(1996-6#1)(2010-4#1)(2012-12#1)
psychological and emotional##2##3##(2009-4#1)(2012-12#1)
psychological and medical##2##3##(1993-12#1)(2008-4#1)
psychological and social##5##3##(1991-12#1)(1994-9#1)(1995-1#1)(2008-1#1)(2008-7#1)
psychological and##27##2##(1991-12#2)(1993-12#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-4#1)(2012-12#2)(2013-1#1)
psychological aspects of##4##3##(2008-12#1)(2008-4#1)(2010-11#1)(2010-3#1)
psychological aspects##7##2##(2008-12#2)(2008-4#1)(2010-11#1)(2010-3#1)(2013-1#2)
psychological autopsy##3##2##(2009-7#3)
psychological challenges after cancer##2##4##(2009-10#2)
psychological challenges after##3##3##(2009-10#3)
psychological challenges##5##2##(2009-10#5)
psychological condition##3##2##(1994-12#2)(1995-4#1)
psychological descriptors##2##2##(2008-5#2)
psychological development##4##2##(2007-12#1)(2008-4#1)(2011-2#2)
psychological distress and##6##3##(2007-12#1)(2008-3#1)(2009-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
psychological distress in##2##3##(2008-9#1)(2012-1#1)
psychological distress##26##2##(2007-11#1)(2007-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-6#3)(2010-8#1)(2011-2#1)(2012-1#4)(2012-3#3)(2013-1#2)(2013-8#1)
psychological disturbances##2##2##(1992-5#1)(2008-10#1)
psychological effects of##3##3##(1992-5#1)(2007-2#1)(2008-11#1)
psychological effects##6##2##(1991-9#1)(1992-5#1)(1996-3#1)(2007-2#1)(2007-6#1)(2008-11#1)
psychological factors##4##2##(1990-6#1)(1993-12#1)(2007-12#1)(2009-2#1)
psychological findings##2##2##(2007-8#2)
psychological function##2##2##(1996-11#1)(2008-4#1)
psychological functioning##4##2##(1995-2#1)(2008-12#2)(2008-2#1)
psychological functions##2##2##(2007-8#1)(2008-7#1)
psychological impact of##5##3##(1997-5#1)(2008-12#1)(2008-4#2)(2008-5#1)
psychological impact##6##2##(1997-5#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-2#1)
psychological implications##2##2##(1990-6#1)(2007-11#1)
psychological intervention##2##2##(1996-6#1)(2012-1#1)
psychological issues##2##2##(2008-11#1)(2008-4#1)
psychological means##2##2##(2008-7#1)(2010-12#1)
psychological mechanisms##2##2##(2008-12#1)(2008-2#1)
psychological methods##2##2##(1992-12#1)(2008-11#1)
psychological needs##2##2##(2007-7#2)
psychological outcomes for##2##3##(2008-6#1)(2010-3#1)
psychological outcomes##3##2##(2008-6#1)(2009-7#1)(2010-3#1)
psychological phenomena##2##2##(2008-5#1)(2010-11#1)
psychological problems##5##2##(1993-6#1)(1996-12#1)(2007-8#1)(2009-11#1)(2011-1#1)
psychological process##4##2##(1990-10#4)
psychological processes##4##2##(2007-8#1)(2008-11#2)(2008-2#1)
psychological responses##2##2##(1991-11#1)(2010-6#1)
psychological sequelae##2##2##(1995-9#1)(2012-1#1)
psychological services##2##2##(1992-1#2)
psychological states##2##2##(2008-11#1)(2010-6#1)
psychological strategies##2##2##(1996-9#1)(1997-5#1)
psychological stress##8##2##(1991-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-2#1)
psychological stressors (adjusted OR 1##2##5##(2008-10#2)
psychological stressors##3##2##(2008-10#3)
psychological support##3##2##(1995-4#1)(2011-1#1)(2012-3#1)
psychological symptoms and##2##3##(2008-2#2)
psychological symptoms##7##2##(1990-10#1)(2008-2#2)(2008-4#2)(2010-6#1)(2012-2#1)
psychological tests##2##2##(1991-5#1)(2013-7#1)
psychological theories##3##2##(2008-9#1)(2009-8#1)(2010-8#1)
psychological theory and##2##3##(1993-12#1)(2010-2#1)
psychological trauma##2##2##(2007-7#1)(2012-2#1)
psychological variables##2##2##(2007-12#2)
psychological well-being and quality of life##2##6##(1997-8#2)
psychological well-being and##3##3##(1997-8#2)(2012-2#1)
psychological well-being of##3##3##(2008-11#2)(2013-1#1)
psychological well-being over time##3##4##(2010-7#3)
psychological well-being over##4##3##(2010-7#4)
psychological well-being##32##2##(1991-12#1)(1992-2#1)(1996-11#1)(1997-8#2)(2007-12#2)(2008-11#3)(2008-2#1)(2009-11#1)(2009-7#2)(2010-2#1)(2010-7#5)(2012-2#6)(2013-1#6)
psychological##336##1##(1990-10#6)(1990-6#2)(1991-11#1)(1991-12#5)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#1)(1992-5#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-4#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#2)(2007-11#3)(2007-12#14)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#7)(2008-1#2)(2008-10#11)(2008-11#15)(2008-12#14)(2008-2#10)(2008-3#2)(2008-4#11)(2008-5#9)(2008-6#7)(2008-7#6)(2008-9#3)(2009-10#7)(2009-11#11)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#9)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#5)(2010-12#1)(2010-2#6)(2010-3#5)(2010-4#2)(2010-6#8)(2010-7#9)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#12)(2012-3#5)(2012-5#1)(2013-1#15)(2013-7#1)(2013-8#7)
psychologically healthy persons##2##3##(1996-9#2)
psychologically##12##1##(1992-12#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-9#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)
psychologist training program##2##3##(2012-2#2)
psychologist##6##1##(1994-12#1)(2008-11#1)(2012-2#2)(2013-1#2)
psychologists and##2##2##(1996-1#1)(2012-12#1)
psychologists of##2##2##(2008-12#1)(2008-5#1)
psychologists##20##1##(1990-6#1)(1993-12#1)(1995-11#1)(1996-1#3)(1996-11#1)(2007-6#1)(2007-8#2)(2008-12#2)(2008-5#2)(2009-10#1)(2009-12#1)(2010-12#1)(2012-12#2)(2013-8#1)
psychology and psychiatry##2##3##(2011-1#2)
psychology and religion##2##3##(2008-12#2)
psychology and##16##2##(1990-2#1)(1990-8#1)(1993-3#1)(1994-2#1)(1996-11#1)(2008-11#1)(2008-12#2)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-8#1)
psychology as a##2##3##(2008-11#1)(2008-5#1)
psychology in##2##2##(2008-2#1)(2013-1#1)
psychology of##3##2##(2008-12#1)(2013-7#1)(2013-8#1)
psychology to##2##2##(2008-2#2)
psychology##65##1##(1990-2#2)(1990-8#2)(1993-2#2)(1993-3#1)(1994-12#4)(1994-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#7)(2008-2#3)(2008-5#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-7#1)(2009-8#5)(2010-12#2)(2010-6#3)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
psychometric analysis##2##2##(2008-7#1)(2011-2#1)
psychometric evaluation##4##2##(1990-3#1)(1994-6#1)(2007-12#2)
psychometric properties and##4##3##(2010-10#1)(2011-1#1)(2013-1#2)
psychometric properties of the instrument##2##5##(2008-1#1)(2008-11#1)
psychometric properties of the##9##4##(2008-1#1)(2008-11#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
psychometric properties of##15##3##(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#3)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
psychometric properties##25##2##(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#3)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
psychometric testing##2##2##(1994-6#1)(2008-7#1)
psychometric tests##3##2##(1990-3#1)(1990-6#1)(1994-6#1)
psychometric##52##1##(1990-3#3)(1990-6#1)(1994-6#3)(1995-3#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-12#3)(2008-1#3)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
psychometrically sound##3##2##(2010-11#1)(2011-8#1)(2012-2#1)
psychometrically##5##1##(2008-6#1)(2010-11#1)(2011-8#1)(2012-2#1)(2012-3#1)
psychomotor development##4##2##(1994-6#2)(2011-2#1)(2012-12#1)
psychomotor##10##1##(1993-6#1)(1994-6#2)(1997-6#1)(2008-11#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
psychomotricity##3##1##(2007-6#3)
psychoorganic##2##1##(2011-2#2)
psychopathic individuals##3##2##(2008-11#2)(2009-9#1)
psychopathic##4##1##(2008-11#2)(2009-9#1)(2010-5#1)
psychopathological features##2##2##(2010-11#1)(2012-5#1)
psychopathological hand disorders##2##3##(2008-9#2)
psychopathological rating##2##2##(1994-6#1)(2008-6#1)
psychopathological##14##1##(1994-6#1)(2008-6#1)(2008-9#5)(2009-10#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-5#1)
psychopathology and##5##2##(2008-11#2)(2008-2#1)(2008-6#1)(2009-7#1)
psychopathology in patients with##2##4##(2008-7#1)(2009-10#1)
psychopathology in##3##2##(2008-7#1)(2009-10#1)(2011-2#1)
psychopathology of##2##2##(2008-1#1)(2013-8#1)
psychopathology##38##1##(1991-1#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-7#1)(2008-1#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#3)(2009-11#3)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-5#3)(2013-1#2)(2013-8#3)
psychopharmacologic##5##1##(2008-4#5)
psychopharmacological treatment##2##2##(1990-3#1)(2008-6#1)
psychopharmacological##5##1##(1990-3#1)(2008-6#2)(2011-1#1)(2012-2#1)
psychopharmacology##5##1##(2008-11#1)(2008-4#4)
psychophysical experience of##2##3##(2008-7#1)(2008-9#1)
psychophysical experiments##2##2##(1990-5#1)(2008-9#1)
psychophysical parameters##3##2##(2008-9#3)
psychophysical##26##1##(1990-5#1)(1991-2#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#10)(2009-8#2)(2011-2#4)(2012-12#1)(2013-8#1)
psychophysiological##7##1##(1992-12#3)(2008-11#1)(2008-5#3)
psychoses##12##1##(1991-12#1)(1993-6#1)(1995-11#2)(1996-5#1)(1996-7#1)(1997-5#5)(2008-5#1)
psychosis cases##2##2##(2008-1#2)
psychosis from##2##2##(2008-11#1)(2011-1#1)
psychosis in an##2##3##(2008-11#1)(2008-4#1)
psychosis in the##2##3##(2008-1#1)(2011-1#1)
psychosis in##11##2##(1993-1#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2011-1#4)
psychosis##64##1##(1992-12#1)(1993-1#1)(1995-11#2)(1996-5#1)(1996-7#9)(1997-2#1)(1997-5#2)(2007-1#1)(2007-6#3)(2008-1#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#4)(2009-9#1)(2011-1#16)(2011-2#7)(2012-1#2)(2012-2#1)(2012-3#1)
psychosis&quot##4##1##(2011-2#1)(2013-8#3)
psychosis]##2##1##(2007-1#1)(2011-2#1)
psychosocial adaptation##2##2##(1996-1#1)(2013-1#1)
psychosocial adjustment of##2##3##(1993-1#1)(1997-8#1)
psychosocial adjustment##5##2##(1993-1#1)(1997-8#1)(2008-6#1)(2008-9#1)(2009-8#1)
psychosocial and economic##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
psychosocial and spiritual distress##2##4##(2013-8#2)
psychosocial and spiritual suffering##2##4##(2013-8#2)
psychosocial and spiritual##5##3##(2007-5#1)(2013-8#4)
psychosocial and##14##2##(1992-3#1)(2007-5#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#5)
psychosocial aspects of##4##3##(1991-3#1)(1992-3#1)(2008-1#2)
psychosocial aspects##5##2##(1991-3#1)(1992-3#1)(2008-1#2)(2011-2#1)
psychosocial consequences##2##2##(2008-2#1)(2013-1#1)
psychosocial development of##3##3##(1993-1#2)(2008-9#1)
psychosocial development##5##2##(1993-1#2)(2008-11#1)(2008-9#1)(2012-12#1)
psychosocial factors associated with##2##4##(2007-12#1)(2008-9#1)
psychosocial factors in##2##3##(1992-9#1)(2013-8#1)
psychosocial factors##14##2##(1992-9#1)(1994-6#1)(1996-12#1)(2007-12#1)(2008-2#5)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2013-8#1)
psychosocial functioning##2##2##(2009-10#1)(2013-1#1)
psychosocial impact##3##2##(1997-5#1)(2008-11#2)
psychosocial intervention##3##2##(1992-3#1)(2007-12#1)(2009-9#1)
psychosocial interventions to##2##3##(1992-12#1)(2013-1#1)
psychosocial interventions##9##2##(1992-12#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-6#1)(2009-7#1)(2013-1#1)
psychosocial issues##2##2##(1996-3#1)(2008-10#1)
psychosocial model##3##2##(1991-1#1)(1994-3#1)(1996-12#1)
psychosocial needs of##3##3##(1991-2#1)(2008-4#1)(2008-9#1)
psychosocial outcomes##2##2##(2013-1#2)
psychosocial problems##3##2##(1997-2#1)(2007-12#1)(2013-1#1)
psychosocial rehabilitation##3##2##(1995-1#1)(1996-3#1)(2012-12#1)
psychosocial responses of school-age children to hospitalization##2##7##(1991-2#2)
psychosocial responses##3##2##(1991-1#1)(1991-2#2)
psychosocial risks##2##2##(2011-2#2)
psychosocial services##4##2##(1991-3#1)(1992-12#1)(1994-1#2)
psychosocial support##2##2##(1992-3#2)
psychosocial treatment##3##2##(1995-5#1)(2009-8#2)
psychosocial treatments##5##2##(1993-2#1)(2008-4#2)(2008-6#1)(2009-7#1)
psychosocial well-being##2##2##(2007-12#1)(2008-11#1)
psychosocial##155##1##(1990-6#1)(1991-1#4)(1991-2#3)(1991-3#3)(1992-12#2)(1992-3#7)(1992-9#1)(1993-1#3)(1993-2#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-5#3)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#2)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#6)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#10)(2008-2#9)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-12#4)(2012-2#1)(2013-1#12)(2013-8#7)
psychosocially##3##1##(2010-11#2)(2010-4#1)
psychosomatic disorders##4##2##(1997-6#1)(1997-7#1)(2011-2#1)(2012-2#1)
psychosomatic##10##1##(1990-11#1)(1990-2#1)(1997-6#1)(1997-7#1)(2008-4#2)(2010-6#1)(2011-2#2)(2012-2#1)
psychostimulant##3##1##(1994-2#1)(1996-12#1)(2009-7#1)
psychostimulants##4##1##(1993-3#1)(2008-4#1)(2008-7#2)
psychotherapeutic practice##2##2##(2008-12#1)(2009-10#1)
psychotherapeutic##13##1##(1995-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-10#2)(2009-7#1)(2010-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
psychotherapists##3##1##(1995-1#1)(2010-9#1)(2012-2#1)
psychotherapy and##2##2##(2008-1#1)(2008-10#1)
psychotherapy for##2##2##(1991-1#1)(2008-4#1)
psychotherapy of##2##2##(1993-1#1)(2013-8#1)
psychotherapy research##3##2##(2008-9#1)(2013-1#2)
psychotherapy##33##1##(1991-1#1)(1991-2#1)(1993-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#3)(2008-6#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-4#1)(2012-12#1)(2013-1#8)(2013-8#2)
psychotic disorder##6##2##(2008-1#1)(2008-4#2)(2008-9#1)(2011-2#2)
psychotic disorders and##2##3##(2008-11#1)(2008-3#1)
psychotic disorders##11##2##(1995-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-12#1)(2009-8#2)(2012-2#1)
psychotic patients##10##2##(1993-8#4)(1995-5#1)(2011-2#3)(2012-12#2)
psychotic symptoms in##3##3##(1995-8#1)(2009-12#1)(2012-2#1)
psychotic symptoms##18##2##(1995-8#2)(2007-6#2)(2008-4#3)(2008-7#2)(2009-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
psychotic syndromes##2##2##(2009-7#1)(2012-2#1)
psychotic##59##1##(1993-8#4)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#2)(1996-7#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#6)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#2)(2011-1#2)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#5)(2013-8#1)
psychotropes##2##1##(2013-1#2)
psychotropic drugs##7##2##(1995-2#1)(1996-10#1)(1996-9#1)(2007-7#2)(2008-11#1)(2009-3#1)
psychotropic effects of##2##3##(2008-10#1)(2008-4#1)
psychotropic medication to##2##3##(1992-12#1)(2008-8#1)
psychotropic medication##3##2##(1992-12#1)(2008-8#1)(2012-3#1)
psychotropic medications##2##2##(1996-9#1)(2013-1#1)
psychotropic##22##1##(1992-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-9#2)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#2)(2013-1#2)
psychrophilic##2##1##(2008-10#1)(2011-2#1)
psychrophilum and F##2##3##(2008-9#2)
psychrophilum and##3##2##(2008-9#3)
psychrophilum##8##1##(2008-9#3)(2009-5#5)
psychrotrophic and##2##2##(2007-3#1)(2011-2#1)
psychrotrophic##6##1##(2007-3#1)(2011-2#4)(2012-2#1)
psylla were##3##2##(2008-10#3)
psylla##11##1##(2008-10#11)
psyllium##3##1##(1993-11#3)
pteridine ring##2##2##(1995-2#2)
pteridine##6##1##(1995-2#4)(2009-12#1)(2010-5#1)
pteridophytes##2##1##(2008-5#1)(2009-6#1)
pterin##5##1##(1997-8#1)(2010-5#4)
pterional##2##1##(2011-2#2)
pterostilbene##3##1##(2008-10#3)
pterygia##4##1##(2008-1#4)
pterygium##4##1##(2008-1#1)(2008-8#1)(2010-11#1)(2011-2#1)
pterygote##3##1##(2007-12#2)(2008-7#1)
pth##3##1##(1994-12#3)
pthN##3##1##(2008-10#3)
ptosis and##2##2##(2007-10#1)(2008-7#1)
ptosis##9##1##(1992-9#1)(2007-10#5)(2007-7#1)(2008-7#1)(2008-9#1)
ptpf##2##1##(1997-7#2)
pts according to IRS scale)##2##5##(2013-8#2)
pts in##2##2##(2007-7#1)(2010-12#1)
pts received##3##2##(1996-3#1)(2010-3#2)
pts were##2##2##(2010-3#2)
pts##33##1##(1994-9#3)(1996-3#1)(2007-11#1)(2007-7#2)(2010-12#3)(2010-3#16)(2013-1#5)(2013-8#2)
pts) and##3##2##(1994-9#1)(2008-7#1)(2010-12#1)
pts)##9##1##(1994-9#2)(2007-7#2)(2008-7#1)(2010-12#3)(2010-3#1)
pu##2##1##(2013-1#2)
pu-erh and black teas##2##4##(2008-10#2)
pu-erh##4##1##(2008-10#4)
pubertal development##2##2##(2008-4#1)(2011-1#1)
pubertal stage III##2##3##(2011-2#2)
pubertal stage##3##2##(2011-2#3)
pubertal##15##1##(2008-3#1)(2008-4#1)(2010-3#1)(2011-1#7)(2011-2#5)
puberty and##9##2##(1991-2#1)(1995-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#2)
puberty were##2##2##(1993-2#1)(2007-7#1)
puberty##52##1##(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#2)(1993-2#2)(1995-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-6#4)(2010-4#2)(2011-1#6)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
pubes##2##1##(1995-6#2)
pubescens##6##1##(2008-10#1)(2008-11#1)(2008-8#2)(2012-6#2)
pubescentis##2##1##(2012-3#2)
pubic hair##4##2##(2007-8#1)(2008-4#1)(2011-2#2)
pubic symphysis##2##2##(2011-1#1)(2012-12#1)
pubic##8##1##(1991-6#1)(1995-6#1)(2007-8#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
pubis##10##1##(1994-3#1)(1995-6#2)(2006-10#1)(2008-5#2)(2012-1#2)(2012-12#2)
public about##3##2##(1991-11#1)(1992-1#1)(1995-1#1)
public acceptance##3##2##(1996-12#1)(1996-3#1)(2008-7#1)
public accountability##3##2##(1994-2#1)(1996-2#2)
public administrators##2##2##(1991-3#1)(1995-12#1)
public and personal health##2##4##(2008-10#2)
public and private health##2##4##(1993-3#1)(1996-3#1)
public and private schools in##3##5##(2008-9#2)(2011-2#1)
public and private sector##2##4##(1996-12#1)(1996-2#1)
public and private sectors##4##4##(1992-12#1)(1996-2#1)(1997-3#1)(2013-1#1)
public and private##26##3##(1992-12#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#3)(1997-6#1)(2007-8#1)(2008-12#1)(2008-7#3)(2008-9#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
public and##45##2##(1992-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-6#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
public as##2##2##(1997-3#1)(2010-8#1)
public attention##3##2##(1990-6#1)(1991-12#1)(1992-3#1)
public attitudes toward##2##3##(2008-11#1)(2010-12#1)
public attitudes##4##2##(1991-5#1)(1993-1#1)(2008-11#1)(2010-12#1)
public authorities##2##2##(1990-6#1)(1996-2#1)
public awareness and##3##3##(1992-1#1)(2007-5#1)(2008-7#1)
public awareness of##3##3##(1994-1#1)(1995-1#1)(2008-10#1)
public awareness##9##2##(1992-1#1)(1994-1#1)(1994-3#1)(1995-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
public concern##3##2##(2008-10#2)(2008-12#1)
public database##2##2##(2008-7#1)(2008-8#1)
public databases indicated that the sequences of##3##7##(1995-8#1)(1996-10#1)(1996-2#1)
public databases##7##2##(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(2008-4#1)(2008-7#2)
public datasets##2##2##(2008-4#1)(2011-3#1)
public debate on##2##3##(1993-6#1)(2010-11#1)
public debate##3##2##(1993-6#1)(2008-11#1)(2010-11#1)
public dental##3##2##(1996-9#1)(2008-9#2)
public disclosure##2##2##(2009-4#2)
public domain##8##2##(1994-12#1)(1996-1#1)(1996-2#1)(2008-4#3)(2009-12#1)(2013-1#1)
public education##2##2##(1996-1#1)(2008-11#1)
public elementary##2##2##(2011-1#1)(2012-2#1)
public employees##4##2##(1994-2#3)(2008-12#1)
public expenditures##4##2##(1993-6#1)(1994-2#3)
public forum##2##2##(1993-12#1)(1996-11#1)
public funding##3##2##(1991-12#1)(1994-2#1)(1996-1#1)
public good##4##2##(1993-2#1)(1995-2#1)(2008-10#1)(2012-3#1)
public goods games##4##3##(2012-3#4)
public goods##9##2##(2008-10#4)(2012-3#5)
public health activities##5##3##(1992-1#2)(1996-12#2)(2008-11#1)
public health agencies to##2##4##(1995-12#2)
public health agencies##15##3##(1995-12#5)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(2009-5#1)
public health agenda##2##3##(1997-1#2)
public health and medical##3##4##(1995-2#3)
public health and medicine##6##4##(1995-2#5)(2009-5#1)
public health and##32##3##(1992-8#1)(1994-1#1)(1995-2#9)(1996-1#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#3)(2007-2#2)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
public health approaches##2##3##(2007-12#1)(2008-11#1)
public health authorities##4##3##(1992-9#1)(1995-6#1)(1997-3#1)(2010-5#1)
public health burden in##2##4##(2010-3#1)(2011-2#1)
public health burden##3##3##(2010-12#1)(2010-3#1)(2011-2#1)
public health care##6##3##(1991-3#1)(1994-9#2)(1997-4#1)(2008-7#1)(2011-1#1)
public health concepts##2##3##(1992-1#1)(2007-12#1)
public health concern##6##3##(2007-12#1)(2008-11#2)(2010-6#1)(2012-3#1)(2013-1#1)
public health concerns in the##2##5##(2012-12#1)(2013-8#1)
public health concerns in##3##4##(2012-12#1)(2013-8#2)
public health concerns with##2##4##(1995-12#1)(2012-2#1)
public health concerns##5##3##(1995-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
public health core functions##2##4##(1995-12#1)(1996-3#1)
public health decision making##3##4##(1996-2#2)(1997-3#1)
public health decision##4##3##(1996-2#3)(1997-3#1)
public health departments##4##3##(1996-12#2)(1996-2#1)(1997-1#1)
public health education##2##3##(1996-1#1)(1997-3#1)
public health efforts##3##3##(1996-2#1)(2012-2#2)
public health emergency preparedness##3##4##(2010-8#3)
public health functions##7##3##(1995-12#2)(1996-12#1)(1996-2#3)(1996-3#1)
public health goals##2##3##(1996-2#2)
public health has##3##3##(1996-3#2)(2013-1#1)
public health have##2##3##(1997-2#1)(2007-12#1)
public health impact of##3##4##(1991-3#2)(1997-3#1)
public health impact##5##3##(1991-3#3)(1993-12#1)(1997-3#1)
public health implications of##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
public health implications##8##3##(1996-1#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
public health importance of##2##4##(2010-8#1)(2013-8#1)
public health importance##7##3##(1997-3#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-8#1)
public health in##5##3##(1993-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2010-12#1)
public health information and##3##4##(1995-12#1)(1997-2#1)(1997-3#1)
public health information systems##5##4##(1996-3#1)(1997-3#4)
public health information##15##3##(1995-12#3)(1996-3#1)(1997-2#2)(1997-3#7)(2008-11#1)(2013-1#1)
public health infrastructure##2##3##(1995-12#1)(1997-1#1)
public health initiatives##5##3##(1995-12#1)(1996-3#3)(2008-8#1)
public health insurance##5##3##(1995-3#1)(2008-7#2)(2013-1#2)
public health is to##2##4##(1996-3#1)(1997-1#1)
public health is##5##3##(1996-3#1)(1997-1#1)(2010-8#1)(2012-12#1)(2013-1#1)
public health issue##8##3##(1991-6#1)(1996-1#1)(2008-9#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
public health issues##7##3##(1993-2#1)(1995-5#1)(1996-2#1)(2009-12#1)(2011-1#2)(2012-2#1)
public health measures##6##3##(1997-3#1)(2008-9#1)(2010-1#1)(2011-2#3)
public health model of Medicaid emergency room use##2##8##(1992-1#2)
public health needs##3##3##(1994-3#1)(1996-3#1)(1997-3#1)
public health nurses and##4##4##(2010-9#4)
public health nurses##9##3##(1995-3#1)(1996-2#2)(2008-1#1)(2010-9#5)
public health nursing##5##3##(1996-2#5)
public health nutritionists##9##3##(1991-2#2)(1993-1#3)(1993-2#4)
public health officials and##2##4##(1995-12#1)(2012-12#1)
public health officials to##2##4##(1996-5#1)(2012-12#1)
public health officials##8##3##(1993-6#1)(1995-12#3)(1996-1#1)(1996-5#1)(2012-12#2)
public health overlap with##2##4##(1996-2#1)(2010-12#1)
public health performance##9##3##(1995-12#4)(1996-12#2)(1996-3#3)
public health perspective##3##3##(1995-12#1)(2008-6#1)(2008-7#1)
public health policy and##2##4##(1993-2#1)(2011-1#1)
public health policy##6##3##(1993-2#1)(1997-2#1)(1997-3#2)(2011-1#1)(2013-1#1)
public health practice content##2##4##(1997-2#2)
public health practice in##2##4##(1996-2#1)(1997-3#1)
public health practice##17##3##(1995-12#1)(1996-1#4)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#3)(1997-3#2)(2012-2#1)
public health practices##2##3##(1996-12#1)(2008-7#1)
public health practitioners##5##3##(1995-12#1)(1997-2#3)(2013-1#1)
public health problem and##2##4##(2009-5#1)(2011-2#1)
public health problem in the world##3##6##(2008-10#1)(2009-5#1)(2012-3#1)
public health problem in the##7##5##(1997-1#1)(2008-10#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
public health problem in##16##4##(1992-9#2)(1993-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
public health problem of##2##4##(2008-11#1)(2011-2#1)
public health problem worldwide##2##4##(2010-5#1)(2013-8#1)
public health problem##44##3##(1992-9#2)(1993-6#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
public health problems in##3##4##(2008-7#1)(2011-2#1)(2012-1#1)
public health problems##6##3##(1993-1#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-1#1)
public health professionals##6##3##(1996-1#1)(1996-2#1)(2009-3#1)(2013-1#3)
public health program##4##3##(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
public health programs##4##3##(1995-12#1)(1996-3#1)(1997-3#1)(2009-9#1)
public health providers##3##3##(1997-2#1)(1997-3#1)(2011-1#1)
public health research##4##3##(1997-1#1)(2008-12#1)(2008-8#1)(2011-1#1)
public health response to##3##4##(1991-3#1)(1997-1#2)
public health responses##4##3##(1997-3#1)(2011-2#3)
public health risk##2##3##(2008-5#1)(2011-2#1)
public health service##2##3##(1992-4#1)(1995-2#1)
public health services##4##3##(1994-3#1)(1996-3#1)(1997-1#1)(1997-2#1)
public health settings##2##3##(1995-1#1)(2012-2#1)
public health staff##3##3##(2007-12#1)(2013-8#2)
public health students##2##3##(1996-1#1)(2008-1#1)
public health surveillance and assessment##2##5##(1997-3#2)
public health surveillance and##5##4##(1997-3#3)(2008-11#1)(2012-2#1)
public health surveillance in the##2##5##(1997-3#2)
public health surveillance system##3##4##(1997-3#2)(2012-12#1)
public health surveillance systems##5##4##(1997-3#1)(2008-7#4)
public health surveillance##26##3##(1997-3#16)(2008-1#1)(2008-11#2)(2008-7#5)(2012-12#1)(2012-2#1)
public health system in Arizona##2##5##(1995-12#2)
public health system in##4##4##(1995-12#2)(1996-2#1)(1997-2#1)
public health system##8##3##(1995-12#3)(1996-2#2)(1997-2#2)(2008-6#1)
public health threat##7##3##(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#1)
public health to##4##3##(1991-12#1)(1996-11#1)(1997-2#1)(2008-7#1)
public health training by##2##4##(1996-3#2)
public health training##3##3##(1996-3#2)(1997-2#1)
public health under##2##3##(1995-12#1)(2011-1#1)
public health was##2##3##(1996-3#1)(1997-2#1)
public health will##2##3##(1996-12#1)(1997-2#1)
public health work plan##2##4##(2008-1#2)
public health work##3##3##(1995-6#1)(2008-1#2)
public health worker##3##3##(1997-5#3)
public health workforce##2##3##(1997-3#1)(2013-1#1)
public health##638##2##(1990-11#1)(1991-12#1)(1991-2#4)(1991-3#6)(1991-6#1)(1992-1#10)(1992-4#1)(1992-8#1)(1992-9#3)(1993-1#6)(1993-12#2)(1993-2#6)(1993-3#1)(1993-6#3)(1994-1#2)(1994-2#1)(1994-3#3)(1994-7#1)(1994-9#2)(1995-1#2)(1995-12#43)(1995-2#12)(1995-3#4)(1995-5#1)(1995-6#4)(1996-1#24)(1996-11#1)(1996-12#20)(1996-2#35)(1996-3#36)(1996-5#1)(1996-6#2)(1997-1#16)(1997-2#26)(1997-3#59)(1997-4#2)(1997-5#3)(2007-10#1)(2007-11#1)(2007-12#14)(2007-2#3)(2007-7#3)(2008-1#13)(2008-10#14)(2008-11#18)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#18)(2008-8#10)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#6)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#14)(2010-9#6)(2011-1#15)(2011-2#30)(2012-1#3)(2012-12#22)(2012-2#13)(2012-3#4)(2013-1#26)(2013-8#10)
public health's core functions##2##4##(1996-2#1)(1997-2#1)
public health's##5##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#2)
public healthcare##3##2##(2007-12#1)(2012-12#2)
public hospital##14##2##(1992-1#1)(1992-11#1)(1995-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#6)(2013-8#1)
public hospitals and##3##3##(1990-6#1)(1994-2#1)(2012-2#1)
public hospitals##18##2##(1990-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-2#3)(1996-3#1)(2008-8#4)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
public image##2##2##(1996-1#1)(1997-1#1)
public in the##2##3##(2008-7#1)(2011-2#1)
public in##7##2##(1994-3#1)(1996-12#2)(2008-7#1)(2011-2#1)(2013-1#2)
public information campaign##3##3##(1992-2#3)
public information##6##2##(1992-2#5)(1996-6#1)
public institutions##2##2##(1995-6#1)(2008-10#1)
public interest in##3##3##(1991-3#1)(2008-10#1)(2009-7#1)
public interest##7##2##(1991-3#2)(1993-1#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
public involvement in##2##3##(1996-12#2)
public involvement##6##2##(1996-12#2)(2008-7#4)
public is##7##2##(1991-3#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
public library##2##2##(1993-1#2)
public managed care##2##3##(1995-1#1)(2006-10#1)
public mental health##2##3##(2009-9#2)
public opinion and##2##3##(1996-1#1)(2008-12#1)
public opinion##6##2##(1991-3#1)(1993-1#1)(1996-1#1)(2008-12#1)(2013-1#2)
public places##4##2##(1991-5#1)(1996-1#2)(2009-7#1)
public policies for##3##3##(2013-1#3)
public policies that##2##3##(2009-9#1)(2013-1#1)
public policies##11##2##(1993-1#1)(2008-12#1)(2009-9#1)(2012-12#2)(2012-2#1)(2013-1#5)
public policy##30##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#2)(1994-2#1)(1996-1#2)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#1)(2007-5#1)(2008-11#1)(2008-12#3)(2008-8#1)(2010-12#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
public primary##3##2##(2011-2#1)(2013-1#2)
public relations activities in##2##4##(2008-12#2)
public relations activities##7##3##(2008-12#7)
public relations and##2##3##(2008-12#2)
public relations functions##2##3##(2008-12#2)
public relations has##2##3##(2008-12#2)
public relations##31##2##(1991-1#1)(1991-2#1)(1997-3#1)(2008-12#25)(2008-6#3)
public reporting##3##2##(2013-1#3)
public resources##2##2##(2009-7#1)(2013-8#1)
public safety##4##2##(1991-3#1)(2008-1#1)(2008-6#2)
public school students##4##3##(2012-12#4)
public school##7##2##(1993-5#1)(2011-2#1)(2012-12#4)(2013-8#1)
public schools and 1##3##4##(2008-9#3)
public schools##8##2##(1991-12#1)(2008-9#6)(2011-1#1)
public sector##12##2##(1991-1#1)(1994-3#1)(1995-3#2)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(2008-11#1)(2010-3#1)(2012-12#1)
public service##2##2##(1994-2#1)(2012-12#1)
public services##2##2##(1996-3#1)(2008-7#1)
public sources##2##2##(1995-2#1)(2009-11#1)
public stigma##3##2##(2011-1#3)
public to##7##2##(1991-8#1)(1992-2#1)(1994-1#1)(1996-4#1)(2008-4#1)(2008-7#2)
public university##3##2##(1993-1#1)(2012-3#1)(2013-1#1)
public##1224##1##(1990-11#1)(1990-6#3)(1991-1#4)(1991-11#3)(1991-12#8)(1991-2#7)(1991-3#17)(1991-5#3)(1991-6#2)(1991-8#2)(1992-1#14)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#5)(1992-4#1)(1992-8#1)(1992-9#5)(1993-1#17)(1993-12#4)(1993-2#12)(1993-3#7)(1993-5#2)(1993-6#5)(1994-1#5)(1994-12#3)(1994-2#18)(1994-3#12)(1994-5#1)(1994-7#1)(1994-9#3)(1995-1#7)(1995-11#1)(1995-12#50)(1995-2#15)(1995-3#8)(1995-5#3)(1995-6#9)(1995-8#1)(1996-1#35)(1996-10#1)(1996-11#6)(1996-12#40)(1996-2#51)(1996-3#49)(1996-4#2)(1996-5#4)(1996-6#5)(1996-9#2)(1997-1#17)(1997-2#35)(1997-3#69)(1997-4#2)(1997-5#5)(1997-6#4)(1997-8#2)(2006-10#6)(2007-10#1)(2007-11#1)(2007-12#20)(2007-2#3)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#16)(2008-10#33)(2008-11#31)(2008-12#44)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#5)(2008-6#12)(2008-7#48)(2008-8#18)(2008-9#16)(2009-10#4)(2009-11#4)(2009-12#4)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#2)(2009-7#6)(2009-8#1)(2009-9#6)(2010-1#2)(2010-11#3)(2010-12#18)(2010-3#3)(2010-4#6)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#18)(2010-9#6)(2011-1#21)(2011-2#44)(2011-3#2)(2012-1#5)(2012-12#36)(2012-2#20)(2012-3#19)(2013-1#67)(2013-7#1)(2013-8#18)
public-private partnerships##2##2##(1995-3#1)(1996-12#1)
public-private##4##1##(1995-3#2)(1996-12#2)
public-sector##2##1##(1996-2#1)(2007-4#1)
publication bias##2##2##(1993-12#2)
publication by##2##2##(1991-6#1)(2008-10#1)
publication in##7##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-5#1)
publication of clinical guidelines##2##4##(2008-3#2)
publication of clinical##3##3##(1992-2#1)(2008-3#2)
publication of research results##2##4##(1992-12#1)(1993-6#1)
publication of research##3##3##(1990-2#1)(1992-12#1)(1993-6#1)
publication of the##11##3##(1994-3#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
publication of##27##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-3#2)(1996-12#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
publication or##2##2##(1992-9#1)(2008-9#1)
publication##133##1##(1990-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#5)(1993-6#1)(1994-3#2)(1994-6#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#12)(2008-10#10)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-8#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-1#17)(2011-2#12)(2011-3#1)(2012-1#10)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
publications about##4##2##(2011-2#2)(2012-12#1)(2012-3#1)
publications and##4##2##(2007-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
publications are##4##2##(1995-9#1)(2008-8#1)(2010-7#1)(2011-2#1)
publications has##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
publications have##2##2##(2008-11#1)(2008-7#1)
publications in the##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
publications in##8##2##(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
publications indicate##2##2##(2007-8#1)(2011-2#1)
publications is##2##2##(2011-2#1)(2013-1#1)
publications on the##4##3##(2008-10#2)(2008-9#1)(2012-1#1)
publications on this##3##3##(1990-9#1)(2008-8#1)(2008-9#1)
publications on##15##2##(1990-9#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#3)(2009-11#1)(2011-2#1)(2012-1#1)
publications report##2##2##(2009-5#1)(2013-1#1)
publications that are##2##3##(1995-8#1)(2013-7#1)
publications that##6##2##(1995-8#1)(2007-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-7#1)
publications using##2##2##(2008-10#1)(2008-11#1)
publications##115##1##(1990-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
publications]##2##1##(1992-2#1)(1993-3#1)
publicity plan##3##2##(1992-12#3)
publicity##13##1##(1991-2#1)(1992-12#4)(1993-12#1)(1993-9#2)(2008-11#2)(2008-8#1)(2009-6#1)(2010-5#1)
publicized##5##1##(1993-3#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
publicizing##2##1##(1995-12#1)(1996-2#1)
publicly available databases##2##3##(2008-4#1)(2009-3#1)
publicly available##18##2##(1996-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
publicly financed competition##2##3##(1992-2#2)
publicly financed##4##2##(1992-2#2)(1994-2#1)(2008-12#1)
publicly funded##4##2##(1996-12#1)(2008-6#1)(2010-10#1)(2011-2#1)
publicly insured##3##2##(1994-2#2)(1997-3#1)
publicly##30##1##(1992-2#2)(1994-2#3)(1995-2#1)(1996-11#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
publics##6##1##(1992-3#1)(1997-1#2)(2008-12#3)
publish##11##1##(1991-12#1)(1991-2#1)(1993-12#1)(2008-7#2)(2009-11#1)(2010-12#3)(2011-2#1)(2012-2#1)
published DNA##2##2##(2008-10#2)
published ET cases##3##3##(2013-1#3)
published PCR##2##2##(2008-1#1)(2011-1#1)
published a##10##2##(1991-3#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
published and unpublished##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
published and##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
published articles on##4##3##(1997-1#1)(2008-10#1)(2009-7#1)(2011-7#1)
published articles##7##2##(1994-3#1)(1997-1#1)(2008-10#1)(2009-7#1)(2010-2#1)(2011-7#1)(2012-12#1)
published as##3##2##(1993-11#1)(2008-8#1)(2011-2#1)
published at##2##2##(1990-12#1)(2008-4#1)
published before##3##2##(2008-3#1)(2010-2#1)(2012-12#1)
published between January##3##3##(2007-10#1)(2008-7#1)(2012-12#1)
published between##16##2##(1994-2#1)(2006-10#1)(2007-10#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
published by the##4##3##(2008-8#1)(2010-8#1)(2010-9#1)(2013-1#1)
published by##12##2##(1993-6#1)(1994-2#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2013-1#1)
published case of##2##3##(1991-11#1)(2008-5#1)
published case##6##2##(1990-12#1)(1991-11#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
published cases##6##2##(2007-10#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
published clinical trials##2##3##(1990-9#1)(2007-11#1)
published clinical##3##2##(1990-9#1)(2006-6#1)(2007-11#1)
published criteria for##2##3##(2008-8#1)(2008-9#1)
published data and##2##3##(2008-10#1)(2011-2#1)
published data are##2##3##(1993-8#1)(2012-2#1)
published data from##4##3##(1996-1#1)(2008-11#2)(2011-2#1)
published data on the##7##4##(1996-5#1)(2007-8#1)(2008-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
published data on##11##3##(1996-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
published data regarding##2##3##(2008-11#1)(2013-1#1)
published data##41##2##(1990-3#1)(1991-2#1)(1992-10#1)(1992-7#1)(1993-8#1)(1995-1#1)(1996-1#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
published during the##2##3##(1994-3#1)(1997-6#1)
published during##3##2##(1994-3#1)(1997-6#1)(2010-12#1)
published evidence##3##2##(1990-8#1)(1993-3#1)(2009-7#1)
published examples##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
published experimental data##3##3##(2008-2#1)(2008-7#1)(2010-10#1)
published experimental##5##2##(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#1)
published findings##5##2##(1990-7#1)(2007-12#3)(2012-2#1)
published for the##2##3##(1993-6#1)(2011-2#1)
published for##6##2##(1993-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
published from 1980 to##2##4##(2009-5#1)(2012-2#1)
published from January##2##3##(2009-8#1)(2013-1#1)
published from##15##2##(1993-12#1)(1993-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
published guidelines for##2##3##(1991-8#1)(1995-6#1)
published guidelines##3##2##(1991-8#1)(1995-6#1)(1997-8#1)
published here##3##2##(1992-8#1)(2008-11#1)(2009-10#1)
published in English##4##3##(1996-9#1)(2008-7#1)(2012-2#1)(2013-8#1)
published in Mexico##2##3##(1997-8#2)
published in literature##2##3##(2007-11#1)(2008-10#1)
published in the IFSCC##2##4##(2008-5#2)
published in the Journal of##2##5##(2008-5#2)
published in the international literature##2##5##(2008-5#1)(2008-7#1)
published in the last##2##4##(2008-10#1)(2008-3#1)
published in the##24##3##(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#1)(2009-3#1)(2010-5#1)(2012-12#1)
published in this issue of##6##5##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2010-11#1)
published in this##7##3##(1994-11#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2010-11#1)
published in##86##2##(1990-2#1)(1991-5#1)(1993-12#4)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-2#3)(1995-8#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
published information##2##2##(1997-1#1)(2008-1#1)
published its##2##2##(1996-12#1)(2013-1#1)
published literature and##5##3##(2008-10#1)(2010-10#1)(2010-12#2)(2010-8#1)
published literature##20##2##(1991-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-3#1)
published meta-analyses##2##2##(2010-2#1)(2013-1#1)
published method##2##2##(2008-10#2)
published methods##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
published model##3##2##(2008-3#1)(2010-10#1)(2012-3#1)
published more than##2##3##(1993-12#1)(2012-2#1)
published on##13##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#4)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
published online##2##2##(2008-12#1)(2013-1#1)
published over the past##2##4##(2008-8#1)(2010-8#1)
published over the##3##3##(2008-2#1)(2008-8#1)(2010-8#1)
published over##4##2##(2008-2#1)(2008-8#1)(2010-8#1)(2012-2#1)
published papers##6##2##(1994-11#1)(2008-10#3)(2013-1#1)(2013-7#1)
published previously##5##2##(2008-10#2)(2008-2#1)(2008-7#2)
published randomised##2##2##(2007-11#1)(2008-5#1)
published randomized##2##2##(1995-2#1)(2008-6#1)
published recently##2##2##(1994-3#1)(2011-1#1)
published report##4##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
published reports from##2##3##(2008-10#1)(2008-2#1)
published reports in##2##3##(1992-5#1)(2009-2#1)
published reports of##2##3##(2007-10#1)(2012-12#1)
published reports on##2##3##(2011-1#1)(2013-1#1)
published reports##18##2##(1990-9#1)(1992-5#1)(1993-12#1)(1995-9#1)(2007-10#1)(2008-10#2)(2008-2#2)(2009-2#1)(2010-2#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
published research##7##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
published results of##2##3##(1992-11#1)(2008-9#1)
published results##12##2##(1992-11#1)(1993-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
published sequence##4##2##(1990-7#1)(1993-6#1)(1994-12#1)(2008-2#1)
published sequences of##2##3##(2008-10#2)
published sequences##5##2##(1994-11#1)(1995-6#1)(2008-10#2)(2010-10#1)
published series of##2##3##(2008-9#1)(2012-3#1)
published series##4##2##(1995-11#1)(2008-9#1)(2010-9#1)(2012-3#1)
published since##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
published studies have##2##3##(2008-7#1)(2008-9#1)
published studies of##3##3##(1990-6#1)(2008-12#1)(2008-8#1)
published studies on##2##3##(1991-5#1)(2008-7#1)
published studies##21##2##(1990-2#1)(1990-6#1)(1991-5#1)(1993-11#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#3)(2011-2#2)(2012-3#2)
published study of##2##3##(2008-7#1)(2008-8#1)
published study##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
published the##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2010-8#1)
published through##2##2##(2012-12#2)
published to date##4##3##(1990-11#1)(2007-11#1)(2008-9#1)(2011-2#1)
published to##5##2##(1990-11#1)(2007-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
published trials##3##2##(1995-9#1)(1996-6#1)(2008-12#1)
published values##4##2##(1994-9#1)(2008-10#1)(2008-2#1)(2008-9#1)
published work##2##2##(2009-8#1)(2010-11#1)
published##624##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#10)(1993-2#3)(1993-3#2)(1993-6#4)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#5)(1994-3#4)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#5)(2006-10#5)(2006-6#1)(2007-10#5)(2007-11#9)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#7)(2008-10#68)(2008-11#25)(2008-12#7)(2008-2#15)(2008-3#22)(2008-4#8)(2008-5#22)(2008-6#12)(2008-7#29)(2008-8#20)(2008-9#19)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#5)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#10)(2010-2#5)(2010-3#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#3)(2011-1#7)(2011-2#28)(2011-7#2)(2012-1#3)(2012-12#22)(2012-2#13)(2012-3#15)(2013-1#31)(2013-7#1)(2013-8#8)
publisher##14##1##(2008-11#2)(2008-12#1)(2008-4#1)(2013-8#10)
publishes a##2##2##(1993-1#1)(1994-12#1)
publishing##21##1##(1991-5#5)(1993-12#2)(1994-12#1)(1994-3#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-12#3)(2010-6#1)(2011-4#1)(2013-1#2)
pubmed##2##1##(2012-12#1)(2012-3#1)
pucker##3##1##(1993-11#1)(1993-3#2)
puckered##2##1##(1994-11#1)(1995-2#1)
pudendal nerve##3##2##(1992-6#1)(1997-7#1)(2009-4#1)
puerarin##2##1##(2008-10#1)(2011-3#1)
puerperal madness&quot##3##2##(2009-10#3)
puerperal##10##1##(1995-6#3)(2009-10#5)(2012-12#1)(2013-1#1)
puerperium##5##1##(1991-3#1)(1992-5#1)(1993-10#1)(2008-11#1)(2012-12#1)
puff##5##1##(1995-8#2)(2007-12#3)
puffer fish##3##2##(1995-2#1)(2008-7#2)
puffer##4##1##(1995-2#1)(2008-7#2)(2013-1#1)
puffiness##3##1##(2008-7#1)(2010-5#1)(2012-2#1)
puffs##3##1##(1992-2#1)(1995-8#2)
pugp##2##1##(1990-5#2)
puis##4##1##(2009-4#1)(2013-1#3)
pulcher##3##1##(2010-8#3)
pulcherrima isolated##2##2##(2008-10#2)
pulcherrima##6##1##(2008-10#5)(2011-2#1)
pulcherrimum disomic##2##2##(2008-8#2)
pulcherrimum##4##1##(2008-8#4)
pulegium L##3##2##(2008-10#3)
pulegone##3##1##(1990-12#1)(2008-10#2)
pulicaria##2##1##(2008-10#1)(2012-3#1)
pull out##2##2##(2008-7#1)(2012-2#1)
pull the##3##2##(1994-3#1)(1995-2#1)(2008-11#1)
pull##10##1##(1990-8#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
pull&quot##3##1##(1990-8#1)(1994-3#1)(2009-4#1)
pull-down##2##1##(2012-2#2)
pull-out strength##3##2##(2007-11#3)
pull-out##4##1##(2007-11#3)(2012-3#1)
pull-through##4##1##(2008-10#2)(2013-1#2)
pullback initiation/termination##2##2##(2011-1#2)
pullback##4##1##(2011-1#4)
pulled straw##2##2##(2013-8#2)
pulled##9##1##(1992-5#1)(2008-6#2)(2008-7#1)(2009-7#1)(2013-1#2)(2013-8#2)
pulley in##3##2##(2008-9#3)
pulley##10##1##(2008-9#10)
pulleys##4##1##(2008-9#3)(2011-2#1)
pulling rates##4##2##(2009-7#4)
pulling##19##1##(1990-5#1)(1995-5#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#2)(2009-7#5)(2009-9#1)(2011-2#1)
pullout##2##1##(2008-9#2)
pullulan##4##1##(2007-12#4)
pullulans and##2##2##(2008-10#2)
pullulans##8##1##(2007-11#1)(2008-10#7)
pulmonary SCC##2##2##(2009-8#2)
pulmonary TB in children##3##4##(2011-2#3)
pulmonary TB in##4##3##(2011-2#4)
pulmonary TB patients##2##3##(2008-5#1)(2013-1#1)
pulmonary TB##8##2##(2008-5#1)(2010-5#1)(2011-2#5)(2013-1#1)
pulmonary abscess##2##2##(1991-3#1)(2007-6#1)
pulmonary actinomycosis##2##2##(2008-1#2)
pulmonary adenomas##4##2##(1990-7#1)(2008-9#3)
pulmonary air leaks##2##3##(1994-6#2)
pulmonary air##3##2##(1992-2#1)(1994-6#2)
pulmonary alveolar macrophages (PAM)##2##4##(1993-8#1)(1996-3#1)
pulmonary alveolar##6##2##(1993-2#1)(1993-8#1)(1996-3#1)(2007-2#1)(2012-12#1)(2012-2#1)
pulmonary and hepatic metastases##2##4##(2011-1#2)
pulmonary and peritoneal##2##3##(2007-12#1)(2013-1#1)
pulmonary and systemic##3##3##(1996-3#1)(1997-1#1)(2008-11#1)
pulmonary and##21##2##(1991-3#1)(1995-10#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-3#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
pulmonary angiography##4##2##(2007-10#1)(2010-10#1)(2010-6#1)(2011-2#1)
pulmonary arterial circulation of RHR##2##5##(2008-11#2)
pulmonary arterial hypertension (PAH)##5##4##(2009-10#1)(2010-10#4)
pulmonary arterial hypertension in##2##4##(2010-10#1)(2013-1#1)
pulmonary arterial hypertension##20##3##(1990-6#1)(1996-3#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-10#10)(2010-5#1)(2011-3#1)(2013-1#1)
pulmonary arterial hypertension]##3##3##(2008-10#2)(2013-1#1)
pulmonary arterial pressure##2##3##(1991-6#1)(2008-11#1)
pulmonary arterial##34##2##(1990-6#1)(1991-6#1)(1996-3#1)(2008-10#7)(2008-11#5)(2009-10#1)(2009-12#1)(2010-10#10)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
pulmonary arteries and veins##2##4##(2010-8#2)
pulmonary arteries and##7##3##(1993-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2012-3#1)
pulmonary arteries##20##2##(1993-3#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-7#5)(2009-5#1)(2010-10#1)(2010-5#1)(2010-6#3)(2010-8#2)(2012-3#1)
pulmonary arteriography##2##2##(2010-6#2)
pulmonary arteriovenous fistulae##2##3##(2008-11#1)(2008-7#1)
pulmonary arteriovenous malformation##2##3##(2008-1#1)(2010-10#1)
pulmonary arteriovenous##7##2##(2008-1#2)(2008-11#3)(2008-7#1)(2010-10#1)
pulmonary artery and##2##3##(1997-8#1)(2008-11#1)
pulmonary artery banding##5##3##(2007-8#5)
pulmonary artery dissection##2##3##(2010-10#2)
pulmonary artery endothelial cells##2##4##(1991-9#1)(1993-3#1)
pulmonary artery occlusion##2##3##(1997-8#2)
pulmonary artery pressure##7##3##(1991-8#1)(1992-2#1)(1997-5#1)(2007-9#1)(2010-10#1)(2010-4#1)(2010-8#1)
pulmonary artery smooth muscle cells##2##5##(1995-2#1)(2011-3#1)
pulmonary artery smooth muscle##3##4##(1995-2#1)(2010-12#1)(2011-3#1)
pulmonary artery thrombosis##2##3##(2013-1#2)
pulmonary artery with##2##3##(2007-8#1)(2010-8#1)
pulmonary artery##60##2##(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#2)(1995-12#1)(1995-2#1)(1997-5#2)(1997-8#6)(2007-8#10)(2007-9#1)(2008-1#1)(2008-11#7)(2008-12#1)(2010-10#7)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-2#1)(2011-3#2)(2012-12#2)(2013-1#2)
pulmonary aspergilloma##2##2##(2008-1#2)
pulmonary aspergillosis in patients with##2##5##(2011-2#1)(2012-12#1)
pulmonary aspergillosis in##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
pulmonary aspergillosis##11##2##(2008-1#4)(2008-5#2)(2011-2#3)(2012-12#1)(2013-1#1)
pulmonary autograft patch##2##3##(2007-8#2)
pulmonary autograft##4##2##(2007-8#4)
pulmonary blood flow##4##3##(1996-3#1)(2007-8#2)(2010-10#1)
pulmonary capillary wedge pressure##3##4##(1991-6#1)(2008-3#1)(2010-8#1)
pulmonary capillary wedge##4##3##(1991-6#1)(2008-3#1)(2008-5#1)(2010-8#1)
pulmonary capillary##5##2##(1991-6#1)(1991-9#1)(2008-3#1)(2008-5#1)(2010-8#1)
pulmonary carcinoid##2##2##(2008-8#2)
pulmonary carcinoma##3##2##(1997-5#1)(2007-8#1)(2008-9#1)
pulmonary circulation##4##2##(1992-3#1)(1994-8#1)(2006-10#1)(2007-9#1)
pulmonary clearance##3##2##(1991-8#3)
pulmonary complications after##2##3##(1997-3#1)(2011-2#1)
pulmonary complications##10##2##(1991-8#1)(1997-3#2)(2006-10#2)(2007-8#2)(2011-2#3)
pulmonary cryptococcosis##2##2##(2008-10#1)(2012-3#1)
pulmonary deposition##2##2##(1996-12#2)
pulmonary disease and##7##3##(2007-10#1)(2008-7#2)(2009-1#1)(2011-2#3)
pulmonary disease in##7##3##(1992-1#1)(1995-12#1)(1997-3#1)(2007-12#1)(2010-2#1)(2012-2#2)
pulmonary disease##83##2##(1991-4#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#2)(1995-12#3)(1996-1#2)(1996-5#1)(1997-3#1)(1997-7#2)(2007-10#1)(2007-12#2)(2007-6#2)(2007-8#2)(2008-1#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2010-10#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#19)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
pulmonary diseases##6##2##(1991-12#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-2#1)
pulmonary drug##2##2##(1992-3#1)(1997-1#1)
pulmonary edema formation in##2##4##(1994-8#1)(2010-10#1)
pulmonary edema in##3##3##(1994-8#1)(2008-11#1)(2011-2#1)
pulmonary edema##22##2##(1991-9#1)(1992-2#5)(1994-8#3)(2008-10#1)(2008-11#2)(2009-1#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-2#1)
pulmonary effects of##2##3##(1996-12#2)
pulmonary embolism (PE) and##2##4##(2008-3#1)(2011-2#1)
pulmonary embolism (PE)##5##3##(2007-8#1)(2008-3#1)(2011-2#2)(2012-2#1)
pulmonary embolism and##4##3##(1991-11#1)(1991-3#1)(2010-10#1)(2013-1#1)
pulmonary embolism##50##2##(1991-11#7)(1991-3#1)(1992-5#1)(1996-6#4)(1997-2#1)(2007-10#4)(2007-11#1)(2007-7#1)(2007-8#4)(2008-12#1)(2008-3#2)(2008-7#3)(2010-1#1)(2010-10#2)(2010-6#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
pulmonary embolism]##3##2##(1991-11#1)(2007-10#1)(2013-8#1)
pulmonary embolisms##2##2##(1993-5#1)(1993-9#1)
pulmonary emphysema##3##2##(2008-7#3)
pulmonary endarterectomy##4##2##(2010-10#1)(2010-6#1)(2013-1#2)
pulmonary evaluation##2##2##(2006-10#2)
pulmonary fibrosis and pulmonary##2##4##(2011-3#2)
pulmonary fibrosis and##3##3##(2006-10#1)(2011-3#2)
pulmonary fibrosis is##2##3##(2010-5#1)(2012-1#1)
pulmonary fibrosis with##2##3##(2006-10#1)(2010-5#1)
pulmonary fibrosis##20##2##(1994-3#1)(1995-8#1)(2006-10#6)(2008-1#1)(2009-10#1)(2010-5#3)(2011-3#2)(2012-1#4)(2013-8#1)
pulmonary function and##2##3##(2011-2#1)(2012-12#1)
pulmonary function deterioration##2##3##(2011-2#2)
pulmonary function tests and##3##4##(1996-1#1)(1996-3#1)(2007-2#1)
pulmonary function tests##7##3##(1991-12#1)(1996-1#1)(1996-3#2)(2006-10#1)(2007-2#1)(2008-8#1)
pulmonary function##28##2##(1991-12#2)(1992-5#1)(1992-6#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-2#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
pulmonary functions in##2##3##(2012-2#2)
pulmonary functions##3##2##(2012-2#3)
pulmonary granulomas##2##2##(1997-3#1)(2008-5#1)
pulmonary heart disease##3##3##(2011-2#3)
pulmonary hemorrhage as##2##3##(2011-2#2)
pulmonary hemorrhage##4##2##(2006-10#1)(2008-1#1)(2011-2#2)
pulmonary hilar##2##2##(2008-1#1)(2010-8#1)
pulmonary hypertension (PH)##3##3##(2010-10#2)(2010-6#1)
pulmonary hypertension and other##2##4##(2009-10#1)(2012-2#1)
pulmonary hypertension and##4##3##(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
pulmonary hypertension in##2##3##(2008-1#1)(2011-2#1)
pulmonary hypertension##53##2##(1991-6#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(1997-5#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-10#3)(2009-4#1)(2010-10#7)(2010-12#2)(2010-5#3)(2010-6#11)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
pulmonary hypoplasia##3##2##(1994-6#1)(2008-7#1)(2012-3#1)
pulmonary infarction##3##2##(2007-8#3)
pulmonary infection by##2##3##(1990-12#1)(2007-11#1)
pulmonary infection##6##2##(1990-12#1)(1991-11#1)(1991-3#1)(1996-11#1)(2007-11#1)(2007-12#1)
pulmonary infections##4##2##(1997-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
pulmonary infiltrates##2##2##(2008-5#1)(2010-11#1)
pulmonary injury and##2##3##(1991-9#1)(1996-12#1)
pulmonary involvement##5##2##(1991-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
pulmonary lesion##2##2##(2006-10#1)(2012-1#1)
pulmonary lesions##10##2##(1991-8#1)(2007-10#1)(2008-5#1)(2010-8#5)(2012-1#1)(2013-8#1)
pulmonary maintenance program##3##3##(2010-10#3)
pulmonary metastases and##2##3##(2010-3#2)
pulmonary metastases from##2##3##(2010-3#1)(2012-1#1)
pulmonary metastases in##3##3##(2010-3#2)(2013-1#1)
pulmonary metastases##18##2##(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-3#7)(2012-1#1)(2013-1#5)(2013-8#1)
pulmonary metastasis in##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
pulmonary metastasis##10##2##(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-1#2)(2013-7#1)
pulmonary mucormycosis##2##2##(2013-1#1)(2013-8#1)
pulmonary nodule##4##2##(1990-2#1)(2007-8#2)(2008-1#1)
pulmonary nodules are##2##3##(2008-10#1)(2008-6#1)
pulmonary nodules##12##2##(2008-10#2)(2008-6#6)(2012-12#1)(2012-3#2)(2013-7#1)
pulmonary obstruction##3##2##(1991-4#1)(2008-10#1)(2011-2#1)
pulmonary oedema##7##2##(1991-11#1)(1995-11#1)(2010-7#3)(2011-2#1)(2013-8#1)
pulmonary or##2##2##(2007-9#1)(2008-6#1)
pulmonary perfusion##2##2##(2006-10#2)
pulmonary pressure##3##2##(2010-10#1)(2010-6#2)
pulmonary rehabilitation in##2##3##(2011-2#2)
pulmonary rehabilitation programmes##2##3##(1997-8#1)(2011-2#1)
pulmonary rehabilitation##19##2##(1997-8#1)(2007-6#2)(2010-1#2)(2011-2#10)(2012-12#3)(2013-7#1)
pulmonary resection##4##2##(2007-8#2)(2007-9#1)(2010-8#1)
pulmonary resections in##2##3##(2007-8#1)(2008-10#1)
pulmonary resections##5##2##(2007-8#1)(2008-10#3)(2010-8#1)
pulmonary sarcoidosis##2##2##(2008-7#2)
pulmonary surfactant##4##2##(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)
pulmonary syndrome##3##2##(2011-2#3)
pulmonary system##2##2##(2012-3#1)(2013-8#1)
pulmonary thromboembolism (PTE)##2##3##(2008-1#1)(2008-10#1)
pulmonary thromboembolism in a patient with hereditary spherocytosis##2##8##(2008-12#2)
pulmonary thromboembolism##7##2##(2008-1#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-6#2)
pulmonary tuberculosis (PTB)##2##3##(2011-1#1)(2013-8#1)
pulmonary tuberculosis and##3##3##(1996-11#1)(2010-5#1)(2013-1#1)
pulmonary tuberculosis in children##2##4##(2011-2#2)
pulmonary tuberculosis in##3##3##(1995-3#1)(2011-2#2)
pulmonary tuberculosis patients##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
pulmonary tuberculosis##27##2##(1995-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-3#1)(2007-7#3)(2008-12#1)(2008-7#2)(2009-5#1)(2010-5#1)(2011-1#4)(2011-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
pulmonary valvotomy##2##2##(2008-11#2)
pulmonary vascular disease##2##3##(2010-10#1)(2010-6#1)
pulmonary vascular remodeling##2##3##(2008-1#2)
pulmonary vascular resistance##11##3##(1990-11#1)(1991-9#2)(1997-5#1)(2008-11#1)(2008-12#2)(2010-10#2)(2010-6#1)(2012-2#1)
pulmonary vascular##21##2##(1990-11#1)(1991-8#1)(1991-9#2)(1992-2#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2010-10#3)(2010-6#2)(2012-2#1)
pulmonary vein myocardium##4##3##(2013-1#4)
pulmonary vein##9##2##(2009-7#1)(2010-4#1)(2011-2#3)(2013-1#4)
pulmonary veins myocardium##2##3##(2013-1#2)
pulmonary veins##7##2##(1997-1#1)(2007-8#1)(2008-11#1)(2013-1#4)
pulmonary##929##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#1)(1991-11#11)(1991-12#8)(1991-2#2)(1991-3#6)(1991-4#3)(1991-5#1)(1991-6#3)(1991-8#9)(1991-9#12)(1992-1#1)(1992-11#4)(1992-12#4)(1992-2#13)(1992-3#6)(1992-5#5)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#5)(1994-6#3)(1994-8#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#3)(1996-12#6)(1996-3#7)(1996-5#1)(1996-6#6)(1997-1#7)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#6)(1997-7#2)(1997-8#9)(2006-10#20)(2007-10#11)(2007-11#2)(2007-12#8)(2007-2#3)(2007-6#6)(2007-7#6)(2007-8#48)(2007-9#5)(2008-1#31)(2008-10#36)(2008-11#29)(2008-12#10)(2008-3#6)(2008-4#2)(2008-5#16)(2008-6#16)(2008-7#31)(2008-8#8)(2008-9#5)(2009-1#2)(2009-10#7)(2009-12#2)(2009-4#2)(2009-5#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#5)(2010-10#44)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#14)(2010-4#2)(2010-5#17)(2010-6#42)(2010-7#4)(2010-8#17)(2011-1#9)(2011-2#91)(2011-3#11)(2012-1#10)(2012-12#13)(2012-2#17)(2012-3#20)(2013-1#40)(2013-7#8)(2013-8#19)
pulmonary/mediastinal##2##1##(2012-2#2)
pulmonates##2##1##(2008-9#2)
pulmonology##2##1##(2013-1#2)
pulp and paper##2##3##(2008-10#2)
pulp and##3##2##(2008-10#3)
pulp fibers##3##2##(2008-3#3)
pulp is##2##2##(2008-10#1)(2011-2#1)
pulp of##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
pulp therapy##2##2##(2011-2#2)
pulp tissue##2##2##(2012-2#1)(2013-1#1)
pulp##63##1##(1990-9#1)(1991-2#3)(1996-2#1)(1997-6#1)(2008-10#14)(2008-11#1)(2008-3#4)(2008-5#4)(2008-6#7)(2008-7#3)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#7)
pulpal##2##1##(2011-2#1)(2013-1#1)
pulpotomy##6##1##(1990-3#1)(2011-2#5)
pulps##2##1##(2008-10#1)(2012-2#1)
pulsatile flow##2##2##(2008-11#1)(2008-7#1)
pulsatile hydrodynamics##2##2##(2008-7#2)
pulsatile secretion##2##2##(1990-9#1)(1997-7#1)
pulsatile tinnitus##2##2##(2006-12#2)
pulsatile##23##1##(1990-9#1)(1994-11#1)(1995-3#1)(1997-2#2)(1997-7#1)(2006-12#2)(2007-8#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#5)(2010-6#2)(2010-8#1)(2012-3#1)
pulsatility index in the affected##2##5##(2007-10#2)
pulsatility index##5##2##(1996-6#1)(2007-10#3)(2011-2#1)
pulsatility##8##1##(1990-9#1)(1996-6#1)(2007-10#3)(2007-7#1)(2011-2#1)(2013-1#1)
pulsating##5##1##(1996-2#1)(1997-3#1)(2008-12#1)(2009-3#1)(2009-7#1)
pulsation in##2##2##(2007-11#1)(2008-7#1)
pulsation##6##1##(2007-11#2)(2008-10#1)(2008-7#2)(2008-9#1)
pulsations and##2##2##(2007-11#2)
pulsations in class-B solid-state lasers##2##5##(2007-11#2)
pulsations in##4##2##(2007-11#3)(2011-8#1)
pulsations of##3##2##(2007-11#2)(2008-3#1)
pulsations that##2##2##(2007-11#2)
pulsations##16##1##(1993-1#1)(2007-11#10)(2007-12#2)(2008-2#1)(2008-3#1)(2011-8#1)
pulse ECT##3##2##(2012-12#3)
pulse allows the##2##3##(2007-11#1)(2007-12#1)
pulse amperometry##2##2##(2008-10#2)
pulse amplification##14##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#6)
pulse amplitude and##2##3##(1997-2#1)(2008-10#1)
pulse amplitude of##3##3##(2008-10#3)
pulse amplitude##12##2##(1997-2#2)(2007-12#1)(2008-10#8)(2008-3#1)
pulse and a##2##3##(2007-12#2)
pulse and the##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
pulse and##22##2##(1992-12#1)(2007-11#4)(2007-12#4)(2008-10#9)(2008-3#4)
pulse anodic stripping voltammetric##4##4##(2008-10#4)
pulse anodic stripping voltammetry##20##4##(2008-10#19)(2010-2#1)
pulse anodic stripping##24##3##(2008-10#23)(2010-2#1)
pulse are##4##2##(2008-2#2)(2008-3#2)
pulse as##2##2##(2007-11#1)(2007-12#1)
pulse asymmetry##2##2##(2007-12#2)
pulse at 800 nm##2##4##(2007-11#1)(2010-1#1)
pulse at the##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
pulse at##9##2##(2007-11#4)(2007-12#1)(2008-1#1)(2008-3#2)(2010-1#1)
pulse breakup##2##2##(2007-11#1)(2008-3#1)
pulse broadening##2##2##(2007-12#1)(2008-2#1)
pulse by use of##2##4##(2007-11#1)(2007-12#1)
pulse by##6##2##(2007-11#3)(2007-12#2)(2008-2#1)
pulse can be##3##3##(2007-12#1)(2008-3#2)
pulse cathodic stripping voltammetry##5##4##(2008-10#5)
pulse cathodic stripping##8##3##(2008-10#8)
pulse cathodic##9##2##(2008-10#9)
pulse characterization is##2##3##(2007-11#2)
pulse characterization##6##2##(2007-11#5)(2007-12#1)
pulse compression in##4##3##(2007-11#3)(2007-12#1)
pulse compression to##2##3##(2007-11#2)
pulse compression##16##2##(2007-11#8)(2007-12#6)(2008-2#1)(2008-3#1)
pulse compressor##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
pulse contrast##2##2##(2007-11#1)(2010-1#1)
pulse current##2##2##(2008-10#2)
pulse cyclophosphamide##3##2##(1993-2#1)(2007-7#2)
pulse differential voltammetry##2##3##(2008-10#2)
pulse differential##3##2##(2008-10#3)
pulse distortion##2##2##(2007-11#2)
pulse duration and a##3##4##(2007-11#2)(2008-3#1)
pulse duration and wavelength##2##4##(2007-11#2)
pulse duration and##10##3##(2007-11#8)(2007-12#1)(2008-3#1)
pulse duration from##2##3##(2007-12#2)
pulse duration in##3##3##(2007-11#1)(2008-3#2)
pulse duration is##5##3##(1991-2#1)(2007-12#2)(2008-3#2)
pulse duration of 120 ns##2##5##(2008-3#2)
pulse duration of##11##3##(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#6)
pulse duration was##2##3##(1991-2#1)(1994-3#1)
pulse duration were##2##3##(2008-3#1)(2009-8#1)
pulse duration##54##2##(1991-2#4)(1994-3#1)(2007-11#13)(2007-12#8)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#16)(2008-7#1)(2008-8#1)(2009-8#2)
pulse durations in##2##3##(2007-11#1)(2007-12#1)
pulse durations of less than##2##5##(2008-3#2)
pulse durations of##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
pulse durations##15##2##(2007-11#6)(2007-12#4)(2008-2#2)(2008-3#3)
pulse energies as high as##2##5##(2007-12#2)
pulse energies as##3##3##(2007-11#1)(2007-12#2)
pulse energies of##4##3##(2007-12#4)
pulse energies##14##2##(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#3)
pulse energy and the##3##4##(2007-11#2)(2008-3#1)
pulse energy and##12##3##(1992-12#1)(2007-11#5)(2007-12#1)(2008-3#5)
pulse energy is##2##3##(2007-11#1)(2007-12#1)
pulse energy of##8##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
pulse energy##44##2##(1992-12#1)(2007-11#14)(2007-12#14)(2008-2#3)(2008-3#12)
pulse for##2##2##(2008-10#1)(2008-3#1)
pulse frequency##7##2##(1992-11#2)(1992-12#1)(2008-10#1)(2013-1#3)
pulse from a##3##3##(2007-12#2)(2008-3#1)
pulse from the##2##3##(2008-3#2)
pulse from##7##2##(1991-9#1)(2007-11#1)(2007-12#2)(2008-3#3)
pulse generated by##2##3##(2007-11#1)(2007-12#1)
pulse generation by##2##3##(2007-12#2)
pulse generation in##2##3##(2007-12#2)
pulse generation##8##2##(2007-11#3)(2007-12#5)
pulse height##3##2##(2008-10#3)
pulse in a##5##3##(2007-11#2)(2007-12#3)
pulse in the##10##3##(2007-11#4)(2007-12#4)(2008-10#1)(2008-3#1)
pulse in##22##2##(2007-11#9)(2007-12#9)(2008-10#1)(2008-2#1)(2008-3#2)
pulse increases##2##2##(2008-2#1)(2008-3#1)
pulse intensity##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
pulse interactions in dispersion-managed##2##4##(2007-11#2)
pulse interactions##3##2##(2007-11#3)
pulse into##3##2##(2007-11#1)(2007-12#2)
pulse irradiation of##2##3##(2008-8#1)(2008-9#1)
pulse irradiation##3##2##(2008-8#2)(2008-9#1)
pulse is##28##2##(1991-5#1)(2007-11#9)(2007-12#10)(2008-10#2)(2008-2#3)(2008-3#3)
pulse itself##2##2##(2007-11#1)(2008-3#1)
pulse laser##2##2##(2008-3#1)(2008-5#1)
pulse lasers##2##2##(2007-12#2)
pulse length of##2##3##(2008-2#1)(2008-3#1)
pulse length##8##2##(1990-5#1)(1991-5#1)(2007-12#2)(2008-2#1)(2008-3#2)(2012-2#1)
pulse lengths##3##2##(2007-12#2)(2008-2#1)
pulse number##2##2##(2008-10#1)(2009-9#1)
pulse of the##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
pulse of##12##2##(1991-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2013-1#1)
pulse on the##2##3##(2008-2#1)(2008-3#1)
pulse oximetry##8##2##(1993-1#3)(2007-12#1)(2007-8#1)(2008-2#1)(2009-5#1)(2010-4#1)
pulse pairs##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
pulse parameters##2##2##(2007-11#1)(2007-12#1)
pulse peak power##3##3##(2007-12#1)(2008-3#2)
pulse per##2##2##(2008-10#1)(2008-5#1)
pulse permits##2##2##(2007-11#1)(2007-12#1)
pulse phase in a##2##4##(2007-12#2)
pulse phase##3##2##(2007-12#3)
pulse polarographic determination##8##3##(2008-10#8)
pulse polarographic##16##2##(2008-10#16)
pulse polarography (DPP)##7##3##(2008-10#7)
pulse polarography##22##2##(2008-10#22)
pulse power##2##2##(2007-11#2)
pulse pressure##4##2##(1990-8#1)(2007-10#2)(2008-7#1)
pulse propagating in##3##3##(2007-11#3)
pulse propagating##7##2##(2007-11#5)(2007-12#1)(2008-2#1)
pulse propagation in a##2##4##(2007-11#1)(2007-12#1)
pulse propagation in optical fibers##2##5##(2007-11#1)(2008-3#1)
pulse propagation in##7##3##(2007-11#4)(2007-12#2)(2008-3#1)
pulse propagation##13##2##(2007-11#6)(2007-12#4)(2008-3#3)
pulse radiolysis technique##2##3##(2008-9#2)
pulse radiolysis##4##2##(2008-10#1)(2008-9#3)
pulse rate##5##2##(2008-11#1)(2009-5#1)(2009-9#2)(2010-5#1)
pulse rates##3##2##(2007-12#1)(2009-9#2)
pulse repetition frequency##5##3##(2007-12#2)(2008-3#3)
pulse repetition rate of##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
pulse repetition rate##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
pulse repetition##10##2##(2007-11#1)(2007-12#4)(2008-3#5)
pulse routing in a##2##4##(2007-11#1)(2007-12#1)
pulse routing##3##2##(2007-11#2)(2007-12#1)
pulse sequence is##2##3##(2012-2#1)(2012-8#1)
pulse sequence##11##2##(1997-8#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#1)
pulse sequences with##2##3##(2007-12#1)(2009-9#1)
pulse sequences##12##2##(1997-8#1)(2007-11#2)(2007-12#2)(2009-9#3)(2010-9#1)(2012-2#1)(2012-7#1)(2013-1#1)
pulse shape##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
pulse shaper##9##2##(2007-11#3)(2007-12#6)
pulse shaping##9##2##(2007-11#6)(2007-12#3)
pulse shortening##3##2##(2007-11#1)(2008-2#2)
pulse spectrum is##2##3##(2008-3#2)
pulse spectrum##4##2##(2008-3#4)
pulse splitting##2##2##(2007-12#2)
pulse spreading##2##2##(2007-12#2)
pulse stretching##3##2##(2008-3#3)
pulse that##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
pulse therapy##4##2##(2007-7#2)(2008-1#1)(2013-1#1)
pulse to##7##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)
pulse train at##2##3##(2007-11#1)(2007-12#1)
pulse train emitted by a##2##5##(2007-11#1)(2007-12#1)
pulse train generated by##2##4##(2007-12#2)
pulse train##17##2##(1991-2#1)(2007-11#8)(2007-12#7)(2008-3#1)
pulse trains at##2##3##(2007-11#1)(2008-2#1)
pulse trains from##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
pulse trains##18##2##(2007-11#7)(2007-12#4)(2008-2#1)(2008-3#5)(2011-1#1)
pulse trapping##2##2##(2007-11#2)
pulse voltammetric determination of##2##4##(2008-10#2)
pulse voltammetric determination##3##3##(2008-10#3)
pulse voltammetric##10##2##(2008-10#10)
pulse voltammetry (DPV)##11##3##(2008-10#11)
pulse voltammetry##25##2##(1995-5#1)(2008-10#24)
pulse volume##2##2##(2008-3#1)(2011-2#1)
pulse was##3##2##(1994-6#1)(2007-11#1)(2007-12#1)
pulse wave velocity (PWV)##2##4##(2007-10#1)(2013-3#1)
pulse wave velocity##3##3##(2007-10#2)(2013-3#1)
pulse wave##5##2##(2007-10#2)(2008-5#1)(2013-3#1)(2013-8#1)
pulse were##2##2##(2008-3#1)(2013-8#1)
pulse width ECT##3##3##(2012-12#3)
pulse width and amplitude jitter noises of##2##7##(2007-12#2)
pulse width and##3##3##(2007-12#2)(2008-3#1)
pulse width in##2##3##(2007-11#2)
pulse width is##2##3##(2008-2#1)(2008-3#1)
pulse width jitter##2##3##(2007-12#2)
pulse width of the##3##4##(2007-12#1)(2008-2#1)(2012-12#1)
pulse width of##12##3##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#3)(2012-12#1)
pulse width remains constant##2##4##(2007-12#1)(2008-3#1)
pulse width when##4##3##(2008-10#1)(2008-3#3)
pulse width##60##2##(2007-11#7)(2007-12#15)(2008-10#7)(2008-2#4)(2008-3#22)(2012-12#5)
pulse widths of the##2##4##(2007-12#1)(2008-3#1)
pulse widths of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
pulse widths##7##2##(2007-11#1)(2007-12#2)(2008-3#4)
pulse with a##2##3##(2008-3#2)
pulse with##7##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#3)(2010-8#1)
pulse##1009##1##(1990-5#1)(1990-8#1)(1991-2#6)(1991-5#3)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#1)(1993-1#5)(1993-2#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-8#5)(2007-10#4)(2007-11#211)(2007-12#210)(2007-7#9)(2007-8#1)(2008-1#4)(2008-10#197)(2008-11#6)(2008-2#67)(2008-3#164)(2008-4#1)(2008-5#5)(2008-7#8)(2008-8#4)(2008-9#4)(2009-5#2)(2009-8#2)(2009-9#8)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#10)(2012-2#5)(2012-3#1)(2012-7#2)(2012-8#1)(2013-1#11)(2013-3#1)(2013-7#2)(2013-8#5)
pulse's duration##2##2##(2007-11#2)
pulse's##4##1##(2007-11#4)
pulse)##4##1##(2007-12#2)(2008-10#1)(2008-11#1)
pulse-burst laser system has been##2##5##(2007-12#2)
pulse-burst laser system##3##3##(2007-12#3)
pulse-chase experiments##2##2##(1992-12#2)
pulse-chase labeling##2##2##(2008-4#2)
pulse-chase##4##1##(1992-12#2)(2008-4#2)
pulse-energy##2##1##(2007-11#1)(2007-12#1)
pulse-front tilt and##2##3##(2007-11#2)
pulse-front tilt##3##2##(2007-11#3)
pulse-front##4##1##(2007-11#4)
pulse-labeling##2##1##(1997-4#1)(2008-4#1)
pulse-pair ratio##2##2##(2008-2#2)
pulse-pair##3##1##(2008-2#3)
pulse-repetition rate##3##2##(2007-11#2)(2008-3#1)
pulse-repetition##4##1##(2007-11#3)(2008-3#1)
pulse-sequence generation##2##2##(2007-12#2)
pulse-shape##2##1##(2007-12#1)(2008-3#1)
pulse-shaping technique##2##2##(2007-12#1)(2008-2#1)
pulse-to-pulse timing jitter and##2##4##(2007-11#2)
pulse-to-pulse##8##1##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
pulse-voltammetric##2##1##(2008-10#2)
pulse-width##2##1##(2007-12#1)(2008-3#1)
pulsed Nd##8##2##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)
pulsed UV laser##2##3##(2012-2#2)
pulsed UV##4##2##(2012-2#4)
pulsed amperometric detection (PAD)##3##4##(1991-7#1)(2008-10#2)
pulsed amperometric detection##15##3##(1991-7#2)(1992-1#1)(1995-2#1)(2008-10#10)(2008-6#1)
pulsed amperometric##17##2##(1991-7#2)(1992-1#1)(1995-2#1)(2008-10#12)(2008-6#1)
pulsed and##2##2##(2008-2#1)(2008-3#1)
pulsed beam propagation##2##3##(2007-12#2)
pulsed cavity ringdown experiment##2##4##(2008-3#2)
pulsed coherent##3##2##(2008-2#1)(2008-3#2)
pulsed digital holography is##2##4##(2008-3#2)
pulsed digital holography##4##3##(2008-3#4)
pulsed digital##5##2##(2008-3#5)
pulsed diode##2##2##(2007-11#1)(2008-3#1)
pulsed doubly resonant optical parametric##2##5##(2007-11#2)
pulsed dye laser##3##3##(1996-11#1)(2008-3#1)(2009-4#1)
pulsed dye##4##2##(1996-11#2)(2008-3#1)(2009-4#1)
pulsed electric##3##2##(2008-9#3)
pulsed excitation##3##2##(2008-2#1)(2008-3#2)
pulsed field gel electrophoresis##5##4##(1995-8#1)(2008-10#1)(2012-3#3)
pulsed flow of solution##2##4##(2008-10#2)
pulsed flow##4##2##(2008-10#4)
pulsed galvanostatic##2##2##(2008-10#2)
pulsed gradient magnetic field##3##4##(2008-9#3)
pulsed infrared##2##2##(2008-3#2)
pulsed laser beam##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
pulsed laser radiation##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
pulsed laser vaporization##2##3##(2008-10#2)
pulsed laser##35##2##(1992-1#1)(2007-11#8)(2007-12#5)(2008-10#5)(2008-2#7)(2008-3#6)(2010-11#1)(2012-2#2)
pulsed lasers##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
pulsed lidar##2##2##(2008-3#2)
pulsed light is##2##3##(2008-3#2)
pulsed light##5##2##(2008-3#3)(2010-6#1)(2011-2#1)
pulsed magnetic field##2##3##(2009-11#1)(2011-2#1)
pulsed mode##4##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
pulsed optical beam##2##3##(2008-3#2)
pulsed optical parametric oscillator##4##4##(2007-11#1)(2008-3#3)
pulsed optical##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
pulsed photoacoustic##2##2##(2008-3#2)
pulsed quantum-cascade distributed feedback laser##2##5##(2008-3#2)
pulsed quench-flow apparatus##3##3##(1990-2#3)
pulsed top-hat beam excitation and a near-field detection scheme##2##9##(2007-12#1)(2008-3#1)
pulsed top-hat beam##4##3##(2007-12#1)(2008-3#3)
pulsed treatment##2##2##(1995-5#2)
pulsed tunable dye laser##2##4##(2008-10#1)(2008-2#1)
pulsed ultrasound##4##2##(2008-3#2)(2012-2#1)(2013-1#1)
pulsed with##2##2##(2008-11#1)(2008-8#1)
pulsed##243##1##(1990-2#3)(1990-6#2)(1991-3#1)(1991-7#2)(1992-1#4)(1992-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#2)(2007-11#21)(2007-12#26)(2008-10#37)(2008-11#1)(2008-2#29)(2008-3#74)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-2#9)(2012-3#3)(2013-1#1)
pulsed-field gel electrophoresis (PFGE)##3##4##(1993-12#2)(2008-10#1)
pulsed-field gel electrophoresis##16##3##(1993-12#2)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)
pulsed-field##20##1##(1993-12#2)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)
pulsed-laser##5##1##(2007-12#3)(2008-2#2)
pulses (10##2##2##(2007-11#1)(2008-3#1)
pulses and a##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
pulses and##28##2##(2007-11#10)(2007-12#10)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-8#1)
pulses are analyzed##3##3##(2007-12#1)(2008-2#2)
pulses are detected##2##3##(2008-2#1)(2008-3#1)
pulses are generated##2##3##(2007-11#2)
pulses are##23##2##(2007-11#7)(2007-12#7)(2008-2#5)(2008-3#4)
pulses as a result of##2##5##(2007-11#1)(2007-12#1)
pulses as short as##8##4##(2007-11#3)(2007-12#4)(2008-2#1)
pulses as##13##2##(2007-11#5)(2007-12#6)(2008-2#2)
pulses at 1##7##3##(2007-11#5)(2007-12#2)
pulses at 1064 nm##2##4##(2007-11#2)
pulses at 532 nm##2##4##(2007-12#1)(2008-2#1)
pulses at 800 nm##2##4##(2007-12#2)
pulses at a 1-kHz repetition rate are obtained##2##8##(2007-11#1)(2007-12#1)
pulses at a repetition rate of##3##6##(2007-11#1)(2007-12#2)
pulses at a wavelength near##2##5##(2007-11#1)(2007-12#1)
pulses at a##16##3##(2007-11#5)(2007-12#8)(2008-2#1)(2008-3#1)(2011-1#1)
pulses at an##2##3##(2007-11#2)
pulses at the##2##3##(2007-12#1)(2008-3#1)
pulses at##55##2##(2007-11#18)(2007-12#24)(2008-2#5)(2008-3#7)(2011-1#1)
pulses by use of a##8##5##(2007-11#4)(2007-12#3)(2008-2#1)
pulses by use of##14##4##(2007-11#7)(2007-12#6)(2008-2#1)
pulses by using a##2##4##(2007-11#2)
pulses by##34##2##(2007-11#16)(2007-12#14)(2008-2#2)(2008-3#2)
pulses can be##3##3##(2007-11#2)(2007-12#1)
pulses can##4##2##(2007-11#2)(2007-12#2)
pulses centered at##2##3##(2007-11#1)(2008-3#1)
pulses emitted##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
pulses for##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
pulses from a Kerr-lens mode-locked Ti##2##6##(2007-12#2)
pulses from a Kerr-lens mode-locked##3##5##(2007-11#1)(2007-12#2)
pulses from a Ti##6##4##(2007-11#1)(2007-12#4)(2008-3#1)
pulses from a diode-pumped##3##4##(2007-12#2)(2008-2#1)
pulses from a mode-locked Ti##2##5##(2007-12#2)
pulses from a mode-locked##4##4##(2007-12#4)
pulses from a##24##3##(2007-11#5)(2007-12#15)(2008-1#1)(2008-2#1)(2008-3#2)
pulses from##32##2##(2007-11#8)(2007-12#20)(2008-1#1)(2008-2#1)(2008-3#2)
pulses generated by##3##3##(2007-12#3)
pulses generated##5##2##(2007-11#2)(2007-12#3)
pulses has been##2##3##(2007-11#1)(2007-12#1)
pulses in a single transverse mode##2##6##(2007-12#1)(2008-3#1)
pulses in a##23##3##(2007-11#6)(2007-12#11)(2008-10#1)(2008-2#1)(2008-3#4)
pulses in dispersive##2##3##(2007-11#2)
pulses in high-speed##2##3##(2007-11#1)(2007-12#1)
pulses in long-distance##2##3##(2007-12#2)
pulses in optical##3##3##(2007-11#1)(2007-12#2)
pulses in the range##2##4##(2007-12#1)(2008-3#1)
pulses in the visible##3##4##(2007-12#3)
pulses in the##19##3##(1992-11#1)(1997-2#1)(1997-5#1)(2007-11#6)(2007-12#9)(2008-3#1)
pulses in##77##2##(1992-11#1)(1997-2#1)(1997-5#1)(2007-11#29)(2007-12#34)(2008-10#1)(2008-2#2)(2008-3#7)(2013-7#1)
pulses induced##2##2##(2008-2#1)(2008-5#1)
pulses into##3##2##(1991-9#1)(2007-11#2)
pulses is##13##2##(2007-11#5)(2007-12#4)(2008-2#2)(2008-3#2)
pulses near##3##2##(2007-12#2)(2008-3#1)
pulses of &lt##2##3##(2007-11#1)(2007-12#1)
pulses of 1##2##3##(2007-11#1)(2013-1#1)
pulses of as much as##2##5##(2007-11#1)(2007-12#1)
pulses of terahertz (THz) radiation##2##5##(2007-12#2)
pulses of terahertz radiation##2##4##(2007-12#2)
pulses of terahertz##4##3##(2007-12#4)
pulses of the##2##3##(1996-12#1)(2011-1#1)
pulses of##39##2##(1991-5#1)(1996-12#1)(2007-11#13)(2007-12#11)(2008-2#2)(2008-3#8)(2011-1#1)(2012-2#1)(2013-1#1)
pulses on##3##2##(1991-2#1)(2007-11#1)(2007-12#1)
pulses per##2##2##(2008-1#1)(2008-2#1)
pulses propagating in air##3##4##(2007-11#1)(2007-12#2)
pulses propagating in##5##3##(2007-11#2)(2007-12#3)
pulses shorter than##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
pulses that are##6##3##(2007-11#4)(2007-12#2)
pulses that##12##2##(2007-11#8)(2007-12#4)
pulses through##6##2##(2007-11#3)(2008-2#1)(2008-3#2)
pulses to a##6##3##(2007-12#4)(2008-3#2)
pulses to the##3##3##(1993-3#1)(2007-11#1)(2010-11#1)
pulses to##19##2##(1993-3#2)(2007-11#4)(2007-12#7)(2008-2#1)(2008-3#4)(2010-11#1)
pulses tunable from##2##3##(2008-2#2)
pulses tunable in##2##3##(2007-11#1)(2007-12#1)
pulses tunable##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
pulses under##2##2##(2007-11#1)(2007-12#1)
pulses was##6##2##(2007-11#2)(2008-3#3)(2011-1#1)
pulses were obtained##2##3##(2007-12#1)(2008-3#1)
pulses were##15##2##(1993-3#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-3#2)(2008-6#1)
pulses with 1##2##3##(2007-12#2)
pulses with a##15##3##(2007-11#5)(2007-12#5)(2008-2#1)(2008-3#4)
pulses with an average power of 0##3##7##(2007-11#1)(2007-12#2)
pulses with an average power##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
pulses with an##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
pulses with durations##2##3##(2007-11#1)(2007-12#1)
pulses with energies of##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
pulses with energies##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
pulses with energy of##2##4##(2007-11#1)(2007-12#1)
pulses with peak##2##3##(2007-12#1)(2008-3#1)
pulses with pulse##2##3##(2007-11#1)(2008-3#1)
pulses with##55##2##(2007-11#18)(2007-12#21)(2008-2#4)(2008-3#12)
pulses within##3##2##(2007-12#3)
pulses##754##1##(1991-2#4)(1991-5#6)(1991-9#1)(1992-11#1)(1992-8#1)(1993-3#3)(1995-6#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#5)(2007-11#235)(2007-12#280)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#67)(2008-3#109)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#3)(2012-2#4)(2013-1#2)(2013-7#1)
pulsing##3##1##(2008-11#1)(2008-4#1)(2008-5#1)
pulverized##4##1##(2008-10#3)(2013-1#1)
pumice##6##1##(2008-10#4)(2008-7#2)
pumilus##5##1##(2008-10#3)(2011-1#1)(2011-2#1)
pumilus)##4##1##(2008-10#4)
pummelo 2240##3##2##(2008-5#3)
pummelo##6##1##(2008-10#2)(2008-5#4)
pump absorption##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
pump and a##2##3##(1994-6#1)(2010-8#1)
pump and signal##2##3##(2007-12#2)
pump and##23##2##(1992-1#1)(1994-3#1)(1994-6#1)(2007-11#3)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2010-8#1)(2013-1#1)
pump at a##2##3##(2007-12#1)(2008-10#1)
pump at##5##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-3#2)
pump band excitation##2##3##(2008-3#2)
pump beam in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
pump beam with##2##3##(2007-12#2)
pump beam##32##2##(2007-11#5)(2007-12#7)(2008-2#6)(2008-3#14)
pump beams##2##2##(2007-12#1)(2008-2#1)
pump can be##2##3##(2007-11#1)(2008-10#1)
pump can##3##2##(2007-11#1)(2008-10#2)
pump carrier solution##2##3##(2008-10#2)
pump cavity##3##2##(2007-12#1)(2008-2#2)
pump configuration##2##2##(2007-12#1)(2008-2#1)
pump depletion##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
pump efficiency##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
pump energies##4##2##(2008-3#4)
pump energy of##4##3##(2007-11#2)(2008-2#2)
pump energy##10##2##(2007-11#3)(2008-2#3)(2008-3#3)(2008-7#1)
pump fields##3##2##(2007-12#3)
pump flow##3##2##(2008-10#3)
pump fluence##3##2##(2008-3#3)
pump for##6##2##(1994-5#1)(2007-12#1)(2008-10#3)(2008-4#1)
pump frequencies##2##2##(2007-11#2)
pump in##3##2##(2007-12#1)(2008-11#1)(2008-8#1)
pump inhibitor##14##2##(1996-2#2)(1996-3#4)(2008-11#1)(2009-11#1)(2010-12#1)(2012-2#4)(2013-1#1)
pump inhibitors##9##2##(2006-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#5)
pump intensities##4##2##(2008-2#1)(2008-3#3)
pump intensity of##2##3##(2007-12#1)(2008-3#1)
pump intensity##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
pump is##5##2##(2007-12#2)(2008-11#2)(2008-8#1)
pump laser is##2##3##(2007-11#2)
pump laser##13##2##(2007-11#6)(2007-12#1)(2008-2#4)(2008-3#2)
pump lasers##2##2##(2007-11#2)
pump level of##2##3##(2007-12#2)
pump levels##3##2##(2008-2#1)(2008-3#2)
pump light distributions##3##3##(2008-2#3)
pump light##8##2##(2007-12#2)(2008-2#6)
pump may##2##2##(2011-2#2)
pump of##3##2##(1994-11#1)(1995-11#1)(2007-11#1)
pump or##2##2##(1991-8#1)(2008-8#1)
pump polarization is##2##3##(2008-2#1)(2008-3#1)
pump polarization##3##2##(2008-2#2)(2008-3#1)
pump power and the##2##4##(2008-2#1)(2008-3#1)
pump power and##4##3##(2008-2#1)(2008-3#3)
pump power at##3##3##(2007-12#2)(2008-3#1)
pump power increased##2##3##(2007-11#1)(2008-2#1)
pump power is##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
pump power of 1##3##4##(2007-12#2)(2008-3#1)
pump power of 200 mW##2##5##(2007-12#1)(2008-3#1)
pump power of only##2##4##(2008-2#2)
pump power of##19##3##(2007-11#2)(2007-12#8)(2008-2#5)(2008-3#4)
pump power threshold##2##3##(2007-11#2)
pump power was##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
pump power##76##2##(2007-11#22)(2007-12#20)(2008-2#16)(2008-3#18)
pump power)##2##2##(2007-12#1)(2008-3#1)
pump powers##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
pump pulse in##2##3##(2007-11#1)(2007-12#1)
pump pulse to##2##3##(2007-11#1)(2008-2#1)
pump pulse##15##2##(2007-11#7)(2007-12#5)(2008-2#1)(2008-3#1)(2012-2#1)
pump pulses##8##2##(2007-11#1)(2007-12#6)(2008-3#1)
pump radiation##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
pump repetition##2##2##(2008-2#1)(2008-3#1)
pump source at##2##3##(2008-2#1)(2008-3#1)
pump source##22##2##(2007-11#3)(2007-12#8)(2008-2#3)(2008-3#8)
pump sources##2##2##(2007-11#1)(2007-12#1)
pump speed##2##2##(1991-3#1)(2008-10#1)
pump system for##2##3##(2008-10#1)(2009-11#1)
pump that##2##2##(1997-8#1)(2010-6#1)
pump therapy##7##2##(2008-1#7)
pump threshold##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
pump to##7##2##(1991-3#1)(2007-11#2)(2007-12#2)(2008-10#2)
pump was used##3##3##(2008-10#2)(2013-1#1)
pump was##5##2##(2008-10#4)(2013-1#1)
pump wave to##2##3##(2007-11#1)(2008-3#1)
pump wave##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
pump wavelength##7##2##(2007-11#4)(2007-12#2)(2008-2#1)
pump wavelengths##3##2##(2007-11#2)(2007-12#1)
pump waves##4##2##(2007-11#4)
pump were##2##2##(2008-10#2)
pump with an##2##3##(2008-10#2)
pump with##3##2##(2008-10#2)(2008-8#1)
pump##506##1##(1990-11#2)(1991-3#2)(1991-8#3)(1992-1#4)(1992-12#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#3)(1995-11#1)(1996-2#2)(1996-3#4)(1996-5#1)(1997-8#1)(2006-10#1)(2007-11#96)(2007-12#95)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#51)(2008-11#13)(2008-2#65)(2008-3#90)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#6)(2009-11#3)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#3)(2011-2#10)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#5)
pump)##3##1##(2007-8#1)(2009-11#1)(2011-2#1)
pump-beam##4##1##(2008-2#1)(2008-3#3)
pump-enhanced optical parametric oscillator##2##4##(2007-12#2)
pump-induced thermal##2##2##(2008-2#1)(2008-3#1)
pump-power threshold##2##2##(2007-12#2)
pump-power##9##1##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)
pump-probe experiments##2##2##(1996-2#1)(2008-3#1)
pump-probe fluorescence microscopy##2##3##(2008-3#2)
pump-probe geometry##2##2##(2007-11#1)(2008-3#1)
pump-probe measurements##2##2##(2007-11#1)(2007-12#1)
pump-probe method##2##2##(2007-11#1)(2008-2#1)
pump-probe##20##1##(1996-2#1)(2007-11#5)(2007-12#4)(2008-2#2)(2008-3#7)(2010-7#1)
pump-wavelength##2##1##(2007-11#2)
pumped Nd(3+)##2##2##(2007-12#1)(2008-3#1)
pumped at 0##2##3##(2008-10#2)
pumped at 1##2##3##(2007-12#1)(2008-3#1)
pumped at 532 nm by a##2##6##(2007-12#2)
pumped at 532 nm##3##4##(2007-12#2)(2008-3#1)
pumped at 975 nm##2##4##(2007-11#2)
pumped at a##3##3##(1991-5#1)(2008-10#1)(2010-3#1)
pumped at##16##2##(1991-5#1)(2007-11#3)(2007-12#5)(2008-10#3)(2008-3#3)(2010-3#1)
pumped by 1##2##3##(2007-12#2)
pumped by a 4-W laser diode##2##6##(2007-12#1)(2008-2#1)
pumped by a Bessel beam##2##5##(2008-2#2)
pumped by a Q-switched Nd##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
pumped by a compact##2##4##(2007-11#1)(2008-3#1)
pumped by a cw##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
pumped by a diode laser##2##5##(2007-12#2)
pumped by a diode##3##4##(2007-12#2)(2008-2#1)
pumped by a multilongitudinal-mode beam##2##5##(2007-12#2)
pumped by a pulsed##2##4##(2008-10#1)(2008-3#1)
pumped by a single##2##4##(2007-12#2)
pumped by a##54##3##(2007-11#7)(2007-12#22)(2008-10#1)(2008-2#15)(2008-3#8)(2008-5#1)
pumped by an##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
pumped by nanosecond pulses##2##4##(2007-11#1)(2008-2#1)
pumped by the second harmonic of the same Nd##2##9##(2008-2#2)
pumped by the second harmonic of##3##6##(2008-2#2)(2008-3#1)
pumped by the##10##3##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#1)
pumped by two##4##3##(2007-11#2)(2007-12#2)
pumped by##93##2##(2007-11#15)(2007-12#36)(2008-10#1)(2008-2#28)(2008-3#12)(2008-5#1)
pumped optical parametric oscillator##4##4##(2007-11#3)(2008-3#1)
pumped optical parametric oscillators##2##4##(2007-11#1)(2008-3#1)
pumped optical parametric##7##3##(2007-11#4)(2008-3#3)
pumped through a##2##3##(2008-10#2)
pumped through the##5##3##(2008-10#4)(2008-11#1)
pumped through##7##2##(2008-10#6)(2008-11#1)
pumped to##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
pumped with a##6##3##(2007-11#3)(2007-12#3)
pumped with##13##2##(2007-11#6)(2007-12#5)(2008-2#1)(2008-3#1)
pumped within##2##2##(2008-3#2)
pumped##195##1##(1990-2#1)(1991-5#1)(1993-5#1)(1994-2#1)(2007-11#38)(2007-12#56)(2008-10#14)(2008-11#2)(2008-2#34)(2008-3#43)(2008-5#1)(2008-7#2)(2010-3#1)
pumping and##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
pumping at##6##2##(2007-11#2)(2007-12#2)(2008-3#1)(2008-7#1)
pumping by##3##2##(1995-2#2)(2007-11#1)
pumping cavities are##2##3##(2008-2#1)(2008-3#1)
pumping efficiency was##2##3##(2008-2#2)
pumping efficiency##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
pumping in##2##2##(2007-11#2)
pumping is##2##2##(2007-11#1)(2007-12#1)
pumping method##2##2##(2008-2#2)
pumping of a##2##3##(2008-2#1)(2008-3#1)
pumping of the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
pumping of##10##2##(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
pumping power##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
pumping rate##2##2##(2007-12#1)(2008-2#1)
pumping scheme##2##2##(2008-3#2)
pumping source##3##2##(2008-3#3)
pumping system##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
pumping the##4##2##(1990-6#1)(2007-11#2)(2008-3#1)
pumping was##2##2##(2008-10#1)(2008-2#1)
pumping with a##3##3##(2007-12#1)(2008-2#2)
pumping with the##3##3##(2008-2#2)(2008-3#1)
pumping with##8##2##(2007-12#2)(2008-2#4)(2008-3#2)
pumping##122##1##(1990-11#1)(1990-6#1)(1990-8#1)(1995-2#4)(1997-8#1)(2007-11#24)(2007-12#17)(2007-8#1)(2008-10#5)(2008-2#26)(2008-3#32)(2008-7#2)(2008-9#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-3#1)
pumpkin and##2##2##(2008-10#1)(2012-3#1)
pumpkin##10##1##(1994-8#1)(1997-4#2)(2008-10#6)(2012-3#1)
pumps a##2##2##(2008-10#2)
pumps and##2##2##(2010-6#1)(2011-2#1)
pumps can##2##2##(2011-2#2)
pumps were##2##2##(1991-3#1)(1995-12#1)
pumps##61##1##(1990-8#1)(1991-12#1)(1991-3#1)(1992-5#2)(1995-12#2)(1997-1#1)(2007-11#4)(2007-7#1)(2008-10#9)(2008-11#4)(2008-4#1)(2008-8#2)(2009-11#1)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#18)(2012-12#1)(2012-3#1)
punch biopsies were taken from##2##5##(1996-6#1)(2008-5#1)
punch biopsies were##3##3##(1994-1#1)(1996-6#1)(2008-5#1)
punch biopsy##2##2##(2007-12#1)(2012-3#1)
punch##7##1##(1994-1#1)(1996-6#1)(2007-12#1)(2008-5#2)(2011-2#1)(2012-3#1)
puncta##2##1##(1997-2#1)(2011-1#1)
punctata##12##1##(1995-11#3)(2008-10#5)(2008-7#3)(2009-10#1)
punctate##8##1##(1991-12#1)(1995-6#1)(1996-12#1)(2008-8#1)(2009-10#1)(2009-8#3)
punctatus##4##1##(2007-12#2)(2010-3#2)
punctigera##4##1##(2011-2#4)
punctuate##5##1##(1994-5#1)(2008-11#2)(2010-6#2)
punctuated by##2##2##(2011-2#1)(2012-2#1)
punctuated##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
punctum##2##1##(2007-7#2)
puncture at##3##2##(1992-5#1)(2011-1#1)(2013-1#1)
puncture headache##4##2##(1993-10#3)(2009-7#1)
puncture in suspected purulent##2##4##(1995-11#2)
puncture is##2##2##(1990-10#1)(1995-11#1)
puncture of the##4##3##(1994-9#1)(1997-6#1)(1997-8#1)(2008-4#1)
puncture of##5##2##(1994-9#1)(1997-6#1)(1997-8#1)(2008-4#1)(2012-2#1)
puncture or##3##2##(2008-7#1)(2012-2#2)
puncture showed##2##2##(1991-5#1)(2012-3#1)
puncture site##3##2##(1991-12#1)(1994-9#1)(2011-2#1)
puncture technique##2##2##(2007-8#1)(2008-1#1)
puncture was performed##2##3##(1990-12#1)(1992-5#1)
puncture##58##1##(1990-10#2)(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-5#2)(1992-6#1)(1993-10#6)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#5)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#1)
punctured##6##1##(1993-10#1)(1997-6#4)(2008-3#1)
punctures and##4##2##(1996-2#1)(2007-7#1)(2008-7#1)(2012-2#1)
punctures##6##1##(1990-3#1)(1996-2#1)(2007-7#1)(2008-7#1)(2012-2#1)(2012-3#1)
pungency##4##1##(2008-10#4)
punic##2##1##(2008-5#2)
punishment or##2##2##(1997-3#1)(2009-9#1)
punishment that##2##2##(2008-8#2)
punishment##24##1##(1992-1#2)(1993-9#1)(1994-3#6)(1995-5#1)(1995-9#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-8#6)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
punitive damages##11##2##(1992-2#5)(1992-3#5)(1994-1#1)
pup##7##1##(2008-11#1)(2008-4#2)(2008-8#1)(2012-12#1)(2013-8#2)
pup-directed##2##1##(2008-11#2)
pupa##4##1##(2007-12#1)(2008-6#3)
pupae of Calliphora vicina##2##4##(1990-7#2)
pupae of##5##2##(1990-7#2)(2008-11#1)(2008-6#2)
pupae were registered##2##3##(2008-5#2)
pupae were##4##2##(2008-5#4)
pupae##18##1##(1990-7#2)(1995-2#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-5#5)(2008-6#4)(2008-8#1)(2008-9#2)
pupal##9##1##(2007-12#5)(2008-11#1)(2008-5#2)(2008-8#1)
puparia##3##1##(2011-2#3)
pupariation##2##1##(1995-2#2)
pupation##5##1##(2008-10#1)(2008-9#2)(2010-10#1)(2011-2#1)
pupil diameter of##2##3##(2007-11#1)(2013-1#1)
pupil diameter##3##2##(2007-11#1)(2013-1#2)
pupil of a##2##3##(2007-12#1)(2008-2#1)
pupil of##5##2##(2007-12#1)(2008-2#3)(2008-7#1)
pupil size and##2##3##(2007-11#1)(2012-12#1)
pupil size##5##2##(2007-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
pupil##47##1##(2007-11#9)(2007-12#3)(2008-2#9)(2008-3#13)(2008-7#4)(2010-1#1)(2010-8#1)(2011-1#3)(2012-12#1)(2013-1#3)
pupil-plane filter##2##2##(2007-12#2)
pupil-plane##3##1##(2007-12#3)
pupillary##6##1##(1990-9#1)(2008-7#2)(2011-1#3)
pupils aged##2##2##(1994-6#1)(2009-10#1)
pupils in##3##2##(1996-6#1)(2009-10#1)(2012-3#1)
pupils##12##1##(1994-6#1)(1995-12#1)(1996-6#3)(2008-10#1)(2008-7#1)(2009-10#3)(2011-2#1)(2012-3#1)
pupils' attitudes towards mental illness##2##5##(2011-2#2)
puppet##2##1##(2008-12#1)(2012-3#1)
puppies##2##1##(2009-4#2)
puppy##4##1##(2012-12#1)(2012-2#3)
pups born##2##2##(1995-6#1)(2008-11#1)
pups were##7##2##(1996-12#1)(1996-5#2)(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
pups##22##1##(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-5#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
purchase and##9##2##(1991-1#1)(1992-12#2)(1996-2#2)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)
purchase of##5##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2010-9#1)
purchase##35##1##(1991-1#1)(1992-12#3)(1993-1#1)(1993-12#3)(1993-3#1)(1994-3#2)(1995-2#3)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-2#3)
purchased##13##1##(1992-3#1)(1992-5#1)(1994-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-2#1)
purchaser and##2##2##(1994-1#1)(1996-2#1)
purchaser demands##2##2##(1994-2#1)(1996-1#1)
purchaser##7##1##(1994-1#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#2)(1997-2#1)
purchasers and providers is producing profound changes in the##2##9##(1994-12#2)
purchasers and providers##6##3##(1994-1#2)(1994-12#2)(1995-12#1)(1997-1#1)
purchasers and##8##2##(1994-1#2)(1994-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)
purchasers of care##2##3##(1993-3#1)(1996-2#1)
purchasers of health care##3##4##(1991-12#1)(1997-3#2)
purchasers of health##4##3##(1991-12#1)(1996-2#1)(1997-3#2)
purchasers of##8##2##(1991-12#2)(1993-3#1)(1996-12#1)(1996-2#2)(1997-3#2)
purchasers to##4##2##(1994-12#1)(1996-2#2)(1997-1#1)
purchasers##33##1##(1991-12#2)(1991-3#2)(1993-12#3)(1993-3#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#4)(1997-1#3)(1997-3#3)(2008-11#1)
purchases##8##1##(1991-1#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(1997-1#1)(2011-2#2)
purchasing a##2##2##(1992-12#2)
purchasing and##2##2##(1996-2#1)(2008-11#1)
purchasing cooperatives##2##2##(1994-12#1)(1997-3#1)
purchasing decisions##6##2##(1991-2#1)(1994-3#2)(1996-8#1)(1997-3#1)(2008-10#1)
purchasing strategies##2##2##(1994-1#1)(1996-12#1)
purchasing##34##1##(1991-2#1)(1992-1#1)(1992-12#3)(1992-2#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#4)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-8#1)(1997-2#1)(1997-3#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-9#2)
pure 2D PCs##2##3##(2007-11#2)
pure CH(4)##2##2##(2008-2#2)
pure DPPC##5##2##(1992-3#1)(2008-10#3)(2008-8#1)
pure L-(+)-lactic acid##2##3##(2008-6#2)
pure L-amino acids##4##3##(1992-11#1)(1995-3#3)
pure active##2##2##(2008-4#1)(2008-5#1)
pure and mixed cultures as well as##2##7##(1997-6#1)(2011-1#1)
pure and mixed cultures##3##4##(1997-6#1)(2008-10#1)(2011-1#1)
pure and mixed##4##3##(1997-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
pure and pharmaceutical##3##3##(2008-10#3)
pure and##16##2##(1991-5#1)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
pure apatite##4##2##(2008-10#4)
pure cells##2##2##(2008-4#1)(2008-9#1)
pure component spectra##3##3##(2007-12#3)
pure component##4##2##(2007-12#4)
pure components emission##2##3##(2008-10#2)
pure components##5##2##(2008-10#5)
pure compound##3##2##(1996-2#1)(2008-10#2)
pure compounds##3##2##(2006-12#1)(2008-10#2)
pure conjugate##2##2##(1990-8#2)
pure copper##5##2##(1996-2#1)(2008-8#4)
pure culture##9##2##(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)
pure cultures of##3##3##(2008-10#2)(2008-9#1)
pure cultures##7##2##(2008-10#5)(2008-6#1)(2008-9#1)
pure curvature and twist distribution fields##2##6##(2008-3#2)
pure curvature and twist##3##4##(2008-3#3)
pure drug##4##2##(2008-10#3)(2012-2#1)
pure drugs-of-abuse##2##2##(2010-5#2)
pure fetal##2##2##(2013-1#2)
pure form and in pharmaceutical##2##5##(2008-10#2)
pure form and in##3##4##(2008-10#3)
pure form##13##2##(2008-10#10)(2008-5#1)(2010-5#1)(2012-2#1)
pure forms##2##2##(2007-11#1)(2008-11#1)
pure fused silica##2##3##(2007-12#2)
pure gold##3##2##(2008-10#3)
pure laparoscopic##3##2##(2013-8#3)
pure liquid##3##2##(1992-5#1)(2008-2#1)(2008-3#1)
pure motor weakness of an##2##5##(2007-10#2)
pure nitrogen##2##2##(2008-10#1)(2008-3#1)
pure pesticide vapor and##2##4##(2008-10#2)
pure populations of##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
pure protein##7##2##(1991-5#1)(1996-3#1)(1997-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-7#1)
pure recombinant##2##2##(2008-4#2)
pure red cell aplasia (PRCA)##2##5##(2008-10#1)(2008-12#1)
pure red cell aplasia##4##4##(2007-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
pure red cell##6##3##(2007-10#1)(2008-10#1)(2008-12#2)(2013-1#2)
pure red##7##2##(2007-10#1)(2008-10#1)(2008-12#2)(2013-1#3)
pure rotational Raman##4##3##(2008-3#4)
pure rotational coherent##2##3##(2008-3#2)
pure rotational##6##2##(2008-3#6)
pure seawater##2##2##(2008-3#2)
pure silica##3##2##(2007-11#2)(2007-12#1)
pure solutions##2##2##(2008-10#2)
pure stand##3##2##(2008-10#3)
pure stands and mixtures##2##4##(2008-10#2)
pure stands and##3##3##(2008-10#3)
pure stands##11##2##(2008-10#11)
pure substances##2##2##(2008-5#1)(2008-7#1)
pure variables##2##2##(2008-10#2)
pure water and seawater##2##4##(2008-2#2)
pure water was##2##3##(2008-11#1)(2008-2#1)
pure water with##2##3##(2008-10#1)(2008-3#1)
pure water##29##2##(1995-3#2)(1997-6#1)(2008-10#7)(2008-11#1)(2008-2#10)(2008-3#6)(2010-4#1)(2013-8#1)
pure##406##1##(1990-12#2)(1990-2#3)(1990-5#3)(1990-8#4)(1991-5#3)(1992-10#1)(1992-11#2)(1992-3#3)(1992-5#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#5)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#6)(1997-6#3)(2006-12#1)(2007-10#3)(2007-11#16)(2007-12#11)(2008-1#1)(2008-10#119)(2008-11#8)(2008-12#4)(2008-2#19)(2008-3#40)(2008-4#8)(2008-5#12)(2008-6#12)(2008-7#12)(2008-8#10)(2008-9#8)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#9)
pure&quot##2##1##(1991-1#1)(2011-2#1)
pure) dermally for##2##3##(2008-9#2)
pure) in##3##2##(2008-9#3)
pure)##7##1##(2008-8#1)(2008-9#6)
pure-phase##3##1##(2008-2#1)(2008-3#2)
purely##36##1##(1990-7#1)(1992-11#1)(1992-5#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)
purge and trap##3##3##(2008-10#2)(2010-11#1)
purge and##4##2##(2008-10#3)(2010-11#1)
purge gas##2##2##(2008-10#2)
purge##13##1##(1990-11#1)(1995-6#1)(2008-10#7)(2008-5#1)(2010-11#1)(2010-4#1)(2011-1#1)
purge-and-trap and##2##2##(2008-10#2)
purge-and-trap##5##1##(2008-10#5)
purged into the##2##3##(2008-10#2)
purged##3##1##(1997-7#1)(2008-10#2)
purging##12##1##(1994-5#1)(2007-7#1)(2008-10#7)(2008-3#1)(2013-1#2)
purification and characterization of the##3##5##(1991-5#1)(1997-6#1)(2008-4#1)
purification and characterization of##6##4##(1990-8#2)(1991-5#1)(1996-12#1)(1997-6#1)(2008-4#1)
purification and characterization##9##3##(1990-11#1)(1990-8#2)(1991-12#1)(1991-5#1)(1996-12#1)(1997-6#1)(2008-4#2)
purification and concentration##2##3##(2008-10#1)(2008-2#1)
purification and##30##2##(1990-11#2)(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1995-2#1)(1996-12#2)(1997-6#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)
purification by##6##2##(1992-3#1)(1993-8#1)(2008-11#1)(2008-4#2)(2012-2#1)
purification can be##2##3##(2008-10#1)(2008-4#1)
purification from##5##2##(1993-6#1)(1993-8#1)(1995-12#1)(2008-10#2)
purification method##2##2##(1991-12#1)(2013-1#1)
purification methods##2##2##(2008-11#1)(2008-4#1)
purification of a##7##3##(1990-8#1)(1992-3#1)(1994-12#1)(2008-10#2)(2008-4#2)
purification of large##2##3##(2008-2#1)(2010-10#1)
purification of mouse##2##3##(1994-11#1)(2008-4#1)
purification of proteins##2##3##(2008-10#1)(2008-2#1)
purification of recombinant proteins##2##4##(2008-2#1)(2008-4#1)
purification of recombinant##4##3##(1995-6#1)(2008-1#1)(2008-2#1)(2008-4#1)
purification of streptokinase##2##3##(2012-2#2)
purification of the enzyme##5##4##(1991-5#1)(1993-9#1)(1995-8#1)(1997-4#1)(2011-1#1)
purification of the major##2##4##(1995-3#1)(2008-4#1)
purification of the##36##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-8#1)(1997-2#1)(1997-4#2)(2008-10#4)(2008-11#5)(2008-2#2)(2008-4#3)(2008-5#1)(2009-9#1)(2011-1#1)(2013-1#1)
purification of these enzymes##2##4##(1991-5#2)
purification of these##3##3##(1991-5#2)(2008-4#1)
purification of this##2##3##(1992-11#1)(1995-2#1)
purification of##143##2##(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#4)(1992-11#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#4)(1995-8#2)(1996-5#1)(1997-2#4)(1997-4#3)(2008-1#5)(2008-10#15)(2008-11#10)(2008-2#10)(2008-4#27)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2011-1#4)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
purification or##2##2##(2009-12#1)(2011-1#1)
purification procedure by##2##3##(1992-6#1)(1994-8#1)
purification procedure for##2##3##(1992-12#1)(2008-10#1)
purification procedure to##2##3##(1994-8#1)(2008-3#1)
purification procedure##14##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2009-12#1)
purification procedures##7##2##(1992-11#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-8#1)
purification process of##2##3##(2008-11#1)(2012-3#1)
purification process##5##2##(1994-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
purification protocol##2##2##(2008-4#2)
purification step##7##2##(1991-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
purification steps##7##2##(1996-12#1)(2008-10#4)(2008-12#1)(2008-7#1)
purification using methacrylate##2##3##(2013-1#2)
purification using##6##2##(2008-11#1)(2008-2#2)(2008-4#1)(2013-1#2)
purification was##6##2##(1990-11#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-7#1)
purification were##2##2##(2008-7#1)(2011-3#1)
purification with##2##2##(1994-5#1)(2008-4#1)
purification##333##1##(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#7)(1990-7#2)(1990-8#5)(1991-12#4)(1991-2#2)(1991-5#7)(1991-7#1)(1992-11#4)(1992-12#1)(1992-3#4)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#3)(1996-5#1)(1997-2#4)(1997-4#3)(1997-6#1)(2007-11#2)(2008-1#9)(2008-10#54)(2008-11#20)(2008-12#1)(2008-2#18)(2008-3#2)(2008-4#58)(2008-5#1)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#3)(2009-3#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#3)
purifications##7##1##(1990-12#1)(1996-5#2)(2008-10#2)(2008-4#1)(2008-7#1)
purified C##2##2##(2007-12#1)(2008-10#1)
purified DNA##2##2##(1991-9#1)(1996-12#1)
purified GDH##2##2##(1993-9#2)
purified HC##2##2##(2008-10#2)
purified HIV-1##2##2##(1992-8#1)(1997-3#1)
purified NK cells##2##3##(2008-4#2)
purified NK##4##2##(2008-4#4)
purified PKC##2##2##(1994-11#1)(2008-8#1)
purified PLRV##2##2##(2008-10#2)
purified RNA##5##2##(1994-3#1)(1995-5#1)(2008-10#1)(2008-9#2)
purified a##5##2##(1991-5#1)(1992-11#1)(1992-8#1)(1994-6#1)(2008-11#1)
purified alpha##4##2##(1991-12#1)(1992-2#1)(1992-9#1)(1993-8#1)
purified and characterized from##2##4##(1995-6#1)(1997-6#1)
purified and characterized##6##3##(1992-12#1)(1993-9#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-8#1)
purified and cloned##2##3##(1992-10#1)(2009-8#1)
purified and##36##2##(1990-4#1)(1990-5#2)(1992-10#1)(1992-12#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#3)(2007-11#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-8#2)(2009-8#2)(2011-1#1)(2012-12#1)
purified approximately##2##2##(1992-6#1)(1996-5#1)
purified as a stable##2##4##(1994-5#1)(2008-4#1)
purified as a##4##3##(1993-3#1)(1993-8#1)(1994-5#1)(2008-4#1)
purified as##5##2##(1993-3#1)(1993-8#1)(1994-5#1)(2008-4#2)
purified bacterial##3##2##(1992-3#2)(1992-8#1)
purified beta-cells##3##2##(1990-8#3)
purified by HPLC##3##3##(1992-3#1)(1995-11#1)(2008-6#1)
purified by a combination of affinity##2##6##(1991-5#1)(1994-3#1)
purified by a##3##3##(1991-5#1)(1994-3#1)(2008-11#1)
purified by affinity chromatography##8##4##(1991-9#1)(1995-6#1)(1997-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)
purified by affinity##9##3##(1991-9#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)
purified by ammonium sulfate##2##4##(2010-11#1)(2010-2#1)
purified by anion-exchange chromatography##2##4##(1994-12#1)(2008-4#1)
purified by gel filtration##2##4##(1994-8#1)(2008-4#1)
purified by gel##3##3##(1990-8#1)(1994-8#1)(2008-4#1)
purified by high performance liquid chromatography##3##6##(1990-8#1)(2010-2#2)
purified by immunoaffinity##2##3##(1994-11#1)(2008-10#1)
purified by reverse phase##2##4##(1991-8#1)(1997-4#1)
purified by sequential##3##3##(1990-12#1)(1994-11#1)(1994-8#1)
purified by##71##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#3)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#1)(1993-11#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#4)(2008-9#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-2#1)(2013-8#1)
purified caveolae##2##2##(1995-2#2)
purified compound##2##2##(2008-10#1)(2008-11#1)
purified cultures of##2##3##(2008-11#1)(2008-7#1)
purified cultures##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
purified cytochrome##2##2##(1992-8#1)(1995-2#1)
purified cytosolic##3##2##(1990-11#2)(1995-11#1)
purified diets containing either 0##3##5##(1997-4#3)
purified diets##5##2##(1997-4#3)(2008-10#1)(2012-2#1)
purified eIF-2B##2##2##(1991-12#2)
purified enzyme is##2##3##(1990-7#1)(1993-8#1)
purified enzyme##23##2##(1990-11#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-8#1)(1995-2#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)
purified enzymes##2##2##(1990-5#1)(1996-5#1)
purified fibrinogen by##2##3##(1993-11#1)(2008-10#1)
purified fibrinogen##4##2##(1993-11#1)(2008-10#3)
purified for##2##2##(1992-8#1)(2010-3#1)
purified form##2##2##(1990-11#1)(1994-11#1)
purified forms##3##2##(1991-12#1)(2008-10#2)
purified fractions##2##2##(1994-6#1)(1996-12#1)
purified from E##3##3##(1991-3#1)(1994-11#1)(1994-9#1)
purified from Escherichia coli##3##4##(1993-8#1)(2008-9#1)(2009-5#1)
purified from Jurkat cells##2##4##(1992-11#1)(1994-6#1)
purified from a##3##3##(1990-8#1)(1994-5#1)(2008-10#1)
purified from bovine brain##2##4##(1991-2#1)(1994-6#1)
purified from bovine##9##3##(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(2008-8#1)(2008-9#1)
purified from culture filtrates of##2##5##(2008-10#2)
purified from culture##3##3##(2008-10#3)
purified from human placenta##2##4##(1992-12#1)(1993-3#1)
purified from human##8##3##(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-2#1)
purified from rabbit##2##3##(1993-8#1)(1995-2#1)
purified from rat liver and##2##5##(1990-5#1)(1995-6#1)
purified from rat liver##5##4##(1990-5#1)(1993-8#2)(1995-6#1)(2008-10#1)
purified from rat##8##3##(1990-5#1)(1991-9#1)(1992-11#1)(1993-8#2)(1994-8#1)(1995-6#1)(2008-10#1)
purified from soybean##2##3##(1997-6#2)
purified from the##17##3##(1990-11#1)(1991-5#1)(1992-9#1)(1993-3#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)
purified from##122##2##(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-8#6)(1992-9#4)(1993-11#4)(1993-3#3)(1993-6#1)(1993-8#7)(1994-11#6)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-2#4)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
purified human fibrinogen##2##3##(2008-10#2)
purified human##12##2##(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-4#1)
purified in a single step##2##5##(2008-10#1)(2008-11#1)
purified in a##4##3##(1994-5#1)(1997-4#1)(2008-10#1)(2008-11#1)
purified in##9##2##(1994-5#2)(1995-3#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-8#1)
purified insulin receptors##2##3##(1993-8#2)
purified liver##2##2##(1991-12#1)(1992-3#1)
purified material##3##2##(1990-12#2)(2008-5#1)
purified materials##2##2##(2008-10#2)
purified mutant##3##2##(1990-10#1)(1993-8#1)(1994-6#1)
purified nucleocapsid##2##2##(2008-10#1)(2008-8#1)
purified on a##2##3##(1995-11#1)(2008-2#1)
purified on##9##2##(1990-5#2)(1991-12#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-2#1)
purified or##2##2##(1996-12#1)(2008-1#1)
purified p29##2##2##(1990-11#2)
purified pancreatic##2##2##(1991-5#1)(2010-12#1)
purified peptides##3##2##(1990-5#1)(1990-7#1)(1995-11#1)
purified placental AP##2##3##(2008-11#2)
purified plasma##2##2##(1992-3#1)(1994-11#1)
purified primary##2##2##(1995-12#1)(1995-2#1)
purified pro-PO##3##2##(1997-2#3)
purified protein as##2##3##(1992-3#1)(1997-4#1)
purified protein derivative (PPD) positive##2##5##(1997-2#1)(2008-7#1)
purified protein derivative (PPD)##3##4##(1997-2#1)(2008-10#1)(2008-7#1)
purified protein kinase C##4##4##(1990-11#1)(1991-2#1)(1992-9#2)
purified protein was##6##3##(1990-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-9#1)
purified protein##32##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-2#1)(1992-3#2)(1992-7#2)(1992-8#2)(1992-9#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#1)
purified proteins##6##2##(1993-6#1)(1997-3#1)(2008-4#3)(2009-9#1)
purified rabbit##2##2##(1993-8#1)(2008-11#1)
purified rat##9##2##(1990-5#1)(1990-7#1)(1991-12#2)(1993-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)
purified receptor##2##2##(1990-11#1)(2008-4#1)
purified receptors##3##2##(2012-2#3)
purified recombinant##13##2##(1990-12#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-2#2)(1997-4#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-11#1)(2013-1#1)
purified retroviral integrase##2##3##(1994-9#2)
purified single compound showed##2##4##(2008-11#2)
purified soybean##2##2##(1990-12#1)(1997-6#1)
purified the##9##2##(1991-2#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-6#2)(2012-2#1)
purified through##2##2##(2008-9#1)(2013-8#1)
purified to apparent homogeneity##4##4##(1990-12#1)(1992-8#1)(1994-8#1)(1997-2#1)
purified to electrophoretic homogeneity##3##4##(1990-7#1)(1993-8#1)(1994-8#1)
purified to homogeneity and##4##4##(1990-2#1)(1991-2#1)(1992-8#1)(1997-4#1)
purified to homogeneity by##9##4##(1990-5#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-8#1)(1997-4#1)(2008-8#1)(2009-3#1)(2010-4#1)
purified to homogeneity from the##4##5##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)
purified to homogeneity from##12##4##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-8#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-8#2)
purified to homogeneity with##2##4##(1990-5#1)(1995-12#1)
purified to homogeneity##40##3##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-8#4)(2009-3#1)(2010-4#1)
purified to near homogeneity from##4##5##(1990-5#2)(1990-8#1)(1993-11#1)
purified to near homogeneity##10##4##(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-6#1)(1994-8#1)(2008-4#1)(2012-2#1)
purified to##64##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#5)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#5)(1995-6#1)(1997-2#2)(1997-4#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#6)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
purified using a##3##3##(1994-11#1)(1997-4#1)(2008-1#1)
purified using##8##2##(1994-11#1)(1994-6#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-9#1)
purified virions##3##2##(2008-10#3)
purified virus##6##2##(2008-10#5)(2013-8#1)
purified water##3##2##(2008-10#2)(2012-2#1)
purified with##6##2##(1990-5#1)(1995-12#1)(2008-10#3)(2011-1#1)
purified yeast##2##2##(1997-8#1)(2008-8#1)
purified##815##1##(1990-10#2)(1990-11#24)(1990-12#13)(1990-2#2)(1990-4#1)(1990-5#23)(1990-7#13)(1990-8#14)(1991-12#16)(1991-2#11)(1991-3#1)(1991-5#14)(1991-7#1)(1991-8#7)(1991-9#7)(1992-10#1)(1992-11#7)(1992-12#9)(1992-2#2)(1992-3#10)(1992-6#9)(1992-7#3)(1992-8#26)(1992-9#11)(1993-11#13)(1993-12#5)(1993-3#8)(1993-6#6)(1993-8#26)(1993-9#4)(1994-11#17)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#10)(1994-6#13)(1994-8#24)(1994-9#4)(1995-11#8)(1995-12#4)(1995-2#26)(1995-3#2)(1995-5#7)(1995-6#14)(1995-8#2)(1996-12#6)(1996-2#5)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#11)(1997-3#4)(1997-4#21)(1997-6#10)(1997-7#3)(1997-8#1)(2007-11#3)(2007-12#2)(2008-1#11)(2008-10#101)(2008-11#27)(2008-12#4)(2008-2#8)(2008-4#34)(2008-5#10)(2008-6#8)(2008-7#6)(2008-8#31)(2008-9#17)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#2)(2010-11#3)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#3)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#13)(2013-1#3)(2013-8#3)
purify proteins##2##2##(2008-2#1)(2008-4#1)
purify the##4##2##(1990-11#1)(1991-7#1)(1994-5#1)(2012-2#1)
purify##27##1##(1990-11#1)(1991-12#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-4#3)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
purifying##13##1##(1991-11#1)(1991-8#1)(2008-10#1)(2008-2#2)(2008-4#7)(2009-9#1)
purine and pyrimidine##4##3##(1992-8#2)(2008-10#2)
purine bases##2##2##(1993-12#1)(2008-10#1)
purine deoxynucleotide radical cations##2##4##(2008-9#2)
purine dinucleotides##2##2##(2008-4#2)
purine load##2##2##(2008-7#2)
purine metabolism##3##2##(1990-5#1)(1995-12#1)(1996-5#1)
purine nucleoside phosphorylase##3##3##(1994-8#1)(2010-4#2)
purine nucleoside##4##2##(1994-8#2)(2010-4#2)
purine nucleotide metabolism in##2##4##(1991-4#2)
purine nucleotide##3##2##(1991-4#2)(1994-11#1)
purine nucleotides##5##2##(1993-8#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-4#1)
purine residues##2##2##(1992-4#1)(2008-10#1)
purine units within the ODN-chains##2##5##(2008-10#2)
purine units within the##3##4##(2008-10#3)
purine units##5##2##(2008-10#5)
purine##71##1##(1990-5#1)(1991-4#3)(1992-4#4)(1992-8#4)(1993-12#3)(1993-8#3)(1994-11#4)(1994-8#3)(1995-12#4)(1995-3#1)(1995-8#1)(1996-5#3)(1996-8#1)(1997-7#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-4#7)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#2)(2013-1#2)
purine-rich##3##1##(1992-12#1)(2008-10#2)
purinergic agonists##3##2##(1995-11#3)
purinergic receptor##3##2##(1995-8#1)(2008-4#1)(2008-6#1)
purinergic receptors##4##2##(1994-11#1)(1994-6#1)(2008-4#2)
purinergic signaling in the##2##4##(2008-4#1)(2009-3#1)
purinergic signaling##9##2##(2008-4#3)(2008-5#1)(2009-3#3)(2013-8#2)
purinergic signalling in##2##3##(2008-4#2)
purinergic##34##1##(1990-5#1)(1994-11#1)(1994-6#1)(1995-11#3)(1995-8#4)(2008-2#1)(2008-4#16)(2008-5#1)(2008-6#1)(2009-3#3)(2013-8#2)
purines are##2##2##(2013-8#2)
purines##17##1##(1992-4#1)(1995-12#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-4#5)(2008-8#1)(2013-8#5)
purinoceptor##8##1##(1990-7#2)(1995-11#5)(1995-12#1)
purinoceptors and##2##2##(1995-12#1)(2008-7#1)
purinoceptors##8##1##(1995-11#1)(1995-12#6)(2008-7#1)
purities##3##1##(1994-5#1)(2008-10#1)(2011-1#1)
purity (&gt##2##2##(2008-2#1)(2008-7#1)
purity and enantiopurity##2##3##(2008-10#2)
purity and##15##2##(1996-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)
purity fluorapatite##2##2##(2008-10#2)
purity in the##2##3##(2008-2#1)(2008-7#1)
purity in##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
purity of 99##3##3##(2007-11#1)(2008-7#1)(2011-1#1)
purity of the##9##3##(1994-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)
purity of##32##2##(1992-11#2)(1994-5#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#2)(2011-1#3)(2013-1#1)
purity testing of##2##3##(1990-8#1)(2010-4#1)
purity was##3##2##(2007-10#1)(2008-4#1)(2008-7#1)
purity##109##1##(1990-8#1)(1992-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#6)(2008-10#35)(2008-11#8)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#4)(2012-2#2)(2013-1#2)
purity)##2##1##(2008-11#1)(2009-3#1)
puromycin sensitivity##2##2##(1992-8#2)
puromycin##9##1##(1992-6#1)(1992-8#3)(1994-9#1)(1997-1#1)(1997-7#1)(2009-6#2)
purple acid phosphatase##4##3##(1991-8#1)(1992-3#3)
purple bacterial##2##2##(2008-8#1)(2010-2#1)
purple color##3##2##(1994-5#1)(2008-10#2)
purple coloured##2##2##(2008-10#2)
purple coneflower (Echinacea purpurea)##2##4##(2008-10#2)
purple coneflower##3##2##(2008-10#3)
purple gene##2##2##(1997-8#2)
purple##37##1##(1990-12#1)(1991-8#1)(1992-3#3)(1993-11#1)(1993-8#2)(1994-5#1)(1997-8#4)(2008-10#12)(2008-2#1)(2008-8#2)(2008-9#1)(2009-9#2)(2010-2#2)(2011-2#2)(2011-3#1)(2013-1#1)
purported benefits of the##2##4##(1992-2#2)
purported benefits of##3##3##(1992-2#2)(2012-3#1)
purported cues to perceived##2##4##(2007-12#2)
purported to be##2##3##(2008-10#1)(2010-1#1)
purported to##3##2##(2008-10#1)(2008-5#1)(2010-1#1)
purported##10##1##(1992-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-1#1)(2012-3#1)
purportedly##7##1##(2008-10#3)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
purpose a##4##2##(1991-3#1)(2008-10#1)(2008-3#2)
purpose and##21##2##(1993-1#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
purpose as##2##2##(2008-1#1)(2009-5#1)
purpose for##4##2##(1992-1#1)(2008-1#1)(2008-9#1)(2010-11#1)
purpose in##7##2##(1991-2#1)(1994-1#1)(2008-12#1)(2008-3#1)(2010-2#1)(2010-9#1)(2012-3#1)
purpose is not##2##3##(2008-8#1)(2010-3#1)
purpose is to analyze##2##4##(2008-9#1)(2009-7#1)
purpose is to assess the##3##5##(1994-12#1)(1995-3#1)(2007-11#1)
purpose is to introduce##2##4##(1996-2#1)(2008-3#1)
purpose is to##25##3##(1992-1#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#2)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#5)
purpose is##31##2##(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#2)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#6)
purpose of a##2##3##(2008-11#1)(2008-9#1)
purpose of evaluating##2##3##(1992-3#1)(2008-7#1)
purpose of gene##2##3##(1993-8#1)(2013-8#1)
purpose of launching##6##3##(2010-12#6)
purpose of our study##5##4##(2007-8#3)(2008-10#1)(2008-9#1)
purpose of our##9##3##(2007-11#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
purpose of providing##4##3##(1997-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
purpose of the present study was to##16##7##(1990-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
purpose of the present study##20##5##(1990-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(2007-10#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
purpose of the present##32##4##(1990-5#1)(1990-8#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
purpose of the program##3##4##(1992-1#1)(1996-2#1)(2008-4#1)
purpose of the study was to evaluate##5##7##(1996-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)
purpose of the study was to##17##6##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-8#1)
purpose of the study was##18##5##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-8#1)
purpose of the study##22##4##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(1996-9#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
purpose of the##86##3##(1990-5#1)(1990-8#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#2)(2007-10#5)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
purpose of this article is to discuss##2##7##(1995-1#1)(1996-2#1)
purpose of this article is to##46##6##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-8#2)
purpose of this article##52##4##(1992-1#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-8#2)
purpose of this case study is to##2##7##(1993-1#1)(2012-12#1)
purpose of this case study##3##5##(1993-1#1)(2010-5#1)(2012-12#1)
purpose of this case##4##4##(1993-1#1)(2010-5#1)(2010-9#1)(2012-12#1)
purpose of this meeting was to##2##6##(2008-5#2)
purpose of this paper is to demonstrate the##2##8##(2008-11#1)(2009-8#1)
purpose of this paper is to##24##6##(1991-4#1)(1992-1#1)(1992-2#1)(1997-1#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#2)
purpose of this paper##25##4##(1991-4#1)(1992-1#1)(1992-2#2)(1997-1#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#2)
purpose of this pilot study was to examine the##3##9##(1995-3#1)(2008-11#1)(2008-12#1)
purpose of this pilot study was to investigate##2##8##(2008-12#2)
purpose of this pilot study was to##7##7##(1995-3#1)(2008-11#1)(2008-12#4)(2013-1#1)
purpose of this presentation is to##3##6##(2008-7#1)(2011-1#1)(2012-2#1)
purpose of this review is to##7##6##(2007-8#1)(2008-3#2)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
purpose of this review is##8##5##(2007-8#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
purpose of this review##11##4##(1996-6#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#2)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
purpose of this study is to##30##6##(1995-4#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
purpose of this study is##31##5##(1995-4#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
purpose of this study was to analyse the##3##8##(2008-6#1)(2010-3#1)(2013-8#1)
purpose of this study was to describe##3##7##(2008-12#1)(2013-1#2)
purpose of this study was to determine if a##2##9##(2008-12#1)(2008-9#1)
purpose of this study was to determine if##5##8##(1995-2#1)(1996-5#1)(2008-12#1)(2008-9#1)(2010-6#1)
purpose of this study was to determine the##26##8##(1990-12#1)(1991-11#1)(1992-11#1)(1994-2#1)(1994-5#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#3)(2008-5#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#3)(2013-1#2)
purpose of this study was to determine##37##7##(1990-10#1)(1990-12#1)(1991-11#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#3)(2011-2#1)(2012-2#3)(2013-1#2)
purpose of this study was to examine the##11##8##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2008-5#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
purpose of this study was to examine##18##7##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-6#2)(2008-12#1)(2008-5#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
purpose of this study was to obtain##3##7##(1993-1#1)(1997-3#1)(2008-10#1)
purpose of this study was to##183##6##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#2)(1992-3#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-10#9)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#4)(2007-8#6)(2008-10#9)(2008-11#3)(2008-12#15)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#3)
purpose of this study was##188##5##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#2)(1992-3#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-10#9)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#5)(2007-7#1)(2007-8#6)(2008-10#9)(2008-11#3)(2008-12#15)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#3)
purpose of this study##226##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-11#2)(1992-3#3)(1993-1#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#2)(1997-8#2)(2007-10#10)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#5)(2007-7#2)(2007-8#6)(2008-10#13)(2008-11#5)(2008-12#15)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#4)
purpose of this work##11##4##(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
purpose of this##411##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-4#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#3)(1993-1#3)(1993-12#8)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-6#2)(1997-8#3)(2006-6#1)(2007-10#11)(2007-11#3)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#4)(2007-8#9)(2008-1#2)(2008-10#17)(2008-11#13)(2008-12#26)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#15)(2008-6#8)(2008-7#13)(2008-8#6)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#8)(2011-2#20)(2012-1#2)(2012-12#7)(2012-2#18)(2012-3#9)(2013-1#18)(2013-7#4)(2013-8#8)
purpose of##601##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#4)(1992-7#1)(1993-1#5)(1993-11#1)(1993-12#10)(1993-2#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#4)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#2)(1997-3#3)(1997-6#2)(1997-8#3)(2006-6#1)(2007-10#16)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#14)(2008-1#7)(2008-10#35)(2008-11#23)(2008-12#28)(2008-2#4)(2008-3#15)(2008-4#9)(2008-5#19)(2008-6#8)(2008-7#20)(2008-8#9)(2008-9#26)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#12)(2010-2#1)(2010-3#7)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#9)(2011-2#25)(2011-3#1)(2012-1#5)(2012-12#7)(2012-2#25)(2012-3#12)(2013-1#22)(2013-7#4)(2013-8#16)
purpose the##4##2##(1997-1#1)(2008-3#1)(2008-5#1)(2008-8#1)
purpose to##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
purpose was to determine##3##4##(1991-6#1)(1993-2#1)(2013-1#1)
purpose was to investigate the##2##5##(1995-12#1)(2008-3#1)
purpose was to##13##3##(1990-7#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-12#1)(2008-3#1)(2009-7#1)(2010-3#1)(2013-1#4)
purpose was##14##2##(1990-7#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-12#1)(2008-3#1)(2009-7#1)(2010-3#1)(2011-1#1)(2013-1#4)
purpose we##5##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
purpose##858##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#7)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-7#1)(1993-1#9)(1993-11#1)(1993-12#13)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#4)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#4)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#9)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#3)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#6)(1996-5#3)(1996-6#2)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2006-6#1)(2007-10#16)(2007-11#13)(2007-12#7)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#6)(2007-8#15)(2008-1#12)(2008-10#88)(2008-11#37)(2008-12#31)(2008-2#10)(2008-3#31)(2008-4#12)(2008-5#28)(2008-6#9)(2008-7#26)(2008-8#15)(2008-9#31)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#3)(2009-7#8)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#8)(2010-12#12)(2010-2#2)(2010-3#9)(2010-4#7)(2010-5#5)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#5)(2011-1#11)(2011-2#32)(2011-3#1)(2012-1#5)(2012-12#9)(2012-2#30)(2012-3#20)(2012-9#1)(2013-1#37)(2013-7#5)(2013-8#18)
purpose&quot##2##1##(2008-10#1)(2009-4#1)
purposeful sample of##2##3##(2008-11#1)(2013-8#1)
purposeful##7##1##(1995-5#1)(2008-1#1)(2008-11#1)(2010-8#2)(2013-1#1)(2013-8#1)
purposely##2##1##(2008-3#1)(2008-9#1)
purposes and it##2##3##(2008-10#1)(2013-8#1)
purposes and##10##2##(1991-2#1)(1994-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2013-8#1)
purposes are##4##2##(1991-9#1)(2008-10#1)(2010-8#1)(2013-8#1)
purposes for##2##2##(1993-1#1)(1996-9#1)
purposes in##7##2##(1990-6#1)(1991-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)
purposes is presented##2##3##(2008-3#2)
purposes is##5##2##(1990-3#1)(1990-8#1)(2008-10#1)(2008-3#2)
purposes of the##5##3##(1994-12#1)(1994-3#1)(1996-3#1)(1996-9#1)(2008-6#1)
purposes of this review##2##4##(2009-1#1)(2013-1#1)
purposes of this study were##4##5##(1993-12#1)(2008-12#1)(2010-11#1)(2010-3#1)
purposes of this study##6##4##(1993-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-3#1)
purposes of this##13##3##(1993-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
purposes of##44##2##(1990-3#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
purposes since##2##2##(2008-10#1)(2008-7#1)
purposes such as##2##3##(1992-8#1)(1996-3#1)
purposes with##2##2##(1992-12#1)(2008-5#1)
purposes would##2##2##(1992-12#1)(2008-11#1)
purposes##238##1##(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#2)(1991-12#6)(1991-2#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#3)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#2)(2008-1#3)(2008-10#43)(2008-11#13)(2008-12#9)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#7)(2009-1#1)(2009-11#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
purposes)##2##1##(2008-10#2)
purposive sample of##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2011-1#1)
purposive##7##1##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)(2010-3#1)(2011-1#1)
purposively selected##2##2##(2008-11#1)(2010-3#1)
purposively##4##1##(2008-11#1)(2010-11#1)(2010-3#1)(2012-12#1)
purpura and##5##2##(1990-8#1)(2007-7#1)(2008-4#1)(2012-2#1)(2013-8#1)
purpura in##3##2##(1997-8#1)(2008-1#1)(2008-10#1)
purpura##27##1##(1990-8#1)(1991-11#1)(1991-3#2)(1992-5#1)(1995-3#2)(1997-4#1)(1997-8#5)(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-8#2)
purpuratus##6##1##(2009-2#2)(2011-2#1)(2013-8#3)
purpurea and##2##2##(2008-10#2)
purpurea##23##1##(2006-11#1)(2008-10#14)(2008-5#3)(2008-9#5)
purpurea)##4##1##(2008-10#4)
purpuric rash##2##2##(1997-8#1)(2008-8#1)
purpuric##5##1##(1997-8#2)(2008-8#1)(2010-6#1)(2013-1#1)
purpurin##3##1##(1992-1#1)(2008-10#2)
purse##2##1##(2007-8#1)(2008-10#1)
purse-string##2##1##(1990-3#1)(2007-8#1)
purslane##2##1##(2008-12#1)(2012-3#1)
pursuant to##2##2##(1991-8#1)(2008-11#1)
pursue this##2##2##(1992-1#1)(2008-8#1)
pursue to##2##2##(1991-3#1)(2008-11#1)
pursue##25##1##(1991-2#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-2#1)(1993-3#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
pursued##15##1##(1991-2#1)(1994-12#1)(1995-1#1)(1996-1#2)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2013-1#1)
pursuing a##4##2##(1995-12#1)(2008-1#1)(2009-12#1)(2010-12#1)
pursuing the##2##2##(1994-1#1)(2008-9#1)
pursuing##21##1##(1993-12#1)(1994-1#1)(1995-12#3)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
pursuit of a moving##2##4##(2009-8#2)
pursuit of a##4##3##(1994-3#1)(2009-8#2)(2012-3#1)
pursuit of quality##2##3##(1996-12#1)(1997-3#1)
pursuit of the##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
pursuit of##22##2##(1993-2#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
pursuit##26##1##(1993-2#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#2)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
pursuits##3##1##(1996-1#1)(2008-6#1)(2010-4#1)
purulent and##2##2##(1993-2#1)(2007-6#1)
purulent discharge##2##2##(2007-7#1)(2013-8#1)
purulent drainage##2##2##(2011-2#2)
purulent secretion##2##2##(1993-2#2)
purulent##19##1##(1993-2#3)(1995-11#2)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
puréed diets##2##2##(1995-3#2)
puréed##5##1##(1995-3#5)
pus culture##2##2##(1993-3#1)(2007-8#1)
pus were##2##2##(1993-3#1)(2011-2#1)
pus##10##1##(1993-3#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
push component##2##2##(2009-8#2)
push the##2##2##(2008-10#1)(2008-3#1)
push to##3##2##(1994-2#1)(2008-3#1)(2013-1#1)
push##18##1##(1990-8#2)(1991-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-8#1)(2013-1#1)
push-pull tracking error signal##2##4##(2008-2#2)
push-pull##11##1##(1995-12#1)(2007-11#1)(2008-2#3)(2008-3#5)(2010-2#1)
pushed into the##2##3##(2008-10#1)(2013-7#1)
pushed##6##1##(1996-5#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-7#1)
pushes the##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
pushing the##3##2##(1993-3#1)(2008-7#1)(2013-1#1)
pushing##11##1##(1992-1#2)(1993-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(2008-7#2)(2009-7#1)(2012-1#1)(2013-1#1)
pusillus##2##1##(1992-8#1)(2008-5#1)
pustular##4##1##(1997-5#2)(2012-2#1)(2012-3#1)
pustule production was##2##3##(2008-10#2)
pustule production##3##2##(2008-10#3)
pustule##11##1##(2008-10#11)
pustules on##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
pustules per##3##2##(2008-10#3)
pustules##13##1##(2008-10#9)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
pustulosis##3##1##(2006-10#2)(2013-1#1)
put a##3##2##(2010-5#1)(2012-3#1)(2013-8#1)
put forth in##2##3##(1992-12#1)(1997-3#1)
put forth##5##2##(1992-12#1)(1997-3#1)(2008-11#1)(2009-12#1)(2012-2#1)
put forward##12##2##(1993-11#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-2#1)
put in place##10##3##(1991-1#1)(1991-3#1)(1995-12#1)(1995-2#2)(1997-2#1)(2008-2#1)(2010-1#1)(2011-3#1)(2012-12#1)
put in the##2##3##(1993-9#1)(2008-2#1)
put in##18##2##(1991-1#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-2#2)(1997-2#1)(2008-12#1)(2008-2#2)(2008-6#1)(2010-1#2)(2011-2#1)(2011-3#1)(2012-12#1)
put into a##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
put into effect##2##3##(2007-8#1)(2008-2#1)
put into practice##2##3##(2011-1#1)(2013-1#1)
put into##14##2##(1990-11#1)(1994-1#2)(1995-3#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
put it##3##2##(1990-5#1)(2008-11#1)(2009-10#1)
put on a##2##3##(1995-2#1)(2012-12#1)
put on the##3##3##(2006-10#1)(2011-2#2)
put on##10##2##(1990-9#1)(1995-2#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
put the##7##2##(1991-3#1)(1992-1#1)(1994-1#1)(1995-6#1)(2008-11#1)(2008-2#1)(2010-5#1)
put them in##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
put them##4##2##(1996-3#1)(1997-6#1)(2008-10#1)(2011-2#1)
put to##2##2##(2008-10#1)(2008-2#1)
put together to##2##3##(2008-3#1)(2010-7#1)
put together##3##2##(2008-3#1)(2010-7#1)(2011-2#1)
put under##2##2##(1997-3#1)(2008-10#1)
put##108##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-9#2)(1994-1#3)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
putamen and##5##2##(1995-8#1)(1996-12#2)(2008-7#2)
putamen of##3##2##(1993-12#1)(2008-7#2)
putamen##23##1##(1993-12#4)(1993-5#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#5)(2007-10#1)(2008-7#7)(2012-12#1)
putaminal hemorrhage##3##2##(2007-10#3)
putative &quot##2##2##(1996-6#1)(2008-10#1)
putative DNA##4##2##(1990-11#1)(1995-5#1)(1997-4#1)(2012-2#1)
putative RNA##2##2##(2008-10#2)
putative amino##2##2##(2008-10#1)(2013-1#1)
putative avirulence gene##2##3##(2008-10#2)
putative avirulence##3##2##(2008-10#3)
putative binding sites for##2##4##(1993-3#1)(2008-7#1)
putative binding sites##4##3##(1993-3#1)(1994-6#1)(2008-7#1)(2009-8#1)
putative binding##7##2##(1992-8#1)(1993-12#1)(1993-3#2)(1994-6#1)(2008-7#1)(2009-8#1)
putative closteroviruses##2##2##(2008-10#2)
putative coding region##2##3##(1994-9#2)
putative converted isolates##2##3##(2008-10#2)
putative cytoplasmic##3##2##(1993-9#1)(1994-6#1)(2008-7#1)
putative endogenous##2##2##(2012-2#2)
putative eukaryotic##2##2##(1991-9#1)(1995-8#1)
putative family of##2##3##(1995-5#1)(2009-9#1)
putative function of##2##3##(2008-10#1)(2009-11#1)
putative functional##4##2##(1992-8#1)(2008-10#3)
putative functions##2##2##(2008-11#1)(2008-7#1)
putative gene##2##2##(1996-6#1)(2008-5#1)
putative genes were identified##2##4##(1995-12#2)
putative genes##7##2##(1994-12#1)(1995-12#4)(2008-8#2)
putative genetic loci##3##3##(2008-10#3)
putative genetic##5##2##(2008-10#4)(2008-7#1)
putative identification##2##2##(2008-10#1)(2012-3#1)
putative inhibitor##3##2##(1993-3#1)(1995-12#1)(2009-11#1)
putative inhibitory##2##2##(2007-12#2)
putative lipoprotein##2##2##(2010-10#2)
putative melatonin receptor##3##3##(1990-7#1)(1992-3#2)
putative membrane-spanning domains##3##3##(1991-2#1)(1995-2#1)(1997-7#1)
putative molecular##2##2##(1990-5#1)(2011-2#1)
putative movement protein##3##3##(2008-10#3)
putative new##7##2##(1992-6#1)(1994-8#1)(1995-9#1)(1997-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
putative phosphoinositide-specific##2##2##(1997-4#2)
putative primer tRNA##2##3##(1992-6#2)
putative product of##2##3##(1993-2#1)(1995-6#1)
putative product##3##2##(1993-2#1)(1995-6#1)(1997-7#1)
putative promoter region##3##3##(1996-10#1)(2008-9#1)(2013-1#1)
putative promoter##11##2##(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#2)
putative protein kinase##3##3##(1991-7#1)(2008-10#1)(2008-9#1)
putative protein##10##2##(1991-7#1)(1994-2#1)(1995-6#1)(1996-3#2)(1997-4#1)(2008-10#2)(2008-9#1)(2010-5#1)
putative proteinaceous##2##2##(2008-10#2)
putative proteins##3##2##(1995-9#1)(2008-10#1)(2008-8#1)
putative random amplified polymorphic DNA (RAPD) loci and##2##8##(2008-10#2)
putative random amplified polymorphic DNA##3##5##(2008-10#3)
putative ras gene of##2##4##(1997-4#2)
putative recombinant isolates##2##3##(2008-10#2)
putative regulatory elements##2##3##(1991-9#1)(1994-12#1)
putative regulatory##4##2##(1991-9#1)(1992-6#1)(1993-3#1)(1994-12#1)
putative resistance##2##2##(2008-10#2)
putative rice P450s##2##3##(2008-9#2)
putative risk factors##2##3##(2011-2#1)(2012-12#1)
putative role for##3##3##(1990-11#1)(1996-5#1)(2008-3#1)
putative role in##3##3##(1990-5#1)(1992-5#1)(2009-8#1)
putative role of##9##3##(1993-3#1)(1994-6#1)(1994-9#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-8#1)
putative role##16##2##(1990-11#1)(1990-5#1)(1992-5#1)(1993-3#1)(1994-6#1)(1994-9#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#2)(2009-8#2)
putative second##2##2##(1990-11#1)(1990-7#1)
putative secreted##2##2##(1993-12#1)(2013-1#1)
putative signal peptide of##2##4##(1992-8#1)(1993-2#1)
putative signal peptide##4##3##(1990-12#1)(1992-8#1)(1993-2#1)(2009-2#1)
putative signal##5##2##(1990-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(2009-2#1)
putative sister##2##2##(2008-10#2)
putative sites of bleeding were##2##5##(1993-8#2)
putative sites of##3##3##(1993-8#2)(1997-8#1)
putative species##3##2##(2008-10#2)(2010-6#1)
putative stem cells##2##3##(2008-11#1)(2009-12#1)
putative stem##3##2##(2008-11#1)(2009-12#2)
putative thioesterase##2##2##(2009-11#2)
putative transcription start##2##3##(1990-11#1)(1997-2#1)
putative transcription##5##2##(1990-11#1)(1991-9#1)(1993-6#1)(1994-8#1)(1997-2#1)
putative transcriptional##2##2##(1997-8#1)(2008-7#1)
putative transmembrane##8##2##(1990-5#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-9#1)(1996-2#1)
putative transposable##3##2##(1995-12#1)(2008-10#2)
putative tumor suppressor##2##3##(1991-10#1)(1997-2#1)
putative virus-resistant transgenic##2##3##(2008-10#2)
putative virus-resistant##3##2##(2008-10#3)
putative zinc##2##2##(1991-5#1)(2008-10#1)
putative##478##1##(1990-10#1)(1990-11#8)(1990-12#2)(1990-5#7)(1990-7#6)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#9)(1992-12#4)(1992-3#6)(1992-5#2)(1992-6#9)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#8)(1993-2#6)(1993-3#10)(1993-6#4)(1993-8#4)(1993-9#4)(1994-11#2)(1994-12#16)(1994-2#2)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#6)(1995-1#1)(1995-12#7)(1995-2#9)(1995-3#3)(1995-5#2)(1995-6#6)(1995-8#6)(1995-9#4)(1996-10#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#3)(1997-2#5)(1997-3#4)(1997-4#12)(1997-5#1)(1997-7#7)(1997-8#4)(1997-9#2)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#91)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#12)(2008-8#12)(2008-9#7)(2009-10#9)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#3)(2010-10#5)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#9)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#2)
putatively identified as##2##3##(1996-10#1)(1996-5#1)
putatively identified##3##2##(1996-10#2)(1996-5#1)
putatively responsible for##2##3##(2007-12#1)(2011-1#1)
putatively##21##1##(1990-7#1)(1995-2#1)(1996-10#2)(1996-5#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2013-8#1)
putida WCS358##5##2##(2008-10#5)
putida and##2##2##(2008-10#2)
putida strain##2##2##(2008-10#1)(2012-2#1)
putida was##3##2##(2008-10#2)(2008-7#1)
putida##67##1##(1990-11#1)(1991-5#1)(1991-7#2)(1993-11#2)(1994-12#3)(1994-5#1)(1994-6#1)(1995-8#1)(1997-2#2)(2008-10#35)(2008-6#1)(2008-7#7)(2011-1#1)(2011-2#6)(2012-2#3)
putidaredoxin##3##1##(1994-5#3)
putorius##2##1##(2008-6#2)
putrefaction##2##1##(2008-10#1)(2012-2#1)
putrefied corpses##2##2##(1995-6#2)
putrefied##3##1##(1995-2#1)(1995-6#2)
putrescentiae##3##1##(2011-2#3)
putrescine and cadaverine##3##3##(2008-10#3)
putrescine and##6##2##(2008-10#6)
putrescine oxidase (PUO)##2##3##(2008-10#2)
putrescine oxidase enzyme activity##2##4##(2008-10#2)
putrescine oxidase##6##2##(2008-10#6)
putrescine was##2##2##(2008-10#1)(2009-6#1)
putrescine##31##1##(1991-12#2)(1994-8#1)(2008-10#18)(2008-8#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#3)
puts considerable##2##2##(1995-6#1)(1996-3#1)
puts forward the##2##3##(2009-9#1)(2012-2#1)
puts into##2##2##(2008-10#1)(2008-3#1)
puts pressure on##2##3##(1992-3#1)(1993-2#1)
puts the##2##2##(2008-10#1)(2008-4#1)
puts this##2##2##(1997-8#1)(2010-11#1)
puts##21##1##(1992-3#2)(1993-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-3#2)
putting on##2##2##(1990-3#1)(2013-1#1)
putting the##3##2##(1997-3#1)(2006-10#1)(2008-2#1)
putting##17##1##(1990-3#1)(1992-2#1)(1995-3#1)(1997-3#2)(1997-4#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
puzzle in##3##2##(2009-2#1)(2009-7#1)(2013-1#1)
puzzle##11##1##(1990-8#1)(1995-2#1)(1996-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#2)
puzzles in##2##2##(2008-10#1)(2012-3#1)
puzzles##5##1##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
puzzling##8##1##(1992-12#1)(1992-6#1)(1994-11#1)(1997-7#1)(2008-11#2)(2008-8#1)(2012-3#1)
pv##306##1##(1993-9#1)(2008-10#295)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2010-10#2)(2010-4#2)
pvs##19##1##(2008-10#19)
py##2##1##(1996-2#1)(2009-11#1)
pycnia##2##1##(2008-10#2)
pycnial##2##1##(2008-10#2)
pycnidia and conidia##2##3##(2008-10#2)
pycnidia and##3##2##(2008-10#3)
pycnidia on##3##2##(2008-10#3)
pycnidia or ascocarps##2##3##(2008-10#2)
pycnidia per canker##2##3##(2008-10#2)
pycnidia##24##1##(2008-10#24)
pycnidial coverage##2##2##(2008-10#2)
pycnidiospore-derived isolates##3##2##(2008-10#3)
pycnometric density##2##2##(2008-10#2)
pyelectasis##5##1##(2007-8#4)(2008-7#1)
pyelo-ureteral junction obstruction##2##3##(2008-1#2)
pyelogram##3##1##(1991-1#1)(2008-7#1)(2009-1#1)
pyelonephritic group##2##2##(2011-2#2)
pyelonephritic##4##1##(2011-2#4)
pyelonephritis and##4##2##(2007-7#1)(2011-1#1)(2011-2#2)
pyelonephritis in##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
pyelonephritis were##2##2##(2008-10#1)(2011-2#1)
pyelonephritis##28##1##(1995-2#1)(2007-10#1)(2007-7#3)(2008-1#2)(2008-10#3)(2008-8#3)(2011-1#2)(2011-2#7)(2012-3#2)(2013-1#4)
pyeloplasty in##2##2##(2007-10#1)(2008-4#1)
pyeloplasty##5##1##(2007-10#1)(2008-10#3)(2008-4#1)
pygmy hogs##3##2##(2011-2#3)
pygmy phenotype##2##2##(1995-8#2)
pygmy##7##1##(1995-8#2)(1995-9#1)(2011-2#4)
pyknotic##2##1##(2008-1#1)(2008-10#1)
pylon##2##1##(2007-8#2)
pylori and##10##2##(1991-2#1)(1996-6#1)(1997-1#3)(1997-4#1)(2008-1#1)(2008-12#2)(2013-1#1)
pylori are##2##2##(2008-1#1)(2011-2#1)
pylori bound to##2##3##(1995-2#1)(1996-12#1)
pylori can##2##2##(1996-11#1)(1997-1#1)
pylori cells##2##2##(1996-12#2)
pylori eradication therapy##2##3##(2010-12#1)(2012-2#1)
pylori eradication##6##2##(1997-1#2)(2008-1#1)(2010-12#2)(2012-2#1)
pylori from gastric biopsy specimens##2##5##(2008-12#2)
pylori from##3##2##(1997-1#1)(2008-12#2)
pylori has been shown##2##4##(1997-1#1)(2011-2#1)
pylori has been##3##3##(1997-1#2)(2011-2#1)
pylori has##4##2##(1997-1#2)(2008-1#1)(2011-2#1)
pylori in##4##2##(1997-8#1)(2008-1#2)(2012-12#1)
pylori infected individuals##2##3##(2008-1#1)(2008-12#1)
pylori infected##3##2##(2008-1#1)(2008-12#1)(2012-12#1)
pylori infection and IR##3##4##(2013-1#3)
pylori infection and##6##3##(1997-1#1)(2008-5#1)(2013-1#4)
pylori infection in##7##3##(1992-5#1)(2008-1#2)(2011-1#2)(2011-2#1)(2012-12#1)
pylori infection is##2##3##(2010-12#1)(2011-1#1)
pylori infection rates##2##3##(2008-1#2)
pylori infection with chronic antral gastritis##2##6##(2008-5#2)
pylori infection with##3##3##(2008-5#2)(2013-8#1)
pylori infection##42##2##(1990-2#1)(1992-5#2)(1995-2#2)(1996-11#1)(1997-1#8)(2008-1#5)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-12#2)(2010-4#1)(2011-1#5)(2011-2#1)(2012-12#2)(2013-1#5)(2013-8#1)
pylori isolates from##2##3##(2007-7#1)(2012-12#1)
pylori isolates##5##2##(1997-8#1)(2007-7#2)(2012-12#2)
pylori on##2##2##(2008-12#1)(2008-5#1)
pylori positive##2##2##(1997-8#1)(2008-1#1)
pylori proteins##2##2##(2009-6#2)
pylori strains##3##2##(2008-12#3)
pylori to antimicrobial##2##3##(2012-12#2)
pylori to##4##2##(2011-2#1)(2012-12#3)
pylori was##6##2##(1990-3#1)(2008-12#1)(2008-5#2)(2012-12#2)
pylori were##2##2##(1997-8#1)(2008-12#1)
pylori with##2##2##(2012-12#2)
pylori##171##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-5#3)(1995-2#4)(1996-11#3)(1996-12#9)(1996-6#1)(1996-8#1)(1997-1#27)(1997-4#1)(1997-7#4)(1997-8#5)(2007-7#2)(2008-1#21)(2008-10#2)(2008-12#15)(2008-5#9)(2008-7#4)(2008-8#1)(2009-6#5)(2009-8#1)(2010-12#5)(2010-4#1)(2011-1#6)(2011-2#8)(2012-1#1)(2012-12#17)(2012-2#1)(2013-1#7)(2013-8#2)
pylori)##2##1##(2008-5#1)(2011-2#1)
pylori-infection##2##1##(1990-2#2)
pylori-mediated activation of NFκB and##2##5##(2011-2#2)
pyloric foregut##2##2##(2007-12#2)
pyloric stenosis##6##2##(1990-9#1)(1993-2#1)(2007-5#1)(2009-5#1)(2010-12#1)(2011-2#1)
pyloric##17##1##(1990-6#4)(1990-9#2)(1991-3#1)(1993-2#1)(1997-1#1)(2007-12#3)(2007-5#1)(2009-5#1)(2010-12#2)(2011-2#1)
pyloroplasty##5##1##(1990-6#5)
pylorus##2##1##(1990-9#1)(2013-8#1)
pylorus-preserving##2##1##(2008-12#1)(2012-2#1)
pyoderma gangrenosum##3##2##(2006-10#2)(2013-1#1)
pyoderma##8##1##(1996-6#1)(2006-10#2)(2013-1#5)
pyogenes and##2##2##(2008-8#2)
pyogenes infection##2##2##(2008-9#2)
pyogenes is##2##2##(2008-9#2)
pyogenes##25##1##(1991-8#1)(1992-2#3)(1994-11#1)(1995-8#2)(1996-12#2)(2007-8#1)(2008-8#3)(2008-9#6)(2011-2#6)
pyogenic liver abscess##2##3##(2006-10#2)
pyogenic meningitis with##2##3##(2007-8#2)
pyogenic meningitis##6##2##(2007-8#4)(2008-7#1)(2013-7#1)
pyogenic##11##1##(2006-10#2)(2007-8#5)(2008-7#1)(2010-6#1)(2012-3#1)(2013-7#1)
pyoluteorin##2##1##(2008-10#2)
pyomyositis##4##1##(2006-10#2)(2008-5#1)(2013-8#1)
pyopneumothorax##3##1##(2007-6#1)(2010-5#2)
pyoverdin##2##1##(2008-10#2)
pyramid wave-front##2##2##(2007-11#2)
pyramid##20##1##(1992-1#1)(1996-2#1)(2007-11#3)(2007-9#1)(2008-10#2)(2008-6#10)(2008-7#1)(2012-2#1)
pyramid-based##2##1##(2008-6#2)
pyramidal cells and##2##3##(1990-5#2)
pyramidal cells in##4##3##(1995-3#1)(1997-3#1)(2008-11#2)
pyramidal cells##20##2##(1990-5#3)(1991-7#1)(1993-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-11#6)(2009-8#1)
pyramidal crystals that##2##3##(2008-2#2)
pyramidal crystals##5##2##(2008-2#5)
pyramidal ice##2##2##(2008-2#1)(2008-3#1)
pyramidal neurones were##2##3##(1993-12#2)
pyramidal neurones##5##2##(1993-12#5)
pyramidal neurons of the##2##4##(1995-3#1)(2013-8#1)
pyramidal neurons of##3##3##(1995-3#1)(1996-5#1)(2013-8#1)
pyramidal neurons##16##2##(1990-7#2)(1991-2#1)(1992-12#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-5#3)(2008-11#2)(2009-8#1)(2013-8#1)
pyramidal silicon##4##2##(2007-12#4)
pyramidal tract##4##2##(1996-5#3)(2007-10#1)
pyramidal##77##1##(1990-5#3)(1990-7#2)(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#7)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#3)(1996-12#1)(1996-5#8)(1997-2#2)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#6)(2007-8#1)(2008-10#1)(2008-11#14)(2008-2#8)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#2)(2010-2#1)(2013-8#1)
pyramiding of##2##2##(2008-10#2)
pyramiding##9##1##(2008-10#8)(2008-8#1)
pyramids##10##1##(1993-12#3)(1997-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-2#1)(2011-2#1)
pyranose 2-oxidase##2##2##(2008-6#2)
pyranose##3##1##(1995-2#1)(2008-6#2)
pyrantel pamoate and mebendazole##2##4##(2008-10#2)
pyrantel pamoate in##2##3##(2008-10#2)
pyrantel pamoate##7##2##(2008-10#7)
pyrantel##8##1##(2008-10#8)
pyrazinamide##5##1##(2008-1#1)(2008-10#2)(2008-8#2)
pyrazine##5##1##(1991-6#2)(1992-10#1)(2008-10#2)
pyrazole##6##1##(1993-11#1)(1994-11#1)(2008-10#1)(2008-5#3)
pyrazoline##2##1##(2007-1#1)(2009-12#1)
pyrazolo[3##3##1##(2008-4#1)(2013-7#2)
pyrazolone##3##1##(2008-10#2)(2013-1#1)
pyrazolyl##2##1##(1996-2#2)
pyrenaica##2##1##(2008-10#2)
pyrene at##2##2##(2008-10#1)(2008-4#1)
pyrene carboxylic acid to##2##4##(2008-10#2)
pyrene carboxylic acid##8##3##(2008-10#8)
pyrene##28##1##(1990-11#1)(1992-6#2)(1995-5#1)(2008-10#19)(2008-11#1)(2008-4#3)(2009-11#1)
pyrene-labeled##2##1##(1992-4#1)(2008-4#1)
pyrenoid##2##1##(2009-10#2)
pyrethroid##10##1##(1996-12#1)(1997-5#2)(2007-10#1)(2008-10#4)(2008-9#1)(2011-2#1)
pyrethroids in##2##2##(1997-5#1)(2008-10#1)
pyrethroids##10##1##(1997-5#1)(2008-10#6)(2011-2#2)(2012-12#1)
pyrethrum##2##1##(2008-10#2)
pyrexia of unknown origin##2##4##(2007-7#1)(2012-12#1)
pyrexia##5##1##(1991-3#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)
pyrheliometric##3##1##(2008-2#3)
pyri##3##1##(2008-10#3)
pyridazine##2##1##(1991-3#1)(1997-7#1)
pyridine 2##2##2##(2008-10#2)
pyridine and its##2##3##(2007-11#1)(2008-10#1)
pyridine and##4##2##(1996-2#1)(2007-11#1)(2008-10#2)
pyridine derivatives##3##2##(2008-10#3)
pyridine nucleotide##7##2##(1992-1#3)(1994-3#1)(1994-8#1)(1996-2#1)(2009-9#1)
pyridine nucleotides##4##2##(1990-11#1)(1994-8#2)(1996-2#1)
pyridine or imidazole##2##3##(2009-11#1)(2012-12#1)
pyridine or##3##2##(2008-10#1)(2009-11#1)(2012-12#1)
pyridine ring as ionophores##2##4##(2008-10#2)
pyridine ring##6##2##(1995-2#1)(2007-11#1)(2008-10#3)(2009-11#1)
pyridine##60##1##(1990-11#1)(1990-6#1)(1992-1#3)(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#4)(1995-2#1)(1996-2#7)(1997-7#2)(2007-11#4)(2008-10#21)(2008-3#2)(2009-11#3)(2009-9#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
pyridine)##2##1##(1996-2#1)(2008-10#1)
pyridines##8##1##(1993-8#3)(1997-7#2)(2008-10#2)(2009-10#1)
pyridinium##13##1##(1990-7#1)(1992-12#2)(1995-8#1)(1996-12#1)(2008-10#4)(2008-4#1)(2010-6#1)(2011-2#2)
pyridinoline##2##1##(1994-12#1)(1995-2#1)
pyridoxal 5'-phosphate (PLP)##3##3##(1992-6#1)(1996-5#1)(1997-7#1)
pyridoxal 5'-phosphate##4##2##(1992-6#2)(1996-5#1)(1997-7#1)
pyridoxal##12##1##(1991-12#2)(1992-6#2)(1995-6#4)(1996-5#1)(1997-7#1)(2009-11#1)(2013-1#1)
pyridoxine HCl##2##2##(2008-10#1)(2008-11#1)
pyridoxine and carnitine##2##3##(1995-6#2)
pyridoxine and##4##2##(1995-6#4)
pyridoxine hydrochloride##6##2##(2008-10#6)
pyridoxine##26##1##(1995-6#5)(2008-10#10)(2008-11#1)(2008-7#2)(2010-9#1)(2011-1#5)(2013-1#2)
pyridyl ligands##2##2##(1997-7#2)
pyridyl##4##1##(1997-7#2)(2008-10#2)
pyridylazo##3##1##(2008-10#3)
pyrifoliae and##3##2##(2008-10#3)
pyrifoliae##6##1##(2008-10#6)
pyrimethamine##5##1##(1990-9#1)(2008-10#4)
pyrimethanil##2##1##(2011-2#2)
pyrimidine bases##2##2##(2008-10#1)(2008-11#1)
pyrimidine biosynthesis##4##2##(1990-7#1)(1992-8#1)(1995-5#1)(1997-2#1)
pyrimidine##28##1##(1990-7#2)(1992-8#3)(1993-11#1)(1993-8#2)(1994-8#4)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
pyrimidine-rich##2##1##(1995-6#1)(1997-7#1)
pyrimidines and purines on##2##4##(2008-10#2)
pyrimidines##7##1##(2008-10#2)(2008-8#1)(2008-9#3)(2009-9#1)
pyrina##2##1##(2008-10#2)
pyrite as a sensor##2##4##(2008-10#2)
pyrite##3##1##(2008-10#3)
pyrithione (ZPT)##2##2##(2008-10#1)(2008-5#1)
pyrithione##9##1##(2008-10#2)(2008-11#1)(2008-5#6)
pyrocarbon PIP##2##2##(2008-9#2)
pyrocarbon##3##1##(2008-9#3)
pyrocarbonate (DEPC)##2##2##(1992-6#1)(1995-5#1)
pyrocarbonate##4##1##(1990-12#1)(1992-6#1)(1995-5#1)(2008-4#1)
pyrocatechol violet complexes on##2##4##(2008-10#2)
pyrocatechol violet##5##2##(2008-10#5)
pyrocatechol##15##1##(2008-10#15)
pyrochlore##3##1##(1992-11#1)(2008-10#2)
pyroelectric detector##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
pyroelectric radiometer##2##2##(2008-3#2)
pyroelectric##11##1##(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#3)(2011-1#1)
pyrogallic acid##2##2##(2008-10#2)
pyrogallol and##2##2##(2008-10#2)
pyrogallol red##2##2##(2008-10#2)
pyrogallol##23##1##(2008-10#23)
pyrogenic activity##2##2##(1990-2#2)
pyrogenic##4##1##(1990-2#3)(2008-11#1)
pyroglutamic acid residue##2##3##(1991-2#1)(2008-7#1)
pyroglutamic##3##1##(1991-2#1)(1994-8#1)(2008-7#1)
pyroglutamyl aminopeptidase##2##2##(1990-2#1)(1992-8#1)
pyrolysis and atomization steps were##2##5##(2008-10#2)
pyrolysis and atomization temperatures were##2##5##(2008-10#2)
pyrolysis and atomization temperatures##13##4##(2008-10#13)
pyrolysis and atomization were respectively of##2##6##(2008-10#2)
pyrolysis and atomization were##3##4##(2008-10#3)
pyrolysis and atomization##21##3##(2008-10#21)
pyrolysis and vaporization##2##3##(2008-10#2)
pyrolysis and##26##2##(2008-10#25)(2008-11#1)
pyrolysis at 1350 degrees C##2##5##(2008-10#2)
pyrolysis behavior of##2##3##(2008-10#2)
pyrolysis of the##3##3##(2008-10#2)(2008-3#1)
pyrolysis of##5##2##(2008-10#4)(2008-3#1)
pyrolysis products##2##2##(2008-3#1)(2010-3#1)
pyrolysis temperature of##2##3##(2008-10#2)
pyrolysis temperature##9##2##(2008-10#9)
pyrolysis temperatures of##2##3##(2008-10#2)
pyrolysis temperatures##7##2##(2008-10#7)
pyrolysis##69##1##(2008-10#62)(2008-11#2)(2008-3#2)(2010-3#2)(2013-1#1)
pyrolysis-gas chromatography/mass spectrometry##3##3##(2008-10#3)
pyrolysis-mass spectrometry##2##2##(2008-10#2)
pyrolytic carbon##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
pyrolytic graphite electrode##2##3##(2008-10#2)
pyrolytic graphite##11##2##(2008-10#10)(2008-8#1)
pyrolytic##16##1##(2008-10#11)(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)
pyromania##3##1##(2008-6#3)
pyronin Y##2##2##(2008-9#2)
pyrophosphatase##6##1##(1997-6#4)(2008-11#1)(2008-7#1)
pyrophosphate synthase##2##2##(2008-8#2)
pyrophosphate##18##1##(1990-12#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1996-9#2)(1997-7#1)(2008-10#4)(2008-4#2)(2008-8#3)
pyrophosphates##3##1##(2008-4#3)
pyrosequencing of##2##2##(2012-3#1)(2013-8#1)
pyrosequencing##7##1##(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
pyrrole and##2##2##(2008-10#2)
pyrrole derivatives##2##2##(2007-11#1)(2008-5#1)
pyrrole in the##2##3##(1996-5#1)(2008-10#1)
pyrrole moiety##2##2##(2008-10#2)
pyrrole monomer##2##2##(2008-10#2)
pyrrole ring##4##2##(1992-3#1)(1994-9#2)(1995-3#1)
pyrrole units##2##2##(1995-3#1)(1996-5#1)
pyrrole##28##1##(1992-3#1)(1994-5#2)(1994-9#2)(1995-3#3)(1996-5#2)(2007-11#2)(2008-10#11)(2008-5#4)(2011-1#1)
pyrroles##3##1##(1994-5#1)(2009-5#2)
pyrrolic##2##1##(1990-8#1)(2011-1#1)
pyrrolidine dithiocarbamate (APDC)##9##3##(2008-10#9)
pyrrolidine dithiocarbamate##10##2##(2008-10#10)
pyrrolidine##18##1##(1991-5#1)(1992-8#1)(1995-11#1)(2008-10#11)(2009-5#1)(2012-2#3)
pyrrolidinecarbodithioate chelates##2##2##(2008-10#2)
pyrrolidinecarbodithioate##3##1##(2008-10#3)
pyrrolidinedithiocarbamate##3##1##(2008-10#2)(2008-11#1)
pyrrolidines##2##1##(1996-5#1)(2009-5#1)
pyrrolidone##7##1##(1990-12#1)(2008-10#2)(2008-5#3)(2010-5#1)
pyrrolnitrin##2##1##(2008-10#2)
pyrrolo[1##4##1##(2007-11#2)(2008-11#2)
pyrrolobenzoxazepines##2##1##(2012-2#2)
pyrroloquinoline##2##1##(2008-10#2)
pyruvate and##2##2##(1994-9#1)(2008-7#1)
pyruvate carboxylase##4##2##(1991-3#1)(1993-11#1)(2008-11#2)
pyruvate decarboxylase and##2##3##(2008-10#1)(2011-2#1)
pyruvate decarboxylase##5##2##(1993-8#1)(2008-10#2)(2008-6#1)(2011-2#1)
pyruvate dehydrogenase##6##2##(1991-3#2)(1996-5#1)(2010-12#1)(2013-1#2)
pyruvate in##6##2##(2008-10#5)(2008-7#1)
pyruvate kinase (PK)##3##3##(1997-6#1)(2008-7#1)(2013-1#1)
pyruvate kinase L gene##3##4##(1990-8#3)
pyruvate kinase activity##4##3##(1995-12#4)
pyruvate kinase and##2##3##(1990-8#1)(2008-7#1)
pyruvate kinase only##2##3##(1990-5#2)
pyruvate kinase##33##2##(1990-5#8)(1990-8#8)(1991-3#1)(1994-3#1)(1994-8#1)(1995-12#5)(1995-2#2)(1997-6#1)(2008-7#4)(2013-1#2)
pyruvate metabolism##6##2##(1991-5#3)(2008-10#1)(2008-6#2)
pyruvate oxidase G##2##3##(2008-10#2)
pyruvate oxidase##3##2##(2008-10#3)
pyruvate to##3##2##(1997-1#1)(2008-6#1)(2012-3#1)
pyruvate was##2##2##(1992-6#1)(2008-10#1)
pyruvate were##3##2##(1993-11#1)(1994-9#1)(2008-10#1)
pyruvate##117##1##(1990-5#8)(1990-8#8)(1991-3#4)(1991-5#5)(1991-8#3)(1992-11#1)(1992-6#2)(1992-8#4)(1993-11#6)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#2)(1995-12#5)(1995-2#4)(1995-5#2)(1995-8#2)(1996-5#1)(1997-1#1)(1997-6#2)(2008-10#20)(2008-11#2)(2008-6#6)(2008-7#9)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#6)
pyruvate-kinase##2##1##(1991-3#2)
pyruvic##5##1##(1993-8#1)(1994-9#1)(1995-6#1)(2008-11#1)(2008-7#1)
pythiaceous species##3##2##(2008-10#3)
pythium species##2##2##(2008-10#2)
pythium##5##1##(2008-10#5)
p &lt##12##1##(2012-12#1)(2012-5#7)(2013-1#2)(2013-8#2)
p =##3##1##(2013-1#3)
p = 0##10##1##(2012-5#3)(2013-1#4)(2013-8#3)
p &lt##9##1##(2010-11#7)(2011-2#1)(2012-2#1)
p = 0##14##1##(2010-11#4)(2011-2#3)(2012-2#2)(2012-7#2)(2013-1#3)
q (Ab)##3##2##(2008-11#3)
q##12##1##(1991-6#1)(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2010-3#1)(2011-2#1)
q(2) = 0##2##3##(2007-11#2)
q(2)##3##1##(2007-11#2)(2011-2#1)
q-PCR##3##1##(2008-10#3)
q-switched laser##2##2##(2008-2#1)(2008-3#1)
q-switched##3##1##(2008-2#1)(2008-3#2)
q/ha)##2##1##(2011-1#2)
q11) translocation##2##2##(2007-11#1)(2012-12#1)
q11)##4##1##(2007-11#3)(2012-12#1)
q2##4##1##(1995-3#4)
q21) translocation##2##2##(1990-5#1)(2010-11#1)
q21)##5##1##(1990-5#1)(2009-2#1)(2009-8#2)(2010-11#1)
q24)##4##1##(2009-2#4)
q34##2##1##(2007-11#2)
qEEG##6##1##(2008-7#6)
qHBsAg##3##1##(2013-8#3)
qPCR assay##5##2##(2008-12#3)(2009-6#1)(2013-1#1)
qPCR##15##1##(2008-12#3)(2009-6#3)(2010-4#1)(2010-6#4)(2013-1#3)(2013-8#1)
qRT-PCR##3##1##(2012-1#1)(2013-1#2)
q] and##2##2##(2009-3#2)
q] nanotubes##2##2##(2009-3#2)
q]##4##1##(2009-3#4)
qcr1 and qcr4##2##3##(2012-3#2)
qcr1##4##1##(2012-3#4)
qcr4##4##1##(2012-3#4)
qdot##2##1##(2008-10#2)
qdots##3##1##(2008-10#3)
qi and strengthening##2##3##(2013-8#2)
qi##6##1##(2008-10#3)(2013-8#3)
qigong##4##1##(2008-10#3)(2010-12#1)
qk(v) mice##2##2##(2012-2#2)
qk(v)##5##1##(2012-2#5)
qkI locus##2##2##(2012-2#2)
qkI##4##1##(2012-2#4)
qrsA##2##1##(1994-12#2)
qu'une##2##1##(2008-11#1)(2008-5#1)
qua##2##1##(2008-7#1)(2012-2#1)
quad##3##1##(2007-12#1)(2008-10#1)(2013-1#1)
quadecaurelia##2##1##(2008-12#2)
quadrant and##2##2##(2008-3#1)(2012-3#1)
quadrant of the breast##3##4##(1994-7#3)
quadrant of the##6##3##(1991-12#1)(1994-7#3)(2009-7#1)(2011-2#1)
quadrant of##7##2##(1991-12#1)(1994-7#4)(2009-7#1)(2011-2#1)
quadrant##17##1##(1991-12#1)(1994-7#4)(2007-12#1)(2008-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
quadrantectomy and##3##2##(1992-12#1)(1994-12#2)
quadrantectomy##4##1##(1992-12#2)(1994-12#2)
quadrants of the##2##3##(1996-7#1)(2009-7#1)
quadrants of##3##2##(1996-7#1)(2009-7#2)
quadrants##8##1##(1996-7#1)(2008-3#1)(2009-7#2)(2009-8#3)(2011-2#1)
quadrapole detector in Shimadzu QP-5000 gas chromatograph-mass spectrometer##2##8##(2008-10#2)
quadrat shape##3##2##(2008-10#3)
quadrat size and shape##3##4##(2008-10#3)
quadrat size and##5##3##(2008-10#5)
quadrat size##15##2##(2008-10#14)(2008-8#1)
quadrat sizes tested##3##3##(2008-10#3)
quadrat sizes##6##2##(2008-10#6)
quadrat to the##2##3##(2008-10#2)
quadrat variance##3##2##(2008-10#3)
quadrat was##2##2##(2008-10#2)
quadrat##48##1##(2008-10#45)(2008-5#1)(2008-8#2)
quadrat-based##2##1##(2008-10#2)
quadratic and cubic nonlinearities##3##4##(2007-11#1)(2007-12#2)
quadratic and cubic##4##3##(2007-11#1)(2007-12#3)
quadratic and##6##2##(2007-11#1)(2007-12#5)
quadratic coefficients##2##2##(2007-12#1)(2008-10#1)
quadratic cost functional##2##3##(2007-12#1)(2008-2#1)
quadratic cost##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
quadratic discriminant analysis (QDA)##2##4##(2008-10#2)
quadratic discriminant##4##2##(1991-12#2)(2008-10#2)
quadratic effect##2##2##(2008-2#1)(2008-3#1)
quadratic equation##5##2##(2008-10#4)(2008-2#1)
quadratic growth##2##2##(2008-1#2)
quadratic indices##4##2##(2007-11#4)
quadratic medium##3##2##(2007-11#1)(2007-12#2)
quadratic model##2##2##(1995-9#1)(2013-1#1)
quadratic nonlinear##5##2##(2007-11#1)(2007-12#4)
quadratic nonlinearity##3##2##(2007-12#3)
quadratic phase##3##2##(2007-12#2)(2008-3#1)
quadratic processes##3##2##(2007-12#3)
quadratic selection##4##2##(2008-8#4)
quadratic solitons##5##2##(2007-12#5)
quadratic spatial solitons in##3##4##(2007-11#1)(2007-12#2)
quadratic spatial solitons##4##3##(2007-11#2)(2007-12#2)
quadratic spatial##5##2##(2007-11#3)(2007-12#2)
quadratic with##2##2##(1992-10#1)(1993-5#1)
quadratic##108##1##(1991-12#3)(1992-10#1)(1993-5#1)(1993-9#1)(1995-9#1)(2007-11#20)(2007-12#35)(2008-1#2)(2008-10#17)(2008-2#5)(2008-3#8)(2008-6#3)(2008-7#1)(2008-8#4)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
quadrats and##2##2##(2007-5#1)(2008-10#1)
quadrats of##4##2##(2008-10#3)(2008-8#1)
quadrats with##2##2##(2008-10#2)
quadrats##24##1##(2007-5#1)(2008-10#21)(2008-5#1)(2008-8#1)
quadrature detection to##2##3##(2007-11#2)
quadrature detection##3##2##(2007-11#2)(2008-2#1)
quadrature filters##2##2##(2007-12#2)
quadrature scheme for##2##3##(2008-3#2)
quadrature scheme##5##2##(2008-3#5)
quadrature signals##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
quadrature##32##1##(2007-11#4)(2007-12#3)(2008-2#8)(2008-3#14)(2009-3#1)(2011-1#1)(2012-1#1)
quadriceps muscle strength##5##3##(2011-2#3)(2013-1#2)
quadriceps muscle##13##2##(2007-11#2)(2008-4#1)(2011-2#6)(2012-3#1)(2013-1#3)
quadriceps##24##1##(2007-11#2)(2007-8#3)(2008-12#2)(2008-4#1)(2009-3#1)(2009-4#1)(2011-2#6)(2012-1#1)(2012-3#1)(2013-1#6)
quadrigeminal plate##2##2##(2008-7#2)
quadrigeminal##3##1##(1996-5#1)(2008-7#2)
quadrilateral space##2##2##(1993-9#1)(2008-8#1)
quadrilateral##3##1##(1993-9#2)(2008-8#1)
quadriparesis##3##1##(2008-12#1)(2008-7#2)
quadriplegia##2##1##(2008-7#2)
quadrivalent HPV-6/11/16/18##2##2##(2013-1#2)
quadrivalent meningococcal conjugate vaccine##2##4##(2010-10#1)(2013-1#1)
quadrivalent meningococcal vaccine##2##3##(2013-1#2)
quadrivalent meningococcal##4##2##(2010-10#1)(2013-1#3)
quadrivalent##10##1##(1995-5#1)(2007-2#1)(2010-10#1)(2011-1#1)(2013-1#6)
quadrupedal##3##1##(1994-8#2)(2011-2#1)
quadruple therapy##2##2##(2008-1#1)(2010-12#1)
quadruple##6##1##(2007-11#1)(2008-1#1)(2008-3#1)(2010-12#2)(2011-2#1)
quadrupled by##2##2##(2008-2#1)(2008-3#1)
quadrupled##5##1##(2008-11#1)(2008-2#2)(2008-3#2)
quadruplex DNA##3##2##(1994-11#3)
quadruplex##11##1##(1994-11#4)(1995-11#2)(2008-12#4)(2008-4#1)
quadruplicate##2##1##(1992-6#1)(2008-10#1)
quadruply bridged##2##2##(2009-11#2)
quadrupolar glass fiber##2##3##(2007-12#2)
quadrupolar##7##1##(1990-7#1)(1997-7#1)(2007-11#1)(2007-12#3)(2012-7#1)
quadrupole and##2##2##(2008-10#2)
quadrupole ion##2##2##(2008-10#1)(2010-7#1)
quadrupole mass spectrometer##3##3##(2008-10#2)(2010-9#1)
quadrupole mass spectrometry##3##3##(2008-10#3)
quadrupole mass##7##2##(2008-10#6)(2010-9#1)
quadrupole time-of-flight mass##2##3##(2008-10#2)
quadrupole time-of-flight##3##2##(2008-10#3)
quadrupole##29##1##(1995-5#1)(2007-11#3)(2007-12#2)(2008-10#19)(2008-2#1)(2010-7#1)(2010-9#1)(2013-8#1)
quadrupoles##2##1##(2008-10#1)(2010-4#1)
quail (Coturnix##5##2##(1997-3#2)(2008-12#2)(2010-4#1)
quail OPN##2##2##(2009-7#2)
quail and##3##2##(1993-6#1)(1997-6#1)(2008-12#1)
quail chicks##4##2##(2008-6#4)
quail embryo fibroblasts##3##3##(1993-6#2)(1995-2#1)
quail##30##1##(1993-6#5)(1995-2#2)(1995-6#3)(1997-3#2)(1997-6#1)(2008-12#9)(2008-6#4)(2008-8#1)(2009-7#2)(2010-4#1)
quails##10##1##(1997-3#3)(2008-12#7)
quake##2##1##(1994-2#1)(2008-2#1)
qualia##5##1##(2012-2#5)
qualification of##5##2##(1992-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)
qualification##15##1##(1992-9#1)(1994-12#2)(1996-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-3#1)
qualifications of##3##2##(1990-12#1)(1992-1#1)(2008-9#1)
qualifications##13##1##(1990-12#3)(1992-1#2)(1993-3#1)(1994-12#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
qualified and##2##2##(1992-3#1)(2008-11#1)
qualified as a##2##3##(2007-12#1)(2012-3#1)
qualified as##4##2##(1991-6#1)(2007-12#1)(2012-3#2)
qualified by##2##2##(2008-11#1)(2010-1#1)
qualified faculty applicants##2##3##(2012-3#2)
qualified for the##2##3##(1995-1#1)(2012-3#1)
qualified for##5##2##(1991-12#1)(1995-1#1)(2011-2#1)(2012-3#2)
qualified in the##2##3##(2008-10#1)(2013-8#1)
qualified in##3##2##(2008-10#1)(2009-12#1)(2013-8#1)
qualified managers##2##2##(1995-2#1)(2012-3#1)
qualified nurses##3##2##(2008-11#2)(2008-12#1)
qualified personnel##4##2##(1992-1#1)(1995-2#1)(2008-2#1)(2011-1#1)
qualified to##6##2##(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
qualified##53##1##(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#2)(1994-1#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#2)
qualify for##5##2##(1990-4#1)(1993-3#1)(1994-2#1)(2008-1#1)(2012-12#1)
qualify##8##1##(1990-4#1)(1992-12#1)(1993-3#1)(1994-2#1)(2007-11#1)(2008-1#1)(2012-12#1)(2012-3#1)
qualifying##11##1##(1991-11#1)(1993-3#1)(2008-11#5)(2012-12#1)(2013-8#3)
qualitative abnormalities in##2##3##(1997-7#1)(2012-12#1)
qualitative agreement with##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
qualitative agreement##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2013-8#1)
qualitative analyses##3##2##(2008-12#2)(2008-5#1)
qualitative analysis of the##5##4##(1993-3#1)(1994-2#1)(2008-2#1)(2009-5#1)(2011-2#1)
qualitative analysis of##18##3##(1993-3#1)(1994-2#1)(1996-1#2)(2007-11#1)(2008-10#7)(2008-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
qualitative analysis##24##2##(1993-3#1)(1994-2#1)(1996-1#2)(2007-11#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#4)
qualitative and quantitative analysis of##5##5##(2008-10#3)(2008-5#1)(2012-3#1)
qualitative and quantitative analysis##8##4##(2008-10#5)(2008-5#1)(2012-3#1)(2013-7#1)
qualitative and quantitative differences in the##3##6##(2008-10#1)(2008-5#1)(2013-1#1)
qualitative and quantitative differences in##4##5##(2008-10#1)(2008-5#1)(2013-1#2)
qualitative and quantitative information##2##4##(2008-10#1)(2013-1#1)
qualitative and quantitative research##2##4##(1996-4#1)(2008-1#1)
qualitative and quantitative##42##3##(1994-12#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-3#1)(2007-5#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
qualitative and##48##2##(1991-5#1)(1994-12#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-3#2)(2007-5#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-10#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
qualitative approach was##2##3##(2012-3#1)(2013-1#1)
qualitative approach##7##2##(2008-10#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-3#2)(2013-1#1)
qualitative aspects of##4##3##(1992-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
qualitative aspects##5##2##(1992-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
qualitative case study##4##3##(2008-11#1)(2008-9#2)(2010-8#1)
qualitative changes in##4##3##(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
qualitative conclusions##2##2##(1995-5#1)(2008-8#1)
qualitative content analysis##9##3##(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-3#2)
qualitative content##11##2##(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
qualitative data from##2##3##(2007-10#1)(2008-11#1)
qualitative data on the##2##4##(1991-8#1)(2008-8#1)
qualitative data on##4##3##(1991-8#1)(2008-8#1)(2009-5#1)(2012-2#1)
qualitative data##17##2##(1990-9#1)(1991-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
qualitative descriptive study##5##3##(2008-11#1)(2010-10#1)(2010-9#1)(2011-1#1)(2013-8#1)
qualitative descriptive##6##2##(2008-11#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
qualitative detection##2##2##(2008-9#2)
qualitative differences in the##3##4##(1994-3#1)(2007-11#1)(2008-10#1)
qualitative differences in##6##3##(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
qualitative differences##9##2##(1993-6#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
qualitative evaluation of##2##3##(2008-1#1)(2008-10#1)
qualitative evaluation##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
qualitative features of the##3##4##(1990-8#1)(1992-9#1)(2008-2#1)
qualitative features of##4##3##(1990-8#1)(1992-9#1)(2008-2#1)(2008-8#1)
qualitative features##6##2##(1990-8#1)(1992-9#1)(2007-11#1)(2008-2#1)(2008-8#2)
qualitative feedback from##2##3##(2008-11#1)(2010-5#1)
qualitative findings from a study##2##5##(2008-12#1)(2009-5#1)
qualitative findings from##3##3##(2008-12#1)(2009-5#1)(2010-10#1)
qualitative information##6##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-2#2)
qualitative interaction##3##2##(1997-7#3)
qualitative interpretation of the##2##4##(2008-10#1)(2008-3#1)
qualitative interview study##2##3##(2011-1#1)(2013-1#1)
qualitative interviews were##2##3##(2010-4#1)(2013-1#1)
qualitative interviews##7##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
qualitative measurements of##2##3##(1991-12#1)(2008-10#1)
qualitative method##2##2##(2007-11#1)(2008-10#1)
qualitative methodology##5##2##(2007-12#1)(2008-10#1)(2008-12#2)(2009-4#1)
qualitative methods to##5##3##(2008-12#1)(2008-6#1)(2012-3#1)(2013-1#2)
qualitative methods##9##2##(2008-12#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#3)
qualitative or quantitative##2##3##(2008-10#1)(2012-2#1)
qualitative phase##2##2##(2008-11#1)(2011-2#1)
qualitative research and##3##3##(1997-3#1)(2008-10#1)(2012-3#1)
qualitative research design was##2##4##(2008-1#1)(2010-3#1)
qualitative research design##3##3##(1995-12#1)(2008-1#1)(2010-3#1)
qualitative research is##2##3##(1997-3#2)
qualitative research methodology##4##3##(1995-3#2)(2008-11#1)(2008-9#1)
qualitative research project##2##3##(1995-1#1)(2008-9#1)
qualitative research##31##2##(1992-2#1)(1995-1#1)(1995-12#1)(1995-3#2)(1997-1#2)(1997-3#5)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-3#2)
qualitative resistance##2##2##(2008-10#2)
qualitative result##2##2##(2008-10#1)(2011-2#1)
qualitative studies of##2##3##(2008-10#1)(2010-5#1)
qualitative studies##4##2##(1997-3#1)(2007-6#1)(2008-10#1)(2010-5#1)
qualitative study among##3##3##(1995-6#2)(2013-1#1)
qualitative study conducted##2##3##(2009-10#1)(2013-8#1)
qualitative study of the experiences of##2##6##(2008-11#1)(2008-9#1)
qualitative study of the##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
qualitative study of##10##3##(1996-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2013-1#2)
qualitative study using##2##3##(2008-12#1)(2008-7#1)
qualitative study was##5##3##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)(2011-2#1)
qualitative study##51##2##(1995-6#2)(1996-3#1)(2007-10#1)(2008-11#5)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
qualitative study]##2##2##(1993-8#1)(2013-1#1)
qualitative##409##1##(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1996-1#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#9)(1997-4#1)(1997-7#4)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#56)(2008-11#30)(2008-12#16)(2008-2#8)(2008-3#10)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#13)(2009-10#3)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-10#14)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#9)(2011-2#14)(2011-7#1)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#17)(2013-1#36)(2013-7#5)(2013-8#7)
qualitative&quot##2##1##(1990-4#1)(2008-10#1)
qualitatively and quantitatively in##2##4##(2007-12#1)(2008-2#1)
qualitatively and quantitatively##12##3##(1991-5#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-7#1)
qualitatively better##2##2##(2008-2#1)(2013-1#1)
qualitatively by##2##2##(2008-10#1)(2008-5#1)
qualitatively consistent with##4##3##(2008-3#1)(2009-10#1)(2013-1#2)
qualitatively different from the##2##4##(2008-7#1)(2008-9#1)
qualitatively different from##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
qualitatively different to##2##3##(2008-10#1)(2008-12#1)
qualitatively different##10##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
qualitatively distinct##2##2##(1994-5#1)(2009-12#1)
qualitatively for##3##2##(1997-8#1)(2008-10#2)
qualitatively from that##2##3##(2007-12#1)(2008-1#1)
qualitatively from##3##2##(2007-12#1)(2008-1#1)(2010-8#1)
qualitatively preserved##2##2##(2008-7#2)
qualitatively similar to those##2##4##(1993-5#1)(1994-3#1)
qualitatively similar to##5##3##(1993-5#1)(1994-3#1)(1996-5#1)(2008-4#1)(2008-8#1)
qualitatively similar##9##2##(1990-7#1)(1993-5#1)(1994-3#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#1)
qualitatively the##2##2##(2008-11#1)(2009-5#1)
qualitatively##89##1##(1990-7#1)(1991-5#1)(1991-6#1)(1993-5#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
qualities and##4##2##(1990-12#1)(2008-1#1)(2011-2#1)(2012-5#1)
qualities of the##9##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
qualities of##18##2##(1995-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-11#1)(2011-1#1)(2012-12#1)
qualities were##3##2##(1995-1#1)(2011-2#2)
qualities##54##1##(1990-12#4)(1993-12#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)
quality -##3##2##(2012-3#2)(2013-1#1)
quality according##2##2##(2008-5#1)(2013-1#1)
quality across the##2##3##(2012-12#1)(2012-3#1)
quality across##4##2##(1995-2#1)(2007-7#1)(2012-12#1)(2012-3#1)
quality after##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
quality among##2##2##(1996-6#1)(2008-9#1)
quality and a##3##3##(1996-12#1)(2008-3#1)(2008-9#1)
quality and accessibility of##2##4##(1995-2#1)(2008-11#1)
quality and accessibility##3##3##(1995-2#1)(2008-11#2)
quality and cost##7##3##(1991-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)
quality and efficiency##4##3##(1992-2#1)(1996-12#1)(1996-2#1)(2013-1#1)
quality and low##2##3##(1997-3#1)(2008-3#1)
quality and outcomes##2##3##(1994-2#1)(2009-12#1)
quality and patient satisfaction##3##4##(1995-1#1)(1995-3#1)(2007-8#1)
quality and patient##5##3##(1995-1#1)(1995-3#1)(2007-8#2)(2011-2#1)
quality and productivity##2##3##(1992-2#1)(2008-10#1)
quality and quantity culture##2##4##(2012-12#2)
quality and quantity of the##2##5##(2008-10#1)(2008-7#1)
quality and quantity of##6##4##(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-10#1)(2012-2#1)
quality and quantity##11##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-10#1)(2012-12#4)(2012-2#1)(2013-1#1)
quality and safety of##3##4##(2011-2#2)(2013-1#1)
quality and safety##9##3##(2010-7#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-8#2)
quality and service levels##2##4##(1996-1#1)(1996-2#1)
quality and service##3##3##(1995-12#1)(1996-1#1)(1996-2#1)
quality and shelf##2##3##(2007-3#1)(2010-4#1)
quality and the reliability of##2##5##(2007-2#1)(2008-3#1)
quality and the##9##3##(1993-8#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
quality and to##2##3##(2007-5#1)(2013-1#1)
quality and utilization##2##3##(1994-12#1)(1995-1#1)
quality and value##2##3##(1993-3#1)(1995-2#1)
quality and##172##2##(1991-2#2)(1991-3#1)(1991-6#1)(1992-2#4)(1993-12#3)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#3)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#4)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#3)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#2)(2013-1#10)(2013-8#2)
quality are discussed##2##3##(2008-2#1)(2008-9#1)
quality are expected to##2##4##(1996-12#1)(2008-3#1)
quality are##10##2##(1993-3#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-1#1)
quality as##6##2##(1994-1#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
quality assessment and improvement system for long-term care##2##8##(1997-1#2)
quality assessment and improvement##7##4##(1993-2#3)(1996-1#1)(1997-1#2)(1997-2#1)
quality assessment and##9##3##(1993-2#3)(1993-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(2008-10#1)
quality assessment tools##2##3##(2008-12#1)(2012-12#1)
quality assessment##29##2##(1991-3#1)(1993-2#3)(1993-3#1)(1996-1#1)(1997-1#3)(1997-2#1)(2007-5#1)(2008-10#4)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
quality assurance (QA)##4##3##(1994-2#2)(1995-3#2)
quality assurance and audits##2##4##(2008-11#2)
quality assurance and quality control##2##5##(2008-10#2)
quality assurance and quality##3##4##(1991-1#1)(2008-10#2)
quality assurance and##10##3##(1991-1#1)(1994-1#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#2)(2012-2#1)
quality assurance in##5##3##(1991-12#1)(1992-1#1)(1996-12#1)(2010-12#1)(2012-2#1)
quality assurance is##3##3##(1991-12#1)(1992-11#1)(1995-2#1)
quality assurance of##4##3##(1992-9#1)(1994-3#1)(2008-1#1)(2008-10#1)
quality assurance process##2##3##(1994-3#1)(2008-1#1)
quality assurance program##7##3##(1997-4#1)(2007-4#1)(2008-4#1)(2008-6#4)
quality assurance programs##7##3##(1991-1#1)(1991-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(2010-12#1)(2012-2#1)
quality assurance standards##3##3##(1993-2#1)(2008-10#2)
quality assurance system##3##3##(2012-12#2)(2012-2#1)
quality assurance testing##2##3##(2008-10#1)(2008-9#1)
quality assurance##92##2##(1990-9#1)(1991-1#3)(1991-12#4)(1992-1#1)(1992-11#4)(1992-5#1)(1992-9#2)(1993-2#3)(1993-3#5)(1993-9#1)(1994-1#1)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#5)(1996-1#1)(1996-12#3)(1997-1#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#7)(2008-9#1)(2010-12#2)(2012-12#3)(2012-2#5)
quality at the community level##2##5##(2013-1#2)
quality at the##4##3##(1997-3#1)(2007-5#1)(2013-1#2)
quality at##14##2##(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#2)
quality attributes##2##2##(1995-12#1)(2012-2#1)
quality but##2##2##(2007-12#1)(2008-3#1)
quality by##6##2##(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#2)
quality can be##5##3##(1996-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
quality can##7##2##(1995-1#1)(1996-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2012-2#1)
quality care for##4##3##(1992-12#1)(1995-1#1)(1997-2#1)(2011-1#1)
quality care to##2##3##(1994-2#1)(2008-11#1)
quality care##27##2##(1991-1#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2010-7#1)(2011-1#1)(2013-8#1)
quality changes##3##2##(1993-1#2)(2011-2#1)
quality circles##2##2##(1992-3#1)(1994-2#1)
quality clinical##3##2##(1992-3#1)(1995-6#1)(2008-11#1)
quality control analysis##3##3##(2008-10#2)(2012-2#1)
quality control and##9##3##(1994-6#1)(2008-10#3)(2010-9#1)(2011-1#2)(2011-3#1)(2013-1#1)
quality control during##2##3##(2010-8#1)(2012-2#1)
quality control in the##2##4##(2008-10#1)(2008-9#1)
quality control in##9##3##(1992-11#1)(1994-3#1)(2008-10#4)(2008-4#1)(2008-9#2)
quality control material##2##3##(2008-10#2)
quality control measures##5##3##(1992-9#1)(1994-6#1)(1996-12#1)(1996-3#1)(2013-1#1)
quality control of the##3##4##(1994-1#1)(2008-9#1)(2012-3#1)
quality control of##27##3##(1991-9#1)(1994-1#1)(1995-5#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-3#1)(2012-2#1)(2012-3#1)
quality control program##2##3##(1994-12#1)(2008-9#1)
quality control##113##2##(1991-9#1)(1992-10#3)(1992-11#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-3#2)(2007-11#1)(2007-7#2)(2008-10#35)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-9#13)(2009-7#2)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-3#2)(2012-2#4)(2012-3#1)(2013-1#3)
quality could##2##2##(2008-11#1)(2011-2#1)
quality course management##2##3##(2008-12#2)
quality criteria##8##2##(1994-3#1)(1995-2#1)(2008-11#4)(2008-5#1)(2011-2#1)
quality data##2##2##(1994-3#1)(2012-12#1)
quality determinants##3##2##(1993-12#3)
quality differences between##2##3##(1992-3#1)(2008-8#1)
quality differences##3##2##(1992-3#1)(2008-8#2)
quality dimensions##2##2##(1994-2#2)
quality due to the##2##4##(2008-10#1)(2008-7#1)
quality due to##3##3##(2008-10#2)(2008-7#1)
quality evaluation of##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
quality evaluation##5##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
quality factor of##3##3##(2008-3#1)(2009-5#1)(2010-4#1)
quality factor##15##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)(2009-5#1)(2010-4#1)(2012-2#1)(2013-8#2)
quality filters##2##2##(1992-12#1)(2008-9#1)
quality for use##2##3##(2008-10#1)(2008-3#1)
quality for##11##2##(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-8#1)(2013-1#1)
quality goals##2##2##(1994-2#1)(1995-1#1)
quality habitat##2##2##(2008-5#1)(2008-9#1)
quality has##2##2##(1992-11#1)(2008-7#1)
quality have##2##2##(2008-3#1)(2008-7#1)
quality health care services##2##4##(1994-12#1)(2008-11#1)
quality health care##10##3##(1991-1#1)(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)(2008-11#1)(2010-11#1)
quality implications##2##2##(2008-10#1)(2012-3#1)
quality improvement (CQI)##10##3##(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-3#1)
quality improvement (QI)##2##3##(1994-12#1)(2013-1#1)
quality improvement activities##2##3##(1994-2#1)(1996-3#1)
quality improvement and##8##3##(1993-12#1)(1993-3#2)(1994-3#1)(1995-3#2)(1996-2#1)(2009-3#1)
quality improvement at##2##3##(1993-3#1)(2010-6#1)
quality improvement efforts##10##3##(1992-12#1)(1994-12#1)(1995-1#1)(1995-12#3)(1995-3#1)(1997-1#1)(2012-3#1)(2013-1#1)
quality improvement in health care##2##5##(1994-1#1)(1995-12#1)
quality improvement in the##4##4##(1993-3#2)(1994-2#1)(1995-12#1)
quality improvement in##13##3##(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#3)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)
quality improvement indicators##3##3##(1995-12#2)(1996-1#1)
quality improvement initiative##6##3##(1994-2#1)(1995-1#1)(2008-3#1)(2013-1#3)
quality improvement initiatives##3##3##(1995-3#1)(1997-1#1)(2010-8#1)
quality improvement methods and##3##4##(1994-12#1)(1995-3#2)
quality improvement methods##4##3##(1994-12#2)(1995-3#2)
quality improvement of##2##3##(1993-12#1)(1997-8#1)
quality improvement paradigm##2##3##(1996-2#2)
quality improvement process##4##3##(1993-2#1)(1995-2#2)(1996-3#1)
quality improvement program##2##3##(1992-3#1)(1993-12#1)
quality improvement programs##3##3##(1995-12#1)(1996-12#1)(2012-2#1)
quality improvement project models##2##4##(1993-12#2)
quality improvement project##4##3##(1993-12#2)(1993-3#1)(2013-1#1)
quality improvement strategies##3##3##(1994-3#1)(2008-7#1)(2013-1#1)
quality improvement team##3##3##(1993-12#2)(1994-12#1)
quality improvement teams##5##3##(1993-12#3)(1994-1#1)(2008-4#1)
quality improvement to manage##2##4##(1994-3#1)(1995-12#1)
quality improvement to##3##3##(1994-3#1)(1995-12#1)(1995-3#1)
quality improvement tool##4##3##(1994-3#1)(1997-1#3)
quality improvement tools##2##3##(1993-2#1)(1994-1#1)
quality improvement using##2##3##(1995-3#1)(2012-2#1)
quality improvement##173##2##(1992-12#2)(1992-3#1)(1993-12#14)(1993-2#8)(1993-3#14)(1994-1#8)(1994-12#10)(1994-2#8)(1994-3#9)(1995-1#7)(1995-12#11)(1995-2#6)(1995-3#11)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#7)(1996-9#1)(1997-1#11)(1997-2#4)(1997-3#2)(1997-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#4)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#8)
quality improvements##2##2##(1996-12#1)(1997-2#1)
quality in a##3##3##(1993-12#1)(2007-11#1)(2011-2#1)
quality in an##2##3##(2008-9#1)(2010-9#1)
quality in health care##3##4##(1995-3#1)(1996-1#1)(1996-2#1)
quality in health##5##3##(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)
quality in qualitative research##2##4##(2008-11#2)
quality in terms of##2##4##(1995-2#1)(2008-3#1)
quality in the##7##3##(1992-11#1)(1992-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-9#1)(2008-10#1)
quality in##55##2##(1992-11#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
quality indicator##3##2##(1993-12#1)(2013-1#2)
quality indicators (QIs)##2##3##(1996-2#2)
quality indicators and##2##3##(1997-3#1)(2008-11#1)
quality indicators for##2##3##(1996-2#1)(2008-7#1)
quality indicators in##2##3##(2010-12#2)
quality indicators##18##2##(1996-2#4)(1997-3#4)(2008-11#3)(2008-7#3)(2009-8#1)(2010-12#2)(2012-2#1)
quality indices##2##2##(2008-11#1)(2012-2#1)
quality information##7##2##(1993-2#1)(1994-2#2)(1997-3#2)(2008-11#1)(2008-8#1)
quality initiative##7##2##(1994-12#2)(1995-3#1)(2013-1#4)
quality initiatives##2##2##(1995-1#1)(1995-12#1)
quality is directly##2##3##(2008-3#1)(2011-2#1)
quality is improved##2##3##(2008-10#1)(2008-3#1)
quality is not##2##3##(2007-7#1)(2008-4#1)
quality is##30##2##(1991-3#1)(1991-6#1)(1993-3#2)(1995-2#1)(1996-3#1)(1997-3#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#3)(2013-8#1)
quality issues##3##2##(1994-2#2)(2008-11#1)
quality levels##2##2##(1996-3#1)(2013-1#1)
quality life##2##2##(1994-7#2)
quality management (TQM) is##2##4##(1994-2#1)(1995-3#1)
quality management (TQM)##17##3##(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#4)(1995-1#2)(1995-3#4)(1996-2#1)
quality management and##4##3##(1993-12#1)(1996-2#1)(1997-3#1)(2008-4#1)
quality management in##6##3##(1994-12#1)(1994-2#2)(1995-1#1)(2008-12#1)(2008-3#1)
quality management process##4##3##(1992-2#1)(1994-1#1)(1994-2#2)
quality management program##2##3##(1993-3#1)(1995-3#1)
quality management programs##4##3##(1994-2#1)(1995-3#1)(1996-1#1)(2013-1#1)
quality management techniques##2##3##(1995-1#1)(1996-3#1)
quality management to improve##2##4##(1993-3#1)(1994-1#1)
quality management##88##2##(1992-12#2)(1992-2#1)(1993-12#3)(1993-2#2)(1993-3#7)(1994-1#12)(1994-12#2)(1994-2#13)(1994-3#2)(1995-1#6)(1995-12#4)(1995-3#12)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-9#2)(2013-1#1)
quality measure##2##2##(1991-3#1)(2012-2#1)
quality measurement##9##2##(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(2008-11#1)(2008-4#1)(2008-7#1)
quality measures for##2##3##(1996-2#1)(2010-9#1)
quality measures##8##2##(1994-3#1)(1996-2#2)(1997-2#2)(2008-2#1)(2008-3#1)(2010-9#1)
quality medical care##3##3##(1991-2#1)(2007-7#1)(2009-6#1)
quality model##3##2##(1996-3#1)(1996-6#1)(2008-11#1)
quality monitoring##6##2##(1992-9#1)(2008-10#4)(2008-7#1)
quality movement##2##2##(1992-11#1)(1996-2#1)
quality nursing care##2##3##(1991-2#1)(1995-3#1)
quality nursing##3##2##(1991-2#1)(1995-3#1)(2008-11#1)
quality of a##9##3##(2008-10#1)(2008-2#2)(2008-3#4)(2011-1#1)(2011-2#1)
quality of all##2##3##(2008-10#1)(2013-1#1)
quality of attention##3##3##(2008-10#3)
quality of care and##11##4##(1992-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#3)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)
quality of care as##2##4##(1991-1#1)(2008-11#1)
quality of care delivered to##2##5##(1995-2#1)(1997-1#1)
quality of care delivered##3##4##(1995-2#1)(1997-1#1)(2008-7#1)
quality of care for##3##4##(1996-12#1)(1997-2#1)(2008-3#1)
quality of care in the##2##5##(1997-3#1)(2008-11#1)
quality of care in these##2##5##(1992-3#1)(1997-1#1)
quality of care in##12##4##(1992-3#1)(1994-12#1)(1995-12#1)(1996-2#3)(1997-1#1)(1997-3#1)(2008-11#1)(2008-3#1)(2012-3#2)
quality of care indicators##2##4##(2008-6#1)(2012-3#1)
quality of care is##2##4##(1996-12#1)(1996-3#1)
quality of care of patients with##2##6##(2008-1#1)(2008-3#1)
quality of care of##3##4##(1991-6#1)(2008-1#1)(2008-3#1)
quality of care to##2##4##(1996-1#1)(2010-10#1)
quality of care under##3##4##(1992-2#1)(1996-2#2)
quality of care##114##3##(1990-6#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#3)(1996-1#6)(1996-12#6)(1996-2#13)(1996-3#4)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#4)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#5)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#5)(2013-1#3)
quality of clinical##5##3##(1992-2#1)(1995-9#1)(1997-6#1)(2010-3#1)(2010-4#1)
quality of communication##3##3##(2010-4#1)(2011-2#1)(2013-1#1)
quality of data##6##3##(1994-2#1)(1995-8#1)(2009-10#1)(2009-11#1)(2012-12#2)
quality of drinking water##3##4##(2009-7#1)(2013-8#2)
quality of food##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
quality of health care in##2##5##(1997-4#1)(2008-1#1)
quality of health care##10##4##(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1996-2#2)(1996-3#1)(1997-4#1)(2008-1#1)(2008-7#1)
quality of health services##3##4##(1993-6#1)(1997-1#1)(2008-11#1)
quality of health##15##3##(1991-12#1)(1991-6#1)(1993-12#2)(1993-2#1)(1993-6#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-7#2)
quality of healthcare##3##3##(2008-1#1)(2013-1#2)
quality of home-made##2##3##(1991-9#2)
quality of hospital##4##3##(1991-12#1)(1991-3#1)(1992-3#1)(1994-3#1)
quality of its##2##3##(1994-12#1)(2008-10#1)
quality of life (OR##2##4##(2012-1#1)(2012-12#1)
quality of life (QOL) in##3##5##(1994-12#1)(1995-4#1)(2011-2#1)
quality of life (QOL)##10##4##(1994-12#1)(1995-4#1)(2008-6#1)(2008-7#3)(2010-4#1)(2011-2#2)(2012-2#1)
quality of life (QoL) for##2##5##(2008-6#1)(2013-8#1)
quality of life (QoL) in##2##5##(2012-1#1)(2013-1#1)
quality of life (QoL)##7##4##(2008-10#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
quality of life after surgery##2##5##(1995-8#1)(2007-8#1)
quality of life after##3##4##(1995-8#1)(2007-8#1)(2008-5#1)
quality of life among##4##4##(2008-7#1)(2009-12#1)(2009-5#1)(2010-5#1)
quality of life and cost##2##5##(2007-7#1)(2008-7#1)
quality of life and health##2##5##(1991-12#1)(2009-5#1)
quality of life and reduce the##2##6##(2010-11#1)(2011-2#1)
quality of life and social##2##5##(1992-1#1)(2011-2#1)
quality of life and survival##3##5##(2010-10#1)(2010-5#1)(2011-2#1)
quality of life and the##2##5##(2012-12#1)(2013-8#1)
quality of life and treatment##2##5##(1995-2#1)(2013-1#1)
quality of life and##37##4##(1991-12#1)(1992-1#1)(1994-11#1)(1995-2#1)(1996-6#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
quality of life as well as##2##6##(1996-12#1)(2010-12#1)
quality of life as##4##4##(1996-12#1)(2008-6#1)(2008-7#1)(2010-12#1)
quality of life by##2##4##(2007-7#1)(2008-5#1)
quality of life for a##2##5##(2009-11#1)(2010-12#1)
quality of life for individuals with##2##6##(2008-11#2)
quality of life for many##2##5##(2010-8#1)(2012-12#1)
quality of life for patients and their##2##7##(2010-12#1)(2012-3#1)
quality of life for patients##3##5##(2008-7#1)(2010-12#1)(2012-3#1)
quality of life for##18##4##(1994-5#1)(1995-1#1)(1995-12#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)
quality of life in Bulgaria##3##5##(2013-1#3)
quality of life in children with##3##6##(2009-3#1)(2012-2#2)
quality of life in patients with chronic##2##7##(2008-4#1)(2011-2#1)
quality of life in patients with##11##6##(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#1)(2009-9#1)(2011-2#2)(2013-8#3)
quality of life in patients##13##5##(1991-6#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-7#1)(2009-9#1)(2011-2#2)(2013-8#3)
quality of life in the##5##5##(1993-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
quality of life in these patients##2##6##(1990-2#1)(1991-6#1)
quality of life in##47##4##(1990-2#1)(1991-6#2)(1992-11#1)(1993-6#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#6)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
quality of life instrument##2##4##(2008-7#1)(2011-2#1)
quality of life is##4##4##(1996-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
quality of life of patients with##3##6##(2008-7#1)(2009-1#1)(2011-2#1)
quality of life of patients##6##5##(1996-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-1#1)(2011-2#1)
quality of life of the patient##2##6##(1993-11#1)(2011-3#1)
quality of life of the patients##3##6##(2007-11#2)(2013-1#1)
quality of life of the##8##5##(1993-11#1)(2007-11#3)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
quality of life of these##2##5##(2007-11#1)(2011-2#1)
quality of life of##32##4##(1990-10#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-3#1)(1996-2#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-4#4)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)
quality of life than##2##4##(1991-2#1)(2013-1#1)
quality of life through##3##4##(2007-11#1)(2012-3#1)(2013-8#1)
quality of life was##6##4##(1992-10#1)(2007-1#1)(2007-11#1)(2008-7#2)(2009-10#1)
quality of life were##3##4##(2008-4#1)(2011-1#1)(2011-2#1)
quality of life with##3##4##(1995-3#1)(2007-11#1)(2009-6#1)
quality of life##351##3##(1990-10#2)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-3#3)(1997-5#1)(1997-8#3)(2006-10#1)(2007-1#2)(2007-11#19)(2007-12#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#8)(2008-7#48)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#4)(2009-3#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#8)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#33)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#9)(2012-2#8)(2012-3#11)(2013-1#18)(2013-7#3)(2013-8#12)
quality of life)##2##3##(2010-11#1)(2010-5#1)
quality of life]##2##3##(2008-4#1)(2009-10#1)
quality of medical##7##3##(1991-2#1)(1992-2#2)(1993-3#1)(1996-12#1)(1996-3#1)(1997-5#1)
quality of middle age and older women from Primorsko-Goranska County##2##10##(2011-2#2)
quality of nursing home care##2##5##(1996-2#1)(2009-3#1)
quality of nursing##6##3##(1990-2#1)(1996-2#1)(2008-12#1)(2009-3#1)(2012-12#1)(2012-3#1)
quality of obstetric care##2##4##(2011-1#2)
quality of optical##2##3##(2008-2#2)
quality of our##3##3##(1994-12#1)(2009-4#1)(2011-2#1)
quality of patient care##9##4##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-1#1)(2008-11#2)(2009-8#1)(2012-3#1)
quality of patient##10##3##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-1#1)(2008-11#2)(2009-8#1)(2012-3#1)(2013-1#1)
quality of prenatal##5##3##(1993-3#1)(1994-3#1)(1995-12#1)(1996-6#1)(2013-1#1)
quality of primary##2##3##(1996-9#1)(2011-2#1)
quality of reduction##3##3##(1991-9#1)(2007-11#1)(2007-8#1)
quality of research##2##3##(2007-7#1)(2012-3#1)
quality of restoration##2##3##(2008-3#2)
quality of rice##2##3##(2008-12#1)(2008-9#1)
quality of service##8##3##(1992-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(2008-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
quality of services##4##3##(1992-12#1)(1997-3#1)(2007-4#1)(2013-1#1)
quality of teaching##2##3##(1993-3#1)(2008-7#1)
quality of the data##4##4##(1990-3#1)(1995-8#1)(2008-3#1)(2013-1#1)
quality of the individual##2##4##(2008-10#1)(2008-3#1)
quality of the products##2##4##(2008-10#1)(2008-8#1)
quality of the results##2##4##(2008-2#1)(2010-11#1)
quality of the transmission##2##4##(2007-12#1)(2008-3#1)
quality of the##124##3##(1990-3#3)(1991-6#3)(1992-2#1)(1992-5#1)(1993-1#1)(1993-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-11#6)(2007-12#5)(2007-8#3)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#22)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
quality of their##8##3##(1992-2#1)(1993-3#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#1)
quality of these##4##3##(2007-12#1)(2008-1#1)(2008-3#1)(2010-3#1)
quality of working life##3##4##(1992-3#1)(2008-11#2)
quality of working##4##3##(1992-3#1)(2008-11#2)(2012-3#1)
quality of##908##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#1)(1991-1#3)(1991-11#3)(1991-12#8)(1991-2#2)(1991-3#3)(1991-6#9)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#8)(1992-3#6)(1992-5#2)(1992-8#1)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#9)(1993-6#3)(1994-1#3)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#8)(1995-3#7)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#2)(1996-1#7)(1996-11#1)(1996-12#9)(1996-2#24)(1996-3#8)(1996-6#2)(1996-7#3)(1996-9#3)(1997-1#10)(1997-2#7)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(2006-10#1)(2006-4#2)(2007-1#3)(2007-11#29)(2007-12#13)(2007-2#1)(2007-4#1)(2007-7#7)(2007-8#9)(2007-9#1)(2008-1#14)(2008-10#52)(2008-11#36)(2008-12#12)(2008-2#11)(2008-3#43)(2008-4#10)(2008-5#10)(2008-6#11)(2008-7#63)(2008-8#12)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#8)(2009-12#8)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#8)(2010-12#11)(2010-2#2)(2010-3#8)(2010-4#8)(2010-5#5)(2010-6#3)(2010-8#8)(2010-9#2)(2011-1#16)(2011-2#54)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#16)(2012-2#14)(2012-3#30)(2013-1#41)(2013-7#3)(2013-8#22)
quality on a##3##3##(1993-2#1)(1995-12#1)(2008-9#1)
quality on the##2##3##(2008-3#1)(2009-11#1)
quality on##8##2##(1993-2#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-11#1)(2010-3#1)
quality or##3##2##(1990-6#1)(1994-3#1)(1997-1#1)
quality orientation##3##2##(1997-3#3)
quality outcomes##2##2##(1996-2#2)
quality oversight##3##2##(1996-2#2)(2006-5#1)
quality parameters and##2##3##(2008-10#2)
quality parameters of beers##2##4##(2008-10#2)
quality parameters of##3##3##(2008-10#3)
quality parameters##12##2##(2008-10#7)(2010-2#4)(2013-1#1)
quality patient care##8##3##(1991-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-3#1)
quality performance##2##2##(2008-10#1)(2008-11#1)
quality planning##7##2##(1993-12#4)(1994-2#3)
quality process##3##2##(1993-3#1)(1994-1#1)(1995-1#1)
quality protein##2##2##(1991-12#1)(2012-2#1)
quality requirements##3##2##(1995-5#1)(2008-11#1)(2012-2#1)
quality revealed##2##2##(2008-12#1)(2011-2#1)
quality review##2##2##(1993-2#1)(1996-2#1)
quality scores##4##2##(2008-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
quality service##3##2##(1994-3#1)(1995-2#1)(1996-3#1)
quality services##3##2##(1993-12#1)(1995-12#1)(1997-2#1)
quality should be##5##3##(1994-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2013-1#1)
quality standard of##2##3##(2009-3#1)(2012-3#1)
quality standard##4##2##(1991-3#1)(2008-7#1)(2009-3#1)(2012-3#1)
quality standards##5##2##(1992-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
quality studies were##2##3##(2008-11#1)(2013-1#1)
quality studies##4##2##(2007-7#1)(2008-11#1)(2008-8#1)(2013-1#1)
quality systems and##2##3##(2008-11#1)(2013-1#1)
quality teams##2##2##(1994-3#1)(1996-3#1)
quality than##2##2##(2008-5#1)(2011-1#1)
quality that is##3##3##(1992-1#1)(2007-11#1)(2008-1#1)
quality that##7##2##(1992-1#1)(1993-12#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-3#2)
quality to that##2##3##(1994-3#1)(2010-8#1)
quality to##7##2##(1994-3#1)(1994-8#1)(1995-2#1)(2008-10#1)(2010-8#1)(2012-12#2)
quality traits##5##2##(2010-4#4)(2012-2#1)
quality treatment##3##2##(1993-6#1)(1994-12#1)(2009-6#1)
quality using the##2##3##(2011-2#1)(2012-1#1)
quality using##3##2##(2008-3#1)(2011-2#1)(2012-1#1)
quality via##2##2##(2008-10#1)(2010-9#1)
quality was evaluated##2##3##(2012-12#1)(2012-3#1)
quality was not##2##3##(1995-9#1)(2007-5#1)
quality was##17##2##(1995-9#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
quality were##10##2##(1995-3#1)(2008-10#4)(2008-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
quality will##2##2##(2008-8#1)(2009-7#1)
quality with##6##2##(1991-12#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-12#1)(2010-4#1)
quality work##4##2##(1995-1#1)(2008-11#1)(2012-3#2)
quality##2622##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#2)(1990-9#1)(1991-1#8)(1991-11#5)(1991-12#17)(1991-2#9)(1991-3#14)(1991-6#11)(1991-9#5)(1992-1#6)(1992-10#4)(1992-11#14)(1992-12#15)(1992-2#18)(1992-3#16)(1992-5#3)(1992-8#1)(1992-9#10)(1993-1#12)(1993-10#1)(1993-11#3)(1993-12#49)(1993-2#27)(1993-3#48)(1993-6#6)(1993-8#2)(1993-9#1)(1994-1#38)(1994-11#2)(1994-12#33)(1994-2#54)(1994-3#44)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#44)(1995-11#1)(1995-12#38)(1995-2#33)(1995-3#57)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#5)(1995-9#4)(1996-1#25)(1996-11#2)(1996-12#32)(1996-2#67)(1996-3#41)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#7)(1997-1#37)(1997-2#29)(1997-3#39)(1997-4#4)(1997-5#5)(1997-6#5)(1997-7#1)(1997-8#11)(2006-10#1)(2006-4#2)(2006-5#1)(2007-1#3)(2007-10#4)(2007-11#53)(2007-12#30)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#7)(2007-7#14)(2007-8#16)(2007-9#2)(2008-1#27)(2008-10#203)(2008-11#103)(2008-12#40)(2008-2#40)(2008-3#121)(2008-4#23)(2008-5#27)(2008-6#30)(2008-7#89)(2008-8#39)(2008-9#52)(2009-1#1)(2009-10#8)(2009-11#11)(2009-12#9)(2009-3#12)(2009-4#1)(2009-5#8)(2009-6#6)(2009-7#7)(2009-8#4)(2009-9#5)(2010-1#4)(2010-10#7)(2010-11#9)(2010-12#16)(2010-2#12)(2010-3#9)(2010-4#27)(2010-5#11)(2010-6#5)(2010-7#6)(2010-8#19)(2010-9#13)(2011-1#35)(2011-10#1)(2011-2#100)(2011-3#5)(2011-7#3)(2012-1#21)(2012-12#47)(2012-2#66)(2012-3#52)(2013-1#97)(2013-7#7)(2013-8#39)
quality--the##2##1##(1994-1#1)(1994-2#1)
quality-adjusted life##4##2##(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)
quality-adjusted##6##1##(1993-1#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
quality-assurance (QA)##2##2##(1996-2#2)
quality-assurance##4##1##(1991-12#2)(1996-2#2)
quality-based compensation model##3##3##(1996-3#1)(1997-1#2)
quality-based##4##1##(1996-3#1)(1997-1#2)(1997-3#1)
quality-improvement##3##1##(1996-2#1)(2009-11#1)(2010-8#1)
quality-measurement##2##1##(1996-2#2)
quality-monitoring system##2##2##(1996-2#1)(1997-1#1)
quality-of-care issues##2##2##(1992-3#2)
quality-of-care##5##1##(1992-3#2)(1993-1#1)(1993-12#1)(1996-2#1)
quality-of-life##14##1##(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
quality-test of TiO(2)-photocatalyst in water##2##5##(2008-10#2)
quality?##2##1##(1992-5#1)(1993-3#1)
quandary##2##1##(2013-8#2)
quanta##3##1##(1997-7#1)(2008-3#1)(2008-7#1)
quantal presynaptic##2##2##(1997-7#2)
quantal##8##1##(1996-2#1)(1997-7#4)(2009-5#1)(2009-9#1)(2012-12#1)
quanti-qualitative##2##1##(2008-9#1)(2012-3#1)
quantifiable##10##1##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-1#3)(2012-2#1)(2012-3#1)
quantification (LOQ) were 0##2##4##(2008-10#2)
quantification (LOQ) were##3##3##(2008-10#2)(2011-1#1)
quantification (LOQ)##12##2##(2008-10#11)(2011-1#1)
quantification analysis##4##2##(2008-11#1)(2008-9#1)(2011-1#1)(2011-7#1)
quantification and##14##2##(1991-5#1)(1996-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
quantification are##2##2##(2008-10#2)
quantification at##3##2##(2008-10#2)(2011-1#1)
quantification by##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
quantification data##2##2##(2012-3#2)
quantification for##4##2##(2008-10#3)(2012-2#1)
quantification have been##2##3##(2008-10#2)
quantification have##3##2##(2008-10#2)(2010-7#1)
quantification in##12##2##(2008-10#6)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-3#2)
quantification is##7##2##(2008-1#1)(2008-10#2)(2008-5#1)(2010-2#2)(2011-2#1)
quantification limit (0##2##3##(2008-10#2)
quantification limit for##3##3##(2008-10#3)
quantification limit of##3##3##(2008-10#3)
quantification limit was 0##2##4##(2008-10#2)
quantification limit was##5##3##(2008-10#5)
quantification limit##18##2##(2008-10#18)
quantification limits were##4##3##(2008-10#4)
quantification limits##17##2##(2008-10#17)
quantification method##3##2##(2008-11#1)(2013-1#2)
quantification of 0##2##3##(2008-10#2)
quantification of M##2##3##(2008-10#2)
quantification of all##2##3##(2008-10#1)(2009-6#1)
quantification of ammonium##2##3##(2008-10#2)
quantification of antibacterial activity##2##4##(2007-11#2)
quantification of ascorbic acid##2##4##(2008-10#2)
quantification of cell growth##2##4##(2007-2#1)(2008-5#1)
quantification of changes in##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
quantification of chemical##2##3##(2008-3#2)
quantification of d-malate and l-malate##2##5##(2008-10#2)
quantification of eight##3##3##(2008-10#2)(2012-2#1)
quantification of ligands##2##3##(2008-10#1)(2008-5#1)
quantification of protein##2##3##(1990-12#1)(2008-10#1)
quantification of pyruvate##2##3##(2008-10#2)
quantification of sodium##2##3##(2008-10#2)
quantification of the number of##2##5##(2008-2#1)(2008-9#1)
quantification of the##25##3##(1990-12#1)(2008-10#15)(2008-2#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
quantification of these##3##3##(2008-10#2)(2010-1#1)
quantification of##188##2##(1990-12#3)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1996-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#5)(2008-10#103)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#6)(2008-7#1)(2008-9#5)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#4)(2013-8#1)
quantification techniques##2##2##(2008-10#1)(2012-2#1)
quantification using a##2##3##(2008-10#1)(2008-4#1)
quantification using##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
quantification was carried out##2##4##(2008-10#2)
quantification was##8##2##(2008-10#5)(2008-5#1)(2011-2#2)
quantification were 0##3##3##(2008-10#3)
quantification were carried out##2##4##(2008-10#1)(2010-5#1)
quantification were##11##2##(2008-10#9)(2010-5#1)(2011-3#1)
quantification##382##1##(1990-12#3)(1990-6#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-9#2)(1993-2#1)(1994-1#1)(1994-12#2)(1995-2#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#7)(2008-10#218)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#11)(2008-7#3)(2008-9#14)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#7)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-2#9)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#4)
quantifications##5##1##(2008-10#2)(2010-11#1)(2010-6#1)(2011-1#1)
quantified and##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
quantified as##5##2##(2008-10#2)(2008-7#2)(2010-4#1)
quantified at##3##2##(2008-10#2)(2011-2#1)
quantified by HPLC##2##3##(1993-11#1)(2008-10#1)
quantified by an##2##3##(2008-10#2)
quantified by measuring the##2##4##(2008-11#1)(2008-7#1)
quantified by measuring##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
quantified by the##7##3##(1990-12#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
quantified by##53##2##(1990-12#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(2006-6#2)(2007-12#1)(2008-1#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-4#1)(2013-7#1)
quantified directly##2##2##(2008-10#1)(2008-11#1)
quantified during##2##2##(1997-2#1)(2011-2#1)
quantified for##3##2##(2008-10#2)(2008-5#1)
quantified in terms of the##2##5##(2007-11#1)(2008-2#1)
quantified in terms of##5##4##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
quantified in the##5##3##(1995-11#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
quantified in##27##2##(1991-11#1)(1993-6#1)(1995-11#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#2)(2008-7#2)(2010-8#1)(2013-1#1)(2013-8#1)
quantified on a##2##3##(2008-10#1)(2008-9#1)
quantified on##5##2##(2008-10#2)(2008-5#1)(2008-9#2)
quantified over a##2##3##(2008-10#1)(2008-5#1)
quantified smoking##3##2##(2008-10#3)
quantified the##8##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-2#1)
quantified to##2##2##(1991-12#1)(2008-3#1)
quantified using a##3##3##(2008-2#1)(2009-10#1)(2009-7#1)
quantified using an##2##3##(1991-12#1)(2008-10#1)
quantified using the##2##3##(2008-10#1)(2012-12#1)
quantified using##19##2##(1991-12#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
quantified with a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
quantified with##9##2##(2008-10#7)(2008-3#1)(2008-5#1)
quantified##205##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#3)(1992-3#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#73)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#12)(2008-7#10)(2008-8#4)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#5)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#3)(2013-7#2)(2013-8#3)
quantifier##2##1##(2012-2#1)(2013-1#1)
quantifies the##8##2##(1992-1#1)(1992-9#1)(2007-11#2)(2008-10#2)(2008-8#1)(2012-12#1)
quantifies##12##1##(1992-1#1)(1992-9#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
quantify and##8##2##(1997-3#1)(2008-10#3)(2008-11#1)(2010-5#1)(2012-2#2)
quantify differences##2##2##(1996-3#1)(2008-10#1)
quantify five##2##2##(2008-10#2)
quantify human##2##2##(2008-12#1)(2012-2#1)
quantify its##2##2##(2008-10#1)(2008-5#1)
quantify optical##2##2##(2008-2#1)(2008-3#1)
quantify the degree of##3##4##(2008-10#1)(2008-8#1)(2010-3#1)
quantify the effect of##4##4##(2008-10#2)(2008-7#2)
quantify the effects of##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2012-3#1)
quantify the relationship between##2##4##(2008-10#1)(2013-8#1)
quantify the relative##2##3##(2008-4#1)(2009-2#1)
quantify the##95##2##(1990-7#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-2#2)(2009-5#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
quantify##232##1##(1990-6#1)(1990-7#1)(1991-12#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-6#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#3)(2008-10#77)(2008-11#9)(2008-12#3)(2008-2#6)(2008-3#18)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#10)(2008-9#5)(2009-10#1)(2009-2#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#7)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
quantifying and##3##2##(2008-11#2)(2008-8#1)
quantifying the effect of##2##4##(1992-9#1)(2008-12#1)
quantifying the number of##2##4##(2008-10#1)(2008-4#1)
quantifying the##33##2##(1992-9#1)(1994-11#1)(1995-12#1)(1997-7#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#3)(2013-1#1)(2013-7#1)
quantifying##66##1##(1992-9#1)(1994-11#1)(1995-12#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2010-3#1)(2011-2#3)(2012-2#3)(2013-1#3)(2013-7#1)
quantile##4##1##(1990-8#1)(2010-2#1)(2012-1#2)
quantiles are##2##2##(1990-8#1)(2012-1#1)
quantitate the##11##2##(1991-9#1)(1992-12#1)(1992-6#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)
quantitate##43##1##(1990-12#3)(1991-9#2)(1992-12#2)(1992-6#2)(1992-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#8)(2008-6#1)(2008-9#6)(2009-10#1)(2012-2#1)
quantitated by##10##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-9#1)(2008-4#2)(2008-9#1)
quantitated in##8##2##(1991-9#1)(1992-11#1)(1994-5#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)
quantitated using##4##2##(1991-2#1)(2008-10#2)(2008-7#1)
quantitated##33##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
quantitating the##7##2##(1990-12#1)(1990-7#1)(1994-5#1)(1995-2#1)(2006-6#1)(2008-4#2)
quantitating##15##1##(1990-12#1)(1990-7#1)(1994-5#1)(1995-2#1)(2006-6#1)(2008-10#3)(2008-4#5)(2008-9#1)(2012-2#1)
quantitation (LOQ) of 1##2##4##(1992-8#1)(2008-10#1)
quantitation (LOQ)##9##2##(1992-8#1)(1996-5#1)(2008-10#7)
quantitation and##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
quantitation by##3##2##(1995-11#1)(2008-10#2)
quantitation in##2##2##(1991-9#1)(2007-2#1)
quantitation limit of##2##3##(2008-10#2)
quantitation limit##5##2##(2008-10#5)
quantitation limits of##2##3##(2008-10#2)
quantitation method##2##2##(2008-10#2)
quantitation of the##11##3##(1993-3#1)(1997-2#2)(2008-10#7)(2008-9#1)
quantitation of##68##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#1)(1996-5#2)(1997-2#4)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#38)(2008-11#1)(2008-3#1)(2008-4#7)(2008-9#2)(2009-4#1)(2012-12#1)(2013-8#1)
quantitation was##7##2##(1996-5#1)(2008-10#4)(2008-5#1)(2009-10#1)
quantitation were##6##2##(2008-10#6)
quantitation##129##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-8#2)(1993-3#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-5#4)(1997-2#4)(1997-3#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#78)(2008-11#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-4#1)(2010-3#2)(2012-12#1)(2013-1#1)(2013-8#1)
quantitative &quot##2##2##(2007-5#1)(2008-4#1)
quantitative EEG##2##2##(1996-7#1)(2008-7#1)
quantitative PCR (qPCR)##2##3##(2008-4#1)(2013-8#1)
quantitative PCR assays were##2##4##(2008-10#2)
quantitative PCR for##2##3##(2008-4#1)(2013-1#1)
quantitative PCR in##3##3##(1993-6#1)(2008-11#1)(2011-2#1)
quantitative PCR##20##2##(1993-6#2)(1995-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
quantitative RT-PCR and##2##3##(2008-5#1)(2011-2#1)
quantitative RT-PCR##5##2##(2008-11#2)(2008-5#2)(2011-2#1)
quantitative accuracy##2##2##(2009-5#1)(2012-12#1)
quantitative agreement between##3##3##(1997-5#1)(2007-11#1)(2007-12#1)
quantitative agreement with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
quantitative agreement##8##2##(1997-5#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2009-5#1)
quantitative analyses of the##2##4##(1997-2#1)(2009-7#1)
quantitative analyses of##6##3##(1997-2#1)(2008-10#2)(2008-9#1)(2009-7#1)(2011-2#1)
quantitative analyses##11##2##(1997-2#2)(2008-10#3)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
quantitative analysis and##3##3##(2008-10#2)(2011-1#1)
quantitative analysis in##2##3##(2008-10#2)
quantitative analysis of calcium carbonate##2##5##(2008-10#2)
quantitative analysis of the##22##4##(1994-6#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-2#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
quantitative analysis of##76##3##(1994-6#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#37)(2008-12#1)(2008-2#7)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
quantitative analysis##109##2##(1994-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#56)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-12#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
quantitative analytical##3##2##(2008-10#2)(2012-2#1)
quantitative and qualitative analyses of##2##5##(2008-12#1)(2008-5#1)
quantitative and qualitative aspects##2##4##(2009-9#1)(2012-12#1)
quantitative and qualitative assessments##2##4##(1995-2#1)(2009-10#1)
quantitative and qualitative changes in##2##5##(2008-5#1)(2008-7#1)
quantitative and qualitative data##3##4##(1991-8#1)(2008-11#1)(2013-8#1)
quantitative and qualitative differences##2##4##(2008-10#1)(2008-5#1)
quantitative and qualitative methods##2##4##(2008-12#1)(2008-8#1)
quantitative and qualitative performance##2##4##(2008-3#1)(2008-7#1)
quantitative and qualitative##30##3##(1991-8#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-2#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
quantitative and reproducible##2##3##(2008-10#2)
quantitative and##49##2##(1991-8#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#2)(1997-2#2)(2007-11#2)(2007-6#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
quantitative appraisal##3##2##(2012-3#3)
quantitative approach to##2##3##(2008-10#1)(2008-9#1)
quantitative approach##11##2##(2006-4#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
quantitative aspects of##5##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
quantitative assay of##2##3##(2008-10#2)
quantitative assay##7##2##(2008-1#1)(2008-10#4)(2008-12#1)(2010-4#1)
quantitative assays##2##2##(2008-9#1)(2011-1#1)
quantitative assessment of the##6##4##(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-5#1)
quantitative assessment of##18##3##(1995-5#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)
quantitative at##2##2##(2008-10#2)
quantitative autoradiography and##2##3##(1994-2#1)(1995-12#1)
quantitative autoradiography##6##2##(1992-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#1)
quantitative changes in genomic DNA##2##5##(2008-4#2)
quantitative changes in##3##3##(2008-11#1)(2008-4#2)
quantitative changes##6##2##(1996-11#1)(2008-11#1)(2008-12#1)(2008-4#2)(2011-1#1)
quantitative characterisation of##2##3##(2008-10#2)
quantitative comparison of the##2##4##(2007-12#1)(2008-10#1)
quantitative comparison of##4##3##(2007-12#2)(2008-10#1)(2008-7#1)
quantitative comparison with##2##3##(2008-3#1)(2012-2#1)
quantitative comparison##8##2##(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
quantitative contribution of##2##3##(2008-10#1)(2009-10#1)
quantitative conversion of##2##3##(2008-10#1)(2008-6#1)
quantitative cultures##2##2##(1996-9#1)(2008-5#1)
quantitative data from##2##3##(2008-12#1)(2009-5#1)
quantitative data##13##2##(1990-5#1)(1990-9#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
quantitative description of the##5##4##(1997-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
quantitative description of##8##3##(1996-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)
quantitative detection of##8##3##(2008-1#1)(2008-10#3)(2008-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
quantitative detection##10##2##(2008-1#1)(2008-10#5)(2008-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
quantitative determination by##2##3##(2008-10#1)(2008-5#1)
quantitative determination method for##2##4##(2008-10#2)
quantitative determination method##3##3##(2008-10#3)
quantitative determination of both##2##4##(1991-2#1)(2008-10#1)
quantitative determination of lead##2##4##(2008-10#2)
quantitative determination of small##3##4##(2008-10#3)
quantitative determination of the##4##4##(1991-5#1)(2008-10#3)
quantitative determination of various##2##4##(2008-10#2)
quantitative determination of##64##3##(1991-2#1)(1991-5#3)(1996-5#1)(1997-2#2)(2008-1#1)(2008-10#46)(2008-12#1)(2008-2#1)(2008-5#4)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
quantitative determination##81##2##(1991-2#1)(1991-5#3)(1996-5#1)(1997-2#2)(2008-1#1)(2008-10#59)(2008-12#1)(2008-2#1)(2008-5#8)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
quantitative differences##5##2##(2008-10#1)(2008-5#1)(2009-9#1)(2013-1#2)
quantitative effect##2##2##(2008-7#1)(2008-8#1)
quantitative enrichment##2##2##(2008-10#2)
quantitative estimates of##3##3##(1993-9#1)(2008-10#1)(2008-8#1)
quantitative estimates##4##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
quantitative estimation of##7##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-3#2)
quantitative estimation##8##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#2)(2012-3#2)
quantitative evaluation of the##6##4##(1990-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
quantitative evaluation of##19##3##(1990-12#1)(1991-12#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#4)
quantitative evaluation##23##2##(1990-12#1)(1991-12#2)(1993-1#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#4)
quantitative extraction of##12##3##(2008-10#12)
quantitative extraction##15##2##(2008-10#15)
quantitative features##2##2##(2008-10#1)(2008-3#1)
quantitative fluorescence in situ hybridization##2##5##(2008-1#1)(2008-9#1)
quantitative fluorescence##4##2##(1995-5#1)(2008-1#1)(2008-2#1)(2008-9#1)
quantitative form##2##2##(1994-5#1)(2008-10#1)
quantitative formation of##2##3##(1992-12#1)(1996-2#1)
quantitative genetic##7##2##(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)
quantitative genetics##3##2##(1997-5#2)(2008-8#1)
quantitative histopathological parameters##2##3##(1996-9#2)
quantitative host resistance##4##3##(2008-10#4)
quantitative in##5##2##(1993-1#1)(1993-5#1)(1996-12#1)(2008-1#1)(2008-10#1)
quantitative indexes##2##2##(1991-12#2)
quantitative information about the##2##4##(2008-10#2)
quantitative information about##4##3##(2008-10#2)(2008-2#2)
quantitative information in##2##3##(2008-3#1)(2012-2#1)
quantitative information on##4##3##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
quantitative information that##2##3##(2008-10#1)(2012-2#1)
quantitative information##22##2##(1996-3#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
quantitative investigation of##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
quantitative isolation of##2##3##(1994-12#1)(2008-10#1)
quantitative measurement of the##6##4##(1995-3#1)(2007-12#2)(2008-3#2)(2012-2#1)
quantitative measurement of##15##3##(1991-12#1)(1995-3#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#1)
quantitative measurement##20##2##(1991-12#1)(1995-3#1)(2007-12#2)(2008-10#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#1)
quantitative measurements of##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)
quantitative measurements were##2##3##(2008-11#1)(2008-2#1)
quantitative measurements##17##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-9#5)(2013-1#1)
quantitative measures##3##2##(1992-9#1)(2008-10#2)
quantitative metal ion##2##3##(2008-10#2)
quantitative metal##3##2##(2008-10#3)
quantitative method has been##2##4##(2008-10#2)
quantitative method to##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
quantitative method##13##2##(1990-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#3)(2012-2#1)(2012-3#1)
quantitative methods to##2##3##(1997-8#1)(2008-9#1)
quantitative methods##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
quantitative microscopy##4##2##(2008-3#2)(2008-9#2)
quantitative model##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#2)
quantitative models for##2##3##(2009-5#1)(2013-8#1)
quantitative models##6##2##(1991-5#1)(1993-12#1)(2007-11#1)(2008-9#1)(2009-5#1)(2013-8#1)
quantitative monitoring of##2##3##(2008-10#1)(2008-11#1)
quantitative monitoring##3##2##(2008-10#2)(2008-11#1)
quantitative optical##2##2##(2007-12#1)(2008-3#1)
quantitative parameters of##2##3##(1995-11#1)(2011-1#1)
quantitative parameters##5##2##(1995-11#1)(2008-10#1)(2008-6#1)(2011-1#2)
quantitative phase##5##2##(2007-11#2)(2011-1#2)(2011-2#1)
quantitative polymerase chain reaction (PCR) with##2##6##(2008-10#2)
quantitative polymerase chain reaction (PCR)##5##5##(2008-10#4)(2013-1#1)
quantitative polymerase chain reaction (Q-PCR)##2##5##(2008-10#2)
quantitative polymerase chain reaction##13##4##(1994-8#1)(2008-10#9)(2009-6#1)(2013-1#1)(2013-8#1)
quantitative prediction of the##2##4##(2008-7#1)(2009-6#1)
quantitative prediction of##3##3##(1992-5#1)(2008-7#1)(2009-6#1)
quantitative prediction##5##2##(1992-5#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-5#1)
quantitative protein##3##2##(2008-4#3)
quantitative proteome##2##2##(2008-4#1)(2008-9#1)
quantitative proteomic analysis##2##3##(2008-9#1)(2010-12#1)
quantitative proteomic methods##3##3##(2010-11#3)
quantitative proteomic##6##2##(2008-2#1)(2008-9#1)(2010-11#3)(2010-12#1)
quantitative real-time PCR##7##3##(2009-2#2)(2010-11#1)(2010-7#1)(2012-3#3)
quantitative real-time polymerase chain reaction##4##5##(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#1)
quantitative real-time##14##2##(2008-10#2)(2008-9#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
quantitative recoveries of##2##3##(2008-10#2)
quantitative recoveries were##2##3##(2008-10#2)
quantitative recoveries##7##2##(2008-10#7)
quantitative recovery and##3##3##(2008-10#3)
quantitative recovery of##7##3##(2008-10#6)(2011-1#1)
quantitative recovery##15##2##(2008-10#13)(2011-1#2)
quantitative relation between##2##3##(2008-3#1)(2009-6#1)
quantitative relationship between##3##3##(2008-12#1)(2008-8#1)(2010-11#1)
quantitative relationship##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)
quantitative relationships##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
quantitative research##11##2##(1993-2#1)(1996-4#1)(2007-6#2)(2008-1#1)(2008-11#4)(2012-3#1)(2013-1#1)
quantitative resistance to##7##3##(2008-10#7)
quantitative resistance##17##2##(2008-10#13)(2008-9#1)(2009-10#2)(2011-10#1)
quantitative results for##2##3##(2008-10#2)
quantitative results were obtained##2##4##(2008-10#2)
quantitative results##11##2##(1993-11#2)(2008-10#7)(2011-2#1)(2012-2#1)
quantitative reverse transcription-PCR (Q-RT-PCR) analysis of##2##6##(2008-9#2)
quantitative reverse transcription-polymerase chain reaction##2##5##(2008-10#1)(2011-2#1)
quantitative reverse##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#1)
quantitative review of##3##3##(2008-10#2)(2008-8#1)
quantitative risk assessments##2##3##(2008-10#1)(2011-2#1)
quantitative risk##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
quantitative screening##2##2##(2008-10#1)(2012-2#1)
quantitative separation of##2##3##(2008-10#2)
quantitative solution hybridisation-RNase protection assay##2##5##(1996-12#2)
quantitative sorption of metal##2##4##(2008-10#2)
quantitative sorption of##4##3##(2008-10#4)
quantitative sorption##10##2##(2008-10#10)
quantitative structure activity##2##3##(2007-11#1)(2012-2#1)
quantitative structure-activity relationship (QSAR)##2##4##(2008-10#2)
quantitative structure-activity relationship##5##3##(1995-3#1)(2008-10#2)(2009-3#1)(2010-12#1)
quantitative structure-property relationship##2##3##(2008-10#2)
quantitative studies##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
quantitative study of the##2##4##(2008-10#1)(2012-2#1)
quantitative study##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
quantitative systematic##2##2##(2007-5#1)(2013-7#1)
quantitative technique for##2##3##(2008-1#1)(2010-3#1)
quantitative terms##3##2##(2007-11#1)(2008-3#2)
quantitative tests##2##2##(1997-5#2)
quantitative trait Loci for##5##4##(2008-10#5)
quantitative trait Loci##6##3##(2008-10#6)
quantitative trait loci (QTL) analysis##2##5##(2008-10#1)(2012-3#1)
quantitative trait loci (QTL) associated with##4##6##(2008-10#4)
quantitative trait loci (QTL) for##7##5##(2008-10#7)
quantitative trait loci (QTL) studies##2##5##(2008-10#1)(2008-8#1)
quantitative trait loci (QTL) that contribute to##2##7##(2008-10#1)(2008-8#1)
quantitative trait loci (QTL) that##4##5##(2008-10#3)(2008-8#1)
quantitative trait loci (QTL) were identified for##2##7##(2008-10#2)
quantitative trait loci (QTL) were identified##3##6##(2008-10#3)
quantitative trait loci (QTL)##32##4##(2008-10#25)(2008-7#1)(2008-8#3)(2011-1#1)(2012-3#2)
quantitative trait loci (QTLs) for##2##5##(2008-10#1)(2008-8#1)
quantitative trait loci (QTLs) were##2##5##(2008-10#1)(2008-4#1)
quantitative trait loci (QTLs)##6##4##(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)
quantitative trait loci##47##3##(2008-10#29)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2011-1#1)(2012-3#5)
quantitative trait locus (QTL) mapping##2##5##(2008-8#1)(2012-3#1)
quantitative trait locus (QTL) on chromosome##3##6##(2008-10#3)
quantitative trait locus (QTL)##13##4##(2008-10#9)(2008-8#2)(2012-3#1)(2013-8#1)
quantitative trait locus##21##3##(2008-10#15)(2008-5#1)(2008-8#2)(2010-4#1)(2012-3#1)(2013-8#1)
quantitative trait##86##2##(2008-10#50)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#10)(2008-9#3)(2009-10#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-3#13)(2013-8#1)
quantitative traits in##3##3##(2008-8#1)(2012-3#2)
quantitative traits##15##2##(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#2)(2012-3#4)
quantitative two-dimensional##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
quantitative understanding of##3##3##(1991-5#1)(2008-9#1)(2009-3#1)
quantitative ways##2##2##(2008-7#1)(2010-10#1)
quantitative##1134##1##(1990-12#3)(1990-5#1)(1990-9#2)(1991-11#1)(1991-12#8)(1991-2#1)(1991-5#6)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#3)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#7)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#2)(1996-9#3)(1997-2#9)(1997-3#1)(1997-5#6)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#18)(2007-12#14)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#13)(2008-10#443)(2008-11#24)(2008-12#15)(2008-2#29)(2008-3#46)(2008-4#21)(2008-5#40)(2008-6#2)(2008-7#29)(2008-8#25)(2008-9#46)(2009-10#6)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#8)(2009-6#5)(2009-7#2)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#9)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#7)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#16)(2011-10#1)(2011-2#18)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#23)(2012-3#38)(2012-7#1)(2013-1#22)(2013-7#6)(2013-8#16)
quantitatively accurate##2##2##(2008-3#2)
quantitatively adsorbed on##7##3##(2008-10#7)
quantitatively adsorbed##8##2##(2008-10#8)
quantitatively analyzed by##2##3##(2008-10#1)(2008-2#1)
quantitatively analyzed##8##2##(1996-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2012-2#1)
quantitatively and almost all##2##4##(2008-10#1)(2008-6#1)
quantitatively and qualitatively##6##3##(1994-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-9#1)(2010-5#1)
quantitatively and##13##2##(1994-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-12#1)
quantitatively as##2##2##(1993-12#1)(2008-10#1)
quantitatively assess##4##2##(2008-10#2)(2008-8#1)(2011-1#1)
quantitatively at##3##2##(2008-10#3)
quantitatively by##11##2##(1992-6#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-3#1)
quantitatively compared to##2##3##(2008-10#1)(2008-11#1)
quantitatively compared##6##2##(2008-10#4)(2008-11#1)(2008-8#1)
quantitatively detect##2##2##(2008-10#1)(2013-8#1)
quantitatively detects##2##2##(2008-10#1)(2009-7#1)
quantitatively determined in##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
quantitatively determined##11##2##(1996-12#1)(2008-10#7)(2008-3#2)(2011-2#1)
quantitatively different##2##2##(2008-11#1)(2008-3#1)
quantitatively during passage of aqueous##2##5##(2008-10#2)
quantitatively eluted with 0##2##4##(2008-10#2)
quantitatively eluted with##3##3##(2008-10#3)
quantitatively eluted##4##2##(2008-10#4)
quantitatively enriched##2##2##(2008-10#2)
quantitatively evaluated by the##2##4##(1995-8#1)(2008-3#1)
quantitatively evaluated##4##2##(1995-8#1)(2008-3#1)(2010-5#1)(2012-2#1)
quantitatively explain the##2##3##(2008-11#1)(2008-9#1)
quantitatively explain##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
quantitatively extracted into##2##3##(2008-10#2)
quantitatively extracted to the##2##4##(2008-10#2)
quantitatively extracted##8##2##(2008-10#8)
quantitatively for##3##2##(2008-10#2)(2008-3#1)
quantitatively from##4##2##(2008-10#3)(2008-2#1)
quantitatively in terms of##3##4##(1991-8#2)(2008-3#1)
quantitatively in the##2##3##(2008-10#1)(2008-11#1)
quantitatively in##11##2##(1991-8#2)(1994-8#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)
quantitatively measure##5##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
quantitatively monitor##2##2##(2008-7#1)(2011-7#1)
quantitatively on a##2##3##(2008-10#2)
quantitatively on##4##2##(2008-10#4)
quantitatively recovered##5##2##(1992-9#1)(1997-2#1)(2008-10#3)
quantitatively retained on the column##2##5##(2008-10#2)
quantitatively retained on the##3##4##(2008-10#3)
quantitatively retained on##8##3##(2008-10#8)
quantitatively retained##13##2##(2008-10#13)
quantitatively the##20##2##(1991-9#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)
quantitatively through##2##2##(2008-2#1)(2008-3#1)
quantitatively to##4##2##(1992-6#1)(1993-8#1)(2008-10#2)
quantitatively using##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
quantitatively with the##2##3##(2008-10#1)(2008-3#1)
quantitatively with##10##2##(1990-12#1)(2008-10#6)(2008-3#2)(2008-7#1)
quantitatively##289##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#139)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#22)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-11#1)(2009-12#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-5#4)(2010-8#3)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-7#2)(2013-8#4)
quantities and##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
quantities are##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
quantities as##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
quantities can be separated##2##4##(2008-10#1)(2008-4#1)
quantities can be##3##3##(2008-10#2)(2008-4#1)
quantities from##3##2##(1990-8#1)(2008-10#2)
quantities in##8##2##(1994-8#1)(2007-10#1)(2008-10#5)(2008-11#1)
quantities of DNA of##2##4##(2008-10#2)
quantities of DNA##4##3##(2008-10#4)
quantities of a##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
quantities of pure##2##3##(2008-10#1)(2008-7#1)
quantities of the##3##3##(2008-10#2)(2008-9#1)
quantities of these##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
quantities of##97##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-10#31)(2008-11#9)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#3)(2008-9#6)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
quantities such as##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
quantities were##4##2##(1997-4#1)(2008-10#2)(2008-5#1)
quantities##184##1##(1990-5#1)(1990-8#5)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-10#60)(2008-11#15)(2008-2#2)(2008-3#22)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#5)
quantity and quality of##5##4##(1994-2#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
quantity and quality##8##3##(1994-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
quantity and##16##2##(1994-1#1)(1994-2#1)(2008-10#4)(2008-12#2)(2008-5#2)(2008-9#3)(2009-11#1)(2012-3#1)(2013-1#1)
quantity as##2##2##(2008-12#1)(2013-1#1)
quantity but##2##2##(2008-11#1)(2008-9#1)
quantity in##4##2##(1990-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
quantity is an##2##3##(2008-2#2)
quantity is##7##2##(1995-5#1)(1997-4#1)(2008-10#1)(2008-2#2)(2011-2#1)(2012-12#1)
quantity of AHLV were##2##4##(2011-1#2)
quantity of HCl##2##3##(2008-10#2)
quantity of drug##3##3##(1992-3#3)
quantity of food##2##3##(2008-9#2)
quantity of the##9##3##(1990-6#1)(1996-12#1)(2008-10#5)(2008-7#1)(2008-9#1)
quantity of##72##2##(1990-6#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-2#2)(1994-8#1)(1995-5#2)(1996-1#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#4)(2009-4#1)(2009-6#1)(2009-9#2)(2010-4#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
quantity on##2##2##(2008-10#1)(2008-9#1)
quantity to##2##2##(1995-6#1)(2008-5#1)
quantity##153##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-8#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-12#3)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#38)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#11)(2008-7#1)(2008-8#3)(2008-9#10)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-4#1)(2011-1#6)(2011-10#1)(2011-2#2)(2012-12#9)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
quantization for##2##2##(2007-11#1)(2008-3#1)
quantization of the##2##3##(2007-12#1)(2008-3#1)
quantization of##3##2##(2007-12#1)(2008-3#2)
quantization process##2##2##(2007-11#2)
quantization##22##1##(2007-11#5)(2007-12#1)(2008-2#4)(2008-3#11)(2008-7#1)
quantized##11##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)
quantum Hall states##2##3##(1990-4#1)(2012-2#1)
quantum Hall##4##2##(1990-4#1)(1993-5#1)(2012-2#2)
quantum and classical##3##3##(2012-2#1)(2013-1#2)
quantum boxes located in pillar microcavities##2##6##(2007-12#2)
quantum cascade (QC)##3##3##(2007-11#1)(2007-12#2)
quantum cascade distributed-feedback##2##3##(2007-11#2)
quantum cascade laser##3##3##(2007-11#2)(2007-12#1)
quantum cascade lasers##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
quantum cascade##12##2##(2007-11#6)(2007-12#5)(2013-8#1)
quantum chemical calculations##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
quantum chemical descriptors##2##3##(2007-11#1)(2012-2#1)
quantum chemical studies##3##3##(2010-10#1)(2013-1#2)
quantum chemical##17##2##(2007-11#1)(2008-10#3)(2008-5#2)(2010-10#1)(2010-7#1)(2011-3#1)(2012-2#2)(2013-1#5)(2013-8#1)
quantum chemistry calculation##2##3##(2011-2#1)(2013-8#1)
quantum chemistry##4##2##(2011-2#2)(2011-3#1)(2013-8#1)
quantum coherence##2##2##(1991-9#1)(1993-3#1)
quantum correlation##2##2##(2007-11#2)
quantum critical##2##2##(2012-2#2)
quantum cryptographic##2##2##(2008-2#2)
quantum cryptography##3##2##(1992-8#1)(2007-12#2)
quantum dot##8##2##(1992-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-2#2)
quantum dots (QDs) by##2##4##(2008-10#1)(2009-11#1)
quantum dots (QDs)##7##3##(2008-10#4)(2009-11#2)(2013-8#1)
quantum dots and##3##3##(2008-10#2)(2008-7#1)
quantum dots are##2##3##(2008-7#1)(2012-2#1)
quantum dots as##4##3##(2007-11#2)(2008-10#1)(2013-8#1)
quantum dots in##5##3##(2007-11#3)(2008-10#1)(2008-5#1)
quantum dots was##2##3##(2007-11#2)
quantum dots##52##2##(1995-3#2)(2007-11#12)(2007-12#4)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#6)(2009-10#1)(2009-11#6)(2009-6#1)(2012-2#1)(2013-8#3)
quantum efficiencies##2##2##(2008-2#2)
quantum efficiency of##6##3##(2007-11#2)(2007-12#2)(2008-2#2)
quantum efficiency##17##2##(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#4)
quantum electrodynamics##2##2##(2007-11#1)(2008-3#1)
quantum information##2##2##(2007-12#1)(2012-2#1)
quantum interference in##5##3##(1992-11#1)(2007-11#3)(2007-12#1)
quantum interference##8##2##(1992-11#1)(2007-11#4)(2007-12#1)(2008-7#2)
quantum key distribution##3##3##(2007-11#2)(2007-12#1)
quantum mechanical##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
quantum mechanics##7##2##(1996-5#1)(2007-12#1)(2008-2#1)(2008-5#2)(2010-10#1)(2012-2#1)
quantum noise in##2##3##(1992-8#1)(2007-11#1)
quantum noise##5##2##(1992-8#1)(2007-11#2)(2007-12#2)
quantum nondemolition##2##2##(2007-12#1)(2008-3#1)
quantum partition function##2##3##(2009-9#2)
quantum phase##2##2##(2007-12#1)(2008-7#1)
quantum size##2##2##(1993-5#1)(2010-7#1)
quantum state##2##2##(1993-5#1)(2007-12#1)
quantum teleportation##2##2##(2007-12#2)
quantum well structure can be used to produce##2##8##(2008-2#2)
quantum well structure##3##3##(2008-2#2)(2008-3#1)
quantum well with##2##3##(2007-12#1)(2008-2#1)
quantum well##8##2##(2007-12#2)(2008-2#5)(2008-3#1)
quantum wells near the##2##4##(2007-12#2)
quantum wells##16##2##(1994-2#1)(2007-11#3)(2007-12#5)(2008-2#6)(2008-3#1)
quantum yield of##9##3##(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
quantum yield##29##2##(1992-12#2)(1992-4#1)(1994-12#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-9#6)(2009-4#1)
quantum yields were##2##3##(2008-2#1)(2009-5#1)
quantum yields##8##2##(2008-10#3)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2010-2#1)
quantum##288##1##(1990-12#1)(1990-4#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-8#2)(1993-3#1)(1993-5#3)(1994-12#2)(1994-2#1)(1995-3#3)(1996-5#1)(2007-11#48)(2007-12#45)(2008-10#37)(2008-11#3)(2008-2#24)(2008-3#18)(2008-4#1)(2008-5#5)(2008-7#14)(2008-9#6)(2009-10#1)(2009-11#7)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#7)(2010-10#2)(2010-12#2)(2010-2#1)(2010-7#4)(2011-2#3)(2011-3#2)(2012-2#19)(2013-1#7)(2013-8#6)
quantum-cascade distributed-feedback laser##2##3##(2007-12#1)(2008-3#1)
quantum-cascade distributed-feedback##4##2##(2007-12#3)(2008-3#1)
quantum-cascade laser##2##2##(2007-12#1)(2008-3#1)
quantum-cascade lasers##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
quantum-cascade##15##1##(2007-11#2)(2007-12#6)(2008-3#7)
quantum-chemical##2##1##(2007-12#1)(2008-10#1)
quantum-limited##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
quantum-mechanical##2##1##(2008-2#1)(2009-3#1)
quantum-noise reduction##2##2##(2007-11#2)
quantum-noise##3##1##(2007-11#2)(2007-12#1)
quantum-sized ZnO was##2##3##(2009-8#2)
quantum-sized ZnO##3##2##(2009-8#3)
quantum-sized##4##1##(2008-10#1)(2009-8#3)
quantum-well lasers##3##2##(2008-3#3)
quantum-well##7##1##(2007-12#2)(2008-3#5)
quarantine measures##3##2##(2008-10#3)
quarantine pest##2##2##(2008-10#1)(2011-2#1)
quarantine##29##1##(1992-6#1)(1996-11#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#18)(2008-12#1)(2010-3#1)(2011-2#4)
quarries##2##1##(2008-10#2)
quarry##2##1##(2008-10#1)(2010-4#1)
quarter 1995##3##2##(1995-12#1)(1997-1#1)(1997-2#1)
quarter and center layer##2##4##(2013-8#2)
quarter and##3##2##(2010-8#1)(2013-8#2)
quarter cases##2##2##(1996-8#2)
quarter century##2##2##(2007-12#1)(2011-2#1)
quarter milk samples##3##3##(1993-2#3)
quarter of 1999##2##3##(2008-5#2)
quarter of the##11##3##(1993-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
quarter of##17##2##(1992-3#1)(1992-6#1)(1993-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
quarter##44##1##(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#4)(1995-12#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
quarter-wave liquid-crystal cell for a high-contrast reflective display##2##8##(2007-12#2)
quarter-wave plate (QWP)##2##3##(2008-2#1)(2008-3#1)
quarter-wave plate and##2##3##(2008-2#1)(2008-3#1)
quarter-wave plate##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
quarter-wave plates##4##2##(2007-11#1)(2008-3#3)
quarter-wave retardance##2##2##(2008-2#2)
quarter-wave##26##1##(2007-11#2)(2007-12#4)(2008-2#8)(2008-3#12)
quarter-wavelength##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
quartered##2##1##(2008-10#1)(2012-2#1)
quarterly##8##1##(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-5#1)(2012-3#1)
quarters of the cows in##2##5##(1990-6#2)
quarters of##4##2##(1990-6#2)(2007-2#1)(2012-2#1)
quarters##15##1##(1990-6#3)(1991-5#1)(1996-3#2)(1996-8#2)(1997-8#1)(2007-12#1)(2007-2#1)(2010-5#1)(2012-2#1)(2012-3#2)
quartets##4##1##(1997-5#1)(1997-6#1)(2013-1#2)
quartile of##5##2##(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
quartile##13##1##(2007-10#5)(2008-3#1)(2008-7#1)(2009-3#3)(2011-2#1)(2012-12#1)(2013-1#1)
quartiles were##2##2##(2007-10#1)(2011-2#1)
quartiles##5##1##(1996-9#1)(2007-10#1)(2008-9#1)(2009-3#1)(2011-2#1)
quartz and##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
quartz cell##4##2##(2008-10#4)
quartz crystal impedance analysis##2##4##(2008-10#2)
quartz crystal impedance##6##3##(2008-10#6)
quartz crystal in##3##3##(2008-10#2)(2013-8#1)
quartz crystal microbalance (QCM) was##2##5##(2008-10#2)
quartz crystal microbalance (QCM)##11##4##(2008-10#11)
quartz crystal microbalance##25##3##(2008-10#25)
quartz crystal##61##2##(2008-10#56)(2008-3#1)(2009-5#2)(2013-8#2)
quartz crystals##2##2##(2008-10#2)
quartz fiber##4##2##(2008-10#3)(2008-3#1)
quartz filter##2##2##(2008-10#2)
quartz filters##2##2##(2008-5#2)
quartz flow cell##3##3##(2008-10#3)
quartz glass by##2##3##(2008-3#2)
quartz glass##3##2##(2008-10#1)(2008-3#2)
quartz in the##3##3##(2010-5#1)(2013-8#2)
quartz in##7##2##(2008-10#1)(2010-5#1)(2013-8#5)
quartz or##2##2##(2008-10#1)(2008-5#1)
quartz plate##5##2##(2007-11#2)(2007-9#1)(2008-2#1)(2008-3#1)
quartz plates##2##2##(2008-3#2)
quartz sand##2##2##(2008-2#2)
quartz substrate##4##2##(2007-12#1)(2008-2#1)(2008-5#1)(2009-11#1)
quartz substrates##3##2##(2007-12#2)(2008-10#1)
quartz surface##2##2##(2008-10#2)
quartz surfaces##4##2##(2008-10#4)
quartz was##2##2##(2008-1#1)(2008-5#1)
quartz##159##1##(1990-8#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-1#3)(2008-10#96)(2008-2#5)(2008-3#17)(2008-5#7)(2008-7#1)(2009-11#1)(2009-5#2)(2010-5#1)(2012-2#1)(2013-8#15)
quartz-crystal-microbalance##3##1##(2008-10#2)(2010-4#1)
quartz-enhanced photoacoustic spectroscopy##4##3##(2013-8#4)
quasi extinction##2##2##(2008-8#2)
quasi phase matching in a##2##5##(2007-12#2)
quasi phase matching##4##3##(2007-11#2)(2007-12#2)
quasi phase##5##2##(2007-11#3)(2007-12#2)
quasi##17##1##(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2012-2#1)
quasi-continuous##5##1##(2008-11#2)(2008-2#1)(2008-3#2)
quasi-cw mode##2##2##(2007-12#1)(2008-3#1)
quasi-cw##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
quasi-elastic light scattering##4##3##(2008-10#2)(2008-3#2)
quasi-elastic##6##1##(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#2)
quasi-experimental design##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
quasi-experimental evaluation##2##2##(1995-1#1)(2008-12#1)
quasi-experimental studies##2##2##(2007-11#2)
quasi-experimental study##5##2##(2008-12#2)(2008-4#1)(2013-1#2)
quasi-experimental##15##1##(1995-1#1)(1996-3#1)(2007-11#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-1#3)
quasi-firm##3##1##(1992-12#3)
quasi-firms##2##1##(1992-12#2)
quasi-infinite##2##1##(2008-10#1)(2008-7#1)
quasi-likelihood##2##1##(2010-12#2)
quasi-linear##7##1##(2007-11#5)(2008-10#1)(2008-3#1)
quasi-monochromatic light##2##2##(2008-3#2)
quasi-monochromatic##10##1##(2007-11#1)(2007-12#3)(2008-3#6)
quasi-optical##4##1##(2007-12#2)(2008-3#1)(2011-1#1)
quasi-periodic optical superlattice##2##3##(2007-11#2)
quasi-periodic##7##1##(2007-11#4)(2008-3#3)
quasi-phase matched##2##2##(2007-12#2)
quasi-phase matching in##2##3##(2007-11#1)(2007-12#1)
quasi-phase matching##7##2##(2007-11#4)(2007-12#3)
quasi-phase##11##1##(2007-11#4)(2007-12#7)
quasi-phase-matched KTiOPO(4)##2##2##(2007-12#2)
quasi-phase-matched crystal##2##2##(2007-12#2)
quasi-phase-matched device##3##2##(2007-11#1)(2008-2#2)
quasi-phase-matched generation of##2##3##(2007-12#2)
quasi-phase-matched parametric##2##2##(2007-12#2)
quasi-phase-matched second-harmonic generation##7##3##(2007-11#2)(2007-12#4)(2008-3#1)
quasi-phase-matched##37##1##(2007-11#8)(2007-12#25)(2008-2#2)(2008-3#2)
quasi-phase-matching grating##3##2##(2007-11#1)(2007-12#2)
quasi-phase-matching##10##1##(2007-11#3)(2007-12#6)(2008-3#1)
quasi-reversible##4##1##(1990-5#1)(2008-10#3)
quasi-simultaneous##2##1##(2008-10#1)(2008-3#1)
quasi-species##3##1##(1997-6#1)(2006-10#1)(2012-2#1)
quasi-stadium laser diodes##2##3##(2007-11#2)
quasi-static and##3##2##(2008-2#2)(2008-3#1)
quasi-static elastography##3##2##(2010-8#3)
quasi-static##10##1##(2008-2#4)(2008-3#2)(2010-8#3)(2012-2#1)
quasi-steady##2##1##(2008-7#1)(2008-9#1)
quasi-three-dimensional##2##1##(2007-12#1)(2009-11#1)
quasi-three-level longitudinally pumped##2##3##(2008-3#2)
quasicrystals##2##1##(2006-4#1)(2012-2#1)
quasispecies##10##1##(1997-3#1)(2006-10#1)(2013-1#1)(2013-8#7)
quasistatic##3##1##(1996-4#2)(2012-2#1)
quaternary alkylammonium cations##2##3##(2008-10#2)
quaternary ammonium ion##3##3##(2008-10#2)(2013-1#1)
quaternary ammonium ions##3##3##(2008-10#3)
quaternary ammonium salt is##2##4##(2008-10#2)
quaternary ammonium salt##3##3##(2008-10#2)(2010-4#1)
quaternary ammonium salts in##2##4##(2008-10#2)
quaternary ammonium salts##3##3##(2008-10#3)
quaternary ammonium##23##2##(2008-10#19)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
quaternary carbon##3##2##(1996-5#1)(2007-11#1)(2008-6#1)
quaternary chloride##2##2##(1997-2#2)
quaternary enhancement effect##4##3##(1990-8#1)(1997-2#3)
quaternary enhancement##10##2##(1990-8#6)(1997-2#4)
quaternary mixtures of##2##3##(2008-10#2)
quaternary mixtures##5##2##(2008-10#4)(2013-8#1)
quaternary structure##13##2##(1990-8#2)(1992-11#1)(1992-2#1)(1994-8#1)(1995-5#1)(1997-2#1)(2008-4#6)
quaternary##76##1##(1990-5#1)(1990-7#1)(1990-8#11)(1992-11#1)(1992-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-2#9)(2007-11#1)(2007-8#1)(2008-10#29)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
quaternized##7##1##(1995-3#2)(2008-10#3)(2008-5#1)(2010-4#1)
quatrième ventricule##2##2##(2013-1#2)
quattrocistronic artificial##2##2##(2008-11#2)
qubits##5##1##(2008-7#4)(2012-2#1)
que la##3##2##(2008-5#3)
que le##2##2##(2008-5#1)(2013-1#1)
que les##2##2##(2008-11#1)(2008-5#1)
que##13##1##(2008-11#2)(2008-5#7)(2009-4#2)(2013-1#2)
quebec##2##1##(2008-10#1)(2012-2#1)
queen number##2##2##(2008-5#1)(2008-8#1)
queen##10##1##(2007-5#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-3#1)
queen)##2##1##(2008-5#2)
queen-worker conflict over reproductive allocation##3##5##(2008-8#3)
queen-worker conflict over##4##3##(2008-8#4)
queens and workers##4##3##(2008-8#4)
queens and##5##2##(2008-5#1)(2008-8#4)
queens in##3##2##(2008-5#2)(2008-8#1)
queens##15##1##(2007-12#2)(2008-11#1)(2008-5#4)(2008-8#7)(2009-5#1)
queer##3##1##(2009-7#3)
queleas##3##1##(2008-8#3)
quench of cellular fura-2##3##4##(1992-5#3)
quench of##5##2##(1990-5#1)(1992-5#4)
quench the fluorescence of##4##4##(1995-5#1)(2008-10#2)(2008-9#1)
quench the##5##2##(1995-5#1)(2008-10#2)(2008-8#1)(2008-9#1)
quench##18##1##(1990-5#1)(1992-5#7)(1992-9#1)(1995-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
quenched by addition of##2##4##(1992-5#2)
quenched by##8##2##(1992-5#2)(1997-7#1)(2008-10#3)(2008-2#1)(2008-7#1)
quenched fluorescence##3##2##(2008-10#3)
quenched in##2##2##(1996-6#1)(2008-10#1)
quenched the##2##2##(1995-6#2)
quenched##25##1##(1990-12#1)(1992-5#2)(1995-6#2)(1996-4#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)
quencher in##3##2##(1997-2#1)(2008-10#2)
quencher##18##1##(1992-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1997-2#2)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2010-5#1)
quenchers##3##1##(1990-11#1)(1992-12#1)(2008-5#1)
quenches the fluorescence##2##3##(2008-10#2)
quenches the##4##2##(1992-3#1)(2008-10#3)
quenches##6##1##(1992-3#1)(2008-10#4)(2012-2#1)
quenching and##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
quenching by##7##2##(1992-12#1)(1994-5#1)(1997-7#1)(2008-10#3)(2008-8#1)
quenching constant##4##2##(2008-10#3)(2008-9#1)
quenching constants##2##2##(2008-10#2)
quenching corrections##2##2##(2008-2#2)
quenching cross sections for##2##4##(2008-2#2)
quenching data##3##2##(1995-6#1)(2008-10#2)
quenching effect of##4##3##(2008-10#3)(2013-8#1)
quenching effect on 8-OHdG formation##2##5##(2008-4#2)
quenching effect on##4##3##(2008-10#1)(2008-4#3)
quenching effect##12##2##(2008-10#8)(2008-4#3)(2013-8#1)
quenching efficiency##3##2##(1994-5#1)(2013-8#2)
quenching in##3##2##(1992-12#1)(2008-2#1)(2008-3#1)
quenching intensity##2##2##(2008-10#1)(2013-8#1)
quenching is##2##2##(1995-5#1)(2008-10#1)
quenching mechanism is##2##3##(2008-10#2)
quenching method was##2##3##(2008-10#2)
quenching method##7##2##(2008-10#7)
quenching of a##4##3##(2008-10#3)(2013-8#1)
quenching of conjugated##2##3##(2009-11#2)
quenching of dansyl fluorescence##2##4##(2008-10#2)
quenching of fluorescence##2##3##(1994-12#1)(2008-10#1)
quenching of intrinsic fluorescence##2##4##(1992-6#1)(1995-5#1)
quenching of the fluorescence of##2##5##(2008-10#2)
quenching of the fluorescence##3##4##(2008-10#3)
quenching of the protein##2##4##(1992-12#1)(1994-6#1)
quenching of the##13##3##(1992-12#1)(1994-5#1)(1994-6#2)(1997-2#1)(2008-10#7)(2008-8#1)
quenching of##50##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#30)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-7#1)(2013-1#1)(2013-8#1)
quenching process##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
quenching reaction of##2##3##(2008-10#2)
quenching reaction##4##2##(2008-10#4)
quenching spectra##2##2##(2008-10#2)
quenching that depends on##2##4##(2008-3#2)
quenching the##2##2##(2008-11#1)(2010-4#1)
quenching was##2##2##(2008-10#2)
quenching will##2##2##(2008-9#2)
quenching with##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
quenching##170##1##(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#3)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#3)(1994-6#2)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#1)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#1)(2008-10#97)(2008-11#1)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#5)(2009-11#2)(2009-7#1)(2010-4#2)(2012-2#1)(2013-1#1)(2013-8#6)
quercetagetin##2##1##(2008-11#2)
quercetin and luteolin##2##3##(2008-10#1)(2008-4#1)
quercetin and##7##2##(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)
quercetin in##3##2##(2008-10#2)(2009-12#1)
quercetin##34##1##(1994-8#1)(1995-11#1)(2008-10#16)(2008-11#3)(2008-4#5)(2008-5#2)(2008-9#3)(2009-12#1)(2012-1#1)(2012-12#1)
quercina from##2##2##(2008-10#2)
quercina##6##1##(2008-10#6)
quercitrin##2##1##(2008-10#2)
queried##3##1##(2011-2#1)(2012-12#1)(2012-2#1)
queries was##2##2##(1995-12#1)(2007-7#1)
queries##11##1##(1995-12#1)(2007-7#1)(2008-4#3)(2008-6#1)(2008-7#3)(2009-11#1)(2010-5#1)
query##19##1##(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-7#1)
querying##5##1##(1997-2#1)(2008-4#1)(2008-7#2)(2011-9#1)
quest for mercy##4##3##(2008-8#4)
quest for##11##2##(1992-2#1)(1993-3#1)(2008-12#1)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
quest religious##2##2##(2008-12#1)(2009-7#1)
quest to##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2010-4#1)
quest##18##1##(1992-2#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#4)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
question a##2##2##(1992-12#1)(1997-2#1)
question and the##2##3##(1996-4#1)(2008-8#1)
question and##8##2##(1996-4#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-8#1)(2013-1#1)
question arises##3##2##(2011-1#1)(2011-2#2)
question as##5##2##(1991-12#1)(1995-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
question has##2##2##(1990-12#1)(1992-4#1)
question in##10##2##(1995-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2012-2#1)
question is how##4##3##(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
question is whether##3##3##(1994-2#1)(1996-4#1)(2008-1#1)
question is##19##2##(1992-6#1)(1994-2#1)(1996-1#1)(1996-4#1)(1996-9#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#1)
question its##2##2##(1991-1#1)(2008-5#1)
question of how to##3##4##(1995-9#1)(1996-12#1)(2012-2#1)
question of how##13##3##(1991-9#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
question of interest is##2##4##(1994-2#1)(2008-11#1)
question of interest##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
question of the##12##3##(1991-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-8#1)(2011-2#1)
question of what##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
question of whether to##3##4##(1996-2#1)(1997-1#1)(2008-7#1)
question of whether##18##3##(1991-3#1)(1992-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-2#2)
question of##76##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-12#2)(1992-2#2)(1993-12#1)(1993-2#2)(1994-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
question remains##3##2##(1994-5#1)(2007-11#1)(2008-11#1)
question that has##2##3##(2008-6#1)(2013-1#1)
question that##7##2##(1996-2#1)(2008-11#2)(2008-6#2)(2013-1#2)
question the##13##2##(1992-3#1)(1993-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-6#1)(2011-1#1)(2013-1#1)
question to##5##2##(2007-12#1)(2008-11#1)(2009-10#1)(2010-3#1)(2011-2#1)
question was##7##2##(1995-6#1)(1995-8#2)(1996-11#1)(1997-5#1)(2008-10#1)(2010-11#1)
question whether the##3##3##(1990-9#1)(2008-7#1)(2009-6#1)
question whether##9##2##(1990-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-7#1)(2009-6#1)
question##318##1##(1990-12#2)(1990-2#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#4)(1991-3#3)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#23)(2008-1#1)(2008-10#10)(2008-11#18)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#13)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#6)(2009-7#5)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#13)(2012-2#9)(2012-3#4)(2013-1#13)(2013-8#3)
question]##2##1##(1993-3#1)(2013-1#1)
questionable accuracy##2##2##(2008-1#1)(2008-12#1)
questionable and##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
questionable for##3##2##(1992-6#1)(1995-2#1)(2008-2#1)
questionable##44##1##(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#2)(1995-11#1)(1995-2#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
questionable]##2##1##(1992-6#1)(1996-9#1)
questioned and##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
questioned by##4##2##(1990-8#1)(1992-11#1)(1992-9#2)
questioned in##2##2##(1995-1#1)(2008-12#1)
questioned##35##1##(1990-8#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
questioning about##2##2##(1996-5#1)(2008-7#1)
questioning##11##1##(1990-3#1)(1992-12#1)(1995-11#1)(1996-5#2)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)
questionnaire about their##2##3##(1992-8#1)(2008-1#1)
questionnaire about##4##2##(1992-8#1)(1994-12#1)(1997-2#1)(2008-1#1)
questionnaire among##3##2##(1992-6#1)(1996-9#1)(2013-1#1)
questionnaire and a##2##3##(2008-7#1)(2013-1#1)
questionnaire and the##3##3##(1996-12#1)(2010-3#1)(2011-2#1)
questionnaire and##13##2##(1993-2#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
questionnaire applied##2##2##(1993-6#1)(2011-2#1)
questionnaire as##2##2##(2012-3#1)(2013-1#1)
questionnaire at 6##2##3##(1996-11#1)(2008-6#1)
questionnaire at##4##2##(1996-11#1)(2008-6#1)(2009-10#1)(2011-2#1)
questionnaire concerning##2##2##(1993-3#1)(1996-9#1)
questionnaire consisted of##3##3##(1991-2#1)(2008-1#1)(2011-2#1)
questionnaire contained##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
questionnaire containing##2##2##(2007-10#1)(2011-2#1)
questionnaire data##5##2##(1994-2#1)(1996-2#1)(2007-2#1)(2008-12#1)(2011-1#1)
questionnaire designed##3##2##(1992-2#1)(2008-11#1)(2013-1#1)
questionnaire during##3##2##(1990-2#1)(2008-1#1)(2010-10#1)
questionnaire for the diagnosis of##2##5##(1994-6#1)(1997-2#1)
questionnaire for the diagnosis##3##4##(1993-2#1)(1994-6#1)(1997-2#1)
questionnaire for the##4##3##(1993-2#2)(1994-6#1)(1997-2#1)
questionnaire for##11##2##(1993-2#2)(1994-6#1)(1997-2#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
questionnaire improved##3##2##(2008-11#1)(2008-12#1)(2010-8#1)
questionnaire in the##3##3##(1992-12#1)(1996-3#1)(2008-11#1)
questionnaire in##9##2##(1992-12#1)(1996-3#1)(2008-11#2)(2008-7#2)(2010-4#1)(2012-2#1)(2013-1#1)
questionnaire included##2##2##(2012-2#1)(2013-1#1)
questionnaire of##4##2##(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
questionnaire on the##2##3##(1992-6#1)(1997-4#1)
questionnaire on##5##2##(1992-6#1)(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
questionnaire regarding##3##2##(2008-10#1)(2008-11#1)(2013-7#1)
questionnaire requesting##2##2##(1996-9#1)(2010-10#1)
questionnaire revealed##2##2##(2010-6#1)(2011-2#1)
questionnaire study of##2##3##(1997-3#1)(2008-1#1)
questionnaire study##11##2##(1992-6#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-1#2)(2008-11#1)(2010-10#1)
questionnaire survey of##5##3##(1992-11#1)(1994-6#1)(1995-2#1)(1997-5#1)(2008-1#1)
questionnaire survey was carried out##3##5##(1997-3#1)(2010-5#1)(2011-1#1)
questionnaire survey was##8##3##(1992-6#1)(1997-3#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-2#1)
questionnaire survey##21##2##(1992-11#1)(1992-6#2)(1994-6#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)
questionnaire that##5##2##(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
questionnaire to assess##3##3##(2008-10#1)(2012-1#1)(2013-1#1)
questionnaire to examine##3##3##(2008-11#2)(2009-5#1)
questionnaire to##17##2##(1992-1#1)(1992-12#1)(1993-12#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
questionnaire was also##2##3##(1993-2#1)(2008-11#1)
questionnaire was conducted##2##3##(2010-2#1)(2011-1#1)
questionnaire was designed to##3##4##(1991-1#1)(2007-7#1)(2012-12#1)
questionnaire was developed and##3##4##(1992-1#1)(1994-12#1)(1995-12#1)
questionnaire was developed##4##3##(1992-1#1)(1994-12#1)(1995-12#1)(2010-9#1)
questionnaire was given to##3##4##(1993-12#1)(2008-12#1)(2013-1#1)
questionnaire was given##5##3##(1993-12#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
questionnaire was made##2##3##(2013-1#1)(2013-7#1)
questionnaire was mailed to##4##4##(1991-3#1)(1996-3#1)(2008-4#2)
questionnaire was sent to all##4##5##(1995-6#3)(2012-2#1)
questionnaire was sent to##20##4##(1990-2#1)(1991-6#1)(1993-2#2)(1994-1#1)(1995-6#3)(1996-1#1)(1997-2#1)(1997-3#1)(2007-2#4)(2007-7#1)(2008-1#2)(2012-2#1)(2013-1#1)
questionnaire was sent##21##3##(1990-2#1)(1991-6#1)(1993-2#2)(1994-1#1)(1995-6#3)(1996-1#1)(1997-2#1)(1997-3#1)(2007-2#4)(2007-7#1)(2008-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
questionnaire was used to##6##4##(1990-9#1)(1994-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2013-8#1)
questionnaire was used##9##3##(1990-9#1)(1994-12#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-8#2)
questionnaire was##59##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#4)(1994-1#1)(1994-12#2)(1995-12#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-2#4)(2007-7#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
questionnaire were##4##2##(1992-3#1)(2007-11#1)(2010-1#1)(2013-8#1)
questionnaire with##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
questionnaire##373##1##(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#5)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#6)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#4)(1993-2#11)(1993-3#4)(1993-6#4)(1993-9#2)(1994-1#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#3)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-8#2)(1996-9#4)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#6)(2007-6#2)(2007-7#6)(2007-8#5)(2008-1#14)(2008-10#11)(2008-11#28)(2008-12#10)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#14)(2011-2#22)(2012-1#2)(2012-12#13)(2012-2#10)(2012-3#6)(2013-1#28)(2013-7#2)(2013-8#7)
questionnaire-based##5##1##(2007-2#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
questionnaires about##3##2##(1995-1#1)(1996-9#1)(2008-9#1)
questionnaires and##12##2##(1993-2#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-12#1)(2009-6#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
questionnaires are##3##2##(2007-8#1)(2010-1#1)(2012-2#1)
questionnaires assessing##2##2##(2012-2#1)(2013-1#1)
questionnaires at##4##2##(2007-12#1)(2009-12#1)(2011-1#1)(2012-12#1)
questionnaires based on##2##3##(2010-11#1)(2012-2#1)
questionnaires for evaluating##2##3##(2007-8#1)(2010-11#1)
questionnaires for##4##2##(2007-8#1)(2008-8#1)(2010-11#1)(2012-12#1)
questionnaires in##2##2##(2010-3#1)(2010-4#1)
questionnaires on##4##2##(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
questionnaires or##3##2##(2008-11#2)(2010-8#1)
questionnaires plus##2##2##(2009-4#2)
questionnaires to##7##2##(1992-5#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
questionnaires were mailed##2##3##(1993-12#1)(2008-1#1)
questionnaires were returned by##2##4##(1996-1#1)(1997-3#1)
questionnaires were returned##4##3##(1996-1#1)(1997-3#1)(2007-2#1)(2008-8#1)
questionnaires were sent to##4##4##(1994-2#1)(1997-8#1)(2007-7#1)(2011-1#1)
questionnaires were sent##5##3##(1994-2#1)(1997-8#1)(2007-7#1)(2008-1#1)(2011-1#1)
questionnaires were used to##3##4##(2008-8#1)(2008-9#1)(2010-3#1)
questionnaires were used##4##3##(2008-1#1)(2008-8#1)(2008-9#1)(2010-3#1)
questionnaires were##27##2##(1993-12#1)(1994-2#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
questionnaires##140##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#2)(1995-1#2)(1995-12#1)(1996-1#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-12#4)(2007-2#4)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#5)(2008-11#9)(2008-12#4)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-11#3)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#6)(2013-1#12)(2013-7#1)(2013-8#2)
questions a##2##2##(1990-10#1)(1991-3#1)
questions about how##3##3##(2008-11#2)(2009-12#1)
questions about the role of##2##5##(1992-12#1)(1993-6#1)
questions about the##21##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1995-12#1)(2007-2#1)(2008-11#3)(2009-10#1)(2009-8#2)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
questions about their##2##3##(1991-2#1)(2011-2#1)
questions about whether##2##3##(1995-2#1)(2008-9#1)
questions about##48##2##(1990-5#1)(1991-2#2)(1991-8#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-11#7)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
questions addressed##2##2##(1996-2#1)(2008-11#1)
questions and##23##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
questions answered##2##2##(2008-6#1)(2013-1#1)
questions are addressed##2##3##(1996-3#1)(2009-5#1)
questions are discussed##3##3##(1995-12#1)(2008-8#1)(2012-2#1)
questions are highlighted##2##3##(2012-2#2)
questions are raised##2##3##(2010-10#1)(2012-1#1)
questions are##19##2##(1991-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#4)
questions arise as to how##2##5##(1992-12#1)(2008-3#1)
questions arise##3##2##(1992-12#1)(2008-11#1)(2008-3#1)
questions as to##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
questions as##4##2##(1993-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
questions asked by##2##3##(1991-5#1)(1993-2#1)
questions asked##3##2##(1990-2#1)(1991-5#1)(1993-2#1)
questions but also##2##3##(2008-11#1)(2012-2#1)
questions but##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
questions can be##2##3##(2008-11#1)(2013-8#1)
questions can##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
questions concerning the##2##3##(1993-12#1)(2007-12#1)
questions concerning##10##2##(1992-1#1)(1993-12#2)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)
questions emerge##2##2##(2008-11#1)(2008-12#1)
questions for##11##2##(1993-1#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-9#1)(2007-10#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
questions from the##3##3##(2008-7#2)(2012-3#1)
questions from##9##2##(1990-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
questions have been the##2##4##(1992-9#1)(2010-9#1)
questions have been##3##3##(1992-9#1)(1996-1#1)(2010-9#1)
questions have##4##2##(1992-9#1)(1995-8#1)(1996-1#1)(2010-9#1)
questions in a##2##3##(1991-6#1)(2010-3#1)
questions in the##2##3##(2008-11#1)(2008-7#1)
questions in##9##2##(1991-6#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-8#1)
questions must##3##2##(1993-2#1)(1997-1#1)(2008-7#1)
questions of the##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
questions of##18##2##(1991-1#1)(1994-12#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-2#1)(2009-3#1)(2011-2#2)(2012-3#2)
questions on the##6##3##(1997-3#1)(2008-10#1)(2008-7#1)(2010-12#2)(2013-8#1)
questions on##16##2##(1991-9#1)(1992-3#1)(1992-9#1)(1994-3#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2010-12#2)(2013-1#1)(2013-8#1)
questions or##2##2##(1995-1#1)(2008-1#1)
questions pertaining to##2##3##(1997-2#1)(2012-2#1)
questions posed##3##2##(1992-2#1)(2008-3#1)(2008-7#1)
questions raised by the##2##4##(2008-2#1)(2008-3#1)
questions raised by##4##3##(1997-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
questions regarding the##10##3##(1992-10#1)(1992-6#1)(1993-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-7#1)(2011-2#2)(2013-1#1)
questions regarding##27##2##(1990-11#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
questions related to the##2##4##(2008-10#1)(2009-4#1)
questions related to##3##3##(1991-6#1)(2008-10#1)(2009-4#1)
questions remain about##2##3##(1994-3#1)(2008-11#1)
questions remain##8##2##(1994-3#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
questions resulting from##2##3##(2008-10#1)(2010-12#1)
questions should##3##2##(2007-11#1)(2011-2#1)(2011-8#1)
questions surrounding##2##2##(2008-2#1)(2008-8#1)
questions that a##2##3##(2007-7#1)(2009-3#1)
questions that are##4##3##(2007-5#1)(2008-7#2)(2009-3#1)
questions that might##2##3##(1993-12#1)(2013-8#1)
questions that remain##2##3##(2009-6#1)(2013-8#1)
questions that were##4##3##(1993-2#1)(1995-1#2)(1996-1#1)
questions that will be##2##4##(1995-1#1)(2008-5#1)
questions that will##3##3##(1995-1#1)(1996-1#1)(2008-5#1)
questions that##31##2##(1992-5#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-1#3)(1996-1#2)(1997-3#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-7#4)(2009-12#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#2)
questions the##5##2##(1990-12#1)(1997-7#1)(2008-2#1)(2008-3#1)(2011-2#1)
questions to be##2##3##(2008-10#1)(2011-2#1)
questions to##14##2##(1992-5#1)(1993-2#2)(1995-2#1)(1995-6#1)(1996-12#1)(2007-10#1)(2008-10#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
questions used in##3##3##(1993-2#1)(2008-12#2)
questions was used##2##3##(2008-9#1)(2012-3#1)
questions was##6##2##(1996-1#1)(2008-9#2)(2009-5#1)(2010-4#1)(2012-3#1)
questions were analyzed##2##3##(2013-1#1)(2013-7#1)
questions were used##2##3##(2008-8#1)(2013-8#1)
questions were##18##2##(1991-8#1)(1992-1#1)(1993-2#1)(2007-12#1)(2008-12#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
questions which have to be##2##5##(1994-1#1)(2012-3#1)
questions which##3##2##(1994-1#1)(1994-11#1)(2012-3#1)
questions will be##3##3##(2008-4#2)(2009-10#1)
questions will##4##2##(2008-4#2)(2009-10#1)(2012-3#1)
questions##483##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#9)(1993-2#11)(1993-3#3)(1993-6#2)(1993-8#2)(1994-1#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-8#1)(1995-1#6)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#6)(1996-7#3)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#6)(2007-11#1)(2007-12#6)(2007-2#2)(2007-4#3)(2007-5#1)(2007-7#1)(2008-1#8)(2008-10#14)(2008-11#40)(2008-12#16)(2008-2#6)(2008-3#8)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#26)(2008-8#12)(2008-9#6)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#19)(2011-8#2)(2012-1#3)(2012-12#11)(2012-2#12)(2012-3#13)(2013-1#25)(2013-7#1)(2013-8#15)
questions?##2##1##(2008-8#2)
questions]##2##1##(1993-10#1)(1995-11#1)
quetiapine##3##1##(2008-3#1)(2013-1#2)
queuing##6##1##(2008-8#3)(2008-9#2)(2009-3#1)
qui a été##2##3##(2013-1#2)
qui##8##1##(2008-5#2)(2009-4#1)(2011-2#1)(2013-1#4)
quick and easy to##2##4##(2008-4#1)(2008-5#1)
quick and easy##5##3##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#2)
quick and effective##4##3##(2007-11#1)(2008-10#2)(2009-8#1)
quick and reliable##2##3##(1990-8#1)(2008-1#1)
quick and simple method##2##4##(2008-10#2)
quick and simple##4##3##(2008-10#3)(2008-4#1)
quick and##26##2##(1990-8#1)(1992-3#1)(1995-5#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#3)(2008-5#3)(2008-9#1)(2009-8#1)(2010-8#1)
quick in##2##2##(1992-4#1)(2008-10#1)
quick leaching test##3##3##(2008-10#3)
quick method##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
quick onset of##2##3##(2012-2#2)
quick to##2##2##(1992-9#1)(2008-10#1)
quick##104##1##(1990-8#1)(1990-9#1)(1991-3#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-5#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#10)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-8#3)
quicker and##3##2##(2008-10#3)
quicker than##2##2##(1997-2#1)(2008-3#1)
quicker##17##1##(1993-6#1)(1996-1#1)(1997-2#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#3)(2010-1#1)(2011-2#1)(2013-1#1)
quickly and accurately##3##3##(1996-7#1)(2008-10#1)(2008-6#1)
quickly and easily##3##3##(2008-12#1)(2008-9#1)(2013-7#1)
quickly and reproducibly##2##3##(2012-2#2)
quickly and##23##2##(1996-12#1)(1996-7#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
quickly at##2##2##(2008-10#1)(2008-3#1)
quickly become##2##2##(2008-4#1)(2008-7#1)
quickly identify##2##2##(2008-10#1)(2011-2#1)
quickly if##2##2##(1994-8#1)(2012-2#1)
quickly in the##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
quickly in##8##2##(1993-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
quickly reached##2##2##(2008-10#1)(2008-3#1)
quickly to##4##2##(1995-1#1)(1997-3#1)(2008-6#1)(2013-7#1)
quickly with##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
quickly##158##1##(1990-12#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#27)(2008-11#13)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#9)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#8)(2012-5#1)(2013-1#2)(2013-7#3)(2013-8#2)
quiescence and##2##2##(1996-4#1)(2008-10#1)
quiescence##14##1##(1994-8#2)(1996-4#2)(2008-10#4)(2008-11#2)(2008-8#1)(2009-12#1)(2012-2#1)(2013-8#1)
quiescent and##2##2##(2008-10#1)(2008-4#1)
quiescent cells##2##2##(1991-5#1)(1993-6#1)
quiescent conditions##2##2##(2008-10#1)(2008-7#1)
quiescent embryos##2##2##(1994-8#2)
quiescent infections##5##2##(2008-10#5)
quiescent lysates##3##2##(1994-8#3)
quiescent peripheral blood##3##3##(1994-6#2)(1997-3#1)
quiescent##45##1##(1991-5#1)(1992-3#2)(1992-8#1)(1993-12#4)(1993-6#1)(1994-6#3)(1994-8#5)(1994-9#2)(1995-3#1)(1997-3#3)(1997-7#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2012-2#1)
quiet##5##1##(2007-7#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)
quin 2##2##2##(1990-8#2)
quinacrine##2##1##(1993-11#1)(1994-3#1)
quinalizarine##2##1##(2008-10#2)
quinalphos in##3##2##(2008-10#3)
quinapril##5##1##(1995-3#3)(2010-5#2)
quinidine##2##1##(2008-10#1)(2010-8#1)
quinine and##6##2##(1992-11#1)(1992-6#1)(1993-8#1)(2007-11#1)(2008-10#2)
quinine modified resin##3##3##(2008-10#3)
quinine##35##1##(1992-11#5)(1992-6#1)(1993-12#2)(1993-8#2)(1994-8#1)(1996-8#1)(1997-4#3)(2007-11#1)(2008-10#16)(2010-6#1)(2011-1#1)(2012-12#1)
quinoa##12##1##(2008-10#12)
quinoidal base##2##2##(2008-10#2)
quinoidal##6##1##(2008-10#3)(2011-2#3)
quinol##4##1##(1990-11#1)(2008-10#3)
quinolinate-lesioned##2##1##(1992-3#2)
quinoline degradation##2##2##(2008-7#2)
quinoline derivatives##3##2##(1993-8#1)(1995-5#1)(2008-10#1)
quinoline oxidoreductase##3##2##(1993-11#3)
quinoline##17##1##(1992-3#1)(1993-11#3)(1993-8#1)(1995-5#1)(2007-11#1)(2008-10#5)(2008-7#5)
quinoline-8-ol##4##1##(2008-10#4)
quinolinic acid in##2##3##(1993-12#1)(1995-5#1)
quinolinic acid##10##2##(1992-11#1)(1993-12#2)(1994-8#1)(1995-12#2)(1995-5#3)(2008-5#1)
quinolinone acid-containing compounds##2##3##(2011-3#2)
quinolone antibacterial##2##2##(1995-3#1)(2008-10#1)
quinolone antibacterials##2##2##(2008-10#2)
quinolone##13##1##(1995-3#2)(2008-10#6)(2009-6#1)(2011-2#2)(2012-3#2)
quinolones have##2##2##(2012-3#2)
quinolones##15##1##(1996-3#1)(2007-7#1)(2008-10#8)(2011-2#1)(2012-3#4)
quinone carbonyl##2##2##(1996-5#2)
quinone electron acceptor##2##3##(1992-6#2)
quinone oxidoreductase##5##2##(1992-11#1)(1992-6#1)(1993-3#1)(1997-8#1)(2008-11#1)
quinone oxidoreductase1##2##2##(1994-8#2)
quinone##29##1##(1991-5#2)(1992-11#2)(1992-6#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-5#3)(1996-5#2)(1997-8#1)(2008-10#9)(2008-11#1)
quinones and##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
quinones are more##2##3##(2009-9#2)
quinones are##3##2##(1990-7#1)(2009-9#2)
quinones on##2##2##(2009-9#2)
quinones##28##1##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-8#6)(1994-11#2)(1994-8#2)(2008-10#4)(2008-11#1)(2009-9#8)(2011-2#1)
quinpirole##10##1##(1992-3#1)(1993-3#8)(2008-7#1)
quinquefolius)##5##1##(1997-2#1)(2008-10#4)
quinquetaeniata##4##1##(2010-3#4)
quintana##2##1##(2013-1#2)
quirogae##2##1##(2008-5#2)
quis##3##1##(1991-9#3)
quisqualate##4##1##(1990-8#2)(1992-10#1)(1996-5#1)
quisqualic##3##1##(1991-9#2)(1992-10#1)
quisqualis##6##1##(2008-10#6)
quit attempts and##2##3##(2013-1#2)
quit attempts##7##2##(2008-4#1)(2010-11#1)(2013-1#5)
quit rates of##2##3##(2011-2#2)
quit rates##3##2##(2011-2#3)
quit smoking##9##2##(1993-2#1)(1997-4#1)(2008-11#1)(2013-1#2)(2013-8#4)
quit##38##1##(1991-12#2)(1991-5#1)(1993-2#1)(1996-3#1)(1997-4#1)(2008-11#2)(2008-4#3)(2008-6#1)(2010-11#1)(2010-2#3)(2011-2#5)(2013-1#11)(2013-8#6)
quite a##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
quite clear##2##2##(2008-9#1)(2009-3#1)
quite close##2##2##(1993-3#1)(2008-10#1)
quite common in the##2##4##(1991-6#1)(2008-10#1)
quite common in##5##3##(1991-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
quite common##8##2##(1991-6#1)(1993-6#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
quite complex##5##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
quite different from that of##3##5##(1996-2#1)(2008-3#1)(2010-12#1)
quite different from the##2##4##(2008-8#1)(2010-11#1)
quite different from##10##3##(1992-12#1)(1996-2#1)(1997-8#1)(2007-4#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)
quite different##30##2##(1992-11#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
quite difficult to obtain##2##4##(2008-3#1)(2008-9#1)
quite difficult to##4##3##(2008-10#1)(2008-3#1)(2008-9#2)
quite difficult##8##2##(2008-10#3)(2008-3#1)(2008-9#3)(2009-1#1)
quite effective in##3##3##(1992-12#1)(2007-8#1)(2009-12#1)
quite effective##4##2##(1992-12#1)(2007-11#1)(2007-8#1)(2009-12#1)
quite extensive##2##2##(2007-5#1)(2008-7#1)
quite frequent##2##2##(2012-2#1)(2013-1#1)
quite general##3##2##(1990-3#1)(2007-12#1)(2008-8#1)
quite good##3##2##(2008-10#3)
quite heterogeneous##2##2##(2008-10#1)(2008-11#1)
quite high##6##2##(1991-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)
quite insensitive to##3##3##(1995-5#1)(2007-11#1)(2007-12#1)
quite large##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
quite likely##4##2##(1990-5#1)(1991-2#1)(1997-1#1)(2008-4#1)
quite low##7##2##(1996-2#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-3#1)
quite often##4##2##(1990-9#1)(1996-2#1)(1997-4#1)(2011-2#1)
quite possibly##2##2##(2008-5#1)(2008-8#1)
quite rare##2##2##(2007-7#1)(2008-5#1)
quite satisfactory##4##2##(2008-10#3)(2008-3#1)
quite sensitive to##2##3##(2008-10#2)
quite sensitive##3##2##(2008-10#2)(2008-9#1)
quite similar to##5##3##(1993-6#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-4#1)
quite similar##10##2##(1993-6#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)
quite simple##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
quite small##4##2##(1992-1#1)(1992-5#1)(2008-10#1)(2008-3#1)
quite stable for##2##3##(2008-10#1)(2008-2#1)
quite stable##6##2##(2008-10#3)(2008-2#3)
quite substantial##2##2##(1994-3#1)(2008-3#1)
quite sufficient##2##2##(2008-3#1)(2008-4#1)
quite useful##3##2##(1990-5#1)(2008-4#1)(2012-1#1)
quite variable##5##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
quite weak##2##2##(2008-8#1)(2012-2#1)
quite well##6##2##(1994-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
quite##228##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#5)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#4)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-11#4)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#47)(2008-11#3)(2008-12#4)(2008-2#9)(2008-3#14)(2008-4#7)(2008-5#10)(2008-7#6)(2008-8#8)(2008-9#10)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#7)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
quitting smoking##2##2##(2010-2#1)(2011-2#1)
quitting##12##1##(1991-12#1)(1993-12#1)(1995-6#1)(2007-12#1)(2008-4#1)(2010-2#3)(2011-2#3)(2013-1#1)
quiz##4##1##(2007-11#1)(2008-11#1)(2010-5#1)(2011-1#1)
quorum sensing (QS)##4##3##(2008-10#1)(2009-6#1)(2010-10#1)(2013-1#1)
quorum sensing##11##2##(1995-2#1)(2008-10#3)(2008-8#1)(2009-6#1)(2009-8#2)(2010-10#2)(2013-1#1)
quorum##15##1##(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#3)(2010-10#2)(2012-2#1)(2013-1#1)
quorum-quenching enzymes##4##2##(2008-9#4)
quorum-quenching##5##1##(2008-9#5)
quorum-sensing signal##3##2##(2008-9#2)(2009-6#1)
quorum-sensing signals##3##2##(2008-9#3)
quorum-sensing##7##1##(2008-9#6)(2009-6#1)
quot##14##1##(2012-2#6)(2013-7#6)(2013-8#2)
quota##3##1##(1993-6#1)(2008-10#1)(2008-11#1)
quotas##2##1##(1992-1#1)(2007-8#1)
quote the##2##2##(2008-10#1)(2009-4#1)
quoted##7##1##(1991-3#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-7#1)
quotidian##2##1##(2012-3#2)
quotient between##3##2##(1994-5#1)(2008-10#2)
quotient of##5##2##(2008-3#2)(2012-3#2)(2012-6#1)
quotient##17##1##(1990-8#1)(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2012-1#1)(2012-3#2)(2012-6#1)
quotients##3##1##(1993-8#1)(2008-11#2)
r &gt##2##2##(2008-10#1)(2011-1#1)
r = -0##6##3##(1991-2#1)(1991-3#1)(2008-12#1)(2011-3#2)(2013-1#1)
r = 0##31##3##(1990-8#3)(1991-2#2)(1991-5#1)(1991-8#2)(1992-2#2)(1993-8#1)(1995-11#2)(1995-2#4)(2008-10#5)(2008-3#2)(2008-4#1)(2011-2#1)(2011-3#4)(2013-1#1)
r =##45##2##(1990-8#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#2)(1992-2#2)(1993-8#1)(1995-11#2)(1995-2#4)(2007-10#2)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-10#1)(2010-8#3)(2011-2#1)(2011-3#6)(2013-1#2)
r and##4##2##(1997-4#1)(2008-10#3)
r of##2##2##(2007-11#1)(2008-10#1)
r values##4##2##(2008-10#3)(2008-7#1)
r##100##1##(1990-8#3)(1990-9#5)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-2#2)(1993-8#1)(1995-11#2)(1995-2#4)(1997-4#1)(2007-10#2)(2007-11#3)(2008-10#30)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-9#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-3#6)(2012-2#1)(2013-1#3)(2013-8#1)
r&amp##3##1##(2009-3#2)(2011-2#1)
r(0) and theta(0)##2##3##(2008-2#2)
r(0)##4##1##(2008-2#4)
r(2) = 0##6##3##(2008-10#6)
r(2) values of##3##3##(2008-10#3)
r(2) values##4##2##(2008-10#4)
r(2)##17##1##(2007-11#1)(2008-10#13)(2008-7#1)(2009-3#2)
r(2)&gt##3##1##(1995-3#2)(2012-2#1)
r(2))##2##1##(2008-10#1)(2010-12#1)
r(2)=0##19##1##(2008-10#18)(2008-4#1)
r(G) = 0##2##3##(2008-10#2)
r(g)##4##1##(2008-10#4)
r(m) values##2##2##(2011-2#2)
r(m)##4##1##(2008-12#1)(2011-2#3)
r(rs) values##2##2##(2008-2#2)
r(rs)##4##1##(2008-2#4)
r-HuEPO##4##1##(2008-1#4)
r-[K4HPgK5HPg]##3##1##(1993-8#3)
r-[K4HPg]##3##1##(1993-8#3)
r-[K5HPg]##3##1##(1993-8#3)
r-bp key strings##2##3##(2008-7#2)
r-hu IFN-gamma##4##2##(1993-9#4)
r-l##3##1##(1993-2#3)
r-protein##2##1##(1991-6#1)(1995-8#1)
r-proteins##4##1##(1991-6#1)(1995-8#1)(2008-11#1)(2008-8#1)
r-selected##2##1##(2008-10#2)
r/min##2##1##(2008-8#1)(2011-1#1)
r1 relaxivity##2##2##(2008-7#2)
r1-sc##2##1##(2012-3#2)
r=##2##1##(2008-4#2)
r=0##23##1##(2008-10#18)(2008-7#3)(2010-11#1)(2010-4#1)
r=1##5##1##(2008-10#5)
rAAV is##2##2##(2008-5#1)(2008-9#1)
rAAV production##3##2##(2008-11#1)(2008-8#2)
rAAV was##2##2##(2008-8#1)(2008-9#1)
rAAV##21##1##(2008-11#2)(2008-5#5)(2008-8#6)(2008-9#8)
rAAV-mediated gene##2##2##(2008-8#1)(2008-9#1)
rBCG expressing##2##2##(1995-5#2)
rBCG##6##1##(1995-5#6)
rCA-GTase##2##1##(1992-9#2)
rCBF in the##2##3##(1996-2#1)(2008-7#1)
rCBF in##3##2##(1995-5#1)(1996-2#1)(2008-7#1)
rCBF##12##1##(1995-5#3)(1996-2#2)(1996-5#3)(2007-10#3)(2008-7#1)
rCBV and rCBF##2##3##(2007-10#2)
rCGCCCGCG##3##1##(1991-8#3)
rCGCUUGCG##2##1##(1991-8#2)
rCHO cells##2##2##(2008-11#2)
rCHO##3##1##(2008-11#3)
rCHO-A##2##1##(2008-11#2)
rCHO-B##2##1##(2008-11#2)
rCYP3A4##2##1##(2011-2#2)
rCYP3A5##2##1##(2011-2#2)
rDNA ITS##2##2##(2008-10#1)(2008-5#1)
rDNA and##9##2##(2008-10#8)(2013-1#1)
rDNA fragment##2##2##(2008-10#1)(2008-9#1)
rDNA from isolates of AG-13##2##5##(2008-10#2)
rDNA from##4##2##(2008-10#4)
rDNA gene##5##2##(2008-10#3)(2008-12#2)
rDNA genotypes##2##2##(2008-10#2)
rDNA in the##2##3##(2008-10#1)(2012-2#1)
rDNA in##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
rDNA intergenic spacer##3##3##(1995-8#2)(2008-10#1)
rDNA intergenic##4##2##(1995-8#2)(2008-10#1)(2008-5#1)
rDNA is##2##2##(1995-8#1)(2008-10#1)
rDNA of##3##2##(1995-8#1)(1997-3#1)(2008-10#1)
rDNA repeat units##2##3##(2008-5#2)
rDNA repeat##3##2##(2008-10#1)(2008-5#2)
rDNA revealed##2##2##(2008-10#2)
rDNA sequence analysis##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
rDNA sequence and RAPD##2##4##(2008-10#2)
rDNA sequence##8##2##(2008-10#6)(2008-11#1)(2013-7#1)
rDNA showed that##2##3##(2008-10#2)
rDNA spacer##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
rDNA was##3##2##(2008-10#3)
rDNA were used to##2##4##(2008-10#2)
rDNA were##4##2##(2008-10#4)
rDNA##118##1##(1995-8#6)(1997-3#1)(2007-12#5)(2008-10#81)(2008-11#2)(2008-12#2)(2008-5#9)(2008-8#1)(2008-9#2)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)
rDNA)##2##1##(2008-10#2)
rDNA-ITS region##3##2##(2008-10#3)
rDNA-ITS sequences##3##2##(2008-10#2)(2012-3#1)
rDNA-ITS##6##1##(2008-10#5)(2012-3#1)
rDNA-internal transcribed spacer##2##3##(2008-10#2)
rDR4##2##1##(1997-4#2)
rEP3A receptor##2##2##(1994-9#2)
rEP3A##4##1##(1994-9#4)
rEP3B receptor cDNA##2##3##(1994-9#2)
rEP3B receptor##4##2##(1994-9#4)
rFurin##8##1##(2008-11#8)
rGO sheets##2##2##(2013-1#2)
rGO##4##1##(2013-1#4)
rGO/SWCNT-modified##2##1##(2013-1#2)
rH##8##1##(2013-8#8)
rHDL at##2##2##(1995-5#2)
rHDL##5##1##(1995-5#5)
rHGH##5##1##(2007-11#5)
rHsp70/FCA##2##1##(2009-5#2)
rHuEPO##5##1##(1995-1#5)
rIFN-gamma##2##1##(1994-8#2)
rIL-2##6##1##(1990-12#5)(1991-8#1)
rMtL##4##1##(2008-10#4)
rNG-hCGalpha##7##1##(1995-8#7)
rNT-3##3##1##(2008-8#3)
rP27(kip 1)##2##2##(2008-9#2)
rP27(kip##3##1##(2008-9#3)
rPEA##4##1##(2008-10#4)
rPRL promoter activity##2##3##(1994-8#2)
rPRL promoter was obtained##2##4##(1994-8#2)
rPRL promoter##4##2##(1994-8#4)
rPRL##6##1##(1994-8#5)(1995-11#1)
rPlg##6##1##(1995-6#6)
rRNA and##8##2##(1992-11#1)(1992-6#3)(1996-6#1)(2008-10#3)
rRNA gene as##2##3##(2008-8#1)(2011-1#1)
rRNA gene of##2##3##(2008-12#1)(2008-8#1)
rRNA gene sequences##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
rRNA gene##37##2##(1994-12#1)(2008-10#11)(2008-12#2)(2008-6#1)(2008-8#4)(2009-6#3)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-8#2)
rRNA genes and##2##3##(2008-10#1)(2008-8#1)
rRNA genes are##2##3##(2011-2#2)
rRNA genes positively correlated with##2##5##(2008-10#2)
rRNA genes##17##2##(1992-3#1)(2008-10#6)(2008-5#3)(2008-8#2)(2011-2#3)(2012-2#1)(2013-1#1)
rRNA in this##2##3##(2010-4#2)
rRNA in##4##2##(1990-11#1)(2010-4#3)
rRNA internal##2##2##(2008-10#1)(2008-9#1)
rRNA is##3##2##(2007-12#1)(2008-8#2)
rRNA locus##2##2##(2008-5#2)
rRNA sequences##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
rRNA were##2##2##(2008-8#1)(2009-2#1)
rRNA##132##1##(1990-11#1)(1992-11#1)(1992-3#3)(1992-6#6)(1993-11#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-8#7)(1996-6#1)(1996-8#1)(1997-2#1)(1997-7#3)(2007-12#4)(2008-10#27)(2008-12#2)(2008-2#1)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#14)(2008-9#4)(2009-2#1)(2009-6#3)(2010-4#7)(2010-6#2)(2011-1#2)(2011-2#13)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#2)
rRNAs##4##1##(1993-11#1)(1997-7#1)(2008-5#1)(2010-4#1)
rTFA intake and##2##3##(2012-2#2)
rTFA isomers##2##2##(2012-2#2)
rTFA##5##1##(2012-2#5)
rTFPI##2##1##(1992-10#2)
rTMS as##2##2##(2011-2#1)(2013-8#1)
rTMS for##2##2##(2012-2#2)
rTMS to##3##2##(2008-9#1)(2011-2#2)
rTMS treatment##2##2##(2013-1#2)
rTMS##27##1##(2008-9#2)(2010-7#1)(2011-2#6)(2012-2#7)(2013-1#10)(2013-8#1)
rTNF-alpha was##2##2##(1994-8#2)
rTNF-alpha##7##1##(1991-12#3)(1994-8#4)
rVIIa##2##1##(1995-6#2)
rZIC gene##2##2##(2008-9#2)
ra##3##1##(1995-12#3)
rab##3##1##(1996-10#2)(1996-5#1)
rab-related small GTP binding protein##2##5##(1997-4#2)
rab2##2##1##(1996-5#1)(1997-4#1)
rab3##3##1##(1995-8#1)(1996-5#2)
rab6##2##1##(1995-8#1)(1996-5#1)
rabbit CK-II##2##2##(1993-2#2)
rabbit DSIP##2##2##(1990-5#2)
rabbit IgG and##2##3##(2008-10#2)
rabbit IgG was##2##3##(2008-10#2)
rabbit IgG##14##2##(2008-10#13)(2009-6#1)
rabbit alveolar##2##2##(1992-8#1)(1994-12#1)
rabbit and human##2##3##(1990-12#1)(2008-10#1)
rabbit and pig##2##3##(1990-11#1)(1992-11#1)
rabbit and rat##2##3##(1992-6#1)(2008-10#1)
rabbit and##9##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1996-12#1)(1997-4#1)(2008-10#2)
rabbit antibodies toward##2##3##(1991-12#1)(1991-5#1)
rabbit antibodies##7##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#2)(1996-5#1)(2008-10#1)
rabbit antibody##2##2##(1995-6#1)(2008-10#1)
rabbit antisera##4##2##(1992-9#1)(1994-6#1)(1994-8#1)(1996-12#1)
rabbit antiserum raised against##2##4##(2008-10#2)
rabbit antiserum##5##2##(2008-10#5)
rabbit aorta##7##2##(1990-12#1)(1990-2#3)(1993-6#1)(1995-12#2)
rabbit arteries##6##2##(1996-2#1)(2008-4#2)(2011-1#3)
rabbit beta-globin gene##2##3##(1991-9#1)(1992-12#1)
rabbit beta-globin##4##2##(1991-9#1)(1992-12#1)(2008-11#2)
rabbit bladder smooth muscle##2##4##(1994-8#2)
rabbit bladder##3##2##(1994-8#3)
rabbit blood##3##2##(1994-2#1)(2008-10#2)
rabbit brain##4##2##(1992-3#1)(1993-12#2)(1997-1#1)
rabbit by##2##2##(2008-9#1)(2012-3#1)
rabbit cardiac muscle microvessel endothelial##2##5##(1991-5#2)
rabbit carotid artery##3##3##(1995-12#1)(2007-10#1)(2013-1#1)
rabbit ear##5##2##(1992-12#1)(2008-9#4)
rabbit gamma-preprotachykinin I cDNA##2##4##(1993-8#2)
rabbit gastric glands##2##3##(1995-12#2)
rabbit gastric##3##2##(1995-12#3)
rabbit genomic##2##2##(1992-6#1)(1993-6#1)
rabbit heart##3##2##(1991-9#2)(2007-8#1)
rabbit hearts##2##2##(1990-7#1)(2007-8#1)
rabbit immunoglobulin##2##2##(2008-10#2)
rabbit kidney##2##2##(1993-6#1)(1994-8#1)
rabbit liver MT complexes##2##4##(2008-10#2)
rabbit liver MT##3##3##(2008-10#3)
rabbit liver##5##2##(2008-10#5)
rabbit lung##2##2##(1993-8#1)(1994-12#1)
rabbit mEH##2##2##(1997-7#2)
rabbit model##6##2##(1997-6#2)(2007-8#1)(2008-4#1)(2009-3#1)(2012-3#1)
rabbit monoclonal antibodies##2##3##(2012-12#2)
rabbit muscle LDH##2##3##(1992-11#2)
rabbit muscle##11##2##(1992-11#3)(1992-4#1)(1993-11#1)(1994-5#1)(1997-2#1)(2008-11#4)
rabbit myocardium##3##2##(1990-11#1)(1994-8#2)
rabbit ooplasm##3##2##(2008-9#3)
rabbit or human##3##3##(1995-2#2)(1995-6#1)
rabbit or##4##2##(1993-8#1)(1995-2#2)(1995-6#1)
rabbit polyclonal antibodies raised against##2##5##(1990-8#1)(1996-12#1)
rabbit polyclonal antibodies##3##3##(1990-8#1)(1992-6#1)(1996-12#1)
rabbit polyclonal antibody##4##3##(2008-10#3)(2013-8#1)
rabbit polyclonal##7##2##(1990-8#1)(1992-6#1)(1996-12#1)(2008-10#3)(2013-8#1)
rabbit reticulocyte lysate##4##3##(1990-11#1)(1991-10#1)(1991-12#1)(1993-12#1)
rabbit reticulocyte lysates##3##3##(1990-2#1)(1992-11#1)(1994-8#1)
rabbit reticulocyte##10##2##(1990-11#2)(1990-2#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-5#1)
rabbit reticulocytes##2##2##(1996-2#2)
rabbit skeletal muscle fiber##2##4##(1991-12#2)
rabbit skeletal muscle ryanodine##3##4##(1994-9#1)(2008-9#2)
rabbit skeletal muscle##10##3##(1990-7#1)(1991-12#2)(1994-9#2)(1995-2#1)(1995-6#1)(1997-7#1)(2008-9#2)
rabbit skeletal##11##2##(1990-7#1)(1991-12#2)(1994-9#3)(1995-2#1)(1995-6#1)(1997-7#1)(2008-9#2)
rabbit skin##7##2##(1992-6#3)(2007-11#1)(2008-5#2)(2008-8#1)
rabbit small intestinal##2##3##(1990-11#2)
rabbit small intestine##3##3##(1990-11#1)(1991-12#2)
rabbit small##5##2##(1990-11#3)(1991-12#2)
rabbit spines##2##2##(2008-8#2)
rabbit using##2##2##(2008-10#1)(2008-11#1)
rabbit uterine##2##2##(1992-1#1)(1993-8#1)
rabbit ventricular myocytes##2##3##(1995-5#1)(2013-1#1)
rabbit ventricular##4##2##(1990-11#2)(1995-5#1)(2013-1#1)
rabbit with##2##2##(2012-1#1)(2013-1#1)
rabbit##335##1##(1990-11#9)(1990-12#5)(1990-2#4)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-12#8)(1991-2#1)(1991-5#6)(1991-6#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#6)(1992-12#4)(1992-3#1)(1992-4#1)(1992-6#15)(1992-8#4)(1992-9#4)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#5)(1993-8#7)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#13)(1994-9#5)(1995-11#4)(1995-12#11)(1995-2#4)(1995-5#5)(1995-6#6)(1996-12#4)(1996-2#4)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#9)(2007-10#1)(2007-11#4)(2007-8#3)(2008-1#1)(2008-10#46)(2008-11#13)(2008-12#1)(2008-4#12)(2008-5#7)(2008-8#6)(2008-9#22)(2009-3#2)(2009-6#1)(2010-4#3)(2011-1#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
rabbit's##4##1##(2008-10#1)(2008-2#2)(2008-5#1)
rabbiteye##2##1##(2008-10#2)
rabbits after##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
rabbits and##6##2##(2008-10#1)(2008-9#2)(2009-7#1)(2010-7#1)(2011-2#1)
rabbits are##2##2##(1995-9#1)(2008-11#1)
rabbits as##3##2##(1994-3#1)(1995-6#1)(2007-10#1)
rabbits expressing##2##2##(2008-11#2)
rabbits from##4##2##(1993-12#1)(2008-12#1)(2010-4#2)
rabbits immunized##2##2##(2008-7#1)(2008-9#1)
rabbits in the##4##3##(1996-3#1)(2008-11#2)(2013-1#1)
rabbits in##5##2##(1996-3#1)(2008-11#3)(2013-1#1)
rabbits is##2##2##(1994-8#1)(1995-9#1)
rabbits of the##2##3##(1993-12#1)(2008-12#1)
rabbits only##2##2##(1994-8#1)(1996-12#1)
rabbits showed##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
rabbits was##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
rabbits were used##2##3##(2008-8#1)(2012-3#1)
rabbits were##13##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-1#1)(1992-3#4)(1996-3#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
rabbits with the##2##3##(1996-2#1)(2008-10#1)
rabbits with##10##2##(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-8#3)
rabbits##151##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-3#4)(1992-6#1)(1993-1#1)(1993-12#6)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-8#5)(1995-11#1)(1995-12#6)(1995-5#1)(1995-6#3)(1995-9#5)(1996-12#2)(1996-2#2)(1996-3#3)(1996-9#2)(1997-4#1)(1997-8#2)(2007-10#1)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#5)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#4)(2008-9#7)(2009-3#1)(2009-7#1)(2010-10#1)(2010-4#10)(2010-7#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#5)(2013-1#1)
rabbits]##3##1##(2010-12#1)(2011-2#1)(2013-8#1)
rabeprazole and lansoprazole##4##3##(2012-2#4)
rabeprazole##9##1##(2008-10#2)(2012-2#7)
rabiei in##3##2##(2008-10#3)
rabiei##13##1##(2008-10#13)
rabies and##2##2##(2012-12#1)(2013-1#1)
rabies control##2##2##(2011-2#1)(2012-3#1)
rabies in##7##2##(1992-5#1)(2007-10#1)(2007-12#2)(2011-2#2)(2012-3#1)
rabies incidence##2##2##(2011-2#2)
rabies vaccine##3##2##(1996-11#1)(1996-8#2)
rabies virus##5##2##(1994-2#1)(1995-2#2)(2007-12#1)(2008-11#1)
rabies##34##1##(1992-5#1)(1994-2#1)(1995-2#3)(1996-11#1)(1996-8#2)(2007-10#2)(2007-12#5)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#8)(2012-12#4)(2012-3#2)(2013-1#2)
rac p21s##7##2##(1993-8#7)
rac##10##1##(1993-8#7)(1996-2#3)
raccoon dogs##2##2##(2008-12#2)
raccoon##3##1##(2008-12#3)
race (race##2##2##(2008-10#2)
race 0##6##2##(2008-10#6)
race 1 and race 2##4##5##(2008-10#4)
race 1 and race##5##4##(2008-10#5)
race 1 and##8##3##(2008-10#8)
race 1 in##2##3##(2008-10#2)
race 1 isolate##2##3##(2008-10#2)
race 1 isolates##9##3##(2008-10#9)
race 1 of##3##3##(2008-10#3)
race 1##49##2##(2008-10#49)
race 2 and race##2##4##(2008-10#2)
race 2 isolates##3##3##(2008-10#3)
race 2 of##2##3##(2008-10#2)
race 2##38##2##(2008-10#38)
race 3 (T3)##2##3##(2008-10#2)
race 3 in the##2##4##(2008-10#2)
race 3 in##3##3##(2008-10#3)
race 3 isolates from##2##4##(2008-10#2)
race 3 isolates##4##3##(2008-10#4)
race 3 was##3##3##(2008-10#3)
race 3##21##2##(2008-10#21)
race 4##6##2##(2008-10#6)
race 5##11##2##(2008-10#11)
race 6##6##2##(2008-10#6)
race 6-specific##2##2##(2008-10#2)
race 65##2##2##(2008-10#2)
race 7##4##2##(2008-10#4)
race 8##3##2##(2008-10#3)
race Ct1##2##2##(2008-10#2)
race and ethnicity##3##3##(2010-9#1)(2011-2#1)(2012-12#1)
race and gender##3##3##(2007-10#2)(2008-8#1)
race and##14##2##(2007-10#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
race clusters using the 195 isolates##2##6##(2008-10#2)
race clusters##4##2##(2008-10#4)
race designation##2##2##(2008-10#2)
race in the##3##3##(1995-2#2)(2009-7#1)
race in##5##2##(1995-2#2)(2008-10#1)(2009-7#1)(2011-2#1)
race is##2##2##(1991-11#1)(2008-11#1)
race of G##4##3##(2008-10#4)
race of P##3##3##(1997-6#1)(2008-10#2)
race of##12##2##(1997-6#1)(2008-10#9)(2008-8#1)(2011-1#1)
race on##2##2##(1995-12#1)(2011-2#1)
race or gender##2##3##(2007-10#1)(2008-7#1)
race or##4##2##(2007-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
race specificity##2##2##(2008-8#2)
race structure##8##2##(2008-10#8)
race with##2##2##(1990-2#1)(2008-10#1)
race##320##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-2#1)(1995-12#1)(1995-2#3)(1997-3#1)(1997-6#1)(2007-10#3)(2007-7#1)(2008-10#241)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#9)(2009-12#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
race-change mutants##6##2##(2008-10#6)
race-ethnicity##2##1##(2009-7#1)(2012-2#1)
race-nonspecific resistance##3##2##(2008-10#3)
race-related amygdala activity##2##3##(2008-11#2)
race-specific genes##3##2##(2008-10#3)
race-specific resistance to##3##3##(2008-10#3)
race-specific resistance##7##2##(2008-10#7)
race-specific##15##1##(2008-10#15)
race/ethnicity and language##2##3##(2013-1#2)
race/ethnicity and##4##2##(2009-7#1)(2013-1#2)(2013-8#1)
race/ethnicity##12##1##(2008-12#1)(2009-5#1)(2009-7#1)(2011-2#3)(2013-1#5)(2013-8#1)
racemase activity##2##2##(1995-2#2)
racemase##4##1##(1995-2#4)
racemate##3##1##(1992-12#1)(2010-12#1)(2010-4#1)
racemates in##2##2##(1990-6#1)(2013-1#1)
racemates##6##1##(1990-6#1)(2008-10#4)(2013-1#1)
racemic amino acid##2##3##(1992-11#1)(2010-12#1)
racemic mixture##2##2##(1996-5#1)(2008-10#1)
racemic naproxen amide##2##3##(1994-3#2)
racemic naproxen nitrile##4##3##(1994-3#4)
racemic naproxen##6##2##(1994-3#6)
racemic##21##1##(1991-5#1)(1992-11#1)(1992-12#1)(1994-3#6)(1995-3#1)(1996-5#3)(1997-4#1)(2007-11#1)(2008-10#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
racemosa##6##1##(2007-9#2)(2008-10#3)(2008-5#1)
racemosus roots##2##2##(2010-5#1)(2013-1#1)
racemosus##7##1##(2008-10#1)(2010-5#3)(2013-1#3)
races 0 and##2##3##(2008-10#2)
races 0##5##2##(2008-10#5)
races 1 and 2 of##2##5##(2008-10#2)
races 1 and 2##3##4##(2008-10#3)
races 1 and 3##2##4##(2008-10#2)
races 1 and 8##3##4##(2008-10#3)
races 1 and##14##3##(2008-10#14)
races 1##27##2##(2008-10#27)
races 2 and 5##2##4##(2008-10#2)
races 2 and##3##3##(2008-10#3)
races 2##7##2##(2008-10#7)
races 6##2##2##(2008-10#2)
races PST-41 and PST-45##2##4##(2008-10#2)
races and##9##2##(1992-2#1)(2008-10#6)(2008-9#1)(2010-3#1)
races are##2##2##(2008-10#2)
races from##2##2##(1996-6#1)(2008-10#1)
races in##5##2##(2008-10#3)(2008-9#1)(2010-1#1)
races of F##4##3##(2008-10#4)
races of P##8##3##(2008-10#8)
races of Podosphaera xanthii and one race of G##2##9##(2008-10#2)
races of the fungus##2##4##(2008-10#2)
races of the pathogen##5##4##(2008-10#5)
races of the##7##3##(2008-10#7)
races of##34##2##(2008-10#31)(2008-8#1)(2008-9#1)(2010-1#1)
races that##2##2##(2008-10#2)
races was##4##2##(2008-10#4)
races were##9##2##(2008-10#9)
races with race 1##2##4##(2008-10#2)
races with##4##2##(2008-10#4)
races##179##1##(1992-2#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-6#1)(2008-10#157)(2008-12#1)(2008-8#2)(2008-9#4)(2009-12#2)(2010-1#2)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#2)
rachilla##2##1##(2008-10#1)(2008-5#1)
rachis susceptibility##3##2##(2008-10#3)
rachis##13##1##(2008-10#12)(2008-9#1)
rachises##2##1##(2008-10#2)
racial and ethnic disparities##2##4##(2011-2#2)
racial and ethnic groups and##2##5##(1997-1#1)(2008-5#1)
racial and ethnic groups##4##4##(1997-1#1)(2008-5#2)(2011-2#1)
racial and ethnic##12##3##(1997-1#1)(2008-10#1)(2008-5#5)(2011-1#2)(2011-2#3)
racial and##15##2##(1997-1#1)(2008-10#1)(2008-5#5)(2008-7#2)(2009-7#1)(2011-1#2)(2011-2#3)
racial barrier##2##2##(2009-7#2)
racial differences##4##2##(1991-7#1)(2008-5#1)(2011-2#1)(2012-2#1)
racial disparities in##3##3##(2010-3#1)(2011-2#1)(2012-3#1)
racial disparities##5##2##(2010-3#3)(2011-2#1)(2012-3#1)
racial gap##2##2##(2011-2#2)
racial groups##6##2##(2008-11#1)(2008-5#4)(2009-6#1)
racial socialization and democratic-involved parenting##2##5##(2009-7#2)
racial socialization and##3##3##(2009-7#3)
racial socialization##4##2##(2009-7#4)
racial##53##1##(1991-7#1)(1993-6#1)(1994-12#1)(1994-3#2)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#11)(2008-7#2)(2009-6#1)(2009-7#9)(2009-9#2)(2010-3#3)(2011-1#2)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#1)
racial-ethnic centrality##2##2##(2009-7#2)
racial-ethnic identities##2##2##(2009-7#2)
racial-ethnic##5##1##(2009-7#5)
racial/ethnic groups##2##2##(2011-2#1)(2012-12#1)
racial/ethnic minorities##2##2##(2011-2#1)(2013-1#1)
racial/ethnic##9##1##(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
racially and ethnically diverse##3##4##(2010-1#1)(2012-3#2)
racially diverse##2##2##(1994-2#1)(2010-11#1)
racially##7##1##(1994-2#1)(2007-10#1)(2008-11#1)(2010-1#1)(2010-11#1)(2012-3#2)
racially/ethnically##2##1##(2012-2#1)(2013-1#1)
rack##2##1##(2008-11#1)(2012-2#1)
racket and ball kinematics##2##4##(2011-2#2)
racket and ball##3##3##(2011-2#3)
racket##5##1##(2011-2#5)
raclopride on##4##2##(2008-6#4)
raclopride##9##1##(2008-6#8)(2008-7#1)
racquet##4##1##(1991-6#1)(2011-2#3)
rad and##2##2##(2008-3#2)
rad##7##1##(2007-11#1)(2008-3#6)
rad9 delta cells##2##3##(1996-3#2)
rad9 delta##3##2##(1996-3#3)
radA null mutants##2##3##(1997-4#2)
radA##6##1##(1997-4#6)
radar and the##3##3##(2008-3#3)
radar and##4##2##(2008-2#1)(2008-3#3)
radar cross sections##2##3##(2008-3#2)
radar cross##3##2##(2008-3#3)
radar image##3##2##(2007-12#2)(2008-3#1)
radar parameters##2##2##(2008-3#2)
radar safety##2##2##(2008-3#2)
radar##44##1##(2007-11#2)(2007-12#6)(2008-2#4)(2008-3#31)(2008-6#1)
radars##3##1##(2008-2#2)(2008-3#1)
radial access##4##2##(2011-2#4)
radial and circumferential##2##3##(2008-7#1)(2009-7#1)
radial and ulnar##2##3##(2008-7#1)(2008-9#1)
radial and##7##2##(2008-3#1)(2008-7#3)(2008-9#1)(2009-7#1)(2011-2#1)
radial approach##3##2##(2011-2#3)
radial arm maze##3##3##(1992-12#1)(2008-4#1)(2012-2#1)
radial arm##4##2##(1992-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
radial artery harvest for##3##4##(2007-8#3)
radial artery harvest##4##3##(2007-8#4)
radial artery in a##2##4##(2011-2#1)(2013-1#1)
radial artery in##3##3##(1990-8#1)(2011-2#1)(2013-1#1)
radial artery is##4##3##(1990-8#1)(2008-11#1)(2011-2#2)
radial artery occlusion and radial artery spasm##3##7##(2011-2#3)
radial artery occlusion##5##3##(2007-8#1)(2011-2#4)
radial artery perforators##3##3##(2008-9#3)
radial artery spasm##5##3##(2011-2#5)
radial artery##53##2##(1990-8#6)(2007-8#12)(2008-11#2)(2008-7#2)(2008-9#9)(2011-2#20)(2013-1#2)
radial basis function networks##2##4##(2008-10#2)
radial basis function neural##4##4##(2008-10#3)(2008-2#1)
radial basis function##8##3##(2008-10#7)(2008-2#1)
radial basis function-artificial neural networks (RBF-ANN)##2##6##(2008-10#2)
radial basis##10##2##(2008-10#9)(2008-2#1)
radial bone##2##2##(2007-8#1)(2010-11#1)
radial data##2##2##(2008-10#2)
radial direction##5##2##(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)
radial distribution functions##2##3##(1992-9#1)(2008-10#1)
radial distribution of##2##3##(2008-10#2)
radial distribution##5##2##(1992-9#1)(2008-10#3)(2008-2#1)
radial flow cell for##2##4##(2008-10#2)
radial flow cell##4##3##(2008-10#4)
radial flow monolithic column##2##4##(2008-10#2)
radial flow##8##2##(2008-10#8)
radial forearm fascial##2##3##(2008-9#2)
radial forearm flap##5##3##(2007-12#1)(2008-9#3)(2011-2#1)
radial forearm free flap##4##4##(2007-12#1)(2011-2#3)
radial forearm free##5##3##(2007-12#1)(2011-2#4)
radial forearm##12##2##(2007-12#2)(2008-9#5)(2011-2#5)
radial growth of strain##2##4##(2008-10#1)(2008-5#1)
radial growth of##3##3##(2008-10#2)(2008-5#1)
radial growth##7##2##(2008-10#5)(2008-5#1)(2012-5#1)
radial immunodiffusion##4##2##(1990-2#1)(1993-2#1)(2007-10#1)(2008-10#1)
radial maze##3##2##(1993-6#1)(1994-2#1)(1994-6#1)
radial nerve injury##4##3##(2008-9#1)(2012-2#3)
radial nerve##13##2##(2008-7#5)(2008-9#2)(2012-2#6)
radial occlusion##2##2##(2011-2#2)
radial or##2##2##(1990-11#1)(2008-10#1)
radial rate##2##2##(2008-10#2)
radial recurrent fasciocutaneous flap##2##4##(2011-2#2)
radial shrinkage of fresh##2##4##(2012-2#2)
radial shrinkage##3##2##(2012-2#3)
radial strain##3##2##(2008-3#1)(2010-6#1)(2013-7#1)
radial velocity of##2##3##(2008-10#1)(2008-3#1)
radial velocity##4##2##(2008-10#1)(2008-3#3)
radial##240##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#6)(1990-9#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-5#2)(1995-6#1)(1997-3#2)(2007-10#1)(2007-11#7)(2007-12#4)(2007-8#16)(2008-10#41)(2008-11#2)(2008-2#13)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#14)(2008-9#21)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#54)(2012-2#10)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#4)
radial-growing##2##1##(2008-10#2)
radially inhomogeneous##2##2##(2008-2#2)
radially symmetric##3##2##(1994-2#1)(2008-3#1)(2013-8#1)
radially##14##1##(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-7#1)(2013-1#1)(2013-8#2)
radiance and the##2##3##(2008-2#1)(2008-3#1)
radiance and##7##2##(2008-2#3)(2008-3#4)
radiance at the##2##3##(2008-2#1)(2008-3#1)
radiance at##3##2##(2008-2#2)(2008-3#1)
radiance data over the##2##4##(2008-2#1)(2008-3#1)
radiance distribution##3##2##(2008-2#3)
radiance for each##2##3##(2008-2#2)
radiance for##6##2##(2008-2#2)(2008-3#4)
radiance from##4##2##(2008-2#1)(2008-3#3)
radiance in##5##2##(2008-2#1)(2008-3#4)
radiance is##2##2##(2008-3#2)
radiance measured by##2##3##(2008-2#1)(2008-3#1)
radiance measured##3##2##(2008-2#1)(2008-3#2)
radiance measurements##8##2##(2008-2#5)(2008-3#3)
radiance model##3##2##(2008-2#2)(2008-3#1)
radiance of##3##2##(2008-2#2)(2008-3#1)
radiance spectra##3##2##(2008-3#3)
radiance spectrum##2##2##(2008-2#1)(2008-3#1)
radiance that##2##2##(2008-2#1)(2008-3#1)
radiance with##2##2##(2008-2#2)
radiance##119##1##(2008-2#54)(2008-3#65)
radiances at##3##2##(2008-2#2)(2008-3#1)
radiances exiting the##2##3##(2008-2#2)
radiances from##4##2##(2008-2#1)(2008-3#3)
radiances have##2##2##(2008-3#2)
radiances in the##2##3##(2008-2#1)(2008-3#1)
radiances in##3##2##(2008-2#2)(2008-3#1)
radiances is##2##2##(2008-3#2)
radiances measured##3##2##(2008-2#3)
radiances to##2##2##(2008-2#1)(2008-3#1)
radiances with##4##2##(2008-2#1)(2008-3#3)
radiances##49##1##(2008-2#22)(2008-3#27)
radiant##7##1##(1992-3#1)(2008-2#2)(2008-3#3)(2013-8#1)
radiata and##2##2##(2010-8#2)
radiata from the##2##3##(1997-4#1)(2008-12#1)
radiata##31##1##(1995-2#2)(1997-4#1)(2007-10#7)(2008-10#4)(2008-12#12)(2008-7#1)(2010-8#3)(2013-7#1)
radiata)##3##1##(1997-4#1)(2008-10#1)(2009-4#1)
radiate##2##1##(1995-3#1)(2008-3#1)
radiated by the##2##3##(2008-3#2)
radiated by##3##2##(2008-3#2)(2008-5#1)
radiated from the##2##3##(2008-3#1)(2008-8#1)
radiated##10##1##(1996-6#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#2)
radiating##8##1##(2007-12#3)(2008-2#2)(2008-3#2)(2013-8#1)
radiation (193 nm)##2##3##(2008-2#2)
radiation (UVR)##2##2##(2008-1#1)(2011-2#1)
radiation X-ray fluorescence##2##3##(2008-10#2)
radiation absorbed##2##2##(1992-7#1)(2013-1#1)
radiation adaptive response##2##3##(2008-7#2)
radiation after##3##2##(1991-2#1)(1995-6#1)(2009-11#1)
radiation and chemotherapy##3##3##(1993-2#1)(2010-3#1)(2013-1#1)
radiation and hydrogen peroxide##2##4##(1990-5#2)
radiation and other##2##3##(2008-7#1)(2013-1#1)
radiation and reduce##2##3##(2007-11#1)(2013-8#1)
radiation and the##5##3##(2007-12#2)(2008-2#2)(2008-8#1)
radiation and##41##2##(1990-5#2)(1990-7#1)(1992-3#1)(1993-2#2)(1995-8#1)(1996-6#2)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#6)(2008-8#1)(2010-1#2)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#3)(2013-8#1)
radiation are discussed##2##3##(2008-10#1)(2008-3#1)
radiation are##7##2##(2008-10#1)(2008-3#1)(2008-7#2)(2010-6#1)(2011-2#1)(2013-1#1)
radiation as a##2##3##(2008-3#1)(2008-6#1)
radiation as##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
radiation at 2##3##3##(2007-11#2)(2007-12#1)
radiation at 355 nm##2##4##(2008-10#1)(2008-3#1)
radiation at a wavelength of 10##4##6##(2007-11#3)(2007-12#1)
radiation at a wavelength of##6##5##(2007-11#3)(2007-12#2)(2008-2#1)
radiation at wavelengths##3##3##(2007-12#1)(2008-3#2)
radiation at##36##2##(2007-11#7)(2007-12#10)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#9)(2008-7#1)(2013-7#1)
radiation beam##2##2##(2008-3#2)
radiation burden from##2##3##(2012-2#2)
radiation burden##5##2##(2012-2#5)
radiation by an##2##3##(2007-11#1)(2008-3#1)
radiation by##12##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)
radiation can be##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
radiation can cause##2##3##(2008-7#2)
radiation can##11##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#6)
radiation causes##2##2##(2007-12#1)(2008-5#1)
radiation compared##2##2##(2008-7#1)(2011-2#1)
radiation contaminated territories and##2##4##(2011-1#2)
radiation damage##5##2##(1990-12#1)(1994-3#1)(1995-6#1)(2008-10#2)
radiation dose of##4##3##(1992-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
radiation dose##21##2##(1992-11#1)(1994-3#3)(1997-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#5)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)
radiation doses from##2##3##(1995-12#1)(2013-1#1)
radiation doses##11##2##(1995-12#1)(1996-6#2)(2008-10#1)(2008-7#4)(2012-2#1)(2013-1#2)
radiation during##2##2##(1995-12#1)(2008-10#1)
radiation effects##5##2##(1996-6#2)(2008-11#1)(2008-7#2)
radiation exposure and##4##3##(1994-3#1)(1996-6#1)(2008-4#1)(2008-7#1)
radiation exposure are##2##3##(2008-7#2)
radiation exposure from##2##3##(1996-6#1)(2008-4#1)
radiation exposure to the##2##4##(2008-7#1)(2012-1#1)
radiation exposure##25##2##(1994-3#1)(1996-6#3)(2008-1#1)(2008-12#2)(2008-4#2)(2008-7#12)(2012-1#2)(2012-2#1)(2013-8#1)
radiation exposures##4##2##(1996-6#1)(2008-7#2)(2013-1#1)
radiation field##3##2##(2010-7#2)(2013-1#1)
radiation fields##3##2##(1992-10#1)(2008-3#2)
radiation for the##2##3##(2006-4#1)(2009-11#1)
radiation for##12##2##(1991-12#1)(1995-9#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-11#1)(2011-2#1)
radiation from a##8##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
radiation from the##7##3##(1990-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
radiation from##29##2##(1990-12#2)(1994-2#1)(1996-6#1)(2007-11#5)(2007-12#7)(2008-10#3)(2008-2#3)(2008-3#6)(2012-2#1)
radiation generated by##2##3##(2007-12#1)(2008-2#1)
radiation generated##3##2##(2007-12#2)(2008-2#1)
radiation has been##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
radiation has##11##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-12#1)
radiation have##3##2##(2007-12#1)(2008-3#2)
radiation hormesis in##3##3##(2008-7#1)(2013-1#2)
radiation hormesis##12##2##(2008-7#9)(2013-1#3)
radiation hormesis)##4##2##(2008-7#3)(2013-1#1)
radiation hybrid##3##2##(1997-8#2)(2008-8#1)
radiation hybrids##4##2##(1994-12#2)(1996-6#2)
radiation in a##9##3##(2007-12#4)(2008-10#1)(2008-2#3)(2008-5#1)
radiation in pure##2##3##(2008-2#1)(2008-5#1)
radiation in the range of##2##5##(2008-3#1)(2008-5#1)
radiation in the range##4##4##(2007-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
radiation in the##21##3##(1993-9#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#8)(2008-3#4)(2008-5#1)(2008-7#1)(2010-4#1)
radiation in##55##2##(1990-9#1)(1993-9#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#14)(2008-3#5)(2008-5#4)(2008-7#2)(2008-8#3)(2010-4#1)(2011-2#1)(2013-1#1)
radiation incident##2##2##(2008-2#1)(2008-3#1)
radiation induced damage##2##3##(2013-8#2)
radiation induced##11##2##(1996-2#1)(2008-10#2)(2008-5#2)(2013-8#6)
radiation intensity##2##2##(2008-10#1)(2009-10#1)
radiation into##4##2##(1996-4#1)(2007-12#2)(2008-2#1)
radiation is a##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)
radiation is also##2##3##(2007-12#1)(2008-3#1)
radiation is being##2##3##(1997-4#1)(2008-3#1)
radiation is coupled##2##3##(2007-12#1)(2008-2#1)
radiation is demonstrated##2##3##(2007-11#1)(2007-12#1)
radiation is generated by a##2##5##(2007-11#1)(2008-3#1)
radiation is generated by##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
radiation is generated##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
radiation is produced##2##3##(2007-12#1)(2008-2#1)
radiation is the##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
radiation is##47##2##(1997-4#1)(2007-11#3)(2007-12#11)(2008-10#1)(2008-2#12)(2008-3#6)(2008-5#2)(2008-7#6)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-8#1)
radiation level##2##2##(2013-1#2)
radiation linear dichroism##2##3##(2010-5#2)
radiation loss##3##2##(2008-3#3)
radiation may##4##2##(1994-8#1)(2008-7#2)(2013-1#1)
radiation measurements##2##2##(2008-2#1)(2008-3#1)
radiation near##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
radiation of a##3##3##(2007-12#1)(2008-2#2)
radiation of the##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
radiation of##15##2##(1995-3#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2010-3#1)
radiation on the##7##3##(2008-3#3)(2011-2#1)(2013-1#2)(2013-7#1)
radiation on##20##2##(1993-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
radiation oncologists and##2##3##(2008-10#1)(2013-1#1)
radiation oncologists##4##2##(2008-10#2)(2009-2#1)(2013-1#1)
radiation oncology##10##2##(1994-3#3)(1996-2#1)(2007-4#5)(2008-10#1)
radiation or##7##2##(1995-8#1)(2008-10#1)(2008-7#3)(2008-9#1)(2012-2#1)
radiation pattern of##2##3##(2007-12#2)
radiation pattern##3##2##(2007-12#3)
radiation plays a major role##2##5##(2008-10#1)(2010-4#1)
radiation pollution##2##2##(2010-4#2)
radiation power##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
radiation pressure noise##2##3##(2007-12#2)
radiation pressure##10##2##(2007-12#7)(2008-2#2)(2008-3#1)
radiation propagating##2##2##(2008-2#1)(2008-3#1)
radiation protection policy##2##3##(1996-6#1)(2013-1#1)
radiation protection standards##2##3##(1994-12#1)(2008-7#1)
radiation protection##21##2##(1993-12#1)(1994-12#1)(1995-1#1)(1996-6#3)(2008-12#2)(2008-7#5)(2012-2#4)(2013-1#2)(2013-8#2)
radiation protection]##2##2##(1996-6#1)(2013-1#1)
radiation received##2##2##(2007-10#1)(2008-5#1)
radiation risk from##2##3##(2008-7#2)
radiation risk##7##2##(1997-8#1)(2008-7#6)
radiation safety##6##2##(1994-12#2)(1995-1#1)(2007-4#1)(2013-1#2)
radiation sensitivity of##5##3##(1994-8#1)(2008-5#1)(2008-9#3)
radiation sensitivity##8##2##(1994-8#1)(2008-5#1)(2008-9#5)(2013-1#1)
radiation sensitizer##3##2##(1991-3#1)(1995-8#1)(2007-11#1)
radiation source for extreme-ultraviolet lithography##2##5##(2008-3#2)
radiation source for##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
radiation source##15##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)
radiation sources have##2##3##(2008-10#1)(2008-7#1)
radiation sources##4##2##(2006-4#2)(2008-10#1)(2008-7#1)
radiation spectra##4##2##(2008-2#1)(2008-3#3)
radiation spectrum##3##2##(2008-2#1)(2008-3#2)
radiation such##2##2##(2008-3#2)
radiation temperature of##2##3##(2008-3#1)(2013-1#1)
radiation temperature##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
radiation than##2##2##(1991-5#1)(2008-11#1)
radiation that is tunable over##2##5##(2007-11#1)(2008-2#1)
radiation that is##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
radiation that##7##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#2)
radiation the##2##2##(2008-2#1)(2008-3#1)
radiation therapy (IMRT)##2##3##(2010-5#1)(2012-1#1)
radiation therapy and chemotherapy##2##4##(2013-8#2)
radiation therapy and##11##3##(1991-2#1)(1993-8#1)(1994-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)(2013-8#3)
radiation therapy for##11##3##(1991-2#2)(1993-8#1)(1994-12#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-8#2)
radiation therapy have been##2##4##(2007-5#1)(2008-9#1)
radiation therapy in##4##3##(1994-12#1)(1994-6#1)(1995-9#1)(2008-7#1)
radiation therapy is##4##3##(1990-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
radiation therapy of##6##3##(1990-12#1)(1992-12#1)(1994-8#1)(2008-7#2)(2011-2#1)
radiation therapy or##2##3##(2008-1#1)(2008-6#1)
radiation therapy with##2##3##(1995-9#1)(2008-6#1)
radiation therapy##95##2##(1990-12#2)(1990-2#1)(1991-2#5)(1992-12#2)(1993-2#1)(1993-8#5)(1993-9#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-8#2)(1995-9#3)(1997-3#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#13)(2008-7#16)(2008-9#1)(2009-11#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2013-8#6)
radiation therapy-induced##2##2##(2008-7#2)
radiation through a##2##3##(2007-11#1)(2008-2#1)
radiation through the##3##3##(2008-2#1)(2008-3#2)
radiation through##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
radiation to be##2##3##(2008-2#2)
radiation to the##6##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
radiation to##17##2##(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#1)(2011-2#3)(2012-1#1)
radiation toxicity##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
radiation transfer##2##2##(2008-2#1)(2008-3#1)
radiation transport##4##2##(1994-3#2)(2008-2#1)(2008-3#1)
radiation treatment for##3##3##(1992-6#1)(1992-7#1)(2008-7#1)
radiation treatment planning##3##3##(1995-8#1)(2009-11#1)(2010-5#1)
radiation treatment##11##2##(1992-6#1)(1992-7#1)(1995-8#1)(2008-6#1)(2008-7#3)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
radiation used##2##2##(2008-3#1)(2008-7#1)
radiation using##2##2##(2008-10#1)(2010-1#1)
radiation was obtained##2##3##(2007-11#1)(2008-2#1)
radiation was significantly##2##3##(2008-9#1)(2010-1#1)
radiation was##14##2##(1991-5#1)(1992-9#1)(1993-2#1)(2007-11#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)
radiation were performed##2##3##(1997-8#1)(2008-3#1)
radiation were##5##2##(1997-8#1)(2008-2#2)(2008-3#1)(2013-1#1)
radiation with a##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
radiation with respect to the##2##5##(2008-3#1)(2013-1#1)
radiation with the##2##3##(2007-12#1)(2008-2#1)
radiation with wall plug efficiency of 0##2##7##(2007-12#2)
radiation with##16##2##(2007-11#2)(2007-12#4)(2007-4#1)(2008-2#2)(2008-3#2)(2008-7#2)(2010-3#1)(2011-1#1)(2013-1#1)
radiation within##2##2##(2008-2#1)(2008-3#1)
radiation without##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
radiation##1181##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-5#2)(1990-7#2)(1990-9#2)(1991-12#2)(1991-2#6)(1991-3#1)(1991-5#4)(1991-6#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#2)(1993-8#6)(1993-9#6)(1994-12#11)(1994-2#2)(1994-3#11)(1994-6#1)(1994-8#8)(1995-1#2)(1995-10#1)(1995-12#3)(1995-3#1)(1995-6#5)(1995-8#10)(1995-9#4)(1996-11#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#20)(1996-8#1)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#7)(2006-12#1)(2006-4#6)(2007-10#1)(2007-11#66)(2007-12#93)(2007-4#8)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#77)(2008-11#23)(2008-12#11)(2008-2#116)(2008-3#141)(2008-4#2)(2008-5#31)(2008-6#21)(2008-7#176)(2008-8#10)(2008-9#18)(2009-10#4)(2009-11#8)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#7)(2010-3#9)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#8)(2011-2#37)(2012-1#7)(2012-12#4)(2012-2#24)(2012-3#2)(2013-1#48)(2013-7#5)(2013-8#19)
radiation) or##2##2##(2008-7#1)(2013-1#1)
radiation)##5##1##(2008-10#1)(2008-3#1)(2008-7#2)(2013-1#1)
radiation-induced CAS##2##2##(2011-2#2)
radiation-induced DNA damage##3##3##(2008-11#1)(2008-7#2)
radiation-induced DNA##4##2##(1997-4#1)(2008-11#1)(2008-7#2)
radiation-induced DSBs##2##2##(2011-2#1)(2013-1#1)
radiation-induced cancer##2##2##(2008-7#2)
radiation-induced cell death##2##3##(1995-12#2)
radiation-induced heritable##2##2##(2008-7#2)
radiation-induced mutations##2##2##(2008-7#2)
radiation-induced thymic##2##2##(1995-11#1)(2008-7#1)
radiation-induced##53##1##(1990-10#1)(1991-3#1)(1992-12#1)(1992-9#2)(1993-5#1)(1994-8#3)(1995-11#1)(1995-12#3)(1996-10#1)(1997-4#1)(2006-10#1)(2007-4#1)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#3)(2008-7#20)(2011-2#4)(2013-1#1)(2013-8#1)
radiations are##5##2##(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#2)
radiations##19##1##(1991-2#2)(1996-4#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#1)(2013-1#1)
radiative characteristics of##2##3##(2008-2#2)
radiative characteristics##4##2##(2007-11#1)(2008-2#3)
radiative cooling##2##2##(2008-10#1)(2008-2#1)
radiative forcing by use of##2##5##(2008-2#2)
radiative forcing##6##2##(2008-2#5)(2013-8#1)
radiative perturbation theory to##2##4##(2008-2#2)
radiative perturbation theory##3##3##(2008-2#3)
radiative properties of a##2##4##(2008-2#2)
radiative properties of##6##3##(2008-2#5)(2008-3#1)
radiative properties##7##2##(2008-2#5)(2008-3#2)
radiative recombination##2##2##(2007-11#2)
radiative transfer calculations##4##3##(2008-2#2)(2008-3#2)
radiative transfer code for##2##4##(2008-3#2)
radiative transfer code##5##3##(2008-2#2)(2008-3#3)
radiative transfer equation for##3##4##(2008-2#1)(2008-3#2)
radiative transfer equation##17##3##(2007-12#2)(2008-2#10)(2008-3#5)
radiative transfer from a##3##4##(2007-12#3)
radiative transfer in a##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
radiative transfer in the##2##4##(2008-2#1)(2008-3#1)
radiative transfer in##8##3##(2008-10#1)(2008-2#4)(2008-3#3)
radiative transfer model and##2##4##(2008-2#1)(2008-3#1)
radiative transfer model is##2##4##(2008-3#2)
radiative transfer model that is##2##5##(2008-2#1)(2008-3#1)
radiative transfer model##17##3##(2008-2#6)(2008-3#11)
radiative transfer models##3##3##(2008-2#1)(2008-3#2)
radiative transfer problem##2##3##(2008-3#2)
radiative transfer simulations##2##3##(2008-3#2)
radiative transfer theory and##2##4##(2008-2#1)(2008-3#1)
radiative transfer theory##7##3##(2008-2#2)(2008-3#5)
radiative transfer##85##2##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#30)(2008-3#47)
radiative transport##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
radiative##125##1##(1992-3#1)(1996-7#2)(2007-11#6)(2007-12#7)(2008-10#3)(2008-2#50)(2008-3#55)(2013-8#1)
radiative-transfer model##4##2##(2008-2#2)(2008-3#2)
radiative-transfer##7##1##(2008-2#4)(2008-3#3)
radiatively##4##1##(2008-11#1)(2008-2#2)(2008-3#1)
radiator##2##1##(2008-10#1)(2008-3#1)
radiators##2##1##(2007-12#1)(2008-3#1)
radiatum##4##1##(1994-2#1)(1995-12#1)(1996-12#1)(2008-7#1)
radical Hz##3##2##(2008-3#3)
radical and its##3##3##(1994-11#1)(1996-5#1)(2008-10#1)
radical and superoxide##2##3##(1990-5#1)(2008-10#1)
radical and the##2##3##(1990-5#1)(1993-11#1)
radical and##17##2##(1990-5#3)(1993-11#2)(1994-11#2)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-7#2)(2009-5#1)
radical anion##4##2##(2008-10#2)(2008-5#2)
radical aromatic substitution##2##3##(2009-5#2)
radical attack##2##2##(2008-10#1)(2008-5#1)
radical by##3##2##(1993-3#1)(2008-10#1)(2008-2#1)
radical cation##3##2##(1992-6#1)(2008-10#1)(2010-12#1)
radical cations##6##2##(2008-9#5)(2010-12#1)
radical chain reaction##2##3##(2008-10#2)
radical change in the##2##4##(1993-6#1)(1995-1#1)
radical change##4##2##(1993-6#1)(1995-1#1)(1995-8#1)(1996-12#1)
radical clearance##2##2##(1997-4#2)
radical concentration in##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
radical concentration##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
radical cyclization##4##2##(1996-5#2)(2007-11#1)(2009-10#1)
radical cyclizations##2##2##(2008-9#1)(2009-5#1)
radical cystectomy##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
radical debridement##2##2##(2008-9#1)(2011-2#1)
radical formation##6##2##(1995-3#1)(1995-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
radical from##2##2##(1996-5#1)(2008-10#1)
radical generating azo compound##3##4##(1995-6#3)
radical generating system##2##3##(1992-12#1)(2008-5#1)
radical generating##6##2##(1992-12#1)(1994-6#1)(1995-6#3)(2008-5#1)
radical generation by##2##3##(1990-12#1)(1991-12#1)
radical generation##10##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-11#2)(1996-2#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-9#1)
radical hysterectomy##4##2##(1994-2#4)
radical in##6##2##(1994-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#2)
radical initiator##2##2##(1995-6#1)(2008-5#1)
radical intermediates##2##2##(1992-11#1)(1997-7#1)
radical is a##2##3##(1993-11#1)(2008-4#1)
radical is##11##2##(1990-5#1)(1993-11#3)(1993-3#2)(2008-10#3)(2008-2#1)(2008-4#1)
radical lymphadenectomy##2##2##(2008-10#1)(2013-1#1)
radical mastectomy and##2##3##(1990-12#1)(1992-12#1)
radical mastectomy for##2##3##(1994-12#1)(1994-7#1)
radical mastectomy was performed##2##4##(2008-10#2)
radical mastectomy##10##2##(1990-12#1)(1992-12#2)(1994-12#2)(1994-7#2)(1995-4#1)(2008-10#2)
radical nephrectomy and thrombectomy of the IVC##2##7##(2011-2#2)
radical nephrectomy and##3##3##(2008-1#1)(2011-2#2)
radical nephrectomy##4##2##(2008-1#1)(2011-2#2)(2012-2#1)
radical of##3##2##(1990-2#1)(1995-2#1)(2008-8#1)
radical operation##7##2##(1990-3#2)(1990-9#2)(1993-11#1)(2007-8#1)(2008-12#1)
radical operations for##2##3##(1990-9#2)
radical operations##3##2##(1990-9#2)(2012-3#1)
radical oxygen species##2##3##(2011-2#2)
radical polymerization of##3##3##(2008-12#1)(2008-3#1)(2009-10#1)
radical polymerization##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)
radical production##6##2##(1990-12#1)(1991-9#1)(1995-12#1)(2008-5#2)(2013-8#1)
radical prostatectomies##2##2##(2008-10#1)(2010-11#1)
radical prostatectomy and##3##3##(2009-2#1)(2009-5#1)(2011-2#1)
radical prostatectomy in##2##3##(2010-10#1)(2011-2#1)
radical prostatectomy##14##2##(1990-9#1)(1995-11#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
radical reaction##6##2##(1996-2#4)(2007-11#1)(2010-4#1)
radical resection and##2##3##(2007-11#1)(2009-12#1)
radical resection of##2##3##(2007-11#2)
radical resection##6##2##(1990-2#1)(2007-11#3)(2007-8#1)(2009-12#1)
radical retropubic##2##2##(1996-9#1)(2008-1#1)
radical scavenger##24##2##(1991-9#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-8#3)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#2)
radical scavengers and antioxidants##2##4##(2008-11#1)(2008-5#1)
radical scavengers and##3##3##(2008-11#2)(2008-5#1)
radical scavengers##20##2##(1991-9#3)(1994-6#1)(1995-2#2)(1995-6#2)(1996-2#2)(2008-11#2)(2008-5#6)(2011-2#2)
radical scavenging activities of the##2##5##(2008-12#1)(2008-5#1)
radical scavenging activities##4##3##(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
radical scavenging activity##8##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2009-6#1)
radical scavenging and##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
radical scavenging capacity##2##3##(1996-2#1)(2012-2#1)
radical scavenging effect##2##3##(2008-11#2)
radical scavenging##31##2##(1996-2#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-5#6)(2008-7#3)(2009-3#1)(2009-6#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
radical surgery as##2##3##(1990-9#1)(2011-2#1)
radical surgery for##2##3##(2013-1#2)
radical surgery with##2##3##(2010-11#1)(2012-2#1)
radical surgery##25##2##(1990-6#2)(1990-9#4)(1992-10#2)(1992-6#1)(1992-8#1)(1993-9#1)(1994-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-11#2)(2011-2#2)(2012-2#2)(2013-1#2)
radical surgical resection##2##3##(1994-6#1)(2008-7#1)
radical surgical treatment of##2##4##(1990-6#1)(2011-2#1)
radical surgical treatment##3##3##(1990-6#1)(2011-2#2)
radical surgical##11##2##(1990-6#2)(1991-11#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
radical to##5##2##(1995-2#2)(2008-10#1)(2008-4#1)(2010-7#1)
radical treatment of##2##3##(1992-8#1)(2008-10#1)
radical with##4##2##(1993-11#1)(1993-3#1)(2008-9#2)
radical##473##1##(1990-12#5)(1990-2#2)(1990-3#5)(1990-5#7)(1990-6#6)(1990-9#9)(1991-11#1)(1991-12#1)(1991-3#2)(1991-9#9)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#11)(1993-3#6)(1993-6#2)(1993-9#1)(1994-11#6)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#10)(1994-7#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#7)(1995-8#5)(1996-12#1)(1996-2#14)(1996-5#15)(1996-9#3)(1997-1#1)(1997-4#4)(1997-7#2)(1997-8#2)(2007-10#2)(2007-11#13)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#63)(2008-11#19)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#29)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#12)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#12)(2010-7#3)(2011-1#9)(2011-2#16)(2011-3#1)(2012-12#1)(2012-2#10)(2012-3#3)(2013-1#7)(2013-8#7)
radical)##2##1##(1994-5#1)(2008-10#1)
radical-induced##2##1##(1990-5#1)(1992-9#1)
radical-mediated##3##1##(1991-9#1)(2008-4#1)(2012-2#1)
radical-scavenging##5##1##(1992-5#1)(1995-6#1)(2008-10#2)(2008-12#1)
radical?(I)##2##1##(2007-12#2)
radicalHz and##2##2##(2008-3#2)
radicalHz##8##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
radicale##2##1##(2011-2#2)
radicality##3##1##(2008-10#1)(2008-6#1)(2010-12#1)
radically altered##2##2##(1994-12#1)(2007-11#1)
radically##12##1##(1994-1#1)(1994-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-9#1)
radicals and the##3##3##(1995-6#1)(2007-11#1)(2012-2#1)
radicals and##25##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-9#1)(2007-11#1)(2008-10#4)(2008-5#4)(2009-6#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
radicals are capable of##2##4##(1994-11#1)(1996-2#1)
radicals are the##2##3##(2008-10#1)(2010-10#1)
radicals are##12##2##(1994-11#1)(1995-5#1)(1996-2#1)(1997-4#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#2)
radicals by##6##2##(1990-12#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
radicals for##2##2##(1990-5#1)(1996-12#1)
radicals generated by##4##3##(1990-12#1)(1993-3#1)(1994-11#1)(1997-8#1)
radicals generated from##2##3##(1995-8#1)(2008-10#1)
radicals generated##10##2##(1990-12#1)(1993-3#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-8#1)(2008-10#3)
radicals has been##2##3##(2008-8#1)(2009-5#1)
radicals in a##3##3##(1990-12#1)(2008-10#2)
radicals in the##2##3##(2008-10#1)(2008-5#1)
radicals in##14##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-9#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)
radicals is##3##2##(1993-3#1)(2007-11#1)(2008-3#1)
radicals of##2##2##(2008-10#1)(2010-4#1)
radicals play a##3##3##(1991-9#1)(1992-9#1)(1995-12#1)
radicals play an important role in the##2##7##(1995-8#1)(2011-2#1)
radicals play##5##2##(1991-9#1)(1992-9#1)(1995-12#1)(1995-8#1)(2011-2#1)
radicals produced##4##2##(1993-2#1)(1993-3#1)(1993-6#1)(1995-6#1)
radicals that##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-8#1)
radicals to##2##2##(1997-2#1)(2008-11#1)
radicals were##4##2##(1993-3#1)(2007-11#1)(2008-10#2)
radicals##209##1##(1990-12#4)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#4)(1991-9#9)(1992-11#1)(1992-12#2)(1992-9#8)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#5)(1993-6#5)(1993-8#1)(1994-11#7)(1994-6#2)(1995-12#5)(1995-3#2)(1995-5#4)(1995-6#5)(1995-8#5)(1996-12#1)(1996-2#9)(1996-5#2)(1996-9#4)(1997-2#1)(1997-4#1)(1997-8#3)(2007-11#11)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#37)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#10)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#4)
radicicola##2##1##(2008-10#2)
radicina and##3##2##(2008-10#3)
radicina##6##1##(2008-10#6)
radicis-cucumerinum##5##1##(2008-10#5)
radicis-lycopersici and##3##2##(2008-10#3)
radicis-lycopersici##18##1##(2008-10#18)
radicle##2##1##(2008-9#2)
radicles##2##1##(2008-10#2)
radicular artery##2##2##(2008-7#1)(2012-1#1)
radicular pain##4##2##(2007-11#1)(2011-2#1)(2012-2#2)
radicular symptoms##3##2##(2007-11#1)(2008-7#2)
radicular##13##1##(1991-11#1)(1997-3#1)(2007-11#2)(2008-7#3)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
radiculopathy and##3##2##(2008-7#2)(2012-3#1)
radiculopathy##23##1##(2007-11#4)(2007-8#2)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-3#4)(2013-8#1)
radii and##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
radii as small as##2##4##(2008-3#2)
radii of curvature##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
radii of the##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
radii of##7##2##(1992-3#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#2)
radii##27##1##(1992-3#1)(1996-2#1)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#6)(2009-12#3)(2011-2#4)
radio and television##2##3##(2009-4#1)(2010-8#1)
radio and##6##2##(1992-3#1)(1996-5#1)(2009-3#1)(2009-4#1)(2010-8#1)(2013-1#1)
radio frequency identification (RFID)##2##4##(2008-7#2)
radio frequency##5##2##(2008-3#1)(2008-7#2)(2008-9#1)(2010-7#1)
radio to##2##2##(1995-2#1)(2009-3#1)
radio##38##1##(1990-11#1)(1992-3#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-3#4)(2009-4#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#1)(2013-1#3)
radio-HPLC##2##1##(1991-5#1)(2013-1#1)
radio-cephalic##3##1##(2007-7#3)
radio-frequency ablation##2##2##(1995-11#1)(2011-2#1)
radio-frequency##10##1##(1992-3#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
radio-immunoassay##2##1##(1990-12#1)(2008-10#1)
radio-iodinated##2##1##(1991-12#2)
radio-isotope scanning##2##2##(2008-4#2)
radio-opaque##3##1##(2008-7#1)(2010-5#1)(2012-2#1)
radioactive band##2##2##(1991-5#1)(1992-8#1)
radioactive dynamic##2##2##(2008-10#2)
radioactive iodine##3##2##(2008-5#2)(2012-12#1)
radioactive materials##2##2##(1991-9#1)(2008-10#1)
radioactive or##2##2##(2008-10#1)(2008-4#1)
radioactive palmitic acid##2##3##(1992-8#1)(1993-11#1)
radioactive spot on##2##3##(1995-2#1)(2008-9#1)
radioactive tracer##3##2##(1990-2#1)(1993-8#1)(2008-7#1)
radioactive waste##4##2##(1990-3#1)(1991-3#1)(2008-10#2)
radioactive##64##1##(1990-11#2)(1990-2#3)(1990-3#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#3)(1993-11#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-5#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-10#13)(2008-4#7)(2008-5#2)(2008-7#1)(2008-9#4)(2010-3#1)(2012-12#1)(2013-1#3)
radioactively##4##1##(1993-11#1)(2008-4#3)
radioactivities##2##1##(1995-6#1)(2008-11#1)
radioactivity and the##3##3##(1992-2#1)(2008-2#2)
radioactivity and##6##2##(1990-12#1)(1991-3#1)(1992-2#1)(1993-11#1)(2008-2#2)
radioactivity from##4##2##(1994-6#1)(1994-8#1)(1995-8#1)(2008-11#1)
radioactivity in the##2##3##(1992-2#1)(2008-4#1)
radioactivity in##5##2##(1992-2#1)(1992-8#2)(2008-4#1)(2008-8#1)
radioactivity incorporated##2##2##(1994-5#1)(1996-2#1)
radioactivity into the##3##3##(1990-11#1)(1994-8#1)(2008-4#1)
radioactivity of the##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
radioactivity of##7##2##(1990-10#1)(1990-8#1)(1991-3#1)(1993-11#1)(2008-11#2)(2008-5#1)
radioactivity was##7##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1997-2#1)(2008-10#1)
radioactivity##63##1##(1990-10#1)(1990-11#1)(1990-12#6)(1990-8#2)(1991-12#2)(1991-3#2)(1992-2#2)(1992-3#2)(1992-8#3)(1993-11#5)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#7)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)
radiobacter strain K84##3##3##(2008-10#3)
radiobacter##7##1##(2008-10#7)
radiobiological basis##2##2##(1993-9#1)(2008-7#1)
radiobiological##9##1##(1993-9#1)(1994-3#1)(1995-9#2)(2007-4#2)(2008-7#2)(2011-2#1)
radiobiology##7##1##(2008-10#3)(2008-7#3)(2013-1#1)
radiocaesium is##2##2##(1992-3#1)(1993-8#1)
radiocaesium##7##1##(1992-3#5)(1993-8#2)
radiocarpal##3##1##(2008-10#1)(2008-9#2)
radiochemical separation##2##2##(2008-10#2)
radiochemical##9##1##(1991-12#2)(1991-4#1)(1991-5#2)(2007-10#1)(2008-10#3)
radiochemotherapy in##2##2##(1993-3#1)(2013-1#1)
radiochemotherapy##3##1##(1993-3#1)(2013-1#2)
radioembolization##4##1##(2013-1#4)
radiofluorography##2##1##(2008-7#2)
radiofrequency (RF) ablation##3##3##(2007-8#1)(2010-12#1)(2010-6#1)
radiofrequency (RF)##4##2##(2007-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
radiofrequency ablation of##5##3##(2007-8#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-8#1)
radiofrequency ablation##13##2##(2007-8#3)(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
radiofrequency catheter##3##2##(2007-8#1)(2008-5#1)(2013-1#1)
radiofrequency device##4##2##(2011-1#2)(2013-1#2)
radiofrequency maze##2##2##(2007-8#2)
radiofrequency##44##1##(1990-2#1)(1992-11#1)(1994-3#1)(2007-8#9)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#2)(2009-5#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
radiogram##4##1##(2007-11#2)(2007-8#1)(2008-10#1)
radiograms of##3##2##(2007-11#1)(2007-8#2)
radiograms##12##1##(2007-11#3)(2007-8#9)
radiograph and##5##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
radiograph revealed##2##2##(2010-2#1)(2012-3#1)
radiograph was##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
radiograph##27##1##(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-7#1)
radiographed##3##1##(1997-8#1)(2009-4#1)(2011-2#1)
radiographers in##2##2##(1992-1#1)(1996-1#1)
radiographers##6##1##(1991-2#1)(1992-1#1)(1995-2#1)(1996-1#2)(2008-10#1)
radiographers' organizational commitment##2##3##(1996-1#2)
radiographic ASD##2##2##(2012-12#2)
radiographic abnormalities of##2##3##(2007-11#1)(2011-2#1)
radiographic abnormalities##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
radiographic and clinical##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
radiographic and endoscopic##2##3##(1991-11#1)(2008-5#1)
radiographic and##10##2##(1991-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
radiographic changes##2##2##(1991-12#1)(2007-11#1)
radiographic evaluation##4##2##(2007-11#1)(2008-2#1)(2008-6#1)(2008-9#1)
radiographic examination##4##2##(1997-4#1)(2007-11#1)(2008-9#1)(2011-2#1)
radiographic features and##2##3##(2008-4#1)(2010-12#1)
radiographic features##6##2##(1993-12#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-12#1)
radiographic findings were##2##3##(2009-1#1)(2013-8#1)
radiographic findings##8##2##(2007-7#1)(2008-6#1)(2009-1#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
radiographic follow-up##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
radiographic imaging##6##2##(2007-11#1)(2008-12#2)(2010-12#1)(2011-1#1)(2012-2#1)
radiographic interpretation##2##2##(2012-12#1)(2013-1#1)
radiographic measurements##3##2##(2008-12#2)(2009-10#1)
radiographic outcomes##5##2##(2011-2#1)(2013-1#4)
radiographic results##2##2##(2009-3#1)(2013-1#1)
radiographic signs of##2##3##(2006-10#1)(2007-11#1)
radiographic studies##4##2##(1997-8#1)(2007-12#1)(2012-2#2)
radiographic technique##2##2##(2008-12#1)(2009-4#1)
radiographic##105##1##(1991-11#1)(1991-12#3)(1992-2#1)(1993-12#1)(1997-4#1)(1997-8#1)(2006-10#3)(2007-11#9)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#3)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#8)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#12)(2013-8#2)
radiographically##7##1##(1990-12#1)(1997-4#2)(1997-8#1)(2008-12#2)(2009-10#1)
radiographs (DRRs)##2##2##(2009-11#1)(2009-2#1)
radiographs and CT scan##2##4##(2008-12#1)(2013-1#1)
radiographs and##9##2##(2008-12#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
radiographs are##2##2##(2008-12#1)(2008-3#1)
radiographs for##2##2##(1991-12#1)(2008-12#1)
radiographs in##2##2##(2013-1#2)
radiographs of##4##2##(2007-8#1)(2008-12#1)(2008-9#1)(2009-4#1)
radiographs revealed##2##2##(2008-12#1)(2008-9#1)
radiographs showed##2##2##(1997-3#1)(2013-1#1)
radiographs were digitized##2##3##(2008-12#1)(2008-3#1)
radiographs were evaluated for##2##4##(2009-3#1)(2013-1#1)
radiographs were evaluated##4##3##(2007-8#1)(2008-8#1)(2009-3#1)(2013-1#1)
radiographs were##11##2##(2007-8#1)(2008-12#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#2)(2013-1#1)
radiographs##54##1##(1991-12#2)(1992-5#1)(1997-3#1)(2007-8#2)(2008-11#1)(2008-12#9)(2008-3#3)(2008-8#4)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#10)
radiography and computed##2##3##(2011-2#2)
radiography and fluoroscopy##2##3##(1993-12#1)(2008-9#1)
radiography and ultrasonography##2##3##(2007-11#1)(2012-3#1)
radiography and##10##2##(1993-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-9#2)(2011-2#2)(2012-3#1)
radiography in the##3##3##(1997-8#1)(2008-9#1)(2011-2#1)
radiography in##5##2##(1997-8#1)(2007-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
radiography is the##2##3##(2010-3#1)(2011-2#1)
radiography is##7##2##(1997-8#2)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
radiography of##4##2##(1997-8#1)(2009-1#2)(2013-1#1)
radiography were##2##2##(1990-3#1)(2007-11#1)
radiography with##2##2##(2011-1#1)(2012-2#1)
radiography##63##1##(1990-3#1)(1991-12#1)(1993-12#1)(1995-2#4)(1995-5#1)(1997-8#6)(2006-10#1)(2006-4#2)(2007-11#5)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#2)(2009-4#2)(2009-9#2)(2010-3#2)(2010-6#2)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
radioimmune##2##1##(2008-10#1)(2008-3#1)
radioimmunoassay (RIA)##10##2##(1990-11#1)(1990-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)
radioimmunoassay and##2##2##(1990-8#1)(1991-3#1)
radioimmunoassay for##2##2##(1992-12#1)(1996-2#1)
radioimmunoassay in##4##2##(1990-5#1)(1990-9#1)(1992-3#1)(1996-2#1)
radioimmunoassay was##2##2##(1995-12#1)(2008-5#1)
radioimmunoassay##33##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#3)(1997-3#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)
radioimmunoassayed##2##1##(1991-12#1)(1996-2#1)
radioimmunoassays##5##1##(1990-11#1)(1990-2#2)(1992-8#1)(2008-4#1)
radioimmunotherapy##2##1##(1995-9#1)(2007-10#1)
radioiodinated fatty acids##2##3##(1992-10#2)
radioiodinated##10##1##(1990-12#1)(1992-10#3)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-4#1)
radioiodination of purified##2##3##(2008-1#2)
radioiodination of##4##2##(2008-1#4)
radioiodination##5##1##(2008-1#5)
radioiodine##4##1##(1992-5#1)(2008-11#1)(2008-4#1)(2013-1#1)
radioisotope and##3##2##(1992-2#2)(2007-11#1)
radioisotope##11##1##(1990-11#1)(1990-12#1)(1992-2#3)(2007-11#3)(2008-10#2)(2010-9#1)
radioisotopes##10##1##(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#3)(2010-3#1)
radiolabel in##2##2##(1992-3#1)(1992-9#1)
radiolabel##15##1##(1990-2#4)(1991-12#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-6#1)(1996-2#1)(2008-11#2)(2008-7#1)
radiolabeled Affibody molecule##2##3##(2009-9#2)
radiolabeled DNA##2##2##(1996-3#1)(2008-4#1)
radiolabeled antigen##3##2##(1990-12#1)(2008-4#2)
radiolabeled proteins##2##2##(2008-4#2)
radiolabeled##59##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#4)(1994-8#1)(1995-11#1)(1995-3#1)(1996-3#3)(1997-1#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#12)(2008-8#2)(2009-12#1)(2009-9#3)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
radiolabeling method##2##2##(1992-2#1)(2008-4#1)
radiolabeling of##2##2##(1992-2#1)(2008-4#1)
radiolabeling##8##1##(1990-7#1)(1992-2#2)(2007-10#1)(2008-1#1)(2008-4#2)(2008-7#1)
radiolabelled annexin A5##2##3##(2008-8#2)
radiolabelled annexin##3##2##(2008-11#1)(2008-8#2)
radiolabelled##18##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#2)
radiolabelling##3##1##(1995-8#1)(2008-5#2)
radiolar appendages##2##2##(2011-2#2)
radiolar##5##1##(2011-2#5)
radioligand binding assays##3##3##(1994-2#1)(1994-6#1)(1995-12#1)
radioligand binding##13##2##(1991-6#2)(1992-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(2008-4#3)
radioligand was##2##2##(1994-8#2)
radioligand##25##1##(1990-11#1)(1991-6#2)(1992-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#5)(1995-11#3)(1995-12#3)(1996-5#1)(2008-4#3)
radioligands were##2##2##(1992-3#1)(1993-3#1)
radioligands##3##1##(1992-3#1)(1993-3#2)
radiologic and##5##2##(1992-1#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-8#1)
radiologic evaluation##3##2##(1994-6#1)(2007-11#1)(2012-3#1)
radiologic features##5##2##(1991-6#1)(2007-12#1)(2011-2#3)
radiologic findings##3##2##(2006-12#1)(2008-7#1)(2013-8#1)
radiologic technologists##6##2##(1993-12#1)(1994-1#2)(1995-1#1)(1996-2#1)(1996-3#1)
radiologic##49##1##(1990-10#1)(1991-6#1)(1992-1#2)(1993-12#1)(1994-1#3)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
radiological abnormalities##2##2##(1991-11#1)(2007-8#1)
radiological and clinical##2##3##(1991-11#1)(2007-8#1)
radiological and histological findings##2##4##(2009-3#1)(2010-5#1)
radiological and histological##3##3##(1991-11#1)(2009-3#1)(2010-5#1)
radiological and histopathological##3##3##(2007-12#1)(2007-7#1)(2010-11#1)
radiological and pathological##2##3##(2008-7#1)(2009-5#1)
radiological and##19##2##(1991-11#2)(1991-6#1)(1992-5#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2013-8#1)
radiological appearance of##3##3##(2008-1#1)(2012-12#1)(2012-3#1)
radiological appearance##4##2##(2008-1#1)(2010-11#1)(2012-12#1)(2012-3#1)
radiological changes##2##2##(2011-2#1)(2013-1#1)
radiological clearance##2##2##(2010-5#2)
radiological data##2##2##(2007-11#1)(2008-7#1)
radiological diagnosis##6##2##(2007-11#1)(2007-8#2)(2010-5#1)(2011-2#1)(2012-2#1)
radiological evaluation of the##2##4##(2007-8#1)(2012-3#1)
radiological evaluation of##4##3##(2007-11#1)(2007-8#2)(2012-3#1)
radiological evaluation##7##2##(2007-11#3)(2007-8#2)(2011-2#1)(2012-3#1)
radiological examination of##2##3##(1995-6#1)(1995-9#1)
radiological examination was##2##3##(1993-3#1)(2011-1#1)
radiological examination##14##2##(1991-3#1)(1993-3#1)(1995-6#1)(1995-9#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
radiological examinations##2##2##(1992-9#1)(2013-1#1)
radiological features of##5##3##(1992-12#1)(2008-7#1)(2011-2#1)(2012-2#2)
radiological features##11##2##(1992-12#1)(1992-4#1)(2008-7#3)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
radiological findings and the##2##4##(2008-8#1)(2013-1#1)
radiological findings and##4##3##(1997-3#1)(2008-8#1)(2012-3#1)(2013-1#1)
radiological findings is##2##3##(2009-5#1)(2012-2#1)
radiological findings were##2##3##(1991-3#1)(2012-2#1)
radiological findings##19##2##(1991-3#1)(1997-3#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
radiological follow-up##2##2##(1997-3#1)(2008-7#1)
radiological imaging##5##2##(2007-8#1)(2008-6#1)(2012-2#3)
radiological intervention##2##2##(1991-5#1)(2008-7#1)
radiological investigations##3##2##(1990-12#1)(1991-11#1)(2012-2#1)
radiological lesions##2##2##(1992-5#1)(2007-8#1)
radiological methods##5##2##(1990-5#1)(1995-8#1)(2007-10#1)(2007-11#1)(2012-2#1)
radiological or##2##2##(1990-3#1)(2008-1#1)
radiological parameters##3##2##(2010-3#1)(2011-2#2)
radiological physics and technology##3##4##(2010-9#3)
radiological picture##4##2##(2007-11#3)(2008-5#1)
radiological presentation##2##2##(1997-8#1)(2012-12#1)
radiological procedures##3##2##(2008-1#1)(2008-7#1)(2012-2#1)
radiological protection##2##2##(1996-6#1)(2009-12#1)
radiological report##2##2##(2012-2#1)(2013-8#1)
radiological signs of##3##3##(1991-9#1)(2006-7#1)(2011-2#1)
radiological signs##5##2##(1991-9#1)(1992-5#1)(1997-3#1)(2006-7#1)(2011-2#1)
radiological study##3##2##(1990-6#1)(1992-5#1)(2008-11#1)
radiological symptoms##2##2##(1991-11#1)(2007-11#1)
radiological techniques to##2##3##(2007-7#1)(2007-8#1)
radiological techniques##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
radiological temporal bone##2##3##(2008-9#2)
radiological##206##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#7)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-5#4)(1992-9#1)(1993-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#2)(2006-7#1)(2007-10#1)(2007-11#18)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#18)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#15)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-8#2)(2010-11#3)(2010-3#2)(2010-5#6)(2010-9#3)(2011-1#1)(2011-2#12)(2012-12#11)(2012-2#21)(2012-3#5)(2013-1#10)(2013-8#4)
radiologically and##3##2##(2007-12#1)(2008-11#1)(2010-3#1)
radiologically confirmed##3##2##(2007-8#1)(2008-7#1)(2008-8#1)
radiologically evident##2##2##(2008-6#1)(2008-7#1)
radiologically guided fine-needle aspiration biopsy##2##5##(2008-6#2)
radiologically##21##1##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#3)(2008-8#1)(2010-11#1)(2010-3#2)(2012-3#1)(2013-1#1)
radiologist and##4##2##(1991-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
radiologist to##4##2##(2011-2#1)(2012-2#3)
radiologist##25##1##(1991-3#1)(1993-3#2)(1995-3#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#7)(2013-1#3)
radiologist's##4##1##(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
radiologists and the##2##3##(2007-4#1)(2012-2#1)
radiologists and##10##2##(1990-10#1)(1992-1#1)(1993-1#1)(1995-3#1)(1996-3#1)(2007-4#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
radiologists are##2##2##(2007-4#1)(2012-2#1)
radiologists for##2##2##(1997-8#1)(2007-11#1)
radiologists was##2##2##(2007-8#1)(2012-2#1)
radiologists who##2##2##(2007-4#2)
radiologists##47##1##(1990-10#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#2)(1995-12#1)(1995-3#1)(1996-2#3)(1996-3#1)(1997-8#3)(2007-11#2)(2007-4#6)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#8)(2012-3#1)
radiology administrators##11##2##(1991-12#1)(1993-1#1)(1994-1#3)(1995-12#3)(1996-2#3)
radiology administrators' salaries and##2##4##(1991-2#1)(1991-3#1)
radiology and##8##2##(1990-5#1)(1991-12#1)(1993-9#1)(1995-3#2)(2009-4#1)(2009-9#1)(2013-1#1)
radiology as a##2##3##(2007-4#1)(2012-2#1)
radiology as##3##2##(2007-4#2)(2012-2#1)
radiology department has##2##3##(1993-12#1)(1996-1#1)
radiology department is##2##3##(1993-3#1)(1996-3#1)
radiology department##21##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#2)(1994-3#1)(1995-1#1)(1995-2#2)(1996-1#3)(1996-2#1)(1996-3#1)(1997-8#1)(2007-4#1)(2008-3#1)(2009-6#1)(2012-2#3)
radiology departments##19##2##(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(2007-4#8)(2012-2#2)
radiology equipment insurance program##2##4##(1993-12#2)
radiology equipment##3##2##(1993-12#2)(1996-3#1)
radiology film##2##2##(1996-3#1)(2008-10#1)
radiology groups and their##2##4##(2007-4#2)
radiology has##2##2##(2007-4#1)(2009-9#1)
radiology imaging##2##2##(1993-1#1)(2010-8#1)
radiology in the management of##2##5##(2008-1#1)(2009-9#1)
radiology in the##5##3##(2007-11#1)(2008-1#2)(2009-9#1)(2012-2#1)
radiology in##11##2##(1995-3#1)(2007-11#1)(2008-1#3)(2009-9#4)(2012-2#2)
radiology information system##6##3##(1991-1#1)(1992-12#2)(1994-2#1)(1996-3#1)(2007-4#1)
radiology information systems##2##3##(1993-1#1)(1994-2#1)
radiology information##9##2##(1991-1#1)(1992-12#2)(1992-2#1)(1993-1#1)(1994-2#2)(1996-3#1)(2007-4#1)
radiology is##3##2##(1997-8#1)(2008-1#1)(2011-2#1)
radiology management##2##2##(1992-12#1)(1993-2#1)
radiology managers can##2##3##(1991-12#1)(1993-2#1)
radiology managers must##2##3##(1993-2#1)(1995-1#1)
radiology managers##10##2##(1991-1#1)(1991-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)
radiology nurses##2##2##(1995-2#1)(1995-3#1)
radiology practice##4##2##(1995-1#1)(1996-1#1)(2009-9#2)
radiology practices to##2##3##(1993-3#2)
radiology practices##7##2##(1993-3#6)(2007-4#1)
radiology reports##4##2##(2012-2#4)
radiology service##2##2##(1993-1#1)(2012-2#1)
radiology services##3##2##(1991-12#1)(1993-1#1)(2012-2#1)
radiology staff##4##2##(1995-2#2)(1995-3#2)
radiology##215##1##(1990-5#1)(1991-1#6)(1991-12#8)(1991-2#3)(1991-3#1)(1992-1#2)(1992-12#6)(1992-2#2)(1992-3#3)(1993-1#7)(1993-12#5)(1993-2#6)(1993-3#14)(1993-9#1)(1994-1#8)(1994-12#4)(1994-2#4)(1994-3#1)(1995-1#7)(1995-12#3)(1995-2#9)(1995-3#10)(1996-1#6)(1996-2#12)(1996-3#6)(1997-8#4)(2007-11#1)(2007-4#25)(2008-1#6)(2008-10#1)(2008-3#1)(2009-4#2)(2009-6#2)(2009-9#8)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#24)(2013-1#1)(2013-8#1)
radiology?##2##1##(2007-4#1)(2010-12#1)
radiology]##2##1##(1995-2#1)(1997-2#1)
radiolucency##4##1##(1993-9#1)(2008-12#2)(2013-1#1)
radiolucent##6##1##(1993-9#1)(2007-11#1)(2008-12#1)(2010-5#2)(2013-1#1)
radiolytic##2##1##(1995-3#1)(2008-8#1)
radiometer for##4##2##(2008-3#4)
radiometer with##2##2##(2008-2#1)(2008-3#1)
radiometer##34##1##(1995-6#1)(2007-9#1)(2008-10#1)(2008-2#6)(2008-3#25)
radiometers##16##1##(2008-2#8)(2008-3#8)
radiometric accuracy##2##2##(2008-3#2)
radiometric analysis##2##2##(2007-11#1)(2008-3#1)
radiometric and##2##2##(2008-2#1)(2008-3#1)
radiometric calibration method##2##3##(2008-2#2)
radiometric calibration of the##3##4##(2008-2#2)(2008-3#1)
radiometric calibration that##2##3##(2008-3#2)
radiometric calibration##11##2##(2008-2#8)(2008-3#3)
radiometric measurements of##2##3##(2008-2#1)(2008-3#1)
radiometric measurements##5##2##(2008-2#2)(2008-3#3)
radiometric method##4##2##(2008-10#3)(2008-2#1)
radiometric sensitivity##3##2##(2008-3#3)
radiometric stability##3##2##(2008-2#1)(2008-3#2)
radiometric##46##1##(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#17)(2008-3#24)
radiometrically##2##1##(2008-2#1)(2008-3#1)
radiometry for##2##2##(2008-10#1)(2008-3#1)
radiometry##5##1##(2008-10#3)(2008-3#2)
radionecrosis of rectum##2##3##(2008-12#2)
radionecrosis##3##1##(1991-5#1)(2008-12#2)
radionuclide and##2##2##(2007-10#1)(2008-12#1)
radionuclide imaging##5##2##(2007-11#3)(2008-7#2)
radionuclide therapy##2##2##(2007-11#1)(2010-3#1)
radionuclide treatment##2##2##(2007-11#1)(2008-7#1)
radionuclide##22##1##(1991-2#1)(1993-9#1)(1994-1#1)(1996-5#1)(2007-10#1)(2007-11#5)(2008-12#1)(2008-7#6)(2010-3#1)(2011-1#2)(2011-2#1)(2013-1#1)
radionuclides##10##1##(1993-8#1)(1994-9#2)(1995-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)
radiopacifier##2##1##(2013-1#2)
radiopaque##4##1##(2008-12#1)(2012-2#1)(2013-1#2)
radiopharmaceutical##4##1##(1997-8#1)(2007-10#1)(2007-12#1)(2008-7#1)
radiopharmaceuticals for##3##2##(1994-5#1)(2010-6#1)(2012-12#1)
radiopharmaceuticals##8##1##(1994-5#1)(2010-6#1)(2012-12#3)(2013-1#3)
radioprotection was##2##2##(2008-10#2)
radioprotection##3##1##(2008-10#2)(2008-7#1)
radioprotective agent##5##2##(1994-5#2)(2011-2#3)
radioprotective##10##1##(1990-10#1)(1994-5#2)(2008-10#1)(2008-7#2)(2011-2#4)
radioprotectors##2##1##(2011-2#1)(2013-8#1)
radioresistant##2##1##(1993-9#1)(2013-1#1)
radiosensitive and##2##2##(1993-9#1)(2013-1#1)
radiosensitive##7##1##(1990-12#1)(1993-8#1)(1993-9#1)(1997-3#2)(2013-1#2)
radiosensitivity of##3##2##(2008-5#3)
radiosensitivity##6##1##(1993-9#1)(2008-5#3)(2008-9#1)(2013-1#1)
radiosensitization##4##1##(1995-8#1)(2008-6#1)(2010-3#1)(2011-2#1)
radiosensitizer in##2##2##(1991-2#1)(2013-1#1)
radiosensitizer##4##1##(1990-6#1)(1991-2#1)(2008-9#1)(2013-1#1)
radiosensitizing##2##1##(1997-2#1)(2008-6#1)
radiosonde measurements##2##2##(2008-3#2)
radiosonde sensor response##2##3##(2008-3#2)
radiosonde##4##1##(2008-3#4)
radiosondes##3##1##(2008-2#2)(2008-3#1)
radiosurgery after##2##2##(1996-3#2)
radiosurgery for##4##2##(1997-4#1)(2008-7#1)(2011-2#2)
radiosurgery on##2##2##(2008-7#1)(2011-2#1)
radiosurgery or##2##2##(2008-7#2)
radiosurgery##43##1##(1993-9#3)(1994-3#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-3#5)(1997-4#3)(2008-7#18)(2010-9#1)(2011-2#9)
radiosurgical treatment##2##2##(1996-3#2)
radiosurgical##3##1##(1996-3#3)
radiotelemetry##2##1##(2008-8#1)(2009-4#1)
radiotherapeutic treatment##2##2##(1991-2#1)(2008-6#1)
radiotherapeutic##5##1##(1991-2#1)(1993-9#3)(2008-6#1)
radiotherapists##2##1##(2008-10#1)(2008-6#1)
radiotherapy (IMRT)##3##2##(2008-2#2)(2011-2#1)
radiotherapy (RT)##4##2##(1995-5#1)(2007-10#1)(2010-3#1)(2013-1#1)
radiotherapy after##2##2##(2008-10#1)(2008-6#1)
radiotherapy alone or##4##3##(2007-11#2)(2008-6#1)(2012-3#1)
radiotherapy alone##8##2##(1990-6#2)(1995-9#1)(2007-11#2)(2008-6#1)(2011-3#1)(2012-3#1)
radiotherapy and chemotherapy in the treatment of##2##7##(1993-9#1)(2013-1#1)
radiotherapy and chemotherapy##11##3##(1990-8#1)(1993-9#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
radiotherapy and concomitant##2##3##(2008-6#2)
radiotherapy and systemic##2##3##(1991-8#1)(2007-11#1)
radiotherapy and the##3##3##(1995-8#1)(2008-7#2)
radiotherapy and##37##2##(1990-6#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-7#1)(2007-11#3)(2008-11#1)(2008-12#2)(2008-6#6)(2008-7#4)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
radiotherapy and/or chemotherapy##3##3##(1990-5#1)(1992-12#1)(2012-3#1)
radiotherapy are##4##2##(1990-2#1)(1990-6#1)(2010-8#1)(2013-1#1)
radiotherapy as##2##2##(1991-9#1)(1996-6#1)
radiotherapy by##4##2##(2008-6#2)(2008-7#1)(2012-12#1)
radiotherapy can##2##2##(1991-4#1)(1992-3#1)
radiotherapy combined with##2##3##(2008-6#1)(2010-8#1)
radiotherapy compared##2##2##(1996-9#1)(2013-8#1)
radiotherapy dose##4##2##(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
radiotherapy for bone metastases##2##4##(2007-11#1)(2008-10#1)
radiotherapy for breast##2##3##(2007-10#1)(2011-3#1)
radiotherapy for prevention of##2##4##(1994-8#1)(2007-11#1)
radiotherapy for the##2##3##(1996-9#1)(1997-3#1)
radiotherapy for##24##2##(1992-10#1)(1992-12#1)(1992-3#1)(1994-8#1)(1995-9#3)(1996-9#1)(1997-3#2)(2007-10#1)(2007-11#3)(2008-10#1)(2008-6#2)(2009-3#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#3)
radiotherapy had##3##2##(1990-6#1)(1996-9#1)(2008-11#1)
radiotherapy in the management of##4##5##(1991-4#1)(1993-9#1)(1995-9#1)(2007-10#1)
radiotherapy in the treatment of##4##5##(1990-6#1)(1994-8#1)(1995-9#1)(2011-2#1)
radiotherapy in the##10##3##(1990-6#1)(1991-4#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-9#2)(2007-10#1)(2011-2#1)
radiotherapy in##31##2##(1990-10#2)(1990-6#2)(1991-4#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-8#4)(1995-9#3)(1997-3#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#2)(2009-11#1)(2010-3#1)(2011-2#3)(2013-1#1)
radiotherapy is effective##2##3##(2007-11#1)(2013-1#1)
radiotherapy is##7##2##(1990-12#1)(1991-12#1)(2007-11#1)(2008-2#1)(2009-1#1)(2013-1#1)(2013-8#1)
radiotherapy of head and neck cancer##2##6##(1992-10#1)(2008-5#1)
radiotherapy of head and neck##3##5##(1992-10#2)(2008-5#1)
radiotherapy of prostate##2##3##(2012-12#2)
radiotherapy of the pelvis##2##4##(1992-12#2)
radiotherapy of the##3##3##(1992-12#2)(2013-1#1)
radiotherapy of##19##2##(1990-10#2)(1992-10#2)(1992-12#2)(1995-8#1)(1995-9#1)(2007-11#1)(2008-5#1)(2008-7#4)(2009-11#1)(2012-12#3)(2013-1#1)
radiotherapy only##2##2##(2008-6#2)
radiotherapy or##4##2##(1993-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
radiotherapy physicists##2##2##(2007-4#2)
radiotherapy planning##7##2##(2008-2#4)(2008-6#1)(2008-7#1)(2009-5#1)
radiotherapy plus##3##2##(1991-2#1)(2011-2#1)(2013-8#1)
radiotherapy seems to##2##3##(1992-12#1)(2007-10#1)
radiotherapy should be##2##3##(1997-3#1)(2007-8#1)
radiotherapy to the##4##3##(2007-11#1)(2007-6#1)(2008-6#2)
radiotherapy to##7##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-6#3)
radiotherapy treatment for##2##3##(2008-11#1)(2008-7#1)
radiotherapy treatment##5##2##(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2013-1#1)
radiotherapy was given##2##3##(1991-8#1)(2007-5#1)
radiotherapy was##8##2##(1990-6#1)(1991-4#1)(1991-8#1)(1992-8#1)(2007-5#1)(2008-10#1)(2008-6#1)(2012-2#1)
radiotherapy were##4##2##(1990-12#2)(1992-8#1)(2010-3#1)
radiotherapy with##5##2##(1990-12#1)(2009-11#2)(2011-2#1)(2013-1#1)
radiotherapy##353##1##(1990-10#4)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#9)(1990-8#3)(1991-12#1)(1991-2#2)(1991-4#7)(1991-5#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#4)(1992-12#10)(1992-3#4)(1992-8#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#4)(1993-9#6)(1994-2#1)(1994-3#3)(1994-8#6)(1995-11#1)(1995-5#1)(1995-8#3)(1995-9#13)(1996-11#1)(1996-6#1)(1996-9#5)(1997-3#4)(1997-4#1)(1997-5#3)(1997-7#1)(2007-10#7)(2007-11#15)(2007-4#5)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#5)(2008-10#13)(2008-11#8)(2008-12#3)(2008-2#17)(2008-3#2)(2008-5#2)(2008-6#32)(2008-7#20)(2008-8#2)(2009-1#1)(2009-11#7)(2009-2#2)(2009-3#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#10)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#16)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#7)(2013-1#20)(2013-7#1)(2013-8#3)
radiotoxicity##4##1##(1991-12#4)
radiotracer##2##1##(1996-5#1)(2008-10#1)
radiotracers##12##1##(2007-11#1)(2008-10#3)(2010-6#5)(2010-9#2)(2013-1#1)
radioulnar ligaments##3##2##(2008-9#3)
radioulnar##5##1##(2008-9#4)(2011-2#1)
radish (Raphanus sativus)##2##3##(2008-10#2)
radish (Raphanus##3##2##(2008-10#2)(2008-8#1)
radish and##2##2##(2008-10#2)
radish##31##1##(2008-10#27)(2008-12#2)(2008-5#1)(2008-8#1)
radius and the##6##3##(1995-6#2)(2008-2#1)(2008-3#3)
radius and ulna##3##3##(1995-6#1)(2010-3#1)(2012-1#1)
radius and##16##2##(1993-8#1)(1995-6#3)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-1#1)
radius deformity##2##2##(2008-9#2)
radius for##2##2##(1991-4#1)(2007-11#1)
radius fractures##10##2##(2008-9#9)(2011-2#1)
radius has##2##2##(1991-11#1)(1995-6#1)
radius in a##2##3##(2008-3#1)(2010-11#1)
radius in the##2##3##(1991-11#1)(2008-2#1)
radius in##5##2##(1991-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
radius is##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2013-8#1)
radius of 0##2##3##(2007-12#1)(2008-3#1)
radius of curvature of the##3##5##(2008-3#3)
radius of curvature of##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
radius of curvature##13##3##(1990-12#1)(1992-3#1)(2007-11#1)(2008-2#2)(2008-3#7)(2008-9#1)
radius of gyration##4##3##(2008-2#2)(2008-3#2)
radius of the##12##3##(1990-7#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-5#1)
radius of##47##2##(1990-11#1)(1990-12#1)(1990-7#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#9)(2008-3#15)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)
radius on##2##2##(2008-10#1)(2008-3#1)
radius with##2##2##(2008-2#1)(2008-3#1)
radius##159##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#2)(1991-4#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#4)(1997-7#1)(2007-11#11)(2007-12#4)(2008-10#13)(2008-2#27)(2008-3#44)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#20)(2009-3#3)(2009-5#2)(2010-11#2)(2010-3#1)(2010-4#3)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
radius)##6##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)
radix and##2##2##(2010-8#1)(2011-1#1)
radix##17##1##(2008-10#2)(2010-8#1)(2011-1#7)(2011-2#1)(2012-3#5)(2013-8#1)
radon exposure##2##2##(2008-7#2)
radon in##2##2##(1995-2#1)(2013-1#1)
radon levels and##2##3##(2008-7#2)
radon##22##1##(1991-3#1)(1995-2#1)(1996-4#3)(1996-6#1)(2008-11#1)(2008-7#14)(2013-1#1)
radula##3##1##(1990-2#1)(1994-8#1)(2011-2#1)
raf##2##1##(1994-6#2)
raffinose##5##1##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
raft cultures of##3##3##(2008-4#3)
raft cultures##4##2##(2008-4#4)
raft mussels##4##2##(2010-5#4)
raft##10##1##(2008-4#5)(2009-7#1)(2010-5#4)
rafts##12##1##(2008-11#5)(2008-4#3)(2008-7#3)(2011-2#1)
rage##2##1##(1996-3#1)(2008-10#1)
ragged##2##1##(1994-11#1)(2008-10#1)
rai (Brassica juncea)##2##3##(2011-1#2)
rail##7##1##(2007-8#1)(2008-2#1)(2008-3#1)(2009-10#4)
railroad workers##3##2##(1991-12#3)
railroad##6##1##(1991-12#3)(2008-2#1)(2012-12#2)
railroads##5##1##(1991-12#5)
rain and##4##2##(2008-10#3)(2013-8#1)
rain but##2##2##(2008-10#2)
rain episodes##3##2##(2008-10#3)
rain event##2##2##(2008-10#2)
rain events##7##2##(2008-10#7)
rain forest##6##2##(2008-5#4)(2008-9#1)(2010-3#1)
rain forests##2##2##(2008-5#1)(2008-8#1)
rain intensity and##3##3##(2008-10#3)
rain intensity##8##2##(2008-10#8)
rain or##3##2##(2008-10#3)
rain shields##2##2##(2008-10#2)
rain simulation##2##2##(2008-10#2)
rain simulator##2##2##(2008-10#2)
rain splash##3##2##(2008-10#3)
rain was##4##2##(2008-10#4)
rain water##2##2##(2008-10#2)
rain##96##1##(2008-10#81)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-8#2)(2008-9#1)(2010-3#1)(2012-7#1)(2013-8#1)
rainbow angle##2##2##(2008-2#1)(2008-3#1)
rainbow hologram##2##2##(2008-1#1)(2008-3#1)
rainbow is##2##2##(2008-2#1)(2008-3#1)
rainbow lorikeet (Trichoglossus haematodus)##2##4##(2008-5#2)
rainbow refractometry##3##2##(2008-2#3)
rainbow thermometry##2##2##(2008-2#2)
rainbow trout (Oncorhynchus mykiss)##5##4##(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)
rainbow trout Oncorhynchus##2##3##(2010-8#2)
rainbow trout cell##2##3##(2008-11#2)
rainbow trout##22##2##(1990-12#1)(1993-5#1)(1994-11#1)(1994-5#3)(1997-9#2)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-5#3)(2009-6#1)(2010-8#3)
rainbow##57##1##(1990-12#1)(1993-5#1)(1994-11#1)(1994-5#3)(1997-9#2)(2007-11#1)(2008-1#1)(2008-11#3)(2008-2#20)(2008-3#10)(2008-5#4)(2008-6#2)(2008-7#1)(2009-5#3)(2009-6#1)(2010-8#3)
rainbows of a##2##3##(2008-2#2)
rainbows of##3##2##(2008-2#3)
rainbows produced by##2##3##(2008-2#1)(2008-3#1)
rainbows##11##1##(2008-2#7)(2008-3#4)
raindrop##4##1##(2008-10#2)(2008-3#2)
raindrops##8##1##(2008-10#2)(2008-3#6)
rainfall amounts##2##2##(2008-10#2)
rainfall and air and water##2##5##(2013-7#2)
rainfall and##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#2)
rainfall during##2##2##(2008-10#2)
rainfall environment##2##2##(2008-10#2)
rainfall events##3##2##(2008-10#3)
rainfall for infection##2##3##(2008-10#2)
rainfall in##3##2##(2008-10#3)
rainfall or##3##2##(2008-10#3)
rainfall seasonality##2##2##(2013-7#2)
rainfall##56##1##(2007-2#1)(2007-7#1)(2008-10#36)(2008-5#4)(2008-8#3)(2008-9#1)(2009-10#2)(2012-9#1)(2013-7#6)(2013-8#1)
rainfall)##4##1##(2008-10#4)
rainforest tree##2##2##(1992-8#1)(2010-10#1)
rainforest##6##1##(1992-8#1)(2010-10#2)(2010-7#2)(2013-7#1)
rains##8##1##(2008-10#7)(2012-2#1)
rainstorms with wind##2##3##(2008-10#2)
rainstorms##3##1##(2008-10#3)
rainwater and##2##2##(2008-10#2)
rainwater collected##2##2##(2008-10#2)
rainwater samples##3##2##(2008-10#3)
rainwater##25##1##(2008-10#25)
rainy and dry season##2##4##(2012-2#1)(2013-7#1)
rainy and dry##3##3##(2012-2#1)(2013-7#2)
rainy and##5##2##(1997-6#1)(2012-2#1)(2013-7#3)
rainy days in April and May##5##6##(2008-10#5)
rainy days in##6##3##(2008-10#6)
rainy days##7##2##(2008-10#7)
rainy season##19##2##(1994-9#1)(1997-6#1)(2007-2#1)(2008-10#4)(2008-5#6)(2008-6#1)(2008-8#1)(2013-7#4)
rainy seasons##4##2##(2008-5#1)(2008-8#1)(2013-7#2)
rainy##39##1##(1993-3#1)(1994-9#1)(1997-6#2)(2007-2#1)(2008-10#11)(2008-5#7)(2008-6#1)(2008-8#4)(2012-2#2)(2013-7#9)
raise a##5##2##(1993-1#1)(1994-12#1)(1996-1#1)(2010-11#1)(2011-2#1)
raise an##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
raise new##2##2##(2008-11#1)(2008-7#1)
raise of##2##2##(1992-3#1)(2008-2#1)
raise questions about the##2##4##(2009-8#1)(2012-2#1)
raise questions about##5##3##(1993-1#1)(1995-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
raise the possibility of##2##4##(1992-12#1)(2007-11#1)
raise the possibility that the##2##5##(1992-7#1)(1994-8#1)
raise the possibility that##9##4##(1991-2#2)(1992-3#1)(1992-7#1)(1994-8#1)(1995-5#1)(2008-9#1)(2010-4#1)(2012-12#1)
raise the possibility##13##3##(1991-2#2)(1992-12#1)(1992-3#1)(1992-7#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)
raise the question of whether##2##5##(2009-11#1)(2009-7#1)
raise the question of##3##4##(2008-8#1)(2009-11#1)(2009-7#1)
raise the question##4##3##(2008-8#1)(2009-11#1)(2009-7#1)(2011-2#1)
raise the##40##2##(1990-8#1)(1991-2#2)(1991-5#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
raise##93##1##(1990-12#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-7#1)(1993-1#3)(1993-2#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#1)(2009-11#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
raised ICP and##2##3##(1996-9#1)(2008-7#1)
raised ICP##9##2##(1996-9#1)(2008-7#3)(2010-5#5)
raised a##3##2##(2009-6#1)(2011-2#1)(2012-3#1)
raised against purified##3##3##(1991-12#1)(1992-8#1)(1993-9#1)
raised against the purified##4##4##(1990-7#1)(1992-8#1)(1993-12#1)(2007-12#1)
raised against the##21##3##(1990-7#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#1)
raised against##53##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-12#4)(2008-10#9)(2008-11#2)(2008-4#1)(2008-6#1)
raised and##4##2##(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
raised as to the##4##4##(2008-10#3)(2010-10#1)
raised blood##3##2##(1990-5#1)(1997-2#1)(2010-12#1)
raised by immunizing##2##3##(2008-7#1)(2008-8#1)
raised by the use of##2##5##(1991-12#1)(1993-3#1)
raised by the##5##3##(1991-12#1)(1993-3#1)(1996-11#1)(2008-2#1)(2008-3#1)
raised by these##2##3##(1991-3#1)(2013-1#1)
raised by this##2##3##(1991-12#1)(1997-8#1)
raised by##22##2##(1991-12#2)(1991-3#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
raised concentrations##3##2##(1991-12#1)(1992-11#1)(1993-8#1)
raised concerns about##2##3##(2007-12#1)(2009-4#1)
raised concerns##4##2##(1994-3#1)(1996-12#1)(2007-12#1)(2009-4#1)
raised from room temperature##2##4##(2008-3#1)(2011-2#1)
raised from##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
raised in rabbit##5##3##(1991-5#2)(1997-4#1)(2008-10#2)
raised in the##3##3##(1991-12#2)(2008-10#1)
raised in##33##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-11#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2012-3#1)
raised on##2##2##(1990-12#1)(1997-5#1)
raised questions about##2##3##(1992-2#1)(2008-9#1)
raised questions##3##2##(1992-2#1)(2008-9#1)(2013-1#1)
raised regarding##2##2##(1992-3#1)(2011-1#1)
raised serum##6##2##(1991-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(2011-2#1)(2013-1#1)
raised the possibility##2##3##(2009-4#1)(2011-2#1)
raised the question##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
raised the##12##2##(1992-12#1)(1995-12#2)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#2)(2011-2#1)(2013-1#1)
raised to##12##2##(1990-11#1)(1990-2#1)(1990-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
raised triglyceride##2##2##(1993-12#1)(2013-1#1)
raised using##2##2##(1995-11#1)(2013-1#1)
raised whether##2##2##(1996-9#1)(2008-8#1)
raised##275##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-11#1)(1991-12#12)(1991-2#2)(1991-3#1)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#7)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#33)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#6)(2009-11#1)(2009-4#4)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#7)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#9)(2013-8#1)
raises a number of##2##4##(1997-1#1)(2008-11#1)
raises a##5##2##(1994-5#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)
raises an##2##2##(2008-10#1)(2012-3#1)
raises concern##3##2##(1992-8#1)(1996-3#2)
raises concerns about the##3##4##(1995-1#1)(2008-10#1)(2008-11#1)
raises concerns about##4##3##(1995-1#1)(1996-11#1)(2008-10#1)(2008-11#1)
raises concerns##5##2##(1995-1#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
raises questions about how##2##4##(2008-11#1)(2009-12#1)
raises questions about##3##3##(1990-5#1)(2008-11#1)(2009-12#1)
raises questions##6##2##(1990-5#1)(2008-10#2)(2008-11#1)(2009-12#1)(2013-8#1)
raises some##3##2##(1993-6#1)(2008-1#1)(2008-3#1)
raises the issue of##2##4##(1991-3#1)(1994-3#1)
raises the possibility of##3##4##(1995-6#1)(1996-3#1)(1997-1#1)
raises the possibility that##3##4##(1995-8#1)(2007-2#1)(2011-2#1)
raises the possibility##6##3##(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-2#1)(2011-2#1)
raises the question as to##2##5##(1995-12#1)(2012-3#1)
raises the question of whether##2##5##(1996-2#1)(2012-2#1)
raises the question of##4##4##(1993-2#1)(1996-2#1)(2008-2#1)(2012-2#1)
raises the question##7##3##(1993-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(2008-2#1)(2012-2#1)(2012-3#1)
raises the##28##2##(1991-3#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#3)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#2)
raises##80##1##(1990-3#1)(1990-5#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#3)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#3)(2009-12#1)(2009-2#1)(2009-8#1)(2010-3#4)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#2)
raising a##2##2##(1993-1#1)(2008-8#1)
raising an##3##2##(2008-10#1)(2008-6#1)(2009-12#1)
raising awareness##4##2##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
raising concerns over##2##3##(2010-8#1)(2013-8#1)
raising in##4##2##(1991-3#1)(1992-3#1)(1993-3#1)(1997-1#1)
raising of the##2##3##(2008-11#1)(2008-6#1)
raising plasma##2##2##(1991-12#1)(1991-7#1)
raising questions##2##2##(1992-6#1)(2009-8#1)
raising the awareness of##2##4##(2007-11#1)(2008-7#1)
raising the possibility of##2##4##(2008-7#1)(2012-3#1)
raising the possibility that a##2##5##(1996-6#1)(2008-10#1)
raising the possibility that##7##4##(1994-8#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
raising the possibility##9##3##(1994-8#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
raising the##22##2##(1994-8#1)(1995-11#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
raising##83##1##(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#3)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#6)(2008-7#4)(2008-8#2)(2009-12#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
raisins##6##1##(2008-10#6)
raison du##2##2##(2008-5#1)(2013-1#1)
raison##3##1##(2008-5#2)(2013-1#1)
raked##2##1##(2008-10#2)
raloxifene##2##1##(2008-10#1)(2008-4#1)
ram epididymal##2##2##(2008-12#2)
ram lambs##2##2##(2008-12#2)
ram##6##1##(1995-8#1)(1996-2#1)(2008-12#4)
ramadan##5##1##(2012-3#5)
ramets in##2##2##(2008-10#1)(2008-9#1)
ramets of the##2##3##(2008-9#1)(2009-12#1)
ramets##5##1##(2008-10#1)(2008-9#3)(2009-12#1)
ramification##2##1##(2008-10#1)(2013-7#1)
ramifications that##2##2##(1995-12#1)(2008-11#1)
ramifications##13##1##(1995-12#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-9#3)(2013-7#1)
ramified##6##1##(2007-12#3)(2008-10#1)(2008-12#1)(2008-6#1)
ramipril and telmisartan##3##3##(2010-3#3)
ramipril and##4##2##(2010-12#1)(2010-3#3)
ramipril##7##1##(2010-12#2)(2010-3#5)
ramnogalacturonan##3##1##(2008-10#3)
ramorum DNA##2##2##(2008-10#2)
ramorum and##3##2##(2008-10#3)
ramorum elicitins##2##2##(2008-10#2)
ramorum from##5##2##(2008-10#4)(2009-2#1)
ramorum in plant material##3##4##(2008-10#3)
ramorum in##8##2##(2008-10#7)(2009-2#1)
ramorum was detected##2##3##(2008-10#2)
ramorum was recovered from##2##4##(2008-10#2)
ramorum was##8##2##(2008-10#8)
ramorum##68##1##(2008-10#61)(2009-2#7)
ramosa##5##1##(2008-10#5)
ramp and##2##2##(2012-2#1)(2013-1#1)
ramp direction##3##2##(2008-10#3)
ramp##16##1##(1993-5#1)(1995-11#1)(2008-10#8)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#2)
rampant##2##1##(1997-8#1)(2008-1#1)
ramped##5##1##(2008-10#3)(2008-3#1)(2012-2#1)
rams##2##1##(2008-12#2)
ramus##4##1##(1995-6#3)(2012-3#1)
ramus-condyle unit fractures in growing patients##2##6##(2007-12#2)
ramus-condyle unit fractures##4##3##(2007-12#4)
ran parallel##2##2##(1993-12#1)(2013-2#1)
ran##8##1##(1992-8#1)(1993-12#1)(1995-12#1)(2007-5#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-2#1)
ranarum##3##1##(2007-7#3)
ranch##2##1##(2008-4#1)(2008-6#1)
rancid rapeseed##2##2##(2008-10#2)
rancid##3##1##(2008-10#2)(2010-4#1)
random DNA##2##2##(1996-3#1)(2008-8#1)
random access##3##2##(2008-3#2)(2009-11#1)
random addition model##2##3##(1990-7#2)
random allocation##2##2##(2012-1#2)
random amplified microsatellite##2##3##(2008-10#1)(2008-5#1)
random amplified polymorphic DNA (RAPD) analysis##5##6##(2008-10#5)
random amplified polymorphic DNA (RAPD) markers were##2##7##(2008-10#2)
random amplified polymorphic DNA (RAPD) markers##11##6##(2008-10#10)(2013-7#1)
random amplified polymorphic DNA (RAPD) technique##3##6##(2008-10#3)
random amplified polymorphic DNA (RAPD)##33##5##(2008-10#32)(2013-7#1)
random amplified polymorphic DNA and##3##5##(2008-10#3)
random amplified polymorphic DNA loci##2##5##(2008-10#2)
random amplified polymorphic DNA marker##3##5##(2008-10#3)
random amplified polymorphic DNA markers##7##5##(2008-10#7)
random amplified polymorphic DNA##59##4##(2007-10#1)(2008-10#55)(2011-2#1)(2012-3#1)(2013-7#1)
random amplified polymorphic##60##3##(2007-10#1)(2008-10#55)(2008-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
random amplified polymorphism DNA##2##4##(2008-10#2)
random amplified##66##2##(2007-10#1)(2008-10#60)(2008-5#2)(2011-2#1)(2012-3#1)(2013-7#1)
random and conditional##2##3##(2012-2#2)
random and systematic##2##3##(2008-2#1)(2008-3#1)
random and##14##2##(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#3)(2012-3#1)
random assignment##4##2##(2012-2#1)(2013-1#2)(2013-7#1)
random background##2##2##(2007-12#1)(2008-10#1)
random birefringence##3##2##(2007-12#3)
random code##2##2##(2008-2#2)
random coil##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
random distribution of##6##3##(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#1)
random distribution##7##2##(1995-9#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#1)
random drift##3##2##(1995-5#1)(1996-6#1)(2008-10#1)
random effect models##2##3##(1997-8#1)(2008-8#1)
random effect##3##2##(1997-8#1)(2008-8#1)(2010-11#1)
random effects distribution##2##3##(2008-8#2)
random effects method##2##3##(1996-3#2)
random effects model for##2##4##(1993-11#1)(1997-4#1)
random effects model##3##3##(1993-11#1)(1997-4#1)(2011-1#1)
random effects models##2##3##(1997-4#1)(1997-8#1)
random effects##15##2##(1993-11#1)(1996-3#4)(1997-4#2)(1997-8#1)(2008-10#1)(2008-8#4)(2011-1#2)
random error##6##2##(1992-5#1)(2008-10#2)(2008-3#2)(2008-7#1)
random errors of##2##3##(2008-10#1)(2011-2#1)
random errors##8##2##(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2011-2#1)
random field##2##2##(2007-12#1)(2008-6#1)
random fluctuations in##2##3##(1990-3#1)(2008-9#1)
random fluctuations##4##2##(1990-3#1)(2008-3#2)(2008-9#1)
random for##2##2##(1997-8#1)(2008-10#1)
random forests and logic regression##2##5##(2012-3#2)
random from##6##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
random gain##2##2##(2008-3#2)
random genetic drift##5##3##(1996-6#2)(2008-10#3)
random genetic##6##2##(1996-6#3)(2008-10#3)
random genomic##2##2##(2008-10#1)(2008-8#1)
random group##2##2##(2007-11#1)(2012-3#1)
random image##2##2##(2008-2#2)
random in##3##2##(1997-8#1)(2008-10#1)(2010-8#1)
random mating model##2##3##(2008-9#2)
random mating##10##2##(2008-10#7)(2008-8#1)(2008-9#2)
random measurement errors##2##3##(2008-3#2)
random media##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
random medium with##2##3##(2008-2#2)
random medium##5##2##(2007-11#1)(2008-2#4)
random mutagenesis##2##2##(1993-2#1)(2008-10#1)
random mutation##2##2##(2008-10#1)(2010-5#1)
random mutations##2##2##(2008-7#1)(2008-9#1)
random noise##3##2##(2007-12#1)(2008-3#2)
random nucleotides##2##2##(1992-6#2)
random number generator##2##3##(2008-11#1)(2008-7#1)
random number##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)
random numbers##2##2##(2008-3#1)(2011-2#1)
random or##2##2##(1991-9#1)(2011-1#1)
random order##6##2##(1991-8#1)(1992-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(2013-8#1)
random orientation of the##2##4##(2008-3#1)(2009-5#1)
random orientation##5##2##(2008-2#1)(2008-3#3)(2009-5#1)
random pattern of##3##3##(1995-1#1)(1997-8#1)(2008-10#1)
random pattern##4##2##(1995-1#1)(1997-8#1)(2008-10#2)
random patterns##6##2##(2008-3#6)
random peptides##2##2##(2008-4#1)(2008-8#1)
random phase codes##8##3##(2007-12#4)(2008-3#4)
random phase encoding##2##3##(2008-3#2)
random phase mask##2##3##(2008-2#2)
random phase masks##3##3##(2008-3#3)
random phase##21##2##(2007-12#4)(2008-2#3)(2008-3#14)
random plasma glucose##2##3##(1992-9#1)(2008-7#1)
random primers were##2##3##(2008-10#2)
random process##4##2##(1997-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
random rough surface##2##3##(2007-12#1)(2008-3#1)
random rough##3##2##(2007-12#1)(2008-3#2)
random sample from##3##3##(1992-6#1)(2008-7#2)
random sample of 500##2##4##(1991-3#1)(1993-12#1)
random sample of family##3##4##(1991-3#1)(1991-8#2)
random sample of the##4##4##(1995-3#1)(1996-8#1)(2010-11#1)(2013-1#1)
random sample of##42##3##(1990-9#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
random sample##52##2##(1990-9#1)(1991-3#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-3#3)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
random samples of##2##3##(2008-10#1)(2009-5#1)
random sampling##9##2##(1993-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
random scattering##2##2##(2007-11#2)
random sequence##3##2##(1995-2#1)(1996-3#1)(2008-10#1)
random sequences##2##2##(1995-8#1)(2008-11#1)
random shape##2##2##(2008-3#2)
random sound##2##2##(2013-8#2)
random spatial distribution##2##3##(1991-6#1)(2007-11#1)
random spatial##3##2##(1991-6#1)(2007-11#1)(2008-10#1)
random target##2##2##(2008-2#1)(2008-3#1)
random targets##3##2##(2008-10#3)
random time##2##2##(2008-7#2)
random times##2##2##(1996-3#1)(2008-7#1)
random to##2##2##(2008-1#1)(2008-10#1)
random variables##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
random variates##2##2##(1992-9#1)(2008-10#1)
random walk##6##2##(2008-2#3)(2008-9#1)(2012-3#1)(2013-8#1)
random wave##4##2##(2008-2#2)(2008-3#2)
random with respect to##2##4##(1995-2#1)(2008-9#1)
random##563##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-6#2)(1990-7#4)(1990-9#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#8)(1996-6#5)(1996-8#2)(1997-2#2)(1997-3#4)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#7)(1997-9#1)(2007-10#3)(2007-11#13)(2007-12#24)(2007-5#1)(2008-1#2)(2008-10#136)(2008-11#6)(2008-12#3)(2008-2#40)(2008-3#68)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#22)(2008-8#20)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#9)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#11)(2013-1#9)(2013-7#2)(2013-8#6)
random-coil##3##1##(1992-6#1)(1997-2#1)(2009-2#1)
random-effects meta-analysis##2##2##(1995-12#1)(2008-10#1)
random-effects regression##3##2##(1995-2#3)
random-effects##8##1##(1995-12#3)(1995-2#4)(2008-10#1)
random-field##2##1##(1991-9#1)(2008-2#1)
random-mated populations##2##2##(2008-10#2)
random-mated##4##1##(2008-10#4)
random-number generator##2##2##(2008-3#2)
random-phase##3##1##(2008-3#3)
random-time (45##2##2##(2008-5#2)
random-walk##2##1##(2008-2#1)(2008-3#1)
randomised clinical trial##5##3##(1990-6#1)(1991-3#1)(2010-5#1)(2013-1#2)
randomised clinical##7##2##(1990-6#1)(1991-3#1)(1995-6#1)(2010-5#2)(2013-1#2)
randomised controlled clinical trial##2##4##(2010-5#2)
randomised controlled trial##12##3##(1990-3#1)(1996-11#1)(2007-11#1)(2008-2#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#5)
randomised controlled trials##8##3##(1993-12#1)(2007-11#1)(2007-6#1)(2007-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
randomised controlled##24##2##(1990-3#1)(1993-12#1)(1996-11#1)(2007-11#3)(2007-6#1)(2007-9#1)(2008-2#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#5)
randomised double-blind##2##2##(2008-2#1)(2012-2#1)
randomised study##4##2##(2007-5#1)(2007-7#1)(2007-8#1)(2013-8#1)
randomised surgical##2##2##(2008-8#1)(2012-3#1)
randomised to##2##2##(2008-3#1)(2008-8#1)
randomised trial##8##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-2#1)(1996-8#1)(1997-5#1)(2008-8#1)(2013-1#1)
randomised trials of##2##3##(1996-3#1)(2012-3#1)
randomised trials##3##2##(1996-3#1)(2008-5#1)(2012-3#1)
randomised##70##1##(1990-2#1)(1990-3#3)(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-11#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#3)(2009-4#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#1)
randomization and##2##2##(1993-8#1)(2012-3#1)
randomization to##2##2##(2008-10#1)(2012-3#1)
randomization##17##1##(1990-5#1)(1993-8#1)(1995-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
randomized and##6##2##(1996-5#1)(2008-10#1)(2008-5#3)(2013-7#1)
randomized block design##2##3##(2008-10#2)
randomized clinical study##4##3##(2008-5#2)(2012-3#1)(2013-1#1)
randomized clinical trial comparing##2##4##(1995-11#1)(1995-2#1)
randomized clinical trial##24##3##(1991-12#1)(1991-2#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#2)(1996-3#1)(1996-6#2)(1997-4#1)(2008-7#3)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
randomized clinical trials (RCTs)##2##4##(2008-10#1)(2010-3#1)
randomized clinical trials have##2##4##(2008-8#1)(2012-1#1)
randomized clinical trials in##3##4##(2008-12#1)(2008-9#1)(2010-6#1)
randomized clinical trials of##2##4##(2008-7#1)(2013-1#1)
randomized clinical trials##25##3##(1992-9#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
randomized clinical##55##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#4)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-3#3)(2013-1#3)(2013-8#1)
randomized comparison of##2##3##(1995-9#1)(2012-12#1)
randomized complete block design with##3##5##(2008-10#1)(2008-12#2)
randomized complete block design##6##4##(2008-10#4)(2008-12#2)
randomized control trial##4##3##(2008-10#2)(2010-7#1)(2013-1#1)
randomized control trials##2##3##(2008-10#1)(2012-2#1)
randomized control##9##2##(1995-12#1)(2008-10#3)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
randomized controlled clinical trial##2##4##(2010-12#1)(2013-1#1)
randomized controlled clinical trials (RCTs)##2##5##(2009-8#1)(2010-11#1)
randomized controlled clinical trials##3##4##(2009-8#1)(2010-11#1)(2010-4#1)
randomized controlled clinical##6##3##(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#2)
randomized controlled pilot##2##3##(2009-11#1)(2010-10#1)
randomized controlled studies##2##3##(2008-7#1)(2010-12#1)
randomized controlled study##8##3##(2008-12#3)(2008-8#2)(2009-12#1)(2012-2#1)(2012-3#1)
randomized controlled trial (RCT)##2##4##(2013-1#2)
randomized controlled trial of##5##4##(2008-8#1)(2012-2#2)(2013-1#2)
randomized controlled trial to##2##4##(2008-8#1)(2010-3#1)
randomized controlled trial##28##3##(1997-2#1)(1997-4#1)(2007-7#1)(2008-7#3)(2008-8#3)(2009-12#1)(2010-10#3)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)
randomized controlled trials (RCT)##2##4##(2009-4#1)(2011-2#1)
randomized controlled trials (RCTs)##5##4##(1993-12#1)(2007-7#1)(2008-10#1)(2009-11#1)(2011-2#1)
randomized controlled trials and##3##4##(1995-2#1)(2012-12#2)
randomized controlled trials are##2##4##(2007-7#1)(2012-2#1)
randomized controlled trials have been##2##5##(2008-8#1)(2013-1#1)
randomized controlled trials have##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
randomized controlled trials that##3##4##(1993-12#1)(2010-2#1)(2012-3#1)
randomized controlled trials to##2##4##(2007-10#1)(2011-2#1)
randomized controlled trials##41##3##(1993-12#2)(1994-6#1)(1995-2#1)(2007-10#2)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
randomized controlled##95##2##(1993-12#2)(1994-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-7#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#5)(2008-8#8)(2009-11#3)(2009-12#3)(2009-2#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#16)(2013-7#1)
randomized double-blind##4##2##(2008-5#3)(2008-7#1)
randomized field##2##2##(1994-2#1)(2010-10#1)
randomized placebo controlled##2##3##(2008-11#1)(2012-3#1)
randomized placebo-controlled trials##2##3##(2008-7#1)(2010-2#1)
randomized placebo-controlled##4##2##(2008-3#1)(2008-7#1)(2010-2#1)(2013-1#1)
randomized sample of##3##3##(1993-2#1)(1995-12#1)(2013-1#1)
randomized studies are##3##3##(1990-6#1)(1997-3#1)(2006-10#1)
randomized studies##11##2##(1990-6#1)(1991-8#1)(1995-9#1)(1996-11#1)(1997-3#2)(2006-10#1)(2007-8#1)(2008-10#2)(2011-2#1)
randomized study for##2##3##(2008-1#1)(2008-11#1)
randomized study of##3##3##(1993-12#1)(1994-12#1)(2007-12#1)
randomized study##18##2##(1991-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#3)
randomized study]##2##2##(1997-3#1)(2008-10#1)
randomized to adalimumab##2##3##(2012-2#2)
randomized to continue##2##3##(2008-4#1)(2010-3#1)
randomized to either continue##2##4##(2010-3#1)(2012-3#1)
randomized to either##5##3##(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2012-3#1)
randomized to one of##2##4##(2010-11#1)(2011-1#1)
randomized to receive##8##3##(2007-7#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
randomized to##37##2##(1992-8#1)(2007-7#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#6)
randomized trial comparing##5##3##(1993-1#2)(1993-11#1)(1995-12#1)(2007-7#1)
randomized trial in##4##3##(1990-5#1)(1992-12#1)(1994-8#1)(1996-9#1)
randomized trial of##9##3##(1991-11#1)(1993-9#1)(1994-3#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#1)
randomized trial on##2##3##(1993-11#1)(2012-12#1)
randomized trial##43##2##(1990-5#1)(1990-6#1)(1991-11#1)(1992-12#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)
randomized trials are##5##3##(1997-4#1)(2009-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
randomized trials of##3##3##(2008-5#1)(2008-8#1)(2009-9#1)
randomized trials##28##2##(1992-10#1)(1993-12#4)(1995-11#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-8#1)(2012-1#2)(2012-3#5)(2013-1#1)
randomized within##2##2##(2007-10#1)(2008-11#1)
randomized##465##1##(1990-12#1)(1990-5#2)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1995-4#1)(1995-9#2)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#3)(1997-3#6)(1997-4#3)(1997-7#2)(2006-10#1)(2007-10#9)(2007-11#1)(2007-12#4)(2007-7#7)(2007-8#5)(2008-1#3)(2008-10#26)(2008-11#6)(2008-12#13)(2008-2#3)(2008-3#11)(2008-4#6)(2008-5#16)(2008-6#12)(2008-7#26)(2008-8#18)(2008-9#2)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#4)(2009-9#3)(2010-10#8)(2010-11#5)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#28)(2012-1#4)(2012-12#12)(2012-2#15)(2012-3#29)(2013-1#38)(2013-7#2)(2013-8#3)
randomized)##2##1##(1992-10#1)(1993-12#1)
randomly amplified polymorphic DNA (RAPD) fragments##2##6##(2008-10#1)(2008-5#1)
randomly amplified polymorphic DNA (RAPD) markers##2##6##(1995-6#1)(1996-10#1)
randomly amplified polymorphic DNA (RAPD)##7##5##(1995-6#1)(1996-10#1)(2008-10#4)(2008-5#1)
randomly amplified polymorphic DNA##9##4##(1995-6#1)(1996-10#1)(1997-8#1)(2008-10#4)(2008-5#2)
randomly and##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#1)
randomly assigned into two##3##4##(2008-12#1)(2010-7#1)(2013-8#1)
randomly assigned into##6##3##(2007-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
randomly assigned to 10##2##4##(2008-10#1)(2013-1#1)
randomly assigned to a##5##4##(2008-12#2)(2009-11#1)(2012-2#1)(2013-1#1)
randomly assigned to be##2##4##(1991-5#1)(2013-1#1)
randomly assigned to one of the three groups##2##8##(2007-6#1)(2013-8#1)
randomly assigned to one of the##3##6##(2007-6#1)(2010-4#1)(2013-8#1)
randomly assigned to one of##7##5##(2007-6#1)(2008-4#1)(2010-4#2)(2011-2#2)(2013-8#1)
randomly assigned to##53##3##(1990-9#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-1#2)(1994-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#7)(2008-3#2)(2008-4#3)(2008-5#4)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
randomly assigned##66##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-1#2)(1994-2#1)(1995-3#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#8)(2008-3#2)(2008-4#3)(2008-5#5)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#3)
randomly birefringent##2##2##(2007-11#2)
randomly by##2##2##(1995-2#1)(2008-2#1)
randomly chosen##7##2##(2008-10#5)(2008-5#1)(2008-6#1)
randomly distributed in##2##3##(2008-9#1)(2013-8#1)
randomly distributed##11##2##(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
randomly divided into two equal groups##2##6##(2007-7#1)(2007-9#1)
randomly divided into two groups of##4##6##(1991-3#1)(2008-10#1)(2008-5#1)(2010-7#1)
randomly divided into two groups##9##5##(1991-3#1)(1993-2#1)(1994-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-7#1)(2013-1#1)
randomly divided into two##11##4##(1991-3#1)(1993-2#1)(1994-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#1)(2010-7#1)(2013-1#1)
randomly divided into##25##3##(1991-3#1)(1993-12#1)(1993-2#1)(1994-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
randomly divided##26##2##(1991-3#1)(1993-12#1)(1993-2#1)(1994-7#1)(1997-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
randomly from##7##2##(1993-1#1)(1994-3#1)(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)
randomly generated##2##2##(1995-6#1)(2008-3#1)
randomly in##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
randomly oriented hexagonal ice columns##3##5##(2008-3#3)
randomly oriented hexagonal##4##3##(2008-3#4)
randomly oriented in the horizontal plane##2##6##(2008-3#2)
randomly oriented##10##2##(2008-2#1)(2008-3#9)
randomly placed##2##2##(2007-5#1)(2008-7#1)
randomly polarized##2##2##(2008-2#1)(2008-3#1)
randomly presented##2##2##(2007-12#1)(2011-1#1)
randomly primed##2##2##(1991-6#1)(2008-10#1)
randomly rough boundary##3##3##(2008-3#3)
randomly rough surfaces##2##3##(2007-12#1)(2008-2#1)
randomly rough##10##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#5)
randomly sampled##6##2##(1997-2#1)(2008-10#3)(2012-2#2)
randomly selected Canadian organizations having at least 500 employees##2##9##(1993-1#1)(1994-2#1)
randomly selected for##7##3##(1993-12#1)(1996-12#1)(1997-3#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
randomly selected from a##3##4##(1992-11#1)(2008-7#2)
randomly selected from##11##3##(1992-11#1)(1996-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#2)(2010-3#1)(2013-1#1)
randomly selected patients##3##3##(1993-2#1)(1997-6#1)(2007-10#1)
randomly selected sample##4##3##(1990-5#2)(1994-12#1)(2012-12#1)
randomly selected samples##2##3##(2008-10#1)(2012-2#1)
randomly selected to be##2##4##(1995-6#1)(2013-1#1)
randomly selected to##3##3##(1995-6#1)(2009-7#1)(2013-1#1)
randomly selected##75##2##(1990-5#2)(1992-11#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#4)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-7#1)(2010-3#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#8)
randomly shifted##2##2##(2008-2#2)
randomly to##5##2##(1991-1#1)(1992-1#1)(2008-5#1)(2008-8#1)(2009-6#1)
randomly were##2##2##(2008-12#1)(2012-2#1)
randomly##321##1##(1990-5#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#5)(1993-11#1)(1993-12#4)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#4)(1995-9#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-8#1)(2007-10#5)(2007-11#7)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#45)(2008-11#4)(2008-12#17)(2008-2#10)(2008-3#24)(2008-4#3)(2008-5#15)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-7#5)(2010-8#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#22)(2013-7#2)(2013-8#5)
randomness of the##2##3##(2008-10#1)(2012-2#1)
randomness of##4##2##(2008-10#3)(2012-2#1)
randomness##8##1##(2008-10#4)(2008-2#1)(2010-10#1)(2012-12#1)(2012-2#1)
range (0##5##2##(1993-12#1)(2008-10#3)(2008-5#1)
range (1##11##2##(2008-10#11)
range (2##2##2##(2008-10#2)
range (3##2##2##(1993-8#1)(2008-10#1)
range (alb/Cr ratio &gt##2##4##(1992-9#2)
range (i##2##2##(1992-8#1)(2008-3#1)
range (pH##3##2##(1991-5#1)(2008-10#2)
range 0 &lt##3##3##(2008-3#3)
range 0 degrees to 180 degrees##2##6##(2007-12#2)
range 0 degrees##3##3##(2007-12#2)(2008-2#1)
range 0##145##2##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#121)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#2)
range 0-2##2##2##(1990-2#1)(2008-10#1)
range 1##44##2##(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#33)(2008-2#2)(2008-5#1)(2008-7#1)(2013-1#2)
range 1-20##2##2##(2008-10#1)(2008-12#1)
range 10##2##2##(2007-11#1)(2008-2#1)
range 15-45##2##2##(2008-2#1)(2008-7#1)
range 2##24##2##(1992-11#1)(2008-10#22)(2009-3#1)
range 2-8##2##2##(2008-10#1)(2008-5#1)
range 20-100 ng ml(-1)##2##4##(2008-10#2)
range 20-100##3##2##(2008-10#3)
range 3##17##2##(1996-5#1)(2007-12#1)(2008-10#14)(2008-3#1)
range 3-6##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
range 4##12##2##(1990-5#1)(2007-11#1)(2008-10#10)
range 5##16##2##(1992-6#1)(2008-10#15)
range 5-100%)##3##2##(2008-9#3)
range 6##11##2##(2008-10#10)(2008-7#1)
range 650-1000 nm##2##3##(2008-3#2)
range 7##6##2##(1995-5#1)(2008-10#5)
range 8##2##2##(2008-10#2)
range 9##4##2##(2008-10#4)
range =##4##2##(1995-11#2)(2007-7#1)(2008-8#1)
range accuracy##2##2##(2008-3#2)
range and a##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
range and are##2##3##(2006-4#1)(2009-9#1)
range and detection##3##3##(2008-10#3)
range and in the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
range and in##4##3##(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
range and is##2##3##(1997-6#1)(2007-11#1)
range and sensitivity##3##3##(2008-10#1)(2008-3#2)
range and slope##4##3##(2008-10#4)
range and symptomatology##2##3##(2008-10#2)
range and that##2##3##(1990-12#1)(1997-2#1)
range and the##11##3##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)(2013-8#1)
range and to##2##3##(2008-10#1)(2008-3#1)
range and##97##2##(1990-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-1#1)(2007-11#8)(2007-12#3)(2008-10#44)(2008-11#1)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#1)(2013-1#4)(2013-8#1)
range approximately##2##2##(1995-6#1)(2008-10#1)
range are discussed##2##3##(2007-11#2)
range are measured for channel waveguides with##2##7##(2008-2#2)
range are##10##2##(1993-11#1)(1996-4#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)
range as the##3##3##(1991-3#1)(1994-11#1)(2008-2#1)
range as##11##2##(1990-11#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-11#1)(1995-5#1)(2008-2#2)(2008-3#2)(2012-2#1)
range at a##2##3##(2007-11#1)(2008-3#1)
range between 0 and##2##4##(2008-10#2)
range between 0##15##3##(2008-10#13)(2008-3#1)(2012-2#1)
range between 1 and##3##4##(2008-10#2)(2008-3#1)
range between 1##9##3##(2008-10#8)(2008-3#1)
range between 10 and##2##4##(2008-10#2)
range between 10 pg and##2##5##(2008-10#2)
range between 10##4##3##(2008-10#4)
range between 2 and##2##4##(2008-10#1)(2013-7#1)
range between 2##3##3##(2008-10#2)(2013-7#1)
range between 4 and##2##4##(2008-10#2)
range between 4##4##3##(2008-10#3)(2008-3#1)
range between 7##2##3##(2008-10#1)(2008-11#1)
range between 96##2##3##(2008-10#2)
range between##54##2##(1992-3#1)(2008-10#42)(2008-11#1)(2008-2#2)(2008-3#3)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
range but with##2##3##(2008-3#1)(2008-5#1)
range but##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
range by the##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
range by use of##2##4##(2008-3#2)
range by##19##2##(2007-11#5)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2010-4#1)(2011-2#1)(2013-1#1)
range can be extended up to##2##6##(2008-10#2)
range can be##6##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)
range covered##2##2##(2007-11#1)(2008-10#1)
range dependence of the##2##4##(2008-3#2)
range during the##2##3##(2010-8#1)(2012-2#1)
range estimates##2##2##(1995-3#1)(2008-3#1)
range examined##4##2##(2008-10#4)
range expansion##2##2##(1997-4#1)(2010-8#1)
range extends##2##2##(2008-10#2)
range for a set of##2##5##(2008-10#2)
range for a##6##3##(2008-10#2)(2008-2#1)(2008-3#3)
range for determination of##2##4##(2008-10#1)(2008-3#1)
range for determination##3##3##(2008-10#2)(2008-3#1)
range for the determination of##5##5##(2008-10#5)
range for the##20##3##(1994-11#1)(2007-11#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)
range for this##2##3##(2008-10#1)(2008-11#1)
range for##71##2##(1991-12#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-1#1)(1997-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#37)(2008-11#2)(2008-2#4)(2008-3#8)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
range found##2##2##(2008-10#1)(2008-3#1)
range from 0 to 0##2##5##(2008-10#1)(2010-4#1)
range from 0 to 1##3##5##(2008-10#2)(2008-5#1)
range from 0 to##14##4##(1993-8#1)(2008-10#8)(2008-3#2)(2008-5#1)(2010-4#1)(2013-1#1)
range from 0##56##3##(1990-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-5#1)(1996-7#1)(2007-11#2)(2008-10#32)(2008-2#2)(2008-3#6)(2008-5#1)(2010-4#3)(2012-3#1)(2013-1#2)
range from 1 to 2##2##5##(1993-9#1)(2007-11#1)
range from 1 to##7##4##(1993-9#1)(2007-11#1)(2008-10#4)(2008-3#1)
range from 1##27##3##(1990-2#1)(1993-9#1)(1994-8#1)(1997-7#1)(2007-11#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
range from 10 to##8##4##(1990-8#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-4#1)
range from 10##9##3##(1990-8#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)
range from 10(-1) to##2##4##(2008-10#2)
range from 10(-4) to##2##4##(2008-10#2)
range from 2 to##7##4##(2007-7#1)(2008-10#5)(2012-2#1)
range from 2##16##3##(1996-2#2)(2007-12#2)(2007-7#1)(2008-10#10)(2012-2#1)
range from 20 to##3##4##(1990-8#1)(2008-10#1)(2008-12#1)
range from 25 to##3##4##(2007-11#1)(2008-10#2)
range from 25##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
range from 3 to##2##4##(2008-10#2)
range from 3##7##3##(2007-11#1)(2008-10#6)
range from 300 to##4##4##(2008-2#1)(2008-3#3)
range from 4 to##2##4##(2008-10#1)(2008-11#1)
range from 4##7##3##(2007-12#1)(2008-10#5)(2008-11#1)
range from 40 to##2##4##(2008-10#1)(2008-2#1)
range from 400 to##2##4##(2008-10#1)(2008-3#1)
range from 5 to##7##4##(2008-10#5)(2008-3#1)(2013-1#1)
range from 5##15##3##(1997-2#1)(2008-10#11)(2008-3#2)(2013-1#1)
range from 50 to##4##4##(2008-10#3)(2008-3#1)
range from 54 to##2##4##(1995-3#1)(2008-2#1)
range from 6##3##3##(1992-12#1)(1994-9#1)(2008-9#1)
range from 7##2##3##(2008-10#1)(2012-1#1)
range from 70##2##3##(1992-2#1)(2008-10#1)
range from 8##3##3##(2008-10#3)
range from 80 to##3##4##(2008-10#2)(2008-3#1)
range from 80##4##3##(1993-8#1)(2008-10#2)(2008-3#1)
range from 91 to##4##4##(2008-10#4)
range from a##4##3##(1991-8#1)(2008-2#1)(2008-8#1)(2012-2#1)
range from about##2##3##(1997-2#1)(2007-12#1)
range from approximately##2##3##(1991-9#1)(2008-2#1)
range from assessing##2##3##(1997-2#1)(2008-10#1)
range from the##6##3##(1993-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)
range from##286##2##(1990-12#1)(1990-2#1)(1990-8#4)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1993-10#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#4)(1996-7#1)(1997-2#7)(1997-7#1)(2007-10#1)(2007-11#11)(2007-12#9)(2007-2#1)(2007-7#2)(2008-10#144)(2008-11#3)(2008-12#1)(2008-2#18)(2008-3#26)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#4)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)
range has been obtained##2##4##(2008-2#1)(2008-3#1)
range has been##8##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-2#1)
range has##9##2##(1993-11#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-2#1)
range have been##2##3##(2008-2#2)
range in size from##2##4##(1992-12#1)(1997-8#1)
range in the##4##3##(1995-2#1)(2007-7#1)(2008-10#2)
range in which##2##3##(2008-10#1)(2008-2#1)
range in##34##2##(1991-4#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-7#4)(2008-10#11)(2008-2#2)(2008-3#1)(2008-7#3)(2009-4#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
range includes##2##2##(2008-10#1)(2008-3#1)
range including##2##2##(2007-12#1)(2008-3#1)
range increases##2##2##(2008-3#1)(2009-11#1)
range investigated##4##2##(1991-12#1)(2008-10#2)(2008-3#1)
range is 0##4##3##(2008-10#4)
range is 1##3##3##(2008-10#3)
range is 2##3##3##(2008-10#3)
range is between##2##3##(2008-10#1)(2013-8#1)
range is##52##2##(1990-12#1)(1995-1#1)(1995-9#1)(2007-11#5)(2007-12#2)(2008-10#28)(2008-2#3)(2008-3#6)(2008-5#1)(2008-8#2)(2012-2#1)(2013-8#1)
range limit##2##2##(2008-3#2)
range limits##4##2##(2008-3#1)(2008-8#2)(2008-9#1)
range measurements##2##2##(2008-2#2)
range near##2##2##(2007-11#1)(2007-12#1)
range obtained##2##2##(2008-2#1)(2008-3#1)
range of &gt##3##3##(2008-2#2)(2008-3#1)
range of (1##2##3##(1995-2#1)(2008-10#1)
range of 0##162##3##(1990-12#1)(1990-7#3)(1992-11#1)(1992-8#1)(1993-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#135)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-11#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
range of 0-10##2##3##(2008-10#2)
range of 0-25##2##3##(2008-10#1)(2010-5#1)
range of 0-7##2##3##(2008-10#2)
range of 1##47##3##(1990-5#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#33)(2008-11#1)(2008-2#1)(2008-3#3)(2011-1#2)(2011-2#1)
range of 1-10##2##3##(1994-12#1)(2008-10#1)
range of 1-1000##2##3##(1992-8#1)(2008-10#1)
range of 10 to##2##4##(1993-9#1)(2008-10#1)
range of 10##11##3##(1993-9#1)(1994-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)
range of 10-100##3##3##(1994-8#1)(2008-10#2)
range of 100 nM##2##4##(1994-5#1)(2009-11#1)
range of 100##8##3##(1994-5#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-11#1)
range of 100-10##2##3##(2008-10#2)
range of 15##2##3##(2008-10#1)(2008-3#1)
range of 15%##2##3##(2007-12#1)(2008-2#1)
range of 150##2##3##(2008-3#1)(2008-9#1)
range of 2##35##3##(2007-11#1)(2008-10#31)(2008-3#1)(2010-2#1)(2013-1#1)
range of 20##2##3##(1997-6#1)(2008-10#1)
range of 25##2##3##(2008-3#1)(2008-6#1)
range of 3##17##3##(2008-10#15)(2008-12#1)(2010-3#1)
range of 3-7 for##2##4##(1991-9#2)
range of 30##2##3##(1991-9#1)(2009-5#1)
range of 4 to##2##4##(2008-10#1)(2013-1#1)
range of 4##16##3##(1995-12#1)(2008-10#11)(2008-11#1)(2008-6#1)(2013-1#2)
range of 5 x##2##4##(2008-10#2)
range of 5##24##3##(2008-10#20)(2008-3#2)(2010-5#1)(2013-8#1)
range of 50##3##3##(2007-11#1)(2008-2#2)
range of 50-1000##2##3##(2008-10#2)
range of 6##9##3##(2008-10#6)(2008-7#1)(2008-8#1)(2013-1#1)
range of 7##12##3##(2008-10#8)(2008-3#1)(2008-4#1)(2010-5#1)(2012-2#1)
range of 8##5##3##(2008-10#4)(2008-4#1)
range of 9##3##3##(2008-10#3)
range of 90##2##3##(2008-10#1)(2008-2#1)
range of 94-100%##2##3##(2008-10#2)
range of DNA##2##3##(1994-6#1)(2008-10#1)
range of H(2)O(2) and##2##4##(2008-10#1)(2013-1#1)
range of a few##2##4##(2008-3#2)
range of a##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
range of about##3##3##(1997-3#1)(2008-10#2)
range of absorption##2##3##(2008-3#1)(2008-5#1)
range of acceptance##2##3##(2007-10#1)(2008-3#1)
range of activities##2##3##(2008-12#2)
range of alternative##2##3##(2008-8#1)(2008-9#1)
range of amino acids##2##4##(1992-9#1)(2011-2#1)
range of analytical##2##3##(1996-3#1)(2007-12#1)
range of angles of incidence##2##5##(2008-3#2)
range of angles##3##3##(2008-3#3)
range of annual##3##3##(2011-2#3)
range of application##2##3##(2008-10#2)
range of applications of##3##4##(1997-4#1)(2008-7#1)(2012-2#1)
range of applications##14##3##(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-12#1)(2012-2#3)
range of approximately##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
range of at least##3##4##(2008-10#1)(2008-3#2)
range of available##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
range of biological activities##2##4##(2008-7#1)(2011-3#1)
range of biological##6##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-3#1)(2012-3#1)
range of cell##3##3##(1994-8#1)(2008-10#1)(2012-1#1)
range of cellular processes##4##4##(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
range of cellular##5##3##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
range of chemical##2##3##(1994-8#1)(2007-12#1)
range of chronic conditions##2##4##(1992-12#1)(2013-1#1)
range of chronic##3##3##(1992-12#1)(2008-7#1)(2013-1#1)
range of clinical##3##3##(1990-2#1)(2008-11#2)
range of complications##2##3##(2007-12#1)(2011-2#1)
range of compounds##2##3##(2008-10#1)(2011-1#1)
range of concentration##6##3##(1994-11#1)(2008-10#3)(2008-5#1)(2010-3#1)
range of concentrations in##2##4##(1992-6#1)(2008-10#1)
range of concentrations##14##3##(1992-6#2)(1994-11#1)(2008-10#9)(2008-5#1)(2008-7#1)
range of conditions##11##3##(1990-8#1)(1997-2#1)(2008-10#4)(2008-2#2)(2008-8#2)(2009-7#1)
range of content##2##3##(2008-10#1)(2011-1#1)
range of copper##2##3##(2008-10#2)
range of current##2##3##(2007-12#1)(2008-2#1)
range of decision##4##3##(1997-3#3)(2013-1#1)
range of demographic characteristics##2##4##(2009-9#1)(2012-3#1)
range of demographic##3##3##(2009-9#1)(2010-11#1)(2012-3#1)
range of detection##2##3##(2008-10#2)
range of different##7##3##(1997-6#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-6#1)(2011-1#2)
range of disciplines##2##3##(2008-12#1)(2009-11#1)
range of disease##2##3##(2008-10#2)
range of diseases##5##3##(1992-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
range of dissolved##2##3##(2008-10#1)(2008-11#1)
range of doses##2##3##(1992-5#1)(2011-2#1)
range of effects##2##3##(2012-3#1)(2013-1#1)
range of elements##2##3##(2008-10#1)(2013-8#1)
range of environmental chemicals##2##4##(1994-3#1)(2009-9#1)
range of environmental conditions##4##4##(2008-10#3)(2008-5#1)
range of environmental##6##3##(1994-3#1)(2008-10#3)(2008-5#1)(2009-9#1)
range of environments##5##3##(2007-12#1)(2008-8#1)(2011-2#2)(2013-1#1)
range of experimental##3##3##(1997-2#1)(2008-11#1)(2008-7#1)
range of factors##3##3##(1995-3#1)(2008-11#1)(2008-8#1)
range of flexion##4##3##(2007-8#3)(2008-9#1)
range of flow##4##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-9#1)
range of four##2##3##(2008-10#1)(2012-1#1)
range of from##4##3##(2008-2#3)(2008-3#1)
range of functions##3##3##(1992-1#1)(2007-8#1)(2008-11#1)
range of genetic##2##3##(2008-10#1)(2008-9#1)
range of health##5##3##(1994-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
range of host plants##4##4##(2008-10#3)(2010-10#1)
range of host##6##3##(2008-10#5)(2010-10#1)
range of human##4##3##(2008-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
range of important##2##3##(1997-3#1)(2008-10#1)
range of inflammatory mediators##2##4##(2008-7#2)
range of influence##2##3##(2008-10#1)(2013-1#1)
range of input##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
range of interest##2##3##(2008-3#1)(2009-9#1)
range of issues##2##3##(1994-12#1)(2008-11#1)
range of linear response##2##4##(2008-10#2)
range of linear##4##3##(2008-10#3)(2011-1#1)
range of linearity##7##3##(2008-10#6)(2009-8#1)
range of low##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
range of medical##2##3##(2008-11#1)(2010-6#1)
range of memory##2##3##(2007-8#1)(2008-2#1)
range of methods##4##3##(1996-11#1)(2008-5#1)(2009-7#1)(2010-5#1)
range of mixture compositions##2##4##(2008-6#2)
range of molecular##3##3##(2008-10#1)(2009-10#1)(2009-12#1)
range of motion (AROM)##2##4##(2008-12#2)
range of motion (ROM)##4##4##(2008-12#2)(2009-1#1)(2013-1#1)
range of motion and##5##4##(1993-11#1)(1996-3#1)(2007-11#1)(2009-1#1)(2010-12#1)
range of motion in subjects with a history of lateral ligament sprain##2##12##(2007-11#2)
range of motion in##5##4##(2007-11#2)(2007-8#1)(2008-12#1)(2013-1#1)
range of motion of the knee##3##6##(2007-8#1)(2011-2#1)(2013-1#1)
range of motion of the##6##5##(2007-12#1)(2007-8#2)(2011-2#2)(2013-1#1)
range of motion of##7##4##(2007-12#1)(2007-8#2)(2011-2#2)(2013-1#2)
range of motion was##2##4##(2007-8#1)(2012-2#1)
range of motion were##3##4##(2007-11#2)(2012-12#1)
range of motion##56##3##(1993-11#1)(1996-3#1)(2007-11#7)(2007-12#2)(2007-8#6)(2008-12#9)(2008-2#1)(2008-6#1)(2008-9#4)(2009-1#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#9)
range of movement in the##3##5##(2007-8#3)
range of movement of the##2##5##(2007-11#1)(2007-8#1)
range of movement of##3##4##(2007-11#1)(2007-8#1)(2012-2#1)
range of movement##15##3##(1992-9#1)(2007-11#2)(2007-8#8)(2012-2#2)(2013-1#1)(2013-8#1)
range of nutrient##2##3##(2008-11#1)(2013-1#1)
range of only##2##3##(1994-12#1)(2013-1#1)
range of optical##3##3##(2007-11#2)(2008-3#1)
range of organisms##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
range of other##3##3##(2008-10#3)
range of outcomes##2##3##(2008-2#1)(2009-5#1)
range of pH 2##2##4##(2008-10#2)
range of pH from##2##4##(2008-10#2)
range of pH values##4##4##(1992-8#2)(2008-10#2)
range of pH##22##3##(1992-8#2)(1994-3#1)(1995-2#1)(2008-10#14)(2008-5#3)(2013-1#1)
range of parameter values##5##4##(1994-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
range of parameter##6##3##(1994-2#1)(2008-3#1)(2008-8#3)(2008-9#1)
range of parameters##5##3##(2008-3#2)(2008-8#2)(2008-9#1)
range of parasites##2##3##(1997-7#1)(2008-8#1)
range of pathogens##5##3##(2008-10#4)(2011-2#1)
range of patients##2##3##(2008-2#1)(2009-5#1)
range of personal care##2##4##(2008-5#2)
range of phenotypes##2##3##(2008-9#1)(2009-10#1)
range of physiological and##2##4##(1991-2#1)(1992-6#1)
range of physiological##6##3##(1990-11#1)(1991-2#1)(1992-6#1)(1996-2#1)(2008-11#1)(2011-2#1)
range of plant##5##3##(2008-10#2)(2008-7#1)(2009-8#1)(2010-10#1)
range of possible##4##3##(1995-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
range of productivities##2##3##(2008-8#1)(2008-9#1)
range of refractive indices##2##4##(2008-3#1)(2009-5#1)
range of response times##2##4##(2010-3#2)
range of responses##3##3##(1993-9#1)(1996-1#1)(2008-8#1)
range of s##2##3##(2008-11#1)(2008-3#1)
range of samples##2##3##(2010-5#1)(2013-1#1)
range of sensitivities##3##3##(1994-12#1)(2008-10#2)
range of services##4##3##(1992-12#1)(1994-1#1)(2008-1#1)(2009-6#1)
range of silica##2##3##(2007-12#1)(2010-7#1)
range of small##2##3##(2008-10#1)(2010-11#1)
range of social##2##3##(2008-4#1)(2012-2#1)
range of spatial##7##3##(2007-11#1)(2008-10#4)(2008-2#1)(2008-9#1)
range of species##4##3##(2008-11#2)(2008-8#1)(2013-8#1)
range of stability##2##3##(2008-11#1)(2008-6#1)
range of structurally##2##3##(1992-8#1)(2008-11#1)
range of studies##3##3##(2008-12#1)(2008-8#1)(2013-8#1)
range of substrates##2##3##(2008-11#1)(2008-2#1)
range of surgical##2##3##(2007-12#1)(2008-6#1)
range of targets##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
range of temperatures##13##3##(2008-10#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#2)(2012-8#1)
range of the assay##3##4##(2008-10#1)(2008-11#2)
range of the calibration graph is##2##6##(2008-10#2)
range of the calibration graph##3##5##(2008-10#3)
range of the calibration##6##4##(2008-10#6)
range of the device##2##4##(2007-11#1)(2007-12#1)
range of the instrument##2##4##(2008-10#1)(2008-3#1)
range of the investigated##2##4##(2008-3#2)
range of the laser##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
range of the method was##2##5##(2008-10#2)
range of the method##8##4##(2008-10#7)(2008-5#1)
range of the optical path##2##5##(2013-8#2)
range of the optical##5##4##(2007-12#1)(2008-3#1)(2011-2#1)(2013-8#2)
range of the proposed##2##4##(2008-10#1)(2008-3#1)
range of the sensor##5##4##(2008-10#4)(2008-3#1)
range of the virus##3##4##(2008-10#3)
range of the##100##3##(1990-11#1)(1995-2#1)(2007-11#5)(2007-12#5)(2008-10#51)(2008-11#3)(2008-2#4)(2008-3#15)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#4)
range of therapeutic##3##3##(1991-11#1)(1997-8#1)(2008-5#1)
range of these##4##3##(2008-10#3)(2012-2#1)
range of this method is##2##5##(2008-10#2)
range of this method was##3##5##(2008-10#3)
range of this method##5##4##(2008-10#5)
range of this##9##3##(1995-6#1)(2008-10#7)(2008-5#1)
range of topics##4##3##(1994-12#1)(2008-5#2)(2012-2#1)
range of treatment##2##3##(1993-1#1)(2008-2#1)
range of tree##2##3##(2008-8#1)(2008-9#1)
range of typical##2##3##(2008-5#1)(2012-2#1)
range of validity##7##3##(2008-2#2)(2008-3#5)
range of values from##2##4##(1990-2#1)(1993-12#1)
range of values##8##3##(1990-2#1)(1993-12#1)(1993-9#1)(2008-10#2)(2008-3#2)(2008-6#1)
range of variation in the##2##5##(2008-10#1)(2011-2#1)
range of variation in##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
range of variation##6##3##(2008-1#1)(2008-10#1)(2008-8#2)(2011-2#1)(2012-2#1)
range of wavelengths##11##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-2#1)
range of ~10##2##3##(2007-11#1)(2008-3#1)
range of##1889##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#5)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#10)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#9)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#5)(1995-5#3)(1995-6#5)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#5)(1996-4#2)(1996-5#4)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#10)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#53)(2007-12#46)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#21)(2008-1#9)(2008-10#765)(2008-11#59)(2008-12#24)(2008-2#64)(2008-3#138)(2008-4#14)(2008-5#48)(2008-6#20)(2008-7#39)(2008-8#46)(2008-9#27)(2009-1#2)(2009-10#7)(2009-11#5)(2009-12#5)(2009-2#1)(2009-4#2)(2009-5#9)(2009-6#9)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#9)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#9)(2010-6#1)(2010-7#6)(2010-8#3)(2011-1#21)(2011-2#45)(2011-3#3)(2011-7#1)(2012-1#8)(2012-12#14)(2012-2#27)(2012-3#12)(2012-7#1)(2012-8#2)(2013-1#49)(2013-7#2)(2013-8#20)
range on a##2##3##(2008-3#1)(2010-10#1)
range on##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-10#1)
range or##4##2##(2007-8#1)(2008-10#2)(2011-1#1)
range over which##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
range over##7##2##(2007-11#1)(2007-12#1)(2008-10#4)(2010-5#1)
range pH##4##2##(2008-10#4)
range resolution of##2##3##(2008-2#1)(2008-3#1)
range resolution##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
range shifts##2##2##(2010-4#1)(2013-8#1)
range size and##2##3##(2008-8#2)
range size##4##2##(2008-8#4)
range spanning##3##2##(1994-5#1)(2008-10#1)(2012-2#1)
range studied##7##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-6#1)
range studies##4##2##(2008-10#3)(2010-10#1)
range than##5##2##(1993-12#1)(2007-11#1)(2008-10#2)(2008-5#1)
range that is##2##3##(2008-3#2)
range that##8##2##(1995-8#1)(1997-7#1)(2007-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-8#1)
range the##3##2##(1995-5#1)(2008-10#2)
range to 1##2##3##(2008-10#2)
range to a##2##3##(1993-8#1)(2008-2#1)
range to be##3##3##(2007-11#1)(2008-10#2)
range to the##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
range to##17##2##(1990-7#1)(1993-8#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#4)(2010-8#1)
range up to##9##3##(2008-10#8)(2008-3#1)
range using##2##2##(2008-10#1)(2008-2#1)
range was 0##9##3##(2006-10#1)(2008-10#6)(2010-5#1)(2011-1#1)
range was 1##3##3##(1990-8#1)(2008-10#2)
range was achieved with##2##4##(2007-12#1)(2008-10#1)
range was also##2##3##(2008-10#1)(2008-2#1)
range was between 1##3##4##(2008-10#3)
range was between##4##3##(2008-10#4)
range was considerably smaller##2##4##(2008-10#1)(2008-2#1)
range was determined##2##3##(2007-11#1)(2011-2#1)
range was found to be 3##2##6##(2008-10#2)
range was found to be##3##5##(2008-10#2)(2008-3#1)
range was from 1##2##4##(2008-10#2)
range was from##8##3##(2008-10#8)
range was obtained##2##3##(2008-10#2)
range was##76##2##(1990-8#1)(1992-12#1)(1992-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#59)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
range were obtained##3##3##(2008-10#3)
range were used to##2##4##(2007-10#1)(2008-10#1)
range were##23##2##(1993-6#1)(1994-12#1)(2007-10#1)(2007-11#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-2#2)
range where##2##2##(1993-9#2)
range which is##2##3##(1996-2#1)(2008-10#1)
range which##3##2##(1996-2#1)(2008-10#2)
range with a detection limit##3##5##(2008-10#3)
range with a##7##3##(2007-12#1)(2008-10#5)(2008-3#1)
range with##18##2##(1991-9#1)(2006-6#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#3)(2010-9#1)
range within the##2##3##(2008-10#1)(2008-5#1)
range within##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
range without##2##2##(2007-12#1)(2008-3#1)
range##4124##1##(1990-11#5)(1990-12#9)(1990-2#10)(1990-3#3)(1990-5#5)(1990-6#1)(1990-7#6)(1990-8#10)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#8)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#8)(1992-2#4)(1992-3#11)(1992-5#2)(1992-6#6)(1992-8#7)(1992-9#9)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#11)(1993-9#6)(1994-1#4)(1994-11#10)(1994-12#15)(1994-2#6)(1994-3#3)(1994-5#9)(1994-6#5)(1994-8#11)(1994-9#3)(1995-1#5)(1995-11#5)(1995-12#6)(1995-2#13)(1995-3#8)(1995-5#12)(1995-6#7)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#12)(1996-2#15)(1996-3#5)(1996-4#5)(1996-5#9)(1996-7#2)(1996-9#4)(1997-1#3)(1997-2#23)(1997-3#12)(1997-4#10)(1997-5#3)(1997-6#7)(1997-7#5)(1997-8#4)(2006-10#2)(2006-4#1)(2006-6#3)(2007-1#1)(2007-10#9)(2007-11#144)(2007-12#111)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#13)(2007-8#24)(2008-1#11)(2008-10#1883)(2008-11#87)(2008-12#29)(2008-2#204)(2008-3#368)(2008-4#22)(2008-5#73)(2008-6#31)(2008-7#75)(2008-8#76)(2008-9#47)(2009-1#2)(2009-10#7)(2009-11#9)(2009-12#7)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#13)(2009-6#9)(2009-7#6)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#10)(2010-11#6)(2010-12#10)(2010-2#2)(2010-3#10)(2010-4#14)(2010-5#17)(2010-6#1)(2010-7#7)(2010-8#13)(2010-9#1)(2011-1#32)(2011-2#60)(2011-3#6)(2011-7#1)(2012-1#11)(2012-12#20)(2012-2#43)(2012-3#20)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#74)(2013-7#9)(2013-8#29)
range) and##4##2##(2008-10#1)(2008-4#1)(2011-2#1)(2012-1#1)
range)##21##1##(1992-3#1)(1995-12#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
range-dependent##4##1##(2008-3#4)
range-finding##2##1##(2007-11#1)(2011-2#1)
range-resolved##3##1##(2008-3#3)
ranged as high as##3##4##(1993-8#1)(1995-12#1)(2008-10#1)
ranged between 0##16##3##(1990-10#1)(2007-7#1)(2008-10#7)(2008-12#2)(2008-5#3)(2011-2#1)(2013-7#1)
ranged between 1##3##3##(2008-10#2)(2008-6#1)
ranged between 15 and##2##4##(2008-4#1)(2008-5#1)
ranged between 4 and##2##4##(2007-9#1)(2008-9#1)
ranged between 4##3##3##(2007-9#1)(2008-9#1)(2013-1#1)
ranged between 86##2##3##(2008-10#2)
ranged between 95##3##3##(2008-10#3)
ranged between 97##2##3##(2008-10#2)
ranged between 98##2##3##(2008-10#2)
ranged between##64##2##(1990-10#1)(1991-8#1)(1993-2#1)(1994-6#1)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#27)(2008-12#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-9#2)(2009-10#1)(2011-10#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
ranged from &lt##2##3##(2008-10#1)(2008-7#1)
ranged from 0 to##7##4##(2008-10#2)(2008-9#2)(2011-1#1)(2012-8#1)(2013-8#1)
ranged from 0##113##3##(1990-11#1)(1991-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-5#1)(2007-7#2)(2008-10#63)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#2)(2010-11#2)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#3)
ranged from 0% in##2##4##(2008-10#1)(2010-8#1)
ranged from 0%##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
ranged from 1 to##9##4##(1997-3#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
ranged from 1##32##3##(1993-3#1)(1997-3#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#2)
ranged from 10 to##5##4##(2008-10#4)(2011-2#1)
ranged from 100 to##2##4##(2008-7#1)(2011-1#1)
ranged from 100##3##3##(2008-7#1)(2011-1#2)
ranged from 12 to##4##4##(1997-8#1)(2008-10#1)(2009-7#1)(2013-8#1)
ranged from 12##6##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2013-8#1)
ranged from 14 to##2##4##(2008-1#1)(2008-10#1)
ranged from 16##3##3##(2008-12#1)(2010-3#1)(2011-2#1)
ranged from 17##4##3##(2007-7#1)(2008-10#3)
ranged from 18##2##3##(2008-10#1)(2008-4#1)
ranged from 2##14##3##(1991-2#1)(1993-12#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-5#1)(2011-1#1)
ranged from 20 to##4##4##(1996-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
ranged from 200 to##2##4##(1991-12#1)(2008-10#1)
ranged from 21 to##2##4##(2007-7#1)(2008-10#1)
ranged from 25##2##3##(2008-7#1)(2008-9#1)
ranged from 27 to##2##4##(2008-10#1)(2012-12#1)
ranged from 27##4##3##(1990-12#1)(2008-10#2)(2012-12#1)
ranged from 28%##2##3##(1995-3#1)(2008-10#1)
ranged from 3 to##2##4##(2008-10#1)(2013-8#1)
ranged from 3##9##3##(1997-2#1)(2007-10#1)(2007-5#2)(2008-10#4)(2013-8#1)
ranged from 30 to##3##4##(1997-8#1)(2008-5#1)(2011-2#1)
ranged from 31 to##2##4##(2007-12#1)(2008-10#1)
ranged from 35##3##3##(2008-10#2)(2009-7#1)
ranged from 4##11##3##(1990-11#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-12#2)(2008-9#1)(2010-10#1)(2011-1#1)
ranged from 45 to##2##4##(2010-7#1)(2011-2#1)
ranged from 48##2##3##(2007-11#1)(2011-2#1)
ranged from 5 to##8##4##(1990-6#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
ranged from 5##17##3##(1990-2#1)(1990-6#1)(1993-6#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
ranged from 5%##3##3##(2008-10#2)(2008-9#1)
ranged from 54 to##2##4##(2008-10#2)
ranged from 54##3##3##(2008-10#3)
ranged from 6##7##3##(1993-8#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-5#1)(2012-2#1)
ranged from 60##2##3##(1996-12#1)(2012-12#1)
ranged from 62##2##3##(2008-10#1)(2011-1#1)
ranged from 68 to##2##4##(2008-10#2)
ranged from 68##3##3##(2008-10#3)
ranged from 7 to##2##4##(2008-10#2)
ranged from 7##6##3##(1993-6#1)(2008-10#3)(2008-2#1)(2011-2#1)
ranged from 74##2##3##(2008-6#1)(2013-7#1)
ranged from 75 to##2##4##(2008-10#1)(2011-1#1)
ranged from 8##2##3##(2008-10#1)(2009-11#1)
ranged from 80 to##2##4##(2008-10#2)
ranged from 81##2##3##(2008-10#2)
ranged from 86 to##2##4##(2008-10#2)
ranged from 88 to##2##4##(2008-10#2)
ranged from 88##3##3##(2008-10#3)
ranged from 89##2##3##(2008-10#2)
ranged from 9 to##2##4##(2008-7#1)(2012-2#1)
ranged from 9##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
ranged from 90 to##2##4##(2008-10#2)
ranged from 91 to##2##4##(2008-10#2)
ranged from 93 to##2##4##(2008-10#2)
ranged from 95##4##3##(2008-10#4)
ranged from 96 to 103%##2##5##(2008-10#2)
ranged from 96 to##3##4##(2008-10#3)
ranged from 96##5##3##(2008-10#5)
ranged from 97##5##3##(1992-11#1)(2008-10#4)
ranged from 98##2##3##(2008-10#2)
ranged from 99 to 101%##3##5##(2008-10#3)
ranged from 99 to##4##4##(2008-10#4)
ranged from 99##10##3##(1992-11#1)(2008-10#8)(2010-3#1)
ranged from approximately 0##2##4##(2008-10#1)(2008-2#1)
ranged from approximately##4##3##(2008-10#2)(2008-2#1)(2012-2#1)
ranged from two to##2##4##(2008-5#2)
ranged from##436##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-6#2)(1991-12#3)(1991-2#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#4)(1993-3#4)(1993-6#2)(1993-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-8#2)(1996-12#3)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#7)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#203)(2008-11#3)(2008-12#12)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#4)(2010-10#1)(2010-11#3)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#16)(2011-2#20)(2012-1#1)(2012-12#4)(2012-2#8)(2012-8#1)(2013-1#8)(2013-7#2)(2013-8#8)
ranged in age from##3##4##(2007-11#1)(2008-9#1)(2010-10#1)
ranged in##5##2##(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)
ranged over##3##2##(1991-5#1)(1994-11#1)(2008-5#1)
ranged##519##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-6#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#2)(1996-12#3)(1996-3#2)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#8)(2007-6#1)(2007-7#9)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#235)(2008-11#4)(2008-12#14)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#22)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#4)(2010-10#2)(2010-11#3)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#16)(2011-10#1)(2011-2#25)(2012-1#1)(2012-12#5)(2012-2#8)(2012-8#1)(2013-1#10)(2013-7#4)(2013-8#9)
rangelands##2##1##(2008-10#1)(2008-12#1)
rangeof##2##1##(2008-11#2)
ranges (1##2##2##(2008-10#1)(2008-2#1)
ranges 1##2##2##(2008-10#2)
ranges 4##2##2##(2008-10#2)
ranges and##9##2##(1991-11#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
ranges are 0##5##3##(2008-10#5)
ranges are##12##2##(2007-12#1)(2008-10#9)(2008-8#1)(2011-1#1)
ranges at the##2##3##(2008-10#1)(2008-9#1)
ranges at##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
ranges between 0##2##3##(2008-10#1)(2012-2#1)
ranges between##6##2##(2007-12#1)(2008-10#3)(2008-9#1)(2012-2#1)
ranges for the analysis of##2##5##(2008-10#2)
ranges for the##5##3##(2008-10#5)
ranges for##17##2##(1992-9#1)(1995-3#1)(2008-10#13)(2008-8#1)(2012-2#1)
ranges from 0##7##3##(1993-12#1)(2008-10#2)(2008-7#2)(2010-6#1)(2013-1#1)
ranges from 1##3##3##(1995-11#1)(2008-10#1)(2013-8#1)
ranges from 3##2##3##(1992-6#1)(2008-10#1)
ranges from 5 to##2##4##(2008-10#2)
ranges from 5##3##3##(2008-1#1)(2008-10#2)
ranges from approximately 0##2##4##(2008-3#1)(2010-5#1)
ranges from one##2##3##(2008-10#2)
ranges from##50##2##(1991-3#1)(1991-5#1)(1992-6#2)(1993-12#1)(1994-3#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-12#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
ranges in the##2##3##(2007-12#1)(2008-10#1)
ranges in##7##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)
ranges of 0##5##3##(2008-10#4)(2011-1#1)
ranges of 1##8##3##(2007-12#1)(2008-10#6)(2013-8#1)
ranges of 2##3##3##(2008-10#3)
ranges of CEC and CEP##2##5##(2010-1#2)
ranges of drug concentrations (microgram/g)##2##5##(1995-2#2)
ranges of motion##3##3##(2011-2#3)
ranges of the calibration##4##4##(2008-10#4)
ranges of the order of##3##5##(2008-3#3)
ranges of the##14##3##(2008-10#4)(2008-2#1)(2008-3#6)(2008-7#1)(2012-1#1)(2012-2#1)
ranges of##99##2##(1992-6#1)(1992-8#1)(1994-12#2)(1995-2#3)(1995-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#52)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#4)(2008-7#1)(2009-11#1)(2010-1#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
ranges over##2##2##(2008-10#1)(2010-4#1)
ranges studied##2##2##(2008-10#1)(2008-11#1)
ranges than##3##2##(2008-10#1)(2008-8#2)
ranges that##2##2##(2008-10#1)(2008-6#1)
ranges to be##2##3##(2008-10#2)
ranges to##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
ranges were 0##4##3##(2008-10#3)(2008-7#1)
ranges were 5##2##3##(2008-10#2)
ranges were found to##2##4##(2008-10#1)(2008-3#1)
ranges were obtained##2##3##(2008-10#2)
ranges were##26##2##(1994-12#1)(1997-2#1)(2008-10#21)(2008-3#2)(2008-7#1)
ranges##368##1##(1991-11#1)(1991-3#1)(1991-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#4)(1994-3#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-7#1)(2007-11#4)(2007-12#10)(2008-1#2)(2008-10#185)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#27)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#6)(2008-8#11)(2008-9#3)(2009-11#1)(2009-12#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
ranges)##2##1##(1992-9#1)(2008-2#1)
ranging 0##2##2##(2008-10#2)
ranging and##4##2##(2008-2#2)(2008-3#1)(2008-8#1)
ranging between 0##10##3##(1992-3#1)(1994-6#1)(2008-10#6)(2011-2#1)(2013-1#1)
ranging between 1##2##3##(2008-10#1)(2011-3#1)
ranging between 4##2##3##(2008-10#1)(2008-3#1)
ranging between 97##2##3##(2008-10#2)
ranging between##27##2##(1992-3#1)(1992-5#1)(1994-6#1)(1995-11#1)(2008-10#13)(2008-3#4)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#2)
ranging from 0 to 100##2##5##(2008-10#1)(2011-2#1)
ranging from 0 to##9##4##(1993-12#1)(2008-10#3)(2008-11#1)(2009-11#1)(2009-6#2)(2011-2#1)
ranging from 0##72##3##(1991-12#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1997-8#1)(2007-12#2)(2007-5#1)(2008-10#32)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#2)(2009-11#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
ranging from 1 to 4##2##5##(2008-10#1)(2011-2#1)
ranging from 1 to##10##4##(1995-5#1)(2008-10#8)(2011-2#1)
ranging from 1##27##3##(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
ranging from 10 to##5##4##(2008-10#3)(2008-3#1)(2008-6#1)
ranging from 12 to##5##4##(2008-1#1)(2008-10#3)(2013-1#1)
ranging from 12##6##3##(2008-1#1)(2008-10#3)(2010-8#1)(2013-1#1)
ranging from 14 to##2##4##(1993-12#1)(2008-1#1)
ranging from 18##2##3##(1992-6#1)(2007-8#1)
ranging from 2 to##2##4##(1990-2#1)(2008-10#1)
ranging from 2##11##3##(1990-2#1)(1995-5#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2013-1#1)
ranging from 20 to##3##4##(1992-11#1)(2008-10#1)(2008-2#1)
ranging from 20##5##3##(1992-11#1)(1994-8#1)(2008-10#1)(2008-2#2)
ranging from 200##2##3##(2008-10#1)(2008-2#1)
ranging from 22 to##3##4##(1997-2#1)(2008-10#2)
ranging from 22##4##3##(1990-9#1)(1997-2#1)(2008-10#2)
ranging from 23##2##3##(2009-3#1)(2011-2#1)
ranging from 25 to##3##4##(1995-5#1)(1995-8#1)(2008-10#1)
ranging from 250 to##2##4##(2008-10#1)(2008-2#1)
ranging from 3 to##5##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
ranging from 3##11##3##(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2012-3#1)
ranging from 30 to##4##4##(1991-9#1)(1996-12#1)(2008-10#1)(2008-3#1)
ranging from 30##5##3##(1991-9#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-3#1)
ranging from 39##3##3##(1995-3#1)(2008-10#1)(2012-1#1)
ranging from 4 to##3##4##(2008-10#2)(2008-5#1)
ranging from 4##7##3##(1996-12#1)(2008-10#5)(2008-5#1)
ranging from 40 to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
ranging from 400 to##3##4##(2008-10#2)(2008-2#1)
ranging from 400##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
ranging from 5 to 15##2##5##(2008-10#2)
ranging from 5 to##5##4##(1996-12#1)(2008-10#4)
ranging from 5##12##3##(1990-11#2)(1991-9#1)(1996-12#1)(2006-10#1)(2007-5#1)(2008-10#6)
ranging from 5% to##3##4##(2008-3#2)(2013-1#1)
ranging from 50 to##4##4##(2008-10#3)(2008-5#1)
ranging from 50##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
ranging from 6 to##4##4##(2007-12#1)(2008-10#2)(2010-4#1)
ranging from 6##6##3##(2007-12#1)(2008-10#3)(2010-4#1)(2013-8#1)
ranging from 7 to##3##4##(2008-10#2)(2013-1#1)
ranging from 90 to##2##4##(2008-10#2)
ranging from 97##2##3##(2008-10#2)
ranging from approximately 1##2##4##(1992-8#1)(2008-10#1)
ranging from approximately##6##3##(1992-8#1)(1997-8#1)(2008-10#3)(2008-3#1)
ranging from fully susceptible to highly resistant##2##7##(2008-10#2)
ranging from less than##2##4##(1990-12#1)(2008-10#1)
ranging from medical##2##3##(2008-4#1)(2008-7#1)
ranging from mild##2##3##(2008-2#1)(2008-9#1)
ranging from simple##2##3##(2007-11#1)(2008-4#1)
ranging from the dipeptide sugar-substitute aspartame to clinically used hormones##2##10##(2008-4#2)
ranging from the##7##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-8#1)
ranging from very low to##2##5##(2008-10#1)(2012-2#1)
ranging from very low##3##4##(1997-1#1)(2008-10#1)(2012-2#1)
ranging from very##4##3##(1994-12#1)(1997-1#1)(2008-10#1)(2012-2#1)
ranging from##384##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#5)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#4)(1995-8#1)(1996-1#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#3)(2006-10#1)(2007-11#5)(2007-12#12)(2007-5#3)(2007-6#1)(2007-8#3)(2008-1#8)(2008-10#140)(2008-11#11)(2008-12#1)(2008-2#12)(2008-3#16)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#8)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#10)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#7)
ranging in age from 29 to##2##6##(1993-12#1)(2007-8#1)
ranging in age from##9##4##(1990-2#1)(1993-12#1)(1996-5#1)(1997-3#1)(2007-8#3)(2008-11#1)(2009-9#1)
ranging in age##10##3##(1990-2#1)(1993-12#1)(1996-5#1)(1997-3#1)(2007-8#3)(2008-11#1)(2008-4#1)(2009-9#1)
ranging in size from##5##4##(1990-12#1)(1992-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
ranging in##19##2##(1990-12#1)(1990-2#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-3#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#2)(2009-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-7#1)
ranging over##2##2##(2007-12#1)(2008-3#1)
ranging##454##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#4)(1995-8#1)(1996-1#1)(1996-12#4)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#3)(2006-10#1)(2007-11#5)(2007-12#13)(2007-5#3)(2007-6#1)(2007-8#6)(2008-1#10)(2008-10#158)(2008-11#12)(2008-12#1)(2008-2#15)(2008-3#30)(2008-4#11)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#8)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-8#2)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#7)
ranitidine and##2##2##(1991-5#1)(1995-12#1)
ranitidine##24##1##(1991-5#2)(1992-11#4)(1992-2#2)(1992-8#2)(1995-12#1)(1996-11#2)(2008-10#4)(2008-11#7)
rank and replace and combined methods##2##6##(2010-3#2)
rank and replace##4##3##(2010-3#4)
rank and##5##2##(1993-2#1)(2010-3#4)
rank correlation coefficient##2##3##(2008-7#2)
rank correlation coefficients##2##3##(2008-10#2)
rank correlation##7##2##(2008-10#4)(2008-7#2)(2011-1#1)
rank order of potency for##2##5##(1995-12#2)
rank order of potency##6##4##(1993-3#1)(1993-6#1)(1995-12#3)(2009-12#1)
rank order of##14##3##(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-8#1)(2008-10#1)(2009-12#1)
rank order##20##2##(1990-11#1)(1991-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-8#2)(1997-2#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#1)
rank test##5##2##(1990-8#1)(1997-3#1)(1997-8#1)(2010-6#1)(2013-1#1)
rank test)##2##2##(1990-6#1)(1997-7#1)
rank the##5##2##(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
rank##84##1##(1990-11#1)(1990-6#1)(1990-8#2)(1991-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-8#2)(1996-1#1)(1997-2#1)(1997-3#4)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#15)(2008-11#6)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#6)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
rank-order of the##2##3##(1995-11#2)
rank-order##3##1##(1992-8#1)(1995-11#2)
ranked as the##3##3##(1991-3#1)(2008-9#1)(2011-2#1)
ranked as##5##2##(1991-3#1)(1994-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
ranked based on##2##3##(1995-3#1)(2008-10#1)
ranked first in##2##3##(2008-1#1)(2010-12#1)
ranked highest##2##2##(1991-6#1)(2008-10#1)
ranked in##3##2##(1995-2#1)(1995-6#1)(2008-8#1)
ranked on##2##2##(1993-12#1)(2008-10#1)
ranked the##2##2##(2008-7#1)(2008-9#1)
ranked##44##1##(1991-3#3)(1991-6#2)(1993-12#3)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
ranking and##2##2##(2012-12#1)(2012-2#1)
ranking in the##2##3##(1997-3#1)(2010-3#1)
ranking of the##4##3##(1993-12#1)(1993-2#1)(2008-5#1)(2009-4#1)
ranking of##9##2##(1990-6#1)(1991-2#1)(1993-12#1)(1993-2#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-4#1)
ranking##33##1##(1990-6#1)(1991-2#1)(1993-12#2)(1993-2#1)(1995-6#1)(1997-3#2)(2007-11#1)(2008-10#3)(2008-11#6)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
rankings##10##1##(1993-2#2)(1997-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2013-1#2)
ranks of##3##2##(1995-2#1)(1997-2#1)(2008-12#1)
ranks##19##1##(1990-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
rap1 and##2##2##(1992-11#2)
rap1##3##1##(1992-11#3)
rap1-GAPm##3##1##(1992-11#3)
rap2 protein##2##2##(1992-11#2)
rap2##3##1##(1992-11#3)
rap2A##3##1##(1992-11#3)
rapa cv##4##2##(2008-10#4)
rapa##12##1##(2008-10#12)
rapae crucivora##3##2##(2008-5#1)(2008-6#2)
rapae##11##1##(1997-8#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-8#5)
rapamycin##18##1##(1991-9#1)(1993-11#1)(1993-8#3)(1995-6#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2013-1#3)
rape straw##2##2##(2013-1#2)
rape##18##1##(1996-5#1)(2008-10#11)(2008-11#2)(2011-2#2)(2013-1#2)
rapeseed meal##2##2##(2008-10#2)
rapeseed methyl ester##2##3##(2008-6#1)(2011-2#1)
rapeseed oil##5##2##(2008-6#5)
rapeseed oils##2##2##(2008-10#2)
rapeseed##19##1##(2008-10#8)(2008-11#4)(2008-6#6)(2011-2#1)
raphani and##2##2##(2008-10#2)
raphani##5##1##(2008-10#5)
raphe nuclei of the##2##4##(1996-12#1)(2008-7#1)
raphe nuclei##12##2##(1991-2#1)(1995-12#2)(1996-12#1)(1997-2#1)(2008-7#7)
raphe nucleus##9##2##(1991-2#1)(1992-3#2)(1993-12#3)(1993-3#1)(1995-5#1)(2012-3#1)
raphe obscurus##2##2##(1991-12#1)(1997-2#1)
raphe##39##1##(1991-12#2)(1991-2#4)(1992-3#2)(1993-12#3)(1993-3#2)(1994-2#3)(1995-12#3)(1995-5#2)(1996-12#3)(1997-2#2)(1997-3#1)(1997-6#1)(2008-7#10)(2012-3#1)
rapid (&lt##3##2##(1994-9#1)(2008-10#2)
rapid (within##2##2##(2008-10#1)(2008-12#1)
rapid Ca2+##2##2##(1993-8#1)(1996-2#1)
rapid DNA extraction##2##3##(2008-10#1)(2008-12#1)
rapid PCR-based##2##2##(1994-12#1)(2012-2#1)
rapid absorption##2##2##(1997-4#1)(2008-4#1)
rapid access neurology clinic##2##4##(2010-12#2)
rapid access to##2##3##(1990-6#1)(2008-10#1)
rapid access##4##2##(1990-6#1)(2008-10#1)(2010-12#2)
rapid acting analogs##2##3##(2008-1#2)
rapid acting##3##2##(2008-1#3)
rapid activation of##3##3##(1996-5#1)(2008-11#1)(2010-9#1)
rapid activation##4##2##(1992-12#1)(1996-5#1)(2008-11#1)(2010-9#1)
rapid advancement of##2##3##(2008-4#1)(2008-8#1)
rapid advances in##2##3##(1992-1#1)(1994-9#1)
rapid advances##3##2##(1992-1#1)(1994-9#1)(2011-2#1)
rapid amplification of cDNA ends (RACE)##4##6##(1992-12#1)(1997-6#1)(2010-5#2)
rapid amplification of cDNA ends##5##5##(1992-12#1)(1997-6#1)(2008-5#1)(2010-5#2)
rapid analysis of##6##3##(2008-10#4)(2008-11#1)(2010-9#1)
rapid analysis##7##2##(2008-10#5)(2008-11#1)(2010-9#1)
rapid analytical test methods##2##4##(2008-10#2)
rapid analytical##6##2##(2008-10#6)
rapid and accelerated rises##2##4##(2010-4#2)
rapid and accelerated##3##3##(2010-4#3)
rapid and accurate identification of##2##5##(2008-10#1)(2008-5#1)
rapid and accurate method for the##3##6##(2008-10#3)
rapid and accurate##13##3##(2008-10#10)(2008-5#2)(2010-5#1)
rapid and automated##2##3##(2007-11#1)(2008-10#1)
rapid and complete##2##3##(2008-10#1)(2008-5#1)
rapid and convenient##2##3##(2008-4#1)(2011-1#1)
rapid and cost##2##3##(1991-12#1)(2008-10#1)
rapid and cost-effective##3##3##(2008-9#1)(2010-6#1)(2011-2#1)
rapid and direct##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
rapid and easy##2##3##(2008-10#1)(2008-11#1)
rapid and economical differential pulse polarographic##2##6##(2008-10#2)
rapid and economical method for##2##5##(2008-10#1)(2008-8#1)
rapid and economical##6##3##(2008-10#4)(2008-8#1)(2009-8#1)
rapid and efficient##14##3##(1991-12#1)(1991-5#1)(1994-11#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-4#1)(2008-7#1)
rapid and extensive##2##3##(1994-3#1)(1995-1#1)
rapid and highly efficient##2##4##(1994-5#1)(2012-1#1)
rapid and highly sensitive##2##4##(2008-10#2)
rapid and highly##5##3##(1994-5#1)(2008-10#3)(2012-1#1)
rapid and inexpensive##2##3##(2008-10#2)
rapid and precise##8##3##(2007-7#1)(2008-10#6)(2011-2#1)
rapid and quantitative##2##3##(2008-7#1)(2008-9#1)
rapid and reliable method##2##4##(2008-10#2)
rapid and reliable##8##3##(2007-12#1)(2007-2#2)(2008-10#3)(2011-2#1)(2013-8#1)
rapid and reproducible##4##3##(1994-3#1)(2008-10#2)(2008-5#1)
rapid and reversible##2##3##(1993-6#1)(2008-11#1)
rapid and robust##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
rapid and selective determination##2##4##(2008-10#2)
rapid and selective##6##3##(2008-10#6)
rapid and sensitive and has been##2##6##(2008-10#2)
rapid and sensitive and##4##4##(2008-10#4)
rapid and sensitive flow injection##3##5##(2008-10#3)
rapid and sensitive liquid chromatographic technique to determine##2##8##(1992-6#1)(1993-9#1)
rapid and sensitive method for the determination of##5##8##(2008-10#5)
rapid and sensitive method for the##12##6##(2007-7#1)(2008-10#9)(2008-5#1)(2010-4#1)
rapid and sensitive method for##13##5##(2007-7#1)(2008-10#10)(2008-5#1)(2010-4#1)
rapid and sensitive method is##3##5##(2008-10#3)
rapid and sensitive method was##2##5##(2008-10#2)
rapid and sensitive method##20##4##(1991-5#1)(2007-7#1)(2008-10#15)(2008-5#1)(2010-4#1)(2011-2#1)
rapid and sensitive procedure##2##4##(2008-10#2)
rapid and sensitive spectrophotometric method has been developed for the assay of##2##12##(2008-10#2)
rapid and sensitive spectrophotometric##4##4##(2008-10#4)
rapid and sensitive##64##3##(1990-12#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-3#1)(2007-7#1)(2008-10#48)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
rapid and simple method##4##4##(2008-10#2)(2008-12#1)(2012-3#1)
rapid and simple##24##3##(2008-10#18)(2008-11#2)(2008-12#1)(2008-4#1)(2009-11#1)(2012-3#1)
rapid and simultaneous##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
rapid and specific##6##3##(2008-10#5)(2008-7#1)
rapid and suitable for automatic and continuous analysis##2##8##(2008-10#2)
rapid and suitable for##3##4##(2008-10#3)
rapid and transient##7##3##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1996-2#1)(1997-1#1)
rapid and##260##2##(1990-12#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-3#2)(1992-6#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-7#3)(2008-10#148)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#6)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
rapid antigen detection##2##3##(2007-2#1)(2007-7#1)
rapid as##3##2##(1993-1#1)(2007-2#1)(2008-9#1)
rapid assay##4##2##(1993-12#1)(2008-10#2)(2008-11#1)
rapid assays of##2##3##(2008-10#1)(2008-9#1)
rapid assessment of##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
rapid assessment##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)
rapid bone loss##3##3##(1993-11#1)(2008-11#1)(2012-12#1)
rapid cell death##2##3##(2008-10#2)
rapid cell##8##2##(1994-11#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-1#1)
rapid change in##3##3##(1996-2#1)(2008-10#1)(2013-1#1)
rapid change##7##2##(1993-12#1)(1996-2#1)(1997-3#2)(2008-1#1)(2008-10#1)(2013-1#1)
rapid changes in the##2##4##(2008-11#1)(2009-5#1)
rapid changes in##5##3##(1990-8#1)(1996-3#1)(2008-11#1)(2008-9#1)(2009-5#1)
rapid changes##8##2##(1990-6#1)(1990-8#1)(1993-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)
rapid clearance##2##2##(1992-10#1)(2008-10#1)
rapid clinical##4##2##(2008-7#1)(2011-2#2)(2013-7#1)
rapid contraction##2##2##(2009-11#1)(2011-1#1)
rapid convergence##2##2##(2007-12#1)(2008-8#1)
rapid cycle##2##2##(2008-7#1)(2013-8#1)
rapid death##2##2##(2007-6#1)(2008-10#1)
rapid decline##6##2##(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
rapid decompression and##2##3##(2008-3#1)(2008-7#1)
rapid decrease of##2##3##(1996-11#1)(2008-7#1)
rapid decrease##5##2##(1990-12#1)(1996-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
rapid degradation##2##2##(1990-7#1)(2008-5#1)
rapid depletion of##2##3##(2008-10#1)(2008-5#1)
rapid desensitization protocols##2##3##(2008-8#2)
rapid desensitization to##2##3##(2011-1#2)
rapid desensitization##7##2##(1992-3#1)(2008-8#4)(2011-1#2)
rapid desensitizations##3##2##(2008-8#3)
rapid detection of the##2##4##(2008-10#2)
rapid detection of##13##3##(1995-2#1)(1997-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
rapid detection##19##2##(1993-12#1)(1995-2#1)(1997-3#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
rapid deterioration##2##2##(1993-2#1)(2008-1#1)
rapid determination of the##2##4##(2008-10#2)
rapid determination of##20##3##(2007-12#1)(2008-10#18)(2011-2#1)
rapid determination##21##2##(2007-12#1)(2008-10#19)(2011-2#1)
rapid development of##16##3##(1990-2#1)(1994-12#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
rapid development##18##2##(1990-2#1)(1994-12#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2012-2#1)(2013-8#2)
rapid developments##2##2##(1992-12#1)(2010-12#1)
rapid diagnosis and##2##3##(2008-7#1)(2012-12#1)
rapid diagnosis of##7##3##(2007-7#2)(2007-8#1)(2008-10#2)(2010-5#1)(2012-2#1)
rapid diagnosis##13##2##(1996-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)
rapid diagnostic tests##3##3##(2013-1#3)
rapid diagnostic##8##2##(2007-9#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#3)
rapid differential##3##2##(2008-10#2)(2013-8#1)
rapid dip stick##2##3##(2010-8#2)
rapid disease progression##2##3##(2009-9#1)(2013-1#1)
rapid diversification of##2##3##(2008-8#1)(2010-5#1)
rapid during the##2##3##(2008-10#1)(2008-12#1)
rapid enough##2##2##(1992-6#1)(2007-12#1)
rapid enzymatic assay of##2##4##(2008-10#2)
rapid establishment of##2##3##(1993-9#1)(2008-11#1)
rapid evaluation of##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
rapid evolution of the##3##4##(1994-8#1)(2006-10#1)(2013-1#1)
rapid evolution of##7##3##(1994-8#1)(2006-10#1)(2008-10#1)(2008-8#3)(2013-1#1)
rapid evolution##10##2##(1994-8#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-8#1)(2013-1#1)
rapid evolutionary##2##2##(2007-12#1)(2011-2#1)
rapid exchange##3##2##(1991-8#1)(1995-2#1)(2008-10#1)
rapid expansion of##8##3##(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
rapid expression of##2##3##(1995-2#1)(2008-11#1)
rapid extraction##4##2##(2007-11#1)(2008-10#3)
rapid eye movement (REM) sleep##5##5##(1990-7#1)(1991-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
rapid fall##2##2##(1991-3#1)(2008-7#1)
rapid functional##2##2##(1996-6#1)(2012-2#1)
rapid generation of##2##3##(2009-9#1)(2013-8#1)
rapid growth and##3##3##(1992-2#1)(1996-3#1)(2010-2#1)
rapid growth in the##3##4##(2009-11#1)(2009-3#1)(2010-11#1)
rapid growth in##7##3##(1992-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(2009-11#1)(2009-3#1)(2010-11#1)
rapid growth of the##2##4##(1991-9#1)(2008-7#1)
rapid growth of##8##3##(1990-11#1)(1991-12#1)(1991-9#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-3#2)
rapid growth rate##2##3##(1992-2#2)
rapid growth##31##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#4)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-3#2)
rapid identification of##9##3##(2007-7#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-4#2)(2013-1#1)
rapid identification protocol##3##3##(2007-7#3)
rapid identification##14##2##(2007-7#4)(2008-10#4)(2008-12#1)(2008-9#1)(2010-12#1)(2010-4#2)(2013-1#1)
rapid in##5##2##(1991-12#1)(1991-6#1)(2008-10#2)(2008-3#1)
rapid inactivation##2##2##(1990-5#1)(1993-11#1)
rapid increase in electrolyte leakage##2##5##(2008-10#2)
rapid increase in the demand for medical manpower##2##8##(1990-6#2)
rapid increase in the##6##4##(1990-2#1)(1990-6#2)(1995-6#1)(2008-10#1)(2013-8#1)
rapid increase in##19##3##(1990-2#1)(1990-6#2)(1991-12#1)(1992-9#1)(1995-6#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
rapid increase of##8##3##(1990-7#1)(1994-2#1)(2007-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
rapid increase##28##2##(1990-2#1)(1990-6#2)(1990-7#1)(1991-12#1)(1992-9#1)(1994-2#1)(1995-6#1)(1997-1#1)(2007-10#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
rapid increases in##3##3##(1995-3#1)(1996-12#1)(2008-10#1)
rapid increases##4##2##(1995-3#1)(1996-12#1)(2008-10#1)(2010-12#1)
rapid induction of##4##3##(1992-12#1)(2008-10#2)(2012-12#1)
rapid influenza diagnostic test methods##2##5##(2011-1#2)
rapid influenza##5##2##(2011-1#2)(2011-2#3)
rapid inhibition of##4##3##(1992-12#1)(1992-3#1)(2008-5#1)(2008-8#1)
rapid initial##3##2##(2008-3#1)(2013-1#2)
rapid intravenous administration of phenytoin##2##5##(2008-7#2)
rapid invasion of##2##3##(1994-9#1)(2008-12#1)
rapid isolation##2##2##(2008-10#1)(2008-11#1)
rapid local##2##2##(2008-11#1)(2008-7#1)
rapid loss of##2##3##(2008-6#1)(2008-9#1)
rapid manner##2##2##(2010-7#1)(2012-2#1)
rapid means of##2##3##(1994-12#1)(2008-10#1)
rapid method for determining##2##4##(2008-10#2)
rapid method for simultaneous determination of##2##6##(2008-10#2)
rapid method for the determination of##5##6##(2008-10#5)
rapid method for the##12##4##(2008-10#10)(2010-12#1)(2011-1#1)
rapid method for##25##3##(1990-11#1)(1991-11#1)(1995-2#1)(2008-10#18)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)
rapid method has been developed for the determination##2##8##(2008-10#2)
rapid method is described for the##2##6##(2008-10#2)
rapid method is##3##3##(2008-10#3)
rapid method##41##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1994-11#1)(1995-2#1)(2008-10#27)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
rapid methods##2##2##(2008-10#1)(2008-5#1)
rapid migration of##2##3##(1992-6#1)(2011-2#1)
rapid molecular##3##2##(2010-5#2)(2013-7#1)
rapid noninvasive##2##2##(2012-2#1)(2013-8#1)
rapid on-line##2##2##(2008-10#2)
rapid onset of##2##3##(2008-3#2)
rapid onset##3##2##(2008-3#2)(2013-1#1)
rapid pace of##2##3##(1996-2#1)(2011-1#1)
rapid pace##6##2##(1994-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
rapid peak##2##2##(1993-3#2)
rapid phase##3##2##(1993-11#1)(1996-1#1)(2008-5#1)
rapid phosphorylation of##3##3##(1990-12#1)(1991-5#1)(1993-6#1)
rapid polymerase chain reaction-based##2##4##(2008-10#2)
rapid polymerase chain##3##3##(2008-10#3)
rapid potentiometric##2##2##(2008-10#2)
rapid procedure##6##2##(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#3)
rapid processing and##2##3##(2009-10#1)(2010-5#1)
rapid production of large quantities of##2##6##(2008-11#2)
rapid production of##3##3##(1995-8#1)(2008-11#2)
rapid production##4##2##(1995-8#1)(2008-10#1)(2008-11#2)
rapid progress##5##2##(1993-3#1)(2008-10#1)(2008-11#2)(2008-7#1)
rapid progression of##2##3##(2009-4#1)(2011-2#1)
rapid progression##5##2##(2008-1#2)(2009-10#1)(2009-4#1)(2011-2#1)
rapid prototyping##5##2##(2008-3#1)(2008-8#1)(2009-9#1)(2010-9#2)
rapid quality control of##2##4##(2011-1#1)(2012-2#1)
rapid quality##3##2##(2011-1#1)(2012-2#2)
rapid quench of##2##3##(1992-5#2)
rapid radiation##2##2##(1996-4#1)(2008-7#1)
rapid rate of##2##3##(1991-1#1)(1995-11#1)
rapid recovery##4##2##(1993-8#1)(1995-5#1)(2011-2#1)(2012-2#1)
rapid release of##2##3##(1990-5#1)(1991-8#1)
rapid removal##2##2##(1990-2#1)(1994-5#1)
rapid response time##2##3##(2008-10#2)
rapid response##7##2##(1992-1#1)(2007-11#1)(2008-10#4)(2011-2#1)
rapid responses##7##2##(1994-3#1)(2007-8#5)(2012-2#1)
rapid rise##2##2##(1994-1#1)(1994-2#1)
rapid screening methods for##2##4##(1997-4#1)(2008-10#1)
rapid screening of##8##3##(2007-11#2)(2008-10#2)(2008-11#2)(2008-4#1)(2013-1#1)
rapid screening##14##2##(1997-4#2)(2007-11#2)(2008-10#5)(2008-11#2)(2008-4#1)(2010-5#1)(2013-1#1)
rapid separation and purification of acid-soluble nuclear proteins##2##8##(1997-2#2)
rapid separation and purification of##3##5##(1997-2#2)(2008-10#1)
rapid separation and##6##3##(1997-2#2)(2008-10#4)
rapid separation of##3##3##(1996-5#1)(2008-10#2)
rapid separation##11##2##(1996-5#1)(1997-2#2)(2008-10#8)
rapid serial visual presentation##2##4##(2009-4#1)(2010-7#1)
rapid spectrophotometric method for the determination of##2##7##(2008-10#2)
rapid spectrophotometric method##4##3##(2008-10#4)
rapid spectrophotometric##6##2##(2008-10#6)
rapid spread of the##2##4##(2008-10#1)(2011-2#1)
rapid spread of##5##3##(1996-12#1)(2008-10#3)(2011-2#1)
rapid spread##10##2##(1996-12#1)(2008-1#1)(2008-10#3)(2008-9#4)(2011-2#1)
rapid staining##3##2##(1991-2#1)(2008-2#1)(2008-4#1)
rapid stimulation of##2##3##(2008-10#1)(2012-2#1)
rapid synthesis of##3##3##(1992-8#1)(2008-10#1)(2008-12#1)
rapid technique for the##2##4##(2008-10#1)(2008-8#1)
rapid technique##5##2##(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#1)
rapid technological##2##2##(2008-7#1)(2013-1#1)
rapid test##2##2##(1990-12#1)(2008-10#1)
rapid trace##2##2##(2008-10#2)
rapid transcription##2##2##(2008-10#1)(2011-2#1)
rapid transcriptional##2##2##(1994-8#1)(2010-5#1)
rapid turnover of the##2##4##(1990-7#1)(1992-1#1)
rapid turnover of##3##3##(1990-7#1)(1992-1#1)(1993-9#1)
rapid turnover##4##2##(1990-7#1)(1992-1#1)(1993-9#1)(2008-1#1)
rapid visual##2##2##(2008-7#1)(2011-2#1)
rapid wastewater toxicity assessment##2##4##(2008-10#2)
rapid with##3##2##(2008-10#2)(2012-2#1)
rapid##1361##1##(1990-11#3)(1990-12#16)(1990-2#7)(1990-5#4)(1990-6#4)(1990-7#6)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#5)(1992-5#2)(1992-6#7)(1992-8#4)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#5)(1994-2#8)(1994-3#7)(1994-5#6)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#10)(1995-3#4)(1995-5#3)(1995-6#6)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#6)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#7)(1997-4#7)(1997-6#2)(1997-7#2)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#8)(2007-12#21)(2007-2#6)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#18)(2007-8#11)(2007-9#1)(2008-1#11)(2008-10#481)(2008-11#45)(2008-12#14)(2008-2#12)(2008-3#25)(2008-4#28)(2008-5#24)(2008-6#6)(2008-7#40)(2008-8#37)(2008-9#37)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#1)(2010-3#5)(2010-4#8)(2010-5#16)(2010-6#6)(2010-7#6)(2010-8#8)(2010-9#5)(2011-1#23)(2011-2#38)(2011-3#2)(2012-1#4)(2012-12#6)(2012-2#23)(2012-3#11)(2013-1#24)(2013-7#3)(2013-8#15)
rapid-cycling##4##1##(1996-7#3)(2008-4#1)
rapid-switching##2##1##(2008-2#2)
rapide##2##1##(2011-2#1)(2013-1#1)
rapidity and##5##2##(1990-12#1)(1997-4#1)(2008-10#2)(2009-6#1)
rapidity of##7##2##(1992-9#1)(1993-5#1)(1995-3#1)(2008-10#2)(2011-1#1)(2011-2#1)
rapidity##28##1##(1990-12#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-5#1)(1995-3#1)(1997-4#1)(2008-10#16)(2008-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
rapidly (within##3##2##(1996-2#1)(1997-6#1)(2008-10#1)
rapidly absorbed##2##2##(1996-1#1)(2012-12#1)
rapidly acquire##3##2##(2008-4#1)(2011-1#2)
rapidly activated##2##2##(1993-11#1)(1993-9#1)
rapidly after##5##2##(1994-3#1)(1996-1#1)(2008-10#2)(2008-11#1)
rapidly among##4##2##(1990-3#1)(1996-11#2)(2008-10#1)
rapidly and accurately##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
rapidly and completely##3##3##(1991-8#1)(2008-7#1)(2008-8#1)
rapidly and easily##4##3##(2008-10#2)(2008-4#1)(2010-6#1)
rapidly and effectively##2##3##(1995-1#1)(1995-5#1)
rapidly and efficiently##2##3##(2008-9#1)(2012-2#1)
rapidly and quantitatively##2##3##(2008-10#2)
rapidly and##52##2##(1990-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
rapidly as the##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
rapidly as##8##2##(1994-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)
rapidly at higher temperatures##2##4##(2008-10#1)(2008-6#1)
rapidly at##6##2##(2008-10#4)(2008-6#1)(2012-2#1)
rapidly becoming##4##2##(2008-2#1)(2008-4#1)(2009-6#1)(2012-2#1)
rapidly by##3##2##(1992-5#1)(2008-11#1)(2008-3#1)
rapidly changing environment##2##3##(2007-10#1)(2008-10#1)
rapidly changing##14##2##(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2012-2#1)
rapidly declined##2##2##(2008-10#2)
rapidly decreased in##2##3##(2008-10#1)(2008-11#1)
rapidly decreased##5##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
rapidly decreases##3##2##(1997-1#1)(2008-5#1)(2010-12#1)
rapidly degraded##2##2##(2006-6#1)(2008-7#1)
rapidly detect##5##2##(2008-10#2)(2008-4#1)(2012-2#2)
rapidly deteriorating##2##2##(2008-7#1)(2012-12#1)
rapidly determine##2##2##(2008-10#2)
rapidly developing##5##2##(1992-9#1)(2008-11#2)(2008-12#1)(2011-2#1)
rapidly diffuse##2##2##(1990-11#1)(2008-4#1)
rapidly during the##3##3##(1993-12#1)(1997-1#1)(2008-10#1)
rapidly emerging##5##2##(1992-1#1)(1993-12#1)(2008-10#2)(2010-8#1)
rapidly enter##2##2##(2012-2#2)
rapidly established##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
rapidly evolving health care##2##4##(1994-1#1)(2008-1#1)
rapidly evolving##8##2##(1994-1#1)(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
rapidly exchangeable sites##3##3##(1995-6#3)
rapidly expanding field##4##3##(1994-3#1)(1994-9#1)(2008-5#1)(2008-7#1)
rapidly expanding##9##2##(1994-3#1)(1994-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2013-1#1)
rapidly fatal##3##2##(1995-1#1)(1996-3#1)(2013-1#1)
rapidly following##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
rapidly formed##2##2##(1992-9#1)(2008-11#1)
rapidly from the##2##3##(2008-3#1)(2009-11#1)
rapidly from##9##2##(1990-5#1)(1991-11#1)(1991-2#1)(2008-10#3)(2008-3#1)(2009-11#1)(2010-6#1)
rapidly growing inoperable breast##2##4##(1992-10#2)
rapidly growing##24##2##(1990-5#1)(1991-6#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-2#1)(1994-8#1)(2007-7#1)(2008-12#2)(2008-6#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
rapidly identified##3##2##(1995-3#1)(2008-10#2)
rapidly improved##2##2##(1994-3#1)(2013-8#1)
rapidly improving##2##2##(1990-8#1)(2008-7#1)
rapidly in the##6##3##(1995-3#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2010-5#1)
rapidly in##20##2##(1992-11#1)(1994-1#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-7#1)(2012-2#1)
rapidly increased in##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
rapidly increased##9##2##(1990-7#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
rapidly increasing##5##2##(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
rapidly induced by##3##3##(1994-11#1)(1994-12#1)(1996-12#1)
rapidly induced##8##2##(1991-2#1)(1991-5#1)(1991-7#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-1#1)
rapidly internalized##2##2##(1993-6#1)(1994-6#1)
rapidly lost##2##2##(2008-11#1)(2011-3#1)
rapidly on##2##2##(2008-10#1)(2008-8#1)
rapidly over the##2##3##(1991-2#1)(1993-11#1)
rapidly over##4##2##(1991-2#1)(1993-11#1)(2008-8#1)(2009-10#1)
rapidly performed##2##2##(1990-12#1)(2006-12#1)
rapidly phosphorylated##3##2##(1991-5#1)(1995-8#1)(2009-5#1)
rapidly processed##2##2##(1994-5#1)(2012-2#1)
rapidly progressing##5##2##(2007-12#1)(2008-1#1)(2010-12#1)(2010-5#1)(2011-2#1)
rapidly progressive glomerulonephritis##4##3##(2007-7#2)(2008-1#1)(2008-7#1)
rapidly progressive##12##2##(1993-2#1)(2007-7#3)(2008-1#3)(2008-7#1)(2011-2#2)(2013-1#2)
rapidly reversible##5##2##(1990-5#2)(1992-3#3)
rapidly rising##2##2##(1991-12#1)(1992-3#1)
rapidly since##2##2##(1991-6#1)(2008-2#1)
rapidly spread##2##2##(2008-10#1)(2008-6#1)
rapidly stimulates##2##2##(1992-10#1)(1997-1#1)
rapidly than other##2##3##(2008-10#1)(2012-3#1)
rapidly than##17##2##(1992-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
rapidly the##2##2##(1994-9#1)(2008-10#1)
rapidly through##5##2##(1992-6#1)(1996-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
rapidly to infection##2##3##(2008-10#1)(2008-2#1)
rapidly to##9##2##(1990-8#1)(1993-12#1)(1996-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-9#1)(2013-1#1)
rapidly varying##2##2##(2008-3#2)
rapidly when##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
rapidly while##2##2##(2008-10#1)(2008-4#1)
rapidly with increasing##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
rapidly with the##2##3##(2007-12#1)(2008-8#1)
rapidly with##11##2##(1997-7#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
rapidly##600##1##(1990-11#3)(1990-12#1)(1990-3#3)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#6)(1992-5#2)(1992-6#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#6)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#6)(1995-3#5)(1995-5#3)(1995-6#6)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#4)(1996-5#2)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#4)(2007-11#6)(2007-12#11)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#107)(2008-11#31)(2008-12#8)(2008-2#11)(2008-3#19)(2008-4#16)(2008-5#9)(2008-6#8)(2008-7#21)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#4)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#20)(2012-3#3)(2012-8#1)(2013-1#12)(2013-8#5)
rapidly-growing##2##1##(1990-5#2)
rapidness and##2##2##(2008-10#1)(2013-8#1)
rapifera##2##1##(2008-10#2)
rapists##2##1##(1992-9#1)(2009-10#1)
rapport and##2##2##(2008-11#1)(2008-8#1)
rapport##6##1##(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
rapportons un cas##2##3##(2011-2#1)(2013-1#1)
rapportons##8##1##(2011-2#2)(2013-1#6)
rare (1##2##2##(2008-10#1)(2012-12#1)
rare alleles##9##2##(2008-10#2)(2012-3#7)
rare and a##3##3##(1990-9#1)(2010-12#1)(2012-2#1)
rare and aggressive##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
rare and are##2##3##(2008-7#2)
rare and associated with##2##4##(2008-6#1)(2011-3#1)
rare and common##2##3##(2010-5#1)(2012-3#1)
rare and difficult to##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
rare and has been reported##2##5##(1992-8#1)(2007-11#1)
rare and in##2##3##(1992-9#1)(1993-8#1)
rare and is##5##3##(1990-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
rare and metastasis##2##3##(2008-6#1)(2010-6#1)
rare and most##2##3##(1991-11#1)(2009-5#1)
rare and only##3##3##(1991-11#1)(2010-6#1)(2013-8#1)
rare and the##3##3##(2007-8#1)(2012-3#1)(2013-1#1)
rare and unusual##2##3##(2008-11#1)(2011-1#1)
rare and was##3##3##(2008-12#1)(2009-10#1)(2012-3#1)
rare and##87##2##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-6#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#4)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#6)
rare anomalies##2##2##(2008-10#1)(2008-7#1)
rare anomaly##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
rare association##7##2##(2007-2#1)(2008-10#1)(2010-8#2)(2012-12#1)(2012-2#2)
rare autoimmune##2##2##(1997-5#1)(2013-8#1)
rare because##2##2##(2008-4#1)(2009-3#1)
rare benign mesenchymal##2##3##(2010-6#1)(2013-7#1)
rare benign tumors of the##2##5##(2010-3#1)(2013-8#1)
rare benign tumour##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
rare benign##15##2##(1992-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
rare but devastating##2##3##(2008-9#1)(2011-1#1)
rare but important cause##2##4##(2007-2#1)(2008-7#1)
rare but life threatening##2##4##(2008-8#1)(2011-2#1)
rare but life-threatening##2##3##(2008-12#1)(2012-12#1)
rare but serious##3##3##(2007-7#1)(2008-11#1)(2011-2#1)
rare but##25##2##(1992-12#1)(1996-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
rare case and review##2##4##(2013-1#2)
rare case of a##13##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-2#1)
rare case of an##2##4##(1992-12#1)(2012-2#1)
rare case of breast##2##4##(1992-6#1)(2008-10#1)
rare case of herniation of##2##5##(2007-8#1)(2011-2#1)
rare case of short bowel##2##5##(2008-10#2)
rare case of##83##3##(1990-5#2)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#9)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#5)(2013-2#1)(2013-7#1)
rare case report##7##3##(2007-7#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
rare case with##3##3##(2008-12#1)(2008-7#1)(2010-5#1)
rare case##100##2##(1990-5#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-7#1)(1997-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#5)(2008-6#2)(2008-7#12)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#4)(2011-2#9)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#9)(2013-2#1)(2013-7#1)(2013-8#1)
rare cases of##3##3##(1993-3#2)(2008-7#1)
rare cases##15##2##(1993-3#2)(1993-6#1)(1993-8#1)(2007-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-6#1)(2010-4#1)(2011-2#2)
rare causal variants##2##3##(2012-3#2)
rare cause of intestinal obstruction##2##5##(2008-12#2)
rare cause of##26##3##(2007-12#1)(2007-8#1)(2008-12#3)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
rare cause##31##2##(1996-6#1)(2007-12#1)(2007-8#1)(2008-12#3)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
rare causes of##2##3##(2009-7#1)(2012-12#1)
rare causes##3##2##(2009-7#1)(2010-11#1)(2012-12#1)
rare cells##5##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#1)
rare chez##2##2##(2013-1#2)
rare clinical##7##2##(1991-12#1)(2008-10#1)(2009-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
rare combination of##2##3##(2009-11#1)(2012-3#1)
rare combination##4##2##(2007-7#1)(2009-11#1)(2012-3#1)(2013-1#1)
rare compared to##2##3##(1993-5#1)(2012-12#1)
rare complication after##5##3##(2007-8#2)(2008-12#1)(2009-3#1)(2012-12#1)
rare complication in patients with##3##5##(2007-10#1)(2011-2#1)(2012-1#1)
rare complication of##36##3##(1990-5#1)(1991-5#1)(1993-5#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)
rare complication##53##2##(1990-5#1)(1991-5#1)(1992-11#1)(1993-5#1)(1996-3#1)(2006-10#1)(2007-10#2)(2007-8#4)(2008-1#1)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-3#2)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#5)
rare condition with only##2##4##(2007-8#1)(2012-3#1)
rare condition with##5##3##(1992-9#1)(2007-8#1)(2008-10#1)(2012-3#2)
rare condition##27##2##(1990-12#1)(1992-9#1)(1993-3#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#3)(2008-10#3)(2008-7#3)(2008-8#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#3)(2013-8#1)
rare congenital anomaly in##2##4##(1991-8#1)(2008-9#1)
rare congenital anomaly##5##3##(1991-8#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-5#1)
rare congenital cardiac##2##3##(2010-6#1)(2012-2#1)
rare congenital malformation##5##3##(2008-10#2)(2008-11#2)(2013-8#1)
rare congenital##15##2##(1991-8#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2010-11#2)(2010-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
rare connective tissue disease##2##4##(1995-11#2)
rare coronary anomaly##2##3##(2009-11#1)(2011-2#1)
rare cutting enzymes##2##3##(1992-6#1)(1996-6#1)
rare cutting##3##2##(1992-6#1)(1996-6#1)(2008-10#1)
rare diagnosis##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
rare disease in##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
rare disease with a##2##4##(1997-5#1)(2008-12#1)
rare disease##30##2##(1992-12#1)(1992-4#1)(1993-6#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
rare diseases in##2##3##(2011-7#1)(2013-1#1)
rare diseases##11##2##(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-7#3)(2013-1#3)
rare disorder##6##2##(1991-11#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#2)
rare earth element##4##3##(2008-10#4)
rare earth elements (REE) in##2##5##(2008-10#2)
rare earth elements (REE)##6##4##(2008-10#5)(2012-2#1)
rare earth elements (REEs)##4##4##(2008-10#3)(2008-9#1)
rare earth elements and##3##4##(2008-10#3)
rare earth elements in soils and sediments##2##7##(2008-10#2)
rare earth elements in##7##4##(2008-10#7)
rare earth elements##25##3##(2008-10#23)(2008-9#1)(2012-2#1)
rare earth mixtures##2##3##(2008-10#2)
rare earth##46##2##(2007-12#1)(2008-10#43)(2008-9#1)(2012-2#1)
rare earths and##4##3##(2008-10#4)
rare earths has been##2##4##(2008-10#2)
rare earths with##2##3##(2008-10#2)
rare earths##18##2##(1992-11#1)(2008-10#17)
rare entities##2##2##(2008-3#1)(2012-12#1)
rare entity and##4##3##(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)
rare entity having##2##3##(2010-11#1)(2012-3#1)
rare entity in##2##3##(2011-2#1)(2013-8#1)
rare entity of##3##3##(2008-6#1)(2009-4#1)(2012-1#1)
rare entity##35##2##(1993-8#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
rare event##11##2##(2007-7#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
rare events##5##2##(1996-12#1)(2008-6#1)(2008-9#2)(2010-1#1)
rare exceptions##2##2##(2008-12#2)
rare finding##4##2##(1992-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
rare for##5##2##(1997-2#1)(2007-7#1)(2008-6#1)(2009-5#1)(2011-1#1)
rare form of##9##3##(1991-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
rare form##10##2##(1991-6#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
rare functional variants##2##3##(2012-3#2)
rare genetic##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
rare genotypes##2##2##(2008-10#1)(2008-8#1)
rare group of##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
rare in Western countries##2##4##(1996-8#1)(2008-2#1)
rare in adults##3##3##(2008-5#1)(2012-12#1)(2013-8#1)
rare in childhood##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
rare in children##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
rare in other##2##3##(2008-5#1)(2008-9#1)
rare in the literature##2##4##(2012-1#1)(2012-2#1)
rare in the##13##3##(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)
rare in##60##2##(1990-9#1)(1991-11#1)(1996-11#2)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
rare inflammatory##3##2##(2011-1#1)(2013-1#2)
rare inherited##2##2##(2008-11#1)(2011-2#1)
rare injury##4##2##(2007-8#1)(2009-3#1)(2010-7#1)(2012-2#1)
rare lesion##4##2##(1990-10#1)(1993-12#1)(2008-10#1)(2013-1#1)
rare lesions##5##2##(1991-5#1)(2008-1#1)(2011-7#1)(2012-2#1)(2012-3#1)
rare leukodystrophy##2##2##(2012-12#2)
rare localization##3##2##(1992-6#1)(2008-10#1)(2010-3#1)
rare location of##2##3##(1996-9#1)(2007-12#1)
rare location##4##2##(1996-9#1)(2007-12#1)(2012-12#1)(2013-1#1)
rare malignancy##2##2##(1997-5#1)(2010-3#1)
rare malignant tumor of the##2##5##(2007-8#1)(2008-10#1)
rare malignant tumor##4##3##(2007-5#1)(2007-8#1)(2008-10#1)(2013-1#1)
rare malignant##6##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#2)(2013-1#1)
rare manifestation##2##2##(2006-10#1)(2012-12#1)
rare mitotic figures##3##3##(1997-6#2)(2008-11#1)
rare mutation##3##2##(2008-2#1)(2011-1#1)(2011-3#1)
rare mutations##2##2##(1993-6#1)(2011-1#1)
rare neoplasm##11##2##(1991-5#1)(1993-8#1)(2007-5#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-8#1)
rare neoplasms##3##2##(2007-10#1)(2008-1#1)(2011-2#1)
rare occurrence and##2##3##(1992-9#1)(2011-2#1)
rare occurrence of##3##3##(2008-10#2)(2013-1#1)
rare occurrence##16##2##(1992-9#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-3#2)(2009-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
rare on##3##2##(2008-10#2)(2008-7#1)
rare or##3##2##(2008-5#1)(2008-8#1)(2013-1#1)
rare pathology##2##2##(1992-6#1)(2007-8#1)
rare phenomenon##6##2##(1996-2#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-12#1)
rare presentation of##3##3##(2007-7#1)(2010-12#1)(2012-3#1)
rare presentation##9##2##(2007-7#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
rare primary##4##2##(1993-3#1)(2010-11#1)(2010-6#1)(2012-12#1)
rare side##3##2##(1991-3#2)(2010-4#1)
rare site##3##2##(2007-5#1)(2008-6#1)(2010-3#1)
rare skin##2##2##(2011-2#1)(2013-7#1)
rare small##2##2##(1993-9#1)(1997-3#1)
rare soft tissue##3##3##(2007-8#1)(2011-2#1)(2013-7#1)
rare syndrome##3##2##(1997-3#1)(2008-11#1)(2012-2#1)
rare to##2##2##(2008-10#1)(2008-11#1)
rare tumor and##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
rare tumor of the##2##4##(2008-10#1)(2012-3#1)
rare tumor##12##2##(1991-6#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
rare tumors##10##2##(1990-6#1)(1997-8#1)(2006-12#1)(2007-5#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
rare tumour##3##2##(2008-8#1)(2012-2#1)(2013-7#1)
rare tumours##8##2##(2007-8#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
rare type of##3##3##(1997-7#1)(2011-2#1)(2012-3#1)
rare variant genotypes predict##2##4##(2012-3#2)
rare variant genotypes##3##3##(2012-3#3)
rare variant of##7##3##(1990-6#1)(2008-12#1)(2008-6#2)(2009-10#1)(2012-3#1)(2013-1#1)
rare variant##13##2##(1990-6#1)(2008-11#1)(2008-12#1)(2008-6#2)(2009-10#1)(2010-6#1)(2012-3#5)(2013-1#1)
rare variants are##3##3##(2012-3#3)
rare variants in##5##3##(2012-3#5)
rare variants with##2##3##(2012-3#2)
rare variants##39##2##(1990-8#1)(1991-8#1)(2012-3#37)
rare variety of##2##3##(2008-10#1)(2011-2#1)
rare variety##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
rare vascular##2##2##(2007-7#1)(2013-1#1)
rare with##4##2##(1997-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
rare yet##2##2##(2012-2#1)(2013-1#1)
rare##1349##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#6)(1990-6#4)(1990-8#5)(1990-9#3)(1991-11#10)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#6)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-4#2)(1992-5#4)(1992-6#6)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#3)(1993-6#6)(1993-8#5)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#7)(1997-5#4)(1997-6#4)(1997-7#3)(1997-8#5)(2006-10#8)(2006-12#2)(2007-10#7)(2007-11#11)(2007-12#10)(2007-2#5)(2007-4#2)(2007-5#12)(2007-6#2)(2007-7#21)(2007-8#40)(2008-1#13)(2008-10#148)(2008-11#24)(2008-12#37)(2008-2#11)(2008-3#6)(2008-4#9)(2008-5#12)(2008-6#22)(2008-7#58)(2008-8#18)(2008-9#30)(2009-1#6)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#16)(2009-4#7)(2009-5#14)(2009-6#1)(2009-7#7)(2009-8#8)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#13)(2010-12#17)(2010-2#1)(2010-3#20)(2010-4#3)(2010-5#16)(2010-6#12)(2010-7#5)(2010-8#7)(2011-1#34)(2011-2#87)(2011-3#3)(2011-7#4)(2012-1#8)(2012-12#48)(2012-2#47)(2012-3#106)(2012-8#1)(2012-9#1)(2013-1#105)(2013-2#1)(2013-7#15)(2013-8#30)
rare-cutting##3##1##(1996-6#1)(1997-2#1)(2008-10#1)
rare-earth elements##4##2##(2008-10#4)
rare-earth ions##2##2##(2007-11#1)(2008-3#1)
rare-earth##13##1##(2007-11#1)(2008-10#5)(2008-2#6)(2008-3#1)
rare-earth-doped crystals##2##2##(2007-12#2)
rare-earth-doped##6##1##(2007-12#3)(2008-2#2)(2008-3#1)
rare-event analysis##2##2##(2008-9#2)
rarefaction is##3##2##(2009-5#3)
rarefaction##11##1##(1991-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#5)(2012-3#1)
rarely affected##2##2##(2008-10#2)
rarely been described##2##3##(2011-2#1)(2012-2#1)
rarely been reported previously##2##4##(2006-10#1)(2013-8#1)
rarely been reported##9##3##(1990-6#1)(1991-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2009-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
rarely been##19##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-8#1)
rarely caused by##2##3##(1996-11#1)(2007-7#1)
rarely causes##2##2##(2011-2#1)(2012-12#1)
rarely described in##2##3##(2008-7#1)(2010-12#1)
rarely described##4##2##(2008-7#2)(2010-12#1)(2012-3#1)
rarely diagnosed##4##2##(1995-11#1)(1996-11#1)(2008-7#1)(2013-8#1)
rarely discussed##3##2##(1996-2#1)(1996-6#1)(2008-11#1)
rarely effective##2##2##(2006-10#1)(2012-2#1)
rarely encountered by the##2##4##(2009-3#1)(2013-1#1)
rarely encountered##5##2##(2007-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
rarely found in##8##3##(1990-9#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
rarely found##12##2##(1990-9#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
rarely in the##3##3##(2008-10#2)(2008-5#1)
rarely in##8##2##(1991-2#1)(2007-10#1)(2008-10#2)(2008-5#2)(2013-1#1)(2013-8#1)
rarely include##2##2##(2011-1#1)(2011-2#1)
rarely observed in##3##3##(1990-3#2)(2008-5#1)
rarely observed##5##2##(1990-3#2)(1997-3#1)(2008-10#1)(2008-5#1)
rarely occur in##2##3##(1996-2#1)(2010-11#1)
rarely occurs##3##2##(2008-7#2)(2008-8#1)
rarely present in##4##3##(2006-10#1)(2007-8#1)(2008-6#1)(2009-8#1)
rarely present##6##2##(2006-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)
rarely reported in the literature##2##5##(2011-2#1)(2013-1#1)
rarely reported in the##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
rarely reported in##4##3##(2006-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
rarely reported##9##2##(1991-6#1)(2006-10#2)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#3)
rarely seen in the##2##4##(2012-12#1)(2013-8#1)
rarely seen in##5##3##(1992-11#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
rarely seen##8##2##(1992-11#1)(2007-5#1)(2007-7#1)(2008-11#2)(2011-2#1)(2012-12#1)(2013-8#1)
rarely studied in##2##3##(2007-12#1)(2009-11#1)
rarely studied##3##2##(2007-12#1)(2009-11#1)(2010-1#1)
rarely to##2##2##(2010-3#1)(2011-1#1)
rarely used##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
rarely were##2##2##(1994-6#1)(2008-10#1)
rarely##212##1##(1990-12#1)(1990-3#3)(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#2)(1992-11#1)(1992-2#3)(1992-4#1)(1992-5#3)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#3)(1996-2#2)(1996-5#1)(1996-6#3)(1996-9#2)(1997-2#2)(1997-3#3)(1997-7#1)(2006-10#6)(2007-10#2)(2007-12#2)(2007-5#1)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#14)(2008-8#8)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#6)(2013-1#8)(2013-8#4)
rareness of##2##2##(2008-10#1)(2011-2#1)
rareness##3##1##(2007-5#1)(2008-10#1)(2011-2#1)
rarer than##2##2##(2008-7#1)(2010-12#1)
rarer##21##1##(1993-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
rarest##4##1##(1997-7#1)(2008-4#1)(2010-3#1)(2011-2#1)
rarity and##5##2##(1990-12#1)(2006-12#1)(2008-12#1)(2011-2#2)
rarity of its##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
rarity of this lesion and##2##5##(1990-9#1)(2008-5#1)
rarity of this##9##3##(1990-9#1)(1992-5#1)(2007-10#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#2)
rarity of##25##2##(1990-5#1)(1990-9#1)(1991-11#1)(1992-5#1)(1992-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
rarity##39##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#4)(2010-7#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#3)
ras clone I##6##3##(2008-11#6)
ras gene##6##2##(1990-11#1)(1995-2#1)(1997-4#4)
ras oncogene##6##2##(1991-2#1)(1992-8#1)(2008-11#4)
ras protein##3##2##(1990-11#1)(1994-12#1)(2008-11#1)
ras proteins##3##2##(1990-11#1)(1992-11#2)
ras##39##1##(1990-11#7)(1991-2#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-8#3)(1994-12#1)(1994-6#1)(1995-2#2)(1997-4#4)(2008-11#15)
ras-GAP##2##1##(1992-11#2)
ras-amplified recombinant BHK-21##2##3##(2008-11#2)
ras-amplified##3##1##(2008-11#3)
ras-induced maturation of Xenopus oocytes##2##5##(1991-12#2)
ras-like##2##1##(1992-8#1)(1996-6#1)
ras-p21##2##1##(1991-12#1)(1995-9#1)
ras-rBHK-IgG##3##1##(2008-11#3)
ras-related##3##1##(1992-11#1)(1992-8#1)(1995-8#1)
rasburicase dosing for##2##3##(2008-7#2)
rasburicase##7##1##(2008-7#7)
rash and##5##2##(1997-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
rash is a##2##3##(2007-7#1)(2013-1#1)
rash is##3##2##(2007-7#1)(2013-1#2)
rash on##2##2##(2009-12#1)(2012-3#1)
rash with##2##2##(2006-10#1)(2013-1#1)
rash##48##1##(1991-3#1)(1991-9#1)(1992-11#1)(1995-11#1)(1996-3#1)(1997-6#1)(1997-8#3)(2006-10#4)(2007-12#1)(2007-2#3)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#4)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
rashes are##2##2##(2007-2#1)(2008-12#1)
rashes##9##1##(2007-2#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)
raster images##2##2##(2008-3#2)
raster##4##1##(2008-3#4)
rat A(1)##2##2##(2008-4#2)
rat C6 glioma##2##3##(1994-11#1)(2012-2#1)
rat C6##3##2##(1994-11#2)(2012-2#1)
rat CBF-C##2##2##(1995-2#2)
rat CL##5##2##(2008-8#2)(2008-9#3)
rat DRG##4##2##(1991-12#1)(1993-12#1)(1996-12#1)(2010-12#1)
rat EFIA cDNA##3##3##(1993-2#3)
rat EFIA##4##2##(1993-2#4)
rat Epo##4##2##(2008-11#4)
rat Gadd45 cDNA##2##3##(1994-12#2)
rat Gadd45##3##2##(1994-12#3)
rat HDC##3##2##(1990-12#3)
rat IA2 and IA1##2##4##(1990-5#2)
rat IA2##3##2##(1990-5#3)
rat IGFBP-6 gene##2##3##(1993-3#2)
rat L1##2##2##(1996-12#2)
rat MPP alpha##2##3##(1993-8#2)
rat MTHFR##2##2##(2008-8#2)
rat Microryzomys minutus##2##3##(2008-5#2)
rat NR2C##2##2##(1996-12#2)
rat P-450(11 beta)##2##3##(1990-5#2)
rat PACAP##4##2##(1990-12#4)
rat PROT##2##2##(1995-6#2)
rat Schwann cell incorporation of [3H]thymidine##2##6##(1995-2#2)
rat Schwann##3##2##(1993-5#1)(1995-2#2)
rat TGF-beta type II receptor##2##5##(1993-3#2)
rat adipocytes##7##2##(1992-11#1)(1994-8#1)(1997-1#2)(2008-8#2)(2011-2#1)
rat adipose tissue##4##3##(2008-10#1)(2008-11#2)(2010-6#1)
rat adipose##5##2##(2008-10#1)(2008-11#3)(2010-6#1)
rat adrenal and##2##3##(1995-12#2)
rat adrenal cortex##3##3##(1991-5#1)(1996-2#1)(1996-5#1)
rat adrenal gland##4##3##(1990-5#1)(1996-12#2)(1996-2#1)
rat adrenal medulla pheochromocytoma cell line##2##6##(2008-11#2)
rat adrenal##16##2##(1990-5#1)(1991-12#1)(1991-5#1)(1995-12#4)(1996-12#2)(1996-2#2)(1996-5#1)(2008-11#4)
rat alpha 1-protease inhibitor##2##4##(1990-8#2)
rat alpha##3##2##(1990-8#2)(1993-11#1)
rat alpha-CGRP##2##2##(1992-6#2)
rat alveolar macrophages##3##3##(1990-5#1)(1993-3#2)
rat and bovine oxytocin##2##4##(1991-2#2)
rat and bovine##5##3##(1990-11#1)(1991-2#2)(1992-3#1)(1993-6#1)
rat and chick brain##2##4##(1990-7#1)(1996-12#1)
rat and chick##8##3##(1990-7#1)(1996-12#3)(1996-2#1)(1997-1#3)
rat and human liver##2##4##(1991-5#1)(1995-2#1)
rat and human##16##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#1)(2012-2#2)
rat and its##2##3##(1991-2#1)(2008-11#1)
rat and mouse embryos##4##4##(1995-3#4)
rat and mouse liver##2##4##(1991-8#2)
rat and mouse##23##3##(1991-12#1)(1991-6#2)(1991-8#4)(1992-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#4)(1996-5#1)(2008-4#4)(2010-11#1)
rat and rabbit##2##3##(1991-6#1)(1992-3#1)
rat and the##2##3##(2008-11#2)
rat and yeast##2##3##(1994-6#1)(1997-2#1)
rat and##75##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#1)(1992-3#3)(1992-6#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#3)(1994-9#1)(1995-2#1)(1995-3#4)(1995-6#1)(1996-12#4)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-4#5)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#2)
rat angiotensin II receptor##2##4##(1991-5#1)(1992-9#1)
rat angiotensin##3##2##(1991-5#1)(1992-3#1)(1992-9#1)
rat anterior pituitary cells##3##4##(1990-12#1)(1990-2#1)(1996-2#1)
rat anterior pituitary##6##3##(1990-12#1)(1990-2#1)(1992-3#1)(1994-6#1)(1996-2#1)(1996-5#1)
rat aorta##18##2##(1990-12#2)(1990-2#1)(1991-9#3)(1993-3#1)(1994-11#2)(1995-12#2)(1997-7#4)(2008-3#1)(2008-8#1)(2011-2#1)
rat aortic smooth muscle cells##2##5##(1991-5#1)(1994-6#1)
rat aortic smooth muscle##4##4##(1991-5#1)(1993-3#1)(1994-6#1)(2008-6#1)
rat aortic##10##2##(1990-12#2)(1990-8#1)(1991-5#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(2008-6#1)
rat as##4##2##(1992-12#1)(1995-2#1)(1997-2#1)(2013-8#1)
rat ascites hepatoma##6##3##(2008-11#6)
rat ascites##8##2##(1993-8#1)(2008-11#7)
rat at##6##2##(1990-5#1)(1991-2#1)(1993-12#1)(1994-2#1)(2008-8#1)(2012-1#1)
rat blood##4##2##(2008-10#2)(2013-1#2)
rat bone marrow cells##2##4##(2008-8#1)(2008-9#1)
rat bone marrow##5##3##(1990-12#1)(1995-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
rat bone##7##2##(1990-11#1)(1990-12#1)(1995-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
rat brain RNA##2##3##(1990-12#1)(1990-7#1)
rat brain after##2##3##(1993-12#1)(2008-10#1)
rat brain and##9##3##(1991-7#1)(1993-11#1)(1993-5#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-2#2)(2008-4#1)
rat brain by##7##3##(1992-12#1)(1996-12#2)(1997-1#2)(2008-10#1)(2009-12#1)
rat brain cDNA library##2##4##(1992-6#1)(1996-12#1)
rat brain cDNA##3##3##(1991-2#1)(1992-6#1)(1996-12#1)
rat brain in vivo##2##4##(1993-3#1)(1995-11#1)
rat brain in##3##3##(1993-3#1)(1994-8#1)(1995-11#1)
rat brain is##3##3##(1993-8#1)(2008-10#2)
rat brain regions##4##3##(1995-11#1)(1996-12#1)(1997-2#1)(2008-4#1)
rat brain slices##4##3##(1993-5#1)(2008-2#2)(2009-12#1)
rat brain to##2##3##(1996-5#2)
rat brain using##4##3##(1993-8#1)(2008-1#1)(2008-7#1)(2011-1#1)
rat brain was##2##3##(1994-12#1)(1994-6#1)
rat brain##143##2##(1990-11#1)(1990-12#3)(1990-5#5)(1990-7#7)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#4)(1993-3#4)(1993-5#3)(1993-6#4)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#5)(1995-11#3)(1995-12#2)(1995-3#3)(1995-6#1)(1995-9#1)(1996-12#11)(1996-2#6)(1996-5#3)(1997-1#3)(1997-2#8)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#14)(2008-2#3)(2008-4#4)(2008-7#2)(2009-12#4)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
rat brains##7##2##(1991-5#1)(1991-7#1)(1996-12#2)(2008-1#1)(2008-8#1)(2009-12#1)
rat by##7##2##(1991-2#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1996-12#1)(2013-8#1)
rat cDNA encoding##2##3##(1991-12#1)(1995-2#1)
rat cDNA##6##2##(1991-12#1)(1992-10#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-6#1)
rat cardiac myocytes in##2##4##(1993-3#1)(2008-7#1)
rat cardiac myocytes##5##3##(1993-3#2)(2007-11#1)(2008-7#1)(2008-9#1)
rat cardiac##6##2##(1993-3#2)(1994-11#1)(2007-11#1)(2008-7#1)(2008-9#1)
rat cardiomyocytes##7##2##(1994-3#1)(1994-6#1)(1995-11#1)(2010-12#3)(2013-1#1)
rat carotid##2##2##(1992-9#1)(1995-12#1)
rat cdk4 is##2##3##(1993-3#2)
rat cells##7##2##(1992-3#1)(1995-6#1)(1996-2#5)
rat central nervous system##5##4##(1991-12#1)(1993-11#1)(1993-12#1)(1996-12#1)(1996-5#1)
rat central##6##2##(1991-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-5#1)
rat cerebellar cortex##2##3##(1995-2#1)(1995-8#1)
rat cerebellar granule##2##3##(1996-5#2)
rat cerebellar##8##2##(1991-12#1)(1992-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)
rat cerebellum##7##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-11#3)(1995-2#1)
rat cerebral cortex and##2##4##(1996-12#1)(1997-2#1)
rat cerebral cortex was##3##4##(1991-12#1)(1992-12#1)(1996-5#1)
rat cerebral cortex##9##3##(1991-12#1)(1992-12#2)(1996-12#1)(1996-5#2)(1997-2#2)(2008-11#1)
rat cerebral##10##2##(1991-12#1)(1992-12#2)(1996-12#1)(1996-5#2)(1997-2#2)(2008-11#1)(2010-12#1)
rat cerebrum##4##2##(1991-2#2)(1994-6#1)(1996-12#1)
rat collagen##2##2##(1991-11#1)(1995-12#1)
rat colon##7##2##(1991-12#1)(1996-5#1)(1997-4#5)
rat corpus luteum##2##3##(1994-6#1)(2008-9#1)
rat corpus##4##2##(1992-7#1)(1994-6#1)(2008-9#1)(2009-5#1)
rat cortical astrocytes##2##3##(1996-12#1)(2008-4#1)
rat cortical membranes##2##3##(1990-5#1)(1996-2#1)
rat cortical##4##2##(1990-5#1)(1996-12#1)(1996-2#1)(2008-4#1)
rat cultures##3##2##(1996-2#3)
rat dams##3##2##(2012-3#3)
rat dentate gyrus##4##3##(1990-5#1)(1995-12#1)(1997-6#1)(2009-8#1)
rat diaphragm##3##2##(1994-8#1)(1996-12#2)
rat dorsal horn following##2##4##(1990-7#1)(1997-3#1)
rat dorsal root ganglia##2##4##(2008-7#1)(2008-9#1)
rat dorsal root##4##3##(1991-12#1)(1993-12#1)(2008-7#1)(2008-9#1)
rat dorsal##6##2##(1990-7#1)(1991-12#1)(1993-12#1)(1997-3#1)(2008-7#1)(2008-9#1)
rat duodenum##2##2##(1993-3#1)(1996-5#1)
rat embryo fibroblasts##2##3##(1993-8#2)
rat embryo##3##2##(1990-11#1)(1993-8#2)
rat embryos##3##2##(1993-12#1)(2011-2#1)(2012-1#1)
rat epididymal fat##2##3##(1992-11#1)(1993-6#1)
rat epiphyseal cartilage cells##2##4##(1990-11#2)
rat epiphyseal cartilage##3##3##(1990-11#3)
rat erythrocyte##2##2##(1990-2#1)(1991-5#1)
rat eye##5##2##(1992-6#1)(1997-2#2)(2008-4#2)
rat fat##2##2##(1990-11#1)(1997-1#1)
rat fetuses##2##2##(1993-12#1)(1995-11#1)
rat fibroblasts##3##2##(1991-11#1)(2012-1#2)
rat fibronectin##2##2##(1993-8#2)
rat focal cerebral##3##3##(1996-12#2)(2007-10#1)
rat forebrain##4##2##(1990-7#1)(1992-3#1)(1995-11#1)(1995-5#1)
rat frontal cortex##2##3##(1994-6#1)(1995-12#1)
rat galanin##2##2##(1994-8#2)
rat gastric##2##2##(1992-3#1)(1992-6#1)
rat genomic DNA##4##3##(1990-12#1)(1991-5#1)(1991-9#1)(1993-12#1)
rat genomic library##5##3##(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)
rat genomic##9##2##(1990-12#1)(1991-5#1)(1991-9#2)(1992-3#1)(1993-12#2)(1993-3#1)(1993-8#1)
rat glioma##2##2##(1991-12#1)(1995-9#1)
rat glucagon receptor##2##3##(1994-11#2)
rat growth##2##2##(1990-12#1)(1990-2#1)
rat guanylin##2##2##(1994-12#2)
rat heart model##2##3##(1995-3#1)(2011-1#1)
rat heart sarcolemma##2##3##(1990-7#2)
rat heart##21##2##(1990-5#2)(1990-7#2)(1991-12#1)(1991-9#2)(1992-11#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-9#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
rat hearts##10##2##(1991-9#1)(1992-11#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-9#1)(2013-7#4)
rat heatstroke by reducing hypothalamic serotonin release##2##7##(1995-12#2)
rat hepatic and##2##3##(1990-11#1)(2008-10#1)
rat hepatic microsomes##4##3##(1994-6#1)(2011-1#3)
rat hepatic stellate##2##3##(2008-11#1)(2013-8#1)
rat hepatic##15##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-6#2)(1995-2#1)(2008-10#1)(2008-11#1)(2011-1#3)(2013-8#1)
rat hepatocyte cell lines##2##4##(2008-11#2)
rat hepatocyte cultures##3##3##(1993-3#1)(2008-4#2)
rat hepatocyte##8##2##(1991-12#1)(1993-3#2)(2008-11#3)(2008-4#2)
rat hepatocytes and##4##3##(1993-8#1)(1996-5#1)(2008-11#1)(2008-8#1)
rat hepatocytes was##2##3##(1992-3#1)(2008-9#1)
rat hepatocytes were##3##3##(1992-3#1)(1993-3#1)(1995-12#1)
rat hepatocytes##57##2##(1990-12#3)(1990-2#2)(1990-5#4)(1990-7#2)(1990-8#1)(1991-12#3)(1991-9#1)(1992-3#6)(1993-11#1)(1993-3#4)(1993-6#2)(1993-8#4)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#2)(1996-2#2)(1996-5#1)(1997-4#1)(2008-1#2)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#3)
rat hepatoma 3924A##2##3##(1990-5#2)
rat hepatoma cell line##2##4##(1991-12#1)(2008-11#1)
rat hepatoma cell##3##3##(1991-12#1)(1994-6#1)(2008-11#1)
rat hepatoma cells by##2##4##(1992-3#1)(2008-11#1)
rat hepatoma cells##6##3##(1992-10#1)(1992-3#3)(1994-11#1)(2008-11#1)
rat hepatoma##12##2##(1990-5#2)(1991-12#1)(1992-10#1)(1992-3#3)(1994-11#2)(1994-6#1)(2008-11#2)
rat hindlimb muscle membranes with##2##5##(1993-11#2)
rat hippocampal CA1##4##3##(1990-12#1)(1996-5#1)(1997-2#2)
rat hippocampal neurones##2##3##(1995-5#1)(1996-2#1)
rat hippocampal slices##6##3##(1990-12#2)(1995-12#1)(1996-2#1)(1997-2#1)(2008-2#1)
rat hippocampal##18##2##(1990-12#3)(1993-12#1)(1994-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#3)(1997-6#1)(2008-2#1)(2008-7#1)
rat hippocampus##15##2##(1990-5#2)(1995-12#6)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-7#1)
rat homolog of##2##3##(1993-3#1)(1996-12#1)
rat homologue##2##2##(1991-12#1)(1997-7#1)
rat ileal brush border membrane##3##5##(1990-11#1)(1991-9#2)
rat in##5##2##(1993-3#1)(1995-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
rat intestinal mucin##2##3##(1991-12#2)
rat intestinal##10##2##(1991-12#2)(1992-9#1)(1993-8#1)(1994-8#2)(1995-2#1)(2008-11#1)(2011-1#1)(2011-3#1)
rat is##9##2##(1991-12#1)(1992-3#1)(1994-8#2)(2007-8#1)(2008-4#2)(2008-9#1)(2011-1#1)
rat islet isolation##2##3##(2008-11#2)
rat islet##3##2##(1993-8#1)(2008-11#2)
rat islets of Langerhans##2##4##(1995-8#1)(1997-4#1)
rat islets##3##2##(1990-12#1)(1995-8#1)(1997-4#1)
rat jejunum##4##2##(1991-12#1)(1991-5#3)
rat kidney##25##2##(1991-12#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#2)(1997-7#3)(2008-11#3)(2012-2#1)
rat kidneys##2##2##(1994-6#1)(2008-10#1)
rat liver S9##3##3##(2008-8#2)(2008-9#1)
rat liver and##10##3##(1990-12#1)(1990-5#1)(1990-7#2)(1992-6#2)(1995-6#1)(2008-10#3)
rat liver by##5##3##(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)
rat liver cells##10##3##(1990-12#2)(1993-6#1)(1994-6#3)(1995-6#1)(2008-8#3)
rat liver cytosol##3##3##(1993-6#1)(1993-8#1)(1996-5#1)
rat liver cytosolic##3##3##(1993-8#2)(1995-2#1)
rat liver glucokinase##3##3##(1990-11#1)(1990-7#2)
rat liver is described##3##4##(1990-12#1)(1996-5#1)(2008-10#1)
rat liver membranes##2##3##(1994-3#2)
rat liver microsomal##2##3##(1993-11#1)(1994-8#1)
rat liver microsomes but##2##4##(1994-8#2)
rat liver microsomes by##2##4##(1990-12#1)(1994-8#1)
rat liver microsomes containing##2##4##(1994-8#2)
rat liver microsomes in the presence of NADPH##2##8##(1990-12#1)(1991-5#1)
rat liver microsomes in the presence of##3##7##(1990-12#1)(1991-5#1)(1995-6#1)
rat liver microsomes were##2##4##(1991-2#1)(2011-3#1)
rat liver microsomes##21##3##(1990-11#2)(1990-12#2)(1990-8#1)(1991-2#1)(1991-5#3)(1992-8#1)(1993-11#1)(1993-8#1)(1994-8#6)(1995-6#1)(2011-3#2)
rat liver mitochondria in the presence of##2##7##(1991-5#1)(1994-8#1)
rat liver mitochondria##9##3##(1990-2#1)(1991-5#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-12#1)(2013-1#1)
rat liver mitochondrial##3##3##(1994-11#1)(1995-2#2)
rat liver plasma membranes##3##4##(1995-8#3)
rat liver revealed##2##3##(1993-6#2)
rat liver uricase##3##3##(1990-11#1)(1992-8#2)
rat liver was##4##3##(1992-6#1)(1994-11#1)(1996-12#1)(2009-8#1)
rat liver##176##2##(1990-10#2)(1990-11#6)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#4)(1990-8#5)(1991-12#8)(1991-2#2)(1991-5#4)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#5)(1992-8#6)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#6)(1993-8#10)(1994-11#4)(1994-12#4)(1994-3#4)(1994-6#9)(1994-8#13)(1995-12#3)(1995-2#6)(1995-5#1)(1995-6#5)(1995-8#5)(1995-9#1)(1996-12#2)(1996-5#5)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#3)(2008-8#7)(2008-9#1)(2009-11#1)(2009-8#2)(2011-3#2)(2013-1#1)
rat livers##3##2##(1991-3#2)(2008-8#1)
rat lung##7##2##(1993-3#1)(1994-11#1)(1995-2#3)(1995-8#2)
rat lungs##5##2##(1994-5#1)(2007-8#2)(2008-12#2)
rat luteal##2##2##(1994-6#1)(1997-1#1)
rat macrophages##3##2##(2008-10#3)
rat malignant fibrous histiocytoma##2##4##(2008-11#1)(2012-1#1)
rat mammary cells##3##3##(1995-11#3)
rat mammary tumors##2##3##(1993-1#1)(1995-9#1)
rat mammary##10##2##(1993-1#1)(1993-11#2)(1995-11#5)(1995-9#1)(2008-10#1)
rat mandible##3##2##(2008-7#3)
rat mast##2##2##(1991-2#1)(1993-3#1)
rat mesangial##4##2##(1992-6#1)(1993-8#1)(1995-11#1)(2011-2#1)
rat mesentery-derived mesothelial-cell (M-cell)##2##4##(2008-11#2)
rat mesentery-derived##3##2##(2008-11#3)
rat model of Parkinson's disease##2##5##(1995-12#1)(2008-12#1)
rat model of acute renal failure induced by uranyl nitrate##2##10##(2008-8#2)
rat model of##26##3##(1994-6#2)(1995-12#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#5)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
rat model was##2##3##(1995-2#1)(2011-3#1)
rat model##45##2##(1990-12#1)(1992-9#1)(1994-6#2)(1995-12#3)(1995-2#1)(1996-5#2)(1997-2#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#5)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#5)(2011-3#1)(2012-2#7)(2012-3#2)(2013-1#2)
rat models of parkinsonism and##2##5##(1997-2#2)
rat models of##4##3##(1993-8#1)(1997-2#3)
rat motor##2##2##(1990-5#1)(2013-8#1)
rat mucin##2##2##(1991-12#1)(1993-8#1)
rat muscle##3##2##(1993-11#1)(2008-8#1)(2008-9#1)
rat myoblasts##3##2##(1990-12#2)(1997-1#1)
rat myocardial cell culture system##2##5##(1992-3#2)
rat myocardium##2##2##(2010-6#2)
rat neocortex##2##2##(2008-11#2)
rat nerve##2##2##(1993-5#1)(2011-2#1)
rat neuronal cell##6##3##(1993-6#2)(1995-12#1)(2008-11#3)
rat neuronal cells##2##3##(1993-6#1)(1994-12#1)
rat neuronal##10##2##(1993-6#3)(1994-12#1)(1995-12#1)(2008-11#3)(2008-9#1)(2010-12#1)
rat nuclear##2##2##(1993-11#2)
rat of##3##2##(1990-7#1)(1992-8#2)
rat or hamster liver S9##2##5##(2008-9#2)
rat or rabbit##2##3##(1992-6#1)(1995-11#1)
rat or##6##2##(1992-6#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-9#2)
rat ovarian##4##2##(1992-2#1)(1994-6#1)(1995-8#1)(2008-9#1)
rat ovary##6##2##(1992-3#1)(1997-1#1)(2008-12#1)(2008-5#1)(2008-9#2)
rat pancreas##7##2##(1990-12#2)(1992-8#2)(1993-6#1)(1995-11#2)
rat pancreatic acinar cells##2##4##(1991-5#1)(1993-6#1)
rat pancreatic acini##4##3##(1991-8#2)(1992-12#1)(1995-11#1)
rat pancreatic islets##3##3##(1990-12#1)(1995-8#1)(2008-11#1)
rat pancreatic##12##2##(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#2)(1992-12#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-8#1)(2008-11#2)
rat parietal cells##2##3##(1992-3#2)
rat parotid acinar cells##2##4##(1991-8#2)
rat paw##2##2##(1995-12#1)(2011-1#1)
rat penis##2##2##(1992-8#2)
rat peripheral##3##2##(1990-12#2)(1991-12#1)
rat peritoneal macrophages##2##3##(2008-10#1)(2008-11#1)
rat peritoneal mast cells##6##4##(1991-12#2)(1991-2#1)(1992-3#1)(1995-11#1)(2008-10#1)
rat peritoneal##9##2##(1991-12#2)(1991-2#1)(1992-3#1)(1995-11#1)(2008-10#2)(2008-11#2)
rat pheochromocytoma (PC12) cells##2##4##(2008-4#1)(2013-8#1)
rat pheochromocytoma cell line PC12##3##5##(1990-5#1)(2008-11#2)
rat pheochromocytoma cell line##5##4##(1990-5#1)(1993-8#1)(1994-11#1)(2008-11#2)
rat pheochromocytoma##10##2##(1990-2#1)(1990-5#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-8#2)
rat pineal gland and##2##4##(2008-10#2)
rat pituitary adenylate cyclase activating polypeptide (PACAP)##2##7##(1990-12#2)
rat pituitary and##3##3##(1992-12#1)(1993-3#2)
rat pituitary cells##7##3##(1991-6#1)(1992-6#3)(1994-9#1)(1996-2#1)(1997-2#1)
rat pituitary gland##2##3##(1992-6#1)(1993-3#1)
rat pituitary lactotropes##2##3##(1993-11#2)
rat pituitary##29##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-6#1)(1992-12#6)(1992-6#5)(1992-9#1)(1993-11#2)(1993-3#4)(1993-5#1)(1994-8#1)(1994-9#1)(1996-2#1)(1997-2#1)
rat placenta##3##2##(1995-12#2)(2008-10#1)
rat plasma and##3##3##(1990-7#2)(1991-5#1)
rat plasma##15##2##(1990-7#2)(1990-8#1)(1991-3#3)(1991-5#1)(1997-2#2)(2008-10#4)(2011-2#2)
rat platelet##3##2##(1993-3#2)(1994-11#1)
rat platelets##4##2##(1990-8#2)(1993-8#2)
rat preproendothelin-1##2##2##(1991-2#2)
rat primary cortical##3##3##(1995-5#1)(2008-4#2)
rat primary##9##2##(1990-5#1)(1995-5#1)(2008-11#4)(2008-4#2)(2011-2#1)
rat prolactin##5##2##(1994-11#3)(1995-11#1)(2008-4#1)
rat prostate##3##2##(1991-5#1)(1993-8#1)(1995-8#1)
rat pulmonary artery##3##3##(1991-9#1)(1993-6#1)(2011-3#1)
rat pulmonary veins##2##3##(2013-1#2)
rat pulmonary##5##2##(1991-9#1)(1993-6#1)(2011-3#1)(2013-1#2)
rat pups##6##2##(1994-3#1)(1995-12#1)(1996-12#1)(2008-10#3)
rat pyruvate kinase##2##3##(1990-8#2)
rat receptor##2##2##(1991-12#1)(1992-9#1)
rat renal anemia##2##3##(2008-8#2)
rat renal##7##2##(1990-11#1)(1994-5#1)(1995-11#1)(1997-1#2)(2008-8#2)
rat retina##2##2##(1996-2#1)(2008-7#1)
rat retinal explants##3##3##(1996-5#3)
rat retinal##6##2##(1996-5#5)(2012-3#1)
rat sciatic##2##2##(1996-2#1)(2008-7#1)
rat sequence##3##2##(1991-9#1)(1996-10#1)(2008-7#1)
rat sera##4##2##(2008-10#1)(2008-11#3)
rat serum##6##2##(1991-12#1)(1994-11#3)(2008-11#2)
rat single-pass intestinal perfusion##2##4##(2011-3#2)
rat skeletal muscle extensor digitorum longus##2##6##(2008-9#2)
rat skeletal muscle tissue under two-photon excitation##2##7##(2008-2#2)
rat skeletal muscle to##2##4##(1991-12#1)(1995-8#1)
rat skeletal muscle##19##3##(1991-12#4)(1991-2#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-8#2)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#2)
rat skeletal##20##2##(1990-12#1)(1991-12#4)(1991-2#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-8#2)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#2)
rat skin##2##2##(1992-6#2)
rat small intestine##6##3##(1990-12#2)(1991-12#2)(1995-11#1)(1997-6#1)
rat soleus muscle##2##3##(1991-12#1)(1995-12#1)
rat soleus##3##2##(1991-12#1)(1991-2#1)(1995-12#1)
rat somatosensory##2##2##(1997-3#1)(2008-1#1)
rat spinal cord##11##3##(1992-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-5#1)(1996-5#2)(2008-11#1)
rat spinal##12##2##(1992-11#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-5#1)(1996-5#2)(2008-11#1)
rat splenic##2##2##(1995-12#2)
rat stomach##7##2##(1991-5#1)(1992-6#1)(1993-11#2)(1997-4#2)(1997-7#1)
rat strains##3##2##(1993-12#1)(2008-11#1)(2012-3#1)
rat striatal slices##3##3##(1993-12#1)(1995-12#2)
rat striatal##7##2##(1993-12#1)(1995-11#1)(1995-12#3)(1996-2#1)(1996-5#1)
rat striatum##16##2##(1991-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-5#4)(1997-7#1)
rat stroke model##2##3##(2008-7#2)
rat superior cervical ganglion##2##4##(1996-5#1)(2008-8#1)
rat superior##3##2##(1996-5#1)(2008-7#1)(2008-8#1)
rat suprachiasmatic nucleus##2##3##(1993-12#1)(1993-9#1)
rat suprachiasmatic##3##2##(1993-12#1)(1993-9#2)
rat tail tendon##2##3##(2008-3#2)
rat testis##6##2##(1990-5#1)(1994-11#1)(2008-9#2)(2009-10#1)(2012-2#1)
rat that##2##2##(1990-11#1)(2008-4#1)
rat thoracic aorta##2##3##(1995-11#1)(2010-12#1)
rat thoracic##3##2##(1995-11#1)(1995-12#1)(2010-12#1)
rat thyroid lobes##2##3##(1991-12#2)
rat thyroid##6##2##(1990-12#1)(1991-12#2)(1992-8#1)(1993-8#2)
rat tissue##3##2##(1991-11#1)(1994-6#1)(2011-2#1)
rat tissues##17##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#3)(1994-11#1)(1994-12#1)(1995-11#1)(1997-4#1)(2009-8#1)(2012-3#1)
rat trachea##6##2##(2008-9#6)
rat transforming growth factor-beta##2##4##(1993-3#2)
rat trigeminal ganglion##3##3##(1996-12#2)(2008-6#1)
rat trigeminal##4##2##(1996-12#2)(1997-2#1)(2008-6#1)
rat type##2##2##(1991-5#1)(1992-3#1)
rat urinary bladder##4##3##(1992-12#1)(1992-3#3)
rat urine##7##2##(1994-8#1)(2008-10#4)(2013-8#2)
rat uterine model of##2##4##(1992-12#2)
rat uterine##3##2##(1992-12#2)(1994-8#1)
rat uterus##3##2##(1991-5#1)(1992-10#1)(2013-7#1)
rat vascular AT1 receptor##2##4##(1992-9#2)
rat vascular##4##2##(1992-9#2)(1995-12#1)(2008-9#1)
rat ventricular myocytes##4##3##(1993-3#2)(1994-12#1)(1994-6#1)
rat vibrissal##3##2##(2011-2#3)
rat was##8##2##(1993-6#2)(1995-3#1)(1996-12#1)(1997-2#1)(2011-2#1)(2011-3#1)(2012-1#1)
rat were##6##2##(1991-12#2)(1994-2#1)(1995-12#1)(1996-5#1)(2011-3#1)
rat whole embryo culture##2##4##(1993-12#2)
rat##2118##1##(1990-10#2)(1990-11#29)(1990-12#54)(1990-2#14)(1990-3#3)(1990-5#47)(1990-6#1)(1990-7#39)(1990-8#19)(1991-1#8)(1991-10#1)(1991-11#4)(1991-12#58)(1991-2#39)(1991-3#6)(1991-4#2)(1991-5#32)(1991-6#8)(1991-7#3)(1991-8#8)(1991-9#22)(1992-1#2)(1992-10#9)(1992-11#15)(1992-12#28)(1992-2#3)(1992-3#54)(1992-5#1)(1992-6#36)(1992-7#1)(1992-8#24)(1992-9#16)(1993-1#3)(1993-11#34)(1993-12#55)(1993-2#9)(1993-3#63)(1993-5#11)(1993-6#33)(1993-8#54)(1993-9#3)(1994-11#38)(1994-12#26)(1994-2#18)(1994-3#15)(1994-5#8)(1994-6#51)(1994-8#52)(1994-9#6)(1995-11#39)(1995-12#82)(1995-2#29)(1995-3#15)(1995-5#10)(1995-6#16)(1995-8#18)(1995-9#7)(1996-10#1)(1996-12#61)(1996-2#41)(1996-5#54)(1996-6#1)(1996-9#3)(1997-1#15)(1997-2#39)(1997-3#3)(1997-4#14)(1997-6#9)(1997-7#22)(1997-9#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#8)(2008-10#77)(2008-11#87)(2008-12#12)(2008-2#11)(2008-3#4)(2008-4#49)(2008-5#13)(2008-6#4)(2008-7#28)(2008-8#45)(2008-9#41)(2009-10#2)(2009-11#4)(2009-12#8)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#10)(2010-4#1)(2010-6#4)(2011-1#15)(2011-2#27)(2011-3#14)(2012-1#14)(2012-12#1)(2012-2#16)(2012-3#9)(2012-4#1)(2013-1#20)(2013-7#11)(2013-8#12)
rat's blood and brain##4##4##(2008-10#4)
rat's ileum##2##2##(2008-12#2)
rat's##14##1##(1991-2#1)(1992-7#2)(1993-3#1)(1995-12#1)(2008-10#4)(2008-12#4)(2008-3#1)
rat)##2##1##(1995-2#1)(1997-4#1)
rat-##2##1##(1992-3#1)(2008-11#1)
rat-liver epithelial-cells##2##2##(1992-9#2)
rat-liver##6##1##(1991-3#1)(1992-9#5)
rat]##4##1##(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
rate (0##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
rate (1##3##2##(1992-2#1)(1993-8#1)(2008-9#1)
rate (2##2##2##(2008-7#1)(2009-9#1)
rate (5##2##2##(1996-11#1)(2012-3#1)
rate (BER)##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
rate (GFR)##5##2##(2008-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
rate (HR) and##4##3##(1992-12#1)(2013-8#3)
rate (HR)##17##2##(1990-5#1)(1991-2#1)(1992-12#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#5)
rate (P &lt##2##3##(2008-10#1)(2011-2#1)
rate (P##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
rate (RR)##4##2##(1992-12#1)(2008-10#2)(2012-2#1)
rate (from##2##2##(2008-12#2)
rate (i##2##2##(2008-10#1)(2011-2#1)
rate (per 100##2##3##(1994-12#1)(2013-8#1)
rate (t1/2##2##2##(1992-8#1)(1995-3#1)
rate 0##6##2##(1994-3#1)(2008-10#4)(2008-6#1)
rate 1##2##2##(2008-10#1)(2008-8#1)
rate 4##2##2##(1990-3#1)(2009-5#1)
rate 5##2##2##(1990-3#1)(2008-10#1)
rate =##2##2##(1991-12#1)(2009-2#1)
rate V(max)) of the##2##4##(2008-10#2)
rate a##3##2##(2007-12#2)(2008-2#1)
rate achieved##3##2##(1991-12#1)(2007-12#1)(2008-3#1)
rate after elective lumbar spine surgery##2##6##(2012-12#2)
rate after treatment was##2##4##(1990-12#1)(1991-9#1)
rate after##11##2##(1990-12#1)(1991-9#1)(1993-8#1)(1994-6#1)(1995-6#1)(2007-11#1)(2008-8#1)(2010-3#1)(2012-12#2)(2012-2#1)
rate against##3##2##(2007-7#1)(2008-11#1)(2008-12#1)
rate among the##2##3##(1995-1#1)(2008-7#1)
rate among women##2##3##(1991-11#1)(2013-8#1)
rate among##14##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-8#1)(1995-1#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
rate and a##7##3##(1990-8#1)(1992-8#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
rate and an##2##3##(2008-10#1)(2008-8#1)
rate and arterial pressure##2##4##(1990-6#1)(1993-12#1)
rate and better##2##3##(2008-3#1)(2012-12#1)
rate and body##2##3##(1990-9#1)(2008-5#1)
rate and extent of deuterium oxide-mediated fluorescence enhancement of##2##9##(1992-6#2)
rate and extent of##5##4##(1992-6#2)(1992-8#1)(2008-10#2)
rate and final##2##3##(2008-10#1)(2008-11#1)
rate and frequency response##2##4##(2007-12#2)
rate and higher##2##3##(1993-1#1)(2010-10#1)
rate and in##3##3##(1990-9#1)(2008-3#1)(2008-7#1)
rate and increased the##2##4##(1996-3#1)(2008-10#1)
rate and increased##4##3##(1991-10#1)(1996-3#1)(2008-10#1)(2012-12#1)
rate and lower##2##3##(2007-12#1)(2013-8#1)
rate and maximum cell##2##4##(2008-11#2)
rate and maximum##3##3##(2008-11#2)(2011-2#1)
rate and output##2##3##(2008-10#1)(2009-12#1)
rate and relative##3##3##(2008-10#2)(2008-8#1)
rate and should be##3##4##(2007-11#2)(2008-10#1)
rate and temperature on##2##4##(2009-7#1)(2010-4#1)
rate and temperature##4##3##(2008-10#2)(2009-7#1)(2010-4#1)
rate and that the##2##4##(2008-10#1)(2008-7#1)
rate and that##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
rate and the discharge##2##4##(1997-7#1)(2008-3#1)
rate and the rate##2##4##(2008-3#1)(2008-6#1)
rate and the temperature##2##4##(2009-7#1)(2011-2#1)
rate and the##31##3##(1992-8#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1996-3#1)(1997-7#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)
rate and time to##2##4##(2008-3#1)(2008-8#1)
rate and to##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
rate and##258##2##(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1992-1#1)(1992-6#2)(1992-8#3)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#2)(1994-8#1)(1995-12#4)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#58)(2008-11#19)(2008-12#7)(2008-2#1)(2008-3#10)(2008-5#5)(2008-6#3)(2008-7#14)(2008-8#11)(2008-9#7)(2009-1#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-12#2)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#8)(2013-8#3)
rate are##11##2##(1993-2#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-8#1)(2009-6#1)(2010-4#1)
rate as a function of##2##5##(2008-3#2)
rate as a##3##3##(2007-11#1)(2008-3#2)
rate as an##2##3##(1994-5#1)(2008-8#1)
rate as high as##3##4##(2008-10#1)(2008-3#2)
rate as the##2##3##(2008-10#1)(2008-8#1)
rate as well as##2##4##(2008-10#1)(2011-2#1)
rate as well##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
rate as##20##2##(1994-5#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
rate associated with##4##3##(1995-12#1)(2007-8#1)(2008-10#1)(2013-8#1)
rate at the##5##3##(1990-9#1)(1996-4#1)(2008-3#1)(2008-5#1)(2010-2#1)
rate at which the##8##4##(1991-2#1)(1993-8#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)
rate at which##20##3##(1991-2#1)(1992-6#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#6)(2010-12#1)(2010-8#1)(2013-8#1)
rate at##40##2##(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#2)(1993-8#1)(1996-4#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#8)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
rate because##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
rate below##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
rate between the##2##3##(2008-12#1)(2013-1#1)
rate between##14##2##(1990-6#2)(1990-8#1)(1993-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
rate both##2##2##(1996-12#1)(2008-7#1)
rate by the##3##3##(2008-11#2)(2008-12#1)
rate by##20##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#2)
rate calibration##2##2##(2008-9#2)
rate can be decreased##2##4##(2008-11#1)(2008-5#1)
rate can be##9##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2011-3#1)
rate changes##4##2##(2008-10#1)(2008-6#1)(2008-7#2)
rate comparable to that##3##4##(1997-4#2)(1997-7#1)
rate comparable##4##2##(1997-4#2)(1997-7#1)(2009-8#1)
rate compared to the##2##4##(1995-1#1)(2007-7#1)
rate compared to##6##3##(1992-8#1)(1995-1#1)(2007-7#1)(2008-7#1)(2011-1#1)(2012-2#1)
rate compared with##2##3##(2008-12#1)(2010-8#1)
rate compared##8##2##(1992-8#1)(1995-1#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
rate condition##2##2##(1996-2#1)(2007-12#1)
rate conditions##2##2##(2008-10#1)(2008-11#1)
rate constant (k(s)) for##2##4##(2008-10#2)
rate constant (k(s))##5##3##(2008-10#5)
rate constant and the##2##4##(1993-3#1)(1996-12#1)
rate constant for the reaction of##2##6##(1990-7#1)(1994-5#1)
rate constant for the reaction##3##5##(1990-7#1)(1994-5#1)(2008-10#1)
rate constant for the##8##4##(1990-7#1)(1991-5#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
rate constant for##14##3##(1990-7#2)(1991-5#1)(1992-6#1)(1994-5#1)(1995-2#2)(1996-5#1)(2008-10#3)(2008-7#2)(2008-8#1)
rate constant k##3##3##(2008-10#2)(2008-7#1)
rate constant of 0##2##4##(1992-6#1)(1995-6#1)
rate constant of the##5##4##(1995-2#1)(2008-10#4)
rate constant of##15##3##(1992-6#2)(1995-2#2)(1995-6#2)(1997-7#1)(2008-10#6)(2008-11#1)(2008-4#1)
rate constant was##3##3##(1992-6#1)(1994-3#1)(2008-10#1)
rate constant##78##2##(1990-11#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-5#1)(1992-6#4)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#3)(1995-2#6)(1995-6#2)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#6)(2008-8#2)(2009-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
rate constants and##4##3##(1992-6#1)(1997-7#1)(2008-10#2)
rate constants are##2##3##(2008-11#1)(2008-5#1)
rate constants by##2##3##(1995-8#1)(2008-10#1)
rate constants for##8##3##(1992-8#1)(1995-2#1)(1997-2#2)(2008-10#2)(2008-2#1)(2008-4#1)
rate constants obtained##2##3##(2008-10#2)
rate constants of the##4##4##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
rate constants of##9##3##(1990-9#1)(1992-6#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
rate constants were##3##3##(1993-1#1)(2008-10#1)(2008-9#1)
rate constants##52##2##(1990-9#2)(1991-5#3)(1992-12#1)(1992-6#2)(1992-8#1)(1993-1#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#4)(1997-7#2)(2007-11#3)(2008-10#14)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-8#1)
rate control##2##2##(2008-7#1)(2012-2#1)
rate controlled##2##2##(2008-10#1)(2008-11#1)
rate could##2##2##(2006-10#1)(2008-7#1)
rate coupled with##2##3##(1995-11#1)(2008-7#1)
rate data##5##2##(1997-2#1)(2008-10#3)(2008-7#1)
rate declined with##2##3##(2008-10#1)(2008-3#1)
rate declined##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
rate decrease##2##2##(2008-11#1)(2008-8#1)
rate decreased from##3##3##(1995-6#1)(2008-1#1)(2008-3#1)
rate decreased with increasing##2##4##(2008-11#1)(2008-7#1)
rate decreased##11##2##(1991-8#1)(1995-6#1)(1996-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2012-12#1)
rate decreases with increasing##2##4##(1993-8#1)(2008-10#1)
rate decreases##4##2##(1991-11#1)(1993-8#1)(2008-10#1)(2011-2#1)
rate dependence of##2##3##(1996-4#1)(2009-10#1)
rate dependence##5##2##(1996-4#1)(2008-10#2)(2009-10#1)(2011-1#1)
rate depends##2##2##(1996-12#1)(2007-12#1)
rate determined##2##2##(2008-10#1)(2009-11#1)
rate determining##3##2##(1991-6#1)(2008-10#1)(2009-8#1)
rate due to the##2##4##(2008-11#1)(2012-2#1)
rate due to##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
rate during the##6##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)
rate during##10##2##(1990-11#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#1)
rate enhancement##2##2##(1993-9#1)(2011-2#1)
rate equation model##2##3##(2008-3#2)
rate equation##14##2##(1990-8#1)(1993-3#1)(2008-10#4)(2008-3#8)
rate equations##12##2##(1990-8#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-7#2)(2008-9#1)
rate exceeds##2##2##(2008-7#1)(2008-8#1)
rate expressed as##2##3##(2008-7#1)(2008-9#1)
rate fell##2##2##(1995-9#1)(2013-8#1)
rate following##6##2##(1992-1#1)(1993-3#1)(1994-9#1)(1995-8#1)(2008-6#1)(2008-7#1)
rate for a##5##3##(1994-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
rate for all patients##2##4##(2010-3#1)(2012-1#1)
rate for all##6##3##(1997-2#1)(2007-12#1)(2008-6#1)(2009-5#1)(2010-3#1)(2012-1#1)
rate for blood##2##3##(2007-11#1)(2011-2#1)
rate for each##2##3##(1995-3#1)(2008-7#1)
rate for patients##2##3##(2010-3#1)(2012-3#1)
rate for the experimental##2##4##(1995-2#1)(2011-2#1)
rate for the##19##3##(1992-5#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-7#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
rate for these##3##3##(1996-3#1)(2008-6#1)(2013-1#1)
rate for##72##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
rate from##17##2##(1991-6#2)(1995-11#1)(1995-8#1)(1996-11#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)
rate has##5##2##(1997-7#1)(2007-12#2)(2008-1#1)(2010-12#1)
rate imaging##2##2##(2008-6#1)(2009-10#1)
rate in 1991##2##3##(1992-2#1)(1995-2#1)
rate in a##5##3##(1990-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-8#1)
rate in both##2##3##(2008-9#1)(2012-3#1)
rate in patients with##2##4##(2007-10#1)(2011-2#1)
rate in prepared serum group##2##5##(2008-10#2)
rate in the presence of##2##5##(2007-11#1)(2008-4#1)
rate in the range##2##4##(2008-10#2)
rate in the##26##3##(1990-2#1)(1991-2#2)(1991-6#1)(1994-8#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-8#1)
rate in this##2##3##(1991-12#1)(2012-3#1)
rate in##112##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#16)(2008-11#6)(2008-12#5)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#2)
rate increase##2##2##(1994-12#1)(2009-11#1)
rate increased to##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
rate increased with the##2##4##(2008-11#1)(2012-12#1)
rate increased with##6##3##(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)(2013-7#1)
rate increased##22##2##(1990-6#1)(1991-10#1)(1994-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
rate increases with age##2##4##(2008-7#1)(2011-2#1)
rate increases with##4##3##(1990-6#1)(1991-8#1)(2008-7#1)(2011-2#1)
rate increases##11##2##(1990-6#1)(1991-8#1)(1994-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
rate information##2##2##(2008-11#1)(2008-4#1)
rate is also##2##3##(1994-2#1)(2007-12#1)
rate is dependent upon the##2##5##(1990-11#1)(2008-5#1)
rate is every##2##3##(2008-10#2)
rate is high##7##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#2)(2011-1#1)(2012-1#1)
rate is higher##2##3##(2007-2#1)(2008-8#1)
rate is known to##2##4##(1990-8#1)(2008-8#1)
rate is low##2##3##(2008-8#2)
rate is maintained##2##3##(1992-7#1)(2008-10#1)
rate is not##3##3##(1994-11#1)(2008-8#1)(2012-2#1)
rate is obtained##2##3##(2007-12#1)(2008-10#1)
rate is reduced by##2##4##(2008-3#1)(2008-6#1)
rate is reduced##3##3##(1996-6#1)(2008-3#1)(2008-6#1)
rate is significantly##2##3##(2008-4#1)(2013-8#1)
rate is the##3##3##(1991-8#1)(1992-5#1)(2008-8#1)
rate is##93##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-6#1)(1991-8#1)(1992-5#2)(1992-7#1)(1992-9#2)(1993-1#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-3#1)(1996-6#1)(1997-5#1)(2007-11#1)(2007-12#6)(2007-2#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#14)(2008-9#2)(2009-12#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
rate isomorphy in##2##3##(2008-8#2)
rate isomorphy##8##2##(2008-8#8)
rate limited##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
rate limiting step in##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
rate limiting step##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
rate limiting##12##2##(1991-9#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-1#1)
rate may be##4##3##(1991-3#1)(1996-8#1)(2011-1#1)(2012-12#1)
rate may vary##2##3##(1997-2#1)(2007-11#1)
rate may##9##2##(1991-3#1)(1995-4#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#1)(2010-5#1)(2011-1#1)(2012-12#1)
rate measurements##3##2##(1994-5#1)(2008-10#2)
rate method##3##2##(2008-10#3)
rate methods##2##2##(2008-10#2)
rate models##2##2##(2012-3#2)
rate nor the##3##3##(1997-7#2)(2008-5#1)
rate nor##4##2##(1990-8#1)(1997-7#2)(2008-5#1)
rate observed for##2##3##(1997-8#1)(2013-1#1)
rate observed##4##2##(1995-2#1)(1997-8#1)(2013-1#2)
rate obtained##2##2##(2008-10#1)(2012-12#1)
rate of &lt##2##3##(2007-12#1)(2008-10#1)
rate of 0##37##3##(1992-12#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
rate of 1##39##3##(1990-9#1)(1992-12#1)(2007-11#1)(2008-10#25)(2008-3#2)(2008-5#2)(2010-3#2)(2011-1#3)(2011-2#1)(2012-12#1)
rate of 10 Hz##2##4##(2008-3#2)
rate of 10##9##3##(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
rate of 100 Hz##3##4##(2008-3#3)
rate of 100##9##3##(2007-12#1)(2008-10#4)(2008-3#3)(2011-2#1)
rate of 100%##2##3##(2008-10#1)(2011-1#1)
rate of 12##3##3##(2008-11#1)(2008-3#1)(2009-2#1)
rate of 15 samples h(-1)##2##5##(2008-10#2)
rate of 15##6##3##(2008-1#1)(2008-10#5)
rate of 154 GHz##2##4##(2007-11#2)
rate of 2##16##3##(1992-12#1)(2007-12#3)(2007-7#1)(2008-10#8)(2008-3#1)(2008-7#1)(2011-2#1)
rate of 20##4##3##(1995-12#1)(2008-10#2)(2013-1#1)
rate of 200##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
rate of 24##2##3##(2008-10#2)
rate of 25##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
rate of 3##9##3##(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
rate of 30##6##3##(2008-10#4)(2008-2#1)(2013-8#1)
rate of 4##6##3##(2007-12#1)(2008-10#4)(2009-8#1)
rate of 40##6##3##(1991-6#1)(2008-10#4)(2008-6#1)
rate of 5##10##3##(1997-5#1)(2007-12#1)(2008-10#4)(2008-7#1)(2010-3#1)(2012-12#1)(2012-3#1)
rate of 50##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
rate of 50%##2##3##(1993-12#1)(1994-6#1)
rate of 500##2##3##(2008-10#2)
rate of 6##10##3##(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2012-2#1)(2013-8#1)
rate of 60##7##3##(2008-10#5)(2008-3#1)(2011-2#1)
rate of 60%##2##3##(2007-12#1)(2008-7#1)
rate of 7##3##3##(1990-6#1)(2007-7#1)(2012-3#1)
rate of 90##5##3##(2007-12#1)(2008-10#4)
rate of 93##2##3##(2010-8#1)(2013-1#1)
rate of 94##2##3##(2006-10#1)(2007-8#1)
rate of Ca2+##4##3##(1990-12#2)(1992-6#2)
rate of DNA##3##3##(1992-11#1)(1993-3#1)(1993-8#1)
rate of JH synthesis##2##4##(2008-7#2)
rate of Si##2##3##(2008-10#2)
rate of a##13##3##(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#2)(2008-9#1)
rate of about##9##3##(1992-9#1)(1996-11#1)(2008-10#6)(2008-7#1)
rate of acid##2##3##(1990-2#1)(1997-4#1)
rate of activation##3##3##(1992-9#2)(1995-6#1)
rate of adult##2##3##(1996-5#1)(2011-2#1)
rate of aging in##2##4##(2008-9#2)
rate of aging is##2##4##(2008-9#2)
rate of aging##8##3##(1994-5#1)(2008-9#6)(2009-5#1)
rate of approximately##4##3##(1997-5#1)(2008-10#1)(2008-11#2)
rate of as much as##2##5##(2008-3#2)
rate of ascospore##2##3##(2008-10#2)
rate of aspartate##3##3##(1990-7#1)(1991-3#2)
rate of bilirubin##2##3##(1992-3#1)(2008-5#1)
rate of bone##2##3##(1993-11#2)
rate of both##2##3##(2008-6#1)(2012-3#1)
rate of cell##2##3##(1996-12#1)(2008-7#1)
rate of cells##4##3##(1992-3#1)(1995-2#1)(2008-11#2)
rate of change in##4##4##(1990-7#1)(2008-10#2)(2008-8#1)
rate of change of##3##4##(2007-11#1)(2008-8#1)(2009-6#1)
rate of change##15##3##(1990-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#2)(2009-6#1)(2009-9#4)
rate of colonization##2##3##(2008-10#1)(2013-8#1)
rate of complete##3##3##(1994-2#1)(2010-12#1)(2011-2#1)
rate of complications and##2##4##(2013-1#2)
rate of complications in##3##4##(1990-9#1)(1991-9#1)(2008-1#1)
rate of complications##14##3##(1990-9#1)(1991-3#1)(1991-9#2)(1992-10#1)(1997-8#1)(2007-7#1)(2008-1#1)(2010-7#1)(2012-12#1)(2013-1#4)
rate of consanguineous marriages##2##4##(2008-4#1)(2011-2#1)
rate of convergence##2##3##(2008-10#1)(2008-7#1)
rate of disease increase##3##4##(2008-10#3)
rate of disease progress and##2##5##(2008-10#2)
rate of disease progress##3##4##(2008-10#3)
rate of disease progression##2##4##(2008-10#2)
rate of disease##10##3##(2008-10#10)
rate of drugs##3##3##(2008-10#1)(2008-5#2)
rate of early##2##3##(1991-9#1)(2008-8#1)
rate of eggs##2##3##(1996-12#1)(2010-8#1)
rate of either##2##3##(2007-8#1)(2008-10#1)
rate of energy transfer##2##4##(2008-10#1)(2012-2#1)
rate of evolution##2##3##(1995-11#1)(2011-2#1)
rate of false##2##3##(1996-9#1)(2008-7#1)
rate of first##3##3##(2010-7#1)(2013-1#2)
rate of formation##2##3##(1993-11#2)
rate of glucose feeding##2##4##(2008-6#2)
rate of glucose##5##3##(1991-7#1)(2008-11#1)(2008-6#2)(2008-7#1)
rate of growth and##2##4##(2008-8#1)(2009-6#1)
rate of growth of##5##4##(1990-7#1)(1996-3#1)(1997-1#1)(2011-2#1)(2012-2#1)
rate of growth##15##3##(1990-7#1)(1991-1#1)(1992-2#1)(1992-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
rate of heat##2##3##(2008-2#1)(2008-3#1)
rate of hemoglobin##2##3##(1993-8#1)(2013-8#1)
rate of hepatic##3##3##(1991-7#2)(2012-2#1)
rate of hydrolysis of##4##4##(1990-11#1)(1990-5#1)(1992-11#1)(1994-11#1)
rate of hydrolysis##5##3##(1990-11#1)(1990-5#1)(1992-11#1)(1994-11#1)(2013-1#1)
rate of incorporation##4##3##(1991-12#1)(1997-1#1)(2008-1#1)(2008-11#1)
rate of increase in##6##4##(1990-7#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-9#1)(2008-9#1)
rate of increase of##2##4##(2008-10#2)
rate of increase##14##3##(1990-7#2)(1992-6#1)(1993-12#1)(1993-3#3)(1994-9#1)(2008-10#3)(2008-9#1)(2011-2#2)
rate of infected and##2##4##(1994-9#1)(2008-10#1)
rate of infection of##2##4##(2008-10#2)
rate of infection##4##3##(2007-10#1)(2008-10#3)
rate of infusion##2##3##(2008-4#1)(2008-7#1)
rate of intravenous rt-PA use##2##5##(2007-10#2)
rate of isolation##2##3##(2008-12#1)(2008-5#1)
rate of late##3##3##(1994-11#1)(2008-8#1)(2010-11#1)
rate of lesion expansion##2##4##(2008-10#2)
rate of local recurrence##2##4##(2007-8#1)(2008-11#1)
rate of local##6##3##(1991-4#1)(2007-8#2)(2008-11#1)(2008-8#1)(2009-12#1)
rate of lymph node##2##4##(2008-1#1)(2013-1#1)
rate of major##2##3##(1994-1#1)(2008-11#1)
rate of metal ion##2##4##(2008-10#2)
rate of metal##3##3##(2008-10#3)
rate of migration##2##3##(1992-6#1)(2008-8#1)
rate of morbidity##2##3##(1993-6#1)(2012-2#1)
rate of more than##3##4##(2007-12#1)(2008-2#1)(2013-7#1)
rate of movement of##2##4##(1991-5#2)
rate of natural##5##3##(2007-7#3)(2011-2#2)
rate of new##2##3##(1991-8#1)(2013-1#1)
rate of occurrence of##2##4##(1996-4#2)
rate of occurrence##3##3##(1996-4#2)(2011-2#1)
rate of oxidation##3##3##(2008-10#2)(2008-12#1)
rate of oxygen consumption##4##4##(1997-1#1)(2008-10#1)(2010-11#2)
rate of oxygen##6##3##(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-11#2)
rate of patients with##2##4##(2007-10#1)(2008-1#1)
rate of patients##5##3##(1997-8#2)(2007-10#1)(2008-1#1)(2008-11#1)
rate of population##3##3##(1994-7#1)(2008-10#1)(2008-8#1)
rate of positive##3##3##(1997-4#1)(2008-12#1)(2012-12#1)
rate of positivity##2##3##(1997-2#2)
rate of post-ESD##2##3##(2012-2#2)
rate of pregnancy##2##3##(1996-12#1)(2008-3#1)
rate of primary##2##3##(2008-10#1)(2011-2#1)
rate of progression to##2##4##(2011-3#1)(2012-2#1)
rate of progression##3##3##(1991-8#1)(2011-3#1)(2012-2#1)
rate of protein##4##3##(1990-11#1)(1990-5#1)(1994-6#1)(2008-5#1)
rate of pustule appearance##3##4##(2008-10#3)
rate of pustule##4##3##(2008-10#4)
rate of quench##2##3##(1992-5#2)
rate of reaction##3##3##(1995-5#1)(2008-10#2)
rate of recovery of##2##4##(2008-11#1)(2008-7#1)
rate of recovery##4##3##(2008-11#1)(2008-12#2)(2008-7#1)
rate of recurrence##4##3##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
rate of renal##3##3##(1994-5#1)(1995-12#1)(2008-1#1)
rate of reoperation##2##3##(2010-3#1)(2012-12#1)
rate of reported##4##3##(1994-2#1)(2007-12#1)(2013-8#2)
rate of resistance##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
rate of resource##3##3##(2008-8#3)
rate of responding##3##3##(1993-6#1)(1997-7#1)(2008-5#1)
rate of response to##2##4##(1993-11#1)(2009-8#1)
rate of response##3##3##(1993-11#1)(2009-12#1)(2009-8#1)
rate of return##2##3##(1992-1#1)(1992-12#1)
rate of secretion##2##3##(1990-8#1)(1991-5#1)
rate of smoking##2##3##(1991-11#1)(2007-8#1)
rate of spontaneous##2##3##(1994-3#1)(2012-2#1)
rate of spread of the##2##5##(2008-10#2)
rate of streptokinase production##2##4##(2012-2#2)
rate of substrate##2##3##(2008-10#1)(2008-7#1)
rate of suicide##2##3##(2011-2#1)(2012-2#1)
rate of surface##3##3##(1994-5#1)(2008-4#1)(2009-12#1)
rate of surfactant##2##3##(1994-5#2)
rate of synthesis##2##3##(1994-2#1)(1994-8#1)
rate of the disease and##2##5##(2008-1#1)(2011-2#1)
rate of the disease##4##4##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
rate of the overall##3##4##(1995-9#1)(2008-7#1)(2008-8#1)
rate of the propagation period##3##5##(1991-12#3)
rate of the protein##2##4##(2008-2#1)(2009-12#1)
rate of the reaction##3##4##(2008-10#3)
rate of the skin##2##4##(2008-5#1)(2012-3#1)
rate of the titrant##3##4##(2008-10#3)
rate of the##111##3##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#4)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-3#1)(1997-6#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-12#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
rate of their##2##3##(1991-9#1)(2007-7#1)
rate of these##3##3##(1997-4#1)(2008-10#1)(2008-12#1)
rate of this##5##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
rate of tobacco##2##3##(2013-1#2)
rate of transmission##2##3##(1996-11#1)(2008-10#1)
rate of transport##4##3##(1995-11#1)(2008-10#3)
rate of treatment##2##3##(1991-12#1)(2008-2#1)
rate of tumor growth##2##4##(1990-7#1)(2013-8#1)
rate of tumor##4##3##(1990-7#1)(1997-7#1)(2013-1#1)(2013-8#1)
rate of up to 30##2##5##(1997-1#1)(2008-10#1)
rate of up to##4##4##(1997-1#1)(2007-11#1)(2008-10#1)(2010-8#1)
rate of uptake of##2##4##(1991-5#1)(1992-6#1)
rate of uptake##5##3##(1991-5#1)(1992-6#1)(1995-11#2)(2008-10#1)
rate of urea##2##3##(1993-11#1)(2013-8#1)
rate of vertical transmission of HBV##2##6##(2011-1#2)
rate of very##2##3##(2007-11#1)(2011-2#1)
rate of water##3##3##(2008-10#2)(2010-4#1)
rate of##1325##2##(1990-11#11)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#5)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#3)(1991-11#2)(1991-12#13)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#8)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#9)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#6)(1992-2#6)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#11)(1992-8#1)(1992-9#6)(1993-1#1)(1993-11#12)(1993-12#2)(1993-3#7)(1993-6#4)(1993-8#4)(1993-9#3)(1994-1#3)(1994-11#5)(1994-12#4)(1994-2#9)(1994-3#7)(1994-5#9)(1994-6#7)(1994-7#4)(1994-8#8)(1994-9#4)(1995-11#6)(1995-12#7)(1995-2#8)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#7)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#2)(1996-8#4)(1996-9#2)(1997-1#7)(1997-2#3)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#5)(2006-10#3)(2006-6#1)(2007-10#4)(2007-11#26)(2007-12#28)(2007-2#1)(2007-7#12)(2007-8#10)(2008-1#19)(2008-10#312)(2008-11#52)(2008-12#29)(2008-2#17)(2008-3#39)(2008-4#11)(2008-5#22)(2008-6#20)(2008-7#49)(2008-8#37)(2008-9#27)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#5)(2010-10#1)(2010-11#6)(2010-12#5)(2010-3#9)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#12)(2011-1#17)(2011-2#43)(2011-3#3)(2011-7#1)(2012-12#18)(2012-2#28)(2012-3#26)(2013-1#32)(2013-7#4)(2013-8#20)
rate on the##13##3##(1993-8#1)(1996-4#1)(1997-2#3)(2008-10#4)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#1)
rate on##37##2##(1990-2#1)(1993-8#1)(1994-11#1)(1996-12#2)(1996-4#1)(1997-2#3)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
rate or the##2##3##(1994-5#1)(2008-10#1)
rate or##8##2##(1990-2#1)(1994-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
rate over##7##2##(1994-9#1)(2008-11#2)(2008-6#2)(2010-3#1)(2011-2#1)
rate parameter##3##2##(2008-10#3)
rate parameters##4##2##(1994-9#1)(2008-10#1)(2008-11#1)(2010-11#1)
rate per enzyme adsorbed##2##4##(2008-7#2)
rate per unit of##2##4##(2007-11#1)(2008-10#1)
rate per year##2##3##(2008-7#1)(2008-8#1)
rate per##11##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)
rate profiles of##2##3##(2008-5#1)(2008-7#1)
rate profiles##3##2##(1991-9#1)(2008-5#1)(2008-7#1)
rate provided##2##2##(2008-1#1)(2008-10#1)
rate raises the##2##3##(1993-12#1)(2008-3#1)
rate ranged##2##2##(2008-8#1)(2011-10#1)
rate ranging from##2##3##(2007-12#1)(2008-10#1)
rate ratio of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
rate ratio##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
rate ratios and##2##3##(2008-10#1)(2011-2#1)
rate ratios##5##2##(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
rate reached##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2012-3#1)
rate remained constant##2##3##(1994-5#2)
rate remained##3##2##(1994-5#2)(2008-11#1)
rate remains constant##2##3##(2008-10#1)(2008-11#1)
rate restrictions and open enrolment##3##5##(2008-7#3)
rate seems to be##2##4##(2007-12#1)(2007-8#1)
rate seems to##3##3##(2007-12#1)(2007-8#1)(2008-7#1)
rate showed a##2##3##(2008-11#1)(2012-12#1)
rate showed##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
rate significantly##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)
rate similar to that of the##2##6##(1994-8#1)(1995-2#1)
rate similar to that##3##4##(1993-8#1)(1994-8#1)(1995-2#1)
rate stability##2##2##(1991-1#1)(2008-10#1)
rate studies##2##2##(1991-9#1)(1993-8#1)
rate system##3##2##(1995-2#1)(2008-4#2)
rate than did##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
rate than that##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
rate than the##7##3##(1992-12#1)(1995-3#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
rate than##33##2##(1990-8#1)(1991-3#2)(1992-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
rate that is##3##3##(1994-2#1)(2007-11#1)(2013-1#1)
rate that##11##2##(1994-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#3)
rate the##6##2##(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
rate their##8##2##(1993-1#1)(1993-2#1)(1996-2#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-4#2)
rate through##2##2##(2011-1#1)(2012-3#1)
rate throughout the##2##3##(1994-7#1)(2008-11#1)
rate times##3##2##(1993-1#1)(1994-12#1)(1996-12#1)
rate to be##3##3##(2008-11#1)(2008-3#1)(2010-12#1)
rate to generate##2##3##(1995-6#1)(2008-7#1)
rate to predict##2##3##(2008-10#1)(2008-7#1)
rate to the##2##3##(2008-11#1)(2008-3#1)
rate to##25##2##(1990-9#1)(1993-6#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2010-12#1)(2012-2#3)(2012-3#1)(2012-8#1)
rate up to##2##3##(1994-3#1)(2008-6#1)
rate using##2##2##(2008-10#1)(2008-12#1)
rate variability (HRV)##7##3##(2008-12#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
rate variability##15##2##(2008-12#3)(2008-6#1)(2008-7#1)(2009-11#2)(2010-12#2)(2010-5#3)(2011-2#1)(2012-2#1)(2013-8#1)
rate varied from##3##3##(2008-6#1)(2008-9#2)
rate varied##4##2##(2007-5#1)(2008-6#1)(2008-9#2)
rate was 0##7##3##(1990-6#1)(1994-3#1)(2007-5#1)(2008-8#1)(2011-2#2)(2012-3#1)
rate was 0%##2##3##(1991-2#1)(2008-6#1)
rate was 1##4##3##(1991-2#1)(1994-11#1)(2008-10#1)(2008-7#1)
rate was 100%##3##3##(1997-3#1)(2012-3#2)
rate was 11##2##3##(2007-7#1)(2008-10#1)
rate was 11%##2##3##(1996-12#1)(2010-3#1)
rate was 12##2##3##(1996-8#1)(1997-7#1)
rate was 12%##2##3##(1994-3#1)(1996-9#1)
rate was 2##4##3##(1992-9#1)(2008-5#1)(2011-1#1)(2012-12#1)
rate was 20##3##3##(2008-10#1)(2013-1#2)
rate was 3##4##3##(1991-9#1)(2007-5#1)(2007-7#1)(2008-5#1)
rate was 30##2##3##(2008-10#1)(2013-8#1)
rate was 4##4##3##(1992-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
rate was 40%##2##3##(1995-5#1)(2012-2#1)
rate was 53%##3##3##(1991-3#1)(2008-6#1)(2010-8#1)
rate was 58%##2##3##(1993-1#1)(2008-12#1)
rate was 61##2##3##(1990-9#1)(2011-1#1)
rate was 64##2##3##(1996-12#1)(1997-7#1)
rate was 72%##2##3##(1993-5#1)(2008-11#1)
rate was 77##2##3##(1997-7#1)(2007-8#1)
rate was 85##2##3##(2007-8#1)(2008-1#1)
rate was 88%##3##3##(1991-2#1)(1991-6#1)(2008-7#1)
rate was 90##2##3##(2008-10#1)(2008-11#1)
rate was 94##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
rate was 95##2##3##(2006-12#1)(2008-10#1)
rate was about##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
rate was achieved##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
rate was also##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
rate was calculated##6##3##(1990-9#1)(2008-10#1)(2008-5#2)(2008-8#2)
rate was decreased by##2##4##(1995-12#1)(2012-3#1)
rate was decreased##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
rate was determined##2##3##(2008-7#1)(2010-5#1)
rate was equal to##2##4##(1990-12#1)(2008-10#1)
rate was estimated to be##2##5##(2007-11#1)(2012-2#1)
rate was found to be##5##5##(1994-3#1)(1995-12#2)(2007-8#1)(2008-7#1)
rate was found to##6##4##(1994-3#1)(1995-12#2)(2007-8#1)(2008-7#2)
rate was found##9##3##(1992-6#1)(1994-3#1)(1995-12#2)(2007-8#1)(2008-7#3)(2013-8#1)
rate was high##3##3##(1991-6#1)(2008-10#1)(2008-8#1)
rate was higher in##3##4##(2007-8#1)(2012-3#1)(2013-1#1)
rate was higher than##2##4##(2008-11#1)(2013-1#1)
rate was higher##5##3##(2007-8#1)(2008-11#1)(2012-3#1)(2013-1#2)
rate was in##2##3##(2007-7#1)(2008-10#1)
rate was increased##2##3##(1996-2#1)(2008-10#1)
rate was low##2##3##(1990-3#1)(2008-11#1)
rate was lower than##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
rate was lower##5##3##(1992-9#1)(2008-10#1)(2008-11#2)(2008-7#1)
rate was measured##2##3##(1995-3#1)(2009-11#1)
rate was much lower##3##4##(1994-9#1)(2008-6#1)(2013-8#1)
rate was not significantly affected##2##5##(2008-11#1)(2010-11#1)
rate was not##3##3##(2008-11#1)(2010-11#1)(2012-3#1)
rate was observed##4##3##(1994-5#1)(2008-11#2)(2008-3#1)
rate was obtained##2##3##(2008-11#1)(2008-3#1)
rate was only##2##3##(1992-10#1)(1994-7#1)
rate was over##2##3##(1994-2#1)(2008-10#1)
rate was reduced##2##3##(1993-1#1)(2013-8#1)
rate was significantly higher in##5##5##(1990-12#1)(1991-6#1)(2007-7#1)(2008-10#1)(2008-7#1)
rate was significantly higher##6##4##(1990-12#1)(1991-6#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)
rate was significantly##9##3##(1990-12#1)(1991-6#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#2)
rate was slightly##2##3##(1990-11#1)(2008-6#1)
rate was slower in##2##4##(1995-12#1)(2013-1#1)
rate was##274##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-6#3)(1990-9#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-6#3)(1992-9#3)(1993-1#5)(1993-11#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#2)(1994-9#2)(1995-12#7)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#5)(1997-8#1)(2006-12#2)(2007-10#2)(2007-11#3)(2007-5#2)(2007-7#7)(2007-8#9)(2008-1#2)(2008-10#41)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#7)(2008-7#18)(2008-8#6)(2008-9#4)(2009-11#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#13)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#10)(2013-8#10)
rate were also##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
rate were optimized##3##3##(2008-10#3)
rate were##31##2##(1990-12#1)(1993-10#1)(1993-11#1)(1994-5#1)(1996-2#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#4)(2008-7#3)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
rate when##6##2##(1995-5#1)(1997-6#1)(2007-11#1)(2008-8#1)(2009-10#1)(2011-2#1)
rate which##3##2##(1991-9#1)(1993-5#1)(2008-11#1)
rate while the##2##3##(2008-10#1)(2008-12#1)
rate while##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
rate will##2##2##(1996-3#1)(2008-3#1)
rate with respect to##2##4##(2007-12#1)(2011-1#1)
rate with temperature##2##3##(2008-10#1)(2010-4#1)
rate with the##4##3##(1993-8#1)(2008-12#1)(2008-7#1)(2009-12#1)
rate with##18##2##(1993-8#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-3#1)
rate within##3##2##(2007-7#1)(2008-2#1)(2008-7#1)
rate without##2##2##(2008-2#1)(2011-2#1)
rate would##2##2##(2012-12#1)(2013-8#1)
rate##3991##1##(1990-10#1)(1990-11#17)(1990-12#13)(1990-2#5)(1990-3#6)(1990-5#12)(1990-6#17)(1990-7#11)(1990-8#14)(1990-9#15)(1991-1#5)(1991-10#2)(1991-11#6)(1991-12#25)(1991-2#12)(1991-3#10)(1991-4#2)(1991-5#14)(1991-6#14)(1991-7#3)(1991-8#11)(1991-9#17)(1992-1#5)(1992-10#6)(1992-11#6)(1992-12#11)(1992-2#11)(1992-3#9)(1992-4#1)(1992-5#8)(1992-6#27)(1992-7#2)(1992-8#9)(1992-9#13)(1993-1#19)(1993-10#1)(1993-11#19)(1993-12#10)(1993-2#7)(1993-3#12)(1993-5#4)(1993-6#12)(1993-8#19)(1993-9#6)(1994-1#3)(1994-10#1)(1994-11#9)(1994-12#16)(1994-2#16)(1994-3#24)(1994-5#27)(1994-6#10)(1994-7#10)(1994-8#16)(1994-9#10)(1995-1#2)(1995-11#10)(1995-12#32)(1995-2#24)(1995-3#16)(1995-4#4)(1995-5#10)(1995-6#18)(1995-8#6)(1995-9#4)(1996-1#3)(1996-11#9)(1996-12#23)(1996-2#18)(1996-3#13)(1996-4#8)(1996-5#4)(1996-6#5)(1996-8#9)(1996-9#3)(1997-1#9)(1997-2#18)(1997-3#4)(1997-4#15)(1997-5#3)(1997-6#9)(1997-7#27)(1997-8#14)(2006-10#8)(2006-12#2)(2006-6#2)(2007-10#16)(2007-11#82)(2007-12#90)(2007-2#3)(2007-4#5)(2007-5#3)(2007-7#38)(2007-8#29)(2007-9#2)(2008-1#44)(2008-10#806)(2008-11#211)(2008-12#82)(2008-2#60)(2008-3#136)(2008-4#33)(2008-5#72)(2008-6#74)(2008-7#196)(2008-8#154)(2008-9#95)(2009-1#1)(2009-10#11)(2009-11#13)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#15)(2009-6#9)(2009-7#12)(2009-8#19)(2009-9#9)(2010-1#1)(2010-10#6)(2010-11#11)(2010-12#17)(2010-2#2)(2010-3#29)(2010-4#15)(2010-5#17)(2010-6#2)(2010-7#6)(2010-8#32)(2010-9#3)(2011-1#44)(2011-10#2)(2011-2#130)(2011-3#8)(2011-7#1)(2012-1#7)(2012-12#51)(2012-2#91)(2012-3#68)(2012-5#2)(2012-8#1)(2013-1#102)(2013-7#9)(2013-8#75)
rate) and##8##2##(1991-6#1)(1994-3#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-7#1)(2012-2#1)
rate) was##2##2##(2008-11#1)(2010-12#1)
rate) were##6##2##(2008-10#5)(2013-1#1)
rate)##40##1##(1991-6#1)(1991-8#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-11#3)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
rate- and state-dependent##2##3##(1996-4#2)
rate-dependent friction##2##2##(1996-4#2)
rate-dependent##4##1##(1996-4#3)(2008-8#1)
rate-determining step##2##2##(1992-6#1)(2008-10#1)
rate-determining##3##1##(1992-6#1)(1997-7#1)(2008-10#1)
rate-equation##3##1##(2008-3#2)(2009-11#1)
rate-limiting chemical step in##2##4##(1991-9#2)
rate-limiting during##2##2##(1991-5#2)
rate-limiting enzyme in the##4##4##(1991-9#1)(1994-6#1)(2010-2#1)(2012-2#1)
rate-limiting enzyme in##9##3##(1991-9#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(2008-5#1)(2010-2#1)(2012-2#1)
rate-limiting enzyme##12##2##(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-2#1)
rate-limiting step in##5##3##(1990-2#1)(1990-5#1)(1991-5#1)(1995-6#1)(1996-2#1)
rate-limiting step of##4##3##(1992-12#1)(2011-2#1)(2012-2#2)
rate-limiting step##13##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#2)
rate-limiting##44##1##(1990-2#1)(1990-5#1)(1991-5#4)(1991-9#5)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#3)
rate-related##2##1##(1993-11#1)(1996-2#1)
rated as more##2##3##(2009-7#1)(2012-2#1)
rated as the##2##3##(2007-11#1)(2010-10#1)
rated as##16##2##(1993-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
rated by the##2##3##(1991-2#1)(2007-12#1)
rated by##9##2##(1991-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2012-2#2)
rated each##2##2##(1996-1#1)(2009-9#1)
rated higher##3##2##(1993-12#2)(2008-9#1)
rated highest##3##2##(1993-2#1)(2009-11#1)(2011-2#1)
rated on a##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
rated satisfaction with##2##3##(1993-2#1)(2012-3#1)
rated severity##2##2##(2007-12#2)
rated significantly higher than##2##4##(1993-2#2)
rated the overall##2##3##(2008-11#1)(2012-12#1)
rated the##13##2##(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
rated their##6##2##(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)
rated themselves positively##2##3##(2010-3#2)
rated themselves##3##2##(2007-7#1)(2010-3#2)
rated##100##1##(1991-2#1)(1992-2#1)(1993-12#2)(1993-2#7)(1993-3#1)(1994-2#1)(1995-1#2)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-8#2)
ratemeter##5##1##(1996-2#5)
rater##3##1##(2008-10#1)(2012-2#2)
raters in##2##2##(1995-5#1)(2012-3#1)
raters to##3##2##(1997-3#2)(2013-1#1)
raters##31##1##(1993-12#2)(1994-2#1)(1995-5#1)(1997-3#5)(2008-10#3)(2008-12#2)(2008-9#2)(2009-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)
rates (&lt##2##2##(2008-3#1)(2008-7#1)
rates (1##2##2##(2008-10#1)(2010-5#1)
rates (up to##2##3##(2008-3#1)(2012-3#1)
rates 4##2##2##(1991-8#1)(2008-7#1)
rates across##3##2##(2008-8#1)(2012-3#2)
rates affect##2##2##(1994-3#1)(1995-3#1)
rates after##10##2##(1992-11#1)(1997-6#1)(2006-10#1)(2007-8#2)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#1)
rates allowed##2##2##(2008-10#1)(2008-7#1)
rates along##2##2##(1996-12#1)(2012-2#1)
rates always##2##2##(2008-10#1)(2008-3#1)
rates among##15##2##(1990-6#1)(1990-9#1)(1991-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
rates and clinical##2##3##(1997-5#1)(2008-3#1)
rates and high##3##3##(2007-12#2)(2008-3#1)
rates and low##2##3##(2008-6#1)(2013-8#1)
rates and of##2##3##(1995-11#1)(1996-3#1)
rates and population##2##3##(2008-11#1)(2008-8#1)
rates and risk##2##3##(2008-7#1)(2009-7#1)
rates and temporal##2##3##(2008-11#1)(2008-7#1)
rates and that the##2##4##(2008-8#2)
rates and the##7##3##(1990-5#1)(1990-8#1)(1995-12#1)(2008-10#2)(2008-2#2)
rates and##121##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#3)(1993-3#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#3)(1996-1#1)(1996-12#2)(1996-3#3)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#14)(2008-11#13)(2008-12#3)(2008-2#5)(2008-3#4)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#3)(2009-5#1)(2009-7#2)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
rates approaching##2##2##(2008-10#1)(2013-8#1)
rates are high##2##3##(2008-3#1)(2013-8#1)
rates are higher##2##3##(1991-6#1)(2008-9#1)
rates are in##2##3##(1990-2#1)(2007-12#1)
rates are linear##2##3##(2008-10#1)(2012-3#1)
rates are low##2##3##(2008-8#1)(2011-2#1)
rates are more##2##3##(1992-12#1)(1995-2#1)
rates are significantly##2##3##(2009-7#1)(2013-8#1)
rates are within##2##3##(2008-2#1)(2012-2#1)
rates are##57##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1995-2#1)(1995-5#1)(1996-3#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
rates as high as##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
rates as##19##2##(1991-6#1)(1991-8#1)(1992-1#1)(1994-2#1)(1994-7#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
rates at 5 years were##2##5##(1994-12#1)(2010-3#1)
rates at which##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
rates at##16##2##(1992-12#1)(1994-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
rates based##2##2##(2008-7#1)(2012-12#1)
rates below##2##2##(2008-7#1)(2009-7#1)
rates between the##2##3##(1995-4#1)(1996-12#1)
rates between##15##2##(1991-12#1)(1994-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#2)(2013-1#1)
rates but##4##2##(1990-12#1)(1993-6#1)(2008-8#1)(2008-9#1)
rates by##10##2##(1993-12#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2012-1#1)(2012-3#1)
rates can be##4##3##(1992-6#1)(2007-11#1)(2010-12#1)(2010-3#1)
rates can##8##2##(1992-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-8#2)(2010-12#1)(2010-3#1)
rates comparable to##2##3##(1992-6#1)(2008-6#1)
rates comparable##3##2##(1992-6#1)(2008-6#1)(2013-8#1)
rates compared to##2##3##(2007-7#1)(2012-12#1)
rates compared with##2##3##(2007-12#1)(2008-2#1)
rates compared##6##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-12#2)
rates continue to##2##3##(1992-2#1)(2008-7#1)
rates could be##3##3##(2008-1#1)(2008-7#1)(2012-12#1)
rates could##4##2##(2008-1#1)(2008-7#1)(2012-12#1)(2013-8#1)
rates declined##2##2##(1995-9#1)(2008-7#1)
rates decreased##3##2##(2008-11#1)(2011-3#1)(2012-3#1)
rates depend on the##3##4##(2008-11#2)(2013-1#1)
rates differ in##2##3##(1994-1#1)(2012-3#1)
rates due to##3##3##(2008-11#2)(2009-7#1)
rates during the##4##3##(1991-12#1)(2007-10#1)(2007-5#1)(2008-4#1)
rates during##9##2##(1991-12#1)(1992-2#1)(1995-12#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-7#1)
rates expected##2##2##(1997-3#1)(2008-7#1)
rates following##5##2##(1991-3#1)(2007-5#1)(2008-11#1)(2011-2#1)(2012-12#1)
rates for Medicare##2##3##(1992-1#1)(2012-3#1)
rates for a##2##3##(1991-2#1)(2008-8#1)
rates for all##3##3##(2008-12#1)(2008-7#1)(2010-3#1)
rates for children##2##3##(1995-3#1)(2013-1#1)
rates for each##2##3##(2007-8#1)(2013-1#1)
rates for patients with advanced##2##5##(2007-7#1)(2012-3#1)
rates for patients with##4##4##(2007-7#1)(2010-11#1)(2010-3#1)(2012-3#1)
rates for patients##5##3##(2007-7#1)(2010-11#1)(2010-3#2)(2012-3#1)
rates for the##9##3##(1993-12#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-3#1)(2013-1#1)
rates for various##2##3##(1990-9#1)(2007-12#1)
rates for##68##2##(1990-9#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-10#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#5)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)
rates from 10 to##2##4##(2008-6#1)(2009-7#1)
rates from breast cancer##3##4##(1991-12#2)(1997-7#1)
rates from the##2##3##(2007-11#1)(2011-2#1)
rates from##19##2##(1991-12#2)(1996-12#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#1)
rates greater than##2##3##(2008-10#1)(2008-6#1)
rates had##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
rates have been reported with##2##5##(2008-10#1)(2011-2#1)
rates have been##11##3##(1990-2#1)(1991-1#1)(1992-12#1)(1993-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)
rates have increased##2##3##(1997-8#1)(2007-2#1)
rates have not##2##3##(2011-1#1)(2012-3#1)
rates have##19##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1997-8#1)(2007-2#2)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
rates in New##2##3##(1996-3#1)(2008-8#1)
rates in a##5##3##(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)
rates in children##2##3##(2007-12#1)(2010-8#1)
rates in comparison##2##3##(2007-10#1)(2008-11#1)
rates in patients with##3##4##(2007-8#1)(2008-1#1)(2012-2#1)
rates in patients##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-2#1)
rates in the absence of##2##5##(1991-12#1)(2008-11#1)
rates in the population##2##4##(1994-6#1)(2008-8#1)
rates in the whole##2##4##(2007-10#1)(2011-1#1)
rates in the##21##3##(1991-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-1#1)(2007-10#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-8#1)
rates in##94##2##(1990-11#1)(1990-2#1)(1991-12#2)(1992-2#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-1#2)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#5)
rates increase##4##2##(1990-6#1)(2007-10#1)(2008-7#1)(2008-8#1)
rates increased from##2##3##(2008-10#1)(2008-6#1)
rates increased##8##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2013-1#1)
rates investigated##2##2##(2008-10#1)(2008-11#1)
rates is##6##2##(1991-1#1)(1992-12#1)(1997-7#2)(2008-4#1)(2008-9#1)
rates leads to a##2##4##(2008-10#1)(2009-6#1)
rates may be##3##3##(1994-3#1)(1996-12#1)(2008-8#1)
rates may##6##2##(1993-12#1)(1994-3#1)(1996-12#1)(2008-8#2)(2010-4#1)
rates observed##3##2##(1995-6#1)(2007-12#1)(2012-3#1)
rates obtained##2##2##(1996-12#1)(2008-10#1)
rates occur##2##2##(2010-3#1)(2013-1#1)
rates occurred##2##2##(2008-11#1)(2013-1#1)
rates of 0##6##3##(1991-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
rates of 1##2##3##(2008-10#1)(2013-7#1)
rates of 2##2##3##(2008-11#2)
rates of 8##2##3##(1991-12#1)(2008-10#1)
rates of 9##2##3##(2008-10#2)
rates of JH synthesis##2##4##(2008-7#2)
rates of JH##3##3##(2008-7#3)
rates of Si##3##3##(2008-10#3)
rates of a##6##3##(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)(2009-7#1)
rates of acquisition##2##3##(2008-10#1)(2008-5#1)
rates of adverse##2##3##(1995-2#1)(2008-11#1)
rates of all##2##3##(1997-4#1)(2008-7#1)
rates of as much as##2##5##(2007-11#1)(2008-3#1)
rates of both##2##3##(1990-8#1)(2013-1#1)
rates of cervical intraepithelial neoplasia##2##5##(1994-12#1)(2011-1#1)
rates of change in the##2##5##(1992-12#1)(2007-12#1)
rates of change of##2##4##(2008-3#1)(2009-7#1)
rates of change##5##3##(1992-12#2)(2007-12#1)(2008-3#1)(2009-7#1)
rates of childhood##2##3##(2008-11#1)(2010-3#1)
rates of children##2##3##(1994-2#1)(2008-4#1)
rates of clonal##2##3##(2008-9#2)
rates of coronary##2##3##(1992-6#1)(2008-7#1)
rates of dephosphorylation##2##3##(1996-2#2)
rates of different##2##3##(2008-11#1)(2008-7#1)
rates of disease##4##3##(1994-3#1)(2008-10#2)(2013-8#1)
rates of disfluency##3##3##(2008-2#3)
rates of dispersal##2##3##(2008-8#2)
rates of each of##2##4##(1993-12#1)(2008-8#1)
rates of formation##2##3##(1993-6#1)(2008-10#1)
rates of gastrovascular transport##2##4##(2010-2#2)
rates of glucose##2##3##(2008-11#1)(2008-7#1)
rates of heterotopic ossification##2##4##(2012-12#2)
rates of hydrolysis##2##3##(2008-5#1)(2009-2#1)
rates of infection##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
rates of low##3##3##(1992-2#1)(1994-8#1)(2008-7#1)
rates of many##2##3##(1994-3#1)(2009-7#1)
rates of mortality##4##3##(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#1)
rates of native AVFs##2##4##(2007-7#2)
rates of oxygen uptake and carbon dioxide evolution of animal cell##2##11##(2008-11#2)
rates of oxygen uptake and carbon dioxide evolution##3##8##(2008-11#3)
rates of patients##2##3##(2007-5#1)(2012-2#1)
rates of population increase##2##4##(2010-8#1)(2011-2#1)
rates of population##3##3##(2008-9#1)(2010-8#1)(2011-2#1)
rates of re-bleeding and mortality in##2##6##(2013-1#2)
rates of recombination and##4##4##(2008-10#3)(2009-10#1)
rates of recombination##5##3##(2008-10#4)(2009-10#1)
rates of recurrence##4##3##(2011-2#2)(2012-2#1)(2013-1#1)
rates of response##2##3##(1993-6#2)
rates of rotation##2##3##(1992-10#1)(1997-7#1)
rates of schizotypal traits in##2##5##(2008-1#2)
rates of serious##2##3##(2008-11#1)(2011-2#1)
rates of several##2##3##(1991-3#1)(2008-5#1)
rates of smoking##2##3##(1991-11#1)(2013-8#1)
rates of spread and##2##4##(2008-8#2)
rates of spread##4##3##(2008-8#4)
rates of success##2##3##(1994-7#1)(2013-8#1)
rates of the cell##2##4##(2008-11#2)
rates of the##32##3##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)
rates of their##2##3##(2008-10#2)
rates of these##4##3##(1995-6#1)(2008-2#1)(2008-8#1)(2010-8#1)
rates of total##2##3##(2009-3#1)(2013-1#1)
rates of up to##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
rates of##522##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-8#2)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#2)(1993-12#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#5)(1996-4#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-7#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#2)(2008-1#11)(2008-10#76)(2008-11#36)(2008-12#12)(2008-2#14)(2008-3#11)(2008-4#3)(2008-5#19)(2008-6#6)(2008-7#24)(2008-8#31)(2008-9#20)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#7)(2011-1#9)(2011-2#15)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#11)(2012-3#5)(2013-1#29)(2013-7#1)(2013-8#9)
rates on the##2##3##(1991-8#1)(2010-11#1)
rates on##13##2##(1991-8#1)(1996-4#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#2)(2012-2#1)
rates only##2##2##(1991-5#1)(2008-10#1)
rates or##7##2##(1994-2#1)(1996-2#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#2)
rates over a##2##3##(2008-6#1)(2008-7#1)
rates over##6##2##(1991-1#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)
rates ranged from##2##3##(2007-5#2)
rates ranging from 0##2##4##(2008-10#1)(2009-7#1)
rates ranging from 8##2##4##(2008-1#1)(2009-7#1)
rates ranging from##6##3##(2008-1#1)(2008-10#1)(2009-7#2)(2012-12#1)(2012-2#1)
rates remain##2##2##(1993-3#1)(2012-12#1)
rates remained##2##2##(1996-3#1)(2008-11#1)
rates reported in##2##3##(1991-3#1)(2010-5#1)
rates reported##5##2##(1991-3#1)(1993-12#1)(2010-5#1)(2013-8#2)
rates resulting in##2##3##(2008-11#1)(2008-8#1)
rates revealed##2##2##(1990-6#1)(1993-3#1)
rates seen##2##2##(2008-11#1)(2013-1#1)
rates should be##4##3##(2008-10#1)(2008-7#1)(2008-9#2)
rates should##5##2##(2008-10#2)(2008-7#1)(2008-9#2)
rates showed##4##2##(1991-6#1)(2007-5#1)(2007-8#1)(2008-11#1)
rates similar to those obtained##2##5##(1996-8#1)(2008-10#1)
rates similar to those##4##4##(1996-8#1)(2007-7#1)(2008-10#1)(2008-7#1)
rates suggest that##2##3##(1997-5#1)(2008-8#1)
rates than in##2##3##(2012-7#1)(2013-1#1)
rates than other##2##3##(2008-10#1)(2008-11#1)
rates than those##2##3##(2008-6#1)(2013-1#1)
rates than##15##2##(1991-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-6#3)(2008-8#1)(2009-7#1)(2012-12#1)(2012-7#1)(2013-1#2)
rates that are##4##3##(2008-3#1)(2013-8#3)
rates that were##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
rates that##15##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#4)
rates through##3##2##(2008-10#2)(2013-1#1)
rates to be##2##3##(2008-10#1)(2008-8#1)
rates to standard##2##3##(2008-6#1)(2010-11#1)
rates to those##3##3##(1991-3#1)(1992-2#1)(2008-8#1)
rates to##24##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-2#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
rates under##2##2##(1995-6#1)(2009-10#1)
rates up to##8##3##(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
rates using##2##2##(1997-1#1)(2008-9#1)
rates varied from##2##3##(2008-10#1)(2010-8#1)
rates varied##4##2##(2007-5#1)(2008-10#2)(2010-8#1)
rates vary##4##2##(1994-2#1)(2009-7#1)(2012-3#1)(2013-1#1)
rates was##6##2##(1992-10#1)(2008-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
rates were 0##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
rates were 30##2##3##(1991-8#1)(2011-1#1)
rates were analyzed##3##3##(1994-3#1)(2008-12#1)(2011-2#1)
rates were associated with##2##4##(1996-12#1)(2013-8#1)
rates were calculated and##2##4##(2008-11#1)(2013-8#1)
rates were calculated##6##3##(1995-3#1)(2008-11#3)(2011-2#1)(2013-8#1)
rates were determined by##2##4##(1996-1#1)(2008-10#1)
rates were determined##5##3##(1991-12#1)(1996-1#1)(2007-5#1)(2008-10#1)(2012-3#1)
rates were evaluated##2##3##(2008-10#1)(2008-6#1)
rates were found##3##3##(1993-12#1)(1995-3#1)(2008-6#1)
rates were higher in##2##4##(2007-5#1)(2011-2#1)
rates were higher##6##3##(2007-5#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#1)
rates were highest##2##3##(2008-5#1)(2008-7#1)
rates were increased##2##3##(1994-3#1)(2008-9#1)
rates were lower in##2##4##(1991-12#1)(2008-8#1)
rates were lower##4##3##(1991-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
rates were not##2##3##(2008-11#1)(2011-2#1)
rates were observed in##2##4##(1990-8#1)(2013-8#1)
rates were observed##5##3##(1990-8#2)(2008-10#1)(2008-12#1)(2013-8#1)
rates were obtained##2##3##(2008-10#1)(2008-11#1)
rates were recorded##2##3##(1993-6#1)(2008-12#1)
rates were significantly higher##2##4##(2007-11#1)(2008-7#1)
rates were significantly lower##2##4##(2008-10#1)(2012-3#1)
rates were significantly##6##3##(2007-11#2)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
rates were similar##4##3##(1990-2#1)(1994-5#1)(2007-8#1)(2012-12#1)
rates were##120##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-8#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-3#3)(1994-5#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#14)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-6#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#5)
rates when##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
rates which##2##2##(1990-12#1)(2008-11#1)
rates with the##2##3##(2008-7#1)(2008-9#1)
rates with##19##2##(1992-3#1)(1996-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#2)(2010-12#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
rates within##4##2##(1997-3#1)(2008-11#1)(2008-8#1)(2012-12#1)
rates without##5##2##(1997-6#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
rates##1900##1##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#8)(1990-3#2)(1990-5#5)(1990-6#5)(1990-8#7)(1990-9#4)(1991-1#6)(1991-11#2)(1991-12#18)(1991-2#5)(1991-3#8)(1991-5#7)(1991-6#5)(1991-8#6)(1991-9#4)(1992-1#5)(1992-10#4)(1992-11#2)(1992-12#12)(1992-2#12)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#1)(1992-9#1)(1993-1#6)(1993-11#1)(1993-12#18)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#7)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#10)(1994-2#13)(1994-3#12)(1994-5#5)(1994-6#3)(1994-7#4)(1994-8#8)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#12)(1995-3#12)(1995-4#2)(1995-5#2)(1995-6#6)(1995-8#2)(1995-9#3)(1996-1#5)(1996-12#28)(1996-2#10)(1996-3#10)(1996-4#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#8)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#8)(1997-8#2)(2006-10#4)(2006-12#1)(2006-7#1)(2007-10#19)(2007-11#17)(2007-12#31)(2007-2#3)(2007-4#1)(2007-5#18)(2007-7#23)(2007-8#12)(2008-1#32)(2008-10#222)(2008-11#134)(2008-12#37)(2008-2#31)(2008-3#48)(2008-4#7)(2008-5#35)(2008-6#38)(2008-7#91)(2008-8#104)(2008-9#57)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#11)(2009-6#6)(2009-7#22)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#7)(2010-11#5)(2010-12#8)(2010-2#4)(2010-3#17)(2010-4#9)(2010-5#4)(2010-6#4)(2010-7#6)(2010-8#18)(2011-1#31)(2011-10#3)(2011-2#74)(2011-3#2)(2011-7#1)(2012-1#8)(2012-12#42)(2012-2#38)(2012-3#43)(2012-6#1)(2012-7#1)(2013-1#79)(2013-7#5)(2013-8#49)
rates)##5##1##(1992-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
rates--a##2##1##(1994-8#1)(2008-9#1)
ratesetting##5##1##(1991-2#2)(1993-12#2)(1994-2#1)
rather a##7##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)
rather complex##2##2##(1993-12#1)(2008-9#1)
rather complicated##2##2##(2008-2#1)(2008-3#1)
rather high detection##2##3##(1996-5#1)(2008-10#1)
rather high##11##2##(1991-11#2)(1996-5#1)(2008-10#5)(2008-3#1)(2008-8#1)(2013-1#1)
rather it##4##2##(1992-8#1)(1994-11#1)(1996-3#1)(2007-12#1)
rather large##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
rather limited##5##2##(1996-2#1)(2008-12#1)(2008-2#1)(2009-5#1)(2013-1#1)
rather low and##2##3##(2008-10#1)(2008-8#1)
rather low##8##2##(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)
rather modest##2##2##(1991-1#1)(1995-5#1)
rather rare##6##2##(1993-9#1)(2007-5#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)
rather scarce##2##2##(1990-5#1)(2008-10#1)
rather short##3##2##(1990-6#1)(1996-12#1)(2013-1#1)
rather similar##5##2##(1992-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
rather simple##3##2##(1993-6#1)(2008-10#2)
rather slow##2##2##(2008-10#1)(2013-8#1)
rather small##2##2##(2008-12#1)(2008-2#1)
rather specific##2##2##(1994-11#1)(2008-7#1)
rather stable##2##2##(1995-5#1)(2008-10#1)
rather than a &quot##2##4##(2011-2#1)(2013-8#1)
rather than a single##3##4##(2008-3#1)(2008-5#1)(2008-9#1)
rather than a specific##2##4##(2009-8#1)(2012-2#1)
rather than a##40##3##(1990-5#1)(1990-8#1)(1992-2#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-11#1)(1996-4#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2011-2#2)(2012-2#1)(2013-8#2)
rather than an##9##3##(1993-8#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
rather than as a##6##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
rather than as an##4##4##(1996-3#1)(2008-7#1)(2013-1#2)
rather than as##12##3##(1990-11#1)(1990-5#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2013-1#2)
rather than being##8##3##(1990-5#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)
rather than between##3##3##(2008-10#2)(2010-10#1)
rather than by a##2##4##(1995-12#1)(2008-10#1)
rather than by##12##3##(1990-11#1)(1990-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-6#1)(2012-12#1)
rather than conventional##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
rather than direct##3##3##(1992-3#1)(2008-2#1)(2008-9#1)
rather than for##2##3##(2008-9#1)(2013-8#1)
rather than from##5##3##(1997-2#1)(2007-11#1)(2008-10#2)(2008-9#1)
rather than having##2##3##(1995-1#1)(2013-1#1)
rather than improving##2##3##(1995-3#1)(2012-2#1)
rather than in the##13##4##(1990-11#1)(1992-4#1)(1993-12#1)(1995-3#1)(1997-2#1)(2008-2#2)(2008-3#2)(2008-4#1)(2012-3#2)(2013-1#1)
rather than in##24##3##(1990-11#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
rather than increase##2##3##(2008-10#1)(2013-1#1)
rather than individual##2##3##(2007-12#1)(2010-4#1)
rather than its##4##3##(1991-12#1)(1994-8#1)(2007-11#1)(2008-7#1)
rather than just the##2##4##(1993-12#1)(2009-8#1)
rather than just##7##3##(1990-9#1)(1993-12#1)(1994-2#2)(1994-3#1)(2008-11#1)(2009-8#1)
rather than making##2##3##(1995-12#1)(2008-9#1)
rather than maximize##2##3##(1997-3#2)
rather than merely##2##3##(2008-10#1)(2009-5#1)
rather than on more##2##4##(1990-11#1)(2012-2#1)
rather than on the##5##4##(1993-2#1)(1994-9#1)(1997-8#1)(2008-10#1)(2011-2#1)
rather than on##15##3##(1990-11#1)(1991-11#1)(1993-2#1)(1994-9#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
rather than one##3##3##(2008-10#1)(2008-9#2)
rather than only##2##3##(2009-8#1)(2010-11#1)
rather than physical##2##3##(2008-5#1)(2008-8#1)
rather than pure##2##3##(2009-8#1)(2010-5#1)
rather than sexual##2##3##(2008-10#1)(2012-3#1)
rather than simply##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
rather than solely##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
rather than species-specific##2##3##(2007-12#1)(2008-10#1)
rather than specific##2##3##(1995-6#1)(2008-11#1)
rather than that of##2##4##(2008-10#1)(2011-1#1)
rather than the more##2##4##(1994-5#1)(2008-2#1)
rather than the number of##4##5##(1993-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
rather than the traditional##3##4##(2008-10#2)(2008-3#1)
rather than the##68##3##(1990-11#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-2#4)(2008-3#8)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2010-4#2)(2010-5#1)(2010-7#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
rather than their##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
rather than those##4##3##(1993-3#1)(1994-1#1)(1994-3#1)(2008-7#1)
rather than through##4##3##(1994-1#2)(1994-10#1)(2008-4#1)
rather than to a##3##4##(1992-6#1)(1993-8#1)(2008-10#1)
rather than to##20##3##(1990-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#2)
rather than with##3##3##(1990-5#1)(2008-10#1)(2008-8#1)
rather than##538##2##(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#2)(1990-8#6)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#6)(1993-6#2)(1993-8#5)(1994-1#5)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#3)(2007-11#4)(2007-12#10)(2007-4#1)(2007-6#2)(2007-7#1)(2008-1#4)(2008-10#66)(2008-11#18)(2008-12#6)(2008-2#14)(2008-3#26)(2008-4#9)(2008-5#10)(2008-6#3)(2008-7#18)(2008-8#15)(2008-9#15)(2009-11#2)(2009-12#3)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#15)(2012-1#2)(2012-12#7)(2012-2#20)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#6)
rather that the##3##3##(1990-11#1)(1995-2#1)(2008-9#1)
rather that##4##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-9#1)
rather the##4##2##(1993-11#1)(1994-11#1)(1995-6#1)(2011-2#1)
rather##751##1##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#9)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#5)(1991-2#3)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#8)(1993-2#3)(1993-3#6)(1993-6#4)(1993-8#6)(1993-9#1)(1994-1#6)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#7)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#4)(2007-11#6)(2007-12#17)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#7)(2008-10#95)(2008-11#23)(2008-12#9)(2008-2#21)(2008-3#32)(2008-4#9)(2008-5#14)(2008-6#7)(2008-7#24)(2008-8#20)(2008-9#24)(2009-10#3)(2009-11#3)(2009-12#3)(2009-4#3)(2009-5#7)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#21)(2012-1#2)(2012-12#9)(2012-2#26)(2012-3#13)(2012-8#1)(2013-1#24)(2013-7#1)(2013-8#10)
rating and##7##2##(1994-2#1)(1996-7#1)(2008-10#3)(2012-12#2)
rating by##2##2##(1994-6#1)(2011-2#1)
rating categories##2##2##(2011-2#2)
rating for##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
rating of 1##2##3##(2008-7#1)(2012-2#1)
rating of##14##2##(1993-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
rating or##2##2##(2008-10#1)(2008-9#1)
rating scale of##3##3##(1993-2#1)(2007-11#1)(2013-8#1)
rating scale was##2##3##(2008-1#1)(2008-10#1)
rating scale##22##2##(1990-3#1)(1991-6#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-7#1)(2011-2#2)(2011-8#1)(2012-2#3)(2013-8#1)
rating scales##8##2##(1996-7#2)(2007-8#1)(2008-6#1)(2008-7#2)(2010-8#1)(2012-2#1)
rating system##2##2##(2011-2#2)
rating systems##2##2##(2008-10#1)(2008-9#1)
rating the##3##2##(2008-11#1)(2008-9#2)
rating were##2##2##(2008-10#2)
rating##107##1##(1990-3#1)(1991-12#1)(1991-6#1)(1992-1#3)(1993-2#1)(1993-3#2)(1994-2#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-3#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#12)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#2)
rating)##4##1##(2007-12#3)(2008-10#1)
ratings and##6##2##(1991-3#1)(1994-2#1)(1996-7#1)(1997-3#1)(2007-12#1)(2013-8#1)
ratings are##2##2##(1992-2#1)(2009-7#1)
ratings as##2##2##(1993-3#1)(2008-10#1)
ratings by##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
ratings for##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
ratings in##6##2##(1990-5#1)(1995-12#1)(2008-10#4)
ratings of a##2##3##(1993-1#1)(1994-3#1)
ratings of perceived exertion (RPE)##2##5##(2013-8#2)
ratings of perceived exertion##3##4##(2013-8#3)
ratings of problem##2##3##(1995-12#1)(2008-12#1)
ratings of the##10##3##(1991-12#1)(1991-6#1)(2007-12#2)(2008-10#2)(2008-4#1)(2009-7#1)(2012-2#2)
ratings of##42##2##(1991-12#1)(1991-3#2)(1991-6#1)(1993-1#1)(1993-5#1)(1994-3#2)(1995-12#4)(1996-2#1)(2007-12#3)(2008-10#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#2)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#4)
ratings to their##2##3##(1993-2#2)
ratings to##3##2##(1993-2#2)(2012-2#1)
ratings were significantly##2##3##(2008-10#1)(2009-11#1)
ratings were##15##2##(1995-12#1)(1996-7#1)(2008-10#6)(2008-4#1)(2008-9#2)(2009-11#2)(2010-12#1)(2011-1#1)
ratings with##3##2##(2008-2#1)(2008-9#2)
ratings##132##1##(1990-5#1)(1991-12#1)(1991-3#5)(1991-6#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#2)(1995-12#9)(1996-1#2)(1996-2#1)(1996-7#2)(1997-3#3)(2007-12#6)(2008-10#30)(2008-11#2)(2008-12#2)(2008-2#7)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#6)(2009-11#2)(2009-5#1)(2009-7#4)(2009-8#2)(2010-12#2)(2010-4#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-8#6)
ratio &gt##9##2##(1992-9#2)(1994-3#1)(1994-6#1)(1997-6#1)(2007-10#1)(2008-10#2)(2011-2#1)
ratio (0##4##2##(1990-8#1)(1996-2#1)(2008-7#1)(2011-2#1)
ratio (1##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
ratio (OR) 1##2##3##(2012-12#1)(2013-1#1)
ratio (OR)##14##2##(1992-10#1)(2007-10#1)(2008-4#1)(2008-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
ratio (SMR)##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
ratio (SNR) of##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
ratio (SNR)##16##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
ratio (VBR) and prefrontal sulcal prominence (PSP)##3##7##(1996-7#3)
ratio (n =##2##3##(1990-2#2)
ratio (p##3##2##(2008-12#2)(2008-3#1)
ratio (r = 0##2##4##(1995-12#1)(2008-11#1)
ratio (r =##3##3##(1995-12#1)(2008-11#1)(2011-2#1)
ratio (the ratio of the##2##5##(2008-1#1)(2008-3#1)
ratio (the##3##2##(2008-1#1)(2008-3#1)(2008-6#1)
ratio 0##4##2##(1994-6#2)(2010-6#1)(2012-3#1)
ratio 1##23##2##(1992-3#1)(2007-10#1)(2008-10#11)(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
ratio 10##2##2##(2007-2#1)(2008-10#1)
ratio 2##7##2##(2007-10#3)(2008-10#2)(2008-3#1)(2011-1#1)
ratio 3##6##2##(1991-8#1)(2007-10#1)(2007-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
ratio 4##4##2##(1990-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
ratio 6##2##2##(2008-1#1)(2008-10#1)
ratio = 0##4##3##(2008-12#1)(2008-3#1)(2010-2#2)
ratio = 2)##3##3##(2007-8#1)(2008-10#2)
ratio = 4##2##3##(2008-12#1)(2013-8#1)
ratio =##13##2##(1990-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#2)(2010-2#2)(2013-8#1)
ratio LOA##2##2##(2009-1#2)
ratio [HR]##2##2##(2012-6#1)(2013-8#1)
ratio analysis##3##2##(2008-10#2)(2008-3#1)
ratio and a##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
ratio and heavy metals##2##4##(2008-12#2)
ratio and heavy##3##3##(2008-12#3)
ratio and the##17##3##(1990-11#1)(1990-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)
ratio and varied pH##3##4##(2008-10#3)
ratio and##88##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-6#1)(1993-9#1)(1994-6#1)(1995-8#1)(2007-11#3)(2007-12#4)(2008-10#12)(2008-11#1)(2008-12#5)(2008-2#5)(2008-3#21)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
ratio approach##2##2##(2008-10#1)(2013-1#1)
ratio are##9##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#2)
ratio as a function of##3##5##(1996-5#1)(2008-2#1)(2008-3#1)
ratio as a##5##3##(1991-12#1)(1996-5#1)(2008-2#1)(2008-3#1)(2012-12#1)
ratio as the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
ratio as well as##3##4##(1990-11#1)(1994-2#1)(2007-10#1)
ratio as##15##2##(1990-11#1)(1991-12#1)(1994-2#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-2#3)(2008-3#3)(2012-12#1)(2013-7#1)
ratio associated with##2##3##(2008-3#1)(2010-8#1)
ratio at the##2##3##(2007-11#1)(2008-2#1)
ratio at##9##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#2)
ratio being##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
ratio between the##21##3##(1991-5#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
ratio between##35##2##(1991-5#1)(1993-2#1)(1995-11#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#2)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
ratio by##6##2##(1990-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
ratio can be##5##3##(2008-2#3)(2008-3#2)
ratio can##10##2##(1990-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)
ratio compared to##2##3##(1997-6#1)(2012-2#1)
ratio compared with##3##3##(2008-3#3)
ratio compared##5##2##(1997-6#1)(2008-3#3)(2012-2#1)
ratio could##2##2##(2008-8#1)(2012-12#1)
ratio data##6##2##(2008-10#2)(2008-2#2)(2008-7#1)(2009-9#1)
ratio decreased with##3##3##(2008-10#2)(2008-2#1)
ratio decreased##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
ratio decreases##2##2##(2008-10#1)(2008-3#1)
ratio derivative polarography##2##3##(2008-10#2)
ratio derivative##3##2##(2008-10#3)
ratio does not##2##3##(2008-2#1)(2008-3#1)
ratio estimation##2##2##(1994-2#1)(2012-2#1)
ratio for a##4##3##(2008-3#4)
ratio for each##2##3##(2008-2#1)(2008-3#1)
ratio for patients##2##3##(2008-12#1)(2008-9#1)
ratio for the##10##3##(1990-11#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)
ratio for two##2##3##(2008-3#1)(2008-7#1)
ratio for##41##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-5#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-3#2)
ratio from##3##2##(1994-2#1)(2008-2#1)(2008-3#1)
ratio had##2##2##(2008-10#1)(2012-2#1)
ratio has##2##2##(2008-2#1)(2009-3#1)
ratio in a##2##3##(2007-11#1)(2008-8#1)
ratio in an##2##3##(2008-3#1)(2012-3#1)
ratio in the##15##3##(1990-2#1)(1990-5#1)(1991-11#1)(1992-6#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2010-2#1)
ratio in##47##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(2007-11#4)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
ratio increased##3##2##(2010-4#1)(2011-2#1)(2013-8#1)
ratio index##5##2##(1994-5#2)(1996-5#1)(2008-12#2)
ratio indicates##2##2##(1994-6#1)(2008-12#1)
ratio influenced the##2##3##(1997-1#1)(2008-8#1)
ratio is 1##2##3##(1993-11#1)(2008-10#1)
ratio is about##2##3##(1992-5#1)(2008-8#1)
ratio is approximately##2##3##(2008-1#1)(2008-2#1)
ratio is calculated##2##3##(2008-3#1)(2008-8#1)
ratio is higher##2##3##(2008-10#1)(2008-2#1)
ratio is not##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
ratio is##42##2##(1990-9#1)(1992-5#1)(1993-11#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#5)(2008-3#9)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)
ratio larger than##2##3##(2007-11#1)(2008-7#1)
ratio less than##2##3##(1990-9#1)(1995-5#1)
ratio measurements##3##2##(2008-10#2)(2008-2#1)
ratio method##5##2##(1994-2#1)(2008-10#4)
ratio methods##3##2##(1994-2#1)(2008-10#2)
ratio observed in##2##3##(1995-9#1)(2008-9#1)
ratio obtained in##2##3##(1993-6#1)(2008-10#1)
ratio obtained##4##2##(1993-6#1)(2008-10#2)(2008-2#1)
ratio of &gt##3##3##(2007-12#1)(2008-3#2)
ratio of 0##16##3##(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)
ratio of 1##24##3##(1990-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#2)
ratio of 10##3##3##(2008-10#3)
ratio of 100##2##3##(2008-10#2)
ratio of 14##2##3##(2007-12#1)(2008-1#1)
ratio of 2##6##3##(1994-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)
ratio of 20##2##3##(2008-10#1)(2008-3#1)
ratio of 3##21##3##(1990-8#1)(1991-5#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
ratio of 3)##2##3##(2008-10#1)(2008-3#1)
ratio of 4##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
ratio of 40##2##3##(2007-12#1)(2011-3#1)
ratio of 45##2##3##(2008-3#1)(2011-1#1)
ratio of 5##8##3##(1993-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#2)
ratio of 50##2##3##(2007-12#1)(2008-3#1)
ratio of a##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
ratio of an##2##3##(2008-2#1)(2008-3#1)
ratio of approximately 3##2##4##(1992-6#1)(2008-11#1)
ratio of approximately##9##3##(1992-6#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#4)
ratio of at least##2##4##(2007-7#1)(2008-3#1)
ratio of hapten##3##3##(2008-11#3)
ratio of intensity##2##3##(1995-5#1)(2008-3#1)
ratio of lactic acid to acetic acid and quality score##2##10##(2012-2#2)
ratio of male to female##3##5##(1993-9#1)(2007-2#1)(2011-2#1)
ratio of one##2##3##(2008-10#1)(2008-3#1)
ratio of patients##2##3##(2008-1#1)(2011-1#1)
ratio of the CH(2)##2##4##(2008-10#2)
ratio of the difference##2##4##(2008-2#1)(2008-5#1)
ratio of the ion##2##4##(2008-10#2)
ratio of the metal##2##4##(2008-10#2)
ratio of the number of##3##5##(1997-7#1)(2008-11#1)(2010-8#1)
ratio of the population##2##4##(2008-10#1)(2012-2#1)
ratio of the rates of##2##5##(1990-11#1)(1991-5#1)
ratio of the two##4##4##(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
ratio of the##106##3##(1990-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-5#1)(1997-7#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#23)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#2)(2012-1#1)(2012-2#2)(2013-1#1)
ratio of these##3##3##(1990-8#1)(2008-3#1)(2009-10#1)
ratio of this##2##3##(2008-10#1)(2008-2#1)
ratio of three##3##3##(2008-10#3)
ratio of total##2##3##(2008-11#1)(2008-3#1)
ratio of unsaturated to##2##4##(1994-3#1)(2010-4#1)
ratio of##501##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-5#4)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#5)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#10)(2007-12#20)(2007-2#1)(2007-7#3)(2008-1#7)(2008-10#127)(2008-11#21)(2008-12#6)(2008-2#30)(2008-3#70)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#10)(2011-2#10)(2011-3#2)(2012-1#3)(2012-12#2)(2012-2#10)(2012-3#2)(2012-7#1)(2013-1#10)(2013-8#3)
ratio on##6##2##(2008-10#3)(2008-3#1)(2011-1#1)(2013-1#1)
ratio or##5##2##(1993-11#1)(1994-9#1)(2008-2#1)(2008-5#1)(2010-1#1)
ratio profile##2##2##(2008-3#2)
ratio profiles##3##2##(2008-3#3)
ratio represents a unique context for selection on attractive traits##2##10##(2008-8#2)
ratio showed a##2##3##(1994-8#1)(1994-9#1)
ratio showed##3##2##(1994-8#1)(1994-9#1)(2008-11#1)
ratio spectra derivative spectrophotometry##2##4##(2008-10#2)
ratio spectra##9##2##(2008-10#8)(2011-1#1)
ratio statistic##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
ratio technique##2##2##(2008-3#2)
ratio test is##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
ratio test##11##2##(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2013-1#2)
ratio tests##3##2##(1994-11#1)(2008-9#2)
ratio than that of the##2##5##(2008-10#1)(2009-7#1)
ratio than the##2##3##(2008-10#1)(2008-3#1)
ratio than##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-7#1)(2011-2#1)
ratio that is##3##3##(1993-11#1)(2008-3#2)
ratio that##5##2##(1993-11#1)(2008-2#1)(2008-3#3)
ratio to a##2##3##(1994-6#1)(2008-3#1)
ratio to be##4##3##(2007-12#2)(2008-2#1)(2010-4#1)
ratio to the##2##3##(2008-3#1)(2013-1#1)
ratio to##18##2##(1994-6#1)(1995-2#1)(1995-5#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-4#1)(2013-1#1)
ratio values##7##2##(1990-8#1)(1990-9#1)(2008-10#4)(2008-5#1)
ratio variance##2##2##(2008-3#1)(2008-9#1)
ratio variation##2##2##(2008-10#1)(2008-9#1)
ratio was 0##2##3##(2008-10#1)(2008-8#1)
ratio was 6##2##3##(1991-11#1)(2008-7#1)
ratio was also##2##3##(1994-8#1)(1996-2#1)
ratio was calculated##2##3##(2008-12#1)(2010-12#1)
ratio was found to be significantly##2##6##(1994-3#1)(2008-10#1)
ratio was found to be##3##5##(1994-3#1)(2008-10#1)(2010-4#1)
ratio was found to##4##4##(1994-3#1)(2008-10#1)(2010-4#2)
ratio was found##5##3##(1994-3#1)(2008-10#2)(2010-4#2)
ratio was higher##2##3##(2008-10#1)(2011-2#1)
ratio was normal##2##3##(2008-1#1)(2008-7#1)
ratio was not significantly##2##4##(2008-1#1)(2008-12#1)
ratio was observed##2##3##(1996-5#1)(2008-5#1)
ratio was obtained##3##3##(2007-11#2)(2008-10#1)
ratio was of 1##2##4##(2007-8#1)(2013-7#1)
ratio was of##3##3##(2007-8#1)(2013-7#2)
ratio was significantly decreased##2##4##(2008-7#1)(2013-8#1)
ratio was significantly##5##3##(1993-8#1)(2008-7#2)(2010-8#1)(2013-8#1)
ratio was##69##2##(1991-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-8#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#3)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
ratio were measured in##2##4##(1990-2#1)(2012-12#1)
ratio were##17##2##(1990-2#1)(1990-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
ratio which##5##2##(1991-3#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
ratio with an##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
ratio with the##2##3##(2008-12#1)(2008-3#1)
ratio with##15##2##(1993-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-9#1)(2012-2#1)(2012-3#1)
ratio within##2##2##(2007-7#1)(2008-3#1)
ratio##1695##1##(1990-11#5)(1990-12#4)(1990-2#8)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#8)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#2)(1991-3#2)(1991-5#8)(1991-6#3)(1991-8#5)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#7)(1992-7#3)(1992-8#1)(1992-9#6)(1993-11#8)(1993-12#3)(1993-2#2)(1993-6#7)(1993-8#9)(1993-9#5)(1994-11#7)(1994-12#8)(1994-2#5)(1994-3#8)(1994-5#6)(1994-6#8)(1994-8#9)(1994-9#6)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#6)(1995-6#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#5)(1996-7#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#6)(2006-10#2)(2006-12#1)(2007-10#14)(2007-11#35)(2007-12#59)(2007-2#3)(2007-7#7)(2007-8#5)(2008-1#21)(2008-10#347)(2008-11#44)(2008-12#38)(2008-2#118)(2008-3#242)(2008-4#6)(2008-5#38)(2008-6#16)(2008-7#36)(2008-8#42)(2008-9#32)(2009-1#4)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#4)(2010-4#13)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#14)(2010-9#2)(2011-1#26)(2011-2#41)(2011-3#3)(2012-1#6)(2012-12#24)(2012-2#29)(2012-3#21)(2012-6#1)(2012-7#1)(2013-1#40)(2013-7#5)(2013-8#24)
ratio'##2##1##(2008-10#2)
ratio) in##2##2##(2008-10#1)(2008-5#1)
ratio) was##2##2##(1993-12#1)(2008-7#1)
ratio) with a##2##3##(2008-2#1)(2008-3#1)
ratio) with##3##2##(2008-2#2)(2008-3#1)
ratio)##28##1##(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)
ratio=2) and the##3##3##(2008-10#3)
ratio=2)##4##1##(2008-10#4)
ratio=3)##3##1##(2008-10#3)
ratiometric##5##1##(2008-10#4)(2008-3#1)
ratiometry is##2##2##(2008-10#2)
ratiometry##9##1##(2008-10#9)
ration and##3##2##(2010-8#3)
ration##19##1##(2008-12#1)(2010-8#14)(2011-1#3)(2011-2#1)
rational and##7##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-9#2)(2010-10#2)
rational approach to the treatment of##2##6##(1996-3#1)(2008-7#1)
rational approach to the##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
rational approach to##6##3##(1996-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
rational approach##11##2##(1994-9#1)(1995-5#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
rational approaches to##2##3##(1995-3#1)(2008-7#1)
rational basis for##3##3##(1990-3#1)(2008-3#1)(2008-9#1)
rational decisions##2##2##(2009-6#1)(2011-2#1)
rational design of##8##3##(2008-10#2)(2009-9#1)(2010-11#2)(2010-12#1)(2011-2#1)(2013-7#1)
rational design##10##2##(2008-10#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-2#1)(2013-7#1)
rational drug design##5##3##(1992-9#1)(2008-5#1)(2009-7#1)(2011-3#2)
rational drug##6##2##(1992-9#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-3#2)
rational for##2##2##(1997-6#1)(2011-2#1)
rational treatment##5##2##(1990-11#1)(1990-6#1)(1993-9#1)(1996-3#1)(1997-8#1)
rational use of##7##3##(1993-9#1)(1995-2#1)(1997-3#1)(2007-7#2)(2008-3#1)(2011-2#1)
rational vaccine design##2##3##(1995-5#1)(2012-12#1)
rational##110##1##(1990-11#1)(1990-3#1)(1990-6#2)(1991-11#2)(1991-2#1)(1992-1#1)(1992-5#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-11#1)(1996-3#5)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-4#1)(2007-7#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#6)(2011-3#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
rational&quot##2##1##(2007-11#1)(2008-7#1)
rationale and design of##2##4##(2008-8#2)
rationale and design##4##3##(2007-8#1)(2008-8#2)(2008-9#1)
rationale and##16##2##(1990-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)(2012-3#1)
rationale behind the##3##3##(1995-2#1)(2008-12#1)(2008-9#1)
rationale behind##10##2##(1995-2#1)(2008-12#2)(2008-3#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
rationale for a##2##3##(2008-6#1)(2010-5#1)
rationale for establishing##2##3##(1993-1#1)(1995-12#1)
rationale for the use of##5##5##(1990-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-6#1)
rationale for the##16##3##(1990-3#1)(1993-8#1)(1994-6#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-6#1)(2013-8#1)
rationale for their##2##3##(1993-8#1)(2008-4#1)
rationale for this##3##3##(1992-9#1)(2010-4#1)(2011-2#1)
rationale for use of##2##4##(1994-9#1)(1996-9#1)
rationale for using this##2##4##(2008-11#1)(2008-5#1)
rationale for using##4##3##(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
rationale for##68##2##(1990-10#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#2)(1993-8#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#2)(2009-4#2)(2009-6#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2013-1#2)(2013-8#3)
rationale is that the##2##4##(2008-9#2)
rationale is##4##2##(2008-8#1)(2008-9#2)(2009-7#1)
rationale of the##2##3##(2008-10#1)(2008-7#1)
rationale of##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
rationale that##2##2##(2008-2#1)(2010-12#1)
rationale##127##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#6)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#3)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#3)
rationales##3##1##(1997-2#1)(2008-8#1)(2008-9#1)
rationalisation of##2##2##(2008-1#1)(2013-1#1)
rationalisation##3##1##(2007-8#1)(2008-1#1)(2013-1#1)
rationality##3##1##(2008-11#1)(2008-5#1)(2011-3#1)
rationalization of##2##2##(2008-11#1)(2008-7#1)
rationalization##5##1##(1992-3#1)(1996-5#1)(2008-11#1)(2008-7#1)(2009-2#1)
rationalize the##6##2##(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)
rationalize##8##1##(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-7#1)
rationalized by##2##2##(1994-5#1)(2008-12#1)
rationalized in terms of##4##4##(1991-8#1)(2008-10#2)(2011-1#1)
rationalized##10##1##(1991-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-1#1)
rationalizing the##2##2##(1993-8#1)(2012-2#1)
rationalizing##4##1##(1993-8#1)(1997-2#1)(1997-3#1)(2012-2#1)
rationally designed##2##2##(1995-2#1)(1995-6#1)
rationally##11##1##(1993-12#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2012-3#1)
rationed##2##1##(1996-8#1)(2010-4#1)
rationing decisions##2##2##(1992-3#1)(1997-3#1)
rationing in##2##2##(1992-2#1)(1996-8#1)
rationing##18##1##(1991-12#1)(1992-12#1)(1992-2#3)(1992-3#3)(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-8#2)(1997-3#2)(2008-4#1)(2012-3#1)
rations##11##1##(2008-10#1)(2008-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#6)
ratios (1##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
ratios (HR)##2##2##(2009-3#1)(2011-2#1)
ratios (ORs)##2##2##(2008-8#1)(2011-2#1)
ratios (from##2##2##(2008-10#1)(2012-2#1)
ratios 1##2##2##(2008-10#1)(2008-2#1)
ratios among##3##2##(2008-10#2)(2009-4#1)
ratios and##27##2##(1991-12#1)(1991-5#1)(1993-11#1)(1995-9#1)(2008-10#6)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#4)(2013-1#1)
ratios are##13##2##(1992-8#1)(1994-8#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#3)
ratios as high as 50##2##5##(2008-10#1)(2008-3#1)
ratios as high as##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
ratios as##8##2##(1992-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)
ratios at the##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
ratios at##6##2##(1993-11#1)(2008-10#2)(2008-3#2)(2011-2#1)
ratios between##5##2##(1994-8#1)(2008-10#3)(2010-11#1)
ratios by##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
ratios change##2##2##(2007-11#1)(2008-1#1)
ratios could##2##2##(1993-1#1)(2008-10#1)
ratios for the##5##3##(1990-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
ratios for##24##2##(1990-9#2)(1991-12#1)(1992-12#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
ratios from##5##2##(1992-3#1)(2008-10#1)(2008-3#2)(2008-7#1)
ratios has##2##2##(1997-2#1)(2008-10#1)
ratios in both##2##3##(2008-10#1)(2008-3#1)
ratios in##27##2##(1990-9#1)(1992-3#3)(1993-12#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-11#2)(2007-11#1)(2008-10#7)(2008-3#1)(2008-8#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
ratios indicated##2##2##(2008-10#1)(2010-5#1)
ratios is##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
ratios less than##3##3##(2008-2#1)(2008-3#2)
ratios measured##2##2##(1992-3#1)(2008-2#1)
ratios of 0##2##3##(1994-8#1)(2008-11#1)
ratios of 1##2##3##(1992-6#1)(2008-10#1)
ratios of a synthetic##2##4##(2008-10#1)(2009-4#1)
ratios of approximately##5##3##(1995-2#2)(2008-10#1)(2008-11#1)(2008-3#1)
ratios of the##15##3##(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#4)(2012-3#1)
ratios of##98##2##(1991-12#1)(1991-5#3)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#27)(2008-11#5)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
ratios on##3##2##(2009-8#1)(2010-5#1)(2013-1#1)
ratios or##2##2##(2008-3#2)
ratios ranging from##4##3##(1994-5#1)(2006-10#1)(2008-3#1)(2008-9#1)
ratios similar to those of##2##5##(1992-3#1)(1994-8#1)
ratios than##3##2##(1997-4#1)(2008-10#1)(2013-8#1)
ratios that##4##2##(2008-10#1)(2008-3#2)(2008-8#1)
ratios to##5##2##(1994-2#1)(1995-1#1)(2008-1#1)(2008-5#1)(2008-8#1)
ratios up to 1##2##4##(2008-10#2)
ratios up to 20##2##4##(1990-2#1)(2008-3#1)
ratios up to##5##3##(1990-2#1)(2008-10#3)(2008-3#1)
ratios was##5##2##(1992-7#1)(2008-10#2)(2008-12#1)(2008-3#1)
ratios were calculated and##2##4##(2011-2#1)(2012-2#1)
ratios were calculated##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
ratios were determined##2##3##(1992-3#1)(2012-12#1)
ratios were evaluated##2##3##(2008-10#1)(2012-12#1)
ratios were significantly##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
ratios were##40##2##(1992-1#2)(1992-3#1)(1992-9#2)(1993-11#2)(1994-8#1)(1996-12#3)(1996-2#1)(1997-6#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#2)(2013-1#1)
ratios when##2##2##(2008-8#1)(2010-4#1)
ratios with##3##2##(1992-7#1)(2008-3#2)
ratios##496##1##(1990-12#2)(1990-2#3)(1990-5#1)(1990-9#3)(1991-12#6)(1991-3#1)(1991-5#5)(1992-1#2)(1992-11#2)(1992-12#2)(1992-3#10)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-2#3)(1994-5#2)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-9#1)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#7)(2008-1#2)(2008-10#123)(2008-11#15)(2008-12#6)(2008-2#27)(2008-3#61)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#14)(2008-9#10)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-8#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#7)(2011-1#3)(2011-2#22)(2012-12#7)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#3)
ratios)##4##1##(1993-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
ratites##3##1##(2013-1#3)
rats (0##4##2##(1991-9#1)(1996-12#2)(1997-2#1)
rats (P less than 0##2##5##(1991-12#1)(1992-3#1)
rats (Rattus norvegicus)##2##3##(2008-10#1)(2008-12#1)
rats (i##3##2##(1997-2#2)(2010-5#1)
rats (n = 3)##2##4##(1992-3#1)(1993-8#1)
rats (n =##8##3##(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1997-8#1)(2007-10#2)(2008-11#1)
rats (p &lt##2##3##(1994-11#1)(2008-9#1)
rats 2##2##2##(1990-12#1)(1991-12#1)
rats adapted to##4##3##(1997-6#2)(2013-1#2)
rats administered##2##2##(2008-10#1)(2008-9#1)
rats after##19##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-8#2)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
rats aged##4##2##(1995-5#1)(1995-8#1)(2008-7#1)(2009-5#1)
rats also##2##2##(1994-6#1)(2010-5#1)
rats and a##2##3##(1995-11#1)(2009-8#1)
rats and dogs##4##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-5#1)
rats and in##2##3##(1990-7#1)(1993-6#1)
rats and its##3##3##(1995-6#1)(2010-11#1)(2013-8#1)
rats and mice and##2##4##(2008-4#1)(2008-7#1)
rats and mice##21##3##(1991-1#1)(1991-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2008-10#3)(2008-4#10)(2008-7#2)(2008-9#1)
rats and no##2##3##(1991-5#1)(1992-11#1)
rats and other##2##3##(1990-12#1)(2008-4#1)
rats and rabbits##3##3##(1990-11#3)
rats and rats##2##3##(1997-7#1)(2013-1#1)
rats and that##3##3##(1991-2#1)(1995-5#1)(2010-1#1)
rats and thus##2##3##(1990-8#1)(1992-7#1)
rats and##89##2##(1990-11#3)(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#5)(1996-5#2)(1997-2#2)(1997-7#1)(2008-10#5)(2008-11#2)(2008-4#11)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
rats anesthetized with urethane##2##4##(1997-7#1)(2008-10#1)
rats anesthetized with##3##3##(1997-2#1)(1997-7#1)(2008-10#1)
rats are not##2##3##(1994-8#1)(1996-12#1)
rats are##9##2##(1990-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#3)
rats as compared to##5##4##(1994-2#2)(1995-12#1)(2008-11#1)(2012-2#1)
rats as compared with##2##4##(1993-12#1)(2008-7#1)
rats as compared##7##3##(1993-12#1)(1994-2#2)(1995-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
rats as well as##2##4##(1994-11#1)(1994-6#1)
rats as well##3##3##(1994-11#2)(1994-6#1)
rats as##18##2##(1991-12#1)(1993-12#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-2#1)
rats at a dose of 0##2##6##(1994-6#1)(1995-3#1)
rats at a##3##3##(1994-6#1)(1995-3#1)(2012-2#1)
rats at any time##2##4##(1994-5#2)
rats at rest##3##3##(2013-1#3)
rats at the##2##3##(1994-11#1)(2008-3#1)
rats at##25##2##(1990-2#1)(1991-12#1)(1993-12#1)(1994-11#1)(1994-5#3)(1994-6#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-1#1)(2010-6#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
rats bearing##6##2##(1993-12#1)(1993-6#1)(1993-8#3)(1994-8#1)
rats but##6##2##(1994-2#2)(1995-12#1)(1997-1#1)(2008-7#1)(2009-11#1)
rats by in situ hybridization##2##5##(1997-4#1)(2008-5#1)
rats by##24##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
rats can be##2##3##(2008-10#1)(2011-2#1)
rats can##3##2##(1993-12#1)(2008-10#1)(2011-2#1)
rats cannot##2##2##(1990-6#1)(1994-5#1)
rats caused##2##2##(1994-8#1)(1995-12#1)
rats causes##2##2##(1990-5#1)(1995-12#1)
rats chronically intoxicated with ethanol##2##5##(2009-8#2)
rats chronically##3##2##(1993-12#1)(2009-8#2)
rats compared to##3##3##(1990-8#1)(1996-5#1)(2011-2#1)
rats compared with##4##3##(1993-12#1)(1994-8#1)(1995-11#1)(2008-7#1)
rats compared##7##2##(1990-8#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-5#1)(2008-7#1)(2011-2#1)
rats could##5##2##(1990-7#1)(1992-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
rats decreased##3##2##(1995-12#1)(1995-8#1)(2008-8#1)
rats delayed##2##2##(1994-8#1)(1995-12#1)
rats depleted##2##2##(1994-3#1)(1997-4#1)
rats deprived of##2##3##(1992-3#1)(1997-2#1)
rats develop##2##2##(1993-6#1)(1995-12#1)
rats did not##6##3##(1991-9#1)(1992-12#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-7#1)
rats displayed##3##2##(1992-11#1)(1995-12#1)(1996-12#1)
rats dosed with##2##3##(1994-8#1)(2008-9#1)
rats during##5##2##(1991-12#1)(1992-12#1)(1992-5#1)(1997-6#1)(2011-2#1)
rats every##2##2##(1994-2#1)(1995-12#1)
rats exposed to a##2##4##(2008-10#1)(2008-12#1)
rats exposed to##12##3##(1991-5#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2012-2#1)
rats expressing##2##2##(1990-11#1)(1995-2#1)
rats fasted##2##2##(1994-8#1)(1995-11#1)
rats fed a diet##2##4##(1991-12#1)(1995-11#1)
rats fed vitamin E##3##4##(1994-5#3)
rats fed vitamin##4##3##(1993-12#1)(1994-5#3)
rats fed with##4##3##(2011-2#1)(2012-12#1)(2012-2#2)
rats fed##20##2##(1991-12#2)(1992-11#1)(1993-12#3)(1993-6#1)(1994-2#1)(1994-5#3)(1995-11#1)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
rats following##6##2##(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(2009-5#1)
rats for a##2##3##(2009-12#1)(2012-2#1)
rats for##9##2##(1990-5#1)(1991-9#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#1)
rats from each##2##3##(1993-12#1)(2011-2#1)
rats from##7##2##(1991-5#1)(1993-12#1)(1993-3#1)(1994-6#2)(2008-10#1)(2011-2#1)
rats given Ni3S2 +##2##4##(1994-5#2)
rats given ethanol##2##3##(1995-3#1)(2008-11#1)
rats given##6##2##(1993-9#1)(1994-5#2)(1995-3#1)(2008-11#1)(2012-1#1)
rats had a##2##3##(1991-6#1)(1993-8#1)
rats had##10##2##(1991-6#1)(1993-8#2)(1996-5#1)(2008-5#1)(2008-7#2)(2008-9#2)(2013-1#1)
rats have shown##2##3##(2008-10#1)(2008-7#1)
rats have##8##2##(1993-12#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)
rats implanted with##2##3##(1997-2#1)(2008-8#1)
rats in a##3##3##(1991-2#1)(1992-1#1)(1992-11#1)
rats in comparison with##2##4##(1994-6#1)(1995-8#1)
rats in order to##2##4##(1997-2#1)(2008-10#1)
rats in the##12##3##(1990-5#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-7#1)(1997-2#2)(2011-2#3)(2013-1#2)
rats in##29##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#1)(1994-6#1)(1994-7#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#3)(2008-10#2)(2008-11#1)(2008-12#2)(2009-8#1)(2011-2#3)(2013-1#2)
rats increased##2##2##(2008-8#1)(2011-2#1)
rats increases##2##2##(1993-6#1)(1995-12#1)
rats induced by##3##3##(1991-2#1)(1995-3#1)(2013-1#1)
rats induced##4##2##(1991-2#1)(1994-8#1)(1995-3#1)(2013-1#1)
rats induces##2##2##(1995-3#1)(2007-10#1)
rats injected with##6##3##(1993-11#1)(1996-7#1)(1997-7#1)(2008-11#1)(2013-7#2)
rats intoxicated with##2##3##(1994-7#2)
rats irradiated##2##2##(1992-9#2)
rats is##14##2##(1990-11#1)(1993-5#1)(1994-11#1)(1995-12#2)(1995-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
rats it##4##2##(1996-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
rats learned##2##2##(1993-6#1)(2008-7#1)
rats made##2##2##(1992-12#1)(1994-3#1)
rats may be##2##3##(1992-12#1)(1993-12#1)
rats may##5##2##(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1996-2#1)
rats of a##2##3##(1993-3#1)(2008-6#1)
rats of both sexes##9##4##(1995-8#1)(2008-10#1)(2008-12#2)(2008-7#4)(2009-11#1)
rats of different ages##2##4##(1995-6#1)(1997-6#1)
rats of different##4##3##(1990-2#1)(1995-6#1)(1997-6#1)(2012-1#1)
rats of the##2##3##(1993-5#1)(1994-6#1)
rats of##26##2##(1990-2#1)(1991-12#1)(1993-3#1)(1993-5#1)(1994-6#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-6#1)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#5)(2009-11#1)(2012-1#1)(2013-1#2)
rats on day##2##3##(1993-12#1)(1994-2#1)
rats on the##2##3##(1997-3#1)(2008-11#1)
rats on##8##2##(1993-12#1)(1994-11#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-11#2)
rats only##3##2##(2008-10#2)(2012-2#1)
rats or##3##2##(1991-12#1)(1996-1#1)(2011-1#1)
rats orally##4##2##(1993-3#1)(2008-11#2)(2012-2#1)
rats pretreated with##7##3##(1992-11#1)(1993-12#1)(1994-9#1)(1995-12#2)(2008-6#2)
rats produce##2##2##(1993-6#1)(2008-10#1)
rats produced a significant##2##4##(2008-12#1)(2010-5#1)
rats produced a##3##3##(1996-12#1)(2008-12#1)(2010-5#1)
rats produced##6##2##(1994-2#1)(1996-12#1)(2008-12#1)(2008-4#1)(2010-5#1)(2012-2#1)
rats received a##3##3##(1992-12#1)(1993-12#1)(2012-7#1)
rats received an##3##3##(1991-12#1)(1994-8#1)(2013-1#1)
rats received bilateral##2##3##(1993-3#1)(1994-3#1)
rats received##26##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-5#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
rats receiving##3##2##(1994-8#1)(1996-12#1)(2012-12#1)
rats resulted in a##2##4##(1991-8#1)(1995-12#1)
rats resulted in##4##3##(1991-8#1)(1993-12#1)(1995-12#1)(1995-2#1)
rats revealed##3##2##(1992-11#1)(1994-6#1)(1996-12#1)
rats show##4##2##(1990-11#2)(1990-7#1)(1994-3#1)
rats showed a significant increase in##2##6##(1994-3#1)(1997-2#1)
rats showed a significant##3##4##(1994-11#1)(1994-3#1)(1997-2#1)
rats showed a##8##3##(1993-12#1)(1993-3#2)(1994-11#1)(1994-3#1)(1997-2#2)(2009-12#1)
rats showed higher##2##3##(1994-6#1)(2013-1#1)
rats showed significantly##2##3##(2008-12#1)(2008-9#1)
rats showed that##2##3##(1994-2#1)(2012-3#1)
rats showed##18##2##(1992-8#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1997-2#2)(2008-12#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#2)
rats still##2##2##(1993-3#2)
rats subjected to porta-caval anastomosis##3##5##(1993-3#3)
rats subjected to##5##3##(1991-12#1)(1993-3#3)(2012-1#1)
rats subsequently##3##2##(1992-8#1)(1993-6#2)
rats suggests##2##2##(1994-11#1)(1997-2#1)
rats than in control rats##2##5##(1990-7#1)(1995-12#1)
rats than in##7##3##(1990-7#1)(1991-12#2)(1993-12#2)(1994-6#1)(1995-12#1)
rats than##9##2##(1990-7#1)(1991-12#2)(1993-12#2)(1994-6#1)(1995-12#1)(2008-12#1)(2008-3#1)
rats that had##2##3##(1992-1#1)(2008-11#1)
rats that inhaled oxygen-17 gas##2##5##(1990-5#2)
rats that received##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
rats that were##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
rats that##15##2##(1990-5#2)(1992-1#1)(1993-12#1)(1993-6#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-11#1)(2012-2#1)(2013-1#1)
rats the##7##2##(1990-11#1)(1994-2#2)(1994-8#1)(1995-12#2)(2008-7#1)
rats to determine##2##3##(1994-6#1)(1996-5#1)
rats to the##2##3##(1996-3#1)(2010-5#1)
rats to##22##2##(1990-7#1)(1992-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#2)(2007-10#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-1#2)(2012-2#2)
rats trained to discriminate ethanol from vehicle##2##7##(1997-7#2)
rats trained##3##2##(1997-7#2)(2008-7#1)
rats treated with menthol cigarette and##2##6##(2011-1#2)
rats treated with normal cigarette##2##5##(2011-1#2)
rats treated with##31##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-5#1)(1997-1#1)(2007-10#1)(2008-10#2)(2008-5#2)(2009-4#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
rats treated##32##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#2)(2009-4#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
rats under##4##2##(1991-12#1)(1991-5#1)(1993-6#1)(1995-12#1)
rats underwent##2##2##(1993-3#1)(2011-2#1)
rats up to##2##3##(1995-5#1)(2008-3#1)
rats used##2##2##(1992-11#1)(2012-1#1)
rats using a##2##3##(1994-2#1)(2007-11#1)
rats using##7##2##(1994-2#1)(1995-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#1)
rats was investigated##2##3##(1991-5#1)(1993-8#1)
rats was markedly reduced##2##4##(1993-12#1)(1997-2#1)
rats was studied by##2##4##(2008-8#1)(2012-1#1)
rats was studied##5##3##(1995-12#1)(1996-2#1)(2008-8#2)(2012-1#1)
rats was used##3##3##(1991-12#2)(1994-6#1)
rats was##32##2##(1990-11#1)(1991-1#1)(1991-12#3)(1991-5#1)(1992-3#1)(1993-11#2)(1993-12#3)(1993-8#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-3#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
rats we##3##2##(1995-3#1)(2007-10#1)(2008-12#1)
rats weighing##5##2##(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
rats were administered##9##3##(1991-12#1)(1995-3#1)(2008-10#2)(2008-9#5)
rats were allocated to##2##4##(2009-8#1)(2011-2#1)
rats were also##3##3##(1994-5#2)(2008-10#1)
rats were dermally administered 0##2##5##(2008-9#2)
rats were determined##2##3##(1990-3#1)(1990-5#1)
rats were divided into four groups##2##6##(2008-7#1)(2011-1#1)
rats were divided into##7##4##(2007-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
rats were examined##3##3##(1991-12#1)(1992-11#1)(2008-10#1)
rats were exposed to##2##4##(2008-12#2)
rats were exposed##3##3##(1996-12#1)(2008-12#2)
rats were fed##6##3##(1993-11#1)(1994-2#1)(1996-12#1)(2012-2#1)(2013-1#2)
rats were given a##2##4##(1992-3#1)(2013-1#1)
rats were given drinking water containing 0##2##7##(2008-10#2)
rats were given##11##3##(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-10#3)(2008-9#1)(2013-1#1)
rats were implanted with##2##4##(1993-12#1)(1995-5#1)
rats were injected intraperitoneally with##3##5##(1992-11#1)(2008-11#1)(2008-5#1)
rats were injected##4##3##(1992-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
rats were intratracheally##2##3##(2008-10#2)
rats were investigated##5##3##(1990-11#1)(1993-8#1)(1994-5#1)(1996-2#1)(2012-1#1)
rats were killed##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
rats were more##2##3##(1994-6#1)(2008-10#1)
rats were randomly divided into five groups##2##7##(2010-1#1)(2011-3#1)
rats were randomly divided into##4##5##(2008-10#1)(2010-1#1)(2011-2#1)(2011-3#1)
rats were randomly##5##3##(2008-10#1)(2010-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
rats were sacrificed at##2##4##(1994-6#1)(1995-11#1)
rats were significantly##2##3##(1997-2#1)(1997-6#1)
rats were studied##5##3##(1990-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(2012-2#1)
rats were subjected to##8##4##(1993-3#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#2)(2013-7#1)
rats were tested##5##3##(1993-12#2)(1993-3#1)(2008-11#1)(2011-2#1)
rats were trained on##2##4##(1993-12#1)(1997-2#1)
rats were trained to discriminate##2##5##(1991-12#1)(1992-10#1)
rats were trained to##4##4##(1991-12#1)(1992-10#1)(1992-11#1)(2008-10#1)
rats were trained##8##3##(1990-7#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1997-2#1)(2008-10#1)
rats were treated with##4##4##(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
rats were treated##8##3##(1993-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
rats were used for##3##4##(1993-3#1)(1997-2#1)(2007-10#1)
rats were used##6##3##(1993-3#1)(1997-2#1)(2007-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
rats were##155##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#4)(1991-2#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#7)(1993-3#6)(1993-8#1)(1994-2#2)(1994-5#6)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#2)(1997-2#5)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#4)(2008-10#17)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#6)(2008-9#8)(2009-8#2)(2010-1#1)(2011-1#5)(2011-2#8)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#1)
rats when##2##2##(1992-5#1)(2011-1#1)
rats which##5##2##(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(2011-2#1)
rats while##2##2##(1994-2#1)(2013-7#1)
rats with a##6##3##(1991-2#2)(1991-5#1)(1993-2#1)(1993-3#2)
rats with acute cerebral##2##4##(2012-3#1)(2013-8#1)
rats with an##4##3##(1994-11#1)(1996-5#1)(1997-2#1)(2008-8#1)
rats with chronic##2##3##(1994-2#1)(2007-10#1)
rats with excitotoxic##2##3##(1992-10#1)(2008-10#1)
rats with myocardial infarction##3##4##(1996-2#2)(2012-12#1)
rats with nephrotic syndrome##2##4##(2009-6#2)
rats with severe##2##3##(2012-1#1)(2013-8#1)
rats with the##3##3##(1990-5#1)(1997-7#1)(2011-1#1)
rats with##70##2##(1990-12#2)(1990-5#1)(1991-2#2)(1991-5#1)(1992-10#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#2)(1996-2#2)(1996-5#3)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#3)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
rats without##3##2##(1991-12#1)(1993-2#1)(2011-2#1)
rats would##2##2##(1993-6#1)(2008-3#1)
rats##1958##1##(1990-11#17)(1990-12#11)(1990-2#7)(1990-3#7)(1990-5#18)(1990-6#6)(1990-7#19)(1990-8#5)(1991-1#5)(1991-10#1)(1991-12#58)(1991-2#15)(1991-5#16)(1991-6#4)(1991-8#2)(1991-9#7)(1992-1#4)(1992-10#9)(1992-11#34)(1992-12#27)(1992-2#1)(1992-3#19)(1992-5#5)(1992-6#4)(1992-7#4)(1992-8#11)(1992-9#13)(1993-11#11)(1993-12#88)(1993-2#3)(1993-3#33)(1993-5#9)(1993-6#26)(1993-8#17)(1993-9#2)(1994-11#26)(1994-12#5)(1994-2#42)(1994-3#17)(1994-5#37)(1994-6#44)(1994-7#7)(1994-8#40)(1994-9#1)(1995-11#21)(1995-12#82)(1995-2#8)(1995-3#34)(1995-5#12)(1995-6#3)(1995-8#9)(1996-1#2)(1996-12#42)(1996-2#19)(1996-3#2)(1996-5#33)(1996-7#3)(1996-9#3)(1997-1#5)(1997-2#55)(1997-3#1)(1997-4#8)(1997-6#21)(1997-7#15)(1997-8#1)(2006-12#2)(2007-10#19)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#100)(2008-11#59)(2008-12#52)(2008-2#3)(2008-3#14)(2008-4#47)(2008-5#22)(2008-6#7)(2008-7#72)(2008-8#23)(2008-9#36)(2009-10#2)(2009-11#9)(2009-12#8)(2009-4#1)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#13)(2010-1#6)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#11)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#35)(2011-2#50)(2011-3#9)(2012-1#28)(2012-12#4)(2012-2#47)(2012-3#15)(2012-7#2)(2013-1#80)(2013-7#16)(2013-8#16)
rats' skin##6##2##(2011-3#6)
rats'##11##1##(1992-7#1)(1994-8#1)(2010-12#1)(2011-3#7)(2013-1#1)
rats) was##3##2##(1992-9#3)
rats)##12##1##(1991-12#1)(1992-9#4)(1993-12#1)(1994-8#1)(1995-5#1)(1997-7#2)(2008-11#2)
rats]##28##1##(2010-12#9)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#6)
rattlesnake Crotalus atrox##2##3##(1992-8#1)(1994-8#1)
rattlesnake##7##1##(1992-8#4)(1994-6#2)(1994-8#1)
raubitschekii##3##1##(2009-2#3)
ravages##2##1##(1997-6#1)(2008-5#1)
raw IR##2##2##(2008-10#2)
raw and cooked hamburgers##2##4##(2010-4#2)
raw and cooked##5##3##(2010-4#5)
raw and pasteurized##2##3##(2008-12#2)
raw and##13##2##(2008-10#2)(2008-12#4)(2010-4#6)(2012-12#1)
raw beef patties##3##3##(2010-4#3)
raw bit-error rate##3##3##(2007-11#2)(2008-2#1)
raw data from##2##3##(2008-3#1)(2011-7#1)
raw data##12##2##(1993-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-7#1)(2012-12#2)
raw material and from##2##4##(2008-10#2)
raw material and##5##3##(2008-10#5)
raw material for the##2##4##(2008-10#1)(2008-5#1)
raw material for##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
raw material to##2##3##(2008-6#1)(2013-1#1)
raw material was##2##3##(2008-6#1)(2013-1#1)
raw material##24##2##(1997-2#1)(2008-10#10)(2008-4#1)(2008-5#3)(2008-6#2)(2009-8#1)(2011-2#2)(2013-1#4)
raw materials and##5##3##(2008-10#2)(2008-11#1)(2008-5#2)
raw materials used for the##2##5##(2008-10#2)
raw materials used##3##3##(2008-10#3)
raw materials with##2##3##(2008-10#1)(2008-11#1)
raw materials##34##2##(1994-3#3)(2007-11#2)(2008-10#14)(2008-11#4)(2008-5#4)(2008-6#3)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
raw milk##9##2##(2008-10#5)(2010-2#4)
raw or##2##2##(2007-2#1)(2010-4#1)
raw pork meat##4##3##(1997-4#2)(2010-4#2)
raw pork##11##2##(1997-4#3)(2010-2#6)(2010-4#2)
raw seeds##2##2##(2011-2#2)
raw water##2##2##(1992-5#1)(2008-10#1)
raw##160##1##(1992-5#1)(1993-12#1)(1994-3#4)(1997-2#1)(1997-4#4)(2007-11#4)(2007-12#2)(2007-2#2)(2008-10#51)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#11)(2010-4#14)(2010-8#1)(2011-2#11)(2011-7#1)(2012-12#4)(2012-2#1)(2013-1#6)(2013-8#2)
ray aberration##2##2##(2008-3#2)
ray and##3##2##(2008-10#1)(2008-3#2)
ray blight##8##2##(2008-10#8)
ray deflections##2##2##(2008-2#1)(2008-3#1)
ray distribution##2##2##(2008-3#2)
ray in##2##2##(2008-3#1)(2008-5#1)
ray of##2##2##(2007-7#1)(2008-7#1)
ray optics and##2##3##(2008-3#2)
ray optics model is##2##4##(2008-3#2)
ray optics model##6##3##(2008-3#6)
ray optics##15##2##(2007-11#1)(2008-2#2)(2008-3#11)(2011-1#1)
ray path##2##2##(2008-3#2)
ray paths##2##2##(2008-3#2)
ray propagation##2##2##(2008-2#1)(2008-3#1)
ray trace to##2##3##(2008-3#2)
ray trace##7##2##(2008-2#2)(2008-3#5)
ray tracing for##2##3##(2008-3#2)
ray tracing is##2##3##(2008-2#1)(2008-3#1)
ray tracing##24##2##(2008-2#15)(2008-3#9)
ray##110##1##(1993-12#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#10)(2008-2#31)(2008-3#48)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
ray-optics approach##2##2##(2008-3#2)
ray-optics approximation##2##2##(2008-2#1)(2008-3#1)
ray-optics model##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
ray-optics##11##1##(2007-11#1)(2008-2#2)(2008-3#8)
ray-tracing and##2##2##(2008-3#2)
ray-tracing approach##2##2##(2008-2#1)(2008-3#1)
ray-tracing method##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
ray-tracing simulations##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
ray-tracing technique##2##2##(2008-3#2)
ray-tracing##34##1##(2007-12#3)(2008-2#9)(2008-3#22)
rays are##6##2##(1997-6#1)(2008-2#3)(2008-3#2)
rays at##2##2##(2007-11#1)(2013-1#1)
rays by##2##2##(2008-2#2)
rays from##2##2##(2008-3#1)(2008-5#1)
rays in the##5##3##(2007-12#1)(2008-3#2)(2013-7#2)
rays in##11##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)(2013-7#2)
rays of##3##2##(2008-2#1)(2008-5#1)(2013-7#1)
rays that##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
rays through##4##2##(2008-3#3)(2013-8#1)
rays to##3##2##(1995-12#1)(2008-2#1)(2013-1#1)
rays with##2##2##(2008-3#2)
rays##79##1##(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-6#2)(2007-11#5)(2007-12#6)(2008-10#1)(2008-2#14)(2008-3#24)(2008-5#5)(2008-6#1)(2008-7#4)(2011-2#1)(2013-1#4)(2013-7#5)(2013-8#1)
rays&quot##2##1##(1997-6#2)
razor##3##1##(2008-5#2)(2012-12#1)
rbE-II##2##1##(1997-4#2)
rbcS genes##3##2##(1993-12#3)
rbcS##5##1##(1993-12#4)(1994-8#1)
rbcS-m3##4##1##(1994-8#4)
rbsA##2##1##(2011-1#2)
rdo##5##1##(2008-9#5)
rds1 is##2##2##(1995-8#2)
rds1##7##1##(1995-8#7)
re##11##1##(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2010-7#1)(2012-1#1)(2013-8#1)
re-Ad##2##1##(1997-4#2)
re-addition of serum##2##3##(1996-2#2)
re-addition of##3##2##(1996-2#2)(2008-8#1)
re-admission##3##1##(1997-7#1)(2007-2#1)(2012-3#1)
re-affirm##2##1##(1994-9#1)(2008-1#1)
re-analysis of##2##2##(2008-7#1)(2008-9#1)
re-analysis##3##1##(2008-7#1)(2008-9#1)(2010-11#1)
re-analyzed##3##1##(2008-10#1)(2009-4#1)(2012-2#1)
re-assessed##2##1##(2008-10#1)(2011-1#1)
re-bleeding##4##1##(2013-1#4)
re-calibration##2##1##(2008-10#2)
re-create##2##1##(2008-8#1)(2011-2#1)
re-dislocation##2##1##(2009-3#2)
re-dissolved##3##1##(2008-10#2)(2008-5#1)
re-education##2##1##(2008-12#1)(2008-5#1)
re-emergence of##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
re-emerging infectious##2##2##(2009-2#1)(2012-12#1)
re-emerging##6##1##(2009-2#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
re-engagement##6##1##(2010-2#6)
re-engineer##3##1##(1996-2#1)(2007-12#1)(2008-11#1)
re-engineered##2##1##(1996-1#1)(1996-2#1)
re-engineering of##2##2##(2008-11#1)(2008-7#1)
re-engineering##13##1##(1995-12#1)(1995-2#2)(1996-1#2)(1996-2#5)(1996-3#1)(2008-11#1)(2008-7#1)
re-entry##8##1##(2007-8#2)(2008-11#3)(2008-4#1)(2012-3#1)(2013-1#1)
re-epithelialization##2##1##(2009-12#1)(2012-3#1)
re-establish##2##1##(1996-8#1)(2013-1#1)
re-established##6##1##(1994-3#2)(1997-5#1)(2012-2#1)(2012-4#1)(2013-1#1)
re-establishment of##2##2##(2008-11#1)(2013-1#1)
re-establishment##4##1##(2008-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
re-evaluate##5##1##(1995-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)
re-evaluated##10##1##(1990-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-2#1)
re-evaluation of the##3##3##(1993-11#1)(1993-2#1)(2013-8#1)
re-evaluation of##5##2##(1993-11#1)(1993-2#1)(2013-1#2)(2013-8#1)
re-evaluation##9##1##(1993-11#1)(1993-2#1)(2007-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
re-exacerbation##3##1##(2011-2#3)
re-examination of the##2##3##(1991-2#1)(2009-3#1)
re-examination of##3##2##(1991-2#1)(2008-11#1)(2009-3#1)
re-examination##6##1##(1991-2#2)(1991-8#1)(2008-11#1)(2008-12#1)(2009-3#1)
re-examined##10##1##(1991-8#1)(1991-9#1)(1992-5#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-2#1)
re-examines##3##1##(1993-12#1)(2008-12#1)(2008-9#1)
re-excretion##2##1##(1997-6#2)
re-exploration##2##1##(1991-3#1)(2008-7#1)
re-exposure to##2##2##(1993-12#1)(2008-11#1)
re-exposure##6##1##(1993-12#2)(2007-5#2)(2008-11#1)(2013-1#1)
re-expressed##4##1##(1993-3#1)(1997-6#1)(2008-3#1)(2013-1#1)
re-formed##2##1##(1991-9#1)(1995-5#1)
re-growth##2##1##(2012-2#1)(2013-7#1)
re-implantation##4##1##(2008-10#2)(2008-4#1)(2013-1#1)
re-infarction or death##2##3##(2009-6#2)
re-infarction##5##1##(2009-6#5)
re-infection##2##1##(2008-1#1)(2012-12#1)
re-initiates DNA replication##2##3##(1997-6#2)
re-initiation of##2##2##(1997-6#1)(2012-12#1)
re-initiation##4##1##(1997-6#2)(2012-12#2)
re-integration##2##1##(2008-10#2)
re-introduced##2##1##(1996-8#1)(2011-1#1)
re-introduction of##3##2##(2008-4#1)(2008-8#1)(2011-2#1)
re-investigate##2##1##(2007-11#1)(2008-7#1)
re-investigated##2##1##(1992-3#1)(2007-12#1)
re-leptin##2##1##(1997-4#2)
re-occurrence of##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
re-operation##9##1##(1991-3#1)(2007-8#5)(2009-4#1)(2010-8#1)(2011-2#1)
re-operative##2##1##(2007-8#1)(2009-5#1)
re-oxidation of the##2##3##(2008-10#2)
re-oxidation of##3##2##(2008-10#3)
re-oxidation##4##1##(2008-10#3)(2008-5#1)
re-randomized##2##1##(2008-5#1)(2012-3#1)
re-stenosis##2##1##(2011-2#1)(2013-1#1)
re-surgery##2##1##(1997-8#1)(2013-7#1)
re-testing##2##1##(2008-12#2)
re-treatment##4##1##(1991-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
re-uptake##6##1##(1995-12#3)(1996-12#2)(2012-3#1)
re-use##3##1##(1994-11#1)(2008-10#1)(2008-7#1)
re-used rockwool##2##2##(2008-10#2)
re-used##5##1##(1994-5#2)(2008-10#3)
re-virus##4##1##(1993-6#4)
reCsnSN##3##1##(1994-12#3)
reabsorption in the kidney##2##4##(1995-12#1)(2012-12#1)
reabsorption loss##2##2##(2007-12#1)(2008-2#1)
reabsorption##12##1##(1990-2#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
reabsorptive##2##1##(1995-12#1)(2008-11#1)
reaccumulation##2##1##(1991-2#1)(1993-3#1)
reach a consensus##2##3##(1993-1#1)(2008-7#1)
reach a critical##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
reach a plateau##2##3##(2008-10#2)
reach a##25##2##(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
reach an##4##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-8#1)
reach as high as##2##4##(2008-9#1)(2009-11#1)
reach as##4##2##(1994-1#1)(2007-12#1)(2008-9#1)(2009-11#1)
reach considerable##2##2##(2011-2#1)(2013-1#1)
reach equilibrium##2##2##(1992-6#1)(2008-10#1)
reach its##4##2##(1992-3#1)(2008-11#1)(2008-3#2)
reach maximal##2##2##(1992-5#1)(1996-2#1)
reach of the##4##3##(2007-12#1)(2008-3#1)(2010-8#2)
reach of##11##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#2)(2012-12#1)(2013-1#1)
reach out to##3##3##(1992-3#1)(2010-8#1)(2011-2#1)
reach out##4##2##(1992-3#1)(1997-2#1)(2010-8#1)(2011-2#1)
reach significance##3##2##(1992-11#1)(1995-12#1)(2012-3#1)
reach steady state##3##3##(2008-10#2)(2009-5#1)
reach such##2##2##(2007-10#1)(2013-8#1)
reach the tumor##2##3##(2008-11#2)
reach the##43##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-5#1)(1995-11#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
reach their peak##2##3##(2008-10#1)(2008-5#1)
reach their##5##2##(1995-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)
reach values of##2##3##(2007-8#1)(2013-1#1)
reach##230##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-3#3)(1992-5#3)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-4#1)(2007-8#3)(2008-1#4)(2008-10#44)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#7)(2011-1#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
reachable##2##1##(2008-10#1)(2008-6#1)
reached 0##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
reached 100%##2##2##(2008-10#1)(2013-1#1)
reached 18 years##2##3##(2007-8#1)(2011-2#1)
reached 2##3##2##(1997-8#1)(2008-9#1)(2011-1#1)
reached 5##2##2##(2008-8#1)(2010-12#1)
reached 7##2##2##(2008-11#1)(2009-4#1)
reached 71##2##2##(2007-11#1)(2013-1#1)
reached 83%##2##2##(1991-4#1)(2012-3#1)
reached a consensus##2##3##(1994-2#1)(1997-3#1)
reached a level of##3##4##(1991-12#1)(1991-3#1)(1997-7#1)
reached a maximal level##2##4##(1997-7#1)(2008-10#1)
reached a maximal##5##3##(1991-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-8#1)
reached a maximum 1##2##4##(2008-10#2)
reached a maximum at##3##4##(1993-11#1)(1993-8#1)(2013-1#1)
reached a maximum cell##2##4##(2008-11#2)
reached a maximum in##2##4##(1997-8#1)(2008-10#1)
reached a maximum##16##3##(1992-3#1)(1993-11#2)(1993-8#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#3)(2012-2#1)(2013-1#1)(2013-8#1)
reached a mean##3##3##(1990-6#1)(1993-12#1)(2008-7#1)
reached a peak##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
reached a plateau##8##3##(1990-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#2)(2011-2#1)
reached a value of##2##4##(2008-11#1)(2008-2#1)
reached a##62##2##(1990-12#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2009-6#1)(2010-3#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
reached about##2##2##(2008-10#1)(2008-7#1)
reached after##5##2##(1995-12#1)(2008-10#2)(2008-5#1)(2011-1#1)
reached an equilibrium##2##3##(1995-6#1)(2008-10#1)
reached an##8##2##(1995-6#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
reached and a##2##3##(1993-2#1)(2013-1#1)
reached and the##2##3##(1993-12#1)(2008-10#1)
reached and##8##2##(1993-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
reached approximately##2##2##(1992-9#1)(2011-2#1)
reached around##2##2##(1992-3#1)(2008-11#1)
reached as##3##2##(1994-6#1)(1995-2#1)(2013-8#1)
reached at##5##2##(1993-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
reached by other##2##3##(2008-2#1)(2013-8#1)
reached by subjects##2##3##(2007-6#2)
reached by the##2##3##(2008-10#1)(2013-7#1)
reached by##14##2##(1990-6#1)(2007-6#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-2#1)(2013-7#1)(2013-8#1)
reached confluence##2##2##(2008-11#2)
reached consensus##2##2##(2008-7#1)(2010-9#1)
reached during##2##2##(2007-6#1)(2013-1#1)
reached for the##2##3##(2008-10#2)
reached for##6##2##(2008-10#4)(2008-3#1)(2013-1#1)
reached full coverage##2##3##(2008-10#2)
reached higher##2##2##(2008-10#1)(2013-8#1)
reached in##11##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2011-1#2)(2011-2#1)(2012-12#1)
reached its maximum after##2##4##(2008-10#2)
reached its peak on the day##2##6##(2007-10#2)
reached its peak##3##3##(1991-5#1)(2007-10#2)
reached its##6##2##(1991-5#1)(2007-10#2)(2008-10#2)(2009-8#1)
reached maximal levels##2##3##(1990-12#1)(1994-11#1)
reached out to##2##3##(2008-6#1)(2012-12#1)
reached over##2##2##(2008-10#1)(2010-3#1)
reached skeletal maturity##2##3##(2007-8#1)(2008-6#1)
reached statistical significance##3##3##(1990-6#1)(1992-11#1)(2006-12#1)
reached the highest##2##3##(2008-10#1)(2008-11#1)
reached the maximal level##2##4##(1993-6#1)(2008-9#1)
reached the maximum at##2##4##(2008-4#1)(2008-9#1)
reached the maximum level##2##4##(1994-6#1)(2008-9#1)
reached the maximum##5##3##(1994-6#1)(1997-2#1)(2008-4#1)(2008-9#2)
reached the recommended levels##2##4##(2011-2#2)
reached the target##2##3##(1995-12#1)(2007-10#1)
reached the##40##2##(1990-10#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
reached their##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
reached three##2##2##(1990-12#1)(2008-11#1)
reached to the##2##3##(1994-11#1)(2008-6#1)
reached to##5##2##(1994-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
reached two##2##2##(1992-3#1)(2010-5#1)
reached using##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
reached values of##2##3##(1994-7#1)(2008-10#1)
reached when##3##2##(2008-5#1)(2008-8#1)(2013-8#1)
reached with##5##2##(1990-12#1)(2007-12#1)(2008-10#2)(2008-2#1)
reached##383##1##(1990-10#1)(1990-12#5)(1990-6#3)(1990-7#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#7)(1992-5#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#2)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-3#1)(2007-6#4)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#82)(2008-11#28)(2008-12#4)(2008-2#8)(2008-3#11)(2008-4#3)(2008-5#10)(2008-6#8)(2008-7#10)(2008-8#9)(2008-9#8)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#5)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#18)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#6)
reaches 1##2##2##(2008-9#1)(2012-1#1)
reaches a maximum at##2##4##(2008-8#1)(2012-12#1)
reaches a maximum##6##3##(1991-5#1)(1992-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
reaches a##14##2##(1991-5#1)(1992-7#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)
reaches as high as##2##4##(2011-2#2)
reaches its maximum##2##3##(2007-11#1)(2013-8#1)
reaches the peak##2##3##(2008-9#2)
reaches the##14##2##(1990-7#1)(1992-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-5#1)
reaches##64##1##(1990-7#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-3#2)(1994-5#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
reaching a maximum at##3##4##(1995-2#1)(1997-2#1)(2011-2#1)
reaching a maximum in##3##4##(1994-9#1)(2008-10#1)(2013-7#1)
reaching a maximum##11##3##(1990-7#1)(1992-12#1)(1992-6#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-2#2)(2008-10#1)(2011-2#1)(2013-7#1)
reaching a peak at##2##4##(1990-2#1)(2009-12#1)
reaching a peak##3##3##(1990-2#1)(1992-6#1)(2009-12#1)
reaching a##28##2##(1990-2#1)(1990-7#3)(1990-9#1)(1992-12#1)(1992-6#2)(1994-9#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
reaching an##6##2##(1994-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
reaching and##5##2##(1996-2#1)(2008-8#1)(2012-2#2)(2013-1#1)
reaching epidemic proportions##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
reaching equilibrium##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
reaching for food##2##3##(1992-11#1)(1994-3#1)
reaching its maximum##2##3##(1992-11#1)(2009-5#1)
reaching movements##3##2##(2008-6#3)
reaching out to##2##3##(1992-3#1)(1993-3#1)
reaching out##3##2##(1992-3#1)(1993-3#1)(2007-10#1)
reaching peak##2##2##(1990-5#1)(2008-10#1)
reaching success##2##2##(1992-11#1)(1994-3#1)
reaching target##2##2##(1991-6#2)
reaching the highest##2##3##(1997-2#1)(2011-2#1)
reaching the liver##2##3##(1994-5#2)
reaching the lowest level##2##4##(2008-10#1)(2013-1#1)
reaching the same##2##3##(2008-10#1)(2008-5#1)
reaching the##32##2##(1990-5#1)(1993-5#1)(1994-5#2)(1994-6#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-2#1)(2009-7#1)(2010-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
reaching their##2##2##(2010-12#1)(2012-2#1)
reaching to##2##2##(1996-4#1)(2008-5#1)
reaching work area##2##3##(2010-7#2)
reaching##157##1##(1990-2#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-11#6)(1992-12#1)(1992-3#2)(1992-6#4)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#5)(1994-5#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#6)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#7)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#4)(2009-2#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
reacquisition##4##1##(1994-8#1)(2007-12#1)(2008-5#2)
react against##3##2##(1990-11#1)(1990-8#1)(2013-7#1)
react at##2##2##(2008-10#2)
react in##2##2##(1991-12#1)(2008-10#1)
react more strongly to##2##4##(2010-4#2)
react more##6##2##(1996-11#1)(1997-8#2)(2008-10#1)(2010-4#2)
react preferentially##2##2##(2008-10#1)(2008-8#1)
react to##11##2##(1990-3#2)(1993-12#1)(1993-3#1)(1995-12#1)(1995-6#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#1)
react with a##3##3##(1991-7#1)(2008-10#1)(2010-4#1)
react with common##2##3##(2008-10#2)
react with free##2##3##(1992-9#1)(2008-10#1)
react with specific##2##3##(1996-5#1)(2008-10#1)
react with the##17##3##(1990-5#1)(1990-8#1)(1993-11#1)(1995-2#1)(1996-2#1)(2006-6#1)(2008-10#7)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
react with##91##2##(1990-5#2)(1990-8#2)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#3)(2006-6#1)(2007-11#1)(2008-10#47)(2008-11#2)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#1)
react##135##1##(1990-11#2)(1990-3#2)(1990-5#2)(1990-8#3)(1991-12#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-7#3)(1997-8#2)(2006-6#1)(2007-11#1)(2008-10#55)(2008-11#4)(2008-2#1)(2008-4#6)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#4)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
reactant and##2##2##(1996-5#1)(2008-10#1)
reactant ion chemistry##3##3##(2008-10#3)
reactant ion##6##2##(2008-10#6)
reactant ions and##2##3##(2008-10#2)
reactant ions##6##2##(2008-10#6)
reactant##23##1##(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#14)(2008-3#1)(2013-8#5)
reactants and##2##2##(2008-10#1)(2013-8#1)
reactants are##3##2##(1990-5#1)(2008-10#2)
reactants were##2##2##(1995-6#1)(2008-10#1)
reactants##20##1##(1990-5#1)(1990-7#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-8#2)
reactants)##2##1##(2008-10#2)
reacted in##5##2##(1990-7#1)(1995-12#1)(2007-11#1)(2008-10#1)(2010-8#1)
reacted less##2##2##(1991-7#1)(1994-6#1)
reacted on##4##2##(1992-2#1)(1992-3#1)(1995-6#1)(2008-10#1)
reacted only##2##2##(1993-6#1)(2008-10#1)
reacted positively to##2##3##(2007-5#1)(2008-10#1)
reacted positively##4##2##(1990-3#1)(2007-5#1)(2008-10#2)
reacted specifically with##2##3##(2008-10#2)
reacted strongly with##2##3##(1992-12#1)(2008-10#1)
reacted subsequently with##2##3##(2008-10#2)
reacted to##8##2##(1990-3#1)(1992-1#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#2)
reacted with a##13##3##(1992-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-5#1)
reacted with an enzyme##2##4##(1993-6#2)
reacted with anti-A beta##3##4##(1995-12#3)
reacted with antibodies##2##3##(1993-6#1)(2008-5#1)
reacted with hydrazine##2##3##(2008-10#1)(2008-11#1)
reacted with iodide##2##3##(2008-10#2)
reacted with the##14##3##(1991-9#2)(1993-11#1)(2008-10#8)(2008-11#2)(2008-5#1)
reacted with##103##2##(1990-5#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#3)(1994-11#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-6#2)(1996-12#2)(1996-5#4)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#10)(2008-10#39)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#5)(2012-12#1)(2013-1#1)
reacted##157##1##(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#4)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-6#4)(1996-12#2)(1996-3#1)(1996-5#4)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#11)(2007-5#1)(2008-10#61)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#5)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
reacting by##2##2##(1994-12#2)
reacting material##2##2##(1997-8#1)(2008-10#1)
reacting the##3##2##(1992-9#1)(1995-3#1)(2008-7#1)
reacting to the##2##3##(2008-11#1)(2008-3#1)
reacting to##5##2##(1991-1#1)(1993-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
reacting with a##2##3##(2007-11#1)(2008-10#1)
reacting with##16##2##(1990-12#2)(1990-8#1)(1991-2#1)(1992-8#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-8#1)(2011-2#1)
reacting##45##1##(1990-12#2)(1990-8#1)(1991-1#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#4)(1994-2#1)(1995-3#2)(1997-2#1)(1997-8#1)(2007-11#2)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
reaction (2)##2##2##(2008-10#2)
reaction (AR)##2##2##(1992-8#1)(2008-8#1)
reaction 2 and##2##3##(1992-6#2)
reaction 2##3##2##(1992-6#3)
reaction a##2##2##(1991-6#1)(2008-10#1)
reaction after##4##2##(1997-8#1)(2007-7#1)(2008-10#2)
reaction alone##2##2##(2008-10#2)
reaction also##2##2##(1993-8#1)(2008-11#1)
reaction among##3##2##(2006-9#1)(2008-10#2)
reaction and a##5##3##(1993-8#1)(2008-10#2)(2008-5#2)
reaction and chemiluminescence detection##2##4##(2008-10#2)
reaction and chemiluminescence##3##3##(2008-10#3)
reaction and no##2##3##(1993-8#1)(2008-10#1)
reaction and the##10##3##(1990-12#1)(1992-3#1)(1993-11#1)(1995-11#1)(2007-10#1)(2007-5#1)(2008-10#3)(2011-2#1)
reaction and##98##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-2#2)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-10#44)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
reaction are##8##2##(1990-11#1)(1992-8#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-6#1)
reaction around##2##2##(1991-11#1)(1996-12#1)
reaction as a##2##3##(1992-6#1)(2007-7#1)
reaction as##7##2##(1992-6#1)(2007-7#2)(2008-10#3)(2009-4#1)
reaction assay##8##2##(1995-11#1)(1996-12#1)(2007-6#1)(2008-10#4)(2012-2#1)
reaction at a##2##3##(1997-3#1)(2010-5#1)
reaction at low pH##2##4##(1993-8#1)(2010-4#1)
reaction at pH##2##3##(1994-8#1)(2008-10#1)
reaction at the##5##3##(1990-6#1)(1992-11#1)(1996-5#1)(2008-10#2)
reaction at##20##2##(1990-6#1)(1990-8#1)(1992-11#1)(1993-8#3)(1994-8#1)(1996-5#1)(1997-3#1)(2008-10#7)(2010-4#2)(2010-5#1)(2012-3#1)
reaction before##2##2##(2008-8#1)(2013-1#1)
reaction being##2##2##(1990-3#1)(2008-10#1)
reaction between 1##3##3##(2008-10#1)(2010-12#1)(2010-7#1)
reaction between a##2##3##(2008-10#2)
reaction between ascorbic acid and##2##5##(2008-10#2)
reaction between hydrogen peroxide and##2##5##(2008-10#2)
reaction between hydrogen peroxide##3##4##(2008-10#3)
reaction between iron(III)##2##3##(2008-10#2)
reaction between luminol and periodate##2##5##(2008-10#2)
reaction between luminol and##5##4##(2008-10#5)
reaction between luminol##6##3##(2008-10#6)
reaction between nitrite##2##3##(2008-10#2)
reaction between tetrabutylammonium periodate and phenothiazine in##2##7##(2008-10#2)
reaction between the##13##3##(2007-11#1)(2008-10#11)(2008-5#1)
reaction between##104##2##(1990-5#1)(1991-12#1)(1992-6#1)(1995-5#1)(1996-5#1)(2007-11#2)(2008-10#87)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
reaction buffer##2##2##(2008-10#1)(2008-4#1)
reaction by##11##2##(1991-5#1)(1992-1#1)(1992-6#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-9#1)
reaction can be##8##3##(1991-9#1)(1992-5#1)(1992-6#1)(1996-5#1)(2008-10#3)(2008-9#1)
reaction can complete##2##3##(2008-10#2)
reaction can##12##2##(1991-9#1)(1992-5#1)(1992-6#1)(1994-9#1)(1996-5#1)(1997-7#1)(2008-10#5)(2008-9#1)
reaction catalyzed by##7##3##(1991-12#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#2)
reaction cell and##3##3##(2008-10#3)
reaction cell##7##2##(2008-10#7)
reaction center (RC)##3##3##(1993-11#1)(2008-8#1)(2010-2#1)
reaction center associated##2##3##(1993-8#2)
reaction center##10##2##(1992-6#2)(1993-11#1)(1993-8#3)(2008-8#3)(2010-2#1)
reaction centers from Rhodobacter sphaeroides RS601##2##6##(2008-9#2)
reaction centers was##2##3##(2008-8#1)(2008-9#1)
reaction centers##15##2##(1992-6#1)(1993-11#3)(2008-10#1)(2008-8#2)(2008-9#6)(2010-2#2)
reaction chamber##2##2##(2008-10#1)(2008-6#1)
reaction characterized by##2##3##(1996-12#1)(2008-10#1)
reaction chemistry##2##2##(1990-7#1)(2012-2#1)
reaction coil and##2##3##(2008-10#2)
reaction coil length##3##3##(2008-10#3)
reaction coil to##3##3##(2008-10#3)
reaction coil was##3##3##(2008-10#3)
reaction coil##21##2##(1990-8#1)(2008-10#20)
reaction coils##2##2##(2008-10#2)
reaction components##2##2##(2008-10#2)
reaction condition)##2##2##(2008-6#2)
reaction conditions and the##3##4##(1997-2#1)(2008-10#2)
reaction conditions and##7##3##(1997-2#1)(2008-10#5)(2009-10#1)
reaction conditions are##2##3##(2008-10#2)
reaction conditions for##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
reaction conditions of##2##3##(1991-5#1)(2012-3#1)
reaction conditions the##2##3##(1997-4#1)(2008-10#1)
reaction conditions to##2##3##(2007-11#1)(2008-10#1)
reaction conditions were##8##3##(2008-10#6)(2009-12#1)(2013-8#1)
reaction conditions with##2##3##(1996-5#1)(2008-10#1)
reaction conditions##52##2##(1991-5#1)(1992-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(2007-11#2)(2008-10#28)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
reaction could##2##2##(1990-7#1)(2008-10#1)
reaction cycle##3##2##(1995-5#1)(1995-6#1)(2009-9#1)
reaction developed##2##2##(2008-10#1)(2008-7#1)
reaction does##2##2##(1996-2#1)(2008-10#1)
reaction equilibrium##2##2##(2008-10#1)(2008-9#1)
reaction events##3##2##(1995-6#3)
reaction field##6##2##(2008-10#2)(2010-12#2)(2013-1#2)
reaction followed by##3##3##(1992-2#1)(1993-3#1)(2008-4#1)
reaction followed##4##2##(1992-2#1)(1993-3#1)(2008-10#1)(2008-4#1)
reaction following the##2##3##(1993-3#1)(2008-5#1)
reaction following##4##2##(1992-12#1)(1993-3#1)(2008-5#2)
reaction for the determination of##2##5##(2008-10#2)
reaction for the##10##3##(1996-11#1)(2008-10#4)(2008-4#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
reaction for##23##2##(1990-11#1)(1996-11#1)(2007-10#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#2)(2010-4#1)(2012-3#1)(2013-8#2)
reaction forces##3##2##(2010-3#1)(2010-9#1)(2013-1#1)
reaction from the##3##3##(1995-12#1)(2007-11#1)(2008-4#1)
reaction from##12##2##(1994-11#1)(1994-8#1)(1995-12#1)(2007-11#1)(2008-10#5)(2008-4#2)(2008-8#1)
reaction has been proposed##2##4##(2008-10#1)(2008-8#1)
reaction has been##7##3##(1995-11#1)(1995-6#1)(2008-10#4)(2008-8#1)
reaction has##11##2##(1995-11#1)(1995-5#1)(1995-6#1)(2008-10#6)(2008-4#1)(2008-8#1)
reaction in a##3##3##(1995-12#1)(1997-7#1)(2008-10#1)
reaction in all##2##3##(1990-8#1)(2008-8#1)
reaction in both##2##3##(1994-3#1)(2008-10#1)
reaction in living cells##3##4##(2010-12#1)(2013-1#2)
reaction in patients with##2##4##(1991-12#1)(2008-7#1)
reaction in patients##3##3##(1991-12#1)(2008-7#1)(2011-1#1)
reaction in the##15##3##(1991-11#1)(1992-6#1)(1992-8#1)(2008-10#6)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2012-2#1)
reaction in##70##2##(1990-8#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1996-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#2)(2008-10#21)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#7)
reaction indicates that the##2##4##(1990-7#1)(1994-5#1)
reaction induced by##3##3##(2008-3#1)(2008-8#2)
reaction induces##2##2##(2008-4#1)(2008-5#1)
reaction interface##5##2##(2008-10#5)
reaction intermediate##2##2##(1990-5#1)(1990-7#1)
reaction intermediates##2##2##(1991-9#1)(2009-9#1)
reaction involved##3##2##(1995-3#1)(1995-5#1)(2008-10#1)
reaction involving##6##2##(2008-10#2)(2009-11#1)(2010-3#1)(2011-1#1)(2013-8#1)
reaction is a##5##3##(1996-5#1)(2008-10#3)(2008-8#1)
reaction is also##3##3##(2008-10#2)(2008-5#1)
reaction is coupled##2##3##(1992-6#1)(2008-10#1)
reaction is discussed##2##3##(2008-10#1)(2010-4#1)
reaction is monitored spectrophotometrically by measuring the decrease in##2##9##(2008-10#2)
reaction is monitored spectrophotometrically##3##4##(2008-10#3)
reaction is monitored##4##3##(2008-10#4)
reaction is not##2##3##(1990-6#1)(2008-10#1)
reaction is proposed##4##3##(1995-2#1)(2008-10#3)
reaction is##78##2##(1990-6#2)(1990-7#1)(1990-8#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-7#1)(2008-10#40)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
reaction kinetics##9##2##(1990-5#1)(1995-3#1)(2008-10#4)(2009-12#1)(2010-4#1)(2013-1#1)
reaction leading to##2##3##(1995-5#1)(2008-3#1)
reaction may##4##2##(1990-3#1)(2007-10#1)(2013-1#2)
reaction mechanism for the##2##4##(1991-12#1)(2008-10#1)
reaction mechanism for##3##3##(1991-12#1)(2008-10#2)
reaction mechanism in##2##3##(2008-10#1)(2009-11#1)
reaction mechanism is##3##3##(2008-10#2)(2008-12#1)
reaction mechanism of the##2##4##(1995-3#1)(2008-10#1)
reaction mechanism of##4##3##(1995-3#1)(1995-5#1)(1995-6#1)(2008-10#1)
reaction mechanism was##3##3##(2008-10#3)
reaction mechanism##25##2##(1990-5#1)(1990-7#1)(1991-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-12#2)(2009-11#1)
reaction mechanisms for##2##3##(1994-8#1)(2007-11#1)
reaction mechanisms##10##2##(1992-8#1)(1994-6#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#1)
reaction media##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
reaction medium##19##2##(1996-5#1)(2008-10#14)(2008-7#3)(2013-1#1)
reaction method##5##2##(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#2)
reaction mixture containing##2##3##(1993-3#1)(1997-4#1)
reaction mixture is##2##3##(1991-5#1)(2008-10#1)
reaction mixture was##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
reaction mixture with##2##3##(1992-9#1)(1997-4#1)
reaction mixture##21##2##(1991-12#1)(1991-5#3)(1992-9#1)(1993-3#1)(1994-5#1)(1997-4#2)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)
reaction mixtures##7##2##(1992-3#1)(2008-10#5)(2008-7#1)
reaction monitoring##15##2##(2008-10#7)(2011-1#4)(2011-2#1)(2011-3#2)(2013-1#1)
reaction norm##3##2##(2008-10#1)(2008-8#2)
reaction norms for##2##3##(2008-8#2)
reaction norms##7##2##(2008-8#7)
reaction observed##3##2##(1995-2#1)(2008-10#1)(2009-6#1)
reaction occurred##3##2##(1991-8#1)(1995-2#1)(2010-11#1)
reaction occurs##5##2##(1993-11#1)(1995-5#1)(2008-10#2)(2008-7#1)
reaction of 1##2##3##(1996-2#1)(2008-10#1)
reaction of 4 with##2##4##(1996-5#2)
reaction of 5 with##2##4##(1996-5#2)
reaction of 5##4##3##(1996-5#3)(2008-10#1)
reaction of Cr(VI) with##2##4##(2008-10#2)
reaction of Cu(II) with##5##4##(2008-10#5)
reaction of HRP with hydrogen peroxide and p-iodophenol##2##8##(2008-10#2)
reaction of HRP##3##3##(2008-10#3)
reaction of a##7##3##(2007-11#1)(2008-10#2)(2008-6#1)(2009-6#1)(2009-8#1)(2013-1#1)
reaction of an##3##3##(1996-5#1)(2007-11#1)(2009-2#1)
reaction of aromatic##2##3##(2008-10#1)(2012-3#1)
reaction of ascorbic acid##2##4##(2008-10#2)
reaction of bilirubin##2##3##(2008-10#2)
reaction of closo-1##2##3##(1996-2#2)
reaction of cobalt(II)##2##3##(2008-10#2)
reaction of enzyme##2##3##(1990-7#2)
reaction of equimolar##2##3##(1996-2#1)(2007-11#1)
reaction of ethyl##2##3##(2007-11#1)(2012-3#1)
reaction of inflammation##2##3##(2013-1#2)
reaction of l-cysteine with##2##4##(2008-10#2)
reaction of luminol with hydrogen peroxide##3##6##(2008-10#3)
reaction of luminol with##7##4##(2008-10#7)
reaction of luminol##8##3##(2008-10#8)
reaction of methyl##2##3##(1996-5#1)(2008-10#1)
reaction of metoclopramide##2##3##(2008-10#2)
reaction of silica##2##3##(2008-10#1)(2008-3#1)
reaction of silver##2##3##(2008-10#2)
reaction of sulfide with##2##4##(2008-10#2)
reaction of sulfide##3##3##(2008-10#3)
reaction of tert-butyl##2##3##(2007-11#1)(2009-8#1)
reaction of the analyte with##2##5##(2008-10#2)
reaction of the produced##2##4##(2008-10#2)
reaction of the##46##3##(1990-7#1)(1991-5#1)(1992-2#1)(1992-8#1)(1994-5#1)(1995-5#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#21)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2013-8#1)
reaction of this##3##3##(2008-10#3)
reaction of##334##2##(1990-11#1)(1990-5#1)(1990-7#4)(1991-5#3)(1991-9#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#6)(1994-6#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-2#9)(1996-5#19)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-11#13)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#199)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
reaction on tobacco##2##3##(2008-10#2)
reaction on##7##2##(1994-11#1)(1994-8#1)(2008-10#5)
reaction or##3##2##(1991-9#1)(1993-3#1)(2008-10#1)
reaction pathway##5##2##(1991-9#1)(2008-1#1)(2008-10#2)(2008-3#1)
reaction pathways##4##2##(1997-6#1)(1997-7#1)(2008-10#1)(2009-11#1)
reaction pattern##2##2##(1996-5#1)(2008-10#1)
reaction patterns##2##2##(2008-5#1)(2008-6#1)
reaction proceeds through##2##3##(2008-10#1)(2009-10#1)
reaction proceeds##4##2##(1996-5#1)(2008-10#1)(2009-10#1)(2010-8#1)
reaction process##4##2##(2008-10#3)(2008-2#1)
reaction produced a##2##3##(1995-5#1)(2008-10#1)
reaction product is##4##3##(1990-8#1)(2008-10#3)
reaction product was##2##3##(1992-3#1)(2008-6#1)
reaction product##21##2##(1990-7#1)(1990-8#1)(1991-5#1)(1992-3#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#12)(2008-6#1)
reaction products by##3##3##(1992-6#1)(1994-11#1)(2008-4#1)
reaction products of##2##3##(2008-10#2)
reaction products were##6##3##(1991-5#1)(1994-6#1)(1994-8#1)(2008-11#2)(2010-4#1)
reaction products##31##2##(1990-7#2)(1991-12#1)(1991-5#2)(1992-6#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#2)(1996-5#1)(2008-10#6)(2008-11#3)(2008-4#5)(2008-7#1)(2009-8#1)(2010-4#1)
reaction profile##2##2##(2008-10#1)(2010-5#1)
reaction profiles##3##2##(2008-10#3)
reaction progress##3##2##(1994-5#1)(2008-10#1)(2010-8#1)
reaction rate and the##2##4##(2008-10#1)(2009-12#1)
reaction rate and##4##3##(2007-11#1)(2008-10#2)(2009-12#1)
reaction rate constant##4##3##(1990-7#1)(2008-10#2)(2008-8#1)
reaction rate constants##5##3##(2007-11#3)(2008-10#1)(2008-9#1)
reaction rate is##3##3##(2008-10#1)(2008-7#2)
reaction rate of##2##3##(2008-10#2)
reaction rate was##4##3##(2008-10#3)(2008-7#1)
reaction rate##29##2##(1990-7#1)(1992-6#1)(2007-11#4)(2008-10#13)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)
reaction rates##10##2##(1995-11#1)(2008-10#3)(2008-7#4)(2008-9#1)(2011-2#1)
reaction reporting##2##2##(2008-3#1)(2013-8#1)
reaction required##2##2##(1994-6#1)(1995-2#1)
reaction scheme##4##2##(1993-6#1)(1994-2#2)(1997-2#1)
reaction sequence##8##2##(1991-9#1)(1995-11#1)(1996-5#3)(1997-3#1)(2008-10#1)(2013-7#1)
reaction sequences##2##2##(2008-10#1)(2008-7#1)
reaction solution##3##2##(2008-10#2)(2013-8#1)
reaction step##3##2##(2008-10#2)(2009-5#1)
reaction strength##2##2##(1993-12#1)(2010-4#1)
reaction system was##2##3##(2008-10#2)
reaction system##19##2##(2008-10#15)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
reaction systems##5##2##(1992-3#1)(1996-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
reaction taking place##2##3##(2008-11#1)(2008-8#1)
reaction technique##4##2##(1990-12#1)(1991-9#1)(2008-12#1)(2010-4#1)
reaction temperature and##4##3##(2008-10#3)(2011-2#1)
reaction temperature##9##2##(2008-10#5)(2011-2#2)(2013-1#2)
reaction that##11##2##(1990-7#1)(1993-2#1)(2008-10#2)(2008-2#1)(2008-4#3)(2009-3#1)(2009-6#1)(2012-2#1)
reaction the K(m) for the##2##5##(2008-7#2)
reaction the##3##2##(2008-10#1)(2008-7#2)
reaction time (RT)##3##3##(2008-11#1)(2008-7#1)(2010-1#1)
reaction time and##8##3##(1995-12#1)(2008-10#6)(2009-2#1)
reaction time in the##2##4##(2013-1#2)
reaction time of##4##3##(1996-2#1)(2008-10#2)(2008-6#1)
reaction time variance contributed by base time##2##7##(2008-8#2)
reaction time variance##3##3##(2008-8#3)
reaction time was##2##3##(2008-10#1)(2008-5#1)
reaction time##50##2##(1991-6#1)(1992-11#2)(1995-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-4#1)(2008-10#20)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#3)(2010-1#2)(2011-2#1)(2013-1#2)
reaction time)##2##2##(2008-10#2)
reaction times for##3##3##(2008-11#1)(2010-6#2)
reaction times##16##2##(2007-11#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-6#2)(2010-8#1)(2012-1#1)
reaction to P##2##3##(2008-10#2)
reaction to Physiogel SRK##2##4##(1991-11#2)
reaction to an##2##3##(2007-12#1)(2012-12#1)
reaction to form##4##3##(1990-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
reaction to give##2##3##(2007-11#1)(2008-5#1)
reaction to isolates##2##3##(2008-10#2)
reaction to the##8##3##(1991-1#1)(1993-12#1)(1993-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
reaction to trauma##2##3##(1992-3#1)(1992-4#1)
reaction to tuberculin##2##3##(1990-6#2)
reaction to##75##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1996-12#2)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-1#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
reaction took place##2##3##(2008-10#1)(2008-4#1)
reaction types##2##2##(2010-10#2)
reaction under##2##2##(1996-2#1)(2008-10#1)
reaction using the analyte pulse perturbation technique##2##7##(2008-10#2)
reaction using the##3##3##(1997-7#1)(2008-10#2)
reaction using##24##2##(1990-8#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1997-7#2)(2008-10#11)(2008-7#2)(2010-6#1)(2012-12#1)(2012-2#1)
reaction vessel##3##2##(2008-10#2)(2008-7#1)
reaction was also discussed##3##4##(2008-10#3)
reaction was also##5##3##(2008-10#5)
reaction was applied to the##2##5##(2008-10#2)
reaction was applied to##3##4##(2008-10#3)
reaction was carried out using##2##5##(1991-5#1)(2008-10#1)
reaction was carried out##4##4##(1991-5#1)(2008-10#2)(2008-7#1)
reaction was developed##2##3##(2008-10#2)
reaction was examined##2##3##(1992-6#1)(1996-12#1)
reaction was first##2##3##(1995-6#1)(2008-10#1)
reaction was found to##2##4##(2008-10#2)
reaction was found##4##3##(1993-6#1)(2007-10#1)(2008-10#2)
reaction was investigated##3##3##(1993-8#1)(2008-10#2)
reaction was monitored##6##3##(2008-10#6)
reaction was not##2##3##(1996-2#1)(2008-10#1)
reaction was observed between##2##4##(2008-10#1)(2010-4#1)
reaction was observed##4##3##(1990-6#1)(2007-10#1)(2008-10#1)(2010-4#1)
reaction was studied##4##3##(2008-10#4)
reaction was used to##9##4##(1990-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(2007-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
reaction was used##10##3##(1990-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(2007-6#1)(2008-10#2)(2012-3#1)(2013-1#1)
reaction was##96##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-6#2)(1993-8#2)(1995-6#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-2#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-10#50)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
reaction were investigated##2##3##(2008-10#2)
reaction were##17##2##(1991-12#1)(1994-11#1)(1994-9#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-8#1)
reaction when##3##2##(1991-12#1)(2008-10#2)
reaction where##2##2##(2008-10#1)(2009-8#1)
reaction wherein##2##2##(2008-10#2)
reaction which is##2##3##(1994-9#1)(2008-10#1)
reaction which##6##2##(1990-11#1)(1990-8#1)(1994-9#1)(2008-10#3)
reaction with O6-benzylguanine##2##3##(1995-5#2)
reaction with a##6##3##(1992-12#1)(1992-2#1)(1997-1#1)(1997-7#1)(2008-10#2)
reaction with luminol##2##3##(1995-3#1)(2008-10#1)
reaction with methyl##2##3##(2008-10#1)(2010-8#1)
reaction with potassium##3##3##(2008-10#3)
reaction with the studied##2##4##(2008-10#2)
reaction with the##10##3##(1993-8#1)(2007-11#1)(2008-10#8)
reaction with##129##2##(1990-8#2)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-5#2)(1995-3#2)(1995-5#3)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#84)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2009-10#1)(2009-9#2)(2010-8#1)(2011-1#3)(2013-8#1)
reaction without##2##2##(2008-10#1)(2009-11#1)
reaction yield##2##2##(2008-10#1)(2008-5#1)
reaction yielded##2##2##(2008-10#1)(2011-1#1)
reaction yields##2##2##(2008-10#1)(2008-6#1)
reaction zone##2##2##(2008-10#1)(2008-2#1)
reaction zones##3##2##(2008-3#3)
reaction##2729##1##(1990-11#7)(1990-12#10)(1990-2#4)(1990-3#6)(1990-5#9)(1990-6#9)(1990-7#24)(1990-8#17)(1991-1#2)(1991-11#5)(1991-12#13)(1991-2#2)(1991-5#19)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#18)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#5)(1992-3#14)(1992-4#3)(1992-5#2)(1992-6#23)(1992-8#14)(1992-9#8)(1993-1#2)(1993-11#12)(1993-12#7)(1993-2#7)(1993-3#11)(1993-6#11)(1993-8#30)(1993-9#3)(1994-1#2)(1994-11#12)(1994-12#10)(1994-2#5)(1994-3#4)(1994-5#19)(1994-6#13)(1994-7#1)(1994-8#8)(1994-9#5)(1995-11#7)(1995-12#11)(1995-2#8)(1995-3#6)(1995-5#20)(1995-6#16)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#3)(1996-12#20)(1996-2#21)(1996-3#1)(1996-5#49)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#12)(1997-3#6)(1997-4#8)(1997-6#15)(1997-7#15)(1997-8#8)(1997-9#1)(2006-8#1)(2006-9#1)(2007-10#10)(2007-11#39)(2007-12#12)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#8)(2007-8#3)(2008-1#5)(2008-10#1333)(2008-11#40)(2008-12#14)(2008-2#12)(2008-3#12)(2008-4#48)(2008-5#49)(2008-6#28)(2008-7#58)(2008-8#58)(2008-9#22)(2009-10#11)(2009-11#4)(2009-12#8)(2009-2#6)(2009-3#1)(2009-4#3)(2009-5#9)(2009-6#6)(2009-8#15)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#11)(2010-2#5)(2010-3#2)(2010-4#16)(2010-5#5)(2010-6#11)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#19)(2011-2#43)(2011-3#3)(2012-1#7)(2012-12#6)(2012-2#15)(2012-3#18)(2013-1#57)(2013-7#2)(2013-8#20)
reaction) and##2##2##(1996-12#1)(2008-5#1)
reaction)##12##1##(1990-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)
reaction-diffusion model##2##2##(2008-8#2)
reaction-diffusion models##2##2##(2008-8#1)(2008-9#1)
reaction-diffusion##9##1##(2008-10#1)(2008-8#4)(2008-9#1)(2009-8#1)(2013-8#2)
reaction-rate##2##1##(1996-5#1)(2008-10#1)
reaction?##2##1##(1990-9#1)(2009-5#1)
reactional##12##1##(1991-11#1)(2007-7#2)(2008-10#1)(2011-2#8)
reactions after##2##2##(1996-8#1)(2008-10#1)
reactions among##2##2##(2008-10#2)
reactions and the##2##3##(1997-7#1)(2008-10#1)
reactions and##40##2##(1991-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-9#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#2)(2013-1#1)
reactions are common and##2##4##(2008-10#1)(2008-8#1)
reactions are common##4##3##(1992-8#1)(1997-8#1)(2008-10#1)(2008-8#1)
reactions are##37##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#11)(2008-4#1)(2008-7#2)(2008-8#3)(2010-7#1)(2010-8#1)(2012-2#2)
reactions as##2##2##(1994-8#1)(2008-10#1)
reactions associated with##3##3##(2008-8#1)(2010-5#1)(2012-12#1)
reactions at the##3##3##(1990-6#1)(2008-10#1)(2013-8#1)
reactions at##5##2##(1990-6#1)(1993-12#1)(2008-10#2)(2013-8#1)
reactions between the##3##3##(1996-11#1)(1997-7#1)(2008-10#1)
reactions between##15##2##(1992-6#1)(1996-11#1)(1996-5#1)(1997-7#2)(2008-10#8)(2008-7#1)(2009-11#1)
reactions by##6##2##(1991-9#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
reactions can be prevented by##2##5##(1990-3#2)
reactions can be##6##3##(1990-3#2)(1994-9#1)(2008-10#1)(2008-8#2)
reactions can have##2##3##(2008-10#2)
reactions can##11##2##(1990-3#2)(1994-9#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-8#2)(2009-11#1)
reactions catalyzed by##4##3##(1990-8#1)(1992-3#1)(1994-8#1)(2008-7#1)
reactions commonly##2##2##(2008-10#1)(2009-12#1)
reactions during the##2##3##(2008-10#1)(2008-8#1)
reactions during##5##2##(1991-2#1)(1992-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
reactions for##7##2##(1997-3#1)(2008-10#3)(2009-10#1)(2010-12#1)(2013-8#1)
reactions from##6##2##(1992-11#1)(1993-2#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#1)
reactions has been##3##3##(1994-5#1)(2008-10#1)(2010-5#1)
reactions has##4##2##(1994-5#1)(1996-2#1)(2008-10#1)(2010-5#1)
reactions have been##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
reactions in a##2##3##(1992-6#1)(2009-1#1)
reactions in an##2##3##(2008-8#1)(2011-2#1)
reactions in patients##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
reactions in solution##3##3##(1995-6#1)(1997-2#1)(2009-9#1)
reactions in the presence of##3##5##(1992-8#1)(2008-10#1)(2009-8#1)
reactions in the##16##3##(1990-7#1)(1991-9#1)(1992-8#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
reactions in which##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
reactions in##61##2##(1990-5#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#4)(2013-8#1)
reactions included##2##2##(1990-2#1)(1994-12#1)
reactions including##7##2##(1991-9#1)(1993-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
reactions induced by##2##3##(2009-11#1)(2013-1#1)
reactions involved##2##2##(2008-10#2)
reactions involving##4##2##(1994-11#1)(2008-4#1)(2011-1#1)(2012-3#1)
reactions is##10##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#2)
reactions may be##3##3##(1990-3#1)(2008-4#1)(2008-5#1)
reactions may##5##2##(1990-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-5#1)
reactions observed##2##2##(1992-3#1)(2008-10#1)
reactions occur##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
reactions of an##2##3##(1992-9#1)(2008-5#1)
reactions of iodine##2##3##(2008-10#2)
reactions of the##17##3##(1991-3#1)(1992-6#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#9)(2008-7#1)(2012-2#1)
reactions of these##2##3##(1992-6#1)(2008-8#1)
reactions of thioisatin with thiazolidine-2-carboxylic acid##2##6##(2012-3#2)
reactions of three##2##3##(1992-11#1)(1992-6#1)
reactions of##96##2##(1990-5#3)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#2)(1992-6#6)(1992-9#1)(1993-11#1)(1995-2#1)(1995-3#1)(1996-5#2)(1996-6#2)(1997-2#3)(1997-7#2)(2007-11#5)(2007-12#2)(2008-10#34)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
reactions on solid##2##3##(1997-4#1)(2008-10#1)
reactions on the##2##3##(1995-6#1)(2008-6#1)
reactions on##10##2##(1990-3#1)(1991-5#1)(1995-6#1)(1997-4#1)(2008-10#5)(2008-6#1)
reactions or##2##2##(2008-10#1)(2011-2#1)
reactions previously##2##2##(2010-12#2)
reactions such as##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
reactions that are##2##3##(1990-8#1)(2008-11#1)
reactions that##11##2##(1990-8#1)(1994-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)
reactions through##3##2##(2010-11#1)(2010-12#1)(2013-8#1)
reactions to drugs##4##3##(1990-12#1)(1993-10#1)(1994-9#1)(2008-10#1)
reactions to mosquito bites in##2##5##(2011-1#2)
reactions to mosquito bites##5##4##(2011-1#5)
reactions to stress##2##3##(1996-5#1)(2007-6#1)
reactions to the##10##3##(1990-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)
reactions to trauma##2##3##(2011-2#2)
reactions to##62##2##(1990-12#1)(1990-2#1)(1990-3#1)(1993-1#1)(1993-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-3#3)(1996-5#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2011-1#9)(2011-2#4)(2012-12#1)(2012-2#1)
reactions under##2##2##(1992-11#1)(2008-10#1)
reactions using##6##2##(2008-10#3)(2008-4#1)(2009-6#1)(2013-1#1)
reactions was##12##2##(1993-6#1)(1994-8#1)(2008-10#6)(2008-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
reactions were not##2##3##(1990-7#1)(2008-10#1)
reactions were observed in##2##4##(2008-10#1)(2010-5#1)
reactions were observed##4##3##(1990-2#1)(1992-9#1)(2008-10#1)(2010-5#1)
reactions were performed##2##3##(2008-10#1)(2008-5#1)
reactions were reported in##2##4##(1991-11#1)(2011-2#1)
reactions were studied##3##3##(1992-6#1)(2008-10#2)
reactions were##39##2##(1990-2#1)(1990-7#1)(1991-11#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-8#1)(1994-12#1)(1995-6#2)(2007-11#1)(2007-2#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)
reactions when##2##2##(2008-5#1)(2008-6#1)
reactions which##4##2##(1991-3#1)(1992-6#1)(1997-2#1)(2008-11#1)
reactions will##3##2##(2008-10#1)(2010-7#1)(2012-6#1)
reactions with the##6##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
reactions with##38##2##(1992-3#1)(1993-12#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-2#2)(1996-5#2)(1997-6#1)(1997-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-3#3)
reactions within the##3##3##(2008-7#1)(2009-12#1)(2009-9#1)
reactions within##5##2##(2008-10#1)(2008-7#1)(2009-12#1)(2009-9#2)
reactions##880##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#5)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#8)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#3)(1991-7#1)(1991-9#6)(1992-10#3)(1992-11#5)(1992-12#1)(1992-3#6)(1992-4#1)(1992-6#16)(1992-8#4)(1992-9#8)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#4)(1994-8#3)(1994-9#3)(1995-11#3)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#9)(1996-5#10)(1996-6#4)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#7)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#8)(1997-8#5)(2006-10#1)(2007-10#3)(2007-11#11)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#7)(2008-1#1)(2008-10#233)(2008-11#29)(2008-12#7)(2008-2#8)(2008-3#8)(2008-4#15)(2008-5#27)(2008-6#8)(2008-7#29)(2008-8#35)(2008-9#7)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#6)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#5)(2010-10#4)(2010-11#2)(2010-12#7)(2010-3#1)(2010-4#5)(2010-5#10)(2010-6#5)(2010-7#8)(2010-8#4)(2011-1#19)(2011-2#35)(2012-1#3)(2012-12#11)(2012-2#10)(2012-3#11)(2012-6#1)(2013-1#11)(2013-8#10)
reactivate HIV from latency##2##4##(2012-12#2)
reactivate##11##1##(1990-5#1)(1995-6#2)(1997-7#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2012-12#2)(2013-8#1)
reactivated by incubation with##2##4##(1992-12#1)(1993-11#1)
reactivated by##5##2##(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1995-8#1)
reactivated with##2##2##(1990-11#1)(1993-6#1)
reactivated##13##1##(1990-11#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-6#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)
reactivates##2##1##(1995-6#1)(2008-10#1)
reactivation and##3##2##(2008-5#1)(2009-4#1)(2012-12#1)
reactivation by##2##2##(2007-11#1)(2013-8#1)
reactivation from##2##2##(1994-6#1)(2006-10#1)
reactivation in##2##2##(2009-3#1)(2013-1#1)
reactivation of the##3##3##(1991-5#1)(2008-7#2)
reactivation of##16##2##(1991-5#1)(1993-8#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
reactivation##42##1##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2010-12#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
reactive against##3##2##(1990-11#1)(1997-5#1)(2008-4#1)
reactive aldehydes##2##2##(1993-3#1)(2008-7#1)
reactive and##13##2##(2007-12#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)
reactive antibodies##2##2##(1997-6#1)(2008-1#1)
reactive arthritis##9##2##(1990-6#5)(1994-8#3)(2012-2#1)
reactive astrocytes may##2##3##(1995-12#1)(2013-7#1)
reactive astrocytes##3##2##(1995-12#2)(2013-7#1)
reactive blending##3##2##(2008-10#3)
reactive carbonyl##2##2##(2008-5#2)
reactive cells##2##2##(1990-2#1)(2008-9#1)
reactive cellular##2##2##(1992-8#1)(2012-12#1)
reactive centers##2##2##(1994-5#2)
reactive changes##3##2##(1997-3#1)(2010-9#1)(2011-2#1)
reactive control##5##2##(2009-8#1)(2011-2#4)
reactive dye##2##2##(2008-10#2)
reactive dyes##2##2##(2008-10#2)
reactive for cytokeratin AE1/3##2##4##(1994-8#2)
reactive group##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
reactive hyperemia in##2##3##(2008-4#2)
reactive hyperemia##4##2##(2008-4#4)
reactive in##3##2##(1993-6#1)(2008-12#1)(2012-3#1)
reactive intermediate##4##2##(1990-7#1)(1995-6#3)
reactive intermediates##3##2##(1991-9#1)(1996-12#1)(2013-8#1)
reactive ion etching (RIE)##2##4##(2009-11#2)
reactive ion etching##6##3##(2008-2#1)(2008-3#3)(2009-11#2)
reactive ion##7##2##(2008-2#1)(2008-3#3)(2009-11#3)
reactive iron##3##2##(2008-10#3)
reactive mechanism##2##2##(2008-10#2)
reactive metabolites to##2##3##(1991-1#1)(1994-5#1)
reactive metabolites##4##2##(1991-1#1)(1994-5#1)(2008-10#1)(2008-3#1)
reactive microglia##2##2##(1995-12#2)
reactive molecules##2##2##(1994-2#1)(2009-12#1)
reactive nitrogen species (RNS)##2##4##(2008-5#1)(2011-2#1)
reactive nitrogen species##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
reactive nitrogen##5##2##(1991-6#1)(1996-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
reactive nurses who##2##3##(1996-2#2)
reactive oxidant##2##2##(2008-10#1)(2012-12#1)
reactive oxygen and nitrogen species)##2##5##(2008-5#1)(2008-7#1)
reactive oxygen and nitrogen##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
reactive oxygen and##6##3##(2008-5#1)(2008-7#2)(2009-8#2)(2011-2#1)
reactive oxygen generation##2##3##(1994-8#1)(2008-7#1)
reactive oxygen intermediates##2##3##(1991-9#1)(2008-7#1)
reactive oxygen metabolites and paraoxonase 1##2##6##(2012-12#2)
reactive oxygen metabolites and##3##4##(2012-12#2)(2012-3#1)
reactive oxygen metabolites produced by##2##5##(1993-6#2)
reactive oxygen metabolites##6##3##(1993-6#2)(2012-12#3)(2012-3#1)
reactive oxygen radicals##2##3##(1991-9#1)(1995-8#1)
reactive oxygen species (ROS) and##3##5##(2009-5#1)(2010-5#1)(2012-2#1)
reactive oxygen species (ROS) are##2##5##(2008-10#2)
reactive oxygen species (ROS) as##2##5##(1994-11#1)(2010-1#1)
reactive oxygen species (ROS) production##4##5##(2008-1#1)(2008-10#1)(2008-4#1)(2012-1#1)
reactive oxygen species (ROS) superoxide##2##5##(2008-10#1)(2011-2#1)
reactive oxygen species (ROS) which##2##5##(2008-10#1)(2008-11#1)
reactive oxygen species (ROS)##51##4##(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(2006-10#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-5#1)(2011-10#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-6#1)(2013-1#1)(2013-8#2)
reactive oxygen species and##5##4##(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
reactive oxygen species by##4##4##(2008-10#1)(2008-11#1)(2009-3#1)(2010-1#1)
reactive oxygen species in the##4##5##(1997-4#1)(2009-12#1)(2009-8#1)(2010-10#1)
reactive oxygen species in##5##4##(1994-6#1)(1997-4#1)(2009-12#1)(2009-8#1)(2010-10#1)
reactive oxygen species that##2##4##(2008-8#1)(2011-1#1)
reactive oxygen species##105##3##(1990-11#1)(1991-9#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#2)(1997-4#2)(2006-10#1)(2008-1#5)(2008-10#15)(2008-11#9)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#5)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-6#1)(2013-1#5)(2013-8#4)
reactive oxygen species-potentiated invasive capacity by simultaneously treating AH109A cells with##2##11##(2008-11#2)
reactive oxygen##130##2##(1990-11#1)(1991-9#4)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-11#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-8#1)(1997-4#2)(2006-10#1)(2008-1#5)(2008-10#16)(2008-11#11)(2008-2#1)(2008-4#3)(2008-5#6)(2008-7#9)(2008-8#2)(2008-9#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#7)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#4)
reactive phosphate##2##2##(2008-10#2)
reactive phosphorus (DRP)##3##3##(2008-10#3)
reactive protein##5##2##(1996-1#1)(2008-3#3)(2013-1#1)
reactive response##2##2##(1997-3#1)(2009-8#1)
reactive site loop of maspin##2##5##(1995-6#2)
reactive site##6##2##(1991-8#3)(1995-6#2)(2010-4#1)
reactive species##8##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)
reactive strains##2##2##(1995-8#2)
reactive surface##2##2##(2008-10#2)
reactive systems##2##2##(2007-12#1)(2008-2#1)
reactive to##8##2##(1991-5#1)(1993-12#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#3)
reactive with a##2##3##(1995-9#1)(2008-10#1)
reactive with##17##2##(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-6#1)
reactive##433##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-6#8)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#7)(1992-11#1)(1992-12#3)(1992-3#6)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#5)(1994-6#3)(1994-8#6)(1994-9#2)(1995-12#8)(1995-3#1)(1995-6#5)(1995-8#7)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#7)(2008-1#8)(2008-10#71)(2008-11#23)(2008-12#3)(2008-2#4)(2008-3#16)(2008-4#12)(2008-5#16)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#6)(2009-11#3)(2009-12#6)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-8#18)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-9#3)(2011-1#3)(2011-10#1)(2011-2#18)(2012-1#2)(2012-12#7)(2012-2#9)(2012-3#2)(2012-6#1)(2013-1#9)(2013-7#2)(2013-8#5)
reactive-appearing &quot##2##2##(1992-8#2)
reactive-ion etching##5##2##(2008-3#5)
reactivities of patients with##2##4##(2009-8#2)
reactivities of##6##2##(1992-6#1)(1997-6#1)(2008-10#1)(2009-8#2)(2012-3#1)
reactivities were##2##2##(1992-6#1)(2010-12#1)
reactivities##14##1##(1992-6#3)(1992-8#1)(1995-6#1)(1997-6#2)(2008-10#1)(2008-11#1)(2009-8#2)(2010-12#1)(2010-5#1)(2012-3#1)
reactivity after##2##2##(2008-4#1)(2008-8#1)
reactivity against##2##2##(1990-12#1)(2012-12#1)
reactivity and##9##2##(1995-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-12#2)(2013-1#1)
reactivity are##2##2##(2008-10#1)(2008-8#1)
reactivity as##2##2##(1997-2#1)(2008-7#1)
reactivity behavior##2##2##(1992-6#2)
reactivity between##3##2##(1995-5#1)(2008-8#1)(2011-2#1)
reactivity during the Valsalva maneuver##2##5##(2012-3#2)
reactivity during##3##2##(2008-11#1)(2012-3#2)
reactivity for##2##2##(1993-12#1)(2008-5#1)
reactivity in Gujarati Indian##2##4##(2012-2#2)
reactivity in the##6##3##(1995-12#2)(1995-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
reactivity in##18##2##(1990-9#1)(1991-12#1)(1994-6#1)(1995-12#2)(1995-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#3)(2012-3#1)
reactivity is##4##2##(1995-8#1)(2008-7#2)(2013-1#1)
reactivity level##2##2##(1995-8#2)
reactivity of the two##3##4##(1991-8#1)(1996-2#1)(2007-11#1)
reactivity of the##19##3##(1991-8#1)(1994-12#1)(1994-3#1)(1995-12#2)(1996-2#4)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#5)(2012-2#1)(2013-1#1)
reactivity of these##2##3##(1992-2#1)(2008-10#1)
reactivity of two##3##3##(1990-12#1)(1994-11#1)(2008-4#1)
reactivity of##53##2##(1990-12#2)(1990-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#2)(1996-2#4)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#4)(2007-12#1)(2008-10#13)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#3)(2013-1#2)
reactivity on##2##2##(1990-12#1)(2013-1#1)
reactivity ratios##3##2##(2012-12#3)
reactivity through Mcl-1/Bim##2##3##(2013-1#2)
reactivity to stress##2##3##(1993-12#1)(2008-11#1)
reactivity to##21##2##(1991-12#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-11#1)(2010-4#1)(2011-2#5)(2012-2#1)
reactivity toward##2##2##(1992-9#1)(1994-6#1)
reactivity towards##2##2##(1992-9#1)(2008-10#1)
reactivity was##8##2##(1990-12#1)(1991-9#1)(2008-10#1)(2008-4#1)(2008-7#3)(2011-2#1)
reactivity were##2##2##(1996-5#1)(2008-12#1)
reactivity with all##2##3##(1995-12#1)(2008-5#1)
reactivity with both##2##3##(1990-12#1)(2012-1#1)
reactivity with##15##2##(1990-12#2)(1992-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2010-11#1)(2012-1#1)
reactivity without##2##2##(2008-10#1)(2008-7#1)
reactivity##230##1##(1990-12#8)(1990-5#1)(1990-9#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#4)(1995-11#1)(1995-12#6)(1995-2#1)(1995-5#5)(1995-8#9)(1996-12#1)(1996-2#5)(1996-5#2)(1997-2#2)(1997-3#1)(2006-10#1)(2007-11#6)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#32)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#11)(2008-7#12)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#9)(2012-1#1)(2012-12#10)(2012-2#13)(2012-3#4)(2013-1#8)
reactor (KR)##2##2##(2008-10#2)
reactor 1##2##2##(2008-10#2)
reactor 2##2##2##(2008-10#2)
reactor and a##3##3##(2008-10#3)
reactor and##9##2##(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)
reactor at##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
reactor coil##2##2##(2008-10#2)
reactor column##4##2##(2008-10#4)
reactor containing##2##2##(2008-10#2)
reactor for##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
reactor in the##2##3##(2008-10#2)
reactor in##3##2##(2008-10#3)
reactor is##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2013-1#1)
reactor length##3##2##(2008-10#3)
reactor performance##2##2##(2008-11#1)(2008-7#1)
reactor productivity##2##2##(2008-11#1)(2008-7#1)
reactor temperature##2##2##(2009-2#1)(2013-1#1)
reactor used##2##2##(2008-3#1)(2008-7#1)
reactor using##3##2##(2008-10#2)(2008-7#1)
reactor volume##2##2##(2008-10#1)(2008-11#1)
reactor was used##2##3##(1994-5#1)(2008-10#1)
reactor was##8##2##(1994-5#1)(2008-10#5)(2008-6#1)(2013-1#1)
reactor with a##2##3##(2008-11#1)(2008-7#1)
reactor with##9##2##(1991-5#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-6#3)(2008-7#1)
reactor##180##1##(1991-5#4)(1992-11#2)(1994-11#1)(1994-5#2)(1995-3#3)(1997-2#1)(2008-10#81)(2008-11#23)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#17)(2008-7#18)(2008-9#2)(2009-2#3)(2011-2#2)(2013-1#15)
reactors and##5##2##(2008-10#3)(2008-12#2)
reactors for the determination of##3##5##(2008-10#3)
reactors for##5##2##(2008-10#3)(2008-6#1)(2008-7#1)
reactors have##2##2##(1997-6#1)(2008-12#1)
reactors in##2##2##(2008-10#2)
reactors using##2##2##(2008-10#1)(2008-7#1)
reactors was##5##2##(2008-10#3)(2008-7#2)
reactors with##2##2##(2008-10#1)(2008-12#1)
reactors##62##1##(1992-11#1)(1997-6#1)(2008-10#30)(2008-11#3)(2008-12#6)(2008-2#2)(2008-6#3)(2008-7#13)(2011-2#2)(2013-1#1)
reacts in slightly acidic (0##2##5##(2008-10#2)
reacts in##6##2##(1997-7#1)(2008-10#5)
reacts on Western blots with##2##5##(1992-8#1)(1995-12#1)
reacts rapidly with##2##3##(1997-7#1)(2008-10#1)
reacts to##3##2##(1993-5#1)(1995-5#1)(2008-5#1)
reacts with Fe(III)##2##3##(2008-10#2)
reacts with a##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
reacts with excess##3##3##(2008-10#3)
reacts with silylated##2##3##(1996-5#2)
reacts with the##5##3##(1997-1#1)(2008-10#4)
reacts with##83##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-6#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#2)(1996-2#4)(1996-3#1)(1996-5#3)(1997-1#2)(1997-2#1)(2007-11#2)(2008-10#57)(2008-8#1)(2010-5#2)
reacts##103##1##(1990-2#1)(1990-5#1)(1990-7#3)(1991-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-2#4)(1996-3#1)(1996-5#4)(1997-1#2)(1997-2#1)(1997-7#2)(2007-11#2)(2008-10#64)(2008-5#1)(2008-8#1)(2010-5#2)
read and write##5##3##(2008-2#1)(2008-4#1)(2008-9#1)(2013-8#2)
read and##7##2##(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-8#2)
read at##3##2##(2008-10#2)(2008-2#1)
read by##3##2##(2008-10#2)(2008-3#1)
read data##2##2##(2012-3#2)
read noise##2##2##(2007-12#1)(2008-3#1)
read out by##4##3##(2007-11#1)(2008-3#2)(2012-12#1)
read out##9##2##(2007-11#1)(2008-2#1)(2008-3#6)(2012-12#1)
read signal is##2##3##(2008-3#2)
read the##8##2##(1993-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
read##87##1##(1990-12#3)(1990-3#1)(1993-2#1)(1994-2#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#4)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
read-out##4##1##(2008-3#1)(2008-9#1)(2013-8#2)
read-through##5##1##(1994-12#1)(1994-8#1)(1997-2#1)(2012-2#1)(2012-3#1)
readability and comprehensiveness of consumer##2##5##(2011-1#2)
readability and comprehensiveness of##3##4##(2011-1#3)
readability and##4##2##(2011-1#3)(2012-3#1)
readability##11##1##(2007-5#2)(2008-12#2)(2011-1#4)(2011-2#1)(2012-3#2)
readable format##2##2##(2008-4#1)(2010-8#1)
readable##6##1##(2008-10#1)(2008-4#2)(2010-8#3)
readdress the##2##2##(2007-12#1)(2008-3#1)
reader##39##1##(1990-12#1)(1992-2#2)(1996-12#1)(1996-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#3)(2009-12#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
readers in##2##2##(1996-2#1)(2008-9#1)
readers through##2##2##(1995-2#1)(2008-12#1)
readers to##8##2##(2008-11#1)(2008-2#2)(2008-4#3)(2008-8#1)(2009-4#1)
readers with a##2##3##(2008-7#1)(2012-2#1)
readers with##5##2##(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
readers##47##1##(1991-3#1)(1993-2#1)(1995-2#1)(1996-2#1)(2007-5#2)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-12#3)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#6)
readers'##2##1##(2007-11#1)(2011-2#1)
readership##6##1##(1995-1#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
readily accept##3##2##(2007-2#1)(2008-7#1)(2010-8#1)
readily accepted##2##2##(1995-3#1)(2008-9#1)
readily accessible##5##2##(1995-2#1)(2008-1#1)(2008-7#2)(2012-3#1)
readily achieved by##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
readily achieved##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
readily adaptable to other##2##4##(2008-2#1)(2008-3#1)
readily adaptable to##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
readily adaptable##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
readily adapted to##3##3##(2008-4#1)(2008-6#1)(2010-7#1)
readily amenable to##2##3##(2008-10#1)(2008-8#1)
readily apparent##2##2##(1996-12#1)(2008-3#1)
readily applicable to##3##3##(2008-10#1)(2008-2#1)(2010-11#1)
readily applicable##5##2##(1997-6#1)(2008-10#2)(2008-2#1)(2010-11#1)
readily as##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
readily available and##5##3##(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
readily available components##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
readily available in##3##3##(2008-11#2)(2008-9#1)
readily available reagents##2##3##(2008-10#1)(2008-4#1)
readily available starting materials##2##4##(2008-10#1)(2008-8#1)
readily available to##2##3##(2008-11#1)(2008-5#1)
readily available##45##2##(1992-9#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
readily be##15##2##(1990-3#1)(1992-12#1)(1994-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#3)(2008-9#1)(2009-9#1)(2011-1#2)
readily cleaved##2##2##(1997-4#2)
readily converted to##2##3##(1995-6#1)(1996-5#1)
readily degraded by##2##3##(1994-11#1)(2008-2#1)
readily degraded##3##2##(1994-11#1)(1996-2#1)(2008-2#1)
readily detectable##2##2##(1996-12#1)(2011-2#1)
readily detected by##2##3##(1991-5#1)(1993-2#1)
readily detected in##2##3##(1995-2#1)(2008-10#1)
readily detected with##2##3##(2008-10#2)
readily detected##9##2##(1991-12#1)(1991-5#1)(1993-2#1)(1995-2#1)(2007-7#1)(2008-10#4)
readily determined##5##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#1)
readily distinguishable##2##2##(2008-5#2)
readily distinguished##2##2##(2008-10#2)
readily explained by##2##3##(2008-7#1)(2009-8#1)
readily extended##2##2##(2008-10#1)(2008-9#1)
readily formed##2##2##(2007-12#1)(2008-10#1)
readily identifiable##2##2##(2007-10#1)(2009-1#1)
readily identified##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-6#1)
readily in the##2##3##(2008-10#2)
readily in##4##2##(2008-10#4)
readily into##2##2##(1990-3#1)(1991-9#1)
readily observed in##2##3##(1996-5#1)(2008-10#1)
readily observed##5##2##(1996-5#1)(2007-12#1)(2007-6#1)(2008-10#2)
readily obtained from##2##3##(1991-5#1)(1997-4#1)
readily obtained##4##2##(1991-5#2)(1997-4#1)(2008-3#1)
readily performed##3##2##(1990-8#1)(2008-1#1)(2008-10#1)
readily prepared##3##2##(1993-11#1)(1996-5#1)(2008-10#1)
readily reacted##2##2##(2007-11#1)(2008-10#1)
readily recognized by##2##3##(2007-2#1)(2008-4#1)
readily regenerated with##2##3##(2008-10#2)
readily removed by##3##3##(1997-4#1)(2008-4#2)
readily reversible##2##2##(1992-8#1)(2008-10#1)
readily to##5##2##(1992-6#1)(1995-2#1)(2008-11#1)(2008-7#1)(2010-12#1)
readily visible##2##2##(1990-7#1)(2010-6#1)
readily with##3##2##(2008-11#2)(2012-12#1)
readily##315##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-8#3)(1992-9#3)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#10)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#5)(1997-2#1)(1997-3#2)(1997-4#5)(1997-6#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#66)(2008-11#12)(2008-12#4)(2008-2#7)(2008-3#13)(2008-4#16)(2008-5#9)(2008-6#4)(2008-7#15)(2008-8#7)(2008-9#10)(2009-1#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
readiness assessment##3##2##(1996-1#1)(2013-1#2)
readiness for##9##2##(1994-2#1)(2008-11#2)(2008-2#1)(2008-4#3)(2010-2#1)(2011-2#1)
readiness to change##4##3##(2008-11#3)(2013-8#1)
readiness to engage in research##2##5##(2012-3#2)
readiness to engage in##3##4##(2012-3#3)
readiness to##10##2##(1994-2#1)(1995-12#1)(2008-11#3)(2008-4#1)(2012-3#3)(2013-8#1)
readiness##35##1##(1994-2#2)(1995-12#1)(1996-1#2)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#4)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#9)(2013-1#2)(2013-8#1)
reading abilities##2##2##(2011-2#1)(2012-3#1)
reading ability##3##2##(2012-2#3)
reading accuracy##2##2##(2010-7#2)
reading acquisition##2##2##(2008-11#2)
reading aloud##3##2##(1995-2#1)(2008-9#1)(2009-2#1)
reading and writing##2##3##(2008-12#2)
reading and##12##2##(2007-12#1)(2007-2#1)(2008-12#3)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
reading comprehension##6##2##(2008-12#3)(2011-2#2)(2013-1#1)
reading data##2##2##(2008-2#1)(2013-1#1)
reading efficiency in##3##3##(2012-2#3)
reading efficiency##5##2##(2012-2#5)
reading experience##2##2##(2011-2#2)
reading frame 1##2##3##(1990-11#1)(1995-2#1)
reading frame in##2##3##(1994-11#1)(1995-9#1)
reading frame of human##2##4##(1990-5#1)(2008-4#1)
reading frame of the##7##4##(1990-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#1)
reading frame of##50##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#4)(1991-1#1)(1991-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-6#2)(1997-9#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)
reading frame was##5##3##(1990-12#1)(1992-9#1)(1993-3#1)(2008-10#1)(2008-4#1)
reading frame were##2##3##(1997-4#1)(2008-10#1)
reading frame##184##2##(1990-11#7)(1990-12#2)(1990-2#1)(1990-5#6)(1990-7#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#1)(1994-11#5)(1994-12#11)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#5)(1995-8#11)(1995-9#3)(1996-10#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#7)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#3)(1997-9#1)(2008-10#22)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#6)(2009-5#2)(2012-3#1)(2013-1#2)(2013-8#1)
reading frames (ORFs) in##2##4##(2008-10#2)
reading frames (ORFs)##36##3##(1991-9#1)(1994-12#2)(1995-12#1)(1995-6#2)(1995-9#3)(1996-3#5)(1996-6#4)(1997-3#6)(1997-6#1)(2008-10#10)(2008-7#1)
reading frames flanking##2##3##(1993-9#1)(1994-12#1)
reading frames##94##2##(1990-11#2)(1991-7#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#4)(1995-12#2)(1995-6#4)(1995-8#1)(1995-9#6)(1996-12#2)(1996-3#8)(1996-6#8)(1997-3#13)(1997-6#1)(1997-7#1)(1997-9#1)(2008-10#23)(2008-7#3)(2008-8#1)(2008-9#3)(2011-1#2)
reading in magneto-optical##2##3##(2007-12#2)
reading in##7##2##(1991-1#1)(2007-12#3)(2008-12#2)(2011-2#1)
reading instruction##2##2##(2008-12#1)(2013-1#1)
reading light##4##2##(2008-3#4)
reading of the##3##3##(1990-12#1)(2008-3#1)(2012-2#1)
reading of##10##2##(1990-12#1)(1992-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-7#2)(2012-2#1)(2012-3#1)
reading passages##2##2##(2008-12#1)(2012-12#1)
reading pattern is##2##3##(1996-2#1)(2008-3#1)
reading patterns##2##2##(2008-3#1)(2012-1#1)
reading performance##2##2##(2008-11#1)(2008-12#1)
reading problems##2##2##(2008-12#1)(2013-1#1)
reading sentences##2##2##(2008-9#1)(2013-8#1)
reading skills##7##2##(2008-12#5)(2011-2#2)
reading tests##2##2##(2008-11#1)(2012-2#1)
reading the##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)
reading times##2##2##(2007-12#1)(2013-1#1)
reading words##2##2##(2009-2#1)(2010-7#1)
reading##451##1##(1990-11#9)(1990-12#4)(1990-2#1)(1990-5#6)(1990-7#1)(1991-1#2)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#4)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#1)(1994-11#8)(1994-12#15)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-6#9)(1995-8#12)(1995-9#9)(1996-10#2)(1996-12#4)(1996-2#3)(1996-3#9)(1996-6#8)(1996-8#1)(1997-2#8)(1997-3#16)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#1)(1997-9#2)(2007-11#1)(2007-12#11)(2007-2#1)(2008-10#50)(2008-11#7)(2008-12#29)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#11)(2008-9#16)(2009-2#2)(2009-4#4)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#9)(2011-1#8)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#11)(2012-3#3)(2013-1#13)(2013-8#6)
readings and##5##2##(1994-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
readings at##3##2##(2008-10#3)
readings in##4##2##(1994-11#1)(2008-10#2)(2008-5#1)
readings of the same##2##4##(2008-10#1)(2012-2#1)
readings of the##4##3##(2008-10#3)(2012-2#1)
readings of##6##2##(2007-8#1)(2008-10#3)(2010-3#1)(2012-2#1)
readings on##2##2##(1995-1#2)
readings was##2##2##(1990-8#1)(2008-11#1)
readings##48##1##(1990-8#2)(1991-12#1)(1993-1#1)(1993-2#1)(1994-11#2)(1994-3#1)(1995-1#4)(1996-12#1)(1997-3#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-5#6)(2008-8#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
readings) when the BG rate of change is##2##8##(2009-9#2)
readings)##3##1##(2008-10#1)(2009-9#2)
readmission rates##5##2##(1996-1#2)(1997-2#1)(2008-11#1)(2013-1#1)
readmission##18##1##(1996-1#3)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2011-1#1)(2011-2#6)(2013-1#4)
readmissions during##2##2##(1990-12#1)(2011-2#1)
readmissions##11##1##(1990-12#1)(1997-2#1)(1997-5#2)(2011-2#4)(2013-1#2)(2013-8#1)
readmitted##5##1##(2008-7#1)(2011-2#3)(2012-12#1)
readout beam##5##2##(2008-2#2)(2008-3#3)
readout beams##2##2##(2008-2#1)(2008-3#1)
readout for optical storage with phase jump##2##7##(2008-3#2)
readout for##3##2##(2008-3#2)(2008-8#1)
readout is##3##2##(2008-3#3)
readout mechanism for match##2##4##(2013-8#2)
readout of a##2##3##(2008-3#2)
readout of the##2##3##(2008-1#1)(2008-3#1)
readout of##5##2##(2008-1#1)(2008-10#1)(2008-3#3)
readout optical modulator##5##3##(2008-2#5)
readout scheme##2##2##(2008-3#2)
readout signal and##2##3##(2008-3#2)
readout signal is##2##3##(2008-3#2)
readout signal##7##2##(2008-2#1)(2008-3#6)
readout system for##3##3##(2007-12#3)
readout system##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
readout technique##2##2##(2007-11#1)(2008-2#1)
readout with##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
readout##88##1##(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#25)(2008-3#45)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
readouts##3##1##(2008-3#1)(2008-9#1)(2013-1#1)
reads the##2##2##(2008-3#1)(2012-2#1)
reads##11##1##(1995-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
reads)##2##1##(2011-2#1)(2012-2#1)
readthrough##3##1##(2008-10#3)
ready for a##2##3##(1992-2#1)(2013-8#1)
ready for prime time?##3##4##(2009-4#1)(2010-5#1)(2013-8#1)
ready for##20##2##(1991-9#1)(1992-2#1)(1994-12#1)(1994-3#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-4#2)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
ready to be used in a new assay##2##8##(2008-10#2)
ready to be##3##3##(2008-10#2)(2009-10#1)
ready to eat##2##3##(2010-4#1)(2010-7#1)
ready to##13##2##(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-7#2)(2010-8#1)
ready##49##1##(1991-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
ready-to-eat foods in##2##3##(2008-1#2)
ready-to-eat##8##1##(1997-4#2)(2008-1#2)(2011-2#4)
ready?##3##1##(1995-12#2)(2010-12#1)
reaffirms##2##1##(1994-3#1)(2011-2#1)
reagent 1##5##2##(2008-10#5)
reagent RBCs##2##2##(1994-6#2)
reagent addition##4##2##(2008-10#4)
reagent amounts and##2##3##(2008-10#2)
reagent amounts##5##2##(2008-10#5)
reagent and ammonium tetraphenylborate##2##4##(2008-10#2)
reagent and organic solvent##2##4##(2008-10#2)
reagent and sample##3##3##(2008-10#3)
reagent and the##3##3##(2008-10#3)
reagent and their##2##3##(2008-10#2)
reagent and##37##2##(2008-10#35)(2008-4#1)(2008-7#1)
reagent because##2##2##(2008-10#2)
reagent blank##8##2##(2008-10#8)
reagent blanks of microwave digestion system##2##6##(2008-10#2)
reagent carrier##2##2##(2008-10#2)
reagent channel##2##2##(2008-10#2)
reagent chemical##2##2##(2008-10#2)
reagent chemistry##2##2##(2008-10#2)
reagent composition##2##2##(2008-10#2)
reagent concentration and of various foreign ions##2##7##(2008-10#2)
reagent concentration gradient##2##3##(2008-10#2)
reagent concentration##14##2##(1990-7#1)(2008-10#13)
reagent concentrations##4##2##(2008-10#4)
reagent consumption and the##2##4##(2008-10#2)
reagent consumption and##3##3##(2008-10#3)
reagent consumption of##3##3##(2008-10#3)
reagent consumption##15##2##(2008-10#14)(2011-1#1)
reagent containing##3##2##(1993-9#1)(1995-8#1)(2008-10#1)
reagent cost##2##2##(2008-9#1)(2009-12#1)
reagent flow##2##2##(2008-10#2)
reagent for determination of##3##4##(2008-10#3)
reagent for selective##2##3##(2008-10#2)
reagent for spectrophotometric determination of boron##2##6##(2008-10#2)
reagent for spectrophotometric determination of##3##5##(2008-10#3)
reagent for the spectrophotometric determination of cobalt##2##7##(2008-10#2)
reagent for the spectrophotometric determination of##3##6##(2008-10#3)
reagent for the##10##3##(2008-10#9)(2009-12#1)
reagent for##40##2##(1990-8#1)(2008-10#36)(2008-8#1)(2008-9#1)(2009-12#1)
reagent gas##2##2##(2008-10#2)
reagent gives##3##2##(2008-10#2)(2008-8#1)
reagent has been##2##3##(2008-10#1)(2008-4#1)
reagent has##3##2##(2008-10#2)(2008-4#1)
reagent in a##3##3##(2008-10#3)
reagent in alkaline medium##3##4##(2008-10#3)
reagent in the##8##3##(2008-10#7)(2008-5#1)
reagent in xylene from 0##2##5##(2008-10#2)
reagent in xylene from##3##4##(2008-10#3)
reagent in##27##2##(1990-8#1)(2008-10#25)(2008-5#1)
reagent is##6##2##(1990-2#1)(1990-8#1)(2008-10#2)(2008-4#1)(2012-2#1)
reagent mixture##2##2##(2008-10#2)
reagent of##3##2##(2008-10#2)(2008-8#1)
reagent on the##5##3##(2008-10#4)(2008-11#1)
reagent or##2##2##(2008-10#2)
reagent reacts with##3##3##(2008-10#3)
reagent reacts##4##2##(2008-10#4)
reagent regeneration##2##2##(2008-10#2)
reagent solution##10##2##(2008-10#10)
reagent solutions##4##2##(2008-10#4)
reagent stream containing##2##3##(2008-10#2)
reagent stream##7##2##(2008-10#7)
reagent strip##3##2##(1996-12#3)
reagent strips##3##2##(1996-12#2)(2008-10#1)
reagent that##2##2##(2007-11#1)(2008-10#1)
reagent to form##2##3##(2008-10#2)
reagent to##8##2##(2008-10#7)(2008-4#1)
reagent used in##2##3##(2008-4#2)
reagent used##6##2##(2008-10#4)(2008-4#2)
reagent volumes##4##2##(2008-10#4)
reagent was replaced by 1##2##5##(2008-10#2)
reagent was##14##2##(1992-3#1)(1993-11#1)(2008-10#9)(2010-3#1)(2012-2#2)
reagent with##3##2##(1990-8#1)(1994-6#1)(2008-10#1)
reagent zones##3##2##(2008-10#3)
reagent##516##1##(1990-12#3)(1990-2#3)(1990-7#3)(1990-8#10)(1991-5#1)(1992-3#2)(1992-6#1)(1993-11#7)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#4)(1994-8#1)(1995-6#2)(1995-8#2)(1996-12#5)(1996-5#2)(1997-7#1)(2007-10#1)(2007-11#4)(2008-10#413)(2008-11#4)(2008-4#13)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-12#3)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#7)(2013-8#1)
reagent)##3##1##(2008-10#2)(2012-3#1)
reagent-injection FI method##3##3##(2008-10#3)
reagent-injection flow injection photometric method##2##5##(2008-10#2)
reagent-injection flow injection technique##2##4##(2008-10#2)
reagent-injection flow injection##5##3##(2008-10#5)
reagent-injection##8##1##(2008-10#8)
reagentless pH sensors##2##3##(2008-10#2)
reagentless##12##1##(2008-10#10)(2008-3#1)(2008-7#1)
reagents and sample##3##3##(2008-10#3)
reagents and their##2##3##(2008-4#1)(2013-8#1)
reagents and##29##2##(1992-12#1)(1997-4#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-3#1)(2013-8#1)
reagents are frequently##2##3##(2008-10#1)(2008-9#1)
reagents are used##2##3##(1990-2#1)(2008-10#1)
reagents are##13##2##(1990-2#1)(1993-12#1)(2008-10#8)(2008-4#2)(2008-9#1)
reagents for the##5##3##(1992-2#1)(2008-10#4)
reagents for use in immunoassays##2##5##(2008-10#2)
reagents for##19##2##(1990-8#1)(1992-2#1)(2008-10#12)(2008-11#1)(2008-4#3)(2012-2#1)
reagents has been##2##3##(2008-10#2)
reagents have been##4##3##(1993-11#1)(1993-9#1)(2008-4#1)(2008-9#1)
reagents in the##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
reagents in##10##2##(1994-3#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-7#1)
reagents into##2##2##(2008-10#1)(2008-4#1)
reagents is##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
reagents like##2##2##(2008-10#1)(2010-11#1)
reagents of##6##2##(2008-10#4)(2008-4#1)(2008-9#1)
reagents or##4##2##(1996-5#1)(2008-10#3)
reagents such as##3##3##(1990-2#1)(2008-11#1)(2009-12#1)
reagents that##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
reagents to##8##2##(2008-10#4)(2008-4#1)(2008-9#1)(2009-10#2)
reagents used for##2##3##(1996-6#1)(2008-9#1)
reagents used in the##2##4##(1992-3#1)(2008-10#1)
reagents used in##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
reagents used##7##2##(1992-3#1)(1996-6#1)(2008-10#2)(2008-4#2)(2008-9#1)
reagents was also##2##3##(2008-10#2)
reagents was##7##2##(2008-10#7)
reagents were##9##2##(1993-6#1)(1995-2#1)(2008-10#7)
reagents with##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
reagents##289##1##(1990-12#2)(1990-2#3)(1990-5#1)(1990-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-4#1)(2007-7#1)(2008-1#3)(2008-10#164)(2008-11#12)(2008-2#2)(2008-4#29)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#17)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
reaggregation##2##1##(1993-3#1)(2008-7#1)
real and artificial##2##3##(1996-2#1)(2008-10#1)
real and imaginary parts of the##2##6##(2008-2#2)
real and imaginary##3##3##(2008-2#3)
real and perceived##2##3##(1996-3#1)(1997-7#1)
real and the imaginary parts of the complex refractive##2##9##(2007-11#1)(2008-2#1)
real and the imaginary parts of the##10##7##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
real and the imaginary parts of##11##6##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#4)
real and the imaginary##13##4##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#5)
real and the##14##3##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#6)
real and##28##2##(1991-3#1)(1992-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#7)(2008-8#1)(2009-9#1)(2012-2#1)
real applications##2##2##(2008-10#1)(2008-7#1)
real atmospheric##2##2##(2008-2#1)(2008-3#1)
real benefit##3##2##(1996-1#1)(1997-1#1)(2008-10#1)
real biological##3##2##(1996-5#1)(2008-8#1)(2012-3#1)
real communities##2##2##(2008-9#2)
real complex##2##2##(1994-9#1)(2013-8#1)
real conditions##3##2##(2008-10#2)(2008-3#1)
real contaminated##2##2##(2008-10#2)
real crystals##2##2##(2008-3#2)
real danger of##3##3##(1994-2#1)(1995-12#1)(1996-11#1)
real data are##2##3##(2008-5#1)(2011-2#1)
real data examples##2##3##(2010-1#1)(2013-1#1)
real data sets##2##3##(2008-6#1)(2009-9#1)
real data##20##2##(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
real difference##2##2##(1996-2#1)(2008-11#1)
real environmental##2##2##(2008-10#1)(2009-11#1)
real example##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
real habitat patch##2##3##(2008-8#2)
real hope##2##2##(2007-12#1)(2008-7#1)
real human##2##2##(2007-12#1)(2008-10#1)
real image of##2##3##(2008-2#1)(2008-3#1)
real image##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
real increase in##2##3##(1990-6#1)(1992-12#1)
real life##8##2##(1997-4#1)(2008-10#1)(2008-11#3)(2010-3#1)(2010-4#1)(2012-3#1)
real need for##2##3##(1991-2#1)(2010-11#1)
real need##4##2##(1991-2#1)(1993-12#1)(2008-11#1)(2010-11#1)
real objects##2##2##(2012-2#2)
real one##2##2##(2008-10#1)(2008-2#1)
real optical##2##2##(2008-2#1)(2008-3#1)
real or##5##2##(1997-7#1)(2008-2#2)(2008-3#1)(2012-3#1)
real part of the complex refractive index was##2##8##(2008-3#2)
real part of the complex refractive index##4##7##(2008-3#4)
real part of the refractive index##5##6##(2008-2#1)(2008-3#4)
real part of the##13##4##(2008-2#1)(2008-3#12)
real part of##14##3##(2007-11#1)(2008-2#1)(2008-3#12)
real part##17##2##(2007-11#2)(2008-2#1)(2008-3#14)
real possibility##2##2##(1993-9#1)(2011-2#1)
real problem##3##2##(1994-1#1)(2009-4#1)(2011-2#1)
real rTMS##2##2##(2013-1#2)
real refractive index##2##3##(2008-3#1)(2011-1#1)
real sample analysis##8##3##(2008-10#8)
real sample##21##2##(2008-10#21)
real samples (pharmaceutical preparations)##2##4##(2008-10#2)
real samples analysis##2##3##(2008-10#2)
real samples and##5##3##(2008-10#5)
real samples are##2##3##(2008-10#2)
real samples by##4##3##(2008-10#4)
real samples from##5##3##(2008-10#5)
real samples of water##2##4##(2008-10#2)
real samples of##6##3##(2008-10#5)(2008-3#1)
real samples such as##6##4##(2008-10#6)
real samples to##2##3##(2008-10#1)(2008-5#1)
real samples was##3##3##(2008-10#3)
real samples were also##2##4##(2008-10#2)
real samples were##5##3##(2008-10#5)
real samples with##4##3##(2008-10#4)
real samples##117##2##(1997-2#1)(2008-10#112)(2008-3#1)(2008-5#2)(2010-11#1)
real sediment##2##2##(2008-10#2)
real soil samples##2##3##(2008-10#2)
real soil##3##2##(2008-10#3)
real solution##5##2##(1994-1#1)(2008-10#3)(2011-2#1)
real space##5##2##(2007-11#1)(2008-8#1)(2008-9#1)(2012-1#2)
real spectra##3##2##(2008-10#2)(2008-3#1)
real time and with##2##4##(2008-3#2)
real time and##6##3##(2008-1#1)(2008-10#2)(2008-3#2)(2011-1#1)
real time determination##2##3##(2008-10#2)
real time in##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
real time quantitative PCR##2##4##(2008-10#1)(2008-11#1)
real time##93##2##(1995-12#1)(1995-2#2)(1997-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#9)(2008-3#25)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
real urine samples were##2##4##(2008-10#2)
real urine samples##3##3##(2008-10#3)
real urine##4##2##(2008-10#4)
real value##2##2##(1991-12#1)(2008-3#1)
real water samples and##2##4##(2008-10#1)(2012-1#1)
real water samples##12##3##(2008-10#11)(2012-1#1)
real water##15##2##(2008-10#13)(2010-4#1)(2012-1#1)
real words##2##2##(1996-2#1)(2010-7#1)
real world samples##3##3##(2008-10#3)
real world##29##2##(1993-2#1)(1994-1#4)(1994-12#2)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#3)(2013-8#2)
real world&quot##6##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)
real##636##1##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#10)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#5)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2006-12#1)(2007-11#11)(2007-12#15)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#244)(2008-11#15)(2008-12#4)(2008-2#36)(2008-3#85)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#16)(2008-8#12)(2008-9#6)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#4)(2010-1#1)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#3)(2010-7#2)(2010-8#3)(2011-1#6)(2011-2#7)(2012-1#5)(2012-12#3)(2012-2#13)(2012-3#6)(2013-1#13)(2013-8#10)
real-life situations##2##2##(2012-3#1)(2013-1#1)
real-life##13##1##(1991-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
real-plane##2##1##(2008-2#2)
real-space##2##1##(2007-11#1)(2012-2#1)
real-time PCR and the##2##4##(2012-2#1)(2012-3#1)
real-time PCR and##4##3##(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
real-time PCR assay##7##3##(2008-10#4)(2010-4#2)(2011-2#1)
real-time PCR assays##7##3##(2008-10#6)(2008-9#1)
real-time PCR method##2##3##(2010-6#1)(2013-8#1)
real-time PCR technique##2##3##(2008-10#2)
real-time PCR to##4##3##(2008-2#1)(2008-4#1)(2010-7#1)(2012-3#1)
real-time PCR##61##2##(2008-10#25)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#8)(2013-1#3)(2013-8#1)
real-time RT-PCR##5##2##(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
real-time and##2##2##(2008-10#2)
real-time applications##2##2##(2008-2#1)(2008-3#1)
real-time characterization##2##2##(2007-12#1)(2009-7#1)
real-time clinical##2##2##(2008-7#1)(2010-8#1)
real-time data acquisition##2##3##(2008-4#1)(2009-6#1)
real-time data##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)
real-time detection of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
real-time detection##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
real-time determination of tissue optical properties##2##6##(2008-3#2)
real-time display##3##2##(2007-11#2)(2008-3#1)
real-time fluorescent##2##2##(2008-10#2)
real-time gray-scale##2##2##(2007-11#2)
real-time hologram##2##2##(2008-3#2)
real-time holographic##4##2##(2008-2#2)(2008-3#2)
real-time image processing##2##3##(2008-2#1)(2008-3#1)
real-time image##5##2##(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#1)
real-time imaging of##2##3##(2008-8#1)(2011-7#1)
real-time imaging##4##2##(2008-8#1)(2009-7#1)(2011-1#1)(2011-7#1)
real-time measurement of##2##3##(2008-10#1)(2008-2#1)
real-time monitoring of##11##3##(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2010-5#2)(2013-1#1)(2013-8#1)
real-time monitoring##14##2##(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#1)(2010-5#2)(2013-1#1)(2013-8#2)
real-time operation##5##2##(2007-12#1)(2008-3#1)(2013-1#3)
real-time optical spectrum##2##3##(2008-3#2)
real-time phase-difference amplification##2##3##(2008-3#2)
real-time polarization measurement##2##3##(2007-11#1)(2007-12#1)
real-time polymerase chain reaction (PCR) assay was developed to##2##9##(2008-10#2)
real-time polymerase chain reaction (PCR) assay was developed##3##8##(2008-10#3)
real-time polymerase chain reaction (PCR) assay##5##6##(2008-10#5)
real-time polymerase chain reaction (PCR)##13##5##(2008-10#11)(2012-12#1)(2012-3#1)
real-time polymerase chain reaction (qPCR)##2##5##(2009-6#1)(2012-3#1)
real-time polymerase chain reaction assays##2##5##(2008-10#2)
real-time polymerase chain reaction for##2##5##(2008-10#1)(2012-3#1)
real-time polymerase chain reaction##34##4##(2008-10#21)(2009-6#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)
real-time polymerase chain##36##3##(2008-10#22)(2008-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)
real-time processing##2##2##(2007-12#1)(2009-6#1)
real-time quantitative PCR##3##3##(2008-10#2)(2008-4#1)
real-time quantitative RT-PCR##2##3##(2008-11#1)(2008-5#1)
real-time quantitative polymerase chain reaction (PCR)##3##6##(2008-10#3)
real-time quantitative polymerase chain reaction##6##5##(2008-10#6)
real-time quantitative reverse##2##3##(2008-10#1)(2008-9#1)
real-time quantitative##14##2##(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)
real-time reverse transcription PCR##2##4##(2010-5#1)(2011-2#1)
real-time reverse transcription##3##3##(2010-5#1)(2011-2#1)(2012-2#1)
real-time reverse transcription-polymerase chain reaction (RT-PCR)##2##6##(2008-10#2)
real-time reverse transcription-polymerase chain reaction##5##5##(2008-10#4)(2013-1#1)
real-time reverse##9##2##(2008-10#4)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
real-time reverse-transcription polymerase chain reaction##2##5##(2008-10#1)(2011-1#1)
real-time sampling and display in##2##5##(2012-3#2)
real-time sampling##3##2##(1992-3#1)(2012-3#2)
real-time three-dimensional##3##2##(2007-11#1)(2007-8#1)(2008-3#1)
real-time ultrasound##3##2##(1991-6#1)(2008-1#1)(2012-2#1)
real-time ultrasound-guided##2##2##(2008-1#2)
real-time video##2##2##(2008-3#1)(2011-1#1)
real-time##366##1##(1991-2#1)(1991-6#1)(1992-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-8#1)(2007-11#22)(2007-12#20)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#93)(2008-11#8)(2008-12#2)(2008-2#16)(2008-3#44)(2008-4#5)(2008-5#2)(2008-6#9)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#1)(2010-11#2)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#11)(2011-2#11)(2011-7#2)(2012-1#3)(2012-12#1)(2012-2#14)(2012-3#17)(2013-1#10)(2013-8#8)
real-time&quot##2##1##(2008-10#1)(2008-4#1)
real-valued##2##1##(2008-3#2)
real-world applications##4##2##(2007-11#2)(2008-3#1)(2010-7#1)
real-world practice##2##2##(2011-2#1)(2013-1#1)
real-world samples##4##2##(2008-10#2)(2010-5#2)
real-world##23##1##(1994-3#1)(1995-11#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-3#4)(2009-8#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
realign##3##1##(1995-3#1)(2007-12#1)(2009-8#1)
realigned##3##1##(1993-3#1)(2008-3#1)(2009-3#1)
realignment is##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
realignment of pelvic fracture urethral injuries##2##6##(2013-8#2)
realignment of##4##2##(1991-3#1)(1995-3#1)(2013-8#2)
realignment##10##1##(1991-3#2)(1993-3#1)(1995-3#1)(1995-5#1)(2008-3#1)(2008-6#1)(2013-8#3)
realise the##4##2##(1997-8#1)(2008-11#2)(2008-12#1)
realise##7##1##(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-3#1)
realised by##2##2##(2008-1#1)(2008-2#1)
realised in##5##2##(2007-6#3)(2008-11#1)(2008-5#1)
realised##17##1##(1991-3#1)(1996-11#1)(1996-12#1)(2007-6#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-1#1)(2011-2#1)
realism and##4##2##(2008-8#1)(2011-2#3)
realism of sexually threatening role plays##2##6##(2009-11#2)
realism of##5##2##(2009-11#4)(2012-2#1)
realism##13##1##(1991-5#1)(2008-8#1)(2009-11#5)(2011-2#5)(2012-2#1)
realistic and##6##2##(1995-1#1)(1996-2#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)
realistic application##2##2##(2008-5#2)
realistic conditions##3##2##(2008-2#1)(2008-3#2)
realistic experimental##2##2##(2008-3#2)
realistic geometries##2##2##(2008-3#1)(2013-8#1)
realistic in##2##2##(1991-12#1)(2009-7#1)
realistic model##2##2##(2009-8#1)(2013-1#1)
realistic objective##2##2##(2008-7#2)
realistic scenarios##2##2##(2008-7#1)(2012-2#1)
realistic simulation of##2##3##(2008-11#1)(2008-3#1)
realistic simulation##4##2##(2008-11#1)(2008-3#1)(2010-12#1)(2010-6#1)
realistic##124##1##(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-9#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-4#2)(1997-2#1)(1997-3#2)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#27)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
realistically##8##1##(1995-6#1)(1996-2#1)(1997-6#1)(2008-3#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
realities and##3##2##(1995-2#1)(1995-3#1)(2008-11#1)
realities of##8##2##(1995-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2010-4#1)(2013-1#1)(2013-8#1)
realities##26##1##(1990-6#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#2)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
reality and##4##2##(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)
reality for the##2##3##(1995-2#1)(2011-2#1)
reality for##3##2##(1994-12#1)(1995-2#1)(2011-2#1)
reality in the##2##3##(2009-10#1)(2013-8#1)
reality in##6##2##(1991-3#1)(2008-10#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
reality is that##2##3##(2008-11#1)(2010-8#1)
reality is##3##2##(1994-2#1)(2008-11#1)(2010-8#1)
reality of the##3##3##(1997-2#1)(2008-11#2)
reality of##14##2##(1994-12#2)(1997-2#1)(2007-11#1)(2008-11#3)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
reality to##3##2##(1993-3#1)(2010-1#1)(2010-8#1)
reality with##2##2##(1991-3#1)(2008-10#1)
reality##111##1##(1990-6#1)(1991-3#2)(1991-8#1)(1992-12#2)(1993-3#3)(1994-1#3)(1994-12#5)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#3)(1997-2#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#11)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-10#3)(2009-11#2)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#4)(2011-2#5)(2011-7#2)(2012-12#2)(2012-3#4)(2013-1#6)(2013-8#2)
reality&quot##2##1##(1993-5#1)(2007-2#1)
reality?##5##1##(1991-1#1)(1991-8#1)(1994-1#1)(2008-11#2)
realizable##5##1##(1990-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2013-8#1)
realization of a##12##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)(2008-7#1)(2011-2#1)
realization of an##2##3##(2011-1#1)(2013-1#1)
realization of the##12##3##(1992-3#1)(1992-5#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2012-1#1)(2012-2#1)
realization of these##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
realization of this##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
realization of##52##2##(1992-3#1)(1992-5#1)(1995-1#1)(1996-5#2)(2007-11#6)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#12)(2008-7#3)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
realization that##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
realization##64##1##(1992-3#1)(1992-5#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-5#2)(2007-11#6)(2007-12#4)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#13)(2008-7#3)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#5)
realizations of##3##2##(2008-3#2)(2009-9#1)
realizations##5##1##(2008-3#4)(2009-9#1)
realize a##6##2##(2008-3#3)(2008-5#1)(2010-5#1)(2013-8#1)
realize an##2##2##(2007-11#1)(2008-2#1)
realize that##11##2##(1991-2#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
realize the##15##2##(1994-3#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-8#1)
realize their##4##2##(2008-10#1)(2010-12#2)(2012-12#1)
realize##61##1##(1991-2#1)(1992-1#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-3#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
realized a##4##2##(1995-1#1)(2007-11#1)(2007-12#1)(2008-3#1)
realized after##2##2##(2008-10#1)(2010-2#1)
realized and##2##2##(2008-8#1)(2010-3#1)
realized as a##2##3##(2007-11#1)(2008-3#1)
realized as##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)
realized at##2##2##(2008-3#1)(2010-5#1)
realized based on##2##3##(2008-2#1)(2012-3#1)
realized by a##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
realized by means of##2##4##(2008-2#1)(2008-3#1)
realized by the##2##3##(2007-10#1)(2008-10#1)
realized by use of##7##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
realized by##31##2##(2007-10#1)(2007-11#6)(2007-12#6)(2008-10#4)(2008-2#4)(2008-3#3)(2009-10#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
realized for##2##2##(1994-12#1)(2008-2#1)
realized in the##3##3##(2008-3#1)(2009-9#1)(2011-2#1)
realized in##9##2##(1997-6#1)(2007-11#1)(2008-2#1)(2008-3#3)(2009-9#1)(2011-2#1)(2012-3#1)
realized on##2##2##(2008-10#1)(2008-3#1)
realized that##6##2##(1997-1#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
realized through##2##2##(1994-2#1)(2008-5#1)
realized under##2##2##(2007-11#1)(2007-8#1)
realized when##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
realized with a##3##3##(2007-12#1)(2008-3#2)
realized with##8##2##(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2013-1#1)
realized without##2##2##(2008-3#2)
realized##136##1##(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#14)(2007-12#16)(2007-8#2)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#13)(2008-3#21)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
realizes the##2##2##(2008-3#1)(2008-4#1)
realizes##6##1##(1997-1#1)(2008-3#3)(2008-4#1)(2008-7#1)
realizing the##4##2##(1991-3#1)(1996-3#1)(2008-10#2)
realizing##14##1##(1991-3#1)(1994-1#2)(1995-1#1)(1996-3#1)(2007-12#2)(2008-10#2)(2008-3#5)
reallocation of resources##2##3##(1994-2#1)(2010-7#1)
reallocation of##4##2##(1994-2#1)(2010-10#1)(2010-7#1)(2011-2#1)
reallocation##8##1##(1994-2#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#2)
really a##6##2##(1994-1#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
really high##2##2##(2008-10#1)(2011-2#1)
really know##2##2##(1991-12#1)(1992-3#1)
really matter##2##2##(1995-12#1)(2008-7#1)
really superior to##2##3##(1994-3#1)(2011-1#1)
really tell##2##2##(1997-4#1)(2008-8#1)
really the##2##2##(1995-1#1)(2008-10#1)
really##74##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#4)(1995-1#3)(1995-12#1)(1995-3#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-4#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
realm##16##1##(1990-6#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2013-7#1)
realms##2##1##(2008-11#1)(2010-9#1)
reamplification of##2##2##(1997-4#1)(2008-1#1)
reanalysed in##2##2##(2008-10#1)(2008-5#1)
reanalysed##3##1##(2008-10#2)(2008-5#1)
reanalysis of the data##2##4##(2008-2#1)(2008-9#1)
reanalysis of the##3##3##(1991-2#1)(2008-2#1)(2008-9#1)
reanalysis of##4##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
reanalysis##7##1##(1991-2#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-9#1)
reanalyze##3##1##(1996-12#1)(2008-3#1)(2013-1#1)
reanalyzed the data##2##3##(1992-11#1)(2008-8#1)
reanastomosis of##2##2##(1996-2#1)(2008-10#1)
reanastomosis##5##1##(1995-1#1)(1996-2#3)(2008-10#1)
reanimation##4##1##(2007-10#1)(2008-10#1)(2010-4#1)(2013-1#1)
reap the benefits of##2##4##(1991-2#1)(1996-1#1)
reap the##3##2##(1991-2#1)(1996-1#1)(2008-10#1)
reap##7##1##(1991-2#1)(1994-1#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
reappearance of##2##2##(1994-12#1)(2008-8#1)
reappearance##3##1##(1994-12#2)(2008-8#1)
reappeared##3##1##(2008-11#1)(2012-12#1)(2012-3#1)
reappears##2##1##(1994-12#1)(2007-12#1)
reappointment##2##1##(1994-12#1)(1994-3#1)
reappraisal of the##3##3##(1991-12#1)(2008-3#1)(2013-8#1)
reappraisal of##7##2##(1991-12#1)(1995-3#1)(2006-10#1)(2008-3#2)(2008-6#1)(2013-8#1)
reappraisal##11##1##(1990-5#1)(1991-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(2006-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2013-8#1)
rear mirror##3##2##(2008-10#1)(2008-3#2)
rear##15##1##(1991-2#1)(1996-12#1)(1996-8#1)(2007-12#3)(2008-10#3)(2008-3#5)(2013-1#1)
reared as##2##2##(2007-7#1)(2008-1#1)
reared by##2##2##(2008-8#1)(2008-9#1)
reared controls##2##2##(1992-11#1)(1996-5#1)
reared from##3##2##(2008-6#1)(2010-4#1)(2010-8#1)
reared in##8##2##(1992-11#2)(2008-12#4)(2008-8#1)(2010-4#1)
reared on##7##2##(2008-10#1)(2008-6#4)(2008-9#1)(2013-1#1)
reared##40##1##(1992-11#3)(1996-5#5)(1997-7#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-12#4)(2008-6#5)(2008-8#2)(2008-9#3)(2009-9#1)(2010-4#3)(2010-8#1)(2013-1#1)(2013-8#1)
rearing and##2##2##(1990-3#1)(1997-2#1)
rearing conditions##4##2##(1991-2#3)(2013-7#1)
rearing##26##1##(1990-3#2)(1991-2#3)(1992-11#1)(1995-12#2)(1997-2#2)(2007-12#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-4#3)(2012-2#1)(2013-7#1)
rearrange##2##1##(2007-11#1)(2008-3#1)
rearrangeable##2##1##(2008-2#1)(2008-3#1)
rearranged into##3##2##(1996-6#2)(2008-5#1)
rearranged##16##1##(1990-6#1)(1992-3#1)(1996-5#1)(1996-6#2)(1997-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
rearrangement and##2##2##(1993-6#1)(1996-2#1)
rearrangement in##4##2##(1993-8#1)(1993-9#1)(1994-7#1)(2008-6#1)
rearrangement occurs##2##2##(1995-8#1)(1996-5#1)
rearrangement of prenyl phenyl##2##4##(2009-11#2)
rearrangement of the##4##3##(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#1)
rearrangement of##21##2##(1993-11#1)(1994-6#1)(1995-6#2)(1996-5#5)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-11#3)(2009-12#1)(2010-10#1)
rearrangement product##3##2##(1995-3#2)(1996-5#1)
rearrangement reaction##2##2##(1993-11#1)(1996-5#1)
rearrangement to##5##2##(1993-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(2012-12#1)
rearrangement##76##1##(1990-6#1)(1990-7#1)(1990-8#1)(1993-11#3)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-2#3)(1996-5#12)(1996-6#1)(1997-3#1)(1997-9#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-8#4)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
rearrangements and##2##2##(2008-7#1)(2010-3#1)
rearrangements are##2##2##(2008-7#1)(2012-3#1)
rearrangements in the##2##3##(2010-3#2)
rearrangements in these##2##3##(1994-9#1)(2008-9#1)
rearrangements in##5##2##(1994-9#1)(2008-7#1)(2008-9#1)(2010-3#2)
rearrangements of##4##2##(1994-3#1)(1994-8#1)(1995-5#1)(2008-2#1)
rearrangements were##3##2##(1993-6#1)(1993-9#1)(1997-9#1)
rearrangements##52##1##(1992-11#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-7#1)(1997-9#3)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-3#5)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#6)
rearranges the##2##2##(1992-5#1)(2008-2#1)
rearranges##5##1##(1990-7#1)(1992-5#1)(1996-5#2)(2008-2#1)
rears##2##1##(1994-12#1)(2011-2#1)
reason for a##2##3##(1991-12#1)(2012-3#1)
reason for admission##2##3##(1995-5#1)(2013-1#1)
reason for disability##2##3##(1995-12#1)(1997-6#1)
reason for encounter in general practice##2##6##(2012-3#2)
reason for its##2##3##(2008-10#1)(2008-5#1)
reason for revision##2##3##(2008-8#1)(2013-1#1)
reason for the low##2##4##(1991-9#1)(1997-7#1)
reason for the##23##3##(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
reason for this improvement##2##4##(2008-10#1)(2008-2#1)
reason for this is that the##2##6##(2008-2#1)(2010-12#1)
reason for this is that##3##5##(2008-2#1)(2009-8#1)(2010-12#1)
reason for this is the##3##5##(2007-11#1)(2008-3#1)(2009-7#1)
reason for this is##6##4##(2007-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-12#1)
reason for this##17##3##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
reason for##86##2##(1991-12#1)(1991-9#2)(1992-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#1)
reason is that the##2##4##(2008-9#1)(2013-1#1)
reason is that##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
reason is the##3##3##(1993-8#1)(2010-7#1)(2012-2#1)
reason is##7##2##(1993-8#1)(2006-10#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
reason of##7##2##(2007-11#2)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-8#1)
reason that##8##2##(1991-5#1)(1992-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
reason the##2##2##(1992-1#1)(2008-1#1)
reason to believe that##3##4##(1993-12#1)(1994-6#1)(2012-2#1)
reason to consider##2##3##(2008-12#1)(2012-3#1)
reason to##14##2##(1990-8#1)(1991-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
reason was##3##2##(1990-6#1)(2008-10#1)(2010-8#1)
reason why the##2##3##(2008-10#1)(2012-2#1)
reason why##7##2##(2008-10#2)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
reason##205##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(2006-10#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-6#2)(2007-7#1)(2008-1#5)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#5)(2009-1#2)(2009-11#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#5)
reasonable accommodation##3##2##(1995-6#2)(1996-2#1)
reasonable agreement with the##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)
reasonable agreement with##7##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)
reasonable agreement##11##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)
reasonable and##4##2##(2008-10#4)
reasonable assumption that##2##3##(2008-3#1)(2008-7#1)
reasonable cost##7##2##(1991-1#1)(1992-1#1)(1996-3#1)(2008-10#3)(2008-6#1)
reasonable explanation##2##2##(1993-3#1)(1993-8#1)
reasonable in##2##2##(2011-2#1)(2013-1#1)
reasonable quality##2##2##(1997-6#1)(2008-3#1)
reasonable selectivity##2##2##(2008-10#2)
reasonable separation##2##2##(2008-10#2)
reasonable to assume##3##3##(1991-6#2)(1997-7#1)
reasonable to##20##2##(1990-6#1)(1990-9#1)(1991-6#2)(1993-11#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
reasonable##136##1##(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#18)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
reasonableness##5##1##(1992-2#2)(1993-12#1)(1995-9#1)(2008-7#1)
reasonably accurate##2##2##(1996-4#1)(2008-2#1)
reasonably good agreement with##2##4##(2007-11#1)(2008-10#1)
reasonably good##5##2##(2007-11#1)(2008-10#3)(2008-2#1)
reasonably high##2##2##(2008-10#1)(2008-9#1)
reasonably low##2##2##(2008-10#1)(2011-2#1)
reasonably well with the##4##4##(2007-11#1)(2008-10#2)(2008-2#1)
reasonably well##10##2##(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2011-2#1)
reasonably##56##1##(1990-8#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-3#1)(2011-1#1)(2011-2#3)
reasoned action##3##2##(2012-12#3)
reasoned##7##1##(1992-12#1)(1995-12#1)(2008-7#1)(2009-6#1)(2012-12#3)
reasoning and##4##2##(2008-11#1)(2008-12#1)(2009-8#1)(2012-12#1)
reasoning in the##2##3##(2008-12#1)(2010-11#1)
reasoning in##4##2##(2008-10#1)(2008-12#1)(2010-11#1)(2010-9#1)
reasoning of##3##2##(1990-3#1)(2008-11#1)(2010-9#1)
reasoning support##2##2##(2008-7#2)
reasoning was##2##2##(1990-3#1)(2012-2#1)
reasoning with##2##2##(2008-11#1)(2008-9#1)
reasoning##49##1##(1990-3#4)(1992-12#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#14)(2008-12#4)(2008-7#3)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-9#2)(2012-1#2)(2012-12#2)(2012-2#3)
reasons a##2##2##(1993-12#1)(2008-3#1)
reasons and##6##2##(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2009-5#1)
reasons are##10##2##(1990-3#1)(1992-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-8#1)(2013-8#2)
reasons behind##3##2##(1993-2#1)(2007-12#1)(2010-12#1)
reasons for a##2##3##(1993-6#1)(2010-9#1)
reasons for contacting##2##3##(1991-9#1)(1996-6#1)
reasons for drop-out##2##3##(1992-5#1)(2007-12#1)
reasons for failure of##2##4##(2008-7#1)(2012-12#1)
reasons for failure##4##3##(2008-7#1)(2012-12#1)(2013-1#2)
reasons for hospitalization##2##3##(1995-12#1)(2013-1#1)
reasons for lack of##2##4##(2007-12#1)(2012-2#1)
reasons for not##4##3##(1993-1#1)(2007-10#2)(2011-2#1)
reasons for selecting##2##3##(1992-11#1)(2012-1#1)
reasons for the failure of##2##5##(2008-8#1)(2012-2#1)
reasons for the rarity of##2##5##(2007-10#1)(2008-9#1)
reasons for the##25##3##(1992-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
reasons for these differences##2##4##(1993-11#1)(2008-1#1)
reasons for these##4##3##(1991-9#1)(1993-11#1)(2008-1#1)(2013-1#1)
reasons for this are discussed##2##5##(1991-4#1)(1994-8#1)
reasons for this##15##3##(1991-4#1)(1992-12#1)(1994-8#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)
reasons for unmet need##2##4##(2010-8#2)
reasons for use##2##3##(1995-3#1)(2008-11#1)
reasons for##128##2##(1990-12#1)(1990-3#1)(1991-4#1)(1991-6#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-5#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#3)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#2)
reasons of##10##2##(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
reasons that##7##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
reasons they##2##2##(2008-12#1)(2013-8#1)
reasons to##10##2##(1994-3#1)(1997-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-8#1)(2013-1#1)
reasons were##2##2##(1991-9#1)(2013-1#1)
reasons which##2##2##(2008-7#1)(2009-6#1)
reasons why academic people##2##4##(2009-11#2)
reasons why people##3##3##(2009-6#2)(2012-12#1)
reasons why the##6##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)
reasons why##23##2##(1991-2#1)(1991-9#1)(1993-12#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#2)(2009-6#3)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
reasons##329##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-6#4)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#4)(1997-5#1)(1997-7#1)(2006-7#1)(2007-10#6)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#24)(2008-11#13)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#10)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#14)(2012-1#2)(2012-12#7)(2012-2#10)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#11)
reassembled##4##1##(1997-4#1)(2008-2#1)(2008-8#1)(2012-2#1)
reassembly of##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
reassembly##7##1##(1993-8#1)(2008-8#4)(2008-9#1)(2011-2#1)
reassess their##2##2##(1991-3#1)(2008-3#1)
reassess##6##1##(1991-3#1)(1996-3#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
reassessed##7##1##(1995-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
reassessment of the##2##3##(2008-11#1)(2009-9#1)
reassessment of##6##2##(1991-2#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-9#1)
reassessment##15##1##(1991-2#1)(1994-9#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
reassignment##3##1##(1995-3#1)(2007-10#1)(2008-1#1)
reassortant strain##4##2##(2008-10#4)
reassortant##11##1##(2008-10#9)(2011-2#1)(2013-8#1)
reassortants among##2##2##(2008-10#1)(2012-12#1)
reassortants between the two##2##4##(2008-10#2)
reassortants of##2##2##(2008-10#1)(2012-12#1)
reassortants##11##1##(2008-10#4)(2012-12#7)
reassortment##9##1##(2007-12#1)(2008-10#4)(2011-2#1)(2012-12#2)(2013-8#1)
reassuring##3##1##(1990-6#1)(1995-2#1)(2007-11#1)
reattachment##2##1##(2010-2#1)(2011-1#1)
rebagliati##2##1##(2013-1#2)
rebalanced hemostasis##2##2##(2013-1#2)
rebalancing##2##1##(2011-2#1)(2013-1#1)
rebased##2##1##(1992-1#2)
rebasing##2##1##(1993-12#2)
rebinding to##2##2##(1994-11#1)(1994-5#1)
rebinding##5##1##(1994-11#1)(1994-5#1)(2008-10#3)
rebled##3##1##(1997-6#1)(2007-8#1)(2008-7#1)
rebleed##2##1##(1995-11#1)(2007-10#1)
rebleeding and##2##2##(2008-7#1)(2013-1#1)
rebleeding from##2##2##(2008-7#1)(2012-2#1)
rebleeding rate##3##2##(1995-5#1)(2008-7#2)
rebleeding##14##1##(1995-11#1)(1995-5#1)(1997-3#1)(2008-7#7)(2012-2#1)(2013-1#3)
rebound following##2##2##(1992-3#1)(2008-5#1)
rebound of##3##2##(2008-4#3)
rebound was##3##2##(1990-5#1)(1991-5#1)(2009-8#1)
rebound##22##1##(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1995-12#1)(1995-3#1)(1997-7#2)(1997-8#1)(2008-2#1)(2008-4#5)(2008-5#1)(2009-5#1)(2009-8#1)(2012-2#2)
reboxetine##2##1##(2008-4#1)(2011-2#1)
rebuild##5##1##(1992-2#1)(2007-11#2)(2007-8#1)(2009-11#1)
rebuilding of##2##2##(1992-11#1)(2007-11#1)
rebuilding##6##1##(1992-11#1)(1992-12#1)(2007-11#3)(2008-8#1)
rebuilt##2##1##(2008-11#1)(2010-8#1)
rec##3##1##(1990-11#3)
recA gene##4##2##(1993-9#2)(1995-8#2)
recA mutant##2##2##(1995-8#2)
recA##17##1##(1993-9#5)(1995-2#1)(1995-8#6)(1997-7#2)(2008-10#3)
recA-like gene##3##2##(1993-9#2)(1995-6#1)
recA-like genes##4##2##(1995-6#2)(1995-8#2)
recA-like proteins##2##2##(1995-6#1)(1995-8#1)
recA-like##9##1##(1993-9#2)(1995-6#4)(1995-8#3)
recalcitrant coronary artery spasm##2##4##(2008-7#2)
recalcitrant facial plane warts##2##4##(2013-1#2)
recalcitrant rural smokers##2##3##(2013-1#2)
recalcitrant##13##1##(1991-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#5)
recalculated##3##1##(1994-1#1)(2008-10#2)
recalibrated##3##1##(1993-1#1)(2008-12#1)(2013-8#1)
recalibration##6##1##(1992-12#1)(1992-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
recall and##6##2##(1991-2#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)
recall of##3##2##(1991-2#1)(2011-2#2)
recall processes##2##2##(1994-8#2)
recall the##2##2##(2008-1#1)(2008-10#1)
recall##43##1##(1991-10#1)(1991-11#1)(1991-2#2)(1994-12#1)(1994-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2010-1#2)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-3#2)(2013-1#2)
recalled##7##1##(1990-3#1)(1992-1#1)(1993-12#2)(1994-2#1)(2008-3#1)(2011-2#1)
recalling##3##1##(1996-11#1)(2008-10#1)(2008-11#1)
recalls##3##1##(1991-12#2)(2011-2#1)
recanalisation##2##1##(2011-2#2)
recanalization during##2##2##(2013-1#2)
recanalization of the MCA##2##4##(2007-10#2)
recanalization of the##6##3##(2007-10#3)(2008-7#1)(2009-9#2)
recanalization of##11##2##(1990-6#1)(1991-3#1)(1997-6#1)(2007-10#3)(2008-12#1)(2008-7#1)(2009-9#3)
recanalization or##2##2##(2007-8#1)(2008-12#1)
recanalization##27##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#2)(1993-9#1)(1997-6#1)(2007-10#4)(2007-8#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-9#3)(2013-1#6)(2013-8#1)
recanalized##3##1##(1997-8#1)(2007-10#1)(2008-7#1)
recapitulate the##3##2##(2009-3#1)(2012-1#1)(2012-2#1)
recapitulate##9##1##(2008-2#1)(2008-4#2)(2008-5#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
recapitulated in##3##2##(2010-3#1)(2011-2#1)(2012-3#1)
recapitulated##4##1##(1993-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
recapitulates the##4##2##(2008-11#2)(2008-4#1)(2009-3#1)
recapitulates##8##1##(2008-11#2)(2008-4#2)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)
recapture##4##1##(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)
recaptured##2##1##(1997-7#1)(2010-8#1)
recaptures##2##1##(2009-10#1)(2010-8#1)
receding##2##1##(2008-10#1)(2008-9#1)
receipt of a##5##3##(2012-12#4)(2013-1#1)
receipt of##12##2##(1990-11#1)(1995-12#1)(1996-1#1)(2008-11#1)(2008-4#1)(2012-12#4)(2013-1#3)
receipt##16##1##(1990-11#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2012-12#4)(2013-1#3)
receivable##5##1##(1993-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-9#1)
receivables##3##1##(1992-3#1)(1993-1#1)(1993-8#1)
receive 100 mg##2##3##(2008-5#1)(2011-2#1)
receive a##12##2##(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-3#1)
receive adequate##4##2##(1997-5#1)(1997-8#1)(2011-2#1)(2012-3#1)
receive an##3##2##(1990-3#1)(1995-6#1)(2013-1#1)
receive and##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
receive care##6##2##(1994-3#1)(1995-8#1)(1996-12#2)(2008-4#1)(2008-7#1)
receive either##8##2##(1990-9#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-7#1)(2013-1#1)
receive excitatory##2##2##(1996-2#1)(2013-8#1)
receive feedback##2##2##(2009-10#2)
receive greater##4##2##(1997-8#1)(2011-2#1)(2013-1#2)
receive help##3##2##(1992-2#1)(1992-4#1)(1996-3#1)
receive information from##2##3##(1995-8#1)(2007-8#1)
receive information##4##2##(1995-8#1)(1996-1#1)(2007-8#1)(2009-5#1)
receive injections of##2##3##(2011-2#1)(2012-2#1)
receive input from##2##3##(1991-5#1)(2007-12#1)
receive inputs##2##2##(1993-12#1)(2008-4#1)
receive less##2##2##(2009-11#1)(2012-2#1)
receive local##2##2##(1993-12#1)(2008-6#1)
receive one##2##2##(1992-8#1)(2009-2#1)
receive optimal##2##2##(2008-5#1)(2011-2#1)
receive postanesthesia##2##2##(1993-1#2)
receive preventive##2##2##(1994-2#2)
receive services##2##2##(1994-2#1)(2009-6#1)
receive the most##2##3##(1992-2#1)(2008-3#1)
receive the##14##2##(1990-2#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-6#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
receive their##2##2##(2008-11#1)(2009-2#1)
receive this##3##2##(1995-1#2)(2008-11#1)
receive treatment##3##2##(2008-7#2)(2013-1#1)
receive##244##1##(1990-2#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-5#2)(1994-6#3)(1994-9#2)(1995-1#5)(1995-12#3)(1995-2#4)(1995-6#3)(1995-8#3)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-6#1)(1997-8#5)(2007-10#4)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#15)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#8)(2013-1#14)(2013-7#1)(2013-8#4)
received &gt##4##2##(2008-6#2)(2008-7#2)
received 0##6##2##(1996-12#1)(1996-5#1)(2008-12#1)(2008-5#1)(2011-2#2)
received 1##2##2##(2007-7#1)(2008-7#1)
received 10##2##2##(2007-11#1)(2011-2#1)
received 15##2##2##(1996-8#1)(2008-8#1)
received 2##3##2##(1990-6#1)(1991-6#1)(2008-7#1)
received 20##2##2##(2011-2#1)(2012-2#1)
received 200##2##2##(1996-12#1)(2008-1#1)
received 3 doses of##2##4##(1994-9#1)(2008-7#1)
received 3##3##2##(1994-9#1)(2008-5#1)(2008-7#1)
received 5##2##2##(1994-3#1)(2011-2#1)
received 6##3##2##(2007-10#1)(2011-2#1)(2013-1#1)
received 60 Gy##2##3##(1991-4#1)(1992-11#1)
received 60##3##2##(1991-4#1)(1992-11#1)(2011-2#1)
received 8##2##2##(2007-10#1)(2008-9#1)
received AP##2##2##(1996-12#2)
received a Nucleus##2##3##(2008-9#2)
received a diagnosis of##2##4##(2008-9#1)(2011-1#1)
received a single intraperitoneal injection of##2##6##(1992-12#1)(2008-10#1)
received a single##5##3##(1992-12#1)(2007-11#1)(2008-10#1)(2011-2#2)
received a specific##2##3##(2010-4#1)(2012-1#1)
received a standard dose of##2##5##(2007-11#1)(2008-7#1)
received a##62##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#4)(2010-10#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-8#1)
received additional##2##2##(2007-8#1)(2008-10#1)
received adjuvant chemotherapy##2##3##(2008-10#1)(2010-3#1)
received amlodipine##2##2##(2007-10#1)(2008-3#1)
received an average##2##3##(2008-7#2)
received an equal volume of##2##5##(1991-12#1)(2008-12#1)
received an equal##3##3##(1991-12#1)(2008-10#1)(2008-12#1)
received an i##3##3##(1991-12#2)(2008-12#1)
received an oral##2##3##(1991-3#1)(1994-6#1)
received an##29##2##(1990-6#1)(1991-12#3)(1991-3#1)(1992-3#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#4)(2009-9#1)(2010-4#2)(2012-2#1)(2013-1#1)
received and##5##2##(1993-10#1)(1996-2#1)(1996-3#1)(2007-7#1)(2010-1#1)
received any##2##2##(2006-10#1)(2008-1#1)
received as##3##2##(2008-10#3)
received at least##2##3##(2011-2#1)(2012-1#1)
received at##5##2##(2007-12#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
received attention as##2##3##(2008-10#1)(2012-2#1)
received attention##4##2##(2008-10#1)(2009-11#1)(2012-2#2)
received between##2##2##(1993-6#1)(2008-12#1)
received bilateral destruction of##2##4##(1993-3#1)(1994-3#1)
received bilateral##4##2##(1993-3#1)(1994-3#3)
received blood##3##2##(1991-7#1)(1992-6#1)(2007-7#1)
received both##5##2##(1993-1#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-6#1)
received by each##2##3##(1992-2#1)(2012-2#1)
received by the plants##2##4##(2008-10#2)
received by the students##2##4##(2008-11#1)(2010-3#1)
received by the##12##3##(1991-2#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2009-11#1)(2010-3#1)
received by these##2##3##(1990-12#1)(1995-12#1)
received by##29##2##(1990-12#1)(1991-2#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-6#1)(2007-10#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
received chemotherapy##6##2##(1990-2#1)(1994-2#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
received cochlear implants##4##3##(2008-9#4)
received combination##2##2##(2011-2#1)(2012-2#1)
received considerable attention##3##3##(1997-5#1)(2008-11#1)(2013-1#1)
received considerable##4##2##(1997-5#1)(2008-11#1)(2009-6#1)(2013-1#1)
received data##2##2##(1991-11#1)(2007-11#1)
received dermal applications of##5##4##(2008-9#5)
received different##2##2##(1994-9#1)(2010-4#1)
received during##2##2##(1997-5#1)(2007-10#1)
received either a##2##3##(1992-5#1)(2008-10#1)
received either placebo or##3##4##(2008-5#1)(2008-6#1)(2010-1#1)
received either##14##2##(1990-5#1)(1992-5#1)(1994-8#2)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-1#1)
received equal##3##2##(1993-12#1)(2008-12#1)(2012-2#1)
received extensive##2##2##(1996-9#1)(2008-2#1)
received external##2##2##(2008-6#1)(2008-7#1)
received far##2##2##(1996-1#1)(2009-5#1)
received fasciectomies##2##2##(2008-9#2)
received four##2##2##(1994-12#1)(2013-1#1)
received from the##5##3##(1991-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
received from##18##2##(1991-1#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
received further##2##2##(1992-11#1)(1992-6#1)
received home care##2##3##(2011-2#2)
received home##4##2##(1997-4#1)(2011-2#2)(2012-12#1)
received i##6##2##(2007-7#6)
received in a##2##3##(2011-2#1)(2012-12#1)
received in the##2##3##(2008-11#1)(2012-1#1)
received in##9##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
received increased attention##4##3##(1992-1#1)(1996-3#1)(2008-10#1)(2012-3#1)
received increasing attention as a##2##5##(2008-8#2)
received increasing attention##7##3##(1994-2#1)(2008-1#1)(2008-7#1)(2008-8#2)(2011-2#2)
received increasing##9##2##(1994-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#2)
received individual##2##2##(2007-10#1)(2012-2#1)
received information##2##2##(1994-2#1)(2008-11#1)
received intracerebroventricular##2##2##(1994-8#1)(1995-12#1)
received intrastriatal##2##2##(2008-7#2)
received intravenous##2##2##(2008-12#1)(2008-7#1)
received less##5##2##(1994-1#1)(1996-2#1)(1997-6#1)(2008-2#1)(2008-9#1)
received little attention in##4##4##(1995-1#1)(2008-10#1)(2008-11#1)(2010-3#1)
received little attention##11##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)
received little##14##2##(1995-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-1#2)(2010-3#1)(2011-2#1)
received local therapy##2##3##(2008-6#2)
received mandibular##3##2##(2013-1#3)
received more than##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
received more##5##2##(1992-8#1)(1997-6#1)(2008-10#2)(2011-2#1)
received much##4##2##(1990-6#1)(2008-3#1)(2008-5#1)(2008-9#1)
received no##14##2##(1990-2#1)(1991-5#1)(1992-11#1)(1995-6#3)(1997-2#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-1#1)(2013-1#2)
received one of##2##3##(2008-9#1)(2011-2#1)
received one##7##2##(1994-7#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
received only##10##2##(1991-3#1)(1992-5#1)(1993-1#2)(1995-2#1)(1996-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
received optical signal##2##3##(2008-3#1)(2008-9#1)
received optical##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
received placebo##5##2##(1996-3#1)(2007-8#1)(2008-5#3)
received prenatal care##2##3##(1993-6#1)(1995-2#1)
received preoperative##2##2##(2007-8#1)(2011-2#1)
received previous chemotherapy##2##3##(1992-10#1)(2008-6#1)
received previous treatment##2##3##(1992-8#1)(2012-12#1)
received previous##6##2##(1992-10#1)(1992-8#1)(2007-8#1)(2008-6#1)(2008-9#1)(2012-12#1)
received prior chemotherapy##2##3##(1990-6#1)(1991-3#1)
received prior##3##2##(1990-6#1)(1991-3#1)(1991-4#1)
received proper##2##2##(1996-6#1)(2008-12#1)
received prophylaxis##2##2##(2007-7#2)
received radiation##2##2##(1991-2#1)(2009-10#1)
received radiotherapy and##2##3##(1992-12#1)(2011-1#1)
received radiotherapy##5##2##(1992-12#1)(2008-6#2)(2009-11#1)(2011-1#1)
received rasburicase##2##2##(2008-7#2)
received routine##4##2##(1991-12#1)(1994-7#1)(2009-12#1)(2010-12#1)
received rt-PA##3##2##(2007-10#3)
received significantly##2##2##(1991-2#1)(2010-7#1)
received special##2##2##(1994-6#1)(1995-6#1)
received specific##2##2##(2008-11#1)(2010-3#1)
received standard care##3##3##(2008-4#1)(2010-4#2)
received standard##5##2##(2008-4#1)(2008-6#1)(2010-4#2)(2012-3#1)
received subcutaneous##3##2##(1992-5#1)(1996-5#1)(2008-3#1)
received successful##2##2##(2007-8#2)
received supplemental oxygen##2##3##(1993-1#2)
received support##2##2##(2010-3#1)(2013-1#1)
received surgery or##2##3##(2008-7#1)(2011-2#1)
received surgical##2##2##(2008-6#1)(2013-1#1)
received thalidomide##2##2##(2008-5#2)
received the same##3##3##(1995-3#1)(2007-8#1)(2009-6#1)
received the##21##2##(1990-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#2)(2010-4#2)(2010-5#1)(2013-1#3)
received this diagnosis##2##3##(1991-9#2)
received this##4##2##(1991-9#2)(1997-6#1)(2008-1#1)
received three##4##2##(1994-3#1)(1994-7#1)(1996-5#1)(2008-8#1)
received thrombolytic therapy##2##3##(2007-9#1)(2008-7#1)
received thrombolytic##3##2##(2007-10#1)(2007-9#1)(2008-7#1)
received training in##2##3##(2008-4#1)(2012-12#1)
received training##4##2##(1995-6#1)(2008-4#1)(2012-12#1)(2012-3#1)
received treatment with##3##3##(1991-11#1)(1991-3#1)(2007-7#1)
received two##4##2##(1994-3#1)(2012-2#1)(2013-1#2)
received unilateral##3##2##(1992-11#1)(1993-6#1)(1995-5#1)
received various##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
received vehicle##2##2##(2012-2#1)(2012-3#1)
received was##4##2##(1992-2#1)(1993-6#1)(2008-9#1)(2009-5#1)
received were##2##2##(1990-2#1)(2008-10#1)
received##826##1##(1990-11#1)(1990-12#7)(1990-2#6)(1990-5#4)(1990-6#7)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#6)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#13)(1993-10#4)(1993-12#9)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#6)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#8)(1994-5#1)(1994-6#3)(1994-7#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#7)(1995-6#7)(1995-8#4)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#4)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#7)(1997-7#2)(1997-8#1)(2006-10#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#17)(2007-11#11)(2007-12#5)(2007-4#1)(2007-7#19)(2007-8#16)(2007-9#3)(2008-1#12)(2008-10#48)(2008-11#25)(2008-12#23)(2008-2#8)(2008-3#23)(2008-4#11)(2008-5#37)(2008-6#25)(2008-7#42)(2008-8#12)(2008-9#33)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#4)(2010-12#1)(2010-3#12)(2010-4#10)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#9)(2011-2#39)(2012-1#3)(2012-12#9)(2012-2#20)(2012-3#11)(2012-7#1)(2013-1#36)(2013-7#1)(2013-8#6)
receiver and##3##2##(2008-3#1)(2009-10#2)
receiver aperture##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
receiver are##2##2##(2007-12#1)(2008-3#1)
receiver array##2##2##(2008-3#2)
receiver field of view##3##4##(2008-3#3)
receiver for##6##2##(2007-11#2)(2008-2#3)(2008-8#1)
receiver front end##2##3##(2008-3#2)
receiver is##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
receiver operating characteristic (ROC) analysis##2##5##(2010-9#1)(2011-1#1)
receiver operating characteristic (ROC) curve##3##5##(2007-8#1)(2008-10#1)(2012-1#1)
receiver operating characteristic (ROC)##5##4##(2007-8#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-1#1)
receiver operating characteristic curve analysis##3##5##(2008-10#3)
receiver operating characteristic curve##4##4##(2008-10#3)(2008-3#1)
receiver operating characteristic##11##3##(2007-8#1)(2008-10#4)(2008-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
receiver operating characteristics##2##3##(2008-2#1)(2011-2#1)
receiver operating##16##2##(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
receiver operator##2##2##(2012-12#1)(2013-1#1)
receiver performance##2##2##(2008-2#1)(2008-3#1)
receiver sensitivities##2##2##(2007-12#2)
receiver with##2##2##(2008-2#2)
receiver##118##1##(1995-5#2)(1996-12#1)(2007-11#11)(2007-12#6)(2007-8#1)(2008-10#8)(2008-2#39)(2008-3#30)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
receiver-operating characteristic (ROC)##2##3##(2010-8#1)(2011-1#1)
receiver-stimulator package##3##2##(2012-2#3)
receiver-stimulator##7##1##(2008-9#4)(2012-2#3)
receivers for##2##2##(2008-2#1)(2008-3#1)
receivers on##2##2##(2008-2#1)(2009-8#1)
receivers that are##2##3##(2008-2#1)(2008-3#1)
receivers that##3##2##(2008-2#2)(2008-3#1)
receivers with##2##2##(2007-12#1)(2008-2#1)
receivers##38##1##(1995-5#4)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#9)(2008-3#13)(2008-8#2)(2009-12#1)(2009-8#1)(2013-1#3)
receives a##2##2##(1996-5#1)(2008-10#1)
receives input##2##2##(1994-3#2)
receives##20##1##(1990-4#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
receiving 6##2##2##(1996-12#1)(2012-3#1)
receiving 60##2##2##(1997-6#1)(2007-10#1)
receiving BCT##2##2##(1995-4#1)(2008-6#1)
receiving a total##2##3##(1990-6#1)(2013-1#1)
receiving a##17##2##(1990-6#1)(1991-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2013-1#1)
receiving an##4##2##(1992-2#1)(1993-12#1)(2008-7#1)(2008-9#1)
receiving and##2##2##(1995-1#1)(2010-4#1)
receiving bone##3##2##(1991-2#1)(2011-1#2)
receiving chemotherapy for##2##3##(2008-6#1)(2008-7#1)
receiving chemotherapy##16##2##(1991-4#1)(2008-6#1)(2008-7#12)(2010-2#1)(2013-1#1)
receiving concurrent##2##2##(2006-10#1)(2013-1#1)
receiving erythropoietin##3##2##(1993-2#1)(2008-1#2)
receiving esomeprazole##2##2##(2011-2#2)
receiving hemodialysis##4##2##(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
receiving high-dose##4##2##(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
receiving highly##2##2##(2007-12#1)(2008-7#1)
receiving home##3##2##(1995-3#1)(2012-12#1)(2013-1#1)
receiving hormonal##2##2##(2008-6#1)(2013-1#1)
receiving increasing attention##5##3##(1993-1#1)(2007-10#1)(2013-1#1)(2013-8#2)
receiving increasing##6##2##(1993-1#1)(2007-10#1)(2009-5#1)(2013-1#1)(2013-8#2)
receiving inpatient##2##2##(1991-2#1)(1993-1#1)
receiving intensive##2##2##(1991-12#1)(2008-7#1)
receiving medical##2##2##(1994-2#1)(2010-10#1)
receiving no##2##2##(2007-12#1)(2010-6#1)
receiving occupational therapy##2##3##(2013-7#2)
receiving other##2##2##(1991-12#1)(2008-11#1)
receiving placebo##3##2##(2008-5#1)(2008-7#1)(2009-8#1)
receiving recombinant##2##2##(1991-8#1)(2007-7#1)
receiving services##2##2##(1994-3#1)(2011-1#1)
receiving single fraction##2##3##(2008-10#2)
receiving single##3##2##(2008-10#3)
receiving steroids##2##2##(2008-7#1)(2013-1#1)
receiving such##3##2##(1991-8#1)(1992-3#1)(2010-3#1)
receiving synthetic##2##2##(2008-10#2)
receiving the##10##2##(1992-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#2)(2013-1#2)
receiving treatment at##3##3##(1996-2#1)(2012-2#1)(2013-8#1)
receiving treatment for##2##3##(1996-3#1)(2011-1#1)
receiving treatment##6##2##(1996-2#1)(1996-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
receiving##327##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#6)(1991-4#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-4#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1997-1#1)(1997-3#2)(1997-6#1)(2006-10#4)(2007-10#5)(2007-11#6)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#23)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#13)(2008-6#4)(2008-7#34)(2008-8#4)(2008-9#6)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#8)(2011-2#15)(2012-12#13)(2012-2#5)(2012-3#4)(2013-1#25)(2013-7#2)(2013-8#8)
recency effect##2##2##(2009-2#2)
recency of##2##2##(1990-12#1)(1992-11#1)
recency##7##1##(1990-12#1)(1992-11#3)(1993-3#1)(2009-2#2)
recent American##2##2##(2008-3#1)(2008-4#1)
recent Canadian##2##2##(1997-3#1)(2008-11#1)
recent Consensus##2##2##(2008-2#1)(2013-8#1)
recent Letter##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
recent United##2##2##(1992-1#1)(1992-2#1)
recent achievements in##2##3##(2008-10#1)(2008-11#1)
recent achievements##3##2##(2008-10#2)(2008-11#1)
recent addition##5##2##(1994-8#1)(2008-4#1)(2008-6#1)(2009-5#1)(2012-2#1)
recent advancements in the##3##4##(2008-10#1)(2009-3#1)(2010-6#1)
recent advancements in##4##3##(2008-10#1)(2009-3#1)(2010-6#1)(2012-2#1)
recent advances and the key strategies##2##6##(2008-10#1)(2012-3#1)
recent advances and##4##3##(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
recent advances in our understanding of##4##6##(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)
recent advances in our##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-1#1)
recent advances in the field##4##5##(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)
recent advances in the##18##4##(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
recent advances in these##2##4##(1993-12#1)(2011-2#1)
recent advances in this field##2##5##(2008-1#1)(2008-4#1)
recent advances in understanding the##4##5##(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
recent advances in##58##3##(1993-12#1)(1994-2#1)(1994-3#1)(1997-4#1)(2006-10#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)
recent advances of##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)
recent advances##75##2##(1990-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1997-4#1)(2006-10#1)(2007-7#3)(2008-1#2)(2008-10#6)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)
recent analytical##2##2##(2008-11#1)(2010-7#1)
recent and##10##2##(1991-9#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)(2013-7#1)
recent antibiotics##2##2##(1994-11#1)(2010-4#1)
recent applications of##3##3##(2008-10#1)(2010-5#1)(2010-9#1)
recent applications to##2##3##(1994-9#1)(2008-9#1)
recent applications##6##2##(1994-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-9#1)
recent attempts##3##2##(1992-1#1)(1995-1#1)(2008-4#1)
recent balloon flights##2##3##(2008-3#2)
recent case of##4##3##(1990-9#1)(1991-12#1)(2007-12#1)(2008-1#1)
recent case reports##2##3##(2008-7#1)(2009-11#1)
recent case##9##2##(1990-9#2)(1991-12#1)(2007-12#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-11#1)
recent case-control##2##2##(2008-7#2)
recent cases of##2##3##(2007-12#1)(2007-8#1)
recent cases##6##2##(1990-9#1)(1992-12#1)(2007-12#2)(2007-8#1)(2008-7#1)
recent changes in the##2##4##(1992-12#1)(2012-3#1)
recent changes in##3##3##(1990-8#1)(1992-12#1)(2012-3#1)
recent claims##3##2##(2007-11#1)(2010-4#1)(2010-7#1)
recent clinical studies##2##3##(1996-11#1)(2011-1#1)
recent clinical trial##2##3##(2008-1#1)(2008-7#1)
recent clinical trials in##2##4##(2008-11#1)(2008-5#1)
recent clinical trials of##2##4##(2012-12#1)(2012-3#1)
recent clinical trials##7##3##(2008-11#1)(2008-5#1)(2008-9#2)(2010-5#1)(2012-12#1)(2012-3#1)
recent clinical##17##2##(1996-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#1)
recent common ancestor##5##3##(2008-10#5)
recent comprehensive##2##2##(1996-2#1)(2008-7#1)
recent conceptual syntheses##2##3##(2008-9#2)
recent conceptual##3##2##(2008-9#2)(2009-4#1)
recent crystal##2##2##(2008-8#1)(2010-5#1)
recent data from##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
recent data indicate that##3##4##(2008-11#1)(2008-5#1)(2012-3#1)
recent data on##4##3##(2008-1#1)(2008-3#1)(2008-9#1)(2012-1#1)
recent data show that##2##4##(2008-3#1)(2013-1#1)
recent data suggest that##3##4##(1996-3#1)(2007-11#1)(2007-8#1)
recent data##31##2##(1993-3#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
recent decades##11##2##(2007-2#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
recent demonstration##2##2##(1996-2#1)(2009-5#1)
recent development and##2##3##(1995-2#1)(2008-6#1)
recent development of a##4##4##(1990-2#1)(1997-2#1)(2008-4#1)(2010-1#1)
recent development of##17##3##(1990-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-8#1)
recent development##23##2##(1990-2#1)(1992-8#1)(1993-11#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-6#2)(2010-7#1)(2010-8#2)
recent developmental##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
recent developments and##2##3##(2006-9#1)(2008-10#1)
recent developments in the application of##2##6##(2008-1#1)(2008-10#1)
recent developments in the##11##4##(1992-12#1)(1994-9#1)(1996-3#1)(2008-1#2)(2008-10#3)(2008-6#1)(2008-7#1)(2010-4#1)
recent developments in##30##3##(1990-8#1)(1992-12#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)
recent developments on cost-effective flow-based analysis##2##6##(2008-10#2)
recent developments on##3##3##(2008-10#2)(2009-10#1)
recent developments regarding##2##3##(2009-10#1)(2011-2#1)
recent developments with##2##3##(1997-4#1)(2010-7#1)
recent developments##49##2##(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-4#1)(2006-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#4)(2012-1#1)(2013-8#1)
recent discoveries##2##2##(2008-10#1)(2009-7#1)
recent discovery of##5##3##(1990-6#1)(1993-5#1)(1996-4#1)(2007-10#1)(2008-11#1)
recent discovery##6##2##(1990-6#1)(1993-5#1)(1996-4#1)(2007-10#1)(2008-11#1)(2008-4#1)
recent discussions##2##2##(2006-10#1)(2008-11#1)
recent efforts to##2##3##(1993-6#1)(1996-1#1)
recent efforts##4##2##(1993-3#1)(1993-6#1)(1996-1#1)(2008-4#1)
recent emerging##2##2##(2008-9#1)(2009-2#1)
recent empirical##2##2##(1996-11#1)(2008-8#1)
recent epidemiological studies have##2##4##(1991-4#1)(2011-2#1)
recent epidemiological studies##3##3##(1991-4#1)(1994-6#1)(2011-2#1)
recent epidemiological##4##2##(1991-4#1)(1994-6#1)(1997-7#1)(2011-2#1)
recent evidence from##2##3##(2008-2#1)(2008-7#1)
recent evidence suggests that##2##4##(1995-6#1)(2008-5#1)
recent evidence##12##2##(1995-6#1)(1996-4#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2013-1#2)
recent examples of##2##3##(1997-4#1)(2008-7#1)
recent examples##3##2##(1996-6#1)(1997-4#1)(2008-7#1)
recent experience of##2##3##(2008-11#2)
recent experience##5##2##(2007-5#1)(2007-8#1)(2008-11#2)(2008-7#1)
recent experimental results##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
recent experimental##6##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
recent experiments on##2##3##(2007-12#1)(2008-7#1)
recent experiments##7##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#2)
recent finding that##3##3##(2008-8#1)(2009-8#2)
recent finding##6##2##(1990-8#1)(2008-10#1)(2008-8#1)(2009-8#2)(2010-11#1)
recent findings and##2##3##(2008-10#1)(2008-8#1)
recent findings concerning##2##3##(2008-11#1)(2008-4#1)
recent findings have##2##3##(2008-4#1)(2010-8#1)
recent findings in the##2##4##(2011-1#1)(2012-2#1)
recent findings in##5##3##(2008-1#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
recent findings of##2##3##(2008-6#1)(2010-9#1)
recent findings on##8##3##(1997-7#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
recent findings regarding##2##3##(2008-5#1)(2011-2#1)
recent findings showing that##2##4##(2008-7#1)(2013-7#1)
recent findings that suggest##2##4##(2008-11#1)(2008-7#1)
recent findings that##5##3##(1994-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
recent findings##46##2##(1991-2#1)(1991-3#1)(1994-8#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#3)
recent genetic##2##2##(1995-6#1)(2011-2#1)
recent government##2##2##(2008-11#2)
recent graduates##2##2##(1994-3#1)(2011-2#1)
recent high-resolution##2##2##(1996-4#1)(2008-2#1)
recent history of##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
recent history##4##2##(1991-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
recent identification of##6##3##(1996-2#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
recent improvement##2##2##(1996-3#1)(2008-7#1)
recent improvements##5##2##(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)(2012-8#1)
recent infection##3##2##(1990-3#1)(2007-2#1)(2008-12#1)
recent information on##2##3##(1997-2#1)(2008-4#1)
recent innovations in##2##3##(2008-8#1)(2010-1#1)
recent innovations##3##2##(2008-8#1)(2009-12#1)(2010-1#1)
recent insights into##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
recent insights##5##2##(2008-1#1)(2008-7#2)(2011-2#1)(2013-1#1)
recent interest in##3##3##(1995-5#1)(1997-7#1)(2008-3#1)
recent interest##4##2##(1995-5#1)(1997-7#1)(2008-3#1)(2010-7#1)
recent introduction of the##2##4##(1993-12#1)(2008-10#1)
recent introduction of##8##3##(1991-2#1)(1993-12#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-3#1)(2011-2#1)
recent introduction##9##2##(1991-2#1)(1993-12#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#1)(2011-2#1)
recent investigations have##2##3##(1992-3#1)(2008-2#1)
recent investigations##3##2##(1992-3#1)(2008-11#1)(2008-2#1)
recent knowledge##2##2##(2008-10#1)(2008-2#1)
recent large##4##2##(1992-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
recent legal##5##2##(2008-11#4)(2009-11#1)
recent literature concerning##2##3##(1997-7#1)(2010-9#1)
recent literature in##2##3##(2010-2#1)(2013-1#1)
recent literature on the##3##4##(1991-12#1)(2009-6#1)(2011-1#1)
recent literature on##6##3##(1991-12#1)(1994-6#1)(1996-1#1)(2009-5#1)(2009-6#1)(2011-1#1)
recent literature##27##2##(1990-6#1)(1991-12#1)(1991-2#1)(1993-5#1)(1994-6#1)(1996-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
recent mathematical##2##2##(2008-9#1)(2009-5#1)
recent method##2##2##(2008-7#1)(2013-8#1)
recent methods##2##2##(1997-4#1)(2008-11#1)
recent migrants##2##2##(2008-6#1)(2012-12#1)
recent modifications##3##2##(1996-1#1)(2008-10#1)(2008-4#1)
recent molecular##3##2##(1992-3#1)(2007-12#1)(2008-4#1)
recent neuroimaging##3##2##(2008-11#2)(2008-6#1)
recent observation of##2##3##(1990-2#1)(2007-12#1)
recent observations##5##2##(1992-5#1)(2007-12#1)(2008-10#1)(2008-3#2)
recent ongoing##2##2##(2008-11#1)(2010-5#1)
recent onset of##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
recent onset##5##2##(2008-10#1)(2011-1#1)(2012-12#1)(2013-1#2)
recent or##2##2##(1992-1#1)(2008-10#1)
recent outbreak of##2##3##(2007-12#1)(2008-10#1)
recent outbreaks##4##2##(2007-6#3)(2008-10#1)
recent paper by##2##3##(2008-3#2)
recent paper in##4##3##(2009-8#4)
recent paper##11##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-6#1)(2009-8#5)
recent phase##2##2##(2008-6#1)(2010-12#1)
recent population##4##2##(2008-10#1)(2009-2#1)(2010-8#2)
recent progress in the development and##2##6##(1994-3#1)(2013-1#1)
recent progress in the development of##3##6##(2011-2#1)(2011-3#1)(2013-1#1)
recent progress in the development##5##5##(1994-3#1)(2011-2#1)(2011-3#1)(2013-1#2)
recent progress in the##11##4##(1991-2#1)(1994-3#1)(2008-11#1)(2009-10#2)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#2)
recent progress in##20##3##(1990-6#1)(1991-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#2)
recent progress made in##2##4##(2008-10#1)(2012-12#1)
recent progress on##2##3##(2009-7#1)(2011-2#1)
recent progress##30##2##(1990-6#1)(1991-2#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
recent proposals for##2##3##(1993-3#1)(1996-6#1)
recent proposals##3##2##(1993-3#1)(1994-9#1)(1996-6#1)
recent prospective##3##2##(2007-7#1)(2008-3#1)(2012-12#1)
recent publication##4##2##(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
recent publications##10##2##(1993-3#1)(1996-8#1)(2006-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
recent published##5##2##(1995-11#1)(1995-12#1)(1995-3#1)(2006-6#1)(2008-10#1)
recent recommendations##2##2##(2008-10#1)(2008-11#1)
recent report that##2##3##(2009-8#1)(2012-2#1)
recent report##13##2##(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#1)(1997-6#1)(2006-10#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-2#1)
recent reports have##3##3##(1992-12#1)(2008-8#1)(2009-10#1)
recent reports in the literature##2##5##(1991-2#1)(2008-2#1)
recent reports of##2##3##(1997-5#1)(2011-2#1)
recent reports on##2##3##(2006-10#1)(2008-11#1)
recent reports##18##2##(1990-5#1)(1991-2#1)(1991-4#1)(1992-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
recent research findings##3##3##(1991-2#2)(2008-11#1)
recent research has shown that##2##5##(2008-11#1)(2008-2#1)
recent research has suggested##2##4##(2012-3#1)(2013-8#1)
recent research has##7##3##(2008-11#2)(2008-2#2)(2008-8#1)(2012-3#1)(2013-8#1)
recent research on the##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
recent research suggests##2##3##(2008-8#1)(2013-1#1)
recent research##30##2##(1991-2#2)(1991-6#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
recent research]##2##2##(1991-6#1)(1997-6#1)
recent results in##2##3##(2008-7#1)(2010-5#1)
recent results obtained##2##3##(2008-5#1)(2011-2#1)
recent results of##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-3#1)
recent results##15##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)
recent resurgence##2##2##(2008-7#1)(2008-8#1)
recent scientific##3##2##(1997-3#1)(2008-1#1)(2010-12#1)
recent series##3##2##(2007-8#2)(2008-10#1)
recent state##2##2##(1993-2#1)(2008-11#1)
recent structural##2##2##(2008-8#1)(2009-8#1)
recent studies conducted in##2##4##(1996-1#1)(2009-1#1)
recent studies have demonstrated that##2##5##(2008-1#1)(2011-2#1)
recent studies have implicated##2##4##(1993-11#1)(1997-7#1)
recent studies have shown that the##2##6##(1996-2#1)(2008-8#1)
recent studies have shown##3##4##(1996-2#1)(2008-7#1)(2008-8#1)
recent studies have suggested that##2##5##(2010-12#1)(2013-1#1)
recent studies have suggested##3##4##(2010-12#1)(2013-1#2)
recent studies have##20##3##(1993-11#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-1#3)
recent studies of the##3##4##(2008-5#1)(2008-8#1)(2012-2#1)
recent studies of##7##3##(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
recent studies on the##3##4##(2008-5#1)(2009-6#1)(2011-2#1)
recent studies on this##2##4##(1997-8#1)(2012-1#1)
recent studies on##7##3##(1997-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)
recent studies show that##2##4##(2008-3#1)(2008-8#1)
recent studies show##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
recent studies suggest that##4##4##(1993-6#1)(1994-8#1)(1995-12#1)(2011-2#1)
recent studies that##3##3##(1994-2#1)(2008-10#1)(2010-4#1)
recent studies##76##2##(1992-6#1)(1993-1#1)(1993-11#2)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-2#8)(2012-1#1)(2012-2#1)(2013-1#5)
recent study has##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
recent study of##3##3##(1991-12#1)(1997-7#1)(2008-1#1)
recent study showed##2##3##(2008-5#1)(2013-1#1)
recent study##32##2##(1990-11#1)(1991-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#2)(2009-5#1)(2009-8#3)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-3#1)(2013-1#1)
recent surge in##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
recent survey of##5##3##(1994-3#1)(1995-1#1)(1995-2#1)(2008-3#1)(2008-6#1)
recent survey##8##2##(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(2006-12#1)(2008-3#1)(2008-6#1)
recent surveys##2##2##(2008-8#1)(2008-9#1)
recent synaptic##2##2##(2008-11#2)
recent technical##3##2##(1996-4#1)(2008-4#1)(2010-2#1)
recent technological##3##2##(2008-11#1)(2010-7#1)(2012-2#1)
recent ten years##2##3##(2012-3#2)
recent times##4##2##(1996-1#1)(2007-7#1)(2008-11#1)(2009-12#1)
recent transfers##2##2##(1995-11#1)(2013-1#1)
recent travel##2##2##(2007-2#1)(2011-2#1)
recent trend of##3##3##(2008-11#1)(2009-12#1)(2012-12#1)
recent trend##5##2##(2007-11#1)(2008-11#1)(2008-4#1)(2009-12#1)(2012-12#1)
recent trends in the##2##4##(1991-1#1)(1992-12#1)
recent trends in##7##3##(1991-1#1)(1992-12#1)(1994-6#1)(2007-7#1)(2008-1#1)(2011-2#2)
recent trends##11##2##(1991-1#1)(1992-12#1)(1994-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#2)
recent trials and##2##3##(2008-8#1)(2009-10#1)
recent use of##2##3##(1992-9#1)(2008-11#1)
recent viral##2##2##(1992-3#1)(2008-1#1)
recent work has identified##2##4##(1991-3#1)(2008-11#1)
recent work has##3##3##(1991-3#1)(1996-2#1)(2008-11#1)
recent work on##4##3##(2007-5#1)(2008-2#1)(2009-9#1)(2013-8#1)
recent work with##2##3##(2008-9#1)(2009-3#1)
recent work##17##2##(1991-3#1)(1994-11#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
recent years as##5##3##(1996-1#1)(2007-7#1)(2008-10#2)(2011-1#1)
recent years has##5##3##(1992-11#1)(1997-4#1)(2008-4#1)(2008-7#1)(2013-1#1)
recent years in##3##3##(1992-1#1)(2013-1#1)(2013-8#1)
recent years it has been##3##5##(1990-11#1)(1994-11#1)(2008-12#1)
recent years it has##4##4##(1990-11#1)(1994-11#1)(2008-12#1)(2008-7#1)
recent years several studies have shown##2##6##(1995-4#1)(2008-3#1)
recent years the##5##3##(1991-6#1)(1995-5#1)(2007-5#1)(2008-11#1)(2009-6#1)
recent years there has been##5##5##(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#2)
recent years there have been##3##5##(1990-11#1)(2008-11#1)(2011-2#1)
recent years there##8##3##(1990-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#1)
recent years##207##2##(1990-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1993-1#2)(1993-11#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#17)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#2)(2009-2#1)(2009-6#3)(2009-7#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#5)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#11)(2013-8#7)
recent##1455##1##(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#6)(1990-8#3)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#7)(1991-2#11)(1991-3#5)(1991-4#2)(1991-6#6)(1991-8#2)(1991-9#5)(1992-1#7)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#6)(1992-9#3)(1993-1#5)(1993-11#6)(1993-12#5)(1993-2#6)(1993-3#6)(1993-5#2)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#5)(1994-12#4)(1994-2#6)(1994-3#9)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#3)(1995-1#7)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#1)(1996-1#8)(1996-11#6)(1996-12#1)(1996-2#9)(1996-3#9)(1996-4#5)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#7)(1997-5#4)(1997-6#6)(1997-7#9)(1997-8#6)(2006-10#10)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#13)(2007-12#21)(2007-2#4)(2007-5#5)(2007-6#6)(2007-7#12)(2007-8#11)(2008-1#36)(2008-10#125)(2008-11#74)(2008-12#9)(2008-2#23)(2008-3#34)(2008-4#38)(2008-5#33)(2008-6#15)(2008-7#79)(2008-8#44)(2008-9#32)(2009-1#1)(2009-10#14)(2009-11#8)(2009-12#8)(2009-2#9)(2009-3#5)(2009-4#4)(2009-5#19)(2009-6#11)(2009-7#9)(2009-8#27)(2009-9#4)(2010-1#5)(2010-10#3)(2010-11#11)(2010-12#21)(2010-2#5)(2010-3#5)(2010-4#9)(2010-5#18)(2010-6#8)(2010-7#14)(2010-8#18)(2010-9#5)(2011-1#20)(2011-2#80)(2011-3#9)(2011-7#4)(2012-1#9)(2012-12#26)(2012-2#28)(2012-3#28)(2012-5#1)(2012-8#1)(2013-1#46)(2013-7#3)(2013-8#22)
recently accumulated##2##2##(1991-9#1)(2010-3#1)
recently acquired##4##2##(1990-5#1)(2008-2#1)(2009-8#1)(2011-2#1)
recently added##2##2##(2008-11#1)(2008-12#1)
recently adopted by the##2##4##(1992-2#1)(1995-12#1)
recently adopted##3##2##(1992-2#1)(1994-2#1)(1995-12#1)
recently and##7##2##(1992-3#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-9#2)(2009-12#1)
recently appointed##2##2##(1997-6#1)(2008-11#1)
recently approved##4##2##(1992-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
recently as a##2##3##(2007-2#1)(2008-7#1)
recently as##3##2##(1994-1#1)(2007-2#1)(2008-7#1)
recently available data##3##3##(1992-3#1)(1993-2#1)(2009-10#1)
recently available##5##2##(1992-3#1)(1993-2#1)(2008-2#1)(2008-8#1)(2009-10#1)
recently became##2##2##(2006-6#1)(2009-7#1)
recently become##5##2##(1993-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)
recently been associated with##2##4##(1995-2#1)(2013-8#1)
recently been described##5##3##(1990-5#1)(1992-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
recently been developed to##2##4##(2008-2#1)(2008-3#1)
recently been developed##9##3##(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
recently been found##3##3##(2007-8#1)(2008-10#1)(2009-4#1)
recently been identified as a##3##5##(1994-11#1)(1994-12#1)(2008-5#1)
recently been identified as##5##4##(1994-11#1)(1994-12#1)(1996-2#1)(2008-5#1)(2012-1#1)
recently been identified##8##3##(1990-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-5#1)(2012-1#1)(2013-1#1)
recently been introduced##2##3##(1994-2#1)(2008-7#1)
recently been investigated##2##3##(2011-1#1)(2012-4#1)
recently been made##2##3##(1993-1#1)(2011-1#1)
recently been observed##2##3##(2008-10#1)(2012-2#1)
recently been proposed##6##3##(1994-6#1)(1995-12#1)(2007-12#1)(2008-2#1)(2013-1#2)
recently been reported in##2##4##(2008-5#1)(2009-8#1)
recently been reported##9##3##(1992-5#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)
recently been shown to be##4##5##(1995-2#1)(2008-8#1)(2009-5#1)(2012-2#1)
recently been shown to##12##4##(1990-12#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-12#1)(2012-2#1)
recently been shown##15##3##(1990-12#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#2)(2012-12#1)(2012-2#1)
recently been suggested##4##3##(1990-3#1)(1994-12#1)(2010-12#1)(2013-1#1)
recently been##131##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-2#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#4)(2010-12#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2012-4#1)(2013-1#8)(2013-7#1)(2013-8#1)
recently begun to##2##3##(2008-1#1)(2008-9#1)
recently begun##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
recently characterized##4##2##(1993-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
recently cloned from##2##3##(1997-2#1)(2008-10#1)
recently cloned##9##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-6#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)
recently come##2##2##(2008-4#1)(2009-8#1)
recently completed a##2##3##(1997-2#1)(2007-7#1)
recently completed##7##2##(1994-7#1)(1995-6#1)(1996-1#1)(1997-2#1)(2007-7#1)(2008-11#1)(2010-11#1)
recently conducted##2##2##(1997-4#1)(2010-3#1)
recently created##3##2##(1994-12#1)(2007-7#1)(2011-2#1)
recently defined##4##2##(1997-7#1)(2008-2#1)(2008-5#1)(2012-3#1)
recently demonstrated in##4##3##(1994-12#1)(2008-11#2)(2008-2#1)
recently demonstrated that##10##3##(1994-2#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#3)(2010-11#1)(2011-1#1)
recently demonstrated##19##2##(1994-12#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
recently derived##2##2##(2008-8#2)
recently described S##2##3##(2008-10#1)(2009-6#1)
recently described an##3##3##(1990-8#1)(1994-5#1)(2011-2#1)
recently described in the##2##4##(1991-11#1)(2008-11#1)
recently described in##4##3##(1990-11#1)(1991-11#1)(2008-11#1)(2010-10#1)
recently described##28##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-6#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
recently detected##4##2##(1990-5#1)(2006-4#1)(2008-10#1)(2012-2#1)
recently determined##4##2##(1995-12#1)(1996-12#1)(1997-3#1)(2012-2#1)
recently detoxified##2##2##(1996-7#2)
recently developed a##4##3##(1996-7#1)(2008-11#1)(2011-2#1)(2012-3#1)
recently developed an##2##3##(1994-2#1)(2008-3#1)
recently developed and##2##3##(2008-3#2)
recently developed by##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
recently developed for##4##3##(2008-11#2)(2008-3#1)(2009-9#1)
recently developed method##4##3##(1997-4#1)(2008-10#1)(2008-3#2)
recently developed methods for##2##4##(2008-7#1)(2012-3#1)
recently developed statistical##2##3##(1996-3#1)(2008-10#1)
recently developed technique##3##3##(2007-12#2)(2008-9#1)
recently developed to##2##3##(2008-4#1)(2009-5#1)
recently developed##78##2##(1991-5#1)(1992-6#1)(1994-2#1)(1995-11#2)(1995-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-12#4)(2007-8#1)(2008-10#7)(2008-11#5)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-5#1)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
recently diagnosed##5##2##(1994-12#1)(1994-2#1)(2007-2#1)(2008-10#1)(2011-2#1)
recently discovered that the##3##4##(2009-6#1)(2011-2#2)
recently discovered that##4##3##(2009-6#1)(2010-7#1)(2011-2#2)
recently discovered##19##2##(1990-3#2)(1993-11#1)(1994-6#1)(1995-12#1)(1995-3#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
recently diverged##2##2##(2008-10#1)(2013-1#1)
recently emerged as##4##3##(2008-11#2)(2008-3#1)(2010-11#1)
recently emerged##8##2##(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#1)
recently employed##2##2##(2009-12#1)(2011-2#1)
recently enacted##2##2##(1991-2#2)
recently encountered##2##2##(1995-4#1)(2008-10#1)
recently established##8##2##(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)
recently evolved##4##2##(2008-10#3)(2011-2#1)
recently fabricated##2##2##(2007-11#1)(2008-3#1)
recently for##7##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-6#1)(2013-1#1)
recently found in##2##3##(2008-10#1)(2008-5#1)
recently found that##3##3##(1991-12#1)(1994-3#1)(2011-2#1)
recently found##10##2##(1991-12#1)(1994-11#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
recently generated##2##2##(1995-2#1)(2009-10#1)
recently had##3##2##(2010-12#1)(2010-6#1)(2013-7#1)
recently has been##2##3##(2011-7#1)(2013-8#1)
recently has##4##2##(2008-9#1)(2011-7#1)(2012-1#1)(2013-8#1)
recently have been##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
recently have##9##2##(1991-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-7#1)(2010-8#1)
recently identified as the##3##4##(1994-11#1)(1997-5#1)(2008-5#1)
recently identified as##6##3##(1994-11#2)(1996-12#1)(1997-5#1)(2008-10#1)(2008-5#1)
recently identified in the##2##4##(1991-5#1)(1994-11#1)
recently identified in##3##3##(1990-7#1)(1991-5#1)(1994-11#1)
recently identified tumor##2##3##(1994-6#1)(2008-5#1)
recently identified##29##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-11#1)(1994-11#3)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-7#1)
recently implemented##2##2##(2008-3#1)(2013-1#1)
recently in the##5##3##(1994-3#1)(1994-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
recently in##12##2##(1991-12#1)(1994-3#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-12#1)
recently increased##2##2##(1991-3#1)(2008-6#1)
recently integrated##2##2##(2008-12#1)(2008-7#1)
recently introduced##23##2##(1990-6#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
recently is##2##2##(1993-3#1)(1997-6#1)
recently isolated viruses##2##3##(2013-8#2)
recently isolated##7##2##(1991-2#1)(1992-6#1)(1994-12#1)(1995-12#1)(2008-5#1)(2013-8#2)
recently joined##2##2##(1991-1#1)(2011-2#1)
recently led to the##2##4##(1995-5#1)(2008-5#1)
recently led to##4##3##(1995-5#1)(2007-6#1)(2008-5#1)(2011-2#1)
recently made in##2##3##(2007-7#1)(2007-8#1)
recently made##5##2##(1992-6#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-11#1)
recently mapped##3##2##(1994-12#1)(1996-8#1)(2007-7#1)
recently observed in##2##3##(2008-10#1)(2008-3#1)
recently observed that##3##3##(1990-5#1)(1997-7#1)(2008-10#1)
recently observed##8##2##(1990-5#1)(1992-9#1)(1996-4#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-3#1)
recently obtained##4##2##(2007-11#1)(2008-2#1)(2009-3#1)(2011-2#1)
recently predicted##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
recently presented##3##2##(2008-3#2)(2008-7#1)
recently proposed for##3##3##(2008-10#2)(2012-2#1)
recently proposed method of##2##4##(2007-12#1)(2008-2#1)
recently proposed method##4##3##(2007-12#1)(2008-2#1)(2008-7#2)
recently proposed that the##2##4##(2008-10#1)(2008-11#1)
recently proposed that##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
recently proposed to##2##3##(1990-8#1)(2012-3#1)
recently proposed##37##2##(1990-8#1)(1991-12#1)(1991-5#1)(1994-9#1)(1995-12#2)(2007-11#1)(2007-12#4)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-7#3)(2009-8#1)(2012-2#1)(2012-3#1)
recently published data##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
recently published in##2##3##(1995-2#1)(2010-5#1)
recently published model##2##3##(2008-3#1)(2012-3#1)
recently published studies##2##3##(2008-12#1)(2012-3#1)
recently published##34##2##(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-2#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
recently purified##3##2##(1991-2#1)(1992-12#1)(1993-9#1)
recently received##4##2##(1992-1#1)(1992-12#1)(2008-11#1)(2010-10#1)
recently released##2##2##(2008-10#1)(2013-1#1)
recently reported from##2##3##(1992-9#1)(1995-11#1)
recently reported in##2##3##(2008-5#1)(2008-7#1)
recently reported on##2##3##(2008-11#1)(2011-2#1)
recently reported that the##3##4##(1993-6#1)(1995-6#1)(2008-2#1)
recently reported that##10##3##(1992-6#1)(1993-6#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-2#1)(2008-8#1)(2009-8#2)(2012-2#1)
recently reported the##6##3##(1991-2#1)(1991-8#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-1#1)
recently reported##40##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#4)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
recently revealed that##2##3##(1992-11#1)(2008-8#1)
recently revised##4##2##(1994-5#1)(2008-5#1)(2009-4#1)(2012-2#1)
recently revived##2##2##(2008-10#1)(2012-3#1)
recently showed that##2##3##(2008-10#1)(2009-2#1)
recently shown that the##2##4##(2008-11#1)(2009-5#1)
recently shown that##18##3##(1990-5#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-5#1)(2009-8#7)(2011-2#2)
recently shown to be##2##4##(1994-5#1)(2009-8#1)
recently shown to##4##3##(1993-3#1)(1994-5#1)(2009-10#1)(2009-8#1)
recently shown##23##2##(1990-5#1)(1992-9#1)(1993-3#1)(1994-5#2)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#2)(2009-8#8)(2011-2#2)
recently started##2##2##(2008-7#1)(2012-2#1)
recently suggested to##2##3##(2008-8#1)(2010-12#1)
recently suggested##3##2##(2008-5#1)(2008-8#1)(2010-12#1)
recently synthesized 1##2##3##(2008-10#2)
recently synthesized##16##2##(1990-11#1)(2008-10#14)(2008-2#1)
recently taken##2##2##(1991-1#1)(1997-3#1)
recently that##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
recently the##2##2##(1996-6#1)(2011-2#1)
recently there has been##2##4##(2012-1#1)(2013-1#1)
recently to the##2##3##(2008-10#2)
recently to##8##2##(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#1)(2012-1#1)
recently under##2##2##(2008-10#2)
recently undergone##3##2##(1995-3#1)(1996-3#1)(2007-12#1)
recently used##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
recently utilized##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
recently with##4##2##(1993-3#1)(2008-2#2)(2010-4#1)
recently##1024##1##(1990-11#3)(1990-12#3)(1990-3#4)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#8)(1991-3#4)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#7)(1992-8#5)(1992-9#6)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#10)(1993-6#4)(1993-8#1)(1993-9#3)(1994-1#3)(1994-11#7)(1994-12#12)(1994-2#5)(1994-3#7)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#4)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#9)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#4)(1997-9#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-10#4)(2007-11#9)(2007-12#21)(2007-2#3)(2007-6#1)(2007-7#6)(2007-8#9)(2008-1#10)(2008-10#120)(2008-11#49)(2008-12#11)(2008-2#35)(2008-3#51)(2008-4#21)(2008-5#26)(2008-6#8)(2008-7#42)(2008-8#27)(2008-9#17)(2009-10#8)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#25)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#12)(2010-12#6)(2010-3#7)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#5)(2011-1#10)(2011-2#51)(2011-3#1)(2011-7#2)(2012-1#4)(2012-12#13)(2012-2#27)(2012-3#16)(2012-4#1)(2013-1#28)(2013-7#5)(2013-8#13)
receptacle area##8##2##(2008-10#8)
receptacle of##2##2##(2007-12#1)(2008-7#1)
receptacle##19##1##(1996-9#1)(2007-12#2)(2008-10#11)(2008-7#5)
receptacles##2##1##(2007-10#1)(2008-10#1)
reception of the##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
reception of##5##2##(2008-11#2)(2008-2#2)(2012-2#1)
reception##12##1##(1996-1#1)(2008-11#2)(2008-2#2)(2009-6#1)(2009-8#2)(2012-12#2)(2012-2#2)
receptive and expressive##2##3##(2011-1#1)(2012-2#1)
receptive field##9##2##(1995-11#2)(1996-2#1)(2008-11#1)(2008-8#4)(2012-2#1)
receptive fields of simple cells in the##2##7##(1996-2#1)(2008-11#1)
receptive fields##9##2##(1995-11#1)(1996-2#1)(2007-12#1)(2008-11#3)(2008-8#3)
receptive language##3##2##(2008-9#2)(2010-4#1)
receptive neurons in the##2##4##(1992-3#2)
receptive neurons##3##2##(1992-3#3)
receptive stage##4##2##(1994-9#4)
receptive to##3##2##(1991-6#1)(2008-10#1)(2010-11#1)
receptive##45##1##(1991-6#1)(1992-3#3)(1993-1#1)(1994-9#5)(1995-11#3)(1996-2#2)(1997-1#1)(2007-12#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-8#7)(2008-9#2)(2010-11#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
receptivity of##2##2##(2008-10#1)(2012-3#1)
receptivity##8##1##(1994-9#3)(2008-10#1)(2008-9#2)(2012-3#2)
receptor (AR)##4##2##(1990-11#2)(1995-12#1)(2011-2#1)
receptor (AhR)##4##2##(1993-11#1)(2008-10#3)
receptor (EGF-R)##4##2##(1992-9#1)(1994-8#1)(1994-9#1)(1995-6#1)
receptor (EGFR)##14##2##(1992-8#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2012-1#3)(2012-3#1)(2013-1#1)
receptor (ER) content##2##3##(1993-1#1)(2007-10#1)
receptor (ER)##17##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-1#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)
receptor (FR)##2##2##(2011-1#1)(2013-8#1)
receptor (GHR) and##2##3##(1995-8#1)(2008-4#1)
receptor (GHR) in##2##3##(2010-5#1)(2012-1#1)
receptor (GHR)##5##2##(1995-8#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-1#1)
receptor (Ki = 0##2##4##(1995-12#2)
receptor (LDLR)##2##2##(1995-2#1)(2013-1#1)
receptor (LHR)##2##2##(2008-8#2)
receptor (PR)##3##2##(1995-11#1)(1996-5#1)(1997-7#1)
receptor (TCR) transgenic mice##2##4##(2008-11#2)
receptor (TCR)##6##2##(1994-3#1)(2008-11#3)(2009-8#1)(2011-1#1)
receptor (TR)##2##2##(1990-8#1)(1995-8#1)
receptor (V2R)##2##2##(1993-6#1)(1994-8#1)
receptor (VDR)##6##2##(1992-12#1)(1995-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)
receptor (hIL-6R)##2##2##(2008-8#2)
receptor (nAChR)##2##2##(1994-5#1)(2008-8#1)
receptor 1##4##2##(1995-2#1)(1997-1#1)(2008-11#1)(2012-2#1)
receptor 2##7##2##(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#3)
receptor 3##3##2##(2008-3#2)(2012-3#1)
receptor 4 as##2##3##(1997-7#1)(2010-11#1)
receptor 4##5##2##(1997-7#1)(2008-3#2)(2010-11#1)(2010-8#1)
receptor EP3 subtype##2##3##(1994-9#2)
receptor Flt-1##2##2##(2008-8#2)
receptor LIN-12##2##2##(1994-12#1)(2007-12#1)
receptor action##2##2##(2011-2#1)(2013-8#1)
receptor activated by##3##3##(2008-4#3)
receptor activation by##4##3##(1990-5#1)(1994-6#1)(2008-10#1)(2008-4#1)
receptor activation is##3##3##(1993-8#1)(1996-12#1)(1997-2#1)
receptor activation##30##2##(1990-5#2)(1992-4#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#3)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-4#6)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
receptor activator of nuclear factor kappa B ligand (RANKL)##2##9##(2011-1#2)
receptor activator of nuclear factor kappa B ligand##3##8##(2010-10#1)(2011-1#2)
receptor activator of nuclear factor##4##5##(2007-8#1)(2010-10#1)(2011-1#2)
receptor activator of nuclear##5##4##(2007-8#1)(2008-7#1)(2010-10#1)(2011-1#2)
receptor activator of##8##3##(2007-8#1)(2008-11#2)(2008-7#1)(2010-10#1)(2011-1#2)(2013-1#1)
receptor activator##9##2##(1991-2#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-10#1)(2011-1#2)(2013-1#1)
receptor activity##12##2##(1991-2#3)(1991-5#1)(1992-12#1)(1994-6#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-4#2)(2011-2#1)
receptor affinity and##2##3##(1994-5#1)(2008-11#1)
receptor affinity##8##2##(1992-12#1)(1993-8#1)(1994-5#1)(1996-5#2)(1997-1#1)(2007-11#1)(2008-11#1)
receptor agonist and##2##3##(2008-2#1)(2008-4#1)
receptor agonist##44##2##(1993-5#1)(1994-2#2)(1995-11#1)(1995-12#15)(1995-2#1)(1996-2#6)(1997-1#1)(1997-2#3)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#1)(2010-6#1)(2010-8#1)(2012-2#1)
receptor agonists and antagonists##2##4##(2008-4#1)(2009-7#1)
receptor agonists and##3##3##(1993-12#1)(2008-4#1)(2009-7#1)
receptor agonists in##3##3##(1996-2#1)(1996-5#1)(1997-7#1)
receptor agonists on the##2##4##(1995-12#1)(2008-12#1)
receptor agonists on##3##3##(1995-12#2)(2008-12#1)
receptor agonists##27##2##(1993-12#2)(1993-3#1)(1994-2#3)(1995-12#7)(1995-8#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-7#1)(2008-12#1)(2008-4#3)(2008-7#2)(2009-7#1)
receptor alpha subunit##4##3##(1991-2#2)(1993-12#1)(1995-6#1)
receptor alpha##21##2##(1991-2#2)(1991-9#1)(1993-12#2)(1995-11#1)(1995-6#1)(1996-12#1)(1997-9#2)(2008-11#2)(2008-12#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
receptor alpha-chain##2##2##(1995-6#1)(1997-7#1)
receptor also mediates##2##3##(2008-4#1)(2008-5#1)
receptor also##3##2##(2008-4#2)(2008-5#1)
receptor and a##3##3##(1992-3#1)(1993-3#1)(2008-11#1)
receptor and adrenoreceptor##2##3##(2013-1#2)
receptor and in##2##3##(1993-3#1)(2008-4#1)
receptor and is##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
receptor and its##4##3##(1992-8#1)(1995-11#1)(2008-8#1)(2012-2#1)
receptor and plasminogen activator activity by estrogen are related to the##2##11##(2008-11#2)
receptor and subsequent##4##3##(1995-6#1)(2008-11#1)(2011-2#1)(2013-7#1)
receptor and that##3##3##(1991-12#1)(1992-4#1)(1997-6#1)
receptor and the##7##3##(1990-12#1)(1992-8#2)(2008-11#1)(2008-4#2)(2008-7#1)
receptor and to##2##3##(2008-4#1)(2008-9#1)
receptor and with the##2##4##(1996-2#2)
receptor and##96##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-8#4)(1993-3#3)(1993-9#1)(1994-12#2)(1994-2#3)(1994-8#1)(1995-11#3)(1995-12#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#4)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#4)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#10)(2008-3#2)(2008-4#12)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-8#2)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-7#1)
receptor antagonism have##2##3##(2007-8#1)(2008-2#1)
receptor antagonism##5##2##(2007-8#3)(2008-2#1)(2013-8#1)
receptor antagonist (IL-1ra)##4##3##(1995-2#1)(2007-11#1)(2008-5#1)(2011-1#1)
receptor antagonist and an##3##4##(1995-8#1)(2008-6#2)
receptor antagonist and##5##3##(1995-12#1)(1995-8#1)(2008-6#2)(2012-12#1)
receptor antagonist bicuculline##2##3##(1997-2#2)
receptor antagonist in##2##3##(1994-9#1)(1995-12#1)
receptor antagonist on##2##3##(1992-3#1)(1995-12#1)
receptor antagonist with##3##3##(1995-12#2)(1996-2#1)
receptor antagonist##130##2##(1990-12#2)(1990-5#4)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#7)(1992-8#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#6)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#24)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#8)(1996-5#2)(1997-2#5)(1997-4#4)(1997-7#5)(2006-6#3)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-1#4)
receptor antagonist)##4##2##(1995-12#2)(2008-5#1)(2012-2#1)
receptor antagonists and##4##3##(1995-10#2)(1995-12#1)(2008-7#1)
receptor antagonists in##2##3##(1992-11#1)(2008-1#1)
receptor antagonists on##3##3##(1991-5#1)(1992-3#1)(1994-2#1)
receptor antagonists to##2##3##(1992-3#1)(1994-11#1)
receptor antagonists were##3##3##(1995-12#1)(2007-11#1)(2008-5#1)
receptor antagonists##58##2##(1991-5#3)(1991-8#1)(1992-11#1)(1992-3#3)(1994-11#3)(1994-2#1)(1994-8#1)(1995-10#2)(1995-11#3)(1995-12#7)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-12#1)
receptor antibodies##5##2##(1991-12#1)(1991-5#1)(1995-6#1)(2008-4#1)(2009-11#1)
receptor antibody##4##2##(1991-5#1)(1994-3#1)(2008-11#1)(2013-1#1)
receptor are##3##2##(1992-12#1)(1995-12#1)(2009-5#1)
receptor as##5##2##(1995-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)
receptor at##6##2##(1992-12#1)(1993-1#1)(1993-6#1)(1995-6#2)(2008-8#1)
receptor autoantibodies##3##2##(1992-12#1)(2012-3#2)
receptor autophosphorylation##4##2##(1990-12#1)(1992-10#1)(1994-6#2)
receptor availability##2##2##(1996-5#1)(2011-1#1)
receptor based on##2##3##(1991-1#1)(2008-4#1)
receptor behavior##2##2##(2008-10#1)(2008-5#1)
receptor beta chain##3##3##(1997-5#2)(2008-4#1)
receptor beta##6##2##(1995-8#1)(1996-2#1)(1997-5#2)(2008-4#1)(2008-7#1)
receptor beta-chain##3##2##(1994-11#2)(1995-6#1)
receptor between##2##2##(1991-12#1)(1996-12#1)
receptor binding affinity##3##3##(1992-8#1)(1993-1#1)(1997-4#1)
receptor binding and Nb2 cell proliferation##2##6##(1994-11#2)
receptor binding and##11##3##(1993-3#1)(1994-11#3)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-4#1)
receptor binding assays##5##3##(1991-12#1)(1992-12#1)(1994-5#1)(1995-3#1)(1995-8#1)
receptor binding capacity##3##3##(1997-6#1)(2008-9#2)
receptor binding in##6##3##(1990-11#1)(1991-5#1)(1992-3#1)(1993-12#1)(1996-5#2)
receptor binding of##3##3##(1991-1#1)(1996-12#1)(2008-4#1)
receptor binding site##3##3##(1993-3#1)(1994-11#1)(1994-8#1)
receptor binding sites##4##3##(1990-12#3)(1995-11#1)
receptor binding was##3##3##(1993-12#1)(1996-12#1)(1996-2#1)
receptor binding##70##2##(1990-11#2)(1990-12#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#4)(1993-1#1)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#3)(1997-4#2)(1997-6#1)(2007-11#1)(2008-4#3)(2008-8#1)(2008-9#4)(2009-2#1)(2013-8#2)
receptor binds and##2##3##(1995-2#1)(1995-6#1)
receptor binds##6##2##(1990-5#1)(1991-2#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-6#1)
receptor blockade##6##2##(1994-11#1)(1994-9#1)(1995-12#1)(2008-4#1)(2010-4#1)(2011-2#1)
receptor blocker##12##2##(1994-2#4)(1995-12#1)(1996-12#1)(1996-2#1)(2008-4#3)(2008-9#1)(2012-3#1)
receptor blockers and##2##3##(1996-3#1)(2008-11#1)
receptor blockers in##2##3##(2008-11#1)(2008-8#1)
receptor blockers##12##2##(1996-3#1)(1996-6#3)(2008-1#1)(2008-11#3)(2008-7#1)(2008-8#2)(2011-2#1)
receptor but##3##2##(1990-11#2)(1994-9#1)
receptor by protein kinase C##2##5##(1992-11#1)(1995-6#1)
receptor by##22##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(2008-8#1)
receptor c-Mpl##2##2##(2008-8#2)
receptor cDNA as a probe##2##5##(1994-11#1)(1995-6#1)
receptor cDNA coding##2##3##(1992-3#1)(1993-3#1)
receptor cDNA fragment##2##3##(1991-5#1)(1993-3#1)
receptor cDNA was##2##3##(1992-3#1)(1995-12#1)
receptor cDNA##22##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-3#3)(1994-11#2)(1994-9#2)(1995-12#2)(1995-6#4)(1997-9#1)(2008-8#1)
receptor cDNAs##3##2##(1992-9#1)(1995-12#1)(1997-2#1)
receptor can be##3##3##(1993-9#1)(1994-2#1)(1995-11#1)
receptor can##7##2##(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
receptor cell##4##2##(2007-12#2)(2008-10#1)(2008-7#1)
receptor cells in taste buds##2##5##(2013-1#2)
receptor cells in##3##3##(1994-2#1)(2013-1#2)
receptor cells##9##2##(1991-5#1)(1994-2#1)(2007-12#3)(2008-7#1)(2013-1#3)
receptor chains##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
receptor channel##3##2##(2008-4#3)
receptor class##3##2##(1993-12#1)(1995-11#1)(2013-1#1)
receptor complex##16##2##(1991-1#2)(1993-11#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-8#1)(1996-2#2)(1996-7#2)(2009-8#1)(2010-5#1)
receptor complexes##5##2##(1992-11#2)(1995-11#1)(1996-2#1)(2008-9#1)
receptor conformation##3##2##(1991-5#1)(1992-9#1)(1993-3#1)
receptor consists of##3##3##(1991-5#1)(1995-6#1)(2007-12#1)
receptor contact##2##2##(1994-5#2)
receptor content##5##2##(1991-12#1)(1993-1#1)(1994-9#1)(2008-11#2)
receptor could be##3##3##(1993-9#1)(2008-4#1)(2008-8#1)
receptor could##4##2##(1993-9#1)(2008-4#1)(2008-8#2)
receptor coupled to##2##3##(1991-2#1)(1993-8#1)
receptor coupled##4##2##(1991-2#1)(1993-8#1)(1995-3#1)(1996-5#1)
receptor deficient mice##2##3##(2008-6#2)
receptor degradation##2##2##(1993-8#1)(1997-5#1)
receptor densities and##2##3##(1994-2#2)
receptor densities##8##2##(1994-2#4)(1996-7#1)(2008-11#3)
receptor density and mRNA##3##4##(1995-2#3)
receptor density and##5##3##(1992-5#1)(1995-12#1)(1995-2#3)
receptor density in the##3##4##(1992-5#3)
receptor density in##4##3##(1992-5#3)(1993-12#1)
receptor density on##2##3##(1992-12#1)(1995-2#1)
receptor density was##4##3##(1992-5#4)
receptor density##27##2##(1992-12#1)(1992-5#8)(1993-12#4)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#3)(1996-7#3)(2008-11#2)
receptor desensitization##3##2##(1995-12#1)(1997-1#1)(2008-5#1)
receptor did not##2##3##(1990-2#1)(2008-4#1)
receptor distribution##2##2##(1996-12#1)(2012-1#1)
receptor domains##5##2##(1993-6#3)(1994-6#1)(1996-2#1)
receptor dysfunction##2##2##(1995-12#1)(2008-6#1)
receptor exhibited##2##2##(1994-12#1)(1995-6#1)
receptor expressed in Xenopus##2##4##(1992-3#1)(2008-4#1)
receptor expressed in##5##3##(1992-3#2)(1995-11#1)(2008-4#1)(2009-12#1)
receptor expressed##8##2##(1992-12#1)(1992-3#2)(1993-3#1)(1995-11#1)(2008-4#2)(2009-12#1)
receptor expressing##2##2##(1991-2#1)(1996-5#1)
receptor expression and##4##3##(1994-9#1)(2008-11#1)(2008-3#1)(2010-8#1)
receptor expression by##3##3##(1991-5#1)(1992-5#1)(2008-5#1)
receptor expression in##9##3##(1991-2#1)(1991-5#1)(1994-11#2)(1995-12#1)(2008-4#1)(2010-11#1)(2012-3#1)(2013-7#1)
receptor expression on##2##3##(2008-4#2)
receptor expression##43##2##(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1992-5#3)(1994-11#4)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#1)(2010-11#3)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
receptor extracellular domain##2##3##(1990-12#1)(1995-11#1)
receptor family of##2##3##(1994-9#1)(2008-4#1)
receptor family##12##2##(1993-2#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-1#1)(2008-4#3)(2013-8#1)
receptor for VEGF##2##3##(1992-9#2)
receptor for sperm##2##3##(1994-5#1)(1995-6#1)
receptor for the##4##3##(1995-2#1)(2008-4#2)(2011-2#1)
receptor for##34##2##(1990-11#2)(1990-5#2)(1991-12#1)(1992-12#2)(1992-9#4)(1993-11#1)(1994-11#1)(1994-5#2)(1994-6#2)(1995-2#1)(1995-6#2)(1996-12#1)(2008-10#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#2)
receptor from human placenta##2##4##(1990-2#2)
receptor from the##2##3##(1990-12#1)(1990-8#1)
receptor from##7##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#1)(2008-11#1)(2008-4#1)
receptor function was##2##3##(1992-3#1)(2008-5#1)
receptor function##13##2##(1990-12#1)(1991-5#1)(1992-3#2)(1995-11#3)(1995-12#1)(1995-5#1)(2008-4#2)(2008-5#1)(2011-1#1)
receptor functions##3##2##(1991-9#1)(1996-2#1)(1997-2#1)
receptor gamma 2 subunit subtype##3##5##(1995-11#3)
receptor gamma 2 subunit##4##4##(1995-11#3)(1995-12#1)
receptor gamma 2##5##3##(1994-12#1)(1995-11#3)(1995-12#1)
receptor gamma##6##2##(1994-12#1)(1995-11#3)(1995-12#1)(2009-8#1)
receptor gene and##2##3##(2008-4#1)(2008-9#1)
receptor gene expression##6##3##(1991-12#2)(1992-9#1)(1993-9#1)(1994-5#1)(2010-5#1)
receptor gene has##2##3##(1993-11#1)(1993-9#1)
receptor gene in the##4##4##(1990-11#1)(1991-2#1)(1991-5#1)(1995-6#1)
receptor gene in##9##3##(1990-11#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-12#2)(1995-6#1)(2008-11#1)(2010-11#1)
receptor gene that##2##3##(1993-11#1)(1994-8#1)
receptor gene transfer##2##3##(2012-2#2)
receptor gene was##3##3##(1991-5#2)(2008-1#1)
receptor gene##67##2##(1990-11#1)(1991-12#3)(1991-2#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#2)(1996-12#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#6)(2010-11#1)(2010-5#1)(2012-2#2)(2013-8#1)
receptor genes##16##2##(1991-2#2)(1992-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1997-2#2)(1997-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)
receptor genotype##2##2##(1995-9#1)(2010-4#1)
receptor has been##7##3##(1992-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
receptor has##10##2##(1992-3#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)
receptor have##2##2##(2007-12#1)(2008-11#1)
receptor in a##6##3##(1992-12#2)(1993-3#1)(1993-8#1)(1995-11#1)(2008-4#1)
receptor in human##4##3##(1990-2#2)(2008-10#1)(2008-5#1)
receptor in rat##2##3##(1992-12#1)(1995-12#1)
receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat##2##19##(1995-12#2)
receptor in the##23##3##(1990-11#1)(1990-5#1)(1990-7#2)(1991-7#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
receptor in these##3##3##(1994-12#2)(2008-4#1)
receptor in##84##2##(1990-11#3)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#4)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#5)(1994-11#2)(1994-12#3)(1994-2#2)(1994-8#4)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#4)(2009-2#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
receptor independent##2##2##(2009-8#2)
receptor inhibitors in##3##3##(2008-1#1)(2009-4#1)(2012-1#1)
receptor inhibitors##4##2##(2006-6#1)(2008-1#1)(2009-4#1)(2012-1#1)
receptor interaction##5##2##(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(2013-8#1)
receptor interactions##6##2##(1990-4#1)(1994-5#1)(1996-2#1)(2008-4#2)(2008-9#1)
receptor internalization##5##2##(1990-11#2)(1995-2#1)(1996-2#1)(2008-5#1)
receptor involved in##2##3##(2008-4#1)(2008-7#1)
receptor involvement##2##2##(1991-2#1)(1994-11#1)
receptor is a##4##3##(1991-2#1)(1993-3#1)(1993-6#1)(1995-11#1)
receptor is an##3##3##(1993-3#1)(1994-8#1)(2008-4#1)
receptor is currently##2##3##(2008-4#1)(2008-5#1)
receptor is involved in the##2##5##(2008-4#1)(2008-5#1)
receptor is involved in##4##4##(2008-4#2)(2008-5#1)(2008-8#1)
receptor is necessary for##3##4##(1990-11#2)(1995-2#1)
receptor is##53##2##(1990-11#3)(1990-12#1)(1991-2#4)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#5)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#3)(1996-5#1)(1997-2#1)(2007-10#2)(2008-11#2)(2008-4#7)(2008-5#3)(2008-8#1)(2011-2#1)
receptor isoforms##3##2##(1994-9#1)(1997-1#1)(2008-10#1)
receptor kinase##5##2##(1991-12#2)(1992-12#1)(1992-3#1)(2011-2#1)
receptor kinases##2##2##(1995-2#1)(2009-8#1)
receptor knockout##2##2##(2008-11#1)(2008-5#1)
receptor level as well as plasminogen activator activity in MCF-7 cells##3##11##(2008-11#3)
receptor level##6##2##(1991-9#1)(1993-6#1)(2008-11#3)(2008-7#1)
receptor levels and the##2##4##(1991-2#1)(1993-11#1)
receptor levels in##2##3##(1993-12#1)(2013-1#1)
receptor levels##12##2##(1991-2#1)(1993-11#1)(1993-12#2)(1994-2#2)(1994-5#1)(1995-12#1)(1996-12#3)(2013-1#1)
receptor ligand##6##2##(1993-3#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2009-8#1)
receptor ligands in##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
receptor ligands including##2##3##(1995-6#1)(2009-8#1)
receptor ligands##18##2##(1992-3#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-8#1)(2013-1#1)
receptor mRNA and##5##3##(1991-5#1)(1993-3#1)(1993-5#1)(1996-2#2)
receptor mRNA expression in##2##4##(1993-3#1)(2010-12#1)
receptor mRNA expression##6##3##(1993-3#2)(1996-2#1)(2008-5#2)(2010-12#1)
receptor mRNA from##2##3##(1994-9#1)(2008-7#1)
receptor mRNA in the##2##4##(1996-5#1)(2008-5#1)
receptor mRNA in##6##3##(1993-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-5#1)
receptor mRNA is##2##3##(1993-11#1)(1993-12#1)
receptor mRNA level##2##3##(1991-5#1)(1995-2#1)
receptor mRNA levels were##2##4##(1992-12#1)(1994-11#1)
receptor mRNA were##2##3##(1993-3#1)(1994-11#1)
receptor mRNA##41##2##(1991-12#1)(1991-5#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#2)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-2#6)(1996-5#3)(2008-4#1)(2008-5#5)(2008-7#1)(2010-12#1)
receptor mRNAs in##2##3##(1993-12#1)(1995-12#1)
receptor mRNAs##5##2##(1993-12#2)(1995-12#1)(1996-2#1)(2008-6#1)
receptor may be##3##3##(1995-2#1)(2008-10#2)
receptor may play a##2##4##(1990-11#1)(2008-4#1)
receptor may##11##2##(1990-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)
receptor mediated##7##2##(1991-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-8#1)
receptor mediating##2##2##(1995-12#1)(1997-7#1)
receptor messenger RNA##2##3##(1991-5#1)(1994-6#1)
receptor might be##2##3##(1990-5#1)(1993-3#1)
receptor modulators with##2##3##(2007-12#1)(2008-4#1)
receptor modulators##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#2)
receptor molecule##2##2##(2008-1#1)(2012-2#1)
receptor molecules and##3##3##(1996-12#2)(2008-5#1)
receptor molecules in##2##3##(1993-8#1)(1996-12#1)
receptor molecules##14##2##(1993-8#3)(1994-9#1)(1996-12#5)(2008-1#2)(2008-4#1)(2008-5#1)(2009-8#1)
receptor negative##2##2##(2008-2#1)(2011-1#1)
receptor neurons##10##2##(2007-12#8)(2008-7#1)(2009-12#1)
receptor nor##4##2##(1992-8#1)(1994-6#1)(1995-12#1)(2008-11#1)
receptor number##2##2##(1990-5#1)(1993-6#1)
receptor occurs##2##2##(1992-8#1)(1992-9#1)
receptor of bacterial chemotaxis##2##4##(1992-8#1)(1994-5#1)
receptor of the##3##3##(1995-8#1)(1997-6#1)(2011-2#1)
receptor of##18##2##(1990-7#2)(1991-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-5#2)(1995-2#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-8#2)(2011-2#1)
receptor on the##5##3##(1990-5#2)(1994-11#1)(2008-11#1)(2008-5#1)
receptor on##14##2##(1990-5#2)(1992-10#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(2008-11#3)(2008-5#1)(2012-2#1)(2013-7#1)
receptor operated##2##2##(1993-8#1)(1995-5#1)
receptor or##5##2##(1990-8#1)(1993-9#1)(1995-3#1)(2008-4#1)(2013-1#1)
receptor pathway##6##2##(2008-4#2)(2012-2#2)(2013-1#1)(2013-8#1)
receptor phosphorylation##6##2##(1992-3#1)(1993-3#1)(1995-6#2)(1996-12#1)(2013-7#1)
receptor plays a##5##3##(1993-3#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-4#1)
receptor polymorphism##2##2##(2008-1#1)(2008-3#1)
receptor population##2##2##(1994-9#1)(2008-3#1)
receptor populations##3##2##(1991-4#1)(1994-11#1)(1994-9#1)
receptor positive##5##2##(1993-9#2)(2008-12#1)(2010-1#1)(2013-1#1)
receptor present##2##2##(1993-6#1)(1994-11#1)
receptor production##2##2##(2008-11#2)
receptor promoter##4##2##(1991-7#1)(1994-11#1)(1996-5#1)(2008-6#1)
receptor protein tyrosine kinase##3##4##(1993-8#2)(1997-7#1)
receptor protein##14##2##(1990-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-8#2)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#1)
receptor proteins##6##2##(1992-2#1)(1992-3#1)(1994-11#1)(1995-8#2)(2009-12#1)
receptor pseudogene##2##2##(1993-12#1)(1993-2#1)
receptor purified##2##2##(1991-12#1)(1992-11#1)
receptor recognition site##2##3##(1991-2#1)(1995-12#1)
receptor recognition##3##2##(1991-2#1)(1995-12#1)(2008-8#1)
receptor regulated##3##2##(1993-6#1)(1994-12#1)(2008-8#1)
receptor regulation and##2##3##(2008-4#2)
receptor regulation##6##2##(1993-6#1)(2008-4#3)(2008-8#1)(2009-8#1)
receptor remains##2##2##(1994-8#1)(1995-6#1)
receptor represents a##2##3##(1995-11#1)(1996-12#1)
receptor selective##3##2##(1991-12#1)(1994-11#1)(1995-3#1)
receptor selectivity##2##2##(1992-3#1)(2011-2#1)
receptor sequence##2##2##(1995-6#1)(2011-2#1)
receptor showed##2##2##(1995-11#1)(1997-2#1)
receptor signal##2##2##(1992-12#1)(1996-2#1)
receptor signaling in##5##3##(2008-11#1)(2010-11#2)(2012-2#2)
receptor signaling##17##2##(1991-9#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#4)(2010-3#1)(2012-2#3)
receptor signalling##2##2##(2008-4#2)
receptor since##2##2##(1993-1#1)(1995-6#1)
receptor site##3##2##(1990-5#1)(1995-3#1)(2007-11#1)
receptor sites on##2##3##(1991-2#1)(1995-11#1)
receptor sites##5##2##(1991-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-5#1)
receptor specifically##2##2##(1994-12#1)(1995-6#1)
receptor status and##2##3##(1991-12#1)(2013-1#1)
receptor status##11##2##(1991-12#1)(1992-8#1)(1993-11#2)(1994-7#1)(1995-4#2)(1995-9#1)(2007-4#1)(2009-12#1)(2013-1#1)
receptor stimulates##2##2##(1994-6#1)(1997-7#1)
receptor stimulation is##2##3##(1994-2#1)(1995-11#1)
receptor stimulation##9##2##(1994-2#1)(1995-11#2)(1995-2#1)(1996-6#1)(1997-2#1)(2008-4#2)(2010-12#1)
receptor substrates##2##2##(1992-10#1)(2008-6#1)
receptor subtype activation)##2##3##(1995-12#2)
receptor subtype##34##2##(1991-9#1)(1992-12#1)(1992-3#4)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#3)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-4#4)
receptor subtypes are##2##3##(1990-5#1)(1995-12#1)
receptor subtypes have been##2##4##(1993-12#1)(1995-11#1)
receptor subtypes have##3##3##(1993-12#1)(1994-6#1)(1995-11#1)
receptor subtypes in the##2##4##(1991-9#1)(1996-5#1)
receptor subtypes in##4##3##(1990-11#1)(1991-11#1)(1991-9#1)(1996-5#1)
receptor subtypes##36##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-12#4)(1993-3#1)(1994-11#1)(1994-6#4)(1995-11#2)(1995-12#2)(1995-2#2)(1996-2#1)(1996-5#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)
receptor subunit genes##2##3##(1990-8#1)(1996-2#1)
receptor subunit in the##2##4##(1995-12#2)
receptor subunit##23##2##(1990-8#1)(1993-11#2)(1993-12#2)(1994-5#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-12#5)(1996-2#1)(1996-5#2)(1997-2#3)(2008-7#1)
receptor subunits##11##2##(1990-8#2)(1993-9#1)(1995-5#3)(1997-2#1)(1997-7#2)(2010-8#1)(2013-1#1)
receptor superfamily##14##2##(1991-5#1)(1993-6#1)(1994-12#3)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#2)(2006-8#1)(2007-8#1)(2008-3#1)
receptor synthesis##3##2##(1992-9#1)(1993-8#1)(1994-5#1)
receptor system##4##2##(1990-12#2)(2008-11#1)(2008-4#1)
receptor systems##2##2##(1994-2#1)(2008-4#1)
receptor targeting##2##2##(1993-8#1)(2011-1#1)
receptor that is##2##3##(1996-12#1)(2008-4#1)
receptor that##8##2##(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-4#3)
receptor to DNA##2##3##(1995-2#1)(2008-4#1)
receptor to the##3##3##(1990-7#1)(1994-11#1)(1995-11#1)
receptor to##11##2##(1990-7#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
receptor transcripts##2##2##(1993-3#1)(1994-9#1)
receptor transfected cells was##2##4##(1993-9#2)
receptor type##4##2##(1994-6#1)(1996-12#1)(2011-2#1)(2013-8#1)
receptor tyrosine kinase activity##4##4##(1990-12#2)(1991-12#1)(1997-1#1)
receptor tyrosine kinase domain##2##4##(1992-12#2)
receptor tyrosine kinase gene##2##4##(1992-9#1)(2008-7#1)
receptor tyrosine kinase genes##2##4##(1993-8#1)(2008-7#1)
receptor tyrosine kinase inhibitor##2##4##(2008-6#1)(2010-7#1)
receptor tyrosine kinase##21##3##(1990-12#2)(1991-12#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-6#1)(2008-7#3)(2010-4#1)(2010-7#1)(2012-1#1)
receptor tyrosine kinases (RTKs)##2##4##(1993-8#1)(2009-9#1)
receptor tyrosine kinases##8##3##(1993-8#1)(1994-11#1)(1995-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)
receptor tyrosine##29##2##(1990-12#2)(1991-12#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-8#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-8#1)(1997-1#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-1#1)
receptor using##2##2##(1992-11#1)(1992-9#1)
receptor variants in isolated adipocytes##2##5##(1991-12#2)
receptor variants##3##2##(1991-12#2)(2012-2#1)
receptor varies##2##2##(1995-12#1)(1996-2#1)
receptor via##2##2##(1990-12#1)(1995-6#1)
receptor was involved in##3##4##(1994-12#1)(2008-4#1)(2008-8#1)
receptor was##26##2##(1990-11#1)(1990-2#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-8#1)(1997-2#1)(2008-11#3)(2008-4#6)(2008-8#3)(2008-9#1)(2011-2#1)(2013-7#1)
receptor were##7##2##(1991-11#1)(1991-5#1)(1992-12#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
receptor which##4##2##(1991-2#1)(1992-12#1)(1992-8#1)(2008-11#1)
receptor with a##4##3##(1990-12#1)(1993-3#1)(1994-12#1)(1995-11#1)
receptor with the##2##3##(1990-8#1)(1993-3#1)
receptor with##13##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-11#1)(2008-4#1)(2013-7#1)
receptor##2748##1##(1990-11#36)(1990-12#33)(1990-2#14)(1990-4#4)(1990-5#29)(1990-6#2)(1990-7#13)(1990-8#14)(1991-1#7)(1991-11#3)(1991-12#33)(1991-2#35)(1991-3#3)(1991-4#1)(1991-5#33)(1991-6#5)(1991-7#3)(1991-8#1)(1991-9#16)(1992-10#6)(1992-11#14)(1992-12#42)(1992-2#3)(1992-3#52)(1992-4#4)(1992-5#12)(1992-6#3)(1992-7#1)(1992-8#23)(1992-9#32)(1993-1#7)(1993-11#24)(1993-12#42)(1993-2#5)(1993-3#68)(1993-5#9)(1993-6#26)(1993-8#45)(1993-9#21)(1994-11#59)(1994-12#43)(1994-2#39)(1994-3#3)(1994-5#28)(1994-6#33)(1994-7#1)(1994-8#43)(1994-9#28)(1995-10#2)(1995-11#65)(1995-12#120)(1995-2#66)(1995-3#22)(1995-4#3)(1995-5#12)(1995-6#73)(1995-8#28)(1995-9#2)(1996-12#55)(1996-2#57)(1996-3#2)(1996-5#46)(1996-6#11)(1996-7#13)(1996-9#1)(1997-1#13)(1997-2#39)(1997-3#3)(1997-4#15)(1997-5#6)(1997-6#11)(1997-7#34)(1997-8#2)(1997-9#5)(2006-6#10)(2006-8#2)(2007-10#5)(2007-11#10)(2007-12#21)(2007-4#1)(2007-7#1)(2007-8#8)(2008-1#18)(2008-10#44)(2008-11#111)(2008-12#6)(2008-2#8)(2008-3#20)(2008-4#208)(2008-5#45)(2008-6#23)(2008-7#55)(2008-8#79)(2008-9#42)(2009-11#1)(2009-12#12)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#5)(2009-7#6)(2009-8#26)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#11)(2010-12#5)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#19)(2011-2#44)(2011-3#2)(2012-1#13)(2012-12#10)(2012-2#35)(2012-3#14)(2013-1#46)(2013-7#11)(2013-8#16)
receptor&quot##2##1##(1990-11#1)(1995-2#1)
receptor'##2##1##(2008-11#1)(2012-12#1)
receptor(s) in##2##2##(2008-10#1)(2013-1#1)
receptor(s)##7##1##(1990-5#2)(1993-3#1)(1994-9#1)(1997-2#1)(2008-10#1)(2013-1#1)
receptor) and##3##2##(2008-4#1)(2010-6#1)(2011-2#1)
receptor)##11##1##(1993-12#1)(1994-12#1)(1995-6#1)(2008-11#2)(2008-4#3)(2008-8#1)(2010-6#1)(2011-2#1)
receptor-##2##1##(2008-7#1)(2013-1#1)
receptor-1##5##1##(1993-6#2)(1995-8#1)(2009-3#1)(2010-5#1)
receptor-activated##2##1##(1996-2#1)(2008-4#1)
receptor-alpha##3##1##(2011-2#2)(2013-1#1)
receptor-associated##4##1##(1995-8#1)(2008-8#1)(2013-1#2)
receptor-bearing neurons##3##2##(1991-12#3)
receptor-binding affinity##4##2##(2012-2#4)
receptor-binding region##2##2##(1990-4#2)
receptor-binding##14##1##(1990-4#2)(1991-2#1)(1992-3#3)(1995-12#1)(2008-10#1)(2012-2#6)
receptor-bound##6##1##(1993-8#3)(1994-5#1)(1995-11#1)(2009-8#1)
receptor-centered gene networks##4##3##(2013-1#4)
receptor-dependent mechanism##2##2##(1992-8#1)(1995-8#1)
receptor-dependent##9##1##(1992-8#1)(1993-12#1)(1995-12#1)(1995-8#1)(1997-1#1)(2009-8#1)(2013-1#3)
receptor-derived##2##1##(1992-4#1)(2008-11#1)
receptor-effector##2##1##(1990-5#1)(1995-6#1)
receptor-encoding gene##2##2##(1993-6#1)(2013-8#1)
receptor-independent##3##1##(1992-3#1)(1993-12#1)(1995-2#1)
receptor-induced##2##1##(1992-6#1)(2011-2#1)
receptor-ligand binding##3##2##(2008-1#1)(2008-4#1)(2009-2#1)
receptor-ligand interactions##2##2##(1995-11#1)(2008-4#1)
receptor-ligand##9##1##(1994-12#1)(1995-11#1)(2008-1#1)(2008-12#1)(2008-4#2)(2009-10#1)(2009-2#1)(2009-3#1)
receptor-like##9##1##(1991-5#1)(1993-12#1)(1996-2#2)(2008-10#1)(2008-11#2)(2009-10#2)
receptor-mediated activation of##2##3##(2008-4#1)(2008-7#1)
receptor-mediated antigen delivery and incorporation system##2##6##(1993-3#2)
receptor-mediated endocytosis##7##2##(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#2)
receptor-mediated glutamatergic##2##2##(1995-12#1)(2008-4#1)
receptor-mediated inhibition of adenylyl cyclase##2##5##(1995-12#1)(1997-1#1)
receptor-mediated inhibition##4##2##(1995-12#1)(1997-1#1)(2011-2#2)
receptor-mediated inositol##2##2##(1995-11#1)(1997-1#1)
receptor-mediated inward current##2##3##(1995-11#2)
receptor-mediated inward currents evoked##2##4##(1995-11#2)
receptor-mediated inward currents##4##3##(1995-11#4)
receptor-mediated inward##6##2##(1995-11#6)
receptor-mediated mechanisms##2##2##(1992-3#1)(1996-12#1)
receptor-mediated responses##2##2##(1990-12#1)(2008-4#1)
receptor-mediated##72##1##(1990-12#1)(1991-12#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-3#6)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#9)(1995-12#4)(1995-2#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#9)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
receptor-negative##3##1##(1990-8#1)(1997-7#1)(2011-1#1)
receptor-operated##4##1##(1993-11#1)(1993-8#1)(2008-8#2)
receptor-positive##6##1##(1991-12#1)(1992-4#1)(1997-7#1)(1997-8#1)(2008-11#1)(2011-1#1)
receptor-regulated SMAD##2##2##(2011-2#2)
receptor-selective##3##1##(1991-1#1)(1994-11#1)(1995-12#1)
receptor-specific regulation of the##2##4##(1993-6#2)
receptor-specific##6##1##(1992-12#1)(1993-1#1)(1993-6#2)(1994-2#1)(2010-5#1)
receptor-stimulated phosphoinositide##2##2##(1992-10#1)(1996-5#1)
receptor-stimulated##5##1##(1992-10#1)(1992-3#1)(1996-2#1)(1996-5#1)(1996-9#1)
receptor-targeted##2##1##(2008-8#1)(2013-8#1)
receptor-type##2##1##(1997-7#2)
receptor/channel complex##2##2##(1992-3#1)(1994-8#1)
receptor?##2##1##(1991-1#1)(1995-11#1)
receptors (ER)##3##2##(1994-9#1)(2012-2#1)(2013-8#1)
receptors (RXR)##2##2##(1995-8#1)(2008-5#1)
receptors (TCR)##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
receptors activate##2##2##(1996-2#1)(2008-7#1)
receptors agonists##2##2##(1994-11#1)(2013-1#1)
receptors alpha##2##2##(1994-6#1)(2008-4#1)
receptors also##4##2##(1991-1#1)(1995-12#1)(2008-4#2)
receptors and are##2##3##(1993-8#1)(2008-8#1)
receptors and beta-adrenoceptors in##3##4##(1995-12#3)
receptors and beta-adrenoceptors##5##3##(1995-12#5)
receptors and has##3##3##(1991-2#1)(2008-7#1)(2011-2#1)
receptors and is##2##3##(1992-11#1)(1997-7#1)
receptors and its##2##3##(1992-12#1)(2009-7#1)
receptors and may##2##3##(1990-6#1)(1995-2#1)
receptors and other##2##3##(2008-4#1)(2008-9#1)
receptors and that the##2##4##(1991-5#1)(1994-12#1)
receptors and the##14##3##(1991-5#1)(1993-2#1)(1994-2#1)(1995-12#3)(1995-2#1)(1996-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#2)
receptors and their##8##3##(1991-5#1)(1994-2#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)
receptors and was##2##3##(1995-3#2)
receptors and##120##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#5)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#4)(1995-5#1)(1996-12#3)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#13)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-12#2)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#5)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
receptors appear to be##2##4##(2008-5#2)
receptors are also##3##3##(1995-2#1)(2009-8#1)(2012-2#1)
receptors are expressed in the##3##5##(1992-9#1)(2008-4#2)
receptors are expressed in##4##4##(1992-9#1)(2008-4#2)(2008-6#1)
receptors are expressed##5##3##(1992-9#1)(2008-4#3)(2008-6#1)
receptors are involved in##4##4##(1993-5#1)(1994-8#1)(2008-4#1)(2008-8#1)
receptors are involved##5##3##(1993-5#1)(1994-8#1)(2008-1#1)(2008-4#1)(2008-8#1)
receptors are known to##2##4##(1991-12#1)(2011-1#1)
receptors are likely to be##2##5##(2008-4#2)
receptors are localized##2##3##(1996-12#1)(2008-4#1)
receptors are more##2##3##(2008-4#1)(2008-6#1)
receptors are present in##2##4##(1993-3#1)(2008-6#1)
receptors are widely##2##3##(2008-3#1)(2011-2#1)
receptors are##69##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#3)(1996-7#1)(1997-2#1)(1997-7#1)(2008-1#3)(2008-3#1)(2008-4#25)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)
receptors as well as##5##4##(1993-8#1)(1995-11#1)(2008-4#2)(2013-8#1)
receptors as##13##2##(1992-11#1)(1993-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(2008-11#2)(2008-4#4)(2008-7#1)(2013-8#1)
receptors associated with##3##3##(1991-5#1)(1994-8#1)(2010-5#1)
receptors at the##3##3##(1991-12#1)(1992-12#1)(2008-4#1)
receptors at##4##2##(1991-12#1)(1992-12#1)(2008-4#1)(2009-9#1)
receptors but not with##2##4##(1997-7#2)
receptors but not##3##3##(1995-11#1)(1997-7#2)
receptors but##5##2##(1992-12#1)(1995-11#1)(1995-3#1)(1997-7#2)
receptors by both##2##3##(1995-11#1)(1995-6#1)
receptors by##20##2##(1990-11#1)(1991-12#1)(1992-4#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(2008-4#2)(2008-8#1)
receptors can be##4##3##(1993-5#1)(1994-6#1)(1995-11#1)(2008-4#1)
receptors can##10##2##(1990-11#1)(1993-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(2007-12#2)(2008-4#2)(2013-1#1)
receptors contain##2##2##(1990-11#1)(1994-11#1)
receptors contributes to##2##3##(1994-6#1)(2012-12#1)
receptors could##2##2##(2008-7#2)
receptors differ##2##2##(1993-3#1)(1993-6#1)
receptors display##2##2##(1990-12#1)(1995-11#1)
receptors do not##2##3##(2006-10#1)(2008-7#1)
receptors expressed in Xenopus oocytes##2##5##(1995-11#2)
receptors expressed in##4##3##(1991-9#1)(1995-11#2)(1995-12#1)
receptors expressed##6##2##(1991-9#1)(1995-11#3)(1995-12#1)(2008-4#1)
receptors expression##4##2##(2008-4#1)(2009-3#1)(2011-2#2)
receptors for the##4##3##(1993-5#1)(1995-8#1)(2008-4#1)(2011-2#1)
receptors for##41##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
receptors from##6##2##(1994-6#2)(1995-11#1)(1995-2#1)(1996-12#1)(2008-7#1)
receptors had no effect##2##4##(1994-8#2)
receptors had##5##2##(1993-8#1)(1994-8#2)(2012-12#1)(2012-2#1)
receptors has been##4##3##(1993-6#1)(1994-11#1)(1994-3#1)(2007-10#1)
receptors have been characterized##2##4##(2008-4#2)
receptors have been identified##3##4##(1995-12#1)(1995-2#1)(2008-4#1)
receptors have been shown to##2##5##(1996-12#1)(2009-6#1)
receptors have been##10##3##(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-4#3)(2008-7#1)(2009-6#1)
receptors have##14##2##(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-6#1)
receptors in NHEKs##3##3##(2008-4#3)
receptors in a##3##3##(1992-3#1)(1996-12#1)(2008-4#1)
receptors in breast##2##3##(1994-2#1)(1997-7#1)
receptors in diabetic##2##3##(1994-11#1)(1996-9#1)
receptors in different##2##3##(2008-9#1)(2009-7#1)
receptors in human##9##3##(1993-6#1)(1994-3#1)(1994-6#1)(1996-5#1)(2008-4#2)(2008-5#2)(2009-7#1)
receptors in rabbit##5##3##(1990-11#1)(1997-7#2)(2008-4#2)
receptors in rat brain##2##4##(1993-11#1)(1997-1#1)
receptors in rat##4##3##(1993-11#1)(1995-11#1)(1995-12#1)(1997-1#1)
receptors in rats##2##3##(1991-1#1)(1995-12#1)
receptors in the hippocampus##2##4##(1996-12#1)(2008-11#1)
receptors in the nervous system##2##5##(2008-5#1)(2008-7#1)
receptors in the rat eye##2##5##(1997-2#1)(2008-4#1)
receptors in the rat##4##4##(1995-12#2)(1997-2#1)(2008-4#1)
receptors in the striatum##3##4##(1991-4#1)(1994-2#1)(1995-12#1)
receptors in the substantia nigra##3##5##(1995-2#3)
receptors in the##58##3##(1990-11#1)(1990-5#3)(1990-6#1)(1991-4#2)(1992-10#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)
receptors in these##2##3##(1991-10#1)(2009-7#1)
receptors in vitro##3##3##(1993-5#1)(1995-5#1)(1995-6#1)
receptors in##157##2##(1990-11#3)(1990-5#4)(1990-6#1)(1991-1#2)(1991-10#1)(1991-4#2)(1992-10#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#1)(1993-5#3)(1993-6#4)(1993-8#2)(1993-9#4)(1994-11#1)(1994-2#5)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#10)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#2)(1997-6#1)(1997-7#4)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#20)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#5)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
receptors including##4##2##(2008-4#3)(2013-7#1)
receptors induced by##2##3##(1995-12#1)(2008-8#1)
receptors induced##3##2##(1995-12#1)(1995-6#1)(2008-8#1)
receptors inhibit##2##2##(2008-7#2)
receptors involved in the##2##4##(1995-12#1)(1995-2#1)
receptors involved in##4##3##(1995-12#1)(1995-2#1)(2008-4#1)(2008-8#1)
receptors involved##5##2##(1995-12#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
receptors is not##2##3##(1994-2#1)(1995-12#1)
receptors is##21##2##(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-4#5)(2008-7#1)(2011-2#2)
receptors labeled with##2##3##(1991-5#1)(1994-2#1)
receptors leads to##2##3##(1995-12#1)(2010-11#1)
receptors like##2##2##(2011-2#1)(2012-12#1)
receptors located in##2##3##(1995-12#1)(2008-7#1)
receptors located##4##2##(1993-12#1)(1995-12#1)(2008-7#2)
receptors may be a##3##4##(1996-5#1)(2008-4#2)
receptors may be##9##3##(1991-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-5#2)(2008-4#2)(2008-9#1)
receptors may have##2##3##(1996-2#1)(2007-12#1)
receptors may lead to##2##4##(2008-4#1)(2012-3#1)
receptors may play##2##3##(1995-12#1)(2008-4#1)
receptors may##27##2##(1990-11#1)(1991-12#1)(1991-9#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-5#1)(2007-12#1)(2008-2#1)(2008-4#7)(2008-5#1)(2008-9#1)(2012-3#1)
receptors mediate contraction##2##3##(1994-11#1)(1995-12#1)
receptors mediate##7##2##(1990-7#1)(1994-11#1)(1995-12#2)(2008-4#3)
receptors mediating##2##2##(1997-4#1)(1997-7#1)
receptors might be##2##3##(2008-4#1)(2011-1#1)
receptors of a##2##3##(1993-2#1)(1995-3#1)
receptors of the##4##3##(1994-9#1)(1996-2#1)(2009-8#1)(2013-1#1)
receptors of##21##2##(1991-1#1)(1991-3#1)(1993-2#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-9#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#2)
receptors on human##2##3##(1995-12#1)(1995-2#1)
receptors on the##7##3##(1991-12#1)(1997-2#1)(2007-12#2)(2008-7#1)(2009-7#1)(2010-10#1)
receptors on##30##2##(1990-5#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-12#2)(1995-2#1)(1997-2#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-4#3)(2008-7#1)(2009-7#1)(2010-10#1)(2012-1#2)(2013-1#1)(2013-7#1)
receptors or##5##2##(1991-1#1)(1994-6#1)(1996-12#1)(2008-10#1)(2008-4#1)
receptors per cell##3##3##(1995-6#1)(2008-11#2)
receptors play a role in##2##5##(2008-4#1)(2008-5#1)
receptors play a##5##3##(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)
receptors play##6##2##(1995-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)
receptors prepared##3##2##(1994-6#3)
receptors present##2##2##(2009-2#1)(2011-1#1)
receptors purified on##2##3##(1990-5#2)
receptors results in##2##3##(1991-5#1)(2010-3#1)
receptors revealed##2##2##(1993-12#1)(1995-11#1)
receptors since##2##2##(1991-5#1)(2008-4#1)
receptors stimulated##2##2##(1995-11#1)(1996-2#1)
receptors such as##2##3##(2008-7#1)(2011-2#1)
receptors than##2##2##(1995-11#1)(2008-8#1)
receptors that##16##2##(1992-3#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
receptors then##2##2##(1993-8#1)(2008-8#1)
receptors to a##2##3##(1995-11#1)(1997-7#1)
receptors to their##2##3##(1993-6#1)(2008-10#1)
receptors to##12##2##(1993-6#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
receptors was not##2##3##(1991-9#1)(1993-12#1)
receptors was performed##2##3##(2007-11#1)(2008-4#1)
receptors was##16##2##(1991-12#1)(1991-9#3)(1993-12#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-6#1)(2012-2#1)
receptors were also##2##3##(1990-12#1)(1995-11#1)
receptors were blocked##2##3##(1992-9#1)(1996-2#1)
receptors were detected##2##3##(1994-6#1)(1996-5#1)
receptors were expressed in Xenopus oocytes##2##6##(1995-5#1)(2008-4#1)
receptors were less##2##3##(1993-12#1)(1994-2#1)
receptors were present##2##3##(1993-12#1)(2008-4#1)
receptors were studied##2##3##(1990-11#1)(2008-4#1)
receptors were undetectable in##2##4##(1990-11#2)
receptors were used to##2##4##(1993-12#1)(1996-12#1)
receptors were##38##2##(1990-11#3)(1990-12#1)(1991-12#1)(1992-9#1)(1993-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#5)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#4)(1996-5#3)(2008-4#7)(2008-6#1)(2008-8#1)(2012-2#1)
receptors which##7##2##(1992-7#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-7#1)
receptors with##11##2##(1990-5#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
receptors within##2##2##(1993-12#1)(1995-11#1)
receptors##1437##1##(1990-11#14)(1990-12#7)(1990-2#4)(1990-5#10)(1990-6#2)(1990-7#3)(1990-8#6)(1990-9#1)(1991-1#8)(1991-10#1)(1991-11#1)(1991-12#21)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#14)(1991-7#2)(1991-8#1)(1991-9#12)(1992-10#2)(1992-11#5)(1992-12#8)(1992-3#9)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#9)(1993-1#2)(1993-11#6)(1993-12#25)(1993-2#9)(1993-3#15)(1993-5#11)(1993-6#18)(1993-8#20)(1993-9#14)(1994-11#17)(1994-12#8)(1994-2#31)(1994-3#6)(1994-5#3)(1994-6#19)(1994-8#16)(1994-9#8)(1995-11#47)(1995-12#87)(1995-2#27)(1995-3#22)(1995-5#12)(1995-6#11)(1995-8#11)(1996-12#30)(1996-2#42)(1996-5#20)(1996-7#2)(1996-9#2)(1997-1#6)(1997-2#18)(1997-4#9)(1997-5#2)(1997-6#4)(1997-7#22)(1997-9#1)(2006-10#2)(2006-6#3)(2007-10#3)(2007-11#4)(2007-12#13)(2007-2#1)(2007-8#5)(2008-1#10)(2008-10#22)(2008-11#28)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#217)(2008-5#34)(2008-6#12)(2008-7#62)(2008-8#24)(2008-9#12)(2009-1#1)(2009-10#1)(2009-12#11)(2009-2#1)(2009-3#7)(2009-5#1)(2009-6#5)(2009-7#13)(2009-8#18)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-8#2)(2011-1#8)(2011-2#35)(2012-1#7)(2012-12#13)(2012-2#27)(2012-3#6)(2013-1#19)(2013-7#6)(2013-8#10)
receptors) are##2##2##(1996-2#1)(2009-12#1)
receptors)##18##1##(1993-12#3)(1994-11#2)(1994-2#1)(1995-11#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-4#3)(2008-5#1)(2009-12#1)(2009-8#1)(2009-9#1)
recertification##2##1##(1994-12#1)(1996-9#1)
recess##16##1##(1990-5#1)(2006-12#1)(2007-11#2)(2008-7#1)(2008-9#1)(2011-2#6)(2012-2#2)(2013-1#2)
recessed##2##1##(1990-2#1)(2008-10#1)
recession##11##1##(1993-12#1)(1993-3#1)(2008-1#1)(2008-12#2)(2009-8#1)(2011-1#1)(2012-3#3)(2013-1#1)
recessive allele##2##2##(1990-5#1)(2008-10#1)
recessive alleles##2##2##(2013-1#2)
recessive disease##4##2##(1995-6#1)(1997-1#1)(2007-7#1)(2011-1#1)
recessive disorder characterized by##3##4##(2007-7#1)(2011-1#2)
recessive disorder##8##2##(1991-8#1)(1991-9#1)(2007-7#1)(2008-7#1)(2010-3#1)(2011-1#2)(2012-12#1)
recessive dystrophic epidermolysis bullosa##3##4##(2012-3#3)
recessive form##2##2##(2008-11#2)
recessive gene controlled resistance to##2##5##(2008-10#2)
recessive gene for##3##3##(2008-10#3)
recessive gene##24##2##(1990-9#1)(2008-10#17)(2008-5#1)(2008-8#1)(2008-9#4)
recessive genes were detected in##4##5##(2008-10#4)
recessive genes were##5##3##(2008-10#5)
recessive genes##10##2##(2008-10#10)
recessive genetic##3##2##(2007-7#1)(2008-10#1)(2011-3#1)
recessive inheritance of##3##3##(1994-11#1)(2008-10#2)
recessive inheritance##7##2##(1994-11#1)(2007-7#1)(2008-10#2)(2008-7#2)(2011-1#1)
recessive juvenile parkinsonism (AR-JP)##2##4##(2008-7#2)
recessive mutation##3##2##(1990-5#1)(1994-12#1)(2008-10#1)
recessive phenotype##2##2##(1994-12#2)
recessive##130##1##(1990-5#2)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#42)(2008-11#4)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-10#1)(2010-2#1)(2010-3#2)(2011-1#7)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#2)
recessively inherited##2##2##(1990-8#1)(2008-1#1)
recessively##3##1##(1990-8#1)(2008-1#2)
recharge##2##1##(2008-2#1)(2009-12#1)
recidive##4##1##(1994-2#2)(2011-2#2)
recidivism##4##1##(2007-8#1)(2008-6#1)(2009-11#1)(2011-2#1)
recidivisms##2##1##(2011-2#2)
recipe##6##1##(1993-3#1)(1994-12#1)(2008-9#1)(2012-2#1)(2013-8#2)
recipes##8##1##(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#1)
recipient age##2##2##(1991-11#1)(2008-1#1)
recipient and donor##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
recipient and the donor##2##4##(2008-9#1)(2011-2#1)
recipient and the##3##3##(2008-9#1)(2011-2#2)
recipient and##8##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#3)
recipient cells in##2##3##(2008-4#2)
recipient cells##5##2##(1995-2#1)(2008-4#3)(2013-1#1)
recipient embryos##2##2##(2008-11#2)
recipient of the##4##3##(1994-12#1)(1996-2#2)(2011-6#1)
recipient of##6##2##(1994-12#1)(1996-2#2)(1997-4#1)(2007-10#1)(2011-6#1)
recipient strain##5##2##(1991-7#1)(1991-9#1)(1997-3#1)(2008-10#2)
recipient##92##1##(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-6#2)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#9)(2009-10#1)(2009-2#2)(2009-5#1)(2010-11#4)(2010-6#1)(2011-2#12)(2011-3#4)(2011-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
recipient]##3##1##(1990-9#1)(1991-3#1)(2011-2#1)
recipients and##11##2##(1996-12#1)(1996-2#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-12#2)(2012-2#2)
recipients are##5##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
recipients at##3##2##(1992-12#1)(2007-10#1)(2008-1#1)
recipients compared##2##2##(1992-2#1)(2007-7#1)
recipients have##2##2##(1991-12#1)(1995-12#1)
recipients in##7##2##(1991-1#1)(1991-2#1)(1992-2#1)(1994-9#2)(2007-7#2)
recipients is##3##2##(2007-8#1)(2008-3#2)
recipients of##8##2##(1994-12#1)(1994-9#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)
recipients to##5##2##(1994-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)
recipients were##4##2##(1994-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
recipients who##3##2##(1994-3#1)(2008-4#1)(2012-2#1)
recipients with##8##2##(1991-12#1)(1994-2#1)(1995-2#2)(1997-2#1)(2011-2#1)(2013-1#2)
recipients##161##1##(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#4)(1994-12#1)(1994-2#3)(1994-3#3)(1994-9#12)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-8#3)(1997-2#4)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#4)(2007-8#4)(2008-1#14)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#8)(2008-4#8)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#13)(2009-5#3)(2010-10#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#10)(2012-1#1)(2012-2#6)(2013-1#2)
reciprocal altruism##4##2##(2008-8#2)(2012-3#2)
reciprocal and##2##2##(2009-7#2)
reciprocal cross##2##2##(2008-10#1)(2008-9#1)
reciprocal crosses in##2##3##(2008-12#1)(2009-12#1)
reciprocal crosses were made between##2##5##(2008-10#1)(2009-12#1)
reciprocal crosses##7##2##(2008-10#1)(2008-12#2)(2009-12#3)(2012-3#1)
reciprocal friends##3##2##(2009-7#3)
reciprocal influences##2##2##(1995-3#1)(2007-10#1)
reciprocal inhibition##2##2##(1993-3#2)
reciprocal interactions##3##2##(1990-11#1)(2008-7#2)
reciprocal pair##2##2##(2008-3#1)(2011-2#1)
reciprocal phase##3##2##(2008-3#3)
reciprocal populations##2##2##(2008-10#2)
reciprocal relationship##3##2##(2008-3#1)(2009-7#2)
reciprocal social##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
reciprocal translocation##3##2##(2007-11#2)(2012-12#1)
reciprocal velocity##2##2##(1992-3#2)
reciprocal##98##1##(1990-11#5)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#14)(2008-12#2)(2008-2#2)(2008-3#12)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#3)(2009-7#8)(2009-8#1)(2010-1#2)(2010-3#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#1)(2013-8#1)
reciprocally##5##1##(1994-3#1)(1996-5#1)(2008-11#1)(2008-9#1)(2012-2#1)
reciprocating##2##1##(2008-10#1)(2008-8#1)
reciprocity and##2##2##(2008-11#1)(2008-2#1)
reciprocity inequality##3##2##(2007-12#3)
reciprocity principle is##2##3##(2008-2#1)(2008-3#1)
reciprocity principle##3##2##(2008-2#1)(2008-3#2)
reciprocity theorem##5##2##(2008-3#5)
reciprocity##32##1##(1992-3#1)(1993-3#1)(2007-11#1)(2007-12#4)(2008-11#1)(2008-2#8)(2008-3#8)(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#5)
recirculated##2##1##(2008-10#1)(2008-6#1)
recirculating##8##1##(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)
recirculation of##3##2##(1997-4#1)(2008-3#1)(2009-7#1)
recirculation##10##1##(1990-5#1)(1991-5#1)(1997-4#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#1)
reckless##2##1##(1996-5#1)(1997-5#1)
reclaiming##2##1##(1997-3#1)(2012-2#1)
reclassification of##4##2##(1993-1#1)(2008-10#1)(2008-5#1)(2009-12#1)
reclassified as##2##2##(1991-9#1)(1997-6#1)
reclassified##4##1##(1991-9#1)(1997-6#1)(2006-8#1)(2009-8#1)
recognise and##3##2##(2008-11#1)(2008-6#1)(2012-2#1)
recognise that##2##2##(1996-11#1)(2008-8#1)
recognise the##6##2##(1991-6#1)(1994-8#1)(2008-12#1)(2008-7#1)(2011-2#2)
recognise##23##1##(1991-6#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
recognised and##3##2##(2008-11#2)(2011-1#1)
recognised as a##5##3##(1994-2#1)(2008-11#1)(2008-12#1)(2012-2#2)
recognised as an essential##2##4##(2007-10#1)(2011-1#1)
recognised as an important##3##4##(2007-7#1)(2008-11#1)(2009-5#1)
recognised as an##5##3##(2007-10#1)(2007-7#1)(2008-11#1)(2009-5#1)(2011-1#1)
recognised as##12##2##(1994-2#1)(2007-10#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-2#2)
recognised by##8##2##(1990-11#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-3#1)(2012-12#1)
recognised in##4##2##(1991-3#1)(1992-6#1)(2008-10#2)
recognised that##2##2##(2008-11#2)
recognised to##2##2##(2008-8#1)(2012-2#1)
recognised##52##1##(1990-11#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-2#1)(1995-3#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)
recognises the##2##2##(2008-12#1)(2013-8#1)
recognises##3##1##(1995-12#1)(2008-12#1)(2013-8#1)
recognising the##4##2##(1991-6#1)(1996-3#1)(2008-11#2)
recognising##7##1##(1991-6#1)(1996-11#1)(1996-3#1)(2008-1#1)(2008-11#2)(2013-8#1)
recognition ability##3##2##(2008-10#2)(2012-2#1)
recognition analysis##2##2##(2008-10#2)
recognition and management of##3##4##(2008-1#1)(2008-3#1)(2013-1#1)
recognition and management##4##3##(2008-1#1)(2008-3#1)(2010-10#1)(2013-1#1)
recognition and signaling##2##3##(2008-10#1)(2012-2#1)
recognition and treatment of##3##4##(2008-1#1)(2012-3#1)(2013-1#1)
recognition and treatment##5##3##(2007-11#1)(2008-1#1)(2012-3#2)(2013-1#1)
recognition and##56##2##(1990-5#1)(1991-9#1)(1992-4#2)(1993-5#1)(1995-5#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2010-10#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
recognition are##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
recognition as a##4##3##(1993-2#1)(1994-12#1)(2008-10#1)(2013-1#1)
recognition as an##2##3##(2008-2#1)(2010-3#1)
recognition as##8##2##(1993-2#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
recognition at##2##2##(1995-5#1)(2008-7#1)
recognition based on##3##3##(2008-3#2)(2008-8#1)
recognition between##3##2##(1992-6#1)(2008-10#2)
recognition by means of##2##4##(2008-3#2)
recognition by the##6##3##(1992-4#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(2013-1#1)
recognition by use of##4##4##(2007-12#2)(2008-3#2)
recognition by##31##2##(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-3#6)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
recognition capability##2##2##(2008-10#2)
recognition during##2##2##(2008-4#1)(2009-3#1)
recognition element##4##2##(2008-10#4)
recognition elements##4##2##(1993-11#1)(2008-10#3)
recognition event##3##2##(1990-12#1)(2009-3#2)
recognition for##8##2##(1991-3#1)(1994-1#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-9#1)(2012-2#1)
recognition in cochlear implant##2##4##(2008-9#2)
recognition in mice##2##3##(2008-11#1)(2008-4#1)
recognition in the##6##3##(1990-12#1)(1992-4#1)(1993-1#1)(2008-7#2)(2008-8#1)
recognition in##31##2##(1990-12#1)(1991-6#1)(1992-4#1)(1993-1#1)(1994-9#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#6)(2009-5#2)
recognition is proposed##6##3##(2008-10#1)(2008-3#4)(2008-6#1)
recognition is##12##2##(1992-6#1)(1994-5#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-6#1)
recognition material##2##2##(2008-10#2)
recognition memory##10##2##(1991-2#1)(1992-10#1)(1993-3#2)(1994-3#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-9#1)
recognition methods##3##2##(2008-10#2)(2010-7#1)
recognition motif for##2##3##(1990-11#2)
recognition motif##6##2##(1990-11#2)(1993-12#1)(2010-11#1)(2010-12#1)(2012-2#1)
recognition of MHC##2##3##(2008-8#2)
recognition of a##7##3##(1991-10#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-5#1)
recognition of contour objects##2##4##(2008-3#2)
recognition of damaged and apoptotic cells##2##6##(1995-2#2)
recognition of damaged##3##3##(1993-3#1)(1995-2#2)
recognition of danger signs##2##4##(2012-12#2)
recognition of each##2##3##(2008-10#1)(2010-4#1)
recognition of new##2##3##(1997-3#1)(2008-10#1)
recognition of pathogens and##2##4##(2009-3#1)(2009-8#1)
recognition of specific##2##3##(2008-1#1)(2008-3#1)
recognition of such##2##3##(2010-11#1)(2010-5#1)
recognition of the importance of##3##5##(1995-1#1)(2007-8#1)(2010-10#1)
recognition of the need for##2##5##(1996-7#1)(2008-11#1)
recognition of the##35##3##(1990-12#1)(1991-9#1)(1993-1#1)(1993-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)
recognition of their##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
recognition of these##2##3##(2008-11#1)(2010-5#1)
recognition of this##7##3##(1997-3#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
recognition of##165##2##(1990-12#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#7)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#11)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#3)(2009-1#1)(2009-3#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#1)
recognition on##2##2##(2008-10#2)
recognition or##2##2##(2013-1#1)(2013-8#1)
recognition pattern##2##2##(1995-2#1)(1996-12#1)
recognition performance##2##2##(2007-8#1)(2009-8#1)
recognition procedures##6##2##(2008-10#5)(2010-5#1)
recognition process##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
recognition properties##5##2##(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
recognition rate##2##2##(2008-3#1)(2010-8#1)
recognition receptors##6##2##(2009-6#1)(2009-8#2)(2010-8#1)(2012-2#1)(2013-1#1)
recognition scores##2##2##(2008-9#2)
recognition sequence##13##2##(1990-7#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-12#4)(1995-3#1)(1995-6#1)(1995-8#3)
recognition sequences##3##2##(1990-12#1)(1992-3#1)(1994-12#1)
recognition site##16##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-6#4)(1997-2#1)(2013-1#1)
recognition sites of##2##3##(1991-6#1)(1997-2#1)
recognition sites##9##2##(1990-11#1)(1990-12#1)(1991-6#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2010-12#1)
recognition step##2##2##(1994-8#1)(2008-10#1)
recognition system that##2##3##(2007-11#1)(2008-2#1)
recognition system##12##2##(2007-11#1)(2008-2#5)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#3)
recognition systems##5##2##(2007-12#2)(2008-8#2)(2008-9#1)
recognition task##8##2##(1992-11#1)(1993-3#1)(1994-3#3)(2008-6#1)(2008-7#1)(2011-2#1)
recognition techniques##7##2##(2008-10#7)
recognition test##2##2##(1992-10#1)(2008-9#1)
recognition tests##4##2##(1992-10#1)(2008-9#1)(2009-8#2)
recognition that the##2##3##(2008-3#1)(2008-4#1)
recognition that##15##2##(1991-12#1)(1992-9#1)(1995-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-3#1)(2011-2#1)(2013-8#1)
recognition was##2##2##(2008-10#1)(2008-9#1)
recognition with##8##2##(2008-2#1)(2008-3#7)
recognition within##2##2##(1994-12#1)(2008-9#1)
recognition##673##1##(1990-11#4)(1990-12#5)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-10#5)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#5)(1992-6#5)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#8)(1993-5#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#7)(1994-5#4)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#12)(1995-3#3)(1995-5#4)(1995-6#12)(1995-8#5)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#7)(2007-12#17)(2007-2#1)(2007-7#6)(2007-8#7)(2008-1#13)(2008-10#93)(2008-11#21)(2008-12#4)(2008-2#14)(2008-3#61)(2008-4#14)(2008-5#5)(2008-6#17)(2008-7#17)(2008-8#21)(2008-9#33)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#7)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#9)(2010-10#4)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#4)(2011-1#6)(2011-2#12)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#13)(2012-3#10)(2013-1#20)(2013-7#3)(2013-8#7)
recognizable by##2##2##(1994-11#1)(1997-4#1)
recognizable##11##1##(1991-5#1)(1994-11#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-4#3)(2007-12#2)(2010-3#1)
recognize a##9##2##(1991-2#1)(1992-8#1)(1994-12#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
recognize all##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
recognize and bind to the##2##5##(1992-8#1)(2008-9#1)
recognize and bind to##3##4##(1992-8#1)(2008-9#1)(2009-7#1)
recognize and bind##4##3##(1992-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
recognize and##24##2##(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#3)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
recognize cell surface##2##3##(1995-6#1)(2008-10#1)
recognize each##2##2##(1996-12#1)(2008-3#1)
recognize specific##3##2##(2008-1#1)(2008-4#2)
recognize such##2##2##(1995-6#1)(2008-1#1)
recognize taste stimuli##2##3##(2008-7#2)
recognize that the##5##3##(1992-6#1)(1994-3#1)(1995-12#1)(1996-6#1)(2008-2#1)
recognize that##14##2##(1992-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)
recognize the illness##2##3##(2011-2#2)
recognize the importance of##2##4##(1993-1#1)(2010-1#1)
recognize the need for##2##4##(1995-1#1)(1996-1#1)
recognize the need##3##3##(1995-1#1)(1996-1#1)(2009-4#1)
recognize the presence##2##3##(2008-3#2)
recognize the same##2##3##(1992-2#1)(2008-10#1)
recognize the##49##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#2)(1996-1#1)(1996-2#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
recognize two##2##2##(1995-2#1)(1996-12#1)
recognize various##2##2##(1996-12#1)(2013-1#1)
recognize##212##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-5#2)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#13)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#3)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)
recognized a single##3##3##(1991-9#1)(1995-6#1)(1997-7#1)
recognized a##11##2##(1991-12#1)(1991-9#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
recognized all##2##2##(2008-10#1)(2008-5#1)
recognized and##14##2##(1994-6#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2009-8#1)(2009-9#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
recognized antigens##2##2##(1990-12#1)(2008-5#1)
recognized as a cause of##2##5##(2008-7#1)(2012-3#1)
recognized as a critical##2##4##(2009-3#1)(2013-1#1)
recognized as a key##2##4##(2008-11#1)(2008-8#1)
recognized as a major##4##4##(1997-1#1)(2008-2#1)(2008-4#1)(2013-8#1)
recognized as a##26##3##(1990-9#1)(1992-1#1)(1995-6#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
recognized as an important##3##4##(2008-5#1)(2008-6#1)(2008-8#1)
recognized as an##6##3##(1997-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)
recognized as one of the##2##5##(2008-10#2)
recognized as safe##2##3##(2008-10#1)(2012-12#1)
recognized as the##13##3##(1994-2#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-9#1)
recognized as##71##2##(1990-9#1)(1992-1#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-10#3)(2007-7#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#3)
recognized at##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
recognized by a##7##3##(1995-2#1)(1995-3#2)(1995-6#1)(2008-3#1)(2008-5#2)
recognized by an antibody##2##4##(1992-11#1)(1993-11#1)
recognized by an##4##3##(1992-11#1)(1993-11#1)(1993-8#1)(1997-8#1)
recognized by antibodies in##2##4##(1990-11#2)
recognized by antibodies##5##3##(1990-11#2)(1994-11#1)(2008-4#1)(2011-2#1)
recognized by mAbs##2##3##(2008-4#2)
recognized by polyclonal##3##3##(1991-2#1)(2008-4#2)
recognized by sera from##2##4##(1990-5#1)(2009-6#1)
recognized by the##24##3##(1990-11#2)(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2013-1#1)
recognized by##80##2##(1990-11#4)(1990-2#1)(1990-5#1)(1991-2#2)(1991-5#3)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#2)(1993-11#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#9)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#2)(2011-2#2)(2013-1#1)
recognized complication of##2##3##(2007-8#1)(2008-7#1)
recognized complication##3##2##(2007-8#1)(2008-7#1)(2009-7#1)
recognized early##3##2##(1995-11#1)(2008-12#1)(2008-8#1)
recognized for its role in##2##5##(1995-2#1)(2012-2#1)
recognized for its##3##3##(1995-12#1)(1995-2#1)(2012-2#1)
recognized for##5##2##(1995-12#1)(1995-2#1)(1996-3#1)(2010-3#1)(2012-2#1)
recognized from##3##2##(1996-4#1)(2008-2#1)(2008-4#1)
recognized human##3##2##(1990-5#1)(1994-9#1)(2008-5#1)
recognized in the##8##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)
recognized in##29##2##(1996-9#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#2)(2009-12#2)(2009-7#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
recognized is##2##2##(1995-1#1)(2008-11#1)
recognized not only##2##3##(1996-6#1)(2012-1#1)
recognized on Western##2##3##(1991-2#1)(1993-12#1)
recognized on##5##2##(1991-2#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-9#1)
recognized pathogenic##2##2##(2008-1#1)(2012-12#1)
recognized that##19##2##(1990-9#1)(1993-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2010-1#1)(2010-2#1)(2011-2#2)(2012-3#1)
recognized the need to##5##4##(1991-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2012-3#1)
recognized the##23##2##(1991-3#1)(1991-5#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-3#2)
recognized to be##5##3##(1990-6#1)(1992-5#1)(2008-10#1)(2008-7#2)
recognized to play a##2##4##(2012-12#1)(2013-7#1)
recognized to play##3##3##(2010-12#1)(2012-12#1)(2013-7#1)
recognized to##11##2##(1990-6#1)(1992-5#1)(2008-10#1)(2008-7#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
recognized with the##2##3##(1997-2#1)(2008-6#1)
recognized with##3##2##(1995-11#1)(1997-2#1)(2008-6#1)
recognized worldwide as##2##3##(2008-10#1)(2010-6#1)
recognized worldwide##3##2##(2008-10#1)(2009-3#1)(2010-6#1)
recognized##435##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#6)(1995-5#2)(1995-6#9)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#5)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#45)(2008-11#20)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#17)(2008-5#19)(2008-6#4)(2008-7#21)(2008-8#13)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#2)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#15)(2012-1#2)(2012-12#11)(2012-2#8)(2012-3#10)(2013-1#7)(2013-7#3)(2013-8#4)
recognizes a##6##2##(1995-2#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-11#1)(2009-8#1)
recognizes and##2##2##(1990-5#1)(2008-6#1)
recognizes both##3##2##(1990-12#1)(1995-6#1)(2008-11#1)
recognizes specifically##2##2##(1995-12#1)(2008-11#1)
recognizes that##3##2##(1995-2#1)(1997-3#1)(2007-11#1)
recognizes the##11##2##(1992-10#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-3#1)(2009-8#1)
recognizes##43##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#2)(2011-1#1)(2013-1#1)(2013-8#1)
recognizing a##8##2##(1991-3#1)(1995-2#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
recognizing and cleaving at##2##4##(1993-9#2)
recognizing and##6##2##(1992-3#1)(1993-9#2)(2008-10#1)(2008-11#1)(2008-4#1)
recognizing that##3##2##(1993-11#1)(1994-1#1)(1995-12#1)
recognizing the Tn antigen##2##4##(1992-8#2)
recognizing the benefits##2##3##(1990-2#1)(2006-10#1)
recognizing the##23##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#2)
recognizing these##2##2##(2008-8#1)(2009-9#1)
recognizing##85##1##(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(2006-10#1)(2007-10#2)(2007-12#4)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)
recoil##9##1##(1991-12#1)(1992-9#1)(2008-1#1)(2008-7#3)(2009-7#1)(2013-1#1)(2013-7#1)
recollection##2##1##(2008-11#1)(2010-8#1)
recollective experience##2##2##(2008-9#2)
recolonization##5##1##(2008-10#3)(2008-8#1)(2008-9#1)
recombinant (r)##2##2##(1993-8#1)(2013-1#1)
recombinant 21-hydroxylase##2##2##(1992-8#2)
recombinant APP695##2##2##(1992-6#2)
recombinant BV##2##2##(1997-4#2)
recombinant BmNPV harboring##2##3##(1997-4#2)
recombinant BmNPV##4##2##(1997-4#3)(2008-11#1)
recombinant C-terminal##2##2##(2008-11#1)(2011-2#1)
recombinant CHO and BHK##2##4##(2008-11#2)
recombinant CHO cell line##7##4##(2008-11#7)
recombinant CHO cell lines##3##4##(2008-11#3)
recombinant CHO cell##11##3##(2008-11#11)
recombinant CHO cells##2##3##(2008-11#2)
recombinant CHO##16##2##(2008-11#16)
recombinant Chinese hamster ovary (rCHO) cells##2##6##(2008-11#2)
recombinant Chinese hamster ovary cell##2##5##(2008-11#2)
recombinant Chinese hamster ovary cells##2##5##(2008-11#2)
recombinant Chinese hamster ovary##9##4##(2008-11#9)
recombinant Chinese##10##2##(2008-11#10)
recombinant DNA techniques##3##3##(1990-8#1)(1994-2#1)(2013-1#1)
recombinant DNA technology##2##3##(2007-7#1)(2011-2#1)
recombinant DNA##16##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1994-2#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
recombinant E##11##2##(1990-8#2)(1994-12#1)(1995-2#1)(2008-6#2)(2008-7#3)(2011-1#1)(2011-2#1)
recombinant EPO##2##2##(2007-7#1)(2008-11#1)
recombinant Escherichia coli strain##2##4##(1994-12#1)(2011-1#1)
recombinant Escherichia coli##10##3##(1994-12#2)(1995-2#1)(2008-10#1)(2008-7#4)(2011-1#1)(2013-1#1)
recombinant IFN-gamma##2##2##(2008-11#2)
recombinant IFN-γ##2##2##(2011-2#2)
recombinant M##2##2##(2008-10#1)(2011-2#1)
recombinant NS0##2##2##(2008-11#1)(2008-7#1)
recombinant PVX##4##2##(2008-10#4)
recombinant Potato virus X (PVX)##2##5##(2008-10#2)
recombinant RNA1s were##2##3##(2008-10#2)
recombinant RNA1s##3##2##(2008-10#3)
recombinant SIV-PR##2##2##(1991-9#2)
recombinant XFGFR-1##2##2##(1993-6#2)
recombinant Zymomonas##2##2##(2008-6#2)
recombinant adeno-associated viral vector##2##4##(2008-9#2)
recombinant adeno-associated viral##3##3##(2008-9#3)
recombinant adeno-associated virus (rAAV)##2##4##(2008-8#2)
recombinant adeno-associated virus vector##2##4##(2008-8#1)(2008-9#1)
recombinant adeno-associated virus##6##3##(1993-2#1)(2008-8#4)(2008-9#1)
recombinant adeno-associated##9##2##(1993-2#1)(2008-8#4)(2008-9#4)
recombinant adenoviral vector##4##3##(2008-11#1)(2008-8#1)(2010-1#2)
recombinant adenoviral vectors##2##3##(2008-11#2)
recombinant adenoviral##6##2##(2008-11#3)(2008-8#1)(2010-1#2)
recombinant adenovirus could##2##3##(2008-8#2)
recombinant adenovirus##11##2##(1995-2#1)(1997-4#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#5)
recombinant adenoviruses##3##2##(1992-9#1)(1995-12#1)(2008-11#1)
recombinant alpha-toxin##3##2##(2010-6#3)
recombinant and##5##2##(2007-2#1)(2008-10#2)(2008-8#1)(2009-5#1)
recombinant antibodies against the##2##4##(2008-11#2)
recombinant antibodies##5##2##(2008-10#2)(2008-11#2)(2013-8#1)
recombinant antibody##7##2##(1994-8#1)(1997-2#1)(2008-11#5)
recombinant antigen##2##2##(1994-3#1)(2010-6#1)
recombinant antigens##2##2##(1995-5#1)(1997-7#1)
recombinant baculovirus containing##3##3##(1994-10#1)(1997-4#1)(2008-11#1)
recombinant baculovirus with an##2##4##(2008-11#1)(2008-7#1)
recombinant baculovirus##16##2##(1992-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1997-4#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)
recombinant baculovirus-infected##2##2##(1991-2#1)(1995-2#1)
recombinant baculoviruses##10##2##(1992-8#1)(1994-8#2)(1997-8#2)(2008-2#4)(2008-7#1)
recombinant cDNA##4##2##(1992-8#1)(1997-2#1)(2008-4#2)
recombinant cell line##2##3##(2008-10#1)(2008-11#1)
recombinant cell lines##6##3##(2008-11#5)(2012-3#1)
recombinant cell##8##2##(2008-10#1)(2008-11#6)(2012-3#1)
recombinant cells##2##2##(2008-11#2)
recombinant chicken PTH-(1-88)##2##3##(1991-3#2)
recombinant chicken##3##2##(1991-3#2)(2008-11#1)
recombinant clones##3##2##(1990-5#1)(1991-9#1)(2008-10#1)
recombinant constructs##2##2##(2008-10#1)(2008-11#1)
recombinant cosmid##2##2##(2008-6#2)
recombinant cutinase##3##2##(1995-3#1)(2008-7#2)
recombinant eel growth hormone##2##4##(1990-8#2)
recombinant enzyme##5##2##(1992-8#2)(1994-6#1)(2006-10#1)(2011-1#1)
recombinant enzymes##2##2##(1995-2#1)(2011-2#1)
recombinant erythropoietin##2##2##(2008-11#1)(2010-7#1)
recombinant expression##2##2##(1991-9#1)(1994-9#1)
recombinant factor VIIa##4##3##(1995-6#1)(2007-8#2)(2011-2#1)
recombinant factor##6##2##(1995-6#1)(2007-8#2)(2008-11#1)(2008-8#1)(2011-2#1)
recombinant forms of##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
recombinant fusion##2##2##(1995-12#1)(1997-2#1)
recombinant genes into##2##3##(1994-5#1)(2008-4#1)
recombinant genes##4##2##(1994-5#2)(2008-4#1)(2008-7#1)
recombinant genotypes##2##2##(2008-10#2)
recombinant glycoprotein##7##2##(2008-11#2)(2008-7#4)(2011-2#1)
recombinant glycoproteins##2##2##(2008-11#2)
recombinant hFGF-10 adenovirus##3##3##(2011-3#3)
recombinant hepatitis B surface antigen##2##5##(1997-4#1)(2008-11#1)
recombinant hepatitis B virus surface antigen##2##6##(1994-11#1)(1997-4#1)
recombinant hepatitis B##4##3##(1994-11#1)(1997-4#2)(2008-11#1)
recombinant human NGF was##3##4##(1990-8#3)
recombinant human alpha##4##3##(1990-12#1)(1990-2#2)(1995-11#1)
recombinant human and##2##3##(1993-8#2)
recombinant human bone morphogenetic protein-2##2##5##(2011-2#1)(2013-8#1)
recombinant human erythropoietin (r-HuEPO)##2##4##(2007-7#1)(2008-1#1)
recombinant human erythropoietin##7##3##(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2011-2#1)
recombinant human glucagon##4##3##(2008-8#4)
recombinant human growth hormone##2##4##(1997-2#1)(1997-8#1)
recombinant human interleukin-1 beta##3##4##(1990-12#3)
recombinant human interleukin-6##2##3##(1990-5#1)(2008-11#1)
recombinant human monoclonal antibody##2##4##(2008-11#2)
recombinant human plasminogen##2##3##(1995-6#2)
recombinant human thyrotropin##3##3##(1995-12#1)(2013-1#2)
recombinant human tissue plasminogen activator##2##5##(1992-12#1)(2008-7#1)
recombinant human tissue##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
recombinant human transferrin produced##2##4##(2008-11#2)
recombinant human transferrin##3##3##(2008-11#3)
recombinant human uPA##4##3##(2008-11#4)
recombinant human##94##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#4)(1990-8#6)(1991-9#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-6#6)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#21)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#5)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
recombinant inbred (RI) strains##2##4##(1994-8#1)(2008-12#1)
recombinant inbred (RI)##4##3##(1994-8#1)(2008-10#2)(2008-12#1)
recombinant inbred line population##4##4##(2008-10#4)
recombinant inbred line##6##3##(2008-10#6)
recombinant inbred lines (RILs) derived##2##5##(2008-10#2)
recombinant inbred lines (RILs) from##2##5##(2008-10#1)(2008-8#1)
recombinant inbred lines (RILs)##9##4##(2008-10#7)(2008-8#1)(2012-3#1)
recombinant inbred lines derived from##2##5##(2008-10#2)
recombinant inbred lines from the cross##2##6##(2008-10#2)
recombinant inbred lines of the##2##5##(2008-10#1)(2012-3#1)
recombinant inbred lines of##3##4##(2008-10#2)(2012-3#1)
recombinant inbred lines##19##3##(1997-7#1)(2008-10#15)(2008-8#1)(2012-3#2)
recombinant inbred population##4##3##(2008-10#4)
recombinant inbred##33##2##(1994-8#1)(1997-7#1)(2008-10#27)(2008-12#1)(2008-8#1)(2012-3#2)
recombinant insulin##2##2##(2008-11#2)
recombinant interferon##2##2##(1991-2#1)(1991-8#1)
recombinant interferon-gamma##2##2##(2008-11#2)
recombinant isolates##4##2##(2008-10#4)
recombinant line##3##2##(2008-10#3)
recombinant lines##2##2##(2008-10#2)
recombinant mammalian cell cultures##2##4##(2008-11#2)
recombinant mammalian cell lines##3##4##(2008-11#3)
recombinant mammalian cell##5##3##(2008-11#5)
recombinant mammalian##7##2##(2008-11#7)
recombinant mouse##3##2##(2008-10#2)(2008-4#1)
recombinant murine##3##2##(1993-8#1)(1994-12#1)(1995-2#1)
recombinant phage##3##2##(1991-9#1)(1992-3#1)(1993-8#1)
recombinant phosphatase 2A##2##3##(1992-9#2)
recombinant plasmid##14##2##(1990-5#1)(1992-9#1)(1994-3#3)(1997-6#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)
recombinant plasmids##6##2##(1991-7#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-8#2)
recombinant precursor##2##2##(2008-9#1)(2011-2#1)
recombinant product##4##2##(1994-11#1)(2008-11#1)(2008-7#1)(2010-11#1)
recombinant production##2##2##(2011-1#1)(2013-8#1)
recombinant protein by##2##3##(2008-11#2)
recombinant protein expression in##3##4##(2008-11#3)
recombinant protein expression##7##3##(2008-11#6)(2008-7#1)
recombinant protein hyper-producing##2##3##(2008-11#2)
recombinant protein is##5##3##(1993-2#1)(1994-8#1)(2008-11#1)(2008-8#2)
recombinant protein production and##2##4##(2008-11#1)(2012-2#1)
recombinant protein production from##2##4##(2008-11#1)(2012-3#1)
recombinant protein production in plants##2##5##(2008-7#2)
recombinant protein production in##8##4##(2008-11#3)(2008-7#3)(2011-2#2)
recombinant protein production of##2##4##(2008-11#2)
recombinant protein production##30##3##(1992-12#1)(2008-11#15)(2008-2#1)(2008-5#1)(2008-7#5)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)
recombinant protein purification##2##3##(2008-4#2)
recombinant protein showed##2##3##(1995-2#1)(2010-12#1)
recombinant protein was##8##3##(1990-11#1)(1990-8#1)(1994-3#1)(2008-11#4)(2008-8#1)
recombinant protein##90##2##(1990-11#3)(1990-8#2)(1992-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#45)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#10)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)
recombinant proteins at##2##3##(1993-9#1)(1997-3#1)
recombinant proteins for research##2##4##(2008-11#1)(2012-2#1)
recombinant proteins for##9##3##(1994-5#1)(1995-5#1)(1997-4#1)(2008-11#5)(2012-2#1)
recombinant proteins in transgenic plants##2##5##(2008-7#2)
recombinant proteins in##9##3##(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#2)
recombinant proteins produced by##2##4##(2008-11#1)(2011-2#1)
recombinant proteins produced in##2##4##(2008-4#1)(2008-7#1)
recombinant proteins produced##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
recombinant proteins with##2##3##(1995-5#1)(2008-11#1)
recombinant proteins##64##2##(1990-11#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#4)(1995-5#2)(1996-11#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#28)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#4)(2009-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
recombinant rat##11##2##(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(2008-11#4)(2008-4#1)(2008-8#2)
recombinant receptor##3##2##(1995-11#3)
recombinant retrovirus##5##2##(1990-5#1)(1997-8#1)(2009-10#3)
recombinant retroviruses##2##2##(1990-5#2)
recombinant silkworm eclosion hormone##2##4##(1990-12#2)
recombinant strain##6##2##(2008-8#4)(2013-1#2)
recombinant strains##5##2##(2011-1#1)(2012-3#1)(2013-1#3)
recombinant subunit##2##2##(2009-7#1)(2009-8#1)
recombinant tPA##2##2##(2008-11#2)
recombinant therapeutic proteins##2##3##(2008-10#2)
recombinant therapeutic##5##2##(2008-10#2)(2008-11#2)(2011-2#1)
recombinant tissue plasminogen activator##5##4##(2007-10#1)(2008-7#2)(2009-11#1)(2009-6#1)
recombinant tissular plasminogen activator (t-PA)##2##5##(2008-11#2)
recombinant tumor necrosis factor##3##4##(1991-12#2)(1994-8#1)
recombinant tumor necrosis##4##3##(1991-12#2)(1994-8#2)
recombinant uPA##5##2##(2008-11#5)
recombinant vaccine##3##2##(1993-6#1)(1995-5#1)(2008-8#1)
recombinant vaccines##5##2##(1996-3#1)(1997-4#2)(2007-6#1)(2008-4#1)
recombinant vaccinia virus##6##3##(1991-5#2)(1995-6#1)(2008-8#3)
recombinant vaccinia##7##2##(1991-5#2)(1995-6#1)(2008-8#4)
recombinant vector##4##2##(1994-5#1)(2008-9#1)(2010-4#1)(2011-2#1)
recombinant viral##3##2##(1997-4#1)(2008-4#1)(2010-4#1)
recombinant virus##8##2##(1994-11#1)(1994-6#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)
recombinant viruses##9##2##(1991-5#1)(1993-6#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-7#1)
recombinant wild-type##3##2##(1992-9#1)(1994-8#1)(1995-6#1)
recombinant yeast##8##2##(1993-9#1)(1995-2#1)(1997-2#1)(2008-7#3)(2008-8#1)(2011-1#1)
recombinant zebrafish FSH##2##3##(2010-5#2)
recombinant zebrafish##3##2##(2010-5#3)
recombinant##979##1##(1990-11#8)(1990-12#7)(1990-2#2)(1990-5#10)(1990-8#15)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#9)(1991-7#1)(1991-8#2)(1991-9#8)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-6#2)(1992-8#16)(1992-9#9)(1993-11#1)(1993-2#3)(1993-6#7)(1993-8#10)(1993-9#4)(1994-10#1)(1994-11#9)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#10)(1994-6#8)(1994-8#14)(1994-9#3)(1995-11#11)(1995-12#8)(1995-2#17)(1995-3#1)(1995-5#9)(1995-6#13)(1995-8#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#6)(1997-3#5)(1997-4#28)(1997-6#2)(1997-7#6)(1997-8#6)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#7)(2008-10#95)(2008-11#231)(2008-12#3)(2008-2#11)(2008-3#1)(2008-4#28)(2008-5#10)(2008-6#13)(2008-7#51)(2008-8#49)(2008-9#15)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#3)(2010-11#4)(2010-12#2)(2010-4#4)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#42)(2011-3#3)(2012-12#1)(2012-2#5)(2012-3#11)(2013-1#12)(2013-8#8)
recombinant-inbred lines (RILs)##2##3##(2008-10#2)
recombinantantibody##2##1##(2008-11#2)
recombinantly expressed##2##2##(1995-2#1)(1995-6#1)
recombinantly##3##1##(1995-2#1)(1995-6#1)(2013-1#1)
recombinants and##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
recombinants from##3##2##(1994-11#1)(2008-10#2)
recombinants in##2##2##(1997-4#1)(2008-10#1)
recombinants to##2##2##(1992-6#1)(1994-12#1)
recombinants were##5##2##(1991-6#1)(1995-2#1)(2008-10#3)
recombinants##36##1##(1991-6#2)(1991-9#1)(1992-6#2)(1994-11#1)(1994-12#2)(1995-2#2)(1995-9#1)(1997-3#2)(1997-4#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
recombinase target##2##2##(2008-11#2)
recombinase##10##1##(1991-9#1)(1994-11#2)(1994-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
recombinases##7##1##(2008-11#4)(2008-6#1)(2011-2#1)(2012-3#1)
recombination among##6##2##(2008-10#5)(2012-2#1)
recombination and duplication of a limited set of domains##2##9##(2009-5#1)(2011-2#1)
recombination and repair##3##3##(1994-9#2)(1997-2#1)
recombination and##25##2##(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#2)(1997-2#1)(1997-7#2)(2008-10#6)(2008-11#1)(2008-7#1)(2009-10#3)(2009-5#2)(2010-4#1)(2011-2#1)(2013-8#1)
recombination are##2##2##(1995-8#1)(2009-8#1)
recombination as##3##2##(1990-11#1)(1990-8#1)(1994-11#1)
recombination at##2##2##(1991-3#1)(1995-8#1)
recombination between EV71##2##3##(2013-8#2)
recombination between the##4##3##(1997-3#1)(2008-10#2)(2009-2#1)
recombination between##17##2##(1990-11#1)(1995-8#3)(1996-6#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-2#1)(2013-8#2)
recombination event##5##2##(1994-12#1)(1997-3#1)(2008-10#2)(2013-1#1)
recombination events between##2##3##(2008-10#1)(2013-8#1)
recombination events was##2##3##(2008-10#1)(2008-12#1)
recombination events##14##2##(1990-5#1)(1994-9#1)(1995-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2013-8#1)
recombination experiments##3##2##(1992-6#1)(2008-10#1)(2008-6#1)
recombination frequencies##2##2##(2008-10#1)(2008-5#1)
recombination hot##2##2##(2008-10#2)
recombination in the##6##3##(1993-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
recombination in##25##2##(1991-3#1)(1993-12#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#5)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
recombination is##9##2##(1994-8#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-3#1)
recombination may##5##2##(2008-10#4)(2013-1#1)
recombination occurred between##2##3##(2008-10#1)(2013-8#1)
recombination occurred##4##2##(1993-9#1)(1995-8#1)(2008-10#1)(2013-8#1)
recombination of the##6##3##(1991-6#1)(1995-2#2)(1996-10#1)(2008-9#1)(2010-4#1)
recombination of##21##2##(1990-8#1)(1991-3#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-4#1)(2013-8#1)
recombination or##2##2##(2008-10#1)(2012-2#1)
recombination process##3##2##(2008-4#1)(2009-3#1)(2013-1#1)
recombination rate##8##2##(2008-12#1)(2008-8#5)(2010-3#1)(2012-3#1)
recombination rates##3##2##(2012-3#3)
recombination reaction in##2##3##(1997-7#1)(2008-10#1)
recombination reaction##3##2##(1997-7#2)(2008-10#1)
recombination signal##2##2##(1997-7#1)(2008-7#1)
recombination sites##3##2##(1994-12#1)(1995-8#1)(2008-4#1)
recombination systems##2##2##(1994-8#1)(2008-8#1)
recombination that##2##2##(1995-8#1)(2008-12#1)
recombination time##2##2##(2007-11#2)
recombination using##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
recombination vectors##2##2##(1993-12#2)
recombination was found##2##3##(2008-10#2)
recombination was##4##2##(1990-8#1)(1991-3#1)(2008-10#2)
recombination were##3##2##(1990-8#1)(1994-8#1)(2008-10#1)
recombination with##4##2##(1990-5#1)(1991-9#1)(1994-8#1)(1995-2#1)
recombination within##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
recombination##327##1##(1990-11#2)(1990-5#5)(1990-8#4)(1991-3#4)(1991-5#1)(1991-6#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-12#7)(1993-2#1)(1993-9#3)(1994-11#2)(1994-12#4)(1994-8#11)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#1)(1995-6#4)(1995-8#15)(1995-9#2)(1996-10#3)(1996-2#6)(1996-6#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-7#11)(2007-11#4)(2007-6#1)(2008-1#1)(2008-10#80)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#16)(2008-5#3)(2008-6#2)(2008-7#14)(2008-8#21)(2008-9#7)(2009-10#3)(2009-2#2)(2009-3#3)(2009-5#2)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#3)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#7)(2013-8#9)
recombination)##3##1##(1995-8#1)(2008-10#2)
recombinational##3##1##(1993-12#1)(1993-2#1)(1995-3#1)
recombine with##2##2##(1992-12#1)(1992-3#1)
recombine##8##1##(1991-3#1)(1992-12#1)(1992-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
recombined single chain insulin##5##4##(2008-9#5)
recombined with##2##2##(1992-3#1)(1995-2#1)
recombined##10##1##(1992-3#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-9#6)
recombining##6##1##(1994-8#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
recombinogenic##3##1##(1994-8#2)(2008-11#1)
recommend a##8##2##(1993-3#1)(1996-8#1)(1997-8#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-9#1)(2010-5#1)
recommend acupuncture##2##2##(1993-3#2)
recommend directions for##2##3##(1991-2#1)(2010-9#1)
recommend it for##2##3##(2008-7#1)(2012-3#1)
recommend it##4##2##(1992-12#1)(1996-2#1)(2008-7#1)(2012-3#1)
recommend that the##2##3##(2008-10#2)
recommend that##21##2##(1990-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
recommend the use of##3##4##(2007-11#1)(2008-10#2)
recommend the##15##2##(1991-3#1)(1993-12#3)(1994-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#2)(2013-7#1)
recommend this##3##2##(1992-12#1)(2007-8#1)(2008-11#1)
recommend to##2##2##(2007-8#1)(2013-7#1)
recommend use of##2##3##(2008-7#1)(2008-9#1)
recommend##114##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-12#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1994-2#2)(1994-9#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#10)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
recommendable##3##1##(1990-6#1)(1993-11#1)(2008-7#1)
recommendation for##9##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#2)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
recommendation of##6##2##(1996-6#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
recommendation to##3##2##(1990-8#1)(1994-2#1)(1996-11#1)
recommendation##37##1##(1990-8#1)(1991-8#1)(1994-2#1)(1996-11#2)(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
recommendations about the##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
recommendations about##6##2##(1992-3#1)(1995-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
recommendations and##5##2##(1996-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-12#1)
recommendations apply to##3##3##(2008-6#2)(2011-2#1)
recommendations are based on##2##4##(2008-11#1)(2013-1#1)
recommendations are discussed##2##3##(1996-2#1)(1997-3#1)
recommendations are made##4##3##(1992-12#1)(1992-9#1)(2008-11#1)(2008-12#1)
recommendations are not##2##3##(2007-2#1)(2008-11#1)
recommendations are offered##2##3##(2008-12#1)(2012-3#1)
recommendations are presented##2##3##(2007-2#1)(2008-12#1)
recommendations are proposed##3##3##(2012-12#2)(2012-3#1)
recommendations are provided for##2##4##(1993-2#1)(2009-5#1)
recommendations are provided##4##3##(1993-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
recommendations are##29##2##(1992-12#1)(1992-9#1)(1993-2#1)(1996-2#1)(1997-3#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#1)(2009-5#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
recommendations based on the##2##4##(1995-5#1)(2008-12#1)
recommendations based on##10##3##(1993-1#1)(1993-12#2)(1995-5#1)(2008-12#1)(2008-8#1)(2010-9#2)(2012-12#1)(2013-1#1)
recommendations by the##3##3##(1994-12#1)(2007-12#2)
recommendations developed##2##2##(1995-12#1)(2011-2#1)
recommendations focus##2##2##(2008-12#1)(2008-7#1)
recommendations for children##2##3##(1995-1#1)(2012-2#1)
recommendations for further##3##3##(2008-11#1)(2008-12#1)(2008-4#1)
recommendations for future research##4##4##(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
recommendations for future##8##3##(1992-3#1)(1996-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
recommendations for improving##2##3##(1996-2#1)(2009-5#1)
recommendations for research##2##3##(1996-3#1)(2011-2#1)
recommendations for the management of##2##5##(2008-3#1)(2010-12#1)
recommendations for the use of##9##5##(1996-6#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)
recommendations for the##25##3##(1990-2#1)(1993-12#1)(1994-3#1)(1995-2#2)(1996-6#1)(2008-1#1)(2008-11#2)(2008-3#6)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-12#1)(2012-2#2)(2013-1#1)
recommendations for their##2##3##(2007-12#1)(2009-7#1)
recommendations for those##2##3##(2012-12#1)(2012-2#1)
recommendations for travelers##3##3##(2011-2#3)
recommendations for using##2##3##(2008-11#1)(2010-3#1)
recommendations for vaccination of##2##4##(2007-11#1)(2008-4#1)
recommendations for##115##2##(1990-2#1)(1990-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#4)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#3)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#6)(2009-11#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#1)
recommendations from the##5##3##(1996-6#1)(1997-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
recommendations from##8##2##(1996-6#1)(1997-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-3#1)(2013-1#1)
recommendations have##3##2##(1992-9#1)(2008-2#1)(2008-3#1)
recommendations in the##4##3##(1990-6#1)(2008-10#3)
recommendations in##10##2##(1990-6#1)(1993-12#1)(2008-10#3)(2008-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
recommendations made by##2##3##(2011-1#1)(2013-1#1)
recommendations made##3##2##(1992-1#1)(2011-1#1)(2013-1#1)
recommendations of the##14##3##(1993-6#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
recommendations of##20##2##(1993-6#1)(1994-12#1)(1995-2#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
recommendations on how##3##3##(2012-12#1)(2012-2#1)(2013-8#1)
recommendations on the investigation and##2##5##(2007-12#2)
recommendations on the##5##3##(2007-12#2)(2008-12#1)(2008-3#1)(2011-2#1)
recommendations on##15##2##(1991-1#1)(1991-11#1)(2007-12#2)(2008-12#1)(2008-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
recommendations regarding the##2##3##(2008-3#1)(2013-1#1)
recommendations regarding##6##2##(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
recommendations that##9##2##(1991-1#1)(1993-12#1)(1995-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-5#1)
recommendations to help##2##3##(1996-3#1)(2011-2#1)
recommendations to the##2##3##(1996-1#1)(2008-12#1)
recommendations to##11##2##(1991-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
recommendations was##4##2##(1990-6#1)(2008-1#1)(2008-12#1)(2011-1#1)
recommendations were made##2##3##(1994-2#1)(2013-1#1)
recommendations were##8##2##(1992-3#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-1#2)
recommendations##382##1##(1990-2#2)(1990-6#2)(1990-8#2)(1991-1#2)(1991-11#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#9)(1993-2#1)(1993-6#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#4)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#12)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#9)(2008-10#18)(2008-11#23)(2008-12#19)(2008-2#3)(2008-3#16)(2008-4#6)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#8)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#5)(2011-1#8)(2011-2#28)(2011-3#2)(2012-12#11)(2012-2#8)(2012-3#14)(2013-1#19)(2013-8#8)
recommendations]##3##1##(1997-8#1)(2009-5#1)(2011-2#1)
recommended ABC approach##2##3##(2012-3#2)
recommended a##2##2##(1993-12#1)(1994-11#1)
recommended and##5##2##(1994-1#1)(2007-11#1)(2007-6#1)(2008-6#1)(2011-2#1)
recommended as a first-line##2##4##(2008-10#1)(2013-1#1)
recommended as a##9##3##(1990-10#1)(1991-3#1)(2008-10#2)(2008-4#1)(2010-5#1)(2012-1#1)(2013-1#2)
recommended as an##5##3##(1991-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2013-1#1)
recommended as first choice##2##4##(1991-6#1)(2008-3#1)
recommended as##27##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-6#1)(1992-3#1)(2007-10#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)
recommended at##2##2##(1997-8#1)(2008-6#1)
recommended because of the##2##4##(1993-8#1)(2006-10#1)
recommended because##4##2##(1991-12#1)(1993-8#1)(2006-10#1)(2008-2#1)
recommended by some##2##3##(1993-10#1)(1995-1#1)
recommended by the American##2##4##(2008-10#1)(2010-8#1)
recommended by the Association##2##4##(1990-6#1)(2008-10#1)
recommended by the National##2##4##(2008-10#1)(2011-2#1)
recommended by the World Health Organization##3##6##(1991-9#1)(2008-1#1)(2011-2#1)
recommended by the World##4##4##(1991-9#1)(2008-1#1)(2011-2#2)
recommended by the##23##3##(1990-6#1)(1991-9#1)(1993-1#1)(1994-3#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
recommended by##36##2##(1990-6#1)(1991-9#1)(1993-1#1)(1993-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
recommended daily allowances##2##3##(1992-9#1)(2010-6#1)
recommended daily##8##2##(1992-9#1)(1997-4#2)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
recommended diagnostic##2##2##(1996-9#1)(2013-8#1)
recommended dose##3##2##(2007-11#1)(2007-7#1)(2012-2#1)
recommended drugs##3##2##(1995-1#1)(1997-3#1)(2011-2#1)
recommended for a##3##3##(1990-12#1)(1992-8#1)(2008-7#1)
recommended for inclusion in##2##4##(2008-7#1)(2012-12#1)
recommended for patients with a##2##5##(1994-12#1)(2007-8#1)
recommended for patients with##6##4##(1990-12#1)(1994-12#1)(2007-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
recommended for patients##8##3##(1990-12#1)(1994-12#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
recommended for the treatment of##2##5##(1995-12#1)(2007-12#1)
recommended for the##10##3##(1990-8#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
recommended for use in##2##4##(2007-7#1)(2008-8#1)
recommended for use##4##3##(1991-2#1)(1996-3#1)(2007-7#1)(2008-8#1)
recommended for##65##2##(1990-12#3)(1990-8#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
recommended in most cases##2##4##(2006-10#1)(2011-2#1)
recommended in the##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
recommended in##19##2##(1990-2#1)(1990-3#1)(1990-8#1)(1993-8#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
recommended levels of##4##3##(2011-2#4)
recommended levels##12##2##(1997-3#1)(2008-5#5)(2010-11#1)(2011-2#5)
recommended method for##2##3##(2008-10#1)(2009-11#1)
recommended method was##3##3##(2008-10#3)
recommended method##8##2##(2008-10#7)(2009-11#1)
recommended on the##2##3##(1996-1#1)(2011-2#1)
recommended other##2##2##(1992-6#1)(1993-3#1)
recommended procedure##6##2##(2008-10#6)
recommended procedures##2##2##(2008-10#1)(2008-11#1)
recommended that blood##2##3##(1995-6#1)(2011-2#1)
recommended that patients##2##3##(1997-3#1)(2010-8#1)
recommended that the##10##3##(1994-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#3)
recommended that##42##2##(1991-3#2)(1991-4#1)(1993-12#1)(1994-11#1)(1994-3#2)(1995-6#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)
recommended the##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
recommended to be##2##3##(2009-4#1)(2011-2#1)
recommended to evaluate##2##3##(1994-2#1)(2008-10#1)
recommended to improve##2##3##(2007-7#1)(2008-9#1)
recommended to reduce##2##3##(2008-12#1)(2009-2#1)
recommended to##28##2##(1992-11#1)(1994-11#1)(1994-2#1)(1995-4#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
recommended treatment is##2##3##(2009-3#1)(2012-12#1)
recommended treatment##4##2##(2008-3#1)(2009-3#1)(2009-8#1)(2012-12#1)
recommended values##4##2##(2008-10#4)
recommended when##2##2##(1991-5#1)(2007-8#1)
recommended##503##1##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#4)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#3)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#3)(1993-10#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#6)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#5)(1997-5#2)(1997-7#2)(1997-8#6)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#6)(2007-4#1)(2007-6#1)(2007-7#13)(2007-8#4)(2008-1#6)(2008-10#77)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#13)(2008-8#8)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#3)(2010-8#8)(2010-9#1)(2011-1#8)(2011-2#54)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#14)(2012-3#7)(2013-1#26)(2013-7#2)(2013-8#8)
recommending##13##1##(1992-12#2)(1992-8#1)(1994-12#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
recommends a##2##2##(2008-7#1)(2010-5#1)
recommends against##2##2##(2010-9#1)(2011-1#1)
recommends that the##2##3##(2008-10#1)(2008-11#1)
recommends that##10##2##(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
recommends the##3##2##(1995-12#1)(2008-10#1)(2011-3#1)
recommends##28##1##(1990-9#1)(1991-3#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-10#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2013-1#1)
recomposition##2##1##(2007-11#2)
recompressed##2##1##(1991-6#1)(2008-3#1)
recompression##4##1##(1991-6#2)(2007-11#1)(2007-12#1)
reconcile the##10##2##(1992-3#1)(1993-11#1)(1994-11#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)
reconcile##16##1##(1992-3#1)(1993-11#1)(1994-11#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-8#1)
reconciled##9##1##(1995-3#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
reconciliation analysis##2##2##(2008-1#2)
reconciliation##7##1##(2008-1#2)(2008-11#2)(2008-2#1)(2008-8#1)(2013-1#1)
reconciling##3##1##(2007-11#1)(2012-3#1)(2013-1#1)
recondita f##7##2##(2008-10#7)
recondita##10##1##(2008-10#10)
reconditioned##2##1##(1996-3#1)(2008-5#1)
reconditioning##3##1##(2008-10#2)(2011-3#1)
reconfigurable binary optical##2##3##(2007-11#1)(2007-12#1)
reconfigurable##8##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2009-3#1)
reconfiguration of the##3##3##(1992-2#1)(2008-10#1)(2008-3#1)
reconfiguration of##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2009-6#1)
reconfiguration##10##1##(1991-1#2)(1992-2#1)(1993-2#1)(1994-2#1)(2008-10#3)(2008-3#1)(2009-6#1)
reconfiguring##3##1##(1992-2#1)(1994-12#1)(2012-3#1)
reconfirmed##4##1##(1993-12#1)(1996-5#1)(2011-2#1)(2013-8#1)
reconnection##2##1##(2008-7#1)(2012-12#1)
reconsider##5##1##(1991-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)
reconsideration of##4##2##(2008-1#1)(2008-4#1)(2009-3#1)(2009-7#1)
reconsideration##6##1##(1993-12#1)(1996-11#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-7#1)
reconsidered##5##1##(1991-2#1)(2007-12#1)(2008-11#1)(2009-7#1)(2011-2#1)
reconsidering##2##1##(1997-5#1)(2013-1#1)
reconstitute the##3##2##(1990-2#1)(1992-3#1)(1997-7#1)
reconstitute##9##1##(1990-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2012-2#1)
reconstituted InsP(3) receptor##4##3##(2008-8#4)
reconstituted basement membrane (Matrigel)##2##4##(2008-11#1)(2008-4#1)
reconstituted basement membrane##6##3##(1992-9#1)(2008-11#4)(2008-4#1)
reconstituted by##2##2##(2008-1#1)(2008-5#1)
reconstituted complexes##2##2##(1993-8#2)
reconstituted in vitro##5##3##(1992-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-4#1)
reconstituted in##13##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-4#2)(2008-8#2)
reconstituted into liposomes##2##3##(1995-2#1)(2008-8#1)
reconstituted into##5##2##(1990-11#1)(1995-2#1)(1995-8#1)(2008-8#2)
reconstituted serum##3##2##(2008-10#3)
reconstituted system containing##2##3##(1995-6#1)(1996-3#1)
reconstituted system##3##2##(1995-6#1)(1996-3#1)(2010-12#1)
reconstituted with a##2##3##(1990-8#1)(1997-4#1)
reconstituted with##14##2##(1990-8#3)(1991-12#1)(1991-9#1)(1993-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(1997-4#1)(2008-4#1)(2008-8#1)(2011-2#1)
reconstituted##98##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-8#4)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-8#4)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#3)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#3)(2008-1#1)(2008-10#6)(2008-11#6)(2008-4#7)(2008-5#4)(2008-6#1)(2008-8#15)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#2)
reconstitutes##2##1##(1994-5#1)(2008-1#1)
reconstitution and##3##2##(1995-8#1)(2008-8#1)(2009-9#1)
reconstitution experiments##2##2##(1992-12#1)(1997-2#1)
reconstitution in##3##2##(2008-7#1)(2008-8#1)(2009-12#1)
reconstitution inflammatory##6##2##(2008-10#1)(2009-7#1)(2010-5#2)(2012-2#2)
reconstitution into##2##2##(1995-2#1)(1995-8#1)
reconstitution of the##4##3##(1990-5#1)(1991-5#1)(1994-8#1)(2008-7#1)
reconstitution of##19##2##(1990-5#1)(1990-8#1)(1991-5#2)(1992-3#1)(1992-8#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#2)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2013-7#1)
reconstitution system##3##2##(1990-7#1)(1991-5#1)(2008-4#1)
reconstitution##54##1##(1990-5#1)(1990-7#1)(1990-8#3)(1991-5#5)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-8#5)(1997-2#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-5#2)(2012-2#2)(2013-7#1)
reconstruct the wave front##2##4##(2008-3#2)
reconstruct the##29##2##(2007-12#9)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
reconstruct##59##1##(1994-6#1)(1995-5#1)(2007-11#2)(2007-12#10)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#15)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
reconstructed and##3##2##(2007-11#2)(2008-3#1)
reconstructed blastocyst##2##2##(2008-9#2)
reconstructed breast##2##2##(2013-1#2)
reconstructed by##15##2##(1992-3#1)(2007-11#2)(2007-12#4)(2008-3#7)(2008-9#1)
reconstructed data##2##2##(2008-11#1)(2008-3#1)
reconstructed embryos were##2##3##(2008-9#2)
reconstructed epidermis##9##2##(2008-5#9)
reconstructed from computer-generated holograms##2##4##(2008-3#2)
reconstructed from the##2##3##(2008-3#2)
reconstructed from##18##2##(1997-3#1)(2007-8#1)(2008-2#2)(2008-3#11)(2008-7#2)(2008-9#1)
reconstructed human epidermis##3##3##(2008-5#3)
reconstructed image fidelity is##2##4##(2008-3#2)
reconstructed image##16##2##(2007-11#3)(2008-1#1)(2008-3#10)(2012-12#2)
reconstructed images##10##2##(2007-11#1)(2008-2#1)(2008-3#6)(2010-8#1)(2011-2#1)
reconstructed in##3##2##(1990-5#1)(2008-3#2)
reconstructed on##3##2##(1994-12#1)(2008-3#1)(2008-5#1)
reconstructed skin model##2##3##(2008-5#2)
reconstructed skin##4##2##(2008-5#4)
reconstructed the##2##2##(2011-2#1)(2013-1#1)
reconstructed to##2##2##(2010-10#1)(2013-8#1)
reconstructed using##5##2##(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
reconstructed wave##4##2##(2008-2#2)(2008-3#2)
reconstructed with a##5##3##(2008-3#4)(2011-2#1)
reconstructed with the##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
reconstructed with##17##2##(2007-11#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
reconstructed##185##1##(1990-5#1)(1991-5#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-2#1)(1997-3#1)(1997-8#1)(2007-11#12)(2007-12#15)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#8)(2008-3#62)(2008-5#19)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#11)(2009-1#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
reconstructing a##3##2##(1995-6#1)(2011-3#1)(2012-12#1)
reconstructing an##2##2##(2008-3#1)(2012-12#1)
reconstructing the profiles##2##3##(2008-3#2)
reconstructing the##8##2##(2007-12#2)(2008-12#1)(2008-3#4)(2008-8#1)
reconstructing##39##1##(1995-6#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2011-3#1)(2011-7#1)(2012-12#2)(2013-1#1)
reconstruction across the field##2##4##(2012-12#2)
reconstruction after##6##2##(1996-3#1)(2009-7#1)(2010-6#1)(2012-2#2)(2012-8#1)
reconstruction algorithm##9##2##(2007-11#2)(2007-12#1)(2008-3#4)(2011-1#2)
reconstruction algorithms for##2##3##(2008-3#2)
reconstruction algorithms##7##2##(2008-3#4)(2010-2#1)(2012-1#2)
reconstruction and that##2##3##(2008-3#2)
reconstruction and##17##2##(2008-2#1)(2008-3#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#1)
reconstruction are##3##2##(2008-3#1)(2011-2#2)
reconstruction as##2##2##(2008-11#1)(2012-12#1)
reconstruction but##2##2##(2008-9#1)(2013-1#1)
reconstruction by##5##2##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)
reconstruction can be##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
reconstruction can##4##2##(2007-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
reconstruction error##7##2##(2008-3#7)
reconstruction errors##3##2##(2008-2#2)(2008-7#1)
reconstruction even##3##2##(2008-3#3)
reconstruction following##3##2##(1990-9#1)(1992-9#1)(2008-6#1)
reconstruction for##7##2##(1990-6#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
reconstruction from noisy##3##3##(2007-12#2)(2008-3#1)
reconstruction from##8##2##(1991-12#1)(2007-12#3)(2008-3#3)(2012-1#1)
reconstruction has##4##2##(2008-3#2)(2009-5#1)(2011-2#1)
reconstruction image##2##2##(2007-11#1)(2012-1#1)
reconstruction in patients##2##3##(2008-10#1)(2012-2#1)
reconstruction in the presence of severe anamorphism##2##7##(2007-11#2)
reconstruction in the##3##3##(2007-11#2)(2011-1#1)
reconstruction in turbid media##3##4##(2007-12#2)(2011-1#1)
reconstruction in##24##2##(1990-3#1)(1992-5#1)(2007-11#4)(2007-12#3)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
reconstruction is usually##2##3##(1992-5#1)(2012-2#1)
reconstruction is##14##2##(1992-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
reconstruction method##7##2##(2007-11#1)(2008-2#2)(2008-3#3)(2009-5#1)
reconstruction methods##7##2##(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
reconstruction of a simulated##2##4##(2008-3#2)
reconstruction of a two-dimensional##2##4##(2007-11#1)(2008-3#1)
reconstruction of a##12##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2012-12#1)
reconstruction of an##4##3##(1990-3#1)(2008-3#3)
reconstruction of anterior##2##3##(2007-11#1)(2013-1#1)
reconstruction of complex##2##3##(2011-2#1)(2012-2#1)
reconstruction of defects##2##3##(1991-5#1)(2007-12#1)
reconstruction of lower##2##3##(2013-8#2)
reconstruction of the anterior##4##4##(2007-8#2)(2009-3#1)(2013-1#1)
reconstruction of the proximal##2##4##(2008-6#1)(2013-8#1)
reconstruction of the underlying##2##4##(2008-3#1)(2010-10#1)
reconstruction of the##55##3##(1990-3#1)(1991-5#1)(1996-3#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#3)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#2)
reconstruction of tissue optical##2##4##(2008-3#1)(2011-1#1)
reconstruction of##145##2##(1990-3#2)(1990-5#1)(1991-5#2)(1993-6#2)(1994-3#1)(1996-3#1)(1996-4#1)(1996-8#1)(2007-11#11)(2007-12#11)(2007-8#4)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#27)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#4)(2009-7#2)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#7)
reconstruction on the##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
reconstruction on##4##2##(2008-3#2)(2008-5#1)(2013-1#1)
reconstruction operations##2##2##(1990-8#1)(2008-6#1)
reconstruction or##2##2##(1991-4#1)(2008-2#1)
reconstruction people from schistosomiasis endemic areas##2##6##(2012-3#2)
reconstruction procedure##3##2##(2008-3#2)(2011-1#1)
reconstruction process##5##2##(1995-6#1)(2007-11#2)(2008-3#2)
reconstruction quality of##2##3##(2008-2#1)(2008-3#1)
reconstruction quality##3##2##(2008-2#1)(2008-3#2)
reconstruction software##2##2##(2008-3#1)(2009-3#1)
reconstruction system##2##2##(1995-6#1)(2008-2#1)
reconstruction technique##7##2##(2008-3#6)(2011-2#1)
reconstruction techniques##3##2##(2008-3#1)(2008-8#2)
reconstruction to##8##2##(2007-11#1)(2008-2#1)(2008-3#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
reconstruction using a##3##3##(2008-2#1)(2008-3#1)(2009-1#1)
reconstruction using the##3##3##(1990-9#1)(2011-2#2)
reconstruction using##9##2##(1990-9#1)(2008-2#1)(2008-3#1)(2009-1#1)(2011-2#3)(2011-3#1)(2012-2#1)
reconstruction was performed##2##3##(2008-3#1)(2008-7#1)
reconstruction was##7##2##(2007-12#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-7#1)
reconstruction were identified##2##3##(2013-1#2)
reconstruction will##2##2##(1995-6#1)(2008-7#1)
reconstruction with a##7##3##(2007-11#2)(2008-3#2)(2008-7#2)(2008-9#1)
reconstruction with hamstrings##4##3##(2013-1#4)
reconstruction with the##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
reconstruction with##35##2##(1993-11#1)(1993-9#1)(1996-3#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-1#2)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#7)
reconstruction without##2##2##(2007-12#1)(2009-4#1)
reconstruction##611##1##(1990-3#4)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-5#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#4)(1996-3#4)(1996-4#1)(1996-8#1)(2007-11#36)(2007-12#43)(2007-5#1)(2007-8#14)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#35)(2008-3#119)(2008-4#6)(2008-5#2)(2008-6#15)(2008-7#20)(2008-8#14)(2008-9#14)(2009-1#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#9)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-6#4)(2010-7#1)(2010-8#4)(2011-1#16)(2011-2#43)(2011-3#1)(2011-7#1)(2012-1#12)(2012-12#8)(2012-2#34)(2012-3#16)(2012-8#1)(2013-1#41)(2013-8#12)
reconstruction]##2##1##(1990-5#1)(2013-1#1)
reconstructions and##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
reconstructions are##6##2##(2007-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
reconstructions can be##2##3##(2008-3#1)(2008-4#1)
reconstructions for##7##2##(2008-10#1)(2008-2#1)(2008-3#4)(2013-1#1)
reconstructions have##4##2##(2007-11#1)(2008-7#1)(2010-9#1)(2012-2#1)
reconstructions in diffraction tomography##2##4##(2008-3#2)
reconstructions in##5##2##(1992-5#1)(2007-11#1)(2008-3#2)(2012-2#1)
reconstructions may be##2##3##(2008-2#1)(2008-4#1)
reconstructions of##7##2##(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#3)(2010-5#1)
reconstructions##71##1##(1992-5#1)(1993-12#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#9)(2012-7#1)(2013-1#6)
reconstructive challenge##2##2##(2012-12#1)(2012-2#1)
reconstructive hand##2##2##(2008-7#1)(2011-2#1)
reconstructive options for##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
reconstructive options##6##2##(2007-12#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
reconstructive procedure##2##2##(1991-4#1)(2008-7#1)
reconstructive surgeons##2##2##(2009-3#1)(2012-2#1)
reconstructive surgery in##3##3##(1993-11#1)(2007-11#1)(2011-2#1)
reconstructive surgery##21##2##(1990-9#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(1996-6#1)(2007-11#3)(2008-11#3)(2008-7#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#3)
reconstructive surgical##4##2##(1992-5#1)(2007-12#1)(2007-7#1)(2011-2#1)
reconstructive techniques##4##2##(1994-12#1)(2007-12#1)(2010-3#1)(2013-8#1)
reconstructive treatment##3##2##(1992-1#1)(1992-3#1)(2011-2#1)
reconstructive##84##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-11#1)(1994-12#1)(1996-6#1)(2007-11#5)(2007-12#13)(2007-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-3#1)(2009-5#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#15)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#3)
reconstructs the##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
reconstructs##11##1##(2007-11#1)(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)
recontamination##3##1##(1991-11#1)(2013-8#2)
recontouring of the##2##3##(2008-6#1)(2010-8#1)
record a##2##2##(2008-11#1)(2008-3#1)
record and##5##2##(1994-3#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-7#1)
record data##2##2##(2012-2#1)(2012-3#1)
record for the##3##3##(1992-3#1)(2008-5#1)(2008-6#1)
record for##4##2##(1992-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
record high##2##2##(2007-12#2)
record in##4##2##(1994-6#1)(2008-10#2)(2010-8#1)
record is##9##2##(1992-2#1)(1997-5#4)(2008-1#1)(2008-5#1)(2013-1#2)
record keeping##6##2##(1992-12#1)(1994-3#1)(1995-1#1)(2008-12#1)(2008-6#1)(2012-1#1)
record linkage to##2##3##(1997-8#1)(2008-8#1)
record linkage##4##2##(1990-9#1)(1997-8#1)(2008-8#1)(2011-2#1)
record of a##2##3##(1995-3#1)(2008-10#1)
record of the##3##3##(1991-6#1)(2008-5#1)(2010-8#1)
record of##22##2##(1990-9#1)(1991-6#2)(1995-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-3#2)
record system##2##2##(2009-10#1)(2012-3#1)
record systems##4##2##(1991-1#1)(1993-12#1)(2010-4#1)(2011-2#1)
record that##2##2##(1993-12#1)(1995-12#1)
record the##24##2##(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
record was##4##2##(2007-10#1)(2008-11#1)(2010-6#1)(2013-1#1)
record##207##1##(1990-2#1)(1990-9#3)(1991-1#1)(1991-3#1)(1991-6#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#4)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#3)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#3)(1996-3#2)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#9)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#12)(2007-2#3)(2007-4#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#17)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-6#2)(2010-8#8)(2011-1#4)(2011-2#6)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#2)
record-keeping##5##1##(1992-12#2)(1994-12#1)(1995-1#1)(1997-8#1)
recordable compact##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
recordable##10##1##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-9#1)
recorded a##3##2##(2008-5#1)(2010-8#1)(2013-1#1)
recorded activity##2##2##(1997-7#1)(2012-2#1)
recorded after the##3##3##(1993-9#1)(2007-11#1)(2008-10#1)
recorded after##6##2##(1990-10#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
recorded among##3##2##(1990-3#1)(2008-10#2)
recorded and analysed using##2##4##(2008-11#1)(2008-12#1)
recorded and analysed##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
recorded and analyzed##5##3##(1990-7#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-11#1)
recorded and compared with##2##4##(2008-12#1)(2008-2#1)
recorded and##29##2##(1990-7#1)(1993-12#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-4#1)(2013-1#1)
recorded as a##4##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
recorded as##18##2##(1990-6#1)(1994-2#1)(1996-2#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#2)
recorded at a##4##3##(2007-12#1)(2008-4#1)(2008-8#1)(2013-8#1)
recorded at different##3##3##(2008-10#1)(2008-3#2)
recorded at the##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
recorded at##36##2##(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2009-9#1)(2013-7#1)(2013-8#1)
recorded before and after##2##4##(2007-2#1)(2008-3#1)
recorded before and##3##3##(1993-1#1)(2007-2#1)(2008-3#1)
recorded before##5##2##(1992-12#1)(1993-1#1)(1995-12#1)(2007-2#1)(2008-3#1)
recorded between##9##2##(1995-12#1)(2008-10#4)(2008-12#2)(2010-8#1)(2013-8#1)
recorded by a##7##3##(1990-9#1)(1993-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
recorded by an image sensor##2##5##(2008-3#2)
recorded by the##6##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
recorded by use of a##7##5##(1996-5#1)(2007-12#3)(2008-2#2)(2008-3#1)
recorded by use of##9##4##(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)
recorded by##46##2##(1990-9#1)(1993-9#1)(1995-2#1)(1996-5#1)(1997-5#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-12#1)(2008-2#7)(2008-3#9)(2008-5#2)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
recorded cells##2##2##(1993-12#1)(1995-11#1)
recorded continuously##3##2##(1991-10#1)(1995-12#1)(2008-7#1)
recorded during the##3##3##(2008-3#1)(2008-5#1)(2013-8#1)
recorded during##19##2##(1993-6#1)(1996-2#1)(1996-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
recorded for a##2##3##(1994-8#1)(2008-10#1)
recorded for all##2##3##(2009-8#1)(2009-9#1)
recorded for each##2##3##(1997-4#1)(2007-2#1)
recorded for the first time##3##5##(2013-1#3)
recorded for the wild-type##2##4##(2008-10#2)
recorded for the##7##3##(2008-10#2)(2010-12#1)(2013-1#3)(2013-8#1)
recorded for##27##2##(1991-9#1)(1993-11#1)(1994-7#1)(1994-8#1)(1997-4#1)(2007-2#1)(2008-10#8)(2008-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#5)(2013-8#2)
recorded from a##2##3##(2008-3#1)(2009-5#1)
recorded from the##9##3##(1990-7#1)(1993-12#1)(1995-12#1)(1996-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-7#1)
recorded from##39##2##(1990-7#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#3)(1996-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
recorded holograms##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
recorded images of##2##3##(2008-3#1)(2008-9#1)
recorded in a photorefractive##2##4##(2008-2#2)
recorded in a##12##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-9#1)(2011-2#1)
recorded in all##3##3##(2008-5#1)(2009-12#1)(2013-1#1)
recorded in an##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
recorded in both##2##3##(2007-12#1)(2011-2#1)
recorded in different##3##3##(1992-6#1)(1995-12#1)(2008-2#1)
recorded in the##29##3##(1990-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2010-8#2)(2011-2#2)(2012-1#1)(2013-1#1)
recorded in three##3##3##(1991-12#1)(1996-12#1)(2010-4#1)
recorded in veins##2##3##(1995-12#2)
recorded in##126##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-12#4)(1996-12#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-12#1)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#10)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
recorded marks##2##2##(2008-3#2)
recorded on a##9##3##(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)
recorded on an##2##3##(2008-2#1)(2008-3#1)
recorded on the##2##3##(2006-4#1)(2008-3#1)
recorded on##22##2##(1991-3#1)(1994-3#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)
recorded only##3##2##(1994-8#1)(2012-3#1)(2013-8#1)
recorded outside the##2##3##(2008-10#1)(2008-8#1)
recorded over##5##2##(1993-9#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
recorded sensory##2##2##(1993-12#2)
recorded signals##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
recorded simultaneously on##2##3##(2008-3#1)(2008-4#1)
recorded simultaneously##5##2##(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#1)
recorded the##11##2##(1997-3#1)(2007-11#1)(2007-7#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-9#1)(2012-3#1)
recorded through##4##2##(2008-3#1)(2008-6#1)(2010-8#1)(2013-1#1)
recorded to##4##2##(2007-5#1)(2008-3#2)(2008-7#1)
recorded under##2##2##(1996-6#1)(2011-2#1)
recorded up to##2##3##(2010-5#1)(2013-1#1)
recorded using the##2##3##(2008-10#1)(2008-11#1)
recorded using##10##2##(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
recorded via##2##2##(1993-1#1)(2008-10#1)
recorded was##4##2##(1995-6#1)(2008-11#1)(2008-3#1)(2008-8#1)
recorded weekly##3##2##(1995-3#1)(2008-10#2)
recorded when##4##2##(1995-12#1)(2008-11#1)(2008-12#1)(2008-3#1)
recorded while##2##2##(1994-3#1)(2013-1#1)
recorded with a spectrograph and##2##5##(2007-12#1)(2008-10#1)
recorded with a##16##3##(1991-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#7)
recorded with an##5##3##(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
recorded with the goal of equal hologram##2##7##(2008-2#2)
recorded with the##3##3##(2008-2#2)(2008-8#1)
recorded with two##2##3##(2008-3#1)(2008-9#1)
recorded with##39##2##(1991-3#1)(1993-9#1)(1995-8#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-2#7)(2008-3#13)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)
recorded##740##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#4)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#2)(1991-10#1)(1991-12#3)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#11)(1993-2#2)(1993-3#1)(1993-6#3)(1993-9#4)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#10)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#6)(1996-6#5)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-10#3)(2007-11#19)(2007-12#25)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#107)(2008-11#20)(2008-12#24)(2008-2#41)(2008-3#94)(2008-4#7)(2008-5#31)(2008-6#4)(2008-7#25)(2008-8#15)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#15)(2010-9#1)(2011-1#7)(2011-2#26)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#8)(2012-7#1)(2013-1#30)(2013-7#4)(2013-8#17)
recorder##4##1##(2008-10#2)(2011-1#1)(2012-3#1)
recording a##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
recording and numerical##2##3##(2008-3#2)
recording and readout##3##3##(2008-2#2)(2008-3#1)
recording and reconstruction##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
recording and the##2##3##(2007-12#1)(2008-3#1)
recording and##27##2##(1993-12#1)(1994-2#1)(2007-11#1)(2007-12#6)(2008-2#7)(2008-3#10)(2010-8#1)
recording beams##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
recording by##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
recording chamber##2##2##(2009-9#1)(2013-1#1)
recording characteristics of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
recording characteristics##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
recording conditions##2##2##(2008-2#1)(2008-3#1)
recording density##2##2##(2008-2#2)
recording for##3##2##(2008-7#2)(2011-1#1)
recording from neuronal dendrites##2##4##(2008-4#2)
recording from##4##2##(2007-12#1)(2008-4#3)
recording geometry##2##2##(2007-11#1)(2008-2#1)
recording in LiNbO(3)##2##3##(2007-11#1)(2007-12#1)
recording in a##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2008-7#1)
recording in the##3##3##(1994-2#1)(2008-2#1)(2011-2#1)
recording in##23##2##(1991-6#1)(1994-11#1)(1994-2#1)(2007-11#2)(2007-12#7)(2008-2#3)(2008-3#3)(2008-7#1)(2011-2#3)(2013-1#1)
recording is##4##2##(2007-12#1)(2008-2#2)(2013-1#1)
recording layers##3##2##(2008-2#1)(2008-3#2)
recording material is##2##3##(2007-12#1)(2008-2#1)
recording material##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
recording media##4##2##(2008-2#1)(2008-3#3)
recording medium##7##2##(2007-11#1)(2007-12#3)(2008-3#2)(2008-4#1)
recording method##8##2##(2007-12#1)(2008-11#1)(2008-3#5)(2013-1#1)
recording methods##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
recording of an##4##3##(2007-11#3)(2007-12#1)
recording of each##2##3##(2007-12#1)(2008-2#1)
recording of holograms##2##3##(2007-12#1)(2008-3#1)
recording of the##13##3##(1994-6#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#2)
recording of vaccination rates##2##4##(2008-4#2)
recording of volume holographic memories##2##5##(2008-2#2)
recording of volume##3##3##(2008-2#2)(2008-3#1)
recording of##64##2##(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#8)(2007-12#7)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#14)(2008-4#5)(2008-5#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
recording parameters##3##2##(2008-3#3)
recording process in##2##3##(2008-1#1)(2008-3#1)
recording process##5##2##(2007-12#1)(2008-1#1)(2008-3#3)
recording schedule##5##2##(2007-12#5)
recording scheme in##2##3##(2008-2#1)(2008-3#1)
recording scheme##3##2##(2008-2#2)(2008-3#1)
recording sensitivity##3##2##(2007-12#2)(2008-3#1)
recording sources##2##2##(2008-3#2)
recording spatial and spectral data##2##5##(2008-2#1)(2008-3#1)
recording speed##3##2##(2008-2#1)(2008-3#2)
recording system##7##2##(1992-11#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-8#1)
recording systems##2##2##(2008-3#1)(2010-12#1)
recording technique##3##2##(1996-5#1)(2008-3#2)
recording techniques were used##2##4##(1993-12#1)(1996-2#1)
recording techniques##5##2##(1990-7#1)(1993-12#1)(1995-12#1)(1996-2#1)(2009-10#1)
recording the##20##2##(1993-3#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#1)(2009-4#1)(2009-5#1)(2010-4#1)(2012-2#2)(2013-7#1)(2013-8#1)
recording time##4##2##(1992-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
recording was##3##2##(1995-3#1)(2007-11#1)(2008-5#1)
recording were##2##2##(1991-12#1)(2008-3#1)
recording with a##2##3##(2007-12#1)(2008-4#1)
recording with##11##2##(2007-12#5)(2008-2#2)(2008-3#3)(2008-4#1)
recording##388##1##(1990-5#2)(1990-7#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-12#5)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#18)(2007-12#60)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#4)(2008-2#49)(2008-3#110)(2008-4#13)(2008-5#8)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#3)(2010-8#5)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
recordings and##5##2##(1996-5#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
recordings are##2##2##(2008-11#1)(2008-3#1)
recordings at##3##2##(1995-12#1)(2007-11#1)(2010-7#1)
recordings carried out##2##3##(1991-9#1)(1995-11#1)
recordings during##2##2##(1993-1#1)(2010-8#1)
recordings from##9##2##(1990-5#1)(1992-3#1)(1994-2#1)(1997-7#1)(2007-12#2)(2008-11#1)(2009-8#1)(2013-1#1)
recordings have##2##2##(1997-7#1)(2010-8#1)
recordings in##2##2##(1995-11#1)(2008-1#1)
recordings of##11##2##(1990-7#1)(1990-8#1)(1991-6#1)(1994-8#1)(1995-6#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)
recordings showed##3##2##(1990-8#1)(1995-11#1)(2008-1#1)
recordings were made from##5##4##(1993-12#1)(1995-12#2)(2008-8#1)(2008-9#1)
recordings were made##6##3##(1993-12#1)(1995-12#2)(2008-7#1)(2008-8#1)(2008-9#1)
recordings were obtained from##2##4##(1992-11#1)(1995-8#1)
recordings were##11##2##(1992-11#1)(1992-8#1)(1993-12#1)(1995-12#2)(1995-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)
recordings##85##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#4)(1995-12#3)(1995-6#1)(1995-8#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#3)(2012-2#2)(2013-1#1)(2013-8#2)
recordkeeping##2##1##(1993-12#2)
records a##2##2##(2008-3#1)(2009-10#1)
records analysis##2##2##(1995-12#1)(2012-3#1)
records and National##2##3##(2012-12#1)(2013-8#1)
records and##28##2##(1990-9#2)(1993-2#1)(1994-12#1)(1994-3#2)(1995-3#1)(1996-2#2)(1997-2#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-8#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
records are##4##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-2#1)
records by##2##2##(1994-3#1)(2007-12#1)
records can##2##2##(1997-1#1)(2008-8#1)
records data##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
records for Guam and##2##4##(2008-10#2)
records for the##7##3##(1990-6#1)(2008-5#4)(2012-2#1)(2012-9#1)
records for##20##2##(1990-6#2)(1992-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-5#4)(2008-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-9#1)
records from##10##2##(1990-6#1)(1992-1#1)(1992-9#1)(1994-3#2)(2007-2#1)(2008-1#1)(2012-12#1)(2013-8#2)
records in the##2##3##(1994-1#1)(2011-2#1)
records in##8##2##(1993-11#3)(1994-1#1)(1994-6#2)(2007-11#1)(2011-2#1)
records included##2##2##(2008-1#1)(2008-5#1)
records information##2##2##(2010-8#1)(2012-3#1)
records is##2##2##(1991-3#1)(1995-1#1)
records of all##2##3##(1994-7#1)(1996-2#1)
records of patients who had##2##5##(1992-3#1)(1993-11#1)
records of patients with##6##4##(1996-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
records of patients##12##3##(1992-3#1)(1993-11#1)(1996-1#1)(1996-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
records of the##18##3##(1990-5#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-7#1)
records of##91##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-7#3)(2008-1#7)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
records to identify##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
records to##10##2##(1994-3#2)(2007-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
records were reviewed##5##3##(1996-1#1)(2007-10#1)(2008-10#1)(2008-9#2)
records were used##2##3##(1990-2#1)(1996-2#1)
records were##13##2##(1990-2#1)(1992-11#1)(1993-12#1)(1996-1#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-3#1)
records with a##2##3##(1990-9#2)
records##334##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#4)(1990-9#5)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#2)(1994-12#6)(1994-3#11)(1994-6#4)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#3)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#4)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#13)(2008-10#12)(2008-11#11)(2008-12#7)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#11)(2009-10#6)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#10)(2011-1#5)(2011-2#12)(2012-12#12)(2012-2#7)(2012-3#12)(2012-7#1)(2012-9#1)(2013-1#17)(2013-7#1)(2013-8#5)
records)##2##1##(2012-12#1)(2013-7#1)
recount the##2##2##(1996-2#1)(2008-6#1)
recount##5##1##(1996-2#1)(2008-12#1)(2008-6#2)(2011-2#1)
recounting##2##1##(1992-3#1)(1994-1#1)
recounts the##2##2##(1994-2#1)(2008-9#1)
recouplings in##2##2##(2007-11#2)
recourse to the##2##3##(2007-8#1)(2008-3#1)
recourse to##14##2##(1996-8#1)(1997-2#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
recourse##15##1##(1996-8#1)(1997-2#1)(2007-11#3)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
recover after##4##2##(1991-9#1)(1995-8#1)(2008-10#1)(2013-1#1)
recover and##3##2##(2008-7#1)(2013-1#2)
recover from##4##2##(2007-5#1)(2008-10#2)(2013-1#1)
recover the original##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
recover the phase##2##3##(2008-2#1)(2008-3#1)
recover the##21##2##(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#3)(2009-5#1)
recover##69##1##(1990-5#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-12#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-10#11)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-1#3)(2012-12#1)(2013-1#6)(2013-8#2)
recoverable##6##1##(1991-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-7#1)
recovered after##11##2##(1991-2#1)(1995-12#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#1)(2013-1#2)(2013-8#1)
recovered and nonrecovered patients##2##4##(1996-7#2)
recovered and the##2##3##(1996-7#1)(1997-8#1)
recovered and##15##2##(1994-9#1)(1996-7#4)(1996-8#1)(1997-8#1)(2008-10#5)(2008-7#1)(2011-2#1)(2013-1#1)
recovered apple trees##2##3##(2008-10#2)
recovered as##2##2##(1991-12#1)(2007-11#1)
recovered at##6##2##(1991-12#1)(2008-10#4)(2013-8#1)
recovered between years##2##3##(2008-10#2)
recovered between##3##2##(2008-10#3)
recovered by a##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
recovered by co-treatment with##2##4##(1997-4#1)(2008-4#1)
recovered by##21##2##(1991-12#1)(1992-8#1)(1993-12#1)(1995-8#1)(1997-4#1)(2007-11#2)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
recovered cells##2##2##(2008-10#1)(2008-4#1)
recovered completely##3##2##(1996-6#1)(2008-1#1)(2013-1#1)
recovered fluorescence##2##2##(2008-10#1)(2008-12#1)
recovered following##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
recovered four##2##2##(2008-10#1)(2010-4#1)
recovered from PD after the following winter##2##7##(2008-10#2)
recovered from PD##3##3##(2008-10#3)
recovered from a POI##2##4##(2008-10#2)
recovered from a##8##3##(2008-10#8)
recovered from all of the##2##5##(2011-2#1)(2012-3#1)
recovered from all##5##3##(1990-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
recovered from diseased lettuce and tomato plants##2##7##(2008-10#2)
recovered from diseased##8##3##(2008-10#8)
recovered from individual##2##3##(2008-10#2)
recovered from noncultivated hosts##4##4##(2008-10#4)
recovered from noncultivated##5##3##(2008-10#5)
recovered from soil samples##3##4##(2008-10#3)
recovered from the##32##3##(1996-12#2)(1997-7#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
recovered from these##3##3##(2008-10#3)
recovered from##149##2##(1990-12#1)(1990-5#1)(1992-7#1)(1993-12#1)(1994-5#1)(1996-12#3)(1996-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#95)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2009-3#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
recovered fully##2##2##(1996-11#1)(2007-7#1)
recovered fungi##2##2##(2008-10#1)(2010-6#1)
recovered in the##5##3##(1992-9#1)(1993-8#2)(1995-8#1)(2010-3#1)
recovered in##13##2##(1992-9#1)(1993-8#2)(1994-5#1)(1995-1#1)(1995-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-3#1)(2011-2#1)
recovered its##2##2##(1993-6#1)(2008-5#1)
recovered more slowly##2##3##(1994-7#1)(2011-1#1)
recovered more##4##2##(1994-7#1)(2007-12#1)(2011-1#2)
recovered most##2##2##(1991-2#1)(2008-10#1)
recovered on##7##2##(2008-10#6)(2008-12#1)
recovered only##3##2##(2007-6#1)(2008-10#1)(2012-3#1)
recovered quantitatively##5##2##(2008-10#5)
recovered spectral images##2##3##(2013-8#2)
recovered the##3##2##(1997-2#1)(2010-4#1)(2011-2#1)
recovered their##2##2##(2008-11#1)(2008-4#1)
recovered to immediate preoperative##2##4##(2013-1#2)
recovered to the##2##3##(1997-2#1)(2008-7#1)
recovered to##8##2##(1997-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
recovered trees##3##2##(2008-10#3)
recovered uneventfully and##2##3##(2011-1#1)(2013-1#1)
recovered uneventfully##4##2##(2007-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
recovered well##5##2##(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
recovered when##2##2##(2008-11#1)(2008-5#1)
recovered with the##3##3##(2008-10#2)(2008-3#1)
recovered with##11##2##(1997-3#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2011-2#1)
recovered within##3##2##(1991-8#1)(1993-12#1)(2011-2#1)
recovered##415##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#3)(1994-5#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-6#1)(1996-7#5)(1996-8#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#182)(2008-11#4)(2008-12#9)(2008-2#8)(2008-3#9)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#16)(2008-8#5)(2008-9#4)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#11)(2013-8#11)
recovered)##4##1##(2008-10#4)
recoveries (&gt##5##2##(2008-10#5)
recoveries and##5##2##(2008-10#4)(2011-1#1)
recoveries are##9##2##(2008-10#9)
recoveries between 95##2##3##(2008-10#2)
recoveries between 98##2##3##(2008-10#2)
recoveries between##10##2##(2008-10#10)
recoveries for all##2##3##(2008-10#2)
recoveries for both##3##3##(2008-10#3)
recoveries for the spiked##2##4##(2008-10#2)
recoveries for the##7##3##(1997-2#1)(2008-10#6)
recoveries for##26##2##(1997-2#1)(2008-10#24)(2010-3#1)
recoveries from spiked##2##3##(2008-10#2)
recoveries from the##3##3##(2008-10#3)
recoveries from##11##2##(2008-10#10)(2012-3#1)
recoveries in the##2##3##(2008-10#2)
recoveries in##5##2##(2008-10#5)
recoveries obtained for##2##3##(2008-10#2)
recoveries obtained in##2##3##(1997-6#1)(2008-10#1)
recoveries obtained##13##2##(1997-6#1)(2008-10#12)
recoveries of &gt##3##3##(2008-10#1)(2013-8#2)
recoveries of 101##4##3##(2008-10#4)
recoveries of PAHs from##2##4##(2008-10#2)
recoveries of analytes##2##3##(2008-10#2)
recoveries of certified values##2##4##(2008-10#2)
recoveries of spiked##2##3##(2008-10#2)
recoveries of the analytes##2##4##(2008-10#2)
recoveries of the two##2##4##(2008-10#2)
recoveries of the##15##3##(2008-10#12)(2008-7#1)(2011-1#1)(2013-1#1)
recoveries of these##3##3##(2008-10#3)
recoveries of##101##2##(1990-2#1)(1992-11#2)(1997-6#1)(2008-10#83)(2008-11#1)(2008-5#1)(2008-7#2)(2011-1#6)(2011-2#1)(2013-1#1)(2013-8#2)
recoveries range from##2##3##(2008-10#2)
recoveries range##3##2##(2008-10#3)
recoveries ranged between##4##3##(2008-10#4)
recoveries ranged from 96##2##4##(2008-10#2)
recoveries ranged from##8##3##(2008-10#7)(2011-1#1)
recoveries ranged##12##2##(2008-10#11)(2011-1#1)
recoveries than##2##2##(2008-10#2)
recoveries were 98##2##3##(2008-10#1)(2011-1#1)
recoveries were between##4##3##(2008-10#3)(2012-1#1)
recoveries were found to be##3##5##(2008-10#3)
recoveries were in the range of 99##2##7##(2008-10#2)
recoveries were in the range of##3##6##(2008-10#3)
recoveries were in the##4##4##(2008-10#4)
recoveries were in##5##3##(2008-10#5)
recoveries were observed##2##3##(2008-10#2)
recoveries were obtained in##3##4##(2008-10#3)
recoveries were obtained##6##3##(2008-10#6)
recoveries were reached##2##3##(2008-10#2)
recoveries were##43##2##(1992-11#1)(2008-10#36)(2011-1#5)(2012-1#1)
recoveries with##2##2##(2008-10#1)(2008-6#1)
recoveries##300##1##(1990-2#1)(1992-11#3)(1993-2#1)(1994-5#1)(1997-2#2)(1997-6#2)(2008-10#261)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-3#1)(2011-1#13)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
recoverin##5##1##(1995-6#5)
recovering clusters##2##2##(2008-7#2)
recovering from##12##2##(1990-5#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-5#1)(2009-10#2)(2009-8#1)(2010-4#1)(2013-1#2)
recovering its##2##2##(1997-4#1)(2008-11#1)
recovering the##2##2##(1991-6#1)(2008-6#1)
recovering##38##1##(1990-5#1)(1991-1#1)(1991-6#1)(1992-9#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#2)(2009-8#1)(2010-4#1)(2012-1#1)(2013-1#4)
recovers##9##1##(1996-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-7#1)
recovery (&gt##2##2##(2008-10#2)
recovery achieved for##2##3##(2008-10#2)
recovery after hip fracture##3##4##(2008-8#3)
recovery after##20##2##(1990-2#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#2)
recovery and high##4##3##(2008-10#2)(2013-1#2)
recovery and its##2##3##(2008-10#2)
recovery and the##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
recovery and was discharged##2##4##(2010-12#1)(2011-1#1)
recovery and was##3##3##(2010-12#1)(2011-1#1)(2013-1#1)
recovery and##60##2##(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#3)(1997-5#1)(2008-1#2)(2008-10#23)(2008-11#2)(2008-2#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
recovery are##2##2##(2008-8#1)(2010-3#1)
recovery assay based on standard additions method##2##7##(2008-10#2)
recovery assay##3##2##(2008-10#3)
recovery at##7##2##(2008-10#4)(2008-6#1)(2013-1#2)
recovery both##2##2##(1996-5#1)(2013-1#1)
recovery by##5##2##(2008-10#1)(2008-6#1)(2008-8#3)
recovery can be##2##3##(1994-5#1)(2012-2#1)
recovery can##4##2##(1994-5#1)(2008-4#1)(2012-2#1)(2013-1#1)
recovery compared to##2##3##(2008-10#2)
recovery compared##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
recovery due to##2##3##(2012-2#1)(2012-3#1)
recovery during the##2##3##(2008-5#1)(2008-7#1)
recovery during##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
recovery efficiency##2##2##(2008-10#1)(2013-1#1)
recovery experiment and##2##3##(2008-10#1)(2008-5#1)
recovery experiment##5##2##(2008-10#1)(2008-5#2)(2013-8#2)
recovery experiments##5##2##(2008-10#4)(2012-1#1)
recovery factor##3##2##(2008-10#3)
recovery following##4##2##(1996-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
recovery for all##3##3##(1991-12#1)(2008-10#2)
recovery for##20##2##(1991-12#1)(1994-9#1)(2008-10#13)(2008-5#3)(2008-6#1)(2013-1#1)
recovery from mild##2##3##(2008-6#1)(2013-8#1)
recovery from neuromuscular blockade##2##4##(2010-7#2)
recovery from refractoriness in##2##4##(1991-2#2)
recovery from refractoriness##3##3##(1991-2#3)
recovery from stroke##2##3##(2008-2#1)(2008-8#1)
recovery from the disease##2##4##(2008-7#1)(2011-1#1)
recovery from the##8##3##(2008-10#4)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)
recovery from##58##2##(1990-5#1)(1990-7#2)(1991-2#3)(1992-3#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2009-8#1)(2010-1#1)(2010-3#2)(2010-7#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
recovery in a##2##3##(1993-9#1)(2008-2#1)
recovery in patients##2##3##(1996-3#1)(2013-1#1)
recovery in the##5##3##(2008-10#1)(2008-6#2)(2013-1#2)
recovery in##25##2##(1992-3#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#3)(2009-11#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
recovery is from##2##3##(2008-10#2)
recovery is in the range##2##5##(2008-10#2)
recovery is in##3##3##(2008-10#2)(2008-6#1)
recovery is##19##2##(1991-9#1)(1993-5#1)(2007-10#1)(2008-10#9)(2008-2#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-12#1)
recovery kinetics##2##2##(2008-8#2)
recovery level##2##2##(1992-1#1)(2008-10#1)
recovery method##3##2##(2008-10#2)(2012-12#1)
recovery occurred##2##2##(1991-6#1)(2008-6#1)
recovery of &gt##2##3##(2008-10#2)
recovery of 0##2##3##(2008-10#2)
recovery of 100##3##3##(2008-10#3)
recovery of 101%##2##3##(2008-10#2)
recovery of 95##2##3##(2008-10#2)
recovery of 99##4##3##(2008-10#4)
recovery of U(VI)##2##3##(2008-10#2)
recovery of a##6##3##(1994-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)
recovery of activity##3##3##(1992-3#2)(2011-2#1)
recovery of added##3##3##(1990-11#1)(1995-2#1)(2008-10#1)
recovery of all##3##3##(2008-10#3)
recovery of autonomic function following MCAO##2##6##(2007-10#2)
recovery of both##2##3##(2008-10#2)
recovery of copper was##2##4##(2008-10#2)
recovery of copper##7##3##(2008-10#7)
recovery of each##3##3##(2008-10#2)(2008-5#1)
recovery of function following##3##4##(1991-2#3)
recovery of function##8##3##(1991-2#3)(1995-11#1)(2007-8#1)(2008-11#1)(2008-2#2)
recovery of human##3##3##(1995-6#1)(2008-12#1)(2008-7#1)
recovery of left ventricular##2##4##(2007-9#1)(2008-11#1)
recovery of lysozyme##2##3##(2008-7#1)(2011-2#1)
recovery of patients##2##3##(1994-6#1)(2012-1#1)
recovery of perchlorate##2##3##(2008-10#2)
recovery of protein##2##3##(1991-5#1)(1994-6#1)
recovery of renal function##2##4##(2008-1#1)(2008-4#1)
recovery of responding to the extinguished stimulus during##2##8##(2008-5#2)
recovery of spiked##5##3##(1997-2#1)(2008-10#4)
recovery of spikes##2##3##(2008-10#2)
recovery of sporamin##2##3##(2008-6#2)
recovery of standard##2##3##(2008-10#1)(2012-2#1)
recovery of the analyte##4##4##(2008-10#3)(2012-12#1)
recovery of the method was##2##5##(2008-10#1)(2011-1#1)
recovery of the method##3##4##(2008-10#2)(2011-1#1)
recovery of the spiked##2##4##(2008-10#2)
recovery of the##57##3##(1990-3#1)(1990-7#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-8#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-8#1)(2010-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
recovery of these##2##3##(2008-10#2)
recovery of total##2##3##(2008-10#2)
recovery of##324##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-5#1)(1996-9#2)(1997-2#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#163)(2008-11#13)(2008-12#6)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#11)(2008-8#1)(2008-9#4)(2009-11#1)(2009-8#2)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
recovery on##3##2##(2008-10#2)(2012-3#1)
recovery or##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
recovery percentage##2##2##(2008-10#2)
recovery percentages##4##2##(2008-10#4)
recovery period##11##2##(1992-3#1)(1995-3#1)(2007-11#1)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
recovery phase##4##2##(1996-2#2)(2010-7#1)(2013-1#1)
recovery phenotype##2##2##(2008-10#2)
recovery procedure##2##2##(2008-2#2)
recovery process##10##2##(1991-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#4)(2013-1#2)
recovery processes##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
recovery range of##3##3##(2008-10#2)(2008-5#1)
recovery range##5##2##(2008-10#4)(2008-5#1)
recovery rate (RR)##2##3##(2008-10#2)
recovery rate of##3##3##(1996-12#1)(2008-10#2)
recovery rate was##8##3##(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-8#1)
recovery rate##16##2##(1996-12#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2013-8#1)
recovery rates##13##2##(1996-12#1)(2008-10#11)(2008-12#1)
recovery requirements##2##2##(2008-10#2)
recovery results##2##2##(2008-10#2)
recovery room##4##2##(2008-7#1)(2010-7#2)(2011-2#1)
recovery studies were##2##3##(2008-10#1)(2011-2#1)
recovery studies##12##2##(2008-10#7)(2010-5#4)(2011-2#1)
recovery study##4##2##(2008-10#3)(2009-6#1)
recovery term##2##2##(2008-10#2)
recovery test was performed##2##4##(2008-10#2)
recovery test##6##2##(2008-10#6)
recovery tests##5##2##(2008-10#5)
recovery the##2##2##(1991-2#1)(2008-10#1)
recovery through##2##2##(2008-11#1)(2012-12#1)
recovery time in semiconductor optical amplifiers##2##6##(2007-11#2)
recovery time in##3##3##(2007-11#2)(2008-9#1)
recovery time of##2##3##(2008-3#1)(2013-1#1)
recovery time were##2##3##(2012-2#2)
recovery time##15##2##(1996-3#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#4)(2013-1#1)
recovery times##4##2##(1996-2#1)(2008-10#2)(2013-1#1)
recovery to the##2##3##(2008-3#2)
recovery to##8##2##(1995-12#3)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
recovery under isothermal##2##3##(2009-7#2)
recovery under##5##2##(2009-7#2)(2013-8#3)
recovery using##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
recovery value##2##2##(2008-10#2)
recovery values are##4##3##(2008-10#4)
recovery values from##2##3##(2008-10#2)
recovery values obtained##4##3##(2008-10#4)
recovery values were obtained##2##4##(2008-10#1)(2011-2#1)
recovery values were##5##3##(2008-10#4)(2011-2#1)
recovery values##24##2##(2008-10#23)(2011-2#1)
recovery was calculated##2##3##(2008-10#2)
recovery was found in##2##4##(2008-10#1)(2008-5#1)
recovery was found##3##3##(2008-10#2)(2008-5#1)
recovery was obtained##3##3##(2007-8#1)(2008-10#2)
recovery was seen##2##3##(2011-2#1)(2012-2#1)
recovery was##49##2##(1990-2#2)(1990-8#2)(1991-2#1)(1991-5#1)(1993-12#1)(1994-6#1)(1995-11#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#2)(2012-3#1)(2013-8#2)
recovery were obtained for##2##4##(2008-10#2)
recovery were##12##2##(1990-8#1)(1994-8#1)(1996-12#1)(2008-10#6)(2010-2#1)(2011-2#1)(2012-3#1)
recovery when##3##2##(2008-4#1)(2008-5#1)(2010-7#1)
recovery with##4##2##(1995-5#1)(2008-3#1)(2008-6#1)(2010-5#1)
recovery within##2##2##(1991-8#1)(2013-8#1)
recovery without##4##2##(1996-6#1)(2007-2#1)(2011-2#1)(2012-2#1)
recovery##1080##1##(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#5)(1990-7#7)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#12)(1991-3#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#8)(1992-6#2)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#5)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#4)(1995-8#1)(1996-12#9)(1996-2#4)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#6)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#441)(2008-11#29)(2008-12#16)(2008-2#14)(2008-3#20)(2008-4#7)(2008-5#23)(2008-6#26)(2008-7#28)(2008-8#23)(2008-9#13)(2009-1#1)(2009-11#2)(2009-3#1)(2009-6#2)(2009-7#7)(2009-8#7)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#8)(2011-1#9)(2011-2#31)(2011-3#3)(2012-1#6)(2012-12#14)(2012-2#30)(2012-3#15)(2013-1#52)(2013-7#1)(2013-8#25)
recovery)##2##1##(2008-10#2)
recreated##2##1##(2008-11#1)(2009-11#1)
recreating the##2##2##(2013-1#2)
recreation and leisure activities##2##4##(2012-12#2)
recreation and##3##2##(2007-11#1)(2012-12#2)
recreation therapy##3##2##(1993-2#2)(2007-7#1)
recreation##7##1##(1993-2#2)(1994-3#1)(2007-11#1)(2007-7#1)(2012-12#2)
recreational activities##5##2##(1992-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
recreational and##2##2##(2008-8#1)(2013-1#1)
recreational drugs##2##2##(1991-1#1)(2011-2#1)
recreational facilities##2##2##(2011-2#1)(2013-1#1)
recreational screen-based##2##2##(2013-1#2)
recreational soccer player##2##3##(2011-2#2)
recreational sports##3##2##(2012-12#3)
recreational##31##1##(1990-2#1)(1991-1#1)(1992-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-2#6)(2012-12#9)(2012-2#1)(2013-1#4)(2013-8#1)
recrudescence##3##1##(2008-5#2)(2011-2#1)
recruit and retain##3##3##(1991-3#1)(2007-10#1)(2008-5#1)
recruit and##4##2##(1991-3#1)(2007-10#1)(2008-5#1)(2011-2#1)
recruit the##5##2##(1994-8#1)(2007-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
recruit##33##1##(1991-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-11#4)(2008-4#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
recruited a##2##2##(2013-1#2)
recruited and followed##2##3##(1992-2#1)(2007-8#1)
recruited and##9##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
recruited at##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
recruited by the##2##3##(2008-11#1)(2012-1#1)
recruited by##7##2##(2008-11#3)(2008-12#1)(2008-3#1)(2009-5#1)(2012-1#1)
recruited during##3##2##(2007-2#1)(2007-5#1)(2013-1#1)
recruited for the study##4##4##(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
recruited for the##6##3##(2008-11#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
recruited for##15##2##(1995-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
recruited from a##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
recruited from the##4##3##(2008-1#1)(2010-11#1)(2010-2#1)(2013-8#1)
recruited from##30##2##(1995-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#3)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#5)(2013-8#1)
recruited in a##2##3##(2007-8#1)(2013-1#1)
recruited in##8##2##(2007-8#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
recruited into##7##2##(1994-3#1)(2008-1#1)(2008-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
recruited to the##3##3##(2007-5#1)(2008-2#1)(2012-2#1)
recruited to##13##2##(1992-6#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#2)(2011-2#1)(2012-2#1)
recruited when subjects##2##3##(2008-11#1)(2012-12#1)
recruited##136##1##(1992-2#2)(1992-6#1)(1994-3#2)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#1)(2006-10#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#11)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#21)(2013-8#7)
recruiters##3##1##(1993-2#1)(2008-12#1)(2012-3#1)
recruiting and##3##2##(1991-2#1)(2008-5#1)(2012-2#1)
recruiting of##3##2##(1994-1#1)(1995-8#1)(2008-5#1)
recruiting patients##4##2##(2008-11#1)(2010-5#1)(2011-1#1)(2012-3#1)
recruiting##24##1##(1991-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#2)(1995-5#1)(1995-8#1)(1996-3#2)(2007-5#1)(2008-11#2)(2008-5#2)(2009-7#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
recruitment and activation##2##3##(2008-8#1)(2009-11#1)
recruitment and retention of##4##4##(1994-3#1)(2008-12#1)(2009-5#1)(2012-3#1)
recruitment and retention strategies##2##4##(1995-2#1)(2007-10#1)
recruitment and retention##15##3##(1991-2#1)(1994-3#2)(1995-2#1)(2007-10#1)(2008-11#3)(2008-12#2)(2008-8#1)(2009-5#1)(2010-11#1)(2012-3#2)
recruitment and##37##2##(1991-11#1)(1991-2#1)(1991-6#1)(1994-2#2)(1994-3#2)(1995-2#1)(1996-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#6)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
recruitment by##2##2##(2008-3#1)(2012-2#1)
recruitment challenges##2##2##(2010-10#1)(2010-11#1)
recruitment efforts##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#2)
recruitment for##2##2##(2008-10#1)(2013-7#1)
recruitment from##3##2##(1992-1#1)(2008-11#1)(2013-8#1)
recruitment in##4##2##(1993-11#1)(1994-2#1)(2008-5#1)(2008-8#1)
recruitment of T cells to the##2##6##(2008-5#1)(2013-1#1)
recruitment of additional##2##3##(1994-2#1)(2009-6#1)
recruitment of blood##3##3##(1997-8#1)(2008-12#1)(2008-7#1)
recruitment of participants##2##3##(2008-4#1)(2010-3#1)
recruitment of small-diameter fibers by the long-duration pulses##2##8##(1991-2#2)
recruitment of##41##2##(1991-2#2)(1992-1#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#2)(2009-3#1)(2009-6#4)(2010-11#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
recruitment patterns in the Florida Keys##2##6##(2007-5#2)
recruitment patterns in the##3##4##(2007-5#2)(2012-2#1)
recruitment patterns##5##2##(2007-5#3)(2011-2#1)(2012-2#1)
recruitment to the##5##3##(1997-2#1)(2008-10#1)(2009-10#1)(2013-1#1)(2013-7#1)
recruitment to##9##2##(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
recruitment##184##1##(1990-2#2)(1991-11#1)(1991-2#4)(1991-6#1)(1992-1#4)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-6#1)(1994-11#1)(1994-2#4)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-5#6)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#4)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#10)(2008-9#3)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#4)(2010-10#4)(2010-11#8)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#6)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#10)(2013-1#12)(2013-7#5)(2013-8#2)
recruits and blood donors##2##4##(1996-11#2)
recruits and##3##2##(1990-2#1)(1996-11#2)
recruits in##4##2##(2007-5#1)(2008-12#1)(2013-1#2)
recruits of##2##2##(2007-5#1)(2011-2#1)
recruits were##2##2##(2007-5#2)
recruits##26##1##(1990-2#1)(1990-3#1)(1991-1#1)(1994-11#1)(1996-11#2)(1997-2#1)(2007-5#6)(2008-11#1)(2008-12#3)(2009-3#1)(2009-7#1)(2011-2#2)(2013-1#4)(2013-8#1)
recrystallization##4##1##(2008-3#1)(2010-2#1)(2010-4#1)(2013-8#1)
recrystallized##3##1##(2008-10#2)(2008-3#1)
rectal administration##2##2##(2008-10#1)(2012-3#1)
rectal and sacral tumor##2##4##(2013-8#2)
rectal and##5##2##(2009-11#2)(2012-12#1)(2013-8#2)
rectal bleeding and##2##3##(2007-10#1)(2011-2#1)
rectal bleeding##6##2##(1993-9#1)(2007-10#2)(2011-2#2)(2013-1#1)
rectal cancer and##2##3##(1993-9#1)(2013-8#1)
rectal cancer are##2##3##(2008-10#2)
rectal cancer is##5##3##(2008-10#3)(2009-12#1)(2011-2#1)
rectal cancer patients##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
rectal cancer with##2##3##(2009-8#1)(2013-8#1)
rectal cancer##46##2##(1990-10#2)(1990-9#6)(1992-8#2)(1993-6#1)(1993-9#2)(1994-8#1)(1997-7#3)(1997-8#1)(2008-1#1)(2008-10#7)(2009-12#4)(2009-8#1)(2010-6#2)(2011-2#5)(2011-3#1)(2013-1#1)(2013-8#6)
rectal cancers##3##2##(1991-6#1)(2007-8#1)(2011-2#1)
rectal carcinoma##2##2##(2007-10#1)(2008-11#1)
rectal carcinoma]##4##2##(1990-3#1)(1990-9#1)(1996-8#1)(1997-3#1)
rectal examination and##2##3##(2008-7#1)(2012-12#1)
rectal examination in##2##3##(2008-7#2)
rectal examination##6##2##(1991-7#1)(2008-7#4)(2012-12#1)
rectal examinations##6##2##(1991-7#4)(1994-12#1)(2008-4#1)
rectal lumen##3##2##(2013-1#3)
rectal mucosa following its topical##2##5##(2010-12#2)
rectal mucosa##3##2##(2010-12#2)(2012-1#1)
rectal mucosal prolapse and##3##4##(2013-1#3)
rectal mucosal prolapse##6##3##(2013-1#6)
rectal polypoid##5##2##(2013-1#4)(2013-8#1)
rectal temperature##6##2##(1990-5#1)(1990-9#1)(1991-3#1)(2013-1#1)(2013-7#2)
rectal toxicity##2##2##(2008-7#2)
rectal tumor##2##2##(2013-8#2)
rectal vs##2##2##(2012-12#2)
rectal##148##1##(1990-10#2)(1990-3#1)(1990-5#1)(1990-9#9)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#6)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#3)(1997-8#1)(2007-10#4)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-7#8)(2009-10#1)(2009-11#4)(2009-12#8)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-5#1)(2010-6#3)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#7)(2012-3#2)(2013-1#16)(2013-7#2)(2013-8#12)
rectangle##2##1##(1996-2#1)(2008-2#1)
rectangle-packing##2##1##(2008-6#2)
rectangles can be##2##3##(2008-3#1)(2008-6#1)
rectangles or##2##2##(2008-4#1)(2012-1#1)
rectangles##12##1##(2008-3#1)(2008-4#1)(2008-6#9)(2012-1#1)
rectangular lattice##2##2##(1995-3#1)(2008-2#1)
rectangular shape##3##2##(2007-12#1)(2012-1#1)(2012-2#1)
rectangular symmetry##2##2##(2007-11#1)(2008-3#1)
rectangular##48##1##(1992-12#1)(1995-3#1)(1996-2#2)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
rectangular-shaped##2##1##(2008-3#2)
rectification (type##2##2##(1996-2#2)
rectification in##3##2##(2007-11#2)(2007-12#1)
rectification of##4##2##(2007-11#2)(2008-6#1)(2008-8#1)
rectification##26##1##(1994-12#1)(1996-2#5)(2007-11#7)(2007-12#6)(2008-6#1)(2008-8#5)(2011-2#1)
rectified##9##1##(1997-7#1)(2007-11#4)(2008-3#1)(2008-7#1)(2008-8#2)
rectifier K(+)##4##2##(2008-8#3)(2009-12#1)
rectifier K(+)-channel##2##2##(1993-3#2)
rectifier##9##1##(1993-3#2)(1996-5#1)(2008-8#4)(2009-12#1)(2013-7#1)
rectifying##10##1##(1993-12#1)(1996-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#3)(2011-2#1)
rectilinear in the##2##3##(2008-10#2)
rectilinear over the##6##3##(2008-10#6)
rectilinear##12##1##(2008-10#12)
recto-sigmoid##2##1##(1997-3#1)(2008-10#1)
rectocolitis##5##1##(1990-3#1)(1992-3#3)(1996-6#1)
rectosigmoid##4##1##(1993-12#2)(2008-10#1)(2013-1#1)
rectosigmoidoscopy with##2##2##(2008-7#2)
rectosigmoidoscopy##3##1##(1991-5#1)(2008-7#2)
rectum and##9##2##(1992-5#1)(1992-8#1)(2007-8#1)(2008-7#1)(2009-12#2)(2012-1#1)(2012-12#2)
rectum presenting##2##2##(2008-12#1)(2013-8#1)
rectum wall##3##2##(2007-12#1)(2012-1#1)(2012-12#1)
rectum##62##1##(1990-10#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-3#1)(1992-5#3)(1992-8#2)(1993-8#3)(1993-9#4)(1994-2#1)(1996-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2011-2#2)(2012-1#4)(2012-12#8)(2012-3#1)(2013-1#1)(2013-8#5)
rectus abdominis flap##2##3##(1991-5#1)(2008-4#1)
rectus abdominis muscle##2##3##(1993-12#1)(2012-2#1)
rectus abdominis myocutaneous flap##2##4##(1990-9#1)(2013-1#1)
rectus abdominis##10##2##(1990-9#1)(1991-5#1)(1993-12#1)(2008-4#1)(2009-6#1)(2012-12#1)(2012-2#3)(2013-1#1)
rectus abdominus##2##2##(2012-2#1)(2013-1#1)
rectus femoris muscle length##3##4##(2008-12#3)
rectus femoris muscle##6##3##(2008-12#4)(2011-2#2)
rectus femoris##11##2##(2008-12#5)(2010-4#1)(2011-2#3)(2012-1#2)
rectus muscle##4##2##(1991-12#1)(1993-12#2)(2012-3#1)
rectus##28##1##(1990-9#1)(1991-12#1)(1991-5#1)(1993-12#3)(2008-12#5)(2008-4#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
recumbency##3##1##(1994-7#2)(2011-1#1)
recuperation period##2##2##(1996-1#1)(1997-4#1)
recuperation##3##1##(1996-1#1)(1997-4#1)(2008-10#1)
recur after##3##2##(2010-3#1)(2011-2#1)(2013-1#1)
recur##17##1##(1990-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#3)
recurred after##2##2##(2007-8#1)(2013-8#1)
recurred in##5##2##(1991-4#1)(1997-6#1)(1997-7#1)(2008-6#1)(2013-1#1)
recurred locally##2##2##(1990-9#1)(1991-6#1)
recurred##26##1##(1990-9#1)(1991-4#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-6#2)(2008-8#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
recurrence 30##2##2##(2008-7#1)(2013-1#1)
recurrence after primary surgery##2##4##(1990-6#1)(1993-9#1)
recurrence after surgery##2##3##(2007-10#1)(2012-3#1)
recurrence after surgical##4##3##(2008-7#1)(2009-1#1)(2010-3#1)(2013-1#1)
recurrence after treatment##2##3##(2008-1#1)(2010-6#1)
recurrence after##18##2##(1990-3#1)(1990-6#1)(1991-11#1)(1993-3#1)(1993-9#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-7#1)(2009-1#1)(2010-3#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#2)
recurrence along##2##2##(2010-11#1)(2011-2#1)
recurrence and a##2##3##(2008-1#1)(2012-12#1)
recurrence and metastasis##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
recurrence and the##3##3##(2007-10#1)(2010-6#1)(2012-3#1)
recurrence and##34##2##(1990-12#1)(1991-8#1)(1995-4#1)(1996-11#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
recurrence as##2##2##(2008-10#1)(2008-6#1)
recurrence at##5##2##(2011-1#2)(2012-2#2)(2012-3#1)
recurrence following##2##2##(1994-8#1)(2008-10#1)
recurrence for##3##2##(2008-7#1)(2012-1#1)(2013-1#1)
recurrence from##3##2##(1990-12#1)(2008-10#1)(2010-6#1)
recurrence has been observed##2##4##(2008-10#1)(2011-2#1)
recurrence has been reported in##2##5##(2008-8#1)(2011-2#1)
recurrence has been##5##3##(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#2)
recurrence has##7##2##(2007-5#1)(2008-10#1)(2008-8#2)(2010-8#1)(2011-2#2)
recurrence in patients with##2##4##(2012-3#1)(2013-1#1)
recurrence in patients##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
recurrence in the##2##3##(1990-12#1)(2008-10#1)
recurrence in##14##2##(1990-12#1)(1997-7#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-6#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
recurrence is##5##2##(2006-10#1)(2008-2#1)(2008-6#1)(2010-6#1)(2012-12#1)
recurrence may##2##2##(2008-7#1)(2010-12#1)
recurrence of disease##2##3##(2008-6#1)(2011-2#1)
recurrence of infection##2##3##(2007-12#1)(2008-8#1)
recurrence of melanoma##2##3##(1993-12#1)(2008-9#1)
recurrence of stenosis##2##3##(2008-1#2)
recurrence of the disease##3##4##(1995-4#1)(2008-10#1)(2009-5#1)
recurrence of the tumor##2##4##(2007-8#1)(2008-11#1)
recurrence of the tumour##3##4##(2008-6#3)
recurrence of the##16##3##(1995-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
recurrence of##65##2##(1990-11#1)(1990-8#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-7#2)(1997-8#1)(2006-10#2)(2007-11#4)(2007-12#2)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
recurrence or metastasis##2##3##(2008-6#1)(2011-2#1)
recurrence or##8##2##(1993-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-6#2)(2011-2#1)(2013-8#1)
recurrence plots##3##2##(2008-11#3)
recurrence post##2##2##(2013-1#2)
recurrence rate and##5##3##(2007-11#2)(2011-2#3)
recurrence rate of##3##3##(1992-6#1)(2007-12#1)(2009-2#1)
recurrence rate was##6##3##(1990-12#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-5#1)(2013-1#1)
recurrence rate##25##2##(1990-12#1)(1992-11#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-9#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-3#1)(2011-2#6)(2013-1#2)(2013-7#1)(2013-8#1)
recurrence rates of##2##3##(1993-1#1)(2012-1#1)
recurrence rates to##3##3##(2009-12#1)(2010-8#1)(2011-2#1)
recurrence rates##17##2##(1993-1#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-6#2)(2009-12#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#1)
recurrence reported##2##2##(2008-10#1)(2012-3#1)
recurrence was detected##3##3##(1990-2#1)(2008-12#1)(2013-7#1)
recurrence was observed##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2010-11#1)(2011-1#1)
recurrence was seen##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
recurrence was##24##2##(1990-12#1)(1990-2#1)(1992-10#1)(1993-9#1)(1994-12#1)(1997-3#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
recurrence were##3##2##(2008-7#1)(2012-1#1)(2013-8#1)
recurrence##389##1##(1990-11#3)(1990-12#6)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-11#2)(1991-4#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-9#3)(1994-12#3)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-3#2)(1995-4#4)(1995-5#1)(1996-11#2)(1996-7#2)(1996-9#2)(1997-3#2)(1997-5#1)(1997-7#4)(1997-8#1)(2006-10#4)(2006-12#1)(2007-10#4)(2007-11#6)(2007-12#6)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#12)(2008-1#8)(2008-10#16)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#25)(2008-7#17)(2008-8#10)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#12)(2010-4#1)(2010-5#1)(2010-6#7)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#38)(2012-1#5)(2012-12#5)(2012-2#9)(2012-3#13)(2013-1#29)(2013-7#5)(2013-8#12)
recurrence-free survival##2##2##(2008-6#1)(2011-2#1)
recurrences after##2##2##(2013-1#1)(2013-8#1)
recurrences and##4##2##(2008-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
recurrences by##3##2##(1990-6#1)(1992-5#2)
recurrences following##2##2##(1990-6#1)(2013-1#1)
recurrences in patients with##2##4##(2010-3#1)(2011-2#1)
recurrences in##3##2##(1992-12#1)(2010-3#1)(2011-2#1)
recurrences is##3##2##(1991-9#1)(2007-11#1)(2007-8#1)
recurrences occurred##2##2##(1996-9#1)(2011-1#1)
recurrences of the##3##3##(1997-4#1)(2008-6#1)(2013-1#1)
recurrences of##9##2##(1991-2#1)(1991-6#1)(1995-9#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#1)
recurrences were##3##2##(1990-12#1)(1993-9#1)(2013-1#1)
recurrences##71##1##(1990-12#2)(1990-3#1)(1990-6#6)(1991-12#2)(1991-2#1)(1991-4#2)(1991-6#3)(1991-9#2)(1992-12#1)(1992-5#2)(1993-3#1)(1993-9#2)(1994-1#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-8#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-6#6)(2008-7#2)(2009-8#1)(2010-3#2)(2011-1#4)(2011-2#4)(2012-2#2)(2013-1#5)(2013-8#2)
recurrent abdominal pain in##2##4##(1992-5#2)
recurrent acute otitis media##2##4##(2007-10#1)(2013-8#1)
recurrent and##5##2##(1992-9#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-7#1)
recurrent angina-like chest pain##2##4##(1996-3#1)(2012-2#1)
recurrent aphthous stomatitis##2##3##(2007-12#1)(2010-1#1)
recurrent bacterial infections##2##3##(2008-1#1)(2011-2#1)
recurrent bladder tumours##3##3##(1991-6#3)
recurrent bladder##5##2##(1991-6#4)(2013-8#1)
recurrent bleeding in##2##3##(2007-8#2)
recurrent bleeding##4##2##(2007-8#4)
recurrent breast cancer##6##3##(1993-1#2)(1994-12#2)(1994-7#2)
recurrent cancer##2##2##(2007-7#1)(2008-2#1)
recurrent carcinoma##2##2##(1994-1#1)(2013-1#1)
recurrent carcinomas##3##2##(1991-4#3)
recurrent cardiac tamponade##2##3##(2010-5#2)
recurrent carpal tunnel syndrome##3##4##(2008-9#3)
recurrent cases##2##2##(2008-11#1)(2009-3#1)
recurrent chest##2##2##(2008-12#1)(2009-3#1)
recurrent collaterals of##2##3##(1996-5#2)
recurrent disease after##2##3##(1994-5#1)(1997-4#1)
recurrent disease and##2##3##(2007-7#1)(2010-3#1)
recurrent disease##12##2##(1991-6#1)(1994-5#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-6#1)(2009-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
recurrent episodes of##5##3##(1990-2#1)(2007-5#1)(2008-6#1)(2013-1#2)
recurrent episodes##6##2##(1990-2#1)(2007-5#1)(2008-11#1)(2008-6#1)(2013-1#2)
recurrent epistaxis##6##2##(2007-10#2)(2008-7#1)(2010-6#1)(2011-1#1)(2012-1#1)
recurrent event##3##2##(1997-4#3)
recurrent events##4##2##(1997-4#2)(2008-11#1)(2008-8#1)
recurrent haemoptysis##2##2##(1992-9#2)
recurrent head and neck cancer##2##5##(1990-12#1)(2007-7#1)
recurrent hematoma##2##2##(2008-7#2)
recurrent hematuria##2##2##(2008-1#2)
recurrent hernias##2##2##(1996-9#2)
recurrent hernias)##2##2##(1992-5#2)
recurrent infection##5##2##(1992-11#1)(2008-8#2)(2011-2#1)(2011-3#1)
recurrent infections##5##2##(1992-11#1)(2010-5#1)(2011-1#1)(2011-2#2)
recurrent laryngeal##2##2##(2008-2#2)
recurrent malignancies of the##2##4##(1993-6#1)(1994-1#1)
recurrent myocardial infarction##2##3##(1991-3#1)(2008-3#1)
recurrent nerve##2##2##(1991-11#1)(2008-2#1)
recurrent network##3##2##(2008-2#1)(2013-8#2)
recurrent neural networks##5##3##(2010-8#5)
recurrent neural##10##2##(2008-11#4)(2008-2#1)(2010-8#5)
recurrent or##4##2##(1992-6#1)(2008-5#1)(2008-6#1)(2013-1#1)
recurrent orbital inflammation##2##3##(2011-1#2)
recurrent osteosarcoma##2##2##(2008-6#1)(2010-3#1)
recurrent pain##4##2##(2008-11#4)
recurrent parent##6##2##(2008-10#5)(2008-9#1)
recurrent post-bronchiolitis##2##2##(2008-1#2)
recurrent renal##2##2##(1990-12#1)(2007-7#1)
recurrent respiratory##4##2##(1997-1#1)(1997-2#1)(2008-7#1)(2013-8#1)
recurrent seizures##3##2##(2008-7#1)(2009-8#1)(2011-2#1)
recurrent spontaneous abortion##2##3##(1991-3#1)(1991-8#1)
recurrent spontaneous##4##2##(1991-3#1)(1991-8#1)(2008-7#1)(2013-1#1)
recurrent stasis ulcers##2##3##(2013-1#2)
recurrent stroke##6##2##(1991-11#1)(2007-10#1)(2008-8#3)(2012-12#1)
recurrent stupor##2##2##(1994-2#1)(1996-11#1)
recurrent superficial bladder tumours##2##4##(1991-6#2)
recurrent tumour##2##2##(2008-1#2)
recurrent tumours##2##2##(2008-6#1)(2009-4#1)
recurrent ulcer##3##2##(1992-11#1)(1992-5#1)(2012-2#1)
recurrent urinary tract infection##2##4##(1990-11#1)(2009-5#1)
recurrent urinary tract infections and##2##5##(2012-2#1)(2013-1#1)
recurrent urinary tract infections##4##4##(2008-10#1)(2012-2#2)(2013-1#1)
recurrent urinary tract##6##3##(1990-11#1)(2008-10#1)(2009-5#1)(2012-2#2)(2013-1#1)
recurrent vascular##2##2##(2008-8#2)
recurrent ventricular##2##2##(2008-12#2)
recurrent vulvovaginal candidiasis##2##3##(2008-5#1)(2012-3#1)
recurrent vulvovaginal##3##2##(2007-10#1)(2008-5#1)(2012-3#1)
recurrent wheals##2##2##(2010-6#2)
recurrent##398##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-6#11)(1991-8#1)(1992-11#3)(1992-2#1)(1992-4#1)(1992-5#7)(1992-6#1)(1992-9#5)(1993-1#4)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#8)(1997-5#4)(1997-8#3)(2006-10#4)(2006-12#1)(2007-10#7)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#10)(2007-8#12)(2008-1#10)(2008-10#14)(2008-11#16)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#8)(2008-7#18)(2008-8#14)(2008-9#11)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#8)(2010-7#1)(2010-8#6)(2011-1#10)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#17)(2013-1#17)(2013-7#3)(2013-8#7)
recurrently##3##1##(1996-2#1)(1997-5#1)(2008-5#1)
recurring outcome##2##2##(1997-4#2)
recurring themes##2##2##(2008-12#1)(2008-5#1)
recurring##24##1##(1991-3#2)(1993-1#1)(1993-9#1)(1997-4#5)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
recurs##2##1##(1995-12#1)(1997-7#1)
recursion##2##1##(2007-11#1)(2008-2#1)
recursive partitioning analysis##2##3##(1991-12#1)(2008-3#1)
recursive partitioning##5##2##(1991-12#2)(1995-2#1)(2008-3#1)(2013-1#1)
recursive##13##1##(1991-12#2)(1995-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2013-1#1)
recursively##2##1##(2008-2#1)(2013-1#1)
recyclable##2##1##(1996-1#1)(2008-10#1)
recycle batch##5##2##(2008-11#1)(2008-7#4)
recycle##12##1##(1995-6#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-9#1)
recycled HDPE##5##2##(2009-3#5)
recycled##15##1##(1990-8#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-7#1)(2009-3#6)(2013-1#1)
recycling of a##2##3##(2008-3#1)(2008-8#1)
recycling of eIF-2##2##3##(1991-12#2)
recycling of the##2##3##(1990-11#1)(2008-11#1)
recycling of##18##2##(1990-11#1)(1991-12#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#1)
recycling site##2##2##(2008-10#2)
recycling##57##1##(1990-11#1)(1991-12#2)(1993-11#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-1#2)(1996-12#4)(1996-3#5)(1997-1#4)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#2)(2012-2#3)(2013-1#1)
red (NR)##3##2##(2008-10#2)(2010-5#1)
red S##6##2##(2008-10#4)(2013-7#2)
red alga##5##2##(2008-10#2)(2008-11#3)
red algae##3##2##(2008-10#1)(2008-8#1)(2011-10#1)
red and blue##2##3##(2008-3#1)(2008-8#1)
red and green##2##3##(2008-10#1)(2008-3#1)
red and white##3##3##(2008-10#3)
red and##15##2##(2007-11#1)(2008-10#8)(2008-3#5)(2008-8#1)
red areas##2##2##(1990-10#1)(2008-7#1)
red beds##6##2##(2013-8#6)
red beet##2##2##(1994-8#1)(2008-10#1)
red blood cell (RBC)##2##4##(2008-3#1)(2013-1#1)
red blood cell membrane##2##4##(1994-12#2)
red blood cell transfusion##2##4##(2008-7#2)
red blood cell transfusions during the study##2##7##(2008-7#2)
red blood cell##27##3##(1990-8#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-8#1)(1997-6#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#1)(2013-1#3)
red blood cells (RBC)##3##4##(1996-7#1)(2008-10#1)(2010-8#1)
red blood cells (RBCs)##11##4##(1994-12#5)(1994-3#1)(1994-6#2)(1994-9#1)(2008-10#1)(2009-11#1)
red blood cells and##4##4##(1995-3#1)(1997-8#1)(2008-3#1)(2012-12#1)
red blood cells from##3##4##(1994-2#1)(1996-12#1)(2008-3#1)
red blood cells in##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
red blood cells of the##2##5##(2008-8#1)(2012-2#1)
red blood cells of##4##4##(1994-12#1)(1997-6#1)(2008-8#1)(2012-2#1)
red blood cells to##2##4##(2008-10#1)(2012-2#1)
red blood cells##91##3##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#1)(1994-6#4)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#3)(1996-7#1)(1997-6#1)(1997-8#1)(2008-10#15)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
red blood##118##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#10)(1994-2#3)(1994-3#1)(1994-6#4)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-7#1)(1997-6#3)(1997-8#1)(2007-11#1)(2008-10#18)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#4)
red blotchiness##2##2##(2008-5#2)
red cell antigens##4##3##(1992-9#2)(1993-12#1)(1994-3#1)
red cell aplasia (PRCA)##3##4##(2007-10#1)(2008-10#1)(2008-12#1)
red cell aplasia##5##3##(2007-10#2)(2008-10#1)(2008-12#1)(2013-1#1)
red cell mass##2##3##(2008-4#2)
red cell phenotype##2##3##(1993-12#1)(1994-12#1)
red cell units##2##3##(1994-12#1)(1994-9#1)
red cell##47##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-9#2)(1992-12#2)(1992-6#3)(1992-9#3)(1993-12#2)(1994-12#3)(1994-3#3)(1994-6#1)(1994-9#5)(1995-6#1)(1996-7#1)(1997-6#1)(2006-6#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#1)(2011-3#1)(2012-2#1)(2013-1#2)
red cells and##3##3##(1992-12#1)(1993-9#1)(1994-3#1)
red cells from the proposita##3##5##(1992-12#3)
red cells from##7##3##(1992-12#5)(1993-12#1)(1994-12#1)
red cells lack##2##3##(1995-6#2)
red cells of##2##3##(1990-9#1)(1994-12#1)
red cells treated with##2##4##(1992-9#1)(1994-12#1)
red cells were##5##3##(1993-12#2)(1994-3#1)(2008-10#1)(2008-3#1)
red cells##40##2##(1990-11#2)(1990-8#2)(1990-9#1)(1992-12#8)(1992-9#2)(1993-12#6)(1993-9#1)(1994-12#3)(1994-3#4)(1995-6#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
red clover mottle##2##3##(1995-12#2)
red clover##3##2##(1995-12#2)(2008-10#1)
red coloured##3##2##(2008-10#3)
red complex with##2##3##(2008-10#2)
red complex##8##2##(2008-10#8)
red deer (Cervus elaphus) in Ireland##2##6##(1993-2#2)
red disarrayed&quot##2##2##(1990-3#2)
red discoloration of##2##3##(1995-11#1)(2013-1#1)
red dyes##2##2##(2008-10#2)
red emission##3##2##(2007-12#2)(2008-10#1)
red flag documentation##2##3##(2008-12#2)
red flag items##3##3##(2008-12#3)
red flag##5##2##(2008-12#5)
red flags##5##2##(1997-4#1)(2008-12#3)(2013-7#1)
red flour beetle##2##3##(1992-8#1)(2008-12#1)
red fluorescent##2##2##(2008-4#1)(2008-8#1)
red in##3##2##(2008-10#3)
red laser light##2##3##(2008-3#1)(2012-2#1)
red laser##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
red leading edges stimulated an ETR under##2##7##(2011-2#2)
red light and##4##3##(1990-5#1)(2008-4#2)(2013-1#1)
red light is##2##3##(2007-11#1)(2007-12#1)
red light##28##2##(1990-11#1)(1990-5#4)(1992-1#1)(1992-6#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
red light-induced amaranthin##2##3##(2008-4#2)
red mangrove (Rhizophora mangle)##3##4##(2007-5#1)(2008-5#1)(2011-2#1)
red mangrove##4##2##(2007-5#1)(2008-5#1)(2011-2#2)
red marrow##2##2##(2008-6#2)
red meat##2##2##(2012-12#1)(2012-2#1)
red nucleus##12##2##(1992-11#11)(1997-2#1)
red ochre##3##2##(2008-10#3)
red or green##2##3##(1992-12#1)(2011-2#1)
red or##4##2##(1992-12#1)(2008-3#2)(2011-2#1)
red orange extract##2##3##(2008-5#2)
red pepper##4##2##(1997-6#1)(2008-10#2)(2012-3#1)
red pine##3##2##(2008-10#3)
red resinous exudates##2##3##(2008-10#2)
red shift of##4##3##(1992-12#1)(2007-11#1)(2008-10#2)
red shift##10##2##(1990-5#1)(1992-12#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#4)(2011-1#1)
red tilapia##3##2##(2008-12#3)
red to##3##2##(2008-10#2)(2008-5#1)
red wine consumption##2##3##(2008-7#2)
red wine might##2##3##(2008-10#2)
red wine or##3##3##(2011-2#2)(2012-12#1)
red wine samples##3##3##(2008-10#3)
red wine##29##2##(2008-10#13)(2008-7#9)(2011-2#6)(2012-12#1)
red wines using##2##3##(2008-10#2)
red wines##10##2##(2008-10#10)
red winter wheat##4##3##(2008-10#2)(2008-5#2)
red with##2##2##(2008-10#2)
red##563##1##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#5)(1990-7#1)(1990-8#6)(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#15)(1992-12#12)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#6)(1993-12#11)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#16)(1994-2#3)(1994-3#9)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#7)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#3)(1996-4#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#15)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#142)(2008-11#11)(2008-12#14)(2008-2#11)(2008-3#24)(2008-4#15)(2008-5#18)(2008-6#3)(2008-7#19)(2008-8#14)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#4)(2010-8#5)(2011-1#3)(2011-10#1)(2011-2#22)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#2)(2013-1#14)(2013-7#3)(2013-8#9)
red-##2##1##(1993-9#1)(2008-8#1)
red-bellied newt##2##2##(2008-6#2)
red-bellied##3##1##(1997-4#1)(2008-6#2)
red-cell reinfusion##2##2##(2008-8#2)
red-cell##4##1##(1992-9#1)(1997-5#1)(2008-8#2)
red-colored##2##1##(2009-11#1)(2011-2#1)
red-coloured##2##1##(1990-12#1)(2008-10#1)
red-emitting CdTe quantum dots##2##4##(2008-10#2)
red-green-blue##2##1##(2008-3#1)(2009-11#1)
red-region fluorescent reagent##2##3##(2008-10#2)
red-region fluorescent##3##2##(2008-10#3)
red-sensitive##6##1##(1990-12#4)(2008-2#1)(2008-8#1)
red-shift##3##1##(1992-12#1)(1996-12#2)
red-shifted to##2##2##(2008-10#2)
red-shifted##10##1##(1993-11#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-2#1)(2010-2#2)
red-smear##3##1##(2012-2#3)
red/infrared irradiation had##2##3##(2008-10#2)
reddening##2##1##(2008-3#1)(2008-5#1)
redder##2##1##(2010-4#1)(2011-2#1)
reddish##2##1##(2008-10#1)(2012-3#1)
reddish-brown##3##1##(2008-10#2)(2008-2#1)
redefine the##5##2##(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(2011-2#1)
redefine##7##1##(1994-1#1)(1994-3#1)(1995-2#2)(1996-1#1)(2008-7#1)(2011-2#1)
redefined##4##1##(1995-1#1)(1995-3#2)(2008-10#1)
redefining the##4##2##(1994-2#1)(1995-12#1)(2008-3#1)(2011-3#1)
redefining##7##1##(1993-3#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-3#1)
redeployment##8##1##(1993-1#3)(1994-2#1)(1995-1#3)(1995-2#1)
redesign and##2##2##(1996-1#1)(2007-12#1)
redesign of the##3##3##(1996-3#1)(1997-3#1)(2008-7#1)
redesign of##5##2##(1996-3#1)(1997-2#2)(1997-3#1)(2008-7#1)
redesign process##3##2##(1996-12#1)(1996-3#2)
redesign##35##1##(1992-12#2)(1993-12#2)(1993-3#2)(1994-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#7)(1997-1#2)(1997-2#3)(1997-3#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-7#1)
redesigned its##2##2##(1995-12#1)(1996-1#1)
redesigned to##3##2##(1994-12#1)(1995-1#1)(2008-6#1)
redesigned##9##1##(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
redesigning of##2##2##(1992-3#1)(2008-11#1)
redesigning the##6##2##(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#2)(2008-2#1)
redesigning##18##1##(1992-3#2)(1993-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)
redirected to##2##2##(2008-10#1)(2008-11#1)
redirected##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
redirection and frequency filtering##2##4##(2008-3#2)
redirection of##2##2##(2008-11#2)
redirection##7##1##(2007-11#1)(2008-11#4)(2008-3#2)
redirects##2##1##(1994-3#1)(2008-11#1)
rediscovered##4##1##(2007-12#1)(2008-6#1)(2008-7#1)(2012-1#1)
redisplacement##6##1##(1991-9#1)(2011-2#5)
redissolution##3##1##(2008-10#3)
redistributed to##2##2##(1992-11#1)(1992-2#1)
redistributed##3##1##(1992-11#1)(1992-2#1)(2007-12#1)
redistribution in the##2##3##(2008-5#2)
redistribution in##4##2##(1992-5#1)(1995-8#1)(2008-5#2)
redistribution of energy##2##3##(2007-12#2)
redistribution of the##3##3##(1994-6#1)(1995-6#1)(2008-10#1)
redistribution of##17##2##(1992-11#1)(1993-11#1)(1993-8#1)(1994-6#3)(1995-6#1)(1996-9#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-8#3)(2012-1#1)
redistribution was##2##2##(1992-5#2)
redistribution within the##2##3##(2008-7#1)(2013-7#1)
redistribution##40##1##(1992-11#1)(1992-5#3)(1993-11#1)(1993-8#1)(1994-6#3)(1995-6#2)(1995-8#1)(1996-9#1)(2007-1#1)(2007-12#5)(2008-10#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#4)(2011-2#3)(2012-1#3)(2012-2#2)(2013-7#1)
redistributive##2##1##(1997-2#2)
redness of##2##2##(2008-5#1)(2008-8#1)
redness##8##1##(2007-11#1)(2008-5#5)(2008-8#1)(2011-2#1)
redness)##2##1##(2012-12#1)(2013-1#1)
redo cardiac surgery##2##3##(2007-8#1)(2007-9#1)
redo surgery##2##2##(2007-8#1)(2007-9#1)
redo##5##1##(2007-8#2)(2007-9#2)(2011-2#1)
redolens f##2##2##(2008-10#2)
redolens##5##1##(2008-10#5)
redolens-F##3##1##(2008-10#3)
redox active##2##2##(1990-12#1)(1995-6#1)
redox agents##2##2##(2008-8#1)(2011-2#1)
redox and##2##2##(2009-9#1)(2010-4#1)
redox behavior of##2##3##(2008-10#2)
redox behavior##6##2##(2008-10#6)
redox catalyst##2##2##(2008-10#2)
redox couple due to##2##4##(2008-10#2)
redox couple##10##2##(2008-10#9)(2008-7#1)
redox couples##2##2##(1996-2#1)(2008-10#1)
redox cycle##4##2##(1992-8#3)(2008-10#1)
redox cycling##4##2##(1992-8#2)(2008-10#1)(2008-11#1)
redox disproportionation##2##2##(1996-2#2)
redox electrode detector##3##3##(2008-10#3)
redox electrode##6##2##(2008-10#6)
redox environment##2##2##(2008-10#1)(2008-7#1)
redox enzymes##2##2##(1997-7#1)(2008-10#1)
redox equilibrium##2##2##(2008-10#1)(2008-7#1)
redox homeostasis##5##2##(1994-8#2)(2009-6#1)(2009-9#1)(2012-2#1)
redox indicator##3##2##(2008-10#3)
redox indicators##3##2##(2008-10#3)
redox initiation polymerization##2##3##(2008-10#2)
redox initiation##3##2##(2008-10#3)
redox labels##2##2##(2008-12#2)
redox mechanism##3##2##(2008-10#3)
redox mediator##10##2##(2008-10#10)
redox partner##2##2##(1994-5#1)(1994-9#1)
redox partners##3##2##(1990-5#2)(1995-2#1)
redox peak##3##2##(2008-10#2)(2008-8#1)
redox peaks##4##2##(2008-10#4)
redox polymer##4##2##(2008-10#4)
redox potential and##2##3##(2008-10#1)(2008-7#1)
redox potential##17##2##(1993-11#1)(1995-2#1)(1995-5#1)(1996-9#1)(2008-10#6)(2008-11#3)(2008-7#4)
redox potentials##5##2##(2008-10#5)
redox process##5##2##(1996-2#1)(2008-10#4)
redox processes##4##2##(1994-8#1)(2008-10#2)(2009-9#1)
redox properties of##6##3##(1993-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
redox properties##7##2##(1993-11#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
redox protein##3##2##(1993-9#1)(1995-2#1)(2009-9#1)
redox proteins##3##2##(1990-5#1)(1995-5#1)(2010-12#1)
redox ratio##3##2##(1995-12#1)(2008-11#1)(2011-2#1)
redox reaction between bromate and##3##5##(2008-10#3)
redox reaction between##8##3##(2008-10#8)
redox reaction of cysteine with iron(III)##2##6##(2008-10#2)
redox reaction of##6##3##(2008-10#6)
redox reaction with##2##3##(2008-10#2)
redox reaction##25##2##(2008-10#24)(2013-8#1)
redox reactions##6##2##(1994-11#2)(1997-7#1)(2008-10#2)(2009-10#1)
redox speciation##2##2##(2008-10#2)
redox species##2##2##(2008-10#2)
redox state of the##2##4##(1991-2#1)(2008-11#1)
redox state of##7##3##(1990-8#1)(1991-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
redox state##13##2##(1990-8#2)(1991-2#1)(1992-8#1)(1993-6#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#2)(2010-12#1)
redox status##2##2##(2008-10#1)(2008-7#1)
redox stress and remodeling##2##4##(2011-2#2)
redox stress##5##2##(2011-2#5)
redox system##5##2##(1994-11#1)(2008-10#4)
redox waves##4##2##(1996-5#1)(2008-10#3)
redox##249##1##(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-2#2)(1992-11#1)(1992-6#1)(1992-8#7)(1993-11#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#4)(1995-5#4)(1995-6#1)(1996-2#5)(1996-5#1)(1996-9#1)(1997-7#3)(2008-10#142)(2008-11#11)(2008-12#2)(2008-5#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#1)(2009-9#5)(2010-10#2)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#7)(2012-2#1)(2013-8#1)
redox-active mediator##2##2##(2008-10#2)
redox-active##10##1##(1993-9#1)(1995-5#1)(2008-10#5)(2008-12#1)(2009-10#2)
redox-cycling quinones##3##2##(2009-9#3)
redox-cycling##5##1##(2009-9#5)
redox-potentiometric##2##1##(2008-10#2)
redress##6##1##(1996-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-12#2)
redshift##2##1##(1990-12#1)(2007-11#1)
reduce CVD##4##2##(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)
reduce FBS##2##2##(2008-11#2)
reduce Fusarium##2##2##(2008-10#2)
reduce HIV##2##2##(1995-9#1)(2011-2#1)
reduce O2##2##2##(1991-3#1)(1994-11#1)
reduce a##7##2##(1993-1#1)(1995-6#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-1#1)
reduce aflatoxin##2##2##(2008-10#2)
reduce and##3##2##(1993-8#1)(2012-2#1)(2012-3#1)
reduce blood pressure##4##3##(1990-11#1)(1993-2#1)(1995-2#1)(2008-8#1)
reduce blood##5##2##(1990-11#1)(1993-2#1)(1995-2#1)(2006-12#1)(2008-8#1)
reduce both##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
reduce cardiovascular morbidity##2##3##(1993-11#1)(2012-12#1)
reduce cardiovascular##4##2##(1993-11#1)(2008-6#1)(2010-12#1)(2012-12#1)
reduce cell##2##2##(2010-11#1)(2011-2#1)
reduce child##3##2##(2008-11#1)(2009-7#1)(2010-12#1)
reduce cholesterol##2##2##(1991-6#1)(2008-5#1)
reduce cost##3##2##(1997-3#1)(2008-7#1)(2012-2#1)
reduce costs and##3##3##(1995-2#1)(1997-1#1)(2010-9#1)
reduce costs##17##2##(1990-4#1)(1991-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#2)(1997-1#2)(1997-2#1)(2007-11#1)(2009-4#2)(2010-9#1)(2011-2#1)
reduce damage##2##2##(2008-10#1)(2008-7#1)
reduce disease##5##2##(2008-10#4)(2011-2#1)
reduce drinking##2##2##(1994-2#1)(2008-11#1)
reduce expenses##2##2##(1994-2#1)(1995-3#1)
reduce exposure to##2##3##(2008-11#1)(2008-5#1)
reduce fracture risk##2##3##(1993-11#1)(2012-12#1)
reduce growth##2##2##(1995-6#1)(2008-12#1)
reduce health care##2##3##(1994-12#1)(1996-2#1)
reduce health##4##2##(1994-12#1)(1996-2#1)(2010-5#1)(2012-2#1)
reduce host##2##2##(2008-8#1)(2008-9#1)
reduce infarct##2##2##(1990-12#1)(2008-2#1)
reduce inflammation and##3##3##(1992-11#1)(1993-9#1)(2011-2#1)
reduce inflammation##5##2##(1992-11#1)(1993-9#1)(2008-7#1)(2008-8#1)(2011-2#1)
reduce inflammatory##2##2##(2008-7#1)(2011-2#1)
reduce its##3##2##(2008-7#1)(2012-12#1)(2012-3#1)
reduce length of stay and##3##5##(1993-3#1)(1995-3#1)(2012-3#1)
reduce length of stay##7##4##(1993-3#2)(1995-3#1)(2008-3#1)(2012-2#2)(2012-3#1)
reduce levels of##2##3##(2007-5#1)(2008-9#1)
reduce levels##3##2##(2007-5#1)(2008-1#1)(2008-9#1)
reduce life##2##2##(1997-4#1)(2008-8#1)
reduce long-term##4##2##(2008-2#1)(2008-3#1)(2013-1#2)
reduce maternal mortality##3##3##(1994-3#1)(2008-11#2)
reduce medical costs##2##3##(1991-1#1)(2010-8#1)
reduce medical##3##2##(1991-1#1)(2008-7#1)(2010-8#1)
reduce morbidity##4##2##(1990-2#1)(2007-12#1)(2008-7#1)(2011-2#1)
reduce mortality in##2##3##(1997-1#1)(2008-3#1)
reduce mortality##10##2##(1990-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
reduce or##11##2##(1992-2#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-10#1)(2010-5#2)(2013-1#1)
reduce oxidative stress##2##3##(2008-11#1)(2008-7#1)
reduce oxidative##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
reduce pain##5##2##(2007-11#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
reduce patient##3##2##(1996-2#1)(2009-9#1)(2011-7#1)
reduce quality##2##2##(2008-6#1)(2010-7#1)
reduce recurrence##3##2##(2007-8#1)(2011-2#2)
reduce redundancy##2##2##(1996-2#1)(2010-8#1)
reduce risk in##2##3##(1997-1#1)(2008-7#1)
reduce risk of##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)
reduce risk##13##2##(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-5#1)(2011-1#1)
reduce risks from##2##3##(1991-3#1)(2008-9#1)
reduce risks##3##2##(1991-3#2)(2008-9#1)
reduce root disease severity##2##4##(2008-10#2)
reduce serum##2##2##(1991-6#1)(2011-2#1)
reduce significantly the##6##3##(1993-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
reduce stroke##2##2##(2007-8#1)(2008-8#1)
reduce symptoms##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
reduce the amount of##5##4##(2007-9#1)(2008-10#2)(2008-11#2)
reduce the biological##2##3##(1991-12#1)(2008-7#1)
reduce the burden of##6##4##(2007-12#1)(2008-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
reduce the chance of##2##4##(1995-6#1)(2007-8#1)
reduce the chance##3##3##(1995-6#1)(2007-8#1)(2008-7#1)
reduce the coherent##2##3##(2007-11#1)(2008-3#1)
reduce the complication##2##3##(2008-10#1)(2010-8#1)
reduce the computation time##3##4##(2008-3#3)
reduce the computation##4##3##(2008-2#1)(2008-3#3)
reduce the concentration of##2##4##(1996-12#1)(2008-9#1)
reduce the cost and##2##4##(1996-12#1)(2008-3#1)
reduce the cost of##3##4##(1997-4#1)(2013-1#1)(2013-8#1)
reduce the cost##7##3##(1996-12#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
reduce the costs of##3##4##(1997-1#1)(2008-1#1)(2008-11#1)
reduce the costs##4##3##(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)
reduce the degree of##3##4##(1997-3#2)(2009-11#1)
reduce the dose##3##3##(1992-12#1)(2008-7#1)(2013-1#1)
reduce the expression of##2##4##(2008-6#1)(2009-12#1)
reduce the growth##3##3##(1990-11#1)(1995-6#1)(2009-10#1)
reduce the high##2##3##(2007-8#1)(2008-12#1)
reduce the incidence of##26##4##(1991-12#1)(1992-12#2)(1993-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
reduce the incidence##28##3##(1991-12#1)(1992-12#2)(1993-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
reduce the influence of##3##4##(2008-2#2)(2008-3#1)
reduce the influence##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
reduce the latter##2##3##(1992-8#1)(2008-3#1)
reduce the length of##2##4##(1995-3#1)(2007-11#1)
reduce the level of contamination##2##5##(2008-1#1)(2008-10#1)
reduce the level of##5##4##(1991-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-3#1)
reduce the levels of##2##4##(2008-3#1)(2012-3#1)
reduce the likelihood of##4##4##(2008-3#1)(2010-12#1)(2011-2#2)
reduce the matrix##2##3##(2009-8#1)(2010-11#1)
reduce the morbidity##5##3##(1996-9#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)
reduce the need for##6##4##(1996-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-9#1)
reduce the need##7##3##(1996-8#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-9#1)
reduce the number of##25##4##(1990-11#1)(1994-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
reduce the number##26##3##(1990-11#1)(1994-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
reduce the occurrence of##2##4##(2007-8#1)(2008-12#1)
reduce the overall##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
reduce the peak##2##3##(2007-12#1)(2008-2#1)
reduce the potential for##5##4##(1993-10#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
reduce the probability of##4##4##(1997-4#1)(2008-10#1)(2010-5#1)(2012-3#1)
reduce the probability##5##3##(1991-12#1)(1997-4#1)(2008-10#1)(2010-5#1)(2012-3#1)
reduce the range of##2##4##(2008-8#2)
reduce the range##3##3##(2008-10#1)(2008-8#2)
reduce the rate of##3##4##(1994-11#1)(1994-12#1)(2010-7#1)
reduce the relative##2##3##(1990-7#1)(2008-4#1)
reduce the risk for##2##4##(2006-10#1)(2013-1#1)
reduce the risk of a##2##5##(2008-4#1)(2012-2#1)
reduce the risk of cardiovascular disease##2##6##(1993-11#1)(2012-2#1)
reduce the risk of cardiovascular##3##5##(1993-11#1)(2008-3#1)(2012-2#1)
reduce the risk of coronary##2##5##(1991-8#1)(1996-3#1)
reduce the risk of developing##2##5##(2009-6#1)(2010-2#1)
reduce the risk of fractures##2##5##(2007-8#1)(2008-4#1)
reduce the risk of##38##4##(1990-2#1)(1990-8#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-9#1)(1995-6#1)(1996-3#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-6#2)(2010-1#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#3)(2013-8#5)
reduce the risk##42##3##(1990-2#1)(1990-8#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-9#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-6#2)(2010-1#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#6)
reduce the risks of##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
reduce the risks##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
reduce the severity of the disease##2##6##(2008-10#1)(2012-3#1)
reduce the severity of##6##4##(2008-10#4)(2010-1#1)(2012-3#1)
reduce the severity##7##3##(2008-10#4)(2008-12#1)(2010-1#1)(2012-3#1)
reduce the size of the##3##5##(1996-3#1)(2008-5#1)(2010-10#1)
reduce the size of##5##4##(1994-11#1)(1996-3#1)(2008-5#1)(2010-10#1)(2010-11#1)
reduce the size##6##3##(1994-11#1)(1996-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#1)
reduce the spatial##2##3##(2008-3#1)(2009-5#1)
reduce the surface##2##3##(2008-3#2)
reduce the time needed for##2##5##(2008-10#1)(2008-3#1)
reduce the time required to develop##2##6##(2008-11#2)
reduce the time required to##3##5##(2008-10#1)(2008-11#2)
reduce the time##7##3##(2008-10#3)(2008-11#2)(2008-3#1)(2010-12#1)
reduce the use of##2##4##(1991-1#1)(2012-3#1)
reduce the variability of##3##4##(2008-10#2)(2008-2#1)
reduce the volume of the##2##5##(1995-12#1)(2009-5#1)
reduce the##432##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#4)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#8)(2008-10#57)(2008-11#14)(2008-12#7)(2008-2#22)(2008-3#41)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#10)(2008-9#11)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#15)
reduce their##12##2##(1991-6#1)(1996-9#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2013-1#1)
reduce this risk##3##3##(1994-12#1)(2008-1#1)(2010-9#1)
reduce this##10##2##(1994-12#1)(1994-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-8#1)
reduce to##6##2##(1994-5#1)(2007-11#2)(2008-2#2)(2008-3#1)
reduce tobacco##2##2##(2009-7#1)(2013-1#1)
reduce uncertainties##2##2##(2008-2#1)(2008-5#1)
reduce unnecessary##2##2##(1997-2#1)(2008-9#1)
reduce variation in##2##3##(1993-3#1)(1994-12#1)
reduce variation##3##2##(1993-3#1)(1994-12#1)(1996-1#1)
reduce viral##2##2##(1994-6#1)(2013-8#1)
reduce waste##2##2##(1997-3#1)(2008-6#1)
reduce##1052##1##(1990-11#4)(1990-12#2)(1990-2#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#5)(1991-12#4)(1991-2#3)(1991-3#4)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#7)(1993-2#7)(1993-3#7)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#5)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#9)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#9)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#3)(1996-12#4)(1996-2#7)(1996-3#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#9)(1997-2#10)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#20)(2007-12#19)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#15)(2007-9#2)(2008-1#18)(2008-10#131)(2008-11#42)(2008-12#14)(2008-2#38)(2008-3#68)(2008-4#10)(2008-5#29)(2008-6#12)(2008-7#46)(2008-8#38)(2008-9#24)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#8)(2009-6#4)(2009-7#6)(2009-8#2)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#6)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#9)(2010-9#5)(2011-1#16)(2011-2#35)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#15)(2012-2#22)(2012-3#18)(2013-1#49)(2013-7#3)(2013-8#23)
reduced (P &lt##5##3##(1992-12#2)(2008-5#1)(2010-2#1)(2011-3#1)
reduced 13##2##2##(2008-10#2)
reduced 2##2##2##(1995-3#1)(2010-9#1)
reduced CO##2##2##(1993-11#1)(1997-2#1)
reduced FHB##2##2##(2008-10#2)
reduced Fusarium##2##2##(2008-10#2)
reduced GSH##2##2##(2008-7#2)
reduced H##2##2##(2008-10#2)
reduced IGF-I##3##2##(1990-12#1)(2007-7#2)
reduced IL-2##2##2##(1990-2#1)(2008-11#1)
reduced IS##2##2##(2013-1#1)(2013-7#1)
reduced MR image artifact##2##4##(2009-7#2)
reduced TAT specific activity##2##4##(1997-4#2)
reduced ability of##2##3##(1991-7#1)(2008-10#1)
reduced ability to##4##3##(1992-10#1)(1994-11#2)(2012-2#1)
reduced ability##6##2##(1991-7#1)(1992-10#1)(1994-11#2)(2008-10#1)(2012-2#1)
reduced about##2##2##(1992-1#1)(2008-12#1)
reduced access##3##2##(1991-1#1)(2011-2#2)
reduced activity of##3##3##(1992-6#1)(2009-6#1)(2012-3#1)
reduced activity toward##2##3##(1995-5#1)(1997-2#1)
reduced activity##10##2##(1992-6#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-2#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-3#1)
reduced after the##2##3##(1990-9#1)(2009-4#1)
reduced after treatment##2##3##(1992-8#1)(2013-1#1)
reduced after##13##2##(1990-12#1)(1990-9#1)(1992-8#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-5#1)(2013-1#2)(2013-7#1)
reduced all##3##2##(1996-5#1)(2008-12#1)(2012-2#1)
reduced among##2##2##(2010-1#1)(2012-2#1)
reduced amount##2##2##(2008-10#1)(2008-5#1)
reduced amounts##2##2##(1993-9#1)(2008-5#1)
reduced and a##2##3##(2008-10#1)(2008-11#1)
reduced and oxidized##2##3##(1993-11#1)(2011-1#1)
reduced and the##7##3##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
reduced and##34##2##(1990-6#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-11#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
reduced anxiety##2##2##(2008-12#1)(2011-2#1)
reduced approximately 50%##3##3##(1994-11#1)(2006-10#1)(2008-10#1)
reduced as a result of##2##5##(2007-12#1)(2008-10#1)
reduced as compared##2##3##(1992-6#1)(1995-12#1)
reduced as the##3##3##(1997-2#1)(2007-12#1)(2010-2#1)
reduced as##13##2##(1992-6#1)(1994-3#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-5#1)
reduced at -0##2##3##(2008-10#2)
reduced at a##6##3##(1990-8#1)(2008-10#5)
reduced at the##6##3##(1994-9#1)(1995-8#1)(2008-10#2)(2008-7#1)(2012-12#1)
reduced at##25##2##(1990-8#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#15)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
reduced availability of##2##3##(1994-5#1)(2011-2#1)
reduced bacterial##4##2##(2008-10#3)(2012-2#1)
reduced barrier function##3##3##(2008-5#3)
reduced below##2##2##(2008-3#1)(2008-8#1)
reduced binding##2##2##(1992-9#1)(1996-12#1)
reduced biological##2##2##(1993-8#1)(2008-8#1)
reduced body mass##2##3##(1997-4#1)(2012-3#1)
reduced body weights##2##3##(1997-6#1)(2008-9#1)
reduced body##8##2##(1995-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
reduced bone##6##2##(1997-8#1)(2009-4#1)(2009-7#1)(2011-1#1)(2013-1#2)
reduced both the##3##3##(1990-5#1)(1995-12#1)(2008-10#1)
reduced both##8##2##(1990-5#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
reduced but##5##2##(1990-5#1)(1990-8#1)(2008-10#1)(2009-12#1)(2012-2#1)
reduced by 0##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
reduced by 10%##3##3##(1996-7#1)(2008-10#1)(2008-2#1)
reduced by 20%##2##3##(1995-12#1)(2008-2#1)
reduced by 36%##2##3##(2008-3#1)(2012-1#1)
reduced by 40%##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
reduced by 50%##3##3##(1995-8#1)(2008-1#1)(2008-10#1)
reduced by a factor of##8##5##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
reduced by a##12##3##(1991-5#1)(1995-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)
reduced by about##5##3##(2008-10#2)(2008-6#1)(2012-12#1)(2013-8#1)
reduced by addition of the##3##5##(2008-3#2)(2008-5#1)
reduced by an##2##3##(1995-12#1)(2008-10#1)
reduced by applying##2##3##(2008-10#2)
reduced by approximately##3##3##(1992-11#1)(1992-6#1)(2008-6#1)
reduced by as much as##2##5##(2007-11#1)(2013-8#1)
reduced by heat treatment##2##4##(2008-10#1)(2008-2#1)
reduced by increasing##3##3##(1997-8#1)(2008-8#1)(2009-5#1)
reduced by more than##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2010-3#1)
reduced by over##2##3##(1997-1#1)(2008-5#1)
reduced by the presence of##2##5##(1995-3#1)(2008-3#1)
reduced by the use of##2##5##(1994-3#1)(2011-2#1)
reduced by the##16##3##(1990-12#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-4#1)(2011-2#1)
reduced by use of##3##4##(2008-2#2)(2008-3#1)
reduced by##210##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#5)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#3)(1995-8#4)(1996-11#1)(1996-12#3)(1996-2#4)(1996-5#1)(1996-7#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#2)(2007-10#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#51)(2008-11#3)(2008-12#5)(2008-2#9)(2008-3#16)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
reduced capacity to##2##3##(2008-7#2)
reduced capacity##3##2##(1996-11#1)(2008-7#2)
reduced carbohydrate##2##2##(2008-10#1)(2008-5#1)
reduced cell growth##2##3##(2008-11#2)
reduced cell viability##2##3##(1995-12#1)(1996-3#1)
reduced cell##7##2##(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#3)
reduced cellular##2##2##(1990-2#1)(2008-11#1)
reduced colonization##2##2##(2008-10#2)
reduced compared to##5##3##(1992-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
reduced compared with the##4##4##(1996-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
reduced compared with##13##3##(1994-12#1)(1995-8#1)(1996-11#1)(2008-10#4)(2008-3#3)(2008-4#1)(2011-2#1)(2012-12#1)
reduced compared##18##2##(1992-10#1)(1994-12#1)(1995-8#1)(1996-11#1)(2008-10#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)
reduced complication rates##2##3##(2008-1#1)(2010-6#1)
reduced concentration of##2##3##(1992-8#1)(1993-1#1)
reduced concentration##3##2##(1992-8#1)(1993-1#1)(2008-11#1)
reduced concentrations of##2##3##(1992-12#1)(2011-2#1)
reduced concreteness##3##2##(2008-8#3)
reduced considerably##5##2##(1996-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
reduced cost of##3##3##(2007-7#1)(2008-11#1)(2008-6#1)
reduced cost##8##2##(1996-1#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)
reduced costs##4##2##(1992-2#1)(1997-1#1)(2008-10#1)(2008-11#1)
reduced counterpart##2##2##(2008-10#2)
reduced crystal##2##2##(2007-11#1)(2008-3#1)
reduced damage##2##2##(2007-12#1)(2008-9#1)
reduced decay caused by all three##2##6##(2008-10#2)
reduced decay##3##2##(2008-10#3)
reduced diameter##2##2##(2012-1#2)
reduced disease in##3##3##(2008-10#3)
reduced disease incidence and##2##4##(2008-10#2)
reduced disease incidence in the##2##5##(2008-10#2)
reduced disease incidence##8##3##(2008-10#8)
reduced disease severity by##2##4##(2008-10#2)
reduced disease severity##6##3##(2008-10#6)
reduced disease symptoms##2##3##(2008-10#1)(2011-1#1)
reduced disease##28##2##(2008-10#27)(2011-1#1)
reduced doses of##2##3##(2008-10#1)(2011-1#1)
reduced doses##3##2##(2008-10#2)(2011-1#1)
reduced drug accumulation##2##3##(2008-11#2)
reduced drug##3##2##(2008-11#2)(2008-6#1)
reduced during the##3##3##(2008-1#2)(2012-2#1)
reduced during##5##2##(1994-5#1)(2008-1#2)(2008-10#1)(2012-2#1)
reduced effect of##3##3##(2007-11#1)(2008-12#1)(2008-3#1)
reduced effect##4##2##(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#1)
reduced epidermal##2##2##(2008-5#2)
reduced exercise capacity##2##3##(2010-10#1)(2012-2#1)
reduced expression of the##2##4##(1997-6#1)(2008-5#1)
reduced expression of##8##3##(1992-1#1)(1997-6#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-7#1)(2012-2#1)
reduced expression##9##2##(1992-1#1)(1993-12#1)(1997-6#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-7#1)(2012-2#1)
reduced fertility##3##2##(1994-2#1)(2012-3#2)
reduced following##2##2##(2008-10#1)(2010-12#1)
reduced food intake##3##3##(1993-12#1)(1996-2#1)(2008-7#1)
reduced food##4##2##(1993-12#1)(1996-2#1)(2008-7#1)(2008-9#1)
reduced for##6##2##(1993-8#1)(2008-10#4)(2011-2#1)
reduced form of the##2##4##(2008-10#1)(2009-7#1)
reduced form of##7##3##(1991-3#1)(1994-5#1)(2008-10#4)(2009-7#1)
reduced form##13##2##(1991-3#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#6)(2009-7#1)(2011-2#1)(2013-8#1)
reduced formation of##3##3##(1991-9#1)(1995-12#1)(2008-10#1)
reduced fracture##3##2##(2007-8#1)(2013-1#2)
reduced frequency of##2##3##(1992-8#1)(2010-4#1)
reduced from 0##2##3##(2007-11#1)(2008-10#1)
reduced from a##2##3##(2007-11#1)(2008-5#1)
reduced from##30##2##(1991-3#1)(1993-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
reduced function##2##2##(1996-6#1)(2008-7#1)
reduced germination##3##2##(2008-10#2)(2011-2#1)
reduced glutathione (GSH)##12##3##(1990-2#1)(1991-9#1)(1995-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
reduced glutathione and##2##3##(1992-8#1)(2013-1#1)
reduced glutathione as##2##3##(1990-12#1)(1993-2#1)
reduced glutathione in##3##3##(2008-10#3)
reduced glutathione##27##2##(1990-12#1)(1990-2#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-2#3)(2008-10#7)(2008-12#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#2)
reduced gradually##2##2##(1990-11#1)(2013-8#1)
reduced growth and development##2##4##(2008-8#2)
reduced growth and##4##3##(2008-11#1)(2008-12#1)(2008-8#2)
reduced growth of##2##3##(2008-10#2)
reduced growth rate##4##3##(2008-11#1)(2010-10#1)(2010-4#1)(2010-8#1)
reduced growth rates##2##3##(2008-11#2)
reduced growth##17##2##(1997-2#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-7#1)
reduced host##2##2##(2007-12#1)(2008-7#1)
reduced human##2##2##(1995-2#2)
reduced hyphal##3##2##(2008-10#3)
reduced if the##2##3##(2008-10#1)(2008-7#1)
reduced if##8##2##(1996-8#1)(2008-10#5)(2008-7#2)
reduced immune response##2##3##(2008-9#1)(2013-1#1)
reduced immune##3##2##(2008-9#2)(2013-1#1)
reduced in 1998##2##3##(2008-10#1)(2008-5#1)
reduced in Alzheimer's disease##2##4##(1995-5#1)(1996-12#1)
reduced in Gadd45(as)/MCF-7##2##3##(2008-9#2)
reduced in KB##2##3##(1991-10#2)
reduced in a dose-dependent##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
reduced in a##8##3##(1990-5#1)(1992-12#1)(2007-12#1)(2008-10#4)(2008-5#1)
reduced in all the##2##4##(1992-2#1)(2008-3#1)
reduced in all##4##3##(1992-2#1)(1995-3#1)(1996-12#1)(2008-3#1)
reduced in both##2##3##(1993-12#1)(2012-2#1)
reduced in cells##2##3##(1995-8#1)(1996-5#1)
reduced in comparison with##2##4##(2008-12#1)(2008-8#1)
reduced in comparison##3##3##(2008-12#1)(2008-5#1)(2008-8#1)
reduced in its ability to##2##5##(2008-10#2)
reduced in number and##2##4##(1993-12#1)(1995-12#1)
reduced in number##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
reduced in one##3##3##(2008-10#1)(2008-7#2)
reduced in size##2##3##(1996-2#1)(2007-11#1)
reduced in the presence of##2##5##(1995-11#1)(1997-8#1)
reduced in the##27##3##(1990-5#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#3)
reduced in##149##2##(1990-11#3)(1990-12#1)(1990-5#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-2#1)(1994-5#3)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#7)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#13)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#3)
reduced incidence of##7##3##(1997-3#1)(2008-10#4)(2009-4#1)(2010-1#1)
reduced incidence##8##2##(1997-3#1)(2008-10#5)(2009-4#1)(2010-1#1)
reduced infarct##2##2##(2012-2#1)(2013-7#1)
reduced infection by##2##3##(2008-10#2)
reduced infection##5##2##(2008-10#5)
reduced initial##2##2##(1991-12#1)(2008-3#1)
reduced insulin secretion##3##3##(1990-12#2)(1991-7#1)
reduced insulin##5##2##(1990-12#2)(1991-7#1)(2008-4#1)(2009-9#1)
reduced interest in##2##3##(1996-2#2)
reduced into##2##2##(1991-5#1)(2008-10#1)
reduced intron content##2##3##(2008-7#2)
reduced it##3##2##(1992-7#1)(1994-2#1)(1994-3#1)
reduced leaf##4##2##(2008-10#3)(2013-1#1)
reduced length of##2##3##(1991-12#1)(2012-2#1)
reduced leptin levels##2##3##(2007-7#1)(2013-1#1)
reduced lesion frequency##2##3##(2008-10#2)
reduced lesion##5##2##(1995-12#1)(2008-10#4)
reduced level of##6##3##(2007-2#1)(2008-5#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
reduced level##7##2##(2007-2#1)(2008-5#2)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
reduced levels of##14##3##(1990-12#1)(1990-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
reduced levels##15##2##(1990-12#1)(1990-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
reduced liver##2##2##(1992-5#1)(2012-2#1)
reduced lung function##2##3##(1992-9#1)(1996-3#1)
reduced markedly##2##2##(1990-12#1)(1994-6#1)
reduced medical costs by##2##4##(1995-1#2)
reduced medical##3##2##(1995-1#3)
reduced mobility constants##2##3##(2008-10#2)
reduced model##5##2##(2007-11#1)(2007-12#1)(2008-6#3)
reduced morbidity and mortality##3##4##(2009-4#1)(2010-12#1)(2012-2#1)
reduced morbidity and##4##3##(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)
reduced morbidity##7##2##(2008-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
reduced more##2##2##(2008-10#2)
reduced morphine##2##2##(1990-7#1)(2008-7#1)
reduced mortality##4##2##(1995-2#1)(1996-6#1)(2008-8#1)(2012-2#1)
reduced near-stoichiometric##2##2##(2007-11#1)(2008-2#1)
reduced need##2##2##(1991-9#1)(1995-5#1)
reduced neurite length##2##3##(2013-1#2)
reduced neurite##3##2##(2008-10#1)(2013-1#2)
reduced number of##10##3##(1991-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)
reduced numbers of astrocytes##2##4##(2009-3#2)
reduced numbers of##7##3##(1991-5#1)(2008-10#2)(2009-3#2)(2011-2#1)(2013-1#1)
reduced ocelli##2##2##(2008-9#2)
reduced on the##6##3##(1990-5#1)(2008-10#4)(2008-5#1)
reduced on##9##2##(1990-5#1)(2008-10#6)(2008-5#1)(2008-7#1)
reduced only in##2##3##(1996-12#1)(1997-2#1)
reduced only##5##2##(1993-12#1)(1996-12#1)(1997-2#2)(2008-10#1)
reduced opportunities for##2##3##(2008-10#1)(2013-1#1)
reduced optical##2##2##(2008-10#1)(2008-3#1)
reduced or eliminated##2##3##(2008-9#1)(2013-8#1)
reduced or##10##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-8#2)
reduced overall##2##2##(1992-10#1)(2008-10#1)
reduced oxidative stress##2##3##(2008-7#1)(2013-7#1)
reduced oxygen tension of the##2##5##(2007-2#1)(2011-2#1)
reduced oxygen tension##3##3##(2007-2#1)(2011-1#1)(2011-2#1)
reduced oxygen##5##2##(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
reduced pain scores##2##3##(2008-7#2)
reduced pain##8##2##(1990-6#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-7#2)(2013-1#1)
reduced pathogen populations##2##3##(2008-10#2)
reduced pathogen##3##2##(2008-10#3)
reduced perfusion##2##2##(1990-8#1)(2008-11#1)
reduced phosphorus##3##2##(2008-10#3)
reduced plant##3##2##(2008-8#2)(2013-1#1)
reduced platelet##2##2##(1997-7#1)(2008-3#1)
reduced population##4##2##(2008-10#2)(2008-9#2)
reduced potency##2##2##(1994-6#1)(1997-6#1)
reduced potential for##2##3##(2010-3#1)(2011-2#1)
reduced power##2##2##(2008-11#1)(2010-11#1)
reduced pregnenolone production&quot##2##3##(2012-2#2)
reduced presence of##2##3##(2008-10#2)
reduced pressure to##2##3##(2008-11#1)(2008-5#1)
reduced pressure##7##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-4#1)(2013-7#1)
reduced production of##2##3##(2008-10#1)(2009-6#1)
reduced production##4##2##(1990-2#1)(2008-10#1)(2008-11#1)(2009-6#1)
reduced proliferation of##2##3##(2011-2#1)(2012-4#1)
reduced protein##3##2##(1990-12#1)(1993-8#1)(1995-12#1)
reduced pulmonary##2##2##(2008-8#1)(2010-10#1)
reduced pyridine##3##2##(1995-2#1)(1996-2#2)
reduced quality of life##4##4##(1995-8#1)(1996-2#1)(2007-11#1)(2008-7#1)
reduced quality##6##2##(1994-7#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
reduced rates of##4##3##(1994-5#1)(1997-7#1)(2008-9#1)(2009-5#1)
reduced rates##6##2##(1993-6#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-9#1)(2009-5#1)
reduced reactivity##2##2##(1994-12#1)(1995-8#1)
reduced replication##3##2##(2011-2#2)(2013-1#1)
reduced respiration##2##2##(2008-9#1)(2011-2#1)
reduced responsiveness##2##2##(2008-10#1)(2008-3#1)
reduced risk of##13##3##(1991-8#1)(1992-10#1)(1993-9#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#1)
reduced risk##15##2##(1991-8#1)(1992-10#1)(1992-9#1)(1993-9#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#2)
reduced root galling##2##3##(2008-10#2)
reduced root rot severity##3##4##(2008-10#3)
reduced root##5##2##(2008-10#5)
reduced sample##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
reduced scattering coefficient##7##3##(2008-2#2)(2008-3#4)(2011-1#1)
reduced scattering coefficients##8##3##(2008-2#2)(2008-3#6)
reduced scattering##24##2##(2008-2#7)(2008-3#16)(2011-1#1)
reduced sclerotia##2##2##(2008-10#2)
reduced secondary spectrum##3##3##(2008-3#3)
reduced secondary##4##2##(2008-3#3)(2012-5#1)
reduced secretion##2##2##(1994-11#1)(2013-8#1)
reduced sensitive##3##2##(2007-6#3)
reduced sensitivity and##2##3##(2008-10#2)
reduced sensitivity##7##2##(1991-3#1)(1996-9#1)(2007-6#2)(2008-10#2)(2012-2#1)
reduced serum##7##2##(1993-12#1)(1994-10#1)(1994-6#1)(2008-11#1)(2008-7#2)(2009-9#1)
reduced shear##2##2##(2008-11#1)(2008-12#1)
reduced significantly (P##2##3##(2010-2#2)
reduced significantly in##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
reduced significantly the##4##3##(1996-5#1)(2008-10#1)(2011-2#1)(2013-7#1)
reduced significantly##25##2##(1996-5#2)(1997-2#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#3)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
reduced size##2##2##(2008-10#1)(2009-2#1)
reduced speck severity##2##3##(2008-10#2)
reduced sporulation##4##2##(2008-10#4)
reduced stability##2##2##(1993-6#1)(1994-6#1)
reduced stress-induced##4##2##(2008-4#2)(2011-2#2)
reduced substantially##5##2##(1996-8#1)(2008-2#1)(2008-3#2)(2009-10#1)
reduced sulfur compounds (RSC)##3##4##(2008-10#3)
reduced sulfur compounds##5##3##(2008-10#5)
reduced sulfur##8##2##(2008-10#8)
reduced surface##2##2##(1997-4#1)(2010-4#1)
reduced survival during##2##3##(2008-6#1)(2008-7#1)
reduced survival##10##2##(1993-1#1)(1993-11#2)(1994-10#1)(2008-6#1)(2008-7#2)(2012-2#2)(2012-3#1)
reduced susceptibility to##2##3##(1997-2#1)(2011-2#1)
reduced symptoms of##5##3##(2008-10#4)(2008-6#1)
reduced temperature##3##2##(1992-6#1)(1996-2#1)(2008-11#1)
reduced temporal##2##2##(1996-7#1)(2008-9#1)
reduced the EFS-evoked##3##3##(2008-2#3)
reduced the ability##2##3##(2008-10#1)(2012-12#1)
reduced the activity##2##3##(1992-3#1)(1996-12#1)
reduced the affinity##2##3##(1992-9#1)(1994-8#1)
reduced the amount of##4##4##(1994-8#1)(1995-6#1)(2008-10#1)(2008-7#1)
reduced the cost of##2##4##(1990-2#1)(2008-6#1)
reduced the degree of##2##4##(2008-2#1)(2012-1#1)
reduced the disease##2##3##(2008-10#2)
reduced the effect of##2##4##(1991-5#1)(1995-6#1)
reduced the effectiveness of##2##4##(2008-10#2)
reduced the elevated##2##3##(1990-7#1)(2010-5#1)
reduced the expression of##2##4##(2008-10#2)
reduced the formation of##2##4##(1992-3#1)(2013-7#1)
reduced the frequency of##2##4##(1992-8#1)(2011-2#1)
reduced the growth of soybeans##2##5##(2008-10#2)
reduced the growth of the##2##5##(2008-10#1)(2008-12#1)
reduced the growth of##7##4##(2008-10#6)(2008-12#1)
reduced the growth##8##3##(1996-3#1)(2008-10#6)(2008-12#1)
reduced the incidence of fire blight##2##6##(2008-10#2)
reduced the incidence of##8##4##(2008-10#6)(2008-5#1)(2008-6#1)
reduced the incidence##10##3##(1992-5#1)(2008-10#7)(2008-5#1)(2008-6#1)
reduced the increase##2##3##(1995-8#1)(1996-2#1)
reduced the infarct area##2##4##(1995-12#1)(2011-2#1)
reduced the infarct##4##3##(1995-12#1)(2011-2#3)
reduced the infection##2##3##(2008-10#2)
reduced the intracellular##3##3##(1994-12#1)(2008-11#2)
reduced the level of lipid peroxides at the surface of UVA-exposed skin##2##12##(2008-5#2)
reduced the level of##4##4##(1992-3#1)(2008-5#2)(2012-3#1)
reduced the levels of##4##4##(1993-6#1)(2008-10#1)(2008-11#2)
reduced the magnitude of##2##4##(1990-2#1)(2008-2#1)
reduced the need##2##3##(1995-5#1)(2007-7#1)
reduced the number of infected##2##5##(2008-10#2)
reduced the number of##20##4##(1990-3#1)(1990-6#1)(1992-11#1)(1993-11#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
reduced the number##21##3##(1990-3#1)(1990-6#1)(1992-11#1)(1993-11#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
reduced the numbers of##2##4##(2008-10#2)
reduced the occurrence of##5##4##(1992-12#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)
reduced the occurrence##6##3##(1992-12#1)(1996-11#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)
reduced the overall##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
reduced the peak##2##3##(2008-10#1)(2012-2#1)
reduced the predictive ability of the##2##6##(2008-10#2)
reduced the promoter activity##2##4##(1995-6#1)(1997-2#1)
reduced the rate of##5##4##(1990-7#1)(1991-12#1)(2008-10#3)
reduced the rate##6##3##(1990-7#1)(1991-12#1)(1992-6#1)(2008-10#3)
reduced the response##3##3##(1992-8#1)(1996-2#1)(1997-3#1)
reduced the risk of##3##4##(2008-3#1)(2008-7#1)(2010-6#1)
reduced the risk##4##3##(2008-3#1)(2008-7#1)(2010-6#1)(2013-7#1)
reduced the severity of##4##4##(2008-10#3)(2008-5#1)
reduced the size##2##3##(2008-10#1)(2008-4#1)
reduced the time required to inactivate chlamydospores##2##7##(2008-10#2)
reduced the time required to##3##5##(1993-12#1)(2008-10#2)
reduced the time required##4##4##(1993-12#1)(2008-10#3)
reduced the time to##2##4##(2008-9#1)(2010-7#1)
reduced the time##6##3##(1993-12#1)(2008-10#3)(2008-9#1)(2010-7#1)
reduced the total amount of##2##5##(2008-10#1)(2008-11#1)
reduced the tumor##2##3##(1994-12#1)(2008-6#1)
reduced the variability##2##3##(2008-10#2)
reduced the yield of cv##2##5##(2008-10#2)
reduced the##283##2##(1990-11#1)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#5)(1991-12#2)(1991-5#3)(1992-11#2)(1992-12#2)(1992-3#4)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-12#11)(1995-5#4)(1995-6#4)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#81)(2008-11#12)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#4)(2009-1#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#4)(2013-8#1)
reduced their##9##2##(1990-6#2)(1991-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#2)(2012-3#1)
reduced thermal##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
reduced this##4##2##(1994-3#1)(2007-8#1)(2008-10#2)
reduced tillage##3##2##(2008-10#3)
reduced time of analysis##2##4##(2008-10#2)
reduced time to exhaustion##2##4##(2013-8#2)
reduced time##6##2##(1994-8#1)(2008-10#2)(2013-1#1)(2013-8#2)
reduced to &lt##2##3##(2007-11#1)(2008-10#1)
reduced to 0##3##3##(2008-3#3)
reduced to 1##2##3##(1993-1#1)(2008-1#1)
reduced to 30##2##3##(1996-5#1)(2008-10#1)
reduced to Cr(III)##3##3##(2008-10#2)(2011-2#1)
reduced to Fe(II)##3##3##(2008-10#3)
reduced to a##9##3##(1993-12#1)(1995-5#1)(1997-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
reduced to about##3##3##(1995-12#1)(1996-6#1)(2010-8#1)
reduced to less than##4##4##(2007-7#1)(2008-3#2)(2008-5#1)
reduced to one third##2##4##(1993-6#1)(2008-10#1)
reduced to the##11##3##(1995-3#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-10#1)
reduced to two##2##3##(1992-4#1)(1995-5#1)
reduced to##104##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#31)(2008-11#4)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
reduced total##3##2##(1997-7#1)(1997-8#1)(2008-10#1)
reduced toxicity in##3##3##(2008-8#1)(2008-9#1)(2010-11#1)
reduced toxicity##5##2##(1992-6#1)(1992-8#1)(2008-8#1)(2008-9#1)(2010-11#1)
reduced tube##2##2##(2007-11#1)(2008-10#1)
reduced tumor##2##2##(2008-11#1)(2013-1#1)
reduced under##4##2##(2008-10#1)(2012-1#1)(2012-6#1)(2013-1#1)
reduced uptake of##2##3##(1995-11#1)(2008-5#1)
reduced use of##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
reduced using##2##2##(1996-5#1)(2008-11#1)
reduced viability of##2##3##(2008-10#1)(2008-5#1)
reduced viability##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
reduced viral replication##2##3##(2013-1#2)
reduced virulence##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
reduced visual##2##2##(2011-2#1)(2013-1#1)
reduced water and##3##3##(1995-12#1)(2008-11#1)(2012-3#1)
reduced water##7##2##(1995-12#1)(2008-11#4)(2010-4#1)(2012-3#1)
reduced when the##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
reduced when##14##2##(1993-3#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
reduced with NaBH4##3##3##(1995-3#1)(2007-11#2)
reduced with dithiothreitol (DTT)##2##4##(1990-12#1)(2012-2#1)
reduced with##19##2##(1990-12#1)(1991-5#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-2#1)(2007-11#4)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
reduced within##2##2##(2008-10#2)
reduced without##2##2##(1991-12#1)(2011-2#1)
reduced yield##5##2##(2008-10#4)(2011-1#1)
reduced##2424##1##(1990-11#11)(1990-12#17)(1990-2#11)(1990-3#6)(1990-5#16)(1990-6#11)(1990-7#9)(1990-8#6)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#10)(1991-2#4)(1991-3#3)(1991-5#20)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#13)(1992-1#3)(1992-10#6)(1992-11#8)(1992-12#14)(1992-2#4)(1992-3#10)(1992-4#1)(1992-5#5)(1992-6#11)(1992-7#3)(1992-8#12)(1992-9#8)(1993-1#5)(1993-11#12)(1993-12#18)(1993-2#4)(1993-3#7)(1993-6#8)(1993-8#19)(1993-9#11)(1994-10#2)(1994-11#11)(1994-12#7)(1994-2#7)(1994-3#9)(1994-5#13)(1994-6#12)(1994-7#1)(1994-8#15)(1994-9#7)(1995-1#3)(1995-11#6)(1995-12#38)(1995-2#31)(1995-3#10)(1995-5#20)(1995-6#9)(1995-8#13)(1996-1#2)(1996-11#4)(1996-12#22)(1996-2#21)(1996-3#3)(1996-4#2)(1996-5#11)(1996-6#6)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#13)(1997-2#18)(1997-3#9)(1997-4#12)(1997-5#1)(1997-6#9)(1997-7#8)(1997-8#9)(2006-10#1)(2007-10#8)(2007-11#39)(2007-12#38)(2007-2#3)(2007-4#1)(2007-6#6)(2007-7#9)(2007-8#9)(2007-9#2)(2008-1#18)(2008-10#597)(2008-11#76)(2008-12#27)(2008-2#47)(2008-3#95)(2008-4#30)(2008-5#67)(2008-6#29)(2008-7#96)(2008-8#48)(2008-9#38)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#10)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#3)(2009-9#4)(2010-1#6)(2010-10#6)(2010-11#7)(2010-12#4)(2010-2#9)(2010-3#8)(2010-4#8)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#10)(2010-9#5)(2011-1#18)(2011-10#1)(2011-2#72)(2011-3#3)(2012-1#12)(2012-12#19)(2012-2#52)(2012-3#20)(2012-4#2)(2012-5#3)(2012-6#2)(2012-7#3)(2012-8#1)(2013-1#64)(2013-7#16)(2013-8#19)
reduced)##2##1##(2008-8#1)(2009-4#1)
reduced-pathogenicity##2##1##(2008-10#2)
reduced-resolution filter##2##2##(2008-3#2)
reduced-resolution optical correlators##2##3##(2008-2#1)(2008-3#1)
reduced-resolution optical##3##2##(2008-2#2)(2008-3#1)
reduced-resolution##8##1##(2008-2#3)(2008-3#5)
reduced-scattering coefficients##3##2##(2008-2#2)(2008-3#1)
reduced-scattering##7##1##(2008-2#4)(2008-3#3)
reduced-size drawings##2##2##(2007-12#2)
reduced-size##3##1##(2007-12#2)(2010-4#1)
reduced/denatured RNase A##3##3##(2011-1#3)
reducer##2##1##(2008-10#1)(2008-6#1)
reduces activity##3##2##(1992-3#2)(2008-4#1)
reduces blood pressure##3##3##(1995-12#1)(2007-10#1)(2008-4#1)
reduces blood##5##2##(1995-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)
reduces both the##3##3##(2008-10#2)(2011-2#1)
reduces both##8##2##(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
reduces cardiovascular risk##2##3##(2008-1#1)(2008-6#1)
reduces cardiovascular##3##2##(2008-1#2)(2008-6#1)
reduces cell##2##2##(1991-9#1)(2008-11#1)
reduces hospitalization##2##2##(2007-8#1)(2011-2#1)
reduces infarct size##3##3##(1996-9#1)(2007-10#1)(2012-2#1)
reduces its##2##2##(1991-12#1)(2008-8#1)
reduces morbidity and##2##3##(2006-10#1)(2008-3#1)
reduces or##2##2##(1995-11#2)
reduces pain and##2##3##(2007-11#1)(2009-3#1)
reduces pain##5##2##(1995-3#1)(2007-11#1)(2008-12#1)(2009-3#1)(2010-4#1)
reduces postoperative##2##2##(2010-7#1)(2013-1#1)
reduces reagent##2##2##(2008-10#1)(2009-12#1)
reduces sample##3##2##(2008-10#2)(2010-11#1)
reduces the activation energy##2##4##(1996-7#1)(2008-10#1)
reduces the affinity of agonists for##2##6##(1990-5#1)(1996-2#1)
reduces the affinity of##3##4##(1990-5#1)(1992-6#1)(1996-2#1)
reduces the average##2##3##(2007-11#1)(2008-9#1)
reduces the effect of##2##4##(2007-11#1)(2008-2#1)
reduces the effectiveness of the##2##5##(1997-1#1)(2008-2#1)
reduces the effectiveness of##5##4##(1990-9#1)(1997-1#1)(2007-11#1)(2008-2#1)(2008-6#1)
reduces the effects of##4##4##(1995-11#1)(2008-2#2)(2013-7#1)
reduces the incidence of##8##4##(1990-9#1)(1991-9#1)(1992-2#1)(1992-9#1)(1994-6#1)(2007-8#3)
reduces the level of##2##4##(1993-3#1)(1993-9#1)
reduces the noise##2##3##(1996-12#1)(2008-3#1)
reduces the number of##8##4##(1991-11#1)(1991-2#1)(1992-3#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2010-3#1)
reduces the number##9##3##(1991-11#1)(1991-2#1)(1992-3#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
reduces the possibility of##2##4##(1991-2#1)(2008-3#1)
reduces the prevalence of##2##4##(2008-10#1)(2013-8#1)
reduces the probability of##2##4##(2008-3#1)(2010-8#1)
reduces the risk of stroke##2##5##(1991-11#1)(2008-8#1)
reduces the risk of##7##4##(1991-11#2)(2007-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
reduces the severity##2##3##(2008-10#1)(2012-3#1)
reduces the time required for##2##5##(2008-10#2)
reduces the time required##3##4##(1997-4#1)(2008-10#2)
reduces the time##4##3##(1997-4#1)(2008-10#2)(2009-10#1)
reduces the##146##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-11#3)(1991-2#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#2)(1997-1#2)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-8#5)(2008-10#13)(2008-11#5)(2008-2#6)(2008-3#17)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
reduces to a##2##3##(2008-10#1)(2008-3#1)
reduces to the##2##3##(2007-12#1)(2009-8#1)
reduces to##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2009-8#1)
reduces waste##2##2##(2008-10#2)
reduces##333##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-2#2)(1992-3#6)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#4)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#3)(1995-5#2)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#12)(2007-12#10)(2007-7#1)(2007-8#10)(2008-1#2)(2008-10#38)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#30)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#12)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#12)(2012-12#1)(2012-2#8)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#5)
reducible##11##1##(1994-6#3)(1996-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-9#1)
reducing HIV##2##2##(2008-4#1)(2009-7#1)
reducing LOS##3##2##(1993-12#1)(1995-12#2)
reducing a##3##2##(1995-1#1)(1996-9#1)(2008-10#1)
reducing activity##2##2##(1993-6#1)(1996-2#1)
reducing agent and##3##3##(1990-9#1)(2008-10#2)
reducing agent for##2##3##(1996-5#1)(2008-10#1)
reducing agent##19##2##(1990-9#1)(1995-11#3)(1996-5#1)(2008-10#13)(2011-2#1)
reducing agent)##2##2##(2007-11#1)(2008-10#1)
reducing agents and##2##3##(2008-10#1)(2012-2#1)
reducing agents##10##2##(1990-5#2)(1991-2#1)(1992-6#2)(1992-9#1)(2008-10#2)(2008-4#1)(2012-2#1)
reducing airway##2##2##(1994-6#2)
reducing alcohol##2##2##(2008-11#1)(2008-2#1)
reducing and##2##2##(1995-12#1)(2008-5#1)
reducing associated##2##2##(2007-7#1)(2012-2#1)
reducing both the##2##3##(2008-10#2)
reducing capacity of##2##3##(2008-11#2)
reducing capacity##3##2##(2008-11#3)
reducing cardiovascular risk##2##3##(1990-2#1)(2008-8#1)
reducing cardiovascular##4##2##(1990-2#1)(1992-6#1)(2008-8#1)(2012-12#1)
reducing child poverty##2##3##(2008-11#2)
reducing child##3##2##(1996-2#1)(2008-11#2)
reducing complications##2##2##(1996-9#1)(2011-2#1)
reducing conditions##11##2##(1990-12#1)(1990-5#1)(1993-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#1)
reducing conversion rates to full-blown illness and decreasing symptom severity##2##10##(2009-8#2)
reducing coronary##2##2##(1995-12#1)(2013-1#1)
reducing costs##5##2##(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
reducing disease incidence##2##3##(2008-10#2)
reducing disease##6##2##(2008-10#5)(2008-8#1)
reducing disparities in##2##3##(2013-1#2)
reducing drug##3##2##(1996-2#1)(2008-6#1)(2008-7#1)
reducing energy##2##2##(2010-3#1)(2012-2#1)
reducing equivalents from##2##3##(1992-6#1)(2009-9#1)
reducing equivalents##7##2##(1991-2#1)(1992-6#1)(1994-11#1)(1995-3#1)(2009-4#1)(2009-9#2)
reducing germination of##2##3##(2008-10#2)
reducing health care##2##3##(1996-3#1)(2008-11#1)
reducing health disparities in##2##4##(2008-4#1)(2012-2#1)
reducing health risks##2##3##(2008-6#1)(2009-7#1)
reducing health##6##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-7#1)(2012-2#1)
reducing hospital##4##2##(1991-11#1)(1992-12#1)(1992-2#1)(2013-1#1)
reducing incontinence episodes##2##3##(2008-3#2)
reducing inflammation##2##2##(2012-2#1)(2013-7#1)
reducing ischemic##2##2##(2007-9#1)(2008-3#1)
reducing its##4##2##(1994-8#1)(1995-11#1)(2008-10#1)(2008-9#1)
reducing morbidity##3##2##(1994-3#1)(2011-2#1)(2012-2#1)
reducing myopia progression to between##2##5##(2012-12#2)
reducing myopia progression to##3##4##(2012-12#3)
reducing negative##3##2##(2008-8#1)(2009-5#1)(2013-7#1)
reducing of the##2##3##(2008-12#1)(2013-8#1)
reducing of##3##2##(1992-5#1)(2008-12#1)(2013-8#1)
reducing or eliminating##2##3##(1997-3#1)(2008-11#1)
reducing or##4##2##(1992-5#1)(1997-3#1)(2008-11#1)(2008-4#1)
reducing overall##2##2##(1997-1#1)(2013-1#1)
reducing oxidative stress##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
reducing oxidative##4##2##(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
reducing postoperative##2##2##(2010-7#1)(2012-1#1)
reducing power consumption##2##3##(2008-7#1)(2010-11#1)
reducing power##9##2##(2008-10#2)(2008-7#4)(2010-11#1)(2010-5#1)(2013-1#1)
reducing radiation exposure##2##3##(1996-6#1)(2012-2#1)
reducing radiation##3##2##(1996-6#1)(2012-1#1)(2012-2#1)
reducing reagent##3##2##(2008-10#3)
reducing recurrence##2##2##(2011-2#1)(2012-1#1)
reducing risk##3##2##(1993-11#1)(1995-3#1)(2011-2#1)
reducing sequence length##2##3##(2008-9#2)
reducing serum##2##2##(1991-6#1)(2009-3#1)
reducing sexual risk##2##3##(2008-4#1)(2013-1#1)
reducing staff##2##2##(1993-1#1)(2007-9#1)
reducing sugar##3##2##(2008-10#2)(2008-7#1)
reducing sugars content##2##3##(2008-10#2)
reducing sugars in##3##3##(2008-10#3)
reducing sugars##15##2##(1992-12#1)(1994-6#1)(1995-11#1)(2008-10#10)(2013-1#2)
reducing the ability of##2##4##(1997-7#1)(2008-10#1)
reducing the amount of##2##4##(2008-10#1)(2008-3#1)
reducing the computational##2##3##(2009-9#1)(2011-2#1)
reducing the efficacy of##2##4##(2008-10#1)(2011-2#1)
reducing the impact of##2##4##(2008-10#1)(2011-2#1)
reducing the incidence of##4##4##(1993-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
reducing the incidence##5##3##(1993-10#1)(2008-7#2)(2008-8#1)(2012-2#1)
reducing the length of stay##2##5##(1992-12#1)(2006-10#1)
reducing the level of##2##4##(2008-10#1)(2008-9#1)
reducing the number of##10##4##(1995-5#1)(1997-2#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)
reducing the number##11##3##(1990-3#1)(1995-5#1)(1997-2#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)
reducing the prevalence of##2##4##(2007-10#1)(2007-11#1)
reducing the probability##2##3##(2008-3#1)(2008-7#1)
reducing the production of##2##4##(1991-12#1)(2008-10#1)
reducing the rate of##2##4##(1990-9#1)(1992-2#1)
reducing the risk of##6##4##(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
reducing the risk##9##3##(1991-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
reducing the severity of##3##4##(2008-10#3)
reducing the severity##4##3##(2008-10#3)(2008-5#1)
reducing the time of##2##4##(2008-10#2)
reducing the time##4##3##(2007-7#1)(2008-10#3)
reducing the total##2##3##(2008-6#1)(2010-5#1)
reducing the use of##2##4##(1992-3#1)(2008-11#1)
reducing the volume of##2##4##(2008-10#1)(2008-6#1)
reducing the##174##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#39)(2008-11#7)(2008-2#9)(2008-3#13)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
reducing their##5##2##(2008-10#2)(2008-8#1)(2010-5#1)(2010-9#1)
reducing total##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
reducing urinary##2##2##(2008-3#1)(2013-1#1)
reducing utilization##2##2##(1997-1#1)(2008-8#1)
reducing wound##3##2##(2007-8#1)(2010-12#1)(2012-2#1)
reducing##632##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1995-1#1)(1995-11#9)(1995-12#8)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-11#10)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#135)(2008-11#24)(2008-12#1)(2008-2#17)(2008-3#24)(2008-4#8)(2008-5#14)(2008-6#8)(2008-7#25)(2008-8#21)(2008-9#7)(2009-10#3)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#30)(2011-3#1)(2012-1#4)(2012-12#14)(2012-2#20)(2012-3#7)(2012-6#1)(2013-1#27)(2013-7#4)(2013-8#8)
reductance##2##1##(2008-11#2)
reductant and##2##2##(1994-5#1)(2008-10#1)
reductant for##2##2##(1995-5#1)(2008-10#1)
reductant##18##1##(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-5#1)(1995-5#1)(2008-10#9)(2008-8#1)(2013-1#1)
reductants##7##1##(1990-5#1)(1992-6#2)(1994-8#1)(2008-10#2)(2008-3#1)
reductase (EC 1##2##3##(1995-8#2)
reductase (MTHFR)##2##2##(2008-11#1)(2008-8#1)
reductase activities##3##2##(1992-3#1)(1994-9#1)(2008-6#1)
reductase activity in##3##3##(1990-11#1)(1993-6#1)(1996-3#1)
reductase activity##19##2##(1990-11#4)(1990-2#1)(1992-8#3)(1993-6#2)(1994-2#1)(1995-3#1)(1996-3#1)(2008-10#3)(2008-11#1)(2009-9#2)
reductase and oxidase##2##3##(1995-2#2)
reductase and sorbitol dehydrogenase##3##4##(1996-2#3)
reductase and##15##2##(1992-1#1)(1992-8#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-2#3)(1996-8#1)(2008-1#1)(2008-11#1)(2008-8#1)
reductase as##3##2##(1990-12#1)(1994-9#1)(1996-3#1)
reductase by##4##2##(1993-11#1)(1994-8#1)(2009-8#2)
reductase cDNA##2##2##(1990-8#1)(1993-3#1)
reductase component of##4##3##(2008-11#4)
reductase domain##2##2##(1994-9#1)(2010-12#1)
reductase enzyme##3##2##(1991-6#1)(2008-6#1)(2009-11#1)
reductase from Escherichia coli##2##4##(1991-5#1)(2011-1#1)
reductase from##15##2##(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-11#2)(1995-8#1)(1996-3#1)(1996-8#1)(2008-6#2)(2009-7#1)(2011-1#1)
reductase gene##7##2##(1992-8#3)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
reductase has##3##2##(1991-5#1)(1991-6#1)(2008-11#1)
reductase in##9##2##(1990-12#1)(1990-2#1)(1991-5#2)(1994-8#1)(1997-2#2)(2008-11#1)(2009-7#1)
reductase inhibitor##7##2##(1991-12#2)(1993-6#1)(1994-8#2)(2008-5#1)(2009-11#1)
reductase inhibitors##11##2##(1991-6#2)(1994-8#1)(1995-5#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
reductase into##3##2##(1994-6#2)(1994-8#1)
reductase is##4##2##(1993-11#1)(1993-6#1)(2009-7#1)(2009-8#1)
reductase reaction##2##2##(1994-11#2)
reductase that##2##2##(2008-5#1)(2008-6#1)
reductase to##2##2##(1994-8#1)(1995-2#1)
reductase was##8##2##(1990-11#1)(1990-8#1)(1993-6#1)(1994-11#1)(1996-3#3)(2008-11#1)
reductase##242##1##(1990-11#6)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#7)(1991-6#5)(1992-1#3)(1992-10#2)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#14)(1993-11#5)(1993-3#2)(1993-6#11)(1993-8#2)(1994-11#6)(1994-2#1)(1994-3#1)(1994-6#5)(1994-8#14)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#6)(1996-2#4)(1996-3#7)(1996-8#3)(1997-2#5)(1997-3#1)(1997-5#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#18)(2008-2#4)(2008-4#2)(2008-5#4)(2008-6#7)(2008-8#3)(2009-11#3)(2009-3#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)
reductase)##5##1##(1994-8#1)(1996-12#1)(2008-10#1)(2008-6#1)(2012-2#1)
reductase-encoding##2##1##(1994-12#1)(2008-10#1)
reductases##13##1##(1990-5#2)(1991-5#1)(1992-3#1)(1992-4#1)(1992-8#2)(1996-3#1)(1997-2#1)(2009-10#1)(2009-9#2)(2012-2#1)
reduction (p##2##2##(1993-1#1)(1997-2#1)
reduction (p&lt##2##2##(2011-2#1)(2013-1#1)
reduction across##2##2##(2010-7#1)(2011-2#1)
reduction after##2##2##(1995-2#1)(2008-7#1)
reduction among##2##2##(2007-10#1)(2010-4#1)
reduction and internal fixation with a reamed##2##7##(2009-3#2)
reduction and internal fixation with##3##5##(2009-3#2)(2012-2#1)
reduction and internal fixation##7##4##(2008-12#1)(2008-8#1)(2009-3#2)(2012-2#2)(2013-1#1)
reduction and oxidation of##3##4##(2008-10#2)(2008-3#1)
reduction and oxidation##7##3##(2008-10#6)(2008-3#1)
reduction and reoxidation of##2##4##(1990-5#2)
reduction and the##3##3##(1992-3#1)(2008-8#1)(2010-7#1)
reduction and uptake##2##3##(2009-9#2)
reduction and##60##2##(1990-5#2)(1991-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-9#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-9#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
reduction as well as##2##4##(2007-11#1)(2007-8#1)
reduction as##4##2##(2007-11#1)(2007-8#1)(2011-2#2)
reduction assay##3##2##(1993-12#1)(2008-11#1)(2013-1#1)
reduction at -1##4##3##(2008-10#4)
reduction at the##2##3##(1996-2#1)(2008-5#1)
reduction at##12##2##(1996-2#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2012-2#1)
reduction based on##3##3##(2008-10#1)(2012-2#2)
reduction below the##2##3##(1993-3#1)(2007-12#1)
reduction below##4##2##(1990-9#1)(1993-3#2)(2007-12#1)
reduction by the##3##3##(1992-1#1)(1994-11#1)(1994-3#1)
reduction by##20##2##(1990-2#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-3#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-9#1)(2009-9#2)(2010-6#1)(2012-2#1)
reduction can be##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
reduction can##4##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
reduction coil##4##2##(2008-10#4)
reduction column##3##2##(2008-10#3)
reduction compared##2##2##(2012-2#1)(2012-3#1)
reduction constant##2##2##(1993-8#2)
reduction current of the adsorbed##2##5##(2008-10#2)
reduction current of##4##3##(2008-10#4)
reduction current##6##2##(2008-10#6)
reduction due to##3##3##(2008-10#3)
reduction followed by##2##3##(2007-8#1)(2008-10#1)
reduction for the##2##3##(1997-2#1)(2008-10#1)
reduction for##4##2##(1997-2#1)(2008-10#2)(2012-3#1)
reduction from##6##2##(1993-8#1)(1994-3#1)(2007-8#1)(2008-3#1)(2008-6#1)(2012-3#1)
reduction in HOMA-IR##2##3##(2008-3#1)(2013-8#1)
reduction in LDL cholesterol##2##4##(2008-3#1)(2012-2#1)
reduction in LDL##3##3##(2008-3#2)(2012-2#1)
reduction in MC##3##3##(1992-11#1)(2013-7#2)
reduction in RH##3##3##(2008-10#3)
reduction in agonist##2##3##(2008-3#1)(2013-8#1)
reduction in apple##2##3##(2008-10#2)
reduction in blood##2##3##(2007-10#1)(2012-2#1)
reduction in body weight##2##4##(1993-8#1)(2008-12#1)
reduction in body##4##3##(1993-8#1)(2008-12#1)(2009-6#1)(2012-3#1)
reduction in both##4##3##(1990-12#1)(1991-8#1)(1993-8#1)(1995-12#1)
reduction in cell##4##3##(1990-6#1)(1993-8#1)(1994-10#1)(1996-7#1)
reduction in circulating white blood cells##2##6##(1994-8#2)
reduction in clinical##2##3##(2007-11#1)(2008-3#1)
reduction in death##2##3##(2007-10#1)(2007-5#1)
reduction in deep##2##3##(2007-8#1)(2008-6#1)
reduction in diastolic##2##3##(1996-3#1)(2008-3#1)
reduction in disease incidence##2##4##(2008-10#2)
reduction in disease severity##3##4##(2008-10#2)(2012-2#1)
reduction in disease##7##3##(2008-10#6)(2012-2#1)
reduction in either##2##3##(2008-10#1)(2009-9#1)
reduction in elasticity##2##3##(2008-5#1)(2012-2#1)
reduction in energy##5##3##(1994-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
reduction in fat mass##2##4##(2008-3#1)(2008-5#1)
reduction in flow rates with##2##5##(1996-12#2)
reduction in growth##4##3##(1994-2#1)(2008-6#2)(2009-9#1)
reduction in host density as a result of parasite-induced host##2##10##(2008-9#2)
reduction in hypogastric nerve activity##2##5##(1995-12#2)
reduction in hypoglycemic##2##3##(2008-3#1)(2010-10#1)
reduction in incidence of##2##4##(2011-1#1)(2013-1#1)
reduction in infarct##2##3##(1991-9#1)(2007-10#1)
reduction in intensity of##3##4##(1995-6#1)(2008-10#2)
reduction in length of stay##2##5##(1994-3#1)(2012-2#1)
reduction in luc expression##2##4##(1993-6#2)
reduction in microvascular conductance##2##4##(1995-12#2)
reduction in morbidity and mortality##2##5##(1992-11#1)(2008-3#1)
reduction in morbidity##3##3##(1990-11#1)(1992-11#1)(2008-3#1)
reduction in mortality from##2##4##(1995-12#1)(1996-3#1)
reduction in mortality##6##3##(1995-12#1)(1995-5#1)(1996-3#1)(2008-7#1)(2009-7#1)(2013-1#1)
reduction in numbers of##3##4##(1997-3#1)(2008-5#1)(2010-1#1)
reduction in pain##5##3##(1994-3#1)(2007-11#1)(2007-8#1)(2010-4#1)(2010-7#1)
reduction in pathogen##2##3##(2008-10#2)
reduction in photoplethysmography##2##3##(2008-2#2)
reduction in plant##2##3##(1992-3#1)(2008-10#1)
reduction in plasma##4##3##(1994-11#1)(1995-2#2)(2008-10#1)
reduction in postoperative##2##3##(2012-1#2)
reduction in pressure##2##3##(1996-6#1)(2007-8#1)
reduction in proliferation##2##3##(1997-6#1)(2009-12#1)
reduction in renal plasma flow and glomerular filtration rate and##2##10##(1995-12#2)
reduction in renal##3##3##(1995-12#2)(2008-10#1)
reduction in reward magnitude##2##4##(1993-12#2)
reduction in reward##3##3##(1993-12#3)
reduction in root lesions)##2##4##(2008-10#2)
reduction in serum##4##3##(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
reduction in size of the##3##5##(2008-10#1)(2008-8#1)(2011-1#1)
reduction in size of##4##4##(2008-10#2)(2008-8#1)(2011-1#1)
reduction in size##5##3##(1995-3#1)(2008-10#2)(2008-8#1)(2011-1#1)
reduction in stroke##2##3##(1993-10#1)(2007-9#1)
reduction in the amount of##4##5##(1990-12#1)(2008-10#2)(2008-12#1)
reduction in the cost##2##4##(2008-9#1)(2010-11#1)
reduction in the development##2##4##(2008-5#1)(2013-1#1)
reduction in the frequency##2##4##(2007-8#1)(2009-10#1)
reduction in the incidence of##6##5##(1992-9#1)(1993-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
reduction in the level of##5##5##(1990-5#1)(1994-8#1)(1995-6#1)(2008-6#1)(2010-12#1)
reduction in the levels of##4##5##(1997-4#1)(2008-8#1)(2009-12#1)(2010-5#1)
reduction in the number of patients##2##6##(1992-1#1)(1996-9#1)
reduction in the number of##20##5##(1992-1#1)(1992-11#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-12#1)(1996-9#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
reduction in the overall##2##4##(1993-11#1)(2007-12#1)
reduction in the percentage of##2##5##(2008-10#1)(2008-4#1)
reduction in the presence of##2##5##(2009-9#2)
reduction in the production of##2##5##(1991-12#1)(2008-10#1)
reduction in the production##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
reduction in the rate of##5##5##(2008-1#1)(2008-10#1)(2008-5#2)(2011-2#1)
reduction in the risk of##4##5##(1991-8#1)(2010-6#1)(2012-2#1)(2013-8#1)
reduction in the severity##2##4##(1991-8#1)(1995-11#1)
reduction in the size of the##2##6##(2008-1#1)(2012-2#1)
reduction in the time##2##4##(1991-12#1)(2011-1#1)
reduction in the total##2##4##(1994-3#1)(2008-8#1)
reduction in the##176##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#4)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-9#4)(1993-11#3)(1993-12#2)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#22)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
reduction in their##6##3##(1990-5#1)(1996-12#1)(2008-7#2)(2009-10#1)(2011-2#1)
reduction in time##2##3##(2008-10#1)(2008-9#1)
reduction in total cholesterol##2##4##(1991-8#1)(2008-3#1)
reduction in total##6##3##(1991-8#1)(2008-3#2)(2008-8#2)(2012-2#1)
reduction in triglycerides##2##3##(2008-3#2)
reduction in viability##2##3##(2008-10#1)(2009-4#1)
reduction in yield##2##3##(2008-10#2)
reduction in##643##2##(1990-11#4)(1990-12#4)(1990-2#3)(1990-5#7)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#6)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#6)(1991-9#4)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#10)(1994-9#3)(1995-11#2)(1995-12#16)(1995-2#8)(1995-3#2)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#8)(1996-2#3)(1996-3#3)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#2)(2007-10#4)(2007-11#11)(2007-12#11)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#5)(2008-10#91)(2008-11#15)(2008-12#7)(2008-2#13)(2008-3#43)(2008-4#2)(2008-5#27)(2008-6#12)(2008-7#26)(2008-8#11)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#7)(2011-10#1)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#22)(2012-3#3)(2012-5#1)(2013-1#16)(2013-7#4)(2013-8#18)
reduction intervention##3##2##(2008-4#2)(2008-6#1)
reduction is a##3##3##(1992-8#1)(1995-12#1)(2013-1#1)
reduction is the##2##3##(1995-2#1)(2007-8#1)
reduction is##20##2##(1991-1#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-1#2)
reduction kinetics##2##2##(1992-6#1)(2008-10#1)
reduction mechanism of##2##3##(2008-10#2)
reduction mechanism##4##2##(2008-10#4)
reduction method##6##2##(2012-2#5)(2013-1#1)
reduction occurs##3##2##(1994-3#1)(2008-10#1)(2009-6#1)
reduction of 1##3##3##(1994-11#1)(1995-3#2)
reduction of 18%##2##3##(1991-11#1)(2008-10#1)
reduction of 2##2##3##(1994-6#1)(1995-3#1)
reduction of 2-heptanone##2##3##(2008-10#2)
reduction of Cr(VI)##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
reduction of Cu(2+)##2##3##(2008-10#2)
reduction of Fe(3+)##2##3##(2008-10#2)
reduction of Fe(III) to Fe(II)##2##5##(1995-6#1)(2008-10#1)
reduction of Fe(III)##3##3##(1995-6#1)(2008-10#2)
reduction of H(2)O(2)##3##3##(2008-10#3)
reduction of Hg(II) ions##2##4##(2008-10#2)
reduction of Hg(II)##3##3##(2008-10#3)
reduction of NO by##2##4##(1992-3#1)(2010-6#1)
reduction of a##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
reduction of about##4##3##(1993-11#1)(1996-6#1)(2008-11#1)(2008-5#1)
reduction of adhesion formation##2##4##(1991-1#1)(1992-1#1)
reduction of adhesion##3##3##(1991-1#1)(1992-1#2)
reduction of antibiotic##2##3##(2008-1#1)(2013-7#1)
reduction of benzodiazepine##2##3##(1995-11#1)(1995-12#1)
reduction of bone##2##3##(2009-7#1)(2013-1#1)
reduction of both##2##3##(1992-1#1)(2008-10#1)
reduction of breast cancer##3##4##(2011-2#1)(2012-3#2)
reduction of cardiovascular##2##3##(1992-8#1)(2008-4#1)
reduction of catechin autoxidation intermediate##2##5##(2008-10#2)
reduction of central##2##3##(2008-1#1)(2011-2#1)
reduction of copper##2##3##(2008-10#1)(2010-5#1)
reduction of coronary##2##3##(1992-8#1)(2010-2#1)
reduction of fat mass was##2##5##(2008-3#2)
reduction of growth##2##3##(2008-10#1)(2008-11#1)
reduction of hearing##3##3##(1990-12#3)
reduction of hydrogen peroxide##5##4##(2008-10#5)
reduction of hydrogen##6##3##(2008-10#6)
reduction of iNOS expression and nitrite production##2##7##(1996-12#2)
reduction of iNOS expression##3##4##(1996-12#3)
reduction of incidence and mortality##2##5##(1991-6#1)(1992-12#1)
reduction of inoculum##2##3##(2008-10#2)
reduction of insulin##3##3##(1990-12#1)(2008-3#1)(2013-8#1)
reduction of lead##2##3##(2008-10#2)
reduction of mortality##3##3##(2008-10#1)(2011-2#2)
reduction of nitrate to nitrite##4##5##(2008-10#4)
reduction of nitrate to##5##4##(2008-10#5)
reduction of one of the##2##5##(1991-5#1)(1995-3#1)
reduction of only##2##3##(2008-7#1)(2008-9#1)
reduction of oxygen##4##3##(1995-2#1)(2008-10#2)(2013-8#1)
reduction of pain##3##3##(1990-12#1)(1990-9#1)(2007-11#1)
reduction of plasma##4##3##(1990-12#1)(1990-5#1)(1992-9#1)(1994-8#1)
reduction of quantized kinoforms##2##4##(2008-2#2)
reduction of residual##2##3##(2007-8#1)(2008-2#1)
reduction of risk##4##3##(1991-8#2)(2009-4#1)(2012-12#1)
reduction of serum##3##3##(1995-3#1)(2009-8#1)(2012-2#1)
reduction of symptoms##2##3##(2011-10#1)(2011-2#1)
reduction of the amount of##3##5##(1990-10#1)(2007-11#1)(2008-10#1)
reduction of the body##2##4##(1990-9#1)(1992-5#1)
reduction of the first##2##4##(1995-12#1)(2008-9#1)
reduction of the hip##2##4##(2008-8#1)(2013-7#1)
reduction of the nidus##3##4##(1991-2#1)(2008-7#2)
reduction of the nitro group##2##5##(1995-6#1)(1996-2#1)
reduction of the nitro##3##4##(1995-6#1)(1996-2#1)(2008-10#1)
reduction of the number of##4##5##(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
reduction of the size of the##2##6##(2007-5#1)(2008-10#1)
reduction of the structurally##2##4##(1993-11#1)(1995-3#1)
reduction of the symptoms##2##4##(1990-11#1)(2008-10#1)
reduction of the##143##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-4#1)(2006-10#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#36)(2008-11#10)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#3)(2013-7#1)(2013-8#1)
reduction of this##2##3##(2008-4#1)(2011-2#1)
reduction of total##4##3##(2007-11#1)(2008-10#1)(2008-6#1)(2013-1#1)
reduction of virus##2##3##(2008-10#2)
reduction of##589##2##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#4)(1992-1#6)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#3)(1993-3#3)(1994-11#3)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#8)(1995-5#3)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#5)(1997-2#5)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#3)(2006-10#3)(2007-10#2)(2007-11#17)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#7)(2008-1#5)(2008-10#167)(2008-11#24)(2008-12#4)(2008-2#12)(2008-3#27)(2008-4#5)(2008-5#13)(2008-6#6)(2008-7#15)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#21)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#4)(2012-7#1)(2013-1#22)(2013-7#4)(2013-8#7)
reduction on the##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)
reduction on##13##2##(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)
reduction or complete##2##3##(1990-9#1)(2008-11#1)
reduction or##10##2##(1990-9#1)(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
reduction peak at -0##2##4##(1990-5#1)(2008-10#1)
reduction peak current of##3##4##(2008-10#3)
reduction peak current##5##3##(2008-10#5)
reduction peak of##2##3##(2008-10#2)
reduction peak##16##2##(1990-5#1)(2008-10#15)
reduction peaks##4##2##(1990-5#1)(2008-10#3)
reduction potential of##4##3##(1991-8#2)(2008-10#2)
reduction potential##7##2##(1990-5#1)(1991-8#2)(2008-10#4)
reduction potentials##6##2##(1990-5#1)(1991-8#2)(1995-5#2)(1995-8#1)
reduction process was##3##3##(2008-10#3)
reduction process##11##2##(2008-10#10)(2011-2#1)
reduction product of##2##3##(2008-10#2)
reduction product##5##2##(2008-10#5)
reduction products of##2##3##(1995-3#1)(2008-10#1)
reduction products##4##2##(1995-3#1)(2008-10#3)
reduction programs##3##2##(1994-3#1)(1995-2#1)(1997-5#1)
reduction rate of##3##3##(1995-8#1)(2008-2#1)(2008-7#1)
reduction rate##5##2##(1995-8#2)(1997-7#1)(2008-2#1)(2008-7#1)
reduction rates##2##2##(1990-8#2)
reduction reaction##4##2##(2008-10#3)(2008-8#1)
reduction reactions##2##2##(1995-8#1)(2008-10#1)
reduction should be##3##3##(1996-11#1)(2007-8#1)(2008-8#1)
reduction step is##2##3##(2008-10#2)
reduction step##4##2##(2008-10#4)
reduction strategies##4##2##(1994-2#1)(2008-10#2)(2012-1#1)
reduction strategy##2##2##(1996-4#1)(2008-2#1)
reduction technique##2##2##(2008-2#1)(2008-3#1)
reduction techniques##4##2##(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
reduction through##10##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#3)(2009-7#1)(2013-1#1)(2013-8#1)
reduction to nitrite##2##3##(2008-10#2)
reduction to##14##2##(1993-11#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-6#1)
reduction treatment##2##2##(2008-3#2)
reduction was also##2##3##(1993-12#1)(2008-10#1)
reduction was measured##2##3##(1997-3#1)(2008-10#1)
reduction was more##2##3##(1990-11#1)(2012-3#1)
reduction was observed in##2##4##(1991-8#1)(1993-12#1)
reduction was performed##2##3##(2008-10#1)(2011-2#1)
reduction was the##2##3##(1990-6#1)(1994-3#1)
reduction was##39##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-8#1)
reduction wave##2##2##(2008-10#2)
reduction with a##2##3##(2008-3#1)(2008-5#1)
reduction with good##2##3##(2007-8#1)(2008-10#1)
reduction with lithium aluminum##2##4##(1996-5#1)(2007-11#1)
reduction with sodium##2##3##(1993-11#1)(2008-10#1)
reduction with##28##2##(1993-11#3)(1993-6#1)(1996-5#6)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-7#3)(2013-1#1)
reduction##1855##1##(1990-10#2)(1990-11#8)(1990-12#12)(1990-2#10)(1990-3#2)(1990-5#15)(1990-6#5)(1990-8#5)(1990-9#6)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#2)(1991-5#8)(1991-6#2)(1991-7#1)(1991-8#15)(1991-9#7)(1992-1#9)(1992-11#5)(1992-12#7)(1992-2#1)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#9)(1992-7#1)(1992-8#8)(1992-9#7)(1993-1#4)(1993-10#1)(1993-11#19)(1993-12#16)(1993-2#1)(1993-3#11)(1993-6#4)(1993-8#9)(1993-9#2)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#8)(1994-3#12)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#15)(1994-9#4)(1995-11#5)(1995-12#25)(1995-2#20)(1995-3#15)(1995-5#11)(1995-6#5)(1995-8#6)(1995-9#3)(1996-1#5)(1996-11#2)(1996-12#13)(1996-2#10)(1996-3#5)(1996-4#3)(1996-5#16)(1996-6#9)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#9)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#1)(2006-10#3)(2007-10#7)(2007-11#40)(2007-12#31)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#10)(2007-8#32)(2007-9#2)(2008-1#13)(2008-10#445)(2008-11#55)(2008-12#18)(2008-2#41)(2008-3#90)(2008-4#13)(2008-5#46)(2008-6#32)(2008-7#59)(2008-8#18)(2008-9#23)(2009-1#3)(2009-10#5)(2009-11#6)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#3)(2009-6#6)(2009-7#8)(2009-8#5)(2009-9#15)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#10)(2010-5#4)(2010-6#4)(2010-7#9)(2010-8#6)(2011-1#16)(2011-10#2)(2011-2#53)(2011-3#1)(2012-1#8)(2012-12#5)(2012-2#48)(2012-3#15)(2012-5#3)(2012-7#1)(2013-1#53)(2013-7#11)(2013-8#35)
reduction) and##5##2##(1990-12#1)(1992-8#1)(1996-2#1)(2008-10#1)(2009-9#1)
reduction) in the CMM group and from 7##2##8##(2008-7#2)
reduction) in the##4##3##(2008-7#4)
reduction) in##6##2##(2008-10#2)(2008-7#4)
reduction)##20##1##(1990-12#1)(1992-8#1)(1996-2#3)(2008-10#9)(2008-7#4)(2009-9#1)(2010-4#1)
reductionist##4##1##(1997-6#2)(2010-12#1)(2012-12#1)
reductions and##5##2##(1992-8#1)(2007-7#1)(2008-10#2)(2008-7#1)
reductions for##3##2##(1997-3#1)(2012-3#1)(2013-1#1)
reductions in LDL##2##3##(1991-2#1)(1991-8#1)
reductions in a##2##3##(1994-12#1)(2008-10#1)
reductions in both##4##3##(1995-8#1)(2007-10#1)(2008-10#1)(2009-9#1)
reductions in host##2##3##(2008-10#1)(2008-9#1)
reductions in lesion##2##3##(2008-10#1)(2012-3#1)
reductions in the levels##2##4##(2008-5#2)
reductions in the use of##2##5##(1995-12#1)(2008-4#1)
reductions in the##17##3##(1995-1#1)(1995-12#2)(1997-2#1)(1997-5#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2011-2#1)
reductions in##99##2##(1991-2#1)(1991-8#1)(1992-2#1)(1992-8#2)(1993-10#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-8#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-3#1)(2008-10#29)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
reductions of the##3##3##(1992-3#1)(1997-7#1)(2008-10#1)
reductions of##26##2##(1991-11#1)(1992-12#4)(1992-3#1)(1993-3#1)(1993-8#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
reductions or##2##2##(1994-1#1)(2008-7#1)
reductions ranging from##2##3##(2008-10#1)(2012-1#1)
reductions that##2##2##(1996-1#1)(2006-10#1)
reductions were found##2##3##(1997-3#1)(2008-10#1)
reductions were##14##2##(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)
reductions##182##1##(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#3)(1993-1#1)(1993-10#2)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#4)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#8)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#47)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
reductive activation of##3##3##(1995-2#1)(2009-10#2)
reductive amination##3##2##(1996-5#3)
reductive charge##3##2##(2008-10#3)
reductive cleavage##3##2##(2008-4#1)(2010-12#2)
reductive dechlorination##2##2##(2011-1#2)
reductive desorption of the##2##4##(2008-10#2)
reductive desorption of##3##3##(2008-10#3)
reductive desorption##5##2##(2008-10#5)
reductive elution##2##2##(2008-10#2)
reductive sulphur##6##2##(2008-10#6)
reductive##49##1##(1990-7#1)(1992-12#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#3)(2008-1#3)(2008-10#21)(2008-11#3)(2008-4#2)(2009-10#2)(2009-3#1)(2010-12#2)(2010-8#1)(2011-1#3)(2013-8#1)
reductor column##4##2##(2008-10#4)
reductor##5##1##(2008-10#5)
redundancies##2##1##(1996-3#1)(2008-7#1)
redundancy and##4##2##(2008-3#1)(2008-5#1)(2011-3#2)
redundancy in the##2##3##(2008-5#1)(2009-6#1)
redundancy in##7##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-8#1)(2012-3#1)
redundancy of##3##2##(1996-2#2)(1997-6#1)
redundancy or##3##2##(2008-7#1)(2009-10#1)(2009-5#1)
redundancy seems##2##2##(2007-11#1)(2008-1#1)
redundancy##30##1##(1993-12#1)(1994-8#1)(1996-2#4)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-3#3)
redundant information##2##2##(2008-3#2)
redundant role in##2##3##(2009-10#1)(2013-1#1)
redundant role##3##2##(2009-10#2)(2013-1#1)
redundant skin##2##2##(2009-5#2)
redundant##28##1##(1991-5#1)(1993-12#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#3)(2009-5#3)(2012-2#1)(2013-1#1)(2013-8#1)
redundantly##3##1##(1991-2#2)(2009-10#1)
redwater##2##1##(2010-1#2)
redwood##3##1##(2008-10#2)(2008-11#1)
reeducation##5##1##(1990-2#1)(1992-12#1)(2008-5#1)(2013-1#2)
reef at##3##2##(2007-5#2)(2008-5#1)
reef communities##2##2##(2007-5#2)
reef coral##2##2##(2008-6#1)(2012-12#1)
reef fish##4##2##(2007-5#1)(2008-8#2)(2013-1#1)
reef fishes##2##2##(2007-5#1)(2010-8#1)
reef sharks Carcharhinus melanopterus##2##4##(2010-8#2)
reef##45##1##(2007-5#21)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#2)(2010-8#3)(2011-2#7)(2012-12#1)(2013-1#1)(2013-7#1)
reef-building##4##1##(1992-6#2)(2007-5#1)(2008-5#1)
reefs and##2##2##(2008-5#1)(2011-2#1)
reefs at##3##2##(2008-3#1)(2008-5#2)
reefs were surveyed##2##3##(2008-5#2)
reefs##23##1##(2007-5#9)(2008-3#1)(2008-5#7)(2008-9#1)(2011-2#5)
reeler##2##1##(2012-2#2)
reelin immunoreactivity##3##2##(2009-8#3)
reelin is##2##2##(2009-8#2)
reelin##15##1##(2009-8#15)
reemerged in##2##2##(1995-3#1)(2008-10#1)
reemerged##3##1##(1995-3#1)(2008-10#1)(2011-1#1)
reemergence of##4##2##(1992-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
reemission of##2##2##(2008-11#1)(2008-3#1)
reengineer##3##1##(1995-1#1)(1996-1#1)(2011-7#1)
reengineering is##2##2##(1995-1#1)(1997-3#1)
reengineering may be##2##3##(1994-12#1)(1995-3#1)
reengineering##23##1##(1994-1#1)(1994-12#3)(1995-1#4)(1995-3#4)(1996-1#2)(1997-3#9)
reentrant tachycardia##4##2##(1993-2#3)(2008-11#1)
reentrant##7##1##(1993-2#4)(2008-11#1)(2008-2#1)(2010-8#1)
reentry##3##1##(1994-9#2)(2008-2#1)
reesei##12##1##(1991-9#2)(1993-8#2)(2008-10#2)(2008-6#3)(2008-9#2)(2011-2#1)
reestablish##3##1##(2008-1#1)(2012-2#1)(2013-1#1)
reestablished##2##1##(1991-2#1)(2009-8#1)
reestablishment of##3##2##(1991-12#1)(1995-2#1)(2009-3#1)
reevaluate##2##1##(2008-11#1)(2008-3#1)
reevaluated##3##1##(1990-5#1)(2006-8#1)(2008-10#1)
reevaluation of the##2##3##(2006-8#1)(2008-1#1)
reevaluation of##5##2##(1993-12#1)(2006-8#1)(2008-1#1)(2009-6#1)(2011-2#1)
reevaluation##7##1##(1992-1#1)(1993-12#1)(1996-11#1)(2006-8#1)(2008-1#1)(2009-6#1)(2011-2#1)
reevii Hr##3##2##(1991-10#3)
reevii##5##1##(1991-10#5)
reexamination of##5##2##(1993-8#1)(1994-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
reexamination##7##1##(1993-8#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
reexamine##5##1##(1995-2#1)(1996-12#1)(2008-8#2)(2008-9#1)
reexamined in##2##2##(1996-11#1)(1997-1#1)
reexamined##13##1##(1993-11#1)(1996-11#1)(1996-5#2)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
reexcision##2##1##(2008-11#1)(2013-1#1)
reextraction##2##1##(2008-10#2)
ref##2##1##(1993-9#1)(2008-10#1)
refeeding##7##1##(2008-3#1)(2008-4#1)(2008-7#4)(2012-3#1)
refer a##2##2##(1996-1#1)(2008-9#1)
refer as a##2##3##(2007-12#1)(2010-8#1)
refer patients##2##2##(1993-2#1)(1993-3#1)
refer the##3##2##(1992-5#1)(2008-11#1)(2008-2#1)
refer their##2##2##(2007-2#1)(2011-1#1)
refer to a##7##3##(1991-9#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
refer to any##2##3##(1995-2#1)(2008-4#1)
refer to as the##2##4##(1995-6#1)(2012-12#1)
refer to as##4##3##(1992-6#1)(1995-6#1)(2011-2#1)(2012-12#1)
refer to the##4##3##(1993-2#1)(1997-1#1)(2008-10#1)(2008-7#1)
refer to##38##2##(1990-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-2#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
refer travellers to##2##3##(2007-2#2)
refer##56##1##(1990-6#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-5#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
refered to##2##2##(2008-10#1)(2008-7#1)
reference 3D##2##2##(2008-3#2)
reference and##14##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2010-3#1)(2011-2#1)(2012-12#1)
reference arm##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
reference beam and##3##3##(2008-2#1)(2008-3#2)
reference beam in##2##3##(2008-3#2)
reference beam is##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
reference beam to##3##3##(2008-2#1)(2008-3#2)
reference beam##30##2##(2007-11#2)(2007-12#3)(2008-2#7)(2008-3#18)
reference beams##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
reference blood samples##2##3##(1995-11#1)(2009-11#1)
reference blood##3##2##(1995-11#1)(2009-11#1)(2009-9#1)
reference code##2##2##(2008-12#1)(2008-3#1)
reference compound##3##2##(1991-12#1)(1995-3#1)(2008-10#1)
reference compounds##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)
reference data##8##2##(1996-12#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
reference drug##6##2##(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
reference electrode and a##2##4##(2008-10#2)
reference electrode was##2##3##(2008-10#2)
reference electrode##26##2##(1991-5#1)(2008-10#24)(2008-9#1)
reference electrode)##7##2##(2008-10#7)
reference electrodes##2##2##(2008-10#2)
reference field##2##2##(2007-11#1)(2008-10#1)
reference food##2##2##(2008-1#2)
reference for the##6##3##(1990-12#1)(1995-3#1)(2007-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
reference for those##2##3##(2008-11#1)(2008-12#1)
reference for##11##2##(1990-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#2)
reference frame##3##2##(2008-3#3)
reference function##3##2##(2007-11#1)(2008-3#2)
reference gratings##2##2##(2008-2#2)
reference group##5##2##(1991-5#1)(1994-6#1)(2008-10#1)(2012-1#1)(2013-8#1)
reference groups were##2##3##(2011-2#2)
reference groups##4##2##(2008-5#1)(2011-2#3)
reference haplotypes##2##2##(2012-3#2)
reference image and##2##3##(2008-3#2)
reference image##7##2##(2008-2#1)(2008-3#6)
reference images for##2##3##(2008-2#1)(2008-3#1)
reference images##4##2##(2008-2#1)(2008-3#3)
reference in the##3##3##(1994-3#2)(2008-3#1)
reference in##5##2##(1994-3#2)(2008-3#1)(2012-3#1)(2013-8#1)
reference interval##5##2##(1990-8#1)(1991-5#2)(1992-3#1)(1992-9#1)
reference into##2##2##(2008-1#1)(2008-10#1)
reference is made to##2##4##(1994-2#1)(2008-10#1)
reference is##7##2##(1990-2#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-11#1)
reference isolates of##2##3##(2008-10#1)(2008-5#1)
reference isolates##4##2##(2008-10#3)(2008-5#1)
reference laser##2##2##(2007-11#1)(2008-2#1)
reference levels##3##2##(2011-2#1)(2012-2#2)
reference librarians to##2##3##(1996-1#1)(1997-3#1)
reference librarians##5##2##(1996-1#4)(1997-3#1)
reference light##5##2##(2007-11#4)(2008-11#1)
reference lists of##4##3##(2012-12#3)(2013-8#1)
reference lists##6##2##(2008-10#1)(2011-2#1)(2012-12#3)(2013-8#1)
reference material (CRM) of##2##4##(2008-10#2)
reference material (CRM)##3##3##(2008-10#3)
reference material (GBW##3##3##(2008-10#3)
reference material NIST##3##3##(2008-10#3)
reference material and applied to##2##5##(2008-10#2)
reference material and##11##3##(2008-10#11)
reference material for the##2##4##(2008-10#2)
reference material for##3##3##(2008-10#2)(2013-8#1)
reference material from##2##3##(2008-10#2)
reference material##89##2##(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#84)(2011-2#1)(2013-8#1)
reference materials (CRM##2##3##(2008-10#2)
reference materials (CRMs)##7##3##(2008-10#7)
reference materials (whole##2##3##(2008-10#2)
reference materials SRM##2##3##(2008-10#2)
reference materials and comparing the##2##5##(2008-10#2)
reference materials and##18##3##(2008-10#18)
reference materials are##4##3##(2008-10#4)
reference materials by##3##3##(2008-10#3)
reference materials of biological origin##2##5##(2008-10#2)
reference materials of##12##3##(2008-10#12)
reference materials were in##2##4##(2008-10#2)
reference materials were##6##3##(2008-10#6)
reference materials##150##2##(2008-10#150)
reference materials)##2##2##(2008-10#2)
reference measurements##2##2##(2008-10#1)(2008-3#1)
reference memory group##2##3##(2008-12#2)
reference memory##9##2##(1993-12#2)(1994-8#1)(2008-11#1)(2008-12#4)(2008-7#1)
reference method and##2##3##(2008-10#2)
reference method at the 95% confidence level##2##7##(2008-10#2)
reference method based on##2##4##(1996-12#1)(2008-10#1)
reference method for##5##3##(2008-10#5)
reference method##47##2##(1996-12#1)(2008-10#42)(2008-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
reference methods at##2##3##(2008-10#2)
reference methods##17##2##(2008-10#15)(2011-1#2)
reference mirror##4##2##(2008-2#1)(2008-3#3)
reference object##5##2##(2008-2#2)(2008-3#3)
reference or##4##2##(2008-10#2)(2011-2#2)
reference orientations##2##2##(1990-11#2)
reference panel to##2##3##(2012-3#2)
reference panel##3##2##(2012-3#3)
reference phase-encoded JTC##2##3##(2008-3#2)
reference phase-encoded##3##2##(2008-3#3)
reference point##2##2##(2008-12#1)(2010-10#1)
reference points##7##2##(1992-2#1)(2007-5#1)(2008-2#2)(2008-3#2)(2008-4#1)
reference population##3##2##(1996-3#1)(2008-11#2)
reference procedure##9##2##(2008-10#9)
reference procedures##2##2##(2008-10#2)
reference pulse##5##2##(2008-2#1)(2008-3#4)
reference range and##2##3##(1993-2#1)(2013-1#1)
reference range for##2##3##(1993-2#1)(1994-11#1)
reference range##10##2##(1990-2#1)(1991-2#1)(1993-2#3)(1994-11#1)(2012-2#2)(2013-1#2)
reference ranges##4##2##(1994-11#2)(1994-12#1)(2011-1#1)
reference sample##5##2##(2008-10#4)(2013-8#1)
reference samples##6##2##(2008-10#4)(2008-12#1)(2008-3#1)
reference scales##2##2##(2011-2#2)
reference service##3##2##(1994-12#1)(1994-2#1)(1996-1#1)
reference services in##2##3##(1995-1#1)(1996-3#1)
reference services##5##2##(1994-12#1)(1995-1#1)(1996-3#2)(1997-1#1)
reference set##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
reference signal##6##2##(2008-2#5)(2008-3#1)
reference solid and water materials with##2##6##(2008-10#2)
reference solution##5##2##(2008-10#5)
reference solutions in##2##3##(2008-10#1)(2008-5#1)
reference solutions##6##2##(2008-10#5)(2008-5#1)
reference source##3##2##(2008-10#1)(2008-2#2)
reference spectra##2##2##(2008-10#1)(2008-3#1)
reference spectrophotometer is##2##3##(2008-3#2)
reference spectrophotometer##4##2##(2008-3#4)
reference spectrophotometric##2##2##(2008-10#2)
reference standard##11##2##(1991-5#1)(2008-10#6)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
reference standards##5##2##(2008-10#3)(2009-9#1)(2010-3#1)
reference strain##15##2##(2007-10#1)(2008-10#7)(2008-5#1)(2011-10#1)(2011-2#5)
reference strains for##2##3##(2008-10#2)
reference strains of##7##3##(1996-12#1)(1997-6#1)(2008-10#5)
reference strains were##5##3##(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
reference strains##26##2##(1996-12#1)(1997-6#1)(2008-10#16)(2008-5#4)(2011-1#2)(2011-2#2)
reference surface and##2##3##(2008-3#2)
reference surface##6##2##(2008-11#1)(2008-3#5)
reference technique##2##2##(2008-10#2)
reference that##2##2##(1995-3#1)(2008-10#1)
reference to a##2##3##(1992-6#1)(2009-9#1)
reference to the##26##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#1)(1993-10#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)
reference to their##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
reference to understand the##2##4##(1996-1#1)(2008-10#1)
reference to##92##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
reference transition at##2##3##(2007-12#2)
reference transition##3##2##(2007-12#2)(2008-3#1)
reference value##5##2##(1996-1#1)(2008-10#2)(2008-3#2)
reference values for the##2##4##(2011-2#1)(2013-1#1)
reference values for##8##3##(1994-5#1)(1996-12#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#2)
reference values were##2##3##(1996-12#1)(2008-10#1)
reference values##29##2##(1991-8#1)(1993-2#2)(1994-5#1)(1996-12#3)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#3)
reference wave##8##2##(2008-2#1)(2008-3#7)
reference wavelength##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
reference waves##2##2##(2008-3#2)
reference with##2##2##(2008-10#1)(2008-3#1)
reference##1090##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#7)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#5)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#4)(1995-8#1)(1996-1#8)(1996-12#7)(1996-2#2)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#17)(2007-12#26)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#505)(2008-11#21)(2008-12#21)(2008-2#52)(2008-3#134)(2008-4#5)(2008-5#13)(2008-7#20)(2008-8#3)(2008-9#7)(2009-10#4)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#13)(2011-10#1)(2011-2#32)(2011-3#1)(2012-1#5)(2012-12#7)(2012-2#13)(2012-3#16)(2012-5#1)(2013-1#15)(2013-7#3)(2013-8#7)
reference)##3##1##(2008-10#2)(2008-5#1)
reference-wave accuracy##2##2##(2008-3#2)
reference-wave##3##1##(2007-12#1)(2008-3#2)
referenced to the##2##3##(2008-10#1)(2008-2#1)
referenced to##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
referenced##14##1##(1997-2#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
references and##4##2##(2008-10#1)(2008-4#2)(2010-9#1)
references are##2##2##(2008-10#1)(2008-3#1)
references for the##2##3##(2008-10#1)(2011-2#1)
references for those##2##3##(2008-9#2)
references for##5##2##(2008-10#1)(2008-3#1)(2008-9#2)(2011-2#1)
references from##2##2##(1992-11#1)(2011-2#1)
references is##2##2##(1994-1#1)(2008-10#1)
references of##2##2##(2008-11#1)(2013-1#1)
references to the##4##3##(1992-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
references to##7##2##(1992-12#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)
references##53##1##(1991-12#1)(1992-11#1)(1992-12#2)(1993-6#1)(1994-1#1)(1996-12#1)(2007-11#2)(2007-2#1)(2007-5#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-7#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-2#3)(2013-1#1)(2013-8#1)
references)##2##1##(2008-10#1)(2009-12#1)
referencing##4##1##(2008-2#1)(2008-4#1)(2009-3#1)(2013-1#1)
referent group##5##2##(1996-6#4)(2008-11#1)
referent##8##1##(1993-2#1)(1995-2#1)(1996-6#4)(2008-11#1)(2013-1#1)
referential##2##1##(2008-10#1)(2010-12#1)
referents##3##1##(1995-2#1)(2008-7#1)(2010-6#1)
referral and##2##2##(1991-12#1)(1996-12#1)
referral center in##2##3##(2012-2#1)(2013-8#1)
referral center##8##2##(2007-8#1)(2011-2#4)(2012-2#1)(2013-8#2)
referral centers in##2##3##(2007-7#1)(2011-2#1)
referral centers##7##2##(2007-7#1)(2011-2#5)(2013-1#1)
referral centre##5##2##(2007-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
referral centres for##2##3##(2008-11#1)(2008-9#1)
referral centres##3##2##(1995-10#1)(2008-11#1)(2008-9#1)
referral decisions##4##2##(1994-1#4)
referral for evaluation of##2##4##(2007-12#1)(2008-12#1)
referral for##7##2##(1991-6#1)(1994-12#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)
referral hospital##4##2##(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
referral hospitals##4##2##(1990-11#1)(2008-1#2)(2010-8#1)
referral of patients##3##3##(2008-1#2)(2010-1#1)
referral of##7##2##(1990-12#1)(1992-12#1)(1996-12#1)(2008-1#2)(2010-1#1)(2011-1#1)
referral patterns##5##2##(1992-1#1)(1993-12#1)(1996-3#1)(2007-2#1)(2008-6#1)
referral policies##2##2##(1997-3#2)
referral practices of##2##3##(2011-1#2)
referral practices##3##2##(2011-1#3)
referral process##2##2##(1997-3#1)(2008-1#1)
referral rates##2##2##(2010-10#2)
referral services##3##2##(1994-1#1)(1994-2#1)(1996-1#1)
referral sources##3##2##(1992-1#1)(1996-1#1)(2007-2#1)
referral to the##2##3##(1993-12#1)(2008-8#1)
referral to##12##2##(1993-12#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-9#1)
referral was##2##2##(2008-11#1)(2010-2#1)
referral##139##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-12#2)(1994-1#7)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-3#3)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-7#3)(2007-8#3)(2008-1#15)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#12)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#4)
referral]##2##1##(1993-2#1)(1993-6#1)
referrals for##4##2##(1994-1#1)(1994-2#1)(2008-1#1)(2008-12#1)
referrals from##4##2##(1993-12#1)(1995-1#1)(2008-12#1)(2011-2#1)
referrals made##2##2##(2007-11#1)(2010-10#1)
referrals##36##1##(1990-12#1)(1991-11#3)(1991-8#3)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#4)(1995-1#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-12#4)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
referred as##2##2##(2008-10#1)(2008-12#1)
referred at##2##2##(2007-11#1)(2008-9#1)
referred back to##2##3##(1994-9#1)(2008-12#1)
referred by##6##2##(1990-12#2)(2008-12#2)(2011-2#1)(2013-1#1)
referred cardiac pain and##2##4##(2008-9#2)
referred for cardiac##2##3##(2007-8#1)(2011-2#1)
referred for evaluation##3##3##(1997-3#1)(2008-10#1)(2013-8#1)
referred for investigation##2##3##(1992-11#1)(1994-6#1)
referred for this##2##3##(2007-11#1)(2007-8#1)
referred for thymectomy##2##3##(2007-8#2)
referred for##40##2##(1990-2#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
referred from the##2##3##(2011-2#1)(2012-12#1)
referred from##6##2##(1996-9#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
referred pain areas of##2##4##(2010-9#2)
referred pain##12##2##(2008-12#2)(2008-9#3)(2010-9#7)
referred the##3##2##(1990-3#1)(1993-12#1)(1995-6#1)
referred to a specialist##3##4##(2008-11#1)(2013-8#2)
referred to a##9##3##(1994-11#1)(1997-3#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
referred to an##3##3##(1990-12#1)(1993-12#1)(2010-10#1)
referred to as &quot##8##4##(1992-1#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#2)
referred to as a##5##4##(2007-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-4#1)
referred to as an##2##4##(2008-3#1)(2010-10#1)
referred to as the &quot##5##5##(1991-2#1)(1996-1#1)(1996-12#1)(2008-11#1)(2011-2#1)
referred to as the##12##4##(1991-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
referred to as##93##3##(1991-2#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#4)(2010-4#1)(2011-2#6)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
referred to in the##2##4##(1994-2#1)(2008-10#1)
referred to in##3##3##(1992-11#1)(1994-2#1)(2008-10#1)
referred to our clinic##3##4##(2011-1#1)(2012-2#1)(2013-1#1)
referred to our##16##3##(1994-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
referred to the Department of##2##5##(1995-6#1)(1997-8#1)
referred to the##24##3##(1990-12#1)(1990-3#1)(1990-5#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-6#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-1#1)
referred to us##4##3##(1995-11#1)(2007-12#1)(2008-1#1)(2011-2#1)
referred to##183##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#4)(2008-12#7)(2008-2#2)(2008-3#9)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#5)(2010-11#2)(2010-12#2)(2010-3#5)(2010-4#1)(2011-1#3)(2011-2#12)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#5)
referred with##2##2##(2009-8#1)(2011-2#1)
referred without ADHD##2##3##(2010-8#2)
referred##293##1##(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#26)(2008-11#5)(2008-12#15)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#6)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#1)(2010-8#3)(2010-9#8)(2011-1#7)(2011-2#20)(2011-3#1)(2012-12#3)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#8)
referring clinicians##4##2##(2012-2#4)
referring physician##4##2##(1992-3#1)(1993-2#1)(1996-3#1)(2007-8#1)
referring physicians and##2##3##(1993-1#1)(1996-1#1)
referring physicians##9##2##(1991-1#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(2011-2#1)(2012-2#1)
referring the##2##2##(2008-10#1)(2009-8#1)
referring to the##4##3##(1991-11#1)(2007-10#1)(2008-1#1)(2011-1#1)
referring to##10##2##(1991-11#1)(1991-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-6#2)(2010-12#1)(2011-1#1)(2012-2#1)
referring##42##1##(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-3#3)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#2)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#6)(2013-8#1)
refers to a##5##3##(2008-10#2)(2008-12#1)(2008-2#2)
refers to power per unit##2##5##(2008-3#2)
refers to the use##2##4##(2008-4#1)(2010-8#1)
refers to the##17##3##(1992-6#1)(1996-12#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)
refers to##44##2##(1990-11#1)(1992-6#2)(1993-9#2)(1994-11#2)(1995-3#1)(1996-12#1)(1997-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#3)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
refers##45##1##(1990-11#1)(1992-6#2)(1993-9#2)(1994-11#2)(1995-3#1)(1996-12#1)(1997-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#3)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
refill##2##1##(2010-11#1)(2010-7#1)
refine the##15##2##(1996-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-8#1)
refine these##2##2##(2008-8#1)(2009-2#1)
refine##30##1##(1994-7#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
refined and##5##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
refined at 2##6##3##(1991-5#1)(1992-4#2)(1993-8#2)(1995-11#1)
refined at##7##2##(1991-5#1)(1992-4#2)(1993-8#2)(1995-11#1)(1997-4#1)
refined in##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
refined structures##2##2##(1994-5#2)
refined through the##2##3##(2008-10#2)
refined through##3##2##(2008-10#2)(2013-1#1)
refined to a crystallographic R-factor of 19##2##7##(1993-8#1)(1997-4#1)
refined to a##3##3##(1993-8#1)(1995-3#1)(1997-4#1)
refined to##8##2##(1992-8#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)
refined##75##1##(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#4)(1992-8#1)(1993-12#1)(1993-8#3)(1994-12#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1997-4#2)(1997-8#1)(2007-12#1)(2007-6#1)(2008-10#10)(2008-11#5)(2008-3#5)(2008-4#1)(2008-6#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-7#1)(2010-1#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
refinement and##9##2##(1992-2#1)(1993-3#1)(1993-8#1)(1996-2#1)(2008-10#2)(2008-7#1)(2009-2#1)(2009-4#1)
refinement is##2##2##(2008-10#1)(2008-3#1)
refinement of inhomogeneous films##2##4##(2008-3#2)
refinement of the model##3##4##(1997-7#2)(2007-11#1)
refinement of the##10##3##(1994-2#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-7#1)(2011-2#1)
refinement of##25##2##(1991-12#1)(1994-2#1)(1995-1#1)(1997-7#3)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-7#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#2)
refinement to the absolute optimum##2##5##(2008-10#2)
refinement to##4##2##(1992-9#1)(2008-10#3)
refinement while##2##2##(2010-8#1)(2012-2#1)
refinement##62##1##(1991-12#1)(1992-2#3)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-7#4)(2007-11#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#3)
refinements and##2##2##(2008-5#1)(2013-1#1)
refinements in the##2##3##(1992-2#2)
refinements in##3##2##(1992-2#2)(1996-1#1)
refinements to##2##2##(1994-5#1)(2012-2#1)
refinements##10##1##(1992-2#3)(1994-5#1)(1996-1#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
refineries##2##1##(2008-10#1)(2009-10#1)
refinery##5##1##(1991-12#2)(2008-10#2)(2011-2#1)
refining the##4##2##(1993-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
refining##18##1##(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-8#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
refirming##2##1##(2008-5#2)
reflect a decrease##2##3##(2007-2#1)(2008-10#1)
reflect a different##2##3##(1993-1#1)(1995-2#1)
reflect a lack of##3##4##(2006-10#1)(2008-8#1)(2012-1#1)
reflect a##27##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-1#1)(2013-8#1)
reflect adaptive##2##2##(1995-12#1)(2008-8#1)
reflect an##2##2##(1996-2#1)(2007-12#1)
reflect both##3##2##(2008-3#1)(2010-6#1)(2011-2#1)
reflect changes in the##2##4##(1996-4#1)(2008-7#1)
reflect changes in##4##3##(1996-4#1)(2008-11#1)(2008-7#1)(2013-1#1)
reflect changes##5##2##(1990-7#1)(1996-4#1)(2008-11#1)(2008-7#1)(2013-1#1)
reflect differences in##2##3##(1990-8#1)(1994-3#1)
reflect different##4##2##(2008-11#2)(2008-8#1)(2011-1#1)
reflect functional##4##2##(1993-2#1)(1994-9#1)(2008-10#1)(2008-6#1)
reflect in##3##2##(2008-4#1)(2009-12#1)(2013-8#1)
reflect more##2##2##(2007-11#1)(2010-8#1)
reflect on the##3##3##(1994-9#1)(2008-12#1)(2012-3#1)
reflect on their##2##3##(2008-11#2)
reflect on##11##2##(1994-9#2)(1995-1#1)(2008-11#2)(2008-12#2)(2011-2#1)(2012-3#2)(2013-1#1)
reflect only##2##2##(2008-10#1)(2011-2#1)
reflect physiological constraints##2##3##(2009-8#1)(2010-8#1)
reflect physiological##3##2##(2008-11#1)(2009-8#1)(2010-8#1)
reflect similar##3##2##(1995-11#1)(1995-2#1)(2009-12#1)
reflect some##3##2##(1990-6#1)(1993-2#1)(1995-12#1)
reflect that##5##2##(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-3#1)
reflect the ability of##2##4##(2008-10#1)(2012-2#1)
reflect the clinical##2##3##(2008-3#1)(2011-2#1)
reflect the combined effects of##2##5##(2008-10#1)(2008-2#1)
reflect the effects of##2##4##(1991-3#1)(2008-2#1)
reflect the same##2##3##(2007-12#1)(2008-7#1)
reflect the state of##2##4##(2008-11#1)(2009-12#1)
reflect the true##2##3##(2008-11#1)(2011-2#1)
reflect the##99##2##(1991-12#2)(1991-3#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#6)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
reflect their##5##2##(1994-3#1)(2008-10#1)(2009-10#1)(2011-1#1)(2013-1#1)
reflect two##2##2##(1991-11#1)(2007-9#1)
reflect variation in##2##3##(1992-12#1)(2010-8#1)
reflect##277##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#4)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#2)(1994-2#1)(1994-3#5)(1994-5#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#8)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2006-10#3)(2006-5#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#18)(2008-12#4)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#12)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#7)(2013-8#6)
reflectance NIR##2##2##(2008-10#2)
reflectance and the##3##3##(2008-3#2)(2013-8#1)
reflectance and transmittance measurements##3##4##(2008-2#3)
reflectance and transmittance of a slab with a randomly rough boundary##2##11##(2008-3#2)
reflectance and transmittance##6##3##(2008-2#3)(2008-3#3)
reflectance and##20##2##(2008-10#2)(2008-2#6)(2008-3#11)(2013-8#1)
reflectance as##2##2##(2008-10#1)(2008-3#1)
reflectance at a##2##3##(2008-2#1)(2008-3#1)
reflectance at the##2##3##(2008-3#2)
reflectance at three##2##3##(2008-2#1)(2008-3#1)
reflectance at##19##2##(1991-2#1)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#9)
reflectance can be##2##3##(2008-3#2)
reflectance components##2##2##(2008-3#2)
reflectance data close to##2##4##(2008-3#2)
reflectance data from##2##3##(2008-3#2)
reflectance data##14##2##(2008-2#5)(2008-3#9)
reflectance distribution##13##2##(2008-2#3)(2008-3#10)
reflectance factor##2##2##(2008-2#1)(2008-3#1)
reflectance for##4##2##(2008-2#1)(2008-3#3)
reflectance from##5##2##(2008-2#1)(2008-3#3)(2008-5#1)
reflectance imaging of##2##3##(2008-3#1)(2009-8#1)
reflectance imaging##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
reflectance in the##9##3##(2008-10#1)(2008-2#4)(2008-3#4)
reflectance in##10##2##(2008-10#1)(2008-2#5)(2008-3#4)
reflectance infrared##10##2##(2008-1#2)(2008-10#8)
reflectance into##2##2##(2008-10#1)(2008-3#1)
reflectance is##11##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#6)
reflectance measurements##11##2##(2008-10#5)(2008-2#1)(2008-3#5)
reflectance method##3##2##(2008-10#2)(2008-3#1)
reflectance methods##2##2##(2008-10#1)(2008-3#1)
reflectance models##2##2##(2008-2#1)(2008-3#1)
reflectance near##4##2##(2008-3#3)(2011-1#1)
reflectance of a##4##3##(2008-2#1)(2008-3#3)
reflectance of sunlight from##2##4##(2008-10#2)
reflectance of the multilayer coating##4##5##(2008-2#3)(2008-3#1)
reflectance of the##13##3##(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#5)(2013-8#1)
reflectance of##32##2##(2007-11#6)(2008-10#3)(2008-2#10)(2008-3#12)(2013-8#1)
reflectance on##3##2##(2008-3#3)
reflectance or##2##2##(2008-2#1)(2008-3#1)
reflectance profiles##2##2##(2008-2#1)(2008-3#1)
reflectance properties##2##2##(2008-2#1)(2008-3#1)
reflectance ratio##3##2##(2008-2#1)(2008-3#2)
reflectance sensor##2##2##(2008-10#2)
reflectance spectra and##4##3##(2008-10#4)
reflectance spectra##9##2##(2008-10#5)(2008-3#4)
reflectance spectrometry and##2##3##(2008-10#1)(2008-8#1)
reflectance spectrometry##4##2##(2008-10#3)(2008-8#1)
reflectance spectrophotometry##2##2##(2008-10#1)(2008-5#1)
reflectance spectroscopic##4##2##(2008-10#4)
reflectance spectroscopy (DRS)##2##3##(2008-10#2)
reflectance spectroscopy (NIRS)##3##3##(2008-10#3)
reflectance spectroscopy of##2##3##(2008-3#1)(2008-5#1)
reflectance spectroscopy##21##2##(1992-8#1)(2007-12#1)(2008-10#11)(2008-3#5)(2008-5#1)(2010-4#1)(2013-8#1)
reflectance spectrum is##2##3##(2008-2#1)(2008-3#1)
reflectance spectrum##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
reflectance values##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
reflectance was##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
reflectance were##3##2##(2008-10#3)
reflectance with##2##2##(2007-12#1)(2008-2#1)
reflectance##362##1##(1991-2#1)(1992-8#1)(2007-11#8)(2007-12#13)(2008-1#2)(2008-10#88)(2008-12#2)(2008-2#72)(2008-3#160)(2008-5#5)(2008-8#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-8#4)
reflectances of the##4##3##(2008-12#1)(2008-2#2)(2008-3#1)
reflectances of##7##2##(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#3)
reflectances were##2##2##(2007-11#1)(2008-3#1)
reflectances##19##1##(2007-11#2)(2008-12#1)(2008-2#4)(2008-3#12)
reflected a##4##2##(1991-8#2)(2008-10#1)(2012-12#1)
reflected and transmitted light##2##4##(2008-3#2)
reflected and##4##2##(2007-11#1)(2008-3#2)(2008-5#1)
reflected as##2##2##(1991-9#1)(2008-4#1)
reflected at##3##2##(1990-5#1)(2008-3#2)
reflected atmospheric radiance##2##3##(2008-3#2)
reflected beam is##3##3##(2008-2#2)(2008-3#1)
reflected beam##9##2##(2007-12#1)(2008-2#5)(2008-3#3)
reflected beams##5##2##(2008-1#1)(2008-3#4)
reflected both in##2##3##(1992-9#1)(2012-3#1)
reflected both##4##2##(1992-9#1)(1995-5#1)(2008-10#1)(2012-3#1)
reflected by a mirror##3##4##(2008-10#2)(2008-2#1)
reflected by a##7##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
reflected by the ratio of##2##5##(1994-12#1)(2010-8#1)
reflected by the##12##3##(1990-8#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-3#1)(2007-12#1)(2008-3#3)(2009-10#1)(2010-8#1)
reflected by##35##2##(1990-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
reflected from a##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
reflected from the##3##3##(2008-3#3)
reflected from##11##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)(2010-5#1)
reflected in a##6##3##(1993-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-2#1)
reflected in an##3##3##(1996-12#1)(2008-10#2)
reflected in its##2##3##(2010-9#1)(2011-2#1)
reflected in the observed##2##4##(1994-2#1)(2009-7#1)
reflected in the##26##3##(1990-5#1)(1991-12#1)(1992-3#2)(1992-6#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
reflected in##57##2##(1990-5#1)(1991-12#1)(1992-3#2)(1992-6#2)(1993-6#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-8#1)
reflected intensity##2##2##(2007-11#1)(2008-10#1)
reflected light##11##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)
reflected off##3##2##(2008-2#1)(2008-3#2)
reflected on the##3##3##(2008-3#2)(2011-2#1)
reflected photon##2##2##(2008-3#2)
reflected radiance##2##2##(2008-3#2)
reflected rays##3##2##(2008-2#3)
reflected solar##3##2##(2008-3#3)
reflected the##20##2##(1990-8#1)(1992-3#1)(1995-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#2)(2009-9#1)(2010-8#1)(2012-12#1)(2012-3#1)
reflected their##2##2##(1995-11#1)(2008-11#1)
reflected through##2##2##(2008-1#1)(2008-12#1)
reflected waves##2##2##(2007-11#1)(2008-3#1)
reflected##251##1##(1990-11#1)(1990-5#2)(1990-8#2)(1991-12#2)(1991-2#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#9)(2007-12#11)(2008-1#3)(2008-10#26)(2008-11#14)(2008-12#3)(2008-2#19)(2008-3#57)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#9)(2012-12#4)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
reflected-light##2##1##(2008-2#1)(2008-3#1)
reflecting a##6##2##(1996-5#2)(2008-7#1)(2009-5#1)(2010-11#1)(2013-8#1)
reflecting an##6##2##(1994-3#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-7#1)
reflecting on the##4##3##(2008-10#2)(2008-12#2)
reflecting on##6##2##(2008-10#2)(2008-11#1)(2008-12#2)(2012-3#1)
reflecting surfaces##6##2##(2008-2#1)(2008-3#5)
reflecting the presence of##2##4##(2008-10#1)(2013-8#1)
reflecting the reproducibility and reliability of the developed method##3##9##(2008-10#3)
reflecting the##37##2##(1991-5#1)(1994-2#2)(1995-12#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-11#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-6#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
reflecting their##3##2##(2008-11#1)(2011-1#1)(2013-7#1)
reflecting these##2##2##(2008-10#1)(2011-2#1)
reflecting##145##1##(1991-5#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-11#9)(2007-12#4)(2008-10#18)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#20)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#4)
reflection FTIR##2##2##(2008-10#2)
reflection X-ray fluorescence##2##3##(2008-10#2)
reflection about the##2##3##(2008-7#1)(2013-1#1)
reflection about##3##2##(1992-11#1)(2008-7#1)(2013-1#1)
reflection and polarization properties##2##4##(2007-12#1)(2008-3#1)
reflection and the##2##3##(2007-11#1)(2008-3#1)
reflection and transmission coefficients##2##4##(2007-12#1)(2008-3#1)
reflection and transmission##8##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
reflection and##33##2##(1990-8#1)(2007-11#2)(2007-12#4)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#11)(2011-2#1)(2013-1#1)
reflection appeared at 0##2##4##(2008-8#2)
reflection as a##4##3##(2008-11#1)(2008-12#3)
reflection as an##2##3##(2008-11#1)(2008-12#1)
reflection as##6##2##(2008-11#2)(2008-12#4)
reflection at a nonlinear-linear##3##4##(2007-12#3)
reflection at the interface between the##2##6##(2008-2#1)(2008-3#1)
reflection at the##4##3##(2008-2#2)(2008-3#2)
reflection at##11##2##(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#4)(2012-3#1)
reflection based##2##2##(2007-12#1)(2008-11#1)
reflection by##2##2##(2007-12#1)(2008-2#1)
reflection characteristics##3##2##(2008-3#3)
reflection coefficient of a stratified sea##2##6##(2008-2#2)
reflection coefficient of##3##3##(2008-2#3)
reflection coefficient##8##2##(2008-2#6)(2008-3#2)
reflection coefficients and##2##3##(2007-11#1)(2008-3#1)
reflection coefficients##4##2##(2007-11#1)(2008-3#3)
reflection configuration##2##2##(2007-12#1)(2008-10#1)
reflection confocal optical##2##3##(2008-3#2)
reflection confocal##5##2##(2007-12#2)(2008-3#3)
reflection data##2##2##(1997-5#1)(2008-8#1)
reflection for##6##2##(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)
reflection from a##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
reflection from the##4##3##(2008-2#1)(2008-3#3)
reflection from##13##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#7)
reflection geometry##3##2##(2008-2#1)(2008-3#2)
reflection grating##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
reflection gratings##5##2##(2008-2#1)(2008-3#4)
reflection hologram is##2##3##(2008-1#1)(2008-3#1)
reflection hologram recorded##2##3##(2008-3#2)
reflection hologram##4##2##(2008-1#1)(2008-3#3)
reflection in the##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
reflection in##16##2##(2007-11#2)(2007-12#1)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2009-5#1)
reflection interference##2##2##(2007-12#1)(2008-2#1)
reflection is##7##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2013-1#1)
reflection losses##3##2##(2008-2#1)(2008-3#2)
reflection may be instrumental in##2##5##(2008-11#2)
reflection mode##4##2##(2007-12#1)(2008-2#3)
reflection model##4##2##(2008-2#1)(2008-3#3)
reflection of a##6##3##(1996-9#1)(2007-11#1)(2007-12#1)(2008-3#3)
reflection of light##2##3##(2007-11#1)(2008-2#1)
reflection of the##10##3##(1991-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2012-12#1)
reflection of##33##2##(1991-5#1)(1993-12#1)(1996-5#1)(1996-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#10)(2008-7#1)(2012-12#1)(2012-3#1)
reflection on a##2##3##(2008-11#1)(2008-3#1)
reflection on practice##2##3##(2008-11#2)
reflection on the##7##3##(1993-9#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
reflection on##18##2##(1993-9#1)(1996-12#1)(2008-11#5)(2008-2#1)(2008-3#3)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#4)
reflection or##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
reflection properties##3##2##(2008-2#1)(2008-3#2)
reflection spectra##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
reflection spectral##2##2##(2007-12#1)(2008-3#1)
reflection spectroscopy##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
reflection spectrum##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
reflection the##2##2##(2008-3#2)
reflection to##2##2##(2008-11#1)(2008-3#1)
reflection upon##2##2##(2008-11#2)
reflection was##5##2##(2007-12#1)(2008-11#1)(2008-2#2)(2012-12#1)
reflection wavelength##3##2##(2007-12#2)(2008-3#1)
reflection with##2##2##(2008-3#2)
reflection##395##1##(1990-2#1)(1990-8#1)(1991-5#3)(1992-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-5#1)(2007-10#1)(2007-11#29)(2007-12#41)(2008-1#5)(2008-10#23)(2008-11#44)(2008-12#14)(2008-2#65)(2008-3#127)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
reflection-absorption##2##1##(2008-10#1)(2013-8#1)
reflection-on-action##2##1##(2007-10#1)(2008-11#1)
reflection-type all-optical switch for ultrashort pulses based on a single asymmetrically confined photonic crystal##2##14##(2007-11#2)
reflection-type confocal microscope with a phase-conjugate mirror##2##7##(2008-2#2)
reflection-type##9##1##(2007-11#3)(2007-12#1)(2008-2#5)
reflections (I &gt##2##3##(1997-7#2)
reflections and##6##2##(1996-9#1)(2007-12#1)(2008-3#3)(2013-1#1)
reflections at the##2##3##(2008-3#2)
reflections from##4##2##(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)
reflections in the##3##3##(1992-12#1)(2008-2#2)
reflections in##4##2##(1992-12#1)(2008-2#3)
reflections of a##2##3##(1994-2#1)(1996-8#1)
reflections of##9##2##(1994-2#1)(1996-5#1)(1996-8#1)(2008-11#2)(2008-3#3)(2012-2#1)
reflections on the##10##3##(1993-6#1)(1994-2#1)(1995-2#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
reflections on##17##2##(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-1#2)(2008-11#4)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
reflections that##2##2##(2007-11#1)(2008-3#1)
reflections upon##2##2##(2007-12#1)(2008-11#1)
reflections with I &gt##4##4##(1996-2#2)(1997-7#2)
reflections with##5##2##(1996-2#2)(1997-4#1)(1997-7#2)
reflections##85##1##(1992-12#1)(1992-4#1)(1993-6#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#5)(2007-10#1)(2007-11#2)(2007-12#6)(2008-1#5)(2008-10#1)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#18)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
reflective and transmissive##2##3##(2008-3#2)
reflective and##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2013-1#1)
reflective at the##2##3##(2008-2#2)
reflective bistable twisted nematic##2##4##(2007-12#2)
reflective coatings##2##2##(2008-2#1)(2008-3#1)
reflective grating interferometer##2##3##(2007-11#1)(2008-3#1)
reflective grating##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
reflective journal##3##2##(2007-10#1)(2012-12#2)
reflective learning##2##2##(2008-11#1)(2008-12#1)
reflective liquid-crystal##3##2##(2007-11#2)(2008-3#1)
reflective of the##4##3##(1992-3#1)(2009-4#1)(2010-11#2)
reflective of##9##2##(1992-3#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-4#1)(2010-11#2)(2011-2#1)
reflective optics##2##2##(2008-3#2)
reflective phases##3##2##(2008-11#3)
reflective practice in##3##3##(1997-4#1)(2008-11#2)
reflective practice##14##2##(1997-4#3)(2008-11#8)(2008-12#1)(2012-12#1)(2013-1#1)
reflective practitioners##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
reflective sessions##2##2##(2008-12#2)
reflective speckle##4##2##(2008-3#4)
reflective surface##2##2##(2008-2#1)(2008-3#1)
reflective surfaces##2##2##(2008-2#1)(2008-3#1)
reflective thinking and practice during##2##5##(2012-12#2)
reflective thinking and practice##4##4##(2012-12#4)
reflective##124##1##(1990-5#1)(1992-3#1)(1997-4#3)(2007-10#1)(2007-11#5)(2007-12#7)(2008-10#5)(2008-11#24)(2008-12#9)(2008-2#12)(2008-3#37)(2008-4#2)(2008-9#1)(2009-4#1)(2010-11#2)(2010-3#1)(2011-2#2)(2012-12#8)(2013-1#2)
reflectivities for##2##2##(2008-3#2)
reflectivities of##2##2##(2008-2#1)(2008-3#1)
reflectivities##7##1##(2008-2#2)(2008-3#5)
reflectivity and the##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
reflectivity and##10##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#5)
reflectivity as a function of##2##5##(2007-12#2)
reflectivity at the##2##3##(2008-2#1)(2008-3#1)
reflectivity at##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
reflectivity by##2##2##(2008-3#1)(2011-1#1)
reflectivity can##2##2##(2007-11#1)(2008-3#1)
reflectivity change##2##2##(2007-11#2)
reflectivity changes of##2##3##(2008-3#2)
reflectivity changes##3##2##(2007-11#1)(2008-3#2)
reflectivity distribution##2##2##(2008-3#2)
reflectivity in##3##2##(2007-12#1)(2008-2#2)
reflectivity is##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
reflectivity measurements##4##2##(2008-2#1)(2008-3#3)
reflectivity mirror##2##2##(2008-2#1)(2008-3#1)
reflectivity mirrors##2##2##(2008-3#2)
reflectivity of a##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
reflectivity of approximately##2##3##(2008-2#1)(2008-3#1)
reflectivity of the##7##3##(2007-11#1)(2008-2#1)(2008-3#5)
reflectivity of##32##2##(2007-11#5)(2007-12#4)(2008-2#6)(2008-3#17)
reflectivity profile in the##2##4##(2008-2#2)
reflectivity was measured##3##3##(2007-11#1)(2008-2#2)
reflectivity was##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
reflectivity with##4##2##(2007-11#1)(2008-3#3)
reflectivity##131##1##(2007-11#22)(2007-12#18)(2008-2#27)(2008-3#63)(2011-1#1)
reflectometer for##3##2##(2007-12#2)(2008-3#1)
reflectometer##12##1##(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#3)
reflectometers for surface anisotropy##2##4##(2008-3#2)
reflectometers##3##1##(1993-9#1)(2008-3#2)
reflectometric and ellipsometric##4##3##(2008-3#4)
reflectometric interference spectroscopy##2##3##(2008-10#2)
reflectometric##8##1##(2008-10#3)(2008-3#5)
reflectometry##19##1##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#8)(2008-7#2)(2011-1#1)
reflector as##3##2##(2007-11#1)(2008-3#2)
reflector for##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
reflector is##2##2##(2008-3#2)
reflector losses##2##2##(2008-3#2)
reflector##43##1##(2007-11#8)(2007-12#2)(2008-2#6)(2008-3#27)
reflectors and##2##2##(2007-11#1)(2008-7#1)
reflectors in##2##2##(2008-3#2)
reflectors of##2##2##(2007-11#1)(2008-3#1)
reflectors##15##1##(2007-11#6)(2008-2#1)(2008-3#7)(2008-7#1)
reflects a##12##2##(1991-9#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#1)(2012-2#1)(2013-7#1)
reflects alterations##2##2##(2008-5#1)(2009-6#1)
reflects an##5##2##(1990-2#1)(1994-5#1)(1997-2#1)(2007-7#1)(2008-1#1)
reflects its##3##2##(2007-4#1)(2009-5#1)(2011-2#1)
reflects less than##2##3##(2007-2#1)(2008-2#1)
reflects on##5##2##(1994-12#1)(2008-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
reflects that##2##2##(1992-8#1)(2008-10#1)
reflects the current##2##3##(2007-4#1)(2008-1#1)
reflects the degree of##2##4##(2008-10#1)(2013-1#1)
reflects the need##2##3##(1994-9#1)(2007-8#1)
reflects the##47##2##(1990-12#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1997-6#2)(2006-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2010-12#1)(2010-6#1)(2011-2#4)(2013-1#1)(2013-8#2)
reflects##122##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#6)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#3)
reflex and##8##2##(1993-12#1)(1995-11#1)(2007-12#1)(2008-4#5)
reflex in##6##2##(1990-5#2)(1993-12#1)(1994-2#2)(1995-3#1)
reflex irradiation was##2##3##(1995-8#2)
reflex is##2##2##(1990-11#1)(1994-2#1)
reflex of the##2##3##(1996-2#1)(2007-10#1)
reflex pathway##2##2##(1993-12#1)(1997-2#1)
reflex pathways##2##2##(1990-5#1)(2008-7#1)
reflex responses in##2##3##(1995-8#1)(2013-1#1)
reflex responses##6##2##(1993-12#2)(1995-12#2)(1995-8#1)(2013-1#1)
reflex sympathetic dystrophy syndrome##2##4##(2006-10#1)(2008-4#1)
reflex sympathetic dystrophy##4##3##(2006-10#2)(2008-10#1)(2008-4#1)
reflex tests##5##2##(1990-9#1)(1994-3#4)
reflex was##5##2##(1993-12#1)(1996-2#1)(2009-12#3)
reflex##88##1##(1990-11#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-11#1)(1992-3#2)(1993-12#7)(1993-9#2)(1994-2#8)(1994-3#4)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#2)(1995-6#1)(1995-8#4)(1996-2#4)(1996-5#1)(1997-2#1)(2006-10#2)(2007-10#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#12)(2008-7#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#4)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
reflex-mediated##2##1##(1995-3#1)(2009-12#1)
reflexes and##5##2##(1993-12#2)(2007-12#2)(2009-5#1)
reflexes are##2##2##(1996-2#1)(2008-12#1)
reflexes in the##2##3##(1992-12#1)(2008-7#1)
reflexes in##4##2##(1992-12#1)(1996-2#1)(2007-12#1)(2008-7#1)
reflexes were##3##2##(1995-8#1)(1996-2#1)(2008-7#1)
reflexes##39##1##(1992-12#6)(1993-12#6)(1994-2#1)(1995-8#2)(1996-2#5)(1996-7#3)(2007-11#1)(2007-12#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-1#1)(2011-1#1)(2013-1#1)
reflexia##2##1##(2008-4#2)
reflexive shift of##2##3##(2008-11#2)
reflexive##7##1##(2008-11#4)(2008-12#1)(2010-6#1)(2013-8#1)
reflexology##5##1##(1997-6#4)(2008-4#1)
reflexus##2##1##(2008-12#2)
reflow##5##1##(1991-9#1)(1993-3#2)(2007-10#1)(2010-3#1)
reflux (VUR)##3##2##(2008-10#2)(2009-5#1)
reflux and##6##2##(1996-3#3)(2008-10#3)
reflux disease (GERD)##4##3##(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
reflux disease and##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
reflux disease in an impoverished##2##5##(2011-2#2)
reflux disease in##4##3##(2009-1#1)(2011-2#2)(2013-8#1)
reflux disease##21##2##(1990-2#1)(1994-2#2)(2008-3#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-12#2)(2011-2#4)(2013-1#3)(2013-8#4)
reflux esophagitis##5##2##(1996-2#2)(2008-12#2)(2013-8#1)
reflux had##2##2##(2008-4#2)
reflux in childhood##2##3##(1992-11#1)(2007-7#1)
reflux in the##2##3##(1991-6#1)(1992-3#1)
reflux in##8##2##(1991-6#1)(1992-11#1)(1992-3#1)(1997-5#1)(2007-7#1)(2008-10#1)(2010-11#1)(2012-3#1)
reflux is##2##2##(1990-12#1)(2008-10#1)
reflux may##2##2##(1996-3#1)(2013-1#1)
reflux using##4##2##(2008-10#2)(2008-4#2)
reflux was found##2##3##(1990-8#1)(2008-4#1)
reflux was##4##2##(1990-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
reflux with##2##2##(2008-10#1)(2008-6#1)
reflux##110##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-6#2)(1992-11#3)(1992-3#2)(1992-9#1)(1994-2#3)(1995-10#1)(1996-2#2)(1996-3#6)(1997-1#1)(1997-5#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#28)(2008-12#2)(2008-3#1)(2008-4#10)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#9)
refluxing##5##1##(1996-2#1)(2008-10#4)
refocus##2##1##(1993-12#1)(2008-11#1)
refocused##2##1##(1997-2#1)(2008-3#1)
refocusing##3##1##(2008-10#1)(2008-2#1)(2011-1#1)
refold##2##1##(1995-3#1)(2008-4#1)
refolded and##2##2##(1995-11#1)(1997-4#1)
refolded by##2##2##(1994-12#1)(2008-1#1)
refolded##11##1##(1994-12#1)(1995-11#2)(1995-2#2)(1997-4#2)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#1)
refolding and##2##2##(1995-3#1)(1995-5#1)
refolding from##2##2##(1992-6#1)(1995-5#1)
refolding of 0##2##3##(2011-2#2)
refolding of the##4##3##(1997-4#1)(2008-4#1)(2008-8#2)
refolding of##10##2##(1995-8#2)(1997-4#1)(2008-4#1)(2008-8#2)(2009-3#1)(2011-2#3)
refolding phases##2##2##(1990-7#2)
refolding##34##1##(1990-11#1)(1990-7#2)(1992-5#1)(1992-6#1)(1995-3#2)(1995-5#3)(1995-8#3)(1997-4#1)(2008-10#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#10)
reform and the##7##3##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-2#1)
reform and##21##2##(1991-12#1)(1993-12#3)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-2#1)(2008-4#1)(2010-8#1)
reform are##5##2##(1994-12#1)(1994-2#1)(1996-1#3)
reform debate##5##2##(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1997-1#1)
reform efforts##6##2##(1994-1#1)(1996-1#3)(1996-2#1)(2012-3#1)
reform for##4##2##(1993-12#3)(1994-3#1)
reform has##7##2##(1993-12#1)(1994-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2011-1#1)
reform have##3##2##(1994-8#1)(1996-3#1)(1997-3#1)
reform in the##8##3##(1993-12#1)(1994-1#1)(1995-1#2)(1995-12#1)(1996-6#1)(1997-3#1)(2010-8#1)
reform in##20##2##(1991-1#1)(1993-12#1)(1994-1#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-3#1)
reform initiative##2##2##(1995-1#1)(1995-12#1)
reform initiatives##8##2##(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#2)(2013-1#1)
reform is a##3##3##(1996-1#1)(1996-12#1)(1997-2#1)
reform is##14##2##(1993-1#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-12#1)(1997-2#1)(1997-3#1)(2013-1#1)
reform legislation##6##2##(1994-8#1)(1995-12#1)(1995-3#1)(1997-3#2)(2012-3#1)
reform of health care##2##4##(1994-12#1)(1997-2#1)
reform of health##3##3##(1994-12#1)(1997-2#1)(2012-12#1)
reform of the##5##3##(1992-1#1)(1992-12#1)(1993-12#1)(1997-2#1)(2011-2#1)
reform of##13##2##(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1997-2#2)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
reform on##3##2##(1994-1#1)(1995-12#2)
reform plan##2##2##(1993-12#1)(1994-2#1)
reform project##2##2##(1994-2#1)(2008-2#1)
reform proposal##2##2##(1993-3#1)(1994-2#1)
reform proposals##6##2##(1993-12#3)(1995-1#2)(1996-3#1)
reform that##2##2##(1996-3#1)(1997-5#1)
reform the##6##2##(1992-5#1)(1994-12#1)(1996-3#1)(1997-1#1)(2007-5#1)(2008-4#1)
reform through##2##2##(1995-1#2)
reform was##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
reform will##5##2##(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)
reform##363##1##(1991-1#3)(1991-12#6)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-1#2)(1993-12#28)(1993-2#3)(1993-3#8)(1993-5#4)(1993-8#1)(1994-1#15)(1994-12#36)(1994-2#13)(1994-3#9)(1994-8#5)(1995-1#21)(1995-12#25)(1995-2#17)(1995-3#10)(1995-6#1)(1996-1#30)(1996-12#9)(1996-2#6)(1996-3#13)(1996-6#1)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#15)(1997-5#1)(1997-8#3)(2007-4#1)(2007-5#2)(2008-10#1)(2008-11#3)(2008-2#6)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-3#5)(2013-1#4)(2013-7#1)
reform?##8##1##(1993-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)
reform]##2##1##(1990-2#1)(1997-8#1)
reformation and##2##2##(2009-8#1)(2011-1#1)
reformation##11##1##(1991-1#1)(1992-1#5)(1994-12#1)(1994-2#1)(2008-3#1)(2009-8#1)(2011-1#1)
reformations##2##1##(2008-7#1)(2011-2#1)
reformed its##2##2##(1994-12#1)(1995-3#1)
reformed##6##1##(1992-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)
reforming the##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
reforming##6##1##(1993-3#1)(1994-1#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)
reforms and health##2##3##(1997-1#1)(2013-8#1)
reforms and##4##2##(1997-1#1)(2008-11#1)(2009-6#1)(2013-8#1)
reforms in the##2##3##(1993-2#1)(1997-1#1)
reforms in##5##2##(1993-2#1)(1994-12#1)(1996-1#1)(1997-1#2)
reforms that##3##2##(1992-3#1)(2012-1#1)(2013-1#1)
reforms##48##1##(1991-8#1)(1992-1#1)(1992-3#1)(1993-2#4)(1993-3#1)(1994-12#2)(1994-2#2)(1994-7#1)(1995-12#3)(1995-3#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#6)(1997-5#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#2)
reformulated##8##1##(1996-1#1)(1996-2#1)(2008-2#1)(2008-3#4)(2010-1#1)
reformulation##8##1##(1993-1#1)(1993-6#1)(1996-1#1)(1996-2#1)(2008-3#2)(2010-4#2)
reformulations of##2##2##(1996-2#1)(2008-3#1)
refracted and##2##2##(2008-2#1)(2008-3#1)
refracted##8##1##(2007-11#1)(2008-2#2)(2008-3#5)
refractile##3##1##(1994-8#1)(1995-11#1)(2012-2#1)
refracting##4##1##(2008-2#2)(2008-3#2)
refraction and dispersion##2##3##(2007-11#2)
refraction and internal reflection in##2##5##(2008-2#2)
refraction and##19##2##(2007-11#5)(2007-12#1)(2008-2#9)(2008-3#4)
refraction at##2##2##(2008-2#1)(2008-7#1)
refraction halos##4##2##(2008-2#4)
refraction in##8##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
refraction of the##5##3##(2008-2#1)(2008-3#4)
refraction of##15##2##(2008-2#7)(2008-3#7)(2008-4#1)
refraction through##3##2##(2007-11#1)(2008-3#2)
refraction with##2##2##(2008-3#1)(2010-1#1)
refraction##118##1##(1991-9#1)(2007-11#18)(2007-12#7)(2008-10#1)(2008-2#41)(2008-3#45)(2008-4#1)(2008-7#1)(2009-6#1)(2010-1#1)(2011-1#1)
refractive and##3##2##(2008-3#3)
refractive elements##2##2##(2007-12#1)(2008-2#1)
refractive error##2##2##(2010-8#1)(2012-12#1)
refractive errors##3##2##(2009-9#1)(2010-8#2)
refractive index (RI)##4##3##(1991-7#1)(2007-11#1)(2008-10#2)
refractive index accurately##2##3##(2008-2#1)(2008-3#1)
refractive index and extinction coefficient of##2##6##(2008-3#2)
refractive index and the size distribution##2##6##(2008-2#2)
refractive index and the size##3##5##(2008-2#3)
refractive index and the##10##4##(2008-2#3)(2008-3#6)(2011-1#1)
refractive index and thickness##3##4##(2007-11#3)
refractive index and##24##3##(2007-11#5)(2008-2#6)(2008-3#12)(2011-1#1)
refractive index are##2##3##(2008-2#1)(2008-3#1)
refractive index as well as##2##5##(2007-12#1)(2008-2#1)
refractive index as##3##3##(2007-12#2)(2008-2#1)
refractive index at##3##3##(2007-12#2)(2008-3#1)
refractive index by##3##3##(2007-11#1)(2008-3#2)
refractive index can be##2##4##(2007-12#1)(2008-3#1)
refractive index changes##3##3##(2007-12#2)(2008-10#1)
refractive index for##2##3##(2008-10#1)(2008-3#1)
refractive index gradient##2##3##(2008-10#2)
refractive index in##3##3##(2008-10#1)(2008-3#2)
refractive index is presented##2##4##(2008-3#2)
refractive index is##20##3##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#12)
refractive index may##2##3##(2007-11#1)(2008-3#1)
refractive index n##8##3##(2008-10#1)(2008-2#1)(2008-3#6)
refractive index n(2) of##2##4##(2007-11#2)
refractive index of a film##2##5##(2008-3#2)
refractive index of a##7##4##(2008-2#1)(2008-3#6)
refractive index of air##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
refractive index of an##2##4##(2007-11#1)(2008-2#1)
refractive index of particles##2##4##(2008-2#2)
refractive index of the##26##4##(2007-11#7)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#10)(2009-6#1)(2010-2#1)
refractive index of##68##3##(2007-11#9)(2007-12#5)(2008-10#4)(2008-2#13)(2008-3#35)(2009-6#1)(2010-2#1)
refractive index on##2##3##(2008-3#2)
refractive index sensitivities##2##3##(2008-7#1)(2010-2#1)
refractive index to##3##3##(2007-12#1)(2008-3#2)
refractive index was altered##2##4##(2007-11#2)
refractive index was##7##3##(2007-11#2)(2008-2#1)(2008-3#3)(2013-8#1)
refractive index with an##2##4##(2008-3#2)
refractive index with temperature##2##4##(2008-2#2)
refractive index with##6##3##(2007-11#1)(2008-2#2)(2008-3#3)
refractive index##273##2##(1991-7#1)(2007-11#37)(2007-12#18)(2008-10#21)(2008-2#58)(2008-3#122)(2008-4#1)(2008-7#2)(2009-6#3)(2010-2#2)(2010-8#1)(2011-1#6)(2013-8#1)
refractive index)##3##2##(2008-10#1)(2008-3#2)
refractive indices and thicknesses of##2##5##(2008-3#2)
refractive indices and thicknesses##4##4##(2008-3#4)
refractive indices and##12##3##(2008-2#8)(2008-3#4)
refractive indices are measured##2##4##(2007-11#1)(2008-3#1)
refractive indices are##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
refractive indices is presented##2##4##(2008-2#1)(2008-3#1)
refractive indices is##3##3##(2008-2#1)(2008-3#2)
refractive indices of silicon and##2##5##(2008-2#1)(2008-3#1)
refractive indices of##18##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#12)
refractive indices on##2##3##(2008-3#2)
refractive indices that##2##3##(2008-2#2)
refractive indices were##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
refractive indices##74##2##(2007-11#6)(2007-12#3)(2008-2#28)(2008-3#36)(2009-5#1)
refractive lens##4##2##(2007-11#2)(2008-3#1)(2011-2#1)
refractive lenses##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
refractive sounding##2##2##(2008-2#2)
refractive surgery##2##2##(1991-9#1)(2013-1#1)
refractive turbulence on coherent lidar##2##5##(2008-3#2)
refractive turbulence on##4##3##(2008-3#4)
refractive turbulence##6##2##(2008-3#6)
refractive##400##1##(1991-7#1)(1991-9#1)(2007-11#49)(2007-12#22)(2008-10#23)(2008-2#98)(2008-3#180)(2008-4#1)(2008-7#2)(2009-5#1)(2009-6#3)(2009-9#1)(2010-2#2)(2010-8#4)(2011-1#7)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
refractive-index and##2##2##(2007-11#1)(2008-2#1)
refractive-index change in##5##3##(2007-12#1)(2008-3#4)
refractive-index change is##2##3##(2007-12#2)
refractive-index change##17##2##(2007-11#1)(2007-12#8)(2008-3#8)
refractive-index changes##7##2##(2007-11#3)(2007-12#2)(2008-3#2)
refractive-index contrast##2##2##(2007-11#1)(2007-12#1)
refractive-index detection scheme##2##3##(2008-2#2)
refractive-index detection##4##2##(2008-2#4)
refractive-index difference##7##2##(2007-12#3)(2008-2#4)
refractive-index differences##3##2##(2007-12#3)
refractive-index distribution and##2##3##(2008-2#2)
refractive-index distribution##8##2##(2007-12#2)(2008-2#2)(2008-3#4)
refractive-index gradients in##2##3##(2008-2#1)(2008-3#1)
refractive-index gradients##3##2##(2008-2#2)(2008-3#1)
refractive-index grating##2##2##(2007-12#2)
refractive-index gratings##2##2##(2007-11#1)(2008-2#1)
refractive-index increase##3##2##(2008-2#1)(2008-3#2)
refractive-index measurement##2##2##(2008-3#2)
refractive-index mismatch on##2##3##(2008-2#1)(2008-3#1)
refractive-index mismatch##5##2##(2008-2#1)(2008-3#4)
refractive-index modification of fused silica##2##5##(2007-11#2)
refractive-index modification of##3##3##(2007-11#3)
refractive-index modulation of##2##3##(2007-11#1)(2008-2#1)
refractive-index modulation##12##2##(2007-11#4)(2007-12#3)(2008-2#1)(2008-3#4)
refractive-index modulations##2##2##(2007-12#1)(2008-3#1)
refractive-index perturbation##3##2##(2007-12#2)(2008-3#1)
refractive-index profile of##2##3##(2007-12#1)(2008-2#1)
refractive-index profile##9##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
refractive-index profiles from##2##3##(2008-3#2)
refractive-index profiles of##2##3##(2008-3#2)
refractive-index profiles##8##2##(2008-2#1)(2008-3#7)
refractive-index structure##2##2##(2008-2#2)
refractive-index turbulence##4##2##(2008-3#4)
refractive-index variation##4##2##(2008-3#4)
refractive-index##143##1##(2007-11#24)(2007-12#31)(2008-2#31)(2008-3#57)
refractivity##3##1##(2008-2#1)(2008-3#2)
refractometer based on##4##3##(2007-11#1)(2008-3#3)
refractometer##8##1##(2007-11#3)(2008-3#5)
refractometric prism##2##2##(2008-3#2)
refractometric##4##1##(2008-3#3)(2009-6#1)
refractometry##6##1##(2008-2#5)(2008-3#1)
refractoriness in##3##2##(1991-2#2)(2013-1#1)
refractoriness of##2##2##(1993-12#1)(2013-1#1)
refractoriness##10##1##(1991-2#4)(1992-8#2)(1993-12#1)(2013-1#3)
refractory DME##2##2##(2011-2#2)
refractory angina##3##2##(2008-12#1)(2008-3#1)(2010-6#1)
refractory ascites##4##2##(2007-12#3)(2013-1#1)
refractory asthma##4##2##(2010-5#4)
refractory chronic##3##2##(2008-5#1)(2009-3#2)
refractory diabetic macular oedema##2##4##(2011-2#2)
refractory disease##5##2##(2008-5#1)(2010-4#1)(2010-5#2)(2011-1#1)
refractory hypertension##3##2##(1990-9#1)(2008-1#1)(2008-12#1)
refractory neuropathic pain##2##3##(2006-12#2)
refractory patients##5##2##(2008-1#1)(2009-9#1)(2013-1#3)
refractory period##5##2##(1991-2#1)(1992-6#1)(2008-11#3)
refractory seizures##2##2##(2008-7#1)(2009-8#1)
refractory to conventional##2##3##(1991-6#1)(2011-2#1)
refractory to infliximab##2##3##(2012-3#2)
refractory to or##2##3##(2007-10#1)(2012-3#1)
refractory to other##2##3##(2012-3#2)
refractory to therapy##2##3##(1994-7#1)(2008-7#1)
refractory to treatment##3##3##(1993-8#1)(1995-3#1)(2012-12#1)
refractory to##40##2##(1991-6#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#6)(2013-1#2)(2013-8#1)
refractory yttrium##2##2##(2008-10#2)
refractory##139##1##(1990-3#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-12#2)(2007-10#3)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#9)(2013-1#6)(2013-8#4)
refrain##2##1##(1996-9#1)(2008-11#1)
refraining from##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
refresh##2##1##(2007-12#1)(2012-12#1)
refresher course##2##2##(2008-1#1)(2009-3#1)
refresher##4##1##(2008-1#1)(2008-12#1)(2008-9#1)(2009-3#1)
refrigerated##7##1##(1994-9#1)(2007-3#1)(2008-10#3)(2012-12#1)(2012-2#1)
refrigeration temperature##2##2##(1997-4#1)(2012-2#1)
refrigeration##10##1##(1996-1#1)(1997-4#1)(2007-3#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)
refrigerator##4##1##(2008-10#1)(2010-4#1)(2012-12#2)
refuge for##2##2##(2008-5#1)(2013-7#1)
refuge##10##1##(1993-6#3)(1995-6#1)(2008-5#3)(2009-5#2)(2013-7#1)
refugee campuses##2##2##(2011-2#2)
refugee##9##1##(1994-9#1)(1996-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)
refugees and##3##2##(1995-11#2)(1997-3#1)
refugees in##4##2##(1990-6#1)(2008-7#1)(2010-1#1)(2011-2#1)
refugees residing in##2##3##(2008-7#1)(2011-2#1)
refugees##17##1##(1990-6#1)(1995-11#2)(1995-8#1)(1997-3#1)(2008-12#1)(2008-7#4)(2010-1#1)(2011-2#3)(2013-1#3)
refuges and##2##2##(2008-5#1)(2013-1#1)
refuges##6##1##(2008-10#1)(2008-5#3)(2008-6#1)(2013-1#1)
refusal of##2##2##(1991-6#1)(1995-5#1)
refusal to##5##2##(1995-12#1)(1995-6#1)(2008-11#2)(2009-6#1)
refusal##11##1##(1991-6#2)(1992-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-11#2)(2008-4#1)(2009-6#1)(2009-7#1)
refusals and##2##2##(2008-7#1)(2009-6#1)
refuse piles##4##2##(2008-10#4)
refuse to participate in##2##4##(2009-6#2)
refuse to take part in##2##5##(2009-6#2)
refuse to##6##2##(2008-7#1)(2009-6#5)
refuse treatment##4##2##(1995-12#2)(1995-2#1)(2010-9#1)
refuse##25##1##(1990-11#1)(1991-9#1)(1992-12#2)(1994-12#1)(1995-12#2)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-6#6)(2010-9#1)(2013-8#1)
refused or##2##2##(1997-5#1)(2008-11#1)
refused to dismiss##2##3##(1995-12#1)(1996-5#1)
refused to##12##2##(1992-12#1)(1995-12#1)(1995-6#4)(1996-5#1)(1997-5#1)(2007-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
refused##30##1##(1990-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-11#1)(1995-12#4)(1995-6#6)(1996-5#2)(1997-5#2)(1997-6#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-9#1)(2009-6#3)(2011-1#1)(2011-2#1)
refusers##7##1##(1990-6#1)(1991-6#6)
refuses to##3##2##(1995-6#2)(2010-8#1)
refusing to##3##2##(1995-6#3)
refusing##6##1##(1993-6#1)(1995-6#3)(1997-5#1)(2008-12#1)
refute##4##1##(1991-12#1)(1996-3#1)(1997-8#1)(2008-3#1)
refuted##3##1##(2007-7#1)(2008-3#1)(2013-7#1)
refuting the refutation of dogma##2##5##(2007-5#2)
refuting the##3##2##(2007-5#2)(2008-10#1)
refuting##4##1##(1995-5#1)(2007-5#2)(2008-10#1)
regain a##2##2##(2011-1#1)(2011-3#1)
regain the##2##2##(2008-1#1)(2008-10#1)
regain their##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
regain##15##1##(1995-8#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-9#1)(2010-10#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
regained a##2##2##(2008-10#1)(2013-1#1)
regained the ability to walk##2##5##(1996-9#2)
regained the ability to##3##4##(1996-9#2)(2007-8#1)
regained the##4##2##(1996-9#2)(2007-8#1)(2008-5#1)
regained##23##1##(1992-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-9#3)(1997-6#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-6#1)(2009-3#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
regaining##4##1##(2007-11#1)(2007-8#1)(2008-10#1)(2012-7#1)
regalis##2##1##(2010-8#2)
regard for##2##2##(2008-12#1)(2008-5#1)
regard the##2##2##(1997-4#1)(1997-5#1)
regard to confounding##2##3##(1992-3#1)(2008-9#1)
regard to diagnosis##2##3##(2009-9#1)(2011-2#1)
regard to the clinical##2##4##(2008-10#1)(2008-11#1)
regard to the development of##2##5##(2007-11#1)(2008-12#1)
regard to the influence##2##4##(2008-10#2)
regard to the##55##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-3#3)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
regard to their##12##3##(1992-3#1)(1995-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)
regard to these##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
regard to##243##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1995-1#2)(1995-11#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#18)(2008-12#12)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-10#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#5)(2012-9#1)(2013-1#2)(2013-8#3)
regard##296##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1995-1#2)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#25)(2008-12#14)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#8)(2008-9#4)(2009-10#1)(2009-11#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#6)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#4)
regarded as a model##2##4##(2008-9#1)(2009-2#1)
regarded as a useful##2##4##(2008-3#1)(2011-2#1)
regarded as a##39##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#2)(2013-1#1)
regarded as an important##2##4##(1997-4#1)(2013-1#1)
regarded as an##11##3##(1994-3#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-3#1)(2009-12#1)(2009-5#1)(2010-3#1)(2013-1#1)
regarded as important##3##3##(1991-6#1)(2007-12#1)(2008-11#1)
regarded as one of the most##2##6##(2008-10#1)(2011-2#1)
regarded as one of the##5##5##(1991-4#1)(1994-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
regarded as safe for##2##4##(2008-3#1)(2009-6#1)
regarded as target##2##3##(1993-3#1)(2012-2#1)
regarded as the most##3##4##(1993-2#1)(1994-11#1)(2012-3#1)
regarded as the##18##3##(1992-6#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#1)
regarded as##132##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#2)(1995-11#2)(1995-2#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#5)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2010-11#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#6)(2012-3#2)(2013-1#2)
regarded to be##2##3##(1994-9#1)(1996-3#1)
regarded to##4##2##(1991-12#1)(1994-9#1)(1996-3#1)(2007-12#1)
regarded##149##1##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-7#2)(1994-9#1)(1995-11#2)(1995-2#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#4)(2007-12#5)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#7)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2010-11#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-2#6)(2012-3#2)(2013-1#2)
regarding a preference for individuals with##2##6##(1994-12#2)
regarding a##8##2##(1990-3#1)(1994-12#2)(1996-9#1)(2007-12#1)(2008-10#1)(2009-4#1)(2009-5#1)
regarding adjuvant therapy##2##3##(2008-6#2)
regarding adjuvant##3##2##(2008-6#2)(2011-2#1)
regarding anatomy##2##2##(2007-11#1)(2012-2#1)
regarding any##2##2##(1997-5#1)(2011-2#1)
regarding application of##2##3##(2008-10#1)(2012-3#1)
regarding appropriate##4##2##(2008-3#1)(2010-1#1)(2012-12#1)(2013-8#1)
regarding both##2##2##(2006-10#1)(2007-12#1)
regarding breast##2##2##(1990-8#1)(2010-8#1)
regarding cigarette smoking##2##3##(1991-5#1)(2009-5#1)
regarding cigarette use##2##3##(2013-1#2)
regarding cigarette##4##2##(1991-5#1)(2009-5#1)(2013-1#2)
regarding decision##2##2##(1996-1#1)(2010-2#1)
regarding disease##2##2##(2008-3#1)(2008-7#1)
regarding drug##2##2##(1993-1#1)(2010-5#1)
regarding early##2##2##(2008-11#1)(2012-3#1)
regarding etiology##2##2##(2008-9#1)(2013-1#1)
regarding existing##2##2##(1991-5#1)(2008-10#1)
regarding factors##2##2##(2008-10#1)(2012-3#1)
regarding further##2##2##(2008-10#1)(2012-2#1)
regarding health care##2##3##(1994-12#1)(2012-2#1)
regarding health##3##2##(1994-12#1)(2009-9#1)(2012-2#1)
regarding his##3##2##(2009-2#1)(2011-1#1)(2013-1#1)
regarding how##7##2##(1994-12#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2012-2#1)
regarding isolation of##2##3##(2007-7#1)(2008-2#1)
regarding its application##2##3##(2011-2#1)(2012-2#1)
regarding its potential##2##3##(2008-4#1)(2012-2#1)
regarding its##15##2##(1997-2#1)(1997-8#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
regarding long-term##2##2##(2008-8#1)(2013-1#1)
regarding management of##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
regarding nutrition##2##2##(1991-3#1)(2013-7#1)
regarding outcomes##2##2##(2008-9#1)(2011-2#1)
regarding patient characteristics##2##3##(2007-7#1)(2010-7#1)
regarding patient##4##2##(1992-3#1)(2007-7#1)(2010-7#1)(2013-1#1)
regarding physician##2##2##(1996-1#2)
regarding potential##4##2##(2007-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
regarding prevention##2##2##(2008-12#1)(2012-12#1)
regarding protein##2##2##(2008-4#1)(2010-11#1)
regarding quality##2##2##(1996-3#1)(2008-7#1)
regarding risk##2##2##(2008-4#1)(2010-12#1)
regarding sexual##7##2##(2008-12#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
regarding specific##2##2##(1995-1#1)(2008-4#1)
regarding student##3##2##(2008-11#2)(2011-2#1)
regarding such##2##2##(1995-1#1)(2012-3#1)
regarding surgical##2##2##(2008-9#1)(2013-8#1)
regarding surveillance##2##2##(2012-3#1)(2013-1#1)
regarding the &quot##2##3##(1995-11#1)(2010-7#1)
regarding the ability of##2##4##(2008-11#1)(2013-8#1)
regarding the advantages##2##3##(2007-2#1)(2009-5#1)
regarding the analysis##2##3##(2008-10#2)
regarding the assessment##2##3##(2008-10#1)(2008-6#1)
regarding the best management##2##4##(2007-12#1)(2010-3#1)
regarding the best##5##3##(2007-12#1)(2008-7#1)(2010-3#2)(2011-2#1)
regarding the clinical##3##3##(1990-9#1)(2008-1#1)(2011-2#1)
regarding the contribution of##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
regarding the degree of##3##4##(1997-3#2)(2012-2#1)
regarding the determination of##2##4##(2008-10#2)
regarding the development of##4##4##(2008-12#1)(2008-2#1)(2008-6#1)(2012-12#1)
regarding the different##3##3##(2009-6#1)(2013-1#2)
regarding the effect of##5##4##(2007-10#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
regarding the effectiveness and##2##4##(2013-1#2)
regarding the effectiveness of##2##4##(2008-12#1)(2012-2#1)
regarding the effectiveness##4##3##(2008-12#1)(2012-2#1)(2013-1#2)
regarding the effects of##3##4##(1991-10#1)(1993-3#1)(2013-8#1)
regarding the effects##4##3##(1991-10#1)(1993-3#1)(2009-5#1)(2013-8#1)
regarding the efficacy##2##3##(2008-11#2)
regarding the etiology##2##3##(2008-10#1)(2008-7#1)
regarding the evolution##2##3##(1996-2#1)(2010-6#1)
regarding the formation of##2##4##(1991-6#1)(2013-1#1)
regarding the function of##2##4##(1995-11#1)(2008-7#1)
regarding the functional##3##3##(2008-6#1)(2009-10#2)
regarding the genetic##3##3##(2008-4#1)(2009-10#1)(2011-2#1)
regarding the identity##2##3##(2008-11#2)
regarding the impact of##6##4##(2008-11#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
regarding the impact##7##3##(1995-5#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
regarding the implementation of a##3##5##(2007-11#1)(2010-10#2)
regarding the influence of##2##4##(2007-10#1)(2008-9#1)
regarding the key##2##3##(2006-10#1)(2008-8#1)
regarding the management of##3##4##(2008-11#1)(2008-3#1)(2010-2#1)
regarding the mechanisms##2##3##(1994-11#1)(2012-12#1)
regarding the medical##2##3##(1993-12#1)(2011-2#1)
regarding the nature of##2##4##(1996-12#1)(2008-11#1)
regarding the need for##2##4##(1995-2#1)(1997-3#1)
regarding the need##3##3##(1995-2#1)(1997-3#1)(2009-7#1)
regarding the possibility##2##3##(2008-7#1)(2011-2#1)
regarding the potential##4##3##(1992-3#1)(1994-1#2)(2009-11#1)
regarding the pros and cons of##2##6##(1996-6#1)(2008-4#1)
regarding the regulation of##2##4##(1997-1#1)(2008-1#1)
regarding the relationship between##3##4##(2008-4#1)(2009-10#1)(2011-2#1)
regarding the relationship##4##3##(1991-2#1)(2008-4#1)(2009-10#1)(2011-2#1)
regarding the relative##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
regarding the results##2##3##(1991-3#1)(2010-6#1)
regarding the risk of##2##4##(2009-11#1)(2013-1#1)
regarding the risks of##2##4##(1993-2#1)(2010-1#1)
regarding the risks##3##3##(1993-2#1)(2007-9#1)(2010-1#1)
regarding the role of##9##4##(1995-1#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
regarding the safety of##2##4##(2008-11#1)(2010-12#1)
regarding the surrounding##2##3##(2008-12#1)(2008-7#1)
regarding the timing##2##3##(2009-6#1)(2010-8#1)
regarding the topic##2##3##(2012-12#1)(2013-8#1)
regarding the use of##8##4##(1992-9#1)(2007-10#1)(2008-12#1)(2009-11#1)(2010-5#1)(2013-1#3)
regarding the use##9##3##(1992-9#1)(2007-10#1)(2008-12#1)(2008-6#1)(2009-11#1)(2010-5#1)(2013-1#3)
regarding the##327##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#2)(1994-11#2)(1994-12#4)(1994-5#1)(1994-6#1)(1995-1#5)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-8#3)(2006-10#1)(2007-10#4)(2007-11#5)(2007-12#4)(2007-2#3)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#6)(2008-10#20)(2008-11#27)(2008-12#11)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#2)(2009-10#9)(2009-11#3)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#5)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#3)(2011-2#15)(2012-12#9)(2012-2#7)(2012-3#2)(2013-1#23)(2013-8#9)
regarding their##23##2##(1992-12#1)(1994-12#1)(1994-3#1)(1995-1#2)(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2012-12#1)(2012-5#1)(2013-1#3)(2013-7#1)
regarding these##7##2##(1996-2#1)(1997-1#1)(2007-8#1)(2008-8#2)(2011-2#1)(2012-2#1)
regarding this##7##2##(1990-11#1)(2008-2#1)(2008-8#1)(2010-10#1)(2013-1#2)(2013-8#1)
regarding treatment of##2##3##(2008-5#1)(2012-3#1)
regarding use of##4##3##(1992-5#1)(1996-2#1)(2013-1#2)
regarding use##5##2##(1992-5#1)(1996-2#1)(2013-1#3)
regarding which##3##2##(2011-8#1)(2012-3#1)(2013-8#1)
regarding workplace##2##2##(1992-1#1)(2010-6#1)
regarding##784##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#4)(1991-6#2)(1991-8#2)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#4)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#9)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#11)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#6)(1996-12#6)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-5#3)(1997-8#7)(2006-10#2)(2007-10#6)(2007-11#6)(2007-12#10)(2007-2#4)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#12)(2008-10#38)(2008-11#50)(2008-12#25)(2008-2#10)(2008-3#12)(2008-4#16)(2008-5#10)(2008-6#20)(2008-7#29)(2008-8#15)(2008-9#11)(2009-10#11)(2009-11#7)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#6)(2010-11#6)(2010-12#10)(2010-2#4)(2010-3#9)(2010-4#4)(2010-5#8)(2010-6#5)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#18)(2011-2#41)(2011-3#3)(2011-7#1)(2011-8#1)(2012-1#1)(2012-12#26)(2012-2#33)(2012-3#15)(2012-5#1)(2013-1#59)(2013-7#4)(2013-8#20)
regardless of BMI##2##3##(1994-12#1)(2008-9#1)
regardless of RH##2##3##(2008-10#2)
regardless of ability to##2##4##(1994-2#1)(2010-12#1)
regardless of affective valence##2##4##(2008-11#2)
regardless of age##3##3##(1993-12#1)(2008-5#1)(2008-7#1)
regardless of gender and##2##4##(2008-7#1)(2013-1#1)
regardless of gender##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
regardless of its##2##3##(1991-12#1)(2013-1#1)
regardless of race##2##3##(2008-5#2)
regardless of sex##5##3##(2007-11#1)(2008-5#1)(2009-11#1)(2009-7#1)(2011-1#1)
regardless of size##2##3##(1996-12#1)(2008-10#1)
regardless of stage##2##3##(2008-8#1)(2012-3#1)
regardless of the cause##2##4##(1991-7#1)(2011-1#1)
regardless of the degree of##2##5##(1992-1#1)(2007-12#1)
regardless of the host##2##4##(2008-10#2)
regardless of the irrigation##2##4##(2008-10#2)
regardless of the method##2##4##(2007-8#1)(2008-10#1)
regardless of the origin of##2##5##(2008-10#2)
regardless of the origin##3##4##(2008-10#3)
regardless of the presence of##3##5##(1993-8#1)(2008-10#2)
regardless of the presence or absence of##5##7##(1992-9#1)(1993-12#1)(1993-3#1)(2008-10#2)
regardless of the presence##8##4##(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(2008-10#4)
regardless of the site of##2##5##(2008-10#1)(2008-9#1)
regardless of the type of##2##5##(2008-1#1)(2010-11#1)
regardless of the##79##3##(1990-8#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#3)(2008-9#3)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
regardless of their##15##3##(1990-5#1)(1994-9#2)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
regardless of whether the##10##4##(1991-5#1)(1995-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2009-3#1)(2010-5#1)
regardless of whether they are##2##5##(1994-9#1)(2009-4#1)
regardless of whether they##3##4##(1994-9#1)(2008-10#1)(2009-4#1)
regardless of whether##20##3##(1991-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)
regardless of which definition is selected##2##6##(2013-1#2)
regardless of which##4##3##(2007-12#1)(2008-7#1)(2013-1#2)
regardless of year##2##3##(2008-10#2)
regardless of##209##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#4)(1995-11#1)(1995-2#4)(1995-6#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#47)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#9)(2008-5#7)(2008-7#8)(2008-8#1)(2008-9#11)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-1#5)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#14)(2013-8#2)
regardless##212##1##(1990-11#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#4)(1995-11#1)(1995-2#4)(1995-6#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#47)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#9)(2008-5#7)(2008-7#8)(2008-8#1)(2008-9#11)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-1#6)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#14)(2013-8#2)
regards the##10##2##(1990-2#1)(1990-5#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-10#3)(2011-2#1)
regards their##3##2##(1990-2#1)(2007-10#1)(2010-12#1)
regards to the##8##3##(2008-8#1)(2009-10#2)(2009-3#1)(2010-8#1)(2011-2#2)(2013-8#1)
regards to their##2##3##(2008-10#1)(2011-1#1)
regards to##22##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
regards##62##1##(1990-2#3)(1990-5#1)(1990-6#2)(1991-6#3)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#2)
regenerable chemiluminescent##2##2##(2008-10#2)
regenerable##4##1##(2008-10#3)(2008-4#1)
regenerants##3##1##(2008-10#1)(2008-9#2)
regenerate the##5##2##(2008-10#2)(2008-5#2)(2013-1#1)
regenerate##26##1##(1995-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2010-10#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
regenerated bone##2##2##(2007-11#1)(2012-12#1)
regenerated by passing##2##3##(2008-10#1)(2008-12#1)
regenerated by simple polishing##2##4##(2008-10#2)
regenerated by using##2##3##(2008-10#2)
regenerated by##19##2##(2008-10#16)(2008-12#1)(2008-5#1)(2008-6#1)
regenerated fiber##2##2##(2007-11#1)(2013-8#1)
regenerated from##3##2##(2008-10#1)(2008-8#2)
regenerated grating##2##2##(2007-11#2)
regenerated host##3##2##(2011-2#3)
regenerated in##2##2##(1992-9#1)(2013-1#1)
regenerated plants##2##2##(2008-8#1)(2009-6#1)
regenerated using##2##2##(2008-10#2)
regenerated##74##1##(1992-1#1)(1992-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-4#1)(2007-11#4)(2008-10#32)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#4)(2011-7#1)(2012-12#1)(2013-1#3)(2013-8#5)
regenerates##2##1##(2008-3#1)(2013-1#1)
regenerating liver##4##2##(1990-5#2)(1991-12#1)(2008-8#1)
regenerating process of collecting ducts and ureters of##2##8##(1997-6#2)
regenerating the##2##2##(2008-10#1)(2012-2#1)
regenerating##28##1##(1990-5#2)(1991-12#1)(1993-12#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-6#3)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
regeneration ability##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
regeneration after DEX exposure##2##4##(1995-12#2)
regeneration after##8##2##(1993-2#1)(1995-12#2)(1995-6#1)(2010-11#2)(2012-2#2)
regeneration and anatomical plasticity##2##4##(1995-11#2)
regeneration and repair##2##3##(2012-12#1)(2013-1#1)
regeneration and##15##2##(1992-8#1)(1993-2#1)(1993-5#1)(1995-11#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
regeneration at##2##2##(2013-1#1)(2013-8#1)
regeneration by##5##2##(1995-12#2)(2008-12#1)(2011-2#1)(2012-3#1)
regeneration capacity of##2##3##(2008-9#1)(2009-3#1)
regeneration capacity##4##2##(2008-9#2)(2009-12#1)(2009-3#1)
regeneration cycles##2##2##(2008-10#2)
regeneration field##2##2##(2008-5#2)
regeneration following##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2010-5#1)
regeneration from##2##2##(2008-12#1)(2010-10#1)
regeneration in the##2##3##(1996-12#1)(2010-1#1)
regeneration in##13##2##(1990-11#1)(1993-5#1)(1995-12#1)(1996-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#1)
regeneration is##3##2##(1995-12#1)(2010-1#1)(2013-1#1)
regeneration of a##2##3##(2008-12#1)(2008-5#1)
regeneration of the central nervous system##2##6##(2008-5#2)
regeneration of the periodontal attachment apparatus##2##6##(2012-3#2)
regeneration of the##19##3##(1995-12#1)(2008-10#7)(2008-5#6)(2010-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
regeneration of##45##2##(1991-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#10)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-7#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
regeneration process##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
regeneration through##3##2##(1993-5#1)(2010-10#1)(2013-7#1)
regeneration was##2##2##(2008-10#1)(2008-5#1)
regeneration whole plantlets from root##2##5##(2008-12#2)
regeneration whole plantlets##3##3##(2008-12#3)
regeneration with##5##2##(1993-8#1)(2007-12#1)(2008-5#1)(2009-5#1)(2012-3#1)
regeneration##231##1##(1990-11#2)(1990-9#1)(1991-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#5)(1993-8#3)(1995-11#2)(1995-12#7)(1995-6#1)(1996-12#1)(1997-6#1)(2007-12#6)(2007-8#2)(2008-10#26)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#26)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#5)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#3)(2010-1#3)(2010-10#8)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#4)(2011-2#6)(2012-12#7)(2012-2#10)(2012-3#12)(2012-7#1)(2013-1#15)(2013-7#2)(2013-8#9)
regeneration]##3##1##(2013-1#2)(2013-8#1)
regenerative amplifier and an adaptive phase controller##2##7##(2007-11#2)
regenerative amplifier and##3##3##(2007-11#2)(2008-3#1)
regenerative amplifier that##2##3##(2007-11#1)(2008-2#1)
regenerative amplifier with a##2##4##(2007-11#1)(2008-3#1)
regenerative amplifier##19##2##(2007-11#8)(2007-12#6)(2008-2#3)(2008-3#2)
regenerative amplifiers##4##2##(2007-11#3)(2008-3#1)
regenerative capacity##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
regenerative medicine##31##2##(2008-11#4)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#2)(2010-10#6)(2010-3#2)(2012-12#3)(2012-5#2)(2012-6#2)(2013-1#1)
regenerative potential##4##2##(2007-12#1)(2010-8#1)(2012-12#2)
regenerative process##2##2##(2010-12#1)(2013-8#1)
regenerative sprouting##2##2##(1996-12#1)(1997-3#1)
regenerative therapies##2##2##(2010-6#1)(2012-12#1)
regenerative##90##1##(1993-3#1)(1994-5#2)(1996-12#1)(1997-3#1)(2007-11#11)(2007-12#8)(2008-11#5)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#4)(2009-12#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#6)(2010-12#3)(2010-3#2)(2010-6#1)(2010-8#1)(2012-12#10)(2012-2#2)(2012-5#2)(2012-6#2)(2012-7#1)(2013-1#3)(2013-8#2)
regia and##3##2##(2008-10#2)(2013-1#1)
regia##17##1##(2008-10#16)(2013-1#1)
regime and the##2##3##(2008-8#1)(2011-1#1)
regime and##11##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
regime compared##2##2##(2008-10#1)(2010-3#1)
regime during##2##2##(2008-2#1)(2009-8#1)
regime for##5##2##(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)
regime in which the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
regime in which##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
regime in##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#1)
regime is identified in which##2##5##(2007-11#1)(2007-12#1)
regime is##6##2##(1992-8#1)(2007-11#1)(2007-12#3)(2008-6#1)
regime of a##2##3##(1992-11#1)(2007-11#1)
regime of the##2##3##(2008-7#1)(2008-8#1)
regime of##13##2##(1990-11#1)(1992-11#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
regime which##2##2##(2008-8#1)(2009-5#1)
regime with##6##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
regime##167##1##(1990-11#1)(1991-12#1)(1992-11#1)(1992-8#2)(1995-6#1)(1996-3#1)(1996-4#2)(1997-6#1)(2006-4#1)(2007-11#29)(2007-12#26)(2008-1#2)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#21)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-3#3)(2010-8#3)(2011-1#6)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#2)
regime)##3##1##(2008-3#2)(2008-9#1)
regimen (p##2##2##(1994-2#1)(2008-10#1)
regimen A##4##2##(1997-7#4)
regimen B##2##2##(1994-7#1)(1997-7#1)
regimen and##4##2##(1990-6#1)(1994-3#1)(2008-11#1)(2013-1#1)
regimen can##2##2##(2007-10#1)(2008-3#1)
regimen comprising##2##2##(1995-8#1)(2010-3#1)
regimen for patients with##2##4##(1992-10#1)(2009-4#1)
regimen for the##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-3#1)
regimen for##20##2##(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-7#1)
regimen has been##2##3##(1993-11#1)(2010-12#1)
regimen has##4##2##(1993-11#1)(2008-12#1)(2010-12#1)(2013-1#1)
regimen in order to##2##4##(1992-12#1)(2008-5#1)
regimen in the treatment of advanced##2##6##(1990-12#2)
regimen in the treatment of##3##5##(1990-12#2)(1990-2#1)
regimen in##11##2##(1990-12#3)(1990-2#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
regimen is##8##2##(1990-2#1)(1992-12#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
regimen may be##2##3##(1994-2#1)(2010-12#1)
regimen may##4##2##(1994-2#1)(2007-11#1)(2008-11#1)(2010-12#1)
regimen of##17##2##(1992-8#1)(1992-9#1)(1993-11#1)(1997-4#3)(1997-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-3#1)(2012-3#1)
regimen on##2##2##(2008-3#1)(2011-2#1)
regimen to treat##2##3##(2010-12#1)(2012-3#1)
regimen to##3##2##(1992-9#1)(2010-12#1)(2012-3#1)
regimen using##3##2##(2007-10#1)(2008-7#1)(2009-8#1)
regimen was changed to##2##4##(2013-8#2)
regimen was effective in##2##4##(1990-12#1)(2009-12#1)
regimen was##11##2##(1990-12#1)(1992-8#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-8#2)
regimen were##3##2##(1995-3#1)(2008-6#1)(2013-8#1)
regimen with##6##2##(1991-9#1)(1992-6#1)(1993-2#1)(2007-10#1)(2008-6#1)(2008-7#1)
regimen##192##1##(1990-12#6)(1990-2#2)(1990-6#3)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#4)(1992-2#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-2#2)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-3#3)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-7#7)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#2)(2008-3#8)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#4)(2010-4#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#8)
regimens and##7##2##(1990-6#1)(2008-10#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-1#1)
regimens are##3##2##(2009-9#1)(2010-12#1)(2010-6#1)
regimens based##2##2##(2008-5#1)(2011-2#1)
regimens can##2##2##(2008-1#1)(2008-6#1)
regimens consisting of##2##3##(2008-1#1)(2013-1#1)
regimens for##6##2##(1991-2#1)(2007-7#1)(2009-4#1)(2010-4#1)(2012-3#1)(2013-1#1)
regimens have demonstrated##2##3##(2007-5#1)(2013-1#1)
regimens have##5##2##(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#1)
regimens in patients with##2##4##(1991-9#1)(2008-6#1)
regimens in##8##2##(1991-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
regimens include##2##2##(2008-3#1)(2012-3#1)
regimens of##5##2##(1990-12#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
regimens on##4##2##(2008-1#1)(2008-12#2)(2012-3#1)
regimens or##3##2##(2008-7#1)(2009-8#1)(2010-6#1)
regimens that##5##2##(2007-7#1)(2008-11#2)(2008-3#1)(2011-2#1)
regimens used##2##2##(2007-4#1)(2008-7#1)
regimens were##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
regimens with##3##2##(2008-6#1)(2008-7#1)(2011-2#1)
regimens##143##1##(1990-12#3)(1990-6#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#5)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#2)(2007-7#4)(2008-1#6)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#9)(2008-7#12)(2008-8#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-3#6)(2013-1#8)
regimes and##2##2##(2008-10#1)(2008-8#1)
regimes are##4##2##(2007-12#1)(2008-2#1)(2008-8#1)(2011-1#1)
regimes in the##2##3##(2008-10#2)
regimes in which##2##3##(2008-11#1)(2008-3#1)
regimes in##9##2##(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)
regimes of the##2##3##(2008-11#1)(2008-8#1)
regimes of##9##2##(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#1)
regimes on##3##2##(1990-8#1)(2008-12#2)
regimes ranging from##2##3##(2008-10#2)
regimes that##2##2##(2008-10#1)(2008-8#1)
regimes were##2##2##(1996-12#1)(2008-10#1)
regimes with##3##2##(2008-10#2)(2010-3#1)
regimes##95##1##(1990-11#1)(1990-8#1)(1994-2#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-10#30)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#12)(2008-7#3)(2008-8#7)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#1)
regimes)##3##1##(2008-10#2)(2008-7#1)
regio- and stereoselective##2##3##(1996-5#2)
regio- and##3##2##(1996-5#3)
regioisomer##2##1##(1996-5#1)(2009-9#1)
regioisomers##3##1##(1996-5#1)(2009-12#1)(2010-7#1)
region (4##2##2##(1992-10#1)(1997-2#1)
region (CR) sequences##3##3##(2008-10#2)(2010-8#1)
region (CR)##4##2##(2008-10#2)(2008-8#1)(2010-8#1)
region (France)##2##2##(2008-10#2)
region (MAR)##2##2##(1992-10#1)(2008-8#1)
region (NTR)##2##2##(2008-10#1)(2013-8#1)
region (UTR)##8##2##(1990-12#1)(1992-8#1)(1994-12#1)(1996-5#1)(1997-7#1)(2008-10#3)
region (residues##4##2##(1990-7#1)(1991-5#1)(1993-8#1)(1997-3#1)
region (the##3##2##(1992-11#1)(1995-2#1)(2008-5#1)
region 1##4##2##(2008-10#3)(2008-4#1)
region 2##2##2##(2008-10#2)
region DNA##2##2##(1994-11#1)(2008-10#1)
region I##3##2##(1990-3#3)
region a##2##2##(2007-11#1)(2007-12#1)
region above##3##2##(2008-3#3)
region after##3##2##(1990-7#1)(1993-3#1)(2007-12#1)
region allowed##2##2##(1990-5#1)(1991-9#1)
region alone##3##2##(2008-10#3)
region along##2##2##(2007-11#1)(2010-11#1)
region also contains##2##3##(1993-6#1)(1997-3#1)
region also##4##2##(1992-9#1)(1993-6#1)(1997-3#1)(2008-8#1)
region among##3##2##(1991-8#1)(2012-2#1)(2013-8#1)
region and a##11##3##(1990-11#1)(1991-7#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)(2013-1#1)
region and an##3##3##(1990-6#1)(2008-6#1)(2008-8#1)
region and in the##2##4##(1992-2#1)(1996-10#1)
region and in##3##3##(1991-6#1)(1992-2#1)(1996-10#1)
region and that##2##3##(1997-3#1)(2008-2#1)
region and the##20##3##(1991-6#1)(1992-3#1)(1994-11#2)(1994-3#1)(1994-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#1)
region and to##2##3##(1994-2#1)(1996-2#1)
region and##105##2##(1990-11#2)(1990-5#1)(1990-6#1)(1991-6#2)(1991-7#1)(1992-2#3)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-5#3)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#1)
region are not##2##3##(1992-3#1)(2008-7#1)
region are presented##2##3##(1990-6#1)(2008-3#1)
region are##14##2##(1990-6#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
region around##3##2##(1990-11#1)(1992-9#1)(2008-3#1)
region as a result of##2##5##(2008-2#2)
region as a##3##3##(1993-3#1)(2008-2#2)
region as the##2##3##(2008-10#2)
region as well as##3##4##(1994-6#1)(2008-3#1)(2011-2#1)
region as##12##2##(1993-3#1)(1994-11#1)(1994-6#1)(1995-6#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2011-2#1)
region at a##2##3##(1992-2#1)(2007-2#1)
region at the##6##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
region at##19##2##(1990-5#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
region because##3##2##(1992-11#1)(2008-2#1)(2008-3#1)
region before##3##2##(1995-2#1)(1997-6#1)(2012-2#1)
region between the catalytic##2##4##(1995-11#1)(1997-2#1)
region between the##14##3##(1991-6#1)(1992-11#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-12#1)(1997-2#2)(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#1)
region between##36##2##(1991-6#2)(1991-8#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#4)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
region but##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
region by use of##3##4##(2007-12#1)(2008-3#2)
region by##20##2##(1991-12#1)(1992-12#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-8#1)(1997-8#1)(2007-12#3)(2008-10#3)(2008-3#5)(2008-4#1)(2010-8#1)
region can be used##2##4##(1993-9#1)(2008-3#1)
region can be##5##3##(1993-9#1)(2007-12#1)(2008-2#1)(2008-3#2)
region can##7##2##(1990-3#1)(1993-9#1)(2007-12#1)(2008-2#2)(2008-3#2)
region centered##2##2##(2008-10#1)(2008-2#1)
region close to the GRPR locus on the X chromosome##2##10##(1996-12#2)
region close to the##4##4##(1990-7#1)(1996-12#2)(1996-3#1)
region close to##5##3##(1990-7#1)(1996-12#2)(1996-3#1)(2008-10#1)
region coding for##3##3##(1991-6#1)(1997-7#1)(2013-1#1)
region compared to##2##3##(1992-6#1)(2008-10#1)
region compared with##2##3##(2008-10#1)(2008-3#1)
region compared##4##2##(1992-6#1)(2008-10#2)(2008-3#1)
region comprising the##2##3##(1990-5#1)(1996-10#1)
region comprising##3##2##(1990-5#1)(1991-6#1)(1996-10#1)
region consists of two##2##4##(1997-2#1)(2008-8#1)
region contained##6##2##(1992-11#1)(1993-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(2009-10#1)
region containing the##4##3##(1994-12#1)(1996-12#1)(1997-4#1)(1997-7#1)
region containing##8##2##(1994-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2009-5#1)
region contains a##3##3##(1991-11#1)(1992-11#1)(2008-8#1)
region contains at least##2##4##(1995-8#1)(1996-6#1)
region contains the##2##3##(1991-2#1)(1993-12#1)
region contains##18##2##(1990-11#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-8#1)(1996-6#2)(1996-8#1)(2008-8#1)
region could##3##2##(1994-12#1)(2008-10#2)
region depends##3##2##(1995-2#2)(1996-3#1)
region derived from the##2##4##(1990-11#1)(1992-6#1)
region did not##2##3##(1997-2#1)(1997-9#1)
region downstream of the##2##4##(1996-12#1)(1997-2#1)
region downstream of##3##3##(1991-7#1)(1996-12#1)(1997-2#1)
region during the##3##3##(2008-10#2)(2012-3#1)
region during##6##2##(1992-10#1)(2008-10#3)(2008-2#1)(2012-3#1)
region encoding the##4##3##(1994-12#1)(1997-2#2)(2008-10#1)
region encoding##5##2##(1994-12#2)(1997-2#2)(2008-10#1)
region encompassing##2##2##(1991-5#1)(2008-10#1)
region examined##2##2##(1997-2#1)(2013-1#1)
region extending##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
region for membrane##2##3##(1994-12#1)(1996-3#1)
region for the##4##3##(1990-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
region for this##2##3##(1990-7#1)(1994-8#1)
region for##35##2##(1990-7#2)(1991-12#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-4#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-9#1)(2009-3#1)(2009-4#1)(2010-7#1)(2012-3#2)(2013-1#1)
region from 25##2##3##(2008-1#1)(2008-10#1)
region from both##2##3##(2008-10#2)
region from the##4##3##(1990-11#1)(1996-3#1)(1996-4#1)(2008-11#1)
region from##29##2##(1990-11#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-8#1)(2008-9#1)
region gene##3##2##(1994-8#1)(1997-8#1)(2008-11#1)
region had no##2##3##(2008-10#2)
region had##3##2##(1990-9#1)(2008-10#2)
region has been developed##2##4##(2008-10#1)(2008-2#1)
region has been measured##2##4##(2008-2#1)(2008-3#1)
region has been##14##3##(1992-11#1)(1993-6#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-9#1)(2011-2#1)
region has##20##2##(1990-10#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
region have##2##2##(1997-3#1)(2008-12#1)
region homologous to##2##3##(1993-6#1)(2008-10#1)
region in a patient with##2##5##(1990-12#1)(1990-5#1)
region in a##5##3##(1990-12#1)(1990-5#1)(2007-11#2)(2011-2#1)
region in an##2##3##(1994-2#1)(2008-3#1)
region in human##2##3##(1997-2#1)(1997-7#1)
region in the##28##3##(1990-5#1)(1990-8#1)(1992-11#1)(1992-8#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-5#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
region in which##2##3##(2007-12#1)(2008-2#1)
region in##75##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-9#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
region includes##3##2##(1990-11#1)(1995-6#1)(1996-12#1)
region including the##2##3##(1996-12#1)(2008-10#1)
region including##4##2##(1996-12#1)(1997-7#1)(2008-10#1)(2011-1#1)
region increases##2##2##(2009-6#2)
region into the##2##3##(2013-7#1)(2013-8#1)
region into##3##2##(2008-10#1)(2013-7#1)(2013-8#1)
region involved in##4##3##(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#1)
region is a##3##3##(1990-6#1)(1992-9#1)(1996-12#1)
region is also##3##3##(1994-8#1)(2008-10#1)(2012-2#1)
region is an##2##3##(1995-6#1)(2008-9#1)
region is characterized by##2##4##(1993-11#1)(1994-11#1)
region is composed of##2##4##(2007-12#1)(2008-8#1)
region is considered##2##3##(2008-2#2)
region is demonstrated by use of##2##6##(2007-11#2)
region is given##2##3##(2008-11#1)(2008-3#1)
region is highly conserved##2##4##(1994-12#1)(2008-10#1)
region is presented##2##3##(2008-2#2)
region is required for##2##4##(1992-9#1)(2008-7#1)
region is##67##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-9#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#3)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-8#2)
region just##3##2##(1991-6#1)(2007-11#1)(2012-2#1)
region lies between##2##3##(2008-2#1)(2012-12#1)
region located##3##2##(1992-11#1)(1993-2#1)(1996-6#1)
region may##5##2##(1994-12#1)(1996-4#1)(2008-10#1)(2008-4#1)(2008-5#1)
region might be##2##3##(2008-10#2)
region might##3##2##(2008-10#2)(2008-8#1)
region near 1##2##3##(2007-11#2)
region near the##3##3##(1993-6#1)(2007-12#1)(2013-7#1)
region near##9##2##(1993-6#1)(2007-11#3)(2007-12#2)(2008-3#2)(2013-7#1)
region not##2##2##(1995-6#1)(2007-12#1)
region of 1##2##3##(2007-12#1)(2008-10#1)
region of 55 bp##2##4##(1990-11#2)
region of Australia##2##3##(1992-2#1)(2012-12#1)
region of Brazil##2##3##(1993-6#1)(2013-8#1)
region of DNA that##2##4##(1990-5#1)(1994-12#1)
region of DNA##3##3##(1990-5#1)(1994-12#1)(1996-3#1)
region of Nepal##3##3##(2008-7#2)(2012-3#1)
region of P##2##3##(2008-10#2)
region of Poland##3##3##(2008-12#3)
region of Quebec##2##3##(1992-1#1)(2007-12#1)
region of Turkey##2##3##(1997-3#1)(2008-12#1)
region of Venezuela##3##3##(2008-10#2)(2008-5#1)
region of WSMoV NSs protein##2##5##(2008-10#2)
region of a##27##3##(1990-12#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#2)(2009-2#1)(2012-1#1)
region of all##2##3##(1993-12#1)(2012-3#1)
region of alpha 1-AGP gene is##2##6##(1992-12#2)
region of an##5##3##(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
region of bacterial chromosomes##2##4##(1994-12#1)(1995-8#1)
region of both##2##3##(1993-6#1)(1994-3#1)
region of chromosome 11##2##4##(2008-11#1)(2012-12#1)
region of chromosome 21##2##4##(1993-12#1)(1996-2#1)
region of chromosome 6##2##4##(1994-11#1)(2008-8#1)
region of chromosome##19##3##(1993-12#1)(1994-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2012-12#1)
region of each##5##3##(1995-12#1)(1997-3#1)(2008-10#1)(2008-5#2)
region of homology to##3##4##(1993-12#1)(1993-6#1)(2008-6#1)
region of homology##4##3##(1992-8#1)(1993-12#1)(1993-6#1)(2008-6#1)
region of human##14##3##(1990-2#1)(1990-8#1)(1991-12#2)(1994-6#5)(1995-12#1)(1996-6#1)(2008-4#1)(2009-7#2)
region of interest (ROI)##2##4##(2010-2#1)(2010-8#1)
region of interest analysis##2##4##(2008-10#1)(2012-12#1)
region of interest##15##3##(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
region of lambdaN##4##3##(2008-8#4)
region of mitochondrial DNA##3##4##(2007-10#1)(2008-10#2)
region of mouse chromosome##3##4##(1993-2#1)(1995-2#1)(1997-2#1)
region of nodD3##2##3##(2008-8#1)(2008-9#1)
region of origin##4##3##(2008-10#4)
region of phenyl cyanate##2##4##(2010-2#2)
region of rDNA##2##3##(2008-10#2)
region of rat##2##3##(1991-2#1)(1992-12#1)
region of ribosomal DNA##3##4##(2008-10#2)(2009-2#1)
region of sorghumpsbA gene##2##4##(2008-9#2)
region of target##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
region of the Bacillus subtilis genome##4##6##(1995-12#1)(1996-8#2)(1997-7#1)
region of the Bacillus subtilis##5##5##(1991-9#1)(1995-12#1)(1996-8#2)(1997-7#1)
region of the United States##13##5##(1997-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-9#1)
region of the brachial fascia##2##5##(2009-1#2)
region of the brain##7##4##(1992-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-6#1)(2010-1#1)
region of the cell##2##4##(2008-1#1)(2008-6#1)
region of the chromosome##3##4##(1990-5#1)(1995-2#1)(2010-8#1)
region of the enzyme##2##4##(1993-8#1)(1997-4#1)
region of the gene##9##4##(1991-9#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-8#1)
region of the genome##3##4##(1996-2#1)(2008-10#1)(2012-3#1)
region of the hepatitis##3##4##(1994-11#1)(1997-6#2)
region of the hippocampus##4##4##(1994-8#1)(1996-12#1)(1997-2#1)(2008-7#1)
region of the human gene##2##5##(1990-7#1)(1991-7#1)
region of the human##24##4##(1990-7#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-4#2)
region of the insulin##2##4##(1992-6#1)(2008-4#1)
region of the long arm##2##5##(2008-10#1)(2008-9#1)
region of the mRNA##2##4##(1992-11#1)(1993-6#1)
region of the major##2##4##(1994-11#1)(1995-6#1)
region of the molecule##2##4##(1991-2#1)(2008-5#1)
region of the mouse##3##4##(1991-2#1)(1991-6#2)
region of the nuclear ribosomal RNA gene##3##7##(2008-10#3)
region of the nuclear ribosomal##4##5##(2008-10#4)
region of the nucleus##2##4##(1992-10#1)(1993-6#1)
region of the protein##8##4##(1990-11#1)(1990-5#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-6#1)(1996-3#1)(2012-12#1)
region of the rDNA##4##4##(2008-10#4)
region of the rat##6##4##(1990-12#1)(1991-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(2008-9#1)
region of the ribosomal DNA##2##5##(2008-10#2)
region of the ribosomal##4##4##(2008-10#3)(2008-5#1)
region of the spectrum##14##4##(2007-11#4)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#1)
region of the state##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
region of the upper##2##4##(2007-8#1)(2009-1#1)
region of the viral##2##4##(1995-2#1)(1997-2#1)
region of the##325##3##(1990-11#5)(1990-12#3)(1990-2#2)(1990-5#6)(1990-7#3)(1991-12#1)(1991-2#4)(1991-6#6)(1991-7#3)(1991-9#9)(1992-10#1)(1992-11#2)(1992-12#4)(1992-3#3)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#8)(1993-8#5)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#3)(1995-11#2)(1995-12#3)(1995-2#7)(1995-3#1)(1995-6#4)(1995-8#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#7)(1997-7#9)(1997-8#3)(2007-11#4)(2007-12#8)(2007-8#3)(2008-1#3)(2008-10#43)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#8)(2008-5#11)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#5)(2009-1#3)(2010-1#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)
region of these##4##3##(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
region of this gene##2##4##(1994-6#1)(2008-11#1)
region of this##6##3##(1990-12#1)(1993-11#1)(1994-6#1)(1997-3#1)(2008-11#1)(2009-8#1)
region of##716##2##(1990-10#1)(1990-11#9)(1990-12#9)(1990-2#4)(1990-4#1)(1990-5#8)(1990-7#5)(1990-8#3)(1991-10#1)(1991-12#3)(1991-2#5)(1991-5#2)(1991-6#8)(1991-7#3)(1991-8#1)(1991-9#12)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#9)(1992-2#2)(1992-3#4)(1992-6#3)(1992-8#7)(1992-9#1)(1993-11#4)(1993-12#11)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#11)(1993-8#8)(1993-9#3)(1994-11#9)(1994-12#12)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#12)(1994-8#8)(1994-9#4)(1995-11#4)(1995-12#7)(1995-2#15)(1995-3#2)(1995-5#2)(1995-6#15)(1995-8#4)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#6)(1996-5#4)(1996-6#5)(1996-8#3)(1997-1#1)(1997-2#9)(1997-3#7)(1997-4#5)(1997-5#3)(1997-6#8)(1997-7#13)(1997-8#5)(2007-10#1)(2007-11#8)(2007-12#19)(2007-8#3)(2008-1#8)(2008-10#103)(2008-11#13)(2008-12#8)(2008-2#17)(2008-3#23)(2008-4#12)(2008-5#19)(2008-6#7)(2008-7#21)(2008-8#22)(2008-9#12)(2009-1#3)(2009-10#2)(2009-2#2)(2009-7#3)(2009-8#4)(2010-1#1)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#12)(2012-1#3)(2012-12#9)(2012-2#6)(2012-3#8)(2012-7#1)(2013-1#10)(2013-8#3)
region on chromosome 6q##2##4##(2009-4#1)(2012-3#1)
region on chromosome##10##3##(1996-2#1)(1997-2#1)(2008-1#1)(2009-10#1)(2009-4#1)(2010-3#2)(2012-3#3)
region on the##11##3##(1996-12#6)(1996-6#2)(2008-10#1)(2008-11#1)(2008-9#1)
region on##31##2##(1991-7#1)(1992-4#1)(1993-3#1)(1996-12#6)(1996-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#3)(2010-5#1)(2012-3#3)
region or the##2##3##(1991-6#1)(2007-12#1)
region or##11##2##(1990-8#1)(1991-6#1)(1993-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2011-2#1)
region overlapping##2##2##(1993-8#1)(2007-7#1)
region presents a##2##3##(2007-11#1)(2008-10#1)
region previously##3##2##(1993-9#1)(2008-11#1)(2008-4#1)
region quasi-phase matches a##2##4##(2007-12#2)
region represent##2##2##(2007-5#1)(2011-2#1)
region required for##2##3##(1990-11#1)(1994-12#1)
region resolved##2##2##(2008-10#1)(2010-8#1)
region revealed##3##2##(1993-2#1)(1997-3#1)(2008-10#1)
region selection##4##2##(1995-3#2)(2008-10#1)(2008-6#1)
region sequence##2##2##(1990-7#1)(2008-10#1)
region sequenced##2##2##(1994-8#1)(2008-10#1)
region sequences##3##2##(1997-3#1)(2008-12#2)
region showed that##4##3##(2008-10#4)
region showed##9##2##(1991-5#1)(1992-12#1)(1993-12#1)(1994-3#1)(2008-10#5)
region shows that the##2##4##(1997-6#1)(2008-7#1)
region shows##4##2##(1992-3#1)(1997-6#1)(2008-10#1)(2008-7#1)
region spanning##3##2##(1991-6#1)(1992-12#1)(2008-10#1)
region specific to##2##3##(1990-7#1)(2008-10#1)
region specific##5##2##(1990-7#1)(1994-12#1)(1995-5#1)(1996-8#1)(2008-10#1)
region surrounding the##4##3##(1991-7#1)(1997-5#1)(2007-11#1)(2012-3#1)
region surrounding##6##2##(1991-7#1)(1994-11#1)(1997-5#1)(2007-11#1)(2008-3#1)(2012-3#1)
region that contains##2##3##(1997-4#1)(2008-10#1)
region that could##2##3##(1994-12#1)(1997-5#1)
region that encodes the##2##4##(1993-2#1)(1995-2#1)
region that has##4##3##(1990-8#1)(1994-11#1)(2008-10#1)(2008-2#1)
region that is most important##2##5##(1994-3#1)(2008-10#1)
region that is##7##3##(1990-5#1)(1991-12#1)(1994-3#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
region that was##3##3##(1993-12#1)(2008-10#2)
region that##34##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#2)(1997-4#2)(1997-5#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)
region then##2##2##(1997-5#1)(2008-8#1)
region through##2##2##(2008-10#1)(2008-5#1)
region to another##2##3##(2008-1#1)(2013-1#1)
region to be##3##3##(1990-11#1)(1990-12#1)(1997-3#1)
region to the##2##3##(2008-10#1)(2008-3#1)
region to##22##2##(1990-11#2)(1990-12#1)(1992-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2013-1#2)
region upstream of the##2##4##(1993-8#1)(1997-7#1)
region upstream##3##2##(1993-8#1)(1994-11#1)(1997-7#1)
region usage##2##2##(1995-5#1)(2010-3#1)
region using a##2##3##(2008-2#1)(2008-4#1)
region using##7##2##(1991-9#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
region was calculated##2##3##(2008-3#1)(2012-2#1)
region was examined##2##3##(1992-3#1)(2008-10#1)
region was formed##2##3##(2007-11#1)(2007-12#1)
region was separated##2##3##(1990-7#1)(2008-9#1)
region was sequenced##2##3##(1990-7#1)(1994-12#1)
region was used##3##3##(2008-10#2)(2008-2#1)
region was##57##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#3)(1991-12#2)(1991-2#2)(1991-6#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-2#3)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#1)(2008-10#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-6#1)(2010-5#1)(2012-2#2)(2012-3#1)
region we##2##2##(2008-3#1)(2012-2#1)
region were analyzed##2##3##(1997-7#1)(2008-12#1)
region were sequenced##2##3##(1993-2#1)(2008-10#1)
region were##39##2##(1990-5#2)(1991-11#2)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
region where the##2##3##(1993-11#1)(2008-3#1)
region where##13##2##(1993-11#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
region which##8##2##(1990-6#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-3#1)
region with a##6##3##(1994-8#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
region with high##2##3##(1995-8#1)(2008-8#1)
region with three groups of##2##5##(2012-1#2)
region with three##3##3##(2008-10#1)(2012-1#2)
region with##32##2##(1992-11#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-8#2)(1996-10#1)(1996-2#2)(1997-4#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#3)
region within the##5##3##(1992-3#1)(1995-6#1)(2007-11#1)(2008-11#1)(2008-2#1)
region within##8##2##(1992-3#1)(1992-8#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
region without##2##2##(1997-3#1)(2012-2#1)
region##2679##1##(1990-10#2)(1990-11#28)(1990-12#20)(1990-2#5)(1990-3#6)(1990-4#2)(1990-5#23)(1990-6#5)(1990-7#17)(1990-8#10)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#12)(1991-2#14)(1991-3#3)(1991-5#8)(1991-6#23)(1991-7#11)(1991-8#7)(1991-9#20)(1992-1#1)(1992-10#5)(1992-11#16)(1992-12#18)(1992-2#8)(1992-3#17)(1992-4#1)(1992-5#1)(1992-6#13)(1992-8#15)(1992-9#15)(1993-1#1)(1993-11#13)(1993-12#29)(1993-2#20)(1993-3#16)(1993-5#4)(1993-6#28)(1993-8#25)(1993-9#9)(1994-11#31)(1994-12#43)(1994-2#9)(1994-3#12)(1994-5#13)(1994-6#22)(1994-8#22)(1994-9#8)(1995-11#11)(1995-12#19)(1995-2#37)(1995-3#11)(1995-5#8)(1995-6#34)(1995-8#18)(1996-1#3)(1996-10#7)(1996-11#5)(1996-12#33)(1996-2#11)(1996-3#14)(1996-4#4)(1996-5#10)(1996-6#22)(1996-7#1)(1996-8#12)(1996-9#1)(1997-1#1)(1997-2#46)(1997-3#27)(1997-4#18)(1997-5#13)(1997-6#17)(1997-7#35)(1997-8#24)(1997-9#7)(2006-12#2)(2006-4#1)(2007-10#5)(2007-11#42)(2007-12#81)(2007-2#1)(2007-5#5)(2007-7#7)(2007-8#8)(2008-1#30)(2008-10#390)(2008-11#60)(2008-12#40)(2008-2#95)(2008-3#135)(2008-4#39)(2008-5#50)(2008-6#19)(2008-7#59)(2008-8#87)(2008-9#56)(2009-1#4)(2009-10#13)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#8)(2009-8#8)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#8)(2010-4#4)(2010-5#14)(2010-6#2)(2010-7#7)(2010-8#19)(2011-1#17)(2011-2#51)(2011-3#1)(2011-9#1)(2012-1#8)(2012-12#24)(2012-2#29)(2012-3#30)(2012-6#1)(2012-7#1)(2013-1#56)(2013-7#12)(2013-8#22)
region's##2##1##(2008-11#1)(2013-1#1)
region(s)##2##1##(1996-5#1)(1997-5#1)
region) and##8##2##(1991-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)
region) are##2##2##(2008-3#1)(2010-4#1)
region) as a##2##3##(1995-2#2)
region) of the##2##3##(2008-1#1)(2008-5#1)
region) of##5##2##(2008-1#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#1)
region)##33##1##(1990-12#1)(1991-12#1)(1991-5#2)(1992-3#1)(1994-8#1)(1995-2#2)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
region-of-interest##2##1##(2008-3#1)(2011-1#1)
region-specific##6##1##(1993-9#1)(1994-8#1)(1996-8#1)(2008-10#1)(2008-8#1)(2009-6#1)
region]##6##1##(1990-9#1)(1992-11#1)(1995-8#1)(2008-8#1)(2012-3#1)(2013-8#1)
regional PWV##2##2##(2013-3#2)
regional albedo values##2##3##(2008-3#2)
regional albedo##3##2##(2008-3#3)
regional anaesthesia##5##2##(1990-6#1)(1992-11#1)(2006-10#2)(2010-7#1)
regional anaesthetic techniques##2##3##(1994-3#2)
regional anaesthetic##3##2##(1994-3#2)(2008-8#1)
regional and general anaesthesia##2##4##(2010-7#1)(2011-1#1)
regional and general##3##3##(2008-12#1)(2010-7#1)(2011-1#1)
regional and global##2##3##(1996-12#1)(2011-1#1)
regional and local##2##3##(2008-9#1)(2012-3#1)
regional and##15##2##(1992-5#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-3#1)
regional anesthesia##8##2##(2008-8#2)(2009-5#1)(2012-2#4)(2012-3#1)
regional areas##2##2##(1996-2#1)(2011-2#1)
regional attrition##5##2##(1994-3#5)
regional authorities or##2##3##(1997-3#1)(2008-7#1)
regional brain syndromes##4##3##(2008-7#4)
regional brain##11##2##(1990-9#1)(1991-10#1)(2008-10#1)(2008-4#1)(2008-7#5)(2009-6#1)(2013-8#1)
regional cancer##2##2##(1996-2#1)(2010-3#1)
regional cerebral blood flow (rCBF)##4##5##(1995-5#1)(1996-2#1)(1996-5#2)
regional cerebral blood flow##10##4##(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#3)(2007-10#2)(2008-7#1)
regional cerebral##12##2##(1993-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#3)(2007-10#3)(2008-7#1)
regional coexistence##2##2##(2008-8#2)
regional continuity##2##2##(1994-3#2)
regional difference##2##2##(1990-7#1)(1993-12#1)
regional differences and##2##3##(1996-2#1)(2009-10#1)
regional differences in the##3##4##(1992-3#1)(1994-2#1)(2013-8#1)
regional differences in##9##3##(1992-3#1)(1994-2#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
regional differences##15##2##(1990-7#1)(1991-6#1)(1992-3#1)(1994-2#2)(1996-2#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
regional distribution of##2##3##(1994-5#1)(2010-12#1)
regional distribution##4##2##(1993-9#1)(1994-5#1)(1996-12#1)(2010-12#1)
regional dosages delivered##2##3##(1994-12#2)
regional dosages##4##2##(1994-12#4)
regional effect##2##2##(1993-3#1)(2011-1#1)
regional health authorities##3##3##(1994-3#1)(1997-2#1)(2008-11#1)
regional health care##2##3##(1994-12#1)(1995-3#1)
regional health##13##2##(1994-12#1)(1994-3#3)(1995-3#2)(1996-12#1)(1997-1#1)(1997-2#2)(2008-11#1)(2011-1#1)(2011-2#1)
regional hospital##5##2##(1993-12#1)(1995-5#3)(2008-5#1)
regional hospitals##8##2##(1993-12#1)(1995-1#1)(1995-5#1)(2008-1#1)(2011-2#4)
regional invasion##2##2##(2008-10#2)
regional level##7##2##(1990-11#1)(1994-2#1)(2008-10#3)(2009-7#1)(2010-8#1)
regional levels##2##2##(1994-12#1)(2008-10#1)
regional lymph node##2##3##(2012-12#1)(2013-8#1)
regional lymph nodes##5##3##(1992-8#1)(1997-4#1)(2008-1#1)(2009-1#1)(2010-8#1)
regional lymph##8##2##(1992-8#1)(1997-4#1)(2008-1#1)(2008-10#1)(2009-1#1)(2010-8#1)(2012-12#1)(2013-8#1)
regional lymphadenopathy##2##2##(2011-1#1)(2013-1#1)
regional myocardial##2##2##(1991-9#1)(2007-8#1)
regional or national##2##3##(2011-2#1)(2012-3#1)
regional or##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
regional planning##5##2##(1992-12#1)(1994-12#1)(1994-3#2)(2008-7#1)
regional plans of organization of services##2##6##(2008-2#2)
regional populations##2##2##(2011-2#2)
regional prevalence##2##2##(2008-10#1)(2009-10#1)
regional reference##2##2##(1994-9#1)(2011-2#1)
regional scale##7##2##(2008-10#5)(2008-8#1)(2011-2#1)
regional spatial##2##2##(2008-10#1)(2009-2#1)
regional spread of##3##3##(1997-3#1)(2008-10#2)
regional spread##4##2##(1997-3#1)(2008-10#3)
regional system##3##2##(1992-12#3)
regional systems##6##2##(1992-12#5)(2013-8#1)
regional variability##2##2##(2008-9#2)
regional variation in the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
regional variation in##7##3##(2007-10#2)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)
regional variation##9##2##(2007-10#3)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)(2012-1#1)
regional wall motion abnormalities##3##4##(2011-2#1)(2013-1#2)
regional##379##1##(1990-11#4)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#3)(1991-10#2)(1991-12#2)(1991-2#2)(1991-4#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#11)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-9#3)(1994-12#7)(1994-2#3)(1994-3#15)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#7)(1995-6#1)(1995-8#1)(1996-12#5)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#3)(2007-10#8)(2007-12#4)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#34)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#17)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#2)(2009-2#4)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#22)(2012-1#2)(2012-12#12)(2012-2#9)(2012-3#6)(2013-1#10)(2013-3#4)(2013-7#2)(2013-8#7)
regionalized##2##1##(1994-1#1)(1995-1#1)
regionally based study was adopted in 2008##2##7##(2013-1#2)
regionally##10##1##(1991-5#1)(1996-2#2)(2008-10#1)(2008-4#1)(2008-8#2)(2010-3#1)(2013-1#2)
regions (UTR)##2##2##(1993-12#1)(1997-4#1)
regions affected by the##2##4##(2010-4#1)(2013-1#1)
regions and a##2##3##(1993-8#1)(1994-12#1)
regions and in##4##3##(1996-12#1)(2008-11#1)(2008-12#1)(2012-3#1)
regions and the##11##3##(1993-12#1)(1993-8#1)(1995-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
regions and their##2##3##(1994-11#1)(1997-2#1)
regions and##61##2##(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#2)(1996-12#1)(1997-2#6)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)
regions are also##2##3##(2007-7#1)(2010-5#1)
regions are associated with##2##4##(2008-10#1)(2008-7#1)
regions are characterized##2##3##(2008-10#1)(2008-9#1)
regions are##38##2##(1990-8#1)(1991-11#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
regions around the##4##3##(1992-9#1)(1995-5#1)(2009-5#1)(2011-2#1)
regions as the##4##3##(1993-8#1)(1994-3#1)(2008-3#1)(2008-4#1)
regions as##6##2##(1990-3#1)(1993-8#1)(1994-3#1)(2008-3#1)(2008-4#1)(2012-1#1)
regions associated with resistance##2##4##(2008-10#2)
regions associated with##7##3##(1995-12#1)(2008-10#4)(2008-11#1)(2012-12#1)
regions at the dough stage##2##5##(2008-10#2)
regions at the##5##3##(1991-6#1)(2008-10#3)(2008-6#1)
regions at##8##2##(1991-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)
regions between##4##2##(2008-10#2)(2008-9#2)
regions but not in the##2##5##(1993-8#1)(2007-10#1)
regions but##4##2##(1993-8#1)(1995-2#1)(2007-10#1)(2013-1#1)
regions by##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)
regions can##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
regions common##2##2##(1993-6#1)(2008-10#1)
regions contained##2##2##(1992-9#1)(1994-12#1)
regions containing##3##2##(1992-11#1)(1993-8#1)(1995-5#1)
regions corresponding to##3##3##(1993-2#1)(2008-8#1)(2013-1#1)
regions demonstrated##2##2##(2008-10#1)(2008-3#1)
regions derived from the##2##4##(1991-10#2)
regions derived from##3##3##(1991-10#2)(2008-10#1)
regions did##2##2##(2008-10#1)(2008-11#1)
regions do not##2##3##(2008-10#1)(2013-1#1)
regions during##7##2##(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2011-1#2)
regions examined##4##2##(1993-12#1)(1994-2#1)(1995-2#1)(1997-7#1)
regions following##2##2##(1996-5#1)(1997-6#1)
regions for##15##2##(1990-8#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
regions form##2##2##(1995-3#1)(2010-7#1)
regions found##2##2##(1997-4#1)(2013-8#1)
regions from the##7##3##(1990-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#1)
regions from##15##2##(1990-3#1)(1994-12#1)(1996-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
regions had elevated##2##3##(2009-10#2)
regions had##3##2##(2008-10#1)(2009-10#2)
regions has##2##2##(2008-10#1)(2008-9#1)
regions have been##3##3##(1993-8#1)(2008-8#1)(2013-1#1)
regions have##6##2##(1993-8#1)(1994-2#1)(2008-8#1)(2010-8#1)(2012-1#1)(2013-1#1)
regions homologous to##3##3##(1990-5#1)(1991-2#1)(1991-6#1)
regions implicated in##4##3##(1995-2#1)(2008-4#1)(2009-2#1)(2013-8#1)
regions in South Africa##2##4##(2011-1#2)
regions in normal##2##3##(1997-3#1)(2012-2#1)
regions in the genome##2##4##(2007-6#1)(2009-6#1)
regions in the putative##2##4##(1991-2#2)
regions in the##27##3##(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-11#1)(1997-6#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
regions in which##4##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-9#1)
regions in##81##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
regions indicated that##3##3##(2008-10#2)(2013-8#1)
regions inside the##2##3##(2007-11#1)(2007-12#1)
regions involved in the##2##4##(1996-8#1)(2009-5#1)
regions involved in##7##3##(1995-6#1)(1996-8#1)(1997-7#1)(2008-4#1)(2009-2#1)(2009-5#1)(2013-8#1)
regions is##12##2##(1991-10#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-7#1)
regions known to##2##3##(1996-12#1)(2008-8#1)
regions may be##2##3##(1991-12#1)(1995-11#1)
regions may##5##2##(1991-12#1)(1993-8#1)(1995-11#1)(2008-11#1)(2013-1#1)
regions near##3##2##(1996-8#1)(1997-5#1)(2009-11#1)
regions of 25##2##3##(2008-10#1)(2010-10#1)
regions of Asia##2##3##(2007-12#1)(2008-10#1)
regions of Brazil##2##3##(2008-10#2)
regions of California##2##3##(2008-10#1)(2011-2#1)
regions of China##3##3##(2008-10#2)(2011-2#1)
regions of France##2##3##(2008-10#2)
regions of Malawi##2##3##(2008-10#2)
regions of Mexico##2##3##(2008-10#1)(2011-2#1)
regions of North America##2##4##(2008-10#1)(2008-8#1)
regions of Saudi Arabia##2##4##(2008-1#2)
regions of South America##3##4##(1991-11#1)(2008-10#1)(2012-12#1)
regions of Spain##2##3##(1990-8#1)(1996-12#1)
regions of a##5##3##(1994-11#1)(1995-5#1)(2008-2#1)(2008-9#1)(2011-2#1)
regions of antibodies##3##3##(1992-8#2)(2008-4#1)
regions of apple pectin with##2##5##(1990-9#2)
regions of both##3##3##(1992-3#1)(1994-3#1)(1995-3#1)
regions of cortical bone##2##4##(1995-6#2)
regions of cortical##3##3##(1995-6#2)(2007-10#1)
regions of equal##2##3##(1996-1#1)(2007-12#1)
regions of genes##2##3##(1991-9#1)(1995-8#1)
regions of high##6##3##(1997-8#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-5#1)(2011-2#1)
regions of homology##2##3##(1990-7#1)(2008-4#1)
regions of human plasminogen##2##4##(1993-8#2)
regions of human##3##3##(1993-8#2)(1995-2#1)
regions of interest##13##3##(1997-5#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-6#2)(2009-10#1)(2009-8#1)(2012-1#2)(2012-3#2)
regions of mammalian##2##3##(1993-9#1)(1995-11#1)
regions of many genes##2##4##(1997-2#1)(1997-4#1)
regions of rDNA##2##3##(2008-10#2)
regions of rice##2##3##(2008-8#1)(2008-9#1)
regions of the L genes##2##5##(2008-10#2)
regions of the United States##3##5##(2008-10#2)(2013-8#1)
regions of the adult##4##4##(1994-12#1)(1995-2#1)(1996-5#1)(2008-7#1)
regions of the amygdala##2##4##(1991-10#2)
regions of the brain##6##4##(1992-9#1)(1997-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-2#1)
regions of the central nervous system##2##6##(1996-12#1)(2008-7#1)
regions of the country##2##4##(2008-10#1)(2012-1#1)
regions of the different##2##4##(1990-5#1)(2013-8#1)
regions of the electromagnetic spectrum##2##5##(2008-2#1)(2012-12#1)
regions of the genome##10##4##(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
regions of the human##6##4##(1993-2#2)(1993-3#1)(1993-6#1)(2008-11#1)(2008-7#1)
regions of the mouse and human genes are##2##8##(1993-3#1)(1993-6#1)
regions of the nuclear ribosomal DNA##2##6##(2008-10#2)
regions of the nucleus##2##4##(1993-5#1)(1993-6#1)
regions of the peptide##2##4##(1995-2#1)(1995-5#1)
regions of the protein that##2##5##(1993-12#1)(2008-4#1)
regions of the protein##6##4##(1993-11#2)(1993-12#1)(1995-6#1)(2008-4#1)(2008-7#1)
regions of the rat brain##2##5##(1993-8#1)(1994-8#1)
regions of the rat epididymis##2##5##(1992-3#2)
regions of the rat##5##4##(1992-3#2)(1993-8#2)(1994-8#1)
regions of the respiratory tract##2##5##(1994-12#1)(2008-10#1)
regions of the world##14##4##(2007-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
regions of the##192##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#4)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#6)(1993-8#3)(1994-12#5)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#2)(1996-5#2)(1997-2#3)(1997-6#3)(1997-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#44)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
regions of these##3##3##(2008-10#1)(2008-11#2)
regions of this##4##3##(1992-11#1)(1992-8#1)(1997-4#1)(2008-4#1)
regions of two##2##3##(1997-2#2)
regions of##429##2##(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#3)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-8#3)(1992-9#4)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#8)(1993-8#9)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#6)(1995-5#3)(1995-6#7)(1995-8#2)(1996-1#1)(1996-12#7)(1996-2#4)(1996-5#2)(1997-2#8)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(1997-9#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#85)(2008-11#14)(2008-12#4)(2008-2#6)(2008-3#17)(2008-4#10)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#7)(2009-10#5)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#8)
regions on both sides of the##2##6##(1991-8#1)(1995-8#1)
regions on chromosomes##2##3##(2008-5#1)(2012-3#1)
regions on the##6##3##(1993-11#1)(1993-3#1)(1995-2#1)(1997-8#1)(2008-10#1)(2010-7#1)
regions on##14##2##(1991-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
regions or##7##2##(1996-6#1)(2008-10#4)(2009-10#1)(2010-4#1)
regions outside##2##2##(2008-1#1)(2008-3#1)
regions over a period of##2##5##(2008-10#1)(2008-2#1)
regions over##3##2##(1994-3#1)(2008-10#1)(2008-2#1)
regions previously##4##2##(1993-9#1)(1994-2#1)(1995-2#1)(2008-10#1)
regions resulted##2##2##(2008-10#1)(2010-4#1)
regions revealed a##2##3##(1994-12#1)(2008-11#1)
regions revealed##6##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-8#1)
regions sampled##2##2##(2008-10#1)(2012-3#1)
regions share##2##2##(1991-12#1)(1991-9#1)
regions should have##2##3##(2008-4#1)(2012-2#1)
regions should##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
regions show##2##2##(2008-10#1)(2008-11#1)
regions showed##4##2##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#1)
regions studied##3##2##(1996-12#1)(2008-10#2)
regions such as the##2##4##(2007-2#1)(2009-10#1)
regions such as##3##3##(1994-6#1)(2007-2#1)(2009-10#1)
regions surrounding the##2##3##(1996-12#1)(1997-7#1)
regions tested##2##2##(2008-10#1)(2008-5#1)
regions than##3##2##(1996-12#1)(2009-5#1)(2013-8#1)
regions that are##5##3##(1994-8#1)(1996-4#1)(2008-11#1)(2008-3#1)(2012-3#1)
regions that have##4##3##(1994-2#1)(1995-2#1)(2008-3#1)(2008-7#1)
regions that lack##2##3##(2007-12#1)(2012-2#1)
regions that were##3##3##(1995-6#2)(1996-12#1)
regions that##33##2##(1990-8#1)(1991-12#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-3#1)(2010-4#1)(2011-10#1)(2012-2#2)(2012-3#3)(2013-1#1)
regions there##2##2##(1996-12#1)(2008-8#1)
regions they##2##2##(2010-10#1)(2012-12#1)
regions to##5##2##(1994-3#1)(1995-2#1)(2008-11#1)(2008-4#1)(2013-1#1)
regions using##6##2##(1994-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#1)
regions was##7##2##(1990-11#1)(1994-5#1)(1997-8#1)(2008-10#1)(2008-5#1)(2013-7#1)(2013-8#1)
regions we##2##2##(2008-10#1)(2008-7#1)
regions were also##2##3##(1994-12#1)(2008-8#1)
regions were cloned##2##3##(1992-9#1)(2008-10#1)
regions were identical##2##3##(1991-9#1)(2008-10#1)
regions were identified##2##3##(2008-10#2)
regions were not##2##3##(1991-12#1)(1997-5#1)
regions were sequenced##2##3##(1991-12#1)(2008-10#1)
regions were##29##2##(1990-5#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-8#2)(2009-10#1)(2011-1#1)(2012-2#1)
regions where more##2##3##(2007-10#1)(2008-6#1)
regions where the##6##3##(2008-3#3)(2008-4#1)(2011-1#1)(2013-1#1)
regions where##19##2##(1994-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#3)(2011-1#1)(2012-1#1)(2013-1#1)
regions which are##2##3##(1992-8#1)(1997-2#1)
regions which##8##2##(1992-8#1)(1992-9#1)(1993-3#1)(1997-2#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
regions with different##2##3##(2008-10#1)(2008-6#1)
regions with high##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
regions with the##2##3##(2012-1#1)(2013-8#1)
regions with##31##2##(1992-12#1)(1992-6#1)(1993-1#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#1)(2010-3#1)(2011-1#1)(2012-1#2)(2013-8#2)
regions within the##7##3##(1992-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2013-7#1)
regions within##11##2##(1991-6#1)(1992-6#2)(1993-12#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#2)(2013-1#1)(2013-7#1)
regions worldwide##4##2##(2008-10#4)
regions##1470##1##(1990-11#6)(1990-12#3)(1990-3#6)(1990-4#3)(1990-5#7)(1990-7#2)(1990-8#8)(1990-9#3)(1991-1#1)(1991-10#12)(1991-11#5)(1991-12#14)(1991-2#7)(1991-5#4)(1991-6#7)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#5)(1992-2#2)(1992-3#6)(1992-6#5)(1992-8#6)(1992-9#9)(1993-1#1)(1993-11#5)(1993-12#16)(1993-2#6)(1993-3#9)(1993-5#1)(1993-6#11)(1993-8#24)(1993-9#3)(1994-11#4)(1994-12#13)(1994-2#11)(1994-3#5)(1994-5#5)(1994-6#9)(1994-7#3)(1994-8#8)(1994-9#3)(1995-11#7)(1995-12#12)(1995-2#20)(1995-3#7)(1995-5#13)(1995-6#14)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#25)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#11)(1996-6#5)(1996-8#2)(1997-2#22)(1997-3#3)(1997-4#9)(1997-5#4)(1997-6#13)(1997-7#8)(1997-8#9)(1997-9#2)(2006-12#2)(2007-10#6)(2007-11#20)(2007-12#32)(2007-2#4)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#6)(2008-1#12)(2008-10#261)(2008-11#57)(2008-12#19)(2008-2#27)(2008-3#67)(2008-4#36)(2008-5#25)(2008-6#14)(2008-7#35)(2008-8#37)(2008-9#18)(2009-10#19)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#1)(2009-5#11)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#5)(2010-10#4)(2010-12#3)(2010-3#6)(2010-4#10)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#14)(2011-10#1)(2011-2#40)(2011-3#3)(2011-7#1)(2012-1#17)(2012-12#10)(2012-2#21)(2012-3#29)(2012-7#1)(2013-1#28)(2013-7#6)(2013-8#28)
regions)##3##1##(2008-10#2)(2008-7#1)
regions]##3##1##(1991-2#1)(1997-8#1)(2012-3#1)
regioselective acylation##2##2##(2008-4#1)(2008-7#1)
regioselective formation of##2##3##(1994-11#1)(2009-8#1)
regioselective ring opening of the oxabicycloheptadienes##2##6##(2008-8#2)
regioselective##17##1##(1992-3#1)(1994-11#1)(1996-5#3)(2007-11#2)(2008-10#2)(2008-4#4)(2008-7#1)(2008-8#2)(2009-8#1)
regioselectively##3##1##(2007-11#1)(2008-4#1)(2009-5#1)
regioselectivity at##2##2##(1996-5#1)(2009-8#1)
regioselectivity is##2##2##(1990-11#1)(1992-3#1)
regioselectivity##12##1##(1990-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#2)(2008-8#2)(2009-8#1)(2012-3#1)
register a##3##2##(2008-11#1)(2008-3#1)(2010-9#1)
register of all##2##3##(2008-10#2)
register of##6##2##(1995-8#1)(2006-10#1)(2007-2#2)(2008-10#2)
register##39##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#7)(1996-1#1)(1996-11#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-2#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-9#1)(2012-3#1)(2013-8#4)
register&quot##2##1##(1996-11#1)(2008-10#1)
registered and##7##2##(1991-9#1)(1994-12#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-2#1)
registered as##3##2##(1993-8#1)(2008-1#1)(2008-10#1)
registered at##5##2##(1996-12#1)(2008-5#1)(2008-6#1)(2013-7#1)(2013-8#1)
registered between##2##2##(2008-11#1)(2013-1#1)
registered by a##2##3##(1990-6#1)(2008-3#1)
registered by the Ragusa Cancer Registry##2##6##(1991-2#1)(1992-12#1)
registered by##4##2##(1990-6#1)(1991-2#1)(1992-12#1)(2008-3#1)
registered dietitian##2##2##(1995-3#2)
registered during the##2##3##(2008-5#2)
registered during##3##2##(2008-5#3)
registered for the##5##3##(1994-9#1)(1997-7#1)(2008-1#1)(2008-6#1)(2012-2#1)
registered for##8##2##(1994-9#1)(1995-8#1)(1997-7#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
registered in a##3##3##(1996-6#1)(2008-7#1)(2012-3#1)
registered in ambulatory##2##3##(2010-4#2)
registered in the Swedish Prescribed Drug Register##2##7##(2010-3#2)
registered in the##14##3##(1991-11#1)(1991-6#1)(1993-8#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-6#2)(2010-3#2)(2013-1#1)(2013-8#2)
registered in this##2##3##(1995-6#1)(2008-10#1)
registered in##40##2##(1990-2#1)(1991-11#1)(1991-6#2)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-6#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-3#2)(2010-4#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
registered mental##2##2##(2008-11#1)(2010-5#1)
registered nurse##5##2##(2007-10#1)(2008-11#3)(2010-2#1)
registered nurses (RNs)##5##3##(1991-2#1)(2008-12#1)(2010-10#1)(2013-1#2)
registered nurses who##2##3##(2008-1#1)(2008-11#1)
registered nurses##30##2##(1991-2#1)(1994-3#1)(2007-10#2)(2008-1#1)(2008-11#8)(2008-12#4)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#2)(2012-3#2)(2013-1#4)
registered nurses'##2##2##(2007-10#1)(2008-12#1)
registered when##2##2##(1991-11#1)(2008-11#1)
registered with the U##2##4##(2008-10#1)(2008-9#1)
registered with the##4##3##(1995-12#1)(1996-8#1)(2008-10#1)(2008-9#1)
registered with##7##2##(1990-10#1)(1995-12#1)(1996-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-1#1)
registered##186##1##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#3)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1993-9#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#4)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#5)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#17)(2008-12#7)(2008-3#2)(2008-5#7)(2008-6#6)(2008-7#2)(2008-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#4)
registering##4##1##(2007-12#1)(2008-11#1)(2009-10#1)(2010-8#1)
registers of##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
registers##13##1##(1991-11#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#3)(2013-1#3)
registrants for the##2##3##(1994-9#2)
registrar##2##1##(1990-3#1)(2010-12#1)
registrars##3##1##(1992-2#1)(2008-11#1)(2011-2#1)
registration accuracy##2##2##(2007-12#1)(2009-12#1)
registration algorithm##3##2##(2008-2#1)(2011-2#2)
registration and##11##2##(1991-11#1)(1996-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2012-12#5)
registration as##2##2##(1992-1#1)(2011-1#1)
registration for##3##2##(1996-3#1)(2008-11#1)(2008-3#1)
registration in##2##2##(1990-12#1)(2008-10#1)
registration is##2##2##(2008-3#1)(2012-12#1)
registration of births and deaths##2##5##(2008-11#1)(2012-12#1)
registration of births##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
registration of pain##2##3##(1991-11#2)
registration of the##3##3##(2008-10#1)(2009-12#1)(2013-8#1)
registration of##18##2##(1990-6#2)(1991-11#3)(1993-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
registration on##2##2##(1996-5#1)(2008-3#1)
registration systems##5##2##(1993-12#1)(2012-12#4)
registration techniques##2##2##(1996-7#1)(2008-3#1)
registration##107##1##(1990-12#2)(1990-6#2)(1991-11#5)(1991-3#1)(1992-1#4)(1992-10#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#2)(1994-12#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#14)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#4)(2009-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#12)(2012-2#1)(2013-8#1)
registrations##6##1##(1990-2#1)(1991-6#1)(1996-7#1)(2008-7#1)(2010-9#1)(2012-12#1)
registries were##2##2##(1996-12#1)(2012-12#1)
registries##20##1##(1991-2#1)(1993-12#1)(1996-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-10#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)
registry and##2##2##(1996-12#1)(2008-1#1)
registry data##2##2##(2008-3#1)(2012-12#1)
registry in##3##2##(1992-10#1)(2007-10#2)
registry of the##2##3##(1993-9#1)(2013-1#1)
registry of##6##2##(1993-9#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2013-1#1)
registry##38##1##(1992-10#2)(1993-5#1)(1993-9#1)(1996-12#1)(2007-10#2)(2008-1#6)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-6#3)(2011-2#7)(2012-12#2)(2013-1#1)(2013-8#1)
región of##2##2##(2013-8#2)
regress##6##1##(1991-11#1)(1992-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-8#1)
regressed against##3##2##(2008-10#1)(2013-1#2)
regressed and##3##2##(1990-11#1)(1995-3#1)(2010-2#1)
regressed in##2##2##(2008-3#2)
regressed with##3##2##(2008-10#1)(2008-5#2)
regressed##20##1##(1990-11#1)(1991-3#1)(1993-1#1)(1993-11#1)(1995-3#2)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#2)(2010-2#1)(2013-1#2)
regressing out##2##2##(2011-2#2)
regressing##4##1##(2008-3#1)(2009-8#1)(2011-2#2)
regression (MLR)##6##2##(2008-10#6)
regression (PCR) and partial least squares (PLS)##3##7##(2008-10#2)(2013-8#1)
regression (PCR) and partial##4##4##(2008-10#3)(2013-8#1)
regression (PCR)##12##2##(2008-10#11)(2013-8#1)
regression (PLS) and artificial neural##2##5##(2008-10#2)
regression (PLS)##8##2##(2008-10#8)
regression (PLSR)##2##2##(2008-10#1)(2013-8#1)
regression (r##2##2##(1995-2#1)(2008-10#1)
regression after##2##2##(1992-2#1)(2011-1#1)
regression analyses found##2##3##(1996-2#1)(2013-1#1)
regression analyses indicated##2##3##(2007-7#1)(2008-11#1)
regression analyses of the##2##4##(2008-10#2)
regression analyses of##3##3##(2008-10#2)(2011-2#1)
regression analyses revealed##2##3##(2009-5#1)(2010-11#1)
regression analyses showed that##2##4##(2008-8#1)(2011-1#1)
regression analyses showed##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
regression analyses were performed to estimate##2##6##(2007-10#1)(2010-11#1)
regression analyses were performed to##4##5##(2007-10#1)(2008-10#1)(2008-3#1)(2010-11#1)
regression analyses were performed##5##4##(2007-10#1)(2008-10#1)(2008-3#1)(2010-11#1)(2012-2#1)
regression analyses were used to##4##5##(2007-10#1)(2008-10#1)(2010-4#1)(2012-2#1)
regression analyses were##11##3##(2007-10#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)(2012-2#2)
regression analyses##40##2##(1992-2#1)(1994-12#1)(1996-2#1)(1996-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#2)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
regression analysis and##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2011-1#1)
regression analysis between##4##3##(2008-10#2)(2009-11#1)(2011-2#1)
regression analysis indicated that the##3##5##(1996-3#1)(2008-7#1)(2010-7#1)
regression analysis indicated that##5##4##(1996-3#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)
regression analysis is##2##3##(2010-2#1)(2010-6#1)
regression analysis of potentiometric##2##4##(2008-10#2)
regression analysis of the##4##4##(1993-3#1)(2008-10#2)(2012-3#1)
regression analysis of##15##3##(1993-3#1)(2008-10#9)(2008-11#2)(2008-5#1)(2012-3#2)
regression analysis revealed that##6##4##(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
regression analysis revealed##10##3##(1992-6#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
regression analysis showed that the##2##5##(2008-10#1)(2011-1#1)
regression analysis showed that##9##4##(2008-10#1)(2008-11#2)(2008-7#1)(2011-1#3)(2011-2#2)
regression analysis showed##14##3##(1993-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#3)(2011-2#2)
regression analysis was performed##2##4##(2008-10#1)(2012-1#1)
regression analysis was used to evaluate the##2##7##(2011-1#1)(2013-1#1)
regression analysis was used to##5##5##(2008-3#1)(2011-1#2)(2013-1#2)
regression analysis was utilized to##2##5##(2008-11#1)(2008-12#1)
regression analysis was##14##3##(1993-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#3)(2012-1#1)(2013-1#2)(2013-8#1)
regression analysis were##2##3##(2008-11#2)
regression analysis##129##2##(1990-3#1)(1991-1#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-3#1)(1996-5#2)(1996-7#1)(2007-10#2)(2007-11#3)(2007-8#2)(2008-10#41)(2008-11#11)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#6)(2008-8#2)(2009-11#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#2)
regression analysis)##2##2##(2008-4#2)
regression and the##5##3##(1992-6#1)(1995-2#1)(2009-9#1)(2012-3#1)(2013-8#1)
regression and##21##2##(1991-8#1)(1992-6#1)(1995-2#1)(2008-10#9)(2008-3#1)(2009-8#3)(2009-9#1)(2012-3#3)(2013-8#1)
regression approach##4##2##(1995-2#1)(2008-10#3)
regression approaches##2##2##(2008-10#2)
regression are##3##2##(1991-8#1)(2008-10#2)
regression based##3##2##(2009-3#2)(2013-8#1)
regression between the##2##3##(2008-10#1)(2008-3#1)
regression between##5##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)
regression by apoptosis##2##3##(1994-11#1)(1995-6#1)
regression by##3##2##(1994-11#1)(1995-6#1)(2008-10#1)
regression calibration##2##2##(2007-12#1)(2008-10#1)
regression coefficient of 0##2##4##(2008-10#2)
regression coefficient of##4##3##(2008-10#3)(2012-2#1)
regression coefficient##8##2##(2008-10#7)(2012-2#1)
regression coefficients are##2##3##(1997-8#1)(2010-11#1)
regression coefficients of##3##3##(1995-9#1)(2008-10#2)
regression coefficients##15##2##(1995-2#1)(1995-9#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2010-11#1)
regression diagnostics##3##2##(2008-10#3)
regression dilution bias##2##3##(1990-3#2)
regression equation for##3##3##(1995-6#1)(2008-10#2)
regression equation has##2##3##(2008-10#1)(2011-3#1)
regression equation of the calibration graph##4##6##(2008-10#4)
regression equation of##6##3##(2008-10#6)
regression equation##21##2##(1995-6#1)(2008-10#17)(2008-7#1)(2009-11#1)(2011-3#1)
regression equations##4##2##(2007-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
regression for##6##2##(1991-1#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)
regression in the##3##3##(1995-2#1)(2008-10#2)
regression in##9##2##(1992-12#1)(1995-2#1)(2008-10#3)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)
regression indicated that##4##3##(1993-12#1)(2007-6#1)(2007-8#1)(2008-11#1)
regression is##2##2##(2008-10#1)(2012-3#1)
regression line##7##2##(1990-8#1)(2008-10#6)
regression method for##2##3##(2008-3#1)(2012-3#1)
regression method to##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
regression method##25##2##(1995-2#4)(2008-10#15)(2008-3#1)(2012-3#3)(2013-8#2)
regression methods to##3##3##(2008-10#2)(2009-8#1)
regression methods##16##2##(1994-11#1)(1994-2#1)(2008-10#10)(2008-6#1)(2009-8#2)(2012-3#1)
regression model for##7##3##(1992-6#1)(1995-2#1)(1995-9#1)(1997-4#1)(1997-8#1)(2008-8#1)(2011-2#1)
regression model of##2##3##(2011-2#1)(2012-2#1)
regression model that##2##3##(2008-10#1)(2008-3#1)
regression model to##4##3##(1995-2#1)(1997-8#1)(2008-10#1)(2010-8#1)
regression model was used to##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
regression model was##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
regression model with##2##3##(1997-8#1)(2008-8#1)
regression model##56##2##(1992-1#1)(1992-6#1)(1995-2#2)(1995-9#2)(1997-4#1)(1997-8#4)(2007-11#3)(2008-10#12)(2008-11#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
regression modeling of##3##3##(2008-10#2)(2012-1#1)
regression modeling##7##2##(2008-10#3)(2008-8#2)(2012-1#2)
regression modelling##2##2##(2007-12#1)(2009-6#1)
regression models and##3##3##(1992-9#1)(2011-1#1)(2013-1#1)
regression models explained##2##3##(2008-10#2)
regression models for##4##3##(1991-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
regression models to##4##3##(1995-2#1)(2010-12#1)(2011-1#1)(2012-12#1)
regression models were used to##4##5##(2008-10#1)(2012-2#1)(2013-1#2)
regression models were##12##3##(1994-1#1)(2008-10#4)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#4)
regression models with##2##3##(1995-2#1)(2012-1#1)
regression models##61##2##(1990-2#1)(1991-1#1)(1992-9#2)(1994-1#1)(1994-2#1)(1995-2#3)(2007-10#1)(2007-11#1)(2008-10#17)(2008-11#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#2)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
regression neural##2##2##(2008-10#2)
regression of a##3##3##(2008-1#2)(2011-3#1)
regression of laryngeal##2##3##(1990-6#2)
regression of the##14##3##(1991-12#1)(1992-12#1)(1997-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
regression of##49##2##(1990-2#3)(1990-3#1)(1990-6#3)(1991-12#1)(1992-12#1)(1992-3#1)(1994-5#2)(1994-9#1)(1995-9#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
regression on the##2##3##(2008-10#1)(2010-5#1)
regression on##5##2##(1991-5#1)(2008-10#2)(2010-5#1)(2013-8#1)
regression or##2##2##(1990-12#1)(1992-9#1)
regression parameters##4##2##(1992-9#1)(1997-8#1)(2008-3#1)(2008-7#1)
regression problems##2##2##(1997-4#1)(2008-6#1)
regression results##6##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
regression showed##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
regression slope##4##2##(2008-10#3)(2013-1#1)
regression slopes were##2##3##(1990-7#1)(2008-10#1)
regression surface##2##2##(2008-6#2)
regression technique##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
regression techniques##4##2##(2008-10#3)(2008-2#1)
regression to##11##2##(1991-1#1)(2008-10#5)(2008-9#1)(2010-5#1)(2012-3#2)(2013-1#1)
regression tree##4##2##(2008-10#4)
regression triplet##3##2##(2008-10#3)
regression was performed to##2##4##(2008-10#1)(2012-1#1)
regression was used for##2##4##(2008-10#2)
regression was used to assess##2##5##(2011-1#1)(2012-12#1)
regression was used to estimate##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
regression was used to find the straight line that fitted the experimental data##2##13##(2008-10#2)
regression was used to test##3##5##(2010-2#1)(2013-1#2)
regression was used to##18##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
regression was used##21##3##(1994-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
regression was##34##2##(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#3)
regression were##5##2##(2009-4#1)(2009-8#1)(2013-1#2)(2013-8#1)
regression with##11##2##(1996-7#1)(2007-11#2)(2008-10#4)(2009-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
regression##809##1##(1990-12#1)(1990-2#4)(1990-3#5)(1990-6#3)(1990-7#1)(1990-8#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#3)(1992-9#7)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#15)(1995-6#4)(1995-9#7)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#7)(2007-10#8)(2007-11#13)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#299)(2008-11#25)(2008-12#7)(2008-2#4)(2008-3#18)(2008-4#6)(2008-5#3)(2008-6#10)(2008-7#16)(2008-8#19)(2008-9#10)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#4)(2010-1#1)(2010-11#5)(2010-12#4)(2010-2#4)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#21)(2011-2#28)(2011-3#3)(2012-1#8)(2012-12#13)(2012-2#12)(2012-3#33)(2012-7#1)(2013-1#28)(2013-7#3)(2013-8#24)
regression-based##3##1##(1997-1#1)(2008-2#1)(2008-3#1)
regressions on##2##2##(2007-11#1)(2013-1#1)
regressions were##2##2##(2008-10#1)(2013-1#1)
regressions##19##1##(1991-2#1)(2007-11#2)(2008-10#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-4#1)(2011-2#3)(2013-1#4)(2013-7#1)
regressive##5##1##(1991-3#1)(1993-2#1)(1996-6#1)(2008-11#1)(2009-10#1)
regrets that this article is an accidental duplication of an article that has already been published in##6##17##(2008-11#5)(2008-7#1)
regrets that this article is an accidental duplication of an article that has already been published##7##16##(2008-11#5)(2008-7#1)(2012-3#1)
regrets that this article##8##4##(2008-11#6)(2008-7#1)(2012-3#1)
regrow a noticeable amount of hair##2##6##(2008-5#2)
regrowth of##5##2##(1992-9#1)(1995-11#2)(2008-7#2)
regrowth than##2##2##(1997-7#1)(2008-7#1)
regrowth##17##1##(1992-2#1)(1992-9#4)(1995-11#2)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#6)
regular and##7##2##(1993-3#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
regular clinical##2##2##(1990-9#1)(1992-12#1)
regular consumption of##5##3##(2008-5#1)(2009-5#3)(2011-2#1)
regular contact with##2##3##(2008-11#2)
regular control##2##2##(2007-11#1)(2011-2#1)
regular exercise##5##2##(1995-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
regular follow up in##2##4##(2008-8#1)(2011-2#1)
regular follow up##4##3##(2008-8#1)(2011-2#3)
regular follow-up##4##2##(1996-7#1)(2011-2#2)(2013-1#1)
regular grid##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
regular labeling of##2##3##(2008-10#2)
regular long-term##2##2##(2008-9#1)(2013-8#1)
regular medical##2##2##(1994-12#1)(2010-8#1)
regular night nursing##2##3##(2010-7#2)
regular or##2##2##(2007-11#1)(2008-3#1)
regular pattern##3##2##(1994-9#1)(2007-11#1)(2009-8#1)
regular patterns of##2##3##(2008-10#1)(2008-7#1)
regular patterns##3##2##(1993-11#1)(2008-10#1)(2008-7#1)
regular physical activity##4##3##(2007-6#2)(2008-5#1)(2009-3#1)
regular polygon and slit##2##4##(2008-3#2)
regular primary##2##2##(1996-1#1)(2009-3#1)
regular sieving structures##2##3##(2008-7#2)
regular solution theory##6##3##(2008-10#6)
regular solution##7##2##(1994-12#1)(2008-10#6)
regular structures##2##2##(1993-3#1)(2008-7#1)
regular suture##2##2##(1991-12#2)
regular toileting##2##2##(1991-8#2)
regular use of these##2##4##(1991-9#1)(2008-5#1)
regular use of##8##3##(1990-9#1)(1991-9#2)(1992-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)
regular use##9##2##(1990-9#1)(1991-9#2)(1992-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
regular users##2##2##(2008-12#1)(2012-1#1)
regular##249##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-9#2)(1991-12#3)(1991-2#1)(1991-8#4)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-3#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#9)(2008-10#32)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#20)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
regularities in the##2##3##(2012-2#2)
regularities##6##1##(2008-11#1)(2010-9#1)(2012-2#3)(2013-1#1)
regularity of##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
regularity##16##1##(2007-12#1)(2008-10#6)(2008-11#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#4)
regularization method##2##2##(2008-3#2)
regularization parameter##6##2##(2008-10#1)(2008-3#2)(2010-2#3)
regularization parameters##2##2##(2008-3#2)
regularization scheme##3##2##(2008-2#1)(2008-3#2)
regularization solution##2##2##(2008-3#2)
regularization##35##1##(1996-4#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#21)(2008-6#3)(2010-2#3)(2012-12#2)
regularized functional##2##2##(2008-2#2)
regularized least-squares##2##2##(2008-2#1)(2008-6#1)
regularized phase-tracking (RPT)##4##3##(2008-3#4)
regularized phase-tracking technique##3##3##(2008-3#3)
regularized phase-tracking##8##2##(2008-3#8)
regularized##22##1##(2007-12#1)(2008-2#5)(2008-3#10)(2008-6#5)(2010-1#1)
regularly and##4##2##(1990-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
regularly assessed##2##2##(2011-2#1)(2012-1#1)
regularly by##2##2##(1993-8#1)(1997-8#1)
regularly distributed##2##2##(2008-10#1)(2008-3#1)
regularly documented included##2##3##(2008-12#2)
regularly for##2##2##(2008-7#1)(2011-2#1)
regularly from##2##2##(1990-12#1)(1996-2#1)
regularly in##3##2##(1997-8#1)(2007-11#1)(2013-8#1)
regularly monitored##2##2##(2008-11#1)(2011-1#1)
regularly observed in##2##3##(1992-3#1)(1993-11#1)
regularly over##2##2##(1992-9#1)(2008-5#1)
regularly scheduled##4##2##(2008-4#2)(2009-4#1)(2012-12#1)
regularly spaced##2##2##(2008-10#1)(2008-3#1)
regularly updated##2##2##(2011-2#1)(2013-1#1)
regularly with##2##2##(1996-2#1)(2008-10#1)
regularly##85##1##(1990-12#2)(1990-3#1)(1990-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-8#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
regulatable##2##1##(2008-11#2)
regulate P2##2##2##(2008-4#2)
regulate a large number of##2##5##(2008-4#1)(2009-8#1)
regulate a number of##3##4##(1996-12#1)(2008-11#1)(2009-5#1)
regulate a##11##2##(1990-8#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#1)
regulate actin##4##2##(1996-2#1)(2012-2#3)
regulate body##2##2##(2008-5#1)(2009-5#1)
regulate both##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
regulate cell cycle progression##2##4##(1991-9#1)(1994-8#1)
regulate cell growth##2##3##(1995-8#1)(2008-11#1)
regulate cell##7##2##(1991-9#1)(1994-6#1)(1994-8#1)(1995-8#1)(2008-11#2)(2012-12#1)
regulate cellular responses##2##3##(1997-4#1)(2009-12#1)
regulate cellular##3##2##(1997-4#1)(2009-12#1)(2013-1#1)
regulate diverse##2##2##(2007-12#2)
regulate expression of the##2##4##(1995-2#1)(2008-7#1)
regulate gene expression##11##3##(1993-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)
regulate glucose##2##2##(2008-1#1)(2011-2#1)
regulate immune##2##2##(2007-2#1)(2012-12#1)
regulate its##2##2##(2007-12#1)(2008-11#1)
regulate many##2##2##(2008-4#1)(2008-8#1)
regulate market share##2##3##(1996-12#1)(1997-2#1)
regulate neuronal##4##2##(1995-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
regulate plant##2##2##(2008-8#1)(2009-6#1)
regulate specific##2##2##(1995-2#1)(2009-5#1)
regulate synaptic##2##2##(2008-4#1)(2008-7#1)
regulate the activity of##5##4##(1995-2#1)(1995-5#2)(2008-9#1)(2009-8#1)
regulate the cell##3##3##(1994-11#1)(2008-11#1)(2012-3#1)
regulate the development of##2##4##(2008-9#1)(2010-5#1)
regulate the expression of a##3##5##(1995-12#1)(2010-8#1)(2012-12#1)
regulate the expression of##17##4##(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#1)
regulate the gene expression##2##4##(2008-9#1)(2011-2#1)
regulate the gene##3##3##(1995-6#1)(2008-9#1)(2011-2#1)
regulate the rate of##2##4##(1990-8#1)(2008-10#1)
regulate the##76##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#1)
regulate their##4##2##(1995-8#1)(2008-10#1)(2009-3#1)(2012-2#1)
regulate these##2##2##(1992-3#1)(2012-2#1)
regulate this##4##2##(2007-12#1)(2008-7#1)(2009-6#1)(2009-8#1)
regulate transcription##5##2##(1991-2#1)(1995-2#1)(1997-2#1)(2008-9#1)(2011-2#1)
regulate vascular tone##2##3##(1995-2#1)(2012-4#1)
regulate##286##1##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#8)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#4)(1996-2#7)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#16)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#17)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#11)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#3)(2009-6#3)(2009-8#8)(2009-9#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#13)(2012-2#22)(2012-3#6)(2012-4#1)(2013-1#9)(2013-7#1)(2013-8#4)
regulated and constitutive secretory##3##4##(1992-12#3)
regulated and constitutive##4##3##(1992-12#4)
regulated and##16##2##(1990-7#1)(1992-12#4)(1994-9#1)(1995-12#1)(1995-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
regulated are##2##2##(2008-9#1)(2012-2#1)
regulated as##2##2##(1992-3#1)(2009-3#1)
regulated at the transcriptional level##2##5##(1991-12#1)(2009-8#1)
regulated at the##6##3##(1991-12#1)(1992-3#1)(1992-8#1)(2009-6#1)(2009-8#1)(2013-1#1)
regulated at translation level##2##4##(2008-9#2)
regulated at##13##2##(1991-12#1)(1992-3#1)(1992-8#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2013-1#2)
regulated by Ca(2+)##2##3##(2008-8#2)
regulated by Ca2+##2##3##(1994-6#1)(1995-6#1)
regulated by Se##2##3##(1991-12#1)(2012-2#1)
regulated by a balance between##2##5##(1990-5#1)(2007-10#1)
regulated by a balance##3##4##(1990-5#1)(2007-10#1)(2013-1#1)
regulated by a complex##4##4##(1992-8#1)(2009-8#1)(2010-8#1)(2012-2#1)
regulated by a protein kinase##2##5##(1993-3#1)(1997-1#1)
regulated by a##17##3##(1990-5#2)(1990-9#1)(1992-8#1)(1993-3#1)(1994-12#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
regulated by an##2##3##(2008-10#1)(2008-5#1)
regulated by carbon sources##2##4##(1991-9#2)
regulated by cell##2##3##(1995-8#1)(2010-7#1)
regulated by covalent modification##2##4##(1990-8#2)
regulated by endogenous##2##3##(1996-10#1)(2008-1#1)
regulated by genetic##2##3##(2008-2#1)(2013-1#1)
regulated by intracellular##2##3##(1995-11#1)(2008-8#1)
regulated by mechanisms##2##3##(1992-5#1)(2009-6#1)
regulated by multiple##3##3##(1997-7#1)(2009-3#1)(2012-3#1)
regulated by protein kinase A##2##5##(1991-2#1)(2008-8#1)
regulated by several##2##3##(2008-7#1)(2008-8#1)
regulated by tetracycline##2##3##(2008-2#1)(2013-1#1)
regulated by the##23##3##(1990-5#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-12#2)(1995-2#2)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2013-1#1)
regulated by these##2##3##(1997-2#1)(1997-7#1)
regulated by two##4##3##(1994-5#1)(1995-8#1)(2008-9#1)(2011-2#1)
regulated by various##2##3##(1994-8#1)(2008-4#1)
regulated by##185##2##(1990-11#2)(1990-5#4)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#5)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#6)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#4)(2009-10#1)(2009-3#5)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#9)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
regulated during oogenesis##2##3##(2009-3#2)
regulated during##8##2##(1991-9#1)(1993-3#1)(1997-4#1)(2008-8#1)(2009-3#3)(2010-8#1)
regulated expression of##6##3##(1992-6#1)(1993-3#1)(1993-9#2)(1997-4#1)(2008-11#1)
regulated expression##7##2##(1992-6#1)(1993-3#1)(1993-9#2)(1997-4#1)(2008-11#2)
regulated genes##2##2##(1992-6#1)(1993-6#1)
regulated has##2##2##(2008-11#1)(2008-9#1)
regulated in a##4##3##(1991-12#1)(1993-8#1)(1995-2#1)(1997-2#1)
regulated in human##2##3##(1991-11#1)(1995-6#1)
regulated in response to##5##4##(1994-8#1)(1996-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
regulated in the##9##3##(1991-11#1)(1992-3#1)(1993-5#1)(2008-10#3)(2009-3#1)(2010-12#1)(2011-2#1)
regulated in##34##2##(1990-11#1)(1990-7#1)(1991-11#2)(1991-12#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-10#4)(2008-4#1)(2009-3#2)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2013-1#1)
regulated kinases##2##2##(1994-8#1)(2008-4#1)
regulated mainly##2##2##(1993-6#1)(2008-5#1)
regulated manner##6##2##(1994-9#1)(2008-1#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
regulated membrane fusion##2##3##(2009-7#1)(2012-2#1)
regulated or##3##2##(1991-12#1)(2008-5#1)(2008-8#1)
regulated primarily##2##2##(1990-12#1)(2008-9#1)
regulated processes##2##2##(2009-8#1)(2011-2#1)
regulated protein##3##2##(1990-2#1)(2008-4#1)(2008-8#1)
regulated proteins##5##2##(1994-12#1)(1996-5#1)(2008-4#1)(2008-8#1)(2009-2#1)
regulated secretory granules##2##3##(1992-12#2)
regulated secretory##8##2##(1990-5#2)(1992-12#2)(1993-5#1)(1994-11#2)(2010-11#1)
regulated system##2##2##(1990-8#1)(2008-11#1)
regulated the expression of##2##4##(1997-7#1)(2008-11#1)
regulated the##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2013-1#1)
regulated through the##2##3##(1995-11#1)(2012-2#1)
regulated through##6##2##(1993-6#1)(1995-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
regulated to##3##2##(2008-5#1)(2009-9#1)(2013-8#1)
regulated under##2##2##(1996-3#1)(2009-9#1)
regulated via##3##2##(1996-7#1)(1997-1#1)(2008-9#1)
regulated##443##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#7)(1990-7#2)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#4)(1991-9#3)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#6)(1993-5#5)(1993-6#6)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#9)(1994-12#11)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#1)(1995-11#6)(1995-12#4)(1995-2#11)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#8)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-5#3)(1996-7#1)(1997-1#3)(1997-2#7)(1997-3#1)(1997-4#3)(1997-6#5)(1997-7#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#19)(2008-11#16)(2008-12#2)(2008-2#3)(2008-4#18)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#18)(2008-9#16)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#11)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#19)(2009-9#3)(2010-11#7)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#14)(2012-3#2)(2013-1#15)(2013-8#4)
regulated)##2##1##(1994-12#1)(2008-11#1)
regulated?##2##1##(1992-8#1)(1997-6#1)
regulates ERK##2##2##(2009-8#1)(2010-10#1)
regulates a##5##2##(1995-12#1)(2008-11#1)(2008-8#1)(2010-9#1)(2011-2#1)
regulates cellular##2##2##(2008-8#1)(2012-2#1)
regulates gene##2##2##(1995-2#1)(2011-2#1)
regulates migration of##2##3##(1995-8#1)(2010-8#1)
regulates osteoclast##2##2##(1991-12#1)(2012-3#1)
regulates several##2##2##(2008-1#1)(2008-10#1)
regulates the activity of##2##4##(1993-6#1)(1994-10#1)
regulates the expression of##4##4##(1991-9#1)(1992-8#1)(1994-9#1)(2010-7#1)
regulates the##29##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
regulates tumor cell##2##3##(2009-3#1)(2011-1#1)
regulates β-cell function##3##3##(2012-2#3)
regulates##125##1##(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#4)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-3#3)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#8)(2012-2#11)(2012-3#4)(2012-7#1)(2013-1#5)
regulating Notch##2##2##(2010-3#2)
regulating activity of##2##3##(1993-3#1)(1993-8#1)
regulating activity##3##2##(1993-3#1)(1993-8#1)(2009-5#1)
regulating angiogenesis##3##2##(2008-9#2)(2013-1#1)
regulating both##2##2##(2007-10#1)(2009-8#1)
regulating cell##10##2##(1991-12#1)(1992-9#1)(1996-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-2#1)
regulating expression##2##2##(2008-11#1)(2010-8#1)
regulating gene expression##4##3##(1996-3#1)(2007-12#1)(2008-4#2)
regulating hormone##2##2##(2008-4#1)(2008-5#1)
regulating hospital##2##2##(1993-3#1)(1996-2#1)
regulating insulin secretion##2##3##(2008-4#1)(2010-11#1)
regulating its##2##2##(1995-6#1)(2010-8#1)
regulating lipid##2##2##(2008-1#1)(2008-9#1)
regulating proteins##3##2##(2008-9#2)(2012-2#1)
regulating stomatal##3##2##(1994-11#1)(2008-8#2)
regulating the dynamics of##2##4##(2009-8#1)(2012-2#1)
regulating the expression of the##3##5##(1997-7#2)(1997-8#1)
regulating the expression of##8##4##(1997-7#2)(1997-8#1)(2008-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)
regulating the level of##2##4##(1992-6#1)(2009-8#1)
regulating the level##3##3##(1992-6#1)(2008-11#1)(2009-8#1)
regulating the synthesis##2##3##(1997-8#1)(2013-1#1)
regulating the##57##2##(1991-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-5#1)(1996-12#1)(1997-3#1)(1997-7#2)(1997-8#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2009-5#1)(2009-8#3)(2010-11#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
regulating their##2##2##(1996-12#1)(2013-1#1)
regulating these##2##2##(2013-1#1)(2013-7#1)
regulating vascular tone##2##3##(1994-6#1)(1995-12#1)
regulating β-cell mass##2##3##(2010-11#2)
regulating##226##1##(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#7)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#6)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#3)(1997-8#2)(1997-9#1)(2007-10#1)(2007-12#4)(2008-1#2)(2008-10#4)(2008-11#15)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#13)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#15)(2008-9#8)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#3)(2009-8#9)(2009-9#2)(2010-1#1)(2010-11#4)(2010-2#1)(2010-3#6)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#2)(2011-2#11)(2011-3#1)(2012-12#8)(2012-2#7)(2012-3#5)(2013-1#11)(2013-7#3)(2013-8#1)
regulation 21 CFR Part 11##2##5##(2008-10#2)
regulation among##2##2##(2008-7#1)(2012-2#1)
regulation and apoptosis##4##3##(1995-2#3)(2011-2#1)
regulation and control##2##3##(1995-2#1)(2008-9#1)
regulation and expression of the creatine transporter##2##7##(2008-5#2)
regulation and expression of##3##4##(2008-5#2)(2012-12#1)
regulation and the##2##3##(2008-4#1)(2008-8#1)
regulation and to##3##3##(1995-2#1)(2008-8#1)(2009-3#1)
regulation and##51##2##(1990-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-2#6)(1995-6#1)(1996-10#1)(1996-9#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
regulation are##3##2##(1992-11#1)(1994-8#1)(2009-8#1)
regulation as a##2##3##(1994-8#1)(1996-1#1)
regulation as well as##2##4##(2008-11#1)(2009-8#1)
regulation as##5##2##(1994-8#1)(1996-1#1)(1997-1#1)(2008-11#1)(2009-8#1)
regulation at the##2##3##(1990-8#1)(2011-2#1)
regulation at##3##2##(1990-8#1)(2011-2#2)
regulation by 1alpha##2##3##(2008-11#2)
regulation by a##2##3##(1990-2#1)(2009-6#1)
regulation by the##5##3##(1993-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(2012-2#1)
regulation by##37##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-8#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
regulation can##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
regulation during##2##2##(2009-8#1)(2013-1#1)
regulation effects##3##2##(2008-10#2)(2008-9#1)
regulation factors##2##2##(2008-2#1)(2012-3#1)
regulation for##4##2##(1991-2#1)(1991-3#1)(2008-10#1)(2008-8#1)
regulation function##2##2##(2008-8#1)(2012-3#1)
regulation have##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
regulation in breast cancer##2##4##(1991-3#1)(2009-4#1)
regulation in the##10##3##(1993-11#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#1)
regulation in##37##2##(1991-3#1)(1993-11#1)(1994-11#2)(1995-11#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-1#1)(2008-3#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2011-1#1)(2012-3#2)(2013-7#1)
regulation involving##2##2##(1990-2#1)(2008-7#1)
regulation is associated with##2##4##(1990-8#1)(1994-10#1)
regulation is not##2##3##(2008-6#1)(2008-7#1)
regulation is##23##2##(1990-8#1)(1991-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#1)
regulation may be##2##3##(2008-1#1)(2010-12#1)
regulation may##3##2##(1994-2#1)(2008-1#1)(2010-12#1)
regulation mechanism of##4##3##(1997-6#1)(1997-8#1)(2008-11#1)(2008-9#1)
regulation mechanism##6##2##(1993-12#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
regulation mechanisms of##2##3##(2008-11#1)(2008-7#1)
regulation mechanisms##5##2##(2008-11#1)(2008-7#2)(2008-8#1)(2011-1#1)
regulation of APS reductase by##2##5##(2009-8#2)
regulation of CRH##2##3##(2008-11#1)(2008-4#1)
regulation of PEPCK gene expression##6##5##(1995-6#4)(1996-2#2)
regulation of PEPCK gene transcription##3##5##(1996-2#3)
regulation of PEPCK gene##9##4##(1995-6#4)(1996-2#5)
regulation of PI3K##2##3##(2010-9#2)
regulation of T-type##2##3##(2008-8#2)
regulation of a##4##3##(1990-11#1)(1997-7#1)(2007-5#1)(2010-12#1)
regulation of angiogenesis##2##3##(2008-1#2)
regulation of apoptosis and##2##4##(1994-10#1)(2008-7#1)
regulation of apoptosis##4##3##(1994-10#1)(2008-7#1)(2008-8#2)
regulation of basal##2##3##(1995-5#1)(2013-1#1)
regulation of behavior##2##3##(2008-7#1)(2010-4#1)
regulation of blood##2##3##(1992-12#1)(2010-11#1)
regulation of brain##3##3##(1991-5#1)(2007-8#1)(2008-1#1)
regulation of cell cycle##3##4##(2009-3#1)(2012-12#1)(2012-3#1)
regulation of cell growth and##2##5##(2008-4#1)(2008-8#1)
regulation of cell growth##3##4##(1994-12#1)(2008-4#1)(2008-8#1)
regulation of cell proliferation##4##4##(1993-9#1)(2008-4#3)
regulation of cell##17##3##(1992-8#1)(1993-9#1)(1994-12#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-4#4)(2008-8#2)(2009-3#1)(2009-8#1)(2012-12#2)(2012-3#1)
regulation of cellular##10##3##(1991-5#1)(1994-9#1)(2007-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2013-7#1)
regulation of channel##2##3##(2008-8#2)
regulation of cholesterol##3##3##(1991-5#1)(1995-12#1)(2013-1#1)
regulation of clinical##2##3##(1994-12#1)(2012-3#1)
regulation of developmental##2##3##(1996-10#1)(2008-8#1)
regulation of endothelial##3##3##(2008-10#1)(2010-9#1)(2012-3#1)
regulation of energy##7##3##(1994-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)
regulation of eosinophil-specific genes##2##4##(2012-3#2)
regulation of expression of the##3##5##(1996-5#1)(2008-7#1)(2009-9#1)
regulation of expression##4##3##(1991-5#1)(1996-5#1)(2008-7#1)(2009-9#1)
regulation of gastric function##2##4##(1992-6#2)
regulation of gastric##3##3##(1992-6#2)(1997-1#1)
regulation of gene expression in##3##5##(2007-11#1)(2008-7#1)(2011-2#1)
regulation of gene expression##22##4##(1991-6#1)(1992-6#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#4)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
regulation of gene##23##3##(1991-6#1)(1992-6#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#4)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
regulation of genes involved in##2##5##(2008-1#1)(2012-12#1)
regulation of genes##4##3##(1996-12#1)(2008-1#2)(2012-12#1)
regulation of glucose transport##2##4##(1992-11#1)(1994-12#1)
regulation of glucose##5##3##(1992-11#1)(1994-12#1)(2008-11#2)(2008-4#1)
regulation of growth##5##3##(1990-12#1)(1994-8#2)(1995-11#1)(2013-1#1)
regulation of hIK1##2##3##(2008-8#2)
regulation of hepatic##2##3##(1990-3#1)(1993-8#1)
regulation of hippocampal##2##3##(1996-5#1)(2009-8#1)
regulation of hormonal##2##3##(2012-2#1)(2013-1#1)
regulation of human##7##3##(1990-2#2)(1991-12#1)(1993-8#1)(1994-6#1)(1995-2#1)(2008-4#1)
regulation of immune##2##3##(2011-2#1)(2013-1#1)
regulation of insulin gene##2##4##(2008-1#1)(2010-11#1)
regulation of insulin##4##3##(2008-1#1)(2010-11#1)(2013-1#2)
regulation of intestinal##3##3##(1994-8#1)(1995-12#1)(1996-5#1)
regulation of intracellular##2##3##(1990-12#1)(2013-1#1)
regulation of its##3##3##(1995-11#1)(1996-2#1)(1996-5#1)
regulation of many cellular##2##4##(2009-4#1)(2009-5#1)
regulation of many##3##3##(2008-5#1)(2009-4#1)(2009-5#1)
regulation of muscle##5##3##(1995-2#3)(2009-3#1)(2012-2#1)
regulation of nuclear##2##3##(1994-5#1)(2009-6#1)
regulation of private health insurance##2##5##(1993-3#1)(2008-7#1)
regulation of proliferation and##2##4##(2012-1#1)(2013-1#1)
regulation of proliferation##5##3##(1992-8#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
regulation of protein kinase C activity##2##6##(1990-5#1)(1990-8#1)
regulation of protein##6##3##(1990-5#1)(1990-8#2)(1992-8#1)(1996-2#1)(2008-11#1)
regulation of sympathetic##2##3##(2008-1#1)(2008-2#1)
regulation of synaptic##4##3##(1996-12#1)(2008-7#1)(2009-8#1)(2012-2#1)
regulation of the expression of##3##5##(1992-12#1)(1993-9#1)(2008-9#1)
regulation of the gene##3##4##(1991-5#1)(1991-6#1)(1993-12#1)
regulation of the human##4##4##(1990-5#1)(1994-8#1)(2008-11#1)(2008-8#1)
regulation of the metabolism of##2##5##(1992-11#1)(1993-6#1)
regulation of the##93##3##(1990-2#1)(1990-5#2)(1991-1#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#4)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#4)(1997-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
regulation of their expression##4##4##(1992-3#1)(1994-11#1)(2008-4#1)(2008-8#1)
regulation of their##5##3##(1992-3#1)(1994-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
regulation of these genes##2##4##(1990-3#1)(1990-5#1)
regulation of these two##2##4##(1991-5#1)(2009-8#1)
regulation of these##10##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1993-6#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
regulation of this##2##3##(1994-11#1)(2011-2#1)
regulation of transcription##2##3##(2010-2#1)(2011-2#1)
regulation of tumor cell##2##4##(2008-4#1)(2012-1#1)
regulation of uterine##2##3##(1994-9#1)(2012-3#1)
regulation of various biological##2##4##(2008-11#1)(2008-9#1)
regulation of##631##2##(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#5)(1990-8#3)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#13)(1991-6#3)(1991-7#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#5)(1992-3#1)(1992-6#11)(1992-8#5)(1992-9#4)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-5#7)(1993-6#10)(1993-8#7)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#6)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#11)(1994-9#4)(1995-11#9)(1995-12#12)(1995-2#8)(1995-3#3)(1995-5#5)(1995-6#8)(1995-8#7)(1996-10#2)(1996-12#11)(1996-2#15)(1996-3#1)(1996-5#5)(1997-1#5)(1997-2#3)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#2)(2007-8#2)(2008-1#10)(2008-10#10)(2008-11#30)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#29)(2008-5#8)(2008-6#8)(2008-7#33)(2008-8#33)(2008-9#16)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#18)(2009-9#4)(2010-10#2)(2010-11#8)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#5)(2010-9#5)(2011-1#5)(2011-2#26)(2011-3#2)(2012-1#5)(2012-12#10)(2012-2#13)(2012-3#11)(2012-7#1)(2013-1#21)(2013-7#5)(2013-8#5)
regulation on##3##2##(1995-2#1)(2010-7#1)(2011-2#1)
regulation or##5##2##(1994-12#1)(2008-4#1)(2010-5#1)(2012-12#2)
regulation properties##2##2##(2008-10#1)(2009-10#1)
regulation remains to be##2##4##(1995-2#1)(2008-9#1)
regulation requires##2##2##(2008-4#1)(2012-3#1)
regulation systems##4##2##(1991-5#1)(2008-10#1)(2008-11#2)
regulation that##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
regulation to##4##2##(1996-3#1)(1997-7#1)(2008-7#1)(2012-12#1)
regulation using##2##2##(1995-11#1)(2013-8#1)
regulation was##4##2##(1994-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
regulation which##3##2##(1994-6#1)(2008-1#1)(2008-11#1)
regulation will##2##2##(2008-7#1)(2010-3#1)
regulation##1079##1##(1990-11#5)(1990-12#2)(1990-2#8)(1990-3#2)(1990-5#12)(1990-6#1)(1990-8#8)(1991-1#1)(1991-12#13)(1991-2#4)(1991-3#5)(1991-5#19)(1991-6#3)(1991-7#2)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#6)(1992-3#3)(1992-6#13)(1992-8#6)(1992-9#5)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#4)(1993-5#8)(1993-6#14)(1993-8#11)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#13)(1994-12#9)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#4)(1994-8#15)(1994-9#6)(1995-1#1)(1995-11#14)(1995-12#16)(1995-2#20)(1995-3#5)(1995-5#5)(1995-6#13)(1995-8#8)(1996-1#3)(1996-10#3)(1996-12#11)(1996-2#19)(1996-3#3)(1996-5#6)(1996-9#1)(1997-1#8)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#4)(1997-8#3)(1997-9#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-5#2)(2007-8#3)(2008-1#17)(2008-10#28)(2008-11#57)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#44)(2008-5#14)(2008-6#14)(2008-7#65)(2008-8#60)(2008-9#42)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#12)(2009-4#5)(2009-5#6)(2009-6#10)(2009-7#4)(2009-8#28)(2009-9#4)(2010-1#1)(2010-10#6)(2010-11#10)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#8)(2011-2#47)(2011-3#3)(2012-1#9)(2012-12#21)(2012-2#19)(2012-3#24)(2012-7#1)(2013-1#29)(2013-7#8)(2013-8#12)
regulation)##5##1##(1991-1#1)(1993-12#1)(2008-11#1)(2008-7#1)(2009-10#1)
regulations and controls on safe use of OP particularly in Asian countries are recommended##2##14##(2013-1#2)
regulations and##17##2##(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1995-2#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
regulations are##7##2##(1993-12#1)(1993-3#1)(1995-3#1)(1995-9#1)(2007-5#1)(2008-11#1)(2012-3#1)
regulations as##2##2##(1994-1#1)(2008-11#1)
regulations concerning##3##2##(1991-11#1)(1992-11#1)(1995-2#1)
regulations for##5##2##(1991-8#1)(1992-11#1)(1993-3#1)(1994-1#1)(2008-11#1)
regulations governing the##2##3##(1990-2#1)(2007-11#1)
regulations of the##2##3##(2008-11#1)(2012-3#1)
regulations of##5##2##(1995-6#1)(2008-11#2)(2009-5#1)(2012-3#1)
regulations on##4##2##(1990-2#1)(1991-2#1)(1995-2#2)
regulations regarding##2##2##(2008-10#1)(2013-8#1)
regulations such as those imposed by the USP##2##8##(2012-2#2)
regulations that##2##2##(1994-2#1)(1996-8#1)
regulations were##2##2##(1993-3#1)(2007-12#1)
regulations##114##1##(1990-10#1)(1990-2#3)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#8)(1994-1#3)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#12)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
regulations'##2##1##(1994-2#1)(2008-11#1)
regulative effect of acupuncture on##2##5##(2012-3#2)
regulative effect of##3##3##(2008-9#1)(2012-3#2)
regulative##7##1##(1992-5#1)(2008-11#1)(2008-9#2)(2009-6#1)(2012-3#2)
regulator (CFTR)##3##2##(1990-8#1)(1997-3#1)(2011-3#1)
regulator (Fur) protein##2##3##(1997-7#1)(2009-6#1)
regulator for##2##2##(2008-11#1)(2011-2#1)
regulator in the presence of##2##5##(1990-7#1)(1994-11#1)
regulator in##6##2##(1990-7#1)(1993-11#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#1)
regulator of angiogenesis##2##3##(2013-1#1)(2013-8#1)
regulator of cell cycle##2##4##(2008-4#1)(2012-3#1)
regulator of cell##6##3##(1995-12#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)(2013-1#1)
regulator of inflammation##2##3##(2007-7#1)(2008-7#1)
regulator of insulin secretion##3##4##(1997-4#1)(2010-11#2)
regulator of insulin##4##3##(1996-2#1)(1997-4#1)(2010-11#2)
regulator of skeletal##2##3##(1994-2#1)(2012-12#1)
regulator of the##7##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)
regulator of vascular##2##3##(1995-2#1)(2011-1#1)
regulator of##59##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-11#5)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
regulator that##4##2##(2009-8#1)(2012-12#1)(2012-2#2)
regulator which##2##2##(1991-12#1)(2008-8#1)
regulator##128##1##(1990-11#1)(1990-5#1)(1990-7#7)(1990-8#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-6#4)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#5)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#1)
regulators and##6##2##(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#3)
regulators have##3##2##(2007-5#1)(2008-11#1)(2012-1#1)
regulators in##4##2##(1993-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
regulators of the##5##3##(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#1)(2013-1#1)
regulators of##42##2##(1992-3#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-8#2)(2007-12#2)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#1)
regulators or##3##2##(2008-9#1)(2012-2#2)
regulators##108##1##(1991-5#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#3)(1997-3#1)(1997-4#2)(1997-7#2)(2007-12#3)(2007-3#1)(2007-5#3)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#1)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#2)
regulatory (R)##2##2##(1990-8#1)(1994-8#1)
regulatory B##2##2##(2010-5#1)(2011-2#1)
regulatory T cells and##3##4##(2007-5#1)(2010-5#1)(2012-1#1)
regulatory T cells##13##3##(2007-5#3)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-8#1)
regulatory T##16##2##(2007-5#3)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-3#2)(2013-8#1)
regulatory agencies in##2##3##(2008-1#1)(2008-10#1)
regulatory agencies##10##2##(1992-2#1)(1992-3#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-2#1)
regulatory analysis##2##2##(1992-12#1)(2008-11#1)
regulatory and catalytic##2##3##(1992-6#1)(2008-11#1)
regulatory and##10##2##(1991-3#1)(1992-6#1)(1993-3#1)(2008-11#1)(2008-7#2)(2010-11#1)(2010-5#1)(2012-3#1)(2013-7#1)
regulatory approach##2##2##(1996-1#1)(1997-1#1)
regulatory aspects##2##2##(2008-11#1)(2009-9#1)
regulatory authorities##5##2##(2008-10#1)(2008-11#1)(2008-8#2)(2013-8#1)
regulatory authority##3##2##(1991-3#1)(2008-11#2)
regulatory binding sites##2##3##(1993-8#1)(2008-11#1)
regulatory binding##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
regulatory bodies and##2##3##(2008-10#1)(2008-4#1)
regulatory bodies##6##2##(2008-10#1)(2008-11#2)(2008-4#1)(2009-11#1)(2011-2#1)
regulatory cascade##2##2##(1994-8#1)(2009-9#1)
regulatory changes##2##2##(1991-3#1)(2008-11#1)
regulatory circuit##4##2##(1997-4#2)(2012-3#1)(2013-1#1)
regulatory complexes##2##2##(2007-12#1)(2008-4#1)
regulatory compliance##3##2##(2008-10#3)
regulatory control##3##2##(1994-1#1)(1994-11#1)(1996-12#1)
regulatory domain##7##2##(1990-7#1)(1994-8#1)(1995-6#1)(1997-6#1)(2011-3#1)(2012-12#1)(2012-2#1)
regulatory domains of##2##3##(1995-11#1)(1995-6#1)
regulatory effect of##2##3##(2008-10#1)(2013-1#1)
regulatory effect##4##2##(2007-12#1)(2008-10#1)(2013-1#2)
regulatory effects of##2##3##(1993-6#1)(1996-5#1)
regulatory effects##3##2##(1993-6#1)(1996-5#1)(1997-4#1)
regulatory element is##3##3##(1991-11#1)(1995-2#1)(1997-2#1)
regulatory element of##4##3##(1993-6#1)(1997-4#2)(2008-11#1)
regulatory element##14##2##(1990-5#1)(1991-11#2)(1993-6#1)(1995-2#4)(1997-2#1)(1997-4#2)(1997-6#1)(2008-11#1)(2012-2#1)
regulatory elements and##2##3##(1997-7#2)
regulatory elements in the##2##4##(1993-12#1)(1997-7#1)
regulatory elements in##6##3##(1993-12#3)(1993-6#1)(1997-7#1)(2008-7#1)
regulatory elements of##2##3##(1994-5#1)(1995-2#1)
regulatory elements with##2##3##(1995-2#1)(2008-11#1)
regulatory elements##36##2##(1991-11#1)(1991-7#1)(1991-9#1)(1993-12#7)(1993-5#1)(1993-6#4)(1994-12#2)(1994-5#1)(1995-2#3)(1997-2#1)(1997-7#4)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2012-3#2)
regulatory environment##4##2##(2008-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
regulatory enzymes##3##2##(2009-10#1)(2010-11#1)(2012-1#1)
regulatory events##3##2##(1990-12#1)(2009-3#1)(2010-2#1)
regulatory factor##3##2##(2008-10#2)(2012-3#1)
regulatory factors on the##2##4##(1991-12#1)(1995-6#1)
regulatory factors##8##2##(1991-12#1)(1991-5#1)(1993-12#1)(1995-6#2)(2011-1#1)(2012-3#1)(2013-8#1)
regulatory focus and##2##3##(2009-5#2)
regulatory focus theory##2##3##(2009-6#2)
regulatory focus##6##2##(2009-5#3)(2009-6#3)
regulatory framework##2##2##(2010-6#1)(2013-1#1)
regulatory function of##2##3##(2008-8#1)(2008-9#1)
regulatory function##4##2##(1991-5#1)(2008-8#1)(2008-9#2)
regulatory functions##4##2##(1993-2#1)(2010-11#1)(2012-1#2)
regulatory gene networks##2##3##(2008-1#1)(2008-2#1)
regulatory gene##10##2##(1991-9#1)(1992-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2011-1#1)
regulatory genes in##2##3##(1991-6#1)(2008-8#1)
regulatory genes##7##2##(1991-6#1)(1993-9#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-3#1)
regulatory impacts##2##2##(1996-1#2)
regulatory interactions##2##2##(1990-8#1)(2009-8#1)
regulatory issues##2##2##(1995-5#2)
regulatory level##2##2##(2008-10#2)
regulatory limit##2##2##(2008-10#2)
regulatory loop##5##2##(1995-6#1)(2011-1#2)(2011-2#2)
regulatory mechanism for##4##3##(1991-5#1)(1995-2#1)(1997-4#1)(2011-10#1)
regulatory mechanism of##3##3##(1992-8#1)(1997-2#1)(2013-1#1)
regulatory mechanism##17##2##(1991-5#1)(1992-8#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#2)(2011-10#1)(2012-1#1)(2013-1#1)
regulatory mechanisms are##2##3##(2008-11#1)(2013-8#1)
regulatory mechanisms of gene##2##4##(2007-12#1)(2011-2#1)
regulatory mechanisms of##6##3##(1993-11#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#2)
regulatory mechanisms that##3##3##(1994-8#1)(2007-12#1)(2013-1#1)
regulatory mechanisms##23##2##(1992-12#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(2007-12#2)(2008-11#4)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
regulatory modules##2##2##(2012-3#1)(2013-1#1)
regulatory molecule##2##2##(1990-4#1)(2008-10#1)
regulatory molecules##6##2##(1990-9#1)(1991-2#1)(1993-6#1)(2008-1#1)(2008-11#1)(2013-1#1)
regulatory motifs##3##2##(1992-3#2)(2008-11#1)
regulatory network##9##2##(2008-5#1)(2008-7#3)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#2)
regulatory networks and##2##3##(2008-11#1)(2008-7#1)
regulatory networks in##4##3##(2008-7#3)(2011-2#1)
regulatory networks that##2##3##(2008-7#1)(2010-4#1)
regulatory networks##24##2##(2008-11#4)(2008-7#11)(2008-8#1)(2009-3#1)(2010-10#3)(2010-4#1)(2011-2#2)(2013-1#1)
regulatory or##2##2##(2008-7#1)(2012-12#1)
regulatory pathway in##2##3##(2007-12#1)(2008-11#1)
regulatory pathway##5##2##(1994-6#1)(1995-2#1)(2007-12#1)(2008-11#1)(2010-10#1)
regulatory pathways##6##2##(1994-5#1)(2007-12#1)(2008-7#1)(2010-11#1)(2012-2#1)(2012-3#1)
regulatory peptide##2##2##(1992-9#1)(2011-1#1)
regulatory phosphorylation##3##2##(1990-8#1)(1995-2#2)
regulatory physiology##2##2##(1997-1#1)(2008-4#1)
regulatory potential##2##2##(1991-10#1)(2008-11#1)
regulatory process##2##2##(2008-5#1)(2008-7#1)
regulatory processes##6##2##(2008-11#1)(2009-8#1)(2010-3#1)(2012-1#1)(2013-1#2)
regulatory properties of##2##3##(1990-5#1)(1997-6#1)
regulatory properties##3##2##(1990-5#1)(1997-6#1)(1997-7#1)
regulatory protein of##2##3##(1992-3#1)(2008-8#1)
regulatory protein##18##2##(1990-7#6)(1992-3#3)(1995-12#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)
regulatory proteins and transcriptional factors##2##5##(2008-9#2)
regulatory proteins and##4##3##(1997-8#1)(2008-9#2)(2012-12#1)
regulatory proteins##27##2##(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
regulatory region of the##2##4##(1994-9#1)(2008-4#1)
regulatory region of##4##3##(1990-7#1)(1994-9#1)(2008-11#1)(2008-4#1)
regulatory region was##2##3##(1997-7#1)(2009-6#1)
regulatory region##16##2##(1990-7#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1997-2#1)(1997-7#2)(2008-11#4)(2008-4#1)(2008-8#1)(2009-6#1)
regulatory regions of the human##2##5##(2008-11#1)(2008-7#1)
regulatory regions of##4##3##(1993-6#1)(2008-11#2)(2008-7#1)
regulatory regions##12##2##(1992-6#1)(1993-3#1)(1993-6#1)(1994-6#1)(1997-6#1)(2007-11#1)(2008-11#4)(2008-7#1)(2012-2#1)
regulatory requirement##2##2##(2009-11#1)(2012-3#1)
regulatory requirements and##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
regulatory requirements##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)
regulatory role for the##2##4##(1993-8#1)(1994-9#1)
regulatory role for##6##3##(1991-5#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-6#1)(2008-4#1)
regulatory role in the##3##4##(1993-3#1)(2008-2#1)(2008-7#1)
regulatory role in##7##3##(1991-12#1)(1993-3#1)(1994-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
regulatory role of##4##3##(1995-2#1)(2009-12#1)(2012-12#1)(2012-2#1)
regulatory role##18##2##(1991-12#1)(1991-5#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
regulatory roles in##2##3##(1995-8#1)(2008-7#1)
regulatory roles##5##2##(1995-8#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-5#1)
regulatory sequence##7##2##(1991-6#1)(1991-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-9#1)
regulatory sequences##9##2##(1990-12#1)(1991-9#1)(1995-2#2)(1995-8#1)(1997-2#1)(1997-7#1)(2008-7#2)
regulatory signals##2##2##(1992-12#1)(1994-12#1)
regulatory site##2##2##(1990-7#1)(2008-10#1)
regulatory sites##7##2##(1990-7#1)(1993-8#1)(1995-6#1)(1997-7#1)(1997-9#1)(2008-8#2)
regulatory step##2##2##(1990-8#1)(1993-11#1)
regulatory subunit of##4##3##(1990-2#1)(1992-12#1)(1995-2#1)(1997-1#1)
regulatory subunit##14##2##(1990-2#3)(1990-8#1)(1992-12#1)(1995-11#1)(1995-2#5)(1997-1#1)(2008-8#1)(2011-2#1)
regulatory subunits##3##2##(1990-8#2)(1995-11#1)
regulatory system##8##2##(1992-8#1)(1996-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-10#1)(2011-1#1)
regulatory systems##10##2##(1994-12#2)(1996-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-7#3)(2008-9#1)
regulatory##648##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-4#1)(1990-5#3)(1990-7#11)(1990-8#7)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#6)(1992-12#5)(1992-2#1)(1992-3#7)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#10)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#11)(1993-8#6)(1993-9#3)(1994-1#2)(1994-11#6)(1994-12#10)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#3)(1995-11#3)(1995-12#5)(1995-2#23)(1995-3#2)(1995-5#2)(1995-6#9)(1995-8#5)(1996-1#6)(1996-12#9)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#5)(1997-2#8)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#10)(1997-8#2)(1997-9#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-5#4)(2008-1#8)(2008-10#38)(2008-11#50)(2008-12#4)(2008-2#5)(2008-3#2)(2008-4#16)(2008-5#5)(2008-6#1)(2008-7#41)(2008-8#17)(2008-9#10)(2009-10#4)(2009-11#3)(2009-12#1)(2009-3#5)(2009-5#4)(2009-6#7)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#9)(2010-11#6)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#12)(2011-10#1)(2011-2#25)(2011-3#1)(2012-1#7)(2012-12#9)(2012-2#12)(2012-3#19)(2013-1#16)(2013-7#2)(2013-8#9)
regulon##3##1##(1995-6#1)(2011-2#2)
regurgitation and##5##2##(1993-10#1)(1993-2#1)(2008-7#1)(2010-5#1)(2012-2#1)
regurgitation due to##2##3##(2007-8#1)(2009-4#1)
regurgitation in the##2##3##(2007-8#1)(2013-1#1)
regurgitation in##3##2##(2007-8#1)(2012-3#1)(2013-1#1)
regurgitation##47##1##(1990-3#1)(1993-10#1)(1993-2#1)(1995-3#4)(1997-5#2)(1997-8#5)(2006-10#1)(2007-8#7)(2008-11#3)(2008-7#3)(2009-10#2)(2009-3#1)(2009-4#3)(2010-5#3)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#3)
regúlate the##2##2##(2013-8#2)
rehabilitated##4##1##(1996-6#1)(2007-8#1)(2010-10#1)(2010-5#1)
rehabilitating##2##1##(2012-2#2)
rehabilitation (CR)##3##2##(2007-11#1)(2009-10#1)(2013-1#1)
rehabilitation (PR)##2##2##(2010-1#1)(2013-8#1)
rehabilitation after arthroscopic reconstruction of the anterior cruciate ligament##2##9##(2007-8#2)
rehabilitation after##14##2##(1991-12#1)(1995-5#1)(1997-2#1)(2007-11#3)(2007-8#3)(2008-3#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
rehabilitation and reintegration##2##3##(1990-9#1)(1992-3#1)
rehabilitation and##23##2##(1990-9#1)(1991-12#2)(1992-3#1)(1993-12#1)(1995-5#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#5)(2013-8#1)
rehabilitation are##4##2##(1993-3#1)(1993-6#1)(2007-8#1)(2011-2#1)
rehabilitation as##2##2##(1994-5#1)(2013-1#1)
rehabilitation averaged##2##2##(2008-4#2)
rehabilitation based on##2##3##(2009-8#1)(2010-10#1)
rehabilitation center##3##2##(1992-1#1)(1993-1#2)
rehabilitation centers##2##2##(2007-11#1)(2013-1#1)
rehabilitation exercises##3##2##(2007-8#1)(2010-9#1)(2012-2#1)
rehabilitation facility##2##2##(1995-3#1)(2008-7#1)
rehabilitation for##9##2##(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#2)
rehabilitation hospital##5##2##(1990-5#2)(2007-10#3)
rehabilitation in patients##2##3##(2013-1#2)
rehabilitation in##13##2##(1992-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-9#2)(2010-10#1)(2011-2#2)(2013-1#3)
rehabilitation is##6##2##(2007-11#2)(2007-8#2)(2011-2#1)(2013-1#1)
rehabilitation may##3##2##(2007-10#1)(2008-11#1)(2008-6#1)
rehabilitation measures##3##2##(1991-5#1)(1995-5#2)
rehabilitation methods##3##2##(2007-8#2)(2012-1#1)
rehabilitation of a##4##3##(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
rehabilitation of patients after##2##4##(2007-8#2)
rehabilitation of patients with spinal##2##5##(2007-8#1)(2008-10#1)
rehabilitation of patients with##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2010-3#1)(2013-1#2)
rehabilitation of patients##9##3##(2007-11#2)(2007-8#3)(2008-10#1)(2010-3#1)(2013-1#2)
rehabilitation of the patient##2##4##(2008-10#1)(2010-3#1)
rehabilitation of the##11##3##(1992-12#1)(1995-2#1)(1995-5#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-5#1)(2009-3#1)(2010-3#1)
rehabilitation of##48##2##(1992-12#1)(1992-3#1)(1995-2#1)(1995-5#1)(2007-11#5)(2007-12#2)(2007-8#7)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#3)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
rehabilitation on##3##2##(1995-5#1)(2009-10#1)(2013-1#1)
rehabilitation outcome in patients with degenerative##2##6##(2007-11#1)(2007-8#1)
rehabilitation outcome##5##2##(1995-3#1)(2007-11#1)(2007-8#3)
rehabilitation patients##2##2##(1993-12#1)(2013-1#1)
rehabilitation professionals##4##2##(1992-3#1)(1996-2#2)(2008-9#1)
rehabilitation program in##3##3##(2008-3#1)(2008-7#1)(2013-7#1)
rehabilitation program##17##2##(1995-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#3)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#3)(2013-7#1)
rehabilitation programme##9##2##(2007-11#2)(2008-10#1)(2008-9#2)(2010-10#1)(2013-1#3)
rehabilitation programmes##5##2##(1996-11#1)(1997-8#1)(2011-2#3)
rehabilitation programs for##2##3##(1993-3#1)(2007-11#1)
rehabilitation programs##5##2##(1992-3#1)(1993-3#1)(1996-3#1)(2007-11#1)(2013-1#1)
rehabilitation psychology##5##2##(2009-8#5)
rehabilitation services in##3##3##(1994-3#1)(1995-12#1)(2011-2#1)
rehabilitation services##7##2##(1991-6#1)(1993-12#1)(1994-3#1)(1995-12#1)(2006-5#2)(2011-2#1)
rehabilitation sessions##2##2##(2008-9#2)
rehabilitation should be##2##3##(2010-10#1)(2013-1#1)
rehabilitation specialists##3##2##(1993-3#1)(2007-11#1)(2013-1#1)
rehabilitation strategies after rotator cuff repair##2##6##(2013-1#2)
rehabilitation strategies##4##2##(2008-2#1)(2008-8#1)(2013-1#2)
rehabilitation therapies##2##2##(1994-12#1)(2008-6#1)
rehabilitation to##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
rehabilitation treatment##4##2##(2007-11#1)(2011-2#1)(2013-1#2)
rehabilitation unit##2##2##(1990-5#1)(1996-5#1)
rehabilitation was##5##2##(2007-11#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
rehabilitation with##5##2##(2008-12#2)(2008-9#1)(2010-10#1)(2011-2#1)
rehabilitation##421##1##(1990-5#4)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#8)(1993-1#4)(1993-12#9)(1993-3#4)(1993-6#3)(1994-12#2)(1994-3#3)(1994-5#1)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#12)(1996-11#2)(1996-2#2)(1996-3#4)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-5#4)(2007-10#8)(2007-11#40)(2007-12#7)(2007-5#1)(2007-6#5)(2007-8#44)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#12)(2008-8#6)(2008-9#14)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#12)(2010-1#2)(2010-10#10)(2010-3#4)(2010-4#1)(2010-7#2)(2010-9#3)(2011-1#3)(2011-2#26)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#8)(2012-3#7)(2013-1#52)(2013-7#1)(2013-8#3)
rehabilitation)##2##1##(2007-11#1)(2008-9#1)
rehabilitation]##3##1##(1992-5#1)(1993-6#1)(2008-11#1)
rehabilitations##2##1##(2011-7#1)(2013-1#1)
rehabilitative programme##4##2##(2008-10#3)(2011-2#1)
rehabilitative##17##1##(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-9#3)(2009-10#1)(2011-2#1)(2013-1#5)
rehabilited##6##1##(2007-11#5)(2011-7#1)
rehydrated##4##1##(2008-10#2)(2008-5#1)(2013-7#1)
rehydration solution (ORS) was##2##4##(1991-9#1)(2008-1#1)
rehydration solution##3##2##(1991-9#2)(2008-1#1)
rehydration therapy##2##2##(1991-11#1)(1991-3#1)
rehydration##10##1##(1990-3#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-5#1)(2008-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
rei##2##1##(2008-10#2)
reimaging camera##2##2##(2008-3#2)
reimaging##4##1##(2008-3#4)
reimburse##7##1##(1993-3#1)(1997-2#1)(1997-5#2)(2008-12#3)
reimbursed for##2##2##(1995-3#1)(2007-4#1)
reimbursed##11##1##(1990-9#1)(1991-1#1)(1992-3#1)(1995-3#1)(1996-1#2)(1997-1#1)(2007-4#1)(2008-12#2)(2012-12#1)
reimbursement and##3##2##(1991-3#1)(1993-3#1)(1994-1#1)
reimbursement for partial##2##3##(1991-1#1)(1992-1#1)
reimbursement for##12##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-1#2)(2008-11#1)(2011-2#1)
reimbursement in##5##2##(1992-12#1)(1993-3#1)(1994-12#1)(2008-7#1)(2011-2#1)
reimbursement is##2##2##(1994-2#1)(1996-12#1)
reimbursement methodology##2##2##(1996-12#1)(1996-3#1)
reimbursement of##6##2##(1992-1#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-12#2)
reimbursement patterns##3##2##(1992-2#1)(1995-3#2)
reimbursement policies##2##2##(1992-1#1)(2008-12#1)
reimbursement policy##3##2##(2007-12#1)(2008-11#1)(2012-3#1)
reimbursement rates##6##2##(1993-12#3)(1996-12#1)(1997-2#1)(1997-3#1)
reimbursement system##2##2##(1991-2#1)(1993-12#1)
reimbursement to the prospective payment system##2##6##(1991-2#1)(1991-3#1)
reimbursement to##6##2##(1991-1#2)(1991-2#1)(1991-3#1)(1994-3#1)(1996-3#1)
reimbursement##100##1##(1990-4#1)(1991-1#4)(1991-12#2)(1991-2#2)(1991-3#4)(1992-1#5)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#7)(1993-3#5)(1994-1#3)(1994-12#4)(1994-2#4)(1994-3#4)(1995-1#2)(1995-12#2)(1995-3#4)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1997-1#4)(1997-2#1)(1997-3#2)(2007-12#2)(2008-1#3)(2008-11#4)(2008-12#5)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2011-2#3)(2012-3#1)(2013-7#1)
reimbursements for##2##2##(1997-2#1)(2009-6#1)
reimbursements##7##1##(1991-1#1)(1997-2#1)(2007-4#1)(2009-6#1)(2010-9#1)(2011-7#1)(2012-3#1)
reimbursing##3##1##(1996-12#1)(1997-1#1)(2008-12#1)
reimplantation and##3##2##(2008-1#1)(2008-9#2)
reimplantation for##2##2##(2007-8#1)(2012-2#1)
reimplantation in##3##2##(2008-1#1)(2008-9#2)
reimplantation of the##3##3##(1990-3#1)(2007-8#1)(2008-9#1)
reimplantation of##5##2##(1990-3#1)(2007-8#1)(2008-1#1)(2008-9#2)
reimplantation with a##2##3##(2012-2#2)
reimplantation with##4##2##(2012-2#4)
reimplantation##35##1##(1990-10#3)(1990-3#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-2#1)(2008-9#14)(2012-2#7)(2013-1#1)
reimplanted##5##1##(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
rein in##3##2##(1994-3#1)(2008-7#1)(2013-7#1)
reindeer##7##1##(1990-8#3)(1995-6#4)
reinfection##2##1##(1991-2#1)(2008-12#1)
reinfestation##2##1##(2011-2#2)
reinforce one another##2##3##(2013-1#2)
reinforce the idea that##3##4##(1995-2#1)(2013-1#2)
reinforce the##14##2##(1992-11#1)(1992-2#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2013-1#2)
reinforce##29##1##(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-8#2)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#1)
reinforced by a##2##3##(1990-3#1)(2008-3#1)
reinforced by the##5##3##(1994-3#1)(1996-2#1)(2008-5#1)(2009-7#1)(2009-8#1)
reinforced by##11##2##(1990-3#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)
reinforced polycarbonate##2##2##(2009-11#2)
reinforced the##3##2##(1997-8#1)(2007-2#1)(2010-5#1)
reinforced##35##1##(1990-3#2)(1991-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#2)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#1)
reinforcement and##5##2##(1993-6#3)(1994-2#1)(2009-7#1)
reinforcement learning##2##2##(2008-11#1)(2011-1#1)
reinforcement mechanisms##3##2##(2009-7#2)(2012-3#1)
reinforcement of the##2##3##(1992-12#1)(2009-10#1)
reinforcement of##8##2##(1991-1#1)(1992-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
reinforcement##56##1##(1991-1#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-6#11)(1994-2#3)(1994-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
reinforcements##2##1##(2011-1#1)(2013-8#1)
reinforcer##9##1##(1993-6#3)(1996-5#1)(1997-6#1)(1997-7#2)(2008-5#1)(2011-2#1)
reinforcers##10##1##(1991-1#1)(1992-10#1)(1993-6#1)(1996-5#1)(2007-8#1)(2009-10#1)(2010-5#1)(2011-2#3)
reinforces the need##2##3##(2008-10#1)(2008-8#1)
reinforces the##10##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
reinforces##14##1##(1993-2#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
reinforcing actions##2##2##(1993-6#1)(2008-4#1)
reinforcing and##3##2##(1993-6#1)(1994-2#1)(2013-1#1)
reinforcing effects of##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
reinforcing effects##4##2##(1994-2#1)(1994-8#1)(2008-10#1)(2008-4#1)
reinforcing the##3##2##(2007-5#1)(2008-6#1)(2009-10#1)
reinforcing##21##1##(1991-1#1)(1993-6#3)(1994-2#2)(1994-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-10#1)(2013-1#1)
reinfused##3##1##(1996-9#2)(2012-12#1)
reinfusion drains##3##2##(2008-8#3)
reinfusion##9##1##(1996-9#2)(2008-8#5)(2013-1#2)
reinhardti##3##1##(2008-7#2)(2008-9#1)
reinhardtii##13##1##(1993-11#3)(1995-8#5)(2009-10#3)(2012-3#2)
reinjection##5##1##(1992-5#3)(2008-3#1)(2013-1#1)
reinnervation of CGRP(+) IENFs##2##4##(2013-8#2)
reinnervation of##3##2##(2013-8#3)
reinnervation##8##1##(1993-5#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-8#4)
reinsertion##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
reinstituted##2##1##(2007-7#1)(2011-2#1)
reinsurance##3##1##(1991-12#1)(1993-12#1)(1995-2#1)
reintegration##9##1##(1990-9#1)(1992-1#1)(1992-3#1)(1993-1#4)(1994-5#1)(2008-5#1)
reinterpretation##2##1##(1993-8#1)(2008-5#1)
reintroduced##5##1##(1990-3#1)(1991-12#1)(2008-10#1)(2008-7#1)(2010-1#1)
reintroduction of##4##2##(1994-5#1)(1994-8#1)(1997-7#1)(2010-3#1)
reintroduction##6##1##(1994-5#1)(1994-8#1)(1997-7#1)(2007-2#1)(2008-7#1)(2010-3#1)
reinvent##3##1##(1994-12#1)(2006-5#1)(2008-1#1)
reinvented##2##1##(1996-2#2)
reinvention##2##1##(2008-9#2)
reinvestigated##8##1##(1991-5#1)(1992-11#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)
reirradiation##2##1##(2008-10#2)
reisolated from##4##2##(2008-10#4)
reisolated##5##1##(1997-3#1)(2008-10#4)
reisolation##2##1##(2008-10#2)
reiterate the##3##2##(2007-12#1)(2010-8#1)(2013-1#1)
reiterated##2##1##(1993-3#1)(2012-12#1)
reiterative motifs##2##2##(1991-2#2)
reiterative##4##1##(1991-2#2)(2008-11#1)(2009-6#1)
reject the##10##2##(1995-5#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)
reject##21##1##(1990-2#1)(1992-1#1)(1995-5#2)(1995-8#1)(1996-5#1)(2008-10#5)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)
rejected an##3##2##(1995-12#1)(1995-6#2)
rejected applicants##2##2##(1995-5#2)
rejected by##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
rejected for##3##2##(1991-1#1)(2008-10#1)(2012-3#1)
rejected the##5##2##(1995-6#3)(1996-5#1)(2008-10#1)
rejected##41##1##(1991-1#1)(1991-6#1)(1993-12#1)(1995-12#4)(1995-5#3)(1995-6#5)(1996-5#2)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
rejecting the##4##2##(1991-12#1)(1993-1#1)(1995-2#1)(1996-5#1)
rejecting##7##1##(1991-12#1)(1993-1#1)(1995-2#1)(1996-5#1)(2008-2#1)(2008-7#1)(2012-12#1)
rejection after##3##2##(1993-2#1)(1994-3#1)(2008-10#1)
rejection and##10##2##(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)
rejection episodes##5##2##(1990-11#1)(1994-5#1)(2007-7#2)(2011-2#1)
rejection events##2##2##(1993-2#1)(2009-3#1)
rejection in the##2##3##(2008-2#1)(2009-5#1)
rejection in##6##2##(2007-7#1)(2008-1#2)(2008-2#1)(2009-5#1)(2012-3#1)
rejection of a##2##3##(2008-7#1)(2010-3#1)
rejection of the hypothesis##2##4##(1995-5#1)(2008-9#1)
rejection of the##9##3##(1995-5#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
rejection of##21##2##(1995-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
rejection##91##1##(1990-11#1)(1991-11#1)(1993-12#1)(1993-2#3)(1994-3#1)(1994-5#1)(1995-5#2)(1995-8#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#6)(2007-8#1)(2008-1#5)(2008-10#14)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
rejections##12##1##(1991-1#1)(1992-6#1)(1997-5#1)(2007-2#1)(2008-3#1)(2008-7#1)(2010-3#2)(2010-8#3)(2011-2#1)
rejects##5##1##(1995-11#1)(1995-6#1)(1996-4#1)(1996-5#1)(2008-10#1)
rejuvenation##12##1##(2008-5#1)(2008-7#4)(2009-9#2)(2010-8#4)(2012-2#1)
rekindles##2##1##(1997-5#1)(2008-7#1)
relaparotomy##2##1##(1994-3#1)(2007-5#1)
relapse after##3##2##(1993-2#1)(1997-8#1)(2011-1#1)
relapse and the##2##3##(1992-3#1)(2012-12#1)
relapse and##9##2##(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-8#1)(1997-5#1)(2007-7#1)(2008-5#1)(2012-12#1)
relapse could be##2##3##(2007-5#1)(2008-5#1)
relapse free##2##2##(1990-10#1)(2012-3#1)
relapse in patients##2##3##(1994-5#1)(2010-12#1)
relapse in the##2##3##(2011-2#2)
relapse in##10##2##(1991-4#2)(1993-2#1)(1994-5#1)(2009-7#1)(2010-12#1)(2011-2#4)
relapse is##2##2##(1991-4#1)(2007-5#1)
relapse occurred##2##2##(1991-3#1)(1996-7#1)
relapse of the disease##2##4##(1990-6#1)(1995-4#1)
relapse of the##4##3##(1990-6#1)(1995-4#1)(2008-4#1)(2009-11#1)
relapse of##9##2##(1990-6#1)(1995-4#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-11#1)(2013-1#2)(2013-8#1)
relapse or##3##2##(1991-1#1)(1993-12#1)(2010-12#1)
relapse rate##4##2##(1996-11#1)(2008-1#1)(2011-2#1)(2013-1#1)
relapse rates##2##2##(2009-10#1)(2011-2#1)
relapse triggers##4##2##(2009-9#4)
relapse was##3##2##(1991-4#1)(1995-5#1)(2012-3#1)
relapse within##2##2##(2008-5#1)(2011-2#1)
relapse##122##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#4)(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-4#2)(1995-5#1)(1996-11#2)(1996-7#1)(1997-5#1)(1997-8#4)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-4#1)(2009-7#1)(2009-9#7)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#19)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#2)
relapse-free survival and##2##3##(1991-4#1)(2012-3#1)
relapse-free survival##10##2##(1990-8#1)(1991-4#2)(1994-12#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-3#1)
relapse-free##11##1##(1990-8#1)(1991-4#2)(1994-12#1)(1995-12#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-3#1)
relapsed acute myeloid##2##3##(2008-5#1)(2010-4#1)
relapsed acute##3##2##(2008-5#1)(2010-11#1)(2010-4#1)
relapsed after##5##2##(1990-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2011-2#1)
relapsed and died##2##3##(1991-4#1)(2008-10#1)
relapsed and refractory myeloma##2##4##(2010-4#2)
relapsed and refractory##3##3##(2010-4#3)
relapsed and##7##2##(1991-4#1)(1992-6#1)(1996-7#1)(2008-10#1)(2010-4#3)
relapsed at##2##2##(1990-12#1)(2007-5#1)
relapsed into smoking##2##3##(1997-4#2)
relapsed or##4##2##(2007-4#1)(2008-7#1)(2012-12#1)(2013-7#1)
relapsed patients##2##2##(1992-6#1)(2007-2#1)
relapsed##47##1##(1990-12#2)(1990-8#1)(1991-4#2)(1991-6#1)(1992-6#2)(1994-5#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-4#2)(2007-10#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#5)(2011-2#2)(2012-12#1)(2013-7#1)
relapsed/refractory CLL##2##2##(2009-12#2)
relapsed/refractory patients##2##2##(2011-2#2)
relapsed/refractory##7##1##(1994-12#1)(1995-9#1)(2009-12#3)(2011-2#2)
relapses and##4##2##(1991-6#1)(1996-11#1)(2010-5#1)(2013-8#1)
relapses are##2##2##(1994-6#1)(2011-2#1)
relapses occurred in##2##3##(1991-4#1)(2008-6#1)
relapses of##2##2##(2010-12#1)(2011-2#1)
relapses##29##1##(1990-3#2)(1990-9#1)(1991-4#2)(1991-6#1)(1993-2#1)(1994-6#1)(1995-8#1)(1996-11#2)(1996-9#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-4#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
relapsing and demyelinating##2##3##(1995-12#2)
relapsing disease##2##2##(1993-8#1)(2007-5#1)
relapsing patients##3##2##(1991-2#3)
relapsing##22##1##(1991-2#6)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#3)(2007-5#1)(2008-1#1)(2008-7#2)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
relapsing-remitting##3##1##(2007-11#1)(2010-12#1)(2012-3#1)
relate directly to##3##3##(1995-12#1)(2008-10#1)(2008-9#1)
relate it##2##2##(2008-10#1)(2011-2#1)
relate the##19##2##(1990-3#1)(1997-2#1)(2008-10#4)(2008-2#2)(2008-3#6)(2008-5#3)(2008-9#1)(2012-2#1)
relate their##3##2##(1996-2#1)(2008-11#1)(2008-9#1)
relate them to##3##3##(1997-7#1)(2008-12#1)(2012-2#1)
relate these##6##2##(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-4#1)(2013-1#1)
relate to the##18##3##(1991-2#1)(1992-6#1)(1994-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-12#1)
relate to##66##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-8#3)(2009-9#1)(2010-9#2)(2011-2#2)(2012-12#3)(2012-5#1)(2013-8#1)
relate##135##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#14)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#6)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-4#1)(2010-9#2)(2011-2#6)(2012-12#3)(2012-2#3)(2012-5#1)(2013-1#3)(2013-8#2)
related 2##2##2##(1995-12#1)(2008-5#1)
related DNA sequences##2##3##(2008-4#1)(2008-9#1)
related DNA##4##2##(1996-2#1)(2007-11#1)(2008-4#1)(2008-9#1)
related NCA-160##2##2##(1993-8#2)
related P##2##2##(2008-10#1)(2008-5#1)
related Quercus##2##2##(2012-5#2)
related TCAA##2##2##(2008-10#2)
related activities##2##2##(2008-2#1)(2008-7#1)
related and##11##2##(1993-1#1)(1994-2#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#2)(2010-7#1)
related articles##2##2##(2007-2#1)(2010-8#1)
related as expected to##3##4##(2007-12#3)
related as##4##2##(2007-12#3)(2008-10#1)
related biological##2##2##(1995-2#1)(2008-8#1)
related but distinct##2##3##(2008-10#1)(2009-9#1)
related but##5##2##(2008-10#2)(2008-9#1)(2009-9#1)(2011-2#1)
related by##7##2##(1991-12#2)(1993-8#1)(2007-12#1)(2008-4#2)(2008-6#1)
related cerebral##2##2##(2008-8#1)(2009-12#1)
related changes in the##4##4##(1990-11#3)(2010-8#1)
related changes in##5##3##(1990-11#3)(2010-8#1)(2011-2#1)
related changes of##2##3##(1994-3#1)(2011-2#1)
related changes##9##2##(1990-11#3)(1994-3#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#2)
related chemicals##2##2##(2008-10#1)(2008-7#1)
related closely to##2##3##(2008-10#1)(2008-2#1)
related complexes##2##2##(1992-4#1)(2008-10#1)
related complications##5##2##(1996-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)
related components##4##2##(2008-10#1)(2008-11#3)
related compound##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
related compounds and##2##3##(2008-10#1)(2008-5#1)
related compounds on##4##3##(2008-11#4)
related compounds were##2##3##(2008-10#1)(2008-11#1)
related compounds##30##2##(1990-8#2)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#7)(2008-5#1)(2008-7#1)
related crystal##2##2##(1992-9#1)(2011-1#1)
related data##2##2##(1990-7#1)(1992-2#1)
related derivatives##3##2##(1991-6#1)(1992-8#1)(1997-7#1)
related directly##2##2##(1993-6#1)(2012-3#1)
related diseases##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
related disorders##16##2##(1992-6#2)(1996-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-3#1)(2009-7#1)(2012-2#1)
related donors##2##2##(2008-1#1)(2008-10#1)
related effects##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
related either to##2##3##(1991-8#1)(1994-3#1)
related enzymes##2##2##(1992-3#1)(1995-12#1)
related events##4##2##(1991-2#2)(2008-11#1)(2008-7#1)
related experiments##3##2##(1991-5#1)(2007-12#1)(2013-7#1)
related factors##7##2##(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
related features##2##2##(1995-11#1)(2009-10#1)
related fields##2##2##(2008-7#1)(2010-8#1)
related forms of##2##3##(1990-12#1)(1995-11#1)
related functional##2##2##(1996-1#1)(2007-12#1)
related fungi##5##2##(2008-10#4)(2008-5#1)
related future research##2##3##(2010-10#1)(2013-8#1)
related gene (protein)##3##3##(2011-3#3)
related gene expression##2##3##(2008-10#1)(2013-1#1)
related gene##7##2##(2008-10#1)(2008-8#2)(2011-3#3)(2013-1#1)
related genes##8##2##(1990-8#1)(1992-3#1)(1994-11#1)(1994-8#1)(2008-4#2)(2008-8#1)(2008-9#1)
related genus##2##2##(2008-6#2)
related group##2##2##(2008-10#2)
related growth factors##4##3##(1991-3#2)(2010-8#1)(2013-8#1)
related growth##5##2##(1991-3#2)(1994-12#1)(2010-8#1)(2013-8#1)
related hormones##2##2##(1995-12#1)(2011-2#1)
related impairments##8##2##(2011-1#8)
related in a##2##3##(2008-10#1)(2008-9#1)
related in part to##3##4##(1990-8#1)(1994-3#1)(2009-10#1)
related in##7##2##(1990-8#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)
related indicators##2##2##(2009-10#1)(2011-1#1)
related individuals##2##2##(2010-8#1)(2012-3#1)
related information##2##2##(2008-2#1)(2009-12#1)
related inhibitor##2##2##(1993-11#1)(2013-8#1)
related isolates##3##2##(2008-10#1)(2011-2#2)
related issues##6##2##(1995-2#1)(1996-1#1)(2008-11#1)(2008-5#1)(2009-9#1)(2012-3#1)
related literature##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
related mainly to##2##3##(2008-10#2)
related metabolic##2##2##(2008-1#1)(2008-10#1)
related minor##2##2##(2008-10#1)(2013-1#1)
related more to##2##3##(1995-2#1)(2009-5#1)
related mortality##3##2##(1994-2#1)(2009-4#1)(2011-2#1)
related natural##2##2##(1994-6#1)(2008-4#1)
related not only to##2##4##(2008-5#1)(2009-7#1)
related only to the##2##4##(1991-2#1)(2008-10#1)
related or##4##2##(2007-12#1)(2008-1#1)(2012-12#1)(2013-1#1)
related parameters##3##2##(2008-10#1)(2010-5#1)(2011-3#1)
related pathology##3##2##(1996-12#1)(2008-1#1)(2008-9#1)
related peptide in##3##3##(1992-9#1)(1994-2#2)
related peptide##10##2##(1990-12#1)(1991-3#1)(1992-9#1)(1994-2#3)(1994-9#1)(1995-12#1)(2013-7#2)
related peptides##5##2##(1991-1#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-9#1)
related phenomena##3##2##(1992-1#1)(2008-3#2)
related populations##2##2##(1996-6#1)(2008-9#1)
related potentials##2##2##(2008-11#2)
related primarily to##2##3##(1994-2#1)(2009-3#1)
related problems##6##2##(1995-3#1)(2008-10#2)(2008-11#1)(2010-7#1)(2013-8#1)
related procedures##2##2##(2008-9#1)(2009-5#1)
related programs##2##2##(1996-1#1)(2012-2#1)
related protein##8##2##(1990-11#1)(1992-12#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
related proteins##12##2##(1990-5#2)(1991-5#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-7#2)(2012-12#1)
related quality of life##3##4##(2008-12#1)(2011-2#2)
related quantities##2##2##(2008-10#1)(2008-7#1)
related risk factors##11##3##(2012-1#1)(2013-8#10)
related sequences##3##2##(1993-2#1)(1994-11#1)(2008-4#1)
related species were##2##3##(2008-10#2)
related species##35##2##(1991-5#1)(1995-11#2)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
related strain##2##2##(2007-7#1)(2008-10#1)
related strains##2##2##(2008-4#1)(2011-2#1)
related structures##4##2##(1993-6#1)(2010-11#1)(2010-6#1)(2012-3#1)
related substances##4##2##(1995-2#1)(2008-10#3)
related symptoms##3##2##(1990-10#1)(2006-10#1)(2011-2#1)
related taxonomic traits were##3##4##(2008-8#3)
related taxonomic traits##4##3##(2008-8#4)
related techniques##2##2##(2007-12#1)(2012-3#1)
related to AIDS##2##3##(1990-11#1)(1991-6#1)
related to E##2##3##(2008-10#2)
related to EPS##2##3##(2011-2#2)
related to M##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
related to Ménière's disease##2##4##(2008-2#2)
related to P##4##3##(2008-10#1)(2008-5#2)(2012-3#1)
related to SA##2##3##(2008-10#2)
related to a decrease in the##3##6##(1990-5#1)(2008-10#1)(2010-4#1)
related to a deficiency in##3##5##(2013-1#3)
related to a direct##2##4##(1990-5#1)(1992-6#1)
related to a greater##2##4##(2010-11#1)(2010-12#1)
related to a particular##2##4##(2008-12#1)(2012-12#1)
related to a##41##3##(1990-5#2)(1991-8#1)(1992-12#1)(1992-6#2)(1994-12#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
related to abdominal##2##3##(2008-10#1)(2010-8#1)
related to abnormal induction of sister chromatid exchanges##2##8##(1997-7#2)
related to acquired##2##3##(1995-2#1)(2008-7#1)
related to acute##5##3##(1992-6#1)(2008-3#2)(2009-5#2)
related to adolescents'##3##3##(2009-11#2)(2009-7#1)
related to age at##2##4##(1994-6#1)(2008-9#1)
related to age##8##3##(1990-3#1)(1992-2#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-9#1)
related to an increased##2##4##(1990-7#1)(1990-8#1)
related to an##14##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1994-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-12#1)(2012-2#1)
related to areas##2##3##(2008-8#1)(2009-2#1)
related to at least##2##4##(2008-4#1)(2013-1#1)
related to atherosclerosis##3##3##(1995-8#1)(2008-1#1)(2008-4#1)
related to attitudes##2##3##(2007-12#1)(2011-1#1)
related to average##2##3##(2008-10#1)(2008-9#1)
related to being a successful##2##5##(2012-3#2)
related to better health##2##4##(2010-2#2)
related to better##5##3##(1994-9#1)(2007-12#1)(2010-2#2)(2011-2#1)
related to blood##3##3##(1996-12#1)(2007-5#1)(2008-11#1)
related to body##3##3##(2007-12#1)(2007-7#1)(2008-5#1)
related to both the##2##4##(1992-9#1)(1997-7#1)
related to both##8##3##(1992-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)
related to breast cancer##2##4##(1990-8#1)(1997-1#1)
related to cancer##5##3##(1990-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
related to cardiovascular##2##3##(2010-6#1)(2011-2#1)
related to care##2##3##(1995-3#1)(2009-10#1)
related to cell growth##2##4##(2008-6#1)(2011-1#1)
related to cell##7##3##(1990-5#1)(1992-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)
related to cerebral##2##3##(2011-2#1)(2013-1#1)
related to certain##2##3##(1993-12#1)(1995-8#1)
related to change##2##3##(1994-6#1)(2012-12#1)
related to changes in the##2##5##(1994-3#1)(2008-10#1)
related to changes in##7##4##(1991-8#1)(1994-3#1)(2008-10#2)(2008-6#1)(2012-7#1)(2013-1#1)
related to changes##8##3##(1991-8#1)(1994-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-7#1)(2013-1#1)
related to childbirth##2##3##(1995-1#1)(2007-2#1)
related to concentration of##2##4##(2008-10#2)
related to consumer##2##3##(1993-12#1)(2013-1#1)
related to contact##2##3##(2009-4#1)(2010-6#1)
related to current##3##3##(2007-12#1)(2010-4#1)(2013-8#1)
related to delayed##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
related to diabetes##2##3##(2008-1#1)(2012-3#1)
related to dietary##2##3##(2008-11#1)(2011-2#1)
related to differences in##6##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)
related to different##5##3##(2007-11#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-12#1)
related to differentiation##2##3##(2008-8#1)(2010-3#1)
related to disease##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
related to dose##2##3##(2008-10#1)(2008-7#1)
related to drought##2##3##(2008-10#1)(2012-7#1)
related to drug development##2##4##(1991-3#1)(2008-5#1)
related to drug##3##3##(1991-3#1)(2008-5#1)(2012-2#1)
related to each other and##2##5##(2008-10#1)(2008-5#1)
related to each other##9##4##(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
related to each##15##3##(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
related to either##3##3##(1995-1#1)(2008-11#1)(2010-4#1)
related to employees'##2##3##(2011-2#1)(2012-3#1)
related to epidermal growth factor##2##5##(1991-2#2)
related to exposure##2##3##(1990-5#1)(1995-2#1)
related to family##3##3##(1995-12#1)(2008-7#1)(2009-10#1)
related to feeding##2##3##(2010-6#1)(2011-2#1)
related to gender and##2##4##(1996-6#1)(2011-1#1)
related to gender or##2##4##(1994-6#1)(2013-1#1)
related to gender##7##3##(1994-6#1)(1996-6#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
related to genetic##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
related to groups based##2##4##(1991-3#1)(2008-10#1)
related to growth##2##3##(2012-5#1)(2013-7#1)
related to health##5##3##(1997-3#2)(2010-11#1)(2012-3#1)(2013-1#1)
related to higher##3##3##(1992-3#1)(2009-7#2)
related to home##2##3##(1991-12#1)(1995-3#1)
related to hormone##2##3##(2010-9#1)(2012-3#1)
related to human##4##3##(1996-12#1)(2008-11#1)(2008-8#1)(2013-8#1)
related to hydraulic conductance##2##4##(2008-10#1)(2009-8#1)
related to improved##2##3##(2008-12#1)(2008-6#1)
related to increased##7##3##(1990-7#1)(1993-12#1)(2008-10#2)(2009-9#1)(2011-1#1)(2013-7#1)
related to individual##2##3##(2008-11#1)(2010-10#1)
related to infection##2##3##(2008-10#1)(2012-3#1)
related to influenza##2##3##(1992-6#1)(2009-12#1)
related to inhibition of##2##4##(1990-12#1)(2008-7#1)
related to initial##2##3##(2008-10#1)(2008-9#1)
related to internalizing##2##3##(2012-12#1)(2013-1#1)
related to it##2##3##(1996-6#1)(2012-3#1)
related to its##17##3##(1991-6#1)(1992-1#1)(1992-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)(2011-2#2)(2013-1#1)
related to location##2##3##(2008-12#1)(2008-6#1)
related to loss of##3##4##(1992-2#1)(1994-5#1)(2008-10#1)
related to low##4##3##(2008-10#1)(2009-10#1)(2009-7#1)(2013-1#1)
related to lower levels of##2##5##(2009-7#2)
related to major##2##3##(1993-1#1)(2007-12#1)
related to managed care##2##4##(1995-12#1)(1997-2#1)
related to many##2##3##(2008-5#1)(2008-9#1)
related to medical##2##3##(2008-10#1)(2008-11#1)
related to mental health##2##4##(2008-11#1)(2011-2#1)
related to mental##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
related to more##2##3##(2010-7#1)(2012-12#1)
related to multiple##3##3##(2008-11#2)(2012-2#1)
related to muscle##2##3##(2010-4#1)(2010-8#1)
related to neurodegenerative##2##3##(2009-9#1)(2010-11#1)
related to normal##3##3##(2007-8#1)(2008-5#1)(2013-1#1)
related to nursing##5##3##(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#1)
related to other diseases##2##4##(1990-6#1)(1991-5#1)
related to other##6##3##(1990-6#1)(1991-5#1)(1996-12#1)(2008-10#2)(2008-7#1)
related to our##2##3##(2008-10#1)(2009-9#1)
related to oxidative stress##2##4##(1996-9#1)(2008-10#1)
related to oxygen##2##3##(1990-12#1)(1991-9#1)
related to parental##2##3##(1996-3#1)(2009-7#1)
related to patient##3##3##(1992-3#1)(1993-12#1)(2010-3#1)
related to people's satisfaction##3##4##(2010-2#3)
related to perceptions##2##3##(2011-2#1)(2012-3#1)
related to personal##2##3##(1996-3#1)(2012-1#1)
related to physical##5##3##(2008-12#1)(2009-11#1)(2009-7#1)(2010-3#1)(2010-6#1)
related to plant##3##3##(2008-8#2)(2008-9#1)
related to pollen##2##3##(2009-8#1)(2011-2#1)
related to poor##4##3##(1991-12#1)(2007-12#1)(2008-9#1)(2013-1#1)
related to population##3##3##(1996-3#1)(2008-10#1)(2008-9#1)
related to post-operative##2##3##(2007-11#1)(2012-2#1)
related to postoperative##2##3##(2008-7#2)
related to primary##2##3##(1990-11#1)(2007-5#1)
related to prolonged##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
related to protein##2##3##(1995-2#1)(2008-9#1)
related to psychological##2##3##(1990-6#1)(2010-2#1)
related to public##3##3##(1996-2#1)(2008-7#2)
related to rainfall##2##3##(2008-10#2)
related to reduced##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
related to respiratory##2##3##(2008-10#1)(2010-5#1)
related to safety##2##3##(1991-3#1)(2010-6#1)
related to self-rated##2##3##(2011-2#1)(2012-3#1)
related to several##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
related to severity of##2##4##(1994-2#1)(2013-1#1)
related to sexual##4##3##(1996-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
related to skin##2##3##(2008-5#1)(2010-8#1)
related to social##3##3##(2008-4#1)(2009-8#1)(2010-1#1)
related to socioeconomic##2##3##(1994-6#2)
related to specific##4##3##(1991-6#1)(2008-11#1)(2011-1#1)(2011-2#1)
related to stocking rate##2##4##(1996-12#2)
related to stress##2##3##(2008-7#1)(2011-1#1)
related to students'##2##3##(2008-12#2)
related to success##2##3##(1996-2#1)(2012-3#1)
related to such##2##3##(2008-10#1)(2010-1#1)
related to suicide##2##3##(1996-1#2)
related to surface##2##3##(2007-11#1)(2008-3#1)
related to survival##2##3##(2008-10#1)(2013-1#1)
related to symptoms##2##3##(2008-6#1)(2008-7#1)
related to that of##3##4##(1997-8#1)(2008-10#1)(2008-12#1)
related to that##4##3##(1992-3#1)(1997-8#1)(2008-10#1)(2008-12#1)
related to the ability of the##2##6##(2008-10#2)
related to the ability of##3##5##(2008-10#2)(2013-8#1)
related to the ability##4##4##(1995-12#1)(2008-10#2)(2013-8#1)
related to the absorption coefficient##2##5##(2008-2#1)(2008-3#1)
related to the absorption##3##4##(2008-2#1)(2008-3#2)
related to the aetiology of##2##5##(1997-1#1)(2008-9#1)
related to the amount of##6##5##(1990-2#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
related to the application of##2##5##(2008-10#1)(2011-1#1)
related to the areas##2##4##(2008-10#1)(2008-4#1)
related to the availability of##3##5##(1994-3#1)(2011-2#1)(2012-2#1)
related to the capacity of##2##5##(1995-3#1)(2013-1#1)
related to the clinical##3##4##(1990-5#1)(1991-6#1)(2007-6#1)
related to the concentration of##9##5##(1991-12#1)(2008-10#8)
related to the content of##2##5##(2008-10#2)
related to the corresponding##2##4##(1990-7#1)(2008-10#1)
related to the decrease of##2##5##(2008-10#2)
related to the degree of##6##5##(1990-5#1)(1991-7#1)(2007-12#1)(2008-10#2)(2008-7#1)
related to the development of##6##5##(1997-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
related to the development##7##4##(1997-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
related to the different##2##4##(1997-7#1)(2008-7#1)
related to the dose##2##4##(1992-12#1)(2009-8#1)
related to the duration of##2##5##(2008-10#2)
related to the efficacy##2##4##(2011-2#1)(2013-1#1)
related to the energy transfer##2##5##(2008-10#2)
related to the energy##4##4##(1995-11#1)(2008-10#2)(2008-3#1)
related to the establishment of##2##5##(1994-5#1)(2008-11#1)
related to the establishment##3##4##(1994-12#1)(1994-5#1)(2008-11#1)
related to the estimated##2##4##(1995-12#1)(1995-3#1)
related to the exposure to##2##5##(1991-12#1)(2011-2#1)
related to the extent of##2##5##(1996-12#1)(2008-8#1)
related to the formation of##2##5##(2008-10#1)(2008-7#1)
related to the formation##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
related to the function of the##2##6##(2008-4#1)(2008-7#1)
related to the geometry##3##4##(1990-5#1)(2007-12#1)(2008-3#1)
related to the glucose concentration##3##5##(2008-10#3)
related to the increased##2##4##(1994-5#1)(2008-10#1)
related to the interaction##2##4##(1994-2#1)(2012-2#1)
related to the level of##3##5##(1993-6#1)(1995-2#1)(2008-5#1)
related to the level##4##4##(1993-6#1)(1995-2#1)(2008-11#1)(2008-5#1)
related to the location of##2##5##(1991-6#1)(1995-11#1)
related to the loss of##2##5##(1992-11#1)(1993-3#1)
related to the low##2##4##(1990-11#1)(2011-2#1)
related to the magnitude of the##2##6##(1990-5#1)(2013-8#1)
related to the magnitude of##5##5##(1990-11#1)(1990-5#1)(1990-8#1)(2010-5#1)(2013-8#1)
related to the management of##2##5##(2010-12#1)(2013-1#1)
related to the occurrence of##3##5##(2008-10#1)(2009-3#1)(2012-2#1)
related to the optical##3##4##(2007-12#2)(2008-2#1)
related to the organization##2##4##(1994-2#1)(2011-1#1)
related to the original##2##4##(2008-1#1)(2008-10#1)
related to the potential##2##4##(2008-10#2)
related to the presence of##11##5##(1990-12#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
related to the prevalence of tuberculosis among people living with HIV/AIDS##2##11##(2011-1#2)
related to the prevalence of##4##5##(2008-12#1)(2011-1#2)(2013-8#1)
related to the properties of##2##5##(1992-3#1)(2008-11#1)
related to the risk of ischemic stroke##2##7##(2011-1#2)
related to the risk of##3##5##(1991-4#1)(2011-1#2)
related to the secretion of##2##5##(2008-6#1)(2008-8#1)
related to the severity of##4##5##(1992-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
related to the size of the##2##6##(1991-11#1)(1996-12#1)
related to the size of##4##5##(1991-11#1)(1993-10#1)(1996-12#1)(1997-6#1)
related to the structure of##3##5##(1990-5#1)(2008-10#2)
related to the structure##4##4##(1990-5#1)(2008-10#2)(2008-9#1)
related to the time##3##4##(1992-2#1)(2008-9#1)(2012-1#1)
related to the total##3##4##(1991-12#1)(2008-5#1)(2009-5#1)
related to the treatment##2##4##(2008-5#1)(2008-7#1)
related to the type##2##4##(1990-3#1)(2012-12#1)
related to the underlying##2##4##(2008-4#1)(2008-7#1)
related to the unique##3##4##(2007-11#1)(2008-10#1)(2009-11#1)
related to the use of##3##5##(2007-10#1)(2008-9#1)(2011-2#1)
related to the vaccine##2##4##(1990-3#1)(2013-8#1)
related to the work##2##4##(2010-5#1)(2012-3#1)
related to the##540##3##(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#2)(1991-12#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-6#4)(1997-7#2)(1997-8#1)(2006-10#4)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#9)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#107)(2008-11#17)(2008-12#8)(2008-2#13)(2008-3#20)(2008-4#6)(2008-5#14)(2008-6#6)(2008-7#20)(2008-8#11)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#12)(2011-2#24)(2011-3#2)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#7)
related to their degree of##3##5##(1993-9#1)(1995-3#1)(1997-3#1)
related to their##28##3##(1991-1#1)(1991-2#1)(1992-12#1)(1993-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
related to thermographic results##2##4##(1993-11#2)
related to these two##2##4##(2008-10#1)(2008-11#1)
related to these##8##3##(1991-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
related to this##5##3##(1992-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-7#1)
related to those##3##3##(2008-10#3)
related to thymus##2##3##(2011-2#2)
related to treatment##2##3##(2008-4#1)(2010-11#1)
related to tumor##4##3##(1993-11#1)(2008-8#2)(2013-8#1)
related to type##2##3##(1990-8#1)(2008-10#1)
related to volume##2##3##(1991-2#1)(2008-3#1)
related to work##2##3##(2013-1#2)
related to##1691##2##(1990-11#6)(1990-12#9)(1990-2#6)(1990-3#3)(1990-5#13)(1990-6#3)(1990-7#5)(1990-8#7)(1991-1#1)(1991-11#2)(1991-12#14)(1991-2#5)(1991-3#7)(1991-4#2)(1991-5#3)(1991-6#11)(1991-7#1)(1991-8#5)(1991-9#7)(1992-1#3)(1992-11#5)(1992-12#12)(1992-2#7)(1992-3#9)(1992-5#1)(1992-6#8)(1992-8#4)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#12)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#7)(1993-8#3)(1993-9#6)(1994-11#4)(1994-12#7)(1994-2#7)(1994-3#7)(1994-5#8)(1994-6#12)(1994-8#6)(1994-9#5)(1995-1#6)(1995-11#4)(1995-12#13)(1995-2#7)(1995-3#9)(1995-5#7)(1995-6#5)(1995-8#7)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#20)(1996-2#6)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#6)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#13)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#5)(2006-10#5)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#6)(2007-11#13)(2007-12#33)(2007-2#5)(2007-5#3)(2007-6#5)(2007-7#9)(2007-8#5)(2007-9#1)(2008-1#12)(2008-10#268)(2008-11#53)(2008-12#29)(2008-2#23)(2008-3#38)(2008-4#20)(2008-5#45)(2008-6#18)(2008-7#64)(2008-8#41)(2008-9#60)(2009-1#1)(2009-10#14)(2009-11#8)(2009-12#3)(2009-2#6)(2009-3#7)(2009-4#5)(2009-5#9)(2009-6#2)(2009-7#25)(2009-8#15)(2009-9#6)(2010-1#8)(2010-10#11)(2010-11#10)(2010-12#10)(2010-2#9)(2010-3#7)(2010-4#7)(2010-5#10)(2010-6#8)(2010-7#5)(2010-8#14)(2010-9#4)(2011-1#35)(2011-10#1)(2011-2#86)(2011-3#3)(2012-1#10)(2012-12#23)(2012-2#25)(2012-3#31)(2012-5#1)(2012-7#2)(2013-1#56)(2013-7#11)(2013-8#27)
related variables##2##2##(2011-1#1)(2011-2#1)
related with a better working memory##2##6##(2012-3#2)
related with a##6##3##(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#2)
related with the##14##3##(1991-11#1)(1991-6#1)(1993-11#1)(2008-10#7)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
related with##50##2##(1990-6#1)(1991-11#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
related##2592##1##(1990-10#1)(1990-11#13)(1990-12#13)(1990-2#6)(1990-3#4)(1990-5#16)(1990-6#4)(1990-7#6)(1990-8#12)(1991-1#3)(1991-11#3)(1991-12#17)(1991-2#11)(1991-3#15)(1991-4#2)(1991-5#7)(1991-6#13)(1991-7#2)(1991-8#6)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#7)(1992-12#18)(1992-2#9)(1992-3#13)(1992-4#1)(1992-5#2)(1992-6#13)(1992-7#1)(1992-8#9)(1992-9#9)(1993-1#4)(1993-10#1)(1993-11#7)(1993-12#21)(1993-2#4)(1993-3#3)(1993-5#4)(1993-6#14)(1993-8#9)(1993-9#7)(1994-1#1)(1994-11#9)(1994-12#10)(1994-2#15)(1994-3#12)(1994-5#9)(1994-6#17)(1994-8#10)(1994-9#7)(1995-1#6)(1995-11#10)(1995-12#22)(1995-2#16)(1995-3#14)(1995-5#10)(1995-6#11)(1995-8#11)(1995-9#2)(1996-1#11)(1996-10#1)(1996-11#2)(1996-12#27)(1996-2#12)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#7)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#15)(1997-3#9)(1997-4#6)(1997-5#3)(1997-6#6)(1997-7#11)(1997-8#5)(1997-9#1)(2006-10#6)(2006-12#2)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#7)(2007-11#19)(2007-12#46)(2007-2#11)(2007-4#1)(2007-5#3)(2007-6#9)(2007-7#15)(2007-8#6)(2007-9#1)(2008-1#28)(2008-10#430)(2008-11#87)(2008-12#48)(2008-2#30)(2008-3#53)(2008-4#42)(2008-5#65)(2008-6#26)(2008-7#97)(2008-8#64)(2008-9#80)(2009-1#2)(2009-10#21)(2009-11#10)(2009-12#10)(2009-2#9)(2009-3#9)(2009-4#9)(2009-5#11)(2009-6#3)(2009-7#29)(2009-8#19)(2009-9#9)(2010-1#8)(2010-10#14)(2010-11#13)(2010-12#14)(2010-2#10)(2010-3#10)(2010-4#10)(2010-5#12)(2010-6#11)(2010-7#8)(2010-8#27)(2010-9#5)(2011-1#57)(2011-10#1)(2011-2#126)(2011-3#10)(2012-1#15)(2012-12#32)(2012-2#40)(2012-3#50)(2012-5#4)(2012-7#2)(2013-1#71)(2013-7#16)(2013-8#54)
related)##4##1##(2008-1#1)(2008-10#2)(2008-7#1)
relatedness and##6##2##(2008-5#1)(2009-10#2)(2009-5#2)(2010-4#1)
relatedness between##4##2##(2008-10#2)(2008-5#1)(2009-5#1)
relatedness in##2##2##(2008-8#1)(2010-4#1)
relatedness of##7##2##(1997-4#1)(2007-6#1)(2008-10#5)
relatedness to SbDV##2##3##(2008-10#2)
relatedness to##4##2##(2008-10#2)(2009-5#1)(2012-2#1)
relatedness##42##1##(1996-12#1)(1997-4#1)(2007-6#1)(2008-10#10)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#9)(2008-9#6)(2009-10#2)(2009-5#4)(2010-4#2)(2010-8#1)(2012-2#1)
relates directly to the##2##4##(2008-2#1)(2008-7#1)
relates how##4##2##(1992-2#1)(1994-2#1)(2007-2#1)(2010-12#1)
relates the##17##2##(1990-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-8#1)
relates these##2##2##(2007-5#1)(2008-9#1)
relates to a##2##3##(2008-6#1)(2013-1#1)
relates to the##11##3##(1993-9#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-12#2)(2013-8#1)
relates to##45##2##(1992-9#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
relates##79##1##(1990-2#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#2)(1994-9#1)(1995-1#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
relating the intensity of##2##4##(1990-6#1)(2008-10#1)
relating the##14##2##(1990-6#1)(1992-12#1)(1993-5#1)(2008-10#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)
relating to a##2##3##(1993-11#1)(2011-2#1)
relating to human##2##3##(2008-5#1)(2010-4#1)
relating to research##2##3##(1992-12#1)(2007-8#1)
relating to the##22##3##(1991-5#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#2)(2012-12#2)(2013-1#1)
relating to##103##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-8#2)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#1)
relating##145##1##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-8#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1994-1#2)(1994-12#2)(1994-2#2)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-8#2)(2008-10#17)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#2)
relation among##3##2##(2008-3#1)(2008-5#1)(2008-9#1)
relation and##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
relation at##2##2##(1996-4#1)(2008-3#1)
relation between RC teacher practices and child##2##7##(2008-12#2)
relation between RC teacher practices and##3##6##(2008-12#3)
relation between RC##4##3##(2008-12#4)
relation between disease activity and QoL##2##6##(2012-1#2)
relation between growth##2##3##(2009-6#2)
relation between histological##2##3##(2008-6#2)
relation between physician and patient##2##5##(1993-11#2)
relation between the##38##3##(1991-11#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-5#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
relation between##136##2##(1990-5#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-5#1)(1994-1#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-6#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
relation exists between the##2##4##(2008-12#1)(2008-3#1)
relation for the##2##3##(2007-11#1)(2008-3#1)
relation for##7##2##(1995-3#1)(2007-11#1)(2008-2#3)(2008-3#1)(2013-1#1)
relation in the##3##3##(2008-10#2)(2009-7#1)
relation in##5##2##(1995-6#1)(2008-1#1)(2008-10#2)(2009-7#1)
relation is##2##2##(1990-5#1)(2008-5#1)
relation of the##9##3##(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
relation of##24##2##(1990-6#1)(1993-12#2)(1994-3#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-8#1)
relation that##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
relation to a number of##2##5##(1991-12#1)(1991-3#1)
relation to a##10##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(2008-1#2)(2008-2#1)(2008-3#1)
relation to an##2##3##(2008-10#2)
relation to certain##2##3##(1993-10#1)(1994-9#1)
relation to clinical##5##3##(1991-6#1)(2007-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
relation to different##4##3##(1993-5#1)(1995-3#1)(1996-6#1)(2008-10#1)
relation to insulin##3##3##(1994-12#1)(2008-3#2)
relation to its##4##3##(1995-11#1)(2007-11#1)(2008-1#1)(2008-5#1)
relation to other##6##3##(1993-11#1)(1994-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
relation to pretreatment##2##3##(2007-10#2)
relation to the genetic##2##4##(1997-2#1)(2008-9#1)
relation to the intracellular Ca2+ concentration##2##6##(1990-7#1)(1992-8#1)
relation to the type of##2##5##(1990-3#1)(2011-2#1)
relation to the##125##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-8#2)(1993-12#1)(1993-5#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
relation to their##10##3##(1993-9#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#2)(2009-7#1)(2012-2#1)
relation to##440##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#3)(1990-9#3)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#6)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#5)(1992-6#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#4)(1993-6#3)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#2)(2006-12#1)(2007-10#7)(2007-11#6)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#64)(2008-11#24)(2008-12#15)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#12)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#12)(2011-2#10)(2012-1#6)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#21)(2013-7#2)(2013-8#5)
relation was found between##5##4##(1991-5#1)(1991-6#1)(1993-2#1)(2008-10#1)(2013-1#1)
relation was found##7##3##(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(2008-10#2)(2013-1#1)
relation was##10##2##(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-9#1)(2008-10#2)(2008-5#2)(2013-1#1)
relation with the##5##3##(1990-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
relation with##17##2##(1990-5#1)(1990-8#1)(1994-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
relation##688##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#10)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#6)(1992-6#2)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#5)(1993-6#3)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#2)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#2)(1995-3#3)(1995-5#5)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#5)(1997-8#2)(2006-12#1)(2007-10#7)(2007-11#11)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#85)(2008-11#26)(2008-12#24)(2008-2#19)(2008-3#37)(2008-4#7)(2008-5#21)(2008-6#8)(2008-7#23)(2008-8#19)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#4)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#18)(2011-2#16)(2012-1#9)(2012-12#10)(2012-2#15)(2012-3#6)(2013-1#26)(2013-7#2)(2013-8#8)
relational and##2##2##(2008-10#1)(2012-3#1)
relational behavior##3##2##(1990-3#3)
relational climate##2##2##(2008-11#2)
relational contexts##2##2##(2009-7#2)
relational data##3##2##(2008-7#1)(2010-8#2)
relational database management##2##3##(1992-3#1)(2008-7#1)
relational database##10##2##(1992-3#1)(1996-2#1)(2008-3#2)(2008-4#3)(2008-7#3)
relational databases##4##2##(2008-4#3)(2008-9#1)
relational responding##2##2##(2011-2#2)
relational##57##1##(1990-3#5)(1992-3#1)(1996-2#4)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#7)(2008-3#2)(2008-4#7)(2008-7#8)(2008-9#1)(2009-11#2)(2009-7#3)(2010-1#1)(2010-10#1)(2010-8#3)(2011-2#5)(2012-12#2)(2012-3#1)
relations activities##8##2##(2008-12#8)
relations among the##3##3##(2008-3#2)(2008-8#1)
relations among##12##2##(1990-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#2)(2013-1#1)
relations and the##2##3##(2007-7#1)(2008-12#1)
relations and##13##2##(1994-3#1)(2007-7#2)(2008-11#1)(2008-12#5)(2008-3#2)(2009-8#2)
relations are##7##2##(1991-1#1)(1991-12#1)(2008-2#1)(2008-3#4)
relations as##4##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
relations between the##9##3##(1993-6#1)(1996-1#1)(1996-2#1)(2008-3#2)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#1)
relations between##31##2##(1993-6#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
relations for##6##2##(1990-9#1)(1991-3#1)(2007-11#1)(2008-12#2)(2008-3#1)
relations in the##2##3##(1990-8#1)(2008-3#1)
relations in##10##2##(1990-8#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-4#1)(2013-1#2)
relations of the##2##3##(2008-2#1)(2008-4#1)
relations of trust and##2##4##(2008-1#1)(2012-12#1)
relations of##9##2##(1990-3#1)(1997-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)
relations practitioners##2##2##(2008-12#2)
relations that are##2##3##(1990-8#1)(2007-11#1)
relations that##4##2##(1990-8#1)(2007-11#1)(2008-3#2)
relations to the##3##3##(1993-6#1)(1994-12#1)(2008-10#1)
relations to##9##2##(1993-6#1)(1994-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#1)(2012-2#1)
relations were##4##2##(2008-10#2)(2008-11#1)(2010-2#1)
relations with the##2##3##(1991-8#1)(2012-2#1)
relations with##8##2##(1991-12#1)(1991-8#1)(1994-2#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
relations##205##1##(1990-12#2)(1990-3#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#1)(1993-6#2)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-3#4)(1997-4#1)(2007-11#6)(2007-7#3)(2008-1#2)(2008-10#9)(2008-11#10)(2008-12#33)(2008-2#5)(2008-3#20)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#3)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#5)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#3)
relations)##2##1##(1996-12#1)(2008-7#1)
relationship (QSAR)##4##2##(2007-11#2)(2008-10#2)
relationship among isolates##3##3##(2008-10#3)
relationship among the##6##3##(1997-4#1)(2007-11#1)(2008-10#2)(2010-9#1)(2011-2#1)
relationship among##24##2##(1995-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
relationship and a##2##3##(2008-10#1)(2011-2#1)
relationship and the##6##3##(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
relationship and##29##2##(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-7#1)(2010-10#1)(2010-5#2)(2011-2#4)(2012-1#1)(2012-3#2)(2013-8#1)
relationship are discussed##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
relationship are##7##2##(1995-1#2)(1995-3#1)(2008-10#2)(2008-2#1)(2012-1#1)
relationship as##4##2##(1996-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
relationship between &quot##2##3##(1993-12#1)(1994-2#1)
relationship between HIV##2##3##(2008-6#1)(2012-2#1)
relationship between HMO##2##3##(1991-3#1)(2008-11#1)
relationship between I##2##3##(2008-10#1)(2008-11#1)
relationship between a##10##3##(1991-3#1)(1994-1#1)(1996-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#1)(2011-2#1)(2013-8#1)
relationship between absorbance##2##3##(2008-10#2)
relationship between aluminum and spontaneous pneumothorax##2##6##(2007-8#2)
relationship between anger##2##3##(2010-11#2)
relationship between barriers##2##3##(2010-11#2)
relationship between body mass index##2##5##(2011-1#1)(2011-2#1)
relationship between body##8##3##(2007-12#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)
relationship between both##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
relationship between brain development and feeding##2##6##(2012-2#2)
relationship between brain##3##3##(2008-7#1)(2012-2#2)
relationship between breastfeeding##2##3##(2008-10#1)(2010-6#1)
relationship between cardiovascular##2##3##(2013-8#2)
relationship between catenation##2##3##(1994-6#2)
relationship between child and parent##2##5##(2008-3#2)
relationship between child##3##3##(2008-12#1)(2008-3#2)
relationship between childhood##2##3##(2008-11#1)(2009-7#1)
relationship between concentration##2##3##(1996-12#1)(2010-5#1)
relationship between disease##4##3##(2008-10#3)(2012-1#1)
relationship between early##3##3##(1990-3#1)(2008-12#1)(2009-7#1)
relationship between educational##2##3##(1996-12#1)(2008-12#1)
relationship between elevated##2##3##(2007-10#1)(2008-7#1)
relationship between estimated and actual severity##2##6##(2008-10#2)
relationship between experience##2##3##(1992-9#1)(2011-2#1)
relationship between expression of##2##4##(2008-11#2)
relationship between ghrelin levels and growth parameters in the##2##9##(2011-1#2)
relationship between growth##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
relationship between hamstring##2##3##(2012-2#2)
relationship between health##2##3##(1991-6#1)(2008-11#1)
relationship between home range area and##2##6##(2008-8#2)
relationship between home range##3##4##(2008-8#3)
relationship between home##5##3##(1992-2#1)(2008-8#3)(2010-7#1)
relationship between hospital##3##3##(1996-3#2)(2013-1#1)
relationship between host##3##3##(2008-10#2)(2009-2#1)
relationship between hydrogen##2##3##(2008-7#1)(2009-9#1)
relationship between hypertension##2##3##(1993-11#1)(2008-8#1)
relationship between in vitro##2##4##(1994-2#1)(2008-10#1)
relationship between in##3##3##(1994-2#1)(2008-10#1)(2009-12#1)
relationship between incidence##4##3##(2008-10#4)
relationship between increased##3##3##(2008-8#1)(2013-8#2)
relationship between increasing##2##3##(2008-10#1)(2008-5#1)
relationship between innovation and continuous##2##5##(1994-1#1)(1995-1#1)
relationship between invasiveness and##2##4##(1997-3#2)
relationship between lipid##3##3##(1994-5#1)(1996-2#1)(2010-4#1)
relationship between local##4##3##(1994-2#1)(1994-8#1)(1996-10#1)(2008-7#1)
relationship between mean##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
relationship between medical care costs and##2##6##(2008-11#2)
relationship between medical##3##3##(1991-2#1)(2008-11#2)
relationship between negative##2##3##(2009-11#1)(2010-10#1)
relationship between nursing##2##3##(2008-1#1)(2010-3#1)
relationship between oxidative stress and##2##5##(1996-9#1)(2008-3#1)
relationship between parental##2##3##(2008-9#1)(2009-7#1)
relationship between peak height and##3##5##(2008-10#3)
relationship between peak##6##3##(2008-10#6)
relationship between physician and##2##4##(1995-2#1)(2008-3#1)
relationship between plasma##3##3##(1992-9#1)(2008-6#1)(2012-12#1)
relationship between prenatal##2##3##(1995-2#1)(2008-11#1)
relationship between protein##4##3##(1993-6#1)(2008-11#1)(2010-4#1)(2013-8#1)
relationship between proteins##3##3##(2008-2#1)(2008-4#2)
relationship between psoas tension and low back pain##2##8##(2009-4#2)
relationship between relative##2##3##(2008-3#1)(2013-1#1)
relationship between religion and##2##4##(2009-11#2)
relationship between rumination and##2##4##(2009-11#1)(2010-10#1)
relationship between serum corticosterone##2##4##(2008-7#2)
relationship between serum##3##3##(2008-7#2)(2013-1#1)
relationship between sexting and##2##4##(2013-1#2)
relationship between sleep##3##3##(1996-7#1)(2013-1#2)
relationship between social support and##2##5##(2009-7#1)(2013-8#1)
relationship between social##5##3##(2009-7#1)(2009-8#1)(2010-2#1)(2013-8#2)
relationship between species##3##3##(2008-10#1)(2008-8#2)
relationship between specific##2##3##(2010-2#1)(2010-5#1)
relationship between stroke and##2##4##(2007-10#2)
relationship between structure and##5##4##(1992-6#1)(2009-5#2)(2010-4#1)(2012-2#1)
relationship between subjective##2##3##(2007-12#1)(2010-7#1)
relationship between the P-R interval and##2##6##(1994-5#2)
relationship between the age at which##2##6##(2008-8#1)(2009-5#1)
relationship between the catalytic current and##2##6##(2008-10#2)
relationship between the concentration of the##2##6##(2008-10#2)
relationship between the concentration of##6##5##(2008-10#5)(2008-8#1)
relationship between the degree of##2##5##(1990-2#1)(2008-8#1)
relationship between the distribution of##4##5##(1994-2#1)(2008-10#2)(2011-1#1)
relationship between the electric##2##4##(2008-10#1)(2008-3#1)
relationship between the expression of##2##5##(1997-6#1)(2013-8#1)
relationship between the frequency shift and the##2##7##(2007-12#1)(2008-10#1)
relationship between the level of##2##5##(1992-10#1)(2008-5#1)
relationship between the load##2##4##(2009-2#1)(2010-6#1)
relationship between the number of audible pops##2##7##(2008-12#2)
relationship between the number of##8##5##(1990-2#1)(2008-11#1)(2008-12#3)(2008-8#1)(2013-1#1)(2013-8#1)
relationship between the outcome##2##4##(2008-9#1)(2011-2#1)
relationship between the peak current and##2##6##(2008-10#2)
relationship between the primary##2##4##(2008-10#1)(2011-2#1)
relationship between the rate of##3##5##(1992-8#1)(2008-7#1)(2008-8#1)
relationship between the relative##3##4##(2008-10#2)(2008-5#1)
relationship between the specific##2##4##(1994-5#1)(1995-5#1)
relationship between the structure and##2##5##(1997-2#1)(2008-8#1)
relationship between the structure##3##4##(1997-2#1)(2008-10#1)(2008-8#1)
relationship between the two##7##4##(2008-10#1)(2008-11#1)(2009-8#1)(2010-6#1)(2012-2#3)
relationship between the use of##3##5##(1996-3#2)(2008-9#1)
relationship between the##229##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#2)(1991-2#2)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#53)(2008-11#8)(2008-12#7)(2008-2#2)(2008-3#13)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#12)(2008-9#9)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#10)(2012-12#1)(2012-2#6)(2012-5#1)(2013-1#4)(2013-8#10)
relationship between their##2##3##(2007-12#1)(2008-9#1)
relationship between these two##2##4##(2007-2#1)(2012-3#1)
relationship between these##5##3##(1994-3#1)(2007-2#1)(2007-5#1)(2008-2#1)(2012-3#1)
relationship between this##4##3##(1991-11#1)(2007-2#1)(2008-10#1)(2013-7#1)
relationship between two##2##3##(1995-3#1)(2007-12#1)
relationship between virulence and##2##4##(2008-10#1)(2008-9#1)
relationship between##916##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#4)(1991-12#6)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#3)(1994-2#9)(1994-3#7)(1994-5#7)(1994-6#4)(1994-7#2)(1994-8#5)(1995-1#4)(1995-11#3)(1995-12#5)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#8)(1996-2#6)(1996-3#8)(1996-5#1)(1996-6#2)(1996-7#4)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2006-6#2)(2007-10#6)(2007-11#4)(2007-12#13)(2007-2#3)(2007-5#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#146)(2008-11#35)(2008-12#20)(2008-2#9)(2008-3#26)(2008-4#8)(2008-5#23)(2008-6#12)(2008-7#31)(2008-8#44)(2008-9#24)(2009-10#6)(2009-11#9)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#7)(2009-6#1)(2009-7#15)(2009-8#4)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#7)(2010-12#2)(2010-2#7)(2010-3#4)(2010-4#7)(2010-5#3)(2010-6#8)(2010-7#5)(2010-8#13)(2010-9#4)(2011-1#22)(2011-10#1)(2011-2#39)(2011-3#1)(2012-1#6)(2012-12#8)(2012-2#31)(2012-3#6)(2012-5#1)(2013-1#28)(2013-7#3)(2013-8#30)
relationship building##2##2##(2008-12#1)(2013-1#1)
relationship can be##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
relationship can##4##2##(1990-7#1)(2008-10#2)(2008-2#1)
relationship could be##3##3##(2008-1#1)(2008-10#2)
relationship development##2##2##(2008-11#1)(2012-2#1)
relationship distress and dissolution##2##4##(2009-9#1)(2012-2#1)
relationship distress##6##2##(2008-12#3)(2009-9#1)(2012-2#2)
relationship education##8##2##(2010-5#1)(2012-2#7)
relationship existed between##2##3##(1992-2#1)(2008-12#1)
relationship existed##3##2##(1992-2#1)(1993-12#1)(2008-12#1)
relationship exists between##7##3##(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2013-7#1)
relationship exists##8##2##(1995-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2013-7#1)
relationship for the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
relationship for this##2##3##(1995-3#1)(2008-9#1)
relationship for##16##2##(1990-8#1)(1991-12#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)
relationship found between the##2##4##(2008-11#1)(2008-2#1)
relationship functioning##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
relationship has been##4##3##(1990-8#1)(1991-12#1)(2008-1#1)(2012-2#1)
relationship has not been##2##4##(2008-9#1)(2010-3#1)
relationship has##6##2##(1990-8#1)(1991-12#1)(2008-1#1)(2008-9#1)(2010-3#1)(2012-2#1)
relationship in a##3##3##(1994-5#1)(2011-2#2)
relationship in the range of##3##5##(2008-10#3)
relationship in the##10##3##(2008-10#6)(2008-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
relationship in##21##2##(1994-5#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
relationship is accurate##2##3##(2008-8#1)(2009-2#1)
relationship is not##2##3##(2008-5#1)(2009-5#1)
relationship is used##2##3##(2007-12#1)(2008-3#1)
relationship is##25##2##(1990-6#1)(1991-3#1)(1991-4#1)(1994-2#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
relationship management##2##2##(2008-12#2)
relationship may##3##2##(2008-10#1)(2009-2#1)(2012-12#1)
relationship memory##3##2##(2010-8#3)
relationship of body##2##3##(2007-12#1)(2008-9#1)
relationship of cardiovascular risk factors measured at different ages to##2##10##(2008-7#2)
relationship of depressive symptoms##2##4##(2009-5#2)
relationship of the##23##3##(1990-8#1)(1991-2#1)(1991-3#1)(1995-9#1)(1997-4#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
relationship of these factors##2##4##(1995-3#1)(2011-1#1)
relationship of these##8##3##(1990-2#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2011-1#1)(2011-3#1)(2012-1#1)
relationship of##114##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-2#2)(1995-1#1)(1995-3#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#2)(2009-12#1)(2009-5#2)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#3)(2012-1#2)(2012-2#3)(2013-1#4)(2013-8#2)
relationship on##2##2##(2009-7#1)(2012-12#1)
relationship outcomes##2##2##(2007-10#1)(2012-2#1)
relationship over the entire##2##4##(2008-10#1)(2013-1#1)
relationship persists after adjusting for##3##5##(1993-12#2)(1994-2#1)
relationship quality and##2##3##(2008-2#1)(2010-5#1)
relationship satisfaction was##2##3##(2009-7#1)(2010-8#1)
relationship satisfaction##11##2##(2008-6#1)(2008-9#1)(2009-7#6)(2010-8#2)(2012-2#1)
relationship status##2##2##(2008-12#1)(2010-7#1)
relationship studies##4##2##(1994-5#1)(1995-3#3)
relationship study of##3##3##(1996-5#1)(2008-10#1)(2010-12#1)
relationship study##6##2##(1995-3#1)(1996-5#2)(2008-10#2)(2010-12#1)
relationship suggests that##2##3##(1990-7#1)(2009-2#1)
relationship that##6##2##(1991-6#1)(1993-3#1)(1995-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
relationship to growth##2##3##(1994-5#1)(2008-8#1)
relationship to health##2##3##(2008-7#1)(2012-12#1)
relationship to its##2##3##(1992-12#1)(2013-1#1)
relationship to other##3##3##(2008-10#2)(2012-2#1)
relationship to the##20##3##(1993-11#2)(1993-2#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#4)(2012-3#1)(2013-8#1)
relationship to##86##2##(1990-11#1)(1990-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
relationship was detected between##2##4##(2008-10#1)(2012-12#1)
relationship was found between the##4##5##(1991-2#2)(1993-2#1)(2008-10#1)
relationship was found between##17##4##(1990-12#1)(1991-2#2)(1993-12#1)(1993-2#1)(1995-8#1)(2008-10#7)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
relationship was found to be##3##5##(2008-10#2)(2013-1#1)
relationship was found to##4##4##(2008-10#3)(2013-1#1)
relationship was found with##2##4##(1991-2#1)(2008-10#1)
relationship was found##24##3##(1990-12#1)(1991-2#3)(1993-12#1)(1993-2#1)(1995-8#1)(2008-10#12)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
relationship was not observed##2##4##(2008-10#1)(2012-12#1)
relationship was not##3##3##(2008-10#2)(2012-12#1)
relationship was observed between##6##4##(1990-7#1)(1991-2#1)(2008-10#3)(2008-2#1)
relationship was observed##7##3##(1990-7#1)(1991-2#1)(2008-10#3)(2008-2#1)(2011-1#1)
relationship was##58##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#4)(1993-12#2)(1993-2#1)(1994-9#1)(1995-8#1)(2008-10#32)(2008-2#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
relationship were##3##2##(2008-5#1)(2009-11#1)(2009-4#1)
relationship with an##2##3##(2007-12#1)(2012-2#1)
relationship with baseline##2##3##(2011-2#1)(2012-12#1)
relationship with clinical##3##3##(1994-12#1)(2012-3#1)(2013-1#1)
relationship with health care provider##2##5##(2013-7#2)
relationship with its##2##3##(2008-10#2)
relationship with other##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
relationship with some##2##3##(2008-10#1)(2013-7#1)
relationship with the##31##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-12#2)(2013-1#2)
relationship with their##6##3##(2007-12#1)(2008-10#3)(2012-3#1)(2013-1#1)
relationship with##122##2##(1990-12#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#11)(2013-7#3)
relationship within the##3##3##(1992-12#1)(2008-12#1)(2010-10#1)
relationship within##5##2##(1992-12#1)(1997-1#1)(2007-12#1)(2008-12#1)(2010-10#1)
relationship##1743##1##(1990-11#2)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#4)(1990-6#5)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#4)(1991-12#12)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#6)(1992-2#8)(1992-3#6)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#17)(1993-2#9)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-1#7)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#16)(1994-3#9)(1994-5#14)(1994-6#5)(1994-7#2)(1994-8#7)(1994-9#1)(1995-1#8)(1995-11#4)(1995-12#10)(1995-2#10)(1995-3#14)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#14)(1996-2#10)(1996-3#10)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#10)(1997-2#2)(1997-3#6)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#4)(2006-10#1)(2006-6#2)(2007-1#1)(2007-10#9)(2007-11#14)(2007-12#31)(2007-2#4)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#13)(2008-10#300)(2008-11#54)(2008-12#41)(2008-2#22)(2008-3#46)(2008-4#19)(2008-5#41)(2008-6#22)(2008-7#62)(2008-8#61)(2008-9#46)(2009-1#1)(2009-10#10)(2009-11#13)(2009-12#4)(2009-2#6)(2009-3#3)(2009-4#7)(2009-5#12)(2009-6#1)(2009-7#27)(2009-8#5)(2009-9#7)(2010-1#6)(2010-10#8)(2010-11#7)(2010-12#3)(2010-2#9)(2010-3#11)(2010-4#9)(2010-5#8)(2010-6#11)(2010-7#6)(2010-8#23)(2010-9#9)(2011-1#34)(2011-10#1)(2011-2#64)(2011-3#8)(2012-1#14)(2012-12#22)(2012-2#66)(2012-3#18)(2012-5#1)(2012-9#1)(2013-1#62)(2013-7#11)(2013-8#45)
relationship&quot##2##1##(1993-12#1)(2013-1#1)
relationship)##3##1##(1994-12#2)(2008-12#1)
relationship?##3##1##(1995-3#1)(2009-8#1)(2011-2#1)
relationships among adipogenic genes##2##4##(2010-4#2)
relationships among all##2##3##(2008-8#1)(2008-9#1)
relationships among body##2##3##(2007-12#1)(2008-9#1)
relationships among different##2##3##(2008-10#1)(2008-3#1)
relationships among isolates##2##3##(2008-10#2)
relationships among phenotypes##3##3##(2011-1#3)
relationships among several##2##3##(1997-3#1)(2010-7#1)
relationships among temperature##2##3##(2008-10#2)
relationships among the##13##3##(1997-4#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#2)(2010-5#1)(2010-6#1)(2010-8#1)
relationships among these##6##3##(1992-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
relationships among##79##2##(1992-2#1)(1992-3#1)(1993-2#2)(1994-11#1)(1995-12#1)(1995-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#8)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#2)(2012-3#1)(2013-8#2)
relationships and provided information on the##2##6##(2008-10#2)
relationships and the##6##3##(1992-12#1)(2007-2#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
relationships and to##2##3##(2007-11#1)(2013-8#1)
relationships and##27##2##(1991-3#1)(1992-12#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
relationships are##15##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
relationships at##3##2##(2008-12#1)(2008-7#2)
relationships become##2##2##(2008-10#1)(2009-7#1)
relationships between disease incidence##2##4##(2008-10#2)
relationships between disease##4##3##(2008-10#4)
relationships between family members##2##4##(1996-9#1)(2008-11#1)
relationships between functional##2##3##(1996-2#1)(2013-7#1)
relationships between individual##2##3##(2008-7#1)(2010-8#1)
relationships between physical health and spiritual##2##6##(2010-2#2)
relationships between physical##3##3##(2008-9#1)(2010-2#2)
relationships between risk##2##3##(1991-12#1)(2011-1#1)
relationships between social##2##3##(1992-3#1)(2008-5#1)
relationships between species##3##3##(2008-8#2)(2013-7#1)
relationships between stress##2##3##(1992-3#1)(2008-7#1)
relationships between the##31##3##(1995-8#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
relationships between these two##2##4##(2008-10#1)(2009-12#1)
relationships between these##8##3##(2007-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
relationships between##178##2##(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1993-1#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#37)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#11)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#1)
relationships by##4##2##(1995-1#1)(2009-7#1)(2011-2#2)
relationships can be##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
relationships developed in the##2##4##(2008-10#2)
relationships for the##4##3##(1995-6#2)(2007-11#1)(2008-10#1)
relationships for##15##2##(1991-1#1)(1991-12#1)(1991-3#1)(1995-6#2)(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#3)(2011-1#1)
relationships found##2##2##(2008-11#1)(2008-4#1)
relationships have##3##2##(1990-5#1)(2008-5#1)(2008-9#1)
relationships in a##5##3##(2008-10#1)(2008-12#1)(2010-8#1)(2013-1#2)
relationships in epidemiologic studies##2##4##(2008-7#2)
relationships in human experimental exposure to##2##6##(2008-7#2)
relationships in human##3##3##(1994-8#1)(2008-7#2)
relationships in the##8##3##(1991-3#2)(1992-4#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)
relationships in this##2##3##(2008-11#1)(2009-4#1)
relationships in##40##2##(1990-7#1)(1991-3#2)(1992-4#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-8#1)
relationships is##5##2##(1991-3#1)(1995-6#1)(2008-2#1)(2008-8#1)(2010-2#1)
relationships may be##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
relationships of resistance##2##3##(2008-10#2)
relationships of the##10##3##(1995-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-7#1)
relationships of##53##2##(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-3#2)(2010-6#2)(2010-9#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
relationships revealed##2##2##(2007-6#1)(2008-6#1)
relationships should be disclosed to research participants##2##7##(2009-4#2)
relationships should be##4##3##(2008-11#1)(2009-4#3)
relationships suggest that the##2##4##(1991-5#1)(1995-3#1)
relationships suggest that##3##3##(1991-5#1)(1995-3#1)(2008-10#1)
relationships suggested that##2##3##(2008-10#2)
relationships that##7##2##(1993-1#1)(1994-1#1)(2008-10#2)(2008-11#1)(2011-7#1)(2013-1#1)
relationships to one another##2##4##(2007-12#1)(2008-7#1)
relationships to##17##2##(1993-2#1)(1995-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
relationships was##2##2##(1997-4#1)(2011-1#1)
relationships we##2##2##(2013-1#2)
relationships were established##2##3##(1991-2#1)(2008-10#1)
relationships were found between##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
relationships were found##6##3##(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-7#1)
relationships were not##2##3##(2009-4#1)(2010-7#1)
relationships were observed##2##3##(2008-10#1)(2009-4#1)
relationships were similar to the##2##5##(2008-11#1)(2008-8#1)
relationships were##26##2##(1991-2#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#3)(2010-1#1)(2010-7#1)(2012-2#1)(2013-7#1)
relationships with each##2##3##(1995-1#1)(1997-6#1)
relationships with other##2##3##(1991-12#1)(2013-7#1)
relationships with referring physicians##2##4##(1995-1#1)(1995-12#1)
relationships with some##2##3##(2008-12#1)(2012-12#1)
relationships with the##3##3##(2008-10#1)(2008-7#2)
relationships with their parents##2##4##(2009-7#2)
relationships with their teachers##2##4##(2008-12#2)
relationships with their##6##3##(1994-12#1)(2008-12#2)(2009-7#2)(2011-1#1)
relationships with##46##2##(1990-12#1)(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-9#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-12#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
relationships within the genus##2##4##(2008-10#1)(2010-4#1)
relationships within the##7##3##(2007-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-4#1)
relationships within##14##2##(1992-1#1)(1996-12#1)(2007-2#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)
relationships##759##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#7)(1991-2#4)(1991-3#8)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#4)(1993-5#2)(1994-1#6)(1994-11#2)(1994-12#6)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#5)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-12#4)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#1)(2007-11#9)(2007-12#12)(2007-2#2)(2007-5#3)(2007-6#3)(2008-1#8)(2008-10#140)(2008-11#21)(2008-12#21)(2008-2#6)(2008-3#5)(2008-4#11)(2008-5#14)(2008-6#15)(2008-7#45)(2008-8#35)(2008-9#34)(2009-10#3)(2009-11#3)(2009-12#4)(2009-4#11)(2009-5#7)(2009-6#1)(2009-7#11)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#7)(2010-4#8)(2010-5#4)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#5)(2011-1#18)(2011-2#25)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#14)(2012-3#10)(2012-5#1)(2013-1#26)(2013-7#8)(2013-8#12)
relationships)##3##1##(1995-4#1)(2011-1#1)(2013-7#1)
relative EC50/IC50##5##2##(2012-2#5)
relative PKA activity levels##2##4##(2008-10#2)
relative S##8##2##(2008-10#8)
relative abilities##2##2##(2008-10#1)(2009-9#1)
relative abundance and##6##3##(2008-10#1)(2008-5#1)(2010-8#1)(2012-6#3)
relative abundance in##2##3##(2008-8#1)(2013-7#1)
relative abundance of C##2##4##(2012-6#2)
relative abundance of##16##3##(1992-12#1)(1994-11#1)(1994-8#1)(1997-2#1)(2008-10#4)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)(2012-6#2)
relative abundance patterns##2##3##(2008-8#2)
relative abundance##29##2##(1992-12#1)(1994-11#1)(1994-8#1)(1997-2#1)(1997-6#1)(2008-10#5)(2008-5#5)(2008-8#5)(2008-9#1)(2010-8#1)(2012-2#1)(2012-6#5)(2013-7#1)
relative abundances of##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
relative abundances##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
relative accuracy of##2##3##(2008-10#1)(2008-2#1)
relative accuracy##7##2##(1990-5#1)(2008-10#4)(2008-2#1)(2010-11#1)
relative activities##4##2##(1992-12#1)(2008-10#1)(2008-11#2)
relative activity of##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
relative activity##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
relative advantages##2##2##(2008-10#1)(2008-3#1)
relative affinities of the##2##4##(1990-7#1)(2011-2#1)
relative affinities of##3##3##(1990-7#1)(2008-9#1)(2011-2#1)
relative affinity for##3##3##(1991-12#1)(1996-2#1)(2008-10#1)
relative affinity##4##2##(1990-7#1)(1991-12#1)(1996-2#1)(2008-10#1)
relative amount of##7##3##(1991-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-2#1)(2009-2#1)(2013-1#1)
relative amounts of the metabolites##2##5##(2011-3#2)
relative amounts of the##7##4##(1991-5#1)(1996-9#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-3#2)
relative amounts of##15##3##(1991-5#2)(1992-12#1)(1993-8#1)(1996-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-3#2)
relative amounts##16##2##(1991-5#2)(1992-12#1)(1993-1#1)(1993-8#1)(1996-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-3#2)
relative amplitude##2##2##(2008-4#1)(2008-7#1)
relative and absolute##4##3##(2008-3#1)(2008-8#2)(2012-2#1)
relative and##7##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-1#1)(2012-2#1)
relative area under the disease progress##2##6##(2008-10#2)
relative area under the##5##4##(2008-10#5)
relative attractiveness##3##2##(2008-10#3)
relative average##2##2##(2008-10#1)(2011-2#1)
relative binding affinities of##2##4##(1990-11#1)(1993-6#1)
relative binding##6##2##(1990-11#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)
relative bioavailability##2##2##(2008-5#1)(2011-2#1)
relative blood##2##2##(2007-10#2)
relative carrier-envelope phase##2##3##(2007-11#2)
relative cell counts##2##3##(2011-1#2)
relative cell##3##2##(2008-5#1)(2011-1#2)
relative cerebellar metabolism##2##3##(1996-5#2)
relative cerebellar##3##2##(1995-5#1)(1996-5#2)
relative cerebral blood volume (rCBV)##2##5##(2007-10#1)(2008-7#1)
relative cerebral blood##3##3##(2007-10#2)(2008-7#1)
relative cerebral##4##2##(2007-10#2)(2008-7#1)(2011-1#1)
relative change in##3##3##(2007-7#1)(2008-3#2)
relative change##5##2##(2007-7#1)(2008-3#2)(2008-6#1)(2011-2#1)
relative changes##4##2##(1990-5#1)(2008-2#1)(2008-7#2)
relative collision##2##2##(2008-10#2)
relative comparison with##2##3##(2008-10#1)(2008-3#1)
relative concentration of##3##3##(1991-12#1)(1996-9#1)(2008-10#1)
relative concentration##5##2##(1991-12#1)(1996-9#1)(2008-10#2)(2011-1#1)
relative contraindications##2##2##(1991-6#1)(2011-2#1)
relative contribution of##15##3##(1992-6#2)(1994-2#1)(2007-12#2)(2008-10#4)(2008-8#1)(2009-1#1)(2011-2#1)(2013-1#3)
relative contribution to the##2##4##(2008-2#1)(2008-7#1)
relative contribution to##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
relative contribution##19##2##(1992-6#2)(1994-2#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#3)
relative contributions of subjective##2##4##(2007-12#2)
relative contributions of these##2##4##(2008-12#1)(2008-7#1)
relative contributions of##10##3##(2007-12#2)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)
relative contributions to##2##3##(1990-8#1)(1991-8#1)
relative contributions##15##2##(1990-8#1)(1991-8#1)(1996-11#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-8#1)
relative cost##2##2##(1993-2#1)(2008-8#1)
relative costs##2##2##(1993-2#1)(2008-8#1)
relative decrease in##2##3##(2007-11#1)(2008-2#1)
relative decrease##3##2##(2007-11#1)(2008-2#1)(2013-8#1)
relative deviations##2##2##(2008-10#2)
relative difference in##4##3##(1995-9#1)(2008-2#1)(2008-3#1)(2009-2#1)
relative difference##5##2##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)
relative differences in##2##3##(2008-10#1)(2008-3#1)
relative differences##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
relative disease##2##2##(2008-10#1)(2012-2#1)
relative distance of##2##3##(2008-2#1)(2010-10#1)
relative ease##4##2##(2007-8#1)(2008-7#1)(2009-12#1)(2011-1#1)
relative effect of##2##3##(1992-11#1)(1996-11#1)
relative efficacy of LAIV##2##4##(2011-2#2)
relative efficacy of##6##3##(1994-12#1)(2008-10#1)(2011-2#4)
relative efficacy##9##2##(1990-5#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#4)
relative efficiency of the##2##4##(1992-3#1)(1992-9#1)
relative efficiency##3##2##(1992-3#1)(1992-9#1)(2008-3#1)
relative electrophoretic mobility##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
relative energies of##3##3##(1997-7#1)(2012-12#2)
relative error &lt##3##3##(2008-10#3)
relative error in the##3##4##(2008-10#3)
relative error in##4##3##(2008-10#4)
relative error lower than 10%##2##5##(2008-10#2)
relative error of 5##2##4##(2008-10#2)
relative error of##14##3##(2008-10#12)(2008-2#1)(2013-8#1)
relative error##35##2##(2008-10#29)(2008-2#1)(2008-3#2)(2011-1#1)(2013-8#2)
relative errors of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
relative errors of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
relative errors##11##2##(2008-10#9)(2008-2#1)(2008-3#1)
relative expression of##3##3##(2008-11#1)(2008-3#1)(2009-11#1)
relative expression##5##2##(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-2#1)
relative fitness cost##2##3##(2008-8#2)
relative fitness##5##2##(2008-10#3)(2008-8#2)
relative fluorescence intensity of##3##4##(2008-10#3)
relative fluorescence intensity was##2##4##(2008-10#2)
relative fluorescence intensity##6##3##(2008-10#6)
relative fluorescence##11##2##(2008-10#9)(2008-3#2)
relative frequencies of##3##3##(2008-10#1)(2008-8#2)
relative frequencies##4##2##(2008-10#2)(2008-8#2)
relative frequency of##5##3##(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
relative frequency##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
relative growth rates for##2##4##(2008-7#1)(2013-7#1)
relative growth rates##3##3##(2008-7#2)(2013-7#1)
relative growth##7##2##(1992-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2013-7#1)
relative hazards##2##2##(1997-3#2)
relative hippocampal volume##3##3##(1994-3#3)
relative humidities##13##2##(1996-12#1)(2008-10#9)(2010-4#2)(2011-2#1)
relative humidity &gt##2##3##(2008-10#2)
relative humidity (RH) on the##2##5##(1996-12#1)(2008-2#1)
relative humidity (RH) on##3##4##(1996-12#1)(2008-10#1)(2008-2#1)
relative humidity (RH)##20##3##(1996-12#1)(2007-11#1)(2008-10#17)(2008-2#1)
relative humidity and##6##3##(2008-10#4)(2008-5#1)(2013-1#1)
relative humidity at##5##3##(2008-10#2)(2008-2#2)(2008-5#1)
relative humidity during##2##3##(2008-10#2)
relative humidity of##2##3##(1995-3#1)(2008-2#1)
relative humidity was##3##3##(2008-10#3)
relative humidity##84##2##(1995-3#3)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#57)(2008-2#5)(2008-3#2)(2008-5#6)(2008-8#2)(2010-10#1)(2010-5#1)(2013-1#2)(2013-8#2)
relative humidity)##3##2##(1996-2#1)(2008-10#2)
relative impact of##3##3##(2008-1#1)(2008-10#1)(2009-8#1)
relative importance and##3##3##(2007-2#1)(2008-5#1)(2010-4#1)
relative importance in##2##3##(2008-10#1)(2008-8#1)
relative importance of##34##3##(1990-7#1)(1990-9#1)(1992-2#1)(1994-2#1)(1996-6#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2010-1#1)(2011-1#1)(2012-3#1)
relative importance##43##2##(1990-7#1)(1990-9#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-6#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#7)(2008-9#2)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
relative inclusion rate##2##3##(1994-9#2)
relative increase in cell counts##2##5##(2011-1#2)
relative increase in##4##3##(2008-2#1)(2008-7#1)(2011-1#2)
relative increase##6##2##(1991-12#1)(1995-5#1)(2008-2#1)(2008-7#1)(2011-1#2)
relative influence##4##2##(1996-1#1)(1996-3#1)(2008-10#1)(2010-1#1)
relative intensity noise of##2##4##(2007-12#1)(2008-2#1)
relative intensity noise##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
relative intensity of##6##3##(2008-10#3)(2008-3#1)(2008-8#2)
relative intensity##10##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#2)(2013-8#1)
relative interfacial pressure##2##3##(2008-10#2)
relative lack of##4##3##(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
relative leaf##2##2##(2008-12#1)(2008-8#1)
relative levels of##4##3##(1990-3#1)(2008-7#3)
relative localization##2##2##(1990-3#2)
relative location##2##2##(1994-12#1)(1996-12#1)
relative low##2##2##(2007-12#1)(2008-10#1)
relative magnitude of##2##3##(2007-10#1)(2008-8#1)
relative measurements of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
relative measurements##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
relative measures##3##2##(1990-2#1)(2008-10#1)(2008-3#1)
relative merits of##4##3##(2008-3#2)(2008-4#1)(2011-2#1)
relative merits##7##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
relative molecular mass of##6##4##(1991-12#2)(1993-8#1)(2008-10#1)(2008-11#2)
relative molecular mass##8##3##(1991-12#2)(1991-2#2)(1993-8#1)(2008-10#1)(2008-11#2)
relative molecular weight of the##2##5##(1994-2#1)(2008-10#1)
relative molecular##12##2##(1990-5#1)(1991-12#2)(1991-2#2)(1992-12#1)(1993-8#1)(1994-2#1)(2008-10#2)(2008-11#2)
relative motion between the##2##4##(2008-2#1)(2012-1#1)
relative motion##3##2##(2008-2#1)(2012-1#2)
relative noise##2##2##(2008-2#1)(2008-9#1)
relative nuclear DNA content##2##4##(2008-9#2)
relative of the##2##3##(2010-3#1)(2011-2#1)
relative of##7##2##(1995-2#1)(2008-10#3)(2008-8#1)(2010-3#1)(2011-2#1)
relative order of##2##3##(2008-10#1)(2008-4#1)
relative orientation of the##2##4##(2008-10#1)(2008-3#1)
relative orientation of##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
relative orientation##4##2##(2008-10#1)(2008-3#1)(2009-7#1)(2010-2#1)
relative parameters##3##2##(2008-10#1)(2008-5#2)
relative peak##2##2##(1995-6#1)(2008-10#1)
relative percentage##2##2##(1991-3#1)(2008-10#1)
relative percentages of##2##3##(2008-10#2)
relative performance of the##3##4##(1994-9#1)(2008-10#1)(2008-2#1)
relative performance of##7##3##(1994-1#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
relative performance##8##2##(1994-1#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
relative phase shift between the##2##5##(2008-3#2)
relative phase##8##2##(2007-11#1)(2008-10#2)(2008-3#5)
relative photodynamic oxidation rates of##2##5##(2008-5#2)
relative photosynthetic rate##3##3##(2008-10#3)
relative population doubling##2##3##(2011-1#2)
relative populations##2##2##(2008-10#1)(2008-8#1)
relative position##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
relative potencies##2##2##(1992-9#1)(1993-3#1)
relative potency of##3##3##(1990-2#1)(1992-9#1)(1993-8#1)
relative potency##6##2##(1990-2#1)(1992-9#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-5#1)
relative power in spectral band##2##5##(2008-7#2)
relative power##7##2##(2007-11#1)(2008-3#2)(2008-7#4)
relative prediction error of##2##4##(2008-10#1)(2008-3#1)
relative prediction error##3##3##(2008-10#2)(2008-3#1)
relative prediction##5##2##(2008-10#4)(2008-3#1)
relative predictive error##2##3##(2008-10#2)
relative predictive##3##2##(2008-10#3)
relative prevalence of##2##3##(2010-8#2)
relative prices##2##2##(1991-12#2)
relative proportions of##5##3##(1995-2#1)(2008-10#1)(2008-7#2)(2010-5#1)
relative proportions##6##2##(1995-2#1)(2008-10#1)(2008-7#2)(2010-5#1)(2012-2#1)
relative protein##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
relative quantification of##2##3##(2008-10#1)(2008-12#1)
relative quantification##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
relative quantitative##2##2##(1993-12#1)(2008-10#1)
relative rate of##3##3##(2008-10#2)(2008-11#1)
relative rate##5##2##(2008-10#4)(2008-11#1)
relative rates of##5##3##(1991-12#1)(1995-3#1)(2008-10#1)(2008-2#1)(2009-2#1)
relative rates##7##2##(1991-12#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-2#1)(2009-2#1)(2012-12#1)
relative receptor-binding potencies in the range##2##6##(1992-3#2)
relative recoveries##2##2##(2008-10#1)(2012-1#1)
relative resistance of##2##3##(1997-4#1)(2008-10#1)
relative resistance##3##2##(1997-4#1)(2008-10#1)(2008-4#1)
relative resource##2##2##(2008-8#1)(2009-10#1)
relative response##3##2##(1994-9#2)(2008-10#1)
relative rigidity##2##2##(1995-8#1)(2008-10#1)
relative risk (RR) and##2##4##(1993-9#1)(2013-1#1)
relative risk (RR) of##2##4##(1992-11#1)(2011-1#1)
relative risk (RR)##5##3##(1992-11#1)(1993-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
relative risk 0##2##3##(1991-11#1)(2008-10#1)
relative risk and##2##3##(1995-9#1)(1997-5#1)
relative risk approaches##4##3##(1997-5#4)
relative risk estimates##2##3##(1996-3#2)
relative risk for##3##3##(2006-10#1)(2008-6#1)(2012-12#1)
relative risk of death##3##4##(1990-5#1)(2007-12#1)(2008-6#1)
relative risk of##18##3##(1990-5#1)(1991-7#1)(1992-2#1)(1993-9#2)(1994-2#1)(1994-9#2)(1995-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2013-1#2)
relative risk was##2##3##(1991-2#1)(1993-9#1)
relative risk##54##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-9#4)(1994-2#2)(1994-9#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#2)(1997-5#7)(1997-8#3)(2006-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
relative risks of##2##3##(1992-6#1)(2008-11#1)
relative risks were##2##3##(1991-3#1)(1996-11#1)
relative risks##8##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-9#1)(1996-11#1)(2008-11#1)(2008-7#1)
relative roles of##6##3##(1991-8#1)(2008-10#1)(2008-8#4)
relative roles##7##2##(1991-8#1)(2008-10#1)(2008-8#5)
relative root mean##2##3##(2008-10#2)
relative seed##2##2##(2008-10#2)
relative selectivity##2##2##(2008-10#2)
relative sensitivity of the composite##2##5##(2008-10#2)
relative sensitivity##5##2##(2008-10#4)(2008-12#1)
relative signal##2##2##(2008-10#1)(2008-3#1)
relative simplicity##4##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)
relative size##2##2##(1991-9#1)(1996-5#1)
relative spectral##2##2##(2007-11#1)(2008-3#1)
relative stability of##5##3##(1990-7#2)(2008-3#1)(2008-8#2)
relative stability##6##2##(1990-7#2)(2008-3#1)(2008-8#2)(2012-9#1)
relative standard derivation##2##3##(2008-10#2)
relative standard deviation &lt##2##4##(2008-10#2)
relative standard deviation (%R##2##4##(2008-10#2)
relative standard deviation (R##76##4##(2008-10#76)
relative standard deviation (RSD) of 0##2##6##(2008-10#2)
relative standard deviation (RSD) of##5##5##(2008-10#5)
relative standard deviation (RSD) was##3##5##(2008-10#1)(2013-8#2)
relative standard deviation (RSD)##19##4##(2008-10#16)(2009-8#1)(2013-8#2)
relative standard deviation (n=10) was##3##5##(2008-10#3)
relative standard deviation (n=10)##4##4##(2008-10#4)
relative standard deviation (n=11)##3##4##(2008-10#3)
relative standard deviation (n=5)##2##4##(2008-10#2)
relative standard deviation 0##2##4##(2008-10#2)
relative standard deviation 1##3##4##(2008-10#3)
relative standard deviation at##3##4##(2008-10#3)
relative standard deviation between##3##4##(2008-10#3)
relative standard deviation for eight replicate##4##6##(2008-10#4)
relative standard deviation for eight##5##5##(2008-10#5)
relative standard deviation for six##2##5##(2008-10#2)
relative standard deviation for ten##2##5##(2008-10#2)
relative standard deviation for the determination of##3##7##(2008-10#3)
relative standard deviation for the##8##5##(2008-10#8)
relative standard deviation for##40##4##(2008-10#40)
relative standard deviation in##6##4##(2008-10#4)(2008-3#2)
relative standard deviation is 2##3##5##(2008-10#3)
relative standard deviation is 3##3##5##(2008-10#3)
relative standard deviation is##17##4##(2008-10#17)
relative standard deviation obtained##3##4##(2008-10#3)
relative standard deviation of +/-0##3##5##(2008-10#3)
relative standard deviation of 0##7##5##(2008-10#7)
relative standard deviation of 1##18##5##(2008-10#18)
relative standard deviation of 1%##2##5##(2008-10#2)
relative standard deviation of 2##15##5##(2008-10#15)
relative standard deviation of 3##6##5##(2008-10#6)
relative standard deviation of 5##3##5##(2008-10#2)(2011-1#1)
relative standard deviation of less than##8##6##(2008-10#8)
relative standard deviation of the##11##5##(2008-10#11)
relative standard deviation of three##2##5##(2008-10#2)
relative standard deviation of##111##4##(1994-9#1)(2008-10#109)(2011-1#1)
relative standard deviation ranging from##2##5##(2008-10#2)
relative standard deviation values for##3##5##(2008-10#3)
relative standard deviation values of##3##5##(2008-10#3)
relative standard deviation values##9##4##(2008-10#9)
relative standard deviation was 1##6##5##(2008-10#6)
relative standard deviation was 2##7##5##(2008-10#7)
relative standard deviation was 3##4##5##(2008-10#4)
relative standard deviation was 4##3##5##(1990-8#1)(2008-10#2)
relative standard deviation was 5##2##5##(2008-10#2)
relative standard deviation was below##2##5##(2008-10#2)
relative standard deviation was##39##4##(1990-8#1)(2008-10#38)
relative standard deviation were##4##4##(2008-1#1)(2008-10#3)
relative standard deviation##392##3##(1990-8#1)(1994-9#1)(1995-12#1)(2008-1#1)(2008-10#381)(2008-3#2)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#2)
relative standard deviation) of##2##4##(2008-10#2)
relative standard deviation)##3##3##(2008-10#3)
relative standard deviations (R##18##4##(2008-10#18)
relative standard deviations (RSD) for##2##5##(2008-10#1)(2008-5#1)
relative standard deviations (RSD)##4##4##(2008-10#2)(2008-5#1)(2012-1#1)
relative standard deviations (RSDs)##5##4##(2008-10#2)(2011-1#3)
relative standard deviations (n = 5)##3##6##(2008-10#3)
relative standard deviations (n =##6##5##(2008-10#4)(2011-1#2)
relative standard deviations are##2##4##(2008-10#2)
relative standard deviations for samples were##2##6##(2008-10#1)(2008-5#1)
relative standard deviations for the##2##5##(2008-10#2)
relative standard deviations for##19##4##(2008-10#18)(2008-5#1)
relative standard deviations obtained for##2##5##(2008-10#2)
relative standard deviations obtained##3##4##(2008-10#2)(2008-5#1)
relative standard deviations of 2##4##5##(2008-10#4)
relative standard deviations of less than##4##6##(2008-10#4)
relative standard deviations of migration times and##2##7##(2008-10#2)
relative standard deviations of##29##4##(2008-10#28)(2008-5#1)
relative standard deviations ranging from##2##5##(1997-2#1)(2008-10#1)
relative standard deviations ranging##3##4##(1997-2#1)(2008-10#2)
relative standard deviations were 2##2##5##(2008-10#2)
relative standard deviations were lower than##2##6##(2008-10#2)
relative standard deviations were##16##4##(2008-10#14)(2011-1#2)
relative standard deviations##123##3##(1994-9#1)(1997-2#1)(2008-10#105)(2008-5#5)(2010-5#1)(2011-1#9)(2012-1#1)
relative standard error (R##3##4##(2008-10#3)
relative standard error for##2##4##(2008-10#2)
relative standard error##7##3##(2008-10#7)
relative standard##531##2##(1990-8#1)(1994-9#2)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#501)(2008-2#1)(2008-3#2)(2008-5#5)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#10)(2012-1#1)(2013-8#2)
relative strength of the##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
relative strength of##7##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
relative strengths##3##2##(2007-8#1)(2008-4#1)(2012-3#1)
relative surface##2##2##(2008-10#2)
relative to EO baseline than to EC##2##7##(2013-8#2)
relative to a non-imprinted control set##2##6##(2008-7#2)
relative to a number of interfering##2##6##(2008-10#2)
relative to a visual##2##4##(2008-10#2)
relative to a##19##3##(1995-2#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-7#1)(2011-1#1)
relative to an##2##3##(2008-11#1)(2008-2#1)
relative to both##2##3##(2008-3#1)(2010-2#1)
relative to control##5##3##(1995-1#1)(1995-9#1)(2008-10#1)(2008-3#2)
relative to controls##10##3##(1993-6#1)(1994-3#1)(1994-9#2)(1995-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2009-12#1)
relative to conventional##2##3##(2008-10#1)(2008-12#1)
relative to direct##2##3##(2008-8#1)(2008-9#1)
relative to each other##3##4##(1991-12#1)(1995-3#1)(2008-5#1)
relative to each##4##3##(1991-12#1)(1995-3#1)(2008-10#1)(2008-5#1)
relative to either##2##3##(2008-10#1)(2008-9#1)
relative to fee-for-service##2##3##(1994-1#2)
relative to healthy##2##3##(2008-4#1)(2011-2#1)
relative to how##2##3##(1991-12#1)(2008-5#1)
relative to incongruent associations##2##4##(2012-1#2)
relative to incongruent##3##3##(2012-1#3)
relative to its##3##3##(1992-5#1)(1992-6#1)(2008-3#1)
relative to native##2##3##(1990-7#2)
relative to neutral##2##3##(2008-2#2)
relative to one another##2##4##(1992-9#1)(2008-3#1)
relative to other##6##3##(1996-3#1)(2008-10#2)(2008-2#1)(2008-9#1)(2013-1#1)
relative to pregnancy##2##3##(1992-5#2)
relative to pure##2##3##(2008-10#2)
relative to that of a##2##5##(2007-11#2)
relative to that of the##3##5##(1994-5#1)(2007-12#1)(2008-2#1)
relative to that of##10##4##(1991-3#1)(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-9#1)
relative to that##15##3##(1991-3#1)(1994-5#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2009-9#1)
relative to the control was##2##5##(1994-11#1)(2008-10#1)
relative to the control##3##4##(1994-11#1)(2008-10#1)(2008-11#1)
relative to the first##2##4##(1990-12#1)(2008-4#1)
relative to the free##2##4##(1995-5#1)(2008-10#1)
relative to the native##2##4##(1995-2#1)(2008-10#1)
relative to the noninoculated control##2##5##(2008-10#2)
relative to the normal##2##4##(1994-12#1)(1995-11#1)
relative to the number of##2##5##(1994-11#1)(2011-2#1)
relative to the other##4##4##(2008-10#1)(2008-3#1)(2010-2#1)(2010-3#1)
relative to the strength of stabilizing selection##2##7##(2008-8#2)
relative to the strength of##3##5##(2008-8#3)
relative to the total##3##4##(1994-12#1)(2008-10#1)(2008-6#1)
relative to the two##2##4##(2008-10#1)(2011-2#1)
relative to the value of current reproduction##2##7##(2008-8#2)
relative to the##139##3##(1990-12#1)(1990-7#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#3)(1995-8#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-3#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#13)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#2)
relative to their##11##3##(1994-6#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
relative to those##9##3##(1992-11#1)(1994-11#1)(1995-3#2)(1997-6#1)(2007-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
relative to total##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
relative to traditional##2##3##(2011-1#1)(2011-2#1)
relative to wild type##2##4##(1995-2#1)(2011-1#1)
relative to wild-type##2##3##(1990-8#1)(1994-8#1)
relative to##393##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-12#4)(1991-3#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#5)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#2)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#7)(1995-3#9)(1995-5#4)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#4)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#10)(2008-1#1)(2008-10#69)(2008-11#6)(2008-12#1)(2008-2#25)(2008-3#26)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#18)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#13)(2013-8#5)
relative uncertainty of##5##3##(2007-12#2)(2008-10#1)(2008-3#2)
relative value scales##2##3##(1991-2#2)
relative value system##2##3##(1991-12#2)
relative value units##4##3##(1991-12#1)(1992-3#1)(1994-1#1)(2013-1#1)
relative value##15##2##(1991-12#4)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(2008-4#1)(2013-1#1)
relative variability##2##2##(1996-3#1)(2008-10#1)
relative weight of the##2##4##(1994-12#1)(1995-3#1)
relative weight of##3##3##(1994-12#1)(1995-3#1)(2008-10#1)
relative weight##5##2##(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
relative with##3##2##(2010-3#1)(2011-1#1)(2011-2#1)
relative yield##2##2##(2008-10#1)(2012-2#1)
relative yield-per-recruit##2##2##(2013-7#2)
relative##2073##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#6)(1990-6#1)(1990-7#9)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#18)(1991-2#6)(1991-3#5)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#3)(1992-11#4)(1992-12#11)(1992-2#5)(1992-3#10)(1992-5#6)(1992-6#8)(1992-8#1)(1992-9#7)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#4)(1993-3#4)(1993-6#6)(1993-8#6)(1993-9#5)(1994-1#4)(1994-11#6)(1994-12#11)(1994-2#7)(1994-3#7)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#13)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#11)(1995-3#17)(1995-5#8)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#3)(1996-12#7)(1996-2#5)(1996-3#8)(1996-5#8)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#5)(1997-5#10)(1997-6#5)(1997-7#6)(1997-8#4)(2006-10#2)(2006-6#1)(2007-10#8)(2007-11#23)(2007-12#34)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#891)(2008-11#26)(2008-12#12)(2008-2#72)(2008-3#105)(2008-4#27)(2008-5#46)(2008-6#15)(2008-7#41)(2008-8#77)(2008-9#35)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#7)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#7)(2010-3#4)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#30)(2011-2#47)(2011-3#3)(2012-1#10)(2012-12#13)(2012-2#20)(2012-3#11)(2012-6#7)(2012-7#1)(2012-9#2)(2013-1#29)(2013-7#4)(2013-8#23)
relatively &quot##2##2##(1992-3#1)(2009-10#1)
relatively abundant##3##2##(1996-8#1)(2008-10#1)(2009-7#1)
relatively benign##3##2##(1993-10#1)(2011-2#1)(2012-3#1)
relatively better##2##2##(2008-11#1)(2008-3#1)
relatively brief##2##2##(1994-8#1)(1996-12#1)
relatively broad##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
relatively cheap##2##2##(2008-1#1)(2009-5#1)
relatively closed and##2##3##(2008-5#1)(2013-8#1)
relatively common##12##2##(1991-12#1)(1991-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-3#1)
relatively compact##2##2##(2007-12#1)(2008-3#1)
relatively complex##2##2##(2008-8#2)
relatively consistent##5##2##(2008-10#1)(2008-11#2)(2010-8#1)(2012-12#1)
relatively constant during the##2##4##(1990-11#1)(2008-10#1)
relatively constant for##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
relatively constant in##2##3##(2008-10#1)(2012-2#1)
relatively constant##15##2##(1990-11#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
relatively crude##2##2##(1992-3#1)(2008-1#1)
relatively distinct##3##2##(2008-4#2)(2009-9#1)
relatively dry##2##2##(2008-10#1)(2008-6#1)
relatively early##5##2##(1991-6#1)(1993-6#1)(1996-5#1)(2011-1#2)
relatively easily##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
relatively easy to perform##2##4##(2009-8#1)(2011-2#1)
relatively easy to##12##3##(1991-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
relatively easy##19##2##(1991-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-12#1)
relatively effective##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
relatively fast response time and can be used##3##8##(2008-10#3)
relatively fast response time##4##4##(2008-10#4)
relatively fast##9##2##(2008-10#7)(2008-3#1)(2011-2#1)
relatively few of##2##3##(1995-3#1)(2012-12#1)
relatively few##20##2##(1991-12#2)(1995-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#2)
relatively free##2##2##(2008-10#1)(2012-2#1)
relatively frequent##5##2##(1991-12#1)(2008-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
relatively good##6##2##(1992-8#1)(1994-9#1)(2007-10#1)(2008-10#2)(2009-11#1)
relatively healthy older adults aged 50 or above##2##8##(2011-1#2)
relatively healthy older##3##3##(2011-1#3)
relatively high concentration of##2##4##(1992-6#1)(2008-10#1)
relatively high concentration##5##3##(1992-6#1)(1997-2#1)(2008-10#2)(2008-8#1)
relatively high concentrations of##3##4##(1996-1#1)(2008-10#1)(2012-12#1)
relatively high concentrations##4##3##(1996-1#1)(2008-10#2)(2012-12#1)
relatively high free##2##3##(1992-6#1)(2008-5#1)
relatively high in the##2##4##(1993-3#1)(2008-9#1)
relatively high in##4##3##(1991-6#1)(1993-3#1)(2008-7#1)(2008-9#1)
relatively high level of##4##4##(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
relatively high levels of##3##4##(1994-3#1)(1997-1#1)(2008-10#1)
relatively high levels##4##3##(1994-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
relatively high proportion##4##3##(1990-12#1)(1997-2#1)(2008-8#1)(2008-9#1)
relatively high rate of##2##4##(1993-11#1)(1997-8#1)
relatively high sensitivity##4##3##(2008-10#3)(2008-2#1)
relatively high##96##2##(1990-12#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
relatively higher##10##2##(1990-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2012-7#1)
relatively homogeneous##5##2##(1995-12#1)(2008-10#2)(2008-2#1)(2010-3#1)
relatively independent##2##2##(2008-3#1)(2011-1#1)
relatively inexpensive##8##2##(2008-10#6)(2008-3#1)(2008-8#1)
relatively insensitive to the##3##4##(1995-2#1)(2008-10#1)(2008-9#1)
relatively insensitive to##10##3##(1992-12#1)(1992-3#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
relatively insensitive##13##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
relatively intact##4##2##(1993-12#1)(1996-5#1)(2008-10#1)(2008-4#1)
relatively large amounts of##3##4##(2008-10#3)
relatively large and##2##3##(1992-6#1)(2007-12#1)
relatively large proteins##2##3##(1997-2#2)
relatively large##41##2##(1990-8#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-2#1)(1997-2#2)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#3)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
relatively larger##3##2##(2008-2#1)(2010-8#1)(2011-2#1)
relatively late in##2##3##(2009-8#1)(2010-2#1)
relatively late##3##2##(2006-6#1)(2009-8#1)(2010-2#1)
relatively less sensitive##2##3##(1991-1#1)(2008-8#1)
relatively less##8##2##(1990-12#1)(1991-1#1)(2008-1#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)
relatively limited##2##2##(1992-9#1)(2008-7#1)
relatively little is known about the##2##6##(2009-5#1)(2013-1#1)
relatively little is known about##5##5##(1995-2#1)(2007-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
relatively little is##6##3##(1995-2#1)(2007-10#1)(2007-8#1)(2009-5#1)(2010-8#1)(2013-1#1)
relatively little##20##2##(1992-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
relatively long and##4##3##(1992-12#1)(1996-10#1)(1996-2#1)(2010-8#1)
relatively long##12##2##(1991-2#1)(1992-12#1)(1996-10#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-8#1)
relatively low affinity##2##3##(1990-12#1)(1991-1#1)
relatively low compared##2##3##(2010-4#1)(2011-2#1)
relatively low concentrations##4##3##(2008-10#4)
relatively low cost of##2##4##(2008-1#1)(2008-3#1)
relatively low cost##6##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-1#1)
relatively low in##2##3##(1994-2#1)(2008-7#1)
relatively low incidence of##2##4##(1993-9#1)(2008-7#1)
relatively low levels of##2##4##(2008-10#1)(2011-2#1)
relatively low pressure##2##3##(2008-10#1)(2008-6#1)
relatively low rate##2##3##(2008-3#1)(2008-7#1)
relatively low##99##2##(1990-12#1)(1990-8#1)(1991-1#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-1#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#5)(2013-1#3)(2013-7#1)
relatively lower##2##2##(2008-10#1)(2010-7#1)
relatively mature##2##2##(2008-7#1)(2008-9#1)
relatively mild##3##2##(1995-8#1)(2009-6#1)(2011-2#1)
relatively minor##7##2##(1993-6#1)(2008-10#3)(2008-11#1)(2009-9#1)(2012-2#1)
relatively modest##4##2##(1991-11#1)(1992-3#1)(2008-3#1)(2008-7#1)
relatively more##9##2##(1991-12#1)(1992-6#1)(1993-12#2)(1995-2#1)(2008-11#2)(2008-5#1)(2008-6#1)
relatively narrow##6##2##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)
relatively neglected##2##2##(2008-10#1)(2009-8#1)
relatively new technique##3##3##(2008-10#1)(2010-1#1)(2010-3#1)
relatively new##28##2##(1992-5#1)(1992-8#1)(1995-11#1)(1995-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-8#2)
relatively nontoxic##2##2##(1994-6#1)(2007-11#1)
relatively passive##2##2##(1990-9#1)(2010-12#1)
relatively poor##9##2##(1992-12#1)(1994-1#1)(1994-3#1)(2008-10#2)(2008-5#1)(2008-6#2)(2010-12#1)
relatively poorly##2##2##(1991-6#1)(2013-1#1)
relatively pure##2##2##(2008-4#1)(2008-5#1)
relatively quickly##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
relatively rapid and##2##3##(1992-3#1)(2011-3#1)
relatively rapid##5##2##(1992-3#1)(2008-10#1)(2008-8#1)(2011-3#1)(2012-12#1)
relatively rare and##3##3##(1993-8#1)(2008-3#1)(2013-1#1)
relatively rare occurrence##2##3##(2008-3#1)(2013-1#1)
relatively rare##29##2##(1991-12#1)(1992-5#1)(1993-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
relatively rarely##2##2##(1991-3#1)(2013-8#1)
relatively recent##5##2##(1991-12#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
relatively recently##2##2##(1993-3#1)(1994-9#1)
relatively resistant to##6##3##(1990-12#1)(1994-11#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-7#1)
relatively restricted##2##2##(1996-4#1)(2011-1#1)
relatively rich in##2##3##(1990-11#1)(1995-6#1)
relatively rich##3##2##(1990-11#1)(1995-6#1)(2008-9#1)
relatively rigid##2##2##(1994-3#1)(1995-6#1)
relatively safe and##3##3##(1996-1#1)(2008-9#1)(2012-2#1)
relatively safe##6##2##(1996-1#1)(2007-10#1)(2007-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
relatively selective and##3##3##(1995-11#1)(2008-10#2)
relatively selective##4##2##(1995-11#1)(2008-10#3)
relatively sensitive##2##2##(1990-12#1)(1991-1#1)
relatively short distances##2##3##(2008-10#1)(2013-8#1)
relatively short duration of##2##4##(2008-1#1)(2009-8#1)
relatively short time##7##3##(1995-11#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)
relatively short##25##2##(1990-7#1)(1994-2#1)(1995-11#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
relatively similar##2##2##(1997-2#1)(2011-2#1)
relatively simple and##4##3##(1990-11#1)(2006-6#1)(2008-3#2)
relatively simple##29##2##(1990-11#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)
relatively slow##8##2##(1993-12#1)(1994-5#1)(2006-6#1)(2008-10#3)(2009-6#1)(2010-8#1)
relatively small compared##2##3##(2008-10#2)
relatively small number of##5##4##(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-3#1)
relatively small proportion of##2##4##(1991-12#1)(2008-10#1)
relatively small##61##2##(1990-12#1)(1991-12#2)(1991-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)
relatively specific##2##2##(1991-12#1)(2010-11#1)
relatively stable##14##2##(1991-12#1)(1994-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2013-8#1)
relatively strong for##2##3##(2008-10#1)(2011-2#1)
relatively strong##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
relatively to##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
relatively unaffected##3##2##(1994-6#1)(1995-5#1)(2008-6#1)
relatively unchanged##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
relatively uncommon in##2##3##(2008-8#1)(2013-1#1)
relatively uncommon##11##2##(1992-4#1)(1994-11#1)(2008-1#1)(2008-8#1)(2009-1#1)(2009-5#1)(2013-1#4)(2013-8#1)
relatively unexplored##3##2##(2008-10#2)(2010-12#1)
relatively uniform##4##2##(2008-10#2)(2008-2#1)(2010-3#1)
relatively unimportant for##2##3##(2008-9#1)(2012-3#1)
relatively unstable##3##2##(1990-5#1)(1991-12#1)(2008-9#1)
relatively volatile##2##2##(2008-10#2)
relatively weak##11##2##(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
relatively well characterized##3##3##(2008-8#2)(2011-1#1)
relatively well##7##2##(1994-12#1)(1996-3#1)(1997-2#1)(2008-8#2)(2011-1#1)(2012-2#1)
relatively young patients with unipolar major depression##2##7##(1996-7#2)
relatively young patients with unipolar##3##5##(1996-7#3)
relatively young patients with##4##4##(1996-7#3)(2008-7#1)
relatively young patients##5##3##(1991-8#1)(1996-7#3)(2008-7#1)
relatively young##14##2##(1991-8#1)(1995-5#1)(1996-7#3)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)
relatively##971##1##(1990-11#5)(1990-12#9)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#15)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#6)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#5)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#6)(1994-8#3)(1994-9#2)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#5)(1996-4#2)(1996-5#4)(1996-7#3)(1996-8#1)(1997-1#3)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#3)(2006-6#3)(2007-10#5)(2007-11#12)(2007-12#21)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#15)(2008-10#181)(2008-11#36)(2008-12#5)(2008-2#28)(2008-3#58)(2008-4#17)(2008-5#31)(2008-6#16)(2008-7#31)(2008-8#33)(2008-9#25)(2009-1#3)(2009-10#4)(2009-11#4)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#10)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#19)(2011-2#29)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#19)(2012-3#10)(2012-7#1)(2013-1#23)(2013-7#2)(2013-8#9)
relativement##2##1##(2008-11#1)(2008-5#1)
relatives and##4##2##(1993-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
relatives are##5##2##(1997-8#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)
relatives by##2##2##(1990-3#1)(2008-10#1)
relatives in the##2##3##(1992-9#1)(1997-8#1)
relatives in##4##2##(1992-9#1)(1997-8#1)(2009-10#1)(2009-6#1)
relatives is##2##2##(1991-6#1)(2009-10#1)
relatives may be##2##3##(1997-7#1)(2008-7#1)
relatives of patients with##3##4##(1991-11#1)(2007-5#1)(2012-12#1)
relatives of patients##4##3##(1991-11#1)(2007-5#1)(2008-7#1)(2012-12#1)
relatives of the##2##3##(1994-2#2)
relatives of wheat##2##3##(2008-10#2)
relatives of##18##2##(1991-11#3)(1992-9#3)(1994-2#2)(1997-4#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-7#2)(2010-8#1)(2012-12#1)(2013-8#1)
relatives to##5##2##(1997-3#1)(2009-5#1)(2010-11#3)
relatives with normal mucosa##2##4##(1991-11#2)
relatives with##8##2##(1990-11#1)(1991-11#3)(2007-7#1)(2011-1#1)(2011-2#2)
relatives##106##1##(1990-11#1)(1990-3#1)(1991-11#7)(1991-3#1)(1991-6#1)(1992-9#4)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#3)(1995-1#1)(1995-9#1)(1996-3#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-5#1)(2007-7#5)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#5)(2009-10#3)(2009-11#1)(2009-5#2)(2009-6#3)(2009-8#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#5)(2013-8#3)
relatives'##4##1##(2007-8#1)(2009-5#1)(2010-10#1)(2012-12#1)
relatives]##2##1##(1990-11#1)(1993-3#1)
relativistic intensity##2##2##(2007-12#2)
relativistic##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
relativity##5##1##(1992-8#1)(2008-3#4)
relax##5##1##(2007-11#1)(2008-2#1)(2008-7#2)(2008-8#1)
relaxant##9##1##(1992-3#2)(1992-9#2)(1995-12#1)(1996-2#2)(1997-4#1)(2008-12#1)
relaxants##2##1##(2007-8#1)(2008-10#1)
relaxation after##3##2##(1992-6#1)(1993-8#1)(2007-8#1)
relaxation and##7##2##(1994-3#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#2)
relaxation behavior of##2##3##(1995-11#1)(2008-10#1)
relaxation during##2##2##(1991-2#1)(2008-7#1)
relaxation effect##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
relaxation effects##2##2##(1995-12#1)(2013-1#1)
relaxation experiments##2##2##(1992-6#1)(1995-5#1)
relaxation in the##3##3##(2007-11#1)(2008-3#2)
relaxation in##9##2##(1990-6#1)(1991-12#1)(1992-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)
relaxation induced by##2##3##(1995-2#1)(2012-3#1)
relaxation is##5##2##(1990-6#1)(1991-12#1)(1994-8#1)(1995-8#1)(2008-2#1)
relaxation measurements##6##2##(1993-11#1)(1995-2#2)(2009-11#3)
relaxation of the##8##3##(1990-6#1)(1995-3#1)(2008-10#1)(2009-10#2)(2011-1#1)(2013-1#2)
relaxation of##21##2##(1990-6#1)(1991-12#1)(1993-6#2)(1995-12#2)(1995-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
relaxation on##2##2##(1991-12#1)(2012-3#1)
relaxation or##2##2##(1990-5#1)(1990-6#1)
relaxation oscillation frequency##5##3##(2007-11#4)(2007-12#1)
relaxation oscillation##9##2##(2007-11#5)(2007-12#4)
relaxation oscillations##2##2##(2007-12#2)
relaxation process##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
relaxation processes##5##2##(1990-8#1)(1995-3#1)(2008-10#2)(2008-2#1)
relaxation properties##2##2##(2009-6#2)
relaxation rate in the##2##4##(1994-8#1)(2007-11#1)
relaxation rate##8##2##(1991-8#2)(1994-5#1)(1994-8#3)(2007-11#1)(2008-7#1)
relaxation rates##5##2##(1991-8#2)(1995-2#1)(2009-6#2)
relaxation techniques##2##2##(1996-6#1)(2010-7#1)
relaxation time of the##7##4##(1990-7#1)(2007-11#2)(2008-3#3)(2009-11#1)
relaxation time of##10##3##(1990-7#2)(2007-11#2)(2008-10#1)(2008-3#4)(2009-11#1)
relaxation time##32##2##(1990-7#3)(1991-12#1)(1994-11#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-3#10)(2008-7#2)(2008-9#1)(2009-11#1)(2010-9#1)(2012-2#1)(2012-7#1)(2013-7#1)
relaxation times for the##2##4##(1995-11#2)
relaxation times##16##2##(1991-12#1)(1991-5#1)(1995-11#4)(1995-3#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-7#2)(2011-1#1)(2012-7#2)
relaxation to##3##2##(1993-8#1)(2013-1#2)
relaxation was##5##2##(1991-12#1)(1995-12#2)(1996-2#1)(2007-8#1)
relaxation were##2##2##(1995-12#1)(2008-3#1)
relaxation##236##1##(1990-5#1)(1990-6#8)(1990-7#3)(1990-8#1)(1991-12#9)(1991-2#1)(1991-5#2)(1991-8#4)(1991-9#3)(1992-12#3)(1992-6#5)(1992-8#1)(1993-11#2)(1993-6#4)(1993-8#3)(1994-11#4)(1994-3#2)(1994-5#1)(1994-8#7)(1995-11#6)(1995-12#8)(1995-2#5)(1995-3#3)(1995-5#1)(1995-8#1)(1996-2#3)(1996-6#1)(1997-4#3)(1997-7#4)(2007-1#2)(2007-11#14)(2007-12#12)(2007-6#3)(2007-8#4)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#18)(2008-5#4)(2008-7#9)(2008-9#1)(2009-10#2)(2009-11#4)(2009-2#1)(2009-6#4)(2009-7#6)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#7)(2012-7#3)(2013-1#9)(2013-7#2)
relaxations in##2##2##(1994-11#1)(1995-12#1)
relaxations##7##1##(1994-11#1)(1995-12#2)(2007-8#1)(2008-10#2)(2010-10#1)
relaxed DNA##2##2##(1995-6#1)(2008-9#1)
relaxed and##2##2##(1990-2#1)(2010-4#1)
relaxed by##2##2##(1997-7#1)(2008-5#1)
relaxed##25##1##(1990-2#1)(1993-8#1)(1995-3#1)(1995-6#3)(1996-2#1)(1997-7#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)
relaxes the##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
relaxes##13##1##(1992-12#1)(1994-11#1)(2007-1#3)(2007-11#2)(2007-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-3#1)
relaxin##6##1##(1994-9#1)(1995-8#3)(1997-2#1)(2008-4#1)
relaxing factor (EDRF)##3##3##(1991-9#3)
relaxing factor##4##2##(1990-12#1)(1991-9#3)
relaxing factors##3##2##(1991-12#1)(1993-3#1)(2010-10#1)
relaxing this assumption##2##3##(1997-4#1)(2008-8#1)
relaxing##17##1##(1990-12#1)(1991-12#1)(1991-9#3)(1993-3#1)(1993-8#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-6#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-10#1)
relaxivities##2##1##(2008-7#2)
relaxivity contrast agents in MR##2##5##(2008-7#2)
relaxivity contrast agents in##3##4##(2008-7#3)
relaxivity contrast agents##4##3##(2008-7#4)
relaxivity of the entrapped Gd-DTPA##2##5##(1990-2#2)
relaxivity of##6##2##(1990-2#4)(2008-7#2)
relaxivity##19##1##(1990-2#5)(2008-7#12)(2009-6#2)
relay distances##2##2##(2008-2#2)
relay lens##2##2##(2008-2#1)(2008-3#1)
relay neurons##3##2##(1993-12#2)(2008-2#1)
relay optics##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
relay system##4##2##(2008-2#3)(2008-3#1)
relay##30##1##(1993-12#2)(1995-2#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#6)(2009-8#1)(2010-11#3)(2011-1#1)
relayed##4##1##(1992-8#1)(1993-12#1)(1995-12#1)(2010-1#1)
relays were arranged in a##2##5##(2008-2#2)
relays##3##1##(2008-10#1)(2008-2#2)
releasable##3##1##(1997-7#1)(2008-7#1)(2009-3#1)
release ATP##3##2##(2008-4#3)
release GABA##2##2##(1993-12#1)(1994-2#1)
release MT##4##2##(2008-11#4)
release NO##2##2##(2008-5#1)(2008-7#1)
release a##4##2##(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)
release and antibacterial##2##3##(2008-5#2)
release and heavy metal##2##4##(2008-7#2)
release and permeation##3##3##(2008-5#3)
release and subsequent##2##3##(1991-8#1)(2008-9#1)
release and the##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
release and##52##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#10)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-2#1)
release are##4##2##(1995-12#1)(2008-10#1)(2008-4#2)
release as a##2##3##(1992-6#1)(2008-11#1)
release as measured by##2##4##(1997-2#1)(2008-9#1)
release as##11##2##(1990-5#1)(1991-12#1)(1992-6#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-5#1)(2013-1#1)
release assay##8##2##(1990-12#1)(1991-12#1)(1992-9#1)(1994-11#1)(2008-4#2)(2013-1#2)
release associated with##2##3##(1992-12#1)(2008-10#1)
release associated##3##2##(1992-12#1)(2008-10#1)(2010-5#1)
release at##4##2##(1990-12#1)(1992-12#1)(1993-5#1)(2008-10#1)
release both in##3##3##(1994-8#1)(1995-11#1)(1995-5#1)
release by Kupffer cells##3##4##(1997-4#3)
release by intraluminal##2##3##(1990-12#1)(1992-6#1)
release by the##3##3##(1991-7#1)(1997-1#1)(2008-5#1)
release by##42##2##(1990-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#4)(1993-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-6#2)(1996-2#2)(1997-1#1)(1997-4#3)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-5#1)
release can##4##2##(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
release channel##2##2##(2008-8#1)(2008-9#1)
release characteristics##3##2##(2008-11#1)(2010-3#2)
release data##4##2##(1990-8#1)(1992-1#1)(2010-5#1)(2012-2#1)
release during the##2##3##(2008-5#1)(2008-7#1)
release during##6##2##(1992-12#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
release factors##2##2##(2008-11#2)
release for##4##2##(2009-7#1)(2010-4#1)(2012-2#2)
release from a##2##3##(1990-2#1)(2008-10#1)
release from endothelial cells##2##4##(1991-5#1)(1995-12#1)
release from human neutrophils##2##4##(1992-5#2)
release from intracellular stores and##3##5##(1990-12#1)(1992-9#1)(2012-2#1)
release from intracellular stores##5##4##(1990-12#1)(1992-9#1)(1994-11#1)(1996-12#1)(2012-2#1)
release from isolated##3##3##(1990-12#1)(1991-8#1)(1995-11#1)
release from masking improves##2##4##(2009-5#2)
release from masking##3##3##(2009-5#3)
release from rat peritoneal##4##4##(1991-12#2)(2008-11#2)
release from rat##7##3##(1991-12#2)(1992-3#1)(1994-8#1)(1995-12#1)(2008-11#2)
release from striatal slices from saline-treated##2##6##(1995-12#2)
release from the endoplasmic reticulum and##2##6##(2009-8#1)(2013-1#1)
release from the isolated##2##4##(1990-12#1)(1991-2#1)
release from the membrane##2##4##(1994-6#1)(2008-5#1)
release from the mesenteric##2##4##(1992-3#2)
release from the##30##3##(1990-12#2)(1991-2#1)(1991-5#1)(1992-3#2)(1992-7#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1997-2#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
release from##100##2##(1990-12#5)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#1)(1992-12#1)(1992-3#4)(1992-5#3)(1992-6#1)(1992-7#2)(1992-9#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#4)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#4)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2009-11#2)(2009-5#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#3)(2012-2#2)(2013-1#2)
release has##2##2##(2008-10#1)(2013-7#1)
release in a concentration-dependent manner##3##5##(1992-3#1)(1992-6#1)(1995-12#1)
release in a##4##3##(1992-3#1)(1992-6#1)(1995-12#1)(2008-10#1)
release in both##2##3##(1992-7#1)(1995-12#1)
release in permeabilized##2##3##(1992-12#1)(1993-8#1)
release in raphe##2##3##(1995-12#1)(2008-7#1)
release in rat##2##3##(1991-1#1)(1995-12#1)
release in response to##4##4##(1992-12#1)(2008-1#1)(2008-3#1)(2008-4#1)
release in the hippocampus##2##4##(1992-7#1)(2013-8#1)
release in the##16##3##(1990-2#1)(1991-2#1)(1992-3#1)(1992-7#2)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-8#1)(2013-8#1)
release in vivo##3##3##(1995-12#2)(2010-11#1)
release in##71##2##(1990-2#2)(1991-1#1)(1991-12#1)(1991-2#2)(1992-12#3)(1992-3#2)(1992-6#1)(1992-7#5)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#10)(1995-8#1)(1996-2#1)(1996-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#2)(2010-12#1)(2012-2#2)(2012-8#3)(2013-8#1)
release increased##5##2##(1991-12#1)(2008-10#4)
release induced by##3##3##(1994-11#1)(1995-12#1)(2008-10#1)
release into the medium##3##4##(1994-11#1)(1994-6#1)(1996-2#1)
release into the##9##3##(1994-11#1)(1994-6#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-3#1)
release is##17##2##(1990-12#1)(1991-2#1)(1991-9#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-7#1)(2013-8#1)
release kinetics of the##2##4##(2008-5#1)(2009-12#1)
release kinetics##5##2##(1993-11#1)(2008-5#1)(2009-12#1)(2010-5#2)
release may##2##2##(1994-5#1)(2008-7#1)
release mechanism##4##2##(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
release melatonin##2##2##(2008-11#2)
release nitric oxide##2##3##(2008-5#2)
release of 43K+##3##3##(1992-11#3)
release of ATP from##3##4##(2008-4#2)(2008-5#1)
release of ATP##9##3##(2008-4#7)(2008-5#1)(2009-3#1)
release of BDNF##3##3##(2009-3#2)(2009-8#1)
release of C2H2##2##3##(1992-3#2)
release of CGRP from##2##4##(1992-6#2)
release of Ca(2+) from##2##4##(2007-11#1)(2007-12#1)
release of Ca2+##4##3##(1991-12#1)(1991-8#1)(1993-8#2)
release of DA was##2##4##(1996-12#1)(1997-2#1)
release of DA##3##3##(1996-12#2)(1997-2#1)
release of DOX##3##3##(2009-11#3)
release of KC/gro protein##2##4##(1993-11#2)
release of LDH##4##3##(1992-11#2)(1994-2#1)(2008-11#1)
release of LH from the pituitary##2##6##(1995-3#1)(1997-2#1)
release of NO##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
release of Smac/DIABLO##2##3##(2008-11#2)
release of [14C]-5-HT##2##3##(1992-11#2)
release of [3H]5-HT##2##3##(1995-12#2)
release of a##5##3##(1992-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
release of acetylcholine##4##3##(1992-3#1)(1993-12#1)(1995-12#1)(2008-8#1)
release of adenosine from##2##4##(1996-2#2)
release of adenosine##3##3##(1996-2#3)
release of all three##2##4##(1990-2#1)(1990-5#1)
release of an##2##3##(1992-8#1)(1994-11#1)
release of arachidonic acid##3##4##(1995-12#1)(1996-2#1)(2011-2#1)
release of ascospores occurred##2##4##(2008-10#2)
release of ascospores##5##3##(2008-10#5)
release of beta-APP##2##3##(1993-8#2)
release of calcium##2##3##(2008-10#1)(2008-4#1)
release of creatine kinase##2##4##(1995-8#2)
release of cytosolic##3##3##(1991-2#1)(1995-6#1)(2008-7#1)
release of dexamethasone##2##3##(2009-11#2)
release of dopamine from##3##4##(1992-3#1)(1997-7#1)(2008-4#1)
release of dopamine##7##3##(1992-3#1)(1992-7#1)(1997-2#2)(1997-7#1)(2008-4#1)(2009-6#1)
release of drugs##2##3##(1995-11#1)(2010-10#1)
release of endogenous##3##3##(1995-12#1)(1997-1#1)(2008-3#1)
release of endothelin-1##2##3##(1992-3#1)(2008-1#1)
release of endothelium-derived relaxing##2##4##(1990-12#1)(1993-3#1)
release of free fatty acids from##2##6##(1990-8#1)(1994-8#1)
release of free##4##3##(1990-8#1)(1994-8#1)(1997-7#1)(2008-6#1)
release of glucose##3##3##(1994-6#1)(2008-10#2)
release of glutamate##4##3##(1993-12#1)(1994-8#1)(2008-4#2)
release of hormones##2##3##(2013-7#2)
release of insulin##5##3##(1990-12#1)(1992-6#1)(1995-8#1)(2008-11#1)(2011-1#1)
release of intracellular##4##3##(1990-12#1)(1990-8#1)(2008-11#2)
release of lactate dehydrogenase##4##4##(1990-5#1)(1995-11#1)(1995-3#1)(2008-7#1)
release of low numbers of##2##5##(2008-10#2)
release of neurotensin##2##3##(1997-7#2)
release of physician-specific##3##3##(1994-2#3)
release of pollutants##2##3##(2008-10#2)
release of pro-inflammatory mediators##3##4##(2008-11#1)(2008-5#2)
release of pro-inflammatory##6##3##(2008-11#1)(2008-5#3)(2008-7#1)(2009-12#1)
release of radioactivity##2##3##(1995-8#1)(2008-4#1)
release of saturated##2##3##(1990-2#2)
release of serotonin##4##3##(1995-12#4)
release of soluble##2##3##(2008-10#1)(2008-4#1)
release of the##39##3##(1990-11#1)(1990-2#2)(1990-5#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#2)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-5#2)(2013-1#1)(2013-8#1)
release of these##3##3##(1995-12#1)(2008-5#1)(2008-9#1)
release of toxic##4##3##(2008-10#1)(2009-7#1)(2009-8#1)(2011-2#1)
release of transgenic##2##3##(2008-8#1)(2011-2#1)
release of##380##2##(1990-11#1)(1990-12#9)(1990-2#7)(1990-5#5)(1990-8#3)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#9)(1992-12#3)(1992-2#1)(1992-3#8)(1992-6#5)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#4)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#3)(1995-11#11)(1995-12#13)(1995-2#2)(1995-3#6)(1995-5#2)(1995-6#1)(1995-8#4)(1996-12#5)(1996-2#8)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#5)(1997-7#5)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#51)(2008-11#16)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#19)(2008-5#16)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#5)(2009-12#2)(2009-3#4)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#2)(2010-3#3)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#4)(2012-2#1)(2012-6#2)(2013-1#5)(2013-7#3)(2013-8#5)
release on##2##2##(1996-4#1)(2010-9#1)
release or##2##2##(1990-8#1)(2008-7#1)
release over##2##2##(2008-10#1)(2011-1#1)
release pattern##4##2##(2008-5#2)(2010-3#2)
release phenomena##2##2##(2008-7#1)(2011-2#1)
release play an important role in##2##6##(1995-12#1)(1997-2#1)
release profile##2##2##(2011-1#1)(2012-6#1)
release profiles of##2##3##(2008-11#1)(2008-5#1)
release profiles##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)
release rate##10##2##(1995-12#4)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2013-8#1)
release rates##4##2##(1996-12#1)(2008-10#3)
release reaction##2##2##(1990-5#1)(2008-8#1)
release response##4##2##(1992-3#2)(1993-3#1)(1995-8#1)
release showed##2##2##(1992-3#1)(1997-2#1)
release site##3##2##(1994-8#1)(1996-2#1)(2008-10#1)
release sites within the##2##4##(1991-8#2)
release sites##5##2##(1991-8#2)(2008-4#1)(2012-2#2)
release studies##2##2##(2008-5#2)
release tests##2##2##(2008-10#2)
release the cells from##2##4##(1992-6#1)(2008-11#1)
release the##11##2##(1990-2#1)(1992-6#1)(1994-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2012-2#1)
release through##3##2##(1996-12#1)(2008-4#2)
release to the##2##3##(1996-2#1)(2008-5#1)
release to##4##2##(1995-8#1)(1996-2#1)(2008-10#1)(2008-5#1)
release under##2##2##(2008-10#1)(2008-7#1)
release via##3##2##(1992-6#1)(1995-12#1)(2008-4#1)
release was also##2##3##(1991-3#1)(1993-8#1)
release was due to##2##4##(1990-2#1)(2008-5#1)
release was not##2##3##(1996-12#1)(2011-2#1)
release was significantly##3##3##(1991-8#1)(1992-12#1)(1994-8#1)
release was studied by##2##4##(2008-10#1)(2011-1#1)
release was##25##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-8#2)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#5)(2008-5#3)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
release were##9##2##(1990-8#1)(1992-7#1)(1994-3#1)(1995-11#2)(1997-7#2)(2008-10#1)(2008-7#1)
release when##2##2##(2008-10#1)(2008-7#1)
release which was##2##3##(1990-12#1)(1995-11#1)
release which##3##2##(1990-12#1)(1995-11#1)(1997-2#1)
release with##2##2##(1990-5#1)(2008-5#1)
release##1191##1##(1990-11#4)(1990-12#30)(1990-2#17)(1990-5#10)(1990-8#17)(1991-1#3)(1991-12#14)(1991-2#11)(1991-3#2)(1991-5#9)(1991-6#2)(1991-7#1)(1991-8#8)(1991-9#8)(1992-1#2)(1992-11#9)(1992-12#16)(1992-2#1)(1992-3#22)(1992-5#3)(1992-6#19)(1992-7#10)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#3)(1993-3#4)(1993-5#6)(1993-6#4)(1993-8#13)(1993-9#1)(1994-11#14)(1994-12#1)(1994-2#9)(1994-3#6)(1994-5#1)(1994-6#9)(1994-8#23)(1994-9#5)(1995-11#29)(1995-12#51)(1995-2#5)(1995-3#13)(1995-5#8)(1995-6#11)(1995-8#7)(1996-1#2)(1996-12#15)(1996-2#20)(1996-3#1)(1996-4#1)(1996-5#5)(1996-9#2)(1997-1#9)(1997-2#23)(1997-3#1)(1997-4#16)(1997-6#1)(1997-7#13)(1997-8#1)(2006-10#4)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#6)(2008-10#136)(2008-11#54)(2008-12#9)(2008-2#4)(2008-3#11)(2008-4#49)(2008-5#64)(2008-6#6)(2008-7#39)(2008-8#20)(2008-9#21)(2009-10#2)(2009-11#10)(2009-12#7)(2009-3#6)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#1)(2010-10#3)(2010-11#6)(2010-12#2)(2010-2#1)(2010-3#12)(2010-4#4)(2010-5#22)(2010-6#1)(2010-9#3)(2011-1#7)(2011-2#14)(2011-3#1)(2012-12#6)(2012-2#22)(2012-3#2)(2012-5#1)(2012-6#3)(2012-8#4)(2013-1#16)(2013-7#7)(2013-8#14)
release)##6##1##(1991-9#1)(1992-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)
released ATP##2##2##(2008-4#2)
released CGRP##2##2##(1992-6#2)
released a##2##2##(1992-3#1)(2008-10#1)
released after##4##2##(1992-12#1)(1996-2#1)(2008-10#1)(2008-11#1)
released amount##3##2##(2008-5#3)
released as a##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
released as an##2##3##(1995-3#1)(2011-1#1)
released as##6##2##(1993-11#1)(1995-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)
released at##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
released between##2##2##(2008-10#2)
released by PMNs##2##3##(2008-4#2)
released by a##3##3##(2008-10#2)(2008-5#1)
released by enzymatic##2##3##(1990-7#1)(2008-10#1)
released by proteolysis##2##3##(2008-4#1)(2008-5#1)
released by the##6##3##(1990-8#1)(1992-3#1)(2007-12#1)(2008-10#2)(2008-7#1)
released by##46##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-6#1)(1991-8#2)(1992-12#2)(1992-3#1)(1992-6#1)(1994-11#1)(1994-8#2)(1997-4#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-4#3)(2008-5#4)(2008-7#2)(2010-4#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#2)
released during degranulation##2##3##(2008-4#2)
released during the##4##3##(1990-5#1)(1992-6#1)(1994-12#1)(2008-10#1)
released during##12##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-4#2)(2008-6#1)
released for transplantation##2##3##(2011-2#2)
released for##3##2##(2008-10#1)(2011-2#2)
released from a point source##2##5##(2008-10#2)
released from a##5##3##(2008-10#3)(2008-4#2)
released from activated platelets##2##4##(2010-3#2)
released from activated##3##3##(1997-1#1)(2010-3#2)
released from an##2##3##(2008-10#1)(2008-2#1)
released from astrocytes##2##3##(2008-4#1)(2008-7#1)
released from damaged cells##2##4##(2008-11#1)(2008-4#1)
released from damaged##3##3##(2008-11#1)(2008-4#1)(2010-8#1)
released from the##28##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#3)
released from##96##2##(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#4)(1992-7#1)(1993-1#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-8#2)(2008-10#16)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#4)(2009-10#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
released in a##4##3##(1991-2#1)(2008-1#1)(2008-10#1)(2010-5#1)
released in the##6##3##(2007-10#1)(2008-10#2)(2008-11#1)(2009-12#1)(2011-2#1)
released in##20##2##(1991-2#1)(1992-6#1)(1997-1#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)
released into the circulation##3##4##(1991-8#1)(1993-11#1)(2008-3#1)
released into the culture medium##2##5##(1993-6#1)(1994-11#1)
released into the culture##3##4##(1992-8#1)(1993-6#1)(1994-11#1)
released into the medium##3##4##(1990-2#1)(1994-9#1)(2013-7#1)
released into the##17##3##(1990-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(2008-11#3)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
released into##21##2##(1990-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#2)(1997-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
released males of##2##3##(2011-2#2)
released substances##2##2##(1994-8#1)(1997-1#1)
released the##3##2##(1997-5#1)(2008-7#1)(2013-1#1)
released their##2##2##(2008-10#2)
released to the##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
released to##6##2##(1991-1#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
released upon##3##2##(1992-6#1)(1994-11#1)(2008-4#1)
released was##3##2##(1995-12#1)(2008-10#2)
released when##2##2##(1990-12#1)(2008-10#1)
released with##5##2##(1990-5#1)(1992-8#1)(1994-11#1)(2008-10#2)
released##347##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-5#4)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#7)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-12#8)(1992-3#7)(1992-5#1)(1992-6#11)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#4)(1993-2#1)(1993-3#2)(1993-6#4)(1994-11#5)(1994-12#3)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1997-1#4)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#5)(2007-5#1)(2008-1#2)(2008-10#71)(2008-11#17)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#24)(2008-5#17)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-8#4)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#3)(2012-4#1)(2013-1#6)(2013-7#2)(2013-8#2)
releaser##2##1##(2008-10#1)(2008-7#1)
releasers##3##1##(1995-2#1)(2008-10#1)(2010-7#1)
releases from##3##2##(1996-6#1)(2008-2#1)(2012-2#1)
releases of##4##2##(1990-11#1)(2008-10#2)(2008-7#1)
releases the##3##2##(1997-4#1)(2008-10#1)(2008-9#1)
releases##37##1##(1990-11#2)(1991-6#1)(1992-6#1)(1992-7#1)(1993-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
releasing activity in##3##3##(1990-12#1)(1992-3#2)
releasing activity##4##2##(1990-12#2)(1992-3#2)
releasing factor##2##2##(1990-12#1)(1992-12#1)
releasing hormone (CRH)##2##3##(1992-6#1)(2008-4#1)
releasing hormone##17##2##(1990-12#2)(1991-3#3)(1992-6#4)(1992-9#1)(1995-5#1)(1996-11#1)(2007-7#3)(2008-4#2)
releasing hormones##3##2##(1994-9#2)(2012-1#1)
releasing of##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
releasing the##5##2##(1994-3#1)(1995-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
releasing##67##1##(1990-12#5)(1991-12#1)(1991-3#3)(1992-12#2)(1992-3#2)(1992-6#4)(1992-9#3)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-7#1)(2007-7#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
relegated to##4##2##(1992-2#1)(1994-2#1)(2008-5#1)(2012-12#1)
relegated##6##1##(1991-6#1)(1992-2#1)(1994-2#1)(2008-12#1)(2008-5#1)(2012-12#1)
relentless##2##1##(1994-2#1)(1995-2#1)
relentlessly##2##1##(2008-1#1)(2012-3#1)
relevance and##7##2##(1991-2#1)(1995-2#1)(2007-2#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-3#1)
relevance as##3##2##(2007-10#1)(2009-2#1)(2013-1#1)
relevance for the##4##3##(1994-2#1)(1994-8#1)(1995-5#1)(1997-1#1)
relevance for##20##2##(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#2)(2012-3#3)
relevance in the##4##3##(1990-5#1)(1991-1#1)(1995-3#1)(2008-10#1)
relevance in##13##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-6#1)(1993-9#1)(1995-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
relevance is##3##2##(1991-3#1)(2008-12#1)(2013-1#1)
relevance of a##2##3##(2008-10#1)(2008-8#1)
relevance of low##2##3##(1990-3#1)(2008-7#1)
relevance of the##19##3##(1991-2#1)(1994-3#2)(1995-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
relevance of these findings##3##4##(1994-11#1)(2008-10#2)
relevance of these results to##2##5##(1995-3#1)(2008-10#1)
relevance of these results##5##4##(1993-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2009-8#1)
relevance of these##21##3##(1993-11#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-10#5)(2008-3#1)(2008-7#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
relevance of this##10##3##(1992-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
relevance of##106##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#3)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-7#1)(2007-12#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#1)(2013-8#2)
relevance since##2##2##(1990-6#1)(2008-10#1)
relevance to clinical##2##3##(2007-7#1)(2012-8#1)
relevance to protein##2##3##(2007-11#1)(2008-9#1)
relevance to the pathogenesis of##2##5##(2007-12#1)(2008-7#1)
relevance to the##20##3##(1991-5#1)(1992-12#1)(1993-12#1)(1994-8#2)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
relevance to##48##2##(1991-5#2)(1992-12#1)(1993-12#1)(1993-2#1)(1994-8#2)(1996-4#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
relevance##239##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1992-12#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#3)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#3)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#7)(2008-12#6)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#5)(2011-1#5)(2011-2#9)(2012-12#4)(2012-2#7)(2012-3#8)(2012-4#1)(2012-8#1)(2013-1#5)(2013-8#7)
relevancy##2##1##(2007-5#1)(2008-5#1)
relevant analytical parameters##2##3##(2008-10#2)
relevant anatomy##2##2##(2011-2#1)(2013-8#1)
relevant and should##2##3##(2008-11#1)(2008-5#1)
relevant and##13##2##(1991-1#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
relevant animal##2##2##(2007-12#1)(2009-7#1)
relevant applications in##2##3##(2008-10#2)
relevant applications##5##2##(2008-10#4)(2013-1#1)
relevant articles##8##2##(1994-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
relevant as##2##2##(1991-6#1)(2007-11#1)
relevant case##2##2##(1992-1#1)(2008-10#1)
relevant clinical information##2##3##(2007-12#1)(2011-1#1)
relevant clinical##6##2##(1992-5#1)(2007-12#1)(2008-1#1)(2009-11#1)(2011-1#1)(2012-2#1)
relevant colonic##2##2##(1991-6#2)
relevant complications##2##2##(2008-8#1)(2013-1#1)
relevant concentration##2##2##(1995-2#1)(2008-11#1)
relevant concentrations##2##2##(1992-5#1)(1993-8#1)
relevant conditions##2##2##(1995-2#1)(2011-2#1)
relevant control measures##2##3##(1991-9#1)(2008-12#1)
relevant covariates##2##2##(2012-12#1)(2013-1#1)
relevant data##11##2##(1990-3#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-2#3)(2012-1#1)(2013-1#1)
relevant diagnostic##2##2##(1996-3#1)(2013-1#1)
relevant differences in##2##3##(2012-2#1)(2013-7#1)
relevant differential##2##2##(1995-6#1)(2008-7#1)
relevant disease##4##2##(2010-11#4)
relevant dose##2##2##(2008-10#1)(2008-3#1)
relevant doses of##2##3##(2008-10#1)(2008-5#1)
relevant doses##3##2##(2008-10#2)(2008-5#1)
relevant endpoints##2##2##(2008-7#1)(2011-2#1)
relevant environmental##2##2##(2008-10#1)(2011-2#1)
relevant evidence##3##2##(2011-2#2)(2012-1#1)
relevant factors##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
relevant findings##5##2##(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
relevant for a##2##3##(2008-4#1)(2011-2#1)
relevant for further##2##3##(2012-1#1)(2013-1#1)
relevant for the assessment of##2##5##(2008-5#1)(2008-7#1)
relevant for the design of##2##5##(2008-3#1)(2012-2#1)
relevant for the##11##3##(1993-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#3)
relevant for##43##2##(1992-5#1)(1993-11#1)(1994-5#1)(1995-5#2)(1996-5#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-3#2)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)
relevant from##2##2##(2008-5#1)(2012-3#1)
relevant fungi##2##2##(2008-11#2)
relevant genes##2##2##(1991-9#1)(2008-7#1)
relevant human##2##2##(2008-7#1)(2008-9#1)
relevant hypotheses##2##2##(1992-3#1)(2008-10#1)
relevant in a##2##3##(1994-3#1)(1994-8#1)
relevant in the##3##3##(1993-2#2)(2008-10#1)
relevant in##15##2##(1993-2#2)(1993-6#1)(1994-3#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-8#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
relevant information about##2##3##(1997-3#1)(2010-7#1)
relevant information and##2##3##(1993-12#1)(2012-12#1)
relevant information for##2##3##(2007-4#1)(2013-8#1)
relevant information from the##2##4##(2008-4#1)(2008-6#1)
relevant information on the##3##4##(1997-6#1)(2008-7#1)(2013-1#1)
relevant information on##4##3##(1997-6#1)(2008-7#1)(2010-4#1)(2013-1#1)
relevant information to##2##3##(2008-11#1)(2012-3#1)
relevant information##29##2##(1993-12#1)(1997-3#2)(1997-6#1)(2007-4#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
relevant issues##4##2##(1994-6#1)(1996-2#1)(1997-2#1)(2012-3#1)
relevant levels##4##2##(1997-1#1)(2008-10#2)(2008-11#1)
relevant literature on##2##3##(2007-5#1)(2012-2#1)
relevant literature##16##2##(1994-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#1)
relevant literatures##2##2##(1990-12#1)(2007-7#1)
relevant macromolecules##2##2##(2008-12#1)(2008-7#1)
relevant manner##3##2##(1990-8#1)(1994-8#1)(2008-1#1)
relevant markers##2##2##(2008-7#1)(2008-9#1)
relevant method##2##2##(2008-5#1)(2012-1#1)
relevant model for##4##3##(1996-2#1)(2008-4#1)(2009-12#1)(2012-3#1)
relevant molecular##2##2##(1993-12#1)(2012-2#1)
relevant outcomes and##2##3##(2007-8#2)
relevant outcomes##12##2##(2007-8#12)
relevant papers##2##2##(2007-8#1)(2012-12#1)
relevant parameters for##2##3##(2008-11#1)(2008-3#1)
relevant parameters such as##2##4##(2008-10#1)(2008-2#1)
relevant parameters##8##2##(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)
relevant population##2##2##(2008-9#1)(2011-2#1)
relevant pressure##2##2##(2008-7#1)(2010-4#1)
relevant proteins##2##2##(2008-1#1)(2008-4#1)
relevant publications##2##2##(2008-8#1)(2008-9#1)
relevant randomised controlled##2##3##(1993-12#1)(2007-11#1)
relevant research on##2##3##(1995-2#1)(2009-11#1)
relevant research##5##2##(1995-2#1)(2008-7#2)(2008-8#1)(2009-11#1)
relevant results##2##2##(1997-4#1)(2010-8#1)
relevant role##5##2##(1992-9#1)(1993-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
relevant studies were identified and##2##5##(2008-10#1)(2012-12#1)
relevant studies were identified##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
relevant studies were##4##3##(2008-10#1)(2009-11#1)(2012-12#1)(2013-1#1)
relevant studies##12##2##(2008-10#2)(2008-12#1)(2009-11#1)(2009-2#2)(2011-2#2)(2012-12#1)(2013-1#3)
relevant system##2##2##(2008-2#1)(2008-3#1)
relevant targets##2##2##(2010-5#1)(2011-2#1)
relevant temporal##2##2##(2009-8#1)(2013-7#1)
relevant thermodynamic##2##2##(1990-8#1)(2009-11#1)
relevant to a##2##3##(1992-3#1)(1996-2#1)
relevant to all##5##3##(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
relevant to both##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
relevant to diabetes##2##3##(2008-1#1)(2009-5#1)
relevant to its##3##3##(1991-12#1)(2008-2#1)(2012-2#1)
relevant to other##2##3##(2007-11#1)(2012-2#1)
relevant to public##2##3##(2008-10#1)(2008-7#1)
relevant to the immune system##3##5##(2008-10#3)
relevant to the study##2##4##(2008-5#1)(2009-9#1)
relevant to the treatment of##2##5##(2008-3#1)(2012-12#1)
relevant to the##36##3##(1990-2#1)(1990-7#1)(1992-3#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)
relevant to their##6##3##(1992-1#1)(1992-3#1)(1995-2#1)(2008-12#1)(2008-2#1)(2013-8#1)
relevant to##128##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-12#2)(1992-3#3)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
relevant treatment##2##2##(1993-9#1)(2008-7#1)
relevant variables##3##2##(2008-10#2)(2008-8#1)
relevant##702##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-5#3)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#4)(1995-12#5)(1995-2#6)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#6)(1996-5#5)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#10)(2007-12#10)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#5)(2007-8#16)(2008-1#8)(2008-10#75)(2008-11#30)(2008-12#11)(2008-2#12)(2008-3#34)(2008-4#16)(2008-5#19)(2008-6#5)(2008-7#45)(2008-8#25)(2008-9#9)(2009-10#2)(2009-11#8)(2009-12#5)(2009-2#7)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#6)(2010-3#6)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#36)(2011-8#1)(2012-1#7)(2012-12#6)(2012-2#21)(2012-3#15)(2012-5#1)(2012-8#2)(2013-1#31)(2013-7#2)(2013-8#9)
relevant?##2##1##(2009-9#1)(2011-2#1)
reliabilities for##2##2##(2007-12#1)(2010-4#1)
reliabilities##4##1##(2007-12#2)(2010-4#1)(2012-2#1)
reliability and construct validity##2##4##(2011-1#1)(2012-1#1)
reliability and reproducibility##2##3##(2007-7#1)(2010-11#1)
reliability and validity of the##6##5##(1993-3#1)(2008-12#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-12#1)
reliability and validity of##11##4##(1992-3#1)(1993-11#1)(1993-3#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
reliability and validity##17##3##(1992-3#1)(1993-11#1)(1993-3#1)(1996-3#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
reliability and##41##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
reliability for##6##2##(1996-3#1)(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)
reliability in##10##2##(1996-7#1)(2008-10#1)(2008-7#4)(2010-12#2)(2012-2#1)(2013-8#1)
reliability is##4##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
reliability of 'specialized' physical therapists in##2##6##(1993-12#2)
reliability of a##12##3##(1991-12#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-9#1)(2012-1#1)
reliability of current##2##3##(2007-2#1)(2008-12#1)
reliability of its##2##3##(2007-12#1)(2009-1#1)
reliability of the audit##2##4##(1993-1#2)
reliability of the determination was proved##3##6##(2008-10#3)
reliability of the developed method##4##5##(2008-10#4)
reliability of the developed##5##4##(2008-10#5)
reliability of the entire##3##4##(2007-11#1)(2008-10#2)
reliability of the marking process##2##5##(2008-11#2)
reliability of the method##7##4##(2008-10#5)(2008-3#1)(2008-7#1)
reliability of the results##2##4##(2008-5#1)(2011-2#1)
reliability of the##60##3##(1990-9#1)(1991-6#1)(1992-10#1)(1993-1#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#3)
reliability of these methods##2##4##(2008-10#2)
reliability of these##6##3##(2008-10#3)(2008-3#1)(2008-4#1)(2012-12#1)
reliability of this##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
reliability of##135##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-12#4)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2008-10#42)(2008-11#6)(2008-12#7)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
reliability on a##2##3##(2008-10#1)(2008-3#1)
reliability studies##2##2##(2009-7#1)(2013-1#1)
reliability study##2##2##(1996-7#1)(2010-12#1)
reliability testing of the##2##4##(2010-10#2)
reliability testing##5##2##(1996-3#1)(2010-10#3)(2011-1#1)
reliability was tested by##2##4##(2008-10#2)
reliability was tested##3##3##(2008-10#2)(2010-10#1)
reliability was##9##2##(2007-8#1)(2008-10#5)(2010-10#1)(2013-1#1)(2013-8#1)
reliability when##2##2##(2008-12#1)(2012-1#1)
reliability##307##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#7)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-7#5)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#3)(2007-11#2)(2007-12#9)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#68)(2008-11#12)(2008-12#14)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#8)(2010-11#2)(2010-12#6)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#8)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#8)
reliability)##2##1##(2008-10#2)
reliable analytical procedures##2##3##(2008-10#1)(2010-11#1)
reliable analytical techniques##2##3##(2008-10#1)(2010-11#1)
reliable analytical##11##2##(1996-12#1)(2008-10#8)(2010-11#2)
reliable and accurate##2##3##(2007-11#1)(2011-2#1)
reliable and can##2##3##(2008-10#1)(2008-4#1)
reliable and consistent with##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
reliable and easy to##2##4##(1990-8#1)(2008-10#1)
reliable and effective##2##3##(2008-11#1)(2008-9#1)
reliable and powerful##2##3##(2008-8#1)(2013-1#1)
reliable and quick##2##3##(2008-10#1)(2010-6#1)
reliable and rapid##2##3##(2008-10#2)
reliable and reproducible##6##3##(1990-11#1)(2007-7#1)(2008-10#3)(2008-12#1)
reliable and robust##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
reliable and safe##2##3##(2008-4#1)(2011-2#1)
reliable and sensitive##5##3##(1991-3#1)(2008-10#2)(2008-12#1)(2008-2#1)
reliable and specific##2##3##(2008-10#1)(2013-8#1)
reliable and suitable for##2##4##(2008-10#1)(2012-3#1)
reliable and valid##6##3##(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
reliable and##73##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#26)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
reliable as##3##2##(1997-7#1)(2008-10#1)(2008-4#1)
reliable assay##2##2##(2008-10#1)(2008-7#1)
reliable assessment of##2##3##(2008-10#2)
reliable clinical##2##2##(1996-3#1)(2010-11#1)
reliable data in the##3##4##(1993-9#1)(2008-2#1)(2008-3#1)
reliable data##10##2##(1993-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#1)
reliable detection methods##2##3##(2008-11#2)
reliable detection of##8##3##(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#2)(2013-8#1)
reliable detection##11##2##(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2011-2#2)(2013-8#1)
reliable determination of##3##3##(2008-10#2)(2008-9#1)
reliable diagnosis of##2##3##(2008-6#1)(2008-7#1)
reliable diagnosis##7##2##(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-3#1)
reliable diagnostic##7##2##(1992-3#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
reliable estimate of##6##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
reliable estimates of the##3##4##(1993-9#1)(2008-10#1)(2008-9#1)
reliable estimates of##4##3##(1992-9#1)(1993-9#1)(2008-10#1)(2008-9#1)
reliable estimates##5##2##(1992-9#1)(1993-9#1)(2008-10#2)(2008-9#1)
reliable evaluation of##2##3##(2008-10#1)(2008-7#1)
reliable external##2##2##(2011-2#1)(2013-7#1)
reliable features##2##2##(1996-3#1)(2008-12#1)
reliable for the determination of##2##5##(1996-3#1)(2008-10#1)
reliable for the##4##3##(1996-3#1)(2008-10#3)
reliable for##16##2##(1990-5#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#8)(2008-3#2)(2008-5#2)
reliable identification of##2##3##(2008-10#1)(2011-2#1)
reliable identification##3##2##(2008-10#2)(2011-2#1)
reliable in##7##2##(1994-3#1)(2006-5#1)(2007-10#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
reliable indicator of##4##3##(1991-12#1)(1993-12#1)(2013-7#2)
reliable information on##3##3##(1991-2#1)(2008-9#1)(2011-1#1)
reliable information##8##2##(1991-2#1)(1996-3#1)(1997-3#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)
reliable instrument##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
reliable is##2##2##(1991-6#1)(1995-5#1)
reliable means of##5##3##(1990-8#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-7#1)
reliable means##7##2##(1990-8#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-7#1)
reliable measures##2##2##(1996-2#1)(2008-7#1)
reliable method for##15##3##(1997-7#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
reliable method to##5##3##(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-7#1)
reliable method##32##2##(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
reliable methods for the##2##4##(1993-6#1)(2008-10#1)
reliable methods for##3##3##(1993-6#1)(2008-10#1)(2008-9#1)
reliable methods##4##2##(1993-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
reliable molecular##2##2##(2008-6#1)(2008-9#1)
reliable or##2##2##(2008-10#1)(2010-10#1)
reliable procedures##3##2##(2008-10#2)(2008-2#1)
reliable protocols for##3##3##(2008-1#1)(2008-4#2)
reliable real-time##2##2##(2008-10#2)
reliable recognition##2##2##(1991-11#1)(2008-1#1)
reliable results for a##2##4##(2008-2#1)(2008-9#1)
reliable results for##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
reliable results in##2##3##(2008-10#1)(2009-8#1)
reliable results##11##2##(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)
reliable technique##5##2##(1996-6#1)(2012-2#3)(2012-3#1)
reliable than##5##2##(1992-1#1)(2008-10#1)(2008-12#1)(2010-6#1)(2012-2#1)
reliable to##4##2##(1990-9#1)(1996-11#1)(2008-3#1)(2012-2#1)
reliable tool for##2##3##(2008-2#1)(2011-2#1)
reliable tool##5##2##(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
reliable tools##2##2##(2012-1#1)(2012-2#1)
reliable use of##2##3##(2008-10#1)(2008-6#1)
reliable values##2##2##(2008-2#1)(2009-3#1)
reliable way##3##2##(1993-12#1)(2008-10#2)
reliable with##2##2##(2008-10#1)(2008-5#1)
reliable##515##1##(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-12#8)(1993-2#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#2)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#145)(2008-11#9)(2008-12#10)(2008-2#13)(2008-3#22)(2008-4#14)(2008-5#12)(2008-6#7)(2008-7#18)(2008-8#7)(2008-9#20)(2009-11#2)(2009-12#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#5)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#5)(2013-1#17)(2013-7#5)(2013-8#8)
reliably and rapidly##2##3##(2008-3#1)(2008-4#1)
reliably and##4##2##(2008-3#1)(2008-4#1)(2009-5#1)(2013-8#1)
reliably be##2##2##(2010-10#1)(2010-8#1)
reliably detect##3##2##(1993-9#1)(2008-10#1)(2008-3#1)
reliably distinguished##2##2##(2008-10#1)(2009-12#1)
reliably employed for##2##3##(2008-10#1)(2008-11#1)
reliably employed##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
reliably for the##2##3##(2008-10#2)
reliably for##3##2##(2008-10#3)
reliably higher than##2##3##(1992-1#2)
reliably in##2##2##(1996-6#1)(2008-5#1)
reliably measured##3##2##(2008-12#1)(2008-3#1)(2008-4#1)
reliably predict##4##2##(1993-6#1)(1996-3#1)(2009-4#1)(2012-1#1)
reliably predicts the##2##3##(2008-10#1)(2013-1#1)
reliably predicts##3##2##(2008-10#2)(2013-1#1)
reliably the##2##2##(1995-12#1)(1995-2#1)
reliably to##2##2##(1993-12#1)(2008-10#1)
reliably used by##2##3##(2008-10#1)(2008-7#1)
reliably used for##2##3##(1990-12#1)(2008-10#1)
reliably used##7##2##(1990-12#1)(1992-3#1)(1997-3#1)(2008-10#3)(2008-7#1)
reliably with##2##2##(2008-10#1)(2008-9#1)
reliably##108##1##(1990-12#1)(1990-8#1)(1991-3#1)(1992-1#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-1#3)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#7)(2013-1#4)(2013-7#1)(2013-8#2)
reliance on the##3##3##(1991-2#1)(1994-3#1)(2008-3#1)
reliance on##18##2##(1991-2#3)(1993-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-2#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#2)(2009-7#1)(2010-12#1)(2011-1#1)
reliance##21##1##(1991-2#3)(1992-1#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#2)(2009-7#1)(2010-12#1)(2011-1#1)
reliant on##6##2##(2007-12#2)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
relics of##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
relics##4##1##(2008-10#1)(2008-7#1)(2011-2#2)
relied heavily on##2##3##(1995-1#1)(2008-10#1)
relied on a##2##3##(1996-5#1)(1997-1#1)
relied on##20##2##(1991-1#1)(1991-3#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#4)(2013-8#1)
relied upon the##2##3##(2008-7#1)(2012-3#1)
relied upon##9##2##(1995-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-3#1)
relied##36##1##(1991-1#1)(1991-3#1)(1994-11#2)(1995-1#2)(1995-11#1)(1995-2#1)(1996-5#1)(1997-1#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
relief after##5##2##(1990-6#1)(1997-6#1)(2007-11#1)(2011-2#1)(2012-12#1)
relief and##6##2##(1993-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-10#1)
relief for##5##2##(1992-5#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
relief from symptoms##2##3##(2007-8#1)(2011-3#1)
relief from##8##2##(1992-5#1)(1993-2#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-9#1)(2011-3#1)
relief has been##2##3##(1994-1#1)(2010-11#1)
relief in##9##2##(2006-10#4)(2007-7#1)(2007-9#1)(2008-11#2)(2009-4#1)
relief of a##2##3##(1996-5#1)(2011-2#1)
relief of dentin hypersensitivity##3##4##(2011-2#3)
relief of pain##5##3##(1995-5#1)(2007-11#1)(2008-9#2)(2011-2#1)
relief of symptomatology##2##3##(1994-6#1)(1996-9#1)
relief of symptoms##5##3##(1996-9#1)(1997-1#1)(2008-3#1)(2008-6#1)(2008-9#1)
relief of the##5##3##(1996-3#1)(2007-8#1)(2008-11#1)(2009-1#1)(2013-1#1)
relief of##40##2##(1993-1#1)(1993-10#1)(1994-6#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2013-1#4)
relief structure##2##2##(2008-3#2)
relief that##2##2##(2008-10#1)(2008-3#1)
relief was achieved##2##3##(1990-10#1)(2007-11#1)
relief was obtained##2##3##(2008-3#1)(2008-6#1)
relief was##6##2##(1990-10#1)(2007-11#2)(2008-3#1)(2008-6#1)(2011-2#1)
relief with##4##2##(1995-10#2)(2008-3#1)(2008-7#1)
relief##166##1##(1990-10#1)(1990-6#1)(1991-3#2)(1992-1#2)(1992-5#4)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#2)(1995-5#1)(1996-3#2)(1996-5#1)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#7)(2007-11#17)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#12)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#7)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#3)
relief)##2##1##(2008-11#1)(2010-2#1)
relies heavily on##5##3##(2008-4#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#1)
relies heavily upon##2##3##(1996-1#1)(2007-11#1)
relies heavily##7##2##(1996-1#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#1)
relies on a##9##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2013-1#1)(2013-8#1)
relies on the ability to##2##5##(2008-3#1)(2009-11#1)
relies on the ability##3##4##(1997-8#1)(2008-3#1)(2009-11#1)
relies on the immobilization of##2##5##(2008-10#2)
relies on the use of a##4##6##(1990-5#1)(2007-12#2)(2008-3#1)
relies on the use of##5##5##(1990-5#1)(2007-11#1)(2007-12#2)(2008-3#1)
relies on the##38##3##(1990-5#1)(1992-5#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#3)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#8)(2008-7#1)(2008-9#2)(2009-11#1)(2013-1#1)(2013-8#1)
relies on two##2##3##(2007-12#1)(2008-3#1)
relies on##89##2##(1990-5#1)(1991-11#1)(1992-5#1)(1992-6#1)(1994-2#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#9)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#4)(2008-3#15)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#2)
relies primarily on##2##3##(2008-11#1)(2009-8#1)
relies upon the##2##3##(2008-10#2)
relies upon##4##2##(1995-3#1)(2008-10#2)(2008-12#1)
relies##109##1##(1990-5#1)(1991-11#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-1#2)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#7)(2007-12#9)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#16)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
relieve pain##4##2##(2007-11#2)(2008-9#1)(2009-12#1)
relieve suffering##2##2##(1992-5#1)(2012-3#1)
relieve the##4##2##(1995-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
relieve##32##1##(1991-9#1)(1992-5#1)(1993-3#1)(1995-8#1)(1996-6#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-9#2)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#3)
relieved by##5##2##(1991-5#1)(1997-8#1)(2008-7#1)(2009-8#1)(2012-12#1)
relieved in##3##2##(1995-8#1)(2008-11#2)
relieved the##2##2##(1997-8#1)(2007-8#1)
relieved##24##1##(1990-9#2)(1991-12#1)(1991-5#1)(1995-11#1)(1995-8#1)(1997-8#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#2)(2009-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
reliever and##2##2##(2008-10#1)(2010-9#1)
reliever##3##1##(2008-10#1)(2008-3#1)(2010-9#1)
relievers##2##1##(2013-1#1)(2013-8#1)
relieves the symptoms##2##3##(2008-1#1)(2010-7#1)
relieves the##3##2##(1993-8#1)(2008-1#1)(2010-7#1)
relieves##7##1##(1993-8#1)(2007-8#1)(2008-1#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
relieving pain##2##2##(1994-11#1)(2008-11#1)
relieving the##2##2##(1994-12#1)(1994-8#1)
relieving##10##1##(1994-11#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-7#2)(2010-5#1)(2011-2#3)
religation##2##1##(1994-8#1)(1995-5#1)
religion and##10##2##(2009-11#5)(2009-6#2)(2009-7#2)(2010-8#1)
religion are##4##2##(2008-12#2)(2010-10#1)(2013-1#1)
religion in##3##2##(2008-11#1)(2009-7#2)
religion is##3##2##(2008-12#1)(2009-6#1)(2009-7#1)
religion##40##1##(1991-2#1)(2008-11#1)(2008-12#5)(2008-4#2)(2008-5#2)(2009-11#8)(2009-4#1)(2009-5#1)(2009-6#6)(2009-7#7)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
religion/spirituality##3##1##(2010-8#3)
religions##4##1##(2008-12#1)(2008-4#1)(2009-7#2)
religiosity and##4##2##(2009-7#4)
religiosity is##2##2##(2010-12#2)
religiosity##17##1##(2008-4#3)(2009-11#2)(2009-7#6)(2010-12#3)(2010-8#1)(2011-1#2)
religious activities##3##2##(2009-7#2)(2012-12#1)
religious affiliation of##3##3##(1993-12#1)(2009-6#1)(2009-7#1)
religious affiliation##9##2##(1993-12#5)(2009-11#1)(2009-6#1)(2009-7#2)
religious and spiritual##2##3##(2010-2#1)(2011-1#1)
religious and##6##2##(1996-9#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)
religious beliefs and##2##3##(2008-12#1)(2009-10#1)
religious beliefs##7##2##(2008-12#2)(2008-4#1)(2009-10#1)(2012-12#3)
religious coping styles##3##3##(2008-12#1)(2009-11#2)
religious coping##18##2##(2008-12#7)(2008-4#4)(2009-11#7)
religious group##2##2##(1995-3#1)(2009-6#1)
religious groups##3##2##(2008-12#1)(2009-11#1)(2010-8#1)
religious involvement##4##2##(2009-7#3)(2010-10#1)
religious leaders##2##2##(1993-8#1)(2011-1#1)
religious orientation as a therapy intervention##2##6##(2009-7#2)
religious orientation##3##2##(2008-12#1)(2009-7#2)
religious paradigms##2##2##(2008-12#2)
religious participation and##2##3##(2010-10#1)(2010-2#1)
religious participation##4##2##(2010-10#3)(2010-2#1)
religious perspectives##2##2##(2008-12#2)
religious practices##2##2##(2010-2#2)
religious service attendance and##2##4##(2009-8#2)
religious service attendance##3##3##(2009-8#3)
religious service##4##2##(2009-8#4)
religious services##2##2##(2009-8#1)(2010-2#1)
religious support##2##2##(1990-10#1)(2008-4#1)
religious traditions##2##2##(2008-1#1)(2008-12#1)
religious values and beliefs##2##4##(2008-12#2)
religious values##3##2##(2008-12#2)(2009-7#1)
religious##114##1##(1990-10#1)(1991-3#1)(1991-6#1)(1993-12#5)(1993-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#25)(2008-4#6)(2008-7#2)(2008-9#1)(2009-10#5)(2009-11#11)(2009-6#2)(2009-7#17)(2009-8#5)(2010-10#5)(2010-2#5)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#5)(2013-8#1)
religiously##2##1##(2008-12#1)(2009-6#1)
religiousness##5##1##(2009-11#2)(2009-7#3)
reline##2##1##(2008-12#2)
relining##2##1##(2013-1#2)
relinquish##2##1##(1991-3#1)(2007-7#1)
relocated##8##1##(1994-8#1)(1995-5#1)(2007-5#2)(2008-8#1)(2012-3#1)(2013-7#2)
relocating##2##1##(1996-1#1)(2009-12#1)
relocation of a posterior dislocation of##2##6##(2012-12#2)
relocation of individuals of E##2##5##(2013-7#2)
relocation of the##2##3##(1991-1#1)(2009-9#1)
relocation of##8##2##(1991-1#1)(1994-6#1)(2008-7#1)(2009-9#1)(2012-12#2)(2013-7#2)
relocation##18##1##(1991-1#1)(1992-1#1)(1994-6#1)(2007-5#2)(2008-10#1)(2008-7#1)(2009-8#2)(2009-9#1)(2012-12#2)(2013-7#6)
reluctance to##6##2##(1990-6#1)(1996-5#1)(1997-4#1)(2008-5#1)(2008-7#1)(2010-9#1)
reluctance##8##1##(1990-6#1)(1996-5#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-9#1)
reluctant to##9##2##(1991-2#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-12#1)(2010-8#2)(2012-12#1)(2012-3#1)
reluctant##12##1##(1991-2#1)(1996-12#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
rely heavily on##3##3##(1996-1#1)(2007-5#1)(2008-1#1)
rely on a##7##3##(1992-3#1)(1992-6#1)(2007-12#2)(2008-8#1)(2012-3#1)(2013-8#1)
rely on the use of##2##5##(1997-7#1)(2008-10#1)
rely on the##20##3##(1990-12#1)(1990-8#1)(1994-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2013-8#1)
rely on##73##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
rely primarily on##4##3##(1994-1#2)(2008-9#1)(2009-6#1)
rely upon##3##2##(2008-11#1)(2008-2#1)(2010-8#1)
rely##91##1##(1990-12#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
relying on the##4##3##(1997-6#1)(1997-7#1)(2008-3#2)
relying on##26##2##(1992-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#4)
relying##28##1##(1992-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#4)
remain a major##3##3##(1994-3#1)(2010-8#2)
remain a##14##2##(1994-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#2)(2010-3#1)(2010-8#2)(2011-2#4)(2012-3#1)
remain about the##3##3##(1991-11#1)(2008-11#1)(2012-2#1)
remain about##6##2##(1991-11#1)(1994-3#1)(2008-11#2)(2012-12#1)(2012-2#1)
remain alive##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
remain amongst the##2##3##(2007-8#1)(2011-2#1)
remain an important##4##3##(1992-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
remain an##5##2##(1992-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
remain as the##2##3##(2011-3#2)
remain as##4##2##(1991-11#1)(2008-7#1)(2011-3#2)
remain asymptomatic for long##2##4##(1991-5#1)(2011-2#1)
remain asymptomatic for##3##3##(1991-5#1)(2011-2#2)
remain asymptomatic##8##2##(1991-5#1)(2008-10#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-2#1)
remain at a local##2##4##(1993-6#2)
remain at a##3##3##(1993-6#2)(2012-2#1)
remain at##10##2##(1992-8#1)(1993-6#2)(1995-1#1)(1996-12#1)(2008-8#3)(2012-12#1)(2012-2#1)
remain available for##3##3##(1992-3#1)(1996-1#1)(2008-10#1)
remain challenging##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
remain constant##2##2##(1995-9#1)(2008-10#1)
remain controversial##10##2##(2008-5#1)(2008-8#2)(2010-8#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
remain elevated##2##2##(1997-7#1)(2011-2#1)
remain elusive##9##2##(2008-11#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
remain for the##2##3##(2008-11#1)(2008-7#1)
remain for##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
remain free of##3##3##(1991-4#1)(1994-1#1)(2008-10#1)
remain high##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
remain higher than##2##3##(2008-3#1)(2012-12#1)
remain highly##2##2##(1996-3#1)(2011-2#1)
remain in terms of##3##4##(1997-5#1)(2007-11#1)(2013-1#1)
remain in the##6##3##(1994-12#1)(2008-12#2)(2008-6#1)(2008-9#1)(2012-2#1)
remain in##21##2##(1991-3#1)(1994-12#1)(1995-1#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
remain intact##3##2##(1992-10#1)(1996-5#1)(1996-6#1)
remain invariant##2##2##(2007-12#1)(2013-8#1)
remain largely unknown##3##3##(1995-12#1)(1997-6#1)(2011-2#1)
remain largely##4##2##(1995-12#1)(1997-6#1)(2010-12#1)(2011-2#1)
remain limited##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)(2013-1#1)
remain low##2##2##(2008-8#1)(2012-12#1)
remain lower than##2##3##(2011-3#1)(2013-1#1)
remain major##2##2##(2008-11#1)(2008-12#1)
remain many unanswered questions##2##4##(2007-2#1)(2008-4#1)
remain obscure##2##2##(2008-11#1)(2008-7#1)
remain poorly defined##3##3##(2009-8#1)(2010-11#1)(2011-2#1)
remain poorly understood##5##3##(1992-3#1)(2008-9#1)(2011-1#1)(2012-2#2)
remain poorly##8##2##(1992-3#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)
remain relatively##5##2##(1993-12#1)(2007-8#1)(2008-10#2)(2008-2#1)
remain stable for##6##3##(1993-2#2)(2008-10#4)
remain stable##14##2##(1993-2#2)(1993-3#1)(2007-12#1)(2008-10#6)(2008-7#1)(2013-1#2)(2013-8#1)
remain the mainstay of##2##4##(1995-5#1)(2011-2#1)
remain the most##2##3##(2006-6#1)(2009-1#1)
remain the same or##2##4##(1993-1#1)(2008-4#1)
remain the same##3##3##(1993-1#1)(2008-12#1)(2008-4#1)
remain the##20##2##(1993-1#1)(1994-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
remain to be answered##2##4##(1993-11#1)(2009-6#1)
remain to be determined##2##4##(2011-2#2)
remain to be discovered##2##4##(2008-10#1)(2008-8#1)
remain to be elucidated##3##4##(1994-5#1)(1994-8#1)(2013-1#1)
remain to be established##2##4##(1997-7#1)(2008-7#1)
remain to be fully elucidated##2##5##(2008-5#1)(2011-2#1)
remain to be fully##3##4##(2008-12#1)(2008-5#1)(2011-2#1)
remain to be identified##5##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)
remain to be investigated##2##4##(2008-4#1)(2013-8#1)
remain to be##27##3##(1993-11#1)(1994-5#1)(1994-8#1)(1995-4#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#2)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
remain to##28##2##(1993-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-4#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#2)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
remain unanswered##5##2##(1992-2#1)(2007-4#1)(2008-11#1)(2009-4#1)(2013-8#1)
remain uncertain##3##2##(1994-8#1)(2012-12#1)(2013-1#1)
remain unchanged##8##2##(1990-11#1)(1992-3#1)(1993-6#1)(2008-10#1)(2008-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
remain unclear##12##2##(1995-5#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
remain undescribed##2##2##(2008-10#2)
remain unidentified##3##2##(1994-8#1)(2007-6#1)(2008-12#1)
remain unknown##13##2##(1991-4#1)(1993-8#1)(1994-8#1)(1996-2#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-12#1)(2013-8#2)
remain unloaded##2##2##(2013-1#2)
remain unresolved##4##2##(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)
remain unsolved##2##2##(2010-3#1)(2013-7#1)
remain untreated##2##2##(2007-10#2)
remain valid##2##2##(2008-2#1)(2008-4#1)
remain very##2##2##(1997-1#1)(2012-2#1)
remain viable##6##2##(1994-12#1)(1996-1#1)(1997-3#1)(2008-7#2)(2009-5#1)
remain##451##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#3)(1994-5#4)(1994-8#4)(1995-1#2)(1995-12#2)(1995-4#1)(1995-5#4)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#2)(2007-12#6)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#8)(2008-10#44)(2008-11#17)(2008-12#8)(2008-2#7)(2008-3#10)(2008-4#7)(2008-5#9)(2008-6#5)(2008-7#13)(2008-8#19)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-3#4)(2010-5#1)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#4)(2011-2#33)(2011-3#3)(2011-7#1)(2012-1#2)(2012-12#17)(2012-2#14)(2012-3#5)(2012-5#1)(2013-1#24)(2013-7#2)(2013-8#16)
remainder of the##13##3##(1991-12#1)(1992-4#1)(1993-12#1)(1994-3#2)(1996-1#1)(2007-6#1)(2008-10#3)(2008-2#1)(2010-10#1)(2011-1#1)
remainder of##15##2##(1991-12#1)(1992-4#1)(1993-12#1)(1994-3#2)(1996-1#1)(2007-6#1)(2008-10#3)(2008-2#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-2#1)
remainder were##5##2##(1997-3#1)(1997-4#3)(2008-9#1)
remainder##39##1##(1990-8#1)(1991-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#3)(2007-6#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
remained a##7##2##(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
remained above##2##2##(2008-10#1)(2013-1#1)
remained after##3##2##(1993-12#1)(2008-10#1)(2012-12#1)
remained almost##2##2##(1991-12#1)(2008-7#1)
remained an##4##2##(1995-11#1)(2008-5#1)(2010-3#1)(2011-1#1)
remained approximately##4##2##(1993-9#1)(1997-1#1)(2008-6#1)(2011-2#1)
remained as such##2##3##(1990-5#1)(1990-8#1)
remained as##4##2##(1990-5#1)(1990-8#1)(2008-10#1)(2011-2#1)
remained associated with##3##3##(2007-10#1)(2012-1#2)
remained associated##4##2##(1992-3#1)(2007-10#1)(2012-1#2)
remained at 6##2##3##(2008-10#1)(2008-12#1)
remained at a low##2##4##(1997-8#1)(2008-10#1)
remained at a##3##3##(1997-8#1)(2008-10#1)(2012-12#1)
remained at this##2##3##(2007-10#1)(2013-1#1)
remained at##16##2##(1993-3#1)(1995-9#1)(1996-11#2)(1996-5#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2012-12#1)(2013-1#2)
remained attached to the##2##4##(2008-5#1)(2013-1#1)
remained below##4##2##(2007-7#1)(2008-1#2)(2013-1#1)
remained bound##2##2##(1992-6#2)
remained comparable to##2##3##(1992-3#1)(2008-10#1)
remained comparable##3##2##(1992-3#1)(2008-10#1)(2012-3#1)
remained constant over the##3##4##(1994-6#1)(2013-8#2)
remained constant##16##2##(1992-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2012-8#1)(2013-8#2)
remained dominant##2##2##(2008-10#1)(2008-5#1)
remained effective##2##2##(2008-10#2)
remained elevated during##2##3##(1993-1#1)(1994-2#1)
remained elevated in##3##3##(1994-3#1)(1994-5#1)(2007-10#1)
remained elevated##9##2##(1993-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1997-3#1)(2007-10#1)(2013-1#1)
remained elusive##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)
remained enigmatic##2##2##(2009-8#1)(2010-1#1)
remained essentially identical##2##3##(2008-10#1)(2008-11#1)
remained essentially unaltered##2##3##(1992-9#1)(1994-11#1)
remained essentially unchanged##2##3##(1992-6#1)(2008-10#1)
remained essentially##7##2##(1992-6#1)(1992-9#1)(1994-1#1)(1994-11#1)(2008-10#2)(2008-11#1)
remained even after##2##3##(2008-5#1)(2011-1#1)
remained for##2##2##(2008-10#1)(2008-12#1)
remained free of##2##3##(2007-7#1)(2008-10#1)
remained high in the##2##4##(1993-12#1)(2011-2#1)
remained high throughout the##2##4##(2008-10#2)
remained high##13##2##(1992-6#1)(1993-12#1)(1994-6#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#3)(2012-3#1)
remained higher than in##2##4##(1996-3#1)(2008-10#1)
remained highly##3##2##(2008-10#2)(2008-7#1)
remained in a##2##3##(2010-6#1)(2012-3#1)
remained in the final##2##4##(2008-10#1)(2008-3#1)
remained in the##12##3##(1993-3#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#2)
remained in##23##2##(1990-6#1)(1990-9#1)(1993-3#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)
remained independent of##2##3##(1990-11#1)(2008-3#1)
remained intact in##2##3##(1997-7#1)(2008-5#1)
remained intact##7##2##(1993-3#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
remained largely##5##2##(1991-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-3#1)
remained limited##3##2##(2008-2#1)(2009-11#1)(2010-1#1)
remained low##9##2##(1994-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-8#2)(2011-1#1)
remained minimal##2##2##(2008-10#1)(2011-2#1)
remained moist##3##2##(2008-10#3)
remained negative##4##2##(1996-11#1)(1997-5#1)(2008-1#1)(2011-2#1)
remained neurologically intact##2##3##(2008-7#1)(2009-3#1)
remained normal##4##2##(2006-6#1)(2008-7#2)(2010-4#1)
remained on the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
remained on##4##2##(2008-10#1)(2008-11#2)(2008-7#1)
remained positive and the##2##4##(1994-12#1)(1996-12#1)
remained positive##7##2##(1993-11#1)(1994-12#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-5#1)(2013-8#1)
remained relatively constant##5##3##(2008-10#3)(2008-11#1)(2012-2#1)
remained relatively stable##2##3##(2007-5#1)(2008-8#1)
remained relatively unchanged##2##3##(2008-10#1)(2008-8#1)
remained relatively##11##2##(2007-5#1)(2008-10#4)(2008-11#2)(2008-8#2)(2011-2#1)(2012-2#1)
remained significant##8##2##(1996-1#1)(1997-6#1)(2008-10#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-5#1)(2013-1#1)
remained significantly##7##2##(1993-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-2#2)
remained similar##2##2##(2008-10#1)(2012-12#1)
remained stable at##3##3##(1993-3#1)(2008-10#1)(2011-1#1)
remained stable for##2##3##(1993-9#1)(2010-4#1)
remained stable in##2##3##(2008-1#1)(2008-10#1)
remained stable##20##2##(1993-3#1)(1993-9#1)(1996-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#2)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
remained susceptible to##2##3##(2008-10#1)(2013-1#1)
remained susceptible##3##2##(2008-10#2)(2013-1#1)
remained the same##5##3##(1995-6#1)(2007-8#2)(2008-10#1)(2008-11#1)
remained the##8##2##(1995-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-2#1)
remained unaffected##8##2##(1990-12#1)(1990-5#2)(1992-12#1)(2008-10#2)(2008-8#1)(2012-8#1)
remained unaltered##7##2##(1994-11#1)(1994-2#1)(2008-11#3)(2008-3#1)(2011-2#1)
remained uncertain##3##2##(1996-4#1)(2008-10#1)(2008-3#1)
remained unchanged for##3##3##(1991-11#1)(1992-6#1)(1995-8#1)
remained unchanged in the##4##4##(1990-12#1)(1991-6#1)(1996-12#1)(2011-2#1)
remained unchanged in##6##3##(1990-12#1)(1991-6#1)(1996-1#1)(1996-12#1)(2011-2#1)(2013-1#1)
remained unchanged or decreased##2##4##(2007-8#1)(2008-10#1)
remained unchanged over the##2##4##(2007-7#1)(2008-10#1)
remained unchanged throughout the##2##4##(2008-7#2)
remained unchanged##47##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#2)(1992-6#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
remained unclear##4##2##(2007-2#1)(2008-10#1)(2009-6#1)(2011-2#1)
remained under the##2##3##(1993-12#1)(2011-2#1)
remained under##3##2##(1993-12#1)(2010-8#1)(2011-2#1)
remained uninfected##2##2##(2008-10#2)
remained unknown##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
remained untreated##3##2##(1992-5#1)(2008-7#1)(2013-8#1)
remained viable##4##2##(2008-10#1)(2008-11#2)(2010-11#1)
remained well##2##2##(1997-5#1)(2008-7#1)
remained within normal limits##2##4##(2008-1#1)(2010-7#1)
remained within normal##4##3##(1997-5#1)(2008-1#1)(2008-5#1)(2010-7#1)
remained within the##2##3##(2008-6#1)(2013-1#1)
remained within##9##2##(1997-5#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#2)(2010-7#1)(2013-1#1)
remained##471##1##(1990-11#3)(1990-12#4)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#7)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#6)(2007-8#8)(2008-1#9)(2008-10#79)(2008-11#24)(2008-12#5)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#18)(2008-6#8)(2008-7#22)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#8)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#9)(2011-2#24)(2011-3#1)(2011-9#1)(2012-1#5)(2012-12#9)(2012-2#7)(2012-3#6)(2012-5#2)(2012-8#2)(2013-1#16)(2013-8#9)
remaining 1##2##2##(1996-6#1)(2013-8#1)
remaining 2 patients##2##3##(2007-11#1)(2011-1#1)
remaining 2##6##2##(1994-12#1)(2007-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
remaining 20##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
remaining 3##5##2##(1993-12#1)(1993-2#1)(2007-10#1)(2008-7#1)(2008-8#1)
remaining 4##4##2##(1993-9#1)(2007-10#1)(2008-11#1)(2008-7#1)
remaining 81%##2##2##(1995-6#1)(2013-1#1)
remaining ORFs##2##2##(1995-6#1)(1997-3#1)
remaining activity)##2##2##(2013-1#2)
remaining at##2##2##(2008-10#1)(2008-11#1)
remaining binding sites are blocked by immersing the membrane in a##2##11##(2008-4#2)
remaining binding##3##2##(1994-2#1)(2008-4#2)
remaining challenges##2##2##(2009-5#1)(2010-8#1)
remaining dopaminergic##2##2##(1996-12#2)
remaining females entered the 392-day##3##5##(1997-4#3)
remaining five##2##2##(2008-10#1)(2008-9#1)
remaining from##2##2##(2008-10#1)(2008-3#1)
remaining green leaf area##2##4##(2008-10#2)
remaining in the##2##3##(1995-9#1)(2008-10#1)
remaining in##7##2##(1994-6#1)(1995-6#1)(1995-9#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
remaining isolates were of the US-8 strain##2##7##(2008-10#2)
remaining isolates were##3##3##(2008-10#3)
remaining isolates##6##2##(2008-10#6)
remaining life expectancy##2##3##(1993-11#1)(1994-6#1)
remaining life##3##2##(1993-11#1)(1994-6#1)(2011-2#1)
remaining neurons##2##2##(1995-5#1)(1997-2#1)
remaining nidus and##2##3##(2008-7#2)
remaining nidus##5##2##(2008-7#5)
remaining nine##2##2##(2008-11#1)(2009-1#1)
remaining part of the##4##4##(2008-7#2)(2011-2#2)
remaining part##5##2##(2008-10#1)(2008-7#2)(2011-2#2)
remaining patients##9##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-5#1)(1992-9#1)(2007-7#1)(2008-6#1)(2010-6#1)(2011-1#1)
remaining solution##2##2##(2008-10#1)(2008-11#1)
remaining three##3##2##(1992-6#1)(2008-3#1)(2009-2#1)
remaining two##7##2##(1992-5#1)(1993-5#1)(1995-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-2#1)
remaining vegetation##2##2##(2008-8#2)
remaining##342##1##(1990-11#2)(1990-12#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#6)(1996-2#3)(1996-3#2)(1996-6#2)(1997-2#2)(1997-3#4)(1997-4#6)(1997-7#3)(2006-12#1)(2007-10#7)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#65)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#17)(2008-8#10)(2008-9#2)(2009-1#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#12)(2012-12#1)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#11)(2013-8#4)
remains a challenge for the##3##5##(2008-11#2)(2013-8#1)
remains a challenge##10##3##(2007-12#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
remains a challenging problem##3##4##(2010-4#1)(2010-6#1)(2012-2#1)
remains a challenging##5##3##(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#1)
remains a clinical##2##3##(2008-5#1)(2008-7#1)
remains a concern##2##3##(2011-2#1)(2013-8#1)
remains a difficult and##2##4##(1994-5#1)(2010-5#1)
remains a difficult##3##3##(1994-5#1)(2007-7#1)(2010-5#1)
remains a highly##3##3##(1996-8#1)(2008-12#1)(2010-4#1)
remains a key##3##3##(2008-11#1)(2011-2#1)(2011-3#1)
remains a leading cause of death##3##6##(1995-9#1)(2010-8#1)(2012-1#1)
remains a major cause of death##2##6##(2010-12#1)(2012-2#1)
remains a major cause of##3##5##(2007-7#1)(2010-12#1)(2012-2#1)
remains a major health problem##2##5##(2008-9#1)(2013-8#1)
remains a major problem in##2##5##(1997-1#1)(2008-11#1)
remains a major problem##4##4##(1997-1#1)(2008-11#1)(2008-2#1)(2012-12#1)
remains a major public health problem##2##6##(2007-10#1)(2011-1#1)
remains a major##15##3##(1997-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
remains a matter of debate##2##5##(1997-5#1)(2010-11#1)
remains a matter of##4##4##(1997-5#1)(2008-10#1)(2010-11#1)(2013-8#1)
remains a mystery##3##3##(1996-12#1)(2008-7#2)
remains a point of##2##4##(1990-5#1)(2008-1#1)
remains a problem of##2##4##(2007-12#1)(2008-3#1)
remains a problem##5##3##(1993-12#1)(2007-12#1)(2008-3#1)(2010-12#1)(2011-1#1)
remains a rare##2##3##(1996-2#1)(2006-10#1)
remains a serious problem##2##4##(1997-5#1)(2010-3#1)
remains a serious##3##3##(1997-5#1)(2008-10#1)(2010-3#1)
remains a significant problem##2##4##(2006-10#1)(2008-11#1)
remains a significant public health problem##2##6##(1997-1#1)(2011-1#1)
remains a significant##9##3##(1997-1#1)(2006-10#2)(2008-11#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#1)
remains a##112##2##(1990-5#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2006-10#3)(2007-10#1)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#5)
remains an enigma##2##3##(2011-2#1)(2012-2#1)
remains an important cause of morbidity and mortality##2##8##(2011-2#1)(2012-2#1)
remains an important cause of##3##5##(2011-2#2)(2012-2#1)
remains an important tool for##2##5##(2008-1#1)(2009-4#1)
remains an important##9##3##(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
remains an incurable disease##2##4##(2008-10#1)(2008-6#1)
remains an integral##2##3##(1997-4#1)(2012-3#1)
remains an issue##2##3##(1994-5#1)(2008-7#1)
remains an##30##2##(1992-3#1)(1994-5#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-8#2)
remains approximately constant##2##3##(2007-12#1)(2008-11#1)
remains as one of the##2##5##(2010-10#1)(2011-2#1)
remains as##6##2##(1991-5#1)(2007-12#1)(2008-11#1)(2010-10#1)(2010-11#1)(2011-2#1)
remains asymptomatic##5##2##(1991-11#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
remains at##3##2##(1993-6#1)(1996-2#1)(2008-3#1)
remains below##4##2##(1996-2#1)(2008-3#2)(2012-2#1)
remains considerable##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
remains constant while the##2##4##(2007-12#1)(2008-10#1)
remains constant##12##2##(1992-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
remains controversial and##4##3##(2008-6#1)(2008-7#1)(2011-2#2)
remains controversial in the##2##4##(2012-3#1)(2013-1#1)
remains controversial in##5##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
remains controversial whether##2##3##(1994-12#1)(2008-7#1)
remains controversial##25##2##(1992-3#1)(1994-12#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
remains difficult to##6##3##(1997-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)
remains difficult##9##2##(1997-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
remains disease free##2##3##(2008-6#1)(2011-2#1)
remains disease-free##3##2##(2008-6#1)(2011-2#2)
remains elusive##10##2##(1992-9#1)(1994-10#1)(1997-4#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
remains enigmatic##2##2##(2008-7#1)(2009-10#1)
remains essential##2##2##(1994-9#1)(2007-2#1)
remains even##2##2##(1996-8#1)(2011-2#1)
remains extremely poor##2##3##(2011-2#1)(2012-12#1)
remains fixed##2##2##(2007-12#1)(2008-2#1)
remains for##2##2##(2008-7#1)(2013-1#1)
remains free of##2##3##(2008-6#1)(2012-2#1)
remains heterogeneous##2##2##(1997-4#1)(2010-11#1)
remains high##5##2##(1997-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)
remains important##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
remains in place##2##3##(2007-12#1)(2008-9#1)
remains in the membrane of the##2##6##(1990-12#2)
remains in the##9##3##(1990-12#2)(1992-8#1)(1993-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
remains in##14##2##(1990-12#2)(1992-8#1)(1993-8#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)
remains intact##2##2##(1995-2#1)(1996-2#1)
remains largely unexplored##2##3##(1992-12#1)(2008-8#1)
remains largely unknown##7##3##(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
remains largely##14##2##(1992-12#1)(1994-12#1)(2007-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
remains limited to##2##3##(2008-7#1)(2008-8#1)
remains limited##7##2##(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
remains more##2##2##(2007-2#1)(2008-2#1)
remains mostly##2##2##(1992-11#1)(1993-11#1)
remains necessary##2##2##(2008-12#1)(2010-10#1)
remains obscure##3##2##(1995-5#1)(2008-10#1)(2012-2#1)
remains of a##2##3##(1990-8#1)(1995-6#1)
remains of##5##2##(1990-8#1)(1995-6#1)(2008-10#2)(2008-7#1)
remains on the##2##3##(1991-6#1)(2008-12#1)
remains one of the major##2##5##(2007-12#1)(2011-2#1)
remains one of the most##5##5##(2008-7#1)(2011-2#2)(2013-1#2)
remains one of the##10##4##(2007-11#1)(2007-12#1)(2008-7#2)(2011-2#3)(2012-12#1)(2013-1#2)
remains over##2##2##(1992-1#1)(2008-2#1)
remains poor##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
remains poorly studied##2##3##(2008-9#1)(2012-2#1)
remains poorly understood##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-12#1)
remains poorly##11##2##(1993-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#2)
remains practically##2##2##(1990-7#1)(2008-10#1)
remains problematic##2##2##(2006-10#1)(2008-7#1)
remains relatively##3##2##(1996-2#1)(1997-1#1)(2008-10#1)
remains small##3##2##(2008-11#1)(2008-3#1)(2012-3#1)
remains sparse##2##2##(2011-2#1)(2012-2#1)
remains stable for##2##3##(1992-9#1)(2008-10#1)
remains stable##4##2##(1992-9#1)(1996-2#1)(2008-10#1)(2008-2#1)
remains the best##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)
remains the cornerstone of##2##4##(2008-12#1)(2012-12#1)
remains the gold standard for##2##5##(2011-2#1)(2012-3#1)
remains the gold standard##8##4##(2007-8#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)
remains the main cause of##2##5##(1993-5#1)(1994-5#1)
remains the main##3##3##(1993-5#1)(1994-5#1)(2007-7#1)
remains the most important##2##4##(2010-8#1)(2012-2#1)
remains the most##10##3##(1997-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#2)(2010-8#1)(2012-2#1)(2013-1#1)
remains the only##4##3##(1991-11#1)(1992-8#1)(1996-3#1)(2007-7#1)
remains the standard##2##3##(2007-10#1)(2012-1#1)
remains the treatment of choice for##3##6##(1997-3#1)(2010-10#1)(2010-8#1)
remains the treatment of choice##4##5##(1990-2#1)(1997-3#1)(2010-10#1)(2010-8#1)
remains the##62##2##(1990-2#1)(1991-11#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#3)(2008-12#3)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#2)
remains tightly##2##2##(1990-5#1)(1991-12#1)
remains to be ascertained##2##4##(1991-2#1)(1995-12#1)
remains to be determined whether##5##5##(2006-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)
remains to be determined##20##4##(1990-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)
remains to be done to##2##5##(1995-6#1)(2007-8#1)
remains to be done##6##4##(1992-3#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-7#1)
remains to be elucidated##10##4##(1994-12#1)(1995-8#1)(1997-7#1)(2008-5#1)(2008-9#1)(2009-7#2)(2009-8#1)(2012-2#2)
remains to be established##15##4##(1990-12#1)(1991-9#1)(1992-3#1)(1995-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
remains to be fully##2##4##(2008-12#1)(2011-2#1)
remains to be investigated##3##4##(2009-8#1)(2011-2#1)(2013-1#1)
remains to be learned about##2##5##(2008-8#1)(2009-5#1)
remains to be resolved##3##4##(1990-7#1)(1995-3#1)(1996-6#1)
remains to be seen whether##3##5##(1994-3#1)(2008-9#1)(2012-2#1)
remains to be seen##5##4##(1994-3#1)(1994-9#1)(2007-7#1)(2008-9#1)(2012-2#1)
remains to be shown##3##4##(2008-10#2)(2013-8#1)
remains to be##90##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#3)
remains to##95##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#3)
remains uncertain##7##2##(1991-2#1)(1991-9#1)(1994-9#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-7#1)
remains unchanged during##2##3##(1992-12#1)(1995-2#1)
remains unchanged##10##2##(1992-12#1)(1995-2#2)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-3#2)
remains unclear and##2##3##(1993-11#1)(2007-12#1)
remains unclear if##2##3##(2010-5#1)(2013-8#1)
remains unclear whether##4##3##(2010-5#1)(2012-2#1)(2013-1#2)
remains unclear##49##2##(1991-2#1)(1993-11#1)(1994-8#1)(1995-8#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
remains undefined##2##2##(2008-3#1)(2011-2#1)
remains undetermined##2##2##(1993-1#1)(2008-11#1)
remains unexplained##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
remains unknown whether##3##3##(2010-3#1)(2012-2#1)(2012-3#1)
remains unknown##36##2##(1990-3#1)(1994-12#1)(1994-8#1)(1996-11#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#1)
remains unproven##2##2##(2007-11#1)(2009-11#1)
remains unresolved##4##2##(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
remains valid##2##2##(2008-9#1)(2012-12#1)
remains very##2##2##(2008-11#1)(2012-3#1)
remains well##2##2##(2007-10#1)(2010-7#1)
remains##750##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#6)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#9)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#1)(2006-10#6)(2007-10#9)(2007-11#8)(2007-12#14)(2007-2#4)(2007-7#12)(2007-8#13)(2008-1#12)(2008-10#48)(2008-11#31)(2008-12#13)(2008-2#8)(2008-3#22)(2008-4#8)(2008-5#14)(2008-6#10)(2008-7#40)(2008-8#29)(2008-9#15)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#7)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#6)(2010-3#5)(2010-4#6)(2010-5#8)(2010-6#5)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#8)(2011-2#55)(2011-3#4)(2012-1#6)(2012-12#14)(2012-2#43)(2012-3#28)(2013-1#25)(2013-7#5)(2013-8#18)
remanded##5##1##(1996-12#4)(1997-5#1)
remapping##2##1##(2009-8#2)
remark##3##1##(2008-11#3)
remarkable ability to##2##3##(2008-11#1)(2013-1#1)
remarkable and##3##2##(2008-12#1)(2008-2#1)(2008-5#1)
remarkable change##3##2##(1991-3#1)(1993-8#1)(2008-1#1)
remarkable chromosomal##2##2##(2008-5#1)(2010-3#1)
remarkable consistency##3##2##(2013-1#3)
remarkable decrease in the##2##4##(1994-3#1)(2008-1#1)
remarkable decrease in##3##3##(1994-3#1)(2008-1#1)(2008-11#1)
remarkable decrease##4##2##(1994-3#1)(2008-1#1)(2008-11#1)(2011-2#1)
remarkable difference##3##2##(1993-8#1)(2007-12#1)(2011-2#1)
remarkable differences##2##2##(1994-12#1)(2008-10#1)
remarkable diversity##2##2##(1993-9#1)(2010-3#1)
remarkable effects##2##2##(2008-1#1)(2008-8#1)
remarkable feature##2##2##(1992-3#1)(2008-10#1)
remarkable for##4##2##(2008-11#1)(2008-7#2)(2011-1#1)
remarkable growth##2##2##(1992-9#1)(2007-4#1)
remarkable improvement in##5##3##(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
remarkable in##3##2##(1991-3#1)(2007-6#1)(2008-11#1)
remarkable increase in the##4##4##(1991-2#1)(1993-3#1)(2008-5#1)(2012-3#1)
remarkable increase in##5##3##(1991-2#1)(1993-3#1)(2008-11#1)(2008-5#1)(2012-3#1)
remarkable increase##10##2##(1991-2#1)(1992-6#1)(1993-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
remarkable increases##2##2##(1996-2#1)(2008-10#1)
remarkable long-term stability##2##3##(2008-10#2)
remarkable mechanical##2##2##(2007-12#1)(2008-7#1)
remarkable progress in##2##3##(2007-8#1)(2008-11#1)
remarkable progress##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
remarkable properties##3##2##(2008-3#1)(2009-12#2)
remarkable property##2##2##(2008-12#1)(2012-1#1)
remarkable resemblance in##2##3##(2010-12#2)
remarkable results##2##2##(2008-10#1)(2012-2#1)
remarkable sensitivity##2##2##(2008-10#2)
remarkable stability##7##2##(1990-5#1)(1993-12#1)(2008-10#3)(2008-5#1)(2012-2#1)
remarkable variation##2##2##(1994-5#1)(2008-5#1)
remarkable##195##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#6)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#26)(2008-11#9)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#4)(2010-3#5)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#7)(2013-8#4)
remarkably conserved##2##2##(2012-2#1)(2012-3#1)
remarkably constant##2##2##(1995-12#1)(2008-5#1)
remarkably high##2##2##(1990-6#1)(2008-10#1)
remarkably higher than that##2##4##(2008-9#2)
remarkably higher##4##2##(1990-8#1)(1996-2#1)(2008-9#2)
remarkably increased##2##2##(2008-9#1)(2012-2#1)
remarkably low compared##2##3##(2008-1#1)(2008-10#1)
remarkably low##4##2##(2008-1#1)(2008-10#3)
remarkably lower##2##2##(2008-10#1)(2009-4#1)
remarkably reduced##2##2##(1995-8#1)(2008-10#1)
remarkably similar to##3##3##(1993-3#1)(1995-6#1)(2008-9#1)
remarkably similar##13##2##(1991-1#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-2#1)(2012-2#1)
remarkably stable##2##2##(2008-5#2)
remarkably successful##2##2##(2008-7#1)(2011-2#1)
remarkably well with##2##3##(2008-4#1)(2008-6#1)
remarkably well##3##2##(2008-4#1)(2008-6#1)(2012-2#1)
remarkably##94##1##(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-4#1)(2007-11#5)(2007-12#2)(2008-1#2)(2008-10#16)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#8)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)
remarks on the##4##3##(1994-12#1)(1995-5#1)(1996-5#1)(2007-12#1)
remarks##10##1##(1991-6#1)(1994-12#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
remating##4##1##(2008-5#4)
remedial approach##2##2##(1994-2#1)(1995-11#1)
remedial computer##2##2##(2013-1#2)
remedial##9##1##(1994-2#1)(1995-11#1)(1995-8#1)(1996-6#1)(2006-10#1)(2007-11#1)(2010-12#1)(2013-1#2)
remediation of##2##2##(2008-4#1)(2013-1#1)
remediation##6##1##(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#3)
remedies for##2##2##(2008-7#1)(2008-9#1)
remedies in##2##2##(1991-1#1)(2008-10#1)
remedies under##2##2##(1996-1#1)(2008-11#1)
remedies##17##1##(1991-1#1)(1992-2#1)(1996-1#1)(2007-4#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
remedy for the treatment of##2##5##(2011-1#1)(2013-7#1)
remedy for##4##2##(1994-12#1)(2008-10#1)(2011-1#1)(2013-7#1)
remedy##19##1##(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-7#2)(2010-11#1)(2011-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
remedy) on##2##2##(2008-10#2)
remedy)##3##1##(2008-10#3)
remember that##4##2##(1991-11#1)(1992-1#1)(2008-5#1)(2013-1#1)
remember the##2##2##(1994-3#1)(1995-3#1)
remember##17##1##(1991-11#1)(1992-1#1)(1994-3#1)(1995-3#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
remembered##13##1##(1994-9#1)(1996-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
remembering##9##1##(1997-3#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#3)(2013-7#2)
remifentanil##13##1##(2008-10#1)(2011-2#10)(2012-12#2)
remind##6##1##(2007-11#2)(2008-1#1)(2008-12#1)(2008-3#1)(2009-8#1)
reminder letter##2##2##(1997-2#1)(2008-1#1)
reminder letters##2##2##(2010-8#1)(2012-3#1)
reminder phone calls on reducing no-show rates in##2##8##(2012-3#2)
reminder system##2##2##(2007-12#1)(2013-1#1)
reminder telephone##2##2##(2007-2#1)(2012-3#1)
reminder##19##1##(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#4)(2013-1#2)
reminders to##2##2##(1994-2#1)(2013-1#1)
reminders##7##1##(1994-2#1)(1997-2#1)(2007-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
reminds us that##2##3##(1995-1#1)(2012-3#1)
reminds us##3##2##(1995-1#1)(2012-3#2)
reminds##6##1##(1995-1#1)(2008-4#1)(2012-3#3)(2013-1#1)
reminiscence##4##1##(2008-10#1)(2008-11#1)(2009-2#2)
reminiscent of the##14##3##(1992-9#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-10#1)(1997-2#1)(1997-9#1)(2007-12#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)
reminiscent of##23##2##(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1995-2#2)(1996-10#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)
remission (CR)##3##2##(2007-4#1)(2008-10#2)
remission after##3##2##(2008-1#2)(2008-7#1)
remission and in##2##3##(1993-12#2)
remission and##8##2##(1993-12#2)(1996-11#1)(2007-5#1)(2007-7#3)(2010-12#1)
remission as##2##2##(2008-8#1)(2013-8#1)
remission following##2##2##(2007-7#1)(2009-9#1)
remission for##2##2##(2008-1#1)(2008-10#1)
remission from##4##2##(2009-3#3)(2010-5#1)
remission in depression##2##3##(2012-3#2)
remission in patients with##2##4##(2008-10#1)(2008-8#1)
remission in##15##2##(1992-5#2)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#3)(2012-3#2)
remission is##3##2##(1990-11#2)(2011-2#1)
remission of the##2##3##(1990-10#1)(2013-7#1)
remission of##18##2##(1990-10#1)(1991-8#1)(1992-5#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-11#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
remission or##2##2##(1990-8#1)(1992-3#1)
remission rate##2##2##(1990-12#1)(1992-2#1)
remission rates were##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
remission rates##6##2##(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
remission was achieved in##2##4##(1995-5#1)(1997-3#1)
remission was achieved##3##3##(1995-5#1)(1997-3#1)(2011-2#1)
remission was##9##2##(1990-2#1)(1992-2#1)(1995-5#1)(1997-3#1)(2007-7#1)(2008-6#2)(2011-2#1)(2012-3#1)
remission were##2##2##(1990-11#1)(2007-11#1)
remission with##5##2##(1991-5#1)(1991-9#1)(1993-2#1)(2007-7#1)(2011-1#1)
remission##173##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#4)(1990-6#3)(1990-8#2)(1990-9#1)(1991-2#5)(1991-4#4)(1991-5#4)(1991-6#2)(1991-8#8)(1991-9#1)(1992-10#2)(1992-2#2)(1992-3#1)(1992-5#5)(1993-12#4)(1993-2#2)(1994-12#3)(1994-5#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#3)(1996-2#1)(1996-6#1)(1997-3#3)(1997-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#1)(2008-1#10)(2008-10#9)(2008-3#1)(2008-5#3)(2008-6#7)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-3#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#1)(2013-7#1)(2013-8#5)
remissions##8##1##(1990-2#2)(1991-2#2)(2006-10#1)(2010-5#1)(2013-8#2)
remit of##3##2##(2008-11#2)(2009-10#1)
remit##6##1##(2008-11#5)(2009-10#1)
remitted##3##1##(1995-11#1)(2008-2#1)(2013-8#1)
remnant of Atlantic##2##3##(2008-6#2)
remnant of the##2##3##(1995-5#1)(2008-10#1)
remnant of##7##2##(1995-5#1)(2008-10#1)(2008-6#2)(2009-6#1)(2009-8#1)(2011-2#1)
remnant##22##1##(1991-1#2)(1995-5#1)(2008-10#4)(2008-5#1)(2008-6#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#2)(2013-1#5)
remnant-like##2##1##(1993-12#2)
remnants have##2##2##(2008-12#1)(2013-7#1)
remnants of triglyceride-rich lipoproteins##2##4##(1995-6#2)
remnants of##6##2##(1995-6#2)(2007-5#1)(2008-5#1)(2008-7#1)(2011-2#1)
remnants##10##1##(1995-6#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
remobilization##2##1##(2008-10#1)(2008-12#1)
remodel##3##1##(2007-8#1)(2009-7#1)(2012-2#1)
remodeled##2##1##(2007-8#1)(2008-10#1)
remodeling and repair##2##3##(2008-1#1)(2012-2#1)
remodeling and##18##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-1#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
remodeling associated##2##2##(1997-8#1)(2008-1#1)
remodeling by##2##2##(2008-11#1)(2012-3#1)
remodeling in##11##2##(1994-11#1)(1994-2#1)(1994-8#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-8#2)
remodeling is##4##2##(1996-8#1)(2009-1#1)(2011-2#2)
remodeling of the extracellular matrix##2##5##(2008-1#1)(2009-8#1)
remodeling of the hip joint##3##5##(2007-11#1)(2007-8#2)
remodeling of the##14##3##(2007-11#3)(2007-8#4)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-3#1)
remodeling of##20##2##(2007-11#3)(2007-8#5)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-7#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
remodeling process##3##2##(2007-8#1)(2010-9#1)(2011-2#1)
remodeling##107##1##(1991-11#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-11#5)(2007-8#11)(2008-1#4)(2008-10#1)(2008-11#7)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#5)(2009-10#2)(2009-11#4)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2011-9#2)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#6)
remodelling and##2##2##(2008-11#1)(2010-10#1)
remodelling of the##2##3##(2008-7#1)(2010-6#1)
remodelling of##6##2##(1996-2#1)(2008-6#1)(2008-7#2)(2010-6#2)
remodelling##36##1##(1990-5#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#11)(2009-4#1)(2010-10#1)(2010-6#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
remote and##3##2##(2008-1#1)(2008-11#1)(2010-8#1)
remote areas are##2##3##(2008-9#1)(2013-1#1)
remote areas##8##2##(1990-6#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
remote carbonyl groups##2##3##(1996-5#2)
remote communities##2##2##(1997-4#1)(2010-9#1)
remote consultation##3##2##(2008-1#3)
remote control##2##2##(2008-10#1)(2011-2#1)
remote detection of##4##3##(2008-2#1)(2008-3#3)
remote detection##6##2##(2008-2#2)(2008-3#4)
remote experience to present behavior##2##5##(2007-8#2)
remote experience##3##2##(2007-8#3)
remote health professionals##2##3##(1995-1#1)(1995-3#1)
remote health##3##2##(1993-6#1)(1995-1#1)(1995-3#1)
remote locations##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
remote measurement of##3##3##(2008-3#3)
remote measurements of##2##3##(2007-12#1)(2008-3#1)
remote memory##2##2##(1991-9#1)(2012-2#1)
remote places##2##2##(2008-7#1)(2013-1#1)
remote primary##3##2##(1996-2#1)(1997-4#1)(2008-10#1)
remote sensing and##4##3##(2008-10#1)(2008-3#2)(2008-8#1)
remote sensing by##2##3##(2008-3#1)(2013-8#1)
remote sensing of atmospheric ammonia by use of a coherent##2##10##(2008-3#2)
remote sensing of atmospheric##3##4##(2008-3#3)
remote sensing of cirrus clouds##2##5##(2007-12#1)(2008-2#1)
remote sensing of ocean color from space##2##7##(2008-3#2)
remote sensing of ocean color##5##5##(2008-2#1)(2008-3#4)
remote sensing of ocean##6##4##(2008-2#2)(2008-3#4)
remote sensing of the##2##4##(2008-3#2)
remote sensing of water##2##4##(2008-2#1)(2008-3#1)
remote sensing of##22##3##(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#14)
remote sensing reflectance##2##3##(2008-2#1)(2013-8#1)
remote sensing variables##2##3##(2008-8#2)
remote sensing##63##2##(2007-12#2)(2008-10#5)(2008-12#3)(2008-2#15)(2008-3#23)(2008-8#11)(2013-8#4)
remote site##4##2##(1990-5#1)(1997-4#2)(2012-12#1)
remote sounding##3##2##(2008-3#3)
remote structural similarity to##2##4##(2010-10#2)
remote##176##1##(1990-10#1)(1990-5#2)(1990-6#1)(1991-9#1)(1992-1#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-4#5)(1997-8#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#21)(2008-11#3)(2008-12#4)(2008-2#23)(2008-3#41)(2008-5#1)(2008-7#5)(2008-8#11)(2008-9#3)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
remote-sensing devices##2##2##(2008-3#2)
remote-sensing reflectance from##2##3##(2008-2#1)(2008-3#1)
remote-sensing reflectance model##2##3##(2008-3#2)
remote-sensing reflectance##12##2##(2008-2#4)(2008-3#8)
remote-sensing system##3##2##(2008-3#3)
remote-sensing##28##1##(2008-2#9)(2008-3#19)
remotely and##2##2##(2008-2#1)(2008-4#1)
remotely from the##2##3##(2008-10#1)(2008-6#1)
remotely from##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
remotely piloted aircraft##2##3##(2008-3#2)
remotely sensed images##2##3##(2008-3#2)
remotely sensed##10##2##(2007-5#1)(2008-2#1)(2008-3#6)(2008-8#2)
remotely##30##1##(1990-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2012-12#1)
removable##11##1##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#6)
removal ability##2##2##(2008-12#2)
removal and##11##2##(2007-12#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-5#1)
removal appeared to##2##3##(2007-8#1)(2008-12#1)
removal are##2##2##(2008-11#1)(2008-4#1)
removal by##8##2##(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#2)(2011-2#1)
removal efficiencies##2##2##(2011-2#1)(2013-1#1)
removal efficiency##2##2##(2013-1#1)(2013-8#1)
removal from the##4##3##(1991-3#1)(1995-8#1)(1996-2#1)(2008-6#1)
removal from water##2##3##(2008-10#2)
removal from##13##2##(1991-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#2)(2013-1#1)
removal in a##2##3##(2008-2#1)(2013-7#1)
removal in##10##2##(1990-3#1)(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2013-7#1)
removal is##8##2##(1994-12#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2013-1#1)
removal mechanism##2##2##(2011-2#1)(2013-8#1)
removal mechanisms##2##2##(1990-2#1)(2008-8#1)
removal of DNA alterations##2##4##(2008-7#2)
removal of a##8##3##(1991-9#1)(1992-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-5#1)(2013-1#1)
removal of all##3##3##(1996-5#1)(2008-12#1)(2008-8#1)
removal of an##4##3##(1994-5#1)(2008-10#1)(2009-4#1)(2010-12#1)
removal of contaminating##2##3##(1995-6#1)(2008-9#1)
removal of cumulus cells##2##4##(2013-1#2)
removal of debris##2##3##(2008-9#1)(2012-3#1)
removal of excess##2##3##(2008-8#1)(2011-2#1)
removal of free##2##3##(1991-2#1)(2008-10#1)
removal of histones##2##3##(1995-2#2)
removal of large##3##3##(2008-10#2)(2008-7#1)
removal of medium##2##3##(1990-7#1)(1992-6#1)
removal of mercury from coal is##2##6##(2008-6#2)
removal of mercury##3##3##(2008-10#1)(2008-6#2)
removal of most of the##3##5##(1990-12#1)(2008-4#1)(2013-1#1)
removal of necrotic##2##3##(2011-2#2)
removal of one##3##3##(1996-2#1)(1997-4#1)(2012-3#1)
removal of protecting groups##2##4##(2008-7#1)(2009-9#1)
removal of residual yolk sac##2##5##(2008-12#2)
removal of residual##4##3##(2007-11#1)(2008-10#1)(2008-12#2)
removal of submucous leiomyomas##2##4##(1991-2#2)
removal of surface##2##3##(2008-10#1)(2008-11#1)
removal of susceptible##2##3##(2008-10#2)
removal of the biofilm##2##4##(2012-2#1)(2013-1#1)
removal of the calcific deposits##2##5##(2012-12#2)
removal of the infected##2##4##(2007-12#1)(2011-2#1)
removal of the lesion##2##4##(2007-12#1)(2010-10#1)
removal of the medial##2##4##(1994-8#1)(2008-7#1)
removal of the residual yolk sac##2##6##(2008-12#2)
removal of the residual##3##4##(2008-10#1)(2008-12#2)
removal of the salivary glands##2##5##(2008-4#2)
removal of the tumor##5##4##(2006-12#1)(2008-12#1)(2009-3#1)(2011-2#2)
removal of the tumour##4##4##(2007-11#1)(2008-7#3)
removal of the##104##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-5#1)(1997-8#1)(2006-12#2)(2007-11#3)(2007-12#3)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#10)(2012-12#6)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
removal of these##4##3##(1994-9#1)(2007-5#1)(2008-4#1)(2011-1#1)
removal of this##3##3##(1990-5#1)(2008-2#1)(2012-3#1)
removal of##342##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#2)(1990-7#2)(1991-12#3)(1991-2#5)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#4)(1992-6#4)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-4#1)(1995-5#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-9#1)(1997-4#2)(1997-7#1)(1997-8#2)(2006-12#2)(2007-11#5)(2007-12#4)(2007-5#4)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#54)(2008-11#7)(2008-12#9)(2008-2#2)(2008-3#4)(2008-4#9)(2008-5#5)(2008-6#9)(2008-7#30)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#10)(2011-2#22)(2012-12#6)(2012-2#2)(2012-3#5)(2013-1#22)(2013-7#2)(2013-8#3)
removal on the##3##3##(1992-10#1)(2009-9#1)(2013-1#1)
removal on##4##2##(1992-10#1)(1996-11#1)(2009-9#1)(2013-1#1)
removal or##5##2##(2007-12#1)(2008-4#1)(2008-6#1)(2009-6#1)(2013-1#1)
removal process##4##2##(1997-5#1)(2008-2#1)(2011-1#1)(2011-2#1)
removal rate##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
removal rates were##2##3##(2008-12#1)(2013-1#1)
removal rates##3##2##(2008-12#1)(2008-5#1)(2013-1#1)
removal torque##4##2##(2009-7#4)
removal using##2##2##(2008-10#1)(2013-1#1)
removal was##12##2##(1991-6#1)(1994-3#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2013-1#1)
removal with##2##2##(2008-10#1)(2012-3#1)
removal without##2##2##(1991-2#1)(1996-11#1)
removal##555##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#3)(1990-7#2)(1991-12#4)(1991-2#8)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#4)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#4)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-5#4)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-12#2)(2007-10#4)(2007-11#7)(2007-12#11)(2007-5#4)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#5)(2008-10#78)(2008-11#12)(2008-12#18)(2008-2#7)(2008-3#14)(2008-4#14)(2008-5#15)(2008-6#17)(2008-7#44)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#7)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#14)(2011-2#29)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#10)(2013-1#38)(2013-7#4)(2013-8#8)
removals##4##1##(2008-8#2)(2008-9#1)(2009-10#1)
remove a##5##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)
remove cells##2##2##(2008-8#1)(2008-9#1)
remove interfering##2##2##(2008-10#2)
remove low-molecular-weight contaminants##2##3##(2008-9#2)
remove material##2##2##(2008-3#2)
remove sperm##2##2##(2008-8#1)(2012-12#1)
remove the voxelization##2##3##(2011-2#2)
remove the##52##2##(1990-11#1)(1992-3#1)(1993-3#1)(1994-8#2)(1996-5#1)(1997-2#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#20)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#4)(2013-8#2)
remove this##2##2##(2010-6#1)(2012-3#1)
remove##168##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#50)(2008-11#1)(2008-12#4)(2008-2#5)(2008-3#11)(2008-4#5)(2008-5#4)(2008-6#8)(2008-7#4)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#2)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#3)
removed after##5##2##(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
removed all##3##2##(1996-12#1)(1997-2#1)(1997-3#1)
removed and replaced##4##3##(1992-6#1)(2008-10#2)(2008-9#1)
removed and the##5##3##(1993-8#1)(1995-12#1)(2008-7#3)
removed and##23##2##(1992-6#1)(1993-8#1)(1993-9#1)(1995-12#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-12#3)(2008-7#7)(2008-9#1)(2011-2#2)(2013-1#1)
removed as a##2##3##(2008-7#1)(2011-2#1)
removed as##3##2##(2008-7#1)(2011-2#2)
removed at autopsy##2##3##(1995-12#1)(2008-7#1)
removed at random##3##3##(1995-2#3)
removed at surgery##2##3##(2010-3#1)(2012-3#1)
removed at the##2##3##(1990-11#1)(2011-2#1)
removed at##15##2##(1990-11#1)(1990-8#1)(1994-3#1)(1995-12#1)(1995-2#3)(2008-5#1)(2008-7#1)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
removed before##3##2##(2007-10#1)(2008-2#1)(2013-1#1)
removed bilaterally##2##2##(1993-12#1)(1994-8#1)
removed by a##3##3##(1993-12#1)(2007-12#1)(2008-11#1)
removed by an endoscopic transsphenoidal approach##2##6##(2011-2#2)
removed by an##3##3##(2008-3#1)(2011-2#2)
removed by endoscopic##2##3##(2012-2#1)(2013-8#1)
removed by precipitation##3##3##(2008-10#2)(2013-1#1)
removed by subsequent washing##2##4##(1991-9#1)(2008-10#1)
removed by subsequent##3##3##(1991-9#1)(2008-10#1)(2009-11#1)
removed by the##6##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
removed by treatment with##3##4##(1994-5#1)(2008-10#1)(2008-4#1)
removed by use of a##3##5##(2007-12#1)(2008-3#1)(2008-9#1)
removed by##61##2##(1991-6#1)(1991-9#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-5#2)(1997-4#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
removed during##2##2##(1997-8#1)(2011-2#1)
removed endoscopically##4##2##(1993-9#1)(2008-5#1)(2011-2#2)
removed for##3##2##(1992-11#1)(2006-6#1)(2008-10#1)
removed from both##2##3##(1994-12#1)(2008-2#1)
removed from the##33##3##(1991-11#2)(1992-5#1)(1993-11#1)(1993-8#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
removed from##66##2##(1990-2#1)(1991-11#2)(1991-3#1)(1992-5#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#7)(2008-7#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
removed gold-cyanide ion##2##3##(2008-6#2)
removed in##11##2##(1990-8#1)(1991-6#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-8#1)
removed on##4##2##(1990-8#1)(1991-12#1)(2011-1#1)(2013-1#1)
removed or##2##2##(1997-3#2)
removed surgically##4##2##(2007-8#1)(2008-8#1)(2010-7#1)(2011-2#1)
removed the right##2##3##(2007-12#1)(2011-1#1)
removed the##8##2##(1990-9#1)(1994-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2009-4#1)(2011-1#1)(2012-12#1)
removed through##3##2##(1994-9#1)(2008-7#1)(2013-1#1)
removed to##3##2##(1997-7#1)(2008-10#1)(2008-6#1)
removed under##3##2##(2007-8#3)
removed using##3##2##(2008-10#2)(2011-2#1)
removed via a##2##3##(2008-7#1)(2011-2#1)
removed via##5##2##(1995-3#1)(2008-7#2)(2011-2#1)(2012-2#1)
removed with the##3##3##(1990-5#1)(2012-2#1)(2012-3#1)
removed with##9##2##(1990-5#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
removed without##3##2##(1991-3#1)(1994-3#1)(2006-12#1)
removed##371##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#3)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#4)(1993-6#3)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#4)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2006-12#5)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#8)(2008-10#61)(2008-11#12)(2008-12#6)(2008-2#8)(2008-3#12)(2008-4#6)(2008-5#17)(2008-6#6)(2008-7#24)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#30)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#15)(2013-8#4)
removes or##2##2##(1991-2#1)(1996-5#1)
removes some##2##2##(2008-10#1)(2008-8#1)
removes the COOH-terminal##3##3##(1990-2#2)(1992-9#1)
removes the##16##2##(1990-2#2)(1990-3#1)(1992-9#1)(1995-10#1)(1995-5#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)
removes##43##1##(1990-2#2)(1990-3#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-11#5)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
removing Cu(II) ions##2##3##(2008-10#2)
removing a##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
removing any##2##2##(2007-11#1)(2008-9#1)
removing both##2##2##(2008-2#1)(2009-12#1)
removing formulations##2##2##(2008-10#2)
removing of##2##2##(2007-8#1)(2008-10#1)
removing organic##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
removing the##28##2##(1991-2#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
removing##107##1##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-6#2)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#1)
remunerated##3##1##(1994-12#3)
remuneration##7##1##(1990-6#1)(1993-1#1)(1994-3#1)(2008-1#2)(2008-7#1)(2010-10#1)
remyelination in##2##2##(2008-12#1)(2012-2#1)
remyelination is##3##2##(2008-12#1)(2008-7#2)
remyelination##12##1##(2008-12#6)(2008-7#5)(2012-2#1)
renaissance in##2##2##(2008-10#1)(2008-8#1)
renal Cd concentrations##2##3##(1997-4#2)
renal ECM accumulation##2##3##(2011-2#2)
renal MT##2##2##(1993-12#2)
renal Na(+)##3##2##(2011-2#3)
renal abnormalities##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
renal abscesses##2##2##(2012-2#2)
renal actions of##2##3##(2011-1#1)(2013-1#1)
renal agenesis##2##2##(1992-6#1)(2007-7#1)
renal allograft recipients##5##3##(2008-1#4)(2008-4#1)
renal allograft##10##2##(2007-7#1)(2008-1#5)(2008-3#1)(2008-4#1)(2011-2#2)
renal allografts##4##2##(2007-7#1)(2008-1#1)(2008-8#2)
renal amyloidosis##3##2##(1993-2#1)(2007-7#1)(2010-5#1)
renal and liver##2##3##(1996-3#1)(2008-12#1)
renal and subclavian##2##3##(2011-2#2)
renal and##15##2##(1990-11#1)(1991-12#1)(1992-5#1)(1994-5#3)(1995-12#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-12#1)(2011-1#1)(2011-2#2)
renal and/or##2##2##(2008-1#1)(2012-3#1)
renal anemia##6##2##(2008-10#1)(2008-8#5)
renal apical membranes##4##3##(1990-11#4)
renal apical##5##2##(1990-11#5)
renal arteries was##2##3##(1997-8#1)(2008-7#1)
renal arteries were##3##3##(1993-8#1)(1997-8#1)(2009-11#1)
renal arteries##13##2##(1990-9#2)(1993-8#2)(1997-8#3)(2008-11#1)(2008-12#1)(2008-7#3)(2009-11#1)
renal artery aneurysm##2##3##(2008-1#1)(2010-4#1)
renal artery is##2##3##(2008-1#2)
renal artery stenosis and##2##4##(1990-2#1)(1997-8#1)
renal artery stenosis##13##3##(1990-2#1)(1997-8#3)(2007-7#1)(2008-1#3)(2008-12#4)(2013-8#1)
renal artery##38##2##(1990-2#2)(1992-5#1)(1993-3#1)(1994-9#2)(1997-8#4)(2007-7#3)(2008-1#9)(2008-11#1)(2008-12#5)(2010-12#1)(2010-4#7)(2011-2#1)(2013-8#1)
renal aspergillosis##2##2##(2008-10#2)
renal autotransplantation##3##2##(2008-8#2)(2013-8#1)
renal biopsies##7##2##(2008-1#6)(2008-4#1)
renal biopsy is##2##3##(2008-1#2)
renal biopsy showed##3##3##(1992-5#1)(2013-8#2)
renal biopsy specimen##2##3##(2007-7#1)(2008-7#1)
renal biopsy was##3##3##(2007-8#1)(2008-1#2)
renal biopsy##20##2##(1992-5#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
renal blood flow##5##3##(1990-9#1)(1992-8#1)(1996-6#1)(2010-12#1)(2013-8#1)
renal calculi##2##2##(1995-8#1)(2008-1#1)
renal cancer patients##4##3##(1993-8#1)(1993-9#3)
renal cancer##12##2##(1991-6#1)(1993-8#2)(1993-9#3)(2007-11#3)(2008-5#1)(2011-2#2)
renal cancer]##2##2##(1997-6#1)(2012-2#1)
renal carcinoma##6##2##(1990-12#1)(1992-12#1)(1992-6#3)(2013-1#1)
renal carcinomas##2##2##(1995-10#2)
renal cell cancer##4##3##(2008-1#1)(2008-6#2)(2011-2#1)
renal cell carcinoma (RCC)##7##4##(1990-2#1)(2007-4#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
renal cell carcinoma and##4##4##(2008-11#2)(2008-8#1)(2009-5#1)
renal cell carcinoma cell##2##4##(2008-11#1)(2010-8#1)
renal cell carcinoma##47##3##(1990-2#2)(1990-5#1)(1990-8#2)(1991-8#4)(1992-3#4)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-12#4)(1997-6#1)(2007-4#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#3)
renal cell carcinoma)##2##3##(1994-3#1)(1994-6#1)
renal cell carcinoma]##3##3##(2011-1#1)(2011-3#1)(2012-3#1)
renal cell carcinomas##3##3##(2009-4#1)(2010-8#1)(2011-2#1)
renal cell tumors##2##3##(1992-8#1)(2007-7#1)
renal cell##64##2##(1990-2#2)(1990-5#1)(1990-8#2)(1991-8#4)(1992-3#4)(1992-5#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#4)(1997-6#1)(2007-4#2)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#3)
renal cells##3##2##(1991-12#1)(1992-5#1)(2008-10#1)
renal concentrating mechanism##2##3##(2013-1#2)
renal cortex##3##2##(1994-5#1)(2011-1#2)
renal cortical slices##2##3##(1994-5#2)
renal cyst##3##2##(2007-10#1)(2010-6#1)(2013-1#1)
renal cysts##2##2##(1993-8#1)(2008-4#1)
renal damage##3##2##(1995-3#1)(2008-1#1)(2008-7#1)
renal disease (ESRD) in##4##4##(2007-7#1)(2008-1#3)
renal disease (ESRD) or##2##4##(2006-10#1)(2012-2#1)
renal disease (ESRD) patients undergoing##2##5##(2007-12#1)(2008-7#1)
renal disease (ESRD) patients##5##4##(1991-3#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-7#1)
renal disease (ESRD) were##2##4##(2008-1#1)(2008-4#1)
renal disease (ESRD)##29##3##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#2)(1997-1#1)(2006-10#1)(2007-12#2)(2007-7#10)(2008-1#5)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
renal disease and renal##2##4##(2008-1#1)(2010-11#1)
renal disease and##7##3##(2007-12#1)(2008-1#2)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
renal disease can##3##3##(2007-7#3)
renal disease in the##3##4##(2007-12#1)(2008-1#1)(2011-2#1)
renal disease in##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)
renal disease is##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
renal disease on##2##3##(2007-7#1)(2012-12#1)
renal disease patients##8##3##(2007-12#1)(2008-1#1)(2008-7#3)(2010-5#2)(2010-7#1)
renal disease without##2##3##(2008-1#2)
renal disease##115##2##(1991-3#2)(1992-8#2)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1996-2#2)(1997-1#2)(2006-10#2)(2007-12#6)(2007-7#23)(2008-1#28)(2008-10#4)(2008-4#4)(2008-7#6)(2008-8#1)(2009-5#2)(2009-6#3)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
renal disease]##2##2##(1991-2#2)
renal diseases in children##3##4##(2007-7#1)(2008-4#2)
renal diseases in the##2##4##(1994-5#1)(2007-7#1)
renal diseases in##5##3##(1994-5#1)(2007-7#2)(2008-4#2)
renal diseases##18##2##(1991-12#1)(1994-5#1)(1997-5#1)(2007-7#5)(2008-1#3)(2008-4#2)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
renal disorders##5##2##(1997-7#2)(2008-1#1)(2008-10#2)
renal dysfunction and##3##3##(1997-4#1)(2007-4#1)(2011-1#1)
renal dysfunction in##3##3##(1997-4#1)(2011-2#1)(2013-1#1)
renal dysfunction##19##2##(1997-4#5)(2007-4#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#3)
renal effects of##3##3##(1990-9#1)(1995-12#1)(2008-1#1)
renal effects##4##2##(1990-9#1)(1995-12#1)(2008-1#1)(2008-5#1)
renal epithelial cells##3##3##(2008-3#1)(2012-12#2)
renal epithelial##4##2##(1991-12#1)(2008-3#1)(2012-12#2)
renal excretion##3##2##(1993-9#1)(2007-11#1)(2012-2#1)
renal failure (CRF)##8##3##(2007-7#4)(2008-1#3)(2011-2#1)
renal failure (ESRF)##4##3##(2008-1#3)(2008-4#1)
renal failure and had##2##4##(2013-1#1)(2013-8#1)
renal failure and##14##3##(1991-5#1)(1992-5#1)(1993-3#1)(1994-9#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
renal failure developed##3##3##(1992-5#1)(1996-6#2)
renal failure due to##3##4##(1997-5#1)(1997-8#1)(2008-4#1)
renal failure in the intensive care unit##2##7##(2008-4#2)
renal failure in the##7##4##(2007-7#1)(2008-1#2)(2008-4#4)
renal failure in##27##3##(1990-8#1)(1995-5#1)(2007-7#3)(2007-8#1)(2008-1#11)(2008-3#1)(2008-4#9)
renal failure is##6##3##(1994-5#1)(2008-1#2)(2008-3#1)(2011-2#2)
renal failure of##3##3##(1991-11#1)(2008-1#2)
renal failure on##2##3##(2006-10#1)(2013-1#1)
renal failure patients and##2##4##(2007-7#1)(2008-10#1)
renal failure patients##12##3##(2007-7#2)(2008-1#3)(2008-10#1)(2008-4#2)(2011-1#4)
renal failure to##3##3##(1995-12#2)(2008-1#1)
renal failure was##2##3##(2007-7#1)(2007-8#1)
renal failure with##3##3##(1990-9#1)(1997-8#1)(2007-8#1)
renal failure##196##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-5#2)(1992-5#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-5#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#3)(2006-10#1)(2007-12#1)(2007-6#2)(2007-7#17)(2007-8#6)(2008-1#54)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#27)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#4)(2011-2#11)(2012-2#1)(2012-3#2)(2013-1#13)(2013-8#4)
renal failure]##5##2##(1997-2#1)(2008-10#1)(2008-7#2)(2013-8#1)
renal flow##2##2##(2010-4#1)(2013-1#1)
renal fossa##2##2##(2008-1#2)
renal function and the incidence of heart failure##2##8##(2010-8#2)
renal function and the##3##4##(2010-8#2)(2011-2#1)
renal function and##12##3##(2007-12#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-7#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-3#1)
renal function in patients##2##4##(2008-1#1)(2013-1#1)
renal function in##4##3##(2008-1#2)(2011-2#1)(2013-1#1)
renal function is##4##3##(2008-1#1)(2008-4#1)(2011-2#2)
renal function or##2##3##(2008-1#1)(2008-10#1)
renal function was##2##3##(2007-8#1)(2008-4#1)
renal function##78##2##(1991-11#2)(1992-8#2)(1994-5#1)(1994-6#1)(1995-11#1)(1997-4#1)(2006-10#1)(2007-12#5)(2007-7#2)(2007-8#2)(2008-1#14)(2008-10#6)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#3)(2011-1#1)(2011-2#15)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
renal functional impairment##2##3##(2008-1#2)
renal functional reserve##3##3##(2008-1#3)
renal functional##6##2##(2008-1#6)
renal functions##2##2##(2007-7#1)(2008-1#1)
renal graft##3##2##(1990-9#1)(2008-1#1)(2009-5#1)
renal hemodynamics##2##2##(1992-8#1)(2010-9#1)
renal histological##2##2##(2013-1#2)
renal histology##2##2##(1997-3#1)(2008-1#1)
renal hydatid disease##3##3##(2007-7#2)(2008-10#1)
renal hydatid##4##2##(2007-7#2)(2008-10#2)
renal impairment##12##2##(2006-10#1)(2008-1#3)(2008-8#1)(2011-2#1)(2013-1#6)
renal infarction##2##2##(2007-7#1)(2008-1#1)
renal injuries##4##2##(1990-9#2)(2008-10#1)(2012-2#1)
renal injury in##3##3##(1995-12#2)(2009-6#1)
renal injury##12##2##(1994-5#3)(1995-12#2)(2008-1#4)(2009-6#1)(2013-8#2)
renal insufficiency and##2##3##(1990-9#1)(2008-1#1)
renal insufficiency or##3##3##(1990-2#1)(2006-10#2)
renal insufficiency with##2##3##(2008-4#1)(2008-7#1)
renal insufficiency##33##2##(1990-2#2)(1990-5#1)(1990-9#3)(1993-3#1)(1993-5#1)(1994-12#1)(2006-10#4)(2007-12#1)(2007-7#4)(2008-1#4)(2008-12#1)(2008-4#2)(2008-7#3)(2011-2#2)(2011-3#1)(2013-1#2)
renal insult##2##2##(2008-4#2)
renal involvement and##2##3##(2008-1#1)(2008-7#1)
renal involvement##9##2##(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-7#1)(2011-1#1)(2011-2#2)
renal length##3##2##(2008-10#3)
renal lesions were##2##3##(2008-5#2)
renal lesions##7##2##(2008-1#1)(2008-5#3)(2012-2#1)(2013-1#2)
renal manifestations of##4##3##(2007-7#1)(2008-8#1)(2013-1#2)
renal manifestations##5##2##(2007-7#1)(2008-8#1)(2013-1#3)
renal masses has##2##3##(2012-2#2)
renal masses##6##2##(2012-2#6)
renal measures##2##2##(2013-1#2)
renal medulla##2##2##(1990-2#1)(2008-7#1)
renal nerve##2##2##(1995-12#1)(2013-8#1)
renal nurses in##3##3##(2007-10#3)
renal nurses##4##2##(2007-10#4)
renal or hepatic##2##3##(1995-11#1)(2012-3#1)
renal or##5##2##(1995-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
renal ossifying tumor of infancy##2##5##(2008-10#2)
renal ossifying tumor##3##3##(2008-10#3)
renal osteodystrophy (ROD)##2##3##(2008-4#1)(2011-2#1)
renal osteodystrophy##4##2##(2008-4#2)(2011-2#2)
renal outcome##2##2##(1991-8#1)(2006-10#1)
renal parenchyma##5##2##(1993-2#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
renal parenchymal##4##2##(1996-6#1)(2008-1#2)(2010-4#1)
renal patients##6##2##(2007-12#4)(2007-7#1)(2008-10#1)
renal pelvis and##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
renal pelvis##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
renal perfusion##4##2##(1992-8#3)(1995-12#1)
renal plasma flow and glomerular filtration rate##3##7##(1995-12#3)
renal prognosis##2##2##(2007-8#1)(2013-1#1)
renal protection##3##2##(1996-6#2)(2013-1#1)
renal proximal tubule cells##4##4##(1991-5#1)(1992-8#2)(2008-11#1)
renal proximal tubule##5##3##(1991-5#1)(1992-8#2)(1997-1#1)(2008-11#1)
renal proximal tubules##3##3##(1997-1#3)
renal proximal##8##2##(1991-5#1)(1992-8#2)(1997-1#4)(2008-11#1)
renal regulation##2##2##(2008-6#2)
renal replacement therapy (RRT)##2##4##(2011-2#1)(2012-3#1)
renal replacement therapy in this##2##5##(2008-11#1)(2008-8#1)
renal replacement therapy in##4##4##(2008-11#2)(2008-3#1)(2008-8#1)
renal replacement therapy##18##3##(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#1)
renal replacement##19##2##(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#1)
renal resistive index##2##3##(2008-10#1)(2013-1#1)
renal scan##4##2##(2012-12#3)(2013-1#1)
renal scarring##8##2##(1990-3#1)(2008-10#1)(2008-4#5)(2009-5#1)
renal scintigraphy##3##2##(2008-1#2)(2013-1#1)
renal sodium##5##2##(1997-3#3)(1997-7#2)
renal stone##2##2##(1990-12#1)(2008-1#1)
renal stones##7##2##(2007-7#3)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
renal surgery##3##2##(2008-10#1)(2009-2#2)
renal survival##4##2##(1994-5#1)(2008-1#1)(2013-1#2)
renal systems##2##2##(2010-9#2)
renal tissue##6##2##(1990-12#1)(1992-3#1)(1993-9#1)(2011-2#3)
renal toxicity of gold##4##4##(1994-5#4)
renal toxicity##9##2##(1994-5#6)(2012-12#3)
renal transplant patients##14##3##(1990-3#1)(2008-1#10)(2008-3#1)(2009-10#1)(2010-7#1)
renal transplant population##2##3##(2007-7#1)(2008-1#1)
renal transplant recipient##4##3##(2007-7#2)(2008-1#2)
renal transplant recipients##16##3##(2007-7#1)(2008-1#1)(2008-3#7)(2008-4#6)(2008-8#1)
renal transplant##55##2##(1990-3#1)(1995-2#2)(2007-2#1)(2007-7#7)(2008-1#18)(2008-10#1)(2008-3#8)(2008-4#8)(2008-7#1)(2008-8#2)(2009-10#1)(2010-7#2)(2011-2#1)(2013-1#2)
renal transplantation conducted##2##3##(2010-7#1)(2012-12#1)
renal transplantation in a patient##2##5##(1992-12#1)(2012-12#1)
renal transplantation in patients with##2##5##(1991-11#1)(2013-1#1)
renal transplantation in the Arab countries##2##6##(2008-4#2)
renal transplantation in the Arab##3##5##(2008-4#3)
renal transplantation in the##5##4##(2008-1#1)(2008-4#4)
renal transplantation in##10##3##(1991-11#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-4#4)(2012-12#1)(2013-1#1)
renal transplantation was##2##3##(2007-7#1)(2008-4#1)
renal transplantation##58##2##(1991-11#3)(1991-9#1)(1992-12#1)(1994-5#2)(1997-3#1)(2007-10#2)(2007-12#1)(2007-7#7)(2008-1#14)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#2)(2010-7#2)(2011-2#2)(2012-12#4)(2013-1#2)
renal transplantations##2##2##(2008-1#2)
renal transplants##5##2##(1991-11#1)(2006-10#1)(2008-1#3)
renal transport##2##2##(2008-11#1)(2013-1#1)
renal trauma##2##2##(2013-8#2)
renal tuberculosis##2##2##(2008-1#1)(2011-2#1)
renal tubular cells##3##3##(1992-3#1)(1996-12#1)(2008-8#1)
renal tubular dysfunction##2##3##(1996-6#2)
renal tubular epithelial cells##2##4##(1992-3#1)(2013-1#1)
renal tubular##12##2##(1992-3#2)(1996-12#1)(1996-6#2)(2007-7#2)(2008-1#2)(2008-4#1)(2008-8#1)(2013-1#1)
renal tubule degeneration in 100 mg/kg males##3##7##(2008-9#3)
renal tubule degeneration in 350 and 700 mg/L males##2##9##(2008-9#2)
renal tubule degeneration in##6##4##(2008-9#6)
renal tubule degeneration##7##3##(2008-9#7)
renal tubule dilatation in all exposed groups of males##2##9##(2008-9#2)
renal tubule dilatation in##3##4##(2008-9#3)
renal tubule hypertrophy in##2##4##(2008-9#2)
renal tubule hypertrophy##3##3##(2008-9#3)
renal tubule##14##2##(2008-11#1)(2008-9#13)
renal tumor of infancy##2##4##(2008-10#2)
renal tumor##7##2##(1992-2#1)(2007-7#1)(2008-10#3)(2012-3#1)(2013-1#1)
renal tumors##5##2##(1992-8#1)(1994-5#3)(2009-5#1)
renal ultrasound##2##2##(2007-7#1)(2008-4#1)
renal vascular resistance##2##3##(1995-12#1)(2008-1#1)
renal vascular##3##2##(1995-12#2)(2008-1#1)
renal vasoconstriction##3##2##(1995-12#2)(2006-10#1)
renal vein##7##2##(2007-7#1)(2008-7#1)(2010-11#4)(2011-2#1)
renal##1325##1##(1990-11#8)(1990-12#4)(1990-2#9)(1990-3#4)(1990-5#2)(1990-8#4)(1990-9#15)(1991-11#10)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#4)(1991-6#2)(1991-8#5)(1991-9#2)(1992-12#3)(1992-2#1)(1992-3#7)(1992-5#12)(1992-6#5)(1992-8#17)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#4)(1993-5#1)(1993-8#6)(1993-9#5)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#27)(1994-6#5)(1994-8#7)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#26)(1995-2#2)(1995-3#4)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#10)(1997-1#6)(1997-2#1)(1997-3#10)(1997-4#8)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#12)(2006-10#16)(2007-10#16)(2007-11#4)(2007-12#23)(2007-2#1)(2007-4#3)(2007-6#3)(2007-7#106)(2007-8#10)(2008-1#226)(2008-10#57)(2008-11#14)(2008-12#10)(2008-3#19)(2008-4#75)(2008-5#8)(2008-6#7)(2008-7#35)(2008-8#27)(2008-9#17)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#8)(2009-6#6)(2009-7#1)(2010-10#2)(2010-11#8)(2010-12#2)(2010-3#2)(2010-4#10)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#6)(2011-1#15)(2011-2#86)(2011-3#7)(2012-1#2)(2012-12#18)(2012-2#16)(2012-3#15)(2013-1#81)(2013-8#29)
renal&quot##2##1##(2008-1#2)
renal-cell cancer##5##2##(1992-10#3)(2008-8#2)
renal-cell##6##1##(1991-2#1)(1992-10#3)(2008-8#2)
renamed##2##1##(1991-12#1)(2007-5#1)
renaturation and##2##2##(1990-5#1)(2008-4#1)
renaturation##6##1##(1990-5#1)(2008-10#2)(2008-4#1)(2009-3#1)(2011-1#1)
renatured##4##1##(1990-11#1)(1992-8#1)(1995-6#1)(1997-4#1)
renaturing##2##1##(1995-8#1)(1997-6#1)
rendement scolaire##2##2##(2008-11#2)
rendement##3##1##(2008-11#3)
render a##4##2##(1996-12#1)(1997-3#1)(1997-5#1)(2010-3#1)
render high-technological medical##2##3##(2011-2#2)
render the##8##2##(1990-12#1)(1990-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)
render them##3##2##(2008-9#1)(2010-7#2)
render this##4##2##(2007-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
render##38##1##(1990-12#1)(1990-5#1)(1991-2#1)(1994-1#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-3#2)(1997-5#2)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#1)
rendered by the##2##3##(2006-12#1)(2013-1#1)
rendered by##3##2##(1996-3#1)(2006-12#1)(2013-1#1)
rendered it##2##2##(1995-6#1)(2008-10#1)
rendered more##3##2##(1997-4#1)(1997-7#1)(2008-3#1)
rendered or##2##2##(1992-12#1)(2008-7#1)
rendered the##3##2##(1992-7#1)(1995-8#1)(2013-1#1)
rendered this##2##2##(1992-11#1)(2008-10#1)
rendered##51##1##(1991-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2010-1#1)(2010-3#2)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
rendering it##2##2##(2008-11#1)(2011-1#1)
rendering of##4##2##(2007-11#1)(2008-2#1)(2008-6#2)
rendering the method suitable for determination of##2##7##(2008-10#2)
rendering the method suitable for##3##5##(2008-10#3)
rendering the##9##2##(1994-11#1)(1996-9#1)(2008-10#4)(2008-7#2)(2013-1#1)
rendering them##2##2##(2008-8#2)
rendering##47##1##(1992-1#1)(1994-11#1)(1996-9#2)(2007-10#1)(2007-11#3)(2007-5#1)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#11)(2008-7#2)(2008-8#2)(2009-9#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
renderings##3##1##(2011-7#3)
renders it##2##2##(1997-2#1)(2008-10#1)
renders the##4##2##(1995-2#1)(1996-11#1)(1997-7#1)(2008-1#1)
renders##17##1##(1991-2#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-1#1)(2010-4#1)
rendition of##2##2##(2008-8#1)(2013-1#1)
renewable microcolumn##2##2##(2008-10#2)
renewable resources##3##2##(2008-6#2)(2008-8#1)
renewable surface##3##2##(2008-10#3)
renewable##22##1##(1993-3#1)(2008-10#14)(2008-6#4)(2008-8#1)(2013-1#2)
renewal and##3##2##(1995-1#1)(2008-11#1)(2008-5#1)
renewal of the##2##3##(2008-10#1)(2008-5#1)
renewal of##4##2##(1994-12#1)(2008-10#2)(2008-5#1)
renewal##31##1##(1990-11#1)(1993-2#3)(1994-12#1)(1995-1#4)(1997-5#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-8#2)(2008-9#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)
renewed attention##3##2##(1992-12#1)(1996-3#1)(2013-1#1)
renewed by##2##2##(2008-10#2)
renewed focus on##2##3##(2008-11#1)(2008-12#1)
renewed focus##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
renewed interest in the##2##4##(2008-7#1)(2013-8#1)
renewed interest in##7##3##(1995-6#1)(2008-7#1)(2009-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
renewed interest##8##2##(1995-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
renewed##36##1##(1991-2#1)(1992-12#1)(1992-6#1)(1993-1#2)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#3)(1997-1#1)(2007-2#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
renewing##4##1##(1995-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
renews##2##1##(1994-2#1)(2012-2#1)
reniform nematode##2##2##(2008-10#2)
reniformis and##2##2##(2008-10#2)
reniformis on cotton##2##3##(2008-10#2)
reniformis on##4##2##(2008-10#4)
reniformis##11##1##(2008-10#11)
renin activity##3##2##(1990-5#1)(1997-3#1)(2008-7#1)
renin and prorenin##2##3##(1996-5#2)
renin and##5##2##(1996-5#4)(2008-1#1)
renin angiotensin system in##2##4##(2008-11#2)
renin angiotensin system##5##3##(2008-11#3)(2012-3#1)(2013-1#1)
renin in##3##2##(1990-8#2)(1996-5#1)
renin mRNA levels and renin production##2##6##(1993-6#2)
renin mRNA levels##3##3##(1993-6#3)
renin mRNA##5##2##(1993-6#5)
renin production##3##2##(1993-6#3)
renin was##2##2##(1996-5#2)
renin##44##1##(1990-5#3)(1990-8#6)(1991-9#2)(1993-6#11)(1996-5#9)(1997-3#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-7#2)(2012-3#2)(2013-1#2)
renin-angiotensin system (RAS)##2##3##(2008-7#1)(2013-1#1)
renin-angiotensin system##13##2##(1990-2#1)(1993-12#4)(1996-3#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-7#2)(2013-1#1)(2013-7#1)
renin-angiotensin##14##1##(1990-2#1)(1993-12#4)(1996-3#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2013-1#1)(2013-7#1)
renin-angiotensin-aldosterone axis##2##2##(2013-1#2)
renin-angiotensin-aldosterone##8##1##(1992-8#1)(1994-7#1)(1996-6#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
rennet##4##1##(2008-10#1)(2010-2#3)
renocolic fistula##4##2##(2013-1#4)
renogram##3##1##(2008-10#1)(2008-4#1)(2013-1#1)
renography##2##1##(2008-1#2)
renormalization##2##1##(2008-2#1)(2008-8#1)
renovascular disease##3##2##(1990-6#1)(1997-2#1)(2007-7#1)
renovascular hypertension and##4##3##(1992-5#1)(1994-9#1)(2008-1#2)
renovascular hypertension##14##2##(1990-2#3)(1992-5#1)(1994-9#1)(2007-7#3)(2008-1#4)(2010-4#2)
renovascular##18##1##(1990-2#3)(1990-6#1)(1992-5#1)(1994-9#1)(1997-2#1)(2007-7#4)(2008-1#4)(2010-4#3)
renovation of##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#2)
renovation##8##1##(1991-12#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#1)(2012-3#2)
renovations##2##1##(1994-1#1)(1995-1#1)
renowned##2##1##(2007-8#1)(2012-3#1)
reocclusion and##2##2##(1992-9#1)(2006-6#1)
reocclusion##5##1##(1992-9#1)(1993-1#1)(1997-8#1)(2006-6#1)(2007-8#1)
reopened##4##1##(1996-9#1)(1997-3#1)(2008-11#1)(2012-3#1)
reoperated because of##2##3##(2008-10#1)(2008-6#1)
reoperated##6##1##(1992-10#1)(2007-8#2)(2008-10#2)(2008-6#1)
reoperation rate##2##2##(1996-11#1)(2012-12#1)
reoperation was##3##2##(2007-11#1)(2012-12#2)
reoperation with change of##2##4##(2007-11#2)
reoperation with##4##2##(2007-11#2)(2012-3#2)
reoperation##32##1##(1994-7#1)(1995-3#1)(1996-11#1)(2007-11#5)(2007-8#4)(2008-6#1)(2008-9#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#9)(2012-3#3)(2013-1#1)
reoperations##3##1##(2007-8#1)(2012-3#1)(2013-1#1)
reordering##5##1##(2008-7#5)
reorganisation##3##1##(1991-3#1)(1996-5#1)(2011-2#1)
reorganization and recruitment##3##3##(2012-2#3)
reorganization and##6##2##(1994-9#1)(2008-11#1)(2012-2#4)
reorganization as##2##2##(1993-8#1)(2012-12#1)
reorganization during##2##2##(2008-7#1)(2011-2#1)
reorganization in##3##2##(1991-2#1)(1996-12#1)(2009-11#1)
reorganization of F-actin##3##3##(1993-8#3)
reorganization of health services##3##4##(1993-6#3)
reorganization of the##9##3##(1992-2#1)(1995-1#1)(1997-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#2)
reorganization of##22##2##(1992-2#1)(1993-6#3)(1993-8#3)(1994-8#1)(1995-1#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
reorganization##54##1##(1991-2#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#3)(1993-8#4)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#3)(2008-9#3)(2009-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
reorganize##5##1##(1992-2#1)(2008-2#2)(2008-4#1)(2008-9#1)
reorganized##4##1##(1995-3#1)(2008-3#1)(2011-2#2)
reorient##5##1##(1992-11#1)(1993-2#1)(1995-5#1)(2008-1#1)(2009-5#1)
reorientation of the nematic##2##4##(2007-12#1)(2008-2#1)
reorientation of the##11##3##(1990-8#1)(1993-1#1)(1995-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
reorientation of##17##2##(1990-8#1)(1993-1#1)(1995-11#1)(1995-5#1)(1997-1#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#2)
reorientation##27##1##(1990-8#3)(1992-2#1)(1993-1#1)(1995-11#1)(1995-5#1)(1997-1#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2011-2#2)
reoriented##2##1##(1995-5#1)(2008-6#1)
reorienting the##2##2##(2007-10#1)(2007-11#1)
reorients##3##1##(1991-5#2)(1994-5#1)
reovirus in##2##2##(1997-6#1)(2008-10#1)
reovirus##10##1##(1997-4#1)(1997-6#4)(2007-6#2)(2008-10#3)
reoviruses##2##1##(2007-6#1)(2008-10#1)
reoxidation of the##3##3##(1990-5#1)(1997-4#1)(2008-10#1)
reoxidation of##5##2##(1990-5#2)(1995-2#1)(1997-4#1)(2008-10#1)
reoxidation##8##1##(1990-5#2)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#3)
reoxidized##2##1##(1997-4#1)(2008-10#1)
reoxygenation##6##1##(1990-7#2)(1996-9#2)(2008-11#2)
rep gene mutants##2##3##(2008-10#2)
rep gene##6##2##(2008-10#6)
rep##10##1##(2008-10#8)(2008-8#2)
rep-PCR and##2##2##(2008-10#2)
rep-PCR data##2##2##(2008-10#2)
rep-PCR fingerprints of##2##3##(2008-10#2)
rep-PCR fingerprints##6##2##(2008-10#6)
rep-PCR##25##1##(2008-10#25)
repK mRNA##2##2##(1997-6#2)
repK##4##1##(1997-6#4)
repaglinide##2##1##(2010-4#2)
repair (EVAR)##2##2##(2010-12#1)(2012-2#1)
repair -##2##2##(2007-8#1)(2012-12#1)
repair activity##3##2##(1992-3#1)(1993-11#1)(2008-8#1)
repair after##2##2##(1997-4#1)(2008-11#1)
repair and V(D)J recombination##4##4##(1996-2#2)(2013-1#2)
repair and recombination##2##3##(2008-7#1)(2011-2#1)
repair and regeneration##2##3##(2008-9#2)
repair and the##2##3##(2008-5#1)(2009-5#1)
repair and##40##2##(1993-8#1)(1994-5#1)(1994-9#1)(1996-2#2)(1997-2#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#7)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#8)
repair appears to##2##3##(2011-2#2)
repair as##2##2##(2008-11#1)(2009-5#1)
repair at##3##2##(2007-8#1)(2008-12#1)(2012-3#1)
repair by##5##2##(1994-8#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
repair capacity##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
repair enzyme##3##2##(1994-5#1)(1995-2#2)
repair enzymes##4##2##(1994-5#2)(1995-5#1)(1997-4#1)
repair foci##2##2##(2011-2#2)
repair following##4##2##(2008-7#1)(2011-2#2)(2013-1#1)
repair for##6##2##(2007-8#1)(2008-10#1)(2009-5#3)(2011-2#1)
repair from##2##2##(2009-5#2)
repair gene##4##2##(1997-9#1)(2010-8#1)(2011-1#2)
repair genes##3##2##(1994-8#1)(2010-6#1)(2011-2#1)
repair has a##2##3##(2009-5#1)(2010-7#1)
repair has##8##2##(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#4)
repair have##2##2##(2010-8#1)(2011-2#1)
repair in an##2##3##(2012-12#1)(2012-2#1)
repair in mammalian cells##3##4##(1995-6#2)(1997-6#1)
repair in the##2##3##(2007-8#1)(2008-10#1)
repair in##23##2##(1990-5#1)(1992-5#2)(1995-6#3)(1997-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#2)(2011-2#1)(2012-12#2)(2012-2#2)
repair is##17##2##(1992-5#1)(1993-2#1)(1993-3#1)(1994-8#1)(1996-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)
repair may##3##2##(1993-8#1)(2008-7#1)(2011-2#1)
repair mechanism##4##2##(2007-12#2)(2008-8#1)(2013-1#1)
repair mechanisms##2##2##(1994-6#1)(2011-1#1)
repair of a##4##3##(1990-6#1)(1996-6#1)(2009-3#1)(2011-2#1)
repair of abdominal##3##3##(2008-3#1)(2010-12#2)
repair of aortic arch##2##4##(2008-8#1)(2011-2#1)
repair of atrial##2##3##(2007-9#1)(2008-11#1)
repair of bladder exstrophy##2##4##(2008-10#2)
repair of coarctation of the aorta##2##6##(2007-8#1)(2012-1#1)
repair of congenital##2##3##(2007-8#1)(2008-9#1)
repair of distal##3##3##(1993-1#1)(2007-8#1)(2012-3#1)
repair of m7Gua##2##3##(1994-5#2)
repair of proximal hypospadias##2##4##(2008-10#1)(2009-5#1)
repair of proximal##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
repair of the##4##3##(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
repair of type A##2##4##(2007-8#1)(2013-1#1)
repair of type##3##3##(2007-8#1)(2008-8#1)(2013-1#1)
repair of ventral##2##3##(2009-7#1)(2011-2#1)
repair of##76##2##(1990-6#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-5#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-6#1)(2006-12#2)(2007-11#2)(2007-8#7)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-3#2)(2009-5#2)(2009-7#1)(2010-12#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#10)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
repair on##2##2##(1992-3#1)(2012-2#1)
repair or##6##2##(2008-11#1)(2008-9#2)(2009-9#1)(2011-2#2)
repair pathway##2##2##(1995-9#1)(2012-12#1)
repair pathways##3##2##(2008-11#2)(2008-7#1)
repair procedures##2##2##(2007-8#1)(2011-2#1)
repair processes of##2##3##(2007-8#2)
repair processes##5##2##(1997-4#1)(2007-8#2)(2008-11#1)(2010-10#1)
repair protein##4##2##(1993-12#1)(1994-8#1)(1995-5#1)(2013-1#1)
repair proteins##2##2##(2013-1#2)
repair rates##4##2##(1994-5#1)(2008-11#3)
repair remains##2##2##(2008-5#1)(2009-5#1)
repair requests##2##2##(2008-9#2)
repair response##2##2##(1993-3#1)(2012-12#1)
repair sequences##2##2##(2008-9#2)
repair that##2##2##(2008-11#1)(2008-12#1)
repair the damage##2##3##(2008-5#1)(2008-7#1)
repair the##7##2##(1992-9#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2013-8#1)
repair through##2##2##(2008-11#1)(2008-9#1)
repair to##5##2##(2007-12#1)(2008-11#2)(2011-1#1)(2011-2#1)
repair using a##4##3##(1996-9#1)(2007-8#1)(2010-8#1)(2012-12#1)
repair using mesh##2##3##(2007-10#1)(2011-2#1)
repair using##11##2##(1996-9#1)(2007-10#1)(2007-8#6)(2010-8#1)(2011-2#1)(2012-12#1)
repair was##3##2##(1993-2#1)(1997-6#1)(2011-2#1)
repair when##2##2##(2009-3#1)(2009-4#1)
repair with##10##2##(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-8#2)(2011-2#1)
repair##533##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-5#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#4)(1993-8#3)(1993-9#2)(1994-3#1)(1994-5#9)(1994-6#1)(1994-8#7)(1994-9#4)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#3)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-9#5)(1997-2#5)(1997-4#4)(1997-6#2)(1997-7#1)(1997-9#1)(2006-12#3)(2007-10#2)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#36)(2007-9#2)(2008-1#4)(2008-10#30)(2008-11#33)(2008-12#6)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#32)(2008-8#15)(2008-9#21)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#7)(2009-4#3)(2009-5#19)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#13)(2011-1#8)(2011-2#66)(2011-3#1)(2012-1#4)(2012-12#14)(2012-2#12)(2012-3#4)(2013-1#32)(2013-7#1)(2013-8#6)
repair)##2##1##(2007-8#1)(2008-7#1)
repair]##2##1##(2008-10#1)(2011-3#1)
repaired by MAS were##2##4##(1996-2#2)
repaired by##7##2##(1996-2#2)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)
repaired in##2##2##(2011-2#2)
repaired the##2##2##(2007-12#1)(2012-1#1)
repaired with a single patch##2##5##(2007-8#2)
repaired with a##4##3##(2007-8#2)(2008-12#1)(2011-2#1)
repaired with##11##2##(1991-2#1)(1993-3#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
repaired##34##1##(1991-2#1)(1993-3#1)(1996-2#3)(1997-6#1)(2007-12#1)(2007-8#5)(2008-10#1)(2008-11#3)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)
repairing the##2##2##(1991-9#1)(2011-2#1)
repairing##11##1##(1991-9#1)(2008-5#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
repairs in##2##2##(2008-10#1)(2008-9#1)
repairs##15##1##(1993-1#1)(2008-10#3)(2008-9#2)(2009-5#4)(2010-6#1)(2011-2#4)
repanda##4##1##(2008-10#4)
reparative process##2##2##(2006-12#1)(2013-1#1)
reparative##10##1##(1992-6#2)(2006-12#5)(2009-9#1)(2012-12#1)(2013-1#1)
repayment##4##1##(1992-5#2)(2008-11#2)
repealed##2##1##(1996-5#2)
repeat DNA##2##2##(2008-5#1)(2008-8#1)
repeat amplification##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)
repeat analysis of pharmacokinetically anomalous samples##2##6##(2010-11#2)
repeat analysis##4##2##(2010-11#4)
repeat and a##2##3##(2008-11#1)(2008-6#1)
repeat and##8##2##(1990-12#1)(1992-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-1#1)
repeat array##2##2##(1992-11#1)(1997-6#1)
repeat domain##5##2##(1993-12#1)(1996-2#1)(1997-7#1)(2008-7#1)(2008-8#1)
repeat in##5##2##(2008-12#1)(2008-6#2)(2008-7#1)(2009-5#1)
repeat length##2##2##(1997-3#1)(2012-2#1)
repeat median sternotomy##2##3##(2007-8#2)
repeat of the##2##3##(1992-3#1)(2013-8#1)
repeat of##9##2##(1992-3#1)(1995-8#1)(1996-10#1)(2008-10#3)(2008-7#1)(2012-2#1)(2013-8#1)
repeat polymorphism in##2##3##(1997-5#1)(2008-9#1)
repeat polymorphism##3##2##(1997-5#2)(2008-9#1)
repeat prescribing and##2##3##(2008-11#2)
repeat prescribing has not been##2##5##(2008-11#2)
repeat prescribing##5##2##(2008-11#5)
repeat prescription##3##2##(1996-9#1)(2008-11#2)
repeat prescriptions##4##2##(1995-11#1)(2008-11#3)
repeat probe##2##2##(1993-9#1)(1997-7#1)
repeat protein##2##2##(2008-9#1)(2009-8#1)
repeat purchase##2##2##(1993-12#2)
repeat region of the##2##4##(1990-12#1)(1991-7#1)
repeat region of##3##3##(1990-12#1)(1991-7#1)(1997-7#1)
repeat region##9##2##(1990-12#1)(1991-7#1)(1991-8#1)(1997-7#1)(2008-10#3)(2008-6#1)(2010-8#1)
repeat regions##3##2##(1991-8#2)(2008-7#1)
repeat sequence##11##2##(1993-11#1)(1993-2#1)(1994-8#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
repeat sequences##8##2##(1991-2#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-8#3)(2009-10#1)
repeat smear##2##2##(1992-8#2)
repeat study samples##2##3##(2010-11#2)
repeat study##3##2##(2010-11#3)
repeat testing##3##2##(1994-6#2)(2011-2#1)
repeat to consultation ratios##2##4##(2008-11#2)
repeat to consultation##3##3##(2008-11#3)
repeat to##5##2##(1992-6#2)(2008-11#3)
repeat unit##4##2##(1995-6#1)(2008-10#3)
repeat units in##2##3##(1997-6#1)(2008-5#1)
repeat units##9##2##(1997-6#2)(1997-7#2)(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#1)
repeat##264##1##(1990-12#3)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#4)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#4)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#7)(1997-6#4)(1997-7#9)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#3)(2008-10#33)(2008-11#18)(2008-12#13)(2008-2#1)(2008-4#2)(2008-5#8)(2008-6#9)(2008-7#13)(2008-8#10)(2008-9#6)(2009-10#1)(2009-5#5)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#11)(2010-12#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
repeat)##2##1##(2008-4#1)(2008-7#1)
repeat-containing##2##1##(1992-11#1)(2013-8#1)
repeatabilities##3##1##(2008-10#2)(2008-3#1)
repeatability (R##2##2##(2008-10#2)
repeatability (RSD)##2##2##(2008-10#1)(2012-1#1)
repeatability and recovery##2##3##(2008-10#2)
repeatability and reproducibility of##3##4##(2008-10#1)(2008-5#2)
repeatability and reproducibility##4##3##(2008-10#2)(2008-5#2)
repeatability and##24##2##(2007-11#1)(2008-1#1)(2008-10#17)(2008-5#2)(2009-11#1)(2009-4#1)(2012-12#1)
repeatability at the##3##3##(2008-10#3)
repeatability for##5##2##(2008-10#4)(2008-3#1)
repeatability is##3##2##(2008-10#3)
repeatability of 0##3##3##(2008-10#1)(2008-3#2)
repeatability of determination (R##2##4##(2008-10#2)
repeatability of the measurements##2##4##(2008-10#1)(2008-3#1)
repeatability of the##22##3##(2007-11#1)(2008-10#19)(2008-3#2)
repeatability of##46##2##(1996-3#1)(2007-11#1)(2008-10#31)(2008-3#7)(2008-5#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
repeatability was 0##2##3##(2008-10#2)
repeatability was##6##2##(1994-9#1)(2008-10#5)
repeatability were##2##2##(2008-10#2)
repeatability with##2##2##(2007-11#1)(2008-10#1)
repeatability##140##1##(1994-9#1)(1996-3#1)(2007-11#3)(2008-1#2)(2008-10#111)(2008-3#8)(2008-5#4)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
repeatable (R##2##2##(2008-10#2)
repeatable and reproducible##5##3##(2008-10#2)(2008-5#2)(2012-2#1)
repeatable and##7##2##(2008-10#2)(2008-5#2)(2008-7#1)(2012-2#1)(2013-8#1)
repeatable##24##1##(1995-12#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-12#2)(2008-5#2)(2008-7#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
repeated AMPH##2##2##(2013-8#2)
repeated DNA##2##2##(2008-10#1)(2008-8#1)
repeated administration of##3##3##(1995-12#1)(1995-5#1)(1996-12#1)
repeated administration##5##2##(1995-12#2)(1995-5#1)(1996-12#1)(2008-11#1)
repeated after##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
repeated amphetamine##2##2##(1993-6#1)(2008-4#1)
repeated analysis##2##2##(2008-10#2)
repeated and prolonged##2##3##(2008-10#1)(2010-8#1)
repeated and##3##2##(2008-10#1)(2008-7#1)(2010-8#1)
repeated application of##4##3##(2007-12#2)(2008-5#2)
repeated applications##2##2##(1990-7#1)(2008-8#1)
repeated as##3##2##(1990-6#1)(1991-12#1)(2006-10#1)
repeated aspirating/dispensing cycles##2##3##(2008-10#2)
repeated at##4##2##(1991-11#1)(1992-3#1)(2008-10#1)(2013-1#1)
repeated attacks of##3##3##(1995-5#1)(2009-7#2)
repeated attacks##4##2##(1995-5#1)(2009-7#3)
repeated batch cultures##3##3##(2008-11#2)(2008-6#1)
repeated batch##10##2##(1994-5#2)(2008-11#3)(2008-6#2)(2008-7#2)(2013-1#1)
repeated batches##2##2##(1994-5#1)(2011-1#1)
repeated blood transfusions##2##3##(2008-1#1)(2013-8#1)
repeated blood##4##2##(1993-10#1)(2008-1#1)(2011-2#1)(2013-8#1)
repeated cocaine administration##2##3##(2011-2#2)
repeated cycles of##2##3##(1991-6#1)(2008-10#1)
repeated cycles##3##2##(1991-6#1)(2008-10#1)(2008-7#1)
repeated dose oral##2##3##(2013-1#2)
repeated dose##3##2##(2008-5#1)(2013-1#2)
repeated episodes of##3##3##(2007-2#1)(2007-7#1)(2007-8#1)
repeated every 21 days##2##4##(1991-4#1)(2008-10#1)
repeated every 3 weeks##3##4##(2007-10#1)(2008-10#1)(2008-7#1)
repeated every##9##2##(1990-2#1)(1991-4#1)(1992-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)
repeated exposure to##7##3##(1993-12#3)(2008-7#1)(2012-2#3)
repeated exposure##9##2##(1993-12#3)(2008-10#1)(2008-7#1)(2012-2#4)
repeated exposures##2##2##(2008-10#2)
repeated fasting/refeeding##3##2##(2012-3#3)
repeated gentle##2##2##(1992-7#2)
repeated haemorrhage##2##2##(1997-6#1)(2008-7#1)
repeated in reverse order##2##4##(1993-2#1)(2008-10#1)
repeated in##9##2##(1993-2#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-6#1)(2011-1#1)
repeated injection##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
repeated injections of##3##3##(2008-10#2)(2009-3#1)
repeated injections##4##2##(2008-10#2)(2009-3#1)(2013-8#1)
repeated measurement##2##2##(1994-2#1)(2012-2#1)
repeated measurements of##4##3##(1992-9#1)(2008-10#2)(2008-9#1)
repeated measurements on##3##3##(1996-3#2)(2008-3#1)
repeated measurements##13##2##(1990-8#1)(1992-9#2)(1996-3#2)(2008-10#5)(2008-3#1)(2008-9#1)(2013-1#1)
repeated measures ANOVA and##2##4##(2008-5#1)(2009-3#1)
repeated measures ANOVA##4##3##(2008-5#3)(2009-3#1)
repeated measures analysis of variance##2##5##(2010-9#1)(2013-1#1)
repeated measures analysis##3##3##(2008-10#1)(2010-9#1)(2013-1#1)
repeated measures and##3##3##(1997-3#1)(2008-12#1)(2008-9#1)
repeated measures data##2##3##(1994-9#1)(1997-7#1)
repeated measures design##3##3##(1993-3#1)(1996-3#1)(2008-10#1)
repeated measures with##2##3##(2010-10#1)(2013-1#1)
repeated measures##31##2##(1992-6#2)(1992-9#3)(1993-12#1)(1993-3#1)(1994-9#2)(1996-2#1)(1996-3#1)(1997-3#4)(1997-7#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-9#1)(2009-3#1)(2010-10#1)(2010-9#1)(2013-1#3)(2013-8#1)
repeated mechanical##2##2##(2007-12#1)(2008-10#1)
repeated observations##2##2##(1996-3#1)(2009-12#1)
repeated on##5##2##(1990-2#1)(1994-7#1)(1996-3#1)(2008-10#2)
repeated or chronic##2##3##(2010-12#2)
repeated oral administration##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
repeated psychiatric occupational therapy##2##4##(2012-1#2)
repeated sequences##3##2##(1990-11#1)(1996-6#1)(2008-10#1)
repeated short-term##3##2##(1995-2#1)(1997-2#2)
repeated stereotactic##2##2##(2008-7#2)
repeated surgical##4##2##(2006-12#1)(2007-8#1)(2011-1#1)(2012-12#1)
repeated testing##2##2##(1993-6#2)
repeated the##4##2##(1997-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
repeated three times##4##3##(1990-8#1)(1994-2#1)(1997-2#1)(2008-10#1)
repeated treatment with##2##3##(1995-12#2)
repeated treatment##4##2##(1995-12#2)(2008-7#1)(2011-2#1)
repeated treatments##2##2##(2008-10#1)(2012-2#1)
repeated twice##3##2##(1994-9#1)(1996-6#1)(2008-5#1)
repeated until##3##2##(1997-6#1)(2008-1#1)(2008-11#1)
repeated use##3##2##(2008-10#2)(2011-2#1)
repeated##387##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#5)(1992-7#3)(1992-9#5)(1993-10#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#3)(1994-11#1)(1994-2#5)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#4)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#5)(1996-12#1)(1996-2#2)(1996-3#6)(1996-4#3)(1996-6#4)(1996-8#1)(1997-2#4)(1997-3#6)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#7)(2007-8#3)(2008-1#4)(2008-10#55)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#18)(2008-8#7)(2008-9#8)(2009-11#1)(2009-12#2)(2009-3#2)(2009-7#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#8)(2013-1#23)(2013-8#10)
repeated-measures##3##1##(2008-3#1)(2008-5#1)(2012-2#1)
repeated-noun##2##1##(2007-12#2)
repeatedly and##3##2##(1991-3#1)(2008-10#1)(2012-3#1)
repeatedly applied##2##2##(2008-10#1)(2013-1#1)
repeatedly been##4##2##(1993-11#1)(1996-3#1)(2008-7#1)(2011-2#1)
repeatedly by##2##2##(1990-7#1)(1994-8#1)
repeatedly exposed to##6##3##(1992-3#1)(1993-12#4)(1995-5#1)
repeatedly in##3##2##(2008-10#2)(2008-9#1)
repeatedly over time##3##3##(1994-2#1)(2008-9#1)(2010-1#1)
repeatedly over##4##2##(1991-12#1)(1994-2#1)(2008-9#1)(2010-1#1)
repeatedly with##3##2##(1991-6#1)(1994-9#1)(2007-12#1)
repeatedly##75##1##(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-5#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#2)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
repeaters##2##1##(2008-2#1)(2008-3#1)
repeating pattern of##2##3##(1992-9#1)(2008-7#1)
repeating the##5##2##(2008-10#1)(2008-4#2)(2008-9#1)(2012-3#1)
repeating unit of the antigen from Klebsiella type 2##2##9##(1995-11#2)
repeating unit##4##2##(1992-12#1)(1995-11#2)(2009-7#1)
repeating units of##2##3##(1995-11#1)(1995-6#1)
repeating units there was one##2##5##(2008-10#2)
repeating units##8##2##(1992-12#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-6#1)(2008-10#2)
repeating##31##1##(1990-12#1)(1992-12#3)(1992-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-11#4)(1995-2#1)(1995-6#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
repeats and several##2##3##(1993-12#1)(1995-12#1)
repeats and##11##2##(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-7#1)
repeats are##5##2##(1995-3#1)(1996-10#1)(1997-6#1)(2008-7#1)(2010-3#1)
repeats as##2##2##(1997-6#1)(2008-10#1)
repeats in the##4##3##(1995-5#1)(1996-8#1)(1997-5#1)(2011-2#1)
repeats in##10##2##(1990-12#1)(1992-11#1)(1993-8#1)(1995-5#1)(1996-8#1)(1997-5#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
repeats located##2##2##(2008-10#1)(2008-11#1)
repeats of a##4##3##(1990-5#1)(1992-10#1)(1994-12#1)(1997-7#1)
repeats of the##4##3##(1991-7#1)(1991-9#1)(1996-6#1)(2008-10#1)
repeats of##16##2##(1990-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#2)(1994-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-8#1)
repeats that##2##2##(2012-2#1)(2012-3#1)
repeats was##3##2##(1995-8#1)(2008-10#1)(2008-5#1)
repeats were##3##2##(1992-3#1)(1997-5#1)(2008-10#1)
repeats within the##3##3##(1995-6#1)(1997-5#1)(2008-7#1)
repeats within##4##2##(1994-11#1)(1995-6#1)(1997-5#1)(2008-7#1)
repeats##133##1##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-3#2)(1992-6#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#5)(1994-5#2)(1994-8#2)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#6)(1996-10#2)(1996-2#1)(1996-6#2)(1996-8#3)(1997-2#1)(1997-4#1)(1997-5#5)(1997-6#4)(1997-7#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#3)(2010-3#3)(2010-7#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
repeats)##3##1##(1994-3#1)(1997-5#2)
repelled from the##2##3##(2008-10#1)(2008-5#1)
repellency##5##1##(2008-5#1)(2011-2#4)
repellent formulations##2##2##(2008-5#2)
repellent##8##1##(2008-10#3)(2008-5#3)(2009-8#2)
repellents##5##1##(2007-2#1)(2011-2#3)(2013-8#1)
repercussion in##2##2##(1991-11#1)(2011-2#1)
repercussion##6##1##(1991-11#1)(2008-10#2)(2008-11#2)(2011-2#1)
repercussions##6##1##(1991-2#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-7#1)(2011-2#1)
reperfused##6##1##(1991-9#1)(1995-12#1)(1996-9#1)(2008-12#1)(2012-12#1)(2013-7#1)
reperfusion and##3##2##(1996-12#1)(2012-3#1)(2013-1#1)
reperfusion damage##2##2##(1991-9#1)(1994-3#1)
reperfusion for 240 min##2##4##(2010-1#2)
reperfusion for##5##2##(1990-7#1)(1993-3#1)(1995-12#1)(2010-1#2)
reperfusion in##5##2##(1990-3#1)(2007-10#4)
reperfusion injury in##2##3##(1990-3#1)(2013-1#1)
reperfusion injury##17##2##(1990-3#1)(1991-8#1)(1991-9#3)(1992-9#3)(1996-2#1)(2007-10#1)(2007-8#1)(2010-3#1)(2012-2#1)(2013-1#4)
reperfusion of##2##2##(1996-9#2)
reperfusion therapy for##2##3##(1997-8#1)(2008-3#1)
reperfusion therapy##9##2##(1997-8#1)(2008-3#8)
reperfusion##95##1##(1990-3#3)(1990-7#1)(1991-8#1)(1991-9#9)(1992-9#4)(1993-3#1)(1994-3#1)(1995-12#5)(1996-12#3)(1996-2#1)(1996-5#1)(1996-9#8)(1997-6#1)(1997-8#1)(2007-10#9)(2007-8#3)(2008-10#4)(2008-12#1)(2008-3#10)(2008-4#2)(2008-7#1)(2009-12#2)(2010-1#4)(2010-3#3)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
reperfusion)##3##1##(1995-12#1)(2011-2#1)(2012-2#1)
repertoire of B cells##3##4##(2008-11#3)
repertoire of behaviors##2##3##(2008-10#1)(2012-2#1)
repertoire of the##4##3##(1996-12#1)(1997-9#1)(2008-11#1)(2011-2#1)
repertoire of##19##2##(1991-2#1)(1995-3#1)(1996-12#1)(1997-9#1)(2008-1#1)(2008-10#2)(2008-11#6)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
repertoire##31##1##(1990-6#1)(1991-2#1)(1995-3#1)(1996-12#1)(1997-9#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#3)
repertoires of##2##2##(2008-11#2)
repertoires##13##1##(1994-12#2)(2007-12#1)(2008-11#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#2)(2010-3#1)
repetition detection##2##2##(2013-8#2)
repetition effects##2##2##(2012-2#2)
repetition frequencies##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
repetition frequency of##3##3##(2007-12#2)(2008-3#1)
repetition frequency##12##2##(2007-11#2)(2007-12#4)(2008-3#5)(2011-1#1)
repetition of the##2##3##(2008-7#2)
repetition of##9##2##(1996-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-2#2)(2013-1#1)
repetition priming to##2##3##(2010-7#2)
repetition priming##3##2##(2010-7#3)
repetition rate and##5##3##(2007-11#3)(2007-12#1)(2011-1#1)
repetition rate are##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
repetition rate by##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
repetition rate for a##2##4##(2008-3#2)
repetition rate in##2##3##(2007-12#1)(2008-3#1)
repetition rate is##5##3##(2007-12#4)(2008-2#1)
repetition rate of the##4##4##(2007-11#1)(2008-3#3)
repetition rate of##36##3##(2007-11#10)(2007-12#11)(2008-2#2)(2008-3#13)
repetition rate with##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
repetition rate##100##2##(2007-11#27)(2007-12#38)(2008-2#10)(2008-3#23)(2010-1#1)(2011-1#1)
repetition rates and##3##3##(2007-12#2)(2008-2#1)
repetition rates are##2##3##(2007-11#1)(2007-12#1)
repetition rates##15##2##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#5)
repetition##159##1##(1996-4#2)(2007-11#34)(2007-12#48)(2008-10#3)(2008-2#14)(2008-3#37)(2008-4#1)(2008-7#2)(2009-11#2)(2010-1#1)(2010-4#1)(2010-7#3)(2011-1#3)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#3)
repetition-rate##8##1##(2007-11#4)(2007-12#3)(2008-3#1)
repetitions of the##2##3##(1994-2#1)(2008-11#1)
repetitions of##4##2##(1992-4#1)(1994-2#1)(2008-11#1)(2010-1#1)
repetitions were completed##2##3##(2010-1#2)
repetitions were##3##2##(2008-10#1)(2010-1#2)
repetitions##13##1##(1992-4#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-1#3)(2010-7#1)(2011-2#1)(2013-1#1)
repetitive DNA sequences##6##3##(1990-5#1)(1997-4#1)(2008-10#3)(2008-9#1)
repetitive DNA##17##2##(1990-5#1)(1991-9#1)(1993-11#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)
repetitive SIB##2##2##(2008-11#2)
repetitive and##4##2##(2008-10#4)
repetitive applications of Pseudomonas putida 06909-rif/nal##2##6##(2008-10#2)
repetitive determinations of##2##3##(2008-10#2)
repetitive element##4##2##(1991-2#1)(1995-8#1)(2008-10#2)
repetitive element-based polymerase chain reaction (rep-PCR)##2##6##(2008-10#2)
repetitive elements in##2##3##(2008-7#1)(2010-3#1)
repetitive elements##7##2##(1991-6#1)(1991-9#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
repetitive extragenic palindromic polymerase chain reaction##2##6##(2008-10#2)
repetitive extragenic palindromic##5##3##(1990-11#1)(2008-10#4)
repetitive hand use and##2##4##(2008-9#2)
repetitive hand use##5##3##(2008-9#5)
repetitive injections of##2##3##(2008-10#2)
repetitive intrathecal##2##2##(2010-12#2)
repetitive measurements##2##2##(2008-10#1)(2008-2#1)
repetitive peptide with a consensus sequence of##2##7##(1990-8#1)(1991-12#1)
repetitive peptide##3##2##(1990-8#1)(1991-12#1)(1993-8#1)
repetitive pulses (+50 mV/20##2##4##(2008-8#2)
repetitive regions##2##2##(1995-8#1)(2008-10#1)
repetitive sequence##2##2##(2008-5#1)(2013-1#1)
repetitive sequence-based polymerase chain reaction (rep-PCR)##2##6##(2008-10#2)
repetitive sequence-based polymerase chain reaction##7##5##(2008-10#7)
repetitive sequences##13##2##(1991-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-5#1)(2009-10#1)(2010-3#2)(2010-8#1)(2012-2#1)
repetitive stimulation##2##2##(1990-5#1)(2012-3#1)
repetitive tasks##2##2##(1991-6#1)(1996-3#1)
repetitive transcranial magnetic stimulation (rTMS) to##2##6##(2010-5#1)(2011-2#1)
repetitive transcranial magnetic stimulation (rTMS)##3##5##(2010-5#1)(2010-7#1)(2011-2#1)
repetitive transcranial magnetic stimulation##10##4##(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)
repetitive##176##1##(1990-11#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#2)(1992-11#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#60)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-3#4)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)
repetitive-sequence-based##2##1##(2008-10#2)
repetitively##13##1##(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2013-1#1)
repigmentation##5##1##(2007-7#5)
replace Ca2+##3##2##(1990-5#1)(1995-11#2)
replace a##4##2##(1991-9#1)(2008-12#1)(2009-10#1)(2009-5#1)
replace and##3##2##(2008-8#1)(2010-3#2)
replace conventional##4##2##(1991-4#1)(1992-12#1)(2007-12#1)(2008-7#1)
replace or##2##2##(1990-11#1)(2010-7#1)
replace the &quot##2##3##(2010-8#1)(2012-1#1)
replace the##29##2##(1990-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#2)(2009-5#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
replace##108##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-6#1)(1996-12#2)(1996-2#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
replaceable##2##1##(2008-10#1)(2008-11#1)
replaced at##2##2##(1997-7#1)(2008-10#1)
replaced by Ala##3##3##(1992-6#1)(1994-5#2)
replaced by a single##3##4##(1994-5#1)(2008-10#2)
replaced by a##20##3##(1990-12#1)(1991-2#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2009-8#1)(2010-5#1)
replaced by an##4##3##(1991-7#1)(1996-11#1)(2008-3#1)(2009-1#1)
replaced by the##12##3##(1990-2#2)(1990-5#1)(1993-11#1)(1995-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
replaced by##92##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-5#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-2#2)(1997-2#2)(1997-3#2)(1997-6#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
replaced the##11##2##(1991-10#1)(1995-12#1)(1995-6#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)
replaced with a##6##3##(1991-3#1)(2008-10#1)(2008-3#2)(2009-5#1)(2011-1#1)
replaced with glycine##2##3##(1994-11#1)(1994-5#1)
replaced with one##2##3##(1993-2#1)(1993-8#1)
replaced with the##4##3##(1991-12#1)(1995-5#1)(2008-12#1)(2010-7#1)
replaced with valine##3##3##(1995-2#1)(1996-2#2)
replaced with##47##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#3)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
replaced##195##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-6#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#5)(1995-8#2)(1996-1#1)(1996-11#3)(1996-2#6)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#21)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#9)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
replacement and##9##2##(1993-9#4)(1996-1#1)(2007-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
replacement arthroplasty##2##2##(2008-11#1)(2010-4#1)
replacement at##3##2##(1990-11#1)(2008-11#1)(2008-9#1)
replacement before##2##2##(2008-1#1)(2011-2#1)
replacement by##5##2##(1992-6#1)(1992-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
replacement cassette##2##2##(1996-6#2)
replacement costs##2##2##(1992-3#2)
replacement followed by##2##3##(1992-9#1)(2007-8#1)
replacement for the##5##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
replacement for##17##2##(1992-3#1)(1996-9#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
replacement in a##3##3##(2007-8#2)(2012-12#1)
replacement in the##3##3##(1997-8#2)(2012-12#1)
replacement in##21##2##(1990-11#1)(1996-11#1)(1997-8#2)(2007-10#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-6#2)(2011-2#3)(2012-12#5)(2012-2#1)
replacement is a##2##3##(1990-8#1)(2010-10#1)
replacement is##7##2##(1990-8#1)(1996-6#1)(2009-4#1)(2009-5#1)(2010-10#1)(2013-1#1)(2013-8#1)
replacement materials##3##2##(2009-9#2)(2011-2#1)
replacement method##3##2##(1997-4#1)(2008-8#1)(2008-9#1)
replacement methods##3##2##(1992-8#1)(1995-3#1)(2008-8#1)
replacement of a##2##3##(2008-3#1)(2008-7#1)
replacement of glycine##2##3##(2008-10#2)
replacement of histone##2##3##(1994-9#1)(2008-7#1)
replacement of lost##2##3##(2008-7#1)(2011-2#1)
replacement of normal##2##3##(2008-8#1)(2013-1#1)
replacement of one##2##3##(1992-3#1)(2008-10#1)
replacement of the ascending aorta##4##5##(2007-8#4)
replacement of the maxillary central incisors##2##6##(2009-8#2)
replacement of the other##2##4##(1991-9#1)(2008-6#1)
replacement of the##28##3##(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#6)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-8#2)(2012-2#1)
replacement of##91##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#3)(1992-12#1)(1992-3#3)(1992-6#4)(1992-8#3)(1993-1#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#7)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#3)(2013-8#1)
replacement on##4##2##(1991-8#1)(2007-11#1)(2007-8#1)(2008-11#1)
replacement or repair##2##3##(2007-8#2)
replacement or##3##2##(2007-8#2)(2010-3#1)
replacement series##2##2##(2008-10#1)(2008-8#1)
replacement strategies##2##2##(2008-11#1)(2009-9#1)
replacement strategy##3##2##(1992-12#1)(2009-9#1)(2012-12#1)
replacement surgery##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
replacement therapies##4##2##(2006-10#1)(2010-8#1)(2012-12#1)(2012-2#1)
replacement therapy (HRT)##5##3##(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
replacement therapy and##2##3##(1991-3#1)(2010-6#1)
replacement therapy for##3##3##(1993-11#1)(1997-1#1)(2010-3#1)
replacement therapy in the##3##4##(1993-11#1)(2008-3#2)
replacement therapy in##13##3##(1991-6#1)(1993-11#1)(1993-2#1)(1996-11#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-8#1)(2012-3#2)
replacement therapy is##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
replacement therapy to##3##3##(1996-6#1)(2008-11#1)(2008-6#1)
replacement therapy with imiglucerase##2##4##(2008-10#2)
replacement therapy with##5##3##(2007-7#1)(2008-10#3)(2013-1#1)
replacement therapy##88##2##(1991-3#2)(1991-6#1)(1992-2#1)(1993-11#3)(1993-2#1)(1994-5#1)(1994-9#2)(1996-11#3)(1996-6#1)(1997-1#2)(1997-5#2)(1997-8#2)(2006-10#2)(2007-7#4)(2008-1#3)(2008-10#4)(2008-11#6)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#2)
replacement using the##3##3##(1992-4#1)(1993-8#1)(2011-2#1)
replacement using##7##2##(1992-4#1)(1993-8#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)
replacement vector##3##2##(2008-8#3)
replacement was##3##2##(1990-11#1)(1994-2#1)(2006-10#1)
replacement we##2##2##(1990-8#1)(2011-2#1)
replacement were##3##2##(1994-3#1)(2007-8#1)(2011-2#1)
replacement will become##2##3##(1997-8#1)(2009-5#1)
replacement with a##5##3##(1991-10#1)(2007-8#3)(2012-2#1)
replacement with the##3##3##(2007-8#2)(2009-3#1)
replacement with##17##2##(1991-10#1)(1993-11#1)(1995-3#1)(2007-11#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-9#1)(2012-2#1)
replacement##491##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#5)(1991-10#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#2)(1992-6#5)(1992-8#7)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-8#4)(1993-9#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#6)(1996-1#4)(1996-11#5)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#4)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-7#1)(1997-8#7)(2006-10#6)(2006-12#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-7#4)(2007-8#41)(2008-1#5)(2008-10#26)(2008-11#21)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#15)(2008-5#6)(2008-6#8)(2008-7#15)(2008-8#16)(2008-9#10)(2009-10#2)(2009-12#2)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#7)(2010-10#10)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#28)(2011-3#1)(2012-1#1)(2012-12#30)(2012-2#14)(2012-3#10)(2012-6#1)(2013-1#15)(2013-7#1)(2013-8#6)
replacement)##3##1##(1993-8#1)(2007-11#2)
replacements and##7##2##(1991-5#1)(1992-3#1)(1997-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-8#1)
replacements are##2##2##(1991-6#1)(2009-7#1)
replacements at##3##2##(1990-11#1)(1992-3#1)(1995-5#1)
replacements for##5##2##(1992-3#1)(1993-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
replacements in##4##2##(1995-5#1)(1997-9#1)(2008-10#1)(2008-11#1)
replacements##39##1##(1990-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-3#7)(1993-11#1)(1995-5#3)(1996-1#1)(1996-12#1)(1997-9#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2009-7#3)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
replaces a##2##2##(1993-12#1)(2008-11#1)
replaces the##10##2##(1992-5#1)(1994-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2012-2#2)(2012-3#1)
replaces##19##1##(1992-5#1)(1993-12#1)(1994-12#1)(1995-11#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
replacing a##2##2##(2008-11#2)
replacing an##2##2##(1991-1#1)(2010-3#1)
replacing oxygen##2##2##(2008-10#1)(2009-2#1)
replacing the##14##2##(1991-5#1)(1991-8#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-10#1)(2013-1#1)
replacing their##2##2##(2008-11#1)(2008-4#1)
replacing##59##1##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
replant disease and##2##3##(2008-10#2)
replant disease##11##2##(2008-10#11)
replant orchard soils##3##3##(2008-10#3)
replant orchard##4##2##(2008-10#4)
replant soils with##2##3##(2008-10#2)
replant soils##7##2##(2008-10#7)
replant##23##1##(2008-10#23)
replantation of##2##2##(2008-9#2)
replantation##9##1##(1993-2#1)(2008-9#8)
replanted##6##1##(2008-10#3)(2008-9#3)
replated##3##1##(1997-7#1)(2008-11#2)
replay##6##1##(1994-3#1)(2007-12#1)(2008-2#1)(2013-1#2)(2013-8#1)
replayed##2##1##(2008-2#2)
replenished by##2##2##(2007-12#1)(2008-7#1)
replenished##6##1##(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
replenishment of##3##2##(1997-7#1)(2007-12#2)
replenishment##6##1##(1990-5#1)(1993-3#1)(1997-7#1)(2007-12#2)(2010-7#1)
repletion##6##1##(1992-9#1)(1993-12#1)(2007-7#1)(2008-1#1)(2012-2#1)(2013-1#1)
replica exchange##4##2##(2008-12#3)(2012-2#1)
replica gratings##2##2##(2008-3#2)
replica of the input##2##4##(2007-12#1)(2008-3#1)
replica of the##4##3##(2007-12#1)(2008-3#3)
replica##18##1##(2007-12#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#3)(2008-9#1)(2010-5#1)(2012-2#1)
replicability of##2##2##(2008-11#2)
replicas of the##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
replicas of##7##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
replicas##14##1##(1990-12#1)(1992-12#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#2)(2011-2#1)
replicase and movement protein##2##4##(2008-9#2)
replicase gene##3##2##(2008-10#2)(2008-9#1)
replicase##11##1##(2008-10#6)(2008-9#5)
replicase-based DNA vaccine##3##3##(2013-1#3)
replicase-mediated resistance##2##2##(2008-10#2)
replicase-mediated##3##1##(2008-10#3)
replicate analyses of##6##3##(2008-10#6)
replicate analyses##8##2##(2008-10#7)(2008-5#1)
replicate analysis (n=5) of##2##4##(2008-10#2)
replicate analysis of##3##3##(2008-10#3)
replicate analysis##9##2##(2008-10#9)
replicate and##4##2##(1995-2#2)(2008-9#1)(2010-6#1)
replicate assay plates##2##3##(2008-10#2)
replicate determination of##4##3##(2008-10#4)
replicate determinations at the 0##2##5##(2008-10#2)
replicate determinations at the##4##4##(2008-10#4)
replicate determinations at##7##3##(2008-10#7)
replicate determinations of 0##2##4##(2008-10#2)
replicate determinations of 1##3##4##(2008-10#3)
replicate determinations of 2##2##4##(2008-10#2)
replicate determinations of 5##2##4##(2008-10#2)
replicate determinations of##21##3##(2008-10#21)
replicate determinations##32##2##(2008-10#32)
replicate in the##2##3##(1997-3#1)(2008-5#1)
replicate in##8##2##(1990-5#1)(1995-2#1)(1997-3#2)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
replicate injections of##4##3##(2008-10#4)
replicate injections##7##2##(2008-10#7)
replicate lines of##2##3##(2008-8#1)(2008-9#1)
replicate lines##3##2##(2008-8#2)(2008-9#1)
replicate measurements is##2##3##(2008-10#2)
replicate measurements of##5##3##(2008-10#5)
replicate measurements##10##2##(2007-12#1)(2008-10#9)
replicate plots##2##2##(2008-10#1)(2013-7#1)
replicate sample##2##2##(2008-10#2)
replicate samples##3##2##(2008-10#2)(2008-5#1)
replicate the##5##2##(1992-11#1)(1995-1#1)(2008-3#1)(2008-5#1)(2010-12#1)
replicate##131##1##(1990-5#1)(1992-11#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-2#3)(1995-5#1)(1997-3#2)(2007-10#1)(2007-12#1)(2008-10#86)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#6)(2008-8#6)(2008-9#4)(2009-6#1)(2010-12#1)(2010-2#2)(2010-6#1)(2012-1#1)(2013-7#2)(2013-8#1)
replicated DNA can be##2##4##(2008-9#1)(2012-2#1)
replicated DNA##3##2##(2008-9#1)(2012-2#2)
replicated and##2##2##(1997-3#1)(2008-7#1)
replicated field##6##2##(2008-10#4)(2008-4#1)(2008-8#1)
replicated in##19##2##(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-10#1)
replicated well##2##2##(1994-8#1)(2007-6#1)
replicated##67##1##(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-1#1)(1997-3#2)(2007-12#3)(2007-6#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
replicates and extends previous##2##4##(1996-2#1)(2008-12#1)
replicates and##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
replicates for##2##2##(2008-10#1)(2012-3#1)
replicates in##4##2##(1995-2#1)(1996-12#1)(2008-9#2)
replicates of##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
replicates per##2##2##(2008-12#1)(2010-2#1)
replicates the phase##2##3##(2008-11#2)
replicates the##4##2##(1994-2#1)(2008-11#2)(2008-3#1)
replicates##50##1##(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-2#1)(2012-3#2)
replicates)##2##1##(2008-10#2)
replicating and##2##2##(2008-3#1)(2008-8#1)
replicating the##2##2##(2008-11#1)(2011-2#1)
replicating##20##1##(1990-3#1)(1994-8#1)(1995-2#3)(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#1)(2011-3#2)(2013-8#1)
replication activity##2##2##(1991-12#1)(2008-9#1)
replication after##4##2##(1990-5#1)(1995-12#1)(2006-10#1)(2010-11#1)
replication and packaging##2##3##(2008-4#1)(2008-9#1)
replication and repair and##2##4##(1997-2#1)(2009-2#1)
replication and repair##3##3##(1993-3#1)(1997-2#1)(2009-2#1)
replication and spread##2##3##(1992-8#1)(2013-8#1)
replication and transcription##4##3##(1994-8#1)(2008-11#1)(2008-7#1)(2010-2#1)
replication and##52##2##(1990-5#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-2#2)(1997-2#2)(1997-3#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#5)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
replication as##2##2##(1994-6#1)(2010-3#1)
replication at the##3##3##(1997-8#1)(2008-2#1)(2008-9#1)
replication at##6##2##(1990-11#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-8#1)
replication by##9##2##(1990-5#2)(1991-12#1)(1995-2#2)(1997-4#1)(2008-10#1)(2013-1#2)
replication compared with##2##3##(2008-5#1)(2013-1#1)
replication complex##4##2##(1994-11#2)(2008-11#2)
replication cycle##7##2##(2008-10#2)(2008-4#1)(2011-3#4)
replication deficient##2##2##(1994-5#1)(2008-11#1)
replication efficiency##3##2##(2011-2#1)(2013-1#2)
replication fork and##2##3##(1991-12#1)(2012-2#1)
replication fork progression##3##3##(2012-3#3)
replication fork##14##2##(1991-12#3)(1992-3#4)(1995-5#1)(2011-2#1)(2012-2#1)(2012-3#4)
replication forks##7##2##(1992-3#1)(2011-2#1)(2012-3#5)
replication from##2##2##(1997-6#2)
replication in Escherichia coli##2##4##(1991-12#1)(1994-11#1)
replication in the##2##3##(1995-5#1)(2007-6#1)
replication in vitro##2##3##(1994-6#1)(1997-3#1)
replication in vivo and in vitro##3##6##(1991-12#1)(1994-12#2)
replication in##19##2##(1990-8#1)(1991-12#2)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1995-5#1)(1997-3#2)(2007-6#1)(2007-8#1)(2008-8#1)(2010-2#1)(2012-2#2)(2013-1#1)
replication is the##2##3##(1997-2#1)(2013-8#1)
replication is##11##2##(1990-5#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2010-2#1)(2013-8#1)
replication occurred##2##2##(2008-10#2)
replication of AZT-resistant strains of HIV-1##2##6##(1994-6#2)
replication of AZT-resistant##3##3##(1994-6#3)
replication of HIV##2##3##(2008-5#1)(2011-3#1)
replication of HIV-1##4##3##(1991-3#1)(2011-2#1)(2011-3#2)
replication of a##2##3##(1991-12#1)(1995-2#1)
replication of both##2##3##(1994-6#1)(2009-6#1)
replication of human immunodeficiency virus##2##5##(1991-9#1)(2010-2#1)
replication of human##3##3##(1991-9#1)(2008-9#1)(2010-2#1)
replication of the virus##2##4##(2008-5#2)
replication of the##8##3##(1990-11#1)(1990-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)(2012-12#1)
replication of##51##2##(1990-11#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1994-11#1)(1994-6#4)(1994-8#2)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#6)(2009-6#1)(2009-7#2)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-3#2)(2013-1#2)
replication or##2##2##(2008-10#1)(2012-3#1)
replication origin region##2##3##(1995-8#2)
replication origin##8##2##(1994-11#1)(1994-12#3)(1994-8#1)(1995-8#2)(2008-10#1)
replication process##3##2##(2008-3#2)(2010-3#1)
replication region##2##2##(1990-11#2)
replication specificity element##2##3##(2008-10#2)
replication specificity##5##2##(2008-10#5)
replication stress##6##2##(2011-2#5)(2012-3#1)
replication to##2##2##(2008-5#1)(2013-1#1)
replication was##9##2##(1997-3#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-5#1)
replication##414##1##(1990-11#7)(1990-5#6)(1990-7#1)(1990-8#1)(1991-12#8)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-11#17)(1994-12#12)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#8)(1994-7#1)(1994-8#10)(1995-12#2)(1995-2#11)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1997-1#1)(1997-2#6)(1997-3#17)(1997-4#2)(1997-6#5)(1997-8#1)(2006-10#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#57)(2008-11#17)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#24)(2009-11#1)(2009-2#7)(2009-3#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#3)(2010-2#8)(2010-3#3)(2011-1#2)(2011-2#15)(2011-3#11)(2012-12#4)(2012-2#13)(2012-3#17)(2013-1#24)(2013-8#4)
replication-associated protein (Rep)##2##3##(2008-10#2)
replication-associated protein##3##2##(2008-10#3)
replication-associated##5##1##(2008-10#3)(2011-2#2)
replication-competent##5##1##(1995-2#1)(2008-11#1)(2008-4#2)(2012-12#1)
replication-defective##6##1##(2008-4#4)(2008-5#1)(2008-9#1)
replication-related##2##1##(1995-6#2)
replications in##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
replications##23##1##(1993-2#1)(1994-12#1)(2008-10#12)(2008-12#8)(2010-4#1)
replicative senescence##4##2##(1992-9#2)(1997-7#1)(2011-2#1)
replicative##18##1##(1991-5#1)(1992-9#2)(1993-3#1)(1994-8#1)(1995-2#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-2#2)(2011-3#3)
replicon##8##1##(1994-12#1)(2008-4#1)(2008-8#1)(2011-2#5)
replicons##8##1##(1994-12#1)(1997-3#1)(2008-4#3)(2011-2#3)
replied to##2##2##(2008-12#1)(2011-2#1)
replied##4##1##(1990-9#1)(1996-9#1)(2008-12#1)(2011-2#1)
replies from##3##2##(1990-9#1)(1996-2#1)(2008-4#1)
replies##5##1##(1990-9#1)(1993-5#2)(1996-2#1)(2008-4#1)
reply to##6##2##(1993-12#1)(1993-3#1)(1993-6#1)(2008-2#2)(2012-3#1)
reply##33##1##(1990-11#2)(1990-12#1)(1990-4#2)(1991-9#3)(1992-11#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1997-8#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2009-9#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
repolarization abnormalities##2##2##(2010-8#2)
repolarization in##2##2##(1992-11#1)(2013-7#1)
repolarization##16##1##(1992-11#1)(1996-2#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-8#4)(2011-1#1)(2012-3#5)(2013-7#1)
repolarizing effect##2##2##(1992-11#2)
repolarizing##3##1##(1992-11#2)(2010-8#1)
report &quot##2##2##(1990-11#1)(2007-4#1)
report 10 patients##2##3##(2008-1#1)(2008-6#1)
report 7##2##2##(1990-3#1)(2013-8#1)
report a 30-year-old##3##3##(2007-10#1)(2012-12#1)(2013-1#1)
report a 50-year-old##2##3##(2008-7#1)(2009-5#1)
report a case in which##5##5##(1990-2#1)(1992-2#1)(2007-7#1)(2012-2#2)
report a case of a 16-year-old##2##6##(2011-1#1)(2012-3#1)
report a case of a patient with##3##7##(2007-8#1)(2012-2#1)(2012-3#1)
report a case of a##47##5##(1991-11#1)(1992-5#1)(1997-6#1)(2006-10#1)(2007-7#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-3#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
report a case of an##8##5##(2007-5#1)(2007-8#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
report a case of congenital##2##5##(2008-12#1)(2010-11#1)
report a case of familial##2##5##(1992-9#1)(2009-12#1)
report a case of primary##5##5##(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
report a case of retroperitoneal##2##5##(1990-6#1)(1994-6#1)
report a case of severe##3##5##(1990-10#1)(1991-11#1)(2013-8#1)
report a case of spontaneous##2##5##(1992-2#1)(2008-7#1)
report a case of successful##2##5##(2012-12#1)(2013-8#1)
report a case of##202##4##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-6#1)(1992-2#3)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1997-6#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#11)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#12)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-8#2)(2011-1#11)(2011-2#11)(2012-12#11)(2012-2#6)(2012-3#8)(2013-1#9)(2013-8#8)
report a case##219##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#3)(1991-6#1)(1992-2#4)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1997-6#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#11)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#13)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#3)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#4)(2010-8#3)(2011-1#12)(2011-2#11)(2012-12#12)(2012-2#8)(2012-3#8)(2013-1#10)(2013-8#8)
report a female patient with##2##5##(2012-12#1)(2013-1#1)
report a female patient##3##4##(2012-12#2)(2013-1#1)
report a method for##2##4##(2007-12#1)(2008-10#1)
report a method##5##3##(1992-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)
report a new case of##2##5##(2007-8#1)(2010-8#1)
report a new case##4##4##(1991-11#1)(2007-8#1)(2009-1#1)(2010-8#1)
report a new##18##3##(1991-11#1)(1994-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-1#1)(2009-9#1)(2010-8#2)(2012-2#1)
report a novel method##5##4##(2007-12#1)(2008-11#1)(2009-7#1)(2010-12#1)(2013-1#1)
report a novel technique##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
report a novel##18##3##(1997-4#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
report a patient who developed##4##5##(2007-7#1)(2008-12#1)(2008-7#1)(2010-12#1)
report a patient who##7##4##(2007-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
report a patient with##10##4##(2008-1#1)(2008-7#3)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
report a patient##19##3##(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
report a rare case of##20##5##(1991-12#1)(1992-12#1)(2007-8#1)(2008-12#4)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-2#1)
report a rare complication##2##4##(2008-7#1)(2012-3#1)
report a rare##25##3##(1991-12#1)(1992-12#1)(2007-8#1)(2008-12#4)(2008-6#1)(2008-7#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-2#1)
report a retrospective study of##2##5##(1993-5#1)(2007-8#1)
report a retrospective##3##3##(1993-5#1)(2007-8#1)(2011-2#1)
report a series of##4##4##(1990-10#1)(1993-5#1)(2008-12#1)(2009-7#1)
report a simple##5##3##(1990-7#1)(2007-11#2)(2008-2#1)(2008-7#1)
report a single##3##3##(2007-10#1)(2009-10#1)(2013-1#1)
report a unique##2##3##(2008-10#1)(2011-1#1)
report a##466##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#4)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-5#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-12#1)(2007-10#6)(2007-11#16)(2007-12#22)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#14)(2007-8#23)(2008-1#7)(2008-10#16)(2008-11#11)(2008-12#21)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#8)(2008-7#29)(2008-8#7)(2008-9#4)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#4)(2010-12#6)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#6)(2010-7#1)(2010-8#6)(2011-1#19)(2011-2#18)(2012-12#23)(2012-2#22)(2012-3#14)(2013-1#30)(2013-2#1)(2013-7#1)(2013-8#14)
report about a##2##3##(1990-3#1)(1994-5#1)
report about##5##2##(1990-3#1)(1994-5#1)(2009-3#1)(2013-1#1)(2013-8#1)
report addresses the##2##3##(2011-2#1)(2012-2#1)
report adds to the##2##4##(2007-12#1)(2009-2#1)
report adverse##2##2##(2011-2#1)(2013-8#1)
report aims to##2##3##(1997-7#1)(2012-12#1)
report allows##2##2##(1992-10#1)(2013-1#1)
report also##3##2##(1995-12#1)(2006-10#1)(2007-12#1)
report an analytical##2##3##(2007-11#1)(2008-10#1)
report an improved##2##3##(2007-11#1)(2008-11#1)
report an unusual case of##12##5##(2006-10#1)(2007-8#1)(2008-10#2)(2010-10#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
report an unusual case##13##4##(2006-10#1)(2007-8#1)(2008-10#2)(2010-10#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
report an unusual##15##3##(2006-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-10#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
report an##56##2##(1990-11#1)(1991-3#1)(1995-2#1)(1996-12#1)(1997-8#1)(2006-10#2)(2007-11#5)(2007-12#4)(2007-7#3)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)
report and discuss##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2012-12#1)
report and literature review##29##4##(2007-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#2)
report and literature review]##2##4##(1993-8#1)(2012-12#1)
report and literature##31##3##(1993-8#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#2)
report and management##2##3##(2008-12#1)(2013-1#1)
report and review of the literature##33##6##(2006-12#1)(2007-12#1)(2007-2#3)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
report and review of the literature]##9##6##(1992-9#1)(1993-6#1)(1993-9#1)(2008-10#5)(2011-2#1)
report and review of the##43##5##(1992-9#1)(1993-6#1)(1993-9#1)(2006-12#1)(2007-12#1)(2007-2#3)(2007-5#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
report and review of##59##4##(1992-9#1)(1993-6#1)(1993-9#1)(2006-12#1)(2007-12#2)(2007-2#3)(2007-5#2)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
report and review##64##3##(1992-9#1)(1993-6#1)(1993-9#1)(2006-12#1)(2007-12#2)(2007-2#3)(2007-5#3)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
report and##124##2##(1992-1#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-6#2)(1993-8#1)(1993-9#1)(1995-2#1)(1996-2#1)(2006-12#1)(2007-10#2)(2007-12#2)(2007-2#5)(2007-5#4)(2007-8#1)(2008-1#5)(2008-10#9)(2008-11#4)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#13)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#3)
report are##5##2##(1991-12#1)(1993-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
report being##3##2##(1997-6#1)(2008-9#2)
report both##2##2##(2007-12#1)(2008-7#1)
report by##6##2##(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(2010-11#1)
report can be##2##3##(1990-10#1)(1994-2#1)
report card on##2##3##(2008-12#1)(2010-12#1)
report card##8##2##(1992-3#1)(1994-2#1)(1997-3#4)(2008-12#1)(2010-12#1)
report cards for##3##3##(1996-3#1)(1997-2#2)
report cards on##2##3##(1997-3#2)
report cards##11##2##(1996-3#4)(1997-2#2)(1997-3#4)(2008-11#1)
report cases of##2##3##(2008-6#1)(2010-4#1)
report confirming##3##2##(2011-2#2)(2013-1#1)
report confirms##2##2##(2007-7#1)(2012-3#1)
report contains##2##2##(1991-2#1)(1993-12#1)
report data on##2##3##(2012-2#1)(2013-1#1)
report data##4##2##(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
report deals with##3##3##(1993-5#1)(2008-11#1)(2008-9#1)
report demonstrates that the##2##4##(1994-3#1)(2013-8#1)
report demonstrates that##5##3##(1994-3#1)(1997-6#1)(2008-10#1)(2009-4#1)(2013-8#1)
report demonstrates the##3##3##(2007-8#1)(2008-1#1)(2012-2#1)
report demonstrates##9##2##(1994-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
report demonstrating##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
report describes a case of##9##5##(1994-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#1)(2009-4#1)(2012-12#1)
report describes a new##2##4##(2007-11#1)(2007-7#1)
report describes a patient##2##4##(2008-7#1)(2011-1#1)
report describes a rare##2##4##(2010-4#1)(2013-1#1)
report describes a##33##3##(1993-12#1)(1994-12#1)(1995-2#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#3)
report describes an##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
report describes the case of a##2##6##(2007-8#1)(2011-2#1)
report describes the##36##3##(1990-2#1)(1991-5#1)(1992-1#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-7#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
report describes##87##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-9#1)(1997-7#2)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
report detailed##2##2##(2008-11#1)(2013-8#1)
report details##2##2##(2010-12#1)(2011-2#1)
report discusses the##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
report discusses##5##2##(1991-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
report early##2##2##(2009-5#1)(2011-1#1)
report emphasizes the importance##2##4##(1992-4#1)(2011-1#1)
report emphasizes the##4##3##(1991-2#1)(1992-4#1)(2011-1#1)(2012-12#1)
report emphasizes##5##2##(1991-2#1)(1992-4#1)(2007-12#1)(2011-1#1)(2012-12#1)
report evaluates##2##2##(2008-11#1)(2008-7#1)
report evidence##3##2##(1991-5#1)(1994-9#1)(2008-5#1)
report examined at least##2##4##(2008-7#2)
report experience##2##2##(1990-11#1)(1996-3#1)
report extended##2##2##(2007-12#1)(2008-3#1)
report findings##2##2##(1995-3#1)(2012-2#1)
report focuses on##3##3##(2006-12#1)(2008-5#1)(2008-7#1)
report focuses##4##2##(1992-11#1)(2006-12#1)(2008-5#1)(2008-7#1)
report for the first time on##2##6##(1996-3#1)(2009-2#1)
report for the first time the successful##2##7##(1995-6#1)(2010-12#1)
report for the first time the##3##6##(1995-6#1)(2008-7#1)(2010-12#1)
report for the first time##8##5##(1992-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-12#1)
report for##12##2##(1992-6#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)
report four cases of##2##4##(2007-7#1)(2008-9#1)
report four##3##2##(2007-7#1)(2008-9#1)(2011-1#1)
report from the National Heart##2##5##(2009-12#2)
report from the National##3##4##(2008-1#1)(2009-12#2)
report from the##13##3##(1993-8#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-12#2)(2011-2#1)(2013-8#1)
report from##23##2##(1992-8#1)(1993-8#1)(1994-3#1)(1996-1#1)(1997-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2009-12#2)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
report further##2##2##(2008-7#1)(2013-1#1)
report gene##3##2##(2008-8#1)(2008-9#2)
report generation##2##2##(2007-11#1)(2011-2#1)
report gives an##2##3##(2008-10#1)(2008-11#1)
report gives##5##2##(2008-10#3)(2008-11#1)(2008-6#1)
report has##3##2##(1992-8#1)(2010-5#1)(2012-3#1)
report having##4##2##(1995-12#2)(1996-6#1)(1997-6#1)
report here a case of a##2##6##(1992-10#1)(2007-8#1)
report here a case of##9##5##(1992-10#1)(2007-7#5)(2007-8#1)(2009-2#1)(2010-1#1)
report here a novel##2##4##(1992-12#1)(2009-9#1)
report here a##17##3##(1992-10#1)(1992-12#1)(1997-7#2)(2007-7#5)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-1#1)
report here on##10##3##(1993-12#1)(1994-12#1)(2008-1#1)(2008-10#2)(2010-6#2)(2011-2#1)(2012-1#1)(2012-3#1)
report here that##32##3##(1990-5#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-8#2)(1995-11#2)(1995-2#2)(1996-2#2)(1997-4#1)(1997-7#2)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
report here the##29##3##(1990-12#1)(1991-2#1)(1992-11#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-5#2)(1997-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#2)(2011-2#1)(2011-8#1)
report here##102##2##(1990-12#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#4)(1995-11#4)(1995-2#3)(1996-2#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#4)(1997-9#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-6#2)(2011-2#4)(2011-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
report herein##12##2##(1991-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
report higher levels of burnout than##2##6##(2010-9#2)
report higher##3##2##(1996-9#1)(2010-9#2)
report highlights the##6##3##(2008-10#3)(2010-5#1)(2012-2#1)(2013-1#1)
report illustrates the##7##3##(1996-1#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
report illustrates##8##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
report in an##2##3##(2007-5#1)(2007-7#1)
report in the literature##2##4##(2007-8#1)(2012-2#1)
report in the##5##3##(2007-10#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
report in this##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
report in##20##2##(1997-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
report includes##2##2##(2008-1#1)(2011-2#1)
report indicates##2##2##(2006-10#1)(2008-12#1)
report is a##5##3##(2007-12#1)(2009-3#1)(2011-2#1)(2013-1#2)
report is of a##2##4##(2008-11#1)(2008-12#1)
report is of##3##3##(2007-7#1)(2008-11#1)(2008-12#1)
report is to describe##3##4##(2008-10#1)(2008-8#1)(2010-9#1)
report is to##13##3##(1992-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
report is##36##2##(1990-11#2)(1992-1#1)(1992-12#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
report less##2##2##(1996-1#1)(2008-5#1)
report low##2##2##(2010-10#1)(2013-8#1)
report more##5##2##(1995-3#1)(2007-12#1)(2008-6#1)(2010-4#1)(2011-2#1)
report new evidence##2##3##(2008-6#1)(2009-9#1)
report observations on the##2##4##(1996-2#1)(2008-11#1)
report observations##3##2##(1996-2#1)(2007-11#1)(2008-11#1)
report of 2##3##3##(1992-5#1)(2006-10#1)(2013-1#1)
report of 25 cases##2##4##(2008-1#1)(2010-11#1)
report of 3##2##3##(2007-5#1)(2011-2#1)
report of a case and review of literature##2##8##(2008-12#1)(2008-7#1)
report of a case and review of the literature##4##9##(2007-2#1)(2007-7#1)(2008-12#1)(2013-1#1)
report of a case and review of##6##7##(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2013-1#1)
report of a case and##7##5##(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-1#1)
report of a case of##3##5##(2008-10#2)(2012-3#1)
report of a case with literature review##2##7##(2007-10#2)
report of a case with review of literature##2##8##(2008-11#1)(2008-12#1)
report of a case with##6##5##(1991-6#1)(1992-5#1)(2007-10#2)(2008-11#1)(2008-12#1)
report of a case##24##4##(1991-12#1)(1991-6#1)(1992-5#1)(1996-9#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#5)(2008-7#1)(2010-3#1)(2011-2#3)(2012-3#2)(2013-1#1)
report of a patient with##2##5##(2007-7#1)(2012-3#1)
report of a patient##4##4##(2007-7#1)(2007-8#1)(2012-12#1)(2012-3#1)
report of a rare##2##4##(1995-11#1)(2013-1#1)
report of a##68##3##(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-9#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#9)(2008-11#5)(2008-12#8)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)
report of an asymptomatic##2##4##(2007-8#1)(2012-12#1)
report of an unusual##2##4##(1993-8#1)(2008-10#1)
report of an##15##3##(1991-9#1)(1992-10#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
report of five cases##2##4##(2008-7#1)(2009-12#1)
report of four cases##4##4##(1990-12#1)(1991-12#1)(2007-2#1)(2011-2#1)
report of four##5##3##(1990-12#1)(1991-12#1)(2007-2#1)(2011-2#2)
report of oligodendroglioma in##2##4##(2011-1#2)
report of such a##2##4##(2008-12#1)(2011-1#1)
report of such##4##3##(2007-10#1)(2007-12#1)(2008-12#1)(2011-1#1)
report of the 2008-09##2##4##(2010-3#2)
report of the##38##3##(1990-7#1)(1993-1#1)(1995-6#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-11#1)(2010-3#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
report of this organism##2##4##(2009-2#1)(2012-12#1)
report of this##6##3##(1990-6#1)(1991-11#1)(1992-3#1)(1996-9#1)(2009-2#1)(2012-12#1)
report of three cases##9##4##(1991-6#1)(2007-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
report of two cases and##3##5##(2008-7#1)(2010-9#1)(2011-2#1)
report of two cases##22##4##(1990-10#1)(1991-6#1)(1992-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
report of two##27##3##(1990-10#1)(1991-6#1)(1992-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
report of water buffalo##2##4##(2008-12#2)
report of##276##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#3)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#3)(1997-2#1)(1997-7#1)(2006-10#3)(2007-10#6)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#8)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#10)(2008-12#13)(2008-2#1)(2008-3#2)(2008-6#4)(2008-7#12)(2008-8#1)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#6)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#13)(2011-3#3)(2012-1#1)(2012-12#11)(2012-2#7)(2012-3#13)(2013-1#23)(2013-7#1)(2013-8#6)
report on a comparative##2##4##(2008-3#1)(2008-9#1)
report on a new##6##4##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
report on a novel##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
report on a patient with##3##5##(2006-12#1)(2009-4#1)(2011-3#1)
report on a patient##5##4##(1997-3#1)(2006-12#1)(2009-4#1)(2011-2#1)(2011-3#1)
report on a pilot##2##4##(1996-2#1)(2008-11#1)
report on a simple##2##4##(1996-5#1)(2008-8#1)
report on a##72##3##(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-3#4)(1997-5#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#12)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
report on an initial genome screen##2##6##(1997-5#2)
report on an##15##3##(1993-12#1)(1993-2#1)(1997-5#3)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#6)
report on our##4##3##(1991-12#1)(1996-8#1)(2007-6#1)(2008-2#1)
report on recent##3##3##(1993-6#1)(2009-7#1)(2010-3#1)
report on the development and testing of a##2##8##(1996-2#1)(2007-11#1)
report on the development and##3##5##(1996-2#1)(2007-11#1)(2012-2#1)
report on the development of##3##5##(2007-11#1)(2008-12#1)(2010-4#1)
report on the development##6##4##(1996-2#1)(2007-11#2)(2008-12#1)(2010-4#1)(2012-2#1)
report on the effects of##2##5##(1992-6#1)(2008-11#1)
report on the fabrication##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
report on the measurement of##2##5##(2008-3#2)
report on the use of##4##5##(1990-5#1)(2008-10#1)(2008-3#2)
report on the##97##3##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#2)(1992-10#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#10)(2007-12#7)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#12)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)
report on their experience##2##4##(1990-5#1)(2006-12#1)
report on their##3##3##(1990-5#1)(1994-3#1)(2006-12#1)
report on three##3##3##(1993-9#1)(2009-7#1)(2011-2#1)
report on two##5##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
report on various##2##3##(2008-3#1)(2011-2#1)
report on##276##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#5)(1997-5#4)(1997-6#1)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#23)(2007-12#18)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#7)(2008-12#2)(2008-2#13)(2008-3#44)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#8)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
report one case of##4##4##(1993-5#1)(2008-5#1)(2009-5#1)(2012-12#1)
report one##8##2##(1993-5#1)(2007-7#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#2)
report or not##3##3##(1991-2#1)(1995-12#1)(2011-2#1)
report or##4##2##(1991-2#1)(1995-12#1)(2011-2#1)(2012-12#1)
report our experience in##2##4##(2011-2#1)(2013-1#1)
report our experience of##2##4##(1991-9#1)(1995-10#1)
report our experience with##5##4##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
report our experience##10##3##(1991-9#1)(1995-10#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
report our##18##2##(1991-9#1)(1995-10#1)(1995-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
report outcome##3##2##(2012-1#1)(2012-3#1)(2013-1#1)
report outlines##4##2##(1994-3#1)(2007-12#1)(2008-7#1)(2008-9#1)
report pain##3##2##(2009-3#1)(2010-11#2)
report poor##2##2##(2009-5#1)(2013-8#1)
report preliminary results of##2##4##(2008-3#1)(2011-2#1)
report preliminary results##4##3##(2008-3#2)(2011-2#1)(2012-1#1)
report presents a##3##3##(2008-11#1)(2009-3#1)(2012-12#1)
report presents an##2##3##(2007-10#1)(2013-1#1)
report presents the##5##3##(1993-8#1)(1995-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
report presents##14##2##(1991-11#1)(1993-12#1)(1993-8#1)(1995-3#1)(2007-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
report provides##5##2##(1996-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)
report recent##2##2##(2011-1#1)(2013-1#1)
report results from##3##3##(2007-12#1)(2008-3#1)(2009-9#1)
report results of##2##3##(2008-11#1)(2008-9#1)
report results##8##2##(1992-9#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-5#1)
report reviews##4##2##(1991-2#1)(2007-8#1)(2008-11#1)(2011-10#1)
report showed##3##2##(1991-6#1)(2008-10#1)(2008-7#1)
report showing##5##2##(1992-8#1)(1992-9#1)(1995-6#1)(2009-12#1)(2012-12#1)
report shows that##5##3##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)
report shows##8##2##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(2007-8#1)(2008-10#1)(2010-5#1)
report significant##3##2##(1995-12#1)(2007-11#1)(2008-9#1)
report some##4##2##(1992-6#1)(1994-8#1)(1996-5#1)(2008-11#1)
report such a case##2##4##(2009-10#1)(2012-3#1)
report suggests that a##2##4##(2007-7#1)(2012-2#1)
report suggests that##4##3##(2007-7#1)(2012-2#3)
report suggests##5##2##(2007-7#1)(2012-12#1)(2012-2#3)
report summarizes the proceedings##2##4##(2008-8#1)(2011-2#1)
report summarizes the##6##3##(1993-12#1)(1994-9#1)(2007-12#1)(2008-8#1)(2011-2#2)
report summarizes##13##2##(1991-5#1)(1993-12#1)(1994-9#3)(1995-6#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#2)
report that a##7##3##(1990-5#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-5#1)
report that sodium##2##3##(1992-9#1)(2008-11#1)
report that the##16##3##(1991-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#2)(2007-12#1)(2008-7#3)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
report that they##4##3##(1993-3#1)(1995-6#1)(2007-10#1)(2008-5#1)
report that##113##2##(1990-11#2)(1990-2#2)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#3)(1991-9#1)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#4)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#8)(2013-1#1)
report the NMR##4##3##(2009-7#4)
report the absence of##3##4##(1994-12#1)(2008-7#1)(2013-1#1)
report the assignment of##3##4##(1991-12#1)(2009-7#2)
report the association of##2##4##(2008-1#1)(2010-12#1)
report the case of a patient who##2##7##(1993-8#1)(2011-2#1)
report the case of a patient##5##6##(1993-6#1)(1993-8#1)(2011-2#1)(2013-1#2)
report the case of a##60##5##(1991-11#2)(1993-6#1)(1993-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#6)(2008-9#1)(2009-1#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#2)
report the case of an##3##5##(1990-6#1)(2008-10#1)(2010-5#1)
report the case of##69##4##(1990-6#1)(1991-11#2)(1991-6#1)(1993-6#1)(1993-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#7)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#2)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
report the case##72##3##(1990-6#1)(1991-11#2)(1991-6#1)(1993-6#1)(1993-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#4)(2008-7#7)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#2)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#2)
report the clinical case of a##2##6##(2011-2#1)(2013-1#1)
report the clinical##4##3##(2008-5#1)(2011-2#1)(2013-1#2)
report the cloning and##5##4##(1991-12#1)(1992-3#1)(1994-12#1)(1995-8#1)(2008-4#1)
report the cloning of the##3##5##(1990-11#1)(1994-12#1)(1995-11#1)
report the cloning of##7##4##(1990-11#1)(1991-2#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-8#1)(2008-7#1)
report the cloning##14##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-2#1)(1994-12#2)(1995-11#1)(1995-8#2)(2008-4#1)(2008-7#1)(2013-1#1)
report the complete##2##3##(1996-10#1)(2007-11#1)
report the construction##4##3##(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)
report the demonstration of##4##4##(2007-11#1)(2007-12#3)
report the development of a##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
report the development of##6##4##(1990-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
report the development##8##3##(1990-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#2)(2013-8#1)
report the effects of##2##4##(2009-5#1)(2010-4#1)
report the experience of##2##4##(1993-9#1)(2008-7#1)
report the experience##3##3##(1993-9#1)(2008-7#1)(2012-3#1)
report the expression and##2##4##(1996-5#1)(2009-9#1)
report the expression of##2##4##(1992-8#1)(1992-9#1)
report the expression##5##3##(1992-8#1)(1992-9#1)(1996-5#1)(2009-3#1)(2009-9#1)
report the fabrication##2##3##(2008-12#1)(2012-2#1)
report the first experimental##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
report the first observation##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
report the first##28##3##(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
report the generation and##3##4##(2007-11#1)(2007-12#1)(2012-2#1)
report the generation##5##3##(2007-11#2)(2007-12#2)(2012-2#1)
report the identification of##9##4##(1990-11#1)(1993-6#2)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#2)
report the identification##10##3##(1990-11#1)(1993-6#2)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#2)(2013-8#1)
report the isolation and characterization of a##3##7##(1990-12#1)(1993-12#1)(1994-6#1)
report the isolation and characterization of##4##6##(1990-12#1)(1993-12#1)(1994-6#1)(1995-8#1)
report the isolation and##7##4##(1990-12#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-8#1)(1997-7#1)
report the isolation of a cDNA##2##6##(1994-8#1)(1995-2#1)
report the isolation of a##3##5##(1994-8#1)(1995-2#1)(2008-8#1)
report the isolation of two##2##5##(1990-5#1)(1997-3#1)
report the isolation of##6##4##(1990-5#1)(1994-8#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-8#1)
report the isolation##14##3##(1990-12#1)(1990-5#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-8#1)
report the management##2##3##(2008-7#1)(2011-2#1)
report the molecular##2##3##(1990-7#1)(1993-12#1)
report the nucleotide sequence of a##2##6##(1997-3#1)(2008-10#1)
report the observation of##12##4##(2007-11#3)(2007-12#6)(2008-3#1)(2008-5#1)(2013-1#1)
report the observation##13##3##(2007-11#3)(2007-12#6)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
report the occurrence##4##3##(1993-11#1)(2008-5#1)(2010-10#1)(2012-2#1)
report the phenomenon of##2##4##(2008-6#1)(2009-6#1)
report the presence of##2##4##(2008-5#1)(2011-2#1)
report the results of a systematic##2##6##(1994-10#1)(2013-1#1)
report the results of a##9##5##(1990-5#1)(1993-12#1)(1994-10#1)(2007-11#2)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
report the results of the first##2##6##(1996-6#1)(2012-12#1)
report the results of the##3##5##(1996-6#1)(2008-12#1)(2012-12#1)
report the results of##27##4##(1990-5#1)(1990-9#1)(1993-12#1)(1994-10#1)(1996-11#1)(1996-6#1)(1997-6#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
report the results##30##3##(1990-5#2)(1990-9#1)(1993-12#1)(1994-10#1)(1996-11#1)(1996-6#1)(1997-6#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#2)(2008-9#1)(2009-9#1)(2010-6#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
report the structure and##2##4##(1991-6#1)(2008-10#1)
report the study##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
report the successful management of a##2##6##(2007-8#2)
report the successful##5##3##(1994-6#1)(2007-8#2)(2008-7#1)(2010-6#1)
report the synthesis and characterization of##2##6##(2008-10#2)
report the synthesis of##7##4##(1995-11#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-6#1)(2012-2#1)
report the synthesis##9##3##(1995-11#1)(2007-11#1)(2008-10#3)(2009-10#1)(2009-11#1)(2009-6#1)(2012-2#1)
report the technique##2##3##(1994-2#2)
report the use of the##5##5##(2007-12#1)(2007-8#1)(2009-5#1)(2010-5#1)(2011-2#1)
report the use of##14##4##(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-2#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
report the##413##2##(1990-11#2)(1990-12#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-6#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-6#3)(1994-8#1)(1995-11#2)(1995-2#3)(1995-6#4)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#7)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#20)(2007-12#25)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#27)(2008-11#6)(2008-12#5)(2008-2#11)(2008-3#11)(2008-4#1)(2008-5#9)(2008-6#8)(2008-7#23)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#16)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#1)(2011-1#7)(2011-2#18)(2012-12#5)(2012-2#14)(2012-3#11)(2012-4#1)(2013-1#25)(2013-7#2)(2013-8#7)
report their experience in##2##4##(1990-5#1)(1993-5#1)
report their experience of##5##4##(1990-3#1)(1990-9#1)(1992-6#1)(1993-5#1)(1993-9#1)
report their experience##11##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-5#2)(1992-6#1)(1993-5#2)(1993-9#2)
report their##16##2##(1990-3#1)(1990-5#1)(1990-9#2)(1991-3#1)(1992-5#2)(1992-6#1)(1993-5#2)(1993-9#3)(2007-11#1)(2007-8#1)(2013-1#1)
report this case##7##3##(1996-3#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#1)
report this##10##2##(1996-3#1)(2007-8#1)(2008-12#2)(2008-7#3)(2009-3#1)(2011-2#1)(2013-1#1)
report three cases of##2##4##(1991-11#1)(2012-12#1)
report three cases##3##3##(1991-11#1)(2008-7#1)(2012-12#1)
report three##5##2##(1991-11#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
report to Congress##2##3##(1990-8#1)(1993-3#1)
report to##8##2##(1990-5#1)(1990-8#1)(1991-6#1)(1993-3#1)(2009-12#1)(2009-3#1)(2010-8#1)(2012-2#1)
report turnaround time##2##3##(1992-2#1)(1996-3#1)
report two cases of##23##4##(1992-5#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-8#5)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
report two cases##26##3##(1992-5#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-8#5)(2008-10#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#2)
report two##39##2##(1990-3#1)(1992-5#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#4)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#6)(2013-7#2)
report using##2##2##(1994-8#1)(2009-9#1)
report was to##5##3##(2008-6#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
report was##12##2##(1993-12#1)(1993-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
report we describe a##3##4##(1992-11#1)(2008-4#1)(2012-3#1)
report we describe##8##3##(1990-8#1)(1992-11#1)(1997-9#1)(2007-7#1)(2008-4#1)(2008-6#1)(2012-3#2)
report we discuss##2##3##(2007-11#1)(2012-3#1)
report we have##6##3##(1990-5#1)(1990-7#1)(1992-9#1)(1996-3#1)(2008-4#1)(2011-2#1)
report we present a##4##4##(2007-10#1)(2007-8#1)(2008-7#2)
report we present##8##3##(2007-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
report we##35##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)
report will provide##2##3##(2008-11#1)(2008-9#1)
report will##6##2##(2008-11#2)(2008-7#1)(2008-9#1)(2009-4#1)(2012-3#1)
report with##9##2##(1994-8#1)(1997-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
report##3260##1##(1990-10#7)(1990-11#11)(1990-12#17)(1990-2#9)(1990-3#8)(1990-4#1)(1990-5#13)(1990-6#9)(1990-7#8)(1990-8#10)(1990-9#7)(1991-1#5)(1991-11#12)(1991-12#11)(1991-2#15)(1991-3#6)(1991-4#3)(1991-5#8)(1991-6#14)(1991-8#5)(1991-9#5)(1992-1#4)(1992-10#10)(1992-11#9)(1992-12#11)(1992-2#18)(1992-3#14)(1992-4#1)(1992-5#8)(1992-6#10)(1992-7#1)(1992-8#16)(1992-9#15)(1993-1#5)(1993-11#11)(1993-12#22)(1993-2#7)(1993-3#14)(1993-5#6)(1993-6#18)(1993-8#16)(1993-9#14)(1994-1#5)(1994-10#2)(1994-11#9)(1994-12#18)(1994-2#7)(1994-3#8)(1994-5#2)(1994-6#9)(1994-7#3)(1994-8#10)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#10)(1995-12#11)(1995-2#19)(1995-3#9)(1995-5#5)(1995-6#14)(1995-8#9)(1995-9#3)(1996-1#9)(1996-10#3)(1996-11#5)(1996-12#9)(1996-2#11)(1996-3#14)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#7)(1997-1#3)(1997-2#14)(1997-3#24)(1997-4#4)(1997-5#9)(1997-6#7)(1997-7#12)(1997-8#9)(1997-9#2)(2006-10#21)(2006-12#8)(2007-1#1)(2007-10#30)(2007-11#105)(2007-12#134)(2007-2#13)(2007-4#2)(2007-5#16)(2007-6#3)(2007-7#75)(2007-8#70)(2007-9#5)(2008-1#42)(2008-10#194)(2008-11#106)(2008-12#88)(2008-2#48)(2008-3#79)(2008-4#20)(2008-5#34)(2008-6#44)(2008-7#151)(2008-8#34)(2008-9#61)(2009-1#10)(2009-10#14)(2009-11#5)(2009-12#7)(2009-2#12)(2009-3#19)(2009-4#17)(2009-5#22)(2009-6#13)(2009-7#33)(2009-8#12)(2009-9#21)(2010-1#5)(2010-10#9)(2010-11#18)(2010-12#22)(2010-2#2)(2010-3#25)(2010-4#14)(2010-5#24)(2010-6#23)(2010-7#7)(2010-8#16)(2010-9#15)(2011-1#68)(2011-10#1)(2011-2#181)(2011-3#4)(2011-8#1)(2012-1#12)(2012-12#91)(2012-2#98)(2012-3#75)(2012-4#1)(2012-8#2)(2013-1#173)(2013-2#1)(2013-7#10)(2013-8#58)
report)##6##1##(2008-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
report?##2##1##(1990-8#1)(2012-2#1)
report]##44##1##(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#3)(1992-9#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2009-1#1)(2009-5#5)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)
reportable##7##1##(1997-3#3)(2007-12#1)(2010-11#1)(2010-2#1)(2012-2#1)
reported &quot##2##2##(2011-2#1)(2012-12#1)
reported 826 cases of AIDS to the World Health Organization##2##10##(1997-6#2)
reported VCGs##2##2##(2008-10#2)
reported VRE occurences##2##3##(2007-12#2)
reported a case of an##2##5##(2011-1#1)(2012-3#1)
reported a case of##7##4##(1997-3#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-1#2)(2012-3#1)
reported a low##2##3##(2007-8#1)(2009-5#1)
reported a lower##2##3##(2009-5#1)(2011-2#1)
reported a significantly##2##3##(2008-7#1)(2009-8#1)
reported a##48##2##(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-12#2)(2011-1#3)(2011-2#4)(2012-12#4)(2012-3#1)(2013-1#4)(2013-8#3)
reported about##4##2##(1990-12#1)(1992-3#1)(2008-10#1)(2008-6#1)
reported acquiring##2##2##(1993-1#1)(2008-12#1)
reported adverse effects##2##3##(1997-6#1)(2011-2#1)
reported adverse event is##2##4##(2008-6#1)(2008-8#1)
reported adverse events##2##3##(2008-11#2)
reported adverse##7##2##(1997-6#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#2)
reported after##3##2##(1990-5#1)(2010-12#1)(2012-3#1)
reported along with##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
reported along##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
reported among##5##2##(1991-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-5#1)
reported an IIEF5##2##3##(2011-2#2)
reported an##9##2##(1990-12#1)(1990-6#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
reported and the##2##3##(2008-10#1)(2011-2#1)
reported and##32##2##(1990-6#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
reported are##2##2##(2007-10#1)(2008-3#1)
reported as &quot##3##3##(2008-10#1)(2010-6#1)(2012-3#1)
reported as a##8##3##(1990-8#1)(1995-3#1)(1995-8#1)(2008-10#2)(2008-7#1)(2012-1#1)(2013-1#1)
reported as an##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
reported as being##3##3##(1991-8#1)(1996-11#1)(2008-9#1)
reported as benign##2##3##(2011-1#2)
reported as having##4##3##(1995-6#1)(1996-11#2)(2012-12#1)
reported as markers##2##3##(2012-12#1)(2013-8#1)
reported as resistant##2##3##(2011-2#2)
reported as the##4##3##(1994-11#1)(2008-10#1)(2008-9#1)(2013-8#1)
reported as##54##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-2#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
reported associations##2##2##(1997-1#1)(2012-6#1)
reported at least one##2##4##(2008-12#1)(2013-1#1)
reported at least##4##3##(2007-8#1)(2008-12#1)(2012-12#1)(2013-1#1)
reported at the##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
reported at##9##2##(1996-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#2)(2013-1#1)
reported because##2##2##(1992-6#1)(2008-10#1)
reported before##7##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
reported behavior##2##2##(1992-2#1)(2008-12#1)
reported being &quot##3##3##(2008-12#3)
reported being##15##2##(1993-1#1)(1995-1#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
reported beneficial effects of##2##4##(2008-5#1)(2012-2#1)
reported better##2##2##(2010-5#1)(2011-1#1)
reported between##4##2##(1992-6#1)(1994-5#1)(2010-6#1)(2013-1#1)
reported bite rate##2##3##(2013-8#2)
reported both##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
reported but##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
reported by 4 patients##2##4##(2007-8#1)(2008-5#1)
reported by different investigators##2##4##(2008-2#2)
reported by other##3##3##(1991-2#1)(2008-6#1)(2012-12#1)
reported by others##4##3##(1993-12#1)(1993-8#1)(2008-5#1)(2011-2#1)
reported by patients##2##3##(1996-1#1)(2013-1#1)
reported by some##2##3##(2009-4#1)(2012-2#1)
reported by the##15##3##(1991-2#1)(1993-9#1)(1996-1#1)(2006-10#1)(2008-10#7)(2008-6#1)(2011-2#1)(2013-1#2)
reported by us##3##3##(1990-2#1)(1995-6#1)(2008-10#1)
reported by women##4##3##(1993-9#1)(1994-2#1)(2013-1#1)(2013-8#1)
reported by##88##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-5#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-6#1)(1996-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#2)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
reported cDNA##2##2##(1991-9#1)(1993-6#1)
reported case from##2##3##(1991-2#1)(2012-2#1)
reported case in##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2010-6#1)
reported case is##2##3##(2008-7#1)(2011-2#1)
reported case of a##4##4##(1995-4#1)(2008-10#1)(2008-7#2)
reported case of##31##3##(1995-4#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
reported case##43##2##(1991-2#1)(1991-9#1)(1995-4#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
reported cases have##2##3##(2007-7#1)(2008-1#1)
reported cases in the literature##2##5##(2008-3#1)(2008-7#1)
reported cases in the##3##4##(2008-3#1)(2008-6#1)(2008-7#1)
reported cases in##4##3##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
reported cases of##17##3##(1990-6#1)(1992-2#1)(1994-9#1)(1995-3#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)
reported cases were##2##3##(1991-11#1)(2011-2#1)
reported cases##44##2##(1990-6#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-8#1)(1994-9#1)(1995-3#1)(2006-10#2)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2013-1#3)
reported clinical##3##2##(2009-8#1)(2010-6#1)(2012-12#1)
reported complication##2##2##(2008-1#1)(2012-12#1)
reported concentration##2##2##(2008-10#1)(2011-2#1)
reported data##8##2##(1992-5#1)(2008-10#4)(2008-4#1)(2010-3#1)(2013-8#1)
reported earlier##8##2##(1992-9#2)(1994-8#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-8#1)(2013-1#1)
reported eating##2##2##(2012-1#2)
reported elsewhere##3##2##(1994-3#1)(2008-10#2)
reported ever##2##2##(2008-12#1)(2012-12#1)
reported evidence##2##2##(1992-12#1)(2008-10#1)
reported experience##2##2##(1991-6#1)(2008-11#1)
reported experimental results##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
reported experimental##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
reported feeling##3##2##(2008-8#1)(2008-9#1)(2010-9#1)
reported fewer##2##2##(2009-9#1)(2013-1#1)
reported findings##3##2##(1993-1#1)(2007-7#1)(2009-8#1)
reported following##2##2##(2007-2#1)(2013-8#1)
reported for a##2##3##(1991-5#1)(1994-6#1)
reported for any##2##3##(2008-8#1)(2010-3#1)
reported for each##2##3##(2010-11#1)(2013-1#1)
reported for measuring##2##3##(2008-10#1)(2008-3#1)
reported for natural##2##3##(2008-10#1)(2008-8#1)
reported for other##4##3##(1990-8#1)(1991-8#1)(2007-12#1)(2008-5#1)
reported for the analysis##2##4##(2008-10#2)
reported for the determination of##4##5##(2008-10#4)
reported for the first time from##2##6##(2008-5#1)(2010-3#1)
reported for the first time in##2##6##(1994-11#2)
reported for the first time##19##5##(1992-3#1)(1994-11#2)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)
reported for the first##20##4##(1991-12#1)(1992-3#1)(1994-11#2)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)
reported for the##54##3##(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-3#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
reported for their##2##3##(1992-12#1)(2012-12#1)
reported for this##3##3##(1993-8#1)(1996-12#1)(2008-6#1)
reported for two##2##3##(1993-8#1)(1995-6#1)
reported for##136##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#3)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(2006-4#2)(2007-11#2)(2007-12#2)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#10)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
reported from a##4##3##(1994-3#1)(1996-2#2)(2008-10#1)
reported from other countries##2##4##(1995-8#1)(2008-1#1)
reported from other##7##3##(1993-2#1)(1995-8#2)(2007-7#1)(2008-1#1)(2008-10#1)(2010-6#1)
reported from the##6##3##(1990-11#1)(1992-6#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-8#1)
reported from this##2##3##(2007-7#1)(2012-2#1)
reported from##36##2##(1990-11#1)(1990-6#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-8#2)(1996-2#2)(2007-7#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
reported gene##2##2##(2008-10#1)(2008-8#1)
reported genes##6##2##(1995-8#3)(1996-10#1)(1996-2#1)(1996-6#1)
reported good##2##2##(1990-6#1)(2011-2#1)
reported greater##6##2##(1996-3#1)(2007-12#1)(2008-6#2)(2008-9#1)(2010-9#1)
reported had##2##2##(2006-10#1)(2013-8#1)
reported having been vaccinated for##2##5##(2009-5#2)
reported having##10##2##(1995-6#1)(2007-2#3)(2008-11#1)(2008-8#1)(2009-5#3)(2013-1#1)
reported here and##2##3##(1995-11#1)(1996-12#1)
reported here are##2##3##(2008-10#1)(2008-12#1)
reported here for the first time##3##6##(2008-10#1)(2010-8#1)(2012-12#1)
reported here for##4##3##(2008-10#2)(2010-8#1)(2012-12#1)
reported here is##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-7#1)
reported here provide##2##3##(2008-12#1)(2009-7#1)
reported here show that##2##4##(2008-10#1)(2009-2#1)
reported here suggest##2##3##(2007-12#1)(2009-5#1)
reported here was a##2##4##(1997-8#1)(2008-12#1)
reported here was##8##3##(1991-5#1)(1992-8#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#2)
reported here we##2##3##(1992-3#1)(2008-7#1)
reported here were##2##3##(2008-5#2)
reported here##73##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#8)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-5#2)(2010-8#1)(2011-2#4)(2012-12#1)(2013-7#1)(2013-8#1)
reported herein##4##2##(1996-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
reported high levels of##3##4##(2008-10#2)(2008-12#1)
reported high##6##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)
reported higher levels of##5##4##(1994-2#2)(2008-6#1)(2009-7#1)(2010-1#1)
reported higher##10##2##(1994-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-1#1)
reported human##3##2##(1992-10#1)(1993-8#1)(2012-3#1)
reported improved##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
reported improvement##2##2##(1992-5#1)(1997-2#1)
reported in Australia##2##3##(2008-10#1)(2012-12#1)
reported in Europe##2##3##(1997-6#1)(2008-10#1)
reported in a##15##3##(1990-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-5#1)(2009-5#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
reported in an earlier##2##4##(1991-3#1)(2008-3#1)
reported in an##3##3##(1991-3#1)(2008-3#1)(2008-6#1)
reported in association with##4##4##(2006-10#1)(2007-7#1)(2008-7#1)(2011-2#1)
reported in clinical##2##3##(2011-2#1)(2013-1#1)
reported in drinking water##2##4##(2008-10#2)
reported in humans##2##3##(2007-7#1)(2009-7#1)
reported in literature for##2##4##(2007-8#1)(2008-10#1)
reported in literature##15##3##(1990-2#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-5#1)(2010-12#1)(2011-7#1)(2012-2#1)
reported in only one##2##4##(2007-8#1)(2009-1#1)
reported in only##3##3##(1992-8#1)(2007-8#1)(2009-1#1)
reported in other species##2##4##(1991-3#1)(1997-9#1)
reported in other##10##3##(1991-12#1)(1991-3#1)(1992-2#1)(1997-1#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
reported in patients with##11##4##(1994-12#1)(1995-11#1)(1997-8#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-1#1)(2012-12#1)(2012-3#1)
reported in preclinical##2##3##(2010-4#1)(2012-3#1)
reported in previous studies##2##4##(1994-12#1)(2008-10#1)
reported in previous##5##3##(1994-12#1)(1996-7#1)(2008-10#1)(2008-3#1)(2010-8#1)
reported in several##6##3##(1991-12#1)(1994-11#1)(1995-12#1)(2007-10#1)(2008-7#1)(2011-2#1)
reported in some##5##3##(2007-12#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-7#1)
reported in terms of##2##4##(1997-3#1)(2010-8#1)
reported in the English literature##5##5##(2006-12#1)(2008-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
reported in the United States##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
reported in the included##2##4##(2008-10#1)(2013-1#1)
reported in the international literature##2##5##(1997-8#1)(2011-3#1)
reported in the literature and##3##5##(2008-2#1)(2008-7#1)(2011-2#1)
reported in the literature are##3##5##(1994-6#1)(2007-11#1)(2008-10#1)
reported in the literature as##3##5##(2008-3#1)(2009-5#1)(2013-1#1)
reported in the literature for##7##5##(1991-3#2)(1992-9#1)(2007-12#1)(2008-10#2)(2008-6#1)
reported in the literature have##2##5##(2008-8#2)
reported in the literature in##2##5##(1991-3#1)(2013-1#1)
reported in the literature shows that##2##6##(1990-8#1)(2008-5#1)
reported in the literature##94##4##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
reported in the medical literature##5##5##(1990-8#1)(2007-7#1)(2010-6#2)(2013-1#1)
reported in the past##2##4##(1991-12#1)(1992-2#1)
reported in the scientific literature##2##5##(2008-5#1)(2010-7#1)
reported in the study##2##4##(2008-5#1)(2013-1#1)
reported in the world##2##4##(2008-6#1)(2009-3#1)
reported in the##156##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#7)(2010-7#2)(2011-1#5)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#3)
reported in these patients##2##4##(2008-2#1)(2008-6#1)
reported in these##5##3##(1991-2#1)(1996-5#1)(2008-2#1)(2008-6#1)(2011-2#1)
reported in this article##3##4##(1991-1#1)(2010-11#1)(2010-3#1)
reported in this paper##7##4##(1995-3#1)(2008-10#5)(2008-9#1)
reported in this study##6##4##(2008-1#1)(2008-10#1)(2009-11#1)(2011-2#3)
reported in this work##2##4##(2008-10#2)
reported in this##27##3##(1991-1#1)(1992-12#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-3#1)(2011-2#4)(2013-7#1)(2013-8#1)
reported in three##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
reported in vitro##3##3##(1995-12#1)(2008-9#1)(2013-8#1)
reported in which##5##3##(1995-3#1)(1997-8#1)(2007-11#2)(2008-10#1)
reported in##430##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#5)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#7)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-6#3)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-3#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#6)(1997-9#1)(2006-10#4)(2006-12#1)(2007-10#5)(2007-11#4)(2007-12#9)(2007-7#8)(2007-8#9)(2008-1#6)(2008-10#59)(2008-11#6)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#8)(2009-1#1)(2009-11#1)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#7)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#9)(2010-7#2)(2010-8#2)(2011-1#12)(2011-2#18)(2011-3#3)(2011-7#1)(2012-1#1)(2012-12#10)(2012-2#9)(2012-3#5)(2012-8#1)(2013-1#21)(2013-7#3)(2013-8#7)
reported incidence of##4##3##(2007-12#1)(2008-7#2)(2013-8#1)
reported increased##2##2##(2008-12#1)(2013-1#1)
reported instances of##2##3##(1991-12#1)(2008-7#1)
reported is##3##2##(2007-7#1)(2008-10#1)(2009-8#1)
reported lack of##2##3##(1991-2#1)(2009-4#1)
reported less##7##2##(2008-1#1)(2008-12#1)(2009-7#1)(2011-1#1)(2013-1#3)
reported levels of##2##3##(2008-4#1)(2009-7#1)
reported levels##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
reported linkages##2##2##(1997-5#2)
reported low##2##2##(1991-2#1)(1996-6#1)
reported lower##2##2##(2012-12#1)(2013-1#1)
reported method##2##2##(1997-2#1)(2008-10#1)
reported methods##9##2##(2008-10#8)(2009-10#1)
reported more##14##2##(1991-2#1)(1996-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
reported nausea or vomiting##2##4##(2008-7#2)
reported no use##2##3##(2009-5#2)
reported no##10##2##(1993-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-5#2)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
reported not using condoms during##2##5##(2010-7#2)
reported not##3##2##(2007-2#1)(2010-7#2)
reported occurrence##2##2##(2008-10#1)(2010-8#1)
reported of##7##2##(1990-6#2)(1991-3#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-3#1)
reported on a##2##3##(2008-10#1)(2008-7#1)
reported on children's##2##3##(2009-10#1)(2009-4#1)
reported on previously##2##3##(2008-2#1)(2012-2#1)
reported on the##8##3##(1990-11#1)(1990-8#1)(1994-1#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2013-1#1)
reported on their##2##3##(2009-7#1)(2009-8#1)
reported on##30##2##(1990-11#1)(1990-8#1)(1994-1#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#3)
reported one##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
reported only in##2##3##(2008-10#1)(2008-8#1)
reported only##9##2##(1991-5#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
reported or##3##2##(2007-7#1)(2008-3#1)(2011-2#1)
reported outcomes##2##2##(2010-12#1)(2012-12#1)
reported over##2##2##(2008-11#1)(2008-8#1)
reported pain##2##2##(2007-11#1)(2010-11#1)
reported prevalence##3##2##(2008-1#2)(2011-2#1)
reported previously by##2##3##(1991-2#1)(1994-9#1)
reported previously for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
reported previously in##5##3##(2006-10#1)(2007-11#1)(2008-10#2)(2011-1#1)
reported previously using##2##3##(2008-10#2)
reported previously with##2##3##(1997-3#1)(2007-11#1)
reported previously##49##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
reported recently for##2##3##(2007-11#1)(2013-1#1)
reported recently##5##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
reported relief##2##2##(2008-7#1)(2008-9#1)
reported result##2##2##(1994-3#1)(2010-5#1)
reported results##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)
reported satisfaction##3##2##(2007-10#1)(2013-1#2)
reported sequence##2##2##(1994-12#1)(1996-6#1)
reported series##4##2##(1992-8#1)(2007-10#1)(2007-12#1)(2009-10#1)
reported sexual behavior##2##3##(2008-12#2)
reported showing##2##2##(1996-3#1)(1997-3#1)
reported side effect##2##3##(2007-8#1)(2008-8#1)
reported side effects##3##3##(1991-3#1)(1993-2#2)
reported side##5##2##(1991-3#1)(1993-2#2)(2007-8#1)(2008-8#1)
reported significant##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
reported significantly higher##2##3##(2010-9#1)(2011-2#1)
reported significantly lower##2##3##(1995-2#1)(2010-10#1)
reported significantly##8##2##(1995-2#1)(2008-5#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
reported since##6##2##(1995-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-7#1)
reported smoking##2##2##(1991-9#1)(2011-2#1)
reported so far to##2##4##(2008-2#1)(2008-5#1)
reported so far##20##3##(1990-5#1)(1990-8#1)(1992-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
reported some##6##2##(2007-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
reported statistically significant##2##3##(2012-12#2)
reported studies##10##2##(1992-1#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)(2009-9#1)(2010-6#1)(2013-1#1)
reported survival##3##2##(2012-1#1)(2012-2#1)(2013-8#1)
reported symptoms##4##2##(2007-8#1)(2008-6#1)(2012-1#1)(2012-2#1)
reported that a##3##3##(1996-5#1)(2010-6#1)(2011-2#1)
reported that in##3##3##(1996-12#1)(2008-12#1)(2011-2#1)
reported that more##2##3##(1997-6#1)(2008-7#1)
reported that the group##2##4##(1993-3#2)
reported that the use of##2##5##(2011-2#1)(2013-1#1)
reported that the##32##3##(1990-7#1)(1992-12#1)(1993-3#2)(1993-6#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-11#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-1#1)
reported that their##3##3##(1990-8#1)(2008-11#1)(2010-10#1)
reported that they had##4##4##(1995-6#1)(1996-2#1)(2009-3#1)(2012-12#1)
reported that they were &quot##2##5##(2008-7#2)
reported that they were##3##4##(1991-6#1)(2008-7#2)
reported that they##27##3##(1991-12#1)(1991-6#1)(1993-1#2)(1995-6#2)(1996-2#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-6#2)(2010-4#4)(2010-8#1)(2011-1#1)(2012-12#4)(2013-1#1)
reported that##154##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
reported the identification of a##3##5##(1993-12#1)(2008-8#1)(2009-8#1)
reported the molecular##2##3##(1991-8#1)(2010-3#1)
reported the occurrence##2##3##(2008-10#1)(2012-12#1)
reported the presence of##2##4##(1994-6#1)(2008-11#1)
reported the use of##2##4##(2008-10#1)(2013-1#1)
reported the##39##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-8#1)(2009-8#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-8#2)
reported their peak##2##3##(2013-8#2)
reported their##9##2##(1994-6#1)(1994-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-1#1)(2013-8#3)
reported they##2##2##(1994-1#1)(2012-2#1)
reported thus far##2##3##(2007-12#1)(2012-12#1)
reported to CDC were##2##4##(1992-6#2)
reported to be a##5##4##(1992-6#1)(2008-10#2)(2012-12#1)(2013-1#1)
reported to be associated with##3##5##(1994-5#1)(2011-2#1)(2012-1#1)
reported to be beneficial##2##4##(1992-7#1)(2007-11#1)
reported to be between##2##4##(2007-12#1)(2011-2#1)
reported to be capable of##2##5##(1991-1#1)(2008-7#1)
reported to be highly##2##4##(1993-12#1)(2011-1#1)
reported to be important##3##4##(1992-8#1)(2008-7#1)(2009-5#1)
reported to be more##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
reported to be present in##3##5##(1994-12#1)(2008-3#1)(2008-9#1)
reported to be the##4##4##(1994-8#1)(1996-5#1)(2007-7#1)(2008-4#1)
reported to be##71##3##(1990-7#1)(1991-1#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
reported to bind##2##3##(2008-10#1)(2013-7#1)
reported to cause##5##3##(2006-10#1)(2008-10#3)(2012-3#1)
reported to contain##3##3##(1995-12#1)(2008-10#2)
reported to date##21##3##(1991-12#1)(1995-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-2#2)(2008-3#2)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
reported to decrease##3##3##(2011-2#2)(2013-1#1)
reported to exhibit potent##2##4##(2008-5#1)(2009-12#1)
reported to exhibit##5##3##(1995-2#1)(2008-11#1)(2008-5#1)(2009-12#1)(2013-8#1)
reported to have a high##2##5##(2007-10#1)(2011-1#1)
reported to have a##6##4##(2007-10#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
reported to have both##2##4##(1994-12#1)(1996-2#1)
reported to have##24##3##(1991-5#1)(1992-5#1)(1994-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2010-11#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
reported to increase##5##3##(1992-2#1)(2008-10#2)(2008-4#1)(2011-2#1)
reported to induce##2##3##(1995-9#1)(2009-12#1)
reported to limit the##2##4##(1993-3#1)(2009-4#1)
reported to occur##9##3##(1995-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
reported to possess##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
reported to produce##2##3##(2008-8#1)(2011-2#1)
reported to the police##2##4##(1993-3#1)(1997-8#1)
reported to the##12##3##(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-9#1)(1996-11#1)(1997-8#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)
reported to##217##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2006-10#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#31)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#15)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#8)
reported use##3##2##(1991-9#1)(2008-10#2)
reported using##10##2##(1993-12#2)(1995-9#1)(1997-7#1)(2009-5#1)(2010-10#1)(2012-12#2)(2013-1#1)(2013-8#1)
reported values and##2##3##(2007-11#1)(2008-10#1)
reported values for##2##3##(1990-7#1)(2008-10#1)
reported values##10##2##(1990-7#1)(2007-11#1)(2008-10#7)(2009-11#1)
reported was##2##2##(1996-2#1)(2008-12#1)
reported were##4##2##(1992-6#1)(2008-1#1)(2009-9#1)(2013-1#1)
reported when##2##2##(1993-11#1)(2008-2#1)
reported which##5##2##(1990-2#1)(1990-5#1)(1997-6#1)(2008-2#1)(2008-7#1)
reported with a##2##3##(2008-10#2)
reported with the##4##3##(2008-10#3)(2013-1#1)
reported with##30##2##(1993-1#1)(1996-11#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
reported within##2##2##(2008-3#1)(2010-2#1)
reported yet##2##2##(2008-8#1)(2008-9#1)
reported##3053##1##(1990-10#2)(1990-11#8)(1990-12#12)(1990-2#9)(1990-3#6)(1990-5#15)(1990-6#18)(1990-7#8)(1990-8#12)(1990-9#5)(1991-1#5)(1991-11#6)(1991-12#20)(1991-2#20)(1991-3#13)(1991-4#1)(1991-5#11)(1991-6#11)(1991-7#1)(1991-8#12)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#11)(1992-2#10)(1992-3#8)(1992-4#1)(1992-5#12)(1992-6#23)(1992-7#1)(1992-8#11)(1992-9#14)(1993-1#12)(1993-11#6)(1993-12#19)(1993-2#7)(1993-3#13)(1993-6#13)(1993-8#15)(1993-9#11)(1994-1#3)(1994-11#12)(1994-12#14)(1994-2#10)(1994-3#11)(1994-5#7)(1994-6#13)(1994-8#10)(1994-9#10)(1995-1#4)(1995-10#1)(1995-11#9)(1995-12#23)(1995-2#11)(1995-3#18)(1995-4#1)(1995-5#3)(1995-6#15)(1995-8#11)(1995-9#3)(1996-1#7)(1996-10#1)(1996-11#8)(1996-12#17)(1996-2#11)(1996-3#8)(1996-5#9)(1996-6#8)(1996-7#4)(1996-8#4)(1996-9#3)(1997-1#4)(1997-2#13)(1997-3#13)(1997-4#6)(1997-5#7)(1997-6#11)(1997-7#8)(1997-8#14)(1997-9#1)(2006-10#19)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#24)(2007-11#52)(2007-12#58)(2007-2#24)(2007-5#1)(2007-6#1)(2007-7#40)(2007-8#43)(2008-1#34)(2008-10#496)(2008-11#83)(2008-12#56)(2008-2#64)(2008-3#96)(2008-4#19)(2008-5#75)(2008-6#35)(2008-7#108)(2008-8#43)(2008-9#50)(2009-1#3)(2009-10#10)(2009-11#9)(2009-12#12)(2009-2#9)(2009-3#10)(2009-4#14)(2009-5#29)(2009-6#3)(2009-7#15)(2009-8#25)(2009-9#13)(2010-1#8)(2010-10#9)(2010-11#10)(2010-12#16)(2010-2#3)(2010-3#16)(2010-4#10)(2010-5#11)(2010-6#24)(2010-7#12)(2010-8#19)(2010-9#7)(2011-1#50)(2011-2#140)(2011-3#6)(2011-7#1)(2011-9#1)(2012-1#14)(2012-12#79)(2012-2#50)(2012-3#45)(2012-6#1)(2012-8#1)(2013-1#124)(2013-7#7)(2013-8#71)
reported)##2##1##(2007-12#1)(2008-10#1)
reportedly##16##1##(1990-11#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(2007-2#2)(2008-11#1)(2010-3#1)(2010-8#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
reporter and##3##2##(1997-4#1)(2008-10#1)(2008-9#1)
reporter assay##4##2##(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
reporter assays##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
reporter construct##2##2##(1995-2#1)(1996-3#1)
reporter constructs##5##2##(1994-11#2)(1994-2#3)
reporter gene activity##2##3##(1993-3#1)(2010-11#1)
reporter gene and##4##3##(1992-12#1)(1992-9#1)(2008-10#2)
reporter gene assay##4##3##(2010-2#3)(2010-5#1)
reporter gene construct##2##3##(2008-10#2)
reporter gene driven by##2##4##(2008-11#1)(2008-8#1)
reporter gene expression was##2##4##(1995-2#1)(2008-10#1)
reporter gene expression##11##3##(1995-2#1)(2008-10#2)(2008-11#2)(2008-8#4)(2008-9#1)(2009-10#1)
reporter gene in##3##3##(1991-6#2)(1996-5#1)
reporter gene to##4##3##(1991-5#1)(1991-9#1)(2008-10#1)(2010-5#1)
reporter gene under the control of CaMV35S##2##7##(2008-9#2)
reporter gene under the control of the##2##7##(1994-12#1)(1997-4#1)
reporter gene under the control of##7##6##(1994-12#1)(1994-5#2)(1995-8#1)(1997-4#1)(2008-9#2)
reporter gene was##5##3##(1994-2#2)(1997-4#2)(2008-11#1)
reporter gene##97##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#2)(1995-2#2)(1995-6#1)(1995-8#3)(1996-5#1)(1997-1#1)(1997-4#6)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#16)(2008-11#10)(2008-4#3)(2008-5#1)(2008-8#8)(2008-9#8)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-5#2)(2011-1#1)(2011-3#1)
reporter genes containing##2##3##(1992-12#1)(2008-8#1)
reporter genes##12##2##(1990-5#1)(1991-9#1)(1992-12#1)(1993-6#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)
reporter groups##4##2##(1991-12#1)(2008-1#1)(2008-4#2)
reporter molecule##4##2##(1996-6#1)(2008-7#1)(2008-9#2)
reporter plasmid##4##2##(1994-12#1)(1994-8#1)(1995-2#1)(1996-3#1)
reporter plasmids##2##2##(1993-8#1)(2012-2#1)
reporter protein##7##2##(1996-3#1)(2008-11#5)(2009-5#1)
reporter strain##2##2##(2008-9#1)(2011-2#1)
reporter system##6##2##(1992-12#1)(1994-2#1)(2008-7#1)(2008-9#3)
reporter under the control of##2##5##(2008-11#1)(2010-2#1)
reporter##202##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-12#4)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#6)(1994-5#2)(1994-8#1)(1995-2#9)(1995-6#2)(1995-8#3)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#8)(1997-6#3)(1997-7#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#23)(2008-2#2)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#11)(2008-9#20)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-5#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reporter-gene##2##1##(2009-12#2)
reporters of##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
reporters##11##1##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-8#1)
reporting a##15##2##(2007-7#1)(2007-8#1)(2008-12#3)(2008-6#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
reporting an##5##2##(1995-2#1)(2008-11#1)(2009-3#1)(2012-12#2)
reporting and##11##2##(1997-3#1)(2008-10#4)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
reporting bias##2##2##(2008-11#1)(2008-9#1)
reporting diagnostic##2##2##(2010-5#2)
reporting fewer##2##2##(1993-9#1)(1995-12#1)
reporting form##2##2##(2012-12#2)
reporting format##2##2##(2011-2#2)
reporting forms##4##2##(2008-10#1)(2012-12#3)
reporting from##2##2##(1997-8#1)(2007-2#1)
reporting guidelines##3##2##(1996-8#1)(2013-7#2)
reporting higher##2##2##(2009-5#1)(2011-2#1)
reporting in the##2##3##(1991-2#1)(2006-5#1)
reporting in##6##2##(1991-2#1)(2006-5#1)(2008-3#1)(2009-9#1)(2012-3#2)
reporting increased##2##2##(1995-12#1)(2011-2#1)
reporting is##3##2##(1996-1#1)(2008-11#1)(2010-7#1)
reporting no##2##2##(2011-3#1)(2012-12#1)
reporting of adverse events##2##4##(2011-2#1)(2012-2#1)
reporting of adverse##4##3##(2008-11#1)(2011-2#2)(2012-2#1)
reporting of health##2##3##(1997-3#1)(2013-7#1)
reporting of the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
reporting of##38##2##(1991-11#1)(1992-12#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-3#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
reporting on a##2##3##(2007-12#1)(2012-12#1)
reporting on the##3##3##(2008-4#1)(2008-7#1)(2010-7#1)
reporting on##8##2##(1991-6#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#1)
reporting outcomes following C-ADR (Bryan disc##2##6##(2012-12#2)
reporting outcomes following C-ADR##3##4##(2012-12#3)
reporting outcomes##4##2##(2012-12#4)
reporting procedures##2##2##(2008-10#1)(2011-2#1)
reporting program##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
reporting quality of##2##3##(2008-10#1)(2011-2#1)
reporting quality##3##2##(2008-10#1)(2011-2#2)
reporting requirements##6##2##(1992-3#2)(1993-3#1)(1994-2#1)(1997-3#1)(2012-2#1)
reporting system in##2##3##(1996-2#1)(2007-2#1)
reporting system##7##2##(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-2#2)(2010-8#1)
reporting the##8##2##(1990-2#1)(1994-11#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
reporting to##3##2##(2008-12#1)(2010-3#1)(2011-2#1)
reporting##283##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#2)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#6)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#5)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#19)(2008-11#11)(2008-12#9)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#4)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#31)(2011-3#1)(2012-12#19)(2012-2#13)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#17)
reports a case of##12##4##(1990-6#2)(1991-5#1)(1992-5#1)(1992-6#2)(2007-12#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)
reports a case##13##3##(1990-6#2)(1991-5#1)(1992-5#1)(1992-6#2)(2007-12#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)
reports a##32##2##(1990-6#4)(1991-5#2)(1992-5#1)(1992-6#2)(1995-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#1)
reports about the##4##3##(2008-10#1)(2008-9#1)(2009-2#1)(2010-5#1)
reports about##10##2##(1996-3#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
reports an##8##2##(1992-9#1)(1994-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
reports and clinical##2##3##(2007-7#1)(2008-1#1)
reports and##26##2##(1991-2#2)(1991-3#2)(1993-12#1)(1994-12#1)(1996-4#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
reports are available##3##3##(2008-4#1)(2008-9#1)(2012-2#1)
reports are published##2##3##(1993-12#1)(2008-11#1)
reports are##12##2##(1990-6#1)(1990-9#1)(1993-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)
reports based##2##2##(2008-5#1)(2013-1#1)
reports by##5##2##(1990-10#1)(1996-3#1)(1996-8#1)(2008-5#1)(2008-9#1)
reports can be##4##3##(1991-3#1)(1994-3#1)(2007-7#1)(2012-2#1)
reports concerning the effects of##2##5##(1991-12#1)(1995-12#1)
reports concerning the##3##3##(1991-12#1)(1995-12#1)(2008-3#1)
reports concerning##7##2##(1991-12#1)(1995-12#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
reports data from##2##3##(2008-1#1)(2011-2#1)
reports data##3##2##(2008-1#1)(2009-8#1)(2011-2#1)
reports demonstrate##2##2##(2009-8#1)(2011-2#1)
reports describe##2##2##(2008-10#1)(2013-1#1)
reports describing##4##2##(2008-3#1)(2008-7#1)(2010-6#1)(2012-12#1)
reports did##2##2##(1997-3#1)(2013-1#1)
reports documenting##2##2##(2011-2#1)(2012-2#1)
reports exist##2##2##(2008-11#1)(2008-6#1)
reports findings of##3##3##(1996-7#1)(2008-4#1)(2011-2#1)
reports findings##7##2##(1995-11#1)(1996-7#1)(2008-11#2)(2008-4#1)(2010-2#1)(2011-2#1)
reports for the##5##3##(1995-6#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
reports for##11##2##(1995-6#1)(1996-12#1)(2008-5#4)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#2)
reports from Europe##2##3##(2007-7#1)(2008-10#1)
reports from a##2##3##(2009-5#1)(2011-2#1)
reports from other##2##3##(2007-7#2)
reports from the##2##3##(2008-1#1)(2012-3#1)
reports from##19##2##(1992-11#1)(1996-9#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
reports have been published##2##4##(2008-10#1)(2008-11#1)
reports have been##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
reports have described the##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
reports have described##6##3##(2008-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
reports have focused on the##2##5##(1994-1#1)(2008-8#1)
reports have indicated that##3##4##(1994-3#1)(1994-8#1)(2008-8#1)
reports have not##2##3##(2008-3#1)(2008-6#1)
reports have shown that##3##4##(2008-7#3)
reports have shown##5##3##(1992-12#1)(2008-10#1)(2008-7#3)
reports have suggested that##2##4##(2008-11#1)(2009-10#1)
reports have##37##2##(1991-3#1)(1992-12#1)(1994-1#1)(1994-3#1)(1994-8#1)(1996-2#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
reports in the literature are##2##5##(1996-7#1)(2008-7#1)
reports in the literature##9##4##(1991-2#1)(1994-2#1)(1996-7#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)
reports in the##12##3##(1991-2#1)(1994-2#1)(1996-7#1)(1997-6#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
reports in which##2##3##(1992-5#1)(2011-2#1)
reports in##23##2##(1991-2#1)(1992-5#1)(1994-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#2)
reports indicate that##2##3##(2008-3#1)(2012-12#1)
reports indicated##2##2##(2007-12#1)(2008-4#1)
reports involving##2##2##(2008-10#1)(2010-2#1)
reports of a##6##3##(1991-8#1)(1997-5#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#1)
reports of adverse events##2##4##(2008-8#1)(2010-8#1)
reports of cases##2##3##(2007-2#1)(2012-3#1)
reports of fatal and non-fatal incidents involving tourists##2##8##(2007-2#2)
reports of physician quality##2##4##(2013-1#2)
reports of possible##2##3##(1997-5#2)
reports of resistance##2##3##(2008-10#1)(2011-2#1)
reports of the##7##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
reports of##130##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-3#3)(1997-5#4)(2006-10#2)(2007-10#2)(2007-12#3)(2007-2#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#1)
reports on a qualitative##2##4##(2009-5#1)(2013-8#1)
reports on a survey of##2##5##(1993-1#1)(1995-1#1)
reports on a##13##3##(1993-1#1)(1993-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-5#1)(2013-8#1)
reports on an##4##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
reports on qualitative##2##3##(2008-3#1)(2009-5#1)
reports on the design##2##4##(1996-2#1)(2008-12#1)
reports on the use of a##3##6##(2008-10#1)(2008-12#1)(2013-8#1)
reports on the use of##8##5##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
reports on the##42##3##(1990-3#1)(1991-9#1)(1992-5#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#3)(1996-2#2)(2007-10#1)(2007-7#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
reports on two##2##3##(1994-2#1)(2010-12#1)
reports on##102##2##(1990-3#1)(1991-9#1)(1992-2#2)(1992-5#1)(1993-1#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-5#2)(2010-1#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
reports or##3##2##(2008-11#1)(2012-1#1)(2013-1#1)
reports our##2##2##(1990-2#1)(1996-12#1)
reports published##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
reports received##2##2##(1991-2#1)(2008-8#1)
reports regarding##3##2##(2007-2#1)(2007-8#1)(2011-3#1)
reports results from a##3##4##(1994-3#1)(1996-3#1)(2011-2#1)
reports results##4##2##(1990-12#1)(1994-3#1)(1996-3#1)(2011-2#1)
reports should##2##2##(1990-3#1)(1992-8#1)
reports show that##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
reports show##4##2##(1993-8#1)(2008-3#1)(2011-2#1)(2013-8#1)
reports showed that##2##3##(2008-12#1)(2008-9#1)
reports showing##4##2##(1990-5#1)(1997-5#1)(2011-2#1)(2012-12#1)
reports suggest that##9##3##(1993-6#1)(1994-11#1)(1994-5#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#1)
reports suggest##12##2##(1993-6#1)(1994-11#1)(1994-5#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
reports suggested##2##2##(2008-11#1)(2009-7#1)
reports that provide##2##3##(1991-1#1)(2011-1#1)
reports that the##2##3##(1990-5#1)(1995-2#1)
reports that##28##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)
reports the clinical##2##3##(1990-12#1)(2008-10#1)
reports the development of a##4##5##(2008-10#3)(2008-5#1)
reports the development of##5##4##(1996-12#1)(2008-10#3)(2008-5#1)
reports the findings of a##3##5##(1995-1#1)(2008-11#2)
reports the findings of##4##4##(1995-1#1)(2008-11#2)(2008-9#1)
reports the findings##5##3##(1995-1#1)(2007-12#1)(2008-11#2)(2008-9#1)
reports the results obtained##3##4##(1990-6#1)(2008-10#1)(2008-11#1)
reports the results of a case##2##6##(1996-1#1)(2010-8#1)
reports the results of a study of##2##7##(1992-1#1)(1992-5#1)
reports the results of a study##5##6##(1992-1#1)(1992-5#1)(1993-3#1)(1996-1#1)(2008-5#1)
reports the results of a survey##2##6##(1994-12#1)(1996-12#1)
reports the results of a##12##5##(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#3)(1996-12#1)(2008-5#1)(2010-8#1)
reports the results of##17##4##(1990-6#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#3)(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#1)
reports the results##20##3##(1990-6#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#3)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#1)
reports the synthesis of##2##4##(2008-4#1)(2010-4#1)
reports the use of##6##4##(2008-10#4)(2010-4#1)(2013-1#1)
reports the##82##2##(1990-12#1)(1990-6#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-1#1)(1996-1#3)(1996-12#2)(1997-2#1)(1997-7#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)
reports to the contrary##2##4##(1991-4#1)(1993-6#1)
reports to the##3##3##(1991-4#1)(1993-6#1)(2008-11#1)
reports to##10##2##(1991-1#1)(1991-4#1)(1993-12#1)(1993-6#1)(1994-3#1)(2008-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
reports two##3##2##(1993-3#1)(1995-1#1)(2012-1#1)
reports using##4##2##(1997-6#1)(2008-7#1)(2009-3#1)(2011-2#1)
reports was##2##2##(1997-3#1)(2011-2#1)
reports were reviewed##2##3##(1990-3#1)(2008-7#1)
reports were##8##2##(1990-3#1)(1990-6#1)(1991-1#1)(2006-8#1)(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
reports what##3##2##(1995-8#1)(1996-1#1)(2013-1#1)
reports which##4##2##(1991-6#1)(2008-12#1)(2008-5#1)(2008-7#1)
reports with##2##2##(2007-8#1)(2008-4#1)
reports##826##1##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#8)(1990-5#3)(1990-6#8)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#6)(1991-4#1)(1991-5#7)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#6)(1993-8#1)(1993-9#2)(1994-1#5)(1994-11#3)(1994-12#6)(1994-2#7)(1994-3#9)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#5)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#4)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#6)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#2)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#5)(2006-12#1)(2006-8#2)(2007-10#9)(2007-11#3)(2007-12#10)(2007-2#6)(2007-7#12)(2007-8#8)(2008-1#11)(2008-10#76)(2008-11#48)(2008-12#15)(2008-2#9)(2008-3#10)(2008-4#12)(2008-5#17)(2008-6#13)(2008-7#35)(2008-8#12)(2008-9#21)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#7)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#7)(2011-1#9)(2011-2#48)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#22)(2012-2#10)(2012-3#19)(2012-7#1)(2013-1#36)(2013-7#3)(2013-8#14)
reports)##3##1##(1991-8#1)(2008-12#1)(2011-2#1)
reports]##6##1##(1991-11#1)(1991-5#1)(1992-5#1)(1992-6#1)(2008-10#1)(2008-7#1)
reposition##2##1##(2007-8#1)(2009-8#1)
repositioning in##2##2##(2008-11#1)(2010-7#1)
repositioning of the##3##3##(2008-1#1)(2009-4#1)(2012-2#1)
repositioning of##4##2##(2008-1#1)(2009-4#1)(2011-2#1)(2012-2#1)
repositioning##16##1##(1994-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
repositories##11##1##(1995-12#1)(2008-11#1)(2008-7#5)(2010-12#3)(2013-1#1)
repository for##2##2##(1991-5#1)(2010-10#1)
repository of##2##2##(1991-2#1)(2008-7#1)
repository##10##1##(1991-2#1)(1991-5#1)(1996-3#1)(2008-7#4)(2010-10#1)(2010-9#1)(2013-8#1)
represent a class of##2##4##(1995-2#1)(2008-3#1)
represent a common##2##3##(1995-12#1)(2008-10#1)
represent a compensatory mechanism##2##4##(2008-7#1)(2011-1#1)
represent a different##2##3##(1992-8#1)(1997-3#1)
represent a distinct##4##3##(2008-10#3)(2009-3#1)
represent a global##2##3##(2008-3#1)(2012-2#1)
represent a group of##2##4##(2009-12#1)(2010-6#1)
represent a large##3##3##(1994-11#1)(2009-11#1)(2009-8#1)
represent a major cause of morbidity##2##6##(2008-1#1)(2008-7#1)
represent a major step forward in##2##6##(2009-3#1)(2012-2#1)
represent a major##11##3##(1990-4#1)(1995-1#1)(1995-2#1)(2008-1#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-2#1)
represent a new class of##4##5##(1991-9#1)(2008-3#1)(2008-5#2)
represent a new##15##3##(1991-2#1)(1991-6#1)(1991-9#1)(1993-3#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)
represent a novel##10##3##(1990-5#1)(1991-5#1)(1991-9#1)(1996-9#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
represent a number of##2##4##(2008-11#1)(2008-7#1)
represent a particular##2##3##(2007-2#1)(2008-9#1)
represent a possible##2##3##(2008-10#1)(2011-2#1)
represent a potential##4##3##(2007-12#1)(2008-10#3)
represent a potentially##3##3##(2009-12#1)(2010-1#1)(2012-12#1)
represent a promising##2##3##(1992-12#1)(2008-11#1)
represent a range of##2##4##(2008-10#1)(2009-11#1)
represent a rare##3##3##(1990-6#1)(2008-10#1)(2010-12#1)
represent a relatively##3##3##(2008-10#1)(2008-5#2)
represent a second##2##3##(2010-12#1)(2010-3#1)
represent a significant##5##3##(1991-5#1)(1994-5#1)(2008-10#1)(2008-11#1)(2010-6#1)
represent a single##3##3##(2008-10#2)(2008-5#1)
represent a subgroup of##2##4##(1991-4#1)(2011-2#1)
represent a unique##2##3##(2008-7#1)(2009-8#1)
represent a useful##2##3##(1990-8#1)(2008-11#1)
represent a valuable##2##3##(2008-7#1)(2008-8#1)
represent a viable##2##3##(2009-5#1)(2013-1#1)
represent a wide##2##3##(2008-10#1)(2008-3#1)
represent a##188##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#5)(2007-2#1)(2008-1#3)(2008-10#27)(2008-11#7)(2008-3#6)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-11#5)(2010-12#5)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#3)(2012-2#4)(2012-8#1)(2013-1#1)(2013-8#3)
represent an altered##2##3##(1993-1#1)(2011-2#1)
represent an alternative##2##3##(2008-10#1)(2008-5#1)
represent an early##2##3##(1996-9#1)(2008-7#1)
represent an emerging##2##3##(2007-4#1)(2010-5#1)
represent an important challenge in##2##5##(1994-12#1)(1997-2#1)
represent an important##9##3##(1994-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-7#1)
represent an##48##2##(1992-3#1)(1992-6#1)(1993-1#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
represent another##2##2##(1994-3#1)(2010-5#1)
represent both a##2##3##(1992-5#1)(2008-9#1)
represent common##2##2##(2012-2#2)
represent complex##2##2##(2008-6#2)
represent different##6##2##(1992-3#1)(2008-10#3)(2008-12#1)(2008-9#1)
represent distinct##6##2##(2008-10#3)(2008-9#1)(2010-3#1)(2010-6#1)
represent early##4##2##(1991-12#1)(2008-9#2)(2009-11#1)
represent functional##2##2##(1991-11#1)(2008-11#1)
represent good candidates for##2##4##(2008-2#1)(2013-1#1)
represent good##3##2##(1997-6#1)(2008-2#1)(2013-1#1)
represent important##9##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-7#2)(2008-8#1)(2013-7#2)(2013-8#1)
represent its##2##2##(1992-2#1)(2013-1#1)
represent miniaturized##2##2##(2008-10#1)(2010-6#1)
represent molecular##2##2##(1995-11#1)(2009-4#1)
represent more##3##2##(2008-5#1)(2008-8#2)
represent novel##3##2##(1991-5#1)(2009-6#1)(2010-3#1)
represent one of the most##2##5##(1992-5#1)(2010-11#1)
represent one of the##5##4##(1992-5#1)(2007-3#1)(2008-5#1)(2010-11#2)
represent only a##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
represent only##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
represent output function##2##3##(1991-6#2)
represent potential##3##2##(2008-4#1)(2011-1#1)(2012-12#1)
represent single##2##2##(1993-11#2)
represent some##2##2##(2008-7#1)(2013-8#1)
represent the best##2##3##(2007-8#1)(2008-10#1)
represent the effects of##2##4##(2008-10#1)(2013-1#1)
represent the entire##2##3##(2008-4#1)(2008-7#1)
represent the first demonstration of##2##5##(1994-3#1)(1994-5#1)
represent the first demonstration##3##4##(1994-3#1)(1994-5#1)(2008-8#1)
represent the first##10##3##(1990-2#1)(1990-5#1)(1991-6#1)(1992-3#1)(1994-3#1)(1994-5#1)(2008-10#2)(2008-8#1)(2009-10#1)
represent the major source##2##4##(2008-11#1)(2010-11#1)
represent the major##4##3##(1990-12#1)(1993-6#1)(2008-11#1)(2010-11#1)
represent the most common##2##4##(2008-4#1)(2009-12#1)
represent the most##9##3##(1993-1#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
represent the neural##2##3##(2007-8#1)(2008-11#1)
represent the##106##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-2#2)(1996-4#2)(1996-8#1)(1997-2#1)(1997-3#1)(2007-12#2)(2007-8#3)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
represent three##4##2##(2008-10#3)(2011-2#1)
represent two different##2##3##(1996-1#1)(2008-10#1)
represent two##6##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-3#1)
represent what##2##2##(1993-8#1)(2008-2#1)
represent##554##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#6)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#7)(2008-10#82)(2008-11#23)(2008-12#3)(2008-2#8)(2008-3#12)(2008-4#8)(2008-5#23)(2008-6#8)(2008-7#35)(2008-8#13)(2008-9#11)(2009-10#2)(2009-11#4)(2009-12#7)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#7)(2010-1#2)(2010-11#9)(2010-12#8)(2010-3#6)(2010-5#5)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#28)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#4)(2012-8#1)(2013-1#12)(2013-7#4)(2013-8#11)
representation and##4##2##(2008-11#1)(2008-3#1)(2010-8#1)(2012-1#1)
representation for a##2##3##(2008-6#2)
representation for##4##2##(2008-6#3)(2012-2#1)
representation in the##4##3##(1996-5#2)(2008-9#1)(2010-3#1)
representation in##9##2##(1996-5#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-3#1)(2012-2#1)
representation of DNA sequences##2##4##(2013-8#2)
representation of a##3##3##(1993-11#1)(1995-5#1)(2008-11#1)
representation of cancer##2##3##(2008-9#2)
representation of the##27##3##(1992-11#1)(1993-11#1)(1995-5#2)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
representation of##72##2##(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#1)(1994-3#1)(1995-12#1)(1995-5#3)(1996-2#1)(1996-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#4)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
representation on the Poincaré sphere##2##5##(2008-3#2)
representation on the##3##3##(2008-3#2)(2011-2#1)
representation on##4##2##(1996-12#1)(2008-3#2)(2011-2#1)
representation##144##1##(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-5#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-11#8)(2008-2#4)(2008-3#10)(2008-4#6)(2008-5#2)(2008-6#7)(2008-7#10)(2008-8#2)(2008-9#8)(2009-10#7)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
representational##4##1##(2008-7#1)(2009-10#2)(2012-3#1)
representations and##2##2##(2008-2#1)(2010-1#1)
representations are##4##2##(1995-12#1)(2008-3#1)(2008-6#1)(2009-10#1)
representations as##2##2##(1992-3#1)(2013-8#1)
representations of motherhood and pregnancy in##2##6##(2012-12#2)
representations of the##12##3##(1996-4#1)(2007-8#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
representations of##29##2##(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#4)(2013-8#7)
representations##71##1##(1990-11#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-11#2)(1995-12#3)(1996-4#1)(1996-5#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#7)(2008-3#3)(2008-6#4)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#3)(2009-7#1)(2009-8#3)(2010-1#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#9)
representative applications##2##2##(2008-1#1)(2008-9#1)
representative chemicals##2##2##(2008-11#2)
representative data##2##2##(2008-7#1)(2013-8#1)
representative examples##4##2##(2008-10#1)(2010-10#1)(2010-7#1)(2012-3#1)
representative for##3##2##(1995-2#1)(2008-5#1)(2008-9#1)
representative images##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
representative isolates of##5##3##(2008-10#5)
representative isolates##12##2##(2008-10#10)(2011-2#1)(2012-12#1)
representative material##2##2##(1991-11#1)(2012-2#1)
representative of a##4##3##(1991-2#1)(2008-7#1)(2011-2#2)
representative of an##2##3##(1996-2#1)(2009-8#1)
representative of the general##2##4##(1994-6#1)(1997-3#1)
representative of the underlying##2##4##(2008-2#1)(2010-11#1)
representative of the##34##3##(1990-11#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-6#1)(1997-3#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
representative of##65##2##(1990-11#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-7#1)(2013-1#1)(2013-8#2)
representative sample of the##4##4##(2007-2#1)(2008-5#2)(2011-2#1)
representative sample of##23##3##(1991-12#1)(1991-6#1)(1993-1#1)(1994-6#1)(1995-8#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#2)(2009-7#3)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
representative sample##26##2##(1991-12#1)(1991-6#1)(1993-1#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-6#1)(2007-2#1)(2008-1#2)(2008-12#1)(2008-5#2)(2009-7#3)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
representative samples of##2##3##(1991-9#1)(2008-10#1)
representative samples##4##2##(1991-9#1)(2008-10#1)(2008-3#2)
representative species of##2##3##(2007-12#1)(2008-8#1)
representative strains##5##2##(2008-10#5)
representative survey##2##2##(2013-1#2)
representative##237##1##(1990-11#3)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#58)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#6)(2009-8#1)(2010-1#1)(2010-10#6)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#12)(2012-12#4)(2012-2#3)(2012-3#4)(2012-7#2)(2013-1#10)(2013-8#8)
representatives and##3##2##(1991-12#1)(2008-4#1)(2010-3#1)
representatives are##2##2##(2008-7#2)
representatives at##2##2##(1994-3#1)(2008-11#1)
representatives from all##2##3##(2008-11#1)(2008-12#1)
representatives from##10##2##(1996-1#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-1#1)
representatives in##2##2##(2008-4#1)(2013-1#1)
representatives of the##3##3##(2007-12#1)(2011-2#2)
representatives of these genera##2##4##(2008-10#1)(2008-12#1)
representatives of these##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
representatives of##24##2##(1991-6#1)(1992-7#1)(1994-1#2)(1995-6#1)(1997-2#1)(1997-4#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
representatives##66##1##(1991-1#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-3#1)(1994-1#2)(1994-3#1)(1994-7#1)(1995-3#2)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2010-3#2)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)
represented 37##2##2##(1992-1#1)(2008-5#1)
represented HEV71##2##2##(2013-8#2)
represented a significant##2##3##(1994-2#1)(2008-11#1)
represented a##20##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-8#1)(1992-3#1)(1994-2#2)(1995-1#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2010-6#1)(2012-1#1)
represented about##2##2##(2008-10#1)(2009-8#1)
represented all##4##2##(2008-10#2)(2008-11#1)(2012-1#1)
represented an##2##2##(2010-8#1)(2012-12#1)
represented approximately##3##2##(1992-1#1)(1996-4#1)(2008-10#1)
represented as a##3##3##(1992-3#1)(2008-2#1)(2013-1#1)
represented as##9##2##(1992-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-5#1)(2013-1#1)
represented at the##2##3##(1991-9#1)(2008-3#1)
represented at##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
represented by a single##3##4##(1990-7#1)(2008-10#2)
represented by a##16##3##(1990-12#1)(1990-7#1)(1993-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-8#1)
represented by an##4##3##(2008-11#1)(2008-2#1)(2011-3#1)(2012-2#1)
represented by the area##2##4##(2008-3#1)(2012-12#1)
represented by the##30##3##(1992-6#1)(1992-9#2)(1995-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-1#2)(2009-9#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-7#1)
represented by##97##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-2#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-5#2)(2008-1#1)(2008-10#14)(2008-11#6)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#8)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
represented each##2##2##(2008-10#1)(2008-12#1)
represented in terms of##2##4##(2008-3#1)(2009-8#1)
represented in the##16##3##(1991-2#2)(1992-3#1)(1993-12#1)(1994-9#1)(1995-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#1)
represented in this##3##3##(1997-3#1)(2008-12#1)(2010-8#1)
represented in##37##2##(1991-2#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-2#4)(2012-1#1)(2013-1#2)
represented nearly##2##2##(1992-1#1)(2008-10#1)
represented only##3##2##(1993-8#1)(1994-8#1)(2007-12#1)
represented the best evidence on##2##5##(2007-8#2)
represented the best evidence to answer the##2##7##(2007-8#2)
represented the best evidence##4##4##(2007-8#4)
represented the main##2##3##(1994-2#1)(2008-11#1)
represented the major##3##3##(1992-6#1)(1994-2#2)
represented the most##4##3##(2008-10#2)(2009-5#1)(2011-1#1)
represented the##26##2##(1992-3#1)(1992-6#1)(1994-2#3)(2007-8#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
represented two##3##2##(1993-12#1)(2008-10#2)
represented unique##2##2##(2008-10#2)
represented with##2##2##(1990-8#1)(2008-7#1)
represented##273##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#5)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#6)(1992-6#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#8)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#3)(1995-6#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#3)(2007-8#5)(2008-1#5)(2008-10#44)(2008-11#14)(2008-12#5)(2008-2#8)(2008-3#8)(2008-4#9)(2008-5#7)(2008-6#5)(2008-7#12)(2008-8#1)(2008-9#4)(2009-1#2)(2009-11#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#17)(2011-3#3)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#4)
representing 11##2##2##(2008-7#1)(2010-4#1)
representing 2##2##2##(2008-10#2)
representing 56##2##2##(2008-10#1)(2009-9#1)
representing 92##2##2##(2008-11#1)(2008-12#1)
representing a complex##2##3##(2008-10#1)(2008-7#1)
representing a new##2##3##(2008-7#1)(2008-8#1)
representing a range of##4##4##(1995-11#1)(2008-10#2)(2009-9#1)
representing a##31##2##(1990-5#1)(1992-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
representing all##5##2##(1992-2#1)(1995-1#1)(1996-6#1)(2008-10#1)(2010-3#1)
representing an##7##2##(1993-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
representing and##2##2##(2008-7#1)(2011-2#1)
representing approximately##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
representing different##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
representing four##3##2##(1996-1#1)(2008-10#2)
representing health professionals from different specialties and interests in the field##2##11##(2013-1#2)
representing health##3##2##(1992-3#1)(2013-1#2)
representing more than##2##3##(2008-7#1)(2012-12#1)
representing more##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
representing only##4##2##(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
representing the diverse##2##3##(2009-5#1)(2009-7#1)
representing the first##3##3##(1993-11#1)(1995-3#1)(1996-5#1)
representing the known genetic and pathogenic diversity##2##7##(2008-10#2)
representing the known##3##3##(2008-10#3)
representing the two##2##3##(2008-10#2)
representing the##55##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#2)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2012-3#3)(2013-1#2)(2013-8#2)
representing three##2##2##(2008-10#2)
representing unique##2##2##(2008-10#1)(2010-4#1)
representing various##4##2##(1992-3#1)(1993-8#1)(2008-10#2)
representing##241##1##(1990-11#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#5)(2008-10#62)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#8)
represents 1##2##2##(2007-10#1)(2012-3#1)
represents a challenge for##2##4##(2008-7#1)(2012-12#1)
represents a complex##2##3##(1994-11#1)(2009-10#1)
represents a form of##2##4##(2009-11#1)(2009-9#1)
represents a fundamental##2##3##(2008-11#1)(2009-6#1)
represents a general##2##3##(1994-8#1)(1995-2#1)
represents a key##3##3##(1990-8#1)(2008-9#1)(2009-10#1)
represents a limiting##2##3##(1994-11#1)(2008-11#1)
represents a major challenge##2##4##(1991-1#1)(2008-7#1)
represents a major limitation to##2##5##(2008-11#1)(2008-6#1)
represents a major threat to##2##5##(1997-5#1)(2011-2#1)
represents a major##12##3##(1991-1#1)(1993-11#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2011-2#2)
represents a mechanism##3##3##(1993-3#1)(1995-2#1)(1996-12#1)
represents a new approach##2##4##(1992-2#1)(2008-10#1)
represents a new##10##3##(1991-5#1)(1992-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)
represents a novel and##4##4##(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)
represents a novel##7##3##(1991-11#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)
represents a potential health##2##4##(2007-5#1)(2008-7#1)
represents a potential##3##3##(1993-8#1)(2007-5#1)(2008-7#1)
represents a potentially##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
represents a powerful##2##3##(2008-11#1)(2012-3#1)
represents a promising technique##2##4##(2008-3#1)(2010-3#1)
represents a promising##6##3##(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
represents a safe and##3##4##(1995-11#1)(1995-8#1)(2007-8#1)
represents a serious##3##3##(2008-10#1)(2012-12#2)
represents a significant improvement in##2##5##(1990-2#1)(2008-11#1)
represents a significant improvement##3##4##(1990-2#1)(2008-11#1)(2010-5#1)
represents a significant##11##3##(1990-2#1)(1991-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#1)
represents a simple##2##3##(2008-10#1)(2008-3#1)
represents a small##2##3##(1990-2#1)(1997-7#1)
represents a stable##2##3##(2008-2#1)(2008-5#1)
represents a unique##5##3##(2008-11#1)(2008-8#2)(2009-8#1)(2013-8#1)
represents a useful model for##2##5##(1995-12#1)(2008-10#1)
represents a useful##4##3##(1995-12#1)(2008-10#1)(2009-10#1)(2010-11#1)
represents a valid alternative for the determination of##2##8##(2008-10#2)
represents a valid alternative##3##4##(1992-6#1)(2008-10#2)
represents a valid##4##3##(1990-3#1)(1992-6#1)(2008-10#2)
represents a valuable##3##3##(1990-2#1)(2009-1#1)(2012-3#1)
represents a viable##3##3##(1992-2#1)(2008-11#1)(2013-1#1)
represents a##202##2##(1990-2#3)(1990-3#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-2#3)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#12)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#8)(2013-8#1)
represents about##2##2##(1990-9#1)(2008-8#1)
represents an alternative to##3##4##(2006-12#1)(2008-3#1)(2008-4#1)
represents an alternative##5##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
represents an approach##2##3##(1995-2#1)(2008-10#1)
represents an attractive target for##3##5##(1995-2#1)(2008-11#1)(2011-2#1)
represents an attractive##4##3##(1995-2#1)(1997-3#1)(2008-11#1)(2011-2#1)
represents an exciting##2##3##(2008-4#1)(2009-5#1)
represents an important step##2##4##(2010-11#1)(2012-2#1)
represents an important##10##3##(1994-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-2#2)(2013-7#1)
represents an increase##2##3##(2007-11#1)(2008-11#1)
represents an integration##2##3##(1994-11#1)(1997-5#1)
represents an interesting##3##3##(2008-11#1)(2010-10#1)(2010-11#1)
represents an##69##2##(1991-2#1)(1991-6#2)(1992-11#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-12#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
represents one of the most difficult##3##6##(2007-7#1)(2011-2#1)(2012-2#1)
represents one of the most##7##5##(1995-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
represents one of the##12##4##(1995-1#1)(2007-7#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
represents one of##13##3##(1995-1#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
represents only a##2##3##(1993-6#1)(2011-1#1)
represents only##4##2##(1993-6#1)(2008-11#1)(2008-3#1)(2011-1#1)
represents that##2##2##(1990-8#1)(1992-3#1)
represents the best##2##3##(1997-7#1)(2008-8#1)
represents the first evidence of##2##5##(1992-8#1)(2008-9#1)
represents the first evidence##3##4##(1992-8#1)(2008-9#1)(2013-8#1)
represents the first example of##2##5##(1995-2#1)(2008-10#1)
represents the first report##2##4##(2008-10#2)
represents the first##19##3##(1991-3#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-5#1)(2013-8#1)
represents the highest##3##3##(2006-10#1)(2008-2#2)
represents the major##2##3##(2008-10#1)(2008-7#1)
represents the most common##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
represents the most frequent##2##4##(2012-2#1)(2013-1#1)
represents the most##10##3##(1993-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
represents the primary##2##3##(1990-2#1)(1996-9#1)
represents the second##2##3##(1994-12#1)(2008-6#1)
represents the slope##2##3##(2008-10#1)(2008-2#1)
represents the source of##2##4##(2007-8#1)(2008-1#1)
represents the typical##2##3##(2008-10#1)(2008-7#1)
represents the##109##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#5)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-6#2)(2009-7#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
represents value##2##2##(1994-3#1)(2011-2#1)
represents##460##1##(1990-2#4)(1990-3#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#2)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#10)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#2)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#7)(2007-12#13)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#9)(2008-10#56)(2008-11#18)(2008-12#4)(2008-2#9)(2008-3#15)(2008-4#6)(2008-5#14)(2008-6#8)(2008-7#21)(2008-8#12)(2008-9#11)(2009-1#3)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#23)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#6)(2012-4#1)(2013-1#13)(2013-7#1)(2013-8#3)
repress gene expression##2##3##(2008-4#1)(2013-1#1)
repress the##7##2##(1992-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-7#1)
repress transcription##2##2##(1991-5#1)(2008-4#1)
repress##16##1##(1991-5#1)(1992-12#1)(1993-9#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
repressed by##7##2##(1993-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(2008-9#1)(2012-2#1)
repressed expression after pathogen infection##2##5##(2008-9#2)
repressed expression##3##2##(2008-9#2)(2009-10#1)
repressed in the##2##3##(1990-5#1)(1994-12#1)
repressed in##5##2##(1990-5#1)(1993-3#1)(1994-12#1)(1997-7#1)(2008-11#1)
repressed the expression of##2##4##(1993-6#1)(2008-11#1)
repressed##26##1##(1990-11#1)(1990-5#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2012-2#1)
represses the##3##2##(2008-10#1)(2009-8#1)(2013-1#1)
represses transcription##2##2##(2008-11#1)(2011-1#1)
represses##17##1##(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-10#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#3)
repressible##2##1##(1993-12#1)(1997-7#1)
repressing the##2##2##(2008-11#1)(2011-2#1)
repressing##6##1##(1997-3#1)(2008-11#2)(2011-2#1)(2012-12#1)(2013-1#1)
repression by##8##2##(1993-12#1)(1994-12#1)(1995-3#3)(1995-6#1)(2008-10#2)
repression of c-fos gene##2##4##(1994-11#2)
repression of fabA transcription##2##4##(1992-8#2)
repression of the expression of##2##5##(1995-12#2)
repression of the##7##3##(1990-8#1)(1991-10#1)(1993-5#1)(1995-12#2)(2008-10#1)(2008-11#1)
repression of##27##2##(1990-5#1)(1990-8#1)(1991-10#1)(1992-8#3)(1993-5#1)(1994-11#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#2)(1995-8#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
repression##61##1##(1990-5#2)(1990-8#1)(1991-10#3)(1992-11#1)(1992-8#4)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#6)(1995-6#4)(1995-8#2)(1996-2#1)(1996-3#2)(1996-6#1)(2008-10#11)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)
repressive activity##2##2##(1992-6#1)(2008-4#1)
repressive and##3##2##(1994-8#1)(2009-7#2)
repressive##10##1##(1990-6#1)(1992-6#1)(1994-8#4)(2008-4#1)(2009-7#2)(2012-2#1)
repressor and activator##2##3##(2012-3#2)
repressor and##8##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-6#2)(2010-4#1)(2012-3#2)
repressor is##2##2##(1995-3#1)(1996-2#1)
repressor of##4##2##(1991-10#1)(1992-8#1)(2010-8#1)(2011-2#1)
repressor protein##4##2##(1994-3#1)(1995-8#1)(2008-9#2)
repressor region##2##2##(1992-11#2)
repressor to its##2##3##(2008-11#1)(2008-8#1)
repressor to##3##2##(1995-3#1)(2008-11#1)(2008-8#1)
repressor##65##1##(1990-11#2)(1990-5#3)(1991-10#2)(1991-12#1)(1991-5#1)(1992-11#2)(1992-4#5)(1992-6#5)(1992-8#4)(1993-11#2)(1994-12#1)(1994-3#1)(1995-3#6)(1995-6#1)(1995-8#6)(1996-2#1)(1996-6#1)(2007-11#2)(2008-11#2)(2008-7#1)(2008-8#7)(2008-9#2)(2009-6#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-3#2)
repressor/operator##3##1##(1990-5#1)(1994-3#2)
repressors of##2##2##(1994-9#1)(2009-8#1)
repressors##8##1##(1990-5#1)(1991-5#1)(1992-4#1)(1994-9#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-8#1)
reprint##2##1##(1991-3#2)
reprinted from##3##2##(1993-1#1)(1995-1#1)(1995-2#1)
reprinted in##3##2##(1994-12#1)(1995-2#1)(1996-2#1)
reprinted##7##1##(1993-1#1)(1994-12#1)(1995-1#1)(1995-2#3)(1996-2#1)
reprocessing of##2##2##(2008-3#1)(2011-2#1)
reprocessing##8##1##(1995-2#1)(2008-1#3)(2008-10#1)(2008-3#1)(2011-2#2)
reproduce in##2##2##(2008-10#1)(2013-8#1)
reproduce our##2##2##(2008-10#1)(2008-3#1)
reproduce the behavior##2##3##(2008-11#1)(2008-8#1)
reproduce the experimental##3##3##(1993-11#1)(2008-11#1)(2008-12#1)
reproduce the##21##2##(1993-11#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-8#2)(2008-9#1)(2012-1#1)(2013-1#1)
reproduce this##2##2##(2008-3#1)(2008-9#1)
reproduce##59##1##(1992-7#1)(1992-9#2)(1993-11#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#5)(2009-11#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#3)
reproduced and##2##2##(2008-10#1)(2008-8#1)
reproduced by the##2##3##(2008-10#1)(2009-8#1)
reproduced by##11##2##(1990-6#1)(1991-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-2#1)
reproduced in##10##2##(1992-11#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
reproduced on the##2##3##(2008-10#2)
reproduced the##3##2##(1994-6#1)(2008-2#1)(2011-2#1)
reproduced when##2##2##(2008-10#1)(2011-2#1)
reproduced with a##4##3##(1991-8#1)(1992-3#1)(2008-10#1)(2008-2#1)
reproduced with##8##2##(1991-8#1)(1992-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)
reproduced##57##1##(1990-6#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#5)(2012-3#1)(2013-1#1)
reproduces all##2##2##(2008-10#1)(2013-7#1)
reproduces at##2##2##(2008-10#1)(2008-8#1)
reproduces the in vivo##2##4##(1995-3#1)(2008-5#1)
reproduces the##6##2##(1995-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
reproduces##15##1##(1995-3#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
reproducibilities##4##1##(2008-10#4)
reproducibility ( approximately##2##3##(2008-10#2)
reproducibility (0##2##2##(2008-10#2)
reproducibility (S##4##2##(2008-10#4)
reproducibility (n=5) of##2##3##(2008-10#2)
reproducibility and accuracy of##3##4##(1991-3#1)(2008-10#2)
reproducibility and accuracy##5##3##(1991-3#1)(2008-10#3)(2013-1#1)
reproducibility and detection##2##3##(2008-10#2)
reproducibility and high##2##3##(2008-10#2)
reproducibility and lifetime##3##3##(2008-10#3)
reproducibility and recovery##2##3##(2008-10#1)(2012-1#1)
reproducibility and reliability of##4##4##(2008-10#3)(2008-11#1)
reproducibility and the##2##3##(2008-10#2)
reproducibility and##35##2##(1991-3#1)(2008-10#24)(2008-11#2)(2008-5#3)(2009-11#1)(2012-1#1)(2012-3#1)(2013-1#2)
reproducibility are##3##2##(1991-5#1)(2008-10#2)
reproducibility between##4##2##(2008-10#4)
reproducibility for the##2##3##(2008-10#2)
reproducibility for##5##2##(2008-10#4)(2010-9#1)
reproducibility in the##2##3##(2007-10#1)(2008-10#1)
reproducibility in##3##2##(2007-10#1)(2008-10#1)(2009-1#1)
reproducibility is around##2##3##(2008-10#2)
reproducibility is##9##2##(1997-2#1)(2008-1#1)(2008-10#6)(2008-5#1)
reproducibility obtained##2##2##(2008-10#2)
reproducibility of 1##4##3##(2008-10#4)
reproducibility of different##2##3##(2008-10#2)
reproducibility of the method##8##4##(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#2)
reproducibility of the results##5##4##(1996-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
reproducibility of the system##2##4##(2008-10#1)(2008-2#1)
reproducibility of the tumor position##2##5##(2009-11#2)
reproducibility of the##41##3##(1995-3#1)(1996-12#1)(1997-8#1)(2007-10#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2010-7#2)(2012-2#1)(2013-8#1)
reproducibility of these##2##3##(2008-10#1)(2012-2#1)
reproducibility of##77##2##(1994-9#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-10#2)(2008-10#39)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#2)(2012-2#3)(2012-3#1)(2013-8#1)
reproducibility to##3##2##(2008-10#2)(2008-2#1)
reproducibility was good and little carryover was found##2##8##(2008-10#2)
reproducibility was##18##2##(1990-2#1)(2008-10#15)(2008-5#1)(2009-11#1)
reproducibility were##4##2##(2008-10#4)
reproducibility with##5##2##(2008-10#5)
reproducibility##299##1##(1990-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1994-9#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-8#5)(2007-10#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#205)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#10)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#4)(2009-2#1)(2009-8#1)(2010-11#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-7#1)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#3)
reproducible (relative standard##2##3##(2008-10#2)
reproducible and highly##2##3##(2008-10#1)(2008-11#1)
reproducible and reliable##2##3##(1991-5#1)(2010-8#1)
reproducible and selective##2##3##(2008-10#2)
reproducible and sensitive##3##3##(1990-12#1)(1996-5#1)(2008-10#1)
reproducible and specific##3##3##(1996-5#1)(2008-10#2)
reproducible and stable##2##3##(2008-10#2)
reproducible and##41##2##(1990-12#1)(1991-5#1)(1991-9#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2010-5#1)(2010-8#1)(2011-1#1)
reproducible experimental results##2##3##(2008-11#1)(2008-9#1)
reproducible experimental##4##2##(2008-11#3)(2008-9#1)
reproducible for##2##2##(1995-12#1)(2008-10#1)
reproducible method##10##2##(1994-6#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-11#1)(2011-2#1)
reproducible model of##3##3##(2007-8#2)(2008-7#1)
reproducible model##5##2##(2007-6#1)(2007-8#2)(2008-7#1)(2008-9#1)
reproducible response of##2##3##(2008-10#2)
reproducible response##4##2##(2008-10#4)
reproducible results and##2##3##(1991-5#1)(2008-10#1)
reproducible results##9##2##(1990-12#1)(1991-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)
reproducible with a##2##3##(1993-9#1)(2008-10#1)
reproducible with##3##2##(1993-9#1)(2008-10#2)
reproducible within a relative standard deviation of 1##2##8##(2008-10#2)
reproducible within a##3##3##(2008-10#3)
reproducible within##6##2##(2008-10#6)
reproducible wringing##3##2##(2008-3#3)
reproducible##248##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-3#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-9#1)(1997-2#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#105)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#10)(2008-7#12)(2008-8#4)(2008-9#10)(2009-1#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
reproducibly##15##1##(1991-11#1)(1997-2#1)(2008-10#3)(2008-11#4)(2008-6#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#2)
reproducing in##2##2##(2008-5#1)(2008-8#1)
reproducing population##2##2##(2008-8#1)(2009-2#1)
reproducing##20##1##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#2)(2009-4#1)(2009-7#1)(2012-2#1)(2013-8#2)
reproduction among##2##2##(2008-8#2)
reproduction and development##3##3##(2010-5#1)(2011-1#1)(2012-1#1)
reproduction and feeding##2##3##(2008-5#2)
reproduction and life span##2##4##(2008-3#2)
reproduction and##17##2##(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#5)(2008-9#3)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)
reproduction are##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
reproduction by##2##2##(2008-10#1)(2008-3#1)
reproduction can##2##2##(2008-8#1)(2012-3#1)
reproduction cycle##3##2##(2008-7#2)(2008-8#1)
reproduction for##3##2##(2008-8#1)(2008-9#2)
reproduction has##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
reproduction in the##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
reproduction in##16##2##(1990-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-12#1)(2012-3#2)(2013-8#1)
reproduction is##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
reproduction medicine##3##2##(1991-11#2)(1996-9#1)
reproduction mode##2##2##(2008-9#2)
reproduction occurs##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
reproduction of the##8##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-9#1)
reproduction of##26##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#5)(2008-8#3)(2008-9#2)(2009-4#1)(2011-1#1)(2013-1#1)
reproduction on the##2##3##(2008-10#1)(2012-3#1)
reproduction probably##2##2##(2008-10#1)(2008-8#1)
reproduction rate##2##2##(2008-10#2)
reproduction to##2##2##(2008-10#1)(2008-9#1)
reproduction was##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2012-1#1)
reproduction with##2##2##(2008-9#1)(2010-1#1)
reproduction##235##1##(1990-12#1)(1990-7#1)(1991-11#2)(1991-3#2)(1991-6#1)(1992-12#1)(1996-9#1)(1997-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#47)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#9)(2008-8#54)(2008-9#30)(2009-4#2)(2009-5#3)(2009-6#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#4)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#4)(2012-2#1)(2012-3#7)(2013-1#5)(2013-7#3)(2013-8#2)
reproduction?##2##1##(2008-8#1)(2010-3#1)
reproduction]##2##1##(1991-11#1)(1996-9#1)
reproductive age groups##3##3##(2011-2#3)
reproductive age##14##2##(1993-6#1)(1994-9#1)(2008-3#2)(2010-11#1)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#1)
reproductive and developmental##3##3##(2008-11#1)(2010-1#1)(2012-1#1)
reproductive and sexual health##2##4##(2008-11#2)
reproductive and##11##2##(1997-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-1#1)(2010-3#1)(2012-1#1)(2013-7#1)
reproductive assurance##2##2##(2008-9#2)
reproductive axis##2##2##(2008-3#1)(2008-4#1)
reproductive behavior##3##2##(1996-2#1)(2008-5#1)(2008-6#1)
reproductive biology##4##2##(2008-12#1)(2009-3#1)(2009-6#1)(2013-8#1)
reproductive capacity##2##2##(2008-10#1)(2013-7#1)
reproductive competition##3##2##(2008-9#3)
reproductive cost##2##2##(2008-9#2)
reproductive costs##2##2##(2008-8#1)(2008-9#1)
reproductive cycle##4##2##(1990-12#2)(2012-12#2)
reproductive development##2##2##(2008-10#1)(2009-10#1)
reproductive diapause##2##2##(2008-8#2)
reproductive disorders##3##2##(2008-10#2)(2010-3#1)
reproductive dormancy##3##2##(2008-8#3)
reproductive effort in##2##3##(2008-8#2)
reproductive effort##14##2##(2008-8#11)(2008-9#1)(2010-8#2)
reproductive events##3##2##(1991-12#1)(2008-8#1)(2012-2#1)
reproductive factors##2##2##(1990-6#1)(2008-10#1)
reproductive function##9##2##(1992-3#1)(2008-4#2)(2008-6#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-8#2)
reproductive functions##4##2##(1994-6#2)(2008-12#1)(2008-3#1)
reproductive health in##3##3##(2008-1#1)(2012-12#2)
reproductive health needs##2##3##(2008-1#1)(2013-1#1)
reproductive health outcomes##2##3##(2013-1#2)
reproductive health services##5##3##(1995-6#1)(2008-1#1)(2008-11#3)
reproductive health##36##2##(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(2008-1#7)(2008-11#10)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#1)
reproductive history##3##2##(1990-6#1)(2008-12#1)(2012-12#1)
reproductive investment##2##2##(2010-8#2)
reproductive isolation between##5##3##(2008-8#4)(2012-3#1)
reproductive isolation in##2##3##(2008-8#1)(2008-9#1)
reproductive isolation is##3##3##(2008-8#1)(2008-9#2)
reproductive isolation##20##2##(1996-6#1)(2008-8#12)(2008-9#5)(2009-2#1)(2012-3#1)
reproductive life##2##2##(2009-7#1)(2012-12#1)
reproductive lifespan##3##2##(2009-12#3)
reproductive number##9##2##(2008-10#6)(2008-8#1)(2011-3#1)(2013-8#1)
reproductive organs##7##2##(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)
reproductive outcome##6##2##(1992-3#3)(1994-9#1)(2009-5#1)(2011-1#1)
reproductive outcomes##2##2##(2010-9#1)(2011-2#1)
reproductive output and##2##3##(2008-8#2)
reproductive output##9##2##(2008-10#1)(2008-8#7)(2008-9#1)
reproductive parasitism##2##2##(2008-9#2)
reproductive performance of the##2##4##(2008-10#1)(2010-8#1)
reproductive performance of##6##3##(2008-10#1)(2008-12#1)(2009-5#2)(2010-8#2)
reproductive performance##8##2##(1996-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#2)(2010-8#2)
reproductive period##9##2##(1997-4#8)(2013-1#1)
reproductive potential##12##2##(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#2)(2013-8#3)
reproductive rate of##2##3##(2008-9#1)(2012-12#1)
reproductive rate##10##2##(2008-8#3)(2008-9#1)(2011-2#2)(2012-12#3)(2012-2#1)
reproductive roles##3##2##(1996-12#1)(2008-9#2)
reproductive rounds##3##2##(1997-4#3)
reproductive strategies##2##2##(2008-5#1)(2012-3#1)
reproductive strategy##2##2##(2008-10#1)(2013-8#1)
reproductive structure of##2##3##(2011-2#2)
reproductive structure##3##2##(2011-2#3)
reproductive success and##3##3##(2008-9#2)(2009-12#1)
reproductive success for##2##3##(2008-10#1)(2009-12#1)
reproductive success from##2##3##(2008-9#1)(2009-12#1)
reproductive success in##4##3##(2008-9#2)(2010-8#1)(2012-3#1)
reproductive success of##13##3##(1996-6#1)(2008-6#2)(2008-8#1)(2008-9#5)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
reproductive success than##2##3##(2008-9#2)
reproductive success was positively##2##4##(2008-8#1)(2009-12#1)
reproductive success was##4##3##(2008-10#1)(2008-8#2)(2009-12#1)
reproductive success##55##2##(1996-6#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#13)(2008-9#20)(2009-12#8)(2010-8#2)(2012-2#1)(2012-3#5)
reproductive surgery##3##2##(1992-2#2)(1992-3#1)
reproductive system##13##2##(1993-3#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-2#1)
reproductive tactics##3##2##(2008-8#1)(2010-8#2)
reproductive technologies##4##2##(1992-2#2)(2008-11#1)(2011-1#1)
reproductive technology##3##2##(1996-12#1)(2007-2#1)(2012-3#1)
reproductive tissues##3##2##(1991-12#1)(2008-10#1)(2008-4#1)
reproductive tract including##2##3##(1994-9#1)(2011-1#1)
reproductive tract infections##5##3##(2011-1#5)
reproductive tract of##2##3##(2013-1#2)
reproductive tract##27##2##(1990-11#1)(1991-12#1)(1993-2#1)(1994-9#2)(1996-12#6)(2007-12#1)(2008-11#1)(2010-3#1)(2011-1#10)(2011-2#1)(2013-1#2)
reproductive tracts##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
reproductive traits of##2##3##(2012-12#1)(2012-3#1)
reproductive traits that##2##3##(1995-2#1)(2012-3#1)
reproductive traits##10##2##(1995-2#1)(2008-8#1)(2008-9#1)(2009-7#3)(2012-12#2)(2012-3#2)
reproductive vacancies##3##2##(2008-9#3)
reproductive##488##1##(1990-11#1)(1990-12#2)(1990-6#2)(1991-1#2)(1991-12#4)(1991-6#2)(1992-2#5)(1992-3#5)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-6#2)(1994-9#5)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#9)(1996-2#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-4#19)(2007-10#1)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#8)(2008-10#28)(2008-11#17)(2008-12#11)(2008-3#7)(2008-4#6)(2008-5#11)(2008-6#7)(2008-7#11)(2008-8#77)(2008-9#55)(2009-10#2)(2009-12#13)(2009-2#1)(2009-3#1)(2009-5#5)(2009-6#2)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-8#18)(2010-9#1)(2011-1#18)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#18)(2012-2#7)(2012-3#14)(2012-8#2)(2013-1#10)(2013-7#4)(2013-8#10)
reproductively active##2##2##(1995-12#1)(2012-3#1)
reproductively isolated##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
reproductively##8##1##(1995-12#1)(2008-10#1)(2008-6#1)(2008-8#3)(2009-12#1)(2012-3#1)
reproductives##4##1##(2007-12#4)
reproductivity##2##1##(2008-10#2)
reprogramming##8##1##(1990-11#1)(2008-8#2)(2008-9#1)(2009-3#3)(2010-7#1)
reprotonation##3##1##(2008-10#3)
reps during##2##2##(2013-1#2)
reptile species##2##2##(2008-10#1)(2010-3#1)
reptile##8##1##(1995-3#1)(2008-10#1)(2008-8#1)(2010-3#2)(2012-3#2)(2013-7#1)
reptiles and##2##2##(2010-3#2)
reptiles##14##1##(2008-8#1)(2010-3#12)(2011-1#1)
reptilian genomes##3##2##(2010-3#3)
reptilian species##3##2##(2008-10#1)(2010-3#2)
reptilian##13##1##(2008-10#1)(2009-10#1)(2010-3#10)(2011-2#1)
republic of##4##2##(2012-2#1)(2013-8#3)
repulsion and##2##2##(1990-8#1)(1994-12#1)
repulsion between##5##2##(1997-7#1)(2008-10#2)(2008-9#2)
repulsion is##2##2##(1993-9#1)(1996-7#1)
repulsion of##2##2##(2007-12#1)(2012-2#1)
repulsion phase##3##2##(2008-10#3)
repulsion##29##1##(1990-8#1)(1992-6#1)(1993-9#3)(1994-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#9)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2012-2#1)
repulsions##3##1##(2008-10#1)(2010-5#1)(2012-2#1)
repulsive##4##1##(2007-11#2)(2008-11#1)(2010-2#1)
repurified##2##1##(1990-8#1)(2008-8#1)
repurposing##3##1##(2012-1#3)
reputation as##2##2##(2008-7#1)(2009-10#1)
reputation##19##1##(1990-4#1)(1992-12#2)(1996-1#7)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#1)(2012-2#1)(2013-8#2)
request for##11##2##(1990-3#1)(1991-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(1997-6#1)(2008-1#2)(2008-11#1)(2010-11#1)
request in##2##2##(1995-12#1)(2007-8#1)
request of the##7##3##(1990-11#1)(1997-4#1)(2008-10#4)(2008-3#1)
request of##10##2##(1990-11#1)(1991-12#1)(1997-4#1)(2008-10#4)(2008-3#1)(2012-1#1)(2013-8#1)
request##50##1##(1990-11#1)(1990-3#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-12#2)(1992-3#1)(1994-12#2)(1994-2#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#3)(1996-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-12#1)(2013-8#3)
requested by the##2##3##(1991-3#1)(2010-3#1)
requested by##4##2##(1991-3#1)(1995-1#1)(2010-3#1)(2010-8#1)
requested to##5##2##(1991-11#1)(2008-11#2)(2010-1#1)(2012-2#1)
requested##26##1##(1991-11#1)(1991-3#1)(1993-12#1)(1993-8#1)(1995-1#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-5#2)(2010-1#1)(2010-3#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-8#2)
requesting support##2##2##(2012-12#2)
requesting##15##1##(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1996-1#1)(1996-9#1)(2008-9#1)(2010-10#1)(2010-3#2)(2010-8#2)(2012-12#2)
requests and##2##2##(1991-8#1)(1995-12#1)
requests are##3##2##(1991-8#1)(1992-2#1)(1992-8#1)
requests for##6##2##(1992-12#1)(1994-1#1)(1994-2#1)(1997-3#1)(2008-11#1)(2010-8#1)
requests to##3##2##(1997-5#1)(2010-5#1)(2012-2#1)
requests##28##1##(1991-8#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
require a change in##2##4##(2012-12#1)(2013-8#1)
require a great##2##3##(1991-6#1)(2008-10#1)
require a new##2##3##(1994-1#1)(2009-5#1)
require a significant##2##3##(2008-11#1)(2009-3#1)
require a##68##2##(1990-8#1)(1991-6#1)(1992-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
require activation of##2##3##(1996-2#1)(2008-4#1)
require activation##3##2##(1995-6#1)(1996-2#1)(2008-4#1)
require active participation##2##3##(1996-12#1)(2010-1#1)
require active##6##2##(1994-8#1)(1996-12#1)(2008-7#1)(2009-5#1)(2010-1#1)(2012-3#1)
require additional##6##2##(1994-2#1)(2007-10#1)(2007-12#1)(2009-8#1)(2012-12#1)(2013-1#1)
require an understanding of##2##4##(2008-8#1)(2008-9#1)
require an##12##2##(1990-12#1)(1991-3#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-10#1)
require and##3##2##(1994-3#1)(2009-6#1)(2012-12#1)
require approximately##2##2##(2008-10#1)(2008-11#1)
require being##2##2##(2008-10#1)(2013-8#1)
require both##4##2##(1990-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
require cardiac##2##2##(2007-8#2)
require careful attention##2##3##(1992-3#1)(2008-7#1)
require careful##3##2##(1992-3#1)(2008-11#1)(2008-7#1)
require changes in##2##3##(2008-11#1)(2012-2#1)
require close##3##2##(1991-2#1)(1993-8#1)(2009-6#1)
require complete##4##2##(1992-6#1)(2007-11#1)(2008-2#1)(2012-3#1)
require complex##5##2##(1995-12#2)(2008-11#1)(2010-10#1)(2013-1#1)
require confirmation##2##2##(1996-7#1)(2008-10#1)
require considerable##4##2##(1995-12#1)(2007-11#1)(2008-10#1)(2013-1#1)
require continued##2##2##(2008-11#1)(2011-2#1)
require conversion##2##2##(1991-9#1)(2008-4#1)
require different##4##2##(1994-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
require extensive##3##2##(1993-2#1)(1994-12#1)(2008-11#1)
require extra##2##2##(1997-8#1)(2008-11#1)
require further investigation##4##3##(1995-5#1)(2008-10#1)(2010-3#1)(2013-8#1)
require further research##2##3##(2008-11#1)(2013-1#1)
require further study##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
require further##16##2##(1992-12#1)(1995-5#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
require high##3##2##(1994-6#1)(2007-11#1)(2008-1#1)
require higher##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
require immediate##3##2##(2007-11#1)(2008-6#1)(2009-4#1)
require in##2##2##(2008-3#1)(2008-4#1)
require information##2##2##(2008-10#1)(2008-4#1)
require initial##2##2##(2007-12#1)(2008-11#1)
require integration of##2##3##(2012-2#1)(2013-1#1)
require intensive##3##2##(2010-12#1)(2011-1#1)(2012-2#1)
require investigation##2##2##(2008-10#1)(2013-8#1)
require knowledge of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
require knowledge##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
require large##2##2##(1997-5#1)(2008-10#1)
require less##4##2##(1994-11#1)(1996-2#1)(2008-7#1)(2012-3#1)
require lithographic##2##2##(2007-12#1)(2008-7#1)
require long-term##3##2##(1992-1#1)(2007-7#1)(2011-2#1)
require many##2##2##(2008-2#1)(2008-7#1)
require medical##2##2##(1993-12#1)(2013-8#1)
require modification##2##2##(2008-11#1)(2013-1#1)
require more information about##2##4##(2008-5#1)(2012-12#1)
require more##14##2##(1994-12#1)(1995-4#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-12#2)(2013-1#1)
require new and##2##3##(1990-12#1)(1996-3#1)
require new approaches##3##3##(2007-8#1)(2007-9#1)(2010-12#1)
require new##10##2##(1990-12#1)(1990-3#1)(1992-1#1)(1995-3#1)(1996-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-12#1)(2010-9#1)
require nuclear##2##2##(2008-8#1)(2011-2#1)
require only one##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
require only##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)
require orthopedic##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
require prior##2##2##(2008-10#1)(2009-7#1)
require public##2##2##(1996-3#1)(2008-12#1)
require several years##2##3##(1992-12#1)(2008-10#1)
require several##4##2##(1992-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
require significant##3##2##(2008-6#1)(2009-3#1)(2012-2#1)
require skills##2##2##(2008-11#1)(2008-9#1)
require solutions##2##2##(2008-10#1)(2010-7#1)
require specialized##2##2##(2008-9#2)
require specific##6##2##(1991-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-1#1)(2012-2#1)
require suitable##2##2##(2008-1#1)(2008-10#1)
require surgery##5##2##(1991-5#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-2#1)
require surgical repair##2##3##(2008-7#1)(2011-2#1)
require surgical##6##2##(1991-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
require that the##4##3##(1992-2#1)(2008-9#1)(2012-1#1)(2012-12#1)
require that##11##2##(1992-1#1)(1992-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2012-1#1)(2012-12#1)
require the activation of##2##4##(1996-2#1)(2013-1#1)
require the addition of##4##4##(1992-9#1)(2008-3#1)(2008-5#1)(2012-3#1)
require the development##2##3##(2008-10#1)(2009-12#1)
require the expensive##2##3##(2009-10#1)(2011-2#1)
require the input of##2##4##(2009-11#1)(2011-3#1)
require the presence of##2##4##(2008-10#1)(2008-3#1)
require the use of##7##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)
require the use##8##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-12#1)
require the##56##2##(1991-2#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#3)(2013-8#1)
require treatment##4##2##(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
require use of##2##3##(1994-2#1)(2008-4#1)
require validation##2##2##(2013-1#1)(2013-7#1)
require very little##2##3##(2008-4#1)(2008-9#1)
require very##4##2##(2008-4#1)(2008-9#3)
require##623##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#8)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#4)(1992-12#4)(1992-2#1)(1992-3#6)(1992-6#2)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#7)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#6)(1996-3#7)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#11)(2007-12#17)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#70)(2008-11#29)(2008-12#4)(2008-2#14)(2008-3#32)(2008-4#20)(2008-5#8)(2008-6#11)(2008-7#18)(2008-8#10)(2008-9#27)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#22)(2011-3#2)(2012-1#5)(2012-12#14)(2012-2#21)(2012-3#8)(2013-1#30)(2013-7#1)(2013-8#8)
required NADPH##3##2##(1990-11#1)(1995-6#1)(2008-11#1)
required a dose##2##3##(1990-8#1)(2008-10#1)
required a second##6##3##(1990-12#1)(1994-9#1)(1995-2#1)(1996-1#1)(2009-7#1)(2012-12#1)
required a total of##2##4##(2011-2#1)(2013-1#1)
required a##27##2##(1990-12#1)(1990-8#1)(1991-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2009-7#1)(2011-2#2)(2012-12#2)(2013-1#2)
required additional##3##2##(1997-8#1)(2008-6#1)(2013-1#1)
required admission to the##2##4##(2012-3#1)(2013-1#1)
required admission to##3##3##(2012-3#1)(2013-1#2)
required after##2##2##(2007-11#1)(2008-10#1)
required an##5##2##(2008-1#1)(2008-11#1)(2008-8#1)(2010-3#1)(2013-8#1)
required and can##2##3##(1994-12#1)(1994-3#1)
required and##8##2##(1990-6#1)(1994-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#2)
required approximately##2##2##(2008-10#2)
required are##2##2##(1995-12#1)(2008-11#1)
required as an##2##3##(2008-11#1)(2012-2#1)
required as##9##2##(1990-8#1)(1994-11#1)(2008-10#3)(2008-11#1)(2010-10#1)(2012-2#1)(2012-3#1)
required at least##2##3##(1995-2#1)(2007-12#1)
required at##7##2##(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
required before##6##2##(1992-3#1)(1994-8#1)(1997-1#1)(1997-3#1)(2008-11#1)(2010-4#1)
required by most##2##3##(1995-6#1)(2007-11#1)
required by the##16##3##(1990-8#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-10#1)(2009-2#1)(2010-7#1)(2012-2#2)(2012-3#1)
required by these##2##3##(2010-5#1)(2012-3#1)
required by##50##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(2007-11#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
required cardiopulmonary bypass##2##3##(2008-7#1)(2013-1#1)
required cofactors for##2##3##(2012-12#2)
required conversion to##2##3##(2007-8#2)
required costly equipment##2##3##(2012-2#2)
required data##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
required dialysis for##2##3##(2008-1#1)(2013-8#1)
required dialysis##3##2##(2008-1#1)(2008-4#1)(2013-8#1)
required divalent cations such as##2##5##(1994-6#1)(1995-2#1)
required due to the##3##4##(2008-10#2)(2012-3#1)
required during##3##2##(1992-12#1)(2008-2#1)(2011-2#1)
required fewer##2##2##(1996-11#1)(2008-10#1)
required for 90% control of the disease##2##7##(2008-10#2)
required for 90%##3##3##(2008-10#3)
required for DNA synthesis##2##4##(1993-11#1)(1995-11#1)
required for a##13##3##(1991-11#1)(1992-9#1)(1994-12#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
required for accurate##4##3##(2008-10#2)(2008-6#1)(2010-4#1)
required for activity##2##3##(1994-3#1)(2008-4#1)
required for all##2##3##(2008-10#1)(2011-2#1)
required for an##3##3##(1994-8#1)(1997-4#1)(2008-5#1)
required for analysis##2##3##(2008-10#1)(2008-3#1)
required for both##9##3##(1992-3#1)(1993-12#1)(1994-5#1)(1994-9#2)(1995-2#1)(2007-12#1)(2008-3#1)(2009-7#1)
required for complete##3##3##(1996-2#1)(2008-7#1)(2010-7#1)
required for development##2##3##(2008-10#2)
required for effective##4##3##(2008-12#1)(2009-10#1)(2011-2#1)(2013-1#1)
required for efficient##2##3##(1995-6#1)(2011-1#1)
required for extracellular secretion of pullulanase##2##6##(1993-9#2)
required for extracellular secretion of##3##5##(1993-9#3)
required for formation##2##3##(1993-2#1)(2009-8#1)
required for full##4##3##(1995-12#1)(2007-11#1)(2008-10#2)
required for growth##6##3##(1996-8#1)(1997-4#2)(2008-11#1)(2008-7#1)(2011-2#1)
required for half-maximal inhibition##2##4##(1990-5#1)(1995-6#1)
required for high-level expression##2##4##(1994-12#1)(1996-3#1)
required for infection and##2##4##(2008-10#2)
required for infection##4##3##(2008-10#4)
required for inhibition##2##3##(1990-5#1)(2008-10#1)
required for its##5##3##(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
required for maintenance of##3##4##(1995-2#1)(2008-11#1)(2010-1#1)
required for male##2##3##(2007-12#1)(2008-9#1)
required for maximal##4##3##(1991-5#1)(1997-3#2)(2008-4#1)
required for mitogenic##2##3##(1994-11#1)(1996-2#1)
required for modeling##2##3##(2007-12#1)(2008-2#1)
required for normal##6##3##(1992-3#1)(2008-9#1)(2009-3#1)(2010-9#1)(2012-2#1)(2012-3#1)
required for nuclear migration in differentiating##2##6##(2008-9#2)
required for nuclear##4##3##(1994-8#1)(1995-2#1)(2008-9#2)
required for obtaining##2##3##(2008-10#2)
required for optimal##3##3##(1995-3#1)(1995-5#1)(2012-3#1)
required for pathogen##3##3##(2008-10#2)(2011-2#1)
required for persistence##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
required for pollen##3##3##(2008-10#1)(2009-10#2)
required for proper##7##3##(1995-11#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
required for restoration of##2##4##(2008-7#1)(2010-2#1)
required for sample##2##3##(2008-10#2)
required for secretion of##2##4##(1993-9#1)(1995-2#1)
required for secretion##3##3##(1993-9#1)(1995-2#2)
required for significant##2##3##(2008-10#1)(2009-7#1)
required for sporulation##2##3##(1995-9#2)
required for stable##2##3##(1997-7#1)(2007-11#1)
required for successful##3##3##(1991-1#1)(2008-1#1)(2008-11#1)
required for synthesis of##3##4##(1993-11#1)(1994-12#1)(2008-10#1)
required for the control of##2##5##(1993-9#1)(2008-10#1)
required for the determination of##3##5##(1993-12#1)(2008-10#2)
required for the determination##5##4##(1993-12#1)(2008-10#3)(2010-11#1)
required for the diagnosis##3##4##(2010-8#1)(2013-1#2)
required for the first##2##4##(2008-9#1)(2010-4#1)
required for the formation of##4##5##(1993-12#1)(1993-2#1)(2008-10#1)(2013-1#1)
required for the production of##3##5##(1991-5#1)(1991-9#1)(2013-1#1)
required for the##97##3##(1990-11#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-8#2)(1997-3#1)(2006-10#1)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#6)(2013-7#2)
required for their##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
required for these##2##3##(1991-12#1)(2008-3#1)
required for this##5##3##(1990-5#1)(1994-11#1)(2008-9#1)(2012-12#1)(2012-2#1)
required for transcription##3##3##(1992-6#1)(1993-12#1)(2008-7#1)
required for##534##2##(1990-11#3)(1990-5#5)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#3)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#7)(1994-11#5)(1994-12#5)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#14)(1994-9#2)(1995-11#6)(1995-12#2)(1995-2#14)(1995-3#5)(1995-5#2)(1995-6#13)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#5)(2006-10#1)(2006-6#1)(2007-11#4)(2007-12#11)(2008-1#4)(2008-10#82)(2008-11#18)(2008-12#3)(2008-2#12)(2008-3#23)(2008-4#14)(2008-5#5)(2008-6#7)(2008-7#16)(2008-8#9)(2008-9#16)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#17)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#11)(2013-1#12)(2013-7#3)(2013-8#6)
required four##2##2##(2008-3#1)(2008-4#1)
required from##3##2##(1992-12#1)(2010-6#1)(2013-1#1)
required ground##2##2##(2008-10#1)(2008-3#1)
required hemodialysis##2##2##(2008-7#2)
required high##3##2##(1992-8#1)(1993-9#1)(2007-12#1)
required higher##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
required hospitalization##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
required if##3##2##(1993-3#1)(1997-6#1)(2013-1#1)
required in addition to##2##4##(2008-12#1)(2008-2#1)
required in order to achieve##2##5##(1994-5#1)(1995-12#1)
required in order to##7##4##(1994-12#1)(1994-5#1)(1995-12#1)(2007-11#1)(2008-4#1)(2010-11#1)(2010-6#1)
required in patients with##2##4##(2007-8#1)(2012-2#1)
required in some##2##3##(2011-2#1)(2012-3#1)
required in the##11##3##(1991-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
required in these##2##3##(1996-12#1)(2008-10#1)
required in this##6##3##(1992-11#1)(2007-8#1)(2008-10#2)(2010-6#1)(2013-1#1)
required in##60##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
required is##3##2##(1993-11#1)(2008-3#1)(2008-4#1)
required less##5##2##(1993-2#1)(1996-3#1)(1997-2#1)(2008-7#1)(2010-9#1)
required long##2##2##(1992-12#1)(2008-9#1)
required longer##2##2##(2008-10#1)(2013-1#1)
required medical##2##2##(1993-12#1)(1995-12#1)
required minimal##3##2##(2008-10#2)(2011-2#1)
required more than##3##3##(1993-12#1)(2008-10#1)(2011-1#1)
required more##4##2##(1993-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
required much##2##2##(1993-9#1)(2008-10#1)
required no##2##2##(2007-7#1)(2008-10#1)
required number of##4##3##(1996-3#2)(2008-11#1)(2012-3#1)
required of the##2##3##(2008-3#1)(2011-2#1)
required of##7##2##(1994-3#2)(1996-2#1)(2008-2#1)(2008-3#2)(2011-2#1)
required on the##3##3##(1997-5#1)(2008-12#1)(2010-11#1)
required on##5##2##(1997-5#1)(2008-12#1)(2010-11#2)(2013-8#1)
required only##7##2##(1990-2#1)(1991-3#1)(1994-8#1)(2008-10#3)(2013-8#1)
required operative##2##2##(2007-8#1)(2008-4#1)
required precursor for##2##3##(2009-5#1)(2010-11#1)
required removal##3##2##(2008-6#1)(2008-9#1)(2010-12#1)
required reoperation##2##2##(2007-11#1)(2008-6#1)
required respirator use##3##3##(2008-12#3)
required revision##2##2##(2008-9#1)(2012-12#1)
required significantly##2##2##(2008-10#1)(2012-3#1)
required standard##2##2##(1990-11#1)(2008-10#1)
required subsequent##2##2##(1994-12#1)(2013-1#1)
required suction curettage##2##3##(1995-8#2)
required support##3##2##(1996-3#1)(2007-8#2)
required surgical##4##2##(1990-8#1)(1990-9#1)(1991-8#1)(2010-7#1)
required that##4##2##(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
required the development of##2##4##(1997-1#1)(2011-1#1)
required the presence of##2##4##(1991-3#1)(1997-3#1)
required the use of##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
required the##17##2##(1991-3#1)(1993-6#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
required time for##2##3##(2008-10#1)(2008-12#1)
required time of##2##3##(2007-8#1)(2008-10#1)
required time##4##2##(2007-8#1)(2008-10#2)(2008-12#1)
required to accurately##2##3##(2008-6#1)(2008-7#1)
required to achieve##11##3##(1994-12#1)(1996-1#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
required to activate the##2##4##(1990-5#1)(1992-6#1)
required to assess##2##3##(1996-1#1)(2008-10#1)
required to be##6##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)
required to better##3##3##(1990-6#1)(2008-11#1)(2013-1#1)
required to cause##2##3##(1995-3#1)(1995-8#1)
required to clarify the##3##4##(2010-8#1)(2011-2#1)(2012-2#1)
required to clarify##5##3##(1994-9#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
required to complement##2##3##(1995-5#1)(2012-3#1)
required to complete##4##3##(1993-12#1)(2008-10#1)(2008-12#1)(2013-7#1)
required to confirm the##3##4##(2008-10#2)(2008-11#1)
required to confirm##5##3##(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)
required to decide whether##2##4##(1993-2#1)(2006-6#1)
required to decrease##2##3##(1992-11#1)(2008-10#1)
required to demonstrate##2##3##(2008-11#1)(2008-8#1)
required to detect these##2##4##(1995-10#1)(2010-9#1)
required to detect##5##3##(1992-9#1)(1995-10#1)(2008-10#1)(2008-11#1)(2010-9#1)
required to determine the##4##4##(1993-2#1)(2008-1#1)(2008-4#1)(2012-12#1)
required to determine##7##3##(1992-12#1)(1993-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-4#1)(2012-12#1)
required to develop##7##3##(1993-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-3#1)(2013-1#1)
required to enable the##2##4##(1997-4#1)(2008-7#1)
required to enable##3##3##(1997-4#1)(2008-11#1)(2008-7#1)
required to ensure that##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
required to ensure##8##3##(1996-2#1)(2008-11#2)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#2)
required to establish##8##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2012-3#1)
required to evaluate##4##3##(1993-11#1)(1995-2#1)(2008-10#1)(2011-2#1)
required to exceed a cumulative catch of##2##7##(2008-10#2)
required to explain##2##3##(1993-11#1)(2008-7#1)
required to gather##3##3##(2011-2#3)
required to generate the##2##4##(1995-2#1)(2008-10#1)
required to generate##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
required to guarantee##2##3##(2008-12#1)(2008-7#1)
required to have##4##3##(1993-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
required to identify##5##3##(1990-9#1)(1996-5#1)(1997-4#1)(2008-1#1)(2013-1#1)
required to implement##3##3##(2007-11#1)(2008-2#2)
required to improve the##3##4##(2008-10#2)(2011-1#1)
required to improve##7##3##(1997-3#1)(2008-10#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
required to initiate##2##3##(1995-8#1)(2011-2#1)
required to maintain##5##3##(1992-2#1)(2007-7#1)(2008-4#1)(2012-2#1)(2013-1#1)
required to make##2##3##(1990-8#1)(2008-1#1)
required to manage##2##3##(1993-12#1)(1996-3#1)
required to meet##3##3##(2008-10#1)(2008-2#1)(2009-3#1)
required to obtain a##7##4##(1995-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
required to obtain##18##3##(1992-11#1)(1992-12#1)(1995-11#1)(1995-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2011-2#1)
required to optimize##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
required to produce a##5##4##(1990-8#1)(1993-12#1)(1994-6#1)(1995-5#1)(2008-11#1)
required to produce##10##3##(1990-12#2)(1990-8#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(2008-11#2)
required to protect##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
required to provide##6##3##(1993-11#1)(1993-3#1)(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
required to reach##5##3##(1991-11#1)(1996-5#1)(2008-10#3)
required to reduce##4##3##(1997-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
required to remove##2##3##(1994-3#1)(2013-1#1)
required to respond##2##3##(2008-9#2)
required to return##2##3##(1993-12#1)(2008-3#1)
required to search##2##3##(1994-3#1)(2008-3#1)
required to show##2##3##(1992-2#1)(1995-5#1)
required to support##2##3##(2008-7#1)(2010-10#1)
required to suppress##3##3##(2008-10#2)(2008-9#1)
required to treat##4##3##(1993-1#1)(1993-2#1)(2007-12#1)(2008-5#1)
required to understand##2##3##(2008-10#1)(2012-1#1)
required to undertake##2##3##(2008-11#2)
required to use the##2##4##(1992-11#1)(2008-3#1)
required to use##5##3##(1992-11#2)(2008-11#1)(2008-12#1)(2008-3#1)
required to validate##2##3##(2008-1#2)
required to##345##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#3)(1992-4#1)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-12#5)(2007-7#2)(2007-8#2)(2008-1#9)(2008-10#43)(2008-11#25)(2008-12#6)(2008-2#7)(2008-3#9)(2008-4#8)(2008-5#6)(2008-6#5)(2008-7#19)(2008-8#4)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#14)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#2)
required treatment##2##2##(1996-12#1)(2007-11#1)
required us to##2##3##(1991-5#1)(2008-11#1)
required use of##2##3##(1992-3#1)(2011-2#1)
required was##4##2##(2008-11#1)(2010-6#3)
required which##2##2##(1994-8#1)(2008-11#1)
required with##4##2##(1994-6#1)(1997-1#1)(2010-11#1)(2013-7#1)
required##1688##1##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#9)(1990-6#2)(1990-7#3)(1990-8#13)(1990-9#3)(1991-1#2)(1991-11#4)(1991-12#4)(1991-2#6)(1991-3#4)(1991-5#6)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#10)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#12)(1992-8#2)(1992-9#7)(1993-1#3)(1993-10#2)(1993-11#11)(1993-12#17)(1993-2#7)(1993-3#7)(1993-6#7)(1993-8#2)(1993-9#11)(1994-1#2)(1994-11#8)(1994-12#16)(1994-2#8)(1994-3#12)(1994-5#6)(1994-6#9)(1994-8#23)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#7)(1995-12#10)(1995-2#27)(1995-3#7)(1995-5#7)(1995-6#17)(1995-8#8)(1995-9#3)(1996-1#10)(1996-11#2)(1996-12#8)(1996-2#13)(1996-3#10)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#4)(1997-1#4)(1997-2#2)(1997-3#16)(1997-4#10)(1997-5#4)(1997-6#4)(1997-7#7)(1997-8#3)(2006-10#4)(2006-6#2)(2007-10#1)(2007-11#26)(2007-12#27)(2007-2#1)(2007-5#2)(2007-7#6)(2007-8#18)(2007-9#2)(2008-1#26)(2008-10#250)(2008-11#74)(2008-12#21)(2008-2#38)(2008-3#92)(2008-4#33)(2008-5#17)(2008-6#20)(2008-7#64)(2008-8#21)(2008-9#44)(2009-1#1)(2009-10#18)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#8)(2009-4#3)(2009-5#6)(2009-6#7)(2009-7#6)(2009-8#10)(2009-9#3)(2010-1#4)(2010-10#4)(2010-11#13)(2010-12#3)(2010-2#3)(2010-3#9)(2010-4#10)(2010-5#7)(2010-6#6)(2010-7#8)(2010-8#8)(2010-9#5)(2011-1#17)(2011-10#1)(2011-2#64)(2012-1#5)(2012-12#21)(2012-2#39)(2012-3#37)(2012-4#1)(2013-1#50)(2013-7#5)(2013-8#20)
requirement and##4##2##(1996-12#1)(2007-12#1)(2008-12#1)(2010-2#1)
requirement by##3##2##(1992-11#1)(2008-10#1)(2008-6#1)
requirement for a##5##3##(1991-2#1)(1993-12#1)(2007-12#1)(2008-7#1)(2010-1#1)
requirement for an##2##3##(1992-8#1)(2010-3#1)
requirement for long-term##2##3##(2008-10#1)(2011-2#1)
requirement for more than##2##4##(1996-1#1)(2011-2#1)
requirement for the##4##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-11#1)
requirement for##80##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-6#2)(1996-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#4)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2010-1#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
requirement in##9##2##(1994-11#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)
requirement is##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
requirement of a##3##3##(2008-10#1)(2009-12#1)(2013-8#1)
requirement of protein##2##3##(1990-5#1)(2013-8#1)
requirement of the##6##3##(1990-5#2)(1994-8#1)(2007-9#1)(2008-3#1)(2011-1#1)
requirement of##43##2##(1990-5#3)(1992-10#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(2007-12#2)(2007-9#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#6)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
requirement to##10##2##(1993-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2009-11#1)(2010-12#1)
requirement was increased##2##3##(1993-6#1)(2011-2#1)
requirement was##7##2##(1990-4#1)(1993-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
requirement##211##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#4)(2007-12#6)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#20)(2008-11#16)(2008-12#3)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#2)(2009-10#3)(2009-11#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#7)
requirements and allowing##2##3##(2011-2#1)(2013-1#1)
requirements and limitations##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
requirements and the##7##3##(1992-3#1)(1994-2#1)(1996-11#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
requirements and##45##2##(1991-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1994-2#2)(1996-11#1)(1996-3#4)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#2)(2011-2#2)(2012-2#3)(2013-1#3)(2013-8#1)
requirements are presented##2##3##(2008-5#1)(2010-8#1)
requirements are##17##2##(1994-2#1)(1994-3#1)(1995-9#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2010-9#1)
requirements as##4##2##(1991-5#1)(1997-3#1)(2008-11#1)(2012-3#1)
requirements between##2##2##(2007-11#1)(2010-9#1)
requirements by##2##2##(2012-2#1)(2013-1#1)
requirements can##2##2##(1997-1#1)(2010-7#1)
requirements control##2##2##(1993-6#1)(2008-10#1)
requirements during##2##2##(2007-7#1)(2012-3#1)
requirements for a##8##3##(1994-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)
requirements for effective##2##3##(1997-4#1)(2011-1#1)
requirements for oxygen##2##3##(1991-6#1)(2008-9#1)
requirements for the##12##3##(1990-8#1)(1991-12#1)(1991-6#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
requirements for##120##2##(1990-11#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-9#2)(1993-2#3)(1993-3#2)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-1#2)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#4)(2013-8#1)
requirements have##3##2##(1991-12#1)(1994-3#1)(2009-3#1)
requirements in the##2##3##(1996-2#1)(2008-11#1)
requirements in##7##2##(1996-2#1)(1996-9#1)(2007-7#1)(2008-11#2)(2010-8#2)
requirements is##3##2##(1993-11#1)(2008-2#1)(2008-7#1)
requirements must be##3##3##(1993-12#1)(1994-1#1)(2008-7#1)
requirements of a##7##3##(1993-9#1)(1996-2#1)(2008-1#1)(2009-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
requirements of the##24##3##(1992-1#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(2007-12#2)(2008-11#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2013-1#2)
requirements of##77##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
requirements on the##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
requirements on##9##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-2#1)
requirements put forth##2##3##(1997-3#1)(2009-12#1)
requirements seem to##2##3##(1992-1#1)(2009-11#1)
requirements set forth by the##2##5##(1993-2#1)(1993-3#1)
requirements that##7##2##(1993-12#1)(1993-2#2)(1993-3#1)(1994-5#1)(2008-8#1)(2013-1#1)
requirements to##7##2##(1997-1#1)(1997-3#1)(2007-11#1)(2008-3#1)(2009-12#1)(2013-1#1)(2013-8#1)
requirements under the##3##3##(1991-1#1)(1993-1#1)(1994-2#1)
requirements under##4##2##(1991-1#1)(1991-12#1)(1993-1#1)(1994-2#1)
requirements were##4##2##(1990-5#1)(1994-2#1)(1996-12#1)(2008-7#1)
requirements with##2##2##(1993-2#1)(1995-1#1)
requirements##500##1##(1990-11#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-12#7)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#5)(1992-6#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#10)(1993-3#8)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#3)(1994-12#8)(1994-2#9)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#10)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#4)(1997-4#3)(1997-6#1)(2007-11#9)(2007-12#8)(2007-2#1)(2007-4#4)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#42)(2008-11#15)(2008-12#8)(2008-2#19)(2008-3#38)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#24)(2008-8#13)(2008-9#9)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#5)(2009-5#2)(2009-6#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#17)(2010-9#3)(2011-1#5)(2011-2#12)(2012-12#3)(2012-2#17)(2012-3#9)(2012-4#1)(2013-1#22)(2013-7#1)(2013-8#6)
requires NF-kappa B##2##3##(1993-3#1)(2010-3#1)
requires a different##2##3##(2008-11#1)(2013-1#1)
requires a good##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
requires a high index of suspicion##3##6##(2010-10#1)(2011-2#2)
requires a high level of##2##5##(1995-3#1)(2008-10#1)
requires a high##7##3##(1995-3#1)(2008-10#2)(2008-4#1)(2010-10#1)(2011-2#2)
requires a large##4##3##(2007-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
requires a long-term##2##3##(1994-1#1)(2008-7#1)
requires a meticulous##2##3##(2008-10#1)(2008-8#1)
requires a minimum##2##3##(2008-10#1)(2008-2#1)
requires a multidisciplinary approach##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
requires a reorientation of##2##4##(1997-1#1)(2011-2#1)
requires a sound##2##3##(2008-9#1)(2011-2#1)
requires a suitable##2##3##(2008-11#2)
requires a thorough understanding of##2##5##(2008-5#1)(2008-8#1)
requires a##95##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
requires accurate##6##2##(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)(2010-9#1)(2011-2#1)
requires active##5##2##(1992-1#1)(1992-9#1)(1993-6#1)(2008-7#1)(2009-7#1)
requires additional steps##2##3##(2008-10#1)(2008-4#1)
requires additional##8##2##(1990-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-8#1)
requires adequate##3##2##(2010-6#1)(2011-2#1)(2012-2#1)
requires an additional##2##3##(2007-12#1)(2008-4#1)
requires an assessment##2##3##(1996-2#1)(2006-5#1)
requires an integrated##2##3##(2009-4#1)(2012-1#1)
requires an understanding of the##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
requires an understanding of##5##4##(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
requires an##23##2##(1993-2#1)(1993-8#1)(1995-2#2)(1996-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-3#2)
requires at least two##2##4##(2008-1#1)(2011-2#1)
requires at least##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
requires at##5##2##(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
requires attention to the##2##4##(2007-11#1)(2011-1#1)
requires attention to##3##3##(2007-11#1)(2008-9#1)(2011-1#1)
requires attention##4##2##(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
requires both an##2##3##(1991-5#1)(2007-12#1)
requires both##7##2##(1990-8#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
requires careful assessment##2##3##(2007-12#1)(2011-1#1)
requires careful consideration##2##3##(2007-12#1)(2008-4#1)
requires careful##10##2##(2007-12#2)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
requires clinical##2##2##(1996-12#1)(2007-12#1)
requires close##4##2##(1997-4#1)(2008-9#1)(2010-6#1)(2012-2#1)
requires conceptual##2##2##(1996-12#1)(2012-2#1)
requires considerable##4##2##(2008-11#1)(2008-3#1)(2008-4#2)
requires considering##2##2##(2009-3#1)(2012-3#1)
requires continuous##4##2##(1991-12#1)(1992-12#1)(2006-10#1)(2009-11#1)
requires cooperation##2##2##(1996-1#1)(2008-10#1)
requires different##2##2##(2008-9#1)(2013-1#1)
requires direct##3##2##(1993-2#1)(2008-4#1)(2011-2#1)
requires expertise##2##2##(1994-1#1)(2008-10#1)
requires extraction##2##2##(2008-10#2)
requires fewer##4##2##(2008-1#1)(2008-2#2)(2013-1#1)
requires five##2##2##(1990-7#1)(1995-2#1)
requires further development##5##3##(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)
requires further evaluation##2##3##(2007-7#1)(2010-10#1)
requires further investigation##2##3##(2008-6#1)(2008-7#1)
requires further study##4##3##(2007-11#1)(2007-7#1)(2008-6#1)(2010-4#1)
requires further##19##2##(1993-11#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-2#1)
requires genetic##2##2##(2007-11#1)(2008-8#1)
requires good##2##2##(1994-2#1)(1996-12#1)
requires high##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
requires huge##2##2##(1997-8#1)(2010-4#1)
requires identification of##2##3##(1996-3#1)(2008-11#1)
requires in##3##2##(2008-11#1)(2008-8#1)(2009-11#1)
requires individuals##2##2##(1994-12#1)(2008-11#1)
requires information##2##2##(2008-10#1)(2010-8#1)
requires interaction##2##2##(1991-5#1)(2008-4#1)
requires investigation##2##2##(1996-1#1)(2011-2#1)
requires knowledge of the##3##4##(2008-2#3)
requires knowledge of##11##3##(1996-4#1)(2008-10#2)(2008-2#3)(2008-3#2)(2010-12#1)(2012-12#1)(2012-2#1)
requires large##2##2##(2008-7#1)(2013-1#1)
requires less##4##2##(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#1)
requires little##3##2##(2008-10#2)(2008-2#1)
requires long##2##2##(1994-8#1)(2008-7#1)
requires measurement of##2##3##(1993-11#1)(2007-12#1)
requires minimal##4##2##(2008-11#1)(2008-2#1)(2009-10#1)(2013-1#1)
requires more sophisticated##2##3##(1996-12#1)(2008-10#1)
requires more than##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
requires more##10##2##(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2012-12#1)
requires multiple##5##2##(1994-3#1)(2008-1#1)(2008-3#3)
requires neither a##2##3##(2008-3#2)
requires new##2##2##(1996-2#1)(2008-7#1)
requires no##21##2##(1994-1#1)(1996-1#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2010-3#1)
requires not only##2##3##(1992-9#1)(1994-11#1)
requires one##3##2##(1994-9#1)(2008-2#1)(2008-5#1)
requires only a single##2##4##(2008-11#1)(2008-2#1)
requires only a##7##3##(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
requires only one##2##3##(1990-11#1)(1997-8#1)
requires only two##2##3##(2008-2#1)(2008-3#1)
requires only##24##2##(1990-11#1)(1997-4#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#1)
requires patients to##2##3##(2008-10#1)(2010-4#1)
requires precise##5##2##(2007-8#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-6#1)
requires rapid##3##2##(1997-3#1)(2007-2#1)(2009-9#1)
requires several##2##2##(2008-1#1)(2008-3#1)
requires significant##2##2##(1993-2#1)(2008-2#1)
requires simple##2##2##(2008-10#2)
requires simultaneous##2##2##(1994-9#1)(2007-12#1)
requires small##2##2##(2007-12#1)(2008-10#1)
requires some##4##2##(1992-1#1)(2007-12#1)(2008-9#2)
requires sophisticated##2##2##(1992-3#1)(2008-10#1)
requires special##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
requires specific##2##2##(2011-2#1)(2013-1#1)
requires strong##3##2##(1994-3#1)(1995-2#1)(2008-10#1)
requires substantial##3##2##(1992-8#1)(2010-1#1)(2011-1#1)
requires sufficient##2##2##(2009-12#2)
requires surgical##3##2##(1991-6#1)(1994-9#1)(2008-4#1)
requires that a##2##3##(1994-3#1)(2008-3#1)
requires that the##11##3##(1990-6#1)(1990-7#1)(1995-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-8#2)
requires that##25##2##(1990-6#1)(1990-7#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-6#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-1#1)
requires the availability of##2##4##(2008-10#2)
requires the calculation of##2##4##(2008-2#1)(2008-3#1)
requires the establishment of a##2##5##(2009-9#1)(2010-4#1)
requires the integration of##2##4##(1995-12#1)(2012-12#1)
requires the measurement of##2##4##(2008-3#1)(2008-9#1)
requires the presence of##4##4##(1992-11#1)(1993-8#1)(1995-3#1)(1995-6#1)
requires the sequential##2##3##(1990-2#1)(1995-2#1)
requires the use of a##2##5##(2008-3#1)(2011-2#1)
requires the use of an##2##5##(1990-3#1)(1996-5#1)
requires the use of##10##4##(1990-3#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)
requires the##79##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
requires three##2##2##(1997-4#1)(2007-7#1)
requires to##2##2##(2010-1#1)(2011-2#1)
requires##758##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#5)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-12#7)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#6)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#2)(1993-8#4)(1994-1#9)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#4)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-12#6)(1995-2#10)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#8)(1996-12#6)(1996-2#7)(1996-3#2)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-5#1)(2007-11#14)(2007-12#31)(2007-2#2)(2007-5#2)(2007-7#5)(2007-8#5)(2008-1#11)(2008-10#85)(2008-11#40)(2008-12#7)(2008-2#27)(2008-3#62)(2008-4#28)(2008-5#7)(2008-6#5)(2008-7#23)(2008-8#20)(2008-9#24)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#5)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#11)(2011-2#33)(2012-1#5)(2012-12#12)(2012-2#17)(2012-3#9)(2013-1#16)(2013-8#4)
requiring a##12##2##(1990-5#1)(1996-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
requiring additional##5##2##(1995-5#1)(2008-10#1)(2009-1#1)(2010-6#1)(2013-7#1)
requiring aggressive##2##2##(2008-1#1)(2008-2#1)
requiring an additional##2##3##(2008-10#1)(2009-5#1)
requiring an##6##2##(1995-2#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-12#1)
requiring at least##2##3##(2008-10#1)(2011-2#1)
requiring both##3##2##(1995-2#1)(2007-11#1)(2008-10#1)
requiring early##2##2##(2007-8#1)(2008-11#1)
requiring endoscopic##2##2##(2008-10#1)(2013-8#1)
requiring further##2##2##(2008-7#1)(2013-1#1)
requiring hemodialysis##4##2##(2007-12#1)(2007-7#2)(2012-2#1)
requiring hospitalization##4##2##(2010-10#1)(2012-12#1)(2013-1#2)
requiring hospitals##2##2##(1992-12#1)(1995-12#1)
requiring immediate##7##2##(1994-3#1)(1997-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
requiring minimal##2##2##(2007-11#1)(2008-11#1)
requiring more##3##2##(1993-11#1)(1993-2#1)(2008-7#1)
requiring multiple surgical##2##3##(1991-12#1)(2011-1#1)
requiring multiple##3##2##(1991-12#1)(2008-3#1)(2011-1#1)
requiring no sample##2##3##(2008-10#2)
requiring no##4##2##(2008-10#4)
requiring only##6##2##(1993-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)
requiring reoperation##2##2##(1994-7#1)(2012-12#1)
requiring specific##3##2##(2011-2#2)(2012-3#1)
requiring surgical##2##2##(2010-4#1)(2011-2#1)
requiring the##9##2##(1992-7#1)(1997-1#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
requiring transfusion##2##2##(1994-12#1)(1995-12#1)
requiring treatment in##2##3##(1992-6#1)(2011-1#1)
requiring treatment with##2##3##(1992-5#1)(2007-9#1)
requiring treatment##7##2##(1992-5#1)(1992-6#1)(2007-9#1)(2008-5#1)(2011-1#1)(2013-1#2)
requiring##206##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-7#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#20)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
requisite for the##2##3##(1991-5#1)(1995-2#1)
requisite for##5##2##(1991-5#1)(1992-12#1)(1994-8#1)(1995-11#1)(1995-2#1)
requisite##18##1##(1991-3#2)(1991-5#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
requisites##3##1##(2008-10#1)(2010-8#1)(2011-2#1)
rer##8##1##(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#2)
rerio##2##1##(1993-12#1)(2012-3#1)
rerio) as##2##2##(2008-11#1)(2013-1#1)
rerio)##6##1##(1992-9#1)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
rerupture##2##1##(1993-11#1)(1997-3#1)
resampled##2##1##(2008-3#2)
resampling the##2##2##(2008-3#1)(2008-6#1)
resampling##10##1##(1997-4#1)(2008-10#2)(2008-3#6)(2008-6#1)
resazurin##2##1##(2008-10#1)(2008-11#1)
rescaled##2##1##(2008-3#2)
rescaling##3##1##(2008-2#1)(2008-3#1)(2008-7#1)
rescheduling##2##1##(1992-5#1)(2012-3#1)
rescreening##2##1##(1991-6#2)
rescue and##2##2##(2008-10#1)(2008-4#1)
rescue effects##2##2##(2008-8#1)(2012-2#1)
rescue experiments##2##2##(2007-12#1)(2008-11#1)
rescue of##7##2##(1992-3#2)(1993-12#1)(1995-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
rescue procedure##2##2##(2007-8#1)(2012-3#1)
rescue the##7##2##(1993-9#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-8#1)
rescue therapy##5##2##(2008-11#2)(2010-12#1)(2012-12#2)
rescue##66##1##(1992-3#2)(1992-6#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#5)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
rescued by##9##2##(1995-2#1)(1995-9#1)(1996-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
rescued##19##1##(1990-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)
rescues the##2##2##(2008-8#1)(2012-2#1)
rescues##3##1##(2008-8#2)(2012-2#1)
research &quot##2##2##(1991-9#1)(1997-3#1)
research about##2##2##(2009-11#1)(2012-2#1)
research activities and##2##3##(2008-10#1)(2012-3#1)
research activities that##2##3##(1991-12#1)(1993-3#1)
research activities##10##2##(1991-12#1)(1993-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-3#1)
research activity and##2##3##(1997-6#1)(2008-7#1)
research addresses##2##2##(2009-8#1)(2013-8#1)
research agenda for##5##3##(1992-12#1)(2008-12#1)(2008-3#1)(2011-2#2)
research agenda##13##2##(1991-1#1)(1992-12#2)(1994-12#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#2)
research aimed at identifying##2##4##(2010-10#1)(2013-1#1)
research aimed at understanding##2##4##(2008-9#1)(2010-3#1)
research aimed at##12##3##(1991-6#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-3#1)(2013-1#2)
research aimed to##2##3##(1993-6#1)(2007-12#1)
research aimed##14##2##(1991-6#2)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-3#1)(2013-1#2)
research also suggests that##2##4##(2007-12#1)(2010-2#1)
research also##4##2##(2007-12#1)(2008-7#1)(2010-2#1)(2012-2#1)
research and applications##3##3##(1997-1#1)(2007-11#1)(2008-7#1)
research and clinical application##2##4##(2007-12#1)(2013-8#1)
research and clinical applications##2##4##(2008-10#1)(2011-2#1)
research and clinical##16##3##(1994-12#1)(1997-5#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
research and development (R&amp##3##4##(2008-5#1)(2009-5#1)(2010-12#1)
research and development areas##2##4##(2008-8#1)(2013-8#1)
research and development of##9##4##(1991-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#2)
research and development##32##3##(1991-1#1)(1992-12#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
research and diagnosis##2##3##(1995-6#1)(2012-3#1)
research and diagnostic##2##3##(2008-11#1)(2008-9#1)
research and drug##2##3##(2008-4#1)(2008-5#1)
research and education##2##3##(1994-12#1)(2008-7#1)
research and evaluation##2##3##(2008-12#1)(2008-8#1)
research and family##2##3##(2008-9#1)(2010-4#1)
research and future##2##3##(1996-2#1)(2008-8#1)
research and health care##2##4##(1996-12#1)(1997-8#1)
research and in##2##3##(2008-11#1)(2010-7#1)
research and management##3##3##(2007-10#2)(2013-8#1)
research and offers##2##3##(2009-5#1)(2010-9#1)
research and practice##19##3##(2006-10#1)(2008-1#1)(2008-7#1)(2010-10#11)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
research and technology##2##3##(1992-3#1)(1997-7#1)
research and the##7##3##(1992-6#1)(1995-1#1)(1995-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-7#1)
research and training##2##3##(1997-7#1)(2008-10#1)
research and will##2##3##(1994-3#1)(2012-3#1)
research and##209##2##(1990-11#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#4)(1997-1#3)(1997-3#3)(1997-5#1)(1997-7#3)(1997-8#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#17)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#10)(2008-7#9)(2008-8#4)(2008-9#4)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#12)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#4)(2011-3#1)(2011-7#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#4)
research applications##5##2##(1993-3#1)(2008-4#2)(2010-8#1)(2012-2#1)
research approach to##2##3##(2008-11#1)(2012-12#1)
research approach was adopted##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
research approach##9##2##(1994-3#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#1)(2012-12#1)
research approaches##4##2##(1992-12#1)(1996-12#1)(2008-8#1)(2012-1#1)
research are being##2##3##(1997-8#1)(2008-11#1)
research are discussed##13##3##(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-10#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)
research are explored##2##3##(1996-2#1)(2007-10#1)
research are presented together##2##4##(1990-2#1)(2013-1#1)
research are presented##4##3##(1990-2#1)(1991-2#1)(2012-12#1)(2013-1#1)
research are provided##2##3##(2009-5#1)(2012-12#1)
research are the##2##3##(1991-3#1)(2011-2#1)
research are##41##2##(1990-2#1)(1991-2#1)(1991-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#4)(2012-2#1)(2013-1#2)
research area that##2##3##(2008-11#1)(2009-7#1)
research area##11##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
research areas##9##2##(1993-2#2)(1996-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#1)(2012-3#1)
research articles##2##2##(2012-12#1)(2012-2#1)
research as a##4##3##(1993-2#1)(2008-8#1)(2009-6#1)(2011-2#1)
research as the##2##3##(2008-12#1)(2011-2#1)
research as well##2##3##(2009-9#1)(2011-2#1)
research as##12##2##(1993-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-2#3)(2013-1#1)(2013-8#1)
research assistants##2##2##(2009-4#2)
research at the##4##3##(2007-7#1)(2008-12#1)(2009-9#1)(2010-10#1)
research at##6##2##(2007-7#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)(2010-2#1)
research attention##3##2##(2008-6#2)(2008-9#1)
research available##4##2##(1992-1#1)(2007-11#1)(2008-11#2)
research awareness##2##2##(2008-12#2)
research base##2##2##(1992-12#1)(2009-5#1)
research based on##3##3##(1994-2#1)(2008-2#1)(2009-10#1)
research based##4##2##(1994-2#1)(2008-12#1)(2008-2#1)(2009-10#1)
research because##3##2##(2008-4#1)(2008-7#1)(2009-6#1)
research being##2##2##(2009-6#1)(2012-2#1)
research between##2##2##(2012-2#1)(2012-3#1)
research by##12##2##(1993-2#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
research can be##4##3##(1994-3#1)(2008-10#1)(2008-3#1)(2010-3#1)
research can##7##2##(1994-12#1)(1994-3#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-3#1)
research capacity##4##2##(2007-12#1)(2010-10#2)(2012-12#1)
research carried out in##2##4##(1991-9#1)(2012-3#1)
research carried out##4##3##(1991-9#1)(2010-1#1)(2012-12#1)(2012-3#1)
research centered on##2##3##(2008-10#1)(2012-3#1)
research centres##3##2##(1997-5#1)(2008-11#2)
research challenges##3##2##(1994-12#1)(2009-11#1)(2010-12#1)
research communities##2##2##(2007-5#1)(2008-10#1)
research community is##2##3##(2008-10#1)(2008-6#1)
research community##8##2##(1997-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-4#1)
research concerning##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
research conducted in the##2##4##(2008-1#1)(2008-11#1)
research conducted in##4##3##(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#1)
research conducted##9##2##(1993-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-1#2)
research continues##2##2##(2007-12#1)(2013-8#1)
research contributions##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
research criteria##3##2##(1997-8#1)(2011-2#2)
research data##10##2##(1997-2#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-8#1)
research describing##2##2##(2008-4#1)(2012-3#1)
research design for the##2##4##(2013-1#2)
research design for##3##3##(2013-1#3)
research design was##3##3##(2008-1#1)(2008-12#1)(2010-3#1)
research design##14##2##(1991-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-3#2)(2013-1#5)
research designs##4##2##(1996-3#1)(2009-8#1)(2011-2#2)
research directions are##6##3##(1994-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2009-5#1)(2009-9#1)
research directions##12##2##(1994-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
research does not##2##3##(1991-9#1)(1997-1#1)
research done##2##2##(1990-3#1)(2008-10#1)
research due to##2##3##(1995-2#1)(2008-10#1)
research during##2##2##(1992-11#1)(2010-9#1)
research education##2##2##(2008-11#2)
research efforts are focused on##2##5##(1994-9#1)(2008-5#1)
research efforts are##5##3##(1994-9#1)(1997-1#1)(2008-5#1)(2010-12#1)(2010-8#1)
research efforts have##3##3##(2009-11#1)(2010-11#1)(2012-12#1)
research efforts to##2##3##(2008-5#1)(2010-12#1)
research efforts##16##2##(1990-6#1)(1993-2#1)(1994-9#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-6#1)(2008-5#2)(2009-11#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)
research ethics committees##3##3##(1996-11#3)
research ethics##6##2##(1996-11#3)(1997-5#1)(2008-9#1)(2011-3#1)
research evaluating##2##2##(2007-6#1)(2012-2#1)
research evidence##8##2##(1997-4#1)(2007-11#1)(2008-11#4)(2008-12#1)(2008-3#1)
research examined##2##2##(1997-2#1)(2008-12#1)
research examining##5##2##(1996-2#1)(2008-12#1)(2009-7#1)(2010-10#1)(2013-1#1)
research exists##2##2##(2008-12#1)(2008-9#1)
research experience##5##2##(1994-12#1)(2009-4#2)(2009-6#1)(2012-2#1)
research experiences##2##2##(1997-1#1)(2010-10#1)
research explored##2##2##(2007-12#1)(2008-12#1)
research field of##2##3##(2008-5#1)(2008-7#1)
research field##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)
research fields##4##2##(2008-10#2)(2011-3#1)(2012-12#1)
research findings and##5##3##(2008-12#1)(2013-1#4)
research findings are##4##3##(1993-2#2)(2007-7#1)(2009-12#1)
research findings from the##2##4##(2008-12#1)(2010-10#1)
research findings in##2##3##(2008-12#1)(2013-1#1)
research findings on the##3##4##(1994-1#1)(1996-2#1)(2007-11#1)
research findings on##6##3##(1991-2#1)(1991-3#1)(1994-1#1)(1996-2#1)(2007-11#1)(2008-8#1)
research findings##28##2##(1991-2#2)(1991-3#1)(1993-2#3)(1994-1#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-8#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#5)
research foci##2##2##(2008-9#2)
research focus on##2##3##(2011-2#1)(2013-1#1)
research focus##3##2##(2011-2#2)(2013-1#1)
research focused on##3##3##(2008-10#1)(2008-12#1)(2010-9#1)
research focuses on##4##3##(1990-11#1)(2007-12#1)(2011-2#1)(2012-2#1)
research focuses##5##2##(1990-11#1)(2007-12#1)(2011-2#1)(2012-2#2)
research focusing on##2##3##(1996-12#1)(1996-3#1)
research for a##2##3##(2009-6#1)(2013-8#1)
research for many years##2##4##(2008-10#1)(2008-3#1)
research for the##4##3##(2008-10#2)(2009-6#1)(2010-2#1)
research for##18##2##(1991-2#1)(1992-1#1)(1993-2#1)(1997-3#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2009-6#2)(2010-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
research found that##2##3##(2009-7#1)(2012-12#1)
research found##3##2##(1996-3#1)(2009-7#1)(2012-12#1)
research framework##2##2##(1997-1#1)(2011-2#1)
research from##3##2##(2007-12#1)(2008-7#1)(2010-12#1)
research funding##7##2##(2007-4#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#2)
research group##7##2##(2008-10#1)(2008-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)
research groups and##2##3##(1991-6#1)(1992-8#1)
research groups from##2##3##(2008-7#1)(2011-1#1)
research groups##15##2##(1991-12#1)(1991-6#1)(1992-8#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-7#5)(2010-10#1)(2011-1#1)
research has accumulated##2##3##(2008-9#1)(2012-2#1)
research has been carried out##2##5##(2012-1#1)(2013-1#1)
research has been conducted on##3##5##(2007-6#1)(2011-2#1)(2012-2#1)
research has been conducted to##4##5##(2008-10#1)(2008-11#2)(2008-12#1)
research has been conducted##9##4##(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
research has been devoted to##3##5##(1993-3#1)(2008-10#1)(2010-6#1)
research has been done##5##4##(1991-3#1)(1994-3#1)(2008-3#1)(2013-1#2)
research has been##25##3##(1991-3#1)(1993-1#1)(1993-3#1)(1994-3#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
research has demonstrated a##3##4##(1994-2#1)(2008-8#1)(2012-2#1)
research has demonstrated that##2##4##(2008-11#1)(2008-7#1)
research has demonstrated##8##3##(1990-11#1)(1992-12#1)(1994-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-2#1)
research has evaluated##2##3##(2008-10#1)(2011-1#1)
research has examined the##2##4##(2008-11#1)(2012-12#1)
research has examined##4##3##(1995-1#1)(2008-11#2)(2012-12#1)
research has explored##2##3##(2009-7#1)(2012-2#1)
research has focused on the##4##5##(1997-6#1)(2008-2#1)(2009-9#1)(2013-1#1)
research has focused on##11##4##(1993-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
research has focused##12##3##(1993-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
research has generated##2##3##(2009-10#1)(2012-12#1)
research has identified##4##3##(2008-6#1)(2009-5#1)(2010-3#1)(2012-3#1)
research has indicated##2##3##(2007-12#1)(2008-2#1)
research has shown that##8##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
research has shown##10##3##(1990-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#1)
research has suggested that##4##4##(2008-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
research has suggested##6##3##(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
research has the##2##3##(2008-9#1)(2013-1#1)
research has##109##2##(1990-11#2)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#10)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#1)
research have been##5##3##(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)
research have##12##2##(1995-6#1)(1997-1#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#1)
research help##2##2##(2008-12#1)(2010-9#1)
research highlights##4##2##(1996-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
research implications##3##2##(1991-1#1)(2008-12#1)(2008-5#1)
research in Canada##3##3##(1993-3#2)(2013-1#1)
research in a##3##3##(1993-6#1)(1995-3#1)(2008-9#1)
research in child and adolescent partial hospitalization##2##7##(1992-1#2)
research in child and adolescent##3##5##(1992-1#2)(2008-4#1)
research in emergency situations should##2##5##(2009-6#2)
research in home care##2##4##(1996-2#1)(2006-5#1)
research in human##2##3##(1994-9#1)(2010-10#1)
research in order to##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
research in our##2##3##(1990-12#1)(2007-8#1)
research in primary care##2##4##(1996-9#1)(2008-7#1)
research in primary##3##3##(1993-2#1)(1996-9#1)(2008-7#1)
research in recent years##2##4##(2008-9#1)(2010-8#1)
research in relation to##2##4##(2008-5#1)(2011-2#1)
research in stroke##2##3##(2008-8#2)
research in the area of##6##5##(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
research in the field of##3##5##(1993-1#1)(2010-10#1)(2012-2#1)
research in the field##6##4##(1992-1#1)(1993-1#1)(1994-3#1)(2008-11#1)(2010-10#1)(2012-2#1)
research in the past decades##2##5##(2009-5#1)(2010-10#1)
research in the past##5##4##(2008-11#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-2#1)
research in the##38##3##(1990-6#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-3#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-5#3)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#3)(2010-3#1)(2011-2#1)(2012-2#2)
research in this area has##2##5##(2008-10#1)(2013-1#1)
research in this area##12##4##(1992-9#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#2)(2013-8#2)
research in this field is##4##5##(1996-9#1)(2006-10#1)(2010-12#1)(2012-12#1)
research in this field##9##4##(1996-2#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-7#1)
research in this##24##3##(1992-9#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#2)
research in##170##2##(1990-12#1)(1990-6#1)(1991-6#1)(1992-1#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#4)(1993-3#3)(1993-6#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-3#2)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#9)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#7)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
research include##2##2##(2008-10#1)(2013-1#1)
research including##2##2##(2010-12#1)(2013-1#1)
research indicate that##2##3##(1990-10#1)(2008-12#1)
research indicate##3##2##(1990-10#1)(2008-12#1)(2013-7#1)
research indicates that##8##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-2#1)(2011-2#1)(2011-3#1)
research information##2##2##(1992-2#1)(1993-12#1)
research initiatives##4##2##(2008-7#1)(2009-11#1)(2011-2#2)
research institutes##3##2##(1994-2#1)(2008-5#1)(2008-7#1)
research institution##2##2##(2009-4#1)(2010-1#1)
research instruments##3##2##(1993-2#1)(1994-12#1)(2008-9#1)
research interests##2##2##(2008-12#1)(2008-9#1)
research into interventions##2##3##(2009-11#1)(2010-12#1)
research into new##2##3##(1996-11#2)
research into practice##2##3##(2009-11#1)(2010-10#1)
research into the##14##3##(2007-10#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
research into##54##2##(1991-2#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#2)(1997-7#2)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#2)(2011-1#1)(2011-2#2)(2013-1#6)
research investigated the##3##3##(2007-12#1)(2009-9#1)(2010-2#1)
research investigated##5##2##(2007-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)
research investigating the##2##3##(2007-12#1)(2010-2#1)
research investigating##4##2##(1992-1#1)(2007-12#1)(2008-1#1)(2010-2#1)
research investigations##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
research involved##8##2##(2007-11#3)(2007-8#5)
research involving##4##2##(2008-7#1)(2010-10#1)(2010-11#2)
research is also##3##3##(1994-9#1)(2010-2#1)(2013-8#1)
research is an##3##3##(2006-5#1)(2008-11#1)(2009-6#1)
research is being conducted##2##4##(2008-10#1)(2009-7#1)
research is being##4##3##(1997-5#1)(2008-10#1)(2009-3#1)(2009-7#1)
research is conducted##2##3##(2008-10#1)(2008-12#1)
research is necessary to##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
research is necessary##5##3##(2007-12#1)(2008-3#1)(2012-3#1)(2013-7#1)(2013-8#1)
research is needed in##2##4##(1995-3#1)(2012-3#1)
research is needed on the##2##5##(1995-11#1)(2008-11#1)
research is needed on##4##4##(1990-9#1)(1995-11#1)(2008-11#1)(2012-2#1)
research is needed to better understand##2##6##(2007-12#1)(2009-5#1)
research is needed to determine##5##5##(1994-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
research is needed to evaluate this##2##6##(2008-11#1)(2009-12#1)
research is needed to evaluate##4##5##(1994-2#1)(2008-11#1)(2009-12#1)(2010-7#1)
research is needed to identify##2##5##(2008-7#1)(2010-10#1)
research is needed to##26##4##(1994-12#1)(1994-2#1)(2007-12#1)(2007-4#1)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
research is needed##39##3##(1990-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(2007-12#1)(2007-4#1)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
research is recommended##2##3##(1996-1#1)(2007-6#1)
research is required to better understand##2##6##(2008-11#1)(2013-1#1)
research is required to##5##4##(2007-11#1)(2008-11#1)(2011-2#2)(2013-1#1)
research is required##6##3##(2007-11#1)(2008-11#2)(2011-2#2)(2013-1#1)
research is still##3##3##(1994-1#1)(2010-10#1)(2012-2#1)
research is the##6##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
research is therefore##2##3##(1996-11#1)(2011-2#1)
research is to##7##3##(1994-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
research is warranted##3##3##(2009-4#1)(2012-2#1)(2013-1#1)
research is##125##2##(1990-12#2)(1990-9#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1997-1#1)(1997-3#3)(1997-5#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2008-10#4)(2008-11#13)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#3)(2010-10#4)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
research issues##7##2##(1992-12#1)(2008-11#1)(2008-6#2)(2010-3#1)(2012-2#1)(2013-1#1)
research it##2##2##(2008-2#1)(2010-5#1)
research knowledge##2##2##(2007-10#1)(2008-11#1)
research laboratories##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
research laboratory##2##2##(2008-4#1)(2008-9#1)
research linking##4##2##(1994-2#1)(2009-5#2)(2010-7#1)
research literature suggests that##2##4##(1995-3#1)(2012-2#1)
research literature##10##2##(1992-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-4#1)(2011-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
research may be##2##3##(2008-9#1)(2013-1#1)
research may##7##2##(1992-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2013-1#1)
research method##5##2##(1991-3#1)(2007-10#1)(2008-1#2)(2012-12#1)
research methodology##8##2##(1994-2#1)(1995-3#2)(2008-11#2)(2008-9#1)(2009-6#1)(2009-9#1)
research methods are##2##3##(2008-12#2)
research methods for##2##3##(2008-11#1)(2008-3#1)
research methods##13##2##(1992-5#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2009-7#1)(2011-2#1)
research might##3##2##(1990-6#1)(2007-12#1)(2010-4#1)
research model##3##2##(1991-2#1)(2007-7#1)(2011-1#1)
research must be##3##3##(1995-2#1)(2013-1#2)
research must##4##2##(1995-2#1)(2011-2#1)(2013-1#2)
research needs are##2##3##(2008-10#1)(2011-1#1)
research needs in##2##3##(2009-4#1)(2010-7#1)
research needs that##2##3##(1993-12#1)(2008-6#1)
research needs to be conducted to##2##6##(2010-8#1)(2013-8#1)
research needs to be##3##4##(2009-5#1)(2010-8#1)(2013-8#1)
research needs to##5##3##(1994-2#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
research needs##13##2##(1993-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
research network##2##2##(2008-10#1)(2011-2#1)
research nurse##3##2##(2008-11#3)
research objective##2##2##(2008-7#1)(2011-2#1)
research of the##7##3##(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-2#1)(2012-3#1)
research of##37##2##(1991-12#1)(1994-12#1)(1994-3#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#2)(2009-10#1)(2009-5#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
research often##2##2##(2008-4#1)(2013-1#1)
research on biological control of##2##5##(2008-10#2)
research on biological##4##3##(1992-12#2)(2008-10#2)
research on epidemiology##2##3##(2008-10#1)(2012-3#1)
research on social##2##3##(2010-3#1)(2012-2#1)
research on the effects of##4##5##(1991-2#1)(1995-2#1)(2008-11#1)(2012-3#1)
research on the##51##3##(1991-2#1)(1993-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
research on these##3##3##(1992-9#1)(2013-1#2)
research on this topic##3##4##(1990-11#1)(2011-2#1)(2013-1#1)
research on this##6##3##(1990-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
research on##144##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#5)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#8)
research opportunities##6##2##(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)
research or##4##2##(2008-11#2)(2010-12#1)(2011-2#1)
research orchard##2##2##(2008-10#2)
research organization##4##2##(1991-9#1)(1994-1#1)(2008-10#1)(2010-5#1)
research outcomes##3##2##(1996-12#1)(2013-1#2)
research over the last few decades##2##6##(1995-1#1)(2008-5#1)
research over##3##2##(1995-1#1)(2008-11#1)(2008-5#1)
research papers on##2##3##(2008-3#1)(2008-5#1)
research papers##4##2##(2008-3#1)(2008-5#2)(2013-8#1)
research paradigm##3##2##(1997-2#1)(2008-11#1)(2008-4#1)
research participants##9##2##(1995-1#2)(2009-4#3)(2009-6#2)(2012-2#2)
research participation##4##2##(2009-4#3)(2009-6#1)
research partnerships##2##2##(2008-1#1)(2012-2#1)
research plan##3##2##(1997-1#1)(2008-7#1)(2011-2#1)
research plots##2##2##(2008-10#2)
research point##2##2##(1990-12#1)(2008-5#1)
research presented here##2##3##(2008-3#2)
research presented##3##2##(2007-12#1)(2008-3#2)
research priorities for critical care nursing##2##6##(2007-11#2)
research priorities for critical care##3##5##(2007-11#3)
research priorities for##7##3##(2007-11#5)(2008-10#1)(2010-12#1)
research priorities##10##2##(2007-11#7)(2008-10#1)(2010-10#1)(2010-12#1)
research process##12##2##(1996-3#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-12#2)(2009-4#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
research productivity in##3##3##(1997-1#2)(2009-4#1)
research productivity##4##2##(1997-1#2)(2007-4#1)(2009-4#1)
research profile##3##2##(2008-11#3)
research program on##2##3##(2008-8#1)(2011-3#1)
research program##11##2##(1992-12#2)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-3#1)(2012-3#1)
research programmes##4##2##(1992-6#1)(1993-6#1)(2008-7#1)(2013-1#1)
research programs that##3##3##(1996-2#1)(2009-8#2)
research programs##10##2##(1996-2#1)(1996-5#1)(2007-4#2)(2008-11#1)(2008-4#1)(2009-8#2)(2010-9#2)
research progress in##3##3##(2012-3#1)(2013-8#2)
research project to##4##3##(1991-6#1)(1996-3#1)(2008-12#1)(2010-10#1)
research project##20##2##(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1995-1#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-10#3)(2012-12#2)(2013-1#1)(2013-8#1)
research projects in##4##3##(2008-7#2)(2009-6#1)(2010-3#1)
research projects that##3##3##(1997-1#1)(2008-6#1)(2012-3#1)
research projects which##2##3##(1992-3#1)(2013-1#1)
research projects##22##2##(1992-3#1)(1992-5#1)(1992-6#1)(1994-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-6#2)(2010-10#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
research proposals##3##2##(2008-1#1)(2010-4#1)(2012-2#1)
research propositions##2##2##(1996-2#1)(2007-12#1)
research protocols##9##2##(1992-12#1)(1992-3#2)(1997-1#1)(2008-1#1)(2009-4#2)(2011-1#2)
research provides##3##2##(2008-3#1)(2009-5#1)(2011-2#1)
research publications##2##2##(2013-7#2)
research purposes##6##2##(1992-4#1)(1993-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
research quality##2##2##(2010-5#2)
research question that##2##3##(1996-2#1)(2008-11#1)
research question##8##2##(1996-2#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-4#1)
research questions are##2##3##(2008-7#1)(2009-5#1)
research questions were##2##3##(2008-12#1)(2013-1#1)
research questions##11##2##(1990-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
research records##2##2##(1991-3#1)(1997-5#1)
research regarding##2##2##(2008-1#1)(2008-7#1)
research related to##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
research relationship##2##2##(1997-1#2)
research reported##3##2##(2007-10#1)(2008-2#1)(2010-5#1)
research reports##2##2##(1995-12#1)(2010-2#1)
research reputation##2##2##(1996-1#2)
research requirements##2##2##(1996-12#1)(2008-4#1)
research requires##3##2##(1996-2#1)(2012-1#1)(2013-1#1)
research results from##2##3##(1993-6#1)(2008-10#1)
research results to##2##3##(2009-6#1)(2011-2#1)
research results##19##2##(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
research setting##4##2##(2008-6#1)(2009-9#1)(2011-2#1)(2012-12#1)
research settings##2##2##(2009-8#1)(2013-1#1)
research should be carried out on the##2##7##(2007-2#1)(2013-8#1)
research should be##6##3##(1996-12#1)(2007-2#1)(2008-1#1)(2010-11#1)(2013-8#2)
research should focus on##3##4##(2008-3#1)(2010-11#1)(2011-1#1)
research should focus##4##3##(2008-3#1)(2010-11#1)(2011-1#1)(2013-1#1)
research should##18##2##(1995-12#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
research show that##3##3##(1991-2#1)(2008-12#1)(2010-10#1)
research show##4##2##(1991-2#1)(2008-10#1)(2008-12#1)(2010-10#1)
research showed that the##2##4##(1995-12#1)(2008-1#1)
research showed that##6##3##(1995-12#1)(1997-3#1)(2008-1#1)(2008-12#2)(2013-1#1)
research showing##2##2##(2008-9#1)(2013-1#1)
research shows that the##3##4##(2008-3#1)(2009-8#1)(2013-8#1)
research shows that##9##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#2)(2010-12#1)(2012-2#1)(2013-8#2)
research shows##11##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
research skills##3##2##(2007-3#1)(2008-11#2)
research sought to##2##3##(1993-12#1)(2012-3#1)
research station##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
research stations##2##2##(2008-10#2)
research strategies##2##2##(1995-3#1)(2010-10#1)
research strategy##2##2##(2008-10#1)(2009-8#1)
research studies and##2##3##(2010-11#1)(2013-1#1)
research studies are##2##3##(2008-10#1)(2013-1#1)
research studies have##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
research studies on the##2##4##(2008-11#1)(2013-1#1)
research studies that##2##3##(2008-4#1)(2010-12#1)
research studies##21##2##(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#5)(2013-7#1)
research study was##2##3##(2008-12#1)(2012-12#1)
research study##17##2##(1994-2#1)(1996-3#1)(2007-10#2)(2008-11#4)(2008-12#3)(2008-4#2)(2012-12#2)(2013-1#2)
research subjects##2##2##(2009-4#2)
research suggested##2##2##(2008-12#1)(2008-9#1)
research suggests that##10##3##(1994-2#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
research suggests##12##2##(1994-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
research support for##2##3##(1995-3#1)(2008-11#1)
research supporting the##2##3##(2011-2#1)(2013-8#1)
research supports the##2##3##(2008-8#1)(2012-2#1)
research take##2##2##(2008-6#1)(2012-12#1)
research targeting##2##2##(2009-4#1)(2011-2#1)
research team##7##2##(1992-12#1)(1997-1#1)(2008-9#1)(2010-11#1)(2010-3#1)(2013-1#2)
research teams##3##2##(1993-12#1)(1993-2#1)(2008-8#1)
research techniques##4##2##(1995-2#1)(1995-3#2)(2013-1#1)
research tested the##2##3##(2008-8#1)(2010-8#1)
research that are##2##3##(2008-10#1)(2010-5#1)
research that is##2##3##(2009-11#1)(2012-3#1)
research that there##2##3##(2009-1#1)(2009-2#1)
research that used##2##3##(2007-12#1)(2012-2#1)
research that was##2##3##(2008-8#1)(2010-3#1)
research that would##2##3##(1992-12#1)(2011-3#1)
research that##46##2##(1992-12#1)(1992-3#1)(1993-12#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
research the##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
research through##4##2##(1993-3#1)(2008-1#1)(2008-9#1)(2013-1#1)
research to be##2##3##(1997-1#1)(2009-1#1)
research to clinical##2##3##(1991-9#1)(2009-3#1)
research to date##2##3##(2008-7#1)(2012-2#1)
research to develop and evaluate##2##5##(2008-11#2)
research to develop##4##3##(1991-12#1)(2008-11#2)(2011-2#1)
research to inform##2##3##(2009-4#1)(2009-9#1)
research to policymakers##3##3##(2010-4#3)
research to practice##4##3##(2008-3#1)(2008-5#1)(2013-1#2)
research to the##2##3##(1993-12#1)(2010-12#1)
research to understand##2##3##(2008-10#1)(2011-1#1)
research to##50##2##(1991-12#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-1#1)(1996-1#1)(1996-11#1)(1997-1#2)(1997-3#1)(1997-4#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)
research tool##6##2##(2008-11#2)(2008-9#2)(2009-10#1)(2011-2#1)
research tools##5##2##(2007-6#1)(2008-10#2)(2008-4#1)(2008-8#1)
research topics##3##2##(2008-7#1)(2010-12#2)
research trainees##3##2##(1992-6#3)
research trends##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
research trial##3##2##(2008-8#2)(2012-12#1)
research trials##2##2##(2009-10#1)(2010-11#1)
research uptake as##2##3##(2010-10#2)
research uptake##5##2##(2010-10#5)
research use##3##2##(1992-11#1)(2008-11#1)(2008-4#1)
research using a##2##3##(2010-3#1)(2012-3#1)
research using the##2##3##(2009-9#1)(2012-12#1)
research using##12##2##(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
research utilisation##4##2##(2008-11#4)
research was based on the##2##5##(2008-11#1)(2010-8#1)
research was carried out##4##4##(1991-9#1)(2007-11#1)(2008-12#1)(2008-2#1)
research was conducted in##2##4##(1997-6#1)(2008-12#1)
research was conducted##5##3##(1992-1#1)(1997-6#1)(2008-12#1)(2011-2#1)(2013-1#1)
research was to determine##4##4##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
research was to evaluate the##6##5##(2007-11#1)(2007-8#2)(2008-10#1)(2012-2#1)(2013-7#1)
research was to evaluate##7##4##(2007-11#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
research was to provide##2##4##(2011-1#1)(2012-2#1)
research was to##32##3##(1990-5#1)(1990-6#1)(1990-9#1)(1994-3#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
research was undertaken##2##3##(1994-3#1)(2011-2#1)
research was##68##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-3#2)(1996-2#1)(1997-6#2)(2007-11#3)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
research we##6##2##(2008-12#2)(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
research were to determine##3##4##(2008-1#1)(2008-10#2)
research were to##6##3##(2008-1#1)(2008-10#4)(2010-3#1)
research were used##2##3##(1995-2#1)(2008-10#1)
research were##14##2##(1990-10#1)(1995-2#1)(2008-1#1)(2008-10#7)(2009-4#1)(2010-3#1)(2010-9#1)(2012-2#1)
research which has##2##3##(1990-11#1)(2012-3#1)
research which is##2##3##(1996-11#1)(2009-6#1)
research which##6##2##(1990-11#1)(1996-11#2)(1996-6#1)(2009-6#1)(2012-3#1)
research while##3##2##(2008-11#1)(2008-12#2)
research will be##4##3##(2008-11#2)(2008-5#1)(2008-9#1)
research will##15##2##(1992-8#1)(1994-5#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2012-3#1)
research with children##2##3##(2008-10#1)(2010-5#1)
research with the##3##3##(2010-12#1)(2012-12#1)(2012-2#1)
research with##24##2##(1993-12#1)(1994-9#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-4#3)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#3)
research within##4##2##(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#1)
research work##6##2##(1997-8#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
research works##2##2##(2008-10#2)
research would##4##2##(1997-3#1)(2008-11#1)(2008-12#1)(2011-2#1)
research##3045##1##(1990-10#3)(1990-11#7)(1990-12#7)(1990-2#3)(1990-3#6)(1990-5#2)(1990-6#6)(1990-9#4)(1991-1#6)(1991-12#13)(1991-2#9)(1991-3#10)(1991-5#2)(1991-6#7)(1991-9#8)(1992-1#13)(1992-11#4)(1992-12#34)(1992-2#7)(1992-3#12)(1992-4#1)(1992-5#2)(1992-6#12)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#10)(1993-11#3)(1993-12#21)(1993-2#24)(1993-3#14)(1993-5#1)(1993-6#10)(1993-9#1)(1994-1#5)(1994-11#4)(1994-12#19)(1994-2#16)(1994-3#18)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#5)(1995-1#15)(1995-11#3)(1995-12#12)(1995-2#19)(1995-3#21)(1995-4#1)(1995-5#3)(1995-6#15)(1995-8#2)(1995-9#2)(1996-1#13)(1996-11#16)(1996-12#15)(1996-2#17)(1996-3#12)(1996-4#2)(1996-5#1)(1996-6#4)(1996-7#1)(1996-9#5)(1997-1#36)(1997-2#12)(1997-3#36)(1997-4#7)(1997-5#9)(1997-6#6)(1997-7#7)(1997-8#11)(2006-10#7)(2006-12#2)(2006-5#4)(2006-6#1)(2006-8#1)(2007-10#17)(2007-11#33)(2007-12#36)(2007-2#3)(2007-3#3)(2007-4#12)(2007-5#5)(2007-6#7)(2007-7#15)(2007-8#16)(2008-1#39)(2008-10#199)(2008-11#214)(2008-12#130)(2008-2#47)(2008-3#48)(2008-4#53)(2008-5#62)(2008-6#41)(2008-7#103)(2008-8#57)(2008-9#70)(2009-1#8)(2009-10#15)(2009-11#20)(2009-12#10)(2009-2#2)(2009-3#15)(2009-4#66)(2009-5#33)(2009-6#41)(2009-7#26)(2009-8#17)(2009-9#14)(2010-1#13)(2010-10#55)(2010-11#27)(2010-12#33)(2010-2#14)(2010-3#29)(2010-4#25)(2010-5#25)(2010-6#6)(2010-7#18)(2010-8#30)(2010-9#18)(2011-1#52)(2011-10#1)(2011-2#114)(2011-3#9)(2011-7#4)(2011-9#1)(2012-1#14)(2012-12#54)(2012-2#106)(2012-3#57)(2012-8#1)(2013-1#144)(2013-7#11)(2013-8#46)
research)##4##1##(1997-8#1)(2010-8#1)(2013-1#2)
research-based##7##1##(1996-2#1)(2007-11#1)(2008-11#2)(2008-12#2)(2010-5#1)
research-intensive##2##1##(2012-3#2)
research-oriented##2##1##(2008-7#1)(2011-2#1)
research-practice gap##2##2##(2008-11#2)
research-practice##3##1##(2008-11#2)(2008-6#1)
research-related tasks##4##2##(2012-3#4)
research/practice##2##1##(2010-10#2)
research?##3##1##(2009-6#1)(2011-1#1)(2013-8#1)
research]##21##1##(1990-6#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#5)
researchable questions that##2##3##(2009-3#2)
researched and developed##2##3##(2008-10#1)(2013-8#1)
researched##23##1##(1992-1#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-8#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#4)
researcher and##3##2##(1992-2#1)(1997-1#1)(2012-2#1)
researcher on##2##2##(2006-5#1)(2007-11#1)
researcher to##6##2##(2008-1#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2013-1#1)
researcher who##2##2##(2008-7#1)(2008-9#1)
researcher##29##1##(1990-12#2)(1992-12#1)(1992-2#1)(1994-3#2)(1997-1#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
researcher's##6##1##(1997-1#1)(1997-6#1)(2008-4#1)(2008-7#2)(2011-1#1)
researchers and clinicians##7##3##(1992-2#1)(2007-12#2)(2008-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
researchers and practitioners to##2##4##(2010-11#1)(2010-9#1)
researchers and practitioners##3##3##(2010-10#1)(2010-11#1)(2010-9#1)
researchers and the##2##3##(1994-3#1)(1995-1#1)
researchers and##28##2##(1992-2#1)(1994-3#1)(1995-1#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
researchers are##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2012-3#1)
researchers explore##3##2##(2008-8#1)(2013-1#2)
researchers for##4##2##(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
researchers found that##2##3##(1993-2#1)(2007-2#1)
researchers from##3##2##(2008-1#1)(2008-10#1)(2009-12#1)
researchers have been##2##3##(2008-6#1)(2013-1#1)
researchers have begun to##2##4##(2007-8#1)(2009-3#1)
researchers have examined##2##3##(2008-10#1)(2013-1#1)
researchers have focused##2##3##(2008-10#1)(2010-10#1)
researchers have shown##2##3##(2011-2#1)(2013-8#1)
researchers have##26##2##(1992-3#1)(1992-8#1)(1996-5#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#3)(2013-8#2)
researchers in the field of##2##5##(2008-5#1)(2010-7#1)
researchers in the##5##3##(1995-1#1)(2008-10#2)(2008-5#1)(2010-7#1)
researchers in##17##2##(1992-2#1)(1995-1#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2013-1#2)
researchers interested in##2##3##(2011-2#1)(2013-8#1)
researchers investigated##2##2##(2006-10#1)(2011-2#1)
researchers is##4##2##(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)
researchers often##2##2##(1996-3#1)(2010-8#1)
researchers should##3##2##(1992-3#1)(1997-5#1)(2010-6#1)
researchers since##2##2##(2009-8#1)(2010-5#1)
researchers to conduct##2##3##(1994-3#1)(1996-3#1)
researchers to consider##2##3##(2008-7#1)(2013-8#1)
researchers to develop##3##3##(2008-6#1)(2010-10#1)(2011-2#1)
researchers to speculate that##2##4##(1994-2#1)(2008-11#1)
researchers to study##3##3##(2008-7#1)(2009-6#1)(2013-1#1)
researchers to##31##2##(1992-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
researchers who##3##2##(2008-10#1)(2008-4#1)(2009-3#1)
researchers will need to##2##4##(2008-7#1)(2011-2#1)
researchers with a##2##3##(2008-2#1)(2008-9#1)
researchers with the##2##3##(1993-2#1)(2010-5#1)
researchers with##6##2##(1993-2#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)
researchers##264##1##(1991-12#1)(1992-2#2)(1992-3#4)(1992-8#1)(1993-11#1)(1993-2#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#12)(2008-12#8)(2008-2#4)(2008-3#6)(2008-4#13)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#1)(2010-3#4)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#3)(2011-2#14)(2011-3#1)(2012-12#9)(2012-2#6)(2012-3#1)(2013-1#21)(2013-8#4)
researchers'##5##1##(1994-9#1)(1995-6#1)(2008-10#1)(2008-6#1)(2012-2#1)
researches are##2##2##(2011-3#1)(2012-3#1)
researches have##3##2##(1991-6#1)(2008-9#1)(2013-1#1)
researches of##3##2##(2013-8#3)
researches##25##1##(1990-5#1)(1991-6#1)(1991-9#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-1#2)(2010-10#1)(2010-9#1)(2011-1#3)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
researching the##2##2##(2008-10#1)(2009-6#1)
researching##7##1##(1994-2#1)(1994-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-5#1)
resect##2##1##(2008-6#1)(2010-3#1)
resectability##7##1##(2008-1#2)(2008-2#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
resectable##7##1##(1992-10#1)(1992-12#1)(1992-3#1)(2008-1#1)(2008-2#1)(2012-3#1)(2013-1#1)
resected and a##2##3##(2007-5#1)(2012-12#1)
resected and the##2##3##(2006-12#1)(2008-6#1)
resected and##7##2##(2006-12#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
resected by##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
resected colorectal##2##2##(2012-3#1)(2013-1#1)
resected endoscopically##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
resected from the##2##3##(2007-8#1)(2013-1#1)
resected from##4##2##(2007-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
resected gastric cancer##2##3##(2010-12#2)
resected specimen##7##2##(1992-6#1)(2007-8#1)(2008-10#3)(2011-2#1)(2013-1#1)
resected through##2##2##(2007-8#2)
resected tumors##2##2##(2010-12#1)(2011-2#1)
resected##83##1##(1990-8#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-8#11)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#7)(2009-5#1)(2009-9#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#12)(2013-8#3)
resecting##2##1##(2007-8#1)(2013-1#1)
resection after##3##2##(2010-8#3)
resection alone for##2##3##(2008-1#1)(2013-1#1)
resection and reconstruction is##2##4##(2012-1#1)(2012-2#1)
resection and reconstruction##7##3##(2007-11#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
resection and##45##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-6#1)(1994-12#1)(2007-11#5)(2007-8#2)(2008-10#2)(2008-11#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
resection are##4##2##(1992-5#1)(1997-8#1)(2008-10#1)(2008-7#1)
resection between##2##2##(1993-9#1)(2007-8#1)
resection but##2##2##(2009-4#1)(2012-3#1)
resection by##2##2##(1996-2#1)(2009-12#1)
resection can##2##2##(1992-3#1)(2008-9#1)
resection combined with##3##3##(1990-2#1)(2007-8#1)(2012-3#1)
resection followed by##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
resection for##18##2##(1993-12#1)(1994-12#1)(1994-7#1)(1996-3#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#3)(2013-1#3)
resection group##2##2##(1990-2#2)
resection has been##3##3##(1991-6#1)(1992-3#1)(2008-10#1)
resection has##4##2##(1991-6#1)(1992-3#1)(2008-10#1)(2010-12#1)
resection have##2##2##(1990-8#1)(2009-3#1)
resection in##7##2##(2008-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
resection is the##2##3##(1993-9#1)(2008-1#1)
resection is##10##2##(1990-2#1)(1990-9#1)(1993-9#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-7#2)(2009-12#1)
resection margin##6##2##(1990-9#1)(1992-3#1)(2007-8#2)(2008-10#1)(2009-12#1)
resection margins##4##2##(1997-7#1)(2007-8#2)(2008-6#1)
resection may be##2##3##(2007-8#1)(2011-2#1)
resection may##4##2##(2007-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
resection of AVMs##2##3##(2008-7#2)
resection of RCC pulmonary metastases##2##5##(2013-1#2)
resection of a giant##2##4##(2011-2#1)(2013-1#1)
resection of a##9##3##(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#3)(2013-1#1)
resection of bladder##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
resection of colorectal##2##3##(2011-2#1)(2012-12#1)
resection of malignant chest wall##2##5##(2008-6#1)(2012-2#1)
resection of pulmonary##2##3##(2012-1#2)
resection of the cystic##2##4##(1992-9#1)(2008-5#1)
resection of the giant-cell tumour##3##5##(2007-11#3)
resection of the lesion##2##4##(2007-8#1)(2008-7#1)
resection of the nasal septum##3##5##(2012-12#3)
resection of the primary##3##4##(1992-6#1)(2007-10#1)(2011-3#1)
resection of the tumor##5##4##(1995-4#1)(2007-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
resection of the tumour was performed##2##6##(2008-7#1)(2012-12#1)
resection of the tumour##4##4##(2008-10#1)(2008-7#2)(2012-12#1)
resection of the##47##3##(1990-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1995-4#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#2)(2010-7#1)(2011-2#6)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#1)
resection of this##2##3##(2008-10#1)(2011-2#1)
resection of tumor##3##3##(2007-11#2)(2008-5#1)
resection of##121##2##(1990-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-2#1)(1995-4#1)(1997-8#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-6#8)(2008-7#11)(2008-9#4)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#9)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#1)
resection or##7##2##(1990-3#1)(1990-9#1)(1992-6#1)(1996-3#1)(2008-7#1)(2012-8#1)(2013-1#1)
resection procedure with subsequent joint##2##5##(2007-11#2)
resection procedure##4##2##(2007-11#3)(2009-10#1)
resection specimen##2##2##(2008-10#1)(2008-5#1)
resection surgery##2##2##(2007-9#1)(2011-2#1)
resection that##2##2##(2009-3#1)(2011-2#1)
resection the##2##2##(2007-11#1)(2012-12#1)
resection to##2##2##(2010-12#1)(2010-3#1)
resection using##2##2##(1991-6#1)(2012-12#1)
resection was achieved in##2##4##(2008-10#1)(2011-2#1)
resection was achieved##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
resection was performed##6##3##(1992-6#1)(2007-8#1)(2008-10#1)(2011-2#2)(2013-8#1)
resection was##19##2##(1990-11#1)(1992-6#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-8#1)
resection were##3##2##(1990-2#1)(2010-12#1)(2011-2#1)
resection with anterior##2##3##(2007-11#2)
resection with subsequent joint exchange procedure##2##6##(2007-11#2)
resection with subsequent##4##3##(2007-11#4)
resection with##21##2##(1990-2#1)(1992-5#1)(1992-9#1)(1994-6#1)(2007-11#7)(2007-8#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
resection without##2##2##(2007-8#1)(2008-6#1)
resection##462##1##(1990-11#3)(1990-2#8)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#7)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#4)(1992-5#5)(1992-6#4)(1992-9#6)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-12#3)(1994-6#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-2#5)(1996-3#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#3)(2006-12#2)(2007-10#2)(2007-11#27)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#38)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#5)(2008-6#24)(2008-7#26)(2008-8#6)(2008-9#10)(2009-1#2)(2009-10#5)(2009-12#5)(2009-3#5)(2009-4#6)(2009-5#1)(2009-7#1)(2010-12#7)(2010-3#7)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#2)(2011-2#56)(2011-3#2)(2012-1#5)(2012-12#16)(2012-2#8)(2012-3#16)(2012-8#1)(2013-1#28)(2013-7#3)(2013-8#9)
resection)##2##1##(1990-12#1)(2009-12#1)
resection?]##2##1##(1990-11#1)(1990-6#1)
resectional##2##1##(1991-6#1)(2008-10#1)
resections are##2##2##(2010-8#2)
resections for##3##2##(1990-2#1)(1990-9#1)(1991-4#1)
resections of the##5##3##(1992-6#1)(2006-12#1)(2007-11#1)(2011-2#1)(2012-2#1)
resections of##7##2##(1992-6#1)(2006-12#1)(2007-11#1)(2011-2#3)(2012-2#1)
resections via##2##2##(2008-10#1)(2011-2#1)
resections##31##1##(1990-2#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-9#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-8#3)(2008-10#4)(2008-3#1)(2010-3#1)(2010-8#3)(2011-2#4)(2012-2#2)
resections-anastomoses##2##1##(1993-9#2)
resemblance to the##3##3##(1990-11#1)(2008-3#1)(2011-2#1)
resemblance to those##3##3##(1993-11#1)(1997-3#1)(2008-3#1)
resemblance to##10##2##(1990-11#1)(1991-12#1)(1992-8#1)(1993-11#1)(1997-3#1)(2007-5#1)(2008-3#2)(2009-1#1)(2011-2#1)
resemblance##15##1##(1990-11#1)(1991-12#1)(1992-8#1)(1993-11#1)(1997-3#1)(2007-5#1)(2008-3#3)(2009-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
resemble a##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
resemble native##2##2##(1994-3#1)(2013-1#1)
resemble the effects of##2##4##(1993-3#1)(2008-7#1)
resemble the##11##2##(1991-5#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(2008-11#2)(2008-7#2)(2009-8#1)(2012-2#1)
resemble those of##3##3##(1995-11#1)(1997-6#1)(2007-12#1)
resemble those seen in##2##4##(2008-4#1)(2008-7#1)
resemble those##8##2##(1991-5#1)(1992-6#1)(1995-11#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)
resemble##46##1##(1990-5#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
resembled a##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
resembled that of the##2##4##(2008-10#1)(2008-7#1)
resembled that of##5##3##(1990-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
resembled that##6##2##(1990-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
resembled the##7##2##(1992-5#1)(1994-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2012-3#1)
resembled those##2##2##(1991-3#1)(2008-10#1)
resembled##28##1##(1990-11#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-5#1)(1995-2#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
resembles a##2##2##(2007-12#1)(2009-10#1)
resembles an##3##2##(2008-2#1)(2008-9#1)(2009-8#1)
resembles that of the##2##4##(1994-12#1)(2011-2#1)
resembles that of##9##3##(1992-6#1)(1994-12#2)(1996-2#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#1)
resembles that##11##2##(1992-6#1)(1994-12#2)(1996-2#1)(1997-2#1)(2007-12#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#1)
resembles the##15##2##(1992-12#1)(1993-6#2)(1994-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#2)(2011-2#1)
resembles those##2##2##(1991-5#1)(1993-2#1)
resembles##53##1##(1990-12#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-6#3)(1993-9#1)(1994-12#4)(1994-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#2)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#1)
resembling a##3##2##(1994-12#1)(2011-2#1)(2012-2#1)
resembling an##2##2##(2008-7#1)(2009-11#1)
resembling human##2##2##(1994-11#1)(2010-8#1)
resembling native##2##2##(1995-12#1)(1996-12#1)
resembling the##5##2##(1996-12#2)(1997-7#1)(2008-7#1)(2012-2#1)
resembling those of##5##3##(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2010-11#1)
resembling those##7##2##(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2010-11#1)(2011-2#1)
resembling##63##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-8#2)(1992-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-12#2)(1996-12#3)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
resent##2##1##(2008-12#1)(2012-2#1)
resequenced##2##1##(2012-2#1)(2012-3#1)
resequencing##6##1##(2008-10#1)(2008-9#1)(2012-2#2)(2012-3#2)
resequestered##2##1##(1991-8#1)(2008-10#1)
reserpine##16##1##(1992-7#1)(1996-2#1)(2008-10#8)(2008-12#5)(2012-2#1)
reservation##4##1##(1990-2#1)(1991-12#1)(2009-11#1)(2011-2#1)
reservations##3##1##(1991-3#1)(2012-12#2)
reserve capacity of##2##3##(1990-11#1)(1992-12#1)
reserve in##3##2##(1990-3#1)(2008-7#1)(2012-2#1)
reserve of##3##2##(2008-10#2)(2008-12#1)
reserve##33##1##(1990-11#1)(1990-3#1)(1992-12#1)(1992-5#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#6)
reserve)##2##1##(2011-1#1)(2013-8#1)
reserved as a##2##3##(1997-2#1)(2010-12#1)
reserved for patients with##3##4##(2011-2#2)(2012-3#1)
reserved for patients##6##3##(1990-6#1)(2007-7#1)(2008-6#1)(2011-2#2)(2012-3#1)
reserved for##21##2##(1990-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(1996-2#1)(1997-3#2)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
reserved##25##1##(1990-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reserves and##2##2##(2008-5#1)(2009-3#1)
reserves in the##2##3##(2008-10#1)(2013-1#1)
reserves of##2##2##(2009-5#1)(2011-2#1)
reserves##29##1##(1990-3#2)(1995-3#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#2)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#2)
reservoir (H)##3##2##(2008-10#3)
reservoir and##7##2##(1992-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)
reservoir for the##2##3##(1997-4#1)(2011-2#1)
reservoir for##5##2##(1997-4#1)(1997-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
reservoir hosts##2##2##(2008-10#1)(2008-12#1)
reservoir is##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
reservoir of cpe-positive C##2##4##(2011-2#2)
reservoir of##11##2##(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-10#1)(2009-12#1)(2011-2#2)(2013-7#1)
reservoir powder inhaler##4##3##(1996-2#4)
reservoir water##4##2##(2008-10#4)
reservoir##83##1##(1990-9#3)(1992-11#2)(1992-9#1)(1995-2#1)(1996-2#5)(1996-3#1)(1997-4#1)(1997-5#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#31)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2013-1#2)(2013-7#1)
reservoirs and##3##2##(2008-10#1)(2010-1#1)(2011-2#1)
reservoirs for the Lyme disease##2##5##(1997-4#1)(2010-6#1)
reservoirs for the##4##3##(1997-4#1)(2008-10#2)(2010-6#1)
reservoirs for##6##2##(1992-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2010-6#1)
reservoirs in the##2##3##(1997-4#1)(2013-1#1)
reservoirs in##3##2##(1997-4#1)(2008-5#1)(2013-1#1)
reservoirs of##6##2##(2008-10#2)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
reservoirs##28##1##(1992-11#1)(1992-5#1)(1997-4#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#5)(2009-8#1)(2010-1#1)(2010-6#2)(2011-2#3)(2013-1#3)(2013-7#1)
reset to##2##2##(2013-1#1)(2013-8#1)
reset##8##1##(2008-11#1)(2008-5#2)(2008-6#1)(2009-9#1)(2013-1#1)(2013-8#2)
resetting of##2##2##(2008-3#1)(2008-9#1)
reshape##5##1##(1991-1#1)(1994-1#1)(1995-3#2)(2010-8#1)
reshaped##2##1##(2008-3#2)
reshaping of##7##2##(1993-12#1)(2007-12#3)(2008-10#1)(2008-11#1)(2009-7#1)
reshaping the##2##2##(1994-12#1)(2009-8#1)
reshaping##19##1##(1992-6#1)(1993-12#1)(1994-12#1)(2007-12#7)(2008-10#1)(2008-11#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2013-7#1)
reside at##2##2##(2013-8#2)
reside in a##4##3##(1990-5#1)(1994-5#1)(1994-8#1)(2008-1#1)
reside in the##5##3##(1992-6#1)(1995-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
reside in##12##2##(1990-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)
reside on##2##2##(1992-1#1)(2008-10#1)
reside outside the##2##3##(1991-9#1)(2010-6#1)
reside within##2##2##(1992-4#1)(2008-9#1)
reside##29##1##(1990-5#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-8#2)
resided in the##4##3##(1995-6#1)(1995-9#1)(2009-7#1)(2012-3#1)
resided in##7##2##(1995-6#1)(1995-9#1)(2007-10#1)(2008-11#1)(2009-7#1)(2012-3#1)(2013-8#1)
resided within##2##2##(1996-5#1)(2006-10#1)
resided##12##1##(1994-6#1)(1995-6#1)(1995-9#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
residence and##4##2##(1994-6#1)(1996-11#1)(2011-2#1)(2012-3#1)
residence in the##3##3##(2007-10#1)(2008-8#1)(2010-12#1)
residence in##6##2##(2007-10#1)(2008-8#2)(2010-12#2)(2010-8#1)
residence time and##2##3##(2010-5#2)
residence time in##2##3##(2008-12#1)(2008-5#1)
residence time on the efficacy of antidandruff shampoos##2##8##(2008-5#2)
residence time##20##2##(1992-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#2)(2010-5#2)(2010-8#1)(2011-2#1)
residence times##4##2##(1991-12#1)(1995-2#1)(1996-12#1)(2008-7#1)
residence was##2##2##(2013-1#2)
residence##58##1##(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-10#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
residences##2##1##(2008-10#1)(2008-6#1)
residencies##4##1##(1993-2#1)(1994-12#1)(1994-3#1)(2012-3#1)
residency and##2##2##(1994-12#1)(1994-3#1)
residency in##5##2##(1993-12#1)(1994-2#1)(2008-8#2)(2010-8#1)
residency of##2##2##(2010-8#1)(2012-2#1)
residency program##8##2##(1991-12#1)(1994-12#2)(1995-1#2)(1996-9#1)(2007-4#1)(2012-3#1)
residency programs##6##2##(1992-3#1)(1994-1#1)(1994-3#1)(2008-11#1)(2008-7#1)(2010-1#1)
residency training programs##2##3##(1992-1#2)
residency training##7##2##(1992-1#3)(2008-8#1)(2011-2#1)(2012-3#2)
residency##45##1##(1991-12#1)(1991-8#1)(1992-1#3)(1992-3#1)(1993-12#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#3)(1995-1#3)(1995-3#1)(1996-1#1)(1996-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-5#1)(2010-8#3)(2011-2#2)(2012-2#1)(2012-3#4)
resident and##7##2##(1990-2#1)(1997-1#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-7#1)
resident assessment##4##2##(1993-2#1)(1994-3#1)(1997-1#1)(2012-2#1)
resident bacteria##3##2##(2008-5#3)
resident characteristics##2##2##(1991-2#1)(1991-3#1)
resident dependency##2##2##(2012-12#2)
resident doctors##2##2##(2008-7#2)
resident education##3##2##(2007-4#3)
resident epidermal Langerhans cells##2##4##(2008-5#2)
resident flora##3##2##(2008-5#3)
resident in##6##2##(1991-9#1)(1994-2#1)(2008-10#3)(2008-7#1)
resident macrophages##2##2##(1990-2#1)(2008-12#1)
resident microflora##4##2##(2008-10#3)(2008-5#1)
resident on##3##2##(2008-1#2)(2008-5#1)
resident peritoneal macrophages##3##3##(1994-9#1)(2008-11#1)(2008-12#1)
resident population##2##2##(1991-8#1)(1996-3#1)
resident protein##4##2##(1994-11#2)(1996-9#2)
resident species##2##2##(2007-7#1)(2008-5#1)
resident##104##1##(1990-2#3)(1991-1#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-9#2)(1997-1#2)(2007-4#4)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#14)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
resident's##3##1##(2011-1#1)(2011-2#2)
resident-level##2##1##(1996-2#1)(1996-3#1)
residential aged care##3##3##(2010-10#2)(2012-12#1)
residential care##6##2##(1997-1#2)(2008-12#1)(2012-12#2)(2013-1#1)
residential patterns##2##2##(2011-2#2)
residential segregation##2##2##(2011-2#2)
residential treatment##6##2##(2008-6#1)(2013-1#1)(2013-8#4)
residential##47##1##(1991-1#1)(1991-12#2)(1991-2#1)(1993-1#1)(1993-12#2)(1994-2#1)(1995-2#1)(1996-3#2)(1997-1#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#4)(2009-9#1)(2010-10#2)(2010-3#2)(2011-1#3)(2011-2#5)(2012-12#4)(2013-1#3)(2013-8#5)
residents (n =##2##3##(1995-2#1)(2013-1#1)
residents aged##3##2##(1991-6#2)(2008-12#1)
residents and##19##2##(1991-6#1)(1994-3#1)(1995-3#1)(1997-1#2)(2008-1#2)(2008-11#2)(2008-4#3)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
residents are##2##2##(2009-9#1)(2011-1#1)
residents at the##2##3##(2009-11#1)(2011-1#1)
residents at##3##2##(2009-11#1)(2011-1#1)(2012-3#1)
residents from the##3##3##(1992-1#1)(1995-3#1)(2008-1#1)
residents from##6##2##(1992-1#1)(1995-3#1)(2008-1#1)(2008-12#1)(2010-10#1)(2013-1#1)
residents had##2##2##(2008-1#2)
residents have##2##2##(2007-4#1)(2011-1#1)
residents in a##2##3##(1995-3#1)(2011-2#1)
residents in family and community##2##5##(1993-3#1)(1994-2#1)
residents in the##4##3##(1994-9#1)(1995-3#1)(1996-9#1)(2007-5#1)
residents in##25##2##(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-3#4)(1996-9#1)(2007-4#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#1)
residents increased by##2##3##(1991-8#2)
residents of Greater Athens##2##4##(1993-9#2)
residents of a##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
residents of suburban areas##2##4##(2011-2#2)
residents of the##2##3##(1993-3#1)(2011-1#1)
residents of##33##2##(1990-12#1)(1990-2#3)(1992-5#1)(1993-3#1)(1993-9#2)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
residents on##2##2##(1997-1#1)(2008-6#1)
residents to##4##2##(2008-1#1)(2008-11#3)
residents were##7##2##(1997-2#1)(2008-1#1)(2008-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
residents who are##2##3##(1997-1#1)(2011-2#1)
residents who##3##2##(1997-1#1)(2008-11#1)(2011-2#1)
residents with dementia##4##3##(2010-10#3)(2011-1#1)
residents with##7##2##(1993-8#1)(2010-10#3)(2011-1#1)(2011-2#2)
residents##210##1##(1990-12#1)(1990-2#3)(1991-1#1)(1991-2#2)(1991-3#2)(1991-6#3)(1991-8#4)(1992-1#4)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-9#1)(1995-12#5)(1995-2#6)(1995-3#12)(1996-1#1)(1996-2#2)(1996-9#1)(1997-1#5)(1997-2#2)(1997-8#1)(2007-10#1)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#3)(2008-1#11)(2008-10#1)(2008-11#11)(2008-12#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-9#4)(2010-10#8)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#19)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#6)
residents'##7##1##(1991-2#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-4#1)
resides at##2##2##(1994-6#1)(2009-5#1)
resides in a##2##3##(1995-11#1)(2009-8#1)
resides in the##9##3##(1990-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
resides in##16##2##(1990-2#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-8#1)(2013-1#1)
resides on##2##2##(1991-9#1)(2008-1#1)
resides within the##2##3##(1994-11#1)(2010-2#1)
resides##28##1##(1990-11#1)(1990-2#1)(1991-9#1)(1992-11#1)(1994-11#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-6#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
residing at##2##2##(1991-12#1)(2012-3#1)
residing in New##2##3##(2008-11#1)(2012-12#1)
residing in the##12##3##(1990-5#1)(1993-6#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-7#1)(2013-1#1)(2013-8#1)
residing in##33##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-12#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#3)
residing on##3##2##(1994-9#1)(2008-1#1)(2008-3#1)
residing##42##1##(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-12#2)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#3)
residual amplitude##2##2##(2007-12#1)(2008-3#1)
residual anabolic##3##2##(2008-10#3)
residual and##3##2##(1991-3#1)(2008-10#1)(2008-12#1)
residual birefringence##3##2##(2007-12#1)(2008-2#2)
residual carbon##2##2##(2008-10#2)
residual cells##3##2##(2009-11#3)
residual chlorine in##2##3##(2008-10#2)
residual chlorine##8##2##(2008-10#8)
residual confounding##6##2##(1992-9#5)(1997-1#1)
residual disease in the##2##4##(2011-2#1)(2013-8#1)
residual disease##15##2##(1991-4#1)(1995-12#2)(1996-11#1)(2008-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-8#1)
residual effect##2##2##(2008-10#2)
residual effects of##3##3##(1990-3#1)(2008-8#1)(2009-3#1)
residual effects##5##2##(1990-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
residual error##2##2##(2008-10#1)(2008-3#1)
residual glass##2##2##(2009-7#2)
residual hearing##5##2##(2008-9#1)(2012-2#4)
residual leak##2##2##(1997-8#1)(2011-2#1)
residual limb##2##2##(2007-7#2)
residual masses##2##2##(1990-3#2)
residual nutrients##2##2##(2008-10#2)
residual or##3##2##(1993-1#1)(2010-6#1)(2011-2#1)
residual phase noise##2##3##(2007-11#1)(2007-12#1)
residual phase##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
residual plots##2##2##(1995-9#1)(2008-10#1)
residual potency##2##2##(1991-1#2)
residual protein##2##2##(2008-2#1)(2008-6#1)
residual renal function##6##3##(2007-12#3)(2011-2#3)
residual renal##7##2##(2007-12#3)(2008-4#1)(2011-2#3)
residual risk##2##2##(1990-6#1)(2008-7#1)
residual shunt##5##2##(1994-9#1)(2007-8#1)(2008-11#2)(2010-8#1)
residual signs##2##2##(1990-6#1)(2012-12#1)
residual solution##2##2##(2008-10#2)
residual standard deviation##2##3##(1996-8#1)(2007-12#1)
residual strains in the##3##4##(2008-9#3)
residual strains in##5##3##(2008-9#5)
residual strains##7##2##(2008-9#7)
residual stress can##2##3##(2008-2#1)(2009-7#1)
residual stress near##2##3##(2008-2#2)
residual stress##10##2##(2007-11#5)(2008-2#3)(2008-8#1)(2009-7#1)
residual stresses on##2##3##(2008-2#1)(2009-7#1)
residual stresses##4##2##(2008-2#1)(2008-7#1)(2009-7#2)
residual surface##2##2##(2007-12#1)(2008-3#1)
residual triggering##2##2##(2008-9#2)
residual tumor##2##2##(2010-12#1)(2010-3#1)
residual urine volume##2##3##(1993-2#2)
residual urine volumes after##2##4##(1993-2#2)
residual urine##5##2##(1993-2#4)(2011-2#1)
residual variance##2##2##(2008-10#1)(2010-11#1)
residual variances##2##2##(2012-1#2)
residual vinyl groups in##2##4##(2008-10#2)
residual vinyl groups##3##3##(2008-10#3)
residual volume##2##2##(1993-2#1)(1996-2#1)
residual white blood cells##2##4##(2008-9#2)
residual yolk sac on growth##2##5##(2008-12#2)
residual yolk sac##9##3##(2008-12#9)
residual##335##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#7)(1993-1#1)(1993-11#1)(1993-2#6)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#12)(2007-12#12)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#57)(2008-11#8)(2008-12#11)(2008-2#17)(2008-3#24)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#12)(2008-9#15)(2009-10#2)(2009-11#6)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-7#6)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2012-8#1)(2013-1#4)(2013-8#1)
residuals##23##1##(1995-12#1)(1995-9#1)(1997-3#1)(2008-10#9)(2008-7#1)(2008-8#3)(2011-1#1)(2011-2#3)(2012-2#3)
residue (0##4##2##(1993-11#2)(2011-1#2)
residue (I184Y)##2##2##(1992-1#2)
residue 161 is##3##3##(1995-5#3)
residue 161##6##2##(1995-5#6)
residue 3##2##2##(1995-3#1)(1997-4#1)
residue C##2##2##(2008-11#2)
residue after##2##2##(1993-11#1)(2008-10#1)
residue analysis##5##2##(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
residue and the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
residue and##10##2##(1990-12#1)(1992-3#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
residue are##2##2##(1991-5#1)(1992-12#1)
residue as the##2##3##(1991-9#1)(1995-2#1)
residue at position##7##3##(1991-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1997-2#1)(2008-2#1)
residue at the##12##3##(1990-11#1)(1990-2#1)(1992-11#1)(1992-3#2)(1994-12#1)(1995-11#2)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)
residue at##25##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#3)(1992-6#2)(1992-8#1)(1994-11#2)(1994-12#1)(1995-11#2)(1995-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
residue by##3##2##(1991-9#1)(2008-10#2)
residue can##3##2##(1990-8#1)(1992-12#1)(2008-10#1)
residue decomposition##2##2##(2008-11#2)
residue for##2##2##(1993-11#1)(1995-11#1)
residue from the##2##3##(2008-10#2)
residue from##5##2##(2008-10#4)(2008-7#1)
residue has##2##2##(1995-5#1)(1997-2#1)
residue in Ras structure and##2##5##(1995-2#2)
residue in the short##2##4##(1990-11#1)(1993-11#1)
residue in the##21##3##(1990-11#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-2#2)(1995-6#1)(1997-7#1)(2008-10#1)(2011-2#1)
residue in##45##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#2)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#4)(1994-6#1)(1995-2#6)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#3)(2011-1#2)(2011-2#1)(2013-1#2)
residue involved in##2##3##(1992-8#1)(1995-6#1)
residue is the##2##3##(1992-8#2)
residue is##15##2##(1990-8#1)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(2008-5#1)(2009-2#1)
residue may##2##2##(1990-2#1)(2008-10#1)
residue of the##6##3##(1990-7#1)(1992-12#1)(1994-6#1)(1994-9#1)(1997-2#1)(2008-8#1)
residue of##22##2##(1990-7#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
residue on the##4##3##(1993-11#1)(2008-10#2)(2008-5#1)
residue on##8##2##(1990-8#1)(1993-11#1)(2008-10#4)(2008-5#1)(2008-6#1)
residue or##3##2##(1992-3#1)(1992-4#1)(1994-6#1)
residue precursors##2##2##(1992-9#2)
residue size##2##2##(2008-10#2)
residue that is conserved in all##2##6##(1993-11#1)(1993-9#1)
residue that is conserved in##3##5##(1993-11#1)(1993-9#1)(1995-6#1)
residue that is##4##3##(1993-11#1)(1993-9#1)(1995-6#1)(2009-5#1)
residue that##7##2##(1993-11#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-8#1)(2008-3#1)(2009-5#1)
residue to##5##2##(1993-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2012-3#1)
residue using##2##2##(1993-11#1)(2008-10#1)
residue was dissolved in##3##4##(2008-10#2)(2008-11#1)
residue was mutated to##2##4##(1995-2#1)(2008-4#1)
residue was##14##2##(1990-5#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2012-2#1)
residue were##2##2##(1991-5#1)(2008-10#1)
residue which is##2##3##(1992-3#1)(2008-5#1)
residue which##5##2##(1992-3#1)(1992-6#1)(1993-8#1)(1994-2#1)(2008-5#1)
residue with a##2##3##(1991-12#1)(2008-10#1)
residue with##5##2##(1991-12#1)(2008-10#4)
residue##388##1##(1990-11#2)(1990-12#6)(1990-2#2)(1990-5#4)(1990-7#6)(1990-8#5)(1991-10#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#5)(1991-8#4)(1991-9#6)(1992-1#4)(1992-11#3)(1992-12#7)(1992-3#13)(1992-4#1)(1992-6#17)(1992-8#9)(1992-9#4)(1993-11#18)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#6)(1993-8#6)(1993-9#1)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#11)(1994-6#5)(1994-9#2)(1995-11#6)(1995-2#21)(1995-3#1)(1995-5#10)(1995-6#11)(1995-8#3)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-9#1)(2007-12#1)(2007-6#1)(2008-10#60)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#3)(2009-2#2)(2009-3#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#7)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
residue(s)##8##1##(1990-2#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-11#1)(1995-11#1)(2008-4#1)(2008-8#1)
residue)##3##1##(2008-10#1)(2008-4#1)(2011-2#1)
residue-containing##2##1##(1994-12#1)(2008-6#1)
residues (Del##2##2##(1995-2#2)
residues 20##2##2##(1993-8#2)
residues 39##2##2##(1992-4#1)(1993-3#1)
residues 6##3##2##(1995-2#3)
residues 79##2##2##(1991-5#1)(1995-2#1)
residues A##2##2##(2008-11#2)
residues N-terminal to##2##3##(1992-10#2)
residues and a##2##3##(1996-10#1)(2008-4#1)
residues and is##3##3##(1992-9#1)(1994-5#1)(1994-9#1)
residues and the##6##3##(1990-12#1)(1990-7#1)(1992-6#1)(1993-6#1)(1997-9#1)(2008-5#1)
residues and to##2##3##(1990-9#1)(1992-8#1)
residues and##45##2##(1990-12#2)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-11#2)(1992-6#6)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-10#1)(1997-4#2)(1997-8#1)(1997-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
residues are##17##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-6#2)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
residues at position##2##3##(1993-11#1)(1997-6#1)
residues at positions##6##3##(1991-12#1)(1994-3#1)(1994-5#4)
residues at the NS2(Pro) dimer interface that##3##7##(2012-2#3)
residues at the##12##3##(1990-2#1)(1992-6#2)(1993-11#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-8#1)(2012-2#3)
residues at##22##2##(1990-2#1)(1991-12#1)(1992-6#2)(1993-11#2)(1993-3#1)(1994-3#1)(1994-5#4)(1995-11#1)(1995-2#1)(1997-6#1)(2008-10#3)(2008-8#1)(2012-2#3)
residues attached##2##2##(1995-3#1)(2008-11#1)
residues between##2##2##(1996-7#1)(1997-9#1)
residues by site-directed mutagenesis##2##4##(1992-3#1)(1995-2#1)
residues by the##2##3##(1993-8#1)(1996-2#1)
residues by##8##2##(1990-5#2)(1992-12#1)(1992-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-2#1)
residues can be identified##2##4##(1997-4#1)(2008-10#1)
residues can be##3##3##(1994-6#1)(1997-4#1)(2008-10#1)
residues can##5##2##(1994-6#1)(1997-4#1)(2008-10#1)(2012-2#2)
residues close to the##2##4##(1993-8#1)(2009-7#1)
residues conserved##3##2##(1991-5#1)(1994-5#1)(1995-12#1)
residues do not##2##3##(2008-10#1)(2012-2#1)
residues exposed on the##2##4##(1995-6#1)(2008-10#1)
residues exposed##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
residues for##4##2##(1990-12#1)(1993-8#1)(2008-8#2)
residues found in##3##3##(1991-6#1)(1993-11#1)(2011-2#1)
residues from the##7##3##(1991-12#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(2008-10#2)
residues from##19##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)
residues have##2##2##(1992-3#1)(1995-11#1)
residues in food##3##3##(2009-8#1)(2013-8#2)
residues in most##2##3##(1993-6#1)(1997-4#1)
residues in proteins##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
residues in the N-terminal##2##4##(1994-5#1)(2008-9#1)
residues in the alpha-chain##2##4##(1995-6#2)
residues in the beta##2##4##(1990-7#1)(2008-11#1)
residues in the protein##2##4##(2008-1#1)(2008-10#1)
residues in the##54##3##(1990-11#1)(1990-7#2)(1991-12#1)(1991-8#1)(1992-12#4)(1992-3#1)(1992-4#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#4)(1995-6#6)(1996-5#1)(1997-7#2)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#4)(2008-9#3)
residues in this region##2##4##(1994-5#1)(2008-10#1)
residues in three##2##3##(2008-10#1)(2008-8#1)
residues in##126##2##(1990-11#1)(1990-12#1)(1990-7#3)(1991-12#2)(1991-5#1)(1991-8#2)(1992-12#4)(1992-3#1)(1992-4#2)(1992-6#3)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-11#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#10)(1995-6#8)(1995-8#3)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-4#2)(2008-8#8)(2008-9#4)(2009-8#1)(2009-9#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
residues including##2##2##(1994-2#1)(1996-6#1)
residues into the##2##3##(1995-5#1)(2008-10#1)
residues involved in##5##3##(1991-8#1)(1992-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
residues involved##6##2##(1991-8#1)(1992-12#1)(1995-6#1)(2008-4#1)(2008-8#1)(2012-2#1)
residues is##12##2##(1990-5#1)(1991-9#1)(1992-12#1)(1992-4#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-10#1)
residues known to##2##3##(1993-2#1)(1995-2#1)
residues located at the##3##4##(1990-8#1)(2008-8#1)(2011-2#1)
residues located at##4##3##(1990-8#1)(1995-5#1)(2008-8#1)(2011-2#1)
residues located##7##2##(1990-8#1)(1992-6#1)(1995-5#1)(1995-6#1)(2008-4#1)(2008-8#1)(2011-2#1)
residues may##2##2##(1994-11#1)(2008-11#1)
residues near the##2##3##(1995-5#1)(1995-6#1)
residues of HPRG##3##3##(1995-2#3)
residues of human##4##3##(1994-8#1)(1995-2#1)(1995-6#2)
residues of the##19##3##(1990-5#1)(1990-7#2)(1991-10#2)(1991-12#1)(1992-12#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
residues of##64##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-2#6)(1995-3#2)(1995-6#5)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#2)(2011-2#2)
residues on a##2##3##(1995-2#1)(2012-2#1)
residues on the##3##3##(1992-12#1)(1993-11#1)(1994-5#1)
residues on##10##2##(1992-12#1)(1993-11#1)(1994-5#2)(1995-2#1)(1997-9#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
residues or##2##2##(1994-3#1)(2008-4#1)
residues other than those##2##4##(1994-3#1)(2008-5#1)
residues resulted in##2##3##(1992-3#1)(1994-6#1)
residues substituted##2##2##(1995-6#1)(2008-8#1)
residues such as##2##3##(1997-8#1)(2008-1#1)
residues than in##2##3##(2008-10#2)
residues that are##7##3##(1990-8#1)(1994-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
residues that were##5##3##(1992-8#1)(1997-4#1)(2008-10#2)(2010-2#1)
residues that##20##2##(1990-7#1)(1990-8#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-4#2)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
residues to##5##2##(1992-6#2)(1995-5#1)(2008-7#1)(2011-1#1)
residues was##2##2##(1992-4#1)(1993-11#1)
residues were found in##2##4##(2008-10#1)(2013-8#1)
residues were replaced with##2##4##(1994-6#1)(1995-6#1)
residues were replanted into the##2##5##(2008-10#2)
residues were##22##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#3)(2008-10#6)(2011-2#2)(2012-2#1)(2013-8#1)
residues which are##2##3##(1993-11#1)(2008-11#1)
residues which may##2##3##(1996-10#1)(2012-2#1)
residues which##8##2##(1990-8#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-2#1)(2008-11#1)(2012-2#1)
residues with a##7##3##(1990-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)
residues with##20##2##(1990-11#1)(1990-2#3)(1990-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(2008-2#1)(2008-4#1)(2008-8#2)
residues within the##4##3##(1990-11#1)(1995-5#1)(2008-8#1)(2011-1#1)
residues within##8##2##(1990-11#1)(1991-5#1)(1993-2#1)(1994-6#1)(1995-5#1)(2008-8#1)(2010-10#1)(2011-1#1)
residues##830##1##(1990-10#1)(1990-11#10)(1990-12#11)(1990-2#7)(1990-5#10)(1990-7#22)(1990-8#8)(1990-9#2)(1991-10#3)(1991-12#16)(1991-2#5)(1991-5#10)(1991-6#2)(1991-7#2)(1991-8#7)(1991-9#9)(1992-10#4)(1992-11#5)(1992-12#13)(1992-2#1)(1992-3#11)(1992-4#13)(1992-5#3)(1992-6#20)(1992-7#1)(1992-8#21)(1992-9#4)(1993-11#20)(1993-12#2)(1993-2#4)(1993-3#9)(1993-6#6)(1993-8#14)(1993-9#2)(1994-11#13)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#30)(1994-6#9)(1994-8#11)(1994-9#8)(1995-11#5)(1995-12#4)(1995-2#37)(1995-3#8)(1995-5#28)(1995-6#37)(1995-8#7)(1996-10#3)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#4)(1997-3#1)(1997-4#9)(1997-6#4)(1997-7#7)(1997-8#6)(1997-9#7)(2007-11#1)(2008-1#6)(2008-10#102)(2008-11#23)(2008-12#1)(2008-2#2)(2008-4#23)(2008-5#4)(2008-6#7)(2008-7#7)(2008-8#36)(2008-9#9)(2009-12#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#4)(2011-1#8)(2011-2#20)(2012-2#14)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
residues) and##4##2##(1991-5#2)(1992-11#1)(1994-8#1)
residues) is##2##2##(1992-6#1)(1997-2#1)
residues)##20##1##(1990-7#1)(1991-2#2)(1991-5#2)(1992-11#2)(1992-3#1)(1992-6#1)(1993-11#1)(1994-8#2)(1995-8#1)(1997-2#1)(1997-4#1)(1997-9#1)(2008-10#2)(2009-2#1)(2011-2#1)
resignation of##2##2##(2008-11#2)
resignation##4##1##(1993-1#1)(1995-8#1)(2008-11#2)
resilience and##6##2##(2008-6#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)
resilience in##2##2##(2008-12#1)(2011-1#1)
resilience of##3##2##(2009-7#2)(2011-1#1)
resilience##28##1##(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-4#1)
resiliency##4##1##(2008-12#1)(2008-6#1)(2009-8#1)(2010-1#1)
resilient##11##1##(2008-11#2)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
resin (Amberlite##2##2##(2008-10#2)
resin Amberlite XAD-7##2##3##(2008-10#2)
resin Amberlite##7##2##(2008-10#7)
resin acids##3##2##(1997-2#1)(2008-10#2)
resin and a##2##3##(2008-10#2)
resin and the##6##3##(2008-10#5)(2010-4#1)
resin and##24##2##(2008-10#20)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
resin are##4##2##(2008-10#3)(2009-7#1)
resin as a##4##3##(1990-8#1)(2008-10#3)
resin as##7##2##(1990-8#1)(2008-10#6)
resin at pH##2##3##(2008-10#2)
resin at##4##2##(2008-10#4)
resin beads##8##2##(2007-12#2)(2008-10#6)
resin by##4##2##(2008-10#2)(2008-3#1)(2010-4#1)
resin cement on the##2##4##(2008-8#2)
resin cement##5##2##(2008-8#3)(2009-8#1)(2013-1#1)
resin cements to##2##3##(2009-8#2)
resin coated with##3##3##(2008-10#3)
resin column with##2##3##(2008-10#2)
resin column##6##2##(2008-10#6)
resin composites##6##2##(2010-10#1)(2012-2#3)(2013-1#2)
resin containing the##2##3##(2008-10#2)
resin containing##10##2##(2008-10#10)
resin for the separation of##2##5##(2008-10#2)
resin for the##6##3##(2008-10#6)
resin for##19##2##(1990-8#1)(2008-10#17)(2008-9#1)
resin from##2##2##(2008-10#2)
resin functionalized with##5##3##(2008-10#5)
resin has been##8##3##(2008-10#8)
resin has##11##2##(2008-10#11)
resin have been##2##3##(2008-10#2)
resin in the##2##3##(2008-10#2)
resin in##4##2##(2008-10#4)
resin is highly##2##3##(2008-10#2)
resin is##12##2##(2008-10#11)(2008-3#1)
resin loaded with calmagite##2##4##(2008-10#2)
resin loaded with##10##3##(2008-10#10)
resin loading##2##2##(2008-10#2)
resin luting cement##3##3##(2013-1#3)
resin matrix was##2##3##(2008-10#2)
resin matrix##4##2##(2008-10#4)
resin mini-column is##2##3##(2008-10#2)
resin mini-column##5##2##(2008-10#5)
resin modified with##3##3##(2008-10#3)
resin modified##4##2##(2008-10#3)(2013-1#1)
resin packed##2##2##(2008-10#2)
resin phase##11##2##(2008-10#11)
resin shows##2##2##(2008-10#2)
resin surfaces##2##2##(2008-12#2)
resin that##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
resin to##4##2##(2008-10#2)(2008-6#1)(2012-2#1)
resin used##3##2##(1990-11#1)(2008-10#2)
resin was characterised by##2##4##(2008-10#2)
resin was characterized by##4##4##(2008-10#4)
resin was found to##2##4##(2008-10#2)
resin was found##3##3##(2008-10#3)
resin was prepared by##2##4##(2008-10#2)
resin was prepared##3##3##(2008-10#3)
resin was synthesized by##2##4##(2008-10#2)
resin was synthesized##3##3##(1990-8#1)(2008-10#2)
resin was used as a##2##5##(1990-8#1)(2008-10#1)
resin was used as##3##4##(1990-8#1)(2008-10#2)
resin was used##6##3##(1990-8#1)(2008-10#5)
resin was##46##2##(1990-8#2)(2008-10#43)(2008-12#1)
resin were##6##2##(2008-10#5)(2013-1#1)
resin which is##3##3##(2008-10#3)
resin with a spacer##2##4##(2008-10#2)
resin with the##2##3##(2008-10#2)
resin with##11##2##(2008-10#10)(2008-7#1)
resin##474##1##(1990-11#1)(1990-5#1)(1990-8#5)(1992-11#1)(1993-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#381)(2008-12#15)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-7#2)(2009-8#7)(2010-10#1)(2010-4#2)(2010-9#1)(2012-2#4)(2013-1#16)(2013-8#1)
resin)##5##1##(2008-10#4)(2008-7#1)
resin-bonded fixed partial dentures##2##4##(2011-2#2)
resin-bonded##3##1##(2008-7#1)(2011-2#2)
resin-composite applications##2##2##(2010-10#2)
resin-dentin##2##1##(2008-12#2)
resin-resin interfaces##3##2##(2008-12#3)
resinifera##8##1##(2008-10#8)
resiniferatoxin##4##1##(1992-6#2)(1997-8#1)(2013-8#1)
resinous##6##1##(2008-10#6)
resins and##4##2##(1990-3#1)(2008-10#3)
resins are##4##2##(2008-10#1)(2008-2#1)(2008-4#2)
resins as a##2##3##(2008-10#2)
resins as##5##2##(1990-3#1)(2008-10#3)(2008-7#1)
resins for##4##2##(2008-10#3)(2008-4#1)
resins had##2##2##(2008-10#2)
resins of##2##2##(2008-10#2)
resins to##2##2##(1997-4#1)(2008-10#1)
resins was##3##2##(1991-7#1)(2008-10#1)(2012-2#1)
resins were##4##2##(2007-12#1)(2008-10#2)(2012-2#1)
resins##92##1##(1990-3#2)(1990-9#1)(1991-7#1)(1995-5#1)(1997-4#2)(2007-11#2)(2007-12#2)(2008-10#56)(2008-12#4)(2008-2#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#3)(2012-2#3)(2013-1#2)
resist the##5##2##(1991-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)
resist thickness##2##2##(2007-12#2)
resist##36##1##(1991-8#1)(1993-8#1)(2007-12#13)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-10#1)(2009-11#2)(2009-2#2)(2010-2#2)(2010-4#1)(2010-7#1)(2013-1#1)
resistance (APR)##2##2##(2008-10#2)
resistance (IR)##5##2##(2008-3#2)(2010-4#1)(2013-1#1)(2013-8#1)
resistance (MDR)##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
resistance (R) genes##7##3##(2008-10#4)(2008-8#1)(2009-6#1)(2011-2#1)
resistance (R)##11##2##(2008-10#6)(2008-12#1)(2008-8#1)(2009-6#2)(2011-2#1)
resistance -##2##2##(1991-6#1)(2008-7#1)
resistance QTL were##2##3##(2008-10#2)
resistance QTL##7##2##(2008-10#7)
resistance QTLs##6##2##(2008-9#2)(2009-10#4)
resistance affects##3##2##(1996-2#1)(2008-10#2)
resistance after##4##2##(1996-6#1)(2008-10#1)(2010-5#1)(2012-3#1)
resistance against all##2##3##(2008-10#1)(2008-8#1)
resistance against fusarium##2##3##(2008-10#2)
resistance against##34##2##(1992-7#1)(1996-12#2)(2006-12#1)(2008-10#25)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)
resistance allele##4##2##(2008-10#4)
resistance alleles##4##2##(2008-10#4)
resistance also##2##2##(2008-10#2)
resistance among##8##2##(2007-2#1)(2007-7#1)(2008-10#3)(2010-5#1)(2011-2#2)
resistance and a##5##3##(2008-10#4)(2008-3#1)
resistance and an##2##3##(2008-10#2)
resistance and capacitance##2##3##(2008-10#1)(2008-11#1)
resistance and days to##2##4##(2008-10#2)
resistance and high##3##3##(2008-10#1)(2008-3#2)
resistance and its##2##3##(2008-1#1)(2008-10#1)
resistance and molecular##3##3##(2008-10#2)(2013-1#1)
resistance and obesity##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
resistance and susceptibility##3##3##(2008-10#3)
resistance and that##2##3##(2008-10#2)
resistance and the##11##3##(1991-8#1)(1996-3#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#2)
resistance and tolerance profiles##2##4##(2011-10#2)
resistance and tolerance to##3##4##(2008-12#2)(2011-10#1)
resistance and tolerance##6##3##(2008-12#2)(2011-10#4)
resistance and virulence##4##3##(2008-10#3)(2011-2#1)
resistance and##154##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#2)(1994-11#2)(1994-2#1)(1994-8#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#7)(2008-10#48)(2008-11#5)(2008-12#7)(2008-3#13)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-5#1)(2011-1#5)(2011-10#4)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#8)(2013-8#2)
resistance are##11##2##(1997-6#1)(2008-10#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)
resistance arteries##3##2##(1994-9#1)(1997-4#2)
resistance as a##3##3##(1997-2#1)(2008-3#1)(2008-8#1)
resistance as##11##2##(1992-8#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-11#1)(2012-2#1)
resistance associated with##3##3##(2008-10#2)(2011-2#1)
resistance associated##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
resistance at the##3##3##(1993-6#1)(2008-10#2)
resistance at##5##2##(1993-6#1)(2008-10#4)
resistance based on##3##3##(2008-10#3)
resistance breaking##2##2##(2008-10#2)
resistance breeding##4##2##(2008-10#4)
resistance by the##2##3##(1990-2#1)(2008-6#1)
resistance by##16##2##(1990-2#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#10)(2008-6#1)(2011-2#1)
resistance can be##7##3##(1993-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-9#1)
resistance can##13##2##(1993-2#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#3)(2009-9#1)
resistance combined with##2##3##(2008-10#2)
resistance components##2##2##(2008-10#2)
resistance conferred by##5##3##(2008-10#4)(2008-9#1)
resistance could be##3##3##(1990-2#1)(2008-10#1)(2009-8#1)
resistance could##5##2##(1990-2#1)(2008-10#3)(2009-8#1)
resistance derived from##2##3##(2008-10#2)
resistance described here##2##3##(2008-10#2)
resistance described##3##2##(2008-10#2)(2008-11#1)
resistance development##5##2##(2008-10#3)(2011-2#1)(2012-12#1)
resistance did not##4##3##(2008-10#3)(2008-8#1)
resistance does not##2##3##(2008-3#1)(2008-8#1)
resistance during##5##2##(1990-11#1)(2008-10#2)(2008-5#1)(2010-5#1)
resistance elicitors providing##2##3##(2008-10#2)
resistance elicitors##5##2##(2008-10#5)
resistance even##2##2##(2008-1#1)(2008-10#1)
resistance evolution##2##2##(2011-2#2)
resistance expressed at the##2##4##(2008-10#2)
resistance expressed in##2##3##(2008-10#2)
resistance expressed##6##2##(2008-10#6)
resistance factors##5##2##(2008-10#5)
resistance following##2##2##(2008-10#1)(2013-8#1)
resistance for##9##2##(2007-6#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
resistance found##2##2##(2008-12#1)(2013-8#1)
resistance from##8##2##(2007-9#1)(2008-10#5)(2008-12#1)(2013-1#1)
resistance gene Bs2##2##3##(2008-10#2)
resistance gene analog polymorphism (RGAP) markers##2##6##(2008-10#2)
resistance gene analog polymorphism (RGAP)##3##5##(2008-10#3)
resistance gene analogs (RGAs)##2##4##(2008-10#2)
resistance gene analogs##3##3##(2008-10#3)
resistance gene and##2##3##(2008-10#2)
resistance gene at##2##3##(2008-10#2)
resistance gene from##2##3##(2008-5#1)(2008-8#1)
resistance gene in wheat##2##4##(2008-10#2)
resistance gene in##9##3##(2008-10#9)
resistance gene into barley##2##4##(2008-10#2)
resistance gene is##2##3##(2008-10#2)
resistance gene number in##2##4##(2008-10#2)
resistance gene to##3##3##(2008-10#3)
resistance gene was successfully##2##4##(1993-11#1)(2008-10#1)
resistance gene was##6##3##(1993-11#1)(2008-10#4)(2008-6#1)
resistance gene were##3##3##(2008-10#2)(2008-5#1)
resistance gene##122##2##(1991-12#1)(1993-11#1)(2006-12#1)(2008-10#106)(2008-11#1)(2008-5#4)(2008-6#1)(2008-8#5)(2012-3#2)
resistance genes Lr1##2##3##(2008-10#2)
resistance genes and##3##3##(2008-10#3)
resistance genes are##2##3##(2008-10#2)
resistance genes as##2##3##(2008-10#2)
resistance genes for##4##3##(2008-10#4)
resistance genes from##2##3##(2008-10#2)
resistance genes identified##2##3##(2008-10#2)
resistance genes in the##4##4##(2008-10#4)
resistance genes in##16##3##(2008-10#14)(2008-11#1)(2011-2#1)
resistance genes including##2##3##(2008-10#2)
resistance genes on##2##3##(2008-10#2)
resistance genes or##2##3##(2008-10#2)
resistance genes present in cultivar AB 136##2##7##(2008-10#2)
resistance genes present in##4##4##(2008-10#4)
resistance genes that##2##3##(2008-10#2)
resistance genes to powdery mildew##2##5##(2008-10#2)
resistance genes to##5##3##(2008-10#5)
resistance genes using##2##3##(2008-10#2)
resistance genes were##3##3##(2008-10#3)
resistance genes##123##2##(1994-5#1)(2008-10#117)(2008-11#2)(2008-8#1)(2011-2#2)
resistance had##2##2##(2008-10#1)(2008-8#1)
resistance has been##2##3##(2007-8#1)(2008-11#1)
resistance has##12##2##(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-9#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
resistance have been identified##2##4##(2008-10#1)(2009-10#1)
resistance have been##3##3##(2008-10#2)(2009-10#1)
resistance have##4##2##(2008-10#3)(2009-10#1)
resistance identified in##2##3##(2008-10#2)
resistance in Canada##4##3##(2007-12#4)
resistance in Candida##2##3##(2008-5#1)(2011-2#1)
resistance in Enterococcus faecium##2##4##(1995-2#2)
resistance in M##2##3##(2007-7#1)(2008-10#1)
resistance in a##7##3##(2008-10#6)(2008-11#1)
resistance in bacteria##6##3##(2008-3#1)(2010-4#4)(2013-8#1)
resistance in barley##6##3##(2008-10#6)
resistance in both##4##3##(1994-12#1)(2008-10#3)
resistance in cucumber##2##3##(2008-10#2)
resistance in cv##2##3##(2008-10#2)
resistance in four##2##3##(2008-10#2)
resistance in greenhouse##3##3##(2008-10#3)
resistance in host##2##3##(2008-10#2)
resistance in human##2##3##(1992-2#1)(2008-11#1)
resistance in maize##2##3##(2008-10#2)
resistance in oat##3##3##(2008-10#3)
resistance in patients with##2##4##(1997-3#1)(2007-10#1)
resistance in persons##2##3##(2008-3#1)(2011-1#1)
resistance in plants by##2##4##(2008-10#2)
resistance in plants##8##3##(2008-10#7)(2009-8#1)
resistance in radish##2##3##(2008-10#2)
resistance in replicated##2##3##(2008-10#2)
resistance in rice##4##3##(2008-10#2)(2008-9#1)(2009-10#1)
resistance in six##2##3##(2008-10#2)
resistance in soft##2##3##(2008-5#1)(2008-6#1)
resistance in some##3##3##(2008-10#1)(2008-4#1)(2009-8#1)
resistance in sugar##2##3##(2008-10#2)
resistance in the field##4##4##(2008-10#4)
resistance in the host##3##4##(2008-10#3)
resistance in the slash pine-fusiform rust pathosystem##2##7##(2008-10#2)
resistance in the stable fly##2##5##(2011-2#2)
resistance in the##38##3##(1993-8#1)(1996-5#1)(2007-7#1)(2008-10#26)(2008-6#1)(2008-9#2)(2009-6#1)(2011-1#2)(2011-2#3)
resistance in these##4##3##(2008-10#4)
resistance in this##3##3##(2008-10#3)
resistance in tobacco##3##3##(2008-10#3)
resistance in tomato##2##3##(2008-10#2)
resistance in transgenic##3##3##(2008-10#2)(2008-9#1)
resistance in tumor cells##2##4##(2008-11#2)
resistance in vitro and in vivo##2##6##(1994-5#1)(2012-12#1)
resistance in vitro and in##3##5##(1994-5#1)(2008-11#1)(2012-12#1)
resistance in vitro and##4##4##(1994-5#1)(2008-11#1)(2008-4#1)(2012-12#1)
resistance in vitro##5##3##(1991-2#1)(1994-5#1)(2008-11#1)(2008-4#1)(2012-12#1)
resistance in wheat##8##3##(2008-10#5)(2011-2#3)
resistance in##282##2##(1990-3#1)(1990-6#2)(1990-9#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#7)(2007-7#3)(2008-1#5)(2008-10#164)(2008-11#9)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#4)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#4)(2011-1#3)(2011-10#1)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
resistance increased##3##2##(2008-10#2)(2010-8#1)
resistance index##6##2##(1992-6#2)(1996-6#1)(2012-3#2)(2013-1#1)
resistance induced by##3##3##(2008-10#2)(2008-3#1)
resistance induced##4##2##(2008-10#3)(2008-3#1)
resistance into##4##2##(2008-10#4)
resistance is a major##2##4##(2007-7#1)(2008-10#1)
resistance is also discussed##2##4##(1997-3#1)(2008-10#1)
resistance is an##5##3##(2008-10#4)(2010-12#1)
resistance is associated with##2##4##(2008-10#1)(2012-5#1)
resistance is conferred by##2##4##(2008-10#2)
resistance is considered to be##2##5##(2007-7#1)(2008-3#1)
resistance is discussed##2##3##(2008-10#2)
resistance is not##5##3##(1994-12#1)(2008-10#3)(2008-8#1)
resistance is overcome by##2##4##(2008-10#1)(2008-5#1)
resistance is the##6##3##(1990-2#1)(2008-10#4)(2008-7#1)
resistance is unstable##2##3##(2008-10#2)
resistance is##72##2##(1990-2#1)(1994-12#1)(1997-3#1)(1997-6#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#45)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-5#1)(2013-1#1)
resistance level of##2##3##(2008-12#1)(2011-2#1)
resistance level##4##2##(2008-10#2)(2008-12#1)(2011-2#1)
resistance levels##6##2##(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#1)
resistance limits##2##2##(2008-10#1)(2010-11#1)
resistance loci in##3##3##(2008-10#2)(2008-9#1)
resistance loci were##2##3##(2008-10#2)
resistance loci##9##2##(2008-10#7)(2008-8#1)(2008-9#1)
resistance locus##5##2##(2008-10#3)(2012-3#2)
resistance management##4##2##(2008-10#3)(2011-2#1)
resistance markers##3##2##(2008-10#2)(2008-9#1)
resistance may be##8##3##(1997-7#1)(2008-10#3)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)
resistance may##14##2##(1994-12#1)(1997-7#1)(2008-10#7)(2008-12#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)
resistance measured by##4##3##(1996-3#1)(2008-1#2)(2008-10#1)
resistance measurement##2##2##(2011-2#2)
resistance measurements##2##2##(2007-12#1)(2011-2#1)
resistance mechanism##7##2##(2008-10#5)(2009-2#2)
resistance mechanisms and##2##3##(2008-11#1)(2012-12#1)
resistance mechanisms in##2##3##(2008-10#1)(2012-2#1)
resistance mechanisms involved##2##3##(2008-11#1)(2012-1#1)
resistance mechanisms##19##2##(2008-10#5)(2008-11#4)(2008-4#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
resistance mediated by##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
resistance might##2##2##(2008-10#2)
resistance modes##2##2##(2008-10#2)
resistance monitoring##3##2##(2010-4#1)(2011-2#2)
resistance mutations##5##2##(2013-1#5)
resistance occurs##2##2##(2008-10#1)(2008-3#1)
resistance of Escherichia coli to##2##5##(1994-6#1)(2010-8#1)
resistance of H##3##3##(1997-7#1)(2012-12#2)
resistance of Schistosoma##3##3##(2012-3#3)
resistance of a##3##3##(2008-10#3)
resistance of bermudagrass genotypes to##2##5##(2008-10#2)
resistance of bermudagrass genotypes##3##4##(2008-10#3)
resistance of cucumber##2##3##(2008-10#2)
resistance of human##2##3##(1993-3#1)(2008-9#1)
resistance of maize##3##3##(2008-10#3)
resistance of the host##2##4##(2008-10#2)
resistance of the##16##3##(1990-5#1)(1991-5#2)(1994-11#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#2)
resistance of these##2##3##(2008-10#2)
resistance of topical sunscreens##2##4##(2008-5#2)
resistance of tumor cells to##3##5##(1991-2#1)(2008-10#1)(2008-11#1)
resistance of tumor cells##4##4##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
resistance of##115##2##(1990-5#2)(1991-2#2)(1991-3#1)(1991-5#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#43)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
resistance on chromosome##2##3##(2008-10#2)
resistance on the##3##3##(2008-10#3)
resistance on##11##2##(1990-11#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-1#1)(2011-1#1)
resistance only##2##2##(2008-10#2)
resistance or tolerance##2##3##(2008-10#1)(2011-10#1)
resistance or##17##2##(1991-8#1)(1992-3#1)(1994-5#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-8#1)(2011-10#1)(2013-1#1)
resistance pattern##2##2##(2007-6#1)(2012-2#1)
resistance patterns of S##2##4##(2010-8#1)(2013-8#1)
resistance patterns of##7##3##(1991-8#1)(2007-6#1)(2007-7#2)(2010-8#1)(2013-8#2)
resistance patterns##9##2##(1991-8#1)(2007-6#1)(2007-7#2)(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
resistance phenotype##6##2##(2008-10#3)(2008-11#2)(2010-9#1)
resistance phenotypes##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
resistance plays a##2##3##(2008-10#1)(2008-11#1)
resistance probably##2##2##(2008-10#2)
resistance profiles of##2##3##(1994-11#1)(2012-3#1)
resistance profiles##5##2##(1994-11#1)(2008-10#2)(2011-3#1)(2012-3#1)
resistance protein##5##2##(1996-8#2)(2008-11#2)(2012-3#1)
resistance proteins##3##2##(2008-5#1)(2009-8#2)
resistance quantitative trait locus (QTL)##2##5##(2008-10#2)
resistance rate against##2##3##(2007-7#1)(2008-12#1)
resistance rate##5##2##(1996-11#1)(2007-7#2)(2008-12#2)
resistance rates to##2##3##(2007-7#1)(2013-8#1)
resistance rates##6##2##(2007-7#3)(2013-8#3)
resistance rating##3##2##(2008-10#3)
resistance ratio of##2##3##(2008-12#2)
resistance reactions##2##2##(2008-10#2)
resistance remains a##2##3##(2006-10#1)(2012-12#1)
resistance remains##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
resistance response##5##2##(2008-10#4)(2008-9#1)
resistance responses##3##2##(2008-10#2)(2009-6#1)
resistance resulted in a##2##4##(2008-10#2)
resistance resulted in lower population growth rates and stronger density dependence than##2##12##(2008-8#2)
resistance resulted in##4##3##(2008-10#2)(2008-8#2)
resistance revealed that##2##3##(2008-10#1)(2010-11#1)
resistance should##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
resistance sources##2##2##(2008-10#2)
resistance status##5##2##(2008-10#5)
resistance syndrome##4##2##(2008-3#2)(2009-7#1)(2013-1#1)
resistance test##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
resistance than that##2##3##(2008-10#1)(2012-2#1)
resistance than##5##2##(2008-10#2)(2012-2#1)(2012-5#1)(2013-1#1)
resistance that is##2##3##(2008-10#1)(2008-11#1)
resistance that##8##2##(2008-10#4)(2008-11#1)(2008-6#1)(2010-8#1)(2011-1#1)
resistance through##5##2##(2008-10#3)(2008-3#1)(2009-6#1)
resistance to 5-methyltryptophan##2##3##(1994-6#2)
resistance to A##4##3##(1996-12#1)(2008-10#3)
resistance to Adriamycin##3##3##(1995-11#3)
resistance to Aphanomyces root rot##3##5##(2008-10#3)
resistance to Aspergillus ear rot and aflatoxin production##3##8##(2008-10#3)
resistance to Aspergillus ear rot and aflatoxin##4##7##(2008-10#4)
resistance to B##2##3##(2008-10#2)
resistance to C##2##3##(2008-10#1)(2011-2#1)
resistance to Colletotrichum##2##3##(2008-10#2)
resistance to E##2##3##(1993-9#1)(2008-10#1)
resistance to F##7##3##(2008-10#7)
resistance to FHB##7##3##(2008-10#5)(2011-10#2)
resistance to Fusarium wilt##5##4##(2008-10#5)
resistance to Fusarium##9##3##(2008-10#9)
resistance to HER2-targeted therapies##3##4##(2013-1#3)
resistance to HER2-targeted##4##3##(2010-7#1)(2013-1#3)
resistance to IB-49##2##3##(2008-10#2)
resistance to IC-17 was##2##4##(2008-10#2)
resistance to Leptosphaeria maculans##2##4##(2008-10#2)
resistance to M##12##3##(2008-10#9)(2011-10#1)(2012-2#2)
resistance to MStV##3##3##(2008-10#3)
resistance to Magnaporthe##2##3##(2008-10#1)(2013-8#1)
resistance to Melampsora larici-populina leaf rust##2##6##(2008-10#2)
resistance to P##12##3##(2008-10#11)(2009-6#1)
resistance to Phytophthora##2##3##(2008-10#2)
resistance to R##3##3##(2008-10#3)
resistance to SLB##2##3##(2008-10#2)
resistance to STB in##2##4##(2008-10#2)
resistance to STB is##2##4##(2008-10#2)
resistance to STB##9##3##(2008-10#9)
resistance to Sclerotinia trifoliorum and Sclerotium rolfsii##2##7##(2008-10#2)
resistance to Sclerotinia trifoliorum##6##4##(2008-10#6)
resistance to Sclerotinia##7##3##(2008-10#7)
resistance to Sclerotium rolfsii as expressed in excised leaf tissues and whole plants##2##13##(2008-10#2)
resistance to Sclerotium rolfsii##4##4##(2008-10#4)
resistance to Septoria tritici blotch (STB)##2##6##(2008-10#2)
resistance to Septoria tritici blotch##3##5##(2008-10#3)
resistance to Septoria##4##3##(2008-10#4)
resistance to Stewart's wilt##2##4##(2008-10#2)
resistance to Tobacco mosaic virus (TMV)##2##6##(2008-10#2)
resistance to TuMV##3##3##(2008-10#3)
resistance to X##2##3##(2008-10#2)
resistance to a broad range of##2##6##(2008-10#1)(2008-11#1)
resistance to a broad##3##4##(2008-10#2)(2008-11#1)
resistance to a variety of##2##5##(2008-11#1)(2008-7#1)
resistance to a##11##3##(1997-5#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
resistance to aflatoxin production and##2##5##(2008-10#2)
resistance to aflatoxin production in##2##5##(2008-10#2)
resistance to aflatoxin production##5##4##(2008-10#5)
resistance to aflatoxin##6##3##(2008-10#6)
resistance to all##4##3##(2007-6#1)(2008-10#3)
resistance to ampicillin##3##3##(1990-6#2)(2012-3#1)
resistance to anthracnose in the cultivar TO##2##7##(2008-10#2)
resistance to anthracnose##5##3##(2008-10#5)
resistance to antibiotics##2##3##(2011-2#1)(2012-3#1)
resistance to anticancer drugs##2##4##(2008-11#2)
resistance to anticancer##3##3##(2008-11#3)
resistance to apoptosis##3##3##(1994-10#1)(2011-2#1)(2013-1#1)
resistance to bacterial blight##3##4##(2008-10#3)
resistance to bacterial##10##3##(2008-10#8)(2013-8#2)
resistance to barley##3##3##(2008-10#2)(2008-8#1)
resistance to be##2##3##(2012-12#1)(2012-3#1)
resistance to blast##6##3##(2008-10#5)(2012-2#1)
resistance to both##7##3##(2006-12#1)(2008-10#5)(2011-2#1)
resistance to change##4##3##(2007-7#1)(2008-7#1)(2010-10#1)(2011-2#1)
resistance to chemotherapy##3##3##(2008-11#1)(2010-3#1)(2011-2#1)
resistance to cisplatin and##2##4##(1993-1#1)(2008-4#1)
resistance to citrus##2##3##(2008-10#1)(2008-5#1)
resistance to colonization of the##2##5##(2008-10#2)
resistance to colonization##4##3##(2007-6#1)(2008-10#3)
resistance to cytotoxic##2##3##(2008-11#2)
resistance to deer##2##3##(2008-8#2)
resistance to different##2##3##(2008-10#1)(2010-4#1)
resistance to disease##3##3##(2008-10#2)(2008-8#1)
resistance to downy mildew##2##4##(2008-10#2)
resistance to each##2##3##(1993-8#1)(2008-10#1)
resistance to eyespot##3##3##(2008-10#3)
resistance to fluconazole##2##3##(2008-5#2)
resistance to fungal##3##3##(2008-10#3)
resistance to fusarium head blight##2##5##(2008-10#2)
resistance to fusarium##3##3##(2008-10#3)
resistance to gray leaf spot##3##5##(2008-10#3)
resistance to gray##4##3##(2008-10#4)
resistance to hygromycin B##2##4##(2008-10#2)
resistance to hygromycin##3##3##(2008-10#3)
resistance to infection by schistosomes##2##5##(2009-5#2)
resistance to infection by##4##4##(2008-10#2)(2009-5#2)
resistance to infection##7##3##(1990-6#1)(2008-10#4)(2009-5#2)
resistance to infectious diseases##3##4##(2008-10#3)
resistance to insecticides##4##3##(2007-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
resistance to iprodione and##2##4##(2008-10#2)
resistance to iprodione##4##3##(2008-10#4)
resistance to isolate##4##3##(2008-10#4)
resistance to isolates##2##3##(2008-10#2)
resistance to kanamycin##2##3##(1994-12#1)(2008-10#1)
resistance to late blight##2##4##(2008-10#2)
resistance to leaf rust and##3##5##(2008-10#3)
resistance to leaf rust##9##4##(2008-10#9)
resistance to leaf##10##3##(2008-10#10)
resistance to malaria##2##3##(1995-12#1)(2013-8#1)
resistance to many##3##3##(2008-10#2)(2011-10#1)
resistance to necrosis induced by##3##5##(2008-10#3)
resistance to one or more##2##5##(2008-10#1)(2013-8#1)
resistance to other##3##3##(1997-6#1)(2008-10#1)(2011-1#1)
resistance to oxidative stress##2##4##(2008-3#2)
resistance to pathogen##2##3##(2008-10#2)
resistance to pathogens##2##3##(1997-7#1)(2008-10#1)
resistance to pathotype##2##3##(2008-10#2)
resistance to platinum##2##3##(2008-4#2)
resistance to powdery mildew in##2##5##(2008-10#2)
resistance to powdery mildew##6##4##(2008-10#6)
resistance to proteolysis##3##3##(1990-5#2)(1995-8#1)
resistance to race 2##4##4##(2008-10#4)
resistance to race##9##3##(2008-10#9)
resistance to races 1 and 4##3##6##(2008-10#3)
resistance to races 1##5##4##(2008-10#5)
resistance to races##6##3##(2008-10#6)
resistance to rice blast##6##4##(2008-10#6)
resistance to septoria speckled leaf blotch in barley##2##8##(2008-10#2)
resistance to septoria##3##3##(2008-10#3)
resistance to several##3##3##(2008-10#1)(2008-8#2)
resistance to spread of scab within a spike##2##8##(2008-10#2)
resistance to stem rust and##2##5##(2008-10#2)
resistance to stripe rust##8##4##(2008-10#8)
resistance to tan spot##3##4##(2008-10#3)
resistance to the fungus##2##4##(2008-10#1)(2011-10#1)
resistance to the heterologous##2##4##(2008-10#2)
resistance to the inappropriate rust species##2##6##(2008-10#2)
resistance to the isolate IPO323##2##5##(2008-10#2)
resistance to the root-lesion nematode##2##5##(2008-10#2)
resistance to the same isolate##2##5##(2008-10#2)
resistance to the three##2##4##(2008-10#2)
resistance to the##40##3##(1991-3#1)(1993-2#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-1#1)(2011-10#2)(2012-12#1)(2012-3#1)(2013-1#1)
resistance to these pathogens##3##4##(2008-10#2)(2009-10#1)
resistance to these##9##3##(2007-7#1)(2008-10#5)(2009-10#1)(2012-1#1)(2013-1#1)
resistance to this class of##2##5##(2008-11#1)(2011-2#1)
resistance to this##6##3##(1997-4#1)(2008-10#3)(2008-11#1)(2011-2#1)
resistance to three##3##3##(2008-10#2)(2008-8#1)
resistance to thyroid hormone##3##4##(1995-8#3)
resistance to two##6##3##(2008-10#5)(2011-3#1)
resistance to vancomycin##2##3##(2007-12#1)(2010-8#1)
resistance to various anticancer##2##4##(1997-4#1)(2008-7#1)
resistance to various##5##3##(1994-8#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-7#1)
resistance to vincristine##2##3##(1993-8#2)
resistance to virus infection##2##4##(2008-10#2)
resistance to water##2##3##(2008-5#1)(2013-1#1)
resistance to wheat##2##3##(2008-10#2)
resistance to white pine blister rust##6##6##(2008-10#6)
resistance to white pine blister##7##5##(2008-10#7)
resistance to##707##2##(1990-2#1)(1990-5#3)(1990-6#3)(1990-8#1)(1991-2#2)(1991-3#3)(1991-8#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#4)(1993-9#2)(1994-10#1)(1994-12#2)(1994-6#3)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(2006-12#1)(2007-10#5)(2007-12#2)(2007-6#2)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#433)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#7)(2009-6#4)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-10#6)(2011-2#27)(2011-3#4)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#7)
resistance toward##2##2##(2008-10#2)
resistance trained##5##2##(2008-5#5)
resistance training group##2##3##(2013-1#2)
resistance training program##2##3##(2007-12#1)(2008-5#1)
resistance training##18##2##(2007-12#1)(2008-5#10)(2010-1#1)(2012-12#1)(2013-1#5)
resistance trait##2##2##(2008-10#2)
resistance traits in##2##3##(2008-10#2)
resistance traits##6##2##(2008-10#4)(2008-8#2)
resistance transferred##2##2##(2008-10#2)
resistance types##2##2##(2008-8#2)
resistance under##2##2##(2007-12#1)(2008-10#1)
resistance used in##2##3##(2008-10#2)
resistance using a##2##3##(2007-7#1)(2008-10#1)
resistance using##8##2##(2007-7#1)(2008-10#5)(2008-11#1)(2012-2#1)
resistance vessels##2##2##(2007-8#1)(2008-7#1)
resistance via##2##2##(2008-10#2)
resistance was also##2##3##(2008-10#2)
resistance was determined##2##3##(2008-10#1)(2008-3#1)
resistance was estimated by##2##4##(2008-10#1)(2008-3#1)
resistance was estimated##3##3##(2008-10#2)(2008-3#1)
resistance was evaluated##3##3##(2008-10#3)
resistance was found to be##3##5##(2008-10#2)(2011-1#1)
resistance was found##4##3##(2008-10#3)(2011-1#1)
resistance was high##2##3##(2007-7#1)(2008-10#1)
resistance was identified##2##3##(2008-10#2)
resistance was induced##2##3##(2008-10#2)
resistance was manifested##2##3##(2008-10#2)
resistance was measured##2##3##(2008-1#1)(2008-10#1)
resistance was not##4##3##(1991-8#1)(1993-12#1)(2008-10#2)
resistance was observed in##4##4##(2008-10#3)(2008-5#1)
resistance was observed##7##3##(2008-10#6)(2008-5#1)
resistance was obtained##2##3##(2008-10#2)
resistance was##70##2##(1991-8#1)(1993-12#2)(2007-7#1)(2008-1#1)(2008-10#56)(2008-3#4)(2008-5#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
resistance were identified##4##3##(2008-10#3)(2013-8#1)
resistance were not##3##3##(2008-10#3)
resistance were positive for the##2##5##(2011-2#2)
resistance were##26##2##(1992-3#1)(2008-10#18)(2008-12#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
resistance will##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2011-10#1)
resistance with##5##2##(1994-12#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#1)
resistance within##2##2##(2007-7#1)(2008-10#1)
resistance##2942##1##(1990-11#3)(1990-2#7)(1990-3#1)(1990-5#7)(1990-6#6)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#7)(1991-3#6)(1991-5#3)(1991-6#3)(1991-8#9)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#6)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#1)(1994-5#5)(1994-6#6)(1994-8#6)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#4)(1996-1#1)(1996-11#6)(1996-12#6)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#7)(1997-5#4)(1997-6#11)(1997-7#15)(2006-10#1)(2006-12#3)(2007-10#9)(2007-11#4)(2007-12#17)(2007-2#3)(2007-6#8)(2007-7#29)(2007-8#4)(2007-9#2)(2008-1#35)(2008-10#1634)(2008-11#89)(2008-12#29)(2008-2#6)(2008-3#76)(2008-4#23)(2008-5#57)(2008-6#14)(2008-7#26)(2008-8#83)(2008-9#30)(2009-1#1)(2009-10#12)(2009-11#6)(2009-2#6)(2009-3#3)(2009-4#2)(2009-5#11)(2009-6#16)(2009-7#2)(2009-8#13)(2009-9#4)(2010-1#3)(2010-10#8)(2010-11#11)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#11)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#12)(2010-9#1)(2011-1#37)(2011-10#15)(2011-2#105)(2011-3#7)(2012-1#6)(2012-12#21)(2012-2#36)(2012-3#33)(2012-5#5)(2013-1#78)(2013-7#2)(2013-8#32)
resistance&quot##2##1##(2011-2#2)
resistance)##6##1##(1991-8#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)
resistance-associated proteins##2##2##(2008-10#2)
resistance-associated##8##1##(1997-4#1)(2008-10#2)(2008-11#4)(2013-8#1)
resistance-breaking (RB)##2##2##(2008-10#2)
resistance-breaking strains##2##2##(2008-10#2)
resistance-breaking##7##1##(2008-10#7)
resistance-correlated oligonucleotides##6##2##(2011-2#6)
resistance-inducing##3##1##(2008-10#2)(2008-11#1)
resistance-trained males##3##2##(2008-5#3)
resistance-trained##5##1##(2008-5#5)
resistance-training##4##1##(2008-5#4)
resistances and virulence##2##3##(2012-3#2)
resistances in##4##2##(1995-3#1)(1997-5#1)(1997-7#1)(2008-8#1)
resistances to##7##2##(1992-2#1)(2008-10#6)
resistances##15##1##(1992-2#1)(1995-3#1)(1997-5#1)(1997-7#1)(2008-10#7)(2008-8#2)(2012-3#2)
resistant 'Burley 21' transgenic lines##2##5##(2008-10#2)
resistant A(549)/DDP cells##3##3##(2008-9#3)
resistant B##2##2##(2008-10#2)
resistant E##2##2##(2007-7#1)(2008-12#1)
resistant QTL##2##2##(2012-3#2)
resistant RBC mode##2##3##(2008-10#2)
resistant S##3##2##(2007-11#1)(2007-12#1)(2012-3#1)
resistant Salmonella##2##2##(1996-6#1)(2010-4#1)
resistant Staphylococcus aureus (MRSA) strains##2##5##(2007-7#1)(2010-8#1)
resistant Staphylococcus aureus (MRSA)##3##4##(2007-7#1)(2010-2#1)(2010-8#1)
resistant Staphylococcus aureus##5##3##(2007-7#1)(2009-7#1)(2010-2#1)(2010-8#2)
resistant Staphylococcus##6##2##(1991-3#1)(2007-7#1)(2009-7#1)(2010-2#1)(2010-8#2)
resistant TB (XDR-TB)##2##3##(2008-10#1)(2010-5#1)
resistant TB##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
resistant accession##3##2##(2008-10#3)
resistant accessions##4##2##(2008-10#4)
resistant and sensitive pathogen strains##3##5##(2008-10#3)
resistant and sensitive##7##3##(2008-10#5)(2009-4#1)(2010-8#1)
resistant and susceptible barley##2##4##(2008-10#2)
resistant and susceptible cultivar##2##4##(2008-10#2)
resistant and susceptible cultivars##3##4##(2008-10#3)
resistant and susceptible families##2##4##(2008-10#1)(2011-10#1)
resistant and susceptible genotypes##2##4##(2008-10#2)
resistant and susceptible plants##2##4##(2008-10#2)
resistant and susceptible to##2##4##(2008-10#2)
resistant and susceptible##27##3##(1996-12#1)(2008-10#25)(2011-10#1)
resistant and##47##2##(1992-9#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#36)(2008-3#1)(2008-5#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-10#1)
resistant apple fruits##2##3##(2008-10#2)
resistant apple##4##2##(2008-10#4)
resistant at the adult##2##4##(2008-10#2)
resistant at##6##2##(2008-10#6)
resistant bacteria##4##2##(2008-5#2)(2012-2#1)(2013-1#1)
resistant berries##8##2##(2008-10#8)
resistant by resistant##2##3##(2008-10#2)
resistant by##3##2##(2008-10#3)
resistant cactus##4##2##(2008-10#4)
resistant cases##2##2##(1996-3#1)(2012-1#1)
resistant cell lines##3##3##(1990-2#1)(1994-8#1)(2008-11#1)
resistant cell##4##2##(1990-2#1)(1994-8#1)(2008-11#2)
resistant cells##16##2##(1990-2#2)(1991-4#1)(1992-2#2)(1992-9#1)(1994-8#1)(2008-11#8)(2008-4#1)
resistant clinical isolates of Pseudomonas aeruginosa##2##6##(2012-2#2)
resistant clinical isolates##3##3##(2012-2#3)
resistant clones##3##2##(1994-9#1)(1995-11#1)(2008-10#1)
resistant corn genotypes##3##3##(2008-10#3)
resistant corn##4##2##(2008-10#4)
resistant crosses##2##2##(2008-10#2)
resistant cultivar##17##2##(2008-10#16)(2011-10#1)
resistant cultivars is the##2##4##(2008-10#2)
resistant cultivars of##4##3##(2008-10#4)
resistant cultivars would be##2##4##(2008-10#2)
resistant cultivars##45##2##(2008-10#44)(2008-12#1)
resistant cv##8##2##(2008-10#7)(2008-6#1)
resistant cvs##3##2##(2008-10#3)
resistant disease##3##2##(2006-10#2)(2010-7#1)
resistant ecotype S96##2##3##(2008-10#2)
resistant ecotypes##2##2##(2008-10#2)
resistant families##3##2##(2008-10#3)
resistant field##2##2##(2008-10#2)
resistant fruit##3##2##(2008-10#3)
resistant gene##4##2##(1993-8#1)(1997-8#1)(2008-11#1)(2008-8#1)
resistant genotype##8##2##(2008-10#7)(2008-8#1)
resistant genotypes and##2##3##(2008-10#2)
resistant genotypes##17##2##(2008-10#16)(2008-12#1)
resistant host##4##2##(2008-10#3)(2008-8#1)
resistant hypertension##3##2##(2010-6#2)(2013-8#1)
resistant in the##2##3##(1990-12#1)(2008-10#1)
resistant in##4##2##(1990-12#1)(2007-7#1)(2008-10#2)
resistant inbred##3##2##(2008-10#3)
resistant individuals##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
resistant isolates of##4##3##(2008-10#3)(2010-3#1)
resistant isolates##21##2##(2007-7#1)(2008-10#18)(2008-5#1)(2010-3#1)
resistant line##8##2##(1992-2#1)(1997-6#1)(2008-10#6)
resistant lines compared with##2##4##(2008-10#2)
resistant lines##15##2##(1990-2#1)(2008-10#14)
resistant maize lines##2##3##(2008-10#2)
resistant maize##3##2##(2008-10#3)
resistant mutations##2##2##(1997-4#1)(2010-11#1)
resistant only to vinclozolin (S(T)R(V))##2##5##(2008-10#2)
resistant or susceptible to##3##4##(2008-10#3)
resistant or susceptible##5##3##(2008-10#5)
resistant or##9##2##(2008-10#7)(2009-11#1)(2010-4#1)
resistant organisms##4##2##(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
resistant ovary syndrome##2##3##(1996-2#2)
resistant ovary##3##2##(1996-2#2)(2012-3#1)
resistant parent##7##2##(2008-10#7)
resistant pepper##4##2##(2008-10#4)
resistant phenotype was##2##3##(1997-4#1)(2008-10#1)
resistant phenotype##3##2##(1996-9#1)(1997-4#1)(2008-10#1)
resistant plant##2##2##(2008-10#1)(2008-12#1)
resistant plants and##2##3##(2008-10#1)(2008-8#1)
resistant plants showed##2##3##(2008-10#2)
resistant plants##19##2##(2008-10#18)(2008-8#1)
resistant potato##2##2##(2008-10#2)
resistant reactions##2##2##(2008-10#2)
resistant roots##4##2##(2008-10#4)
resistant seedlings##5##2##(2008-10#5)
resistant sorghum##2##2##(2008-10#2)
resistant species##2##2##(1996-5#1)(2008-10#1)
resistant stems##3##2##(2008-10#3)
resistant strain##4##2##(2008-10#1)(2011-2#3)
resistant strains could be##2##4##(2008-1#1)(2008-10#1)
resistant strains were##2##3##(2007-8#1)(2008-10#1)
resistant strains##14##2##(1990-5#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2011-2#1)(2012-2#1)
resistant subline##2##2##(1990-2#2)
resistant sublines##4##2##(1997-4#2)(2008-4#2)
resistant than##12##2##(1990-12#1)(1990-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
resistant to A##2##3##(2008-10#2)
resistant to Fusarium##2##3##(2008-10#2)
resistant to P##4##3##(2008-10#3)(2008-8#1)
resistant to TNF##2##3##(1992-7#1)(1992-9#1)
resistant to TRAIL##2##3##(2009-9#1)(2012-2#1)
resistant to Verticillium##2##3##(2008-10#2)
resistant to activation-induced apoptosis##2##4##(2008-10#2)
resistant to all tested##2##4##(2008-10#1)(2008-5#1)
resistant to all##10##3##(2007-6#1)(2008-10#5)(2008-5#3)(2012-2#1)
resistant to antibiotics##4##3##(1995-3#1)(1997-4#1)(2008-5#1)(2009-10#1)
resistant to apoptosis##2##3##(2008-8#1)(2009-9#1)
resistant to at least##3##4##(1993-8#1)(2008-6#1)(2011-2#1)
resistant to attack##2##3##(2008-10#1)(2011-10#1)
resistant to azoxystrobin and##2##4##(2008-10#2)
resistant to both fungicides (R(T)R(V))##3##5##(2008-10#3)
resistant to both##12##3##(1991-2#1)(1992-9#1)(2008-10#10)
resistant to cephalosporins##2##3##(2011-2#2)
resistant to conservative##3##3##(2008-9#1)(2010-3#1)(2013-1#1)
resistant to conventional##2##3##(2010-12#1)(2011-2#1)
resistant to crown rust##2##4##(2008-10#2)
resistant to enzymatic##2##3##(1993-2#1)(2009-8#1)
resistant to fluconazole##3##3##(2008-10#1)(2008-5#2)
resistant to fluorouracil##3##3##(1990-2#3)
resistant to hydrolysis##2##3##(1994-11#2)
resistant to imatinib or nilotinib##2##5##(2012-12#2)
resistant to infection by##2##4##(2008-10#1)(2010-7#1)
resistant to infection##4##3##(2008-10#2)(2010-7#1)(2011-2#1)
resistant to leaf##2##3##(2008-10#2)
resistant to most##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
resistant to one or##2##4##(2008-10#1)(2013-8#1)
resistant to one##3##3##(2008-10#2)(2013-8#1)
resistant to penicillin##6##3##(1995-3#1)(2007-8#1)(2008-12#2)(2011-2#1)(2013-8#1)
resistant to powdery mildew##3##4##(2008-10#3)
resistant to race 1##2##4##(2008-10#2)
resistant to race##3##3##(2008-10#3)
resistant to strain GMI1000##2##4##(2008-10#2)
resistant to stress##2##3##(1996-2#2)
resistant to stripe rust##2##4##(2008-10#2)
resistant to tamoxifen##3##3##(1992-8#1)(1993-1#2)
resistant to the action of IGF-1##2##6##(1994-11#2)
resistant to the action of##3##5##(1994-11#2)(1995-2#1)
resistant to the##23##3##(1992-9#1)(1993-12#1)(1994-11#2)(1995-2#3)(1996-5#2)(2008-10#8)(2008-11#1)(2008-7#1)(2009-11#1)(2011-10#1)(2011-2#1)(2013-1#1)
resistant to thiophanate-methy1##2##3##(2008-10#2)
resistant to thiophanate-methyl##3##3##(2008-10#3)
resistant to two##3##3##(2008-10#2)(2011-2#1)
resistant to vinclozolin (S(T)R(V))##2##4##(2008-10#2)
resistant to vinclozolin##3##3##(2008-10#3)
resistant to##318##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#5)(1993-9#2)(1994-11#6)(1994-2#2)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#5)(1996-9#1)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#116)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#2)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#5)
resistant tomato##2##2##(2008-10#2)
resistant transgenic##2##2##(2008-8#2)
resistant tuberculosis##2##2##(1996-6#1)(2013-8#1)
resistant varieties##3##2##(2008-10#2)(2011-2#1)
resistant variety##2##2##(2007-7#1)(2011-2#1)
resistant wheat cultivars##2##3##(2008-10#2)
resistant wheat##6##2##(2008-10#6)
resistant x##2##2##(2008-10#2)
resistant##996##1##(1990-11#2)(1990-12#4)(1990-2#12)(1990-5#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-7#1)(1992-8#2)(1992-9#7)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#2)(1994-11#6)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#10)(1996-2#4)(1996-3#2)(1996-5#6)(1996-6#2)(1996-9#2)(1997-3#3)(1997-4#10)(1997-6#4)(1997-7#3)(1997-8#1)(2006-10#4)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#19)(2007-8#7)(2008-1#5)(2008-10#546)(2008-11#26)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#15)(2008-6#6)(2008-7#10)(2008-8#16)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#6)(2011-1#2)(2011-10#4)(2011-2#42)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#12)(2012-3#12)(2012-5#1)(2012-6#1)(2013-1#15)(2013-8#11)
resistant)##8##1##(2008-10#7)(2011-2#1)
resisted removal##2##2##(2008-10#1)(2011-2#1)
resisted##10##1##(1991-11#1)(1992-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(2008-10#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
resistin##8##1##(2008-1#6)(2008-3#1)(2012-12#1)
resisting the disclosure of##2##4##(1992-3#2)
resisting##7##1##(1991-12#2)(1992-3#2)(1996-3#1)(2009-2#1)(2011-3#1)
resistive and##2##2##(1995-3#1)(1996-4#1)
resistive index##4##2##(2008-10#1)(2013-1#3)
resistive strain##2##2##(2007-12#1)(2008-2#1)
resistive##15##1##(1995-3#1)(1996-4#2)(1996-5#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2013-1#5)
resistivity and##2##2##(2008-2#1)(2011-2#1)
resistivity of##2##2##(2008-3#1)(2013-8#1)
resistivity##17##1##(1990-4#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-8#4)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#3)
resistor electrodes##2##2##(2008-10#2)
resistors##4##1##(2008-10#4)
resists##3##1##(2006-12#1)(2007-12#1)(2009-10#1)
resolution 0##2##2##(2013-8#2)
resolution and a##6##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
resolution and accuracy##5##3##(2007-11#1)(2008-11#1)(2008-3#3)
resolution and an##2##3##(2008-3#2)
resolution and contrast##5##3##(2007-12#1)(2008-3#2)(2009-5#1)(2012-2#1)
resolution and dynamic range##2##4##(2007-11#1)(2008-3#1)
resolution and high##2##3##(2008-10#1)(2008-3#1)
resolution and reproducibility##2##3##(1996-5#1)(2009-1#1)
resolution and selectivity##2##3##(2007-12#1)(2008-10#1)
resolution and sensitivity##6##3##(1991-7#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
resolution and signal-to-noise ratio##3##4##(1997-8#1)(2010-9#1)(2013-8#1)
resolution and the##7##3##(1994-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
resolution and##100##2##(1991-7#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-11#7)(2007-12#12)(2008-10#14)(2008-11#1)(2008-2#7)(2008-3#23)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#1)
resolution are##10##2##(2007-12#5)(2007-4#1)(2008-2#1)(2008-3#2)(2012-2#1)
resolution as##3##2##(2008-2#1)(2008-3#2)
resolution at##7##2##(2008-10#1)(2008-3#3)(2008-6#1)(2009-5#1)(2012-2#1)
resolution because of##2##3##(2008-2#1)(2010-6#1)
resolution better than##3##3##(2008-3#2)(2008-7#1)
resolution between##5##2##(2008-10#4)(2009-9#1)
resolution by use of##2##4##(2007-11#1)(2007-12#1)
resolution by using##3##3##(1992-4#1)(2007-12#1)(2008-8#1)
resolution by##15##2##(1992-4#1)(1993-8#1)(1994-8#1)(1994-9#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)
resolution can be improved##2##4##(2007-11#2)
resolution can be obtained##4##4##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
resolution can be##9##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)
resolution capability##2##2##(2008-2#1)(2008-3#1)
resolution close to 1 microm##2##5##(2007-11#1)(2012-2#1)
resolution compared with##3##3##(2008-2#1)(2008-3#2)
resolution compared##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
resolution computed pulmonary##2##3##(2007-8#2)
resolution computed##3##2##(2007-8#3)
resolution enhancement##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
resolution factors##2##2##(2008-10#2)
resolution for the##7##3##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
resolution for##24##2##(1994-1#1)(2006-4#1)(2007-12#4)(2008-10#6)(2008-2#2)(2008-3#6)(2009-11#1)(2011-7#1)(2012-12#1)(2012-3#1)
resolution from##4##2##(2008-2#2)(2008-3#1)(2010-6#1)
resolution gel electrophoresis##2##3##(1994-6#1)(2008-4#1)
resolution has##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
resolution images##3##2##(2012-1#2)(2012-2#1)
resolution imaging of##2##3##(1990-11#1)(2011-7#1)
resolution imaging##4##2##(1990-11#1)(2008-3#1)(2011-1#1)(2011-7#1)
resolution in HPLC##2##3##(2008-10#2)
resolution in a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
resolution in near-field##2##3##(2007-12#1)(2008-3#1)
resolution in order to##2##4##(2010-3#1)(2011-2#1)
resolution in the##10##3##(1993-12#1)(1996-12#2)(2007-11#2)(2007-12#1)(2008-3#3)(2008-5#1)
resolution in three dimensions##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
resolution in two-photon microscopy is##2##5##(2008-3#2)
resolution in##48##2##(1991-9#1)(1993-12#1)(1994-8#1)(1996-12#3)(2007-11#6)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)
resolution increased##2##2##(2008-3#1)(2013-8#1)
resolution inductively##2##2##(2008-10#2)
resolution is 0##3##3##(1993-8#1)(2008-2#1)(2008-3#1)
resolution is achieved##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
resolution is better than##2##4##(2008-3#2)
resolution is determined by the##2##5##(2007-12#1)(2008-3#1)
resolution is limited by the##2##5##(2008-3#2)
resolution is limited##4##3##(2008-3#4)
resolution is not##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
resolution is used to##2##4##(2007-11#1)(2008-2#1)
resolution is##45##2##(1993-8#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#25)(2008-4#2)(2008-7#1)(2011-1#1)(2012-12#2)
resolution limit of##2##3##(2007-12#1)(2009-11#1)
resolution limit##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)
resolution limits of##2##3##(2007-12#2)
resolution limits##5##2##(2007-12#2)(2008-10#1)(2008-3#1)(2009-7#1)
resolution makes##3##2##(2008-4#1)(2008-9#1)(2010-7#1)
resolution mass spectrometry##10##3##(2008-10#7)(2008-11#1)(2010-5#2)
resolution mass##11##2##(2008-10#8)(2008-11#1)(2010-5#2)
resolution measurements##2##2##(2006-10#1)(2008-3#1)
resolution method##3##2##(2008-10#2)(2008-3#1)
resolution methods##4##2##(2008-10#3)(2009-11#1)
resolution near 100 nm##2##4##(2007-12#2)
resolution of 0##13##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#8)
resolution of 1 microm##2##4##(2008-3#2)
resolution of 1##12##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#4)(2010-10#1)
resolution of 10##3##3##(2007-12#1)(2008-3#2)
resolution of 13##2##3##(2007-11#1)(2009-11#1)
resolution of 2##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
resolution of 20 mum##3##4##(2008-2#1)(2008-3#2)
resolution of 20##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2009-5#1)
resolution of 200##2##3##(2007-12#1)(2008-3#1)
resolution of 3##5##3##(2008-3#4)(2010-3#1)
resolution of 4##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
resolution of 50##3##3##(2007-12#1)(2008-3#2)
resolution of 7##2##3##(2008-11#1)(2013-8#1)
resolution of a few##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
resolution of a##9##3##(2007-11#2)(2007-12#3)(2008-3#3)(2008-9#1)
resolution of acute##2##3##(2008-8#1)(2011-2#1)
resolution of all##2##3##(2007-7#1)(2008-10#1)
resolution of approximately 0##3##4##(2008-2#2)(2008-3#1)
resolution of approximately##9##3##(1994-5#1)(2007-12#1)(2008-2#3)(2008-3#4)
resolution of better than##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
resolution of binary##3##3##(2008-10#3)
resolution of both##2##3##(2010-4#1)(2012-3#1)
resolution of clinical##2##3##(1990-3#1)(2008-2#1)
resolution of far-field##2##3##(2007-11#1)(2009-5#1)
resolution of genetic##2##3##(2007-7#1)(2012-3#1)
resolution of glucose and urea##2##5##(2008-3#2)
resolution of her symptoms##3##4##(2008-7#1)(2013-1#1)(2013-8#1)
resolution of his symptoms##2##4##(2010-1#1)(2012-2#1)
resolution of his##3##3##(2008-7#1)(2010-1#1)(2012-2#1)
resolution of inflammation##2##3##(2008-5#2)
resolution of optical coherence tomography##2##5##(2007-11#2)
resolution of optical##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
resolution of several##2##3##(2007-12#1)(2008-3#1)
resolution of single-band##2##3##(2008-3#2)
resolution of symptoms##2##3##(2009-10#1)(2012-12#1)
resolution of the analytes##2##4##(2008-10#2)
resolution of the data##3##4##(2008-3#1)(2008-8#1)(2009-9#1)
resolution of the instrument##2##4##(2008-10#1)(2008-3#1)
resolution of the lesion##2##4##(2008-7#1)(2012-2#1)
resolution of the patient's##2##4##(2007-10#1)(2012-2#1)
resolution of the polarization##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
resolution of the system is##4##5##(2007-12#2)(2008-3#2)
resolution of the system##5##4##(2007-12#2)(2008-3#2)(2013-8#1)
resolution of the##91##3##(1990-6#1)(1993-12#1)(1993-8#2)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#2)(1996-6#1)(1997-2#3)(2007-10#2)(2007-11#4)(2007-12#8)(2008-10#15)(2008-11#2)(2008-2#5)(2008-3#26)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-9#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#2)
resolution of this##3##3##(1991-1#1)(2008-10#1)(2008-2#1)
resolution of three-dimensional##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
resolution of##343##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#1)(1997-2#3)(2006-10#1)(2007-10#2)(2007-11#26)(2007-12#34)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#50)(2008-11#4)(2008-2#24)(2008-3#86)(2008-4#3)(2008-5#6)(2008-7#8)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#4)(2013-8#6)
resolution on the order of##2##5##(2009-12#1)(2009-5#1)
resolution on the##3##3##(2009-12#1)(2009-5#1)(2012-1#1)
resolution on##6##2##(2008-10#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-6#1)(2012-1#1)
resolution or##3##2##(1996-11#1)(2008-4#1)(2008-6#1)
resolution over a##5##3##(2007-11#1)(2007-12#2)(2008-3#1)(2009-8#1)
resolution produced by##2##3##(2008-10#1)(2008-3#1)
resolution range##2##2##(2008-3#1)(2008-8#1)
resolution relative to##2##3##(2008-3#1)(2011-1#1)
resolution results##2##2##(2008-10#2)
resolution reveals##2##2##(1993-8#1)(2010-10#1)
resolution than the##2##3##(1997-4#1)(2008-2#1)
resolution than##7##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)
resolution that can be achieved##2##5##(2008-1#1)(2008-10#1)
resolution that is##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
resolution that##10##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)
resolution through##2##2##(2007-12#1)(2008-2#1)
resolution to##12##2##(1992-9#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-3#3)(2008-6#2)
resolution ultrasound and##2##3##(2011-2#1)(2012-1#1)
resolution using##3##2##(1997-6#1)(2008-10#1)(2012-12#1)
resolution values were shown in the extraction##2##7##(2008-10#2)
resolution was achieved##3##3##(1993-12#1)(2007-2#1)(2008-3#1)
resolution was obtained##2##3##(2007-12#1)(2008-10#1)
resolution was##12##2##(1993-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#3)(2009-5#1)(2010-4#1)
resolution were achieved##2##3##(2007-12#1)(2008-10#1)
resolution were obtained##2##3##(1995-3#1)(2011-3#1)
resolution were##8##2##(1995-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2011-3#1)
resolution with a##5##3##(1991-3#1)(1993-8#1)(2008-2#2)(2008-3#1)
resolution with##12##2##(1991-3#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)
resolution without##4##2##(2007-12#2)(2008-3#1)(2008-7#1)
resolution##1189##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-12#5)(1993-3#1)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#5)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#4)(1996-11#1)(1996-12#7)(1996-2#3)(1996-5#5)(1996-6#1)(1996-7#1)(1997-2#8)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-4#2)(2007-10#2)(2007-11#70)(2007-12#110)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#6)(2008-1#4)(2008-10#169)(2008-11#13)(2008-12#2)(2008-2#96)(2008-3#274)(2008-4#27)(2008-5#12)(2008-6#7)(2008-7#36)(2008-8#12)(2008-9#27)(2009-1#2)(2009-10#2)(2009-11#9)(2009-12#3)(2009-5#12)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#16)(2011-2#14)(2011-3#1)(2011-7#6)(2012-1#7)(2012-12#13)(2012-2#20)(2012-3#6)(2012-8#2)(2013-1#10)(2013-8#13)
resolutions are determined##2##3##(2007-11#2)
resolutions are##7##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)
resolutions in##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
resolutions of the##2##3##(2007-12#2)
resolutions of##10##2##(1994-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)
resolutions##36##1##(1994-1#2)(1994-8#1)(1994-9#1)(1995-3#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-2#5)(2008-3#8)(2008-4#1)(2008-6#3)(2008-8#2)(2013-1#1)
resolvable from##2##2##(2008-9#2)
resolvable##10##1##(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)
resolvase##2##1##(1995-2#2)
resolve a##2##2##(1995-11#1)(2008-10#1)
resolve issues##2##2##(1992-1#1)(2007-12#1)
resolve problems##3##2##(1994-1#1)(1995-5#1)(2008-10#1)
resolve the apparent##2##3##(1993-9#1)(2008-8#1)
resolve the##26##2##(1990-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
resolve these inconsistencies##2##3##(1996-3#1)(2008-8#1)
resolve these##5##2##(1993-12#1)(1996-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
resolve within##2##2##(2008-7#1)(2011-2#1)
resolve##104##1##(1990-12#1)(1990-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#3)(1996-3#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#4)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
resolved a##2##2##(2007-12#1)(2008-10#1)
resolved after the##2##3##(2007-12#1)(2013-8#1)
resolved after##9##2##(1996-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
resolved and##8##2##(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
resolved at##3##2##(2007-11#1)(2008-10#2)
resolved by the##3##3##(1996-2#1)(2008-10#1)(2011-1#1)
resolved by##43##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#2)(2012-12#3)(2012-2#2)
resolved depth steps##2##3##(2008-3#2)
resolved detection of##2##3##(2008-2#1)(2008-3#1)
resolved following##3##2##(2008-7#1)(2008-8#1)(2013-8#1)
resolved from each other##3##4##(1991-5#1)(1994-9#1)(2008-1#1)
resolved from the##3##3##(2008-10#3)
resolved from##8##2##(1991-5#2)(1994-9#1)(2008-1#1)(2008-10#3)(2011-1#1)
resolved in two##2##3##(1997-8#1)(2008-3#1)
resolved in##13##2##(1992-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
resolved into##5##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
resolved on the basis of##2##5##(1993-9#1)(2008-10#1)
resolved on the##4##3##(1993-9#1)(2008-10#3)
resolved on##8##2##(1993-9#1)(1996-5#1)(2006-8#1)(2008-10#4)(2008-7#1)
resolved only##2##2##(1991-3#1)(1994-9#1)
resolved or improved in##2##4##(2008-10#1)(2012-3#1)
resolved or##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
resolved peaks##3##2##(1991-2#1)(2008-10#1)(2010-4#1)
resolved reflectance##3##2##(2008-2#1)(2008-3#2)
resolved spectra##2##2##(2007-12#1)(2008-3#1)
resolved spectral##2##2##(2007-11#1)(2008-2#1)
resolved the##6##2##(1993-11#1)(1996-5#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)
resolved to##2##2##(2008-11#1)(2008-3#1)
resolved via##2##2##(1995-3#1)(2008-10#1)
resolved when##2##2##(1994-5#1)(2008-9#1)
resolved with a##2##3##(2006-10#1)(2011-2#1)
resolved with no##2##3##(2011-2#1)(2013-8#1)
resolved with the##2##3##(2007-12#1)(2013-1#1)
resolved with##15##2##(1990-8#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
resolved within##2##2##(2007-11#1)(2011-2#1)
resolved without##2##2##(1992-10#1)(2009-3#1)
resolved##290##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-5#2)(1994-9#6)(1995-12#1)(1995-2#1)(1995-3#6)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-8#3)(2008-1#5)(2008-10#52)(2008-11#5)(2008-12#1)(2008-2#19)(2008-3#31)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#8)(2011-2#8)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#4)
resolves the##2##2##(2008-3#1)(2010-8#1)
resolves##9##1##(2007-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)(2011-1#1)
resolving chemical mixed signals##2##4##(2008-10#2)
resolving chemical##3##2##(2008-10#3)
resolving power and resolution##2##4##(2008-10#2)
resolving power and##3##3##(2008-10#2)(2008-3#1)
resolving power of the spectrometer##2##5##(2008-10#1)(2008-3#1)
resolving power of the##4##4##(2008-10#2)(2008-3#2)
resolving power of##5##3##(2008-10#2)(2008-3#3)
resolving power##17##2##(2008-10#10)(2008-2#1)(2008-3#5)(2011-2#1)
resolving problems##2##2##(1994-2#1)(1996-2#1)
resolving the##11##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
resolving##63##1##(1994-2#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#11)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
resonance &quot##2##2##(1994-8#1)(1995-5#1)
resonance (MR) imaging##8##3##(1990-10#1)(1994-8#1)(1996-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)
resonance (MR)##19##2##(1990-10#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)
resonance (SPR) technique##2##3##(2008-10#1)(2008-3#1)
resonance (SPR)##24##2##(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#1)
resonance Raman spectra##2##3##(1990-8#1)(2007-1#1)
resonance Raman spectroscopy##2##3##(1995-5#1)(2008-3#1)
resonance Raman##13##2##(1990-8#2)(1995-2#1)(1995-5#2)(2007-1#1)(2008-10#4)(2008-2#1)(2008-3#2)
resonance Rayleigh scattering (RRS)##3##4##(2008-10#3)
resonance Rayleigh scattering##4##3##(2008-10#4)
resonance and the##2##3##(2008-3#2)
resonance and##14##2##(1990-10#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-3#2)(2009-10#1)(2009-5#1)(2010-5#1)(2012-2#1)
resonance angiography (MRA)##7##3##(1997-8#1)(2008-12#1)(2008-7#4)(2012-2#1)
resonance angiography revealed##3##3##(2008-1#1)(2008-12#2)
resonance angiography##22##2##(1997-4#1)(1997-8#2)(2007-10#3)(2007-8#1)(2008-1#2)(2008-12#3)(2008-7#6)(2008-9#1)(2009-4#1)(2009-8#1)(2012-2#1)
resonance angle##3##2##(2008-10#2)(2008-2#1)
resonance assignment of Urm1 from Trypanosoma brucei##2##7##(2009-7#2)
resonance assignment of the##8##4##(2009-7#8)
resonance assignment of##14##3##(2009-7#14)
resonance assignment##16##2##(1991-11#1)(2009-7#15)
resonance assignments for the##2##4##(1994-5#1)(2009-7#1)
resonance assignments of Hahellin##2##4##(2009-7#2)
resonance assignments of the##6##4##(2009-7#6)
resonance assignments of##15##3##(2009-7#15)
resonance assignments##21##2##(1991-11#1)(1994-5#1)(2009-7#19)
resonance at##4##2##(1990-8#2)(2007-11#1)(2008-10#1)
resonance between##2##2##(2008-3#1)(2012-2#1)
resonance condition##3##2##(2007-11#2)(2008-2#1)
resonance energy transfer (BRET)##3##4##(2008-4#2)(2011-3#1)
resonance energy transfer (FRET) between##2##5##(2008-1#1)(2008-10#1)
resonance energy transfer (FRET)##12##4##(2008-1#1)(2008-10#3)(2008-4#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
resonance energy transfer##27##3##(1992-3#2)(1994-3#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-4#5)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
resonance energy##30##2##(1992-3#2)(1994-3#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#5)(2008-4#5)(2008-9#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
resonance experiments##3##2##(2008-8#1)(2009-7#1)(2011-1#1)
resonance fluorescence monochromator with##2##4##(2007-12#2)
resonance for the##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-10#1)
resonance for##11##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-10#2)
resonance frequency and##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
resonance frequency of##2##3##(2008-2#1)(2008-3#1)
resonance frequency shift##5##3##(2009-5#4)(2012-2#1)
resonance frequency##16##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#4)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
resonance image (MRI)##2##3##(2008-7#1)(2013-8#1)
resonance image##6##2##(2007-10#1)(2008-12#1)(2008-7#2)(2010-8#1)(2013-8#1)
resonance images (MRI)##2##3##(2010-7#1)(2012-3#1)
resonance images##14##2##(1995-8#1)(1996-5#2)(1996-7#1)(2006-12#1)(2008-3#2)(2008-7#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
resonance imaging (MRI) and##3##4##(1996-7#1)(2007-11#1)(2008-7#1)
resonance imaging (MRI) findings##5##4##(1996-11#1)(2008-6#1)(2012-12#2)(2012-3#1)
resonance imaging (MRI) has##4##4##(1994-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
resonance imaging (MRI) is##6##4##(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#2)
resonance imaging (MRI) of the lumbar spine##2##7##(2008-12#1)(2012-2#1)
resonance imaging (MRI) of the##4##5##(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
resonance imaging (MRI) showed##4##4##(2008-7#1)(2013-1#1)(2013-8#2)
resonance imaging (MRI) with##2##4##(2008-7#1)(2010-9#1)
resonance imaging (MRI)##69##3##(1994-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#9)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#11)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
resonance imaging (PC-MRI)##2##3##(2008-7#1)(2012-3#1)
resonance imaging and multidetector computed tomography##2##6##(2012-2#2)
resonance imaging and##26##3##(1992-3#1)(2007-10#1)(2007-4#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#2)
resonance imaging at##2##3##(2008-9#1)(2010-8#1)
resonance imaging demonstrated a##2##4##(2008-7#1)(2011-2#1)
resonance imaging demonstrated##4##3##(2006-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
resonance imaging findings##2##3##(1997-8#1)(2008-7#1)
resonance imaging for##3##3##(2010-12#1)(2010-7#1)(2012-3#1)
resonance imaging in the##4##4##(1990-12#1)(2008-1#1)(2008-8#1)(2010-12#1)
resonance imaging in##10##3##(1990-12#1)(1996-7#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#2)(2012-12#1)(2013-3#1)
resonance imaging is the most##2##5##(2010-3#1)(2010-6#1)
resonance imaging is the##4##4##(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
resonance imaging is##9##3##(1990-12#1)(1994-11#1)(2008-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
resonance imaging may be##2##4##(2009-3#1)(2012-2#1)
resonance imaging of the##10##4##(1996-3#3)(2007-10#1)(2009-3#2)(2010-12#1)(2010-9#1)(2011-2#2)
resonance imaging of##22##3##(1991-11#1)(1994-8#1)(1996-3#3)(1997-8#1)(2007-10#1)(2008-7#1)(2009-3#2)(2010-12#5)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#1)
resonance imaging revealed a##2##4##(2008-11#1)(2008-12#1)
resonance imaging revealed##8##3##(2007-10#2)(2008-11#1)(2008-12#3)(2009-3#1)(2013-8#1)
resonance imaging should be##3##4##(1996-3#1)(2008-8#1)(2010-3#1)
resonance imaging showed a##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
resonance imaging showed##6##3##(2007-8#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-7#1)
resonance imaging was performed##3##4##(2011-2#1)(2012-12#2)
resonance imaging was##7##3##(1996-2#1)(2008-11#1)(2009-5#1)(2011-2#2)(2012-12#2)
resonance imaging##297##2##(1990-11#1)(1990-12#3)(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#5)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-5#3)(1996-11#1)(1996-2#2)(1996-3#4)(1996-5#3)(1996-7#4)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#4)(2006-10#3)(2006-12#1)(2007-10#12)(2007-11#5)(2007-4#3)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#2)(2008-11#13)(2008-12#4)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#31)(2008-8#7)(2008-9#11)(2009-1#1)(2009-11#3)(2009-2#1)(2009-3#6)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#15)(2010-2#2)(2010-3#4)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#6)(2011-1#4)(2011-2#20)(2012-1#1)(2012-12#10)(2012-2#20)(2012-3#8)(2013-1#7)(2013-3#2)(2013-7#4)(2013-8#6)
resonance in a##2##3##(1990-4#1)(2007-11#1)
resonance in such##2##3##(2007-11#1)(2008-3#1)
resonance in##8##2##(1990-4#1)(1992-8#1)(2007-11#3)(2007-12#2)(2008-3#1)
resonance interferometry##3##2##(2008-2#3)
resonance ionization imaging detector##2##4##(2008-3#2)
resonance ionization imaging##3##3##(2007-12#1)(2008-3#2)
resonance ionization##4##2##(2007-12#1)(2008-3#3)
resonance is##6##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)
resonance light scattering (RLS) signals##2##5##(2008-10#2)
resonance light scattering (RLS)##6##4##(2008-10#6)
resonance light scattering of##3##4##(2008-10#3)
resonance light scattering ratiometry##2##4##(2008-10#2)
resonance light scattering technique##2##4##(2008-10#2)
resonance light scattering##15##3##(2008-10#15)
resonance light##16##2##(2008-10#16)
resonance light-scattering (RLS)##2##3##(2008-10#2)
resonance light-scattering##3##2##(2008-10#3)
resonance line of##2##3##(2007-11#1)(2008-3#1)
resonance line##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
resonance linewidth##3##2##(2008-2#1)(2008-3#2)
resonance measurements##3##2##(1990-12#1)(2008-11#1)(2010-8#1)
resonance modes##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
resonance of the##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
resonance of##8##2##(1990-8#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
resonance peak##2##2##(2008-3#1)(2009-12#1)
resonance peaks##2##2##(2008-5#1)(2008-9#1)
resonance phenomena##3##2##(2007-9#1)(2008-3#1)(2009-8#1)
resonance phenomenon##2##2##(1995-12#1)(2010-7#1)
resonance position##2##2##(2008-3#2)
resonance scattering (RS) effect##2##4##(2008-10#2)
resonance scattering effect##2##3##(2008-10#2)
resonance scattering spectral method for##2##5##(2008-10#2)
resonance scattering spectral method##3##4##(2008-10#3)
resonance scattering spectral##4##3##(2008-10#4)
resonance scattering##12##2##(2008-10#12)
resonance spectra##4##2##(2008-2#1)(2008-6#2)(2009-6#1)
resonance spectroscopy of the brain##2##5##(1995-12#1)(2010-11#1)
resonance spectroscopy was##2##3##(1996-2#1)(2008-11#1)
resonance spectroscopy##45##2##(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-11#4)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-1#1)(2007-10#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-11#1)(2010-12#2)(2010-5#2)(2011-1#1)(2013-8#1)
resonance spectrum##2##2##(1990-12#1)(1993-11#1)
resonance structure##2##2##(2007-12#1)(2008-2#1)
resonance study##4##2##(1991-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
resonance systems##2##2##(2011-2#2)
resonance technique##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
resonance techniques in##2##3##(2007-7#1)(2008-4#1)
resonance techniques##4##2##(1990-2#1)(2007-7#1)(2008-10#1)(2008-4#1)
resonance wavelength##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2011-1#1)
resonance with the##2##3##(2008-2#1)(2008-3#1)
resonance with##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
resonance##901##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#5)(1991-1#1)(1991-11#4)(1991-12#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#14)(1992-4#1)(1992-8#1)(1993-11#10)(1993-12#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-11#2)(1994-2#5)(1994-3#4)(1994-5#4)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-4#1)(1995-5#11)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-2#5)(1996-3#4)(1996-5#5)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#8)(2006-10#3)(2006-12#2)(2007-1#1)(2007-10#18)(2007-11#37)(2007-12#25)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#8)(2008-10#141)(2008-11#20)(2008-12#10)(2008-2#31)(2008-3#57)(2008-4#11)(2008-5#9)(2008-6#8)(2008-7#55)(2008-8#12)(2008-9#20)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#6)(2009-4#2)(2009-5#10)(2009-6#1)(2009-7#35)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#20)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#7)(2010-6#4)(2010-7#6)(2010-8#10)(2010-9#6)(2011-1#10)(2011-2#29)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#31)(2012-3#12)(2013-1#11)(2013-3#2)(2013-7#5)(2013-8#11)
resonance)##5##1##(2007-11#1)(2008-1#2)(2012-12#2)
resonance-ionization and##2##2##(2007-12#2)
resonances and##3##2##(1995-2#1)(2007-11#1)(2008-2#1)
resonances are observed at##2##4##(1991-8#1)(2008-10#1)
resonances are##5##2##(1991-11#1)(1991-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
resonances in cylindrical microparticles##2##4##(2008-3#2)
resonances in the##4##3##(1993-11#1)(2007-11#1)(2008-2#2)
resonances in##11##2##(1992-4#1)(1993-11#1)(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)
resonances of the##5##3##(1996-2#1)(2008-3#1)(2009-7#3)
resonances of##11##2##(1996-2#1)(2008-2#2)(2008-3#4)(2009-7#3)(2010-2#1)
resonances on the##2##3##(2008-3#1)(2008-6#1)
resonances were##3##2##(1992-3#1)(1993-11#1)(2008-9#1)
resonances within a##2##3##(1994-5#1)(2009-6#1)
resonances within##3##2##(1994-5#1)(2007-11#1)(2009-6#1)
resonances##61##1##(1991-11#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#3)(1994-5#2)(1995-2#1)(1995-5#2)(1996-2#1)(2007-11#10)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#12)(2008-6#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#4)(2010-2#2)(2010-7#1)
resonant OPO is pumped by a##2##6##(2007-11#1)(2007-12#1)
resonant OPO##5##2##(2007-11#3)(2007-12#2)
resonant Raman##2##2##(2007-11#2)
resonant and nonresonant##2##3##(2008-10#1)(2012-2#1)
resonant at##2##2##(2007-12#1)(2008-2#1)
resonant cavity##7##2##(2007-11#1)(2007-12#4)(2008-3#2)
resonant continuous-wave##2##2##(2007-11#1)(2007-12#1)
resonant enhancement of the##2##4##(1996-2#1)(2008-10#1)
resonant filter##3##2##(2008-3#3)
resonant frequencies##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
resonant frequency of the quartz crystal##2##6##(2008-10#2)
resonant frequency of the##4##4##(2007-11#1)(2008-10#3)
resonant frequency of##5##3##(1990-8#1)(2007-11#1)(2008-10#3)
resonant frequency##6##2##(1990-8#1)(2007-11#1)(2008-10#3)(2009-5#1)
resonant grating##4##2##(2007-12#2)(2008-3#2)
resonant interaction##2##2##(1991-8#1)(2007-11#1)
resonant laser ablation##2##3##(2008-3#2)
resonant modes##3##2##(2007-11#1)(2007-12#2)
resonant optical parametric oscillator (OPO)##3##5##(2007-12#2)(2008-3#1)
resonant optical parametric oscillator##13##4##(2007-11#4)(2007-12#8)(2008-3#1)
resonant optical parametric oscillators##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
resonant optical parametric##17##3##(2007-11#5)(2007-12#10)(2008-3#2)
resonant optical##19##2##(2007-11#6)(2007-12#11)(2008-3#2)
resonant photoacoustic##2##2##(2007-12#1)(2008-10#1)
resonant pump##2##2##(2007-12#2)
resonant second-harmonic generation##2##3##(2007-11#1)(2007-12#1)
resonant sequential##2##2##(2007-12#2)
resonant sideband extraction##4##3##(2008-2#4)
resonant tunneling##2##2##(1992-11#1)(2007-12#1)
resonant with##3##2##(2007-11#1)(2007-12#2)
resonant##160##1##(1990-8#1)(1991-8#1)(1992-11#1)(1996-12#1)(1996-2#1)(2006-4#1)(2007-11#35)(2007-12#46)(2008-10#8)(2008-11#3)(2008-2#20)(2008-3#37)(2008-7#2)(2009-11#1)(2009-5#1)(2012-2#1)
resonant-cavity##2##1##(2007-12#2)
resonantly enhanced##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
resonantly excited##2##2##(2007-12#2)
resonantly##13##1##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#4)
resonated##3##1##(2007-12#1)(2008-3#2)
resonator and a##2##3##(2007-12#1)(2008-3#1)
resonator and the##2##3##(2007-11#1)(2008-2#1)
resonator and##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
resonator as##2##2##(2007-11#1)(2008-3#1)
resonator based on##4##3##(2007-11#1)(2008-3#3)
resonator by##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
resonator configuration##2##2##(2008-3#2)
resonator design for##2##3##(2007-11#1)(2008-3#1)
resonator design##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
resonator for##2##2##(2008-3#1)(2011-1#1)
resonator geometries such as##2##4##(2008-2#1)(2008-7#1)
resonator in a##2##3##(2007-11#1)(2008-3#1)
resonator in the##2##3##(2007-12#2)
resonator in##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
resonator is##9##2##(2007-11#1)(2007-12#5)(2008-3#3)
resonator length##2##2##(2007-12#2)
resonator mirrors##2##2##(2008-2#2)
resonator operating at##2##3##(2007-11#1)(2008-2#1)
resonator scheme##2##2##(2007-11#1)(2008-2#1)
resonator that##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
resonator was##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
resonator when##2##2##(2007-11#1)(2008-3#1)
resonator with a##3##3##(2008-2#1)(2008-3#2)
resonator with the##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
resonator with##10##2##(2008-2#2)(2008-3#6)(2011-1#1)(2013-8#1)
resonator without cavity dumping##2##4##(2007-11#1)(2007-12#1)
resonator without##3##2##(2007-11#1)(2007-12#2)
resonator##163##1##(2007-11#26)(2007-12#26)(2008-10#1)(2008-2#34)(2008-3#64)(2008-7#2)(2009-5#3)(2010-4#2)(2011-1#3)(2013-8#2)
resonators and##2##2##(2007-12#1)(2008-2#1)
resonators are##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
resonators based on##2##3##(2007-11#1)(2008-3#1)
resonators for##3##2##(2008-3#1)(2009-5#2)
resonators in##2##2##(2008-2#1)(2008-3#1)
resonators is##2##2##(2007-12#2)
resonators show##2##2##(2007-11#2)
resonators that##4##2##(2007-11#1)(2008-3#3)
resonators with a##3##3##(2008-3#2)(2009-5#1)
resonators with##8##2##(2007-11#1)(2008-3#6)(2009-5#1)
resonators##65##1##(2007-11#18)(2007-12#8)(2008-2#6)(2008-3#29)(2009-5#4)
resorbable membranes##2##2##(2007-12#2)
resorbable##3##1##(2007-12#2)(2012-3#1)
resorbed by##2##2##(1995-2#1)(2008-12#1)
resorbed##10##1##(1995-2#1)(2008-12#2)(2008-5#1)(2009-3#1)(2009-7#1)(2012-12#1)(2013-1#3)
resorbing##6##1##(1993-11#1)(1993-12#3)(1993-8#1)(2012-12#1)
resorcinol (PAR) and##2##3##(2008-10#2)
resorcinol (PAR)##6##2##(2008-10#6)
resorcinol and hydroquinone##2##3##(2008-10#2)
resorcinol and##6##2##(2008-10#6)
resorcinol##25##1##(1992-3#1)(2008-10#21)(2008-11#1)(2008-6#1)(2011-1#1)
resorption and##13##2##(1992-3#1)(1993-11#3)(1997-7#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-12#1)(2013-1#2)
resorption by##5##2##(1992-3#1)(2008-11#2)(2010-10#1)(2013-1#1)
resorption in Quercus brantii##2##4##(2008-12#2)
resorption in##6##2##(1992-3#1)(1993-6#2)(1995-3#1)(2008-12#2)
resorption is##2##2##(1993-6#1)(2013-1#1)
resorption markers##2##2##(2008-10#2)
resorption of bone##2##3##(2007-11#1)(2008-8#1)
resorption of the##4##3##(2008-4#1)(2013-1#3)
resorption of##8##2##(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#3)
resorption using##2##2##(2013-1#2)
resorption villi in the experimental than in the control group (p &lt##2##12##(2011-1#2)
resorption villi##8##2##(2011-1#8)
resorption was lowest at##2##4##(2008-12#2)
resorption was##8##2##(1991-11#1)(1992-3#1)(1995-3#2)(2008-12#2)(2008-7#2)
resorption were##2##2##(1990-7#1)(1991-11#1)
resorption##108##1##(1990-7#1)(1991-11#4)(1992-3#5)(1993-11#6)(1993-6#10)(1994-6#1)(1995-2#1)(1995-3#6)(1996-2#1)(1997-7#2)(2007-11#5)(2007-8#2)(2008-10#4)(2008-11#7)(2008-12#8)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2010-10#1)(2011-1#8)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#18)
resorption)##2##1##(1990-7#1)(1991-11#1)
resorptive##7##1##(1991-12#3)(2011-2#3)(2012-2#1)
resort to##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2013-1#1)
resort##11##1##(1997-2#1)(2007-12#2)(2008-10#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
resorted to##3##2##(1997-5#1)(2008-10#1)(2008-12#1)
resorting to##7##2##(1995-6#1)(2007-12#1)(2008-10#4)(2013-1#1)
resorufin##3##1##(1994-8#1)(2008-10#2)
resource abundance##2##2##(2008-9#2)
resource acquisition##2##2##(2008-8#2)
resource allocation and##3##3##(1992-3#1)(1995-1#1)(2011-2#1)
resource allocation decisions##2##3##(1995-1#1)(1997-1#1)
resource allocation##15##2##(1992-1#1)(1992-3#2)(1995-1#2)(1995-2#1)(1997-1#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-8#3)(2011-2#1)(2013-8#1)
resource and a##2##3##(1993-2#1)(2008-8#1)
resource and##6##2##(1991-3#1)(1993-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)
resource availability can##2##3##(2008-8#1)(2008-9#1)
resource availability##7##2##(2008-8#4)(2008-9#1)(2012-2#2)
resource competition##5##2##(2007-7#1)(2008-8#3)(2008-9#1)
resource constraints##2##2##(2008-11#1)(2008-12#1)
resource consumption##5##2##(1991-12#2)(1995-2#1)(1995-3#1)(2008-8#1)
resource defense##2##2##(2008-8#1)(2012-2#1)
resource densities##3##2##(2008-8#1)(2008-9#2)
resource density##2##2##(2008-8#2)
resource development##3##2##(2008-1#2)(2012-3#1)
resource distribution##2##2##(1995-1#1)(2008-8#1)
resource dynamics##3##2##(2008-8#3)
resource extraction rate is##2##4##(2008-8#2)
resource extraction##3##2##(2008-8#3)
resource for the##4##3##(1993-2#1)(1997-5#1)(2008-10#1)(2008-4#1)
resource for##32##2##(1992-3#1)(1993-2#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-5#1)(2007-5#4)(2008-10#3)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#3)
resource in the##2##3##(1991-3#1)(2008-8#1)
resource in##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
resource intensive and##2##3##(1993-12#1)(2013-1#1)
resource intensive##3##2##(1993-12#1)(2008-12#1)(2013-1#1)
resource is##2##2##(1997-2#1)(2008-12#1)
resource limitation##2##2##(2012-2#2)
resource limited##2##2##(1995-12#1)(2010-8#1)
resource list##2##2##(2008-9#1)(2010-12#1)
resource management##14##2##(1991-1#1)(1993-2#1)(1995-3#4)(1996-12#1)(1996-2#1)(1997-3#1)(2007-5#1)(2011-2#3)(2012-12#1)
resource of##6##2##(1995-2#1)(1996-3#1)(2008-4#2)(2008-7#1)(2008-8#1)
resource patches##4##2##(2008-9#4)
resource poor##7##2##(1995-9#1)(2007-2#2)(2008-4#1)(2009-4#1)(2010-8#1)(2012-2#1)
resource requirements##3##2##(2008-8#2)(2008-9#1)
resource settings##5##2##(2009-6#3)(2011-2#2)
resource supply##3##2##(2008-8#3)
resource that##8##2##(2008-12#2)(2008-4#3)(2008-9#1)(2010-11#1)(2012-2#1)
resource to##3##2##(1993-2#1)(2008-3#1)(2008-9#1)
resource use during##2##3##(1991-12#1)(2007-10#1)
resource use##18##2##(1991-12#2)(1991-2#1)(1993-12#2)(1993-2#1)(1994-3#3)(1995-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-9#2)
resource utilization and##2##3##(1993-3#1)(2009-11#1)
resource utilization in##2##3##(1994-3#1)(2008-3#1)
resource utilization##14##2##(1992-4#1)(1993-3#1)(1994-3#3)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)
resource within##2##2##(2008-11#1)(2008-9#1)
resource##315##1##(1990-11#1)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#2)(1992-1#2)(1992-2#1)(1992-3#3)(1992-4#1)(1993-12#4)(1993-2#7)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#6)(1995-2#6)(1995-3#8)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#4)(1997-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#5)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#10)(2008-3#2)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#58)(2008-9#33)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#6)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#10)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#10)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#1)
resource-based model##3##2##(2008-8#3)
resource-based relative value scale##5##4##(1991-12#1)(1992-1#1)(1992-12#1)(1994-12#2)
resource-based relative value##6##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-12#2)
resource-based##15##1##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-1#2)(1994-12#2)(1996-1#1)(2007-5#1)(2008-4#1)(2008-8#3)(2012-2#1)
resource-constrained##5##1##(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#2)
resource-limited##2##1##(2009-4#1)(2010-11#1)
resource-poor settings##2##2##(2009-6#1)(2012-12#1)
resource-poor##8##1##(2008-11#1)(2008-9#1)(2009-6#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
resource-rich##2##1##(2008-9#2)
resourcefulness##4##1##(2008-12#4)
resources (i##2##2##(2010-8#1)(2011-2#1)
resources allocated##2##2##(2008-10#1)(2008-9#1)
resources and a##2##3##(1993-6#1)(1997-3#1)
resources and expertise##2##3##(1995-1#1)(2011-1#1)
resources and had##2##3##(1991-12#1)(1995-1#1)
resources and personnel##2##3##(1993-12#1)(2008-10#1)
resources and services##2##3##(1993-1#2)
resources and systems##2##3##(1993-12#1)(2009-8#1)
resources and the##6##3##(1996-8#1)(1997-2#1)(1997-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
resources and time##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
resources and to##2##3##(2008-1#1)(2008-10#1)
resources and##70##2##(1991-12#1)(1991-3#1)(1993-1#2)(1993-12#2)(1993-6#1)(1994-12#2)(1994-3#2)(1995-1#3)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#3)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#1)
resources are allocated##2##3##(1997-3#1)(2008-6#1)
resources are limited##2##3##(2009-10#1)(2012-2#1)
resources are scarce##2##3##(2008-12#1)(2008-9#1)
resources are##22##2##(1994-3#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#5)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
resources as well##2##3##(1993-2#1)(2013-8#1)
resources at##2##2##(2009-10#2)
resources availability##2##2##(2013-7#2)
resources available and the##2##4##(2007-11#1)(2012-2#1)
resources available to##5##3##(1994-1#1)(1996-2#1)(2008-4#1)(2010-9#1)(2011-2#1)
resources available##10##2##(1994-1#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-4#3)(2010-9#1)(2011-2#1)(2012-2#1)
resources but##3##2##(2008-8#1)(2008-9#2)
resources by##4##2##(1996-1#1)(2008-11#1)(2008-5#1)(2008-7#1)
resources can be##2##3##(2008-9#1)(2010-2#1)
resources for health##2##3##(1991-6#1)(1997-2#1)
resources for more information are provided in the Literature Cited and Key References sections and in URLs given text and within the Internet Resources section##2##25##(2008-4#1)(2008-9#1)
resources for nursing##2##3##(2008-11#2)
resources for public health##2##4##(1995-12#1)(1997-3#1)
resources for##33##2##(1991-3#1)(1991-6#1)(1992-3#4)(1994-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
resources from##7##2##(1991-3#1)(1994-2#2)(1995-1#1)(1997-1#1)(2008-11#1)(2008-8#1)
resources has##2##2##(2012-12#1)(2012-2#1)
resources have##2##2##(2008-8#1)(2009-2#1)
resources in a##2##3##(2008-7#1)(2010-11#1)
resources in the health##2##4##(1991-6#1)(2013-1#1)
resources in the##8##3##(1990-9#1)(1991-3#1)(1991-6#1)(2008-11#1)(2008-8#1)(2009-6#1)(2013-1#1)(2013-8#1)
resources in this##3##3##(1990-12#1)(1997-3#1)(2010-10#1)
resources in##36##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-6#1)(1993-2#1)(1997-3#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
resources into##3##2##(2007-4#1)(2007-7#1)(2008-9#1)
resources is##3##2##(1992-12#1)(1997-1#1)(2009-8#1)
resources it##2##2##(2008-10#1)(2008-8#1)
resources might be##2##3##(2008-11#1)(2009-5#1)
resources might##3##2##(2008-11#1)(2008-8#1)(2009-5#1)
resources must##3##2##(1995-2#1)(2007-12#1)(2008-11#1)
resources needed for##3##3##(2008-2#1)(2008-4#1)(2010-3#1)
resources needed##5##2##(1991-8#1)(2007-9#1)(2008-2#1)(2008-4#1)(2010-3#1)
resources of the##6##3##(1992-12#1)(1996-2#1)(2008-10#1)(2009-7#1)(2012-2#1)(2013-7#1)
resources of##15##2##(1990-2#1)(1991-3#1)(1992-12#1)(1995-1#1)(1996-2#2)(1997-3#1)(2008-10#3)(2009-7#1)(2012-1#1)(2012-2#2)(2013-7#1)
resources often##2##2##(2008-8#1)(2008-9#1)
resources on the##3##3##(1996-12#1)(2011-2#2)
resources on##13##2##(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#4)
resources or##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
resources required##4##2##(2008-9#1)(2011-1#1)(2012-2#2)
resources should##4##2##(1995-6#1)(2008-7#1)(2008-9#1)(2010-7#1)
resources such as##2##3##(2008-9#1)(2009-7#1)
resources that can##2##3##(2008-4#1)(2008-8#1)
resources that would be##2##4##(1996-1#1)(2012-2#1)
resources that##10##2##(1996-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
resources they##3##2##(2008-11#1)(2008-12#1)(2009-10#1)
resources to a##3##3##(1990-12#1)(1994-12#1)(2009-3#1)
resources to an##2##3##(1993-12#1)(1995-2#1)
resources to meet##3##3##(1992-12#1)(1995-3#1)(2010-4#1)
resources to provide##2##3##(1993-12#1)(1996-3#1)
resources to the##4##3##(1994-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
resources to##45##2##(1990-12#1)(1992-1#1)(1992-12#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#5)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#2)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
resources used##3##2##(1996-11#1)(1997-4#1)(2008-8#1)
resources utilization##3##2##(1991-12#1)(2013-1#2)
resources was##2##2##(1994-1#1)(2012-2#1)
resources were##4##2##(1991-3#1)(2008-6#2)(2008-9#1)
resources which##2##2##(1994-12#1)(1996-2#1)
resources will##4##2##(1990-12#1)(1994-2#1)(1996-11#1)(1996-3#1)
resources with##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
resources within the##2##3##(2008-6#1)(2013-8#1)
resources within##3##2##(1993-2#1)(2008-6#1)(2013-8#1)
resources without##2##2##(2008-8#1)(2008-9#1)
resources##600##1##(1990-12#3)(1990-2#2)(1990-6#3)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#8)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#10)(1993-1#3)(1993-11#1)(1993-12#8)(1993-2#5)(1993-3#1)(1993-6#1)(1994-1#4)(1994-12#7)(1994-2#4)(1994-3#6)(1994-6#1)(1994-9#1)(1995-1#7)(1995-12#5)(1995-2#7)(1995-3#5)(1995-6#1)(1996-1#10)(1996-11#2)(1996-12#10)(1996-2#7)(1996-3#8)(1996-8#1)(1997-1#9)(1997-2#8)(1997-3#17)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#4)(2007-4#4)(2007-5#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#35)(2008-11#42)(2008-12#10)(2008-2#3)(2008-3#3)(2008-4#14)(2008-5#3)(2008-6#10)(2008-7#23)(2008-8#37)(2008-9#36)(2009-10#6)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#5)(2010-8#4)(2010-9#4)(2011-1#11)(2011-10#1)(2011-2#21)(2011-3#2)(2012-1#1)(2012-12#9)(2012-2#27)(2012-3#4)(2013-1#19)(2013-7#6)(2013-8#10)
resourcing##3##1##(2008-11#1)(2012-12#1)(2013-8#1)
resp##3##1##(1995-5#1)(2008-11#1)(2013-1#1)
respect and##5##2##(1991-3#1)(1995-5#1)(2008-12#1)(2011-2#2)
respect for autonomy##2##3##(1997-8#1)(2009-6#1)
respect for persons##3##3##(1992-3#1)(2008-9#1)(2009-6#1)
respect for the##3##3##(1992-2#1)(1992-3#1)(1997-3#1)
respect for##16##2##(1992-2#1)(1992-3#2)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#2)(2011-2#1)
respect of the##3##3##(1995-6#1)(2010-12#1)(2013-8#1)
respect of##13##2##(1992-6#1)(1995-6#1)(2007-7#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2013-8#1)
respect to baseline##2##3##(2008-7#2)
respect to control##5##3##(1992-3#1)(1993-12#1)(2006-6#1)(2010-8#1)(2013-1#1)
respect to different##4##3##(2008-6#2)(2008-7#1)(2010-12#1)
respect to growth##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
respect to human##3##3##(2008-10#2)(2012-2#1)
respect to its##12##3##(1991-2#1)(1993-8#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
respect to morphology##2##3##(1995-9#1)(2008-5#1)
respect to noise##2##3##(2007-11#1)(2008-10#1)
respect to other##2##3##(2008-10#1)(2008-3#1)
respect to practical applications##2##4##(2008-10#1)(2008-2#1)
respect to that of##2##4##(2008-10#1)(2008-3#1)
respect to the conventional##2##4##(2008-10#1)(2013-1#1)
respect to the##228##3##(1990-11#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#4)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-9#1)(2006-10#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-9#1)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#24)(2008-3#45)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
respect to these##4##3##(1995-11#1)(2008-2#1)(2008-7#1)(2010-1#1)
respect to##621##2##(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#7)(1994-12#5)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#8)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-9#1)(2006-10#1)(2006-6#1)(2007-11#18)(2007-12#23)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#114)(2008-11#19)(2008-12#8)(2008-2#44)(2008-3#62)(2008-4#5)(2008-5#17)(2008-6#3)(2008-7#23)(2008-8#9)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#20)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#13)(2013-8#8)
respect##699##1##(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#5)(1992-6#5)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#5)(1993-3#1)(1993-6#3)(1993-8#7)(1994-1#2)(1994-12#5)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#8)(1996-3#2)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#19)(2007-12#23)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#121)(2008-11#22)(2008-12#9)(2008-2#45)(2008-3#63)(2008-4#7)(2008-5#20)(2008-6#3)(2008-7#25)(2008-8#9)(2008-9#10)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#23)(2011-7#1)(2012-1#1)(2012-12#8)(2012-2#12)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#15)(2013-8#9)
respected##7##1##(1991-3#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-9#1)(2011-3#1)(2012-3#1)
respectful manner##2##2##(1990-6#1)(1996-3#1)
respectful of##2##2##(2008-5#1)(2008-9#1)
respectful##5##1##(1990-6#1)(1996-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
respective calibration##2##2##(2008-10#2)
respective control##4##2##(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#1)
respective controls##3##2##(1991-12#1)(1994-6#1)(2008-10#1)
respective enzymes##3##2##(1991-3#1)(2010-7#1)(2011-2#1)
respective hosts##2##2##(2008-10#2)
respective ligands##2##2##(1992-8#1)(1994-2#1)
respective molecular##2##2##(2008-10#1)(2008-3#1)
respective normal groups##2##3##(2008-7#2)
respective pathogens##3##2##(2008-10#3)
respective roles of##2##3##(1992-12#1)(2009-8#1)
respective roles##3##2##(1992-12#1)(1995-2#1)(2009-8#1)
respective state##2##2##(1995-12#1)(2012-3#1)
respective target##2##2##(1996-9#1)(2008-6#1)
respective##208##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#4)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#49)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
respectively (P &lt##3##3##(1994-2#1)(2008-5#1)(2012-3#1)
respectively (P##7##2##(1992-5#1)(1994-2#1)(2008-4#1)(2008-5#1)(2012-3#2)(2013-1#1)
respectively (p &lt##6##3##(1995-3#1)(2008-1#1)(2013-1#4)
respectively (p = NS)##2##4##(1994-12#2)
respectively (p =##3##3##(1994-12#2)(1997-2#1)
respectively (p##10##2##(1994-1#1)(1994-12#2)(1995-3#1)(1997-2#1)(2008-1#1)(2013-1#4)
respectively (p&lt##7##2##(2008-1#1)(2008-6#1)(2009-12#4)(2010-3#1)
respectively (p=0##2##2##(2008-1#1)(2008-6#1)
respectively about##2##2##(1991-5#1)(2008-10#1)
respectively after##3##2##(1994-2#1)(1994-6#1)(2008-12#1)
respectively and for##2##3##(2010-3#1)(2012-2#1)
respectively and the##2##3##(2008-12#1)(2013-1#1)
respectively and##21##2##(1991-6#1)(1993-12#1)(1995-11#1)(1996-2#1)(2007-10#1)(2008-10#3)(2008-12#3)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)
respectively as##5##2##(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#1)
respectively at the##3##3##(1996-6#1)(2008-10#1)(2011-1#1)
respectively at##8##2##(1990-12#1)(1996-6#1)(2008-10#4)(2008-12#1)(2011-1#1)
respectively by the##2##3##(2008-8#1)(2011-2#1)
respectively by##6##2##(1990-7#1)(1991-5#1)(2008-8#3)(2011-2#1)
respectively during##4##2##(1990-3#1)(2008-12#1)(2011-1#1)(2012-2#1)
respectively for the two##2##4##(1993-8#1)(1996-11#1)
respectively for the##5##3##(1993-8#1)(1996-11#1)(2008-6#1)(2011-1#1)(2012-12#1)
respectively for women##2##3##(1992-9#2)
respectively for##18##2##(1992-9#2)(1993-8#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-11#1)(2007-10#2)(2008-10#4)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
respectively from##2##2##(2012-3#1)(2013-1#1)
respectively in the##12##3##(1991-3#1)(1993-8#1)(1994-6#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-3#1)
respectively in##27##2##(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-6#1)(1997-4#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#2)
respectively of##4##2##(1991-2#1)(2008-1#1)(2008-10#2)
respectively on the##2##3##(1993-12#1)(2008-10#1)
respectively the##2##2##(1990-2#1)(2008-10#1)
respectively to##3##2##(1990-3#1)(2008-10#1)(2008-7#1)
respectively were studied##3##3##(2008-5#1)(2013-8#2)
respectively were##11##2##(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#3)
respectively when the##2##3##(1994-12#1)(2008-3#1)
respectively when##5##2##(1994-12#1)(1996-12#1)(1997-3#1)(2008-3#1)(2011-3#1)
respectively while the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
respectively with##9##2##(1992-3#1)(1995-12#1)(1996-2#1)(2008-10#5)(2013-1#1)
respectively##3578##1##(1990-10#4)(1990-11#13)(1990-12#16)(1990-2#16)(1990-3#9)(1990-5#9)(1990-6#9)(1990-7#10)(1990-8#12)(1990-9#5)(1991-10#1)(1991-11#3)(1991-12#17)(1991-2#10)(1991-3#2)(1991-4#5)(1991-5#15)(1991-6#11)(1991-7#1)(1991-8#14)(1991-9#9)(1992-10#4)(1992-11#6)(1992-12#7)(1992-2#4)(1992-3#20)(1992-4#5)(1992-5#5)(1992-6#18)(1992-7#1)(1992-8#9)(1992-9#8)(1993-1#3)(1993-11#21)(1993-12#16)(1993-2#7)(1993-3#8)(1993-5#1)(1993-6#7)(1993-8#22)(1993-9#8)(1994-1#2)(1994-11#15)(1994-12#20)(1994-2#11)(1994-3#5)(1994-5#8)(1994-6#15)(1994-7#4)(1994-8#19)(1994-9#6)(1995-11#19)(1995-12#23)(1995-2#22)(1995-3#15)(1995-5#12)(1995-6#10)(1995-8#6)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#27)(1996-2#22)(1996-3#2)(1996-5#24)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#29)(1997-3#15)(1997-4#17)(1997-5#2)(1997-6#13)(1997-7#22)(1997-8#12)(2006-10#3)(2006-6#3)(2007-10#11)(2007-11#38)(2007-12#39)(2007-2#3)(2007-3#2)(2007-7#19)(2007-8#19)(2007-9#1)(2008-1#15)(2008-10#1394)(2008-11#98)(2008-12#85)(2008-2#39)(2008-3#121)(2008-4#30)(2008-5#51)(2008-6#31)(2008-7#52)(2008-8#67)(2008-9#57)(2009-10#6)(2009-11#8)(2009-12#9)(2009-2#6)(2009-3#6)(2009-4#7)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#9)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#5)(2010-3#19)(2010-4#19)(2010-5#13)(2010-6#6)(2010-7#5)(2010-8#13)(2010-9#1)(2011-1#65)(2011-10#1)(2011-2#96)(2011-3#9)(2012-1#17)(2012-12#16)(2012-2#41)(2012-3#35)(2012-7#2)(2012-8#1)(2013-1#101)(2013-7#9)(2013-8#52)
respectively) after##2##2##(2008-10#1)(2008-12#1)
respectively) and by##2##3##(1991-2#1)(2008-10#1)
respectively) and is##2##3##(2008-10#1)(2008-4#1)
respectively) and relative standard deviation of 1##2##7##(2008-10#2)
respectively) and the##2##3##(2008-10#1)(2012-1#1)
respectively) and##28##2##(1991-2#2)(1995-11#2)(1995-2#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
respectively) are##2##2##(1990-7#1)(2013-1#1)
respectively) as##2##2##(1990-7#1)(2008-10#1)
respectively) but##2##2##(1995-2#1)(2008-5#1)
respectively) for the##2##3##(2008-10#2)
respectively) for##5##2##(1995-3#1)(2008-10#3)(2013-8#1)
respectively) from##2##2##(2008-11#1)(2008-6#1)
respectively) have##2##2##(2008-8#1)(2010-5#1)
respectively) in##6##2##(1990-12#1)(1992-12#1)(1992-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
respectively) of##2##2##(2008-11#1)(2008-2#1)
respectively) on##3##2##(1996-5#1)(2008-12#1)(2011-10#1)
respectively) or##2##2##(1991-12#1)(1994-8#1)
respectively) than##3##2##(1994-9#1)(2008-10#1)(2013-8#1)
respectively) the##2##2##(2007-12#1)(2008-6#1)
respectively) was##7##2##(1995-8#2)(2008-10#3)(2008-3#1)(2013-3#1)
respectively) were obtained##2##3##(2008-10#1)(2008-9#1)
respectively) were##18##2##(1992-11#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)
respectively) which##2##2##(2011-2#1)(2013-8#1)
respectively) with##2##2##(1997-4#1)(2008-10#1)
respectively)##356##1##(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-12#5)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#2)(1992-3#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#4)(1994-9#3)(1995-11#4)(1995-12#7)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#5)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#77)(2008-11#10)(2008-12#14)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#6)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-10#2)(2011-2#27)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2012-5#2)(2013-1#14)(2013-3#1)(2013-7#1)(2013-8#11)
respectively]##7##1##(1996-6#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)
respects and##2##2##(2009-8#1)(2010-8#1)
respects the##2##2##(1997-5#1)(2007-8#1)
respects to##3##2##(1991-5#1)(1995-2#1)(2009-9#1)
respects##20##1##(1990-11#1)(1991-5#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
respirable dust##2##2##(1991-12#2)
respirable##9##1##(1991-12#5)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)
respirable-sized protein##2##2##(1996-1#2)
respirable-sized##3##1##(1996-1#3)
respiration and##7##2##(1994-8#2)(2007-8#1)(2008-1#1)(2008-9#1)(2012-2#1)(2012-5#1)
respiration by##4##2##(1990-5#2)(2008-12#1)(2008-7#1)
respiration in##2##2##(1993-12#1)(2012-2#1)
respiration of##6##2##(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)
respiration rate##10##2##(1994-11#1)(2008-10#2)(2008-6#1)(2008-7#2)(2011-2#4)
respiration rates##3##2##(1994-8#2)(2008-10#1)
respiration was##3##2##(2008-7#2)(2011-2#1)
respiration were##4##2##(1990-2#1)(1991-10#2)(2008-5#1)
respiration##78##1##(1990-2#2)(1990-5#3)(1990-8#1)(1991-10#3)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#7)(1995-2#2)(1997-1#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#11)(2008-9#4)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#9)(2012-2#3)(2012-5#1)(2013-1#2)
respiration)##2##1##(2008-10#1)(2009-8#1)
respirator training##2##2##(2008-12#2)
respirator use##4##2##(2008-12#4)
respirator##15##1##(1991-6#1)(1994-6#1)(1996-2#1)(2008-12#9)(2008-4#1)(2008-5#1)(2010-8#1)
respirators##3##1##(2008-12#3)
respiratory activity##6##2##(1992-8#1)(1997-2#1)(2008-10#1)(2008-5#2)(2008-9#1)
respiratory afferents##2##2##(1996-5#2)
respiratory allergies##3##2##(2012-3#1)(2013-1#2)
respiratory and cardiac##2##3##(1997-2#1)(2007-11#1)
respiratory and cardiovascular##2##3##(2010-6#1)(2013-8#1)
respiratory and contact##2##3##(2008-10#2)
respiratory and##20##2##(1994-3#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
respiratory burst##11##2##(1990-2#2)(1991-2#1)(1992-9#1)(1993-6#2)(1994-6#4)(2009-7#1)
respiratory care##2##2##(2011-1#1)(2013-8#1)
respiratory chain enzyme activities##3##4##(1994-11#3)
respiratory chain##17##2##(1990-11#1)(1994-11#5)(1995-11#2)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#2)
respiratory complex##2##2##(1993-12#1)(2008-10#1)
respiratory complications##4##2##(2007-8#1)(2008-12#1)(2009-5#1)(2011-2#1)
respiratory conditions among##2##3##(2008-12#2)
respiratory conditions##4##2##(2008-12#3)(2012-12#1)
respiratory control ratio##3##3##(1994-11#1)(1994-12#1)(2008-10#1)
respiratory control##4##2##(1992-4#1)(1994-11#1)(1994-12#1)(2008-10#1)
respiratory depression were##2##3##(1993-12#1)(1996-2#1)
respiratory depression##6##2##(1992-5#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-2#2)
respiratory difficulty with wheeze##2##4##(2012-3#2)
respiratory disease and associated##2##4##(2009-10#1)(2013-8#1)
respiratory disease and##3##3##(2009-10#1)(2012-12#1)(2013-8#1)
respiratory disease in##3##3##(1991-8#1)(1997-1#1)(1997-6#1)
respiratory disease##16##2##(1991-11#1)(1991-8#1)(1997-1#2)(1997-6#1)(2008-12#3)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
respiratory diseases in##3##3##(1997-2#1)(2008-11#1)(2008-12#1)
respiratory diseases##18##2##(1996-3#4)(1997-2#1)(2007-11#1)(2008-11#1)(2008-12#2)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
respiratory disorders and##2##3##(1990-3#1)(2008-7#1)
respiratory disorders##6##2##(1990-3#1)(1990-9#1)(1995-8#1)(2008-7#3)
respiratory distress and##2##3##(1990-3#1)(2010-1#1)
respiratory distress in##2##3##(2008-7#1)(2013-1#1)
respiratory distress syndrome (ARDS)##6##4##(1991-9#1)(1993-2#1)(1997-1#1)(2011-2#2)(2012-3#1)
respiratory distress syndrome (RDS)##2##4##(1995-5#1)(2007-11#1)
respiratory distress syndrome and##2##4##(1992-2#1)(2008-12#1)
respiratory distress syndrome##27##3##(1990-11#1)(1990-12#2)(1991-9#3)(1992-2#3)(1993-2#1)(1994-11#1)(1994-6#1)(1995-5#1)(1997-1#2)(2006-10#1)(2007-11#1)(2008-12#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)
respiratory distress syndrome' (ARDS)##2##4##(2010-5#2)
respiratory distress syndrome]##3##3##(1990-11#1)(1996-6#1)(2012-3#1)
respiratory distress##54##2##(1990-11#2)(1990-12#2)(1990-3#1)(1991-3#1)(1991-9#4)(1992-2#4)(1993-2#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-6#1)(1997-1#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#6)(2013-1#6)
respiratory electron##2##2##(1990-11#1)(1994-5#1)
respiratory enzymes##3##2##(2008-10#2)(2012-2#1)
respiratory epithelial adenomatoid hamartoma##2##4##(2008-2#2)
respiratory epithelial cells##3##3##(2008-10#3)
respiratory epithelial##5##2##(2008-10#3)(2008-2#2)
respiratory epithelium and##3##3##(2008-4#1)(2012-3#2)
respiratory epithelium##5##2##(1992-3#1)(2008-2#1)(2008-4#1)(2012-3#2)
respiratory exchange ratio (RER)##4##4##(1992-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
respiratory failure and##7##3##(1993-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-8#1)(2013-1#2)
respiratory failure is##2##3##(1992-2#1)(2008-1#1)
respiratory failure with##3##3##(2006-10#1)(2013-1#2)
respiratory failure##36##2##(1991-6#1)(1992-2#1)(1992-3#1)(1993-10#1)(1995-3#2)(2006-10#3)(2007-8#3)(2008-1#5)(2008-7#1)(2009-5#2)(2009-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#10)
respiratory frequency##4##2##(1992-8#2)(1996-2#1)(1996-5#1)
respiratory function and##4##3##(1991-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
respiratory function##8##2##(1991-12#2)(2008-10#2)(2011-2#1)(2012-2#2)(2013-1#1)
respiratory functions##2##2##(1994-11#1)(2007-10#1)
respiratory health##2##2##(2008-11#1)(2008-12#1)
respiratory horns##2##2##(2007-12#2)
respiratory illness##7##2##(1994-2#1)(2008-10#2)(2008-8#1)(2012-12#2)(2013-8#1)
respiratory illnesses##3##2##(2008-11#1)(2009-5#1)(2012-12#1)
respiratory infection##4##2##(1991-9#1)(1993-5#1)(2008-1#1)(2012-2#1)
respiratory infections in##5##3##(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#2)
respiratory infections##17##2##(1990-12#1)(1990-5#1)(1991-12#1)(1994-9#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-8#3)
respiratory insufficiency and##2##3##(2008-4#1)(2010-12#1)
respiratory insufficiency##4##2##(2008-4#1)(2010-12#1)(2010-7#2)
respiratory lesions##3##2##(1991-8#1)(1997-3#2)
respiratory manifestations of##2##3##(1994-5#1)(2008-5#1)
respiratory manifestations##4##2##(1994-5#1)(2007-8#1)(2008-5#2)
respiratory mechanics##4##2##(2012-2#3)(2013-7#1)
respiratory motion##3##2##(1997-8#1)(2011-1#1)(2012-12#1)
respiratory movements##2##2##(1991-10#1)(1995-12#1)
respiratory muscle fatigue##2##3##(1992-2#1)(2013-7#1)
respiratory muscle##7##2##(1991-6#2)(1992-2#3)(2012-2#1)(2013-7#1)
respiratory muscles##4##2##(1991-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
respiratory outcomes##7##2##(2010-6#7)
respiratory parameters##4##2##(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#1)
respiratory pathogens##4##2##(2007-11#1)(2011-2#2)(2013-8#1)
respiratory pathology##2##2##(1990-9#1)(2007-6#1)
respiratory patterning in##2##3##(1990-7#2)
respiratory patterning##3##2##(1990-7#3)
respiratory protection program##2##3##(2008-12#2)
respiratory protection programs in the##2##5##(2008-12#2)
respiratory protection##7##2##(1996-12#1)(2008-12#5)(2010-5#1)
respiratory rate (RR)##2##3##(1992-12#1)(2012-2#1)
respiratory rate and##3##3##(1991-10#1)(2007-8#1)(2013-1#1)
respiratory rate##13##2##(1990-2#1)(1991-10#1)(1992-12#1)(1994-11#1)(1995-11#1)(1996-3#1)(2007-11#1)(2007-8#2)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
respiratory rehabilitation##3##2##(1990-6#1)(2007-6#1)(2007-8#1)
respiratory responses##2##2##(1996-5#2)
respiratory rhythm##4##2##(1992-8#2)(1995-12#2)
respiratory symptoms and##4##3##(2007-2#1)(2009-9#1)(2010-12#1)(2012-12#1)
respiratory symptoms in##2##3##(1995-8#1)(1997-1#1)
respiratory symptoms##18##2##(1995-6#1)(1995-8#2)(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#3)
respiratory syncytial virus (RSV)##5##4##(1996-3#1)(2008-11#1)(2010-5#1)(2011-2#2)
respiratory syncytial virus##11##3##(1994-6#3)(1995-5#1)(1996-3#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#3)
respiratory syndrome##9##2##(1992-2#1)(2007-12#2)(2007-7#3)(2008-10#1)(2009-5#1)(2010-2#1)
respiratory system of the##2##4##(2007-12#2)
respiratory system##16##2##(1992-2#1)(1995-6#1)(1996-3#2)(1996-8#1)(2007-12#2)(2008-5#2)(2009-12#1)(2010-7#1)(2011-2#2)(2013-7#3)
respiratory tract and the##2##4##(2008-11#1)(2011-1#1)
respiratory tract and##5##3##(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
respiratory tract disease##2##3##(2009-3#1)(2011-2#1)
respiratory tract diseases##2##3##(1992-6#1)(2012-12#1)
respiratory tract infection##6##3##(1991-4#1)(1996-3#1)(2006-10#1)(2008-7#1)(2010-10#1)(2011-1#1)
respiratory tract infections in children##2##5##(2009-5#1)(2012-12#1)
respiratory tract infections in##6##4##(1997-2#2)(2008-11#1)(2009-2#1)(2009-5#1)(2012-12#1)
respiratory tract infections##14##3##(1997-2#2)(2007-12#1)(2008-11#1)(2008-7#1)(2009-2#2)(2009-3#2)(2009-5#1)(2010-5#2)(2011-2#1)(2012-12#1)
respiratory tract is##2##3##(1990-8#1)(1996-1#1)
respiratory tract##74##2##(1990-8#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-9#1)(1994-12#3)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#3)(1996-12#1)(1996-3#3)(1996-7#1)(1997-1#2)(1997-2#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-5#2)(2008-7#2)(2009-2#2)(2009-3#4)(2009-5#2)(2010-10#1)(2010-5#2)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#3)
respiratory virus##4##2##(1995-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
respiratory viruses in##3##3##(2010-5#1)(2011-2#2)
respiratory viruses##5##2##(2010-5#1)(2011-2#2)(2013-8#2)
respiratory##619##1##(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#6)(1991-8#2)(1991-9#6)(1992-11#2)(1992-12#2)(1992-2#12)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#6)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#10)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#8)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#5)(1995-8#6)(1996-1#4)(1996-12#4)(1996-2#3)(1996-3#13)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#9)(1997-2#5)(1997-3#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#5)(2007-10#1)(2007-11#8)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#14)(2008-1#8)(2008-10#27)(2008-11#13)(2008-12#18)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#19)(2008-7#14)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#8)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#16)(2010-6#11)(2010-7#7)(2010-8#6)(2011-1#11)(2011-2#34)(2011-3#1)(2012-1#2)(2012-12#15)(2012-2#19)(2012-3#19)(2013-1#38)(2013-7#5)(2013-8#24)
respiratory-deficient##2##1##(2008-6#2)
respiratory-related facial nerve activity##2##4##(1997-6#2)
respiring cells##2##2##(2008-7#2)
respiring##4##1##(2008-7#3)(2011-2#1)
respite care##4##2##(1990-3#1)(1992-3#1)(1995-12#2)
respite services##2##2##(1995-12#1)(2009-6#1)
respite##11##1##(1990-3#1)(1992-3#4)(1995-12#4)(2009-6#1)(2010-3#1)
respond adequately##2##2##(1990-12#1)(1993-11#1)
respond and##2##2##(1997-5#1)(2011-2#1)
respond appropriately##3##2##(2008-12#1)(2008-6#1)(2009-9#1)
respond better to##2##3##(2008-7#1)(2013-1#1)
respond by##2##2##(1990-11#1)(2009-9#1)
respond differently to##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
respond differently##4##2##(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
respond in##3##2##(1995-11#1)(2008-10#1)(2013-8#1)
respond poorly to##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
respond selectively to##2##3##(2008-10#1)(2009-3#1)
respond similarly to##2##3##(1994-5#1)(2008-10#1)
respond similarly##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
respond to ATP##2##3##(1990-5#1)(2008-4#1)
respond to a##9##3##(1992-8#1)(1993-3#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)
respond to both##2##3##(1992-9#1)(2008-2#1)
respond to certain##2##3##(1992-2#1)(2008-4#1)
respond to environmental##5##3##(1992-6#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
respond to extracellular ATP##2##4##(2008-4#2)
respond to extracellular##3##3##(2008-4#3)
respond to medical##3##3##(1991-11#1)(1996-11#1)(1997-8#1)
respond to new therapies##2##4##(2008-6#2)
respond to new##4##3##(2008-6#2)(2011-2#1)(2012-12#1)
respond to other##2##3##(2007-12#1)(2010-12#1)
respond to previous##2##3##(2012-12#2)
respond to the##29##3##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#3)
respond to them##3##3##(1990-12#1)(1992-12#1)(1994-12#1)
respond to these challenges##2##4##(1994-12#1)(1995-1#1)
respond to these needs##2##4##(1991-12#1)(1992-3#1)
respond to these##11##3##(1991-12#1)(1992-3#1)(1994-12#3)(1995-1#1)(2008-10#4)(2008-4#1)
respond to this##2##3##(1994-6#1)(2008-10#1)
respond to treatment##4##3##(1990-12#1)(1990-2#1)(2007-2#1)(2008-11#1)
respond to various##2##3##(1991-2#1)(2013-1#1)
respond to##213##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#11)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#12)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#3)
respond well to##4##3##(1997-6#1)(2009-4#1)(2010-5#1)(2012-3#1)
respond with##3##2##(2008-9#1)(2009-8#1)(2012-2#1)
respond##282##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#17)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#3)(2008-6#4)(2008-7#9)(2008-8#13)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#12)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#4)
respondants' answers##2##2##(2012-2#2)
responded and##2##2##(2009-9#1)(2012-3#1)
responded by##2##2##(2008-10#1)(2010-8#1)
responded favourably to##3##3##(1992-5#1)(2007-12#1)(2007-7#1)
responded favourably##4##2##(1992-5#1)(2007-12#1)(2007-7#2)
responded linearly to##2##3##(2008-10#2)
responded more##2##2##(2008-5#1)(2008-8#1)
responded positively to##2##3##(1994-12#1)(2008-11#1)
responded positively##4##2##(1990-2#1)(1994-12#1)(2008-11#1)(2013-1#1)
responded promptly to##2##3##(2007-7#1)(2008-11#1)
responded similarly to##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
responded that it was &quot##2##5##(1990-2#2)
responded that they##2##3##(1992-2#1)(2012-12#1)
responded that##4##2##(1990-2#2)(1992-2#1)(2012-12#1)
responded to Ki##2##3##(2008-10#2)
responded to a questionnaire##2##4##(2008-9#1)(2011-1#1)
responded to a##5##3##(1990-2#1)(1993-1#1)(1993-2#1)(2008-9#1)(2011-1#1)
responded to activin A##2##4##(1992-6#2)
responded to both##2##3##(1992-6#1)(2008-4#1)
responded to combination##2##3##(1994-3#1)(2010-11#1)
responded to conventional##3##3##(2008-12#1)(2010-3#1)(2013-7#1)
responded to predation##2##3##(2010-8#2)
responded to the survey##6##4##(1995-1#1)(1995-12#1)(1995-3#1)(2008-12#1)(2012-2#1)(2013-1#1)
responded to the treatment##2##4##(1991-2#1)(2011-2#1)
responded to the##25##3##(1990-2#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-9#1)(2013-1#2)
responded to treatment with##2##4##(2007-7#1)(2008-7#1)
responded to treatment##4##3##(1990-2#1)(2007-7#1)(2008-7#1)(2010-11#1)
responded to##109##2##(1990-12#1)(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#2)(1992-2#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-2#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-7#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#6)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#3)(2013-7#2)
responded well to##6##3##(1995-10#1)(2007-7#3)(2008-10#1)(2011-1#1)
responded well##8##2##(1995-10#1)(1995-11#1)(2007-7#4)(2008-10#1)(2011-1#1)
responded with a##3##3##(1994-3#1)(1996-5#1)(2008-10#1)
responded with##8##2##(1994-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2012-3#1)
responded##190##1##(1990-12#1)(1990-2#6)(1990-5#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-12#2)(2007-7#10)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#9)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#7)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#1)
respondent##6##1##(1993-2#1)(2012-2#1)(2013-1#4)
respondents agreed that##2##3##(2008-8#1)(2010-5#1)
respondents and##4##2##(1990-9#1)(1996-2#1)(2008-12#1)(2009-5#1)
respondents answered##2##2##(1992-5#1)(2008-12#1)
respondents are##3##2##(1991-6#1)(2009-12#1)(2012-2#1)
respondents believed that the##2##4##(2008-4#1)(2012-12#1)
respondents believed that##4##3##(2007-7#1)(2008-4#1)(2012-12#2)
respondents did not##2##3##(1991-6#1)(2007-12#1)
respondents expressed##2##2##(1993-12#1)(1996-1#1)
respondents felt##3##2##(1995-12#1)(1997-3#1)(2007-12#1)
respondents for##2##2##(2008-1#1)(2012-2#1)
respondents found the##2##3##(2010-5#1)(2012-12#1)
respondents from##4##2##(1993-1#1)(1995-3#1)(1995-6#1)(2008-4#1)
respondents had##9##2##(1993-1#1)(1996-9#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
respondents have##2##2##(1996-1#2)
respondents in the##3##3##(1990-6#1)(1991-12#1)(2008-4#1)
respondents in##6##2##(1990-6#1)(1991-12#1)(1997-2#1)(1997-3#1)(2008-4#1)(2013-8#1)
respondents indicating##2##2##(2007-7#1)(2008-12#1)
respondents of the##2##3##(2007-12#1)(2013-1#1)
respondents on##2##2##(2010-8#1)(2011-1#1)
respondents reported##5##2##(1990-6#1)(2008-1#1)(2008-12#1)(2010-8#2)
respondents showed##4##2##(1996-2#1)(2008-11#1)(2011-2#2)
respondents stated that##2##3##(1996-1#1)(2008-11#1)
respondents used##4##2##(1991-6#1)(1993-2#1)(2012-2#1)(2012-3#1)
respondents were asked to##3##4##(1995-11#1)(2010-8#1)(2011-2#1)
respondents were aware of##3##4##(1996-1#1)(2009-10#1)(2010-8#1)
respondents were more likely to be##2##6##(2013-1#2)
respondents were most##2##3##(1993-3#1)(1995-3#1)
respondents were##21##2##(1993-1#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-9#3)(2009-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#4)
respondents when##3##2##(1993-12#1)(1995-3#1)(2011-2#1)
respondents who would##2##3##(2008-1#2)
respondents who##7##2##(1993-6#1)(1995-1#1)(1997-3#1)(2008-1#2)(2009-5#1)(2011-1#1)
respondents with##2##2##(2012-12#1)(2013-1#1)
respondents would##2##2##(2007-7#1)(2011-1#1)
respondents##194##1##(1990-6#2)(1990-9#1)(1991-12#3)(1991-3#1)(1991-6#3)(1992-1#1)(1992-12#1)(1992-5#6)(1992-6#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#6)(1996-2#4)(1996-3#4)(1996-9#3)(1997-2#3)(1997-3#4)(2007-10#3)(2007-12#4)(2007-7#8)(2008-1#6)(2008-10#1)(2008-11#6)(2008-12#8)(2008-4#4)(2008-8#3)(2008-9#5)(2009-10#4)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#4)(2010-8#7)(2011-1#7)(2011-2#9)(2012-1#4)(2012-12#10)(2012-2#7)(2012-3#2)(2013-1#12)(2013-8#3)
respondents' knowledge##2##2##(2009-10#1)(2013-1#1)
respondents'##8##1##(1991-2#1)(1997-1#1)(2007-12#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
responder analysis of##2##3##(2011-2#2)
responder##10##1##(1990-2#1)(2007-8#1)(2008-2#1)(2008-9#2)(2011-2#3)(2012-2#2)
responders and non-responders##3##3##(2007-10#1)(2010-12#1)(2012-12#1)
responders and##7##2##(1994-2#1)(1994-8#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
responders in the##2##3##(2007-12#1)(2008-3#1)
responders in##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
responders stated that the##2##4##(1996-9#1)(1997-8#1)
responders to##4##2##(2008-5#1)(2009-6#1)(2010-3#1)(2012-2#1)
responders undergoing##2##2##(2011-1#1)(2012-3#1)
responders was##2##2##(1990-2#2)
responders were##2##2##(1991-2#1)(2008-12#1)
responders##43##1##(1990-12#1)(1990-2#2)(1990-6#1)(1991-2#1)(1992-10#1)(1992-8#1)(1994-2#1)(1994-8#2)(1996-9#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-6#1)(2010-12#2)(2010-3#3)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
responders&quot##2##1##(2010-3#2)
responders)##3##1##(1990-6#1)(1991-8#2)
responding and##6##2##(1992-11#1)(1992-12#1)(1992-8#1)(2007-11#1)(2008-10#2)
responding for##4##2##(1993-6#2)(2009-8#2)
responding in##3##2##(1992-10#1)(2008-4#1)(2011-1#1)
responding on##2##2##(1993-6#2)
responding to a##3##3##(1996-3#1)(2008-10#1)(2008-2#1)
responding to the##14##3##(1990-11#1)(1994-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-12#1)
responding to##48##2##(1990-11#1)(1991-1#1)(1992-3#1)(1992-6#2)(1993-1#2)(1994-2#3)(1994-9#3)(1996-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
responding with##5##2##(1991-1#1)(1993-6#2)(2012-2#2)
responding##113##1##(1990-11#3)(1991-1#3)(1991-12#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-5#1)(1993-6#13)(1993-8#1)(1994-2#3)(1994-3#1)(1994-9#4)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#6)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-7#1)
responds linearly##3##2##(2008-10#3)
responds preferentially to##2##3##(1990-12#1)(2009-8#1)
responds to the##10##3##(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)
responds to##41##2##(1990-5#1)(1990-8#1)(1994-11#1)(1996-12#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#3)
responds well to##2##3##(2008-4#1)(2010-12#1)
responds##58##1##(1990-12#1)(1990-5#1)(1990-8#1)(1992-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#3)
response (&lt##3##2##(2008-10#2)(2010-3#1)
response (30##2##2##(2008-10#2)
response (CAR)##3##2##(2008-6#2)(2013-1#1)
response (CR)##4##2##(1997-7#1)(2007-10#1)(2008-10#1)(2008-5#1)
response (P =##2##3##(2011-2#1)(2012-3#1)
response (SVR) was achieved in##2##5##(2012-12#1)(2013-1#1)
response (SVR)##4##2##(2012-1#1)(2012-12#1)(2013-1#2)
response (TDAR)##6##2##(2008-10#6)
response (i##3##2##(2008-10#3)
response above##2##2##(2008-10#1)(2008-8#1)
response accuracy and##2##3##(2008-4#1)(2009-2#1)
response accuracy##3##2##(2008-4#1)(2008-8#1)(2009-2#1)
response after##7##2##(1993-2#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
response against the##3##3##(1994-3#1)(2008-11#1)(2012-2#1)
response against##12##2##(1994-3#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-9#3)(2012-2#1)(2013-1#2)
response among##2##2##(1994-9#1)(2012-2#1)
response and a##5##3##(1992-9#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
response and also##2##3##(1992-12#1)(2013-1#1)
response and improved##2##3##(1996-5#1)(2013-1#1)
response and in##2##3##(2007-11#1)(2008-6#1)
response and its##2##3##(2007-10#1)(2008-4#1)
response and recovery times##2##4##(2008-10#2)
response and recovery##5##3##(2008-10#4)(2013-1#1)
response and that##2##3##(2008-10#1)(2009-8#1)
response and the##13##3##(1997-7#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-4#1)
response and toxicity##2##3##(2008-7#1)(2010-8#1)
response and##116##2##(1990-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#3)(2009-8#2)(2010-12#2)(2010-2#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#6)(2012-4#1)(2013-1#10)(2013-7#1)
response appears to be##3##4##(1992-1#1)(1992-2#1)(1995-5#1)
response appears to##4##3##(1992-1#1)(1992-2#1)(1995-5#1)(2008-7#1)
response are discussed##2##3##(1997-7#1)(2008-10#1)
response are##14##2##(1991-2#1)(1992-2#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
response as a function of##3##5##(2008-10#1)(2008-2#1)(2010-3#1)
response as a##5##3##(1991-12#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-3#1)
response as compared to##2##4##(2008-10#1)(2009-10#1)
response as##10##2##(1991-12#1)(1994-8#1)(1995-3#1)(2008-10#3)(2008-2#1)(2009-10#1)(2009-8#1)(2010-3#1)
response assessment##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
response associated with the##2##4##(2008-11#1)(2011-2#1)
response at different##2##3##(1992-12#1)(1992-3#1)
response at pH 5##3##4##(2008-10#2)(2009-10#1)
response at pH##4##3##(2008-10#3)(2009-10#1)
response at the end of##2##5##(1991-8#1)(2013-1#1)
response at the##6##3##(1991-8#1)(2007-12#1)(2008-10#3)(2013-1#1)
response at##25##2##(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-1#1)(1994-9#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-10#12)(2008-2#1)(2009-10#1)(2013-1#2)
response based on the##2##4##(2008-10#2)
response based on##3##3##(2007-12#1)(2008-10#2)
response became##2##2##(1991-9#1)(1996-12#1)
response because##2##2##(2008-10#2)
response behavior of the##2##4##(2008-10#2)
response behavior of##3##3##(2008-10#3)
response behavior##4##2##(2007-11#1)(2008-10#3)
response being##3##2##(2008-10#2)(2008-4#1)
response between the##3##3##(1990-6#1)(2008-5#1)(2009-10#1)
response between##7##2##(1990-6#1)(1992-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-10#1)
response bias##6##2##(2008-11#2)(2011-2#4)
response both##2##2##(1990-8#1)(2008-10#1)
response but##4##2##(1995-6#1)(1997-4#1)(2008-12#1)(2008-6#1)
response by changing the##2##4##(2008-3#1)(2010-4#1)
response by the##2##3##(2007-10#1)(2008-7#1)
response by##31##2##(1991-3#1)(1993-3#1)(1993-6#1)(1995-12#1)(1997-3#2)(1997-8#3)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#2)(2010-4#2)(2012-12#1)(2013-1#1)
response can be##5##3##(1994-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)
response can##10##2##(1994-5#1)(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
response capability##2##2##(2007-12#1)(2011-1#1)
response categories##5##2##(2010-1#2)(2012-2#3)
response caused by##2##3##(1990-5#1)(1996-2#1)
response characteristics and##2##3##(2008-10#2)
response characteristics of the electrode##2##5##(2008-10#2)
response characteristics of the##5##4##(2008-10#4)(2008-3#1)
response characteristics of##14##3##(2008-10#12)(2008-3#2)
response characteristics##27##2##(2008-10#23)(2008-3#4)
response compared to the##3##4##(2008-10#2)(2011-1#1)
response compared to##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
response components##2##2##(2008-11#1)(2009-5#1)
response correctness##5##2##(2008-11#5)
response correlated##2##2##(2008-10#2)
response correlates with##2##3##(2008-10#1)(2012-3#1)
response could be evoked##2##4##(1990-7#2)
response could be##4##3##(1990-7#2)(2008-10#2)
response could##5##2##(1990-7#2)(2008-10#2)(2008-9#1)
response current##3##2##(2008-10#3)
response curve is##2##3##(1995-9#1)(2008-10#1)
response curve of the##2##4##(2007-12#1)(2010-2#1)
response curve of##3##3##(1994-11#1)(2007-12#1)(2010-2#1)
response curve to##2##3##(1990-12#1)(1997-2#1)
response curve##15##2##(1990-12#1)(1994-11#2)(1995-9#2)(1997-2#1)(2007-12#1)(2008-10#5)(2010-2#1)(2010-5#1)(2013-8#1)
response curves for##2##3##(2008-7#1)(2012-2#1)
response curves were##2##3##(2008-11#1)(2013-1#1)
response curves##9##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
response data were obtained##2##4##(1990-8#1)(1997-2#1)
response data##9##2##(1990-8#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-5#1)
response depended on##2##3##(1995-12#1)(2008-7#1)
response depends linearly on##5##4##(2008-10#5)
response depends##7##2##(1997-2#1)(2008-10#6)
response differed##3##2##(1990-12#1)(1992-12#1)(2008-8#1)
response duration##2##2##(1994-8#1)(2010-9#1)
response during the##3##3##(2008-12#1)(2012-2#1)(2012-3#1)
response during##14##2##(1990-5#4)(1994-3#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
response element in##2##3##(1990-8#1)(2012-3#1)
response element##27##2##(1990-8#1)(1991-2#4)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1997-2#2)(2008-7#2)(2008-9#1)(2011-3#1)(2012-12#2)(2012-3#1)
response element-binding protein (CREB)##2##4##(2008-7#1)(2009-3#1)
response element-binding protein##3##3##(2008-7#1)(2009-3#1)(2013-1#1)
response element-binding##4##2##(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#1)
response elements in##2##3##(1994-11#1)(2008-1#1)
response elements of##2##3##(1991-2#1)(1995-12#1)
response elements##11##2##(1991-2#1)(1994-11#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-9#1)(2010-2#1)(2012-3#1)
response elicited by##2##3##(2009-2#1)(2009-8#1)
response evaluation and prediction in##2##5##(2010-12#2)
response evoked by##4##3##(1992-3#2)(2008-4#2)
response factor##2##2##(1994-6#1)(2008-10#1)
response failure##2##2##(2008-7#1)(2011-2#1)
response following##7##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-6#1)(2012-2#1)
response for Cu(2+)##2##3##(2008-10#2)
response for H(2)O(2) in the##2##5##(2008-10#2)
response for Pb(2+) over a wide##2##6##(2008-10#2)
response for UO(2)(2+)##2##3##(2008-10#2)
response for a##3##3##(1996-3#1)(2008-2#1)(2009-5#1)
response for both##4##3##(2008-10#4)
response for each##3##3##(2008-10#3)
response for the clinical##2##4##(1990-2#1)(2009-5#1)
response for the##8##3##(1990-2#1)(1990-8#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)
response for##74##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-2#1)(1996-3#2)(2008-10#53)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-8#2)
response from the##5##3##(2008-10#1)(2008-11#1)(2008-3#2)(2012-3#1)
response from##12##2##(2008-10#5)(2008-11#1)(2008-3#3)(2010-5#1)(2012-3#1)(2013-8#1)
response function##12##2##(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#2)
response functions of the##2##4##(2008-3#2)
response functions of##4##3##(2008-2#2)(2008-3#2)
response functions##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
response gain##2##2##(1997-2#1)(2009-9#1)
response gene##4##2##(1992-7#1)(1994-8#1)(1994-9#1)(1997-7#1)
response genes##11##2##(1992-12#1)(1992-7#1)(1994-5#1)(1994-6#1)(1994-8#2)(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
response group##2##2##(2013-1#2)
response had##2##2##(1995-12#1)(2008-12#1)
response has been##6##3##(1994-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-2#1)(2012-2#1)
response has##8##2##(1994-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
response have been##2##3##(2008-10#2)
response in WKY##2##3##(1994-2#1)(2008-2#1)
response in a##8##3##(1992-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)
response in an##3##3##(2007-11#1)(2008-11#1)(2008-8#1)
response in both##2##3##(2008-2#1)(2013-1#1)
response in mice##2##3##(1990-12#1)(2008-5#1)
response in old rats##2##4##(2008-7#2)
response in one##2##3##(2008-10#1)(2008-9#1)
response in patients with##2##4##(2008-10#1)(2010-1#1)
response in patients##3##3##(2008-10#1)(2008-5#1)(2010-1#1)
response in rats##2##3##(1993-12#1)(2008-12#1)
response in terms of##5##4##(2008-10#2)(2008-2#2)(2008-7#1)
response in the bovine adrenal gland##2##6##(1993-3#2)
response in the concentration range of##4##6##(2008-10#4)
response in the concentration range##6##5##(2008-10#6)
response in the range of##2##5##(1996-12#1)(2008-10#1)
response in the range##3##4##(1996-12#1)(2008-10#2)
response in the##48##3##(1990-2#1)(1992-3#1)(1992-6#1)(1993-12#4)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
response in these##2##3##(2007-10#1)(2008-7#1)
response in vitro##3##3##(1991-1#1)(1997-6#1)(2008-11#1)
response in which##2##3##(1992-9#1)(2008-10#1)
response in##175##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#5)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#3)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#2)(2007-7#2)(2008-10#34)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#7)(2009-10#1)(2010-1#1)(2010-12#1)(2010-5#3)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
response increase##2##2##(2008-10#1)(2008-7#1)
response increases##2##2##(2008-3#1)(2012-3#1)
response induced by immunising##2##4##(1995-12#2)
response induced by##9##3##(1992-8#2)(1995-12#2)(1996-2#1)(1997-4#1)(1997-6#1)(2008-2#1)(2012-2#1)
response induced##10##2##(1992-8#2)(1995-12#3)(1996-2#1)(1997-4#1)(1997-6#1)(2008-2#1)(2012-2#1)
response inhibition##3##2##(1992-12#2)(2013-1#1)
response initiated by##2##3##(2008-10#2)
response initiated##3##2##(2008-10#2)(2008-8#1)
response involving##2##2##(2008-7#1)(2012-3#1)
response is a##3##3##(1992-10#1)(1994-11#1)(2008-3#1)
response is an##2##3##(2008-4#1)(2009-12#1)
response is evaluated##2##3##(2008-10#2)
response is explained##2##3##(2008-10#2)
response is independent of pH##2##5##(2008-10#2)
response is independent of##3##4##(2008-10#3)
response is linear up to##2##5##(2008-10#2)
response is linear##8##3##(2007-12#1)(2008-10#6)(2008-3#1)
response is more##2##3##(2007-12#1)(2008-8#1)
response is not sensitive to##2##5##(1992-8#1)(2008-10#1)
response is not sensitive##3##4##(1992-8#1)(2008-10#2)
response is not##8##3##(1991-5#1)(1992-8#1)(2008-10#4)(2008-8#1)(2010-11#1)
response is observed##4##3##(2007-11#1)(2008-10#3)
response is obtained##3##3##(2008-10#2)(2008-3#1)
response is probably##2##3##(1995-2#1)(1997-1#1)
response is stable##2##3##(2008-10#2)
response is the##5##3##(1994-8#1)(1995-2#1)(2008-7#2)(2012-12#1)
response is##107##2##(1990-9#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-8#1)(1994-11#3)(1994-8#2)(1995-2#2)(1995-5#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#42)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#5)(2009-12#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)
response known##2##2##(2013-1#2)
response latencies##4##2##(1992-11#1)(1993-12#1)(2009-9#1)(2012-3#1)
response latency##3##2##(1990-7#1)(2008-11#2)
response linearity##3##2##(2008-10#3)
response matrix##2##2##(2007-12#1)(2012-2#1)
response may be##10##3##(1990-12#1)(1993-12#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
response may##13##2##(1990-12#1)(1993-12#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
response mechanism of##2##3##(2008-10#2)
response mechanism##6##2##(2008-10#6)
response mechanisms##4##2##(2008-10#1)(2008-7#2)(2011-1#1)
response might##2##2##(2008-7#1)(2008-8#1)
response model for##3##3##(2008-10#3)
response model##10##2##(1997-7#2)(2008-10#7)(2008-7#1)
response modelling##2##2##(2008-10#1)(2008-5#1)
response modifiers##3##2##(2008-5#1)(2010-5#2)
response observed after##2##3##(1994-2#2)
response observed##3##2##(1994-2#2)(2008-10#1)
response obtained##3##2##(1995-12#1)(2008-10#2)
response of 1##2##3##(2007-11#1)(2008-10#1)
response of 30##2##3##(2008-10#1)(2008-3#1)
response of B##2##3##(2011-2#2)
response of M##3##3##(2008-10#2)(2008-7#1)
response of ON##2##3##(2007-12#1)(2008-9#1)
response of VSMC to##2##4##(1994-9#2)
response of Y##2##3##(1997-4#1)(2008-10#1)
response of a##23##3##(1992-3#1)(1996-2#1)(2007-12#5)(2008-10#5)(2008-2#4)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#1)(2010-2#1)
response of aged##2##3##(2008-3#2)
response of all##3##3##(2008-10#2)(2008-9#1)
response of allopurinol was##2##4##(2008-10#2)
response of an##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
response of antenna-coupled##2##3##(2007-12#1)(2008-3#1)
response of ascorbic acid##2##4##(2008-10#2)
response of cells to##3##4##(2007-12#1)(2008-9#2)
response of each##2##3##(2008-10#2)
response of endothelial cells to##3##5##(2008-11#1)(2010-1#1)(2011-2#1)
response of endothelial cells##4##4##(2008-11#2)(2010-1#1)(2011-2#1)
response of extrinsic photoconductors##2##4##(2008-3#2)
response of health##2##3##(1992-12#1)(2007-12#1)
response of human##6##3##(1992-10#1)(1992-2#1)(1994-8#1)(1995-12#2)(2008-7#1)
response of lead(II)##3##3##(2008-10#3)
response of lymphocytes##3##3##(1995-8#1)(2008-10#1)(2008-4#1)
response of metastatic##2##3##(1990-2#1)(1992-10#1)
response of negative##2##3##(2008-4#1)(2008-9#1)
response of norepinephrine##2##3##(2008-10#2)
response of plants to herbivore removal##2##6##(2008-8#2)
response of plants to##4##4##(2008-10#1)(2008-8#2)(2009-8#1)
response of plants##5##3##(1992-8#1)(2008-10#1)(2008-8#2)(2009-8#1)
response of populations##2##3##(2008-9#2)
response of splenic CD4 T cells##2##6##(2008-11#2)
response of such##2##3##(2008-10#1)(2010-2#1)
response of the Fabry-Perot##2##4##(2007-12#1)(2008-3#1)
response of the composite##2##4##(2009-6#1)(2009-7#1)
response of the device##2##4##(2007-12#1)(2008-2#1)
response of the electrode##4##4##(2008-10#4)
response of the film##2##4##(2008-10#2)
response of the laser##3##4##(2008-3#3)
response of the method##2##4##(2008-10#2)
response of the sensor is##2##5##(2007-12#1)(2008-10#1)
response of the sensor to##4##5##(2008-10#4)
response of the sensor##9##4##(2007-12#1)(2008-10#8)
response of the skin to##3##5##(2008-5#3)
response of the tectorial membrane##2##5##(1995-5#2)
response of the##120##3##(1990-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#6)(2008-10#48)(2008-2#10)(2008-3#12)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-3#2)(2013-1#4)(2013-8#1)
response of these##6##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-7#1)
response of this##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
response of tissue##2##3##(1997-7#1)(2012-2#1)
response of vascular##2##3##(1990-8#1)(1994-8#1)
response of##405##2##(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-3#2)(1991-5#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#4)(1992-8#2)(1992-9#4)(1993-12#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-6#4)(1994-8#4)(1994-9#4)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#9)(2007-12#25)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#132)(2008-11#12)(2008-12#1)(2008-2#20)(2008-3#28)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#15)(2008-8#8)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#6)(2013-7#3)(2013-8#2)
response on a##3##3##(1995-9#1)(2007-11#1)(2008-3#1)
response on the##5##3##(1992-11#1)(1993-12#1)(1993-6#1)(2007-2#1)(2008-6#1)
response on##16##2##(1992-11#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-9#1)(2007-11#3)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
response or##14##2##(1990-8#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-4#1)(1996-6#1)(1996-9#2)(2008-9#1)(2009-4#1)(2010-10#1)(2012-3#2)
response over a wide concentration range##3##6##(2008-10#3)
response over a wide##6##4##(2008-10#5)(2008-3#1)
response over a##10##3##(2008-10#6)(2008-3#3)(2010-3#1)
response over the concentration range##3##5##(2008-10#3)
response over the concentration##4##4##(2008-10#4)
response over the range##2##4##(2008-10#2)
response over the##10##3##(2007-12#1)(2007-9#1)(2008-10#8)
response over##22##2##(2007-12#1)(2007-9#1)(2008-10#16)(2008-3#3)(2010-3#1)
response pathway##5##2##(1996-2#1)(2009-8#2)(2010-2#1)(2012-2#1)
response pathways##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
response pattern##4##2##(1990-10#1)(2008-11#1)(2009-8#2)
response patterns for##3##3##(2008-10#3)
response patterns##10##2##(2008-10#4)(2008-11#2)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
response potential##2##2##(1990-3#1)(1991-1#1)
response prediction##2##2##(2010-11#1)(2010-12#1)
response properties of the##3##4##(2008-10#2)(2008-8#1)
response properties of##7##3##(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)
response properties##11##2##(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2013-8#1)
response protein##4##2##(1997-7#2)(2008-10#1)(2011-2#1)
response proteins##2##2##(1996-9#1)(2012-12#1)
response range and##2##3##(2008-10#2)
response range of the sensor##2##5##(2008-10#2)
response range of##7##3##(2008-10#7)
response range##21##2##(2007-8#1)(2008-10#20)
response ranges##2##2##(2008-10#1)(2010-7#1)
response rate and##2##3##(2008-11#1)(2008-3#1)
response rate in the##2##4##(2008-4#1)(2010-3#1)
response rate of patients##2##4##(1997-8#2)
response rate of##13##3##(1992-2#2)(1993-12#1)(1997-8#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
response rate was##21##3##(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1993-1#1)(1994-2#1)(1994-7#1)(1995-4#1)(1995-8#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-5#1)(2011-2#1)(2012-2#1)
response rate##67##2##(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#2)(1993-1#2)(1993-12#1)(1993-6#2)(1994-2#1)(1994-7#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)
response rate) and safe for bone pain palliation in patients with multiple##2##12##(2007-11#2)
response rate)##8##2##(1994-2#1)(1996-3#1)(2007-11#3)(2008-8#1)(2011-1#1)(2013-1#1)
response rates from##2##3##(2008-12#1)(2008-8#1)
response rates of##4##3##(1997-5#1)(2006-10#1)(2008-5#1)(2013-1#1)
response rates were##3##3##(1990-6#1)(1991-8#1)(1993-6#1)
response rates##27##2##(1990-2#1)(1990-6#1)(1991-8#1)(1993-6#3)(1994-7#1)(1995-4#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
response region##2##2##(2008-10#2)
response regulator##3##2##(2008-10#1)(2009-6#1)(2010-10#1)
response related##5##2##(2008-1#1)(2008-9#4)
response relationships##4##2##(2008-10#1)(2008-7#3)
response resulting from##2##3##(1995-12#1)(2008-10#1)
response rules##2##2##(2012-2#2)
response seen##2##2##(1995-3#1)(2006-6#1)
response similar to##2##3##(1992-10#1)(2008-10#1)
response slope of##2##3##(2008-10#2)
response slope##5##2##(2008-10#5)
response stability##2##2##(2008-10#2)
response statistics##2##2##(2007-4#1)(2010-3#1)
response strategies##2##2##(2008-11#1)(2008-3#1)
response study##2##2##(2008-5#2)
response style##3##2##(2010-1#3)
response surface methodology##2##3##(2008-10#1)(2013-1#1)
response surface##16##2##(1994-11#1)(2008-10#11)(2008-5#1)(2009-9#1)(2012-3#1)(2013-1#1)
response surfaces##3##2##(2008-10#3)
response system##4##2##(2008-11#1)(2010-3#3)
response telemetry##5##2##(2008-9#5)
response test##2##2##(2008-10#1)(2008-8#1)
response than that of##2##4##(2008-2#1)(2009-8#1)
response than##7##2##(1990-12#1)(1990-5#1)(2008-10#2)(2008-2#1)(2009-8#1)(2012-3#1)
response that is##5##3##(1995-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
response that##20##2##(1993-8#1)(1994-5#1)(1995-5#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
response the##2##2##(1992-2#1)(2008-8#1)
response through the##2##3##(2008-11#1)(2013-1#1)
response through##4##2##(1992-3#1)(2008-11#1)(2010-5#1)(2013-1#1)
response time &lt##2##3##(2008-10#2)
response time (&lt##4##3##(2008-10#4)
response time (within##3##3##(2008-10#3)
response time and##10##3##(2007-12#1)(2008-10#8)(2010-8#1)
response time are##2##3##(2007-11#1)(2008-10#1)
response time for##4##3##(2008-10#2)(2010-5#1)(2013-8#1)
response time is##5##3##(2007-12#1)(2008-10#3)(2008-2#1)
response time of &lt##8##4##(2007-11#1)(2008-10#7)
response time of about##7##4##(2008-10#7)
response time of less than##5##5##(2007-11#1)(2008-10#3)(2013-1#1)
response time of sensor is##2##5##(2008-10#2)
response time of the electrode is##4##6##(2008-10#4)
response time of the electrode was##3##6##(2008-10#3)
response time of the electrode##7##5##(2008-10#7)
response time of the sensor is##3##6##(2008-10#3)
response time of the sensor##4##5##(2008-10#4)
response time of the##17##4##(2007-11#1)(2007-12#2)(2008-10#13)(2008-2#1)
response time of##66##3##(2007-11#5)(2007-12#5)(2008-10#52)(2008-2#2)(2008-3#1)(2013-1#1)
response time to##2##3##(2008-10#1)(2010-2#1)
response time was##3##3##(2008-10#2)(2008-2#1)
response time##150##2##(1996-12#1)(1996-3#1)(2007-11#7)(2007-12#7)(2007-8#1)(2008-10#114)(2008-2#6)(2008-3#3)(2008-6#1)(2010-2#2)(2010-5#2)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
response times and##3##3##(1994-3#1)(2010-3#1)(2011-1#1)
response times of ambulances##2##4##(2010-3#2)
response times of##3##3##(2008-10#1)(2010-3#2)
response times on##2##3##(2008-2#1)(2009-12#1)
response times to##3##3##(2008-10#1)(2010-3#1)(2012-1#1)
response times##24##2##(1994-3#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#8)(2011-1#1)(2012-1#1)(2012-12#1)
response to AIDS##2##3##(1990-3#1)(1993-3#1)
response to ATP binding##2##4##(1995-2#2)
response to Cd##2##3##(1990-5#1)(2008-7#1)
response to Cu(II) over##2##4##(2008-10#2)
response to Cu(II)##3##3##(2008-10#3)
response to DNA damage##6##4##(1995-2#3)(2009-5#1)(2011-2#2)
response to DNA##7##3##(1995-2#3)(2008-1#1)(2009-5#1)(2011-2#2)
response to E2##3##3##(1990-11#3)
response to HIV-1##2##3##(2009-4#1)(2013-1#1)
response to KLH was##2##4##(2008-10#2)
response to KLH##6##3##(2008-10#6)
response to L-Glu##2##3##(1997-2#2)
response to M##2##3##(2008-10#2)
response to NMDA in##2##4##(1992-8#1)(1996-5#1)
response to PTH##2##3##(1990-11#2)
response to TSH stimulation##2##4##(1990-12#1)(1993-3#1)
response to TSH##3##3##(1990-12#1)(1992-12#1)(1993-3#1)
response to UV##3##3##(2008-1#1)(2008-3#1)(2008-5#1)
response to a T-dependent antigen##2##5##(1994-5#1)(2008-10#1)
response to a fire##2##4##(1993-12#1)(1994-12#1)
response to a given##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
response to a particular##3##4##(2008-1#1)(2008-12#1)(2009-7#1)
response to a plasma cholesterol-lowering diet##2##6##(2012-2#2)
response to a range of##2##5##(1990-12#1)(1992-6#1)
response to a second##2##4##(1996-5#1)(2013-1#1)
response to a single##2##4##(2008-3#1)(2011-10#1)
response to a variety of##5##5##(2008-11#2)(2008-2#1)(2008-4#1)(2011-2#1)
response to a##76##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1992-6#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
response to acute##6##3##(1993-2#1)(1995-12#2)(1995-6#1)(1996-2#1)(2010-10#1)
response to adenosine##3##3##(1993-11#1)(1997-7#1)(2012-3#1)
response to all##5##3##(1995-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
response to an##17##3##(1993-3#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-5#1)
response to antibiotic##2##3##(2011-1#1)(2012-1#1)
response to antibiotics##3##3##(2007-7#1)(2012-3#2)
response to arachidonic acid##2##4##(1993-8#1)(1995-11#1)
response to both##4##3##(1992-4#1)(1992-8#1)(1995-2#1)(2007-12#1)
response to cAMP##3##3##(1991-2#1)(1996-12#1)(1996-2#1)
response to cage transfer##3##4##(2008-11#3)
response to cancer##5##3##(1994-11#1)(1994-2#1)(1997-1#1)(2008-4#1)(2011-2#1)
response to cell##3##3##(2008-7#1)(2008-9#1)(2009-5#1)
response to cellular##4##3##(1993-9#1)(1996-2#1)(2009-5#1)(2010-7#1)
response to challenge##3##3##(1990-11#1)(1991-3#1)(1997-3#1)
response to changes in##8##4##(1990-6#1)(1990-8#1)(1992-12#1)(1995-11#1)(2008-10#2)(2008-3#1)(2009-8#1)
response to changing##4##3##(1992-2#1)(2008-7#1)(2009-6#1)(2012-2#1)
response to chemotherapy##11##3##(1990-12#1)(1991-4#2)(1992-10#1)(1994-2#1)(1997-7#1)(2010-3#3)(2012-3#1)(2013-1#1)
response to chlordiazepoxide##3##3##(1992-7#3)
response to chronic##2##3##(2008-10#1)(2010-4#1)
response to clenbuterol##2##3##(2010-6#2)
response to climate##2##3##(2008-8#1)(2012-7#1)
response to cold##3##3##(1997-7#2)(2008-7#1)
response to contact sensitizers##2##4##(2008-10#2)
response to dietary##2##3##(1991-2#1)(2012-2#1)
response to different##12##3##(1994-12#1)(1996-12#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#1)
response to dilute tropicamide##2##4##(2008-7#2)
response to disturbance##2##3##(2008-8#2)
response to diverse##2##3##(2008-11#1)(2012-12#1)
response to drought##3##3##(2012-5#1)(2012-8#2)
response to drug treatment##2##4##(1995-12#1)(2008-9#1)
response to drugs##4##3##(1993-11#1)(2007-3#1)(2008-7#1)(2013-8#1)
response to electrical stimulation##3##4##(1990-5#1)(1990-7#1)(2008-7#1)
response to electrical##4##3##(1990-5#1)(1990-7#1)(1993-12#1)(2008-7#1)
response to elevated##3##3##(1992-8#1)(2009-5#1)(2010-11#1)
response to endothelin-1##5##3##(1990-8#2)(1995-12#3)
response to environmental##10##3##(2008-8#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-7#1)(2013-8#1)
response to exercise##2##3##(2008-7#1)(2013-8#1)
response to exogenous##4##3##(1994-3#1)(1997-1#1)(2008-10#1)(2008-7#1)
response to food##2##3##(2007-10#1)(2008-7#1)
response to general##2##3##(2008-7#1)(2008-9#1)
response to genotoxic##2##3##(2008-5#1)(2011-2#1)
response to global##2##3##(2012-12#1)(2013-8#1)
response to glucocorticoid##3##3##(1994-10#1)(2008-11#1)(2008-7#1)
response to glucocorticoids##2##3##(1990-11#1)(2008-11#1)
response to glucose##6##3##(1995-8#2)(1996-3#1)(2008-1#1)(2008-10#1)(2010-11#1)
response to growth factors##7##4##(1990-12#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-3#1)(1994-5#1)(2011-2#1)
response to growth##8##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-3#1)(1994-5#1)(1995-11#1)(2011-2#1)
response to heat shock##2##4##(1990-12#1)(2008-7#1)
response to heat##3##3##(1990-12#1)(2008-7#1)(2008-8#1)
response to high##3##3##(1994-8#1)(2008-10#1)(2008-12#1)
response to histamine##2##3##(1992-9#1)(2008-5#1)
response to hypertension##2##3##(2009-7#2)
response to hypoxia##5##3##(1994-5#1)(1995-12#1)(2010-11#1)(2010-4#1)(2012-2#1)
response to i##3##3##(1992-8#2)(1994-2#1)
response to infection was##2##4##(2008-10#2)
response to infection##11##3##(1993-12#1)(2008-10#9)(2008-2#1)
response to initial##3##3##(1996-1#1)(2008-6#1)(2010-11#1)
response to injury##9##3##(1990-7#2)(2008-1#3)(2008-4#1)(2008-7#2)(2008-9#1)
response to innocuous##2##3##(1996-12#2)
response to insulin##4##3##(1995-11#1)(2008-3#1)(2010-11#1)(2010-4#1)
response to integrated treatment##2##4##(2012-3#2)
response to interventions##2##3##(2008-1#1)(2008-6#1)
response to intravenous##5##3##(1990-12#1)(1992-8#1)(1995-12#1)(1997-2#1)(2006-10#1)
response to long-term##2##3##(1994-5#1)(1997-2#1)
response to low##9##3##(2008-7#7)(2009-8#1)(2013-1#1)
response to magnesium##2##3##(1990-9#1)(2008-10#1)
response to management##2##3##(2008-10#1)(2008-7#1)
response to mechanical##3##3##(1993-2#1)(1997-3#1)(2008-9#1)
response to membrane##2##3##(1992-3#1)(2008-4#1)
response to mirtazapine in##2##4##(2008-6#2)
response to natural##2##3##(2008-7#1)(2008-8#1)
response to neoadjuvant chemotherapy##2##4##(1993-11#1)(2010-12#1)
response to neoadjuvant##3##3##(1993-11#1)(2010-12#1)(2010-7#1)
response to osmotic##2##3##(2008-4#1)(2008-7#1)
response to other##3##3##(1994-11#1)(1995-5#1)(2012-12#1)
response to oxygen##2##3##(1990-8#1)(2008-10#1)
response to pH##5##3##(1993-12#1)(2008-10#3)(2008-5#1)
response to parasitism##2##3##(2008-8#2)
response to physiological##2##3##(2008-4#1)(2010-1#1)
response to platelet##2##3##(1994-6#1)(2009-12#1)
response to preoperative chemotherapy was##2##5##(2010-3#2)
response to preoperative chemotherapy##3##4##(2010-3#3)
response to radiotherapy##3##3##(2008-6#1)(2010-12#1)(2010-3#1)
response to recombinant##3##3##(1997-4#2)(2007-11#1)
response to reduced##2##3##(1990-2#1)(2008-7#1)
response to retinoic acid##2##4##(1994-10#1)(2008-9#1)
response to salicylate##2##3##(2008-10#2)
response to selection for##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
response to selection in##2##4##(2008-8#2)
response to selection##11##3##(2008-7#1)(2008-8#9)(2008-9#1)
response to shear stress##3##4##(1993-11#1)(2008-11#1)(2010-1#1)
response to sheep red blood cells##4##6##(1993-12#1)(2008-10#3)
response to sheep##5##3##(1993-12#1)(2008-10#4)
response to skin##3##3##(1992-8#2)(2010-8#1)
response to social##2##3##(1996-3#1)(2012-3#1)
response to sodium##3##3##(1993-12#2)(2008-10#1)
response to some##3##3##(1994-3#1)(2010-3#1)(2012-12#1)
response to specific##4##3##(2008-10#1)(2009-12#1)(2010-11#1)(2012-12#1)
response to standing and to hyperventilation##2##6##(2008-7#2)
response to standing##3##3##(2008-7#3)
response to steroid##2##3##(2008-4#2)
response to stimuli##2##3##(1995-8#1)(2010-1#1)
response to stress##9##3##(1994-11#1)(1994-8#1)(1997-4#1)(2008-11#2)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
response to subsequent##2##3##(2008-10#1)(2008-7#1)
response to such##3##3##(2008-11#1)(2008-9#1)(2010-8#1)
response to surgery##2##3##(2012-1#1)(2013-1#1)
response to surgical stimulation##2##4##(2011-2#2)
response to surgical##4##3##(2008-12#1)(2011-2#3)
response to taste stimuli##5##4##(1996-8#1)(2012-12#2)(2013-1#2)
response to taste##6##3##(1996-8#2)(2012-12#2)(2013-1#2)
response to the HIV epidemic##2##5##(1993-12#1)(2009-7#1)
response to the culture pond water##2##6##(2008-5#2)
response to the current##3##4##(1996-1#1)(1996-12#1)(2008-12#1)
response to the drug##2##4##(1995-12#1)(2008-10#1)
response to the fungicides##2##4##(2008-10#2)
response to the pathogen##2##4##(2008-10#2)
response to the presence of##3##5##(1994-1#1)(2008-8#1)(2008-9#1)
response to the questions##2##4##(2010-4#1)(2013-8#1)
response to the specific##2##4##(2008-10#1)(2012-12#1)
response to the##103##3##(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-8#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#3)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2012-9#1)(2013-7#1)(2013-8#2)
response to therapies##2##3##(2012-3#1)(2013-1#1)
response to therapy among chronic hepatitis C patients with HCV genotype 4##2##12##(2012-12#2)
response to therapy##21##3##(1991-2#1)(1992-8#1)(1994-7#1)(1997-2#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-8#1)
response to these agents##2##4##(1990-2#2)
response to these##7##3##(1990-12#1)(1990-2#2)(1992-4#1)(2008-10#2)(2008-8#1)
response to this challenge##2##4##(1993-12#1)(1994-12#1)
response to this##6##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)
response to thyroid##2##3##(1991-9#1)(1992-12#1)
response to thyrotropin-releasing hormone##2##4##(1994-2#1)(2008-4#1)
response to treatment and##4##4##(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
response to treatment are##2##4##(1996-8#1)(2013-8#1)
response to treatment in##2##4##(1993-2#1)(2007-2#1)
response to treatment of##4##4##(2008-10#1)(2010-3#1)(2011-7#1)(2013-8#1)
response to treatment was##4##4##(1996-6#1)(2007-7#1)(2008-6#1)(2013-1#1)
response to treatment with##2##4##(2008-9#1)(2011-2#1)
response to treatment##31##3##(1993-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#5)
response to two##2##3##(1997-1#1)(2008-3#1)
response to uric acid##2##4##(2008-10#2)
response to vaccination##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
response to various##9##3##(1995-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#1)
response to water##3##3##(2008-10#1)(2009-8#2)
response to wounding and##2##4##(2008-10#1)(2009-8#1)
response to##1230##2##(1990-10#3)(1990-11#9)(1990-12#16)(1990-2#8)(1990-3#1)(1990-5#7)(1990-6#2)(1990-7#5)(1990-8#6)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#4)(1991-8#6)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#6)(1992-2#4)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#16)(1992-9#6)(1993-11#6)(1993-12#22)(1993-2#3)(1993-3#9)(1993-5#1)(1993-6#14)(1993-8#6)(1993-9#2)(1994-1#3)(1994-10#2)(1994-11#14)(1994-12#7)(1994-2#10)(1994-3#6)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#11)(1994-9#1)(1995-11#7)(1995-12#18)(1995-2#12)(1995-5#9)(1995-6#4)(1995-8#11)(1995-9#1)(1996-1#3)(1996-12#13)(1996-2#13)(1996-3#6)(1996-5#6)(1996-6#1)(1996-8#3)(1997-1#11)(1997-2#11)(1997-3#5)(1997-4#3)(1997-6#5)(1997-7#5)(1997-8#1)(2006-10#4)(2007-10#3)(2007-11#8)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#7)(2007-9#1)(2008-1#24)(2008-10#170)(2008-11#42)(2008-12#15)(2008-2#9)(2008-3#7)(2008-4#25)(2008-5#17)(2008-6#17)(2008-7#68)(2008-8#42)(2008-9#38)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#11)(2009-6#8)(2009-7#5)(2009-8#14)(2009-9#5)(2010-1#6)(2010-10#5)(2010-11#10)(2010-12#6)(2010-2#1)(2010-3#13)(2010-4#8)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#6)(2011-1#9)(2011-10#1)(2011-2#31)(2011-7#1)(2012-1#6)(2012-12#23)(2012-2#21)(2012-3#17)(2012-4#1)(2012-5#1)(2012-7#1)(2012-8#2)(2012-9#2)(2013-1#24)(2013-7#7)(2013-8#23)
response toTGF-beta##2##2##(2008-6#2)
response toward fluoride##2##3##(2008-10#2)
response toward##9##2##(2008-10#7)(2010-11#1)(2012-12#1)
response towards##7##2##(2008-10#7)
response under##4##2##(2008-10#3)(2011-2#1)
response upon##2##2##(1995-5#1)(2012-3#1)
response using an##2##3##(2008-4#1)(2012-2#1)
response using##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
response variable Y##2##3##(2008-7#1)(2012-12#1)
response variable and##2##3##(2008-7#1)(2012-12#1)
response variable##8##2##(1997-7#1)(2008-10#2)(2008-6#1)(2008-7#2)(2012-12#2)
response variables to##2##3##(2008-10#2)
response variables##9##2##(1995-12#2)(1997-7#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-2#1)
response versus##3##2##(2008-10#3)
response was achieved in##2##4##(1991-6#1)(2008-10#1)
response was achieved##4##3##(1991-6#1)(2008-10#2)(2012-12#1)
response was also##4##3##(1995-12#1)(2007-2#1)(2007-9#1)(2008-10#1)
response was associated with##3##4##(1991-5#1)(1994-5#1)(2008-11#1)
response was blocked by##2##4##(1995-3#1)(2008-8#1)
response was due##2##3##(2008-10#1)(2010-8#1)
response was elicited by##2##4##(1992-8#1)(1997-8#1)
response was elicited##3##3##(1991-9#1)(1992-8#1)(1997-8#1)
response was evaluated##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)
response was investigated##2##3##(2008-10#2)
response was linear##9##3##(1996-12#2)(1997-2#1)(2008-10#6)
response was monitored##2##3##(1995-12#1)(2008-10#1)
response was not affected##3##4##(1990-5#1)(1994-12#1)(1997-4#1)
response was not significantly##2##4##(1997-8#1)(2008-10#1)
response was not##8##3##(1990-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-7#1)(1997-4#1)(1997-8#1)(2008-10#1)
response was observed in the##3##5##(1992-8#1)(1996-5#1)(2008-10#1)
response was observed in##9##4##(1990-2#1)(1990-6#1)(1991-2#1)(1992-8#1)(1993-9#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-9#1)
response was observed##13##3##(1990-2#2)(1990-6#1)(1991-2#1)(1992-8#1)(1993-9#1)(1995-12#1)(1996-5#1)(2008-10#3)(2008-12#1)(2008-9#1)
response was obtained in the##3##5##(2008-10#3)
response was obtained in##5##4##(1992-12#1)(2008-10#3)(2008-5#1)
response was obtained##15##3##(1992-12#2)(2008-1#1)(2008-10#11)(2008-5#1)
response was seen##4##3##(1991-12#1)(1991-3#1)(1995-12#1)(2008-10#1)
response was significantly##3##3##(1997-3#1)(2008-11#1)(2008-12#1)
response was studied##3##3##(1997-2#1)(2008-10#2)
response was##141##2##(1990-2#4)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#3)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-12#4)(1995-3#1)(1995-8#2)(1996-12#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#56)(2008-11#4)(2008-12#5)(2008-5#3)(2008-8#4)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
response were also##2##3##(2008-10#1)(2010-11#1)
response were observed##2##3##(1993-2#1)(2008-6#1)
response were##14##2##(1991-6#1)(1992-9#1)(1993-2#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#3)(2010-11#1)(2013-1#1)
response when a##2##3##(1990-5#1)(2008-9#1)
response when##11##2##(1990-5#1)(1992-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#1)
response which##3##2##(2008-11#1)(2008-9#2)
response while##4##2##(1990-5#1)(2008-10#2)(2010-12#1)
response will be##2##3##(2008-11#1)(2008-7#1)
response will##3##2##(2008-11#1)(2008-7#2)
response with a slope of##2##5##(2008-10#2)
response with a##6##3##(1990-12#1)(2008-10#4)(2009-4#1)
response with##29##2##(1990-12#1)(1992-9#2)(1993-6#1)(1994-2#1)(1994-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-7#3)(2009-4#1)(2010-1#1)(2011-2#1)
response##4174##1##(1990-10#4)(1990-11#11)(1990-12#28)(1990-2#26)(1990-3#2)(1990-5#22)(1990-6#9)(1990-7#10)(1990-8#17)(1990-9#3)(1991-1#7)(1991-12#19)(1991-2#19)(1991-3#11)(1991-4#4)(1991-5#12)(1991-6#8)(1991-7#1)(1991-8#12)(1991-9#6)(1992-1#4)(1992-10#11)(1992-11#8)(1992-12#29)(1992-2#18)(1992-3#25)(1992-4#2)(1992-5#2)(1992-6#17)(1992-7#5)(1992-8#28)(1992-9#19)(1993-1#3)(1993-11#7)(1993-12#43)(1993-2#7)(1993-3#20)(1993-5#3)(1993-6#28)(1993-8#15)(1993-9#7)(1994-1#5)(1994-10#2)(1994-11#29)(1994-12#13)(1994-2#22)(1994-3#17)(1994-5#16)(1994-6#15)(1994-7#3)(1994-8#35)(1994-9#8)(1995-11#10)(1995-12#47)(1995-2#20)(1995-3#4)(1995-4#2)(1995-5#24)(1995-6#9)(1995-8#22)(1995-9#4)(1996-1#3)(1996-12#26)(1996-2#27)(1996-3#13)(1996-4#3)(1996-5#14)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#5)(1997-1#15)(1997-2#25)(1997-3#18)(1997-4#12)(1997-5#1)(1997-6#12)(1997-7#23)(1997-8#12)(2006-10#10)(2006-6#3)(2007-10#13)(2007-11#55)(2007-12#71)(2007-2#13)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#19)(2007-8#5)(2007-9#3)(2008-1#43)(2008-10#1084)(2008-11#121)(2008-12#42)(2008-2#73)(2008-3#109)(2008-4#67)(2008-5#72)(2008-6#52)(2008-7#184)(2008-8#94)(2008-9#103)(2009-1#1)(2009-10#13)(2009-11#15)(2009-12#16)(2009-2#3)(2009-3#4)(2009-4#14)(2009-5#29)(2009-6#11)(2009-7#8)(2009-8#40)(2009-9#10)(2010-1#20)(2010-10#10)(2010-11#17)(2010-12#21)(2010-2#15)(2010-3#37)(2010-4#18)(2010-5#19)(2010-6#5)(2010-7#6)(2010-8#19)(2010-9#2)(2011-1#28)(2011-10#1)(2011-2#108)(2011-3#1)(2011-7#1)(2012-1#12)(2012-12#57)(2012-2#71)(2012-3#74)(2012-4#2)(2012-5#1)(2012-6#2)(2012-7#2)(2012-8#2)(2012-9#3)(2013-1#99)(2013-7#13)(2013-8#43)
response&quot##3##1##(2008-10#1)(2008-8#2)
response) was##2##2##(2008-10#2)
response)##13##1##(1990-12#1)(1994-12#2)(1995-11#1)(1997-2#1)(2008-10#4)(2008-3#1)(2009-11#1)(2010-8#1)(2012-3#1)
response)/(untreated control response)##2##3##(2008-10#2)
response]##2##1##(1996-6#1)(2012-2#1)
responses (CR)##2##2##(1991-2#1)(2008-5#1)
responses (i##3##2##(1994-2#1)(2007-10#2)
responses after##10##2##(1992-9#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
responses against a##2##3##(2008-11#1)(2009-6#1)
responses against bacterial##3##3##(1992-5#1)(2008-10#1)(2012-12#1)
responses against##17##2##(1992-5#1)(1995-2#2)(1995-5#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)
responses and a##2##3##(2008-3#1)(2008-9#1)
responses and the##3##3##(2008-1#1)(2008-9#2)
responses and##56##2##(1991-2#1)(1992-3#2)(1993-12#1)(1995-1#1)(1995-2#2)(1995-5#2)(1996-1#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
responses are##29##2##(1993-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#3)(2010-12#1)(2011-2#1)(2013-8#2)
responses as a function of##3##5##(2008-11#1)(2008-5#1)(2008-6#1)
responses as a##4##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-6#1)
responses as compared to##2##4##(1995-5#1)(2013-1#1)
responses as##7##2##(1994-11#1)(1994-5#1)(1995-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
responses associated with##4##3##(1995-9#1)(2008-10#1)(2009-10#1)(2011-1#1)
responses at the##2##3##(2009-8#1)(2013-8#1)
responses at##7##2##(2008-10#3)(2008-12#1)(2009-5#1)(2009-8#1)(2013-8#1)
responses before and after##2##4##(1993-6#1)(1996-5#1)
responses but##4##2##(1994-8#1)(1996-5#1)(2008-11#1)(2008-9#1)
responses by##16##2##(1990-5#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)
responses can be##6##3##(1995-11#1)(1995-12#1)(1997-7#1)(2008-3#1)(2008-5#1)(2008-8#1)
responses compared to##2##3##(1994-3#1)(2008-11#1)
responses could be##3##3##(2008-10#2)(2008-5#1)
responses depended on##2##3##(2007-9#1)(2012-6#1)
responses derived##2##2##(2008-7#1)(2009-5#1)
responses differed##2##2##(2008-8#1)(2009-12#1)
responses during the##2##3##(2007-6#1)(2011-2#1)
responses during##12##2##(1993-3#1)(1995-2#1)(2007-6#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#4)
responses elicited by##4##3##(1993-12#1)(1994-8#1)(1997-4#1)(2008-11#1)
responses elicited##5##2##(1993-12#1)(1993-5#1)(1994-8#1)(1997-4#1)(2008-11#1)
responses even##2##2##(2008-5#1)(2008-7#1)
responses evoked by##2##3##(1992-3#1)(1993-12#1)
responses evoked in the nucleus tractus solitarii##2##7##(1992-3#2)
responses evoked in the##3##4##(1992-3#2)(1996-5#1)
responses evoked##5##2##(1992-3#3)(1993-12#1)(1996-5#1)
responses following##3##2##(1995-5#2)(2008-4#1)
responses for all##2##3##(2008-10#1)(2008-2#1)
responses for at least 1##2##5##(2007-10#2)
responses for each##3##3##(2010-11#2)(2013-1#1)
responses for the##2##3##(2008-10#2)
responses for##19##2##(2007-10#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#2)(2012-2#2)(2013-1#1)
responses from a##2##3##(1993-11#1)(2012-3#1)
responses from the##2##3##(1993-12#1)(2007-3#1)
responses from##14##2##(1993-11#1)(1993-12#2)(1994-2#1)(1996-1#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
responses have been##2##3##(2007-12#1)(2008-7#1)
responses have##5##2##(2007-12#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
responses in Arabidopsis##4##3##(1997-8#2)(2009-8#2)
responses in a##4##3##(1992-3#1)(1993-12#1)(1996-2#1)(2008-7#1)
responses in human##2##3##(1992-3#1)(2008-7#1)
responses in mice##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
responses in muscles##2##3##(1995-8#2)
responses in primary##2##3##(2008-11#1)(2008-9#1)
responses in rat##2##3##(1995-12#1)(1996-2#1)
responses in rice##2##3##(2008-10#1)(2008-7#1)
responses in the anterior##2##4##(2009-2#1)(2013-1#1)
responses in the rat##2##4##(1996-5#1)(2008-10#1)
responses in the##25##3##(1993-12#1)(1993-6#2)(1995-12#2)(1995-5#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#1)(2013-1#1)(2013-8#2)
responses in vitro##3##3##(1994-9#1)(1995-12#1)(2008-11#1)
responses in##128##2##(1990-11#1)(1990-12#1)(1991-12#3)(1992-3#3)(1993-11#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-6#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#27)(2008-11#8)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#9)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-8#3)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#4)(2013-8#5)
responses included##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
responses including##2##2##(1990-2#1)(2009-12#1)
responses induced by##12##3##(1990-3#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-3#1)(2009-5#1)
responses is##2##2##(1995-2#1)(1996-2#1)
responses leading to##2##3##(2008-10#1)(2008-9#1)
responses may be##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
responses may##11##2##(1991-9#1)(1994-6#1)(1997-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2012-5#1)(2013-8#1)
responses mediated by##6##3##(1992-2#1)(1992-8#1)(1994-6#1)(1995-11#1)(2006-10#1)(2012-12#1)
responses observed in##2##3##(2008-10#1)(2009-7#1)
responses observed##3##2##(1997-4#1)(2008-10#1)(2009-7#1)
responses obtained##4##2##(1990-8#1)(1991-2#1)(2007-11#1)(2008-10#1)
responses occurred##2##2##(2008-10#2)
responses of 1x10(-5) to##2##4##(2008-10#2)
responses of European##2##3##(2008-9#1)(2012-7#1)
responses of Xenopus oocytes##2##4##(1990-7#2)
responses of cells##2##3##(1996-12#1)(2008-11#1)
responses of human##3##3##(1997-7#1)(2008-4#1)(2013-1#1)
responses of individual species##2##4##(2008-6#1)(2009-8#1)
responses of living cells##2##4##(2007-12#2)
responses of male##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
responses of neurons in##2##4##(2008-7#1)(2008-8#1)
responses of patients##2##3##(1992-3#2)
responses of plant##4##3##(1997-8#1)(2008-8#1)(2012-2#1)(2012-6#1)
responses of plants to##3##4##(2008-10#1)(2008-8#1)(2012-5#1)
responses of rat##2##3##(1990-11#1)(1990-12#1)
responses of the##30##3##(1990-5#2)(1990-9#1)(1992-11#1)(1994-12#1)(1995-8#1)(1997-2#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
responses of these##5##3##(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
responses of##172##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#4)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#3)(2008-10#28)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#11)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#6)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#4)(2012-6#3)(2012-7#2)(2012-9#1)(2013-1#6)(2013-7#1)
responses on the##2##3##(1996-7#1)(2008-7#1)
responses on##8##2##(1993-3#1)(1996-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
responses or##5##2##(1994-8#1)(2008-11#1)(2008-7#2)(2009-11#1)
responses over the##2##3##(2008-10#1)(2010-10#1)
responses over##3##2##(2008-10#2)(2010-10#1)
responses produced by##2##3##(1991-12#1)(1995-12#1)
responses provided by##3##3##(1995-12#1)(2007-12#1)(2008-6#1)
responses provided##6##2##(1995-12#1)(2007-12#1)(2008-12#1)(2008-6#1)(2009-7#1)(2013-1#1)
responses resulting from##2##3##(1996-5#1)(2010-5#1)
responses revealed##2##2##(2008-10#1)(2011-2#1)
responses seen in##2##3##(2008-12#1)(2008-5#1)
responses such as##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
responses than the##2##3##(2007-6#1)(2008-10#1)
responses than##7##2##(2007-12#1)(2007-6#1)(2008-10#2)(2008-9#3)
responses that are##4##3##(1994-11#1)(2008-10#2)(2009-10#1)
responses that were significantly##2##4##(1991-12#1)(2008-10#1)
responses that were##3##3##(1991-12#1)(2008-10#1)(2008-6#1)
responses that##18##2##(1991-12#1)(1994-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-6#1)(2011-2#1)(2012-3#1)
responses to &quot##2##3##(1994-1#1)(2010-4#1)
responses to L-glutamate##2##3##(1996-5#1)(1997-2#1)
responses to NMDA##2##3##(1996-5#2)
responses to VIP##2##3##(1995-11#2)
responses to a thermogenic nutritional supplement at rest##2##8##(2013-8#2)
responses to a##10##3##(1991-5#1)(1994-12#1)(1995-5#1)(1996-1#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-8#2)
responses to acute##3##3##(1991-8#1)(2008-11#1)(2008-7#1)
responses to all##2##3##(2008-10#1)(2012-3#1)
responses to an##4##3##(1991-6#1)(2008-10#1)(2012-2#1)(2012-3#1)
responses to angiotensin##3##3##(1991-12#2)(1994-2#1)
responses to certain##3##3##(1990-5#1)(1990-7#1)(2008-10#1)
responses to changes in##5##4##(1991-9#1)(1993-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
responses to exercise##2##3##(2009-1#1)(2013-8#1)
responses to glucose##2##3##(1995-8#1)(2007-7#1)
responses to increasing##2##3##(1995-2#1)(2008-10#1)
responses to infection##3##3##(1991-11#1)(2008-10#2)
responses to low##2##3##(2008-7#2)
responses to natural##2##3##(2012-12#1)(2012-3#1)
responses to neoadjuvant therapy##2##4##(2007-8#1)(2010-12#1)
responses to nicotine and##3##4##(1990-7#1)(2009-6#1)(2011-2#1)
responses to noise##2##3##(2008-11#1)(2008-9#1)
responses to oral##2##3##(1993-1#1)(1994-12#1)
responses to other##2##3##(2008-10#1)(2008-5#1)
responses to phenylephrine##2##3##(1995-12#1)(2013-8#1)
responses to questions about##2##4##(1992-12#1)(2013-1#1)
responses to selection##2##3##(2008-8#1)(2012-3#1)
responses to sheep red blood cells##2##6##(2008-10#2)
responses to stimulation##2##3##(1993-12#1)(2011-1#1)
responses to tetanus toxoid##2##4##(2011-2#2)
responses to the same##2##4##(1991-5#1)(2008-10#1)
responses to the##30##3##(1990-12#1)(1991-5#1)(1993-6#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
responses to this##2##3##(1995-3#1)(2012-12#1)
responses to treatment##5##3##(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
responses to vaccines##2##3##(2007-11#1)(2013-1#1)
responses to various stimuli##2##4##(2008-4#1)(2010-12#1)
responses to various##3##3##(1991-12#1)(2008-4#1)(2010-12#1)
responses to##345##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#8)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#2)(1992-8#1)(1993-1#2)(1993-12#4)(1993-3#2)(1993-6#2)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#8)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#5)(1997-2#3)(1997-3#1)(1997-4#3)(1997-7#3)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#35)(2008-11#10)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#20)(2008-9#9)(2009-1#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#10)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#3)(2010-8#4)(2011-1#3)(2011-2#13)(2012-1#3)(2012-12#7)(2012-2#12)(2012-3#8)(2012-5#1)(2013-1#10)(2013-8#8)
responses towards##3##2##(1995-5#1)(2007-11#1)(2008-10#1)
responses varied##2##2##(1993-12#1)(2009-2#1)
responses via##3##2##(1992-12#1)(2008-11#1)(2012-3#1)
responses was##7##2##(1993-12#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
responses were characterized##2##3##(2008-10#1)(2012-12#1)
responses were compared with##2##4##(1992-12#1)(2008-11#1)
responses were compared##3##3##(1992-12#1)(2008-11#1)(2013-1#1)
responses were internally coherent##2##4##(2013-8#2)
responses were linear##2##3##(2008-10#2)
responses were located##2##3##(2008-12#2)
responses were measured##2##3##(1993-12#1)(2008-7#1)
responses were not##5##3##(1990-5#1)(2007-10#1)(2008-10#2)(2009-5#1)
responses were observed in##4##4##(2008-10#1)(2008-6#1)(2011-1#1)(2013-8#1)
responses were observed##11##3##(1990-10#1)(1990-12#1)(1990-2#1)(2008-10#5)(2008-6#1)(2011-1#1)(2013-8#1)
responses were obtained##3##3##(1991-6#1)(1992-11#1)(2008-10#1)
responses were received##2##3##(2008-10#1)(2012-12#1)
responses were recorded before##2##4##(1992-12#1)(1995-12#1)
responses were recorded##3##3##(1992-12#1)(1994-8#1)(1995-12#1)
responses were seen in##4##4##(1990-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
responses were significantly##3##3##(1995-5#1)(1996-5#1)(2008-11#1)
responses were##84##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1993-12#2)(1994-1#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-2#2)(2007-10#2)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
responses when##3##2##(2008-6#1)(2009-8#1)(2013-8#1)
responses which##2##2##(1990-12#1)(2008-10#1)
responses with##9##2##(1991-2#1)(1997-4#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)
responses##1518##1##(1990-10#3)(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#1)(1990-5#7)(1990-7#8)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#21)(1991-2#12)(1991-3#2)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#13)(1992-2#6)(1992-3#16)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#6)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#22)(1993-3#6)(1993-5#2)(1993-6#8)(1993-9#3)(1994-1#4)(1994-11#4)(1994-12#6)(1994-2#9)(1994-3#4)(1994-5#1)(1994-6#7)(1994-8#6)(1994-9#5)(1995-1#1)(1995-11#12)(1995-12#19)(1995-2#15)(1995-3#1)(1995-5#28)(1995-6#1)(1995-8#8)(1995-9#2)(1996-1#6)(1996-12#5)(1996-2#16)(1996-3#3)(1996-5#19)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#13)(1997-3#3)(1997-4#10)(1997-6#2)(1997-7#7)(1997-8#5)(2006-10#7)(2006-6#1)(2007-10#10)(2007-11#10)(2007-12#14)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#5)(2007-7#2)(2007-8#11)(2007-9#3)(2008-1#6)(2008-10#241)(2008-11#71)(2008-12#23)(2008-2#8)(2008-3#23)(2008-4#48)(2008-5#37)(2008-6#17)(2008-7#65)(2008-8#60)(2008-9#62)(2009-1#1)(2009-10#10)(2009-11#4)(2009-12#7)(2009-2#7)(2009-3#1)(2009-4#4)(2009-5#10)(2009-6#14)(2009-7#4)(2009-8#31)(2009-9#6)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#5)(2010-4#4)(2010-5#12)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#12)(2011-10#1)(2011-2#40)(2012-1#8)(2012-12#27)(2012-2#29)(2012-3#17)(2012-5#9)(2012-6#5)(2012-7#2)(2012-9#1)(2013-1#33)(2013-7#5)(2013-8#31)
responses) and##2##2##(2008-10#1)(2008-9#1)
responses)##4##1##(2008-10#1)(2008-5#1)(2008-9#2)
responsibilities and##5##2##(1991-2#1)(1992-6#1)(1994-1#1)(2008-1#1)(2010-4#1)
responsibilities are##2##2##(1993-12#1)(2011-1#1)
responsibilities for##7##2##(1991-2#1)(1995-12#3)(2007-5#2)(2012-12#1)
responsibilities in##5##2##(1990-10#1)(1991-12#1)(1992-2#1)(2008-1#1)(2011-2#1)
responsibilities of the##2##3##(1993-2#1)(1995-6#1)
responsibilities of##14##2##(1991-2#1)(1992-12#1)(1993-2#2)(1994-1#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-3#1)(2010-3#1)
responsibilities through##2##2##(1996-1#1)(2013-1#1)
responsibilities to##4##2##(1992-1#1)(1996-1#1)(2007-2#1)(2011-2#1)
responsibilities##75##1##(1990-10#1)(1990-12#1)(1991-12#2)(1991-2#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#3)(1994-1#4)(1994-3#1)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#3)(1996-2#1)(1997-2#2)(1997-4#1)(2007-12#3)(2007-2#1)(2007-5#2)(2008-1#4)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#2)
responsibility and##8##2##(1992-2#1)(1994-2#1)(1995-6#1)(2007-10#2)(2008-11#1)(2010-12#1)(2012-3#1)
responsibility for care of a child with##2##7##(2009-5#2)
responsibility for care of##3##4##(2009-5#3)
responsibility for health care##3##4##(1993-3#1)(1994-2#2)
responsibility for health##4##3##(1993-3#2)(1994-2#2)
responsibility for quality##3##3##(1991-12#1)(1995-3#1)(1996-2#1)
responsibility for the management of##2##5##(1992-12#1)(1992-3#1)
responsibility for the##16##3##(1990-3#1)(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2009-10#1)(2009-5#1)
responsibility for their##3##3##(1994-3#1)(2007-11#1)(2008-6#1)
responsibility for##60##2##(1990-3#1)(1991-1#1)(1991-12#5)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#3)(1994-12#1)(1994-2#2)(1994-3#3)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#2)(2007-11#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#4)(2009-9#1)(2010-2#1)(2010-7#1)(2012-3#2)
responsibility in the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
responsibility in##11##2##(1993-12#1)(1995-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
responsibility is##2##2##(1993-2#1)(2007-11#1)
responsibility of the##9##3##(1991-3#2)(1991-6#1)(1995-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
responsibility of##18##2##(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#1)(1993-1#1)(1994-3#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
responsibility to ensure##2##3##(1992-1#1)(2008-10#1)
responsibility to##9##2##(1992-1#1)(1992-11#1)(1993-3#1)(1994-2#1)(1996-1#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
responsibility when##2##2##(2008-11#1)(2008-5#1)
responsibility##155##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-1#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#6)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#8)(1994-1#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-7#1)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-3#3)(1997-2#1)(1997-8#1)(2007-10#2)(2007-11#4)(2008-10#4)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#6)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)
responsible authorities##2##2##(1992-11#1)(1993-11#1)
responsible factor##2##2##(2008-10#1)(2008-7#1)
responsible for a variety of##2##5##(2011-2#1)(2012-2#1)
responsible for a##22##3##(1992-3#1)(1992-6#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#3)(2012-2#1)
responsible for acute##3##3##(2007-11#1)(2011-2#2)
responsible for an##2##3##(1992-6#1)(2013-1#1)
responsible for better##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
responsible for binding##2##3##(1991-2#1)(2008-9#1)
responsible for both the##3##4##(2007-12#1)(2008-7#1)(2010-5#1)
responsible for cell##4##3##(1991-12#1)(2008-11#2)(2008-4#1)
responsible for chronic##3##3##(1991-4#1)(2009-4#1)(2012-12#1)
responsible for decreased##2##3##(1995-5#1)(2011-2#1)
responsible for different##2##3##(2008-10#1)(2012-2#1)
responsible for disease suppression##2##4##(2008-10#2)
responsible for disease##3##3##(2008-10#2)(2011-2#1)
responsible for expression of##2##4##(1990-5#1)(2008-11#1)
responsible for free##2##3##(1990-8#1)(2012-2#1)
responsible for generating the##2##4##(1996-2#1)(2008-8#1)
responsible for generating##3##3##(1996-2#1)(2008-11#1)(2008-8#1)
responsible for glaucoma##3##3##(2011-1#3)
responsible for increased##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
responsible for inducing##4##3##(1995-2#1)(1996-5#1)(2008-10#1)(2008-3#1)
responsible for induction of##2##4##(2008-10#2)
responsible for interconversion of##2##4##(1992-10#1)(1994-8#1)
responsible for its##4##3##(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
responsible for light##2##3##(2008-10#2)
responsible for maintaining##3##3##(1992-8#1)(2008-10#1)(2009-2#1)
responsible for major##2##3##(2008-8#1)(2013-1#1)
responsible for maternal##2##3##(1992-5#1)(2011-1#1)
responsible for membranoproliferative glomerulonephritis##2##4##(2012-2#2)
responsible for more than##3##4##(1990-12#1)(2010-3#1)(2013-1#1)
responsible for not##2##3##(2011-2#1)(2013-7#1)
responsible for rapid##2##3##(2008-12#1)(2008-2#1)
responsible for resistance##3##3##(2008-10#3)
responsible for severe##3##3##(1994-5#1)(2008-4#1)(2011-2#1)
responsible for significant##6##3##(2008-10#2)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
responsible for some##4##3##(1996-12#1)(2007-12#1)(2012-2#1)(2012-3#1)
responsible for specific##3##3##(1995-11#1)(2008-4#1)(2011-2#1)
responsible for stabilizing##2##3##(1995-12#1)(2010-4#1)
responsible for such##5##3##(1990-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
responsible for suppression of##2##4##(2008-10#1)(2008-9#1)
responsible for systemic##2##3##(2008-10#1)(2009-11#1)
responsible for the DS##2##4##(1996-2#2)
responsible for the TCR##2##4##(2011-1#2)
responsible for the activation of##2##5##(1995-2#1)(2008-5#1)
responsible for the binding of##2##5##(1997-9#1)(2008-10#1)
responsible for the biological activity##3##5##(1990-12#1)(1992-8#1)(2010-12#1)
responsible for the changes in##2##5##(2008-6#1)(2011-2#1)
responsible for the changes##3##4##(2008-6#1)(2008-7#1)(2011-2#1)
responsible for the degradation of##3##5##(1995-6#1)(1995-8#1)(2008-4#1)
responsible for the development of##2##5##(2008-7#1)(2011-2#1)
responsible for the differences##2##4##(1994-5#1)(1997-9#1)
responsible for the different##3##4##(2008-8#1)(2013-1#2)
responsible for the expression of##2##5##(1995-6#1)(2009-3#1)
responsible for the formation of##4##5##(1993-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
responsible for the generation of##2##5##(2009-5#1)(2012-3#1)
responsible for the high##6##4##(1996-12#1)(1996-6#1)(1997-7#1)(2007-10#1)(2008-8#1)(2012-1#1)
responsible for the increase in##3##5##(2008-12#2)(2008-4#1)
responsible for the increase##4##4##(2008-12#2)(2008-3#1)(2008-4#1)
responsible for the increased##5##4##(1990-5#1)(1990-8#1)(2008-4#1)(2008-7#1)(2010-11#1)
responsible for the inhibition of##2##5##(1991-2#1)(2008-8#1)
responsible for the initial##2##4##(1991-7#1)(1992-12#1)
responsible for the loss of##2##5##(1997-7#1)(2009-12#1)
responsible for the low##2##4##(1993-3#1)(2008-7#1)
responsible for the maintenance of##2##5##(1997-2#1)(2008-7#1)
responsible for the majority of##3##5##(2008-1#1)(2009-5#1)(2009-8#1)
responsible for the metabolism of##2##5##(2008-10#1)(2011-1#1)
responsible for the observed##6##4##(1990-5#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-4#1)
responsible for the onset or persistence of rhinogenic deafness##2##9##(2008-4#2)
responsible for the origin of##2##5##(1996-6#1)(2008-8#1)
responsible for the production of##3##5##(1990-8#1)(1996-12#1)(2008-2#1)
responsible for the protective##2##4##(2008-10#1)(2011-1#1)
responsible for the recent##2##4##(1996-3#1)(2008-10#1)
responsible for the reduced##2##4##(2008-10#1)(2008-5#1)
responsible for the resistance of##2##5##(1991-2#1)(2008-10#1)
responsible for the resistance##3##4##(1990-5#1)(1991-2#1)(2008-10#1)
responsible for the suppression of##2##5##(1991-5#1)(2008-10#1)
responsible for the synthesis##2##4##(2008-10#1)(2008-11#1)
responsible for the ts phenotype##2##5##(1990-5#2)
responsible for the variability##2##4##(1992-3#1)(2008-8#1)
responsible for the##255##3##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#6)(1997-9#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#35)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#10)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#3)
responsible for their##10##3##(1992-10#1)(1993-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#1)
responsible for these activities##2##4##(1997-7#1)(2012-3#1)
responsible for these effects##2##4##(2008-11#1)(2011-2#1)
responsible for these##17##3##(1991-9#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-7#2)(2008-11#2)(2008-12#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-3#1)
responsible for this##18##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-12#2)(1994-12#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-1#1)
responsible for tumor##2##3##(1994-8#1)(2011-2#1)
responsible for##691##2##(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#2)(1990-5#12)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#7)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#6)(1992-8#4)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#6)(1995-6#6)(1995-8#5)(1996-1#3)(1996-12#4)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#4)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#3)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#10)(1997-8#2)(1997-9#2)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#13)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#14)(2008-10#99)(2008-11#18)(2008-12#8)(2008-2#10)(2008-3#17)(2008-4#24)(2008-5#20)(2008-6#5)(2008-7#17)(2008-8#19)(2008-9#8)(2009-11#5)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#2)(2010-3#5)(2010-4#4)(2010-5#5)(2010-6#2)(2010-8#1)(2011-1#16)(2011-10#1)(2011-2#29)(2012-1#2)(2012-12#6)(2012-2#15)(2012-3#14)(2013-1#12)(2013-7#2)(2013-8#8)
responsible mechanism##2##2##(2010-6#1)(2013-1#1)
responsible of##3##2##(2008-10#2)(2010-12#1)
responsible to##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
responsible##746##1##(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#3)(1990-5#12)(1990-6#4)(1990-7#1)(1990-8#7)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#7)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#9)(1992-8#4)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#5)(1995-3#3)(1995-5#7)(1995-6#7)(1995-8#5)(1996-1#3)(1996-12#5)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#4)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#11)(1997-8#3)(1997-9#2)(2006-10#3)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#14)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#14)(2008-10#105)(2008-11#21)(2008-12#9)(2008-2#10)(2008-3#17)(2008-4#24)(2008-5#21)(2008-6#5)(2008-7#19)(2008-8#20)(2008-9#10)(2009-11#5)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#5)(2010-6#3)(2010-8#2)(2011-1#17)(2011-10#1)(2011-2#30)(2012-1#2)(2012-12#7)(2012-2#16)(2012-3#14)(2013-1#13)(2013-7#2)(2013-8#8)
responsive breast##2##2##(1990-5#1)(2011-2#1)
responsive cells##5##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
responsive element##18##2##(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#5)(1994-11#1)(1994-6#2)(1995-6#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
responsive gene##2##2##(1997-7#1)(2008-9#1)
responsive genes in##3##3##(2008-9#3)
responsive genes##4##2##(1994-8#1)(2008-9#3)
responsive or##2##2##(2008-2#1)(2011-2#1)
responsive to a##2##3##(2011-2#1)(2013-1#1)
responsive to insulin##2##3##(1994-11#1)(2008-1#1)
responsive to the needs##2##4##(2008-7#1)(2013-8#1)
responsive to the##10##3##(1993-12#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
responsive to##66##2##(1990-12#1)(1991-12#1)(1992-2#2)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#4)(2008-10#10)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
responsive##140##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#13)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#4)(2008-9#12)(2009-12#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#9)(2011-9#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
responsiveness and##2##2##(1992-1#1)(2008-10#1)
responsiveness as##3##2##(1991-12#1)(1995-2#1)(2009-6#1)
responsiveness in the##2##3##(1990-8#1)(1994-6#1)
responsiveness in##5##2##(1990-8#1)(1992-9#1)(1994-5#1)(1994-6#1)(1994-9#1)
responsiveness of the HPA axis##2##5##(1995-12#1)(2008-4#1)
responsiveness of the##9##3##(1991-2#1)(1991-9#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-4#1)(2008-6#1)
responsiveness of##28##2##(1990-5#2)(1991-2#2)(1991-9#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-12#3)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)
responsiveness to a##4##3##(1990-11#1)(1994-5#1)(1994-6#1)(2008-4#1)
responsiveness to bronchodilator##2##3##(2011-2#2)
responsiveness to the##3##3##(1994-2#1)(2008-4#1)(2008-6#1)
responsiveness to these##3##3##(1990-7#1)(1995-12#1)(2008-4#1)
responsiveness to##32##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#3)(1996-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#2)
responsiveness was##2##2##(1993-12#1)(1994-3#1)
responsiveness##96##1##(1990-11#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#5)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#2)(1995-1#1)(1995-12#6)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#5)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
responsivities##4##1##(2008-3#4)
responsivity and##3##2##(2008-3#1)(2008-4#1)(2009-10#1)
responsivity at##3##2##(2007-12#1)(2008-3#1)(2009-10#1)
responsivity in##4##2##(1996-7#2)(2008-2#1)(2008-3#1)
responsivity of various types of##2##5##(2008-2#1)(2008-3#1)
responsivity of##10##2##(1996-7#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
responsivity to##2##2##(1995-8#1)(2008-3#1)
responsivity values##2##2##(2008-3#2)
responsivity##38##1##(1995-8#1)(1996-7#4)(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#18)(2008-4#1)(2009-10#4)(2012-2#1)
rest and##22##2##(1995-3#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#4)(2008-7#6)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
rest as##2##2##(2008-10#1)(2010-6#1)
rest between##2##2##(1991-2#1)(2013-8#1)
rest by##2##2##(1992-2#1)(2007-12#1)
rest had##2##2##(1995-2#1)(2008-7#1)
rest in##6##2##(1991-11#1)(1992-12#1)(1997-4#1)(2008-1#1)(2012-12#1)(2013-1#1)
rest of the##63##3##(1990-3#1)(1991-1#1)(1991-5#2)(1991-8#2)(1992-10#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
rest of##80##2##(1990-3#1)(1991-1#1)(1991-5#2)(1991-8#2)(1992-10#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-2#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
rest on##2##2##(1991-1#1)(1996-2#1)
rest or##4##2##(1994-8#2)(2008-10#1)(2008-8#1)
rest period##2##2##(1991-2#1)(2009-1#1)
rest was##2##2##(1995-3#1)(2009-1#1)
rest went##2##2##(1991-1#1)(1992-2#1)
rest were##2##2##(2008-10#1)(2008-7#1)
rest with##2##2##(2007-12#1)(2008-7#1)
rest##204##1##(1990-3#1)(1991-1#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#21)(2008-8#5)(2008-9#2)(2009-1#2)(2009-2#1)(2009-3#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#14)(2013-7#1)(2013-8#6)
rest/activity##3##1##(2008-6#3)
restart##4##1##(2008-7#2)(2011-2#1)(2013-1#1)
restarted##3##1##(1997-7#1)(2008-10#1)(2012-2#1)
restate##2##1##(2010-5#1)(2013-1#1)
restaurant##2##1##(1990-6#1)(1994-3#1)
restaurants in##2##2##(1994-3#1)(2012-1#1)
rested##3##1##(2007-10#1)(2008-5#1)(2008-9#1)
restenoses##2##1##(1994-11#1)(2008-10#1)
restenosis after##9##2##(1991-5#1)(1992-9#1)(1995-8#1)(1996-8#1)(2007-8#1)(2008-4#2)(2008-7#1)(2009-11#1)
restenosis and##4##2##(2006-6#1)(2008-12#2)(2011-2#1)
restenosis in the##2##3##(1992-9#1)(1994-9#1)
restenosis in##3##2##(1992-9#1)(1994-9#1)(2008-11#1)
restenosis is##2##2##(1994-9#2)
restenosis rates##2##2##(1996-8#1)(2008-11#1)
restenosis was##2##2##(2008-11#2)
restenosis##63##1##(1991-5#1)(1992-4#2)(1992-9#10)(1994-11#4)(1994-9#3)(1995-8#1)(1996-6#1)(1996-8#7)(2006-6#2)(2007-8#1)(2008-11#10)(2008-12#6)(2008-4#6)(2008-5#3)(2008-7#3)(2009-11#1)(2009-5#1)(2011-2#1)
resternotomy##2##1##(1990-2#1)(2007-8#1)
resting B cells##4##3##(1993-11#3)(2008-4#1)
resting GABA efflux##2##3##(1993-12#2)
resting HR##2##2##(2012-2#2)
resting and activated##2##3##(2008-9#1)(2010-1#1)
resting and vigilance-controlled conditions##2##4##(1996-7#2)
resting and##12##2##(1993-11#1)(1994-3#1)(1996-7#2)(2008-7#3)(2008-9#2)(2009-12#1)(2010-1#1)(2011-2#1)
resting blood pressure##5##3##(1990-8#1)(1994-3#3)(2008-3#1)
resting blood##6##2##(1990-3#1)(1990-8#1)(1994-3#3)(2008-3#1)
resting cells of##2##3##(1990-2#1)(1995-3#1)
resting cells##6##2##(1990-11#1)(1990-2#1)(1994-3#1)(1995-3#1)(2008-7#1)(2008-8#1)
resting conditions##4##2##(1995-5#1)(1997-7#1)(2008-4#1)(2008-8#1)
resting energy expenditure##2##3##(2008-5#2)
resting heart##2##2##(1991-8#1)(2008-3#1)
resting hormonal concentrations##2##3##(2008-5#2)
resting limb during##2##3##(2013-8#2)
resting limb##3##2##(2013-8#3)
resting metabolic rate##2##3##(2008-4#2)
resting motor threshold##3##3##(2011-2#3)
resting on##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
resting or##3##2##(1990-12#1)(2008-4#1)(2013-8#1)
resting phase##2##2##(1994-3#1)(2008-5#1)
resting platelets##8##2##(1992-6#2)(1993-8#1)(1997-7#2)(2006-6#3)
resting spores##5##2##(2008-10#5)
resting stage from##2##3##(2013-7#2)
resting state##3##2##(2008-11#1)(2013-8#2)
resting tension##3##2##(1990-12#1)(1996-9#1)(2008-12#1)
resting upper arm##2##3##(2013-8#2)
resting##143##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#6)(1993-11#4)(1993-12#5)(1993-8#1)(1993-9#1)(1994-3#9)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-7#6)(2006-6#3)(2007-10#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#8)(2008-5#7)(2008-7#8)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-1#5)(2010-5#1)(2011-2#6)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#12)
resting&quot##2##1##(1993-11#1)(2009-10#1)
restitution of##2##2##(1994-2#1)(1997-1#1)
restitution##4##1##(1994-2#1)(1995-12#1)(1997-1#1)(2008-7#1)
restless legs syndrome##3##3##(2012-12#1)(2012-3#1)(2013-7#1)
restless legs##4##2##(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
restless legs]##2##2##(2008-4#2)
restless##6##1##(2008-4#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
restlessness and##2##2##(1994-3#1)(1995-8#1)
restlessness##7##1##(1994-3#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)
restoration and the##2##3##(2007-7#1)(2008-11#1)
restoration and##6##2##(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
restoration filter for##3##3##(2008-2#3)
restoration for##2##2##(2008-3#1)(2008-7#1)
restoration from##3##2##(2008-2#1)(2008-3#2)
restoration in##3##2##(2008-2#2)(2010-12#1)
restoration of a##2##3##(1991-5#1)(2007-11#1)
restoration of anterior teeth##2##4##(1990-5#1)(2013-1#1)
restoration of function##4##3##(2007-8#1)(2008-9#3)
restoration of limb##2##3##(2007-11#1)(2010-5#1)
restoration of normal##2##3##(2007-11#1)(2008-11#1)
restoration of the original##3##4##(2008-3#1)(2008-5#1)(2011-2#1)
restoration of the proper##2##4##(2007-8#1)(2013-1#1)
restoration of the two##2##4##(1995-9#1)(2008-2#1)
restoration of the##23##3##(1991-3#1)(1995-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
restoration of##90##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-3#1)(1991-5#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(2007-11#4)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#3)(2008-3#6)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#6)(2009-8#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#3)
restoration performance##2##2##(2008-3#2)
restoration programs##4##2##(2008-4#1)(2013-7#3)
restoration to##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
restoration##171##1##(1990-12#1)(1990-5#4)(1991-12#1)(1991-3#1)(1991-5#2)(1993-3#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-5#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#7)(2008-2#17)(2008-3#22)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#8)(2008-9#6)(2009-7#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#14)(2013-7#7)
restorations and##2##2##(2011-2#1)(2013-1#1)
restorations in the##2##3##(2008-7#1)(2012-12#1)
restorations in##4##2##(2008-7#2)(2012-12#1)(2013-1#1)
restorations were provided##2##3##(2013-1#2)
restorations were##6##2##(2009-8#3)(2011-2#1)(2013-1#2)
restorations##26##1##(1990-9#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-8#8)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)
restorative and prosthetic##2##3##(2013-1#2)
restorative and##4##2##(2008-11#1)(2012-2#1)(2013-1#2)
restorative dental##2##2##(2008-3#1)(2013-1#1)
restorative dentistry##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
restorative material##4##2##(2008-7#1)(2009-7#3)
restorative materials##8##2##(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#4)(2012-6#1)
restorative treatment##2##2##(2010-3#1)(2013-1#1)
restorative##43##1##(1991-6#1)(1992-3#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#1)(2008-7#4)(2009-7#5)(2010-3#5)(2011-2#5)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#5)
restore a##3##2##(1993-9#1)(2008-3#1)(2012-1#1)
restore the##22##2##(1990-6#1)(1993-3#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
restore their##2##2##(2008-3#1)(2008-7#1)
restore##72##1##(1990-2#1)(1990-6#1)(1991-5#1)(1991-7#1)(1993-3#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#2)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)
restored a portion of the life that would have been lost due to##2##13##(2008-7#2)
restored a##3##2##(2008-10#1)(2008-7#2)
restored after##3##2##(1990-12#1)(1991-9#1)(1996-5#1)
restored and##3##2##(2007-11#1)(2007-8#1)(2008-11#1)
restored at##2##2##(1994-6#1)(2009-8#1)
restored by increasing the##2##4##(2008-7#2)
restored by the addition of calcium##2##6##(1992-3#1)(2008-10#1)
restored by the addition of##3##5##(1990-11#1)(1992-3#1)(2008-10#1)
restored by use of a##2##5##(2008-2#1)(2008-3#1)
restored by##28##2##(1990-11#1)(1990-5#1)(1991-5#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-8#1)(1996-3#1)(1996-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2011-3#1)
restored if##2##2##(1994-8#1)(2008-11#1)
restored image##3##2##(2008-2#1)(2008-3#2)
restored images##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
restored in the##2##3##(1997-3#1)(1997-7#1)
restored in##7##2##(1997-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2009-8#1)(2012-3#2)
restored projection image##2##3##(2008-5#2)
restored the GTH-II##2##3##(2008-5#2)
restored the##10##2##(1991-5#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-3#1)(2013-1#1)
restored to Ery+##2##3##(1990-5#2)
restored to normal##3##3##(1993-11#1)(2008-5#1)(2011-2#1)
restored to the level##2##4##(1993-8#1)(2008-9#1)
restored to the##3##3##(1993-8#1)(2008-2#1)(2008-9#1)
restored to##9##2##(1990-5#2)(1992-11#1)(1993-11#1)(1993-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
restored with a##4##3##(2013-1#4)
restored with composite resin##3##4##(2013-1#3)
restored with##12##2##(1990-2#1)(1997-8#1)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#7)
restored##142##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#4)(1991-2#1)(1991-5#4)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#4)(2010-2#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#12)
restorer line##2##2##(2008-10#2)
restorer##3##1##(2008-10#2)(2008-9#1)
restores cell##2##2##(1993-6#2)
restores the##6##2##(1990-5#1)(1993-9#1)(1994-6#1)(2008-10#2)(2010-2#1)
restores##23##1##(1990-5#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#1)
restoring a##2##2##(2010-4#1)(2012-2#1)
restoring dopamine##2##2##(2008-7#1)(2010-12#1)
restoring function##2##2##(2007-8#1)(2008-8#1)
restoring the##7##2##(1990-5#1)(1993-2#1)(1993-8#1)(1995-3#1)(2008-7#1)(2010-1#1)(2012-2#1)
restoring##28##1##(1990-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
restrain the##4##2##(2008-11#1)(2008-2#1)(2010-8#1)(2013-1#1)
restrain##7##1##(1996-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
restrained by##3##2##(1992-2#1)(1997-6#1)(2008-11#1)
restrained least-squares##2##2##(1992-4#1)(1993-8#1)
restrained molecular dynamics##3##3##(1993-11#2)(2008-8#1)
restrained##21##1##(1990-11#1)(1990-4#1)(1991-1#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-8#1)(1994-5#1)(1996-2#1)(1997-6#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)
restraining##3##1##(1991-12#1)(2008-11#1)(2008-8#1)
restraint and##3##2##(1996-2#1)(1997-2#1)(2007-12#1)
restraint rates##2##2##(2008-7#2)
restraint stress##6##2##(1994-2#5)(2010-5#1)
restraint##35##1##(1990-7#1)(1991-12#1)(1993-12#2)(1994-2#6)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-2#1)(1997-2#4)(2007-12#1)(2008-7#5)(2008-8#2)(2009-6#2)(2010-5#1)(2011-2#1)(2013-1#1)
restraints in##2##2##(1994-12#1)(2008-7#1)
restraints on##2##2##(1994-2#1)(2008-5#1)
restraints##18##1##(1991-11#1)(1991-12#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-5#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#3)(2010-7#1)(2012-12#1)
restrict funding##2##2##(1991-1#1)(1994-2#1)
restrict minors'##2##2##(1991-5#2)
restrict the##9##2##(1990-12#1)(1992-1#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
restrict their##3##2##(1996-5#1)(2008-5#1)(2010-6#1)
restrict##37##1##(1990-12#1)(1991-1#1)(1991-3#1)(1991-5#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
restricta##2##1##(2008-5#2)
restricted and##4##2##(1992-9#1)(1995-5#1)(2008-10#1)(2013-1#1)
restricted areas##2##2##(1994-12#1)(2011-2#1)
restricted by the##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-3#1)
restricted by##10##2##(1992-2#1)(1992-4#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
restricted diet##2##2##(2008-3#2)
restricted expression in##2##3##(2008-9#1)(2011-1#1)
restricted expression##4##2##(1994-8#1)(1997-4#1)(2008-9#1)(2011-1#1)
restricted gene flow between##2##4##(2008-10#1)(2012-3#1)
restricted gene flow##5##3##(2008-10#2)(2008-9#1)(2010-8#1)(2012-3#1)
restricted in##5##2##(1991-5#1)(1996-4#1)(2008-10#2)(2012-12#1)
restricted number of##2##3##(1990-8#1)(1993-12#1)
restricted population of##2##3##(1993-12#1)(1994-2#1)
restricted primarily to##3##3##(2008-4#1)(2008-7#2)
restricted range of##2##3##(2007-11#1)(2013-8#1)
restricted range##3##2##(2007-11#1)(2008-9#1)(2013-8#1)
restricted the##5##2##(1992-6#1)(1997-6#1)(2008-10#1)(2009-12#1)(2010-2#1)
restricted to a few##2##4##(2008-5#1)(2013-1#1)
restricted to a narrow##2##4##(1997-1#1)(2008-2#1)
restricted to a single##4##4##(1992-8#1)(1994-2#1)(2007-12#1)(2008-10#1)
restricted to a##13##3##(1992-8#1)(1994-2#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
restricted to any##2##3##(1995-2#1)(2008-11#1)
restricted to certain##2##3##(1990-5#1)(2011-2#1)
restricted to patients##2##3##(2008-11#1)(2012-12#1)
restricted to small##2##3##(2008-3#1)(2010-10#1)
restricted to some##2##3##(1994-2#1)(1995-9#1)
restricted to the epidermis and outer cortex tissues##2##8##(2008-10#2)
restricted to the epidermis and##3##5##(2008-10#3)
restricted to the##45##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1994-12#2)(1995-2#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-4#1)(2012-2#3)(2012-3#2)
restricted to##131##2##(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-12#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-12#2)(1994-12#3)(1994-2#2)(1994-3#2)(1995-2#3)(1995-6#2)(1995-9#1)(1996-4#2)(1996-5#2)(1996-7#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
restricted use of##3##3##(2007-7#1)(2008-10#1)(2012-1#1)
restricted use##4##2##(1992-3#1)(2007-7#1)(2008-10#1)(2012-1#1)
restricted##287##1##(1990-11#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#7)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-7#1)(1994-8#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-4#3)(1996-5#4)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#2)(2008-1#2)(2008-10#52)(2008-11#11)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#14)(2008-6#2)(2008-7#15)(2008-8#13)(2008-9#8)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#3)
restricting the##6##2##(1996-11#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-10#1)
restricting their##3##2##(1993-12#1)(2009-5#1)(2010-4#1)
restricting##17##1##(1993-1#1)(1993-12#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-10#1)(2011-2#2)(2013-1#1)
restriction (CR)##5##2##(1994-5#1)(2008-11#1)(2008-7#2)(2009-5#1)
restriction analysis and##2##3##(1992-3#1)(2008-10#1)
restriction analysis of##5##3##(1993-6#1)(1996-3#1)(1996-6#1)(2008-10#2)
restriction analysis##10##2##(1992-3#1)(1992-8#1)(1993-6#2)(1996-3#1)(1996-6#1)(2008-10#4)
restriction and the##4##3##(1990-2#1)(1990-5#1)(2007-11#1)(2008-10#1)
restriction and##13##2##(1990-2#1)(1990-5#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-7#3)(2009-5#1)(2013-1#1)
restriction by##4##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
restriction did not##2##3##(1990-3#1)(2008-4#1)
restriction digestion of##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
restriction digestion##6##2##(1994-8#1)(2008-10#2)(2008-2#1)(2008-4#2)
restriction digests##2##2##(1992-3#1)(1997-3#1)
restriction endonuclease (ENase)##2##3##(1993-12#1)(1993-9#1)
restriction endonuclease digestion##2##3##(2008-8#1)(2012-3#1)
restriction endonuclease mapping##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
restriction endonuclease##16##2##(1991-2#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-9#1)(1994-12#2)(1996-12#1)(1997-6#2)(2008-10#1)(2008-5#1)(2008-8#2)(2012-3#1)
restriction endonucleases##6##2##(1993-9#2)(2008-1#1)(2008-2#1)(2008-4#1)(2010-4#1)
restriction enzyme digestion and##2##4##(1993-12#1)(2008-10#1)
restriction enzyme digestion##3##3##(1993-12#1)(2008-10#2)
restriction enzyme digests##2##3##(1992-11#1)(2008-10#1)
restriction enzyme recognition sites##2##4##(1997-2#1)(1997-4#1)
restriction enzyme site##2##3##(1991-5#1)(1997-5#1)
restriction enzyme##29##2##(1991-5#1)(1991-9#1)(1992-11#3)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-8#1)(2008-10#9)(2008-5#1)(2008-7#1)
restriction enzyme-mediated integration (REMI)##4##4##(2008-10#4)
restriction enzyme-mediated integration##5##3##(2008-10#5)
restriction enzymes##26##2##(1990-3#1)(1996-2#1)(1997-2#2)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)
restriction for##2##2##(1992-2#1)(2010-4#1)
restriction fragment length polymorphism (RFLP) analyses##2##6##(2008-10#2)
restriction fragment length polymorphism (RFLP) analysis of##3##7##(2008-10#3)
restriction fragment length polymorphism (RFLP) analysis##8##6##(2008-10#6)(2008-5#1)(2012-3#1)
restriction fragment length polymorphism (RFLP) loci##2##6##(2008-10#2)
restriction fragment length polymorphism (RFLP) markers were##2##7##(2008-10#1)(2008-9#1)
restriction fragment length polymorphism (RFLP) markers##8##6##(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#4)(2008-9#1)
restriction fragment length polymorphism (RFLP)##33##5##(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#24)(2008-4#1)(2008-5#1)(2008-9#2)(2012-3#1)(2013-1#1)
restriction fragment length polymorphism analyses##2##5##(2008-10#2)
restriction fragment length polymorphism analysis of a##2##7##(2008-10#2)
restriction fragment length polymorphism analysis of the##3##7##(2008-10#3)
restriction fragment length polymorphism analysis of##7##6##(2008-10#7)
restriction fragment length polymorphism analysis##13##5##(2008-10#11)(2008-4#1)(2008-5#1)
restriction fragment length polymorphism and##2##5##(2008-10#2)
restriction fragment length polymorphism banding##2##5##(2008-10#2)
restriction fragment length polymorphism linkage##2##5##(1996-10#1)(2008-10#1)
restriction fragment length polymorphism loci##2##5##(2008-10#2)
restriction fragment length polymorphism map##2##5##(2008-10#2)
restriction fragment length polymorphism marker##2##5##(2008-10#2)
restriction fragment length polymorphism markers##4##5##(2008-10#4)
restriction fragment length polymorphism of##3##5##(2008-10#3)
restriction fragment length polymorphism probes##3##5##(2008-10#3)
restriction fragment length polymorphism with##2##5##(2008-10#1)(2008-9#1)
restriction fragment length polymorphism##92##4##(1990-3#1)(1992-3#1)(1995-6#1)(1996-10#2)(1996-12#1)(2006-8#1)(2008-10#75)(2008-4#2)(2008-5#2)(2008-9#3)(2012-3#1)(2013-1#2)
restriction fragment length polymorphisms (RFLPs)##6##5##(2008-10#5)(2008-5#1)
restriction fragment length polymorphisms analysis##3##5##(2011-1#3)
restriction fragment length polymorphisms##22##4##(1991-8#1)(1994-11#1)(1996-12#2)(1996-5#1)(1997-5#1)(2008-10#10)(2008-12#1)(2008-5#2)(2011-1#3)
restriction fragment length##115##3##(1990-3#1)(1991-8#1)(1992-3#1)(1994-11#1)(1995-6#1)(1996-10#2)(1996-12#3)(1996-5#1)(1997-5#1)(2006-8#1)(2008-10#86)(2008-12#1)(2008-4#2)(2008-5#4)(2008-9#3)(2011-1#3)(2012-3#1)(2013-1#2)
restriction fragment##118##2##(1990-3#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-6#1)(1996-10#2)(1996-12#3)(1996-5#1)(1997-5#1)(2006-8#1)(2008-1#1)(2008-10#87)(2008-12#1)(2008-4#2)(2008-5#4)(2008-9#3)(2011-1#3)(2012-3#1)(2013-1#2)
restriction fragments containing##2##3##(1995-5#1)(2008-5#1)
restriction fragments from##4##3##(1992-6#1)(1993-2#1)(2008-2#2)
restriction fragments##12##2##(1992-3#1)(1992-6#2)(1993-2#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-5#1)
restriction in##4##2##(1994-3#1)(1994-5#1)(1996-5#1)(2008-3#1)
restriction is##2##2##(2008-4#1)(2009-5#1)
restriction map of##2##3##(1992-3#1)(1993-6#1)
restriction mapping##4##2##(1992-8#1)(1992-9#1)(1994-12#1)(2008-4#1)
restriction maps##2##2##(1992-11#1)(2008-4#1)
restriction of fungal##2##3##(2008-10#2)
restriction of the##3##3##(2008-10#2)(2008-7#1)
restriction of##24##2##(1993-1#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
restriction on the##8##3##(1990-3#1)(1991-9#1)(1993-12#2)(2008-10#1)(2008-3#3)
restriction on##15##2##(1990-3#1)(1990-9#1)(1991-9#2)(1993-12#2)(1996-5#1)(2008-10#2)(2008-3#3)(2008-7#2)(2009-2#1)
restriction pattern##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
restriction patterns##6##2##(1997-2#2)(1997-6#2)(2008-10#2)
restriction profile##2##2##(1997-2#1)(2008-10#1)
restriction profiles##2##2##(1997-2#1)(2008-10#1)
restriction site in##3##3##(1990-7#3)
restriction site polymorphism was##2##4##(2008-10#1)(2008-5#1)
restriction site polymorphism##3##3##(2008-10#2)(2008-5#1)
restriction site##16##2##(1990-12#1)(1990-7#3)(1994-12#2)(1996-4#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-5#3)
restriction sites for##2##3##(1991-5#1)(1996-2#1)
restriction sites in##2##3##(1990-5#1)(2008-11#1)
restriction sites##14##2##(1990-5#4)(1991-5#1)(1991-7#1)(1992-3#1)(1994-12#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
restriction to##3##2##(1990-3#1)(1991-12#1)(2008-10#1)
restriction##415##1##(1990-12#1)(1990-2#2)(1990-3#9)(1990-5#5)(1990-7#3)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-11#4)(1992-2#1)(1992-3#6)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#9)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#5)(1994-11#1)(1994-12#8)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#3)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#7)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#152)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#20)(2008-5#11)(2008-7#12)(2008-8#5)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-4#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
restriction-fragment##2##1##(1992-2#1)(1993-2#1)
restriction-modification (R-M) system##2##3##(1991-9#1)(1993-9#1)
restriction-modification system##2##2##(1993-9#1)(1994-12#1)
restriction-modification##4##1##(1991-9#1)(1993-9#2)(1994-12#1)
restriction/modification systems##2##2##(1990-5#2)
restrictions as##2##2##(1994-2#1)(2010-5#1)
restrictions during##2##2##(1992-3#1)(2010-6#1)
restrictions imposed by##2##3##(1991-11#1)(2008-3#1)
restrictions in##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
restrictions of the##2##3##(2007-12#1)(2008-12#1)
restrictions of##5##2##(1993-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)
restrictions on insurance coverage of abortion for public employees##2##9##(1994-2#2)
restrictions on the##5##3##(1991-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
restrictions on##20##2##(1991-10#1)(1991-5#2)(1992-6#2)(1994-2#4)(1997-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-4#1)(2012-12#1)
restrictions##65##1##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#2)(1992-3#2)(1992-6#2)(1993-1#1)(1993-3#1)(1994-2#9)(1996-3#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
restrictive anorexia nervosa##3##3##(2012-3#3)
restrictive cardiomyopathy is##2##3##(2008-7#2)
restrictive cardiomyopathy##5##2##(2008-7#3)(2010-4#1)(2010-8#1)
restrictive conditions##2##2##(2008-2#1)(2011-1#1)
restrictive in##2##2##(1995-3#1)(2010-8#1)
restrictive lung disease##2##3##(2006-10#1)(2008-8#1)
restrictive lung function##3##3##(1991-12#3)
restrictive lung##5##2##(1991-12#3)(2006-10#1)(2008-8#1)
restrictive pattern##2##2##(1997-3#1)(2010-2#1)
restrictive##48##1##(1990-5#1)(1990-9#1)(1991-12#3)(1991-6#2)(1992-2#1)(1993-1#1)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
restricts its##3##2##(1994-12#1)(1994-8#1)(2008-9#1)
restricts the##5##2##(2008-10#2)(2008-3#3)
restricts##11##1##(1994-12#1)(1994-8#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-12#1)(2010-5#1)(2013-8#1)
restrictus##2##1##(1993-2#1)(2008-11#1)
restructure##7##1##(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(2008-9#1)
restructured environment##3##2##(1994-3#1)(1995-2#1)(1996-3#1)
restructured hospital is##2##3##(1994-12#1)(1994-3#1)
restructured##18##1##(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#3)(2010-8#1)(2012-2#1)
restructuring and##3##2##(1995-12#1)(1996-1#1)(2008-5#1)
restructuring at##2##2##(1994-3#1)(2009-10#1)
restructuring education##2##2##(1995-2#2)
restructuring efforts##2##2##(1994-3#1)(1996-12#1)
restructuring initiative##5##2##(1994-12#1)(1994-3#1)(1996-1#3)
restructuring initiatives##3##2##(1995-2#1)(1996-1#1)(2012-3#1)
restructuring is##2##2##(1995-12#1)(2012-3#1)
restructuring of the##3##3##(1992-1#1)(1996-1#1)(2011-1#1)
restructuring of##6##2##(1991-3#1)(1992-1#1)(1994-12#1)(1996-1#1)(1997-2#1)(2011-1#1)
restructuring on##2##2##(1993-1#1)(2007-12#1)
restructuring process##2##2##(1996-1#1)(1996-12#1)
restructuring program##4##2##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)
restructuring that##3##2##(1995-12#1)(1996-3#1)(2009-10#1)
restructuring the health care##2##4##(1993-12#1)(1996-12#1)
restructuring the##7##2##(1991-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(2008-3#1)(2008-6#1)(2010-4#1)
restructuring##93##1##(1991-1#1)(1991-3#2)(1992-1#2)(1992-12#1)(1993-1#3)(1993-12#7)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#6)(1995-1#4)(1995-12#5)(1995-2#6)(1995-3#3)(1996-1#12)(1996-12#5)(1996-3#3)(1997-2#2)(1997-3#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#5)(2009-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#5)(2013-1#1)
restructuring?##3##1##(1994-2#1)(1994-3#2)
rests on the##4##3##(1994-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
rests on##6##2##(1994-12#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
rests with##4##2##(1992-1#1)(1996-11#1)(1997-7#1)(2007-12#1)
rests##14##1##(1992-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)
result a##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
result after##4##2##(2007-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
result and the##4##3##(1995-9#1)(2007-8#1)(2008-9#1)(2011-2#1)
result and##14##2##(1990-11#1)(1991-3#1)(1991-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)
result as##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
result at##2##2##(2008-10#1)(2012-3#1)
result being##2##2##(1991-9#1)(1992-9#1)
result by##4##2##(1990-11#1)(2007-12#1)(2008-8#1)(2012-1#1)
result can be##4##3##(1993-6#1)(2007-12#1)(2008-10#1)(2010-10#1)
result confirms##4##2##(2008-10#1)(2008-8#3)
result corresponds to##2##3##(2007-11#1)(2008-10#1)
result could be##4##3##(2008-3#2)(2008-7#1)(2011-2#1)
result could##6##2##(2008-3#2)(2008-5#1)(2008-7#2)(2011-2#1)
result demonstrates that##3##3##(2007-11#1)(2008-2#1)(2008-9#1)
result demonstrates##4##2##(2007-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
result does not##3##3##(1992-6#1)(1996-5#1)(2011-1#1)
result either from##2##3##(1997-2#1)(2009-10#1)
result for a##2##3##(2008-3#1)(2013-1#1)
result for the##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2011-2#1)
result for##16##2##(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-9#2)(2011-2#1)(2013-1#1)
result from a##17##3##(1994-3#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2013-8#1)
result from an action##2##4##(1994-8#1)(2010-8#1)
result from an##4##3##(1990-5#1)(1994-8#1)(1995-5#1)(2010-8#1)
result from applying##2##3##(2008-10#1)(2008-5#1)
result from changes in##2##4##(1990-8#1)(1994-9#1)
result from differential##2##3##(2008-6#2)
result from enhanced##2##3##(1994-11#1)(1994-8#1)
result from increased##2##3##(1997-3#1)(2008-9#1)
result from interactions between##2##4##(1997-7#1)(2012-2#1)
result from interactions##3##3##(1997-7#1)(2012-2#1)(2012-3#1)
result from its##2##3##(2008-11#1)(2011-1#1)
result from progressive##2##3##(2012-2#1)(2013-7#1)
result from selective##2##3##(2008-7#1)(2011-2#1)
result from strong##2##3##(2008-8#1)(2008-9#1)
result from structural##3##3##(1995-5#1)(2010-8#1)(2012-3#1)
result from the absence of##3##5##(1990-5#1)(1990-8#1)(2009-10#1)
result from the interaction of##3##5##(1994-3#1)(2008-9#1)(2013-1#1)
result from the##40##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
result from their##2##3##(1990-11#1)(1995-6#1)
result from thermally induced##2##4##(2008-3#2)
result from this##3##3##(1991-3#1)(2006-4#1)(2008-3#1)
result from##171##2##(1990-11#2)(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#4)(1991-12#2)(1991-3#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-5#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
result has been##5##3##(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2012-3#1)
result has##7##2##(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-3#1)
result implies that##7##3##(1996-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
result implies##8##2##(1990-8#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
result in a better understanding of the##2##7##(1991-6#1)(2007-10#1)
result in a better##4##4##(1991-6#1)(2007-10#1)(2008-11#1)(2008-5#1)
result in a decline##2##4##(1991-7#1)(1995-5#1)
result in a greater##2##4##(1997-1#1)(2007-11#1)
result in a higher##3##4##(1994-11#1)(1994-12#1)(2008-10#1)
result in a significant increase in the##2##7##(2008-10#2)
result in a significant increase in##3##6##(2008-10#2)(2008-11#1)
result in a significant##6##4##(2008-10#3)(2008-11#1)(2008-6#1)(2011-1#1)
result in a##66##3##(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-5#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#2)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
result in an increase in the number##4##7##(1991-6#1)(1995-3#1)(1997-6#1)(2008-10#1)
result in an increase of##5##5##(1994-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
result in an increase##9##4##(1991-6#1)(1994-9#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-7#1)
result in an##22##3##(1991-6#1)(1992-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-7#1)(2012-3#1)(2013-7#1)
result in behavioral##2##3##(2008-4#1)(2010-9#1)
result in better##2##3##(2007-11#1)(2011-2#1)
result in both##2##3##(2008-5#1)(2008-7#1)
result in changes in##2##4##(1990-8#1)(2008-3#1)
result in changes of the##2##5##(1997-2#1)(2009-2#1)
result in changes of##3##4##(1992-5#1)(1997-2#1)(2009-2#1)
result in changes##6##3##(1990-8#1)(1992-5#1)(1997-2#1)(2008-3#1)(2009-2#1)(2012-2#1)
result in clinical##2##3##(2010-5#1)(2011-2#1)
result in complete##3##3##(2006-12#1)(2008-11#1)(2008-5#1)
result in different##2##3##(2008-9#1)(2011-2#1)
result in disease##2##3##(2008-9#1)(2010-5#1)
result in either##2##3##(2008-5#1)(2008-9#1)
result in enhanced levels of##2##5##(1995-3#1)(2008-5#1)
result in enhanced##3##3##(1995-3#1)(2008-11#1)(2008-5#1)
result in exposure##2##3##(1992-1#1)(1997-4#1)
result in greater##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
result in high##6##3##(2008-10#2)(2008-3#1)(2008-4#1)(2010-12#1)(2012-3#1)
result in higher##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
result in immunotoxicity##2##3##(2008-10#2)
result in improved quality of##2##5##(1992-3#1)(2010-12#1)
result in improved##6##3##(1992-3#1)(1997-1#1)(2008-3#1)(2009-3#1)(2009-6#1)(2010-12#1)
result in increased##10##3##(1993-2#1)(1995-2#2)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-6#1)(2009-9#1)(2012-3#1)
result in less##2##3##(2011-2#1)(2012-2#1)
result in long-term##2##3##(2012-1#1)(2013-8#1)
result in lung##2##3##(1990-5#1)(2011-2#1)
result in misleading##2##3##(1994-12#1)(2008-11#1)
result in more##5##3##(1992-8#1)(1994-3#1)(1996-3#1)(2009-3#1)(2012-12#1)
result in novel##2##3##(1996-2#1)(2012-1#1)
result in pathology##2##3##(2008-10#1)(2010-3#1)
result in reduced##3##3##(2008-10#1)(2008-5#1)(2010-1#1)
result in reduction of##2##4##(2012-3#2)
result in serious##2##3##(1992-8#1)(2010-8#1)
result in severe##6##3##(1995-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2011-2#2)
result in significant morbidity and##2##5##(1997-3#1)(2008-7#1)
result in significant morbidity##3##4##(1997-3#1)(2006-10#1)(2008-7#1)
result in significant##13##3##(1996-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#2)(2012-3#1)
result in significantly##3##3##(2007-7#1)(2008-10#1)(2010-12#1)
result in substantial##2##3##(1996-12#1)(2013-1#1)
result in systemic##2##3##(1991-4#1)(2008-10#1)
result in the accumulation of##2##5##(1995-6#1)(2008-7#1)
result in the formation of##2##5##(1993-6#1)(2009-2#1)
result in the generation of##2##5##(2008-10#1)(2010-9#1)
result in the loss of##2##5##(2008-8#1)(2008-9#1)
result in the##54##3##(1990-7#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-3#2)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#6)(2008-11#6)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#2)(2013-1#1)
result in unacceptable##3##3##(2007-8#1)(2008-6#1)(2012-2#1)
result in##441##2##(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#49)(2008-11#22)(2008-12#2)(2008-2#9)(2008-3#23)(2008-4#10)(2008-5#9)(2008-6#5)(2008-7#13)(2008-8#11)(2008-9#11)(2009-10#4)(2009-11#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#30)(2012-1#2)(2012-12#2)(2012-2#13)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#5)
result indicated that the##4##4##(2008-1#1)(2008-8#3)
result indicated that##9##3##(2008-1#1)(2008-5#1)(2008-8#6)(2008-9#1)
result indicates that the##5##4##(1991-3#1)(1991-6#1)(2008-10#2)(2008-5#1)
result indicates that##13##3##(1990-12#1)(1991-3#1)(1991-6#1)(1992-5#1)(1994-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2009-9#1)(2012-2#1)
result is a better##2##4##(2008-3#1)(2008-9#1)
result is a new##2##4##(1991-1#1)(2008-2#1)
result is a##13##3##(1991-1#1)(2006-7#1)(2007-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)
result is an##2##3##(1992-3#1)(2008-10#1)
result is discussed##2##3##(1996-5#1)(2008-1#1)
result is in good agreement with##2##6##(2007-11#1)(2007-12#1)
result is in##6##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
result is not##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
result is that the##2##4##(2008-8#1)(2010-1#1)
result is that##13##3##(1991-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#2)(2010-1#1)
result is##67##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#2)(2006-12#1)(2006-7#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
result may be##3##3##(1990-2#1)(1994-5#1)(2011-2#1)
result may##7##2##(1990-2#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
result means that the##2##4##(1993-8#1)(2008-11#1)
result obtained##4##2##(1996-8#1)(2007-8#1)(2008-10#1)(2008-2#1)
result of DNA##2##3##(2008-10#1)(2008-11#1)
result of a complex##3##4##(2008-1#1)(2009-10#1)(2010-12#1)
result of a##51##3##(1990-11#1)(1991-11#1)(1991-2#1)(1994-1#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#3)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
result of all##2##3##(2007-12#1)(2008-5#1)
result of an increase##3##4##(1997-1#2)(2007-12#1)
result of an##14##3##(1993-12#1)(1994-2#1)(1994-5#1)(1996-6#1)(1997-1#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-1#2)
result of binding##2##3##(1990-11#1)(1993-11#1)
result of both##5##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
result of cell##3##3##(1995-11#1)(2008-4#1)(2011-3#1)
result of changes in##4##4##(1992-8#1)(1994-5#1)(2008-11#1)(2008-3#1)
result of changes##5##3##(1992-8#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
result of decreased##4##3##(2007-2#1)(2008-1#1)(2008-8#1)(2013-7#1)
result of different##3##3##(1994-9#1)(1996-3#1)(2007-11#1)
result of exposure to##2##4##(1997-6#1)(2013-8#1)
result of increased##4##3##(1991-3#1)(1994-6#1)(2008-12#1)(2008-9#1)
result of its##6##3##(1995-2#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
result of long standing##2##4##(1997-1#1)(2008-4#1)
result of long##3##3##(1997-1#1)(2008-12#1)(2008-4#1)
result of low##4##3##(2007-11#1)(2007-12#1)(2011-1#1)(2013-1#1)
result of operative treatment##2##4##(2007-11#2)
result of our study##2##4##(2011-1#1)(2012-2#1)
result of our##4##3##(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
result of reduced##2##3##(1995-2#1)(2013-8#1)
result of repeated##2##3##(2008-5#1)(2008-7#1)
result of signal##2##3##(2008-11#1)(2008-2#1)
result of specific##2##3##(2008-3#1)(2008-7#1)
result of the continuous##4##4##(1996-12#1)(2008-10#2)(2008-11#1)
result of the excitation##2##4##(2007-12#1)(2008-2#1)
result of the formation of##2##5##(1993-11#1)(1994-11#1)
result of the interaction##4##4##(1992-3#1)(2008-10#1)(2008-3#2)
result of the introduction of##2##5##(2008-11#1)(2012-12#1)
result of the present study##3##5##(1995-8#1)(2009-12#1)(2012-3#1)
result of the previous##2##4##(1990-2#1)(2010-11#1)
result of the relative##2##4##(2007-11#1)(2008-3#1)
result of the##132##3##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#26)(2008-11#6)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#3)(2009-12#1)(2010-10#2)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
result of their##9##3##(1992-9#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
result of these##8##3##(1992-3#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
result of this research##2##4##(2010-8#1)(2013-1#1)
result of this study##7##4##(1993-3#1)(1995-6#1)(2008-3#1)(2008-7#1)(2013-1#3)
result of this##23##3##(1991-12#1)(1993-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
result of treatment##4##3##(1992-5#1)(2007-11#1)(2007-8#1)(2012-12#1)
result of using##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
result of which##2##3##(1990-6#1)(1991-9#1)
result of##627##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#2)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#6)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#4)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#4)(2007-11#31)(2007-12#27)(2007-2#1)(2007-7#1)(2007-8#10)(2008-1#8)(2008-10#72)(2008-11#28)(2008-12#14)(2008-2#15)(2008-3#33)(2008-4#7)(2008-5#20)(2008-6#8)(2008-7#25)(2008-8#20)(2008-9#18)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#3)(2009-5#3)(2009-7#3)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#9)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#9)(2012-5#1)(2013-1#20)(2013-7#8)(2013-8#15)
result on##2##2##(2008-6#1)(2008-8#1)
result represents##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
result reveals##3##2##(2008-10#1)(2010-11#1)(2010-8#1)
result showed that##15##3##(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
result shows that the##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
result shows that##13##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
result shows the##2##3##(2008-10#2)
result shows##18##2##(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
result strongly suggests that the##2##5##(1990-12#1)(1995-8#1)
result suggested that##10##3##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
result suggests that the##5##4##(1991-2#1)(1996-5#1)(1997-3#1)(2008-10#2)
result suggests that##20##3##(1991-2#3)(1992-3#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-7#1)(2012-12#1)(2013-1#1)
result suggests##23##2##(1991-2#3)(1992-3#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
result supports the##4##3##(1993-9#1)(1997-1#1)(2008-8#1)(2011-2#1)
result supports##5##2##(1993-9#1)(1997-1#1)(2008-8#2)(2011-2#1)
result that##12##2##(1991-12#1)(1992-2#1)(1992-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2011-2#1)(2013-1#1)
result the##7##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-4#1)
result to##2##2##(2007-12#1)(2009-3#1)
result was a##3##3##(1996-12#1)(2008-12#1)(2013-8#1)
result was achieved##3##3##(2008-9#1)(2009-4#1)(2012-3#1)
result was in##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
result was not##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
result was obtained for##2##4##(2008-11#1)(2008-3#1)
result was obtained in##2##4##(1991-6#1)(1991-8#1)
result was obtained with##4##4##(2007-10#1)(2008-10#2)(2008-6#1)
result was obtained##10##3##(1991-6#1)(1991-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
result was that##2##3##(1991-12#1)(2008-2#1)
result was##40##2##(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-5#1)(2007-10#1)(2007-11#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
result we##5##2##(1997-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
result when##4##2##(1991-12#1)(1994-3#1)(2008-3#1)(2008-8#1)
result will be##3##3##(1997-3#1)(2006-10#1)(2010-8#1)
result will##4##2##(1997-3#1)(2006-10#1)(2008-9#1)(2010-8#1)
result with##4##2##(1990-3#1)(1990-9#1)(2007-11#1)(2008-10#1)
result##1947##1##(1990-11#8)(1990-12#5)(1990-2#6)(1990-3#3)(1990-5#11)(1990-6#4)(1990-7#3)(1990-8#10)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#14)(1991-2#10)(1991-3#14)(1991-4#1)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#10)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#12)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#8)(1992-9#8)(1993-1#2)(1993-11#9)(1993-12#12)(1993-2#3)(1993-3#8)(1993-5#1)(1993-6#4)(1993-8#7)(1993-9#5)(1994-1#7)(1994-11#9)(1994-12#7)(1994-2#5)(1994-3#13)(1994-5#6)(1994-6#1)(1994-8#10)(1994-9#7)(1995-1#5)(1995-11#6)(1995-12#5)(1995-2#11)(1995-3#8)(1995-5#8)(1995-6#12)(1995-8#11)(1995-9#4)(1996-1#3)(1996-11#2)(1996-12#16)(1996-2#5)(1996-3#11)(1996-4#3)(1996-5#10)(1996-6#8)(1996-8#4)(1996-9#6)(1997-1#13)(1997-2#16)(1997-3#12)(1997-4#4)(1997-5#6)(1997-6#3)(1997-7#9)(1997-8#10)(2006-10#4)(2006-12#3)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#8)(2007-11#67)(2007-12#65)(2007-2#2)(2007-5#1)(2007-7#7)(2007-8#19)(2008-1#14)(2008-10#224)(2008-11#82)(2008-12#27)(2008-2#55)(2008-3#125)(2008-4#22)(2008-5#49)(2008-6#22)(2008-7#60)(2008-8#72)(2008-9#69)(2009-10#10)(2009-11#3)(2009-12#6)(2009-2#11)(2009-3#12)(2009-4#3)(2009-5#9)(2009-6#3)(2009-7#8)(2009-8#5)(2009-9#9)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#10)(2010-2#1)(2010-3#8)(2010-4#6)(2010-5#11)(2010-6#5)(2010-7#7)(2010-8#12)(2010-9#4)(2011-1#19)(2011-2#77)(2011-3#4)(2012-1#6)(2012-12#16)(2012-2#41)(2012-3#33)(2012-5#1)(2013-1#53)(2013-7#12)(2013-8#40)
resultant acidic##2##2##(2008-5#2)
resultant increase in##3##3##(1993-11#1)(2007-12#1)(2008-11#1)
resultant phase##2##2##(2008-3#2)
resultant##112##1##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#2)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#18)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#2)(2009-1#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
resulted a significant##3##3##(2008-12#1)(2008-7#1)(2009-12#1)
resulted a##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)
resulted from a##4##3##(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#1)
resulted from increased##2##3##(2008-10#1)(2008-9#1)
resulted from the##19##3##(1992-2#1)(1992-9#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
resulted from##63##2##(1992-2#1)(1992-9#1)(1993-11#1)(1994-12#2)(1995-6#1)(1996-11#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
resulted in 100%##2##3##(2008-7#1)(2013-1#1)
resulted in a 1##3##4##(1994-12#1)(1994-9#1)(2008-11#1)
resulted in a 10-fold##2##4##(1992-3#1)(1995-3#1)
resulted in a 35% decrease in##2##6##(1995-2#1)(2008-10#1)
resulted in a 4##2##4##(1995-2#1)(2012-2#1)
resulted in a 50%##2##4##(1993-6#1)(2008-10#1)
resulted in a change of##3##5##(1991-2#1)(2008-10#1)(2008-8#1)
resulted in a change##5##4##(1991-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
resulted in a complete##2##4##(1997-3#1)(2008-10#1)
resulted in a considerable##3##4##(2008-10#2)(2008-6#1)
resulted in a decrease in the##5##6##(1991-9#1)(1993-11#1)(2008-10#1)(2008-7#2)
resulted in a decrease in##11##5##(1991-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#1)
resulted in a decrease of##4##5##(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
resulted in a decrease##15##4##(1991-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
resulted in a deeper##2##4##(2008-9#1)(2012-1#1)
resulted in a dose-dependent##3##4##(1992-11#1)(1994-9#1)(1995-12#1)
resulted in a dramatic##4##4##(1994-8#1)(2007-11#1)(2008-12#1)(2008-7#1)
resulted in a drastic reduction##2##5##(1997-4#1)(2008-10#1)
resulted in a drastic##4##4##(1997-4#1)(1997-5#1)(2008-10#2)
resulted in a greater##2##4##(2010-4#1)(2013-7#1)
resulted in a high##4##4##(2008-10#2)(2010-4#1)(2011-2#1)
resulted in a higher##4##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
resulted in a linear##3##4##(2008-10#2)(2010-2#1)
resulted in a loss of##4##5##(1994-11#1)(1997-3#1)(2008-10#1)(2008-12#1)
resulted in a low##2##4##(2008-10#1)(2008-2#1)
resulted in a lower##2##4##(2007-11#1)(2009-12#1)
resulted in a marked decrease of##2##6##(1995-12#1)(2008-10#1)
resulted in a marked##4##4##(1995-12#1)(1996-12#1)(2008-10#2)
resulted in a more##2##4##(2011-1#1)(2012-12#1)
resulted in a rapid decrease in##2##6##(1990-12#1)(2008-11#1)
resulted in a rapid##9##4##(1990-12#1)(1991-3#1)(1992-3#1)(1992-5#1)(2008-10#2)(2008-11#3)
resulted in a reduced##2##4##(2008-10#1)(2008-7#1)
resulted in a reduction in the##2##6##(1995-6#1)(2012-2#1)
resulted in a reduction##3##4##(1995-6#1)(2011-1#1)(2012-2#1)
resulted in a significant (P &lt##2##6##(1993-12#1)(2008-10#1)
resulted in a significant decrease in##5##6##(1990-7#1)(1991-6#1)(1995-3#1)(2008-5#1)(2012-12#1)
resulted in a significant decrease##7##5##(1990-7#1)(1991-6#1)(1991-9#1)(1995-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
resulted in a significant improvement##2##5##(2012-2#1)(2012-7#1)
resulted in a significant increase in##9##6##(1992-12#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-6#1)(2013-1#1)(2013-7#1)
resulted in a significant increase of##2##6##(2008-10#1)(2008-5#1)
resulted in a significant increase##11##5##(1992-12#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-7#1)
resulted in a significant reduction in##3##6##(1991-12#1)(2008-10#1)(2008-5#1)
resulted in a significant reduction of##3##6##(1992-1#1)(2008-10#1)(2008-3#1)
resulted in a significant reduction##6##5##(1991-12#1)(1992-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
resulted in a significant##40##4##(1990-7#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-7#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2009-12#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#2)(2013-7#1)
resulted in a significantly lower##2##5##(1997-3#1)(2008-10#1)
resulted in a significantly##3##4##(1997-3#1)(2008-10#2)
resulted in a slight decrease##2##5##(2008-10#1)(2011-2#1)
resulted in a substantial##2##4##(1993-8#1)(2008-10#1)
resulted in a transient increase in##2##6##(1993-9#1)(2008-7#1)
resulted in a##267##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#5)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#4)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-12#3)(1995-2#5)(1995-3#4)(1995-6#3)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#63)(2008-11#14)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#8)(2008-7#13)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#5)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#3)
resulted in about##2##3##(2008-11#1)(2008-12#1)
resulted in accumulation of##2##4##(1997-7#1)(2012-3#1)
resulted in activation of##3##4##(1993-3#1)(1994-5#1)(2010-12#1)
resulted in almost complete##3##4##(1990-2#1)(2008-12#1)(2008-7#1)
resulted in an enhanced##2##4##(1990-7#1)(2008-12#1)
resulted in an increase in##10##5##(1990-11#1)(1990-5#1)(1992-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
resulted in an increase of the##2##6##(1993-8#1)(2008-5#1)
resulted in an increase of##3##5##(1993-8#1)(1995-8#1)(2008-5#1)
resulted in an increase##13##4##(1990-11#1)(1990-5#1)(1992-11#1)(1993-8#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
resulted in an increased##8##4##(1991-12#1)(1992-1#1)(1995-12#1)(1995-6#1)(2008-11#1)(2008-2#1)(2009-8#1)(2013-8#1)
resulted in an##54##3##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(2007-10#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
resulted in any##2##3##(2008-10#1)(2008-2#1)
resulted in better##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
resulted in both##2##3##(1991-3#1)(2008-10#1)
resulted in catastrophic##2##3##(2008-10#1)(2008-3#1)
resulted in cell##2##3##(2008-10#1)(2011-1#1)
resulted in changes in##3##4##(1992-6#1)(2008-10#2)
resulted in changes##4##3##(1992-6#1)(2008-10#2)(2008-5#1)
resulted in complete resolution##2##4##(1992-12#1)(2007-7#1)
resulted in complete##10##3##(1991-8#1)(1992-12#1)(1993-12#1)(1996-9#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
resulted in considerable##2##3##(1992-11#1)(2008-10#1)
resulted in decreased##9##3##(1990-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
resulted in delayed##2##3##(1992-8#1)(2007-11#1)
resulted in detection limits of##2##5##(2008-10#2)
resulted in detection of##2##4##(2008-10#2)
resulted in detection##4##3##(2008-10#4)
resulted in disease##3##3##(2008-10#3)
resulted in distinct##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
resulted in dose-dependent inhibition of##2##5##(1994-6#1)(2008-10#1)
resulted in dose-dependent##3##3##(1994-6#1)(2008-10#1)(2013-1#1)
resulted in eight##2##3##(1994-8#1)(2008-10#1)
resulted in either##2##3##(1991-9#1)(2008-10#1)
resulted in elevated##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
resulted in enhanced##3##3##(1992-8#1)(2009-8#1)(2012-12#1)
resulted in extensive##3##3##(1991-5#1)(2007-7#1)(2008-10#1)
resulted in further##3##3##(1993-11#1)(2008-11#1)(2011-1#1)
resulted in greater##7##3##(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2013-1#1)
resulted in greatly reduced##2##4##(2008-10#1)(2008-8#1)
resulted in high##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
resulted in higher##13##3##(1994-6#1)(1996-12#1)(1997-5#1)(2008-10#5)(2008-8#1)(2012-3#1)(2013-1#3)
resulted in immediate##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
resulted in improved overall##2##4##(2008-8#2)
resulted in improved##12##3##(1993-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-4#1)(2011-2#1)
resulted in improvement of##2##4##(1996-2#1)(2008-4#1)
resulted in increased apoptosis##2##4##(2011-1#1)(2012-2#1)
resulted in increased production of##2##5##(1992-8#1)(2008-10#1)
resulted in increased##32##3##(1990-11#1)(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
resulted in infection##3##3##(2008-10#2)(2008-5#1)
resulted in inhibition of##2##4##(1995-12#1)(2011-1#1)
resulted in inhibition##3##3##(1990-7#1)(1995-12#1)(2011-1#1)
resulted in inoculum##2##3##(2008-10#2)
resulted in large##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
resulted in larger##2##3##(2008-10#2)
resulted in less##3##3##(2008-10#2)(2013-1#1)
resulted in loss of##4##4##(1992-8#1)(1993-8#1)(1994-12#1)(2008-10#1)
resulted in lower##11##3##(1997-3#1)(2008-10#3)(2008-7#1)(2008-8#3)(2010-4#1)(2011-2#1)(2012-1#1)
resulted in marked##5##3##(1993-12#2)(1995-2#1)(1996-12#1)(2008-5#1)
resulted in more than##2##4##(1990-7#1)(2008-10#1)
resulted in more##6##3##(1990-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-1#1)
resulted in new##3##3##(1996-2#1)(2008-10#2)
resulted in no significant reduction in the formation of##2##9##(1993-11#2)
resulted in no significant##3##4##(1993-11#2)(2008-5#1)
resulted in no##5##3##(1993-11#2)(1995-2#1)(2008-5#1)(2011-2#1)
resulted in normal##2##3##(1997-7#1)(2008-7#1)
resulted in only##2##3##(2008-3#1)(2010-8#1)
resulted in plants##2##3##(2008-10#1)(2009-10#1)
resulted in positive##2##3##(2007-12#1)(2009-11#1)
resulted in production of##2##4##(2008-10#2)
resulted in progressive##2##3##(2012-2#1)(2012-3#1)
resulted in pronounced##2##3##(2008-10#2)
resulted in rapid##2##3##(1996-11#1)(2012-1#1)
resulted in reduced##9##3##(1991-9#1)(1993-12#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
resulted in reduction##2##3##(1990-9#1)(2013-8#1)
resulted in relatively##3##3##(2008-10#2)(2012-2#1)
resulted in significant changes in##3##5##(1997-4#1)(2008-10#1)(2012-2#1)
resulted in significant differences##2##4##(1994-3#1)(2009-9#1)
resulted in significant improvement in##3##5##(2008-5#1)(2010-5#1)(2012-12#1)
resulted in significant reductions in##2##5##(2008-10#2)
resulted in significant rise##2##4##(2008-5#1)(2013-1#1)
resulted in significant##25##3##(1990-11#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
resulted in significantly greater##3##4##(2007-6#1)(2008-10#2)
resulted in significantly higher##4##4##(2008-10#2)(2011-2#2)
resulted in significantly##12##3##(2007-6#1)(2008-10#6)(2008-9#1)(2011-2#2)(2013-1#2)
resulted in similar##3##3##(2008-10#2)(2010-4#1)
resulted in slightly##2##3##(1992-2#1)(2009-7#1)
resulted in stronger##2##3##(2008-9#1)(2011-2#1)
resulted in suppression of##2##4##(1992-8#1)(2008-11#1)
resulted in systemic##2##3##(2008-10#2)
resulted in the accumulation of##4##5##(1994-11#1)(1997-4#1)(2008-10#1)(2008-7#1)
resulted in the appearance of##2##5##(1992-8#1)(1993-11#1)
resulted in the complete##2##4##(2008-10#1)(2011-1#1)
resulted in the conversion of##2##5##(1993-3#1)(2008-5#1)
resulted in the creation of a##2##6##(1997-3#1)(2010-1#1)
resulted in the creation of the##2##6##(2008-11#1)(2009-7#1)
resulted in the creation of##4##5##(1997-3#1)(2008-11#1)(2009-7#1)(2010-1#1)
resulted in the determination of##2##5##(1994-11#1)(2008-10#1)
resulted in the development of##6##5##(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
resulted in the disappearance of##2##5##(1997-5#1)(2009-2#1)
resulted in the emergence of##2##5##(2008-11#2)
resulted in the expression of##3##5##(1992-3#2)(2008-10#1)
resulted in the final##2##4##(2008-8#1)(2011-1#1)
resulted in the formation of two##2##6##(1997-7#1)(2008-10#1)
resulted in the formation of##13##5##(1990-11#1)(1990-12#1)(1991-2#1)(1992-11#1)(1993-11#1)(1994-6#1)(1996-5#1)(1997-7#2)(2008-10#2)(2009-11#2)
resulted in the greatest##4##4##(2008-10#2)(2008-8#1)(2012-5#1)
resulted in the highest##3##4##(2009-2#1)(2009-6#1)(2013-1#1)
resulted in the identification of##5##5##(2008-10#4)(2008-7#1)
resulted in the induction of##3##5##(1992-8#1)(1995-5#1)(2008-10#1)
resulted in the inhibition of##2##5##(1990-8#1)(2012-2#1)
resulted in the isolation of##5##5##(1994-11#1)(1997-2#1)(1997-3#1)(2008-11#1)(2013-1#1)
resulted in the largest##2##4##(1992-12#1)(1992-8#1)
resulted in the loss of##2##5##(2008-1#1)(2008-10#1)
resulted in the production of##5##5##(1993-6#1)(1994-11#1)(1994-12#1)(1995-11#1)(1997-4#1)
resulted in the reduction of##2##5##(1996-12#1)(2011-1#1)
resulted in the release of##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
resulted in the successful##3##4##(2008-10#1)(2008-7#1)(2009-4#1)
resulted in the suppression of##2##5##(1990-12#1)(2010-1#1)
resulted in the##151##3##(1990-11#2)(1990-12#4)(1990-3#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#3)(1993-10#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#12)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#7)(2009-11#3)(2009-2#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#2)
resulted in transient##3##3##(1994-6#1)(2011-2#2)
resulted in two##4##3##(1990-7#1)(1996-5#1)(2008-11#1)(2008-6#1)
resulted in up to##2##4##(2008-10#1)(2011-1#1)
resulted in very##2##3##(2008-10#2)
resulted in yields##2##3##(2008-10#1)(2008-11#1)
resulted in##1019##2##(1990-11#6)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#8)(1990-8#5)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#4)(1991-5#4)(1991-6#2)(1991-8#4)(1991-9#7)(1992-1#2)(1992-11#5)(1992-12#10)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#10)(1992-9#1)(1993-10#1)(1993-11#7)(1993-12#10)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#7)(1993-8#12)(1993-9#2)(1994-11#6)(1994-12#8)(1994-3#2)(1994-5#2)(1994-6#11)(1994-7#1)(1994-8#6)(1994-9#4)(1995-11#2)(1995-12#13)(1995-2#19)(1995-3#11)(1995-5#1)(1995-6#8)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#4)(1996-5#7)(1996-6#5)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#12)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#2)(2006-10#2)(2007-10#3)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#7)(2008-1#6)(2008-10#241)(2008-11#54)(2008-12#22)(2008-2#8)(2008-3#18)(2008-4#6)(2008-5#22)(2008-6#18)(2008-7#32)(2008-8#23)(2008-9#15)(2009-10#2)(2009-11#6)(2009-12#3)(2009-2#3)(2009-4#4)(2009-6#6)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#5)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#18)(2011-2#30)(2012-1#6)(2012-12#7)(2012-2#15)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#33)(2013-7#6)(2013-8#9)
resulted only##2##2##(2008-10#2)
resulted##1123##1##(1990-11#6)(1990-12#8)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#8)(1990-8#5)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#4)(1991-5#4)(1991-6#2)(1991-8#4)(1991-9#7)(1992-1#2)(1992-11#5)(1992-12#10)(1992-2#4)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#10)(1992-9#2)(1993-10#1)(1993-11#8)(1993-12#11)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#7)(1993-8#12)(1993-9#2)(1994-11#6)(1994-12#10)(1994-3#2)(1994-5#2)(1994-6#12)(1994-7#1)(1994-8#6)(1994-9#4)(1995-11#2)(1995-12#14)(1995-2#19)(1995-3#11)(1995-5#1)(1995-6#9)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#4)(1996-5#7)(1996-6#6)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#14)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#8)(1997-8#3)(2006-10#2)(2007-10#4)(2007-11#11)(2007-12#9)(2007-2#5)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#7)(2008-1#6)(2008-10#270)(2008-11#56)(2008-12#24)(2008-2#10)(2008-3#21)(2008-4#8)(2008-5#24)(2008-6#21)(2008-7#37)(2008-8#24)(2008-9#17)(2009-10#3)(2009-11#6)(2009-12#5)(2009-2#3)(2009-4#4)(2009-6#6)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#5)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#10)(2010-5#1)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#19)(2011-2#35)(2012-1#6)(2012-12#8)(2012-2#15)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#36)(2013-7#8)(2013-8#10)
resulting analysis##2##2##(2008-1#1)(2010-7#1)
resulting both from##2##3##(1997-3#1)(2009-10#1)
resulting complex##3##2##(2007-11#1)(2008-10#2)
resulting data##8##2##(1995-2#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-12#1)
resulting derivative##3##2##(2008-10#2)(2008-9#1)
resulting effects on##2##3##(1995-3#1)(2008-8#1)
resulting fluorescent##2##2##(1994-11#1)(2008-10#1)
resulting fragments##3##2##(1990-7#1)(1992-3#1)(1993-6#1)
resulting from a##13##3##(1990-3#1)(1994-2#1)(1995-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)
resulting from activation of##2##4##(1996-5#2)
resulting from an##3##3##(1993-6#1)(2008-10#2)
resulting from changes in##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
resulting from chronic##3##3##(1993-3#1)(2008-6#1)(2008-7#1)
resulting from differences in##3##4##(2008-5#1)(2012-3#1)(2013-1#1)
resulting from exposure to##2##4##(1991-12#1)(2008-7#1)
resulting from more##2##3##(2011-2#1)(2013-1#1)
resulting from presence of##2##4##(2008-10#1)(2013-8#1)
resulting from primary##2##3##(2008-10#1)(2012-2#1)
resulting from recycled tires##2##4##(2008-10#2)
resulting from small##2##3##(2008-10#1)(2013-8#1)
resulting from the interaction##2##4##(2007-12#1)(2008-10#1)
resulting from the presence of##2##5##(2008-3#2)
resulting from the use of##4##5##(2008-10#1)(2008-7#1)(2010-5#1)(2011-3#1)
resulting from the##55##3##(1990-12#1)(1991-3#2)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-7#2)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
resulting from thermally induced##2##4##(2007-12#2)
resulting from these##3##3##(1990-12#1)(2008-11#1)(2008-2#1)
resulting from this##2##3##(1995-3#1)(2008-9#1)
resulting from##242##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#2)(1991-12#1)(1991-3#5)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#9)(2007-12#7)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#38)(2008-11#13)(2008-12#2)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#7)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#3)
resulting fusion protein was##3##4##(1994-8#1)(2008-10#2)
resulting fusion protein##4##3##(1994-8#1)(2008-10#2)(2008-4#1)
resulting high##3##2##(1995-12#1)(2008-11#1)(2008-3#1)
resulting impact##2##2##(1995-1#1)(2007-7#1)
resulting in 0##2##3##(1993-8#1)(2007-11#1)
resulting in a better##2##4##(1990-10#1)(2007-10#1)
resulting in a decrease in the##2##6##(2006-6#1)(2008-6#1)
resulting in a decrease in##3##5##(2006-6#1)(2008-1#1)(2008-6#1)
resulting in a decreased##3##4##(1992-11#1)(2008-10#1)(2008-11#1)
resulting in a distorted grating pattern##2##6##(2008-3#2)
resulting in a large##2##4##(2008-10#1)(2008-7#1)
resulting in a more##2##4##(2008-12#1)(2008-7#1)
resulting in a poor prognosis##2##5##(2012-2#1)(2013-1#1)
resulting in a reduced##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
resulting in a sensitive assay##2##5##(1995-11#1)(2008-11#1)
resulting in a significant##5##4##(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
resulting in a slightly higher##2##5##(1996-10#1)(2008-10#1)
resulting in a##118##3##(1990-10#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#3)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#1)
resulting in activation of##2##4##(2010-11#2)
resulting in altered##2##3##(1991-5#1)(1997-3#1)
resulting in amino acid##2##4##(1992-3#1)(2012-12#1)
resulting in an accumulation of acetylcholine and continued stimulation of acetylcholine receptors##2##12##(2013-1#2)
resulting in an amino acid change from##2##7##(1991-2#1)(1992-2#1)
resulting in an amino acid substitution of##2##7##(1993-3#1)(1994-11#1)
resulting in an amino acid substitution##3##6##(1993-3#1)(1994-11#1)(2008-10#1)
resulting in an amino acid##5##5##(1991-2#1)(1992-2#1)(1993-3#1)(1994-11#1)(2008-10#1)
resulting in an increase##2##4##(2008-10#1)(2008-3#1)
resulting in an increased##2##4##(2008-3#1)(2013-1#1)
resulting in an intense##2##4##(2008-10#2)
resulting in an overall##3##4##(1992-9#1)(2008-3#1)(2008-7#1)
resulting in an##31##3##(1990-5#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#3)
resulting in better##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
resulting in cell##3##3##(1992-8#1)(1993-12#1)(1995-2#1)
resulting in chronic##2##3##(2008-7#1)(2013-7#1)
resulting in considerable##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
resulting in decreased##2##3##(2008-10#1)(2008-5#1)
resulting in devastating##2##3##(2008-10#2)
resulting in effective##2##3##(1991-12#1)(2008-10#1)
resulting in efficient energy##2##4##(2007-12#2)
resulting in efficient##3##3##(2007-12#2)(2012-2#1)
resulting in either##3##3##(1990-7#1)(2009-5#1)(2010-3#1)
resulting in endothelial##2##3##(2008-1#1)(2008-12#1)
resulting in enhanced##2##3##(1992-6#1)(2012-3#1)
resulting in erratic dosing##2##4##(1996-3#2)
resulting in good##2##3##(2007-7#1)(2012-3#1)
resulting in greater##3##3##(1991-1#1)(1993-12#1)(2009-8#1)
resulting in high sensitivity##2##4##(2009-5#1)(2012-2#1)
resulting in high##6##3##(1991-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)
resulting in higher##5##3##(1993-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)
resulting in improved##5##3##(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
resulting in increased##6##3##(2008-11#1)(2008-3#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-3#1)
resulting in its##2##3##(1994-5#1)(2013-8#1)
resulting in long##2##3##(2007-9#1)(2008-11#1)
resulting in lower##3##3##(1992-12#1)(2009-10#1)(2012-2#1)
resulting in marked##2##3##(2009-6#1)(2010-4#1)
resulting in mechanical##2##3##(1997-3#1)(2007-11#1)
resulting in modulation of the##2##5##(2008-3#1)(2009-10#1)
resulting in more##2##3##(2008-10#1)(2008-6#1)
resulting in no##2##3##(2008-10#1)(2013-1#1)
resulting in significant##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
resulting in strong##2##3##(2007-11#1)(2008-10#1)
resulting in the ability##2##4##(2008-10#1)(2011-1#1)
resulting in the accumulation of##2##5##(1992-6#1)(2008-10#1)
resulting in the formation of the##2##6##(2008-10#1)(2008-4#1)
resulting in the formation of##7##5##(1993-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)
resulting in the generation of##5##5##(1991-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
resulting in the generation##6##4##(1991-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)
resulting in the loss of##2##5##(1993-6#1)(2011-2#1)
resulting in the production of##3##5##(1993-12#1)(2008-6#1)(2011-3#1)
resulting in the##60##3##(1990-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
resulting in total##2##3##(1997-6#1)(2010-3#1)
resulting in two##6##3##(1991-5#1)(1996-10#1)(2008-10#4)
resulting in up to##2##4##(2008-3#1)(2008-8#1)
resulting in yield##2##3##(2008-10#1)(2011-10#1)
resulting in##512##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#4)(1993-12#6)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-12#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#3)(2006-10#2)(2006-6#1)(2007-10#3)(2007-11#11)(2007-12#12)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#98)(2008-11#28)(2008-12#3)(2008-2#4)(2008-3#27)(2008-4#7)(2008-5#11)(2008-6#8)(2008-7#16)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#5)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#14)(2012-3#9)(2012-7#1)(2013-1#17)(2013-7#1)(2013-8#4)
resulting material##2##2##(2008-10#1)(2008-11#1)
resulting model##2##2##(1995-5#1)(2010-12#1)
resulting modified##3##2##(2008-10#3)
resulting mutant##3##2##(1990-7#1)(1991-9#1)(1994-5#1)
resulting number of##2##3##(2012-12#1)(2012-2#1)
resulting optical##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
resulting peptides are##2##3##(1993-8#1)(2008-9#1)
resulting peptides##3##2##(1993-8#1)(2008-4#1)(2008-9#1)
resulting phenotype##2##2##(1996-2#1)(2008-2#1)
resulting plasmid##2##2##(2008-8#2)
resulting protein##2##2##(1990-12#1)(1992-8#1)
resulting public health##2##3##(2007-12#1)(2008-10#1)
resulting recombinant##3##2##(1992-9#1)(2008-6#1)(2008-8#1)
resulting resin##3##2##(2008-10#3)
resulting sensor exhibited##2##3##(2008-10#1)(2013-1#1)
resulting sensor##3##2##(2008-10#2)(2013-1#1)
resulting sequences##2##2##(2008-5#1)(2011-2#1)
resulting solution##7##2##(2008-10#7)
resulting uncertainty##2##2##(1992-6#1)(2013-1#1)
resulting##1174##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#5)(1991-5#3)(1991-6#5)(1991-8#2)(1991-9#8)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#7)(1992-8#5)(1992-9#6)(1993-10#1)(1993-11#4)(1993-12#9)(1993-2#1)(1993-3#3)(1993-6#6)(1993-8#9)(1993-9#2)(1994-11#6)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#7)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#7)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#4)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#5)(1996-2#1)(1996-3#5)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#5)(2006-10#3)(2006-6#2)(2007-10#7)(2007-11#29)(2007-12#23)(2007-6#3)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#12)(2008-10#245)(2008-11#54)(2008-12#8)(2008-2#30)(2008-3#79)(2008-4#29)(2008-5#23)(2008-6#15)(2008-7#38)(2008-8#35)(2008-9#26)(2009-1#2)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#7)(2009-4#3)(2009-5#7)(2009-6#6)(2009-7#3)(2009-8#5)(2009-9#7)(2010-1#1)(2010-10#4)(2010-11#6)(2010-12#8)(2010-2#3)(2010-3#9)(2010-4#7)(2010-5#7)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#29)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#14)(2012-2#25)(2012-3#18)(2012-7#1)(2013-1#29)(2013-7#1)(2013-8#9)
results (&gt##2##2##(2008-10#1)(2012-2#1)
results (R##4##2##(2008-10#4)
results (mean##2##2##(1996-9#1)(2007-11#1)
results a##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
results about##3##2##(2007-12#1)(2008-1#1)(2008-11#1)
results according to##2##3##(1990-6#1)(1996-9#1)
results achieved in##2##3##(1990-6#1)(1992-6#1)
results achieved##9##2##(1990-6#1)(1991-3#1)(1992-6#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2009-10#1)
results acquired##2##2##(2008-10#1)(2008-2#1)
results across##2##2##(1991-9#1)(2008-11#1)
results add to the##2##4##(1994-11#1)(2009-10#1)
results add to##4##3##(1994-11#1)(1995-5#1)(1997-7#1)(2009-10#1)
results after##16##2##(1990-11#1)(1994-6#1)(1995-11#1)(2007-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#3)
results against a reference procedure##2##5##(2008-10#2)
results against##4##2##(1992-12#1)(2008-10#2)(2008-3#1)
results agree to within##2##4##(2008-3#2)
results agree well with##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
results agree with the##3##4##(2008-10#2)(2008-3#1)
results agree with##6##3##(2008-10#4)(2008-3#2)
results agree##14##2##(2008-10#8)(2008-2#1)(2008-3#5)
results agreed well with the##2##5##(2008-10#2)
results agreed with##6##3##(2008-10#5)(2011-2#1)
results agreed##8##2##(2008-10#7)(2011-2#1)
results allow the##2##3##(2007-11#1)(2013-8#1)
results allow to##2##3##(2007-11#1)(2008-10#1)
results allow##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
results allowed the##3##3##(2008-6#1)(2011-2#1)(2013-7#1)
results allowed##7##2##(2008-10#2)(2008-6#2)(2008-8#1)(2011-2#1)(2013-7#1)
results already obtained##2##3##(2007-6#1)(2008-3#1)
results already##4##2##(2007-11#1)(2007-6#1)(2008-3#1)(2013-1#1)
results also demonstrate##2##3##(1995-2#1)(2013-1#1)
results also indicate a##2##4##(1996-2#1)(2013-1#1)
results also indicate that the##3##5##(1990-8#1)(1995-6#1)(2007-11#1)
results also indicate that##12##4##(1990-8#1)(1992-8#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
results also indicate##16##3##(1990-8#1)(1992-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#3)
results also provide##4##3##(1992-3#1)(2008-8#2)(2009-8#1)
results also show that##7##4##(1990-12#1)(1991-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
results also show##10##3##(1990-12#1)(1991-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
results also showed that the##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
results also showed that##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
results also showed##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
results also suggest that the##4##5##(1992-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
results also suggest that##15##4##(1992-6#1)(1993-3#2)(1996-12#1)(2008-10#6)(2008-6#1)(2008-8#2)(2009-10#1)(2012-3#1)
results also suggest the##2##4##(2008-7#1)(2010-8#1)
results also suggest##17##3##(1992-6#1)(1993-3#2)(1996-12#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-8#1)(2012-3#1)
results also suggested that##2##4##(2008-10#1)(2008-12#1)
results also support##3##3##(1992-3#1)(2010-8#1)(2013-8#1)
results also##81##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-3#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
results among##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
results analyzed##2##2##(2008-5#1)(2013-8#1)
results and a##7##3##(2007-12#1)(2008-10#1)(2008-3#4)(2009-5#1)
results and also##3##3##(1992-9#1)(2008-10#1)(2012-2#1)
results and complications##2##3##(2007-7#1)(2011-2#1)
results and demonstrate##2##3##(2008-2#1)(2008-7#1)
results and discuss##3##3##(2007-11#1)(2008-9#1)(2009-3#1)
results and discusses##2##3##(1993-12#1)(1994-3#1)
results and further##2##3##(2008-2#1)(2009-8#1)
results and future##2##3##(1992-4#1)(2013-1#1)
results and is##4##3##(1996-5#1)(2008-10#2)(2008-3#1)
results and may##2##3##(2008-12#1)(2011-2#1)
results and more##2##3##(1996-1#1)(2013-1#1)
results and numerical##2##3##(2007-12#1)(2010-12#1)
results and our##2##3##(2008-3#1)(2008-6#1)
results and patient##2##3##(2007-12#1)(2008-7#1)
results and publication##2##3##(1993-12#2)
results and study weaknesses were tabulated##3##6##(2007-8#3)
results and the TSS concentration##2##5##(2013-8#2)
results and the##22##3##(1990-10#1)(1990-2#1)(1991-6#1)(1992-6#1)(1997-5#1)(2007-11#2)(2008-10#6)(2008-2#3)(2008-8#2)(2009-9#1)(2012-3#1)(2013-8#2)
results and theoretical predictions##2##4##(2007-12#1)(2010-2#1)
results and those of##2##4##(2008-10#1)(2008-5#1)
results and those##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
results and to##3##3##(2010-12#1)(2010-8#1)(2013-7#1)
results and##172##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-3#1)(1993-8#1)(1994-3#4)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#2)(1997-5#1)(2006-4#1)(2007-11#4)(2007-12#7)(2007-7#2)(2007-8#5)(2008-10#25)(2008-11#2)(2008-12#4)(2008-2#11)(2008-3#13)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#5)
results appear to##3##3##(1991-12#1)(2008-11#1)(2008-2#1)
results are a##2##3##(1993-8#1)(2007-2#1)
results are achieved##2##3##(1994-11#1)(2007-12#1)
results are also presented##3##4##(1992-2#1)(2008-3#2)
results are also##8##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)
results are applicable to##4##4##(2008-2#1)(2008-3#2)(2008-8#1)
results are as##3##3##(1992-10#1)(1994-5#1)(2008-2#1)
results are based on##3##4##(2008-12#1)(2008-3#1)(2011-1#1)
results are better than##2##4##(2007-8#1)(2008-7#1)
results are better##3##3##(2007-8#1)(2008-2#1)(2008-7#1)
results are comparable to those##2##5##(2007-8#1)(2008-10#1)
results are comparable with those achieved##2##6##(1991-2#1)(1991-3#1)
results are comparable##4##3##(1991-2#1)(1991-3#1)(2007-8#1)(2008-10#1)
results are compared to those##2##5##(2008-10#2)
results are compared to##9##4##(1991-8#1)(2008-10#4)(2008-3#1)(2008-8#2)(2010-8#1)
results are compared with a##4##5##(2007-12#1)(2008-3#3)
results are compared with experimental data##2##6##(2008-2#2)
results are compared with experimental##3##5##(2008-2#2)(2008-3#1)
results are compared with predictions of##3##6##(2008-2#1)(2008-3#2)
results are compared with the corresponding##2##6##(2008-10#1)(2008-2#1)
results are compared with the data##2##6##(2008-10#1)(2008-2#1)
results are compared with the##13##5##(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#2)
results are compared with theoretical predictions##2##6##(2008-2#1)(2008-3#1)
results are compared with those obtained by##2##7##(2008-3#2)
results are compared with those obtained with##3##7##(2007-11#1)(2008-10#1)(2008-3#1)
results are compared with those obtained##10##6##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#5)
results are compared with those##15##5##(1996-7#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#6)
results are compared with##47##4##(1992-2#1)(1996-7#1)(2007-11#5)(2007-12#3)(2008-10#10)(2008-2#8)(2008-3#17)(2008-5#1)(2009-11#1)
results are compared##58##3##(1991-8#1)(1992-2#1)(1996-7#1)(2007-11#5)(2007-12#3)(2008-10#16)(2008-2#8)(2008-3#18)(2008-5#1)(2008-8#2)(2009-11#1)(2010-8#1)
results are compatible with##2##4##(1991-2#1)(1995-6#1)
results are confirmed with##2##4##(1993-11#1)(2008-3#1)
results are consistent with a hypothesis that##2##7##(2008-11#1)(2009-5#1)
results are consistent with a##13##5##(1990-2#1)(1992-6#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-1#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-5#1)
results are consistent with our##2##5##(1991-12#1)(1996-2#1)
results are consistent with previous observations that##2##7##(2008-10#1)(2010-8#1)
results are consistent with previous work##2##6##(1992-9#1)(2011-1#1)
results are consistent with previous##5##5##(1992-9#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
results are consistent with the hypothesis that the##4##8##(1994-2#1)(1997-3#1)(2007-12#1)(2012-1#1)
results are consistent with the hypothesis that##11##7##(1992-12#1)(1993-12#2)(1993-8#1)(1994-2#1)(1995-2#2)(1997-3#1)(2007-12#1)(2008-10#1)(2012-1#1)
results are consistent with the idea that##2##7##(1990-11#1)(1995-3#1)
results are consistent with the##35##5##(1990-11#2)(1990-8#1)(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2012-1#1)
results are consistent with##70##4##(1990-11#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#3)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
results are demonstrated##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
results are described##8##3##(1995-5#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
results are discussed in light of##4##6##(1997-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
results are discussed in relation to the##4##7##(1990-12#1)(1992-12#1)(2008-10#1)(2008-7#1)
results are discussed in relation to##6##6##(1990-12#1)(1992-12#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
results are discussed in terms of the##10##7##(1990-11#1)(1990-7#2)(1992-6#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(2008-10#1)(2012-1#1)
results are discussed in terms of##19##6##(1990-11#1)(1990-7#2)(1991-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#2)(1995-11#1)(1995-12#1)(2008-10#2)(2008-5#2)(2012-1#1)
results are discussed in the context of##4##7##(1990-11#1)(1996-5#1)(2008-2#1)(2008-9#1)
results are discussed in the##5##5##(1990-11#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-9#1)
results are discussed in##38##4##(1990-11#2)(1990-12#1)(1990-7#2)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#3)(1995-11#1)(1995-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-7#1)
results are discussed with##4##4##(1993-3#1)(1995-12#1)(1995-8#1)(2011-1#1)
results are discussed##58##3##(1990-11#2)(1990-12#1)(1990-7#2)(1990-9#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#3)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
results are due##2##3##(1990-12#1)(2008-10#1)
results are encouraging##2##3##(1994-2#1)(2008-5#1)
results are excellent##2##3##(2008-10#1)(2009-5#1)
results are found for##2##4##(2008-2#2)
results are found##4##3##(2007-12#1)(2008-2#2)(2008-8#1)
results are given in##2##4##(2008-3#2)
results are given##10##3##(1995-3#1)(2007-12#1)(2008-2#3)(2008-3#5)
results are important for##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
results are important##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
results are in accordance with the##2##6##(1994-8#1)(2008-4#1)
results are in agreement with##5##5##(1991-9#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
results are in excellent agreement##2##5##(2008-3#2)
results are in good agreement with the theoretical##2##8##(2008-3#2)
results are in good agreement with the##3##7##(2008-2#1)(2008-3#2)
results are in good agreement with those obtained by##2##9##(2008-10#2)
results are in good agreement with those obtained##3##8##(2008-10#2)(2008-3#1)
results are in good agreement with those##4##7##(2008-10#2)(2008-2#1)(2008-3#1)
results are in good agreement with##11##6##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)
results are in good agreement##12##5##(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#4)
results are in good##13##4##(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#4)
results are in the##2##4##(2008-10#1)(2008-3#1)
results are in##32##3##(1991-9#1)(1994-5#1)(1994-8#1)(2007-12#4)(2008-10#7)(2008-2#3)(2008-3#11)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
results are interpreted in terms of a##2##7##(1994-11#1)(2009-10#1)
results are interpreted in terms of##5##6##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
results are interpreted with##2##4##(2007-12#1)(2011-2#1)
results are interpreted##10##3##(1991-5#1)(1992-6#1)(1994-11#1)(1994-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)
results are more##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
results are not##6##3##(1990-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)
results are observed##3##3##(1992-3#1)(1996-7#1)(2008-10#1)
results are obtained by##2##4##(1990-6#1)(2008-10#1)
results are obtained in##4##4##(1990-12#1)(1996-6#1)(2008-10#1)(2008-3#1)
results are obtained with the##3##5##(2008-10#1)(2008-3#2)
results are obtained with##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
results are obtained##15##3##(1990-12#1)(1990-6#1)(1996-6#1)(2008-10#7)(2008-2#1)(2008-3#3)(2012-2#1)
results are of##2##3##(1995-6#1)(2007-11#1)
results are presented and compared with##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
results are presented and discussed##2##5##(2007-12#1)(2008-3#1)
results are presented and##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
results are presented as##3##4##(2008-2#1)(2013-1#2)
results are presented for a##2##5##(2007-11#1)(2008-3#1)
results are presented for the##3##5##(2008-10#1)(2008-3#2)
results are presented for##14##4##(1992-12#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#7)
results are presented in##5##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)
results are presented on##2##4##(2007-11#2)
results are presented that demonstrate the validity of the##3##9##(2008-3#3)
results are presented that demonstrate the##5##6##(2007-12#1)(2008-3#4)
results are presented that##7##4##(2007-11#1)(2007-12#2)(2008-3#4)
results are presented to##7##4##(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)
results are presented with##2##4##(2008-2#1)(2013-1#1)
results are presented##76##3##(1992-12#1)(2007-11#7)(2007-12#6)(2008-10#4)(2008-2#11)(2008-3#39)(2008-4#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#3)
results are promising##2##3##(1995-11#1)(2008-9#1)
results are provided to##2##4##(2008-2#1)(2008-3#1)
results are provided##6##3##(2008-2#1)(2008-3#5)
results are quantified##2##3##(2008-2#1)(2008-7#1)
results are reported for##2##4##(1994-11#1)(2006-4#1)
results are reported##7##3##(1994-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)
results are shown for##2##4##(1992-9#1)(2008-3#1)
results are shown to be##2##5##(2007-11#1)(2008-3#1)
results are shown##10##3##(1992-9#1)(1996-6#1)(2007-11#1)(2008-2#2)(2008-3#5)
results are similar to those of the##2##7##(1995-5#1)(2008-3#1)
results are similar to those##4##5##(1992-12#1)(1995-5#1)(2008-3#1)(2011-2#1)
results are similar to##5##4##(1992-12#1)(1994-12#1)(1995-5#1)(2008-3#1)(2011-2#1)
results are taken to##2##4##(1993-12#1)(1994-8#1)
results are tested by##2##4##(2008-2#1)(2008-3#1)
results are the first to demonstrate##2##6##(2008-3#1)(2010-11#1)
results are the first##6##4##(1991-5#1)(1997-2#1)(1997-3#1)(2008-3#1)(2010-11#1)(2012-1#1)
results are the##8##3##(1990-6#1)(1991-5#1)(1997-2#1)(1997-3#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
results are used to##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
results are used##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
results are useful for##2##4##(2007-11#1)(2008-3#1)
results are useful##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
results are valid for##2##4##(1994-5#1)(2009-5#1)
results are verified by##2##4##(2007-12#1)(2010-12#1)
results are verified##3##3##(2007-11#1)(2007-12#1)(2010-12#1)
results are very##4##3##(1993-11#1)(1993-9#1)(2012-12#1)(2012-2#1)
results are##550##2##(1990-11#4)(1990-12#4)(1990-2#1)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#4)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#22)(2007-12#26)(2007-2#2)(2007-8#2)(2008-10#75)(2008-11#6)(2008-12#4)(2008-2#52)(2008-3#121)(2008-4#3)(2008-5#15)(2008-6#2)(2008-7#7)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#5)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
results argue##4##2##(1993-11#1)(1993-6#1)(1997-2#1)(2008-8#1)
results as a##2##3##(2008-10#1)(2010-3#1)
results as well##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
results as##18##2##(1990-3#1)(1991-3#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-7#1)
results associated with the##2##4##(1996-1#1)(2008-3#1)
results at different stages##2##4##(2008-8#2)
results at the##3##3##(1997-3#1)(2008-10#1)(2009-9#1)
results at##15##2##(1993-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#5)(2008-4#1)(2008-8#2)(2009-9#1)(2013-1#2)
results based on##11##3##(1997-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-2#1)
results be##2##2##(1994-11#1)(2008-8#1)
results being##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
results better than##3##3##(2008-10#3)
results between laboratories##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
results between##13##2##(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
results both##4##2##(1990-12#1)(1994-3#1)(2008-3#1)(2008-8#1)
results brought##2##2##(1994-6#1)(2008-10#1)
results but##3##2##(1990-12#1)(1994-12#1)(2008-9#1)
results by the##3##3##(2007-2#1)(2008-1#1)(2008-3#1)
results by##16##2##(1993-12#1)(1996-5#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#3)(2009-4#1)
results can be affected by##2##5##(1996-3#1)(2008-3#1)
results can be explained in##2##5##(1993-8#1)(2008-7#1)
results can be explained##3##4##(1993-8#1)(1994-5#1)(2008-7#1)
results can be obtained##6##4##(1993-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
results can be used to##6##5##(2008-10#3)(2008-2#1)(2010-5#1)(2010-7#1)
results can be used##8##4##(2007-12#1)(2008-10#3)(2008-2#1)(2010-5#1)(2010-7#1)(2013-1#1)
results can be##28##3##(1990-12#1)(1990-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-3#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-5#1)(2010-7#1)(2013-1#1)
results can##32##2##(1990-12#1)(1990-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-5#1)(2010-7#1)(2013-1#2)
results cannot be##5##3##(1991-6#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
results cannot##6##2##(1991-6#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-8#1)
results caused by the##3##4##(2008-10#1)(2008-11#2)
results caused by##4##3##(1997-4#1)(2008-10#1)(2008-11#2)
results challenge##2##2##(2008-10#1)(2008-8#1)
results clearly demonstrate that##5##4##(1994-6#1)(2008-5#2)(2009-6#1)(2009-8#1)
results clearly demonstrate##7##3##(1994-6#1)(2008-10#1)(2008-5#2)(2009-6#1)(2009-7#1)(2009-8#1)
results clearly indicate that##3##4##(1997-1#1)(2008-4#1)(2013-1#1)
results clearly show that##7##4##(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
results clearly show##8##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
results clearly showed##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
results clearly##24##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-5#1)(1994-6#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
results closely##2##2##(1991-6#1)(2008-3#1)
results coincide with##2##3##(2008-3#1)(2008-5#1)
results coincide##3##2##(2008-3#2)(2008-5#1)
results collected##3##2##(1991-12#1)(2008-12#1)(2013-1#1)
results comparable to those obtained using##2##6##(2008-10#2)
results comparable to those##4##4##(1991-2#1)(2008-10#3)
results comparable to##7##3##(1991-2#1)(2008-10#4)(2008-9#1)(2013-8#1)
results comparable with##2##3##(2008-10#2)
results comparable##9##2##(1991-2#1)(2008-10#6)(2008-9#1)(2013-8#1)
results compare favourably with##2##4##(2008-10#1)(2008-11#1)
results compare favourably##3##3##(2008-10#2)(2008-11#1)
results compare##5##2##(2007-11#1)(2008-10#3)(2008-11#1)
results compared with the##2##4##(1996-12#1)(2009-11#1)
results compared with##8##3##(1993-5#1)(1996-12#1)(2007-7#1)(2008-10#4)(2009-11#1)
results compared##11##2##(1993-5#1)(1996-12#1)(2007-7#1)(2008-10#6)(2008-6#1)(2009-11#1)
results complement those##2##3##(1994-5#1)(2008-10#1)
results concerning the##5##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
results concerning##13##2##(1993-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#2)
results confirm our##3##3##(1994-3#1)(1997-6#1)(2012-3#1)
results confirm that the##3##4##(1990-8#1)(2008-10#1)(2008-8#1)
results confirm that##16##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1994-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2013-1#1)
results confirm the##14##3##(1990-8#1)(1992-4#1)(1992-5#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-6#1)(2008-9#1)
results confirm##40##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-5#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-6#3)(2007-11#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
results confirmed our##2##3##(1994-8#1)(2013-8#1)
results confirmed that the use of##2##6##(2008-10#1)(2010-6#1)
results confirmed that the##5##4##(1997-2#1)(2007-6#1)(2008-10#2)(2010-6#1)
results confirmed that##10##3##(1997-2#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-7#1)(2010-6#1)(2012-2#1)
results confirmed the##5##3##(2007-11#1)(2008-8#1)(2010-2#1)(2010-6#1)(2010-8#1)
results confirmed##18##2##(1994-3#1)(1994-8#1)(1997-2#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-6#2)(2010-8#1)(2012-2#1)(2013-8#1)
results considering the##2##3##(2008-10#2)
results consistent with the##2##4##(2008-3#1)(2011-2#1)
results consistent with##4##3##(1997-3#1)(2008-3#1)(2009-4#1)(2011-2#1)
results consistent##5##2##(1997-3#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
results constitute##2##2##(2007-11#1)(2009-5#1)
results contribute to a better understanding of##4##7##(2008-10#3)(2011-1#1)
results correlate##2##2##(1990-2#1)(2008-3#1)
results correlated##3##2##(2008-10#3)
results correspond##2##2##(1995-11#1)(2007-12#1)
results could be obtained with##2##5##(2008-3#1)(2012-7#1)
results could be obtained##3##4##(2008-10#1)(2008-3#1)(2012-7#1)
results could be used##2##4##(2008-5#1)(2012-12#1)
results could be##6##3##(2008-10#1)(2008-3#2)(2008-5#1)(2012-12#1)(2012-7#1)
results could##11##2##(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-7#1)
results define##2##2##(1993-12#1)(2012-12#1)
results demonstrate a##9##3##(1993-3#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-9#1)(2010-10#1)(2012-2#1)
results demonstrate an##3##3##(2008-2#1)(2008-5#1)(2008-8#1)
results demonstrate that a##2##4##(1990-8#1)(2007-11#1)
results demonstrate that both##5##4##(1994-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
results demonstrate that exposure to##3##5##(2008-10#2)(2013-1#1)
results demonstrate that exposure##4##4##(1992-8#1)(2008-10#2)(2013-1#1)
results demonstrate that our##2##4##(2008-3#1)(2010-2#1)
results demonstrate that partial##2##4##(1991-12#1)(2011-2#1)
results demonstrate that the proposed##3##5##(2008-3#1)(2010-9#1)(2013-1#1)
results demonstrate that the##38##4##(1991-12#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#3)
results demonstrate that this##3##4##(1997-7#2)(2011-2#1)
results demonstrate that##169##3##(1990-12#4)(1990-5#2)(1990-8#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-6#2)(1994-11#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#4)(1995-2#4)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#4)(2007-11#1)(2007-12#2)(2008-10#31)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#7)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#1)
results demonstrate the ability to##2##5##(2008-7#1)(2012-2#1)
results demonstrate the feasibility of the##2##6##(2008-10#1)(2008-2#1)
results demonstrate the feasibility of##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
results demonstrate the importance of##2##5##(1995-9#1)(2008-10#1)
results demonstrate the potential of##2##5##(2008-10#1)(2009-5#1)
results demonstrate the presence##2##4##(1993-6#1)(1996-2#1)
results demonstrate the utility of##3##5##(1990-5#1)(2007-11#1)(2012-2#1)
results demonstrate the validity of##2##5##(2007-11#1)(2008-3#1)
results demonstrate the##41##3##(1990-5#1)(1990-9#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#9)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#3)
results demonstrate##238##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#5)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#6)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#6)(1996-2#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(2007-11#3)(2007-12#5)(2008-10#38)(2008-11#15)(2008-12#1)(2008-2#7)(2008-3#17)(2008-5#9)(2008-7#8)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#1)
results demonstrated a##4##3##(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
results demonstrated that a##2##4##(1992-9#1)(1995-4#1)
results demonstrated that the##9##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)(2011-1#1)
results demonstrated that##41##3##(1990-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-4#1)(1995-8#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-5#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#5)
results demonstrated the##10##3##(1994-9#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-8#1)
results demonstrated##67##2##(1990-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-9#1)(1995-4#1)(1995-8#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
results demonstrating##2##2##(1997-7#1)(2008-3#1)
results depend on##4##3##(2007-2#1)(2008-10#2)(2012-3#1)
results derived by##3##3##(2007-10#1)(2008-2#1)(2008-3#1)
results derived##5##2##(1990-12#1)(2007-10#1)(2008-2#2)(2008-3#1)
results describe##2##2##(1993-11#1)(2012-3#1)
results determined by##4##3##(2008-10#4)
results determined##5##2##(2008-10#4)(2013-1#1)
results did not differ##2##4##(2012-2#1)(2013-1#1)
results did not##6##3##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#3)
results differ##2##2##(2008-2#1)(2008-8#1)
results do not confirm##2##4##(1991-8#1)(2008-7#1)
results do not support the notion that##2##7##(1990-2#1)(1993-11#1)
results do not support the##4##5##(1990-2#1)(1991-12#1)(1993-11#1)(2008-8#1)
results do not support##6##4##(1990-2#1)(1991-12#1)(1993-11#1)(2007-12#1)(2008-11#1)(2008-8#1)
results do not##13##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1993-11#1)(1994-8#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
results do##14##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1993-11#1)(1994-8#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#1)
results due to##3##3##(2008-10#2)(2011-2#1)
results during##2##2##(2007-8#1)(2008-10#1)
results elucidate the##2##3##(1996-5#1)(2009-2#1)
results emphasize the importance of##5##5##(1991-12#1)(1993-2#1)(1993-3#1)(1997-2#1)(2008-10#1)
results emphasize the##9##3##(1990-5#1)(1991-12#1)(1993-2#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)
results emphasize##10##2##(1990-5#1)(1991-12#1)(1993-2#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
results equivalent to##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
results establish that##6##3##(1990-11#1)(1993-11#1)(1994-11#1)(1995-2#1)(2008-10#1)(2012-3#1)
results establish##8##2##(1990-11#1)(1993-11#1)(1994-11#1)(1995-2#1)(2008-10#1)(2009-6#1)(2012-3#1)(2013-1#1)
results extend previous##2##3##(1994-12#1)(1994-8#1)
results extend##6##2##(1994-12#1)(1994-8#1)(2007-12#1)(2008-9#2)(2012-3#1)
results falling##2##2##(1996-12#1)(2008-10#1)
results favor the##2##3##(2007-8#1)(2011-2#1)
results favor##3##2##(2007-8#1)(2008-3#1)(2011-2#1)
results focused on##2##3##(1996-6#1)(2009-10#1)
results for a test##2##4##(2008-2#1)(2008-3#1)
results for a##18##3##(2007-11#3)(2008-10#2)(2008-2#2)(2008-3#8)(2008-9#1)(2009-9#1)(2013-1#1)
results for an##4##3##(2008-10#1)(2008-3#2)(2008-8#1)
results for both##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
results for each##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2012-1#1)
results for homogeneous##2##3##(2008-2#1)(2008-3#1)
results for several##3##3##(2007-12#1)(2008-10#1)(2009-2#1)
results for the determination of##3##5##(2008-10#3)
results for the development of##2##5##(1994-1#1)(2008-2#1)
results for the##47##3##(1991-9#2)(1992-6#1)(1994-1#1)(1994-2#1)(1996-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-2#4)(2008-3#9)(2008-5#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-1#2)
results for these##2##3##(2007-11#1)(2008-3#1)
results for this##4##3##(2008-10#1)(2008-5#1)(2013-1#2)
results for three##2##3##(2007-11#1)(2012-2#1)
results for##194##2##(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#14)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#54)(2008-12#2)(2008-2#14)(2008-3#36)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#4)(2012-2#2)(2013-1#5)(2013-8#1)
results found by##4##3##(1994-8#1)(2008-10#3)
results found##7##2##(1994-8#1)(2008-10#5)(2009-7#1)
results from a national##2##4##(2012-2#1)(2012-3#1)
results from a number of##2##5##(2007-8#1)(2008-10#1)
results from a randomized##2##4##(1994-8#1)(1996-6#1)
results from a recent##2##4##(1995-1#1)(2008-7#1)
results from a series of##4##5##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
results from a single##2##4##(2010-4#1)(2011-2#1)
results from a study of##2##5##(1994-3#1)(2008-10#1)
results from a study##3##4##(1994-3#1)(2008-10#1)(2010-11#1)
results from a##62##3##(1990-9#1)(1991-1#1)(1991-5#1)(1992-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
results from an imbalance between##2##5##(2008-1#1)(2008-10#1)
results from an##5##3##(1994-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-12#1)
results from both##3##3##(1991-9#1)(1993-11#1)(2012-3#1)
results from chemical##2##3##(1997-2#2)
results from clinical##2##3##(2008-11#1)(2010-5#1)
results from different studies##3##4##(2008-10#3)
results from different##8##3##(1996-3#1)(2008-10#3)(2008-2#2)(2008-4#1)(2011-2#1)
results from impaired##2##3##(1991-7#1)(2008-10#1)
results from in vitro##2##4##(1992-11#1)(2012-2#1)
results from in##3##3##(1990-11#1)(1992-11#1)(2012-2#1)
results from infection##2##3##(1992-12#1)(2011-2#1)
results from its##2##3##(1994-11#1)(1997-2#1)
results from laboratory##3##3##(2008-10#2)(2008-8#1)
results from multiple##2##3##(2008-4#1)(2013-1#1)
results from non-RCT##2##3##(2011-2#2)
results from one##2##3##(1993-6#1)(2008-10#1)
results from our##5##3##(2008-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
results from random##2##3##(2008-10#1)(2008-3#1)
results from reduced##2##3##(2008-5#1)(2008-9#1)
results from repetitive##2##3##(2008-8#1)(2011-2#1)
results from several##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
results from simulation##2##3##(2008-10#1)(2009-12#1)
results from simulations##2##3##(1995-5#1)(2008-3#1)
results from tests##2##3##(2008-2#1)(2012-3#1)
results from the Global Orthopaedic Registry (GLORY)##2##7##(2011-2#2)
results from the measurement##2##4##(2008-10#2)
results from the model##2##4##(2008-3#2)
results from the scattering of light by deformed liquid droplets and droplets with inclusions##2##14##(2008-3#2)
results from the three##2##4##(2008-10#1)(2008-2#1)
results from the##83##3##(1990-11#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#4)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
results from these##5##3##(1992-10#1)(2008-10#4)
results from this study##10##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)
results from this##17##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)
results from two##2##3##(2008-5#1)(2012-12#1)
results from use of##3##4##(2007-12#1)(2008-3#2)
results from##361##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-6#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1995-1#2)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-11#8)(2007-12#11)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#55)(2008-11#12)(2008-12#4)(2008-2#17)(2008-3#33)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#20)(2012-1#5)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#5)
results further demonstrate that##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
results further demonstrate##4##3##(1991-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
results further suggest that##3##4##(1992-12#1)(2008-10#1)(2008-7#1)
results further support the##2##4##(1993-12#1)(2008-7#1)
results further##11##2##(1991-1#1)(1992-12#1)(1993-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#3)
results generally support the view that##2##6##(1993-3#1)(2008-8#1)
results give a##2##3##(2008-2#1)(2008-8#1)
results give new##2##3##(1997-3#1)(2008-11#1)
results give##7##2##(1997-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)
results given here##2##3##(2008-3#2)
results given##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
results had##4##2##(1990-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
results has been##5##3##(1990-3#1)(1995-2#1)(1996-5#1)(2008-10#1)(2011-1#1)
results have a##2##3##(2007-11#1)(2008-2#1)
results have been achieved##2##4##(1994-12#1)(2010-12#1)
results have been compared##2##4##(2008-10#2)
results have been found##2##4##(1996-4#1)(2008-2#1)
results have been obtained with##2##5##(1993-11#1)(2013-1#1)
results have been obtained##4##4##(1993-11#1)(2008-10#2)(2013-1#1)
results have been reported##3##4##(2008-6#1)(2012-3#1)(2013-1#1)
results have been##24##3##(1990-11#1)(1991-3#1)(1993-11#1)(1994-12#1)(1994-6#1)(1996-4#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#1)(2010-8#2)(2012-3#1)(2013-1#2)
results have clearly##2##3##(2010-4#1)(2010-8#1)
results have demonstrated that##2##4##(2008-10#1)(2008-12#1)
results have demonstrated##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
results have implications for##7##4##(1994-6#1)(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
results have implications##9##3##(1994-6#1)(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
results have important implications for##3##5##(2008-7#1)(2009-5#1)(2013-7#1)
results have important implications##4##4##(2007-7#1)(2008-7#1)(2009-5#1)(2013-7#1)
results have important##5##3##(1993-12#1)(2007-7#1)(2008-7#1)(2009-5#1)(2013-7#1)
results have indicated##2##3##(2008-10#1)(2008-5#1)
results have provided##2##3##(2008-11#1)(2008-9#1)
results have shown that##6##4##(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
results have shown the##2##4##(2008-3#1)(2008-7#1)
results have shown##8##3##(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
results have##69##2##(1990-11#1)(1991-3#1)(1993-11#2)(1993-12#1)(1994-12#1)(1994-6#2)(1994-8#1)(1996-4#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
results here##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
results highlight the importance of##5##5##(2008-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
results highlight the need to##2##5##(2008-10#1)(2012-12#1)
results highlight the need##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
results highlight the##16##3##(1990-8#1)(1992-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
results highlight##17##2##(1990-8#1)(1992-10#1)(1993-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
results highlighted that##2##3##(2008-10#1)(2008-8#1)
results i##2##2##(2007-11#2)
results identify##7##2##(1990-11#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-6#1)(2011-2#1)(2012-12#1)
results if the##3##3##(1994-2#1)(2008-3#1)(2011-2#1)
results if##5##2##(1994-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
results illustrate how##2##3##(2008-10#1)(2008-8#1)
results illustrate that the##3##4##(2008-10#1)(2008-6#1)(2010-8#1)
results illustrate that##6##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-8#1)
results illustrate the importance of##3##5##(2008-8#1)(2010-1#1)(2011-2#1)
results illustrate the potential##2##4##(2008-3#2)
results illustrate the##10##3##(1994-2#1)(1994-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-1#1)(2011-2#1)
results illustrate##18##2##(1994-2#1)(1994-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#3)(2010-1#1)(2010-8#1)(2011-2#1)
results illustrated that##2##3##(2008-10#1)(2008-5#1)
results implicate##6##2##(1992-3#1)(1993-11#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#1)
results implied that##2##3##(1997-3#1)(2008-9#1)
results implied##3##2##(1997-3#1)(2008-8#1)(2008-9#1)
results imply that a##5##4##(1993-11#1)(1995-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
results imply that the##7##4##(1995-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
results imply that##28##3##(1993-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
results imply##30##2##(1992-2#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
results in a 50% decrease##2##5##(1990-11#1)(1991-11#1)
results in a decrease in##3##5##(1995-12#1)(2008-4#1)(2013-1#1)
results in a decrease##4##4##(1995-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
results in a dramatic##2##4##(1991-5#1)(1993-3#1)
results in a high##3##4##(1992-11#1)(2008-3#1)(2008-5#1)
results in a large##2##4##(2009-6#1)(2013-1#1)
results in a loss of##2##5##(2008-9#1)(2010-10#1)
results in a marked decrease in the##2##7##(1992-8#1)(1995-3#1)
results in a marked reduction in##2##6##(1993-8#1)(1996-12#1)
results in a marked##5##4##(1992-8#1)(1993-8#1)(1995-3#1)(1996-12#1)(1997-6#1)
results in a new##2##4##(2008-10#1)(2010-2#1)
results in a reduction in##2##5##(1994-8#1)(2012-2#1)
results in a robust##2##4##(2012-12#1)(2012-2#1)
results in a significant##2##4##(2012-12#1)(2012-2#1)
results in a simple##2##4##(2008-2#1)(2008-3#1)
results in a very##2##4##(1990-12#1)(2008-10#1)
results in a##131##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-5#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-6#3)(2006-10#1)(2006-6#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
results in aberrant##2##3##(1991-9#1)(1996-2#1)
results in about##2##3##(1990-12#1)(1992-9#1)
results in agreement with##2##4##(2008-10#1)(2008-3#1)
results in an increase in##5##5##(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
results in an increase##6##4##(1991-5#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
results in an increased##3##4##(1990-2#1)(2008-7#1)(2013-7#1)
results in an##28##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#4)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2013-7#1)
results in both##7##3##(1992-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-12#1)
results in cellular##2##3##(2008-10#1)(2008-9#1)
results in change in##2##4##(2008-10#1)(2008-8#1)
results in clinical##2##3##(2008-12#1)(2011-2#1)
results in comparison with##4##4##(1992-10#1)(1997-8#1)(2008-10#1)(2008-7#1)
results in complete##2##3##(1995-6#1)(2008-3#1)
results in considerable##2##3##(2007-7#1)(2008-3#1)
results in decreased##2##3##(2011-1#1)(2013-1#1)
results in earlier##2##3##(1993-3#1)(2008-8#1)
results in efficient##2##3##(1997-4#1)(2009-6#1)
results in embryonic##2##3##(1995-2#1)(2008-8#1)
results in enhanced##3##3##(2008-10#2)(2008-3#1)
results in good agreement with##2##5##(2008-10#1)(2008-3#1)
results in greater##2##3##(1997-7#1)(2007-11#1)
results in high##4##3##(2008-11#1)(2008-3#1)(2011-2#2)
results in higher##2##3##(2008-11#2)
results in highly##2##3##(2008-11#1)(2009-9#1)
results in improved##6##3##(2007-12#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)
results in increased##9##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
results in induction of##2##4##(1992-8#1)(1994-11#1)
results in loss of##2##4##(2008-7#1)(2013-1#1)
results in more##2##3##(1990-3#1)(1993-2#1)
results in only a small##2##5##(1994-8#1)(2008-3#1)
results in only##3##3##(1994-8#1)(2008-3#1)(2013-8#1)
results in other populations##3##4##(2010-2#1)(2012-2#1)(2013-1#1)
results in other##4##3##(2008-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
results in our##2##3##(2007-11#1)(2008-1#1)
results in patients with##3##4##(2008-10#1)(2010-10#1)(2013-8#1)
results in patients##4##3##(2007-8#1)(2008-10#1)(2010-10#1)(2013-8#1)
results in production of##2##4##(1995-2#1)(2008-4#1)
results in prolonged##2##3##(2008-10#1)(2008-11#1)
results in rapid##2##3##(1992-8#1)(2008-10#1)
results in real time##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
results in reduced##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
results in reduction of the##2##5##(2008-10#1)(2008-9#1)
results in reduction of##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
results in relation to the##2##5##(2007-11#1)(2008-10#1)
results in repeated##2##3##(2008-11#1)(2008-5#1)
results in selected##2##3##(1994-2#1)(1996-11#1)
results in several##3##3##(1992-3#1)(1993-3#1)(2008-10#1)
results in severe##2##3##(2008-9#1)(2011-2#1)
results in significant##8##3##(1992-7#1)(1993-2#1)(2007-11#1)(2008-10#3)(2010-12#1)(2011-1#1)
results in significantly##2##3##(1996-12#1)(2008-2#1)
results in simple##2##3##(1990-6#1)(2008-10#1)
results in substantial##2##3##(2008-8#1)(2011-3#1)
results in terms of##15##4##(1990-6#1)(1992-10#1)(1994-2#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
results in the case of##3##5##(2008-10#2)(2008-2#1)
results in the context of##5##5##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)
results in the decrease of##2##5##(2008-10#1)(2013-1#1)
results in the determination of##3##5##(2008-10#3)
results in the development of##2##5##(2008-6#1)(2011-1#1)
results in the formation of a##3##6##(2007-12#2)(2008-10#1)
results in the formation of isomeric##2##6##(1996-2#1)(1996-5#1)
results in the formation of##11##5##(1996-2#1)(1996-5#2)(2007-12#2)(2008-10#3)(2008-4#1)(2009-10#1)(2012-2#1)
results in the generation of##2##5##(1992-9#1)(2010-4#1)
results in the inhibition of##2##5##(1990-8#1)(1995-2#1)
results in the local##2##4##(1991-5#1)(1992-12#1)
results in the loss of##3##5##(1991-2#1)(1991-9#1)(2008-12#1)
results in the rapid##3##4##(1991-2#1)(1992-12#1)(1994-8#1)
results in the treatment of##4##5##(1990-6#1)(1995-5#1)(2007-8#1)(2011-3#1)
results in the##116##3##(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#5)(1996-5#2)(1997-4#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#6)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)
results in this##4##3##(1995-11#1)(2007-7#1)(2008-9#1)(2012-12#1)
results in tyrosine phosphorylation of Shc##2##6##(1997-7#2)
results in various##2##3##(2009-12#1)(2012-2#1)
results in vitro##3##3##(1995-11#1)(2007-11#1)(2011-2#1)
results in##687##2##(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#6)(1991-7#1)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#2)(1994-12#7)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#8)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#5)(1996-2#8)(1996-4#1)(1996-5#6)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#4)(1997-8#1)(2006-10#2)(2006-6#1)(2007-11#22)(2007-12#16)(2007-6#1)(2007-7#4)(2007-8#9)(2008-1#6)(2008-10#84)(2008-11#25)(2008-12#8)(2008-2#19)(2008-3#31)(2008-4#13)(2008-5#12)(2008-6#12)(2008-7#32)(2008-8#19)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#3)(2010-10#2)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#9)(2011-2#24)(2011-3#3)(2012-1#1)(2012-12#9)(2012-2#19)(2012-3#11)(2013-1#24)(2013-7#1)(2013-8#5)
results include the following##2##4##(1993-8#1)(2008-11#1)
results include the##3##3##(1993-8#1)(2008-11#1)(2008-3#1)
results include##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#2)
results indicate a positive impact##2##5##(2011-2#2)
results indicate a##16##3##(1990-2#1)(1990-6#1)(1991-4#1)(1991-6#1)(1995-11#2)(1995-12#1)(1995-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)
results indicate an important##2##4##(2008-10#1)(2008-2#1)
results indicate an##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#2)
results indicate for the first time##2##6##(1993-6#1)(2013-1#1)
results indicate that (1)##2##4##(1993-1#1)(2007-12#1)
results indicate that GABA##2##4##(2008-8#2)
results indicate that X##2##4##(1997-2#1)(2008-10#1)
results indicate that a##13##4##(1991-11#1)(1991-12#1)(1992-11#1)(1997-2#1)(2008-10#3)(2008-2#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
results indicate that adenosine##3##4##(1994-11#1)(1994-6#2)
results indicate that an##3##4##(1990-8#1)(1992-8#1)(1995-2#1)
results indicate that basal##2##4##(1995-11#1)(2013-1#1)
results indicate that both##6##4##(1991-12#1)(1996-12#1)(1997-4#1)(2008-6#1)(2008-8#1)(2012-3#1)
results indicate that different##2##4##(2007-11#1)(2013-1#1)
results indicate that for##2##4##(1992-1#1)(2008-10#1)
results indicate that in the##4##5##(1994-3#1)(1997-1#1)(2008-2#1)(2008-5#1)
results indicate that in##9##4##(1992-5#1)(1994-3#1)(1997-1#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)
results indicate that intracellular##2##4##(1994-6#1)(2008-8#1)
results indicate that it##4##4##(1992-12#1)(2008-3#2)(2008-4#1)
results indicate that most##3##4##(1990-8#1)(1996-2#1)(2010-3#1)
results indicate that one of the##2##6##(2008-5#1)(2012-1#1)
results indicate that one##3##4##(1991-8#1)(2008-5#1)(2012-1#1)
results indicate that some##3##4##(1995-12#1)(1996-5#1)(2008-5#1)
results indicate that the effect of##2##6##(1996-2#1)(2012-2#1)
results indicate that the effects##2##5##(2008-11#1)(2008-12#1)
results indicate that the electrode##2##5##(2008-10#2)
results indicate that the increased##2##5##(1993-9#1)(2008-10#1)
results indicate that the population##2##5##(1993-5#1)(2008-5#1)
results indicate that the procedure##2##5##(2008-10#1)(2011-2#1)
results indicate that the proposed##2##5##(2007-12#1)(2012-3#1)
results indicate that the shape of the##2##7##(1994-8#1)(2007-12#1)
results indicate that the transmission##2##5##(2008-3#1)(2013-8#1)
results indicate that the##144##4##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-2#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#8)(2008-9#3)(2009-7#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
results indicate that there is a##2##6##(1990-2#1)(2008-5#1)
results indicate that there is no##2##6##(1992-12#1)(1997-1#1)
results indicate that there is##4##5##(1990-2#1)(1992-12#1)(1997-1#1)(2008-5#1)
results indicate that there was##2##5##(2008-5#1)(2013-1#1)
results indicate that there##7##4##(1990-2#1)(1992-12#1)(1997-1#1)(2008-5#3)(2013-1#1)
results indicate that these##3##4##(1994-5#1)(1995-12#1)(2008-10#1)
results indicate that this##6##4##(1991-5#1)(1992-8#1)(1993-6#1)(2007-10#1)(2008-10#1)(2008-11#1)
results indicate that##525##3##(1990-11#2)(1990-12#6)(1990-2#2)(1990-7#6)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#8)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#9)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#8)(1994-8#5)(1994-9#1)(1995-11#4)(1995-12#12)(1995-2#7)(1995-3#5)(1995-5#4)(1995-6#4)(1995-8#4)(1996-1#1)(1996-12#5)(1996-2#10)(1996-5#2)(1996-9#1)(1997-1#7)(1997-2#10)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#83)(2008-11#17)(2008-12#11)(2008-2#7)(2008-3#19)(2008-4#5)(2008-5#19)(2008-6#10)(2008-7#11)(2008-8#23)(2008-9#9)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#3)(2010-10#2)(2010-11#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#5)(2012-6#1)(2013-1#15)(2013-7#1)(2013-8#8)
results indicate the existence of##2##5##(1992-3#1)(2008-10#1)
results indicate the following##2##4##(1992-6#1)(2008-6#1)
results indicate the importance of##2##5##(1990-10#1)(2010-6#1)
results indicate the presence of##2##5##(2007-12#1)(2008-12#1)
results indicate the##20##3##(1990-10#1)(1992-3#1)(1992-6#2)(1993-9#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-6#1)(2011-1#1)(2012-12#1)
results indicate##591##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#3)(1990-6#2)(1990-7#6)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#9)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#3)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#6)(1993-8#5)(1993-9#4)(1994-11#9)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#8)(1994-8#5)(1994-9#2)(1995-11#6)(1995-12#13)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#4)(1996-1#1)(1996-12#5)(1996-2#10)(1996-5#2)(1996-9#1)(1997-1#8)(1997-2#10)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-2#1)(2007-8#3)(2008-1#3)(2008-10#91)(2008-11#20)(2008-12#12)(2008-2#9)(2008-3#22)(2008-4#6)(2008-5#20)(2008-6#11)(2008-7#13)(2008-8#23)(2008-9#10)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#3)(2010-10#2)(2010-11#2)(2010-2#3)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#7)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#9)
results indicated a##12##3##(1992-2#1)(1993-12#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-8#1)
results indicated an##2##3##(1994-6#1)(2008-9#1)
results indicated clearly that##2##4##(2007-11#1)(2008-9#1)
results indicated that in##2##4##(2008-10#1)(2008-12#1)
results indicated that the##49##4##(1990-2#1)(1994-3#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-3#4)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
results indicated that there was a significant##2##7##(2008-10#2)
results indicated that there was a##3##6##(2008-10#3)
results indicated that there was##4##5##(1996-5#1)(2008-10#3)
results indicated that this##2##4##(1997-4#1)(2008-8#1)
results indicated that##131##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#39)(2008-11#6)(2008-12#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#12)(2009-1#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#3)
results indicated##163##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#42)(2008-11#7)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#16)(2009-1#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#5)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#4)
results indicates that##2##3##(1991-12#1)(2008-3#1)
results indicating that the##2##4##(2008-10#1)(2008-11#1)
results indicating that##3##3##(2008-10#1)(2008-11#2)
results indicating##4##2##(2008-10#2)(2008-11#2)
results influenced##2##2##(1992-1#1)(2009-9#1)
results into the##2##3##(1996-6#1)(1997-2#1)
results into##3##2##(1996-6#1)(1997-2#1)(2008-3#1)
results introduce##2##2##(2008-11#1)(2011-2#1)
results involving##2##2##(2008-3#1)(2011-2#1)
results is demonstrated##3##3##(1995-2#1)(2007-12#1)(2008-3#1)
results is discussed##2##3##(2008-2#1)(2008-4#1)
results is##23##2##(1991-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2011-7#1)
results it can be##3##4##(1990-12#1)(2007-12#1)(2008-2#1)
results it is##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
results it was##3##3##(1994-2#1)(2008-3#2)
results it##12##2##(1990-12#1)(1990-8#1)(1993-8#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)
results justify the creation of a new pathovar##2##8##(2008-10#2)
results justify the##3##3##(2008-10#2)(2010-5#1)
results lead us to##3##4##(2008-10#2)(2008-4#1)
results lead##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
results led to a##2##4##(2008-2#1)(2012-2#1)
results led##4##2##(1994-8#1)(2008-2#1)(2008-6#1)(2012-2#1)
results lend support to##3##4##(2007-2#1)(2008-7#1)(2009-7#1)
results lend##4##2##(2007-2#1)(2008-7#1)(2008-9#1)(2009-7#1)
results look##2##2##(1991-3#1)(2008-1#1)
results may be##10##3##(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-2#1)
results may explain##2##3##(1994-8#1)(2008-10#1)
results may indicate that##2##4##(1991-5#1)(2008-10#1)
results may indicate##3##3##(1991-5#1)(1993-12#1)(2008-10#1)
results may reflect the##2##4##(2007-10#1)(2009-10#1)
results may reflect##3##3##(2007-10#1)(2008-7#1)(2009-10#1)
results may##36##2##(1991-5#1)(1993-12#1)(1994-1#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#3)
results measured by##2##3##(2008-10#1)(2011-1#1)
results might##2##2##(2008-7#1)(2008-8#1)
results must be##2##3##(1993-11#1)(2008-10#1)
results need to be##2##4##(2008-7#1)(2009-7#1)
results need##3##2##(2008-1#1)(2008-7#1)(2009-7#1)
results not only##3##3##(1993-11#1)(2008-11#1)(2008-9#1)
results observed in the##2##4##(1992-12#1)(2011-2#1)
results observed in##4##3##(1992-12#1)(1997-3#1)(2007-7#1)(2011-2#1)
results observed##7##2##(1992-12#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-5#1)(2011-2#2)
results obtained after##3##3##(2008-10#3)
results obtained and##2##3##(1992-6#1)(2008-3#1)
results obtained are in good agreement with##2##7##(2008-10#2)
results obtained are in##3##4##(2008-10#3)
results obtained are##17##3##(1997-8#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)
results obtained at##2##3##(2008-3#2)
results obtained by ICP-AES##2##4##(2008-10#2)
results obtained by a##2##4##(2008-2#1)(2008-3#1)
results obtained by both##3##4##(2008-10#3)
results obtained by other##2##4##(1991-9#1)(2008-3#1)
results obtained by the present##2##5##(2008-10#2)
results obtained by the proposed method and those##2##8##(2008-10#2)
results obtained by the proposed method and##4##7##(2008-10#4)
results obtained by the proposed method were##3##7##(2008-10#3)
results obtained by the proposed method##8##6##(2008-10#8)
results obtained by the proposed##11##5##(2008-10#11)
results obtained by the two methods##3##6##(1996-5#1)(2008-10#2)
results obtained by the two##4##5##(1996-5#1)(2008-10#3)
results obtained by the##27##4##(1996-5#1)(2008-10#26)
results obtained by this method were compared with the##2##9##(2008-10#2)
results obtained by this method##4##5##(2008-10#4)
results obtained by this##8##4##(2008-10#7)(2008-3#1)
results obtained by use of##3##5##(2008-3#3)
results obtained by using this electrode##2##6##(2008-10#2)
results obtained by using##5##4##(2008-10#4)(2012-1#1)
results obtained by##77##3##(1990-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-5#1)(2008-10#60)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2012-1#1)
results obtained compared##2##3##(2008-10#2)
results obtained for the assay of##2##6##(2008-10#2)
results obtained for the##12##4##(2008-10#10)(2008-3#1)(2009-4#1)
results obtained for##43##3##(1996-2#1)(2007-12#1)(2008-10#36)(2008-3#3)(2009-4#1)(2010-8#1)
results obtained from in##3##4##(2008-10#2)(2008-11#1)
results obtained from laboratory##2##4##(2008-1#1)(2008-10#1)
results obtained from the##5##4##(2008-10#2)(2008-3#1)(2008-5#2)
results obtained from##34##3##(1995-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#2)(2010-3#1)(2010-8#1)(2012-3#1)
results obtained have##3##3##(1993-8#1)(1996-11#1)(2008-10#1)
results obtained here##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
results obtained in patients##2##4##(2008-5#1)(2011-2#1)
results obtained in the analysis of##3##6##(2008-10#3)
results obtained in the present study##2##6##(2008-10#1)(2008-5#1)
results obtained in the##13##4##(1992-9#1)(1996-5#1)(2008-10#8)(2008-5#2)(2009-12#1)
results obtained in these##2##4##(2008-5#1)(2009-5#1)
results obtained in this##7##4##(1992-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
results obtained in##44##3##(1990-6#1)(1990-7#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-12#1)(1996-5#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-5#1)(2011-2#2)(2013-8#1)
results obtained indicated that##2##4##(1991-5#1)(2008-10#1)
results obtained indicated##4##3##(1991-5#1)(2008-10#3)
results obtained it##2##3##(1991-3#1)(2011-2#1)
results obtained on##2##3##(2008-5#1)(2011-3#1)
results obtained previously##2##3##(2008-3#2)
results obtained revealed##2##3##(2008-10#1)(2008-12#1)
results obtained show that##8##4##(1990-8#1)(1991-12#1)(2008-10#5)(2008-2#1)
results obtained show##11##3##(1990-8#1)(1991-12#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-5#1)
results obtained showed##7##3##(1993-3#1)(2008-10#5)(2013-7#1)
results obtained through##2##3##(2007-11#1)(2012-3#1)
results obtained to date##2##4##(1993-8#1)(2008-7#1)
results obtained using liquid chromatography##2##5##(2008-10#2)
results obtained using the##11##4##(1990-8#1)(1997-4#1)(2008-10#7)(2008-5#1)(2010-8#1)
results obtained using these##2##4##(2008-10#1)(2008-5#1)
results obtained using##26##3##(1990-8#1)(1997-4#2)(2008-10#18)(2008-5#2)(2008-6#1)(2009-8#1)(2010-8#1)
results obtained were in##2##4##(2008-10#2)
results obtained were##20##3##(2007-11#1)(2008-10#14)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-3#1)
results obtained with a##6##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
results obtained with an##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
results obtained with both##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
results obtained with the proposed method##3##6##(2008-10#3)
results obtained with the proposed##4##5##(2008-10#4)
results obtained with the two##2##5##(2008-10#1)(2008-5#1)
results obtained with the##28##4##(2006-6#1)(2008-10#14)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
results obtained with these##2##4##(2008-3#1)(2008-5#1)
results obtained with this technique##2##5##(2007-8#1)(2008-10#1)
results obtained with this##5##4##(1990-3#1)(2007-8#1)(2008-10#3)
results obtained with##71##3##(1990-3#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-8#1)(1996-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#28)(2008-11#3)(2008-2#8)(2008-3#8)(2008-5#3)(2008-7#1)(2008-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
results obtained##460##2##(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#3)(1994-3#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-1#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#258)(2008-11#9)(2008-12#2)(2008-2#18)(2008-3#27)(2008-4#1)(2008-5#27)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
results of 100##2##3##(1992-5#1)(2011-2#1)
results of MTT##2##3##(2008-8#1)(2011-3#1)
results of RT-PCR##2##3##(2008-10#1)(2008-9#1)
results of Western##4##3##(1995-6#1)(2008-8#1)(2008-9#2)
results of a comprehensive##2##4##(1997-2#1)(2008-3#1)
results of a follow-up##2##4##(1990-3#1)(1991-6#1)
results of a modular neck##2##5##(2011-2#2)
results of a multidisciplinary##2##4##(1994-1#1)(2013-8#1)
results of a numerical##3##4##(2007-12#1)(2008-3#2)
results of a pilot study##2##5##(2010-9#1)(2012-1#1)
results of a pilot##3##4##(1993-1#1)(2010-9#1)(2012-1#1)
results of a prospective study##2##5##(2008-8#1)(2009-5#1)
results of a prospective##3##4##(1993-9#1)(2008-8#1)(2009-5#1)
results of a questionnaire##2##4##(1994-12#1)(1996-8#1)
results of a randomized##2##4##(1994-8#1)(2009-12#1)
results of a research##2##4##(2008-9#1)(2013-1#1)
results of a series of##4##5##(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
results of a similar##2##4##(1990-6#1)(1996-11#1)
results of a simulation study##2##5##(1996-3#1)(1997-3#1)
results of a simulation##3##4##(1996-3#1)(1997-3#1)(2008-3#1)
results of a study of the##3##6##(1992-5#1)(2008-5#1)(2009-8#1)
results of a study of##7##5##(1992-1#1)(1992-5#1)(1993-9#1)(1996-12#1)(2008-5#1)(2009-8#1)(2010-10#1)
results of a study on##2##5##(2008-2#1)(2009-4#1)
results of a study##18##4##(1992-1#1)(1992-5#1)(1993-3#1)(1993-9#1)(1996-1#1)(1996-12#2)(2007-11#1)(2008-2#4)(2008-5#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-9#1)
results of a survey conducted among the##2##7##(1996-1#1)(1997-3#1)
results of a survey conducted##3##5##(1996-1#1)(1997-3#1)(2008-11#1)
results of a survey of##4##5##(1993-2#1)(1994-12#1)(1994-3#1)(2008-1#1)
results of a survey##10##4##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)
results of a systematic study##2##5##(1994-10#1)(2008-12#1)
results of a systematic##3##4##(1994-10#1)(2008-12#1)(2013-1#1)
results of a##144##3##(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#3)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
results of all##3##3##(1992-6#1)(1993-2#1)(2008-10#1)
results of an experiment##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
results of an experimental##3##4##(2007-11#2)(2008-8#1)
results of an investigation##4##4##(1993-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
results of an##36##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-8#1)(1993-2#1)(1993-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(2007-11#5)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-8#2)
results of analyses of##2##4##(2008-10#2)
results of analysis of##2##4##(2008-3#1)(2013-1#1)
results of analysis##4##3##(2008-3#1)(2008-7#1)(2010-5#1)(2013-1#1)
results of ankle arthrodesis with screws##2##6##(2011-2#2)
results of any##4##3##(1991-1#1)(2007-12#1)(2008-7#2)
results of both##6##3##(1992-12#1)(1996-6#1)(2008-2#1)(2008-3#1)(2008-7#2)
results of children##2##3##(2011-2#2)
results of clinical studies##2##4##(2012-12#1)(2013-1#1)
results of clinical trials##7##4##(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(2008-7#1)(2008-8#1)(2013-1#1)
results of clinical##10##3##(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
results of combined##2##3##(2007-11#1)(2008-9#1)
results of conservative##2##3##(1993-8#1)(1995-9#1)
results of determination of##4##4##(2008-10#2)(2008-12#1)(2009-8#1)
results of determination##7##3##(2008-10#5)(2008-12#1)(2009-8#1)
results of different##5##3##(1990-6#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
results of epidemiologic##2##3##(1992-3#1)(2011-1#1)
results of experimental and clinical##2##5##(1994-2#1)(1994-7#1)
results of experimental##4##3##(1994-2#1)(1994-7#1)(2008-2#1)(2008-3#1)
results of experiments with##2##4##(1992-6#1)(2008-11#1)
results of experiments##5##3##(1990-12#1)(1992-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
results of extremity##2##3##(2008-6#2)
results of four##2##3##(2008-2#1)(2011-2#1)
results of growth##2##3##(1993-2#1)(2008-10#1)
results of human##2##3##(1994-2#1)(2008-10#1)
results of in##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
results of its##3##3##(1995-5#1)(2008-2#1)(2011-1#1)
results of laboratory##3##3##(1994-11#1)(2008-3#1)(2008-9#1)
results of light scattering##2##4##(2008-2#1)(2008-3#1)
results of light##3##3##(1992-2#1)(2008-2#1)(2008-3#1)
results of many##2##3##(2010-10#1)(2013-7#1)
results of measurement of the##2##5##(2007-11#1)(2007-12#1)
results of measurements of the##2##5##(2007-12#1)(2008-3#1)
results of measurements of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
results of measurements##10##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)(2011-2#2)
results of medical##2##3##(1997-5#1)(2007-8#1)
results of modeling##2##3##(2007-12#1)(2008-3#1)
results of molecular##3##3##(1995-3#1)(2007-12#1)(2011-2#1)
results of morphological##2##3##(1992-11#1)(2008-7#1)
results of multiple##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
results of newer##2##3##(2008-1#1)(2013-1#1)
results of numerical##3##3##(2007-11#1)(2008-3#2)
results of one##2##3##(1996-1#1)(2007-10#1)
results of ongoing##5##3##(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#1)
results of operative treatment##3##4##(2007-11#3)
results of our analysis##2##4##(1997-5#1)(2007-8#1)
results of our own##2##4##(2013-1#1)(2013-8#1)
results of our research##2##4##(2011-1#1)(2011-2#1)
results of our study suggest##2##5##(1992-12#1)(2011-1#1)
results of our study##9##4##(1992-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
results of our##33##3##(1990-9#1)(1992-12#1)(1994-11#1)(1997-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
results of patients##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
results of preclinical##2##3##(2010-3#1)(2012-3#1)
results of previous##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
results of prospective##2##3##(1997-6#1)(2012-3#1)
results of randomized##2##3##(2007-8#1)(2010-6#1)
results of real sample analysis##2##5##(2008-10#2)
results of real sample##3##4##(2008-10#3)
results of recent##7##3##(1996-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
results of renal transplantation##2##4##(2008-1#2)
results of reproductive system##2##4##(2011-2#2)
results of research##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
results of several##5##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-3#1)
results of simulation##2##3##(2008-2#1)(2008-3#1)
results of six##3##3##(1991-3#1)(1993-3#1)(2008-10#1)
results of studies on the##2##5##(2008-10#1)(2008-12#1)
results of studies on##3##4##(2008-10#2)(2008-12#1)
results of studies##12##3##(1994-5#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#1)
results of such##5##3##(1991-2#1)(1994-12#1)(1996-12#1)(2013-1#1)(2013-7#1)
results of surgical treatment of##3##5##(2007-11#1)(2008-8#1)(2013-1#1)
results of surgical treatment##6##4##(2007-11#2)(2007-8#1)(2008-8#2)(2013-1#1)
results of surgical##7##3##(2007-11#2)(2007-8#1)(2008-8#2)(2008-9#1)(2013-1#1)
results of the National##2##4##(1991-12#1)(2012-1#1)
results of the analyses##2##4##(1995-5#1)(2008-11#1)
results of the analysis of synthetic##2##6##(2008-10#2)
results of the analysis of##3##5##(2008-10#3)
results of the analysis##6##4##(1995-12#1)(2008-10#3)(2008-3#1)(2010-5#1)
results of the atmospheric##2##4##(2008-3#2)
results of the current study##3##5##(2007-11#1)(2008-10#1)(2011-2#1)
results of the experiments##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
results of the first two##2##5##(2008-10#1)(2011-2#1)
results of the first##10##4##(1990-2#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
results of the initial##2##4##(1991-3#1)(1997-5#1)
results of the investigation##3##4##(2008-10#2)(2008-3#1)
results of the meta-analysis##3##4##(1996-6#1)(2007-7#1)(2008-2#1)
results of the most##2##4##(1995-6#1)(2013-1#1)
results of the present study suggest that##4##7##(1996-7#1)(2007-12#1)(2008-2#1)(2012-5#1)
results of the present study##16##5##(1994-3#1)(1996-7#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#2)(2010-2#1)(2011-7#1)(2012-5#1)
results of the present##20##4##(1992-11#1)(1994-3#1)(1995-3#1)(1996-7#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#2)(2010-2#1)(2011-7#1)(2012-5#1)(2013-8#1)
results of the proposed##6##4##(1997-8#1)(2008-10#3)(2009-8#1)(2012-1#1)
results of the reflectivity measurements based on##2##7##(2008-3#2)
results of the review##2##4##(1992-1#1)(2012-12#1)
results of the simulation##2##4##(2008-3#2)
results of the simulations show##2##5##(2008-3#2)
results of the study showed##2##5##(2008-10#1)(2008-5#1)
results of the study##19##4##(1990-10#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-1#1)(1996-1#2)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2012-12#1)
results of the survey##4##4##(1991-5#1)(2008-10#2)(2008-12#1)
results of the treatment of##3##5##(1995-8#1)(2011-1#1)(2011-2#1)
results of the treatment##4##4##(1995-8#1)(2007-11#1)(2011-1#1)(2011-2#1)
results of the two##5##4##(2008-10#3)(2008-11#1)(2008-4#1)
results of the##245##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-9#2)(1991-12#2)(1991-3#3)(1991-5#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#2)(1994-1#1)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-6#3)(1996-7#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#7)(2008-12#7)(2008-2#14)(2008-3#28)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2011-7#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#3)
results of their##6##3##(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1996-1#1)(2010-8#1)
results of theoretical##4##3##(2008-2#1)(2008-3#1)(2011-1#1)(2013-7#1)
results of these analyses##5##4##(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-2#1)
results of these experiments##6##4##(1994-3#1)(2008-10#4)(2008-6#1)
results of these studies are##4##5##(1991-9#1)(2007-8#1)(2008-7#1)(2012-1#1)
results of these studies##16##4##(1991-9#1)(1992-11#2)(1996-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#1)
results of these tests##4##4##(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
results of these##46##3##(1991-9#1)(1992-11#2)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
results of this analysis##9##4##(1991-9#1)(1994-11#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-2#1)
results of this investigation##4##4##(2008-10#3)(2008-5#1)
results of this study also show##2##6##(1991-12#1)(1997-2#1)
results of this study and the##2##6##(1990-6#1)(2008-5#1)
results of this study are##6##5##(1994-3#1)(1996-12#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
results of this study clearly##2##5##(2008-10#1)(2008-11#1)
results of this study demonstrated that##4##6##(1992-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
results of this study indicate that##13##6##(1990-5#1)(1991-11#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-6#2)(2009-7#1)(2011-2#1)
results of this study indicate##14##5##(1990-5#1)(1991-11#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-7#1)(2011-2#1)
results of this study may##2##5##(2008-10#1)(2008-12#1)
results of this study show that##4##6##(1990-12#1)(2008-10#1)(2010-2#1)(2011-2#1)
results of this study show##5##5##(1990-12#1)(2008-10#1)(2010-2#1)(2010-3#1)(2011-2#1)
results of this study suggest that##9##6##(1990-2#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-7#1)(2013-1#1)
results of this study suggest##10##5##(1990-2#1)(1991-3#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-7#1)(2013-1#1)
results of this study suggested that##2##6##(1992-2#1)(2011-3#1)
results of this study support##2##5##(1991-9#1)(2008-10#1)
results of this study were as follows##2##7##(1991-2#1)(1997-2#1)
results of this study were##3##5##(1991-2#1)(1997-2#1)(2008-11#1)
results of this study with##2##5##(2008-11#1)(2009-5#1)
results of this study##96##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#19)(2008-11#5)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#3)
results of this##142##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#2)(1992-2#2)(1992-9#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#15)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
results of total##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
results of treating the##2##4##(1992-5#1)(2013-1#1)
results of treating##3##3##(1992-5#1)(1996-11#1)(2013-1#1)
results of treatment of##6##4##(1995-5#1)(2007-8#3)(2010-3#1)(2011-1#1)
results of treatment with##4##4##(1992-2#1)(2007-8#1)(2008-12#1)(2013-1#1)
results of treatment##16##3##(1992-2#1)(1992-5#1)(1995-5#1)(2007-11#2)(2007-8#4)(2008-12#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
results of two##11##3##(1991-2#1)(1994-3#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
results of using##2##3##(2007-12#2)
results of##1268##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#3)(1990-5#4)(1990-6#8)(1990-8#2)(1990-9#8)(1991-1#3)(1991-11#2)(1991-12#11)(1991-2#4)(1991-3#7)(1991-5#4)(1991-6#2)(1991-8#2)(1991-9#4)(1992-1#3)(1992-11#6)(1992-12#3)(1992-2#6)(1992-3#5)(1992-5#6)(1992-6#3)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#7)(1993-2#8)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#3)(1994-1#5)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#7)(1994-3#7)(1994-5#2)(1994-7#1)(1994-8#3)(1995-1#7)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#8)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#12)(1996-11#6)(1996-12#10)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#8)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#10)(1997-4#3)(1997-5#8)(1997-6#3)(1997-7#1)(1997-8#7)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#7)(2007-11#42)(2007-12#29)(2007-2#3)(2007-6#2)(2007-7#4)(2007-8#26)(2007-9#1)(2008-1#14)(2008-10#170)(2008-11#30)(2008-12#35)(2008-2#56)(2008-3#95)(2008-4#12)(2008-5#38)(2008-6#20)(2008-7#38)(2008-8#29)(2008-9#28)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#7)(2009-7#2)(2009-8#8)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#7)(2010-4#3)(2010-5#4)(2010-6#6)(2010-8#9)(2010-9#5)(2011-1#17)(2011-2#41)(2011-3#4)(2011-7#2)(2012-1#10)(2012-12#8)(2012-2#17)(2012-3#17)(2012-5#1)(2013-1#41)(2013-7#5)(2013-8#15)
results offer##5##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
results on synthetic##2##3##(2008-10#1)(2012-12#1)
results on the development of##2##5##(2007-11#1)(2011-2#1)
results on the stability##2##4##(2008-5#1)(2011-2#1)
results on the##22##3##(1991-10#1)(1991-2#1)(1993-12#1)(1996-9#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
results on##50##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
results only##4##2##(1994-3#1)(1996-5#1)(2008-2#1)(2010-2#1)
results open##3##2##(1992-1#1)(2008-10#1)(2008-2#1)
results or##2##2##(1991-12#1)(1994-12#1)
results particularly##2##2##(1993-12#1)(1995-2#1)
results permit##2##2##(1992-8#1)(1993-11#1)
results point out the##2##4##(1991-8#1)(2012-8#1)
results point out##4##3##(1991-8#1)(2008-10#1)(2012-2#1)(2012-8#1)
results point to the need##2##5##(2008-2#1)(2012-3#1)
results point to the##7##4##(1990-6#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-2#1)(2012-3#1)
results point to##12##3##(1990-11#1)(1990-6#1)(1991-10#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
results point##16##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-8#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#1)(2012-3#1)(2012-8#1)
results present##2##2##(1996-1#1)(2008-2#1)
results presented a##2##3##(2008-10#2)
results presented here are##3##4##(1993-6#1)(2008-3#2)
results presented here show that##2##5##(2008-10#1)(2008-3#1)
results presented here##16##3##(1993-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-10#1)(2010-8#1)
results presented in this paper##3##5##(1991-9#1)(1993-6#1)(2008-10#1)
results presented in this##6##4##(1991-9#1)(1992-6#1)(1993-6#1)(2008-10#2)(2008-7#1)
results presented in##7##3##(1991-9#1)(1992-6#1)(1993-6#1)(2008-10#3)(2008-7#1)
results presented##35##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-6#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#4)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
results primarily##2##2##(1995-2#1)(2008-8#1)
results produced by##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
results propose##2##2##(1997-6#1)(2013-1#1)
results prove that the proposed##2##5##(2007-11#1)(2008-3#1)
results prove that##6##3##(1992-9#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
results prove##7##2##(1992-9#1)(1994-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
results proved that##2##3##(1990-8#1)(2008-3#1)
results proved##6##2##(1990-8#1)(2008-10#2)(2008-3#2)(2008-5#1)
results provide a theoretical##2##4##(2008-8#1)(2013-8#1)
results provide a##9##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
results provide additional##2##3##(1991-10#1)(1992-3#1)
results provide an##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
results provide direct evidence that##2##5##(1994-8#1)(2008-10#1)
results provide direct evidence##3##4##(1990-7#1)(1994-8#1)(2008-10#1)
results provide direct##4##3##(1990-7#1)(1994-8#1)(2008-10#2)
results provide evidence for a##2##5##(1997-2#1)(2013-1#1)
results provide evidence for##3##4##(1996-2#1)(1997-2#1)(2013-1#1)
results provide evidence that a##2##5##(1992-3#1)(1993-6#1)
results provide evidence that##9##4##(1990-7#1)(1992-3#1)(1993-12#1)(1993-6#1)(2008-10#3)(2008-8#1)(2013-1#1)
results provide evidence##13##3##(1990-7#1)(1992-3#1)(1993-12#1)(1993-6#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-8#1)(2009-7#1)(2013-1#2)
results provide information##2##3##(2008-11#1)(2013-8#1)
results provide strong##2##3##(1992-2#1)(1996-8#1)
results provide support for the hypothesis that##2##7##(1994-8#1)(2013-8#1)
results provide support for##4##4##(1994-8#1)(1994-9#1)(2011-2#1)(2013-8#1)
results provide the##6##3##(1995-2#1)(2008-10#1)(2009-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
results provide useful information for##2##5##(2008-2#1)(2010-5#1)
results provide##73##2##(1990-7#2)(1991-10#1)(1991-2#1)(1991-6#1)(1992-2#2)(1992-3#3)(1993-12#1)(1993-6#2)(1994-8#2)(1994-9#1)(1995-2#2)(1996-2#1)(1996-8#1)(1997-2#4)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
results provided a##2##3##(2008-10#1)(2008-8#1)
results provided by the proposed method##2##6##(2008-10#2)
results provided##12##2##(1994-7#1)(2008-10#4)(2008-12#1)(2008-8#2)(2008-9#3)(2012-12#1)
results published##2##2##(2007-11#1)(2008-2#1)
results quickly##2##2##(2008-11#1)(2010-5#1)
results reflect the##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
results regarding##5##2##(2007-6#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)
results relating to##2##3##(1992-1#1)(2008-2#1)
results relative to the##2##4##(2008-10#2)
results remain##3##2##(1996-5#1)(2008-2#1)(2008-8#1)
results reported by the labs using the##2##7##(2008-10#2)
results reported by##4##3##(1992-12#1)(2008-10#2)(2008-6#1)
results reported for##2##3##(1990-6#1)(2008-10#1)
results reported from##2##3##(1990-11#1)(1994-3#1)
results reported here##3##3##(2008-10#1)(2008-5#1)(2009-5#1)
results reported in the literature##3##5##(1994-6#1)(2008-10#1)(2013-1#1)
results reported in##5##3##(1991-2#1)(1994-6#1)(2008-10#2)(2013-1#1)
results reported##17##2##(1990-11#1)(1990-6#1)(1991-2#1)(1992-12#1)(1994-3#1)(1994-6#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2013-1#1)
results represent a##2##3##(2008-5#1)(2008-6#1)
results represent the first##2##4##(1992-3#1)(2008-8#1)
results represent##6##2##(1992-3#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)
results require##3##2##(1991-2#1)(2008-2#1)(2013-1#1)
results requires##2##2##(1994-1#1)(2007-12#1)
results reveal a##4##3##(2007-11#1)(2008-11#1)(2008-7#1)(2009-3#1)
results reveal that the##6##4##(1994-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
results reveal that##17##3##(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-9#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
results reveal##25##2##(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-9#1)(2007-11#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
results revealed a##3##3##(2007-7#1)(2008-8#1)(2009-8#1)
results revealed significant##3##3##(2008-10#1)(2008-12#1)(2009-7#1)
results revealed that a##2##4##(2007-10#1)(2008-12#1)
results revealed that the##8##4##(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-8#1)
results revealed that##36##3##(1991-6#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(2007-10#2)(2007-11#1)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
results revealed the##5##3##(1991-2#1)(1997-3#1)(2008-10#3)
results revealed##55##2##(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
results seem to suggest that the##2##6##(1993-3#1)(2009-7#1)
results seem to suggest that##4##5##(1993-3#1)(1995-12#1)(1997-3#1)(2009-7#1)
results seem to##8##3##(1992-6#1)(1993-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-7#1)
results seem##9##2##(1990-5#1)(1992-6#1)(1993-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-7#1)
results seen##2##2##(2007-12#1)(2008-10#1)
results shed light on##3##4##(1994-1#1)(2012-2#1)(2012-3#1)
results should be useful in##2##5##(2008-3#1)(2010-4#1)
results should be##9##3##(1990-3#1)(1991-12#1)(1996-12#1)(1997-5#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-1#1)
results should##17##2##(1990-3#1)(1991-12#1)(1992-6#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
results show a clear##3##4##(1990-5#1)(2008-5#1)(2008-6#1)
results show a low##2##4##(2008-9#1)(2011-2#1)
results show a##23##3##(1990-5#2)(1992-8#1)(1993-11#1)(1993-8#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-8#2)
results show an##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-5#1)
results show different##2##3##(2008-9#1)(2009-11#1)
results show good agreement with the##2##6##(2008-10#1)(2008-3#1)
results show good agreement with##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
results show good agreement##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
results show good##6##3##(2008-10#2)(2008-2#3)(2008-3#1)
results show how##3##3##(2008-3#1)(2009-11#1)(2012-2#1)
results show significant##2##3##(1990-6#1)(2008-4#1)
results show that T##2##4##(1996-2#1)(2008-10#1)
results show that a##11##4##(1990-11#1)(1990-12#1)(1994-2#1)(2006-6#1)(2007-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2013-8#1)
results show that both##8##4##(1993-3#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#1)
results show that by##2##4##(2008-10#1)(2008-11#1)
results show that collapsing##2##4##(2012-3#2)
results show that different##2##4##(2008-1#1)(2012-3#1)
results show that during##2##4##(1992-3#1)(1996-9#1)
results show that in##5##4##(1994-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
results show that it is##2##5##(2008-10#1)(2013-8#1)
results show that it##3##4##(2008-10#2)(2013-8#1)
results show that more##2##4##(2008-10#1)(2010-12#1)
results show that no##2##4##(1993-8#1)(2008-9#1)
results show that only##2##4##(2007-12#1)(2008-3#1)
results show that the extent of##2##6##(2008-10#1)(2008-6#1)
results show that the fully##2##5##(2008-3#2)
results show that the interference##2##5##(2008-3#1)(2013-8#1)
results show that the proposed##3##5##(2008-3#1)(2010-8#1)(2013-8#1)
results show that the use of##2##6##(2008-3#1)(2011-2#1)
results show that the##152##4##(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#39)(2008-11#4)(2008-2#14)(2008-3#20)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#12)(2008-9#3)(2009-11#2)(2009-3#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#12)
results show that there are two##2##6##(2008-3#1)(2008-8#1)
results show that there are##3##5##(1994-9#1)(2008-3#1)(2008-8#1)
results show that there is##5##5##(1991-9#1)(1992-8#1)(2008-10#2)(2008-2#1)
results show that there##8##4##(1991-9#1)(1992-8#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
results show that these##2##4##(2008-10#1)(2008-3#1)
results show that this##11##4##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-8#1)(2013-7#1)
results show that while##2##4##(1991-12#1)(2012-3#1)
results show that with##2##4##(2007-12#1)(2008-10#1)
results show that##403##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#5)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-8#6)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2006-6#2)(2007-10#1)(2007-11#9)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#80)(2008-11#11)(2008-12#3)(2008-2#24)(2008-3#42)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#18)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#3)(2010-10#2)(2010-12#1)(2010-2#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#7)(2012-6#1)(2013-1#5)(2013-7#2)(2013-8#24)
results show the importance of##2##5##(2008-10#1)(2011-2#1)
results show the potential##2##4##(2008-10#2)
results show the##26##3##(1990-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
results show##501##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-12#5)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#4)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#5)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-8#6)(1994-9#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2006-6#2)(2007-10#1)(2007-11#15)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#97)(2008-11#11)(2008-12#3)(2008-2#31)(2008-3#54)(2008-4#3)(2008-5#15)(2008-6#4)(2008-7#9)(2008-8#18)(2008-9#10)(2009-10#2)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#3)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#7)(2012-6#1)(2012-9#1)(2013-1#6)(2013-7#3)(2013-8#28)
results showed a high##2##4##(2008-10#1)(2012-1#1)
results showed a significant decrease of##2##6##(2008-1#1)(2009-6#1)
results showed a significant decrease##3##5##(2008-1#1)(2008-12#1)(2009-6#1)
results showed a significant##6##4##(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-1#1)(2011-2#1)
results showed a##20##3##(1991-9#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
results showed for##2##3##(2008-10#1)(2008-5#1)
results showed good agreement##3##4##(2008-10#3)
results showed no##3##3##(1991-4#1)(1994-5#1)(2012-12#1)
results showed significant##3##3##(2008-12#1)(2010-3#1)(2010-8#1)
results showed that (i)##4##4##(2008-10#1)(2008-8#1)(2008-9#2)
results showed that all##4##4##(1991-5#1)(2008-10#1)(2008-7#1)(2010-3#1)
results showed that both##4##4##(2008-10#2)(2008-9#1)(2010-10#1)
results showed that in the##2##5##(2008-10#1)(2009-6#1)
results showed that in##8##4##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
results showed that the majority of##2##6##(1997-3#1)(2008-8#1)
results showed that the same##3##5##(2008-10#1)(2008-8#1)(2012-1#1)
results showed that the##95##4##(1993-12#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#24)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#6)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#2)(2011-3#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#4)
results showed that there was##2##5##(1997-3#1)(2008-9#1)
results showed that there##6##4##(1997-3#1)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#1)
results showed that these##4##4##(1996-1#1)(2008-10#2)(2008-9#1)
results showed that this##2##4##(2008-10#1)(2013-7#1)
results showed that with##3##4##(2008-2#1)(2011-2#1)(2013-1#1)
results showed that##258##3##(1990-12#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#63)(2008-11#14)(2008-12#12)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#22)(2008-9#23)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#5)(2011-3#4)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#5)(2013-8#13)
results showed the##18##3##(1993-1#1)(2008-10#7)(2008-5#3)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
results showed##341##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#87)(2008-11#17)(2008-12#18)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#15)(2008-6#5)(2008-7#4)(2008-8#24)(2008-9#24)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#9)(2011-3#4)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#9)(2013-7#5)(2013-8#16)
results showing that##2##3##(2008-7#1)(2010-4#1)
results showing the##2##3##(1991-11#1)(2009-3#1)
results showing##7##2##(1991-11#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)
results shown##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
results shows that##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
results similar to those##3##4##(1994-3#1)(2008-10#2)
results similar to##4##3##(1994-3#1)(2008-10#2)(2008-3#1)
results so##2##2##(2006-12#1)(2008-10#1)
results strongly suggest that the##6##5##(1991-12#1)(1993-6#1)(1994-6#1)(1997-4#1)(2008-6#1)(2008-8#1)
results strongly suggest that##19##4##(1990-4#1)(1991-12#3)(1993-6#1)(1994-6#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
results strongly suggest the##2##4##(1994-5#1)(2010-11#1)
results strongly suggest##22##3##(1990-4#1)(1991-12#3)(1991-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#1)
results strongly support##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
results strongly##29##2##(1990-4#1)(1991-12#4)(1991-2#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-5#3)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#2)
results substantiate the##2##3##(1992-12#1)(2008-7#1)
results suggest a possible role##3##5##(1990-11#1)(1991-1#1)(1992-3#1)
results suggest a possible##8##4##(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-6#1)(1994-3#1)
results suggest a potential##2##4##(1994-9#1)(2008-10#1)
results suggest a role for##3##5##(1992-11#1)(1992-12#1)(2012-3#1)
results suggest a##28##3##(1990-11#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2010-4#1)(2010-6#1)(2012-3#1)
results suggest an inhibitory##2##4##(1993-12#1)(2008-5#1)
results suggest an##11##3##(1990-6#1)(1993-12#1)(1994-3#1)(1994-8#2)(1996-9#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#2)
results suggest strongly that##2##4##(1991-8#1)(1992-3#1)
results suggest that (a)##2##4##(1994-2#1)(2008-4#1)
results suggest that (i)##2##4##(1993-9#1)(2008-10#1)
results suggest that Ca2+##2##4##(1990-7#1)(1997-7#1)
results suggest that DNA##2##4##(1990-6#1)(2010-5#1)
results suggest that IL-6##2##4##(1990-5#1)(1996-2#1)
results suggest that NO##2##4##(1995-11#1)(2012-2#1)
results suggest that PKC##2##4##(1993-3#1)(1995-2#1)
results suggest that a minimum##2##5##(2008-2#1)(2010-4#1)
results suggest that a##20##4##(1992-3#1)(1992-6#2)(1993-6#2)(1996-3#1)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#1)(2012-1#1)(2013-1#2)
results suggest that acoustic##2##4##(2008-3#1)(2013-7#1)
results suggest that although##3##4##(1991-4#1)(1997-3#1)(2007-12#1)
results suggest that an##7##4##(1990-2#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
results suggest that both##4##4##(1991-12#1)(1994-5#1)(2008-10#1)(2008-9#1)
results suggest that dietary##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
results suggest that for##4##4##(1990-3#1)(1992-11#1)(2008-7#1)(2009-7#1)
results suggest that human##3##4##(1990-12#1)(1994-2#1)(2008-8#1)
results suggest that in addition to##2##6##(1992-9#1)(1993-3#1)
results suggest that in the##2##5##(1990-2#1)(2008-10#1)
results suggest that in##8##4##(1990-2#1)(1992-9#1)(1993-3#2)(1993-8#2)(2008-10#2)
results suggest that it##2##4##(2008-10#2)
results suggest that large##2##4##(2008-11#1)(2008-8#1)
results suggest that local##2##4##(2008-9#1)(2009-10#1)
results suggest that long-term##2##4##(1994-5#1)(1994-6#1)
results suggest that multiple##2##4##(1991-6#1)(1997-3#1)
results suggest that phage##2##4##(2008-8#1)(2013-1#1)
results suggest that some##3##4##(1996-6#1)(2008-10#1)(2008-9#1)
results suggest that stimulation of##2##5##(1997-7#2)
results suggest that such##2##4##(1993-3#1)(2008-11#1)
results suggest that the altered##2##5##(1992-10#1)(1997-1#1)
results suggest that the amygdala##2##5##(1993-6#2)
results suggest that the effect of##4##6##(1993-3#1)(1994-3#1)(1996-12#1)(2008-8#1)
results suggest that the enhanced##2##5##(2008-10#1)(2008-5#1)
results suggest that the inhibition of##3##6##(1993-12#1)(1997-4#1)(2008-11#1)
results suggest that the inhibitory##3##5##(1990-5#1)(1991-12#1)(1995-11#1)
results suggest that the observed##2##5##(1994-12#1)(1995-12#1)
results suggest that the presence of##2##6##(1990-5#1)(2008-10#1)
results suggest that the role of##2##6##(1996-12#1)(2010-1#1)
results suggest that the use of##2##6##(2012-3#1)(2013-8#1)
results suggest that the##201##4##(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#3)(1990-8#1)(1991-12#3)(1991-2#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-8#3)(1992-9#3)(1993-12#2)(1993-3#4)(1993-6#5)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#3)(1995-12#7)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#6)(1997-4#2)(1997-6#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-10#29)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#6)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-2#9)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
results suggest that there is a##3##6##(2008-3#1)(2009-8#1)(2010-12#1)
results suggest that there is##8##5##(1994-3#1)(2008-10#4)(2008-3#1)(2009-8#1)(2010-12#1)
results suggest that there##12##4##(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
results suggest that these##4##4##(1992-8#1)(1993-11#1)(1994-12#1)(2008-10#1)
results suggest that this##7##4##(1990-5#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
results suggest that when##4##4##(1992-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
results suggest that##790##3##(1990-11#5)(1990-12#7)(1990-2#10)(1990-3#1)(1990-5#10)(1990-6#1)(1990-7#5)(1990-8#4)(1991-11#2)(1991-12#16)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#3)(1991-9#7)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#9)(1992-3#11)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#10)(1992-9#6)(1993-1#1)(1993-11#5)(1993-12#7)(1993-2#1)(1993-3#13)(1993-6#12)(1993-8#11)(1993-9#5)(1994-11#8)(1994-12#10)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#8)(1995-11#10)(1995-12#15)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#3)(1995-8#4)(1995-9#2)(1996-1#1)(1996-12#6)(1996-2#11)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#9)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#3)(2007-10#3)(2007-11#1)(2007-12#8)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#116)(2008-11#48)(2008-12#6)(2008-2#9)(2008-3#12)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#16)(2008-8#31)(2008-9#21)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#21)(2012-1#1)(2012-12#2)(2012-2#18)(2012-3#11)(2012-7#1)(2013-1#15)(2013-7#4)(2013-8#3)
results suggest the involvement of##2##5##(1996-5#1)(1997-1#1)
results suggest the need for##5##5##(1995-1#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-2#1)
results suggest the possibility of a##2##6##(1993-12#1)(1994-8#1)
results suggest the possibility of##4##5##(1993-12#1)(1993-3#1)(1994-8#1)(2009-11#1)
results suggest the possibility that##3##5##(1990-12#1)(1994-11#1)(1996-12#1)
results suggest the possibility##7##4##(1990-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-12#1)(2009-11#1)
results suggest the potential##4##4##(1993-11#1)(2008-10#2)(2008-11#1)
results suggest the presence of a##5##6##(1991-2#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
results suggest the presence of##6##5##(1991-2#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#1)
results suggest the##41##3##(1990-12#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2012-2#1)(2013-8#1)
results suggest two##2##3##(1991-8#1)(2012-3#1)
results suggest##902##2##(1990-11#6)(1990-12#8)(1990-2#10)(1990-3#1)(1990-5#11)(1990-6#2)(1990-7#5)(1990-8#5)(1991-1#1)(1991-11#3)(1991-12#18)(1991-2#4)(1991-4#2)(1991-5#5)(1991-6#3)(1991-8#2)(1991-9#9)(1992-1#1)(1992-10#4)(1992-11#7)(1992-12#11)(1992-3#14)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#11)(1992-9#6)(1993-1#1)(1993-11#6)(1993-12#9)(1993-2#1)(1993-3#15)(1993-6#14)(1993-8#12)(1993-9#5)(1994-11#9)(1994-12#11)(1994-2#6)(1994-3#9)(1994-5#5)(1994-6#5)(1994-7#2)(1994-8#11)(1994-9#9)(1995-1#1)(1995-11#10)(1995-12#17)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#1)(1996-12#7)(1996-2#12)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#9)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#3)(2007-10#4)(2007-11#1)(2007-12#12)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#127)(2008-11#54)(2008-12#7)(2008-2#10)(2008-3#14)(2008-4#5)(2008-5#21)(2008-6#10)(2008-7#18)(2008-8#33)(2008-9#24)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#22)(2012-1#1)(2012-12#2)(2012-2#19)(2012-3#13)(2012-7#1)(2013-1#15)(2013-7#4)(2013-8#4)
results suggested a##4##3##(1990-5#1)(1997-8#1)(2008-6#1)(2008-8#1)
results suggested that the##20##4##(1995-5#1)(1995-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-3#1)(2013-1#1)
results suggested that##56##3##(1991-5#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(2008-10#6)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2010-10#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
results suggested the##2##3##(2008-5#1)(2008-9#1)
results suggested##65##2##(1990-5#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#3)(2008-10#6)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#4)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
results suggesting that##3##3##(1990-9#1)(1993-2#1)(2008-3#1)
results suggesting##4##2##(1990-9#1)(1992-12#1)(1993-2#1)(2008-3#1)
results suggests that##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
results support a role for##5##5##(1990-5#1)(1992-5#1)(1994-8#1)(1995-5#1)(1995-6#1)
results support a##8##3##(1990-5#1)(1992-5#1)(1993-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-5#1)(2008-7#1)
results support an##2##3##(1995-2#1)(2013-8#1)
results support our##2##3##(1996-12#1)(2010-8#1)
results support that##3##3##(2008-5#1)(2010-1#1)(2012-1#1)
results support the concept##2##4##(1991-9#1)(1996-5#1)
results support the conclusion that##2##5##(1992-2#1)(2013-8#1)
results support the hypotheses that##3##5##(2008-10#1)(2008-7#1)(2010-6#1)
results support the hypothesis for##2##5##(2008-10#2)
results support the hypothesis that the##4##6##(1992-7#1)(1994-9#1)(2008-10#2)
results support the hypothesis that##19##5##(1992-5#1)(1992-6#1)(1992-7#2)(1993-8#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-4#1)(2008-10#6)(2008-4#1)(2009-5#1)(2009-8#1)(2012-12#1)
results support the hypothesis##24##4##(1992-5#1)(1992-6#1)(1992-7#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-4#1)(2008-10#8)(2008-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-12#1)
results support the idea that##2##5##(2008-10#1)(2010-10#1)
results support the suggestion that##3##5##(1990-11#1)(1995-8#1)(2007-12#1)
results support the suggestion##4##4##(1990-11#1)(1995-8#1)(1996-5#1)(2007-12#1)
results support the use of##2##5##(2009-12#1)(2012-12#1)
results support the view that##4##5##(1994-2#1)(2008-2#1)(2008-5#1)(2008-8#1)
results support the##58##3##(1990-10#1)(1990-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-12#2)(2013-8#1)
results support##84##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#3)(1992-7#2)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#3)(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
results supported our##2##3##(2008-10#1)(2009-8#1)
results supported##3##2##(2008-10#2)(2009-8#1)
results taken together##3##3##(1990-12#1)(1996-12#1)(2008-11#1)
results than##22##2##(1991-6#1)(1993-11#1)(1997-7#3)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
results that are in##2##4##(1994-5#1)(2008-10#1)
results that are##11##3##(1992-11#1)(1994-5#1)(1997-2#1)(2008-10#2)(2008-3#2)(2009-10#1)(2012-12#3)
results that can be##2##4##(2009-10#1)(2009-8#1)
results that compare##3##3##(1993-9#1)(2008-10#2)
results that confirm##2##3##(2007-11#2)
results that demonstrate a##2##4##(2007-12#1)(2008-2#1)
results that demonstrate the##4##4##(2008-2#2)(2008-3#2)
results that demonstrate##9##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2010-8#1)
results that have##2##3##(2007-8#1)(2008-3#1)
results that show##2##3##(2007-12#1)(2008-3#1)
results that the##5##3##(1996-5#1)(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
results that were##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
results that##59##2##(1992-11#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-12#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#13)(2009-10#2)(2009-8#1)(2010-8#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
results the##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2013-8#1)
results thus indicate a##3##4##(1994-6#1)(1995-2#1)(1996-5#1)
results thus##9##2##(1990-3#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#2)(2013-1#1)
results to a##2##3##(1990-5#1)(2009-7#1)
results to be##4##3##(2008-3#1)(2008-6#1)(2008-7#2)
results to date##5##3##(1990-11#1)(1994-12#1)(1997-3#1)(2008-4#1)(2011-2#1)
results to demonstrate the##2##4##(2007-12#1)(2008-2#1)
results to our##2##3##(2008-10#1)(2008-3#1)
results to the analysis of##2##5##(2008-10#2)
results to the##14##3##(1991-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)
results to those obtained##2##4##(1994-2#1)(2008-10#1)
results to those of##2##4##(1995-12#1)(2008-10#1)
results to those##5##3##(1991-3#1)(1994-2#1)(1995-12#1)(2008-10#2)
results to##68##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#11)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
results together##3##2##(2008-3#2)(2011-1#1)
results under##3##2##(1993-12#1)(2008-2#1)(2013-8#1)
results underscore the importance of##3##5##(1990-6#1)(1996-1#1)(2008-9#1)
results underscore the##4##3##(1990-6#1)(1996-1#1)(1997-1#1)(2008-9#1)
results underscore##5##2##(1990-6#1)(1996-1#1)(1997-1#1)(2008-9#1)(2013-1#1)
results upon##2##2##(2008-11#1)(2008-7#1)
results using a##6##3##(1994-12#1)(1997-6#1)(2008-3#2)(2008-6#1)(2012-1#1)
results using the##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
results using this##2##3##(2008-10#2)
results using##23##2##(1994-12#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
results validate the##4##3##(2008-3#3)(2009-12#1)
results verify that##2##3##(2008-3#1)(2011-1#1)
results verify the##4##3##(2008-3#2)(2008-8#1)(2013-8#1)
results verify##6##2##(2008-3#3)(2008-8#1)(2011-1#1)(2013-8#1)
results warrant further##2##3##(2008-10#1)(2010-12#1)
results was checked by##2##4##(2008-10#2)
results was checked##3##3##(2008-10#3)
results was##28##2##(1990-8#1)(1992-12#1)(1994-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
results we conclude that the##2##5##(1990-5#1)(2008-10#1)
results we obtained##2##3##(2007-11#1)(2008-2#1)
results we##16##2##(1990-5#1)(1992-6#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
results well##3##2##(2008-10#3)
results were achieved without##2##4##(2008-10#1)(2011-1#1)
results were achieved##7##3##(1990-5#1)(1994-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)
results were also##11##3##(1992-3#1)(1992-9#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)
results were analyzed and##2##4##(2008-10#1)(2008-3#1)
results were analyzed by##3##4##(2007-10#1)(2008-10#1)(2012-2#1)
results were analyzed to##2##4##(2008-3#1)(2008-6#1)
results were analyzed##9##3##(2007-10#1)(2008-10#2)(2008-3#2)(2008-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
results were announced##2##3##(2008-5#2)
results were applied to##2##4##(2008-10#2)
results were as follows##5##4##(1990-12#1)(1990-2#1)(1993-8#1)(1995-2#1)(2007-11#1)
results were comparable to the##2##5##(2006-10#1)(2008-10#1)
results were comparable to##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
results were comparable with##2##4##(1997-4#1)(2008-8#1)
results were comparable##6##3##(1997-4#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#1)
results were compared between##2##4##(2007-10#1)(2008-7#1)
results were compared to the##2##5##(2008-10#1)(2008-7#1)
results were compared to those obtained by##2##7##(2008-10#2)
results were compared to those##5##5##(2008-10#4)(2008-8#1)
results were compared to##10##4##(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
results were compared with a##3##5##(2008-10#1)(2010-8#1)(2013-8#1)
results were compared with other##2##5##(2008-10#2)
results were compared with standard##2##5##(2008-10#1)(2008-5#1)
results were compared with the results obtained##2##7##(2008-10#2)
results were compared with the##10##5##(1996-3#1)(2007-11#1)(2008-10#7)(2008-2#1)
results were compared with those obtained by a##2##8##(2008-10#1)(2008-2#1)
results were compared with those obtained by##8##7##(2008-10#6)(2008-2#1)(2008-3#1)
results were compared with those obtained using##4##7##(2008-10#4)
results were compared with those obtained with##3##7##(2008-10#2)(2008-6#1)
results were compared with those obtained##16##6##(1996-5#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-6#1)
results were compared with those of the##2##7##(2008-10#2)
results were compared with those of##4##6##(2008-10#3)(2008-7#1)
results were compared with those##22##5##(1996-5#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)
results were compared with##58##4##(1991-8#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#34)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-1#2)(2012-3#1)(2013-8#1)
results were compared##81##3##(1991-8#1)(1994-3#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#48)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#2)
results were confirmed by##5##4##(1994-11#1)(1997-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
results were confirmed in##2##4##(2007-10#1)(2008-10#1)
results were confirmed##10##3##(1994-11#1)(1997-4#1)(2007-10#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-2#1)
results were consistent with the##3##5##(1990-5#1)(2008-8#1)(2013-1#1)
results were consistent with those##2##5##(2008-10#2)
results were consistent with##6##4##(1990-5#1)(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
results were consistent##9##3##(1990-5#1)(1993-9#1)(2007-12#1)(2008-10#3)(2008-8#1)(2013-1#2)
results were correlated with the##3##5##(2008-2#1)(2008-7#1)(2013-8#1)
results were correlated##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
results were discussed in##2##4##(2008-10#1)(2008-12#1)
results were discussed##3##3##(1993-11#1)(2008-10#1)(2008-12#1)
results were evaluated##4##3##(1992-4#1)(1997-6#1)(2007-8#1)(2008-7#1)
results were excellent##3##3##(1992-6#1)(1992-9#1)(1996-9#1)
results were found for##5##4##(1997-1#1)(2008-10#2)(2008-9#1)(2010-9#1)
results were found in##4##4##(2007-11#2)(2008-8#2)
results were found to be in good agreement with##3##9##(2008-10#3)
results were found to be in##4##6##(2008-10#4)
results were found to be##10##5##(1997-2#1)(2007-7#1)(2008-10#8)
results were found##22##3##(1997-1#1)(1997-2#1)(2007-11#4)(2007-7#1)(2008-10#10)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#1)
results were further##6##3##(1993-3#1)(1994-11#1)(1997-1#1)(2009-6#1)(2010-6#1)(2011-2#1)
results were in agreement with the certified##2##7##(2008-10#2)
results were in agreement with those obtained by##3##8##(2008-10#3)
results were in agreement with those##4##6##(2008-10#4)
results were in agreement with##6##5##(2008-10#6)
results were in agreement##7##4##(1994-6#1)(2008-10#6)
results were in good agreement with the##3##7##(1992-9#1)(2008-10#2)
results were in good agreement with those obtained by##2##9##(2008-10#2)
results were in good agreement with those obtained##3##8##(2008-10#3)
results were in good agreement with those##7##7##(2008-10#7)
results were in good agreement with##16##6##(1992-9#1)(2007-12#1)(2008-10#13)(2008-3#1)
results were in the##2##4##(2008-10#1)(2008-9#1)
results were in##26##3##(1992-9#1)(1994-6#1)(2007-12#1)(2008-10#21)(2008-3#1)(2008-9#1)
results were interpreted##7##3##(1990-11#1)(1993-8#1)(1994-5#1)(2008-10#2)(2008-5#2)
results were not##4##3##(1991-2#1)(1992-2#1)(1994-9#1)(2008-11#1)
results were noted in##2##4##(1990-12#1)(2007-11#1)
results were noted##3##3##(1990-12#1)(2007-11#2)
results were observed with##2##4##(1997-4#1)(2008-5#1)
results were observed##8##3##(1991-4#1)(1994-9#1)(1997-4#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
results were obtained after##3##4##(1990-2#1)(2007-8#1)(2012-1#1)
results were obtained at##2##4##(2008-10#2)
results were obtained by##9##4##(2008-10#7)(2008-3#1)(2008-5#1)
results were obtained for all##2##5##(2008-10#2)
results were obtained for the##5##5##(1991-12#1)(1994-11#1)(2008-10#3)
results were obtained for##15##4##(1991-12#1)(1993-6#1)(1994-11#1)(2007-8#1)(2008-10#11)
results were obtained from##2##4##(2008-10#1)(2008-3#1)
results were obtained in the determination of##3##7##(2008-10#3)
results were obtained in the##6##5##(2008-10#5)(2008-11#1)
results were obtained in##13##4##(1990-2#1)(1994-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
results were obtained using the##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
results were obtained using##10##4##(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#2)(2013-1#1)
results were obtained when##4##4##(2008-10#4)
results were obtained with a##3##5##(2008-10#2)(2008-5#1)
results were obtained with the##8##5##(1992-5#1)(1995-8#1)(1997-3#1)(2008-10#4)(2008-11#1)
results were obtained with##20##4##(1990-8#1)(1992-5#1)(1995-12#1)(1995-8#1)(1997-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-5#1)
results were obtained##98##3##(1990-2#2)(1990-8#1)(1991-12#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-3#1)(2007-12#1)(2007-8#3)(2008-10#61)(2008-11#4)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#2)(2011-2#1)(2012-1#1)(2013-1#1)
results were presented at the##2##5##(2008-5#2)
results were presented##3##3##(2008-5#3)
results were quite##2##3##(1997-4#1)(2008-10#1)
results were satisfactory##6##3##(1990-9#1)(2008-10#5)
results were similar in##2##4##(1994-12#1)(2007-8#1)
results were similar to those##3##5##(1993-12#1)(2008-10#1)(2008-8#1)
results were similar to##4##4##(1993-12#1)(2008-10#2)(2008-8#1)
results were similar##8##3##(1993-12#1)(1994-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
results were statistically compared with##2##5##(2008-10#2)
results were statistically compared##3##4##(2008-10#3)
results were statistically##5##3##(2008-10#4)(2010-5#1)
results were still##2##3##(2008-10#1)(2011-2#1)
results were the##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
results were then compared with##3##5##(2008-3#1)(2012-2#2)
results were then##4##3##(2008-10#1)(2008-3#1)(2012-2#2)
results were used for##2##4##(2008-10#2)
results were used to calculate the##2##6##(2007-8#1)(2008-2#1)
results were used to##4##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
results were used##9##3##(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)
results were well consistent with the##2##6##(2008-10#1)(2013-1#1)
results were##452##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2006-10#1)(2007-10#4)(2007-11#9)(2007-12#6)(2007-2#1)(2007-7#3)(2007-8#9)(2008-1#1)(2008-10#199)(2008-11#7)(2008-12#5)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#17)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#5)(2009-6#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#4)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#4)
results when compared##2##3##(2008-10#1)(2008-12#1)
results when the##3##3##(2008-10#2)(2008-2#1)
results when used##2##3##(2008-10#1)(2008-5#1)
results when##17##2##(1994-3#1)(1996-3#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)
results which##4##2##(1992-12#1)(2008-10#1)(2011-1#2)
results will assist##2##3##(1995-1#1)(2008-11#1)
results will be useful to##2##5##(2008-8#1)(2013-7#1)
results will be useful##3##4##(2007-12#1)(2008-8#1)(2013-7#1)
results will be##10##3##(1990-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-7#1)
results will facilitate##3##3##(2008-8#1)(2008-9#2)
results will help##2##3##(2008-9#1)(2010-6#1)
results will##20##2##(1990-3#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#3)(2010-6#1)(2012-3#1)(2013-7#1)
results with a##13##3##(1992-9#1)(1993-8#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)
results with an##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
results with real samples##2##4##(2008-10#1)(2008-3#1)
results with recent##2##3##(2007-12#1)(2008-8#1)
results with respect to##2##4##(1993-12#1)(2008-2#1)
results with the##26##3##(1990-2#1)(1990-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1997-8#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-3#1)
results with their##2##3##(2011-1#1)(2013-1#1)
results with those obtained by##6##5##(2008-10#5)(2008-2#1)
results with those obtained from##3##5##(2007-11#1)(2008-10#1)(2008-7#1)
results with those obtained##11##4##(2007-11#1)(2008-10#6)(2008-2#2)(2008-7#1)(2009-3#1)
results with those of the##2##5##(2008-7#1)(2010-11#1)
results with those of##5##4##(2008-10#3)(2008-7#1)(2010-11#1)
results with those##23##3##(1995-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2012-3#1)
results with##142##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-9#2)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#3)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-3#2)(2009-4#1)(2010-11#1)(2011-1#2)(2011-2#5)(2012-3#2)(2013-1#2)
results within the##2##3##(1994-1#1)(2008-3#1)
results within##12##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-2#1)
results without##3##2##(1992-10#1)(2007-11#1)(2008-3#1)
results would indicate##2##3##(2008-7#1)(2013-1#1)
results would##7##2##(1990-2#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
results yield##2##2##(2007-12#1)(2008-10#1)
results##10095##1##(1990-10#8)(1990-11#36)(1990-12#55)(1990-2#39)(1990-3#20)(1990-4#1)(1990-5#42)(1990-6#36)(1990-7#26)(1990-8#35)(1990-9#21)(1991-1#11)(1991-10#3)(1991-11#15)(1991-12#72)(1991-2#29)(1991-3#25)(1991-4#8)(1991-5#39)(1991-6#23)(1991-7#2)(1991-8#16)(1991-9#38)(1992-1#11)(1992-10#11)(1992-11#23)(1992-12#50)(1992-2#23)(1992-3#57)(1992-4#6)(1992-5#16)(1992-6#41)(1992-7#5)(1992-8#40)(1992-9#39)(1993-1#12)(1993-11#58)(1993-12#70)(1993-2#24)(1993-3#45)(1993-5#5)(1993-6#47)(1993-8#47)(1993-9#23)(1994-1#15)(1994-10#1)(1994-11#53)(1994-12#41)(1994-2#41)(1994-3#50)(1994-5#31)(1994-6#32)(1994-7#6)(1994-8#59)(1994-9#29)(1995-1#15)(1995-11#40)(1995-12#71)(1995-2#62)(1995-3#43)(1995-4#5)(1995-5#33)(1995-6#31)(1995-8#21)(1995-9#9)(1996-1#20)(1996-11#12)(1996-12#58)(1996-2#55)(1996-3#21)(1996-4#6)(1996-5#45)(1996-6#21)(1996-7#7)(1996-8#7)(1996-9#16)(1997-1#34)(1997-2#60)(1997-3#44)(1997-4#45)(1997-5#20)(1997-6#34)(1997-7#37)(1997-8#30)(1997-9#1)(2006-10#11)(2006-12#2)(2006-4#2)(2006-6#4)(2006-8#3)(2007-1#1)(2007-10#33)(2007-11#236)(2007-12#202)(2007-2#12)(2007-4#1)(2007-5#1)(2007-6#7)(2007-7#26)(2007-8#99)(2007-9#2)(2008-1#61)(2008-10#2064)(2008-11#316)(2008-12#147)(2008-2#372)(2008-3#737)(2008-4#91)(2008-5#286)(2008-6#121)(2008-7#262)(2008-8#304)(2008-9#237)(2009-1#1)(2009-10#34)(2009-11#24)(2009-12#28)(2009-2#17)(2009-3#25)(2009-4#18)(2009-5#36)(2009-6#22)(2009-7#29)(2009-8#49)(2009-9#29)(2010-1#13)(2010-10#21)(2010-11#21)(2010-12#39)(2010-2#27)(2010-3#41)(2010-4#34)(2010-5#37)(2010-6#36)(2010-7#17)(2010-8#70)(2010-9#14)(2011-1#90)(2011-10#3)(2011-2#286)(2011-3#27)(2011-7#3)(2012-1#50)(2012-12#75)(2012-2#150)(2012-3#124)(2012-5#2)(2012-6#2)(2012-7#2)(2012-8#1)(2012-9#2)(2013-1#262)(2013-7#39)(2013-8#141)
results)##2##1##(2008-3#1)(2010-4#1)
results]##16##1##(1990-3#1)(1990-6#2)(1990-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-6#1)(1996-11#1)(1996-3#1)(2007-8#1)(2008-10#1)(2011-2#3)(2013-1#1)
resume the##2##2##(2008-9#1)(2013-1#1)
resume##13##1##(1994-8#1)(2007-12#4)(2008-11#1)(2008-5#2)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
resumed##7##1##(1992-3#1)(1993-6#1)(1994-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
resumption of##4##2##(1992-5#1)(1996-12#1)(2007-7#1)(2008-10#1)
resumption##7##1##(1992-11#1)(1992-5#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)
resurfacing##12##1##(2007-12#3)(2009-4#1)(2011-2#5)(2012-2#2)(2013-1#1)
resurgence in the##3##3##(2008-11#1)(2008-8#1)(2009-12#1)
resurgence of interest in##4##4##(1997-7#1)(2008-7#1)(2011-2#1)(2013-1#1)
resurgence of interest##5##3##(1997-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
resurgence of serious Streptococcus pyogenes##2##5##(1992-2#2)
resurgence of##9##2##(1992-2#2)(1994-9#1)(1997-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
resurgence##12##1##(1992-2#2)(1994-9#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
resurrect##2##1##(1995-12#1)(2008-8#1)
resurrection of##2##2##(2008-10#1)(2008-12#1)
resurrection##5##1##(1993-9#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-5#1)
resuscitate##3##1##(1994-1#1)(2008-10#1)(2010-7#1)
resuscitated and##3##2##(1995-3#1)(2010-7#1)(2012-3#1)
resuscitated##5##1##(1995-3#1)(1996-6#1)(2008-3#1)(2010-7#1)(2012-3#1)
resuscitation and##4##2##(1992-4#1)(1995-5#1)(2011-2#2)
resuscitation for##2##2##(2012-2#1)(2012-3#1)
resuscitation guidelines##2##2##(2008-11#2)
resuscitation in##4##2##(1990-10#1)(1990-9#1)(1993-6#1)(1997-3#1)
resuscitation of##3##2##(1994-6#2)(2012-2#1)
resuscitation package##2##2##(2011-2#2)
resuscitation##58##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#4)(1992-4#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-3#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#2)(2008-10#1)(2008-11#4)(2008-3#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#5)
resuspended in##4##2##(1991-9#1)(1994-8#1)(2008-11#1)(2008-8#1)
resuspended##9##1##(1991-9#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-8#3)
resveratrol in##4##2##(2008-7#2)(2009-12#1)(2011-2#1)
resveratrol##32##1##(2008-10#10)(2008-11#2)(2008-5#3)(2008-7#3)(2009-12#6)(2011-2#5)(2012-4#3)
resynchronisation therapy##2##2##(2008-10#1)(2012-2#1)
resynchronisation##3##1##(2008-10#2)(2012-2#1)
resynchronization therapy##6##2##(2008-11#1)(2008-12#1)(2010-6#1)(2010-8#2)(2011-2#1)
resynchronization##7##1##(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)(2010-8#2)(2011-2#1)
ret##5##1##(1991-9#1)(1993-8#3)(2008-1#1)
retTPC##4##1##(1991-9#4)
retail life##2##2##(2010-4#2)
retail outlets##2##2##(1997-1#2)
retail prescription##2##2##(1997-1#1)(2008-11#1)
retail##18##1##(1991-12#1)(1993-3#2)(1994-1#1)(1994-3#1)(1997-1#4)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-4#2)(2011-2#2)(2013-1#1)
retailers##3##1##(1997-1#1)(2008-1#2)
retailing##3##1##(1994-12#3)
retain a##5##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#2)
retain an##2##2##(1991-12#1)(2008-5#1)
retain its##2##2##(1990-12#1)(2007-12#1)
retain the##14##2##(1994-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#1)
retain their##7##2##(1991-5#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-10#1)
retain this##2##2##(1995-5#1)(2008-9#1)
retain##68##1##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#13)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-1#1)
retained Cr(VI)##3##2##(2008-10#3)
retained a good activity##2##4##(2008-10#2)
retained a##3##2##(2008-10#2)(2010-11#1)
retained after##2##2##(1993-6#1)(1997-8#1)
retained all##3##2##(2008-5#2)(2008-8#1)
retained an##2##2##(1995-6#1)(2008-10#1)
retained analytes##2##2##(2008-10#2)
retained and promoted children##2##4##(2008-12#2)
retained and##11##2##(1990-5#1)(1995-2#3)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)
retained as##4##2##(2008-10#3)(2008-11#1)
retained at a##2##3##(1992-6#1)(2008-10#1)
retained at pH##2##3##(2008-10#2)
retained at##7##2##(1992-6#1)(2008-10#5)(2008-9#1)
retained by the##4##3##(1996-2#2)(2008-10#2)
retained by##18##2##(1990-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1995-2#1)(1996-2#2)(2008-10#7)(2013-1#2)
retained enough##2##2##(1990-2#1)(2008-11#1)
retained in the##18##3##(1992-12#1)(1995-2#1)(2007-12#1)(2008-10#9)(2008-9#2)(2010-5#1)(2011-2#2)(2012-12#1)
retained in##25##2##(1992-12#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#12)(2008-7#1)(2008-9#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
retained its ability to##2##4##(2008-10#2)
retained its binding##2##3##(1995-11#1)(2009-9#1)
retained its##12##2##(1991-12#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-10#5)(2008-5#1)(2009-9#1)(2012-2#1)
retained normal##2##2##(1992-12#1)(2009-2#1)
retained on C(18)##3##3##(2008-10#3)
retained on a##6##3##(2008-10#6)
retained on the column##5##4##(1990-11#1)(2008-10#4)
retained on the filter##2##4##(2008-10#2)
retained on the sorbent##2##4##(2008-10#2)
retained on the surface##2##4##(2008-10#1)(2012-2#1)
retained on the##20##3##(1990-11#1)(2008-10#18)(2012-2#1)
retained on##40##2##(1990-11#1)(1990-12#1)(2008-10#36)(2012-2#1)(2013-7#1)
retained placenta and its effects##2##5##(1996-11#2)
retained placenta##4##2##(1996-11#4)
retained the ability to##2##4##(2008-10#2)
retained the bacteria##2##3##(2008-10#2)
retained the same##2##3##(1994-2#1)(2011-2#1)
retained the##11##2##(1994-2#1)(1997-2#1)(2008-10#4)(2008-11#2)(2011-2#2)(2013-1#1)
retained their##7##2##(1991-5#1)(1996-12#1)(2008-10#3)(2008-7#1)(2011-2#1)
retained this##2##2##(2009-12#1)(2013-1#1)
retained within the##3##3##(1993-9#1)(2008-8#2)
retained wooden foreign bodies##3##4##(2010-5#3)
retained##252##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#2)(1993-9#3)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-6#1)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#114)(2008-11#7)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#4)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)
retaining its##2##2##(2008-6#1)(2010-5#1)
retaining the##6##2##(1991-5#1)(2008-1#1)(2008-10#3)(2008-3#1)
retaining their##3##2##(1993-2#1)(2008-11#1)(2012-2#1)
retaining##45##1##(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-8#1)(1994-1#3)(1994-9#1)(1995-2#2)(1996-3#2)(1997-1#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
retains its 3(10)-helical conformation##2##4##(1995-2#2)
retains its##6##2##(1995-2#2)(2007-11#1)(2008-10#1)(2009-3#1)(2010-11#1)
retains the##12##2##(1990-5#2)(1992-11#1)(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
retains##27##1##(1990-5#2)(1992-11#1)(1993-8#1)(1994-5#1)(1995-2#3)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#1)(2013-1#1)
retard or##2##2##(1992-9#1)(2008-2#1)
retard##11##1##(1992-9#1)(1995-3#2)(1997-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-5#2)(2013-1#1)
retardance and##2##2##(2007-12#1)(2008-2#1)
retardance measurement##2##2##(2008-2#2)
retardance measurements##2##2##(2008-2#1)(2008-3#1)
retardance of##3##2##(2008-2#2)(2008-3#1)
retardance##31##1##(2007-12#5)(2008-2#15)(2008-3#11)
retardation and##11##2##(1993-3#1)(1995-2#2)(1997-7#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
retardation assay##2##2##(1992-11#1)(2008-8#1)
retardation assays##3##2##(1990-5#1)(1993-6#1)(1995-6#1)
retardation in the##2##3##(1995-6#1)(2008-11#1)
retardation in##6##2##(1993-3#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)
retardation is##2##2##(2008-10#1)(2009-5#1)
retardation of DNA##2##3##(1991-5#1)(1995-5#1)
retardation of body##2##3##(1995-3#1)(1996-5#1)
retardation of the##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
retardation of##16##2##(1991-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
retardation on##2##2##(2008-2#1)(2008-3#1)
retardation or##3##2##(1993-3#1)(1997-3#1)(2008-10#1)
retardation##109##1##(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#6)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#3)(2007-7#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#11)(2008-5#3)(2008-6#3)(2008-8#3)(2009-5#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#7)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
retarded and##2##2##(1993-1#1)(2008-11#1)
retarded by##3##2##(1992-5#1)(2008-10#1)(2008-3#1)
retarded growth of##2##3##(1994-3#1)(1995-9#1)
retarded growth##5##2##(1991-6#1)(1994-3#1)(1995-11#1)(1995-9#1)(2013-8#1)
retarded in##3##2##(1992-5#1)(1997-8#1)(2008-10#1)
retarded the##3##2##(1990-7#1)(1994-3#1)(2008-10#1)
retarded##40##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-6#3)(1992-5#3)(1993-1#2)(1994-3#2)(1995-11#1)(1995-9#1)(1997-8#5)(2007-6#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
retarder##18##1##(2007-11#3)(2008-2#7)(2008-3#6)(2010-4#2)
retarders##4##1##(2008-2#4)
retarding##4##1##(1996-6#1)(2008-8#1)(2010-1#1)(2012-2#1)
retards the##2##2##(1996-3#1)(2008-7#1)
retards##5##1##(1995-6#1)(1996-3#1)(2008-7#2)(2009-8#1)
rete##3##1##(1992-11#1)(1996-2#1)(2011-2#1)
retentate and filtrate##2##3##(2008-10#1)(2008-7#1)
retentate and##3##2##(2008-10#2)(2008-7#1)
retentate##6##1##(2008-10#3)(2008-12#1)(2008-7#2)
retentates##3##1##(2008-10#1)(2008-12#2)
retention after##2##2##(1994-2#1)(2008-10#1)
retention among##2##2##(2010-6#1)(2013-8#1)
retention and complexation mechanisms##3##4##(2008-10#3)
retention and elution conditions##3##4##(2008-10#3)
retention and elution##6##3##(2008-10#6)
retention and enantioselectivity of##2##4##(2008-10#2)
retention and enantioselectivity were##2##4##(2008-10#2)
retention and enantioselectivity##5##3##(1995-6#1)(2008-10#4)
retention and recruitment##2##3##(1992-1#1)(2012-3#1)
retention and selectivity of##3##4##(1990-8#1)(2008-10#2)
retention and selectivity##5##3##(1990-8#1)(2008-10#4)
retention and the##2##3##(2008-7#1)(2009-2#1)
retention and##46##2##(1990-8#1)(1992-1#1)(1993-1#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
retention at##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
retention behavior of##5##3##(1996-5#1)(2008-10#4)
retention behavior##11##2##(1996-5#1)(2008-10#10)
retention behaviors of polyaromatic hydrocarbons##2##5##(2008-10#2)
retention behaviour of##2##3##(1995-3#1)(2008-10#1)
retention behaviour##5##2##(1995-3#1)(1996-5#1)(2008-10#3)
retention characteristics of drugs were correlated with their physicochemical##2##9##(1996-5#2)
retention characteristics of##3##3##(1996-5#2)(2008-10#1)
retention characteristics##5##2##(1996-5#3)(2008-10#2)
retention efficiencies##2##2##(2008-10#2)
retention efficiency##4##2##(2008-10#4)
retention factor##4##2##(2008-10#4)
retention factors of##2##3##(2008-10#2)
retention for##3##2##(1994-3#1)(1995-12#1)(2008-10#1)
retention in the##7##3##(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-8#1)
retention in##18##2##(1993-12#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#1)(2013-8#2)
retention increased##2##2##(2008-10#1)(2008-11#1)
retention index##3##2##(2008-10#2)(2011-2#1)
retention indicated that##2##3##(1990-2#1)(2008-10#1)
retention indices for##2##3##(2008-10#2)
retention indices of##6##3##(2008-10#6)
retention indices##11##2##(2008-10#11)
retention is the##2##3##(1997-7#1)(2008-10#1)
retention is##10##2##(1993-12#1)(1997-7#2)(2008-10#4)(2008-8#1)(2013-1#1)(2013-8#1)
retention mechanism of##2##3##(2008-10#2)
retention mechanism##6##2##(2008-10#6)
retention mechanisms of the##2##4##(2008-10#2)
retention mechanisms##5##2##(2008-10#5)
retention of a##2##3##(1993-5#1)(2008-10#1)
retention of arsenic##2##3##(1995-11#2)
retention of configuration at##2##4##(1996-5#1)(2008-4#1)
retention of configuration##3##3##(1996-5#1)(2008-4#1)(2009-12#1)
retention of the temporal component##2##5##(1993-5#2)
retention of the##14##3##(1992-11#1)(1993-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-9#1)(2011-2#1)(2013-8#1)
retention of these##2##3##(1994-3#1)(1994-8#1)
retention of this##2##3##(1992-8#1)(1995-12#1)
retention of viable cells in##2##5##(2008-11#2)
retention of##109##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#6)(1994-1#1)(1994-12#1)(1994-3#3)(1994-8#5)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#3)(1996-3#2)(1996-5#7)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#3)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
retention on the##2##3##(2008-10#1)(2008-12#1)
retention on##3##2##(2008-10#1)(2008-12#2)
retention or##2##2##(1994-8#1)(2013-8#1)
retention performance##4##2##(1994-8#1)(2008-10#1)(2008-11#2)
retention process##3##2##(2008-10#3)
retention test##4##2##(1992-8#1)(1994-3#1)(1994-8#1)(2010-3#1)
retention testing##2##2##(1994-8#1)(2010-3#1)
retention time and##2##3##(2008-10#1)(2008-5#1)
retention time of##8##3##(1990-8#1)(2008-10#3)(2008-11#2)(2011-3#1)(2013-1#1)
retention time##29##2##(1990-2#1)(1990-8#1)(1991-1#1)(2008-10#12)(2008-11#4)(2008-5#1)(2008-9#2)(2010-6#1)(2011-3#2)(2013-1#4)
retention time)##2##2##(2008-6#1)(2008-7#1)
retention times and##3##3##(1997-2#1)(2008-10#1)(2010-11#1)
retention times are##2##3##(2008-10#2)
retention times of the##3##4##(2008-10#1)(2008-11#2)
retention times of##10##3##(1990-8#1)(1992-6#1)(2008-10#4)(2008-11#2)(2009-8#1)(2013-1#1)
retention times##30##2##(1990-12#1)(1990-8#1)(1992-6#4)(1997-2#1)(2008-10#18)(2008-11#2)(2009-8#1)(2010-11#1)(2013-1#1)
retention to##2##2##(2008-5#1)(2010-11#1)
retention was also##2##3##(1995-6#1)(2008-12#1)
retention was##11##2##(1995-6#1)(1997-1#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)
retention##488##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-2#5)(1991-5#1)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#2)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#6)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#2)(1994-8#12)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#4)(1995-6#4)(1996-12#3)(1996-3#3)(1996-5#18)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#5)(1997-8#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#172)(2008-11#30)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#12)(2008-9#5)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-2#2)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#13)(2011-3#5)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#9)
retention)##2##1##(1996-1#1)(2008-8#1)
retention]##2##1##(1991-2#1)(2008-10#1)
reteplase##4##1##(2007-11#3)(2008-7#1)
retest##4##1##(1992-6#1)(1994-1#1)(2008-10#1)(2013-1#1)
retested##7##1##(1994-3#2)(2007-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
retesting##4##1##(1996-12#2)(2008-5#1)(2008-9#1)
rethink the##4##2##(1991-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
rethink##7##1##(1991-12#1)(1995-2#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
rethinking##8##1##(1992-4#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
reticula##2##1##(2007-12#1)(2008-7#1)
reticular and erosive##2##3##(2013-1#2)
reticular and##4##2##(1997-2#1)(2013-1#3)
reticular formation of##3##3##(1990-7#2)(1997-2#1)
reticular formation##17##2##(1990-7#6)(1990-9#4)(1991-5#1)(1993-12#1)(1994-3#1)(1997-2#2)(1997-3#2)
reticular lamina##5##2##(1995-5#5)
reticular nucleus##4##2##(1993-12#1)(1995-8#1)(1997-6#2)
reticular type##2##2##(1992-9#1)(2013-1#1)
reticular##44##1##(1990-6#1)(1990-7#6)(1990-9#4)(1991-12#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#2)(1994-3#1)(1995-5#5)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-6#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#6)
reticularis##4##1##(1990-5#1)(1997-2#1)(2008-6#1)(2012-3#1)
reticulata##6##1##(1993-12#2)(1995-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
reticulata) and##2##2##(2008-10#2)
reticulata)##6##1##(2008-10#3)(2008-8#3)
reticulate evolution##5##2##(2008-8#2)(2010-6#2)(2013-1#1)
reticulate##10##1##(1997-6#2)(2008-8#3)(2008-9#1)(2010-3#1)(2010-6#2)(2013-1#1)
reticulated platelets##7##2##(2006-6#5)(2008-9#2)
reticulated vitreous carbon##4##3##(2008-10#4)
reticulated##13##1##(1997-8#1)(2006-6#5)(2007-12#1)(2008-10#4)(2008-9#2)
reticulation##3##1##(2008-10#1)(2008-8#1)(2009-6#1)
reticulin##2##1##(1991-11#2)
reticulin-antibody-positive##2##1##(1991-11#2)
reticulocyte analysis##2##2##(2006-6#1)(2008-10#1)
reticulocyte count##4##2##(1994-12#1)(1994-6#1)(2006-6#1)(2013-1#1)
reticulocyte counts##2##2##(2008-10#1)(2009-10#1)
reticulocyte lysate##8##2##(1990-11#1)(1991-10#1)(1991-12#1)(1993-12#1)(1994-5#4)
reticulocyte lysates##6##2##(1990-2#1)(1992-11#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-8#1)
reticulocyte##33##1##(1990-11#2)(1990-2#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#3)(1994-12#1)(1994-5#5)(1994-6#2)(1994-8#1)(1995-5#1)(1995-8#1)(2006-6#2)(2008-1#1)(2008-10#3)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
reticulocytes by##2##2##(1993-2#1)(1996-2#1)
reticulocytes in##4##2##(1996-2#1)(2008-9#3)
reticulocytes is##2##2##(1993-2#2)
reticulocytes was##2##2##(1996-12#1)(1996-2#1)
reticulocytes##23##1##(1990-12#1)(1993-2#3)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#5)(2008-9#9)(2010-8#1)(2012-2#1)
reticuloendothelial cells##4##2##(1992-10#2)(1997-7#1)(2008-8#1)
reticuloendothelial system##3##2##(1991-9#1)(2008-7#1)(2010-2#1)
reticuloendothelial##7##1##(1991-9#1)(1992-10#2)(1997-7#1)(2008-7#1)(2008-8#1)(2010-2#1)
reticuloendotheliosis##2##1##(2008-5#2)
reticulum aminopeptidase##2##2##(2012-2#2)
reticulum and##17##2##(1990-7#1)(1994-11#1)(1995-5#1)(1996-9#1)(2007-12#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
reticulum was##2##2##(2008-11#1)(2009-7#1)
reticulum##128##1##(1990-12#1)(1990-2#4)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-9#1)(1992-12#1)(1992-3#3)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#5)(1994-12#2)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#3)(2007-12#7)(2008-1#2)(2008-10#3)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#11)(2008-8#7)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#3)(2009-8#5)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#1)
retina and the##3##3##(1994-5#1)(2008-8#1)(2011-2#1)
retina and##14##2##(1994-5#1)(1996-5#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-12#1)
retina are##2##2##(2007-12#1)(2012-12#1)
retina explants##3##2##(2010-1#3)
retina has been##2##3##(2011-2#1)(2012-12#1)
retina have been##2##3##(2008-1#1)(2008-8#1)
retina in the##2##3##(2008-3#1)(2011-1#1)
retina in vivo##5##3##(2007-11#1)(2008-4#2)(2010-1#2)
retina in##9##2##(2007-11#1)(2008-3#1)(2008-4#2)(2010-1#2)(2011-1#1)(2011-2#1)(2012-12#1)
retina of the##3##3##(1992-3#1)(2008-5#1)(2010-1#1)
retina of##7##2##(1991-10#1)(1992-3#2)(1996-5#1)(2008-5#1)(2010-1#2)
retina with##2##2##(1997-3#2)
retina##117##1##(1990-11#4)(1990-12#1)(1990-7#1)(1991-10#3)(1992-3#2)(1993-3#1)(1993-9#3)(1994-12#1)(1994-5#2)(1995-5#1)(1996-12#2)(1996-2#2)(1996-5#7)(1997-2#2)(1997-3#4)(2007-11#8)(2007-12#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#9)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#2)(2010-1#11)(2010-8#1)(2011-1#3)(2011-2#7)(2011-7#2)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)
retina-specific##4##1##(1990-7#1)(1994-9#3)
retinae##2##1##(1992-3#1)(2012-12#1)
retinal and choroidal##2##3##(2010-1#1)(2011-7#1)
retinal and##4##2##(1994-5#1)(2007-10#1)(2010-1#1)(2011-7#1)
retinal artery occlusion##3##3##(2007-10#2)(2013-7#1)
retinal artery##4##2##(2007-10#2)(2010-3#1)(2013-7#1)
retinal cells##2##2##(1993-12#1)(1996-11#1)
retinal degeneration##5##2##(1990-11#1)(2008-7#1)(2011-1#1)(2012-3#2)
retinal degenerative##2##2##(2010-10#1)(2012-12#1)
retinal detachment in##2##3##(2008-1#1)(2013-8#1)
retinal detachment##7##2##(2008-1#1)(2008-4#1)(2009-4#1)(2013-1#1)(2013-8#3)
retinal diseases##5##2##(2008-10#1)(2009-12#1)(2010-10#2)(2011-1#1)
retinal explants##4##2##(1996-5#4)
retinal ganglion cell##2##3##(1992-3#1)(2008-7#1)
retinal ganglion cells##6##3##(1993-12#2)(2008-7#1)(2009-12#2)(2011-2#1)
retinal ganglion##8##2##(1992-3#1)(1993-12#2)(2008-7#2)(2009-12#2)(2011-2#1)
retinal images of##2##3##(1990-3#1)(2011-1#1)
retinal images##5##2##(1990-3#1)(2007-11#1)(2007-12#2)(2011-1#1)
retinal imaging##4##2##(2007-11#2)(2011-7#2)
retinal input##2##2##(1992-10#1)(2008-7#1)
retinal neovascularization##2##2##(2008-1#1)(2011-1#1)
retinal nerve fiber layer##4##4##(2007-11#2)(2008-3#1)(2012-12#1)
retinal neurons##5##2##(1994-2#1)(2008-8#4)
retinal on-bipolar cell##3##3##(1993-8#3)
retinal pericyte##2##2##(1993-3#1)(2012-4#1)
retinal photocoagulation##2##2##(2011-1#2)
retinal photoreceptors and##2##3##(1994-5#1)(2011-2#1)
retinal physiology##2##2##(1995-5#1)(2008-4#1)
retinal pigment epithelial cells##5##4##(1993-3#3)(2008-12#1)(2012-3#1)
retinal pigment epithelial##8##3##(1993-3#3)(1996-5#2)(2008-12#1)(2010-10#1)(2012-3#1)
retinal pigment epithelium and##2##4##(1990-3#1)(2008-7#1)
retinal pigment epithelium##6##3##(1990-3#1)(2008-4#1)(2008-7#1)(2011-7#2)(2012-3#1)
retinal pigment##15##2##(1990-3#1)(1993-3#3)(1996-5#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-7#2)(2012-3#2)
retinal pigmented epithelium##2##3##(2008-4#2)
retinal pigmented##3##2##(2008-11#1)(2008-4#2)
retinal progenitor cells##3##3##(1996-5#3)
retinal prosthesis##3##2##(2009-12#3)
retinal rod##3##2##(1995-5#2)(1997-1#1)
retinal rods##2##2##(1995-6#1)(1997-1#1)
retinal stem##2##2##(2012-12#2)
retinal thickness##2##2##(2011-2#1)(2011-7#1)
retinal tissue in##2##3##(1996-12#2)
retinal tissue##4##2##(1996-12#2)(2011-1#1)(2011-2#1)
retinal toxicity secondary to hydroxychloroquine##2##5##(2013-1#2)
retinal toxicity##6##2##(2013-1#6)
retinal vascular##3##2##(2009-10#2)(2012-12#1)
retinal vasculature##2##2##(2009-10#1)(2012-2#1)
retinal vein occlusion##5##3##(2011-1#2)(2011-2#2)(2013-1#1)
retinal vessel##4##2##(2007-11#1)(2008-3#3)
retinal##214##1##(1990-11#2)(1990-3#3)(1991-2#1)(1991-5#1)(1992-10#1)(1992-3#3)(1993-12#4)(1993-3#4)(1993-8#4)(1993-9#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#10)(1997-1#2)(1997-3#1)(2007-10#3)(2007-11#7)(2007-12#4)(2007-5#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#6)(2008-5#2)(2008-7#6)(2008-8#7)(2008-9#1)(2009-10#4)(2009-12#9)(2009-4#1)(2009-6#2)(2010-1#2)(2010-10#4)(2010-3#1)(2011-1#18)(2011-2#14)(2011-7#13)(2011-9#2)(2012-12#9)(2012-2#1)(2012-3#4)(2012-4#3)(2013-1#14)(2013-7#1)(2013-8#4)
retinas and##2##2##(1990-11#1)(2007-5#1)
retinas but##2##2##(1994-9#1)(2007-5#1)
retinas of##3##2##(1990-11#2)(2007-5#1)
retinas##18##1##(1990-11#4)(1994-9#1)(1996-5#1)(2007-5#4)(2008-3#3)(2008-4#4)(2010-1#1)
retinex coding##4##2##(2008-3#4)
retinitis pigmentosa and##4##3##(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
retinitis pigmentosa##8##2##(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#2)(2012-2#2)
retinitis with##2##2##(1991-8#1)(2007-12#1)
retinitis##12##1##(1991-8#1)(1996-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)
retinoblastoma cells##3##2##(1994-8#2)(1995-2#1)
retinoblastoma gene product##5##3##(1992-8#1)(1995-2#2)(1997-7#2)
retinoblastoma gene##7##2##(1992-8#1)(1995-2#2)(1997-7#3)(2010-3#1)
retinoblastoma##24##1##(1992-8#1)(1994-8#2)(1995-11#1)(1995-2#3)(1996-6#1)(1997-7#3)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#3)(2011-1#2)(2011-2#4)
retinoblastoma]##2##1##(2011-2#1)(2013-1#1)
retinoic acid (RA) in##2##4##(1994-11#1)(1995-9#1)
retinoic acid (RA)##13##3##(1990-11#1)(1990-6#1)(1992-5#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-5#2)(2008-11#1)(2008-5#2)(2012-1#1)
retinoic acid and##3##3##(1992-8#1)(1992-9#2)
retinoic acid in##5##3##(1990-6#1)(1991-12#1)(1994-11#1)(2007-11#1)(2011-2#1)
retinoic acid induced##2##3##(1992-5#1)(2008-9#1)
retinoic acid or PDGF or bFGF##2##6##(1991-12#2)
retinoic acid or##4##3##(1991-12#3)(2008-5#1)
retinoic acid receptor##3##3##(1991-9#1)(1992-8#1)(2012-1#1)
retinoic acid receptors##3##3##(1994-11#1)(2007-11#1)(2008-5#1)
retinoic acid responsive##2##3##(1991-9#1)(1993-3#1)
retinoic acid##72##2##(1990-11#1)(1990-6#2)(1991-12#4)(1991-9#2)(1992-2#2)(1992-5#2)(1992-8#5)(1992-9#2)(1993-12#4)(1993-3#7)(1994-10#2)(1994-11#5)(1994-6#1)(1994-9#3)(1995-9#1)(1996-5#4)(2007-11#2)(2007-4#1)(2008-11#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)
retinoic acid-induced##4##2##(1992-12#1)(1997-2#1)(1997-7#1)(2008-4#1)
retinoic##81##1##(1990-11#1)(1990-6#2)(1991-12#4)(1991-9#2)(1992-12#1)(1992-2#2)(1992-5#2)(1992-8#6)(1992-9#2)(1993-12#5)(1993-3#8)(1994-10#2)(1994-11#5)(1994-6#1)(1994-9#3)(1995-9#1)(1996-5#4)(1997-2#1)(1997-7#2)(2007-11#2)(2007-4#1)(2008-11#3)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)
retinoid X receptor##2##3##(1995-8#1)(2012-12#1)
retinoid X receptors##5##3##(1993-3#2)(1993-6#1)(1995-8#1)(2008-10#1)
retinoid X##8##2##(1993-3#2)(1993-6#1)(1995-8#3)(2008-10#1)(2012-12#1)
retinoid and##2##2##(1993-3#1)(2008-5#1)
retinoid##26##1##(1991-12#1)(1992-2#1)(1992-9#4)(1993-3#5)(1993-6#1)(1994-6#2)(1995-6#1)(1995-8#3)(2007-11#2)(2008-10#1)(2008-5#2)(2009-6#1)(2010-4#1)(2012-12#1)
retinoid-binding##3##1##(1993-12#1)(1994-9#2)
retinoids may##4##2##(1993-12#1)(1994-6#2)(2008-4#1)
retinoids##18##1##(1992-2#3)(1993-12#1)(1994-6#3)(1996-5#1)(2007-11#2)(2008-4#4)(2008-5#3)(2010-8#1)
retinol and##5##2##(1993-12#1)(2009-6#3)(2011-1#1)
retinol deficient groups##2##3##(1994-8#2)
retinol deficient##7##2##(1994-8#7)
retinol in##3##2##(2008-5#3)
retinol per se##3##3##(2008-5#3)
retinol##47##1##(1993-12#1)(1993-2#1)(1994-8#9)(1995-5#2)(1996-5#1)(2008-5#24)(2009-6#6)(2010-6#1)(2011-1#1)(2013-1#1)
retinol'##2##1##(2008-5#2)
retinol-binding protein and asialo-orosomucoid##2##4##(1995-6#2)
retinol-binding protein is##2##3##(1995-6#2)
retinol-binding protein##8##2##(1990-12#1)(1995-5#1)(1995-6#5)(2009-6#1)
retinol-deficient##2##1##(1994-8#2)
retinopathy (DR)##4##2##(2008-1#2)(2010-8#1)(2011-2#1)
retinopathy and coronary artery disease in type 1 diabetes##2##9##(2013-1#2)
retinopathy and coronary##3##3##(2013-1#3)
retinopathy in##9##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
retinopathy is##4##2##(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
retinopathy of prematurity##6##3##(2011-1#5)(2012-12#1)
retinopathy##65##1##(1990-5#1)(1991-12#2)(1991-8#1)(1991-9#1)(1993-9#1)(1995-9#5)(1996-8#1)(2007-7#1)(2008-1#5)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#7)(2010-12#1)(2010-8#2)(2011-1#7)(2011-2#8)(2012-12#2)(2012-2#4)(2013-1#8)(2013-8#1)
retinula cells##2##2##(2007-12#2)
retinula##3##1##(2007-12#3)
retinyl acetate and tocopherols##2##4##(2008-10#2)
retinyl acetate##3##2##(2008-10#3)
retired workers who##2##3##(1993-1#2)
retired workers##3##2##(1993-1#3)
retired##9##1##(1991-12#1)(1993-1#3)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)
retiree##2##1##(1992-2#1)(1995-1#1)
retirees##4##1##(1991-12#2)(1992-2#1)(1996-12#1)
retirement plan##3##2##(1992-3#2)(1994-1#1)
retirement##23##1##(1991-2#2)(1992-3#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1996-12#1)(2007-3#1)(2007-4#1)(2008-1#4)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#2)
retraces the##2##2##(2010-1#1)(2011-2#1)
retracing##2##1##(2007-12#1)(2008-3#1)
retract##4##1##(2008-5#2)(2010-9#1)(2013-1#1)
retractable##2##1##(1990-7#1)(2008-11#1)
retracted##7##1##(1992-1#1)(2008-10#6)
retracting this article##3##3##(2008-10#3)
retracting##5##1##(1992-1#1)(2008-10#3)(2008-8#1)
retraction and##2##2##(2008-4#1)(2013-1#1)
retraction of the##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
retraction of##8##2##(1994-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
retraction syndrome with##2##3##(2011-1#2)
retraction was##2##2##(2007-8#1)(2008-11#1)
retraction##25##1##(1994-9#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
retractions##2##1##(1996-1#2)
retractor##5##1##(1990-2#1)(1992-1#4)
retraining##2##1##(1995-1#1)(1995-5#1)
retransfusion##4##1##(1990-2#3)(2009-3#1)
retransplantation##3##1##(2006-10#1)(2008-8#1)(2011-2#1)
retreat##7##1##(1991-3#4)(1993-3#1)(1994-1#1)(2008-6#1)
retreatment of##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
retreatment##4##1##(2011-2#2)(2012-12#1)(2013-1#1)
retrenchment plan##2##2##(1996-1#2)
retrenchment##6##1##(1995-3#2)(1996-1#4)
retrenchment)##2##1##(1995-3#2)
retrievability##2##1##(1994-3#1)(2008-3#1)
retrievable##2##1##(2008-10#2)
retrieval algorithm##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
retrieval algorithms##6##2##(2008-2#3)(2008-3#3)
retrieval and relearning##4##3##(1995-12#4)
retrieval and##10##2##(1995-12#4)(2007-8#1)(2008-11#1)(2008-3#2)(2009-3#1)(2011-3#1)
retrieval becomes##2##2##(2008-2#1)(2008-3#1)
retrieval by##2##2##(2007-11#1)(2008-2#1)
retrieval error##4##2##(2008-3#4)
retrieval errors##2##2##(2008-2#1)(2008-3#1)
retrieval for##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
retrieval from##5##2##(1994-12#1)(2008-2#2)(2008-3#1)(2012-3#1)
retrieval in the##2##3##(1994-8#1)(2008-2#1)
retrieval in##4##2##(1994-8#1)(2008-2#1)(2008-3#2)
retrieval interference##2##2##(2007-12#1)(2008-1#1)
retrieval is##7##2##(2008-2#1)(2008-3#5)(2013-8#1)
retrieval method##4##2##(1997-7#1)(2008-2#1)(2013-8#2)
retrieval of a more##2##4##(2010-8#2)
retrieval of a##4##3##(2008-7#1)(2010-8#2)(2012-3#1)
retrieval of aerosol##2##3##(2008-3#2)
retrieval of dilysine-tagged proteins##2##4##(1994-12#2)
retrieval of information on the##2##5##(2007-12#1)(2008-3#1)
retrieval of information##4##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
retrieval of profiles##2##3##(2008-2#1)(2008-3#1)
retrieval of temperature and##2##4##(2008-3#2)
retrieval of the absorption##2##4##(2008-3#2)
retrieval of the optical##2##4##(2007-12#1)(2008-3#1)
retrieval of the##16##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#8)(2008-7#1)
retrieval of urban##2##3##(2008-3#2)
retrieval of##70##2##(1991-8#2)(1993-12#2)(1994-12#2)(2007-11#3)(2007-12#8)(2007-8#1)(2008-11#2)(2008-2#15)(2008-3#26)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#2)(2012-3#1)(2013-8#1)
retrieval or##3##2##(1993-12#2)(2008-3#1)
retrieval performance##2##2##(2008-3#1)(2009-10#1)
retrieval process##3##2##(1991-8#1)(2008-3#1)(2010-8#1)
retrieval processes##3##2##(1995-12#1)(2009-10#1)(2010-8#1)
retrieval scheme##5##2##(2008-2#3)(2008-3#2)
retrieval software##2##2##(2008-3#2)
retrieval system##3##2##(1992-2#1)(1996-3#1)(2007-11#1)
retrieval systems##2##2##(2008-7#1)(2008-9#1)
retrieval technique##2##2##(2008-2#2)
retrieval techniques##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
retrieval to##2##2##(1994-12#1)(2007-12#1)
retrieval was##4##2##(1994-12#2)(2008-3#2)
retrieval with##2##2##(2008-8#2)
retrieval##242##1##(1991-8#6)(1992-1#3)(1992-2#1)(1993-12#5)(1993-3#1)(1993-6#1)(1994-12#7)(1994-3#1)(1994-8#3)(1995-12#5)(1995-9#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#10)(2007-12#14)(2007-5#1)(2007-8#5)(2008-1#3)(2008-11#9)(2008-2#43)(2008-3#77)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-8#4)(2011-3#1)(2012-12#2)(2012-3#3)(2013-7#1)(2013-8#7)
retrievals and##2##2##(2008-2#1)(2008-3#1)
retrievals are##2##2##(2008-2#1)(2008-3#1)
retrievals by##3##2##(2008-2#2)(2008-3#1)
retrievals from##3##2##(2008-2#1)(2008-3#2)
retrievals of the##5##3##(2008-2#3)(2008-3#2)
retrievals of##12##2##(2008-2#5)(2008-3#7)
retrievals over##2##2##(2008-3#2)
retrievals with an accuracy of better than##2##7##(2008-2#2)
retrievals with##3##2##(2008-2#3)
retrievals##41##1##(1992-12#1)(2008-2#20)(2008-3#20)
retrieve a set of##2##4##(2008-8#2)
retrieve a##4##2##(1995-6#1)(2008-2#1)(2008-8#2)
retrieve the##21##2##(1993-12#1)(1997-3#1)(2008-2#3)(2008-3#10)(2008-4#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
retrieve##54##1##(1993-12#2)(1994-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#23)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
retrieved aerosol parameters##2##3##(2008-3#2)
retrieved aerosol##4##2##(2008-2#1)(2008-3#3)
retrieved and rated##2##3##(2010-8#2)
retrieved and##4##2##(2010-8#2)(2011-3#1)(2013-1#1)
retrieved at##3##2##(1993-11#1)(2008-10#1)(2008-3#1)
retrieved by the##4##3##(2008-2#2)(2008-3#2)
retrieved by##10##2##(2007-11#1)(2007-7#1)(2008-2#4)(2008-3#3)(2008-7#1)
retrieved cloud optical thicknesses from##2##5##(2008-2#2)
retrieved data##2##2##(2008-2#1)(2008-3#1)
retrieved from the##9##3##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#5)
retrieved from##18##2##(1991-4#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#9)
retrieved geophysical parameters##2##3##(2008-3#2)
retrieved images##2##2##(2007-12#1)(2008-3#1)
retrieved in##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
retrieved ocean##2##2##(2008-3#2)
retrieved profiles##3##2##(2008-3#3)
retrieved through##3##2##(2008-3#1)(2008-4#1)(2012-2#1)
retrieved under##2##2##(2008-2#1)(2008-3#1)
retrieved with a##2##3##(2007-11#1)(2008-3#1)
retrieved with the##2##3##(2008-3#2)
retrieved with##7##2##(2007-11#1)(2008-3#6)
retrieved##117##1##(1991-4#1)(1993-11#1)(1994-3#3)(1995-3#1)(2007-11#3)(2007-12#8)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#22)(2008-3#54)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-8#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#3)
retriever##5##1##(2013-8#5)
retrieves the##2##2##(2008-3#2)
retrieves##3##1##(2008-3#3)
retrieving the##6##2##(2008-2#1)(2008-3#5)
retrieving##24##1##(1992-12#1)(1994-3#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-2#7)(2008-3#9)(2008-6#1)(2009-12#1)
retro##2##1##(2008-6#1)(2008-7#1)
retro-portal##2##1##(2012-2#2)
retroauricular##7##1##(2008-7#3)(2008-9#2)(2013-8#2)
retrocalcaneal##3##1##(2008-8#2)(2009-10#1)
retroelement##2##1##(1995-12#1)(2008-10#1)
retroelements##3##1##(1995-12#1)(2008-10#1)(2008-5#1)
retroesophageal##2##1##(2008-11#1)(2011-3#1)
retrograde and##2##2##(1990-11#1)(2007-9#1)
retrograde axonal transport##2##3##(1996-2#1)(2008-7#1)
retrograde axonal##3##2##(1996-2#1)(2007-12#1)(2008-7#1)
retrograde balloon dilatation##2##3##(2013-1#2)
retrograde cardioplegia##2##2##(2007-8#1)(2007-9#1)
retrograde cholangiopancreatography##3##2##(2007-10#1)(2013-1#1)(2013-8#1)
retrograde flow##2##2##(2007-8#1)(2008-9#1)
retrograde labeling##2##2##(1990-5#1)(1991-12#1)
retrograde messengers##2##2##(1995-5#1)(2008-7#1)
retrograde traffic##2##2##(2009-2#2)
retrograde transport of##2##3##(1997-2#1)(2008-7#1)
retrograde transport##5##2##(1991-12#2)(1997-2#1)(2008-4#1)(2008-7#1)
retrograde transvenous##4##2##(2006-12#1)(2009-9#1)(2013-1#2)
retrograde##57##1##(1990-11#1)(1990-5#1)(1991-12#4)(1991-3#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-2#3)(1996-5#2)(1997-2#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#7)(2007-9#4)(2008-11#1)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#3)(2009-9#1)(2011-1#1)(2013-1#7)(2013-8#1)
retrogradely labelled##2##2##(1992-8#1)(1997-2#1)
retrogradely transported##4##2##(1991-12#2)(1993-12#1)(1995-12#1)
retrogradely##9##1##(1991-12#4)(1992-8#1)(1993-12#1)(1995-12#1)(1997-2#1)(2007-8#1)
retron EC83##2##2##(1997-6#2)
retropatellar crepitus##2##2##(2011-2#2)
retropatellar##4##1##(2008-9#2)(2011-2#2)
retroperitoneal ESS##2##2##(2009-5#2)
retroperitoneal approach##3##2##(2008-10#1)(2012-12#2)
retroperitoneal benign##2##2##(2012-3#1)(2013-1#1)
retroperitoneal dissection##2##2##(1994-3#2)
retroperitoneal fibrosis associated with generalized atherosclerosis##2##6##(2008-1#2)
retroperitoneal fibrosis##6##2##(2008-1#3)(2009-8#2)(2013-1#1)
retroperitoneal hemangiopericytoma##2##2##(1993-6#2)
retroperitoneal hematoma##2##2##(2007-2#1)(2013-1#1)
retroperitoneal liposarcoma##3##2##(1990-9#2)(2009-9#1)
retroperitoneal lymph##2##2##(1995-5#1)(2008-7#1)
retroperitoneal malignant schwannoma##2##3##(1994-6#2)
retroperitoneal malignant##3##2##(1994-6#3)
retroperitoneal mass##2##2##(2009-4#1)(2012-3#1)
retroperitoneal sarcoma##2##2##(2007-8#1)(2008-6#1)
retroperitoneal soft tissue sarcomas##3##4##(1992-12#3)
retroperitoneal space##2##2##(2008-10#1)(2012-3#1)
retroperitoneal tumor##5##2##(1990-6#1)(2008-5#2)(2008-6#2)
retroperitoneal tumors of the pelvic##2##5##(1990-5#2)
retroperitoneal tumors##4##2##(1990-5#2)(2008-5#1)(2013-1#1)
retroperitoneal undifferentiated##3##2##(2008-5#1)(2009-5#2)
retroperitoneal##80##1##(1990-5#2)(1990-6#2)(1990-9#3)(1992-12#3)(1993-6#2)(1994-3#3)(1994-6#4)(1995-5#1)(1996-6#1)(2007-10#1)(2007-2#1)(2007-8#4)(2008-1#3)(2008-10#6)(2008-5#4)(2008-6#8)(2008-7#1)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#2)(2010-11#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#6)
retroperitoneoscopic approach##2##2##(2008-10#2)
retroperitoneoscopic##9##1##(2008-10#4)(2012-12#5)
retroperitoneum is##2##2##(1992-12#1)(2008-6#1)
retroperitoneum##11##1##(1992-12#1)(1993-6#1)(2008-6#5)(2009-1#1)(2009-9#1)(2012-3#1)(2013-1#1)
retropubic prostatectomy##2##2##(2008-1#1)(2013-1#1)
retropubic##4##1##(1996-9#1)(2008-1#1)(2012-2#1)(2013-1#1)
retrorectal##3##1##(2009-3#3)
retroreflected##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
retroreflection##2##1##(2008-3#2)
retroreflective##7##1##(2008-2#2)(2008-3#3)(2011-2#1)(2013-1#1)
retroreflector##9##1##(2008-2#1)(2008-3#8)
retroreflectors are##2##2##(2008-3#2)
retroreflectors##6##1##(2008-3#6)
retrosigmoid##2##1##(2011-2#2)
retrospective analyses##2##2##(2007-4#1)(2011-2#1)
retrospective analysis of all##2##4##(1993-11#1)(2011-2#1)
retrospective analysis of our##2##4##(1991-12#1)(2008-1#1)
retrospective analysis of the##3##4##(1993-11#1)(1996-9#1)(2008-1#1)
retrospective analysis of##38##3##(1990-6#1)(1990-9#1)(1991-12#1)(1993-11#2)(1993-9#1)(1994-12#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#2)
retrospective analysis showed that the##2##5##(1992-11#1)(2008-5#1)
retrospective analysis was##4##3##(1995-11#1)(2011-2#2)(2012-12#1)
retrospective analysis##56##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-11#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-11#2)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#2)
retrospective and prospective study was##2##5##(2012-12#1)(2013-8#1)
retrospective and prospective study##3##4##(1992-12#1)(2012-12#1)(2013-8#1)
retrospective and prospective##4##3##(1992-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
retrospective and##6##2##(1992-12#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
retrospective approach##2##2##(2008-11#2)
retrospective assessment##2##2##(1991-2#1)(2008-7#1)
retrospective case series##5##3##(2007-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
retrospective case##7##2##(2007-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
retrospective chart review of##6##4##(1991-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
retrospective chart review was##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
retrospective chart review##14##3##(1991-12#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
retrospective chart##15##2##(1991-12#1)(1994-3#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
retrospective clinical study of##2##4##(2010-5#1)(2012-3#1)
retrospective clinical##4##2##(2007-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
retrospective cohort analysis##3##3##(1996-11#1)(2012-2#1)(2013-8#1)
retrospective cohort study##9##3##(2007-10#1)(2008-5#1)(2010-10#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
retrospective cohort##14##2##(1996-11#1)(2007-10#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
retrospective comparison of##3##3##(1992-9#1)(2008-9#1)(2013-8#1)
retrospective data analysis##2##3##(2008-6#1)(2011-2#1)
retrospective data##6##2##(1994-6#1)(2008-6#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
retrospective descriptive study of##2##4##(2012-12#1)(2012-2#1)
retrospective descriptive study##3##3##(2008-1#1)(2012-12#1)(2012-2#1)
retrospective evaluation of##4##3##(1993-6#1)(2007-11#1)(2011-1#1)(2011-2#1)
retrospective medical##2##2##(2008-11#1)(2012-3#1)
retrospective review of a##2##4##(2010-8#1)(2013-1#1)
retrospective review of cases##2##4##(2008-1#2)
retrospective review of the##2##4##(2008-9#1)(2010-12#1)
retrospective review of##20##3##(1994-8#1)(1995-12#1)(1997-8#1)(2008-1#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
retrospective review was performed##2##4##(2008-6#1)(2009-10#1)
retrospective review was##4##3##(1996-1#1)(2008-6#1)(2009-10#1)(2012-3#1)
retrospective review##32##2##(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-1#3)(2008-6#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
retrospective series of##2##3##(1990-12#1)(2009-5#1)
retrospective series##4##2##(1990-12#1)(1994-6#1)(2009-5#1)(2013-1#1)
retrospective studies of##3##3##(1991-11#1)(1994-11#1)(1996-6#1)
retrospective studies##7##2##(1991-11#2)(1994-11#1)(1996-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
retrospective study in##2##3##(1992-5#1)(2009-10#1)
retrospective study included##3##3##(2007-11#1)(2007-8#2)
retrospective study is##2##3##(1997-5#1)(2008-11#1)
retrospective study of the##4##4##(1991-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
retrospective study of##21##3##(1990-3#1)(1990-9#1)(1991-4#1)(1993-11#1)(1993-5#1)(1995-1#1)(1995-5#1)(2007-8#3)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#2)
retrospective study that##4##3##(2011-2#2)(2012-3#1)(2013-1#1)
retrospective study was carried out##3##5##(1991-8#2)(2011-2#1)
retrospective study was conducted##2##4##(2011-2#1)(2012-12#1)
retrospective study was performed on##2##5##(1990-6#1)(2010-3#1)
retrospective study was undertaken##2##4##(1990-12#1)(1996-1#1)
retrospective study was##17##3##(1990-12#1)(1990-6#1)(1991-8#2)(1996-1#1)(1997-8#1)(2007-7#1)(2007-8#2)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#2)
retrospective study we##2##3##(1996-11#1)(1997-2#1)
retrospective study were to##2##4##(2012-3#1)(2013-1#1)
retrospective study##101##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-4#2)(1991-8#2)(1992-5#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-6#1)(1997-2#1)(1997-5#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#11)(2008-1#3)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#2)(2012-3#7)(2013-1#6)
retrospective##327##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-6#2)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-1#2)(1996-11#6)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#3)(2006-10#2)(2007-10#6)(2007-11#7)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#14)(2008-1#10)(2008-10#4)(2008-11#8)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#13)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#10)(2011-2#36)(2012-1#2)(2012-12#14)(2012-2#10)(2012-3#18)(2013-1#19)(2013-7#1)(2013-8#6)
retrospectively analysed##6##2##(1991-3#1)(1995-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
retrospectively analyzed the##4##3##(1993-2#1)(2007-7#1)(2007-8#1)(2012-12#1)
retrospectively analyzed##11##2##(1993-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#3)
retrospectively and the##2##3##(1997-8#1)(2013-1#1)
retrospectively and##6##2##(1990-9#1)(1997-8#2)(2010-8#1)(2011-1#1)(2013-1#1)
retrospectively enrolled##2##2##(2012-3#1)(2013-1#1)
retrospectively evaluate the##2##3##(2011-1#1)(2011-2#1)
retrospectively evaluated##4##2##(1992-10#1)(1996-9#1)(2007-8#1)(2011-2#1)
retrospectively examined##2##2##(1997-8#1)(2011-2#1)
retrospectively for##3##2##(1990-11#1)(1997-8#1)(2012-3#1)
retrospectively identified##2##2##(2009-8#1)(2012-2#1)
retrospectively in##4##2##(1994-12#1)(1994-7#1)(1997-3#1)(2012-2#1)
retrospectively investigated##3##2##(1990-12#1)(2008-7#1)(2013-8#1)
retrospectively reviewed to##3##3##(2007-7#1)(2012-2#1)(2012-3#1)
retrospectively reviewed##20##2##(1997-8#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
retrospectively studied##8##2##(1995-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
retrospectively to##2##2##(1990-6#1)(2008-11#1)
retrospectively##115##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#6)(2006-10#1)(2007-10#1)(2007-7#5)(2007-8#7)(2008-1#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2009-8#2)(2010-1#1)(2010-8#3)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#11)(2013-1#11)(2013-8#2)
retrosternal##3##1##(2008-5#1)(2011-1#2)
retrotransposon##8##1##(1995-5#2)(1995-8#2)(2008-10#1)(2009-10#1)(2012-3#2)
retrotransposons##4##1##(1995-8#2)(2008-10#1)(2008-11#1)
retrovascular##2##1##(2013-1#2)
retroviral expression##2##2##(1994-12#1)(2010-3#1)
retroviral latency##2##2##(1995-2#1)(2012-12#1)
retroviral proteases##2##2##(1990-2#1)(1992-6#1)
retroviral replication##4##2##(1995-2#3)(2011-3#1)
retroviral vector in##3##3##(2008-11#3)
retroviral vector that##2##3##(1997-8#1)(2008-11#1)
retroviral vector##14##2##(1994-5#1)(1997-8#2)(2008-11#8)(2008-8#1)(2008-9#2)
retroviral vectors are##2##3##(1995-2#1)(2008-11#1)
retroviral vectors for##2##3##(1994-5#1)(2008-11#1)
retroviral vectors##9##2##(1994-5#1)(1995-2#1)(1997-8#2)(2008-11#5)
retroviral##60##1##(1990-2#2)(1990-5#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-2#6)(1997-3#2)(1997-8#4)(2008-10#1)(2008-11#19)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-3#1)
retroviral-mediated##2##1##(1995-2#1)(1997-7#1)
retrovirally##2##1##(1991-5#1)(2012-12#1)
retrovirus carrying the##2##3##(2008-11#2)
retrovirus particles##6##2##(2008-11#6)
retrovirus vector##5##2##(1994-5#1)(1997-8#2)(2008-11#1)(2008-8#1)
retrovirus##31##1##(1990-5#1)(1994-5#1)(1995-2#1)(1997-8#2)(2008-11#15)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#3)(2010-10#1)(2012-12#2)
retrovirus-like element Ty3##2##3##(1997-7#2)
retrovirus-like##4##1##(1996-12#2)(1997-7#2)
retrovirus-mediated gene transfer##2##3##(2008-2#1)(2010-12#1)
retrovirus-mediated gene##3##2##(1994-5#1)(2008-2#1)(2010-12#1)
retroviruses in cell cultures##2##4##(2008-11#2)
retroviruses in##3##2##(1990-5#1)(2008-11#2)
retroviruses##21##1##(1990-5#5)(1992-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-11#7)(2008-7#2)(2009-7#1)(2011-2#1)
retrusion##3##1##(2009-7#2)(2013-1#1)
return and##3##2##(1996-3#1)(2010-12#1)(2013-7#1)
return for a##4##3##(1990-4#1)(1993-2#1)(2008-4#1)(2013-1#1)
return for##12##2##(1990-4#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1995-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
return home##2##2##(1995-5#1)(2008-9#1)
return is##2##2##(2008-2#1)(2011-2#1)
return loss at##2##3##(2008-3#2)
return loss##4##2##(2007-12#2)(2008-3#2)
return migration##2##2##(2011-2#1)(2013-8#1)
return of angina in the##2##5##(2007-8#2)
return of the##4##3##(1992-2#1)(1997-3#1)(2008-10#1)(2008-8#1)
return of##15##2##(1992-2#1)(1993-6#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#2)(2012-12#1)
return on investment##4##3##(2007-9#1)(2008-7#2)(2013-1#1)
return on##6##2##(1995-12#1)(2007-9#1)(2008-11#1)(2008-7#2)(2013-1#1)
return power##3##2##(2008-3#3)
return rate##3##2##(1995-2#1)(2007-12#1)(2008-12#1)
return rates##2##2##(1995-2#2)
return signal##6##2##(2008-2#3)(2008-3#3)
return signals from##2##3##(2008-3#2)
return signals##13##2##(2007-12#1)(2008-2#6)(2008-3#6)
return to a##3##3##(1991-3#1)(1994-3#1)(1997-3#1)
return to an##2##3##(2007-8#1)(2013-7#1)
return to normal activity##2##4##(1994-3#1)(2011-2#1)
return to normal##7##3##(1991-6#2)(1992-11#1)(1992-5#1)(1994-3#1)(2011-2#1)(2013-8#1)
return to sinus rhythm##2##4##(1990-9#1)(2007-9#1)
return to the##15##3##(1991-12#2)(1991-3#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
return to their##5##3##(1992-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
return to work rates##2##4##(2007-11#2)
return to work##9##3##(1992-5#1)(1993-12#1)(1997-5#1)(2007-11#2)(2012-12#3)(2012-3#1)
return to##74##2##(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#3)(1992-1#2)(1992-11#1)(1992-5#3)(1993-12#1)(1994-12#2)(1994-3#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-2#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
return were##2##2##(1993-1#1)(2008-12#1)
return with a##2##3##(2007-8#1)(2008-3#1)
return with##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
return##207##1##(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-3#2)(1991-6#3)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#3)(1993-1#6)(1993-12#2)(1993-2#2)(1993-6#2)(1994-12#2)(1994-3#3)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-11#5)(2007-12#5)(2007-2#5)(2007-5#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#5)(2008-2#15)(2008-3#28)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#2)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#10)(2012-12#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
return-based##2##1##(2008-8#2)
return-to-sport##2##1##(2011-1#2)
return-to-zero pulse##2##2##(2007-12#2)
return-to-zero signals by optical time gating of a##2##8##(2007-12#2)
return-to-zero##7##1##(2007-11#1)(2007-12#6)
returned completed##2##2##(1996-3#1)(2007-11#1)
returned for a##3##3##(1997-2#1)(2008-4#1)(2008-9#1)
returned for##5##2##(1997-2#1)(2008-4#1)(2008-9#1)(2011-2#2)
returned from##5##2##(2007-2#3)(2009-7#1)(2011-1#1)
returned questionnaires##2##2##(2012-2#1)(2013-1#1)
returned survey cards for##2##4##(1994-11#2)
returned the questionnaires##2##3##(1997-3#1)(2008-11#1)
returned the##4##2##(1997-2#1)(1997-3#1)(2007-11#1)(2008-11#1)
returned to baseline levels##2##4##(1990-10#1)(2012-2#1)
returned to baseline##6##3##(1990-10#1)(1993-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
returned to control levels##7##4##(1991-5#1)(1995-12#1)(1995-3#1)(1996-12#2)(2007-11#1)(2010-5#1)
returned to control##8##3##(1991-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#2)(2007-11#1)(2010-5#1)
returned to dialysis##2##3##(2008-1#2)
returned to independent living##2##4##(2008-12#1)(2009-10#1)
returned to near##3##3##(1993-11#1)(1995-3#1)(2013-1#1)
returned to normal in##3##4##(1990-11#1)(1991-5#1)(1993-3#1)
returned to normal within##2##4##(1993-12#1)(1996-6#1)
returned to normal##15##3##(1990-11#1)(1990-12#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-6#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
returned to the control##3##4##(1996-2#1)(2008-6#2)
returned to the hospital##3##4##(1996-5#1)(2011-2#1)(2012-12#1)
returned to the prebypass value in##2##6##(2007-8#2)
returned to the##21##3##(1991-6#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-7#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
returned to their##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
returned to work##2##3##(1995-12#1)(2008-7#1)
returned to##81##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#2)(1991-6#2)(1992-2#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
returned##131##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#8)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#2)
returning from endemic##2##3##(2007-2#1)(2011-2#1)
returning from foreign countries##2##4##(2012-3#2)
returning from##9##2##(1991-3#1)(2006-10#1)(2007-2#2)(2008-10#1)(2009-6#1)(2011-2#1)(2012-3#2)
returning to basal##3##3##(1990-7#1)(1992-6#1)(1996-12#1)
returning to baseline##2##3##(1994-3#1)(2013-1#1)
returning to normal values##2##4##(1994-3#1)(2013-1#1)
returning to normal##3##3##(1994-3#1)(2009-11#1)(2013-1#1)
returning to the##5##3##(1991-1#1)(1993-1#1)(2007-8#1)(2008-11#1)(2012-12#1)
returning to##21##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-1#1)(1994-3#2)(1996-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-1#3)
returning travelers##4##2##(2010-12#1)(2011-2#3)
returning travellers##9##2##(2007-2#6)(2009-5#3)
returning##53##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-1#1)(1994-3#2)(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#9)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#3)(2009-6#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)
returns and##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
returns from##7##2##(1993-1#1)(1994-2#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-2#1)
returns is##2##2##(2008-2#1)(2008-3#1)
returns on##2##2##(1995-1#1)(2010-12#1)
returns the##3##2##(2008-3#1)(2008-5#1)(2012-1#1)
returns to normal##2##3##(1990-2#1)(2008-6#1)
returns to the##3##3##(2008-10#2)(2011-2#1)
returns to##9##2##(1990-2#1)(1991-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
returns##44##1##(1990-2#1)(1991-2#1)(1993-1#1)(1994-2#2)(1995-1#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#5)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
reunification##4##1##(1992-1#1)(1995-1#1)(2008-11#1)(2009-11#1)
reuptake complex##2##2##(1991-1#2)
reuptake did not##2##3##(1991-8#1)(1992-7#1)
reuptake inhibitor (SSRI)##2##3##(2008-3#1)(2008-6#1)
reuptake inhibitor##13##2##(1991-1#1)(2008-3#2)(2008-4#4)(2008-6#2)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
reuptake inhibitors (SNRIs)##2##3##(2008-6#1)(2012-3#1)
reuptake inhibitors##20##2##(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-6#6)(2008-9#1)(2012-3#5)(2013-1#1)(2013-8#1)
reuptake of##2##2##(2008-3#1)(2012-3#1)
reuptake##49##1##(1991-1#3)(1991-8#5)(1992-7#1)(1995-12#1)(1996-7#1)(1996-9#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#4)(2008-6#10)(2008-7#1)(2008-9#2)(2010-2#1)(2012-3#7)(2013-1#2)(2013-8#1)
reusability of the##3##3##(2008-10#2)(2010-4#1)
reusability##7##1##(2008-10#3)(2008-6#1)(2009-12#1)(2010-4#1)(2013-1#1)
reusable##11##1##(1992-12#1)(1995-2#1)(2008-10#5)(2010-5#1)(2011-2#3)
reuse has increased##2##3##(2008-1#2)
reuse of##5##2##(1994-11#1)(2008-1#2)(2010-5#1)(2012-3#1)
reuse##24##1##(1992-3#1)(1994-11#1)(2008-1#13)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#2)
reused for##4##2##(2008-10#4)
reused##15##1##(2007-11#1)(2008-10#14)
revaccination##2##1##(1996-8#1)(2013-1#1)
revascularisation##7##1##(2007-7#2)(2007-8#2)(2007-9#3)
revascularization and##4##2##(1992-4#1)(2007-8#1)(2008-9#1)(2013-8#1)
revascularization in patients with##3##4##(2007-8#2)(2012-3#1)
revascularization in patients##4##3##(2007-8#3)(2012-3#1)
revascularization in##6##2##(1997-3#1)(1997-8#1)(2007-8#3)(2012-3#1)
revascularization of the##5##3##(1990-5#2)(2007-8#1)(2010-8#1)(2012-3#1)
revascularization of##9##2##(1990-5#2)(1992-9#1)(2007-8#1)(2008-10#1)(2010-8#2)(2011-3#1)(2012-3#1)
revascularization procedures##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
revascularization that##2##2##(1997-3#1)(2008-1#1)
revascularization was##2##2##(1992-4#1)(2007-8#1)
revascularization with##5##2##(2007-8#4)(2008-9#1)
revascularization##81##1##(1990-5#2)(1990-9#2)(1992-4#3)(1992-9#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-9#3)(1997-3#2)(1997-8#1)(2007-8#19)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#5)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#1)(2009-4#2)(2010-8#2)(2011-3#1)(2012-1#1)(2012-3#4)(2013-1#1)(2013-8#5)
revascularization?##2##1##(2009-10#1)(2012-2#1)
revascularized##2##1##(2007-8#1)(2008-9#1)
reveal a clear##2##3##(1997-5#1)(2008-3#1)
reveal a gradual##2##3##(1995-5#1)(2008-7#1)
reveal a novel##4##3##(2007-12#1)(2012-12#3)
reveal a significant##2##3##(2007-11#1)(2011-2#1)
reveal a##43##2##(1990-8#1)(1991-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#2)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
reveal about##2##2##(1991-5#1)(2009-5#1)
reveal an##9##2##(1992-9#1)(1995-2#1)(1995-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-8#1)
reveal and##2##2##(2008-3#2)
reveal any##20##2##(1992-1#1)(1993-6#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
reveal common##2##2##(1993-5#1)(2007-12#1)
reveal different##2##2##(2008-10#2)
reveal evidence of##2##3##(2009-7#1)(2012-3#1)
reveal how##2##2##(2008-6#1)(2009-5#1)
reveal important##3##2##(1992-12#1)(1996-2#1)(2009-3#1)
reveal interesting##2##2##(2008-10#1)(2008-8#1)
reveal low##2##2##(2010-7#1)(2011-1#1)
reveal more##2##2##(2008-10#1)(2008-5#1)
reveal new##2##2##(1997-9#1)(2013-1#1)
reveal no evidence for##2##4##(1992-8#1)(1993-11#1)
reveal no##4##2##(1992-8#1)(1993-11#2)(2008-2#1)
reveal novel##5##2##(2008-1#1)(2008-4#2)(2011-2#1)(2012-2#1)
reveal sequence##2##2##(1993-9#1)(1997-9#1)
reveal significant differences in##2##4##(2007-11#1)(2008-12#1)
reveal significant##4##2##(2007-11#1)(2008-12#1)(2010-10#1)(2013-8#1)
reveal subtle##2##2##(1994-9#1)(2008-10#1)
reveal that a##3##3##(1993-3#1)(1995-1#1)(2011-2#1)
reveal that all##3##3##(1993-11#1)(1996-5#1)(2007-11#1)
reveal that less##2##3##(1993-12#1)(2007-11#1)
reveal that the majority of the##2##6##(1991-11#1)(2011-2#1)
reveal that the primary##2##4##(1993-3#1)(1995-11#1)
reveal that the risk factors of##8##6##(2013-8#8)
reveal that the##46##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-11#2)(1993-3#1)(1994-1#1)(1994-5#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#2)(2010-2#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#9)
reveal that they are##2##4##(2007-12#1)(2010-11#1)
reveal that this##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
reveal that##124##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#4)(1994-1#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#5)(2007-12#5)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#11)
reveal the changes in##2##4##(2008-3#2)
reveal the development of##2##4##(2008-8#1)(2012-2#1)
reveal the existence of##2##4##(2008-10#1)(2008-3#1)
reveal the function of##2##4##(2008-4#1)(2013-1#1)
reveal the importance of##2##4##(2008-3#1)(2011-1#1)
reveal the molecular##2##3##(2009-2#1)(2009-8#1)
reveal the##55##2##(1990-12#1)(1994-6#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#2)
reveal two##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
reveal##405##1##(1990-11#1)(1990-12#3)(1990-6#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#1)(1993-3#4)(1993-5#3)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#6)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#1)(1997-9#2)(2007-1#1)(2007-10#3)(2007-11#17)(2007-12#10)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#48)(2008-11#10)(2008-12#6)(2008-2#8)(2008-3#22)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#17)(2008-8#6)(2008-9#7)(2009-10#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#10)(2011-2#17)(2012-1#1)(2012-12#7)(2012-2#11)(2012-3#8)(2013-1#8)(2013-8#16)
revealed 1##3##2##(1994-7#1)(2007-7#1)(2008-6#1)
revealed 13##2##2##(1996-3#1)(2011-1#1)
revealed 2##2##2##(1991-11#1)(2009-2#1)
revealed 23##2##2##(1993-8#1)(2008-10#1)
revealed 3##2##2##(2009-1#1)(2012-3#1)
revealed 5##3##2##(1990-11#1)(1991-8#1)(2010-3#1)
revealed a 4 cm##2##4##(2008-12#1)(2010-3#1)
revealed a characteristic##2##3##(2008-5#1)(2012-12#1)
revealed a clear##3##3##(1992-6#1)(2008-5#1)(2012-2#1)
revealed a close relationship##2##4##(2008-10#2)
revealed a complex##3##3##(1991-8#1)(2007-11#1)(2012-3#1)
revealed a consistent##2##3##(2008-10#1)(2011-1#1)
revealed a decrease in##3##4##(1994-3#1)(2008-6#1)(2012-12#1)
revealed a dinuclear complex with##2##5##(1996-2#1)(1997-7#1)
revealed a fibrous##2##3##(2008-3#1)(2008-5#1)
revealed a good##2##3##(1991-8#1)(2008-10#1)
revealed a great##2##3##(2008-10#1)(2009-7#1)
revealed a heterogeneous##2##3##(2008-11#1)(2008-6#1)
revealed a high degree of##2##5##(1993-2#1)(2008-10#1)
revealed a high##8##3##(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
revealed a higher##3##3##(2008-10#2)(2012-12#1)
revealed a large mass in the##2##6##(2008-6#2)
revealed a large mass##4##4##(2008-11#2)(2008-6#2)
revealed a large number of##2##5##(2011-1#1)(2013-1#1)
revealed a large##16##3##(1993-9#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
revealed a low level of##2##5##(2008-10#2)
revealed a low##4##3##(2008-10#3)(2008-5#1)
revealed a major##2##3##(1991-11#1)(1993-6#1)
revealed a mass in the##2##5##(2007-8#1)(2010-11#1)
revealed a mass##3##3##(2007-8#1)(2010-11#1)(2011-2#1)
revealed a moderate##2##3##(1997-4#1)(2008-10#1)
revealed a necrotic##2##3##(2008-7#1)(2012-12#1)
revealed a new##2##3##(1992-6#1)(2008-8#1)
revealed a number of##4##4##(2008-11#1)(2010-10#1)(2011-2#1)(2013-8#1)
revealed a patent foramen ovale##2##5##(2007-10#1)(2011-2#1)
revealed a polypoid##2##3##(1992-6#1)(1993-9#1)
revealed a poor##2##3##(1991-9#1)(1995-3#1)
revealed a previously unidentified##2##4##(1997-7#1)(2011-2#1)
revealed a pulmonary##2##3##(2008-1#1)(2008-6#1)
revealed a reduction##2##3##(1996-6#1)(2008-1#1)
revealed a severe##2##3##(2008-9#1)(2012-3#1)
revealed a significant correlation##2##4##(1997-7#1)(2008-12#1)
revealed a significant difference##2##4##(2009-7#1)(2013-8#1)
revealed a significant reduction in##2##5##(2008-10#2)
revealed a significant##16##3##(1990-5#1)(1992-10#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-8#1)
revealed a significantly##3##3##(1992-11#1)(2008-10#1)(2009-12#1)
revealed a similar pattern##2##4##(1997-2#1)(2008-10#1)
revealed a similar##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
revealed a single approximately##2##4##(1991-9#1)(1995-2#1)
revealed a single##10##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-9#1)(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2009-9#1)
revealed a small##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
revealed a total of##3##4##(2007-10#1)(2008-12#1)(2009-5#1)
revealed a total##4##3##(2007-10#1)(2008-10#1)(2008-12#1)(2009-5#1)
revealed a typical##2##3##(1993-8#1)(2010-6#1)
revealed a very high##2##4##(1994-2#1)(2008-10#1)
revealed a very##4##3##(1994-2#1)(2008-10#2)(2013-7#1)
revealed a wide##6##3##(2008-10#2)(2008-5#1)(2010-10#1)(2010-3#1)(2011-2#1)
revealed a##312##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-12#3)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#1)(2006-10#2)(2007-10#5)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#38)(2008-11#10)(2008-12#11)(2008-2#1)(2008-3#1)(2008-5#11)(2008-6#9)(2008-7#14)(2008-8#6)(2008-9#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2011-1#5)(2011-2#18)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#7)
revealed acute##2##2##(2007-10#1)(2008-12#1)
revealed additional##5##2##(1993-11#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-8#1)
revealed an apparently##2##3##(1994-12#1)(2008-7#1)
revealed an approximately##2##3##(1990-12#1)(2007-8#1)
revealed an association between the##2##5##(2008-8#1)(2013-8#1)
revealed an association##4##3##(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
revealed an increase in##6##4##(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
revealed an increase##7##3##(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-2#1)(2012-2#1)
revealed an increased##3##3##(1994-3#1)(1995-2#1)(2012-12#1)
revealed an interaction##2##3##(2008-10#1)(2012-12#1)
revealed an open reading frame (ORF) of##2##7##(1991-9#1)(1995-8#1)
revealed an open reading frame (ORF)##3##6##(1991-9#1)(1994-12#1)(1995-8#1)
revealed an open reading frame encoding a##3##7##(1994-8#1)(1995-6#1)(2008-8#1)
revealed an open reading frame of##2##6##(1992-3#1)(1997-2#1)
revealed an open reading frame##8##5##(1991-9#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-8#1)
revealed an overall##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
revealed an unexpected##3##3##(2010-3#1)(2010-6#1)(2012-12#1)
revealed an##76##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#1)
revealed as##2##2##(2010-11#1)(2011-2#1)
revealed at least##2##3##(2006-10#1)(2008-10#1)
revealed at##5##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
revealed between##3##2##(1990-5#1)(2011-1#1)(2013-8#1)
revealed bilateral##4##2##(1997-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
revealed bone##2##2##(1995-9#1)(2008-12#1)
revealed both##4##2##(2008-10#3)(2013-8#1)
revealed by a##3##3##(2007-12#1)(2010-12#1)(2013-1#1)
revealed by chromosome##2##3##(2008-11#1)(2010-3#1)
revealed by comparative##2##3##(2010-12#1)(2012-3#1)
revealed by the##13##3##(1992-3#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
revealed by##92##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-5#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
revealed close##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
revealed comparable##3##2##(1993-3#1)(1994-12#1)(2013-1#1)
revealed considerable##3##2##(1990-11#1)(1992-6#1)(2008-7#1)
revealed decreased expression of##2##4##(2009-12#1)(2012-12#1)
revealed decreased##3##2##(1996-5#1)(2009-12#1)(2012-12#1)
revealed differences between##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
revealed differences in the##2##4##(1993-12#1)(2008-10#1)
revealed differences in##3##3##(1990-12#1)(1993-12#1)(2008-10#1)
revealed differences##8##2##(1990-12#1)(1993-12#1)(1997-2#2)(2008-10#2)(2010-10#1)(2013-1#1)
revealed different##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
revealed differential##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
revealed diffuse##4##2##(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
revealed direct##2##2##(2008-10#2)
revealed distinct##2##2##(1991-5#1)(2008-10#1)
revealed enhanced##3##2##(2008-10#2)(2012-2#1)
revealed extensive##5##2##(1991-2#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)
revealed factors affecting##2##3##(1994-3#1)(2009-5#1)
revealed factors##3##2##(1990-7#1)(1994-3#1)(2009-5#1)
revealed features of##2##3##(2010-4#1)(2011-1#1)
revealed features##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
revealed few##2##2##(1992-12#1)(2008-10#1)
revealed five categories##2##3##(2007-11#1)(2009-6#1)
revealed five##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
revealed for the##2##3##(2008-10#1)(2010-4#1)
revealed for##4##2##(1992-6#1)(2007-12#1)(2008-10#1)(2010-4#1)
revealed four##7##2##(1997-7#1)(2008-10#3)(2009-5#1)(2010-10#1)(2010-4#1)
revealed free##2##2##(2007-5#1)(2011-2#1)
revealed frequent##2##2##(1995-12#1)(2008-11#1)
revealed from##2##2##(2008-10#1)(2008-3#1)
revealed good selectivity##4##3##(2008-10#4)
revealed good##9##2##(2008-10#8)(2008-6#1)
revealed greater than##2##3##(2008-10#2)
revealed greater##3##2##(2008-10#2)(2008-8#1)
revealed heterogeneity##2##2##(1992-8#1)(2008-10#1)
revealed high levels of##2##4##(2008-10#1)(2009-11#1)
revealed high##4##2##(2008-10#1)(2008-11#1)(2009-11#1)(2011-1#1)
revealed higher##4##2##(2007-8#1)(2008-10#1)(2012-1#1)(2013-8#1)
revealed important##2##2##(1995-5#1)(2008-11#1)
revealed in the##7##3##(1996-9#1)(2008-12#2)(2008-3#1)(2013-1#3)
revealed in##24##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-9#1)(1994-3#1)(1996-9#1)(2007-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-2#2)(2013-1#3)
revealed increased##8##2##(1990-11#1)(1992-7#1)(2008-3#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
revealed inflammation##2##2##(2008-10#1)(2011-2#1)
revealed inhibition of##2##3##(2008-11#1)(2008-7#1)
revealed inhibition##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
revealed its##4##2##(2008-9#1)(2009-1#1)(2011-2#2)
revealed large##2##2##(2007-7#1)(2008-11#1)
revealed left##2##2##(2007-10#1)(2007-7#1)
revealed less##2##2##(2008-10#1)(2012-2#1)
revealed little evidence of##3##4##(1993-11#1)(2008-8#2)
revealed little##5##2##(1993-11#1)(2008-10#1)(2008-5#1)(2008-8#2)
revealed low##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
revealed major##2##2##(2008-10#1)(2008-7#1)
revealed many##3##2##(1993-8#1)(1997-8#1)(2011-1#1)
revealed mixed##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
revealed more##2##2##(2007-11#1)(2008-2#1)
revealed much##2##2##(1996-10#1)(2012-2#1)
revealed multiple bilateral##2##3##(2008-10#1)(2013-1#1)
revealed multiple##9##2##(1993-8#1)(2007-5#1)(2008-10#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
revealed new##2##2##(2008-10#1)(2013-1#1)
revealed nine##3##2##(2008-10#2)(2008-12#1)
revealed no apparent##3##3##(1992-8#1)(1992-9#1)(2008-10#1)
revealed no differences between##2##4##(1991-2#1)(1993-3#1)
revealed no differences##3##3##(1991-2#1)(1993-3#2)
revealed no evidence of##2##4##(2008-10#1)(2009-3#1)
revealed no evidence##3##3##(2008-10#1)(2009-3#1)(2009-9#1)
revealed no significant correlation##2##4##(2007-2#1)(2008-12#1)
revealed no significant differences among##2##5##(2008-5#1)(2008-9#1)
revealed no significant differences##6##4##(1993-11#1)(2007-2#1)(2008-5#2)(2008-9#1)(2011-2#1)
revealed no significant##11##3##(1993-11#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-8#1)
revealed no statistically significant##2##4##(2008-10#1)(2009-7#1)
revealed no##50##2##(1990-6#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-8#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-5#2)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)(2013-8#1)
revealed normal coronary arteries##2##4##(1991-3#1)(2007-8#1)
revealed normal##4##2##(1991-3#1)(2007-4#1)(2007-8#1)(2010-5#1)
revealed numerous##2##2##(2008-5#1)(2008-7#1)
revealed one##4##2##(1996-11#1)(1996-2#1)(2008-10#1)(2009-11#1)
revealed only a##2##3##(2008-12#1)(2010-5#1)
revealed only five##2##3##(1995-1#1)(2007-2#1)
revealed only inflammatory##2##3##(1990-8#1)(2011-2#1)
revealed only one##3##3##(1990-3#1)(2008-10#1)(2008-12#1)
revealed only##13##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-7#1)(1995-1#1)(2007-2#1)(2008-10#1)(2008-12#3)(2010-5#1)(2011-1#1)(2011-2#1)
revealed over##2##2##(2008-10#2)
revealed polymorphism in##2##3##(1993-6#1)(2008-10#1)
revealed positive##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
revealed reduced##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
revealed relative##2##2##(1992-12#1)(2008-10#1)
revealed relatively##2##2##(2008-10#2)
revealed remarkable##3##2##(2010-9#1)(2013-1#2)
revealed resolution of the##2##4##(2008-10#1)(2013-1#1)
revealed resolution of##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
revealed reversible##2##2##(1993-6#1)(2008-10#1)
revealed several##11##2##(1993-12#2)(1995-11#1)(1995-12#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)
revealed severe##5##2##(1992-5#1)(1993-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
revealed significant differences in##5##4##(1996-7#1)(2008-10#1)(2008-12#1)(2009-6#1)(2012-2#1)
revealed significant differences##6##3##(1996-7#1)(2008-10#2)(2008-12#1)(2009-6#1)(2012-2#1)
revealed significant homology to##2##4##(1995-12#1)(1997-2#1)
revealed significant homology##3##3##(1995-12#1)(1995-5#1)(1997-2#1)
revealed significant positive##3##3##(2007-6#1)(2008-9#1)(2013-8#1)
revealed significant##32##2##(1992-1#1)(1993-2#1)(1995-12#1)(1995-5#1)(1996-7#2)(1997-2#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
revealed significantly##2##2##(1995-12#1)(2009-11#1)
revealed similar##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
revealed similarities##2##2##(2008-10#1)(2010-1#1)
revealed slight##2##2##(1997-3#1)(2008-7#1)
revealed slightly##2##2##(1992-5#1)(2013-1#1)
revealed solid##3##2##(2008-5#1)(2008-8#1)(2012-3#1)
revealed some##6##2##(1994-6#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
revealed specific##2##2##(1991-2#1)(2008-11#1)
revealed statistically significant differences##2##4##(2008-12#2)
revealed striking differences in the extent of##2##7##(2008-10#2)
revealed striking##3##2##(2007-12#1)(2008-10#2)
revealed strong##6##2##(1992-8#1)(2008-10#3)(2008-11#1)(2008-7#1)
revealed substantial##2##2##(2007-11#1)(2008-7#1)
revealed that 33##2##3##(1996-12#1)(2011-2#1)
revealed that F##2##3##(2008-10#1)(2008-5#1)
revealed that M##2##3##(2008-10#1)(2010-2#1)
revealed that SA##3##3##(2009-8#2)(2011-2#1)
revealed that a single##2##4##(2008-10#2)
revealed that a##11##3##(1995-2#1)(1995-5#1)(2007-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2010-1#1)
revealed that all three##2##4##(2008-10#1)(2012-3#1)
revealed that all##12##3##(1990-12#1)(1992-4#1)(2007-6#1)(2008-10#6)(2008-12#2)(2012-3#1)
revealed that at least##4##4##(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)
revealed that both of these##2##5##(1997-3#1)(2012-3#1)
revealed that both of##3##4##(1993-3#1)(1997-3#1)(2012-3#1)
revealed that both##21##3##(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-3#1)(2012-3#3)
revealed that bromination##2##3##(2008-10#2)
revealed that cell##3##3##(1997-1#1)(2008-5#1)(2010-11#1)
revealed that each##2##3##(1993-11#1)(2008-10#1)
revealed that high##2##3##(2008-10#2)
revealed that higher##2##3##(2008-10#1)(2010-2#1)
revealed that human##2##3##(2008-11#1)(2012-12#1)
revealed that in the##4##4##(1991-12#1)(1995-12#1)(2007-12#1)(2008-12#1)
revealed that in##12##3##(1991-12#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)
revealed that isolates of##2##4##(2008-10#2)
revealed that isolates##4##3##(2008-10#4)
revealed that it is##2##4##(1992-12#1)(1997-2#1)
revealed that it##6##3##(1992-12#1)(1992-3#1)(1997-2#1)(1997-4#1)(2008-8#1)(2008-9#1)
revealed that many were##2##4##(1995-6#1)(2008-11#1)
revealed that many##4##3##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)
revealed that molecular##2##3##(1990-11#1)(2012-12#1)
revealed that most of the##2##5##(2008-9#1)(2011-2#1)
revealed that most of##4##4##(1997-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
revealed that most##12##3##(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#1)
revealed that neither##2##3##(2008-10#1)(2008-8#1)
revealed that one of the##3##5##(1994-2#1)(2007-12#1)(2008-8#1)
revealed that one of##4##4##(1994-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
revealed that one##6##3##(1990-2#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#1)
revealed that only##3##3##(1994-12#1)(1996-2#1)(2008-10#1)
revealed that out of##3##4##(2007-7#1)(2008-8#1)(2010-5#1)
revealed that patients with##2##4##(1993-11#1)(2013-1#1)
revealed that performance##2##3##(1993-12#1)(1996-7#1)
revealed that several##3##3##(1996-8#1)(2008-10#2)
revealed that significantly##2##3##(2008-10#1)(2012-12#1)
revealed that some of the##2##5##(2008-10#1)(2008-12#1)
revealed that some##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
revealed that students##2##3##(1996-1#1)(2008-12#1)
revealed that the 8-bp sequence##2##5##(1995-6#2)
revealed that the C-terminal##2##4##(1997-2#1)(2008-8#1)
revealed that the ability of##2##5##(2008-10#2)
revealed that the cause of##2##5##(2013-1#2)
revealed that the core##2##4##(1990-12#1)(1992-8#1)
revealed that the different##2##4##(1993-8#1)(2008-10#1)
revealed that the expression##2##4##(2008-10#1)(2013-1#1)
revealed that the gene##5##4##(1995-6#1)(1997-2#1)(1997-6#1)(2008-10#1)(2013-1#1)
revealed that the mean##2##4##(2009-11#1)(2012-3#1)
revealed that the method##2##4##(2008-10#2)
revealed that the mutant##2##4##(1994-6#1)(2008-10#1)
revealed that the mutations##2##4##(1992-12#1)(2008-10#1)
revealed that the new##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
revealed that the number of##2##5##(1994-12#1)(2010-11#1)
revealed that the peptide##2##4##(1993-11#1)(1995-6#1)
revealed that the performance of##2##5##(2008-10#1)(2008-12#1)
revealed that the presence of##2##5##(2008-10#1)(2008-11#1)
revealed that the proposed procedure##2##5##(2008-10#2)
revealed that the protein##2##4##(2008-11#1)(2012-12#1)
revealed that the surface##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
revealed that the tissue##2##4##(1992-9#1)(2008-6#1)
revealed that the tumor was##2##5##(1994-7#1)(2013-1#1)
revealed that the##232##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-8#3)(1994-12#4)(1994-3#2)(1994-6#3)(1994-7#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#4)(1995-9#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#5)(1997-6#1)(1997-7#2)(1997-8#3)(2007-12#7)(2007-8#1)(2008-10#58)(2008-11#11)(2008-12#10)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#1)
revealed that their##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
revealed that there is##2##4##(1994-11#1)(2008-12#1)
revealed that there was no##2##5##(2008-10#2)
revealed that there was##5##4##(2007-10#1)(2008-10#2)(2008-9#1)(2010-8#1)
revealed that there were##4##4##(1992-8#1)(1996-12#1)(2008-10#1)(2008-9#1)
revealed that there##13##3##(1992-8#1)(1994-11#1)(1996-12#2)(2007-10#1)(2008-10#3)(2008-12#1)(2008-9#3)(2010-8#1)
revealed that these two##3##4##(1990-12#1)(1992-2#1)(2010-2#1)
revealed that these##13##3##(1990-12#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1997-4#1)(1997-8#2)(2008-10#2)(2010-2#1)(2012-2#2)
revealed that they are##3##4##(1994-6#1)(1996-10#1)(2008-10#1)
revealed that they were##5##4##(1993-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
revealed that they##11##3##(1992-11#1)(1993-8#1)(1994-6#1)(1996-10#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
revealed that this gene is##2##5##(1991-6#1)(1994-12#1)
revealed that this protein##2##4##(1991-5#1)(1994-11#1)
revealed that this##14##3##(1990-8#1)(1991-5#1)(1991-6#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)
revealed that three##3##3##(1994-9#1)(2008-10#1)(2009-7#1)
revealed that two of##2##4##(1994-11#1)(2008-9#1)
revealed that two##5##3##(1994-11#1)(2008-10#2)(2008-9#1)(2011-1#1)
revealed that##775##2##(1990-11#3)(1990-12#7)(1990-2#3)(1990-5#3)(1990-7#2)(1990-8#4)(1991-12#4)(1991-2#7)(1991-3#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#6)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#7)(1992-9#4)(1993-11#7)(1993-12#6)(1993-2#3)(1993-3#4)(1993-6#5)(1993-8#6)(1993-9#1)(1994-11#6)(1994-12#9)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#14)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#9)(1997-3#5)(1997-4#3)(1997-6#4)(1997-7#6)(1997-8#9)(2006-10#1)(2007-10#4)(2007-11#3)(2007-12#12)(2007-2#2)(2007-6#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#173)(2008-11#33)(2008-12#24)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#22)(2008-6#10)(2008-7#8)(2008-8#27)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#8)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#8)(2010-3#6)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#21)(2012-1#5)(2012-12#7)(2012-2#21)(2012-3#14)(2013-1#19)(2013-7#2)(2013-8#4)
revealed the accumulation##2##3##(2008-10#1)(2008-11#1)
revealed the different##2##3##(2008-10#1)(2008-7#1)
revealed the existence of a##5##5##(1992-3#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-3#1)
revealed the existence of two##4##5##(1991-1#1)(1993-11#1)(2008-10#1)(2008-11#1)
revealed the existence of##16##4##(1991-1#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2010-6#1)(2010-7#1)
revealed the following concentrations##2##4##(2007-12#1)(2013-1#1)
revealed the following##6##3##(1997-2#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
revealed the formation of##4##4##(2008-10#2)(2012-1#1)(2013-1#1)
revealed the formation##5##3##(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)
revealed the genetic##2##3##(2008-10#1)(2010-4#1)
revealed the genomic##2##3##(1995-8#1)(2008-10#1)
revealed the great##2##3##(2008-5#1)(2008-8#1)
revealed the importance of##3##4##(2008-7#1)(2009-3#2)
revealed the presence of a consensus##2##6##(1993-2#1)(2008-10#1)
revealed the presence of a##14##5##(1991-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(2008-10#4)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
revealed the presence of an##2##5##(1994-9#1)(2008-10#1)
revealed the presence of five##3##5##(1994-12#1)(2008-10#2)
revealed the presence of one##2##5##(1991-9#1)(2008-10#1)
revealed the presence of the##6##5##(1994-10#1)(1994-6#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
revealed the presence of two##3##5##(1990-5#1)(1991-9#1)(2008-10#1)
revealed the presence of##69##4##(1990-5#1)(1991-11#1)(1991-9#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-10#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-4#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)
revealed the recovery of##2##4##(2008-10#1)(2010-4#1)
revealed the##189##2##(1990-10#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#1)(2006-12#2)(2006-4#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#45)(2008-11#10)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#3)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
revealed their##4##2##(1996-5#1)(2008-10#1)(2010-12#1)(2012-12#1)
revealed these differences##2##3##(1995-2#1)(2007-11#1)
revealed these##3##2##(1992-12#1)(1995-2#1)(2007-11#1)
revealed thickening##2##2##(1996-3#1)(2008-10#1)
revealed this##2##2##(1990-7#1)(2008-10#1)
revealed three clades##2##3##(2008-10#2)
revealed three distinct##4##3##(2008-10#2)(2010-6#1)(2012-3#1)
revealed three themes##2##3##(2008-11#1)(2009-5#1)
revealed three##15##2##(1994-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
revealed to be##6##3##(1997-3#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-7#1)
revealed to have##3##3##(1997-4#1)(2008-11#1)(2011-1#1)
revealed to##12##2##(1990-5#1)(1991-2#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
revealed two distinct##6##3##(1990-7#1)(1992-3#1)(1992-6#1)(2008-10#1)(2009-9#1)(2010-10#1)
revealed two independent##2##3##(1991-3#1)(2008-10#1)
revealed two main##3##3##(2008-10#3)
revealed two well##2##3##(2009-9#1)(2013-1#1)
revealed two##34##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-6#1)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#10)(2008-12#1)(2008-7#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-6#1)(2013-1#1)
revealed unilateral##2##2##(2007-12#1)(2011-2#1)
revealed unique##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
revealed very##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
revealed widespread systemic##2##3##(2006-12#1)(2009-4#1)
revealed widespread##5##2##(1997-8#1)(2006-12#1)(2008-7#2)(2009-4#1)
revealed with##2##2##(2008-10#1)(2013-1#1)
revealed##2281##1##(1990-10#2)(1990-11#7)(1990-12#13)(1990-2#6)(1990-3#2)(1990-5#14)(1990-6#4)(1990-7#6)(1990-8#9)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#6)(1991-12#6)(1991-2#14)(1991-3#6)(1991-4#1)(1991-5#6)(1991-6#7)(1991-7#3)(1991-8#5)(1991-9#13)(1992-1#4)(1992-10#2)(1992-11#11)(1992-12#9)(1992-2#5)(1992-3#15)(1992-4#1)(1992-5#6)(1992-6#10)(1992-7#1)(1992-8#18)(1992-9#8)(1993-1#3)(1993-11#16)(1993-12#17)(1993-2#7)(1993-3#13)(1993-5#1)(1993-6#14)(1993-8#16)(1993-9#5)(1994-10#1)(1994-11#13)(1994-12#22)(1994-2#6)(1994-3#11)(1994-5#4)(1994-6#9)(1994-7#5)(1994-8#9)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#16)(1995-2#9)(1995-3#4)(1995-5#5)(1995-6#23)(1995-8#8)(1995-9#3)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#18)(1996-2#4)(1996-3#7)(1996-5#9)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#17)(1997-3#15)(1997-4#11)(1997-5#3)(1997-6#7)(1997-7#17)(1997-8#16)(2006-10#5)(2006-12#3)(2006-4#1)(2007-10#15)(2007-11#16)(2007-12#35)(2007-2#5)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#15)(2007-8#25)(2008-1#15)(2008-10#431)(2008-11#86)(2008-12#69)(2008-2#13)(2008-3#18)(2008-4#14)(2008-5#58)(2008-6#27)(2008-7#71)(2008-8#65)(2008-9#43)(2009-1#3)(2009-10#5)(2009-11#6)(2009-12#5)(2009-2#7)(2009-3#15)(2009-4#8)(2009-5#13)(2009-6#8)(2009-7#15)(2009-8#14)(2009-9#11)(2010-1#8)(2010-10#11)(2010-11#12)(2010-12#11)(2010-2#14)(2010-3#17)(2010-4#13)(2010-5#13)(2010-6#12)(2010-7#5)(2010-8#6)(2010-9#4)(2011-1#36)(2011-2#87)(2012-1#10)(2012-12#38)(2012-2#56)(2012-3#39)(2012-5#1)(2013-1#78)(2013-7#5)(2013-8#28)
revealing a##10##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
revealing an##2##2##(2007-8#1)(2011-2#1)
revealing its##2##2##(2008-5#1)(2013-1#1)
revealing of##2##2##(2008-3#1)(2008-4#1)
revealing that the##4##3##(1995-6#1)(2008-5#1)(2008-8#1)(2009-10#1)
revealing that##7##2##(1995-6#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#1)
revealing the##12##2##(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
revealing their##2##2##(1994-3#1)(2007-11#1)
revealing##75##1##(1990-6#1)(1991-11#2)(1992-3#1)(1994-3#1)(1995-6#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-3#2)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#2)
reveals a high degree of##2##5##(1993-2#1)(1996-6#1)
reveals a high##3##3##(1993-2#1)(1996-6#1)(2007-7#1)
reveals a new fold##2##4##(2010-10#2)
reveals a novel##2##3##(1994-11#1)(2010-10#1)
reveals a number of##2##4##(1991-9#1)(1992-3#1)
reveals a##48##2##(1990-2#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-3#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#2)(2007-11#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#2)(2010-10#4)(2010-11#1)(2010-6#1)(2011-3#1)(2012-1#1)(2012-2#3)
reveals an##11##2##(1993-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
reveals common##2##2##(1990-2#1)(2012-12#1)
reveals differences##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
reveals good##3##2##(2008-10#2)(2008-3#1)
reveals high##2##2##(1996-12#1)(2011-2#1)
reveals how##3##2##(1994-9#1)(2008-11#1)(2008-8#1)
reveals large##3##2##(1995-6#1)(2008-3#1)(2008-7#1)
reveals little##2##2##(1995-2#1)(2008-9#1)
reveals no##2##2##(1992-3#1)(2012-2#1)
reveals significant##2##2##(1996-2#1)(2008-2#1)
reveals some##5##2##(1995-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
reveals structural##2##2##(1993-3#1)(1993-8#1)
reveals that Avicenna has made a significant contribution to the evolution of following knowledge##2##14##(2013-1#2)
reveals that a##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
reveals that an##2##3##(1994-5#1)(2008-10#1)
reveals that it is##4##4##(1994-12#1)(1995-8#1)(2007-12#1)(2012-3#1)
reveals that it##5##3##(1994-12#1)(1994-9#1)(1995-8#1)(2007-12#1)(2012-3#1)
reveals that some##2##3##(1993-3#1)(1997-9#1)
reveals that the two##2##4##(2008-11#1)(2008-8#1)
reveals that the##39##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-1#1)(1995-2#2)(1995-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-8#2)(2009-5#1)(2010-10#3)(2012-12#1)(2012-2#2)(2013-8#1)
reveals that there is##2##4##(2008-10#1)(2008-11#1)
reveals that there##3##3##(2008-10#2)(2008-11#1)
reveals that these##3##3##(1990-8#1)(2007-12#2)
reveals that this##2##3##(1992-12#1)(2009-4#1)
reveals that##116##2##(1990-12#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#6)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#4)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
reveals the following##2##3##(1995-12#1)(1996-3#1)
reveals the presence of a##4##5##(1990-12#1)(1991-2#1)(1995-12#1)(2011-1#1)
reveals the presence of##10##4##(1990-11#1)(1990-12#1)(1991-2#1)(1995-12#1)(1997-3#3)(2008-11#2)(2011-1#1)
reveals the presence##11##3##(1990-11#1)(1990-12#1)(1991-2#1)(1993-3#1)(1995-12#1)(1997-3#3)(2008-11#2)(2011-1#1)
reveals the##34##2##(1990-11#1)(1990-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#3)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
reveals##324##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#4)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#3)(1996-9#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#7)(2007-12#11)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#24)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#9)(2008-4#5)(2008-5#7)(2008-7#10)(2008-8#11)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#9)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#15)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#4)
revenge##3##1##(1997-5#1)(2008-12#1)(2011-1#1)
revenue and##5##2##(1991-3#1)(1992-12#1)(1995-3#1)(2008-11#2)
revenue cycle##2##2##(2007-9#2)
revenue generation activities##2##3##(1991-12#2)
revenue generation##5##2##(1991-12#5)
revenue levels##2##2##(2008-7#2)
revenue was##3##2##(1992-1#1)(1994-9#1)(2008-11#1)
revenue##39##1##(1991-1#1)(1991-12#5)(1991-3#4)(1992-1#1)(1992-12#5)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-3#1)(1996-2#2)(1996-3#2)(1997-3#2)(2007-9#3)(2008-11#5)(2008-7#2)
revenues and expenses##3##3##(2007-4#1)(2010-8#2)
revenues and profits##3##3##(1991-3#1)(2007-4#1)(2008-11#1)
revenues and##7##2##(1991-3#1)(1992-12#1)(2007-4#2)(2008-11#1)(2010-8#2)
revenues grew more##2##3##(1993-3#2)
revenues of##2##2##(1992-1#1)(2008-5#1)
revenues##25##1##(1991-3#1)(1992-1#1)(1992-12#3)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-3#1)(1995-2#2)(1996-12#1)(2007-4#2)(2007-9#1)(2008-11#3)(2008-5#1)(2010-12#1)(2010-8#2)
reverberation activity##2##2##(2008-11#2)
reverberation##4##1##(2008-11#3)(2008-9#1)
reversal by##2##2##(1990-7#1)(2008-7#1)
reversal in the##3##3##(1992-6#1)(2008-10#1)(2009-7#1)
reversal in##5##2##(1990-8#1)(1992-6#1)(2008-10#1)(2008-3#1)(2009-7#1)
reversal of stereoselectivity##2##3##(1991-12#2)
reversal of the##15##3##(1992-10#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-3#1)(1997-7#1)(2006-7#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2010-8#1)
reversal of tolerance##3##3##(1996-2#3)
reversal of ultrafast waveforms by wave mixing##2##7##(2007-12#2)
reversal of ultrafast##3##3##(2007-12#3)
reversal of##46##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#3)(1997-2#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
reversal potential of the current##2##5##(1993-12#1)(1995-12#1)
reversal potential of##3##3##(1990-7#1)(1993-12#1)(1995-12#1)
reversal potential##7##2##(1990-7#1)(1992-11#1)(1993-12#2)(1995-11#1)(1995-12#1)(1995-5#1)
reversal times##2##2##(2008-10#2)
reversal with##2##2##(2010-4#1)(2013-8#1)
reversal##104##1##(1990-12#1)(1990-2#2)(1990-7#3)(1990-8#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-12#3)(1993-3#3)(1993-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1997-2#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-12#7)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
reversals are##2##2##(2008-2#1)(2013-1#1)
reversals in##2##2##(2008-8#2)
reversals of the##2##3##(1995-12#1)(2008-10#1)
reversals of##4##2##(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#1)
reversals##22##1##(1990-7#1)(1992-6#1)(1995-12#1)(1995-6#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#4)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#3)
reverse Na-Ca exchange##2##3##(2013-1#2)
reverse and forward##2##3##(2007-12#1)(2008-10#1)
reverse correlation##2##2##(2008-7#1)(2013-8#1)
reverse direction##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
reverse dot blot system##2##4##(2008-10#2)
reverse dot blot##3##3##(2008-10#3)
reverse flow injection analysis##2##4##(2008-10#2)
reverse flow injection method##2##4##(2008-10#2)
reverse flow injection##5##3##(2008-10#5)
reverse flow##8##2##(1992-5#1)(2008-10#7)
reverse flow-injection##2##2##(2008-10#2)
reverse genetics##3##2##(2008-7#1)(2011-1#1)(2012-3#1)
reverse hybridization##2##2##(2008-4#2)
reverse latissimus dorsi##2##3##(2008-7#2)
reverse light##2##2##(1997-6#2)
reverse micellar##2##2##(1995-3#1)(2008-10#1)
reverse oblique fractures##3##3##(2013-1#3)
reverse oblique##5##2##(2013-1#5)
reverse of the &quot##2##4##(1991-12#1)(2010-7#1)
reverse order##4##2##(1993-2#1)(2007-12#1)(2008-10#2)
reverse phase HPLC##4##3##(1990-12#1)(1991-8#1)(2008-10#1)(2008-8#1)
reverse phase and##2##3##(1991-8#1)(1994-11#1)
reverse phase chromatography##2##3##(1997-4#1)(2008-10#1)
reverse phase high performance liquid chromatography##3##6##(1990-7#1)(1994-6#1)(2008-10#1)
reverse phase liquid chromatography##2##4##(2008-10#2)
reverse phase liquid##3##3##(2008-10#2)(2010-3#1)
reverse phase##22##2##(1990-12#1)(1990-7#1)(1991-8#2)(1992-9#1)(1994-11#2)(1994-6#1)(1995-3#1)(1997-4#1)(2008-10#8)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
reverse radial forearm##2##3##(2008-9#2)
reverse rate##2##2##(1997-2#1)(2009-2#1)
reverse reaction##5##2##(1991-9#2)(1995-6#1)(2008-3#2)
reverse saturable absorber materials##2##4##(2008-3#2)
reverse saturable##3##2##(2008-3#3)
reverse simulated annealing##2##3##(2008-3#2)
reverse the effects of##2##4##(1995-2#1)(2011-1#1)
reverse the inhibitory##2##3##(1992-6#1)(2013-1#1)
reverse the trend##3##3##(1991-3#1)(1992-8#1)(2009-12#1)
reverse the##31##2##(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
reverse these##2##2##(2012-2#2)
reverse this##3##2##(1991-3#1)(1991-6#1)(2008-8#1)
reverse transcribed and##2##3##(1991-11#1)(2008-2#1)
reverse transcribed##3##2##(1991-11#1)(1993-3#1)(2008-2#1)
reverse transcriptase (RT)##3##3##(1991-9#1)(1997-6#1)(2013-1#1)
reverse transcriptase activity##3##3##(1994-6#2)(2008-11#1)
reverse transcriptase and##2##3##(1997-6#1)(2011-3#1)
reverse transcriptase inhibitors##10##3##(2008-1#2)(2008-3#1)(2011-2#4)(2011-3#3)
reverse transcriptase polymerase chain reaction (RT-PCR)##3##6##(1996-12#1)(1997-4#1)(2008-7#1)
reverse transcriptase polymerase chain reaction##7##5##(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-7#1)(2011-2#1)
reverse transcriptase##57##2##(1991-9#1)(1992-3#2)(1992-6#1)(1993-3#3)(1993-6#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#2)(2011-2#8)(2011-3#8)(2013-1#1)
reverse transcriptase-activity##2##2##(2008-11#2)
reverse transcriptase-polymerase chain reaction (RT-PCR)##6##5##(1994-2#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-8#1)
reverse transcriptase-polymerase chain reaction##14##4##(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#3)(1997-6#1)(1997-9#1)(2007-8#1)(2008-10#2)(2008-8#1)(2012-3#1)
reverse transcription PCR##6##3##(1992-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)
reverse transcription and polymerase chain reaction##3##6##(1995-12#2)(2011-2#1)
reverse transcription and##5##3##(1993-8#1)(1995-12#2)(2010-5#1)(2011-2#1)
reverse transcription polymerase chain reaction (RT-PCR)##8##6##(1995-11#1)(1996-12#1)(2007-10#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
reverse transcription polymerase chain reaction##13##5##(1995-11#1)(1996-12#1)(1997-7#1)(2007-10#2)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
reverse transcription##34##2##(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1997-7#1)(2007-10#2)(2007-6#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
reverse transcription-PCR##8##2##(1993-12#1)(1995-8#1)(1996-12#1)(2008-9#3)(2010-11#1)(2013-8#1)
reverse transcription-polymerase chain reaction (RT-PCR) analysis##2##6##(1992-8#1)(2008-10#1)
reverse transcription-polymerase chain reaction (RT-PCR) and##2##6##(1994-11#1)(2008-10#1)
reverse transcription-polymerase chain reaction (RT-PCR) in##2##6##(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR) was used##2##7##(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR)##24##5##(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-9#1)(2010-1#1)
reverse transcription-polymerase chain reaction and##3##5##(1995-12#1)(2008-10#2)
reverse transcription-polymerase chain reaction procedure##2##5##(2008-10#2)
reverse transcription-polymerase chain reaction with##2##5##(2008-10#2)
reverse transcription-polymerase chain reaction##55##4##(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#29)(2008-11#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-1#2)
reverse transcription-polymerase chain##57##3##(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#30)(2008-11#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-1#2)
reverse transfection array##2##3##(2008-7#2)
reverse transfection##4##2##(2008-7#4)
reverse was##2##2##(2008-10#1)(2009-7#1)
reverse##408##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#4)(1992-12#3)(1992-3#6)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#4)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#1)(1994-11#6)(1994-12#5)(1994-2#2)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#8)(1996-2#2)(1996-3#1)(1996-5#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#8)(1997-7#3)(1997-8#1)(1997-9#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#79)(2008-11#13)(2008-2#3)(2008-3#12)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#10)(2008-9#14)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#15)(2011-3#8)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#17)(2013-8#5)
reverse-correlation##7##1##(2008-11#1)(2008-7#1)(2013-8#5)
reverse-flow injection analysis##2##3##(2008-10#2)
reverse-flow injection##3##2##(2008-10#3)
reverse-phase HPLC##7##2##(1990-5#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-7#1)
reverse-phase chromatography##3##2##(2008-10#2)(2008-6#1)
reverse-phase column##2##2##(1990-2#1)(1995-6#1)
reverse-phase high performance liquid chromatography (RP-HPLC)##2##6##(1990-2#1)(2008-10#1)
reverse-phase high performance liquid chromatography##4##5##(1990-2#1)(1992-8#1)(2008-10#2)
reverse-phase high-performance liquid chromatography##2##4##(1990-8#1)(1993-11#1)
reverse-phase liquid chromatography##2##3##(2008-10#1)(2008-5#1)
reverse-phase##21##1##(1990-2#2)(1990-5#1)(1990-8#1)(1991-3#1)(1992-8#1)(1993-11#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)
reverse-transcriptase polymerase chain reaction##2##4##(2008-10#2)
reverse-transcriptase##4##1##(2008-10#3)(2008-9#1)
reverse-transcription polymerase chain reaction (RT-PCR)##6##5##(1993-3#1)(2008-10#4)(2008-4#1)
reverse-transcription polymerase chain reaction##15##4##(1993-3#1)(2008-10#11)(2008-4#1)(2008-5#1)(2011-1#1)
reverse-transcription##16##1##(1993-3#1)(2008-10#11)(2008-4#2)(2008-5#1)(2011-1#1)
reversed a##2##2##(1996-5#1)(1997-5#1)
reversed by NAC##2##3##(2009-9#2)
reversed by the addition of##3##5##(1994-12#1)(2008-7#1)(2008-8#1)
reversed by the##8##3##(1990-7#1)(1991-1#1)(1994-12#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
reversed by##35##2##(1990-5#1)(1990-7#1)(1991-1#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1996-9#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
reversed flow##4##2##(1991-3#2)(1993-3#1)(2008-10#1)
reversed hexagonal##2##2##(1990-12#2)
reversed in the##2##3##(1991-3#1)(2012-3#1)
reversed in##3##2##(1991-3#1)(2008-12#1)(2012-3#1)
reversed micellar##3##2##(1990-5#2)(2008-10#1)
reversed micelles as##3##3##(2008-10#3)
reversed micelles of##2##3##(1995-3#1)(2008-10#1)
reversed micelles##9##2##(1990-5#1)(1995-3#2)(2008-10#5)(2008-6#1)
reversed phase HPLC##2##3##(1991-5#1)(2008-10#1)
reversed phase and##4##3##(2008-10#3)(2011-2#1)
reversed phase chromatography##6##3##(1993-9#1)(1994-11#1)(2008-10#4)
reversed phase columns##2##3##(2008-10#1)(2008-5#1)
reversed phase high performance liquid chromatography##6##6##(1990-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
reversed phase high performance liquid##7##5##(1990-8#1)(2008-10#4)(2008-5#1)(2011-2#1)
reversed phase liquid chromatography (RPLC)##4##5##(2008-10#4)
reversed phase liquid chromatography##11##4##(1990-2#1)(2008-10#10)
reversed phase##42##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(2008-10#29)(2008-5#3)(2010-11#1)(2011-2#2)
reversed polarity##2##2##(2007-12#2)
reversed the effects of##2##4##(1995-11#1)(1997-2#1)
reversed the##21##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#4)(1996-2#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
reversed this##4##2##(1991-2#2)(1992-3#1)(2008-11#1)
reversed to##2##2##(1992-3#1)(2008-10#1)
reversed when##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
reversed with##3##2##(2007-6#1)(2008-1#1)(2011-2#1)
reversed##208##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-5#3)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#9)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-6#2)(2008-1#1)(2008-10#58)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-2#2)(2009-9#3)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-7#2)(2013-8#2)
reversed-phase C18 column##3##3##(2008-10#3)
reversed-phase C18##4##2##(2008-10#4)
reversed-phase HPLC from##2##3##(1993-11#1)(2008-10#1)
reversed-phase HPLC method##3##3##(2008-10#3)
reversed-phase HPLC##33##2##(1990-5#2)(1992-8#1)(1993-11#2)(1993-8#1)(1994-6#1)(1996-12#2)(1996-5#2)(1997-2#3)(2008-10#15)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
reversed-phase chromatographic separation##2##3##(2008-10#2)
reversed-phase chromatographic##3##2##(2008-10#3)
reversed-phase chromatography##3##2##(1995-3#1)(1997-2#1)(2008-10#1)
reversed-phase column and##3##3##(1990-8#1)(1993-11#1)(2013-1#1)
reversed-phase column##10##2##(1990-8#3)(1991-5#1)(1993-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2013-1#1)
reversed-phase columns##5##2##(1992-11#1)(1996-5#1)(2008-10#3)
reversed-phase high performance liquid chromatography##5##5##(2008-10#3)(2008-11#1)(2011-1#1)
reversed-phase high performance liquid##7##4##(2008-10#4)(2008-11#1)(2011-1#2)
reversed-phase high-performance liquid chromatographic (RP-HPLC) method##2##6##(1995-6#1)(2008-10#1)
reversed-phase high-performance liquid chromatographic method##3##5##(1990-8#1)(1991-5#1)(2008-10#1)
reversed-phase high-performance liquid chromatographic##8##4##(1990-8#1)(1991-5#3)(1995-6#1)(1996-5#1)(2008-10#2)
reversed-phase high-performance liquid chromatography (HPLC)##4##5##(1990-8#1)(1992-6#1)(2008-10#2)
reversed-phase high-performance liquid chromatography and##4##5##(1992-6#1)(1993-9#1)(1996-5#1)(2008-10#1)
reversed-phase high-performance liquid chromatography with##7##5##(1990-8#1)(1991-5#2)(1996-5#1)(2008-10#3)
reversed-phase high-performance liquid chromatography##41##4##(1990-8#6)(1991-12#1)(1991-5#7)(1992-6#3)(1993-9#2)(1995-11#1)(1995-6#2)(1996-5#3)(1997-2#2)(2008-10#14)
reversed-phase high-performance liquid##49##3##(1990-8#7)(1991-12#1)(1991-5#10)(1992-6#3)(1993-9#2)(1995-11#1)(1995-6#3)(1996-5#4)(1997-2#2)(2008-10#16)
reversed-phase high-performance##50##2##(1990-8#7)(1991-12#1)(1991-5#10)(1992-6#3)(1993-9#2)(1995-11#1)(1995-6#3)(1996-5#4)(1997-2#2)(2008-10#17)
reversed-phase ion-pair HPLC##2##3##(2008-10#2)
reversed-phase ion-pair##4##2##(2008-10#4)
reversed-phase liquid chromatographic separation of##2##5##(2008-10#2)
reversed-phase liquid chromatography (HPLC)##2##4##(2008-10#1)(2008-5#1)
reversed-phase liquid chromatography##9##3##(1996-5#1)(2008-10#6)(2008-5#2)
reversed-phase liquid##11##2##(1996-5#1)(2008-10#8)(2008-5#2)
reversed-phase mode##2##2##(1996-5#1)(2008-10#1)
reversed-phase packing##3##2##(1991-5#1)(2008-10#2)
reversed-phase silica##2##2##(1990-8#1)(1996-5#1)
reversed-phase##161##1##(1990-5#2)(1990-8#14)(1991-12#1)(1991-5#12)(1992-11#2)(1992-6#3)(1992-8#1)(1993-11#3)(1993-8#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-3#2)(1995-6#3)(1996-12#2)(1996-5#13)(1997-2#8)(1997-4#1)(2008-10#78)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
reverses the##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
reverses##8##1##(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
reversibility and##4##2##(2008-10#3)(2011-2#1)
reversibility in##5##2##(1995-3#1)(2007-2#4)
reversibility of the##7##3##(2008-10#7)
reversibility of##18##2##(1992-10#1)(1993-6#1)(2007-2#2)(2008-10#10)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)
reversibility##42##1##(1992-10#1)(1992-5#1)(1993-6#1)(1995-3#1)(1996-11#1)(2007-2#6)(2008-1#2)(2008-10#19)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#4)
reversible addition fragmentation chain transfer (RAFT)##2##6##(2008-12#1)(2009-10#1)
reversible after##3##2##(1991-11#1)(1991-3#1)(1993-12#1)
reversible airway obstruction##2##3##(1992-3#1)(2008-10#1)
reversible and progressive brain injury##2##5##(2009-10#2)
reversible and reproducible##2##3##(1990-7#1)(2008-10#1)
reversible and the##2##3##(2008-10#2)
reversible and##21##2##(1990-12#1)(1990-7#1)(1990-8#1)(1992-12#1)(1992-3#1)(1994-9#1)(1996-5#1)(1996-9#1)(1997-2#1)(2008-10#7)(2008-7#1)(2008-8#1)(2009-10#2)(2011-2#1)
reversible binding of##2##3##(1990-8#1)(1994-6#1)
reversible binding##3##2##(1990-8#1)(1994-6#1)(2009-7#1)
reversible biotinylation##2##2##(2008-4#2)
reversible by##2##2##(1991-2#1)(2008-1#1)
reversible cause##2##2##(2008-1#1)(2012-12#1)
reversible changes in the##2##4##(2008-3#2)
reversible changes in##3##3##(1996-6#1)(2008-3#2)
reversible changes##4##2##(1993-6#1)(1996-6#1)(2008-3#2)
reversible chemical##2##2##(1993-6#1)(2008-10#1)
reversible decrease##2##2##(2008-11#1)(2008-8#1)
reversible electroporation##3##2##(2009-11#3)
reversible encephalopathy syndrome##4##3##(2010-12#1)(2012-12#2)(2013-1#1)
reversible forebrain ischemia##2##3##(1991-5#2)
reversible in the##2##3##(1992-5#1)(2008-10#1)
reversible in##5##2##(1992-5#1)(1996-5#1)(2008-1#1)(2008-10#2)
reversible increase in##3##3##(1992-3#1)(1996-3#1)(2008-3#1)
reversible increase##4##2##(1992-3#2)(1996-3#1)(2008-3#1)
reversible inhibitor##2##2##(1990-11#1)(1994-8#1)
reversible inhibitors##3##2##(1990-5#2)(2010-9#1)
reversible interconversion between the high##2##5##(2008-10#2)
reversible manner##2##2##(1995-12#1)(2007-11#1)
reversible nature##2##2##(1990-2#1)(2008-10#1)
reversible or##2##2##(2011-2#1)(2012-3#1)
reversible phosphorylation of##3##3##(1995-6#1)(2009-5#2)
reversible redox##4##2##(2008-10#4)
reversible reduction##2##2##(1990-5#1)(2008-10#1)
reversible sensing##2##2##(2008-10#2)
reversible waves##3##2##(2009-9#3)
reversible with##4##2##(1996-5#1)(2009-5#1)(2010-5#1)(2013-7#1)
reversible within##2##2##(1996-11#1)(2008-10#1)
reversible##257##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#6)(1990-7#4)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#10)(1992-5#1)(1992-6#3)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#7)(1993-8#1)(1994-11#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-7#1)(2007-10#2)(2007-11#4)(2007-12#3)(2008-1#3)(2008-10#50)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#1)(2009-10#4)(2009-11#4)(2009-12#1)(2009-5#3)(2009-7#1)(2009-9#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#1)
reversibly in##2##2##(1994-6#1)(2008-10#1)
reversibly inhibited by##2##3##(1990-11#1)(1991-12#1)
reversibly inhibited##3##2##(1990-11#1)(1991-12#1)(1995-5#1)
reversibly##32##1##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-11#2)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
reversing the##11##2##(1992-12#1)(1993-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#2)(2012-3#1)
reversing##21##1##(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1995-6#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
reversion##11##1##(1992-3#1)(1994-8#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
revert to the##2##3##(2008-10#1)(2009-3#1)
revert to##3##2##(2008-10#2)(2009-3#1)
revert##8##1##(1994-8#2)(2008-10#3)(2008-9#1)(2009-3#1)(2012-2#1)
revertant cell lines##3##3##(1992-9#3)
revertant clone R1-5##2##3##(1995-11#2)
revertant clone##3##2##(1995-11#3)
revertant##13##1##(1992-9#3)(1995-11#6)(1995-5#4)
revertants was##2##2##(1995-11#1)(1995-5#1)
revertants##14##1##(1992-2#1)(1992-3#1)(1995-11#2)(1995-5#2)(1995-6#5)(2008-10#2)(2008-9#1)
reverted by##3##2##(1997-1#1)(2009-9#1)(2012-3#1)
reverted to normal##2##3##(1990-7#1)(1994-12#1)
reverted to##4##2##(1990-7#1)(1994-12#1)(2008-10#1)(2012-1#1)
reverted##11##1##(1990-7#1)(1992-12#1)(1994-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-9#1)(2012-1#2)(2012-3#1)
review a##7##2##(1997-3#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
review about the##2##3##(1990-10#1)(2008-12#1)
review about##3##2##(1990-10#1)(2008-12#1)(2012-3#1)
review addresses the##5##3##(2008-6#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
review addresses##11##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-11#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
review aims to summarise##2##4##(2008-9#1)(2011-1#1)
review aims to##8##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
review aims##11##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
review also##3##2##(2008-8#1)(2009-10#1)(2010-10#1)
review and a new##2##4##(1993-12#1)(2008-4#1)
review and a##3##3##(1992-1#1)(1993-12#1)(2008-4#1)
review and case##2##3##(1992-12#1)(2008-11#1)
review and evaluate##2##3##(2012-12#1)(2013-8#1)
review and meta-analysis##5##3##(2009-11#1)(2009-2#1)(2010-10#1)(2012-3#1)(2013-8#1)
review and update##3##3##(2008-8#1)(2012-3#1)(2013-1#1)
review and##61##2##(1991-1#1)(1992-1#2)(1992-12#3)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#4)(2013-8#4)
review are##9##2##(1990-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-5#1)(2012-2#1)
review article focuses on the##3##5##(2010-12#1)(2010-7#1)(2012-12#1)
review article is to##3##4##(2007-4#1)(2008-3#1)(2010-6#1)
review article is##5##3##(2007-4#1)(2008-3#1)(2010-6#1)(2012-2#2)
review article summarizes the##3##4##(1993-12#1)(2007-10#1)(2011-2#1)
review article summarizes##4##3##(1993-12#1)(2007-10#1)(2008-10#1)(2011-2#1)
review article##35##2##(1993-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
review assesses the##2##3##(2009-10#1)(2010-5#1)
review assesses##4##2##(2008-10#1)(2008-4#1)(2009-10#1)(2010-5#1)
review based on##3##3##(1995-12#1)(2008-10#1)(2009-10#1)
review basic##3##2##(1993-12#1)(2012-3#1)(2013-1#1)
review briefly##5##2##(2008-1#1)(2008-3#1)(2009-1#1)(2009-11#1)(2009-5#1)
review by the##4##3##(1993-6#1)(1995-6#1)(2010-3#1)(2012-12#1)
review by##8##2##(1993-6#1)(1995-6#2)(1996-3#1)(1997-3#1)(2007-8#1)(2010-3#1)(2012-12#1)
review can##2##2##(1990-11#1)(2008-11#1)
review clinical##2##2##(1991-2#1)(2009-8#1)
review comparing##4##2##(2008-7#1)(2012-12#2)(2013-1#1)
review concerning##2##2##(2007-11#1)(2009-5#1)
review concludes that##2##3##(2008-11#1)(2010-8#1)
review concludes##5##2##(2008-11#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#1)
review covers the##5##3##(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
review covers##11##2##(2007-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-12#1)
review current knowledge##4##3##(2007-12#1)(2008-7#1)(2008-8#1)(2010-3#1)
review current methods##2##3##(2008-11#1)(2013-1#1)
review current##9##2##(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#2)
review data##3##2##(1991-2#1)(2008-10#1)(2009-10#1)
review deals with the##5##4##(1994-11#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
review deals with##9##3##(1994-11#1)(1994-2#1)(2008-1#2)(2008-10#4)(2008-11#1)
review deals##10##2##(1994-11#1)(1994-2#1)(2008-1#2)(2008-10#5)(2008-11#1)
review demonstrates the##2##3##(1997-6#1)(2008-8#1)
review demonstrates##3##2##(1997-6#1)(2008-8#1)(2010-11#1)
review describes the##14##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
review describes##30##2##(1991-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-7#1)(2013-8#2)
review different##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
review discusses some of the##3##5##(2008-8#1)(2009-5#1)(2011-2#1)
review discusses the potential##2##4##(1997-2#1)(2008-8#1)
review discusses the##18##3##(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
review discusses##37##2##(1993-3#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#4)(2013-8#1)
review does not##2##3##(2008-8#1)(2010-1#1)
review evidence##4##2##(2007-8#1)(2008-11#1)(2008-4#1)(2013-8#1)
review examined the##3##3##(1994-2#1)(2007-12#1)(2013-1#1)
review examines the##6##3##(2008-7#2)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
review examines##10##2##(2008-10#1)(2008-7#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
review existing##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
review experimental##2##2##(2008-2#1)(2009-12#1)
review explores the##5##3##(2008-10#1)(2008-11#2)(2012-12#1)(2012-3#1)
review explores##9##2##(2008-10#1)(2008-11#3)(2009-3#1)(2009-5#1)(2009-9#1)(2012-12#1)(2012-3#1)
review focuses on recent##3##4##(1990-6#1)(2008-10#1)(2008-7#1)
review focuses on the effects of##2##6##(2008-5#1)(2012-2#1)
review focuses on the recent advances##2##6##(2012-2#1)(2012-3#1)
review focuses on the recent##4##5##(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
review focuses on the role##2##5##(2012-12#1)(2012-2#1)
review focuses on the##35##4##(1991-7#1)(1994-1#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#2)(2009-10#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)
review focuses on##49##3##(1990-6#1)(1991-7#1)(1994-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#4)(2009-10#1)(2009-11#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#1)
review focuses upon##2##3##(1997-2#1)(2008-7#1)
review focuses##57##2##(1990-6#1)(1991-7#1)(1994-1#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#6)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#1)(2013-8#1)
review for##3##2##(1992-1#1)(2007-12#1)(2008-9#1)
review found##2##2##(2008-8#1)(2013-1#1)
review from##4##2##(2008-1#2)(2008-10#1)(2012-3#1)
review gives##5##2##(2008-10#1)(2010-11#2)(2011-1#1)(2012-2#1)
review has been##4##3##(2006-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
review has##6##2##(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)
review here the##3##3##(2008-11#1)(2009-12#1)(2012-12#1)
review here##5##2##(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#1)(2013-8#1)
review highlights the##7##3##(1995-8#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
review highlights##13##2##(1995-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
review how##5##2##(2008-8#2)(2010-12#1)(2012-3#1)(2013-8#1)
review human studies##2##3##(2011-1#1)(2012-2#1)
review in##8##2##(1992-1#1)(1997-3#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
review includes##3##2##(1997-4#1)(2008-11#1)(2008-7#1)
review indicate that##2##3##(2012-12#1)(2012-2#1)
review is a##2##3##(1992-1#1)(1994-3#1)
review is aimed at##3##4##(2008-1#1)(2009-3#1)(2012-2#1)
review is an##2##3##(2008-10#1)(2012-3#1)
review is focused on##7##4##(1992-6#1)(2007-7#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
review is given of##2##4##(1992-6#1)(2006-4#1)
review is given##3##3##(1990-10#1)(1992-6#1)(2006-4#1)
review is not to##2##4##(2008-7#1)(2010-7#1)
review is not##3##3##(1993-1#1)(2008-7#1)(2010-7#1)
review is to describe the##2##5##(2008-1#1)(2012-2#1)
review is to describe##3##4##(2008-1#1)(2010-11#1)(2012-2#1)
review is to discuss the##5##5##(2007-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
review is to evaluate the##4##5##(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#1)
review is to evaluate##5##4##(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#1)
review is to identify##2##4##(2010-12#1)(2013-1#1)
review is to summarize##2##4##(2008-10#1)(2010-1#1)
review is to##43##3##(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-3#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
review is##87##2##(1990-10#1)(1992-1#2)(1992-6#2)(1993-1#1)(1994-3#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#3)(2011-3#2)(2012-1#2)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#2)
review it##2##2##(2008-10#1)(2013-1#1)
review its##4##2##(1990-12#1)(1992-12#1)(2008-11#1)(2011-2#1)
review literature##2##2##(1997-2#1)(2009-9#1)
review looks##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
review makes##2##2##(2008-10#1)(2010-7#1)
review may##2##2##(1992-8#1)(2013-1#1)
review of 1##2##3##(1997-8#1)(2012-2#1)
review of 30##2##3##(1991-12#1)(2010-9#1)
review of 42 patients##2##4##(2008-6#1)(2010-5#1)
review of 42##3##3##(2008-6#1)(2008-7#1)(2010-5#1)
review of Canadian##2##3##(2008-11#1)(2008-7#1)
review of a rare##2##4##(2010-5#1)(2013-8#1)
review of a##8##3##(1990-12#1)(1992-12#1)(2008-11#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
review of all##4##3##(2007-10#1)(2008-9#1)(2012-2#2)
review of available##2##3##(2008-12#1)(2009-5#1)
review of both##2##3##(2010-8#1)(2011-7#1)
review of cell##2##3##(2008-10#2)
review of clinical##7##3##(1994-3#1)(1995-9#1)(1997-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)
review of current##9##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
review of data##2##3##(2008-1#1)(2013-1#1)
review of evidence##3##3##(1997-8#1)(2008-8#1)(2011-2#1)
review of health##2##3##(2010-10#1)(2012-12#1)
review of its##2##3##(1992-12#1)(2012-12#1)
review of literature and##3##4##(2008-11#1)(2008-7#1)(2010-7#1)
review of literature is presented##2##5##(2010-11#1)(2010-8#1)
review of literature##43##3##(1990-10#1)(1992-5#1)(1993-6#1)(1993-9#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)
review of literature]##5##3##(1996-8#1)(2009-5#1)(2009-9#1)(2012-3#2)
review of medical##3##3##(1996-3#1)(2009-5#1)(2013-8#1)
review of methods##2##3##(2007-8#1)(2013-1#1)
review of outcome measures##2##4##(2007-11#2)
review of patient##3##3##(2008-12#1)(2010-2#1)(2013-1#1)
review of pertinent literature##2##4##(2006-10#1)(2008-2#1)
review of problems##2##3##(2008-10#1)(2012-12#1)
review of published literature##2##4##(2008-9#1)(2012-3#1)
review of published reports##2##4##(1995-9#1)(2012-12#1)
review of published##8##3##(1995-9#2)(2008-10#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
review of recent publications##2##4##(1993-3#1)(2006-7#1)
review of recent##5##3##(1993-3#1)(1996-1#1)(2006-7#1)(2008-11#1)(2012-12#1)
review of relevant##3##3##(2007-7#1)(2008-11#1)(2009-2#1)
review of research##2##3##(1992-3#1)(2008-10#1)
review of state##2##3##(2007-10#1)(2008-11#1)
review of statistical##2##3##(1995-1#1)(1997-6#1)
review of studies##3##3##(1992-3#1)(2008-3#1)(2011-1#1)
review of the English##2##4##(2009-5#1)(2011-2#1)
review of the English-language literature was undertaken##2##7##(2012-12#2)
review of the English-language literature##3##5##(2007-10#1)(2012-12#2)
review of the association##2##4##(2006-10#1)(2010-1#1)
review of the available##3##4##(1996-1#1)(2008-3#1)(2008-8#1)
review of the current literature on##2##6##(2011-2#2)
review of the current literature##7##5##(2007-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
review of the current##14##4##(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)
review of the development of##3##5##(2008-10#1)(2009-11#1)(2010-12#1)
review of the effectiveness of##2##5##(2013-1#2)
review of the effects##2##4##(2008-11#1)(2011-2#1)
review of the empirical##2##4##(2007-12#1)(2008-2#1)
review of the evidence##5##4##(1996-12#1)(2008-6#1)(2009-4#1)(2013-1#1)(2013-8#1)
review of the last##2##4##(2008-4#1)(2010-12#1)
review of the literature and##14##5##(1990-3#1)(1991-1#1)(1991-3#1)(1995-3#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
review of the literature as well as##2##7##(1996-12#1)(2008-1#1)
review of the literature concerning the##2##6##(2010-9#1)(2011-2#1)
review of the literature concerning##3##5##(2008-8#1)(2010-9#1)(2011-2#1)
review of the literature is given##2##6##(1991-3#1)(1996-9#1)
review of the literature is presented##2##6##(1990-3#1)(2010-12#1)
review of the literature is##8##5##(1990-3#1)(1991-3#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-12#1)
review of the literature of##4##5##(2008-6#1)(2008-9#1)(2012-3#2)
review of the literature on the##5##6##(1996-12#1)(2008-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
review of the literature on this##3##6##(1993-6#1)(2008-5#1)(2010-8#1)
review of the literature on##15##5##(1993-6#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
review of the literature pertaining##2##5##(1993-1#1)(2008-8#1)
review of the literature published##2##5##(2009-8#1)(2010-8#1)
review of the literature regarding##3##5##(2009-3#1)(2013-1#1)(2013-8#1)
review of the literature revealed only##2##6##(1995-1#1)(2008-12#1)
review of the literature revealed##3##5##(1995-1#1)(2006-10#1)(2008-12#1)
review of the literature shows that##4##6##(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
review of the literature suggests that##3##6##(2008-11#2)(2009-3#1)
review of the literature was undertaken to##2##7##(2008-7#1)(2012-2#1)
review of the literature was undertaken##3##6##(2008-7#1)(2012-12#1)(2012-2#1)
review of the literature was##5##5##(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)
review of the literature with##2##5##(2008-10#1)(2009-3#1)
review of the literature##196##4##(1990-3#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#2)(1992-5#2)(1992-6#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#5)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#10)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#6)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#18)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#18)(2013-7#1)(2013-8#3)
review of the literature]##18##4##(1990-5#1)(1990-6#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-2#1)(1997-3#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-1#2)
review of the main##2##4##(2008-10#2)
review of the medical literature##2##5##(1992-12#1)(2012-3#1)
review of the medical##3##4##(1992-12#1)(2008-9#1)(2012-3#1)
review of the most recent##2##5##(1991-2#1)(2008-11#1)
review of the past##2##4##(2008-7#1)(2010-3#1)
review of the protocols by##2##5##(2008-10#2)
review of the recent literature##2##5##(1990-6#1)(2011-2#1)
review of the recent##3##4##(1990-6#1)(1994-3#1)(2011-2#1)
review of the relevant##6##4##(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
review of the results##2##4##(1993-1#1)(2008-4#1)
review of the use of##3##5##(2008-10#2)(2010-8#1)
review of the##361##3##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#1)(1994-3#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#3)(2006-12#3)(2006-5#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#6)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#36)(2008-11#17)(2008-12#11)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#5)(2008-7#13)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#3)(2009-3#6)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#6)(2010-3#5)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#2)(2011-2#27)(2011-3#1)(2011-7#1)(2012-12#6)(2012-2#14)(2012-3#8)(2013-1#29)(2013-7#1)(2013-8#5)
review of their##3##3##(1993-2#1)(2008-11#1)(2009-4#1)
review of these##4##3##(1995-3#1)(2008-10#1)(2008-12#1)(2010-5#1)
review of this##3##3##(2008-10#2)(2011-2#1)
review of treatment##2##3##(2008-10#1)(2009-3#1)
review of two patients##2##4##(2008-10#1)(2012-12#1)
review of two##5##3##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
review of##700##2##(1990-10#1)(1990-12#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-3#4)(1992-5#4)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#6)(1993-8#1)(1993-9#2)(1994-1#1)(1994-2#2)(1994-3#5)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#3)(1996-1#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#5)(2006-12#6)(2006-5#2)(2006-7#1)(2007-10#6)(2007-11#11)(2007-12#10)(2007-2#8)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#13)(2008-10#58)(2008-11#34)(2008-12#17)(2008-2#6)(2008-3#8)(2008-4#14)(2008-5#5)(2008-6#8)(2008-7#27)(2008-8#22)(2008-9#13)(2009-10#1)(2009-11#5)(2009-2#1)(2009-3#9)(2009-4#5)(2009-5#13)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#7)(2010-2#2)(2010-3#5)(2010-5#6)(2010-6#5)(2010-7#2)(2010-8#14)(2010-9#4)(2011-1#8)(2011-2#44)(2011-3#1)(2011-7#2)(2012-1#5)(2012-12#24)(2012-2#24)(2012-3#17)(2013-1#52)(2013-7#2)(2013-8#12)
review offers##2##2##(2010-11#1)(2010-8#1)
review on the##11##3##(1996-7#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
review on##24##2##(1991-3#1)(1995-6#1)(1996-7#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
review organizations##5##2##(1991-3#2)(1993-2#1)(1995-1#1)(1995-12#1)
review our##7##2##(1997-4#1)(2008-1#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
review outlines##8##2##(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2012-1#1)(2012-3#1)
review practices##2##2##(1992-12#2)
review presents the##5##3##(1995-11#1)(2008-10#1)(2011-2#1)(2011-7#1)(2012-12#1)
review presents##13##2##(1995-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)
review process to##3##3##(1993-1#1)(1995-12#1)(2008-8#1)
review process##15##2##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#4)(1993-2#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-3#1)
review provides a##7##3##(2008-10#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-12#1)
review provides examples##2##3##(2008-11#1)(2008-7#1)
review provides##23##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
review recent advances in##2##4##(2008-8#1)(2010-11#1)
review recent developments in##2##4##(1996-9#1)(2008-1#1)
review recent literature##2##3##(2008-10#1)(2011-1#1)
review recent progress in##2##4##(2008-11#1)(2010-12#1)
review recent##18##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
review reports##2##2##(2008-10#1)(2013-1#1)
review revealed##4##2##(2007-10#1)(2007-12#1)(2007-2#1)(2008-6#1)
review reveals that##2##3##(2008-1#1)(2008-8#1)
review serves##3##2##(1997-4#1)(2010-6#1)(2011-2#1)
review several##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
review showed that##2##3##(2007-11#1)(2009-7#1)
review showed##3##2##(2007-11#1)(2009-7#1)(2013-1#1)
review shows that##2##3##(2010-7#1)(2013-8#1)
review shows##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
review some of the##8##4##(1993-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)
review some##13##2##(1990-12#1)(1993-12#1)(1994-8#2)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)
review studies##3##2##(2008-7#1)(2012-2#1)(2013-7#1)
review suggests that##4##3##(1995-1#1)(2006-10#1)(2010-6#1)(2013-8#1)
review summarizes available data##2##4##(2008-4#1)(2013-8#1)
review summarizes our current knowledge##2##5##(2008-1#1)(2010-8#1)
review summarizes our current##3##4##(2008-1#1)(2008-11#1)(2010-8#1)
review summarizes recent advances in##2##5##(2007-7#1)(2008-1#1)
review summarizes recent##4##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)
review summarizes the current##5##4##(2008-11#1)(2008-4#1)(2008-7#2)(2012-3#1)
review summarizes the##25##3##(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#2)(2011-9#1)(2012-12#3)(2012-3#1)(2013-8#1)
review summarizes##47##2##(2006-10#2)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#2)
review that##2##2##(2008-10#1)(2008-6#1)
review the application of##2##4##(2010-8#1)(2011-2#1)
review the available evidence##2##4##(2008-7#1)(2011-2#1)
review the available##3##3##(2008-7#2)(2011-2#1)
review the clinical##4##3##(2007-12#1)(2008-9#1)(2010-12#1)(2013-2#1)
review the current state of knowledge##3##6##(2007-11#1)(2008-11#1)(2010-3#1)
review the current state of##4##5##(2007-11#1)(2008-11#1)(2010-3#1)(2010-9#1)
review the current status of##4##5##(2008-10#1)(2010-12#1)(2010-4#1)(2013-1#1)
review the current##19##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2013-1#2)
review the development of##4##4##(1996-6#1)(2008-11#1)(2008-7#1)(2009-11#1)
review the development##5##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
review the epidemiology##3##3##(2007-2#1)(2010-8#1)(2011-2#1)
review the evidence for##2##4##(2007-10#1)(2008-7#1)
review the evidence that##3##4##(1994-11#1)(2008-7#1)(2009-11#1)
review the evidence##11##3##(1994-11#1)(2007-10#1)(2007-12#1)(2008-7#3)(2008-8#2)(2009-11#1)(2010-2#1)(2010-5#1)
review the evolution of##2##4##(1996-2#1)(2010-3#1)
review the evolution##3##3##(1996-2#1)(2010-3#1)(2011-2#1)
review the existing##2##3##(2010-8#1)(2011-2#1)
review the history of##2##4##(2008-1#1)(2010-8#1)
review the history##4##3##(1997-1#1)(2008-1#1)(2010-8#1)(2012-2#1)
review the impact##2##3##(2008-10#1)(2008-7#1)
review the latest##2##3##(2008-10#1)(2009-12#1)
review the literature and##3##4##(1993-5#1)(2007-10#1)(2008-6#1)
review the literature of##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
review the literature on the##5##5##(2009-1#1)(2010-3#1)(2011-2#2)(2012-2#1)
review the literature on##12##4##(1990-2#1)(2007-8#1)(2009-1#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)
review the literature##26##3##(1990-2#1)(1993-5#1)(1996-9#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-6#3)(2008-7#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)
review the main##7##3##(1992-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#2)(2011-2#1)
review the medical##2##3##(1991-12#1)(2008-6#1)
review the most common##2##4##(2009-12#1)(2010-7#1)
review the most important##2##4##(2008-10#1)(2008-6#1)
review the most##6##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-7#1)(2012-3#1)
review the pathogenesis of##4##4##(1993-2#1)(1993-9#1)(2007-10#1)(2009-1#1)
review the pathophysiology of##2##4##(2008-11#1)(2012-3#1)
review the possible##3##3##(2008-7#2)(2008-8#1)
review the practice of##2##4##(2010-12#1)(2011-1#1)
review the published##4##3##(1995-2#1)(2008-12#1)(2008-3#1)(2009-7#1)
review the recent##6##3##(2007-7#1)(2008-3#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-1#1)
review the relevant literature##2##4##(1994-12#1)(2013-1#1)
review the relevant##3##3##(1994-12#1)(2009-7#1)(2013-1#1)
review the results of##5##4##(1990-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)
review the results##6##3##(1990-2#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)
review the risk##2##3##(2007-12#1)(2012-2#1)
review the role of##4##4##(2007-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
review the state of the art##2##6##(1993-3#1)(2008-5#1)
review the use of##2##4##(2008-10#1)(2008-7#1)
review the use##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
review the##253##2##(1990-2#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-11#1)(1995-2#2)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-3#1)(2006-7#1)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#5)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#16)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#7)(2008-7#18)(2008-8#5)(2008-9#3)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#4)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#10)(2011-2#16)(2011-7#1)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#11)(2013-2#1)(2013-8#4)
review their##4##2##(1994-3#1)(2006-12#1)(2007-11#1)(2009-7#1)
review these issues and##2##4##(2008-11#1)(2008-7#1)
review these##6##2##(1995-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-4#1)
review this##5##2##(1994-3#1)(2008-10#1)(2009-5#1)(2013-1#2)
review to##7##2##(1992-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#2)
review using##3##2##(1993-1#1)(2009-6#1)(2013-8#1)
review various aspects of##2##4##(1996-11#1)(2008-7#1)
review was conducted##5##3##(2007-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
review was made of##3##4##(1996-1#1)(2012-12#1)(2013-1#1)
review was made##4##3##(1996-1#1)(2012-12#2)(2013-1#1)
review was performed of##4##4##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
review was performed on##2##4##(2009-10#1)(2013-1#1)
review was performed to##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
review was performed##10##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
review was to determine whether##2##5##(1996-6#1)(2012-3#1)
review was to##11##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-6#1)(2012-3#2)(2013-1#3)
review was##41##2##(1995-6#1)(1996-1#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#5)(2012-3#4)(2013-1#9)(2013-8#1)
review we aim to##3##4##(2008-7#2)(2013-1#1)
review we discuss evidence##2##4##(1992-2#1)(2008-4#1)
review we discuss##7##3##(1992-2#1)(2007-12#1)(2007-5#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
review we have##2##3##(2008-1#1)(2010-8#1)
review we provide an##2##4##(2008-7#1)(2012-2#1)
review we provide##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
review we##52##2##(1992-2#1)(1992-5#1)(1996-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#10)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
review were##3##2##(2009-1#1)(2011-2#1)(2013-1#1)
review what is##2##3##(2008-3#1)(2008-7#1)
review will address the##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
review will address##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
review will also##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
review will discuss the##7##4##(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
review will discuss##13##3##(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
review will examine##5##3##(2008-10#1)(2008-5#1)(2009-4#1)(2009-6#1)(2012-2#1)
review will focus on##21##4##(1994-3#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#1)(2009-12#1)(2010-8#2)(2012-12#1)(2012-2#1)
review will identify the##2##4##(2008-2#1)(2009-5#1)
review will provide a##3##4##(2008-11#1)(2009-12#1)(2009-5#1)
review will provide##4##3##(2008-11#1)(2009-12#1)(2009-4#1)(2009-5#1)
review will summarize##6##3##(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
review will##77##2##(1994-3#1)(2007-7#1)(2008-1#5)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
review with a##2##3##(2008-7#1)(2010-8#1)
review with##7##2##(1995-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
review##2657##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#4)(1990-9#3)(1991-1#12)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#7)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#14)(1992-10#2)(1992-12#16)(1992-2#7)(1992-3#6)(1992-5#7)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#11)(1993-12#12)(1993-2#13)(1993-3#8)(1993-5#3)(1993-6#8)(1993-8#1)(1993-9#3)(1994-1#4)(1994-11#4)(1994-12#3)(1994-2#7)(1994-3#13)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#9)(1995-11#5)(1995-12#7)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#9)(1995-8#5)(1995-9#3)(1996-1#5)(1996-11#3)(1996-12#6)(1996-2#9)(1996-3#4)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#7)(1997-1#4)(1997-2#13)(1997-3#12)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2006-10#13)(2006-12#8)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2007-10#20)(2007-11#31)(2007-12#28)(2007-2#17)(2007-4#4)(2007-5#8)(2007-6#2)(2007-7#17)(2007-8#14)(2007-9#1)(2008-1#55)(2008-10#204)(2008-11#138)(2008-12#47)(2008-2#24)(2008-3#39)(2008-4#49)(2008-5#51)(2008-6#40)(2008-7#159)(2008-8#77)(2008-9#38)(2009-1#9)(2009-10#15)(2009-11#18)(2009-12#17)(2009-2#6)(2009-3#18)(2009-4#18)(2009-5#38)(2009-6#14)(2009-7#12)(2009-8#16)(2009-9#14)(2010-1#10)(2010-10#16)(2010-11#26)(2010-12#34)(2010-2#4)(2010-3#18)(2010-4#5)(2010-5#26)(2010-6#19)(2010-7#25)(2010-8#36)(2010-9#14)(2011-1#53)(2011-10#1)(2011-2#164)(2011-3#9)(2011-7#7)(2011-9#1)(2012-1#22)(2012-12#102)(2012-2#113)(2012-3#75)(2013-1#147)(2013-2#1)(2013-7#5)(2013-8#73)
review)##4##1##(1994-12#1)(1995-11#1)(2009-10#1)(2012-12#1)
review]##22##1##(1990-12#1)(1991-3#1)(1992-11#1)(1993-8#1)(1996-9#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#6)(2013-1#3)(2013-8#1)
reviewed a##5##2##(1992-1#1)(1992-12#1)(2006-12#1)(2008-12#1)(2011-2#1)
reviewed after##3##2##(1994-2#1)(2009-3#1)(2013-8#1)
reviewed all##3##2##(1994-2#1)(1996-11#1)(2006-10#1)
reviewed and discussed in##3##4##(1994-11#1)(2008-7#2)
reviewed and the##8##3##(1991-6#1)(1993-3#1)(1993-8#1)(2006-8#1)(2008-5#1)(2008-7#2)(2010-8#1)
reviewed and##37##2##(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-12#1)(1996-3#2)(1997-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
reviewed as##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)
reviewed by##7##2##(1992-8#1)(1996-1#1)(2007-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
reviewed cases##2##2##(2008-1#1)(2008-10#1)
reviewed clinical##3##2##(2009-8#1)(2012-3#1)(2013-8#1)
reviewed existing##2##2##(2008-1#1)(2008-12#1)
reviewed for a##2##3##(2008-8#1)(2008-9#1)
reviewed for the##3##3##(1996-11#1)(2011-2#1)(2012-3#1)
reviewed for##14##2##(1995-12#1)(1996-11#1)(1996-3#1)(2007-7#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)
reviewed from the literature##2##4##(1991-12#1)(2008-7#1)
reviewed from the##4##3##(1991-12#1)(1991-8#1)(2007-10#1)(2008-7#1)
reviewed from##10##2##(1991-12#1)(1991-8#1)(1995-6#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2013-1#2)
reviewed here##12##2##(1990-8#1)(1994-12#1)(2006-12#1)(2008-10#2)(2008-4#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
reviewed herein##3##2##(2008-4#1)(2008-7#1)(2009-5#1)
reviewed in terms of##3##4##(1991-2#1)(2008-10#2)
reviewed in the##3##3##(1990-12#1)(1997-6#1)(2012-12#1)
reviewed in this article##6##4##(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-2#1)
reviewed in this paper##2##4##(1993-12#1)(2012-1#1)
reviewed in this##9##3##(1993-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-1#1)(2012-2#1)
reviewed in##23##2##(1990-12#1)(1991-2#1)(1992-1#1)(1993-12#1)(1994-2#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#2)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
reviewed literature##3##2##(2007-7#1)(2008-7#1)(2010-11#1)
reviewed on##2##2##(2008-11#1)(2008-8#1)
reviewed other##2##2##(2008-6#1)(2010-3#1)
reviewed our data##2##3##(1994-12#1)(2007-7#1)
reviewed our##5##2##(1994-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2012-3#1)
reviewed retrospectively##4##2##(1991-2#1)(1993-8#1)(2007-8#2)
reviewed that##3##2##(1996-12#1)(2008-10#1)(2010-10#1)
reviewed the current##2##3##(1995-12#1)(2012-2#1)
reviewed the literature on##2##4##(2007-11#1)(2013-1#1)
reviewed the literature##10##3##(1996-6#1)(2007-11#1)(2008-5#1)(2008-8#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
reviewed the medical records of##5##5##(1990-2#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
reviewed the medical records##6##4##(1990-2#1)(2008-1#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
reviewed the medical##7##3##(1990-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
reviewed the records of the##2##5##(2008-1#2)
reviewed the records of##3##4##(2008-1#2)(2011-2#1)
reviewed the records##4##3##(2008-1#3)(2011-2#1)
reviewed the##62##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-9#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-6#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
reviewed to##9##2##(1991-3#1)(1993-1#1)(2007-7#1)(2010-6#2)(2011-2#1)(2012-2#2)(2012-3#1)
reviewed together with the##2##4##(1996-1#1)(2009-5#1)
reviewed under##2##2##(1994-11#1)(2007-7#1)
reviewed using##3##2##(2007-10#1)(2012-12#2)
reviewed were##3##2##(1997-2#1)(2007-12#1)(2013-1#1)
reviewed which##3##2##(1993-12#1)(2008-8#2)
reviewed with emphasis on the##2##5##(2008-10#2)
reviewed with emphasis on##3##4##(2008-10#2)(2008-2#1)
reviewed with special emphasis on##2##5##(1991-3#1)(2008-7#1)
reviewed with##11##2##(1990-3#1)(1991-3#1)(1996-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
reviewed##604##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#5)(1994-11#3)(1994-12#3)(1994-2#6)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#3)(2006-10#3)(2006-12#3)(2006-7#1)(2006-8#1)(2007-10#8)(2007-11#9)(2007-12#11)(2007-2#3)(2007-4#1)(2007-7#7)(2007-8#15)(2008-1#15)(2008-10#43)(2008-11#20)(2008-12#10)(2008-2#8)(2008-3#13)(2008-4#19)(2008-5#13)(2008-6#9)(2008-7#34)(2008-8#25)(2008-9#7)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#9)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#5)(2010-9#6)(2011-1#14)(2011-2#28)(2011-3#2)(2012-1#2)(2012-12#12)(2012-2#20)(2012-3#17)(2013-1#24)(2013-7#1)(2013-8#12)
reviewer##6##1##(1993-12#1)(1995-12#1)(2008-11#1)(2008-8#2)(2012-3#1)
reviewers assessed##4##2##(2008-10#1)(2012-12#3)
reviewers##28##1##(1993-12#2)(1997-8#1)(2007-11#1)(2008-10#9)(2008-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#6)(2013-1#3)
reviewing and##3##2##(2010-4#1)(2012-3#1)(2013-8#1)
reviewing current##2##2##(2008-10#1)(2010-8#1)
reviewing research##3##2##(1993-12#1)(2009-4#1)(2009-8#1)
reviewing the results of##2##4##(1996-12#1)(2008-6#1)
reviewing the results##3##3##(1995-3#1)(1996-12#1)(2008-6#1)
reviewing the##21##2##(1991-6#1)(1992-6#1)(1995-12#1)(1995-3#2)(1996-12#2)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
reviewing##54##1##(1990-8#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-12#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#2)
reviews -##4##2##(2011-2#4)
reviews a##4##2##(1993-12#2)(2008-1#1)(2008-2#1)
reviews and##12##2##(1991-12#1)(1992-2#1)(1992-6#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-1#1)(2013-8#1)
reviews are##2##2##(1993-12#1)(2010-12#1)
reviews available##2##2##(2008-4#1)(2011-10#1)
reviews by##2##2##(2008-4#1)(2012-3#1)
reviews current##4##2##(2008-4#1)(2009-4#1)(2010-10#1)(2013-8#1)
reviews evidence##2##2##(1991-3#1)(2008-4#1)
reviews existing##4##2##(1996-2#1)(1997-8#1)(2008-11#2)
reviews have##3##2##(2008-10#2)(2008-9#1)
reviews how to##2##3##(2008-4#1)(2008-9#1)
reviews how##3##2##(2008-4#1)(2008-9#1)(2009-9#1)
reviews in##3##2##(1996-11#1)(2007-5#2)
reviews of the##3##3##(1993-12#2)(2012-2#1)
reviews of##16##2##(1993-12#4)(1994-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
reviews on##2##2##(2008-11#1)(2011-2#1)
reviews previous##2##2##(2008-10#1)(2008-11#1)
reviews recent developments in the##3##5##(1994-9#1)(2008-10#1)(2010-4#1)
reviews recent studies##3##3##(2007-2#1)(2008-4#1)(2010-4#1)
reviews recent##15##2##(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-4#2)(2012-12#1)(2013-8#1)
reviews research##3##2##(1995-2#1)(2008-7#1)(2012-3#1)
reviews some of the##11##4##(1992-4#1)(1993-1#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)
reviews some##14##2##(1992-4#1)(1993-1#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#2)(2012-12#1)
reviews the available##6##3##(2007-2#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#2)
reviews the classification##2##3##(2008-4#1)(2011-2#1)
reviews the clinical##4##3##(2007-11#1)(2008-2#2)(2013-1#1)
reviews the current evidence##2##4##(2009-8#1)(2013-1#1)
reviews the current literature##2##4##(2010-11#1)(2012-2#1)
reviews the current state of##3##5##(1997-4#1)(2008-6#1)(2011-2#1)
reviews the current##14##3##(1997-4#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#1)
reviews the development##2##3##(1993-3#1)(2008-10#1)
reviews the evidence##4##3##(2007-10#1)(2008-7#1)(2011-2#2)
reviews the historical##2##3##(1994-6#1)(2011-1#1)
reviews the literature and##2##4##(1997-2#1)(2013-1#1)
reviews the literature on the effects##2##6##(1996-3#1)(2008-7#1)
reviews the literature on the##5##5##(1996-3#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-7#1)
reviews the literature on##9##4##(1994-9#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
reviews the literature##14##3##(1994-9#1)(1996-3#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
reviews the major##3##3##(1994-3#1)(2008-7#1)(2012-2#1)
reviews the management of##2##4##(2012-2#1)(2013-8#1)
reviews the new##2##3##(2008-4#1)(2008-7#1)
reviews the preclinical##2##3##(2008-6#1)(2009-9#1)
reviews the present##3##3##(2008-1#1)(2008-7#1)(2009-12#1)
reviews the processes##2##3##(1995-2#1)(2012-2#1)
reviews the progress##2##3##(2008-5#1)(2008-7#1)
reviews the recent##2##3##(1994-6#1)(2008-1#1)
reviews the theory##2##3##(2008-4#1)(2013-1#1)
reviews the use of##2##4##(2008-10#2)
reviews the##167##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-2#3)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#1)(2008-1#5)(2008-10#4)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#12)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#2)(2009-12#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#4)(2010-6#3)(2011-1#2)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#9)(2013-1#11)(2013-8#4)
reviews these##4##2##(2008-11#2)(2008-6#1)(2012-3#1)
reviews what is known about##2##5##(2008-11#1)(2008-9#1)
reviews what is##3##3##(1995-6#1)(2008-11#1)(2008-9#1)
reviews##381##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#12)(1993-3#3)(1994-1#1)(1994-2#4)(1994-3#3)(1994-6#4)(1994-9#3)(1995-1#1)(1995-2#6)(1995-6#3)(1996-1#4)(1996-11#3)(1996-12#1)(1996-2#6)(1996-3#3)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#3)(2007-11#3)(2007-12#11)(2007-2#5)(2007-5#6)(2007-8#1)(2008-1#9)(2008-10#17)(2008-11#27)(2008-12#5)(2008-2#7)(2008-3#3)(2008-4#23)(2008-5#6)(2008-6#8)(2008-7#17)(2008-8#8)(2008-9#9)(2009-10#1)(2009-12#4)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#3)(2010-5#6)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#26)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#16)(2013-8#11)
revise##4##1##(1996-2#1)(1997-2#1)(2008-10#1)(2012-3#1)
revised Medicare##2##2##(1992-2#1)(2008-4#1)
revised and updated##2##3##(1994-12#1)(2013-1#1)
revised and##9##2##(1994-12#1)(1994-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)(2013-1#1)
revised diagnosis##2##2##(2006-8#1)(2012-2#1)
revised in##2##2##(1991-2#1)(2012-2#1)
revised model of##2##3##(1991-9#2)
revised model##5##2##(1991-9#2)(2008-10#1)(2008-3#1)(2010-6#1)
revised severity##2##2##(2008-9#2)
revised system##2##2##(1992-2#1)(2008-1#1)
revised the##2##2##(1992-3#1)(2008-5#1)
revised to##5##2##(1992-1#1)(1993-2#1)(1996-5#1)(2008-1#1)(2008-11#1)
revised version of##2##3##(2008-7#1)(2009-4#1)
revised##117##1##(1991-2#1)(1991-9#2)(1992-1#3)(1992-2#2)(1992-3#1)(1993-2#2)(1993-6#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#2)(2008-11#7)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#17)(2011-2#14)(2012-1#11)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
revises the##3##2##(1991-3#1)(1995-6#1)(2009-8#1)
revises##4##1##(1991-3#1)(1994-1#1)(1995-6#1)(2009-8#1)
revising medical staff bylaws##2##4##(1991-2#2)
revising##3##1##(1991-2#2)(2009-7#1)
revision THA##4##2##(2009-3#1)(2013-1#3)
revision and##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
revision arthroplasty##4##2##(2007-11#2)(2008-11#1)(2013-1#1)
revision for##3##2##(2008-8#1)(2013-1#2)
revision is##3##2##(1994-2#1)(1997-2#1)(2008-10#1)
revision of the##16##3##(1992-9#1)(1993-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-3#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
revision of##21##2##(1992-9#1)(1993-6#1)(1995-3#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#3)(2013-8#1)
revision stem##2##2##(2013-1#2)
revision surgery and##2##3##(2011-2#1)(2012-3#1)
revision surgery for##3##3##(2008-9#1)(2009-7#1)(2012-3#1)
revision surgery in##2##3##(2008-9#1)(2012-3#1)
revision surgery##17##2##(2008-8#1)(2008-9#3)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)
revision total hip##2##3##(2008-11#1)(2009-3#1)
revision was##2##2##(2010-5#1)(2013-1#1)
revision with##2##2##(2011-2#1)(2013-1#1)
revision##102##1##(1990-6#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#2)(1997-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#8)(2008-9#3)(2009-10#2)(2009-3#3)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#2)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#23)(2013-7#1)(2013-8#2)
revisions of##3##2##(1995-1#1)(2008-10#1)(2008-2#1)
revisions to##3##2##(1992-3#1)(2008-10#1)(2009-10#1)
revisions##16##1##(1992-3#3)(1995-1#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
revisit the##3##2##(2008-3#2)(2010-10#1)
revisit##10##1##(1991-1#1)(1997-8#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2012-2#1)
revisited in##2##2##(2007-11#1)(2013-1#1)
revisited the##2##2##(2010-5#1)(2012-7#1)
revisited##47##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-6#1)(1996-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-7#1)(2013-1#1)
revisits##2##1##(1996-12#1)(2013-1#1)
revitalization of##3##2##(1992-3#1)(1995-12#1)(2008-10#1)
revitalization##6##1##(1992-3#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2009-10#1)
revitalize##2##1##(1996-3#1)(2013-1#1)
revitalizing the##2##2##(1991-3#1)(2010-5#1)
revitalizing##3##1##(1991-3#1)(1997-3#1)(2010-5#1)
revival of##3##2##(1990-12#1)(1997-4#1)(2011-1#1)
revival##6##1##(1990-12#1)(1997-4#2)(2010-3#1)(2011-1#2)
revivals##3##1##(2007-12#3)
revived##4##1##(2008-10#1)(2008-4#1)(2012-3#2)
revolution in##10##2##(1990-8#1)(1996-11#1)(1996-9#1)(1997-8#1)(2007-8#2)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)
revolution of##3##2##(1995-4#1)(2008-10#1)(2011-1#1)
revolution that##3##2##(1993-2#1)(2008-2#1)(2008-3#1)
revolution##35##1##(1990-8#1)(1991-1#1)(1992-11#1)(1993-12#1)(1993-2#2)(1995-12#1)(1995-4#2)(1996-11#1)(1996-9#1)(1997-8#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
revolutionary changes##2##2##(1994-3#1)(1996-2#1)
revolutionary##11##1##(1994-3#1)(1996-1#1)(1996-2#1)(2007-11#1)(2008-7#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2013-8#1)
revolutionize the##5##2##(2008-4#1)(2008-7#1)(2009-5#1)(2010-3#1)(2013-1#1)
revolutionize##8##1##(1995-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
revolutionized our##2##2##(2010-3#1)(2010-7#1)
revolutionized the##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)(2012-8#1)
revolutionized##16##1##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-8#1)
revolutionizing##2##1##(1995-1#1)(2009-5#1)
revolutions##2##1##(2008-3#1)(2012-2#1)
revolves around a##2##3##(1996-3#1)(1996-9#1)
revolves around##4##2##(1994-3#1)(1996-3#1)(1996-9#1)(2008-4#1)
reward and recognition##2##3##(1991-3#2)
reward and##11##2##(1991-3#2)(1993-6#2)(1994-2#1)(1994-8#2)(2007-8#1)(2008-4#1)(2008-7#1)(2013-8#1)
reward circuit##2##2##(2007-8#1)(2009-8#1)
reward circuitry##2##2##(2012-12#1)(2013-8#1)
reward correlates)##2##2##(1994-2#2)
reward is##2##2##(1991-12#1)(2008-11#1)
reward magnitude##4##2##(1992-12#1)(1993-12#3)
reward reduction##2##2##(1993-12#2)
reward structure##4##2##(2009-5#4)
reward system##5##2##(1992-1#1)(2007-8#1)(2008-1#1)(2009-6#1)(2011-2#1)
reward systems##4##2##(1994-1#1)(1995-12#1)(1996-3#2)
reward was##3##2##(1992-11#1)(1992-12#1)(1997-6#1)
reward##94##1##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#2)(1992-12#5)(1992-7#1)(1993-12#8)(1993-2#1)(1993-6#4)(1994-1#1)(1994-2#3)(1994-3#2)(1994-8#3)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-5#2)(1997-6#3)(2007-2#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#7)(2008-7#2)(2008-9#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#6)
reward-related##7##1##(1993-6#3)(1994-2#1)(2007-8#1)(2013-8#2)
reward-relevant axons##2##2##(1992-12#2)
rewarded for##2##2##(1997-1#1)(2012-3#1)
rewarded##7##1##(1993-5#2)(1993-6#1)(1997-1#1)(2008-6#1)(2010-2#1)(2012-3#1)
rewarding##21##1##(1991-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#2)
rewards of##5##2##(1995-12#1)(1997-2#1)(2010-9#2)(2013-1#1)
rewards##14##1##(1992-12#1)(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2010-4#1)(2010-5#1)(2010-9#2)(2012-12#1)(2013-1#1)
rewarming is indicated for##2##4##(2011-2#2)
rewarming is##3##2##(2011-2#3)
rewarming##9##1##(1990-9#1)(2007-10#3)(2011-2#5)
reweighted least-squares##3##2##(2008-10#3)
rewiring##3##1##(2008-11#1)(2010-10#1)(2011-1#1)
rework##3##1##(1996-1#1)(1996-3#2)
reworking##2##1##(1991-12#1)(1997-5#1)
rewritable optical##2##2##(2008-3#2)
rewritable phase-change optical##2##3##(2008-3#2)
rewritable##4##1##(2008-3#4)
rex##3##1##(1991-2#3)
rf signal##2##2##(2007-12#1)(2008-3#1)
rf##14##1##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#4)(2013-8#2)
rh TNF##4##2##(1992-9#4)
rh##5##1##(1992-9#4)(2012-3#1)
rhAPC##2##1##(2007-12#2)
rhAT III##4##2##(2008-7#4)
rhBMP-2 induced periosteal cells##3##4##(2008-5#3)
rhBMP-2##10##1##(2008-5#4)(2011-2#2)(2012-12#4)
rhBMP-7##3##1##(2012-12#3)
rhEPO in##2##2##(2008-8#2)
rhEPO##3##1##(2008-8#3)
rhFKBP12##5##1##(2008-9#5)
rhG-CSF##2##1##(2012-3#2)
rhIL-1 alpha##3##2##(1990-12#1)(1990-2#2)
rhIL-1 beta and rhTNF alpha##2##5##(1990-2#2)
rhIL-1 beta##3##2##(1990-12#1)(1990-2#2)
rhIL-1##6##1##(1990-12#2)(1990-2#4)
rhIL-2##2##1##(2008-11#2)
rhKGF##4##1##(1994-11#4)
rhPC##4##1##(2008-12#4)
rhTNF##7##1##(1990-12#2)(1990-2#2)(1990-7#2)(2008-8#1)
rhTSH patients##3##2##(2013-1#3)
rhTSH##4##1##(2013-1#4)
rhabdom##4##1##(2007-12#4)
rhabdoms##3##1##(2007-12#3)
rhabdomyolysis and acute renal##2##4##(2011-2#1)(2013-8#1)
rhabdomyolysis and##4##2##(2008-1#1)(2011-2#2)(2013-8#1)
rhabdomyolysis due to##2##3##(2011-2#2)
rhabdomyolysis in a##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
rhabdomyolysis in##4##2##(1997-5#1)(2007-12#1)(2008-12#1)(2013-8#1)
rhabdomyolysis was##2##2##(2008-12#1)(2013-1#1)
rhabdomyolysis##29##1##(1992-2#1)(1997-5#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-4#1)(2011-2#8)(2013-1#5)(2013-8#3)
rhabdomyosarcoma in##2##2##(2007-8#1)(2008-10#1)
rhabdomyosarcoma of the bladder in an adult##2##7##(2007-10#2)
rhabdomyosarcoma of the##5##3##(2007-10#2)(2007-8#1)(2013-1#2)
rhabdomyosarcoma of##6##2##(2007-10#2)(2007-8#1)(2010-11#1)(2013-1#2)
rhabdomyosarcoma with##6##2##(2007-7#2)(2010-11#2)(2011-1#1)(2012-12#1)
rhabdomyosarcoma##27##1##(1991-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-6#3)(2010-11#4)(2010-3#1)(2011-1#2)(2012-12#2)(2013-1#2)
rhabdomyosarcoma)##2##1##(1995-12#1)(2008-6#1)
rhabdovirus##4##1##(2008-10#1)(2008-8#3)
rhabdoviruses##2##1##(2008-8#2)
rhamnogalacturonase##2##1##(1990-9#2)
rhamnoides##4##1##(2008-10#3)(2012-8#1)
rhamnolipids##7##1##(2009-6#3)(2012-2#4)
rhamnopyranosyl-(1--&gt##2##1##(1992-12#2)
rhamnose##6##1##(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
rhamnoside##4##1##(2008-5#4)
rhamnosus##3##1##(2008-7#1)(2009-12#2)
rhea (Rhea##2##2##(2013-1#2)
rhea##3##1##(2013-1#3)
rheas (Rhea##2##2##(2013-1#2)
rheas##8##1##(2013-1#8)
rhein##7##1##(2008-10#3)(2010-3#4)
rhenium##3##1##(1996-2#2)(2008-10#1)
rhenium(I)##2##1##(1997-7#2)
rhenium(II)##2##1##(1997-7#2)
rheological and##2##2##(2008-10#1)(2010-4#1)
rheological behavior of##2##3##(2008-5#1)(2008-8#1)
rheological behavior##6##2##(2008-10#1)(2008-5#3)(2008-8#1)(2011-3#1)
rheological behaviour##3##2##(2008-5#3)
rheological measurements##2##2##(2008-5#1)(2009-11#1)
rheological parameters were##2##3##(1994-8#1)(2008-5#1)
rheological parameters##3##2##(1994-8#2)(2008-5#1)
rheological properties of##5##3##(2008-5#3)(2008-7#1)(2011-2#1)
rheological properties##10##2##(2008-5#6)(2008-7#2)(2011-2#2)
rheological##36##1##(1994-3#1)(1994-8#2)(2008-10#2)(2008-5#19)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)
rheology and dielectric spectroscopy##3##4##(2008-5#3)
rheology and##6##2##(1995-6#1)(2008-5#4)(2010-12#1)
rheology of creams##2##3##(2008-5#2)
rheology of the##2##3##(2008-5#1)(2011-1#1)
rheology of##7##2##(2008-5#6)(2011-1#1)
rheology##22##1##(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#14)(2009-4#1)(2010-12#1)(2011-1#2)
rhesus macaques##3##2##(1990-11#1)(2008-4#1)(2012-3#1)
rhesus monkey##7##2##(1991-1#2)(1993-5#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-9#1)
rhesus monkeys##17##2##(1990-11#2)(1991-1#3)(1991-9#1)(1995-2#3)(1996-2#4)(1996-5#1)(2008-4#2)(2008-5#1)
rhesus##28##1##(1990-11#3)(1991-1#5)(1991-9#1)(1993-5#1)(1995-11#2)(1995-12#1)(1995-2#3)(1996-2#4)(1996-5#2)(2008-4#3)(2008-5#1)(2008-9#1)(2012-3#1)
rhetoric and##3##2##(1994-1#1)(2008-11#1)(2008-7#1)
rhetoric##10##1##(1994-1#2)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
rheumaorthopaedics##2##1##(2007-8#2)
rheumatic disease##11##2##(1990-6#2)(1994-8#1)(2006-10#2)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#1)
rheumatic diseases##17##2##(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(2006-10#2)(2007-8#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-1#1)
rheumatic fever##8##2##(1992-2#1)(1996-11#1)(1996-12#4)(2008-7#2)
rheumatic heart disease and##2##4##(1996-12#1)(2008-8#1)
rheumatic mitral##2##2##(1994-3#1)(2008-11#1)
rheumatic##53##1##(1990-12#1)(1990-6#4)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-12#5)(2006-10#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#5)(2008-8#6)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#3)
rheumatica and temporal arteritis##8##4##(1994-9#3)(1997-8#5)
rheumatica##15##1##(1994-11#2)(1994-9#5)(1997-8#5)(2006-10#1)(2008-7#2)
rheumatism and##2##2##(1991-9#1)(2011-1#1)
rheumatism##3##1##(1991-9#1)(2008-7#1)(2011-1#1)
rheumatoid arthritis (RA) in##2##4##(2012-3#2)
rheumatoid arthritis (RA) patients##4##4##(1994-6#1)(2006-10#1)(2008-10#1)(2011-2#1)
rheumatoid arthritis (RA)##14##3##(1994-6#1)(2006-10#2)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-8#1)
rheumatoid arthritis a##2##3##(1993-11#1)(2013-1#1)
rheumatoid arthritis and degenerative arthritis##2##5##(2013-1#2)
rheumatoid arthritis and##14##3##(1991-5#2)(1992-5#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-5#1)(2009-1#1)(2009-5#1)(2012-3#1)(2013-1#3)
rheumatoid arthritis in##4##3##(2006-10#1)(2007-12#1)(2008-8#1)(2012-3#1)
rheumatoid arthritis is##4##3##(1990-6#1)(2007-11#2)(2007-12#1)
rheumatoid arthritis patients of Shen deficiency##2##6##(2013-8#2)
rheumatoid arthritis patients##7##3##(1991-5#2)(2007-11#1)(2008-8#1)(2011-2#1)(2013-8#2)
rheumatoid arthritis with##2##3##(2006-10#1)(2011-2#1)
rheumatoid arthritis##124##2##(1990-2#1)(1990-6#5)(1991-5#4)(1991-8#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#3)(1994-6#1)(1994-8#2)(1995-5#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#13)(2007-1#1)(2007-11#13)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#7)(2008-7#5)(2008-8#9)(2008-9#2)(2009-1#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#7)(2013-8#6)
rheumatoid arthritis]##3##2##(1991-11#2)(1991-3#1)
rheumatoid factor (RF)##2##3##(2011-2#1)(2012-2#1)
rheumatoid factor##4##2##(2008-4#1)(2011-2#2)(2012-2#1)
rheumatoid patients##2##2##(1993-2#1)(2007-11#1)
rheumatoid##139##1##(1990-2#1)(1990-6#5)(1991-11#2)(1991-3#1)(1991-5#4)(1991-8#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#4)(1994-6#1)(1994-8#3)(1995-5#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#13)(2007-1#1)(2007-11#15)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#7)(2008-7#5)(2008-8#9)(2008-9#2)(2009-1#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#7)(2013-8#6)
rheumatologic diseases##2##2##(2012-12#1)(2012-3#1)
rheumatologic##5##1##(1997-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
rheumatological emergency situations##2##3##(1990-6#2)
rheumatological emergency##3##2##(1990-6#3)
rheumatological##12##1##(1990-6#4)(2008-12#1)(2011-2#1)(2013-1#6)
rheumatologist##7##1##(1997-4#4)(1997-6#1)(2006-10#1)(2007-11#1)
rheumatologists##2##1##(2006-10#2)
rheumatology in##2##2##(2006-10#2)
rheumatology##15##1##(1991-11#1)(1997-3#1)(1997-4#1)(2006-10#6)(2007-8#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
rhinitis (AR)##6##2##(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
rhinitis and##8##2##(1991-2#1)(2008-7#1)(2010-6#3)(2012-12#1)(2013-1#1)(2013-8#1)
rhinitis as##2##2##(2008-4#1)(2011-1#1)
rhinitis can##3##2##(1996-3#1)(2007-11#1)(2010-6#1)
rhinitis in##7##2##(2008-5#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
rhinitis is##5##2##(2011-1#2)(2012-1#1)(2012-12#2)
rhinitis were##2##2##(1990-3#1)(2008-4#1)
rhinitis with##2##2##(2007-11#1)(2011-1#1)
rhinitis##100##1##(1990-3#1)(1991-2#1)(1996-3#3)(2007-11#10)(2008-10#2)(2008-11#1)(2008-3#8)(2008-4#6)(2008-5#4)(2008-7#3)(2010-5#1)(2010-6#5)(2011-1#22)(2011-2#3)(2012-1#1)(2012-12#11)(2012-2#3)(2012-3#9)(2013-1#3)(2013-8#3)
rhinobronchitis##2##1##(2008-7#2)
rhinocerebral mucormycosis##2##2##(2011-2#2)
rhinoceros beetles##2##2##(2008-8#2)
rhinoconjunctivitis##2##1##(1991-2#1)(2012-3#1)
rhinogenic##4##1##(2008-4#3)(2012-12#1)
rhinolarynx endoscope portion##2##3##(2008-5#2)
rhinolarynx##3##1##(2008-5#3)
rhinologic procedures##2##2##(2012-1#2)
rhinologists##2##1##(2012-1#2)
rhinology fellowship experience##2##3##(2012-1#2)
rhinology fellowship##4##2##(2012-1#4)
rhinology##6##1##(2012-1#6)
rhinopathy##5##1##(2011-1#3)(2013-1#2)
rhinoplasty for the Asian nose##2##5##(2010-8#2)
rhinoplasty in this##2##3##(2010-8#2)
rhinoplasty in##5##2##(2008-2#1)(2010-8#3)(2012-1#1)
rhinoplasty is##3##2##(2010-8#3)
rhinoplasty##22##1##(2008-2#2)(2010-8#19)(2012-1#1)
rhinorrhea and##2##2##(2008-12#1)(2012-3#1)
rhinorrhea##10##1##(2006-12#3)(2008-12#2)(2011-1#2)(2012-12#1)(2012-3#2)
rhinosinusitis (CRS)##2##2##(2011-2#1)(2013-8#1)
rhinosinusitis caused by##3##3##(2009-2#2)(2012-1#1)
rhinosinusitis in##2##2##(2012-3#1)(2013-8#1)
rhinosinusitis##22##1##(2009-2#3)(2010-6#3)(2011-1#1)(2011-2#3)(2012-1#7)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
rhinotracheitis##2##1##(1997-3#1)(2008-11#1)
rhizo-sphere##2##1##(2008-10#2)
rhizobacteria##15##1##(2008-10#15)
rhizobacterial##3##1##(2008-10#3)
rhizobia##4##1##(2008-7#2)(2011-2#2)
rhizobial##2##1##(2008-10#1)(2011-2#1)
rhizoctonia##4##1##(2008-10#4)
rhizolysis##2##1##(2011-2#2)
rhizoma and##4##2##(2008-10#1)(2011-1#3)
rhizoma##12##1##(2008-10#4)(2011-1#6)(2012-3#2)
rhizomania##10##1##(2008-10#10)
rhizome##3##1##(1996-9#1)(2008-5#1)(2012-3#1)
rhizomes of Paris polyphylla var##2##5##(2013-1#2)
rhizomes of##4##2##(2008-11#1)(2008-12#1)(2013-1#2)
rhizoplane##3##1##(2008-10#3)
rhizosphere abundance of##3##3##(2008-10#3)
rhizosphere and##5##2##(2008-10#5)
rhizosphere bacterium##2##2##(2008-10#2)
rhizosphere colonization by##2##3##(2008-10#2)
rhizosphere colonization was##2##3##(2008-10#2)
rhizosphere colonization##5##2##(2008-10#5)
rhizosphere competence##3##2##(2008-10#3)
rhizosphere densities of##2##3##(2008-10#2)
rhizosphere microorganisms for their ability to induce systemic resistance##2##9##(2008-10#2)
rhizosphere population densities of##3##4##(2008-10#3)
rhizosphere population##5##2##(2008-10#5)
rhizosphere populations of Phytophthora parasitica##3##5##(2008-10#3)
rhizosphere populations of##6##3##(2008-10#6)
rhizosphere priming may##3##3##(2013-8#3)
rhizosphere priming##5##2##(2013-8#5)
rhizosphere soil##4##2##(2008-10#3)(2010-3#1)
rhizosphere were##3##2##(2008-10#3)
rhizosphere##78##1##(2008-10#69)(2008-12#2)(2009-8#1)(2010-3#1)(2013-8#5)
rho 1 receptor function##2##4##(1995-11#2)
rho 1##8##2##(1995-11#4)(1995-5#4)
rho A##4##2##(1994-11#4)
rho A-rho GDI complex purified from##2##6##(1994-11#2)
rho A-rho GDI complex##3##4##(1994-11#3)
rho GDI was##2##3##(1991-2#2)
rho GDI##5##2##(1991-2#4)(1994-11#1)
rho as a function of##2##5##(2008-10#1)(2008-3#1)
rho proteins##5##2##(1991-2#4)(1992-3#1)
rho##51##1##(1991-2#8)(1992-11#1)(1992-3#1)(1994-11#8)(1995-11#4)(1995-5#4)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#10)(2008-2#1)(2008-3#6)(2008-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
rho(p)##2##1##(2008-3#2)
rho(s)##2##1##(2008-3#2)
rho(t##4##1##(2008-10#4)
rho(theta)##3##1##(2008-3#3)
rho(w)##2##1##(2008-2#2)
rho)##2##1##(1995-5#1)(2008-10#1)
rhoA##2##1##(1995-8#1)(1996-5#1)
rhoB##2##1##(1996-5#2)
rhodamine 123##6##2##(1994-2#1)(2008-10#3)(2008-7#1)(2008-9#1)
rhodamine 6G (RhG) and rhodamine S (RhS)##2##7##(2008-10#2)
rhodamine 6G as##2##3##(2008-10#2)
rhodamine 6G##12##2##(2008-10#12)
rhodamine B (RhB)##2##3##(2008-10#2)
rhodamine B and##2##3##(2008-10#2)
rhodamine B hydrazide##4##3##(2008-10#4)
rhodamine B isothiocyanate##2##3##(2008-10#2)
rhodamine B##22##2##(2008-10#20)(2008-12#1)(2013-8#1)
rhodamine S##6##2##(2008-10#6)
rhodamine dyes##4##2##(2008-10#3)(2008-2#1)
rhodamine##64##1##(1990-12#1)(1991-12#1)(1992-9#1)(1993-9#3)(1994-2#1)(1995-5#1)(1997-7#1)(2008-10#50)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
rhodanese##4##1##(1992-12#4)
rhodium has##3##2##(2008-10#3)
rhodium on##2##2##(2008-10#2)
rhodium permanent##2##2##(2008-10#2)
rhodium##35##1##(2008-10#34)(2009-5#1)
rhodium-doped barium titanate##2##3##(2008-2#2)
rhododendron##5##1##(2008-10#4)(2013-7#1)
rhodopsin phosphorylation in##2##3##(1995-6#2)
rhodopsin phosphorylation##3##2##(1995-6#3)
rhodopsin##11##1##(1990-12#2)(1992-3#1)(1992-5#1)(1995-6#3)(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
rhombic##5##1##(1997-7#2)(2007-11#1)(2008-9#1)(2009-7#1)
rhombs##3##1##(2008-2#3)
rhubarbs##2##1##(2008-10#2)
rhumatoid factor##2##2##(2007-8#2)
rhumatoid##3##1##(2007-8#3)
rhusiopathiae endocarditis and##2##3##(2007-12#2)
rhusiopathiae##6##1##(2007-12#6)
rhynchus&quot##2##1##(2008-5#2)
rhythm and the##3##3##(1991-10#1)(1997-6#1)(2008-5#1)
rhythm and##8##2##(1990-3#1)(1990-5#1)(1991-10#1)(1995-12#1)(1997-6#1)(2007-8#1)(2008-5#2)
rhythm disturbances##2##2##(2008-10#1)(2009-10#1)
rhythm generator##3##2##(1992-8#2)(2008-11#1)
rhythm in##15##2##(1993-9#3)(1994-2#1)(1997-2#1)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#1)(2011-1#1)
rhythm is##5##2##(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)
rhythm management##2##2##(2006-10#1)(2010-12#1)
rhythm of the##3##3##(1992-2#1)(1994-5#1)(2008-10#1)
rhythm of##13##2##(1990-7#2)(1991-12#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-5#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#2)
rhythm parameters##2##2##(2008-6#2)
rhythm reversal##3##2##(2008-6#3)
rhythm was##5##2##(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
rhythm##121##1##(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#1)(1992-11#2)(1992-2#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#3)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#4)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#4)(2006-10#1)(2007-6#1)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#12)(2008-12#1)(2008-5#14)(2008-6#10)(2008-7#2)(2008-8#2)(2009-10#2)(2010-12#4)(2010-8#3)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)
rhythm)##2##1##(2008-11#1)(2008-6#1)
rhythmic bladder contractions were##2##4##(1992-3#2)
rhythmic bladder contractions##3##3##(1992-3#3)
rhythmic gymnastics##2##2##(2012-12#2)
rhythmic##21##1##(1990-8#1)(1991-12#1)(1992-3#3)(1994-3#2)(1994-5#1)(1995-12#1)(1996-7#1)(1997-4#2)(1997-7#1)(2007-10#1)(2012-12#3)(2012-2#3)(2013-8#1)
rhythmical jaw movements##2##3##(1990-9#2)
rhythmical jaw##3##2##(1990-9#3)
rhythmical##9##1##(1990-9#4)(1991-12#1)(1991-2#1)(1992-12#1)(2007-8#1)(2008-8#1)
rhythmically##4##1##(1994-11#1)(1994-5#1)(1995-12#1)(2008-3#1)
rhythmicity in##2##2##(1994-5#1)(2008-8#1)
rhythmicity of##2##2##(1994-5#1)(2008-5#1)
rhythmicity##8##1##(1994-5#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-8#1)(2013-8#1)
rhythms and##4##2##(1990-5#1)(1996-2#1)(2008-6#1)(2013-1#1)
rhythms are##5##2##(1990-8#1)(1993-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
rhythms as##2##2##(2008-6#1)(2008-8#1)
rhythms in the##2##3##(2013-7#1)(2013-8#1)
rhythms in##5##2##(1990-3#1)(2008-5#1)(2010-8#1)(2013-7#1)(2013-8#1)
rhythms of##4##2##(1993-12#1)(1995-12#1)(2008-5#1)(2010-8#1)
rhythms##43##1##(1990-3#1)(1990-5#4)(1990-8#1)(1993-12#2)(1995-12#4)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#9)(2008-8#4)(2008-9#2)(2009-8#2)(2010-8#2)(2013-1#1)(2013-7#2)(2013-8#2)
rib cage defect was##2##4##(1996-2#2)
rib cage##6##2##(1996-2#3)(2007-11#2)(2012-2#1)
rib eye area##2##3##(2010-2#2)
rib hump##3##2##(2007-11#3)
rib thickness##3##2##(2010-2#3)
rib waveguide##2##2##(2007-12#1)(2008-2#1)
rib##39##1##(1993-9#1)(1996-2#4)(1997-3#1)(2007-11#6)(2007-12#3)(2007-8#4)(2008-2#1)(2008-3#2)(2008-6#1)(2010-2#5)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#6)
ribavirin in##5##2##(1994-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
ribavirin therapy##3##2##(2008-6#1)(2010-11#1)(2013-7#1)
ribavirin with##2##2##(2008-10#1)(2009-8#1)
ribavirin##27##1##(1990-10#3)(1994-6#2)(1994-8#1)(2007-7#1)(2008-10#3)(2008-6#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-7#1)
ribbon##2##1##(2008-3#2)
ribbon-like inclusions maps to##2##4##(2008-10#2)
ribbon-like inclusions##4##2##(2008-10#4)
ribbon-like structures##5##2##(1992-6#5)
ribbon-like##12##1##(1992-6#8)(2008-10#4)
ribbon-shaped##2##1##(2009-7#1)(2009-8#1)
ribbons##2##1##(2008-3#2)
ribicola was##2##2##(2008-10#2)
ribicola##18##1##(2008-10#18)
riboflavin or##2##2##(1993-9#1)(2008-10#1)
riboflavin was##2##2##(1992-3#1)(2008-10#1)
riboflavin##27##1##(1992-3#1)(1992-9#1)(1993-9#1)(2008-10#12)(2008-9#8)(2012-2#1)(2012-3#2)(2013-1#1)
riboflavine and 0##2##3##(2008-10#2)
riboflavine and##3##2##(2008-10#3)
ribonuclear protein##2##2##(2008-11#1)(2011-2#1)
ribonuclease A##6##2##(1997-2#3)(1997-6#1)(2008-10#1)(2011-2#1)
ribonuclease from human##2##3##(1990-7#2)
ribonuclease or##2##2##(1994-2#1)(2008-7#1)
ribonuclease protection assay##4##3##(1993-3#1)(2008-10#2)(2008-4#1)
ribonuclease protection##5##2##(1993-3#1)(2008-10#3)(2008-4#1)
ribonuclease##24##1##(1990-7#3)(1992-11#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-2#1)(1997-2#3)(1997-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-3#1)
ribonucleases##2##1##(1992-8#1)(2012-3#1)
ribonucleic acid##3##2##(1992-9#1)(1995-12#1)(2009-11#1)
ribonucleic##4##1##(1992-9#1)(1995-12#1)(2008-10#1)(2009-11#1)
ribonucleoprotein components##2##2##(1995-2#2)
ribonucleoprotein particle##4##2##(1992-11#2)(1993-8#1)(2007-12#1)
ribonucleoprotein particles##4##2##(1994-11#2)(1995-2#1)(1995-6#1)
ribonucleoprotein##15##1##(1991-6#1)(1992-11#2)(1993-8#1)(1994-11#2)(1995-2#3)(1995-6#1)(2007-12#1)(2008-8#2)(2008-9#1)(2011-2#1)
ribonucleoproteins##2##1##(1995-6#1)(2007-12#1)
ribonucleoside##5##1##(1990-2#1)(1991-5#1)(1994-5#1)(1995-3#1)(2008-4#1)
ribonucleosides##14##1##(1997-2#3)(2008-4#11)
ribonucleotide reductase by##2##3##(1993-11#1)(1994-8#1)
ribonucleotide reductase##21##2##(1990-12#1)(1990-2#4)(1991-12#1)(1991-5#3)(1992-10#2)(1992-8#3)(1993-11#3)(1994-8#3)(2008-5#1)
ribonucleotide synthetase##3##2##(1993-12#3)
ribonucleotide##27##1##(1990-12#1)(1990-2#4)(1991-12#1)(1991-5#3)(1992-10#2)(1992-8#3)(1993-11#4)(1993-12#4)(1994-8#3)(2008-5#1)(2011-1#1)
ribonucleotides##2##1##(2010-11#1)(2012-2#1)
riboprobes and##2##2##(1996-12#2)
riboprobes##7##1##(1996-12#3)(1996-2#1)(1997-4#1)(2008-10#1)(2008-4#1)
ribose##12##1##(1992-3#1)(1993-11#1)(1993-8#1)(1995-3#1)(1996-5#2)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#2)
riboside##3##1##(1994-8#2)(2008-4#1)
ribosomal (r)DNA##2##2##(2008-10#2)
ribosomal DNA (rDNA)##5##3##(2008-10#4)(2008-9#1)
ribosomal DNA internal transcribed spacer region##2##6##(2008-10#2)
ribosomal DNA internal transcribed spacer##5##5##(2008-10#5)
ribosomal DNA##34##2##(2007-12#1)(2008-10#26)(2008-12#2)(2008-9#1)(2009-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
ribosomal RNA (rRNA)##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
ribosomal RNA coding##2##3##(1997-7#1)(2008-5#1)
ribosomal RNA gene (rDNA)##2##4##(2008-10#1)(2008-8#1)
ribosomal RNA gene##8##3##(2008-10#3)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
ribosomal RNA genes in##2##4##(1992-3#1)(2008-5#1)
ribosomal RNA genes##7##3##(1992-3#1)(2008-10#3)(2008-5#3)
ribosomal RNA in Drosophila melanogaster##2##5##(1997-7#2)
ribosomal RNA##31##2##(1991-9#1)(1992-3#1)(1995-8#1)(1997-7#4)(2008-10#9)(2008-5#5)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#2)
ribosomal RNAs##2##2##(1992-3#1)(2008-7#1)
ribosomal S6##5##2##(1995-6#4)(2011-2#1)
ribosomal cistron##2##2##(1993-12#2)
ribosomal crystallography##2##2##(2009-11#2)
ribosomal frameshifting##5##2##(1995-9#5)
ribosomal gene##2##2##(2008-10#2)
ribosomal genes##3##2##(2008-10#3)
ribosomal intergenic spacer analysis##2##4##(2008-10#2)
ribosomal intergenic spacer##3##3##(2008-10#3)
ribosomal intergenic##4##2##(2008-10#4)
ribosomal internal transcribed spacer (ITS)##2##5##(2008-10#1)(2008-9#1)
ribosomal internal transcribed spacer region##3##5##(2008-10#3)
ribosomal internal transcribed spacer##5##4##(2008-10#4)(2008-9#1)
ribosomal protein S14##4##3##(1996-6#3)(2012-12#1)
ribosomal protein S3a##2##3##(2008-11#2)
ribosomal protein S6##3##3##(1993-2#1)(1996-2#2)
ribosomal protein gene##2##3##(2008-10#1)(2008-8#1)
ribosomal protein genes##3##3##(1996-3#1)(2008-11#1)(2009-8#1)
ribosomal protein in##2##3##(1994-12#1)(2009-11#1)
ribosomal protein operons##2##3##(2008-8#2)
ribosomal protein##39##2##(1991-5#1)(1991-6#1)(1991-7#2)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#3)(1995-6#4)(1995-8#1)(1996-2#2)(1996-3#1)(1996-6#3)(1997-2#1)(2008-10#2)(2008-11#4)(2008-8#6)(2009-11#1)(2009-8#2)(2012-12#1)(2013-8#1)
ribosomal proteins##8##2##(1990-5#1)(1992-8#1)(1993-11#1)(2008-7#2)(2008-8#2)(2013-8#1)
ribosomal stress##2##2##(2012-12#2)
ribosomal subunit##7##2##(1992-6#1)(1992-8#1)(1993-11#1)(2008-11#1)(2009-11#1)(2009-9#2)
ribosomal subunits##2##2##(2011-2#1)(2012-2#1)
ribosomal##174##1##(1990-5#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#4)(1993-11#3)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#3)(1995-6#8)(1995-8#4)(1995-9#5)(1996-2#2)(1996-3#1)(1996-6#3)(1997-2#1)(1997-7#4)(2007-11#1)(2007-12#1)(2008-10#56)(2008-11#6)(2008-12#2)(2008-5#5)(2008-7#4)(2008-8#10)(2008-9#4)(2009-11#4)(2009-2#1)(2009-8#2)(2009-9#3)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
ribosome and##2##2##(1994-11#1)(1995-3#1)
ribosome assembly##2##2##(1993-11#1)(2012-3#1)
ribosome binding sequence##2##3##(2008-10#1)(2010-6#1)
ribosome binding site##2##3##(1992-12#1)(2010-6#1)
ribosome binding##4##2##(1992-12#1)(2008-10#1)(2010-6#2)
ribosome biogenesis##4##2##(2011-2#4)
ribosome is##3##2##(1991-9#1)(2008-11#1)(2008-7#1)
ribosome##41##1##(1991-6#1)(1991-9#2)(1992-12#1)(1992-6#3)(1992-8#1)(1993-11#2)(1994-11#1)(1994-6#1)(1995-3#1)(1997-7#1)(1997-8#2)(2007-12#3)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#2)(2009-9#1)(2010-12#1)(2010-6#2)(2011-2#5)(2012-1#1)(2012-3#1)(2013-8#1)
ribosome-activated ATPase activity of EF-3##3##5##(1996-2#3)
ribosome-activated ATPase activity##4##3##(1996-2#4)
ribosome-binding site##5##2##(1991-9#1)(1993-9#2)(1994-12#2)
ribosome-inactivating protein##4##2##(1993-2#2)(2008-10#2)
ribosome-inactivating proteins##3##2##(1990-11#1)(1990-12#2)
ribosome-inactivating##7##1##(1990-11#1)(1990-12#2)(1993-2#2)(2008-10#2)
ribosomes and##3##2##(1990-11#1)(2007-12#2)
ribosomes from##2##2##(1993-11#1)(2008-7#1)
ribosomes##17##1##(1990-11#1)(1991-12#1)(1992-3#2)(1992-8#1)(1993-11#1)(1995-9#2)(2007-12#2)(2008-10#1)(2008-7#4)(2008-9#1)(2009-11#1)
ribotyping##3##1##(1997-3#1)(1997-4#1)(2008-10#1)
ribozyme in vitro and in vivo##2##6##(2008-9#2)
ribozyme in##5##2##(1993-9#2)(2008-9#3)
ribozyme targeting##2##2##(1997-6#1)(2008-9#1)
ribozyme##32##1##(1993-9#7)(1994-11#6)(1995-3#1)(1997-6#3)(2008-11#1)(2008-3#2)(2008-9#12)
ribozymes and##2##2##(2008-11#1)(2008-7#1)
ribozymes##5##1##(1997-6#1)(2008-11#1)(2008-7#1)(2008-9#2)
ribs and##2##2##(1997-3#1)(2007-12#1)
ribs##10##1##(1991-11#1)(1993-12#2)(1994-12#1)(1997-3#2)(2007-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
ribulose 1##3##2##(1997-6#3)
ribulose##4##1##(1997-6#3)(2009-10#1)
rice (Oryza sativa L##12##4##(1992-8#1)(1994-11#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-9#5)
rice (Oryza sativa##15##3##(1992-8#1)(1994-11#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-9#6)(2009-10#2)
rice (Oryza sativa)##6##3##(2008-10#3)(2008-7#2)(2009-10#1)
rice (Oryza##23##2##(1992-8#1)(1994-11#1)(1996-12#1)(1997-4#2)(2008-10#5)(2008-4#1)(2008-7#2)(2008-9#6)(2009-10#4)
rice 5460S##2##2##(2008-8#2)
rice GTs##2##2##(2009-10#2)
rice MADS box gene##2##4##(1997-2#1)(2008-8#1)
rice MADS box##3##3##(1997-2#1)(1997-8#1)(2008-8#1)
rice Pi21##2##2##(2012-2#2)
rice SVP-group MADS-box proteins##2##4##(2009-8#2)
rice U-box##2##2##(2009-10#2)
rice allergenic protein##2##3##(2008-11#2)
rice and Arabidopsis U-box proteins##3##5##(2009-10#3)
rice and Arabidopsis##4##3##(2009-10#4)
rice and St##3##3##(2008-10#3)
rice and barley gene expression databases##2##6##(2009-10#2)
rice and barley##3##3##(2009-10#3)
rice and maize##2##3##(2008-8#1)(2009-10#1)
rice and wheat##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
rice and##28##2##(2008-10#9)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#1)(2009-10#11)(2011-3#1)(2013-8#1)
rice as##2##2##(2008-7#1)(2011-1#1)
rice bacterial artificial chromosome (BAC) library##2##6##(2008-8#2)
rice bacterial artificial##3##3##(2008-10#1)(2008-8#2)
rice bacterial blight##3##3##(2008-10#3)
rice bacterial##6##2##(2008-10#4)(2008-8#2)
rice blast caused by##2##4##(2008-10#2)
rice blast fungus##5##3##(2008-10#5)
rice blast in the##2##4##(2008-10#2)
rice blast in##3##3##(2008-10#2)(2012-2#1)
rice blast resistance##2##3##(2008-10#2)
rice blast##24##2##(2008-10#23)(2012-2#1)
rice breeding##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
rice by##3##2##(2008-10#2)(2008-9#1)
rice cDNA##4##2##(1996-8#1)(2008-10#1)(2008-9#2)
rice chromosome 1##3##3##(1996-10#2)(2008-10#1)
rice chromosome 4##2##3##(2009-10#2)
rice chromosome 5##2##3##(1996-10#2)
rice chromosome##10##2##(1995-6#1)(1996-10#4)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)
rice chromosomes##7##2##(1996-12#3)(1997-2#2)(2008-8#1)(2008-9#1)
rice cultivar##7##2##(2008-10#6)(2008-9#1)
rice cultivars was##2##3##(2008-10#2)
rice cultivars were##2##3##(2008-10#2)
rice cultivars##14##2##(2008-10#12)(2008-12#1)(2009-10#1)
rice cv##5##2##(2008-10#3)(2008-9#2)
rice epsps cDNA##2##3##(2008-9#2)
rice epsps##4##2##(2008-9#4)
rice flour##7##2##(2008-10#7)
rice from##2##2##(2008-10#2)
rice genome and##2##3##(2008-9#1)(2009-10#1)
rice genome by##2##3##(2008-8#1)(2009-10#1)
rice genome##18##2##(1996-8#2)(2008-10#1)(2008-8#4)(2008-9#8)(2009-10#3)
rice genomic DNA##2##3##(1996-12#1)(2008-8#1)
rice genomic library##4##3##(2008-8#1)(2008-9#3)
rice genomic##6##2##(1996-12#1)(2008-8#2)(2008-9#3)
rice grain##4##2##(2008-10#1)(2013-1#3)
rice grains##5##2##(1995-3#1)(2008-10#2)(2008-12#2)
rice growth stages##2##3##(2008-10#2)
rice growth##3##2##(2008-10#2)(2008-9#1)
rice haploid genome equivalents##2##4##(1996-10#1)(2008-8#1)
rice hull##3##2##(2008-12#3)
rice hybrid##2##2##(2008-9#2)
rice hybrids##2##2##(2008-10#1)(2009-10#1)
rice in the United States##2##5##(2008-10#1)(2013-8#1)
rice in##7##2##(2008-10#3)(2008-12#1)(2013-1#1)(2013-8#2)
rice isolate##2##2##(2008-10#2)
rice leaves##5##2##(2008-10#5)
rice line##3##2##(2008-10#2)(2008-9#1)
rice lines##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
rice paddy##4##2##(2008-12#2)(2008-3#2)
rice pest management##2##3##(2008-10#2)
rice plant##3##2##(2008-10#2)(2009-8#1)
rice plants were##2##3##(2008-10#2)
rice plants##14##2##(2006-12#1)(2008-10#9)(2008-8#1)(2008-9#2)(2013-8#1)
rice plus canola oil##3##4##(2008-10#3)
rice production in##3##3##(2008-10#2)(2008-4#1)
rice production##4##2##(2008-10#3)(2008-4#1)
rice resistance to blast##2##4##(2008-10#1)(2012-2#1)
rice root##7##2##(2008-9#7)
rice samples##3##2##(2008-10#3)
rice seed##2##2##(2008-10#2)
rice seedlings##3##2##(2008-10#3)
rice seeds##4##2##(1992-8#1)(2008-9#3)
rice species##2##2##(2008-8#1)(2009-10#1)
rice starch 4##2##3##(2008-5#2)
rice starch##3##2##(2008-5#3)
rice to##4##2##(1997-3#1)(2008-10#3)
rice tungro spherical virus##2##4##(2008-10#2)
rice tungro##3##2##(2008-10#3)
rice using##5##2##(2008-7#1)(2009-10#1)(2011-1#3)
rice varieties in##2##3##(2008-12#1)(2011-1#1)
rice varieties##11##2##(1996-8#3)(2008-10#1)(2008-12#2)(2008-8#2)(2008-9#1)(2011-1#2)
rice variety##3##2##(2008-9#3)
rice was##3##2##(1993-11#1)(2008-4#1)(2008-9#1)
rice yellow mottle virus##2##4##(2008-10#2)
rice yellow stunt rhabdovirus##2##4##(2008-8#2)
rice yellow##5##2##(2008-10#3)(2008-8#2)
rice yield was##2##3##(2008-12#2)
rice yield##3##2##(2008-12#2)(2013-8#1)
rice##531##1##(1992-8#2)(1993-11#3)(1993-9#1)(1994-11#2)(1995-3#1)(1995-6#2)(1996-10#8)(1996-12#6)(1996-8#7)(1997-2#6)(1997-3#1)(1997-4#2)(1997-8#2)(2006-12#4)(2007-11#1)(2008-10#192)(2008-11#7)(2008-12#24)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#8)(2008-8#59)(2008-9#84)(2009-10#57)(2009-8#4)(2010-2#1)(2011-1#9)(2011-3#3)(2012-12#1)(2012-2#5)(2013-1#9)(2013-8#7)
rice)##2##1##(2008-10#2)
rice-M##2##1##(2009-10#1)(2012-2#1)
rice-diverged##2##1##(2009-10#2)
rich and poor##3##3##(1992-5#1)(2008-11#1)(2008-5#1)
rich and##10##2##(1991-6#1)(1992-5#1)(1994-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2012-3#1)
rich blood supply##2##3##(2008-5#1)(2009-1#1)
rich countries##2##2##(2008-11#1)(2011-1#1)
rich data##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
rich flames##2##2##(2008-3#2)
rich in acidic residues##2##4##(1992-7#1)(1995-6#1)
rich in fat##2##3##(1995-2#1)(1997-8#1)
rich in fibre##2##3##(2010-4#1)(2010-6#1)
rich in##54##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(1997-5#1)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-1#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
rich information##2##2##(2008-10#1)(2012-3#1)
rich phase##2##2##(2008-10#1)(2012-1#1)
rich region##8##2##(1993-3#2)(1997-2#2)(1997-7#2)(2008-8#2)
rich repeat##3##2##(2008-9#2)(2010-10#1)
rich soil##2##2##(2008-10#1)(2008-5#1)
rich source of##4##3##(1992-12#1)(2008-5#1)(2008-9#1)(2012-12#1)
rich sources of##2##3##(1992-3#1)(2008-5#1)
rich variety of##2##3##(2007-12#1)(2008-11#1)
rich##175##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#5)(2007-11#1)(2007-12#5)(2007-9#2)(2008-10#14)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#7)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#9)(2009-1#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#6)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
richer##7##1##(1997-1#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
richest##4##1##(1990-12#1)(2008-10#1)(2008-5#1)(2011-3#1)
richly##3##1##(1995-12#1)(1997-4#1)(2013-1#1)
richness (S)##3##2##(2008-5#1)(2008-8#1)(2013-7#1)
richness and abundance of##2##4##(2008-5#1)(2008-6#1)
richness and abundance##9##3##(2008-5#2)(2008-6#4)(2013-7#3)
richness and altitude##2##3##(2008-8#2)
richness and complexity##3##3##(2008-10#2)(2008-12#1)
richness and composition##3##3##(2008-8#1)(2013-7#2)
richness and diversity##3##3##(2008-10#1)(2008-5#2)
richness and##36##2##(2008-10#4)(2008-12#1)(2008-5#5)(2008-6#4)(2008-8#9)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#7)(2013-8#1)
richness at##2##2##(2008-8#1)(2013-7#1)
richness increased##2##2##(2008-8#2)
richness is##9##2##(2008-10#1)(2008-8#7)(2008-9#1)
richness of##13##2##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2011-2#6)
richness was##4##2##(2008-5#2)(2008-9#1)(2013-7#1)
richness were##3##2##(2008-8#1)(2008-9#1)(2013-7#1)
richness##123##1##(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#13)(2008-6#6)(2008-8#45)(2008-9#15)(2009-10#1)(2010-10#1)(2011-2#9)(2012-2#1)(2013-1#1)(2013-7#20)(2013-8#1)
ricin A chain##2##3##(1990-12#1)(1992-3#1)
ricin and abrin##3##3##(1994-5#3)
ricin and##4##2##(1990-11#1)(1994-5#3)
ricin##13##1##(1990-11#1)(1990-12#1)(1992-3#3)(1993-11#2)(1993-12#1)(1994-5#5)
ricini##3##1##(2008-6#1)(2008-8#2)
rickets and##2##2##(2008-1#2)
rickets in##2##2##(2008-1#2)
rickets is##2##2##(2008-1#2)
rickets##17##1##(1997-3#1)(2008-1#10)(2011-1#5)(2012-2#1)
rickettsiae##2##1##(1995-12#1)(2009-2#1)
rickettsial##5##1##(1994-12#1)(1995-12#1)(1996-1#1)(2007-2#1)(2007-7#1)
rickettsii##3##1##(1991-8#2)(1995-12#1)
ricochetal brachiation##2##2##(2012-12#2)
rid##3##1##(2007-7#1)(2007-8#1)(2009-11#1)
ridden##2##1##(2012-12#2)
riddle of##3##2##(1992-11#1)(1993-12#1)(2008-5#1)
ride##4##1##(1994-2#1)(2008-7#1)(2012-2#1)(2012-3#1)
rider##3##1##(2012-12#3)
rides##2##1##(2012-2#2)
ridge and a##2##3##(1997-5#1)(2007-11#1)
ridge and##4##2##(1997-5#1)(2007-11#1)(2007-12#1)(2008-7#1)
ridge count##2##2##(2012-12#2)
ridge density##3##2##(2012-12#3)
ridge extraction##3##2##(2008-3#3)
ridge gourd##2##2##(2013-8#2)
ridge of##2##2##(2008-3#1)(2008-5#1)
ridge splitting techniques##2##3##(2007-12#2)
ridge tillage##6##2##(2008-10#6)
ridge waveguide##2##2##(2007-12#2)
ridge##51##1##(1993-11#1)(1994-11#1)(1996-5#1)(1997-5#1)(2007-11#4)(2007-12#16)(2008-10#6)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#5)(2010-3#1)(2012-12#6)(2013-1#1)(2013-8#2)
ridges and##2##2##(2008-5#1)(2013-7#1)
ridges of##2##2##(1994-11#1)(2008-5#1)
ridges that are##2##3##(2007-11#1)(2013-1#1)
ridges with##2##2##(2011-2#1)(2013-1#1)
ridges##20##1##(1991-8#2)(1994-11#2)(2007-11#3)(2007-12#2)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
riding##5##1##(2007-3#1)(2008-10#1)(2009-1#1)(2012-12#2)
rifalazil##3##1##(2008-5#3)
rifampicin and##5##2##(1991-11#1)(2008-10#4)
rifampicin resistance##5##2##(2007-7#5)
rifampicin##20##1##(1991-11#1)(2007-7#7)(2008-1#1)(2008-10#7)(2008-12#1)(2008-8#2)(2011-2#1)
rifampicin-resistant##3##1##(2007-6#2)(2008-10#1)
rifampin therapy##2##2##(2007-12#1)(2008-5#1)
rifampin##10##1##(2007-12#4)(2008-5#4)(2011-2#2)
rifamycin B production##2##3##(1994-8#2)
rifamycin B##3##2##(1994-8#3)
rifamycin##4##1##(1994-8#3)(2008-5#1)
rig##5##1##(2007-8#1)(2008-3#2)(2011-2#1)(2013-1#1)
right MCA##4##2##(1997-6#1)(2008-12#3)
right accessory##2##2##(2008-11#1)(2008-7#1)
right adrenal gland##4##3##(2008-5#3)(2012-12#1)
right adrenal##7##2##(2007-10#1)(2008-1#1)(2008-5#3)(2008-8#1)(2012-12#1)
right and left lobes of the thyroid gland##2##8##(2013-1#2)
right and left lobes##3##4##(2013-1#3)
right and left##17##3##(1993-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
right and##25##2##(1990-11#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)
right arm and leg##2##4##(2010-9#2)
right arm and##3##3##(2008-5#1)(2010-9#2)
right arm##25##2##(1990-12#1)(1993-11#1)(1995-6#6)(1995-9#1)(1996-3#2)(1996-6#4)(1997-3#5)(2008-5#1)(2010-9#2)(2011-2#1)(2012-12#1)
right atrial mass##2##3##(2007-8#2)
right atrial pressure##3##3##(1997-5#1)(2007-9#1)(2008-11#1)
right atrial##18##2##(1990-12#2)(1990-5#1)(1997-2#1)(1997-5#1)(2007-8#8)(2007-9#1)(2008-11#1)(2012-1#1)(2012-12#2)
right atrium##25##2##(1997-6#1)(2007-8#13)(2008-11#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-2#2)
right basal##2##2##(1996-9#1)(2007-10#1)
right brain##3##2##(1995-8#1)(1996-2#1)(2009-2#1)
right bundle branch block##4##4##(2008-12#2)(2008-7#1)(2012-12#1)
right calf##3##2##(1991-6#1)(2007-12#1)(2009-3#1)
right cardiac##2##2##(1993-2#1)(2010-6#1)
right carotid artery##2##3##(2009-7#1)(2011-1#1)
right carotid##3##2##(2008-7#1)(2009-7#1)(2011-1#1)
right cerebral##5##2##(1990-3#1)(2011-1#2)(2013-8#2)
right choice in##2##3##(1993-1#1)(2010-5#1)
right choice##3##2##(1993-1#1)(2007-8#1)(2010-5#1)
right coronary artery (RCA)##2##4##(2007-8#1)(2013-2#1)
right coronary artery from the##2##5##(2007-8#1)(2008-12#1)
right coronary artery##11##3##(1994-11#1)(2007-8#6)(2008-12#1)(2010-5#1)(2013-2#1)(2013-8#1)
right coronary##17##2##(1994-11#1)(2007-8#10)(2008-12#1)(2010-5#1)(2012-2#2)(2013-2#1)(2013-8#1)
right ear##3##2##(2008-7#1)(2010-6#1)(2011-2#1)
right elbow##2##2##(2008-5#1)(2008-9#1)
right eye and##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
right eye for the##2##4##(2011-1#1)(2013-7#1)
right eye with##2##3##(2008-7#1)(2011-2#1)
right eye##21##2##(1994-8#1)(2007-7#1)(2008-11#1)(2008-7#2)(2010-10#2)(2011-1#4)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
right femoral##6##2##(1993-12#1)(2006-10#1)(2008-12#1)(2009-4#1)(2012-1#1)(2013-8#1)
right femur##2##2##(2008-12#1)(2011-2#1)
right foot##5##2##(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)(2013-1#1)
right for##4##2##(1992-2#1)(1993-1#1)(2013-1#1)(2013-7#1)
right forelimb lameness##2##3##(2012-3#1)(2013-8#1)
right forelimb##3##2##(2012-3#1)(2013-8#2)
right frontal##6##2##(1996-2#1)(1996-5#1)(2007-10#3)(2008-7#1)
right gastro-epiploic artery##2##3##(2007-8#2)
right hand##8##2##(1990-11#1)(1994-3#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)
right heart catheterization and##2##4##(2006-10#1)(2011-2#1)
right heart catheterization##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
right heart failure##3##3##(2008-3#1)(2010-5#1)(2012-12#1)
right heart##13##2##(1993-5#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-10#2)(2010-5#1)(2011-2#2)(2012-12#1)
right hemicolectomy##2##2##(1993-9#1)(2013-1#1)
right hemiparesis##5##2##(2007-8#1)(2008-7#2)(2010-9#1)(2013-8#1)
right hemiplegia##2##2##(2008-1#1)(2013-8#1)
right hemisphere brain damage##2##4##(2012-3#2)
right hemisphere is##2##3##(2008-11#2)
right hemisphere stroke##2##3##(2008-2#2)
right hemisphere##26##2##(1990-3#5)(1991-11#1)(1996-2#4)(1996-5#3)(1997-8#3)(2008-1#2)(2008-11#2)(2008-2#2)(2009-2#1)(2010-7#1)(2012-3#2)
right hemispheric##4##2##(2007-10#4)
right hemithorax##2##2##(2007-12#1)(2010-12#1)
right hepatic artery##3##3##(1990-3#1)(2012-2#1)(2013-1#1)
right hepatic##4##2##(1990-3#1)(1991-6#1)(2012-2#1)(2013-1#1)
right hip##2##2##(2006-10#1)(2013-7#1)
right iliac fossa##2##3##(2008-7#2)
right in the##2##3##(1990-11#1)(2012-12#1)
right in##5##2##(1990-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(2012-12#1)
right inferior frontal##2##3##(2013-1#2)
right inferior##3##2##(2008-12#1)(2013-1#2)
right internal thoracic artery##4##4##(2007-8#4)
right internal##7##2##(1996-9#1)(2007-7#1)(2007-8#4)(2012-3#1)
right kidney and##2##3##(2008-9#1)(2011-2#1)
right kidney weights of##3##4##(2008-9#3)
right kidney weights##4##3##(2008-9#4)
right kidney##15##2##(1990-9#1)(1994-5#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-9#6)(2011-2#2)(2013-1#1)
right lateral##2##2##(2012-3#1)(2013-1#1)
right leg##2##2##(2007-12#1)(2008-5#1)
right liver##3##2##(1990-6#1)(2012-3#1)(2013-1#1)
right lobe##9##2##(1993-6#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-11#2)(2012-2#2)(2013-8#1)
right lobes##2##2##(2006-10#1)(2008-11#1)
right lower lobe##3##3##(1992-2#1)(2007-12#1)(2007-8#1)
right lower##14##2##(1991-12#1)(1992-2#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-6#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
right lung##12##2##(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-8#1)(2010-7#1)(2011-1#1)(2013-1#1)
right lungs##2##2##(1996-3#1)(2008-10#1)
right maxillary##3##2##(2011-1#2)(2013-1#1)
right middle cerebral##7##3##(1996-3#1)(2008-12#1)(2008-7#4)(2013-8#1)
right middle##15##2##(1996-2#1)(1996-3#2)(2008-1#3)(2008-11#1)(2008-12#2)(2008-7#4)(2013-1#1)(2013-8#1)
right nephrectomy for##2##3##(2008-1#1)(2008-10#1)
right nephrectomy##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2012-2#1)
right of the##2##3##(1990-12#1)(2009-2#1)
right of##4##2##(1990-12#1)(2009-2#2)(2012-2#1)
right on##2##2##(1994-12#1)(2008-1#1)
right or left##2##3##(2008-5#1)(2013-8#1)
right or##7##2##(1991-12#1)(1991-3#1)(1994-1#2)(2008-5#1)(2013-8#2)
right orbit##2##2##(2008-7#1)(2011-1#1)
right parietal##2##2##(2009-1#1)(2013-8#1)
right pneumonectomy##2##2##(2007-8#1)(2008-1#1)
right posterior##2##2##(2007-10#1)(2008-12#1)
right pulmonary artery##4##3##(1997-5#1)(2007-8#1)(2008-11#1)(2010-10#1)
right pulmonary##5##2##(1997-5#1)(2007-8#2)(2008-11#1)(2010-10#1)
right renal artery##3##3##(1990-2#1)(2007-7#2)
right renal##5##2##(1990-2#1)(2007-7#2)(2008-1#1)(2008-10#1)
right shift##2##2##(1997-8#2)
right side##24##2##(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#7)(2013-7#1)
right sided##3##2##(2007-8#1)(2008-1#1)(2012-2#1)
right subclavian artery##4##3##(2007-8#1)(2008-11#2)(2010-5#1)
right subclavian##6##2##(2007-8#1)(2008-11#3)(2010-5#1)(2011-2#1)
right superior parietal##2##3##(2008-11#1)(2013-8#1)
right superior##6##2##(1996-7#1)(1996-9#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
right system##2##2##(2007-8#1)(2011-2#1)
right temporal##4##2##(1992-12#1)(2008-8#1)(2010-7#1)(2013-8#1)
right testis##4##2##(1997-3#1)(2008-10#2)(2008-9#1)
right the##2##2##(1995-12#1)(1997-1#1)
right thigh##4##2##(2007-6#1)(2007-7#1)(2012-3#2)
right thoracic##2##2##(2007-8#1)(2010-4#1)
right to abortion##2##3##(1992-6#1)(1993-3#1)
right to die##2##3##(1994-2#1)(1996-11#1)
right to health##3##3##(1994-2#1)(1995-2#1)(2012-12#1)
right to left##3##3##(2009-10#2)(2009-3#1)
right to life##5##3##(1995-12#1)(2011-2#4)
right to privacy##3##3##(1996-9#1)(1997-5#1)(2008-12#1)
right to refuse treatment##3##4##(1995-12#2)(1995-2#1)
right to refuse##5##3##(1990-11#1)(1992-12#1)(1995-12#2)(1995-2#1)
right to seek##2##3##(1990-12#1)(1997-7#1)
right to self-determination##4##3##(1991-2#2)(1997-8#2)
right to##60##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#2)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1993-12#2)(1993-3#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-12#8)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-3#1)(2009-6#1)(2011-2#4)(2012-12#1)(2013-1#1)
right transradial approach##4##3##(2008-11#3)(2011-2#1)
right up##2##2##(1990-11#1)(2008-5#1)
right upper extremity##2##3##(2008-12#1)(2010-9#1)
right upper lobe##5##3##(2007-12#1)(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
right upper lobectomy##5##3##(2007-8#4)(2012-1#1)
right upper##20##2##(1990-9#1)(2007-12#1)(2007-8#5)(2008-12#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#3)
right ventricle##21##2##(1995-12#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-7#4)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
right ventricular failure##2##3##(2007-8#1)(2010-6#1)
right ventricular outflow tract##3##4##(2007-8#1)(2007-9#1)(2013-2#1)
right ventricular##23##2##(1996-11#1)(1996-3#3)(1997-3#2)(2007-8#4)(2007-9#1)(2008-12#1)(2008-3#2)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-2#1)
right vertebral artery dissection##2##4##(1991-8#1)(2013-8#1)
right vertebral artery##3##3##(1991-8#1)(2013-8#2)
right visual field##2##3##(1996-2#2)
right with##2##2##(1994-11#1)(2008-11#1)
right##911##1##(1990-11#8)(1990-12#7)(1990-2#1)(1990-3#8)(1990-5#4)(1990-6#4)(1990-9#4)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#2)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#11)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#5)(1995-1#5)(1995-11#1)(1995-12#16)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#10)(1995-8#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#11)(1996-3#14)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#9)(1997-1#3)(1997-2#1)(1997-3#11)(1997-5#5)(1997-6#4)(1997-7#1)(1997-8#9)(2006-10#6)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#16)(2007-12#12)(2007-4#2)(2007-6#2)(2007-7#12)(2007-8#76)(2007-9#3)(2008-1#24)(2008-10#23)(2008-11#34)(2008-12#26)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#17)(2008-6#5)(2008-7#41)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#10)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-10#8)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#8)(2010-7#7)(2010-8#3)(2010-9#6)(2011-1#22)(2011-2#61)(2012-1#6)(2012-12#15)(2012-2#19)(2012-3#21)(2012-7#1)(2013-1#39)(2013-2#4)(2013-7#13)(2013-8#24)
right&quot##11##1##(1993-2#1)(1993-3#1)(1994-2#4)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-2#1)
right- and left-handed##2##3##(1995-6#1)(2007-11#1)
right- and##3##2##(1995-6#1)(2007-11#1)(2008-3#1)
right- or##2##2##(1995-11#1)(2008-7#1)
right-##5##1##(1995-11#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-7#1)
right-angle##3##1##(2008-3#2)(2008-9#1)
right-brain-damaged patients##2##2##(2009-10#2)
right-hand##2##1##(2007-12#1)(2008-10#1)
right-handed##11##1##(1992-2#1)(1996-2#2)(2006-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-2#1)
right-handedness##3##1##(1995-11#1)(2007-12#2)
right-pawed##2##1##(1997-2#2)
right-side##5##1##(2007-8#3)(2013-7#2)
right-sided facial pain##2##3##(2011-2#1)(2012-12#1)
right-sided facial##4##2##(2008-7#1)(2011-2#2)(2012-12#1)
right-sided##25##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-3#1)(1993-9#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-8#1)(2013-8#1)
right-to-left shunt##2##2##(2010-5#1)(2011-2#1)
right-to-left##3##1##(1990-11#1)(2010-5#1)(2011-2#1)
right-wing##2##1##(2008-11#1)(2008-7#1)
right?##3##1##(1997-3#1)(2008-11#1)(2012-3#1)
righting modes##2##2##(2007-12#2)
righting##12##1##(1992-11#2)(1992-12#2)(1993-12#1)(2007-12#6)(2008-4#1)
rightly##3##1##(1997-1#1)(2008-7#2)
rights and responsibilities##2##3##(1994-3#1)(2009-10#1)
rights and##12##2##(1990-6#2)(1994-3#1)(1996-7#1)(1996-8#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#3)(2013-8#1)
rights for##3##2##(1992-12#1)(2008-12#1)(2008-5#1)
rights has##2##2##(1991-3#1)(2012-3#1)
rights in##4##2##(1992-2#1)(2008-11#1)(2008-5#1)(2013-8#1)
rights of##10##2##(1995-6#1)(1996-5#1)(1997-5#1)(2008-11#1)(2008-7#3)(2009-11#1)(2010-3#1)(2012-3#1)
rights to##11##2##(1990-12#1)(1994-8#1)(1997-8#2)(2008-11#1)(2008-5#4)(2008-7#1)(2009-7#1)
rights##88##1##(1990-12#1)(1990-2#1)(1990-6#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#3)(1996-1#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-5#6)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#8)
rightsizing##2##1##(1993-1#2)
rightward bisection error##2##3##(2009-10#2)
rightward##10##1##(1990-5#1)(1994-8#1)(1995-12#3)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#2)
rigid and stable##2##3##(2008-10#2)
rigid and##5##2##(1991-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
rigid body##4##2##(1993-3#1)(2008-3#1)(2009-10#2)
rigid bronchoscopy##2##2##(2012-3#1)(2013-1#1)
rigid endoscopes##2##2##(2011-1#2)
rigid fixation##2##2##(2007-8#1)(2012-12#1)
rigid sagittal deformity##2##3##(2008-8#2)
rigid structure of##2##3##(1994-3#1)(2008-12#1)
rigid structure##3##2##(1990-7#1)(1994-3#1)(2008-12#1)
rigid##64##1##(1990-7#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#4)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
rigidity and##8##2##(2008-10#1)(2008-12#2)(2008-7#2)(2009-11#2)(2009-12#1)
rigidity of the##5##3##(1995-8#1)(2007-11#1)(2008-10#2)(2009-4#1)
rigidity of##11##2##(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#3)(2008-12#3)(2009-4#1)(2013-1#1)
rigidity##45##1##(1993-11#1)(1995-2#1)(1995-8#2)(2007-11#1)(2008-10#6)(2008-12#9)(2008-3#1)(2008-5#1)(2008-7#7)(2009-10#1)(2009-11#4)(2009-12#2)(2009-4#4)(2009-9#1)(2010-2#1)(2012-12#1)(2013-1#2)
rigor##7##1##(1992-12#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
rigorous and##5##2##(1992-1#1)(1992-2#1)(2008-8#2)(2012-12#1)
rigorous approach##2##2##(2008-3#2)
rigorous calculations##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
rigorous design to##2##3##(2010-5#1)(2011-2#1)
rigorous diffraction##2##2##(2007-12#1)(2008-3#1)
rigorous electromagnetic##5##2##(2008-2#1)(2008-3#4)
rigorous method##2##2##(2008-3#1)(2009-5#1)
rigorous methodology are##2##3##(2008-10#2)
rigorous methods##2##2##(2008-10#1)(2011-2#1)
rigorous numerical simulations##2##3##(2007-12#1)(2008-3#1)
rigorous numerical##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
rigorous quantitative##2##2##(2009-9#1)(2010-5#1)
rigorous radiative transfer##2##3##(2008-3#2)
rigorous statistical##2##2##(2008-3#1)(2012-2#1)
rigorous study##3##2##(2008-10#1)(2012-3#2)
rigorous theoretical##2##2##(2008-3#1)(2010-2#1)
rigorous theory##2##2##(2008-3#1)(2008-8#1)
rigorous##108##1##(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#5)(2007-12#5)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#10)(2008-3#25)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
rigorously controlled##2##2##(2008-10#1)(2013-1#1)
rigorously##22##1##(1991-8#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#2)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
rigors and##3##2##(1995-12#1)(1997-2#1)(2007-12#1)
rigors##6##1##(1990-10#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-1#1)
rigour##3##1##(2008-11#2)(2008-7#1)
rim of the##3##3##(1996-5#1)(1996-9#1)(2008-8#1)
rim##18##1##(1996-5#3)(1996-9#1)(1997-5#2)(2006-12#4)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
rimalkalim##8##1##(1997-7#8)
rims##4##1##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
rind##2##1##(2008-10#2)
rinderpest##6##1##(1990-3#4)(2011-2#2)
ring analogues and derivatives of##2##5##(1993-1#2)
ring and##9##2##(1994-6#1)(2008-10#3)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
ring annuloplasty##2##2##(2008-10#2)
ring arcs##3##2##(1991-8#3)
ring can be##2##3##(2008-3#1)(2010-12#1)
ring can##3##2##(2008-3#2)(2010-12#1)
ring cavity##19##2##(2007-11#4)(2007-12#8)(2008-2#2)(2008-3#5)
ring cell##5##2##(1993-12#3)(2008-10#2)
ring closure##2##2##(1997-3#1)(2007-11#1)
ring conformations##2##2##(1991-5#1)(2008-5#1)
ring contraction##2##2##(2007-11#2)
ring electrode##2##2##(2008-3#1)(2008-5#1)
ring electrodes##4##2##(2007-12#2)(2008-10#2)
ring formation##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
ring from##3##2##(2008-8#1)(2009-10#1)(2010-7#1)
ring in the##3##3##(1991-3#1)(1995-11#1)(2008-8#1)
ring in##6##2##(1991-11#1)(1991-3#1)(1995-11#1)(1995-5#1)(2007-11#1)(2008-8#1)
ring is##10##2##(1994-12#1)(1994-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
ring laser gyroscope##3##3##(2008-2#2)(2008-3#1)
ring laser gyroscopes##2##3##(2008-3#2)
ring laser is##3##3##(2007-11#2)(2008-2#1)
ring laser with a superluminescent diode##2##6##(2008-2#2)
ring laser##27##2##(2007-11#9)(2007-12#3)(2008-2#8)(2008-3#7)
ring lasers##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
ring nematodes##2##2##(2008-10#2)
ring network##2##2##(2007-11#1)(2008-3#1)
ring nitrogen##2##2##(1993-1#1)(1995-3#1)
ring of the##6##3##(1992-1#1)(1993-11#1)(1994-5#1)(2008-10#3)
ring of##28##2##(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#1)(1996-8#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2010-9#1)(2012-12#1)
ring on the##2##3##(2008-10#1)(2008-9#1)
ring opening##6##2##(1994-5#1)(1995-2#1)(2007-11#1)(2008-8#2)(2012-12#1)
ring optical parametric oscillator##3##4##(2007-11#3)
ring optical##4##2##(2007-11#4)
ring or##3##2##(1992-6#1)(1995-3#1)(2007-12#1)
ring patterns##3##2##(2008-2#3)
ring resonator filter##2##3##(2008-3#2)
ring resonator with##3##3##(2008-3#2)(2011-1#1)
ring resonator##16##2##(2007-11#4)(2007-12#2)(2008-3#7)(2011-1#3)
ring resonators##3##2##(2007-12#1)(2008-3#2)
ring sinus##4##2##(2011-2#4)
ring spots##2##2##(2008-10#2)
ring stages##2##2##(2010-12#2)
ring structure of##2##3##(2009-10#2)
ring structure##9##2##(1990-7#1)(1991-6#1)(2008-10#3)(2008-3#1)(2009-10#2)(2013-8#1)
ring structures##4##2##(1995-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
ring study##2##2##(2008-10#2)
ring system and the##2##4##(1993-12#2)
ring system and##3##3##(1993-12#3)
ring system of##2##3##(1995-2#1)(2008-7#1)
ring system##14##2##(1991-3#1)(1993-12#5)(1995-2#1)(2008-7#1)(2009-7#1)(2009-9#3)(2010-2#2)
ring that##2##2##(2008-3#2)
ring to##7##2##(1991-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-6#1)
ring was##2##2##(2008-10#1)(2009-8#1)
ring were##3##2##(1992-10#1)(2008-11#1)(2009-9#1)
ring with##2##2##(1994-9#1)(2008-10#1)
ring##388##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#8)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#5)(1994-2#1)(1994-5#4)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#5)(1995-3#5)(1995-5#5)(1996-2#3)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2006-8#1)(2007-11#41)(2007-12#25)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#54)(2008-11#7)(2008-12#3)(2008-2#32)(2008-3#42)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#4)(2009-11#2)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#12)(2012-12#2)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#2)
ring-closing##3##1##(1990-9#1)(2008-11#1)(2010-2#1)
ring-disc electrode##4##2##(2008-10#4)
ring-disk dual##2##2##(2008-10#2)
ring-disk working electrode##2##3##(2008-10#2)
ring-disk##6##1##(2008-10#5)(2008-5#1)
ring-down##4##1##(2007-11#2)(2010-7#2)
ring-laser design##2##2##(2008-2#1)(2008-3#1)
ring-opening of##2##2##(1993-11#1)(1996-5#1)
ring-opening##9##1##(1990-9#2)(1993-11#1)(1996-5#1)(2008-12#1)(2009-11#1)(2012-12#3)
ring-shaped##6##1##(2007-11#1)(2008-2#2)(2009-2#1)(2012-2#1)(2013-8#1)
ring-substituted##2##1##(1995-3#2)
ring-toric lenses##2##2##(2008-2#2)
ring-toric##3##1##(2008-2#3)
ring-wedge detector##2##2##(2008-3#2)
ringdown cavity##2##2##(2008-2#1)(2008-3#1)
ringdown spectral photography##2##3##(2008-3#2)
ringdown spectroscopy with##2##3##(2008-2#1)(2008-3#1)
ringdown spectroscopy##17##2##(2007-12#2)(2008-2#2)(2008-3#13)
ringdown time##3##2##(2008-3#3)
ringdown##42##1##(2007-12#4)(2008-2#5)(2008-3#33)
ringed seals##2##2##(2008-10#2)
ringed##5##1##(2007-6#1)(2008-10#4)
ringing##4##1##(2008-3#1)(2011-1#3)
rings and their##2##3##(1997-7#1)(2007-11#1)
rings and##7##2##(1990-12#1)(1991-8#1)(1994-3#1)(1997-7#1)(2007-11#1)(2010-11#1)(2010-2#1)
rings are##4##2##(1994-5#1)(1996-2#1)(1997-7#1)(2011-1#1)
rings have##3##2##(1996-5#1)(2008-10#2)
rings in the##2##3##(1990-3#1)(2008-10#1)
rings of the##4##3##(1994-5#2)(2007-11#2)
rings of##10##2##(1990-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-3#1)
rings was##3##2##(1990-12#1)(1995-3#1)(2008-10#1)
rings were##6##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
rings with##2##2##(2008-8#1)(2008-9#1)
rings##87##1##(1990-12#5)(1990-3#2)(1990-8#1)(1991-5#1)(1991-8#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-7#7)(2007-11#9)(2007-12#4)(2007-8#2)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
rings)##2##1##(2008-10#1)(2013-8#1)
ringspot virus in##2##3##(2008-10#2)
ringspot virus##21##2##(2008-10#21)
ringspot##27##1##(2008-10#27)
ringworm##2##1##(2008-5#2)
ringwulst##2##1##(2011-2#2)
rinse##5##1##(2008-10#2)(2010-3#1)(2013-1#2)
rinsed with##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
rinsed##6##1##(2008-10#2)(2008-12#2)(2008-8#1)(2013-1#1)
rinsing and drying##2##3##(2008-12#2)
rinsing and##3##2##(2008-12#2)(2010-5#1)
rinsing of the##2##3##(2008-10#2)
rinsing with##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
rinsing##16##1##(1991-6#1)(2007-8#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
ripe fleshy fruits##2##3##(2008-9#2)
ripe for a##2##3##(1991-12#1)(2008-7#1)
ripe##12##1##(1991-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2011-2#3)(2013-1#1)
ripened honey##2##2##(2008-10#2)
ripened##4##1##(2008-10#2)(2012-2#2)
ripeness##2##1##(2008-10#2)
ripening fruits##2##2##(2008-10#2)
ripening processes##2##2##(2008-7#2)
ripening stages##2##2##(2008-12#2)
ripening state##2##2##(2008-10#2)
ripening##25##1##(2008-10#8)(2008-12#6)(2008-7#2)(2009-11#1)(2011-2#5)(2012-2#3)
ripple structure##2##2##(2008-3#2)
ripple##8##1##(1997-2#1)(2008-2#1)(2008-3#6)
ripples##6##1##(2007-11#4)(2008-3#2)
rips##2##1##(1991-9#1)(1993-8#1)
rise and decay times##2##4##(2008-2#1)(2008-3#1)
rise and decay##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
rise and##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2013-1#1)
rise as high as##2##4##(1990-11#1)(2008-2#1)
rise as##4##2##(1990-11#1)(1994-5#1)(2008-10#1)(2008-2#1)
rise at##4##2##(1996-3#1)(2007-12#1)(2008-5#1)(2012-3#1)
rise by##2##2##(2008-11#1)(2013-1#1)
rise during##2##2##(1990-12#1)(2008-1#1)
rise in [Ca2+]i in##2##4##(1992-6#1)(1994-2#1)
rise in [Ca2+]i##9##3##(1990-12#1)(1992-6#1)(1994-2#3)(1994-3#1)(1995-12#3)
rise in current##2##3##(1990-5#2)
rise in cytosolic##3##3##(1995-12#2)(1995-5#1)
rise in incidence of##2##4##(2008-10#1)(2008-8#1)
rise in incidence##5##3##(1991-12#1)(1995-2#2)(2008-10#1)(2008-8#1)
rise in intracellular##2##3##(1994-2#1)(1994-6#1)
rise in lipid peroxidation##2##4##(1990-3#1)(2013-1#1)
rise in the number of##2##5##(1990-3#1)(1994-5#1)
rise in the##19##3##(1990-3#1)(1992-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
rise in their##2##3##(1992-3#1)(1995-2#1)
rise in##98##2##(1990-10#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-12#3)(1991-6#2)(1992-1#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#3)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#2)(2013-8#3)
rise induced by the##2##4##(1995-11#1)(2013-1#1)
rise induced by##4##3##(1994-5#1)(1995-11#1)(2008-4#1)(2013-1#1)
rise is##3##2##(1996-7#2)(2010-12#1)
rise of free intracellular calcium##2##5##(1990-2#1)(1995-5#1)
rise of the##5##3##(1991-12#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)
rise of these##2##3##(1994-1#1)(2008-7#1)
rise of##26##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-11#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-1#2)(2013-1#1)
rise or##2##2##(1997-6#1)(2008-10#1)
rise time of##2##3##(2008-10#1)(2008-2#1)
rise time##4##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
rise to a new##5##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)
rise to a##36##3##(1990-11#1)(1991-9#2)(1992-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-8#2)
rise to an increase of the##2##6##(2008-10#1)(2008-2#1)
rise to an##8##3##(1990-11#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)
rise to chromosome##2##3##(2008-11#1)(2012-3#1)
rise to different##2##3##(2008-10#2)
rise to many##3##3##(1992-3#1)(2008-5#1)(2009-1#1)
rise to metastases##2##3##(1991-6#1)(2009-5#1)
rise to multiple##2##3##(1997-4#1)(2008-7#1)
rise to new##4##3##(1992-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
rise to the most##2##4##(2010-7#1)(2013-1#1)
rise to the possibility##2##4##(2007-11#1)(2010-2#1)
rise to the##27##3##(1991-8#1)(1992-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
rise to##198##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-7#1)(2008-1#2)(2008-10#24)(2008-11#12)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#7)
rise was not##2##3##(1997-8#1)(2013-1#1)
rise was##4##2##(1991-12#1)(1997-8#1)(2008-5#1)(2013-1#1)
rise with##3##2##(1993-3#1)(2008-9#1)(2013-1#1)
rise##394##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-12#6)(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-3#3)(1993-5#2)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#9)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#3)(1995-11#3)(1995-12#10)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#4)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#2)(1997-9#1)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#39)(2008-11#20)(2008-12#3)(2008-2#11)(2008-3#16)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#12)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#5)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#13)(2013-8#10)
risen from##2##2##(1997-7#1)(2007-12#1)
risen##13##1##(1994-1#1)(1995-1#1)(1995-3#2)(1997-7#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)
rises in [Ca2+]i caused by##2##5##(1994-2#2)
rises in##6##2##(1990-2#1)(1990-7#1)(1994-2#2)(1994-6#1)(1994-8#1)
rises##22##1##(1990-2#1)(1990-7#1)(1991-12#1)(1992-6#1)(1993-1#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#3)(2011-2#1)(2013-1#1)(2013-8#1)
rising and falling##2##3##(2008-3#2)
rising costs##6##2##(1991-12#2)(1992-12#1)(2007-12#1)(2011-7#1)(2012-3#1)
rising from##2##2##(2008-6#1)(2013-7#1)
rising health care costs and##2##5##(1992-3#1)(1997-1#1)
rising health care costs##3##4##(1992-3#1)(1997-1#1)(2012-2#1)
rising in##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
rising numbers of##3##3##(1995-1#1)(1995-9#1)(1996-3#1)
rising of##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
rising to a##2##3##(2008-10#1)(2008-8#1)
rising to##5##2##(1992-3#1)(1993-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
rising##79##1##(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-4#2)(2010-9#1)(2011-1#5)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#5)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#5)
risk (RR) 0##2##3##(1993-9#1)(2011-1#1)
risk (RR)##7##2##(1992-11#1)(1993-9#2)(2011-1#2)(2011-2#1)(2013-1#1)
risk =##3##2##(1991-2#1)(1997-8#1)(2008-1#1)
risk adjusted capitation##2##3##(1997-1#2)
risk adjustment for##2##3##(1997-1#2)
risk adjustment of##2##3##(1995-2#1)(2010-12#1)
risk adjustment##12##2##(1995-2#3)(1995-3#3)(1997-1#3)(2008-11#1)(2008-7#1)(2010-12#1)
risk after##3##2##(1991-11#1)(1995-1#1)(2007-8#1)
risk among adolescents##2##3##(1994-2#1)(2013-1#1)
risk among##15##2##(1994-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#2)
risk analysis approach##2##3##(2008-10#1)(2012-2#1)
risk analysis in##2##3##(1997-4#1)(2008-10#1)
risk analysis of##3##3##(2008-11#1)(2012-2#2)
risk analysis##19##2##(1990-11#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-10#3)(2009-7#1)(2012-2#7)
risk and long-term##2##3##(1990-8#1)(2013-8#1)
risk and protective factors##5##4##(2008-2#1)(2008-5#1)(2009-7#3)
risk and protective##6##3##(2008-2#1)(2008-5#1)(2009-7#4)
risk and the##2##3##(1991-12#1)(2008-2#1)
risk and uncertainty##2##3##(2012-12#2)
risk and##72##2##(1990-8#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-12#1)(1993-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-5#2)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
risk and/or##3##2##(1995-6#1)(2008-1#1)(2008-12#1)
risk appraisal##2##2##(2010-7#2)
risk are still##2##3##(1990-6#1)(2008-1#1)
risk are##8##2##(1990-6#1)(1994-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
risk areas for##2##3##(2008-8#2)
risk areas##5##2##(2008-8#3)(2012-12#1)(2012-3#1)
risk as a function of##2##5##(1996-11#1)(1997-8#1)
risk as a##4##3##(1994-11#1)(1996-11#1)(1997-8#1)(2008-8#1)
risk assessment and##9##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
risk assessment are##3##3##(1997-3#1)(2008-10#1)(2011-1#1)
risk assessment at##2##3##(2008-10#1)(2011-2#1)
risk assessment by##2##3##(2010-10#1)(2010-4#1)
risk assessment for##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
risk assessment in the cosmetic industry have led to the development of##2##12##(2008-5#2)
risk assessment in the##4##4##(2008-10#1)(2008-3#1)(2008-5#2)
risk assessment in##7##3##(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)
risk assessment model##2##3##(2008-10#1)(2008-8#1)
risk assessment models##2##3##(2008-10#2)
risk assessment of pharmaceutical residues##2##5##(2008-10#2)
risk assessment of plant protection products##2##6##(2008-11#2)
risk assessment of##14##3##(1995-9#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-9#1)(2012-1#1)
risk assessment process##2##3##(2008-10#1)(2008-5#1)
risk assessment to##2##3##(2008-9#1)(2012-3#1)
risk assessment##122##2##(1991-12#3)(1993-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#3)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#29)(2008-11#10)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#4)(2009-4#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
risk assessments and##3##3##(2008-10#2)(2010-4#1)
risk assessments of##2##3##(2008-10#2)
risk assessments##16##2##(1997-8#1)(2008-10#7)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#5)
risk associated with##13##3##(1991-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-6#1)
risk associated##14##2##(1991-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-6#1)
risk at##2##2##(1996-12#1)(2008-7#1)
risk averse##2##2##(2011-2#2)
risk based on##2##3##(1990-8#1)(1997-3#1)
risk because of##2##3##(1991-12#1)(2008-7#1)
risk because##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
risk behavior among##2##3##(2008-12#1)(2011-2#1)
risk behavior in##3##3##(2008-4#1)(2010-5#1)(2013-1#1)
risk behavior##17##2##(2008-12#4)(2008-4#2)(2009-8#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
risk behaviors among##2##3##(2013-1#1)(2013-8#1)
risk behaviors and the##2##4##(2012-12#1)(2013-8#1)
risk behaviors and##6##3##(1991-1#1)(2007-12#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-8#1)
risk behaviors in##5##3##(2008-4#1)(2008-8#1)(2013-1#3)
risk behaviors##32##2##(1991-1#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-12#1)(2008-4#5)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#7)(2013-8#7)
risk behaviour and##2##3##(2008-4#1)(2012-12#1)
risk behaviour##4##2##(2007-7#1)(2008-10#1)(2008-4#1)(2012-12#1)
risk being##2##2##(1991-4#1)(2009-10#1)
risk but##2##2##(1997-8#1)(2010-12#1)
risk by##6##2##(1992-2#1)(1993-11#1)(1996-12#1)(1997-1#1)(2008-4#1)(2010-9#1)
risk calculations were##2##3##(2008-7#2)
risk calculations##4##2##(2008-7#3)(2010-12#1)
risk category##3##2##(2008-1#1)(2008-7#1)(2010-11#1)
risk classification##7##2##(1993-12#2)(1994-12#1)(1995-1#1)(2011-2#3)
risk communication##3##2##(2008-9#1)(2010-11#1)(2013-1#1)
risk compared##2##2##(2008-3#1)(2013-8#1)
risk compensation##2##2##(2008-7#2)
risk conditions##8##2##(1994-1#1)(2009-10#4)(2011-1#3)
risk contracting##2##2##(1991-3#1)(1994-12#1)
risk contracts with##2##3##(1995-12#2)
risk contracts##5##2##(1995-12#3)(1996-3#1)(1997-2#1)
risk control in##2##3##(2008-9#1)(2009-10#1)
risk control##4##2##(2008-9#3)(2009-10#1)
risk could be##2##3##(1990-5#1)(2007-12#1)
risk criteria##2##2##(2008-7#1)(2011-2#1)
risk difference##2##2##(1994-9#1)(2008-11#1)
risk distribution##3##2##(1992-12#3)
risk due to the##3##4##(2008-11#1)(2008-4#1)(2010-12#1)
risk due to##12##3##(1991-12#1)(1992-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-6#1)
risk during##7##2##(2007-8#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#3)
risk emphasis##2##2##(2012-2#2)
risk estimate##2##2##(1996-12#1)(2012-12#1)
risk estimates##7##2##(1990-6#1)(1993-12#1)(1995-8#1)(1996-3#2)(2006-10#1)(2011-2#1)
risk estimation##8##2##(1990-3#1)(1992-6#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-8#1)
risk evaluation and##2##3##(1992-9#1)(2012-3#1)
risk evaluation##3##2##(1992-9#1)(2009-5#1)(2012-3#1)
risk exists##3##2##(1990-12#1)(1995-8#1)(2012-2#1)
risk factor and##4##3##(2007-10#1)(2007-8#1)(2008-8#1)(2013-1#1)
risk factor control##4##3##(2007-11#2)(2011-2#2)
risk factor evaluation##2##3##(2010-9#1)(2012-2#1)
risk factor for atherosclerosis##2##4##(1990-2#1)(2007-10#1)
risk factor for cardiovascular disease##4##5##(2008-1#1)(2008-3#2)(2012-12#1)
risk factor for cardiovascular diseases##2##5##(2010-5#1)(2012-3#1)
risk factor for cardiovascular##8##4##(2008-1#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
risk factor for coronary artery disease##3##6##(1995-6#1)(1997-8#1)(2008-7#1)
risk factor for coronary##4##4##(1995-6#1)(1997-8#1)(2008-6#1)(2008-7#1)
risk factor for developing##6##4##(1992-9#1)(2008-6#1)(2012-2#2)(2012-5#1)(2013-8#1)
risk factor for development of venous##2##6##(1997-3#2)
risk factor for development of##4##5##(1997-3#2)(2007-10#1)(2011-2#1)
risk factor for early revision##2##5##(2013-1#2)
risk factor for falls##2##4##(2008-7#1)(2011-2#1)
risk factor for ischemic stroke##2##5##(2007-10#1)(2008-9#1)
risk factor for premature##2##4##(2008-1#1)(2012-3#1)
risk factor for sporadic##2##4##(1994-5#2)
risk factor for stroke##4##4##(2007-10#3)(2008-8#1)
risk factor for the development of##2##6##(2008-1#1)(2012-12#1)
risk factor for the##5##4##(2008-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
risk factor for##99##3##(1990-2#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-10#7)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#4)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
risk factor in##9##3##(1991-4#1)(1992-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-3#1)(2011-2#1)
risk factor levels in##2##4##(1991-6#1)(2008-7#1)
risk factor levels##3##3##(1991-6#2)(2008-7#1)
risk factor of IHD##2##4##(2008-3#2)
risk factor of##7##3##(1994-12#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
risk factor profile##4##3##(2007-10#1)(2007-8#1)(2008-7#2)
risk factor was##2##3##(1990-6#1)(2011-1#1)
risk factor##181##2##(1990-2#1)(1990-6#2)(1990-8#1)(1991-4#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#2)(1995-6#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-5#2)(1997-8#1)(2006-10#3)(2007-10#14)(2007-11#6)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#19)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#3)
risk factor?##2##2##(2008-6#1)(2013-1#1)
risk factors among##4##3##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
risk factors and clinical##2##4##(2007-10#1)(2007-11#1)
risk factors and protective##2##4##(2010-2#1)(2011-1#1)
risk factors and the##2##4##(2010-6#1)(2013-1#1)
risk factors and their##3##4##(2006-10#1)(2011-2#2)
risk factors and to##2##4##(2008-7#1)(2011-2#1)
risk factors and##58##3##(1991-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1996-12#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#7)(2008-8#1)(2009-7#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#2)
risk factors are associated with##2##5##(2008-11#1)(2010-6#1)
risk factors are more##2##4##(2008-1#1)(2008-9#1)
risk factors are##18##3##(1992-12#1)(1992-4#1)(1994-11#1)(1996-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
risk factors as##3##3##(2008-1#1)(2008-3#2)
risk factors associated with diabetes##2##5##(2008-1#1)(2008-5#1)
risk factors associated with the##3##5##(2009-5#1)(2011-2#1)(2012-12#1)
risk factors associated with this##2##5##(2008-1#1)(2012-2#1)
risk factors associated with##20##4##(1993-11#1)(1993-12#1)(1996-2#1)(2008-1#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
risk factors associated##21##3##(1993-11#1)(1993-12#1)(1996-2#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
risk factors at##2##3##(2009-4#1)(2012-2#1)
risk factors could##2##3##(2011-2#1)(2012-2#1)
risk factors do not##3##4##(1992-9#1)(2008-4#1)(2010-9#1)
risk factors for AVN##2##4##(2007-8#2)
risk factors for CAD##2##4##(1996-2#1)(2011-1#1)
risk factors for HIV infection##2##5##(2007-12#1)(2008-5#1)
risk factors for SIDS##3##4##(1992-11#2)(2008-1#1)
risk factors for atherosclerosis##2##4##(2007-10#1)(2008-10#1)
risk factors for cardiovascular disease##4##5##(2008-3#2)(2011-1#1)(2012-2#1)
risk factors for cardiovascular##5##4##(1994-11#1)(2008-3#2)(2011-1#1)(2012-2#1)
risk factors for cerebral##2##4##(1997-5#1)(2007-10#1)
risk factors for coronary artery disease##2##6##(1993-2#1)(2007-8#1)
risk factors for coronary##4##4##(1993-2#1)(2007-8#1)(2008-12#2)
risk factors for developing##2##4##(2008-8#1)(2013-8#1)
risk factors for heart failure##2##5##(2008-3#1)(2010-8#1)
risk factors for heart##3##4##(2008-3#1)(2010-8#1)(2011-2#1)
risk factors for infection##2##4##(1991-7#1)(2008-12#1)
risk factors for misbehaviour##2##4##(2012-12#2)
risk factors for pulmonary##2##4##(2010-10#1)(2011-2#1)
risk factors for stroke##4##4##(2007-10#3)(2008-8#1)
risk factors for suicide##2##4##(2008-11#1)(2009-7#1)
risk factors for the development of##2##6##(2011-1#1)(2013-7#1)
risk factors for the##7##4##(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
risk factors for these##3##4##(1996-2#1)(2009-10#1)(2012-1#1)
risk factors for this##2##4##(2008-10#1)(2008-7#1)
risk factors for violence##2##4##(2011-1#1)(2013-8#1)
risk factors for##147##3##(1991-7#1)(1992-11#2)(1993-2#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-6#2)(1996-2#2)(1997-4#1)(1997-5#2)(2006-10#1)(2007-10#9)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-4#1)(2010-8#2)(2011-1#8)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#8)
risk factors has##2##3##(2007-10#1)(2008-3#1)
risk factors have been##2##4##(2007-10#1)(2007-7#1)
risk factors have##4##3##(2007-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
risk factors in a##6##4##(1993-10#1)(2010-4#2)(2012-2#1)(2013-8#2)
risk factors in the##13##4##(2008-10#1)(2010-1#1)(2013-8#11)
risk factors in##42##3##(1992-8#1)(1993-10#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-1#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#16)
risk factors include##3##3##(2007-7#1)(2008-2#1)(2008-7#1)
risk factors is##2##3##(2009-2#1)(2012-2#1)
risk factors may be##2##4##(2010-4#1)(2013-1#1)
risk factors may##7##3##(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#4)
risk factors measured at##3##4##(2008-7#3)
risk factors of cardiovascular diseases##2##5##(2008-11#1)(2009-10#1)
risk factors of interest##2##4##(1994-2#1)(2008-7#1)
risk factors of the##3##4##(2007-11#1)(2010-8#1)(2013-1#1)
risk factors of venous##2##4##(1993-5#1)(1996-9#1)
risk factors of##50##3##(1993-5#1)(1994-12#2)(1994-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#8)
risk factors on the abundance##2##5##(2009-5#2)
risk factors on##5##3##(1990-6#1)(1992-9#1)(2009-5#2)(2011-1#1)
risk factors or##3##3##(1991-8#1)(2007-10#2)
risk factors related to the##2##5##(2008-1#1)(2011-1#1)
risk factors related to##5##4##(2008-1#1)(2008-7#1)(2011-1#2)(2011-2#1)
risk factors remains##2##3##(2011-2#1)(2012-3#1)
risk factors such as hypertension##2##5##(2007-10#1)(2008-11#1)
risk factors such as##12##4##(2007-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
risk factors that are unique##2##5##(2011-2#1)(2012-12#1)
risk factors that are##3##4##(2008-7#1)(2011-2#1)(2012-12#1)
risk factors that##8##3##(1992-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
risk factors to be##2##4##(2007-10#1)(2012-12#1)
risk factors to predict##2##4##(1994-2#1)(2013-8#1)
risk factors to##10##3##(1990-3#1)(1993-3#1)(1994-2#1)(2007-10#2)(2008-4#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
risk factors was##3##3##(1991-6#1)(1996-8#1)(2011-2#1)
risk factors were##11##3##(1991-6#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-3#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
risk factors##636##2##(1990-3#1)(1990-6#3)(1990-8#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-4#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#7)(1993-5#1)(1993-9#7)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-8#1)(2006-10#3)(2007-10#33)(2007-11#9)(2007-12#6)(2007-2#2)(2007-7#7)(2007-8#8)(2007-9#2)(2008-1#15)(2008-10#11)(2008-11#20)(2008-12#6)(2008-2#6)(2008-3#24)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#39)(2008-8#15)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#8)(2009-6#2)(2009-7#11)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#8)(2010-6#6)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#32)(2011-2#54)(2011-3#1)(2012-1#3)(2012-12#25)(2012-2#29)(2012-3#12)(2013-1#33)(2013-3#2)(2013-7#1)(2013-8#41)
risk for Alzheimer's##2##3##(2009-10#1)(2011-2#1)
risk for CMM formation##2##4##(2007-10#2)
risk for CVD is##2##4##(2011-1#1)(2013-8#1)
risk for HIV##4##3##(1996-5#1)(1997-5#1)(2009-12#1)(2013-1#1)
risk for MS##3##3##(2011-2#2)(2013-1#1)
risk for a##7##3##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
risk for adjustment problems##3##4##(2009-8#3)
risk for alcoholism##3##3##(1991-1#1)(1994-2#2)
risk for atherosclerosis##2##3##(2007-10#1)(2008-1#1)
risk for bladder cancer##3##4##(2008-4#3)
risk for both##3##3##(1993-12#2)(2008-7#1)
risk for breast cancer##3##4##(1995-9#1)(2010-7#1)(2011-2#1)
risk for cancers##2##3##(1995-9#1)(2012-2#1)
risk for cardiovascular events and##3##5##(2008-3#1)(2012-2#1)(2013-8#1)
risk for cardiovascular events##5##4##(2008-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
risk for cardiovascular##8##3##(2008-3#2)(2010-6#2)(2012-2#2)(2013-1#1)(2013-8#1)
risk for complications##3##3##(1990-11#1)(2011-2#1)(2012-2#1)
risk for congenital malformations##2##4##(1990-5#2)
risk for coronary##3##3##(1990-3#1)(1993-12#1)(1996-11#1)
risk for developing##16##3##(1993-1#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
risk for development of##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
risk for infection##4##3##(2008-10#1)(2009-9#1)(2011-2#2)
risk for patients##4##3##(2007-7#1)(2008-12#1)(2008-5#1)(2009-11#1)
risk for physical##2##3##(1995-1#1)(2008-12#1)
risk for poor##4##3##(1996-12#1)(2008-12#1)(2010-5#1)(2013-1#1)
risk for subsequent##3##3##(2008-11#1)(2008-7#2)
risk for the##12##3##(1991-12#1)(1991-5#1)(1992-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-10#1)(2010-4#1)(2012-3#1)
risk for this##4##3##(2011-2#2)(2012-12#1)(2013-7#1)
risk for those##2##3##(1993-12#1)(2011-2#1)
risk for tumor##3##3##(2007-10#1)(2008-7#2)
risk for violence##2##3##(2013-1#1)(2013-8#1)
risk for##273##2##(1990-11#1)(1990-3#3)(1990-5#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#4)(2007-10#6)(2007-11#3)(2007-12#2)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#12)(2008-11#18)(2008-12#11)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#22)(2012-12#11)(2012-2#13)(2012-3#4)(2013-1#20)(2013-7#3)(2013-8#7)
risk from low##2##3##(2008-7#1)(2013-1#1)
risk from radiation##2##3##(2008-7#1)(2013-1#1)
risk from##15##2##(1996-8#1)(2006-10#1)(2008-10#1)(2008-7#5)(2011-2#2)(2012-12#2)(2013-1#3)
risk group and##3##3##(2011-2#2)(2012-12#1)
risk group for##5##3##(1992-9#1)(2008-11#1)(2008-7#1)(2011-2#2)
risk group##26##2##(1992-9#2)(1994-11#1)(1995-4#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#2)(2011-1#1)(2011-2#8)(2012-12#3)(2012-3#1)(2013-1#1)
risk groups##20##2##(1990-3#1)(1990-9#1)(1993-11#1)(1995-1#1)(1995-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#5)(2013-1#1)(2013-8#2)
risk has been##2##3##(2007-10#1)(2008-5#1)
risk has##3##2##(2007-10#1)(2008-5#1)(2008-8#1)
risk in a population##2##4##(2008-7#1)(2008-9#1)
risk in a##5##3##(1994-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
risk in an##2##3##(2010-5#1)(2012-1#1)
risk in patients with##4##4##(2008-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
risk in patients##5##3##(2008-8#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
risk in relation to##3##4##(2008-8#1)(2011-1#1)(2012-2#1)
risk in the##15##3##(1991-3#1)(1992-2#1)(1992-6#1)(1994-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#2)
risk in type##2##3##(2008-3#1)(2013-1#1)
risk in women##2##3##(2010-12#2)
risk in##87##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-9#2)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#7)(2008-8#9)(2008-9#2)(2009-11#1)(2009-12#2)(2010-11#1)(2010-12#3)(2010-5#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2012-6#1)(2013-1#4)(2013-8#2)
risk include##3##2##(1997-3#1)(2009-12#1)(2010-7#1)
risk increase##2##2##(2009-10#2)
risk indicator of##2##3##(1990-9#1)(2008-7#1)
risk indicator##4##2##(1990-9#1)(2008-7#1)(2010-8#1)(2012-3#1)
risk indicators##2##2##(2008-7#1)(2010-9#1)
risk indices##2##2##(2012-1#1)(2012-3#1)
risk infants##3##2##(1993-12#1)(2008-11#1)(2009-5#1)
risk involved##3##2##(1992-12#1)(2008-11#1)(2011-2#1)
risk is a##2##3##(1992-3#1)(2010-9#1)
risk is compounded##2##3##(1994-2#1)(2010-7#1)
risk is the##2##3##(2008-5#1)(2013-8#1)
risk is##31##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-2#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
risk lesions)##2##2##(1994-6#1)(2011-2#1)
risk level of##2##3##(2008-10#1)(2012-12#1)
risk level##6##2##(1991-6#2)(2007-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
risk levels of latent infection##2##5##(2008-10#2)
risk levels##4##2##(1995-9#1)(2008-10#2)(2009-8#1)
risk management and##4##3##(1991-12#1)(1994-2#1)(2008-8#1)(2013-1#1)
risk management issues##3##3##(1993-1#1)(1993-2#1)(2008-11#1)
risk management policies##2##3##(2012-3#1)(2013-1#1)
risk management program##3##3##(1991-12#1)(1993-2#1)(2013-1#1)
risk management programs##2##3##(1991-12#1)(1996-1#1)
risk management services##2##3##(1991-12#1)(1994-2#1)
risk management strategies##3##3##(1990-11#1)(1994-1#1)(2013-1#1)
risk management##62##2##(1990-11#1)(1991-12#6)(1992-12#2)(1992-3#2)(1993-1#3)(1993-12#1)(1993-2#7)(1994-1#2)(1994-12#2)(1994-2#5)(1994-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2007-11#2)(2007-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#5)
risk management's##2##2##(1994-12#1)(1995-2#1)
risk manager##10##2##(1992-1#1)(1992-2#3)(1993-2#2)(1993-3#1)(1994-1#3)
risk manager's role##4##3##(1992-12#1)(1994-2#1)(1995-1#1)(1996-1#1)
risk manager's##7##2##(1992-12#1)(1994-2#2)(1995-1#1)(1996-1#1)(1997-1#1)(2007-3#1)
risk managers need to know##2##5##(1992-3#1)(1996-2#1)
risk managers to##4##3##(1991-12#1)(1992-2#1)(1994-1#1)(2007-3#1)
risk managers##12##2##(1991-12#1)(1991-3#1)(1992-2#3)(1992-3#1)(1994-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-3#1)
risk maps##3##2##(2008-8#3)
risk marker##2##2##(2010-5#1)(2012-3#1)
risk marketing##2##2##(1997-3#2)
risk may be##4##3##(1994-11#1)(2007-2#1)(2010-12#1)(2011-2#1)
risk may##7##2##(1993-11#1)(1994-11#1)(2007-2#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
risk model for##2##3##(2008-12#1)(2013-1#1)
risk model has been##2##4##(2007-8#1)(2011-2#1)
risk model##10##2##(2007-8#2)(2008-12#1)(2008-7#3)(2011-2#1)(2012-12#1)(2013-1#2)
risk modelling##2##2##(2007-8#1)(2008-8#1)
risk models##6##2##(1992-12#1)(2008-10#1)(2008-7#4)
risk must##2##2##(1997-8#1)(2008-3#1)
risk of 2##2##3##(1993-9#1)(2013-1#1)
risk of DS##2##3##(2012-12#2)
risk of ED##3##3##(2013-8#3)
risk of HCC in patients taking the drugs##2##8##(2008-11#2)
risk of HCC in patients##3##5##(2006-10#1)(2008-11#2)
risk of HCC in##4##4##(2006-10#1)(2008-11#3)
risk of HIV infection##5##4##(1993-6#1)(1995-6#1)(1996-5#1)(2007-7#1)(2011-2#1)
risk of HIV transmission##5##4##(1995-6#1)(2009-5#1)(2012-12#3)
risk of HIV##13##3##(1991-1#1)(1993-6#1)(1995-6#2)(1996-5#1)(2007-7#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#3)
risk of IHD##2##3##(2008-3#2)
risk of M##2##3##(2013-1#2)
risk of NSAID-related gastrointestinal bleeding is##2##6##(2006-10#2)
risk of NSAID-related gastrointestinal bleeding##3##5##(2006-10#3)
risk of NSAID-related##4##3##(2006-10#4)
risk of PC##4##3##(1990-6#4)
risk of Parkinson's disease in##2##5##(2008-7#2)
risk of Parkinson's disease##4##4##(2008-7#3)(2008-8#1)
risk of Parkinson's##5##3##(2008-7#4)(2008-8#1)
risk of SIDS##2##3##(1992-11#1)(2008-1#1)
risk of TB infection##2##4##(2007-2#2)
risk of TEEs##2##3##(2008-7#2)
risk of a##16##3##(1990-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1996-12#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-4#2)(2012-1#1)(2012-2#2)
risk of accidents##2##3##(1995-8#1)(2010-5#1)
risk of acquiring##5##3##(2007-2#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
risk of acute##5##3##(2009-1#1)(2009-12#1)(2013-1#2)(2013-7#1)
risk of adverse effects##4##4##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#1)
risk of adverse##12##3##(1991-11#2)(1991-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#2)
risk of an##7##3##(1990-5#1)(1992-6#1)(1994-3#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
risk of atherosclerosis##5##3##(2008-3#1)(2008-6#3)(2008-7#1)
risk of atherosclerotic##2##3##(1996-2#1)(2008-3#1)
risk of becoming##2##3##(1997-6#1)(2008-12#1)
risk of being##3##3##(1991-3#1)(1997-4#1)(2011-2#1)
risk of bleeding##9##3##(2007-8#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#2)
risk of both##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
risk of bowel##2##3##(1994-2#1)(1996-6#1)
risk of breast cancer and##2##5##(1993-11#1)(2009-4#1)
risk of breast cancer in##3##5##(1991-4#1)(2007-2#1)(2008-3#1)
risk of breast cancer##15##4##(1990-8#1)(1991-2#1)(1991-4#1)(1993-11#1)(1994-2#4)(1994-9#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-4#2)(2012-3#1)
risk of breast##16##3##(1990-8#1)(1991-2#1)(1991-4#1)(1993-11#1)(1994-2#4)(1994-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#2)(2012-3#1)
risk of cancer in##2##4##(1994-2#1)(2012-6#1)
risk of cancer was##2##4##(2012-12#2)
risk of cancer##19##3##(1990-8#1)(1994-2#3)(1994-9#1)(2008-11#2)(2008-7#3)(2012-12#3)(2012-2#1)(2012-6#1)(2013-1#4)
risk of cardiac##2##3##(1992-2#1)(2009-5#1)
risk of cardiovascular disease##14##4##(1992-8#1)(1993-11#1)(1996-6#3)(1997-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
risk of cardiovascular disease]##2##4##(1993-9#1)(2013-8#1)
risk of cardiovascular diseases##2##4##(1993-11#1)(2008-3#1)
risk of cardiovascular events##2##4##(2008-3#1)(2012-3#1)
risk of cardiovascular##22##3##(1992-8#1)(1993-11#2)(1993-9#1)(1996-6#3)(1997-8#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
risk of cerebral embolism##2##4##(2013-1#2)
risk of cerebral##5##3##(1991-11#1)(2007-10#1)(2008-7#1)(2013-1#2)
risk of chronic disease##3##4##(2008-5#1)(2009-5#1)(2010-1#1)
risk of chronic##6##3##(1991-4#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2012-2#1)
risk of colorectal cancer in##2##5##(1993-9#2)
risk of colorectal cancer##5##4##(1993-9#3)(2009-8#1)(2010-6#1)
risk of colorectal##6##3##(1990-2#1)(1993-9#3)(2009-8#1)(2010-6#1)
risk of complications is##2##4##(1994-9#1)(2013-1#1)
risk of complications##18##3##(1990-11#1)(1990-3#2)(1991-6#1)(1994-9#1)(1996-11#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#4)
risk of congenital malformations##2##4##(2013-1#2)
risk of congenital##3##3##(2013-1#3)
risk of contamination##8##3##(2008-10#6)(2008-11#1)(2008-3#1)
risk of contracting##4##3##(2007-2#2)(2011-2#1)(2012-12#1)
risk of coronary heart disease events##2##6##(2008-12#2)
risk of coronary heart disease##5##5##(1991-8#1)(1996-3#1)(2008-12#3)
risk of coronary heart##6##4##(1991-8#1)(1996-3#1)(2008-12#3)(2013-1#1)
risk of coronary##8##3##(1991-8#2)(1996-3#1)(1996-8#1)(2008-12#3)(2013-1#1)
risk of death from cardiovascular disease##2##6##(2008-11#1)(2011-1#1)
risk of death from##4##4##(2007-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
risk of death of##2##4##(1990-5#1)(2011-3#1)
risk of death was##2##4##(2008-6#1)(2011-1#1)
risk of death##15##3##(1990-5#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-3#1)
risk of developing PCOS##2##4##(2008-4#2)
risk of developing TLS is##2##5##(2008-7#2)
risk of developing breast cancer##5##5##(1991-2#1)(1995-9#1)(2008-12#2)(2008-4#1)
risk of developing skin##2##4##(1991-6#1)(2012-3#1)
risk of developing the##4##4##(1990-11#1)(1996-6#1)(2008-11#1)(2008-4#1)
risk of developing##62##3##(1990-11#2)(1990-12#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-9#1)(1996-6#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-4#5)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)
risk of development of##3##4##(1997-3#1)(2007-10#1)(2012-3#1)
risk of development##4##3##(1997-3#1)(2007-10#1)(2012-3#1)(2013-1#1)
risk of diabetes and##3##4##(2008-1#2)(2013-8#1)
risk of diabetes##5##3##(2008-1#2)(2008-10#1)(2010-8#1)(2013-8#1)
risk of disease in##2##4##(2007-1#1)(2008-10#1)
risk of disease##9##3##(1993-11#1)(1997-8#1)(2007-1#1)(2007-2#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
risk of diseases##2##3##(2012-2#2)
risk of dying of other diseases##2##6##(1997-7#2)
risk of dying of##3##4##(1997-7#3)
risk of dying##4##3##(1997-7#3)(2013-1#1)
risk of early##5##3##(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
risk of exposure to##5##4##(1991-11#1)(1991-12#1)(2008-7#1)(2009-12#1)(2012-12#1)
risk of extinction##2##3##(2008-9#1)(2010-8#1)
risk of failure##3##3##(1996-3#1)(2009-7#1)(2012-12#1)
risk of fetal##3##3##(2011-1#1)(2011-2#2)
risk of fracture##5##3##(2007-8#1)(2008-11#2)(2011-2#1)(2013-1#1)
risk of fractures##6##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)
risk of gastric cancer in patients with##3##7##(2008-12#3)
risk of gastric cancer##7##4##(1997-1#1)(2008-12#5)(2011-2#1)
risk of gastric##8##3##(1997-1#1)(2008-1#1)(2008-12#5)(2011-2#1)
risk of growth rate suppression##2##5##(2007-11#2)
risk of growth##3##3##(2007-11#3)
risk of haemorrhage##3##3##(1992-6#1)(1996-6#1)(1996-9#1)
risk of having a##2##4##(2008-11#1)(2008-8#1)
risk of having##3##3##(2008-11#1)(2008-8#1)(2012-1#1)
risk of heart disease##2##4##(2010-9#1)(2013-1#1)
risk of heart##4##3##(2010-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
risk of hepatocellular carcinoma##2##4##(2008-11#1)(2010-12#1)
risk of hospitalization##3##3##(1995-2#2)(2006-10#1)
risk of human##4##3##(2008-8#2)(2010-11#1)(2011-2#1)
risk of hypertension##3##3##(2008-11#2)(2008-5#1)
risk of infection by##2##4##(2007-2#1)(2013-1#1)
risk of infection in##8##4##(1992-6#2)(1994-6#1)(2007-12#3)(2008-10#1)(2013-1#1)
risk of infection with##5##4##(1996-6#1)(2007-2#1)(2009-12#1)(2011-2#2)
risk of infection##27##3##(1990-3#1)(1992-6#2)(1994-6#2)(1996-6#1)(2007-12#3)(2007-2#4)(2008-1#1)(2008-10#3)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-1#3)
risk of infections##2##3##(1995-3#1)(2008-11#1)
risk of initial##2##3##(2008-1#1)(2008-7#1)
risk of injury##6##3##(1992-6#3)(1996-6#1)(1997-7#1)(2008-8#1)
risk of intracranial##3##3##(1992-6#1)(2011-2#1)(2012-2#1)
risk of invasive bladder cancer##2##5##(1993-9#2)
risk of invasive##5##3##(1993-9#2)(2007-12#1)(2008-11#1)(2008-4#1)
risk of ischemic heart disease##2##5##(2008-3#2)
risk of ischemic stroke among##4##5##(2011-1#4)
risk of ischemic stroke##8##4##(2010-4#1)(2011-1#7)
risk of ischemic##10##3##(2008-3#2)(2010-4#1)(2011-1#7)
risk of kidney##2##3##(2011-2#1)(2013-8#1)
risk of late##4##3##(1992-10#1)(2010-7#1)(2011-2#2)
risk of losing##3##3##(1992-5#1)(1996-11#1)(2008-10#1)
risk of lung cancer##2##4##(2008-7#1)(2011-1#1)
risk of lymph node metastasis##2##5##(2009-12#1)(2011-2#1)
risk of major bleeding##2##4##(2008-3#1)(2008-8#1)
risk of major##7##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-3#1)(2013-7#1)
risk of malignancy##2##3##(2007-7#1)(2008-10#1)
risk of malignant transformation##5##4##(2009-12#1)(2009-8#2)(2012-12#1)(2013-1#1)
risk of metabolic##2##3##(2008-3#1)(2013-1#1)
risk of microbial contamination##2##4##(1997-4#1)(2008-5#1)
risk of microbial##3##3##(1997-4#1)(2008-5#1)(2011-2#1)
risk of morbidity and mortality##2##5##(1990-8#1)(2008-10#1)
risk of mortality##7##3##(1994-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
risk of nasal cancer##2##4##(1992-10#2)
risk of neonatal##2##3##(1994-6#1)(2008-11#1)
risk of neurological##3##3##(1996-3#1)(2007-11#1)(2010-8#1)
risk of new##2##3##(2007-2#1)(2008-11#1)
risk of nicotine dependence##2##4##(2011-2#2)
risk of nursing home placement##2##5##(1990-5#2)
risk of nursing home##3##4##(1990-5#2)(2010-12#1)
risk of osteoporosis##4##3##(1993-11#1)(1994-9#1)(1997-8#1)(2008-4#1)
risk of other##2##3##(2009-12#1)(2010-1#1)
risk of ovarian cancer##4##4##(1993-9#2)(1994-9#1)(2012-2#1)
risk of ovarian##5##3##(1993-9#2)(1994-9#1)(2012-12#1)(2012-2#1)
risk of pancreatic cancer##3##4##(1990-6#2)(1994-3#1)
risk of pathogen##2##3##(2008-10#1)(2008-3#1)
risk of patients##2##3##(1994-12#1)(2011-1#1)
risk of perioperative##3##3##(2007-8#1)(2009-5#2)
risk of postoperative##7##3##(1992-5#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
risk of pregnancy##2##3##(1990-6#1)(2008-11#1)
risk of preterm##2##3##(1996-11#1)(2011-2#1)
risk of primary##3##3##(1991-11#1)(1994-6#1)(2008-6#1)
risk of progression to##4##4##(2007-2#1)(2008-9#1)(2010-5#1)(2012-12#1)
risk of progression##9##3##(1994-7#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
risk of puncture or rupture##2##5##(2012-2#2)
risk of radiation##2##3##(2008-7#1)(2013-1#1)
risk of raised ICP##3##4##(2010-5#3)
risk of recurrence##16##3##(1992-1#1)(1993-9#2)(1996-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#3)
risk of recurrent cardiovascular events##2##5##(2008-3#2)
risk of recurrent stroke##2##4##(2008-8#2)
risk of recurrent##7##3##(2008-3#2)(2008-8#4)(2009-12#1)
risk of redisplacement##2##3##(2011-2#2)
risk of rejection##2##3##(1997-5#1)(2006-10#1)
risk of relapse##7##3##(1990-11#1)(1993-1#1)(2008-6#1)(2009-11#1)(2011-2#3)
risk of reoperation##2##3##(2007-8#1)(2012-12#1)
risk of rupture##4##3##(1994-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
risk of serious bacterial##2##4##(1994-9#1)(2008-11#1)
risk of serious complications##2##4##(2008-11#1)(2008-7#1)
risk of serious##9##3##(1994-9#2)(2006-10#1)(2008-11#3)(2008-7#1)(2009-2#1)(2012-2#1)
risk of severe##6##3##(1995-5#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
risk of side effects##2##4##(1997-3#1)(2007-11#1)
risk of skeletal##3##3##(2007-11#2)(2008-8#1)
risk of spinal cord compression##3##5##(2007-11#3)
risk of spontaneous##2##3##(1996-2#1)(2011-2#1)
risk of stroke##17##3##(1991-11#1)(1996-11#1)(2007-10#2)(2008-8#8)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
risk of subsequent##3##3##(1993-3#1)(1994-12#1)(2007-11#1)
risk of sudden death##2##4##(2012-2#1)(2013-8#1)
risk of sudden##3##3##(1992-4#1)(2012-2#1)(2013-8#1)
risk of surgical complications##2##4##(2008-9#1)(2011-1#1)
risk of the disease##4##4##(1993-9#1)(1994-9#1)(2008-1#1)(2012-12#1)
risk of the##15##3##(1990-5#1)(1990-9#1)(1993-9#1)(1994-9#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-4#1)(2010-8#1)(2012-12#1)
risk of thermal##2##3##(1990-2#1)(1995-1#1)
risk of thromboembolic##2##3##(2007-8#1)(2008-7#1)
risk of transmission of##2##4##(2010-5#1)(2013-1#1)
risk of transmission##5##3##(1992-6#2)(2008-10#1)(2010-5#1)(2013-1#1)
risk of tumour##3##3##(2013-1#3)
risk of type 2 diabetes##3##5##(2008-1#1)(2012-2#1)(2013-8#1)
risk of using a##2##4##(2008-11#1)(2011-2#1)
risk of vascular##2##3##(1990-3#1)(2011-2#1)
risk of venous thromboembolism##2##4##(1996-11#1)(2010-11#1)
risk of venous##4##3##(1996-11#1)(1996-3#1)(2007-8#1)(2010-11#1)
risk of vitamin A deficiency##2##5##(1991-8#2)
risk of##1084##2##(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#7)(1990-5#7)(1990-6#9)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#2)(1991-11#7)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#2)(1991-6#3)(1991-7#1)(1991-8#7)(1991-9#4)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#13)(1992-8#2)(1992-9#6)(1993-1#3)(1993-11#7)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#15)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#11)(1994-3#6)(1994-6#6)(1994-7#1)(1994-9#14)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-11#8)(1996-12#3)(1996-2#6)(1996-3#11)(1996-5#1)(1996-6#11)(1996-8#3)(1996-9#4)(1997-1#1)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#4)(2006-10#10)(2006-12#1)(2006-5#2)(2007-1#2)(2007-10#9)(2007-11#18)(2007-12#10)(2007-2#15)(2007-5#4)(2007-7#7)(2007-8#20)(2008-1#23)(2008-10#45)(2008-11#40)(2008-12#22)(2008-2#5)(2008-3#21)(2008-4#20)(2008-5#12)(2008-6#15)(2008-7#42)(2008-8#45)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#14)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#6)(2010-5#9)(2010-6#5)(2010-7#3)(2010-8#9)(2010-9#4)(2011-1#22)(2011-2#79)(2011-3#5)(2012-1#10)(2012-12#30)(2012-2#34)(2012-3#17)(2012-6#1)(2013-1#70)(2013-7#7)(2013-8#26)
risk on the##2##3##(1994-3#1)(1995-5#1)
risk on##5##2##(1994-3#2)(1995-5#1)(2010-8#1)(2011-1#1)
risk or harm reduction##2##4##(2009-7#2)
risk or##10##2##(1994-12#1)(1995-9#1)(1997-3#1)(2008-3#1)(2008-7#2)(2009-7#2)(2013-1#1)(2013-8#1)
risk patients##19##2##(1992-6#1)(1996-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-7#1)(2009-7#1)(2010-10#2)(2010-3#3)(2011-2#1)(2012-12#1)
risk pattern during the period##2##5##(1991-6#2)
risk pattern##4##2##(1991-6#2)(1992-2#1)(2011-1#1)
risk perception in##2##3##(2008-11#2)
risk perception##6##2##(1990-9#1)(2008-11#4)(2012-2#1)
risk period was##2##3##(2011-1#2)
risk plans##2##2##(1996-3#2)
risk pool##3##2##(1993-12#2)(1995-12#1)
risk population##2##2##(1995-1#1)(2007-7#1)
risk populations##3##2##(1994-3#1)(2009-3#1)(2011-2#1)
risk prediction##5##2##(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#1)
risk predictor##2##2##(2008-8#1)(2013-1#1)
risk probability##2##2##(1996-6#1)(2008-10#1)
risk profile##10##2##(1993-11#1)(1993-2#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)
risk profiles of##2##3##(2008-10#1)(2008-11#1)
risk profiles##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
risk program##3##2##(1994-12#1)(1994-3#2)
risk ratio##4##2##(1994-9#1)(1995-2#1)(2008-11#1)(2012-3#1)
risk ratios##2##2##(2008-7#1)(2013-1#1)
risk reduction intervention##2##3##(2008-4#2)
risk reduction of##4##3##(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
risk reduction provided by##2##4##(1994-2#2)
risk reduction##15##2##(1994-2#3)(2008-12#1)(2008-4#2)(2010-2#1)(2011-1#1)(2011-2#5)(2013-1#1)(2013-8#1)
risk related to##2##3##(1995-11#1)(1996-11#1)
risk remain##2##2##(2007-10#1)(2008-4#1)
risk remains##5##2##(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)
risk requires##2##2##(1993-11#1)(1996-12#1)
risk research##2##2##(2010-12#2)
risk score in the##2##4##(1994-11#1)(2011-1#1)
risk score##11##2##(1991-6#3)(1994-11#4)(2010-10#1)(2010-11#1)(2011-1#2)
risk scores##3##2##(1994-11#1)(2012-2#2)
risk screening##2##2##(1997-3#1)(2010-8#1)
risk selection##3##2##(1994-3#1)(1995-1#1)(1997-1#1)
risk should be##2##3##(1992-5#1)(2008-3#1)
risk spreading##2##2##(2008-8#2)
risk status of##2##3##(2011-2#1)(2012-3#1)
risk status##7##2##(1995-9#2)(1996-1#1)(1997-5#1)(2011-2#1)(2012-3#2)
risk stratification in patients##2##4##(2008-8#1)(2010-5#1)
risk stratification in##3##3##(2008-8#1)(2010-5#1)(2010-9#1)
risk stratification of##6##3##(2008-3#1)(2011-2#2)(2012-2#1)(2012-3#2)
risk stratification##19##2##(2008-3#3)(2008-8#2)(2009-1#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#3)
risk such as##2##3##(2009-7#1)(2011-1#1)
risk taking##4##2##(1995-2#1)(2008-11#3)
risk than##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
risk that##6##2##(1992-9#1)(2008-10#2)(2011-2#2)(2013-8#1)
risk threshold##3##2##(2008-10#3)
risk through##5##2##(1992-12#1)(1992-3#1)(1995-3#1)(2008-10#1)(2012-12#1)
risk to be##2##3##(2008-2#1)(2012-1#1)
risk to develop##2##3##(2008-8#1)(2012-12#1)
risk to human##2##3##(2008-12#1)(2008-7#1)
risk to public health##2##4##(2007-12#1)(2008-12#1)
risk to the patient##3##4##(1995-11#1)(1995-12#1)(2012-3#1)
risk to the##7##3##(1995-11#1)(1995-12#1)(1995-2#1)(2006-10#1)(2007-8#1)(2012-3#1)(2013-8#1)
risk to travellers##2##3##(2007-2#2)
risk to##40##2##(1990-9#1)(1991-12#2)(1992-2#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
risk tolerance##4##2##(2011-2#4)
risk using the##2##3##(1995-9#1)(2008-7#1)
risk using##3##2##(1995-9#1)(2008-7#1)(2010-6#1)
risk was also##2##3##(1991-6#1)(1992-10#1)
risk was found##2##3##(1991-2#1)(2011-2#1)
risk was present in##2##4##(1991-3#1)(2007-10#1)
risk was##15##2##(1990-6#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1993-9#1)(2007-10#3)(2008-3#1)(2009-10#2)(2011-2#1)(2013-1#1)
risk were##3##2##(1993-9#1)(2007-8#1)(2013-1#1)
risk while##2##2##(1991-3#1)(2007-10#1)
risk will also be##2##4##(1992-2#1)(1996-12#1)
risk will be##2##3##(1992-3#1)(1997-3#1)
risk will##4##2##(1992-2#1)(1992-3#1)(1996-12#1)(1997-3#1)
risk with##9##2##(1990-6#1)(1997-5#1)(1997-8#2)(2008-7#3)(2009-12#1)(2012-12#1)
risk women##2##2##(2008-1#1)(2011-2#1)
risk youth##2##2##(2007-4#1)(2012-12#1)
risk##3793##1##(1990-11#8)(1990-12#2)(1990-2#8)(1990-3#16)(1990-5#13)(1990-6#23)(1990-7#1)(1990-8#12)(1990-9#7)(1991-1#5)(1991-11#11)(1991-12#24)(1991-2#9)(1991-3#13)(1991-4#6)(1991-5#2)(1991-6#20)(1991-7#2)(1991-8#12)(1991-9#4)(1992-1#5)(1992-10#7)(1992-11#8)(1992-12#30)(1992-2#18)(1992-3#13)(1992-4#3)(1992-5#4)(1992-6#17)(1992-8#5)(1992-9#19)(1993-1#11)(1993-10#1)(1993-11#24)(1993-12#18)(1993-2#23)(1993-3#13)(1993-5#3)(1993-6#5)(1993-8#2)(1993-9#36)(1994-1#10)(1994-11#13)(1994-12#18)(1994-2#46)(1994-3#23)(1994-5#3)(1994-6#10)(1994-7#1)(1994-9#16)(1995-1#10)(1995-11#5)(1995-12#9)(1995-2#15)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#11)(1995-8#7)(1995-9#19)(1996-1#4)(1996-11#17)(1996-12#23)(1996-2#16)(1996-3#29)(1996-4#1)(1996-5#2)(1996-6#18)(1996-8#8)(1996-9#7)(1997-1#16)(1997-2#4)(1997-3#31)(1997-4#12)(1997-5#21)(1997-6#3)(1997-7#5)(1997-8#15)(2006-10#27)(2006-12#1)(2006-5#3)(2007-1#3)(2007-10#80)(2007-11#47)(2007-12#32)(2007-2#27)(2007-3#3)(2007-4#4)(2007-5#11)(2007-7#24)(2007-8#60)(2007-9#3)(2008-1#68)(2008-10#166)(2008-11#134)(2008-12#73)(2008-2#21)(2008-3#93)(2008-4#62)(2008-5#38)(2008-6#32)(2008-7#192)(2008-8#114)(2008-9#45)(2009-1#2)(2009-10#31)(2009-11#5)(2009-12#28)(2009-2#7)(2009-3#12)(2009-4#20)(2009-5#27)(2009-6#7)(2009-7#38)(2009-8#22)(2009-9#7)(2010-1#9)(2010-10#20)(2010-11#13)(2010-12#31)(2010-2#3)(2010-3#10)(2010-4#20)(2010-5#20)(2010-6#20)(2010-7#20)(2010-8#31)(2010-9#20)(2011-1#108)(2011-2#295)(2011-3#7)(2011-7#1)(2012-1#26)(2012-12#109)(2012-2#132)(2012-3#76)(2012-5#1)(2012-6#8)(2013-1#192)(2013-3#3)(2013-7#14)(2013-8#111)
risk&quot##6##1##(1990-2#2)(1992-6#1)(1993-9#1)(1994-6#1)(2012-3#1)
risk)##4##1##(1990-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
risk-adjusted model##2##2##(2007-8#2)
risk-adjusted##8##1##(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-8#3)(2008-11#1)
risk-adjustment##2##1##(1996-2#1)(1997-1#1)
risk-based##6##1##(1991-3#1)(2008-7#3)(2012-2#2)
risk-benefit and##2##2##(2007-12#1)(2008-7#1)
risk-benefit assessment##3##2##(2007-2#1)(2009-6#1)(2012-2#1)
risk-benefit ratio##3##2##(1996-3#1)(2008-3#1)(2010-6#1)
risk-benefit##11##1##(1993-2#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-6#1)(2012-2#1)(2013-1#2)
risk-level cut scores##2##3##(2008-12#2)
risk-level##3##1##(2008-12#3)
risk-reducing recommendations##2##2##(1993-12#2)
risk-reducing##5##1##(1993-12#5)
risk-reduction##3##1##(2010-7#1)(2011-1#1)(2013-1#1)
risk-selection in BI##2##3##(2008-7#2)
risk-selection in##4##2##(2008-7#4)
risk-selection##6##1##(2008-7#6)
risk-taking behavior##2##2##(2013-1#1)(2013-8#1)
risk-taking##6##1##(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
risk-to-benefit ratio##2##2##(1992-11#1)(1996-9#1)
risk/benefit of##2##2##(2011-1#1)(2012-1#1)
risk/benefit##5##1##(1991-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
risk?##13##1##(1991-12#1)(1992-2#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)
risk]##4##1##(1993-3#1)(1994-2#1)(1994-6#1)(2008-11#1)
riskier##3##1##(2008-11#1)(2011-2#2)
risking##8##1##(1990-8#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
risks and benefits of##13##4##(1996-12#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-12#2)(2010-9#1)(2011-2#2)(2013-1#1)
risks and benefits##14##3##(1996-12#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-12#1)(2010-12#2)(2010-9#1)(2011-2#2)(2013-1#1)
risks and hazards##2##3##(1991-12#1)(2013-1#1)
risks and##33##2##(1990-11#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
risks are identified##2##3##(1991-12#1)(2012-12#1)
risks are##4##2##(1991-12#1)(2008-11#1)(2008-3#1)(2012-12#1)
risks as##2##2##(2009-6#1)(2012-12#1)
risks associated with exposure to##2##5##(2007-12#1)(2011-1#1)
risks associated with the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
risks associated with their use##2##5##(2011-3#1)(2013-1#1)
risks associated with their##3##4##(2009-7#1)(2011-3#1)(2013-1#1)
risks associated with this##2##4##(2007-4#1)(2010-8#1)
risks associated with##32##3##(1991-3#1)(1992-2#1)(1995-1#1)(1996-1#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#4)
risks by##2##2##(2008-3#1)(2008-9#1)
risks can be minimized and maximum safety maintained##2##8##(2012-2#2)
risks can be##3##3##(2011-2#1)(2012-2#2)
risks can##4##2##(2008-11#1)(2011-2#1)(2012-2#2)
risks could be##2##3##(2008-7#1)(2013-1#1)
risks during##3##2##(1996-6#1)(2007-2#1)(2008-9#1)
risks factors for CAD##2##4##(2011-1#2)
risks factors for##4##3##(2011-1#2)(2012-12#1)(2013-1#1)
risks factors##5##2##(1991-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
risks for##17##2##(1994-6#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
risks from##7##2##(1991-3#1)(1996-11#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
risks in the##4##3##(1993-12#1)(1996-3#1)(2008-9#1)(2011-1#1)
risks in##15##2##(1990-6#1)(1991-11#1)(1993-12#1)(1996-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
risks inherent in##2##3##(1994-3#1)(2010-12#1)
risks involved in##3##3##(1993-1#1)(1996-2#1)(2007-12#1)
risks involved##7##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-1#1)(1996-2#1)(2007-12#1)(2010-5#1)
risks may be##3##3##(1992-2#1)(2008-11#1)(2008-7#1)
risks may##4##2##(1992-2#1)(2008-11#1)(2008-7#2)
risks of cancer##3##3##(1990-5#1)(2008-11#1)(2008-7#1)
risks of exposure to##2##4##(1991-11#1)(2007-2#1)
risks of infection##2##3##(2007-2#1)(2008-7#1)
risks of perforation and##2##4##(2010-8#2)
risks of these##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
risks of this##2##3##(1994-6#1)(2007-10#1)
risks of##98##2##(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1994-3#1)(1994-6#4)(1994-9#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-2#4)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#10)
risks on##2##2##(2011-1#1)(2011-2#1)
risks should be##2##3##(2008-11#1)(2011-2#1)
risks that##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2010-12#1)
risks to the patients##2##4##(1993-2#1)(2008-7#1)
risks to the##6##3##(1993-2#1)(2008-7#2)(2008-9#1)(2013-8#2)
risks to##15##2##(1991-4#1)(1993-2#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#1)(2013-8#2)
risks versus benefits##2##3##(2007-12#1)(2008-8#1)
risks were observed for##2##4##(1992-10#1)(1994-2#1)
risks were##8##2##(1991-3#1)(1992-10#2)(1994-2#2)(1996-11#1)(2010-8#1)(2011-3#1)
risks will##2##2##(1993-2#1)(2010-3#1)
risks with the##2##3##(2008-11#1)(2010-5#1)
risks##383##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#3)(1991-8#2)(1992-10#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#8)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#2)(1994-2#2)(1994-3#5)(1994-6#8)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#6)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#23)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#4)(2008-6#2)(2008-7#23)(2008-8#12)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#5)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#3)(2010-8#5)(2010-9#2)(2011-1#13)(2011-2#25)(2011-3#2)(2011-9#1)(2012-12#5)(2012-2#11)(2012-3#2)(2013-1#29)(2013-8#10)
risks]##4##1##(1994-6#1)(1995-12#1)(1996-2#1)(2011-3#1)
risky alcohol##2##2##(2009-8#1)(2013-1#1)
risky behavior##7##2##(1996-2#1)(2009-7#3)(2009-8#1)(2009-9#1)(2011-2#1)
risky behaviors##3##2##(2007-12#1)(2010-9#1)(2013-8#1)
risky behaviours##3##2##(2011-1#2)(2011-2#1)
risky decision-making##2##2##(2013-8#2)
risky injection##2##2##(2013-8#2)
risky sexual behavior##2##3##(2013-1#1)(2013-8#1)
risky sexual behaviors##4##3##(2007-12#3)(2013-8#1)
risky sexual##7##2##(2007-12#3)(2011-2#1)(2013-1#1)(2013-8#2)
risky##50##1##(1990-2#1)(1992-1#1)(1996-2#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#3)(2008-3#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-2#2)(2013-1#5)(2013-8#8)
risperidone##6##1##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
risque##6##1##(2008-11#3)(2013-1#3)
ristocetin##2##1##(2007-10#1)(2008-8#1)
ritanserin pretreatment##2##2##(1996-5#2)
ritanserin##6##1##(1995-12#1)(1996-5#5)
ritonavir##7##1##(2008-5#2)(2011-3#5)
ritual circumcision##2##2##(1991-8#2)
ritual##10##1##(1991-8#2)(2008-11#1)(2009-10#5)(2013-1#1)(2013-8#1)
rituals##5##1##(1993-3#2)(2008-11#1)(2009-10#2)
rituximab and##2##2##(2010-11#1)(2011-2#1)
rituximab in##2##2##(2013-1#2)
rituximab##16##1##(2007-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
rituximab-bendamustine regimen##2##2##(2013-8#2)
rival the##2##2##(1992-2#1)(2012-2#1)
rival##11##1##(1992-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-7#1)(2012-2#1)
rivaled##2##1##(1991-12#1)(2008-8#1)
rivalry##3##1##(1992-3#1)(2007-9#1)(2008-11#1)
rivals##3##1##(2008-11#1)(2009-6#1)(2012-2#1)
rivanol##5##1##(2008-10#5)
rivaroxaban and apixaban##2##3##(2012-12#2)
rivastigmine##10##1##(2011-2#10)
river and sea##2##3##(2008-10#2)
river and seawater samples##2##4##(2008-10#2)
river and seawater##5##3##(2008-10#5)
river and tap water and##2##5##(2008-10#2)
river and tap water samples##4##5##(2008-10#4)
river and tap water##6##4##(2008-10#6)
river and the##2##3##(1997-4#1)(2008-10#1)
river and##26##2##(1997-4#1)(2008-10#25)
river at##2##2##(2008-10#2)
river basin##6##2##(2008-10#3)(2008-12#1)(2008-5#2)
river flooding##2##2##(1991-2#1)(2007-5#1)
river humic substances (HS)##2##4##(2008-10#2)
river humic substances##4##3##(2008-10#4)
river kilometre##2##2##(2010-8#2)
river samples##2##2##(2008-10#2)
river sediment##7##2##(2008-10#4)(2008-6#2)(2013-8#1)
river sediments##5##2##(2008-10#4)(2013-8#1)
river system##2##2##(2010-8#1)(2013-1#1)
river water and##7##3##(2008-10#7)
river water samples##23##3##(2008-10#23)
river water spiked with##2##4##(2008-10#2)
river water using##2##3##(2008-10#2)
river water was##2##3##(2008-10#2)
river water##82##2##(2008-10#82)
river waters by##2##3##(2008-10#2)
river waters##15##2##(2008-10#15)
river##202##1##(1991-2#1)(1993-3#1)(1993-6#1)(1996-6#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-10#163)(2008-12#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-8#3)(2009-7#2)(2010-8#6)(2013-1#1)(2013-7#4)(2013-8#3)
riverine communities of the##2##4##(2013-7#2)
riverine communities##3##2##(2013-7#3)
riverine water reference by a graphite furnace atomic absorption spectroscopy##2##10##(2008-10#2)
riverine water##3##2##(2008-10#3)
riverine##10##1##(2008-10#4)(2008-2#1)(2013-7#5)
rivers and##3##2##(2007-5#1)(2008-9#1)(2013-8#1)
rivers in the State of Selangor##2##6##(2008-10#2)
rivers in the##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
rivers##24##1##(2007-5#4)(2008-10#9)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)(2013-8#2)
rivularis##3##1##(2008-10#3)
rizatriptan##2##1##(2008-6#1)(2009-2#1)
rkm##2##1##(2010-8#2)
rms and##2##2##(2008-3#2)
rms at##2##2##(2007-12#1)(2008-3#1)
rms can##2##2##(2008-2#1)(2008-3#1)
rms deviation##2##2##(1992-4#1)(2008-8#1)
rms deviations of##2##3##(1994-5#1)(2008-3#1)
rms deviations##3##2##(1994-5#1)(2008-3#1)(2008-8#1)
rms error in##3##3##(2007-11#1)(2008-3#2)
rms error##8##2##(2007-11#2)(2008-2#2)(2008-3#4)
rms errors of##2##3##(2008-3#2)
rms errors##3##2##(2008-3#3)
rms frequency##2##2##(2007-12#2)
rms timing##2##2##(2007-11#1)(2007-12#1)
rms##78##1##(1992-4#1)(1994-5#1)(2007-11#8)(2007-12#5)(2008-10#1)(2008-2#17)(2008-3#43)(2008-8#2)
rms)##3##1##(2007-12#1)(2008-2#2)
rnpB##3##1##(1997-2#3)
roNa##2##1##(1991-8#2)
roa307##3##1##(1995-8#3)
roach Rutilus rutilus##2##3##(2010-8#2)
roach and burbot##2##3##(2008-7#2)
roach and##3##2##(2008-7#3)
roach##12##1##(2008-11#1)(2008-7#8)(2010-8#3)
road accidents##5##2##(2007-2#1)(2009-10#2)(2013-8#2)
road and##2##2##(2009-10#1)(2013-1#1)
road from##2##2##(2006-12#1)(2013-8#1)
road map for##3##3##(1992-1#1)(1992-2#1)(2008-3#1)
road map##6##2##(1992-1#1)(1992-2#2)(2008-3#1)(2010-12#1)(2011-1#1)
road maps for##2##3##(2010-8#2)
road maps##4##2##(2010-8#4)
road safety##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
road to##6##2##(1992-5#1)(1993-3#1)(1995-1#1)(1995-3#1)(2009-12#1)(2013-8#1)
road traffic accident##2##3##(2008-8#1)(2012-2#1)
road traffic accidents##2##3##(1992-6#1)(2013-7#1)
road traffic and##2##3##(2010-11#2)
road traffic injuries in##2##4##(2008-10#1)(2011-2#1)
road traffic injuries##4##3##(1992-6#1)(2008-10#2)(2011-2#1)
road traffic##19##2##(1992-6#2)(2008-10#4)(2008-11#1)(2008-8#1)(2010-11#8)(2011-2#1)(2012-2#1)(2013-7#1)
road##83##1##(1990-6#5)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#2)(1993-3#1)(1995-1#1)(1995-3#1)(1996-3#3)(1997-2#1)(1997-4#2)(1997-6#1)(2006-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#7)(2009-12#1)(2009-7#2)(2010-11#9)(2010-12#1)(2010-8#4)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#4)
roadblocks##3##1##(1992-1#1)(1993-2#1)(2008-7#1)
roadmap##3##1##(2008-9#1)(2010-8#2)
roads##3##1##(1997-4#1)(2011-2#1)(2012-12#1)
roadside soil##2##2##(2008-10#1)(2008-11#1)
roadside soils##3##2##(2008-10#3)
roadside##7##1##(2008-10#4)(2008-11#1)(2011-2#1)(2013-1#1)
roasted coffee beans##2##3##(2008-10#2)
roasted coffee##3##2##(2008-10#3)
roasted##6##1##(2008-10#5)(2008-11#1)
roasting process##2##2##(2013-1#2)
roasting##4##1##(2008-10#1)(2013-1#3)
robbery##4##1##(1996-5#1)(1997-5#1)(2008-9#2)
robert C##2##2##(2008-3#2)
robin and##2##2##(2008-9#2)
robin##4##1##(2008-10#2)(2008-9#2)
robot hardware##2##2##(2007-12#2)
robot is##4##2##(2007-12#1)(2012-1#2)(2012-2#1)
robot##37##1##(2007-12#8)(2007-8#2)(2008-10#2)(2008-4#1)(2008-6#2)(2009-12#1)(2009-5#4)(2011-1#2)(2011-2#1)(2012-1#11)(2012-2#2)(2013-1#1)
robotic devices##3##2##(2013-1#3)
robotic instrumentation and##2##3##(2007-8#2)
robotic instruments##2##2##(2007-8#2)
robotic surgical system##3##3##(2007-8#3)
robotic surgical##4##2##(2007-8#3)(2013-8#1)
robotic system##2##2##(2008-10#1)(2010-7#1)
robotic systems##2##2##(2008-10#2)
robotic videoendoscopic##2##2##(2007-8#2)
robotic##33##1##(2007-12#2)(2007-8#12)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2010-7#1)(2010-8#1)(2012-1#2)(2013-1#3)(2013-8#2)
robotic-enhanced##2##1##(2007-8#2)
robotically assisted##2##2##(2008-10#1)(2012-3#1)
robotically##3##1##(2008-10#1)(2008-7#1)(2012-3#1)
robotics##10##1##(2007-12#3)(2008-10#4)(2009-5#1)(2010-7#1)(2013-1#1)
robots are##3##2##(2012-1#2)(2012-2#1)
robots that##2##2##(2007-12#1)(2012-2#1)
robots##22##1##(2007-12#8)(2008-11#2)(2009-5#1)(2011-1#1)(2012-1#4)(2012-2#3)(2013-1#3)
robur##7##1##(2008-10#1)(2009-6#1)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-8#1)
robust against##5##2##(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
robust and accurate##2##3##(2008-3#1)(2012-3#1)
robust and can be##2##4##(2010-2#1)(2010-3#1)
robust and can##3##3##(2008-3#1)(2010-2#1)(2010-3#1)
robust and flexible##2##3##(2008-3#1)(2012-2#1)
robust and reliable##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
robust and resistant to##2##4##(2007-12#1)(2008-11#1)
robust and sensitive##3##3##(2008-10#2)(2008-4#1)
robust and##32##2##(2007-12#2)(2008-10#6)(2008-11#2)(2008-3#5)(2008-4#2)(2008-7#3)(2008-9#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
robust brain##2##2##(2008-4#2)
robust clinical##3##2##(2008-12#1)(2008-7#1)(2010-6#1)
robust design##2##2##(1993-3#2)
robust detection##2##2##(2007-12#1)(2008-10#1)
robust enough for##2##3##(2007-11#1)(2011-1#1)
robust enough to##2##3##(2008-10#2)
robust enough##4##2##(2007-11#1)(2008-10#2)(2011-1#1)
robust estimators##2##2##(2008-10#2)
robust even##2##2##(1996-5#1)(2008-5#1)
robust evidence##4##2##(2008-10#1)(2011-2#2)(2013-1#1)
robust expression of##2##3##(2009-8#1)(2013-1#1)
robust flow injection##2##3##(2008-10#2)
robust for##2##2##(2008-2#2)
robust imaging modality##2##3##(2008-7#2)
robust in##3##2##(2007-12#2)(2012-3#1)
robust integrated##2##2##(1997-7#1)(2008-3#1)
robust method for the##2##4##(2008-1#1)(2008-10#1)
robust method for##3##3##(2008-1#1)(2008-10#2)
robust method##7##2##(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)
robust methods##4##2##(2008-10#3)(2009-2#1)
robust of##2##2##(2008-3#1)(2012-3#1)
robust operation##2##2##(2008-10#1)(2008-3#1)
robust performance with respect to##2##5##(2008-2#2)
robust performance##4##2##(2008-10#1)(2008-2#2)(2009-7#1)
robust procedure##2##2##(2008-2#1)(2008-3#1)
robust process##2##2##(2012-2#1)(2013-1#1)
robust psychometric properties##2##3##(2008-1#1)(2011-1#1)
robust regeneration##2##2##(2009-3#1)(2010-7#1)
robust regression method##2##3##(2008-10#2)
robust regression##4##2##(2008-10#4)
robust relationship between##2##3##(2008-12#1)(2008-3#1)
robust rhythms##2##2##(2008-6#2)
robust solid##3##2##(2008-10#2)(2010-12#1)
robust system##2##2##(1996-11#1)(2008-2#1)
robust to noise##2##3##(2007-12#1)(2008-6#1)
robust to##16##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-9#1)(2012-3#1)(2013-1#2)
robust##310##1##(1992-9#1)(1993-3#3)(1994-2#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-5#1)(1997-4#1)(1997-7#2)(2007-11#8)(2007-12#12)(2008-1#2)(2008-10#76)(2008-11#13)(2008-12#3)(2008-2#12)(2008-3#23)(2008-4#11)(2008-5#6)(2008-6#8)(2008-7#14)(2008-8#7)(2008-9#10)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#4)(2010-12#4)(2010-2#1)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#8)(2013-1#18)(2013-7#1)(2013-8#2)
robusta##6##1##(2008-10#5)(2013-8#1)
robustly##10##1##(2007-12#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
robustness and reliability##2##3##(1995-11#1)(2013-8#1)
robustness and##7##2##(1995-11#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-8#1)
robustness are##2##2##(2008-10#1)(2013-8#1)
robustness of our##2##3##(2010-8#1)(2013-1#1)
robustness of the method##3##4##(2008-10#3)
robustness of the proposed method##2##5##(2008-10#2)
robustness of the proposed##5##4##(2008-10#3)(2012-2#2)
robustness of the##26##3##(1993-3#1)(1997-3#2)(1997-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-6#2)(2008-8#1)(2010-5#1)(2012-2#2)(2012-3#1)
robustness of this procedure##2##4##(2008-10#1)(2008-11#1)
robustness of this##9##3##(2007-12#2)(2008-10#2)(2008-11#2)(2008-3#1)(2010-10#1)(2011-2#1)
robustness of##54##2##(1993-3#1)(1994-9#1)(1997-3#3)(1997-5#1)(2007-12#4)(2008-1#1)(2008-10#14)(2008-11#8)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
robustness to kernel estimation##2##4##(2008-3#2)
robustness to##9##2##(1994-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-3#4)(2010-4#1)
robustness was##2##2##(2008-10#2)
robustness with##2##2##(2008-10#2)
robustness##99##1##(1993-3#1)(1994-9#2)(1995-11#1)(1997-3#3)(1997-5#2)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#34)(2008-11#10)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
rock and##5##2##(1993-1#4)(2013-8#1)
rock has##2##2##(2008-10#1)(2013-8#1)
rock sample##6##2##(2008-10#3)(2013-8#3)
rock samples##7##2##(2008-10#6)(2013-8#1)
rock##40##1##(1993-1#4)(1996-4#1)(2007-5#1)(2008-10#16)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#14)
rocket exhausts##2##2##(2008-3#2)
rocket propellant fuel##2##3##(2008-10#2)
rocket##16##1##(1992-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#10)
rocket-borne##2##1##(2008-3#2)
rockets##2##1##(2008-3#2)
rocking##4##1##(2008-11#1)(2008-5#3)
rocking-chair##2##1##(2010-4#2)
rocks and pure apatite##2##4##(2008-10#2)
rocks and##6##2##(2008-10#5)(2010-12#1)
rocks in##3##2##(1996-4#1)(2007-5#1)(2013-1#1)
rocks##24##1##(1996-4#2)(2007-5#2)(2008-10#11)(2008-3#2)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-7#2)
rockwool slabs##2##2##(2008-10#2)
rockwool to##2##2##(2008-10#2)
rockwool##25##1##(2008-10#25)
rocky##3##1##(2008-5#2)(2012-2#1)
rocuronium in an infant##2##4##(2012-12#2)
rocuronium in##4##2##(2009-4#1)(2011-2#1)(2012-12#2)
rocuronium##12##1##(2008-10#1)(2009-4#1)(2011-2#7)(2012-12#3)
rod and##6##2##(1990-7#1)(2007-11#1)(2008-2#2)(2008-7#1)(2013-1#1)
rod derived indices##2##3##(2008-7#2)
rod domain##3##2##(1997-4#2)(2008-8#1)
rod domains##2##2##(1995-3#2)
rod is##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
rod laser##7##2##(2007-12#5)(2008-2#1)(2008-3#1)
rod lenses in the##2##4##(2008-3#2)
rod lenses in##3##3##(2008-3#3)
rod lenses##9##2##(2008-3#9)
rod of##2##2##(2008-2#1)(2008-6#1)
rod outer segments##4##3##(1993-8#1)(1995-5#1)(1997-1#1)(2008-4#1)
rod outer##5##2##(1993-8#1)(1995-5#1)(1997-1#2)(2008-4#1)
rod photoreceptor##2##2##(1990-11#1)(1994-12#1)
rod photoreceptors##2##2##(1994-12#1)(2010-1#1)
rod system##2##2##(2008-12#1)(2012-2#1)
rod was##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
rod with a##2##3##(2007-12#1)(2008-2#1)
rod with an##2##3##(2008-2#2)
rod with##7##2##(2007-12#1)(2008-2#6)
rod##99##1##(1990-11#1)(1990-7#1)(1992-9#1)(1993-8#1)(1994-12#2)(1995-3#3)(1995-5#2)(1997-1#2)(1997-2#3)(1997-4#2)(2007-11#4)(2007-12#11)(2007-5#1)(2008-10#5)(2008-12#2)(2008-2#23)(2008-3#17)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
rod-like structures##2##2##(2008-5#1)(2008-8#1)
rod-packing##3##1##(2008-5#3)
rod-shaped##8##1##(1996-5#1)(2008-10#3)(2008-7#2)(2011-2#1)(2012-2#1)
rodent and human mammary explant##2##5##(1995-9#2)
rodent and human##8##3##(1994-12#1)(1995-12#1)(1995-9#2)(1997-7#1)(2008-11#1)(2008-4#2)
rodent and##14##2##(1992-12#1)(1994-12#1)(1995-12#1)(1995-9#2)(1997-7#1)(2008-11#1)(2008-4#4)(2010-11#2)(2010-6#1)
rodent blood##2##2##(2008-4#1)(2008-9#1)
rodent brain##3##2##(1994-2#1)(1996-12#1)(2008-7#1)
rodent cell lines##5##3##(1993-12#1)(1996-2#1)(2008-11#3)
rodent cell##7##2##(1993-12#1)(1995-9#1)(1996-2#1)(2008-11#3)(2008-7#1)
rodent cells##4##2##(1992-9#1)(1994-8#1)(2008-7#2)
rodent cerebral##2##2##(1997-2#1)(2011-1#1)
rodent guilds##2##2##(2008-8#2)
rodent liver##2##2##(1993-12#1)(1994-6#1)
rodent mast cells##2##3##(2008-4#2)
rodent model##3##2##(2008-4#1)(2011-1#1)(2012-12#1)
rodent models for##2##3##(2008-4#1)(2012-3#1)
rodent models##8##2##(2008-10#2)(2008-4#4)(2010-5#1)(2012-3#1)
rodent species##3##2##(1994-12#1)(2010-6#1)(2012-3#1)
rodent ventricular##2##2##(2008-11#2)
rodent##96##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#3)(1994-12#4)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-9#5)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#7)(2008-4#14)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#5)(2010-11#4)(2010-2#2)(2010-5#1)(2010-6#2)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#2)
rodenticides##3##1##(1996-8#1)(2008-10#2)
rodentium##5##1##(2011-1#5)
rodents and primates##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
rodents and##10##2##(1993-3#1)(1995-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-7#1)(2013-8#1)
rodents from##2##2##(2012-2#1)(2013-1#1)
rodents has##3##2##(2006-12#1)(2008-5#1)(2008-7#1)
rodents that##2##2##(2008-4#1)(2011-2#1)
rodents to##2##2##(1992-2#1)(1997-6#1)
rodents##90##1##(1990-3#1)(1991-9#1)(1992-2#1)(1993-3#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-4#14)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#3)(2009-7#1)(2010-11#2)(2010-4#1)(2010-6#2)(2011-2#6)(2012-12#1)(2012-2#6)(2013-1#3)(2013-8#1)
rodlike##5##1##(2007-11#2)(2007-12#1)(2008-3#1)(2010-4#1)
rods and##2##2##(2008-7#1)(2009-8#1)
rods are##2##2##(2008-7#1)(2012-2#1)
rods have been##2##3##(2007-11#1)(2008-12#1)
rods in##2##2##(2007-8#1)(2012-12#1)
rods of##4##2##(1992-3#1)(2008-2#1)(2008-3#1)(2008-8#1)
rods were##3##2##(2007-5#1)(2008-2#1)(2011-2#1)
rods with##3##2##(2008-2#1)(2009-5#1)(2011-2#1)
rods##41##1##(1992-3#1)(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#4)(2012-12#2)(2012-2#1)
rods)##2##1##(1991-3#1)(2008-8#1)
roentgenogram showed##2##2##(1991-12#1)(1993-6#1)
roentgenogram##3##1##(1991-12#1)(1993-6#1)(2007-8#1)
roentgenograms##5##1##(1992-4#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-7#1)
roentgenographic##3##1##(1993-2#1)(2008-5#2)
roentgenologic##2##1##(1993-6#1)(2013-1#1)
rofecoxib and##2##2##(2008-8#1)(2011-2#1)
rofecoxib##7##1##(2006-10#1)(2008-8#2)(2011-2#4)
roguing##3##1##(2008-10#3)
rolC##6##1##(1991-7#2)(2008-9#4)
role and WHR not reaching significance##2##6##(2007-12#2)
role and contribution##2##3##(1997-8#1)(2011-2#1)
role and future##2##3##(2010-8#1)(2012-3#1)
role and its##2##3##(1995-12#1)(2010-3#1)
role and mechanism of##2##4##(2010-11#1)(2011-2#1)
role and responsibilities##3##3##(1995-3#1)(1997-2#1)(2011-2#1)
role and responsibility##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
role and the##2##3##(1992-2#1)(1996-2#1)
role and value of##2##4##(1995-1#1)(2008-9#1)
role and##52##2##(1990-12#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-2#3)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-3#1)(2013-1#1)
role are##2##2##(1990-12#1)(1994-2#1)
role as a mediator of##2##5##(1992-9#1)(2010-8#1)
role as a##26##3##(1990-11#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-6#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#5)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-1#1)
role as an##3##3##(1991-5#1)(2008-7#1)(2012-3#1)
role as part of##2##4##(2008-3#1)(2011-2#1)
role as the##3##3##(1995-3#2)(2012-1#1)
role as well##2##3##(1992-9#1)(2008-11#1)
role as##55##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-9#2)(1993-6#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#2)(1995-6#2)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)
role at the##2##3##(1994-9#1)(2010-2#1)
role at##5##2##(1990-8#1)(1994-9#1)(1997-1#1)(2009-8#1)(2010-2#1)
role by##4##2##(1993-11#1)(1995-2#1)(2011-2#1)(2012-3#1)
role can be##2##3##(1995-3#1)(2011-1#1)
role can##3##2##(1993-3#1)(1995-3#1)(2011-1#1)
role conflict and professional attitude of##2##6##(1990-2#2)
role conflict and professional attitude##3##5##(1990-2#3)
role conflict and##4##3##(1990-2#4)
role conflict##5##2##(1990-2#5)
role development##2##2##(2008-11#2)
role does##3##2##(1990-2#1)(1995-1#1)(2012-12#1)
role during the##4##3##(1990-11#1)(1992-6#2)(2008-8#1)
role during##17##2##(1990-11#1)(1991-7#1)(1991-9#1)(1992-6#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
role even##2##2##(2008-3#1)(2011-2#1)
role for CGRP##2##3##(1992-6#1)(1992-9#1)
role for DHA##2##3##(2012-1#2)
role for VE-cadherin in modulation of##2##6##(2011-1#2)
role for a##7##3##(1992-6#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
role for insulin##2##3##(2010-11#2)
role for lipid##2##3##(1992-6#1)(2009-12#1)
role for some##2##3##(1993-2#1)(2009-1#1)
role for the##29##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-4#2)(2012-2#2)
role for these##8##3##(1990-3#1)(1990-8#1)(1994-11#1)(1996-5#1)(1997-8#1)(2006-6#1)(2011-2#1)(2012-3#1)
role for this enzyme in##2##5##(1994-8#1)(2008-5#1)
role for this residue##2##4##(1995-2#2)
role for this##14##3##(1990-2#1)(1990-8#1)(1991-1#1)(1992-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)
role for##251##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#6)(1992-5#2)(1992-6#4)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#5)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-5#5)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#4)(2009-12#3)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#3)(2013-7#4)(2013-8#1)
role from##2##2##(2008-7#1)(2012-1#1)
role has##3##2##(2006-10#1)(2008-9#1)(2011-1#1)
role in &quot##2##3##(2008-1#1)(2009-11#1)
role in DNA##4##3##(1990-2#1)(1991-2#1)(2008-11#1)(2009-7#1)
role in RNA##2##3##(1993-12#1)(2012-3#1)
role in a variety of##2##5##(2007-8#1)(2008-4#1)
role in a##10##3##(1990-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1997-1#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
role in activating##4##3##(1995-12#1)(2008-1#1)(2008-11#1)(2009-8#1)
role in activation##3##3##(1991-2#1)(2011-1#1)(2012-12#1)
role in affecting##2##3##(2008-10#1)(2013-8#1)
role in age-related##2##3##(2012-2#1)(2012-3#1)
role in aging##2##3##(1992-5#1)(1994-11#1)
role in all##2##3##(1993-1#1)(2012-2#1)
role in an##3##3##(1992-1#1)(1997-7#1)(2008-3#1)
role in apoptotic cell death##2##5##(2008-7#1)(2012-2#1)
role in apoptotic##3##3##(2008-7#2)(2012-2#1)
role in atherosclerosis##2##3##(1995-12#1)(2008-3#1)
role in biological##2##3##(1991-6#1)(2008-8#1)
role in blood##2##3##(2008-10#1)(2011-2#1)
role in bone##3##3##(1991-11#1)(2007-8#1)(2013-1#1)
role in both the##2##4##(2008-8#1)(2011-2#1)
role in both##5##3##(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
role in brain##2##3##(2008-3#1)(2011-2#1)
role in breast cancer##2##4##(2008-12#1)(2008-4#1)
role in breast##4##3##(2008-12#1)(2008-4#2)(2009-2#1)
role in carcinogenesis##2##3##(1992-8#1)(2013-1#1)
role in causing##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
role in cell growth##4##4##(1992-12#1)(1994-12#1)(2011-2#2)
role in cell proliferation##2##4##(2008-9#1)(2009-5#1)
role in cell##7##3##(1992-12#1)(1994-12#1)(1994-9#1)(2008-9#1)(2009-5#1)(2011-2#2)
role in cellular physiology##2##4##(1994-11#1)(2008-8#1)
role in cellular redox homeostasis##2##5##(2009-6#1)(2009-9#1)
role in cellular##7##3##(1991-5#1)(1994-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)
role in changing##2##3##(1995-6#1)(2008-10#1)
role in cholesterol##2##3##(1995-6#1)(2008-11#1)
role in chronic##5##3##(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#2)
role in clinical##4##3##(2008-12#1)(2008-7#1)(2010-2#2)
role in community##2##3##(2008-9#2)
role in conferring##2##3##(2008-10#1)(2011-1#1)
role in control of##3##4##(1997-7#2)(2009-6#1)
role in controlling the##3##4##(2008-10#1)(2008-9#1)(2009-11#1)
role in controlling##9##3##(1997-1#1)(2008-10#3)(2008-9#2)(2009-11#1)(2010-8#1)(2011-1#1)
role in determining the##9##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-1#1)
role in determining##15##3##(1993-1#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
role in detoxification##2##3##(2008-11#1)(2008-7#1)
role in developing##2##3##(1995-3#1)(2008-11#1)
role in development##2##3##(1993-8#1)(2008-8#1)
role in developmental##2##3##(2008-8#1)(2009-5#1)
role in diagnosis##2##3##(2007-8#1)(2010-11#1)
role in different##2##3##(2007-11#1)(2010-2#1)
role in disease pathogenesis##2##4##(1994-8#1)(1995-3#1)
role in disease suppression##2##4##(2008-10#2)
role in disease##9##3##(1991-12#1)(1994-8#1)(1995-3#1)(2008-10#4)(2010-12#1)(2011-2#1)
role in drug##2##3##(1993-2#1)(2012-2#1)
role in early development of##2##5##(1993-3#1)(2008-4#1)
role in early##6##3##(1993-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
role in enhancing##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
role in establishing##3##3##(1995-12#1)(1997-1#1)(2011-1#1)
role in eukaryotic##3##3##(1993-8#1)(2008-4#1)(2008-8#1)
role in explaining##2##3##(2008-9#1)(2012-1#1)
role in female##2##3##(2009-10#1)(2010-8#1)
role in fetal##2##3##(1995-12#1)(2008-8#1)
role in generating##2##3##(1991-5#1)(1997-3#1)
role in health and disease##2##5##(2011-2#1)(2012-2#1)
role in health and##3##4##(2010-10#1)(2011-2#1)(2012-2#1)
role in health care reform##2##5##(1994-12#1)(1994-3#1)
role in health care##3##4##(1994-12#1)(1994-3#1)(1996-3#1)
role in health##6##3##(1994-12#1)(1994-3#1)(1996-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
role in helping##2##3##(2007-2#1)(2010-11#1)
role in hepatic##2##3##(2008-10#1)(2012-2#1)
role in host defense##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
role in how##4##3##(2008-11#1)(2009-5#1)(2010-1#2)
role in human##7##3##(1991-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
role in identifying##2##3##(2008-11#1)(2008-12#1)
role in immunity##2##3##(2009-6#1)(2010-3#1)
role in immunological##2##3##(2010-12#1)(2012-12#1)
role in immunoregulation and##2##4##(1991-9#1)(2011-2#1)
role in implementing##2##3##(1994-1#1)(2010-4#1)
role in improving the quality of##2##6##(1993-3#1)(2012-3#1)
role in in vivo##2##4##(2008-11#2)
role in in##3##3##(2008-11#2)(2013-1#1)
role in increasing the##2##4##(2008-11#1)(2013-1#1)
role in inducing##2##3##(2008-11#1)(2010-6#1)
role in infection##2##3##(2008-10#1)(2009-8#1)
role in inflammation##4##3##(1990-2#1)(1990-9#1)(2013-8#2)
role in inflammatory##3##3##(1995-12#1)(2007-12#1)(2008-5#1)
role in information##3##3##(1992-1#1)(2009-3#1)(2010-10#1)
role in initiation of##2##4##(1991-9#1)(2008-10#1)
role in insulin##2##3##(2008-1#1)(2010-11#1)
role in its##8##3##(1994-8#1)(2007-5#1)(2008-10#2)(2008-8#2)(2010-8#1)(2011-2#1)
role in learning##2##3##(2012-12#1)(2012-2#1)
role in limiting##2##3##(1997-6#1)(2010-5#1)
role in local##3##3##(1992-6#1)(1993-9#1)(1994-6#1)
role in lung##2##3##(2011-2#1)(2013-7#1)
role in maintaining the##3##4##(2009-10#1)(2009-8#1)(2012-2#1)
role in maintaining##11##3##(1994-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-11#2)(2011-2#2)(2012-2#1)
role in making##2##3##(2010-12#1)(2012-12#1)
role in managing##2##3##(2008-12#1)(2013-8#1)
role in many aspects of##2##5##(1996-6#1)(2008-11#1)
role in many of##2##4##(2008-12#1)(2008-6#1)
role in many##10##3##(1991-9#1)(1996-6#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)
role in mediating the##4##4##(1993-6#1)(1996-5#1)(1997-2#1)(2013-1#1)
role in mediating##14##3##(1990-12#1)(1993-6#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#2)
role in modern##2##3##(1994-3#1)(2011-2#1)
role in modulating the##2##4##(2008-11#1)(2013-7#1)
role in modulating##6##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-7#1)
role in neuronal##2##3##(2008-7#2)
role in normal##4##3##(1992-3#1)(1992-8#1)(2008-5#1)(2009-10#1)
role in our##3##3##(1992-12#1)(2008-9#2)
role in pathogenesis##2##3##(2008-10#1)(2008-7#1)
role in pattern formation##2##4##(1997-4#1)(2008-6#1)
role in pattern##3##3##(1995-11#1)(1997-4#1)(2008-6#1)
role in peptide antigenicity##2##4##(1997-6#2)
role in plant growth##2##4##(2008-10#1)(2008-9#1)
role in plant##4##3##(2008-10#2)(2008-9#1)(2009-6#1)
role in predicting##3##3##(2008-9#1)(2009-9#1)(2010-2#1)
role in promoting##4##3##(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#1)
role in protecting##3##3##(2007-8#1)(2009-12#1)(2013-8#1)
role in protection against##3##4##(2009-6#1)(2013-7#1)(2013-8#1)
role in providing##3##3##(1994-2#1)(2008-5#1)(2009-5#1)
role in public health##2##4##(1996-2#1)(2008-5#1)
role in public##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
role in radiation##2##3##(1995-6#1)(2013-8#1)
role in reducing##8##3##(2008-7#1)(2009-3#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
role in regulating membrane excitability##2##5##(2008-8#2)
role in regulating the##8##4##(1991-3#1)(1994-11#1)(1997-8#1)(2008-11#2)(2008-4#1)(2012-12#1)(2012-3#1)
role in regulating##27##3##(1991-12#1)(1991-3#1)(1994-11#2)(1995-12#2)(1995-2#1)(1996-5#1)(1997-8#1)(1997-9#1)(2008-11#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-8#2)(2010-2#1)(2011-10#1)(2012-12#3)(2012-3#2)(2013-1#1)
role in regulation of##5##4##(1994-12#1)(2008-1#1)(2008-9#1)(2010-11#1)(2013-1#1)
role in renal##3##3##(2011-2#2)(2013-8#1)
role in resistance to##2##4##(2008-10#2)
role in resistance##6##3##(1992-7#1)(2008-10#5)
role in respiratory##2##3##(2011-2#2)
role in risk management##2##4##(1993-2#2)
role in risk##3##3##(1993-2#2)(2008-11#1)
role in selecting##2##3##(1995-12#1)(2009-3#1)
role in several##4##3##(1994-11#1)(2008-1#1)(2012-12#1)(2012-2#1)
role in signal transduction##3##4##(1994-12#1)(1997-8#1)(2012-12#1)
role in skin##2##3##(2008-5#1)(2008-9#1)
role in some##3##3##(1991-12#1)(1995-12#1)(2008-5#1)
role in spore formation##2##4##(2008-8#1)(2010-2#1)
role in suppressing##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
role in synaptic plasticity##2##4##(1996-2#1)(1996-5#1)
role in the activation of##2##5##(1990-5#1)(2008-4#1)
role in the binding of##2##5##(1991-8#1)(2008-10#1)
role in the binding##4##4##(1991-8#1)(2008-10#2)(2010-7#1)
role in the cell##2##4##(2008-2#1)(2011-2#1)
role in the cellular##2##4##(1995-8#1)(2011-2#1)
role in the control of cell proliferation##2##7##(1993-3#1)(2009-5#1)
role in the control of growth##2##6##(1993-9#1)(1994-10#1)
role in the control of##9##5##(1993-3#1)(1993-9#1)(1994-10#2)(1994-2#1)(1996-3#1)(2008-7#1)(2009-5#1)(2013-8#1)
role in the decision-making process##2##5##(2009-6#1)(2011-2#1)
role in the detection of##2##5##(2008-2#1)(2011-2#1)
role in the detection##3##4##(2008-2#1)(2010-12#1)(2011-2#1)
role in the development and progression of breast cancer##2##9##(2009-5#1)(2012-3#1)
role in the development and progression of##3##7##(2009-5#1)(2010-3#1)(2012-3#1)
role in the development and##6##5##(1991-12#1)(1996-2#1)(2008-11#1)(2009-5#1)(2010-3#1)(2012-3#1)
role in the development of breast cancer##2##7##(1994-12#1)(2008-12#1)
role in the development of chronic##2##6##(2010-10#1)(2011-2#1)
role in the development of the##3##6##(1993-3#1)(2008-3#1)(2013-1#1)
role in the development of these##2##6##(2008-11#1)(2011-2#1)
role in the development of##34##5##(1993-3#1)(1994-12#2)(1996-1#1)(2006-6#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
role in the development##40##4##(1991-12#1)(1993-3#1)(1994-12#2)(1996-1#1)(1996-2#1)(2006-6#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
role in the diagnosis and##3##5##(2008-5#1)(2010-12#1)(2012-2#1)
role in the diagnosis of##3##5##(2008-11#1)(2009-11#1)(2012-2#1)
role in the diagnosis##6##4##(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)(2012-2#2)
role in the differentiation##2##4##(1994-12#1)(1995-6#1)
role in the early##7##4##(1992-12#1)(1994-11#1)(1997-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
role in the epidemiology of##2##5##(2008-10#2)
role in the etiology of##3##5##(1990-8#1)(2008-5#1)(2009-11#1)
role in the etiology##4##4##(1990-11#1)(1990-8#1)(2008-5#1)(2009-11#1)
role in the evaluation of##4##5##(2007-4#1)(2008-2#1)(2008-7#1)(2011-2#1)
role in the evolution of the##2##6##(2008-12#1)(2012-12#1)
role in the evolution of##10##5##(1995-8#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
role in the expression of##3##5##(1992-8#1)(1993-3#1)(2008-11#1)
role in the formation of the##2##6##(1992-6#1)(1993-11#1)
role in the formation of##5##5##(1992-3#1)(1992-6#1)(1993-11#1)(2008-7#1)(2010-10#1)
role in the generation##2##4##(2008-3#1)(2008-5#1)
role in the genesis of##2##5##(1995-8#1)(2012-2#1)
role in the health##2##4##(1993-11#1)(1993-12#1)
role in the improvement of##4##5##(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
role in the increased##2##4##(1991-1#1)(2008-7#1)
role in the induction of##3##5##(1991-12#1)(1997-6#1)(2012-3#1)
role in the inflammatory##2##4##(1995-12#1)(2006-10#1)
role in the initiation of##2##5##(1994-11#1)(2008-8#1)
role in the initiation##3##4##(1994-11#1)(2008-8#1)(2013-1#1)
role in the interaction between##2##5##(1995-12#1)(2008-10#1)
role in the interaction##4##4##(1993-3#1)(1995-12#1)(1995-6#1)(2008-10#1)
role in the intracellular##2##4##(1992-5#1)(2008-11#1)
role in the life##2##4##(2008-10#1)(2013-7#1)
role in the maintenance of##8##5##(1996-5#1)(1997-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
role in the maintenance##9##4##(1996-5#1)(1997-1#1)(2008-4#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-3#1)
role in the management of##4##5##(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
role in the management##5##4##(2008-1#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-8#1)
role in the mechanism of##4##5##(1993-6#1)(1995-12#1)(2008-10#1)(2008-7#1)
role in the metabolic activation of##2##6##(1994-6#1)(2008-8#1)
role in the metabolism of##2##5##(2008-10#1)(2011-2#1)
role in the metastatic process##2##5##(1993-9#1)(2008-4#1)
role in the modulation of##3##5##(1993-12#1)(2012-2#1)(2013-8#1)
role in the neural##2##4##(1990-11#1)(1997-4#1)
role in the occurrence of##4##5##(1990-8#1)(1997-3#1)(2010-4#1)(2012-2#1)
role in the pathogenesis of the##4##6##(1990-11#1)(1991-5#1)(1992-6#1)(2008-1#1)
role in the pathogenesis of this##2##6##(1992-2#1)(2012-1#1)
role in the pathogenesis of##30##5##(1990-11#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-1#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-3#1)
role in the pathogenesis##31##4##(1990-11#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-3#1)
role in the pathophysiology of##7##5##(2008-1#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#2)
role in the process of##3##5##(1993-11#1)(1997-7#1)(2008-1#1)
role in the recognition of##2##5##(1995-2#1)(2009-3#1)
role in the recovery##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
role in the regulation of gene expression##2##7##(1991-6#1)(1997-4#1)
role in the regulation of genes##2##6##(2008-1#2)
role in the regulation of proliferation##2##6##(1992-8#1)(2013-1#1)
role in the regulation of the##6##6##(1992-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-9#1)(2013-7#1)
role in the regulation of##36##5##(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#3)(2008-4#4)(2008-8#3)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
role in the response##2##4##(1990-5#1)(2012-7#1)
role in the rise of health care costs##2##8##(1994-2#2)
role in the signal transduction##2##5##(1990-12#1)(2008-8#1)
role in the sorption##2##4##(2008-10#2)
role in the structure and function of##2##7##(2008-4#1)(2008-8#1)
role in the suppression of##4##5##(2008-10#4)
role in the survival and##2##5##(2008-10#1)(2008-7#1)
role in the survival##3##4##(2008-10#2)(2008-7#1)
role in the transcriptional regulation of##2##6##(1996-12#1)(2011-2#1)
role in the transmission of##5##5##(2008-10#2)(2010-1#2)(2013-1#1)
role in the treatment and prevention of##2##7##(2008-5#1)(2008-7#1)
role in the treatment of##10##5##(1991-9#1)(1995-11#1)(2007-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2013-1#1)
role in the treatment##12##4##(1991-9#1)(1995-11#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2011-3#2)(2013-1#1)
role in the##522##3##(1990-10#1)(1990-11#4)(1990-12#1)(1990-5#7)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#4)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#8)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#5)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#9)(1995-2#4)(1995-3#1)(1995-6#6)(1995-8#7)(1996-1#2)(1996-10#1)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#2)(2007-8#1)(2008-1#14)(2008-10#46)(2008-11#17)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#14)(2008-5#13)(2008-6#6)(2008-7#25)(2008-8#18)(2008-9#10)(2009-1#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#9)(2011-10#1)(2011-2#29)(2011-3#2)(2011-7#2)(2012-1#3)(2012-12#6)(2012-2#14)(2012-3#10)(2012-7#1)(2013-1#18)(2013-3#1)(2013-7#4)(2013-8#7)
role in their##6##3##(1992-6#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-8#1)(2010-9#1)
role in these##5##3##(1992-11#1)(1992-9#1)(2007-12#1)(2011-1#1)(2011-3#1)
role in this area##2##4##(1996-1#1)(2008-7#1)
role in this pathway##2##4##(1994-11#1)(2010-2#1)
role in this process##4##4##(1992-9#1)(1993-11#1)(2009-7#1)(2011-2#1)
role in this transition##2##4##(1994-2#1)(2010-8#1)
role in this##22##3##(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)
role in thyroid homeostasis##2##4##(2013-1#2)
role in thyroid##3##3##(2013-1#3)
role in tissue##2##3##(1995-6#1)(2010-1#1)
role in treating##3##3##(2008-3#1)(2008-4#1)(2011-2#1)
role in treatment of##2##4##(2007-11#1)(2010-4#1)
role in tumor progression##2##4##(1993-9#1)(2009-3#1)
role in tumor##6##3##(1993-9#1)(1994-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
role in tumorigenesis##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
role in understanding the##2##4##(2010-1#1)(2012-2#1)
role in understanding##3##3##(2008-8#1)(2010-1#1)(2012-2#1)
role in various##2##3##(1992-6#1)(2009-3#1)
role in vascular##2##3##(2008-3#1)(2009-11#1)
role in vesicle##2##3##(2008-11#1)(2009-8#1)
role in which##2##3##(1994-2#1)(2008-12#1)
role in##1422##2##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#10)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#11)(1991-2#2)(1991-3#1)(1991-5#6)(1991-6#4)(1991-8#1)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#3)(1992-3#6)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#9)(1992-9#4)(1993-1#3)(1993-11#9)(1993-12#10)(1993-2#4)(1993-3#14)(1993-5#1)(1993-6#5)(1993-8#4)(1993-9#6)(1994-1#3)(1994-10#3)(1994-11#14)(1994-12#14)(1994-2#11)(1994-3#3)(1994-5#1)(1994-6#5)(1994-8#7)(1994-9#5)(1995-1#1)(1995-11#4)(1995-12#24)(1995-2#15)(1995-3#5)(1995-5#4)(1995-6#15)(1995-8#8)(1996-1#5)(1996-10#1)(1996-12#12)(1996-2#10)(1996-3#4)(1996-4#1)(1996-5#10)(1996-6#2)(1997-1#7)(1997-2#7)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#5)(1997-7#9)(1997-8#4)(1997-9#2)(2006-10#2)(2006-6#1)(2006-8#2)(2007-10#4)(2007-11#3)(2007-12#16)(2007-2#1)(2007-4#5)(2007-5#1)(2007-7#3)(2007-8#7)(2008-1#28)(2008-10#117)(2008-11#49)(2008-12#11)(2008-2#10)(2008-3#22)(2008-4#39)(2008-5#35)(2008-6#14)(2008-7#63)(2008-8#51)(2008-9#38)(2009-1#4)(2009-10#13)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#6)(2009-5#8)(2009-6#12)(2009-7#11)(2009-8#14)(2009-9#5)(2010-1#7)(2010-10#13)(2010-11#17)(2010-12#12)(2010-2#8)(2010-3#12)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#10)(2010-9#2)(2011-1#28)(2011-10#3)(2011-2#78)(2011-3#5)(2011-7#2)(2012-1#7)(2012-12#28)(2012-2#44)(2012-3#19)(2012-7#2)(2013-1#57)(2013-3#1)(2013-7#8)(2013-8#19)
role is also played by##2##5##(1995-5#1)(2007-8#1)
role is not##3##3##(1994-3#1)(1997-7#1)(2008-1#1)
role is one that##2##4##(2008-1#1)(2008-11#1)
role is to##2##3##(1994-2#1)(1997-2#1)
role is##25##2##(1991-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#1)
role it has##2##3##(1993-6#1)(2008-5#1)
role it##5##2##(1992-6#1)(1993-6#1)(2008-5#1)(2013-1#2)
role limitations due to emotional##3##5##(2007-11#2)(2012-12#1)
role limitations due to physical problems##2##6##(2007-11#2)
role limitations due to##5##4##(2007-11#4)(2012-12#1)
role model##3##2##(2007-7#1)(2008-12#1)(2008-8#1)
role modeling##2##2##(1994-3#1)(1995-12#1)
role modelling##5##2##(2008-12#5)
role models had##2##3##(2008-11#1)(2009-7#1)
role models to##2##3##(1991-2#1)(2008-12#1)
role models##14##2##(1991-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#4)(2009-8#1)(2012-3#1)
role not only in the##2##5##(2008-11#1)(2008-7#1)
role of ATP receptors##2##4##(2008-4#2)
role of COX##2##3##(2007-4#1)(2010-2#1)
role of COX-2 in##2##4##(2008-11#1)(2013-8#1)
role of Cys-138##2##3##(1993-8#2)
role of DCs in##2##4##(2010-5#2)
role of ECM in##2##4##(2009-10#2)
role of H##2##3##(2008-1#1)(2008-10#1)
role of HIV##3##3##(1994-11#1)(1996-8#1)(2008-8#1)
role of HSP in##2##4##(1994-11#2)
role of IRF-8 in the cross talk between melanoma##2##9##(2013-1#2)
role of LMP2 as##2##4##(2012-2#2)
role of MEL##2##3##(2010-8#2)
role of MTs in the##2##5##(2013-7#2)
role of MTs in##3##4##(2008-11#1)(2013-7#2)
role of NGF in##2##4##(2010-8#2)
role of NO##2##3##(2008-10#1)(2008-6#1)
role of P2 receptors##3##4##(2008-4#3)
role of P2##4##3##(2008-4#3)(2008-5#1)
role of PKC##2##3##(1994-11#1)(2008-4#1)
role of RNA##2##3##(1994-8#1)(2010-5#1)
role of Ras in##2##4##(1994-8#2)
role of Src in##2##4##(2012-12#2)
role of TLR4##3##3##(2008-3#1)(2013-8#2)
role of TSPO##3##3##(2012-2#3)
role of XBP1 in##3##4##(2011-2#3)
role of Zn in##2##4##(2012-2#2)
role of a##12##3##(1990-12#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)
role of activated##2##3##(1991-2#1)(2008-10#1)
role of activin##2##3##(1990-11#1)(1994-9#1)
role of adjuvant therapy##2##4##(1992-8#1)(2012-3#1)
role of adjuvant##3##3##(1992-8#1)(2008-6#1)(2012-3#1)
role of advanced##2##3##(2011-2#1)(2013-1#1)
role of affective##3##3##(2008-1#2)(2008-2#1)
role of alpha##2##3##(1994-8#1)(1995-11#1)
role of amino acids##2##4##(1993-3#2)
role of an##7##3##(1990-9#1)(1994-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-4#1)
role of apical##2##3##(2007-8#1)(2008-10#1)
role of apoptosis##2##3##(2006-10#1)(2011-2#1)
role of atypical##3##3##(2008-8#3)
role of beta-amyloid protein##2##4##(2008-7#2)
role of bisphosphonates##3##3##(1993-11#1)(2008-7#1)(2010-4#1)
role of both##2##3##(1997-6#1)(2008-10#1)
role of brain##2##3##(1995-11#1)(2008-5#1)
role of calcium##3##3##(1992-9#1)(1995-11#1)(1995-8#1)
role of cell##3##3##(2008-11#2)(2008-8#1)
role of chemotherapy##2##3##(1991-4#1)(1997-5#1)
role of cholinergic##2##3##(2008-5#1)(2013-8#1)
role of citrate complexes in preventing urolithiasis##2##7##(1992-9#2)
role of classroom##2##3##(2008-12#2)
role of collagens##2##3##(1992-9#2)
role of depression##2##3##(2009-11#1)(2010-4#1)
role of diet##2##3##(1990-8#2)
role of dietary protein intake##2##5##(2008-5#2)
role of dietary protein##3##4##(1994-3#1)(2008-5#2)
role of dietary##4##3##(1993-9#1)(1994-3#1)(2008-5#2)
role of different##9##3##(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
role of each##2##3##(1990-5#1)(1995-11#1)
role of elevated##2##3##(1991-12#1)(1995-2#1)
role of endogenous cytokines in host resistance against an intragastric infection with##2##12##(1996-12#2)
role of endogenous cytokines##3##4##(1996-12#3)
role of endogenous##7##3##(1990-2#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-2#1)
role of endoscopic ultrasound in the evaluation of rectal polypoid lesions in 25 dogs##2##14##(2013-1#2)
role of endoscopic ultrasound##3##4##(2008-2#1)(2013-1#2)
role of environmental##3##3##(2007-8#1)(2008-1#1)(2009-8#1)
role of estrogen in##3##4##(1995-9#1)(2007-10#1)(2010-6#1)
role of estrogen##4##3##(1995-9#1)(2007-10#1)(2008-3#1)(2010-6#1)
role of evidence##2##3##(1993-12#1)(2008-11#1)
role of exercise##5##3##(1993-11#1)(2013-1#4)
role of experience##2##3##(1993-6#1)(2009-9#1)
role of extracellular nucleotides in##2##5##(2008-4#1)(2013-8#1)
role of fine needle aspiration cytology##2##6##(1990-6#1)(2013-8#1)
role of food##3##3##(1994-3#1)(1997-6#1)(2008-5#1)
role of free radicals in##2##5##(1992-12#1)(2008-10#1)
role of functional##2##3##(2008-1#1)(2009-9#1)
role of genes##4##3##(2008-1#1)(2008-2#1)(2012-3#1)(2013-1#1)
role of genetic factors in##2##5##(2009-4#1)(2013-8#1)
role of genetic factors##3##4##(1997-8#1)(2009-4#1)(2013-8#1)
role of genetic##8##3##(1992-3#1)(1997-8#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-4#1)(2013-8#1)
role of glutamate##2##3##(2008-7#1)(2012-12#1)
role of glutathione##2##3##(1992-8#1)(2008-5#1)
role of government in##2##4##(1996-12#1)(2012-2#1)
role of government##4##3##(1994-2#1)(1996-12#1)(2007-12#1)(2012-2#1)
role of health care##2##4##(1997-2#1)(2010-4#1)
role of health##5##3##(1992-12#1)(1993-12#1)(1997-2#1)(2008-11#1)(2010-4#1)
role of heat shock proteins in the##2##7##(1994-11#2)
role of heat shock##3##4##(1994-11#2)(2012-1#1)
role of host##3##3##(2008-10#3)
role of human##3##3##(2009-5#1)(2012-12#1)(2013-1#1)
role of hydrogen##2##3##(1991-1#1)(2011-1#1)
role of imaging in##3##4##(2007-5#1)(2009-4#2)
role of imaging##4##3##(1997-6#1)(2007-5#1)(2009-4#2)
role of information##2##3##(1997-3#1)(2012-12#1)
role of inhibition##2##3##(2008-7#1)(2010-7#1)
role of insulin##3##3##(2008-3#1)(2010-11#1)(2011-1#1)
role of intracellular MIF in##2##5##(2009-6#2)
role of intracellular##5##3##(1994-11#1)(1995-8#2)(2009-6#2)
role of ionic##2##3##(1990-7#1)(2010-7#1)
role of iron in##2##4##(2012-12#1)(2012-2#1)
role of iron##4##3##(1993-11#1)(1996-5#1)(2012-12#1)(2012-2#1)
role of low##3##3##(2008-7#3)
role of magnetic resonance imaging##2##5##(2008-8#1)(2012-2#1)
role of magnetic resonance##4##4##(1994-8#1)(2008-8#1)(2011-2#1)(2012-2#1)
role of managed care##2##4##(1995-12#1)(2008-6#1)
role of maternal##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
role of membrane##2##3##(1995-2#1)(2008-8#1)
role of mitochondria in##2##4##(1994-12#1)(2008-1#1)
role of mitochondria##3##3##(1994-12#1)(2008-1#1)(2013-8#1)
role of molecular##4##3##(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)
role of murine##2##3##(1993-6#1)(2010-6#1)
role of natural##3##3##(2009-1#1)(2010-4#1)(2010-5#1)
role of nicotinic mechanisms in REM sleep generation##2##8##(1990-7#2)
role of nicotinic##3##3##(1990-7#2)(1995-5#1)
role of nitric oxide (NO) in##2##6##(2008-10#1)(2008-8#1)
role of nucleotides in##2##4##(2008-4#2)
role of nursing##3##3##(2008-1#2)(2012-3#1)
role of oncogenes in drug resistance##3##6##(2008-11#3)
role of oospores in##2##4##(2008-10#2)
role of oxidative stress in##3##5##(2008-1#1)(2008-11#1)(2010-12#1)
role of oxygen therapy in##2##5##(2008-8#2)
role of oxygen##3##3##(2008-10#1)(2008-8#2)
role of p53 in##2##4##(2008-9#1)(2011-2#1)
role of pancreatic##2##3##(2010-10#1)(2013-7#1)
role of phenolics##2##3##(2008-10#2)
role of physical therapy##2##4##(2008-7#1)(2010-3#1)
role of platelets in##2##4##(2006-6#1)(2008-1#1)
role of play##2##3##(2008-12#1)(2008-9#1)
role of prostaglandin E2##2##4##(1996-2#1)(1997-2#1)
role of protein kinase C in##2##6##(1992-8#1)(1996-9#1)
role of protein kinase C##4##5##(1992-8#1)(1994-5#1)(1996-9#1)(2013-8#1)
role of protein##7##3##(1992-8#1)(1994-5#1)(1996-9#1)(2008-11#1)(2008-6#1)(2010-12#1)(2013-8#1)
role of public health##3##4##(1996-2#1)(1997-3#2)
role of public relations for image creating in health services##2##10##(2008-12#2)
role of public relations##3##4##(2008-12#3)
role of public##6##3##(1996-2#1)(1997-3#2)(2008-12#3)
role of purinergic signaling##2##4##(2013-8#2)
role of radiotherapy##8##3##(1993-9#1)(1994-8#1)(1995-9#1)(2007-10#1)(2007-11#1)(2009-1#1)(2010-3#1)(2013-1#1)
role of risk management##2##4##(1993-2#1)(1994-2#1)
role of risk##3##3##(1993-2#1)(1994-2#1)(1995-3#1)
role of senior##2##3##(1993-12#1)(1994-2#1)
role of serine##2##3##(1993-3#1)(1994-5#1)
role of serotonin (5-HT) in##2##5##(1993-3#1)(2008-6#1)
role of solvent##2##3##(2008-10#1)(2009-9#1)
role of specific##6##3##(1993-11#1)(2007-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-1#1)
role of spirituality in##2##4##(2008-12#2)
role of standby emergency medication for falciparum malaria##2##8##(2007-2#2)
role of standby emergency##3##4##(2007-2#3)
role of stem##3##3##(2008-5#1)(2010-12#1)(2013-7#1)
role of stress proteins in##2##5##(1992-5#1)(2008-7#1)
role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and##2##18##(2011-3#2)
role of structural##3##3##(2008-7#1)(2011-3#2)
role of sulfhydryl groups in##2##5##(1991-5#1)(1993-6#1)
role of telomeres##2##3##(2010-2#1)(2011-2#1)
role of the adventitia in##2##5##(1997-8#2)
role of the amygdala in##2##5##(1993-12#1)(2008-11#1)
role of the amygdala##3##4##(1993-12#1)(1994-8#1)(2008-11#1)
role of the epidemiologist##2##4##(1994-3#2)
role of the family##3##4##(1991-2#2)(2008-9#1)
role of the immune system in##2##6##(2011-2#1)(2012-3#1)
role of the lecturer practitioner##2##5##(2008-12#2)
role of the lecturer##3##4##(2008-11#1)(2008-12#2)
role of the left##2##4##(1993-9#1)(2008-1#1)
role of the low##2##4##(1992-12#1)(2008-2#1)
role of the medical##5##4##(1994-2#2)(1995-11#1)(2013-1#2)
role of the mitochondria##2##4##(2009-11#2)
role of the nurse##4##4##(2008-11#2)(2008-6#1)(2011-2#1)
role of the peptide in the##2##6##(1992-6#2)
role of the physician##2##4##(1995-2#1)(2012-12#1)
role of the small##2##4##(1994-11#1)(1994-8#1)
role of the substrate##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
role of the two##2##4##(1992-6#1)(1994-9#1)
role of the visual input in the##2##7##(1991-2#2)
role of the##271##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#6)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#4)(1992-6#5)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#5)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2007-11#4)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#21)(2008-11#15)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#2)(2009-10#4)(2009-11#2)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#12)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#5)(2012-6#1)(2013-1#3)(2013-7#3)(2013-8#4)
role of these enzymes##2##4##(1995-3#1)(2008-11#1)
role of these molecules##2##4##(1991-2#1)(2008-4#1)
role of these proteins##3##4##(1995-2#2)(2009-5#1)
role of these##40##3##(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#3)(1995-3#1)(1995-6#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#2)
role of thiamine##2##3##(2008-1#1)(2012-4#1)
role of thiol-containing agents##2##4##(1991-9#2)
role of this phenomenon##2##4##(2008-12#1)(2013-1#1)
role of this protein##2##4##(1997-2#1)(2013-1#1)
role of this##25##3##(1990-11#2)(1991-6#1)(1993-11#1)(1994-8#2)(1995-2#3)(1997-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#3)
role of traditional##2##3##(2009-6#1)(2013-1#1)
role of tumor suppressor##2##4##(1990-12#1)(1995-6#1)
role of tumor##3##3##(1990-12#1)(1995-6#1)(2009-12#1)
role of two of##2##4##(2008-10#1)(2008-3#1)
role of two##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
role of ultrasound##2##3##(2008-10#1)(2012-2#1)
role of various##3##3##(2008-10#2)(2011-1#1)
role of viral##2##3##(1994-1#1)(2008-11#1)
role of vitamin D##2##4##(2012-2#1)(2013-1#1)
role of vitamin##4##3##(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#1)
role of wild##2##3##(1995-9#1)(2013-1#1)
role of women in##2##4##(1992-12#1)(1996-9#1)
role of women##4##3##(1991-6#1)(1992-12#1)(1993-6#1)(1996-9#1)
role of x-rays in the treatment of gas gangrene##2##9##(2013-1#2)
role of##1638##2##(1990-10#1)(1990-11#6)(1990-12#9)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#3)(1990-7#4)(1990-8#8)(1990-9#3)(1991-1#7)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#11)(1991-3#6)(1991-4#1)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#7)(1992-1#3)(1992-12#13)(1992-2#9)(1992-3#12)(1992-5#4)(1992-6#8)(1992-8#8)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#19)(1993-12#15)(1993-2#6)(1993-3#13)(1993-5#5)(1993-6#12)(1993-8#5)(1993-9#6)(1994-1#1)(1994-10#2)(1994-11#14)(1994-12#6)(1994-2#13)(1994-3#7)(1994-5#9)(1994-6#9)(1994-8#16)(1994-9#11)(1995-1#5)(1995-11#6)(1995-12#21)(1995-2#23)(1995-3#5)(1995-5#3)(1995-6#8)(1995-8#8)(1995-9#4)(1996-1#3)(1996-11#2)(1996-12#10)(1996-2#11)(1996-3#5)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#14)(1997-3#6)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#3)(1997-8#8)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#3)(2007-10#7)(2007-11#10)(2007-12#23)(2007-2#4)(2007-4#3)(2007-5#5)(2007-7#6)(2007-8#10)(2008-1#47)(2008-10#116)(2008-11#75)(2008-12#29)(2008-2#20)(2008-3#23)(2008-4#35)(2008-5#25)(2008-6#16)(2008-7#59)(2008-8#42)(2008-9#17)(2009-1#3)(2009-10#15)(2009-11#8)(2009-12#9)(2009-2#2)(2009-3#5)(2009-4#10)(2009-5#9)(2009-6#9)(2009-7#13)(2009-8#17)(2009-9#9)(2010-1#6)(2010-10#4)(2010-11#11)(2010-12#9)(2010-2#4)(2010-3#8)(2010-4#12)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#4)(2011-1#23)(2011-10#1)(2011-2#77)(2011-3#8)(2011-7#1)(2011-9#2)(2012-1#8)(2012-12#29)(2012-2#51)(2012-3#30)(2012-4#1)(2012-6#2)(2013-1#68)(2013-2#1)(2013-7#13)(2013-8#42)
role on the##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
role on##12##2##(1992-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2013-1#2)
role or##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
role over time##2##3##(1996-12#1)(2008-1#1)
role over##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
role played by serine proteases in the development and worsening of vascular complications in##2##14##(2008-1#2)
role played by the##8##4##(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
role played by##31##3##(1990-9#1)(1992-2#1)(1993-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
role played##32##2##(1990-9#1)(1992-2#1)(1993-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
role plays##8##2##(2009-11#7)(2009-12#1)
role remains##2##2##(1997-4#1)(2012-2#1)
role statement##2##2##(1992-2#2)
role statements and##2##3##(1992-12#1)(1992-2#1)
role statements##3##2##(1992-12#1)(1992-2#2)
role than##6##2##(1991-11#1)(1992-3#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
role that##25##2##(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-12#2)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
role the type of vascular access plays in the transmission of##2##11##(2007-7#2)
role these cells##2##3##(1990-5#1)(1997-8#1)
role they##3##2##(1995-2#1)(2008-12#1)(2010-1#1)
role this##2##2##(1992-6#1)(2008-11#1)
role to play in the##6##5##(1992-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
role to play in##11##4##(1992-3#1)(1997-2#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2012-12#1)
role to play##15##3##(1992-3#1)(1993-12#1)(1997-2#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
role to##28##2##(1992-3#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
role transition##3##2##(1995-1#1)(2008-11#2)
role was##6##2##(1991-2#1)(2008-11#3)(2008-7#1)(2010-11#1)
role when##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
role which##3##2##(1991-1#1)(1992-6#1)(2007-11#1)
role within health##2##3##(1995-12#1)(1996-12#1)
role within the##4##3##(1997-7#1)(2008-11#1)(2010-6#1)(2011-2#1)
role within##7##2##(1995-12#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)
role##3927##1##(1990-10#2)(1990-11#17)(1990-12#19)(1990-2#15)(1990-3#3)(1990-5#20)(1990-6#4)(1990-7#5)(1990-8#14)(1990-9#8)(1991-1#14)(1991-10#1)(1991-11#4)(1991-12#18)(1991-2#20)(1991-3#11)(1991-4#1)(1991-5#12)(1991-6#11)(1991-7#4)(1991-8#4)(1991-9#19)(1992-1#7)(1992-10#5)(1992-11#4)(1992-12#29)(1992-2#19)(1992-3#31)(1992-5#9)(1992-6#28)(1992-7#2)(1992-8#18)(1992-9#20)(1993-1#9)(1993-10#1)(1993-11#30)(1993-12#40)(1993-2#14)(1993-3#34)(1993-5#8)(1993-6#22)(1993-8#11)(1993-9#13)(1994-1#5)(1994-10#5)(1994-11#32)(1994-12#24)(1994-2#29)(1994-3#14)(1994-5#11)(1994-6#17)(1994-8#28)(1994-9#19)(1995-1#12)(1995-10#1)(1995-11#12)(1995-12#57)(1995-2#47)(1995-3#19)(1995-5#11)(1995-6#30)(1995-8#18)(1995-9#7)(1996-1#10)(1996-10#1)(1996-11#3)(1996-12#30)(1996-2#35)(1996-3#11)(1996-4#1)(1996-5#22)(1996-6#8)(1996-7#3)(1996-8#5)(1996-9#4)(1997-1#18)(1997-2#28)(1997-3#15)(1997-4#12)(1997-5#8)(1997-6#14)(1997-7#17)(1997-8#17)(1997-9#3)(2006-10#7)(2006-12#2)(2006-5#1)(2006-6#5)(2006-8#2)(2007-10#13)(2007-11#22)(2007-12#50)(2007-2#5)(2007-4#8)(2007-5#6)(2007-6#2)(2007-7#14)(2007-8#18)(2008-1#94)(2008-10#281)(2008-11#180)(2008-12#71)(2008-2#34)(2008-3#55)(2008-4#86)(2008-5#86)(2008-6#41)(2008-7#148)(2008-8#105)(2008-9#66)(2009-1#10)(2009-10#37)(2009-11#24)(2009-12#17)(2009-2#5)(2009-3#11)(2009-4#20)(2009-5#18)(2009-6#28)(2009-7#32)(2009-8#41)(2009-9#18)(2010-1#16)(2010-10#24)(2010-11#40)(2010-12#25)(2010-2#13)(2010-3#28)(2010-4#19)(2010-5#15)(2010-6#10)(2010-7#8)(2010-8#25)(2010-9#7)(2011-1#66)(2011-10#4)(2011-2#195)(2011-3#13)(2011-7#3)(2011-9#2)(2012-1#21)(2012-12#65)(2012-2#108)(2012-3#66)(2012-4#1)(2012-6#2)(2012-7#2)(2013-1#146)(2013-2#1)(2013-3#1)(2013-7#27)(2013-8#68)
role(s) for##4##2##(1991-5#1)(1992-12#1)(1995-3#1)(1995-6#1)
role(s) in##3##2##(1992-11#1)(1995-11#1)(2008-11#1)
role(s) of##4##2##(1993-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
role(s)##11##1##(1991-5#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(2008-11#2)(2008-4#1)(2012-12#1)
role-physical##3##1##(2008-8#2)(2010-5#1)
role-play as a##2##3##(2008-11#2)
role-play as an##2##3##(2008-11#2)
role-play as##4##2##(2008-11#4)
role-play##6##1##(2008-11#6)
role?##2##1##(1995-2#1)(2010-3#1)
roles and responsibilities of##5##4##(1994-1#2)(1995-2#1)(1996-1#1)(2008-3#1)
roles and responsibilities##11##3##(1994-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
roles and##30##2##(1991-1#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
roles are##4##2##(1992-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
roles as a##2##3##(1991-2#1)(2008-10#1)
roles as##8##2##(1991-2#1)(1995-6#1)(2008-10#3)(2008-8#1)(2010-7#1)(2013-8#1)
roles during##5##2##(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-8#1)
roles for B lymphocytes in##2##5##(2010-5#2)
roles for GCC##2##3##(2009-9#2)
roles for both ionotropic and metabotropic##2##6##(2008-7#2)
roles for both##3##3##(2008-7#2)(2008-8#1)
roles for the##6##3##(1993-3#1)(1994-9#1)(1996-3#1)(2009-10#1)(2012-12#1)(2012-2#1)
roles for these##2##3##(1993-9#1)(2008-11#1)
roles for##45##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-12#3)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-8#1)
roles has##2##2##(2008-11#1)(2008-5#1)
roles have been##2##3##(2011-1#1)(2011-2#1)
roles have##4##2##(2008-11#1)(2011-1#2)(2011-2#1)
roles in a##3##3##(1994-1#1)(2009-5#1)(2010-7#1)
roles in biological systems##2##4##(2008-10#1)(2008-9#1)
roles in both##5##3##(1997-2#1)(1997-8#1)(2008-7#2)(2009-6#1)
roles in cell##4##3##(1994-10#1)(2009-8#1)(2011-2#2)
roles in determining##2##3##(1993-6#1)(1995-2#1)
roles in drug abuse##2##4##(1991-1#1)(2009-7#1)
roles in health and disease##2##5##(2008-10#1)(2008-4#1)
roles in health care##2##4##(1992-1#1)(2008-12#1)
roles in health##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
roles in insulin##2##3##(1992-10#1)(2008-1#1)
roles in many biological processes##3##5##(2008-2#1)(2009-11#1)(2010-12#1)
roles in many##7##3##(1994-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-12#1)(2012-2#1)
roles in modulating##2##3##(1994-6#1)(2009-8#1)
roles in neural development##2##4##(1996-12#1)(2009-9#1)
roles in neuronal##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
roles in plant##4##3##(2008-9#2)(2009-8#1)(2012-3#1)
roles in regulating the##3##4##(2007-12#1)(2009-8#1)(2011-2#1)
roles in regulating##5##3##(1995-2#1)(2007-12#1)(2008-11#1)(2009-8#1)(2011-2#1)
roles in regulation of##5##4##(1996-10#1)(2008-1#1)(2008-10#1)(2009-4#1)(2012-3#1)
roles in the development of##2##5##(1991-1#1)(2007-10#1)
roles in the development##3##4##(1991-1#1)(2007-10#1)(2008-8#1)
roles in the growth##2##4##(2008-4#1)(2010-5#1)
roles in the regulation of##5##5##(1993-12#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
roles in the##49##3##(1990-8#1)(1991-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-4#1)(1996-12#1)(1997-2#1)(1997-8#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)
roles in these##3##3##(1992-12#1)(2009-4#1)(2010-11#1)
roles in tissue##2##3##(2010-9#1)(2012-2#1)
roles in##206##2##(1990-8#1)(1991-1#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-2#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-8#3)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#5)(2008-10#8)(2008-11#10)(2008-12#2)(2008-2#2)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#9)(2009-10#5)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#8)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#7)(2013-8#3)
roles is##2##2##(2009-7#1)(2011-2#1)
roles of CNG channels in##2##5##(2009-10#2)
roles of a##4##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-11#1)
roles of glia##3##3##(2008-7#3)
roles of kappa-opioid and NMDA##2##5##(1997-2#2)
roles of management##2##3##(1994-1#1)(1996-3#1)
roles of oestrogen in the male##2##6##(2008-4#2)
roles of other##2##3##(2007-12#1)(2010-12#1)
roles of sex##2##3##(1995-12#1)(2007-7#1)
roles of somatostatin in the##2##5##(1997-2#2)
roles of such##2##3##(1993-12#1)(2010-3#1)
roles of the##13##3##(1992-2#1)(1992-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#2)(2012-2#1)
roles of these##8##3##(1991-11#1)(1991-9#1)(1994-5#1)(1995-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
roles of this type of##2##5##(1994-8#1)(2010-8#1)
roles of this##4##3##(1993-9#1)(1994-8#1)(1995-6#1)(2010-8#1)
roles of three##2##3##(1991-8#1)(1996-2#1)
roles of##173##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#2)
roles on##2##2##(1990-2#1)(2008-8#1)
roles played by##9##3##(1994-12#1)(1997-7#1)(2007-12#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
roles that the##2##3##(2008-7#1)(2012-12#1)
roles that##10##2##(2008-10#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#3)
roles within the##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
roles within##8##2##(1991-12#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
roles##622##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#7)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#8)(1995-2#5)(1995-3#3)(1995-4#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#5)(1996-10#1)(1996-12#9)(1996-2#4)(1996-3#5)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#3)(2006-12#1)(2006-6#2)(2007-10#5)(2007-11#2)(2007-12#6)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#13)(2008-10#25)(2008-11#34)(2008-12#12)(2008-2#6)(2008-3#3)(2008-4#14)(2008-5#10)(2008-6#5)(2008-7#30)(2008-8#22)(2008-9#22)(2009-10#9)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#9)(2009-6#7)(2009-7#5)(2009-8#17)(2009-9#6)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#8)(2010-2#5)(2010-3#4)(2010-4#1)(2010-5#11)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#15)(2011-2#23)(2012-1#2)(2012-12#20)(2012-2#25)(2012-3#13)(2013-1#21)(2013-8#7)
rolfsii and##3##2##(2008-10#3)
rolfsii sclerotia##2##2##(2008-10#2)
rolfsii were##2##2##(2008-10#2)
rolfsii##32##1##(2008-10#27)(2008-6#3)(2008-8#2)
roll##8##1##(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2010-8#1)
roll-off##5##1##(2007-11#1)(2008-3#1)(2008-7#2)(2010-4#1)
roll-out##9##1##(1995-12#1)(2011-1#2)(2011-2#1)(2012-12#5)
roll-over##2##1##(2013-1#2)
rolled##2##1##(2008-4#1)(2013-8#1)
roller bottle##2##2##(2008-11#1)(2008-6#1)
roller bottles##5##2##(2008-11#5)
roller coaster##2##2##(1994-2#1)(1996-3#1)
roller##11##1##(1994-2#1)(1996-3#1)(2008-11#8)(2008-6#1)
rolling of##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
rolling with different reduction##2##4##(2013-8#2)
rolling with##3##2##(2013-8#3)
rolling##17##1##(1993-8#1)(1997-6#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#3)
rolling-circle##2##1##(1997-6#2)
romance##3##1##(2012-2#3)
romantic experiences##2##2##(2009-5#2)
romantic partner##2##2##(2007-12#2)
romantic relationship distress##3##3##(2008-12#3)
romantic relationship##4##2##(2008-12#4)
romantic relationships##4##2##(2007-12#1)(2008-12#1)(2008-9#1)(2010-8#1)
romantic##20##1##(2007-12#3)(2008-12#5)(2008-9#2)(2009-5#4)(2009-9#5)(2010-8#1)
romifidine##5##1##(2012-3#5)
ronchigram##3##1##(2008-3#3)
roof and##2##2##(2008-10#1)(2009-2#1)
roof installed parallel plate##2##4##(2013-1#2)
roof of the##2##3##(2007-8#1)(2010-5#1)
roof of##3##2##(2007-8#1)(2008-5#1)(2010-5#1)
roof##12##1##(2007-8#5)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-5#1)(2013-1#2)
roofs##3##1##(2006-12#1)(2007-10#1)(2008-10#1)
room air##8##2##(1993-1#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#2)(2013-8#1)
room and##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)
room at 15##2##3##(2007-12#1)(2010-7#1)
room at##3##2##(2007-12#1)(2010-7#1)(2011-2#1)
room conditions##2##2##(2008-10#2)
room for improvement in the##3##5##(1996-2#1)(2007-12#1)(2008-3#1)
room for improvement in##4##4##(1996-2#1)(2007-12#1)(2008-3#1)(2012-12#1)
room for improvement##6##3##(1996-2#1)(2007-12#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-3#1)
room for##17##2##(1991-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
room light##2##2##(1994-8#1)(2008-10#1)
room of##3##2##(1995-11#1)(2008-10#2)
room or##2##2##(2007-9#1)(2008-11#1)
room temperature and at 40 degrees##2##6##(2008-5#2)
room temperature and at##3##4##(2008-10#1)(2008-5#2)
room temperature and pressure##2##4##(2007-12#2)
room temperature and##19##3##(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-3#1)(2008-5#3)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
room temperature fluorimetry for##2##4##(2008-10#2)
room temperature fluorimetry##3##3##(2008-10#3)
room temperature for##10##3##(1995-2#3)(1997-7#1)(2008-10#4)(2008-5#1)(2012-12#1)
room temperature have been##2##4##(2007-12#1)(2008-2#1)
room temperature ionic liquids##2##4##(2008-10#2)
room temperature ionic##4##3##(2008-10#4)
room temperature is##4##3##(1995-2#1)(2007-11#1)(2008-10#2)
room temperature or##4##3##(2008-10#2)(2008-5#2)
room temperature phosphorescence (RTP)##6##4##(2008-10#6)
room temperature phosphorescence of##2##4##(2008-10#2)
room temperature phosphorescence##19##3##(2008-10#19)
room temperature to##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)
room temperature was##3##3##(1996-2#1)(2008-3#2)
room temperature with##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
room temperature##213##2##(1990-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-7#1)(1995-11#2)(1995-2#6)(1995-6#1)(1996-12#2)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#12)(2007-12#19)(2008-10#84)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#17)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#6)(2013-7#2)(2013-8#3)
room to##4##2##(1993-7#1)(2008-10#1)(2008-6#2)
room with##6##2##(2008-3#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#2)
room##351##1##(1990-2#1)(1990-3#1)(1991-1#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-12#2)(1994-2#2)(1994-7#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#12)(2007-12#25)(2007-8#3)(2007-9#1)(2008-10#96)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#21)(2008-4#2)(2008-5#8)(2008-6#6)(2008-7#4)(2008-8#10)(2008-9#4)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#12)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#7)
room-temperature diode##3##2##(2008-2#3)
room-temperature laser##3##2##(2008-2#1)(2008-3#2)
room-temperature phosphorescence (RTP)##2##3##(2008-10#2)
room-temperature phosphorescence of##2##3##(2008-10#2)
room-temperature phosphorescence##4##2##(2008-10#4)
room-temperature phosphorimetric##2##2##(2008-10#2)
room-temperature phosphorimetry##2##2##(2008-10#2)
room-temperature##47##1##(1990-4#1)(2007-11#6)(2007-12#6)(2008-10#11)(2008-2#14)(2008-3#7)(2012-2#2)
room?##2##1##(1993-2#1)(2012-2#1)
rooms##19##1##(1990-2#3)(1991-6#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#3)
roosts in##3##2##(2009-9#3)
roosts##5##1##(2009-9#5)
root and apical meristem##2##4##(2008-12#2)
root and crown rot##2##4##(2008-10#2)
root and crown##3##3##(2008-10#3)
root and leaf pathogens##2##4##(2008-10#2)
root and shoot dry weights##2##5##(2008-10#2)
root and shoot were##2##4##(2008-12#2)
root and shoot##5##3##(2008-10#3)(2008-12#2)
root and stem rot##3##4##(2008-10#3)
root and stem##5##3##(2008-10#5)
root and the##4##3##(2007-8#2)(2008-10#2)
root and##39##2##(2007-8#2)(2008-10#24)(2008-12#4)(2008-3#1)(2008-9#2)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
root angulation##2##2##(2010-3#2)
root apex##4##2##(2009-6#2)(2012-2#2)
root apical meristem##3##3##(2008-10#1)(2009-8#2)
root apices##3##2##(2009-6#2)(2012-2#1)
root associated with##2##3##(2008-5#1)(2013-8#1)
root at##2##2##(2008-10#1)(2010-10#1)
root avulsion##2##2##(2008-9#1)(2011-2#1)
root bark of Calotropis gigantea##2##5##(2008-12#2)
root bark of Oroxylum indicum##2##5##(2008-10#2)
root bark of##6##3##(2008-10#3)(2008-11#1)(2008-12#2)
root between##2##2##(1995-3#1)(2008-9#1)
root biomass##2##2##(2008-10#1)(2008-5#1)
root canal filling##5##3##(1991-3#1)(2013-1#4)
root canal morphology##2##3##(2012-12#1)(2013-1#1)
root canal system##2##3##(2008-7#1)(2012-12#1)
root canal treatment##2##3##(2013-1#2)
root canal walls##3##3##(2008-11#2)(2013-1#1)
root canal##22##2##(1991-3#1)(2008-11#3)(2008-7#4)(2012-12#2)(2013-1#12)
root canals##6##2##(2008-11#2)(2012-12#1)(2012-3#2)(2013-1#1)
root cap cells##2##3##(2008-10#2)
root cap was divested##2##4##(2008-9#2)
root cap was##3##3##(2008-9#3)
root cap##10##2##(2008-10#3)(2008-9#5)(2009-8#2)
root carbohydrate concentrations decreased##2##4##(2008-10#2)
root caries##3##2##(2008-1#2)(2008-5#1)
root cause##3##2##(1990-5#1)(2008-6#1)(2009-9#1)
root causes##3##2##(1995-12#1)(1996-3#1)(2009-10#1)
root cells##5##2##(2008-10#3)(2008-7#1)(2011-1#1)
root colonization by##5##3##(2008-10#5)
root colonization##12##2##(2008-10#12)
root compression##2##2##(2011-2#1)(2012-3#1)
root coverage##6##2##(2013-1#6)
root culture##4##2##(1994-11#2)(2008-10#2)
root cultures##9##2##(1992-12#2)(1994-11#5)(2008-11#2)
root damage##2##2##(2008-10#1)(2012-3#1)
root dentin thickness##2##3##(2008-11#2)
root dentin##3##2##(2008-11#2)(2013-1#1)
root development##4##2##(2008-12#2)(2011-1#2)
root dimensions##2##2##(2007-8#2)
root dip##2##2##(2008-10#2)
root disease severity##3##3##(2008-10#3)
root disease##10##2##(2008-10#10)
root diseases##2##2##(2008-10#2)
root epidermis and##3##3##(2008-10#3)
root extract##4##2##(2012-2#3)(2013-8#1)
root extracts##2##2##(2008-10#1)(2013-1#1)
root exudates from##2##3##(2008-10#2)
root exudates##6##2##(2008-10#6)
root galling of cucumber seedlings##2##5##(2008-10#2)
root galling##4##2##(2008-10#4)
root growth for##2##3##(2008-10#1)(2009-8#1)
root growth to inoculum##3##4##(2008-10#3)
root growth to##4##3##(2008-10#4)
root growth##16##2##(2008-10#12)(2008-12#1)(2008-8#1)(2009-8#2)
root hair area##2##3##(2008-10#2)
root hair##3##2##(2008-10#3)
root hairs##2##2##(2008-10#2)
root in the##2##3##(2011-2#1)(2013-1#1)
root in##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
root infection by##7##3##(2008-10#7)
root infection##11##2##(2008-10#11)
root is##4##2##(2008-10#2)(2008-3#1)(2010-3#1)
root length##13##2##(2008-10#8)(2008-12#4)(2008-5#1)
root lesions##2##2##(2008-10#2)
root mean square (RMS)##2##4##(2010-9#1)(2012-12#1)
root mean square (rms)##3##4##(1992-4#1)(2008-2#1)(2008-3#1)
root mean square deviation##2##4##(1994-5#1)(2008-9#1)
root mean square error of calibration##2##6##(2008-1#1)(2008-10#1)
root mean square error of prediction (RMSEP)##3##7##(2008-10#3)
root mean square error of prediction##5##6##(2008-10#5)
root mean square error of##8##5##(2008-1#1)(2008-10#7)
root mean square error##10##4##(2008-1#1)(2008-10#7)(2011-2#1)(2012-1#1)
root mean square##23##3##(1992-4#1)(1994-5#2)(1997-4#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
root mean squared error##2##4##(2008-10#2)
root mean squared##3##3##(2008-10#2)(2008-7#1)
root mean##28##2##(1992-4#1)(1994-5#2)(1997-4#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
root mineralisation##4##2##(2010-5#4)
root necrosis##9##2##(2008-10#9)
root nodules##2##2##(2008-11#1)(2011-2#1)
root of the##17##3##(1993-12#2)(1994-9#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#1)
root of##38##2##(1990-11#1)(1993-12#3)(1993-8#1)(1994-12#1)(1994-9#1)(1996-5#1)(2007-12#4)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
root pathogen##2##2##(2008-10#2)
root pathogens##3##2##(2008-10#3)
root perforation##2##2##(2013-1#2)
root populations##2##2##(2008-10#2)
root powder##3##2##(2008-10#3)
root production for##2##3##(2008-10#2)
root production##8##2##(2008-10#8)
root protection and grub control##2##5##(2011-2#2)
root replacement with the Carboseal##2##5##(2007-8#2)
root representing##2##2##(2011-2#2)
root resorption##7##2##(2013-1#7)
root rot and##5##3##(2008-10#5)
root rot caused by##3##4##(2008-10#3)
root rot complex##2##3##(2008-10#2)
root rot disease##3##3##(2008-10#3)
root rot in##5##3##(2008-10#5)
root rot of apple##3##4##(2008-10#3)
root rot of sugarcane##2##4##(2008-10#2)
root rot of##18##3##(2008-10#18)
root rot severity##7##3##(2008-10#7)
root rot symptoms##3##3##(2008-10#3)
root rot##69##2##(2008-10#69)
root samples from##2##3##(2008-10#2)
root samples##6##2##(2008-10#5)(2012-6#1)
root segments##2##2##(2008-10#2)
root surface##7##2##(2008-10#4)(2013-1#3)
root symbiosis##2##2##(2010-10#1)(2012-8#1)
root symptoms##2##2##(2008-10#2)
root system##7##2##(2008-10#6)(2011-1#1)
root systems of##2##3##(2008-10#2)
root systems##7##2##(2008-10#7)
root tip cells##2##3##(2008-5#1)(2009-10#1)
root tip exudates##3##3##(2008-10#3)
root tip##10##2##(2008-10#5)(2008-5#3)(2009-10#1)(2009-6#1)
root tips were##2##3##(2008-10#1)(2008-9#1)
root tips##8##2##(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)
root tissue##16##2##(2008-10#15)(2008-8#1)
root tissues in##2##3##(2008-10#2)
root tissues of##2##3##(2008-10#2)
root tissues##13##2##(2008-10#12)(2009-8#1)
root to##7##2##(2008-10#1)(2008-5#3)(2008-9#2)(2012-2#1)
root was##11##2##(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
root weight##2##2##(2008-10#2)
root were##2##2##(2008-9#2)
root##735##1##(1990-11#1)(1990-5#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#3)(1992-4#1)(1992-9#1)(1993-12#8)(1993-2#1)(1993-5#2)(1993-8#1)(1994-11#7)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#10)(2008-1#3)(2008-10#371)(2008-11#13)(2008-12#22)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#26)(2008-6#2)(2008-7#19)(2008-8#9)(2008-9#33)(2009-10#3)(2009-4#1)(2009-6#7)(2009-7#1)(2009-8#17)(2009-9#1)(2010-10#3)(2010-11#2)(2010-3#9)(2010-5#6)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#8)(2012-6#1)(2012-8#3)(2013-1#42)(2013-8#9)
root)##4##1##(2008-10#3)(2008-5#1)
root-colonizing##3##1##(2008-10#3)
root-galling##2##1##(2008-10#2)
root-infecting##2##1##(2008-10#1)(2010-10#1)
root-knot and cyst nematodes##2##4##(2008-10#2)
root-knot and cyst##3##3##(2008-10#3)
root-knot nematode Meloidogyne incognita##2##4##(2008-10#2)
root-knot nematode Meloidogyne##7##3##(2008-10#7)
root-knot nematode species##3##3##(2008-10#3)
root-knot nematode##17##2##(2008-10#17)
root-knot nematodes##9##2##(2008-10#9)
root-knot##31##1##(2008-10#31)
root-lesion nematodes##2##2##(2008-10#2)
root-lesion##5##1##(2008-10#5)
root-mean-square deviation##2##2##(1995-3#1)(2008-8#1)
root-mean-square error of an##2##4##(2008-2#1)(2008-3#1)
root-mean-square error of##3##3##(2008-2#2)(2008-3#1)
root-mean-square errors of##2##3##(2007-11#1)(2008-10#1)
root-mean-square##13##1##(1995-3#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#3)
root-related pain##2##2##(2006-12#2)
root-related##3##1##(2006-12#3)
root-resistant##2##1##(2008-10#2)
root-tip cells##2##2##(2008-11#1)(2008-9#1)
root-to-root spread##4##2##(2008-10#4)
root/shoot ratio##2##2##(2008-12#1)(2008-5#1)
rooted in the##5##3##(1993-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
rooted in##11##2##(1991-12#1)(1993-11#1)(1997-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-2#2)
rooted##19##1##(1991-12#1)(1993-11#1)(1995-5#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2009-6#1)(2010-8#1)(2012-2#2)
rooting##3##1##(1992-12#1)(2008-4#2)
rootlets##2##1##(2008-10#2)
roots and a##2##3##(2008-11#1)(2010-5#1)
roots and canals##2##3##(2013-1#2)
roots and hypocotyls##2##3##(2008-10#2)
roots and leaves##6##3##(1992-3#1)(2008-12#3)(2012-7#1)(2013-8#1)
roots and shoots##4##3##(2008-10#1)(2008-12#3)
roots and stems##3##3##(2008-10#3)
roots and the##3##3##(2008-10#2)(2008-11#1)
roots and their##2##3##(2008-9#1)(2009-10#1)
roots and##45##2##(1992-3#1)(1994-8#1)(2008-10#22)(2008-11#2)(2008-12#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#2)(2010-7#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
roots are##5##2##(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#1)
roots as##2##2##(2008-10#1)(2008-9#1)
roots at the##2##3##(2008-10#2)
roots at##3##2##(2008-10#3)
roots but##2##2##(2008-10#2)
roots by##13##2##(2008-10#13)
roots collected##2##2##(2008-10#2)
roots did not##2##3##(2008-10#2)
roots during##3##2##(1994-8#1)(2013-1#2)
roots following##2##2##(2012-1#2)
roots for the treatment##2##4##(2008-9#2)
roots for##3##2##(2008-9#2)(2012-2#1)
roots from plants##2##3##(2008-10#2)
roots from##9##2##(2008-10#8)(2008-7#1)
roots grown##2##2##(2008-10#1)(2010-10#1)
roots in a##2##3##(2008-10#2)
roots in the##5##3##(1993-2#1)(1997-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
roots in which##2##3##(2008-10#2)
roots in##17##2##(1993-2#1)(1997-2#1)(2008-10#10)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#2)
roots increased##2##2##(2008-10#2)
roots inoculated with##2##3##(2008-10#2)
roots is##2##2##(2007-8#1)(2008-10#1)
roots may be##2##3##(1992-12#1)(2008-10#1)
roots occurred##2##2##(2008-10#2)
roots of Brugmansia candida##2##4##(2008-6#2)
roots of apple seedlings grown in##2##6##(2008-10#2)
roots of apple seedlings##3##4##(2008-10#3)
roots of the##8##3##(1992-8#1)(1993-12#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-6#1)
roots of tomato##2##3##(2008-10#2)
roots of##78##2##(1990-11#2)(1991-1#1)(1991-7#1)(1992-8#1)(1993-12#1)(2007-8#1)(2008-10#38)(2008-11#1)(2008-12#5)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#6)(2011-2#5)(2012-6#1)(2013-1#1)(2013-8#1)
roots or##5##2##(2008-10#4)(2013-1#1)
roots prior to##2##3##(2008-10#2)
roots produced on##2##3##(2008-10#2)
roots produced##3##2##(2008-10#3)
roots resulted in##2##3##(1995-9#1)(2008-10#1)
roots revealed##2##2##(2008-10#2)
roots showed##4##2##(2008-10#3)(2010-5#1)
roots than##2##2##(2008-10#2)
roots that were##2##3##(2008-10#2)
roots that##5##2##(2008-10#5)
roots to the##2##3##(2008-10#1)(2008-11#1)
roots to##8##2##(2008-10#4)(2008-11#1)(2008-9#1)(2010-5#1)(2012-2#1)
roots was significantly##2##3##(2008-10#1)(2008-5#1)
roots was##15##2##(2008-10#12)(2008-12#1)(2008-5#1)(2008-9#1)
roots were affected##2##3##(2008-10#2)
roots were infected for Genghis and Savannah##2##7##(2008-10#2)
roots were infected##4##3##(2008-10#4)
roots were##29##2##(1993-12#1)(2008-10#23)(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)
roots with increasing##2##3##(2008-10#1)(2008-12#1)
roots with##8##2##(2008-10#7)(2008-12#1)
roots##448##1##(1990-11#3)(1991-1#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#3)(1993-2#1)(1994-8#2)(1995-9#1)(1996-12#1)(1997-2#1)(2006-12#3)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#278)(2008-11#7)(2008-12#22)(2008-3#1)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#17)(2009-10#4)(2009-11#1)(2009-3#1)(2009-8#7)(2010-10#2)(2010-3#3)(2010-5#8)(2010-6#2)(2010-7#1)(2011-1#7)(2011-10#4)(2011-2#13)(2012-1#3)(2012-2#4)(2012-3#1)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#10)(2013-8#3)
roots)##3##1##(2008-10#3)
rootstock##5##1##(2008-10#5)
rootstocks##9##1##(2008-10#9)
rootworm##9##1##(2008-10#1)(2011-2#8)
ropinirole on blood pressure and noradrenaline##2##6##(2008-7#2)
ropinirole##10##1##(1990-9#1)(2008-7#9)
ropivacain (5##2##2##(2012-3#2)
ropivacain 5##2##2##(2012-3#2)
ropivacain##6##1##(2012-3#6)
roretzi hemocytes##2##2##(2008-6#2)
roretzi plasma##2##2##(2008-6#2)
roretzi##7##1##(1993-6#1)(2008-6#6)
rosa##7##1##(1990-5#5)(1993-6#2)
rosacea##3##1##(2010-8#2)(2013-1#1)
rose (Rosa##2##2##(2008-10#1)(2011-2#1)
rose by##2##2##(2007-7#1)(2010-7#1)
rose from 1##2##3##(1990-12#1)(1990-5#1)
rose from##6##2##(1990-12#1)(1990-5#1)(1991-12#1)(1994-2#1)(1995-3#2)
rose isolates##2##2##(2008-10#2)
rose significantly##6##2##(1992-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-7#1)(2011-1#1)
rose steadily##2##2##(1997-7#1)(2008-10#1)
rose to the##2##3##(2008-7#1)(2008-9#1)
rose to##9##2##(1992-12#1)(1992-3#1)(1994-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)
rose wines##3##2##(2008-10#3)
rose with##3##2##(1994-6#1)(1997-4#1)(2008-11#1)
rose##68##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#5)(1997-4#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-7#2)(2011-1#2)(2011-2#4)(2013-7#1)
rosea IK726##4##2##(2008-10#4)
rosea##12##1##(2008-10#10)(2008-5#2)
rosea)##2##1##(2008-10#1)(2010-3#1)
roseicollis)##2##1##(1997-3#2)
roses##6##1##(2008-10#6)
rosette assistor virus (GRAV)##2##4##(2008-10#2)
rosette assistor virus##3##3##(2008-10#3)
rosette infections##2##2##(2008-10#2)
rosette leaves of Tsu-0 plants##2##5##(2008-10#2)
rosette leaves##3##2##(2008-10#2)(2008-8#1)
rosette virus (GRV)##2##3##(2008-10#2)
rosette##18##1##(2008-10#15)(2008-8#2)(2009-8#1)
rosettes##6##1##(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
rosetting##3##1##(2008-4#2)(2012-12#1)
roseum##8##1##(2008-10#5)(2008-5#3)
roseus)##3##1##(2008-10#3)
rosiglitazone and##2##2##(2010-10#2)
rosiglitazone##9##1##(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#1)(2010-10#2)(2010-7#1)
rosmarinic acid and##2##3##(2007-1#1)(2013-1#1)
rosmarinic acid production##2##3##(2013-1#2)
rosmarinic acid##10##2##(2007-1#2)(2008-10#1)(2013-1#7)
rostellar hooks##2##2##(2011-2#2)
rostochiensis and G##4##3##(2008-10#4)
rostral part of area 23c##2##5##(1996-5#2)
rostral part of area##4##4##(1996-5#4)
rostral part of##5##3##(1993-12#1)(1996-5#4)
rostral ventrolateral medulla##7##3##(1993-12#1)(1997-2#2)(1997-6#2)(2007-10#2)
rostral##27##1##(1990-9#1)(1992-8#1)(1993-12#4)(1993-3#1)(1993-5#1)(1996-12#1)(1996-5#4)(1997-2#2)(1997-6#2)(2007-10#2)(2008-11#3)(2008-7#3)(2011-1#1)(2012-12#1)
rostratum##13##1##(2007-7#3)(2008-10#10)
rostro-caudal##2##1##(1992-12#1)(2013-8#1)
rosuvastatin in##2##2##(2010-12#1)(2011-1#1)
rosuvastatin##11##1##(2010-12#2)(2011-1#9)
rot and##21##2##(2008-10#21)
rot are caused by##2##4##(2008-10#2)
rot caused by##7##3##(2008-10#7)
rot development on##2##3##(2008-10#2)
rot development##3##2##(2008-10#3)
rot disease of##3##3##(2008-10#2)(2008-8#1)
rot disease##4##2##(2008-10#3)(2008-8#1)
rot fungal##2##2##(2008-10#1)(2009-9#1)
rot fungi##3##2##(2008-10#2)(2009-9#1)
rot fungus##3##2##(2008-10#1)(2008-6#1)(2009-9#1)
rot in different##2##3##(2008-10#2)
rot in the##2##3##(2008-10#2)
rot in##24##2##(2008-10#24)
rot incidence##4##2##(2008-10#4)
rot is a##2##3##(2008-10#2)
rot is likely##2##3##(2008-10#2)
rot is##5##2##(2008-10#5)
rot isolates##2##2##(2008-10#2)
rot of citrus##2##3##(2008-10#2)
rot of corn##3##3##(2008-10#3)
rot of sugarcane##3##3##(2008-10#3)
rot of##44##2##(2008-10#44)
rot on##6##2##(2008-10#6)
rot pathogen##2##2##(2008-10#2)
rot pathogens##2##2##(2008-10#2)
rot severity by##3##3##(2008-10#3)
rot severity were##2##3##(2008-10#2)
rot severity##11##2##(2008-10#11)
rot symptoms in##2##3##(2008-10#2)
rot symptoms##7##2##(2008-10#7)
rot was##8##2##(2008-10#8)
rot were##3##2##(2008-10#3)
rot when##2##2##(2008-10#2)
rot##268##1##(1996-12#1)(2008-10#261)(2008-6#1)(2008-8#1)(2009-9#3)(2012-3#1)
rot)##2##1##(2008-10#2)
rotamer##2##1##(1990-5#2)
rotarod test##3##2##(1997-2#3)
rotarod##5##1##(1997-2#4)(2008-7#1)
rotary cultivator##5##2##(2008-10#5)
rotary cutting instruments##2##3##(2012-12#2)
rotary displacement##2##2##(2008-2#2)
rotary##24##1##(2006-4#1)(2008-10#9)(2008-11#3)(2008-2#5)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#2)
rotatable##4##1##(2008-7#1)(2010-12#1)(2012-2#2)
rotate the##4##2##(1995-8#1)(2008-10#1)(2008-2#2)
rotate##13##1##(1993-11#1)(1995-5#1)(1995-8#2)(1997-7#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#1)
rotated and##2##2##(1997-5#1)(2008-3#1)
rotated by##2##2##(2007-11#1)(2007-12#1)
rotated in##2##2##(2008-10#1)(2008-11#1)
rotated to##2##2##(2008-10#1)(2008-3#1)
rotated##40##1##(1991-12#1)(1993-6#1)(1997-5#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)
rotates the polarization##2##3##(2007-12#1)(2008-2#1)
rotates the##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
rotates to##2##2##(1996-2#1)(2008-2#1)
rotates##12##1##(1992-3#1)(1996-2#1)(2007-12#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)
rotating Ronchi##2##2##(2008-2#2)
rotating analyzer##2##2##(2008-3#2)
rotating bioreactor##3##2##(2008-10#3)
rotating biosensor##4##2##(2008-10#4)
rotating clusters##2##2##(2008-10#1)(2009-7#1)
rotating disc electrode##2##3##(2008-10#2)
rotating disc##3##2##(2008-10#2)(2008-7#1)
rotating disk electrode measurements##2##4##(2008-10#2)
rotating disk electrode##3##3##(2008-10#3)
rotating disk##11##2##(2008-10#8)(2008-3#2)(2008-7#1)
rotating glassy carbon##2##3##(2008-10#2)
rotating magnetic field##2##3##(2008-10#2)
rotating magnetic##3##2##(2008-10#3)
rotating the grating##2##3##(2008-3#2)
rotating the##6##2##(2008-3#6)
rotating##84##1##(1990-12#2)(1991-2#1)(1992-3#1)(1994-2#1)(1996-2#1)(2007-11#3)(2007-12#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#18)(2008-5#1)(2008-7#2)(2008-8#4)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#3)
rotating-disc##2##1##(2008-10#2)
rotating-polarizer##4##1##(2008-2#1)(2008-3#3)
rotating-wall vessel##2##2##(2008-11#2)
rotating-wall##3##1##(2008-11#3)
rotation and##16##2##(1992-10#1)(1996-5#3)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-1#1)
rotation angle##10##2##(2007-8#2)(2008-2#4)(2008-3#4)
rotation angles of##2##3##(2008-2#1)(2008-3#1)
rotation angles##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
rotation are##3##2##(2008-3#3)
rotation as well as##2##4##(2007-11#2)
rotation as##4##2##(2007-11#3)(2008-7#1)
rotation between the two helices##2##5##(1993-1#2)
rotation between##4##2##(1993-1#3)(2008-9#1)
rotation by##2##2##(2008-3#1)(2008-7#1)
rotation can##2##2##(2007-11#1)(2008-2#1)
rotation for a##3##3##(2007-12#1)(2008-3#2)
rotation for##5##2##(2007-12#1)(2008-11#2)(2008-3#2)
rotation in a##2##3##(2007-11#1)(2008-3#1)
rotation in its own plane##2##5##(2007-11#1)(2008-3#1)
rotation in the##5##3##(2007-12#1)(2007-8#2)(2008-3#1)(2009-3#1)
rotation in##18##2##(1995-8#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-12#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-3#1)
rotation induced by##2##3##(2007-11#1)(2008-7#1)
rotation invariance##3##2##(2008-3#3)
rotation is a##4##3##(2008-10#2)(2009-3#1)(2011-2#1)
rotation is##9##2##(1993-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)
rotation of a##3##3##(1993-3#1)(2008-2#1)(2008-3#1)
rotation of magnetic beads##2##4##(2007-12#2)
rotation of the lower leg##4##5##(2007-8#4)
rotation of the##40##3##(1991-11#1)(1991-5#1)(1992-12#1)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-8#5)(2008-10#2)(2008-11#2)(2008-3#12)(2008-9#1)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
rotation of##53##2##(1991-11#1)(1991-5#1)(1992-12#1)(1993-3#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#4)(2007-12#7)(2007-8#5)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#14)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#2)(2012-3#1)
rotation on the##2##3##(2008-2#1)(2008-3#1)
rotation on##4##2##(2008-2#1)(2008-3#1)(2009-3#1)(2012-2#1)
rotation or##2##2##(2008-3#1)(2011-2#1)
rotation rate of##2##3##(2008-11#1)(2008-8#1)
rotation rate with##2##3##(2008-3#2)
rotation rate##9##2##(1992-7#2)(1997-2#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)
rotation rates##3##2##(1992-7#1)(1997-7#2)
rotation significantly increased##2##3##(2008-12#2)
rotation speeds##2##2##(1997-2#1)(2008-7#1)
rotation the##2##2##(2009-3#1)(2012-2#1)
rotation was##4##2##(1996-7#1)(2007-11#2)(2008-10#1)
rotation##282##1##(1991-11#1)(1991-5#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-7#4)(1992-9#1)(1993-1#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#5)(1996-5#5)(1996-7#1)(1997-2#2)(1997-3#1)(1997-7#4)(2007-10#1)(2007-11#23)(2007-12#12)(2007-8#17)(2008-10#22)(2008-11#17)(2008-12#13)(2008-2#17)(2008-3#61)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#4)(2009-3#8)(2009-6#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#8)(2012-3#3)(2013-1#3)(2013-7#2)
rotation-invariant pattern recognition##2##3##(2008-3#2)
rotation-invariant##7##1##(2008-2#2)(2008-3#3)(2008-6#2)
rotational (lacking##2##2##(2008-10#2)
rotational CARS##4##2##(2007-12#1)(2008-2#3)
rotational Raman sidebands##3##3##(2007-11#3)
rotational Raman##16##2##(2007-11#5)(2008-10#1)(2008-3#10)
rotational coherent anti-Stokes Raman spectroscopy##2##5##(2007-12#1)(2008-2#1)
rotational coherent anti-Stokes Raman##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
rotational coherent##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
rotational correlation time##4##3##(1995-5#3)(2008-10#1)
rotational diffusion coefficient##3##3##(1990-7#3)
rotational diffusion##6##2##(1990-7#3)(1997-6#1)(1997-7#1)(2008-10#1)
rotational energy transfer##4##3##(2008-2#3)(2008-3#1)
rotational fine structure##2##3##(2008-10#2)
rotational instability##2##2##(2008-8#1)(2012-3#1)
rotational lines##2##2##(2007-12#1)(2008-10#1)
rotational model##2##2##(1993-12#2)
rotational motion##4##2##(1990-2#1)(1994-3#1)(2008-11#1)(2008-6#1)
rotational or##2##2##(2007-11#1)(2008-2#1)
rotational positions##2##2##(2007-12#1)(2008-3#1)
rotational shear##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
rotational shearing##2##2##(2008-3#2)
rotational state##2##2##(2008-2#2)
rotational symmetry##6##2##(1990-12#1)(1990-8#1)(2007-11#1)(2007-12#1)(2008-3#2)
rotational thrombectomy##2##2##(2011-2#2)
rotational transitions##2##2##(2008-2#1)(2008-3#1)
rotational##124##1##(1990-12#2)(1990-2#2)(1990-7#3)(1990-8#2)(1991-11#1)(1991-5#1)(1992-7#1)(1993-12#4)(1994-2#1)(1994-3#1)(1995-5#6)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#12)(2007-12#8)(2008-10#12)(2008-11#2)(2008-2#17)(2008-3#30)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
rotationally symmetric two-dimensional beam##2##4##(2007-12#2)
rotationally symmetric##8##2##(2007-12#3)(2008-3#5)
rotationally##12##1##(2007-12#3)(2008-2#1)(2008-3#8)
rotations and##2##2##(2008-3#1)(2012-2#1)
rotations in a##2##3##(2008-11#1)(2008-3#1)
rotations in the##2##3##(1995-5#1)(2011-2#1)
rotations in##5##2##(1995-5#2)(2008-11#1)(2008-3#1)(2011-2#1)
rotations induced by##2##3##(1995-12#2)
rotations of the##2##3##(2008-11#1)(2008-3#1)
rotations of##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
rotations with##3##2##(2008-10#3)
rotations##33##1##(1995-11#1)(1995-12#4)(1995-5#6)(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-3#5)(2011-2#1)(2012-2#1)(2013-1#1)
rotator cuff disease##2##3##(2007-11#1)(2008-12#1)
rotator cuff lesion##2##3##(2007-11#2)
rotator cuff lesions and##2##4##(2007-11#2)
rotator cuff lesions##3##3##(2007-11#3)
rotator cuff with##2##3##(1994-2#1)(2007-11#1)
rotator cuff##20##2##(1994-2#3)(2007-11#10)(2008-12#1)(2012-12#2)(2012-2#2)(2013-1#2)
rotator##32##1##(1990-3#1)(1994-2#3)(2007-11#11)(2007-12#2)(2008-12#1)(2008-2#5)(2008-3#3)(2012-12#2)(2012-2#2)(2013-1#2)
rotators##7##1##(2007-11#2)(2008-2#1)(2008-8#1)(2010-9#2)(2013-1#1)
rotatory##5##1##(1995-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
rotavirus infections##3##2##(2009-5#3)
rotavirus vaccine##2##2##(1994-9#1)(2013-8#1)
rotavirus##14##1##(1994-9#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-5#3)(2011-2#3)(2012-3#1)(2013-8#3)
rotenoid##2##1##(2008-11#2)
rotenoids##3##1##(2011-1#3)
rotenone and##3##2##(1990-11#1)(1994-11#1)(2011-1#1)
rotenone or##2##2##(1990-5#1)(2008-7#1)
rotenone##15##1##(1990-11#1)(1990-5#4)(1994-11#1)(1994-12#1)(1995-11#3)(1995-3#1)(2008-11#1)(2008-7#1)(2011-1#2)
rotenone-sensitive NADH cytochrome c reductase activity##2##6##(1990-11#2)
rotenone-sensitive##3##1##(1990-11#3)
rotifer populations##2##2##(2010-12#2)
rotifer##3##1##(2010-12#3)
rotifers##2##1##(2010-12#1)(2010-8#1)
rotor is##2##2##(2007-11#1)(2008-8#1)
rotor##5##1##(2007-11#2)(2008-1#1)(2008-10#1)(2008-8#1)
rotors##5##1##(2007-11#1)(2008-2#2)(2008-7#2)
rots and fumonisin##2##3##(2008-10#2)
rots and##4##2##(2008-10#4)
rots##8##1##(2008-10#7)(2008-8#1)
rotted##2##1##(2008-10#2)
rotting of##2##2##(1991-6#1)(2008-10#1)
rotting##6##1##(1991-11#1)(1991-6#1)(2008-10#4)
rottlerin##3##1##(1994-2#3)
rotundata and D##2##3##(2008-5#2)
rotundata and##3##2##(2008-5#3)
rotundata##6##1##(2008-5#6)
rotundifolia##3##1##(2008-10#3)
rotundus##5##1##(2008-12#1)(2008-5#2)(2011-2#2)
rough and##3##2##(1991-2#1)(2008-3#1)(2013-1#1)
rough boundary##4##2##(2008-3#4)
rough endoplasmic reticulum and##2##4##(2007-12#1)(2008-5#1)
rough endoplasmic reticulum##11##3##(1992-12#1)(1992-6#2)(2007-12#1)(2008-5#2)(2008-7#5)
rough endoplasmic##13##2##(1992-12#1)(1992-6#2)(2007-12#2)(2008-5#2)(2008-7#5)(2012-1#1)
rough gold films##2##3##(2008-3#2)
rough gold##3##2##(2007-12#1)(2008-3#2)
rough lemon##7##2##(2008-10#7)
rough mapping##2##2##(2008-11#2)
rough metallic##2##2##(2007-11#1)(2008-2#1)
rough plane surface of##2##4##(2008-3#2)
rough rice##3##2##(2013-1#3)
rough surface is##2##3##(2008-3#2)
rough surface##15##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#9)
rough surfaces in a conical configuration##2##6##(2007-11#2)
rough surfaces in##4##3##(2007-11#2)(2008-3#2)
rough surfaces is##2##3##(2008-2#1)(2008-3#1)
rough surfaces##19##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#13)
rough##108##1##(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#4)(1994-5#1)(1994-9#2)(1997-1#1)(2007-11#6)(2007-12#11)(2008-10#8)(2008-11#3)(2008-2#8)(2008-3#41)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#5)
rough-surface zirconia implants##2##3##(2009-8#2)
rough-surface##3##1##(2008-2#1)(2009-8#2)
roughened##6##1##(2007-12#3)(2008-5#2)(2008-7#1)
roughly 1##3##2##(2008-10#2)(2008-7#1)
roughly 3##3##2##(1991-2#1)(1993-3#1)(2008-2#1)
roughly equal to##2##3##(2008-3#1)(2008-8#1)
roughly equivalent##2##2##(1990-11#1)(1992-10#1)
roughly monitored by counting the numbers of##2##7##(1997-6#1)(1997-8#1)
roughly proportional to the##2##4##(2008-11#1)(2008-3#1)
roughly proportional to##3##3##(1992-12#1)(2008-11#1)(2008-3#1)
roughly with##2##2##(2008-10#1)(2010-2#1)
roughly##61##1##(1990-11#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2010-2#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)
roughness and the##2##3##(2008-3#1)(2008-5#1)
roughness and##15##2##(2008-10#1)(2008-2#3)(2008-3#7)(2008-5#2)(2009-7#1)(2012-7#1)
roughness are##2##2##(2008-3#2)
roughness between##2##2##(2008-3#1)(2012-2#1)
roughness equations##3##2##(2008-3#3)
roughness for##3##2##(2008-3#2)(2012-2#1)
roughness from##3##2##(2007-12#1)(2008-3#2)
roughness in##2##2##(2008-3#1)(2008-7#1)
roughness is##5##2##(2008-3#5)
roughness measurements##3##2##(2008-3#3)
roughness of 0##2##3##(2012-2#2)
roughness of the interfaces##2##4##(2008-3#2)
roughness of the silver film##2##5##(2008-3#2)
roughness of the##12##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#8)
roughness of##26##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#16)(2009-11#1)(2012-2#2)
roughness on##3##2##(2008-3#3)
roughness parameters##4##2##(2008-3#2)(2009-7#2)
roughness to the##2##3##(2008-2#1)(2008-3#1)
roughness values##3##2##(2008-3#3)
roughness was measured##2##3##(2008-2#1)(2008-3#1)
roughness was##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
roughness##120##1##(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#17)(2008-3#70)(2008-5#6)(2008-7#2)(2009-11#1)(2009-7#4)(2011-2#1)(2012-2#6)(2012-7#1)(2013-1#1)(2013-8#1)
roughnesses##4##1##(2008-2#1)(2008-3#3)
round 1##3##2##(1995-9#2)(2007-11#1)
round 5##2##2##(1995-9#2)
round and##7##2##(1997-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#1)
round cells##5##2##(1996-5#4)(2012-3#1)
round had##3##2##(1991-6#1)(1997-4#2)
round harmony##4##2##(2012-12#4)
round mucous##2##2##(2008-6#2)
round nuclei and##2##3##(1991-8#1)(2008-5#1)
round of audit##2##3##(2007-11#2)
round of selection##2##3##(2008-2#1)(2008-9#1)
round of##21##2##(1990-5#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2013-1#1)
round or##5##2##(1995-12#1)(1997-3#1)(2009-5#1)(2010-6#1)(2012-1#1)
round robin test##2##3##(2008-10#2)
round spermatids##2##2##(2008-9#1)(2012-2#1)
round synaptic vesicles and##3##4##(1995-12#2)(1997-2#1)
round trip##2##2##(2007-11#1)(2008-2#1)
round window##3##2##(2008-9#3)
round##120##1##(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#3)(1991-8#2)(1991-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#5)(1995-9#4)(1996-3#1)(1996-5#5)(1997-2#1)(1997-3#1)(1997-4#12)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#8)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#5)(2009-4#1)(2009-5#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#3)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
round-bottom 96-well polystyrene plate coated with##2##6##(2008-11#2)
round-robin experiment##3##2##(2008-3#3)
round-robin##4##1##(2008-3#3)(2009-9#1)
round-trip##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
roundabouts##2##1##(2012-12#2)
rounded##12##1##(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-9#1)
rounding up of##2##3##(1992-12#1)(2007-6#1)
rounding##6##1##(1992-12#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
roundness##2##1##(2008-11#1)(2012-5#1)
rounds and##2##2##(2008-10#1)(2008-7#1)
rounds of selection against##2##4##(2008-10#2)
rounds of selection##3##3##(2008-10#2)(2008-4#1)
rounds of##26##2##(1991-3#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-4#3)(1997-7#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#2)(2013-1#1)
rounds##49##1##(1991-3#1)(1991-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#13)(1997-7#2)(2008-10#13)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-6#2)(2013-1#1)
roundtable discussion##3##2##(2008-3#1)(2008-6#1)(2008-8#1)
roundtable##7##1##(1993-3#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
route and##7##2##(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-4#1)
route by which##4##3##(2008-10#2)(2009-5#1)(2010-7#1)
route by##5##2##(2008-10#2)(2008-5#1)(2009-5#1)(2010-7#1)
route for the##3##3##(1996-5#1)(2007-11#1)(2012-2#1)
route for##11##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-6#1)(1996-5#1)(2007-11#1)(2008-10#3)(2012-2#1)(2013-1#1)
route has##2##2##(2009-11#1)(2011-2#1)
route in##4##2##(1994-9#1)(1997-1#1)(2011-2#1)(2012-2#1)
route is the##2##3##(1990-3#1)(1997-1#1)
route is##6##2##(1990-3#1)(1997-1#1)(1997-3#1)(2010-6#1)(2012-12#1)(2012-2#1)
route may##2##2##(1993-11#1)(2008-10#1)
route of administration##4##3##(1993-11#1)(1997-1#1)(2008-4#1)(2011-2#1)
route of delivery##2##3##(1993-6#1)(2008-8#1)
route of hysterectomy##3##3##(1994-2#1)(1996-2#2)
route of infection##4##3##(2007-7#1)(2008-10#1)(2008-9#1)(2009-6#1)
route of transmission##4##3##(1996-11#1)(2007-12#1)(2007-7#1)(2011-1#1)
route of##38##2##(1993-11#2)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#3)(1997-1#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
route or##2##2##(2008-11#1)(2008-9#1)
route the optical signals##2##4##(2008-3#2)
route the optical##3##3##(2008-2#1)(2008-3#2)
route to the##10##3##(1991-1#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-5#1)
route to##32##2##(1991-1#1)(1994-9#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
route was##3##2##(1994-2#1)(1995-12#1)(2008-7#1)
route##186##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-5#1)(1993-6#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-5#4)(1997-1#4)(1997-3#2)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#5)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
routed##4##1##(1995-2#1)(2007-7#1)(2008-3#2)
router with##4##2##(2007-11#3)(2008-3#1)
router##9##1##(2007-11#5)(2008-3#4)
routes and##5##2##(2008-5#1)(2009-8#1)(2011-2#3)
routes for##4##2##(1992-12#1)(2008-10#2)(2013-1#1)
routes from##2##2##(2008-6#1)(2010-8#1)
routes in southern Somalia##2##4##(2011-2#2)
routes in the##2##3##(1992-3#1)(1993-3#1)
routes in##5##2##(1992-3#1)(1993-3#1)(2008-2#1)(2011-2#2)
routes of administration are##2##4##(1993-11#1)(2010-10#1)
routes of administration##5##3##(1991-1#1)(1993-11#1)(1995-5#1)(2008-7#1)(2010-10#1)
routes of transmission##2##3##(2007-7#1)(2009-5#1)
routes of##22##2##(1991-1#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#2)
routes to##10##2##(1995-3#1)(1996-1#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)
routes##80##1##(1991-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-12#1)(2013-1#1)(2013-8#2)
routine EEG##4##2##(2008-7#4)
routine EEGs##2##2##(2008-7#2)
routine administration of##4##3##(2011-2#1)(2012-12#3)
routine analyses of pharmaceuticals##2##4##(2008-10#2)
routine analyses of##5##3##(2008-10#4)(2008-5#1)
routine analyses##9##2##(1995-2#1)(2008-10#5)(2008-5#2)(2010-5#1)
routine analysis of##16##3##(2008-10#13)(2008-11#1)(2008-3#1)(2012-2#1)
routine analysis##32##2##(2008-10#28)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
routine analytical##2##2##(2008-10#2)
routine and##5##2##(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
routine application of##2##3##(2008-10#1)(2008-6#1)
routine application##3##2##(2008-10#2)(2008-6#1)
routine assay##3##2##(2008-10#2)(2012-2#1)
routine assessment of##2##3##(1993-9#1)(2009-1#1)
routine auditory stimulation##3##3##(1991-12#3)
routine basis##6##2##(2008-3#3)(2008-4#1)(2008-7#2)
routine blood level##2##3##(1991-11#2)
routine blood##4##2##(1991-11#2)(1992-12#1)(1997-3#1)
routine chest##4##2##(1990-6#1)(1997-3#1)(2008-7#1)(2008-8#1)
routine clinical monitoring of##2##4##(1995-2#1)(2013-1#1)
routine clinical practice##7##3##(2007-11#1)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#2)(2012-2#1)
routine clinical##21##2##(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#2)(2009-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
routine control##4##2##(2008-10#3)(2008-5#1)
routine dental##5##2##(1996-2#3)(2013-1#2)
routine detection of##2##3##(2008-10#2)
routine detection##3##2##(2008-10#3)
routine determination of##5##3##(1993-12#1)(2008-10#3)(2010-4#1)
routine diagnosis of##2##3##(2008-10#1)(2008-7#1)
routine diagnostic##3##2##(1992-2#1)(2008-12#1)(2008-7#1)
routine examination of##3##3##(2008-12#1)(2008-9#1)(2012-2#1)
routine examination##7##2##(1990-2#1)(1990-8#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
routine for##2##2##(1993-11#1)(2013-1#1)
routine forensic##2##2##(2008-12#2)
routine health##5##2##(1994-6#1)(2009-6#1)(2010-9#2)(2012-12#1)
routine histological##2##2##(2011-2#1)(2013-1#1)
routine identification##4##2##(2008-1#1)(2008-10#3)
routine in the##2##3##(1992-11#1)(2008-9#1)
routine in##8##2##(1991-6#1)(1992-11#1)(1995-6#1)(1996-3#1)(2008-9#2)(2010-5#1)(2012-3#1)
routine laboratories##5##2##(1994-1#1)(2008-10#3)(2009-8#1)
routine laboratory tests##4##3##(2008-10#1)(2011-2#2)(2012-3#1)
routine laboratory##16##2##(1990-2#1)(1992-9#1)(1994-1#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-3#1)
routine measurement##2##2##(2008-10#1)(2008-7#1)
routine medical##2##2##(1997-1#1)(1997-5#1)
routine method##2##2##(2008-10#2)
routine methods##2##2##(1990-6#1)(2008-10#1)
routine monitoring of##2##3##(2008-10#2)
routine monitoring##6##2##(2008-10#3)(2011-1#1)(2013-8#2)
routine of##2##2##(2013-1#2)
routine operation##2##2##(1991-6#1)(2008-9#1)
routine practice##4##2##(1996-12#1)(1997-6#1)(2008-10#1)(2011-1#1)
routine scan##2##2##(1990-2#2)
routine screening of##2##3##(2007-10#1)(2008-10#1)
routine screening##7##2##(1991-7#1)(1997-8#1)(2007-10#2)(2008-10#2)(2008-4#1)
routine staining of##2##3##(2010-8#1)(2012-12#1)
routine tasks##2##2##(1996-1#1)(2008-11#1)
routine treatment##4##2##(2010-12#4)
routine urine##2##2##(2010-8#1)(2013-8#1)
routine use in##2##3##(2008-10#1)(2011-2#1)
routine use is##2##3##(2007-12#1)(2007-5#1)
routine use of##15##3##(1990-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-3#1)
routine use##27##2##(1990-6#1)(1991-11#1)(1991-6#1)(1995-5#1)(1997-2#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#2)(2011-2#6)(2012-12#1)(2012-3#1)
routine##467##1##(1990-10#1)(1990-12#2)(1990-2#5)(1990-3#1)(1990-6#6)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#1)(1991-6#3)(1991-7#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-9#2)(1994-1#2)(1994-12#1)(1994-3#3)(1994-6#3)(1994-7#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-12#1)(2007-10#6)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#4)(2008-1#6)(2008-10#106)(2008-11#10)(2008-12#9)(2008-2#1)(2008-3#12)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#22)(2008-8#2)(2008-9#25)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-4#4)(2010-5#3)(2010-6#3)(2010-8#6)(2010-9#4)(2011-1#7)(2011-2#26)(2012-1#1)(2012-12#11)(2012-2#15)(2012-3#9)(2013-1#11)(2013-8#5)
routinely and##5##2##(1994-2#1)(1996-3#1)(2008-10#1)(2008-9#1)(2012-2#1)
routinely be##3##2##(1992-6#1)(2008-10#1)(2008-8#1)
routinely collected##3##2##(2010-8#1)(2012-12#1)(2013-8#1)
routinely employed##2##2##(1992-6#1)(2008-10#1)
routinely in##4##2##(1990-8#1)(1995-3#1)(2008-10#1)(2008-9#1)
routinely monitored##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
routinely obtained##5##2##(2008-10#4)(2008-5#1)
routinely offered to##2##3##(1994-2#1)(2007-2#1)
routinely produced##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
routinely used as##2##3##(1993-8#1)(2012-12#1)
routinely used for##2##3##(2008-5#1)(2009-12#1)
routinely used in##4##3##(2008-10#1)(2008-7#1)(2011-2#2)
routinely used to assess##2##4##(2008-4#1)(2008-9#1)
routinely used to##5##3##(1994-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
routinely used##21##2##(1993-8#1)(1994-5#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2011-2#3)(2012-12#1)(2012-2#1)
routinely##118##1##(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1992-5#3)(1992-6#2)(1993-8#1)(1994-2#3)(1994-5#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#10)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
routines and the##3##3##(1990-9#1)(1992-11#1)(2008-3#1)
routines and##7##2##(1990-9#1)(1992-11#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)
routines for##3##2##(1990-6#1)(1994-6#1)(2008-9#1)
routines in##3##2##(1991-12#1)(1993-8#1)(2011-2#1)
routines##29##1##(1990-6#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-2#2)(2010-6#1)(2010-9#4)(2011-2#1)
routing and switching##2##3##(2012-2#2)
routing##16##1##(1993-5#1)(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#1)(2012-2#2)
rove beetle##4##2##(2007-12#2)(2008-7#2)
rovibrational resonance of nitrous oxide##2##5##(2007-11#1)(2007-12#1)
rovibrational transition of##2##3##(2007-12#1)(2008-3#1)
rovibrational##7##1##(2007-11#2)(2007-12#3)(2008-3#2)
row CT##5##2##(2008-7#3)(2010-8#1)(2011-2#1)
row and##2##2##(2008-10#2)
row centering##2##2##(2008-10#2)
row computed tomography##2##3##(2008-7#1)(2009-10#1)
row distance##2##2##(2008-12#2)
row of##6##2##(1994-2#2)(2007-12#2)(2008-10#1)(2011-2#1)
row spacing##3##2##(2008-12#3)
row##40##1##(1994-2#2)(1995-9#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-12#8)(2008-3#2)(2008-7#6)(2009-10#1)(2009-9#1)(2010-8#2)(2011-2#2)(2013-1#1)
rows and##5##2##(1994-11#1)(2008-10#1)(2008-12#2)(2008-7#1)
rows of##12##2##(2007-12#3)(2008-10#3)(2008-5#2)(2011-2#3)(2013-8#1)
rows##37##1##(1994-11#1)(2007-12#3)(2008-10#19)(2008-12#5)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#3)(2013-8#1)
royal jelly##6##2##(2008-10#5)(2011-2#1)
royal##11##1##(2007-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2011-1#1)(2011-2#1)
royalisin was##2##2##(2011-2#2)
royalisin##5##1##(2011-2#5)
rp subgroup##2##2##(2008-10#2)
rp##3##1##(2008-10#3)
rpGH##3##1##(2008-9#3)
rpm##21##1##(2007-11#1)(2008-10#4)(2008-11#9)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#1)
rpm)##6##1##(2008-11#5)(2011-2#1)
rpoB##2##1##(2009-6#2)
rps1##4##1##(2008-10#4)
rps14##3##1##(1996-6#3)
rpsA##3##1##(1997-2#3)
rpsU##2##1##(1994-12#2)
rs10490924 ARMS2##3##2##(2013-1#3)
rs1054##2##1##(1995-8#2)
rs12979860##3##1##(2012-12#1)(2012-2#1)(2013-1#1)
rs1410996 CFH polymorphism##2##3##(2013-1#2)
rs1410996 CFH##4##2##(2013-1#4)
rs1426654##2##1##(2009-5#2)
rs1805794##3##1##(2011-1#3)
rs2735383##2##1##(2011-1#2)
rs8099917##3##1##(2012-12#2)(2012-2#1)
rsd##3##1##(2008-10#3)
rsp1##2##1##(2008-10#2)
rsp2##2##1##(2008-10#2)
rt-PA use in##3##3##(2007-10#3)
rt-PA use##7##2##(2007-10#7)
rt-PA##22##1##(1997-8#1)(2007-10#19)(2008-10#1)(2008-7#1)
rtA181T##3##1##(2013-1#3)
rtA181V and rtA181T##2##3##(2013-1#2)
rtN236T mutant virus showed similar##2##5##(2013-1#2)
rtN236T mutant viruses##2##3##(2013-1#2)
rtN236T mutant##4##2##(2013-1#4)
rtN236T##16##1##(2013-1#16)
rtfMRI##2##1##(2009-6#2)
rtp##4##1##(1993-9#4)
rub##6##1##(2007-12#1)(2008-10#2)(2008-5#2)(2008-8#1)
rubbed##2##1##(2007-12#2)
rubber gloves##2##2##(1995-6#2)
rubber##15##1##(1995-6#2)(2007-11#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
rubbery moduli##2##2##(2009-7#2)
rubbery##4##1##(2009-7#3)(2009-9#1)
rubbing##2##1##(2008-10#1)(2011-2#1)
rubble##3##1##(2007-5#3)
rubella vaccination##2##2##(1992-5#1)(2007-2#1)
rubella vaccine##2##2##(1995-3#1)(2007-2#1)
rubella##16##1##(1992-5#1)(1993-12#1)(1995-3#1)(2007-12#1)(2007-2#3)(2008-11#1)(2008-4#2)(2009-5#1)(2011-2#5)
ruber##7##1##(2009-8#1)(2011-2#6)
rubidate##7##1##(2008-10#7)
rubidium atoms##4##2##(2007-11#1)(2007-12#3)
rubidium##24##1##(2007-11#1)(2007-12#4)(2008-10#10)(2008-2#3)(2008-3#6)
rubisco activase in the presence of##2##6##(1991-9#2)
rubisco activase##7##2##(1991-9#7)
rubisco##9##1##(1991-9#9)
rubrene##2##1##(2007-11#2)
rubrerythrin from Desulfovibrio vulgaris##2##4##(1991-12#2)
rubrerythrin##5##1##(1991-12#5)
rubric##4##1##(2008-11#1)(2008-6#1)(2010-1#1)(2012-2#1)
rubripes##5##1##(1995-2#3)(2008-11#1)(2008-7#1)
rubrum was the##2##3##(2007-7#1)(2008-5#1)
rubrum was##3##2##(2007-7#1)(2008-5#2)
rubrum##15##1##(2007-7#1)(2008-11#2)(2008-5#8)(2009-2#3)(2012-3#1)
ruby laser is##2##3##(2008-3#2)
ruby laser##6##2##(2008-2#1)(2008-3#5)
ruby##10##1##(2007-11#3)(2008-2#2)(2008-3#5)
ruddy bunting (Emberiza rutila)##2##4##(2008-9#2)
rudimentary horn pregnancy##3##3##(2011-1#2)(2013-1#1)
rudimentary horn with##2##3##(2011-1#2)
rudimentary horn##7##2##(2011-1#4)(2013-1#3)
rudimentary##19##1##(1991-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#4)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#1)(2013-1#3)
rue##2##1##(1991-8#1)(2013-8#1)
ruelene and trichlorfon##2##3##(2008-10#2)
ruelene##3##1##(2008-10#3)
ruffling##2##1##(1997-6#1)(2008-7#1)
ruffs##2##1##(2008-8#2)
rugged and##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
rugged terrain##2##2##(2008-2#1)(2008-3#1)
rugged##13##1##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#6)
ruggedness and##2##2##(2008-10#2)
ruggedness of##2##2##(2008-10#1)(2009-10#1)
ruggedness##9##1##(2008-10#7)(2009-10#1)(2010-7#1)
rugosa##7##1##(1994-11#2)(2007-12#1)(2008-5#1)(2008-7#3)
rugose##2##1##(2008-10#2)
rule and##6##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-9#1)
rule for##4##2##(2007-11#1)(2008-1#1)(2008-3#1)(2008-8#1)
rule in which##2##3##(1997-7#1)(2010-2#1)
rule in##8##2##(1997-3#1)(1997-7#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-2#2)
rule is the##2##3##(2007-11#1)(2008-3#1)
rule is##7##2##(1994-11#1)(1995-2#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
rule of##10##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-7#1)(2011-1#1)(2011-2#1)
rule out coronary artery##2##4##(2008-3#2)
rule out the possibility of##3##5##(1994-9#1)(2008-1#1)(2011-2#1)
rule out the possibility##4##4##(1994-9#1)(1997-8#1)(2008-1#1)(2011-2#1)
rule out the presence of##2##5##(1990-10#1)(2011-2#1)
rule out the##10##3##(1990-10#1)(1994-9#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-2#1)(2011-2#3)(2012-12#1)
rule out##33##2##(1990-10#1)(1991-12#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
rule the##2##2##(2007-11#1)(2008-7#1)
rule was##2##2##(2008-9#2)
rule##145##1##(1990-10#1)(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#2)(1994-11#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#10)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
rule&quot##5##1##(2007-11#1)(2008-8#3)(2013-8#1)
rule-based##4##1##(2008-10#1)(2009-5#2)(2013-1#1)
rule-breaking behavior##2##2##(2008-11#2)
ruled grating##2##2##(2008-3#2)
ruled out as a##3##4##(1990-8#1)(1995-6#1)(2008-3#1)
ruled out as##5##3##(1990-8#1)(1992-12#1)(1995-6#1)(2008-10#1)(2008-3#1)
ruled out by##3##3##(1990-3#1)(1996-6#1)(2012-1#1)
ruled out##35##2##(1990-3#1)(1990-7#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#3)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
ruled that a##2##3##(1995-12#1)(1997-5#1)
ruled that the##6##3##(1995-12#2)(1995-6#1)(1996-5#1)(1997-5#2)
ruled that##18##2##(1994-2#1)(1995-12#6)(1995-6#2)(1996-5#1)(1997-5#8)
ruled##63##1##(1990-3#1)(1990-7#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#7)(1995-2#1)(1995-6#4)(1995-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#8)(2007-11#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#9)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
rulemaking##2##1##(1995-3#1)(1996-12#1)
ruler for##2##2##(2008-3#1)(2008-7#1)
ruler##6##1##(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
rules and regulations##3##3##(1996-8#1)(2007-2#1)(2008-7#1)
rules and the##4##3##(1991-2#1)(1993-3#1)(1997-3#1)(2011-3#1)
rules and##19##2##(1991-2#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2011-3#1)(2012-1#1)
rules are##4##2##(1995-6#1)(2007-11#1)(2008-6#1)(2008-9#1)
rules based on the##2##4##(2012-2#1)(2013-1#1)
rules can be##2##3##(2007-12#1)(2008-8#1)
rules can##4##2##(1995-5#1)(2007-12#2)(2008-8#1)
rules for the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
rules for##28##2##(1990-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-4#1)(1997-3#2)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
rules governing##5##2##(1995-5#1)(2008-8#3)(2008-9#1)
rules have##2##2##(1995-6#1)(2008-8#1)
rules in##2##2##(1995-6#2)
rules may##2##2##(1995-6#1)(2008-10#1)
rules of India##2##3##(2007-7#2)
rules of early##2##3##(2008-7#1)(2011-2#1)
rules of the##4##3##(1993-12#1)(2007-11#2)(2008-3#1)
rules of thumb##3##3##(2008-8#2)(2009-10#1)
rules of##18##2##(1993-12#1)(1995-6#1)(1997-2#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2011-2#2)
rules out the##2##3##(1993-12#1)(2010-4#1)
rules out##3##2##(1993-12#1)(2008-6#1)(2010-4#1)
rules that##8##2##(1993-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
rules to##5##2##(1993-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
rules were##3##2##(2008-4#1)(2010-8#1)(2013-8#1)
rules##164##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#3)(1994-2#3)(1994-3#1)(1994-6#1)(1995-2#2)(1995-5#2)(1995-6#8)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#7)(1997-8#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#11)(2008-9#8)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#6)(2013-1#6)(2013-8#3)
ruling against##3##2##(1996-2#1)(1997-5#2)
ruling out##6##2##(1993-12#1)(2006-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
ruling that##2##2##(1997-5#2)
ruling##27##1##(1993-12#1)(1994-2#1)(1995-12#3)(1995-6#2)(1996-2#1)(1996-5#1)(1997-5#8)(1997-6#1)(2006-5#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
rulings##3##1##(1990-6#1)(1992-11#1)(1994-1#1)
rumen bacteria##2##2##(2009-4#2)
rumen bacterial concentrations##3##3##(2009-4#3)
rumen contents and##2##3##(1991-12#1)(2009-4#1)
rumen##18##1##(1991-12#3)(2009-4#10)(2011-2#4)(2013-1#1)
ruminal##2##1##(1991-12#1)(2013-1#1)
ruminant##8##1##(1990-8#1)(1991-8#3)(2007-11#1)(2011-2#2)(2012-3#1)
ruminantium##5##1##(1996-12#4)(2010-1#1)
ruminants in##3##2##(1997-7#1)(2011-2#1)(2012-2#1)
ruminants##17##1##(1991-8#1)(1993-2#2)(1993-8#2)(1997-7#3)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
rumination and##3##2##(2009-11#1)(2010-10#1)(2012-1#1)
rumination frequency##2##2##(2008-8#2)
rumination is##4##2##(2008-8#1)(2009-11#1)(2009-3#1)(2012-1#1)
rumination##24##1##(2008-8#7)(2009-11#7)(2009-3#1)(2010-10#5)(2010-6#1)(2012-1#3)
ruminative thinking##4##2##(2008-8#1)(2012-1#3)
ruminative##5##1##(2008-8#1)(2012-1#3)(2012-12#1)
run a##3##2##(1993-12#1)(2011-2#1)(2012-2#1)
run along##3##2##(2008-7#2)(2013-1#1)
run and##3##2##(1997-1#1)(2008-3#1)(2008-7#1)
run at the##2##3##(2008-9#1)(2013-1#1)
run at##4##2##(1996-5#1)(2008-9#1)(2013-1#2)
run away##2##2##(1994-2#1)(2009-10#1)
run buffer##9##2##(1996-5#2)(2008-10#7)
run by the##2##3##(1996-5#1)(2011-2#1)
run by##7##2##(1991-2#1)(1996-5#1)(2008-2#1)(2008-9#1)(2011-2#3)
run in##5##2##(1990-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
run increased risk of developing##2##5##(1990-9#1)(1994-9#1)
run increased risk of##3##4##(1990-9#1)(1994-9#2)
run length##2##2##(2010-4#1)(2010-8#1)
run off##2##2##(1990-11#1)(2008-5#1)
run on##6##2##(1990-3#1)(2008-10#1)(2008-3#1)(2008-4#2)(2013-1#1)
run over##2##2##(2008-4#1)(2012-12#1)
run the risk of##2##4##(1992-12#1)(2008-8#1)
run the##3##2##(1992-12#1)(2008-4#1)(2008-8#1)
run time of##4##3##(1996-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
run time##7##2##(1996-5#1)(2008-10#2)(2008-3#2)(2011-2#1)(2012-2#1)
run to##4##2##(2008-10#2)(2008-7#1)(2013-7#1)
run was##5##2##(1991-8#1)(1992-11#1)(1995-3#1)(2008-10#2)
run with##6##2##(1990-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
run##146##1##(1990-11#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#5)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#2)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-4#3)(2010-8#2)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
run-in period##2##2##(2012-3#1)(2013-1#1)
run-in phase##2##2##(1995-12#1)(2008-7#1)
run-in##5##1##(1994-11#1)(1995-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
run-off water##2##2##(2008-10#2)
run-off##7##1##(1990-6#1)(1992-1#1)(1992-8#1)(1994-11#1)(2008-10#2)(2008-4#1)
run-off&quot##2##1##(1991-12#2)
run-on##6##1##(1992-12#1)(1995-6#2)(2008-8#1)(2012-3#2)
run-to-run##2##1##(2008-10#1)(2008-3#1)
runaway youths##2##2##(2008-9#2)
runaway##10##1##(1995-2#1)(2008-9#5)(2010-9#1)(2011-2#1)(2013-1#2)
rundown##2##1##(2008-8#1)(2011-2#1)
runner hyphae##2##2##(2008-11#2)
runner##9##1##(2008-10#3)(2008-11#2)(2011-2#3)(2013-8#1)
runners during the##2##3##(2013-8#2)
runners##6##1##(2008-10#1)(2013-8#5)
running a##5##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
running at a##2##3##(2007-12#1)(2008-9#1)
running at##3##2##(2007-12#1)(2008-9#1)(2013-1#1)
running away from##2##3##(1995-5#1)(2008-9#1)
running buffer (pH##2##3##(2008-10#2)
running buffer##12##2##(2008-10#11)(2010-7#1)
running cost##2##2##(2008-10#2)
running in##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
running out##2##2##(1991-3#1)(1992-5#1)
running sutures##2##2##(2012-3#2)
running the##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
running through##2##2##(2008-10#1)(2013-8#1)
running time##4##2##(1996-5#1)(2008-3#1)(2008-5#1)(2009-6#1)
running water##2##2##(2008-10#1)(2013-8#1)
running##90##1##(1990-2#1)(1991-3#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#29)(2008-11#6)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-5#3)(2009-6#1)(2010-7#2)(2010-8#1)(2012-1#3)(2012-3#3)(2013-1#2)(2013-8#2)
runoff by cotton wicks##2##4##(2008-10#2)
runoff##10##1##(2008-10#8)(2011-2#2)
runs analysis##9##2##(2008-10#9)
runs of the##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
runs of##4##2##(1995-6#1)(2008-10#2)(2011-2#1)
runs on##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
runs parallel to the##2##4##(1997-7#1)(2008-7#1)
runs performed##2##2##(2007-9#1)(2011-2#1)
runs posteriorly##2##2##(2008-5#2)
runs the##3##2##(1992-6#1)(2007-12#1)(2012-2#1)
runs with##5##2##(2007-9#3)(2011-2#1)(2013-1#1)
runs##56##1##(1990-3#1)(1992-6#1)(1995-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-9#4)(2008-10#21)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2009-6#2)(2011-2#3)(2012-2#2)(2013-1#2)
runtime analysis of##2##3##(2010-2#2)
runtime##8##1##(2008-6#1)(2009-3#1)(2010-2#6)
rupestris stem-pitting disease##2##3##(2008-10#2)
rupestris##5##1##(2008-10#5)
rupintrivir##5##1##(2008-10#5)
rupture after##2##2##(1990-8#1)(2008-12#1)
rupture and the##2##3##(2006-10#1)(2012-3#1)
rupture and##13##2##(1992-5#2)(1996-4#1)(1996-5#1)(2006-10#1)(2007-8#2)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#2)
rupture causing##2##2##(2007-8#1)(2011-2#1)
rupture due to##2##3##(2008-11#1)(2012-3#1)
rupture event##2##2##(2009-10#1)(2009-9#1)
rupture had##2##2##(1997-3#1)(2011-3#1)
rupture in a patient##2##4##(1992-2#1)(2010-3#1)
rupture in a##5##3##(1992-2#1)(1993-12#1)(2007-8#1)(2009-10#1)(2010-3#1)
rupture in the##2##3##(1996-4#2)
rupture in##14##2##(1992-2#2)(1993-12#1)(1993-9#1)(1995-12#1)(1996-4#2)(2007-8#2)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
rupture is a##4##3##(1997-8#1)(2007-8#1)(2009-10#1)(2012-2#1)
rupture is##8##2##(1997-8#1)(2007-10#1)(2007-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
rupture of a##8##3##(2007-12#1)(2007-6#1)(2007-8#2)(2008-6#1)(2011-2#2)(2012-1#1)
rupture of an anterior communicating artery aneurysm##2##7##(1996-3#2)
rupture of an infected urachal cyst##2##6##(2008-10#2)
rupture of an##8##3##(1991-5#1)(1991-6#1)(1995-5#1)(1996-3#2)(2008-10#2)(2008-7#1)
rupture of hydatid cyst##2##4##(2008-12#2)
rupture of intracranial##3##3##(1995-5#1)(2010-9#1)(2011-2#1)
rupture of membranes##2##3##(2012-3#1)(2013-1#1)
rupture of the aneurysm##2##4##(2008-7#1)(2011-2#1)
rupture of the cyst##2##4##(1990-6#1)(1991-8#1)
rupture of the descending thoracic aorta##2##6##(2010-8#2)
rupture of the right##2##4##(1997-6#1)(2012-3#1)
rupture of the spleen##2##4##(1993-9#1)(2008-11#1)
rupture of the##44##3##(1990-11#1)(1990-2#4)(1990-6#1)(1991-8#2)(1993-9#1)(1994-7#1)(1996-1#1)(1997-6#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#3)(2008-7#2)(2009-4#2)(2009-5#2)(2009-9#1)(2010-3#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)
rupture of##86##2##(1990-11#1)(1990-2#4)(1990-3#1)(1990-6#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-5#2)(1993-9#1)(1994-7#1)(1995-5#2)(1996-1#1)(1996-3#2)(1997-6#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#7)(2008-10#6)(2008-11#4)(2008-12#2)(2008-6#1)(2008-7#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-9#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#2)
rupture risk##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
rupture was##4##2##(1996-3#1)(2009-4#1)(2011-1#1)(2011-3#1)
rupture with##3##2##(1997-8#1)(2008-10#1)(2012-12#1)
rupture##219##1##(1990-11#1)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-2#5)(1992-5#5)(1993-12#3)(1993-9#2)(1994-1#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-5#3)(1996-1#1)(1996-3#6)(1996-4#13)(1996-5#1)(1996-6#2)(1997-3#1)(1997-6#2)(1997-8#3)(2006-10#3)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#17)(2008-10#7)(2008-11#6)(2008-12#5)(2008-3#1)(2008-6#2)(2008-7#14)(2008-9#1)(2009-10#3)(2009-3#1)(2009-4#8)(2009-5#3)(2009-9#6)(2010-3#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#23)(2011-3#2)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#3)(2013-8#3)
ruptured aneurysm##4##2##(1997-3#1)(1997-8#1)(2008-7#1)(2013-8#1)
ruptured basilar tip##2##3##(2008-7#2)
ruptured into the##4##3##(1991-6#1)(1993-5#1)(2008-12#1)(2011-2#1)
ruptured intracranial##3##2##(2006-7#1)(2008-7#2)
ruptured##36##1##(1991-5#1)(1991-6#1)(1993-5#1)(1994-9#1)(1995-12#1)(1997-3#3)(1997-8#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-7#10)(2010-5#2)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
ruptures of the##2##3##(2008-7#1)(2013-1#1)
ruptures of##3##2##(1996-4#1)(2008-7#1)(2013-1#1)
ruptures##12##1##(1993-5#1)(1996-4#4)(2008-7#1)(2009-4#1)(2009-6#1)(2012-2#2)(2013-1#2)
rupturing the##2##2##(2009-11#1)(2013-8#1)
rupturing##3##1##(2008-6#1)(2009-11#1)(2013-8#1)
rural AFDC##2##2##(1996-3#2)
rural Alaska hospitals##2##3##(1996-12#2)
rural Uganda##3##2##(2012-2#1)(2013-1#2)
rural adults##2##2##(2010-10#1)(2010-4#1)
rural and remote areas##2##4##(2007-2#1)(2012-12#1)
rural and urban and##2##4##(2008-6#1)(2010-4#1)
rural and urban areas##3##4##(1994-2#1)(2009-7#1)(2011-2#1)
rural and urban beneficiaries##3##4##(1994-2#2)(1996-3#1)
rural and urban##15##3##(1994-2#4)(1996-3#1)(2007-9#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)
rural and##25##2##(1994-2#4)(1996-3#1)(1997-4#1)(2007-2#1)(2007-9#1)(2008-6#3)(2009-10#1)(2009-7#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-1#6)(2012-12#1)(2012-2#1)
rural area of##5##3##(1995-3#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)
rural area##9##2##(1991-3#1)(1995-3#2)(1997-4#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)
rural areas and##2##3##(1993-6#1)(2007-7#1)
rural areas are##2##3##(1994-2#1)(2013-1#1)
rural areas in##3##3##(1991-6#1)(1994-3#1)(2011-1#1)
rural areas of##6##3##(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
rural areas##57##2##(1991-1#1)(1991-3#2)(1991-6#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-2#2)(1994-3#3)(1994-9#1)(1995-3#1)(1996-12#2)(1996-3#4)(1996-5#1)(1997-2#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#5)(2009-5#1)(2010-1#1)(2010-10#3)(2011-1#6)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#4)
rural based##2##2##(2008-7#1)(2010-3#1)
rural beneficiaries##4##2##(1992-12#3)(1996-3#1)
rural communities in the##2##4##(2008-10#1)(2008-9#1)
rural communities in##4##3##(1994-9#1)(2008-10#1)(2008-9#1)(2011-1#1)
rural communities##15##2##(1992-12#1)(1994-9#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#4)
rural community##13##2##(1994-1#1)(1997-2#1)(2008-11#1)(2008-12#2)(2009-10#1)(2010-3#1)(2010-6#2)(2010-9#2)(2012-2#1)(2013-1#1)
rural counties are##2##3##(1996-3#2)
rural counties##8##2##(1996-3#7)(2008-10#1)
rural development##2##2##(1997-7#1)(2010-5#1)
rural district of##2##3##(2007-12#1)(2010-4#1)
rural district##3##2##(1994-6#1)(2007-12#1)(2010-4#1)
rural dogs##3##2##(2008-12#3)
rural dwellers##3##2##(1994-3#1)(2010-10#1)(2013-1#1)
rural elderly##2##2##(1994-2#1)(2011-1#1)
rural general##2##2##(2008-4#1)(2008-6#1)
rural girls##2##2##(2011-1#2)
rural health care##5##3##(1992-12#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)
rural health##14##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#3)(1997-3#1)(2008-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
rural hospital##7##2##(1991-1#3)(1996-3#4)
rural hospitals are##4##3##(1991-1#1)(1993-12#1)(1993-2#1)(1996-3#1)
rural hospitals in##3##3##(1992-2#2)(1996-3#1)
rural hospitals##25##2##(1991-1#2)(1992-12#3)(1992-2#2)(1992-8#1)(1993-12#5)(1993-2#3)(1995-1#1)(1996-12#1)(1996-3#5)(2008-11#2)
rural hospitals?##2##2##(1992-12#1)(1996-3#1)
rural individuals##2##2##(2013-1#2)
rural locations##3##2##(2008-10#1)(2008-3#2)
rural medical##2##2##(1991-3#1)(2008-12#1)
rural municipalities##2##2##(1994-11#1)(1995-5#1)
rural or##3##2##(1991-1#1)(2008-8#1)(2012-1#1)
rural participants were##2##3##(2007-12#1)(2008-11#1)
rural participants##3##2##(2007-12#1)(2008-11#2)
rural patients##4##2##(1992-12#1)(2007-7#1)(2013-1#2)
rural placement##2##2##(2013-1#2)
rural population##3##2##(2008-8#1)(2011-1#1)(2012-12#1)
rural populations##4##2##(1996-11#2)(2008-10#1)(2008-7#1)
rural practice##6##2##(1991-3#1)(2008-10#1)(2008-12#4)
rural primary care training##2##4##(1996-1#2)
rural primary care##3##3##(1993-12#1)(1996-1#2)
rural residents##4##2##(1995-12#1)(1997-2#1)(2012-3#1)(2013-1#1)
rural setting##5##2##(2007-12#1)(2009-6#1)(2010-5#1)(2012-12#2)
rural sites##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
rural smokers##4##2##(2013-1#4)
rural state##2##2##(2010-5#2)
rural states##4##2##(1994-1#4)
rural veterans##4##2##(2012-1#4)
rural women had decreased odds of##2##6##(2013-1#2)
rural women had##3##3##(2013-1#3)
rural##387##1##(1990-12#2)(1991-1#9)(1991-3#5)(1991-6#1)(1992-12#12)(1992-2#3)(1992-8#1)(1993-10#1)(1993-12#10)(1993-2#6)(1993-3#1)(1993-5#2)(1993-6#2)(1994-1#11)(1994-11#1)(1994-2#9)(1994-3#6)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#33)(1996-5#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(2007-10#3)(2007-12#4)(2007-2#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#17)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#6)(2010-3#3)(2010-4#6)(2010-5#4)(2010-6#5)(2010-7#1)(2010-9#4)(2011-1#12)(2011-2#14)(2012-1#16)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#36)(2013-8#1)
rurality##5##1##(2011-2#4)(2013-1#1)
rush##4##1##(1991-8#1)(1993-1#1)(1994-12#1)(2008-3#1)
rushed to##2##2##(1993-1#1)(2008-7#1)
rushed##3##1##(1993-1#1)(1996-2#1)(2008-7#1)
rust (Puccinia##6##2##(2008-10#6)
rust (Uromyces##2##2##(2008-10#2)
rust (caused by##2##3##(2008-10#2)
rust and anthracnose on the##2##5##(2008-10#2)
rust and stripe rust##6##4##(2008-10#6)
rust and##18##2##(2008-10#18)
rust by##2##2##(2008-10#2)
rust caused by Puccinia##2##4##(2008-10#2)
rust caused by##5##3##(2008-10#5)
rust epidemics##9##2##(2008-10#9)
rust fungi##5##2##(2008-10#5)
rust fungus Puccinia##3##3##(2008-10#3)
rust fungus##13##2##(2008-10#13)
rust have##2##2##(2008-10#2)
rust in##15##2##(2008-10#15)
rust infection##5##2##(2008-10#5)
rust is##3##2##(2008-10#3)
rust isolates##5##2##(2008-10#5)
rust lesions##3##2##(2008-10#3)
rust occurs in##2##3##(2008-10#2)
rust of wheat##3##3##(2008-10#3)
rust of##13##2##(2008-10#13)
rust on##5##2##(2008-10#5)
rust pathogen##7##2##(2008-10#7)
rust pathogens##4##2##(2008-10#4)
rust pathosystem##5##2##(2008-10#5)
rust pathotypes##2##2##(2008-10#2)
rust population in##2##3##(2008-10#2)
rust populations##5##2##(2008-10#5)
rust race##2##2##(2008-10#2)
rust races##5##2##(2008-10#5)
rust ratings##2##2##(2008-10#2)
rust resistance and##4##3##(2008-10#4)
rust resistance gene Lr34##3##4##(2008-10#3)
rust resistance gene in##2##4##(2008-10#2)
rust resistance gene##16##3##(2008-10#16)
rust resistance genes in##2##4##(2008-10#2)
rust resistance genes##14##3##(2008-10#14)
rust resistance in the##4##4##(2008-10#4)
rust resistance in##14##3##(2008-10#14)
rust resistance was##2##3##(2008-10#2)
rust resistance##69##2##(2008-10#69)
rust severity and##5##3##(2008-10#5)
rust severity##16##2##(2008-10#16)
rust species##6##2##(2008-10#6)
rust susceptible##2##2##(2008-10#2)
rust uredospore production and##2##4##(2008-10#2)
rust uredospore production##3##3##(2008-10#3)
rust was detected##2##3##(2008-10#2)
rust was##9##2##(2008-10#9)
rust were##3##2##(2008-10#3)
rust##371##1##(2008-10#371)
rust)##4##1##(2008-10#4)
rustica##2##1##(2008-10#1)(2008-9#1)
rusts in##2##2##(2008-10#2)
rusts##11##1##(2008-10#11)
rusty##2##1##(2008-10#1)(2008-9#1)
ruthenium (III)##2##2##(2008-10#2)
ruthenium and##5##2##(2008-10#4)(2010-7#1)
ruthenium as##2##2##(2008-10#2)
ruthenium catalyst##2##2##(2010-5#1)(2010-7#1)
ruthenium complex##3##2##(2008-10#3)
ruthenium complexes##3##2##(2008-10#3)
ruthenium concentration##2##2##(2008-10#2)
ruthenium in##4##2##(2008-10#4)
ruthenium oxide materials##3##3##(2010-4#3)
ruthenium oxide##4##2##(2010-4#4)
ruthenium with##3##2##(2008-10#3)
ruthenium##50##1##(1996-2#1)(2008-10#39)(2008-12#1)(2009-8#1)(2010-4#4)(2010-5#1)(2010-7#3)
ruthenium(II) complex##2##2##(2008-10#2)
ruthenium(II) complexes containing##2##3##(2008-10#2)
ruthenium(II) complexes##5##2##(1996-2#1)(2008-10#4)
ruthenium(II)##15##1##(1996-2#1)(2008-10#14)
rutile particles in water##2##4##(2008-3#2)
rutile particles##3##2##(2008-3#3)
rutile##5##1##(2008-3#5)
rutile-type titanium oxide coated LTI-carbon##2##5##(2008-8#2)
rutile-type titanium oxide##3##3##(2008-8#3)
rutile-type##4##1##(2008-8#4)
rutilus (L##2##2##(2008-7#1)(2010-8#1)
rutilus##5##1##(2008-7#1)(2010-8#4)
rutin and quercetin##2##3##(2008-9#2)
rutin and##6##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-6#1)
rutin##25##1##(2008-10#18)(2008-11#2)(2008-5#1)(2008-9#3)(2009-6#1)
rvWF/106 cells x day##3##4##(2008-11#3)
ryanae##2##1##(2013-1#2)
ryanodine and##2##2##(1992-3#1)(1996-5#1)
ryanodine binding##4##2##(1990-2#4)
ryanodine receptor##5##2##(1994-8#1)(1994-9#3)(1997-3#1)
ryanodine receptors##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)
ryanodine sensitive ion channel##3##4##(1994-8#3)
ryanodine##25##1##(1990-2#6)(1992-3#3)(1994-8#5)(1994-9#3)(1996-5#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-11#1)(2013-8#1)
rye (Secale cereale)##2##3##(2008-10#1)(2008-5#1)
rye B medium##2##3##(2008-10#2)
rye and barley##2##3##(1991-12#2)
rye and##3##2##(1991-12#2)(2008-8#1)
rye flour##2##2##(1990-3#1)(1993-3#1)
rye grass##3##2##(2008-10#3)
rye telomeric##2##2##(2008-5#2)
rye##36##1##(1990-3#1)(1991-12#2)(1993-3#1)(1995-8#1)(1997-5#1)(2008-10#16)(2008-12#1)(2008-5#9)(2008-8#3)(2011-2#1)
rye-vetch green manure##3##3##(2008-10#3)
ryegrass (Lolium perenne)##3##3##(2008-10#3)
ryegrass (Lolium##5##2##(2008-10#4)(2012-2#1)
ryegrass and##4##2##(2008-10#4)
ryegrass##40##1##(2008-10#37)(2012-2#3)
r = 0##6##1##(2012-5#6)
résection du dôme saillant##2##4##(2011-2#2)
résection##3##1##(2011-2#3)
r = 0##2##1##(2012-1#2)
s = 0##2##3##(2007-11#2)
s = 3##2##3##(2007-11#2)
s =##9##2##(2007-11#7)(2008-5#1)(2009-7#1)
s accumulation time##2##3##(2008-10#2)
s accumulation##3##2##(2008-10#3)
s after addition of##2##4##(1990-5#1)(1991-12#1)
s after the reactants##2##4##(2008-10#2)
s after the start of##2##5##(1995-12#1)(2008-10#1)
s after the##6##3##(1992-11#1)(1995-12#1)(1996-5#1)(2008-10#3)
s after##14##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-11#2)(1995-12#1)(1996-5#1)(2008-10#4)
s and a##4##3##(2008-10#3)(2008-11#1)
s and can be used for at least 3 months without any##2##12##(2008-10#2)
s and can be used for at least##6##8##(2008-10#6)
s and can be used for##8##6##(2008-10#8)
s and p polarization of##2##5##(2007-11#1)(2008-3#1)
s and p polarization##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
s and p##8##3##(2007-11#3)(2007-12#1)(2008-3#4)
s and the detection limit##2##5##(2008-10#2)
s and the membrane##2##4##(2008-10#2)
s and the##6##3##(2008-10#5)(2008-4#1)
s and##39##2##(1992-11#1)(1992-6#1)(1993-11#1)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#23)(2008-11#1)(2008-3#6)(2008-4#1)
s are##2##2##(2008-10#1)(2008-2#1)
s at##4##2##(2008-10#3)(2008-3#1)
s between##2##2##(1993-6#1)(2008-10#1)
s circulation period)##2##3##(1997-2#2)
s for the##2##3##(2008-10#2)
s for##7##2##(2007-12#1)(2008-10#6)
s from##2##2##(2008-10#1)(2008-11#1)
s in a##3##3##(2008-10#3)
s in the##2##3##(1993-8#1)(1996-12#1)
s in##12##2##(1990-7#1)(1991-10#1)(1992-8#1)(1993-8#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-7#1)(2013-8#2)
s is##2##2##(1990-5#1)(2008-3#1)
s of the##2##3##(2008-10#1)(2008-3#1)
s of##11##2##(2008-10#7)(2008-3#1)(2012-3#3)
s or##2##2##(2008-10#1)(2013-1#1)
s per##2##2##(2008-10#1)(2010-5#1)
s polarization##2##2##(2008-3#2)
s polarized##2##2##(2007-12#1)(2008-3#1)
s preconcentration time##8##3##(2008-10#8)
s preconcentration##11##2##(2008-10#11)
s to##3##2##(1990-8#1)(2008-10#2)
s under##2##2##(2008-10#2)
s were##2##2##(2008-10#2)
s with a##2##3##(2008-7#2)
s with##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)
s without##2##2##(2008-10#1)(2008-3#1)
s##454##1##(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#12)(1992-8#2)(1992-9#3)(1993-11#4)(1993-12#7)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#19)(1995-3#1)(1996-12#2)(1996-2#7)(1996-5#6)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#7)(1997-4#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-11#15)(2007-12#16)(2007-8#3)(2008-10#164)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#34)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#12)(2008-9#3)(2009-10#7)(2009-7#2)(2010-1#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#11)
s(-1) and 3##2##3##(2008-3#2)
s(-1) and##10##2##(2008-10#5)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)
s(-1) at##2##2##(2008-10#2)
s(-1) for the##3##3##(1996-2#2)(2009-8#1)
s(-1) for##8##2##(1996-2#2)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)
s(-1)##67##1##(1996-2#2)(1996-7#3)(1997-7#2)(2008-10#36)(2008-11#3)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-8#2)
s(-1))##17##1##(2006-11#1)(2007-5#1)(2008-10#10)(2008-3#2)(2008-9#1)(2009-8#1)(2012-12#1)
s(-2)##2##1##(2008-3#1)(2010-8#1)
s(0)##2##1##(2008-3#2)
s(b)##2##1##(2008-10#2)
s(r##6##1##(2008-10#6)
s(r)##2##1##(2008-10#2)
s(r)&lt##2##1##(2008-10#2)
s(x) of##2##2##(2008-2#1)(2008-3#1)
s(x)##7##1##(2008-2#3)(2008-3#4)
s) and a##2##3##(2008-10#2)
s) and high##2##3##(2008-10#2)
s) and##10##2##(2008-10#6)(2008-12#1)(2008-3#2)(2013-1#1)
s) for##2##2##(2008-10#1)(2008-3#1)
s) in##2##2##(2008-10#1)(2011-1#1)
s) of##3##2##(2008-10#3)
s)##42##1##(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1996-7#1)(2007-12#1)(2008-10#22)(2008-12#1)(2008-3#7)(2009-8#1)(2010-3#3)(2011-1#1)(2013-1#1)
s- and p-polarized light##2##4##(2008-3#2)
s- and p-polarized##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
s- and##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
s-1 and 2##2##3##(1992-6#1)(1997-2#1)
s-1 and##8##2##(1991-5#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)
s-1##47##1##(1990-7#1)(1991-5#9)(1991-9#2)(1992-3#1)(1992-6#6)(1993-8#5)(1993-9#3)(1994-5#5)(1995-11#1)(1995-2#5)(1995-6#2)(1995-8#3)(1997-2#1)(2008-10#3)
s-1) approximately beta-erythro-2-pentulofuranose (0##2##4##(1990-9#2)
s-1) approximately##4##2##(1990-9#4)
s-1) greater than alpha-erythrofuranose##2##4##(1990-9#2)
s-1) greater than alpha-threo-2-pentulofuranose (0##2##5##(1990-9#2)
s-1) greater than alpha-threofuranose##2##4##(1990-9#2)
s-1) greater than##10##3##(1990-9#10)
s-1)##24##1##(1990-9#16)(1995-11#1)(1995-2#2)(1995-6#3)(1997-2#1)(2008-10#1)
s-1M-1)##2##1##(1992-12#2)
s-polarized##7##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
s-triazines##2##1##(2008-10#2)
s-wave polarized##3##2##(2008-2#3)
s/mm2##2##1##(2009-11#2)
sAPP695##2##1##(1994-11#2)
sAPP770##2##1##(1994-11#2)
sCysC in SLE##3##3##(2013-1#3)
sCysC##7##1##(2013-1#7)
sEMG##3##1##(2013-8#3)
sGAG-storage##2##1##(1993-12#2)
sGC##2##1##(2008-4#2)
sGnRH##5##1##(1994-8#5)
sI/R##2##1##(2013-7#2)
sICAM-1##4##1##(1993-8#4)
sIL-1R I##3##2##(2008-10#3)
sIL-1R##10##1##(1995-2#7)(2008-10#3)
sIL-6R##9##1##(1994-2#5)(1997-7#4)
sIgA##5##1##(2008-5#1)(2011-1#4)
sMDH##3##1##(1993-11#3)
sNCT##2##1##(2006-12#2)
sPLA₂ from##2##2##(2013-1#2)
sPLA₂##3##1##(2013-1#3)
sPLA₂s##3##1##(2013-1#3)
sRANKL##2##1##(2013-8#2)
sRNA##3##1##(2008-9#3)
sRNAs##2##1##(2008-9#2)
sTNF-Rs##3##1##(2008-4#3)
sTRAIL##4##1##(2009-3#4)
sTT level was##2##3##(2012-12#2)
sTT##4##1##(2012-12#4)
sTT/PSA ratio in##2##3##(2012-12#2)
sTT/PSA ratio##4##2##(2012-12#4)
sa##2##1##(2008-8#1)(2013-1#1)
saCBMFX##6##1##(2008-11#6)
sac and the##2##3##(2007-12#1)(2007-8#1)
sac and##7##2##(1993-8#1)(2007-12#1)(2007-8#1)(2008-6#1)(2009-12#2)(2012-3#1)
sac during##3##2##(2008-11#2)(2011-3#1)
sac in##3##2##(2007-8#1)(2008-9#1)(2009-8#1)
sac is##3##2##(2007-12#1)(2012-12#2)
sac of##4##2##(2007-12#1)(2008-5#1)(2008-9#1)(2009-12#1)
sac was##4##2##(2007-8#2)(2008-11#1)(2008-12#1)
sac##79##1##(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#2)(1997-3#2)(1997-4#1)(2006-12#4)(2007-12#10)(2007-8#4)(2008-10#9)(2008-11#6)(2008-12#10)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#4)(2009-12#3)(2009-6#1)(2009-8#3)(2011-3#3)(2012-1#4)(2012-12#3)(2012-3#1)
sacB[BamP]##2##1##(1990-11#2)
saccade amplitude##2##2##(2008-7#2)
saccade error##2##2##(2008-7#2)
saccade##11##1##(2008-7#5)(2009-2#4)(2011-1#2)
saccades##6##1##(1991-5#1)(2008-7#2)(2009-2#1)(2010-5#2)
saccadic head movements##2##3##(1993-12#2)
saccadic##6##1##(1991-5#1)(1993-12#3)(2008-7#2)
sacchari##2##1##(2008-10#2)
saccharide composition##2##2##(1991-7#2)
saccharide##9##1##(1991-7#2)(1995-2#1)(2008-10#3)(2008-4#1)(2009-2#1)(2012-3#1)
saccharides##9##1##(1991-7#4)(1995-5#2)(2008-11#1)(2008-4#1)(2009-2#1)
saccharification and fermentation##9##3##(2008-6#7)(2013-1#2)
saccharification and##10##2##(2008-6#8)(2013-1#2)
saccharification of##3##2##(2008-6#3)
saccharification##14##1##(2008-6#12)(2013-1#2)
saccharin and##2##2##(1992-11#1)(2008-5#1)
saccharin aversion##3##2##(2008-5#3)
saccharin preference##2##2##(2008-2#1)(2008-5#1)
saccharin##16##1##(1992-11#1)(1993-12#1)(1995-12#1)(2008-2#1)(2008-5#10)(2011-1#2)
saccharina##3##1##(2008-10#3)
saccharose##3##1##(2008-10#2)(2008-2#1)
saccular IA##2##2##(2007-10#2)
saccular aneurysm arising from the##2##5##(2007-8#2)
saccular aneurysm arising from##3##4##(2007-8#2)(2013-8#1)
saccular aneurysm of##2##3##(2007-8#1)(2008-7#1)
saccular aneurysm##7##2##(2007-8#3)(2008-7#3)(2013-8#1)
saccular##15##1##(1995-11#1)(2007-10#3)(2007-8#3)(2008-5#1)(2008-7#3)(2010-9#1)(2013-8#3)
sacculus##2##1##(1997-8#1)(2007-12#1)
sachalinensis##2##1##(2008-11#2)
sack lunches##3##2##(2012-12#3)
sack##5##1##(1990-5#1)(2012-12#3)(2012-3#1)
sacral bone##4##2##(2007-11#2)(2009-3#1)(2013-8#1)
sacral fractures##2##2##(2008-12#2)
sacral meningocele may##2##3##(2009-3#2)
sacral meningocele##4##2##(2009-3#4)
sacral##26##1##(1997-3#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-7#5)(2008-8#1)(2009-3#5)(2010-6#1)(2013-8#3)
sacred##4##1##(2008-1#2)(2009-8#1)(2011-2#1)
sacredness of##2##2##(2008-1#2)
sacredness##5##1##(2008-1#5)
sacrifice of##2##2##(2008-2#1)(2012-3#1)
sacrifice the##2##2##(1995-5#1)(2008-12#1)
sacrifice##15##1##(1992-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-2#3)(2010-10#1)(2011-2#1)(2012-3#1)
sacrificed 24 h##2##3##(1994-2#1)(1996-12#1)
sacrificed and##4##2##(1996-5#1)(2008-10#1)(2008-7#2)
sacrificed at the##5##3##(1994-2#1)(1997-4#3)(2010-4#1)
sacrificed at##12##2##(1994-2#1)(1994-6#1)(1995-11#1)(1997-4#3)(2008-10#1)(2008-7#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-1#1)
sacrificed during##2##2##(2008-1#1)(2008-9#1)
sacrificed##41##1##(1992-12#1)(1992-2#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-4#6)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#6)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
sacrificial##2##1##(2009-10#1)(2009-9#1)
sacrificing##11##1##(1992-12#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-11#1)
sacrococcygeal teratoma##3##2##(2009-4#1)(2011-1#2)
sacrococcygeal##5##1##(2007-5#2)(2009-4#1)(2011-1#2)
sacroiliac joint##3##2##(2011-2#1)(2012-2#2)
sacroiliac joints in patients with##2##5##(2011-2#2)
sacroiliac joints in##3##3##(2011-2#3)
sacroiliac joints##6##2##(1990-6#2)(2006-10#1)(2011-2#3)
sacroiliac##11##1##(1990-6#3)(2006-10#1)(2011-2#4)(2012-2#3)
sacroiliitis##5##1##(2006-10#2)(2010-12#1)(2011-2#1)(2012-12#1)
sacrum##7##1##(1991-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2013-8#1)
sacs of##4##2##(2007-12#1)(2008-11#2)(2008-9#1)
sacs##13##1##(2007-12#5)(2008-10#1)(2008-11#4)(2008-9#2)(2011-1#1)
sad##6##1##(2008-10#1)(2008-11#2)(2008-6#1)(2010-3#1)(2013-8#1)
saddle anesthesia##2##2##(2008-12#1)(2009-3#1)
saddle##7##1##(1997-3#1)(2007-11#1)(2007-12#1)(2008-12#1)(2009-3#1)(2013-8#2)
sadness##3##1##(2007-7#1)(2008-11#1)(2009-9#1)
sadomasochism associated bleeding##2##3##(2011-1#2)
sadomasochism associated with bleeding##2##4##(2011-1#2)
sadomasochism associated##4##2##(2011-1#4)
sadomasochism##6##1##(2011-1#6)
safe abortion##4##2##(2011-1#3)(2011-2#1)
safe agent##2##2##(1991-9#2)
safe alternative to the##2##4##(1990-8#1)(1997-4#1)
safe alternative to##5##3##(1990-8#1)(1997-4#1)(2008-10#1)(2010-4#1)(2011-2#1)
safe alternative##7##2##(1990-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#2)
safe and clinically##2##3##(2008-11#1)(2008-7#1)
safe and cost##2##3##(1996-11#1)(2008-5#1)
safe and cost-effective##3##3##(1994-11#1)(1997-8#1)(2012-2#1)
safe and easy to##2##4##(2006-10#1)(2009-2#1)
safe and effective in##8##4##(1991-3#1)(2008-11#1)(2008-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
safe and effective method##2##4##(2008-11#1)(2012-2#1)
safe and effective treatment for##3##5##(1993-3#1)(2008-2#1)(2008-9#1)
safe and effective treatment##8##4##(1993-3#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)
safe and effective when used##2##5##(1996-12#1)(2008-11#1)
safe and effective when##3##4##(1996-12#1)(2008-11#1)(2010-12#1)
safe and effective##58##3##(1990-8#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#4)(2013-1#2)
safe and efficacious##4##3##(1993-1#1)(1996-1#1)(1996-9#1)(2008-10#1)
safe and efficient##3##3##(1991-12#1)(1992-6#1)(1994-5#1)
safe and inexpensive##2##3##(2007-7#1)(2008-10#1)
safe and legal##3##3##(2008-11#2)(2008-5#1)
safe and may##2##3##(2007-8#1)(2008-1#1)
safe and novel##2##3##(2010-5#1)(2011-2#1)
safe and reproducible##3##3##(2007-8#1)(2008-8#1)(2013-8#1)
safe and secure environment for##2##5##(1992-2#1)(1992-3#1)
safe and secure##6##3##(1992-2#1)(1992-3#1)(1995-2#2)(1996-12#1)(2010-10#1)
safe and successful##2##3##(2011-2#1)(2013-1#1)
safe and that##2##3##(1994-3#1)(2008-9#1)
safe and well tolerated##6##4##(1992-8#1)(1996-1#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
safe and well-tolerated##3##3##(1995-5#1)(2010-5#1)(2012-2#1)
safe and##154##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#6)(2007-8#5)(2008-1#4)(2008-10#6)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#5)(2008-7#8)(2008-8#4)(2008-9#5)(2009-2#2)(2009-3#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#12)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#6)(2013-8#1)
safe at##2##2##(1993-3#1)(1997-6#1)
safe but##2##2##(2007-2#1)(2009-12#1)
safe delivery of##2##3##(2010-5#1)(2013-1#1)
safe drinking water and##2##4##(2008-10#1)(2013-1#1)
safe drug##4##2##(2008-3#1)(2008-8#1)(2010-4#1)(2011-2#1)
safe drugs##2##2##(2008-7#1)(2008-8#1)
safe evacuation of patients and employees##2##6##(1996-2#2)
safe even##2##2##(2010-6#1)(2013-1#1)
safe for the##2##3##(1992-11#1)(2008-3#1)
safe for##13##2##(1991-12#1)(1991-9#1)(1992-11#1)(1994-9#1)(2007-11#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
safe harbor##3##2##(1992-12#1)(1993-1#2)
safe harbors##8##2##(1991-1#1)(1992-12#2)(1992-3#2)(1993-1#3)
safe health care##2##3##(2008-1#1)(2009-6#1)
safe health##3##2##(2008-1#1)(2009-6#1)(2011-1#1)
safe in children##2##3##(2008-10#1)(2009-5#1)
safe in the##4##3##(2008-11#1)(2008-6#1)(2010-12#2)
safe in##18##2##(1995-5#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
safe management of##3##3##(1996-6#1)(2008-11#1)(2008-3#1)
safe method for##2##3##(1990-11#1)(1993-1#1)
safe method##4##2##(1990-11#1)(1993-1#1)(2007-2#1)(2008-10#1)
safe option for##2##3##(1997-2#1)(2008-4#1)
safe option##3##2##(1997-2#1)(2008-4#1)(2011-1#1)
safe place##2##2##(1993-12#1)(2008-11#1)
safe procedure in##2##3##(2011-2#1)(2012-12#1)
safe procedure##8##2##(1990-6#1)(1994-9#1)(1995-1#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
safe sex practices##3##3##(1997-6#2)(2009-5#1)
safe sex##6##2##(1997-6#5)(2009-5#1)
safe surgical##2##2##(2008-9#1)(2010-3#1)
safe technique##3##2##(1996-3#1)(1996-9#1)(2012-3#1)
safe than##3##2##(1996-12#1)(2008-11#1)(2008-7#1)
safe to use##2##3##(2008-12#1)(2012-3#1)
safe to##9##2##(1993-9#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
safe use of##10##3##(1994-12#1)(2008-2#2)(2008-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
safe##436##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#3)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-3#4)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#7)(1993-12#3)(1993-3#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#4)(1997-2#2)(1997-4#4)(1997-6#7)(1997-8#2)(2006-10#3)(2006-12#2)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#4)(2007-7#6)(2007-8#10)(2008-1#6)(2008-10#29)(2008-11#21)(2008-12#12)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#17)(2008-8#12)(2008-9#11)(2009-1#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2010-1#1)(2010-10#2)(2010-12#7)(2010-3#2)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#12)(2011-2#36)(2012-12#8)(2012-2#14)(2012-3#8)(2013-1#19)(2013-8#5)
safe-haven##3##1##(2007-2#3)
safe-sex##3##1##(1995-1#1)(2010-7#2)
safe?##5##1##(1997-8#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
safeguard against##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
safeguard the##2##2##(2011-2#1)(2012-2#1)
safeguard##10##1##(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
safeguarding##5##1##(1990-9#1)(1991-12#1)(2007-11#1)(2009-10#1)(2011-2#1)
safeguards##4##1##(1993-7#1)(1996-3#1)(2010-8#1)(2011-2#1)
safely and effectively in##2##4##(1991-1#1)(1995-8#1)
safely and effectively##9##3##(1991-1#2)(1992-2#1)(1995-8#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)
safely and##20##2##(1991-1#2)(1991-3#1)(1992-2#1)(1995-8#1)(1996-11#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
safely be inserted##2##3##(1994-8#1)(2012-2#1)
safely be##5##2##(1994-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
safely in##4##2##(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)
safely performed##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
safely removed##2##2##(2008-7#1)(2012-2#1)
safely##72##1##(1990-6#1)(1991-1#2)(1991-12#1)(1991-3#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#2)(1996-11#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
safer and more##3##3##(1997-4#1)(2010-4#1)(2010-8#1)
safer and##4##2##(1997-4#1)(2007-7#1)(2010-4#1)(2010-8#1)
safer sex##4##2##(2008-12#2)(2009-5#2)
safer sexual##2##2##(2009-5#1)(2011-2#1)
safer to use##3##3##(2008-7#1)(2012-3#2)
safer to##4##2##(2008-7#1)(2008-9#1)(2012-3#2)
safer##43##1##(1993-12#1)(1996-1#1)(1996-9#1)(1997-1#2)(1997-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#3)(2009-7#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)
safety and clinical##3##3##(2007-11#1)(2008-7#2)
safety and convenience##2##3##(1991-3#1)(2008-3#1)
safety and cost containment##2##4##(1993-2#1)(2008-9#1)
safety and cost##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
safety and effectiveness##7##3##(2008-10#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)
safety and efficacy of acamprosate##2##5##(2008-2#2)
safety and efficacy of the##3##5##(2008-11#2)(2012-12#1)
safety and efficacy of##33##4##(1991-11#1)(1992-8#1)(1994-5#2)(1996-3#1)(1997-3#1)(2006-10#2)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
safety and efficacy##48##3##(1991-11#1)(1992-3#1)(1992-8#1)(1994-5#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#2)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-5#3)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
safety and efficiency##2##3##(2008-9#1)(2010-3#1)
safety and feasibility##2##3##(2007-10#1)(2013-1#1)
safety and health##7##3##(1993-12#1)(1993-2#1)(1993-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
safety and quality##2##3##(2007-11#1)(2008-10#1)
safety and security directors##2##4##(1992-2#2)
safety and security##5##3##(1992-2#3)(1996-12#2)
safety and the##5##3##(1997-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
safety and viability##2##3##(2007-7#1)(2011-2#1)
safety and##134##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2008-10#6)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
safety are##3##2##(1996-2#1)(2007-12#1)(2008-8#1)
safety as##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)
safety assessment of##2##3##(2010-11#1)(2010-6#1)
safety assessment##6##2##(2008-10#1)(2008-7#1)(2010-11#3)(2010-6#1)
safety assessments##4##2##(2008-8#1)(2009-10#1)(2010-11#2)
safety at home##2##3##(2007-12#1)(2012-2#1)
safety at##5##2##(1991-3#1)(2007-12#1)(2008-11#2)(2012-2#1)
safety benefits##2##2##(2008-11#1)(2008-8#1)
safety between##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
safety by##3##2##(2007-10#1)(2008-12#1)(2012-12#1)
safety climate strength##4##3##(2010-6#4)
safety climate##5##2##(2010-6#5)
safety concerns##7##2##(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
safety considerations##4##2##(1992-3#1)(1994-5#1)(2008-10#1)(2008-2#1)
safety culture##3##2##(2008-8#2)(2011-2#1)
safety data from##2##3##(2008-5#1)(2008-8#1)
safety data##10##2##(2008-11#2)(2008-5#1)(2008-8#5)(2011-1#1)(2012-3#1)
safety day camps##2##3##(2013-1#2)
safety day##3##2##(2013-1#3)
safety due##2##2##(2012-12#1)(2013-1#1)
safety during the##2##3##(2011-2#1)(2012-3#1)
safety during##4##2##(2010-12#2)(2011-2#1)(2012-3#1)
safety evaluation##3##2##(2007-11#1)(2008-11#2)
safety features##3##2##(2010-9#1)(2011-2#1)(2013-1#1)
safety for##2##2##(2010-8#1)(2013-1#1)
safety glasses##2##2##(1991-6#2)
safety in the##6##3##(1996-10#1)(1996-3#1)(2007-12#2)(2008-4#1)(2008-8#1)
safety in##23##2##(1995-3#3)(1996-10#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2012-12#3)(2012-2#1)(2013-1#1)
safety information##2##2##(2008-12#1)(2008-8#1)
safety is a##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
safety is##8##2##(1994-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
safety issues for##2##3##(2007-12#1)(2007-2#1)
safety issues that##2##3##(2008-11#1)(2008-4#1)
safety issues##15##2##(1991-12#1)(1993-2#1)(1993-3#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)
safety management##3##2##(1991-12#1)(2010-8#2)
safety margins##2##2##(1995-2#1)(2009-10#1)
safety measures##4##2##(1991-6#1)(1996-3#1)(2007-11#1)(2009-10#1)
safety net##4##2##(1996-12#1)(1997-5#1)(2008-4#1)(2011-2#1)
safety of a##7##3##(1990-11#1)(1993-2#1)(2008-10#2)(2008-8#1)(2012-3#1)(2013-1#1)
safety of both##2##3##(1991-1#1)(2012-3#1)
safety of percutaneous##2##3##(2008-9#2)
safety of the procedure##2##4##(2008-11#1)(2011-2#1)
safety of the use of##2##5##(1991-2#1)(2008-8#1)
safety of the##22##3##(1990-6#1)(1991-2#1)(1991-3#1)(1996-9#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
safety of these##2##3##(2008-10#1)(2008-7#1)
safety of this drug##2##4##(2008-11#2)
safety of this##6##3##(1992-2#1)(1997-3#2)(2008-11#2)(2008-5#1)
safety of##135##2##(1990-11#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-9#2)(1997-3#3)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#5)(2009-10#2)(2009-5#1)(2009-7#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#14)(2013-8#4)
safety officers##2##2##(1993-3#1)(2007-4#1)
safety practices##3##2##(1996-5#1)(2008-9#1)(2013-1#1)
safety precautions##3##2##(1993-2#1)(1996-3#1)(2007-7#1)
safety procedures##2##2##(2008-4#1)(2012-2#1)
safety profile and##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
safety profile in##2##3##(2008-11#1)(2012-2#1)
safety profile of##8##3##(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2010-5#1)
safety profile##30##2##(1996-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#7)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
safety profiles##2##2##(2007-9#1)(2008-5#1)
safety program##4##2##(1991-12#1)(1994-12#1)(1995-2#1)(2008-12#1)
safety programs##3##2##(1993-3#1)(1994-12#1)(1995-1#1)
safety record##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
safety risk##2##2##(2008-9#1)(2011-2#1)
safety signals##2##2##(2008-8#1)(2013-1#1)
safety solutions##2##2##(2007-10#1)(2012-2#1)
safety standards##5##2##(1993-3#3)(1994-5#1)(2008-10#1)
safety studies##3##2##(2007-2#1)(2012-2#2)
safety system##4##2##(2007-8#1)(2008-3#1)(2011-1#1)(2013-1#1)
safety testing##5##2##(1992-3#2)(2008-5#2)(2010-11#1)
safety to##4##2##(1995-8#1)(2008-12#1)(2008-8#1)(2011-2#1)
safety was##2##2##(2012-12#2)
safety##736##1##(1990-11#3)(1990-12#2)(1990-3#2)(1990-6#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#5)(1991-6#3)(1992-11#1)(1992-2#4)(1992-3#7)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#8)(1993-3#12)(1993-6#1)(1994-12#4)(1994-3#5)(1994-5#5)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#7)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#9)(1996-5#3)(1996-9#2)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-10#8)(2007-11#5)(2007-12#11)(2007-2#6)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#39)(2008-11#48)(2008-12#16)(2008-2#5)(2008-3#7)(2008-4#14)(2008-5#22)(2008-6#11)(2008-7#29)(2008-8#42)(2008-9#19)(2009-10#15)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-9#1)(2010-10#1)(2010-11#12)(2010-12#11)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#9)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#15)(2011-2#54)(2011-3#2)(2012-1#2)(2012-12#27)(2012-2#25)(2012-3#23)(2013-1#52)(2013-8#10)
safety?##2##1##(2008-3#1)(2012-12#1)
safflower oil##2##2##(1992-5#1)(2013-1#1)
safflower seedlings##2##2##(2008-10#2)
safflower##9##1##(1992-5#1)(2008-10#4)(2008-12#2)(2008-5#1)(2013-1#1)
saffron##6##1##(2008-10#4)(2008-12#2)
safranal##4##1##(2008-10#4)
safranin##2##1##(2008-9#1)(2012-3#1)
safranine##2##1##(2008-10#2)
safrole##2##1##(1992-11#1)(1996-2#1)
sag score##2##2##(2008-5#2)
sag treatment lotion##3##3##(2008-5#3)
sag##14##1##(2008-5#10)(2012-2#4)
saga of##2##2##(1991-2#1)(2011-2#1)
saga##4##1##(1990-6#1)(1991-2#1)(1991-6#1)(2011-2#1)
sagging in the cheeks##2##4##(2008-5#2)
sagging in the##3##3##(2008-5#3)
sagging##12##1##(2008-5#11)(2010-8#1)
sagitta##4##1##(2008-3#1)(2013-7#3)
sagittal alignment##2##2##(2013-1#1)(2013-8#1)
sagittal and##6##2##(1995-5#1)(1997-6#1)(2008-3#1)(2009-4#1)(2010-3#1)(2012-2#1)
sagittal balance in the##2##4##(2008-8#1)(2013-8#1)
sagittal plane##11##2##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-9#1)(2011-2#1)(2012-1#2)(2013-1#1)
sagittal sinus pressure##2##3##(1993-1#2)
sagittal sinus##9##2##(1993-1#2)(1997-3#3)(2007-10#1)(2008-7#1)(2013-8#2)
sagittal tomogram##2##2##(2008-2#2)
sagittal##46##1##(1993-1#2)(1993-3#1)(1995-12#1)(1995-5#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#4)(2013-8#5)
said and##2##2##(2007-8#1)(2012-3#1)
said he##3##2##(1995-12#1)(1996-5#1)(2008-10#1)
said it##2##2##(1993-3#1)(1995-6#1)
said that the##2##3##(1990-2#1)(2009-3#1)
said that they##2##3##(1996-1#1)(2013-8#1)
said that##19##2##(1990-2#1)(1992-4#1)(1993-3#1)(1996-1#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
said the##4##2##(1992-8#1)(1995-6#1)(1997-5#1)(2010-12#1)
said they had##2##3##(1994-3#1)(2013-8#1)
said they##3##2##(1994-3#1)(2008-9#1)(2013-8#1)
said to be##6##3##(1993-9#1)(1996-6#1)(1997-8#1)(2008-7#1)(2009-4#1)(2013-8#1)
said to have##2##3##(1995-6#1)(2013-8#1)
said to##9##2##(1993-9#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-8#1)(2008-7#1)(2009-4#1)(2013-8#2)
said##75##1##(1990-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#6)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-5#3)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-8#4)
saikogenin E##3##2##(2008-11#3)
saikosaponin c was##3##3##(2008-11#3)
saikosaponin c##5##2##(2008-11#5)
saimiri##6##1##(1991-6#4)(2008-4#2)
saitoana to##2##2##(2008-10#2)
saitoana##15##1##(2008-10#15)
sake at 2 x 10(6) CFU ml(-1)##2##7##(2008-10#2)
sake at 2 x 10(6)##3##5##(2008-10#3)
sake at 2 x##4##4##(2008-10#4)
sake of##8##2##(1994-12#1)(2008-10#4)(2008-12#1)(2009-6#1)(2013-8#1)
sake##24##1##(1994-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2009-6#1)(2011-1#1)(2013-8#1)
salIM##2##1##(1994-12#2)
salIR##2##1##(1994-12#2)
salad##2##1##(1997-4#2)
salamander and##2##2##(2008-5#2)
salamander##5##1##(2008-5#2)(2008-7#1)(2012-12#2)
salar L##3##2##(2008-7#1)(2009-6#1)(2013-1#1)
salar##4##1##(2008-7#1)(2009-6#1)(2013-1#2)
salaried##3##1##(1991-12#1)(2010-9#1)(2011-2#1)
salaries##16##1##(1991-1#2)(1991-2#2)(1991-3#2)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(2007-4#2)(2007-8#1)(2008-1#1)
salaris##3##1##(2013-1#3)
salary and satisfaction##2##3##(1991-3#1)(1993-3#1)
salary and##4##2##(1991-12#1)(1991-3#1)(1993-3#1)(2012-12#1)
salary increase##2##2##(1995-3#2)
salary is##3##2##(1995-3#3)
salary level##2##2##(1991-12#1)(2013-1#1)
salary or##2##2##(1993-3#1)(1997-2#1)
salary survey##5##2##(1991-12#2)(1991-3#1)(1995-1#1)(1995-3#1)
salary##39##1##(1990-9#1)(1991-1#1)(1991-12#7)(1991-3#4)(1992-6#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#10)(1997-2#2)(2008-12#1)(2008-9#1)(2012-12#3)(2013-1#1)
salbutamol and##2##2##(1990-9#1)(2008-10#1)
salbutamol sulfate##2##2##(2008-10#2)
salbutamol was##2##2##(2008-10#1)(2013-1#1)
salbutamol##32##1##(1990-9#1)(1994-12#1)(1996-1#5)(1996-12#1)(1996-2#2)(2007-2#1)(2008-10#15)(2008-11#2)(2011-1#1)(2013-1#3)
sale of##10##2##(1990-4#1)(1992-11#1)(1992-8#1)(1996-11#2)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)
sale##15##1##(1990-4#2)(1992-11#1)(1992-8#1)(1993-8#1)(1994-6#1)(1996-11#2)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)
sales and##2##2##(1991-5#1)(1994-2#1)
sales in##2##2##(2008-1#1)(2008-5#1)
sales##18##1##(1991-5#1)(1992-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#3)(2008-5#3)(2009-7#1)(2010-5#1)
salexigens flavodoxin and##2##3##(1994-5#2)
salicyl fluorones##2##2##(2008-10#2)
salicylaldehyde thiosemicarbazone##5##2##(2008-10#5)
salicylaldehyde##8##1##(2008-10#8)
salicylamide##3##1##(2008-10#3)
salicylate (SA)##2##2##(2008-10#2)
salicylate and iodide##2##3##(2008-10#2)
salicylate and##4##2##(2008-10#4)
salicylate hydroxylase##3##2##(2008-10#3)
salicylate in##4##2##(2008-10#4)
salicylate ions##2##2##(2008-10#2)
salicylate##42##1##(1993-12#3)(1997-8#1)(2008-10#30)(2008-5#8)
salicylate) (CAS RN##2##3##(2008-5#2)
salicylates##4##1##(1991-8#1)(1993-11#1)(1996-3#1)(2008-10#1)
salicylic Acid##2##2##(2008-10#2)
salicylic acid (SA) and##2##4##(2008-10#1)(2009-8#1)
salicylic acid (SA) in##2##4##(2008-10#1)(2009-8#1)
salicylic acid (SA)##10##3##(2008-10#8)(2009-8#2)
salicylic acid and acetylsalicylic acid##2##5##(2008-10#2)
salicylic acid and##10##3##(1993-11#3)(2008-10#7)
salicylic acid in##4##3##(2008-10#3)(2008-5#1)
salicylic acid with##2##3##(2008-5#2)
salicylic acid##61##2##(1993-11#5)(1995-5#1)(2008-10#41)(2008-5#10)(2008-8#1)(2009-8#2)(2011-10#1)
salicylic acid-dependent##2##2##(2008-10#1)(2009-6#1)
salicylic and##2##2##(2008-10#1)(2008-5#1)
salicylic##72##1##(1990-8#1)(1993-11#5)(1995-5#1)(2008-10#47)(2008-5#13)(2008-8#1)(2009-6#1)(2009-8#2)(2011-10#1)
salience of exercise##2##3##(2007-6#2)
salience of##4##2##(1997-3#1)(2007-6#2)(2011-1#1)
salience##5##1##(1997-3#2)(2007-6#2)(2011-1#1)
saliency##2##1##(2008-11#2)
salient feature of##2##3##(1993-2#1)(2010-5#1)
salient features of the##3##4##(1993-8#1)(2009-11#2)
salient features of##5##3##(1993-8#1)(2007-12#1)(2008-2#1)(2009-11#2)
salient features##8##2##(1993-8#1)(1994-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-11#2)(2010-5#1)
salient results##2##2##(1994-1#1)(2008-7#1)
salient themes##2##2##(1993-3#1)(2013-1#1)
salient##35##1##(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-8#1)(1995-3#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2009-11#3)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
salina 1650##3##2##(2008-6#3)
salina##7##1##(2007-12#4)(2008-6#3)
saline (0##3##2##(1997-4#1)(2011-2#1)(2012-3#1)
saline (n =##3##3##(1996-5#1)(2010-6#1)(2012-3#1)
saline and the##2##3##(2007-10#1)(2008-11#1)
saline and##8##2##(1993-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
saline are##3##2##(2007-7#1)(2010-12#1)(2012-3#1)
saline concentrates for hemodialysis##2##4##(2008-10#2)
saline conditions##2##2##(2008-10#1)(2013-1#1)
saline containing 0##2##3##(2008-10#1)(2009-9#1)
saline controls##3##2##(1995-12#2)(2010-5#1)
saline for##3##2##(1992-11#1)(2011-2#2)
saline in##4##2##(1993-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
saline into the##4##3##(1993-10#3)(2008-7#1)
saline is##2##2##(1997-1#1)(2010-1#1)
saline matrices##6##2##(2008-10#6)
saline matrix##4##2##(2008-10#4)
saline media##4##2##(2008-10#3)(2008-3#1)
saline or##12##2##(1993-1#1)(1993-12#1)(1994-2#2)(1995-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2013-8#2)
saline samples##2##2##(2008-10#2)
saline soil##2##2##(2009-8#1)(2011-2#1)
saline solution##8##2##(1994-9#1)(2008-10#3)(2008-5#2)(2009-6#1)(2010-12#1)
saline solutions##5##2##(2008-10#4)(2012-2#1)
saline using a##2##3##(1991-12#1)(1995-3#1)
saline using##3##2##(1991-12#1)(1993-12#1)(1995-3#1)
saline vehicle##3##2##(1994-8#1)(2011-2#1)(2013-1#1)
saline was##2##2##(1994-2#1)(2013-1#1)
saline water##13##2##(2008-10#10)(2008-12#1)(2012-5#2)
saline waters##2##2##(2008-10#2)
saline##196##1##(1990-7#2)(1991-12#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-1#2)(1993-10#4)(1993-12#6)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#5)(1994-5#1)(1994-8#5)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-7#1)(2007-10#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#55)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#2)(2013-1#8)(2013-8#5)
saline)##6##1##(1995-5#1)(2008-12#1)(2008-4#2)(2008-9#1)(2012-12#1)
saline-instilled##2##1##(2008-10#2)
saline-stressed plants##2##2##(2013-1#2)
saline-treated##5##1##(1994-6#1)(1995-12#3)(1997-4#1)
salinities##7##1##(2008-10#1)(2008-5#4)(2008-7#1)(2012-2#1)
salinity and alkalinity##2##3##(2013-8#2)
salinity and temperature##2##3##(2008-2#1)(2011-2#1)
salinity and temperatures##2##3##(2013-7#2)
salinity and##13##2##(2008-10#1)(2008-2#1)(2008-5#4)(2011-2#1)(2013-1#1)(2013-7#3)(2013-8#2)
salinity level##2##2##(2008-12#1)(2013-1#1)
salinity of##3##2##(2007-5#1)(2008-3#2)
salinity on the##2##3##(2008-10#1)(2008-5#1)
salinity stress##2##2##(2008-11#1)(2008-8#1)
salinity substrate##2##2##(2013-1#2)
salinity tolerance##5##2##(1992-8#1)(2008-12#2)(2011-1#1)(2012-5#1)
salinity##52##1##(1992-8#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#7)(2008-2#3)(2008-3#2)(2008-5#8)(2008-8#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-5#2)(2013-1#6)(2013-7#5)(2013-8#2)
salinized##3##1##(2008-11#1)(2008-12#2)
salinomycin and narasin##2##3##(2007-6#2)
salinomycin##6##1##(2007-6#6)
saliva and urine samples##2##4##(2008-10#2)
saliva and urine##3##3##(2008-10#2)(2009-9#1)
saliva and##9##2##(2008-10#3)(2008-11#1)(2008-12#3)(2009-9#1)(2013-8#1)
saliva by capillary isotachophoresis##2##4##(2008-10#2)
saliva by##3##2##(2008-10#3)
saliva for##2##2##(2008-10#2)
saliva in##2##2##(2008-10#1)(2009-6#1)
saliva of##4##2##(1991-8#1)(2008-10#1)(2008-12#1)(2010-12#1)
saliva osmolality##2##2##(2013-8#2)
saliva production##3##2##(2007-11#3)
saliva samples##8##2##(2008-10#4)(2012-3#3)(2013-1#1)
saliva##82##1##(1990-5#1)(1991-1#1)(1991-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-11#3)(2008-10#36)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#3)(2012-3#6)(2013-1#3)(2013-8#6)
saliva-saliva##2##1##(2008-12#2)
salivarius##2##1##(2008-5#2)
salivary IgA##2##2##(2013-8#2)
salivary bacteria##2##2##(2010-5#2)
salivary biomarkers##2##2##(2010-12#2)
salivary duct##2##2##(2007-12#1)(2008-10#1)
salivary flow##2##2##(2006-10#2)
salivary gland cells##5##3##(2008-10#2)(2008-11#1)(2011-2#2)
salivary gland is##3##3##(1994-7#1)(2009-3#1)(2012-2#1)
salivary gland neoplasm##2##3##(2008-8#1)(2013-1#1)
salivary gland of Chironomus##3##4##(2008-11#3)
salivary gland of the##5##4##(2008-4#3)(2013-1#2)
salivary gland of##8##3##(2008-11#3)(2008-4#3)(2013-1#2)
salivary gland tissue##2##3##(1991-11#1)(2007-11#1)
salivary gland tumours##4##3##(2012-2#4)
salivary gland##48##2##(1990-5#3)(1991-11#1)(1993-9#1)(1994-7#2)(1995-11#3)(1995-8#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#5)(2008-11#4)(2008-4#3)(2008-8#2)(2009-1#1)(2009-3#2)(2011-2#4)(2012-2#5)(2013-1#4)(2013-8#1)
salivary glands and##4##3##(1994-7#1)(2008-10#2)(2011-2#1)
salivary glands in##2##3##(2008-4#1)(2013-1#1)
salivary glands of the##2##4##(1991-11#1)(2013-1#1)
salivary glands of##13##3##(1990-11#2)(1991-11#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
salivary glands##57##2##(1990-11#3)(1990-12#1)(1990-6#2)(1991-11#1)(1994-5#1)(1994-7#5)(2007-12#3)(2007-5#1)(2008-10#23)(2008-4#5)(2008-8#2)(2011-1#2)(2011-2#6)(2013-1#2)
salivary immunoglobulin A##2##3##(2013-1#1)(2013-8#1)
salivary mesenchyme##3##2##(1991-2#3)
salivary α-amylase##2##2##(2013-8#2)
salivary##155##1##(1990-11#3)(1990-12#4)(1990-5#3)(1990-6#3)(1991-11#2)(1991-2#3)(1993-12#4)(1993-9#1)(1994-12#3)(1994-5#1)(1994-7#7)(1995-11#3)(1995-8#1)(1997-5#1)(2006-10#2)(2007-11#2)(2007-12#7)(2007-5#2)(2008-10#34)(2008-11#4)(2008-4#9)(2008-8#4)(2009-1#1)(2009-3#2)(2009-6#1)(2010-12#4)(2010-5#3)(2011-1#4)(2011-2#11)(2012-2#5)(2013-1#11)(2013-8#10)
salivas have##2##2##(2008-10#2)
salivas##3##1##(2008-10#3)
salivation##4##1##(2008-10#3)(2008-7#1)
salmeterol and fluticasone propionate (FP)##2##5##(1996-2#2)
salmeterol and##4##2##(1996-1#2)(1996-2#2)
salmeterol##9##1##(1996-1#4)(1996-2#4)(2008-10#1)
salmon (O##2##2##(2008-11#1)(2008-5#1)
salmon (Oncorhynchus nerka)##2##3##(1995-11#1)(2008-5#1)
salmon (Oncorhynchus##3##2##(1993-3#1)(1995-11#1)(2008-5#1)
salmon GnRH##2##2##(1994-8#1)(1995-11#1)
salmon Oncorhynchus nerka##2##3##(2010-8#2)
salmon calcitonin##6##2##(1990-12#1)(1993-11#4)(1997-4#1)
salmon egg cell cytoplasm was diluted five-fold with 0##2##9##(2008-10#2)
salmon egg cell cytoplasm was##3##5##(2008-10#3)
salmon egg cell cytoplasm##5##4##(2008-10#5)
salmon genome##2##2##(1993-3#2)
salmon population##2##2##(2008-8#1)(2013-1#1)
salmon##53##1##(1990-12#4)(1991-8#1)(1992-6#3)(1992-9#1)(1993-11#4)(1993-3#4)(1994-7#2)(1994-8#1)(1995-11#5)(1997-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#3)(2008-8#4)(2009-6#4)(2010-8#2)(2013-1#3)
salmonella aortitis in a##2##4##(2007-7#2)
salmonella aortitis##3##2##(2007-7#3)
salmonella was##3##2##(1997-3#2)(2007-7#1)
salmonella##11##1##(1993-8#1)(1995-9#1)(1997-3#4)(2007-7#5)
salmonellosis##4##1##(1991-3#1)(1993-8#1)(1997-3#2)
salmonid##5##1##(1995-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
salmonids##8##1##(2008-10#3)(2008-5#1)(2008-7#2)(2009-6#2)
salmoninarum##6##1##(2009-6#6)
salpingectomy##3##1##(1991-3#1)(1993-12#1)(2010-12#1)
salpingitis##6##1##(1994-2#3)(1994-9#1)(1997-6#2)
salpingo-oophorectomy##3##1##(2012-3#1)(2013-8#2)
salpingostomy##2##1##(1993-12#1)(1993-3#1)
salsalate in##4##2##(2008-10#4)
salsalate##7##1##(2008-10#7)
salt 4-N##2##2##(2007-12#2)
salt and sodium##2##3##(2008-10#1)(2008-4#1)
salt and##24##2##(1995-6#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2012-2#1)
salt as##2##2##(2008-10#1)(2010-3#1)
salt bridge##6##2##(1990-8#1)(2008-10#3)(2008-4#1)(2008-8#1)
salt buffer##3##2##(1995-6#3)
salt by##2##2##(2008-10#2)
salt can##2##2##(1990-6#1)(2008-10#1)
salt concentration and##2##3##(1990-5#1)(2009-12#1)
salt concentration##9##2##(1990-5#1)(1990-7#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-12#1)
salt concentrations##13##2##(1990-12#1)(1990-2#1)(1990-5#1)(1995-5#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#1)
salt conditions##2##2##(2009-8#1)(2013-1#1)
salt content##5##2##(1996-5#1)(2008-10#4)
salt effects on##2##3##(2009-10#1)(2012-2#1)
salt intake##2##2##(2008-1#1)(2012-12#1)
salt iodization##2##2##(2007-11#2)
salt is##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
salt linkages##2##2##(1990-8#1)(1997-2#1)
salt of the##2##3##(2008-10#2)
salt of##19##2##(1991-11#1)(1992-9#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#11)(2011-2#1)(2012-2#1)
salt on the##2##3##(2008-5#1)(2010-4#1)
salt or##2##2##(2008-2#1)(2008-5#1)
salt programs##2##2##(2007-11#2)
salt solution##4##2##(1997-2#1)(2010-3#1)(2010-8#1)(2013-1#1)
salt solutions##8##2##(2008-10#5)(2009-10#1)(2009-12#1)(2012-3#1)
salt stress and nonstress##2##4##(2008-9#2)
salt stress in##2##3##(2008-11#1)(2009-8#1)
salt stress responses in Arabidopsis##2##5##(1997-8#2)
salt stress##21##2##(1997-7#1)(1997-8#3)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#5)(2009-8#7)
salt stress-inducible ESTs##2##3##(1997-8#2)
salt technique##2##2##(2013-1#2)
salt tolerance in##2##3##(2008-9#2)
salt tolerance##6##2##(2008-12#1)(2008-9#4)(2011-2#1)
salt tolerant##8##2##(2008-12#7)(2013-1#1)
salt was##4##2##(2008-10#3)(2008-5#1)
salt##306##1##(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-6#1)(1991-9#1)(1992-9#2)(1993-6#2)(1993-8#3)(1994-11#1)(1995-11#3)(1995-3#4)(1995-5#2)(1995-6#6)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#10)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#6)(2007-11#10)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#105)(2008-11#8)(2008-12#12)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#22)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#13)(2009-10#2)(2009-12#2)(2009-8#8)(2009-9#1)(2010-3#3)(2010-4#5)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
salt) and##2##2##(2008-10#2)
salt)##7##1##(2008-10#7)
salt-bridge##3##1##(1992-8#1)(1996-7#2)
salt-free shampoo##2##2##(2008-5#2)
salt-free##5##1##(2008-5#4)(2009-11#1)
salt-relief##2##1##(2008-5#2)
salt-stress##2##1##(2008-9#1)(2009-8#1)
salt-stressed barley##2##2##(2008-9#2)
salt-tolerant##2##1##(2008-8#1)(2009-8#1)
saltation##2##1##(2012-3#2)
salted out##2##2##(1990-5#2)
salted##4##1##(1990-5#2)(1992-10#1)(2008-10#1)
salting out##2##2##(2008-10#1)(2013-1#1)
salting##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
salting-out##7##1##(1990-5#3)(2008-10#4)
salts and##7##2##(2008-10#4)(2008-12#1)(2008-6#1)(2011-2#1)
salts are##4##2##(2008-10#2)(2008-11#1)(2009-8#1)
salts as##4##2##(1990-8#1)(2007-11#1)(2008-10#1)(2010-6#1)
salts at different##2##3##(1992-5#1)(2008-10#1)
salts at##4##2##(1992-5#1)(2008-10#2)(2011-2#1)
salts do##2##2##(2008-10#1)(2009-10#1)
salts have##3##2##(1995-3#1)(1996-5#1)(2008-10#1)
salts in solution##2##3##(2008-10#2)
salts in##7##2##(1990-11#1)(2008-10#5)(2008-5#1)
salts medium##4##2##(2008-10#1)(2008-6#3)
salts of the##3##3##(1995-3#1)(1995-5#1)(1997-2#1)
salts of##14##2##(1992-9#1)(1993-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#1)
salts on the##2##3##(1994-5#1)(2008-10#1)
salts on##3##2##(1994-5#1)(2008-10#1)(2009-10#1)
salts such as##3##3##(2006-4#1)(2008-10#2)
salts to##2##2##(1992-8#1)(2008-11#1)
salts upon##2##2##(2008-10#2)
salts was##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
salts were##4##2##(1995-3#1)(2007-11#1)(2009-8#1)(2010-4#1)
salts with##3##2##(2007-11#1)(2008-10#1)(2009-8#1)
salts##155##1##(1990-11#1)(1990-5#2)(1990-8#3)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-5#4)(1995-3#6)(1995-5#3)(1996-2#1)(1996-5#2)(1997-2#4)(2006-4#1)(2007-11#9)(2008-10#71)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#3)(2009-10#2)(2009-2#2)(2009-8#3)(2010-4#1)(2010-6#1)(2011-2#5)(2012-3#3)(2012-7#1)(2013-1#1)
salts)##3##1##(1997-5#1)(2008-11#1)(2011-1#1)
saltworks##2##1##(2008-5#2)
salutary##4##1##(1994-3#1)(1997-7#1)(2013-1#1)(2013-8#1)
salvage by##3##2##(2008-4#1)(2008-6#1)(2011-3#1)
salvage chemotherapy in heavily pretreated##2##5##(1992-2#2)
salvage chemotherapy in##3##3##(1992-2#3)
salvage chemotherapy##6##2##(1992-2#3)(2007-10#1)(2008-1#1)(2008-6#1)
salvage in##2##2##(2011-2#1)(2012-3#1)
salvage is##3##2##(2008-4#1)(2010-3#1)(2011-1#1)
salvage mastectomy##2##2##(2013-1#2)
salvage of##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
salvage resection##2##2##(2012-3#2)
salvage surgery##4##2##(1990-12#1)(1990-6#1)(2008-8#1)(2010-3#1)
salvage therapy##5##2##(2007-10#1)(2008-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
salvage treatment##2##2##(1991-6#1)(2010-3#1)
salvage was##3##2##(1991-8#1)(2010-3#1)(2011-2#1)
salvage##65##1##(1990-12#1)(1990-6#3)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#3)(1992-8#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-4#2)(2008-6#8)(2008-8#1)(2008-9#3)(2009-1#2)(2009-5#1)(2010-3#7)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)
salvaged##3##1##(1997-5#1)(2008-9#1)(2011-1#1)
salvaging##2##1##(2008-2#1)(2012-2#1)
salvation##2##1##(2008-4#1)(2009-11#1)
salvational process##2##2##(2009-11#2)
salvianolic acid##2##2##(2008-10#2)
salvianolic acids from##2##3##(2008-10#2)
salvianolic acids##4##2##(2008-10#4)
salvianolic##6##1##(2008-10#6)
samarium hydroxide##3##2##(2008-10#3)
samarium iodide##3##2##(2008-10#3)
samarium##15##1##(2007-11#1)(2008-10#13)(2012-2#1)
samarium(III)##2##1##(2008-10#2)
samarium-cobalt magnet##3##2##(2008-10#3)
sambucinum##3##1##(2008-10#3)
same VCG##2##2##(2008-10#2)
same active##2##2##(2008-10#1)(2008-5#1)
same affinity##2##2##(1990-11#1)(2008-10#1)
same age and sex##3##4##(1990-11#1)(1991-11#1)(2008-7#1)
same age and##5##3##(1990-11#1)(1991-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
same age control plants at 14##2##6##(2008-10#2)
same age control##3##3##(2008-10#3)
same age##26##2##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-9#1)(1995-9#1)(1996-6#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
same amount of##8##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
same amount##11##2##(1990-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
same animals were##2##3##(1993-3#1)(1993-6#1)
same animals##3##2##(1993-12#1)(1993-3#1)(1993-6#1)
same antibody##4##2##(1993-11#1)(1997-2#1)(2007-12#1)(2008-7#1)
same approach##5##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
same as##78##2##(1990-12#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-1#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)
same bacterial##2##2##(2008-10#1)(2011-2#1)
same behavior##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
same cell##15##2##(1990-12#1)(1992-9#1)(1993-6#1)(1995-8#1)(2008-10#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-12#1)(2013-1#1)(2013-8#1)
same cells were##2##3##(1992-12#1)(1996-5#1)
same cells##8##2##(1990-8#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-5#1)(2008-11#1)(2008-4#1)(2013-1#1)
same characteristics##3##2##(1994-9#1)(2008-5#1)(2013-1#1)
same compounds##6##2##(1991-5#1)(1992-5#1)(2008-10#2)(2008-4#2)
same condition##4##2##(1991-5#1)(1994-9#1)(2006-10#1)(2013-1#1)
same conditions##36##2##(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#2)
same constant##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
same day##11##2##(1995-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
same developmental##5##2##(1994-12#1)(1995-2#1)(2007-12#2)(2008-9#1)
same device##2##2##(2008-3#1)(2008-5#1)
same dimensions##2##2##(1992-2#1)(2007-11#1)
same dose of##5##3##(1994-8#1)(1995-3#1)(1997-4#1)(2008-5#1)(2012-3#1)
same dose##11##2##(1992-5#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-5#1)(2008-6#1)(2010-11#1)(2012-3#1)
same doses of##3##3##(1991-2#1)(1995-12#1)(2008-10#1)
same doses##7##2##(1991-2#1)(1995-12#1)(2008-10#1)(2008-8#1)(2008-9#3)
same effect##8##2##(1991-5#1)(1995-1#1)(1995-12#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)
same effects##3##2##(1990-2#1)(2008-10#1)(2008-2#1)
same enzyme##5##2##(1990-11#1)(1990-12#1)(1994-8#1)(1995-6#1)(2008-11#1)
same experimental conditions##10##3##(1990-8#1)(1995-12#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)
same experimental##16##2##(1990-8#1)(1995-12#2)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2013-8#1)
same experiments##2##2##(2008-10#1)(2008-3#1)
same factors##3##2##(2007-12#1)(2008-3#1)(2009-11#1)
same four##3##2##(1997-5#1)(2008-10#2)
same functional##2##2##(1992-6#1)(2008-2#1)
same gender sexual partners##3##4##(2011-1#3)
same gender##4##2##(2008-9#1)(2011-1#3)
same gene##14##2##(1990-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-8#1)(2007-12#1)(2008-10#6)(2012-3#1)
same general##3##2##(1997-5#1)(2008-10#1)(2009-12#1)
same group##11##2##(1993-8#1)(1995-4#1)(1997-6#1)(2008-10#3)(2008-6#1)(2010-11#1)(2011-2#1)(2013-8#2)
same grouping##2##2##(2008-10#1)(2008-5#1)
same groups of##3##3##(1991-2#1)(2008-10#2)
same high##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)
same host##8##2##(1997-3#1)(2008-10#5)(2008-6#1)(2008-9#1)
same in both##6##3##(1991-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(2008-11#1)(2012-12#1)
same in##26##2##(1991-11#1)(1991-2#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
same input##2##2##(2008-10#1)(2008-11#1)
same is##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
same location##10##2##(2008-10#4)(2008-2#2)(2008-3#3)(2011-1#1)
same locus##7##2##(1997-7#1)(1997-8#1)(2008-10#4)(2008-7#1)
same mapping population##2##3##(2008-10#1)(2008-5#1)
same mechanisms##3##2##(2007-12#1)(2010-10#1)(2010-5#1)
same medium##5##2##(1992-6#1)(2008-10#2)(2008-11#1)(2011-1#1)
same method##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
same mode##3##2##(1992-5#1)(2008-9#1)(2013-1#1)
same moisturizer##3##2##(2008-5#3)
same month##2##2##(2008-5#1)(2008-6#1)
same mouse##2##2##(1995-2#1)(2008-10#1)
same mutation##3##2##(1993-6#1)(1994-11#1)(2008-10#1)
same nerve##3##2##(2008-5#1)(2008-6#1)(2008-7#1)
same or different##2##3##(2008-12#1)(2008-6#1)
same or##16##2##(1991-2#1)(1993-1#1)(1996-2#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2011-2#1)(2013-1#1)
same organism##5##2##(1993-6#1)(1997-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
same patients##8##2##(1991-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
same pattern of response##2##4##(1990-6#1)(2008-10#1)
same pattern of##4##3##(1990-6#1)(1995-12#1)(2008-10#1)(2008-11#1)
same pattern##15##2##(1990-6#1)(1991-12#1)(1994-9#1)(1995-12#2)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-8#1)
same patterns##2##2##(2008-11#1)(2008-7#1)
same period##29##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-8#1)(1992-6#2)(1995-1#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
same plane##4##2##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
same population##13##2##(1992-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-8#1)(2012-12#1)
same populations##2##2##(2008-9#1)(2011-2#1)
same primer##2##2##(1992-2#1)(2008-10#1)
same procedure was##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
same procedure##9##2##(1993-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#2)(2008-8#1)(2009-6#1)(2012-12#1)
same procedures##3##2##(1996-12#1)(2008-5#1)(2008-9#1)
same rats##4##2##(1993-12#1)(1993-3#1)(1993-6#2)
same region of the##3##4##(1990-12#1)(1994-12#1)(1994-8#1)
same region of##5##3##(1990-12#1)(1992-11#1)(1994-12#1)(1994-8#1)(2008-1#1)
same region##14##2##(1990-12#1)(1991-3#1)(1992-11#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(2008-1#1)(2008-10#4)(2011-1#1)
same result##2##2##(1990-11#1)(1994-11#1)
same results##11##2##(1990-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-6#1)(2012-2#2)(2013-7#1)
same rules##2##2##(1997-2#1)(1997-3#1)
same sample##15##2##(1995-5#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#1)
same samples##11##2##(1993-6#1)(2008-10#9)(2008-3#1)
same set of##9##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2009-11#1)
same sex##6##2##(1994-5#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-1#1)
same side##7##2##(1991-9#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
same site##20##2##(1990-5#3)(1992-5#1)(1993-11#1)(1995-12#1)(1995-5#3)(2007-6#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
same size##12##2##(1992-9#1)(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)(2013-8#1)
same specificity##2##2##(1990-5#1)(2008-10#1)
same step##2##2##(2008-10#2)
same substitution##2##2##(1991-7#1)(1993-3#1)
same system is##2##3##(1996-1#1)(2008-10#1)
same system##7##2##(1996-1#1)(2008-10#3)(2008-2#1)(2010-5#1)(2012-2#1)
same technology##2##2##(2008-10#1)(2008-7#1)
same thickness and##2##3##(2007-11#2)
same thickness##4##2##(2006-6#1)(2007-11#2)(2007-12#1)
same three##3##2##(2008-10#3)
same time period##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
same time##178##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#6)(2008-5#8)(2008-6#4)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
same treatment##12##2##(1993-6#1)(1994-6#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2012-3#1)(2013-8#1)
same volume of##3##3##(1990-7#1)(2012-3#2)
same volume##6##2##(1990-7#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-3#2)
same was found##2##3##(2008-10#1)(2011-2#1)
same was##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
same wave-front##2##2##(2008-3#2)
same way##29##2##(1990-8#1)(1991-9#2)(1993-3#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#1)
same wheat##3##2##(2008-10#2)(2008-9#1)
same year##6##2##(1990-10#1)(1991-2#1)(2008-1#1)(2008-10#2)(2008-8#1)
same##2581##1##(1990-10#3)(1990-11#12)(1990-12#14)(1990-2#14)(1990-3#3)(1990-4#2)(1990-5#20)(1990-6#7)(1990-7#5)(1990-8#8)(1990-9#2)(1991-10#2)(1991-11#5)(1991-12#17)(1991-2#12)(1991-3#8)(1991-4#2)(1991-5#14)(1991-6#4)(1991-7#1)(1991-8#9)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#11)(1992-12#10)(1992-2#10)(1992-3#10)(1992-4#2)(1992-5#6)(1992-6#23)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#3)(1993-11#10)(1993-12#16)(1993-2#4)(1993-3#12)(1993-5#1)(1993-6#22)(1993-8#15)(1993-9#7)(1994-1#6)(1994-10#3)(1994-11#12)(1994-12#22)(1994-2#10)(1994-3#13)(1994-5#10)(1994-6#8)(1994-7#2)(1994-8#20)(1994-9#7)(1995-1#8)(1995-11#13)(1995-12#22)(1995-2#25)(1995-3#16)(1995-4#2)(1995-5#26)(1995-6#18)(1995-8#11)(1995-9#4)(1996-1#6)(1996-11#3)(1996-12#10)(1996-2#14)(1996-3#11)(1996-5#9)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#16)(1997-3#11)(1997-4#13)(1997-5#4)(1997-6#17)(1997-7#12)(1997-8#11)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#11)(2007-11#46)(2007-12#52)(2007-5#2)(2007-6#4)(2007-7#10)(2007-8#12)(2007-9#2)(2008-1#25)(2008-10#571)(2008-11#101)(2008-12#27)(2008-2#68)(2008-3#126)(2008-4#23)(2008-5#87)(2008-6#34)(2008-7#72)(2008-8#77)(2008-9#60)(2009-1#4)(2009-10#13)(2009-11#7)(2009-12#8)(2009-3#2)(2009-4#3)(2009-5#9)(2009-6#11)(2009-7#6)(2009-8#11)(2009-9#6)(2010-1#5)(2010-10#5)(2010-11#5)(2010-12#9)(2010-2#4)(2010-3#9)(2010-4#8)(2010-5#9)(2010-6#2)(2010-7#8)(2010-8#11)(2010-9#1)(2011-1#29)(2011-2#55)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#23)(2012-2#32)(2012-3#27)(2012-4#2)(2013-1#40)(2013-7#3)(2013-8#32)
same-day##2##1##(2008-7#1)(2012-1#1)
same-ethnic##3##1##(2009-7#3)
same-sex helpers##2##2##(2008-9#2)
same-sex##6##1##(2008-12#2)(2008-8#1)(2008-9#2)(2010-7#1)
samfR gene##2##2##(2008-8#2)
samfR##4##1##(2008-8#4)
sample (100##2##2##(2008-10#2)
sample (N =##3##3##(2008-1#1)(2009-8#1)(2012-2#1)
sample (i##3##2##(2008-11#1)(2008-4#1)(2009-10#1)
sample (or##2##2##(2008-10#2)
sample Mueller matrix##2##3##(2008-2#2)
sample acidification##2##2##(2008-10#2)
sample acidity##3##2##(2008-10#3)
sample addition##4##2##(2008-10#4)
sample after the##2##3##(2008-10#2)
sample after##3##2##(2008-10#3)
sample aliquot##4##2##(2008-10#4)
sample aliquots##2##2##(2008-10#2)
sample amount##3##2##(2008-10#3)
sample amounts##2##2##(2008-10#2)
sample analysis and##2##3##(2008-10#2)
sample analysis were##2##3##(2008-10#2)
sample analysis##15##2##(2008-10#13)(2008-9#1)(2013-8#1)
sample and a##4##3##(2007-11#1)(2008-10#3)
sample and by##2##3##(2007-12#1)(2008-10#1)
sample and eluent##5##3##(2008-10#5)
sample and its##2##3##(2007-11#1)(2008-7#1)
sample and organic##2##3##(2008-10#2)
sample and reagent consumption##3##4##(2008-10#2)(2011-1#1)
sample and reagent volumes##2##4##(2008-10#2)
sample and reagent zones##2##4##(2008-10#2)
sample and reagent##15##3##(2008-10#14)(2011-1#1)
sample and reagents are##2##4##(2008-10#2)
sample and reagents##8##3##(2008-10#7)(2010-7#1)
sample and results##2##3##(2008-1#1)(2008-10#1)
sample and standard##2##3##(2008-10#1)(2008-4#1)
sample and the sample##3##4##(2008-10#3)
sample and the##19##3##(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#2)
sample and then##2##3##(2008-10#2)
sample and to##2##3##(2008-10#1)(2012-2#1)
sample and##126##2##(1992-6#1)(1995-12#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#97)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
sample and/or reagent##2##3##(2008-10#2)
sample and/or##6##2##(2008-10#5)(2008-12#1)
sample applications##2##2##(2008-10#1)(2008-2#1)
sample are separated##2##3##(1990-8#1)(2008-10#1)
sample are##10##2##(1990-8#1)(2008-10#5)(2008-2#2)(2008-3#2)
sample area##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
sample as##4##2##(1994-6#1)(2008-10#2)(2008-6#1)
sample aspiration##2##2##(2008-10#1)(2008-11#1)
sample at the##3##3##(2007-12#1)(2008-10#2)
sample at##13##2##(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)
sample before##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
sample blank##2##2##(2008-10#2)
sample breakthrough volume##2##3##(2008-10#2)
sample by means of##2##4##(2008-10#1)(2011-2#1)
sample by the##2##3##(2008-10#2)
sample by##14##2##(2007-12#1)(2008-10#12)(2011-2#1)
sample can be##8##3##(2008-10#6)(2008-2#1)(2008-4#1)
sample carryover##3##2##(2008-10#3)
sample cell##4##2##(2008-3#4)
sample characteristics##3##2##(2009-7#1)(2013-1#2)
sample clean-up##6##2##(1996-5#1)(1997-2#1)(2008-10#3)(2008-12#1)
sample cleanup and##2##3##(2008-10#2)
sample cleanup##7##2##(2008-10#7)
sample collected from##2##3##(2007-7#1)(2008-10#1)
sample collection in##2##3##(2008-10#1)(2013-8#1)
sample collection##17##2##(2008-10#14)(2010-11#1)(2010-4#1)(2013-8#1)
sample collections##2##2##(2008-10#1)(2010-8#1)
sample combustion##2##2##(2008-10#2)
sample compartment of a##2##4##(2008-10#2)
sample compartment of##3##3##(2008-10#2)(2008-3#1)
sample comprised##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
sample comprises##2##2##(1995-1#1)(2013-1#1)
sample concentration and##4##3##(2008-10#4)
sample concentration##11##2##(2008-1#1)(2008-10#9)(2008-4#1)
sample concentrations##2##2##(2008-10#2)
sample consisted of##21##3##(1994-1#1)(1994-6#1)(1995-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
sample consists##2##2##(2007-12#1)(2013-8#1)
sample consumed##3##2##(2008-10#3)
sample consumption##4##2##(2008-10#4)
sample contained##2##2##(1990-9#1)(2008-8#1)
sample containing the##2##3##(2007-12#1)(2008-10#1)
sample containing##23##2##(2007-12#1)(2008-10#21)(2011-1#1)
sample contamination##2##2##(2008-10#2)
sample data##2##2##(2008-3#1)(2008-9#1)
sample depth##3##2##(2008-2#2)(2008-3#1)
sample detected by the method is in good agreement with the certified value##2##13##(2008-10#2)
sample determined##2##2##(2008-10#2)
sample digestion and##3##3##(2008-10#3)
sample digestion##12##2##(2008-10#12)
sample dilution##2##2##(2008-10#2)
sample disks were##2##3##(2008-3#2)
sample dissolution##7##2##(2008-10#5)(2008-5#1)(2012-2#1)
sample drawn##2##2##(1992-6#1)(2008-1#1)
sample due to the##2##4##(2008-10#2)
sample during##4##2##(1990-5#1)(2007-12#1)(2008-10#2)
sample enrichment##2##2##(2008-10#2)
sample extraction##9##2##(2008-10#9)
sample extracts##3##2##(2008-10#3)
sample flow rate and##4##4##(2008-10#4)
sample flow rate##23##3##(2008-10#23)
sample flow##27##2##(2008-10#26)(2008-9#1)
sample followed by##2##3##(2008-10#2)
sample for this##2##3##(1995-6#1)(2006-10#1)
sample for##15##2##(1995-6#1)(1997-5#2)(2006-10#1)(2008-10#8)(2008-12#1)(2008-3#1)(2012-2#1)
sample frame##4##2##(1995-1#3)(1996-1#1)
sample free from sulphur dioxide##2##5##(2008-10#2)
sample free##3##2##(1996-12#1)(2008-10#2)
sample frequency of 27 samples per##2##6##(2008-10#2)
sample frequency of##11##3##(2008-10#11)
sample frequency##14##2##(2008-10#14)
sample from a##8##3##(2008-10#4)(2008-12#1)(2010-11#1)(2010-2#1)(2013-1#1)
sample from the##6##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
sample from##26##2##(1991-6#1)(1992-6#1)(1994-2#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-12#5)(2008-2#1)(2008-4#1)(2008-7#2)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
sample group of##3##3##(1993-11#1)(1993-2#1)(2008-10#1)
sample group##5##2##(1993-11#1)(1993-2#1)(2008-10#2)(2009-11#1)
sample groups##3##2##(2008-10#2)(2009-11#1)
sample h(-1)##3##2##(2008-10#3)
sample had##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
sample handling and##5##3##(2008-1#1)(2008-10#3)(2008-3#1)
sample handling##21##2##(1997-6#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)
sample has been##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
sample has##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
sample heterogeneity##2##2##(2008-9#1)(2011-2#1)
sample in a##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
sample in the##7##3##(2008-10#6)(2008-2#1)
sample in##32##2##(1991-2#2)(1996-12#1)(2007-11#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
sample included##7##2##(1991-2#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-7#1)
sample including##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
sample injection and##5##3##(1992-11#1)(1995-3#1)(2008-10#3)
sample injection by##2##3##(1994-9#1)(2008-10#1)
sample injection is##2##3##(2008-10#2)
sample injection of##2##3##(2008-10#2)
sample injection volume##5##3##(2008-10#4)(2012-3#1)
sample injection##29##2##(1990-8#2)(1992-11#1)(1994-9#1)(1995-3#1)(2008-10#23)(2012-3#1)
sample injections##4##2##(2008-10#4)
sample insertion##2##2##(2008-10#2)
sample into a##3##3##(2008-10#3)
sample into the##4##3##(1990-12#1)(2008-10#3)
sample into##10##2##(1990-12#1)(2008-10#8)(2008-9#1)
sample introduction in##2##3##(2008-10#2)
sample introduction system##6##3##(2008-10#6)
sample introduction techniques##2##3##(2008-10#2)
sample introduction##33##2##(2008-10#32)(2010-7#1)
sample is a##2##3##(2007-11#1)(2007-12#1)
sample is assumed to##2##4##(1994-11#1)(2008-3#1)
sample is directly##3##3##(2008-10#2)(2008-2#1)
sample is fused with##2##4##(2008-10#2)
sample is injected##2##3##(2008-10#2)
sample is introduced##2##3##(2008-10#2)
sample is measured##2##3##(2008-3#2)
sample is presented##2##3##(2007-12#1)(2008-3#1)
sample is required##2##3##(2008-1#1)(2008-10#1)
sample is the##2##3##(2008-10#2)
sample is treated with##2##4##(2008-10#2)
sample is##87##2##(1991-1#1)(1994-11#1)(1995-12#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#50)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#2)(2008-5#3)(2008-9#2)(2009-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
sample loading and##2##3##(2008-10#2)
sample loading flow rate##5##4##(2008-10#5)
sample loading time of##2##4##(2008-10#2)
sample loading time##3##3##(2008-10#3)
sample loading volume##2##3##(2008-10#2)
sample loading##14##2##(2008-10#14)
sample loop of##3##3##(2008-10#3)
sample loop##9##2##(2008-10#9)
sample loss##2##2##(2008-10#1)(2008-11#1)
sample manipulation##4##2##(2008-10#4)
sample mass##8##2##(2008-10#8)
sample material##2##2##(2008-1#1)(2008-5#1)
sample materials##2##2##(2008-10#2)
sample matrices##6##2##(2008-10#4)(2008-3#1)(2010-11#1)
sample matrix and##2##3##(2008-10#2)
sample matrix was##5##3##(2008-10#5)
sample matrix##32##2##(2008-10#31)(2008-5#1)
sample may be stored##2##4##(2008-10#2)
sample may be##3##3##(2008-10#2)(2013-1#1)
sample may##7##2##(1995-1#1)(2008-10#2)(2008-9#1)(2013-1#1)(2013-8#2)
sample mean##2##2##(1994-3#1)(2008-7#1)
sample measurement frequency##4##3##(2008-10#4)
sample measurement##6##2##(2008-10#6)
sample measurements##2##2##(2008-10#2)
sample model##2##2##(1997-3#1)(2008-3#1)
sample number##2##2##(2008-10#2)
sample obtained##2##2##(2008-10#1)(2013-8#1)
sample of 0##2##3##(2008-10#2)
sample of 1##9##3##(1990-9#1)(1992-8#1)(1993-2#1)(1995-8#1)(1996-6#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
sample of 10##3##3##(1993-3#1)(2007-10#1)(2008-11#1)
sample of 127##2##3##(1995-3#1)(2013-1#1)
sample of 133##2##3##(2007-12#1)(2008-7#1)
sample of 15##4##3##(1991-2#1)(2008-5#2)(2010-11#1)
sample of 2##6##3##(1992-12#1)(1992-3#1)(1993-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
sample of 20##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
sample of 24##2##3##(2008-12#1)(2010-8#1)
sample of 3##3##3##(1994-1#1)(2013-8#2)
sample of 30##2##3##(1992-1#1)(2008-10#1)
sample of 37##3##3##(2008-12#1)(2010-6#1)(2013-8#1)
sample of 4##2##3##(1997-4#1)(2012-12#1)
sample of 40##3##3##(1993-2#1)(2007-11#1)(2009-12#1)
sample of 400##2##3##(1994-12#1)(2013-1#1)
sample of 43##2##3##(1993-12#1)(2009-11#1)
sample of 7##2##3##(1991-2#1)(2009-7#1)
sample of MSM##2##3##(2009-5#2)
sample of North##2##3##(2008-11#1)(2009-2#1)
sample of Norwegian general practitioners##2##5##(1993-2#1)(1995-5#1)
sample of a##6##3##(1992-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
sample of adolescents##3##3##(2009-2#1)(2009-7#1)(2010-2#1)
sample of approximately##2##3##(2008-12#1)(2013-1#1)
sample of five##2##3##(2008-11#1)(2013-8#1)
sample of healthy individuals##2##4##(2008-7#1)(2009-10#1)
sample of individuals##2##3##(2009-8#1)(2012-2#1)
sample of interest##2##3##(2008-3#1)(2008-7#1)
sample of known##2##3##(2007-11#1)(2008-3#1)
sample of nurses##3##3##(2007-2#1)(2008-11#1)(2010-11#1)
sample of over##2##3##(2012-1#1)(2012-12#1)
sample of parents##3##3##(2008-9#1)(2012-12#2)
sample of patients##2##3##(2010-3#1)(2011-2#1)
sample of pure##2##3##(2007-12#1)(2008-3#1)
sample of students##2##3##(2008-11#1)(2013-1#1)
sample of subjects##2##3##(1994-9#1)(2008-7#1)
sample of the Italian population##2##5##(2008-7#1)(2010-11#1)
sample of the population##3##4##(1996-8#1)(2007-2#1)(2012-12#1)
sample of the##17##3##(1992-2#1)(1995-3#1)(1996-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
sample of women aged##2##4##(1990-8#1)(1992-1#1)
sample of women##4##3##(1990-8#1)(1992-1#1)(2008-3#1)(2011-2#1)
sample of young##2##3##(2007-4#1)(2009-7#1)
sample of##380##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-8#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-1#2)(1996-2#3)(1996-6#2)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(2007-10#3)(2007-11#5)(2007-12#14)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#40)(2008-11#18)(2008-12#20)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#7)(2009-7#12)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#4)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#12)(2011-2#15)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#8)(2013-1#17)(2013-8#10)
sample on the##2##3##(2008-10#1)(2008-4#1)
sample onto the##2##3##(2008-10#1)(2013-1#1)
sample or a##3##3##(1990-8#1)(2009-10#1)(2010-11#1)
sample or the##2##3##(2008-3#2)
sample or##11##2##(1990-8#1)(2008-10#5)(2008-3#2)(2009-10#1)(2010-11#1)(2010-2#1)
sample pH and##4##3##(2008-10#4)
sample pH##13##2##(2008-10#12)(2008-9#1)
sample pair had##2##3##(2008-12#2)
sample pairs##2##2##(2008-12#2)
sample parameters##3##2##(2008-3#2)(2011-2#1)
sample passes##2##2##(2008-10#2)
sample per##2##2##(2008-10#2)
sample performance##3##2##(1995-5#1)(2009-10#1)(2010-3#1)
sample period##4##2##(2007-12#1)(2008-10#2)(2012-3#1)
sample periods##3##2##(2008-10#3)
sample plan##3##2##(1993-3#1)(2008-10#2)
sample plate##2##2##(2008-10#1)(2012-3#1)
sample plug##5##2##(2008-10#5)
sample points##3##2##(2007-11#1)(2008-3#2)
sample population##5##2##(1990-5#1)(1995-12#1)(2008-10#2)(2012-3#1)
sample positioning##2##2##(2008-10#2)
sample pre-concentration##3##2##(2008-10#2)(2010-5#1)
sample pre-treatment and##3##3##(2008-10#3)
sample pre-treatment procedure##2##3##(2008-10#1)(2013-1#1)
sample pre-treatment##19##2##(2008-10#17)(2010-5#1)(2013-1#1)
sample pre-treatments##2##2##(2008-10#2)
sample preconcentration##4##2##(2008-10#3)(2010-7#1)
sample preparation and determination##2##4##(2008-10#2)
sample preparation and##13##3##(1991-5#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-7#1)
sample preparation for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
sample preparation from##2##3##(1991-5#1)(2008-4#1)
sample preparation in##3##3##(2008-10#2)(2013-1#1)
sample preparation instead of intensive treatments inherent with the##3##9##(2008-10#3)
sample preparation is##5##3##(2008-10#4)(2008-4#1)
sample preparation method based on##3##5##(2008-10#3)
sample preparation method##8##3##(2008-10#7)(2008-9#1)
sample preparation methods##3##3##(2008-10#3)
sample preparation prior to analysis##2##5##(2008-10#1)(2010-5#1)
sample preparation procedure based on##2##5##(2008-10#2)
sample preparation procedure for##2##4##(2008-10#2)
sample preparation procedure##6##3##(2008-10#6)
sample preparation procedures##3##3##(2008-10#3)
sample preparation process##2##3##(2008-10#2)
sample preparation was##3##3##(2008-10#3)
sample preparation##103##2##(1991-5#2)(1994-9#2)(2008-1#1)(2008-10#76)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#4)(2009-4#1)(2010-11#2)(2010-5#1)(2010-7#1)(2012-12#2)(2013-1#1)
sample preparations##3##2##(2008-10#2)(2010-11#1)
sample pretreatment and##3##3##(2008-10#2)(2008-4#1)
sample pretreatment for the##2##4##(2008-10#2)
sample pretreatment for##3##3##(2008-10#3)
sample pretreatment steps##2##3##(2008-10#1)(2010-11#1)
sample pretreatment using##3##3##(2008-10#2)(2009-6#1)
sample pretreatment##26##2##(2008-10#22)(2008-4#1)(2009-6#1)(2010-11#1)(2013-1#1)
sample prior to##3##3##(2008-10#2)(2008-11#1)
sample processing and##2##3##(2008-10#2)
sample processing##12##2##(2007-11#1)(2008-10#7)(2008-11#2)(2008-9#2)
sample rate##2##2##(2008-10#2)
sample refractive index##2##3##(2007-11#1)(2008-2#1)
sample results##3##2##(2008-10#2)(2008-2#1)
sample search##2##2##(1992-12#1)(2010-8#1)
sample set##8##2##(2007-12#2)(2008-10#1)(2013-8#5)
sample sets##2##2##(2008-10#1)(2010-11#1)
sample should be##2##3##(2008-10#1)(2010-11#1)
sample should##4##2##(1995-3#1)(2008-10#2)(2010-11#1)
sample showed##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
sample shows##2##2##(2008-2#1)(2008-3#1)
sample size and##8##3##(1994-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#2)
sample size are##2##3##(2007-10#1)(2008-10#1)
sample size calculation##3##3##(1992-6#1)(2007-7#1)(2013-1#1)
sample size calculations##2##3##(1992-6#1)(2012-3#1)
sample size can##2##3##(2007-7#1)(2008-10#1)
sample size estimate##2##3##(1994-9#1)(2010-4#1)
sample size for##8##3##(1994-9#1)(1995-3#1)(1995-9#1)(2007-7#2)(2008-10#2)(2012-12#1)
sample size formula##2##3##(1992-9#1)(1996-3#1)
sample size formulae##2##3##(2012-3#2)
sample size is##7##3##(2007-7#3)(2008-10#1)(2008-7#1)(2009-11#1)(2012-3#1)
sample size of the##2##4##(2008-8#1)(2012-3#1)
sample size of##4##3##(2008-8#1)(2012-3#1)(2013-1#2)
sample size reassessment##2##3##(2012-2#2)
sample size required to##2##4##(1992-9#1)(1995-9#1)
sample size was##5##3##(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
sample size##106##2##(1992-3#1)(1992-6#5)(1992-9#3)(1994-11#1)(1994-2#1)(1994-9#4)(1995-3#1)(1995-5#1)(1995-9#3)(1996-3#1)(2007-10#2)(2007-7#9)(2008-10#27)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#11)(2013-1#5)
sample sizes are##2##3##(2010-12#1)(2012-3#1)
sample sizes differ##2##3##(2008-10#2)
sample sizes in##4##3##(1992-9#1)(2008-10#2)(2012-3#1)
sample sizes of##2##3##(2008-10#1)(2013-8#1)
sample sizes##32##2##(1991-12#1)(1992-9#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-8#1)
sample solution and eluent##4##4##(2008-10#4)
sample solution and##9##3##(2008-10#9)
sample solution by##2##3##(2008-10#2)
sample solution can be determined##2##5##(2008-10#2)
sample solution containing##7##3##(2008-10#7)
sample solution for##2##3##(2008-10#2)
sample solution from##2##3##(2008-10#2)
sample solution in##3##3##(2008-10#3)
sample solution is injected into the##2##6##(2008-10#2)
sample solution is##8##3##(2008-10#8)
sample solution was injected##6##4##(2008-10#6)
sample solution was introduced into the##2##6##(2008-10#2)
sample solution was##14##3##(2008-10#14)
sample solution were##5##3##(2008-10#5)
sample solution##123##2##(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#118)(2008-3#1)(2013-8#1)
sample solutions by##3##3##(2008-10#3)
sample solutions containing##2##3##(2008-10#2)
sample solutions using##2##3##(2008-10#2)
sample solutions were##5##3##(2008-10#3)(2013-8#2)
sample solutions##19##2##(2008-10#17)(2013-8#2)
sample spiked with##2##3##(2008-10#1)(2010-5#1)
sample stabilization##3##2##(2008-10#3)
sample stacking for##2##3##(2008-10#2)
sample stacking##10##2##(1994-12#1)(1996-5#2)(2008-10#7)
sample storage protocols##2##3##(2008-10#2)
sample storage##4##2##(2008-10#4)
sample stream##4##2##(2008-10#4)
sample structure##3##2##(2008-3#3)
sample studied##2##2##(1991-9#1)(2008-10#1)
sample surface to the##2##4##(2008-10#1)(2008-3#1)
sample surface to##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
sample surface##18##2##(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#6)(2009-7#1)(2012-2#1)(2013-8#1)
sample surveys##3##2##(2010-11#1)(2011-2#1)(2012-2#1)
sample taken##2##2##(2008-10#1)(2008-12#1)
sample temperature##6##2##(2008-10#2)(2008-2#2)(2008-9#2)
sample that is##3##3##(2008-10#2)(2008-2#1)
sample that was##3##3##(1992-6#1)(2007-12#1)(2010-8#1)
sample that##12##2##(1992-6#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)
sample the##10##2##(1992-9#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)
sample then##2##2##(2008-10#2)
sample thickness##4##2##(2008-2#2)(2008-3#2)
sample through the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
sample through##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
sample throughout##2##2##(2008-10#2)
sample throughput and##5##3##(2008-10#3)(2008-9#2)
sample throughput is##3##3##(2008-10#3)
sample throughput of##26##3##(2008-10#26)
sample throughput was##11##3##(2008-10#11)
sample throughput##71##2##(1992-11#1)(2008-10#67)(2008-9#2)(2010-11#1)
sample to another##2##3##(1994-2#1)(2008-10#1)
sample to be##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
sample to the##3##3##(2008-10#2)(2008-3#1)
sample to##28##2##(1992-2#1)(1994-11#1)(1994-2#2)(2007-12#2)(2008-10#16)(2008-3#3)(2008-9#1)(2011-2#1)(2012-12#1)
sample treated##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
sample treatment and##6##3##(2008-10#6)
sample treatment for the##2##4##(2008-10#2)
sample treatment for##3##3##(2008-10#3)
sample treatment is##2##3##(2008-10#2)
sample treatment procedures##2##3##(2008-10#1)(2010-11#1)
sample treatment##31##2##(1990-8#1)(2008-10#29)(2010-11#1)
sample treatments##2##2##(2008-10#2)
sample tube length##2##3##(2008-10#2)
sample tube##5##2##(2008-10#5)
sample type##3##2##(2008-10#3)
sample types##7##2##(2008-10#6)(2008-3#1)
sample under##4##2##(2008-10#1)(2008-3#3)
sample using a##3##3##(2008-10#3)
sample using##11##2##(2008-10#10)(2011-1#1)
sample volume and##5##3##(2008-10#5)
sample volume are##2##3##(2008-10#2)
sample volume injected##2##3##(2008-10#2)
sample volume of 100 ml##3##5##(2008-10#3)
sample volume of 100##4##4##(2008-10#4)
sample volume of##20##3##(2008-10#20)
sample volume up to##2##4##(2008-10#2)
sample volume was##3##3##(2008-10#2)(2012-1#1)
sample volume were##2##3##(2008-10#2)
sample volume with##2##3##(2008-10#1)(2008-2#1)
sample volume##82##2##(1990-12#1)(2007-12#1)(2008-10#74)(2008-12#1)(2008-2#1)(2008-3#2)(2010-11#1)(2012-1#1)
sample volumes and##2##3##(2008-10#2)
sample volumes in##2##3##(2008-10#1)(2013-1#1)
sample volumes##15##2##(1994-9#1)(2008-10#12)(2008-9#1)(2013-1#1)
sample was &lt##2##3##(2008-10#2)
sample was added##2##3##(1997-2#1)(2008-10#1)
sample was also##3##3##(2008-10#3)
sample was analyzed by##2##4##(2008-5#1)(2012-12#1)
sample was analyzed##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
sample was calculated##2##3##(2007-11#1)(2008-10#1)
sample was determined with##2##4##(2008-10#2)
sample was divided into##3##4##(2008-12#1)(2013-1#2)
sample was divided##5##3##(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#2)
sample was injected into the##2##5##(1990-8#1)(2008-10#1)
sample was injected into##4##4##(1990-8#1)(2008-10#3)
sample was injected##6##3##(1990-8#2)(2008-10#4)
sample was measured##2##3##(2008-10#2)
sample was obtained##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
sample was performed##2##3##(1990-8#1)(2011-2#1)
sample was taken##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
sample was used##4##3##(2008-10#3)(2013-7#1)
sample was##96##2##(1990-8#5)(1994-12#3)(1994-2#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-6#1)(2010-1#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
sample weight##2##2##(2008-10#2)
sample were also##3##3##(2008-10#3)
sample were collected from##2##4##(2008-10#1)(2011-1#1)
sample were##29##2##(1992-5#1)(1995-5#1)(2007-2#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
sample where##2##2##(2008-10#1)(2008-3#1)
sample while##3##2##(2008-10#2)(2008-3#1)
sample will be##2##3##(2008-10#1)(2008-3#1)
sample will##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
sample with a##10##3##(2007-12#1)(2008-10#6)(2008-3#3)
sample with satisfactory results##2##4##(2008-10#2)
sample with the##5##3##(2008-10#4)(2008-5#1)
sample with##43##2##(1991-12#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#25)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2012-3#1)
sample without##2##2##(2008-10#2)
sample would##2##2##(1992-12#1)(2012-3#1)
sample zone was##2##3##(2008-10#2)
sample zone##14##2##(2008-10#14)
sample##3135##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#13)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#7)(1991-3#3)(1991-5#4)(1991-6#3)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#5)(1992-12#8)(1992-2#5)(1992-3#2)(1992-5#2)(1992-6#11)(1992-8#6)(1992-9#5)(1993-1#3)(1993-11#2)(1993-12#8)(1993-2#5)(1993-3#3)(1994-1#4)(1994-11#3)(1994-12#7)(1994-2#11)(1994-3#7)(1994-6#7)(1994-9#18)(1995-1#9)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#6)(1995-5#10)(1995-6#1)(1995-8#1)(1995-9#6)(1996-1#4)(1996-12#5)(1996-2#3)(1996-3#3)(1996-5#7)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#7)(1997-4#5)(1997-5#7)(1997-6#3)(1997-8#1)(2006-10#1)(2006-4#2)(2007-10#8)(2007-11#38)(2007-12#63)(2007-2#6)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#12)(2007-9#3)(2008-1#19)(2008-10#1762)(2008-11#54)(2008-12#53)(2008-2#41)(2008-3#134)(2008-4#42)(2008-5#29)(2008-6#7)(2008-7#35)(2008-8#14)(2008-9#44)(2009-10#13)(2009-11#10)(2009-12#8)(2009-2#4)(2009-4#3)(2009-5#14)(2009-6#4)(2009-7#17)(2009-8#9)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#23)(2010-12#3)(2010-2#6)(2010-3#11)(2010-4#6)(2010-5#12)(2010-6#4)(2010-7#11)(2010-8#10)(2010-9#4)(2011-1#32)(2011-2#43)(2012-1#9)(2012-12#28)(2012-2#27)(2012-3#39)(2013-1#62)(2013-3#1)(2013-7#2)(2013-8#48)
sample's##6##1##(2007-11#2)(2008-2#1)(2008-3#2)(2010-7#1)
sample) and##6##2##(1992-9#1)(2008-10#4)(2010-5#1)
sample) for##2##2##(2008-10#2)
sample)##28##1##(1991-12#1)(1992-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)(2010-5#1)(2012-3#1)
sample-and-hold switch##2##2##(2008-3#2)
sample-handling##2##1##(2008-10#2)
sample-preparation and##2##2##(2008-10#1)(2008-3#1)
sample-preparation techniques##2##2##(2010-11#1)(2010-7#1)
sample-preparation##5##1##(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-7#1)
sample-to-sample##5##1##(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
sample/reagent##3##1##(2008-10#3)
sample/standard##3##1##(2008-10#3)
sample]##4##1##(2008-9#1)(2009-9#1)(2013-1#2)
sampled (p&lt##2##2##(2008-4#2)
sampled and analysed##2##3##(1991-5#1)(2008-5#1)
sampled and analyzed##3##3##(2008-10#2)(2013-1#1)
sampled and##15##2##(1991-5#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2013-1#1)
sampled at the##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
sampled at##13##2##(1993-2#1)(2008-10#5)(2008-2#1)(2008-3#3)(2010-5#1)(2011-2#1)(2012-3#1)
sampled by a##2##3##(2008-2#1)(2011-2#1)
sampled by##8##2##(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
sampled during the##2##3##(2008-10#1)(2008-5#1)
sampled during##4##2##(2008-10#3)(2008-5#1)
sampled either##2##2##(2008-2#1)(2008-5#1)
sampled for##3##2##(2008-10#2)(2008-4#1)
sampled from RL##3##3##(2008-10#3)
sampled from a##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
sampled from different##4##3##(2008-10#4)
sampled from nine##2##3##(2008-10#2)
sampled from one##2##3##(2008-10#1)(2009-7#1)
sampled from the same##2##4##(2007-12#1)(2008-10#1)
sampled from the##8##3##(1990-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-2#1)
sampled from two##2##3##(2008-10#2)
sampled from wheat##2##3##(2008-10#2)
sampled from##57##2##(1990-5#1)(1997-3#2)(2007-12#1)(2008-10#44)(2008-11#2)(2008-3#1)(2008-8#1)(2009-7#2)(2012-12#1)(2012-2#1)(2012-3#1)
sampled in a##5##3##(2008-10#5)
sampled in the##8##3##(2008-10#6)(2008-5#1)(2011-2#1)
sampled in##29##2##(1990-3#1)(2008-10#21)(2008-5#3)(2009-9#1)(2011-2#2)(2013-7#1)
sampled on a##2##3##(2008-10#2)
sampled on the##2##3##(2008-10#2)
sampled on##6##2##(2007-6#1)(2008-10#5)
sampled over time##2##3##(2008-10#2)
sampled over##4##2##(2008-10#4)
sampled plants##2##2##(2008-10#1)(2008-5#1)
sampled points##2##2##(2008-10#2)
sampled populations##2##2##(2008-10#2)
sampled seedlings##2##2##(2008-10#2)
sampled sites##2##2##(2008-10#1)(2008-5#1)
sampled speckle##2##2##(2007-12#1)(2008-2#1)
sampled to##3##2##(2008-10#2)(2008-3#1)
sampled using##2##2##(2008-10#1)(2009-6#1)
sampled values##2##2##(2008-2#2)
sampled volume##2##2##(2008-10#1)(2011-1#1)
sampled were##3##2##(2008-10#3)
sampled with##3##2##(2007-10#1)(2008-5#1)(2008-6#1)
sampled##270##1##(1990-3#1)(1990-5#1)(1991-5#1)(1992-1#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#149)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#16)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#3)(2013-7#7)(2013-8#5)
sampler for##6##2##(2008-10#4)(2010-5#2)
sampler height##2##2##(2008-10#2)
sampler is##2##2##(2008-10#2)
sampler method##2##2##(2008-10#1)(2010-5#1)
sampler technique##3##2##(2008-10#3)
sampler to##3##2##(1994-9#1)(2008-4#1)(2012-3#1)
sampler##46##1##(1994-9#1)(1997-7#1)(2008-10#29)(2008-11#3)(2008-4#1)(2008-5#1)(2010-5#7)(2012-3#2)(2012-7#1)
samplers##19##1##(2008-10#10)(2008-11#2)(2008-5#4)(2010-4#1)(2010-5#2)
samples (0##7##2##(2008-10#6)(2013-1#1)
samples (1##2##2##(2008-10#1)(2013-8#1)
samples (30##2##2##(2008-10#2)
samples (52##2##2##(2007-7#1)(2008-12#1)
samples (60##2##2##(2008-12#1)(2010-4#1)
samples (e##2##2##(2008-10#2)
samples (i##2##2##(2008-10#1)(2012-12#1)
samples (n =##3##3##(2012-3#3)
samples (p &lt##2##3##(2008-12#1)(2008-8#1)
samples according to the level of##2##6##(1996-7#1)(2008-10#1)
samples according to their##2##4##(2008-10#2)
samples according to##5##3##(1996-7#1)(2008-10#3)(2009-5#1)
samples after a simple##2##4##(2008-10#2)
samples after a##3##3##(2008-10#3)
samples after adsorption of its##3##5##(2008-10#3)
samples after preconcentration of##3##4##(2008-10#3)
samples after preconcentration##5##3##(2008-10#5)
samples after##21##2##(2008-10#21)
samples against##2##2##(1990-12#1)(2008-10#1)
samples analysed##4##2##(2008-10#3)(2012-12#1)
samples analysis##6##2##(2008-10#4)(2008-12#1)(2011-1#1)
samples analyzed were##2##3##(2008-10#2)
samples analyzed##13##2##(1993-6#1)(2008-10#11)(2008-11#1)
samples and a##8##3##(2008-10#7)(2008-2#1)
samples and after##2##3##(1994-5#1)(2013-1#1)
samples and also##4##3##(2008-10#2)(2010-11#1)(2011-2#1)
samples and between##2##3##(2008-10#1)(2009-2#1)
samples and calibration##2##3##(2008-10#2)
samples and can be##2##4##(2008-1#1)(2008-10#1)
samples and chromium##2##3##(2008-10#2)
samples and compared##2##3##(2008-10#1)(2013-8#1)
samples and for##5##3##(1997-6#1)(2008-10#2)(2008-3#2)
samples and from##2##3##(2008-10#1)(2008-11#1)
samples and good##2##3##(2008-10#2)
samples and in##9##3##(1995-12#1)(2007-10#1)(2008-10#7)
samples and it##2##3##(2008-10#2)
samples and its##3##3##(2008-10#3)
samples and on##2##3##(2008-10#2)
samples and one##2##3##(2008-10#1)(2008-3#1)
samples and other##2##3##(2008-10#2)
samples and several##2##3##(2008-10#2)
samples and spiked##2##3##(2008-10#2)
samples and standard##3##3##(2008-10#3)
samples and the results obtained##2##5##(2008-10#2)
samples and the results were##2##5##(2008-10#2)
samples and the results##6##4##(2008-10#5)(2008-3#1)
samples and the##22##3##(2008-10#20)(2008-3#1)(2008-7#1)
samples and three##4##3##(2008-10#3)(2008-3#1)
samples and to##2##3##(2008-1#1)(2008-10#1)
samples and was##2##3##(2008-10#2)
samples and waters##2##3##(2008-10#2)
samples and were##2##3##(1994-5#1)(2012-3#1)
samples and##219##2##(1990-8#3)(1991-2#1)(1991-8#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#148)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
samples are also##2##3##(2008-10#1)(2008-3#1)
samples are analysed##2##3##(2008-10#2)
samples are collected##2##3##(2008-10#2)
samples are considered##2##3##(2008-10#1)(2008-3#1)
samples are described##3##3##(2008-10#3)
samples are examined##2##3##(2008-2#1)(2012-2#1)
samples are obtained##3##3##(2008-10#2)(2010-6#1)
samples are presented##5##3##(2008-10#3)(2008-3#2)
samples are reviewed##3##3##(2008-10#3)
samples are selected##2##3##(2008-10#1)(2012-3#1)
samples are then##2##3##(2008-4#2)
samples are used##2##3##(2008-10#1)(2008-3#1)
samples are usually##2##3##(2008-10#1)(2010-11#1)
samples are##94##2##(1995-6#1)(1997-4#1)(2008-10#62)(2008-2#2)(2008-3#8)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-11#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
samples as well as in##3##5##(2008-10#2)(2008-11#1)
samples as well as##8##4##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
samples as##16##2##(2008-10#9)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
samples at a##2##3##(2008-10#1)(2011-2#1)
samples at concentration levels between##2##5##(2008-10#2)
samples at different##2##3##(2008-10#1)(2013-7#1)
samples at the##5##3##(1990-12#1)(2008-10#3)(2008-12#1)
samples at trace##2##3##(2008-10#2)
samples at##29##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1997-4#1)(1997-6#1)(2007-5#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
samples based on the use of##2##6##(2008-10#2)
samples based on the##3##4##(2008-10#3)
samples based on##6##3##(2008-10#5)(2012-2#1)
samples because##2##2##(2008-10#1)(2008-4#1)
samples before##5##2##(2008-10#4)(2008-5#1)
samples being##2##2##(2008-10#1)(2012-12#1)
samples belonged to##3##3##(2008-10#2)(2011-2#1)
samples belonging to##3##3##(2007-7#1)(2008-10#1)(2010-4#1)
samples both##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
samples but not##2##3##(2008-10#2)
samples but##4##2##(2008-10#3)(2011-2#1)
samples by FAAS##2##3##(2008-10#2)
samples by a##2##3##(2008-10#2)
samples by capillary##3##3##(2008-10#3)
samples by electrothermal atomic absorption spectrometry using##3##7##(2008-10#3)
samples by electrothermal atomic absorption spectrometry##7##6##(2008-10#7)
samples by electrothermal atomic absorption##8##5##(2008-10#8)
samples by electrothermal##10##3##(2008-10#10)
samples by extraction##2##3##(2008-10#2)
samples by flame AAS##3##4##(2008-10#3)
samples by flame atomic absorption spectrometry##4##6##(2008-10#4)
samples by flame atomic absorption##5##5##(2008-10#5)
samples by flame##8##3##(2008-10#8)
samples by flow-injection##3##3##(2008-10#3)
samples by gas chromatography with##2##5##(2008-10#2)
samples by gas chromatography##4##4##(2008-10#4)
samples by gas##5##3##(2008-10#5)
samples by graphite furnace atomic absorption spectrometry (GFAAS)##2##8##(2008-10#2)
samples by graphite furnace atomic absorption spectrometry after##3##8##(2008-10#3)
samples by graphite furnace atomic absorption spectrometry##7##7##(2008-10#7)
samples by graphite furnace atomic##8##5##(2008-10#8)
samples by high-performance##2##3##(1993-9#1)(2008-10#1)
samples by hydride generation-four-channel##2##4##(2008-10#2)
samples by hydride##6##3##(2008-10#6)
samples by inductively coupled plasma atomic emission spectrometry##3##8##(1992-3#1)(2008-10#2)
samples by inductively coupled plasma atomic emission##4##7##(1992-3#1)(2008-10#3)
samples by inductively coupled plasma##6##5##(1992-3#1)(2008-10#5)
samples by inductively coupled##7##4##(1992-3#1)(2008-10#6)
samples by liquid##2##3##(2008-10#2)
samples by solid-phase##3##3##(2008-10#3)
samples by the proposed##2##4##(2008-10#2)
samples by the standard addition method##2##6##(2008-10#2)
samples by the##12##3##(2007-12#1)(2008-10#11)
samples by this method were##2##5##(2008-10#2)
samples by this method##3##4##(2008-10#3)
samples by this##4##3##(2008-10#4)
samples by using a##3##4##(2008-10#3)
samples by using the##2##4##(2008-10#2)
samples by using##8##3##(2008-10#8)
samples by##164##2##(1992-3#1)(1993-9#1)(1996-12#1)(2007-12#1)(2008-10#146)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#2)
samples came from##2##3##(1992-12#1)(1995-6#1)
samples can be analyzed per hour with a relative standard deviation of less than##2##14##(2008-10#2)
samples can be analyzed per hour with a relative##3##9##(2008-10#3)
samples can be analyzed per hour##4##6##(2008-10#4)
samples can be analyzed##6##4##(2008-10#6)
samples can be##24##3##(1991-5#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-8#1)
samples cannot be##2##3##(2008-10#2)
samples collected at##3##3##(2008-10#3)
samples collected by##3##3##(2008-10#3)
samples collected from 6##2##4##(2008-9#1)(2013-8#1)
samples collected from an##3##4##(2008-10#3)
samples collected from the##9##4##(2008-10#6)(2009-12#1)(2009-2#1)(2010-8#1)
samples collected from##34##3##(1996-12#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-2#2)(2010-8#1)(2012-3#2)(2013-8#1)
samples collected in the##4##4##(2008-10#4)
samples collected in##14##3##(2008-10#10)(2008-3#1)(2011-2#2)(2012-3#1)
samples collected##63##2##(1992-3#2)(1996-12#2)(2008-10#41)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#2)(2010-8#2)(2011-2#3)(2012-3#3)(2013-8#1)
samples coming from the##2##4##(2008-10#2)
samples coming from##3##3##(2008-10#3)
samples compared well with those found by##2##7##(2008-10#2)
samples compared well with those##3##5##(2008-10#3)
samples compared##4##2##(2008-10#4)
samples contain##4##2##(2008-10#2)(2008-2#1)(2008-4#1)
samples contained##3##2##(1993-2#1)(2008-10#1)(2011-2#1)
samples containing 0##2##3##(1992-3#1)(2008-10#1)
samples containing a##3##3##(2008-10#2)(2008-12#1)
samples containing both##2##3##(2008-10#2)
samples containing different concentrations of##2##5##(2008-10#2)
samples containing high##4##3##(2008-10#3)(2009-8#1)
samples containing low concentrations of##2##5##(2008-10#2)
samples containing##46##2##(1991-12#1)(1992-11#1)(1992-3#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-5#1)
samples corresponding to##3##3##(2008-10#3)
samples could be##13##3##(1993-2#1)(1994-2#1)(2008-10#10)(2011-2#1)
samples could##15##2##(1993-2#1)(1994-2#1)(2008-10#12)(2011-2#1)
samples covering a##2##3##(2008-10#1)(2008-3#1)
samples demonstrated that the##2##4##(2008-10#2)
samples demonstrated##4##2##(2008-10#4)
samples determined##2##2##(2008-10#1)(2008-12#1)
samples did not##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
samples directly into##2##3##(1990-8#1)(2008-10#1)
samples directly##4##2##(1990-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
samples displaying##2##2##(1990-2#1)(2008-10#1)
samples does not##2##3##(2008-10#1)(2008-3#1)
samples during##3##2##(1997-6#1)(2011-2#1)(2013-7#1)
samples elaborated##2##2##(2008-10#2)
samples examined##7##2##(1994-6#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
samples exhibited##2##2##(2008-10#1)(2008-2#1)
samples exhibiting##2##2##(2008-10#1)(2011-2#1)
samples extracted from##4##3##(2008-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
samples extracted##5##2##(2008-10#2)(2009-4#1)(2012-3#1)(2013-1#1)
samples fixed in##2##3##(2008-10#1)(2010-12#1)
samples followed by##3##3##(1994-9#1)(2008-10#1)(2012-1#1)
samples followed##4##2##(1994-9#1)(2008-10#1)(2012-1#1)(2012-12#1)
samples following##3##2##(1994-12#1)(2007-12#1)(2008-10#1)
samples for subsequent##2##3##(2008-10#2)
samples for the determination of##3##5##(2008-10#3)
samples for the presence of##2##5##(1994-11#1)(2008-9#1)
samples for the##7##3##(1994-11#1)(2008-10#4)(2008-7#1)(2008-9#1)
samples for which the##2##4##(2008-10#1)(2008-3#1)
samples for##53##2##(1991-11#1)(1991-12#1)(1991-3#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2013-1#2)(2013-7#2)
samples fortified##3##2##(2008-10#3)
samples found##2##2##(1992-12#1)(2008-10#1)
samples from HIV infected patients##2##5##(1990-2#1)(2007-7#1)
samples from a##11##3##(1991-5#1)(1994-12#1)(2008-10#6)(2009-3#1)(2010-11#1)(2011-1#1)
samples from an##7##3##(2008-10#5)(2008-12#1)(2011-2#1)
samples from both##4##3##(1994-2#1)(1995-12#1)(2007-12#1)(2008-12#1)
samples from different##10##3##(2008-10#10)
samples from each##2##3##(2008-12#1)(2011-2#1)
samples from four##2##3##(2008-10#1)(2008-6#1)
samples from groups of##2##4##(1991-3#1)(1996-12#1)
samples from healthy adults##2##4##(2008-10#1)(2009-8#1)
samples from healthy##6##3##(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#2)
samples from individuals##2##3##(1993-12#1)(2008-10#1)
samples from items of the cultural heritage of Valencia (Spain)##2##10##(2008-10#2)
samples from local markets##2##4##(2008-10#2)
samples from patients with##3##4##(1993-9#1)(2011-2#1)(2012-3#1)
samples from patients##6##3##(1991-11#1)(1993-8#1)(1993-9#1)(2008-10#1)(2011-2#1)(2012-3#1)
samples from rural domestic##2##4##(2013-1#2)
samples from several##5##3##(2008-10#5)
samples from the##18##3##(1995-11#1)(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-9#2)(2010-6#2)(2012-12#1)(2013-8#1)
samples from their##2##3##(2008-10#1)(2008-4#1)
samples from three##3##3##(1997-4#1)(2008-10#2)
samples from which##3##3##(2008-10#2)(2008-7#1)
samples from women with##2##4##(1994-3#1)(1995-12#1)
samples from##234##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-8#3)(1996-12#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#3)(2007-2#1)(2007-7#4)(2008-10#107)(2008-11#4)(2008-12#11)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-6#3)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#3)
samples gave##5##2##(1997-4#1)(2008-10#4)
samples h(-1) were##2##3##(2008-10#2)
samples h(-1)##33##2##(2008-10#33)
samples h(-1))##4##2##(2008-10#4)
samples had no##2##3##(2008-10#1)(2008-11#1)
samples had##4##2##(1994-3#1)(2008-10#2)(2008-11#1)
samples harvested##2##2##(2008-11#1)(2010-5#1)
samples has been carried out##2##5##(2008-10#2)
samples has been determined##2##4##(2008-10#2)
samples has been##18##3##(1997-2#1)(2008-10#17)
samples has##23##2##(1997-2#1)(2008-10#21)(2011-2#1)
samples have been collected##2##4##(2008-11#1)(2008-12#1)
samples have been##12##3##(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2012-1#1)
samples have##17##2##(1997-4#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#2)(2012-1#1)
samples having##4##2##(2007-12#1)(2008-10#2)(2012-2#1)
samples heated at 1100 degrees C##2##6##(2010-4#2)
samples in a wide range of##2##6##(2008-10#1)(2008-3#1)
samples in a##11##3##(1994-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#1)(2010-11#1)
samples in aqueous##2##3##(2008-10#2)
samples in order to##5##4##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
samples in the range##3##4##(2008-10#3)
samples in the##16##3##(1992-9#1)(2008-10#11)(2008-3#2)(2009-5#1)(2011-2#1)
samples in this study##2##4##(2008-10#1)(2010-4#1)
samples in##90##2##(1990-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(2007-11#1)(2007-7#1)(2008-10#48)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#3)
samples including##3##2##(2008-10#3)
samples indicated that##2##3##(2008-10#1)(2008-12#1)
samples indicates that the##2##4##(1997-5#1)(2008-3#1)
samples indicates that##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
samples infected##2##2##(2008-10#1)(2008-12#1)
samples into a##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
samples into##7##2##(1990-8#1)(2008-10#4)(2008-4#1)(2008-9#1)
samples investigated##2##2##(2007-11#1)(2008-3#1)
samples is also##2##3##(2008-10#1)(2008-3#1)
samples is demonstrated##5##3##(2008-10#4)(2011-1#1)
samples is described##14##3##(2008-10#14)
samples is discussed##2##3##(2008-10#2)
samples is illustrated##2##3##(2008-10#2)
samples is not##2##3##(2008-10#2)
samples is presented##7##3##(1993-9#1)(2008-10#5)(2008-3#1)
samples is proposed##5##3##(2008-10#5)
samples is successful##3##3##(2008-10#3)
samples is##70##2##(1993-9#1)(1995-2#1)(2008-10#58)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
samples like##2##2##(2008-10#2)
samples may be##2##3##(2008-10#1)(2010-11#1)
samples may##3##2##(2008-10#2)(2010-11#1)
samples more than##2##3##(2008-10#1)(2013-1#1)
samples must be##2##3##(2008-10#2)
samples must##3##2##(2008-10#3)
samples need to be##2##4##(2008-12#1)(2008-5#1)
samples need##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
samples needed##2##2##(2008-10#2)
samples not##2##2##(2008-10#2)
samples obtained at##2##3##(1991-8#1)(1996-9#1)
samples obtained by##7##3##(1990-8#1)(1992-5#1)(1994-1#1)(2008-10#4)
samples obtained from hospitalized##2##4##(1992-3#1)(2008-10#1)
samples obtained from patients##2##4##(1993-9#1)(1995-12#1)
samples obtained from the##2##4##(1993-6#1)(2010-4#1)
samples obtained from##21##3##(1991-12#1)(1992-3#2)(1993-6#1)(1993-9#1)(1995-12#2)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#9)(2008-6#1)(2010-4#1)
samples obtained##35##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1995-12#2)(1996-12#1)(1996-9#1)(1997-3#1)(2007-7#1)(2008-10#14)(2008-2#1)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)
samples of &quot##2##3##(2008-10#2)
samples of 0##2##3##(2008-10#2)
samples of 5##2##3##(2008-10#1)(2009-4#1)
samples of N##2##3##(2008-10#2)
samples of a##5##3##(1990-8#1)(2008-10#3)(2008-11#1)
samples of an##3##3##(2007-12#1)(2008-10#2)
samples of animal##2##3##(2008-10#1)(2013-8#1)
samples of blood##2##3##(2008-7#1)(2010-12#1)
samples of commercial##2##3##(2008-10#2)
samples of different types of##2##5##(2008-10#2)
samples of different types##3##4##(2008-10#3)
samples of different##8##3##(2008-10#8)
samples of distilled##2##3##(2008-10#2)
samples of each##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)
samples of fish##2##3##(2008-10#2)
samples of healthy##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
samples of human##3##3##(1990-12#1)(2008-10#1)(2012-12#1)
samples of interest##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
samples of natural water##3##4##(2008-10#3)
samples of natural##6##3##(2008-10#6)
samples of normal##2##3##(1992-3#1)(2008-5#1)
samples of older##2##3##(2009-3#1)(2011-1#1)
samples of patients with##2##4##(1996-7#1)(2011-2#1)
samples of patients##3##3##(1996-7#1)(2008-10#1)(2011-2#1)
samples of plant##2##3##(2008-10#1)(2013-7#1)
samples of primary##2##3##(1994-9#1)(2008-9#1)
samples of rat##2##3##(2008-2#1)(2013-8#1)
samples of river##2##3##(2008-10#2)
samples of small##2##3##(1996-6#1)(2008-10#1)
samples of stratum corneum##2##4##(2008-5#2)
samples of suspected##2##3##(2012-3#1)(2013-8#1)
samples of the##20##3##(1991-1#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#2)(2012-3#1)
samples of these##2##3##(2007-8#1)(2008-10#1)
samples of two##2##3##(2008-10#1)(2008-5#1)
samples of various##2##3##(2008-3#1)(2009-4#1)
samples of water##3##3##(2008-10#2)(2010-5#1)
samples of women##2##3##(2008-2#1)(2009-4#1)
samples of##281##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-7#2)(2007-10#2)(2007-12#4)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#139)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#14)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#4)(2013-8#6)
samples on a##2##3##(2008-10#2)
samples on the##7##3##(2008-10#5)(2011-1#1)(2012-3#1)
samples on##14##2##(2008-10#10)(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
samples or##8##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)
samples originated##2##2##(2008-10#1)(2011-2#1)
samples originating from##2##3##(2008-10#2)
samples out of##2##3##(2008-10#1)(2008-6#1)
samples over##3##2##(2008-10#2)(2008-6#1)
samples per h and the##2##5##(2008-10#2)
samples per h and##3##4##(2008-10#3)
samples per h with a##3##5##(2008-10#3)
samples per h##13##3##(2008-10#13)
samples per hour analyzed by##2##5##(2008-10#2)
samples per hour and##6##4##(2008-10#6)
samples per hour could be##2##5##(2008-10#2)
samples per hour was achieved##2##5##(2008-10#2)
samples per hour was obtained##2##5##(2008-10#2)
samples per hour was##4##4##(2008-10#4)
samples per hour were##2##4##(2008-10#2)
samples per hour with a relative standard deviation##3##8##(2008-10#3)
samples per hour with a##4##5##(2008-10#4)
samples per hour##50##3##(2008-10#50)
samples per##70##2##(1995-2#1)(2008-10#67)(2009-8#1)(2013-7#1)
samples preparation##2##2##(2008-10#2)
samples prepared from##3##3##(1990-7#1)(2008-10#2)
samples prepared in##5##3##(2008-10#5)
samples prepared using the##2##4##(2008-5#2)
samples prepared using##3##3##(2008-5#3)
samples prepared with##4##3##(2008-10#3)(2011-1#1)
samples prepared##17##2##(1990-7#1)(2008-10#11)(2008-5#4)(2011-1#1)
samples presenting##2##2##(2008-9#2)
samples prior to the##2##4##(2008-10#2)
samples prior to##5##3##(2008-10#5)
samples processed##2##2##(2007-8#1)(2012-1#1)
samples produced##4##2##(1991-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
samples provided##5##2##(2008-10#3)(2008-12#2)
samples range from##2##3##(2008-10#2)
samples ranged from 95##2##4##(2008-10#2)
samples ranged from 97##3##4##(2008-10#3)
samples ranged from 99##3##4##(2008-10#3)
samples ranged from##13##3##(2008-10#12)(2013-1#1)
samples ranged##14##2##(2008-10#13)(2013-1#1)
samples ranging from##2##3##(2008-10#1)(2008-11#1)
samples remained##2##2##(1996-12#1)(2008-5#1)
samples reported##2##2##(2008-10#1)(2011-2#1)
samples representing##2##2##(1992-3#1)(2008-4#1)
samples respectively##2##2##(2013-1#1)(2013-7#1)
samples resulted in##4##3##(2008-10#2)(2008-12#1)(2009-4#1)
samples revealed that the##2##4##(2008-10#2)
samples revealed the##2##3##(2008-10#1)(2010-4#1)
samples revealed##8##2##(2008-10#5)(2009-3#1)(2010-4#1)(2013-8#1)
samples screened##3##2##(2008-10#2)(2008-7#1)
samples should be##2##3##(2008-10#1)(2010-4#1)
samples show##4##2##(1994-9#1)(2008-10#2)(2008-2#1)
samples showed a##2##3##(2008-10#1)(2008-6#1)
samples showed that##2##3##(2008-10#1)(2008-12#1)
samples showed the presence of##2##5##(2008-10#1)(2012-12#1)
samples showed##14##2##(2008-10#6)(2008-12#1)(2008-5#2)(2008-6#2)(2010-4#1)(2012-12#1)(2013-8#1)
samples significantly##2##2##(2007-3#1)(2008-10#1)
samples simultaneously##4##2##(1997-6#1)(2008-1#1)(2008-10#2)
samples since the##2##3##(2008-10#2)
samples solubilized##2##2##(2008-10#2)
samples spiked at##2##3##(2008-10#1)(2011-2#1)
samples spiked with known amounts of##2##6##(2008-10#2)
samples spiked with the target##2##5##(2008-10#2)
samples spiked with##28##3##(1993-9#1)(2008-10#27)
samples spiked##30##2##(1993-9#1)(2008-10#28)(2011-2#1)
samples studied##9##2##(1991-12#1)(1991-5#1)(1996-12#1)(2008-10#5)(2011-2#1)
samples subjected to##2##3##(2009-11#1)(2009-7#1)
samples subjected##3##2##(2008-10#1)(2009-11#1)(2009-7#1)
samples successfully##2##2##(2008-10#2)
samples such as urine##2##4##(2008-10#2)
samples such as water##2##4##(2008-10#2)
samples such as##20##3##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-7#1)
samples taken at##2##3##(1991-9#1)(1995-9#1)
samples taken from an##3##4##(2008-10#3)
samples taken from the##4##4##(1997-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
samples taken from##17##3##(1990-12#1)(1990-8#1)(1990-9#1)(1997-3#1)(2008-10#8)(2008-12#1)(2008-5#1)(2009-10#1)(2010-4#1)(2013-1#1)
samples taken##21##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-9#1)(1994-12#1)(1995-9#1)(1997-3#1)(2008-10#8)(2008-12#2)(2008-5#1)(2009-10#1)(2010-4#1)(2013-1#1)
samples tested##5##2##(2007-7#2)(2008-10#2)(2010-5#1)
samples than##3##2##(1990-8#1)(1994-2#1)(2008-10#1)
samples that are##7##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)
samples that contain##2##3##(2008-10#2)
samples that have been##2##4##(2008-10#1)(2008-4#1)
samples that have##3##3##(2008-10#2)(2008-4#1)
samples that were collected##2##4##(2008-10#1)(2012-3#1)
samples that were##6##3##(1992-6#1)(2008-10#3)(2008-3#1)(2012-3#1)
samples that##30##2##(1992-6#1)(1997-2#1)(2008-10#20)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-3#1)
samples the##9##2##(2008-10#6)(2008-3#1)(2010-12#1)(2010-5#1)
samples through##4##2##(2008-10#4)
samples to be analyzed##2##4##(2008-10#1)(2008-4#1)
samples to be##8##3##(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#2)
samples to determine##4##3##(2008-10#3)(2008-5#1)
samples to the##2##3##(2008-10#1)(2010-6#1)
samples to##34##2##(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)
samples treated with##3##3##(2008-10#1)(2008-5#2)
samples treated##5##2##(2008-10#3)(2008-5#2)
samples under study##3##3##(2008-10#2)(2009-8#1)
samples under ultrasonic effect has been described##2##7##(2008-10#2)
samples under##9##2##(2008-10#6)(2008-4#1)(2009-8#1)(2013-1#1)
samples underwent##3##2##(1994-9#1)(2008-12#1)(2011-2#1)
samples used##2##2##(2008-10#2)
samples using a flow injection##2##5##(2008-10#2)
samples using a##9##3##(1996-5#1)(2008-10#8)
samples using electrothermal atomic absorption spectrometry with##2##7##(2008-10#2)
samples using electrothermal##3##3##(2008-10#3)
samples using flow injection##3##4##(2008-10#3)
samples using inductively coupled plasma##2##5##(2008-10#2)
samples using octadecyl##2##3##(2008-10#2)
samples using on-line##2##3##(2008-10#2)
samples using standard##2##3##(2008-10#2)
samples using the proposed##3##4##(2008-10#3)
samples using the##14##3##(1994-6#1)(2008-10#11)(2010-6#1)(2013-8#1)
samples using this##2##3##(2008-10#2)
samples using##85##2##(1993-2#1)(1994-6#1)(1996-5#1)(1997-2#1)(2008-10#70)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-7#1)(2013-8#1)
samples varied##3##2##(2008-10#3)
samples was 0##3##3##(2008-10#3)
samples was also##9##3##(2008-10#8)(2009-8#1)
samples was assessed##2##3##(2008-10#1)(2008-5#1)
samples was carried out by##2##5##(2008-10#2)
samples was carried out##6##4##(2008-10#6)
samples was checked by##2##4##(2008-10#1)(2013-1#1)
samples was demonstrated##2##3##(2008-10#2)
samples was determined by##3##4##(2008-10#3)
samples was determined##6##3##(2008-10#6)
samples was developed by##2##4##(2008-10#2)
samples was developed##9##3##(2008-10#9)
samples was evaluated##2##3##(2008-10#2)
samples was found to##2##4##(2008-10#2)
samples was found##3##3##(2008-10#3)
samples was investigated##5##3##(2008-10#4)(2011-1#1)
samples was less than##2##4##(2008-10#2)
samples was lower##2##3##(1995-2#1)(2008-12#1)
samples was made##3##3##(2008-10#2)(2008-3#1)
samples was measured##2##3##(2008-10#2)
samples was not##2##3##(2008-10#1)(2008-9#1)
samples was performed in##2##4##(2008-1#1)(2008-10#1)
samples was performed##5##3##(2008-1#1)(2008-10#4)
samples was significantly higher##2##4##(1996-12#1)(2010-4#1)
samples was studied##3##3##(2008-10#2)(2011-1#1)
samples was used##3##3##(2008-10#3)
samples was##118##2##(1990-12#1)(1990-2#1)(1990-8#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#97)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
samples were 0##4##3##(2008-10#3)(2008-5#1)
samples were 1##2##3##(2008-10#2)
samples were 4##2##3##(2008-10#2)
samples were almost##2##3##(2008-10#2)
samples were also obtained##2##4##(1994-12#1)(2013-8#1)
samples were also tested##3##4##(1994-3#1)(2008-10#2)
samples were also##13##3##(1994-12#1)(1994-3#1)(1997-4#1)(2008-10#9)(2013-8#1)
samples were analysed by##2##4##(2008-10#2)
samples were analysed with##3##4##(2008-10#2)(2008-11#1)
samples were analysed##9##3##(2008-10#7)(2008-11#1)(2012-6#1)
samples were analyzed by##4##4##(2008-10#2)(2011-2#2)
samples were analyzed for the##2##5##(1997-2#1)(2008-10#1)
samples were analyzed for total##2##5##(2008-10#1)(2008-5#1)
samples were analyzed for##7##4##(1997-2#1)(2008-10#4)(2008-5#1)(2011-1#1)
samples were analyzed using##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
samples were analyzed##24##3##(1997-2#1)(2007-10#1)(2008-10#13)(2008-12#2)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
samples were assayed##3##3##(1994-11#1)(2012-12#1)(2012-2#1)
samples were between##6##3##(2008-10#5)(2008-5#1)
samples were classified into##2##4##(2008-10#1)(2010-4#1)
samples were classified##3##3##(2008-10#2)(2010-4#1)
samples were collected and used##2##5##(2008-12#1)(2013-1#1)
samples were collected and##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
samples were collected at##5##4##(1991-6#1)(1995-6#1)(2008-10#1)(2008-3#1)(2012-1#1)
samples were collected before and##2##5##(2011-2#1)(2013-1#1)
samples were collected before##4##4##(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
samples were collected for##3##4##(2008-10#1)(2008-12#1)(2010-4#1)
samples were collected from cattle##2##5##(2011-2#1)(2012-2#1)
samples were collected from five##2##5##(2008-10#2)
samples were collected from six##2##5##(2008-10#1)(2010-6#1)
samples were collected from the##4##5##(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)
samples were collected from##31##4##(2007-5#3)(2007-7#2)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#2)
samples were collected in##3##4##(1996-12#1)(2008-10#1)(2011-1#1)
samples were collected to##2##4##(2008-10#1)(2009-4#1)
samples were collected until##2##4##(2008-10#2)
samples were collected##68##3##(1990-12#1)(1991-6#2)(1993-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-10#15)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
samples were comparable##2##3##(2008-10#2)
samples were determined by##5##4##(2008-10#4)(2011-1#1)
samples were determined with satisfactory results##2##6##(2008-10#2)
samples were determined with##4##4##(2008-10#4)
samples were determined##12##3##(2008-10#11)(2011-1#1)
samples were developed##2##3##(1990-8#1)(2008-10#1)
samples were digested by##2##4##(2008-10#2)
samples were digested##5##3##(2008-10#5)
samples were diluted with##2##4##(2008-10#2)
samples were diluted##3##3##(2008-10#3)
samples were drawn at baseline##2##5##(2012-3#1)(2013-8#1)
samples were drawn at##3##4##(1994-9#1)(2012-3#1)(2013-8#1)
samples were drawn from##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
samples were drawn##8##3##(1991-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
samples were estimated##2##3##(2008-10#2)
samples were evaluated for##3##4##(1990-12#1)(2008-5#1)(2009-4#1)
samples were examined by##2##4##(2011-2#1)(2013-1#1)
samples were examined##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
samples were extracted from##2##4##(2008-10#1)(2011-2#1)
samples were extracted with##6##4##(1996-5#1)(2008-10#4)(2011-1#1)
samples were extracted##11##3##(1996-5#1)(2008-10#7)(2011-1#1)(2011-2#1)(2011-3#1)
samples were fabricated##2##3##(2008-2#1)(2008-3#1)
samples were first##2##3##(1994-3#1)(2008-10#1)
samples were fixed##2##3##(2010-2#1)(2012-3#1)
samples were found to contain##3##5##(2008-10#2)(2008-12#1)
samples were found to##5##4##(2008-10#4)(2008-12#1)
samples were found##8##3##(2008-10#7)(2008-12#1)
samples were from##2##3##(2007-7#1)(2008-10#1)
samples were gathered##2##3##(2008-10#1)(2011-2#1)
samples were higher than the##3##5##(2008-12#1)(2010-5#2)
samples were higher than##4##4##(2008-10#1)(2008-12#1)(2010-5#2)
samples were in agreement with those##3##6##(2008-10#3)
samples were in agreement with##4##5##(2008-10#4)
samples were in the range##2##5##(2008-10#2)
samples were in##7##3##(2008-10#7)
samples were inoculated##2##3##(2008-5#1)(2012-2#1)
samples were investigated##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
samples were irradiated##2##3##(2008-10#1)(2008-5#1)
samples were lower than##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
samples were measured##2##3##(2008-10#1)(2010-5#1)
samples were more##2##3##(2008-10#1)(2013-8#1)
samples were obtained by##3##4##(2008-10#1)(2012-1#1)(2012-2#1)
samples were obtained for##2##4##(2008-5#1)(2011-2#1)
samples were obtained from 32##2##5##(2008-10#1)(2013-1#1)
samples were obtained from##9##4##(1994-9#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
samples were obtained##24##3##(1994-9#1)(1995-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
samples were performed##2##3##(2008-10#2)
samples were placed in##4##4##(2008-10#2)(2008-5#1)(2008-6#1)
samples were placed##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2012-1#1)
samples were plated in##2##4##(2008-12#1)(2013-1#1)
samples were plated##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
samples were positive for##5##4##(2007-7#2)(2012-12#2)(2012-2#1)
samples were positive##6##3##(2007-7#2)(2011-2#1)(2012-12#2)(2012-2#1)
samples were pre-treated with##2##4##(2008-10#2)
samples were prepared by##3##4##(2008-1#1)(2008-2#1)(2008-5#1)
samples were prepared using##2##4##(1990-2#1)(2008-10#1)
samples were prepared##7##3##(1990-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
samples were processed##2##3##(2008-5#1)(2012-12#1)
samples were quantitative##3##3##(2008-10#3)
samples were reviewed##2##3##(1992-12#1)(2006-8#1)
samples were screened for##3##4##(2007-7#2)(2008-1#1)
samples were screened##4##3##(2007-7#2)(2008-1#1)(2011-1#1)
samples were separated on##2##4##(1996-2#1)(2011-2#1)
samples were similar to##2##4##(2008-10#1)(2008-2#1)
samples were spiked with known##3##5##(2008-10#3)
samples were spiked with##4##4##(2008-10#4)
samples were studied##2##3##(2008-10#1)(2008-3#1)
samples were subjected to##5##4##(1995-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)
samples were suspended in##2##4##(2008-10#2)
samples were suspended##3##3##(2008-10#3)
samples were taken at##2##4##(2008-10#1)(2013-1#1)
samples were taken for##3##4##(2008-10#1)(2010-1#1)(2012-3#1)
samples were taken from the##3##5##(1997-5#1)(2008-12#1)(2013-8#1)
samples were taken from##10##4##(1995-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
samples were taken monthly##2##4##(2008-5#1)(2010-8#1)
samples were taken##25##3##(1990-3#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
samples were tested by##3##4##(2007-7#1)(2008-12#1)(2013-1#1)
samples were tested for##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
samples were tested##6##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
samples were treated with##2##4##(2008-10#2)
samples were treated##5##3##(2008-10#4)(2011-1#1)
samples were used as a##2##5##(2008-10#1)(2008-11#1)
samples were used as##4##4##(2008-10#3)(2008-11#1)
samples were used to##3##4##(2008-10#3)
samples were used##9##3##(1996-12#1)(2008-10#6)(2008-11#1)(2012-12#1)
samples were##470##2##(1990-12#5)(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#3)(1992-12#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#5)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#3)(2007-7#11)(2007-8#2)(2008-1#4)(2008-10#232)(2008-11#5)(2008-12#19)(2008-2#3)(2008-3#6)(2008-5#19)(2008-6#3)(2008-7#6)(2008-9#1)(2009-11#2)(2009-4#3)(2009-7#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#3)(2010-8#4)(2011-1#9)(2011-2#19)(2011-3#2)(2012-1#3)(2012-12#6)(2012-2#9)(2012-3#6)(2012-6#1)(2013-1#11)(2013-7#4)(2013-8#12)
samples when##6##2##(1996-12#1)(2008-10#2)(2008-3#3)
samples whereas##2##2##(2008-10#1)(2010-5#1)
samples which were collected from##2##5##(2008-11#1)(2013-8#1)
samples which were##5##3##(1993-2#1)(2008-11#1)(2013-8#3)
samples which##10##2##(1993-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2013-8#3)
samples while##4##2##(2008-10#2)(2010-6#1)(2012-12#1)
samples with a recovery of##2##5##(2008-10#1)(2010-4#1)
samples with a recovery range of##2##6##(2008-10#2)
samples with a recovery##4##4##(2008-10#3)(2010-4#1)
samples with a##23##3##(1994-3#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
samples with added##2##3##(1994-8#1)(2008-10#1)
samples with an##3##3##(2008-10#3)
samples with and without##2##4##(2008-10#1)(2008-5#1)
samples with different##7##3##(2008-10#7)
samples with good##2##3##(2008-10#2)
samples with one##2##3##(2008-4#1)(2008-7#1)
samples with respect to##2##4##(2008-10#1)(2010-12#1)
samples with satisfactory results##24##4##(2008-10#24)
samples with satisfactory##26##3##(2008-10#26)
samples with satisfied results##2##4##(2008-10#2)
samples with similar##2##3##(2008-10#1)(2008-2#1)
samples with the##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
samples with this##2##3##(2008-10#2)
samples with unknown##2##3##(2008-10#1)(2008-11#1)
samples with very##2##3##(1994-11#1)(2008-10#1)
samples with##160##2##(1990-2#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#5)(2008-10#113)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
samples within the##2##3##(2008-10#1)(2008-6#1)
samples within##4##2##(1991-9#1)(2008-10#2)(2008-6#1)
samples without any##3##3##(2008-10#3)
samples without previous##2##3##(2008-10#2)
samples without##12##2##(2008-10#10)(2008-9#1)(2011-1#1)
samples##4632##1##(1990-12#18)(1990-2#7)(1990-3#3)(1990-7#4)(1990-8#20)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#10)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#3)(1991-8#4)(1991-9#5)(1992-11#4)(1992-12#4)(1992-3#12)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#13)(1993-6#3)(1993-8#3)(1993-9#6)(1994-1#1)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#6)(1994-5#4)(1994-6#10)(1994-8#6)(1994-9#8)(1995-11#6)(1995-12#13)(1995-2#11)(1995-3#2)(1995-6#8)(1995-8#4)(1995-9#1)(1996-12#35)(1996-2#4)(1996-5#3)(1996-6#2)(1996-7#3)(1996-9#2)(1997-1#1)(1997-2#12)(1997-3#5)(1997-4#20)(1997-5#6)(1997-6#8)(1997-7#3)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#13)(2007-12#23)(2007-2#3)(2007-3#1)(2007-5#6)(2007-7#32)(2007-8#5)(2008-1#17)(2008-10#2999)(2008-11#63)(2008-12#92)(2008-2#46)(2008-3#109)(2008-4#47)(2008-5#98)(2008-6#24)(2008-7#42)(2008-8#13)(2008-9#41)(2009-10#2)(2009-11#10)(2009-12#9)(2009-2#4)(2009-3#5)(2009-4#23)(2009-5#6)(2009-6#4)(2009-7#7)(2009-8#7)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#15)(2010-12#8)(2010-2#5)(2010-3#4)(2010-4#35)(2010-5#17)(2010-6#12)(2010-7#3)(2010-8#9)(2011-1#40)(2011-10#1)(2011-2#91)(2011-3#5)(2012-1#15)(2012-12#28)(2012-2#48)(2012-3#36)(2012-6#1)(2013-1#73)(2013-7#17)(2013-8#48)
samples'##3##1##(2008-10#1)(2009-4#1)(2013-8#1)
samples) and##2##2##(2008-10#1)(2008-4#1)
samples) was##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
samples)##24##1##(1990-8#1)(1994-9#1)(2008-10#15)(2008-3#1)(2008-4#1)(2010-12#3)(2011-1#1)(2011-2#1)
samples/h##7##1##(1993-8#2)(2008-10#5)
samples/hour##2##1##(2008-10#1)(2010-5#1)
samplesh(-1)##6##1##(2008-10#6)
sampling ETAAS method##2##3##(2008-10#2)
sampling ETAAS##6##2##(2008-10#6)
sampling a##3##2##(2008-10#3)
sampling and analysis##2##3##(2008-10#2)
sampling and for##2##3##(1990-8#1)(2008-10#1)
sampling and the##5##3##(1996-3#1)(1997-8#1)(2008-10#3)
sampling and washing##5##3##(2008-10#5)
sampling and##51##2##(1990-8#1)(1992-12#1)(1992-2#1)(1994-9#1)(1995-2#1)(1996-3#2)(1997-8#1)(2007-12#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-8#1)
sampling approach##3##2##(2008-10#2)(2011-2#1)
sampling are##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
sampling arm##5##2##(2008-10#5)
sampling at##4##2##(2008-10#1)(2009-1#1)(2010-8#1)(2013-1#1)
sampling based on##2##3##(2007-11#1)(2010-4#1)
sampling bias##2##2##(1993-9#1)(2008-10#1)
sampling bout##5##2##(2008-10#2)(2008-8#3)
sampling bouts##3##2##(2008-8#3)
sampling by##4##2##(2008-10#3)(2008-3#1)
sampling data##2##2##(1996-3#1)(2010-2#1)
sampling date##8##2##(1996-12#1)(2008-10#5)(2008-7#1)(2012-8#1)
sampling dates in##2##3##(2008-12#1)(2013-8#1)
sampling dates##11##2##(2008-10#6)(2008-12#1)(2008-7#3)(2013-8#1)
sampling density and spatial resolution##2##5##(2008-9#2)
sampling density and##3##3##(2008-3#1)(2008-9#2)
sampling design in##2##3##(1996-3#1)(2008-10#1)
sampling design that##2##3##(2013-7#2)
sampling design##8##2##(1996-3#1)(2008-10#2)(2011-2#1)(2013-7#4)
sampling designs##2##2##(2008-10#1)(2010-11#1)
sampling device##3##2##(2008-10#2)(2012-2#1)
sampling distribution##3##2##(2008-10#3)
sampling duration##3##2##(2008-11#1)(2013-7#2)
sampling electrothermal atomic absorption spectrometry##5##5##(2008-10#5)
sampling electrothermal atomic absorption##6##4##(2008-10#6)
sampling electrothermal##9##2##(2008-10#9)
sampling for##10##2##(1996-12#1)(1996-7#1)(2008-10#8)
sampling frequency is##6##3##(2008-10#4)(2012-2#1)(2012-3#1)
sampling frequency of 30 h(-1)##2##5##(2008-10#2)
sampling frequency of 40h(-1)##2##4##(2008-10#2)
sampling frequency of 50##2##4##(2008-10#2)
sampling frequency of 60 h(-1)##2##5##(2008-10#2)
sampling frequency of the system was##2##6##(2008-10#2)
sampling frequency of##34##3##(2008-10#32)(2010-9#1)(2013-1#1)
sampling frequency was##8##3##(2008-10#8)
sampling frequency##57##2##(2008-10#53)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
sampling from##9##2##(1994-2#1)(1995-2#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
sampling graphite furnace atomic absorption spectrometry##3##6##(2008-10#3)
sampling grating##2##2##(2008-2#2)
sampling grid##4##2##(2008-10#4)
sampling has been##3##3##(2008-10#1)(2008-8#2)
sampling in a##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
sampling in##11##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-3#1)(2013-1#1)(2013-8#1)
sampling interval##5##2##(2008-2#1)(2008-3#3)(2011-2#1)
sampling is an##2##3##(1996-3#1)(2008-10#1)
sampling is##14##2##(1990-2#1)(1992-2#1)(1996-3#2)(2008-10#4)(2008-8#1)(2010-11#2)(2010-4#1)(2010-5#1)(2013-1#1)
sampling locations##2##2##(2008-10#1)(2010-8#1)
sampling loop##2##2##(2008-10#2)
sampling method used##2##3##(2008-1#1)(2008-10#1)
sampling method was used##2##4##(2010-3#1)(2013-1#1)
sampling method was##5##3##(2008-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
sampling method##10##2##(2008-1#2)(2008-10#3)(2010-3#1)(2010-5#1)(2011-1#2)(2013-1#1)
sampling methods for##6##3##(2008-10#4)(2009-4#1)(2010-11#1)
sampling methods##19##2##(1992-12#1)(2008-10#12)(2008-5#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-7#1)(2013-8#1)
sampling models##2##2##(2008-10#2)
sampling of a##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
sampling of different##2##3##(1997-3#1)(2008-10#1)
sampling of the##8##3##(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2011-1#1)
sampling of##48##2##(1995-8#1)(1996-12#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-3#2)
sampling on##2##2##(2008-10#1)(2010-4#1)
sampling period was##2##3##(2008-10#1)(2013-7#1)
sampling period##9##2##(2007-5#3)(2008-10#3)(2008-2#1)(2008-5#1)(2013-7#1)
sampling periods and##3##3##(2007-5#1)(2008-12#1)(2008-7#1)
sampling periods##8##2##(2007-5#2)(2008-10#3)(2008-12#1)(2008-7#1)(2013-1#1)
sampling plan##2##2##(2008-10#2)
sampling point##2##2##(2008-2#1)(2008-3#1)
sampling points##13##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#8)
sampling procedure##6##2##(2008-10#5)(2010-5#1)
sampling procedures##5##2##(1992-2#1)(2008-10#3)(2012-3#1)
sampling process##2##2##(2008-10#1)(2011-2#1)
sampling programs##2##2##(2008-10#2)
sampling properties of##2##3##(1994-9#1)(2009-5#1)
sampling protocol was##2##3##(2008-10#2)
sampling protocols##2##2##(2013-7#2)
sampling pulse##2##2##(2008-2#2)
sampling rate for the##2##4##(2008-10#1)(2011-2#1)
sampling rate for##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
sampling rate of 120##3##4##(2008-10#3)
sampling rate of 30##3##4##(2008-10#3)
sampling rate of 40##2##4##(2008-10#2)
sampling rate of 60##4##4##(2008-10#4)
sampling rate of about##5##4##(2008-10#5)
sampling rate of##34##3##(2008-10#31)(2008-3#3)
sampling rate was about##2##4##(2008-10#2)
sampling rate was##13##3##(2008-10#11)(2008-3#1)(2010-5#1)
sampling rate##63##2##(2007-12#2)(2008-10#52)(2008-3#6)(2010-5#1)(2011-2#1)(2012-2#1)
sampling rates of##3##3##(2008-10#3)
sampling rates##9##2##(2008-10#8)(2008-3#1)
sampling record##2##2##(2008-5#2)
sampling scheme##4##2##(1997-5#1)(2008-10#2)(2010-3#1)
sampling schemes and##2##3##(2008-10#1)(2009-5#1)
sampling schemes##6##2##(1997-5#1)(2008-10#4)(2009-5#1)
sampling seasons##3##2##(2008-10#3)
sampling site##4##2##(2008-10#3)(2008-11#1)
sampling sites of##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
sampling sites##15##2##(2008-10#6)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)(2013-7#4)
sampling spinning rates##2##3##(2008-10#2)
sampling station##2##2##(2007-5#1)(2011-2#1)
sampling strategies##4##2##(2008-10#2)(2008-6#1)(2008-8#1)
sampling strategy##4##2##(2008-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
sampling study##3##2##(1992-2#1)(1996-3#1)(2012-1#1)
sampling system##7##2##(2008-10#5)(2008-12#1)(2008-8#1)
sampling systems##3##2##(2008-10#1)(2008-11#2)
sampling technique##11##2##(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2013-1#1)
sampling techniques##6##2##(1992-2#1)(2008-10#4)(2012-12#1)
sampling the##9##2##(1991-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
sampling theorem##2##2##(2007-11#1)(2008-3#1)
sampling throughput of##2##3##(2008-10#2)
sampling throughput##3##2##(2008-10#3)
sampling time and##2##3##(2008-10#2)
sampling time of##3##3##(2008-10#1)(2008-3#2)
sampling time##14##2##(2008-10#9)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)
sampling times##11##2##(1997-4#1)(2008-10#7)(2008-3#1)(2010-1#1)(2013-8#1)
sampling to##5##2##(1995-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
sampling unit is##2##3##(2008-10#1)(2011-2#1)
sampling unit##8##2##(2008-10#6)(2011-2#2)
sampling units observed in each##2##5##(2008-10#2)
sampling units were##2##3##(2008-10#1)(2011-2#1)
sampling units##22##2##(2008-10#19)(2008-5#1)(2011-2#2)
sampling using##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
sampling variability and package effects associated with particles##2##8##(2008-3#2)
sampling variability##3##2##(2008-3#3)
sampling variance##5##2##(2008-10#4)(2008-8#1)
sampling volume##10##2##(2008-10#4)(2008-3#6)
sampling was conducted##2##3##(2008-10#1)(2008-12#1)
sampling was performed##4##3##(1994-7#1)(2008-5#3)
sampling was used to##2##4##(2008-10#1)(2012-12#1)
sampling was##14##2##(1994-7#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
sampling were##2##2##(2008-10#1)(2008-2#1)
sampling with a##2##3##(2008-10#1)(2012-7#1)
sampling with##6##2##(1991-10#1)(2008-10#2)(2010-5#1)(2012-7#1)(2013-7#1)
sampling year##2##2##(2008-10#2)
sampling zone##2##2##(2008-11#2)
sampling##905##1##(1990-2#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#3)(1992-2#6)(1992-3#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#2)(1995-2#2)(1995-8#1)(1995-9#3)(1996-12#8)(1996-3#12)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2007-11#9)(2007-12#13)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#501)(2008-11#16)(2008-12#9)(2008-2#23)(2008-3#51)(2008-4#3)(2008-5#16)(2008-6#4)(2008-7#15)(2008-8#19)(2008-9#4)(2009-1#1)(2009-11#1)(2009-4#2)(2009-5#2)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#12)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#29)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#9)(2012-7#1)(2012-8#2)(2013-1#15)(2013-7#18)(2013-8#8)
sampling-electrothermal##2##1##(2008-10#2)
sampling-graphite furnace atomic absorption spectrometry##2##5##(2008-10#2)
sampling-unit##4##1##(2008-10#4)
samplings were carried out##2##4##(2008-6#1)(2013-7#1)
samplings were##5##2##(2008-5#2)(2008-6#1)(2013-7#2)
samplings##18##1##(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#5)(2013-7#3)
san##4##1##(1990-11#1)(1995-11#1)(2012-3#2)
sanA is##3##2##(2008-9#3)
sanA##6##1##(2008-9#6)
sanatoriums##5##1##(2009-7#5)
sanctioned by##2##2##(2008-12#1)(2008-7#1)
sanctions that##2##2##(1991-2#2)
sanctions##8##1##(1991-1#1)(1991-2#3)(1992-1#2)(2008-11#1)(2009-7#1)
sanctity##2##1##(2007-2#1)(2009-7#1)
sanctuary##4##1##(2008-4#1)(2013-7#3)
sand + silt + leaf mold##2##6##(2008-12#2)
sand + silt##3##3##(2008-12#3)
sand +##4##2##(2008-12#4)
sand and##5##2##(2007-5#1)(2008-10#3)(2008-2#1)
sand flies and##2##3##(2008-12#1)(2013-1#1)
sand flies##14##2##(2007-12#2)(2008-12#8)(2013-1#4)
sand fly##5##2##(2007-12#1)(2008-12#1)(2008-7#1)(2010-1#1)(2012-2#1)
sand sample##2##2##(2008-10#1)(2008-3#1)
sand soil##2##2##(2008-10#2)
sand treated with 1- and 2-methoxynaphthalene##2##6##(2011-2#2)
sand were##2##2##(2008-8#1)(2011-2#1)
sand with##2##2##(2007-5#1)(2008-2#1)
sand##68##1##(1991-12#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#2)(2008-10#18)(2008-12#14)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#1)(2010-2#1)(2011-2#5)(2012-2#1)(2013-1#4)
sand-injured and punctured fruits##2##4##(1997-6#2)
sand-injured##4##1##(1997-6#4)
sandbar opening and##4##3##(2013-7#4)
sandbar opening##7##2##(2013-7#7)
sandbar##8##1##(2013-7#8)
sandblasting with##2##2##(2009-8#2)
sandblasting##3##1##(2009-7#1)(2009-8#2)
sandflies##2##1##(2007-12#1)(2008-8#1)
sandfly##2##1##(2007-12#1)(2011-1#1)
sandgobies##2##1##(2008-8#2)
sandwich ELISA for##2##3##(2008-10#1)(2010-12#1)
sandwich ELISA system##2##3##(2008-10#1)(2008-11#1)
sandwich ELISA##7##2##(1992-12#1)(2008-10#3)(2008-11#1)(2010-12#2)
sandwich and##2##2##(2008-10#1)(2008-7#1)
sandwich arrays##2##2##(2010-11#2)
sandwich assay##3##2##(2008-10#2)(2010-11#1)
sandwich enzyme-linked immunosorbent assay (ELISA)##2##5##(1995-11#1)(2008-10#1)
sandwich enzyme-linked immunosorbent assay##8##4##(1995-11#2)(2008-10#6)
sandwich hybridization assay##2##3##(2008-10#2)
sandwich immunoassay##3##2##(2008-10#2)(2008-9#1)
sandwich##56##1##(1991-2#1)(1992-12#1)(1993-2#1)(1993-8#1)(1995-11#2)(2007-8#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-11#3)(2010-12#2)
sandwich-ELISA##3##1##(1990-12#2)(2008-10#1)
sandwich-enzyme-linked immunosorbent assay##2##3##(2008-10#2)
sandwich-type##6##1##(2008-10#4)(2008-3#1)(2008-6#1)
sandwiched between two##2##3##(1995-8#1)(2008-10#1)
sandwiched between##7##2##(1993-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
sandwiched by##2##2##(1994-5#1)(2008-10#1)
sandwiched##12##1##(1993-3#1)(1994-5#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)
sandwiching##2##1##(2008-10#1)(2008-2#1)
sandy beach##2##2##(2013-7#2)
sandy loam field soil were larger##2##6##(2008-10#2)
sandy loam##7##2##(2008-10#6)(2011-1#1)
sandy patches##2##2##(1996-12#2)
sandy soil##6##2##(2008-10#4)(2008-12#1)(2011-1#1)
sandy soils##4##2##(2008-10#3)(2013-7#1)
sandy##26##1##(1996-12#2)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#3)
sandyi##2##1##(2008-10#2)
sanguinalis and##2##2##(2008-10#2)
sanguinarine##7##1##(2008-10#3)(2011-2#4)
sanguinea##2##1##(2008-10#2)
sanguinis##3##1##(2012-2#3)
sanguis##4##1##(2006-6#2)(2008-5#2)
sanitary conditions##2##2##(1991-12#1)(2011-1#1)
sanitary control##2##2##(2008-10#1)(2012-12#1)
sanitary regulations##2##2##(2009-10#1)(2013-8#1)
sanitary workers##2##2##(2009-12#2)
sanitary##24##1##(1991-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-10#1)(2009-12#3)(2009-7#4)(2011-1#1)(2011-2#2)(2012-12#4)(2013-8#2)
sanitation and##2##2##(2008-10#1)(2013-8#1)
sanitation in##2##2##(1994-9#1)(2012-1#1)
sanitation of##3##2##(2009-12#1)(2010-1#1)(2011-1#1)
sanitation practices##2##2##(2008-10#2)
sanitation##22##1##(1994-9#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-7#1)(2009-12#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
sanofi pasteur##2##2##(2010-10#1)(2013-1#1)
sanofi##3##1##(2010-10#1)(2013-1#2)
sans##4##1##(1997-6#3)(2013-1#1)
sap inoculation from infected##2##4##(2008-10#2)
sap##9##1##(2007-12#1)(2008-10#5)(2008-11#1)(2009-8#1)(2012-8#1)
saphenofemoral##2##1##(2013-1#2)
saphenous vein (SV)##2##3##(2007-7#1)(2011-2#1)
saphenous vein bypass##2##3##(1996-2#1)(2007-8#1)
saphenous vein graft##10##3##(2006-6#1)(2007-8#8)(2009-5#1)
saphenous vein grafts##4##3##(2007-8#3)(2008-7#1)
saphenous vein harvesting##2##3##(2007-7#2)
saphenous vein##29##2##(1990-9#1)(1991-6#1)(1994-11#1)(1994-6#2)(1996-2#3)(2006-6#1)(2007-7#3)(2007-8#14)(2008-7#1)(2009-5#1)(2011-2#1)
saphenous##39##1##(1990-9#1)(1991-6#2)(1994-11#1)(1994-6#2)(1996-2#3)(1996-5#5)(1997-3#2)(2006-6#1)(2007-7#3)(2007-8#15)(2008-7#1)(2009-5#1)(2011-2#2)
sapiens##8##1##(1991-5#2)(1994-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#1)
sapinea DNA##2##2##(2008-10#2)
sapinea infections in##2##3##(2008-10#2)
sapinea##11##1##(2008-10#11)
sapling crown##2##2##(2008-9#2)
sapling##4##1##(2008-9#4)
saplings of##2##2##(2008-5#1)(2012-5#1)
saplings##11##1##(2008-5#6)(2008-9#1)(2012-5#3)(2012-9#1)
saponification by lead salts##2##4##(2008-10#2)
saponification##5##1##(2008-10#4)(2008-5#1)
saponified##2##1##(2008-10#2)
saponin fraction##3##2##(1997-4#3)
saponin##15##1##(1992-5#1)(1992-8#1)(1995-8#3)(1997-4#5)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#1)
saponins##23##1##(1997-4#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-5#1)(2010-2#1)(2011-1#1)(2011-3#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
sapphire (Ti##2##2##(2007-12#2)
sapphire and Cr##3##3##(2007-11#2)(2007-12#1)
sapphire and##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
sapphire fiber##2##2##(2008-2#2)
sapphire fibers##6##2##(2008-2#3)(2008-3#3)
sapphire laser and##2##3##(2007-12#1)(2008-3#1)
sapphire laser at##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
sapphire laser in the##2##4##(2008-2#1)(2008-3#1)
sapphire laser in##3##3##(2008-2#1)(2008-3#2)
sapphire laser is##4##3##(2007-11#3)(2007-12#1)
sapphire laser operating##2##3##(2008-2#1)(2008-3#1)
sapphire laser producing##2##3##(2007-11#2)
sapphire laser pulses##2##3##(2007-12#1)(2008-2#1)
sapphire laser system##3##3##(2007-11#2)(2008-2#1)
sapphire laser was used##2##4##(2007-11#1)(2008-3#1)
sapphire laser with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
sapphire laser with##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
sapphire laser##62##2##(2007-11#21)(2007-12#21)(2008-2#8)(2008-3#12)
sapphire lasers with##3##3##(2008-3#3)
sapphire lasers##11##2##(2007-11#4)(2007-12#2)(2008-3#5)
sapphire microlenses##3##2##(2008-3#3)
sapphire oscillator##5##2##(2007-12#3)(2008-3#2)
sapphire regenerative amplifier##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
sapphire regenerative##8##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
sapphire ring laser##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
sapphire slab##2##2##(2008-3#2)
sapphire substrate##2##2##(2008-3#2)
sapphire substrates##2##2##(2008-2#1)(2008-3#1)
sapphire system##2##2##(2007-11#1)(2008-2#1)
sapphire waveguide##2##2##(2007-12#1)(2008-10#1)
sapphire##151##1##(1991-1#1)(1993-1#2)(2007-11#34)(2007-12#44)(2008-10#2)(2008-2#23)(2008-3#44)(2008-7#1)
sapphire-fiber##4##1##(2008-10#3)(2008-2#1)
sapphyrin##2##1##(2008-10#2)
saprophyte##4##1##(1993-9#1)(2008-10#2)(2008-9#1)
saprophytes and nonpathogens##2##3##(2008-10#2)
saprophytes and##3##2##(2008-10#3)
saprophytes##6##1##(2008-10#6)
saprophytic ability##2##2##(2008-10#2)
saprophytic bacteria##2##2##(2008-10#2)
saprophytic fungal##2##2##(2008-10#2)
saprophytic phase##2##2##(2008-10#2)
saprophytic##22##1##(2008-10#19)(2008-9#1)(2011-2#1)(2012-3#1)
saprophytically##2##1##(2008-10#2)
saprotrophy##2##1##(2010-6#2)
sapstain fungi##2##2##(2008-10#2)
sapstain fungus##2##2##(2008-10#2)
sapstain##12##1##(2008-10#12)
sapstaining##2##1##(2008-10#2)
sapwood##6##1##(2008-10#6)
sarafotoxin S6c##4##2##(1991-11#1)(1992-12#2)(1994-11#1)
sarafotoxin##6##1##(1991-11#1)(1992-12#4)(1994-11#1)
saralasin##5##1##(1990-12#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-1#1)
sarco/endoplasmic reticulum-type Ca2(+)-ATPase##3##3##(1990-12#3)
sarco/endoplasmic reticulum-type##4##2##(1990-12#4)
sarco/endoplasmic##5##1##(1990-12#5)
sarcoid##4##1##(2008-10#2)(2008-11#1)(2008-7#1)
sarcoidosis after##2##2##(2007-7#1)(2012-12#1)
sarcoidosis and##2##2##(2008-12#1)(2013-7#1)
sarcoidosis is##2##2##(2007-7#1)(2008-4#1)
sarcoidosis with##2##2##(2007-7#1)(2008-1#1)
sarcoidosis##36##1##(1993-2#1)(1994-3#1)(1997-5#1)(2007-6#1)(2007-7#7)(2008-1#1)(2008-12#1)(2008-4#4)(2008-7#3)(2009-5#2)(2010-6#3)(2012-12#5)(2012-3#1)(2013-1#2)(2013-7#3)
sarcoiliac joint##2##2##(2010-1#2)
sarcolemma and##3##2##(1994-8#1)(2009-7#1)(2013-1#1)
sarcolemma##8##1##(1990-7#2)(1994-8#1)(1996-9#1)(2008-8#1)(2009-7#1)(2013-1#2)
sarcolemmal vesicles##2##2##(1991-5#2)
sarcolemmal##5##1##(1991-5#3)(1996-9#2)
sarcoma after##3##2##(2009-5#2)(2011-2#1)
sarcoma and carcinoids##2##3##(1993-9#2)
sarcoma and some##2##3##(2008-6#1)(2011-3#1)
sarcoma and##10##2##(1992-12#1)(1993-9#2)(1994-7#1)(1996-3#1)(2008-6#2)(2009-3#1)(2011-2#1)(2011-3#1)
sarcoma arising from the##2##4##(2008-6#1)(2013-1#1)
sarcoma arising in##3##3##(2008-6#2)(2013-7#1)
sarcoma arising##5##2##(2008-6#3)(2013-1#1)(2013-7#1)
sarcoma associated with the acquired immunodeficiency syndrome##2##7##(1990-9#1)(1992-2#1)
sarcoma at the##2##3##(2008-6#2)
sarcoma cell##2##2##(2008-6#2)
sarcoma cells##5##2##(1990-11#1)(1992-3#1)(2008-6#3)
sarcoma in the left##2##4##(2008-6#2)
sarcoma in the##5##3##(1994-7#1)(2008-6#3)(2011-2#1)
sarcoma in##11##2##(1994-7#1)(2007-9#1)(2008-6#6)(2008-7#1)(2011-2#1)(2013-1#1)
sarcoma is a##2##3##(2007-7#1)(2008-6#1)
sarcoma is##5##2##(1990-8#1)(2007-7#1)(2008-6#3)
sarcoma of the breast##4##4##(1992-2#3)(1994-7#1)
sarcoma of the extremities##3##4##(2008-6#3)
sarcoma of the##27##3##(1990-2#1)(1991-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(1994-7#1)(1996-6#1)(2006-12#1)(2008-6#10)(2008-7#1)(2009-3#1)(2011-2#2)(2012-1#1)(2013-1#2)
sarcoma of##33##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(1994-7#1)(1996-6#1)(2006-12#1)(2008-1#1)(2008-6#12)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#1)
sarcoma patients##5##2##(2008-6#3)(2008-7#1)(2010-3#1)
sarcoma presenting as##2##3##(1990-2#1)(2006-10#1)
sarcoma resistant to##2##3##(2008-6#2)
sarcoma specimens##3##2##(2008-6#3)
sarcoma treatment##2##2##(2008-6#1)(2010-3#1)
sarcoma virus##7##2##(1990-12#1)(1995-6#2)(1997-8#1)(2008-11#2)(2008-9#1)
sarcoma was##3##2##(2008-4#1)(2008-6#1)(2008-7#1)
sarcoma with myxoid##2##3##(1993-2#2)
sarcoma with##8##2##(1990-6#1)(1993-2#2)(2007-8#1)(2008-6#3)(2011-1#1)
sarcoma##223##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#2)(1991-8#3)(1992-12#6)(1992-2#7)(1992-3#2)(1993-12#1)(1993-2#3)(1993-8#1)(1993-9#2)(1994-12#1)(1994-7#4)(1995-6#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#3)(2007-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#103)(2008-7#7)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#5)(2010-3#8)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#7)(2013-7#2)
sarcoma-like##2##1##(1993-2#1)(2012-3#1)
sarcomas and##5##2##(2008-6#3)(2012-12#1)(2013-7#1)
sarcomas are##3##2##(1991-11#1)(2008-6#1)(2009-3#1)
sarcomas in##5##2##(1992-12#1)(2008-6#1)(2008-8#3)
sarcomas of the extremity and superficial trunk##2##7##(1993-9#1)(2008-6#1)
sarcomas of the##4##3##(1993-9#1)(2008-6#3)
sarcomas were##2##2##(2008-6#1)(2010-3#1)
sarcomas##89##1##(1990-12#1)(1991-11#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-9#1)(1994-6#1)(2008-4#1)(2008-6#62)(2008-7#1)(2008-8#3)(2009-3#1)(2010-12#1)(2010-3#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
sarcomatoid carcinoma of the breast##2##5##(1992-8#1)(2012-3#1)
sarcomatoid carcinoma of the##3##4##(1992-8#1)(2009-5#1)(2012-3#1)
sarcomatoid carcinoma##4##2##(1992-8#1)(2009-5#1)(2010-8#1)(2012-3#1)
sarcomatoid##7##1##(1990-8#1)(1992-8#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#2)
sarcomatous components were##2##3##(2012-1#2)
sarcomatous components##4##2##(1991-4#1)(2009-5#1)(2012-1#2)
sarcomatous##12##1##(1990-12#2)(1991-4#1)(1993-6#1)(1994-5#1)(1994-6#1)(2008-6#1)(2009-5#1)(2011-2#2)(2012-1#2)
sarcomere length##2##2##(2010-4#1)(2013-1#1)
sarcomere##3##1##(2008-6#1)(2010-4#1)(2013-1#1)
sarcomeric##2##1##(2008-7#1)(2008-9#1)
sarcoplasmatic proteins##2##2##(2010-4#1)(2012-2#1)
sarcoplasmic reticulum (SR)##5##3##(1994-8#1)(1995-6#1)(2008-11#1)(2008-8#2)
sarcoplasmic reticulum##24##2##(1990-2#4)(1991-12#2)(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#2)(1994-8#1)(1995-6#2)(1997-7#1)(2008-11#1)(2008-8#4)(2009-7#2)(2013-8#1)
sarcoplasmic##26##1##(1990-2#4)(1991-12#2)(1991-2#1)(1991-9#1)(1992-3#2)(1994-11#2)(1994-8#1)(1995-6#2)(1996-9#1)(1997-7#1)(2008-11#1)(2008-8#4)(2009-7#2)(2010-4#1)(2013-8#1)
sarcoptic##2##1##(1990-3#2)
sarcosine##2##1##(2008-10#1)(2011-1#1)
sardine##2##1##(1992-2#1)(2008-10#1)
sardous plots##2##2##(2008-10#2)
sardous##5##1##(2008-10#5)
sarin##3##1##(2008-11#3)
sarkosyl treatment##2##2##(1990-7#2)
sarkosyl##3##1##(1990-7#3)
sarson##2##1##(2011-1#2)
saruplase##3##1##(2007-11#3)
sat##2##1##(2008-10#1)(2008-6#1)
satDNA##2##1##(2008-10#2)
satRNA variants##2##2##(2008-10#2)
satRNA##9##1##(2008-10#9)
satRNA-free##2##1##(2008-10#2)
satRNAs from##2##2##(2008-10#2)
satRNAs##13##1##(2008-10#13)
satellite DNA##9##2##(1997-6#2)(2008-10#1)(2008-8#2)(2010-8#4)
satellite DNAs##3##2##(2008-10#2)(2010-8#1)
satellite RNA##7##2##(1997-6#1)(2008-10#6)
satellite RNAs##3##2##(2008-10#3)
satellite and##2##2##(2008-3#1)(2008-8#1)
satellite cell##4##2##(1993-3#1)(2008-7#1)(2009-3#2)
satellite cells##14##2##(1993-3#2)(1995-12#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#6)
satellite communication##3##2##(2008-3#3)
satellite imagery##4##2##(2007-5#2)(2008-2#2)
satellite images##5##2##(2008-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
satellite instrument##2##2##(2008-2#1)(2008-3#1)
satellite lesions##2##2##(2008-1#1)(2012-3#1)
satellite ocean color imagery##4##4##(2008-3#4)
satellite ocean color##5##3##(2008-3#5)
satellite of##2##2##(1993-12#1)(2008-5#1)
satellite peaks##2##2##(2008-3#2)
satellite retrieval##2##2##(2008-2#2)
satellite sensor##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
satellite sensors##3##2##(2008-2#2)(2008-3#1)
satellite solar occultation##2##3##(2008-2#2)
satellite stem cells##2##3##(2009-3#2)
satellite that##2##2##(2008-3#2)
satellite to##2##2##(2008-2#1)(2008-5#1)
satellite tobacco mosaic virus##4##4##(2008-10#2)(2008-9#2)
satellite was##2##2##(2008-3#2)
satellite were##2##2##(2008-3#2)
satellite##150##1##(1991-8#2)(1993-12#2)(1993-3#3)(1994-1#2)(1995-12#2)(1997-3#1)(1997-6#4)(2007-12#1)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#25)(2008-3#42)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#2)(2009-3#11)(2010-8#6)(2010-9#1)(2012-1#1)(2012-3#1)(2013-8#4)
satellite-based##6##1##(2008-2#1)(2008-3#4)(2013-8#1)
satelliteborne##2##1##(2008-3#2)
satellites and##5##2##(2008-2#1)(2008-8#4)
satellites in##2##2##(2008-2#1)(2012-2#1)
satellites##27##1##(1991-8#1)(1997-7#1)(2008-10#1)(2008-2#9)(2008-3#3)(2008-7#1)(2008-8#10)(2012-2#1)
satiating##2##1##(2012-2#2)
satiety##2##1##(2008-4#1)(2008-7#1)
satin##2##1##(2008-8#2)
satisfaction along with##2##3##(1994-3#1)(1997-3#1)
satisfaction among the##2##3##(2008-10#1)(2010-8#1)
satisfaction among##8##2##(1992-1#1)(1993-2#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)
satisfaction and efficacy##3##3##(1995-2#3)
satisfaction and high##2##3##(2007-11#1)(2012-3#1)
satisfaction and in##2##3##(1994-1#1)(2011-2#1)
satisfaction and more##2##3##(1996-9#1)(2008-6#1)
satisfaction and performance##2##3##(2007-10#2)
satisfaction and psychological##2##3##(2008-11#1)(2011-2#1)
satisfaction and service quality##3##4##(1995-1#3)
satisfaction and the##3##3##(1991-2#1)(2008-11#1)(2011-1#1)
satisfaction and willingness to recommend the provider##3##7##(1993-12#3)
satisfaction and##54##2##(1990-6#1)(1991-2#2)(1992-12#1)(1993-12#5)(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#4)
satisfaction are##2##2##(1996-2#1)(2007-12#1)
satisfaction at##2##2##(1997-3#1)(2007-10#1)
satisfaction data##3##2##(1996-1#1)(1997-2#1)(1997-3#1)
satisfaction did not##3##3##(1997-1#1)(2013-1#2)
satisfaction during##2##2##(2010-2#2)
satisfaction for##4##2##(1990-12#1)(1993-12#1)(2008-9#1)(2011-2#1)
satisfaction in a##2##3##(1997-6#1)(2011-2#1)
satisfaction in the##3##3##(1993-12#2)(1994-1#1)
satisfaction in##12##2##(1993-11#1)(1993-12#2)(1994-1#1)(1997-1#1)(1997-6#1)(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)
satisfaction information as competitive intelligence##2##5##(1996-3#2)
satisfaction information##5##2##(1995-3#1)(1996-2#1)(1996-3#3)
satisfaction is##8##2##(1994-12#2)(1994-3#1)(2008-11#1)(2008-7#1)(2010-10#2)(2011-2#1)
satisfaction levels##3##2##(1994-2#1)(1994-3#1)(2010-10#1)
satisfaction may##3##2##(1995-1#1)(2012-2#2)
satisfaction measures##3##2##(1994-3#1)(1997-2#1)(2010-2#1)
satisfaction of the##6##3##(1991-1#1)(1992-1#1)(1994-5#1)(2008-2#1)(2010-9#1)(2013-1#1)
satisfaction of##17##2##(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-3#1)(2007-10#1)(2008-2#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2013-1#3)(2013-7#1)
satisfaction one##3##2##(2007-10#2)(2009-7#1)
satisfaction or##2##2##(1996-1#1)(2008-9#1)
satisfaction ratings##3##2##(1995-12#1)(1997-3#2)
satisfaction survey to##2##3##(1996-2#1)(2008-12#1)
satisfaction survey##12##2##(1993-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(2007-11#1)(2008-12#5)
satisfaction surveys##9##2##(1994-12#1)(1994-3#1)(1996-2#1)(1996-3#6)
satisfaction than##3##2##(1997-1#1)(2007-12#1)(2013-1#1)
satisfaction to##3##2##(1992-12#1)(1996-2#1)(2007-11#1)
satisfaction was high##2##3##(1995-3#1)(2007-8#1)
satisfaction was##12##2##(1994-2#1)(1995-3#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-2#1)
satisfaction were found##2##3##(2008-11#1)(2010-10#1)
satisfaction were##12##2##(1992-1#1)(1992-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2013-1#1)
satisfaction with care##5##3##(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)
satisfaction with cessation##2##3##(2010-2#2)
satisfaction with clinical##2##3##(2008-11#2)
satisfaction with dental##3##3##(1993-12#2)(2013-1#1)
satisfaction with food-related life##4##4##(2012-2#4)
satisfaction with life##4##3##(1993-6#1)(1997-2#1)(1997-4#1)(2012-2#1)
satisfaction with medical care##2##4##(1996-2#1)(1996-3#1)
satisfaction with music##3##3##(2007-6#2)(2008-9#1)
satisfaction with pain treatment##2##4##(2009-12#2)
satisfaction with radiology##2##3##(1993-1#1)(2012-2#1)
satisfaction with service##2##3##(1993-12#1)(2011-1#1)
satisfaction with the TEMPO+##2##4##(2008-9#2)
satisfaction with the##19##3##(1990-10#1)(1993-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-6#3)(2008-11#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
satisfaction with their bodies##3##4##(2008-9#3)
satisfaction with their##5##3##(1997-1#1)(2008-9#4)
satisfaction with treatment##2##3##(1995-12#1)(2009-12#1)
satisfaction with undergraduate education##3##4##(1993-3#3)
satisfaction with##95##2##(1990-10#1)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-6#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#7)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-6#5)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#10)(2009-12#3)(2009-5#1)(2009-7#3)(2010-10#1)(2010-2#4)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#8)(2012-3#3)(2013-1#2)(2013-8#2)
satisfaction##463##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#7)(1991-3#3)(1992-1#8)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#20)(1993-2#5)(1993-3#6)(1993-6#3)(1994-1#5)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#8)(1994-5#1)(1995-1#6)(1995-12#13)(1995-2#8)(1995-3#8)(1996-1#9)(1996-12#1)(1996-2#17)(1996-3#36)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#16)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-10#10)(2007-11#4)(2007-12#13)(2007-4#2)(2007-6#5)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#17)(2008-12#15)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#17)(2009-10#1)(2009-12#4)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#7)(2009-9#1)(2010-10#9)(2010-11#3)(2010-2#12)(2010-5#2)(2010-8#8)(2010-9#1)(2011-1#3)(2011-2#16)(2012-1#5)(2012-12#1)(2012-2#15)(2012-3#5)(2013-1#20)(2013-7#1)(2013-8#5)
satisfaction) and##2##2##(2007-12#2)
satisfaction)##4##1##(2007-12#2)(2008-7#1)(2013-1#1)
satisfaction/dissatisfaction##2##1##(1992-1#1)(2008-12#1)
satisfaction]##2##1##(1994-6#1)(1996-11#1)
satisfactorily applied for the##4##4##(2008-10#4)
satisfactorily applied to the determination of##13##6##(2008-10#13)
satisfactorily applied to the##17##4##(2008-10#17)
satisfactorily applied to##21##3##(2008-10#21)
satisfactorily applied##26##2##(2008-10#26)
satisfactorily for the determination of##2##5##(2008-10#2)
satisfactorily for##4##2##(2008-10#4)
satisfactorily identified##2##2##(2008-10#1)(2008-3#1)
satisfactorily in the##5##3##(2008-10#4)(2011-2#1)
satisfactorily in##7##2##(1995-6#1)(2008-10#5)(2011-2#1)
satisfactorily predicted##2##2##(2008-10#1)(2008-7#1)
satisfactorily resolve##2##2##(2008-10#1)(2012-3#1)
satisfactorily the##2##2##(2008-10#2)
satisfactorily to##17##2##(2008-1#1)(2008-10#16)
satisfactorily used##3##2##(2008-10#3)
satisfactorily with those##2##3##(2008-10#2)
satisfactorily with##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
satisfactorily##105##1##(1990-11#1)(1991-1#1)(1993-3#1)(1995-6#1)(1996-5#1)(1997-3#2)(2007-11#1)(2008-1#1)(2008-10#79)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
satisfactory accuracy and precision in the presence of excess##2##9##(2008-10#2)
satisfactory accuracy and precision in the presence of##3##8##(2008-10#3)
satisfactory accuracy and precision##5##4##(2008-10#5)
satisfactory accuracy##6##2##(2008-10#5)(2008-3#1)
satisfactory agreement with the##3##4##(2007-12#1)(2008-2#2)
satisfactory agreement with##5##3##(2007-12#1)(2008-10#2)(2008-2#2)
satisfactory agreement##11##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)
satisfactory and##9##2##(2007-8#2)(2008-10#2)(2008-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
satisfactory clinical##3##2##(1995-11#1)(2011-2#1)(2013-1#1)
satisfactory despite##2##2##(2008-7#1)(2011-1#1)
satisfactory evolution##2##2##(1991-11#1)(2013-8#1)
satisfactory for the##3##3##(1992-3#1)(2008-10#2)
satisfactory for##12##2##(1992-3#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-9#1)
satisfactory in two (10%)##3##4##(1996-9#3)
satisfactory in##14##2##(1991-2#1)(1996-11#1)(1996-9#3)(1997-8#1)(2007-8#2)(2008-10#2)(2008-7#2)(2011-2#2)
satisfactory outcome##2##2##(2008-10#1)(2008-7#1)
satisfactory performance##4##2##(2008-10#3)(2008-3#1)
satisfactory precision##4##2##(2008-10#4)
satisfactory recovery##4##2##(2008-10#4)
satisfactory reproducibility##2##2##(2008-10#2)
satisfactory resolution##2##2##(1991-2#1)(2008-10#1)
satisfactory response##3##2##(2011-2#1)(2012-3#2)
satisfactory result##3##2##(2008-10#3)
satisfactory results and##3##3##(2008-10#3)
satisfactory results for##2##3##(2010-11#1)(2013-1#1)
satisfactory results in the##2##4##(2007-8#1)(2008-10#1)
satisfactory results in##8##3##(1994-3#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#1)
satisfactory results obtained##2##3##(1992-6#1)(2008-5#1)
satisfactory results on##2##3##(2008-10#2)
satisfactory results were obtained##2##4##(2008-10#2)
satisfactory results were##4##3##(1994-9#1)(2008-10#2)(2011-2#1)
satisfactory results with##2##3##(1992-9#1)(2008-10#1)
satisfactory results##127##2##(1990-12#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#4)(2008-1#1)(2008-10#98)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#2)
satisfactory separation of##2##3##(2008-10#2)
satisfactory surgical##2##2##(2006-12#1)(2008-7#1)
satisfactory to##3##2##(2008-10#3)
satisfactory when##2##2##(1995-2#1)(2008-2#1)
satisfactory with##4##2##(1990-5#1)(1991-11#1)(2008-10#2)
satisfactory##367##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#5)(1997-3#2)(1997-4#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#12)(2008-1#3)(2008-10#202)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#10)(2008-9#5)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#12)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
satisfactory&quot##2##1##(1993-2#2)
satisfiability##2##1##(2010-2#2)
satisfied by the##2##3##(1992-3#1)(2008-11#1)
satisfied by##4##2##(1990-6#1)(1992-3#1)(2008-11#2)
satisfied customers##2##2##(1992-1#1)(1993-1#1)
satisfied for##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
satisfied or##2##2##(1992-5#1)(2008-10#1)
satisfied than the##2##3##(1996-2#1)(2009-11#1)
satisfied than##5##2##(1996-2#2)(2009-11#1)(2012-2#2)
satisfied that##2##2##(1996-3#1)(2013-1#1)
satisfied with life##2##3##(2007-10#1)(2009-11#1)
satisfied with the treatment##2##4##(2008-9#1)(2013-1#1)
satisfied with the##22##3##(1991-1#1)(1991-2#1)(1992-5#1)(1994-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
satisfied with their bodies##3##4##(2009-5#2)(2010-10#1)
satisfied with their##14##3##(1993-3#2)(1996-2#2)(1996-9#1)(2007-1#2)(2007-10#1)(2008-3#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-3#1)
satisfied with this##2##3##(1990-2#1)(1991-1#1)
satisfied with##46##2##(1990-2#1)(1991-1#2)(1991-2#1)(1992-5#1)(1993-3#4)(1994-1#1)(1995-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#1)(2007-1#2)(2007-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-5#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)
satisfied##84##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-2#2)(1992-1#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-3#5)(1993-6#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-2#5)(1996-3#3)(1996-9#1)(1997-2#1)(2007-1#2)(2007-10#3)(2007-11#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#2)(2008-9#5)(2009-11#2)(2009-5#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#1)
satisfies its##2##2##(2007-10#1)(2010-2#1)
satisfies the##9##2##(2008-10#2)(2008-2#3)(2008-3#3)(2013-1#1)
satisfies##18##1##(2007-10#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
satisfy patients'##2##2##(1994-1#1)(1997-3#1)
satisfy the needs of##2##4##(1994-12#1)(2013-7#1)
satisfy the wave equation##2##4##(2007-12#2)
satisfy the##29##2##(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
satisfy##46##1##(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
satisfying both##2##2##(1995-3#1)(2008-3#1)
satisfying the##7##2##(1993-12#1)(1997-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-12#1)
satisfying##25##1##(1991-12#1)(1993-12#2)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
sativa (L##2##2##(2008-12#1)(2008-5#1)
sativa L##34##2##(1992-8#1)(1994-11#1)(1996-10#1)(1997-4#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#13)(2011-2#2)(2012-3#1)
sativa and##2##2##(2008-10#1)(2008-5#1)
sativa ssp##4##2##(2008-9#1)(2009-10#3)
sativa##71##1##(1992-3#2)(1992-8#1)(1994-11#1)(1996-10#1)(1997-4#2)(2008-10#12)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#20)(2009-10#7)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#3)
sativa) in##2##2##(2008-10#1)(2008-12#1)
sativa)##19##1##(2008-10#14)(2008-12#2)(2008-7#2)(2009-10#1)
sativum##4##1##(2008-10#3)(2011-2#1)
sativum) and##3##2##(1992-9#1)(2008-1#1)(2008-10#1)
sativum)##6##1##(1992-9#1)(1993-6#1)(2008-1#1)(2008-10#3)
sativus L##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-12#1)
sativus and##6##2##(2008-10#6)
sativus isolates##2##2##(2008-10#2)
sativus##32##1##(2008-10#26)(2008-12#1)(2008-5#4)(2009-12#1)
sativus)##11##1##(2008-10#10)(2011-2#1)
saturable Bragg reflector as the##2##5##(2007-11#1)(2008-3#1)
saturable Bragg reflector##7##3##(2007-11#6)(2008-3#1)
saturable absorber is studied##2##4##(2007-12#1)(2008-3#1)
saturable absorber is##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
saturable absorber mirror##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
saturable absorber##36##2##(2007-11#6)(2007-12#6)(2008-2#5)(2008-3#19)
saturable absorbers##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
saturable absorption##5##2##(2008-2#1)(2008-3#4)
saturable and reversible##2##3##(1990-11#1)(1990-8#1)
saturable and##7##2##(1990-11#1)(1990-8#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)
saturable gain##4##2##(2007-12#3)(2008-3#1)
saturable##95##1##(1990-11#2)(1990-8#2)(1991-12#2)(1991-2#1)(1992-3#4)(1992-9#1)(1993-1#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(2007-11#14)(2007-12#15)(2008-2#8)(2008-3#28)(2008-4#2)(2009-8#1)
saturable-absorber mirror##9##2##(2007-11#2)(2007-12#5)(2008-3#2)
saturable-absorber mode locking##2##3##(2007-12#2)
saturable-absorber response##2##2##(2007-12#2)
saturable-absorber##15##1##(2007-11#3)(2007-12#10)(2008-3#2)
saturably##3##1##(1990-7#1)(1993-6#1)(1993-9#1)
saturate##6##1##(1992-10#1)(2008-10#1)(2008-3#3)(2009-11#1)
saturated absorption##2##2##(2008-3#2)
saturated and unsaturated##2##3##(1992-6#1)(2008-10#1)
saturated calomel electrode##2##3##(2008-10#2)
saturated calomel reference electrode##3##4##(2008-10#3)
saturated calomel##5##2##(2008-10#5)
saturated degenerate four-wave mixing##2##4##(2008-3#2)
saturated esters on##2##3##(2008-10#2)
saturated fat##5##2##(1990-11#1)(1993-9#1)(2008-10#1)(2010-4#1)(2012-2#1)
saturated fats##2##2##(2008-3#1)(2008-7#1)
saturated fatty acid (SFA)##2##4##(2010-2#1)(2010-4#1)
saturated fatty acid##12##3##(1990-8#1)(1995-11#1)(2008-12#1)(2010-2#1)(2010-4#1)(2013-1#7)
saturated fatty acids was##2##4##(2008-11#2)
saturated fatty acids were##2##4##(1994-8#1)(2009-8#1)
saturated fatty acids##13##3##(1990-2#2)(1991-12#1)(1992-6#1)(1992-8#2)(1994-8#1)(2008-11#2)(2008-12#1)(2009-8#1)(2010-4#2)
saturated fatty##27##2##(1990-2#2)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-8#1)(2010-2#1)(2010-4#3)(2012-2#1)(2013-1#7)
saturated mixed-chain##2##2##(1990-7#2)
saturated or unsaturated fatty acids##2##5##(1990-2#1)(1994-8#1)
saturated or unsaturated##3##3##(1990-2#1)(1994-8#1)(1995-5#1)
saturated palmitic fatty acid##2##4##(2013-1#2)
saturated side chain##2##3##(1992-3#1)(2007-11#1)
saturated solution of##3##3##(2007-7#1)(2008-10#2)
saturated transmission and##2##3##(2008-3#2)
saturated transmission##3##2##(2008-3#3)
saturated with##5##2##(1996-3#1)(2008-10#2)(2008-2#1)(2011-2#1)
saturated##122##1##(1990-11#1)(1990-2#4)(1990-7#3)(1990-8#1)(1991-12#2)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#16)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-2#1)(2010-4#4)(2011-1#2)(2011-2#1)(2012-2#7)(2013-1#9)
saturated-absorption spectra recorded by use of##2##6##(2007-11#1)(2007-12#1)
saturated-absorption##4##1##(2007-11#2)(2007-12#2)
saturates at##2##2##(2007-12#1)(2008-10#1)
saturates##6##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
saturating concentration of##3##3##(1990-10#1)(1992-3#1)(1993-6#1)
saturating concentration##4##2##(1990-10#1)(1992-3#1)(1993-6#1)(1994-2#1)
saturating concentrations##2##2##(1992-3#1)(1997-2#1)
saturating##15##1##(1990-10#1)(1990-2#1)(1991-5#1)(1992-3#2)(1993-6#1)(1994-2#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-3#2)(2008-8#3)
saturation (SpO2)##2##2##(1993-1#2)
saturation absorption##2##2##(2008-3#2)
saturation and excited-state absorption##2##4##(2008-3#2)
saturation and predominant in the##2##5##(1990-5#2)
saturation and##13##2##(1990-5#2)(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-4#1)(2013-7#1)
saturation as##2##2##(2008-3#1)(2008-8#1)
saturation capacity##2##2##(2008-10#2)
saturation during##2##2##(1993-1#1)(1997-8#1)
saturation effects##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
saturation experiments##3##2##(1993-6#1)(1995-3#1)(1996-2#1)
saturation fluence##3##2##(2008-3#3)
saturation for##2##2##(1994-5#1)(2008-2#1)
saturation in the##2##3##(1994-12#1)(2007-12#1)
saturation in##8##2##(1994-12#1)(2007-12#1)(2008-3#4)(2008-7#1)(2010-10#1)
saturation increased##2##2##(2008-1#1)(2013-1#1)
saturation intensity and##2##3##(2008-2#1)(2008-3#1)
saturation intensity##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
saturation irradiance##10##2##(2008-2#4)(2008-3#6)
saturation is##4##2##(1994-5#1)(1997-6#1)(2008-1#1)(2008-3#1)
saturation kinetics with##2##3##(1991-5#1)(1991-8#1)
saturation level##4##2##(1996-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
saturation mutagenesis##2##2##(2011-1#2)
saturation of the##9##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2011-2#1)(2013-1#1)
saturation of##21##2##(1991-5#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-7#2)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
saturation on the##4##3##(2008-3#4)
saturation properties of terahertz emission from##2##6##(2007-12#2)
saturation spectroscopy##2##2##(2007-12#2)
saturation values##2##2##(2007-12#2)
saturation was##3##2##(1990-3#1)(1991-5#1)(2008-11#1)
saturation with##2##2##(1990-8#1)(2007-12#1)
saturation within##2##2##(2008-10#1)(2008-3#1)
saturation##186##1##(1990-3#1)(1990-5#2)(1990-8#3)(1991-5#3)(1991-6#1)(1991-8#1)(1992-3#3)(1992-5#1)(1993-1#3)(1993-6#1)(1994-12#1)(1994-5#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#17)(2007-7#2)(2008-1#3)(2008-10#18)(2008-11#2)(2008-2#13)(2008-3#46)(2008-5#4)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#6)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
saturation)##4##1##(1994-3#1)(2007-12#2)(2010-2#1)
saturations##2##1##(1990-8#1)(1997-8#1)
saturatus##2##1##(2010-3#2)
saturnus##2##1##(1993-12#2)
sauce##10##1##(1996-2#5)(2008-10#2)(2010-4#3)
saudi arabia##14##2##(2007-7#1)(2008-1#11)(2008-4#2)
saudi##18##1##(2007-7#1)(2008-1#14)(2008-4#3)
sauna bathing##6##2##(2007-10#2)(2008-7#4)
sauna##8##1##(1991-12#1)(2007-10#3)(2008-7#4)
sauropsids has##2##2##(2010-3#2)
sauropsids##4##1##(2010-3#4)
sausage##3##1##(2010-4#1)(2013-1#2)
sausages##10##1##(2008-10#1)(2010-4#7)(2013-1#2)
savannah##2##1##(2008-8#2)
savannas##3##1##(2008-5#3)
savant syndrome##5##2##(2008-3#5)
savant##6##1##(2008-3#6)
savastanoi and##2##2##(2008-10#2)
savastanoi pv##5##2##(2008-10#5)
savastanoi##18##1##(2008-10#18)
save a##4##2##(1997-6#1)(2007-12#1)(2008-3#1)(2012-3#1)
save lives and##2##3##(2009-3#1)(2010-8#1)
save lives##4##2##(1991-3#1)(2009-3#1)(2010-11#1)(2010-8#1)
save money for##3##3##(1994-3#1)(1997-8#1)(2008-6#1)
save money##5##2##(1990-4#1)(1994-3#1)(1995-1#1)(1997-8#1)(2008-6#1)
save the eye##2##3##(2008-7#1)(2011-2#1)
save the life of a##2##5##(1997-7#1)(2008-1#1)
save the life of##4##4##(1997-7#1)(2008-1#2)(2008-6#1)
save the lives of##2##4##(2007-2#1)(2008-11#1)
save the patient's life##2##4##(1990-5#1)(2010-5#1)
save the##14##2##(1990-5#1)(1997-7#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-8#2)(2011-2#1)
save time and##2##3##(2008-10#1)(2008-4#1)
save time##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
save women's##2##2##(1997-5#1)(2008-11#1)
save your##2##2##(1996-2#1)(2012-2#1)
save##56##1##(1990-2#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-5#1)(2010-8#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
saved by##4##2##(1992-2#1)(2008-6#1)(2008-8#1)(2009-5#1)
saved##19##1##(1992-2#2)(1993-8#1)(1997-3#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#2)(2011-2#1)(2013-8#1)
saver##2##1##(2010-8#1)(2013-8#1)
saves##4##1##(1994-12#1)(1997-3#1)(2008-10#2)
saving both##2##2##(2008-8#1)(2012-2#1)
saving of##6##2##(1992-3#1)(1994-5#2)(2008-10#2)(2008-9#1)
saving the##5##2##(1990-3#1)(1993-8#1)(2007-8#1)(2008-12#1)(2008-7#1)
saving##34##1##(1990-11#1)(1990-3#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-5#3)(1997-5#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
savings accounts##3##2##(2007-10#1)(2008-1#1)(2008-4#1)
savings and##4##2##(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)
savings are##3##2##(1992-2#1)(1995-1#1)(1995-2#1)
savings for##4##2##(1991-1#1)(1995-2#1)(1997-2#1)(2009-3#1)
savings from##5##2##(1992-2#1)(1993-12#1)(1994-12#1)(2008-11#2)
savings in Medicaid costs during the first 60 days##2##9##(1993-3#2)
savings in##14##2##(1991-1#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)
savings of##10##2##(1992-2#1)(1994-12#1)(1994-9#1)(1995-2#1)(2008-1#2)(2008-10#3)(2008-7#1)
savings on##2##2##(1992-1#1)(1992-2#1)
savings potential of##2##3##(1992-2#1)(1997-3#1)
savings potential##3##2##(1992-2#1)(1995-2#1)(1997-3#1)
savings targets##2##2##(1995-1#2)
savings through##2##2##(1995-1#1)(1995-2#1)
savings to the##2##3##(1993-12#1)(1993-3#1)
savings to##4##2##(1993-12#1)(1993-3#1)(1994-6#1)(1997-3#1)
savings##94##1##(1990-4#2)(1991-1#2)(1991-12#1)(1992-1#2)(1992-12#1)(1992-2#9)(1992-8#1)(1993-12#3)(1993-3#3)(1994-12#5)(1994-2#3)(1994-3#3)(1994-6#1)(1994-9#2)(1995-1#4)(1995-12#1)(1995-2#7)(1995-3#1)(1996-1#3)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#3)(2007-10#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
savvy##2##1##(1991-1#1)(1991-5#1)
saw a##2##2##(2007-12#1)(2009-10#1)
saw an##2##2##(2007-2#1)(2008-10#1)
saw the##4##2##(1992-1#1)(1993-2#1)(1997-2#1)(2008-7#1)
saw##22##1##(1990-11#1)(1992-1#1)(1992-11#1)(1993-2#1)(1996-4#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)
sawB##6##1##(2008-8#6)
sawbones##4##1##(2008-9#4)
sawdust particles##3##2##(2008-12#3)
sawdust to##2##2##(2008-12#2)
sawdust##16##1##(2008-12#13)(2008-9#1)(2013-1#2)
sawing from the xiphisternum##2##4##(2007-8#2)
sawing##3##1##(1995-6#1)(2007-8#2)
sawmill in Sapele##2##3##(2008-12#2)
sawmill##3##1##(2008-10#1)(2008-12#2)
sawmills##2##1##(2008-10#1)(2008-12#1)
sawtooth##2##1##(2008-3#1)(2009-4#1)
say a##2##2##(1992-11#2)
say about##3##2##(1992-8#1)(1996-4#1)(2012-2#1)
say that##6##2##(1990-6#1)(1991-3#1)(1996-2#1)(1997-6#1)(2008-7#1)(2012-3#1)
say the authors##2##3##(1991-12#1)(1995-2#1)
say the##5##2##(1991-12#1)(1993-5#1)(1995-2#1)(1996-5#1)(2011-2#1)
say to##3##2##(2011-2#1)(2013-1#2)
say##41##1##(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-4#1)(1992-8#2)(1993-5#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
saying the##2##2##(1996-5#1)(2013-8#1)
saying##8##1##(1992-2#1)(1993-2#1)(1994-1#1)(1995-6#2)(1996-5#1)(2012-2#1)(2013-8#1)
says that##2##2##(2009-10#2)
says the author##9##3##(1991-3#1)(1993-2#2)(1994-12#2)(1994-2#1)(1995-2#1)(1996-2#2)
says##38##1##(1990-4#1)(1991-3#1)(1993-12#1)(1993-2#5)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#2)(1995-2#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-5#4)(2008-1#1)(2008-11#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-8#1)(2013-8#1)
sb=0##2##1##(2013-1#2)
sc##6##1##(1990-8#2)(1994-6#2)(2008-10#2)
scFv M97 transfection##2##3##(2008-8#2)
scFv M97##3##2##(2008-8#3)
scFv antibodies##3##2##(2008-10#1)(2010-12#2)
scFv fusion proteins were##3##4##(2008-10#3)
scFv fusion proteins##4##3##(2008-10#4)
scFv in##2##2##(2008-10#2)
scFv is##2##2##(2008-10#1)(2009-9#1)
scFv were##3##2##(2008-10#3)
scFv##26##1##(1993-8#1)(2008-10#16)(2008-4#1)(2008-8#3)(2009-2#2)(2009-9#1)(2010-12#2)
scFvC(L) fusion proteins##3##3##(2008-10#3)
scFvC(L)##4##1##(2008-10#4)
scFvs##3##1##(2008-10#3)
scTcr##3##1##(1994-6#3)
scab (Venturia inaequalis)##3##3##(2008-10#3)
scab and##4##2##(2008-10#4)
scab development##3##2##(2008-10#3)
scab disease##2##2##(2008-10#1)(2008-8#1)
scab in the##2##3##(2008-10#2)
scab in##4##2##(2008-10#4)
scab incidence and severity##2##4##(2008-10#2)
scab incidence##5##2##(2008-10#5)
scab is a##2##3##(2008-10#2)
scab is##4##2##(2008-10#4)
scab lesions##4##2##(1991-11#1)(2008-10#3)
scab management##2##2##(2008-10#2)
scab on##5##2##(2008-10#5)
scab pathogen)##2##2##(2008-10#2)
scab resistance genes##3##3##(2008-10#3)
scab resistance##12##2##(2008-10#12)
scab severity##5##2##(2008-10#5)
scab symptoms##2##2##(2008-10#2)
scab were##2##2##(2008-10#2)
scab##86##1##(1991-11#1)(2008-10#83)(2008-11#1)(2008-8#1)
scab)##2##1##(2008-10#2)
scab-causing streptomycetes##2##2##(2008-10#2)
scab-susceptible##2##1##(2008-10#2)
scabbed##3##1##(2008-10#3)
scabiei##7##1##(1990-3#4)(2008-12#3)
scabies ATCC##2##2##(2008-10#2)
scabies in##4##2##(1997-5#1)(2008-12#1)(2010-6#2)
scabies##26##1##(1991-2#1)(1996-12#4)(1997-5#1)(2008-10#12)(2008-12#3)(2010-2#1)(2010-6#4)
scabra 'Fitzroy'##2##2##(2008-10#2)
scabra##5##1##(2008-10#4)(2010-2#1)
scaffold fabrication##4##2##(2010-9#4)
scaffold for the##3##3##(2007-12#1)(2008-8#1)(2012-2#1)
scaffold for##10##2##(1997-3#2)(2007-12#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#2)
scaffold of##5##2##(2007-12#2)(2008-7#2)(2009-7#1)
scaffold proteins##2##2##(2008-7#1)(2012-12#1)
scaffold that##2##2##(2009-8#1)(2012-2#1)
scaffold to enhance##2##3##(2008-9#1)(2009-12#1)
scaffold to##5##2##(1997-3#1)(2008-9#1)(2009-12#2)(2012-8#1)
scaffold##64##1##(1993-11#3)(1995-8#2)(1997-3#3)(2007-12#5)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-12#3)(2009-7#8)(2009-8#2)(2010-2#1)(2010-9#6)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-8#1)(2013-1#2)
scaffold-associated region (SAR)##2##3##(2008-8#2)
scaffold-free##3##1##(2011-2#3)
scaffolding material##2##2##(2009-12#1)(2009-7#1)
scaffolding##13##1##(1993-2#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-7#3)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
scaffolds and##4##2##(2010-9#1)(2012-4#1)(2012-5#1)(2013-1#1)
scaffolds for tissue engineering##2##4##(2009-11#1)(2009-7#1)
scaffolds for tissue##3##3##(2009-11#1)(2009-7#1)(2010-10#1)
scaffolds for##6##2##(2008-7#1)(2009-11#1)(2009-7#2)(2010-10#1)(2012-8#1)
scaffolds from##2##2##(2009-7#1)(2010-10#1)
scaffolds has##2##2##(2008-5#1)(2009-7#1)
scaffolds have##2##2##(2009-7#2)
scaffolds in##2##2##(2009-7#1)(2011-2#1)
scaffolds is##2##2##(2010-9#1)(2011-2#1)
scaffolds seeded using the##2##4##(2011-2#2)
scaffolds that##3##2##(2008-11#1)(2009-7#1)(2010-10#1)
scaffolds were##6##2##(2009-7#1)(2011-2#1)(2012-2#4)
scaffolds##67##1##(2007-12#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#17)(2010-10#6)(2010-12#1)(2010-9#3)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#9)(2012-3#2)(2012-4#1)(2012-5#1)(2012-8#2)(2013-1#1)(2013-7#1)
scala vestibuli##2##2##(2008-9#1)(2012-2#1)
scalability##6##1##(2008-11#1)(2008-2#2)(2008-3#1)(2009-3#1)(2012-3#1)
scalable approach##2##2##(2008-7#2)
scalable multiprocessor##2##2##(2008-3#2)
scalable to##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
scalable##23##1##(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#3)(2009-3#1)(2010-10#1)(2010-8#1)(2012-2#1)
scalar and##2##2##(2007-12#1)(2008-2#1)
scalar diffraction theory is##3##4##(2008-2#1)(2008-3#2)
scalar diffraction theory##7##3##(2008-2#2)(2008-3#5)
scalar diffraction##13##2##(2007-12#1)(2008-2#4)(2008-3#8)
scalar imaging##2##2##(2008-3#2)
scalar irradiance##2##2##(2008-3#2)
scalar theory##3##2##(2008-3#3)
scalar treatment##2##2##(2007-12#1)(2008-2#1)
scalar wave fields##2##3##(2007-11#1)(2007-12#1)
scalar##43##1##(1996-4#1)(2007-11#5)(2007-12#5)(2008-2#7)(2008-3#23)(2011-1#1)(2011-2#1)
scald##8##1##(2008-10#8)
scalding##2##1##(1995-3#2)
scale (VAS)##6##2##(2007-7#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-2#1)
scale (e##3##2##(2008-10#2)(2013-1#1)
scale (p&lt##2##2##(2008-1#2)
scale (proportion of sampling units with one or more diseased##2##10##(2008-10#2)
scale according to the##2##4##(2011-2#1)(2012-3#1)
scale according to##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
scale analysis##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
scale and in##2##3##(2008-5#2)
scale and that the##2##4##(2008-8#1)(2012-2#1)
scale and the##12##3##(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
scale and##45##2##(1991-11#1)(1994-5#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
scale are##4##2##(2008-1#1)(2008-10#2)(2009-8#1)
scale as##2##2##(2009-7#1)(2009-9#1)
scale at which##3##3##(2008-10#1)(2009-10#1)(2012-12#1)
scale at##4##2##(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
scale based on##2##3##(1990-7#1)(2010-12#1)
scale bases##2##2##(2013-1#2)
scale before##2##2##(2008-10#1)(2012-2#1)
scale between##2##2##(2008-3#1)(2012-2#1)
scale but##2##2##(2008-10#1)(2012-2#1)
scale by##3##2##(1994-3#1)(2007-12#1)(2013-1#1)
scale can be##2##3##(1993-12#1)(2008-10#1)
scale cell##3##2##(2008-11#3)
scale clinical##2##2##(2010-8#1)(2011-1#1)
scale counts##2##2##(2008-8#2)
scale cultivation##2##2##(1994-5#1)(2008-11#1)
scale cultures##2##2##(2008-11#2)
scale did not##2##3##(2008-10#1)(2012-2#1)
scale down##2##2##(2008-7#1)(2012-3#1)
scale experiments##4##2##(1997-2#1)(2008-11#3)
scale factor##3##2##(2008-2#1)(2008-3#2)
scale following##2##2##(1990-8#1)(2007-11#1)
scale for assessing##2##3##(2011-8#1)(2013-1#1)
scale for the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
scale for##15##2##(1991-1#1)(1993-12#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
scale from##4##2##(1992-3#1)(1995-8#1)(2008-10#1)(2008-9#1)
scale has##2##2##(2008-10#1)(2008-9#1)
scale hollow##2##2##(2008-11#2)
scale in the##2##3##(2008-11#1)(2008-8#1)
scale in##14##2##(1993-10#1)(1993-6#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#2)(2012-3#1)
scale insects (Hemiptera##3##3##(2007-12#3)
scale insects##5##2##(2007-12#5)
scale insects)##2##2##(2007-12#2)
scale invariance##4##2##(2008-3#2)(2012-2#2)
scale is##16##2##(1991-12#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#4)(2008-7#2)(2009-2#1)(2012-2#1)(2013-1#1)
scale isometrically with##2##3##(2007-12#1)(2008-8#1)
scale model##3##2##(2010-8#1)(2012-2#2)
scale of 1##2##3##(1994-12#1)(2012-3#1)
scale of 1-5##3##3##(1990-2#2)(2007-11#1)
scale of a##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2012-1#1)
scale of an##2##3##(2008-8#1)(2012-2#1)
scale of operation##3##3##(2008-11#3)
scale of the noise##2##4##(2008-3#1)(2008-8#1)
scale of the##22##3##(1993-2#1)(2007-12#1)(2008-10#7)(2008-3#5)(2008-7#1)(2008-8#4)(2010-9#2)(2011-1#1)
scale of##82##2##(1990-2#2)(1990-3#1)(1991-2#1)(1992-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#10)(2008-4#1)(2008-7#4)(2008-8#8)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
scale on the##3##3##(1991-2#1)(2008-11#1)(2008-2#1)
scale on##4##2##(1991-2#1)(2008-11#1)(2008-2#1)(2013-7#1)
scale or##3##2##(1990-8#1)(1996-4#1)(2008-12#1)
scale production##5##2##(1991-2#1)(2008-11#3)(2011-2#1)
scale ranging from##2##3##(2008-9#1)(2010-10#1)
scale rupture##2##2##(1996-4#2)
scale scores##3##2##(2008-8#1)(2009-11#1)(2009-4#1)
scale study##2##2##(2009-9#1)(2013-8#1)
scale that##2##2##(2007-12#1)(2008-10#1)
scale the##4##2##(2007-12#1)(2008-3#1)(2009-7#1)(2010-4#1)
scale to assess the##2##4##(1997-3#1)(2008-5#1)
scale to assess##4##3##(1997-3#1)(2007-11#1)(2008-5#1)(2012-2#1)
scale to the##2##3##(2008-10#1)(2012-2#1)
scale to##15##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
scale under##2##2##(2009-12#1)(2013-1#1)
scale up and##2##3##(2008-3#1)(2008-7#1)
scale up of antibody production from##2##6##(2008-11#2)
scale up of##3##3##(2008-11#2)(2008-7#1)
scale up##17##2##(2008-11#9)(2008-2#1)(2008-3#1)(2008-7#5)(2009-8#1)
scale using##2##2##(2008-11#1)(2009-2#1)
scale was 0##2##3##(2008-10#1)(2011-2#1)
scale was not##2##3##(2008-10#2)
scale was used##4##3##(1997-8#2)(2008-8#1)(2013-1#1)
scale was##21##2##(1997-8#2)(2007-11#2)(2008-1#2)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
scale were##4##2##(1991-6#1)(2007-11#1)(2008-10#2)
scale when##2##2##(2008-8#1)(2009-12#1)
scale with a##2##3##(1994-3#1)(2012-2#1)
scale with##7##2##(1994-3#1)(2009-2#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
scale##790##1##(1990-12#3)(1990-2#4)(1990-3#3)(1990-7#1)(1990-8#6)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#1)(1991-6#1)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#5)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#6)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#5)(1996-4#10)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#4)(2007-10#4)(2007-11#23)(2007-12#26)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#12)(2008-10#121)(2008-11#66)(2008-12#12)(2008-2#19)(2008-3#50)(2008-4#7)(2008-5#10)(2008-6#9)(2008-7#38)(2008-8#28)(2008-9#21)(2009-10#1)(2009-11#7)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#16)(2011-2#27)(2011-3#1)(2011-8#1)(2012-1#3)(2012-12#5)(2012-2#41)(2012-3#15)(2013-1#27)(2013-7#7)(2013-8#6)
scale's##2##1##(2007-12#1)(2009-11#1)
scale) and##2##2##(2007-11#1)(2012-12#1)
scale) were##3##2##(2007-11#2)(2010-12#1)
scale)##19##1##(2007-11#5)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#3)(2013-8#3)
scale-free##3##1##(2008-1#2)(2012-2#1)
scale-invariant##7##1##(2008-3#6)(2012-2#1)
scale-tunable##2##1##(2008-3#2)
scale-up of##6##2##(2008-11#3)(2008-7#1)(2010-11#1)(2011-2#1)
scale-up##22##1##(1992-12#1)(2008-11#12)(2008-6#2)(2008-7#2)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#2)
scaleable process##2##2##(2008-5#1)(2008-8#1)
scaleable##5##1##(2008-11#3)(2008-5#1)(2008-8#1)
scaled by##2##2##(1996-4#1)(2008-8#1)
scaled from##2##2##(2007-12#1)(2008-3#1)
scaled to##5##2##(1991-12#1)(2007-12#1)(2008-3#1)(2008-7#2)
scaled up##5##2##(1994-12#1)(2008-11#2)(2008-2#1)(2008-7#1)
scaled##32##1##(1991-12#1)(1994-12#1)(1995-5#1)(1996-4#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-2#6)(2008-3#4)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
scaled-up##3##1##(1994-12#1)(2008-11#2)
scales (VAS)##2##2##(1996-3#1)(2011-1#1)
scales and over##2##3##(2008-10#1)(2008-3#1)
scales and the number of##2##5##(2010-1#1)(2013-7#1)
scales and the##4##3##(2008-5#1)(2010-1#1)(2013-7#2)
scales and to##2##3##(1993-2#1)(2013-7#1)
scales and##26##2##(1991-8#1)(1993-2#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2012-1#2)(2012-2#1)(2013-7#4)
scales are##6##2##(1990-5#1)(2007-8#1)(2008-6#2)(2008-8#1)(2013-1#1)
scales as##3##2##(2007-11#1)(2009-12#1)(2012-2#1)
scales between##4##2##(1995-5#1)(2013-7#3)
scales could be##2##3##(2008-10#1)(2012-3#1)
scales could##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
scales for each##2##3##(2008-3#1)(2008-5#1)
scales for##12##2##(1996-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-7#1)
scales from Cyprinus carpio##2##4##(2012-2#2)
scales from the##2##3##(2012-2#2)
scales from##5##2##(2008-3#1)(2012-2#4)
scales have been##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
scales in the##4##3##(2008-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
scales in##10##2##(1990-3#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-8#2)
scales is##2##2##(2008-3#2)
scales linearly with the##3##4##(2007-11#1)(2008-2#1)(2010-4#1)
scales may##2##2##(1993-2#1)(2008-8#1)
scales of biological##2##3##(2008-1#1)(2010-9#1)
scales of spatial##2##3##(2008-10#1)(2008-8#1)
scales of the##8##3##(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)(2010-8#1)
scales of##30##2##(1990-2#1)(1991-6#1)(1996-4#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#4)(2008-9#2)(2010-8#1)(2010-9#1)(2011-1#1)
scales ranging from##2##3##(2008-10#1)(2008-4#1)
scales tested##2##2##(2008-10#2)
scales than##2##2##(2008-10#1)(2008-7#1)
scales that##3##2##(2008-10#1)(2009-11#1)(2011-1#1)
scales to assess the##2##4##(2008-10#1)(2009-5#1)
scales to evaluate##2##3##(2008-9#1)(2013-8#1)
scales to##7##2##(1990-5#1)(1991-3#1)(2008-10#2)(2008-9#1)(2009-5#1)(2013-8#1)
scales were##5##2##(2008-10#1)(2008-5#1)(2009-12#1)(2013-7#2)
scales##300##1##(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1993-2#6)(1993-3#1)(1995-2#3)(1995-5#1)(1996-3#1)(1996-4#2)(1996-7#2)(1997-1#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#48)(2008-11#5)(2008-2#8)(2008-3#19)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#18)(2008-8#24)(2008-9#9)(2009-11#1)(2009-12#4)(2009-2#3)(2009-5#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#4)(2011-8#1)(2012-1#3)(2012-12#1)(2012-2#16)(2012-3#3)(2012-5#1)(2013-1#14)(2013-7#15)(2013-8#6)
scales)##4##1##(1991-8#1)(1996-7#1)(2007-12#1)(2008-3#1)
scaliness##4##1##(2008-5#4)
scaling and alignment of##2##4##(2013-8#2)
scaling and frequency stabilization of##2##5##(2008-3#2)
scaling and##10##2##(1996-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#2)
scaling between these##2##3##(2008-5#1)(2009-8#1)
scaling effects##2##2##(2007-12#2)
scaling exponents##2##2##(1993-5#1)(2008-8#1)
scaling factor##2##2##(2008-3#2)
scaling factors##2##2##(2008-3#1)(2011-2#1)
scaling grating##3##2##(2008-2#3)
scaling in the##2##3##(1993-5#1)(1995-5#1)
scaling in##4##2##(1993-5#1)(1995-5#1)(2009-9#1)(2012-2#1)
scaling law##4##2##(2007-12#2)(2008-3#2)
scaling laws##5##2##(2008-2#2)(2008-3#1)(2010-7#1)(2012-2#1)
scaling of the##6##3##(1993-5#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
scaling of##13##2##(1993-5#1)(1995-9#1)(1996-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2011-2#1)
scaling parameter##2##2##(1996-4#1)(2012-2#1)
scaling parameters##2##2##(2008-5#2)
scaling properties of##2##3##(2007-11#2)
scaling relationships##4##2##(1997-5#1)(2008-2#1)(2008-8#2)
scaling symptoms##2##2##(2008-10#2)
scaling to##2##2##(2008-3#1)(2012-2#1)
scaling up##2##2##(2008-11#1)(2010-8#1)
scaling was##2##2##(2007-11#1)(2012-2#1)
scaling##117##1##(1993-5#3)(1995-5#4)(1995-9#2)(1996-4#2)(1996-7#1)(1997-5#1)(2007-10#5)(2007-11#4)(2007-12#6)(2007-7#2)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#20)(2008-4#2)(2008-5#13)(2008-6#2)(2008-8#8)(2009-5#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#9)(2012-3#1)(2013-8#3)
scaling-up##2##1##(2008-11#1)(2009-7#1)
scallop##4##1##(2013-8#4)
scalp and##6##2##(2007-12#1)(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#1)
scalp at##2##2##(2012-12#1)(2012-3#1)
scalp condition##2##2##(2008-5#2)
scalp distribution##2##2##(2008-8#2)
scalp electrodes##2##2##(2008-11#1)(2008-4#1)
scalp hair samples##2##3##(2008-10#2)
scalp hair##4##2##(2008-10#3)(2010-3#1)
scalp under##2##2##(2008-8#2)
scalp##64##1##(1990-9#1)(1992-4#1)(1992-8#1)(1994-5#1)(1996-7#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#13)(2008-7#2)(2008-8#4)(2008-9#2)(2010-3#1)(2010-5#5)(2010-6#5)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
scalpel technique##2##2##(2012-3#2)
scalpel##8##1##(1992-3#2)(2007-8#1)(2010-8#3)(2012-3#2)
scaly##6##1##(2007-12#1)(2008-5#2)(2012-2#1)(2012-3#2)
scan (p = 0##2##2##(2011-2#1)(2012-2#1)
scan after##3##2##(1990-6#1)(2012-3#1)(2013-1#1)
scan and magnetic resonance imaging##2##5##(1990-12#1)(2007-10#1)
scan and the##2##3##(2008-10#1)(2008-3#1)
scan and##16##2##(1990-12#1)(1992-12#1)(2007-10#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
scan as##2##2##(2008-3#1)(2010-1#1)
scan at##3##2##(2007-11#1)(2008-7#1)(2013-1#1)
scan demonstrated a##2##3##(2008-7#1)(2013-1#1)
scan finding##2##2##(2008-7#1)(2013-1#1)
scan findings##2##2##(1991-8#1)(2008-7#1)
scan for##7##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-12#1)(2012-3#1)
scan in a patient##2##4##(2007-10#1)(2012-3#1)
scan in a##3##3##(2007-10#1)(2008-2#1)(2012-3#1)
scan in the##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
scan in##10##2##(1990-12#1)(2007-10#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
scan increment of##2##3##(2008-10#2)
scan increment##3##2##(2008-10#3)
scan is##4##2##(1995-11#1)(2007-11#1)(2010-12#1)(2010-3#1)
scan may be##2##3##(1992-3#1)(2011-2#1)
scan may##4##2##(1992-3#1)(1995-11#1)(2011-2#1)(2012-12#1)
scan mode##2##2##(2008-10#2)
scan of a##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
scan of the NIMH genetics initiative bipolar pedigrees##3##8##(1997-5#3)
scan of the brain##2##4##(1995-11#1)(2006-10#1)
scan of the thorax##2##4##(2007-12#1)(2007-8#1)
scan of the##14##3##(1995-11#1)(1997-5#3)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
scan of##27##2##(1995-10#1)(1995-11#1)(1997-5#5)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
scan offers##2##2##(2007-11#1)(2008-10#1)
scan performed##3##2##(2007-10#1)(2012-1#1)(2013-1#1)
scan position##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
scan range##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
scan rate and##5##3##(2007-12#1)(2008-10#4)
scan rate in##2##3##(2008-10#2)
scan rate of 100 mV s(-1)##3##6##(2008-10#3)
scan rate of##9##3##(2008-10#9)
scan rate were optimized##2##4##(2008-10#2)
scan rate##38##2##(2007-12#1)(2008-10#35)(2008-2#1)(2008-3#1)
scan revealed a##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
scan revealed##10##2##(1992-11#1)(1992-5#1)(1996-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
scan showed a##7##3##(1990-6#1)(1993-12#1)(1997-3#1)(2008-1#1)(2009-8#1)(2010-1#1)(2013-8#1)
scan showed an##2##3##(1996-5#1)(2013-1#1)
scan showed##20##2##(1990-6#1)(1993-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
scan suggested##2##2##(2008-10#1)(2009-6#1)
scan the##5##2##(1993-9#1)(2007-12#1)(2008-3#2)(2008-7#1)
scan through##2##2##(2007-11#1)(2008-7#1)
scan time##2##2##(2008-7#1)(2009-3#1)
scan to##2##2##(2012-2#1)(2013-1#1)
scan was##11##2##(1997-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
scan with a##3##3##(2007-11#1)(2008-3#2)
scan with the##2##3##(1996-5#2)
scan with##7##2##(1996-5#2)(2007-11#1)(2008-3#2)(2012-2#1)(2013-7#1)
scan within##2##2##(2008-7#1)(2012-12#1)
scan##348##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-11#5)(1996-11#1)(1996-5#5)(1996-9#1)(1997-3#1)(1997-5#7)(2006-10#2)(2007-10#6)(2007-11#20)(2007-12#10)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#78)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#26)(2008-5#1)(2008-6#3)(2008-7#35)(2008-9#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#3)(2010-6#3)(2011-1#6)(2011-2#13)(2012-1#4)(2012-12#10)(2012-2#9)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#6)
scandal##5##1##(1996-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2013-8#1)
scandium##6##1##(2008-10#5)(2010-5#1)
scandium(III) and yttrium(III) from##2##4##(2008-10#2)
scandium(III) and yttrium(III)##4##3##(2008-10#4)
scanned across##2##2##(2007-12#1)(2008-3#1)
scanned and##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
scanned at##2##2##(2008-10#1)(2010-4#1)
scanned by both##2##3##(1996-1#2)
scanned by##3##2##(1996-1#2)(2008-10#1)
scanned for##3##2##(2008-3#1)(2010-5#1)(2013-8#1)
scanned in a##2##3##(2008-10#1)(2008-2#1)
scanned in##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
scanned into##2##2##(2008-3#2)
scanned over##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scanned through##2##2##(2008-3#1)(2012-2#1)
scanned with a##2##3##(2008-3#1)(2012-1#1)
scanned with##4##2##(2008-3#2)(2008-8#1)(2012-1#1)
scanned##50##1##(1996-1#2)(2007-11#4)(2007-12#6)(2008-10#9)(2008-2#3)(2008-3#15)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-2#2)(2013-8#1)
scanner and##2##2##(2008-3#1)(2011-2#1)
scanner can be used##2##4##(2011-1#1)(2012-12#1)
scanner can be##3##3##(2008-3#1)(2011-1#1)(2012-12#1)
scanner can##4##2##(2008-3#1)(2009-5#1)(2011-1#1)(2012-12#1)
scanner for##3##2##(1992-11#2)(2011-1#1)
scanner is##3##2##(2008-2#1)(2008-3#2)
scanner that##2##2##(2008-3#2)
scanner was##4##2##(1993-9#1)(2008-2#1)(2008-7#1)(2011-1#1)
scanner##66##1##(1992-11#4)(1993-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#25)(2008-7#5)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#6)(2011-2#2)(2011-7#2)(2012-1#1)(2012-12#3)(2012-2#1)
scanner)##2##1##(2008-3#1)(2011-2#1)
scanners and the##2##3##(2008-3#1)(2010-9#1)
scanners with##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
scanners##28##1##(1997-8#2)(2007-12#1)(2008-10#3)(2008-3#5)(2008-6#1)(2008-7#7)(2008-9#1)(2009-5#1)(2010-8#2)(2010-9#2)(2012-1#1)(2013-1#2)
scanning a##3##2##(1996-6#1)(2008-2#1)(2008-3#1)
scanning and transmission electron microscopy##10##5##(2007-12#6)(2008-10#2)(2008-11#1)(2008-7#1)
scanning and transmission electron##11##4##(2007-12#7)(2008-10#2)(2008-11#1)(2008-7#1)
scanning and transmission##13##3##(2007-12#7)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)
scanning and##24##2##(1993-8#1)(2007-12#9)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-7#1)(2010-8#1)(2012-2#1)
scanning approach for##2##3##(2008-4#2)
scanning are##2##2##(2008-10#1)(2012-12#1)
scanning at##2##2##(2007-11#1)(2012-1#1)
scanning calorimetric (DSC)##3##3##(1990-7#2)(1990-8#1)
scanning calorimetric##6##2##(1990-7#3)(1990-8#2)(1995-8#1)
scanning calorimetry (DSC)##9##3##(1992-10#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2009-3#1)
scanning calorimetry and##5##3##(1990-2#1)(1995-11#1)(1997-7#1)(2008-10#1)(2011-1#1)
scanning calorimetry##33##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#3)(1994-3#2)(1995-11#1)(1995-5#1)(1997-2#3)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-3#1)(2011-1#2)(2011-2#1)
scanning confocal microscope##2##3##(2008-1#1)(2008-9#1)
scanning confocal##7##2##(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)
scanning device##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
scanning electron micrographs##3##3##(2008-10#3)
scanning electron microscope (SEM)##4##4##(2008-10#1)(2008-5#1)(2009-11#1)(2009-3#1)
scanning electron microscope##16##3##(1992-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#4)(2008-6#1)(2009-11#1)(2009-3#1)(2012-3#2)
scanning electron microscopic (SEM)##2##4##(2007-12#1)(2008-10#1)
scanning electron microscopic##4##3##(1992-12#1)(1995-8#1)(2007-12#1)(2008-10#1)
scanning electron microscopy (SEM) and X-ray##2##6##(2008-10#1)(2009-7#1)
scanning electron microscopy (SEM) and##8##5##(2008-10#2)(2008-7#1)(2009-7#3)(2010-4#1)(2012-2#1)
scanning electron microscopy (SEM) images##3##5##(2008-3#1)(2009-11#1)(2012-1#1)
scanning electron microscopy (SEM)##35##4##(1992-2#1)(1996-3#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-7#4)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
scanning electron microscopy and electrochemical method##2##6##(2008-10#2)
scanning electron microscopy and##8##4##(1995-6#2)(2007-12#1)(2008-10#5)
scanning electron microscopy coupled##2##4##(2008-10#1)(2008-5#1)
scanning electron microscopy of##3##4##(2008-10#1)(2010-4#1)(2011-2#1)
scanning electron microscopy to##3##4##(2007-12#1)(2008-12#1)(2009-7#1)
scanning electron microscopy##97##3##(1991-5#1)(1992-2#2)(1995-6#2)(1996-3#1)(1997-4#1)(2007-12#7)(2008-10#35)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#5)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
scanning electron##125##2##(1991-5#1)(1992-12#2)(1992-2#2)(1995-6#2)(1995-8#1)(1996-3#1)(1997-4#1)(2007-12#9)(2008-10#46)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#3)(2009-3#1)(2009-5#1)(2009-7#5)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
scanning electronic##2##2##(2008-10#1)(2008-7#1)
scanning fluorescence##2##2##(2008-3#1)(2008-9#1)
scanning holography##5##2##(2007-12#2)(2008-3#3)
scanning in##4##2##(1991-3#1)(1995-11#1)(2007-8#1)(2008-2#1)
scanning interferometry is##2##3##(2008-3#2)
scanning interferometry##7##2##(2007-11#2)(2008-3#5)
scanning is##11##2##(1991-3#2)(2007-11#2)(2007-12#1)(2008-3#3)(2008-4#1)(2010-3#1)(2011-2#1)
scanning laser ophthalmoscope##5##3##(2007-11#1)(2008-3#1)(2011-1#3)
scanning laser ophthalmoscopy##3##3##(2007-11#1)(2011-1#1)(2011-7#1)
scanning laser##16##2##(2007-11#3)(2008-1#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#4)(2011-7#1)
scanning measurement##2##2##(2008-3#2)
scanning mechanism##2##2##(2008-3#2)
scanning method##4##2##(2007-12#1)(2008-3#1)(2008-9#1)(2010-9#1)
scanning microscope with a self-pumped phase-conjugate mirror##2##7##(2008-2#2)
scanning microscope##13##2##(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)
scanning microscopes##2##2##(2008-2#1)(2008-3#1)
scanning microscopy and##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
scanning microscopy##22##2##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#4)(2010-8#1)(2011-1#1)
scanning modes##2##2##(2007-12#2)
scanning mutagenesis##4##2##(1990-12#2)(1993-11#1)(2008-10#1)
scanning near-field optical microscope##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
scanning near-field optical microscopy (SNOM)##2##5##(2008-3#2)
scanning near-field optical microscopy##7##4##(2007-12#1)(2008-2#2)(2008-3#4)
scanning near-field optical##13##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#7)
scanning of the##10##3##(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#4)(2011-1#1)
scanning of##16##2##(1994-3#1)(1996-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#6)(2011-1#1)(2011-2#1)
scanning optical delay line##3##4##(2008-3#3)
scanning optical delay##4##3##(2008-3#4)
scanning optical microscope##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
scanning optical##14##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#7)
scanning permittivity measurements##2##3##(2008-11#2)
scanning potentiometry##4##2##(2008-10#4)
scanning probe microscope##3##3##(2008-3#2)(2012-1#1)
scanning probe microscopy-based##2##3##(2008-7#2)
scanning probe##7##2##(2008-3#2)(2008-7#3)(2010-7#1)(2012-1#1)
scanning procedure##3##2##(2011-1#3)
scanning range##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
scanning rate##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
scanning system##7##2##(2007-12#3)(2008-3#4)
scanning systems##2##2##(2008-10#1)(2008-2#1)
scanning techniques##3##2##(1993-12#1)(2007-11#1)(2008-3#1)
scanning the potential in##2##4##(2008-10#2)
scanning the potential##5##3##(2008-10#5)
scanning the##10##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-4#1)
scanning tunneling microscope##7##3##(1990-11#1)(2007-11#1)(2007-12#4)(2010-7#1)
scanning tunneling##12##2##(1990-11#1)(1990-12#1)(2007-11#1)(2007-12#6)(2008-10#1)(2010-7#2)
scanning was##5##2##(1991-3#1)(1996-7#1)(2007-10#1)(2008-4#1)(2008-7#1)
scanning while##2##2##(2008-11#1)(2013-8#1)
scanning white-light##3##2##(2007-11#1)(2008-3#2)
scanning with a##3##3##(1995-12#1)(2008-3#1)(2008-4#1)
scanning with##6##2##(1993-9#1)(1995-12#1)(2008-3#2)(2008-4#1)(2012-3#1)
scanning##574##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-7#4)(1990-8#2)(1991-12#1)(1991-3#5)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-8#5)(1993-9#1)(1994-3#3)(1994-7#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-7#1)(2007-10#2)(2007-11#30)(2007-12#57)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#91)(2008-11#17)(2008-12#1)(2008-2#25)(2008-3#109)(2008-4#15)(2008-5#20)(2008-6#4)(2008-7#27)(2008-8#9)(2008-9#17)(2009-10#1)(2009-11#3)(2009-3#4)(2009-5#1)(2009-7#6)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#12)(2011-2#7)(2011-3#1)(2011-7#2)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#5)
scanning)##3##1##(1993-12#1)(2008-10#1)(2011-2#1)
scanning-beam technique##2##2##(2008-3#2)
scanning-beam##4##1##(2008-3#4)
scanning-electron microscopy##2##2##(2008-3#2)
scanning-electron##3##1##(2007-11#1)(2008-3#2)
scanningelectron microscope##2##2##(2008-11#1)(2008-2#1)
scans across##2##2##(2008-3#2)
scans after##3##2##(1992-12#1)(1994-7#1)(2008-7#1)
scans and a##2##3##(1992-3#1)(2008-2#1)
scans and##8##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)
scans are##3##2##(2006-10#1)(2008-10#1)(2008-9#1)
scans at a##4##3##(1992-3#2)(2008-10#1)(2008-3#1)
scans at##5##2##(1992-3#2)(2008-10#1)(2008-3#2)
scans demonstrated##2##2##(2008-1#1)(2012-12#1)
scans for##3##2##(1996-7#1)(2007-11#1)(2013-1#1)
scans have##5##2##(1993-6#1)(2008-1#1)(2008-9#1)(2011-2#2)
scans in##5##2##(1996-5#1)(2008-10#2)(2010-1#1)(2013-7#1)
scans of the##6##3##(1990-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2013-8#1)
scans of##11##2##(1990-8#2)(1992-2#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
scans per##2##2##(2008-10#2)
scans performed##3##2##(2009-7#1)(2011-2#2)
scans revealed a##2##3##(2008-1#1)(2008-7#1)
scans revealed##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
scans showed##6##2##(1996-5#1)(2007-11#1)(2008-1#2)(2008-7#1)(2011-2#1)
scans the##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
scans was##3##2##(2007-11#1)(2009-8#1)(2011-2#1)
scans were obtained##2##3##(2008-7#1)(2011-2#1)
scans were performed in##2##4##(2008-7#1)(2009-11#1)
scans were performed on##2##4##(2008-7#1)(2013-1#1)
scans were performed##5##3##(2007-10#1)(2008-7#2)(2009-11#1)(2013-1#1)
scans were##13##2##(1996-7#2)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
scans with##4##2##(1996-5#1)(2007-11#1)(2008-3#1)(2010-9#1)
scans##143##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-6#1)(1994-7#1)(1995-5#2)(1996-11#1)(1996-5#6)(1996-7#3)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#13)(2008-5#1)(2008-6#1)(2008-7#19)(2008-9#4)(2009-11#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
scant attention to##2##3##(2008-7#1)(2010-5#1)
scant attention##3##2##(2008-7#1)(2009-5#1)(2010-5#1)
scant literature##2##2##(2006-10#1)(2008-11#1)
scant##10##1##(1990-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-5#1)(2013-1#1)
scanty##6##1##(2008-1#1)(2008-12#1)(2008-5#2)(2011-2#1)(2013-1#1)
scaphoid and##3##2##(2007-11#1)(2008-9#1)(2012-1#1)
scaphoid fracture##3##2##(2008-9#3)
scaphoid fractures##6##2##(2008-9#6)
scaphoid waist fractures##3##3##(2008-9#3)
scaphoid waist##4##2##(2008-9#4)
scaphoid with##2##2##(2007-11#1)(2013-1#1)
scaphoid##22##1##(2007-11#3)(2008-9#17)(2012-1#1)(2013-1#1)
scapholunate##4##1##(2012-1#2)(2013-1#2)
scapular aneurysmal bone cyst in a child##2##7##(2012-12#2)
scapular upward rotators during##2##4##(2010-9#2)
scapular##7##1##(2010-12#1)(2010-9#2)(2012-12#2)(2012-2#1)(2012-3#1)
scapularis##6##1##(2008-11#6)
scar and##9##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2012-1#1)(2013-8#1)
scar fibroblasts treated with##2##4##(2008-9#2)
scar formation##5##2##(2008-9#4)(2010-8#1)
scar in the##2##3##(2012-1#2)
scar in##4##2##(2008-9#1)(2012-1#2)(2013-8#1)
scar on the##2##3##(2007-8#1)(2011-2#1)
scar on##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
scar or##2##2##(2006-12#1)(2008-5#1)
scar reduction##2##2##(2008-9#2)
scar tissue and##2##3##(1997-3#2)
scar tissue##10##2##(1992-12#1)(1997-3#4)(2008-3#1)(2008-9#3)(2013-7#1)
scar was##2##2##(2007-8#1)(2012-3#1)
scar with##2##2##(2007-8#1)(2008-9#1)
scar##81##1##(1990-12#1)(1990-8#1)(1990-9#1)(1992-12#1)(1994-8#1)(1997-3#4)(2006-12#1)(2007-11#6)(2007-8#4)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#22)(2009-10#1)(2009-4#1)(2009-6#4)(2010-6#1)(2010-8#3)(2011-2#3)(2012-1#3)(2012-12#2)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#4)
scarce and##6##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
scarce information##2##2##(2007-5#1)(2013-7#1)
scarce resources##4##2##(1992-3#1)(1993-2#1)(1996-12#1)(2008-7#1)
scarce##51##1##(1990-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-12#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-3#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
scarcely##9##1##(1993-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
scarcity of cadaveric##2##3##(2011-2#2)
scarcity of studies##2##3##(2007-12#1)(2011-2#1)
scarcity of##16##2##(1994-12#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#4)(2011-3#2)(2012-12#1)
scarcity##24##1##(1993-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-5#1)
scare##2##1##(2008-11#1)(2008-9#1)
scarification##3##1##(2013-1#1)(2013-7#2)
scarification&quot##2##1##(2008-5#2)
scarlet gilia##2##2##(2008-9#2)
scarlet##4##1##(1992-2#1)(2008-10#1)(2008-9#2)
scarred##2##1##(1991-12#1)(2009-5#1)
scarring and##5##2##(1997-8#1)(2007-7#1)(2008-4#1)(2011-1#1)(2013-8#1)
scarring in the group##2##4##(1991-2#1)(1997-3#1)
scarring in##5##2##(1991-2#2)(1997-3#1)(2008-10#1)(2008-4#1)
scarring is##2##2##(2008-9#1)(2010-10#1)
scarring of the##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
scarring of##5##2##(1991-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)
scarring were##2##2##(1991-12#2)
scarring##41##1##(1990-3#1)(1991-12#4)(1991-2#2)(1996-1#1)(1997-3#2)(1997-8#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#8)(2008-5#1)(2008-7#1)(2008-9#6)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
scarring?##2##1##(2008-10#1)(2008-9#1)
scars and##3##2##(2007-11#1)(2008-9#2)
scars in the##2##3##(2008-9#1)(2009-6#1)
scars in##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
scars##23##1##(1991-11#1)(1991-2#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#8)(2009-1#1)(2009-4#2)(2009-6#3)(2010-8#1)(2013-1#1)
scat##2##1##(2008-5#2)
scats of opossums##2##3##(2008-5#2)
scats of##4##2##(2008-5#4)
scats##8##1##(2008-5#7)(2013-7#1)
scatter and##2##2##(2007-12#1)(2008-9#1)
scatter are##2##2##(2008-3#2)
scatter distribution##3##2##(2008-5#3)
scatter effects##2##2##(2008-3#2)
scatter estimation##2##2##(2008-5#2)
scatter imaging##2##2##(2007-12#2)
scatter in the##2##3##(1996-12#1)(2008-3#1)
scatter in##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
scatter is##6##2##(2008-3#2)(2008-6#2)(2008-9#2)
scatter##61##1##(1990-8#2)(1991-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(2006-6#1)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#14)(2008-5#9)(2008-6#3)(2008-9#9)(2009-4#1)(2011-1#5)(2012-1#1)(2013-8#1)
scattered across##2##2##(2008-1#1)(2008-5#1)
scattered and##2##2##(1990-8#1)(2008-3#1)
scattered by a##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
scattered by an##2##3##(2008-2#1)(2008-3#1)
scattered by the##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
scattered by##17##2##(2007-11#3)(2007-12#1)(2008-2#5)(2008-3#8)
scattered field is##2##3##(2008-2#1)(2008-3#1)
scattered field##10##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2009-10#1)
scattered fields##3##2##(2008-2#2)(2008-3#1)
scattered from a##6##3##(2008-2#1)(2008-3#5)
scattered from cylindrical rough surfaces##2##5##(2008-3#2)
scattered from##18##2##(1993-5#1)(2007-12#2)(2008-2#4)(2008-3#11)
scattered in the##5##3##(1996-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
scattered in##7##2##(1992-12#1)(1996-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
scattered intensity##3##2##(2008-3#3)
scattered into##2##2##(2007-11#1)(2008-3#1)
scattered laser##2##2##(2008-3#2)
scattered light and fluorescence##2##4##(2008-10#2)
scattered light and the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
scattered light and##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
scattered light from##3##3##(2008-3#3)
scattered light in##5##3##(2008-2#2)(2008-3#2)(2008-9#1)
scattered light intensity##2##3##(2007-12#1)(2011-2#1)
scattered light is##5##3##(2008-2#1)(2008-3#4)
scattered light to##3##3##(2007-11#1)(2008-2#2)
scattered light was##2##3##(2007-12#1)(2008-10#1)
scattered light with##2##3##(2008-3#2)
scattered light##65##2##(2007-11#2)(2007-12#7)(2008-10#5)(2008-2#16)(2008-3#29)(2008-4#1)(2008-9#1)(2011-2#4)
scattered photons##3##2##(2008-2#2)(2008-3#1)
scattered radiance##2##2##(2008-3#2)
scattered radiation##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)
scattered solar##3##2##(2008-2#1)(2008-3#2)
scattered throughout the##3##3##(1996-12#1)(2008-7#1)(2011-2#1)
scattered throughout##4##2##(1992-8#1)(1996-12#1)(2008-7#1)(2011-2#1)
scattered to##2##2##(2008-11#1)(2008-2#1)
scattered waves##2##2##(2008-2#1)(2008-3#1)
scattered##205##1##(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1994-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(2007-11#10)(2007-12#15)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#42)(2008-3#87)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
scattered-light##2##1##(2008-2#2)
scatterer concentration##3##2##(2007-12#3)
scatterer size and concentration in##2##5##(2007-11#1)(2008-3#1)
scatterer size and##3##3##(2007-11#1)(2008-3#2)
scatterer size is##2##3##(2007-11#1)(2008-3#1)
scatterer size##8##2##(2007-11#2)(2008-3#6)
scatterer##26##1##(1995-6#1)(1995-9#1)(2007-11#4)(2007-12#3)(2008-2#4)(2008-3#13)
scatterers are##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
scatterers at##3##2##(2008-2#2)(2008-3#1)
scatterers has been##2##3##(2008-3#2)
scatterers in##2##2##(1995-6#1)(2008-2#1)
scatterers on##3##2##(2008-3#3)
scatterers##39##1##(1995-6#1)(2007-11#3)(2007-12#4)(2008-2#12)(2008-3#19)
scattering (DW-RLS)##2##2##(2008-10#2)
scattering (SAXS)##4##2##(2008-10#3)(2009-6#1)
scattering amplitudes##3##2##(2007-11#1)(2008-3#1)(2010-7#1)
scattering and Rayleigh scattering##2##4##(2007-11#1)(2008-3#1)
scattering and absorbing##5##3##(2008-3#5)
scattering and absorption by##2##4##(2008-2#1)(2008-3#1)
scattering and absorption coefficients of##4##5##(2008-2#2)(2008-3#2)
scattering and absorption coefficients per unit length##2##7##(2008-2#1)(2008-3#1)
scattering and absorption coefficients##10##4##(2008-2#4)(2008-3#5)(2011-1#1)
scattering and absorption cross sections##2##5##(2008-3#2)
scattering and absorption properties##2##4##(2008-3#2)
scattering and absorption##27##3##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#18)(2011-1#1)
scattering and depolarizing##3##3##(2008-2#3)
scattering and fluorescence in##2##4##(2008-10#1)(2008-3#1)
scattering and fluorescence##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
scattering and the absorption##3##4##(2007-11#1)(2008-3#2)
scattering and the##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
scattering and##90##2##(1992-3#1)(1995-11#2)(2007-11#5)(2007-12#4)(2008-10#4)(2008-2#22)(2008-3#45)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
scattering angle for##2##3##(2008-3#2)
scattering angle of##2##3##(2008-3#2)
scattering angle##12##2##(2008-2#4)(2008-3#8)
scattering angles from##2##3##(2008-3#2)
scattering angles##9##2##(2008-2#2)(2008-3#6)(2009-6#1)
scattering anisotropy##4##2##(2008-3#4)
scattering are##8##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
scattering as a function of##2##5##(2008-10#1)(2008-3#1)
scattering as a##5##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#2)
scattering at an##2##3##(2008-3#2)
scattering at##8##2##(2007-11#1)(2008-2#1)(2008-3#5)(2009-11#1)
scattering by a##8##3##(2008-2#2)(2008-3#6)
scattering by an##6##3##(2008-2#4)(2008-3#2)
scattering by dielectric particles##4##4##(2007-11#1)(2008-3#3)
scattering by dielectric##5##3##(2007-11#2)(2008-3#3)
scattering by red blood cells##2##5##(2008-2#2)
scattering by water##2##3##(2008-2#1)(2008-3#1)
scattering by##56##2##(1993-5#1)(2007-11#6)(2007-12#2)(2008-2#23)(2008-3#24)
scattering calculations##3##2##(2007-11#1)(2008-2#1)(2009-12#1)
scattering can be##4##3##(2007-12#1)(2008-3#2)(2009-4#1)
scattering can##5##2##(2007-12#1)(2008-3#3)(2009-4#1)
scattering centers in##3##3##(2008-2#2)(2008-3#1)
scattering centers##8##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
scattering characteristics of##2##3##(2008-3#2)
scattering characteristics##3##2##(2008-2#1)(2008-3#2)
scattering coefficient and the##2##4##(2008-3#2)
scattering coefficient and##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
scattering coefficient b##2##3##(2008-3#2)
scattering coefficient of##4##3##(2008-2#1)(2008-3#3)
scattering coefficient##32##2##(2008-2#12)(2008-3#18)(2011-1#2)
scattering coefficients from##3##3##(2008-2#1)(2008-3#2)
scattering coefficients of##6##3##(2007-11#1)(2008-2#2)(2008-3#3)
scattering coefficients##27##2##(2007-11#2)(2007-12#1)(2008-2#7)(2008-3#17)
scattering component##3##2##(2008-2#1)(2008-3#2)
scattering components##2##2##(2008-2#1)(2009-12#1)
scattering cross section and the##2##5##(2007-12#1)(2008-2#1)
scattering cross section##8##3##(2007-12#3)(2008-2#2)(2008-3#3)
scattering cross sections##4##3##(2007-12#2)(2008-3#2)
scattering cross##12##2##(2007-12#5)(2008-2#2)(2008-3#5)
scattering data##2##2##(2008-2#1)(2008-3#1)
scattering delay##4##2##(2008-2#4)
scattering detection##4##2##(2008-10#4)
scattering direction##4##2##(2008-2#2)(2008-3#2)
scattering does not##2##3##(2008-2#2)
scattering effect##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
scattering effects##4##2##(2007-11#2)(2008-2#2)
scattering efficiency##3##2##(2008-3#3)
scattering errors##2##2##(2008-3#2)
scattering events##3##2##(2008-10#1)(2008-3#2)
scattering experiments##5##2##(1995-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
scattering for##8##2##(2006-4#2)(2008-10#1)(2008-3#5)
scattering from a##2##3##(2008-3#2)
scattering from an optically active sphere##2##6##(2008-2#2)
scattering from an optically##3##4##(2008-2#3)
scattering from cells##2##3##(2008-3#2)
scattering from dielectric bispheres in the specular direction##2##8##(2007-11#2)
scattering from homogeneous##2##3##(2008-2#1)(2008-3#1)
scattering from particulate##2##3##(2008-2#1)(2008-3#1)
scattering from rough surfaces##2##4##(2008-3#2)
scattering from the##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
scattering from##49##2##(2007-1#1)(2007-11#3)(2007-12#4)(2008-2#12)(2008-3#27)(2008-6#2)
scattering function##5##2##(2008-2#2)(2008-3#3)
scattering has been##2##3##(2007-12#1)(2008-3#1)
scattering image##2##2##(2008-2#1)(2008-3#1)
scattering images##3##2##(2007-11#2)(2008-3#1)
scattering in a##8##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
scattering in impulsively excited##2##4##(2007-11#2)
scattering in optical##3##3##(2007-11#2)(2008-3#1)
scattering in the##9##3##(1994-3#1)(2008-10#1)(2008-2#5)(2008-3#1)(2013-8#1)
scattering in##45##2##(1990-12#1)(1994-3#2)(1995-3#1)(2007-11#9)(2007-12#7)(2008-10#1)(2008-2#9)(2008-3#14)(2013-8#1)
scattering intensities##2##2##(2008-10#1)(2008-2#1)
scattering intensity at##2##3##(2008-10#2)
scattering intensity##11##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#1)(2009-12#1)
scattering into##2##2##(2008-2#2)
scattering is a##3##3##(2007-11#1)(2008-3#2)
scattering is presented##3##3##(2006-4#1)(2008-2#2)
scattering is##27##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#9)(2008-3#12)(2008-4#1)(2008-9#1)
scattering layer##6##2##(2008-2#5)(2008-3#1)
scattering layers##6##2##(2007-11#1)(2008-3#5)
scattering length##2##2##(2008-3#2)
scattering lidar##2##2##(2008-3#2)
scattering lidars##3##2##(2008-3#3)
scattering light##2##2##(2008-10#1)(2008-6#1)
scattering loss##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
scattering losses##2##2##(2008-3#2)
scattering matrices##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scattering matrix elements of##2##4##(2008-3#2)
scattering matrix elements##4##3##(2008-2#2)(2008-3#2)
scattering matrix##7##2##(2008-2#2)(2008-3#5)
scattering mean free paths##4##4##(2007-12#2)(2008-3#2)
scattering mean free##5##3##(2007-12#3)(2008-3#2)
scattering measurements for##2##3##(2008-2#1)(2008-3#1)
scattering measurements of polarized light##3##5##(2008-2#3)
scattering measurements on##2##3##(2008-2#1)(2008-3#1)
scattering measurements##11##2##(2008-2#6)(2008-3#5)
scattering media and##2##3##(2008-3#2)
scattering media by use of a##2##6##(2007-12#1)(2008-3#1)
scattering media by use of##4##5##(2007-12#2)(2008-3#2)
scattering media by##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
scattering media in##2##3##(2008-2#2)
scattering media is##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
scattering media with##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
scattering media##60##2##(1992-8#1)(2007-11#2)(2007-12#11)(2008-2#11)(2008-3#35)
scattering medium by##2##3##(2007-12#1)(2008-3#1)
scattering medium##45##2##(2007-11#2)(2007-12#10)(2008-2#11)(2008-3#22)
scattering method for the##2##4##(2008-10#2)
scattering method##4##2##(2008-10#4)
scattering object##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
scattering objects##2##2##(2007-11#2)
scattering of He-Ne laser light##2##5##(2008-3#2)
scattering of a##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-10#1)
scattering of an##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
scattering of light at oblique incidence by##2##7##(2008-2#2)
scattering of light by##9##4##(2008-2#2)(2008-3#7)
scattering of light from##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
scattering of light in##2##4##(2008-2#2)
scattering of light##19##3##(2007-11#1)(2008-10#1)(2008-2#8)(2008-3#8)(2008-9#1)
scattering of optical##2##3##(2008-3#2)
scattering of the##5##3##(2008-2#1)(2008-3#3)(2011-2#1)
scattering of##59##2##(2007-11#3)(2007-12#1)(2008-10#7)(2008-2#19)(2008-3#22)(2008-9#1)(2009-10#2)(2009-4#1)(2011-2#1)(2013-8#2)
scattering on the measured##2##4##(2008-3#2)
scattering on the##6##3##(2008-2#1)(2008-3#5)
scattering on##15##2##(2007-11#1)(2008-2#5)(2008-3#9)
scattering or absorbing##2##3##(2008-2#1)(2008-3#1)
scattering or##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
scattering outside##2##2##(2008-2#1)(2008-3#1)
scattering over##3##2##(2008-2#2)(2008-3#1)
scattering particles##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
scattering path##2##2##(2008-2#1)(2008-3#1)
scattering pattern##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
scattering patterns of##2##3##(2008-2#2)
scattering patterns##6##2##(2007-11#1)(2008-2#4)(2008-5#1)
scattering phase function is##3##4##(2008-2#1)(2008-3#2)
scattering phase function of##2##4##(2008-2#2)
scattering phase function##14##3##(2008-2#7)(2008-3#7)
scattering phase matrix##3##3##(2008-2#2)(2008-3#1)
scattering phase##18##2##(2008-2#9)(2008-3#9)
scattering photons##2##2##(2007-12#2)
scattering problem for##3##3##(2008-2#3)
scattering problem##8##2##(2008-2#6)(2008-3#2)
scattering process##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
scattering properties and##2##3##(2007-11#1)(2011-1#1)
scattering properties are##3##3##(2007-11#1)(2008-3#2)
scattering properties of an##2##4##(2008-2#1)(2008-3#1)
scattering properties of##16##3##(2007-11#2)(2008-2#3)(2008-3#11)
scattering properties##25##2##(2007-11#4)(2008-2#4)(2008-3#16)(2011-1#1)
scattering quantities##4##2##(2008-3#4)
scattering rate##2##2##(2012-2#2)
scattering regimes##2##2##(2008-3#2)
scattering results##3##2##(2008-3#2)(2008-7#1)
scattering samples##4##2##(2007-12#1)(2008-3#3)
scattering shows##2##2##(2007-12#1)(2008-3#1)
scattering signal##4##2##(2007-12#1)(2008-10#1)(2011-1#2)
scattering signals##4##2##(2008-10#4)
scattering slab is presented##2##4##(2008-3#2)
scattering slab is##4##3##(2008-3#4)
scattering slab##7##2##(2008-3#7)
scattering spectra of##2##3##(2008-2#1)(2008-3#1)
scattering spectra##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
scattering spectroscopy##2##2##(1996-2#1)(2008-10#1)
scattering strength##3##2##(2008-3#3)
scattering studies##3##2##(1990-12#1)(1995-3#1)(2008-11#1)
scattering study##2##2##(2008-10#2)
scattering technique##12##2##(2008-10#9)(2008-2#1)(2008-3#1)(2011-2#1)
scattering techniques##4##2##(1992-3#1)(2008-10#1)(2011-2#1)(2012-1#1)
scattering that is due to##2##5##(2007-11#1)(2008-2#1)
scattering that is##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
scattering that##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
scattering theory##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
scattering to the##5##3##(2008-3#5)
scattering to##9##2##(2007-11#1)(2008-3#7)(2009-9#1)
scattering vector##2##2##(2008-10#1)(2008-3#1)
scattering was##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
scattering were##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)
scattering will##2##2##(2007-12#1)(2008-3#1)
scattering with##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-7#1)
scattering##1253##1##(1990-12#3)(1992-3#2)(1992-8#3)(1993-5#1)(1994-2#1)(1994-3#3)(1995-11#2)(1995-3#4)(1995-6#2)(1996-2#1)(2006-4#4)(2007-1#1)(2007-11#85)(2007-12#94)(2008-1#1)(2008-10#109)(2008-11#3)(2008-2#301)(2008-3#570)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#2)(2009-6#2)(2009-9#1)(2010-5#1)(2010-7#4)(2011-1#6)(2011-2#6)(2011-7#1)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#8)
scattering)##3##1##(2007-12#1)(2008-3#2)
scattering-extinction##3##1##(2008-2#1)(2008-3#2)
scattering-loss##2##1##(2008-3#2)
scatterings##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
scatters##3##1##(2008-2#1)(2008-3#1)(2008-7#1)
scavenge free radicals##2##3##(1992-9#1)(2008-7#1)
scavenge##8##1##(1992-5#1)(1992-9#1)(1995-8#1)(2008-11#3)(2008-7#2)
scavenged##4##1##(1992-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
scavenger activity##4##2##(2008-5#3)(2011-2#1)
scavenger in##2##2##(1992-9#1)(2008-5#1)
scavenger of##3##2##(1995-2#1)(2008-11#2)
scavenger properties##3##2##(1994-6#1)(2008-5#1)(2009-8#1)
scavenger receptor##3##2##(1990-2#1)(1993-8#1)(2013-1#1)
scavenger receptors##2##2##(1993-8#1)(2013-1#1)
scavenger##47##1##(1990-2#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-6#2)(1993-8#4)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#3)(1996-2#1)(1997-8#1)(2008-10#7)(2008-11#3)(2008-5#8)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
scavengers and antioxidants##3##3##(2008-11#1)(2008-5#1)(2009-6#1)
scavengers and##5##2##(1996-2#1)(2008-11#2)(2008-5#1)(2009-6#1)
scavengers in the##2##3##(2009-12#1)(2012-2#1)
scavengers of##4##2##(1990-11#1)(1991-9#1)(1992-9#1)(1996-2#1)
scavengers such as##2##3##(2008-7#1)(2011-2#1)
scavengers were##2##2##(1993-8#1)(2008-6#1)
scavengers##36##1##(1990-11#1)(1991-9#4)(1992-9#1)(1993-8#2)(1994-6#1)(1995-2#2)(1995-6#2)(1996-2#4)(2008-11#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#2)(2012-2#1)
scavenges##4##1##(1994-8#1)(1997-7#1)(2008-10#1)(2008-11#1)
scavenging abilities of##2##3##(2008-10#1)(2008-5#1)
scavenging action##2##2##(1995-12#1)(2008-4#1)
scavenging activities in##2##3##(2013-1#1)(2013-8#1)
scavenging activities##6##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
scavenging activity##9##2##(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#3)(2009-6#1)
scavenging and##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)
scavenging by##2##2##(1995-3#1)(2008-9#1)
scavenging effect of##2##3##(1993-6#1)(2008-11#1)
scavenging effect on##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
scavenging effect##5##2##(1993-6#1)(2008-10#1)(2008-11#2)(2012-2#1)
scavenging of##9##2##(1995-3#1)(2008-11#1)(2008-4#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#1)
scavenging superoxide anion##2##3##(2008-10#1)(2013-8#1)
scavenging##73##1##(1991-12#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-6#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-2#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-9#3)(2009-3#1)(2009-6#3)(2010-12#1)(2010-5#4)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
sceletal##4##1##(2007-11#4)
scenario analysis##2##2##(1992-9#1)(1997-3#1)
scenario and the##2##3##(2008-11#1)(2011-2#1)
scenario and##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
scenario for health##2##3##(1992-3#1)(1996-2#1)
scenario for##3##2##(1992-3#1)(1996-2#1)(2012-12#1)
scenario in which the##2##4##(2008-8#1)(2009-2#1)
scenario in which##3##3##(2008-8#1)(2009-2#1)(2013-1#1)
scenario in##4##2##(2008-11#1)(2008-8#1)(2009-2#1)(2013-1#1)
scenario is##3##2##(1995-1#1)(2008-7#1)(2008-9#1)
scenario of##8##2##(2008-1#1)(2008-10#4)(2009-10#1)(2010-8#1)(2011-2#1)
scenario##61##1##(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#5)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-5#1)(2013-1#3)(2013-8#2)
scenario-based design##3##2##(2010-8#3)
scenario-based##5##1##(2008-11#2)(2010-8#3)
scenarios and##3##2##(1996-3#1)(2009-12#1)(2013-1#1)
scenarios are##2##2##(2008-3#1)(2009-10#1)
scenarios based on##2##3##(2010-12#1)(2010-3#1)
scenarios for##5##2##(1996-1#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-1#1)
scenarios generated##2##2##(2009-10#2)
scenarios in which##2##3##(2008-1#1)(2008-6#1)
scenarios in##5##2##(2008-1#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-3#1)
scenarios involving##2##2##(2008-7#1)(2009-10#1)
scenarios of##9##2##(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
scenarios that##2##2##(2011-2#1)(2012-2#1)
scenarios triggered by fire##2##4##(2009-10#2)
scenarios were##4##2##(2008-11#1)(2009-10#1)(2010-8#1)(2013-1#1)
scenarios where the##2##3##(2008-11#1)(2008-6#1)
scenarios where##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
scenarios##92##1##(1996-1#1)(1996-12#2)(1996-3#2)(2008-1#2)(2008-10#5)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#13)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
scene and##2##2##(2008-3#2)
scene for##2##2##(2007-12#1)(2012-2#1)
scene is##3##2##(2008-3#3)
scene of##6##2##(1991-8#1)(1995-11#1)(1996-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
scene with an##2##3##(2007-12#1)(2008-3#1)
scene with##3##2##(2007-12#1)(2008-3#1)(2009-12#1)
scene##67##1##(1991-8#1)(1993-12#1)(1994-12#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-12#5)(2008-2#8)(2008-3#25)(2008-6#3)(2008-7#1)(2008-9#2)(2009-12#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
scene-based##2##1##(2008-3#2)
scenes and##2##2##(2008-10#1)(2008-3#1)
scenes are##2##2##(2008-10#1)(2008-3#1)
scenes of##2##2##(2008-8#1)(2012-12#1)
scenes that##2##2##(2007-12#1)(2008-3#1)
scenes##26##1##(2007-12#2)(2008-10#5)(2008-2#4)(2008-3#10)(2008-6#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
scent##7##1##(2007-12#1)(2008-4#1)(2008-5#3)(2012-2#2)
schachtii J2##2##2##(2008-10#2)
schachtii and##3##2##(2008-10#2)(2008-12#1)
schachtii cysts##4##2##(2008-10#4)
schachtii eggs##2##2##(2008-10#2)
schachtii in##2##2##(2008-10#2)
schachtii multiplied##2##2##(2008-10#2)
schachtii population densities##2##3##(2008-10#2)
schachtii population##4##2##(2008-10#4)
schachtii populations##3##2##(2008-10#3)
schachtii was##2##2##(2008-10#2)
schachtii##41##1##(2008-10#38)(2008-12#3)
schedule and##9##2##(1992-3#1)(1994-1#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2013-8#1)
schedule based##2##2##(1992-12#1)(2011-2#1)
schedule for a##2##3##(2007-11#1)(2008-12#1)
schedule for##10##2##(1990-6#1)(1991-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-12#1)(2013-8#1)
schedule is##3##2##(1991-12#1)(2008-6#1)(2009-4#1)
schedule of ifosfamide##2##3##(2008-6#2)
schedule of male##3##3##(2008-6#3)
schedule of reproductive effort##2##4##(2008-8#2)
schedule of##21##2##(1990-2#2)(1991-12#1)(1991-6#1)(1992-2#2)(1993-2#1)(1993-6#2)(2007-12#1)(2007-2#1)(2008-6#6)(2008-7#2)(2008-8#2)
schedule on##2##2##(1991-2#1)(2007-4#1)
schedule or##4##2##(1991-8#1)(1993-11#1)(2007-12#1)(2009-4#1)
schedule was##3##2##(1991-8#1)(1993-6#1)(2010-8#1)
schedule with##3##2##(1994-8#1)(1995-5#1)(2007-12#1)
schedule##129##1##(1990-12#1)(1990-2#5)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#3)(1991-8#3)(1992-1#4)(1992-12#1)(1992-2#9)(1992-3#2)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#4)(1994-1#9)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#4)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#5)(1996-9#1)(1997-2#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-4#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#10)(2008-7#3)(2008-8#2)(2009-12#2)(2009-4#2)(2010-8#2)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
schedule-induced polydipsia##2##2##(1993-6#2)
scheduled for elective surgery##4##4##(1995-1#1)(1996-9#1)(2006-12#1)(2010-7#1)
scheduled for elective##9##3##(1993-10#1)(1995-1#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-8#1)(2010-7#1)(2011-2#2)
scheduled for mitral valve repair##2##5##(2011-2#2)
scheduled for the##2##3##(2008-5#1)(2010-4#1)
scheduled for##34##2##(1991-2#1)(1993-1#2)(1993-10#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-8#3)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#1)
scheduled to attend##2##3##(1993-3#1)(2007-10#1)
scheduled to be##2##3##(1992-1#1)(2011-4#1)
scheduled to##7##2##(1992-1#1)(1993-3#1)(2007-10#1)(2007-8#1)(2008-5#1)(2011-2#1)(2011-4#1)
scheduled##60##1##(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-10#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-8#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#8)(2011-4#1)(2012-12#2)(2012-2#1)(2013-1#3)
scheduler##4##1##(2008-3#4)
schedules and##7##2##(1993-12#1)(2007-2#1)(2007-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
schedules can##2##2##(2007-2#1)(2010-5#1)
schedules for##2##2##(1993-3#1)(2008-7#1)
schedules have##2##2##(1992-10#2)
schedules in##2##2##(1992-10#1)(1993-3#1)
schedules of##8##2##(1992-12#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)
schedules##57##1##(1991-12#2)(1992-10#4)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-3#3)(1993-9#1)(1995-5#4)(1996-3#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#1)
scheduling and##2##2##(1994-3#1)(2008-7#1)
scheduling can be a##2##4##(1994-2#1)(1996-2#1)
scheduling can##4##2##(1994-2#2)(1996-2#2)
scheduling has##2##2##(2012-3#1)(2013-1#1)
scheduling in a##2##3##(1994-2#1)(1996-3#1)
scheduling in##3##2##(1994-2#1)(1996-3#1)(2008-5#1)
scheduling patients##2##2##(1996-1#1)(2013-1#1)
scheduling process##3##2##(1991-2#1)(1996-1#2)
scheduling system##2##2##(1994-2#2)
scheduling##41##1##(1991-2#4)(1994-2#11)(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#5)(1996-12#1)(1996-2#4)(1996-3#2)(1997-3#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2012-3#2)(2013-1#3)
schema and##2##2##(2010-12#1)(2013-1#1)
schema##9##1##(1994-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2013-1#1)
schemas##3##1##(2008-7#1)(2010-7#1)(2010-8#1)
schematic##5##1##(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#2)
schematically##3##1##(1997-3#1)(2008-4#1)(2008-5#1)
scheme allows##2##2##(2008-10#1)(2008-3#1)
scheme also provides##3##3##(2007-12#2)(2008-3#1)
scheme also##4##2##(2007-12#2)(2008-3#2)
scheme and the##2##3##(2008-2#1)(2008-3#1)
scheme and##12##2##(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-12#1)(2012-3#1)
scheme are##8##2##(1991-12#1)(1996-8#1)(2007-12#3)(2008-2#2)(2008-7#1)
scheme at##2##2##(2008-7#1)(2009-8#1)
scheme based on##6##3##(2007-12#1)(2008-3#3)(2009-11#1)(2009-3#1)
scheme based##7##2##(2007-12#1)(2008-3#3)(2009-11#2)(2009-3#1)
scheme by a##2##3##(2007-12#1)(2008-3#1)
scheme by##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
scheme can be extended##2##4##(2007-11#1)(2007-8#1)
scheme can be##4##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)
scheme can provide##2##3##(2007-12#2)
scheme can##8##2##(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#1)
scheme developed for##2##3##(2007-12#1)(2008-3#1)
scheme for a##4##3##(2007-12#3)(2008-2#1)
scheme for calculating##2##3##(2008-3#1)(2010-3#1)
scheme for phase##2##3##(2008-2#1)(2008-3#1)
scheme for polarization-insensitive and frequency-conversion##2##5##(2007-12#2)
scheme for the##7##3##(1990-8#1)(1991-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
scheme for##69##2##(1990-5#1)(1990-8#1)(1991-5#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-6#1)(1996-8#1)(2007-11#9)(2007-12#11)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#20)(2008-6#1)(2010-3#1)(2013-8#1)
scheme has been demonstrated##2##4##(2007-12#1)(2008-10#1)
scheme has been developed for##3##5##(2008-10#1)(2008-3#2)
scheme has been developed##4##4##(2008-10#2)(2008-3#2)
scheme has been##10##3##(1996-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)
scheme has##13##2##(1996-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2012-2#1)(2012-3#1)
scheme in which the##3##4##(2007-1#1)(2008-2#1)(2008-3#1)
scheme in which##6##3##(2007-1#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
scheme in##14##2##(1994-11#1)(1996-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)
scheme involved##2##2##(1990-12#1)(2008-10#1)
scheme involving##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
scheme is applied##2##3##(2007-11#1)(2012-2#1)
scheme is based on the##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
scheme is demonstrated##2##3##(2008-10#1)(2008-2#1)
scheme is developed##2##3##(2008-3#1)(2008-6#1)
scheme is proposed##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
scheme is##45##2##(1992-10#1)(1993-12#2)(1997-8#1)(2007-11#3)(2007-7#1)(2008-10#6)(2008-2#8)(2008-3#18)(2008-6#1)(2012-2#4)
scheme not only##2##3##(2008-2#1)(2013-8#1)
scheme of##17##2##(1995-11#1)(1995-5#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2013-1#1)
scheme offers a##2##3##(2007-11#1)(2008-10#1)
scheme permits##2##2##(2007-12#1)(2008-3#1)
scheme provides##2##2##(2007-12#1)(2008-2#1)
scheme seems to be##2##4##(2008-10#2)
scheme seems##3##2##(1992-6#1)(2008-10#2)
scheme that employs##2##3##(2008-3#2)
scheme that is capable of##2##5##(2008-3#1)(2012-2#1)
scheme that is##5##3##(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
scheme that uses a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
scheme that uses##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
scheme that we##2##3##(2007-11#1)(2010-8#1)
scheme that##22##2##(1997-3#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#8)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
scheme the##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
scheme to study the##2##4##(2008-10#2)
scheme to##17##2##(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2009-5#1)
scheme used for##2##3##(2007-12#1)(2008-2#1)
scheme used##3##2##(1997-5#1)(2007-12#1)(2008-2#1)
scheme using a##2##3##(2007-11#1)(2008-10#1)
scheme using##4##2##(2007-11#2)(2008-10#1)(2013-8#1)
scheme was developed##2##3##(2008-10#2)
scheme was##10##2##(1994-2#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-9#1)
scheme with a##6##3##(2007-11#2)(2007-12#2)(2008-2#2)
scheme with##14##2##(1990-8#1)(1992-4#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)
scheme##445##1##(1990-12#1)(1990-5#1)(1990-8#3)(1991-12#2)(1991-3#1)(1991-5#1)(1992-10#2)(1992-4#1)(1992-6#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#5)(1996-12#1)(1996-6#2)(1996-8#4)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-1#1)(2007-11#42)(2007-12#51)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#54)(2008-11#8)(2008-12#1)(2008-2#62)(2008-3#109)(2008-5#5)(2008-6#6)(2008-7#9)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#3)(2013-8#5)
schemes and the##3##3##(1993-12#2)(2008-10#1)
schemes and##6##2##(1993-12#2)(2008-10#2)(2008-2#1)(2009-5#1)
schemes are##10##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#2)
schemes as##2##2##(1997-5#1)(2008-7#1)
schemes based on##2##3##(2010-5#1)(2013-7#1)
schemes by##2##2##(2007-11#1)(2010-12#1)
schemes can be##2##3##(1997-1#1)(2007-11#1)
schemes can##3##2##(1995-3#1)(1997-1#1)(2007-11#1)
schemes designed to##2##3##(2008-4#1)(2010-7#1)
schemes for##11##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-9#1)(2011-1#1)(2013-1#1)
schemes in##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2013-7#1)
schemes of the##2##3##(1991-3#1)(1994-6#1)
schemes of##4##2##(1991-3#1)(1994-6#1)(2007-10#1)(2008-10#1)
schemes such as##2##3##(2008-2#1)(2008-7#1)
schemes that are used to##2##5##(1996-2#1)(2008-3#1)
schemes that are##3##3##(1996-2#1)(2008-3#2)
schemes that##5##2##(1991-12#1)(1996-2#1)(2008-3#3)
schemes##113##1##(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#2)(1993-12#2)(1994-12#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#4)(2007-7#2)(2008-1#1)(2008-10#24)(2008-11#1)(2008-2#8)(2008-3#15)(2008-4#3)(2008-7#8)(2008-9#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-5#2)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#2)
schiff##2##1##(2008-7#1)(2011-1#1)
schistosomal##3##1##(1996-8#1)(2013-8#2)
schistosome infection##2##2##(2009-5#1)(2012-3#1)
schistosome##4##1##(1996-12#1)(2009-5#1)(2012-3#2)
schistosomes##7##1##(2009-5#3)(2010-9#1)(2013-1#2)(2013-8#1)
schistosomiasis and##2##2##(2012-3#1)(2013-8#1)
schistosomiasis at##2##2##(1996-12#1)(2008-8#1)
schistosomiasis control strategy with emphasis on controlling sources of infection in lake and marshland endemic##2##15##(2012-3#2)
schistosomiasis control strategy with emphasis on##3##6##(2012-3#3)
schistosomiasis control##5##2##(2008-8#1)(2012-3#4)
schistosomiasis endemic##4##2##(2012-3#4)
schistosomiasis haematobium##2##2##(1996-12#2)
schistosomiasis in##11##2##(1991-9#1)(1996-8#1)(2008-8#1)(2012-3#8)
schistosomiasis japonica in##2##3##(2012-3#2)
schistosomiasis japonica##6##2##(2008-8#2)(2012-3#4)
schistosomiasis of##2##2##(1996-12#1)(2012-3#1)
schistosomiasis patients combined with acute hepatitis##2##6##(2012-3#2)
schistosomiasis surveillance##6##2##(2012-3#6)
schistosomiasis transmission##5##2##(2008-8#2)(2012-3#3)
schistosomiasis were##2##2##(1996-12#1)(2008-8#1)
schistosomiasis##81##1##(1991-9#1)(1996-12#23)(1996-8#2)(2008-10#1)(2008-8#10)(2009-5#2)(2011-2#1)(2012-3#39)(2013-8#2)
schistosomiasis]##2##1##(2012-3#2)
schizo-obsessive subtype##4##2##(2008-3#4)
schizoaffective disorder##5##2##(1997-5#1)(2008-3#1)(2008-8#3)
schizoaffective##11##1##(1996-7#1)(1997-5#4)(2008-3#1)(2008-8#4)(2011-2#1)
schizoid personality disorder##2##3##(2012-12#2)
schizoid##3##1##(2012-12#3)
schizont##2##1##(1990-2#1)(2007-2#1)
schizophrenia (SZ)##3##2##(1997-5#3)
schizophrenia and AD##2##3##(2011-1#2)
schizophrenia and Alzheimer's disease##2##4##(1995-6#1)(2011-1#1)
schizophrenia and bipolar disorder##3##4##(2008-3#1)(2009-6#2)
schizophrenia and bipolar##4##3##(1997-5#1)(2008-3#1)(2009-6#2)
schizophrenia and other##2##3##(2008-5#1)(2013-8#1)
schizophrenia and##37##2##(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#3)(1997-5#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
schizophrenia brain##2##2##(1993-9#2)
schizophrenia but##2##2##(2008-7#1)(2009-12#1)
schizophrenia group##2##2##(2013-1#2)
schizophrenia has##2##2##(2008-3#1)(2012-12#1)
schizophrenia have been##2##3##(1995-12#1)(2010-1#1)
schizophrenia have##3##2##(1995-12#1)(2009-6#1)(2010-1#1)
schizophrenia in the elderly##2##4##(2008-8#2)
schizophrenia in##7##2##(1994-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-8#2)(2009-6#1)
schizophrenia is##11##2##(1990-11#1)(1993-9#2)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-9#1)(2011-2#1)
schizophrenia or schizoaffective##2##3##(1996-7#1)(2008-3#1)
schizophrenia or##8##2##(1996-7#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#4)
schizophrenia patients##5##2##(1995-12#1)(1997-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
schizophrenia remain##2##2##(1996-7#1)(2008-6#1)
schizophrenia spectrum disorders##2##3##(2008-6#1)(2011-2#1)
schizophrenia spectrum##3##2##(1995-11#1)(2008-6#1)(2011-2#1)
schizophrenia was##3##2##(1993-9#1)(2008-3#1)(2011-2#1)
schizophrenia were##2##2##(2008-11#1)(2008-6#1)
schizophrenia##262##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1993-9#11)(1994-12#1)(1995-11#9)(1995-12#8)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#5)(1996-5#9)(1996-6#6)(1996-7#19)(1996-8#1)(1997-5#20)(1997-8#2)(2007-1#1)(2007-10#1)(2007-8#4)(2008-1#5)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#12)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#4)(2009-6#5)(2009-7#6)(2009-9#4)(2010-1#8)(2010-6#5)(2010-9#1)(2011-1#18)(2011-2#23)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
schizophrenia]##6##1##(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#2)(2013-7#1)
schizophrenic and bipolar I disorder##2##5##(1997-5#2)
schizophrenic and##3##2##(1995-5#1)(1997-5#2)
schizophrenic group##4##2##(1995-11#1)(1996-7#2)(2013-1#1)
schizophrenic patient##2##2##(1993-2#1)(2008-7#1)
schizophrenic patients and##4##3##(1995-5#2)(2008-6#1)(2013-1#1)
schizophrenic patients may##2##3##(1996-7#1)(2008-6#1)
schizophrenic patients than in##2##4##(1996-5#1)(1996-7#1)
schizophrenic patients##34##2##(1995-11#2)(1995-12#1)(1995-5#4)(1996-5#2)(1996-7#7)(2008-12#5)(2008-6#6)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#4)
schizophrenic psychosis##2##2##(1996-5#1)(2007-1#1)
schizophrenic subjects##2##2##(1996-5#1)(1996-7#1)
schizophrenic##58##1##(1990-11#2)(1992-12#1)(1993-2#1)(1995-11#4)(1995-12#1)(1995-5#5)(1996-5#5)(1996-7#11)(1997-5#2)(2007-1#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#5)(2008-6#6)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2013-1#5)
schizophrenics with##2##2##(1997-5#2)
schizophrenics##5##1##(1997-5#4)(2007-8#1)
schizotypal personality disorder (SPD)##2##4##(1995-11#1)(2008-1#1)
schizotypal personality disorder##3##3##(1995-11#2)(2008-1#1)
schizotypal traits##3##2##(2008-1#3)
schizotypal##6##1##(1995-11#2)(2008-1#4)
schlieren##2##1##(2008-3#2)
schneideri##2##1##(2010-3#2)
scholar##3##1##(2009-10#1)(2011-1#1)(2012-3#1)
scholarly##10##1##(1995-12#1)(1996-12#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#2)(2012-12#1)
scholars##11##1##(1996-2#1)(2008-10#1)(2008-12#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
scholarship##2##1##(1996-12#1)(2007-2#1)
scholastic##3##1##(1996-1#1)(2012-2#1)(2013-1#1)
schomburgkii##2##1##(2013-7#2)
school adolescents##2##2##(2011-1#2)
school age children##3##3##(2008-3#1)(2012-2#2)
school age##4##2##(2008-3#1)(2011-1#1)(2012-2#2)
school and university##2##3##(2010-2#1)(2012-12#1)
school and##12##2##(1994-12#1)(1996-12#1)(2008-11#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
school based##2##2##(2012-2#2)
school burnout and depressive symptoms##4##5##(2009-9#4)
school burnout and##5##3##(2009-9#5)
school burnout##8##2##(2009-9#8)
school children from##2##3##(1993-6#1)(2007-12#1)
school children in##11##3##(1994-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#2)(2013-8#1)
school children of##2##3##(2009-7#1)(2012-2#1)
school children##31##2##(1991-9#3)(1992-6#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-8#2)
school classes##3##2##(2010-1#3)
school classrooms##2##2##(2009-7#1)(2010-8#1)
school connectedness##6##2##(2009-7#6)
school curricula##2##2##(1994-1#1)(2012-3#1)
school curriculum##5##2##(1996-4#1)(2007-5#1)(2008-1#1)(2008-3#1)(2012-3#1)
school district##2##2##(1991-12#1)(2009-8#1)
school dropout##2##2##(2012-12#1)(2013-1#1)
school engagement##6##2##(2009-7#6)
school entry##2##2##(2008-11#1)(2011-1#1)
school environment##2##2##(2009-7#2)
school environments##3##2##(1996-3#1)(2010-1#1)(2010-5#1)
school for the##2##3##(2007-7#1)(2013-1#1)
school for##4##2##(2007-7#1)(2011-2#1)(2013-1#2)
school going children in##2##4##(2007-7#1)(2008-7#1)
school going children##4##3##(2007-7#2)(2008-7#1)(2012-3#1)
school health personnel##2##3##(2008-10#2)
school health##5##2##(1990-6#2)(1996-10#1)(2008-10#2)
school in##11##2##(1993-1#1)(2008-4#1)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#2)(2013-8#3)
school maintenance##2##2##(1991-12#2)
school nutrition##2##2##(2012-2#2)
school of nursing##3##3##(2008-11#1)(2008-12#1)(2010-3#1)
school of##9##2##(1993-5#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-3#1)(2013-1#1)
school or##4##2##(2008-11#1)(2009-9#2)(2011-2#1)
school outcomes##3##2##(2008-12#1)(2009-7#1)(2012-2#1)
school performance##5##2##(2007-12#1)(2008-11#1)(2008-12#1)(2009-7#2)
school professionals##3##2##(2008-12#3)
school pupils##2##2##(1996-6#1)(2011-2#1)
school readiness##4##2##(2008-11#1)(2008-12#3)
school reintegration intervention##2##3##(1993-1#2)
school reintegration##4##2##(1993-1#4)
school settings##2##2##(1996-3#1)(2012-2#1)
school student##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
school students in##7##3##(2008-12#2)(2012-12#1)(2013-1#4)
school students##30##2##(1990-12#1)(1990-2#1)(1993-3#1)(2007-12#1)(2008-1#2)(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
school teachers##6##2##(1991-12#4)(2008-12#1)(2009-5#1)
school that##2##2##(1990-3#1)(2010-4#1)
school with##2##2##(2008-7#1)(2009-7#1)
school year##5##2##(2008-12#4)(2010-1#1)
school years##2##2##(2008-11#1)(2008-12#1)
school##373##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#4)(1991-12#11)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#10)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#5)(1993-8#1)(1994-1#3)(1994-12#3)(1994-6#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-5#1)(2007-7#4)(2008-1#6)(2008-10#9)(2008-11#17)(2008-12#34)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#37)(2009-8#1)(2009-9#13)(2010-1#10)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#17)(2012-12#17)(2012-2#21)(2012-3#7)(2013-1#21)(2013-7#2)(2013-8#9)
school's##2##1##(1996-1#1)(2008-12#1)
school) and##2##2##(1997-4#1)(2010-1#1)
school-age children 7-14 years##2##4##(2011-2#2)
school-age children anticipating##2##3##(1995-1#2)
school-age children##11##2##(1991-2#2)(1994-12#1)(1995-1#2)(2009-9#1)(2011-1#1)(2011-2#4)
school-age##15##1##(1991-2#3)(1993-12#1)(1994-12#1)(1995-1#2)(1995-12#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-12#1)
school-aged children with##2##3##(2008-9#1)(2009-4#1)
school-aged children##8##2##(1992-2#2)(1993-3#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-3#1)
school-aged##13##1##(1992-12#1)(1992-2#2)(1993-3#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
school-based childhood obesity prevention programs##2##5##(2009-6#1)(2012-2#1)
school-based intervention##2##2##(2010-9#1)(2012-3#1)
school-based##18##1##(1993-1#1)(1995-12#2)(2007-4#1)(2008-7#1)(2008-9#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
school-children##2##1##(2011-1#2)
school-entry##2##1##(2008-4#2)
school-level##2##1##(2009-7#2)
school-related##3##1##(1991-2#1)(2008-12#1)(2009-7#1)
schoolchildren in the##2##3##(1993-11#1)(2013-1#1)
schoolchildren in##5##2##(1990-3#1)(1993-11#1)(2010-8#2)(2013-1#1)
schoolchildren were##2##2##(2010-8#2)
schoolchildren##19##1##(1990-3#3)(1991-6#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-6#1)(1996-11#2)(2008-1#1)(2010-8#6)(2011-2#1)(2013-1#1)
schoolgirls##2##1##(1995-6#1)(2007-12#1)
schooling##5##1##(2009-10#1)(2009-12#1)(2009-9#1)(2011-1#1)(2013-1#1)
schools and health##2##3##(1997-3#1)(2008-9#1)
schools and##13##2##(1991-8#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-7#1)(2008-9#4)(2009-2#1)(2010-12#1)(2010-5#1)(2012-12#1)
schools are##2##2##(2009-7#1)(2012-3#1)
schools as##2##2##(2008-12#1)(2009-7#1)
schools currently##2##2##(1994-2#1)(1997-3#1)
schools has##2##2##(1991-2#1)(1992-6#1)
schools have##3##2##(1994-1#1)(2008-12#1)(2013-1#1)
schools in the United##2##4##(2007-12#1)(2013-1#1)
schools in the##11##3##(2007-12#1)(2007-4#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
schools in##31##2##(1991-12#2)(1991-6#1)(1993-6#1)(1996-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-2#2)(2009-7#3)(2009-8#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
schools is##2##2##(2007-4#1)(2012-12#1)
schools must be##2##3##(2008-10#1)(2012-3#1)
schools of medicine##4##3##(1991-1#1)(1991-6#1)(1994-3#1)(2008-12#1)
schools of nursing are##3##4##(2008-12#2)(2010-8#1)
schools of nursing##8##3##(2008-1#2)(2008-11#1)(2008-12#4)(2010-8#1)
schools of public health##12##4##(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)
schools of##33##2##(1991-1#1)(1991-6#1)(1991-8#1)(1994-2#1)(1994-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)(2008-1#2)(2008-11#1)(2008-12#5)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
schools to##5##2##(2007-4#1)(2008-12#1)(2010-10#1)(2010-5#1)(2012-2#1)
schools were##3##2##(2008-9#1)(2009-10#1)(2012-12#1)
schools with##2##2##(1991-8#1)(2009-7#1)
schools within##2##2##(2013-1#1)(2013-8#1)
schools##204##1##(1991-1#1)(1991-12#5)(1991-2#3)(1991-6#2)(1991-8#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#5)(1997-3#4)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-4#3)(2007-5#2)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#18)(2008-7#5)(2008-8#1)(2008-9#17)(2009-10#5)(2009-11#1)(2009-2#8)(2009-5#1)(2009-6#1)(2009-7#12)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#8)(2012-2#5)(2012-3#8)(2013-1#15)(2013-7#1)(2013-8#2)
schools'##2##1##(2012-2#2)
schoolwork help was##2##3##(2009-7#2)
schoolwork##3##1##(2009-7#2)(2010-9#1)
schwannoma and##3##2##(2008-9#1)(2010-11#2)
schwannoma in a##2##3##(2012-12#1)(2012-3#1)
schwannoma in##4##2##(2012-12#3)(2012-3#1)
schwannoma is##4##2##(2008-7#2)(2012-12#1)(2013-1#1)
schwannoma of the##11##3##(1997-8#2)(2007-8#2)(2008-6#1)(2008-8#2)(2009-3#2)(2011-2#1)(2012-3#1)
schwannoma with##4##2##(2010-11#1)(2011-2#3)
schwannoma##48##1##(1994-6#3)(1997-8#2)(2007-8#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-3#3)(2010-11#4)(2010-4#3)(2011-2#8)(2012-12#5)(2012-3#3)(2013-1#3)
schwannomas are##2##2##(2011-2#2)
schwannomas most commonly##2##3##(2011-2#1)(2013-1#1)
schwannomas##13##1##(1997-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#4)(2013-1#2)
schwerinii##4##1##(2012-3#4)
sciatic myelinated##2##2##(1997-3#2)
sciatic nerve##25##2##(1990-5#1)(1990-7#3)(1993-12#4)(1993-5#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-12#2)(1996-2#2)(1996-5#2)(2008-12#2)(2008-7#1)(2008-8#3)
sciatic neurectomy##3##2##(1993-12#3)
sciatic neuropathy and##2##3##(2008-8#2)
sciatic##46##1##(1990-5#1)(1990-7#3)(1993-12#7)(1993-5#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-12#2)(1996-2#2)(1996-5#5)(1997-2#1)(1997-3#5)(2007-8#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#6)
sciatica##6##1##(1991-11#1)(1996-9#1)(2006-10#1)(2008-7#1)(2012-12#2)
scid mice##4##2##(1994-3#3)(1994-8#1)
scid##8##1##(1994-3#4)(1994-8#1)(1995-2#2)(1996-2#1)
scidar (scintillation##2##2##(2008-2#1)(2008-3#1)
scidar##4##1##(2008-2#3)(2008-3#1)
science and practice of##2##4##(1995-1#1)(2010-10#1)
science and technology##4##3##(1991-3#1)(1994-12#1)(2010-1#1)(2010-8#1)
science and the##4##3##(1993-11#1)(1995-2#1)(2009-7#1)(2010-1#1)
science and##31##2##(1990-2#1)(1991-3#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-8#1)(2012-2#2)(2013-1#1)
science based##2##2##(1992-3#1)(2011-2#1)
science community##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
science continues to##2##3##(2008-10#1)(2009-3#1)
science due to##2##3##(2008-10#1)(2008-7#1)
science during##2##2##(2008-11#2)
science for##3##2##(1994-3#1)(2008-3#1)(2010-1#1)
science has##2##2##(1995-1#1)(2013-1#1)
science in the##3##3##(1997-3#2)(2008-5#1)
science in##9##2##(1991-8#1)(1996-11#2)(1997-3#3)(2007-8#1)(2008-5#1)(2010-11#1)
science into##2##2##(2010-12#1)(2010-3#1)
science is##2##2##(2009-11#1)(2010-12#1)
science literature##2##2##(2008-5#1)(2009-7#1)
science of the##2##3##(2008-12#1)(2009-7#1)
science of##23##2##(1990-3#1)(1991-2#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-11#2)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2012-2#3)(2013-8#1)
science on whole grains##2##4##(2010-1#2)
science on##3##2##(2008-1#1)(2010-1#2)
science or##2##2##(2008-10#1)(2009-5#1)
science research has##2##3##(2008-11#1)(2008-12#1)
science research##12##2##(1995-2#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
science that##2##2##(2007-12#1)(2012-3#1)
science to##2##2##(1994-5#1)(2008-2#1)
science was##2##2##(1991-6#1)(1993-11#1)
science with##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
science##238##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-8#4)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-3#2)(1992-6#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(2007-12#2)(2007-5#2)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#17)(2008-12#8)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#5)(2009-9#1)(2010-1#6)(2010-10#4)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#14)(2012-3#5)(2013-1#9)(2013-8#6)
science&quot##2##1##(2009-6#1)(2013-1#1)
science-based##4##1##(1997-1#1)(2008-11#1)(2008-3#1)(2008-6#1)
science-oriented##2##1##(1994-12#2)
science?##3##1##(1997-3#1)(2008-10#1)(2010-12#1)
sciences and##7##2##(1994-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)
sciences as##2##2##(1994-12#1)(2010-4#1)
sciences have##2##2##(2008-2#1)(2013-1#1)
sciences in##7##2##(1994-12#1)(1997-7#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-2#2)
sciences##111##1##(1991-12#2)(1991-3#2)(1991-5#1)(1991-8#2)(1992-2#3)(1993-6#1)(1994-11#1)(1994-12#9)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#6)(2011-1#3)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#2)
scientific advances##2##2##(1992-2#1)(1996-3#1)
scientific and clinical##2##3##(2008-10#1)(2013-7#1)
scientific and ethical##2##3##(1991-3#1)(2008-4#1)
scientific and medical##2##3##(1996-12#1)(2008-11#1)
scientific and practical##2##3##(1996-6#1)(2008-8#1)
scientific and technical##2##3##(2010-10#1)(2012-12#1)
scientific and technological advances##2##4##(2008-10#1)(2013-1#1)
scientific and technological##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
scientific and the##2##3##(2010-3#1)(2010-7#1)
scientific and##29##2##(1991-3#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
scientific articles##4##2##(1991-11#1)(2008-8#1)(2010-12#1)(2011-1#1)
scientific basis for##2##3##(2008-7#2)
scientific basis##6##2##(1996-3#1)(2008-10#1)(2008-7#3)(2012-2#1)
scientific community has##2##3##(2008-10#1)(2012-2#1)
scientific community have##2##3##(2008-12#2)
scientific community##17##2##(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#2)
scientific concept##3##2##(1992-12#1)(1997-6#1)(2013-1#1)
scientific contributions to the field##2##5##(2012-1#1)(2012-12#1)
scientific data##7##2##(1991-5#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-9#1)
scientific debate##2##2##(1995-6#1)(2008-11#1)
scientific development##2##2##(1993-6#1)(2012-3#1)
scientific developments##3##2##(2007-3#1)(2009-5#1)(2010-12#1)
scientific discipline##2##2##(1994-12#1)(1996-4#1)
scientific disciplines##5##2##(1991-12#1)(2008-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
scientific discoveries##4##2##(1997-3#1)(2008-11#2)(2013-1#1)
scientific discovery##3##2##(2012-2#3)
scientific documentation##3##2##(1993-3#1)(1994-2#1)(1997-4#1)
scientific evaluation of the hazards of##2##6##(2008-11#2)
scientific evaluation##3##2##(2008-11#2)(2013-1#1)
scientific evidence is##3##3##(1993-12#1)(2013-1#2)
scientific evidence on##2##3##(2008-4#1)(2012-2#1)
scientific evidence supporting##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
scientific evidence##22##2##(1993-12#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
scientific experience##2##2##(1992-6#1)(2007-8#1)
scientific fields##4##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-1#1)
scientific findings##2##2##(2009-4#1)(2010-12#1)
scientific foundation and##2##3##(2008-10#2)
scientific foundation##3##2##(2008-10#2)(2010-5#1)
scientific impact##2##2##(2012-2#2)
scientific implications##2##2##(2007-7#1)(2008-2#1)
scientific information and##2##3##(2008-7#1)(2011-2#1)
scientific information##8##2##(1990-2#1)(1993-12#1)(2008-10#2)(2008-7#1)(2010-5#2)(2011-2#1)
scientific interest in##3##3##(2007-8#1)(2008-3#1)(2013-7#1)
scientific interest##8##2##(1992-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-7#2)
scientific investigation##2##2##(1992-3#1)(1996-1#1)
scientific journal##2##2##(1994-12#1)(1997-3#1)
scientific journals and##2##3##(1997-3#1)(2010-1#1)
scientific journals##5##2##(1996-12#1)(1997-3#1)(2010-1#1)(2011-1#1)(2012-12#1)
scientific knowledge##10##2##(1994-6#1)(2009-10#2)(2009-5#2)(2010-1#1)(2011-2#2)(2013-8#2)
scientific literature is##2##3##(2008-11#1)(2011-2#1)
scientific literature on the##2##4##(2012-2#1)(2013-1#1)
scientific literature on##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
scientific literature##20##2##(1993-12#1)(1993-6#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
scientific medicine##3##2##(1997-6#2)(2009-11#1)
scientific meeting##4##2##(2008-7#3)(2009-9#1)
scientific meetings##2##2##(1992-12#1)(2006-9#1)
scientific methods##2##2##(2011-1#1)(2013-1#1)
scientific output##2##2##(2012-2#2)
scientific papers##6##2##(1993-6#1)(2007-4#1)(2007-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
scientific principles##2##2##(2008-10#1)(2009-11#1)
scientific problems##3##2##(1990-11#3)
scientific production in##2##3##(1992-5#1)(2012-3#1)
scientific production##4##2##(1992-5#1)(2009-10#1)(2012-3#2)
scientific progress##3##2##(2010-12#1)(2012-2#2)
scientific publications##5##2##(1992-6#1)(2007-8#1)(2008-11#1)(2012-12#2)
scientific rationale for##3##3##(2008-10#1)(2013-8#2)
scientific rationale##6##2##(2008-10#1)(2008-3#1)(2010-12#2)(2013-8#2)
scientific research##5##2##(2008-2#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)
scientific rigor##3##2##(2009-6#1)(2009-8#1)(2012-12#1)
scientific sessions##4##2##(2007-8#1)(2008-5#1)(2009-5#1)(2009-6#1)
scientific societies##5##2##(1992-12#1)(1993-6#1)(2007-8#2)(2008-10#1)
scientific society##2##2##(2008-10#1)(2012-1#1)
scientific study of##2##3##(1993-3#1)(2008-11#1)
scientific study##4##2##(1992-1#1)(1993-3#1)(2008-11#1)(2008-2#1)
scientific theory##2##2##(2008-11#1)(2008-7#1)
scientific work on the##2##4##(2008-10#1)(2013-1#1)
scientific work##5##2##(1992-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2013-1#1)
scientific##392##1##(1990-11#3)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#5)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#6)(1994-12#6)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#4)(1997-7#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#26)(2008-11#18)(2008-12#7)(2008-2#11)(2008-3#11)(2008-4#9)(2008-5#9)(2008-6#1)(2008-7#25)(2008-8#3)(2008-9#7)(2009-10#8)(2009-11#4)(2009-2#1)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#11)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#10)(2012-2#19)(2012-3#6)(2013-1#19)(2013-7#3)(2013-8#9)
scientifically proven##2##2##(2008-6#1)(2009-7#1)
scientifically sound##2##2##(2008-10#1)(2008-12#1)
scientifically supported##3##2##(2008-5#1)(2010-1#1)(2012-3#1)
scientifically##20##1##(1994-12#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#2)(2009-10#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
scientist##20##1##(1990-3#1)(1990-8#1)(1994-12#1)(1996-3#1)(2008-12#5)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#4)
scientist's##2##1##(2008-7#1)(2012-2#1)
scientists and clinicians##2##3##(2008-10#1)(2008-11#1)
scientists and engineers##4##3##(2008-3#2)(2009-11#1)(2009-12#1)
scientists and##18##2##(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
scientists are##4##2##(1996-9#1)(2008-9#1)(2009-3#1)(2010-12#1)
scientists attended##2##2##(2008-5#2)
scientists engaged in##2##3##(1992-12#1)(2008-10#1)
scientists for##2##2##(2008-1#1)(2009-8#1)
scientists from##3##2##(2008-7#1)(2009-11#1)(2013-8#1)
scientists had##2##2##(2008-11#1)(2010-1#1)
scientists have##6##2##(1991-9#1)(1994-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
scientists in the##2##3##(2008-9#1)(2013-1#1)
scientists in##5##2##(1997-2#1)(2008-11#1)(2008-9#2)(2013-1#1)
scientists of##2##2##(2008-12#1)(2013-7#1)
scientists to##8##2##(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-9#1)(2013-8#1)
scientists who##5##2##(1992-12#1)(1993-12#1)(2008-10#1)(2010-3#1)(2013-8#1)
scientists with##2##2##(2008-10#1)(2012-2#1)
scientists within##2##2##(1994-12#1)(1994-3#1)
scientists working##2##2##(2009-3#1)(2009-6#1)
scientists worldwide##2##2##(2008-11#1)(2011-2#1)
scientists##130##1##(1990-2#1)(1991-9#1)(1992-1#1)(1992-12#3)(1993-12#2)(1994-12#2)(1994-3#1)(1995-6#1)(1996-5#1)(1996-9#2)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#9)(2009-1#1)(2009-11#4)(2009-12#1)(2009-3#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#9)(2013-7#1)(2013-8#3)
scientists'##2##1##(2013-1#2)
sciera##4##1##(1997-3#4)
scierai ectasia##2##2##(1997-3#2)
scimitar syndrome with##2##3##(2007-8#2)
scimitar syndrome##4##2##(2007-8#4)
scincus##4##1##(2010-3#4)
scintigrams##3##1##(1990-12#2)(2008-1#1)
scintigraphic activity##5##2##(2011-2#5)
scintigraphic control was##2##3##(2013-1#2)
scintigraphic renal lesions##2##3##(2013-1#2)
scintigraphic##18##1##(1990-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#7)(2012-2#1)(2013-1#6)
scintigraphy after##2##2##(1992-5#1)(2011-2#1)
scintigraphy and coronary##2##3##(1991-9#1)(2008-7#1)
scintigraphy and##7##2##(1991-2#1)(1991-9#1)(2007-11#3)(2008-7#1)(2010-10#1)
scintigraphy are##2##2##(2008-1#1)(2013-1#1)
scintigraphy for##2##2##(1991-2#1)(2008-1#1)
scintigraphy in patients with##2##4##(1997-8#1)(2007-11#1)
scintigraphy in the##2##3##(2007-11#1)(2008-7#1)
scintigraphy in##9##2##(1990-12#2)(1997-8#2)(2007-11#2)(2008-7#2)(2009-7#1)
scintigraphy performed##2##2##(1992-5#1)(2013-1#1)
scintigraphy to##2##2##(1997-8#1)(2009-10#1)
scintigraphy using##2##2##(2008-7#2)
scintigraphy was##2##2##(1990-6#1)(2008-7#1)
scintigraphy with##3##2##(1990-6#1)(1992-5#1)(2009-4#1)
scintigraphy##57##1##(1990-12#3)(1990-6#2)(1991-11#1)(1991-2#2)(1991-9#1)(1992-5#4)(1996-3#1)(1997-1#1)(1997-8#3)(2007-11#8)(2007-8#2)(2008-1#4)(2008-11#1)(2008-7#7)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-6#3)(2011-2#5)(2013-1#4)
scintillant##2##1##(2008-4#2)
scintillated received wave fronts##2##4##(2008-3#2)
scintillated##3##1##(2008-3#3)
scintillating microplate##2##2##(2008-11#2)
scintillating##5##1##(2008-11#2)(2008-2#3)
scintillation counting##6##2##(1992-5#1)(2008-10#2)(2008-11#2)(2008-8#1)
scintillation index##2##2##(2007-12#2)
scintillation on##2##2##(2008-2#2)
scintillation patterns##3##2##(2008-3#3)
scintillation proximity assay##2##3##(2008-11#1)(2013-1#1)
scintillation##35##1##(1992-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1996-5#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#17)(2008-8#1)(2012-12#1)(2013-1#1)
scintillations##4##1##(2008-3#4)
scintillator##4##1##(1996-2#1)(2009-8#1)(2013-1#2)
scintillators##2##1##(2010-4#1)(2012-12#1)
scintiscan##2##1##(1993-5#1)(2008-10#1)
scion circumference##2##2##(2008-10#2)
scion vigor##2##2##(2008-10#2)
scion##6##1##(2008-10#6)
scions##3##1##(2008-10#3)
scirrhous carcinoma##3##2##(2008-10#3)
scirtid-O##2##1##(2008-12#2)
scirtids##5##1##(2008-12#5)
scissile bond##4##2##(1990-5#1)(1990-7#1)(1994-5#1)(1995-5#1)
scission##5##1##(1990-5#1)(1991-12#1)(1993-11#1)(1995-6#1)(2008-4#1)
scissoring##4##1##(2008-10#4)
scissors##3##1##(1996-2#1)(2010-8#2)
sclera##2##1##(2008-2#1)(2011-1#1)
scleractinian corals##2##2##(2008-5#2)
scleractinian##4##1##(2007-5#2)(2008-5#2)
scleral##3##1##(1996-5#1)(2007-8#1)(2008-7#1)
sclerectomy##2##1##(2013-8#2)
sclerites and##4##2##(2007-12#1)(2008-7#2)(2013-1#1)
sclerites of##3##2##(2008-5#1)(2013-1#2)
sclerites##11##1##(2007-12#1)(2008-5#1)(2008-7#4)(2013-1#5)
scleroderma and##3##2##(1992-8#1)(2006-10#1)(2011-2#1)
scleroderma form##2##2##(1995-11#2)
scleroderma##25##1##(1992-8#5)(1993-9#1)(1995-11#3)(2006-10#6)(2008-10#3)(2011-2#6)(2013-1#1)
sclerosing agent##3##2##(1990-9#1)(1997-8#2)
sclerosing cholangitis##5##2##(1997-6#1)(2006-10#1)(2008-4#1)(2009-8#1)(2010-12#1)
sclerosing panencephalitis##2##2##(2012-12#2)
sclerosing##20##1##(1990-3#1)(1990-9#1)(1992-5#1)(1994-12#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-12#2)(2013-7#1)
sclerosis (MS)##21##2##(1995-12#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#2)(2010-2#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#7)
sclerosis and lichen ruber planus##2##5##(2011-2#2)
sclerosis and##14##2##(1995-12#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-7#1)(2009-8#3)(2010-12#1)(2011-2#2)(2012-3#2)
sclerosis in a##3##3##(1995-11#1)(2007-7#1)(2008-8#1)
sclerosis in##6##2##(1995-11#1)(2007-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
sclerosis is an##2##3##(2012-2#1)(2013-1#1)
sclerosis is##5##2##(1995-11#1)(1995-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
sclerosis of the sacroiliac##2##4##(2006-10#1)(2011-2#1)
sclerosis of##3##2##(2006-10#1)(2007-7#1)(2011-2#1)
sclerosis or##2##2##(2011-2#2)
sclerosis patients in##3##3##(1996-8#1)(2009-8#1)(2012-12#1)
sclerosis patients##9##2##(1996-8#2)(2009-12#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
sclerosis with##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
sclerosis##173##1##(1991-11#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-9#3)(1994-9#1)(1995-11#4)(1995-12#5)(1995-2#1)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-5#2)(1997-8#2)(2006-10#5)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#6)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#3)(2009-11#1)(2009-12#2)(2009-7#1)(2009-8#7)(2009-9#3)(2010-10#2)(2010-12#16)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#22)(2011-7#2)(2012-12#3)(2012-2#8)(2012-3#18)(2013-1#6)(2013-8#5)
sclerosis]##5##1##(1991-3#1)(1994-12#1)(1996-3#1)(2007-10#1)(2008-11#1)
sclerotherapy for##3##2##(2008-8#1)(2012-1#1)(2013-1#1)
sclerotherapy##11##1##(1995-10#1)(2008-8#2)(2011-2#1)(2012-1#1)(2013-1#6)
sclerotia and the##3##3##(2008-10#3)
sclerotia and##8##2##(2008-10#8)
sclerotia buried##2##2##(2008-10#2)
sclerotia from##3##2##(2008-10#3)
sclerotia in##4##2##(2008-10#4)
sclerotia increased##2##2##(2008-10#2)
sclerotia occurred##2##2##(2008-10#2)
sclerotia of Sclerotinia sclerotiorum##2##4##(2008-10#2)
sclerotia of##8##2##(2008-10#8)
sclerotia on##2##2##(2008-10#2)
sclerotia per square centimeter##2##4##(2008-10#2)
sclerotia produced in vitro##2##4##(2008-10#2)
sclerotia produced##4##2##(2008-10#4)
sclerotia to##2##2##(2008-10#2)
sclerotia viability and##3##3##(2008-10#3)
sclerotia was##3##2##(2008-10#3)
sclerotia were##5##2##(2008-10#5)
sclerotia within##2##2##(2008-10#2)
sclerotia##87##1##(2008-10#86)(2008-8#1)
sclerotial development in##2##3##(2008-10#2)
sclerotial development##4##2##(2008-10#4)
sclerotial size##3##2##(2008-10#3)
sclerotial##13##1##(2008-10#13)
sclerotic##4##1##(1990-2#1)(2007-11#1)(2011-2#1)(2013-1#1)
sclerotinia stem rot in##2##4##(2008-10#2)
sclerotinia stem rot##5##3##(2008-10#5)
sclerotinia##8##1##(2008-10#8)
sclerotiorum Sclerotia##2##2##(2008-10#2)
sclerotiorum from##3##2##(2008-10#3)
sclerotiorum in the##2##3##(2008-10#2)
sclerotiorum in##7##2##(2008-10#7)
sclerotiorum isolates##3##2##(2008-10#3)
sclerotiorum populations##2##2##(2008-10#2)
sclerotiorum sclerotia was##2##3##(2008-10#2)
sclerotiorum sclerotia##5##2##(2008-10#5)
sclerotiorum was##6##2##(2008-10#6)
sclerotiorum##62##1##(2008-10#61)(2013-8#1)
sclerotized##5##1##(2007-12#3)(2008-5#2)
sclerotome induction##2##2##(1994-12#2)
sclerotome##6##1##(1994-12#6)
sclerotomy##5##1##(2013-8#5)
scolaire##3##1##(2008-11#3)
scoliosis 6##2##2##(2007-8#2)
scoliosis and##4##2##(2008-4#2)(2012-12#1)(2012-2#1)
scoliosis angle##2##2##(2007-8#2)
scoliosis before and##2##3##(2007-8#1)(2012-2#1)
scoliosis is##2##2##(2008-11#2)
scoliosis repair surgery with intraoperative##2##5##(2011-2#2)
scoliosis repair surgery with##3##4##(2011-2#3)
scoliosis##56##1##(1997-3#1)(1997-4#1)(2007-11#5)(2007-7#1)(2007-8#26)(2008-11#6)(2008-4#2)(2008-8#2)(2009-3#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)
scoliosis]##2##1##(1996-8#1)(2013-1#1)
scoliotic##2##1##(2007-11#1)(2012-2#1)
scolopale rods##2##2##(2008-7#2)
scolopale##5##1##(2008-7#5)
scolopidia##5##1##(2007-12#1)(2008-7#4)
scope and limitations##2##3##(2008-4#1)(2011-2#1)
scope and##19##2##(1992-12#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
scope for##7##2##(1995-2#1)(1997-8#1)(2008-10#2)(2010-12#1)(2010-8#1)(2012-12#1)
scope of practice##18##3##(1996-12#1)(1997-3#1)(2007-10#3)(2008-12#2)(2008-7#1)(2011-1#7)(2011-2#1)(2012-12#2)
scope of responsibilities##2##3##(2008-1#1)(2012-3#1)
scope of responsibility##2##3##(1996-2#1)(1997-2#1)
scope of the##15##3##(1991-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
scope of this##9##3##(2007-10#1)(2008-5#3)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#1)
scope of##85##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-5#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#8)(2011-2#1)(2012-12#4)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
scope##139##1##(1990-5#3)(1990-8#2)(1991-1#2)(1991-12#2)(1991-3#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#7)(2007-11#1)(2007-12#3)(2007-5#2)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#3)(2012-12#6)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
scopolamine (0##5##2##(1991-7#3)(1992-11#1)(1994-8#1)
scopolamine on##3##2##(1992-11#2)(1994-8#1)
scopolamine##21##1##(1990-7#1)(1991-7#4)(1992-11#4)(1992-12#1)(1993-12#1)(1994-8#4)(2007-5#1)(2008-10#5)
scopoletin and##2##2##(2008-10#2)
scopoletin##6##1##(2008-10#6)
scorch virus##2##2##(2008-10#2)
scorch##10##1##(2008-10#10)
score &gt##8##2##(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
score &lt##4##2##(1994-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
score (0##2##2##(2008-3#2)
score (1##2##2##(2006-10#1)(2008-3#1)
score (P =##2##3##(2007-10#1)(2011-2#1)
score (p##2##2##(1993-2#1)(2010-3#1)
score (p=0##2##2##(2008-7#2)
score also##2##2##(1996-7#1)(2013-1#1)
score analysis##2##2##(1997-5#2)
score and in##2##3##(2008-10#1)(2011-2#1)
score and the##4##3##(1992-2#1)(2011-1#2)(2013-1#1)
score and##27##2##(1992-2#1)(1996-7#1)(2007-12#2)(2007-2#1)(2008-10#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
score as a##2##3##(2008-10#1)(2013-1#1)
score as##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
score at the end of##2##5##(1994-6#1)(2013-1#1)
score at the##3##3##(1994-6#2)(2013-1#1)
score at##7##2##(1994-6#2)(1995-6#1)(1997-8#1)(2007-7#1)(2008-6#1)(2013-1#1)
score compared with##2##3##(2012-2#2)
score decreased significantly in the##2##5##(2008-7#1)(2009-12#1)
score decreased##5##2##(2008-5#1)(2008-7#3)(2009-12#1)
score for each##4##3##(1993-12#1)(1994-9#1)(1997-3#1)(2008-10#1)
score for the##4##3##(1990-2#2)(1991-6#1)(2008-10#1)
score for##17##2##(1990-2#2)(1991-2#2)(1991-6#2)(1993-12#1)(1994-9#1)(1996-12#1)(1997-3#1)(2006-10#2)(2008-10#2)(2010-4#1)(2011-1#1)(2012-12#1)
score from##2##2##(2008-8#1)(2010-10#1)
score has##2##2##(2007-11#1)(2008-11#1)
score improved from##2##3##(2008-7#1)(2009-3#1)
score improved##3##2##(2008-7#1)(2009-3#1)(2010-11#1)
score in the##10##3##(1991-4#1)(1994-11#1)(1994-12#1)(2006-10#1)(2007-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
score in##18##2##(1991-4#1)(1994-11#1)(1994-12#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#5)(2013-1#3)(2013-8#1)
score increased to##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
score increased##6##2##(2007-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
score is a##4##3##(1994-11#1)(1994-9#1)(2010-6#1)(2011-2#1)
score is##10##2##(1994-11#1)(1994-9#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
score less than##2##3##(2011-2#2)
score less##4##2##(2011-2#2)(2012-3#2)
score means##2##2##(1990-12#1)(2007-2#1)
score of &gt##2##3##(2008-7#1)(2013-1#1)
score of 0##2##3##(2008-7#1)(2010-8#1)
score of 1##3##3##(1997-3#1)(1997-5#1)(2011-2#1)
score of 2##2##3##(1997-5#1)(2008-5#1)
score of 3##2##3##(1997-5#2)
score of the##3##3##(1995-4#1)(1996-7#1)(2008-1#1)
score of##48##2##(1990-10#1)(1991-12#1)(1991-6#1)(1992-1#1)(1995-4#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-5#5)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#5)(2009-10#1)(2009-11#2)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
score on the##4##3##(2008-6#1)(2008-7#2)(2011-2#1)
score on##8##2##(1997-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#2)
score or##2##2##(2010-8#1)(2011-2#1)
score test##2##2##(1995-9#1)(1997-3#1)
score than##2##2##(2011-2#1)(2012-2#1)
score to##4##2##(1994-3#1)(1994-9#1)(2013-1#1)(2013-8#1)
score was 14##2##3##(1990-12#1)(2013-1#1)
score was 3##2##3##(1990-2#1)(2012-3#1)
score was only##2##3##(1997-5#1)(2011-2#1)
score was the##2##3##(2008-10#1)(2010-3#1)
score was##29##2##(1990-12#2)(1990-2#2)(1991-6#1)(1996-6#1)(1996-7#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
score weighting method##3##3##(2011-1#3)
score weighting##5##2##(2011-1#5)
score were##5##2##(1991-6#1)(1997-5#1)(2008-11#1)(2010-10#1)(2013-8#1)
score with##4##2##(2011-1#2)(2012-2#2)
score##419##1##(1990-10#1)(1990-12#3)(1990-2#4)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#3)(1991-6#7)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-2#2)(1994-11#5)(1994-12#3)(1994-3#4)(1994-6#2)(1994-9#4)(1995-12#1)(1995-2#5)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#4)(1997-3#6)(1997-5#13)(1997-8#2)(2006-10#6)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#5)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#8)(2008-12#4)(2008-3#8)(2008-4#4)(2008-5#7)(2008-6#6)(2008-7#27)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#5)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#6)(2010-4#3)(2010-6#2)(2010-8#7)(2011-1#26)(2011-2#32)(2011-3#3)(2012-1#2)(2012-12#10)(2012-2#17)(2012-3#14)(2012-5#1)(2013-1#43)(2013-7#3)(2013-8#9)
score's##2##1##(2009-12#1)(2009-3#1)
score) and##2##2##(2008-4#1)(2011-2#1)
score)##9##1##(2008-1#1)(2008-4#1)(2010-10#2)(2011-1#2)(2011-2#2)(2013-1#1)
scorecard approach##2##2##(1995-12#2)
scorecard##6##1##(1995-12#3)(2008-11#2)(2011-2#1)
scorecards##5##1##(2008-11#5)
scored above##2##2##(2007-7#1)(2008-9#1)
scored as positive for##2##4##(1994-12#1)(2008-5#1)
scored as##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
scored at##4##2##(2008-1#2)(2008-10#2)
scored below##2##2##(2008-1#1)(2009-10#1)
scored by##6##2##(1995-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2013-1#1)
scored for##9##2##(1991-2#1)(1997-8#1)(2008-10#3)(2008-7#1)(2011-2#3)
scored high##2##2##(2007-7#1)(2011-1#1)
scored higher##2##2##(1991-2#1)(1993-1#1)
scored highest##3##2##(1995-3#1)(2008-11#2)
scored in the##2##3##(2008-10#1)(2010-10#1)
scored in##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
scored less##2##2##(2008-1#1)(2009-7#1)
scored lower##3##2##(1991-6#1)(2010-10#1)(2011-2#1)
scored on##5##2##(1993-1#1)(2007-10#1)(2008-10#2)(2009-4#1)
scored positive for##2##3##(2008-10#2)
scored significantly higher than the##2##5##(1991-5#1)(2010-8#1)
scored significantly higher than##3##4##(1991-5#1)(2010-8#2)
scored significantly higher##4##3##(1991-5#1)(2009-5#1)(2010-8#2)
scored significantly##5##2##(1991-5#1)(2008-9#1)(2009-5#1)(2010-8#2)
scored using a##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
scored using##4##2##(1997-3#2)(2008-10#1)(2013-1#1)
scored##79##1##(1991-2#2)(1991-5#1)(1991-6#1)(1992-9#1)(1993-1#2)(1994-12#1)(1994-3#1)(1995-3#2)(1995-6#1)(1997-3#2)(1997-8#3)(2007-10#1)(2007-7#2)(2008-1#4)(2008-10#16)(2008-11#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#4)
scores among##2##2##(1995-4#1)(2009-11#1)
scores and the##5##3##(1994-6#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
scores and##29##2##(1991-2#1)(1991-4#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-3#1)(2011-2#4)(2012-1#1)(2012-3#1)
scores are##4##2##(1992-2#1)(2008-8#1)(2010-3#1)(2012-2#1)
scores as##5##2##(1996-7#1)(2008-8#1)(2012-2#3)
scores at baseline##2##3##(2012-1#1)(2013-1#1)
scores at the##2##3##(1990-10#1)(2008-10#1)
scores at##9##2##(1990-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
scores averaged##2##2##(2008-9#1)(2012-2#1)
scores between##5##2##(1990-3#1)(1996-12#1)(1996-7#1)(2008-1#1)(2012-2#1)
scores compared with patients##2##4##(2008-7#1)(2013-1#1)
scores decreased##2##2##(2008-7#1)(2008-9#1)
scores did not##4##3##(2007-7#1)(2010-10#1)(2010-11#1)(2010-3#1)
scores during##2##2##(1995-4#1)(2009-4#1)
scores for children##2##3##(2012-2#2)
scores for pain##4##3##(2008-12#1)(2011-2#1)(2012-2#2)
scores for the##6##3##(1996-7#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-7#1)
scores for##37##2##(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(2007-10#2)(2007-11#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#2)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#3)
scores from##4##2##(1995-3#1)(2009-11#1)(2010-9#1)(2013-1#1)
scores had no##2##3##(2011-2#1)(2013-1#1)
scores had##8##2##(1992-1#1)(2008-7#1)(2011-2#3)(2013-1#2)(2013-7#1)
scores improved from##2##3##(2012-2#2)
scores improved##4##2##(1991-12#1)(2008-10#1)(2012-2#2)
scores in both##2##3##(2008-7#1)(2011-2#1)
scores in the##5##3##(1996-2#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
scores in##16##2##(1993-5#1)(1996-2#1)(2007-2#1)(2008-11#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-5#1)(2011-2#2)(2013-1#1)
scores is##3##2##(2008-10#2)(2008-11#1)
scores obtained##3##2##(1994-3#1)(1995-12#1)(2010-3#1)
scores of a##2##3##(2008-10#1)(2008-7#1)
scores of pain (p=0##2##4##(2008-10#2)
scores of the##5##3##(1990-3#1)(1995-4#1)(2008-10#3)
scores of##32##2##(1990-3#1)(1992-1#3)(1995-4#1)(1997-5#3)(2008-1#3)(2008-10#8)(2008-5#2)(2008-6#1)(2008-7#3)(2009-10#3)(2011-1#2)(2013-1#2)
scores on all##4##3##(2007-12#1)(2008-1#1)(2013-1#2)
scores on the##6##3##(1992-2#1)(1993-3#1)(1996-7#1)(2008-12#1)(2008-7#1)(2012-5#1)
scores on##21##2##(1992-2#1)(1993-3#1)(1996-7#1)(2007-12#3)(2008-1#1)(2008-12#5)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-5#1)(2013-1#2)
scores over##3##2##(1994-9#1)(2008-12#2)
scores ranged##2##2##(2008-10#1)(2008-9#1)
scores showed that##2##3##(2008-10#1)(2010-8#1)
scores showed##3##2##(1996-3#1)(2008-10#1)(2010-8#1)
scores similar to##2##3##(2008-9#1)(2013-1#1)
scores than the##2##3##(2010-10#1)(2013-1#1)
scores than##8##2##(1995-3#1)(2007-8#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
scores that##2##2##(2010-9#1)(2012-2#1)
scores using##2##2##(2008-12#1)(2012-1#1)
scores was##8##2##(2007-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
scores were MD/RTS = 0##2##5##(2008-7#2)
scores were associated with##2##4##(2012-1#1)(2012-12#1)
scores were compared##2##3##(2008-9#1)(2010-5#1)
scores were found to be##2##5##(1996-1#1)(1996-7#1)
scores were lower##2##3##(2008-4#1)(2013-1#1)
scores were recorded##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
scores were reduced by##2##4##(1995-3#1)(2008-3#1)
scores were significantly higher##3##4##(2008-6#1)(2008-9#1)(2011-1#1)
scores were significantly##7##3##(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#2)
scores were similar##3##3##(1990-8#1)(1996-7#1)(2012-1#1)
scores were stable over a##2##5##(2007-12#2)
scores were##49##2##(1990-8#1)(1993-1#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-7#2)(1996-9#2)(1997-5#1)(2007-12#3)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#7)(2009-1#1)(2009-4#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#1)
scores when##2##2##(2008-4#1)(2013-1#1)
scores with##2##2##(2008-7#1)(2012-2#1)
scores##445##1##(1990-10#1)(1990-3#3)(1990-8#1)(1991-12#3)(1991-2#4)(1991-4#2)(1991-9#1)(1992-1#5)(1992-2#3)(1993-1#6)(1993-2#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#2)(1995-12#3)(1995-3#5)(1995-4#4)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#8)(1996-9#2)(1997-4#1)(1997-5#4)(1997-6#1)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#32)(2008-11#7)(2008-12#23)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#11)(2008-6#10)(2008-7#28)(2008-8#8)(2008-9#22)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#5)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#13)(2011-2#18)(2012-1#9)(2012-12#5)(2012-2#20)(2012-3#5)(2012-5#2)(2013-1#36)(2013-7#5)(2013-8#2)
scoring and ranking system for##4##5##(2008-11#4)
scoring and ranking##5##3##(2008-11#5)
scoring and##11##2##(1997-1#1)(2008-11#5)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
scoring for##2##2##(1995-12#1)(2008-10#1)
scoring function that can##2##4##(2008-7#2)
scoring function##7##2##(2008-7#3)(2011-3#4)
scoring instructions##2##2##(1994-3#1)(2008-11#1)
scoring matrices##4##2##(2008-11#1)(2008-9#3)
scoring methods##2##2##(1992-9#1)(2012-2#1)
scoring of the##2##3##(2008-11#1)(2009-4#1)
scoring of##10##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-4#1)(2012-1#1)
scoring scale##2##2##(1997-5#1)(2011-2#1)
scoring scheme##2##2##(2013-8#2)
scoring system for##2##3##(2008-5#1)(2013-1#1)
scoring system##17##2##(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
scoring systems##9##2##(2007-8#1)(2010-11#3)(2012-2#1)(2013-1#4)
scoring was performed using##2##4##(2008-5#1)(2011-2#1)
scoring was##5##2##(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)
scoring##99##1##(1992-9#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#12)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#5)(2008-9#9)(2009-11#2)(2009-4#1)(2009-5#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#2)
scorpion beta-toxins##2##2##(2008-8#2)
scorpion##16##1##(1990-8#2)(1993-6#2)(2007-12#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)
scotopic##3##1##(2007-5#1)(2011-2#2)
scourge##2##1##(1995-2#1)(2008-9#1)
scouting##3##1##(2008-10#1)(2011-2#2)
scrX##5##1##(2008-8#5)
scramblase##4##1##(2008-8#4)
scramble##2##1##(2008-9#1)(2013-1#1)
scrambled sentence##2##2##(2007-12#2)
scrambled##5##1##(2007-12#2)(2009-11#1)(2010-1#1)(2013-1#1)
scrap##4##1##(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
scraped##3##1##(1995-11#1)(2008-10#1)(2011-2#1)
scrapie in sheep and##2##4##(1996-3#2)
scrapie##6##1##(1990-6#1)(1994-6#1)(1996-3#2)(1996-5#2)
scraping##5##1##(1991-2#1)(1991-5#1)(2008-5#1)(2010-6#1)(2013-1#1)
scrapings of##4##2##(1992-9#1)(2008-10#3)
scrapings##9##1##(1990-3#1)(1992-9#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2011-1#1)
scratch assay##2##2##(2013-8#2)
scratch##6##1##(1990-3#1)(2008-4#1)(2010-8#1)(2013-8#3)
scratching##5##1##(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
screaming##2##1##(1997-1#1)(2013-1#1)
screen a##6##2##(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(2008-1#1)(2008-4#1)
screen and##5##2##(1995-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-2#1)
screen for##37##2##(1990-7#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
screen in##3##2##(2009-5#1)(2011-2#2)
screen is##3##2##(2008-2#1)(2008-3#2)
screen of a##2##3##(1997-5#1)(2008-10#1)
screen of the##2##3##(2008-3#1)(2011-2#1)
screen of##11##2##(1992-12#1)(1994-8#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#2)
screen that##2##2##(1992-12#1)(2008-3#1)
screen time and##3##3##(2013-1#3)
screen time##6##2##(2008-11#1)(2010-8#2)(2013-1#3)
screen to##4##2##(1992-12#1)(1995-2#1)(2008-10#2)
screen using the##2##3##(2008-10#1)(2011-2#1)
screen using##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
screen was found to be##2##5##(1992-12#1)(1994-5#1)
screen was##3##2##(1992-12#1)(1994-5#1)(2008-9#1)
screen with a##3##3##(2008-2#1)(2008-3#2)
screen with##5##2##(2008-2#1)(2008-3#4)
screen##185##1##(1990-7#1)(1991-6#1)(1991-9#1)(1992-12#5)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#4)(1997-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#7)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#18)(2008-4#4)(2008-7#5)(2008-8#7)(2008-9#12)(2009-10#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#3)
screen-based sedentary behavior and##3##4##(2013-1#3)
screen-based sedentary##4##2##(2013-1#4)
screen-based##6##1##(2013-1#6)
screen-printed amperometric biosensor##2##3##(2008-10#2)
screen-printed amperometric##3##2##(2008-10#3)
screen-printed biosensor##3##2##(2008-10#3)
screen-printed carbon electrode##7##3##(2008-10#7)
screen-printed carbon electrodes (SPCEs)##3##4##(2008-10#3)
screen-printed carbon electrodes##9##3##(2008-10#9)
screen-printed carbon##17##2##(2008-10#17)
screen-printed electrode (SPE)##4##3##(2008-10#4)
screen-printed electrode##15##2##(2008-10#15)
screen-printed electrodes for##2##3##(2008-10#2)
screen-printed electrodes##7##2##(2008-10#7)
screen-printed sensor##2##2##(2008-10#2)
screen-printed##55##1##(2008-10#55)
screen-printing##6##1##(2008-10#6)
screen-time##2##1##(2013-1#2)
screened 12##2##2##(1994-8#1)(1997-5#1)
screened a rat##2##3##(1991-9#1)(1993-8#1)
screened a##5##2##(1991-9#1)(1993-2#1)(1993-8#1)(2008-8#1)(2013-1#1)
screened against##4##2##(1992-6#1)(2008-10#2)(2008-7#1)
screened and##8##2##(1992-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)
screened by##12##2##(1990-11#1)(1992-8#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-1#1)(2010-4#1)(2011-1#1)
screened for antimicrobial activity##2##4##(2010-5#1)(2012-2#1)
screened for lignin##2##3##(2008-6#2)
screened for resistance to##4##4##(2008-10#4)
screened for the presence of##4##5##(1994-11#1)(1996-12#1)(2008-10#2)
screened for the##7##3##(1991-6#1)(1994-11#1)(1996-12#1)(2008-10#4)
screened for their##7##3##(1990-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2012-2#1)
screened for##72##2##(1990-2#2)(1990-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-12#3)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(2007-7#3)(2008-1#3)(2008-10#24)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
screened from a##3##3##(1995-6#1)(2008-8#1)(2012-3#1)
screened from##5##2##(1995-6#1)(1996-2#1)(1997-4#1)(2008-8#1)(2012-3#1)
screened in a##2##3##(1994-5#1)(2008-5#1)
screened in the##2##3##(1991-6#1)(2008-9#1)
screened in vitro against##2##4##(2008-10#1)(2008-5#1)
screened in##11##2##(1991-6#1)(1994-5#1)(1997-6#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)(2013-8#1)
screened the##6##2##(2008-1#1)(2008-10#1)(2008-8#2)(2011-2#1)(2012-3#1)
screened to##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2011-3#1)
screened using a##3##3##(1991-1#1)(1992-3#1)(2009-6#1)
screened using##10##2##(1991-1#1)(1992-3#1)(1992-6#1)(1996-10#1)(2008-10#2)(2008-8#2)(2009-6#1)(2013-1#1)
screened with a##4##3##(1990-8#1)(1991-6#1)(2008-10#1)(2011-2#1)
screened with the##5##3##(1990-12#1)(1990-7#1)(1994-6#1)(1994-8#1)(2008-10#1)
screened with##19##2##(1990-12#2)(1990-7#2)(1990-8#2)(1991-6#2)(1992-3#2)(1992-8#1)(1994-6#1)(1994-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
screened##217##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-6#4)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#4)(2008-1#6)(2008-10#51)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#5)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#9)(2013-1#5)(2013-8#4)
screening (HTS)##4##2##(2008-10#2)(2008-9#1)(2010-2#1)
screening a human genomic library##2##5##(1991-6#1)(1994-11#1)
screening a human##4##3##(1991-6#1)(1994-11#1)(1996-10#1)(2008-8#1)
screening a rat##2##3##(1991-2#1)(1993-12#1)
screening a##13##2##(1991-2#1)(1991-6#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-10#1)(1997-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)
screening activity##2##2##(1991-6#1)(1992-10#1)
screening among low-income##2##3##(1997-2#1)(2013-1#1)
screening among##3##2##(1997-2#1)(2013-1#2)
screening and analysis of##3##4##(2008-10#3)
screening and analysis##4##3##(2008-10#4)
screening and brief intervention##3##4##(2008-11#3)
screening and brief##4##3##(2008-11#4)
screening and early##2##3##(2010-8#1)(2012-3#1)
screening and individual##2##3##(1994-11#1)(1994-3#1)
screening and intervention##2##3##(2008-11#1)(2011-1#1)
screening and interventions##2##3##(1997-3#1)(2008-11#1)
screening and management##2##3##(2008-4#1)(2010-8#1)
screening and quantification##2##3##(2008-10#1)(2010-9#1)
screening and treatment##4##3##(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
screening and##69##2##(1991-9#1)(1992-2#1)(1993-12#2)(1994-11#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#12)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
screening approach##5##2##(2008-10#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
screening approaches##2##2##(2010-3#1)(2012-3#1)
screening assay##3##2##(2008-10#1)(2008-12#1)(2011-3#1)
screening assays##5##2##(2007-7#1)(2008-11#1)(2008-9#1)(2012-12#2)
screening at##2##2##(2007-7#1)(2008-10#1)
screening based on##3##3##(1996-12#1)(1997-1#1)(2008-10#1)
screening before##2##2##(1990-9#1)(2007-7#1)
screening by##6##2##(1991-8#1)(1994-3#1)(1995-2#1)(2008-9#2)(2010-8#1)
screening can be##2##3##(1997-6#1)(2008-11#1)
screening can##5##2##(1997-6#1)(2008-11#1)(2011-2#2)(2013-1#1)
screening center##2##2##(2008-10#1)(2010-8#1)
screening colonoscopy##2##2##(1993-9#1)(2011-2#1)
screening combinatorial##2##2##(1997-3#1)(1997-4#1)
screening criteria##2##2##(2008-3#1)(2011-1#1)
screening database##3##2##(1991-6#1)(2008-10#1)(2010-8#1)
screening experiments##3##2##(2008-2#1)(2009-12#1)(2013-7#1)
screening for Down's syndrome##7##4##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#2)
screening for breast and##2##4##(1990-6#1)(1990-8#1)
screening for breast cancer##3##4##(1990-2#1)(1995-4#2)
screening for breast##5##3##(1990-2#1)(1990-6#1)(1990-8#1)(1995-4#2)
screening for carotid stenosis##2##4##(2008-7#1)(2011-2#1)
screening for cervical cancer##2##4##(1992-10#1)(1992-8#1)
screening for drugs of abuse##2##5##(2008-10#2)
screening for familial##2##3##(1992-12#1)(2007-10#1)
screening for lung cancer##2##4##(2010-5#1)(2011-2#1)
screening for mutations in##2##4##(2008-3#1)(2008-4#1)
screening for resistance##3##3##(2008-10#3)
screening for syphilis##2##3##(1991-6#1)(2011-2#1)
screening for the##7##3##(1990-6#1)(1991-3#1)(1991-8#1)(2007-10#1)(2008-6#1)(2008-7#1)(2008-9#1)
screening for this##4##3##(1991-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
screening for##110##2##(1990-2#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#2)(1991-8#3)(1992-10#1)(1992-12#5)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-4#3)(1996-10#1)(1996-12#4)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-5#2)(2010-5#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
screening guidelines##4##2##(1995-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
screening had##2##2##(2008-10#1)(2013-1#1)
screening has been##2##3##(1990-12#1)(1992-2#1)
screening has##5##2##(1990-12#1)(1992-2#1)(1996-8#1)(2008-10#1)(2008-2#1)
screening healthcare information system##2##4##(2010-8#2)
screening in African American men##3##5##(2009-5#3)
screening in African American##4##4##(2008-4#1)(2009-5#3)
screening in CHCs##2##3##(2011-2#2)
screening in a##2##3##(2008-11#1)(2013-1#1)
screening in the elderly##2##4##(1990-3#1)(1990-9#1)
screening in the##6##3##(1990-3#1)(1990-9#1)(1996-3#2)(2011-2#2)
screening in women##2##3##(1995-9#1)(2008-1#1)
screening in##34##2##(1990-2#1)(1990-3#2)(1990-9#1)(1991-11#1)(1992-3#1)(1995-9#1)(1996-3#3)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2009-2#1)(2009-5#3)(2009-8#2)(2011-2#6)(2012-12#1)(2013-1#3)(2013-7#1)
screening included##2##2##(1991-6#1)(2013-1#1)
screening is recommended##2##3##(2009-3#1)(2013-1#1)
screening is##16##2##(1991-1#1)(1991-6#1)(1992-2#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-8#1)(2013-1#2)
screening it##2##2##(1996-12#1)(2008-10#1)
screening large##4##2##(2008-10#2)(2008-9#1)(2010-12#1)
screening mammography##8##2##(1991-3#2)(1993-2#1)(1996-11#1)(1997-1#1)(2007-4#1)(2008-1#1)(2008-10#1)
screening may##2##2##(2008-11#1)(2008-7#1)
screening method for##7##3##(2008-10#6)(2008-11#1)
screening method is##2##3##(2008-10#1)(2012-2#1)
screening method to##2##3##(2008-10#1)(2011-2#1)
screening method##16##2##(2008-10#12)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
screening methods for##5##3##(1997-4#1)(2008-10#4)
screening methods in##2##3##(2008-10#1)(2008-12#1)
screening methods##16##2##(1995-4#1)(1997-4#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-8#1)(2010-11#1)(2013-1#2)
screening models##4##2##(2008-8#1)(2008-9#1)(2011-3#2)
screening nurseries##3##2##(2008-10#3)
screening of a cDNA library##2##5##(1992-9#1)(1995-2#1)
screening of a large number of##3##6##(1990-12#1)(1997-4#1)(2008-4#1)
screening of a##9##3##(1990-12#1)(1992-9#2)(1994-6#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-10#1)
screening of all##2##3##(1994-11#1)(2010-10#1)
screening of an##3##3##(1997-2#1)(2008-5#1)(2013-1#1)
screening of large##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
screening of molecules##2##3##(2008-5#2)
screening of organophosphorus pesticides##2##4##(2008-10#2)
screening of patients##4##3##(1990-6#1)(1997-3#1)(2007-7#1)(2010-7#1)
screening of the##12##3##(1990-6#1)(1994-6#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2009-8#1)
screening of these##3##3##(2007-10#1)(2008-2#1)(2009-10#1)
screening of water##2##3##(2008-10#2)
screening of women##3##3##(1991-6#1)(2007-8#1)(2008-12#1)
screening of##124##2##(1990-12#1)(1990-6#2)(1991-1#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#2)(1995-2#2)(1996-11#3)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#26)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
screening on##4##2##(1992-10#1)(1992-12#1)(1992-6#2)
screening or##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
screening patients##2##2##(1992-8#1)(1994-11#1)
screening performance##2##2##(1996-12#2)
screening platform##4##2##(2008-10#1)(2008-11#3)
screening practices##2##2##(1995-9#1)(2009-5#1)
screening prior to##2##3##(2007-7#2)
screening procedure##7##2##(1991-3#1)(2008-10#6)
screening procedures##5##2##(1991-7#1)(2008-10#1)(2008-11#1)(2010-8#2)
screening process##8##2##(1991-7#1)(1993-9#1)(2007-11#2)(2008-10#1)(2008-11#2)(2010-11#1)
screening program for cervical cancer##2##5##(1991-6#1)(1992-10#1)
screening program for##4##3##(1991-6#2)(1992-10#1)(2012-12#1)
screening program in Bogotá##2##4##(2012-12#2)
screening program in##4##3##(1992-2#1)(1993-2#1)(2012-12#2)
screening program##17##2##(1991-6#2)(1992-10#2)(1992-2#1)(1993-2#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2011-1#1)(2012-12#4)(2012-3#1)
screening programme##6##2##(1994-11#1)(1996-11#1)(2008-10#1)(2008-2#2)(2010-8#1)
screening programmes##3##2##(1991-8#1)(1995-12#1)(2012-12#1)
screening programs in##2##3##(1990-3#1)(2008-11#1)
screening programs##13##2##(1990-10#1)(1990-3#1)(1990-6#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#2)(2013-1#1)
screening protocol##3##2##(1995-12#1)(2007-10#1)(2008-11#1)
screening purposes##12##2##(1990-6#2)(1995-12#1)(1997-1#1)(2008-10#7)(2008-4#1)
screening rates##2##2##(2009-5#1)(2013-1#1)
screening recommendations##3##2##(1990-8#1)(2008-4#1)(2009-12#1)
screening results##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
screening services##4##2##(1996-2#2)(1997-1#1)(2008-10#1)
screening sites##2##2##(2008-10#2)
screening strategies##2##2##(1997-3#1)(2012-3#1)
screening studies##8##2##(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
screening study##4##2##(1990-8#1)(1995-12#1)(2008-1#1)(2013-1#1)
screening survey##2##2##(1995-12#2)
screening system for##2##3##(2008-10#1)(2010-8#1)
screening system##8##2##(1990-7#1)(1991-12#1)(2008-10#3)(2008-3#1)(2010-8#2)
screening systems for antioxidants##2##4##(2008-10#2)
screening systems##6##2##(1997-4#1)(2008-10#4)(2008-7#1)
screening technique for##3##3##(1993-3#1)(2008-10#1)(2008-9#1)
screening technique to##2##3##(1997-4#2)
screening technique##5##2##(1993-3#1)(1997-4#2)(2008-10#1)(2008-9#1)
screening techniques##4##2##(1996-12#1)(2008-10#2)(2011-2#1)
screening technology##2##2##(2008-10#1)(2009-6#1)
screening test for##5##3##(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)
screening test is##2##3##(1997-2#1)(2012-12#1)
screening test##17##2##(1990-6#2)(1991-9#1)(1992-3#1)(1992-4#1)(1997-2#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2012-12#1)(2012-3#1)
screening tests can##2##3##(1993-3#1)(2008-11#1)
screening tests for##3##3##(1990-2#1)(1992-3#1)(1993-2#1)
screening tests were##2##3##(2010-8#1)(2012-12#1)
screening tests##19##2##(1990-2#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2010-8#1)(2012-12#1)
screening than##2##2##(1990-12#1)(2011-2#1)
screening that##3##2##(2008-10#1)(2008-6#1)(2011-7#1)
screening the##9##2##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2013-1#2)
screening to identify##2##3##(1992-6#1)(2008-8#1)
screening to##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
screening tool for the##3##4##(2008-10#3)
screening tool for##9##3##(1993-12#1)(2008-10#3)(2008-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
screening tool to identify##2##4##(2009-10#1)(2013-1#1)
screening tool to##3##3##(1992-12#1)(2009-10#1)(2013-1#1)
screening tool##17##2##(1992-12#1)(1993-12#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-10#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
screening tools##5##2##(2008-10#2)(2008-11#1)(2008-6#1)(2010-10#1)
screening using a##2##3##(2008-4#1)(2011-1#1)
screening using##6##2##(1995-4#1)(1996-12#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
screening was conducted in##2##4##(1990-8#1)(2007-12#1)
screening was##10##2##(1990-2#1)(1990-8#1)(1992-10#1)(1992-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2013-1#1)
screening were##6##2##(1990-2#1)(1992-2#1)(1993-11#1)(2008-10#1)(2012-12#1)(2013-7#1)
screening with the##3##3##(1993-2#1)(1997-8#1)(2008-10#1)
screening with##13##2##(1992-8#1)(1993-12#1)(1993-2#2)(1997-4#1)(1997-8#1)(2008-10#2)(2009-10#1)(2009-5#1)(2012-2#1)(2013-1#2)
screening##1055##1##(1990-10#1)(1990-12#6)(1990-2#7)(1990-3#4)(1990-5#2)(1990-6#14)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-6#15)(1991-7#7)(1991-8#5)(1991-9#3)(1992-1#2)(1992-10#6)(1992-11#1)(1992-12#7)(1992-2#9)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#3)(1992-8#4)(1992-9#5)(1993-11#1)(1993-12#10)(1993-2#6)(1993-3#3)(1993-9#2)(1994-11#5)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#5)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#12)(1995-2#4)(1995-4#5)(1995-5#1)(1995-6#1)(1995-9#10)(1996-10#2)(1996-11#6)(1996-12#22)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#5)(1996-9#1)(1997-1#14)(1997-2#6)(1997-3#8)(1997-4#15)(1997-5#1)(1997-6#1)(1997-8#5)(2007-10#9)(2007-11#10)(2007-12#4)(2007-4#4)(2007-7#15)(2007-8#7)(2008-1#9)(2008-10#196)(2008-11#55)(2008-12#11)(2008-2#12)(2008-3#10)(2008-4#33)(2008-5#21)(2008-6#8)(2008-7#19)(2008-8#13)(2008-9#25)(2009-1#1)(2009-10#4)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#13)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#21)(2010-9#3)(2011-1#15)(2011-2#46)(2011-3#7)(2011-7#1)(2012-1#1)(2012-12#20)(2012-2#12)(2012-3#22)(2013-1#60)(2013-7#4)(2013-8#8)
screening)##2##1##(1992-2#1)(2012-3#1)
screening?##2##1##(1996-12#1)(2012-2#1)
screenings for##2##2##(1991-6#1)(1995-8#1)
screenings##12##1##(1991-6#5)(1992-2#1)(1993-3#1)(1995-8#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
screens for##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)(2012-4#1)
screens is##2##2##(1997-4#1)(2008-2#1)
screens of##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
screens to##4##2##(1993-12#1)(1997-7#1)(2008-2#1)(2012-3#1)
screens using##2##2##(2008-10#1)(2010-12#1)
screens##38##1##(1992-3#1)(1993-12#1)(1994-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#4)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-4#1)
screw and##4##2##(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
screw diameter##3##2##(2007-11#3)
screw fixation for##2##3##(2011-2#1)(2012-12#1)
screw fixation in the##2##4##(2009-3#1)(2013-1#1)
screw fixation in##5##3##(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
screw fixation##15##2##(2007-8#1)(2008-9#1)(2009-1#1)(2009-3#3)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)
screw placement##5##2##(2008-8#1)(2012-12#3)(2012-3#1)
screw wave-front dislocations##2##3##(2007-11#1)(2007-12#1)
screw##62##1##(2007-11#13)(2007-12#1)(2007-8#3)(2008-10#1)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#3)(2009-3#5)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
screw-retained implant-supported single-tooth crowns##2##4##(2013-1#2)
screw-retained implant-supported##3##2##(2013-1#3)
screw-retained##4##1##(2013-1#4)
screwless fixation##4##2##(2009-3#4)
screws and##5##2##(2008-12#2)(2008-7#1)(2008-8#1)(2012-2#1)
screws for##2##2##(2011-2#1)(2012-12#1)
screws was##2##2##(2007-11#1)(2011-2#1)
screws were used##2##3##(2009-3#1)(2011-2#1)
screws were##5##2##(2007-11#1)(2008-7#1)(2009-3#2)(2011-2#1)
screws##45##1##(1991-9#2)(2007-11#8)(2007-8#4)(2008-10#1)(2008-12#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#4)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
screws)##2##1##(2008-8#1)(2013-1#1)
screws]##2##1##(1991-9#1)(2013-1#1)
script event##4##2##(1996-2#4)
script##13##1##(1993-12#1)(1995-12#1)(1996-2#6)(2008-1#2)(2008-6#1)(2008-9#1)(2009-10#1)
scrotal pouch##3##2##(2008-10#3)
scrotal swelling##2##2##(2010-12#1)(2012-12#1)
scrotal wall##2##2##(2008-10#2)
scrotal##16##1##(1990-9#1)(1994-8#1)(2007-2#1)(2008-10#8)(2010-12#2)(2011-1#2)(2012-12#1)
scrotum##10##1##(1990-9#1)(1994-1#1)(2007-9#1)(2008-10#4)(2008-7#1)(2012-3#1)(2013-1#1)
scrub##3##1##(2007-2#1)(2008-3#1)(2008-5#1)
scrupulous##2##1##(2008-9#1)(2012-12#1)
scrutinised##3##1##(1993-2#1)(2008-10#1)(2010-11#1)
scrutinize the##2##2##(2008-9#1)(2012-3#1)
scrutinized by##2##2##(2012-1#1)(2012-12#1)
scrutinized##7##1##(1991-12#1)(1991-5#1)(1993-12#1)(1995-8#1)(2008-10#1)(2012-1#1)(2012-12#1)
scrutinizing##3##1##(1991-6#1)(2008-12#1)(2008-7#1)
scrutiny by##2##2##(1992-12#1)(2008-11#1)
scrutiny from##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
scrutiny in##2##2##(2008-10#1)(2013-1#1)
scrutiny of the##2##3##(1993-1#1)(2011-2#1)
scrutiny of##6##2##(1991-6#1)(1993-1#1)(1997-1#1)(2008-11#2)(2011-2#1)
scrutiny##33##1##(1991-6#1)(1992-12#2)(1993-1#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
scs##4##1##(1995-2#4)
scs'##2##1##(1995-2#2)
scuba diving##4##2##(1991-6#1)(2008-5#1)(2010-3#2)
scuba##6##1##(1991-6#1)(1996-2#1)(2008-5#1)(2010-3#3)
scuba-diving##2##1##(1996-2#1)(2008-5#1)
sculpins##6##1##(2013-1#6)
sculpted##6##1##(1995-2#5)(2008-7#1)
sculpting for##2##2##(2007-11#2)
sculpting##6##1##(2007-11#3)(2008-7#1)(2009-12#1)(2010-4#1)
sculptured##3##1##(2007-12#1)(2008-3#2)
scurf of potato##2##3##(2008-10#2)
scurf of##4##2##(2008-10#4)
scurf##5##1##(2008-10#4)(2008-12#1)
scutellar##2##1##(2008-10#2)
scutellaris##5##1##(2011-2#4)(2013-8#1)
sd-t(t) gene##2##2##(2008-9#2)
sd-t(t)##5##1##(2008-9#5)
se##44##1##(1990-2#2)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-7#1)(2006-10#1)(2007-7#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-5#6)(2008-6#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
sea and##8##2##(2008-10#5)(2008-3#2)(2011-1#1)
sea bream Sparus##3##3##(2008-7#1)(2010-8#2)
sea bream were##2##3##(2008-7#1)(2010-5#1)
sea bream##11##2##(2008-7#3)(2009-5#3)(2010-5#3)(2010-8#2)
sea level##5##2##(1990-8#1)(1997-5#1)(2008-2#1)(2008-8#2)
sea lion colonies##2##3##(2009-2#2)
sea lion##4##2##(2009-2#4)
sea lions##2##2##(2009-2#2)
sea of##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
sea pansy##3##2##(2008-7#3)
sea raven##2##2##(1994-9#2)
sea surface temperature##2##3##(2008-2#1)(2008-3#1)
sea surface##13##2##(2008-2#2)(2008-3#10)(2008-9#1)
sea temperature in##2##3##(2010-8#2)
sea temperature##4##2##(2010-8#4)
sea turtle##5##2##(1995-3#4)(2007-5#1)
sea urchin cortical vesicles##2##4##(2009-7#1)(2012-2#1)
sea urchin egg##2##3##(1995-3#1)(1995-6#1)
sea urchin eggs##2##3##(1995-3#1)(2012-2#1)
sea urchin##20##2##(1990-5#1)(1991-2#2)(1995-3#3)(1995-6#1)(1996-5#1)(1997-4#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-2#2)(2012-2#2)
sea urchins##5##2##(1990-5#1)(1994-11#1)(1997-4#1)(2009-2#2)
sea water and##7##3##(2008-10#7)
sea water samples by ETAAS##2##5##(2008-10#2)
sea water samples##13##3##(2008-10#13)
sea water using##2##3##(2008-10#2)
sea water##49##2##(1992-11#1)(1992-2#1)(1996-2#1)(2007-10#1)(2008-10#40)(2008-12#2)(2008-5#2)(2010-12#1)
sea waters##3##2##(2008-10#3)
sea with##2##2##(2008-2#2)
sea##182##1##(1990-5#2)(1990-8#3)(1991-2#2)(1992-11#1)(1992-2#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-3#7)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#3)(1997-5#1)(2007-10#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#55)(2008-11#5)(2008-12#2)(2008-2#14)(2008-3#14)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-2#8)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#3)(2010-8#8)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-7#1)
sea-going##2##1##(2008-11#2)
sea-surface temperature##3##2##(1992-7#1)(2008-2#1)(2008-3#1)
sea-surface##5##1##(1992-7#1)(2008-2#1)(2008-3#3)
sea-water and waste-water##2##3##(2008-10#2)
sea-water samples##2##2##(2008-10#2)
sea-water##6##1##(2008-10#6)
seabirds##3##1##(1994-9#2)(2008-9#1)
seabream##3##1##(2008-11#1)(2010-5#2)
seafarers and##3##2##(2011-2#3)
seafarers are##2##2##(2011-2#2)
seafarers in Croatia##2##3##(2011-2#2)
seafarers##21##1##(2011-2#21)
seafood by##3##2##(2008-10#2)(2012-1#1)
seafood products##4##2##(2008-10#2)(2011-2#2)
seafood##14##1##(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)(2011-2#3)(2012-1#2)(2013-7#1)
seagrass and##2##2##(2007-5#2)
seagrass bed##2##2##(2007-5#1)(2008-5#1)
seagrass beds##2##2##(2007-5#1)(2013-7#1)
seagrass community##2##2##(2007-5#2)
seagrass##15##1##(2007-5#9)(2008-5#1)(2011-2#2)(2013-1#2)(2013-7#1)
seagrasses and mangroves##2##3##(2011-2#2)
seagrasses##4##1##(2011-2#3)(2012-2#1)
seahorses##3##1##(2007-5#1)(2012-12#2)
seal and##2##2##(1996-6#1)(2010-8#1)
seal the##4##2##(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
seal##21##1##(1991-3#2)(1991-5#1)(1992-8#2)(1995-6#1)(1996-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#2)(2012-3#1)(2013-1#3)(2013-8#1)
sealant material##2##2##(2007-8#2)
sealant materials##2##2##(2013-1#2)
sealant##11##1##(1992-3#1)(2007-8#2)(2009-6#1)(2012-3#2)(2013-1#5)
sealants##5##1##(1995-2#1)(2008-9#2)(2013-1#2)
sealed in##3##2##(2007-12#1)(2010-10#1)(2012-12#1)
sealed using##2##2##(2008-10#2)
sealed with##3##2##(1996-8#1)(2008-10#1)(2008-6#1)
sealed##25##1##(1996-1#2)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-12#2)(2013-1#2)
sealed-tube##2##1##(2008-11#1)(2008-3#1)
sealer##3##1##(2013-1#3)
sealing system##2##2##(2010-8#2)
sealing the##3##2##(1996-8#1)(2008-10#1)(2013-1#1)
sealing##24##1##(1996-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#4)(2010-8#3)(2011-2#2)(2012-12#1)(2012-3#5)(2013-1#1)
seals on##2##2##(2008-10#1)(2012-2#1)
seals##10##1##(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(2008-10#4)(2011-2#1)(2012-2#1)
seamen##5##1##(1991-12#5)
seamless##9##1##(1994-1#1)(1996-3#1)(2008-11#4)(2008-6#1)(2010-8#1)(2012-3#1)
seamlessly integrated##2##2##(2007-4#1)(2013-8#1)
seamlessly##3##1##(2007-4#1)(2008-4#1)(2013-8#1)
seaports##2##1##(2008-10#1)(2011-2#1)
search a##4##2##(1997-6#1)(2008-12#1)(2008-9#2)
search algorithms for##2##3##(2008-1#1)(2011-2#1)
search and retrieval##4##3##(1996-3#1)(2008-11#3)
search and##10##2##(1996-3#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
search based on##2##3##(2008-8#1)(2012-3#1)
search engine is##2##3##(2010-8#2)
search engine##5##2##(2008-12#1)(2010-8#3)(2013-8#1)
search engines##8##2##(2007-2#1)(2008-11#2)(2010-3#1)(2010-8#4)
search for a##9##3##(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-8#1)(2008-4#2)(2013-1#1)
search for an##2##3##(1992-5#1)(2007-11#1)
search for answers##2##3##(2008-9#1)(2012-3#1)
search for molecular##2##3##(1993-9#1)(2008-10#1)
search for new##11##3##(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#2)
search for other##2##3##(2008-10#1)(2013-1#1)
search for relevant##2##3##(2007-4#1)(2012-2#1)
search for specific##2##3##(1996-12#1)(2011-2#1)
search for the best##2##4##(1995-12#1)(2008-10#1)
search for the cause of##2##5##(2008-11#1)(2010-3#1)
search for the##29##3##(1991-9#1)(1994-3#1)(1995-12#3)(1996-3#1)(1996-8#2)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
search for##144##2##(1991-12#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#3)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#1)
search from##2##2##(2008-8#1)(2012-2#1)
search in the##2##3##(2007-12#1)(2008-12#1)
search in##7##2##(2007-12#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
search is##6##2##(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
search method##5##2##(1995-12#1)(2007-9#1)(2008-7#1)(2010-2#1)(2010-8#1)
search of a##6##3##(2008-3#1)(2008-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2013-8#1)
search of all##3##3##(1990-11#1)(2008-8#1)(2013-1#1)
search of new##2##3##(1995-12#1)(2008-10#1)
search of the PubMed##2##4##(2013-8#2)
search of the literature##4##4##(1992-12#1)(1994-2#1)(1995-5#1)(2008-7#1)
search of the##19##3##(1990-2#1)(1992-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-5#1)(2012-3#2)(2013-8#3)
search of##62##2##(1990-11#2)(1990-2#1)(1992-11#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(2006-10#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
search on##10##2##(1992-12#1)(1994-3#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-2#2)(2011-7#1)(2012-1#1)
search performance##3##2##(2008-6#1)(2010-8#2)
search procedure##2##2##(1992-9#1)(2008-3#1)
search process for##2##3##(1996-2#1)(1996-3#1)
search process##4##2##(1991-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
search program##3##2##(2008-10#1)(2008-4#2)
search requests##2##2##(1991-8#2)
search results##6##2##(1992-12#2)(2008-4#3)(2012-2#1)
search revealed a##2##3##(1990-2#1)(2009-5#1)
search revealed that the##2##4##(1992-3#1)(2008-10#1)
search revealed that##3##3##(1992-3#1)(1996-10#1)(2008-10#1)
search revealed##6##2##(1990-2#1)(1992-12#1)(1992-3#1)(1996-10#1)(2008-10#1)(2009-5#1)
search software##2##2##(1993-3#1)(2008-11#1)
search strategies##5##2##(1995-12#1)(2008-11#1)(2008-8#3)
search strategy##5##2##(1993-3#1)(2010-12#1)(2010-4#1)(2011-2#2)
search system##2##2##(2008-3#1)(2008-4#1)
search task##6##2##(2009-2#1)(2010-8#4)(2012-3#1)
search tasks##2##2##(2009-10#1)(2010-8#1)
search techniques##3##2##(1991-2#1)(2008-3#2)
search terms##5##2##(2008-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
search that##2##2##(1993-2#1)(2008-3#1)
search the OMIM database##2##4##(2008-4#2)
search the literature##2##3##(2007-2#1)(2013-1#1)
search the##12##2##(1991-12#2)(1993-8#1)(1997-6#1)(2007-2#1)(2008-4#4)(2008-8#1)(2011-1#1)(2013-1#1)
search to##5##2##(1996-6#1)(2008-10#1)(2008-7#2)(2012-3#1)
search using##2##2##(2008-10#1)(2009-10#1)
search was conducted##3##3##(1996-12#1)(2008-3#1)(2013-1#1)
search was performed from##2##4##(2008-1#1)(2013-1#1)
search was performed using the##2##5##(2011-1#1)(2013-1#1)
search was performed##7##3##(1994-9#1)(2008-1#2)(2010-6#1)(2011-1#1)(2013-1#2)
search was##15##2##(1994-9#1)(1996-12#1)(2008-1#2)(2008-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
search##497##1##(1990-11#2)(1990-2#2)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#4)(1993-3#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#7)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#3)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#2)(2007-12#10)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#12)(2007-9#2)(2008-1#6)(2008-10#26)(2008-11#18)(2008-12#7)(2008-2#4)(2008-3#22)(2008-4#22)(2008-5#11)(2008-6#7)(2008-7#15)(2008-8#28)(2008-9#9)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#18)(2010-9#1)(2011-1#4)(2011-2#26)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#7)(2012-2#18)(2012-3#12)(2013-1#23)(2013-7#1)(2013-8#10)
searched electronic databases##2##3##(2011-2#1)(2012-12#1)
searched for genes##2##3##(1994-11#1)(2008-7#1)
searched for studies##2##3##(2011-2#1)(2012-3#1)
searched for the##3##3##(1992-12#1)(1994-9#1)(2008-11#1)
searched for##36##2##(1990-7#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#3)(2009-10#2)(2009-3#1)(2009-7#2)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#1)
searched in##2##2##(2010-9#1)(2013-1#1)
searched to##4##2##(2011-2#1)(2012-12#3)
searched##67##1##(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-3#1)(2007-2#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#8)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
searcher##2##1##(1991-1#1)(1994-3#1)
searchers##3##1##(1991-2#1)(1992-12#1)(1995-1#1)
searches and##4##2##(1996-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
searches are##2##2##(1991-3#1)(2008-11#1)
searches by##3##2##(2008-10#1)(2008-4#2)
searches for the##2##3##(2007-12#1)(2012-3#1)
searches for##9##2##(1991-11#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#2)(2013-1#1)
searches have##2##2##(1994-6#1)(2011-2#1)
searches of##3##2##(2009-9#1)(2013-1#2)
searches on##2##2##(1995-3#1)(2008-4#1)
searches using##2##2##(2008-4#2)
searches were##5##2##(1991-1#1)(1992-12#2)(2008-10#2)
searches yielded##2##2##(2013-1#2)
searches##66##1##(1991-1#2)(1991-11#1)(1991-3#2)(1992-1#2)(1992-12#3)(1993-2#1)(1993-6#1)(1994-1#1)(1994-6#1)(1995-3#2)(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#11)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#6)
searching MEDLINE##2##2##(1992-1#1)(1993-3#1)
searching and##7##2##(1991-3#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#2)
searching for females##2##3##(2008-5#2)
searching for mates##2##3##(2008-8#1)(2013-1#1)
searching for new##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
searching for the##3##3##(1992-6#1)(2008-3#1)(2011-2#1)
searching for##23##2##(1990-11#1)(1992-6#1)(1994-6#1)(1994-7#1)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
searching in##2##2##(2008-4#1)(2008-8#1)
searching is##3##2##(2008-8#2)(2008-9#1)
searching of##2##2##(1992-1#1)(2008-7#1)
searching the##5##2##(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
searching to##2##2##(2007-6#1)(2008-4#1)
searching was##2##2##(1991-3#1)(1996-2#1)
searching##102##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#8)(1992-1#3)(1992-12#1)(1992-6#1)(1993-3#3)(1994-12#2)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#14)(2008-5#3)(2008-7#3)(2008-8#9)(2008-9#8)(2009-5#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
searchlight problem##2##2##(2008-3#2)
seas##7##1##(1990-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)
seashore##3##1##(2008-10#2)(2008-3#1)
season (25##2##2##(2008-5#1)(2013-7#1)
season and##14##2##(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-7#1)(2013-1#1)
season are##3##2##(1994-2#1)(2008-10#2)
season as a##2##3##(2008-10#1)(2009-2#1)
season did not##2##3##(2008-10#1)(2008-6#1)
season during##2##2##(2008-10#1)(2013-7#1)
season for##3##2##(1996-12#1)(2012-3#1)(2013-7#1)
season from##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
season in the##3##3##(1991-12#1)(2008-10#2)
season in##19##2##(1991-12#1)(2007-5#1)(2008-10#9)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2013-8#2)
season is##2##2##(2008-10#1)(2009-2#1)
season of##16##2##(2007-5#4)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2013-7#1)(2013-8#1)
season progressed##3##2##(2007-5#1)(2008-10#2)
season resulted in high##2##4##(2008-10#2)
season to##6##2##(2007-2#1)(2007-5#1)(2008-10#2)(2010-8#1)(2013-7#1)
season until the##2##3##(2008-10#1)(2013-7#1)
season was##3##2##(2008-10#2)(2008-5#1)
season were##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
season when##2##2##(2008-10#1)(2008-5#1)
season##298##1##(1991-12#1)(1991-8#1)(1992-2#1)(1992-6#2)(1994-2#1)(1994-9#2)(1995-11#2)(1995-6#1)(1996-12#2)(1996-6#7)(1997-6#1)(2007-2#2)(2007-5#14)(2008-10#122)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#27)(2008-6#7)(2008-7#3)(2008-8#22)(2008-9#4)(2009-2#7)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#7)(2011-2#9)(2012-12#1)(2012-2#7)(2012-3#5)(2012-5#2)(2012-6#1)(2012-7#3)(2013-1#2)(2013-7#13)(2013-8#3)
season)##5##1##(2008-10#2)(2008-5#1)(2012-5#1)(2013-7#1)
season-dependent##2##1##(2008-7#1)(2012-7#1)
seasonal AR##2##2##(2012-12#1)(2013-8#1)
seasonal affective disorder (SAD)##2##4##(1995-11#1)(1997-6#1)
seasonal affective disorder##4##3##(1995-11#2)(1997-6#1)(2008-8#1)
seasonal affective##5##2##(1995-11#2)(1997-6#2)(2008-8#1)
seasonal allergens##5##2##(2011-2#5)
seasonal allergic rhinitis##4##3##(2007-11#2)(2008-3#1)(2012-12#1)
seasonal allergic##5##2##(2007-11#2)(2008-3#1)(2012-12#1)(2013-1#1)
seasonal and daily variations##2##4##(2008-5#2)
seasonal and daily##3##3##(2008-10#1)(2008-5#2)
seasonal and##8##2##(2007-1#1)(2008-10#2)(2008-5#2)(2010-4#1)(2011-1#1)(2013-7#1)
seasonal ascospore##5##2##(2008-10#5)
seasonal change in##2##3##(2008-5#1)(2013-1#1)
seasonal change##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
seasonal changes in the##2##4##(2008-7#1)(2008-9#1)
seasonal changes in##5##3##(1990-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
seasonal changes##6##2##(1990-11#1)(1993-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
seasonal differences in##2##3##(2008-5#1)(2009-4#1)
seasonal distribution of##3##3##(2007-10#2)(2008-10#1)
seasonal distribution##4##2##(2007-10#2)(2008-10#1)(2011-1#1)
seasonal effect##2##2##(2007-5#1)(2011-2#1)
seasonal environments##2##2##(2008-9#2)
seasonal fluctuations##2##2##(2008-10#1)(2008-5#1)
seasonal human##3##2##(2013-1#3)
seasonal influenza##5##2##(2010-4#1)(2011-2#4)
seasonal metabolic adjustments##2##3##(2013-1#2)
seasonal pattern of##2##3##(2008-10#1)(2013-7#1)
seasonal pattern##8##2##(1997-3#1)(1997-6#1)(2008-10#3)(2010-8#1)(2013-7#2)
seasonal patterns of##2##3##(2010-8#1)(2012-2#1)
seasonal time constraints##2##3##(2008-8#2)
seasonal trends##2##2##(2008-5#1)(2011-2#1)
seasonal variation in##5##3##(1997-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-8#1)
seasonal variation of##5##3##(2007-2#1)(2008-10#2)(2012-2#1)(2013-7#1)
seasonal variation##16##2##(1995-11#1)(1997-3#1)(2007-10#2)(2007-2#1)(2008-10#3)(2008-5#2)(2010-8#2)(2012-2#1)(2012-3#2)(2013-7#1)
seasonal variations in##3##3##(1991-8#1)(1992-7#1)(2008-10#1)
seasonal variations##7##2##(1991-8#1)(1992-7#1)(2008-10#2)(2008-11#1)(2013-8#2)
seasonal weather##4##2##(2008-10#1)(2012-3#3)
seasonal##168##1##(1990-11#1)(1990-2#2)(1991-8#4)(1992-7#1)(1993-6#2)(1994-9#1)(1995-11#3)(1997-3#2)(1997-6#3)(2007-1#1)(2007-10#6)(2007-11#2)(2007-2#1)(2007-5#2)(2008-10#31)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#17)(2008-7#3)(2008-8#8)(2008-9#6)(2009-4#1)(2009-7#1)(2009-8#2)(2010-4#2)(2010-8#5)(2011-1#2)(2011-2#15)(2012-12#2)(2012-2#6)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#9)(2013-7#7)(2013-8#5)
seasonality and##3##2##(1997-3#1)(2011-2#1)(2013-7#1)
seasonality of##2##2##(1994-12#1)(2008-5#1)
seasonality##12##1##(1993-2#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-7#2)
seasonally inundated forest on the##2##5##(2008-5#2)
seasonally##9##1##(1995-5#1)(2007-5#2)(2008-5#2)(2008-8#1)(2010-3#1)(2011-3#1)(2013-7#1)
seasoning##2##1##(1990-8#1)(1996-2#1)
seasons and##4##2##(1996-6#1)(2008-8#3)
seasons by##2##2##(2008-10#2)
seasons from##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
seasons in the##2##3##(2008-10#1)(2012-12#1)
seasons in##9##2##(2008-10#5)(2010-2#1)(2012-12#2)(2013-7#1)
seasons of the year##2##4##(2008-12#1)(2008-5#1)
seasons of##8##2##(1994-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-1#1)(2013-8#1)
seasons were##3##2##(2008-10#2)(2011-2#1)
seasons##99##1##(1992-6#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-6#1)(2008-10#56)(2008-11#1)(2008-12#3)(2008-5#5)(2008-8#6)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-8#1)(2013-7#4)(2013-8#1)
seat##12##1##(1990-5#2)(1993-3#1)(1996-12#1)(1997-6#3)(2008-11#1)(2008-4#1)(2012-2#2)(2013-1#1)
seated##8##1##(1995-8#1)(2007-7#1)(2008-6#1)(2010-3#3)(2012-2#2)
seaward##2##1##(1994-8#1)(2008-8#1)
seawater and##6##2##(2008-10#5)(2008-2#1)
seawater are##2##2##(2008-10#1)(2008-2#1)
seawater by##10##2##(2008-10#9)(2008-3#1)
seawater in##3##2##(2008-10#2)(2012-12#1)
seawater is described##2##3##(2008-10#1)(2008-3#1)
seawater is##5##2##(2008-10#2)(2008-3#3)
seawater matrix##3##2##(2008-10#3)
seawater of##3##2##(2008-10#1)(2008-2#2)
seawater pH##2##2##(2008-10#2)
seawater sample##5##2##(2008-10#4)(2009-6#1)
seawater samples containing##2##3##(2008-10#2)
seawater samples from##2##3##(2008-10#2)
seawater samples##21##2##(2008-10#21)
seawater using flow injection##2##4##(2008-10#2)
seawater using the##2##3##(2008-10#2)
seawater using##10##2##(2008-10#10)
seawater was##3##2##(2008-10#2)(2008-2#1)
seawater were##4##2##(2008-10#4)
seawater with##4##2##(2008-10#3)(2008-2#1)
seawater##157##1##(1990-11#1)(2007-5#1)(2008-10#120)(2008-11#1)(2008-2#9)(2008-3#11)(2008-5#4)(2008-6#1)(2008-7#1)(2009-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-5#1)
seawaters##2##1##(2008-10#2)
seaweed##12##1##(2008-10#7)(2008-11#3)(2013-1#2)
seaweed-type photobioreactor##2##2##(2008-6#2)
seaweed-type##4##1##(2008-6#4)
seaweeds##5##1##(2008-10#1)(2008-11#4)
sebacate##3##1##(2008-10#3)
sebaceoma##2##1##(2008-8#1)(2010-8#1)
sebaceous gland hyperplasia##8##3##(2008-9#8)
sebaceous gland##11##2##(2008-5#3)(2008-9#8)
sebaceous glands##4##2##(2008-5#2)(2008-9#1)(2009-2#1)
sebaceous metaplasia##2##2##(2012-3#2)
sebaceous neoplasms##2##2##(2010-8#2)
sebaceous##30##1##(1992-9#1)(2008-5#6)(2008-8#1)(2008-9#9)(2009-2#1)(2010-8#6)(2011-1#4)(2012-3#2)
seborrheic dermatitis##5##2##(2008-5#3)(2010-8#2)
seborrheic keratosis##4##2##(2007-8#2)(2011-2#1)(2012-12#1)
seborrheic##9##1##(2007-8#2)(2008-5#3)(2010-8#2)(2011-2#1)(2012-12#1)
seborrhoeic dermatitis##2##2##(2008-5#2)
seborrhoeic##3##1##(1991-2#1)(2008-5#2)
sebum content##2##2##(2008-5#2)
sebum squalene peroxidation##2##3##(2008-5#2)
sebum##18##1##(2008-5#18)
sec and##5##2##(1990-7#1)(1992-9#1)(1993-11#1)(2008-1#1)(2010-7#1)
sec of##2##2##(1994-8#1)(1995-2#1)
sec##35##1##(1990-2#2)(1990-7#2)(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#3)(1994-12#1)(1994-8#1)(1995-2#1)(1997-5#1)(2007-10#1)(2007-9#2)(2008-1#2)(2008-2#3)(2008-3#4)(2008-5#1)(2010-7#3)(2011-2#1)(2013-1#1)(2013-8#2)
sec)##9##1##(2007-10#4)(2008-4#1)(2008-5#4)
sec18##2##1##(1994-12#1)(1997-1#1)
sec7##3##1##(1997-1#3)
secalis in##3##2##(2008-10#3)
secalis populations##2##2##(2008-10#2)
secalis were##2##2##(2008-10#2)
secalis##26##1##(2008-10#26)
sech(2) pulses##2##2##(2007-12#2)
sech(2)##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
seclusion##5##1##(1991-12#2)(1996-2#1)(2009-6#2)
secobarbital##2##1##(1991-1#1)(2008-6#1)
second (FEV1)##5##2##(2007-2#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-3#1)
second CR##2##2##(2007-4#1)(2008-5#1)
second European##3##2##(2008-2#1)(2010-12#2)
second F(2) population##2##3##(2008-10#2)
second Michelson interferometer##2##3##(2007-11#2)
second Stokes##2##2##(2007-11#1)(2007-12#1)
second aim was to##2##4##(2007-12#1)(2012-1#1)
second alkane-inducible cytochrome P450-encoding gene##2##5##(1991-9#2)
second analysis##3##2##(2008-10#3)
second and the third##4##4##(1990-3#1)(1991-12#1)(2007-7#1)(2008-5#1)
second and third line##3##4##(1992-6#1)(1993-1#2)
second and third##28##3##(1990-3#1)(1992-10#1)(1992-6#1)(1993-1#2)(1993-12#2)(1995-8#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
second and##36##2##(1990-12#1)(1990-3#2)(1991-12#1)(1992-10#1)(1992-6#1)(1993-1#2)(1993-12#2)(1995-8#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
second antibody##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
second application##3##2##(1997-4#1)(2008-11#1)(2011-1#1)
second approach##6##2##(1993-3#1)(1995-2#1)(2008-10#2)(2008-3#2)
second article##2##2##(1994-1#1)(2012-2#1)
second aspect##2##2##(1991-5#1)(2012-2#1)
second at##4##2##(1990-7#1)(1994-11#1)(2008-12#1)(2009-9#1)
second attachment site##2##3##(1995-6#2)
second basic##4##2##(1995-6#1)(2008-4#3)
second birth##2##2##(2009-10#1)(2010-11#1)
second cDNA##2##2##(1992-8#1)(1994-12#1)
second case is##3##3##(2007-10#1)(2007-2#1)(2008-10#1)
second case of##5##3##(1991-4#1)(1993-2#1)(2007-8#1)(2010-3#1)(2013-1#1)
second case##20##2##(1991-4#1)(1993-2#1)(1996-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
second cause##3##2##(1991-11#1)(2010-12#1)(2011-3#1)
second class##3##2##(1990-5#1)(1994-11#1)(2008-11#1)
second codon##2##2##(1993-8#1)(1997-2#1)
second cohort of##2##3##(1996-3#1)(2011-2#1)
second cohort##3##2##(1996-3#1)(2011-2#1)(2013-7#1)
second component##3##2##(1991-12#1)(1994-5#1)(1996-2#1)
second course of##3##3##(2008-1#1)(2008-10#2)
second course##4##2##(2008-1#1)(2008-10#2)(2008-11#1)
second cycle##3##2##(2007-7#1)(2008-10#1)(2008-11#1)
second data##2##2##(2008-7#1)(2009-9#1)
second day##12##2##(1991-9#1)(1993-12#2)(1995-5#1)(2007-12#1)(2008-12#2)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
second decade of life##2##4##(2009-12#1)(2013-1#1)
second degree##3##2##(1992-4#1)(1994-12#1)(2013-7#1)
second derivative for##2##3##(2008-10#1)(2008-2#1)
second derivative spectra##3##3##(2008-10#3)
second derivative spectrophotometric method##3##4##(2008-10#3)
second derivative spectrophotometry##3##3##(2008-10#3)
second derivative##17##2##(2008-10#14)(2008-2#1)(2008-3#1)(2013-8#1)
second design##2##2##(2008-2#2)
second dimension##3##2##(2008-10#2)(2009-10#1)
second dissociation reactions of the##2##5##(2008-10#2)
second dissociation##6##2##(2008-10#6)
second domain##2##2##(1994-8#1)(1997-4#1)
second dose of##2##3##(1992-3#1)(1993-12#1)
second dose##4##2##(1992-3#1)(1993-12#1)(2008-7#2)
second earthquake##2##2##(2012-2#2)
second ed##3##2##(2008-11#1)(2008-12#2)
second edition##4##2##(2008-10#2)(2010-5#1)(2013-8#1)
second example##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
second experiment##13##2##(1993-12#1)(1996-12#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)
second eye##2##2##(2011-1#1)(2011-2#1)
second factor##2##2##(2008-10#1)(2009-11#1)
second flavodoxin gene##2##3##(1997-7#2)
second focus##2##2##(2007-12#1)(2013-8#1)
second form of the##2##4##(1992-3#2)
second gel##2##2##(2008-4#2)
second gene##3##2##(1992-6#1)(2008-10#1)(2009-8#1)
second generation antihistamines##3##3##(2007-11#2)(2008-3#1)
second generation of##5##3##(1991-5#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
second generation##22##2##(1990-2#1)(1991-5#1)(1991-6#2)(1995-2#1)(1997-3#1)(2007-11#3)(2008-10#3)(2008-3#2)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
second goal##3##2##(1997-4#2)(2010-8#1)
second grating##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
second group had##2##3##(2009-7#1)(2012-3#1)
second group of##6##3##(1990-5#1)(1992-8#1)(1993-12#1)(2011-2#1)(2012-3#2)
second group##30##2##(1990-2#2)(1990-5#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-6#1)(2007-11#1)(2007-8#4)(2008-10#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-3#4)(2013-1#1)
second half of the##9##4##(1991-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
second half of##12##3##(1991-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
second half##15##2##(1991-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
second harmonic and##2##3##(2007-11#1)(2009-7#1)
second harmonic generation (SHG)##2##4##(2008-10#1)(2013-1#1)
second harmonic of a Nd##2##5##(2007-11#1)(2008-3#1)
second harmonic of##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
second harmonic was##3##3##(2007-12#2)(2008-2#1)
second harmonic##28##2##(2007-11#6)(2007-12#10)(2008-10#2)(2008-2#4)(2008-3#4)(2009-7#1)(2013-1#1)
second harmonics of##2##3##(2007-12#1)(2008-2#1)
second harmonics##3##2##(2007-12#2)(2008-2#1)
second highest##3##2##(2008-10#1)(2008-7#1)(2009-7#1)
second hour post##2##3##(2012-2#2)
second hour##3##2##(2010-5#1)(2012-2#2)
second hypothesis##3##2##(1994-3#1)(2008-8#2)
second in a series##4##4##(1993-3#1)(1994-1#1)(1996-12#1)(2007-11#1)
second in a##7##3##(1993-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
second in##12##2##(1993-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-2#1)
second independent##4##2##(1991-12#1)(1995-6#1)(2008-12#2)
second injection##5##2##(1990-12#1)(1996-12#2)(2008-12#1)(2013-8#1)
second instrument##2##2##(2007-8#1)(2008-10#1)
second intention##2##2##(2008-12#1)(2008-2#1)
second interview##2##2##(2007-1#1)(2008-11#1)
second intron of the##3##4##(1992-8#1)(1993-8#1)(2012-3#1)
second intron##4##2##(1992-8#1)(1993-8#1)(1994-12#1)(2012-3#1)
second involves##2##2##(1992-3#1)(2008-4#1)
second is a##6##3##(1996-4#1)(2008-2#3)(2008-3#1)(2012-2#1)
second is to##3##3##(1996-2#1)(2008-8#1)(2009-7#1)
second is##25##2##(1996-2#1)(1996-3#1)(1996-4#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-2#2)(2012-3#1)
second kind##2##2##(2008-10#1)(2009-10#1)
second language##3##2##(1993-9#1)(2008-11#1)(2013-8#1)
second largest##6##2##(1992-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2010-3#1)(2010-6#1)
second laser##3##2##(2008-2#2)(2008-3#1)
second law##2##2##(1993-12#1)(2008-10#1)
second layer##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
second leading cause of death##2##5##(2008-8#1)(2013-1#1)
second leading cause of##6##4##(2008-1#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
second leading##7##2##(2008-1#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
second level##4##2##(1993-3#1)(1995-2#1)(2008-7#1)(2008-8#1)
second line chemotherapy##3##3##(1990-2#1)(1994-2#1)(2011-1#1)
second line therapy##4##3##(1990-2#1)(1997-7#1)(2008-5#1)(2009-5#1)
second line##11##2##(1990-2#2)(1993-1#1)(1993-2#1)(1994-2#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-5#1)(2009-5#1)(2011-1#1)
second manifold##2##2##(2008-10#2)
second mating##3##2##(2008-10#1)(2008-5#2)
second mechanism##2##2##(2007-11#1)(2011-1#1)
second messenger in##2##3##(1993-6#1)(1995-8#1)
second messenger##25##2##(1990-7#1)(1992-3#3)(1993-6#3)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-11#1)(2013-7#1)
second messengers and##2##3##(2008-7#1)(2013-1#1)
second messengers in##2##3##(1995-8#1)(2008-11#1)
second messengers##16##2##(1991-3#2)(1991-9#1)(1992-8#1)(1993-6#1)(1995-8#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#2)(2010-11#1)(2013-1#1)
second method is##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
second method was##4##3##(2008-10#2)(2010-4#1)(2010-8#1)
second method##20##2##(2008-10#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#2)(2012-2#1)
second model##5##2##(1990-8#1)(1992-6#2)(1996-4#1)(2008-8#1)
second molars##3##2##(2007-12#1)(2013-1#2)
second most frequently##2##3##(1996-8#1)(2013-1#1)
second most##27##2##(1991-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
second nucleotide##3##2##(1992-6#1)(1993-12#1)(1997-2#1)
second objective was to##2##4##(2008-10#1)(2010-5#1)
second objective##3##2##(1992-11#1)(2008-10#1)(2010-5#1)
second on##2##2##(2008-11#1)(2008-6#1)
second one is##2##3##(2008-3#1)(2008-8#1)
second one was##2##3##(2008-10#1)(2008-8#1)
second one##21##2##(1990-3#1)(1991-3#1)(1994-11#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)
second one)##2##2##(1990-2#1)(1993-2#1)
second only to##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
second open reading frame##2##4##(1995-8#2)
second operation##6##2##(2006-12#1)(2008-6#1)(2008-7#3)(2010-12#1)
second or third line##2##4##(1992-6#1)(1993-1#1)
second or third##5##3##(1992-6#1)(1993-1#1)(2008-1#1)(2008-10#2)
second or##6##2##(1992-6#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-7#1)
second order derivative##3##3##(2008-10#3)
second order##20##2##(2007-11#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-7#1)
second pair of##2##3##(2008-8#1)(2012-3#1)
second paper##2##2##(2008-3#1)(2012-3#1)
second parameter##2##2##(1996-12#1)(2008-2#1)
second part of a two-part article##3##6##(1992-12#1)(1993-2#1)(1994-3#1)
second part of the study##2##5##(2008-1#1)(2013-8#1)
second part of the##6##4##(1990-3#2)(2007-8#1)(2008-1#1)(2008-11#1)(2013-8#1)
second part of this paper##2##5##(1997-4#1)(2008-7#1)
second part of this##3##4##(1997-4#1)(1997-6#1)(2008-7#1)
second part of##12##3##(1990-3#2)(1992-12#1)(1993-2#1)(1994-3#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
second part##24##2##(1990-3#2)(1992-12#1)(1993-2#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2013-1#1)(2013-8#2)
second patient##12##2##(1992-10#1)(2007-11#1)(2008-1#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-7#1)(2012-12#1)(2013-1#2)
second peak##9##2##(1992-11#1)(1992-9#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-3#1)
second period##8##2##(1996-3#2)(2011-2#5)(2013-1#1)
second phase of##7##3##(1993-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-6#1)(2009-7#1)(2010-11#1)
second phase##16##2##(1990-12#1)(1993-1#1)(1993-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#2)(2010-11#1)(2011-2#1)(2013-1#1)
second plasmid##2##2##(1991-5#1)(1995-2#1)
second point##3##2##(1991-9#1)(2008-12#1)(2013-1#1)
second primary##5##2##(1990-8#1)(1991-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
second principal##2##2##(2008-10#1)(2008-6#1)
second procedure##3##2##(1994-9#1)(1996-9#1)(2008-4#1)
second promoter##3##2##(1991-9#3)
second protocol##5##2##(1996-6#1)(2008-2#2)(2008-4#1)(2008-9#1)
second quarter##2##2##(1995-12#1)(2008-5#1)
second question##2##2##(1994-2#1)(2012-12#1)
second region##2##2##(2007-12#1)(2008-10#1)
second report of##4##3##(1995-6#1)(1996-10#1)(2008-12#1)(2012-3#1)
second round of PCR##2##4##(1997-4#1)(1997-7#1)
second round of##5##3##(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)
second round##7##2##(1991-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-3#1)
second sample##2##2##(2008-10#2)
second section##11##2##(1991-1#1)(1992-6#1)(2008-10#2)(2008-4#4)(2010-11#1)(2012-2#2)
second series of##2##3##(1992-6#1)(1997-7#1)
second series##4##2##(1992-6#1)(1997-7#1)(2008-5#1)(2011-2#1)
second set of##7##3##(1993-12#1)(1995-12#1)(2008-10#1)(2009-8#1)(2010-10#1)(2013-1#2)
second set##9##2##(1993-12#1)(1995-12#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-10#1)(2013-1#2)
second site##4##2##(1995-6#1)(2008-8#2)(2011-2#1)
second situation##2##2##(2008-2#1)(2008-8#1)
second stage juvenile##2##3##(2008-12#2)
second stage of##2##3##(2012-3#1)(2013-8#1)
second stage##15##2##(1990-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-5#1)(2009-5#4)(2012-12#1)(2012-3#1)(2013-8#1)
second step##24##2##(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#1)(2008-6#2)(2009-12#1)(2009-5#1)(2009-8#2)(2011-1#1)(2012-2#1)
second structure##2##2##(2008-4#1)(2009-6#1)
second study##22##2##(1991-3#1)(1992-8#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#4)(2009-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
second substrates of the enzyme##2##5##(2008-10#2)
second surgery and##2##3##(2007-5#1)(2013-1#1)
second surgery##3##2##(2007-5#1)(2010-3#1)(2013-1#1)
second surgical##2##2##(1993-3#1)(2010-10#1)
second survey##2##2##(1992-12#1)(2008-10#1)
second test##2##2##(1990-6#1)(2012-3#1)
second time##8##2##(1991-8#1)(1992-12#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
second to the##2##3##(1992-6#2)
second to##6##2##(1990-8#1)(1992-6#2)(2008-10#2)(2011-1#1)
second toe##3##2##(1996-8#1)(2010-11#2)
second tone##3##2##(1996-5#3)
second transition##3##2##(1992-10#1)(1992-6#1)(2007-12#1)
second trial##4##2##(2008-10#1)(2008-5#1)(2009-4#2)
second trimester##12##2##(1990-2#1)(1991-6#1)(1993-3#1)(1994-3#1)(1996-12#2)(1997-7#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
second type##6##2##(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
second was a##2##3##(2008-10#1)(2008-8#1)
second was##4##2##(1994-2#1)(2008-10#1)(2008-8#1)(2009-8#1)
second week##12##2##(1992-3#2)(1995-5#1)(1997-2#2)(2008-10#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)
second window of protection##2##4##(1994-11#1)(1996-9#1)
second with a##3##3##(2008-3#1)(2013-1#2)
second with##4##2##(2008-3#1)(2009-7#1)(2013-1#2)
second year of life##4##4##(1996-11#1)(2007-8#2)(2008-9#1)
second year of the##3##4##(1995-5#1)(2008-10#1)(2010-3#1)
second year of##7##3##(1995-5#1)(1996-11#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-3#1)
second year##21##2##(1991-8#1)(1995-5#1)(1996-11#1)(1996-12#4)(2007-8#2)(2008-10#2)(2008-12#4)(2008-6#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
second##1562##1##(1990-10#1)(1990-11#5)(1990-12#11)(1990-2#9)(1990-3#6)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#7)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#8)(1991-3#7)(1991-4#2)(1991-5#5)(1991-6#7)(1991-8#4)(1991-9#10)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#19)(1992-4#2)(1992-5#4)(1992-6#13)(1992-8#8)(1992-9#3)(1993-1#6)(1993-11#2)(1993-12#13)(1993-2#8)(1993-3#7)(1993-6#5)(1993-8#7)(1993-9#2)(1994-1#2)(1994-11#7)(1994-12#12)(1994-2#5)(1994-3#5)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#4)(1995-12#9)(1995-2#12)(1995-3#4)(1995-5#6)(1995-6#15)(1995-8#8)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#18)(1996-2#11)(1996-3#8)(1996-4#3)(1996-5#5)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#9)(1997-3#12)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#12)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#38)(2007-12#47)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#21)(2007-9#1)(2008-1#14)(2008-10#247)(2008-11#40)(2008-12#33)(2008-2#52)(2008-3#79)(2008-4#30)(2008-5#37)(2008-6#24)(2008-7#32)(2008-8#50)(2008-9#16)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#9)(2009-6#7)(2009-7#12)(2009-8#11)(2009-9#3)(2010-10#6)(2010-11#14)(2010-12#7)(2010-2#1)(2010-3#10)(2010-4#3)(2010-5#6)(2010-6#5)(2010-7#1)(2010-8#8)(2011-1#21)(2011-2#60)(2011-3#1)(2012-1#4)(2012-12#16)(2012-2#26)(2012-3#21)(2013-1#51)(2013-7#4)(2013-8#16)
second)##2##1##(2008-10#1)(2013-1#1)
second- and third-order##2##3##(2007-11#1)(2008-3#1)
second-##6##1##(2007-11#2)(2007-12#1)(2008-3#3)
second-degree atrioventricular block##2##3##(2008-10#1)(2013-8#1)
second-degree##5##1##(2008-10#1)(2008-3#1)(2010-3#1)(2012-2#1)(2013-8#1)
second-derivative spectroscopy##2##2##(1993-8#2)
second-derivative##13##1##(1993-8#2)(2008-10#9)(2008-2#1)(2008-3#1)
second-dimension##2##1##(2008-4#2)
second-generation process##2##2##(2008-11#2)
second-generation##15##1##(1991-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)
second-hand##2##1##(2008-10#1)(2008-11#1)
second-harmonic (2f)##2##2##(2007-12#1)(2008-2#1)
second-harmonic (SH)##2##2##(2007-12#2)
second-harmonic and sum-frequency generation##3##4##(2007-12#3)
second-harmonic and##5##2##(2007-12#5)
second-harmonic beam##2##2##(2007-12#1)(2008-3#1)
second-harmonic detection##2##2##(2008-3#2)
second-harmonic field##2##2##(2008-3#2)
second-harmonic frequencies##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
second-harmonic generation (SHG) and##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
second-harmonic generation (SHG) in##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
second-harmonic generation (SHG) with##2##4##(2007-11#1)(2008-2#1)
second-harmonic generation (SHG)##15##3##(2007-11#5)(2007-12#6)(2008-2#1)(2008-3#3)
second-harmonic generation and two-photon##3##4##(2007-11#1)(2007-12#2)
second-harmonic generation and##10##3##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#2)
second-harmonic generation at 532 nm##2##5##(2008-3#2)
second-harmonic generation at##5##3##(2007-12#3)(2008-3#2)
second-harmonic generation by##2##3##(2007-12#2)
second-harmonic generation for##2##3##(2007-11#1)(2007-12#1)
second-harmonic generation from##2##3##(2007-12#1)(2008-7#1)
second-harmonic generation in a##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
second-harmonic generation in the##2##4##(2007-12#1)(2008-2#1)
second-harmonic generation in##18##3##(2007-11#7)(2007-12#9)(2008-2#1)(2008-3#1)
second-harmonic generation is presented##2##4##(2008-2#1)(2008-3#1)
second-harmonic generation is##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
second-harmonic generation of a##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
second-harmonic generation of##10##3##(2007-12#4)(2008-2#4)(2008-3#2)
second-harmonic generation process##2##3##(2007-12#2)
second-harmonic generation was##2##3##(2007-11#2)
second-harmonic generation with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
second-harmonic generation with##7##3##(2007-11#3)(2007-12#3)(2008-3#1)
second-harmonic generation##113##2##(2007-11#34)(2007-12#49)(2008-2#13)(2008-3#16)(2008-7#1)
second-harmonic intensity##2##2##(2007-12#2)
second-harmonic light##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
second-harmonic output of##2##3##(2007-12#1)(2008-2#1)
second-harmonic output##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
second-harmonic power##3##2##(2007-11#3)
second-harmonic pulses##3##2##(2007-12#3)
second-harmonic radiation##2##2##(2007-12#1)(2008-2#1)
second-harmonic signal is##2##3##(2007-11#1)(2007-12#1)
second-harmonic signal##7##2##(2007-11#3)(2007-12#3)(2008-3#1)
second-harmonic signals##3##2##(2007-12#3)
second-harmonic wave##3##2##(2007-12#3)
second-harmonic waves##2##2##(2007-11#2)
second-harmonic##184##1##(2007-11#51)(2007-12#83)(2008-2#19)(2008-3#28)(2008-7#1)(2011-1#2)
second-harmonic-generation (SHG)##2##2##(2007-11#1)(2007-12#1)
second-harmonic-generation##9##1##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#1)
second-instar larvae##3##2##(2008-10#3)
second-instar##4##1##(2008-10#3)(2011-2#1)
second-line agents##3##2##(2006-10#1)(2008-2#1)(2012-3#1)
second-line drugs##2##2##(2011-2#1)(2012-3#1)
second-line therapy##3##2##(1992-12#1)(1994-12#1)(2010-12#1)
second-line##17##1##(1992-10#1)(1992-12#2)(1993-11#1)(1994-12#1)(2006-10#1)(2008-2#1)(2010-12#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
second-look laparoscopy##2##2##(1992-3#1)(1994-9#1)
second-look##3##1##(1992-2#1)(1992-3#1)(1994-9#1)
second-messenger##2##1##(1994-8#1)(1996-5#1)
second-order DPLL##2##2##(2008-3#2)
second-order PMD##2##2##(2007-11#2)
second-order advantage##4##2##(2008-10#4)
second-order cascading##3##2##(2007-11#2)(2007-12#1)
second-order data##2##2##(2008-10#2)
second-order dispersion and##2##3##(2007-11#1)(2007-12#1)
second-order dispersion of the fiber##2##5##(2007-12#1)(2008-3#1)
second-order dispersion##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
second-order fear conditioning##2##3##(1997-7#2)
second-order hyperpolarizability##2##2##(2007-12#2)
second-order kinetics##2##2##(1996-5#1)(2008-10#1)
second-order nonlinear optical##3##3##(2007-11#1)(2007-12#2)
second-order nonlinear susceptibility of##2##4##(2007-12#1)(2008-10#1)
second-order nonlinear##13##2##(2007-11#2)(2007-12#8)(2008-10#1)(2008-2#2)
second-order nonlinearity of poled##2##4##(2007-12#1)(2008-3#1)
second-order nonlinearity of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
second-order nonlinearity##9##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)
second-order polynomial##6##2##(2008-10#3)(2008-3#1)(2008-6#1)(2011-1#1)
second-order processes in a##3##4##(2007-12#2)(2008-2#1)
second-order processes##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
second-order rate constant##5##3##(1990-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-4#1)
second-order rate constants##3##3##(1995-6#1)(1996-2#1)(2008-10#1)
second-order rate##9##2##(1990-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-4#1)
second-order reaction##4##2##(1993-8#1)(2008-10#2)(2008-6#1)
second-order susceptibility of##2##3##(2007-12#1)(2008-3#1)
second-order susceptibility##4##2##(2007-12#2)(2008-3#2)
second-order##127##1##(1990-5#1)(1992-6#2)(1993-8#2)(1994-5#1)(1995-2#2)(1995-6#1)(1996-2#3)(1996-5#1)(1997-7#3)(2007-11#17)(2007-12#27)(2008-10#23)(2008-2#12)(2008-3#21)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-7#3)(2011-1#1)
second-order-pumped fiber Raman amplifiers##2##4##(2007-11#2)
second-phase Ca2+ response##2##3##(1990-2#2)
second-phase##3##1##(1990-2#2)(1991-5#1)
second-site##2##1##(1992-3#1)(1994-12#1)
second-stage juveniles (J2)##5##3##(2008-10#5)
second-stage juveniles per##2##3##(2008-10#2)
second-stage juveniles##11##2##(2008-10#11)
second-stage##15##1##(2008-10#13)(2012-3#2)
second-year harvest fields##2##3##(2008-10#2)
secondaries##2##1##(1990-12#1)(2008-1#1)
secondarily to a##2##3##(1997-3#1)(2008-9#1)
secondarily##14##1##(1992-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#4)(2010-6#1)(2011-1#1)(2012-3#1)
secondary GN##2##2##(2008-1#2)
secondary TBI##2##2##(2012-2#2)
secondary alcohols##3##2##(1990-8#1)(2007-11#1)(2007-12#1)
secondary aliphatic##3##2##(1996-5#2)(2008-10#1)
secondary amine##2##2##(1996-2#1)(2008-10#1)
secondary amines##6##2##(1996-5#1)(2007-11#2)(2008-10#2)(2011-1#1)
secondary analysis of data##3##4##(2007-4#1)(2008-12#1)(2012-12#1)
secondary analysis of##4##3##(2007-4#1)(2008-12#1)(2012-12#1)(2012-2#1)
secondary analysis##6##2##(2007-4#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-12#1)(2012-2#1)
secondary and primary##2##3##(1996-2#1)(1996-3#1)
secondary and tertiary structural##2##4##(1994-5#1)(1995-5#1)
secondary and tertiary structure of##2##5##(2008-10#1)(2008-9#1)
secondary and tertiary structure##9##4##(1990-5#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#1)
secondary and tertiary##16##3##(1990-5#1)(1990-6#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#1)(2013-1#1)
secondary and##19##2##(1990-5#1)(1990-6#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-9#1)(2013-1#1)
secondary anti-apoptotic##2##2##(2011-2#2)
secondary antibodies##3##2##(1990-12#2)(1990-8#1)
secondary antibody responses##2##3##(2008-10#2)
secondary antibody##12##2##(1991-3#1)(2008-10#4)(2008-4#3)(2008-9#3)(2012-3#1)
secondary appraisals##2##2##(2012-1#2)
secondary arthrosis##2##2##(2007-8#2)
secondary axis##3##2##(2008-6#3)
secondary care##4##2##(2008-7#1)(2010-12#1)(2010-5#1)(2013-8#1)
secondary caries##2##2##(2010-10#1)(2013-1#1)
secondary causes##2##2##(2008-1#2)
secondary center of diversity of##2##5##(2008-10#2)
secondary cleavage##3##2##(1990-8#3)
secondary cloud##2##2##(2008-5#2)
secondary color##2##2##(2008-3#2)
secondary complications##2##2##(1993-11#1)(2008-1#1)
secondary conidia and##2##3##(2008-10#2)
secondary conidia on##2##3##(2008-10#2)
secondary conidia##9##2##(2008-10#9)
secondary conidiation##2##2##(2008-10#2)
secondary data from##2##3##(2008-11#1)(2013-1#1)
secondary data##6##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
secondary databases derived from experimental databases are also widely available##2##10##(2008-2#1)(2008-4#1)
secondary dengue##2##2##(2012-2#1)(2012-3#1)
secondary diagnosis##2##2##(1991-3#1)(1991-8#1)
secondary dispersal##2##2##(2010-4#2)
secondary droplets##2##2##(1995-3#1)(2008-5#1)
secondary education##7##2##(2009-10#1)(2009-9#1)(2010-2#1)(2011-2#4)
secondary effect##3##2##(1990-8#1)(2008-9#1)(2012-2#1)
secondary effects of##3##3##(1992-8#1)(2006-6#1)(2009-12#1)
secondary effects##4##2##(1992-8#1)(1995-12#1)(2006-6#1)(2009-12#1)
secondary electron##2##2##(2008-10#1)(2008-2#1)
secondary female##2##2##(2008-8#2)
secondary flow##2##2##(2007-7#1)(2008-10#1)
secondary foci##3##2##(2007-11#1)(2008-10#2)
secondary form##2##2##(1990-6#1)(2011-2#1)
secondary function##2##2##(1990-11#1)(1992-2#1)
secondary functionality##2##2##(2009-12#2)
secondary germ tubes and a haustorium##2##6##(2008-10#2)
secondary germ tubes##3##3##(2008-10#3)
secondary glomerular diseases##3##3##(2007-7#1)(2008-1#2)
secondary glomerular##4##2##(2007-7#2)(2008-1#2)
secondary growth and##2##3##(2012-5#2)
secondary growth##4##2##(2008-10#2)(2012-5#2)
secondary headspot cells##5##3##(2007-12#5)
secondary high##2##2##(1997-3#1)(2009-9#1)
secondary hydatidosis##2##2##(2007-12#2)
secondary hyperparathyroidism in##2##3##(1997-7#1)(2011-1#1)
secondary hyperparathyroidism with##2##3##(1991-11#1)(2009-5#1)
secondary hyperparathyroidism##15##2##(1991-11#3)(1991-5#1)(1991-8#1)(1993-11#2)(1993-3#2)(1997-7#1)(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
secondary hypertension##5##2##(1997-2#1)(2008-1#2)(2008-12#1)(2011-2#1)
secondary hyphae##7##2##(2008-10#7)
secondary infection in##2##3##(2008-10#1)(2008-12#1)
secondary infection##21##2##(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2010-4#1)(2012-2#1)
secondary infections##6##2##(2007-10#1)(2007-2#1)(2008-10#2)(2010-5#2)
secondary injury##2##2##(2008-10#1)(2008-7#1)
secondary inoculum##4##2##(2008-10#4)
secondary instabilities##2##2##(2007-11#2)
secondary ion mass spectrometry (S-SIMS) for the##2##7##(2008-10#2)
secondary ion mass spectrometry (SIMS)##3##5##(2008-10#1)(2009-2#1)(2012-12#1)
secondary ion mass spectrometry##10##4##(2008-10#3)(2008-2#3)(2008-5#1)(2009-2#1)(2012-12#2)
secondary ion mass##11##3##(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#1)(2009-2#1)(2012-12#2)
secondary ion##12##2##(2008-10#4)(2008-2#3)(2008-4#1)(2008-5#1)(2009-2#1)(2012-12#2)
secondary lesions##2##2##(1993-8#1)(2008-10#1)
secondary malignancies##2##2##(1993-8#1)(2011-2#1)
secondary metabolite biosynthesis##2##3##(2008-10#2)
secondary metabolite production##2##3##(2008-10#2)
secondary metabolite##6##2##(2008-10#4)(2008-7#1)(2011-2#1)
secondary metabolites of##2##3##(1991-12#1)(2008-10#1)
secondary metabolites##11##2##(1991-12#1)(2008-10#5)(2008-4#1)(2008-9#2)(2011-1#1)(2011-2#1)
secondary mutation in##2##3##(1992-9#1)(2012-1#1)
secondary mutation##3##2##(1992-9#2)(2012-1#1)
secondary or##2##2##(2008-4#1)(2011-2#1)
secondary osteoarthritis##4##2##(2013-1#4)
secondary osteoporosis##2##2##(2008-4#1)(2012-12#1)
secondary osteosarcoma##2##2##(2008-8#1)(2010-3#1)
secondary outcome##2##2##(1991-11#1)(2008-9#1)
secondary patency rates##4##3##(2007-7#4)
secondary patency##9##2##(2007-7#7)(2011-3#2)
secondary peaks##2##2##(2008-3#2)
secondary peritonitis##4##2##(1991-2#1)(2013-8#3)
secondary pests##2##2##(2008-5#2)
secondary pneumatization##2##2##(2011-2#2)
secondary polarization##3##2##(2008-3#3)
secondary precursor##2##2##(2007-12#2)
secondary prevention of coronary##2##4##(1995-11#1)(2010-2#1)
secondary prevention of ischemic heart disease##2##6##(2011-2#2)
secondary prevention of ischemic heart##3##5##(1995-11#1)(2011-2#2)
secondary prevention of##10##3##(1995-11#2)(2007-8#1)(2008-11#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)
secondary prevention programs##2##3##(2009-9#1)(2013-1#1)
secondary prevention strategy##2##3##(2008-3#1)(2008-8#1)
secondary prevention##37##2##(1990-12#1)(1990-2#1)(1993-3#1)(1994-2#1)(1995-11#2)(1996-12#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#3)
secondary production##2##2##(2008-5#1)(2008-9#1)
secondary products##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
secondary prophylaxis##3##2##(1990-9#1)(1991-11#2)
secondary reactions##2##2##(2008-10#1)(2009-8#1)
secondary responses##2##2##(2008-5#1)(2008-9#1)
secondary role in##3##3##(2008-2#1)(2008-7#2)
secondary role##4##2##(2008-2#1)(2008-7#2)(2009-9#1)
secondary root##5##2##(2008-10#1)(2008-5#4)
secondary roots##4##2##(2008-10#3)(2008-5#1)
secondary school students##3##3##(1990-2#1)(2013-1#1)(2013-8#1)
secondary school##7##2##(1990-2#1)(1996-6#1)(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
secondary schools in##2##3##(2008-10#1)(2009-7#1)
secondary schools##5##2##(2008-10#2)(2009-7#2)(2013-1#1)
secondary sexual characters in##3##4##(1995-2#2)(2007-7#1)
secondary sexual characters##5##3##(1995-2#4)(2007-7#1)
secondary sexual##11##2##(1995-2#4)(2007-12#1)(2007-7#1)(2008-9#4)(2010-9#1)
secondary source of##2##3##(2007-12#1)(2008-12#1)
secondary sources##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
secondary spectrum##9##2##(2008-2#1)(2008-3#8)
secondary sporidia##4##2##(2008-10#4)
secondary spread of the##2##4##(2008-10#2)
secondary spread of##4##3##(2008-10#4)
secondary spread##12##2##(2008-10#12)
secondary standard##4##2##(1995-2#1)(2008-10#1)(2008-3#2)
secondary stroke prevention##2##3##(2006-7#1)(2008-8#1)
secondary structural elements##4##3##(1993-11#1)(1994-8#1)(1995-5#2)
secondary structural##5##2##(1991-11#1)(1993-11#1)(1994-8#1)(1995-5#2)
secondary structure analysis##3##3##(1993-8#1)(2008-4#2)
secondary structure and##5##3##(1992-4#1)(1993-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
secondary structure common to two RNA sequences##2##7##(2008-4#2)
secondary structure in##4##3##(1991-9#1)(1993-11#1)(1994-3#1)(1995-2#1)
secondary structure of myelin proteins##2##5##(1992-12#2)
secondary structure of subtilisin dissolved in##2##6##(2008-7#2)
secondary structure of the##3##4##(1991-5#1)(1992-6#1)(2008-10#1)
secondary structure of##18##3##(1991-5#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#4)(1993-8#1)(1994-11#1)(2008-10#3)(2008-7#2)(2008-9#1)(2009-7#1)
secondary structure predicted##2##3##(1995-12#1)(2008-10#1)
secondary structure prediction##2##3##(1990-4#1)(2008-4#1)
secondary structure##74##2##(1990-12#1)(1990-4#3)(1990-5#3)(1991-11#1)(1991-5#4)(1991-9#3)(1992-12#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#4)(1993-11#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(2008-10#7)(2008-11#1)(2008-4#10)(2008-7#4)(2008-9#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
secondary structures and##2##3##(2008-10#1)(2009-9#1)
secondary structures have been##2##4##(1995-9#1)(2009-11#1)
secondary structures observed for##2##4##(1992-8#2)
secondary structures of##4##3##(1993-11#1)(1993-3#1)(1994-12#2)
secondary structures##36##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-12#2)(1995-8#1)(1995-9#1)(1997-6#2)(2006-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#5)(2009-7#1)(2009-9#2)(2010-7#1)(2011-2#1)(2011-3#3)(2012-2#1)(2013-1#1)
secondary syphilis##2##2##(1994-3#1)(2013-1#1)
secondary to a##18##3##(1990-10#1)(1990-3#1)(1994-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#6)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#2)
secondary to acute##2##3##(1991-3#1)(2011-1#1)
secondary to all##2##3##(2007-8#1)(2008-7#1)
secondary to an##9##3##(1995-5#1)(2006-10#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2013-1#1)
secondary to arterial##2##3##(2008-10#1)(2008-2#1)
secondary to bilateral##2##3##(2008-10#1)(2011-2#1)
secondary to both##2##3##(2010-8#2)
secondary to breast cancer##3##4##(1997-3#1)(2007-10#1)(2011-2#1)
secondary to hypertension##2##3##(2008-12#1)(2013-1#1)
secondary to massive##2##3##(2006-7#1)(2011-2#1)
secondary to the##13##3##(1991-3#1)(1991-5#1)(1992-1#1)(1995-5#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#2)
secondary to trauma or##2##4##(2008-7#2)
secondary to trauma##3##3##(2008-7#2)(2011-2#1)
secondary to##181##2##(1990-10#2)(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-8#2)(2006-10#3)(2006-12#1)(2006-7#1)(2007-10#3)(2007-12#2)(2007-7#5)(2007-8#1)(2008-1#8)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#5)(2008-7#25)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#5)
secondary tumors##2##2##(1997-3#1)(2008-10#1)
secondary xylem##2##2##(2008-10#2)
secondary##998##1##(1990-10#2)(1990-11#1)(1990-12#9)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#8)(1990-6#2)(1990-7#1)(1990-8#8)(1990-9#2)(1991-11#9)(1991-12#2)(1991-2#3)(1991-3#8)(1991-5#7)(1991-6#3)(1991-8#3)(1991-9#10)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#9)(1992-9#5)(1993-11#7)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#5)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#9)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#7)(1995-3#3)(1995-5#8)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#4)(1996-3#6)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#3)(1997-6#4)(1997-7#1)(1997-8#3)(2006-10#3)(2006-12#4)(2006-6#1)(2006-7#2)(2007-10#5)(2007-11#12)(2007-12#21)(2007-2#1)(2007-4#1)(2007-7#18)(2007-8#8)(2008-1#24)(2008-10#151)(2008-11#14)(2008-12#12)(2008-2#13)(2008-3#30)(2008-4#36)(2008-5#21)(2008-6#12)(2008-7#42)(2008-8#10)(2008-9#33)(2009-10#2)(2009-11#6)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#5)(2009-9#9)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#18)(2011-2#53)(2011-3#7)(2012-1#5)(2012-12#17)(2012-2#24)(2012-3#12)(2012-5#2)(2012-8#1)(2013-1#33)(2013-7#1)(2013-8#12)
secondary)##2##1##(2007-11#1)(2008-7#1)
secondhand##2##1##(2008-11#1)(2012-12#1)
secondly the##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
secondly##24##1##(1990-2#1)(1990-5#1)(1993-12#1)(1995-5#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
secondment to##2##2##(2008-11#1)(2010-1#1)
seconds of##8##2##(1991-9#1)(1992-6#1)(2008-10#1)(2008-3#3)(2009-9#2)
seconds##41##1##(1990-2#2)(1991-5#2)(1991-9#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-5#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
seconds) and##2##2##(2007-12#1)(2010-5#1)
seconds)##4##1##(2007-12#1)(2008-12#1)(2008-3#1)(2010-5#1)
secret##8##1##(1993-3#1)(1994-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
secretagogue receptor and##2##3##(2007-7#1)(2011-2#1)
secretagogue receptor##3##2##(2007-7#1)(2008-3#1)(2011-2#1)
secretagogue##4##1##(2007-7#1)(2008-3#1)(2010-5#1)(2011-2#1)
secretagogues##5##1##(1990-12#2)(1990-7#1)(1994-12#1)(1997-1#1)
secretariat##2##1##(1993-12#2)
secretary##3##1##(1991-8#1)(2008-9#1)(2012-12#1)
secretase&quot##2##1##(1991-9#2)
secrete a##3##2##(1991-2#1)(2007-12#1)(2008-10#1)
secrete insulin in response to##2##5##(1990-8#1)(2010-11#1)
secrete insulin##5##2##(1990-8#1)(2008-1#1)(2010-10#1)(2010-11#2)
secrete into##2##2##(2008-7#1)(2013-1#1)
secrete monoclonal antibodies##2##3##(2008-8#2)
secrete pancreatic##2##2##(2008-1#1)(2009-7#1)
secrete the##4##2##(2007-12#2)(2008-10#2)
secrete##71##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-4#2)(1997-7#1)(2007-12#5)(2008-1#7)(2008-10#5)(2008-11#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2011-10#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
secreted EPO##2##2##(2008-11#2)
secreted IgG##2##2##(2008-7#2)
secreted a##2##2##(1994-8#1)(2008-7#1)
secreted alkaline phosphatase (SEAP)##2##4##(2008-7#1)(2011-2#1)
secreted alkaline phosphatase##3##3##(1993-6#1)(2008-7#1)(2011-2#1)
secreted alpha-amylase##2##2##(1997-3#1)(2008-8#1)
secreted an##2##2##(2008-10#1)(2010-6#1)
secreted and##5##2##(1990-11#1)(1991-6#1)(1992-10#1)(1997-6#1)(2008-4#1)
secreted antibodies##3##2##(1991-9#1)(2008-4#2)
secreted at##3##2##(1990-5#1)(1991-9#1)(1993-3#1)
secreted by activated##3##3##(1994-5#1)(2008-4#2)
secreted by adipocytes##2##3##(1990-4#1)(2008-4#1)
secreted by the##9##3##(1992-3#1)(1994-8#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)
secreted by these##3##3##(1992-4#1)(1992-9#1)(1994-9#1)
secreted by##56##2##(1990-11#2)(1990-4#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#3)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
secreted form of##4##3##(1991-2#1)(1992-12#1)(2008-11#2)
secreted form##5##2##(1991-2#1)(1992-12#1)(1997-1#1)(2008-11#2)
secreted forms##2##2##(1990-12#1)(1992-9#1)
secreted from the cells##2##4##(2008-11#1)(2008-8#1)
secreted from the##6##3##(1991-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-2#1)
secreted from##14##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1997-4#1)(2008-11#4)(2008-4#1)(2008-8#2)(2010-2#1)
secreted higher levels of##2##4##(1992-9#1)(2008-10#1)
secreted human proteins##2##3##(1997-4#2)
secreted human##7##2##(1997-2#1)(1997-4#4)(2008-11#2)
secreted in a##3##3##(1997-2#1)(2008-7#1)(2012-2#1)
secreted in the##2##3##(1992-12#1)(1997-4#1)
secreted in##9##2##(1990-12#1)(1992-12#1)(1992-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-7#1)(2012-2#2)
secreted into the culture medium##6##5##(1993-3#1)(1993-9#3)(1997-4#2)
secreted into the medium##5##4##(1991-9#2)(1992-3#1)(1992-8#1)(1993-3#1)
secreted into the##17##3##(1991-9#2)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-9#4)(1994-11#1)(1997-2#1)(1997-4#2)(2008-5#2)
secreted into##20##2##(1990-12#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-9#4)(1994-11#1)(1997-2#2)(1997-4#2)(2008-11#1)(2008-5#2)
secreted ligands##3##2##(1994-6#3)
secreted molecules##2##2##(2008-4#1)(2008-7#1)
secreted prorenin##2##2##(1990-8#2)
secreted protein was##2##3##(1997-4#1)(2009-3#1)
secreted protein##15##2##(1992-5#1)(1992-8#1)(1995-12#1)(1997-3#2)(1997-4#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)
secreted proteins##6##2##(1990-5#1)(1990-7#1)(1993-12#1)(1995-8#1)(1997-3#1)(2008-2#1)
secreted superoxide dismutase##2##3##(1997-4#2)
secreted the##2##2##(1992-9#1)(2008-4#1)
secreted through the##2##3##(1991-5#1)(1994-11#1)
secreted to the##2##3##(2008-8#1)(2009-3#1)
secreted##258##1##(1990-11#4)(1990-12#4)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#7)(1992-10#1)(1992-12#7)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#6)(1993-12#3)(1993-2#1)(1993-3#6)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#4)(1994-9#4)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#19)(1997-6#2)(2007-12#1)(2008-1#2)(2008-10#18)(2008-11#24)(2008-12#2)(2008-2#2)(2008-4#13)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#4)(2010-10#3)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#1)
secretes a##3##2##(1990-11#1)(2007-12#1)(2008-7#1)
secretes##11##1##(1990-11#2)(1990-12#1)(1990-5#1)(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-7#2)(2011-1#1)
secretin in##2##2##(1994-3#2)
secretin##5##1##(1994-3#2)(1995-5#1)(2009-7#1)(2013-8#1)
secreting an##2##2##(2008-10#1)(2013-7#1)
secreting antibodies##3##2##(1994-9#1)(2008-11#2)
secreting cells##4##2##(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)
secreting monoclonal antibodies##2##3##(2008-10#1)(2008-11#1)
secreting monoclonal antibody##2##3##(2008-11#2)
secreting monoclonal##4##2##(2008-10#1)(2008-11#3)
secreting recombinant##2##2##(2008-11#2)
secreting the##2##2##(1994-3#1)(1997-2#1)
secreting##42##1##(1991-9#1)(1994-3#2)(1994-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-11#15)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-7#1)
secretion activity##2##2##(2008-10#1)(2008-11#1)
secretion and also##2##3##(2008-11#1)(2010-11#1)
secretion and increased##2##3##(2008-10#1)(2008-6#1)
secretion and its##3##3##(1993-5#1)(1994-9#1)(2008-12#1)
secretion and mucosal##2##3##(1997-1#1)(2012-2#1)
secretion and the##2##3##(2006-10#1)(2008-4#1)
secretion and##58##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-12#1)(1991-7#1)(1992-6#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#2)(1997-1#2)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
secretion as##4##2##(1994-3#1)(1996-12#1)(2007-12#1)(2010-11#1)
secretion assay##4##2##(2008-11#3)(2008-4#1)
secretion at##3##2##(1994-12#1)(1995-11#1)(1997-2#1)
secretion but not##2##3##(1991-9#1)(2009-6#1)
secretion by the##3##3##(1992-12#1)(2009-3#1)(2010-9#1)
secretion by##29##2##(1990-12#2)(1990-2#1)(1991-5#1)(1992-12#1)(1993-3#2)(1994-8#1)(1995-11#3)(1995-8#2)(1997-4#1)(2006-6#1)(2008-11#3)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#1)
secretion during##4##2##(1990-5#1)(1991-12#1)(1994-9#1)(1997-2#1)
secretion dynamics##2##2##(2008-11#2)
secretion efficiency##2##2##(1991-6#2)
secretion for##4##2##(1992-9#1)(2008-11#3)
secretion from Bacillus subtilis of a 34-amino acid##2##8##(1991-6#2)
secretion from naive##2##3##(2008-11#2)
secretion from pancreatic##2##3##(2010-11#2)
secretion from the##5##3##(1990-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
secretion from##37##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-6#2)(1992-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#5)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-6#1)(2008-7#1)(2010-11#3)(2011-1#2)(2012-2#1)
secretion in a dose-dependent manner##2##5##(1990-8#1)(1993-11#1)
secretion in bovine##2##3##(1995-11#2)
secretion in humans##2##3##(1995-5#2)
secretion in pancreatic##2##3##(2010-11#1)(2013-1#1)
secretion in rats##3##3##(1992-6#1)(1994-11#2)
secretion in response to##2##4##(1995-8#1)(2010-11#1)
secretion in response##3##3##(1990-8#1)(1995-8#1)(2010-11#1)
secretion in the presence of##3##5##(1994-11#1)(1995-11#1)(2008-11#1)
secretion in the##11##3##(1991-9#1)(1993-12#2)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
secretion in vivo##3##3##(2010-11#3)
secretion in##55##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#7)(1997-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#6)(2010-2#1)(2013-1#1)
secretion increases##2##2##(1997-1#1)(2007-12#1)
secretion induced by##4##3##(1990-7#2)(1995-8#2)
secretion into the##3##3##(1990-12#1)(1994-11#1)(1997-3#1)
secretion into##5##2##(1990-12#1)(1994-11#1)(1997-3#1)(2008-11#1)(2009-9#1)
secretion is not dependent on##3##5##(1990-12#1)(1994-8#1)(1995-11#1)
secretion is stimulated##2##3##(1991-6#1)(1997-1#1)
secretion is##16##2##(1990-12#1)(1991-5#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-11#2)(1997-1#3)(2007-12#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
secretion levels##3##2##(2008-4#1)(2010-11#1)(2012-1#1)
secretion may##2##2##(1995-2#1)(2007-12#1)
secretion observed in##2##3##(1992-8#1)(1996-2#1)
secretion observed##4##2##(1992-8#2)(1996-2#1)(2008-11#1)
secretion of ANP and BNP##2##5##(1991-5#2)
secretion of IFN-gamma##2##3##(1994-9#1)(2008-11#1)
secretion of IL-12 p70##2##4##(2008-8#2)
secretion of IL-12##4##3##(2008-8#4)
secretion of TGF-beta from IECs##2##5##(2008-11#2)
secretion of active##2##3##(1995-6#1)(1997-1#1)
secretion of an##3##3##(1993-11#1)(1995-6#1)(2008-11#1)
secretion of beta-endorphin in##2##4##(1990-12#2)
secretion of beta-endorphin##3##3##(1990-12#2)(1994-9#1)
secretion of heterologous proteins##2##4##(1997-4#1)(2008-7#1)
secretion of insulin##2##3##(2010-11#2)
secretion of proinflammatory cytokines such as##2##6##(2008-11#2)
secretion of proinflammatory cytokines##4##4##(2008-11#4)
secretion of the amyloid precursor protein##2##6##(1993-11#2)
secretion of the##12##3##(1990-9#1)(1991-9#1)(1993-11#2)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-3#1)
secretion of toxins##2##3##(2008-10#1)(2008-11#1)
secretion of transforming growth factor beta##2##6##(2008-11#2)
secretion of vasopressin##2##3##(1994-9#1)(2013-1#1)
secretion of##151##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#3)(1991-9#1)(1992-3#5)(1992-9#1)(1993-11#3)(1993-12#3)(1993-3#2)(1993-6#1)(1993-9#5)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#6)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-1#2)(1997-4#2)(1997-7#1)(2006-6#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#26)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#2)
secretion on the##2##3##(2008-11#1)(2009-8#1)
secretion on##3##2##(2007-8#1)(2008-11#1)(2009-8#1)
secretion or##5##2##(1995-2#1)(2006-6#1)(2008-4#1)(2008-7#1)(2013-8#1)
secretion patterns##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
secretion profile##2##2##(2008-11#2)
secretion profiles##2##2##(2008-11#1)(2011-2#1)
secretion rate of##3##3##(1994-6#1)(2008-11#2)
secretion rate##4##2##(1994-6#1)(2008-11#3)
secretion rates were##2##3##(2013-8#2)
secretion rates##4##2##(1990-5#1)(2013-8#3)
secretion signal##2##2##(1993-2#1)(1997-4#1)
secretion stimulated by##2##3##(1990-2#1)(1995-8#1)
secretion system of Bacillus subtilis##2##5##(1997-4#2)
secretion system of##3##3##(1997-4#2)(2008-11#1)
secretion system##8##2##(1997-4#2)(2008-11#2)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
secretion that##3##2##(1990-5#1)(1991-12#1)(2007-12#1)
secretion to the##2##3##(2008-10#2)
secretion to##4##2##(1993-2#1)(2008-10#2)(2008-7#1)
secretion vector##2##2##(2008-4#1)(2008-8#1)
secretion via##2##2##(1997-1#2)
secretion was not##2##3##(1995-11#1)(2008-11#1)
secretion was##12##2##(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-5#1)
secretion were also##2##3##(2006-6#1)(2011-2#1)
secretion were increased##2##3##(2008-11#1)(2010-11#1)
secretion were##6##2##(1993-11#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)
secretion when##2##2##(2008-11#2)
secretion with an##2##3##(1995-5#1)(1996-2#1)
secretion with##5##2##(1994-11#1)(1995-5#1)(1996-2#1)(2009-8#1)(2013-1#1)
secretion without##2##2##(1994-9#1)(2008-7#1)
secretion##690##1##(1990-11#7)(1990-12#17)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#6)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#5)(1991-6#5)(1991-7#4)(1991-9#7)(1992-12#2)(1992-3#6)(1992-6#4)(1992-8#4)(1992-9#4)(1993-11#8)(1993-12#7)(1993-2#3)(1993-3#6)(1993-5#4)(1993-6#2)(1993-8#3)(1993-9#5)(1994-11#11)(1994-12#5)(1994-2#1)(1994-3#6)(1994-5#4)(1994-6#2)(1994-8#11)(1994-9#13)(1995-11#17)(1995-12#1)(1995-2#11)(1995-3#3)(1995-5#7)(1995-6#5)(1995-8#21)(1996-12#4)(1996-2#7)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#22)(1997-2#2)(1997-3#4)(1997-4#10)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-6#6)(2007-11#2)(2007-12#21)(2007-7#4)(2007-8#3)(2008-1#11)(2008-10#21)(2008-11#83)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#29)(2008-5#9)(2008-6#8)(2008-7#24)(2008-8#15)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#34)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#14)(2011-2#13)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#3)(2012-5#1)(2013-1#12)(2013-7#2)(2013-8#7)
secretion)##3##1##(2007-7#1)(2008-4#1)(2009-12#1)
secretion-affinity fusion system##2##3##(2008-7#2)
secretions and##5##2##(1993-3#1)(1994-8#1)(1997-1#1)(2007-11#1)(2008-5#1)
secretions from the##2##3##(1990-11#1)(2007-12#1)
secretions from##4##2##(1990-11#1)(1991-11#1)(1997-1#1)(2007-12#1)
secretions in##4##2##(1991-11#1)(1994-9#1)(2008-1#1)(2008-11#1)
secretions of the##2##3##(1991-5#1)(2008-12#1)
secretions of##3##2##(1991-5#1)(2008-12#1)(2008-5#1)
secretions were##3##2##(1990-9#1)(1992-9#1)(1997-6#1)
secretions##47##1##(1990-11#2)(1990-9#1)(1991-11#7)(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#2)(1994-9#2)(1996-2#1)(1997-1#3)(1997-6#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#10)(2012-2#1)
secretogranin II##6##2##(1992-12#6)
secretome##2##1##(2010-8#1)(2013-8#1)
secretor##2##1##(2012-2#1)(2013-1#1)
secretory IgA##4##2##(1990-12#2)(2008-10#1)(2013-1#1)
secretory activity of the##2##4##(1993-5#1)(2012-1#1)
secretory activity of##3##3##(1993-5#2)(2012-1#1)
secretory activity##7##2##(1993-5#2)(1997-1#1)(2007-12#1)(2008-7#2)(2012-1#1)
secretory and##2##2##(1991-6#1)(2010-9#1)
secretory cavities##2##2##(1997-6#1)(2007-12#1)
secretory cavity##3##2##(1997-6#3)
secretory cell##2##2##(2007-12#1)(2008-6#1)
secretory cells##13##2##(1993-11#1)(2007-12#8)(2008-6#1)(2008-7#1)(2008-8#2)
secretory cycle##3##2##(2008-7#3)
secretory function and##2##3##(2007-11#1)(2010-10#1)
secretory function in##2##3##(2008-7#1)(2010-10#1)
secretory function##9##2##(1992-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-10#4)
secretory granule##7##2##(1992-6#1)(1993-5#1)(1996-5#1)(2010-11#4)
secretory granules in##2##3##(1992-12#1)(1997-7#1)
secretory granules of##2##3##(1996-5#2)
secretory granules with##2##3##(1992-12#1)(2008-7#1)
secretory granules##23##2##(1992-12#5)(1992-2#1)(1993-5#1)(1995-8#3)(1996-5#3)(1997-7#2)(2007-12#1)(2008-4#2)(2008-7#3)(2010-11#2)
secretory machinery##3##2##(1991-5#2)(1997-3#1)
secretory material##2##2##(1994-5#1)(2007-12#1)
secretory pathway and##4##3##(1990-5#1)(2009-8#1)(2012-2#2)
secretory pathway##20##2##(1990-5#2)(1992-9#1)(1994-11#2)(1995-12#1)(1997-1#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2009-8#1)(2012-2#2)
secretory pathways##5##2##(1992-12#2)(1993-5#1)(1994-11#2)
secretory patterns##2##2##(1995-8#1)(1997-1#1)
secretory portions##4##2##(2007-12#4)
secretory product##3##2##(1994-9#1)(2007-12#2)
secretory products of##2##3##(1990-12#1)(1994-5#1)
secretory products##3##2##(1990-12#1)(1994-5#1)(2007-12#1)
secretory profiles##2##2##(2007-11#1)(2013-1#1)
secretory protein##3##2##(1991-12#1)(1995-2#1)(1997-8#1)
secretory proteins##5##2##(1990-5#1)(1991-5#1)(1994-2#1)(1994-8#1)(2008-4#1)
secretory response to##4##3##(1990-12#2)(1990-5#1)(1996-5#1)
secretory response##10##2##(1990-12#2)(1990-5#1)(1990-8#1)(1993-3#3)(1995-8#1)(1996-5#1)(2012-3#1)
secretory small GTPase Rab27B##2##4##(2011-2#2)
secretory spines##2##2##(2007-12#2)
secretory tissues##3##2##(2012-2#3)
secretory units##2##2##(2007-12#1)(2008-7#1)
secretory vesicles from##2##3##(1992-12#1)(2008-11#1)
secretory vesicles##10##2##(1992-12#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)
secretory##218##1##(1990-12#7)(1990-5#6)(1990-7#2)(1990-8#2)(1991-12#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#9)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#5)(1994-11#7)(1994-12#1)(1994-2#1)(1994-5#5)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#5)(1996-12#1)(1996-5#5)(1997-1#6)(1997-3#2)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#29)(2007-2#1)(2008-1#4)(2008-10#5)(2008-11#10)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#18)(2008-8#4)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#8)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#3)
secrets of##2##2##(1991-11#1)(1993-1#1)
secrets##5##1##(1991-11#1)(1993-1#1)(1995-9#1)(1996-3#1)(2011-2#1)
sect##4##1##(2013-1#4)
section 1115 demonstration waivers##3##4##(1996-1#3)
section 1115 demonstration##4##3##(1996-1#4)
section 1115##6##2##(1996-1#6)
section Flavi##2##2##(2008-10#2)
section and the##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-3#1)
section and##13##2##(1993-10#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2011-2#3)(2012-3#1)
section at##3##2##(1990-4#1)(2007-7#1)(2013-1#1)
section deals with##4##3##(2008-10#1)(2008-4#3)
section discusses##5##2##(1994-3#1)(2008-4#2)(2008-9#1)(2011-2#1)
section followed by##2##3##(2008-7#1)(2013-1#1)
section for##9##2##(1990-9#1)(1995-12#1)(2007-11#2)(2008-2#2)(2008-3#2)(2010-4#1)
section from##2##2##(1993-3#1)(2011-2#1)
section in a##2##3##(2007-12#1)(2008-3#1)
section in which##2##3##(1996-11#1)(2008-10#1)
section in##14##2##(1991-6#1)(1995-4#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#2)(2009-10#1)(2011-2#2)(2012-3#1)
section is organized##2##3##(2007-12#1)(2011-2#1)
section is##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#1)
section of a##6##3##(1992-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
section of the##25##3##(1992-5#1)(1993-12#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#2)(2012-1#1)(2013-7#1)
section of##60##2##(1990-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-10#1)(1994-9#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#5)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-7#2)(2008-8#3)(2009-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
section on##9##2##(1991-2#1)(1992-2#1)(1995-2#1)(1997-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#2)
section presents##2##2##(2008-4#1)(2010-5#1)
section reviews the##2##3##(2006-10#1)(2011-2#1)
section that##2##2##(1994-9#1)(2013-1#1)
section thickness##2##2##(2008-3#1)(2008-6#1)
section to##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
section using##2##2##(2008-10#1)(2008-11#1)
section was performed##3##3##(1992-5#1)(2011-1#1)(2012-8#1)
section was##9##2##(1991-12#1)(1992-5#1)(1995-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-8#1)(2013-1#1)
section with##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
section##339##1##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#3)(1993-10#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#2)(1994-3#3)(1994-7#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#7)(1995-6#1)(1996-1#6)(1996-11#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-8#1)(2006-10#3)(2007-11#17)(2007-12#15)(2007-5#3)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#20)(2008-3#35)(2008-4#17)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-11#4)(2010-4#3)(2010-5#1)(2011-1#3)(2011-2#25)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#1)
section)##3##1##(1992-3#1)(1994-3#1)(1995-12#1)
sectional study##16##2##(1990-6#1)(1997-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
sectional##28##1##(1990-6#1)(1996-4#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
sectioned at##3##2##(1992-12#1)(2009-4#1)(2011-2#1)
sectioned fluorescence lifetime##2##3##(2007-12#2)
sectioned in##3##2##(2008-12#1)(2008-9#1)(2009-12#1)
sectioned##22##1##(1990-2#1)(1992-12#1)(1993-12#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#2)(2013-1#1)
sectioning and##2##2##(1996-12#1)(2011-2#1)
sectioning of##5##2##(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
sectioning with a##2##3##(2008-4#2)
sectioning##28##1##(1990-8#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-3#3)(2008-4#7)(2008-7#1)(2008-9#2)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#1)
sections and a##2##3##(2007-12#1)(2012-1#1)
sections and##17##2##(1990-10#1)(1991-11#1)(1991-2#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)
sections are##6##2##(1995-4#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
sections at##6##2##(1992-11#1)(1994-3#1)(1997-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
sections by##2##2##(1996-12#1)(2008-4#1)
sections for##4##2##(2008-2#3)(2012-3#1)
sections from 28##2##3##(1990-12#1)(1993-9#1)
sections from##9##2##(1990-12#3)(1991-9#1)(1993-9#1)(1994-7#1)(2008-3#1)(2008-7#1)(2008-9#1)
sections in##4##2##(1993-12#1)(1996-11#1)(2008-2#1)(2010-8#1)
sections obtained from##2##3##(1997-6#1)(2008-7#1)
sections of a##4##3##(2008-2#2)(2012-3#1)(2013-8#1)
sections of brain##2##3##(1994-11#1)(2010-11#1)
sections of formalin-fixed##3##3##(1997-3#1)(1997-7#1)(2012-12#1)
sections of human##2##3##(1993-9#1)(2008-10#1)
sections of the##15##3##(1990-11#1)(1992-9#1)(1993-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)
sections of##70##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-8#2)
sections on the##2##3##(1996-1#1)(2012-3#1)
sections on##3##2##(1996-1#1)(2008-3#1)(2012-3#1)
sections revealed##2##2##(1997-2#1)(2008-10#1)
sections show##2##2##(1990-5#1)(2007-12#1)
sections showed##2##2##(2008-5#1)(2010-11#1)
sections stained##2##2##(2008-5#1)(2013-1#1)
sections that##3##2##(1995-6#1)(2008-3#2)
sections the##2##2##(2008-3#1)(2008-9#1)
sections to##6##2##(1993-11#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-4#1)
sections up to##2##3##(2008-3#1)(2008-5#1)
sections using an##2##3##(1991-6#1)(1996-5#1)
sections using##4##2##(1991-5#1)(1991-6#1)(1996-5#2)
sections was##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
sections were cut##2##3##(1997-2#1)(2012-3#1)
sections were obtained##3##3##(2008-2#1)(2012-3#2)
sections were##15##2##(1991-5#1)(1993-12#2)(1996-12#1)(1997-2#3)(2008-2#1)(2011-2#2)(2012-3#4)(2013-8#1)
sections with the##2##3##(1994-3#1)(2008-3#1)
sections with##4##2##(1994-3#1)(2008-3#1)(2009-2#1)(2010-8#1)
sections##272##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-5#2)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#4)(1995-6#5)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#2)(2006-10#1)(2007-11#10)(2007-12#7)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#23)(2008-11#4)(2008-12#3)(2008-2#19)(2008-3#24)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-7#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#11)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#11)(2013-1#2)(2013-8#3)
sector &quot##2##2##(1995-1#1)(2013-7#1)
sector and the##2##3##(1992-2#1)(1997-3#1)
sector and##11##2##(1992-2#1)(1995-2#1)(1995-3#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-1#1)
sector are##3##2##(1991-12#1)(1996-3#1)(2008-11#1)
sector employment##4##2##(1994-12#1)(1996-1#1)(1996-2#2)
sector has##4##2##(1994-3#1)(1995-3#1)(1997-3#1)(2013-8#1)
sector in the##2##3##(2008-8#1)(2010-10#1)
sector in##7##2##(1993-3#1)(2008-12#2)(2008-8#1)(2010-10#1)(2012-12#1)(2012-3#1)
sector is##5##2##(1994-2#1)(1997-2#1)(2011-2#3)
sector of the##3##3##(1995-8#1)(1996-3#2)
sector of##7##2##(1995-11#1)(1995-2#1)(1995-8#1)(1996-3#2)(2008-5#2)
sector should##2##2##(2008-11#1)(2011-2#1)
sector to##2##2##(2008-12#1)(2008-7#1)
sector##168##1##(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#2)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#6)(1994-3#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#9)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#6)(1996-3#3)(1997-1#6)(1997-2#7)(1997-3#5)(1997-5#5)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#3)(2008-10#10)(2008-11#7)(2008-12#7)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#1)
sector-field##2##1##(2008-10#2)
sectors and##2##2##(1991-2#1)(2008-12#1)
sectors in##4##2##(1993-2#1)(1994-1#1)(2008-1#1)(2010-12#1)
sectors of the##6##3##(1992-4#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-4#1)
sectors of##11##2##(1990-12#1)(1991-3#1)(1992-4#1)(1993-2#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-4#1)(2012-2#1)
sectors to##6##2##(1996-2#2)(1997-3#1)(2008-11#1)(2008-7#1)(2012-12#1)
sectors was##2##2##(2008-10#1)(2009-7#1)
sectors within health care##2##4##(2008-11#2)
sectors##55##1##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-4#1)(1993-2#3)(1994-1#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#3)(1996-5#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
secular##6##1##(2008-11#2)(2008-12#1)(2008-8#1)(2009-7#1)(2013-1#1)
secundum atrial septal defect##3##4##(2007-8#2)(2008-11#1)
secundum atrial septal##4##3##(2007-8#2)(2008-11#1)(2009-10#1)
secundum##5##1##(1996-6#1)(2007-8#2)(2008-11#1)(2009-10#1)
secure as##2##2##(2008-2#1)(2013-1#1)
secure attachment##2##2##(2008-12#1)(2012-1#1)
secure data##2##2##(1995-12#1)(2008-3#1)
secure manner##2##2##(2007-12#1)(2008-7#1)
secure##60##1##(1990-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-5#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
secured a##2##2##(1994-2#1)(2008-11#1)
secured by##2##2##(1995-5#1)(2009-9#1)
secured interrupted stitch##2##3##(1991-2#2)
secured stitch##2##2##(1991-2#2)
secured to the##2##3##(2008-9#1)(2013-1#1)
secured##14##1##(1991-2#4)(1994-2#1)(1995-5#1)(1997-4#1)(2008-11#1)(2008-9#2)(2009-3#1)(2009-9#1)(2013-1#1)(2013-8#1)
securely##4##1##(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
securing a##3##2##(1991-3#1)(2007-8#1)(2008-7#1)
securing the##4##2##(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
securing##19##1##(1991-3#1)(1995-3#1)(2007-8#2)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
securities##2##1##(2011-2#2)
security and reliability##2##3##(2008-7#2)
security and safety##2##3##(1991-3#1)(1993-2#1)
security and##19##2##(1991-3#1)(1992-2#2)(1993-12#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-8#3)(2010-9#2)
security as##2##2##(1992-12#1)(1995-2#1)
security awareness##2##2##(1992-12#1)(1995-2#1)
security checkpoints##2##2##(2008-10#2)
security concerns##2##2##(1991-9#1)(2007-12#1)
security department##10##2##(1993-12#2)(1993-2#2)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#2)
security director##2##2##(1996-2#1)(1997-2#1)
security directors##6##2##(1991-3#1)(1992-12#2)(1992-2#2)(1997-2#1)
security guards##3##2##(1995-6#2)(1996-12#1)
security in the##3##3##(1995-2#1)(1996-2#1)(2008-10#1)
security in##7##2##(1991-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2010-8#2)
security initiative##2##2##(1995-2#1)(2008-10#1)
security management##4##2##(1992-12#1)(1993-2#2)(1994-2#1)
security manager##2##2##(1996-12#1)(1997-2#1)
security measures##2##2##(1997-3#1)(2010-8#1)
security must be##2##3##(1991-1#1)(1992-12#1)
security needs##2##2##(1992-12#1)(1992-2#1)
security of Electronic Health##2##4##(2010-8#2)
security of the##5##3##(1992-2#1)(1993-3#1)(1994-3#1)(1997-2#1)(2008-2#1)
security of##15##2##(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-8#3)(2012-3#1)
security officer##4##2##(1992-2#1)(1993-2#2)(1996-2#1)
security officers##11##2##(1991-1#1)(1992-12#1)(1992-2#2)(1993-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)
security personnel##2##2##(1991-12#1)(1991-3#1)
security plan##3##2##(1995-12#1)(1997-2#1)(2008-9#1)
security practices##2##2##(1991-12#1)(1992-2#1)
security problems##3##2##(1993-12#1)(1996-2#2)
security professionals##2##2##(1996-2#1)(1997-2#1)
security program##8##2##(1991-1#4)(1992-12#1)(1994-12#1)(1994-2#1)(1995-2#1)
security requirements of##2##3##(2007-12#1)(2010-8#1)
security requirements##5##2##(2007-12#1)(2010-8#4)
security rule##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
security setting##2##2##(1992-12#1)(1993-2#1)
security survey##3##2##(1991-3#1)(1995-2#1)(1996-2#1)
security system##3##2##(1993-12#1)(2008-3#2)
security training program##2##3##(1991-12#2)
security training##3##2##(1991-12#2)(1992-12#1)
security##266##1##(1991-1#10)(1991-12#5)(1991-3#7)(1991-9#1)(1992-12#18)(1992-2#17)(1993-12#10)(1993-2#18)(1993-3#1)(1994-1#1)(1994-12#8)(1994-2#6)(1994-3#2)(1994-6#1)(1995-12#4)(1995-2#12)(1995-5#5)(1995-6#2)(1996-12#11)(1996-2#15)(1996-9#1)(1997-2#20)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2007-12#7)(2007-2#1)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-6#2)(2010-12#1)(2010-8#20)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
security-related incidents##2##2##(1995-12#1)(1996-2#1)
sedating##4##1##(1992-12#1)(2007-11#1)(2012-2#2)
sedation and analgesia##5##3##(2008-8#4)(2011-2#1)
sedation and##10##2##(1992-3#1)(2008-7#1)(2008-8#4)(2010-4#1)(2011-2#2)(2012-2#1)
sedation for##3##2##(1995-1#1)(1996-3#1)(2009-6#1)
sedation in a##2##3##(1993-1#1)(2008-7#1)
sedation in##5##2##(1990-3#1)(1990-6#1)(1993-1#1)(2008-7#1)(2008-8#1)
sedation management##2##2##(2007-11#2)
sedation or##4##2##(1993-1#1)(1995-3#1)(2008-5#1)(2008-6#1)
sedation protocol##4##2##(2007-11#4)
sedation score##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
sedation was##2##2##(1993-1#1)(2008-8#1)
sedation##65##1##(1990-3#1)(1990-6#1)(1992-3#1)(1993-1#7)(1995-1#3)(1995-11#1)(1995-3#2)(1996-3#1)(1996-6#1)(2007-10#1)(2007-11#8)(2007-4#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#12)(2009-6#1)(2010-3#2)(2010-4#1)(2010-7#3)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)
sedation/analgesia##2##1##(2008-4#2)
sedative agents##2##2##(2010-3#1)(2010-4#1)
sedative and analgesic##2##3##(2008-8#1)(2010-7#1)
sedative and hypnotic##2##3##(2008-6#1)(2011-2#1)
sedative and##4##2##(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)
sedative##14##1##(1991-1#1)(1996-3#1)(2008-10#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-8#1)
sedatives##2##1##(1994-3#1)(2010-10#1)
sedentary behavior and health indicators##2##5##(2013-1#2)
sedentary behavior and##5##3##(2013-1#5)
sedentary behavior##13##2##(2012-2#1)(2013-1#12)
sedentary life##2##2##(2008-7#1)(2010-4#1)
sedentary##42##1##(1991-8#1)(1992-3#2)(1993-11#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#17)(2013-8#1)
sediment BCR-CRM##2##2##(2008-10#2)
sediment and##8##2##(2008-10#5)(2008-11#1)(2008-5#1)(2013-8#1)
sediment certified reference material##2##4##(2008-10#2)
sediment certified reference##4##3##(2008-10#4)
sediment certified##5##2##(2008-10#5)
sediment core##2##2##(2008-10#1)(2013-7#1)
sediment cores##3##2##(1992-3#1)(2013-8#2)
sediment extracts##4##2##(2008-10#4)
sediment in the##3##3##(1997-4#1)(2008-10#2)
sediment in##4##2##(1997-4#1)(2008-1#1)(2008-10#2)
sediment material##2##2##(2008-10#2)
sediment pore waters##3##3##(2008-10#3)
sediment pore##4##2##(2008-10#4)
sediment quality guidelines##2##3##(2012-1#2)
sediment quality##3##2##(2012-1#3)
sediment reference##4##2##(2008-10#4)
sediment samples collected from##2##4##(2008-10#2)
sediment samples from##2##3##(2008-10#2)
sediment samples has been##2##4##(2008-10#2)
sediment samples using##2##3##(2008-10#2)
sediment samples were##3##3##(2008-10#3)
sediment samples with##2##3##(2008-10#2)
sediment samples##27##2##(2008-10#26)(2013-8#1)
sediment slurries##3##2##(2008-10#2)(2008-11#1)
sediment slurry samples by##2##4##(2008-10#2)
sediment using##3##2##(1997-7#1)(2008-10#2)
sediment was##3##2##(1991-3#1)(2008-5#1)(2008-6#1)
sediment were##2##2##(1996-12#1)(2008-11#1)
sediment with##2##2##(2008-10#2)
sediment##137##1##(1991-3#1)(1992-3#3)(1996-12#1)(1997-4#1)(1997-7#2)(2007-5#1)(2008-1#1)(2008-10#100)(2008-11#3)(2008-5#4)(2008-6#2)(2008-9#2)(2011-2#2)(2012-1#5)(2013-1#3)(2013-7#2)(2013-8#4)
sedimentary##6##1##(1992-3#1)(1997-5#1)(2008-10#2)(2010-7#1)(2013-7#1)
sedimentation and##9##2##(1990-12#1)(1990-9#1)(1993-8#1)(1994-6#1)(2008-1#1)(2008-5#3)(2011-2#1)
sedimentation coefficient##2##2##(1990-8#1)(1993-11#1)
sedimentation equilibrium##4##2##(1995-11#2)(1995-6#1)(2008-10#1)
sedimentation levels##4##2##(2008-7#3)(2011-2#1)
sedimentation of##3##2##(1990-12#2)(2008-1#1)
sedimentation rate and##2##3##(1990-9#1)(2008-10#1)
sedimentation rate##15##2##(1990-11#1)(1990-9#1)(1993-2#1)(1993-8#1)(1997-6#1)(1997-8#2)(2007-7#2)(2008-10#3)(2010-5#1)(2013-1#2)
sedimentation rates##2##2##(1990-9#1)(2007-5#1)
sedimentation velocity experiments##2##3##(2008-4#2)
sedimentation velocity##5##2##(1997-2#2)(2008-4#3)
sedimentation##66##1##(1990-11#1)(1990-12#4)(1990-8#1)(1990-9#3)(1992-11#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-8#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#8)(2008-4#4)(2008-5#4)(2008-7#5)(2009-7#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-1#2)
sedimented on##2##2##(1992-12#1)(2008-11#1)
sedimented##6##1##(1990-12#1)(1991-8#1)(1992-12#1)(2008-10#2)(2008-11#1)
sedimenting##3##1##(1996-1#1)(2008-4#1)(2008-9#1)
sediments after##2##2##(2008-10#2)
sediments and fish##2##3##(2008-10#2)
sediments and organisms##2##3##(2008-10#1)(2008-5#1)
sediments and sludges using electrothermal atomic absorption spectrometry##2##8##(2008-10#2)
sediments and soil##2##3##(2008-10#1)(2008-5#1)
sediments and soils##2##3##(2008-10#1)(2008-5#1)
sediments and##16##2##(2007-5#2)(2008-10#9)(2008-5#5)
sediments are##5##2##(2008-10#4)(2013-8#1)
sediments by##5##2##(2008-10#5)
sediments collected in##2##3##(2008-10#2)
sediments during##2##2##(2008-10#2)
sediments from##2##2##(2008-10#2)
sediments has been##2##3##(2008-10#2)
sediments in##2##2##(2007-5#1)(2008-10#1)
sediments is##4##2##(2008-10#4)
sediments of the##4##3##(2007-5#1)(2008-5#1)(2011-2#1)(2012-3#1)
sediments of##6##2##(2007-5#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#1)
sediments using##5##2##(2008-10#5)
sediments with a##2##3##(2008-10#2)
sediments##118##1##(1991-8#1)(1992-3#4)(1992-8#1)(2007-5#6)(2008-10#81)(2008-3#1)(2008-5#12)(2008-9#1)(2010-5#1)(2011-2#5)(2012-3#1)(2013-8#4)
sediments)##2##1##(1992-3#1)(2011-2#1)
see a##6##2##(1990-6#1)(1994-2#1)(1996-12#1)(2008-5#1)(2009-12#1)(2010-8#1)
see as##2##2##(1996-3#1)(2008-6#1)
see how##4##2##(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
see http##36##2##(2008-7#1)(2011-1#15)(2011-2#10)(2012-1#10)
see if##17##2##(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-12#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-12#1)
see in##4##2##(1991-12#1)(1996-8#1)(2008-12#1)(2008-3#1)
see more##3##2##(1996-2#1)(2008-1#1)(2009-4#1)
see text] )##2##3##(2008-10#2)
see text] SE##2##3##(2008-8#2)
see text] The##3##3##(1992-12#1)(1995-11#1)(1995-6#1)
see text] and##5##3##(2008-10#5)
see text] for##3##3##(2008-11#1)(2013-1#2)
see text] of##2##3##(2013-1#2)
see text]##57##2##(1992-12#4)(1992-4#2)(1995-11#3)(1995-6#1)(2008-10#19)(2008-11#4)(2008-3#2)(2008-8#11)(2012-2#3)(2012-7#1)(2013-1#7)
see text]HCl##2##2##(2008-11#2)
see that the##2##3##(1994-12#1)(2008-2#1)
see that##8##2##(1994-12#1)(1994-9#1)(2008-11#2)(2008-2#1)(2009-4#2)(2012-1#1)
see the world##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
see the##21##2##(1991-12#1)(1992-3#1)(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
see this##3##2##(1992-3#1)(2009-10#1)(2012-3#1)
see what##2##2##(2008-10#1)(2008-12#1)
see whether##8##2##(1991-11#1)(1995-11#1)(1995-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-10#1)
see##226##1##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#4)(1992-4#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#4)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#15)(2008-12#6)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#15)(2011-2#15)(2012-1#11)(2012-2#5)(2012-3#6)(2012-7#1)(2013-1#8)(2013-8#2)
see&quot##2##1##(1993-2#2)
see-through##2##1##(2008-3#1)(2008-9#1)
seed albumins and##2##3##(2008-12#2)
seed albumins##3##2##(2008-12#3)
seed and soil treatments with##2##5##(2008-10#2)
seed and soil##3##3##(2008-10#3)
seed and##16##2##(2008-10#13)(2008-12#1)(2008-5#1)(2008-8#1)
seed aqueous extract##2##3##(2008-12#2)
seed bank##5##2##(2008-5#1)(2008-8#4)
seed by##2##2##(2008-10#2)
seed coat##18##2##(2008-10#10)(2011-2#1)(2013-8#7)
seed crops was##2##3##(2008-10#1)(2013-1#1)
seed crops##5##2##(2008-10#3)(2013-1#1)(2013-8#1)
seed defenses##2##2##(2013-1#2)
seed densities##2##2##(2008-7#2)
seed development and##2##3##(1995-6#1)(2009-8#1)
seed development##6##2##(1995-6#1)(2008-10#1)(2008-12#2)(2009-8#2)
seed dispersal##7##2##(2008-12#1)(2008-9#6)
seed embryos were##2##3##(2008-10#2)
seed embryos##3##2##(2008-10#3)
seed extract##6##2##(2008-10#3)(2012-2#3)
seed extracts##2##2##(2008-10#1)(2013-1#1)
seed for##2##2##(2007-11#1)(2008-6#1)
seed formation##2##2##(2008-10#1)(2009-10#1)
seed from##4##2##(2008-10#3)(2011-2#1)
seed germination and seedling growth##2##5##(2008-12#1)(2008-5#1)
seed germination and##4##3##(2008-12#1)(2008-5#2)(2008-7#1)
seed germination in##2##3##(2006-11#1)(2008-5#1)
seed germination##25##2##(2006-11#2)(2008-10#4)(2008-12#4)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#2)(2012-3#1)
seed globulins##2##2##(2008-12#2)
seed had##2##2##(2008-10#2)
seed health testing##2##3##(2008-10#2)
seed health##3##2##(2008-10#3)
seed in farms##2##3##(2008-12#2)
seed in the##3##3##(2008-10#2)(2008-12#1)
seed in##6##2##(2008-10#3)(2008-12#3)
seed infection by##2##3##(2008-10#2)
seed infection##7##2##(2008-10#7)
seed infestation by A##2##4##(2008-10#2)
seed infestation by##3##3##(2008-10#3)
seed lot##9##2##(2006-11#1)(2008-10#8)
seed lots were##2##3##(2008-10#2)
seed lots##10##2##(2008-10#10)
seed mass##4##2##(2008-8#4)
seed maturation##2##2##(2008-10#1)(2008-12#1)
seed meal amendment##5##3##(2008-10#5)
seed meal amendments##4##3##(2008-10#4)
seed meal at a rate of##2##6##(2008-10#2)
seed meal type##2##3##(2008-10#2)
seed meal##21##2##(2008-10#21)
seed meals##2##2##(2008-10#2)
seed of##11##2##(2007-5#1)(2008-10#8)(2008-12#1)(2013-8#1)
seed oil was##2##3##(2008-5#1)(2009-3#1)
seed oil##5##2##(2008-11#1)(2008-5#1)(2009-10#1)(2009-3#1)(2013-1#1)
seed oils##4##2##(2008-11#4)
seed or##3##2##(2008-10#3)
seed orchards##2##2##(2008-10#1)(2009-12#1)
seed parents##3##2##(2008-10#3)
seed particles##3##2##(2008-10#1)(2008-3#2)
seed plant species##3##3##(2008-8#3)
seed plant##5##2##(2008-8#4)(2010-5#1)
seed poles##4##2##(2009-6#4)
seed predation##2##2##(2008-5#1)(2013-1#1)
seed predators##7##2##(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#3)
seed production fields##3##3##(2008-10#3)
seed production in##2##3##(2008-8#1)(2009-12#1)
seed production##13##2##(2008-10#5)(2008-8#4)(2008-9#3)(2009-12#1)
seed quality##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
seed set##3##2##(2008-9#1)(2009-12#2)
seed shattering##2##2##(2009-10#2)
seed size##9##2##(2008-9#9)
seed size)##2##2##(2008-9#2)
seed source for##2##3##(2008-3#1)(2012-9#1)
seed source##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2012-9#1)
seed stocks##2##2##(2008-10#1)(2008-4#1)
seed train##2##2##(2008-11#2)
seed transmission of##3##3##(2008-10#3)
seed transmission##7##2##(2008-10#7)
seed treated with##2##3##(2008-10#2)
seed treatment and##3##3##(2008-10#3)
seed treatment with##3##3##(2008-10#3)
seed treatment##14##2##(2008-10#14)
seed treatments in##2##3##(2008-10#2)
seed treatments##5##2##(2008-10#5)
seed tubers##7##2##(2008-10#7)
seed was##5##2##(2008-10#4)(2008-8#1)
seed weight##4##2##(2008-10#1)(2008-12#1)(2013-8#2)
seed were##3##2##(2008-10#3)
seed with##3##2##(2008-10#2)(2008-12#1)
seed yield and quality in relation to fruit position##2##9##(2008-12#2)
seed yield and##3##3##(2008-10#1)(2008-12#2)
seed yield was##2##3##(2008-10#2)
seed yield##15##2##(2008-10#9)(2008-12#6)
seed yields##2##2##(2008-10#2)
seed##473##1##(1991-8#1)(1994-11#3)(1995-3#1)(1995-6#2)(1997-5#1)(2006-11#3)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#246)(2008-11#10)(2008-12#40)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#5)(2008-8#30)(2008-9#35)(2009-10#8)(2009-12#5)(2009-3#1)(2009-6#5)(2009-8#5)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#11)(2013-7#1)(2013-8#16)
seed)##2##1##(2008-10#2)
seed-borne##3##1##(2008-10#3)
seed-coat##2##1##(2008-10#2)
seed-eating##2##1##(2008-8#2)
seed-producing##2##1##(2008-5#2)
seed-size selection##2##2##(2008-8#2)
seed-size##4##1##(2008-8#2)(2008-9#2)
seed-train##2##1##(2008-11#2)
seed-transmitted endophytes##4##2##(2008-8#4)
seed-transmitted##9##1##(2008-10#5)(2008-8#4)
seedborne in##2##2##(2008-10#2)
seedborne inoculum##2##2##(2008-10#2)
seedborne isolates##2##2##(2008-10#2)
seedborne##18##1##(2008-10#18)
seeded at##4##2##(1994-2#1)(2008-11#1)(2008-3#1)(2013-1#1)
seeded by##3##2##(2007-11#1)(2008-2#2)
seeded on the##2##3##(2008-10#1)(2008-11#1)
seeded on##6##2##(1990-8#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#2)
seeded scaffolds##2##2##(2011-2#2)
seeded with linearly polarized##2##4##(2007-11#1)(2007-12#1)
seeded with sugar beet##2##4##(2008-10#2)
seeded with##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2012-2#2)
seeded##49##1##(1990-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(2007-11#6)(2007-12#3)(2008-10#4)(2008-11#4)(2008-2#5)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-9#2)(2011-2#4)(2012-2#3)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#1)
seeder##3##1##(2007-11#2)(2008-2#1)
seeding and##4##2##(2008-10#1)(2008-12#1)(2009-12#1)(2011-2#1)
seeding are##2##2##(2008-10#1)(2008-4#1)
seeding density of##2##3##(1994-2#1)(2013-1#1)
seeding density##7##2##(1994-2#1)(2008-10#1)(2008-11#2)(2013-1#3)
seeding efficiency##2##2##(2011-2#2)
seeding in##2##2##(2008-8#1)(2011-2#1)
seeding method##2##2##(2011-2#2)
seeding methods##2##2##(2011-2#2)
seeding of the##2##3##(2007-12#1)(2008-10#1)
seeding of##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
seeding to macroporous alginate##2##4##(2012-1#2)
seeding with##2##2##(2007-12#2)
seeding##76##1##(1990-6#1)(1994-11#1)(1994-2#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#14)(2012-1#3)(2012-12#2)(2013-1#3)
seedless laser##2##2##(2007-11#2)
seedling and adult stages##2##4##(2008-10#2)
seedling and adult##3##3##(2008-10#3)
seedling and##10##2##(2008-10#8)(2008-12#2)
seedling blight##5##2##(2008-10#5)
seedling damping-off##2##2##(2008-10#2)
seedling death##2##2##(2008-10#2)
seedling disease##5##2##(2008-10#5)
seedling dry weight##3##3##(2008-12#3)
seedling emergence##5##2##(2008-10#5)
seedling explants##2##2##(2008-12#2)
seedling genes##4##2##(2008-10#4)
seedling growth and##3##3##(2008-5#1)(2008-8#2)
seedling growth of##12##3##(2008-12#10)(2008-5#2)
seedling growth were##2##3##(2008-12#1)(2008-5#1)
seedling growth##25##2##(2008-10#1)(2008-12#15)(2008-5#6)(2008-8#3)
seedling leaves of##2##3##(2008-10#2)
seedling mortality##2##2##(2008-10#1)(2008-9#1)
seedling resistance when##2##3##(2008-10#2)
seedling resistance##5##2##(2008-10#5)
seedling root##2##2##(2008-10#2)
seedling stand##4##2##(2008-10#3)(2008-12#1)
seedling##127##1##(2008-10#77)(2008-12#27)(2008-5#12)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-8#1)
seedlings (r2 = 0##2##4##(2008-5#2)
seedlings and adult plants##2##4##(2008-10#2)
seedlings and saplings##2##3##(2008-5#2)
seedlings and the##3##3##(2008-10#2)(2008-8#1)
seedlings and##16##2##(2008-10#11)(2008-5#3)(2008-8#1)(2011-10#1)
seedlings are##2##2##(1994-8#1)(2008-10#1)
seedlings at##3##2##(2008-10#2)(2008-5#1)
seedlings by strain 4/4##2##4##(2008-10#2)
seedlings by##5##2##(2008-10#5)
seedlings caused by##2##3##(2008-10#2)
seedlings derived from##2##3##(2008-10#2)
seedlings did develop##2##3##(2008-10#2)
seedlings did not##2##3##(2008-10#1)(2008-5#1)
seedlings did##4##2##(2008-10#3)(2008-5#1)
seedlings followed##2##2##(2008-10#2)
seedlings for##2##2##(2008-10#2)
seedlings grown in these##2##4##(2008-10#2)
seedlings grown in##9##3##(2008-10#9)
seedlings had significantly less##2##4##(2008-10#2)
seedlings had the##2##3##(2008-5#1)(2011-2#1)
seedlings had##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
seedlings in a##4##3##(2008-10#2)(2008-5#2)
seedlings in the greenhouse##3##4##(2008-10#3)
seedlings in the##5##3##(2008-10#5)
seedlings in##14##2##(2008-10#12)(2008-5#2)
seedlings infected with##2##3##(2008-10#2)
seedlings inoculated with the##3##4##(2008-10#3)
seedlings inoculated with##6##3##(2008-10#5)(2008-11#1)
seedlings inoculated##7##2##(2008-10#6)(2008-11#1)
seedlings of the##3##3##(2008-10#3)
seedlings of##21##2##(2008-10#16)(2008-11#1)(2008-8#3)(2012-8#1)
seedlings over##2##2##(2008-10#2)
seedlings that were inoculated##2##4##(2008-10#2)
seedlings that were##7##3##(2008-10#6)(2008-9#1)
seedlings that##10##2##(2008-10#9)(2008-9#1)
seedlings treated with both types of CWP##2##7##(2008-10#2)
seedlings was##6##2##(2008-10#6)
seedlings were challenged with##2##4##(2008-10#2)
seedlings were grown in##2##4##(2008-10#2)
seedlings were inoculated##4##3##(2008-10#4)
seedlings were##25##2##(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-10#2)
seedlings with##11##2##(2008-10#10)(2008-9#1)
seedlings##278##1##(1990-11#2)(1991-12#1)(1994-8#3)(1996-10#3)(2008-10#207)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#20)(2008-7#1)(2008-8#9)(2008-9#9)(2009-8#3)(2011-1#2)(2011-10#5)(2011-2#3)(2012-8#1)
seeds after##2##2##(2008-5#1)(2008-8#1)
seeds and its##2##3##(2008-10#1)(2008-11#1)
seeds and seedlings##2##3##(2008-10#2)
seeds and##17##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
seeds by##3##2##(1992-8#1)(2008-5#1)(2008-9#1)
seeds extract on##2##3##(2008-5#1)(2013-7#1)
seeds extract##5##2##(2008-5#4)(2013-7#1)
seeds for##3##2##(2008-12#1)(2010-5#1)(2011-2#1)
seeds from different locations##2##4##(2012-3#2)
seeds from different##3##3##(2012-3#3)
seeds from##12##2##(2008-10#1)(2008-5#5)(2008-9#1)(2012-3#4)(2012-9#1)
seeds had##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
seeds in##6##2##(2008-5#3)(2008-8#1)(2008-9#1)(2009-8#1)
seeds of P##2##3##(2013-7#2)
seeds of a##2##3##(2008-10#1)(2008-8#1)
seeds of improved varieties##4##4##(2008-12#4)
seeds of improved wheat varieties in farms##2##7##(2008-12#2)
seeds of improved##6##3##(2008-12#6)
seeds of the##4##3##(2008-11#1)(2008-5#2)(2011-1#1)
seeds of##40##2##(1990-11#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#11)(2008-5#2)(2008-8#2)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#7)(2012-2#1)(2013-7#4)(2013-8#1)
seeds on##2##2##(2008-5#1)(2012-3#1)
seeds per##3##2##(2008-10#2)(2008-12#1)
seeds to##3##2##(1992-8#1)(2008-10#1)(2008-5#1)
seeds was##7##2##(2008-10#3)(2008-11#1)(2008-9#1)(2013-7#2)
seeds were planted##2##3##(2008-10#2)
seeds were##11##2##(2008-10#4)(2008-12#3)(2008-5#1)(2009-12#1)(2010-2#2)
seeds with##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-12#1)
seeds##249##1##(1990-11#1)(1990-5#4)(1992-3#2)(1992-8#5)(1995-6#2)(1997-4#1)(2007-11#1)(2008-10#57)(2008-11#4)(2008-12#39)(2008-2#1)(2008-3#1)(2008-5#35)(2008-7#2)(2008-8#14)(2008-9#17)(2009-10#1)(2009-12#4)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#7)(2010-5#4)(2011-1#9)(2011-2#5)(2012-2#3)(2012-3#8)(2012-9#1)(2013-1#5)(2013-7#10)(2013-8#1)
seeds)##2##1##(2008-8#1)(2011-2#1)
seeing a##2##2##(1996-4#1)(2013-7#1)
seeing conditions##3##2##(2008-2#2)(2008-3#1)
seeing the##4##2##(2008-7#1)(2008-8#1)(2013-7#1)(2013-8#1)
seeing##25##1##(1991-12#1)(1993-2#1)(1995-12#1)(1996-4#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-7#2)(2013-8#2)
seek a##7##2##(1992-3#1)(1997-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)
seek advice##2##2##(2008-3#1)(2012-3#1)
seek health care##2##3##(2012-12#2)
seek information about##2##3##(1995-3#1)(2008-11#1)
seek information##3##2##(1995-3#1)(2007-12#1)(2008-11#1)
seek medical advice##3##3##(2007-2#1)(2011-2#2)
seek medical attention##3##3##(2009-5#1)(2012-12#2)
seek medical##6##2##(2007-2#1)(2009-5#1)(2011-2#2)(2012-12#2)
seek out##4##2##(1992-6#1)(1996-3#1)(2008-10#1)(2008-7#1)
seek to establish##2##3##(1997-2#1)(2010-4#1)
seek to identify the##2##4##(2008-8#1)(2013-1#1)
seek to improve the##3##4##(1996-12#1)(2008-3#1)(2013-1#1)
seek to improve##4##3##(1996-12#1)(1997-2#1)(2008-3#1)(2013-1#1)
seek to##22##2##(1991-6#1)(1991-7#1)(1993-2#1)(1994-2#1)(1996-12#1)(1997-2#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#4)(2013-8#1)
seek treatment at##2##3##(2008-3#1)(2011-1#1)
seek treatment##5##2##(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
seek ways to##2##3##(1993-1#1)(1996-12#1)
seek##90##1##(1990-12#1)(1990-6#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#3)(1995-3#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-5#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
seeking a##2##2##(1991-5#1)(2008-2#1)
seeking behavior##4##2##(2009-11#1)(2009-9#1)(2011-1#2)
seeking behaviors##2##2##(2008-4#2)
seeking dental##2##2##(2008-5#1)(2011-1#1)
seeking for##3##2##(2008-1#2)(2011-1#1)
seeking health care##2##3##(1993-3#1)(2008-7#1)
seeking information##2##2##(2009-2#1)(2010-6#1)
seeking medical care##3##3##(2011-2#1)(2012-12#2)
seeking medical##4##2##(2007-11#1)(2011-2#1)(2012-12#2)
seeking out##2##2##(2008-9#1)(2010-8#1)
seeking reflects##2##2##(2007-8#2)
seeking the##2##2##(2007-12#1)(2008-4#1)
seeking to apply##2##3##(2008-4#1)(2013-8#1)
seeking to promote##3##3##(2011-2#1)(2013-1#2)
seeking to provide##2##3##(2010-10#1)(2011-2#1)
seeking to##21##2##(1992-3#1)(1993-11#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#2)(2013-1#2)(2013-8#1)
seeking treatment at##2##3##(2011-1#1)(2012-12#1)
seeking treatment for##3##3##(2008-3#1)(2009-9#1)(2011-2#1)
seeking treatment##9##2##(2008-1#1)(2008-12#1)(2008-3#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#2)
seeking##117##1##(1990-10#1)(1991-5#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#3)(1994-2#4)(1994-3#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-8#4)(2008-1#5)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#5)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#8)(2011-2#5)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
seeks medical##2##2##(2006-10#1)(2008-1#1)
seeks to expand##2##3##(1995-12#1)(2008-11#1)
seeks to foster##2##3##(2008-11#1)(2008-6#1)
seeks to identify##2##3##(2007-10#1)(2008-11#1)
seeks to##33##2##(1990-4#1)(1991-3#1)(1992-11#2)(1992-5#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2013-8#2)
seeks##44##1##(1990-4#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-5#1)(1993-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-3#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#2)(2010-12#1)(2010-3#1)(2013-8#2)
seem more##2##2##(2008-11#1)(2010-5#1)
seem not##2##2##(1990-5#1)(1990-8#1)
seem particularly##2##2##(2008-11#1)(2008-7#1)
seem promising##2##2##(1991-9#1)(2008-7#1)
seem to affect the##3##4##(1990-2#1)(2008-5#1)(2013-1#1)
seem to affect##4##3##(1990-2#1)(2008-11#1)(2008-5#1)(2013-1#1)
seem to be a##8##4##(1994-1#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-2#1)(2008-11#1)(2011-2#2)
seem to be an##2##4##(1995-12#1)(2008-5#1)
seem to be associated##2##4##(1997-5#1)(2013-1#1)
seem to be beneficial##2##4##(1995-2#1)(2008-5#1)
seem to be free##2##4##(1993-12#1)(2008-10#1)
seem to be important factors##2##5##(2008-10#1)(2008-11#1)
seem to be important##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
seem to be in##2##4##(1994-6#1)(2008-12#1)
seem to be involved in the##2##6##(1995-12#1)(2008-6#1)
seem to be involved in##4##5##(1995-12#1)(1996-12#1)(2008-11#1)(2008-6#1)
seem to be less##2##4##(2008-11#1)(2012-12#1)
seem to be more##4##4##(1990-2#2)(1990-3#1)(2008-5#1)
seem to be related##3##4##(1991-6#1)(1993-8#1)(2008-7#1)
seem to be the most important##2##6##(1994-12#1)(2013-1#1)
seem to be the most##3##5##(1994-12#1)(2012-3#1)(2013-1#1)
seem to be the##6##4##(1994-12#1)(2007-8#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
seem to be useful##2##4##(1992-2#1)(2012-2#1)
seem to be##98##3##(1990-10#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2009-10#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#6)
seem to cause##2##3##(1992-10#1)(2008-8#1)
seem to confirm the##2##4##(1992-6#1)(2013-1#1)
seem to confirm##3##3##(1992-6#1)(2010-12#1)(2013-1#1)
seem to enhance##2##3##(2011-2#1)(2012-3#1)
seem to have a##5##4##(1990-8#1)(1996-9#1)(2008-12#1)(2008-5#1)(2009-6#1)
seem to have been##2##4##(2007-7#1)(2008-10#1)
seem to have##19##3##(1990-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2009-3#1)(2009-6#1)
seem to indicate that##2##4##(1997-8#1)(2008-2#1)
seem to indicate the##2##4##(2008-12#2)
seem to indicate##5##3##(1997-8#1)(2008-12#2)(2008-2#1)(2008-7#1)
seem to influence##2##3##(2008-12#1)(2008-5#1)
seem to interact directly with the basal transcription##2##8##(1995-6#2)
seem to interact##3##3##(1995-6#2)(2008-10#1)
seem to offer##3##3##(1991-2#1)(1996-6#1)(2009-3#1)
seem to play##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
seem to possess##2##3##(1990-5#1)(1995-1#1)
seem to provide##2##3##(1991-2#1)(2007-7#1)
seem to represent##2##3##(2008-5#1)(2009-4#1)
seem to show##2##3##(2007-11#1)(2008-10#1)
seem to suggest that##6##4##(1993-3#1)(1995-12#1)(1997-3#1)(2009-7#2)(2012-12#1)
seem to suggest##7##3##(1993-3#1)(1995-12#1)(1997-3#1)(2009-7#2)(2010-12#1)(2012-12#1)
seem to take place##2##4##(2008-7#2)
seem to##209##2##(1990-10#1)(1990-2#5)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-2#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#6)(2012-4#1)(2012-5#1)(2013-1#9)
seem useful##2##2##(2008-10#2)
seem##254##1##(1990-10#1)(1990-2#5)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#4)(1990-9#2)(1991-11#1)(1991-2#3)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-5#3)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#6)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#16)(2008-12#7)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#15)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#7)(2012-4#1)(2012-5#1)(2013-1#9)
seemed not##2##2##(2008-9#1)(2011-2#1)
seemed that##2##2##(2008-8#2)
seemed the##2##2##(2009-7#1)(2011-2#1)
seemed to adapt##2##3##(1997-2#2)
seemed to be a##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
seemed to be associated##2##4##(1992-11#1)(1993-12#1)
seemed to be different from##2##5##(2008-10#1)(2008-11#1)
seemed to be more##3##4##(1996-3#1)(2008-10#2)
seemed to be related to##3##5##(1995-12#1)(2008-9#1)(2011-1#1)
seemed to be the main##2##5##(2008-11#1)(2011-1#1)
seemed to be the##8##4##(1997-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#2)
seemed to be##51##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-5#3)(1996-3#1)(1996-9#2)(1997-4#1)(2007-10#1)(2008-10#9)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-7#1)(2010-8#2)(2011-1#5)(2012-2#2)
seemed to have no##2##4##(1991-2#1)(2007-10#1)
seemed to have##10##3##(1991-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
seemed to increase##2##3##(1992-6#1)(1996-6#1)
seemed to induce##3##3##(2008-10#2)(2011-2#1)
seemed to result in##2##4##(1994-11#1)(2008-10#1)
seemed to##88##2##(1990-3#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#16)(2008-11#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#2)(2009-7#2)(2010-10#1)(2010-8#4)(2011-1#6)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
seemed##107##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-2#2)(1991-8#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#18)(2008-11#8)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-2#2)(2009-7#3)(2010-10#1)(2010-8#4)(2011-1#7)(2011-2#7)(2012-2#2)(2013-1#2)(2013-8#1)
seemingly benign##2##2##(2012-12#2)
seemingly contradictory findings##2##3##(1993-3#1)(2008-11#1)
seemingly minor##2##2##(1992-9#1)(2012-12#1)
seemingly normal##2##2##(2008-7#1)(2009-3#1)
seemingly unrelated##4##2##(1991-2#1)(1997-8#1)(2011-2#1)(2012-2#1)
seemingly##36##1##(1990-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#4)(2009-3#2)(2009-6#1)(2010-3#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)
seems a##6##2##(2008-1#1)(2008-10#3)(2008-12#1)(2013-8#1)
seems also to be##2##4##(1991-12#1)(1993-11#1)
seems an##4##2##(1991-3#1)(2008-10#1)(2008-9#1)(2011-2#1)
seems appropriate##2##2##(2008-10#2)
seems at##2##2##(2010-7#1)(2012-3#1)
seems highly##2##2##(2008-10#1)(2009-10#1)
seems likely that##6##3##(1990-11#1)(1992-6#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-3#1)
seems likely##9##2##(1990-11#1)(1992-6#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)
seems logical to##2##3##(1994-6#1)(2008-9#1)
seems lower than##2##3##(1991-2#1)(1996-4#1)
seems more##3##2##(1995-5#1)(2008-10#1)(2009-4#1)
seems not to be##2##4##(1996-2#1)(1997-1#1)
seems not to##7##3##(1994-8#1)(1996-2#1)(1997-1#1)(2008-5#3)(2008-8#1)
seems possible##7##2##(1990-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
seems promising##2##2##(1990-8#1)(1992-3#1)
seems reasonable to##6##3##(1990-6#1)(1990-9#1)(1993-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
seems that the##16##3##(1990-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
seems that there are##2##4##(2008-2#1)(2012-3#1)
seems that there##4##3##(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
seems that##52##2##(1990-12#3)(1991-11#1)(1993-12#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
seems the##2##2##(2006-6#1)(2008-3#1)
seems therefore##3##2##(1991-12#1)(1995-11#1)(2009-8#1)
seems to act##2##3##(2008-10#1)(2012-2#1)
seems to be a good##3##5##(2008-3#1)(2009-8#1)(2013-7#1)
seems to be a sensitive##2##5##(2008-7#1)(2012-3#1)
seems to be a slow process##2##6##(1992-3#1)(2008-1#1)
seems to be a##31##4##(1991-3#1)(1992-3#1)(1993-3#1)(1994-11#2)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
seems to be an appropriate##2##5##(2007-10#1)(2008-9#1)
seems to be an effective##2##5##(2008-12#1)(2008-7#1)
seems to be an important##3##5##(1993-9#1)(2007-11#1)(2008-8#1)
seems to be an##14##4##(1990-8#1)(1992-3#1)(1993-9#1)(1995-3#1)(2007-10#1)(2007-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
seems to be applicable##2##4##(2008-1#1)(2008-7#1)
seems to be associated with a##2##6##(2008-7#1)(2013-1#1)
seems to be common##2##4##(2008-1#1)(2012-3#1)
seems to be due to the##2##6##(2008-10#1)(2008-11#1)
seems to be effective##2##4##(1997-6#1)(2008-7#1)
seems to be higher than##2##5##(1993-8#2)
seems to be less##2##4##(1993-12#1)(2007-10#1)
seems to be more##5##4##(1991-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
seems to be most##2##4##(2008-10#1)(2009-11#1)
seems to be of##3##4##(1991-12#1)(1995-11#1)(2008-10#1)
seems to be related to a##2##6##(1994-8#1)(2010-12#1)
seems to be related to the##3##6##(1995-3#1)(2006-6#1)(2008-6#1)
seems to be related to##7##5##(1994-8#1)(1995-3#1)(2006-6#1)(2008-6#3)(2010-12#1)
seems to be related##9##4##(1994-8#1)(1995-11#1)(1995-3#1)(2006-6#1)(2008-5#1)(2008-6#3)(2010-12#1)
seems to be responsible for the##2##6##(1993-8#1)(2007-10#1)
seems to be responsible for##3##5##(1993-6#1)(1993-8#1)(2007-10#1)
seems to be safe and##2##5##(2008-1#1)(2013-1#1)
seems to be superior##2##4##(2008-10#1)(2011-2#1)
seems to be supported by results##2##6##(1991-11#1)(1992-3#1)
seems to be supported by##3##5##(1991-11#1)(1992-3#1)(1993-3#1)
seems to be that##3##4##(1994-6#1)(2008-5#1)(2011-2#1)
seems to be the best##2##5##(2008-10#2)
seems to be the main##2##5##(2007-8#1)(2008-7#1)
seems to be the most##4##5##(1997-6#1)(2008-10#2)(2013-8#1)
seems to be the##16##4##(1990-6#1)(1991-12#1)(1997-6#1)(2007-11#3)(2007-8#1)(2008-10#5)(2008-7#1)(2009-8#1)(2010-10#1)(2013-8#1)
seems to be useful##2##4##(1995-6#1)(2008-10#1)
seems to be very##4##4##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
seems to be##194##3##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#4)(1991-3#1)(1991-4#1)(1992-3#5)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#3)(1995-3#2)(1995-4#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-8#4)(2008-1#6)(2008-10#18)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
seems to depend on##3##4##(1992-5#1)(2008-7#1)(2008-8#1)
seems to depend##5##3##(1992-5#1)(1992-6#1)(2007-10#1)(2008-7#1)(2008-8#1)
seems to exist##2##3##(1995-12#1)(2008-1#1)
seems to give##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
seems to have been##3##4##(1990-9#1)(2008-10#1)(2008-7#1)
seems to have more##2##4##(2008-10#1)(2009-11#1)
seems to have the##2##4##(1996-2#1)(1997-8#1)
seems to have##21##3##(1990-9#1)(1991-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-11#1)(2012-12#1)(2013-1#2)
seems to improve##2##3##(2008-10#1)(2011-2#1)
seems to indicate that##2##4##(2008-10#1)(2010-12#1)
seems to indicate##3##3##(1993-3#1)(2008-10#1)(2010-12#1)
seems to interact with##2##4##(1993-11#1)(1995-6#1)
seems to involve##3##3##(1991-1#1)(1994-11#1)(2009-2#1)
seems to modulate##2##3##(2009-8#1)(2012-3#1)
seems to play a##2##4##(2008-1#1)(2008-11#1)
seems to play an##2##4##(1991-12#1)(2009-2#1)
seems to play##5##3##(1991-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-2#1)
seems to prevent##2##3##(2008-7#1)(2013-1#1)
seems to produce##2##3##(1991-1#1)(1992-10#1)
seems to provide##2##3##(2008-10#1)(2008-4#1)
seems to reduce the##2##4##(1992-12#1)(1996-3#1)
seems to reduce##4##3##(1992-12#1)(1992-5#1)(1996-3#1)(2010-4#1)
seems to yield##2##3##(1991-3#1)(1992-10#1)
seems to##301##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#4)(1991-12#5)(1991-3#2)(1991-4#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#5)(1992-5#4)(1992-6#2)(1993-11#2)(1993-12#3)(1993-3#4)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#5)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#8)(2008-10#33)(2008-11#13)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#6)(2008-7#17)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#6)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#2)
seems unlikely##2##2##(1990-11#1)(2008-10#1)
seems very##2##2##(1992-6#1)(1997-9#1)
seems##464##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#5)(1991-12#8)(1991-2#1)(1991-3#4)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#6)(1992-5#4)(1992-6#5)(1993-11#4)(1993-12#4)(1993-3#5)(1993-6#4)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#6)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#1)(2006-6#2)(2007-10#4)(2007-11#7)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#6)(2008-1#12)(2008-10#51)(2008-11#17)(2008-12#9)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#20)(2008-6#9)(2008-7#24)(2008-8#12)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#18)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#8)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#3)
seen a##5##2##(1992-8#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
seen after##16##2##(1991-8#1)(1992-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
seen among##4##2##(1997-3#1)(2008-3#1)(2009-5#1)(2013-1#1)
seen an##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
seen and##4##2##(1990-9#1)(1997-6#1)(2007-5#1)(2008-8#1)
seen as a##20##3##(1992-11#1)(1992-3#1)(1993-12#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#4)(2013-1#1)(2013-8#1)
seen as an opportunity to##2##5##(2008-10#1)(2008-12#1)
seen as an##7##3##(1990-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2012-12#2)
seen as being##2##3##(1992-3#1)(1996-9#1)
seen as part of##2##4##(2008-12#1)(2010-11#1)
seen as the##6##3##(1994-1#1)(1996-2#1)(2008-11#2)(2008-8#1)(2013-1#1)
seen as##52##2##(1990-12#1)(1992-11#1)(1992-3#2)(1993-12#1)(1994-1#1)(1995-1#1)(1996-2#1)(1996-9#2)(1997-5#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
seen at a##3##3##(1991-11#1)(1994-3#1)(2008-6#1)
seen at our##3##3##(1994-7#1)(1997-4#1)(2007-10#1)
seen at the##6##3##(1990-5#1)(1996-5#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
seen at##26##2##(1990-5#3)(1991-11#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1996-5#1)(1997-4#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)
seen before##2##2##(1991-6#1)(2008-5#1)
seen between January##2##3##(2008-8#1)(2012-3#1)
seen between the##2##3##(1997-6#1)(2012-2#1)
seen between##11##2##(1997-6#2)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
seen by a neurologist##2##4##(2010-12#2)
seen by a##3##3##(2010-12#2)(2012-12#1)
seen by the##8##3##(1993-12#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)
seen by##23##2##(1990-7#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-8#1)(2012-12#1)(2013-1#1)
seen disorder##2##2##(2007-11#1)(2010-1#1)
seen due to##2##3##(1991-3#1)(2008-3#1)
seen during the##5##3##(1990-12#1)(1990-5#1)(1994-6#1)(2007-7#1)(2012-3#1)
seen during##15##2##(1990-12#1)(1990-5#1)(1992-12#2)(1992-6#2)(1994-6#1)(1997-4#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
seen following##5##2##(1991-3#1)(1993-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
seen for##16##2##(1991-12#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-1#1)
seen frequently##2##2##(2008-2#1)(2008-5#1)
seen from the##3##3##(1992-11#1)(1997-6#1)(2008-10#1)
seen from##7##2##(1990-8#1)(1992-11#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
seen in 1##2##3##(2006-10#1)(2008-10#1)
seen in 100%##3##3##(1991-2#1)(2012-3#1)(2013-1#1)
seen in 2006##2##3##(2010-5#1)(2012-3#1)
seen in 7##2##3##(1997-8#1)(2007-7#1)
seen in 8##2##3##(2007-10#1)(2007-7#1)
seen in a##7##3##(1991-11#1)(1994-5#1)(2007-2#1)(2007-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
seen in all##9##3##(2008-10#2)(2008-5#2)(2008-6#2)(2009-8#1)(2010-1#1)(2011-2#1)
seen in any of the##2##5##(2007-7#1)(2008-5#1)
seen in both##6##3##(1996-12#2)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
seen in cells##3##3##(1994-8#1)(1995-8#1)(2010-11#1)
seen in children with##3##4##(2007-7#1)(2011-1#2)
seen in children##6##3##(1996-3#1)(2007-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
seen in clinical##2##3##(2008-12#1)(2012-12#1)
seen in diabetic##3##3##(1994-12#1)(2008-9#1)(2012-3#1)
seen in general##3##3##(2007-7#1)(2010-4#2)
seen in male or female Tg##3##6##(2008-9#3)
seen in male##7##3##(1992-11#1)(1996-11#1)(2008-9#4)(2012-3#1)
seen in many##2##3##(2008-12#1)(2008-7#1)
seen in most##2##3##(1996-5#1)(2008-10#1)
seen in other##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
seen in our patients##2##4##(2008-1#2)
seen in our##6##3##(1991-11#1)(2007-7#1)(2008-1#2)(2013-1#1)(2013-7#1)
seen in patients with##10##4##(1991-3#1)(1992-5#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-1#1)(2012-3#1)
seen in patients##13##3##(1990-3#1)(1991-11#1)(1991-3#1)(1992-5#1)(1995-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-1#1)(2012-3#1)
seen in previously reported models##2##5##(1994-5#2)
seen in rat##2##3##(1993-3#1)(1995-11#1)
seen in rats##4##3##(1995-11#1)(1996-1#1)(2008-9#1)(2011-2#1)
seen in response to##2##4##(1997-1#1)(2008-11#1)
seen in the field##3##4##(2007-8#1)(2008-10#1)(2008-8#1)
seen in the first##3##4##(1996-9#1)(2008-1#1)(2008-8#1)
seen in the frontal##2##4##(1996-12#1)(2008-7#1)
seen in the incidence##2##4##(1994-12#1)(2008-7#1)
seen in the##83##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-5#1)(1995-8#2)(1996-12#6)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#8)(2008-8#4)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#4)(2013-8#1)
seen in their##2##3##(1991-12#1)(2008-7#1)
seen in these patients##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
seen in these##5##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
seen in this##4##3##(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
seen in vitro##2##3##(1992-3#1)(1997-4#1)
seen in##395##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#7)(1994-7#1)(1994-8#7)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#2)(1996-5#6)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#5)(2006-12#1)(2007-10#5)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#17)(2007-8#6)(2008-1#14)(2008-10#30)(2008-11#9)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#18)(2008-6#4)(2008-7#18)(2008-8#9)(2008-9#9)(2009-1#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#15)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#13)(2012-8#1)(2013-1#8)(2013-7#3)(2013-8#3)
seen many##2##2##(2008-1#1)(2013-8#1)
seen more commonly##2##3##(2008-8#1)(2012-12#1)
seen more##8##2##(1991-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
seen much##2##2##(2008-11#2)
seen on follow-up MR##2##4##(1996-6#2)
seen on follow-up##3##3##(1996-6#2)(2006-12#1)
seen on the##9##3##(1991-6#1)(1991-9#1)(1992-12#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-2#2)
seen on ultrasound##2##3##(2012-2#2)
seen on##29##2##(1991-6#1)(1991-9#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#3)
seen only##2##2##(1994-11#1)(1996-1#1)
seen over a period of##2##5##(1997-8#1)(2008-1#1)
seen over a##3##3##(1997-8#1)(2007-7#1)(2008-1#1)
seen over##4##2##(1997-8#1)(2007-7#1)(2008-1#1)(2011-1#1)
seen spontaneously##2##2##(2008-7#2)
seen that the##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
seen that##16##2##(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
seen the##6##2##(1993-6#1)(1995-12#1)(2008-11#1)(2008-9#2)(2009-5#1)
seen through##2##2##(2009-4#1)(2011-2#1)
seen throughout the##2##3##(1993-12#1)(1997-3#1)
seen to be a##3##4##(1992-1#1)(2008-10#1)(2012-2#1)
seen to be##12##3##(1992-1#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-2#1)
seen to have a##2##4##(2008-12#1)(2008-5#1)
seen to have##5##3##(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-3#1)
seen to increase##2##3##(2008-10#1)(2011-2#1)
seen to##31##2##(1990-11#2)(1991-12#1)(1992-1#1)(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
seen up to##2##3##(2008-1#1)(2008-7#1)
seen upon##4##2##(1991-5#1)(1995-12#1)(2008-10#1)(2009-10#1)
seen using conventional##2##3##(1995-5#1)(2008-9#1)
seen using##3##2##(1992-9#1)(1995-5#1)(2008-9#1)
seen was##2##2##(2007-7#1)(2013-1#1)
seen were##2##2##(2008-5#1)(2010-12#1)
seen when a##2##3##(1992-6#1)(2007-12#1)
seen when##6##2##(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-3#1)
seen with any of the##2##5##(1990-5#1)(1994-11#1)
seen with light##2##3##(2008-10#1)(2008-5#1)
seen with other##2##3##(1997-3#1)(2013-8#1)
seen with the##10##3##(1990-7#1)(1995-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)
seen with three##2##3##(1990-3#1)(1997-3#1)
seen with##63##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
seen within the##5##3##(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
seen within##8##2##(1993-2#1)(1995-3#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2009-11#1)(2013-1#1)
seen##931##1##(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#3)(1990-5#6)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#13)(1991-2#3)(1991-3#4)(1991-5#2)(1991-6#4)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#9)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#8)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#6)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#9)(1994-6#3)(1994-7#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-11#7)(1995-12#12)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#5)(1996-1#3)(1996-11#4)(1996-12#12)(1996-2#6)(1996-3#5)(1996-4#1)(1996-5#9)(1996-6#7)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#16)(1997-4#4)(1997-5#2)(1997-6#9)(1997-7#3)(1997-8#8)(2006-10#8)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#9)(2007-11#4)(2007-12#9)(2007-2#2)(2007-4#2)(2007-5#3)(2007-7#26)(2007-8#12)(2008-1#21)(2008-10#76)(2008-11#40)(2008-12#22)(2008-2#16)(2008-3#26)(2008-4#10)(2008-5#36)(2008-6#8)(2008-7#45)(2008-8#22)(2008-9#19)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#6)(2010-3#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#16)(2011-2#37)(2012-1#6)(2012-12#12)(2012-2#19)(2012-3#20)(2012-8#1)(2013-1#22)(2013-7#3)(2013-8#13)
seepage##2##1##(1996-12#1)(2010-6#1)
sees##10##1##(1993-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)
segment 61-69##2##2##(1992-4#2)
segment Cobb angle decreased in##2##5##(2007-8#2)
segment ST##4##2##(2008-10#4)
segment adjacent to the##2##4##(2008-10#1)(2009-10#1)
segment and##10##2##(1994-3#1)(1996-4#1)(1996-6#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
segment are##2##2##(1993-8#1)(1995-3#1)
segment between##3##2##(1992-4#1)(1997-4#1)(2008-4#1)
segment by##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
segment disease (ASD)##3##3##(2012-12#1)(2012-3#2)
segment disease##6##2##(2012-12#3)(2012-3#3)
segment elevation##9##2##(2008-12#1)(2008-3#6)(2011-2#1)(2012-3#1)
segment from the##3##3##(1996-6#1)(1997-3#1)(2008-10#1)
segment from##4##2##(1995-9#1)(1996-6#1)(1997-3#1)(2008-10#1)
segment in the##3##3##(1995-6#1)(1996-8#1)(2007-12#1)
segment in##8##2##(1995-6#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-10#1)
segment is##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
segment length##3##2##(1991-8#1)(2008-2#1)(2012-2#1)
segment of an##4##3##(2008-6#2)(2008-9#2)
segment of the eye##4##4##(2009-3#1)(2010-1#1)(2011-7#2)
segment of the left##3##4##(1991-3#1)(2008-4#1)(2013-8#1)
segment of the population##4##4##(1992-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
segment of the right##2##4##(2006-6#1)(2008-12#1)
segment of the##37##3##(1990-11#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-1#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-6#1)(2006-6#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-9#2)(2009-3#1)(2009-8#2)(2010-1#1)(2011-7#3)(2012-12#1)(2012-3#3)(2013-8#3)
segment of this##2##3##(1990-12#1)(1991-12#1)
segment of##69##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-6#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2011-7#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#5)
segment on the##2##3##(1997-3#1)(2008-3#1)
segment on##3##2##(1997-3#1)(2008-3#1)(2009-10#1)
segment phase error##2##3##(2008-3#2)
segment polarity gene hedgehog##3##4##(1993-12#2)(1994-12#1)
segment polarity gene##6##3##(1993-12#3)(1994-12#1)(2007-12#2)
segment substitution##2##2##(2008-10#1)(2009-10#1)
segment the##2##2##(2008-3#2)
segment to##3##2##(2007-12#1)(2008-10#2)
segment was long and##2##4##(2007-12#2)
segment was##11##2##(1997-2#1)(2006-8#1)(2007-12#2)(2008-3#2)(2008-8#1)(2009-10#2)(2011-2#1)(2012-3#1)
segment were##3##2##(2008-5#1)(2008-6#1)(2011-1#1)
segment which##2##2##(2007-12#1)(2008-9#1)
segment with##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
segment##321##1##(1990-11#4)(1990-12#3)(1990-3#1)(1990-5#3)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#7)(1994-3#3)(1995-1#2)(1995-11#2)(1995-12#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#17)(2007-8#4)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#20)(2008-4#5)(2008-5#11)(2008-6#10)(2008-7#13)(2008-8#5)(2008-9#5)(2009-10#9)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#16)(2011-7#4)(2012-12#7)(2012-2#6)(2012-3#17)(2013-1#4)(2013-8#12)
segment-polarity gene##2##2##(1993-2#2)
segmental bone defects##2##3##(2008-5#2)
segmental bone##3##2##(2008-5#3)
segmental changes##2##2##(2009-7#1)(2011-2#1)
segmental duplication##3##2##(2009-10#2)(2012-3#1)
segmental glomerulosclerosis (FSGS)##5##3##(2007-7#1)(2008-1#3)(2012-2#1)
segmental glomerulosclerosis##16##2##(2007-7#5)(2007-8#1)(2008-1#9)(2012-2#1)
segmental identity##2##2##(1995-11#1)(2012-2#1)
segmental motion##3##2##(1995-5#1)(2012-12#2)
segmental relaxation##3##2##(2008-10#3)
segmental resection##3##2##(1990-2#1)(1993-12#1)(2007-11#1)
segmental trisomies##2##2##(2008-7#2)
segmental trisomy##2##2##(1997-2#1)(2008-7#1)
segmental##88##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#9)(2007-7#6)(2007-8#2)(2008-1#11)(2008-10#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2009-10#4)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#1)
segmentation algorithms##3##2##(1995-5#1)(2008-6#1)(2010-9#1)
segmentation and##11##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#3)(2009-10#2)(2010-8#1)(2011-7#2)
segmentation in##3##2##(2007-12#1)(2008-6#1)(2012-3#1)
segmentation method##4##2##(2008-2#1)(2010-4#2)(2010-8#1)
segmentation of beef longissimus dorsi##2##5##(2010-4#2)
segmentation of conidia and hyphae##2##5##(2008-3#2)
segmentation of##18##2##(2007-12#3)(2008-10#1)(2008-3#4)(2008-7#2)(2009-12#1)(2010-4#2)(2010-8#3)(2011-7#1)(2012-1#1)
segmentation with a##2##3##(2007-11#1)(2008-3#1)
segmentation with##3##2##(2007-11#1)(2008-3#1)(2009-11#1)
segmentation##85##1##(1991-8#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-2#1)(1997-1#3)(1997-3#1)(2007-11#5)(2007-12#5)(2008-10#3)(2008-2#3)(2008-3#7)(2008-6#16)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#6)(2009-11#1)(2009-12#1)(2010-4#4)(2010-8#8)(2010-9#3)(2011-7#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
segmentations##2##1##(2008-2#1)(2010-8#1)
segmentectomy##2##1##(2010-8#2)
segmented assimilation##2##2##(2009-7#2)
segmented by##2##2##(1991-8#1)(2008-10#1)
segmented flow analysis (SFA)##4##4##(2008-10#4)
segmented flow analysis##7##3##(2008-10#6)(2009-6#1)
segmented flow##10##2##(2008-10#9)(2009-6#1)
segmented into##5##2##(2008-2#1)(2008-3#2)(2008-5#1)(2012-1#1)
segmented mirror##3##2##(2008-3#3)
segmented mirrors##2##2##(2008-2#1)(2008-3#1)
segmented primary mirror##2##3##(2008-3#2)
segmented primary##3##2##(2008-3#3)
segmented using##2##2##(2008-2#1)(2011-2#1)
segmented waveguide##2##2##(2008-2#1)(2008-3#1)
segmented waveguides##5##2##(2008-2#4)(2008-3#1)
segmented##56##1##(1991-8#1)(2007-11#2)(2008-10#11)(2008-2#12)(2008-3#17)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-6#1)(2009-7#2)(2011-2#2)(2012-1#1)(2013-1#1)
segmenting##2##1##(2009-10#1)(2012-3#1)
segments (approximately##3##2##(2008-10#3)
segments and a##2##3##(1991-6#1)(2010-9#1)
segments and##21##2##(1991-5#1)(1991-6#2)(1991-8#1)(1992-5#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
segments are##5##2##(1991-5#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
segments between##2##2##(1997-8#1)(2008-4#1)
segments containing##2##2##(1995-5#1)(2013-7#1)
segments for##2##2##(1992-6#1)(2008-3#1)
segments from the##2##3##(2008-5#2)
segments from##10##2##(1991-2#1)(1994-12#1)(1994-5#1)(2008-10#4)(2008-5#2)(2010-4#1)
segments in the##2##3##(2008-12#1)(2013-7#1)
segments in##6##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2013-7#1)
segments including the##2##3##(1997-2#1)(2008-5#1)
segments including##3##2##(1997-2#1)(2008-5#1)(2013-8#1)
segments incubated in continuous##2##4##(2008-10#2)
segments incubated in##3##3##(2008-10#3)
segments incubated##4##2##(2008-10#4)
segments into##3##2##(1997-7#1)(2008-7#2)
segments is##2##2##(1991-8#1)(1997-2#1)
segments led to##2##3##(1991-9#1)(2008-5#1)
segments located at##2##3##(2008-5#1)(2008-8#1)
segments may##2##2##(1991-10#1)(2007-12#1)
segments of DNA##4##3##(1993-9#1)(2008-11#1)(2008-2#1)(2008-9#1)
segments of each##2##3##(2007-12#1)(2012-2#1)
segments of the##21##3##(1991-12#1)(1995-12#2)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)
segments of##59##2##(1990-5#1)(1991-12#2)(1993-9#1)(1994-10#1)(1994-12#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-12#2)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
segments on the##2##3##(2008-3#1)(2008-8#1)
segments reduced##2##2##(2008-5#2)
segments so that##2##3##(1991-8#1)(1993-12#1)
segments that##5##2##(1993-12#1)(1997-1#1)(2008-4#1)(2008-9#1)(2009-10#1)
segments to##3##2##(1991-8#1)(2007-12#1)(2010-10#1)
segments using##2##2##(1995-5#1)(2008-1#1)
segments was##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
segments were##10##2##(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
segments which##2##2##(1993-12#1)(2010-8#1)
segments with##8##2##(1992-2#1)(1995-2#1)(1997-6#1)(1997-8#1)(2009-11#2)(2009-5#1)(2011-2#1)
segments##274##1##(1990-12#2)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#2)(1991-8#7)(1991-9#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#5)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#4)(1997-9#2)(2006-8#1)(2007-11#1)(2007-12#13)(2007-8#4)(2008-1#1)(2008-10#51)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#16)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#5)(2009-11#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#4)(2013-3#1)(2013-7#2)(2013-8#1)
segments) was##2##2##(1990-7#1)(2008-2#1)
segments)##4##1##(1990-7#1)(1996-2#2)(2008-2#1)
segregant analysis (BSA)##2##3##(2008-10#1)(2008-9#1)
segregant analysis using##3##3##(2008-10#3)
segregant analysis##19##2##(1995-6#2)(2008-10#13)(2008-5#3)(2008-9#1)
segregant##20##1##(1995-6#3)(2008-10#13)(2008-5#3)(2008-9#1)
segregate Prospero##2##2##(2008-7#2)
segregate##10##1##(2008-10#5)(2008-5#1)(2008-7#2)(2009-5#1)(2012-12#1)
segregated 1##2##2##(2008-10#2)
segregated as##2##2##(2008-10#1)(2008-5#1)
segregated for##7##2##(2008-10#5)(2012-3#2)
segregated in Mendelian##2##3##(2008-10#2)
segregated in a 1##4##4##(2008-10#4)
segregated in a##8##3##(2008-10#7)(2008-8#1)
segregated in##12##2##(2008-10#11)(2008-8#1)
segregated into##5##2##(1994-5#1)(1995-11#1)(2008-10#1)(2008-8#2)
segregated##43##1##(1990-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#25)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#2)(2011-2#4)(2012-3#2)
segregates independently of##3##3##(2008-10#2)(2008-12#1)
segregates##6##1##(1993-2#1)(1995-2#1)(2008-10#2)(2008-12#1)(2009-10#1)
segregating F(2)##2##2##(2008-10#2)
segregating for the##2##3##(2008-10#2)
segregating for##6##2##(2008-10#5)(2010-10#1)
segregating in the##2##3##(2008-10#2)
segregating in##3##2##(2008-10#3)
segregating with the##2##3##(2007-7#1)(2011-1#1)
segregating with##4##2##(1997-7#1)(2007-7#1)(2008-9#1)(2011-1#1)
segregating##36##1##(1991-3#1)(1997-5#2)(1997-7#1)(2007-7#1)(2008-10#24)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-3#3)
segregation analysis##5##2##(2008-10#4)(2008-11#1)
segregation and##4##2##(1996-12#1)(2008-9#1)(2009-8#1)(2013-1#1)
segregation by##2##2##(2008-10#1)(2009-5#1)
segregation distortion##2##2##(2008-10#2)
segregation for##6##2##(2008-10#6)
segregation in##9##2##(2008-10#4)(2008-11#3)(2008-12#2)
segregation of a single##2##4##(2008-10#2)
segregation of a##3##3##(2008-10#2)(2008-4#1)
segregation of the##6##3##(1995-8#1)(2008-10#1)(2008-5#1)(2008-9#3)
segregation of##32##2##(1995-8#1)(2007-8#1)(2008-10#15)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#3)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
segregation was##2##2##(2008-10#1)(2008-5#1)
segregation##89##1##(1995-8#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#40)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#2)(2009-8#2)(2010-10#1)(2010-3#1)(2010-8#2)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
seine##2##1##(2008-5#1)(2013-7#1)
seismic hazard reduction##2##3##(1996-4#2)
seismic source##2##2##(1996-4#1)(2012-2#1)
seismic##14##1##(1990-11#1)(1995-3#2)(1996-4#7)(2012-2#4)
seismicity becomes##2##2##(1996-4#2)
seismicity is##3##2##(1996-4#3)
seismicity##21##1##(1996-4#21)
seize##2##1##(1994-12#1)(2007-12#1)
seized from the##2##3##(2008-10#1)(2011-1#1)
seized##7##1##(1997-2#1)(2008-10#1)(2010-5#1)(2011-1#2)(2012-2#2)
seizing##3##1##(2007-12#1)(2008-10#1)(2012-2#1)
seizure activity in##2##3##(2008-1#1)(2010-2#1)
seizure activity##5##2##(1990-5#1)(1997-3#1)(2008-1#1)(2009-11#1)(2010-2#1)
seizure attacks of P77PMC rat##2##5##(2008-8#2)
seizure control##4##2##(1997-3#2)(2008-7#2)
seizure disorder##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
seizure disorders##3##2##(1993-3#1)(1997-3#1)(2012-3#1)
seizure frequency##2##2##(2008-1#1)(2010-4#1)
seizure generation##4##2##(1990-5#1)(2009-8#3)
seizure in a##2##3##(2008-11#1)(2010-1#1)
seizure in##3##2##(2008-11#1)(2008-8#1)(2010-1#1)
seizure intensity##4##2##(1992-12#4)
seizure is presented##2##3##(2008-7#1)(2011-2#1)
seizure or##2##2##(1992-3#1)(2010-12#1)
seizure susceptibility of these animals##2##5##(1996-12#2)
seizure susceptibility##3##2##(1990-5#1)(1996-12#2)
seizure##77##1##(1990-5#7)(1992-12#4)(1992-3#1)(1993-3#2)(1994-2#3)(1995-12#1)(1995-3#1)(1996-12#5)(1997-3#7)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#4)(2008-8#3)(2009-11#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-3#1)(2013-1#1)(2013-8#2)
seizure-induced##2##1##(1995-12#2)
seizure-naive##4##1##(1996-12#4)
seizures after##2##2##(1993-2#1)(2012-12#1)
seizures and##12##2##(1991-12#1)(1992-3#1)(1995-5#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#2)
seizures are##3##2##(1992-3#1)(2009-9#1)(2012-2#1)
seizures as##2##2##(2007-10#1)(2012-2#1)
seizures in a##2##3##(2008-10#1)(2008-11#1)
seizures in adults##2##3##(2006-12#1)(2008-7#1)
seizures in children##4##3##(1997-2#1)(2008-4#1)(2011-1#2)
seizures in the rat##2##4##(1994-2#1)(2009-9#1)
seizures in the##3##3##(1994-2#1)(2009-9#1)(2011-1#1)
seizures in##18##2##(1992-3#3)(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#3)(2012-3#1)(2013-1#1)
seizures induced by##3##3##(1991-12#1)(1995-12#2)
seizures induced##4##2##(1990-5#1)(1991-12#1)(1995-12#2)
seizures of##2##2##(2008-10#1)(2008-4#1)
seizures on##2##2##(1994-2#1)(2009-9#1)
seizures were##6##2##(1994-2#1)(1995-12#1)(1997-3#1)(2008-4#1)(2011-1#2)
seizures##139##1##(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#6)(1993-12#1)(1993-2#1)(1994-2#11)(1995-12#9)(1995-5#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#6)(2006-12#1)(2006-5#2)(2007-10#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#4)(2008-4#6)(2008-5#2)(2008-7#9)(2008-8#4)(2009-3#1)(2009-8#5)(2009-9#5)(2010-1#1)(2010-11#3)(2010-3#1)(2010-8#1)(2011-1#11)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
seje oil##2##2##(2012-2#2)
seje##3##1##(2012-2#3)
seldom been##3##2##(1991-12#1)(2008-5#1)(2008-7#1)
seldom described##2##2##(2007-6#1)(2013-1#1)
seldom performed##2##2##(1990-9#1)(1995-2#1)
seldom##35##1##(1990-11#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)
select a##12##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)
select and##3##2##(2008-9#1)(2011-3#1)(2012-2#1)
select appropriate##4##2##(1991-2#1)(2010-5#1)(2010-8#1)(2012-12#1)
select for the##2##3##(1994-5#1)(2009-3#1)
select for##13##2##(1994-12#1)(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#2)
select group of##4##3##(1995-2#1)(1995-3#1)(2009-3#1)(2013-1#1)
select patients##3##2##(2011-2#3)
select the best##6##3##(2008-10#1)(2008-3#1)(2008-5#2)(2010-8#1)(2012-3#1)
select the most appropriate##5##4##(1992-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
select the most##10##3##(1990-12#1)(1992-8#1)(1993-12#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
select the##45##2##(1990-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
select##185##1##(1990-12#2)(1991-1#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-5#1)(1995-11#1)(1995-2#5)(1995-3#4)(1995-6#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#3)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#2)
selectable marker gene##2##3##(2008-10#2)
selectable marker in##2##3##(1997-2#1)(2008-10#1)
selectable marker is##2##3##(2008-2#1)(2008-4#1)
selectable marker##17##2##(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-2#6)(2008-4#2)
selectable markers##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
selectable##24##1##(1991-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-2#7)(2008-4#2)
selected Hispanic health beliefs and practices##2##6##(2008-9#2)
selected NCDs##2##2##(2013-8#2)
selected PCBs##3##2##(2008-11#3)
selected SSR##2##2##(2008-12#1)(2008-5#1)
selected a##8##2##(1990-12#2)(1995-12#1)(1995-8#1)(1997-2#1)(1997-5#1)(2008-5#2)
selected according to the##2##4##(2008-10#1)(2013-1#1)
selected according to##8##3##(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
selected after##2##2##(2008-10#1)(2012-2#1)
selected amino##2##2##(1992-4#1)(2008-5#1)
selected among##3##2##(2008-10#2)(2009-8#1)
selected anaplerotic##2##2##(2008-7#2)
selected and an##2##3##(1994-12#1)(2008-10#1)
selected and used##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
selected and##30##2##(1992-9#1)(1994-12#2)(1996-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
selected areas of##2##3##(2008-10#1)(2012-2#1)
selected areas##4##2##(1996-6#1)(1997-3#1)(2008-10#1)(2012-2#1)
selected as a##8##3##(1990-8#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-5#1)
selected as the best##2##4##(2008-10#1)(2011-1#1)
selected as the most##2##4##(2008-10#1)(2012-2#1)
selected as the##13##3##(1996-2#1)(2008-10#6)(2008-5#1)(2011-1#3)(2011-2#1)(2012-2#1)
selected as##41##2##(1990-8#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#24)(2008-2#1)(2008-5#2)(2010-5#1)(2011-1#4)(2011-2#2)(2012-2#1)
selected at random from##3##4##(1996-12#1)(2008-10#1)(2012-3#1)
selected at random##7##3##(1990-11#1)(1992-5#1)(1994-5#1)(1996-12#1)(2008-10#2)(2012-3#1)
selected at##10##2##(1990-11#1)(1992-5#1)(1994-5#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
selected based on##6##3##(1990-5#1)(2008-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
selected based##7##2##(1990-5#1)(2007-6#1)(2008-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
selected because##2##2##(2008-10#1)(2008-3#1)
selected blood##2##2##(2008-12#2)
selected branches##2##2##(2008-10#1)(2008-5#1)
selected by a##2##3##(2008-1#1)(2008-2#1)
selected by its##2##3##(1990-8#1)(1993-3#1)
selected by the##10##3##(1995-6#1)(2007-6#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-11#1)(2013-1#2)
selected by##53##2##(1990-8#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-9#1)(2010-11#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#4)(2013-1#5)
selected candidates##2##2##(2011-2#1)(2011-3#1)
selected cases of##6##3##(1990-10#1)(1990-9#1)(1993-11#1)(1993-9#1)(1997-8#1)(2012-2#1)
selected cases##19##2##(1990-10#1)(1990-9#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-3#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-12#1)(2012-2#2)
selected chemical##2##2##(2007-11#1)(2010-4#1)
selected children##2##2##(1996-1#1)(2008-10#1)
selected chromatographic##2##2##(1996-5#1)(2010-3#1)
selected clinical and##2##3##(2008-7#1)(2012-3#1)
selected clinical##4##2##(2008-7#2)(2012-3#1)(2013-1#1)
selected common##2##2##(2008-10#1)(2012-2#1)
selected community##2##2##(2007-10#1)(2013-8#1)
selected compounds##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
selected conditions for##2##3##(2008-10#2)
selected conditions##12##2##(2008-10#12)
selected data##2##2##(2008-10#2)
selected dental##2##2##(2008-5#1)(2013-1#1)
selected differentially##2##2##(2010-8#1)(2011-3#1)
selected diseases##2##2##(1993-12#1)(2013-7#1)
selected donor##2##2##(2008-10#2)
selected drugs##2##2##(1996-5#1)(2011-2#1)
selected elements of the##2##4##(2008-10#1)(2011-1#1)
selected elements##5##2##(2008-10#4)(2011-1#1)
selected examples##5##2##(2006-4#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
selected experimental conditions##2##3##(2008-10#2)
selected findings##3##2##(1990-8#1)(1994-12#1)(2011-2#1)
selected five##2##2##(1996-12#1)(2011-2#1)
selected for a##3##3##(1990-2#1)(1992-2#1)(2012-12#1)
selected for analysis##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
selected for clinical##3##3##(1992-12#1)(1996-9#1)(2010-11#1)
selected for each##5##3##(1993-12#1)(1996-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
selected for further analysis##2##4##(2008-11#1)(2008-9#1)
selected for further study##3##4##(1995-3#1)(1997-3#1)(2008-10#1)
selected for further##7##3##(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)
selected for increased aggressiveness##2##4##(2008-10#2)
selected for increased##4##3##(2008-10#2)(2008-8#2)
selected for more##2##3##(2008-10#1)(2013-1#1)
selected for resistance to##2##4##(2008-10#2)
selected for resistance##4##3##(2008-10#4)
selected for the determination of##5##5##(2008-10#5)
selected for the study##3##4##(1990-3#1)(2010-3#1)(2013-8#1)
selected for the##28##3##(1990-10#1)(1990-3#1)(2007-11#1)(2008-10#17)(2008-3#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
selected for their##6##3##(1991-8#1)(1996-12#1)(2008-10#3)(2008-6#1)
selected for this study##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#2)
selected for this##8##3##(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#4)
selected for##124##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#48)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#1)
selected from 6##2##3##(2011-1#1)(2013-1#1)
selected from a combinatorial##2##4##(1994-8#1)(2008-9#1)
selected from a total of##2##5##(2008-7#1)(2013-8#1)
selected from a##14##3##(1992-11#1)(1993-9#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
selected from each##2##3##(2008-10#2)
selected from the database##2##4##(1995-6#1)(1997-8#1)
selected from the##15##3##(1994-5#1)(1995-6#1)(1997-8#2)(2007-2#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2011-2#1)(2013-8#1)
selected from two##3##3##(2007-11#1)(2008-10#1)(2010-3#1)
selected from##55##2##(1992-11#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#3)
selected fungal##2##2##(2008-10#1)(2010-5#1)
selected gene##2##2##(2013-8#2)
selected genes##6##2##(2008-10#2)(2008-7#2)(2010-11#1)(2010-4#1)
selected germ plasm##2##3##(2008-10#2)
selected group of patients##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
selected group of##7##3##(1990-9#1)(1994-6#1)(1996-9#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
selected group##8##2##(1990-9#1)(1994-6#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
selected hand##2##2##(2007-10#2)
selected high##2##2##(2007-4#1)(2008-1#1)
selected hospitals##3##2##(1993-1#1)(1996-3#1)(2007-12#1)
selected human##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
selected in order to avoid##2##5##(2008-10#2)
selected in order to##4##4##(2008-10#3)(2010-11#1)
selected in this study##2##4##(1997-4#1)(2007-2#1)
selected in##18##2##(1993-9#1)(1997-4#1)(2007-2#1)(2008-10#8)(2008-11#2)(2008-5#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
selected infectious##2##2##(1997-6#1)(2012-3#1)
selected ion monitoring (SIM) mode##4##5##(2008-10#4)
selected ion monitoring (SIM)##6##4##(2008-10#6)
selected ion monitoring mode##7##4##(2008-10#6)(2008-11#1)
selected ion monitoring##17##3##(2008-10#16)(2008-11#1)
selected isolates of##2##3##(2008-10#2)
selected isolates##6##2##(2008-10#6)
selected lines that##2##3##(1994-2#1)(2008-10#1)
selected lines##8##2##(1992-9#1)(1993-5#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
selected manually##2##2##(2011-1#2)
selected markers##2##2##(2008-10#1)(2008-5#1)
selected materials to##2##3##(2011-1#1)(2013-7#1)
selected multivariate##2##2##(2008-10#2)
selected new##2##2##(2008-11#1)(2008-8#1)
selected on the basis of##9##5##(1990-11#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-3#1)
selected on the##10##3##(1990-11#1)(1995-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-3#1)
selected on##13##2##(1990-11#1)(1995-4#1)(1995-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-3#1)
selected patient##5##2##(1996-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
selected patients at risk##2##4##(2008-3#1)(2010-10#1)
selected patients with##11##3##(1990-3#1)(1992-6#2)(1997-6#2)(2007-11#1)(2007-8#2)(2008-11#1)(2009-5#2)
selected patients##39##2##(1990-3#1)(1990-6#1)(1991-9#1)(1992-6#2)(1993-2#1)(1994-6#1)(1997-2#1)(1997-6#2)(1997-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
selected phage##2##2##(2008-1#1)(2008-10#1)
selected plants##2##2##(2008-10#1)(2008-6#1)
selected points##3##2##(2008-10#1)(2012-12#2)
selected population##5##2##(1993-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
selected populations##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
selected procedures##2##2##(2008-4#1)(2008-9#1)
selected proteins##2##2##(1991-2#1)(2008-7#1)
selected randomly from##3##3##(1993-1#1)(1994-3#1)(2008-10#1)
selected regions##2##2##(1996-12#1)(2010-7#1)
selected resistant##2##2##(2008-10#2)
selected rural communities in##2##4##(1994-9#1)(2011-1#1)
selected samples##4##2##(2008-10#3)(2012-2#1)
selected sites##2##2##(1994-12#1)(2010-3#1)
selected strains##2##2##(2008-6#1)(2011-2#1)
selected stress behaviors##2##3##(1991-12#2)
selected structures of##2##3##(2008-11#1)(2013-1#1)
selected surfactants##2##2##(2008-5#2)
selected surgical##2##2##(1991-1#1)(2008-10#1)
selected that##4##2##(1997-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
selected the##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2009-10#1)(2011-2#1)(2012-2#1)
selected through##2##2##(2008-10#1)(2011-2#1)
selected tissues##2##2##(1994-5#1)(2010-5#1)
selected to be##3##3##(1995-6#1)(2008-5#1)(2013-1#1)
selected to participate in this##3##5##(1991-2#1)(2009-7#1)(2010-4#1)
selected to produce##2##3##(2008-3#1)(2008-6#1)
selected to represent the##2##4##(2008-10#2)
selected to represent##3##3##(1991-12#1)(2008-10#2)
selected to##38##2##(1991-12#2)(1991-2#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#2)(2012-9#1)(2013-1#1)(2013-8#1)
selected traditional##2##2##(1993-12#1)(2012-2#1)
selected using a##2##3##(2008-5#1)(2008-7#1)
selected using##6##2##(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-8#1)
selected variables was##2##3##(2008-10#1)(2013-8#1)
selected variables##3##2##(2008-10#2)(2013-8#1)
selected virulent populations##2##3##(2008-10#2)
selected virulent##4##2##(2008-10#4)
selected wastewater protozoa##2##3##(2008-12#2)
selected wavelength##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
selected wavelengths##5##2##(2008-2#1)(2008-3#3)(2010-5#1)
selected were##4##2##(1992-3#1)(2008-10#1)(2008-9#1)(2011-1#1)
selected with##5##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
selected##1190##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#6)(1991-2#4)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#3)(1993-1#4)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#4)(1994-1#3)(1994-10#1)(1994-12#8)(1994-2#5)(1994-3#6)(1994-5#5)(1994-6#4)(1994-8#2)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#5)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#9)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#6)(1997-5#1)(1997-6#8)(1997-7#2)(1997-8#7)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#8)(2007-11#15)(2007-12#12)(2007-2#3)(2007-4#2)(2007-6#5)(2007-7#1)(2007-8#13)(2007-9#1)(2008-1#11)(2008-10#338)(2008-11#29)(2008-12#19)(2008-2#14)(2008-3#34)(2008-4#15)(2008-5#42)(2008-6#17)(2008-7#24)(2008-8#34)(2008-9#22)(2009-10#7)(2009-11#3)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#6)(2009-8#5)(2009-9#5)(2010-10#3)(2010-11#5)(2010-12#2)(2010-3#11)(2010-4#7)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#16)(2011-1#23)(2011-2#53)(2011-3#6)(2012-1#4)(2012-12#16)(2012-2#19)(2012-3#18)(2012-9#1)(2013-1#40)(2013-7#6)(2013-8#24)
selected-ion monitoring (SIM)##2##3##(2008-10#1)(2008-5#1)
selectin functions##2##2##(2008-3#2)
selectin##5##1##(1991-12#1)(1993-8#1)(1996-2#1)(2008-3#2)
selecting PK repeat##2##3##(2010-11#2)
selecting a group of##2##4##(2008-10#1)(2012-3#1)
selecting a suitable##4##3##(2008-4#2)(2008-7#1)(2012-5#1)
selecting a##16##2##(1992-12#1)(1995-12#2)(1995-9#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-1#1)(2012-3#1)(2012-5#1)
selecting an appropriate##3##3##(2008-9#2)(2011-2#1)
selecting an##7##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2011-2#1)
selecting and developing##2##3##(1997-3#1)(2008-7#1)
selecting and implementing##2##3##(1994-12#1)(2010-8#1)
selecting and##8##2##(1994-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
selecting for##2##2##(2008-10#1)(2008-2#1)
selecting health##2##2##(1995-1#1)(1996-3#1)
selecting pairs of glasses for##2##5##(2008-3#2)
selecting patients for##3##3##(2008-7#1)(2009-4#1)(2012-3#1)
selecting patients with##2##3##(2008-8#1)(2013-1#1)
selecting patients##7##2##(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-3#1)(2013-1#1)
selecting the appropriate##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
selecting the best##2##3##(2008-3#1)(2013-1#1)
selecting the most suitable##2##4##(2008-10#1)(2008-12#1)
selecting the most##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
selecting the surgical##2##3##(1990-9#1)(2011-2#1)
selecting the type of##3##4##(1996-1#1)(2007-12#1)(2013-8#1)
selecting the##36##2##(1990-5#1)(1990-9#1)(1992-12#1)(1992-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-8#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
selecting##132##1##(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#4)(1995-2#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#12)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#2)
selectins##5##1##(1993-8#1)(2008-3#4)
selection (MAS)##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
selection acting on##2##3##(2012-3#1)(2013-1#1)
selection acting##5##2##(1995-2#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
selection acts##2##2##(2008-8#1)(2013-1#1)
selection against##7##2##(2008-10#3)(2008-9#2)(2009-2#1)(2009-9#1)
selection algorithm##3##2##(2008-11#1)(2008-6#1)(2012-3#1)
selection among##2##2##(2010-12#1)(2012-12#1)
selection and a##2##3##(2008-4#1)(2008-8#1)
selection and engagement##2##3##(2011-1#1)(2011-2#1)
selection and identification of##2##4##(2008-7#1)(2011-3#1)
selection and implementation of##3##4##(1994-2#1)(2008-9#1)(2010-4#1)
selection and management of##2##4##(1992-12#1)(2007-12#1)
selection and management##3##3##(1992-12#2)(2007-12#1)
selection and random##2##3##(1995-5#1)(1996-6#1)
selection and retention##2##3##(1995-3#1)(2009-12#1)
selection and the##8##3##(2008-8#3)(2008-9#2)(2010-1#1)(2012-3#2)
selection and treatment##2##3##(2008-7#1)(2010-4#1)
selection and##97##2##(1991-12#1)(1991-6#1)(1992-12#2)(1993-12#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#14)(2008-9#7)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#3)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#6)(2013-1#5)(2013-8#1)
selection and/or##2##2##(2008-9#1)(2009-5#1)
selection are not##3##3##(2008-12#1)(2011-3#1)(2013-1#1)
selection are##11##2##(1991-2#2)(1995-2#1)(2008-12#1)(2008-8#2)(2009-12#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
selection as well as##2##4##(1991-2#1)(2008-8#1)
selection as##4##2##(1991-2#1)(1996-3#1)(1996-6#1)(2008-8#1)
selection at multiple##2##3##(2010-4#1)(2013-1#1)
selection at##10##2##(1997-7#1)(2008-8#4)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#2)
selection based on##9##3##(1994-12#1)(1996-6#1)(2008-10#4)(2008-8#3)
selection between the##2##3##(2008-8#1)(2010-8#1)
selection between##4##2##(2008-1#1)(2008-8#1)(2010-8#1)(2013-1#1)
selection bias in##2##3##(1995-2#1)(2013-1#1)
selection bias##10##2##(1995-2#1)(1996-1#1)(1997-3#1)(1997-5#2)(2007-10#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
selection by the host##2##4##(2008-10#2)
selection by the##3##3##(2008-10#2)(2010-8#1)
selection by two##2##3##(2008-8#2)
selection by##17##2##(1990-8#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-8#2)(2012-2#1)
selection can be##2##3##(2008-10#1)(2013-1#1)
selection can##6##2##(1993-12#1)(2007-11#1)(2008-10#1)(2008-8#2)(2013-1#1)
selection cannot##2##2##(1995-5#1)(2008-8#1)
selection could##2##2##(2008-10#1)(2008-8#1)
selection criteria and##3##3##(2008-9#1)(2011-1#1)(2012-12#1)
selection criteria for##3##3##(1990-9#1)(1991-12#1)(1997-1#1)
selection criteria##20##2##(1990-3#1)(1990-9#1)(1991-12#1)(1992-2#2)(1994-9#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-7#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)
selection criterion##2##2##(2008-10#1)(2008-8#1)
selection differed##2##2##(2008-8#1)(2012-3#1)
selection exerted by##2##3##(2013-1#2)
selection experiments##3##2##(2008-10#1)(2008-8#2)
selection favored larger##2##3##(2008-8#1)(2008-9#1)
selection favoring##4##2##(2008-8#2)(2009-8#2)
selection favors##4##2##(1995-2#1)(2008-8#1)(2008-9#1)(2009-8#1)
selection for quantitative resistance to Sclerotinia trifoliorum in alfalfa also##2##10##(2008-10#2)
selection for resistance to##2##4##(2008-10#2)
selection for resistance##6##3##(2008-10#6)
selection for the##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
selection for these##2##3##(2008-8#1)(2012-2#1)
selection for virulence##2##3##(2008-10#2)
selection for##54##2##(1992-12#1)(1993-9#1)(1995-3#1)(1997-4#1)(2008-10#17)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#7)(2009-10#2)(2009-2#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
selection forces##2##2##(2013-8#2)
selection from##4##2##(1993-11#1)(2008-10#1)(2008-4#2)
selection gradients##6##2##(2008-8#6)
selection has been##2##3##(2008-8#1)(2012-3#1)
selection has##8##2##(1995-2#1)(2008-10#1)(2008-8#2)(2012-2#1)(2012-3#3)
selection in a##2##3##(2008-8#1)(2008-9#1)
selection in breeding programs##2##4##(2008-10#1)(2012-3#1)
selection in different##2##3##(1995-2#1)(2013-1#1)
selection in natural populations##2##4##(2008-8#1)(2012-3#1)
selection in plants##3##3##(1995-2#3)
selection in the##10##3##(1995-5#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
selection in##52##2##(1990-11#1)(1991-5#1)(1995-2#5)(1995-5#2)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#9)(2008-9#6)(2009-5#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
selection increased##2##2##(2011-2#1)(2013-1#1)
selection intensity##2##2##(2008-10#1)(2008-8#1)
selection is also##2##3##(1995-2#1)(2010-4#1)
selection is reduced if dose is##2##6##(2008-10#2)
selection is##22##2##(1995-2#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
selection marker##6##2##(1997-4#1)(2008-11#5)
selection may##7##2##(1995-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-12#1)
selection method##4##2##(1995-2#1)(1997-5#1)(2008-1#1)(2008-4#1)
selection methods##8##2##(1993-12#1)(1995-2#1)(1997-5#2)(2008-10#2)(2008-7#1)(2012-3#1)
selection models##2##2##(2008-10#1)(2008-9#1)
selection of a suitable##2##4##(2008-5#2)
selection of a##15##3##(1990-11#1)(1993-1#1)(1993-12#1)(1993-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2010-8#1)(2011-2#1)
selection of an appropriate##2##4##(1990-9#1)(1991-9#1)
selection of an##5##3##(1990-9#1)(1991-9#1)(1992-3#1)(2008-2#1)(2011-2#1)
selection of antihypertensive##2##3##(1992-8#1)(2008-1#1)
selection of appropriate##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
selection of aptamers##2##3##(2008-4#1)(2010-5#1)
selection of articles##2##3##(2006-10#1)(2012-3#1)
selection of candidate##3##3##(2007-7#1)(2008-10#1)(2010-5#1)
selection of different##2##3##(2007-12#1)(2008-11#1)
selection of drug##2##3##(1994-5#1)(2011-2#1)
selection of full-length cDNA by##2##5##(1997-2#2)
selection of genes##2##3##(2008-10#1)(2010-11#1)
selection of internal##2##3##(2008-10#2)
selection of materials##2##3##(2008-2#1)(2008-3#1)
selection of patients for##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
selection of patients who##4##4##(2007-8#1)(2008-7#1)(2008-8#1)(2012-3#1)
selection of patients##16##3##(1991-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
selection of resistant##2##3##(2008-10#1)(2013-1#1)
selection of specific##3##3##(2008-11#2)(2012-2#1)
selection of strains##2##3##(1992-12#1)(2008-10#1)
selection of the appropriate##3##4##(2007-12#1)(2008-10#1)(2008-9#1)
selection of the experimental conditions##2##5##(2008-10#1)(2008-3#1)
selection of the most##3##4##(1997-7#1)(2008-10#1)(2011-2#1)
selection of the proper##2##4##(2008-2#1)(2008-3#1)
selection of the##51##3##(1990-8#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-8#2)(1997-4#1)(1997-7#1)(1997-9#1)(2007-12#2)(2007-7#1)(2008-10#17)(2008-11#2)(2008-2#4)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#3)(2012-12#1)(2012-3#1)
selection of these##4##3##(1993-11#1)(2008-11#2)(2008-8#1)
selection of variables##5##3##(1995-9#1)(2008-10#4)
selection of##293##2##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-9#2)(2006-10#2)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#6)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#61)(2008-11#11)(2008-12#3)(2008-2#13)(2008-3#19)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#12)(2009-10#1)(2009-11#3)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#17)(2011-3#2)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#6)(2013-7#2)
selection often##2##2##(2008-10#1)(2008-9#1)
selection on a heritable##2##4##(2008-8#2)
selection on a##4##3##(2008-8#3)(2008-9#1)
selection on attractive traits##3##4##(2008-8#3)
selection on both##2##3##(2008-9#1)(2010-4#1)
selection on maternal seed size##2##5##(2008-9#2)
selection on pollen hoarding##2##4##(2008-10#2)
selection on resistance##2##3##(2008-8#2)
selection on the##7##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-8#3)(2012-3#1)
selection on##59##2##(1993-8#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-8#31)(2008-9#10)(2009-2#2)(2010-4#2)(2012-3#3)(2013-1#3)
selection or##8##2##(1990-8#1)(1995-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-3#2)
selection over##2##2##(2008-4#1)(2008-8#1)
selection pressure and that##2##4##(2008-10#1)(2013-1#1)
selection pressure for##3##3##(2008-10#1)(2010-7#2)
selection pressure in##2##3##(2008-10#1)(2008-4#1)
selection pressure##17##2##(1994-3#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2010-7#2)(2012-3#1)(2013-1#1)
selection pressures##8##2##(2008-10#1)(2008-11#1)(2008-8#2)(2010-3#1)(2012-3#2)(2013-1#1)
selection procedures##2##2##(2008-10#1)(2009-10#1)
selection process of##2##3##(2008-10#1)(2012-3#1)
selection process##12##2##(1993-12#1)(1994-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(2008-10#2)(2008-6#2)(2012-2#1)(2012-3#1)
selection responses##2##2##(2008-10#1)(2008-8#1)
selection should##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
selection strategies##2##2##(2008-8#1)(2012-3#1)
selection strategy##2##2##(2008-10#1)(2008-9#1)
selection system##3##2##(1991-5#1)(2008-11#1)(2008-2#1)
selection systems##2##2##(2008-11#1)(2013-8#1)
selection that##4##2##(2008-3#1)(2009-10#1)(2010-1#1)(2013-1#1)
selection theory##2##2##(2008-5#1)(2009-10#1)
selection they##2##2##(2008-8#1)(2013-1#1)
selection through##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
selection to achieve##2##3##(2007-11#1)(2008-8#1)
selection to##9##2##(2007-11#1)(2008-10#3)(2008-8#3)(2008-9#1)(2010-4#1)
selection using the##2##3##(2008-6#1)(2012-3#1)
selection using##9##2##(1993-6#1)(2008-4#4)(2008-6#1)(2009-10#1)(2012-3#1)(2013-1#1)
selection valve in##2##3##(2008-10#2)
selection valve##8##2##(2008-10#8)
selection via##3##2##(1995-2#1)(2008-8#2)
selection was also##3##3##(2008-10#2)(2013-1#1)
selection was##21##2##(1990-8#1)(1992-2#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-8#6)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
selection were##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
selection when##3##2##(1996-3#1)(2009-9#1)(2012-3#1)
selection with##6##2##(1992-3#1)(1992-8#1)(1995-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
selection within##2##2##(2008-10#2)
selection without##2##2##(2008-3#1)(2008-8#1)
selection##1227##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#5)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-8#2)(1993-1#1)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#21)(1995-3#3)(1995-5#6)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#5)(1996-6#6)(1996-8#1)(1997-1#10)(1997-2#4)(1997-3#6)(1997-4#8)(1997-5#6)(1997-6#2)(1997-7#5)(1997-8#1)(1997-9#2)(2006-10#2)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#14)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#10)(2008-10#207)(2008-11#32)(2008-12#6)(2008-2#21)(2008-3#33)(2008-4#34)(2008-5#13)(2008-6#8)(2008-7#28)(2008-8#193)(2008-9#78)(2009-10#10)(2009-11#4)(2009-12#3)(2009-2#6)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#5)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#18)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#14)(2011-1#11)(2011-10#1)(2011-2#41)(2011-3#6)(2012-1#2)(2012-12#18)(2012-2#18)(2012-3#69)(2012-8#1)(2013-1#47)(2013-7#2)(2013-8#13)
selection&quot##2##1##(2008-8#2)
selection)##2##1##(2008-10#1)(2008-8#1)
selections and##2##2##(2008-10#1)(2011-2#1)
selections for##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
selections of##4##2##(1995-3#1)(2008-10#3)
selections to##2##2##(2008-10#2)
selections with##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
selections##21##1##(1991-2#1)(1992-3#2)(1995-3#1)(1997-3#2)(2008-10#10)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
selective 5-HT1B##2##2##(1995-12#2)
selective A1-adenosine receptor##2##3##(1997-2#2)
selective AMPA receptor antagonist##2##4##(1994-2#2)
selective COX-2 inhibitor##3##3##(2008-10#1)(2008-12#2)
selective COX-2 inhibitors##3##3##(2008-10#2)(2008-11#1)
selective COX-2##7##2##(2008-10#4)(2008-11#1)(2008-12#2)
selective NMDA receptor antagonist##2##4##(1997-2#1)(2008-8#1)
selective NMDA##3##2##(1996-6#1)(1997-2#1)(2008-8#1)
selective P2Y(1)##3##2##(2008-4#3)
selective access##2##2##(2008-10#1)(2010-8#1)
selective action##3##2##(1990-2#1)(1990-7#1)(2008-10#1)
selective adenosine A1##2##3##(1995-12#2)
selective adenosine##3##2##(1995-12#3)
selective adsorption of heavy metal ions##2##6##(2008-10#2)
selective adsorption##3##2##(2008-10#3)
selective advantage of##4##3##(2008-8#2)(2009-5#1)(2012-3#1)
selective advantage##11##2##(1993-2#1)(1997-3#1)(2008-10#2)(2008-7#1)(2008-8#4)(2009-5#1)(2012-3#1)
selective agonist of##2##3##(1994-8#1)(1995-12#1)
selective agonist##3##2##(1994-8#1)(1995-12#1)(1995-3#1)
selective agonists##4##2##(1995-3#1)(1996-2#1)(2008-4#2)
selective and differential media##2##4##(1991-8#2)
selective and differential##3##3##(1991-8#2)(1997-3#1)
selective and non-selective##5##3##(2008-10#1)(2008-12#1)(2011-2#3)
selective and nonselective##5##3##(2008-10#2)(2008-12#2)(2013-1#1)
selective and rapid method for the determination of##2##8##(2008-10#2)
selective and rapid method##3##4##(2008-10#3)
selective and rapid##5##3##(2008-10#4)(2011-3#1)
selective and reproducible##2##3##(2008-10#2)
selective and sensitive assay of##2##5##(2008-10#2)
selective and sensitive determination of##4##5##(2008-10#4)
selective and sensitive fluorescence##3##4##(2008-10#1)(2008-12#2)
selective and sensitive fluorescent##2##4##(2008-10#2)
selective and sensitive method for the determination of##3##8##(1990-8#1)(2008-10#2)
selective and sensitive method for the##4##6##(1990-8#1)(2008-10#3)
selective and sensitive method##6##4##(1990-8#1)(2008-10#5)
selective and sensitive##32##3##(1990-8#1)(2008-10#28)(2008-12#2)(2011-1#1)
selective and simple##5##3##(2008-10#5)
selective and##85##2##(1990-8#1)(1991-8#2)(1995-11#2)(1995-3#1)(1997-3#1)(2008-10#60)(2008-12#6)(2009-12#1)(2009-2#1)(2010-4#3)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#2)
selective angiography##3##2##(2007-8#1)(2011-2#2)
selective antagonists##2##2##(1995-12#1)(2008-4#1)
selective approach##2##2##(2008-11#1)(2013-1#1)
selective arteriography##3##2##(1990-3#1)(1991-5#2)
selective assay of proteins##2##4##(2008-10#2)
selective attention##2##2##(1992-11#1)(2008-11#1)
selective axonal##3##2##(1996-5#3)
selective binding to the##2##4##(1990-12#1)(1992-8#1)
selective binding##6##2##(1990-12#2)(1992-8#1)(2008-10#2)(2009-6#1)
selective blockade of##2##3##(2008-8#1)(2013-1#1)
selective blocker of##2##3##(1997-2#1)(1997-7#1)
selective brain cooling##3##3##(2010-1#3)
selective brain##6##2##(1994-6#3)(2010-1#3)
selective cells##3##2##(2008-8#3)
selective chromogenic##4##2##(2008-10#4)
selective columns##2##2##(2008-10#1)(2009-5#1)
selective compounds##2##2##(1995-11#1)(2007-12#1)
selective concentration of##2##3##(2008-2#1)(2012-3#1)
selective contracting##2##2##(1994-12#1)(1994-2#1)
selective cyclooxygenase##3##2##(1990-12#1)(1991-8#2)
selective cytotoxicity##2##2##(1997-7#1)(2008-11#1)
selective deposition##2##2##(1994-12#2)
selective destruction of##2##3##(2008-4#1)(2008-5#1)
selective detection of##10##3##(1995-6#2)(2008-10#7)(2008-3#1)
selective detection##15##2##(1995-6#2)(1997-6#1)(2008-10#11)(2008-3#1)
selective detector for##2##3##(2008-10#2)
selective detector##3##2##(2008-10#3)
selective determination of Fe(III) in the presence of Fe(II)##2##9##(2008-10#2)
selective determination of trace amounts of metal##2##7##(2008-10#2)
selective determination of uric acid in##2##6##(2008-10#2)
selective determination of##25##3##(1997-2#1)(2008-10#24)
selective determination##27##2##(1997-2#1)(2008-10#26)
selective displacement##6##2##(1991-1#1)(2008-7#5)
selective disruption of##2##3##(1996-2#1)(2009-2#1)
selective double excision##2##3##(1992-2#2)
selective dysfunction of##2##3##(1991-2#2)
selective edge##2##2##(2008-2#1)(2008-3#1)
selective effect of##2##3##(1993-6#1)(2008-10#1)
selective effect##3##2##(1993-11#1)(1993-6#1)(2008-10#1)
selective electrochemical##2##2##(2008-10#2)
selective electrode based on##5##4##(2008-10#5)
selective electrode is##2##3##(2008-10#2)
selective electrode##27##2##(2008-10#26)(2008-5#1)
selective electrodes##18##2##(2008-10#17)(2008-6#1)
selective elimination##2##2##(2008-7#1)(2012-3#1)
selective embolisation##2##2##(1997-6#1)(2011-2#1)
selective enhancement##2##2##(1997-7#1)(2008-9#1)
selective enrichment of##2##3##(1994-12#1)(2008-10#1)
selective enrichment##3##2##(1994-12#1)(2008-10#1)(2008-7#1)
selective expression of##3##3##(1991-9#1)(1994-5#1)(1994-6#1)
selective extraction and determination of##2##5##(2008-10#2)
selective extraction and##6##3##(2008-10#5)(2008-8#1)
selective extraction of U(VI)##3##4##(2008-10#3)
selective extraction of##12##3##(1992-3#1)(2008-10#11)
selective extraction##24##2##(1992-3#1)(2008-10#22)(2008-8#1)
selective flow injection##6##3##(2008-10#6)
selective flow##7##2##(1990-11#1)(2008-10#6)
selective fluorescence quenching agent for discriminating between alternant versus nonalternant polycyclic aromatic hydrocarbons##2##13##(2008-10#2)
selective fluorescence quenching agent for##3##5##(2008-10#3)
selective fluorescence quenching agent##4##4##(2008-10#4)
selective fluorescence quenching##5##3##(2008-10#5)
selective fluorescence##6##2##(2008-10#6)
selective for creatinine##2##3##(2008-10#2)
selective for the##11##3##(1995-11#1)(1995-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-5#1)
selective for##41##2##(1990-8#1)(1991-5#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-7#1)(2010-1#1)(2010-5#1)
selective force##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
selective forces and##2##3##(1992-9#1)(2008-8#1)
selective forces##9##2##(1992-9#1)(2008-10#1)(2008-8#4)(2010-3#1)(2012-12#1)(2013-1#1)
selective growth##2##2##(1994-12#1)(2012-2#1)
selective hydride##2##2##(2009-6#2)
selective hydrolysis##2##2##(2007-11#1)(2008-4#1)
selective hypersensitivity##3##2##(2013-1#3)
selective illumination of##2##3##(1993-3#2)
selective impact##2##2##(2008-10#1)(2013-1#1)
selective impairment of##3##3##(1996-2#1)(2008-7#1)(2008-8#1)
selective in the##2##3##(2008-10#2)
selective in##5##2##(1990-5#1)(1995-6#1)(2008-10#2)(2009-6#1)
selective inhibition of##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
selective inhibitor of the##2##4##(1994-6#1)(2008-4#1)
selective inhibitor of##11##3##(1990-8#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#1)(2008-4#3)(2008-5#1)(2012-1#2)
selective inhibitor##14##2##(1990-5#1)(1990-8#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2012-1#2)
selective inhibitors##6##2##(2006-10#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)
selective interaction and##2##3##(1990-8#2)
selective interaction##6##2##(1990-8#5)(2008-10#1)
selective ion monitoring##2##3##(2008-10#2)
selective ion##5##2##(2008-10#4)(2008-2#1)
selective laser##3##2##(2007-12#1)(2009-7#1)(2011-2#1)
selective ligand##3##2##(1991-12#2)(2013-7#1)
selective ligands##3##2##(1993-11#1)(1993-8#1)(2009-7#1)
selective loss of##2##3##(2008-1#1)(2008-4#1)
selective marker##2##2##(1996-5#1)(1996-6#1)
selective measurement##2##2##(2008-10#1)(2008-5#1)
selective measurements of##2##3##(2008-10#2)
selective media for isolation of##2##5##(2008-10#2)
selective media##9##2##(1997-6#1)(2008-10#7)(2008-12#1)
selective medium for##2##3##(1997-6#2)
selective medium##15##2##(1991-8#1)(1997-6#2)(2008-10#11)(2008-7#1)
selective membrane potentiometric sensor##2##4##(2008-10#2)
selective membrane potentiometric##3##3##(2008-10#3)
selective membrane##9##2##(1995-6#1)(2008-10#8)
selective membranes##2##2##(2008-10#2)
selective method for the determination of##6##6##(2008-10#6)
selective method for the##9##4##(2008-10#9)
selective method for##12##3##(2008-10#12)
selective method was##3##3##(2008-10#3)
selective method##31##2##(2008-10#30)(2008-5#1)
selective methods##4##2##(2008-10#4)
selective mu-opioid receptor##2##3##(1996-2#2)
selective neuronal##2##2##(2008-7#1)(2013-1#1)
selective optical feedback##2##3##(2007-12#2)
selective optical##4##2##(2007-12#2)(2008-10#1)(2008-2#1)
selective or non-selective##2##3##(1994-3#1)(2011-2#1)
selective or##3##2##(1994-3#1)(1995-5#1)(2011-2#1)
selective oxidation of##2##3##(2008-10#2)
selective oxidation##3##2##(2008-10#3)
selective pecking##2##2##(2008-6#2)
selective plasma separator##3##3##(2011-1#3)
selective polymeric membrane##2##3##(2008-10#2)
selective pre-concentration and differential pulse anodic stripping voltammetry##2##8##(2008-10#2)
selective precipitation of##2##3##(2008-10#1)(2008-7#1)
selective preconcentration##2##2##(2008-10#2)
selective pressure to maintain##2##4##(1991-2#1)(2008-9#1)
selective pressure to##3##3##(1991-2#1)(2008-7#1)(2008-9#1)
selective pressure##11##2##(1991-2#1)(2007-7#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
selective pressures##9##2##(1997-9#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-3#2)
selective protein##2##2##(1992-12#1)(2008-9#1)
selective proteolysis##2##2##(2008-7#1)(2009-7#1)
selective quencher##3##2##(2008-10#3)
selective quenching##2##2##(2008-10#2)
selective reaction##3##2##(2008-10#3)
selective reagents##3##2##(2008-10#2)(2012-2#1)
selective recognition##2##2##(1997-3#1)(2008-10#1)
selective reduction of##2##3##(2007-11#1)(2008-10#1)
selective reduction##4##2##(1994-6#1)(1995-12#1)(2007-11#1)(2008-10#1)
selective regime##2##2##(2008-8#2)
selective removal of##3##3##(1996-5#1)(2008-10#2)
selective sensor##2##2##(2008-10#2)
selective sensors##2##2##(2008-10#2)
selective separation of##3##3##(2008-10#3)
selective separation##7##2##(2008-10#6)(2008-7#1)
selective sequential extractions##2##3##(2008-10#2)
selective sequential##3##2##(2008-10#3)
selective serotonin reuptake inhibitor##4##4##(2008-3#1)(2008-4#1)(2010-2#1)(2012-3#1)
selective serotonin reuptake inhibitors (SSRIs)##5##5##(1996-7#1)(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
selective serotonin reuptake inhibitors##11##4##(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-6#3)(2012-3#1)(2013-8#1)
selective serotonin reuptake##15##3##(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2010-2#1)(2012-3#2)(2013-8#1)
selective serotonin##16##2##(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2010-2#1)(2012-3#3)(2013-8#1)
selective serotonin-reuptake inhibitors##2##3##(2011-1#2)
selective silver staining##2##3##(1997-3#2)
selective solid phase extraction##2##4##(2008-10#2)
selective solid phase##3##3##(2008-10#3)
selective solid##4##2##(2008-10#4)
selective spectrofluorimetric determination of##2##4##(2008-10#2)
selective spectrophotometric method for##2##4##(2008-10#2)
selective spectrophotometric method##3##3##(2008-10#3)
selective spectrophotometric##6##2##(2008-10#6)
selective system##2##2##(2008-10#1)(2008-11#1)
selective to##17##2##(2007-8#1)(2008-10#16)
selective towards##5##2##(1995-11#1)(2008-10#3)(2008-7#1)
selective toxicity for hypoxic cells##2##5##(1995-3#2)
selective translation of##3##3##(1992-12#2)(1992-8#1)
selective uptake##2##2##(2008-10#1)(2008-2#1)
selective vs##2##2##(1995-3#2)
selective with##2##2##(2008-10#1)(2013-7#1)
selective##1087##1##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#4)(1990-7#1)(1990-8#9)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#7)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#6)(1992-5#3)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#6)(1994-8#9)(1995-11#9)(1995-12#22)(1995-3#15)(1995-5#3)(1995-6#7)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#11)(1996-6#3)(1996-7#1)(1996-8#2)(1997-2#7)(1997-3#6)(1997-6#6)(1997-7#3)(1997-8#3)(1997-9#1)(2006-10#2)(2007-11#4)(2007-12#7)(2007-4#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#499)(2008-11#18)(2008-12#11)(2008-2#15)(2008-3#11)(2008-4#27)(2008-5#14)(2008-6#14)(2008-7#26)(2008-8#30)(2008-9#7)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#4)(2009-6#4)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#4)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#3)(2011-1#9)(2011-2#19)(2011-3#2)(2012-1#3)(2012-12#10)(2012-2#13)(2012-3#12)(2013-1#17)(2013-7#6)(2013-8#3)
selectively acting##2##2##(2008-11#1)(2008-7#1)
selectively activated##2##2##(1990-9#1)(2008-11#1)
selectively affect##3##2##(1990-11#1)(1996-5#1)(2012-2#1)
selectively amplified##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
selectively and sensitively detected by##2##5##(2008-10#2)
selectively and##11##2##(1990-12#1)(1994-3#1)(1994-5#1)(2008-10#6)(2009-12#1)(2011-1#1)
selectively at##2##2##(1990-5#1)(2008-10#1)
selectively bind##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
selectively blocked by the##2##4##(1993-11#1)(1994-6#1)
selectively blocked by##3##3##(1993-11#1)(1994-6#1)(2008-8#1)
selectively blocked##6##2##(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-8#1)
selectively by##2##2##(1995-12#1)(2008-5#1)
selectively destroys##2##2##(2010-10#1)(2013-1#1)
selectively detected##4##2##(2008-10#4)
selectively determined##2##2##(2008-10#2)
selectively enriched##2##2##(2008-10#1)(2008-2#1)
selectively expressed in##3##3##(1994-6#1)(1995-11#1)(2008-4#1)
selectively expressed##4##2##(1994-6#2)(1995-11#1)(2008-4#1)
selectively extracted##2##2##(2008-10#2)
selectively from##2##2##(2008-11#1)(2013-1#1)
selectively in##6##2##(1990-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-7#1)
selectively increased##3##2##(2011-2#3)
selectively inhibit##4##2##(1993-11#1)(2006-10#1)(2008-10#1)(2012-3#1)
selectively inhibited##2##2##(1994-8#1)(2012-2#1)
selectively killed by##2##3##(2008-10#1)(2012-2#1)
selectively monitored at##2##3##(2008-10#2)
selectively neutral##2##2##(1997-6#1)(2008-10#1)
selectively on##3##2##(1993-6#1)(2007-11#1)(2008-10#1)
selectively oxidized by##2##3##(2008-10#1)(2010-12#1)
selectively promoted growth and stability of differentiated phenotype in##2##9##(1995-11#2)
selectively quenches##2##2##(2008-10#2)
selectively reduces##2##2##(1991-5#1)(1995-11#1)
selectively retain##2##2##(2008-10#2)
selectively to a##2##3##(2008-10#1)(2008-4#1)
selectively to##9##2##(1992-9#1)(1993-11#1)(1994-12#1)(2008-10#3)(2008-4#1)(2009-3#1)(2012-2#1)
selectively vulnerable##2##2##(1995-12#1)(1996-12#1)
selectively with##2##2##(1991-12#1)(2008-10#1)
selectively##232##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#5)(1990-9#1)(1991-12#2)(1991-4#1)(1991-5#3)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-6#3)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#2)(1995-11#4)(1995-12#3)(1995-6#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#72)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#13)(2008-8#8)(2008-9#1)(2009-11#2)(2009-12#2)(2009-3#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#4)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#3)
selectivities for##6##2##(1994-8#1)(2008-10#5)
selectivities of ISEs##2##3##(2008-10#2)
selectivities of##5##2##(1995-5#1)(2008-10#3)(2008-2#1)
selectivities##27##1##(1994-8#1)(1995-5#1)(2008-10#17)(2008-2#3)(2008-4#1)(2008-6#1)(2010-11#1)(2010-5#1)(2010-7#1)
selectivity against##3##2##(2008-10#2)(2013-7#1)
selectivity and a##2##3##(2008-10#2)
selectivity and in the presence of this cation the host fluorescence intensity was##2##13##(2008-10#2)
selectivity and reproducibility##3##3##(2008-10#3)
selectivity and response time##2##4##(2008-10#2)
selectivity and response##3##3##(2008-10#3)
selectivity and retention##2##3##(2008-10#1)(2009-12#1)
selectivity and sensitivity of##4##4##(2008-10#4)
selectivity and sensitivity##21##3##(1997-6#1)(2008-10#17)(2008-11#1)(2010-7#1)(2013-1#1)
selectivity and specificity##3##3##(2008-10#2)(2008-7#1)
selectivity and stability##3##3##(2008-10#2)(2013-1#1)
selectivity and the##4##3##(2008-10#3)(2008-8#1)
selectivity and##65##2##(1991-5#2)(1994-6#1)(1996-5#1)(1997-6#1)(2008-10#42)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
selectivity are##7##2##(2007-12#1)(2008-10#5)(2008-2#1)
selectivity as well as##2##4##(2008-10#1)(2008-3#1)
selectivity as##3##2##(2008-10#2)(2008-3#1)
selectivity associated with##2##3##(2008-6#1)(2011-2#1)
selectivity between##2##2##(1995-3#1)(2011-2#1)
selectivity by##2##2##(2008-10#1)(2008-7#1)
selectivity can be##7##3##(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-7#1)
selectivity can##8##2##(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-7#1)
selectivity coefficient for##2##3##(2008-10#2)
selectivity coefficient values as determined by##4##6##(2008-10#4)
selectivity coefficient values##6##3##(2008-10#6)
selectivity coefficient##13##2##(2008-10#13)
selectivity coefficients and##3##3##(2008-10#3)
selectivity coefficients for##5##3##(2008-10#5)
selectivity coefficients of a##2##4##(2008-10#2)
selectivity coefficients of ion-selective electrodes##2##5##(2008-10#2)
selectivity coefficients of ion-selective##3##4##(2008-10#3)
selectivity coefficients of##10##3##(2008-10#10)
selectivity coefficients towards##2##3##(2008-10#2)
selectivity coefficients##27##2##(2008-10#27)
selectivity control##2##2##(2008-10#2)
selectivity depends on##2##3##(2008-10#1)(2008-3#1)
selectivity effects##2##2##(1994-5#1)(1995-3#1)
selectivity factor and##2##3##(2008-10#2)
selectivity factor##3##2##(2008-10#2)(2013-1#1)
selectivity factors##2##2##(2008-10#2)
selectivity filter##3##2##(2008-8#2)(2013-8#1)
selectivity for Ag(+)##2##3##(2008-10#2)
selectivity for Cu(2+)##2##3##(2008-10#2)
selectivity for Cu(II)##2##3##(2008-10#2)
selectivity for Mg(2+) over##2##4##(2008-10#2)
selectivity for Pb(2+) over##2##4##(2008-10#2)
selectivity for Pb(II) over##2##4##(2008-10#2)
selectivity for U(VI) over Fe(III)##2##5##(2008-10#2)
selectivity for cesium ion over##2##5##(2008-10#2)
selectivity for cesium over##2##4##(2008-10#2)
selectivity for cesium##5##3##(2008-10#5)
selectivity for headgroup##2##3##(1994-5#2)
selectivity for primary-tertiary alkylammonium cations##2##5##(2008-10#2)
selectivity for sodium and potassium picrates##2##6##(2008-10#2)
selectivity for the##8##3##(2008-10#6)(2008-4#1)(2009-11#1)
selectivity for##86##2##(1990-8#3)(1991-3#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(2008-10#71)(2008-2#1)(2008-4#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)
selectivity gained##2##2##(2007-12#1)(2008-10#1)
selectivity in the##6##3##(2008-10#5)(2008-3#1)
selectivity in##27##2##(1990-5#1)(1992-3#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#3)(2011-2#1)
selectivity is attributed to##2##4##(2008-10#1)(2010-12#1)
selectivity is##15##2##(1994-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-7#1)
selectivity may##2##2##(1994-9#1)(2008-7#1)
selectivity obtained##3##2##(2008-10#2)(2008-2#1)
selectivity of a##3##3##(2007-12#1)(2008-10#2)
selectivity of liquid##2##3##(2008-10#2)
selectivity of organic##2##3##(2008-10#2)
selectivity of the developed##2##4##(2008-10#2)
selectivity of the electrode##2##4##(2008-10#2)
selectivity of the method##4##4##(2008-10#4)
selectivity of the proposed method##3##5##(2008-10#3)
selectivity of the proposed##5##4##(2008-10#4)(2008-3#1)
selectivity of the sensor##3##4##(2008-10#3)
selectivity of the##45##3##(1995-3#1)(1995-6#1)(1996-5#1)(2007-12#2)(2008-10#32)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2013-1#1)
selectivity of this##9##3##(1994-9#1)(1995-11#1)(2008-10#6)(2008-2#1)
selectivity of##120##2##(1990-8#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#2)(2007-12#3)(2008-10#72)(2008-11#2)(2008-2#4)(2008-3#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#2)
selectivity over K(+)##2##3##(2008-10#2)
selectivity over##7##2##(2008-10#7)
selectivity pattern with##3##3##(2008-10#3)
selectivity pattern##5##2##(2008-10#5)
selectivity properties of##2##3##(2008-10#2)
selectivity ratio##3##2##(2008-10#2)(2011-2#1)
selectivity relative to##2##3##(2008-10#2)
selectivity than##3##2##(2008-10#2)(2008-2#1)
selectivity to##9##2##(2008-10#9)
selectivity toward##12##2##(1996-5#1)(2008-10#8)(2008-7#1)(2009-12#1)(2013-1#1)
selectivity towards the##2##3##(2008-10#1)(2008-11#1)
selectivity towards##12##2##(2008-10#10)(2008-11#1)(2008-7#1)
selectivity using##3##2##(2008-10#3)
selectivity was improved##2##3##(2008-10#2)
selectivity was observed##2##3##(2008-10#2)
selectivity was##13##2##(1992-3#1)(1996-5#1)(2008-10#10)(2008-11#1)
selectivity were##4##2##(1996-5#1)(2008-10#3)
selectivity when##3##2##(2008-10#2)(2011-2#1)
selectivity with respect to##2##4##(1996-2#1)(2008-10#1)
selectivity with##6##2##(1994-9#1)(1996-2#1)(2008-10#3)(2012-2#1)
selectivity within##2##2##(2008-10#1)(2012-2#1)
selectivity##642##1##(1990-12#1)(1990-5#1)(1990-8#4)(1991-3#1)(1991-5#3)(1992-12#1)(1992-3#3)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#10)(1995-11#2)(1995-12#1)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#6)(1997-1#2)(1997-2#2)(1997-6#1)(2007-12#8)(2007-8#1)(2008-10#433)(2008-11#11)(2008-2#10)(2008-3#14)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#12)(2008-8#13)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-5#1)(2010-7#7)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#3)
selector in the##3##3##(2008-10#2)(2008-3#1)
selector in##5##2##(2008-10#4)(2008-3#1)
selector valve##2##2##(2008-10#1)(2013-1#1)
selector##26##1##(1996-5#1)(2007-12#1)(2008-10#17)(2008-3#1)(2009-10#1)(2009-5#1)(2010-4#1)(2013-1#3)
selects for##2##2##(1990-8#1)(2008-8#1)
selects the##5##2##(2008-3#2)(2008-8#1)(2010-2#1)(2010-8#1)
selects##19##1##(1990-8#1)(1997-3#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#2)
selegiline##2##1##(1996-5#1)(2008-7#1)
selenate (Se(VI))##3##2##(2008-10#3)
selenate##13##1##(1997-4#1)(2008-10#9)(2011-2#1)(2013-8#2)
selenide##5##1##(1993-11#1)(2008-2#1)(2010-11#1)(2012-2#2)
selenious acid##2##2##(2008-10#2)
selenite (Se(IV))##4##2##(2008-10#4)
selenite and##4##2##(1995-11#1)(2008-10#2)(2011-2#1)
selenite ion selective##2##3##(2008-10#2)
selenite ion##4##2##(2008-10#4)
selenite was##2##2##(1996-2#1)(2008-10#1)
selenite##39##1##(1993-12#2)(1995-11#1)(1996-2#2)(2008-10#28)(2010-11#1)(2011-1#4)(2011-2#1)
selenium (IV)##6##2##(2008-10#6)
selenium (Se)##6##2##(1991-12#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
selenium and lead##2##3##(2008-10#2)
selenium and tin by##2##4##(2008-10#2)
selenium and tin##3##3##(2008-10#3)
selenium and##12##2##(2008-10#10)(2008-11#1)(2010-11#1)
selenium compounds##4##2##(2008-10#2)(2010-11#2)
selenium content in##3##3##(1993-12#1)(2008-10#2)
selenium content of##2##3##(2008-10#2)
selenium content##6##2##(1993-12#1)(2008-10#5)
selenium could##2##2##(2008-10#1)(2008-6#1)
selenium determination in##3##3##(2008-10#3)
selenium determination##4##2##(2008-10#4)
selenium determination/speciation##2##2##(2008-10#2)
selenium donor##2##2##(1993-11#2)
selenium from the##2##3##(2008-10#2)
selenium from##3##2##(2008-10#2)(2013-8#1)
selenium hydride generation##2##3##(2008-10#2)
selenium in natural water##2##4##(2008-10#2)
selenium in the atmosphere##3##4##(2008-10#3)
selenium in the##7##3##(2008-10#6)(2012-2#1)
selenium in urine##2##3##(2008-10#2)
selenium in##32##2##(1992-11#1)(2008-10#29)(2010-11#1)(2012-2#1)
selenium intake##2##2##(1997-8#1)(2012-2#1)
selenium is##6##2##(2008-10#6)
selenium levels and##2##3##(1993-12#2)
selenium levels##4##2##(1993-12#3)(2008-10#1)
selenium present in##2##3##(2008-10#2)
selenium present##3##2##(2008-10#3)
selenium speciation##5##2##(2008-10#5)
selenium species in human urine##2##5##(2008-10#2)
selenium species in##5##3##(2008-10#5)
selenium species##23##2##(2008-10#21)(2010-11#2)
selenium to##2##2##(2008-10#1)(2013-8#1)
selenium was found##2##3##(1993-12#1)(2008-10#1)
selenium was##7##2##(1993-12#1)(2008-10#5)(2010-11#1)
selenium with the##2##3##(2008-10#2)
selenium with##3##2##(1993-12#1)(2008-10#2)
selenium##215##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-11#2)(1993-11#2)(1993-12#8)(1993-6#1)(1997-8#2)(2007-4#1)(2008-10#154)(2008-11#1)(2008-4#1)(2008-6#9)(2008-7#1)(2009-10#4)(2009-5#1)(2010-11#12)(2011-1#1)(2011-2#2)(2012-2#5)(2013-1#1)(2013-8#4)
selenium(IV + VI)##2##3##(2008-10#2)
selenium(IV) and (IV + VI)##2##5##(2008-10#2)
selenium(IV) and (VI)##4##3##(2008-10#4)
selenium(IV) and molybdenum(VI)##3##3##(2008-10#3)
selenium(IV) and##11##2##(2008-10#11)
selenium(IV) in##2##2##(2008-10#2)
selenium(IV) uptake onto##2##3##(2008-10#2)
selenium(IV)##25##1##(2008-10#25)
selenium-containing phycocyanin from##2##3##(2008-8#2)
selenium-containing##6##1##(1995-3#1)(2008-10#2)(2008-8#2)(2012-2#1)
selenium-deficient rats##4##2##(1990-12#1)(1991-12#1)(1992-11#2)
selenium-deficient##6##1##(1990-12#1)(1991-12#1)(1992-11#4)
selenium-dependent glutathione peroxidase##2##3##(1991-12#1)(2008-7#1)
selenium-dependent##5##1##(1990-12#1)(1991-12#1)(1993-11#1)(2008-4#1)(2008-7#1)
selenium-enriched plants##2##2##(2008-10#2)
selenium-rich algae (Spirulina platensis)##2##4##(2008-8#2)
selenoamino acids##5##2##(2008-10#5)
selenocompounds##4##1##(1992-12#1)(2008-10#3)
selenocyanates##2##1##(2007-11#2)
selenocysteine (Sec)##2##2##(2008-10#1)(2012-2#1)
selenocysteine##12##1##(1990-12#1)(1993-6#1)(1997-2#2)(2008-10#4)(2008-9#1)(2010-11#1)(2012-2#2)
selenocystine##5##1##(2008-10#4)(2010-11#1)
selenoenzyme##5##1##(1990-12#2)(1991-12#1)(1992-12#2)
selenoethionine##2##1##(2008-10#2)
selenomethionine (SeMet)##3##2##(2008-10#3)
selenomethionine and##2##2##(2008-10#2)
selenomethionine##10##1##(2008-10#10)
selenophosphate##3##1##(1993-11#1)(2012-2#2)
selenoprotein and##2##2##(1990-12#1)(2012-2#1)
selenoprotein mRNA##3##2##(2012-2#3)
selenoprotein transcripts##2##2##(2012-2#2)
selenoprotein##15##1##(1990-12#2)(2009-10#2)(2012-2#11)
selenoproteins##4##1##(2009-10#1)(2010-11#2)(2012-2#1)
selenospecies##5##1##(2008-10#4)(2010-11#1)
selenoxide##2##1##(2008-10#2)
self and non-self##2##3##(2008-1#1)(2008-9#1)
self and peer assessment and##2##5##(2008-11#2)
self and peer assessment##4##4##(2008-11#4)
self and##11##2##(2007-7#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-9#1)(2010-2#1)
self antigens##2##2##(2008-4#2)
self as a##2##3##(2008-10#1)(2008-6#1)
self assembled##2##2##(2008-10#2)
self assembly##2##2##(1994-12#1)(2010-2#1)
self care##2##2##(1996-1#1)(1996-3#1)
self esteem##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
self from##2##2##(2008-11#1)(2009-8#1)
self in the##2##3##(2008-10#1)(2008-11#1)
self in##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
self is##3##2##(2008-11#2)(2008-6#1)
self limited##2##2##(2007-10#1)(2012-2#1)
self monitoring##6##2##(2008-10#6)
self mutilation in##2##3##(2012-2#2)
self mutilation##3##2##(2012-2#3)
self or##2##2##(2008-4#1)(2013-8#1)
self poisoning##2##2##(1992-5#1)(1995-9#1)
self reflection##2##2##(1993-2#1)(2008-11#1)
self reported##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
self to standards##2##3##(2012-12#2)
self##117##1##(1990-11#1)(1990-3#1)(1990-8#1)(1992-3#1)(1992-5#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-10#3)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#25)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#2)
self- and##2##2##(2009-9#1)(2013-1#1)
self-##3##1##(2008-11#1)(2009-9#1)(2013-1#1)
self-Q-switched laser##2##2##(2007-12#2)
self-absorption##3##1##(1997-7#1)(2008-10#1)(2012-2#1)
self-adaptive##2##1##(2007-12#1)(2008-6#1)
self-administered questionnaire##6##2##(1992-1#1)(1993-2#1)(2008-11#1)(2010-4#1)(2012-12#1)(2012-3#1)
self-administered questionnaires##6##2##(2007-2#1)(2008-10#1)(2010-4#3)(2011-2#1)
self-administered##22##1##(1992-1#1)(1993-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-5#1)(2010-4#4)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
self-administration behavior in##3##3##(2008-4#2)(2012-3#1)
self-administration in##8##2##(1993-6#1)(2008-4#4)(2012-3#3)
self-administration of##5##2##(1991-1#1)(1993-6#1)(2008-10#1)(2008-4#1)(2009-10#1)
self-administration##34##1##(1991-1#5)(1993-6#7)(1997-2#1)(2008-10#1)(2008-4#11)(2009-10#1)(2009-11#1)(2009-7#1)(2012-12#1)(2012-3#5)
self-aggregation##3##1##(2011-2#1)(2012-12#2)
self-aligned##2##1##(2007-11#1)(2008-3#1)
self-aligning##3##1##(2008-2#1)(2008-3#2)
self-alignment##3##1##(2007-11#1)(2008-2#1)(2012-2#1)
self-amputated colonic##2##2##(2008-10#2)
self-assemble##5##1##(1995-5#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-8#1)
self-assembled aminoethanethiol monolayer##2##3##(2008-10#2)
self-assembled bilayers##3##2##(2008-10#3)
self-assembled electrode##4##2##(2008-10#4)
self-assembled monolayer (SAM) modified gold##2##5##(2008-10#2)
self-assembled monolayer (SAM) of##4##4##(2008-10#4)
self-assembled monolayer (SAM)##10##3##(2008-10#10)
self-assembled monolayer film##2##3##(2008-8#2)
self-assembled monolayer modified gold##2##4##(2008-10#2)
self-assembled monolayer modified##3##3##(2008-10#3)
self-assembled monolayer of##5##3##(2008-10#4)(2008-3#1)
self-assembled monolayer on##2##3##(2008-10#2)
self-assembled monolayer##27##2##(2008-10#24)(2008-3#1)(2008-8#2)
self-assembled monolayers (SAMs) of##2##4##(2008-10#1)(2010-4#1)
self-assembled monolayers (SAMs)##4##3##(2008-10#3)(2010-4#1)
self-assembled monolayers surface##2##3##(2008-10#2)
self-assembled monolayers##16##2##(2007-12#1)(2008-10#12)(2008-7#1)(2010-4#1)(2010-7#1)
self-assembled on##3##2##(2008-10#3)
self-assembled##81##1##(1990-4#1)(1995-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#56)(2008-3#1)(2008-7#7)(2008-8#2)(2009-11#2)(2010-12#3)(2010-4#2)(2010-7#1)(2012-2#1)
self-assembling##3##1##(2008-10#1)(2008-2#1)(2012-2#1)
self-assembly of diblock copolymers##2##4##(2008-10#1)(2008-3#1)
self-assembly of##15##2##(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-5#2)(2010-4#1)(2010-9#1)(2013-8#1)
self-assembly process##3##2##(1994-12#1)(2008-10#2)
self-assembly##52##1##(1990-7#2)(1994-12#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#10)(2009-11#2)(2009-12#3)(2009-5#3)(2010-4#1)(2010-9#1)(2013-8#7)
self-assessed skills##2##2##(2007-12#2)
self-assessed##4##1##(2007-12#3)(2008-10#1)
self-assessment of##3##2##(2008-1#1)(2008-5#1)(2013-8#1)
self-assessment##22##1##(1993-2#1)(1995-3#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-5#2)(2008-9#4)(2009-9#2)(2010-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
self-assessments##4##1##(1992-3#2)(2008-5#1)(2008-7#1)
self-association##2##1##(1992-6#1)(1997-2#1)
self-awareness and##2##2##(2008-1#1)(2008-11#1)
self-awareness##13##1##(2008-1#1)(2008-11#3)(2008-12#4)(2012-12#2)(2012-3#1)(2013-1#2)
self-blame##3##1##(2008-11#1)(2010-1#2)
self-burning##3##1##(2011-2#3)
self-calibration##2##1##(2008-3#2)
self-care activities##4##2##(1990-5#2)(2007-11#1)(2010-10#1)
self-care self-efficacy##3##2##(2010-2#3)
self-care##19##1##(1990-5#2)(1995-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-2#3)(2010-5#1)(2010-7#1)
self-catheterisation##2##1##(2008-6#1)(2008-7#1)
self-cleaning##2##1##(1996-12#1)(2008-7#1)
self-competence and intrinsic value for math and English##2##8##(2009-7#2)
self-competence##3##1##(2009-7#3)
self-complementary##2##1##(1992-6#1)(2008-10#1)
self-completion questionnaires##2##2##(2008-8#1)(2010-5#1)
self-concept of##2##2##(2008-11#1)(2009-7#1)
self-concept##14##1##(2008-11#2)(2009-7#11)(2010-3#1)
self-concepts##3##1##(2010-3#3)
self-confidence##4##1##(1990-12#1)(2007-6#2)(2012-3#1)
self-consciousness##2##1##(2007-12#2)
self-consistency##2##1##(1996-4#1)(2007-12#1)
self-consistent##11##1##(1990-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)
self-contained##10##1##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
self-control##9##1##(2008-12#7)(2008-5#1)(2011-1#1)
self-cured##2##1##(1996-12#1)(2013-1#1)
self-cycling fermentation##2##2##(2008-7#2)
self-defense##3##1##(2008-10#2)(2010-11#1)
self-defining##2##1##(2010-8#2)
self-depressive (anxious)##2##2##(2010-8#2)
self-determination##6##1##(1991-2#2)(1997-8#3)(2010-12#1)
self-developed##2##1##(2008-1#1)(2008-12#1)
self-diffraction##7##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
self-diffusion behavior of the##2##4##(2008-3#2)
self-diffusion behavior of##3##3##(2008-3#3)
self-diffusion##5##1##(1995-3#1)(2008-3#4)
self-directed learning##4##2##(2008-11#1)(2008-12#2)(2010-2#1)
self-directed work teams##7##3##(1993-12#5)(1994-1#1)(1994-3#1)
self-directed##17##1##(1993-12#5)(1994-1#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-11#3)(2008-12#2)(2009-11#1)(2010-2#1)(2013-1#1)
self-doubling##2##1##(2007-11#1)(2008-2#1)
self-efficacy and##7##2##(1992-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-9#2)
self-efficacy in##3##2##(2012-2#2)(2012-3#1)
self-efficacy of##2##2##(2008-12#1)(2010-9#1)
self-efficacy##48##1##(1992-1#1)(1993-12#4)(2008-11#1)(2008-12#8)(2008-4#4)(2008-7#1)(2008-9#2)(2009-3#2)(2009-5#2)(2009-7#1)(2010-2#5)(2010-9#4)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)
self-emission##3##1##(2008-2#2)(2008-3#1)
self-enhance##2##1##(2008-5#2)
self-enhancement effect##2##2##(2008-3#1)(2008-5#1)
self-enhancement gain##2##2##(2008-3#2)
self-enhancement in dichromated-gelatin gratings##2##4##(2008-3#2)
self-enhancement in##3##2##(2008-3#3)
self-enhancement##11##1##(2008-3#8)(2008-5#3)
self-esteem and cognitive coping##2##4##(2008-11#2)
self-esteem and##10##2##(1994-12#1)(1995-2#1)(2008-11#4)(2008-5#1)(2008-7#1)(2010-3#1)(2010-7#1)
self-esteem is##2##2##(1993-3#2)
self-esteem of##3##2##(1990-2#1)(1993-3#1)(2008-11#1)
self-esteem was##3##2##(1995-2#1)(2008-11#1)(2012-2#1)
self-esteem##62##1##(1990-2#1)(1992-3#1)(1993-3#4)(1994-12#2)(1995-2#2)(1996-2#1)(2007-12#8)(2008-11#9)(2008-12#3)(2008-5#2)(2008-7#2)(2008-9#2)(2009-11#2)(2009-5#6)(2009-7#6)(2010-1#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)
self-evaluation or self-improvement##2##3##(2007-12#2)
self-evaluation##10##1##(1990-2#1)(1994-1#1)(1994-6#2)(2007-12#4)(2008-5#1)(2012-12#1)
self-evaluative##2##1##(2007-12#1)(2013-8#1)
self-examination##6##1##(1990-8#1)(1994-2#1)(2007-10#2)(2013-1#2)
self-exchange in##2##2##(1993-11#1)(1997-7#1)
self-exchange##4##1##(1993-11#2)(1994-5#1)(1997-7#1)
self-expandable valved stent##2##3##(2007-8#2)
self-expandable##5##1##(2007-8#2)(2013-1#3)
self-expanding##6##1##(1990-8#1)(2007-8#3)(2011-1#1)(2011-2#1)
self-fertile##2##1##(2008-10#2)
self-fertilization##8##1##(2008-8#4)(2008-9#3)(2013-1#1)
self-fertilizing##2##1##(2008-5#2)
self-focus##4##1##(2010-10#4)
self-focused people made##2##3##(2012-12#2)
self-focused##4##1##(2008-11#1)(2009-5#1)(2012-12#2)
self-focusing and##3##2##(2007-11#1)(2007-12#2)
self-focusing in bulk media##2##4##(2007-12#2)
self-focusing in the##3##3##(2007-12#2)(2008-3#1)
self-focusing in##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
self-focusing of##3##2##(2007-11#1)(2007-12#2)
self-focusing##24##1##(2007-11#9)(2007-12#12)(2008-2#1)(2008-3#2)
self-formed##2##1##(2007-12#1)(2009-11#1)
self-frequency shift##6##2##(2007-11#5)(2007-12#1)
self-frequency##8##1##(2007-11#6)(2007-12#2)
self-frequency-doubling##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
self-generated##3##1##(2008-11#2)(2009-8#1)
self-guided##2##1##(2007-12#2)
self-guiding##3##1##(2007-12#3)
self-harm##8##1##(2008-11#1)(2009-7#2)(2009-9#1)(2012-12#1)(2013-1#3)
self-harming##2##1##(2010-9#1)(2012-1#1)
self-healing##3##1##(1991-11#1)(2009-9#1)(2010-12#1)
self-help groups and##3##3##(1994-1#1)(1996-3#1)(2008-4#1)
self-help groups##12##2##(1994-1#2)(1994-12#1)(1995-1#2)(1996-3#2)(2008-4#4)(2011-2#1)
self-help networks##2##2##(1994-1#2)
self-help##29##1##(1994-1#9)(1994-12#2)(1995-1#2)(1995-3#1)(1996-3#9)(2008-4#4)(2010-10#1)(2011-2#1)
self-identification##2##1##(2009-7#2)
self-identified lesbian and bisexual##2##4##(2008-12#2)
self-identified##5##1##(1996-3#1)(2006-10#1)(2008-12#2)(2010-7#1)
self-image and##3##2##(2008-7#1)(2009-1#1)(2011-2#1)
self-image##5##1##(1991-2#1)(2008-7#1)(2009-1#1)(2011-2#2)
self-imaging##8##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#2)
self-improvement##7##1##(1997-1#2)(2007-12#4)(2009-5#1)
self-inactivation##2##1##(1995-5#2)
self-incompatibility##3##1##(1992-8#1)(2009-10#2)
self-incompatible##3##1##(2008-10#3)
self-induced attitude##2##2##(2008-5#2)
self-induced modulational instability##2##3##(2007-11#2)
self-induced##7##1##(2007-11#3)(2008-3#2)(2008-5#2)
self-inflicted injuries##2##2##(1992-2#1)(1995-8#1)
self-inflicted##3##1##(1992-2#1)(1995-8#2)
self-initiated behavioral##2##2##(2012-2#2)
self-injection feedback##3##2##(2007-12#3)
self-injection##5##1##(2007-12#3)(2009-3#2)
self-injurious behavior (SIB)##2##3##(2008-11#1)(2009-10#1)
self-injurious behavior##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
self-injury##4##1##(2008-11#4)
self-insured##6##1##(1993-1#2)(1994-12#1)(1995-12#1)(1997-2#1)(1997-3#1)
self-interest##3##1##(1991-2#1)(1994-3#1)(2008-10#1)
self-ligated##2##1##(1993-9#1)(1997-2#1)
self-ligating brackets##3##2##(2009-7#3)
self-ligating##4##1##(2009-7#4)
self-limited##6##1##(1991-4#1)(1992-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
self-limiting disease##2##2##(1996-6#1)(2011-1#1)
self-limiting disorder##2##2##(1991-9#1)(2012-3#1)
self-limiting##11##1##(1991-9#1)(1992-2#1)(1994-11#1)(1996-6#1)(2007-12#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-1#2)(2012-3#1)
self-managed##2##1##(1992-1#1)(2012-12#1)
self-management and##3##2##(1992-12#1)(2010-5#1)(2011-2#1)
self-management of##3##2##(2010-4#1)(2013-1#2)
self-management policy##2##2##(2012-12#2)
self-management##23##1##(1992-12#1)(1993-12#3)(1994-3#2)(2008-1#2)(2008-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#4)
self-measurement of##2##2##(1991-3#1)(2011-2#1)
self-medication with##2##2##(1995-2#1)(2012-2#1)
self-medication##8##1##(1995-2#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-2#1)
self-mixing laser diode##3##3##(2008-3#3)
self-mixing laser##5##2##(2008-3#5)
self-mixing##11##1##(2007-11#1)(2007-12#2)(2008-3#8)
self-mode locking##3##2##(2008-3#3)
self-mode-locked Ti##3##2##(2007-12#2)(2008-3#1)
self-mode-locked##6##1##(2007-12#4)(2008-3#2)
self-modeling curve resolution##2##3##(2007-12#2)
self-modeling##3##1##(2007-12#2)(2008-10#1)
self-modulation##8##1##(2007-11#6)(2007-12#2)
self-monitored##2##1##(2008-1#1)(2008-11#1)
self-monitoring of##3##2##(1990-3#1)(2008-8#1)(2009-11#1)
self-monitoring##12##1##(1990-3#1)(1992-12#1)(2008-11#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-9#1)
self-motion perception##2##2##(1996-5#2)
self-motion##4##1##(1996-5#4)
self-mutilation in nonpsychotic##2##3##(2009-10#2)
self-mutilation##3##1##(2009-10#3)
self-ordered ring##2##2##(2008-10#2)
self-organization in##4##2##(1990-4#1)(2008-3#1)(2008-8#1)(2008-9#1)
self-organization##9##1##(1990-4#1)(1996-4#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-9#1)(2011-2#1)
self-organized##3##1##(2008-1#1)(2011-2#1)(2012-1#1)
self-organizing emergence of##2##3##(2008-8#2)
self-organizing map##2##2##(2008-7#1)(2012-1#1)
self-organizing neural network##5##3##(2008-3#5)
self-organizing##16##1##(1997-6#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#1)(2012-1#1)
self-paced reading##3##2##(2013-1#3)
self-paced##9##1##(1991-3#1)(1996-3#1)(2008-7#1)(2013-1#5)(2013-8#1)
self-perceived##6##1##(1993-2#1)(2007-11#1)(2008-5#1)(2008-8#2)(2010-8#1)
self-perception after##2##2##(2013-1#2)
self-perception and##2##2##(2007-12#1)(2008-5#1)
self-perception of health literacy##2##4##(2013-7#2)
self-perception of##4##2##(2007-2#1)(2008-5#1)(2013-7#2)
self-perception##11##1##(2007-12#1)(2007-2#1)(2008-5#2)(2009-6#1)(2012-2#1)(2013-1#3)(2013-7#2)
self-perceptions##4##1##(2007-12#3)(2012-2#1)
self-phase modulation and##4##3##(2007-11#2)(2007-12#2)
self-phase modulation in##4##3##(2007-11#2)(2007-12#2)
self-phase modulation is##2##3##(2007-11#2)
self-phase modulation of##3##3##(2007-11#2)(2007-12#1)
self-phase modulation##22##2##(2007-11#12)(2007-12#6)(2008-2#3)(2008-3#1)
self-phase##23##1##(2007-11#13)(2007-12#6)(2008-2#3)(2008-3#1)
self-pollination##4##1##(2008-9#4)
self-practice##2##1##(2008-10#1)(2009-6#1)
self-processing##2##1##(1995-6#1)(2008-11#1)
self-protective##2##1##(2010-12#1)(2012-2#1)
self-pumped phase conjugation##3##3##(2008-2#2)(2008-3#1)
self-pumped phase conjugator##2##3##(2008-3#2)
self-pumped phase##6##2##(2008-2#3)(2008-3#3)
self-pumped phase-conjugate##6##2##(2008-2#4)(2008-3#2)
self-pumped##12##1##(2008-2#7)(2008-3#5)
self-quenching of##2##2##(1993-11#1)(2009-11#1)
self-quenching##3##1##(1993-11#1)(2008-10#1)(2009-11#1)
self-rated health (SRH)##2##3##(2011-2#1)(2013-1#1)
self-rated health##7##2##(2009-11#1)(2011-2#3)(2013-1#2)(2013-8#1)
self-rated perception of health##2##4##(2007-11#2)
self-rated##13##1##(2007-11#2)(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
self-rating##4##1##(1990-3#1)(1992-2#1)(2008-7#1)(2012-3#1)
self-ratings##2##1##(1995-12#1)(1996-7#1)
self-reference##6##1##(2008-10#1)(2008-9#5)
self-referenced##4##1##(2007-11#2)(2008-10#2)
self-referencing technique for##2##3##(2007-11#2)
self-referencing##5##1##(2007-11#3)(2007-12#1)(2008-2#1)
self-referential##3##1##(2008-11#1)(2008-3#1)(2013-8#1)
self-referrals##2##1##(1993-5#1)(1993-8#1)
self-reflection and##2##2##(2008-11#2)
self-reflection##9##1##(2008-11#4)(2008-6#4)(2012-3#1)
self-regenerating##2##1##(2008-10#2)
self-regulate##2##1##(2013-8#2)
self-regulated##2##1##(2010-1#1)(2010-4#1)
self-regulating##3##1##(1995-6#1)(2008-1#1)(2009-9#1)
self-regulation##12##1##(2008-12#3)(2012-3#5)(2013-1#1)(2013-7#3)
self-regulatory##2##1##(2009-5#1)(2012-12#1)
self-reliant##2##1##(2010-10#1)(2010-8#1)
self-renew##3##1##(2008-10#1)(2008-4#1)(2009-3#1)
self-renewal and senescence##3##3##(2013-1#3)
self-renewal and##7##2##(1990-5#1)(2008-4#1)(2009-3#1)(2009-9#1)(2013-1#3)
self-renewal capacity##2##2##(2008-6#1)(2009-12#1)
self-renewal divisions##2##2##(2009-12#1)(2012-2#1)
self-renewal in##2##2##(2008-8#1)(2009-12#1)
self-renewal##20##1##(1990-5#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#3)(2009-3#2)(2009-9#1)(2012-2#1)(2013-1#4)
self-renewing##6##1##(1995-11#1)(2012-12#1)(2013-1#4)
self-replicating##3##1##(1997-6#1)(2008-11#1)(2008-8#1)
self-report data##4##2##(2008-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
self-report measure##3##2##(1996-2#1)(2010-4#1)(2012-1#1)
self-report measures##9##2##(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
self-report of##2##2##(2007-12#1)(2011-1#1)
self-report questionnaires##2##2##(2010-8#1)(2012-2#1)
self-report scales##3##2##(2012-2#2)(2013-1#1)
self-report##36##1##(1996-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#3)(2013-1#6)(2013-8#1)
self-reported adverse##2##2##(1991-1#1)(2008-11#1)
self-reported diabetes mellitus##3##3##(1990-9#2)(2008-11#1)
self-reported function##2##2##(2008-12#1)(2013-1#1)
self-reported functional##2##2##(2008-3#1)(2012-3#1)
self-reported health status##4##3##(1992-9#1)(1995-12#1)(2008-10#1)(2008-8#1)
self-reported health##6##2##(1992-9#1)(1993-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
self-reported physical##4##2##(2008-4#1)(2012-2#1)(2013-1#2)
self-reported smoking##2##2##(1994-6#1)(2013-1#1)
self-reported use of##2##3##(1991-9#1)(2008-12#1)
self-reported##68##1##(1990-9#2)(1991-1#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-6#3)(1995-12#1)(1996-2#1)(1996-3#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#6)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#9)
self-reporting##3##1##(1993-3#1)(2011-2#1)(2013-1#1)
self-reports of##3##2##(2008-4#1)(2009-11#1)(2009-7#1)
self-reports##5##1##(2008-10#1)(2008-4#1)(2009-11#1)(2009-7#1)(2012-12#1)
self-reproducing##2##1##(2008-8#1)(2008-9#1)
self-respect##2##1##(1997-2#1)(2010-10#1)
self-restraint##2##1##(2007-2#1)(2008-12#1)
self-retaining##2##1##(1991-2#1)(1992-1#1)
self-schemas and##2##2##(2010-8#2)
self-schemas##4##1##(2010-8#4)
self-selected##3##1##(2008-3#1)(2008-8#1)(2011-2#1)
self-selection##3##1##(1990-6#1)(2008-8#1)(2010-3#1)
self-serving bias##2##2##(2008-5#1)(2010-2#1)
self-serving judgments##3##2##(2008-6#3)
self-serving##12##1##(2008-5#1)(2008-6#3)(2009-9#6)(2010-2#2)
self-similar##6##1##(1992-11#1)(1996-4#1)(2007-12#2)(2008-11#1)(2008-2#1)
self-similarity##4##1##(1996-4#1)(2008-11#1)(2008-2#1)(2008-8#1)
self-sorted##2##1##(2008-10#2)
self-sorting and##2##2##(2008-10#2)
self-specific##4##1##(2013-8#4)
self-starting Kerr-lens##2##2##(2007-11#1)(2007-12#1)
self-starting and##2##2##(2007-11#1)(2007-12#1)
self-starting##11##1##(2007-11#3)(2007-12#6)(2008-3#2)
self-steepening##2##1##(2007-11#1)(2007-12#1)
self-stimulation of##2##2##(1992-11#1)(1996-2#1)
self-stimulation##12##1##(1991-2#2)(1992-11#2)(1993-6#5)(1994-3#1)(1996-2#2)
self-strangulation##2##1##(2012-12#2)
self-stretching##3##1##(2010-9#3)
self-sufficiency##3##1##(1992-12#1)(1994-2#2)
self-sufficient##2##1##(1995-2#1)(2008-3#1)
self-supporting##2##1##(1994-2#1)(1996-3#1)
self-sustained##2##1##(2007-11#1)(2009-8#1)
self-sustaining##5##1##(2008-10#4)(2008-8#1)
self-tanning formulations##2##2##(2008-5#2)
self-tanning##4##1##(2008-5#4)
self-testing##2##1##(2007-2#2)
self-trapped beams##2##2##(2007-12#2)
self-trapped##9##1##(1992-8#1)(2007-11#3)(2007-12#5)
self-trapping##4##1##(2007-12#4)
self-weighted alternating trilinear decomposition (SWATLD)##2##5##(2008-10#2)
self-worth##5##1##(2008-11#1)(2009-7#1)(2009-9#3)
self-written##3##1##(2007-11#1)(2007-12#2)
self/identity##2##1##(2010-4#2)
selfed##5##1##(2008-10#4)(2008-8#1)
selfing rate##2##2##(2008-8#2)
selfing rates and##2##3##(2008-8#1)(2008-9#1)
selfing rates##6##2##(2008-8#4)(2008-9#2)
selfing##23##1##(2008-10#4)(2008-8#9)(2008-9#10)
selfish genetic##2##2##(2012-3#1)(2013-1#1)
selfish##8##1##(2008-8#2)(2008-9#3)(2009-6#1)(2012-3#1)(2013-1#1)
selfishness is##3##2##(2008-9#3)
selfishness##6##1##(2008-9#5)(2010-2#1)
sell##3##1##(1991-9#1)(1997-2#1)(2008-5#1)
sella##12##1##(1991-11#1)(1991-6#1)(1997-3#1)(2006-12#1)(2011-2#4)(2013-1#4)
sellae and the##2##3##(2006-12#1)(2011-2#1)
sellae##3##1##(2006-12#1)(2011-2#2)
sellar volume##3##2##(2011-2#3)
sellar##10##1##(2011-2#3)(2012-3#5)(2013-1#2)
selling medications##2##2##(2008-9#2)
selling##8##1##(1992-2#1)(1996-1#1)(2008-12#1)(2008-9#3)(2009-10#1)(2012-12#1)
selon##2##1##(2013-1#2)
selves##10##1##(2008-12#1)(2010-6#8)(2013-1#1)
sema##3##1##(1993-12#3)
semagenesis##2##1##(2009-8#2)
semantic dementia (SD)##4##3##(2008-4#1)(2009-2#2)(2009-9#1)
semantic dementia##8##2##(2008-4#1)(2008-9#1)(2009-2#4)(2009-9#2)
semantic differential##4##2##(1991-2#1)(1993-2#1)(1993-3#1)(2012-2#1)
semantic information##4##2##(2008-2#2)(2008-4#1)(2009-2#1)
semantic intervention##3##2##(2011-1#3)
semantic knowledge##4##2##(1996-7#1)(2007-8#1)(2008-4#1)(2009-2#1)
semantic network of patients with##2##5##(1996-7#2)
semantic network##5##2##(1996-7#3)(2008-7#2)
semantic networks##3##2##(1996-7#3)
semantic processing##3##2##(1990-8#1)(1991-2#1)(1996-2#1)
semantic retrieval##3##2##(2007-8#3)
semantic types##2##2##(2008-7#2)
semantic web##2##2##(2008-7#1)(2010-8#1)
semantic##69##1##(1990-8#2)(1991-2#4)(1993-2#1)(1993-3#1)(1996-2#3)(1996-7#7)(2007-8#4)(2008-2#3)(2008-4#7)(2008-6#1)(2008-7#6)(2008-9#2)(2009-2#10)(2009-5#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#6)(2012-2#1)(2012-3#1)(2013-8#1)
semantically##4##1##(2008-7#1)(2009-10#1)(2010-10#1)(2010-5#1)
semantics##4##1##(2008-6#1)(2009-11#1)(2010-4#1)(2013-8#1)
semantics)##2##1##(2013-8#2)
semaphorins##2##1##(2009-8#2)
semen and##4##2##(1991-12#1)(2009-10#1)(2011-1#1)(2013-1#1)
semen from##2##2##(1991-8#1)(2008-6#1)
semen of##3##2##(2008-12#2)(2013-1#1)
semen pH##2##2##(2008-7#2)
semen parameters in##2##3##(2007-10#1)(2010-12#1)
semen quality##4##2##(1996-9#1)(2008-7#1)(2010-12#1)(2010-2#1)
semen volume##4##2##(2008-7#4)
semen##37##1##(1991-12#1)(1991-8#1)(1992-6#1)(1994-8#1)(1996-9#1)(2007-10#2)(2008-12#6)(2008-6#1)(2008-7#8)(2009-10#1)(2009-4#2)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#3)
semeniperda##7##1##(2008-10#7)
semester of##4##2##(1991-12#1)(2009-3#1)(2012-3#2)
semester##16##1##(1991-12#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-3#2)(2009-3#1)(2010-3#2)(2011-2#2)(2012-3#3)(2013-8#1)
semesters##3##1##(1996-1#1)(2008-3#1)(2010-3#1)
semi-aquatic##2##1##(2007-12#1)(2013-8#1)
semi-arid##3##1##(2008-8#1)(2010-10#1)(2012-9#1)
semi-automated##8##1##(2008-10#6)(2009-10#1)(2010-12#1)
semi-automatic##6##1##(1993-8#2)(1995-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
semi-batch##4##1##(2008-10#3)(2009-10#1)
semi-deep and deep tillage##3##4##(2008-12#3)
semi-deep tillage##2##2##(2008-12#2)
semi-deep##6##1##(2008-12#6)
semi-defined##2##1##(2008-10#1)(2008-5#1)
semi-definite tensors##2##2##(2013-1#2)
semi-dwarf##3##1##(2008-9#3)
semi-dwarfing##2##1##(2008-10#2)
semi-empirical##7##1##(1990-9#1)(1992-4#1)(1994-12#1)(1997-2#1)(2008-7#1)(2008-9#1)(2011-3#1)
semi-implantable##2##1##(2008-9#2)
semi-implicit##2##1##(2008-6#1)(2013-8#1)
semi-infinite turbid##3##2##(2008-2#2)(2008-3#1)
semi-infinite##12##1##(2007-11#1)(2008-10#1)(2008-2#6)(2008-3#4)
semi-insulating GaAs##2##2##(2007-12#1)(2008-2#1)
semi-insulating##5##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
semi-liquid core microcapsules##2##3##(2008-11#2)
semi-permanent##2##1##(2008-5#1)(2013-7#1)
semi-permeabilized##2##1##(2008-1#2)
semi-preparative scale##2##2##(2008-10#2)
semi-preparative##5##1##(1990-8#1)(2008-10#3)(2008-5#1)
semi-quantitative PCR##2##2##(1994-11#1)(2011-2#1)
semi-quantitative RT-PCR and##2##3##(2008-8#1)(2011-3#1)
semi-quantitative RT-PCR##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)
semi-quantitative analysis of##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
semi-quantitative calibration##2##2##(2008-10#2)
semi-quantitative##25##1##(1993-9#1)(1994-11#1)(1994-2#1)(1997-3#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#4)(2011-3#1)
semi-quantum dielectric function models##2##4##(2007-12#2)
semi-random mutagenesis##2##2##(1992-8#2)
semi-solid##4##1##(2008-5#2)(2008-8#1)(2009-10#1)
semi-static and PGA-alginate##3##3##(2011-2#3)
semi-static and##4##2##(2011-2#4)
semi-static seeding##2##2##(2011-2#2)
semi-static##6##1##(2011-2#6)
semi-structured interview guide##2##3##(2008-4#1)(2011-1#1)
semi-structured interview##6##2##(2008-1#1)(2008-4#1)(2010-6#1)(2011-1#1)(2012-3#2)
semi-structured interviews and##2##3##(2007-10#1)(2013-8#1)
semi-structured interviews were conducted with##2##5##(2008-12#1)(2013-1#1)
semi-structured interviews were##3##3##(2008-1#1)(2008-12#1)(2013-1#1)
semi-structured interviews with##9##3##(1996-1#1)(2008-12#2)(2009-10#2)(2013-1#4)
semi-structured interviews##24##2##(1991-6#1)(1996-1#1)(2007-10#2)(2008-1#2)(2008-12#3)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
semi-structured questionnaires##2##2##(2008-1#1)(2008-7#1)
semi-structured##45##1##(1991-6#1)(1995-1#1)(1996-1#1)(2006-10#1)(2007-10#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
semi-supervised learning based method##2##4##(2010-7#2)
semi-supervised learning##4##2##(2010-7#4)
semi-thin sections##2##2##(1997-2#1)(2007-12#1)
semi-thin##3##1##(1997-2#2)(2007-12#1)
semi-treated##2##1##(2008-10#1)(2008-5#1)
semi-urban##3##1##(1997-4#1)(2008-3#1)(2011-2#1)
semi-volatile##3##1##(2008-10#1)(2009-8#2)
semialdehyde reductase##5##2##(1997-2#5)
semialdehyde##11##1##(1991-7#1)(1997-2#7)(2008-11#1)(2010-4#2)
semialdehydes##2##1##(2010-4#2)
semianalytical##4##1##(2008-2#3)(2008-3#1)
semiarid##5##1##(2008-8#3)(2008-9#1)(2013-8#1)
semiautomated##3##1##(1994-6#2)(2008-9#1)
semicarbazide and hydrazine in##3##4##(2008-10#3)
semicarbazide and hydrazine##6##3##(2008-10#6)
semicarbazide##10##1##(1990-12#1)(2008-10#9)
semicircular##7##1##(1992-4#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
semiclassical##3##1##(1992-8#1)(2008-2#1)(2010-7#1)
semiconducting behaviour##2##2##(2008-7#1)(2010-12#1)
semiconducting##8##1##(2007-11#1)(2008-10#4)(2008-7#2)(2010-12#1)
semiconductor (CMOS)##2##2##(2008-3#1)(2008-7#1)
semiconductor coupled-waveguide structures##2##3##(2008-3#2)
semiconductor diode lasers##3##3##(2007-11#1)(2007-12#2)
semiconductor diode##5##2##(2007-11#3)(2007-12#2)
semiconductor guiding layer##2##3##(2008-3#2)
semiconductor industry##2##2##(2008-10#1)(2008-7#1)
semiconductor is##4##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-7#1)
semiconductor laser Michelson interferometer##2##4##(2008-3#2)
semiconductor laser and##3##3##(2008-2#1)(2008-3#2)
semiconductor laser arrays##2##3##(2007-11#1)(2007-12#1)
semiconductor laser as a##2##4##(2007-11#1)(2008-10#1)
semiconductor laser by##2##3##(2007-11#1)(2007-12#1)
semiconductor laser diode##3##3##(2007-11#1)(2008-3#2)
semiconductor laser locked directly to an##2##6##(2007-12#2)
semiconductor laser radar##2##3##(2008-3#2)
semiconductor laser with an##2##4##(2008-3#2)
semiconductor laser with##4##3##(2007-12#1)(2008-3#3)
semiconductor laser##60##2##(2007-11#12)(2007-12#19)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#19)
semiconductor lasers is##2##3##(2007-12#2)
semiconductor lasers##22##2##(2007-11#8)(2007-12#9)(2008-2#2)(2008-3#3)
semiconductor materials##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
semiconductor modulator##3##2##(2007-11#1)(2007-12#2)
semiconductor nanocrystals to a fused-silica microsphere##2##6##(2007-12#2)
semiconductor nanocrystals##4##2##(2007-12#3)(2008-7#1)
semiconductor nanostructures##3##2##(2007-12#1)(2008-7#2)
semiconductor optical amplifier##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
semiconductor optical amplifiers##6##3##(2007-11#2)(2007-12#3)(2008-2#1)
semiconductor optical##14##2##(2007-11#3)(2007-12#8)(2008-2#1)(2008-3#2)
semiconductor quantum dots##6##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-7#3)
semiconductor quantum##7##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#3)
semiconductor ring lasers##2##3##(2007-11#2)
semiconductor saturable absorber mirror##3##4##(2007-11#2)(2007-12#1)
semiconductor saturable absorber##6##3##(2007-11#2)(2007-12#3)(2008-2#1)
semiconductor saturable absorbers##2##3##(2007-12#2)
semiconductor saturable##10##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#1)
semiconductor saturable-absorber mirror and emits##2##5##(2007-11#1)(2007-12#1)
semiconductor saturable-absorber mirror##8##3##(2007-11#2)(2007-12#5)(2008-3#1)
semiconductor saturable-absorber##9##2##(2007-11#2)(2007-12#6)(2008-3#1)
semiconductor sensor for##2##3##(2008-10#2)
semiconductor sensor##4##2##(2008-10#4)
semiconductor technology##2##2##(1995-11#1)(2008-7#1)
semiconductor transducer##2##2##(2008-10#2)
semiconductor wafer##2##2##(2007-12#1)(2008-10#1)
semiconductor waveguide##2##2##(2007-12#1)(2008-3#1)
semiconductor waveguides##2##2##(2008-3#2)
semiconductor with##2##2##(2007-12#1)(2012-2#1)
semiconductor##233##1##(1990-11#1)(1990-12#1)(1995-11#1)(1995-3#1)(2007-11#51)(2007-12#74)(2007-8#1)(2008-10#17)(2008-2#18)(2008-3#45)(2008-5#1)(2008-7#13)(2008-8#4)(2012-2#5)
semiconductors in##2##2##(2007-12#1)(2008-7#1)
semiconductors on##2##2##(2007-12#1)(2008-7#1)
semiconductors##19##1##(1990-5#1)(1992-8#1)(2007-11#3)(2007-12#5)(2008-3#4)(2008-7#3)(2008-9#1)(2012-2#1)
semiconfocal##2##1##(2008-2#2)
semicontinuous fermentation##3##2##(2008-6#3)
semicontinuous##6##1##(1992-8#1)(2008-11#1)(2008-6#3)(2008-7#1)
semideciduous tropical forest##2##3##(2008-5#2)
semidominant##2##1##(2008-10#2)
semiempirical molecular orbital methods##4##4##(2012-12#4)
semiempirical molecular orbital##5##3##(2008-11#1)(2012-12#4)
semiempirical##12##1##(1996-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2012-12#4)
semigestructureerde interviews##2##2##(2012-12#2)
semilaevis##4##1##(2010-8#3)(2013-8#1)
semilobar##2##1##(2011-1#2)
semimechanistic models##2##2##(2008-9#2)
semimonolithic##4##1##(2007-12#1)(2008-3#3)
seminal RNase##4##2##(1990-5#4)
seminal and adventitious##2##3##(2008-10#2)
seminal and##3##2##(2008-10#2)(2013-1#1)
seminal characteristics##3##2##(1991-6#2)(2009-4#1)
seminal fluid##4##2##(1997-8#1)(2011-1#2)(2011-2#1)
seminal gamma-GTP##3##2##(1995-11#3)
seminal plasma##5##2##(1990-5#2)(1994-3#2)(1994-6#1)
seminal receptacle##5##2##(2008-7#5)
seminal roots##3##2##(2008-10#2)(2008-9#1)
seminal vesicle##9##2##(1995-3#1)(2008-11#4)(2011-2#4)
seminal vesicles##9##2##(1991-2#1)(1997-8#2)(2008-7#3)(2012-12#3)
seminal##66##1##(1990-5#6)(1991-2#1)(1991-6#2)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#6)(1995-3#1)(1997-4#1)(1997-8#4)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-7#8)(2008-9#3)(2009-4#1)(2010-7#1)(2011-1#3)(2011-2#8)(2012-12#3)(2013-1#1)(2013-8#1)
seminar and##2##2##(1990-3#1)(1994-1#1)
seminar program##2##2##(1994-1#2)
seminar##18##1##(1990-2#1)(1990-3#1)(1993-1#2)(1994-1#5)(1994-2#1)(1995-1#1)(1996-3#1)(2008-1#1)(2008-12#3)(2008-4#1)(2010-1#1)
seminars and##2##2##(1992-3#1)(1994-12#1)
seminars for##2##2##(1994-12#1)(1996-3#1)
seminars##14##1##(1991-2#1)(1992-3#1)(1994-1#3)(1994-12#3)(1994-9#3)(1996-3#1)(2010-8#1)(2011-1#1)
seminiferous epithelium##24##2##(1990-9#1)(2009-10#14)(2012-2#9)
seminiferous tubule##5##2##(2008-5#1)(2009-10#2)(2012-2#1)(2013-1#1)
seminiferous tubules##6##2##(1995-6#2)(2008-7#1)(2009-10#2)(2013-8#1)
seminiferous##41##1##(1990-9#1)(1995-6#3)(2008-5#1)(2008-7#1)(2009-10#20)(2012-2#13)(2013-1#1)(2013-8#1)
seminoma and##3##2##(1990-9#1)(1997-3#1)(2008-6#1)
seminoma##14##1##(1990-9#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-3#1)(2007-5#1)(2007-9#1)(2008-6#7)
seminomas and##2##2##(1995-5#2)
seminomas##4##1##(1995-5#2)(2007-5#1)(2011-2#1)
semiologic##2##1##(2008-5#2)
semiology##2##1##(2008-7#1)(2012-3#1)
semiparametric model##4##2##(1996-2#1)(2010-11#2)(2011-1#1)
semiparametric##12##1##(1996-2#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-11#2)(2010-4#1)(2010-5#2)(2011-1#2)(2012-3#1)
semipenetrans and##2##2##(2008-10#2)
semipenetrans##3##1##(2008-10#3)
semiperiodic zones##2##2##(2007-11#2)
semipermanent##2##1##(2008-5#2)
semipreparative##2##1##(1990-12#1)(2008-11#1)
semiquantitative determination of##2##3##(2008-10#1)(2011-2#1)
semiquantitative evaluation of##2##3##(2007-12#1)(2008-10#1)
semiquantitative##13##1##(1993-12#1)(1995-11#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
semiquantitatively##4##1##(1991-5#1)(1996-12#2)(2008-5#1)
semiquinone##7##1##(1990-5#1)(1992-6#1)(1993-8#1)(1995-5#2)(2008-10#2)
semiquinones##2##1##(1994-8#1)(1996-2#1)
semiselective agar medium##3##3##(2008-10#3)
semiselective medium##6##2##(2008-10#6)
semiselective##12##1##(2008-10#12)
semisolid##7##1##(1995-2#1)(2007-8#1)(2008-10#1)(2008-5#4)
semistructured interviews##5##2##(2007-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
semistructured##13##1##(1993-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2009-5#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
semisynthetic##7##1##(1993-8#2)(1994-8#1)(2008-10#2)(2009-12#1)(2011-1#1)
semitaeniatus and T##2##3##(2008-7#2)
semitaeniatus and##3##2##(2008-7#3)
semitendinosus##4##1##(2013-1#4)
semithin##2##1##(1993-11#1)(2011-2#1)
semitransparent##7##1##(2007-12#1)(2008-2#1)(2008-3#5)
semivariance##2##1##(2008-10#2)
semivariogram analysis##2##2##(2008-10#1)(2008-11#1)
semivariogram parameters##2##2##(2008-10#2)
semivariogram##5##1##(2008-10#4)(2008-11#1)
semivolatile compounds##2##2##(2008-10#2)
semivolatile##6##1##(1994-9#1)(2008-10#5)
semivolatiles##3##1##(2008-10#3)
senS and##2##2##(1993-6#2)
senS##7##1##(1993-6#7)
send##15##1##(1990-12#1)(1991-3#1)(1994-12#1)(1995-1#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#1)
senders##2##1##(2013-1#2)
sending##4##1##(1991-10#1)(1995-11#1)(2008-4#1)(2013-1#1)
sends signals##2##2##(2008-11#2)
sends##9##1##(2007-12#2)(2008-11#2)(2008-3#1)(2009-1#3)(2009-10#1)
senegalensis##4##1##(2010-8#4)
senesced leaves##3##2##(2008-10#2)(2008-5#1)
senesced##5##1##(2008-10#3)(2008-5#1)(2013-1#1)
senescence accelerated mouse##2##3##(1991-12#2)
senescence accelerated##4##2##(1991-12#2)(2008-7#2)
senescence and##9##2##(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-2#1)
senescence as##2##2##(2008-8#1)(2009-12#1)
senescence in##8##2##(1990-5#1)(1994-11#1)(1994-9#1)(1997-7#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
senescence is##3##2##(2008-11#2)(2008-9#1)
senescence of the##2##3##(2008-10#2)
senescence pathways##4##2##(2012-3#2)(2013-1#2)
senescence##97##1##(1990-5#2)(1991-12#3)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#3)(1994-6#3)(1994-9#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-7#4)(2006-10#2)(2008-10#6)(2008-11#13)(2008-12#1)(2008-3#4)(2008-7#6)(2008-8#7)(2008-9#8)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#7)(2013-1#8)(2013-7#1)
senescence-associated##2##1##(2008-10#1)(2012-12#1)
senescence?##2##1##(1996-3#1)(2008-9#1)
senescent animals##2##2##(1993-12#1)(1994-5#1)
senescent cells##4##2##(1997-7#2)(2008-11#1)(2013-7#1)
senescent rats##7##2##(1991-2#3)(2008-3#1)(2013-7#3)
senescent##25##1##(1991-2#3)(1992-9#2)(1993-12#1)(1994-5#2)(1994-6#1)(1996-9#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2013-7#7)
senescing##3##1##(2008-10#2)(2008-3#1)
senile dementia of##3##3##(1994-5#1)(1994-6#2)
senile dementia##11##2##(1991-9#2)(1992-12#1)(1994-5#2)(1994-6#3)(1995-11#1)(2007-11#1)(2008-7#1)
senile lentigo represents a##2##4##(2011-2#2)
senile lentigo##3##2##(2011-2#3)
senile osteoporosis##2##2##(2008-7#2)
senile plaques and##2##3##(2008-7#2)
senile plaques in##2##3##(1993-3#1)(2008-7#1)
senile plaques##7##2##(1991-7#1)(1992-12#1)(1993-3#1)(2008-7#4)
senile##37##1##(1990-3#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#2)(1994-6#3)(1995-11#1)(2007-11#1)(2008-7#8)(2011-1#2)(2011-2#5)(2012-1#1)
senior administrators##2##2##(1993-12#1)(1994-2#1)
senior and##2##2##(1996-1#1)(2011-2#1)
senior author##5##2##(1993-12#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
senior citizens##2##2##(2008-4#1)(2008-7#1)
senior executive##2##2##(1993-12#1)(1996-12#1)
senior executives##2##2##(1993-3#1)(2008-7#1)
senior management positions##2##3##(1995-2#2)
senior management##9##2##(1992-12#1)(1992-2#1)(1993-1#2)(1993-2#1)(1995-2#2)(1995-3#1)(1996-1#1)
senior managers##5##2##(1992-3#1)(1993-2#1)(1997-2#1)(1997-3#1)(2008-1#1)
senior nursing##2##2##(2008-1#1)(2010-3#1)
senior student nurses##2##3##(2008-11#2)
senior volunteerism##5##2##(1994-2#4)(1996-3#1)
senior##75##1##(1990-3#2)(1991-12#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#2)(1994-2#6)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#3)(1997-3#2)(2007-3#1)(2008-1#2)(2008-11#2)(2008-12#5)(2008-4#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
seniority##6##1##(1991-12#1)(2008-10#2)(2011-2#2)(2013-1#1)
seniors##9##1##(1992-3#2)(1993-2#1)(1994-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-9#1)
senology##2##1##(1990-2#2)
sensation and##5##2##(1992-3#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)
sensation in the##3##3##(1990-3#1)(2008-7#1)(2013-1#1)
sensation in##5##2##(1990-3#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
sensation of##7##2##(1995-8#1)(1996-6#1)(2006-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
sensation seeking##2##2##(1994-2#1)(2013-8#1)
sensation##40##1##(1990-3#1)(1990-5#1)(1991-3#1)(1992-3#1)(1994-2#1)(1995-8#1)(1996-6#2)(1997-3#1)(2006-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
sensation-seeking##4##1##(2008-1#1)(2008-3#3)
sensations activated##2##2##(1995-12#2)
sensations are##2##2##(2008-4#1)(2009-10#1)
sensations##12##1##(1992-5#1)(1995-12#2)(2007-12#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)
sense RNA##3##2##(1992-8#1)(1997-6#1)(2012-3#1)
sense and antisense EDRF1 constructs were prepared and transfected into K562 cells##2##12##(2008-8#1)(2008-9#1)
sense and antisense##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
sense and respond to##2##4##(2010-11#1)(2012-1#1)
sense and##11##2##(1993-3#1)(2008-10#1)(2008-8#3)(2008-9#2)(2009-9#1)(2010-11#1)(2012-1#1)(2013-1#1)
sense changes in##2##3##(2008-4#1)(2009-8#1)
sense codons##2##2##(1993-9#1)(1996-3#1)
sense construct##3##2##(1994-10#1)(2008-8#2)
sense of balance##2##3##(2008-1#1)(2008-7#1)
sense of being##2##3##(2008-11#2)
sense of belonging##2##3##(2010-4#1)(2012-12#1)
sense of community##2##3##(1995-12#1)(1997-1#1)
sense of control##2##3##(1993-12#1)(1995-3#1)
sense of purpose##2##3##(2007-2#1)(2013-1#1)
sense of self##3##3##(2008-11#2)(2010-6#1)
sense of smell##5##3##(2008-7#1)(2012-2#1)(2013-1#3)
sense of taste##2##3##(2008-7#2)
sense of the word##2##4##(1995-5#2)
sense of the##8##3##(1995-5#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)
sense of their##2##3##(2008-11#1)(2009-5#1)
sense of well-being##3##3##(2008-7#2)(2011-2#1)
sense of##82##2##(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-9#2)(2009-10#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
sense organs##5##2##(1990-5#1)(2007-12#2)(2008-5#2)
sense primers##2##2##(2008-10#2)
sense the##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)
sense to implement##2##3##(2008-10#1)(2008-11#1)
sense to##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
sense transcript##2##2##(1994-11#1)(2008-7#1)
sense##200##1##(1990-5#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#3)(1996-3#5)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#6)(2008-10#13)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#2)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#2)
sense)##2##1##(2008-2#1)(2009-12#1)
sensed by the detector##2##4##(2008-10#2)
sensed by the##6##3##(2008-10#4)(2008-2#1)(2008-8#1)
sensed by##9##2##(1994-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)
sensed with##3##2##(2008-10#1)(2008-3#2)
sensed##31##1##(1992-5#1)(1994-6#1)(2007-5#1)(2008-10#11)(2008-2#2)(2008-3#9)(2008-5#1)(2008-8#3)(2009-11#1)(2010-2#1)
senses##6##1##(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2010-10#1)(2011-1#1)
sensibilities##2##1##(2008-11#1)(2008-8#1)
sensibility and##2##2##(2008-10#1)(2010-12#1)
sensibility to auxin##3##3##(2008-8#3)
sensibility to##4##2##(2007-10#1)(2008-8#3)
sensibility##11##1##(2007-10#2)(2008-10#3)(2008-8#4)(2008-9#1)(2010-12#1)
sensible and##2##2##(2008-10#1)(2011-2#1)
sensible##13##1##(1991-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
sensibly##4##1##(1990-5#1)(2008-10#1)(2008-5#1)(2010-8#1)
sensilla and##3##2##(2007-12#3)
sensilla basiconica II##3##3##(2007-12#3)
sensilla basiconica##5##2##(2007-12#5)
sensilla in##4##2##(1995-3#1)(2007-12#3)
sensilla of the##3##3##(2007-12#1)(2008-7#2)
sensilla of##8##2##(2007-12#2)(2008-5#1)(2008-7#3)(2010-11#2)
sensilla on the##3##3##(2007-12#3)
sensilla##64##1##(1995-3#3)(2007-12#40)(2008-5#1)(2008-7#7)(2008-8#6)(2010-11#7)
sensilla)##2##1##(2007-12#2)
sensillum styloconicum##5##2##(2008-8#5)
sensillum##16##1##(2007-12#6)(2008-7#2)(2008-8#5)(2010-11#3)
sensillum-lymph cavities##2##2##(2007-12#1)(2008-7#1)
sensillum-lymph##3##1##(2007-12#2)(2008-7#1)
sensing agent##2##2##(2008-10#2)
sensing and control##2##3##(2007-12#1)(2008-3#1)
sensing and power-delivery applications##2##4##(2008-3#2)
sensing and processing##2##3##(2008-6#2)
sensing and##25##2##(2007-12#1)(2008-10#4)(2008-3#7)(2008-6#2)(2008-8#3)(2009-11#2)(2009-8#1)(2010-10#1)(2010-8#2)(2011-1#2)
sensing application##2##2##(2008-10#1)(2008-2#1)
sensing applications##10##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-7#1)(2009-2#1)(2009-6#1)
sensing approach##3##2##(2008-10#2)(2010-2#1)
sensing are##2##2##(2008-10#1)(2008-2#1)
sensing area##2##2##(2008-9#2)
sensing arms##2##2##(2008-3#2)
sensing at##3##2##(2007-12#1)(2008-3#2)
sensing based on##2##3##(2007-11#1)(2008-3#1)
sensing beam##2##2##(2008-2#2)
sensing by optical##2##3##(2007-12#1)(2008-3#1)
sensing by using##2##3##(2008-10#1)(2013-8#1)
sensing by##9##2##(2007-12#4)(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)(2013-8#1)
sensing characteristics##4##2##(2008-10#4)
sensing device for##2##3##(2008-10#2)
sensing device##7##2##(2008-10#6)(2008-3#1)
sensing devices##5##2##(2008-10#2)(2010-6#1)(2010-7#1)(2012-2#1)
sensing electrode embedded in-plane nanopore##2##5##(2012-2#2)
sensing electrode##3##2##(2008-10#1)(2012-2#2)
sensing element consists of a##3##5##(2008-3#3)
sensing element##6##2##(2008-3#6)
sensing elements##5##2##(2008-10#4)(2009-11#1)
sensing fiber was##2##3##(2007-11#1)(2008-3#1)
sensing film##12##2##(2008-10#12)
sensing for##6##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)
sensing from##2##2##(2007-11#1)(2008-8#1)
sensing glass fiber##2##3##(2008-3#2)
sensing has been##2##3##(2008-2#1)(2008-3#1)
sensing in the##4##3##(1992-5#1)(2008-10#1)(2008-2#2)
sensing in##10##2##(1992-5#1)(2008-10#4)(2008-2#4)(2008-8#1)
sensing is accomplished by##2##4##(2007-12#1)(2008-2#1)
sensing is presented##2##3##(2007-11#1)(2008-10#1)
sensing is##15##2##(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#3)(2010-11#1)(2012-2#1)
sensing layer##3##2##(1995-3#1)(2008-10#1)(2010-5#1)
sensing length##3##2##(2007-11#1)(2007-12#2)
sensing material is successfully developed##2##5##(2008-10#2)
sensing material is##3##3##(2007-11#1)(2008-10#2)
sensing material##11##2##(2007-11#1)(2008-10#10)
sensing materials and##2##3##(2008-10#2)
sensing materials##3##2##(2008-10#3)
sensing mechanism##4##2##(2008-10#3)(2013-1#1)
sensing membrane##9##2##(2008-10#9)
sensing membranes##3##2##(2008-10#3)
sensing method##5##2##(2008-10#3)(2008-3#1)(2013-8#1)
sensing molecules##5##2##(2008-10#1)(2013-8#4)
sensing of a##2##3##(2007-12#1)(2008-2#1)
sensing of dopamine at the surface of##2##7##(2008-10#2)
sensing of dopamine##4##3##(2008-10#4)
sensing of nitric oxide##2##4##(2008-10#2)
sensing of ocean color##7##4##(2008-2#3)(2008-3#4)
sensing of ocean##8##3##(2008-2#4)(2008-3#4)
sensing of the##4##3##(2007-11#1)(2008-3#3)
sensing of##45##2##(2007-11#1)(2007-12#3)(2008-10#13)(2008-11#1)(2008-2#10)(2008-3#16)(2009-11#1)
sensing parts##2##2##(2008-10#2)
sensing phase##5##2##(2008-10#5)
sensing platform##3##2##(2008-10#2)(2013-1#1)
sensing properties of##2##3##(2008-10#2)
sensing properties##5##2##(2008-10#5)
sensing strategy##2##2##(2008-3#2)
sensing surface##2##2##(2008-10#2)
sensing system for##2##3##(2008-10#2)
sensing system has##2##3##(2008-10#2)
sensing system was developed using##2##5##(2008-10#2)
sensing system was##5##3##(2008-10#5)
sensing system##21##2##(2008-10#15)(2008-2#1)(2008-3#5)
sensing systems##4##2##(1995-2#2)(2007-11#1)(2008-2#1)
sensing technique##5##2##(2008-10#2)(2008-3#2)(2009-11#1)
sensing techniques##2##2##(2008-8#1)(2009-11#1)
sensing technologies##2##2##(2008-10#2)
sensing tip##2##2##(2008-10#2)
sensing using a##2##3##(2008-10#2)
sensing using##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
sensing was obtained for the electrode membrane containing##2##8##(2008-10#2)
sensing with a##2##3##(2008-2#1)(2008-3#1)
sensing with##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
sensing zone##4##2##(2008-10#4)
sensing##447##1##(1992-5#1)(1995-2#3)(1995-3#1)(2007-11#15)(2007-12#21)(2007-8#1)(2008-10#191)(2008-11#4)(2008-12#3)(2008-2#42)(2008-3#78)(2008-6#3)(2008-7#5)(2008-8#16)(2008-9#2)(2009-11#8)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2012-1#1)(2012-2#6)(2013-1#5)(2013-8#11)
sensitisation by##2##2##(1990-11#1)(1996-8#1)
sensitisation of##2##2##(2008-7#2)
sensitisation##10##1##(1990-11#5)(1996-1#1)(1996-8#1)(2008-7#2)(2011-2#1)
sensitise##2##1##(2011-2#1)(2013-8#1)
sensitised guinea-pigs##2##2##(1994-11#2)
sensitised##4##1##(1994-11#2)(2007-10#1)(2009-9#1)
sensitiser and##2##2##(2008-10#2)
sensitises##2##1##(2008-7#1)(2013-1#1)
sensitive (0##3##2##(1990-2#1)(2008-10#1)(2011-1#1)
sensitive (detection limit##3##3##(2008-10#3)
sensitive A(549)##2##2##(2008-9#2)
sensitive C-reactive protein##2##3##(2009-7#1)(2012-3#1)
sensitive CL##2##2##(2008-10#2)
sensitive FI-ECL response##2##3##(2008-10#2)
sensitive HPLC method##3##3##(1994-8#1)(2011-1#1)(2011-2#1)
sensitive K+##2##2##(1991-9#1)(2008-8#1)
sensitive absorption##4##2##(2007-12#1)(2008-10#3)
sensitive adsorptive##3##2##(2008-10#3)
sensitive amperometric sensor for##2##4##(2008-10#2)
sensitive amperometric##3##2##(2008-10#3)
sensitive analysis of##3##3##(2008-10#2)(2012-1#1)
sensitive analytical method for the##2##5##(2008-10#2)
sensitive analytical##4##2##(2008-10#4)
sensitive and accurate method##2##4##(2008-10#2)
sensitive and accurate##9##3##(2008-10#7)(2010-5#1)(2011-1#1)
sensitive and allows##2##3##(1995-11#1)(2008-11#1)
sensitive and convenient##4##3##(1994-11#1)(2008-10#3)
sensitive and effective##3##3##(1994-11#1)(2008-10#1)(2010-10#1)
sensitive and efficient##3##3##(2008-1#1)(2008-10#2)
sensitive and free##2##3##(2008-10#1)(2012-2#1)
sensitive and highly##2##3##(2008-10#2)
sensitive and insensitive##2##3##(2008-10#2)
sensitive and more##2##3##(1992-6#1)(2008-10#1)
sensitive and precise##3##3##(2008-3#1)(2013-8#2)
sensitive and rapid method##3##4##(1990-8#1)(2008-10#2)
sensitive and rapid##10##3##(1990-8#1)(2008-10#8)(2010-6#1)
sensitive and reliable detection##2##4##(2008-11#1)(2013-8#1)
sensitive and reliable method for##3##5##(1997-7#1)(2008-10#2)
sensitive and reliable##12##3##(1991-12#1)(1997-7#1)(2008-10#7)(2008-11#1)(2010-11#1)(2013-8#1)
sensitive and reproducible##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
sensitive and resistant P388 leukemia cells##2##6##(1991-12#1)(1991-4#1)
sensitive and resistant to##2##4##(1992-2#1)(2008-7#1)
sensitive and resistant##7##3##(1991-12#2)(1991-4#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
sensitive and robust##4##3##(2008-10#3)(2008-3#1)
sensitive and selective chemiluminescence (CL) method##2##6##(2008-10#2)
sensitive and selective detection of##3##5##(1995-6#1)(2008-10#2)
sensitive and selective flow injection##3##5##(2008-10#3)
sensitive and selective method for the determination of##3##8##(2008-10#3)
sensitive and selective method for the##4##6##(2008-10#4)
sensitive and selective method has been developed for##2##8##(2008-10#2)
sensitive and selective method has been##3##6##(2008-10#3)
sensitive and selective method is described for the determination of##2##10##(2008-10#2)
sensitive and selective method is described for##3##7##(2008-10#3)
sensitive and selective method is##7##5##(2008-10#7)
sensitive and selective method##16##4##(2008-10#15)(2008-5#1)
sensitive and selective methods##2##4##(2008-10#2)
sensitive and selective spectrophotometric##3##4##(2008-10#3)
sensitive and selective##58##3##(1995-6#1)(1997-2#1)(2008-10#53)(2008-5#1)(2009-3#1)(2013-1#1)
sensitive and simple method for##3##5##(2008-10#3)
sensitive and simple method##4##4##(2008-10#4)
sensitive and simple##8##3##(2008-10#8)
sensitive and simultaneous##2##3##(2008-10#2)
sensitive and specific detection of##3##5##(2008-10#2)(2010-5#1)
sensitive and specific diagnostic##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
sensitive and specific identification##2##4##(1996-12#1)(2008-9#1)
sensitive and specific method for##3##5##(2008-10#2)(2011-3#1)
sensitive and specific##24##3##(1990-12#1)(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-2#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-3#1)
sensitive and the##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
sensitive and##217##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-2#1)(1993-9#1)(1994-11#2)(1995-11#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-7#1)(2008-1#3)(2008-10#140)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-6#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
sensitive anodic stripping##2##3##(2008-10#2)
sensitive as##8##2##(1992-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)
sensitive assay for##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
sensitive assay of##3##3##(1991-2#1)(2008-10#2)
sensitive assay##12##2##(1991-2#1)(1992-9#1)(1995-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)
sensitive assays##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
sensitive at small distances##2##4##(2008-3#2)
sensitive automatic##2##2##(2008-10#2)
sensitive biosensor based on##2##4##(2008-10#2)
sensitive catalytic##2##2##(2008-10#2)
sensitive cell##3##2##(1991-4#1)(1993-9#1)(2008-11#1)
sensitive cells##5##2##(1990-2#3)(2008-8#2)
sensitive chemiluminescent##3##2##(2008-10#3)
sensitive chromium speciation procedure##2##4##(2008-10#2)
sensitive colorimetric##2##2##(2008-10#2)
sensitive cultivars##3##2##(2008-10#2)(2012-2#1)
sensitive derivative spectrophotometric method##2##4##(2008-10#2)
sensitive detection of##19##3##(1990-12#1)(1994-11#1)(2008-10#13)(2008-4#2)(2010-12#1)(2012-2#1)
sensitive detection##30##2##(1990-12#1)(1994-11#1)(1997-4#1)(2008-10#21)(2008-3#1)(2008-4#2)(2010-12#1)(2010-7#1)(2012-2#1)
sensitive detector##5##2##(2008-10#4)(2008-3#1)
sensitive determination of##20##3##(1992-11#1)(1992-3#1)(2008-10#17)(2008-2#1)
sensitive determination##21##2##(1992-11#1)(1992-3#1)(2008-10#18)(2008-2#1)
sensitive diagnostic technique##2##3##(2008-10#1)(2012-12#1)
sensitive diagnostic##6##2##(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-12#1)
sensitive differential##3##2##(2007-11#1)(2008-10#2)
sensitive direct##2##2##(2008-10#2)
sensitive electrochemical##2##2##(2008-10#2)
sensitive electronic##2##2##(2008-3#2)
sensitive enough to detect##6##4##(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#2)(2011-2#1)
sensitive enough to##9##3##(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-7#1)
sensitive enough##11##2##(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-7#1)
sensitive enzyme immunoassay##2##3##(1990-2#1)(1991-2#1)
sensitive field##2##2##(2008-10#2)
sensitive flow injection chemiluminescence##3##4##(2008-10#3)
sensitive flow injection method with##2##5##(2008-10#2)
sensitive flow injection method##3##4##(2008-10#3)
sensitive flow injection##9##3##(2008-10#9)
sensitive flow##13##2##(1990-12#2)(2008-10#10)(2008-9#1)
sensitive flow-injection method##2##3##(2008-10#2)
sensitive flow-injection##5##2##(2008-10#5)
sensitive fluorescence quenching method##2##4##(2008-10#2)
sensitive fluorescence##10##2##(1992-11#1)(2008-10#6)(2008-12#2)(2008-9#1)
sensitive fluorescent dye##2##3##(1992-6#1)(2009-12#1)
sensitive fluorescent##8##2##(1992-6#1)(2008-10#4)(2008-9#2)(2009-12#1)
sensitive fluorimetric method for the determination of##3##7##(2008-10#3)
sensitive for detecting##2##3##(1994-11#1)(2008-10#1)
sensitive for the##2##3##(2008-10#2)
sensitive for##16##2##(1991-2#1)(1992-2#1)(1994-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
sensitive functional##2##2##(1991-2#1)(1996-5#1)
sensitive genotypes##2##2##(2008-10#2)
sensitive high performance liquid##2##4##(2008-10#2)
sensitive high-performance liquid chromatographic method##4##5##(1991-5#2)(1996-5#1)(2008-10#1)
sensitive high-performance liquid chromatographic##5##4##(1991-5#2)(1996-5#2)(2008-10#1)
sensitive high-performance liquid##6##3##(1991-5#2)(1996-5#2)(2008-10#2)
sensitive high-resolution##2##2##(2007-12#1)(2008-3#1)
sensitive immunoassay##3##2##(2008-10#3)
sensitive in##7##2##(1990-12#1)(1991-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
sensitive index of##3##3##(1994-8#1)(2008-5#1)(2008-7#1)
sensitive indicator of##5##3##(1995-3#1)(2008-10#1)(2008-7#2)(2012-2#1)
sensitive indicator strain in tomato leaf##2##6##(2008-10#2)
sensitive indicator strain in##3##4##(2008-10#3)
sensitive indicator##8##2##(1995-3#1)(2008-10#4)(2008-7#2)(2012-2#1)
sensitive indirect spectrophotometric method##2##4##(2008-10#2)
sensitive information##2##2##(1993-3#1)(2008-4#1)
sensitive isolates##6##2##(1997-7#1)(2008-10#5)
sensitive liquid chromatographic##3##3##(1992-3#1)(1992-6#1)(1993-9#1)
sensitive marker of##4##3##(1990-2#1)(1993-6#1)(2008-7#1)(2011-2#1)
sensitive marker##5##2##(1990-2#1)(1993-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
sensitive mass response##2##3##(2008-10#2)
sensitive means of##2##3##(1995-3#1)(2008-10#1)
sensitive means##4##2##(1992-11#1)(1992-6#1)(1995-3#1)(2008-10#1)
sensitive measure of##2##3##(1993-5#1)(2007-11#1)
sensitive measure##3##2##(1993-5#1)(2007-11#1)(2008-5#1)
sensitive measurements of##2##3##(2007-12#1)(2008-2#1)
sensitive method for determination of##2##5##(2008-10#2)
sensitive method for the determination of trace##4##7##(2008-10#4)
sensitive method for the determination of##19##6##(1990-8#2)(2008-10#17)
sensitive method for the quantitative determination of##2##7##(2008-10#2)
sensitive method for the quantitative##3##5##(2008-10#2)(2010-1#1)
sensitive method for the spectrophotometric determination of##2##7##(2008-10#2)
sensitive method for the##37##4##(1990-8#2)(1993-2#1)(2007-7#1)(2008-10#30)(2008-5#1)(2010-1#1)(2010-4#1)
sensitive method for##45##3##(1990-8#2)(1993-2#1)(2007-7#1)(2008-10#35)(2008-3#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2013-8#1)
sensitive method is described for the determination of##4##8##(2008-10#4)
sensitive method is described for the##5##6##(2008-10#5)
sensitive method is##9##3##(2008-10#8)(2008-4#1)
sensitive method of##4##3##(2008-10#4)
sensitive method that##2##3##(1991-5#1)(2008-5#1)
sensitive method to##3##3##(1997-4#1)(2008-10#2)
sensitive method was developed for the##3##6##(2008-10#3)
sensitive method was developed for##4##5##(2008-10#4)
sensitive method was developed##5##4##(2008-10#4)(2011-1#1)
sensitive method was##6##3##(2008-10#5)(2011-1#1)
sensitive method##77##2##(1990-8#2)(1991-3#1)(1991-5#2)(1993-2#1)(1997-4#1)(2007-7#1)(2008-10#59)(2008-3#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
sensitive methods in##2##3##(2008-10#1)(2008-2#1)
sensitive methods##6##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)
sensitive molecular##3##2##(1995-11#1)(2008-10#1)(2008-12#1)
sensitive molecules##2##2##(2009-6#2)
sensitive nervous formations##2##3##(1990-11#2)
sensitive on-line##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
sensitive optical humidity probe##2##4##(2008-10#2)
sensitive optical##4##2##(2008-10#4)
sensitive or resistant to##4##4##(1992-7#1)(2008-10#2)(2012-12#1)
sensitive or##6##2##(1992-7#1)(2008-10#2)(2010-1#1)(2012-12#2)
sensitive parameter for the##2##4##(1993-12#1)(2008-10#1)
sensitive parameter for##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
sensitive parameter##4##2##(1993-12#1)(2008-10#2)(2012-3#1)
sensitive period##2##2##(1996-6#1)(2008-6#1)
sensitive populations##2##2##(2008-10#2)
sensitive procedure for the determination of##3##6##(2008-10#3)
sensitive procedure for the##4##4##(2008-10#4)
sensitive procedure for##7##3##(2008-10#7)
sensitive procedure##10##2##(2008-10#10)
sensitive procedures for##2##3##(1992-9#1)(2008-4#1)
sensitive response##4##2##(2008-10#4)
sensitive screening##3##2##(2008-11#1)(2013-1#2)
sensitive sequential injection##3##3##(2008-10#3)
sensitive spectrophotometric determination of##2##4##(2008-10#2)
sensitive spectrophotometric method for##5##4##(2008-10#5)
sensitive spectrophotometric method##9##3##(2008-10#9)
sensitive spectrophotometric##18##2##(2008-10#18)
sensitive stage##2##2##(2008-10#1)(2008-6#1)
sensitive strains##8##2##(1991-1#1)(1997-2#1)(2008-10#6)
sensitive system##2##2##(2008-10#2)
sensitive technique for the##2##4##(2008-10#2)
sensitive technique for##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
sensitive technique of##2##3##(1992-9#1)(1996-12#1)
sensitive technique##8##2##(1992-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
sensitive techniques is##2##3##(2008-4#1)(2010-4#1)
sensitive techniques##3##2##(2008-4#1)(2010-4#1)(2010-8#1)
sensitive test##2##2##(1990-12#1)(1994-6#1)
sensitive than##45##2##(1990-12#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-12#1)(1996-8#2)(1997-4#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)
sensitive tissue##2##2##(2008-1#1)(2013-1#1)
sensitive to a##5##3##(1990-8#1)(1994-11#1)(2008-10#2)(2011-1#1)
sensitive to all##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
sensitive to aminoglycosides##3##3##(1995-2#2)(2008-12#1)
sensitive to assumptions##2##3##(2008-8#1)(2009-9#1)
sensitive to benomyl at##2##4##(2008-10#2)
sensitive to both##5##3##(1992-4#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)
sensitive to change in##2##4##(2007-7#1)(2008-10#1)
sensitive to change##3##3##(2007-7#1)(2008-10#1)(2009-11#1)
sensitive to changes in the##4##5##(1995-3#1)(2008-8#1)(2009-6#1)(2010-4#1)
sensitive to changes in##12##4##(1990-8#1)(1994-2#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-4#1)
sensitive to chloramphenicol##2##3##(2007-7#1)(2011-2#1)
sensitive to detect##2##3##(2008-1#1)(2008-10#1)
sensitive to guanine nucleotide##2##4##(1993-9#2)
sensitive to heat##2##3##(1992-3#1)(2008-7#1)
sensitive to individual##2##3##(1997-8#1)(2007-8#1)
sensitive to inhibition##2##3##(1994-9#1)(1995-8#1)
sensitive to ionizing radiation##2##4##(1995-12#1)(1997-7#1)
sensitive to ionizing##3##3##(1995-12#1)(1995-5#1)(1997-7#1)
sensitive to it##2##3##(1992-9#1)(2009-8#1)
sensitive to its##3##3##(1997-2#1)(2008-11#1)(2008-4#1)
sensitive to low##4##3##(1990-3#1)(1990-5#1)(1994-9#1)(2012-3#1)
sensitive to measure##2##3##(2008-10#2)
sensitive to measurement##2##3##(2007-12#1)(2008-11#1)
sensitive to metalaxyl##4##3##(2008-10#4)
sensitive to mismatches##3##3##(2008-4#2)(2008-9#1)
sensitive to model##2##3##(1997-3#1)(2008-3#1)
sensitive to narasin##2##3##(2007-6#2)
sensitive to noise##3##3##(2008-2#2)(2008-3#1)
sensitive to nonionic surfactants##2##4##(2008-10#2)
sensitive to pH in the range of##2##7##(1995-2#1)(2008-8#1)
sensitive to pH##3##3##(1995-2#1)(2008-8#1)(2013-8#1)
sensitive to phase##2##3##(2008-2#1)(2011-1#1)
sensitive to protein##3##3##(1991-2#1)(1993-12#1)(2008-4#1)
sensitive to several##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
sensitive to small changes in##2##5##(1996-7#1)(2008-3#1)
sensitive to small##4##3##(1996-7#1)(2007-11#1)(2008-2#1)(2008-3#1)
sensitive to temperature##4##3##(1994-12#1)(2007-11#1)(2008-9#2)
sensitive to the choice of##2##5##(2008-3#1)(2013-1#1)
sensitive to the effects of##2##5##(1994-5#1)(2008-9#1)
sensitive to the growth inhibitory##2##5##(1992-3#1)(1995-2#1)
sensitive to the numerical##2##4##(2008-10#1)(2008-3#1)
sensitive to the orientation of the##2##6##(1992-6#1)(2007-11#1)
sensitive to the sequence##2##4##(2012-12#1)(2013-1#1)
sensitive to the toxin##2##4##(2008-10#2)
sensitive to the##86##3##(1990-12#3)(1991-2#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-11#4)(2007-12#4)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
sensitive to thermal##2##3##(1995-2#1)(2007-11#1)
sensitive to these##2##3##(1992-6#1)(2011-2#1)
sensitive to treatment with##2##4##(1992-8#1)(1993-3#1)
sensitive to treatment##4##3##(1992-8#1)(1993-3#1)(2008-10#1)(2011-2#1)
sensitive to variations in the##3##5##(2008-2#2)(2008-6#1)
sensitive to vinclozolin (R(T)S(V))##2##4##(2008-10#2)
sensitive to##425##2##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1991-10#1)(1991-2#5)(1991-5#4)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#3)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#8)(2007-12#7)(2007-6#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#78)(2008-11#10)(2008-12#6)(2008-2#14)(2008-3#28)(2008-4#14)(2008-5#5)(2008-6#8)(2008-7#7)(2008-8#19)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#10)(2012-3#5)(2012-4#1)(2013-1#6)(2013-8#4)
sensitive tool for the detection##2##5##(2008-10#2)
sensitive tool for##3##3##(2008-10#2)(2012-2#1)
sensitive tool to##2##3##(2008-10#1)(2008-9#1)
sensitive tool##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
sensitive voltammetric##4##2##(2008-10#4)
sensitive wheat genotypes##2##3##(2008-10#2)
sensitive with##4##2##(2007-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
sensitive yeasts##2##2##(1993-12#2)
sensitive##1648##1##(1990-11#5)(1990-12#18)(1990-2#12)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#8)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#12)(1991-3#5)(1991-4#4)(1991-5#11)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#5)(1992-12#5)(1992-2#7)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#10)(1992-7#3)(1992-8#5)(1992-9#7)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#10)(1994-1#1)(1994-11#9)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#10)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#8)(1995-2#7)(1995-3#5)(1995-5#4)(1995-6#2)(1995-8#5)(1996-12#10)(1996-2#3)(1996-4#2)(1996-5#11)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#18)(2007-12#19)(2007-2#4)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#2)(2008-1#9)(2008-10#756)(2008-11#33)(2008-12#14)(2008-2#29)(2008-3#61)(2008-4#37)(2008-5#23)(2008-6#12)(2008-7#23)(2008-8#28)(2008-9#32)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#5)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#15)(2011-2#28)(2011-3#4)(2012-1#2)(2012-12#9)(2012-2#21)(2012-3#9)(2012-4#1)(2012-5#1)(2013-1#18)(2013-7#1)(2013-8#10)
sensitive)##3##1##(2007-6#1)(2008-9#1)(2010-8#1)
sensitively by##2##2##(2008-10#2)
sensitively detected##5##2##(1994-9#1)(2008-10#3)(2008-7#1)
sensitively on the##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
sensitively with##4##2##(2007-12#1)(2008-10#3)
sensitively##30##1##(1994-12#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-8#2)
sensitiveto##2##1##(2008-11#1)(2008-2#1)
sensitivities and specificities##2##3##(1997-7#1)(2009-9#1)
sensitivities and##6##2##(1997-7#1)(2008-10#3)(2009-9#1)(2012-12#1)
sensitivities are##3##2##(1990-7#1)(2008-10#1)(2008-3#1)
sensitivities for the##2##3##(1990-8#1)(2008-10#1)
sensitivities for##11##2##(1990-8#2)(1995-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-6#1)(2012-12#1)
sensitivities of 0##2##3##(2008-10#1)(2008-3#1)
sensitivities of the##7##3##(2008-10#4)(2008-3#3)
sensitivities of##28##2##(1990-7#1)(1994-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#14)
sensitivities than the##2##3##(1994-12#1)(2008-10#1)
sensitivities to##12##2##(1990-11#1)(1992-12#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2012-2#1)
sensitivities were##6##2##(2007-11#1)(2008-10#2)(2008-3#2)(2011-1#1)
sensitivities##103##1##(1990-11#1)(1990-7#2)(1990-8#3)(1992-12#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#28)(2008-7#2)(2009-6#2)(2009-9#1)(2010-2#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
sensitivity (##2##2##(2007-12#1)(2008-10#1)
sensitivity (0##2##2##(2006-10#1)(2008-10#1)
sensitivity (BRS)##2##2##(1991-10#1)(2008-1#1)
sensitivity (em =##2##3##(2008-10#2)
sensitivity 2##3##2##(1993-9#1)(2007-12#1)(2008-10#1)
sensitivity C-reactive protein##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
sensitivity about##2##2##(2008-10#2)
sensitivity after##3##2##(2008-10#2)(2013-1#1)
sensitivity among##2##2##(1997-7#1)(2008-10#1)
sensitivity analyses##3##2##(2008-12#1)(2008-2#1)(2009-12#1)
sensitivity analysis of##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
sensitivity analysis showed that##2##4##(2008-10#1)(2012-12#1)
sensitivity analysis shows that##2##4##(1994-1#1)(2008-2#1)
sensitivity analysis to##4##3##(1995-12#1)(2008-2#1)(2011-1#1)(2013-1#1)
sensitivity analysis was##3##3##(2009-9#1)(2011-2#1)(2012-12#1)
sensitivity analysis##31##2##(1994-1#1)(1995-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-7#2)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
sensitivity and 100% specificity##2##4##(2009-8#1)(2010-8#1)
sensitivity and a##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
sensitivity and accuracy##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
sensitivity and adequate##2##3##(2008-10#2)
sensitivity and detection##2##3##(2008-10#2)
sensitivity and high specificity##2##4##(1997-3#1)(2011-1#1)
sensitivity and high##4##3##(1997-3#1)(2008-10#1)(2008-9#1)(2011-1#1)
sensitivity and increase##2##3##(1993-2#1)(2008-3#1)
sensitivity and limit of detection of##2##6##(2008-10#2)
sensitivity and limit of detection##3##5##(2008-10#3)
sensitivity and limited##3##3##(2008-3#1)(2008-4#1)(2009-8#1)
sensitivity and limits of detection##3##5##(2008-10#3)
sensitivity and linearity##3##3##(1996-2#1)(2008-10#2)
sensitivity and low##2##3##(2008-10#2)
sensitivity and precision##2##3##(2008-10#2)
sensitivity and reliability of##2##4##(2008-10#2)
sensitivity and repeatability##2##3##(2008-10#2)
sensitivity and reproducibility##7##3##(1990-2#1)(2008-10#4)(2008-4#1)(2008-8#1)
sensitivity and robustness##2##3##(1993-3#1)(2008-10#1)
sensitivity and selectivity in the##2##5##(2008-10#2)
sensitivity and selectivity in##3##4##(2008-10#3)
sensitivity and selectivity of the##3##5##(2008-10#3)
sensitivity and selectivity of##5##4##(1996-12#1)(2008-10#4)
sensitivity and selectivity was##2##4##(2008-10#2)
sensitivity and selectivity##26##3##(1996-12#1)(2008-10#23)(2008-3#1)(2008-9#1)
sensitivity and simplicity##2##3##(2008-10#2)
sensitivity and specificity for##5##4##(2008-10#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
sensitivity and specificity in##2##4##(1996-8#1)(2008-7#1)
sensitivity and specificity of the procedure##2##6##(1990-7#1)(1993-6#1)
sensitivity and specificity of the##11##5##(1990-7#1)(1993-6#1)(1994-11#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
sensitivity and specificity of##33##4##(1990-7#1)(1990-9#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
sensitivity and specificity values##2##4##(2009-7#1)(2010-8#1)
sensitivity and specificity were##2##4##(2008-5#1)(2013-1#1)
sensitivity and specificity##74##3##(1990-7#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-8#3)(1997-3#1)(1997-4#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#4)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
sensitivity and stability of##2##4##(1990-8#1)(2008-10#1)
sensitivity and stability##7##3##(1990-8#1)(2008-10#6)
sensitivity and the##10##3##(1995-12#1)(2007-12#2)(2008-10#3)(2008-7#1)(2010-3#1)(2010-6#1)(2013-8#1)
sensitivity and with an##2##4##(2008-10#1)(2008-3#1)
sensitivity and##272##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-3#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-7#3)(2007-8#1)(2008-10#108)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#8)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#6)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#8)(2013-1#5)(2013-8#4)
sensitivity are##8##2##(1996-9#1)(2008-10#6)(2010-10#1)
sensitivity as##5##2##(1991-6#1)(2008-10#3)(2009-5#1)
sensitivity at the##2##3##(2008-10#2)
sensitivity at##6##2##(1993-9#1)(2007-12#1)(2008-10#3)(2012-2#1)
sensitivity between##3##2##(2008-10#2)(2008-3#1)
sensitivity but##3##2##(2008-3#1)(2012-12#1)(2013-8#1)
sensitivity by a##3##3##(2007-12#1)(2008-10#2)
sensitivity by##13##2##(1993-3#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#2)
sensitivity can be##4##3##(1995-2#1)(1997-6#1)(2008-10#1)(2008-2#1)
sensitivity can##6##2##(1995-2#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
sensitivity characteristics##2##2##(2007-11#1)(2007-12#1)
sensitivity comparable##2##2##(2008-10#1)(2008-3#1)
sensitivity compared with that of##2##5##(2007-11#2)
sensitivity compared with the##2##4##(2008-10#1)(2008-3#1)
sensitivity compared with##6##3##(2007-11#3)(2008-10#2)(2008-3#1)
sensitivity correction##2##2##(2008-10#1)(2008-3#1)
sensitivity could be##2##3##(1991-4#1)(1997-4#1)
sensitivity could##3##2##(1991-4#1)(1997-4#1)(2008-10#1)
sensitivity demonstrated##2##2##(2008-5#1)(2009-5#1)
sensitivity depends on##2##3##(2008-10#1)(2008-2#1)
sensitivity down to##2##3##(2008-10#1)(2010-2#1)
sensitivity drift##3##2##(2008-10#3)
sensitivity during##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
sensitivity enhanced##2##2##(2008-10#1)(2011-1#1)
sensitivity enhancement in##2##3##(2008-10#2)
sensitivity enhancement of##3##3##(2008-10#3)
sensitivity enhancement with##2##3##(2007-11#1)(2008-10#1)
sensitivity enhancement##12##2##(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#1)
sensitivity for a##3##3##(2008-2#1)(2008-3#2)
sensitivity for all##2##3##(2008-10#2)
sensitivity for detecting##2##3##(1995-5#1)(2008-1#1)
sensitivity for detection of##2##4##(1995-2#1)(2008-3#1)
sensitivity for diagnosis of##2##4##(2008-3#1)(2008-6#1)
sensitivity for histamine##2##3##(1996-5#2)
sensitivity for hydrazine##2##3##(2008-10#2)
sensitivity for low##2##3##(2008-10#2)
sensitivity for the detection of##2##5##(2008-10#2)
sensitivity for the determination of##3##5##(2008-10#3)
sensitivity for the##10##3##(2008-10#10)
sensitivity for##65##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1996-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#31)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
sensitivity function##2##2##(2008-8#1)(2009-9#1)
sensitivity gene##3##2##(1995-6#2)(2008-10#1)
sensitivity has been developed for##2##5##(2008-10#2)
sensitivity has been##5##3##(2008-10#4)(2008-7#1)
sensitivity has decreased##2##3##(2007-7#1)(2008-3#1)
sensitivity has##9##2##(2007-7#3)(2008-10#4)(2008-3#1)(2008-7#1)
sensitivity improvement##2##2##(2008-10#1)(2008-3#1)
sensitivity in the detection of##2##5##(2007-12#1)(2008-7#1)
sensitivity in the##16##3##(1993-12#1)(2007-12#1)(2008-10#4)(2008-3#4)(2008-7#2)(2009-9#1)(2011-2#2)(2013-8#1)
sensitivity in vitro##2##3##(2008-10#1)(2008-5#1)
sensitivity in##66##2##(1991-12#1)(1992-2#1)(1993-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
sensitivity increase##2##2##(2008-10#2)
sensitivity increased##2##2##(1992-9#1)(2008-7#1)
sensitivity index##3##2##(1997-7#1)(2011-2#1)(2013-8#1)
sensitivity is achieved by##2##4##(2008-10#2)
sensitivity is achieved##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
sensitivity is calculated##2##3##(2008-10#1)(2008-3#1)
sensitivity is required##2##3##(2008-10#1)(2010-11#1)
sensitivity is##36##2##(1990-2#1)(1990-9#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)
sensitivity occurred##2##2##(1997-4#1)(2007-6#1)
sensitivity of 0##11##3##(1993-2#2)(2008-10#4)(2008-3#4)(2013-1#1)
sensitivity of 1##7##3##(2007-11#2)(2008-10#4)(2010-4#1)
sensitivity of 2##3##3##(2008-10#2)(2008-3#1)
sensitivity of 3##5##3##(2008-10#2)(2008-3#2)(2013-1#1)
sensitivity of 5##2##3##(2008-3#2)
sensitivity of CT##2##3##(2007-8#1)(2012-1#1)
sensitivity of T##2##3##(2008-10#2)
sensitivity of a##10##3##(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)
sensitivity of all##2##3##(2008-10#2)
sensitivity of an##2##3##(2007-12#1)(2011-2#1)
sensitivity of cells to##2##4##(2008-11#1)(2008-9#1)
sensitivity of detection##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
sensitivity of determination##2##3##(2008-10#1)(2011-1#1)
sensitivity of each##2##3##(2008-10#1)(2008-8#1)
sensitivity of fiber distributed-feedback##2##4##(2008-3#2)
sensitivity of highly birefringent fibers to temperature and hydrostatic pressure##2##10##(2008-2#2)
sensitivity of human##4##3##(1993-9#1)(1994-8#1)(1997-7#1)(2008-5#1)
sensitivity of less than##2##4##(2008-10#1)(2008-3#1)
sensitivity of target##2##3##(1997-7#1)(2010-5#1)
sensitivity of the 'König' reaction##2##5##(1993-8#2)
sensitivity of the ELISA was##2##5##(1990-2#1)(2011-2#1)
sensitivity of the assay##2##4##(1990-12#1)(2008-10#1)
sensitivity of the biosensor##2##4##(2008-10#2)
sensitivity of the complex##2##4##(2008-10#2)
sensitivity of the determination of##2##5##(2008-10#2)
sensitivity of the device to##2##5##(2007-11#1)(2008-3#1)
sensitivity of the device##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
sensitivity of the electrode##3##4##(2008-10#3)
sensitivity of the fluorescence##2##4##(2008-10#1)(2008-3#1)
sensitivity of the measured##2##4##(2008-2#1)(2008-3#1)
sensitivity of the method as##2##5##(2008-10#2)
sensitivity of the method can be increased##2##7##(2008-10#2)
sensitivity of the method was##2##5##(2008-10#2)
sensitivity of the method##23##4##(1990-12#1)(1990-8#1)(1996-12#1)(2008-10#18)(2008-2#1)(2008-3#1)
sensitivity of the methods##3##4##(1990-6#1)(2008-10#2)
sensitivity of the microprobes##2##4##(2008-2#2)
sensitivity of the proposed method##2##5##(2008-10#2)
sensitivity of the proposed##3##4##(2008-10#2)(2008-2#1)
sensitivity of the protein##2##4##(2008-4#1)(2008-9#1)
sensitivity of the sensor to##2##5##(2008-2#1)(2008-3#1)
sensitivity of the sensor##5##4##(2008-10#3)(2008-2#1)(2008-3#1)
sensitivity of the system##4##4##(2007-12#1)(2008-11#1)(2008-2#2)
sensitivity of the test##3##4##(1991-12#1)(2008-3#1)(2010-4#1)
sensitivity of the two##3##4##(1991-6#1)(2008-10#1)(2010-9#1)
sensitivity of the##177##3##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-8#3)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2007-11#3)(2007-12#5)(2008-10#75)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#20)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-3#1)(2013-8#1)
sensitivity of thermal##3##3##(2007-12#1)(2008-10#2)
sensitivity of these##5##3##(1990-7#1)(1994-11#1)(2008-10#3)
sensitivity of this method##4##4##(2008-10#3)(2008-7#1)
sensitivity of this##14##3##(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
sensitivity of tumors##2##3##(2008-5#1)(2013-7#1)
sensitivity of##484##2##(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-1#2)(1993-2#3)(1993-8#4)(1993-9#2)(1994-1#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#6)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#7)(2007-10#1)(2007-11#10)(2007-12#13)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#155)(2008-11#17)(2008-12#1)(2008-2#22)(2008-3#62)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#11)(2009-10#1)(2009-11#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#6)(2011-2#12)(2012-1#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#4)
sensitivity on the##4##3##(1990-12#1)(2008-10#1)(2008-2#2)
sensitivity on##6##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#3)
sensitivity or resistance##2##3##(1993-3#1)(2011-2#1)
sensitivity over a##3##3##(2008-10#1)(2008-2#2)
sensitivity over##4##2##(2008-10#1)(2008-2#2)(2009-7#1)
sensitivity pattern##3##2##(2007-7#3)
sensitivity provides##2##2##(1995-2#1)(1996-2#1)
sensitivity required##6##2##(1992-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
sensitivity study##5##2##(2008-3#5)
sensitivity suggest##2##2##(1991-9#1)(2008-10#1)
sensitivity test for##3##3##(2007-2#2)(2011-1#1)
sensitivity test##4##2##(2007-2#2)(2008-11#1)(2011-1#1)
sensitivity testing##5##2##(1990-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#1)
sensitivity tests##3##2##(1996-6#1)(2007-7#1)(2008-10#1)
sensitivity than the##3##3##(1992-5#1)(2007-12#1)(2008-7#1)
sensitivity than##12##2##(1992-5#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2011-2#2)
sensitivity that corresponds to##2##4##(2008-10#1)(2008-2#1)
sensitivity that is##2##3##(2007-11#1)(2008-10#1)
sensitivity that##9##2##(2007-11#2)(2008-10#6)(2008-2#1)
sensitivity to 2##2##3##(2008-10#2)
sensitivity to Ptr ToxA##2##4##(2008-10#2)
sensitivity to Ptr##3##3##(2008-10#3)
sensitivity to a##2##3##(1993-12#1)(1995-2#1)
sensitivity to amikacin##2##3##(2007-7#2)
sensitivity to an##2##3##(1997-3#1)(2008-5#1)
sensitivity to chemotherapeutic##2##3##(1997-7#1)(2013-7#1)
sensitivity to convulsions##2##3##(1993-12#2)
sensitivity to detect##2##3##(2008-10#1)(2008-8#1)
sensitivity to dopamine##2##3##(1993-12#1)(2009-12#1)
sensitivity to growth stimulation by estrogen##2##6##(2008-11#2)
sensitivity to growth##3##3##(2008-11#3)
sensitivity to inhibition by##2##4##(1990-7#1)(1995-11#1)
sensitivity to insulin##3##3##(1991-7#1)(1996-11#1)(2013-8#1)
sensitivity to low##2##3##(2007-12#1)(2009-8#1)
sensitivity to metalaxyl##4##3##(2008-10#4)
sensitivity to mutation##3##3##(1994-5#1)(1997-3#2)
sensitivity to nicotine-induced seizures##2##4##(1996-12#2)
sensitivity to nicotine-induced##3##3##(1996-12#3)
sensitivity to noise##2##3##(2008-3#2)
sensitivity to optical##2##3##(2007-11#1)(2008-2#1)
sensitivity to propiconazole increased##2##4##(2008-10#2)
sensitivity to propiconazole##3##3##(2008-10#3)
sensitivity to small##2##3##(2008-3#2)
sensitivity to temperature##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2012-6#1)
sensitivity to the fungicide mefenoxam##2##5##(2008-10#2)
sensitivity to the presence of##2##5##(1992-8#1)(2008-7#1)
sensitivity to the toxin##3##4##(2008-10#3)
sensitivity to the##34##3##(1992-2#1)(1992-8#1)(1992-9#1)(1994-3#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-3#1)
sensitivity to this##3##3##(2008-10#2)(2008-7#1)
sensitivity to vancomycin##2##3##(2007-7#2)
sensitivity to##229##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-7#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#4)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-6#1)(1996-11#1)(1996-12#6)(1997-3#3)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#4)(2008-1#3)(2008-10#59)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#18)(2008-4#2)(2008-5#8)(2008-7#8)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#5)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#2)
sensitivity toward prolactin##2##3##(1994-11#2)
sensitivity toward##4##2##(1994-11#2)(1997-1#1)(2013-1#1)
sensitivity towards##5##2##(1990-7#1)(2008-10#3)(2008-11#1)
sensitivity using##3##2##(1992-3#1)(2009-11#1)(2009-8#1)
sensitivity versus##2##2##(2008-10#1)(2008-2#1)
sensitivity was 0##2##3##(1992-6#1)(2008-10#1)
sensitivity was achieved##2##3##(2008-10#2)
sensitivity was assessed in##2##4##(2008-10#1)(2008-7#1)
sensitivity was determined to be##2##5##(2007-8#1)(2008-3#1)
sensitivity was determined##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
sensitivity was found for meticlorpindol/ methylbenzoquate##2##6##(2007-6#2)
sensitivity was found for##5##4##(2007-6#5)
sensitivity was found to##2##4##(2007-6#1)(2007-8#1)
sensitivity was found##8##3##(1997-8#1)(2007-6#6)(2007-8#1)
sensitivity was improved##4##3##(1992-3#1)(2008-10#2)(2012-3#1)
sensitivity was investigated##2##3##(1993-9#1)(2008-10#1)
sensitivity was obtained by##2##4##(2008-10#2)
sensitivity was obtained##5##3##(2008-10#5)
sensitivity was shown##2##3##(2008-10#2)
sensitivity was##64##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-9#2)(1994-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-6#6)(2007-7#1)(2007-8#2)(2008-10#27)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
sensitivity were##15##2##(1992-2#1)(2008-10#14)
sensitivity when##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
sensitivity whereas##2##2##(1996-2#1)(2008-3#1)
sensitivity which##2##2##(2008-10#1)(2011-2#1)
sensitivity with no##2##3##(2008-11#1)(2008-12#1)
sensitivity with##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-9#1)(2012-8#1)(2013-8#1)
sensitivity without##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2010-2#1)
sensitivity would##2##2##(2008-3#1)(2012-12#1)
sensitivity##2004##1##(1990-11#5)(1990-12#18)(1990-2#10)(1990-3#3)(1990-5#7)(1990-6#4)(1990-7#9)(1990-8#6)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#2)(1991-6#9)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-2#9)(1992-3#6)(1992-4#1)(1992-5#5)(1992-6#6)(1992-8#6)(1992-9#5)(1993-1#2)(1993-12#7)(1993-2#5)(1993-3#6)(1993-6#1)(1993-8#4)(1993-9#9)(1994-1#3)(1994-11#6)(1994-12#10)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#6)(1995-12#13)(1995-2#9)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-11#1)(1996-12#20)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#16)(1997-4#11)(1997-6#3)(1997-7#8)(1997-8#12)(2006-10#1)(2007-10#6)(2007-11#33)(2007-12#44)(2007-2#5)(2007-5#1)(2007-6#9)(2007-7#23)(2007-8#5)(2008-1#13)(2008-10#726)(2008-11#44)(2008-12#13)(2008-2#74)(2008-3#183)(2008-4#32)(2008-5#26)(2008-6#4)(2008-7#44)(2008-8#26)(2008-9#37)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#4)(2009-4#4)(2009-5#6)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#9)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#9)(2010-5#11)(2010-6#3)(2010-7#3)(2010-8#11)(2010-9#3)(2011-1#22)(2011-2#65)(2012-1#5)(2012-12#21)(2012-2#16)(2012-3#27)(2012-6#2)(2012-8#2)(2013-1#25)(2013-7#2)(2013-8#17)
sensitivity)##7##1##(2007-2#2)(2008-10#2)(2008-3#1)(2011-1#1)(2013-8#1)
sensitization and##6##2##(2007-12#2)(2007-8#1)(2008-8#1)(2008-9#1)(2009-8#1)
sensitization in##5##2##(2008-10#4)(2009-8#1)
sensitization of the##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
sensitization of##11##2##(1993-8#1)(1995-12#2)(1996-12#1)(2007-11#1)(2008-10#3)(2008-9#2)(2010-5#1)
sensitization potential of##3##3##(2008-10#3)
sensitization potential##5##2##(2008-10#5)
sensitization to##8##2##(1990-3#1)(1991-12#1)(1993-6#2)(2012-2#1)(2013-1#3)
sensitization##76##1##(1990-3#1)(1991-12#1)(1992-12#2)(1992-3#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-3#1)(1995-12#3)(1995-3#2)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#23)(2008-11#3)(2008-3#2)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#3)(2009-8#4)(2010-5#2)(2011-2#2)(2012-2#1)(2013-1#6)
sensitize##5##1##(1994-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)
sensitized and##3##2##(1992-3#1)(2008-10#2)
sensitized by hypocrellin B##2##4##(2008-8#2)
sensitized by hypocrellin##4##3##(2008-8#4)
sensitized by##14##2##(1993-8#1)(2008-10#8)(2008-8#5)
sensitized fluorescence##2##2##(2008-10#2)
sensitized modified##2##2##(2008-10#2)
sensitized ormosil-modified electrodes##2##3##(2008-10#2)
sensitized the##2##2##(2008-10#1)(2010-2#1)
sensitized with##8##2##(1992-1#1)(1992-12#2)(1995-12#1)(1997-5#1)(2008-11#2)(2008-3#1)
sensitized##63##1##(1992-1#1)(1992-12#3)(1992-3#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-12#2)(1996-6#1)(1997-5#1)(2007-11#1)(2008-10#30)(2008-11#2)(2008-2#2)(2008-3#3)(2008-8#5)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#2)
sensitizer##14##1##(1991-3#1)(1992-1#1)(1992-8#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-9#2)(2009-11#1)
sensitizers in##2##2##(2008-10#2)
sensitizers##12##1##(2007-7#1)(2008-10#8)(2008-3#1)(2008-8#1)(2013-1#1)
sensitizes the##2##2##(2007-12#1)(2008-8#1)
sensitizes##7##1##(1993-11#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)
sensitizing dose##2##2##(2008-10#2)
sensitizing effect of##5##3##(2008-10#5)
sensitizing effect##6##2##(2008-10#6)
sensitizing potency##7##2##(2008-5#7)
sensitizing potential##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
sensitizing reagent##2##2##(2008-10#1)(2008-4#1)
sensitizing##34##1##(1991-12#1)(1995-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#11)(2008-9#1)(2010-11#1)
sensivity of##3##2##(1995-4#1)(2007-11#1)(2008-10#1)
sensor achieved##2##2##(2008-10#2)
sensor also##3##2##(2008-10#2)(2013-1#1)
sensor and a phase-shifting interferometer for##2##6##(2008-3#2)
sensor and a##7##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
sensor and the##6##3##(1992-5#1)(2008-10#3)(2008-3#1)(2010-2#1)
sensor and##35##2##(1992-5#1)(2007-12#2)(2008-10#14)(2008-2#3)(2008-3#11)(2008-7#2)(2010-2#1)(2012-3#1)
sensor applications##12##2##(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2009-11#1)
sensor are described##2##3##(2008-10#1)(2008-3#1)
sensor are##8##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-1#1)
sensor array based on##2##4##(2008-10#1)(2008-3#1)
sensor array for##4##3##(2008-10#1)(2008-3#1)(2013-1#2)
sensor array to the##2##4##(2008-10#1)(2013-1#1)
sensor array with##2##3##(2008-10#2)
sensor array##22##2##(2008-10#12)(2008-3#2)(2008-7#1)(2009-11#2)(2013-1#5)
sensor as a##4##3##(2008-10#3)(2008-3#1)
sensor at##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
sensor based on 2##2##4##(2008-10#2)
sensor based on a##12##4##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)
sensor based on an##2##4##(2008-10#2)
sensor based on optical##2##4##(2007-11#2)
sensor based on the##10##4##(2008-10#7)(2008-2#1)(2008-3#2)
sensor based on##59##3##(2007-11#4)(2007-12#2)(2008-10#39)(2008-2#5)(2008-3#6)(2009-6#1)(2013-1#2)
sensor by##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
sensor can be used as a##2##6##(2008-10#1)(2008-3#1)
sensor can be used for##2##5##(2008-10#2)
sensor can be used to##2##5##(2008-10#2)
sensor can be used##6##4##(2008-10#5)(2008-3#1)
sensor can be##10##3##(2008-10#8)(2008-3#1)(2009-11#1)
sensor can detect##3##3##(2007-11#2)(2008-10#1)
sensor can##16##2##(2007-11#2)(2008-10#10)(2008-2#2)(2008-3#1)(2009-11#1)
sensor chip surface##2##3##(2008-10#1)(2008-4#1)
sensor chip##11##2##(2008-10#9)(2008-4#1)(2008-9#1)
sensor components##2##2##(2008-2#1)(2009-11#1)
sensor concept##2##2##(2008-3#1)(2010-5#1)
sensor consists of##2##3##(2007-12#1)(2008-3#1)
sensor construction##3##2##(2008-10#3)
sensor contains##2##2##(2008-10#2)
sensor could be##4##3##(2008-10#4)
sensor could##5##2##(2008-10#5)
sensor data##3##2##(2008-10#2)(2008-3#1)
sensor demodulation##2##2##(2008-3#2)
sensor demonstrates##2##2##(2008-10#1)(2008-3#1)
sensor described above##2##3##(2008-10#1)(2008-3#1)
sensor design##2##2##(2007-11#1)(2010-4#1)
sensor designed for##3##3##(2007-12#1)(2008-7#1)(2010-7#1)
sensor device##2##2##(2008-10#2)
sensor devices##2##2##(2008-10#1)(2008-2#1)
sensor displayed##4##2##(2008-10#4)
sensor displays##2##2##(2008-10#2)
sensor electrode##2##2##(2008-10#2)
sensor element##3##2##(2008-10#1)(2011-2#2)
sensor error##2##2##(2009-9#2)
sensor errors##8##2##(2009-9#8)
sensor exhibited a##2##3##(2008-10#2)
sensor exhibited high selectivity and##2##5##(2008-10#2)
sensor exhibited##8##2##(2008-10#6)(2013-1#2)
sensor exhibits a fast##2##4##(2008-10#1)(2008-3#1)
sensor exhibits a linear response##2##5##(2008-10#2)
sensor exhibits a linear##3##4##(2008-10#3)
sensor exhibits a##11##3##(2008-10#10)(2008-3#1)
sensor exhibits##18##2##(2008-10#17)(2008-3#1)
sensor fabrication##3##2##(2008-10#2)(2008-3#1)
sensor for Hg(II)##3##3##(2008-10#3)
sensor for copper##2##3##(2008-10#2)
sensor for detection of##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
sensor for determination of##2##4##(2008-10#2)
sensor for glucose##2##3##(2008-10#2)
sensor for hydrogen##2##3##(2008-10#2)
sensor for isoniazid##2##3##(2008-10#2)
sensor for measurements of##2##4##(2008-2#1)(2008-3#1)
sensor for measuring the##2##4##(2008-10#1)(2008-3#1)
sensor for mercury(II)##2##3##(2008-10#2)
sensor for nitrite using a glassy carbon electrode modified with##2##10##(2008-10#2)
sensor for simultaneous measurement of##2##5##(2007-11#1)(2007-12#1)
sensor for simultaneous##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
sensor for the detection of##3##5##(2008-10#3)
sensor for the determination of##9##5##(2008-10#9)
sensor for the potentiometric##2##4##(2008-10#2)
sensor for the##23##3##(2008-10#21)(2008-3#2)
sensor for##120##2##(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#92)(2008-2#4)(2008-3#16)(2010-8#2)(2013-8#1)
sensor has a linear##2##4##(2007-11#1)(2008-10#1)
sensor has a##5##3##(2007-11#1)(2008-10#4)
sensor has an##2##3##(2008-3#2)
sensor has been successfully##2##4##(2008-10#2)
sensor has been used##5##4##(2008-10#5)
sensor has been##17##3##(2008-10#15)(2008-2#1)(2013-7#1)
sensor has##32##2##(2007-11#2)(2008-10#25)(2008-2#1)(2008-3#3)(2013-7#1)
sensor head##3##2##(2008-2#1)(2008-3#2)
sensor in a##2##3##(2008-10#2)
sensor in the##3##3##(2008-10#2)(2010-9#1)
sensor in##14##2##(2008-10#7)(2008-2#1)(2008-3#3)(2008-8#2)(2010-9#1)
sensor incorporates##2##2##(2008-10#2)
sensor is also capable of##2##5##(2007-12#1)(2008-10#1)
sensor is also##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
sensor is based on the##5##5##(2008-10#4)(2008-3#1)
sensor is based on##13##4##(2008-10#7)(2008-2#3)(2008-3#3)
sensor is being##2##3##(2008-10#1)(2008-2#1)
sensor is described##2##3##(2008-10#2)
sensor is proposed##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
sensor is reported##2##3##(2008-10#1)(2008-2#1)
sensor is simple##2##3##(2008-10#1)(2008-2#1)
sensor is suitable for##2##4##(2007-11#1)(2008-10#1)
sensor is used for##3##4##(2007-11#1)(2008-10#2)
sensor is used##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
sensor is##84##2##(2007-11#5)(2007-12#2)(2008-10#52)(2008-2#10)(2008-3#15)
sensor made##2##2##(2008-10#1)(2008-3#1)
sensor may##4##2##(2007-11#1)(2008-3#3)
sensor membrane##2##2##(2008-10#2)
sensor modified with##2##3##(2008-10#2)
sensor noise##4##2##(2008-2#2)(2008-3#1)(2009-9#1)
sensor of the##2##3##(2008-10#1)(2008-9#1)
sensor of##13##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2009-8#1)(2010-12#1)(2013-8#1)
sensor on a chip for##3##5##(2008-10#3)
sensor on a##4##3##(2008-10#3)(2008-3#1)
sensor on##6##2##(2008-10#4)(2008-3#1)(2011-1#1)
sensor output##3##2##(2008-10#1)(2008-3#2)
sensor over##2##2##(2008-10#2)
sensor performance##11##2##(2008-10#5)(2008-2#1)(2008-3#2)(2011-1#3)
sensor platform##3##2##(2010-2#3)
sensor platforms##2##2##(2010-2#2)
sensor presented##2##2##(2008-10#2)
sensor produced##2##2##(2008-10#1)(2008-3#1)
sensor protein##2##2##(1994-12#2)
sensor provides##2##2##(2008-10#2)
sensor responds to##4##3##(2008-10#4)
sensor responds##6##2##(2008-10#6)
sensor response is##2##3##(2008-10#2)
sensor response to##3##3##(2008-10#2)(2008-7#1)
sensor response##20##2##(2008-10#16)(2008-3#3)(2008-7#1)
sensor responses##2##2##(2008-10#2)
sensor responsive to##2##3##(2008-10#2)
sensor revealed a##2##3##(2008-10#2)
sensor revealed##3##2##(2008-10#3)
sensor scheme##2##2##(2008-3#2)
sensor sensitivity##4##2##(2008-10#2)(2010-2#2)
sensor showed##5##2##(2008-10#5)
sensor shows a linear response##2##5##(2008-10#2)
sensor shows a linear##3##4##(2008-10#3)
sensor shows excellent##2##3##(2008-10#2)
sensor shows##17##2##(2008-10#17)
sensor signal##4##2##(2008-10#4)
sensor signals##8##2##(2007-11#1)(2008-10#6)(2008-3#1)
sensor suitable for use##3##4##(2008-10#2)(2008-3#1)
sensor surface##9##2##(1997-2#1)(2008-10#7)(2008-11#1)
sensor system for the##3##4##(2008-10#2)(2008-3#1)
sensor system for##6##3##(2007-11#1)(2008-10#3)(2008-3#2)
sensor system is##4##3##(2008-10#3)(2008-2#1)
sensor system to##2##3##(2008-10#2)
sensor system using##2##3##(2007-11#1)(2008-10#1)
sensor system was##7##3##(2008-10#4)(2008-3#2)(2008-7#1)
sensor system##35##2##(2007-11#2)(2008-10#22)(2008-2#4)(2008-3#5)(2008-7#1)(2010-8#1)
sensor technologies##2##2##(2008-10#1)(2010-10#1)
sensor technology##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
sensor that is##2##3##(2008-10#1)(2008-3#1)
sensor that uses a##2##4##(2008-2#1)(2008-7#1)
sensor that uses##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
sensor that##13##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-7#1)
sensor to be##2##3##(2008-10#1)(2008-3#1)
sensor to determine##2##3##(2008-10#2)
sensor to measure##4##3##(2007-12#1)(2008-3#3)
sensor to monitor##3##3##(2008-2#3)
sensor to the##3##3##(2008-10#2)(2008-3#1)
sensor to##27##2##(2007-12#1)(2008-10#14)(2008-2#4)(2008-3#5)(2009-11#1)(2013-1#2)
sensor using a##6##3##(2008-10#5)(2013-7#1)
sensor using##17##2##(2007-11#1)(2008-10#14)(2008-3#1)(2013-7#1)
sensor was applied for##3##4##(2008-10#3)
sensor was applied to##3##4##(2008-10#3)
sensor was applied##7##3##(2008-10#7)
sensor was demonstrated##2##3##(2007-11#2)
sensor was developed for##2##4##(2008-10#2)
sensor was developed##6##3##(2008-10#5)(2008-7#1)
sensor was evaluated##4##3##(2008-10#4)
sensor was fabricated by immobilizing##2##5##(1992-11#1)(2008-10#1)
sensor was fabricated by##5##4##(1992-11#1)(2008-10#3)(2013-1#1)
sensor was fabricated##6##3##(1992-11#1)(2008-10#4)(2013-1#1)
sensor was found to be##3##5##(2008-10#3)
sensor was found to##5##4##(2008-10#5)
sensor was prepared by##2##4##(2008-10#2)
sensor was successfully applied to##2##5##(2008-10#2)
sensor was successfully applied##3##4##(2008-10#3)
sensor was successfully##5##3##(2008-10#5)
sensor was tested in##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
sensor was used for##2##4##(2008-10#2)
sensor was used to detect##2##5##(2008-10#2)
sensor was used to monitor##2##5##(2008-10#1)(2008-7#1)
sensor was used to##4##4##(2008-10#3)(2008-7#1)
sensor was used##8##3##(2008-10#6)(2008-3#1)(2008-7#1)
sensor was##78##2##(1992-11#1)(2007-11#2)(2008-10#66)(2008-2#1)(2008-3#2)(2008-7#4)(2010-5#1)(2013-1#1)
sensor were found to##2##4##(2008-10#2)
sensor were investigated##2##3##(2008-10#2)
sensor were##13##2##(2008-10#12)(2013-8#1)
sensor with PPy-calcion##2##3##(2008-10#2)
sensor with a##7##3##(2008-10#3)(2008-2#1)(2008-3#2)(2009-11#1)
sensor with controllable sensitivity##2##4##(2008-3#2)
sensor with fiber Bragg grating##2##5##(2007-11#2)
sensor with optical##2##3##(2007-11#1)(2007-12#1)
sensor with the##2##3##(2008-10#1)(2010-2#1)
sensor with##36##2##(2007-11#4)(2007-12#4)(2008-10#14)(2008-2#2)(2008-3#9)(2008-7#1)(2009-11#1)(2010-2#1)
sensor without##2##2##(2008-10#2)
sensor works well##3##3##(2008-10#3)
sensor works##5##2##(2008-10#5)
sensor##1219##1##(1992-11#4)(1992-5#1)(1993-12#1)(1994-12#4)(1996-5#1)(1997-2#1)(2007-11#45)(2007-12#35)(2008-10#751)(2008-11#4)(2008-2#67)(2008-3#180)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#19)(2008-8#3)(2008-9#4)(2009-11#9)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#12)(2010-10#2)(2010-12#4)(2010-2#12)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#17)(2013-7#2)(2013-8#4)
sensor's##3##1##(2007-11#1)(2008-10#1)(2008-2#1)
sensor-like##3##1##(1994-12#3)
sensor-to-sensor reproducibility##2##2##(2008-10#2)
sensorial characteristics##2##2##(2010-4#1)(2011-2#1)
sensorial functioning##2##2##(2011-2#2)
sensorial##13##1##(2008-5#5)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
sensorimotor and##2##2##(1995-5#1)(2012-12#1)
sensorimotor deficits##2##2##(1993-12#1)(2007-10#1)
sensorimotor polyneuropathy##5##2##(1994-6#1)(2008-1#4)
sensorimotor##29##1##(1992-12#2)(1993-12#4)(1994-6#1)(1995-11#1)(1995-5#2)(1996-2#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-1#1)(2012-12#2)(2013-8#2)
sensorineural deafness##4##2##(2007-7#1)(2008-7#1)(2008-9#1)(2011-1#1)
sensorineural hearing impairment##3##3##(2008-9#2)(2011-1#1)
sensorineural hearing loss and##2##4##(2011-1#1)(2013-1#1)
sensorineural hearing loss in##2##4##(2008-4#1)(2011-2#1)
sensorineural hearing loss is##2##4##(2008-4#1)(2008-9#1)
sensorineural hearing loss##17##3##(1992-2#1)(2006-12#1)(2007-8#1)(2008-4#4)(2008-9#4)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sensorineural hearing##20##2##(1992-2#1)(2006-12#1)(2007-8#1)(2008-4#4)(2008-9#6)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sensorineural##24##1##(1992-2#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-4#4)(2008-7#1)(2008-9#7)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sensors 1##3##2##(2008-10#3)
sensors and a##2##3##(2008-10#1)(2012-2#1)
sensors and biosensors##2##3##(2008-10#1)(2008-3#1)
sensors and##16##2##(2008-10#11)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2012-2#1)
sensors are based on##2##4##(2008-10#1)(2008-3#1)
sensors are based##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
sensors are characterized by##2##4##(2008-3#2)
sensors are presented##2##3##(2008-10#2)
sensors are used##3##3##(2008-10#3)
sensors are##20##2##(2008-10#11)(2008-3#6)(2010-4#1)(2011-1#1)(2012-2#1)
sensors as##4##2##(2008-10#3)(2008-4#1)
sensors based on chemically modified##2##5##(2008-10#2)
sensors based on##29##3##(2008-10#21)(2008-2#2)(2008-3#6)
sensors by use of##2##4##(2008-2#1)(2008-3#1)
sensors by##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
sensors can be##2##3##(2008-10#2)
sensors can##3##2##(2008-10#3)
sensors could##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
sensors exhibit##6##2##(2008-10#4)(2008-3#1)(2009-9#1)
sensors for some##2##3##(2008-10#2)
sensors for the analysis of##2##5##(2008-10#2)
sensors for the determination of##4##5##(2008-10#4)
sensors for the##8##3##(2008-10#8)
sensors for##45##2##(1990-8#1)(2008-10#39)(2008-2#1)(2008-3#2)(2008-7#1)(2010-2#1)
sensors has##2##2##(2007-11#1)(2008-10#1)
sensors have##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
sensors in the##2##3##(2008-10#2)
sensors in##14##2##(2008-10#6)(2008-3#4)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
sensors is##13##2##(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)
sensors of##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)(2009-9#1)
sensors on a##2##3##(2008-3#2)
sensors on##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-9#1)
sensors operating near 2##2##4##(2008-3#2)
sensors or##2##2##(2008-10#2)
sensors responsive to##2##3##(2008-10#2)
sensors sensitive##2##2##(2008-10#2)
sensors show##3##2##(2008-10#2)(2008-3#1)
sensors showed##2##2##(2008-10#2)
sensors that use##3##3##(2007-11#1)(2008-3#2)
sensors that##10##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#3)(2008-6#1)(2009-9#1)
sensors to##5##2##(2008-10#2)(2008-3#2)(2013-1#1)
sensors use##2##2##(2008-10#1)(2008-2#1)
sensors using##8##2##(2007-12#1)(2008-10#7)
sensors was##3##2##(2008-10#2)(2008-3#1)
sensors were also##2##3##(2008-10#1)(2008-2#1)
sensors were evaluated##2##3##(2008-10#2)
sensors were used##2##3##(1993-6#1)(2008-3#1)
sensors were##19##2##(1993-6#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-8#1)
sensors will##2##2##(2008-10#2)
sensors with a detection##2##4##(2008-3#2)
sensors with a##6##3##(2008-2#1)(2008-3#5)
sensors with##22##2##(2008-10#11)(2008-2#1)(2008-3#9)(2008-7#1)
sensors##430##1##(1990-8#2)(1993-6#1)(2007-11#6)(2007-12#12)(2008-10#256)(2008-11#2)(2008-2#23)(2008-3#73)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#3)(2009-1#1)(2009-11#4)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#4)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#4)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#5)
sensory analysis##3##2##(2009-9#1)(2011-2#2)
sensory and motor neuron##2##4##(2013-1#2)
sensory and motor##5##3##(1992-6#1)(2008-7#2)(2013-1#2)
sensory and neuronal mechanisms##3##4##(2007-12#3)
sensory and##16##2##(1990-7#1)(1992-6#1)(1993-1#1)(1995-5#1)(2007-12#4)(2008-10#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#2)
sensory apparatus##3##2##(1990-5#1)(1997-3#1)(2007-12#1)
sensory areas##4##2##(2008-11#2)(2008-5#2)
sensory aspects##3##2##(2008-5#1)(2008-9#2)
sensory assessment##4##2##(2008-5#4)
sensory attention and sensorimotor##2##4##(1993-12#2)
sensory attention##3##2##(1993-12#3)
sensory attributes##10##2##(2008-10#2)(2010-4#3)(2011-2#3)(2012-2#2)
sensory axons##3##2##(1995-2#1)(2013-1#2)
sensory capacity##2##2##(2008-10#2)
sensory cell clusters##2##3##(2007-12#2)
sensory cell##5##2##(2007-12#4)(2008-7#1)
sensory cells of the##2##4##(1993-12#1)(2011-2#1)
sensory cells of##4##3##(1993-12#1)(1997-6#1)(2008-7#1)(2011-2#1)
sensory cells to##2##3##(2007-12#2)
sensory cells##13##2##(1993-12#1)(1997-6#1)(2007-12#7)(2008-7#3)(2011-2#1)
sensory changes##3##2##(2008-10#1)(2010-4#1)(2012-12#1)
sensory characteristics##5##2##(2010-3#1)(2010-4#3)(2010-7#1)
sensory complex##3##2##(2007-12#3)
sensory cortical##2##2##(2008-11#1)(2012-2#1)
sensory cue##2##2##(2009-8#2)
sensory deficit##2##2##(1990-12#1)(2012-12#1)
sensory deficits##3##2##(1996-6#1)(2007-10#1)(2008-12#1)
sensory evaluation##4##2##(2010-2#2)(2010-4#1)(2011-2#1)
sensory experience##2##2##(2008-4#1)(2009-12#1)
sensory fibers##4##2##(1992-6#1)(2006-12#3)
sensory function##3##2##(1993-12#1)(1996-6#1)(2007-12#1)
sensory ganglia##2##2##(1997-6#1)(2008-4#1)
sensory hair cells##3##3##(2009-8#1)(2009-9#1)(2013-1#1)
sensory information into##2##3##(1990-5#2)
sensory information to##2##3##(1995-1#1)(2008-1#1)
sensory information##7##2##(1990-5#2)(1995-1#2)(2008-1#1)(2012-1#1)(2013-8#1)
sensory innervation of the##3##4##(1997-3#1)(2007-12#2)
sensory innervation##4##2##(1996-5#1)(1997-3#1)(2007-12#2)
sensory input is##2##3##(2008-7#1)(2009-12#1)
sensory input##8##2##(1993-12#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-12#2)
sensory inputs##5##2##(2008-4#1)(2008-7#1)(2008-9#2)(2013-1#1)
sensory loss##7##2##(1994-9#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2013-1#1)
sensory modalities##2##2##(2008-1#1)(2008-12#1)
sensory modulation##2##2##(2009-8#2)
sensory nerve transfers##2##3##(2008-9#2)
sensory nerve##11##2##(1990-11#1)(1992-6#1)(1994-9#1)(1995-12#1)(2006-12#1)(2007-12#4)(2008-9#2)
sensory nerves##5##2##(1992-6#3)(1997-1#1)(2008-4#1)
sensory nervous system##3##3##(2007-12#3)
sensory nervous##5##2##(1990-11#1)(2007-12#4)
sensory neuron##2##2##(2007-12#1)(2008-4#1)
sensory neurons and##2##3##(1995-2#1)(2008-5#1)
sensory neurons by##2##3##(2008-4#1)(2008-8#1)
sensory neurons in##3##3##(1992-6#1)(2007-12#1)(2008-6#1)
sensory neurons to##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
sensory neurons##22##2##(1990-7#1)(1992-6#2)(1993-12#1)(1995-2#1)(1996-12#2)(2007-12#3)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)
sensory neuropathy associated with##3##4##(2008-7#1)(2009-3#1)(2013-1#1)
sensory neuropathy##10##2##(1995-5#1)(2008-7#3)(2009-10#1)(2009-3#3)(2012-3#1)(2013-1#1)
sensory or motor##3##3##(1991-6#1)(2012-12#1)(2013-1#1)
sensory organ##5##2##(1993-12#2)(2008-5#1)(2009-5#1)(2012-2#1)
sensory organs##4##2##(2008-5#1)(2008-7#2)(2009-5#1)
sensory phenomena##5##2##(2012-2#5)
sensory predictions##2##2##(2013-8#2)
sensory processing##7##2##(1993-6#1)(2008-11#1)(2008-5#1)(2009-12#2)(2009-8#1)(2013-8#1)
sensory properties of##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
sensory properties##8##2##(2008-10#1)(2008-5#1)(2010-4#3)(2011-2#2)(2012-2#1)
sensory quality and##2##3##(2010-4#2)
sensory quality##3##2##(2010-4#3)
sensory responses##4##2##(1993-12#2)(2008-12#2)
sensory scores##2##2##(2011-2#1)(2013-1#1)
sensory signals##3##2##(2007-12#2)(2007-9#1)
sensory stimulation##4##2##(1992-6#1)(1993-12#1)(2008-11#1)(2008-7#1)
sensory stimuli##4##2##(1995-8#1)(2008-4#1)(2013-1#2)
sensory symptoms and##2##3##(2007-10#1)(2008-7#1)
sensory symptoms##7##2##(2007-10#2)(2008-3#1)(2008-7#1)(2012-12#2)(2012-2#1)
sensory system is##2##3##(2008-10#1)(2009-8#1)
sensory system##8##2##(1996-2#1)(2007-12#1)(2008-10#4)(2009-8#1)(2013-8#1)
sensory systems##3##2##(1990-11#1)(2007-12#1)(2013-8#1)
sensory units##5##2##(1993-12#1)(2007-12#3)(2013-8#1)
sensory##372##1##(1990-11#5)(1990-12#1)(1990-3#1)(1990-5#4)(1990-7#2)(1990-9#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#11)(1993-1#2)(1993-11#1)(1993-12#22)(1993-6#1)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#3)(1995-8#2)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#3)(1997-1#1)(1997-3#5)(1997-6#2)(2006-12#5)(2007-10#4)(2007-12#44)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#11)(2008-5#14)(2008-6#3)(2008-7#20)(2008-8#10)(2008-9#14)(2009-10#1)(2009-12#5)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#13)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#17)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#3)(2013-1#17)(2013-8#9)
sensory-evoked##2##1##(1993-12#1)(2009-5#1)
sensu lato is##3##3##(2008-10#3)
sensu lato##13##2##(2008-10#10)(2011-2#1)(2012-12#2)
sensu stricto and##2##3##(2008-10#1)(2008-8#1)
sensu stricto with##2##3##(2008-10#1)(2012-12#1)
sensu stricto##11##2##(1994-2#1)(2008-10#5)(2008-5#1)(2008-8#1)(2012-12#2)(2013-7#1)
sensu##27##1##(1994-2#1)(2008-10#16)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#4)(2013-7#1)
sent a questionnaire##3##3##(1993-12#1)(1996-9#1)(2011-2#1)
sent a##5##2##(1993-12#1)(1996-9#1)(1997-2#1)(1997-5#1)(2011-2#1)
sent by the##2##3##(1992-2#1)(2012-12#1)
sent by##10##2##(1992-2#1)(1997-3#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#4)
sent for##2##2##(1993-8#1)(2013-1#1)
sent in##2##2##(2007-12#1)(2007-8#1)
sent to a##11##3##(1991-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
sent to all the##2##4##(1993-12#1)(2007-7#1)
sent to all##11##3##(1992-1#1)(1993-12#1)(1995-6#3)(1996-3#1)(1997-8#1)(2007-7#1)(2008-11#1)(2012-2#2)
sent to the##11##3##(1994-1#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-10#1)(2010-8#1)(2013-1#1)
sent to##63##2##(1990-2#1)(1990-6#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#3)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-7#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#2)(2013-1#4)
sent##97##1##(1990-2#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-6#3)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-2#6)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#3)(2011-1#2)(2011-2#8)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)
senta##4##1##(2010-8#4)
sentence comprehension and##2##3##(2009-9#2)
sentence comprehension##6##2##(2008-1#1)(2009-9#5)
sentence decreases following the##2##4##(2007-12#2)
sentence in##2##2##(2007-12#1)(2012-2#1)
sentence processing and##2##3##(2012-3#2)
sentence processing##4##2##(2008-1#2)(2012-3#2)
sentence structure##2##2##(2008-7#1)(2008-9#1)
sentence##44##1##(1996-5#1)(1997-5#3)(1997-8#1)(2007-12#6)(2008-1#4)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-9#5)(2010-7#1)(2011-1#3)(2012-2#1)(2012-3#4)(2013-1#1)
sentence-span task##3##2##(2012-3#3)
sentenced##5##1##(1996-5#3)(1997-5#2)
sentences describing##2##2##(2008-11#1)(2010-2#1)
sentences to##2##2##(2007-2#1)(2012-3#1)
sentences##17##1##(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#2)(2012-3#3)(2013-8#1)
sentencing##2##1##(1996-8#1)(1997-5#1)
sentinel lymph node##7##3##(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
sentinel lymph nodes##4##3##(2012-12#3)(2013-1#1)
sentinel lymph##11##2##(2010-12#1)(2011-2#2)(2012-12#5)(2013-1#2)(2013-8#1)
sentinel marker data##2##3##(2008-1#2)
sentinel node biopsy##3##3##(2007-12#1)(2010-7#1)(2012-2#1)
sentinel node##9##2##(2007-12#1)(2008-10#3)(2010-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
sentinel##39##1##(1991-12#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-9#4)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-2#2)(2012-12#8)(2012-2#1)(2013-1#3)(2013-8#1)
sentinels##8##1##(1995-11#1)(2008-9#7)
separability of##2##2##(2008-10#1)(2008-3#1)
separable from the##2##3##(1990-4#1)(1992-3#1)
separable##14##1##(1990-2#1)(1990-4#1)(1992-3#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
separata##8##1##(1992-6#1)(2007-12#2)(2008-11#5)
separate analysis##2##2##(2008-11#1)(2011-2#1)
separate and independent##2##3##(1991-9#1)(1993-3#1)
separate and##17##2##(1991-9#1)(1993-3#1)(1996-5#1)(1997-2#1)(2008-10#9)(2008-6#2)(2008-8#1)(2008-9#1)
separate bureaus##2##2##(1992-1#2)
separate capillaries##3##2##(2008-3#3)
separate cluster##3##2##(2008-10#2)(2008-5#1)
separate compartments##2##2##(2008-10#1)(2013-1#1)
separate components##4##2##(1995-5#2)(2008-10#1)(2008-2#1)
separate days##2##2##(2008-12#1)(2013-1#1)
separate effects##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
separate entities##2##2##(2008-10#1)(2008-12#1)
separate evolutionary##3##2##(2008-9#1)(2009-6#1)(2011-2#1)
separate experiments##13##2##(1990-5#1)(1994-2#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)
separate from the##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)
separate from##16##2##(1993-11#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
separate genera##2##2##(2007-12#1)(2008-6#1)
separate genes##4##2##(1992-6#2)(1993-9#1)(1997-7#1)
separate groups of##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
separate groups##5##2##(1996-5#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
separate in##2##2##(1995-6#1)(2009-10#1)
separate interferograms##2##2##(2008-2#2)
separate laser and detector chips##2##5##(2008-3#2)
separate laser##3##2##(2007-11#1)(2008-3#2)
separate ligation##2##2##(1997-7#1)(2007-8#1)
separate mechanisms of##2##3##(1995-8#1)(1996-12#1)
separate mechanisms##4##2##(1995-8#2)(1996-12#1)(2008-10#1)
separate mental health##2##3##(1994-1#2)
separate occasions##3##2##(1991-3#1)(2008-8#1)(2011-1#1)
separate pathways##2##2##(2008-9#1)(2009-7#1)
separate phenomena##2##2##(2011-2#1)(2012-2#1)
separate populations##4##2##(2008-10#2)(2008-8#1)(2009-2#1)
separate processes##3##2##(1996-12#1)(2008-9#1)(2010-3#1)
separate regions##3##2##(1990-3#1)(1995-2#1)(2008-10#1)
separate samples##2##2##(2008-10#1)(2008-12#1)
separate sessions##2##2##(2012-2#1)(2013-1#1)
separate sets of##2##3##(2007-8#1)(2009-8#1)
separate sets##3##2##(2007-8#1)(2008-10#1)(2009-8#1)
separate solutions##2##2##(2008-10#2)
separate species##5##2##(1993-8#1)(2008-10#4)
separate studies are##2##3##(2009-11#1)(2011-1#1)
separate studies##4##2##(1991-11#1)(1994-12#1)(2009-11#1)(2011-1#1)
separate study##2##2##(1991-6#1)(2008-5#1)
separate subunits##2##2##(1990-7#1)(2012-2#1)
separate the cells##2##3##(2011-2#2)
separate the epidermis##2##3##(2008-1#1)(2008-3#1)
separate the presacral##2##3##(1994-3#2)
separate the##31##2##(1990-3#1)(1994-3#2)(1997-2#1)(2007-6#1)(2008-1#1)(2008-10#12)(2008-3#3)(2008-4#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-7#1)(2013-8#1)
separate these##3##2##(2007-11#1)(2008-10#2)
separate this##2##2##(1990-11#1)(2007-10#1)
separate two##2##2##(2007-12#1)(2008-10#1)
separate##454##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#2)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#5)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#4)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#5)(1996-7#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#11)(2007-2#3)(2007-5#1)(2007-6#1)(2007-8#5)(2008-1#3)(2008-10#133)(2008-11#13)(2008-12#7)(2008-2#12)(2008-3#26)(2008-4#10)(2008-5#7)(2008-6#6)(2008-7#10)(2008-8#10)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#7)(2013-7#4)(2013-8#3)
separated Al species##2##3##(2008-10#2)
separated P##2##2##(2008-10#2)
separated after##4##2##(1996-5#1)(2008-10#1)(2008-5#1)(2010-11#1)
separated analytes##3##2##(2008-10#3)
separated and determined##3##3##(2008-10#2)(2011-1#1)
separated and quantified by##2##4##(1991-12#1)(2008-10#1)
separated and quantified##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
separated and quantitated by##2##4##(1991-5#1)(1994-9#1)
separated and##22##2##(1990-8#1)(1991-12#1)(1991-5#1)(1993-8#1)(1994-9#2)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-10#9)(2008-12#1)(2011-1#1)
separated as##3##2##(1994-9#1)(2008-12#1)(2013-1#1)
separated at##2##2##(1991-3#1)(2008-10#1)
separated by 1##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
separated by 2##2##3##(2007-12#1)(2007-8#1)
separated by HPLC##5##3##(1991-2#1)(1995-3#1)(2008-10#2)(2008-8#1)
separated by SDS-PAGE and the##2##5##(2008-4#1)(2008-5#1)
separated by SDS-PAGE##3##3##(1990-11#1)(2008-4#1)(2008-5#1)
separated by a##20##3##(1990-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-7#2)(2009-11#2)(2009-7#1)(2011-1#1)(2013-1#2)
separated by an interval of##2##5##(1993-11#1)(1996-8#1)
separated by an##9##3##(1990-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
separated by applying##2##3##(1995-8#1)(2008-10#1)
separated by capillary electrophoresis (CE)##2##5##(2008-10#1)(2010-5#1)
separated by capillary electrophoresis##4##4##(2008-10#3)(2010-5#1)
separated by capillary zone electrophoresis (CZE)##2##6##(2008-10#2)
separated by capillary zone electrophoresis##3##5##(2008-10#3)
separated by capillary##8##3##(2008-10#6)(2010-5#1)(2011-1#1)
separated by gas chromatography##2##4##(1991-12#1)(2008-10#1)
separated by high performance liquid chromatography (HPLC)##2##7##(2008-10#2)
separated by high performance liquid chromatography##3##6##(2008-10#3)
separated by high##4##3##(2008-10#3)(2008-4#1)
separated by high-performance##3##3##(1990-8#1)(1997-2#1)(2008-10#1)
separated by ion##2##3##(1990-8#1)(2008-10#1)
separated by polyacrylamide gel electrophoresis##2##5##(2008-4#1)(2008-7#1)
separated by reversed phase##2##4##(1993-9#1)(1995-2#1)
separated by reversed-phase HPLC##2##4##(1990-5#1)(1996-5#1)
separated by reversed-phase high-performance liquid chromatography##2##6##(1993-9#1)(1995-6#1)
separated by reversed-phase##4##3##(1990-5#1)(1993-9#1)(1995-6#1)(1996-5#1)
separated by the##5##3##(1990-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
separated by##153##2##(1990-10#1)(1990-11#2)(1990-5#2)(1990-7#1)(1990-8#6)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#46)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#4)(2013-1#3)(2013-7#1)(2013-8#2)
separated completely##2##2##(2008-10#2)
separated for##5##2##(1991-12#1)(1995-11#1)(2007-10#1)(2008-10#2)
separated fractions##5##2##(1992-9#1)(2008-10#4)
separated from Cr(III)##4##3##(2008-10#4)
separated from a##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
separated from all##2##3##(2008-10#1)(2010-8#1)
separated from each other by##2##5##(1992-6#1)(2008-10#1)
separated from each other##5##4##(1992-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
separated from large##2##3##(2008-10#2)
separated from other##3##3##(1990-5#1)(2008-10#1)(2009-5#1)
separated from the aqueous phase##2##5##(2008-10#2)
separated from the aqueous##4##4##(2008-10#4)
separated from the bulk##2##4##(2008-10#2)
separated from the solution by##2##5##(2008-10#2)
separated from the solution##3##4##(2008-10#3)
separated from the##32##3##(1990-8#1)(1992-3#2)(1995-5#1)(2008-10#21)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
separated from their##2##3##(1991-2#1)(2008-9#1)
separated from##93##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#52)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2009-8#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
separated group##2##2##(2008-8#2)
separated in a fused-silica capillary##2##5##(1994-9#1)(1996-5#1)
separated in a##6##3##(1994-9#2)(1996-5#1)(2008-10#3)
separated in the##2##3##(2008-10#1)(2008-6#1)
separated in##25##2##(1994-9#2)(1996-5#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)
separated into a##2##3##(2008-10#1)(2010-10#1)
separated into different##2##3##(2008-10#1)(2008-12#1)
separated into the##2##3##(1997-4#1)(2008-10#1)
separated into three##4##3##(1990-7#1)(1992-11#1)(1994-3#1)(2008-10#1)
separated into two groups##4##4##(1991-9#1)(2008-10#3)
separated into two##10##3##(1991-9#1)(2008-10#7)(2008-3#1)(2009-11#1)
separated into##37##2##(1990-7#1)(1991-9#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-4#1)(2006-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-11#1)(2009-7#1)(2010-10#1)(2010-4#1)(2012-2#1)
separated on a reversed-phase column##4##5##(1990-8#3)(1997-2#1)
separated on a reversed-phase##6##4##(1990-8#3)(1997-2#1)(2008-10#2)
separated on a##21##3##(1990-8#3)(1992-2#1)(1997-2#2)(2008-10#10)(2008-4#1)(2008-5#1)(2011-1#3)
separated on the column##2##4##(1991-5#1)(2008-10#1)
separated on the##10##3##(1991-5#1)(1996-5#1)(2008-10#7)(2008-4#1)
separated on##40##2##(1990-8#4)(1991-5#1)(1992-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-2#3)(2007-7#1)(2008-10#17)(2008-2#1)(2008-4#2)(2008-5#1)(2011-1#4)(2011-2#1)
separated on-line from##2##3##(2008-10#2)
separated peaks##2##2##(2008-10#2)
separated sites##2##2##(2007-12#1)(2008-10#1)
separated the effects of##2##4##(2008-8#2)
separated the two species##2##4##(2008-10#1)(2008-9#1)
separated the two##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
separated the##18##2##(1995-6#1)(2007-8#1)(2008-10#9)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
separated under##2##2##(1996-5#1)(2008-4#1)
separated using##8##2##(1990-8#1)(1992-8#1)(1995-3#1)(1996-5#1)(2008-10#3)(2010-2#1)
separated via##2##2##(2008-10#1)(2008-5#1)
separated well##2##2##(2008-10#2)
separated with a##3##3##(2008-10#2)(2013-8#1)
separated with high##3##3##(1995-6#1)(2008-10#2)
separated with##17##2##(1990-8#2)(1992-2#1)(1995-6#1)(2008-10#9)(2008-5#2)(2008-7#1)(2013-8#1)
separated within##12##2##(1994-9#1)(2008-10#10)(2008-5#1)
separated without any##2##3##(2008-10#2)
separated without##5##2##(2008-10#4)(2010-8#1)
separated##592##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#17)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-12#3)(1994-3#1)(1994-9#8)(1995-11#1)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#5)(1995-8#2)(1996-2#3)(1996-3#1)(1996-5#14)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#271)(2008-11#13)(2008-12#7)(2008-2#9)(2008-3#11)(2008-4#14)(2008-5#15)(2008-6#6)(2008-7#14)(2008-8#11)(2008-9#7)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#9)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
separately and together##3##3##(2008-10#3)
separately and##10##2##(1991-2#1)(1994-5#1)(1996-1#1)(2007-11#1)(2008-10#5)(2008-4#1)
separately as##2##2##(2008-12#1)(2008-6#1)
separately at##2##2##(2008-10#1)(2012-12#1)
separately expressed##2##2##(1994-9#1)(2011-3#1)
separately for each##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
separately for##14##2##(1990-11#1)(1992-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
separately from the##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
separately from##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2012-12#1)
separately in the##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
separately in##13##2##(1995-12#1)(1995-3#1)(1996-2#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
separately measured##2##2##(2008-3#1)(2012-2#1)
separately or in##2##3##(2011-1#1)(2011-2#1)
separately or##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
separately the##2##2##(2008-3#1)(2008-7#1)
separately to##4##2##(1995-8#1)(2007-11#1)(2008-2#1)(2008-8#1)
separately under##2##2##(2008-10#1)(2010-5#1)
separately with##2##2##(1990-5#1)(2008-9#1)
separately##161##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#1)(1996-1#1)(1996-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#5)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
separates as##2##2##(1990-11#2)
separates the##6##2##(1990-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-6#1)
separates##17##1##(1990-11#2)(1990-3#1)(1991-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)
separating a##3##2##(2008-11#1)(2008-6#1)(2009-8#1)
separating and detecting##2##3##(2008-10#2)
separating and determining##2##3##(2008-10#2)
separating and##7##2##(2008-10#7)
separating the two##3##3##(1991-12#1)(2007-12#1)(2008-12#1)
separating the##14##2##(1991-12#1)(1991-5#1)(1993-12#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)
separating them##3##2##(2008-10#2)(2008-11#1)
separating these##2##2##(2008-10#1)(2008-4#1)
separating two intermediate regions##2##4##(1990-3#2)
separating##67##1##(1990-3#2)(1991-12#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(2007-12#1)(2008-10#27)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
separation and a##2##3##(2008-10#2)
separation and characterization of##2##4##(1996-5#1)(2008-10#1)
separation and detection of##13##4##(2008-10#12)(2011-1#1)
separation and detection processes were examined and##3##7##(2008-10#3)
separation and detection processes were##4##5##(2008-10#4)
separation and detection processes##5##4##(2008-10#5)
separation and detection system##2##4##(2008-10#2)
separation and detection were investigated##2##5##(2008-10#2)
separation and detection##33##3##(2008-10#30)(2008-12#1)(2008-7#1)(2011-1#1)
separation and determination of##28##4##(1990-8#2)(2008-10#25)(2009-8#1)
separation and determination##32##3##(1990-8#2)(2008-10#29)(2009-8#1)
separation and direct detection of##2##5##(2008-10#2)
separation and enrichment of##2##4##(2008-10#2)
separation and enrichment##3##3##(2008-10#3)
separation and estimation of##3##4##(2008-10#3)
separation and identification of##2##4##(2008-1#1)(2010-9#1)
separation and identification##3##3##(2008-1#1)(2008-12#1)(2010-9#1)
separation and pre-concentration of inorganic arsenic##2##6##(2008-10#2)
separation and pre-concentration of##5##4##(2008-10#5)
separation and preconcentration of U(VI)##2##5##(2008-10#2)
separation and preconcentration of inorganic##2##5##(2008-10#2)
separation and preconcentration of trace##5##5##(2008-10#5)
separation and preconcentration of##28##4##(2008-10#28)
separation and preconcentration technique##2##4##(2008-10#2)
separation and preconcentration##40##3##(2008-10#40)
separation and purification of##5##4##(1997-2#2)(2008-10#3)
separation and quantification of##2##4##(1991-5#1)(2008-10#1)
separation and quantitation of##3##4##(1997-2#1)(2008-10#2)
separation and quantitative##3##3##(2008-2#1)(2008-5#2)
separation and resolution##2##3##(2008-10#2)
separation and the##8##3##(1996-2#1)(2007-12#2)(2008-10#4)(2008-12#1)
separation and to##3##3##(2008-10#2)(2008-3#1)
separation and##196##2##(1990-8#2)(1991-5#1)(1991-8#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#3)(1997-5#1)(2007-12#3)(2008-1#1)(2008-10#158)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)
separation and/or##2##2##(1992-6#1)(2008-10#1)
separation anxiety##3##2##(1993-1#1)(1993-12#1)(2012-2#1)
separation approaches##2##2##(2008-10#2)
separation are##2##2##(2008-10#1)(2008-3#1)
separation as a##2##3##(1996-5#1)(2008-12#1)
separation as##3##2##(1996-5#1)(2008-10#1)(2008-12#1)
separation at##6##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)
separation between the two##2##4##(2008-3#2)
separation between the##13##3##(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#3)(2008-6#1)(2009-2#1)(2009-9#1)
separation between##24##2##(1990-12#1)(1990-8#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2013-7#1)
separation by IP-RPHPLC##2##3##(2008-10#2)
separation by capillary electrophoresis##3##4##(1994-9#1)(2008-10#2)
separation by ion##2##3##(2008-10#2)
separation by##16##2##(1990-12#1)(1994-9#1)(2008-10#13)(2008-11#1)
separation can be##2##3##(2008-10#1)(2011-1#1)
separation capillary##4##2##(2008-10#4)
separation cell##2##2##(2008-10#2)
separation chamber##3##2##(2008-10#2)(2008-11#1)
separation channel##6##2##(2008-10#6)
separation column##4##2##(2008-10#4)
separation condition##3##2##(2008-10#2)(2009-5#1)
separation conditions for##2##3##(2008-10#2)
separation conditions were##4##3##(2008-10#4)
separation conditions##17##2##(1990-8#1)(1994-12#1)(1994-9#1)(1996-5#1)(2008-10#13)
separation device##3##2##(2008-10#1)(2008-11#2)
separation distance between##3##3##(2008-2#2)(2013-1#1)
separation distance##8##2##(2008-2#4)(2008-3#1)(2008-4#1)(2013-1#2)
separation during##2##2##(2009-12#1)(2010-4#1)
separation efficiencies for##2##3##(2008-10#1)(2008-11#1)
separation efficiencies##5##2##(1996-5#1)(2008-10#2)(2008-11#2)
separation efficiency and##2##3##(1996-5#1)(2008-10#1)
separation efficiency of##2##3##(1997-2#1)(2008-10#1)
separation efficiency##10##2##(1994-12#1)(1996-5#1)(1997-2#1)(2008-10#6)(2008-11#1)
separation factor (alpha)##2##3##(2008-10#2)
separation factor##8##2##(1996-5#1)(2008-10#7)
separation factors##7##2##(1997-2#1)(2008-10#6)
separation for all##2##3##(2008-10#2)
separation for the##2##3##(1990-12#1)(2008-10#1)
separation for##8##2##(1990-12#1)(2008-10#6)(2013-1#1)
separation from the##3##3##(2008-10#2)(2008-3#1)
separation from water##2##3##(2008-10#2)
separation from##13##2##(1990-3#1)(1996-3#1)(2008-10#9)(2008-3#1)(2012-3#1)
separation has been##4##3##(2008-10#2)(2008-11#1)(2012-12#1)
separation in a##5##3##(1997-2#1)(2008-3#2)(2010-7#1)(2011-1#1)
separation in the##6##3##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
separation in##19##2##(1992-6#1)(1995-5#1)(1997-2#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
separation into##4##2##(2008-10#2)(2010-4#1)(2011-2#1)
separation is observed##2##3##(2008-10#1)(2011-2#1)
separation is##24##2##(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
separation length##3##2##(2008-10#3)
separation mechanism##3##2##(1990-8#1)(1996-5#1)(2011-2#1)
separation mechanisms##3##2##(2008-10#3)
separation method based on a novel reversed-phase sequential injection chromatography (SIC)##2##11##(2008-10#2)
separation method##6##2##(2008-10#6)
separation methods##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2010-7#1)
separation mode##3##2##(2008-10#2)(2010-7#1)
separation of Cu##2##3##(2008-10#2)
separation of DNA and proteins##2##5##(2008-7#2)
separation of DNA fragments##4##4##(2008-10#2)(2008-2#1)(2008-4#1)
separation of DNA##6##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)
separation of Fe(III)##3##3##(2008-10#3)
separation of Hf##4##3##(2008-10#4)
separation of K(+)##2##3##(2008-10#2)
separation of PEG##2##3##(2008-10#2)
separation of a complex mixture of##2##6##(2008-10#2)
separation of a mixture of##3##5##(2008-10#3)
separation of a mixture##4##4##(2008-10#4)
separation of a set of##2##5##(2008-10#2)
separation of a##12##3##(2008-10#12)
separation of actinides and##2##4##(2008-10#2)
separation of active##2##3##(1996-5#1)(2008-10#1)
separation of all##2##3##(1996-5#1)(2008-10#1)
separation of amino##2##3##(1991-12#1)(2008-7#1)
separation of an##2##3##(1997-2#1)(2008-10#1)
separation of anions##3##3##(2008-10#3)
separation of basic drugs##2##4##(1990-8#1)(1995-6#1)
separation of basic##4##3##(1990-8#1)(1995-6#1)(2008-10#2)
separation of both##2##3##(2008-10#2)
separation of bound##2##3##(1995-11#1)(2008-11#1)
separation of cadmium##2##3##(2008-10#2)
separation of cell##2##3##(2008-4#1)(2009-6#1)
separation of chromium##2##3##(2008-10#2)
separation of different##3##3##(2008-10#3)
separation of diltiazem##2##3##(1990-8#2)
separation of enantiomeric##2##3##(1994-9#1)(1995-6#1)
separation of enantiomers of##2##4##(2008-10#2)
separation of enantiomers##3##3##(1994-9#1)(2008-10#2)
separation of extract from aqueous phase##2##6##(2008-10#2)
separation of five##2##3##(2008-10#2)
separation of four##2##3##(2008-10#2)
separation of gallium##3##3##(2008-10#3)
separation of human##3##3##(1991-5#1)(1997-2#1)(2008-10#1)
separation of inorganic##5##3##(2008-10#5)
separation of iron(III)##3##3##(2008-10#3)
separation of metal ions##5##4##(2008-10#5)
separation of metal##6##3##(2008-10#6)
separation of micron##2##3##(2008-10#2)
separation of nucleosides and##2##4##(1993-12#1)(2008-10#1)
separation of p-sulfonated calix[n]arenes##2##4##(2008-10#2)
separation of palladium(II) from##2##4##(2008-10#2)
separation of palladium(II)##3##3##(2008-10#3)
separation of peptides##2##3##(1994-9#1)(2008-2#1)
separation of platinum##2##3##(2008-10#2)
separation of platinum(IV) from##2##4##(2008-10#2)
separation of proteins and##2##4##(1996-5#1)(2008-6#1)
separation of proteins##6##3##(1996-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2012-2#1)
separation of seven##3##3##(1990-8#1)(2008-10#2)
separation of six##4##3##(2008-10#4)
separation of small##2##3##(1990-8#1)(2010-7#1)
separation of solasodine glycosides##2##4##(2008-11#2)
separation of tellurium(IV) from##2##4##(2008-10#2)
separation of the different##2##4##(2008-10#2)
separation of the formed##2##4##(2008-10#2)
separation of the reaction products##2##5##(2008-10#1)(2008-4#1)
separation of the same compounds##2##5##(2008-10#2)
separation of the spectral##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
separation of the three##4##4##(2008-10#4)
separation of the two##3##4##(1990-7#1)(2008-10#2)
separation of the##76##3##(1990-12#2)(1990-7#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1996-12#1)(1996-5#4)(2007-11#1)(2007-12#2)(2008-10#46)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
separation of these##7##3##(1996-5#1)(2008-10#4)(2008-7#1)(2012-2#1)
separation of this##2##3##(2008-10#1)(2008-12#1)
separation of trace##7##3##(2008-10#7)
separation of trivalent##3##3##(2008-10#3)
separation of two##4##3##(2007-11#1)(2008-10#1)(2009-12#1)(2010-4#1)
separation of uranium by##2##4##(2008-10#2)
separation of uranium##5##3##(2008-10#5)
separation of uranium(VI)##3##3##(2008-10#3)
separation of zinc compounds##2##4##(2008-10#2)
separation of zinc from##2##4##(2008-10#2)
separation of zinc traces from##2##5##(2008-10#2)
separation of zinc##7##3##(2008-10#7)
separation of##472##2##(1990-12#2)(1990-7#1)(1990-8#9)(1991-12#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#3)(1993-12#1)(1993-8#1)(1994-12#3)(1994-9#10)(1995-11#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#15)(1997-2#5)(1997-6#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#317)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#14)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
separation on a##3##3##(1996-12#1)(2008-10#2)
separation on the##3##3##(2008-10#1)(2009-2#1)(2012-2#1)
separation on##11##2##(1996-12#1)(2008-10#8)(2009-2#1)(2012-2#1)
separation or##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2010-11#1)
separation parameters##3##2##(2008-10#2)(2013-1#1)
separation principle is##2##3##(2010-7#2)
separation procedure##9##2##(1994-9#1)(2008-10#8)
separation procedures##5##2##(2008-10#5)
separation process##4##2##(2008-10#4)
separation result##2##2##(2008-10#1)(2009-12#1)
separation selectivity and##2##3##(1996-5#1)(2008-10#1)
separation selectivity##4##2##(1996-5#1)(2008-10#3)
separation space##3##2##(2008-10#3)
separation step##7##2##(2008-10#7)
separation steps##10##2##(2008-10#6)(2008-11#1)(2008-4#2)(2008-6#1)
separation surgery##3##2##(2010-7#3)
separation system was used##2##4##(2008-10#2)
separation system##6##2##(2008-10#3)(2008-7#1)(2012-1#2)
separation systems##2##2##(2008-10#2)
separation technique for##3##3##(1994-9#1)(2008-10#2)
separation technique##9##2##(1994-9#1)(2008-10#7)(2008-12#1)
separation techniques such as##3##4##(2008-10#3)
separation techniques##12##2##(1991-9#1)(2008-10#8)(2008-4#1)(2008-7#2)
separation that##2##2##(2008-2#1)(2008-3#1)
separation time of##2##3##(2008-10#1)(2008-4#1)
separation time##3##2##(2008-10#2)(2008-4#1)
separation to##2##2##(2008-9#1)(2011-2#1)
separation under##2##2##(2008-10#2)
separation using##4##2##(1990-8#1)(2008-10#2)(2008-4#1)
separation voltage and##4##3##(2008-10#4)
separation voltage of##8##3##(2008-10#8)
separation voltage##14##2##(2008-10#14)
separation was accomplished##3##3##(1990-8#1)(2008-10#2)
separation was achieved by##2##4##(2008-10#2)
separation was achieved on##4##4##(2008-10#4)
separation was achieved with##2##4##(2008-10#2)
separation was achieved##9##3##(2008-10#9)
separation was also##3##3##(1992-6#1)(1994-3#1)(2008-10#1)
separation was carried out on##3##5##(2008-10#1)(2011-1#2)
separation was carried out##8##4##(2008-10#6)(2011-1#2)
separation was observed##2##3##(2008-10#2)
separation was obtained##2##3##(2008-10#1)(2008-5#1)
separation was performed on a##3##5##(2008-10#1)(2011-1#1)(2011-3#1)
separation was performed on##4##4##(2008-10#1)(2011-1#2)(2011-3#1)
separation was performed using a##3##5##(2008-10#2)(2013-1#1)
separation was performed##11##3##(1996-5#1)(2008-10#5)(2008-12#1)(2011-1#2)(2011-3#1)(2013-1#1)
separation was##52##2##(1990-8#1)(1992-6#1)(1994-3#1)(1996-5#1)(2008-10#34)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2011-1#4)(2011-2#1)(2011-3#1)(2013-1#1)
separation were##5##2##(2008-10#5)
separation with Amberlite##3##3##(2008-10#3)
separation with a##3##3##(2008-10#3)
separation with##20##2##(1995-5#1)(1997-4#1)(2008-10#17)(2008-3#1)
separation##1326##1##(1990-12#5)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#17)(1991-12#2)(1991-5#4)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#6)(1993-1#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-12#6)(1994-3#1)(1994-5#1)(1994-9#14)(1995-11#1)(1995-3#5)(1995-5#2)(1995-6#5)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#28)(1997-2#14)(1997-4#2)(1997-5#1)(1997-6#1)(2007-11#9)(2007-12#13)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#876)(2008-11#26)(2008-12#13)(2008-2#23)(2008-3#39)(2008-4#19)(2008-5#8)(2008-6#8)(2008-7#30)(2008-8#5)(2008-9#11)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#4)(2010-7#12)(2010-8#3)(2010-9#1)(2011-1#12)(2011-2#14)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
separation)##2##1##(2008-10#2)
separation-of-variables method##3##2##(2008-2#1)(2008-3#2)
separation-of-variables##4##1##(2008-2#1)(2008-3#3)
separation/preconcentration##5##1##(2008-10#5)
separations and mass spectrometry##2##4##(2008-4#1)(2008-7#1)
separations and##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)
separations are##5##2##(1990-2#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)
separations between##2##2##(2008-10#1)(2008-7#1)
separations in##5##2##(2008-10#3)(2008-2#1)(2008-4#1)
separations of neuromediators##2##3##(2008-10#2)
separations of organic compounds##2##4##(2008-10#2)
separations of proteins##2##3##(1996-5#1)(2008-4#1)
separations of##29##2##(1994-9#4)(1996-5#2)(2007-11#1)(2007-12#2)(2008-10#16)(2008-2#1)(2008-4#2)(2011-1#1)
separations or##2##2##(2008-10#1)(2008-2#1)
separations that##3##2##(1997-2#1)(2007-12#1)(2008-3#1)
separations using##5##2##(2008-10#3)(2008-7#2)
separations were achieved by##2##4##(2008-10#1)(2008-7#1)
separations were performed on##2##4##(2008-10#2)
separations were##7##2##(1997-2#1)(2008-10#5)(2008-7#1)
separations with##2##2##(2008-10#2)
separations##104##1##(1990-2#1)(1994-9#7)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#4)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#6)(2008-10#47)(2008-2#4)(2008-3#5)(2008-4#7)(2008-7#8)(2010-11#1)(2010-7#1)(2011-1#1)(2013-1#2)
separative##2##1##(2008-10#2)
separator and##5##2##(2008-10#5)
separator to##2##2##(2008-10#2)
separator##29##1##(2008-10#23)(2010-12#1)(2011-1#4)(2011-2#1)
separators##5##1##(2008-10#2)(2008-11#1)(2011-2#2)
sepedonicus##2##1##(2008-10#2)
sepharose##4##1##(1990-12#1)(1991-12#1)(1994-2#1)(2008-7#1)
sepiolite and determined by flame atomic absorption##2##7##(2008-10#2)
sepiolite and##3##2##(2008-10#3)
sepiolite##8##1##(2008-10#8)
sepsis (p &lt##2##3##(2009-6#2)
sepsis (p##3##2##(2009-6#3)
sepsis after##2##2##(2007-8#1)(2008-8#1)
sepsis and meningitis##3##3##(2009-12#3)
sepsis and septic shock in##3##5##(1996-9#1)(2007-12#1)(2011-2#1)
sepsis and septic shock##8##4##(1996-9#1)(2007-12#3)(2011-2#4)
sepsis and##23##2##(1992-12#1)(1994-6#1)(1995-8#1)(1996-3#1)(1996-9#1)(2007-12#4)(2007-5#1)(2008-4#1)(2009-12#3)(2011-1#1)(2011-2#5)(2013-1#2)(2013-8#1)
sepsis are##2##2##(2008-12#1)(2012-3#1)
sepsis in the##2##3##(2011-2#1)(2012-3#1)
sepsis in##6##2##(2007-5#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
sepsis is##5##2##(1991-5#1)(2008-7#1)(2011-2#2)(2012-3#1)
sepsis or##3##2##(2011-2#2)(2012-2#1)
sepsis was##2##2##(2007-12#1)(2008-7#1)
sepsis##130##1##(1990-3#2)(1990-6#1)(1991-3#5)(1991-5#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(2007-10#1)(2007-12#11)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#3)(2009-12#3)(2009-5#2)(2009-6#8)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#3)(2010-8#1)(2011-1#6)(2011-2#23)(2011-3#1)(2012-2#2)(2012-3#6)(2013-1#7)(2013-8#5)
sepsis)##3##1##(2008-7#1)(2011-2#1)(2013-8#1)
sepsis-induced tissue injury##2##3##(1995-2#2)
sepsis-induced##3##1##(1995-2#2)(2012-3#1)
septa and##2##2##(2008-1#1)(2012-12#1)
septa##11##1##(1990-11#1)(1994-9#1)(2008-1#1)(2008-7#5)(2010-10#1)(2012-12#1)(2012-2#1)
septal aneurysm##3##2##(1994-11#3)
septal area##4##2##(1993-12#2)(1997-2#1)(2013-8#1)
septal button##3##2##(2008-2#3)
septal cholinergic neurons##2##3##(1993-12#1)(1996-12#1)
septal defect with##2##3##(2007-8#1)(2008-11#1)
septal defect##35##2##(1992-2#1)(1996-6#1)(2007-8#15)(2008-11#11)(2008-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
septal defects and open##2##4##(1996-6#1)(1997-8#1)
septal defects##11##2##(1996-6#1)(1997-8#3)(2007-9#1)(2008-11#2)(2009-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
septal grafts##3##2##(1993-12#3)
septal nucleus##2##2##(1992-8#1)(1994-2#1)
septal obliteration technique##2##3##(2007-8#2)
septal occluder##2##2##(1997-8#1)(2009-10#1)
septal perforation##2##2##(2008-2#2)
septal rupture in a##2##4##(1993-12#1)(2007-8#1)
septal rupture##4##2##(1993-12#2)(2007-8#1)(2012-1#1)
septal##97##1##(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-8#4)(1993-12#9)(1994-11#3)(1994-2#2)(1995-3#1)(1996-12#2)(1996-6#2)(1997-2#1)(1997-8#4)(2007-5#1)(2007-8#18)(2007-9#1)(2008-11#14)(2008-2#6)(2008-7#1)(2009-10#2)(2009-5#1)(2011-1#1)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
septate junctions##7##2##(2008-7#7)
septate uterus##2##2##(1994-9#1)(2011-1#1)
septate##15##1##(1994-9#1)(2008-10#3)(2008-7#7)(2011-1#1)(2013-1#3)
septated##2##1##(2011-2#1)(2012-2#1)
septation##2##1##(2010-10#1)(2012-2#1)
septaurelia##4##1##(2008-12#4)
septentrionalis##3##1##(2012-2#3)
septic arthritis and##2##3##(2010-12#1)(2013-8#1)
septic arthritis##11##2##(1991-3#1)(2006-10#2)(2007-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#4)
septic cardiomyopathy##2##2##(2008-7#2)
septic complications after##2##3##(2007-11#1)(2007-8#1)
septic complications were##2##3##(2007-11#2)
septic complications##7##2##(2007-11#4)(2007-8#2)(2010-12#1)
septic loosening##2##2##(2009-4#1)(2012-12#1)
septic patients##2##2##(1991-9#1)(1997-8#1)
septic shock and##4##3##(2007-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
septic shock in##5##3##(1995-2#2)(1996-9#1)(2007-12#1)(2011-2#1)
septic shock##37##2##(1994-8#1)(1995-2#5)(1996-3#3)(1996-9#1)(2006-5#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-4#2)(2008-5#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#11)(2013-1#1)(2013-8#1)
septic##78##1##(1990-6#1)(1991-3#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#5)(1996-3#4)(1996-9#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#12)(2012-12#3)(2013-1#2)(2013-8#6)
septicaemia##12##1##(1990-9#1)(1991-8#1)(1994-3#1)(1995-11#2)(2008-5#4)(2008-7#1)(2009-5#1)(2013-1#1)
septicaemic##3##1##(2011-1#3)
septicemia and##2##2##(2007-7#1)(2009-6#1)
septicemia##13##1##(1994-9#3)(2007-5#1)(2007-7#2)(2008-1#1)(2009-6#1)(2010-2#1)(2011-2#2)(2013-8#2)
septicemia]##2##1##(1990-9#1)(1996-3#1)
septile##2##1##(2008-7#2)
septo-hippocampal cell cultures##3##3##(1996-12#1)(1996-2#2)
septo-hippocampal##6##1##(1993-12#2)(1996-12#1)(1996-2#3)
septo-optic dysplasia is##2##3##(1997-3#1)(2011-1#1)
septo-optic dysplasia##5##2##(1997-3#2)(2011-1#3)
septohippocampal##6##1##(1993-12#3)(1996-12#1)(2013-8#2)
septoria speckled leaf blotch##3##4##(2008-10#3)
septoria tritici blotch##2##3##(2008-10#2)
septoria##6##1##(2008-10#6)
septosporum and##2##2##(2008-10#2)
septosporum##4##1##(2008-10#4)
septum and##7##2##(1991-5#2)(1992-9#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)
septum in the##2##3##(1993-12#1)(2008-11#1)
septum in##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
septum is##2##2##(1991-5#1)(2008-7#1)
septum was##3##2##(1991-5#1)(2012-12#2)
septum##58##1##(1991-5#5)(1991-8#1)(1992-9#1)(1993-12#3)(1994-2#3)(1994-3#1)(1994-8#3)(1994-9#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-3#1)(2007-5#3)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#3)(2012-12#5)(2012-3#4)(2013-1#1)
seqdb_demo##2##1##(2008-4#2)
sequel following##2##2##(2007-11#1)(2008-7#1)
sequel of##4##2##(2008-7#3)(2012-3#1)
sequel##11##1##(1996-11#1)(2007-10#1)(2007-11#1)(2008-7#4)(2011-2#2)(2012-3#1)(2013-8#1)
sequela of##4##2##(1990-9#1)(2008-12#1)(2008-6#1)(2008-7#1)
sequela##6##1##(1990-9#1)(1994-5#1)(2008-12#1)(2008-6#1)(2008-7#2)
sequelae and##3##2##(1997-2#1)(2008-4#1)(2010-12#1)
sequelae associated with##2##3##(1994-5#1)(2008-12#1)
sequelae but##2##2##(1990-12#1)(2011-2#1)
sequelae cause##2##2##(1996-11#1)(2013-1#1)
sequelae in##5##2##(1992-11#1)(1995-2#1)(2008-2#1)(2012-2#1)(2013-1#1)
sequelae of acute##2##3##(1991-9#1)(2011-2#1)
sequelae of traumatic brain injury##2##5##(1990-12#1)(1993-12#1)
sequelae of##29##2##(1990-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-3#1)(1996-8#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
sequelae or##2##2##(2007-10#1)(2011-2#1)
sequelae##89##1##(1990-12#4)(1990-9#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#2)
sequelae]##2##1##(1997-3#1)(2007-3#1)
sequels of##2##2##(1992-1#1)(2008-12#1)
sequels##4##1##(1992-1#1)(2007-8#1)(2008-12#1)(2013-1#1)
sequence (&gt##3##2##(1997-9#1)(2008-10#2)
sequence (1 copy/every##2##3##(1997-2#2)
sequence (an 1##2##3##(2008-11#2)
sequence a##2##2##(2007-6#1)(2011-2#1)
sequence against a##2##3##(2008-4#1)(2011-2#1)
sequence alignment and##2##3##(2008-10#1)(2008-4#1)
sequence alignment of the##2##4##(2008-7#1)(2011-1#1)
sequence alignment of##5##3##(1994-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
sequence alignment revealed##2##3##(2008-10#1)(2011-1#1)
sequence alignment##19##2##(1992-8#1)(1993-12#1)(1994-5#1)(2008-10#4)(2008-4#6)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#2)(2013-1#1)
sequence alignments of##3##3##(1994-6#1)(2008-4#1)(2009-9#1)
sequence alignments##12##2##(1994-6#1)(2008-10#1)(2008-4#5)(2008-7#2)(2009-9#1)(2010-4#1)(2013-8#1)
sequence allows##2##2##(1997-3#1)(2008-10#1)
sequence also contains a##2##4##(1993-3#1)(1995-9#1)
sequence also##7##2##(1991-7#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-6#1)(1995-9#1)(1997-4#1)
sequence alterations##3##2##(1992-3#1)(1994-11#1)(2008-10#1)
sequence amplified##3##2##(1996-8#1)(2008-10#1)(2013-1#1)
sequence analyses and##3##3##(1996-6#1)(2008-10#1)(2013-1#1)
sequence analyses of the##3##4##(1993-12#1)(2008-10#2)
sequence analyses of##7##3##(1993-12#1)(2007-6#1)(2008-10#4)(2008-7#1)
sequence analyses revealed##2##3##(1994-12#1)(2008-11#1)
sequence analyses##23##2##(1991-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-4#1)(2007-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2013-1#2)
sequence analysis and expression##2##4##(1993-2#1)(2008-8#1)
sequence analysis and##12##3##(1990-8#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
sequence analysis has##2##3##(1991-9#1)(1994-11#1)
sequence analysis indicated that##2##4##(2008-10#1)(2008-9#1)
sequence analysis indicated##3##3##(2008-10#2)(2008-9#1)
sequence analysis indicates that##3##4##(1992-6#1)(2008-6#1)(2008-9#1)
sequence analysis is##2##3##(2008-4#1)(2009-2#1)
sequence analysis of a##9##4##(1990-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1997-3#2)(1997-4#1)(2007-6#1)
sequence analysis of the CP gene##2##6##(1997-6#1)(2008-10#1)
sequence analysis of the internal transcribed spacer (ITS)##2##8##(2008-10#2)
sequence analysis of the internal transcribed spacer region 1 (ITS1)##2##10##(2008-10#2)
sequence analysis of the internal transcribed spacer##4##7##(2008-10#4)
sequence analysis of the protein##2##5##(1990-7#1)(1992-3#1)
sequence analysis of the##30##4##(1990-11#2)(1990-7#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-10#15)(2008-6#1)(2009-5#1)
sequence analysis of these##2##4##(1992-3#1)(1994-6#1)
sequence analysis of two##2##4##(1990-12#1)(1993-2#1)
sequence analysis of##66##3##(1990-11#2)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-8#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1994-11#2)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-3#3)(1997-4#1)(1997-6#2)(2007-6#1)(2008-10#23)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)
sequence analysis revealed an open reading frame (ORF)##2##8##(1994-12#1)(1995-8#1)
sequence analysis revealed an##3##4##(1994-12#1)(1995-8#1)(2008-10#1)
sequence analysis revealed that the##3##5##(1992-6#1)(2008-10#2)
sequence analysis revealed that##8##4##(1990-2#1)(1991-12#1)(1992-6#1)(1997-4#1)(2008-10#3)(2008-8#1)
sequence analysis revealed##11##3##(1990-2#1)(1991-12#1)(1992-6#1)(1994-12#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-8#1)
sequence analysis showed that the##2##5##(1990-11#1)(1993-3#1)
sequence analysis showed that##3##4##(1990-11#1)(1993-3#1)(1997-8#1)
sequence analysis showed##5##3##(1990-11#1)(1993-3#1)(1997-8#1)(2008-10#2)
sequence analysis suggests that##2##4##(1991-6#1)(1992-3#1)
sequence analysis##158##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#3)(1992-3#3)(1992-6#2)(1992-8#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-6#5)(1994-11#3)(1994-12#2)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#3)(1995-9#1)(1997-3#3)(1997-4#3)(1997-6#2)(1997-8#1)(1997-9#1)(2007-6#1)(2008-10#46)(2008-11#2)(2008-2#2)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-7#1)
sequence and a##10##3##(1990-7#1)(1991-10#1)(1992-3#1)(1993-6#1)(1994-12#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-11#1)
sequence and annotation##15##3##(2011-2#15)
sequence and characterization of##3##4##(1990-5#1)(1991-9#1)(1994-12#1)
sequence and expression in##3##4##(1990-8#1)(1991-9#1)(1992-3#1)
sequence and expression of the##2##5##(1990-11#1)(1993-12#1)
sequence and expression of##3##4##(1990-11#1)(1992-9#1)(1993-12#1)
sequence and expression##9##3##(1990-11#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#2)(1996-8#1)(2012-2#1)
sequence and is##3##3##(1992-8#1)(1993-6#1)(1994-12#1)
sequence and its##2##3##(1992-11#1)(2010-6#1)
sequence and structural##3##3##(1991-6#1)(1995-2#1)(2008-10#1)
sequence and the##15##3##(1990-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-6#1)
sequence and was##2##3##(1993-2#1)(1996-12#1)
sequence and##125##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#5)(1991-9#5)(1992-11#2)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#6)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#3)(2007-12#1)(2008-10#10)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#2)(2011-2#16)(2012-2#2)(2013-8#1)
sequence annotations##2##2##(2008-7#2)
sequence are located##2##3##(1995-8#1)(2008-9#1)
sequence are##9##2##(1990-8#1)(1992-3#2)(1995-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)
sequence around the##2##3##(1990-11#1)(2008-8#1)
sequence as a probe##3##4##(1990-12#1)(1992-3#1)(1993-2#1)
sequence as a##5##3##(1990-12#1)(1992-10#1)(1992-3#1)(1993-2#1)(1994-12#1)
sequence as##11##2##(1990-12#1)(1991-10#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(2008-10#2)(2009-5#1)(2013-1#1)
sequence associated with##2##3##(2008-2#1)(2008-9#1)
sequence at position##2##3##(2008-8#1)(2011-2#1)
sequence at the NH2 terminus##2##5##(1992-9#1)(1993-3#1)
sequence at the##9##3##(1990-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(2008-10#2)(2008-5#1)
sequence at##14##2##(1990-7#1)(1991-11#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1997-9#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
sequence base##3##2##(1996-6#2)(2008-10#1)
sequence being##2##2##(1992-6#1)(2008-11#1)
sequence between the##2##3##(2008-11#1)(2013-8#1)
sequence between##5##2##(1990-5#1)(1994-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
sequence but##3##2##(1992-6#1)(2008-10#1)(2008-9#1)
sequence by##6##2##(1991-2#1)(1991-5#1)(1993-3#1)(1997-9#1)(2008-10#1)(2008-8#1)
sequence can be used to##2##5##(1991-9#1)(2012-2#1)
sequence can be used##3##4##(1991-9#1)(2008-10#1)(2012-2#1)
sequence can be##4##3##(1991-9#1)(2008-10#1)(2008-4#1)(2012-2#1)
sequence changes##3##2##(1997-3#1)(2008-9#2)
sequence characterized amplified region (SCAR) marker##3##6##(2008-10#2)(2008-5#1)
sequence characterized amplified region (SCAR)##6##5##(2008-10#4)(2008-5#2)
sequence characterized##7##2##(2008-10#4)(2008-5#2)(2012-3#1)
sequence cloned from##2##3##(2008-8#2)
sequence comparison##7##2##(1991-6#2)(1993-8#1)(2008-10#3)(2009-6#1)
sequence comparisons between##2##3##(1995-2#1)(2008-9#1)
sequence comparisons indicated that the##2##5##(2008-10#2)
sequence comparisons##16##2##(1990-12#1)(1992-6#1)(1993-2#1)(1995-2#1)(2008-10#10)(2008-9#2)
sequence complementarity to##2##3##(1997-7#1)(2008-7#1)
sequence conservation between##3##3##(1993-6#1)(2008-7#1)(2012-3#1)
sequence conservation##7##2##(1993-6#2)(1995-12#1)(2008-7#1)(2011-1#1)(2012-3#2)
sequence consists of##3##3##(1997-3#1)(1997-6#1)(2008-8#1)
sequence contained an open reading frame##2##6##(1990-11#1)(1993-12#1)
sequence contained##4##2##(1990-11#1)(1993-12#1)(1997-4#1)(2011-2#1)
sequence containing the##2##3##(1994-9#1)(2008-8#1)
sequence containing##3##2##(1992-3#1)(1994-9#1)(2008-8#1)
sequence contains a##2##3##(1996-3#1)(1997-3#1)
sequence contains an open reading frame of##2##7##(1990-5#1)(1995-6#1)
sequence contains an open reading frame##3##6##(1990-5#1)(1995-6#1)(1995-8#1)
sequence contains several##2##3##(1993-2#1)(1993-6#1)
sequence contains##13##2##(1990-5#1)(1991-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#2)(2008-10#1)(2008-8#1)
sequence context##2##2##(1995-12#1)(2008-4#1)
sequence corresponding to##3##3##(1996-12#3)
sequence corresponds to the##2##4##(1991-12#1)(1993-11#1)
sequence could be##3##3##(1995-6#1)(2008-11#1)(2008-9#1)
sequence data and##4##3##(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)
sequence data for##4##3##(1991-10#1)(1993-11#1)(2007-6#1)(2008-10#1)
sequence data from the##6##4##(1995-8#1)(2008-1#1)(2008-10#4)
sequence data from##13##3##(1994-12#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#5)(2009-2#1)(2010-4#1)(2013-1#1)(2013-7#1)
sequence data of the##4##4##(1995-12#1)(2008-10#2)(2008-5#1)
sequence data of##8##3##(1995-12#3)(1997-6#1)(2008-10#2)(2008-5#1)(2010-3#1)
sequence data revealed##2##3##(2008-10#2)
sequence data that##2##3##(2008-7#1)(2010-6#1)
sequence data using##2##3##(2008-4#1)(2009-2#1)
sequence data##77##2##(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#3)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#6)(1997-8#1)(2007-6#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-7#7)(2008-9#1)(2009-2#2)(2010-3#3)(2010-4#1)(2010-6#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
sequence database for sequences that are similar to a query##2##10##(2008-9#2)
sequence database##4##2##(2008-4#2)(2008-9#2)
sequence databases##14##2##(1995-6#1)(1996-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-6#1)(2010-11#1)(2013-8#1)
sequence deduced from##2##3##(1995-6#1)(1995-8#1)
sequence deduced##4##2##(1991-9#1)(1993-9#1)(1995-6#1)(1995-8#1)
sequence derived from the##2##4##(1993-6#1)(2009-6#1)
sequence derived from##5##3##(1993-6#1)(1994-5#1)(1995-5#1)(2008-10#1)(2009-6#1)
sequence design##3##2##(2008-4#1)(2008-7#2)
sequence determination by##2##3##(1993-8#1)(2008-10#1)
sequence determination of the##4##4##(1996-6#1)(1997-2#1)(2008-10#1)(2010-6#1)
sequence determination of##5##3##(1996-6#1)(1997-2#1)(2008-10#1)(2010-6#2)
sequence determination##8##2##(1993-8#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-8#1)(2010-6#2)
sequence determined##6##2##(1990-7#1)(1991-2#1)(1994-12#1)(1994-9#1)(1996-8#1)(1997-7#1)
sequence differed##2##2##(1991-2#1)(2008-5#1)
sequence difference in the##2##4##(1994-12#1)(2008-10#1)
sequence difference##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
sequence differences between##3##3##(1993-6#1)(1994-6#1)(2008-9#1)
sequence differences##8##2##(1993-6#1)(1994-6#2)(2008-10#2)(2008-9#3)
sequence distribution of##2##3##(2008-10#1)(2012-2#1)
sequence distribution##3##2##(2008-10#2)(2012-2#1)
sequence divergence##4##2##(2008-10#4)
sequence diversity##4##2##(1995-3#1)(2008-10#2)(2009-6#1)
sequence does not##3##3##(1991-9#1)(2008-11#2)
sequence element##3##2##(1992-9#1)(1994-8#1)(2008-11#1)
sequence elements of##2##3##(1991-6#1)(1996-3#1)
sequence elements##5##2##(1991-6#1)(1994-8#1)(1996-3#1)(2013-1#1)(2013-8#1)
sequence encoded##3##2##(1992-9#1)(1994-9#1)(2008-9#1)
sequence encodes a##4##3##(1990-11#1)(1992-12#1)(1993-6#1)(1996-2#1)
sequence encodes##5##2##(1990-11#1)(1992-12#1)(1993-6#1)(1995-9#1)(1996-2#1)
sequence encoding the##8##3##(1992-10#1)(1992-12#1)(1993-2#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-10#2)
sequence encoding##12##2##(1991-6#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-8#1)
sequence evolution##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
sequence families##2##2##(2008-4#1)(2009-3#1)
sequence features##5##2##(1995-5#1)(1996-8#2)(1997-8#1)(2010-5#1)
sequence for a##3##3##(1994-12#1)(2011-2#2)
sequence for the##9##3##(1991-12#1)(1992-10#1)(1993-2#1)(1993-6#1)(1995-8#1)(1997-3#1)(2008-11#1)(2008-4#1)(2013-7#1)
sequence for##32##2##(1991-11#1)(1991-12#1)(1991-5#1)(1992-10#2)(1992-11#1)(1992-8#3)(1993-2#1)(1993-6#3)(1994-12#1)(1995-8#2)(1997-3#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2011-10#1)(2011-2#2)(2013-7#1)
sequence found in##3##3##(1991-2#1)(1993-6#1)(2008-10#1)
sequence found##4##2##(1991-2#1)(1993-6#1)(1997-3#1)(2008-10#1)
sequence from a different##2##4##(2008-4#2)
sequence from a member of the family##3##7##(2011-2#3)
sequence from a member of the##6##6##(2011-2#6)
sequence from a##13##3##(1991-7#1)(1994-12#1)(1994-6#1)(1995-12#1)(2008-4#2)(2011-2#6)(2012-2#1)
sequence from the family##2##4##(2011-2#2)
sequence from the##14##3##(1990-7#1)(1991-7#1)(1991-9#1)(1992-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#3)(2011-2#3)
sequence from##46##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-4#2)(1997-8#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#3)(2011-2#10)(2012-2#1)
sequence functions##2##2##(1991-10#1)(1993-8#1)
sequence had##5##2##(1993-6#1)(1994-11#1)(1994-12#1)(2008-4#1)(2013-1#1)
sequence has been##6##3##(1990-5#1)(1991-11#1)(1993-6#1)(1996-12#1)(2011-2#2)
sequence has revealed the presence of##2##6##(1992-8#1)(1997-3#1)
sequence has##10##2##(1990-5#1)(1991-11#2)(1992-8#1)(1993-11#1)(1993-6#1)(1996-12#1)(1997-3#1)(2011-2#2)
sequence highly homologous to the##2##5##(1990-11#1)(1994-12#1)
sequence homologies of##2##3##(1996-12#2)
sequence homologies with##3##3##(1994-11#1)(2008-10#1)(2010-4#1)
sequence homologies##6##2##(1994-11#1)(1996-12#2)(1997-2#1)(2008-10#1)(2010-4#1)
sequence homologous to a##2##4##(1994-12#1)(2008-8#1)
sequence homologous to that##2##4##(1994-8#1)(2013-1#1)
sequence homologous to the##2##4##(2007-12#1)(2008-10#1)
sequence homologous to##7##3##(1990-11#1)(1994-12#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
sequence homologous##9##2##(1990-11#1)(1994-12#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
sequence homology analysis##2##3##(1997-2#1)(2008-10#1)
sequence homology between the##2##4##(1990-12#1)(2008-8#1)
sequence homology between##3##3##(1990-12#1)(1997-8#1)(2008-8#1)
sequence homology is##2##3##(1993-11#1)(2011-2#1)
sequence homology of##4##3##(1992-3#1)(1997-6#1)(2008-8#2)
sequence homology to a##2##4##(1991-12#1)(1997-3#1)
sequence homology to##7##3##(1991-12#1)(1991-5#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-4#1)
sequence homology with previously described##2##5##(1990-11#1)(1993-11#1)
sequence homology with the##3##4##(1993-12#1)(1994-8#1)(1997-4#1)
sequence homology with those##2##4##(1992-12#1)(2008-9#1)
sequence homology with##16##3##(1990-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-10#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-9#2)(2010-5#1)
sequence homology##48##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#4)(2008-5#1)(2008-8#4)(2008-9#3)(2010-5#1)(2011-2#1)
sequence identical to that of##2##5##(1990-5#1)(1993-3#1)
sequence identities with##2##3##(2008-10#2)
sequence identities##10##2##(1990-7#1)(1997-3#1)(2008-10#7)(2008-11#1)
sequence identity between##5##3##(1991-5#1)(1993-11#1)(2008-10#2)(2012-3#1)
sequence identity in the##3##4##(1993-6#1)(2008-10#2)
sequence identity in##4##3##(1993-6#1)(2008-10#3)
sequence identity to their##2##4##(1997-7#1)(2008-10#1)
sequence identity to##6##3##(1992-8#1)(1997-4#1)(1997-7#1)(2008-10#3)
sequence identity was observed##2##4##(1997-4#1)(2008-10#1)
sequence identity with the maize-type viruses##2##6##(2008-10#2)
sequence identity with the##7##4##(1992-3#1)(1993-2#1)(1995-11#2)(2008-10#3)
sequence identity with##13##3##(1992-3#1)(1993-2#1)(1994-12#1)(1995-11#2)(2008-10#7)(2010-5#1)
sequence identity##55##2##(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#2)(1995-11#2)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#2)(1997-7#1)(2008-10#29)(2008-5#1)(2010-5#1)(2010-6#1)(2012-3#1)
sequence identity)##2##2##(2008-10#1)(2010-10#1)
sequence in a##3##3##(1993-8#1)(2008-10#2)
sequence in one##2##3##(1990-8#1)(1997-9#1)
sequence in the databases##2##4##(1996-3#1)(2008-7#1)
sequence in the family##5##4##(2011-2#5)
sequence in the##26##3##(1991-11#2)(1991-6#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#2)(2011-2#6)
sequence in##50##2##(1990-8#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-7#4)(1997-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-9#2)(2010-7#1)(2011-2#8)(2013-8#1)
sequence includes the##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
sequence includes##5##2##(1990-5#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-10#1)
sequence including the##2##3##(1993-8#1)(2008-8#1)
sequence including##3##2##(1993-8#1)(2008-8#1)(2008-9#1)
sequence information alone##2##3##(1995-3#1)(2008-4#1)
sequence information for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
sequence information has##2##3##(1997-4#1)(2008-6#1)
sequence information of##3##3##(1995-8#1)(1997-8#1)(2008-10#1)
sequence information on a##2##4##(1995-6#1)(2008-7#1)
sequence information on##4##3##(1995-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
sequence information##26##2##(1993-2#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
sequence into the##2##3##(1991-10#1)(1991-9#1)
sequence into##6##2##(1991-10#1)(1991-9#1)(1992-11#1)(2008-3#2)(2008-7#1)
sequence involved in##2##3##(1992-8#1)(1995-6#1)
sequence is a##3##3##(1994-8#1)(1997-4#1)(2008-12#1)
sequence is highly homologous to##2##5##(1993-12#1)(1993-6#1)
sequence is highly##3##3##(1993-12#1)(1993-6#1)(2008-10#1)
sequence is identical to##2##4##(1994-5#1)(1995-6#1)
sequence is located##3##3##(1991-6#1)(1992-11#1)(1993-6#1)
sequence is one of the##2##5##(1995-6#1)(2008-4#1)
sequence is recognized by##2##4##(1994-6#1)(1995-6#1)
sequence is##53##2##(1991-11#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#5)(1996-12#1)(1996-6#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#2)(2008-8#3)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)
sequence length on##2##3##(2008-9#2)
sequence length##3##2##(2008-9#3)
sequence level to the##2##4##(1993-2#1)(1997-4#1)
sequence level##3##2##(1993-2#1)(1997-2#1)(1997-4#1)
sequence library##3##2##(1994-6#1)(2008-4#1)(2008-7#1)
sequence located##2##2##(1994-6#1)(1995-2#1)
sequence may be##3##3##(1991-2#1)(1996-12#1)(2008-5#1)
sequence may have##2##3##(1993-6#1)(2008-9#1)
sequence may##6##2##(1991-2#1)(1993-6#2)(1996-12#1)(2008-5#1)(2008-9#1)
sequence motif##7##2##(1992-6#1)(1993-3#1)(1994-3#1)(1995-6#3)(1997-2#1)
sequence motifs in##3##3##(1992-6#1)(1994-8#1)(2008-7#1)
sequence motifs##12##2##(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-8#3)(1996-2#1)(1997-6#1)(1997-7#1)(2008-7#1)(2008-9#1)
sequence obtained##2##2##(1993-9#1)(2008-4#1)
sequence of 1##6##3##(1995-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-8#1)(2010-2#1)
sequence of 2##2##3##(1991-5#1)(2008-9#1)
sequence of DNaseI hypersensitive site 2##2##6##(2008-8#2)
sequence of MARs##2##3##(2008-8#2)
sequence of Synechocystis sp##2##4##(1996-12#1)(1996-8#1)
sequence of TMV-B##2##3##(2008-8#2)
sequence of a 7941 bp##2##5##(1995-6#2)
sequence of a 8##2##4##(1997-3#2)
sequence of a cDNA clone##2##5##(1990-2#1)(1992-3#1)
sequence of a cDNA encoding the##3##6##(1992-11#1)(1993-3#1)(1994-12#1)
sequence of a cDNA##6##4##(1990-2#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-2#1)
sequence of a member of the genus##7##7##(2011-2#7)
sequence of a member of the##17##6##(2011-2#17)
sequence of a member##18##4##(2011-2#18)
sequence of a new##2##4##(1993-6#1)(2008-9#1)
sequence of a##81##3##(1990-11#2)(1990-2#2)(1990-5#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#6)(1997-4#2)(1997-7#1)(2007-11#1)(2008-10#9)(2008-7#1)(2008-9#3)(2009-3#1)(2011-2#20)
sequence of an 11##2##4##(1995-9#2)
sequence of an##5##3##(1995-9#2)(1996-8#1)(2008-10#2)
sequence of chromosome##3##3##(1995-6#2)(2007-12#1)
sequence of developmental events##2##4##(2007-12#1)(2008-9#1)
sequence of events leading to the##2##6##(1991-5#1)(1993-8#1)
sequence of events leading to##3##5##(1991-5#1)(1993-8#1)(2008-12#1)
sequence of events leading##4##4##(1990-9#1)(1991-5#1)(1993-8#1)(2008-12#1)
sequence of events##14##3##(1990-9#1)(1991-5#1)(1993-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-6#2)(2012-3#1)(2013-8#1)
sequence of human##12##3##(1991-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-2#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)
sequence of independent random patterns##2##5##(2008-3#2)
sequence of its##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
sequence of matrix attachment##2##4##(2008-8#2)
sequence of mouse##2##3##(1991-5#1)(1997-4#1)
sequence of multiple##3##3##(1990-5#2)(2009-6#1)
sequence of one##5##3##(1990-11#1)(1990-12#2)(1990-5#1)(1993-12#1)
sequence of porcine##2##3##(1996-12#2)
sequence of rat##3##3##(1993-3#1)(1993-8#1)(1995-12#1)
sequence of several##2##3##(1993-12#1)(1993-6#1)
sequence of the 16S-23S##2##4##(2008-10#2)
sequence of the 3##2##4##(1996-2#1)(2008-8#1)
sequence of the 5'##2##4##(1994-12#1)(2008-7#1)
sequence of the B##2##4##(1990-11#1)(1994-11#1)
sequence of the CP##2##4##(1997-6#1)(2008-10#1)
sequence of the Escherichia coli K-12 genome corresponding to the##7##10##(1996-12#4)(1996-6#3)
sequence of the ITS region##2##5##(2008-10#1)(2009-2#1)
sequence of the Xenopus##2##4##(1993-12#1)(1997-7#1)
sequence of the beta subunit##2##5##(1992-9#1)(1994-11#1)
sequence of the cDNA##3##4##(1991-6#1)(1993-11#1)(1994-8#1)
sequence of the cloned##4##4##(1990-2#1)(1991-9#1)(1997-4#1)(2008-10#1)
sequence of the entire##2##4##(1991-6#1)(1996-8#1)
sequence of the first##2##4##(1990-7#1)(2012-12#1)
sequence of the four##2##4##(1992-3#1)(2008-8#1)
sequence of the gene##4##4##(1992-3#1)(1993-9#1)(1994-12#2)
sequence of the genome of##3##5##(1997-3#1)(2008-10#2)
sequence of the genomic RNA of##3##6##(2008-10#3)
sequence of the genomic##4##4##(2008-10#4)
sequence of the genus##6##4##(2011-2#6)
sequence of the human##5##4##(1990-8#1)(1994-11#1)(1996-8#1)(1997-7#1)(2008-7#1)
sequence of the internal transcribed spacer (ITS)##2##7##(2008-10#2)
sequence of the mitochondrial##3##4##(1993-2#1)(2009-2#1)(2010-8#1)
sequence of the mouse##2##4##(1992-11#1)(1993-3#1)
sequence of the open reading frame##2##6##(1994-6#1)(1995-8#1)
sequence of the overlapping##2##4##(1996-12#1)(2008-10#1)
sequence of the peptide##2##4##(1993-11#1)(1996-12#1)
sequence of the promoter##2##4##(1991-9#1)(1993-2#1)
sequence of the protein##8##4##(1991-2#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-6#1)(2008-4#2)(2009-2#1)
sequence of the rat##5##4##(1990-12#1)(1990-8#1)(1992-12#1)(1992-8#1)(1996-12#1)
sequence of the reductase was##2##5##(1996-3#1)(2008-11#1)
sequence of the two##2##4##(1991-12#1)(2008-8#1)
sequence of the##237##3##(1990-11#5)(1990-12#4)(1990-2#1)(1990-5#5)(1990-7#5)(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#5)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#5)(1994-11#5)(1994-12#12)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#3)(1996-10#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#4)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#2)(2007-6#1)(2008-10#38)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-2#3)(2009-8#1)(2010-8#1)(2011-2#13)(2012-12#2)(2012-3#1)(2013-1#1)
sequence of this region##2##4##(1993-3#1)(1995-6#1)
sequence of this##19##3##(1990-12#1)(1990-2#1)(1990-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#3)(1996-8#1)(1997-8#1)(2008-10#2)(2008-8#1)
sequence of two##2##3##(1993-2#1)(2013-8#1)
sequence of which##4##3##(1990-11#1)(1994-9#1)(1995-8#1)(1996-12#1)
sequence of##694##2##(1990-11#16)(1990-12#8)(1990-2#6)(1990-3#1)(1990-5#15)(1990-7#9)(1990-8#4)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#8)(1991-3#1)(1991-5#5)(1991-6#6)(1991-7#4)(1991-8#1)(1991-9#6)(1992-10#3)(1992-11#4)(1992-12#5)(1992-3#9)(1992-6#1)(1992-8#9)(1992-9#5)(1993-11#7)(1993-12#13)(1993-2#12)(1993-3#9)(1993-6#13)(1993-8#9)(1993-9#8)(1994-11#11)(1994-12#23)(1994-2#1)(1994-6#6)(1994-8#5)(1994-9#4)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#15)(1995-8#10)(1995-9#4)(1996-10#3)(1996-12#13)(1996-2#5)(1996-3#5)(1996-4#1)(1996-6#7)(1996-8#9)(1997-1#1)(1997-2#7)(1997-3#10)(1997-4#8)(1997-6#3)(1997-7#8)(1997-8#4)(2007-11#4)(2007-12#7)(2007-6#1)(2008-1#2)(2008-10#87)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#29)(2008-9#16)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#82)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
sequence on##7##2##(1992-11#1)(1995-10#1)(1995-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
sequence or##7##2##(1993-12#1)(1994-11#1)(1995-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)
sequence parameters##2##2##(2008-7#2)
sequence patterns surrounding##2##3##(1997-2#2)
sequence patterns##4##2##(1990-7#1)(1997-2#2)(2008-7#1)
sequence polymorphisms##3##2##(1996-6#1)(2008-10#2)
sequence predicts##2##2##(1994-8#1)(1995-8#1)
sequence previously##2##2##(1992-6#1)(1994-12#1)
sequence provides##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
sequence published##2##2##(1993-6#1)(2008-12#1)
sequence reads##2##2##(2011-2#1)(2012-3#1)
sequence reduced##2##2##(1990-5#1)(1997-2#1)
sequence repeat (SSR)##7##3##(2008-10#4)(2008-5#1)(2008-9#2)
sequence repeat markers##3##3##(2008-10#3)
sequence repeat##16##2##(2008-10#11)(2008-5#2)(2008-9#2)(2010-10#1)
sequence repeats##10##2##(1996-8#2)(2008-10#4)(2008-7#4)
sequence represents the##2##3##(1991-12#1)(2008-10#1)
sequence represents##4##2##(1990-8#1)(1991-12#1)(1992-8#1)(2008-10#1)
sequence respectively##3##2##(2008-8#1)(2010-7#2)
sequence resulted in##2##3##(1991-10#1)(1993-12#1)
sequence revealed an open reading frame##2##6##(1994-8#1)(1997-2#1)
sequence revealed an##3##3##(1994-8#1)(1997-2#1)(1997-4#1)
sequence revealed that the##3##4##(1990-2#1)(1991-7#1)(1992-11#1)
sequence revealed that this##2##4##(1994-12#1)(1996-12#1)
sequence revealed that##6##3##(1990-2#1)(1991-7#1)(1992-11#1)(1994-12#1)(1996-12#1)(2008-10#1)
sequence revealed the##2##3##(1996-6#1)(1997-7#1)
sequence revealed two##2##3##(1991-7#1)(1997-4#1)
sequence revealed##18##2##(1990-2#1)(1991-7#2)(1992-11#1)(1992-12#1)(1994-12#2)(1994-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(2008-10#2)
sequence segments##3##2##(1990-7#1)(2008-10#1)(2008-9#1)
sequence sets##4##2##(1995-3#1)(1997-6#1)(2008-4#2)
sequence showed a high degree of homology##2##7##(1990-2#1)(1997-1#1)
sequence showed a high degree of##3##6##(1990-2#1)(1996-2#1)(1997-1#1)
sequence showed a high##4##4##(1990-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
sequence showed a##5##3##(1990-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-5#1)
sequence showed that the##3##4##(1994-12#1)(2008-9#1)(2011-1#1)
sequence showed##15##2##(1990-2#1)(1993-12#1)(1994-12#2)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
sequence shows high##2##3##(1993-12#1)(1993-3#1)
sequence shows two##2##3##(1992-12#1)(1993-2#1)
sequence shows##9##2##(1992-12#1)(1993-12#2)(1993-2#3)(1993-3#1)(1994-8#1)(1995-11#1)
sequence significantly##2##2##(1994-11#1)(2008-10#1)
sequence similar to the##2##4##(1991-9#1)(2008-10#1)
sequence similar to##4##3##(1991-5#1)(1991-9#1)(1997-4#1)(2008-10#1)
sequence similarities to##2##3##(1992-9#1)(1995-8#1)
sequence similarities with the##2##4##(1992-6#1)(2008-10#1)
sequence similarities with##4##3##(1992-6#1)(1995-2#1)(1996-10#1)(2008-10#1)
sequence similarities##10##2##(1990-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(2008-10#3)
sequence similarity among##2##3##(2008-10#2)
sequence similarity and##4##3##(1996-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
sequence similarity between the##3##4##(1991-6#1)(2008-10#1)(2012-2#1)
sequence similarity of##2##3##(1992-8#1)(2008-10#1)
sequence similarity searching and##2##4##(2008-4#2)
sequence similarity searching##3##3##(2008-4#2)(2013-8#1)
sequence similarity to known##2##4##(2008-10#1)(2010-10#1)
sequence similarity to other##2##4##(1994-12#1)(1997-6#1)
sequence similarity to##12##3##(1991-2#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-7#1)(2010-10#1)(2012-3#1)
sequence similarity with##6##3##(1992-11#1)(1993-6#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-4#1)
sequence similarity##51##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-6#1)(1997-7#1)(2008-10#12)(2008-4#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
sequence so##2##2##(2011-2#2)
sequence space##5##2##(1997-6#3)(2008-7#2)
sequence spanning the##2##3##(1990-11#1)(2008-10#1)
sequence specific##12##2##(1990-11#1)(1991-2#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-7#2)(2011-1#1)
sequence specifically##2##2##(1992-3#1)(2008-10#1)
sequence suggests that##2##3##(1992-6#1)(1993-2#1)
sequence surrounding the##4##3##(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)
sequence surrounding##5##2##(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)
sequence tag (EST)##4##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
sequence tagged##3##2##(1994-12#1)(1995-6#1)(2008-10#1)
sequence tags##18##2##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#2)(1997-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#4)(2012-3#1)(2013-8#1)
sequence that binds##2##3##(1992-6#1)(1993-6#1)
sequence that is removed##2##4##(1994-12#1)(1997-7#1)
sequence that is##8##3##(1993-12#1)(1993-2#1)(1994-12#3)(1997-2#1)(1997-7#1)(2008-11#1)
sequence that overlaps##2##3##(1994-8#1)(1996-10#1)
sequence that provides##2##3##(2008-10#2)
sequence that##26##2##(1991-10#1)(1992-6#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#4)(1994-8#1)(1995-2#1)(1995-6#1)(1996-10#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)
sequence through##2##2##(1995-8#1)(2008-11#1)
sequence to be##3##3##(2008-4#1)(2011-2#2)
sequence to that of##2##4##(1990-12#1)(1994-12#1)
sequence to the##3##3##(1994-11#1)(1994-8#2)
sequence to##25##2##(1990-12#1)(1991-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-6#1)(2011-2#2)
sequence types##3##2##(2008-12#2)(2013-8#1)
sequence typing##2##2##(2007-12#1)(2011-2#1)
sequence unique##2##2##(1995-6#1)(2009-9#1)
sequence upstream from the##2##4##(1990-11#1)(1992-12#1)
sequence upstream##3##2##(1990-11#1)(1992-12#1)(2008-10#1)
sequence used for##2##3##(2007-11#1)(2007-6#1)
sequence used##3##2##(2007-11#1)(2007-6#1)(2013-1#1)
sequence using##2##2##(1991-2#1)(2008-10#1)
sequence variability##2##2##(2008-10#2)
sequence variant##3##2##(1992-8#1)(1993-11#1)(2008-10#1)
sequence variants in##3##3##(2008-4#3)
sequence variants##17##2##(1993-9#1)(1994-12#1)(2008-10#10)(2008-4#3)(2011-2#1)(2012-3#1)
sequence variation among##2##3##(1997-9#1)(2010-6#1)
sequence variation in##3##3##(1997-3#1)(2008-12#1)(2008-6#1)
sequence variation of a##2##4##(1996-6#1)(2008-10#1)
sequence variation was##2##3##(1992-8#1)(2010-8#1)
sequence variation##17##2##(1991-6#1)(1992-8#2)(1993-2#1)(1996-6#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-6#1)(2010-8#1)(2012-3#1)
sequence variations##2##2##(1995-8#1)(2008-8#1)
sequence was also##2##3##(1994-12#1)(1996-6#1)
sequence was cloned into##2##4##(1993-6#1)(2008-8#1)
sequence was determined to be##3##5##(1993-3#1)(2008-10#2)
sequence was determined##15##3##(1990-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-8#2)
sequence was found to##4##4##(1993-9#1)(1994-9#1)(1995-6#1)(1997-3#1)
sequence was found##6##3##(1993-12#1)(1993-9#1)(1994-9#1)(1995-6#1)(1997-3#1)(2008-9#1)
sequence was highly homologous to##2##5##(1991-9#1)(1994-12#1)
sequence was identical to##2##4##(2008-11#1)(2008-5#1)
sequence was introduced##2##3##(1997-6#1)(2012-12#1)
sequence was isolated##2##3##(1993-12#1)(2008-10#1)
sequence was not##2##3##(1991-10#1)(1997-2#1)
sequence was obtained##4##3##(1993-6#2)(2008-10#1)(2008-9#1)
sequence was used to##2##4##(1992-9#1)(2008-10#1)
sequence was used##4##3##(1992-9#1)(2008-10#3)
sequence was##92##2##(1990-5#2)(1991-10#3)(1991-2#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#3)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-6#5)(1995-8#1)(1996-12#1)(1996-6#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2008-10#16)(2008-11#4)(2008-5#1)(2008-8#5)(2008-9#3)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
sequence were##11##2##(1992-12#1)(1992-6#2)(1992-8#1)(1993-6#1)(1996-8#1)(2008-10#3)(2010-4#1)(2011-2#1)
sequence which is##3##3##(1990-12#1)(1995-2#1)(2008-8#1)
sequence which##11##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-11#1)(1994-12#1)(1995-2#2)(1997-1#1)(1997-2#1)(2008-8#2)
sequence with a##5##3##(1990-7#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
sequence with the##4##3##(1990-7#1)(1991-11#1)(1994-12#1)(2009-2#1)
sequence with those##3##3##(1991-6#1)(2008-10#2)
sequence with##19##2##(1990-12#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-6#1)(1993-12#1)(1994-12#2)(2007-12#1)(2008-10#6)(2008-4#1)(2008-9#1)(2009-2#1)
sequence within the##2##3##(2008-10#1)(2011-2#1)
sequence within##3##2##(1993-9#1)(2008-10#1)(2011-2#1)
sequence would##2##2##(1993-11#1)(2008-7#1)
sequence##2956##1##(1990-11#40)(1990-12#22)(1990-2#11)(1990-3#1)(1990-5#33)(1990-7#25)(1990-8#14)(1990-9#2)(1991-10#18)(1991-11#12)(1991-12#18)(1991-2#25)(1991-3#1)(1991-5#17)(1991-6#27)(1991-7#13)(1991-8#1)(1991-9#41)(1992-10#12)(1992-11#21)(1992-12#22)(1992-3#38)(1992-4#2)(1992-6#29)(1992-7#1)(1992-8#48)(1992-9#20)(1993-11#29)(1993-12#50)(1993-2#42)(1993-3#29)(1993-6#62)(1993-8#32)(1993-9#29)(1994-11#25)(1994-12#93)(1994-2#5)(1994-3#4)(1994-5#7)(1994-6#22)(1994-8#36)(1994-9#13)(1995-10#1)(1995-11#9)(1995-12#15)(1995-2#32)(1995-3#9)(1995-5#9)(1995-6#60)(1995-8#46)(1995-9#9)(1996-10#11)(1996-12#34)(1996-2#13)(1996-3#12)(1996-4#1)(1996-5#8)(1996-6#25)(1996-8#20)(1997-1#4)(1997-2#35)(1997-3#37)(1997-4#46)(1997-6#39)(1997-7#32)(1997-8#21)(1997-9#11)(2006-6#3)(2007-11#6)(2007-12#24)(2007-6#8)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#453)(2008-11#53)(2008-12#18)(2008-2#28)(2008-3#19)(2008-4#101)(2008-5#22)(2008-6#12)(2008-7#73)(2008-8#99)(2008-9#84)(2009-10#11)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#4)(2009-5#9)(2009-6#13)(2009-7#4)(2009-8#6)(2009-9#7)(2010-1#2)(2010-10#8)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#11)(2010-5#7)(2010-6#14)(2010-7#6)(2010-8#6)(2010-9#1)(2011-1#18)(2011-10#1)(2011-2#166)(2011-3#2)(2012-1#1)(2012-12#9)(2012-2#26)(2012-3#15)(2012-8#1)(2013-1#18)(2013-7#4)(2013-8#17)
sequence)##2##1##(2008-10#1)(2008-7#1)
sequence-##4##1##(2008-10#1)(2008-8#1)(2008-9#1)(2010-7#1)
sequence-based##12##1##(2008-10#8)(2008-7#1)(2011-1#2)(2012-3#1)
sequence-binding protein##2##2##(1992-11#1)(2008-9#1)
sequence-characterized amplified##2##2##(2008-10#2)
sequence-characterized##3##1##(2008-10#3)
sequence-dependent##4##1##(1991-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
sequence-directed##2##1##(1993-11#2)
sequence-independent DNA binding proteins in##2##5##(2008-8#2)
sequence-selective##3##1##(2008-10#3)
sequence-specific DNA binding proteins##2##4##(1992-6#1)(1994-11#1)
sequence-specific DNA binding##3##3##(1992-12#1)(1992-6#1)(1994-11#1)
sequence-specific DNA##5##2##(1991-2#1)(1992-12#1)(1992-6#1)(1994-11#1)(2008-4#1)
sequence-specific and##3##2##(1995-8#1)(2008-4#1)(2008-9#1)
sequence-specific proteases##2##2##(2008-4#2)
sequence-specific##34##1##(1990-11#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1994-11#1)(1995-6#1)(1995-8#2)(2008-10#1)(2008-2#1)(2008-4#9)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2011-1#1)(2011-2#1)
sequence-tagged site (STS) markers##5##4##(1996-10#1)(1996-12#2)(1997-8#1)(2008-10#1)
sequence-tagged site##6##2##(1994-12#1)(1996-10#1)(1996-12#2)(1997-8#1)(2008-10#1)
sequence-tagged##7##1##(1994-12#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-8#1)(2008-10#1)
sequence/structure##2##1##(2008-10#1)(2008-4#1)
sequenced LCAT cDNA##2##3##(1993-6#2)
sequenced a##7##2##(1990-7#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-6#1)(2008-5#1)
sequenced and assembled##2##3##(1996-2#1)(2012-3#1)
sequenced and characterized##3##3##(1991-9#1)(2008-5#1)(2008-8#1)
sequenced and compared##3##3##(1990-11#1)(2008-10#1)(2009-10#1)
sequenced and expressed in##2##4##(1990-11#1)(2008-9#1)
sequenced and found to be##2##5##(1996-12#1)(2008-10#1)
sequenced and its##2##3##(1994-2#1)(2008-10#1)
sequenced and the##6##3##(1990-12#1)(1991-9#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-8#1)
sequenced and##38##2##(1990-11#2)(1990-12#1)(1991-1#1)(1991-9#2)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
sequenced by##4##2##(1990-12#1)(1991-5#1)(1995-12#2)
sequenced for each##2##3##(2008-10#2)
sequenced for##5##2##(2008-10#4)(2010-8#1)
sequenced from the##2##3##(1992-3#1)(1997-3#1)
sequenced from##10##2##(1990-12#1)(1992-3#1)(1993-6#2)(1997-3#1)(2008-10#4)(2008-12#1)
sequenced genome##5##2##(2008-10#1)(2008-2#2)(2008-7#2)
sequenced genomes of##2##3##(2008-7#1)(2011-1#1)
sequenced genomes##4##2##(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)
sequenced in this study##3##4##(1997-8#1)(2008-10#1)(2010-3#1)
sequenced in##6##2##(1997-8#1)(2008-10#3)(2008-8#1)(2010-3#1)
sequenced open reading##2##3##(1996-6#1)(2008-10#1)
sequenced region##2##2##(1994-12#1)(1995-8#1)
sequenced regions##3##2##(1997-6#1)(1997-8#2)
sequenced the##18##2##(1990-5#1)(1991-2#1)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#2)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
sequenced to##8##2##(1993-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-2#1)
sequenced using##3##2##(2006-8#1)(2008-2#1)(2011-2#1)
sequenced##290##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#2)(1993-6#8)(1993-8#2)(1993-9#4)(1994-11#2)(1994-12#8)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-10#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#4)(1997-9#2)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#76)(2008-11#1)(2008-12#5)(2008-2#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#4)(2009-10#3)(2009-5#1)(2009-6#2)(2010-10#2)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
sequencer##4##1##(1993-3#1)(1994-11#2)(2008-9#1)
sequences (0##2##2##(2008-10#1)(2013-1#1)
sequences (1##2##2##(2008-5#2)
sequences (e##2##2##(2008-4#1)(2013-8#1)
sequences 5' to the##2##4##(1991-6#1)(1993-12#1)
sequences after##2##2##(2008-9#1)(2011-2#1)
sequences among##5##2##(1993-12#1)(1994-12#1)(1995-8#1)(2008-10#2)
sequences analyzed##2##2##(2008-10#2)
sequences and a##2##3##(1997-2#1)(1997-8#1)
sequences and deduced##2##3##(1993-6#1)(1996-10#1)
sequences and the##2##3##(1996-3#1)(2008-4#1)
sequences and##58##2##(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
sequences and/or##2##2##(1995-8#1)(2008-7#1)
sequences are available##2##3##(2007-12#1)(2008-7#1)
sequences are conserved##2##3##(2008-7#1)(2012-2#1)
sequences are##40##2##(1990-8#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-2#2)
sequences around##3##2##(1991-5#1)(1994-11#1)(1997-2#1)
sequences as##9##2##(1993-3#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-4#2)(2008-4#1)(2013-1#1)
sequences at both##2##3##(1991-2#1)(2008-4#1)
sequences at the end of##2##5##(2008-9#2)
sequences at the##4##3##(2008-10#1)(2008-5#1)(2008-9#2)
sequences at##11##2##(1991-2#1)(1993-12#1)(1996-12#1)(1996-8#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)
sequences available in##3##3##(1990-11#1)(1994-12#1)(2008-10#1)
sequences available##4##2##(1990-11#1)(1994-12#1)(1994-8#1)(2008-10#1)
sequences based on##2##3##(2008-7#1)(2013-8#1)
sequences because##2##2##(2008-9#1)(2010-3#1)
sequences between the##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
sequences between##7##2##(1994-11#1)(1994-12#1)(1994-9#1)(2008-10#2)(2008-4#2)
sequences but are##2##3##(1992-3#2)
sequences but##4##2##(1992-3#2)(1993-3#1)(2008-7#1)
sequences by hybridization##2##3##(1993-12#1)(2008-10#1)
sequences by##10##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-2#1)
sequences can be##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
sequences can##4##2##(1997-4#1)(2008-10#1)(2008-9#1)(2009-12#1)
sequences coding for##2##3##(1996-6#1)(1997-4#1)
sequences coding##3##2##(1996-6#1)(1997-4#1)(1997-6#1)
sequences complementary to##2##3##(1991-9#2)
sequences comprising the##2##3##(1990-5#1)(1995-2#1)
sequences comprising##3##2##(1990-5#1)(1995-2#1)(2007-8#1)
sequences contain##2##2##(1991-6#1)(2011-2#1)
sequences contained##4##2##(1991-12#1)(1992-6#1)(1997-2#1)(2008-10#1)
sequences containing##5##2##(1990-3#1)(1990-5#1)(1991-6#1)(1992-9#1)(2008-10#1)
sequences corresponding to the##2##4##(1991-2#1)(2012-2#1)
sequences could be##2##3##(2008-10#1)(2011-2#1)
sequences could##3##2##(2008-10#1)(2011-2#2)
sequences demonstrated##2##2##(1993-6#1)(2008-9#1)
sequences due to##2##3##(2008-4#1)(2008-8#1)
sequences during##2##2##(2008-10#2)
sequences encoded##2##2##(1993-6#1)(1993-9#1)
sequences encoding the##4##3##(1990-11#1)(1993-3#1)(1993-9#1)(2008-9#1)
sequences encoding##10##2##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-3#1)
sequences exhibited##2##2##(2008-10#1)(2009-6#1)
sequences flanking the##3##3##(1994-12#1)(1995-2#1)(2008-10#1)
sequences for a##2##3##(2008-10#1)(2008-7#1)
sequences for the##8##3##(1992-6#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-8#1)(2009-10#1)(2010-12#1)(2010-3#1)
sequences for three##2##3##(1990-12#1)(2008-10#1)
sequences for##31##2##(1990-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-3#1)
sequences found in the##2##4##(1992-6#1)(1994-6#1)
sequences found in##4##3##(1990-5#1)(1992-6#1)(1994-6#1)(2008-10#1)
sequences from a##7##3##(1992-11#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
sequences from all##2##3##(2008-10#2)
sequences from human##2##3##(1995-6#1)(2008-7#1)
sequences from the nuclear##2##4##(2008-10#2)
sequences from the##16##3##(1990-12#1)(1995-6#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-7#1)
sequences from##54##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-6#3)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
sequences had##3##2##(1997-9#1)(2008-9#1)(2010-4#1)
sequences has been used to##2##5##(1992-12#1)(1992-6#1)
sequences has been##5##3##(1992-12#1)(1992-3#1)(1992-6#2)(2008-10#1)
sequences has##8##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-6#2)(2008-10#1)(2008-7#2)
sequences have been determined##2##4##(1990-5#1)(2008-8#1)
sequences have been mapped##2##4##(2008-8#2)
sequences have been reported##2##4##(1992-6#1)(2012-2#1)
sequences have been##10##3##(1990-5#1)(1992-6#1)(1993-12#1)(1993-6#2)(2008-8#3)(2008-9#1)(2012-2#1)
sequences have##16##2##(1990-5#1)(1992-6#1)(1993-12#1)(1993-6#2)(1997-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)
sequences homologous to##6##3##(1991-6#1)(1991-7#1)(1993-12#1)(1993-8#1)(1996-6#1)(1997-4#1)
sequences identified##3##2##(1991-9#1)(1993-12#1)(2012-3#1)
sequences in the databases##2##4##(1997-3#1)(2008-10#1)
sequences in the##25##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
sequences in two##3##3##(1993-12#1)(1995-2#1)(2008-9#1)
sequences in vivo##4##3##(1996-5#1)(2008-2#3)
sequences in##70##2##(1990-12#3)(1990-2#1)(1990-5#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
sequences including##2##2##(1992-3#1)(1997-7#1)
sequences indicate that##2##3##(2008-10#1)(2013-1#1)
sequences indicated that##5##3##(1995-8#1)(2008-10#2)(2008-5#1)(2010-8#1)
sequences indicated##7##2##(1995-8#1)(2008-10#4)(2008-5#1)(2010-8#1)
sequences influence##2##2##(1997-4#1)(2008-10#1)
sequences into##5##2##(1997-7#1)(2008-10#2)(2008-4#1)(2013-8#1)
sequences involved in##3##3##(1994-8#1)(1997-2#1)(2008-10#1)
sequences is##12##2##(1990-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2013-8#1)
sequences located in the##2##4##(1993-2#1)(2008-10#1)
sequences located in##3##3##(1993-2#1)(1995-2#1)(2008-10#1)
sequences located##6##2##(1992-12#1)(1993-2#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)
sequences lying between##2##3##(1994-8#1)(2008-10#1)
sequences may be##2##3##(1993-12#1)(1997-3#1)
sequences may play##2##3##(1993-9#1)(2012-3#1)
sequences may##6##2##(1993-12#1)(1993-9#1)(1996-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
sequences might be##2##3##(1995-2#1)(1997-3#1)
sequences nor##2##2##(1994-11#1)(1997-3#1)
sequences obtained from##2##3##(1994-8#1)(2008-10#1)
sequences obtained##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2010-3#1)
sequences occur##2##2##(1993-3#1)(1997-4#1)
sequences of 22##2##3##(1996-10#1)(2013-8#1)
sequences of 40##5##3##(1995-8#2)(1996-2#3)
sequences of 80##2##3##(1996-10#2)
sequences of DNA##2##3##(1992-3#1)(2008-7#1)
sequences of PVV##2##3##(2008-10#2)
sequences of RNA##2##3##(2008-10#2)
sequences of a##6##3##(1994-11#3)(2008-10#1)(2008-4#1)(2008-5#1)
sequences of all four##2##4##(1993-6#1)(1995-6#1)
sequences of all##4##3##(1990-11#1)(1993-6#1)(1995-6#1)(2008-10#1)
sequences of both##6##3##(1990-11#1)(1990-7#1)(1991-2#1)(1992-8#1)(2008-7#1)(2011-1#1)
sequences of different##2##3##(1996-6#1)(2008-6#1)
sequences of four##3##3##(1991-2#1)(1995-8#1)(2008-10#1)
sequences of fracture events##2##4##(2008-8#2)
sequences of groups I and II##2##6##(2008-10#2)
sequences of groups I##3##4##(2008-10#3)
sequences of human##2##3##(1995-11#1)(2008-4#1)
sequences of interest##2##3##(2008-10#1)(2008-2#1)
sequences of other##2##3##(1991-10#1)(2008-8#1)
sequences of rat##2##3##(1990-12#1)(1991-6#1)
sequences of rice##2##3##(2008-8#2)
sequences of several##2##3##(2008-10#1)(2008-3#1)
sequences of six##2##3##(1993-6#1)(1995-6#1)
sequences of the 16S rRNA genes##2##6##(2008-10#2)
sequences of the RNA##2##4##(2008-10#2)
sequences of the Rep##2##4##(2008-10#2)
sequences of the cloned##2##4##(2008-10#1)(2008-11#1)
sequences of the coat protein (CP)##2##6##(2008-10#2)
sequences of the complete##2##4##(2008-10#1)(2008-6#1)
sequences of the first##2##4##(1994-12#1)(2008-9#1)
sequences of the gene##2##4##(1994-8#1)(1996-8#1)
sequences of the genes encoding##2##5##(1993-12#1)(2010-7#1)
sequences of the genes##3##4##(1993-12#1)(2008-11#1)(2010-7#1)
sequences of the human##2##4##(1992-3#1)(2010-5#1)
sequences of the intergenic##2##4##(2008-10#2)
sequences of the internal transcribed spacer (ITS) region of the##2##10##(2008-10#1)(2008-5#1)
sequences of the internal transcribed spacer (ITS) region of##3##9##(2008-10#2)(2008-5#1)
sequences of the internal transcribed spacer (ITS)##4##7##(2008-10#3)(2008-5#1)
sequences of the internal transcribed spacer##7##6##(2008-10#6)(2008-5#1)
sequences of the mitochondrial##2##4##(1991-6#1)(2008-6#1)
sequences of the rat and##2##5##(1993-3#1)(1994-9#1)
sequences of the rat##3##4##(1993-3#1)(1994-9#1)(2008-9#1)
sequences of the same##2##4##(2008-9#1)(2011-2#1)
sequences of the##107##3##(1991-12#1)(1991-2#1)(1991-6#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-6#2)(1996-8#3)(1997-6#2)(1997-7#1)(2007-10#1)(2007-6#2)(2008-10#44)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#2)
sequences of these##8##3##(1991-12#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1997-8#1)(2008-10#2)
sequences of three##2##3##(2008-10#2)
sequences of two##4##3##(1991-6#2)(1993-6#1)(1997-2#1)
sequences of##311##2##(1990-11#4)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-10#1)(1991-12#3)(1991-2#6)(1991-5#1)(1991-6#6)(1991-7#1)(1991-9#4)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#7)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#7)(1996-10#7)(1996-2#7)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#5)(1997-2#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2007-10#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#92)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#9)(2009-10#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-1#4)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
sequences on the basis of##2##5##(1996-6#1)(2008-9#1)
sequences on the##5##3##(1995-6#1)(1996-6#1)(2008-5#1)(2008-9#1)(2012-2#1)
sequences on##9##2##(1992-4#1)(1995-6#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2012-2#1)
sequences or##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
sequences present in##5##3##(1994-12#1)(1994-8#1)(1995-9#1)(1997-3#1)(1997-6#1)
sequences present##7##2##(1994-12#1)(1994-8#2)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#1)
sequences previously reported##2##3##(2008-10#1)(2009-9#1)
sequences previously##3##2##(2008-10#2)(2009-9#1)
sequences provided##2##2##(2008-5#1)(2011-1#1)
sequences recently##2##2##(1995-11#1)(2008-8#1)
sequences related to the##2##4##(1990-11#1)(2008-10#1)
sequences reported##3##2##(1991-5#1)(1993-2#1)(2008-11#1)
sequences represent##2##2##(2008-6#1)(2010-8#1)
sequences required##2##2##(1994-12#1)(1997-3#1)
sequences revealed that##4##3##(1990-12#1)(1993-8#1)(2008-10#2)
sequences revealed two##2##3##(2008-10#1)(2010-10#1)
sequences revealed##10##2##(1990-12#1)(1993-8#1)(1994-11#1)(2008-10#4)(2008-7#1)(2010-10#1)(2013-1#1)
sequences reveals that##3##3##(1991-6#1)(1992-3#1)(2011-2#1)
sequences reveals##4##2##(1991-6#1)(1992-3#2)(2011-2#1)
sequences showed that##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
sequences showed the##2##3##(1992-8#1)(2013-1#1)
sequences showed##6##2##(1990-5#1)(1992-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
sequences similar to##2##3##(1993-2#1)(1994-12#1)
sequences strongly##2##2##(1993-8#1)(2008-10#1)
sequences such that##2##3##(1991-9#1)(2013-8#1)
sequences such##3##2##(1991-9#1)(2013-8#2)
sequences suggest##2##2##(1992-6#1)(1994-8#1)
sequences surrounding##2##2##(1991-5#1)(1995-6#1)
sequences than##2##2##(1995-8#1)(2008-10#1)
sequences that are similar to##3##5##(1995-2#1)(2008-9#2)
sequences that are##11##3##(1991-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-9#2)(2009-9#1)
sequences that can##3##3##(1990-11#1)(2009-12#1)(2012-2#1)
sequences that cross-link with a given protein are##2##8##(2008-2#2)
sequences that lie between##2##4##(1994-8#2)
sequences that##28##2##(1990-11#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-8#2)(1995-2#2)(1995-8#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2012-2#1)(2012-3#1)
sequences the##3##2##(1995-3#1)(2008-4#1)(2008-8#1)
sequences to a##2##3##(1994-11#1)(2008-10#1)
sequences to the##3##3##(1991-5#1)(2008-10#1)(2008-2#1)
sequences to##16##2##(1991-5#1)(1993-8#1)(1994-11#2)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-1#1)
sequences up to##3##3##(1991-2#1)(1994-12#1)(1997-2#1)
sequences upstream of lacZ##2##4##(1997-4#2)
sequences used in##2##3##(1992-6#1)(2008-5#1)
sequences used##3##2##(1992-6#1)(2008-5#1)(2011-2#1)
sequences using fat saturation##2##4##(2007-11#2)
sequences using network BLAST searches##2##5##(2008-4#1)(2008-9#1)
sequences using the##3##3##(1997-7#1)(2008-7#1)(2008-9#1)
sequences using##11##2##(1997-7#1)(2007-11#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#2)(2012-2#1)
sequences was determined by##2##4##(1996-10#1)(2008-10#1)
sequences was found##3##3##(1992-8#1)(1993-2#1)(1995-6#1)
sequences was used to##2##4##(2008-10#1)(2010-3#1)
sequences was##17##2##(1991-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#5)(2010-3#1)
sequences were aligned##2##3##(2008-10#1)(2011-1#1)
sequences were analyzed##2##3##(2011-1#1)(2012-2#1)
sequences were collected##2##3##(1995-3#1)(2013-1#1)
sequences were compared with##3##4##(1991-5#1)(2008-10#1)(2013-8#1)
sequences were compared##6##3##(1991-5#1)(2008-10#3)(2008-2#1)(2013-8#1)
sequences were detected as showing##2##5##(2008-9#2)
sequences were detected##6##3##(1993-9#1)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#1)
sequences were determined by##3##4##(1992-3#1)(1994-11#1)(2008-8#1)
sequences were determined##10##3##(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1996-10#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#2)
sequences were found##2##3##(1992-2#1)(1995-6#1)
sequences were identical##2##3##(2008-12#1)(2011-2#1)
sequences were identified from##2##4##(2008-10#1)(2008-9#1)
sequences were identified##5##3##(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
sequences were located in##2##4##(1996-8#1)(2012-3#1)
sequences were not##3##3##(1995-2#1)(1996-8#1)(2009-5#1)
sequences were obtained for##2##4##(1993-6#1)(2008-10#1)
sequences were obtained##5##3##(1993-2#1)(1993-6#1)(1997-3#1)(2008-10#1)(2013-8#1)
sequences were tested##3##3##(1995-2#1)(2008-10#1)(2013-1#1)
sequences were used to##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
sequences were used##4##3##(1997-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
sequences were##89##2##(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#2)(1996-8#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(1997-9#2)(2008-10#14)(2008-12#3)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-5#2)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
sequences whereas##2##2##(1993-3#1)(2009-5#1)
sequences which are##2##3##(1992-6#1)(2010-7#1)
sequences which##10##2##(1991-6#1)(1992-6#1)(1993-8#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-7#2)(2010-7#1)
sequences with the##4##3##(1992-6#1)(1993-6#1)(1994-12#1)(1996-8#1)
sequences with those of##3##4##(1991-12#1)(1995-2#1)(2008-10#1)
sequences with##24##2##(1991-12#1)(1992-6#1)(1993-6#2)(1994-12#1)(1995-2#2)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2009-9#1)(2011-3#1)
sequences within a##2##3##(2008-4#1)(2009-3#1)
sequences within the##7##3##(1992-9#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
sequences within##14##2##(1990-5#1)(1992-9#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)
sequences##1529##1##(1990-11#11)(1990-12#10)(1990-2#1)(1990-3#2)(1990-5#15)(1990-7#4)(1990-8#5)(1991-10#1)(1991-12#8)(1991-2#18)(1991-5#11)(1991-6#21)(1991-7#3)(1991-8#1)(1991-9#12)(1992-10#3)(1992-11#7)(1992-12#7)(1992-2#4)(1992-3#13)(1992-4#2)(1992-6#22)(1992-8#12)(1992-9#5)(1993-1#2)(1993-11#7)(1993-12#27)(1993-2#15)(1993-3#8)(1993-5#1)(1993-6#21)(1993-8#14)(1993-9#13)(1994-1#1)(1994-11#24)(1994-12#29)(1994-3#1)(1994-5#2)(1994-6#5)(1994-8#17)(1994-9#4)(1995-11#11)(1995-12#6)(1995-2#29)(1995-3#3)(1995-5#4)(1995-6#19)(1995-8#20)(1995-9#3)(1996-10#18)(1996-12#12)(1996-2#12)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#14)(1996-8#12)(1997-2#16)(1997-3#17)(1997-4#23)(1997-5#1)(1997-6#17)(1997-7#17)(1997-8#13)(1997-9#5)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-6#4)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#279)(2008-11#26)(2008-12#12)(2008-2#19)(2008-3#10)(2008-4#74)(2008-5#33)(2008-6#16)(2008-7#50)(2008-8#47)(2008-9#67)(2009-10#9)(2009-11#1)(2009-12#4)(2009-3#3)(2009-5#8)(2009-6#2)(2009-8#1)(2009-9#7)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#9)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#6)(2010-8#5)(2010-9#3)(2011-1#13)(2011-10#1)(2011-2#29)(2011-3#2)(2012-12#2)(2012-2#18)(2012-3#17)(2012-7#1)(2013-1#20)(2013-3#1)(2013-8#22)
sequences)##4##1##(1993-12#1)(1993-8#1)(2008-10#1)(2008-4#1)
sequencing analysis revealed##2##3##(1991-2#1)(1992-8#1)
sequencing analysis##3##2##(1991-2#1)(1992-8#1)(1997-9#1)
sequencing and assembly##2##3##(2008-4#1)(2012-3#1)
sequencing and##33##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#2)(1995-6#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#2)
sequencing are##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
sequencing by##2##2##(1991-2#1)(2009-9#1)
sequencing data##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#2)
sequencing depth##2##2##(2011-2#1)(2012-2#1)
sequencing effort##2##2##(2008-5#1)(2012-3#1)
sequencing efforts##4##2##(2008-10#1)(2009-5#1)(2011-10#1)(2012-3#1)
sequencing for##2##2##(1997-7#1)(2012-2#1)
sequencing has the potential to##2##5##(2010-6#1)(2013-1#1)
sequencing has##4##2##(2009-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
sequencing have been##3##3##(1992-3#1)(2008-4#1)(2010-10#1)
sequencing have##5##2##(1992-3#1)(1995-12#1)(2008-4#1)(2010-10#1)(2012-3#1)
sequencing in##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
sequencing is##3##2##(1995-8#1)(2008-7#1)(2010-10#1)
sequencing libraries##2##2##(2012-2#2)
sequencing method##5##2##(1992-8#1)(1995-12#1)(1995-6#1)(2008-7#1)(2011-1#1)
sequencing of 16S rDNA##2##4##(2008-10#2)
sequencing of 16S##3##3##(2008-10#2)(2012-2#1)
sequencing of a##14##3##(1990-11#1)(1991-8#1)(1994-12#3)(1995-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-9#1)
sequencing of all##2##3##(2008-11#1)(2008-12#1)
sequencing of peptides##2##3##(1990-5#1)(1994-11#1)
sequencing of the amplified fragment##2##5##(1996-8#1)(2008-12#1)
sequencing of the amplified##3##4##(1992-8#1)(1996-8#1)(2008-12#1)
sequencing of the entire##2##4##(1995-12#1)(1996-2#1)
sequencing of the genomes of##2##5##(2008-4#1)(2008-7#1)
sequencing of the human genome##2##5##(2008-4#2)
sequencing of the internal transcribed spacer (ITS)##2##7##(2008-10#1)(2010-10#1)
sequencing of the internal transcribed##3##5##(2008-10#1)(2009-2#1)(2010-10#1)
sequencing of the large subunit##2##5##(1992-8#1)(2008-10#1)
sequencing of the##38##3##(1990-11#1)(1990-2#1)(1992-8#3)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-7#1)(2008-10#7)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#2)
sequencing of these##2##3##(1993-11#1)(2008-10#1)
sequencing of##93##2##(1990-11#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#3)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)
sequencing or##4##2##(1991-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
sequencing primers##3##2##(1990-11#1)(2008-12#2)
sequencing procedure##2##2##(1990-5#1)(2011-2#1)
sequencing projects##4##2##(2008-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
sequencing protocol##2##2##(1995-6#2)
sequencing reactions##3##2##(1995-6#2)(2008-2#1)
sequencing reads##2##2##(2011-2#1)(2013-8#1)
sequencing results##2##2##(2008-10#1)(2008-2#1)
sequencing revealed##5##2##(1992-3#1)(1997-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
sequencing showed##2##2##(1992-8#1)(2011-1#1)
sequencing techniques##3##2##(1997-8#1)(2011-1#1)(2013-1#1)
sequencing technologies##6##2##(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
sequencing technology##4##2##(2010-10#1)(2012-3#3)
sequencing the##9##2##(1990-8#1)(1992-9#1)(1997-7#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
sequencing using##3##2##(1990-11#1)(1995-12#1)(2009-11#1)
sequencing was performed on##2##4##(1994-12#1)(2012-2#1)
sequencing was performed##4##3##(1994-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
sequencing was##5##2##(1994-12#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
sequencing were##2##2##(1992-3#1)(2008-12#1)
sequencing will##2##2##(2008-10#1)(2009-5#1)
sequencing##377##1##(1990-11#8)(1990-12#3)(1990-2#2)(1990-5#9)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-6#2)(1992-8#7)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#7)(1994-3#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-5#1)(1995-6#10)(1995-8#5)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#4)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#8)(1997-8#1)(1997-9#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#5)(2008-12#6)(2008-2#8)(2008-3#1)(2008-4#19)(2008-5#5)(2008-7#15)(2008-8#13)(2008-9#7)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#6)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#21)(2012-1#1)(2012-12#1)(2012-2#26)(2012-3#14)(2013-1#9)(2013-8#5)
sequential PSCT in LABC##2##4##(2007-5#2)
sequential PSCT##3##2##(2007-5#3)
sequential addition of##2##3##(1991-8#1)(1991-9#1)
sequential analysis of Cd and Zn on the same##2##9##(2008-10#2)
sequential analysis of##4##3##(2008-10#4)
sequential analysis##6##2##(2008-10#6)
sequential and##8##2##(1990-6#1)(1992-3#1)(2008-10#2)(2008-7#2)(2011-2#1)(2012-1#1)
sequential application of##2##3##(2008-10#2)
sequential approach##2##2##(2008-10#1)(2008-4#1)
sequential arm movements##2##3##(2008-7#2)
sequential chemotherapy##5##2##(2007-5#2)(2008-5#1)(2010-8#1)(2012-3#1)
sequential chromatography##2##2##(1991-12#1)(1994-8#1)
sequential cooperativity##2##2##(1997-2#2)
sequential designs##2##2##(1995-2#2)
sequential determination of cadmium and lead##2##6##(2008-10#2)
sequential determination of copper and mercury ions in river-water samples##2##10##(2008-10#2)
sequential determination of##16##3##(2008-10#16)
sequential determination##17##2##(2008-10#17)
sequential determinations##2##2##(2008-10#2)
sequential elution##3##2##(2008-10#3)
sequential extraction procedure (SEP)##3##4##(2008-10#3)
sequential extraction procedure for##6##4##(2008-10#6)
sequential extraction procedure##17##3##(2008-10#16)(2011-2#1)
sequential extraction procedures##3##3##(2008-10#3)
sequential extraction protocol##2##3##(2008-10#2)
sequential extraction scheme##2##3##(2008-10#2)
sequential extraction test##3##3##(2008-10#3)
sequential extraction##40##2##(2008-10#39)(2011-2#1)
sequential flow injection##2##3##(2008-10#2)
sequential flow##4##2##(2008-10#4)
sequential inductively coupled plasma atomic emission##2##6##(2008-10#2)
sequential inductively coupled plasma##3##4##(2008-10#3)
sequential injection (SI)##7##3##(2008-10#7)
sequential injection (SIA)##3##3##(2008-10#3)
sequential injection analysis (SIA) and##3##5##(2008-10#3)
sequential injection analysis (SIA) methodology for the fluorimetric determination of##2##10##(2008-10#2)
sequential injection analysis (SIA) system is proposed for the determination of##2##11##(2008-10#2)
sequential injection analysis (SIA) system is##4##6##(2008-10#4)
sequential injection analysis (SIA) system##8##5##(2008-10#8)
sequential injection analysis (SIA) technique##2##5##(2008-10#2)
sequential injection analysis (SIA) was##2##5##(2008-10#2)
sequential injection analysis (SIA)##28##4##(2008-10#28)
sequential injection analysis for##2##4##(2008-10#2)
sequential injection analysis system##6##4##(2008-10#6)
sequential injection analysis technique##2##4##(2008-10#2)
sequential injection analysis using##2##4##(2008-10#2)
sequential injection analysis was##2##4##(2008-10#2)
sequential injection analysis##60##3##(2008-10#60)
sequential injection chromatography (SIC)##3##4##(2008-10#3)
sequential injection chromatography##5##3##(2008-10#5)
sequential injection determination of##2##4##(2008-10#2)
sequential injection extraction##2##3##(2008-10#2)
sequential injection lab-on-valve (SI-LOV) system##2##5##(2008-10#2)
sequential injection method##3##3##(2008-10#3)
sequential injection mode##2##3##(2008-10#2)
sequential injection spectrophotometric determination of##2##5##(2008-10#2)
sequential injection spectrophotometric method for the assay of##2##8##(2008-10#2)
sequential injection spectrophotometric method for the determination of##2##8##(2008-10#2)
sequential injection spectrophotometric method for the##4##6##(2008-10#4)
sequential injection spectrophotometric method##5##4##(2008-10#5)
sequential injection spectrophotometric##8##3##(2008-10#8)
sequential injection system for the##4##5##(2008-10#4)
sequential injection system for trace mercury determination##2##7##(2008-10#2)
sequential injection system for##8##4##(2008-10#8)
sequential injection system##20##3##(2008-10#20)
sequential injection systems##3##3##(2008-10#3)
sequential injection technique##3##3##(2008-10#3)
sequential injection titration system##2##4##(2008-10#2)
sequential injection titration##4##3##(2008-10#4)
sequential injection##150##2##(2008-10#150)
sequential inoculations with the##2##4##(2008-10#2)
sequential integration##3##2##(2009-9#3)
sequential leaching##4##2##(2008-10#4)
sequential method##2##2##(1992-3#1)(2008-10#1)
sequential monitoring##2##2##(1995-2#1)(1997-3#1)
sequential reaction##2##2##(1990-7#1)(2008-10#1)
sequential sampling##4##2##(2008-10#4)
sequential separation##4##2##(2008-10#4)
sequential simplex optimization##2##3##(2008-10#2)
sequential simplex##4##2##(2008-10#4)
sequential steps##3##2##(1991-9#1)(2008-10#1)(2009-11#1)
sequential studies##2##2##(2007-5#1)(2007-6#1)
sequential use of a##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
sequential##461##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-8#2)(1991-9#3)(1992-12#2)(1992-3#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-8#3)(1994-9#4)(1995-12#1)(1995-2#9)(1995-8#2)(1996-11#1)(1996-2#3)(1996-5#1)(1997-2#2)(1997-3#7)(1997-7#2)(1997-8#2)(2007-11#2)(2007-12#5)(2007-5#8)(2007-6#1)(2007-8#3)(2008-10#301)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-2#8)(2012-3#4)(2013-1#5)
sequential-injection analysis##3##2##(2008-10#3)
sequential-injection system##2##2##(2008-10#2)
sequential-injection##5##1##(2008-10#5)
sequential-stage ultrafiltration##3##2##(2008-10#3)
sequentially and##2##2##(2007-12#1)(2013-7#1)
sequentially by##2##2##(2008-3#2)
sequentially deleted peptides##2##3##(1997-6#2)
sequentially denatured##2##2##(1990-7#1)(1995-5#1)
sequentially in##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
sequentially inserted as##2##3##(2008-10#1)(2008-9#1)
sequentially with##2##2##(1992-8#1)(2008-8#1)
sequentially##69##1##(1990-7#1)(1990-8#1)(1991-5#2)(1992-11#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#2)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#20)(2008-11#3)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-7#1)
sequester##7##1##(1993-6#1)(1994-8#1)(2008-10#3)(2009-12#1)(2010-6#1)
sequestered Ca2+ was##2##3##(1991-8#2)
sequestered Ca2+##3##2##(1991-6#1)(1991-8#2)
sequestered by##5##2##(1990-2#1)(1995-2#1)(1997-6#1)(2008-10#2)
sequestered in##3##2##(1996-12#1)(1996-5#1)(2013-1#1)
sequestered##20##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-6#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-12#2)(1996-5#1)(1997-6#1)(2008-10#3)(2013-1#1)
sequestering of##2##2##(1994-3#1)(2009-7#1)
sequestering resin was##2##3##(2008-10#2)
sequestering##12##1##(1990-11#1)(1994-3#1)(2008-10#7)(2008-11#1)(2009-7#1)(2012-2#1)
sequesters the##2##2##(1991-9#1)(2008-11#1)
sequesters##5##1##(1991-9#2)(1994-8#1)(1995-2#1)(2008-11#1)
sequestrant##2##1##(1991-6#1)(2008-7#1)
sequestration in##2##2##(1997-1#1)(2013-8#1)
sequestration of##5##2##(1994-8#2)(2008-5#1)(2009-12#1)(2012-12#1)
sequestration with##2##2##(2013-1#2)
sequestration##22##1##(1994-8#2)(1997-1#1)(1997-4#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-12#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
sera (n =##3##3##(1990-8#1)(1996-12#1)(2010-4#1)
sera and##6##2##(1991-5#1)(1992-8#1)(2007-2#1)(2008-10#2)(2008-11#1)
sera as##2##2##(1992-12#1)(2008-8#1)
sera collected at##2##3##(2008-1#1)(2008-8#1)
sera collected##3##2##(2007-2#1)(2008-1#1)(2008-8#1)
sera diluted##2##2##(2008-10#1)(2010-4#1)
sera for##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
sera from cancer patients##2##4##(1994-3#1)(2008-4#1)
sera from patients with##4##4##(1990-5#1)(1993-2#2)(1996-12#1)
sera from patients##7##3##(1990-5#1)(1991-12#1)(1993-2#2)(1996-12#1)(2007-10#1)(2008-5#1)
sera from##31##2##(1990-5#1)(1991-12#1)(1991-5#2)(1992-11#3)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#2)(1994-6#1)(1996-12#3)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-5#1)(2013-8#1)
sera in##2##2##(2007-11#1)(2008-5#1)
sera obtained from##2##3##(1992-3#1)(2007-10#1)
sera obtained##4##2##(1992-3#1)(2007-10#1)(2008-11#2)
sera of patients with##6##4##(1990-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(2008-10#1)
sera of patients##8##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(2008-10#1)
sera of##18##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-2#1)(1994-11#1)(1994-3#2)(1996-3#1)(1997-4#1)(2008-10#1)(2008-7#1)
sera recognize##2##2##(1995-2#2)
sera showed##3##2##(1996-12#1)(2008-11#1)(2012-12#1)
sera to##3##2##(1997-5#1)(1997-6#1)(2012-3#1)
sera using##2##2##(1990-12#1)(2008-10#1)
sera were negative##2##3##(1997-6#1)(2007-2#1)
sera were tested##2##3##(1996-12#1)(2007-7#1)
sera were##10##2##(1990-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-2#2)(2007-7#1)(2008-12#1)(2013-8#2)
sera with##3##2##(1990-12#1)(1995-2#1)(2008-3#1)
sera##166##1##(1990-11#1)(1990-12#8)(1990-5#1)(1990-8#5)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#1)(1991-8#1)(1992-11#4)(1992-12#3)(1992-3#4)(1992-8#6)(1992-9#4)(1993-1#3)(1993-2#3)(1993-3#1)(1993-8#3)(1994-11#2)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#1)(1996-12#9)(1996-3#1)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#2)(2007-10#2)(2007-11#2)(2007-2#5)(2007-7#2)(2008-1#2)(2008-10#16)(2008-11#12)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-4#1)(2009-6#1)(2010-4#5)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#3)
serendipitous discovery##2##2##(1994-11#1)(2008-7#1)
serendipitous##3##1##(1994-11#1)(2008-7#2)
serial CT scans##2##3##(1990-12#1)(2010-1#1)
serial assessment of##2##3##(2009-10#1)(2012-5#1)
serial deletants and chimeras of##2##5##(2008-8#2)
serial dilution##3##2##(2008-10#2)(2012-3#1)
serial dilutions##6##2##(1994-3#2)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
serial passage in##2##3##(2008-10#2)
serial passage##3##2##(1990-5#1)(2008-10#2)
serial passages in##2##3##(2008-10#1)(2013-1#1)
serial passages##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
serial positions##2##2##(1994-3#1)(2007-12#1)
serial sectioning##2##2##(2008-4#1)(2011-2#1)
serial sections and##2##3##(2008-10#1)(2008-7#1)
serial sections##6##2##(1997-3#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
serial subtraction##2##2##(2008-7#2)
serial transverse sections##2##3##(2011-2#2)
serial##111##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-2#1)(1993-11#1)(1993-8#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#3)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#1)
serial-to-parallel##2##1##(2008-2#2)
serially connected##2##2##(2008-10#2)
serially diluted##2##2##(2008-10#1)(2008-11#1)
serially homologous##2##2##(2007-12#2)
serially passaged##2##2##(2013-1#2)
serially sectioned##2##2##(1993-12#1)(2011-2#1)
serially##21##1##(1990-9#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1997-2#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#2)(2012-2#2)(2013-1#2)
serials budget##2##2##(1996-1#2)
serials retrenchment##3##2##(1996-1#3)
serials##7##1##(1996-1#7)
sericin was##2##2##(2008-11#2)
sericin##10##1##(2008-11#10)
series and the##3##3##(1995-11#1)(1995-3#1)(2008-10#1)
series and##14##2##(1991-12#1)(1993-5#1)(1995-11#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#3)(2008-8#1)(2009-6#1)(2012-12#1)
series are##3##2##(1995-3#1)(2008-3#1)(2010-12#1)
series as##4##2##(1996-9#1)(1997-4#1)(2008-10#1)(2013-8#1)
series at##4##2##(1995-11#1)(1995-8#1)(2008-10#1)(2012-2#1)
series before the##2##3##(2008-10#1)(2008-7#1)
series bulk acoustic wave##3##4##(2008-10#3)
series consisted of##2##3##(1996-9#1)(2008-7#1)
series designed to provide emergency physicians with the background necessary to locate##2##12##(2007-5#2)
series expansion##5##2##(2008-2#2)(2008-3#1)(2009-9#1)(2011-1#1)
series for##5##2##(1990-6#1)(1994-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
series from##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
series have##3##2##(1996-2#1)(2008-11#1)(2008-6#1)
series in##5##2##(2008-2#1)(2008-3#1)(2011-2#2)(2013-1#1)
series is##6##2##(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
series learning##2##2##(2008-3#2)
series of 1##2##3##(2008-10#1)(2008-11#1)
series of 10 procedures##2##4##(2007-8#2)
series of 10##5##3##(1994-8#1)(2007-8#2)(2008-10#2)
series of 150##3##3##(1990-12#2)(1996-2#1)
series of 18##2##3##(1990-2#1)(2008-10#1)
series of 19##2##3##(2007-11#1)(2008-10#1)
series of 20##6##3##(2008-10#2)(2008-7#2)(2008-9#1)(2011-2#1)
series of 25##2##3##(2008-2#1)(2008-9#1)
series of 250##2##3##(2008-7#1)(2012-5#1)
series of 30##4##3##(1990-3#1)(1990-8#1)(2008-7#1)(2010-8#1)
series of 76##2##3##(1990-6#1)(2008-7#1)
series of Chinese##2##3##(1993-9#1)(2008-10#1)
series of acyclic##2##3##(2008-10#2)
series of aqueous solutions##2##4##(2008-10#1)(2008-5#1)
series of arecoline##2##3##(1992-10#2)
series of articles##5##3##(1992-4#1)(1994-12#1)(1995-1#1)(1995-2#1)(2007-11#1)
series of cases##4##3##(1990-10#1)(1991-12#1)(2007-8#1)(2012-12#1)
series of compounds##9##3##(1990-8#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-12#1)
series of developmental##2##3##(2008-11#1)(2008-7#1)
series of dinuclear complexes is##2##5##(1997-7#2)
series of dinuclear complexes##3##4##(1997-7#3)
series of events##9##3##(1992-8#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
series of experiments conducted##2##4##(2008-10#1)(2008-12#1)
series of experiments was##3##4##(1993-8#1)(1994-3#1)(1997-4#1)
series of experiments were conducted##2##5##(2008-10#1)(2008-11#1)
series of experiments were##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
series of experiments##22##3##(1992-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#3)
series of field##3##3##(2008-10#1)(2008-12#1)(2011-8#1)
series of greenhouse##2##3##(2008-10#1)(2008-12#1)
series of hierarchical##3##3##(2008-4#1)(2010-10#1)(2012-1#1)
series of lectures to##2##4##(1993-11#1)(1994-9#1)
series of lectures##3##3##(1993-11#1)(1994-9#1)(2012-2#1)
series of microarray##2##3##(2010-1#1)(2012-3#1)
series of mutations##2##3##(1995-12#1)(2010-3#1)
series of new##6##3##(1992-9#1)(2007-11#1)(2008-8#1)(2012-2#1)(2012-3#2)
series of normal##2##3##(1997-3#1)(2006-6#1)
series of novel##4##3##(1992-3#1)(2007-11#1)(2011-1#1)(2011-3#1)
series of papers##4##3##(2008-10#3)(2008-2#1)
series of patients and##2##4##(1992-10#1)(1993-6#1)
series of patients with##2##4##(2010-8#1)(2012-2#1)
series of patients##7##3##(1992-10#1)(1993-6#1)(1996-9#1)(2006-10#1)(2008-2#1)(2010-8#1)(2012-2#1)
series of peptides##6##3##(1995-3#5)(2008-9#1)
series of potential##2##3##(2008-10#2)
series of protocols##3##3##(2008-9#3)
series of recommendations to##2##4##(1997-3#1)(2008-3#1)
series of recommendations##3##3##(1997-3#1)(2008-12#1)(2008-3#1)
series of samples##5##3##(2008-10#5)
series of six##6##3##(2008-10#3)(2008-5#3)
series of substituted##2##3##(2007-11#1)(2008-12#1)
series of substrates##3##3##(1992-11#1)(1994-5#1)(2008-4#1)
series of synthetic##4##3##(1994-9#1)(2008-10#2)(2008-2#1)
series of techniques##2##3##(2008-8#1)(2008-9#1)
series of ten##4##3##(1991-2#1)(1991-5#1)(2008-10#1)(2009-8#1)
series of tests##4##3##(2008-10#3)(2008-2#1)
series of the##4##3##(2008-10#1)(2008-3#2)(2011-2#1)
series of three##4##3##(1996-12#1)(1996-3#1)(1996-5#1)(2008-8#1)
series of vectors##2##3##(1994-12#1)(2008-11#1)
series of workshops##2##3##(2008-12#1)(2008-5#1)
series of##686##2##(1990-10#1)(1990-11#2)(1990-12#9)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#4)(1992-11#6)(1992-12#7)(1992-3#3)(1992-4#1)(1992-6#5)(1992-8#10)(1992-9#3)(1993-1#2)(1993-11#2)(1993-3#2)(1993-5#4)(1993-6#2)(1993-8#3)(1993-9#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#19)(1995-5#3)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#23)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#9)(2008-1#4)(2008-10#117)(2008-11#25)(2008-12#10)(2008-2#22)(2008-3#29)(2008-4#14)(2008-5#27)(2008-6#2)(2008-7#20)(2008-8#18)(2008-9#19)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#4)(2009-7#5)(2009-8#2)(2009-9#8)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#2)(2010-8#4)(2011-1#4)(2011-2#16)(2011-3#1)(2011-4#2)(2011-8#1)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#9)(2012-5#1)(2013-1#9)(2013-8#6)
series on the##2##3##(1992-12#1)(2008-3#1)
series on##7##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(2008-3#1)(2010-9#2)
series or##2##2##(2009-8#1)(2010-5#1)
series performed##2##2##(1996-3#1)(2011-2#1)
series reported##2##2##(1997-3#1)(2008-3#1)
series that##2##2##(2008-2#1)(2008-3#1)
series the##2##2##(2008-3#1)(2008-5#1)
series to##6##2##(1990-8#1)(2007-10#1)(2008-3#1)(2010-3#1)(2012-2#1)(2013-7#1)
series was##12##2##(1990-2#1)(1992-12#1)(2007-8#2)(2008-10#2)(2008-6#1)(2009-9#2)(2011-2#1)(2012-2#1)(2012-3#1)
series were##5##2##(1993-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
series with a##3##3##(1993-3#1)(2008-11#1)(2010-11#1)
series with##8##2##(1993-3#1)(1995-5#1)(2008-10#3)(2008-11#1)(2010-11#1)(2013-1#1)
series##1068##1##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#6)(1990-7#5)(1990-8#8)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#5)(1991-9#3)(1992-1#3)(1992-10#4)(1992-11#8)(1992-12#9)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#5)(1992-8#11)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#6)(1993-5#8)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#2)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#6)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#9)(1995-12#3)(1995-2#6)(1995-3#29)(1995-5#5)(1995-6#2)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#6)(1996-3#6)(1996-5#4)(1996-6#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#12)(1997-8#2)(2006-10#2)(2006-6#1)(2007-10#8)(2007-11#30)(2007-12#11)(2007-5#5)(2007-7#6)(2007-8#16)(2008-1#5)(2008-10#162)(2008-11#31)(2008-12#15)(2008-2#34)(2008-3#50)(2008-4#24)(2008-5#32)(2008-6#11)(2008-7#30)(2008-8#27)(2008-9#24)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#7)(2009-6#1)(2009-7#5)(2009-8#12)(2009-9#14)(2010-1#3)(2010-10#1)(2010-11#7)(2010-12#2)(2010-3#8)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#5)(2011-1#8)(2011-2#40)(2011-3#1)(2011-4#2)(2011-8#1)(2012-1#3)(2012-12#10)(2012-2#24)(2012-3#17)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#9)
series)##5##1##(1994-9#1)(1995-8#1)(1997-7#2)(2010-12#1)
series]##3##1##(1992-6#1)(1993-6#1)(2009-8#1)
serine (S)##2##2##(1991-2#2)
serine and the##2##3##(1990-7#1)(2008-11#1)
serine and threonine residues##2##4##(1993-3#1)(1994-9#1)
serine and threonine##3##3##(1993-3#1)(1994-9#1)(2008-4#1)
serine and tyrosine residues##2##4##(1991-2#2)
serine and tyrosine##3##3##(1990-12#1)(1991-2#2)
serine and##16##2##(1990-12#1)(1990-7#1)(1991-2#3)(1992-10#1)(1993-3#1)(1994-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)
serine as##2##2##(1994-5#1)(2008-11#1)
serine at##2##2##(1995-2#1)(2007-7#1)
serine binding to##2##3##(1994-5#2)
serine binding##3##2##(1994-5#3)
serine dehydratase was##2##3##(1990-7#2)
serine dehydratase##5##2##(1990-7#4)(2008-10#1)
serine isotopomers##2##2##(1997-1#2)
serine or threonine residues##2##4##(1991-12#1)(2008-11#1)
serine phosphorylation of##2##3##(2008-4#1)(2011-1#1)
serine protease and##2##3##(1991-9#1)(2009-9#1)
serine protease inhibitor##5##3##(1991-11#1)(1994-11#1)(2008-7#1)(2008-8#2)
serine protease inhibitors##2##3##(1997-7#1)(2006-6#1)
serine protease##20##2##(1991-11#1)(1991-9#1)(1992-6#2)(1994-11#1)(1995-3#1)(1995-6#2)(1997-7#1)(2006-6#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-9#1)(2012-12#2)
serine proteases and their##3##4##(2008-4#3)
serine proteases in the##3##4##(2008-1#3)
serine proteases##22##2##(1991-6#2)(1991-9#1)(1993-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(2008-1#4)(2008-4#6)(2008-5#1)(2008-9#1)(2011-2#1)
serine proteinase##5##2##(1992-11#1)(1993-3#1)(1995-5#1)(1995-6#1)(2008-10#1)
serine proteinases##11##2##(1991-5#1)(1992-6#1)(1993-11#3)(1993-3#2)(1995-5#2)(2012-3#2)
serine receptor of##2##3##(1994-5#2)
serine receptor##3##2##(1994-5#3)
serine residue##4##2##(1992-6#3)(2011-2#1)
serine residues##9##2##(1990-12#1)(1991-5#1)(1992-6#1)(1993-8#2)(1994-11#1)(1995-3#1)(2011-2#2)
serine synthesis##2##2##(1992-10#1)(1997-1#1)
serine to##2##2##(1994-5#1)(1997-1#1)
serine##185##1##(1990-11#1)(1990-12#2)(1990-7#8)(1991-11#1)(1991-12#1)(1991-2#5)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#3)(1992-6#9)(1992-9#1)(1993-11#8)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#4)(1994-11#5)(1994-12#2)(1994-5#11)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#6)(1995-3#2)(1995-5#5)(1995-6#6)(1995-8#1)(1997-1#15)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#2)(2007-7#1)(2008-1#4)(2008-10#12)(2008-11#7)(2008-4#9)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)
serine-1177##2##1##(2011-1#2)
serine-143##3##1##(1994-5#3)
serine-protease##2##1##(1992-12#2)
serine-threonine kinases##3##2##(1990-5#2)(2008-4#1)
serine/threonine kinase receptor##2##3##(1994-12#2)
serine/threonine kinase##14##2##(1994-12#3)(1994-9#1)(1995-2#2)(1996-2#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-1#2)
serine/threonine kinases that##2##3##(1995-2#1)(2013-1#1)
serine/threonine kinases##4##2##(1993-3#1)(1994-9#1)(1995-2#1)(2013-1#1)
serine/threonine phosphatase##2##2##(1992-12#1)(1995-2#1)
serine/threonine phosphatases##3##2##(1994-11#1)(1995-8#1)(2009-9#1)
serine/threonine phosphorylation##2##2##(1991-9#1)(1994-11#1)
serine/threonine protein kinase family##2##4##(1991-2#1)(2008-10#1)
serine/threonine protein kinase##5##3##(1991-2#1)(1994-8#1)(1995-6#1)(2008-10#1)(2011-2#1)
serine/threonine protein##10##2##(1991-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-2#1)(2008-10#1)(2011-2#1)
serine/threonine##38##1##(1991-2#1)(1991-9#1)(1992-12#1)(1993-3#2)(1993-6#1)(1994-11#3)(1994-12#3)(1994-8#1)(1994-9#3)(1995-2#4)(1995-6#2)(1995-8#2)(1996-2#3)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#2)(2013-1#1)
serine727##2##1##(2011-2#2)
serines##3##1##(1991-2#1)(1992-6#1)(1994-5#1)
serious CV events##2##3##(2008-11#2)
serious adverse drug reactions##2##4##(2011-2#1)(2013-8#1)
serious adverse effects##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
serious adverse event##3##3##(2007-11#1)(2010-12#1)(2012-2#1)
serious adverse events are##2##4##(2008-10#1)(2008-8#1)
serious adverse events##9##3##(1996-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#4)
serious adverse##19##2##(1996-1#1)(1997-1#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#4)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
serious and life threatening##2##4##(2007-7#1)(2012-3#1)
serious and life-threatening##2##3##(1995-12#1)(2011-2#1)
serious and potentially##2##3##(2007-7#1)(2012-3#1)
serious and##17##2##(1992-3#1)(1995-12#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
serious associated##2##2##(1990-6#1)(2010-11#1)
serious bacterial##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
serious cases##2##2##(1990-5#1)(2008-9#1)
serious cause of##2##3##(2008-11#1)(2009-9#1)
serious challenges##2##2##(2007-5#1)(2013-1#1)
serious chronic##2##2##(2008-7#1)(2013-1#1)
serious clinical problem##2##3##(2007-11#1)(2011-2#1)
serious clinical##6##2##(2007-11#2)(2008-6#2)(2008-7#1)(2011-2#1)
serious complication of##10##3##(1991-11#1)(1991-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-2#1)(2010-5#2)(2011-2#1)(2013-1#1)
serious complication##19##2##(1991-11#1)(1991-8#1)(1994-6#1)(1995-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-7#1)(2009-2#1)(2010-5#2)(2011-2#2)(2012-3#1)(2013-1#3)
serious complications in##3##3##(1990-2#1)(2007-8#1)(2013-1#1)
serious complications of##3##3##(2008-4#1)(2011-3#1)(2012-2#1)
serious complications such as##3##4##(1990-11#1)(2011-2#1)(2013-1#1)
serious complications that##2##3##(1991-3#1)(2009-3#1)
serious complications##26##2##(1990-11#1)(1990-2#1)(1991-3#1)(1992-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#4)
serious concerns##2##2##(1991-9#1)(2007-6#1)
serious condition with##2##3##(2011-2#1)(2012-12#1)
serious condition##6##2##(1995-6#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
serious consequences of##3##3##(2007-11#1)(2010-1#1)(2013-8#1)
serious consequences##7##2##(2007-11#1)(2007-4#1)(2008-1#1)(2008-5#1)(2010-1#1)(2013-1#1)(2013-8#1)
serious consideration##3##2##(1996-11#1)(2008-3#1)(2008-5#1)
serious contamination##2##2##(1996-2#1)(2008-7#1)
serious damage##3##2##(2008-10#1)(2008-11#2)
serious disease##14##2##(1992-2#1)(2008-10#10)(2010-6#1)(2011-2#1)(2012-2#1)
serious diseases##4##2##(2008-10#2)(2012-12#1)(2013-8#1)
serious disorder##3##2##(1991-6#1)(2010-1#1)(2012-2#1)
serious drawbacks##2##2##(1992-9#1)(2008-7#1)
serious economic##2##2##(2008-10#1)(2011-2#1)
serious health problems##3##3##(2010-1#1)(2010-7#1)(2013-8#1)
serious health##9##2##(1991-6#1)(1997-1#1)(2008-12#1)(2010-1#1)(2010-7#1)(2013-1#3)(2013-8#1)
serious illness##6##2##(1995-3#1)(2007-12#1)(2007-5#1)(2008-11#1)(2010-8#1)(2012-12#1)
serious in##4##2##(1993-12#2)(2008-2#1)(2008-8#1)
serious infections##8##2##(1995-3#1)(2008-5#1)(2008-7#3)(2011-2#2)(2013-1#1)
serious infectious##2##2##(1994-9#1)(2007-2#1)
serious injury##2##2##(2009-2#1)(2011-2#1)
serious interference was##2##3##(2008-10#2)
serious interference##6##2##(2007-12#1)(2008-10#5)
serious juvenile offenders##2##3##(2009-7#2)
serious limitations##3##2##(1993-6#1)(1995-2#1)(2008-10#1)
serious manifestation##2##2##(2007-7#1)(2012-3#1)
serious medical problem##2##3##(1997-3#1)(2011-2#1)
serious medical##8##2##(1994-2#1)(1994-3#1)(1997-3#1)(1997-6#1)(2009-5#1)(2011-2#2)(2012-3#1)
serious mental illness##4##3##(2008-7#1)(2009-6#3)
serious mental##6##2##(1991-1#1)(1997-3#1)(2008-7#1)(2009-6#3)
serious or##3##2##(1997-6#1)(2008-11#1)(2012-2#1)
serious outcome##2##2##(2008-11#1)(2008-8#1)
serious problem in##6##3##(1995-5#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#2)
serious problem##19##2##(1991-2#1)(1991-3#1)(1995-5#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
serious problems for##2##3##(1993-3#1)(2008-10#1)
serious problems in##2##3##(1996-3#1)(2013-1#1)
serious problems##6##2##(1993-3#1)(1996-3#1)(2008-10#2)(2011-1#1)(2013-1#1)
serious public health problem##3##4##(2008-12#1)(2008-7#1)(2012-12#1)
serious public health##5##3##(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
serious questions about##2##3##(1996-11#1)(2011-2#1)
serious risk##6##2##(1994-6#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
serious risks##2##2##(1996-3#1)(2013-1#1)
serious sequelae##3##2##(1994-9#1)(2007-11#1)(2011-2#1)
serious side effects or##2##4##(2008-7#1)(2008-8#1)
serious side effects##8##3##(1993-11#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
serious side##9##2##(1993-11#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
serious systemic##2##2##(2007-12#1)(2008-7#1)
serious threats to##2##3##(2012-2#1)(2013-7#1)
serious toxic##2##2##(1991-6#1)(2011-2#1)
serious##461##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-6#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#6)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#2)(1993-6#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#1)(2006-10#2)(2007-11#10)(2007-12#5)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#4)(2008-10#64)(2008-11#19)(2008-12#7)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#8)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#5)(2009-7#3)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#3)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#4)(2011-1#3)(2011-2#45)(2011-3#1)(2012-12#13)(2012-2#11)(2012-3#9)(2012-6#1)(2013-1#27)(2013-7#3)(2013-8#8)
seriously by##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
seriously ill and##2##3##(1992-5#1)(2013-1#1)
seriously ill##6##2##(1992-5#1)(1993-12#1)(1995-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
seriously limits##2##2##(2008-5#1)(2010-10#1)
seriously the##2##2##(2008-10#1)(2008-5#1)
seriously##49##1##(1990-8#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
seriousness of##5##2##(1990-3#1)(1995-6#1)(2009-4#1)(2012-3#1)(2013-1#1)
seriousness##7##1##(1990-3#1)(1991-6#1)(1995-6#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
sero-survey##2##1##(2011-2#2)
serocomplex##2##1##(1992-12#1)(1993-11#1)
seroconversion for##2##2##(1990-9#1)(2009-8#1)
seroconversion rate of##4##3##(2007-7#4)
seroconversion rate##6##2##(1997-8#1)(2007-7#5)
seroconversion rates##3##2##(2007-7#3)
seroconversion##22##1##(1990-3#3)(1990-9#1)(1991-3#1)(1997-8#1)(2007-7#9)(2008-11#1)(2009-12#1)(2009-8#2)(2010-3#1)(2011-2#1)(2013-1#1)
seroconverted##4##1##(1991-3#1)(1995-9#1)(2008-1#1)(2013-1#1)
serodiagnosis of##5##2##(1991-11#1)(1996-12#2)(2007-7#1)(2008-5#1)
serogroup A##3##2##(2007-2#1)(2008-12#1)(2009-5#1)
serogroup B##5##2##(2011-1#3)(2013-8#2)
serogroup C##8##2##(1997-5#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-10#3)
serogroup W135##3##2##(2007-2#2)(2008-12#1)
serogroup Y isolates##2##3##(2007-12#2)
serogroup Y meningococci in##2##4##(2007-12#2)
serogroup Y meningococci##4##3##(2007-12#4)
serogroup Y strains##2##3##(2007-12#2)
serogroup Y##11##2##(2007-12#11)
serogroup##46##1##(1991-8#1)(1992-5#1)(1997-5#1)(2007-12#12)(2007-2#3)(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#3)(2009-5#1)(2010-10#3)(2011-1#3)(2011-2#1)(2012-2#2)(2013-8#2)
serogroups A##5##2##(2010-10#3)(2011-1#1)(2013-1#1)
serogroups B##3##2##(2007-12#3)
serogroups of Neisseria meningitidis##3##4##(2007-12#2)(2011-1#1)
serogroups of##4##2##(2007-12#2)(2008-5#1)(2011-1#1)
serogroups##21##1##(2007-12#5)(2007-7#1)(2008-10#4)(2008-5#1)(2010-10#4)(2011-1#2)(2012-2#3)(2013-1#1)
serologic and##2##2##(1992-12#1)(1992-6#1)
serologic reactions##2##2##(2008-5#2)
serologic study##2##2##(1994-5#1)(1996-12#1)
serologic tests for##3##3##(1992-1#1)(1995-5#2)
serologic tests were##3##3##(2012-3#1)(2013-1#2)
serologic tests##16##2##(1991-12#1)(1992-1#1)(1992-6#1)(1994-12#1)(1995-5#5)(2008-12#1)(2008-5#1)(2012-3#3)(2013-1#2)
serologic##45##1##(1990-3#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#2)(1995-5#7)(1996-12#2)(1996-9#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#4)(2009-8#1)(2011-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
serological and molecular##2##3##(2007-12#1)(2008-10#1)
serological and##8##2##(1990-6#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
serological assays##3##2##(1992-5#1)(2008-10#2)
serological comparisons and##2##3##(2008-10#2)
serological data##2##2##(2008-10#1)(2008-8#1)
serological detection of##3##3##(2008-10#3)
serological diagnosis of##2##3##(1991-5#1)(2012-3#1)
serological evidence of previous HBV infection##2##6##(2007-12#2)
serological evidence of##4##3##(1991-8#1)(2007-12#2)(2007-2#1)
serological markers of##2##3##(1993-6#1)(2008-12#1)
serological markers##4##2##(1993-6#1)(2007-7#1)(2008-12#1)(2008-5#1)
serological methods##3##2##(1990-12#1)(1995-12#1)(2013-8#1)
serological properties##4##2##(2008-10#4)
serological reactions##2##2##(2008-10#1)(2008-5#1)
serological relatedness##2##2##(2007-6#1)(2008-10#1)
serological relationship##3##2##(2008-10#3)
serological study of##2##3##(2007-7#2)
serological study##3##2##(2007-7#3)
serological surveillance of##2##3##(1992-5#1)(2010-4#1)
serological techniques##2##2##(1996-12#1)(2008-10#1)
serological test##2##2##(1996-12#1)(2011-2#1)
serological tests for##2##3##(1997-3#1)(2007-7#1)
serological tests##10##2##(1991-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#3)(2008-10#1)(2011-2#2)
serological typing##2##2##(2008-10#2)
serological##92##1##(1990-12#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-5#2)(1993-6#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#33)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-4#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#1)
serologically defined##2##2##(1992-9#1)(2006-6#1)
serologically distinct from all##2##4##(2008-10#2)
serologically distinct from##4##3##(2008-10#4)
serologically distinct##5##2##(2008-10#5)
serologically proven##2##2##(1997-6#1)(2008-1#1)
serologically related to##2##3##(2008-10#2)
serologically related viruses##2##3##(2007-6#1)(2008-10#1)
serologically related##4##2##(2007-6#1)(2008-10#3)
serologically##21##1##(1992-9#1)(1996-12#2)(1997-6#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-5#1)(2012-2#2)(2013-1#1)
serology and##2##2##(1994-7#1)(1997-6#1)
serology for##3##2##(2007-2#1)(2007-5#1)(2008-7#1)
serology in##3##2##(1993-9#1)(2006-10#1)(2009-7#1)
serology was##2##2##(1996-8#1)(2007-12#1)
serology##36##1##(1991-11#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-7#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#4)(2012-2#1)
seroma##5##1##(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-3#1)
seronegative individuals##2##2##(2013-8#2)
seronegative spondyloarthropathies##2##2##(2006-10#1)(2008-9#1)
seronegative women##4##2##(1990-9#1)(1994-6#3)
seronegative##19##1##(1990-2#1)(1990-9#1)(1991-8#1)(1994-6#3)(1995-9#2)(1997-6#1)(2006-10#2)(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#3)
seropositive cases##3##2##(2007-7#1)(2011-2#1)(2013-8#1)
seropositive for##3##2##(1991-11#1)(2008-11#1)(2011-1#1)
seropositive individuals##3##2##(2013-8#3)
seropositive patients##5##2##(1990-2#1)(1990-9#1)(2007-7#2)(2013-8#1)
seropositive rheumatoid arthritis##2##3##(2006-10#1)(2007-7#1)
seropositive women##3##2##(1994-6#3)
seropositive##43##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-8#2)(1993-8#1)(1994-6#5)(1995-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-7#4)(2008-11#1)(2008-5#1)(2009-11#2)(2010-12#1)(2010-7#4)(2011-1#1)(2011-2#3)(2012-3#3)(2013-8#6)
seropositivity in##4##2##(1991-1#1)(1991-11#1)(1992-2#1)(2013-7#1)
seropositivity was found among##2##4##(1994-6#1)(2007-7#1)
seropositivity was found##3##3##(1994-6#1)(2007-7#2)
seropositivity was##6##2##(1994-6#1)(1996-3#2)(2007-7#3)
seropositivity##27##1##(1991-1#1)(1991-11#2)(1991-12#1)(1992-2#1)(1993-11#2)(1994-6#2)(1996-11#1)(1996-3#3)(2007-12#1)(2007-7#6)(2008-1#1)(2008-5#3)(2013-7#1)(2013-8#2)
seroprevalence data##4##2##(1994-9#3)(2012-2#1)
seroprevalence in males was##2##4##(1995-9#1)(2011-2#1)
seroprevalence in##7##2##(1995-9#3)(2008-8#1)(2011-2#3)
seroprevalence of trypanozoon infection##2##4##(2011-2#2)
seroprevalence of##8##2##(1994-6#1)(2007-12#1)(2007-7#1)(2011-2#5)
seroprevalence were##2##2##(2011-2#2)
seroprevalence##26##1##(1994-6#1)(1994-9#3)(1995-9#4)(2007-12#1)(2007-7#1)(2008-8#1)(2011-2#13)(2012-12#1)(2012-2#1)
serosa##5##1##(1991-5#1)(1992-8#1)(2007-12#2)(2008-5#1)
serosal##4##1##(2008-1#1)(2008-12#1)(2008-6#2)
serositis##3##1##(1995-11#1)(1997-3#1)(2006-10#1)
serostatus##4##1##(1995-9#2)(2009-4#2)
serotonergic agents##2##2##(2008-5#1)(2008-9#1)
serotonergic and##4##2##(1993-5#1)(2008-7#3)
serotonergic dysfunction##2##2##(1992-11#1)(2008-5#1)
serotonergic function##2##2##(1993-3#1)(1996-7#1)
serotonergic innervation##3##2##(2007-12#3)
serotonergic neuronal##2##2##(1992-3#1)(1995-12#1)
serotonergic neurons##5##2##(1995-12#1)(1996-12#1)(1996-5#1)(2008-6#1)(2008-7#1)
serotonergic responsivity in##2##3##(1996-7#2)
serotonergic signaling##6##2##(2012-3#6)
serotonergic##53##1##(1991-1#1)(1991-7#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#2)(1994-2#1)(1995-12#2)(1996-12#2)(1996-5#3)(1996-7#5)(2007-12#3)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#8)(2013-8#1)
serotonin (5-HT) and##3##3##(1992-1#1)(2008-3#1)(2008-5#1)
serotonin (5-HT) in the##2##4##(2008-6#1)(2013-1#1)
serotonin (5-HT) in##3##3##(1993-3#1)(2008-6#1)(2013-1#1)
serotonin (5-HT)##15##2##(1992-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-3#1)(1997-6#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
serotonin (5-hydroxytryptamine##8##2##(1993-2#1)(1995-12#3)(1996-7#2)(2008-2#1)(2012-12#1)
serotonin (5HT)##2##2##(1996-12#1)(2008-6#1)
serotonin 5-HT(2A)##2##2##(2008-11#1)(2008-9#1)
serotonin 5-HT2##3##2##(1991-12#2)(1996-5#1)
serotonin agonists##3##2##(1993-9#1)(1995-12#1)(2008-7#1)
serotonin and dopamine##2##3##(2012-2#1)(2013-1#1)
serotonin and##9##2##(1992-11#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
serotonin content in the##2##4##(2008-5#1)(2008-6#1)
serotonin in the##4##3##(1992-11#1)(1995-12#2)(2013-7#1)
serotonin in##5##2##(1992-11#1)(1995-12#2)(1997-6#1)(2013-7#1)
serotonin metabolism##4##2##(1993-12#1)(1997-7#2)(2013-1#1)
serotonin neurotransmission##2##2##(2012-3#2)
serotonin receptor##4##2##(1995-3#1)(1996-12#2)(2008-3#1)
serotonin release##10##2##(1990-8#1)(1992-12#1)(1995-12#8)
serotonin reuptake inhibitors (SSRIs)##7##4##(1996-7#1)(2008-11#1)(2008-6#2)(2012-3#1)(2013-1#1)(2013-8#1)
serotonin reuptake inhibitors##16##3##(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-6#4)(2008-9#1)(2012-3#3)(2013-1#1)(2013-8#1)
serotonin reuptake##23##2##(1991-1#1)(1996-7#1)(1997-8#3)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#5)(2008-9#1)(2010-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
serotonin synthesis##4##2##(1992-11#2)(1993-12#1)(1996-7#1)
serotonin system##2##2##(2008-7#1)(2012-3#1)
serotonin transporter##11##2##(1995-5#2)(1996-12#2)(1996-5#3)(1996-7#1)(2012-2#1)(2012-3#2)
serotonin turnover in##2##3##(2013-1#2)
serotonin turnover##3##2##(2013-1#3)
serotonin##153##1##(1990-5#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#1)(1992-8#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-9#1)(1994-2#2)(1995-11#2)(1995-12#16)(1995-3#2)(1995-5#2)(1996-12#8)(1996-5#7)(1996-7#5)(1997-6#3)(1997-7#4)(1997-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#8)(2008-7#10)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#11)(2013-1#8)(2013-7#1)(2013-8#1)
serotonin)##3##1##(2008-3#1)(2008-4#1)(2012-3#1)
serotoninergic neurons##2##2##(1995-12#2)
serotoninergic##6##1##(1993-12#2)(1995-12#2)(2008-6#2)
serotype 1##5##2##(1993-2#1)(1996-12#3)(2008-5#1)
serotype 2##5##2##(1993-2#1)(2009-6#4)
serotype A##4##2##(2007-10#1)(2008-5#3)
serotype B##3##2##(2008-5#3)
serotype in##3##2##(2008-10#2)(2008-5#1)
serotype of C##2##3##(2008-5#2)
serotype of infectious bronchitis virus##2##5##(2008-5#2)
serotype of the##2##3##(1994-9#1)(2008-10#1)
serotype of##10##2##(1994-9#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#4)(2011-1#1)
serotype was##2##2##(2008-5#1)(2013-8#1)
serotype##64##1##(1991-12#1)(1992-2#2)(1992-5#1)(1993-2#2)(1994-8#1)(1994-9#1)(1995-5#1)(1996-12#4)(1997-3#1)(2007-10#1)(2007-12#5)(2007-6#1)(2007-7#3)(2008-10#10)(2008-2#1)(2008-5#20)(2008-9#1)(2009-6#4)(2011-1#2)(2011-2#1)(2013-8#1)
serotype-cross-reactivity##2##1##(2012-2#2)
serotypes 1##6##2##(1993-2#1)(1996-12#4)(1997-6#1)
serotypes and their##2##3##(1993-2#1)(1996-12#1)
serotypes and##3##2##(1993-2#1)(1995-5#1)(1996-12#1)
serotypes differed in##2##3##(2008-10#2)
serotypes in##2##2##(2008-10#1)(2008-5#1)
serotypes of##9##2##(2008-10#3)(2011-1#2)(2012-12#3)(2013-8#1)
serotypes was##2##2##(1995-5#1)(2009-5#1)
serotypes were##4##2##(1994-9#1)(1996-12#1)(2013-8#2)
serotypes##49##1##(1990-5#1)(1993-2#3)(1994-9#1)(1995-5#3)(1996-12#7)(1997-3#5)(1997-6#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-1#2)(2012-12#3)(2013-8#6)
serotyping of staphylocoagulase##2##3##(2010-6#2)
serotyping##7##1##(1997-3#1)(2008-5#1)(2010-6#3)(2012-3#2)
serous and##3##2##(2008-7#2)(2011-2#1)
serous carcinomas##3##2##(2012-12#3)
serous cystadenoma of##4##3##(2008-11#1)(2012-2#3)
serous cystadenoma##5##2##(2008-11#1)(2012-2#4)
serous detachment associated with latanoprost/timolol fixed combination##2##7##(2013-1#2)
serous papillary cystadenoma of the##2##5##(2013-7#2)
serous papillary##3##2##(1994-9#1)(2013-7#2)
serous##32##1##(1992-2#2)(1993-6#1)(1993-9#2)(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#5)(2010-11#1)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#1)
serovar 25##2##2##(1992-12#2)
serovar B strains of##2##4##(1997-6#2)
serovar B strains##3##3##(1997-6#3)
serovar B##6##2##(1997-6#5)(2008-5#1)
serovar##38##1##(1990-5#1)(1991-8#3)(1992-12#4)(1997-3#6)(1997-6#5)(2007-6#5)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#6)(2010-4#1)(2012-3#2)
serovars##9##1##(1990-5#1)(1992-12#1)(1993-9#3)(1997-6#2)(2008-9#1)(2011-2#1)
serpentine##4##1##(2007-9#1)(2008-10#3)
serpentis##3##1##(1996-12#1)(2012-3#2)
serpin##3##1##(1993-11#1)(1995-6#1)(2008-4#1)
serpins##3##1##(1995-6#1)(2008-4#2)
serrata##10##1##(2008-9#3)(2013-1#7)
serrated adenoma##2##2##(2009-12#2)
serrated##8##1##(2009-12#8)
serratus anterior##4##2##(2010-9#3)(2012-2#1)
serratus##6##1##(1992-6#1)(1993-9#1)(2010-9#3)(2012-2#1)
sertoli cells##2##2##(2008-4#1)(2010-11#1)
sertraline##3##1##(2008-8#1)(2012-2#1)(2012-3#1)
serum (FBS)##9##2##(1992-11#1)(1995-3#1)(2007-11#1)(2008-11#6)
serum (p##3##2##(1991-9#1)(2008-7#2)
serum 25(OH)D##3##2##(2011-1#2)(2011-2#1)
serum 25-hydroxyvitamin D##4##3##(2008-1#1)(2011-2#2)(2012-2#1)
serum ACE level##2##3##(1990-2#1)(1993-12#1)
serum AST##2##2##(2008-10#1)(2013-1#1)
serum BDNF levels##2##3##(2011-2#2)
serum C3##2##2##(1991-12#1)(2007-2#1)
serum CA 125##2##3##(1991-4#1)(1996-11#1)
serum CA##3##2##(1991-4#1)(1996-11#1)(2008-8#1)
serum CA-125 level##2##3##(2008-10#1)(2012-3#1)
serum CA-125##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
serum CRP##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
serum DC-SIGNR##2##2##(2013-7#2)
serum EC-SOD in Group##2##4##(1992-11#2)
serum EC-SOD##3##2##(1992-11#3)
serum FSH##2##2##(2011-2#2)
serum GTH-II levels##2##3##(2008-5#2)
serum HA concentration in patients with disseminated neoplasm##2##8##(1996-12#2)
serum HAE activity and the##2##5##(1996-12#2)
serum HAE activity##3##3##(1996-12#3)
serum HBV DNA levels after##2##5##(2009-8#2)
serum HBV-DNA ≥ 1##2##4##(2011-1#2)
serum HBV-DNA##4##2##(2011-1#4)
serum IGF-I##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
serum IgE##6##2##(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#2)
serum IgG and##2##3##(2008-11#1)(2011-1#1)
serum IgG##7##2##(2008-10#2)(2008-11#2)(2011-1#2)(2012-12#1)
serum IgM##2##2##(1992-12#1)(2008-10#1)
serum LH levels##2##3##(1995-3#2)
serum LIF levels##2##3##(1995-2#2)
serum Lp(a)##3##2##(1991-12#2)(2013-7#1)
serum MT levels##2##3##(1996-7#2)
serum MT##3##2##(1996-7#3)
serum NAA levels##2##3##(2007-10#2)
serum NSE##3##2##(1990-6#3)
serum PEDF##2##2##(2012-5#2)
serum PSA##3##2##(1990-9#1)(2009-5#1)(2012-12#1)
serum T during##2##3##(2013-8#2)
serum T levels##2##3##(2013-8#2)
serum T##5##2##(2013-8#5)
serum T4 and T3##2##4##(1990-3#2)
serum T4##4##2##(1990-3#2)(1991-12#2)
serum TARC##2##2##(2012-1#2)
serum TBARS##2##2##(2008-10#2)
serum TSH and##2##3##(2008-6#1)(2013-1#1)
serum TSH##3##2##(2008-6#2)(2013-1#1)
serum TT4##2##2##(1995-3#2)
serum adiponectin levels in##3##4##(2011-1#3)
serum adiponectin levels##4##3##(2011-1#3)(2013-8#1)
serum adiponectin##6##2##(2011-1#5)(2013-8#1)
serum after##2##2##(2008-10#2)
serum against##2##2##(1994-11#1)(1997-6#1)
serum agglutination test##2##3##(2011-2#1)(2012-2#1)
serum alanine aminotransferase (ALT)##3##4##(1995-3#1)(2010-4#1)(2012-3#1)
serum alanine aminotransferase##4##3##(1995-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
serum albumen##3##2##(2008-10#3)
serum albumin (BSA) was##6##4##(1993-11#1)(1995-12#1)(1997-2#1)(2008-10#3)
serum albumin (BSA)##37##3##(1990-12#1)(1993-11#1)(1995-12#2)(1995-6#1)(1997-2#1)(2008-10#25)(2008-11#3)(2008-3#1)(2008-7#1)(2009-9#1)
serum albumin and##11##3##(1991-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)
serum albumin as a##2##4##(2008-10#1)(2009-9#1)
serum albumin as the##2##4##(1991-12#1)(2008-10#1)
serum albumin as##6##3##(1991-12#1)(2008-10#2)(2008-11#1)(2009-9#1)(2012-2#1)
serum albumin concentration##4##3##(1993-9#1)(1997-8#1)(2008-1#2)
serum albumin conjugate##4##3##(1990-12#1)(2008-11#2)(2010-5#1)
serum albumin in the olfactory bulb of##2##7##(2008-7#2)
serum albumin in the##4##4##(1995-12#1)(2008-7#3)
serum albumin in##5##3##(1995-12#1)(2008-11#1)(2008-7#3)
serum albumin level##2##3##(2007-12#1)(2008-1#1)
serum albumin##141##2##(1990-11#2)(1990-12#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-2#1)(1993-8#2)(1993-9#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#8)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#3)(1997-8#1)(2007-12#2)(2008-1#4)(2008-10#63)(2008-11#8)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#11)(2008-9#1)(2009-11#1)(2009-9#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
serum alkaline phosphatase##2##3##(1990-6#1)(1991-8#1)
serum also##2##2##(1991-8#1)(1994-12#1)
serum aluminum concentrations##3##3##(1992-11#3)
serum amylase##5##2##(1993-12#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
serum amyloid A (SAA)##2##4##(1991-12#1)(2009-10#1)
serum amyloid A##3##3##(1991-12#1)(2009-10#1)(2009-8#1)
serum amyloid protein##2##3##(2008-7#1)(2010-12#1)
serum amyloid##7##2##(1991-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#2)
serum analysis##2##2##(2008-10#1)(2009-9#1)
serum and a##2##3##(2008-10#1)(2008-5#1)
serum and an eluate##2##4##(1994-6#2)
serum and an##3##3##(1994-6#2)(2008-7#1)
serum and animal##2##3##(2008-11#2)
serum and cervical secretion from patients with condyloma acuminatum##2##9##(2011-1#2)
serum and cervical secretion##3##4##(2011-1#3)
serum and in##2##3##(1990-11#1)(1990-12#1)
serum and pharmaceutical formulations##3##4##(2008-10#3)
serum and pharmaceutical##5##3##(2008-10#5)
serum and plasma##9##3##(1995-2#1)(2008-10#1)(2008-4#3)(2010-11#1)(2011-2#3)
serum and saliva##2##3##(2008-3#2)
serum and the##6##3##(1991-8#1)(1992-6#1)(1997-5#1)(2008-11#1)(2008-7#2)
serum and to##2##3##(2008-10#1)(2011-1#1)
serum and urine citrulline levels (p &lt##2##7##(2006-10#2)
serum and urine citrulline levels##3##5##(2006-10#3)
serum and urine of##7##4##(1992-3#1)(1995-3#2)(2008-10#2)(2008-7#2)
serum and urine samples##5##4##(2008-10#4)(2010-4#1)
serum and urine##32##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-3#2)(1992-8#1)(1995-3#2)(2006-10#5)(2008-10#10)(2008-7#5)(2010-4#1)
serum and whole blood samples##2##5##(2008-10#1)(2008-3#1)
serum and whole blood##4##4##(2008-10#3)(2008-3#1)
serum and##128##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#4)(1992-3#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-6#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#5)(2006-7#1)(2007-8#1)(2008-10#36)(2008-11#12)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#8)(2008-8#3)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#4)(2013-1#1)
serum anti-PRP antibody##2##3##(1995-5#2)
serum antibodies against##2##3##(1997-3#1)(2008-10#1)
serum antibodies##4##2##(1997-3#1)(2008-10#2)(2008-4#1)
serum antibody##6##2##(1991-12#3)(1995-5#2)(2008-10#1)
serum as##2##2##(2008-10#2)
serum aspartate aminotransferase##2##3##(1997-3#1)(2013-8#1)
serum at a##2##3##(2008-10#1)(2008-11#1)
serum at##8##2##(1990-2#2)(1992-9#2)(2008-10#3)(2008-11#1)
serum based##2##2##(2008-10#1)(2008-6#1)
serum beta2-microglobulin##2##2##(2007-12#1)(2011-2#1)
serum bile acids in##2##4##(1991-5#1)(1995-9#1)
serum bile acids##3##3##(1991-5#1)(1995-9#1)(2013-1#1)
serum bile##4##2##(1991-5#1)(1995-9#1)(2008-8#1)(2013-1#1)
serum bilirubin##3##2##(1990-8#1)(2011-2#1)(2013-1#1)
serum biochemical##4##2##(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
serum blocking factors##2##3##(1991-12#2)
serum bone##2##2##(1990-2#1)(1991-5#1)
serum by a##2##3##(2008-10#2)
serum by using##2##3##(2008-10#2)
serum by##22##2##(1990-8#2)(1991-5#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-12#1)(1997-4#1)(2008-10#13)(2008-4#1)
serum c-erbB-2 protein##3##3##(1993-1#3)
serum calcitonin level##2##3##(1993-6#1)(2010-12#1)
serum calcium levels##2##3##(1991-8#1)(2008-12#1)
serum calcium##6##2##(1991-8#1)(1994-7#1)(1995-11#1)(1996-9#1)(2007-11#1)(2008-12#1)
serum cholesterol and##3##3##(1991-6#2)(1993-12#1)
serum cholesterol content##2##3##(2013-8#2)
serum cholesterol in##2##3##(1992-6#1)(2007-11#1)
serum cholesterol level##6##3##(1991-6#2)(1994-11#1)(2007-10#1)(2008-7#1)(2010-3#1)
serum cholesterol levels##3##3##(1991-6#2)(2008-7#1)
serum cholesterol was##3##3##(1991-6#2)(2008-10#1)
serum cholesterol##37##2##(1991-6#11)(1992-6#1)(1993-12#4)(1993-5#1)(1993-9#1)(1994-11#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-7#4)(2009-4#1)(2010-3#1)(2013-8#3)
serum collagenase##2##2##(1994-3#2)
serum complement levels##2##3##(2011-1#2)
serum complement##3##2##(2011-1#3)
serum components##2##2##(2008-11#2)
serum concentration in##3##3##(1993-12#1)(2008-9#1)(2012-2#1)
serum concentration of##8##3##(1990-9#1)(1991-12#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#2)
serum concentration##18##2##(1990-9#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#2)(1995-3#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#2)(2011-2#2)(2012-2#1)
serum concentrations of all##3##4##(1990-11#1)(1991-8#1)(2007-8#1)
serum concentrations of calcium##2##4##(1997-5#1)(2011-1#1)
serum concentrations of##17##3##(1990-11#1)(1990-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)
serum concentrations##22##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-1#2)
serum conditions##2##2##(1994-10#1)(2008-11#1)
serum containing medium##6##3##(2008-11#6)
serum containing##11##2##(1993-12#1)(2008-10#1)(2008-11#9)
serum contains a##2##3##(1991-12#1)(1992-9#1)
serum contains##4##2##(1991-12#1)(1991-5#1)(1992-9#1)(1994-12#1)
serum content##3##2##(2008-7#3)
serum copper##2##2##(1991-3#1)(1992-12#1)
serum corticosterone##5##2##(2008-10#3)(2008-7#2)
serum cortisol level##2##3##(2011-2#2)
serum cortisol suppression##2##3##(2011-2#2)
serum cortisol##8##2##(1992-6#1)(2011-2#6)(2013-1#1)
serum could be##3##3##(1990-8#1)(1994-8#1)(2011-2#1)
serum creatine kinase##2##3##(1990-2#1)(1994-12#1)
serum creatine##3##2##(1990-2#1)(1994-12#1)(2008-3#1)
serum creatinine and##4##3##(1994-12#1)(2008-10#1)(2009-5#1)(2013-8#1)
serum creatinine level##4##3##(1994-6#1)(2006-10#1)(2007-7#1)(2008-1#1)
serum creatinine##30##2##(1990-12#1)(1994-12#1)(1994-6#1)(2006-10#2)(2007-7#1)(2008-1#7)(2008-10#2)(2008-7#3)(2008-8#4)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
serum culture##2##2##(2008-11#2)
serum cytokines##2##2##(2008-10#1)(2013-1#1)
serum depletion##2##2##(1992-9#1)(2008-11#1)
serum deprivation##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
serum deprived##2##2##(1994-11#1)(1996-12#1)
serum during##2##2##(1993-12#1)(2008-7#1)
serum enzymes##3##2##(1990-6#2)(2013-1#1)
serum factor##3##2##(1992-3#1)(1993-6#2)
serum factors##3##2##(1990-2#1)(2007-7#2)
serum ferritin (SF)##2##3##(2008-10#1)(2009-3#1)
serum ferritin levels in##2##4##(2009-8#1)(2013-8#1)
serum ferritin levels##4##3##(2009-8#1)(2013-8#3)
serum ferritin##12##2##(1996-3#1)(2008-1#2)(2008-10#1)(2009-10#1)(2009-3#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#3)
serum for##8##2##(1994-8#1)(1995-5#1)(1996-2#1)(2008-11#3)(2008-7#1)(2012-6#1)
serum free conditions##3##3##(1990-5#1)(1992-11#1)(2008-11#1)
serum free media##2##3##(2008-11#2)
serum free medium##4##3##(2008-11#4)
serum free##16##2##(1990-5#1)(1992-11#1)(1993-12#1)(1994-12#1)(1995-12#1)(2008-11#9)(2008-6#1)(2012-3#1)
serum from##10##2##(1990-3#1)(1991-12#1)(1993-12#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
serum fructosamine and HbA1##3##4##(1991-5#3)
serum fructosamine and##4##3##(1991-12#1)(1991-5#3)
serum fructosamine##6##2##(1991-12#3)(1991-5#3)
serum gamma-glutamyl transferase##2##3##(2006-6#2)
serum globulin##2##2##(1990-3#2)
serum globulins##2##2##(1990-3#1)(1997-8#1)
serum glucose and##2##3##(2010-2#1)(2012-5#1)
serum glucose levels##2##3##(2008-7#1)(2009-3#1)
serum glucose##7##2##(2008-7#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-5#1)(2013-1#1)
serum glutamate pyruvate transaminase##2##4##(2012-2#2)
serum had##2##2##(1994-9#1)(1995-12#1)
serum has been##2##3##(1994-3#1)(2008-3#1)
serum has##3##2##(1993-2#1)(1994-3#1)(2008-3#1)
serum homocysteine levels##2##3##(2008-11#2)
serum homocysteine##4##2##(2008-11#3)(2010-1#1)
serum immunoglobulin##2##2##(1996-12#1)(2009-8#1)
serum immunoglobulins##2##2##(2007-10#1)(2012-3#1)
serum in##11##2##(1991-5#1)(1992-3#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-11#5)(2013-1#1)
serum insulin##5##2##(1992-6#1)(1994-12#1)(2008-3#1)(2008-5#1)(2010-10#1)
serum is described##3##3##(1990-8#1)(2008-10#2)
serum is##15##2##(1990-8#4)(1992-9#1)(1994-9#1)(2008-10#7)(2008-4#1)(2008-7#1)
serum lactate dehydrogenase activity##2##4##(2012-2#2)
serum lactate dehydrogenase##3##3##(2012-2#2)(2012-3#1)
serum leptin and adiponectin levels were##2##6##(2011-1#2)
serum leptin and adiponectin levels##3##5##(2011-1#3)
serum leptin and adiponectin##4##4##(2011-1#4)
serum leptin##8##2##(2008-9#1)(2011-1#6)(2013-8#1)
serum level in##2##3##(1990-11#1)(2013-7#1)
serum level of##5##3##(1990-8#1)(2008-7#3)(2008-9#1)
serum level##13##2##(1990-11#1)(1990-8#2)(1993-2#1)(2008-12#1)(2008-6#2)(2008-7#3)(2008-9#1)(2013-1#1)(2013-7#1)
serum levels did not##2##4##(1993-12#1)(2008-11#1)
serum levels of DC-SIGNR##2##4##(2013-7#2)
serum levels of##41##3##(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-6#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
serum levels were##6##3##(1991-4#1)(1993-3#1)(2008-10#3)(2008-7#1)
serum levels##64##2##(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-4#3)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2009-2#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
serum lipase##2##2##(2011-2#1)(2012-2#1)
serum lipid levels##2##3##(1993-8#1)(2008-12#1)
serum lipid profile##2##3##(1995-11#1)(2008-10#1)
serum lipid profiles##3##3##(2008-3#2)(2009-12#1)
serum lipid##12##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#1)
serum lipids and##4##3##(2011-2#1)(2013-1#3)
serum lipids in##2##3##(2007-7#1)(2008-3#1)
serum lipids##8##2##(2007-7#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
serum lipoprotein (a)##2##3##(1990-12#1)(1992-11#1)
serum lipoprotein##3##2##(1990-12#1)(1992-11#1)(2008-3#1)
serum lipoproteins##4##2##(1990-8#1)(1994-3#1)(2008-10#1)(2010-12#1)
serum luteinizing hormone##2##3##(1995-3#2)
serum lysozyme activity##2##3##(2008-10#2)
serum magnesium and hs-CRP##2##4##(2011-2#2)
serum magnesium##6##2##(2011-2#6)
serum marker##4##2##(1990-9#1)(1995-3#1)(1996-12#1)(2007-10#1)
serum markers of##4##3##(1993-2#1)(2007-10#1)(2008-3#1)(2011-2#1)
serum markers##7##2##(1991-12#1)(1992-9#1)(1993-2#1)(2007-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
serum matrix##2##2##(2008-10#2)
serum may##3##2##(1992-6#1)(1993-2#1)(2012-1#1)
serum melatonin levels##4##3##(1995-3#2)(2008-3#2)
serum melatonin##6##2##(1995-3#2)(1996-7#1)(2008-3#3)
serum neopterin##4##2##(1990-2#3)(2009-12#1)
serum neutralisation test##2##3##(1991-3#2)
serum neutralisation##4##2##(1991-3#4)
serum nitrate level##2##3##(2009-8#2)
serum nitrate##4##2##(2009-8#4)
serum nitrite and citrulline levels##2##5##(2006-10#1)(2008-7#1)
serum nitrite##3##2##(2006-10#2)(2008-7#1)
serum obtained##2##2##(2008-11#1)(2013-8#1)
serum oestradiol levels##2##3##(2011-2#2)
serum of all##2##3##(1991-12#1)(2008-5#1)
serum of patients with##6##4##(1990-6#1)(1992-9#1)(1994-8#2)(1996-10#1)(2008-7#1)
serum of patients##8##3##(1990-6#1)(1992-9#1)(1994-8#2)(1996-10#1)(2008-7#1)(2013-1#2)
serum of the##3##3##(1995-3#1)(1997-4#1)(2008-7#1)
serum of##36##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-8#2)(1995-3#1)(1996-10#1)(1997-4#1)(2007-2#2)(2008-10#4)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
serum on##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2013-8#1)
serum or plasma##7##3##(1990-2#1)(1990-8#1)(1994-2#1)(2008-4#2)(2009-6#1)(2011-2#1)
serum or serum-free##2##3##(1996-5#1)(2008-11#1)
serum or##19##2##(1990-12#1)(1990-2#3)(1990-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1996-5#2)(2008-11#4)(2008-4#2)(2009-6#1)(2011-2#1)(2012-3#1)
serum p53 Abs were##2##4##(2011-2#2)
serum p53 Abs##5##3##(2011-2#5)
serum p53##6##2##(2011-2#6)
serum phospholipids##3##2##(2008-3#3)
serum prolactin##3##2##(1995-3#1)(2011-1#2)
serum protein##11##2##(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
serum proteins##8##2##(1991-12#1)(1992-6#2)(1993-6#1)(1993-9#1)(1996-6#1)(1997-5#1)(2013-8#1)
serum reduction##2##2##(2008-7#2)
serum removal##2##2##(1995-6#2)
serum resistance##4##2##(1991-8#4)
serum sample##9##2##(1990-8#1)(1991-11#1)(2008-10#7)
serum samples after##2##3##(2008-10#2)
serum samples analyzed##2##3##(2008-10#2)
serum samples and##2##3##(2008-10#1)(2008-5#1)
serum samples by##4##3##(2008-10#4)
serum samples collected from##2##4##(1996-12#1)(2008-10#1)
serum samples collected##4##3##(1996-12#1)(2008-10#2)(2011-2#1)
serum samples could##2##3##(2008-10#2)
serum samples from patients##2##4##(1993-9#1)(2008-10#1)
serum samples from##10##3##(1990-3#1)(1991-8#1)(1992-5#1)(1993-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
serum samples of##5##3##(2008-10#1)(2008-5#3)(2013-8#1)
serum samples was illustrated##2##4##(2008-10#2)
serum samples was##3##3##(1995-2#1)(2008-10#2)
serum samples were collected from##2##5##(2007-7#1)(2011-2#1)
serum samples were determined##2##4##(2008-10#2)
serum samples were spiked with known amount of##2##8##(2008-10#2)
serum samples were##13##3##(1990-8#1)(1995-2#1)(2007-7#3)(2008-10#7)(2011-2#1)
serum samples with##2##3##(1990-2#1)(2008-10#1)
serum samples##88##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-5#1)(1993-9#1)(1994-12#1)(1995-2#2)(1996-12#3)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#3)(2008-10#54)(2008-5#6)(2011-2#3)(2013-1#3)(2013-8#1)
serum showed that##2##3##(1994-11#1)(2012-12#1)
serum sickness arteritis in##2##4##(1997-8#2)
serum sickness##3##2##(1997-8#3)
serum sodium##6##2##(1992-11#1)(1996-7#1)(2008-1#1)(2010-1#2)(2010-6#1)
serum specimens##4##2##(1991-12#1)(1994-3#1)(2008-10#2)
serum starvation of donor cells##2##5##(2008-9#2)
serum starvation of##3##3##(2008-9#3)
serum starvation##9##2##(1992-3#1)(1993-9#1)(2008-4#2)(2008-9#4)(2012-12#1)
serum stimulation##3##2##(1997-1#3)
serum substitute##2##2##(2007-11#1)(2008-11#1)
serum testosterone##2##2##(2008-5#1)(2012-12#1)
serum thromboxane##3##2##(1990-12#2)(2008-5#1)
serum thyroid hormone##2##3##(1990-3#1)(2008-4#1)
serum thyroid##3##2##(1990-3#1)(2008-4#1)(2008-6#1)
serum thyroxine##3##2##(2008-11#2)(2008-7#1)
serum to##2##2##(1991-8#1)(2008-10#1)
serum total lipids and serum cholesterol##2##6##(2008-12#2)
serum total lipids##4##3##(2008-12#4)
serum total protein##3##3##(2008-10#2)(2012-2#1)
serum total##13##2##(1990-8#1)(1995-12#1)(2008-10#2)(2008-12#4)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
serum triglyceride level##2##3##(2007-7#1)(2013-8#1)
serum triglyceride##12##2##(1991-12#4)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#3)(2013-8#1)
serum triglycerides##12##2##(1991-6#1)(1991-8#1)(1992-6#4)(1993-12#1)(1993-9#1)(2008-3#2)(2012-2#1)(2012-3#1)
serum tumor markers##2##3##(1994-7#1)(2010-8#1)
serum tumor##3##2##(1994-7#1)(1995-2#1)(2010-8#1)
serum urea##2##2##(2007-7#1)(2012-2#1)
serum uric acid levels##4##4##(2011-1#4)
serum uric acid##5##3##(2011-1#5)
serum using##8##2##(1991-5#1)(1993-12#2)(2008-10#5)
serum vitamin B12 levels were##2##5##(1990-3#2)
serum vitamin##3##2##(1990-3#2)(1992-9#1)
serum was measured##2##3##(2008-10#1)(2008-7#1)
serum was##28##2##(1990-12#1)(1991-8#1)(1992-11#1)(1992-9#1)(1994-9#2)(1995-12#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-7#2)(2013-1#1)(2013-8#2)
serum weaning##2##2##(2008-11#2)
serum were##12##2##(1990-8#2)(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1995-8#1)(2008-10#2)(2008-7#2)(2010-5#1)
serum with a##3##3##(1991-12#1)(1992-3#1)(2008-10#1)
serum with##9##2##(1990-7#1)(1991-12#1)(1992-3#1)(1994-9#1)(2008-10#4)(2008-3#1)
serum zinc level##2##3##(2010-6#2)
serum zinc##5##2##(1990-8#2)(2008-5#1)(2010-6#2)
serum##1798##1##(1990-11#7)(1990-12#24)(1990-2#24)(1990-3#11)(1990-5#1)(1990-6#8)(1990-7#2)(1990-8#33)(1990-9#6)(1991-11#2)(1991-12#40)(1991-2#4)(1991-3#5)(1991-4#5)(1991-5#14)(1991-6#16)(1991-8#19)(1991-9#8)(1992-10#1)(1992-11#21)(1992-12#13)(1992-2#2)(1992-3#16)(1992-4#1)(1992-5#2)(1992-6#18)(1992-8#7)(1992-9#13)(1993-1#4)(1993-11#5)(1993-12#28)(1993-2#16)(1993-3#4)(1993-5#1)(1993-6#9)(1993-8#12)(1993-9#8)(1994-10#1)(1994-11#11)(1994-12#11)(1994-2#2)(1994-3#7)(1994-6#9)(1994-7#2)(1994-8#12)(1994-9#10)(1995-1#1)(1995-11#4)(1995-12#16)(1995-2#16)(1995-3#26)(1995-5#8)(1995-6#3)(1995-8#8)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#23)(1996-2#6)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#5)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#6)(1997-6#4)(1997-7#2)(1997-8#8)(2006-10#11)(2006-6#4)(2006-7#1)(2007-10#8)(2007-11#9)(2007-12#4)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#6)(2008-1#26)(2008-10#365)(2008-11#121)(2008-12#17)(2008-2#1)(2008-3#33)(2008-4#23)(2008-5#29)(2008-6#13)(2008-7#77)(2008-8#18)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#13)(2009-9#4)(2010-1#6)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#51)(2011-2#71)(2012-1#5)(2012-12#12)(2012-2#23)(2012-3#21)(2012-5#4)(2012-6#1)(2013-1#51)(2013-7#9)(2013-8#37)
serum)##8##1##(1992-12#1)(2008-10#4)(2008-11#2)(2008-9#1)
serum-##2##1##(2008-11#1)(2013-1#1)
serum-cholesterol measurements in##2##3##(1990-6#2)
serum-cholesterol##9##1##(1990-6#9)
serum-containing media##3##2##(2008-11#3)
serum-containing medium##7##2##(2008-11#7)
serum-containing##16##1##(1994-9#1)(2008-11#15)
serum-containingmedium##3##1##(2008-11#3)
serum-deprived##7##1##(1990-12#3)(1992-11#1)(1996-2#1)(2008-4#1)(2008-8#1)
serum-fed SMC##2##2##(1994-11#2)
serum-free Vero##2##2##(2008-11#2)
serum-free and##2##2##(2008-11#2)
serum-free cell line McCoy-Plovdiv##3##4##(2008-11#3)
serum-free cell##5##2##(1992-11#1)(2008-11#4)
serum-free conditioned##2##2##(1990-12#1)(1994-6#1)
serum-free conditions##8##2##(1992-12#1)(1993-3#1)(2008-11#5)(2008-7#1)
serum-free culture media##2##3##(2008-11#2)
serum-free culture##9##2##(1992-9#1)(2008-11#8)
serum-free cultures##2##2##(1994-6#1)(2008-11#1)
serum-free defined medium##2##3##(1996-5#2)
serum-free media in##2##3##(2008-11#2)
serum-free media##18##2##(2008-11#16)(2008-7#2)
serum-free medium (SFM)##2##3##(2008-11#1)(2008-7#1)
serum-free medium and##4##3##(1992-9#1)(2008-11#3)
serum-free medium containing##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
serum-free medium or##2##3##(2008-11#1)(2008-4#1)
serum-free medium was##3##3##(2008-11#3)
serum-free medium##52##2##(1990-11#1)(1990-12#1)(1990-7#2)(1992-12#1)(1992-2#2)(1992-9#4)(1993-6#1)(1995-11#1)(2008-11#33)(2008-4#1)(2008-7#2)(2008-9#2)(2012-12#1)
serum-free process##2##2##(2008-11#2)
serum-free quality and quantity control culture##2##6##(2012-12#2)
serum-free quality and quantity##3##4##(2012-12#3)
serum-free suspension process##2##3##(2008-11#2)
serum-free suspension##9##2##(2008-11#9)
serum-free##148##1##(1990-11#1)(1990-12#2)(1990-7#4)(1991-12#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-8#1)(1992-9#5)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-11#2)(1996-5#2)(2008-11#103)(2008-4#2)(2008-7#8)(2008-9#3)(2012-12#4)
serum-independent##4##1##(2008-11#4)
serum-induced##3##1##(1992-8#1)(1992-9#1)(1995-2#1)
serum-stimulated##2##1##(1992-8#1)(1997-1#1)
serum-supplemented medium##6##2##(2008-11#6)
serum-supplemented##11##1##(1994-5#1)(2008-11#10)
serum/plasma##4##1##(1990-11#1)(1996-3#1)(2011-2#2)
serum]##3##1##(1997-8#1)(2013-8#2)
serums##2##1##(2008-10#1)(2009-7#1)
servants##2##1##(1990-3#1)(2008-11#1)
serve a variety of functions##2##5##(2008-11#1)(2012-2#1)
serve a##8##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-9#1)(1995-3#1)(2008-11#1)(2008-8#1)(2012-2#1)
serve an##3##2##(1991-9#1)(1995-1#1)(1997-2#1)
serve as a basis for the development of##2##8##(1994-2#1)(2008-11#1)
serve as a basis for the##3##6##(1994-2#1)(2008-11#1)(2010-6#1)
serve as a basis for##5##5##(1994-2#1)(1994-9#1)(1997-3#1)(2008-11#1)(2010-6#1)
serve as a foundation for##2##5##(1996-1#1)(2011-1#1)
serve as a good##2##4##(2008-10#1)(2008-11#1)
serve as a guide in the##2##6##(1990-9#1)(2011-1#1)
serve as a guide##5##4##(1990-9#1)(1991-12#1)(1994-3#1)(2007-2#1)(2011-1#1)
serve as a guideline for##2##5##(2008-6#1)(2010-9#1)
serve as a guideline##3##4##(2008-3#1)(2008-6#1)(2010-9#1)
serve as a means##2##4##(1992-3#1)(2007-8#1)
serve as a model for##4##5##(1991-9#1)(1993-11#1)(2008-11#1)(2008-4#1)
serve as a new##3##4##(2008-10#1)(2008-11#1)(2010-4#1)
serve as a paradigm##2##4##(2012-12#1)(2013-1#1)
serve as a potential##5##4##(1991-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
serve as a protective factor##3##5##(2009-11#1)(2009-7#1)(2013-8#1)
serve as a reservoir for##2##5##(1997-5#1)(2011-2#1)
serve as a reservoir##3##4##(1995-2#1)(1997-5#1)(2011-2#1)
serve as a resource##2##4##(2008-4#1)(2012-3#1)
serve as a sensitive##2##4##(1993-6#1)(2008-10#1)
serve as a source of##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
serve as a suitable model for##2##6##(2008-1#1)(2008-10#1)
serve as a suitable##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
serve as a surrogate##2##4##(2009-11#1)(2013-8#1)
serve as a useful##5##4##(1995-5#1)(2007-11#1)(2008-9#1)(2009-11#1)(2009-4#1)
serve as a valuable##2##4##(1991-6#1)(2008-12#1)
serve as a##119##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#6)(2009-11#3)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#3)
serve as an alternative to##3##5##(2008-10#1)(2008-8#1)(2012-3#1)
serve as an alternative##4##4##(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
serve as an excellent##2##4##(1991-2#1)(2008-7#1)
serve as an important tool for##2##6##(2008-11#1)(2010-3#1)
serve as an important##5##4##(2008-11#1)(2008-6#1)(2010-3#1)(2011-2#2)
serve as an indicator##2##4##(2008-12#1)(2008-5#1)
serve as an##29##3##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
serve as biomarkers##2##3##(2008-6#1)(2012-2#1)
serve as centerpieces##2##3##(1996-12#1)(1997-2#1)
serve as either##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
serve as good##2##3##(1994-8#1)(2009-5#1)
serve as hospital trustees##2##4##(1994-2#2)
serve as markers for##2##4##(2008-3#1)(2008-9#1)
serve as markers##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
serve as potential##4##3##(1993-2#1)(2008-10#1)(2010-12#1)(2012-3#1)
serve as precursors for##2##4##(1995-3#1)(2010-12#1)
serve as precursors##3##3##(1992-6#1)(1995-3#1)(2010-12#1)
serve as scaffolds##2##3##(2010-10#2)
serve as targets for##2##4##(1997-7#1)(2011-2#1)
serve as the basis##2##4##(1993-12#1)(2012-3#1)
serve as the foundation for##3##5##(2008-1#1)(2010-9#1)(2013-8#1)
serve as the foundation##4##4##(2007-12#1)(2008-1#1)(2010-9#1)(2013-8#1)
serve as the##14##3##(1993-12#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
serve as##277##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#5)(2008-10#33)(2008-11#12)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#15)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#6)
serve both to##2##3##(1997-6#1)(2007-12#1)
serve both##5##2##(1991-12#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)
serve for##2##2##(2008-11#1)(2012-2#1)
serve in the##3##3##(1995-2#1)(2008-5#2)
serve in##6##2##(1994-2#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-5#2)
serve many##2##2##(1995-12#1)(2010-10#1)
serve the purpose of##2##4##(1990-6#1)(2011-2#1)
serve the##8##2##(1990-11#1)(1990-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-3#1)
serve to concentrate##2##3##(1997-7#2)
serve to improve##2##3##(1994-5#1)(1996-12#1)
serve to##37##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-7#2)(2006-10#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
serve##394##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#2)(1994-10#1)(1994-12#4)(1994-2#7)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#6)(1997-3#7)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#2)(2006-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-8#2)(2008-1#9)(2008-10#36)(2008-11#18)(2008-12#4)(2008-2#12)(2008-3#9)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#11)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#21)(2012-1#3)(2012-12#5)(2012-2#13)(2012-3#11)(2013-1#5)(2013-7#1)(2013-8#7)
served a##3##2##(2008-8#2)(2009-5#1)
served as a control group##2##5##(1996-2#1)(1997-2#1)
served as a control##4##4##(1992-9#1)(1996-2#1)(1997-2#1)(2010-11#1)
served as a model system for##2##6##(2008-10#1)(2011-1#1)
served as a protective##2##4##(2009-12#1)(2013-1#1)
served as a##25##3##(1992-9#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(2007-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-11#1)(2011-1#2)(2013-1#2)(2013-8#1)
served as an##7##3##(2008-10#3)(2008-11#1)(2008-5#2)(2010-11#1)
served as both##2##3##(2008-10#2)
served as control##4##3##(1995-12#1)(2007-7#1)(2007-8#1)(2011-1#1)
served as controls##9##3##(1990-5#1)(1991-5#1)(1991-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)
served as subjects##2##3##(1993-2#1)(2008-6#1)
served as the control group##3##5##(1991-8#1)(1993-1#1)(1994-5#1)
served as the##12##3##(1991-8#1)(1993-1#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
served as##85##2##(1990-5#1)(1991-5#1)(1991-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
served by a##2##3##(1991-2#1)(1997-2#1)
served by the##8##3##(1991-11#1)(1991-6#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
served by##20##2##(1991-11#2)(1991-2#1)(1991-6#1)(1993-2#1)(1993-3#1)(1995-2#2)(1995-3#1)(1996-3#3)(1997-2#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)
served for the##2##3##(1996-5#1)(2008-10#1)
served for##3##2##(1993-2#1)(1996-5#1)(2008-10#1)
served in contracted##2##3##(1995-2#2)
served in##5##2##(1995-2#2)(1997-2#1)(2010-11#1)(2011-2#1)
served the##3##2##(1995-1#1)(2008-7#1)(2010-12#1)
served to##8##2##(1992-12#1)(1992-6#1)(1997-3#1)(2008-1#1)(2008-10#3)(2009-12#1)
served##149##1##(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#4)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2009-10#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
server and##2##2##(2008-4#2)
server for##4##2##(2008-1#1)(2008-4#2)(2008-7#1)
server##19##1##(2007-6#5)(2008-1#1)(2008-10#2)(2008-4#6)(2008-7#3)(2008-9#1)(2010-5#1)
servers and##3##2##(1992-2#1)(2008-2#1)(2008-4#1)
servers##5##1##(1992-2#2)(2008-2#1)(2008-4#1)(2010-3#1)
serves a##2##2##(2010-10#1)(2012-3#1)
serves an important##2##3##(1995-12#1)(2012-2#1)
serves an##3##2##(1995-12#1)(1997-2#1)(2012-2#1)
serves as a bridge##2##4##(2011-2#1)(2012-3#1)
serves as a case##2##4##(1996-3#1)(2008-11#1)
serves as a negative##2##4##(1994-8#1)(2013-1#1)
serves as a reminder##2##4##(1994-3#1)(2008-10#1)
serves as a scaffold##2##4##(2008-7#1)(2010-2#1)
serves as a substrate for##3##5##(1994-5#1)(1995-5#1)(2008-5#1)
serves as a##56##3##(1992-2#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
serves as an##10##3##(1991-5#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2012-12#1)(2012-2#1)
serves as the##10##3##(1992-2#1)(1994-8#1)(1995-2#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-2#1)
serves as##82##2##(1991-5#1)(1992-10#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#3)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
serves both##2##2##(1994-3#1)(2010-5#1)
serves for the##2##3##(2008-10#1)(2008-2#1)
serves for##3##2##(2008-10#2)(2008-2#1)
serves the##3##2##(1991-3#1)(2010-5#1)(2011-1#1)
serves to highlight##2##3##(1997-4#1)(2008-2#1)
serves to reinforce##2##3##(1994-2#1)(2008-12#1)
serves to##26##2##(1990-5#2)(1990-7#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
serves##135##1##(1990-5#2)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#3)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2010-10#1)(2010-2#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
service agencies##3##2##(1992-12#1)(1992-3#1)(1995-3#1)
service agreements##2##2##(1994-1#1)(1996-2#1)
service and education##2##3##(2008-1#1)(2008-12#1)
service and the##5##3##(1991-1#1)(1993-3#1)(1995-3#1)(1996-11#1)(1997-8#1)
service and##31##2##(1991-1#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
service are##5##2##(1991-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)
service areas##10##2##(1992-12#2)(1995-3#2)(1996-3#6)
service as well as##3##4##(1995-1#1)(1995-2#1)(2008-6#1)
service as##7##2##(1995-1#2)(1995-12#1)(1995-2#2)(1997-5#1)(2008-6#1)
service assistant##2##2##(1996-2#1)(1997-3#1)
service at the##3##3##(1990-11#1)(1996-2#1)(2007-7#1)
service at##7##2##(1990-11#1)(1991-1#1)(1996-11#1)(1996-2#1)(2007-7#1)(2008-4#1)(2008-7#1)
service being##3##2##(1995-6#1)(2011-2#2)
service by##3##2##(1993-2#1)(1997-2#1)(2013-1#1)
service data##2##2##(2012-2#1)(2012-3#1)
service delivery and##3##3##(1992-12#1)(1995-3#1)(2012-3#1)
service delivery in##2##3##(1993-1#1)(2011-1#1)
service delivery models##2##3##(1994-2#1)(2012-12#1)
service delivery system##4##3##(1991-12#1)(1992-1#1)(1996-2#1)(2008-6#1)
service delivery systems##3##3##(1994-2#1)(1995-2#1)(1996-1#1)
service delivery to##2##3##(1996-3#1)(2008-1#1)
service delivery##67##2##(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#4)(1993-3#1)(1994-1#2)(1994-2#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#2)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2010-10#1)(2010-3#4)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#10)
service development##2##2##(1997-3#1)(2013-1#1)
service effectiveness##2##2##(1994-12#1)(1997-1#1)
service encounter##3##2##(1992-3#1)(1993-12#1)(1997-2#1)
service extension##3##2##(2008-1#3)
service facilities##2##2##(1994-12#1)(1997-8#1)
service firm##2##2##(1992-3#2)
service firms##4##2##(1992-3#2)(1993-1#2)
service for the##2##3##(1991-11#1)(1994-2#1)
service for##12##2##(1990-6#1)(1991-11#3)(1991-12#2)(1994-2#1)(1997-5#1)(1997-8#1)(2008-11#1)(2009-12#1)(2011-1#1)
service has been##2##3##(2008-1#1)(2008-10#1)
service has##3##2##(1995-6#1)(2008-1#1)(2008-10#1)
service improvement##4##2##(1993-12#1)(1994-3#1)(2008-3#1)(2013-8#1)
service in the##4##3##(1991-2#1)(1992-2#1)(1996-2#1)(1996-7#1)
service in##21##2##(1990-3#1)(1991-2#1)(1992-2#2)(1993-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#3)(2013-8#2)
service industry##2##2##(1991-3#1)(1993-12#1)
service integration##2##2##(1996-12#2)
service is a##3##3##(1995-2#1)(1996-1#1)(2011-1#1)
service is##12##2##(1992-11#1)(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#1)(2008-1#3)(2011-1#2)(2012-2#1)
service limitation##3##2##(1993-12#3)
service management##2##2##(1994-1#1)(1997-2#1)
service managers##7##2##(1992-1#3)(1994-12#1)(1996-1#2)(1997-2#1)
service may##2##2##(1992-1#1)(1994-2#1)
service members##4##2##(1995-6#3)(1996-5#1)
service menu##2##2##(1996-2#2)
service models##2##2##(1995-2#1)(2013-1#1)
service needs and##3##3##(1992-3#1)(1994-12#1)(1997-1#1)
service needs##14##2##(1992-1#1)(1992-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-3#1)(1997-1#2)(2008-1#1)(2010-8#1)(2013-1#1)(2013-8#2)
service networks##2##2##(1995-1#1)(1996-3#1)
service of a##3##3##(1994-5#1)(1996-9#1)(2010-8#1)
service of##14##2##(1991-1#1)(1991-6#1)(1994-5#1)(1996-2#1)(1996-6#1)(1996-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
service or##3##2##(1994-2#2)(1995-12#1)
service organization##4##2##(1991-9#1)(1996-2#1)(1997-3#1)(2007-10#1)
service organizations manage their funding##2##5##(1991-12#2)
service organizations##16##2##(1991-12#3)(1993-12#2)(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#2)(1996-2#2)(1996-3#2)(1997-2#1)
service patterns were##2##3##(1991-1#1)(2011-2#1)
service patterns##3##2##(1991-1#1)(1995-3#1)(2011-2#1)
service programs##2##2##(1992-2#1)(2011-2#1)
service provided by##2##3##(1994-2#1)(2008-10#1)
service provided##3##2##(1994-2#1)(2008-10#1)(2009-3#1)
service provider##6##2##(1994-2#1)(1995-6#1)(1996-5#1)(2007-2#1)(2008-11#1)(2011-2#1)
service providers and##3##3##(2008-11#2)(2008-12#1)
service providers in the##2##4##(1995-3#1)(2008-11#1)
service providers to ensure##2##4##(1993-12#1)(2008-11#1)
service providers##23##2##(1993-1#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-11#6)(2008-12#1)(2012-2#2)(2012-3#3)
service provision for##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)
service provision##13##2##(1992-1#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2009-9#1)(2011-1#2)(2012-2#1)
service quality and patient satisfaction##2##5##(1995-1#1)(1995-3#1)
service quality and##4##3##(1993-12#1)(1995-1#1)(1995-3#2)
service quality expectations##2##3##(1995-2#1)(2013-8#1)
service quality in health##2##4##(1995-1#1)(1995-3#1)
service quality in##4##3##(1993-12#1)(1995-1#1)(1995-2#1)(1995-3#1)
service quality##37##2##(1992-3#1)(1993-1#1)(1993-12#6)(1993-2#1)(1994-12#1)(1994-2#4)(1995-1#4)(1995-2#7)(1995-3#6)(1996-3#3)(1997-1#1)(1997-3#1)(2013-8#1)
service redeployment##5##2##(1993-1#3)(1995-1#1)(1995-2#1)
service referrals##2##2##(2010-10#1)(2011-2#1)
service system in##2##3##(1992-1#1)(1994-1#1)
service system##7##2##(1992-1#2)(1993-12#1)(1994-1#1)(1995-3#1)(1997-5#1)(2013-8#1)
service systems##3##2##(1994-1#2)(2008-12#1)
service to the##3##3##(1997-2#1)(2008-11#1)(2009-3#1)
service to##15##2##(1991-12#1)(1994-1#3)(1994-2#1)(1995-1#2)(1995-3#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#1)(2013-8#1)
service use and##2##3##(1992-1#1)(1995-3#1)
service use patterns##3##3##(1991-1#1)(2012-3#2)
service use##18##2##(1991-1#5)(1991-3#2)(1992-1#1)(1993-1#1)(1995-3#2)(1997-2#1)(2011-1#1)(2012-2#1)(2012-3#4)
service user and carer##2##4##(2008-12#1)(2009-6#1)
service user and##3##3##(2008-12#2)(2009-6#1)
service user involvement##3##3##(2008-12#3)
service user##6##2##(2008-12#5)(2009-6#1)
service users and carers##3##4##(2009-6#3)
service users and their carers##2##5##(2008-11#1)(2008-12#1)
service users and##6##3##(2008-11#1)(2008-12#2)(2009-6#3)
service users as##3##3##(2008-12#2)(2012-3#1)
service users in##6##3##(2008-12#5)(2012-3#1)
service users##19##2##(2008-11#1)(2008-12#11)(2009-6#4)(2012-3#3)
service utilization and##3##3##(1994-2#2)(2011-1#1)
service utilization##6##2##(1994-2#3)(2008-7#1)(2011-1#1)(2012-3#1)
service volume##2##2##(1992-12#1)(1994-12#1)
service was##4##2##(1995-11#1)(1997-8#1)(2008-11#1)(2013-1#1)
service were##2##2##(1994-2#1)(2008-9#1)
service with##4##2##(1995-2#1)(1996-2#2)(2007-8#1)
service workers##5##2##(1993-1#1)(1995-1#2)(1996-2#1)(2008-10#1)
service##779##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#14)(1991-11#4)(1991-12#13)(1991-2#4)(1991-3#12)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#14)(1992-11#2)(1992-12#10)(1992-2#8)(1992-3#13)(1992-4#1)(1992-8#1)(1993-1#17)(1993-12#30)(1993-2#9)(1993-3#9)(1993-6#1)(1993-8#1)(1994-1#20)(1994-12#13)(1994-2#30)(1994-3#12)(1994-5#1)(1995-1#30)(1995-11#2)(1995-12#12)(1995-2#24)(1995-3#31)(1995-6#9)(1995-9#3)(1996-1#14)(1996-11#2)(1996-12#5)(1996-2#25)(1996-3#32)(1996-5#3)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#12)(1997-2#11)(1997-3#12)(1997-5#3)(1997-8#7)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#18)(2008-10#5)(2008-11#24)(2008-12#28)(2008-2#2)(2008-3#10)(2008-4#1)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#3)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#14)(2011-2#23)(2012-12#7)(2012-2#9)(2012-3#22)(2013-1#26)(2013-8#31)
service'##2##1##(1994-12#1)(2008-11#1)
service's strategies##2##2##(2012-12#2)
service's##4##1##(2008-6#1)(2012-12#3)
service-learning##3##1##(2008-1#3)
service-oriented##3##1##(1992-12#1)(1993-1#1)(2010-8#1)
service]##3##1##(1992-5#1)(1994-3#1)(1996-3#1)
serviced##2##1##(1995-1#1)(2008-11#1)
services administration and##2##3##(1991-12#1)(1993-3#1)
services administration education##4##3##(1993-1#1)(1993-2#1)(1994-2#1)(1997-2#1)
services administration programs must##2##4##(1997-2#2)
services administration programs##3##3##(1996-3#1)(1997-2#2)
services administration##16##2##(1991-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-2#3)(1997-3#1)
services agencies##2##2##(1994-1#1)(1996-4#1)
services and examine##2##3##(1992-12#1)(1993-12#1)
services and health care##2##4##(1994-1#1)(1995-2#1)
services and health##4##3##(1991-2#1)(1994-1#1)(1995-2#1)(1996-3#1)
services and programs##2##3##(1991-1#1)(1995-1#1)
services and the##10##3##(1991-2#1)(1992-1#2)(1992-5#1)(1994-1#1)(1996-11#1)(1996-9#1)(2008-1#1)(2009-6#1)(2011-1#1)
services and to##2##3##(1991-2#1)(2008-11#1)
services and treatment##2##3##(1994-8#1)(2010-6#1)
services and##83##2##(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-1#2)(1992-12#3)(1992-3#1)(1992-5#1)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#4)(1996-11#1)(1996-2#5)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2007-1#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
services are being##2##3##(1991-12#1)(2013-7#1)
services are discussed##5##3##(1991-12#1)(1991-2#2)(1993-12#1)(1997-1#1)
services are limited##2##3##(1996-12#1)(2008-9#1)
services are##31##2##(1991-1#1)(1991-12#3)(1991-2#2)(1992-11#1)(1992-12#2)(1993-12#1)(1993-3#1)(1995-1#1)(1996-12#1)(1996-9#1)(1997-1#2)(1997-2#1)(2008-1#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#2)
services as a##4##3##(1992-3#1)(2008-2#1)(2010-4#1)(2012-1#1)
services as well as##3##4##(1990-11#1)(1991-3#1)(1994-1#1)
services as##13##2##(1990-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-2#1)(2006-5#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-1#1)(2012-3#1)
services at a##3##3##(1991-2#1)(1992-12#1)(2013-8#1)
services at the##3##3##(1993-12#1)(1994-3#1)(2011-2#1)
services at##15##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#3)(2011-2#1)(2013-1#1)(2013-8#1)
services available for##3##3##(2012-12#1)(2013-1#2)
services available in##2##3##(1993-12#1)(2008-1#1)
services available to##4##3##(1993-6#1)(1994-2#1)(1995-12#1)(2008-11#1)
services available##11##2##(1993-12#1)(1993-6#1)(1994-2#2)(1995-12#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#2)
services by the elderly##2##4##(1995-12#1)(1995-3#1)
services by the##3##3##(1992-2#1)(1995-12#1)(1995-3#1)
services by##15##2##(1992-2#2)(1992-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(2007-12#1)(2010-9#1)
services can be##3##3##(1995-12#1)(1995-2#1)(2007-7#1)
services can##7##2##(1990-8#1)(1995-12#1)(1995-2#1)(2007-7#1)(2008-7#1)(2009-6#1)(2013-7#1)
services delivered##3##2##(1997-2#2)(1997-3#1)
services delivery##6##2##(1992-3#1)(1993-2#1)(1997-1#1)(2007-12#1)(2008-8#1)(2011-1#1)
services did not##2##3##(1994-2#1)(2013-7#1)
services during the##2##3##(1993-3#1)(1995-1#1)
services following##2##2##(1994-1#1)(1996-3#1)
services for children and##2##4##(1992-1#1)(1995-2#1)
services for children##4##3##(1992-1#1)(1995-12#1)(1995-2#1)(2010-12#1)
services for older people##2##4##(1991-2#1)(2013-8#1)
services for patients##2##3##(2008-6#1)(2012-12#1)
services for people with##2##4##(1993-1#1)(1996-1#1)
services for persons with##2##4##(1995-3#1)(2013-7#1)
services for the elderly##2##4##(1991-3#1)(1994-1#1)
services for the##17##3##(1991-3#1)(1992-1#1)(1992-11#1)(1994-1#3)(1994-3#1)(1997-1#1)(1997-2#1)(1997-5#5)(1997-8#1)(2008-1#1)(2009-6#1)
services for their children with##3##5##(1993-1#1)(1993-3#1)(1996-1#1)
services for their##4##3##(1993-1#1)(1993-3#1)(1995-1#1)(1996-1#1)
services for women##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
services for##64##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#4)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-5#5)(1997-7#1)(1997-8#1)(2008-1#3)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
services from the##2##3##(1991-6#1)(2011-1#1)
services from##5##2##(1991-6#1)(1992-12#1)(1994-12#1)(1994-2#1)(2011-1#1)
services has been##2##3##(1996-5#1)(1997-5#1)
services has##7##2##(1991-2#1)(1993-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-5#1)(2010-8#1)
services have##7##2##(1992-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-6#1)(2011-2#2)
services if##3##2##(1992-2#1)(1995-12#2)
services in Nepal##2##3##(2008-7#1)(2010-4#1)
services in New##2##3##(1996-3#1)(2010-4#1)
services in Norway##4##3##(1990-11#1)(1992-11#2)(1995-2#1)
services in Tanzania##4##3##(2010-8#4)
services in a large##2##4##(1997-1#1)(2009-9#1)
services in a##6##3##(1990-3#1)(1993-12#2)(1995-12#1)(1997-1#1)(2009-9#1)
services in an##5##3##(1994-3#1)(1995-1#1)(1997-3#1)(2007-5#1)(2008-11#1)
services in hospital##2##3##(1991-3#1)(2010-8#1)
services in response to##2##4##(2010-3#1)(2010-8#1)
services in the##23##3##(1991-2#1)(1991-9#1)(1993-1#1)(1994-1#2)(1994-8#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
services in this##3##3##(1991-2#1)(1993-12#2)
services in##101##2##(1990-11#1)(1990-3#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-6#2)(1994-1#4)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#6)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
services increased##2##2##(1991-2#1)(1994-1#1)
services into the##2##3##(1991-2#1)(1997-2#1)
services into##3##2##(1991-2#1)(1995-2#1)(1997-2#1)
services is not##2##3##(1993-12#1)(2011-2#1)
services is##22##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
services management development##2##3##(1994-3#1)(1995-3#1)
services management education##3##3##(1992-1#1)(1992-12#1)(1995-3#1)
services management##13##2##(1992-1#4)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(2012-12#1)
services marketing##2##2##(1996-1#1)(2008-12#1)
services may##5##2##(1990-8#1)(1992-1#1)(2009-8#1)(2012-12#1)(2012-3#1)
services more##2##2##(1994-3#1)(1997-4#1)
services must be##2##3##(1996-12#1)(2013-8#1)
services must##3##2##(1996-12#1)(2012-12#1)(2013-8#1)
services of a##3##3##(1995-3#2)(2008-1#1)
services of the##6##3##(1994-1#1)(1996-2#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-2#1)
services of##14##2##(1994-1#2)(1995-3#2)(1996-2#1)(2008-1#2)(2008-2#1)(2008-9#3)(2010-9#1)(2011-2#1)(2012-12#1)
services offered by##3##3##(1993-12#1)(1994-12#1)(1996-12#1)
services offered##9##2##(1993-12#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-12#1)(2007-7#1)(2012-12#1)(2013-1#1)
services on##6##2##(1993-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-12#1)(2013-1#1)
services or##4##2##(1994-3#1)(1996-12#1)(2007-4#1)(2008-5#1)
services organization##2##2##(1991-9#1)(1994-3#1)
services organizations##2##2##(1995-1#1)(1996-3#1)
services outside of the##2##4##(1996-2#1)(2008-11#1)
services over##3##2##(1995-3#1)(1996-2#1)(1997-1#1)
services program##2##2##(1991-3#1)(1994-2#1)
services programs##3##2##(1991-1#2)(1997-3#1)
services provided by the##3##4##(1992-2#1)(1995-1#1)(1996-2#1)
services provided by##5##3##(1992-1#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)
services provided during##2##3##(1992-12#1)(2007-7#1)
services provided in##3##3##(1994-12#1)(1994-3#2)
services provided to##5##3##(1991-3#1)(1992-2#1)(1995-1#1)(1995-12#1)(1995-3#1)
services provided##22##2##(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1994-12#1)(1994-3#2)(1995-1#3)(1995-12#2)(1995-3#2)(1996-1#1)(1996-2#1)(2007-7#1)(2013-1#1)
services received by##3##3##(1992-2#1)(1994-2#1)(1995-12#1)
services research and##2##3##(1992-3#1)(2012-2#1)
services research##15##2##(1991-1#1)(1991-12#1)(1992-3#2)(1993-12#1)(1993-3#3)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-7#1)(2012-2#2)
services should be available##2##4##(1991-12#1)(2007-12#1)
services should be##6##3##(1991-12#2)(1991-6#1)(1995-1#1)(1996-1#1)(2007-12#1)
services should not be##3##4##(1995-1#1)(1997-1#1)(2012-1#1)
services should##11##2##(1991-12#2)(1991-6#1)(1995-1#2)(1996-1#1)(1997-1#1)(1997-8#1)(2007-12#1)(2009-5#1)(2012-1#1)
services since the##2##3##(1997-2#1)(2010-8#1)
services specifically##2##2##(1996-9#1)(1997-1#1)
services such as##4##3##(1994-3#1)(1997-3#1)(2008-1#1)(2012-2#1)
services than##4##2##(1991-1#1)(1993-2#1)(1994-1#1)(1996-3#1)
services that are##5##3##(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2012-12#1)
services that can##3##3##(1992-1#1)(1996-1#1)(1996-3#1)
services that##22##2##(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#2)(1994-12#2)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#2)(2010-3#1)(2012-12#1)(2013-1#1)
services through##3##2##(1994-2#1)(1996-3#1)(2008-7#1)
services to Medicare beneficiaries##3##4##(1991-3#2)(1992-2#1)
services to children##3##3##(1991-3#1)(1992-1#1)(2008-11#1)
services to meet the needs of##2##6##(1993-1#1)(1994-1#1)
services to offenders##2##3##(2008-11#1)(2010-6#1)
services to people with##2##4##(1996-3#1)(2011-1#1)
services to remote##2##3##(1995-1#1)(1997-4#1)
services to the elderly##2##4##(1994-1#2)
services to the##10##3##(1991-1#1)(1994-1#2)(1995-12#1)(1996-12#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
services to their##2##3##(1995-3#2)
services to##67##2##(1991-1#1)(1991-3#4)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1994-1#4)(1994-2#2)(1994-3#3)(1995-1#2)(1995-12#2)(1995-3#3)(1996-12#2)(1996-2#3)(1996-3#2)(1997-2#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#10)
services under Medicare##2##3##(1991-2#1)(1991-3#1)
services under##11##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-2#2)
services used by##3##3##(1991-3#1)(1995-12#1)(1997-3#1)
services utilization##6##2##(1990-12#1)(1994-2#1)(2008-12#1)(2011-1#1)(2012-3#2)
services was##7##2##(1992-2#1)(1993-10#1)(1993-6#1)(1995-12#1)(2012-12#1)(2013-1#2)
services were identified##2##3##(2008-1#1)(2010-8#1)
services were provided to##2##4##(1995-3#1)(1996-1#1)
services were##19##2##(1991-3#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-6#1)(2008-1#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#2)(2012-2#2)
services which can be##2##4##(1992-2#1)(1992-3#1)
services which##4##2##(1992-2#1)(1992-3#1)(1996-3#1)(1997-2#1)
services while##2##2##(1992-2#1)(2007-10#1)
services will be##6##3##(1993-3#1)(1995-12#2)(1996-12#1)(1997-3#1)(2008-7#1)
services will##10##2##(1993-3#1)(1994-1#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(2008-7#2)(2012-2#1)
services with low market penetration##2##5##(1997-1#2)
services with the##3##3##(1993-1#1)(1994-12#1)(1996-3#1)
services with##13##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#3)(1994-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(2011-2#1)(2012-12#1)
services within##3##2##(1995-2#1)(1996-2#1)(2010-12#1)
services would be##2##3##(1995-1#1)(1996-1#1)
services would##4##2##(1995-1#1)(1996-1#1)(2011-2#1)(2012-3#1)
services##1418##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#4)(1991-1#22)(1991-10#1)(1991-11#1)(1991-12#26)(1991-2#30)(1991-3#27)(1991-6#13)(1991-8#1)(1991-9#6)(1992-1#32)(1992-11#11)(1992-12#24)(1992-2#28)(1992-3#22)(1992-5#3)(1992-8#1)(1992-9#2)(1993-1#19)(1993-10#1)(1993-11#3)(1993-12#34)(1993-2#25)(1993-3#20)(1993-6#12)(1994-1#42)(1994-11#1)(1994-12#27)(1994-2#44)(1994-3#45)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#22)(1995-12#40)(1995-2#25)(1995-3#37)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#40)(1996-11#3)(1996-12#26)(1996-2#43)(1996-3#41)(1996-4#1)(1996-5#1)(1996-6#5)(1996-8#2)(1996-9#8)(1997-1#20)(1997-2#37)(1997-3#26)(1997-4#3)(1997-5#8)(1997-7#2)(1997-8#9)(2006-5#3)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#8)(2008-1#27)(2008-10#4)(2008-11#36)(2008-12#23)(2008-2#15)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#9)(2008-7#18)(2008-8#12)(2008-9#13)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#7)(2009-6#14)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#5)(2010-2#2)(2010-3#12)(2010-4#5)(2010-5#2)(2010-6#4)(2010-8#24)(2010-9#2)(2011-1#16)(2011-2#32)(2012-1#3)(2012-12#34)(2012-2#19)(2012-3#17)(2013-1#24)(2013-7#12)(2013-8#20)
services)##2##1##(1992-3#1)(2008-2#1)
services? The##2##2##(1994-8#1)(1995-12#1)
services?##3##1##(1994-8#1)(1995-12#1)(2012-2#1)
services]##13##1##(1992-11#2)(1992-5#1)(1993-6#2)(1994-6#1)(1995-8#1)(1996-11#1)(1996-9#2)(1997-4#1)(1997-5#2)
servicing##4##1##(1991-12#1)(2008-2#1)(2011-2#2)
serving Medicaid##2##2##(1996-2#1)(1997-6#1)
serving as a##8##3##(1994-8#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
serving as an##3##3##(2008-10#1)(2008-6#1)(2010-3#1)
serving as the##7##3##(1991-3#1)(1996-1#1)(2008-10#3)(2011-2#1)(2011-3#1)
serving as##29##2##(1991-3#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
serving children##2##2##(1994-1#1)(2013-1#1)
serving on##2##2##(1996-1#1)(2008-4#1)
serving specific needs that traditional excipients are unable to provide and for which safety studies are necessary to support a novel excipient for marketing applications##2##25##(2012-2#2)
serving the##5##2##(1992-2#1)(1996-1#1)(2007-8#1)(2009-4#1)(2011-1#1)
serving##71##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#3)
servings of fruits##4##3##(1994-2#1)(2010-8#1)(2011-1#2)
servings of vegetables and whole grains##2##6##(2012-12#2)
servings of##9##2##(1994-2#1)(1997-1#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
servings##13##1##(1994-2#1)(1995-2#1)(1997-1#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#1)
servlet##2##1##(2008-9#2)
servo system##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
servo##13##1##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#5)
servus##2##1##(2011-2#2)
seryl##2##1##(1990-2#1)(2012-2#1)
ses##3##1##(2009-4#3)
sesame oil##2##2##(2010-5#2)
sesame##5##1##(1991-8#1)(2008-10#1)(2008-11#1)(2010-5#2)
sesami and cannabina##2##3##(2008-10#2)
sesami##6##1##(2008-10#6)
sesamoid bone##2##2##(2011-2#1)(2012-2#1)
sesamoid##4##1##(2009-10#1)(2011-2#1)(2012-2#2)
sesquiterpene##10##1##(1991-6#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-8#3)
sesquiterpenes##8##1##(2008-10#3)(2008-11#1)(2011-10#2)(2013-1#1)(2013-8#1)
sesquiterpenoid extract of Phellinus##3##4##(2008-8#3)
sesquiterpenoid extract of##4##3##(2008-8#4)
sessile##6##1##(1992-6#1)(1993-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)
session &quot##2##2##(2008-10#1)(2009-6#1)
session and##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#3)(2013-1#2)
session consisted of##2##3##(2013-1#1)(2013-8#1)
session could##2##2##(1990-10#1)(2008-9#1)
session of##8##2##(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)
session on one##2##3##(1994-8#1)(2008-5#1)
session on pediatric nurses' perspectives toward providing spiritual care##2##9##(2011-1#2)
session on##7##2##(1994-2#1)(1994-8#1)(1995-12#1)(2008-5#2)(2011-1#2)
session was maintained##2##3##(1991-2#1)(2008-1#1)
session was##9##2##(1991-2#1)(1994-1#1)(2008-1#1)(2008-5#2)(2010-12#1)(2012-3#1)(2013-1#2)
session##109##1##(1990-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1993-12#2)(1993-6#3)(1994-1#1)(1994-2#1)(1994-8#4)(1995-12#2)(1996-5#1)(1997-8#1)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#7)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-6#1)(2010-1#2)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#11)(2013-8#2)
sessions and##7##2##(1993-6#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-3#1)(2013-1#1)(2013-8#1)
sessions at##2##2##(2008-5#1)(2011-2#1)
sessions correlated##3##2##(2012-3#1)(2013-8#2)
sessions covering##2##2##(1995-3#1)(2008-5#1)
sessions for##2##2##(2008-10#1)(2008-6#1)
sessions in the##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
sessions in##8##2##(1993-12#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-10#1)
sessions of the##2##3##(2008-5#1)(2012-1#1)
sessions of##12##2##(1991-5#1)(1992-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2012-1#1)
sessions on##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
sessions to##3##2##(1994-11#1)(2008-12#1)(2008-9#1)
sessions was##4##2##(1995-1#1)(2007-7#1)(2009-11#1)(2010-12#1)
sessions were held with##2##4##(2010-8#1)(2011-2#1)
sessions were required to obtain a##2##6##(1995-11#1)(2008-9#1)
sessions were##8##2##(1995-11#1)(2007-7#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
sessions which##2##2##(2008-5#1)(2008-7#1)
sessions with##3##2##(1992-1#1)(2008-12#1)(2011-2#1)
sessions within the##2##3##(2008-7#1)(2008-9#1)
sessions##151##1##(1990-3#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#6)(2007-8#3)(2008-1#8)(2008-10#8)(2008-11#5)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#21)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#7)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-8#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#15)(2013-8#4)
sessions)##2##1##(1996-11#1)(2009-9#1)
set (n =##2##3##(2008-10#1)(2013-8#1)
set a##6##2##(1996-3#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
set and its##2##3##(2008-10#2)
set and##19##2##(1990-11#1)(1990-12#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
set are discussed##2##3##(2008-3#1)(2008-8#1)
set are##9##2##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#4)
set aside for##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
set aside##4##2##(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)
set at a##4##3##(1992-3#1)(1996-12#2)(2012-2#1)
set at p &lt##3##4##(2011-2#2)(2013-1#1)
set at##24##2##(1991-2#1)(1992-3#1)(1996-12#2)(2007-12#1)(2008-10#9)(2008-12#1)(2008-9#1)(2010-1#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)
set between##2##2##(2008-10#1)(2008-2#1)
set by the##6##3##(1996-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2010-4#1)
set by##16##2##(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
set can##2##2##(2007-12#1)(2013-1#1)
set comprising##2##2##(1995-5#1)(2008-10#1)
set consisted of##4##3##(2008-10#1)(2008-3#1)(2009-9#2)
set consisting of##4##3##(2007-12#1)(2008-10#3)
set consists of##2##3##(2008-12#1)(2009-7#1)
set containing##4##2##(2008-10#3)(2008-6#1)
set for the##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)
set for##15##2##(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
set forth in the##3##4##(1991-2#1)(1997-5#1)(2007-12#1)
set forth##10##2##(1991-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-5#1)(2007-12#2)(2008-1#1)(2009-11#1)(2010-9#1)
set from##5##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)
set goals and##2##3##(1994-12#1)(1997-1#1)
set goals##3##2##(1994-12#1)(1996-2#1)(1997-1#1)
set in a##2##3##(2008-1#1)(2008-3#1)
set in##13##2##(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2009-11#1)(2012-12#1)(2013-8#1)
set is##7##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)
set new##2##2##(2008-8#1)(2010-11#1)
set of 100##2##3##(2008-10#1)(2008-6#1)
set of 11##3##3##(2008-10#2)(2012-3#1)
set of 16##3##3##(2008-10#2)(2008-9#1)
set of 5##2##3##(2009-1#1)(2009-3#1)
set of Escherichia coli##2##4##(1993-9#1)(2008-7#1)
set of absorption spectra##2##4##(2008-10#1)(2008-3#1)
set of absorption##4##3##(2008-10#2)(2008-3#2)
set of analytical##3##3##(2008-10#2)(2008-9#1)
set of atmospheric##2##3##(2008-3#2)
set of beams##2##3##(2007-11#2)
set of challenges##2##3##(2008-12#1)(2013-1#1)
set of clinical##2##3##(1996-3#1)(2010-8#1)
set of compounds##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
set of conditions##4##3##(2008-10#2)(2008-11#1)(2009-6#1)
set of criteria for##3##4##(2008-10#2)(2008-3#1)
set of criteria##5##3##(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
set of cultivars##2##3##(2008-10#1)(2012-4#1)
set of data##8##3##(1993-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)
set of eight##2##3##(2008-10#1)(2013-7#1)
set of equations##6##3##(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
set of essential genes##2##4##(2012-2#2)
set of essential##3##3##(2007-12#1)(2012-2#2)
set of experimental##5##3##(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-8#1)
set of experiments was##2##4##(2008-6#1)(2008-8#1)
set of experiments##8##3##(1995-12#2)(2008-10#1)(2008-6#2)(2008-8#1)(2009-10#1)(2011-3#1)
set of fractional orders##2##4##(2008-2#1)(2008-3#1)
set of genes##5##3##(1996-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
set of glasses##2##3##(2008-10#2)
set of greenhouse isolates##2##4##(2008-10#2)
set of guiding##2##3##(2008-11#2)
set of hypotheses##2##3##(2007-12#1)(2010-6#1)
set of ideas##2##3##(2008-1#1)(2012-3#1)
set of images was##2##4##(2013-1#2)
set of images##5##3##(2007-12#2)(2008-3#1)(2013-1#2)
set of indicators##3##3##(1996-2#1)(2007-12#1)(2008-11#1)
set of information##2##3##(1995-12#1)(2008-4#1)
set of issues##2##3##(1991-3#1)(2008-1#1)
set of key##2##3##(2008-10#1)(2008-3#1)
set of lidar##2##3##(2008-2#1)(2008-3#1)
set of management##2##3##(1996-3#1)(2010-6#1)
set of matrix##2##3##(2008-10#1)(2008-2#1)
set of measurements##4##3##(2008-3#2)(2009-11#1)(2012-2#1)
set of mirrors##2##3##(2008-3#2)
set of molecular##3##3##(2008-10#3)
set of optical##2##3##(2008-2#1)(2008-3#1)
set of original ganoderma lucidum##2##5##(2013-8#2)
set of p##2##3##(1997-8#1)(2008-10#1)
set of parameters##5##3##(2007-4#1)(2008-3#2)(2008-7#1)(2013-8#1)
set of performance##2##3##(1994-2#1)(1995-12#1)
set of photons that##2##4##(2008-3#2)
set of plasmid##2##3##(1994-12#1)(1995-8#1)
set of points##2##3##(2007-11#1)(2009-8#1)
set of primers that##2##4##(1993-12#1)(1993-6#1)
set of primers##6##3##(1990-7#1)(1993-12#1)(1993-6#1)(1995-8#1)(2008-10#1)(2008-5#1)
set of problems##2##3##(2011-2#1)(2013-1#1)
set of proteins##3##3##(1991-12#1)(2011-3#2)
set of reagents &quot##2##4##(2013-1#2)
set of recommendations for##2##4##(1993-12#1)(1996-6#1)
set of recommendations##3##3##(1993-12#1)(1996-6#1)(2013-8#1)
set of relations between##2##4##(2008-7#1)(2010-6#1)
set of requirements##2##3##(1994-3#1)(2008-1#1)
set of rules##4##3##(1990-11#1)(1995-6#1)(2008-10#1)(2008-3#1)
set of scaled wavelet mother functions##2##6##(2008-2#2)
set of six##3##3##(1994-8#1)(2008-3#1)(2008-8#1)
set of size##2##3##(2008-10#2)
set of spectra##2##3##(2008-10#2)
set of standard##2##3##(2008-10#1)(2010-8#1)
set of standards##4##3##(2008-10#3)(2008-9#1)
set of steady state##2##4##(2008-7#2)
set of studies##2##3##(2010-10#1)(2010-12#1)
set of symptoms##2##3##(2008-12#1)(2008-2#1)
set of the##7##3##(1995-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)
set of tools for##2##4##(2007-12#1)(2012-3#1)
set of tools##4##3##(1994-3#1)(1996-2#1)(2007-12#1)(2012-3#1)
set of values##2##3##(2008-1#1)(2008-3#1)
set of wheat differentials##2##4##(2008-10#2)
set of##608##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-8#1)(1994-9#1)(1995-12#7)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-6#2)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#2)(1997-8#1)(2006-5#1)(2007-11#14)(2007-12#14)(2007-4#1)(2007-8#2)(2008-1#8)(2008-10#121)(2008-11#20)(2008-12#5)(2008-2#25)(2008-3#72)(2008-4#14)(2008-5#8)(2008-6#10)(2008-7#28)(2008-8#17)(2008-9#19)(2009-1#1)(2009-10#8)(2009-11#8)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#4)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#9)(2011-2#10)(2011-3#3)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#14)(2012-4#1)(2013-1#17)(2013-7#1)(2013-8#11)
set on the##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
set on##5##2##(2007-5#1)(2008-10#2)(2008-3#1)(2008-9#1)
set out in##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
set out to determine##2##4##(2010-12#1)(2012-5#1)
set out to establish##2##4##(2009-10#1)(2010-11#1)
set out to evaluate##2##4##(2008-12#1)(2011-2#1)
set out to##14##3##(1996-7#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#1)
set out##21##2##(1991-12#1)(1991-2#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
set point##3##2##(2008-6#2)(2013-1#1)
set ranged between##2##3##(2008-10#2)
set samples##2##2##(2008-10#2)
set sequences##2##2##(2008-10#1)(2008-9#1)
set shifting tasks##2##3##(2008-11#2)
set shifting##5##2##(1995-5#1)(2008-11#4)
set standards##2##2##(1996-3#1)(2013-1#1)
set that##5##2##(1994-12#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-12#1)
set the stage for##6##4##(1997-2#1)(2007-5#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
set the##18##2##(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#3)(2013-7#1)
set time##2##2##(2008-3#1)(2011-2#1)
set to 0##2##3##(2008-10#2)
set to be##2##3##(2013-1#2)
set to the##3##3##(2007-12#3)
set to##20##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#3)
set up a##7##3##(1997-4#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-8#1)
set up and##6##3##(1996-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2013-8#1)
set up as a##2##4##(2008-10#1)(2008-2#1)
set up at##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
set up based on##3##4##(2008-10#2)(2013-1#1)
set up for the##3##4##(2008-10#2)(2008-3#1)
set up in##5##3##(1996-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
set up to##4##3##(1990-3#1)(1991-11#1)(2008-11#1)(2008-2#1)
set up with##2##3##(2008-5#1)(2010-5#1)
set up##64##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-5#1)(1996-1#1)(1996-6#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
set used##3##2##(2008-10#3)
set was randomly##2##3##(1995-9#1)(2008-10#1)
set was used for##3##4##(1995-9#1)(1996-5#1)(2008-10#1)
set was##18##2##(1995-9#2)(1996-5#1)(2007-12#1)(2008-10#12)(2011-2#1)(2013-8#1)
set were##8##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2009-12#1)(2013-1#1)
set with the##2##3##(2008-3#1)(2009-5#1)
set with##8##2##(1990-7#1)(1997-4#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-8#2)
set within##2##2##(1991-9#1)(2009-7#1)
set##1161##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-9#2)(1992-1#1)(1992-12#5)(1992-2#5)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#7)(1994-2#2)(1994-3#5)(1994-8#1)(1994-9#1)(1995-12#7)(1995-3#4)(1995-5#6)(1995-6#6)(1995-8#3)(1995-9#5)(1996-1#3)(1996-12#6)(1996-2#6)(1996-3#7)(1996-5#1)(1996-6#3)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2006-5#1)(2007-11#19)(2007-12#43)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#13)(2008-10#282)(2008-11#41)(2008-12#18)(2008-2#40)(2008-3#111)(2008-4#19)(2008-5#14)(2008-6#21)(2008-7#41)(2008-8#22)(2008-9#34)(2009-1#1)(2009-10#12)(2009-11#11)(2009-12#5)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#8)(2010-1#6)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#9)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#15)(2011-2#26)(2011-3#3)(2012-1#2)(2012-12#11)(2012-2#21)(2012-3#20)(2012-4#1)(2012-5#1)(2013-1#32)(2013-7#6)(2013-8#26)
set) and##2##2##(2008-2#1)(2008-7#1)
set) in##2##2##(2008-2#1)(2008-7#1)
set)##8##1##(1995-6#1)(2008-10#2)(2008-2#3)(2008-7#2)
set-up and the##3##3##(2008-10#1)(2008-11#2)
set-up and##4##2##(2008-10#2)(2008-11#2)
set-up has been##3##3##(1997-4#1)(2008-10#2)
set-up was##2##2##(2008-10#1)(2012-2#1)
set-up##30##1##(1993-9#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-7#4)(2008-9#1)(2011-2#2)(2012-2#2)
setae and##2##2##(2007-12#1)(2013-1#1)
setae on##2##2##(2007-12#1)(2008-5#1)
setae##12##1##(2007-12#8)(2008-5#1)(2013-1#3)
setosus##5##1##(2008-10#5)
sets a##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
sets an upper##2##3##(2007-12#1)(2009-5#1)
sets and##11##2##(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
sets are##9##2##(1992-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)
sets based on##2##3##(1995-3#1)(2008-10#1)
sets can be##2##3##(1996-12#1)(2008-4#1)
sets can##3##2##(1996-12#1)(2008-3#1)(2008-4#1)
sets could##2##2##(2008-10#2)
sets examined##2##2##(2008-9#1)(2012-3#1)
sets exhibited##2##2##(2008-10#1)(2008-11#1)
sets for##12##2##(1995-2#1)(1996-2#1)(2008-10#5)(2008-12#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-2#1)
sets forth##2##2##(1992-3#1)(2008-11#1)
sets of PCR##2##3##(1993-12#1)(2008-10#1)
sets of behavioral##2##3##(2008-8#2)
sets of biologically##2##3##(2007-11#1)(2008-9#1)
sets of children##2##3##(2008-9#1)(2009-10#1)
sets of conditions##6##3##(1994-9#1)(2008-10#3)(2008-4#1)(2010-12#1)
sets of data##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-3#1)
sets of diagnostic##2##3##(1995-11#1)(1995-3#1)
sets of genes in##2##4##(1995-2#1)(2008-7#1)
sets of genes##6##3##(1994-12#1)(1995-2#1)(2008-7#2)(2008-8#1)(2009-8#1)
sets of models##2##3##(2008-10#2)
sets of molecular##2##3##(2007-12#1)(2008-2#1)
sets of parameter##2##3##(1997-2#1)(2008-10#1)
sets of primers##5##3##(2008-10#4)(2011-2#1)
sets of proteins##2##3##(2008-9#1)(2009-9#1)
sets of random##2##3##(2008-10#1)(2008-3#1)
sets of reactions##2##3##(2008-10#2)
sets of results##3##3##(1995-11#1)(2008-7#1)(2009-9#1)
sets of samples##2##3##(2008-10#2)
sets of the##2##3##(2008-3#1)(2011-2#1)
sets of##160##2##(1990-5#1)(1990-8#1)(1991-3#2)(1992-12#3)(1992-3#1)(1993-12#2)(1993-8#4)(1994-12#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#1)(2008-10#36)(2008-11#6)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#8)(2009-1#2)(2009-10#2)(2009-12#1)(2009-5#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
sets out to review##2##4##(2008-11#1)(2010-11#1)
sets out to##4##3##(2007-12#1)(2008-11#1)(2009-5#1)(2010-11#1)
sets out##6##2##(2007-12#1)(2008-11#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-8#1)
sets per##2##2##(2008-10#1)(2012-3#1)
sets that##6##2##(1995-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)
sets the stage for the##2##5##(2008-7#1)(2008-9#1)
sets the stage for##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
sets the##4##2##(1992-1#1)(2008-7#1)(2008-9#1)(2012-3#1)
sets using##4##2##(1995-3#1)(2008-10#2)(2008-6#1)
sets was##4##2##(2008-10#4)
sets were also##2##3##(2008-10#1)(2012-2#1)
sets were designed##3##3##(2008-10#3)
sets were##13##2##(1995-3#1)(1995-5#1)(2008-10#8)(2008-11#1)(2012-2#1)(2013-1#1)
sets with##4##2##(2008-10#1)(2010-7#1)(2010-9#1)(2012-3#1)
sets##422##1##(1990-5#1)(1990-8#1)(1991-3#2)(1992-1#1)(1992-12#4)(1992-3#3)(1993-12#2)(1993-5#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#125)(2008-11#16)(2008-12#2)(2008-2#14)(2008-3#30)(2008-4#15)(2008-5#7)(2008-6#6)(2008-7#16)(2008-8#11)(2008-9#17)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#9)(2009-6#1)(2009-8#3)(2009-9#7)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#4)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#12)(2013-1#3)(2013-8#3)
setting an##2##2##(2007-11#1)(2008-6#1)
setting and that##2##3##(1993-12#1)(2008-9#1)
setting and##23##2##(1991-11#1)(1992-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
setting are##4##2##(1996-2#1)(2008-1#1)(2008-11#1)(2010-7#1)
setting by##5##2##(1994-2#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
setting for the##2##3##(2008-1#1)(2008-9#1)
setting for##12##2##(1991-1#1)(1994-12#2)(2007-1#1)(2008-1#1)(2008-2#2)(2008-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
setting has##4##2##(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
setting in order to##2##4##(2008-7#1)(2012-12#1)
setting in##11##2##(1993-1#1)(1993-2#1)(1996-9#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#1)
setting injury was##2##3##(2013-1#2)
setting injury##3##2##(2013-1#3)
setting is a##2##3##(1996-2#1)(2008-10#1)
setting is##7##2##(1994-2#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
setting must##4##2##(1993-2#1)(1994-3#2)(2012-3#1)
setting of the branch cuts##2##5##(2008-3#2)
setting of the##9##3##(1991-6#2)(2008-3#4)(2008-7#1)(2010-4#1)(2010-9#1)
setting of##55##2##(1991-2#1)(1991-6#2)(1992-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
setting on##3##2##(1991-3#1)(2009-11#1)(2012-12#1)
setting or##2##2##(1995-2#1)(2008-8#1)
setting priorities for##2##3##(1996-3#1)(1997-3#1)
setting quality##2##2##(1992-11#1)(2008-7#1)
setting that##2##2##(1992-2#1)(2009-3#1)
setting the##10##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-9#1)(2011-1#1)
setting to##2##2##(2008-12#1)(2013-1#1)
setting up a##7##3##(1992-1#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2013-8#1)
setting up and##2##3##(2008-11#1)(2008-4#1)
setting up the##2##3##(2008-4#1)(2011-2#1)
setting up##20##2##(1990-10#1)(1990-2#1)(1992-1#1)(1995-12#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#3)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
setting was##5##2##(1996-12#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
setting were##3##2##(1995-5#1)(2009-3#1)(2010-3#1)
setting where##2##2##(1994-2#1)(2008-9#1)
setting with low##2##3##(2007-8#1)(2011-2#1)
setting with##6##2##(1996-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
setting##528##1##(1990-10#1)(1990-2#1)(1991-1#6)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#5)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#9)(1993-3#1)(1993-9#1)(1994-1#5)(1994-12#6)(1994-2#7)(1994-3#6)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#2)(1996-1#4)(1996-12#5)(1996-2#10)(1996-3#6)(1996-9#4)(1997-1#3)(1997-2#7)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#6)(2007-2#1)(2007-5#3)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#10)(2008-11#35)(2008-12#17)(2008-2#4)(2008-3#20)(2008-4#8)(2008-5#3)(2008-6#7)(2008-7#21)(2008-8#16)(2008-9#16)(2009-1#2)(2009-10#5)(2009-11#4)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#5)(2011-1#6)(2011-2#26)(2011-7#3)(2012-1#1)(2012-12#16)(2012-2#16)(2012-3#13)(2013-1#31)(2013-8#10)
setting)##2##1##(2008-8#1)(2010-4#1)
settings and##16##2##(1991-1#1)(1992-1#1)(1992-12#1)(1994-2#1)(1996-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-3#1)(2010-9#2)(2012-2#1)(2013-8#2)
settings are##11##2##(1991-12#2)(1994-3#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-4#1)(2013-1#1)
settings by##4##2##(1996-12#1)(2007-2#1)(2008-10#1)(2013-1#1)
settings during##2##2##(2008-10#1)(2011-2#1)
settings for each##2##3##(2008-3#1)(2008-8#1)
settings for the##4##3##(1995-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
settings for##10##2##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
settings in the##3##3##(1995-6#1)(2008-10#1)(2010-4#1)
settings in which##4##3##(1991-12#1)(2007-11#1)(2008-2#1)(2009-6#1)
settings in##13##2##(1991-12#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-6#2)(2010-4#1)(2011-1#1)(2012-2#1)
settings is##7##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#2)(2012-2#1)
settings of a##2##3##(2010-9#2)
settings of##4##2##(2010-9#2)(2011-2#1)(2012-3#1)
settings required for##2##3##(2008-3#1)(2013-8#1)
settings such as##3##3##(1996-3#1)(2007-12#2)
settings than##2##2##(2013-1#1)(2013-8#1)
settings that##4##2##(2008-1#1)(2008-2#1)(2010-11#1)(2011-2#1)
settings to##8##2##(1995-12#1)(1997-3#1)(2007-12#1)(2008-2#2)(2008-8#1)(2013-1#1)(2013-8#1)
settings was##3##2##(1996-12#1)(2008-11#1)(2012-1#1)
settings were##2##2##(2008-10#1)(2013-1#1)
settings when##2##2##(1996-2#1)(2007-2#1)
settings where##2##2##(2008-11#1)(2012-12#1)
settings will be##2##3##(1997-2#1)(2010-8#1)
settings with one##2##3##(2008-8#1)(2013-1#1)
settings with##6##2##(1993-1#1)(2008-8#2)(2009-6#1)(2009-9#1)(2013-1#1)
settings without##2##2##(1993-1#1)(2011-2#1)
settings##318##1##(1990-2#1)(1991-1#2)(1991-12#6)(1991-3#1)(1992-1#3)(1992-12#4)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#2)(1994-3#7)(1995-1#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#7)(1996-12#4)(1996-2#2)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-8#1)(2008-1#7)(2008-10#9)(2008-11#31)(2008-12#13)(2008-2#10)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#10)(2009-7#2)(2009-8#2)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#7)(2010-9#7)(2011-1#3)(2011-2#16)(2012-1#3)(2012-12#12)(2012-2#11)(2012-3#6)(2013-1#14)(2013-7#2)(2013-8#8)
settings)##2##1##(2008-4#1)(2010-11#1)
settle for##3##2##(1992-2#1)(1996-5#1)(1997-5#1)
settle in patches of##2##4##(2008-8#1)(2008-9#1)
settle in##5##2##(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)
settle##19##1##(1990-6#1)(1991-9#1)(1992-2#1)(1995-6#1)(1996-5#1)(1997-5#2)(2006-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2011-1#1)(2013-1#2)
settled down##2##2##(2011-1#1)(2012-2#1)
settled in an##2##3##(2011-2#1)(2013-1#1)
settled in##4##2##(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
settled##17##1##(1991-5#1)(1992-8#1)(1996-9#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
settlement and##3##2##(2007-5#1)(2010-8#2)
settlement in##3##2##(1997-4#1)(2011-2#1)(2013-8#1)
settlement of the##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
settlement of##8##2##(1990-12#2)(2007-5#1)(2008-10#2)(2008-8#1)(2010-1#1)(2011-2#1)
settlement##39##1##(1990-12#2)(1992-2#1)(1994-2#1)(1995-12#3)(1995-6#2)(1996-5#2)(1997-4#1)(1997-5#3)(2007-5#6)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-5#1)(2010-8#4)(2011-2#3)(2013-8#1)
settlements##7##1##(1995-6#1)(1997-4#1)(2008-12#1)(2008-4#2)(2008-6#1)(2013-7#1)
settlers##5##1##(2008-11#1)(2008-9#4)
settles##2##1##(1997-5#1)(1997-7#1)
settling particle samples##2##3##(2008-10#2)
settling##9##1##(1995-12#1)(1996-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-4#1)
setup and the##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
setup and##15##2##(2007-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)
setup are also##2##3##(2008-9#1)(2009-3#1)
setup are##4##2##(2008-3#1)(2008-9#1)(2009-3#1)(2010-12#1)
setup based on##2##3##(2008-3#2)
setup can be##3##3##(2008-2#2)(2008-3#1)
setup can##4##2##(2008-2#2)(2008-3#2)
setup errors##2##2##(2007-4#1)(2009-11#1)
setup for the recording of##2##5##(2008-2#1)(2008-3#1)
setup for the##7##3##(2008-10#1)(2008-2#1)(2008-3#3)(2010-12#1)(2013-8#1)
setup for##13##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2009-2#1)(2009-6#1)(2010-12#1)(2013-8#1)
setup have been##2##3##(2008-2#1)(2008-3#1)
setup is demonstrated##2##3##(2007-12#1)(2010-12#1)
setup is described##3##3##(2008-2#1)(2008-3#2)
setup is used##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
setup is##26##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#12)(2010-12#1)
setup makes use of##2##4##(2008-2#1)(2008-3#1)
setup mistakes##2##2##(2007-10#2)
setup of the##3##3##(2007-11#1)(2008-2#1)(2010-12#1)
setup of##6##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-12#1)(2013-8#1)
setup that can##2##3##(2008-3#2)
setup that is##2##3##(2008-2#1)(2008-3#1)
setup that uses a##2##4##(2007-11#1)(2008-3#1)
setup that##11##2##(2007-11#3)(2008-2#3)(2008-3#5)
setup to##3##2##(2008-3#2)(2008-6#1)
setup was used##2##3##(2008-10#1)(2010-5#1)
setup was##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
setup with##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
setup##179##1##(1993-12#1)(1993-9#1)(1994-2#1)(2007-10#2)(2007-11#20)(2007-12#11)(2007-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#27)(2008-3#76)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
setups for##4##2##(1997-6#1)(2008-3#2)(2013-1#1)
setups##19##1##(1994-2#1)(1997-6#1)(2007-12#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
sevelamer##2##1##(2012-12#2)
seven (47%)##2##2##(2008-5#2)
seven advisors##2##2##(1995-12#2)
seven amino##2##2##(1994-11#1)(1994-2#1)
seven areas##2##2##(1994-1#1)(1997-3#1)
seven barley##2##2##(2008-10#2)
seven cases of##5##3##(1997-5#1)(2007-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
seven cases##12##2##(1990-9#1)(1991-2#1)(1991-6#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)
seven chemical markers##2##3##(2012-3#2)
seven chromosomes##2##2##(2008-10#1)(2012-3#1)
seven clinical##2##2##(1996-2#1)(1997-2#1)
seven commercial##2##2##(2008-10#1)(2008-7#1)
seven compounds##6##2##(2008-10#2)(2008-12#1)(2011-1#1)(2012-3#2)
seven consecutive measurements##2##3##(2008-10#2)
seven consecutive##4##2##(2008-10#4)
seven conserved##2##2##(1994-11#1)(1997-6#1)
seven countries##3##2##(1992-4#1)(2007-7#1)(2008-10#1)
seven cultivars##2##2##(2008-10#2)
seven days after the first##2##5##(1996-9#1)(2008-7#1)
seven days after the##4##4##(1996-9#1)(2007-12#1)(2008-7#1)(2013-1#1)
seven days##17##2##(1990-3#1)(1992-5#1)(1992-8#1)(1994-5#1)(1994-7#2)(1996-9#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#2)
seven different##17##2##(1992-6#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-3#2)(2008-5#2)(2008-6#1)(2011-2#1)(2013-7#1)
seven distinct##2##2##(2008-10#1)(2008-5#1)
seven elements##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
seven females##2##2##(2007-7#1)(2010-8#1)
seven field trials##3##3##(2008-10#3)
seven field##5##2##(2008-10#5)
seven fragments##2##2##(1997-2#1)(2008-10#1)
seven genes##3##2##(1991-6#1)(1996-10#1)(1996-6#1)
seven group##2##2##(2008-10#1)(2013-1#1)
seven groups##2##2##(1997-6#1)(2008-6#1)
seven had##2##2##(2008-4#1)(2008-5#1)
seven hospitals##2##2##(1991-3#1)(1996-9#1)
seven human##3##2##(1994-11#1)(1995-3#1)(1995-5#1)
seven infants##3##2##(1990-8#1)(1995-5#1)(1997-4#1)
seven introns##2##2##(1993-12#1)(1997-4#1)
seven isolates##7##2##(1997-8#1)(2007-6#1)(2008-10#5)
seven items##2##2##(2012-2#2)
seven locations in the##2##4##(2008-10#1)(2010-8#1)
seven locations in##4##3##(2008-10#3)(2010-8#1)
seven loci##2##2##(2011-2#2)
seven major phenolic compounds##2##4##(2011-1#2)
seven major##4##2##(1994-1#1)(2011-1#2)(2011-2#1)
seven management and planning tools##3##5##(1994-1#1)(1994-2#2)
seven men##2##2##(2011-2#1)(2012-3#1)
seven months##3##2##(1990-11#1)(1990-3#1)(2008-4#1)
seven new##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
seven normal##2##2##(1995-5#1)(1996-2#1)
seven of eight##3##3##(1990-5#1)(2008-10#1)(2008-4#1)
seven of ten##2##3##(1991-2#1)(1992-1#1)
seven of the 13##2##4##(1991-12#1)(2008-9#1)
seven of the eight##2##4##(1994-9#1)(1997-3#1)
seven of the##11##3##(1990-9#1)(1991-12#1)(1994-9#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2013-7#1)
seven of them##5##3##(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-3#1)
seven of these##3##3##(1990-5#1)(1993-2#1)(2013-8#1)
seven of which##3##3##(1995-9#1)(2008-10#1)(2008-8#1)
seven of##30##2##(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-9#2)(1995-9#1)(1996-1#1)(1996-9#1)(1997-3#1)(2007-7#1)(2008-10#6)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2013-7#1)(2013-8#1)
seven orders##2##2##(2008-10#1)(2010-8#1)
seven other##5##2##(1992-8#1)(1993-12#1)(2008-10#1)(2008-6#1)(2013-7#1)
seven out of##3##3##(1996-12#1)(2008-5#1)(2008-8#1)
seven participants##3##2##(2010-10#3)
seven patients treated with##2##4##(1992-9#1)(2013-8#1)
seven patients were##2##3##(2007-7#1)(2007-8#1)
seven patients who had##2##4##(2007-7#1)(2008-1#1)
seven patients who##4##3##(1996-6#1)(2007-7#1)(2008-1#2)
seven patients with##9##3##(1990-12#1)(1991-2#1)(1993-3#2)(1995-4#1)(2006-12#1)(2008-6#1)(2008-7#1)(2010-8#1)
seven patients##35##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-5#1)(1995-4#1)(1996-1#1)(1996-6#2)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-4#1)(2008-6#2)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
seven percent of##4##3##(2007-7#1)(2013-1#3)
seven percent##6##2##(1997-2#1)(2007-7#1)(2013-1#4)
seven putative transmembrane##2##3##(1990-5#1)(1992-12#1)
seven putative##5##2##(1990-5#1)(1991-2#1)(1992-12#1)(2008-5#1)(2008-8#1)
seven replicate##3##2##(2008-10#3)
seven replicates##6##2##(2008-10#6)
seven samples##3##2##(2008-10#3)
seven sampling##2##2##(2008-10#2)
seven sessions##2##2##(2008-5#1)(2010-3#1)
seven species of##2##3##(2008-10#1)(2008-8#1)
seven species##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
seven squabs##2##2##(2008-5#2)
seven states and##2##3##(2008-10#1)(2013-1#1)
seven strains from##2##3##(2011-2#2)
seven strains were##2##3##(2008-10#2)
seven strains##5##2##(2008-10#3)(2011-2#2)
seven times##4##2##(2008-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
seven tissues##2##2##(1990-11#1)(1994-11#1)
seven to##4##2##(1992-11#1)(1995-6#1)(1996-11#1)(2008-8#1)
seven traditional##2##2##(2013-7#2)
seven trials##3##2##(2008-10#2)(2008-3#1)
seven variables##2##2##(2008-10#2)
seven viruses##2##2##(2008-10#2)
seven week##2##2##(2008-11#1)(2008-12#1)
seven weeks##4##2##(1997-5#1)(2008-12#1)(2008-3#1)(2013-8#1)
seven were of grade##2##4##(2013-8#2)
seven were##7##2##(1990-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2013-8#2)
seven women##5##2##(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
seven years of##3##3##(1996-3#1)(2008-1#1)(2008-9#1)
seven years##9##2##(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
seven##614##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-12#7)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-6#5)(1996-8#1)(1996-9#4)(1997-2#9)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#3)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#8)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#7)(2008-1#14)(2008-10#159)(2008-11#10)(2008-12#10)(2008-2#3)(2008-3#9)(2008-4#10)(2008-5#26)(2008-6#8)(2008-7#17)(2008-8#17)(2008-9#10)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-7#2)(2010-8#6)(2011-1#6)(2011-2#22)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#16)(2012-5#1)(2013-1#19)(2013-7#6)(2013-8#9)
seven-fold##2##1##(2008-10#1)(2008-7#1)
seven-item##3##1##(2012-2#2)(2013-1#1)
seven-year##6##1##(1992-5#1)(1996-12#1)(1996-3#1)(2008-3#1)(2011-3#2)
sevenfold increase in##2##3##(2008-3#1)(2013-7#1)
sevenfold##5##1##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-7#1)
seventeen##10##1##(1990-8#1)(1991-1#1)(1991-12#1)(1992-3#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-3#1)
seventeenth century##5##2##(2009-7#3)(2010-1#1)(2013-8#1)
seventeenth##6##1##(2009-7#3)(2010-1#1)(2011-2#1)(2013-8#1)
seventeenth-century New Spain##2##3##(2008-11#2)
seventeenth-century##6##1##(2008-10#4)(2008-11#2)
seventh day##3##2##(2007-8#1)(2008-5#1)(2011-2#1)
seventh decade##2##2##(2008-1#1)(2013-8#1)
seventh generation##2##2##(2008-10#2)
seventh genome sequence in the family##2##6##(2011-2#2)
seventh transmembrane domain of##2##4##(1994-6#2)
seventh transmembrane##3##2##(1994-6#2)(1995-8#1)
seventh##35##1##(1991-1#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-6#2)(1995-4#1)(1995-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
seventh-order nonlinear optical##3##3##(2007-12#3)
seventies and##2##2##(1993-3#1)(2008-4#1)
seventies##3##1##(1993-3#1)(1997-8#1)(2008-4#1)
seventy six##2##2##(2008-9#1)(2013-8#1)
seventy three##3##2##(2008-10#1)(2008-12#2)
seventy##10##1##(1990-3#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#2)(2013-8#2)
seventy-seven##2##1##(2008-1#1)(2013-8#1)
seventy-six##2##1##(2008-10#1)(2008-8#1)
seventy-two##5##1##(1996-8#1)(1997-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
sever##3##1##(2007-8#1)(2008-12#2)
several Brassica spp##2##3##(2008-10#2)
several DNA and RNA##2##4##(1994-11#1)(2011-3#1)
several DNA##3##2##(1994-11#1)(2011-3#2)
several DNA-binding##2##2##(1991-5#1)(1993-12#1)
several European##3##2##(1991-12#1)(1993-3#1)(1997-4#1)
several abnormalities##2##2##(2008-10#1)(2008-3#1)
several active##2##2##(2008-10#2)
several additional##6##2##(1993-8#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-3#1)
several advantages over conventional##6##4##(1994-9#1)(2008-1#1)(2008-10#3)(2011-2#1)
several advantages over the##2##4##(2008-10#2)
several advantages over##17##3##(1990-8#1)(1991-9#1)(1994-9#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-4#1)(2011-2#1)
several advantages##30##2##(1990-8#1)(1991-9#1)(1994-9#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
several agents##4##2##(1990-2#1)(1992-12#1)(2008-5#1)(2008-8#1)
several alternative##3##2##(2008-5#1)(2008-8#2)
several animal##3##2##(1994-5#1)(2008-10#1)(2008-3#1)
several anionic##2##2##(1994-9#1)(2008-5#1)
several apple varieties##2##3##(2008-10#2)
several applications of##3##3##(2008-10#3)
several applications such as##2##4##(2008-2#1)(2008-3#1)
several applications##9##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
several approaches for##2##3##(2008-7#1)(2008-9#1)
several approaches to##4##3##(1992-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
several approaches##9##2##(1992-12#1)(1994-12#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)
several areas of##5##3##(1992-1#1)(1994-11#1)(2008-10#1)(2008-6#1)(2011-3#1)
several areas##10##2##(1990-8#1)(1992-1#1)(1993-3#1)(1994-11#1)(2008-10#2)(2008-6#1)(2009-4#1)(2011-3#1)(2012-3#1)
several articles##2##2##(2009-5#1)(2012-3#1)
several aspects of the##4##4##(1996-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
several aspects of##10##3##(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)
several aspects##14##2##(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2012-5#1)(2013-1#1)
several assays##3##2##(1992-11#1)(1995-2#1)(2008-8#1)
several authors##6##2##(1993-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)
several bands##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
several barriers##3##2##(1994-1#2)(2011-2#1)
several basic##3##2##(2008-4#1)(2008-9#2)
several behavioral##2##2##(2008-11#1)(2008-9#1)
several benefits##4##2##(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
several binding##2##2##(1995-12#1)(2008-10#1)
several biochemical##2##2##(2007-8#1)(2008-11#1)
several biological##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)
several brain regions##3##3##(1994-2#1)(2008-7#1)(2012-3#1)
several cancer cell lines##2##4##(2008-11#1)(2013-1#1)
several cancer##4##2##(2008-11#2)(2009-12#1)(2013-1#1)
several cancers##5##2##(2008-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
several carbohydrates##3##2##(2008-10#3)
several carcinomas##3##2##(2008-12#1)(2009-4#1)(2012-2#1)
several case studies##2##3##(2008-7#1)(2013-1#1)
several case##4##2##(1997-5#1)(2008-3#1)(2008-7#1)(2013-1#1)
several cases of##3##3##(1996-3#1)(2007-11#1)(2011-2#1)
several cases##11##2##(1994-3#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)
several caspase-like activities##2##3##(2009-10#2)
several causes##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
several cell lines##2##3##(1992-6#1)(1994-12#1)
several cell types##5##3##(1992-11#1)(1992-12#1)(2008-4#2)(2008-6#1)
several cell##9##2##(1992-11#1)(1992-12#1)(1992-6#1)(1994-12#1)(2008-4#2)(2008-6#1)(2012-12#1)(2013-8#1)
several cellular##4##2##(1990-12#1)(1992-8#1)(1997-3#1)(2008-8#1)
several centimeters##2##2##(2008-3#2)
several certified reference materials##4##4##(2008-10#4)
several challenges##3##2##(2007-5#1)(2011-2#1)(2012-12#1)
several changes in the##2##4##(1992-2#1)(1997-4#1)
several changes in##3##3##(1992-2#1)(1997-4#1)(2008-10#1)
several characteristic##2##2##(1993-11#1)(2013-1#1)
several characteristics of##2##3##(1991-11#1)(1992-5#1)
several characteristics that##4##3##(1996-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
several characteristics##7##2##(1991-11#1)(1992-5#1)(1996-12#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-3#1)
several characters##2##2##(2008-1#1)(2013-7#1)
several chemical##2##2##(2008-10#2)
several chemotherapeutic##2##2##(2010-3#1)(2012-12#1)
several chronic##4##2##(2008-10#2)(2011-1#1)(2012-2#1)
several classes of##3##3##(2009-10#1)(2010-6#1)(2012-1#1)
several clinical##12##2##(1994-12#1)(1995-3#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
several closely related species##2##4##(2008-10#1)(2008-7#1)
several closely##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
several clusters of##3##3##(2008-10#2)(2008-11#1)
several commercial##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
several common##10##2##(1991-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2010-10#1)(2012-3#1)
several commonly used methods for##2##5##(2008-1#1)(2008-3#1)
several commonly used##4##3##(2008-1#1)(2008-3#1)(2008-6#2)
several complementary##2##2##(1997-8#1)(2008-10#1)
several complex##2##2##(2011-1#1)(2012-2#1)
several complexes##2##2##(1995-2#1)(2008-10#1)
several components of the##4##4##(1992-9#1)(1995-8#1)(2008-10#1)(2008-7#1)
several components of##8##3##(1992-9#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-3#1)
several components##15##2##(1992-9#1)(1995-8#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
several compounds##6##2##(1992-8#1)(1995-8#1)(2008-10#4)
several conditions##3##2##(1994-9#1)(2007-11#1)(2008-6#1)
several conserved##2##2##(1993-12#1)(2008-10#1)
several contiguous##2##2##(1997-3#1)(2008-3#1)
several copies##2##2##(1995-8#1)(2012-3#1)
several countries##8##2##(1990-6#1)(1993-2#1)(1993-3#1)(2008-5#1)(2011-2#3)(2013-1#1)
several criteria to##2##3##(1992-12#1)(1992-3#1)
several criteria##4##2##(1992-12#2)(1992-3#1)(2012-12#1)
several crucial##2##2##(2008-10#1)(2009-12#1)
several cultivars##2##2##(2008-10#2)
several cycles of##2##3##(1991-8#1)(1994-12#1)
several cytokines##2##2##(2008-8#1)(2011-2#1)
several days after inoculation##2##4##(2008-10#2)
several days after##5##3##(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
several days or##2##3##(1991-3#1)(2013-1#1)
several days##21##2##(1990-8#1)(1991-3#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
several decades and##2##3##(2008-10#1)(2010-5#1)
several decades have##2##3##(2011-2#1)(2012-2#1)
several decades##15##2##(1992-12#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)
several designs of##2##3##(2008-10#1)(2008-2#1)
several desirable properties##3##3##(1997-4#1)(2013-1#2)
several diagnostic##2##2##(2007-7#1)(2008-10#1)
several different indices##2##3##(1997-5#1)(2010-8#1)
several different locations##2##3##(2008-10#1)(2011-1#1)
several different species##2##3##(1991-6#1)(2008-4#1)
several different types of##4##4##(1990-5#1)(2008-10#2)(2008-2#1)
several different##64##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2007-12#1)(2008-1#3)(2008-10#11)(2008-11#5)(2008-2#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#5)
several dimensions##2##2##(2010-7#1)(2013-8#1)
several directions##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
several discrepancies##2##2##(2008-10#1)(2008-7#1)
several disease##2##2##(2012-3#1)(2013-8#1)
several diseases##7##2##(1995-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
several distinct##9##2##(1990-11#1)(1992-3#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
several distinctive##2##2##(2011-1#1)(2011-2#1)
several domains##2##2##(2008-4#1)(2012-3#1)
several drawbacks##2##2##(2008-5#1)(2012-3#1)
several ecological##3##2##(2008-6#1)(2008-9#1)(2013-7#1)
several economic##4##2##(1991-12#1)(2008-11#1)(2008-6#1)(2008-7#1)
several elements##4##2##(1992-1#1)(2008-10#3)
several environmental##5##2##(2008-10#3)(2008-2#1)(2012-12#1)
several enzymes active against##2##4##(2010-3#2)
several enzymes##6##2##(2008-10#1)(2008-7#2)(2010-3#2)(2012-12#1)
several epidemiological##3##2##(2008-3#1)(2008-7#2)
several error##2##2##(2008-11#1)(2008-2#1)
several examples of##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2010-6#1)
several examples where the##2##4##(2012-12#1)(2012-2#1)
several examples##10##2##(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
several experimental parameters##2##3##(2008-10#2)
several experimental##6##2##(1994-11#1)(2008-10#4)(2008-5#1)
several experiments##2##2##(1990-11#1)(2008-3#1)
several extraction##2##2##(2008-10#1)(2008-12#1)
several factors associated with##2##4##(2008-5#1)(2013-1#1)
several factors that##3##3##(2008-7#1)(2010-1#1)(2011-2#1)
several factors were##2##3##(2008-3#1)(2011-2#1)
several factors##24##2##(1990-8#1)(1991-1#1)(1992-3#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-1#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#2)
several features of##4##3##(1994-5#1)(2008-3#1)(2008-8#1)(2013-8#1)
several features##6##2##(1994-5#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-10#1)(2013-8#1)
several fish species##3##3##(2008-10#1)(2010-8#2)
several folds##2##2##(1992-9#1)(2008-10#1)
several forms of##6##3##(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)
several forms##8##2##(1991-3#1)(1995-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)
several fragments##2##2##(2007-12#1)(2008-10#1)
several functional##3##2##(1995-8#1)(2008-10#1)(2009-5#1)
several functions of##3##3##(1992-3#1)(2008-9#1)(2011-1#1)
several functions##5##2##(1992-3#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-3#1)
several fungi##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
several gene##2##2##(1992-9#1)(2010-5#1)
several generations##6##2##(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
several genes that##3##3##(1993-3#1)(1997-7#1)(2010-4#1)
several genes##14##2##(1991-5#1)(1993-3#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#1)
several genetic##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
several groups of##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
several groups##11##2##(1992-6#1)(1993-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#1)(2011-7#1)(2013-1#1)
several growth##3##2##(1992-12#1)(2007-11#1)(2008-10#1)
several highly##2##2##(1991-6#1)(1997-8#1)
several host species##3##3##(2008-8#2)(2008-9#1)
several hosts##5##2##(2008-10#5)
several hours after##2##3##(2008-10#1)(2008-7#1)
several hours and##2##3##(1995-2#1)(1997-4#1)
several hours of##2##3##(1992-8#1)(2008-3#1)
several hours to##2##3##(2008-10#1)(2008-2#1)
several hours##16##2##(1992-8#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
several human cancer cell lines##3##5##(2010-6#1)(2011-2#1)(2011-3#1)
several human diseases##2##3##(1997-3#1)(2012-12#1)
several human##16##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-3#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)
several hundred genes##2##3##(2008-7#1)(2013-8#1)
several hundred hertz##2##3##(2008-3#2)
several hundred years##3##3##(2013-1#2)(2013-8#1)
several hundred##27##2##(1991-9#1)(1993-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-7#1)(2013-1#3)(2013-8#2)
several hundreds of##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
several hypotheses about##2##3##(2008-9#1)(2013-8#1)
several hypotheses##5##2##(1993-1#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-8#1)
several immune##2##2##(2008-10#1)(2008-5#1)
several important issues##2##3##(1997-3#1)(2010-12#1)
several important##21##2##(1993-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)
several improvements##2##2##(1997-1#1)(2008-4#1)
several in vitro##5##3##(1992-2#1)(2008-10#1)(2008-4#2)(2012-2#1)
several in##6##2##(1992-2#1)(2008-10#1)(2008-4#2)(2012-2#1)(2012-3#1)
several incidents##2##2##(2008-10#1)(2010-5#1)
several inconsistencies##2##2##(1993-8#1)(1995-3#1)
several independent##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
several indicators of##2##3##(2009-8#1)(2013-1#1)
several indicators##3##2##(2008-11#1)(2009-8#1)(2013-1#1)
several inflammatory##2##2##(2010-12#1)(2013-1#1)
several inherited##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
several innovations##2##2##(2008-3#1)(2009-5#1)
several instances##3##2##(2008-10#2)(2012-12#1)
several institutions##2##2##(1994-1#1)(2012-12#1)
several instrumental##2##2##(2008-10#2)
several intensities##2##2##(2008-10#1)(2008-2#1)
several interesting##2##2##(2008-10#1)(2008-2#1)
several interfering ions##2##3##(2008-10#2)
several interfering##3##2##(2008-10#3)
several international##2##2##(1996-7#1)(2010-5#1)
several investigations##2##2##(2008-5#1)(2009-2#1)
several ions##3##2##(1993-12#1)(2008-10#2)
several isolates of##2##3##(2008-10#2)
several issues including##2##3##(2008-5#1)(2010-5#1)
several issues##4##2##(1997-2#1)(2008-5#1)(2010-5#1)(2010-7#1)
several items##2##2##(1993-12#1)(2012-3#1)
several key enzymes##2##3##(2008-5#2)
several key##9##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-5#2)(2008-9#1)(2009-4#1)(2012-2#1)
several kilometers##3##2##(2007-12#1)(2008-3#2)
several kinases##2##2##(1994-8#1)(1996-2#1)
several kinds of##7##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2013-8#1)
several laboratories##7##2##(1992-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-4#1)(2011-2#1)
several large##2##2##(2007-8#1)(2010-5#1)
several layers##5##2##(1995-5#1)(2008-2#2)(2008-5#1)(2011-2#1)
several leading##2##2##(1993-3#1)(2011-2#1)
several levels##8##2##(1991-6#1)(1992-2#1)(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#1)(2012-3#1)
several limitations##5##2##(2006-10#1)(2007-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
several lines of evidence indicate that##2##6##(2008-7#2)
several lines of evidence##4##4##(1991-9#1)(2008-7#2)(2012-3#1)
several lines of##6##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
several locations##4##2##(2008-10#2)(2008-2#1)(2009-10#1)
several major##5##2##(1995-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-5#1)
several males##3##2##(2008-8#3)
several mammalian cell lines##2##4##(2008-11#1)(2008-9#1)
several mammalian##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
several management##2##2##(2008-10#1)(2012-2#1)
several means of##2##3##(2008-10#1)(2012-2#1)
several measurements##2##2##(1994-2#1)(2008-3#1)
several measures##3##2##(1990-3#1)(1997-7#1)(2008-2#1)
several mechanisms of action##2##4##(2008-1#1)(2008-6#1)
several mechanisms of##3##3##(2008-1#1)(2008-10#1)(2008-6#1)
several mechanisms that##2##3##(2008-7#1)(2011-2#1)
several mechanisms##13##2##(1990-11#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
several medical conditions##2##3##(1993-12#1)(2009-1#1)
several medical##4##2##(1993-12#1)(1994-12#1)(2009-1#1)(2013-8#1)
several members of the same family##2##6##(1997-4#1)(2010-3#1)
several members of the##5##4##(1992-3#1)(1994-8#1)(1997-4#1)(2008-11#1)(2010-3#1)
several members of##7##3##(1992-3#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-3#1)
several members##9##2##(1992-3#1)(1994-8#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2010-3#1)
several metabolic##3##2##(2008-7#1)(2012-1#1)(2013-8#1)
several metal ions##2##3##(2008-10#1)(2008-8#1)
several meters##3##2##(2008-3#3)
several methods for##5##3##(1995-9#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
several methods of##3##3##(2008-12#1)(2008-7#2)
several methods to##2##3##(2008-7#1)(2011-2#1)
several methods##16##2##(1995-9#1)(1997-4#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
several micrometers##4##2##(2008-2#2)(2008-3#2)
several millimeters##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
several minor##2##2##(1990-2#1)(2008-10#1)
several minutes##9##2##(1990-2#1)(1992-8#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-8#1)(2010-7#1)(2013-8#1)
several mixtures of##2##3##(2008-10#2)
several mixtures##4##2##(2008-10#4)
several modalities##2##2##(2008-3#1)(2012-2#1)
several model##2##2##(2008-10#2)
several models of##3##3##(1995-12#1)(2006-10#1)(2008-7#1)
several models##5##2##(1995-12#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-7#1)
several modifications##2##2##(2007-8#1)(2010-8#1)
several molecular##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
several months after removal of##2##5##(2007-11#1)(2008-1#1)
several months after##5##3##(1992-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-9#1)
several months of##3##3##(1995-2#1)(2007-7#1)(2009-12#1)
several months##25##2##(1990-6#1)(1991-8#1)(1992-2#1)(1995-2#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#3)(2010-6#1)(2012-2#2)(2013-7#1)
several more##2##2##(1990-2#1)(1990-5#1)
several mutants##2##2##(1993-8#1)(2008-10#1)
several mutations##2##2##(1997-3#1)(2011-2#1)
several nanoseconds##2##2##(2008-3#2)
several neuropsychiatric disorders##3##3##(1997-5#1)(2012-12#1)(2013-8#1)
several neurotransmitters##2##2##(2008-11#1)(2008-7#1)
several new and##2##3##(2008-12#1)(2008-3#1)
several new antifungal agents##2##4##(2008-7#2)
several new##18##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
several novel##5##2##(1996-10#1)(1997-4#1)(2008-8#1)(2009-12#1)(2013-1#1)
several nutrients##2##2##(1992-8#2)
several of its##2##3##(2011-2#1)(2012-12#1)
several of the##22##3##(1990-11#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-5#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)
several of them##5##3##(1991-9#1)(1992-3#1)(1996-12#1)(2008-12#1)(2008-2#1)
several of these mines##2##4##(2008-10#2)
several of these proteins##2##4##(1994-8#1)(1994-9#1)
several of these##12##3##(1994-8#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-3#1)
several of which##2##3##(1996-5#1)(2010-5#1)
several of##44##2##(1990-11#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#1)
several operational parameters##2##3##(2008-10#2)
several operational##3##2##(2008-10#2)(2008-11#1)
several opportunities##2##2##(1992-2#1)(2008-11#1)
several optical##3##2##(2008-2#2)(2008-3#1)
several orders of magnitude higher than##2##6##(2008-10#2)
several orders of magnitude larger than##2##6##(2008-10#1)(2008-3#1)
several orders of magnitude##15##4##(1994-5#2)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#4)(2010-8#1)(2012-2#1)
several orders of##16##3##(1994-5#2)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#5)(2010-8#1)(2012-2#1)
several organic##5##2##(1997-4#1)(2008-10#2)(2008-3#1)(2010-4#1)
several organisms##2##2##(2008-4#1)(2008-7#1)
several organs##4##2##(2008-10#2)(2010-10#1)(2010-11#1)
several other cell##2##3##(1997-6#1)(2008-11#1)
several other diseases##2##3##(2008-10#1)(2012-2#1)
several other groups##2##3##(1993-11#1)(2008-11#1)
several other recently##2##3##(1995-6#1)(2008-2#1)
several other##56##2##(1990-2#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1994-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#2)
several pH##2##2##(2008-10#2)
several papers##3##2##(2012-3#1)(2013-1#2)
several parameters of##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
several parameters such as macroscopic##2##5##(2008-5#2)
several parameters such as##3##4##(2008-10#1)(2008-5#2)
several parameters##11##2##(1997-2#1)(2008-10#3)(2008-5#3)(2008-7#3)(2013-1#1)
several parts of##2##3##(2008-7#1)(2008-9#1)
several parts##3##2##(2008-7#1)(2008-9#1)(2012-3#1)
several passages##2##2##(1990-5#1)(2008-10#1)
several pathogens##2##2##(2008-10#1)(2013-1#1)
several pathologic##2##2##(1991-9#1)(2011-2#1)
several pathological pathways##2##3##(2010-10#1)(2012-3#1)
several pathological##3##2##(2010-10#1)(2010-12#1)(2012-3#1)
several patients##2##2##(1996-6#1)(2013-8#1)
several percent##3##2##(2008-10#2)(2008-3#1)
several physiological processes##2##3##(1995-2#1)(2009-12#1)
several physiological##5##2##(1995-2#1)(2006-10#1)(2008-12#1)(2009-12#1)(2013-1#1)
several plant##6##2##(1994-6#1)(2008-10#3)(2008-5#1)(2008-7#1)
several points##3##2##(1992-6#1)(2008-3#1)(2010-6#1)
several population##2##2##(2008-4#1)(2009-5#1)
several populations##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
several positive##2##2##(1993-6#1)(2008-8#1)
several possible##6##2##(1990-11#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-8#1)
several post##2##2##(1990-11#1)(2008-8#1)
several potential advantages##2##3##(2008-2#1)(2011-7#1)
several potential##12##2##(1993-12#1)(1993-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-6#1)(2011-7#1)
several practical##2##2##(1997-2#1)(2013-1#1)
several previously##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
several principles##2##2##(1995-2#1)(2007-5#1)
several proapoptotic##2##2##(2013-1#1)(2013-7#1)
several problems##5##2##(1994-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
several procedures##2##2##(2008-10#1)(2008-3#1)
several prognostic##2##2##(1991-4#1)(2008-9#1)
several projections##2##2##(2008-3#1)(2009-5#1)
several prokaryotic and eukaryotic##2##4##(1997-4#1)(1997-7#1)
several protein bands##2##3##(2008-11#2)
several protein##6##2##(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#2)
several proteins##4##2##(1991-5#1)(1993-11#1)(1994-9#1)(2008-10#1)
several putative##4##2##(1993-2#1)(1997-8#1)(2008-10#2)
several questions##3##2##(1996-11#1)(2007-12#1)(2008-7#1)
several reactions##2##2##(1990-12#1)(2008-10#1)
several reasons##11##2##(1991-8#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-2#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
several recent studies have##3##4##(1997-7#1)(2008-7#1)(2009-10#1)
several recent studies##8##3##(1997-7#1)(2008-1#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)
several recent##10##2##(1997-7#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)
several recently##2##2##(1996-3#1)(2008-7#1)
several recombinant##5##2##(1993-6#1)(1994-12#1)(1997-4#1)(2007-2#1)(2008-10#1)
several reference##4##2##(1994-3#1)(2008-10#2)(2011-2#1)
several regions of the##4##4##(1992-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
several regions of##7##3##(1992-9#1)(1993-11#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-4#1)
several regions##12##2##(1992-11#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)
several regulatory##4##2##(1996-12#1)(1997-7#1)(2011-2#1)(2012-1#1)
several related##2##2##(2008-4#1)(2008-7#1)
several reports have##2##3##(1994-8#1)(2008-7#1)
several reports##9##2##(1994-8#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
several research groups##3##3##(1991-6#1)(2008-7#1)(2010-10#1)
several research##5##2##(1991-6#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
several residues##2##2##(1995-2#1)(1997-9#1)
several resistance##2##2##(2008-10#1)(2008-11#1)
several restriction##2##2##(1997-4#1)(2008-8#1)
several risk##2##2##(2008-3#1)(2008-5#1)
several risks##2##2##(2012-3#1)(2013-1#1)
several river##2##2##(2008-10#2)
several routes##2##2##(1992-11#1)(2008-11#1)
several samples##6##2##(1992-5#1)(2008-10#4)(2008-7#1)
several scales##2##2##(1990-5#1)(2008-10#1)
several seconds##4##2##(2007-11#1)(2008-10#1)(2009-5#1)(2012-2#1)
several sequences of##2##3##(1990-5#1)(2008-8#1)
several sequences##3##2##(1990-5#1)(2008-8#1)(2012-3#1)
several short##2##2##(1993-3#1)(2008-8#1)
several similar##2##2##(1992-6#1)(2008-10#1)
several similarities##2##2##(1997-8#1)(2011-2#1)
several simple##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
several sites##2##2##(2008-8#1)(2008-9#1)
several skin##4##2##(2008-10#1)(2008-4#1)(2008-5#2)
several small##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
several soil##3##2##(2008-10#3)
several solid##2##2##(2008-10#2)
several sources of##3##3##(1990-2#1)(2008-8#1)(2012-1#1)
several sources##4##2##(1990-2#1)(2008-10#1)(2008-8#1)(2012-1#1)
several spatial##2##2##(2007-5#1)(2008-9#1)
several species of##11##3##(1990-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-3#1)
several species##21##2##(1990-2#1)(1990-3#1)(1992-10#1)(1992-6#1)(1996-9#1)(2008-10#8)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
several specific##2##2##(1996-3#1)(2008-5#1)
several stages##6##2##(1992-12#1)(1995-6#1)(1996-2#1)(2010-8#1)(2010-9#1)(2013-1#1)
several states##2##2##(2008-10#1)(2008-11#1)
several statistical##4##2##(1995-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
several steps in the##2##4##(1995-2#1)(2008-5#1)
several steps of##3##3##(1994-8#1)(2008-3#1)(2008-8#1)
several steps##9##2##(1990-8#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
several strains of mice##2##4##(2008-12#1)(2008-4#1)
several strains of##10##3##(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#2)
several strains##11##2##(2008-10#6)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)
several strategies for##2##3##(2008-7#1)(2012-3#1)
several strategies##4##2##(2008-10#1)(2008-7#1)(2009-3#1)(2012-3#1)
several structural##2##2##(1993-1#1)(2008-10#1)
several studies have demonstrated##2##4##(2008-3#1)(2010-12#1)
several studies have reported##4##4##(1996-7#1)(2008-1#1)(2011-2#1)(2013-1#1)
several studies have shown that##2##5##(1995-4#1)(2008-12#1)
several studies have shown##3##4##(1995-4#1)(2008-12#1)(2008-3#1)
several studies have##12##3##(1994-6#1)(1995-4#1)(1996-7#1)(2008-1#1)(2008-12#1)(2008-3#3)(2010-12#1)(2011-2#1)(2013-1#2)
several studies in##2##3##(1990-5#1)(2009-5#1)
several studies suggest##2##3##(2008-3#1)(2011-2#1)
several studies that##3##3##(2007-10#2)(2012-12#1)
several studies##34##2##(1990-5#1)(1990-6#1)(1992-10#1)(1993-12#1)(1994-6#1)(1995-4#1)(1996-7#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-4#1)(2013-1#3)
several substances##4##2##(2008-10#2)(2010-5#1)(2013-1#1)
several subtypes##3##2##(2008-5#2)(2010-6#1)
several successful##3##2##(2008-10#2)(2011-1#1)
several synthetic##9##2##(2008-10#8)(2008-3#1)
several systems##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
several taxa##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
several techniques##9##2##(1992-12#1)(1992-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-8#1)
several tens of##5##3##(2007-11#2)(2008-3#2)(2008-7#1)
several tens##6##2##(2007-11#2)(2008-10#1)(2008-3#2)(2008-7#1)
several test##2##2##(2008-10#1)(2009-10#1)
several theories##2##2##(2010-6#1)(2013-1#1)
several therapeutic##3##2##(2008-1#1)(2010-5#1)(2013-1#1)
several therapies##2##2##(1993-2#1)(2009-7#1)
several thousand cells##2##3##(2008-9#1)(2011-1#1)
several thousand##9##2##(1995-6#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-9#1)(2011-1#1)
several thousands of##3##3##(2008-10#1)(2008-3#2)
several time##5##2##(1995-12#1)(2008-10#2)(2008-7#1)(2011-1#1)
several times during##2##3##(1991-5#1)(1993-9#1)
several times in##2##3##(1992-12#1)(1996-5#1)
several times##20##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
several tissues and##2##3##(2008-12#1)(2013-8#1)
several tissues##6##2##(1994-12#1)(2008-12#1)(2008-5#1)(2008-7#2)(2013-8#1)
several trace##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
several transcription factors##2##3##(2008-7#1)(2011-1#1)
several transcription##3##2##(1996-5#1)(2008-7#1)(2011-1#1)
several treatment options##2##3##(2011-1#1)(2013-1#1)
several tree species##2##3##(2008-3#1)(2008-5#1)
several trends##2##2##(1994-5#1)(1997-3#1)
several trials##2##2##(2008-11#1)(2008-7#1)
several tumor##4##2##(1990-11#1)(2009-3#1)(2011-1#1)(2013-1#1)
several tumour##3##2##(2008-7#2)(2013-1#1)
several types of cancer##2##4##(2008-9#1)(2010-1#1)
several types of##36##3##(1990-6#1)(1991-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-7#1)(2013-1#1)(2013-8#1)
several typical##2##2##(1993-2#1)(2012-3#1)
several unknown##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
several urine##2##2##(2008-10#2)
several variables##14##2##(1991-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2008-10#8)(2008-8#1)(2009-8#1)
several varieties of##4##3##(1993-2#1)(2008-10#2)(2011-2#1)
several versions of##2##3##(2008-3#1)(2008-9#1)
several versions##3##2##(2008-3#2)(2008-9#1)
several viral##2##2##(1995-2#1)(2011-2#1)
several ways##9##2##(1991-3#2)(1996-3#1)(1996-6#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)
several weeks and##2##3##(2008-10#1)(2010-12#1)
several weeks##17##2##(1993-3#1)(1994-3#1)(1996-11#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
several wild##2##2##(1990-5#1)(2008-10#1)
several years later##2##3##(2008-4#1)(2013-1#1)
several years of##6##3##(1995-11#1)(1995-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-3#1)
several years the##3##3##(2008-1#1)(2008-12#1)(2010-3#1)
several years to##2##3##(1997-3#1)(2013-1#1)
several years##63##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#3)
several##2669##1##(1990-11#8)(1990-12#3)(1990-2#8)(1990-3#2)(1990-5#15)(1990-6#6)(1990-8#7)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#11)(1991-6#9)(1991-8#8)(1991-9#14)(1992-1#3)(1992-10#2)(1992-11#9)(1992-12#13)(1992-2#7)(1992-3#19)(1992-5#4)(1992-6#10)(1992-8#9)(1992-9#13)(1993-1#8)(1993-11#11)(1993-12#15)(1993-2#13)(1993-3#13)(1993-6#7)(1993-8#7)(1993-9#3)(1994-1#6)(1994-10#3)(1994-11#8)(1994-12#17)(1994-2#8)(1994-3#12)(1994-5#10)(1994-6#8)(1994-7#1)(1994-8#7)(1994-9#9)(1995-1#6)(1995-11#4)(1995-12#11)(1995-2#22)(1995-3#14)(1995-4#1)(1995-5#8)(1995-6#16)(1995-8#9)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#13)(1996-3#13)(1996-4#2)(1996-5#17)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#11)(1997-3#23)(1997-4#15)(1997-5#9)(1997-6#8)(1997-7#12)(1997-8#12)(1997-9#1)(2006-10#7)(2006-12#1)(2007-10#7)(2007-11#25)(2007-12#46)(2007-2#4)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#11)(2007-9#2)(2008-1#31)(2008-10#574)(2008-11#83)(2008-12#29)(2008-2#64)(2008-3#136)(2008-4#74)(2008-5#71)(2008-6#21)(2008-7#108)(2008-8#73)(2008-9#53)(2009-1#2)(2009-10#13)(2009-11#7)(2009-12#18)(2009-2#2)(2009-3#11)(2009-4#6)(2009-5#19)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#7)(2010-1#4)(2010-10#9)(2010-11#5)(2010-12#11)(2010-2#7)(2010-3#10)(2010-4#8)(2010-5#15)(2010-6#17)(2010-7#11)(2010-8#17)(2010-9#4)(2011-1#22)(2011-10#1)(2011-2#93)(2011-3#9)(2011-7#2)(2012-1#6)(2012-12#27)(2012-2#55)(2012-3#52)(2012-4#1)(2012-5#3)(2012-8#2)(2013-1#74)(2013-7#10)(2013-8#23)
several-fold higher##2##2##(1991-6#1)(2008-7#1)
several-fold##4##1##(1991-6#1)(1997-4#1)(2008-7#2)
severalfold##4##1##(1992-5#1)(1995-2#1)(2008-11#1)(2008-7#1)
severe (grade 3)##2##3##(2008-10#1)(2008-6#1)
severe (grade##3##2##(2008-10#2)(2008-6#1)
severe AD##3##2##(2012-1#1)(2012-2#2)
severe abnormality##2##2##(2010-8#1)(2012-12#1)
severe acute asthma##3##3##(1992-3#1)(1997-1#1)(2008-8#1)
severe acute pancreatitis##6##3##(2009-8#2)(2013-1#3)(2013-8#1)
severe acute respiratory syndrome (SARS)##2##5##(2008-10#1)(2010-2#1)
severe acute respiratory syndrome##3##4##(2008-10#1)(2009-5#1)(2010-2#1)
severe acute##18##2##(1990-12#1)(1992-3#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
severe adverse effects##5##3##(2008-7#2)(2008-9#1)(2012-2#2)
severe adverse##10##2##(1996-11#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
severe allergic##2##2##(2010-1#1)(2010-6#1)
severe alopecia##2##2##(2007-7#2)
severe among isolates grouped by markers with the##2##8##(2008-10#2)
severe and life-threatening##2##3##(1995-3#1)(2010-1#1)
severe and persistent mental##2##4##(2008-11#1)(2008-6#1)
severe and persistent##3##3##(1991-8#1)(2008-11#1)(2008-6#1)
severe and sometimes##2##3##(1996-11#1)(2008-11#1)
severe and##28##2##(1990-6#1)(1991-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-11#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
severe anemia and##2##3##(2008-7#1)(2012-1#1)
severe anemia##9##2##(1992-3#1)(2007-12#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
severe aortic regurgitation##7##3##(1997-5#1)(1997-8#4)(2007-8#1)(2008-11#1)
severe aortic##9##2##(1997-5#1)(1997-8#4)(2007-8#2)(2008-11#1)(2011-2#1)
severe aplastic anemia##2##3##(2012-3#2)
severe aplastic##3##2##(2009-2#1)(2012-3#2)
severe arch atheroma##3##3##(2008-8#3)
severe asthma##11##2##(2007-8#4)(2008-11#3)(2008-3#2)(2010-5#1)(2013-8#1)
severe atopic dermatitis##2##3##(2007-7#1)(2012-3#1)
severe auto-inflammatory disease##2##3##(2012-2#2)
severe back pain##5##3##(1993-9#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#1)
severe bacterial##2##2##(2007-5#1)(2013-1#1)
severe black##2##2##(2008-10#2)
severe bleeding##2##2##(1995-11#1)(2008-11#1)
severe bone##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
severe burns##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
severe carotid##2##2##(2008-7#1)(2008-8#1)
severe cases of##2##3##(2007-12#1)(2011-2#1)
severe cases##18##2##(1994-2#1)(1994-9#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#3)
severe challenge##2##2##(1996-12#1)(1997-6#1)
severe changes in the##2##4##(2008-8#1)(2008-9#1)
severe changes##3##2##(1990-9#1)(2008-8#1)(2008-9#1)
severe chest pain##2##3##(2013-1#1)(2013-7#1)
severe childhood##2##2##(2008-11#1)(2009-11#1)
severe cholera##3##2##(2007-2#3)
severe chronic obstructive pulmonary disease##2##5##(1996-1#1)(2011-2#1)
severe chronic##9##2##(1991-3#1)(1992-5#1)(1994-6#1)(1996-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)
severe clinical##4##2##(1991-3#1)(1992-5#1)(2008-2#1)(2012-2#1)
severe cognitive##3##2##(2008-2#1)(2008-7#1)(2010-2#1)
severe colitis##2##2##(1992-9#1)(2009-5#1)
severe combined##2##2##(2008-11#1)(2012-12#1)
severe complications##7##2##(1992-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#2)(2011-3#1)
severe condition##3##2##(1993-3#1)(2008-10#1)(2011-1#1)
severe congenital neutropenia##3##3##(2008-7#3)
severe consequences##2##2##(1996-11#1)(2010-11#1)
severe coronary artery disease##4##4##(2008-8#1)(2011-2#3)
severe coronary artery##5##3##(2008-8#1)(2011-2#3)(2013-1#1)
severe coronary##6##2##(2008-12#1)(2008-8#1)(2011-2#3)(2013-1#1)
severe curly top virus##2##4##(2008-10#2)
severe damage##4##2##(1996-5#1)(2008-10#2)(2008-7#1)
severe dementia##2##2##(1991-11#1)(2008-6#1)
severe depression##8##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-8#2)
severe depressive##2##2##(1995-5#1)(2012-3#1)
severe diarrhea##3##2##(1993-2#1)(2008-4#1)(2011-2#1)
severe disease and##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
severe disease in##2##3##(2008-10#1)(2011-2#1)
severe disease on##2##3##(2008-10#2)
severe disease##22##2##(2006-6#1)(2008-10#7)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#6)(2012-2#1)(2013-1#3)(2013-8#1)
severe distortion of##2##3##(2008-3#1)(2008-6#1)
severe distortion##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
severe drought##2##2##(2012-2#1)(2012-8#1)
severe early##2##2##(2006-8#1)(2011-2#1)
severe effects on##2##3##(2008-12#1)(2008-9#1)
severe enough to##2##3##(2008-1#1)(2008-7#1)
severe environmental##2##2##(2008-10#1)(2008-12#1)
severe epidemics in##2##3##(2008-10#2)
severe epidemics##9##2##(2008-10#9)
severe events##2##2##(1997-3#1)(2008-2#1)
severe exercise##2##2##(2008-1#1)(2008-5#1)
severe facial##2##2##(2008-9#1)(2012-12#1)
severe fibrosis (T4-T5)##2##3##(2013-8#2)
severe fibrosis##6##2##(2013-1#2)(2013-8#4)
severe form of##8##3##(1997-3#1)(2008-7#2)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
severe form##12##2##(1995-9#1)(1997-3#1)(2008-1#1)(2008-7#2)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
severe forms of##3##3##(2008-5#1)(2009-5#1)(2013-1#1)
severe forms##4##2##(2008-5#1)(2009-5#1)(2010-12#1)(2013-1#1)
severe functional##2##2##(1991-6#1)(1995-2#1)
severe grades##4##2##(2011-2#2)(2012-2#2)
severe growth##2##2##(1995-2#1)(2008-3#1)
severe head injury (GCS##2##4##(2008-7#2)
severe head injury##6##3##(2008-7#4)(2013-8#2)
severe headache and##2##3##(1992-2#1)(2012-12#1)
severe headache##4##2##(1992-2#1)(1997-6#1)(2008-7#1)(2012-12#1)
severe heart failure##7##3##(1992-6#2)(2007-8#2)(2008-4#1)(2010-5#1)(2011-2#1)
severe hemorrhage##2##2##(1994-2#1)(2012-3#1)
severe homocyst(e)inemia##2##2##(1995-2#2)
severe human##3##2##(2008-4#1)(2008-8#1)(2013-8#1)
severe hydrocephalus##2##2##(2008-12#1)(2011-2#1)
severe hydronephrosis##3##2##(2007-10#1)(2008-4#2)
severe hyperlipidemia##2##2##(2008-4#1)(2009-12#1)
severe hypertension group (group##2##4##(2008-1#2)
severe hypertension##11##2##(1990-12#1)(1991-6#1)(1993-8#1)(1995-11#1)(2008-1#2)(2009-5#1)(2011-2#3)(2013-8#1)
severe hypospadias##2##2##(2008-1#1)(2009-5#1)
severe hypotension##7##2##(1990-12#1)(1990-8#2)(2008-4#1)(2013-1#3)
severe hypothermia##5##2##(1993-3#1)(2011-2#4)
severe hypothyroidism##4##2##(2011-1#4)
severe illness##3##2##(1990-6#1)(2007-12#1)(2011-2#1)
severe impairment of##3##3##(1990-9#1)(1996-1#1)(1997-7#1)
severe impairments in##2##3##(1993-9#1)(1997-2#1)
severe impairments##3##2##(1993-3#1)(1993-9#1)(1997-2#1)
severe in the##7##3##(1990-7#1)(1996-5#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
severe in##18##2##(1990-2#1)(1990-7#1)(1994-5#1)(1996-5#2)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
severe infection##2##2##(1997-6#1)(2008-5#1)
severe infections##5##2##(1994-5#1)(2008-5#1)(2009-4#1)(2012-3#1)(2013-8#1)
severe infectious##2##2##(2011-2#2)
severe injury##4##2##(1990-6#1)(2009-3#1)(2009-6#1)(2010-8#1)
severe interference##2##2##(2008-10#2)
severe interferences##2##2##(2008-10#2)
severe ischemia##2##2##(1996-12#2)
severe left ventricular##2##3##(1997-3#1)(2013-1#1)
severe left##3##2##(1996-5#1)(1997-3#1)(2013-1#1)
severe levels of##2##3##(1991-1#1)(2008-10#1)
severe levels##3##2##(1991-1#1)(1994-9#1)(2008-10#1)
severe liver cirrhosis##2##3##(2013-8#2)
severe liver##3##2##(2008-12#1)(2013-8#2)
severe local##2##2##(2008-10#1)(2008-6#1)
severe loss of##5##3##(1995-12#1)(2008-1#2)(2010-12#1)(2011-1#1)
severe lupus nephritis##2##3##(2007-7#2)
severe malaria##4##2##(1996-8#1)(2007-2#1)(2012-12#2)
severe malnutrition##2##2##(2013-1#1)(2013-8#1)
severe medical and##2##3##(2008-1#1)(2009-7#1)
severe mental##8##2##(1991-3#1)(1993-1#1)(1993-3#1)(1995-8#1)(2008-6#1)(2010-1#1)(2011-1#2)
severe middle##2##2##(2006-7#1)(2012-2#1)
severe mitral##3##2##(2009-5#1)(2010-5#1)(2012-2#1)
severe morbidity##2##2##(2007-2#1)(2007-8#1)
severe neurologic##4##2##(2007-10#2)(2009-3#1)(2012-12#1)
severe neurological##6##2##(1992-5#1)(1996-11#1)(2007-10#1)(2007-2#1)(2008-7#1)(2012-12#1)
severe neutropenia and##2##3##(2008-10#1)(2008-5#1)
severe neutropenia##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
severe obesity##5##2##(2006-8#4)(2008-12#1)
severe obstructive##3##2##(1990-3#1)(1996-5#1)(1997-3#1)
severe or##3##2##(2007-8#1)(2010-2#1)(2011-1#1)
severe pain and##3##3##(2008-12#1)(2010-11#1)(2010-12#1)
severe pain but##2##3##(2008-7#1)(2013-1#1)
severe pain in##3##3##(2008-7#1)(2009-3#1)(2012-1#1)
severe pain on the left##2##5##(2007-8#1)(2012-3#1)
severe pain##17##2##(2007-11#1)(2007-8#2)(2008-12#1)(2008-7#3)(2009-3#2)(2010-11#1)(2010-12#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
severe pancreatitis##2##2##(2007-8#1)(2008-7#1)
severe pancytopenia##2##2##(2010-11#1)(2012-3#1)
severe pelvic endometriosis##3##3##(1991-3#3)
severe pelvic##5##2##(1991-2#1)(1991-3#3)(2011-1#1)
severe periodontitis##5##2##(2008-10#5)
severe persistent asthma##2##3##(1996-7#1)(2010-5#1)
severe persistent##3##2##(1996-7#1)(2006-10#1)(2010-5#1)
severe physical##2##2##(1997-1#1)(2007-11#1)
severe plucking##2##2##(1990-9#2)
severe pre-capillary##2##2##(2010-10#2)
severe preeclampsia##5##2##(2007-10#3)(2008-11#1)(2009-1#1)
severe primary##3##2##(1992-11#1)(2009-5#1)(2011-3#1)
severe problems##2##2##(2008-10#1)(2009-11#1)
severe pruritus##2##2##(1993-3#1)(2010-6#1)
severe psychiatric##2##2##(2008-9#1)(2011-3#1)
severe pulmonary hypertension##3##3##(2008-10#1)(2010-10#1)(2010-6#1)
severe pulmonary##6##2##(1991-9#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-6#1)
severe reduction of##2##3##(2007-8#1)(2008-10#1)
severe refractory##3##2##(2010-5#1)(2012-1#1)(2012-12#1)
severe renal insufficiency##2##3##(2008-4#1)(2013-1#1)
severe renal##5##2##(2008-1#2)(2008-4#1)(2012-12#1)(2013-1#1)
severe respiratory distress##6##3##(1992-2#1)(1994-6#1)(1996-6#1)(2007-12#1)(2013-1#2)
severe respiratory illness##2##3##(2008-8#1)(2012-12#1)
severe respiratory##11##2##(1992-2#1)(1994-6#3)(1996-6#1)(2007-12#1)(2008-8#1)(2012-12#1)(2013-1#3)
severe rigidity and altered sensorium##2##5##(2009-11#2)
severe safety##2##2##(2008-10#1)(2010-12#1)
severe sepsis (p##2##3##(2009-6#2)
severe sepsis and septic shock##4##5##(2011-2#4)
severe sepsis and##5##3##(2007-12#1)(2011-2#4)
severe sepsis in##2##3##(2009-6#1)(2012-2#1)
severe sepsis##25##2##(2007-12#6)(2008-5#1)(2009-5#2)(2009-6#7)(2009-9#1)(2011-2#7)(2012-2#1)
severe septic shock##2##3##(1996-3#1)(2013-1#1)
severe signs##2##2##(1997-3#1)(2008-10#1)
severe strain of##2##3##(2008-10#2)
severe strain##4##2##(2008-10#4)
severe stroke##2##2##(2007-10#1)(2010-7#1)
severe stunting##2##2##(1990-12#1)(2008-10#1)
severe surgical##2##2##(1991-6#1)(2011-2#1)
severe symptomatic##3##2##(2012-12#2)(2013-7#1)
severe symptoms in##3##3##(2008-10#3)
severe symptoms on##3##3##(2008-10#3)
severe symptoms##14##2##(2007-8#1)(2008-10#8)(2012-2#1)(2013-1#2)(2013-8#2)
severe systemic diseases##2##3##(1993-2#2)
severe systemic##4##2##(1993-2#2)(1996-11#1)(2011-1#1)
severe than##6##2##(1992-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
severe thrombocytopenia##3##2##(1990-10#1)(1993-6#1)(2012-12#1)
severe tibial fractures##2##3##(2007-8#2)
severe to profound##2##3##(2008-9#2)
severe to##3##2##(2008-9#2)(2010-4#1)
severe toxicity##5##2##(1990-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-8#1)
severe trauma##2##2##(2007-11#1)(2009-3#1)
severe traumatic brain injury##3##4##(2008-9#1)(2012-1#2)
severe traumatic##5##2##(2008-1#1)(2008-9#1)(2009-3#1)(2012-1#2)
severe type of##2##3##(2012-12#1)(2013-1#1)
severe type##3##2##(2008-8#1)(2012-12#1)(2013-1#1)
severe underlying##3##2##(2008-5#1)(2010-6#1)(2011-2#1)
severe upper##2##2##(1990-9#1)(2013-1#1)
severe ventricular##2##2##(1991-8#1)(1991-9#1)
severe victimization experiences##3##3##(2012-12#3)
severe with##2##2##(2007-2#1)(2008-6#1)
severe withdrawal##2##2##(1991-12#2)
severe##1172##1##(1990-10#2)(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#7)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#10)(1991-1#1)(1991-11#5)(1991-12#4)(1991-2#4)(1991-3#8)(1991-6#4)(1991-8#5)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#3)(1992-2#4)(1992-3#2)(1992-5#6)(1992-6#3)(1992-7#1)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#6)(1993-3#6)(1993-6#4)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#5)(1994-8#2)(1994-9#3)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#5)(1996-12#3)(1996-3#5)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#7)(1997-3#9)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#6)(2006-10#8)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#5)(2007-10#15)(2007-11#10)(2007-12#19)(2007-2#11)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#35)(2008-1#24)(2008-10#128)(2008-11#23)(2008-12#11)(2008-2#11)(2008-3#9)(2008-4#21)(2008-5#27)(2008-6#13)(2008-7#54)(2008-8#25)(2008-9#25)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#4)(2009-3#12)(2009-4#3)(2009-5#13)(2009-6#10)(2009-7#5)(2009-8#4)(2009-9#4)(2010-1#4)(2010-10#6)(2010-11#6)(2010-12#12)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#10)(2010-6#8)(2010-7#4)(2010-8#6)(2011-1#25)(2011-10#1)(2011-2#73)(2011-3#3)(2012-1#12)(2012-12#35)(2012-2#33)(2012-3#27)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#65)(2013-7#2)(2013-8#37)
severe-to-profound##5##1##(2008-2#3)(2011-1#1)(2012-2#1)
severed##3##1##(1995-11#1)(2008-9#1)(2011-3#1)
severely affect the##2##3##(2008-10#1)(2008-8#1)
severely affected by##2##3##(1997-6#1)(2008-10#1)
severely affected patients##2##3##(2007-10#1)(2008-7#1)
severely affected##12##2##(1997-6#1)(2007-10#2)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
severely compromised in##2##3##(2011-2#1)(2012-12#1)
severely compromised##4##2##(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
severely damaged by##2##3##(2008-10#2)
severely damaged in##2##3##(2008-10#1)(2008-8#1)
severely damaged##9##2##(1997-2#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-10#1)
severely degraded##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
severely depressed##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
severely disabled##2##2##(1995-1#1)(1997-3#1)
severely diseased##3##2##(2008-10#3)
severely ill patients##2##3##(2008-1#1)(2008-11#1)
severely ill##4##2##(1990-8#1)(1992-3#1)(2008-1#1)(2008-11#1)
severely impacted##2##2##(2011-2#1)(2013-1#1)
severely impaired in##2##3##(2007-8#1)(2008-1#1)
severely impaired##13##2##(1993-5#1)(1994-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
severely inhibited##4##2##(1991-12#1)(1993-8#1)(1994-8#1)(2009-6#1)
severely limit##2##2##(1997-2#1)(2008-10#1)
severely limited by the##4##4##(1996-2#1)(2008-3#1)(2010-11#1)(2011-1#1)
severely limited##5##2##(1996-2#1)(2008-3#1)(2010-11#1)(2010-8#1)(2011-1#1)
severely obese##2##2##(1993-2#1)(2011-2#1)
severely reduced##5##2##(1990-3#1)(1992-9#1)(2008-3#1)(2008-7#1)(2009-7#1)
severely##149##1##(1990-11#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#2)(1992-3#2)(1992-9#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#5)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#12)(2008-4#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
severities of##6##2##(2008-10#1)(2008-7#1)(2008-9#4)
severities##14##1##(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2012-2#1)
severity (P##3##2##(2008-10#3)
severity (i##3##2##(1997-3#1)(2008-10#2)
severity accurately##2##2##(2008-10#2)
severity after##2##2##(2008-10#2)
severity and duration##2##3##(2007-7#1)(2008-7#1)
severity and frequency of##2##4##(1995-11#1)(2008-10#1)
severity and impact##2##3##(2008-10#1)(2008-12#1)
severity and outcome##4##3##(2007-10#3)(2011-2#1)
severity and pathogen population##3##4##(2008-10#3)
severity and pathogen##4##3##(2008-10#4)
severity and soil##2##3##(2008-10#2)
severity and the##3##3##(2008-10#2)(2013-1#1)
severity and yield##2##3##(2008-10#2)
severity and##65##2##(1990-12#1)(1990-3#1)(1992-2#1)(1994-11#1)(1995-1#1)(1995-11#1)(1997-6#1)(2007-10#3)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
severity as##6##2##(2008-10#4)(2008-3#1)(2012-2#1)
severity assessment##2##2##(2012-1#2)
severity at##6##2##(2008-10#6)
severity based on##2##3##(2008-10#2)
severity between##3##2##(2008-10#3)
severity but was##2##3##(2008-7#1)(2011-2#1)
severity by##9##2##(2008-10#7)(2008-5#1)(2012-1#1)
severity can be##2##3##(2008-10#1)(2013-8#1)
severity can##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
severity caused by##2##3##(2008-10#2)
severity classes##2##2##(2008-10#2)
severity compared with##4##3##(2008-10#4)
severity data##3##2##(1995-2#1)(2008-10#2)
severity did not##2##3##(2008-10#1)(2013-1#1)
severity factor##4##2##(2013-8#4)
severity for##7##2##(2008-10#6)(2008-11#1)
severity from a##2##3##(2008-10#1)(2008-2#1)
severity from##3##2##(2008-10#2)(2008-2#1)
severity in the##4##3##(2008-10#3)(2010-11#1)
severity in##36##2##(2008-10#27)(2008-5#1)(2008-9#2)(2009-2#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
severity increased##5##2##(2008-10#5)
severity index in##2##3##(2009-8#1)(2012-2#1)
severity index##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
severity indicated that##2##3##(2008-10#2)
severity is##3##2##(1990-9#1)(1997-5#1)(2012-1#1)
severity level##4##2##(2008-10#1)(2009-6#2)(2012-1#1)
severity measures##2##2##(2008-10#1)(2008-8#1)
severity of AP##2##3##(2013-1#2)
severity of Fusarium wilt##4##4##(2008-10#4)
severity of Fusarium##6##3##(2008-10#6)
severity of acute##3##3##(1992-10#1)(2007-7#2)
severity of asthma##3##3##(1997-1#1)(2007-6#1)(2010-8#1)
severity of atherosclerosis##3##3##(1991-9#2)(2007-8#1)
severity of changes##2##3##(2007-11#2)
severity of chronic##2##3##(1997-6#1)(2011-2#1)
severity of depression in mothers##2##5##(2011-2#2)
severity of depression##3##3##(1996-7#1)(2011-2#2)
severity of disease##12##3##(1994-9#1)(1996-12#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
severity of fruit russet##2##4##(2008-10#2)
severity of hepatocyte cytoplasmic vacuolization##2##5##(2008-9#2)
severity of hypertension##3##3##(2013-1#3)
severity of illness and##3##4##(1993-12#1)(1994-2#1)(1996-1#1)
severity of illness##14##3##(1992-3#1)(1993-12#3)(1994-12#2)(1994-2#1)(1995-2#1)(1995-9#1)(1996-1#1)(2007-1#1)(2010-10#1)(2011-2#1)(2012-2#1)
severity of injury##2##3##(1992-6#2)
severity of lesions##2##3##(1991-8#2)
severity of neurologic deficits##2##4##(2008-3#2)
severity of other##2##3##(2008-7#1)(2013-7#1)
severity of pain##3##3##(2007-11#1)(2008-5#1)(2010-12#1)
severity of panicle##2##3##(2008-10#2)
severity of soybean rust##3##4##(2008-10#3)
severity of spinal cord##2##4##(1992-6#1)(2007-11#1)
severity of symptoms##9##3##(2008-10#5)(2008-6#1)(2008-7#1)(2011-2#2)
severity of the disease in##3##5##(1990-9#1)(2008-10#2)
severity of the disease is##2##5##(2010-6#1)(2011-2#1)
severity of the disease##14##4##(1990-9#1)(1991-2#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
severity of the inflammatory##2##4##(1993-1#1)(2006-10#1)
severity of the problem##2##4##(1997-7#1)(2007-11#1)
severity of the##49##3##(1990-11#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-11#1)(1993-1#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#5)(2008-6#1)(2008-7#4)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-3#2)(2013-1#2)
severity of these##3##3##(1991-12#1)(2008-7#1)(2012-7#1)
severity of this##8##3##(1993-2#1)(2008-10#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
severity of translation##2##3##(2011-2#2)
severity of##303##2##(1990-11#1)(1990-3#3)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-3#2)(1992-6#4)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-7#4)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#3)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-6#3)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#65)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#17)(2008-8#2)(2008-9#6)(2009-10#2)(2009-4#1)(2009-5#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#26)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#6)(2012-7#1)(2013-1#18)(2013-7#1)(2013-8#2)
severity on the##5##3##(2008-10#3)(2010-6#1)(2012-2#1)
severity on##19##2##(1995-2#1)(2008-10#14)(2008-12#1)(2010-4#1)(2010-6#1)(2012-2#1)
severity or##7##2##(1990-5#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-3#1)
severity ratings##3##2##(1990-5#1)(1997-3#1)(2008-10#1)
severity scale##2##2##(2007-10#1)(2008-10#1)
severity score##5##2##(1994-9#1)(2008-10#2)(2008-3#2)
severity scores for##2##3##(2010-1#2)
severity scores##7##2##(1994-9#1)(2008-3#1)(2010-1#2)(2010-6#1)(2010-8#1)(2011-1#1)
severity scoring##2##2##(1997-1#1)(2011-1#1)
severity showed##2##2##(2008-10#2)
severity significantly##2##2##(2008-10#2)
severity staging scores##2##3##(2008-9#2)
severity system##3##2##(1992-3#1)(1994-12#1)(1995-2#1)
severity than did plants##2##4##(2008-10#2)
severity than##5##2##(2008-10#4)(2010-2#1)
severity to##3##2##(1992-3#1)(2009-4#1)(2013-1#1)
severity values##4##2##(2008-10#4)
severity varied##2##2##(2008-10#2)
severity was assessed##2##3##(2007-10#1)(2008-10#1)
severity was associated with##2##4##(2008-10#1)(2013-8#1)
severity was estimated##3##3##(2008-10#2)(2008-6#1)
severity was measured by##2##4##(1997-5#1)(2013-1#1)
severity was reduced##3##3##(2008-10#3)
severity was significantly reduced##2##4##(2008-10#2)
severity was significantly##4##3##(2008-10#4)
severity was##42##2##(1996-12#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#32)(2008-6#2)(2008-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
severity were##11##2##(2008-10#11)
severity when##2##2##(2008-10#1)(2008-7#1)
severity with the##2##3##(2008-7#1)(2009-3#1)
severity with##4##2##(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
severity##861##1##(1990-11#1)(1990-12#1)(1990-3#4)(1990-5#2)(1990-9#3)(1991-1#1)(1991-12#4)(1991-2#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-6#5)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-7#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#6)(1995-5#1)(1995-9#1)(1996-1#4)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-5#6)(1997-6#5)(1997-7#2)(1997-8#3)(2006-10#2)(2007-1#1)(2007-10#8)(2007-11#7)(2007-12#9)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#384)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#13)(2008-4#3)(2008-5#17)(2008-6#12)(2008-7#26)(2008-8#4)(2008-9#15)(2009-10#2)(2009-11#1)(2009-2#6)(2009-3#2)(2009-4#8)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#7)(2011-1#12)(2011-2#38)(2011-3#1)(2012-1#8)(2012-12#5)(2012-2#11)(2012-3#11)(2012-7#1)(2013-1#35)(2013-7#2)(2013-8#15)
severity) and##2##2##(2008-10#2)
severity) were##3##2##(2008-10#2)(2008-7#1)
severity)##9##1##(2008-10#8)(2008-7#1)
severity-adjusted data##2##2##(1995-2#1)(1997-1#1)
severity-adjusted##3##1##(1991-2#1)(1995-2#1)(1997-1#1)
severity-of-illness##2##1##(1994-1#1)(1996-9#1)
sevoflurane and##3##2##(2008-10#1)(2012-12#2)
sevoflurane##11##1##(2008-10#1)(2010-7#1)(2011-2#6)(2012-12#2)(2012-3#1)
sevrage de la ventilation mécanique##2##5##(2013-1#2)
sevrage##5##1##(2013-1#5)
sewage and##3##2##(2007-2#1)(2009-12#1)(2013-8#1)
sewage effluent##3##2##(2007-5#1)(2008-10#2)
sewage samples##4##2##(2008-10#4)
sewage sludge amended soil##2##4##(2008-10#2)
sewage sludge production##2##3##(1997-4#2)
sewage sludge##25##2##(1997-4#12)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#4)
sewage sludges and##2##3##(2008-11#2)
sewage sludges##4##2##(2008-10#1)(2008-11#3)
sewage treatment##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#2)
sewage##68##1##(1991-11#1)(1991-7#1)(1994-9#1)(1997-4#12)(2007-12#2)(2007-2#1)(2007-5#3)(2008-10#25)(2008-11#4)(2008-12#6)(2008-5#2)(2008-6#1)(2009-12#1)(2013-1#7)(2013-8#1)
sex after##2##2##(2007-12#1)(2013-1#1)
sex allocation##11##2##(2008-8#8)(2008-9#3)
sex and age##12##3##(1991-6#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-6#1)(2011-2#2)(2012-2#1)
sex and family history of##2##5##(2009-9#2)
sex and sexual risk behavior##2##5##(2010-5#2)
sex and the##3##3##(2008-7#1)(2009-11#1)(2010-8#1)
sex and##49##2##(1990-2#1)(1991-6#2)(1991-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
sex as##5##2##(2008-8#1)(2008-9#1)(2013-1#3)
sex biases in gene flow##2##5##(2009-2#2)
sex biases in##3##3##(1997-3#1)(2009-2#2)
sex biases##4##2##(1997-3#2)(2009-2#2)
sex by##2##2##(2010-3#1)(2013-1#1)
sex change##6##2##(2008-8#1)(2009-10#1)(2010-5#3)(2010-8#1)
sex chromosome system##4##3##(2008-12#1)(2010-8#3)
sex chromosome systems##2##3##(2010-3#2)
sex chromosome##16##2##(2008-12#2)(2010-3#6)(2010-5#4)(2010-8#3)(2012-3#1)
sex chromosomes and##3##3##(2010-3#3)
sex chromosomes##26##2##(2008-12#2)(2008-7#2)(2008-8#1)(2010-3#17)(2010-5#3)(2010-8#1)
sex determination##24##2##(1994-7#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-3#15)(2010-5#1)(2012-12#2)
sex determining##2##2##(2010-3#2)
sex difference in the##2##4##(2008-9#1)(2010-6#1)
sex difference in##5##3##(1994-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-6#1)
sex differences and similarities##3##4##(2008-7#2)(2009-7#1)
sex differences and##4##3##(1994-8#1)(2008-7#2)(2009-7#1)
sex differences in depressive symptoms and delinquent behavior##2##8##(2009-7#2)
sex differences in immune##3##4##(2008-8#1)(2008-9#2)
sex differences in##20##3##(1993-12#1)(1996-5#2)(2007-12#1)(2008-11#1)(2008-4#3)(2008-8#4)(2008-9#6)(2009-7#2)
sex differences were##3##3##(1994-2#1)(2008-12#1)(2008-7#1)
sex differences##31##2##(1993-12#1)(1994-2#1)(1994-8#1)(1996-5#3)(1997-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#4)(2008-8#4)(2008-9#6)(2009-7#3)(2012-3#1)
sex differentiation of dopaminergic neurons##2##5##(1996-5#2)
sex differentiation##7##2##(1996-5#2)(2008-5#2)(2010-5#2)(2012-3#1)
sex distribution##3##2##(2007-8#1)(2008-7#1)(2011-1#1)
sex during##2##2##(1994-7#1)(2010-7#1)
sex education##4##2##(1990-9#1)(1991-1#1)(1993-8#1)(1995-12#1)
sex from##2##2##(1995-6#2)
sex glands##2##2##(2008-10#2)
sex glandular##2##2##(2008-10#2)
sex hormone binding globulin (SHBG)##2##5##(1990-11#1)(2011-2#1)
sex hormone##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
sex hormone-binding globulin##3##3##(1990-2#1)(1990-9#1)(2008-3#1)
sex hormone-dependent##2##2##(2008-11#2)
sex hormones##12##2##(1991-12#1)(1992-5#1)(1994-3#1)(2008-11#2)(2008-7#3)(2010-12#1)(2010-6#2)(2011-2#1)
sex in##7##2##(1991-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
sex is##4##2##(1997-7#1)(2007-12#1)(2009-2#1)(2012-3#1)
sex linkage of##2##3##(2012-3#2)
sex linked##2##2##(2008-4#1)(2008-9#1)
sex of patients##2##3##(1991-8#1)(2008-1#1)
sex of##11##2##(1991-8#2)(1994-7#3)(1996-5#1)(2008-1#1)(2008-5#2)(2008-8#1)(2013-1#1)
sex on the##3##3##(1996-5#1)(2008-7#1)(2010-4#1)
sex on##7##2##(1996-5#1)(1997-7#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-6#1)(2013-7#1)
sex or##5##2##(1991-6#1)(1994-8#1)(2008-5#1)(2009-9#1)(2013-8#1)
sex organs##2##2##(1991-5#1)(2008-4#1)
sex partners in the past##2##5##(2007-12#1)(2013-1#1)
sex partners##17##2##(1993-6#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-12#3)(2009-5#2)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#2)
sex pheromone components##3##3##(2008-10#3)
sex pheromone gland##2##3##(2008-10#2)
sex pheromone glands of Lutzomyia cruzi male sand flies (Diptera##2##10##(2007-12#2)
sex pheromone glands##3##3##(2007-12#3)
sex pheromone in##2##3##(2008-10#1)(2011-2#1)
sex pheromone of##2##3##(2008-10#2)
sex pheromone##17##2##(1990-8#1)(2007-12#4)(2008-10#10)(2011-2#1)(2013-8#1)
sex pheromones##2##2##(1990-8#1)(2008-10#1)
sex ratio distortion##3##3##(2008-8#3)
sex ratio of##2##3##(1990-3#1)(1997-7#1)
sex ratio was##3##3##(2007-8#1)(2008-7#1)(2010-8#1)
sex ratio##36##2##(1990-3#1)(1991-11#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#18)(2008-9#7)(2010-8#1)(2011-2#1)(2012-3#2)
sex ratios of##3##3##(1997-7#1)(2010-8#1)(2011-2#1)
sex ratios##12##2##(1997-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2010-8#1)(2011-2#4)
sex regulatory##2##2##(2007-12#2)
sex related##3##2##(1994-2#1)(2008-7#1)(2012-3#1)
sex reversal##2##2##(2008-4#1)(2008-5#1)
sex steroid##6##2##(1990-11#1)(1996-5#1)(2008-3#1)(2008-5#2)(2013-1#1)
sex steroids are##2##3##(2008-5#1)(2008-6#1)
sex steroids##11##2##(1990-11#1)(1990-2#1)(1993-5#1)(1995-12#1)(1997-6#2)(2008-5#1)(2008-6#1)(2009-6#1)(2009-7#1)(2011-1#1)
sex to##3##2##(1993-6#1)(2007-12#1)(2008-12#1)
sex was##4##2##(1996-9#1)(1997-4#1)(2007-2#1)(2008-12#1)
sex were##9##2##(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#2)
sex with##23##2##(1996-5#2)(2008-10#1)(2008-11#1)(2009-5#9)(2009-7#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#1)(2013-1#2)
sex work##4##2##(2008-12#2)(2010-8#2)
sex workers in##2##3##(2010-8#1)(2013-8#1)
sex workers##9##2##(2007-12#1)(2009-7#1)(2010-8#3)(2011-2#2)(2012-1#1)(2013-8#1)
sex##663##1##(1990-11#4)(1990-2#4)(1990-3#2)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#9)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#6)(1994-8#2)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-3#1)(1996-4#2)(1996-5#13)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#9)(1997-7#9)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#16)(2007-2#2)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#27)(2008-11#14)(2008-12#17)(2008-3#10)(2008-4#11)(2008-5#21)(2008-6#5)(2008-7#30)(2008-8#53)(2008-9#32)(2009-10#1)(2009-11#3)(2009-2#4)(2009-5#18)(2009-6#4)(2009-7#9)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#45)(2010-4#4)(2010-5#19)(2010-6#4)(2010-7#5)(2010-8#18)(2010-9#1)(2011-1#13)(2011-2#33)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#17)(2013-1#34)(2013-7#4)(2013-8#11)
sex)##5##1##(1996-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
sex- and age-specific##2##3##(2012-3#2)
sex- and##3##2##(2008-10#1)(2012-3#2)
sex-##5##1##(1995-11#1)(2008-10#1)(2008-12#1)(2012-3#2)
sex-based##2##1##(2007-11#1)(2009-4#1)
sex-biased##3##1##(1997-3#1)(2009-5#1)(2012-3#1)
sex-changing fish##2##2##(2010-8#2)
sex-changing##4##1##(2008-8#1)(2010-8#3)
sex-determining mechanisms##4##2##(2010-3#4)
sex-determining##7##1##(2008-4#1)(2010-3#5)(2010-5#1)
sex-difference in EPC number in##2##5##(2009-11#2)
sex-difference##3##1##(1994-5#1)(2009-11#2)
sex-linked##6##1##(1993-9#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
sex-ratio##7##1##(1994-8#4)(2008-8#1)(2012-3#2)
sex-related differences in liver##3##4##(1995-12#3)
sex-related differences##4##2##(1995-12#4)
sex-related##6##1##(1994-11#1)(1995-12#4)(2008-3#1)
sex-specific characteristics##2##2##(1996-5#1)(2008-11#1)
sex-specific##17##1##(1994-2#1)(1995-6#1)(1996-5#2)(2007-12#1)(2008-11#2)(2010-5#2)(2010-6#2)(2010-8#1)(2012-3#3)(2013-8#2)
sex-typed##3##1##(2013-8#3)
sexangularis##3##1##(2008-10#3)
sexed##3##1##(1996-12#1)(2007-11#1)(2008-10#1)
sexes and all##2##3##(2008-1#1)(2012-12#1)
sexes and the##2##3##(2008-8#1)(2013-7#1)
sexes and##8##2##(1991-6#1)(2008-1#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
sexes are##3##2##(1997-6#1)(2009-5#1)(2010-3#1)
sexes as##3##2##(1991-6#1)(2009-10#1)(2009-5#1)
sexes in##10##2##(1991-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
sexes may##3##2##(2008-9#2)(2010-8#1)
sexes of##5##2##(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-8#1)
sexes was##2##2##(1995-8#1)(2012-3#1)
sexes were##6##2##(1990-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-7#1)
sexes##120##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#6)(1992-12#1)(1992-6#1)(1993-8#2)(1994-2#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-9#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#8)(2008-7#10)(2008-8#6)(2008-9#11)(2009-10#1)(2009-11#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#5)(2013-8#2)
sexes)##3##1##(2008-5#1)(2010-3#1)(2010-8#1)
sexta##14##1##(1991-12#3)(1995-11#2)(1995-6#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#2)
sexting behavior##2##2##(2013-1#2)
sexting##21##1##(2013-1#21)
sexual IPV##2##2##(2008-12#2)
sexual abuse and##5##3##(2009-7#2)(2009-9#2)(2010-4#1)
sexual abuse can##2##3##(2009-9#1)(2010-10#1)
sexual abuse in a day care##2##6##(1995-6#2)
sexual abuse in a##4##4##(1992-1#1)(1995-6#2)(1996-11#1)
sexual abuse in##5##3##(1992-1#1)(1995-6#2)(1996-11#1)(2009-9#1)
sexual abuse of##4##3##(1995-5#1)(1996-11#2)(2009-9#1)
sexual abuse##43##2##(1992-1#6)(1992-2#1)(1993-12#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#5)(2008-2#1)(2009-10#1)(2009-4#1)(2009-7#2)(2009-9#11)(2010-10#4)(2010-4#4)(2012-1#1)
sexual activity in##2##3##(2011-2#1)(2013-8#1)
sexual activity was##2##3##(2009-7#1)(2012-12#1)
sexual activity##19##2##(1995-12#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#7)
sexual aggression##3##2##(2008-10#1)(2009-10#1)(2010-11#1)
sexual and asexual##5##3##(2008-10#5)
sexual and natural selection##3##4##(2012-3#3)
sexual and nonsexual##2##3##(2008-9#2)
sexual and reproductive health##12##4##(1996-12#1)(2008-11#3)(2008-9#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
sexual and reproductive##15##3##(1996-12#1)(2008-11#3)(2008-9#1)(2009-5#2)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#1)
sexual and##32##2##(1996-12#1)(2008-10#5)(2008-11#4)(2008-9#4)(2009-2#1)(2009-5#2)(2009-7#2)(2010-2#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
sexual assault cases##2##3##(1996-5#1)(2011-2#1)
sexual assault in##2##3##(2011-2#1)(2012-3#1)
sexual assault##18##2##(1996-12#2)(1996-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-5#2)(2010-3#3)(2011-2#2)(2012-3#3)(2013-8#1)
sexual behavior and##7##3##(1991-2#1)(2008-12#1)(2008-4#1)(2009-7#2)(2011-2#1)(2013-1#1)
sexual behavior of##2##3##(1993-8#1)(1995-12#1)
sexual behavior##46##2##(1991-2#9)(1992-12#3)(1993-5#1)(1993-8#2)(1994-2#1)(1995-1#2)(1995-12#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#4)(2011-1#2)(2011-2#3)(2012-1#3)(2013-1#5)(2013-8#1)
sexual behaviors in##3##3##(2009-5#3)
sexual behaviors##13##2##(2007-12#3)(2009-5#6)(2009-7#1)(2013-1#1)(2013-8#2)
sexual behaviour of male rats##2##5##(2008-11#2)
sexual behaviour of##4##3##(1990-9#1)(1996-11#1)(2008-11#2)
sexual behaviour##11##2##(1990-9#1)(1993-9#2)(1996-1#2)(1996-11#1)(1996-6#1)(2007-7#1)(2008-11#2)(2011-1#1)
sexual changes##4##2##(2008-7#4)
sexual characters##8##2##(1995-2#5)(2007-7#1)(2012-3#2)
sexual coercion##2##2##(2009-11#1)(2012-2#1)
sexual concerns##3##2##(2008-7#3)
sexual conflict##6##2##(2008-8#4)(2010-3#1)(2012-3#1)
sexual contact##3##2##(1993-6#1)(1995-12#1)(2007-8#1)
sexual contacts##3##2##(2011-1#2)(2011-2#1)
sexual cross##2##2##(2008-10#2)
sexual cycle of##2##3##(2008-10#1)(2012-2#1)
sexual debut is##2##3##(2011-1#2)
sexual debut##13##2##(1990-9#2)(2011-1#8)(2012-1#2)(2013-8#1)
sexual development and##3##3##(2008-1#1)(2010-12#1)(2010-3#1)
sexual development##6##2##(2008-1#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)
sexual differences##3##2##(1995-6#1)(2008-5#1)(2008-7#1)
sexual differentiation of the##2##4##(1990-11#1)(1994-2#1)
sexual differentiation of##3##3##(1990-11#1)(1994-2#1)(2008-5#1)
sexual differentiation##9##2##(1990-11#1)(1994-2#1)(1997-3#1)(2007-12#2)(2008-5#2)(2012-3#2)
sexual dimorphism in##5##3##(1995-6#2)(2008-8#1)(2010-8#1)(2012-3#1)
sexual dimorphism was found in##2##5##(2007-12#1)(2012-3#1)
sexual dimorphism##16##2##(1995-6#3)(2007-12#1)(2008-5#1)(2008-8#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
sexual displays##3##2##(2008-8#1)(2013-1#2)
sexual division of leadership in volunteer emergency medical service##2##9##(1996-3#2)
sexual division of leadership in##3##5##(1996-3#3)
sexual division of##5##3##(1991-6#2)(1996-3#3)
sexual dysfunction##5##2##(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
sexual encounters##2##2##(2011-2#2)
sexual experiences##4##2##(2009-12#1)(2009-5#2)(2009-9#1)
sexual fruiting##2##2##(2008-10#1)(2008-8#1)
sexual function##11##2##(2008-1#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-2#4)(2012-1#1)(2013-8#1)
sexual harassment##3##2##(1993-2#1)(1996-2#1)(1996-3#1)
sexual health##14##2##(1990-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-5#3)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)
sexual history##2##2##(1991-6#1)(2012-1#1)
sexual hormone binding globulin##2##4##(1991-3#2)
sexual hormones##2##2##(1990-12#1)(1993-3#1)
sexual identity##5##2##(2008-10#1)(2008-12#2)(2009-5#2)
sexual initiation##2##2##(2012-1#2)
sexual intercourse with##4##3##(1997-5#1)(2008-12#1)(2011-2#1)(2012-2#1)
sexual intercourse##17##2##(1992-6#1)(1996-12#1)(1997-5#3)(2007-8#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
sexual isolation between##2##3##(2008-9#2)
sexual isolation##4##2##(2008-8#1)(2008-9#3)
sexual life##2##2##(1996-12#1)(2008-7#1)
sexual lives##2##2##(1997-3#1)(2008-7#1)
sexual maturation##3##2##(1990-7#1)(2010-9#1)(2013-7#1)
sexual maturity##8##2##(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2013-7#2)
sexual minority##3##2##(2008-12#3)
sexual motivation##3##2##(2012-1#1)(2013-1#2)
sexual offenses##3##2##(1992-9#1)(1996-5#1)(2011-2#1)
sexual or parasexual##2##3##(2008-10#2)
sexual or##5##2##(2008-10#3)(2008-7#1)(2013-7#1)
sexual orientation and##4##3##(1995-12#1)(1996-5#1)(2008-12#2)
sexual orientation##13##2##(1995-12#2)(1996-5#1)(2008-12#8)(2010-8#1)(2012-2#1)
sexual ornaments##2##2##(2008-8#2)
sexual partner##3##2##(1993-9#1)(2007-12#1)(2012-2#1)
sexual partners and##2##3##(2011-1#1)(2012-2#1)
sexual partners in the##2##4##(2011-1#1)(2013-1#1)
sexual partners in##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
sexual partners##23##2##(1991-2#3)(1993-9#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-5#2)(2010-4#1)(2011-1#5)(2011-2#3)(2012-2#1)(2013-1#4)
sexual partnership##2##2##(2008-10#1)(2011-3#1)
sexual performance##2##2##(1995-12#1)(2008-11#1)
sexual practices##5##2##(1996-5#1)(2007-12#1)(2012-12#2)(2012-2#1)
sexual problems##4##2##(1996-11#1)(2008-8#3)
sexual recombination between##2##3##(2008-10#2)
sexual recombination##20##2##(2008-10#18)(2008-8#2)
sexual reproduction and##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
sexual reproduction between##2##3##(2008-10#2)
sexual reproduction of##3##3##(1990-7#1)(2008-10#2)
sexual reproduction##33##2##(1990-7#1)(2008-10#16)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2012-3#5)(2013-1#1)
sexual risk among##2##3##(2008-12#1)(2013-1#1)
sexual risk and##2##3##(2008-12#1)(2013-1#1)
sexual risk behavior##7##3##(2008-12#3)(2010-5#2)(2013-1#2)
sexual risk behaviors and##2##4##(2008-12#1)(2008-4#1)
sexual risk behaviors in##2##4##(2008-4#1)(2008-8#1)
sexual risk behaviors##11##3##(2008-12#1)(2008-4#5)(2008-8#1)(2010-7#1)(2012-1#1)(2013-1#2)
sexual risk##29##2##(2008-12#7)(2008-4#6)(2008-8#1)(2009-12#1)(2009-8#3)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#6)
sexual risks##2##2##(2013-1#1)(2013-8#1)
sexual selection and the##3##4##(2008-8#2)(2012-3#1)
sexual selection and##6##3##(2008-8#3)(2012-3#1)(2013-1#2)
sexual selection are##2##3##(1995-2#1)(2012-3#1)
sexual selection can##2##3##(2008-8#1)(2013-1#1)
sexual selection in plants##2##4##(1995-2#2)
sexual selection in##5##3##(1995-2#2)(2008-8#2)(2008-9#1)
sexual selection is##3##3##(1995-2#1)(2008-9#2)
sexual selection on signals of health##3##6##(2008-8#3)
sexual selection on##6##3##(2008-8#6)
sexual selection was##3##3##(2008-8#2)(2012-3#1)
sexual selection##58##2##(1995-2#5)(2008-5#1)(2008-8#30)(2008-9#7)(2009-9#1)(2010-3#1)(2012-3#7)(2013-1#6)
sexual signalling##7##2##(2009-9#7)
sexual situations with##2##3##(2008-12#2)
sexual species##5##2##(2008-8#3)(2009-2#2)
sexual stage##7##2##(1991-5#1)(2008-10#6)
sexual trait expression##3##3##(2012-3#3)
sexual trait##6##2##(2008-9#1)(2012-3#5)
sexual traits##5##2##(2008-8#1)(2008-9#1)(2012-3#3)
sexual transmission and##2##3##(1991-6#1)(2008-9#1)
sexual transmission##5##2##(1991-6#1)(1996-2#1)(2008-9#3)
sexual transmitted##2##2##(2008-11#1)(2011-1#1)
sexual types##2##2##(2008-5#2)
sexual versus asexual##2##3##(2009-5#1)(2010-12#1)
sexual versus##3##2##(2008-9#1)(2009-5#1)(2010-12#1)
sexual violence##6##2##(2009-5#3)(2010-3#3)
sexual##749##1##(1990-11#1)(1990-12#3)(1990-6#2)(1990-7#2)(1990-9#3)(1991-2#12)(1991-3#2)(1991-5#1)(1991-6#5)(1992-1#6)(1992-12#3)(1992-2#3)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-2#3)(1995-1#2)(1995-12#7)(1995-2#10)(1995-3#1)(1995-5#3)(1995-6#7)(1996-1#3)(1996-11#7)(1996-12#6)(1996-2#2)(1996-3#4)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#4)(1997-6#1)(1997-7#1)(2007-12#9)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#70)(2008-11#12)(2008-12#35)(2008-2#2)(2008-4#9)(2008-5#13)(2008-6#1)(2008-7#21)(2008-8#69)(2008-9#35)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#3)(2009-4#2)(2009-5#40)(2009-6#1)(2009-7#11)(2009-8#3)(2009-9#21)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#12)(2010-4#6)(2010-5#5)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#22)(2011-2#32)(2011-3#1)(2012-1#13)(2012-12#15)(2012-2#16)(2012-3#42)(2013-1#34)(2013-7#5)(2013-8#17)
sexual/gender identity formation##2##3##(2009-7#2)
sexuality with##4##2##(2009-5#1)(2011-2#1)(2013-1#2)
sexuality##21##1##(1996-9#1)(1997-7#2)(2008-1#3)(2008-10#2)(2008-4#1)(2009-10#2)(2009-12#1)(2009-5#4)(2009-7#2)(2011-2#1)(2013-1#2)
sexually abused children##4##3##(1995-5#1)(2008-2#2)(2010-10#1)
sexually abused##8##2##(1990-11#1)(1995-5#2)(1996-11#1)(2008-2#2)(2009-9#1)(2010-10#1)
sexually active adolescents##2##3##(1996-12#1)(2008-1#1)
sexually active young##2##3##(2008-11#1)(2012-2#1)
sexually active##23##2##(1996-12#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#4)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#7)
sexually antagonistic genes##2##3##(2008-8#1)(2010-3#1)
sexually antagonistic##3##2##(2008-8#2)(2010-3#1)
sexually dimorphic##8##2##(1992-3#4)(1993-5#1)(1993-8#1)(1995-2#1)(2008-8#1)
sexually experienced##3##2##(1995-12#2)(2011-2#1)
sexually mature##2##2##(2007-12#1)(2008-7#1)
sexually naive##2##2##(1995-12#2)
sexually selected##6##2##(2008-8#1)(2008-9#2)(2012-3#2)(2013-1#1)
sexually transmitted disease##6##3##(1996-12#2)(2008-4#2)(2012-1#1)(2012-3#1)
sexually transmitted diseases (STD)##2##4##(1990-3#1)(1990-6#1)
sexually transmitted diseases##22##3##(1990-3#1)(1990-6#1)(1991-12#1)(1992-4#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-7#2)(2009-12#1)(2011-1#1)(2012-12#1)
sexually transmitted infections (STI)##2##4##(2011-2#2)
sexually transmitted infections (STIs)##2##4##(2007-7#1)(2011-2#1)
sexually transmitted infections and HIV##2##5##(2012-12#1)(2013-1#1)
sexually transmitted infections and unwanted pregnancies##2##6##(2008-11#1)(2012-2#1)
sexually transmitted infections and##5##4##(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
sexually transmitted infections##20##3##(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2009-5#2)(2010-11#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
sexually transmitted viral##2##3##(2008-11#1)(2013-1#1)
sexually transmitted##59##2##(1990-3#1)(1990-6#1)(1991-12#1)(1992-4#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#1)(2007-2#1)(2007-7#3)(2008-11#3)(2008-12#2)(2008-4#2)(2009-12#1)(2009-5#2)(2010-11#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
sexually##143##1##(1990-11#1)(1990-3#2)(1990-6#2)(1991-12#1)(1992-3#4)(1992-4#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-5#2)(1995-9#2)(1996-11#2)(1996-12#4)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-3#2)(1997-6#2)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#4)(2008-7#1)(2008-8#9)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#4)(2009-7#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#13)(2013-8#1)
sexuals##5##1##(2008-5#1)(2008-8#4)
sfr-7DS##6##1##(2008-10#6)
sgcD is##3##2##(2008-9#3)
sgcD##8##1##(2008-9#8)
sgs1 top3##3##2##(2010-2#3)
sgs1##6##1##(2010-2#6)
shAIC##4##1##(2012-2#4)
shRNA##4##1##(2013-1#4)
shRNAs##2##1##(2012-2#1)(2013-1#1)
shack-hartmann wave-front##2##2##(2008-3#2)
shack-hartmann##3##1##(2008-3#3)
shade and##4##2##(2008-10#1)(2008-12#1)(2009-8#2)
shade avoidance##2##2##(2009-8#2)
shade##24##1##(1991-5#1)(2008-10#2)(2008-12#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#8)(2012-2#1)(2012-6#1)(2013-1#1)
shaded##6##1##(2008-10#2)(2008-3#1)(2008-9#3)
shades and##2##2##(2008-12#2)
shades##9##1##(1995-6#1)(2007-12#1)(2008-12#4)(2008-5#2)(2009-8#1)
shading##9##1##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#5)
shadow in the left lower##2##5##(2008-1#2)
shadow in##3##2##(2007-10#1)(2008-1#2)
shadow moiré##3##2##(2008-3#3)
shadow on the##2##3##(2007-10#1)(2008-11#1)
shadow on##3##2##(2007-10#1)(2008-1#1)(2008-11#1)
shadow with##2##2##(1994-7#1)(2008-1#1)
shadow##37##1##(1991-12#2)(1994-7#2)(2007-10#2)(2008-1#7)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#3)(2013-7#2)
shadow-moiré topography is##2##3##(2008-3#2)
shadow-moiré topography##3##2##(2008-3#3)
shadowing function##3##2##(2008-3#3)
shadowing##7##1##(2008-2#1)(2008-3#5)(2010-12#1)
shadows and##5##2##(1996-3#1)(2008-1#1)(2008-2#2)(2008-3#1)
shadows from##2##2##(2008-1#1)(2008-6#1)
shadows in the##3##3##(2008-1#2)(2008-3#1)
shadows in##5##2##(2008-1#3)(2008-3#1)(2008-6#1)
shadows on##2##2##(2008-1#1)(2008-6#1)
shadows##26##1##(1991-12#1)(1992-1#1)(1996-3#1)(2008-1#10)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#1)(2009-10#1)(2009-12#1)(2010-1#1)
shaft fracture##5##2##(2009-3#5)
shaft fractures in##4##3##(2007-11#1)(2012-2#3)
shaft fractures##5##2##(2007-11#1)(2012-2#4)
shaft is##3##2##(2007-7#1)(2008-2#1)(2013-8#1)
shaft localisation##2##2##(2007-11#2)
shaft metastatic##2##2##(2007-11#2)
shaft of femur##2##3##(2007-11#1)(2008-7#1)
shaft of##6##2##(2007-11#2)(2007-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
shaft##49##1##(1991-2#1)(2007-11#10)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#5)(2009-5#1)(2010-11#2)(2011-2#2)(2012-2#5)(2013-1#1)(2013-8#1)
shafts##4##1##(2007-8#1)(2008-5#3)
shake flasks##5##2##(2008-11#2)(2008-12#1)(2011-2#2)
shake##11##1##(1996-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2011-2#2)(2013-7#1)
shake-flask culture##2##2##(2008-11#1)(2008-7#1)
shake-flask##6##1##(2008-11#2)(2008-12#1)(2008-7#3)
shaken in##2##2##(1997-6#1)(2008-5#1)
shaken##7##1##(1997-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)
shaker with##2##2##(2008-11#1)(2011-2#1)
shaker##5##1##(2008-10#1)(2008-11#2)(2011-2#1)(2013-7#1)
shaker-Schott##2##1##(2008-11#2)
shaking time after addition of##2##5##(2008-10#2)
shaking time and##2##3##(2008-10#2)
shaking time##12##2##(2008-10#12)
shaking with##3##2##(2008-10#3)
shaking##30##1##(1996-12#2)(2008-10#19)(2008-4#4)(2008-7#2)(2011-2#1)(2012-2#2)
shall be##4##2##(1991-3#1)(1995-3#1)(1996-12#1)(1997-8#1)
shall continue to##2##3##(1992-4#1)(2008-10#1)
shall##16##1##(1991-3#1)(1992-4#1)(1992-8#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-7#2)(2009-11#1)(2009-3#1)(2012-2#1)(2013-1#2)
shallot##3##1##(2008-10#2)(2012-2#1)
shallow and##4##2##(1994-1#1)(2007-11#1)(2008-10#1)(2008-9#1)
shallow slopes##2##2##(2008-9#1)(2012-2#1)
shallow tillage##3##2##(2008-12#3)
shallow water##2##2##(2008-10#1)(2008-3#1)
shallow waters##4##2##(2008-2#3)(2008-3#1)
shallow##43##1##(1991-10#1)(1991-2#1)(1992-3#1)(1994-1#1)(2007-11#1)(2007-5#3)(2008-10#5)(2008-12#3)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#1)(2008-9#3)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
shallow-water marine##2##2##(2007-5#1)(2008-5#1)
shallow-water##7##1##(2007-5#3)(2008-2#1)(2008-3#1)(2008-5#2)
shallower##4##1##(2008-10#1)(2008-5#1)(2010-8#2)
sham ECS##2##2##(1996-12#2)
sham and SCLP or CLP##2##5##(2012-3#2)
sham and##5##2##(1993-12#1)(1995-11#2)(2012-3#2)
sham animals##2##2##(2008-7#1)(2009-12#1)
sham control##4##2##(1996-9#3)(2008-5#1)
sham operated##5##2##(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(2008-12#1)
sham operation##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
sham or##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
sham stimulation##2##2##(2011-2#1)(2013-1#1)
sham##48##1##(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#4)(1995-12#1)(1996-12#2)(1996-9#3)(2007-10#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#5)(2012-7#2)(2013-1#8)
sham-irradiated rings##2##2##(2008-11#2)
sham-irradiated##3##1##(2008-11#3)
sham-operated (SO)##4##2##(1997-4#3)(2008-5#1)
sham-operated and lesioned rats##2##4##(1994-8#2)
sham-operated and##4##2##(1994-8#2)(1997-6#2)
sham-operated animals##6##2##(1990-5#3)(1994-9#1)(2012-1#2)
sham-operated controls##2##2##(1993-6#1)(1997-2#1)
sham-operated##21##1##(1990-5#4)(1993-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#3)(1997-6#2)(2008-5#1)(2012-1#3)
sham-operation##2##1##(1993-12#1)(1993-3#1)
shame and##6##2##(1997-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2011-2#1)
shame##10##1##(1997-7#1)(2007-12#3)(2008-1#3)(2008-11#2)(2011-2#1)
shame-proneness##2##1##(2009-11#2)
shampoo and##3##2##(2008-10#2)(2008-5#1)
shampoo containing the##2##3##(2008-5#2)
shampoo containing##5##2##(2008-5#5)
shampoo formulations##3##2##(2008-5#3)
shampoo in the##2##3##(2007-7#1)(2008-5#1)
shampoo in##4##2##(2007-7#2)(2008-5#2)
shampoo products##2##2##(2008-5#2)
shampoo viscosity##4##2##(2008-5#4)
shampoo was##4##2##(2007-7#1)(2008-5#3)
shampoo with##2##2##(2008-5#2)
shampoo##60##1##(1991-2#1)(2007-7#3)(2008-10#7)(2008-5#48)(2012-3#1)
shampoo)##2##1##(2008-10#1)(2008-5#1)
shampooing (dE##2##2##(2008-5#2)
shampooing##6##1##(2008-10#1)(2008-5#4)(2011-1#1)
shampooings)##2##1##(2008-5#2)
shampoos and##3##2##(2008-10#1)(2008-5#2)
shampoos are##3##2##(2008-5#3)
shampoos using##2##2##(2008-5#2)
shampoos were##4##2##(2008-5#4)
shampoos with##2##2##(2008-10#1)(2008-5#1)
shampoos##38##1##(2008-10#4)(2008-5#34)
shams##2##1##(2008-11#1)(2013-1#1)
shank##3##1##(2008-10#3)
shape a##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
shape after##3##2##(2007-12#1)(2008-11#2)
shape analysis##2##2##(1996-5#2)
shape and a##3##3##(2008-2#1)(2008-5#1)(2008-7#1)
shape and an##2##3##(2008-3#2)
shape and deformation##2##3##(2008-2#1)(2008-3#1)
shape and intensity##3##3##(1994-6#1)(2008-3#1)(2008-5#1)
shape and location of integrin clusters##2##6##(2010-10#2)
shape and location of##3##4##(2007-11#1)(2010-10#2)
shape and position##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
shape and reflection##2##3##(2008-3#2)
shape and size of the##3##5##(2007-8#1)(2008-5#1)(2010-8#1)
shape and size of##4##4##(2007-8#1)(2008-5#1)(2010-3#1)(2010-8#1)
shape and size##16##3##(1996-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#2)(2009-5#3)(2010-3#1)(2010-8#2)(2011-2#1)(2013-8#1)
shape and the##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)
shape and##88##2##(1992-6#1)(1994-6#1)(1996-7#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#9)(2008-3#17)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-10#2)(2010-3#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-8#2)
shape are##6##2##(2007-11#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-10#1)
shape as##7##2##(1994-8#1)(1997-3#1)(2007-12#2)(2008-2#2)(2008-6#1)
shape between##2##2##(2011-2#1)(2012-3#1)
shape by use of##2##4##(2008-2#1)(2008-3#1)
shape by##4##2##(2008-2#1)(2008-3#2)(2009-12#1)
shape change##7##2##(2009-5#2)(2009-9#2)(2010-5#2)(2011-2#1)
shape changes##5##2##(2007-11#1)(2007-12#1)(2011-2#2)(2012-12#1)
shape children's##2##2##(2009-6#1)(2011-2#1)
shape classification accuracy was##2##4##(2008-6#2)
shape dependence##2##2##(2007-11#1)(2008-2#1)
shape differences##2##2##(2011-1#2)
shape dramatically##2##2##(2008-3#1)(2011-2#1)
shape during the##4##3##(1993-9#1)(2008-3#1)(2011-2#1)(2012-2#1)
shape during##5##2##(1993-9#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
shape effects##3##2##(2008-3#1)(2008-7#2)
shape for##3##2##(1997-7#1)(2008-3#1)(2010-1#1)
shape from the##3##3##(2008-3#2)(2010-5#1)
shape from##5##2##(2008-3#3)(2010-5#1)(2011-1#1)
shape function##3##2##(1995-9#3)
shape how##2##2##(2012-2#2)
shape in the##2##3##(2009-4#1)(2013-7#1)
shape in##8##2##(2007-12#1)(2007-7#1)(2008-3#3)(2009-4#1)(2013-7#2)
shape information##3##2##(1995-9#1)(2008-2#1)(2010-12#1)
shape invariant model##2##3##(1995-9#2)
shape is described##2##3##(2008-11#1)(2008-2#1)
shape is##15##2##(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2009-6#1)(2010-6#1)(2012-1#1)
shape measurement with##2##3##(2008-2#1)(2008-3#1)
shape measurement##9##2##(2008-2#1)(2008-3#8)
shape measurements##2##2##(2008-3#2)
shape memory alloy##2##3##(2009-7#2)
shape memory##7##2##(2009-7#4)(2010-10#1)(2011-1#2)
shape of a##9##3##(1997-7#1)(2007-12#1)(2008-3#4)(2008-4#1)(2009-4#1)(2009-7#1)
shape of each##2##3##(2008-3#1)(2010-8#1)
shape of the distribution##2##4##(2008-3#1)(2008-8#1)
shape of the exposure response##2##5##(2008-7#2)
shape of the lumbar spine in the sagittal plane##2##9##(2012-1#2)
shape of the##85##3##(1990-8#1)(1991-5#1)(1992-3#1)(1994-8#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#10)(2008-3#22)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
shape of##141##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#10)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#16)(2008-3#38)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-7#2)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
shape on the##2##3##(2008-2#1)(2008-7#1)
shape on##3##2##(2007-11#1)(2008-2#1)(2008-7#1)
shape or##5##2##(1993-11#1)(2007-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
shape over##2##2##(1995-9#1)(2007-11#1)
shape parameter##4##2##(2008-10#3)(2008-8#1)
shape parameters##3##2##(2008-10#2)(2008-3#1)
shape permits the##2##3##(2008-2#2)
shape recognition is proposed##2##4##(2008-3#2)
shape similar to##2##3##(2008-10#1)(2008-2#1)
shape that##4##2##(2008-10#1)(2008-2#1)(2009-5#1)(2012-2#1)
shape the future of##4##4##(1991-1#1)(2008-1#3)
shape the way##2##3##(2008-12#1)(2011-2#1)
shape the##26##2##(1991-1#1)(1991-2#1)(1993-12#1)(1995-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-11#1)(2008-12#3)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
shape their##3##2##(2008-9#1)(2009-5#1)(2011-2#1)
shape to##5##2##(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)
shape variation##5##2##(2007-11#1)(2010-5#1)(2012-3#3)
shape was##2##2##(2008-11#1)(2008-4#1)
shape were##5##2##(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)
shape with##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-10#1)
shape##605##1##(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-9#7)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#21)(2007-12#36)(2007-2#1)(2007-7#11)(2007-8#4)(2008-1#5)(2008-10#40)(2008-11#13)(2008-12#5)(2008-2#62)(2008-3#119)(2008-4#8)(2008-5#17)(2008-6#19)(2008-7#22)(2008-8#9)(2008-9#8)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#5)(2009-5#9)(2009-6#4)(2009-7#10)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#5)(2010-12#4)(2010-3#2)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#8)(2011-2#22)(2012-1#7)(2012-12#2)(2012-2#13)(2012-3#9)(2013-1#3)(2013-7#4)(2013-8#7)
shape)##2##1##(2007-12#2)
shape-error curves##2##2##(2008-3#2)
shape-memory##4##1##(2009-7#3)(2012-3#1)
shaped and##4##2##(2008-10#2)(2008-9#1)(2009-5#1)
shaped beam##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
shaped by##11##2##(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#2)
shaped epidural cavernomas##2##3##(2007-8#2)
shaped pulse##2##2##(2007-11#1)(2008-3#1)
shaped pulses are##2##3##(2007-12#2)
shaped pulses in the##3##4##(2007-11#1)(2007-12#2)
shaped pulses##6##2##(2007-11#2)(2007-12#4)
shaped signal##2##2##(2008-3#2)
shaped the##6##2##(1993-2#1)(1994-1#1)(2008-12#1)(2009-10#1)(2010-1#1)(2012-12#1)
shaped with##2##2##(2008-3#2)
shaped##92##1##(1990-11#1)(1993-2#1)(1994-1#1)(1995-12#1)(1997-3#2)(2007-11#7)(2007-12#10)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#19)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#1)
shaper##10##1##(2007-11#3)(2007-12#6)(2008-3#1)
shapes and sizes##3##3##(2007-12#1)(2008-10#1)(2009-8#1)
shapes and the##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
shapes and##21##2##(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)
shapes are##5##2##(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)
shapes as##2##2##(2007-12#1)(2008-2#1)
shapes by##3##2##(2008-10#3)
shapes can be##3##3##(1994-8#1)(2008-2#1)(2008-3#1)
shapes in##8##2##(2007-11#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-6#1)
shapes of objects##2##3##(2008-2#1)(2009-10#1)
shapes of the fitness gain functions##2##6##(2008-9#2)
shapes of the##12##3##(1994-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#2)(2010-5#1)(2013-1#1)
shapes of##30##2##(1994-6#1)(1994-8#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-7#2)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#1)(2010-5#1)(2013-1#1)
shapes were observed##2##3##(2008-10#1)(2011-1#1)
shapes were##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-1#1)
shapes with##2##2##(2008-6#2)
shapes##136##1##(1991-7#1)(1992-6#2)(1994-6#1)(1994-8#2)(1994-9#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#9)(2007-7#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#28)(2008-4#2)(2008-6#6)(2008-7#5)(2008-9#8)(2009-10#4)(2009-11#1)(2009-2#1)(2009-5#4)(2009-6#3)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
shaping a##2##2##(2008-2#2)
shaping and##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)
shaping by##3##2##(2007-11#2)(2008-2#1)
shaping can##2##2##(2007-11#1)(2008-2#1)
shaping in##6##2##(2007-11#3)(2007-12#2)(2008-2#1)
shaping of a##2##3##(2007-11#2)
shaping of the##4##3##(2007-11#3)(2008-11#1)
shaping of##12##2##(2007-11#6)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#2)
shaping the##8##2##(1995-11#1)(1997-1#1)(2008-10#1)(2008-8#2)(2009-6#1)(2011-2#1)(2011-3#1)
shaping##90##1##(1993-1#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-11#26)(2007-12#7)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
shards##3##1##(2008-10#3)
share a common mechanism##2##4##(1990-2#1)(1994-5#1)
share a common##17##3##(1990-2#2)(1990-9#1)(1991-6#1)(1992-7#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-3#1)(2008-8#3)(2008-9#1)(2012-12#1)
share a high degree of##2##5##(1994-11#1)(2008-10#1)
share a high##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
share a similar##2##3##(2007-12#1)(2008-8#1)
share a##40##2##(1990-2#2)(1990-9#1)(1991-6#1)(1992-7#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-12#2)
share about##3##2##(1994-12#1)(2008-7#1)(2011-1#1)
share an##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
share and##5##2##(1993-1#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-12#1)
share approximately##2##2##(2008-10#2)
share common##12##2##(1990-6#1)(1991-5#1)(1994-11#1)(1994-8#1)(2008-10#2)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
share from##2##2##(1991-3#1)(1997-1#1)
share high##2##2##(1994-12#1)(2008-10#1)
share homology with##2##3##(1991-12#1)(1993-9#1)
share identical##2##2##(2009-12#1)(2011-2#1)
share in their##2##3##(1995-12#1)(2008-7#1)
share in##6##2##(1993-1#1)(1995-12#1)(1996-3#1)(2006-10#1)(2008-12#1)(2008-7#1)
share is##2##2##(1993-5#1)(2008-12#1)
share low amino acid identities##2##5##(2008-10#2)
share many characteristics##2##3##(1997-4#1)(2008-9#1)
share many clinical##2##3##(1997-5#1)(2009-5#1)
share many features##2##3##(1997-3#2)
share many##11##2##(1997-3#2)(1997-4#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
share more##2##2##(1991-5#1)(1993-12#1)
share no##3##2##(1995-8#1)(1997-6#1)(2008-8#1)
share of gross domestic product##2##5##(1991-2#1)(1992-12#1)
share of gross##3##3##(1991-2#1)(1992-12#1)(1992-3#1)
share of health##4##3##(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
share of the Nation's health##2##5##(1992-3#1)(1995-3#1)
share of the Nation's##3##4##(1992-12#1)(1992-3#1)(1995-3#1)
share of the##9##3##(1990-4#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1995-3#1)(1997-2#2)(2008-8#1)
share of total##3##3##(1991-2#1)(1996-2#1)(2008-10#1)
share of##35##2##(1990-4#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1994-1#2)(1995-1#1)(1995-3#3)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
share our##3##2##(1995-12#1)(2008-12#2)
share relatively##3##2##(1995-11#1)(2011-2#2)
share responsibility for the##2##4##(1992-3#1)(1992-5#1)
share several common##3##3##(1997-2#1)(1997-4#1)(2010-10#1)
share several##7##2##(1997-2#1)(1997-3#1)(1997-4#1)(2009-10#1)(2010-10#1)(2011-2#2)
share significant##3##2##(1993-12#1)(1995-2#1)(2009-8#1)
share similar##4##2##(1994-8#1)(1995-2#1)(2008-1#1)(2009-9#1)
share some##3##2##(1990-7#1)(1995-11#1)(2007-7#1)
share the common##2##3##(1991-2#1)(1997-1#1)
share the same##10##3##(1992-6#1)(1994-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-8#1)
share the##27##2##(1991-2#1)(1992-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-8#2)
share their##7##2##(2008-11#3)(2008-9#1)(2011-2#2)(2012-12#1)
share with##2##2##(1994-1#1)(2007-12#1)
share##268##1##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#4)(1994-11#2)(1994-12#4)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#3)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2006-10#1)(2007-12#5)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#26)(2008-11#7)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#10)(2008-9#6)(2009-10#3)(2009-12#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#15)(2011-4#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#6)
shared 98##3##2##(2010-4#1)(2010-5#2)
shared a##5##2##(1990-11#1)(1993-8#1)(2008-1#1)(2008-10#2)
shared among##5##2##(2008-10#3)(2008-8#1)(2012-3#1)
shared between##4##2##(1994-8#1)(1997-9#1)(2009-3#1)(2010-5#1)
shared by all##6##3##(1997-3#1)(1997-9#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
shared by both##4##3##(1990-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
shared by humans and##2##4##(1994-2#1)(2008-9#1)
shared by the##4##3##(1992-9#1)(1994-2#1)(1995-11#1)(2008-10#1)
shared by##41##2##(1990-12#1)(1992-6#1)(1992-9#1)(1994-2#2)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-12#2)(2008-10#7)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
shared components##2##2##(2008-11#1)(2010-5#1)
shared decision making##2##3##(2008-1#1)(2011-1#1)
shared experiences##2##2##(1996-4#1)(2010-11#1)
shared genetic##2##2##(2011-2#1)(2012-3#1)
shared governance##2##2##(1993-2#1)(2012-3#1)
shared highest nucleotide sequence identity with##3##6##(2008-10#3)
shared highest nucleotide sequence##4##4##(2008-10#4)
shared identical##2##2##(2008-10#2)
shared in##3##2##(2008-10#2)(2009-6#1)
shared information##2##2##(2011-2#1)(2013-8#1)
shared leadership in##2##3##(1995-1#2)
shared learning and##2##3##(1995-12#1)(2008-11#1)
shared learning##3##2##(1995-12#1)(2008-11#2)
shared memory##2##2##(2011-1#1)(2012-2#1)
shared more##2##2##(2008-11#1)(2012-12#1)
shared on##2##2##(1992-12#1)(2010-10#1)
shared only##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
shared or##2##2##(2009-6#1)(2012-2#1)
shared responsibility##2##2##(2007-10#1)(2012-3#1)
shared risk factors for internalizing##2##5##(2012-12#2)
shared services##3##2##(1992-2#3)
shared similar##4##2##(1997-6#1)(2008-10#1)(2008-9#1)(2009-6#1)
shared the same##2##3##(2007-7#1)(2008-10#1)
shared the##4##2##(2007-7#1)(2008-10#2)(2013-8#1)
shared understanding of##3##3##(1997-3#1)(2008-12#1)(2008-7#1)
shared understanding##4##2##(1997-3#1)(2008-12#1)(2008-7#1)(2013-1#1)
shared vision and##2##3##(1993-12#1)(1996-12#1)
shared vision of##2##3##(1995-2#1)(2008-1#1)
shared vision##6##2##(1993-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(2008-1#1)(2010-10#1)
shared with the##4##3##(1993-2#1)(2008-6#2)(2013-1#1)
shared with##8##2##(1993-2#1)(2008-6#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)
shared##219##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-8#1)(1994-9#3)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#2)(2007-10#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#6)(2008-10#34)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#6)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#4)(2010-10#2)(2010-11#3)(2010-4#1)(2010-5#6)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#7)(2012-12#8)(2012-2#5)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#5)
shareholder and partnership agreements##2##4##(1993-3#2)
shareholder relationships##3##2##(1993-2#1)(1993-3#1)(1994-1#1)
shareholder##6##1##(1993-2#1)(1993-3#3)(1994-1#1)(2007-4#1)
shares 92##2##2##(1993-2#1)(2008-10#1)
shares a common##3##3##(1990-2#1)(1991-6#1)(2008-10#1)
shares a most recent common ancestor with##3##7##(2008-10#3)
shares a similar##2##3##(1992-12#1)(2008-6#1)
shares a##18##2##(1990-2#1)(1991-6#1)(1992-12#1)(1995-6#1)(1996-6#1)(1997-6#2)(2008-10#6)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
shares amino acid##2##3##(2008-10#1)(2011-1#1)
shares features with##2##3##(2008-7#1)(2009-8#1)
shares high##2##2##(1995-6#1)(2008-9#1)
shares homology with##2##3##(2008-9#1)(2010-3#1)
shares many##3##2##(2008-6#1)(2009-11#1)(2011-2#1)
shares no sequence homology with##2##5##(1990-11#1)(1997-7#1)
shares no##3##2##(1990-11#1)(1994-12#1)(1997-7#1)
shares sequence##2##2##(1995-2#1)(1997-3#1)
shares significant homology with##2##4##(1997-3#1)(2008-10#1)
shares significant##3##2##(1997-3#2)(2008-10#1)
shares some##5##2##(1991-6#1)(1995-9#1)(1997-4#1)(1997-7#1)(2013-8#1)
shares structural##3##2##(1990-5#1)(1992-9#1)(1993-9#1)
shares the##6##2##(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
shares this##2##2##(1993-12#1)(1994-2#1)
shares with##4##2##(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)
shares##88##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#3)(1994-2#1)(1995-2#1)(1995-6#4)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(2008-10#14)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
sharing (P &lt##2##3##(1997-5#2)
sharing (P = 0##3##4##(1997-5#3)
sharing (P##5##2##(1997-5#5)
sharing a##6##2##(2008-10#2)(2008-8#1)(2009-11#1)(2012-2#2)
sharing and##2##2##(2009-6#1)(2011-9#1)
sharing common##2##2##(2008-10#1)(2009-12#1)
sharing in the##3##3##(1992-2#1)(1996-3#1)(1997-5#1)
sharing in##8##2##(1992-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-5#1)(2009-6#1)(2012-12#1)
sharing information##2##2##(1995-12#1)(2008-12#1)
sharing more##2##2##(2011-2#2)
sharing of##17##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
sharing that##2##2##(2008-10#1)(2011-2#1)
sharing the same##5##3##(1990-5#1)(2008-1#1)(2008-10#1)(2009-6#1)(2012-2#1)
sharing the##8##2##(1990-5#1)(1993-1#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-2#1)
sharing##108##1##(1990-5#1)(1991-1#1)(1992-2#2)(1993-1#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#4)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#3)(1997-5#13)(1997-7#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#4)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#4)(2011-9#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-8#2)
shark##6##1##(1994-11#3)(1994-2#1)(2008-11#1)(2008-5#1)
sharks##5##1##(2008-5#1)(2010-8#4)
sharp and##4##2##(1997-4#1)(2008-3#1)(2008-6#1)(2012-2#1)
sharp contrast to the##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
sharp contrast##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
sharp decline in##3##3##(2008-7#1)(2009-6#1)(2013-8#1)
sharp decline##5##2##(1991-3#1)(2008-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
sharp decrease##5##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
sharp dissection##2##2##(1993-12#1)(2008-7#1)
sharp edges##4##2##(2007-12#1)(2008-3#3)
sharp increase##5##2##(1993-12#1)(1996-12#1)(2008-10#2)(2008-11#1)
sharp peak##3##2##(2008-10#2)(2008-7#1)
sharp peaks in##2##3##(2008-2#1)(2008-5#1)
sharp peaks##3##2##(1995-3#1)(2008-2#1)(2008-5#1)
sharp spectral features##2##3##(2008-2#1)(2008-7#1)
sharp spectral##3##2##(2007-11#1)(2008-2#1)(2008-7#1)
sharp waves##3##2##(1990-5#3)
sharp##107##1##(1990-3#1)(1990-5#4)(1991-12#2)(1991-3#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#6)(2007-12#7)(2007-8#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#11)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-8#1)
sharp-interface##2##1##(2009-11#2)
sharpen##2##1##(1996-3#1)(2008-3#1)
sharpening the##2##2##(2008-3#1)(2008-5#1)
sharpening##4##1##(2008-10#1)(2008-3#2)(2008-5#1)
sharper##8##1##(1996-8#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
sharply and##4##2##(1992-6#1)(2007-12#1)(2008-3#1)(2012-12#1)
sharply defined##3##2##(2007-12#1)(2008-1#1)(2012-12#1)
sharply enhanced##2##2##(2008-11#1)(2008-2#1)
sharply reduced##3##2##(1992-12#1)(2008-10#1)(2012-1#1)
sharply##37##1##(1990-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)
sharpness##13##1##(2007-12#3)(2008-2#2)(2008-3#8)
sharps##4##1##(2007-7#2)(2008-9#1)(2010-9#1)
sharpshooter##6##1##(2007-12#2)(2008-10#4)
shattering##3##1##(2009-10#2)(2013-1#1)
shaved##4##1##(2008-5#4)
shaving##15##1##(2007-7#1)(2008-5#14)
she can##2##2##(1994-12#1)(2007-2#1)
she developed a##2##3##(2008-7#1)(2009-3#1)
she developed symptoms of##2##4##(2008-4#1)(2011-1#1)
she developed##8##2##(1991-11#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)
she died##3##2##(2008-1#1)(2009-3#1)(2011-2#1)
she experienced##3##2##(2007-8#1)(2009-12#1)(2010-3#1)
she had a##2##3##(1993-6#1)(2011-2#1)
she had been##4##3##(2012-12#3)(2012-2#1)
she had##16##2##(1992-6#1)(1993-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1997-3#1)(2006-10#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
she has##7##2##(1997-1#1)(2007-2#1)(2009-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
she is##8##2##(1996-1#1)(2007-12#1)(2007-7#2)(2007-8#1)(2009-8#1)(2011-2#2)
she practiced##2##2##(2010-7#1)(2011-2#1)
she presented with##2##3##(2008-1#1)(2013-1#1)
she presented##4##2##(2007-8#2)(2008-1#1)(2013-1#1)
she received##2##2##(2008-7#1)(2013-1#1)
she returned##2##2##(1996-5#1)(2008-4#1)
she says##2##2##(1993-2#1)(2013-8#1)
she underwent a##2##3##(2007-7#1)(2012-3#1)
she underwent##7##2##(1992-12#1)(2007-7#1)(2009-3#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
she was classified as##2##4##(2007-10#1)(2009-4#1)
she was diagnosed##2##3##(2010-6#1)(2011-2#1)
she was found to have##3##5##(2008-12#1)(2008-7#1)(2013-8#1)
she was given##2##3##(2008-1#1)(2008-7#1)
she was on##2##3##(2007-7#1)(2012-3#1)
she was taken##2##3##(1995-12#1)(1996-12#1)
she was transferred to##2##4##(2012-12#1)(2013-1#1)
she was##37##2##(1992-10#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-5#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#3)(2008-7#2)(2008-8#1)(2009-4#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
she##146##1##(1990-2#1)(1991-11#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#2)(1994-1#1)(1994-12#2)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#5)(1997-1#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#1)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-6#4)(2010-7#1)(2011-1#2)(2011-2#16)(2012-12#7)(2012-2#2)(2012-3#8)(2013-1#9)(2013-8#5)
shear and##3##2##(2008-2#1)(2008-3#1)(2011-3#1)
shear bond strength of##2##4##(2008-12#1)(2013-1#1)
shear bond##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
shear conditions##2##2##(2006-6#2)
shear flow##4##2##(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
shear flows##2##2##(2013-1#2)
shear force results##2##3##(2013-1#2)
shear force##10##2##(2008-11#2)(2009-11#1)(2010-4#3)(2013-1#4)
shear forces##5##2##(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#2)
shear in##3##2##(2008-11#1)(2011-2#2)
shear interferometry##2##2##(2008-2#2)
shear is##2##2##(2008-10#1)(2008-7#1)
shear rate##8##2##(2007-12#1)(2008-5#1)(2008-9#3)(2009-10#1)(2013-1#2)
shear rates##3##2##(2007-12#1)(2008-11#2)
shear rupture##6##2##(1996-4#6)
shear sensitive insect##2##3##(2008-11#2)
shear stress and##3##3##(2008-11#1)(2010-10#1)(2010-9#1)
shear stress dynamic conditions##2##4##(1992-12#2)
shear stress on the##4##4##(1990-8#1)(1991-9#1)(2008-11#1)(2010-8#1)
shear stress on##6##3##(1990-8#1)(1991-9#1)(1993-11#1)(2008-11#1)(2009-12#1)(2010-8#1)
shear stress to##2##3##(2008-1#1)(2011-2#1)
shear stress##44##2##(1990-8#1)(1991-9#1)(1992-12#3)(1993-11#2)(1994-8#1)(2008-1#2)(2008-11#10)(2008-2#2)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#4)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
shear stresses##2##2##(2008-11#1)(2009-7#1)
shear test##2##2##(2008-12#1)(2009-7#1)
shear thinning##4##2##(2008-5#4)
shear to##2##2##(2008-11#1)(2008-6#1)
shear wave##2##2##(2008-5#1)(2009-5#1)
shear##160##1##(1990-11#1)(1990-8#1)(1991-9#1)(1992-12#3)(1993-11#3)(1994-12#1)(1994-8#1)(1996-4#7)(1997-6#1)(2006-6#5)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#24)(2008-12#3)(2008-2#8)(2008-3#10)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#1)(2010-4#4)(2010-8#1)(2010-9#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#11)
shear-force value of raw pork##3##5##(2010-2#3)
shear-force value##4##2##(2010-2#4)
shear-force##7##1##(2008-2#3)(2010-2#4)
shear-induced platelet##2##2##(2006-6#2)
shear-rate##3##1##(1992-12#1)(2007-12#2)
sheared wave front##2##3##(2008-3#2)
sheared##8##1##(1993-12#1)(2008-2#1)(2008-3#5)(2009-7#1)
shearing interferograms with##2##3##(2008-3#2)
shearing interferograms##7##2##(2008-3#7)
shearing interferometer that##2##3##(2007-11#1)(2008-3#1)
shearing interferometer##17##2##(2007-11#7)(2008-2#2)(2008-3#8)
shearing interferometry##7##2##(2007-11#3)(2007-12#1)(2008-3#3)
shearing motion##2##2##(1995-5#2)
shearing osteochondral fracture##2##3##(2008-8#2)
shearing##51##1##(1995-5#2)(1995-6#1)(2007-11#12)(2007-12#1)(2008-2#5)(2008-3#27)(2008-8#2)(2013-1#1)
shearographic carrier fringes##3##3##(2008-3#3)
shearographic##5##1##(2008-3#5)
shearography is##2##2##(2008-3#2)
shearography##7##1##(2008-3#7)
shears and##2##2##(2008-2#1)(2008-3#1)
shears##11##1##(1992-7#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-6#1)(2012-3#1)
sheath and##4##2##(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
sheath blight development##2##3##(2008-10#2)
sheath blight##16##2##(2008-10#15)(2008-9#1)
sheath cells##4##2##(1994-8#1)(2010-11#2)(2013-8#1)
sheath ganglion##3##2##(2008-9#3)
sheath is##3##2##(2007-12#1)(2008-7#1)(2010-5#1)
sheath of the##2##3##(2008-10#1)(2011-2#1)
sheath of##5##2##(2008-10#3)(2009-6#1)(2011-2#1)
sheath to the##2##3##(2008-10#1)(2008-7#1)
sheath##84##1##(1991-2#2)(1994-8#1)(1997-4#1)(1997-8#1)(2007-12#8)(2007-7#1)(2008-10#36)(2008-2#1)(2008-5#4)(2008-7#9)(2008-8#1)(2008-9#6)(2009-1#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-5#3)(2010-8#1)(2011-2#2)(2013-8#1)
sheaths in##3##2##(2007-12#2)(2009-6#1)
sheaths##13##1##(2007-12#3)(2007-7#1)(2008-10#4)(2009-6#1)(2010-3#1)(2011-2#2)(2013-8#1)
shed and##2##2##(1996-3#1)(2009-9#1)
shed at##2##2##(2008-11#1)(2012-3#1)
shed from leukocytes##2##3##(1992-12#2)
shed from##3##2##(1992-12#2)(2009-6#1)
shed light on how##2##4##(1994-12#1)(2012-3#1)
shed light on the evolution of the##2##7##(1995-11#1)(1997-9#1)
shed light on the molecular mechanisms##2##6##(2009-5#1)(2010-12#1)
shed light on the##14##4##(1994-1#1)(1995-11#1)(1997-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
shed light on these##2##4##(2009-5#1)(2012-2#1)
shed light on##29##3##(1991-9#1)(1994-1#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-5#3)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
shed light##31##2##(1991-9#1)(1994-1#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-5#3)(2009-7#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
shed more light on the##2##5##(1992-9#1)(2008-1#1)
shed more light on##3##4##(1992-9#1)(2008-1#1)(2008-8#1)
shed new light on the##7##5##(2008-2#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#3)
shed new light on##10##4##(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)(2012-2#3)
shed new##11##2##(2008-2#2)(2008-7#2)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)(2012-2#3)
shed some light##2##3##(2008-11#1)(2011-2#1)
shed##70##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-9#1)(1992-12#3)(1992-9#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#1)
shedding and##2##2##(1994-6#1)(2008-5#1)
shedding at intake##2##3##(2013-8#2)
shedding could##2##2##(2008-5#1)(2012-2#1)
shedding of revertant virus##3##4##(1995-5#3)
shedding of##10##2##(1995-5#5)(1996-2#1)(2008-5#2)(2009-6#1)(2012-9#1)
shedding patterns of##2##3##(2012-3#2)
shedding patterns##5##2##(2012-3#4)(2013-8#1)
shedding was##5##2##(1995-5#1)(2008-10#1)(2008-5#2)(2009-6#1)
shedding##49##1##(1994-6#1)(1995-5#7)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-5#11)(2009-6#3)(2010-5#1)(2012-2#2)(2012-3#7)(2012-9#1)(2013-8#10)
sheds light on the##4##4##(2009-4#1)(2010-1#1)(2012-2#1)(2013-1#1)
sheds some light on this##2##5##(2008-8#1)(2012-2#1)
sheds##9##1##(1994-12#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-4#2)(2012-2#2)(2013-1#1)
sheds)##2##1##(2010-4#2)
sheep (Ovis ammon)##2##3##(2009-4#2)
sheep (Ovis##3##2##(1995-2#1)(2009-4#2)
sheep (n =##2##3##(1996-12#1)(1997-1#1)
sheep and goats##5##3##(1996-5#1)(2008-12#3)(2011-2#1)
sheep and##12##2##(1993-8#1)(1996-3#2)(1996-5#1)(2007-11#1)(2008-12#3)(2008-8#1)(2009-4#1)(2011-2#2)
sheep brain##3##2##(1996-11#1)(1996-5#2)
sheep breed##2##2##(2008-12#2)
sheep breeds##4##2##(2011-1#4)
sheep by##3##2##(1991-11#1)(1991-8#1)(1995-6#1)
sheep erythrocytes##2##2##(2008-10#2)
sheep from##2##2##(1995-6#1)(2008-8#1)
sheep in##2##2##(1991-8#1)(2008-12#1)
sheep liver mitochondria##2##3##(2008-5#2)
sheep liver##4##2##(2008-12#1)(2008-5#3)
sheep meat##3##2##(2010-4#1)(2013-1#2)
sheep model##2##2##(2012-1#2)
sheep over a##2##3##(1996-12#1)(2011-2#1)
sheep red blood cells (SRBC)##10##5##(1992-2#1)(2008-10#4)(2008-4#4)(2008-7#1)
sheep red blood cells (SRBCs) and##2##6##(1993-12#1)(2008-6#1)
sheep red blood cells##21##4##(1992-2#1)(1993-12#2)(2008-10#11)(2008-4#4)(2008-6#1)(2008-7#2)
sheep red blood##22##3##(1992-2#1)(1993-12#2)(2008-10#12)(2008-4#4)(2008-6#1)(2008-7#2)
sheep to##3##2##(1991-12#1)(1996-12#2)
sheep using##2##2##(2008-7#1)(2009-4#1)
sheep was significantly different##2##4##(2008-12#2)
sheep was##3##2##(2008-12#2)(2008-8#1)
sheep were challenged with##2##4##(1991-8#2)
sheep were##4##2##(1991-8#2)(2008-12#1)(2009-4#1)
sheep with##5##2##(1997-5#2)(2008-12#1)(2011-1#1)(2012-12#1)
sheep##158##1##(1990-11#1)(1990-5#6)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#7)(1991-9#1)(1992-2#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#4)(1994-5#1)(1994-7#1)(1995-2#1)(1995-6#4)(1996-11#1)(1996-12#10)(1996-3#2)(1996-5#3)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#4)(1997-7#1)(2007-11#1)(2008-10#24)(2008-11#1)(2008-12#16)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2009-4#6)(2010-4#3)(2010-6#1)(2011-1#9)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
sheer##2##1##(2008-12#1)(2010-10#1)
sheet and##4##2##(1995-6#1)(2008-3#2)(2009-11#1)
sheet bed##6##2##(2008-11#6)
sheet for##3##2##(2013-1#3)
sheet is##2##2##(1991-6#1)(2008-3#1)
sheet of##3##2##(2006-12#1)(2008-11#1)(2011-1#1)
sheet with##2##2##(2008-2#1)(2008-3#1)
sheet##59##1##(1991-6#1)(1992-1#1)(1992-8#1)(1992-9#1)(1995-6#1)(1997-7#1)(1997-9#3)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#9)(2008-5#1)(2008-7#2)(2009-11#5)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#8)(2013-8#1)
sheet-like##2##1##(2009-8#1)(2012-1#1)
sheeting##5##1##(2008-10#1)(2008-3#1)(2008-9#3)
sheetlike##2##1##(1992-3#1)(2007-11#1)
sheets and##3##2##(1995-3#1)(2008-9#1)(2013-1#1)
sheets of##3##2##(2008-5#1)(2008-7#1)(2010-9#1)
sheets were##2##2##(1995-11#1)(2008-3#1)
sheets##31##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-7#2)(1997-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#3)
shelf life of##8##3##(2007-3#2)(2008-10#2)(2010-7#1)(2012-2#2)(2013-1#1)
shelf life##17##2##(2007-3#2)(2008-10#7)(2008-12#1)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#1)
shelf##28##1##(1992-1#1)(2007-3#2)(2008-10#7)(2008-12#1)(2008-3#1)(2010-4#1)(2010-7#2)(2010-8#7)(2011-2#3)(2012-2#2)(2013-1#1)
shelf-edge##3##1##(2011-2#3)
shelf-life of##5##2##(1997-4#1)(2008-5#2)(2013-1#2)
shelf-life##19##1##(1994-3#1)(1997-4#6)(2008-10#2)(2008-5#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
shelf-lives##2##1##(2008-5#1)(2011-2#1)
shell and iron##2##3##(2008-10#1)(2010-6#1)
shell and##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
shell at##2##2##(1994-2#1)(2008-2#1)
shell crosslinked##2##2##(2009-9#1)(2010-2#1)
shell for##2##2##(2008-3#1)(2012-2#1)
shell gland##2##2##(2008-12#2)
shell length##3##2##(2008-5#3)
shell oil in##2##3##(1992-2#2)
shell oil##4##2##(1992-2#4)
shell with##2##2##(2008-8#1)(2012-2#1)
shell##74##1##(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-8#1)(1994-2#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#5)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#4)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#6)(2013-1#4)
shellac than when applied by##2##5##(2008-10#2)
shellac than when##3##3##(2008-10#3)
shellac##4##1##(2008-10#4)
shellacked fruit##2##2##(2008-10#2)
shellfish poisoning toxins##2##3##(1994-12#1)(1997-4#1)
shellfish poisoning##4##2##(1994-12#2)(1997-4#2)
shellfish##14##1##(1992-8#1)(1994-12#2)(1997-4#6)(2007-2#1)(2008-10#1)(2008-11#1)(2010-9#1)(2013-7#1)
shells of##3##2##(2008-11#1)(2008-12#2)
shells##22##1##(1994-3#2)(1997-4#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
shelter in##3##2##(2012-3#1)(2013-8#2)
shelter##9##1##(1996-12#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-2#1)(2012-3#1)(2013-8#2)
sheltered##5##1##(2008-10#3)(2008-9#1)(2011-1#1)
shelters##4##1##(1996-3#1)(2008-9#2)(2012-3#1)
sherds##2##1##(2008-10#2)
shh in##2##2##(1993-12#2)
shh##3##1##(1993-12#3)
shibatae##6##1##(2008-9#6)
shield was##2##2##(2009-11#2)
shield##14##1##(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#7)(2011-2#1)
shielded by##2##2##(2008-10#1)(2008-8#1)
shielded the##2##2##(1994-8#1)(2008-3#1)
shielded##5##1##(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
shielding##14##1##(1993-12#1)(1993-8#1)(2007-11#1)(2008-3#4)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#1)(2010-7#1)(2013-1#1)
shields##6##1##(1991-8#1)(2008-10#3)(2008-3#1)(2009-11#1)
shift (&gt##2##2##(2008-10#1)(2009-6#1)
shift against##2##2##(2008-3#1)(2009-5#1)
shift alternative##2##2##(2013-1#2)
shift analysis##4##2##(1993-8#1)(1994-9#1)(2008-9#2)
shift and scale##2##3##(1995-9#1)(1996-3#1)
shift and the##3##3##(2007-12#2)(2008-10#1)
shift and##24##2##(1991-12#1)(1991-2#1)(1995-2#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#8)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#3)(2011-1#1)
shift as a##2##3##(2008-3#1)(2012-2#1)
shift assay##18##2##(1992-12#3)(1993-6#1)(1993-8#2)(1994-12#1)(1995-2#1)(1995-8#1)(2008-11#4)(2008-4#1)(2008-9#3)(2011-2#1)
shift assays with##2##3##(1994-6#1)(2008-10#1)
shift assays##12##2##(1991-11#1)(1994-6#2)(1994-9#1)(1995-6#2)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
shift assignments of the##2##4##(2009-7#2)
shift assignments of##5##3##(2009-7#5)
shift assignments##11##2##(1993-11#1)(2009-7#10)
shift at##2##2##(1992-6#1)(2008-2#1)
shift away from##3##3##(1993-12#1)(2008-9#1)(2010-4#1)
shift between the##5##3##(2007-11#1)(2008-3#4)
shift between##14##2##(2007-11#5)(2008-11#1)(2008-2#2)(2008-3#6)
shift by##5##2##(1994-6#1)(2007-11#2)(2008-11#1)(2008-9#1)
shift can be##4##3##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
shift caused by##3##3##(1995-5#2)(2007-11#1)
shift curves##3##2##(2008-10#3)
shift data##4##2##(1991-9#1)(1992-12#1)(1997-7#1)(2008-10#1)
shift during##2##2##(2007-12#1)(2012-2#1)
shift for the##5##3##(1995-5#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-12#1)
shift for##6##2##(1995-5#1)(2008-2#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-12#1)
shift from a##5##3##(1993-12#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)
shift from inpatient to outpatient services##2##6##(1992-2#1)(1993-1#1)
shift from inpatient to outpatient##3##5##(1992-2#1)(1993-1#1)(1993-12#1)
shift from the##5##3##(1992-6#1)(1993-1#1)(2008-11#1)(2009-3#1)(2012-3#1)
shift from##30##2##(1992-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1994-11#1)(1995-11#1)(1995-2#2)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-3#1)
shift has##2##2##(2008-7#1)(2008-8#1)
shift in a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
shift in baseline##2##3##(2008-10#2)
shift in care##3##3##(1996-2#1)(2007-10#1)(2008-3#1)
shift in our##2##3##(2010-7#1)(2013-1#1)
shift in public health##2##4##(2011-1#1)(2012-1#1)
shift in the absorption##3##4##(2007-11#2)(2008-2#1)
shift in the reading frame##2##5##(1990-7#1)(1994-12#1)
shift in the##40##3##(1990-5#3)(1990-7#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
shift in virulence##2##3##(2008-10#2)
shift in##97##2##(1990-5#3)(1990-7#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#2)(1997-7#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#8)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
shift invariant##2##2##(2008-3#2)
shift is shown to be##2##5##(2008-2#1)(2008-3#1)
shift is##16##2##(1995-5#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2013-1#1)
shift measurement##2##2##(2008-2#2)
shift occurred##2##2##(2008-7#1)(2008-9#1)
shift of a##3##3##(2007-12#1)(2009-5#2)
shift of equilibrium between the two fluorescent forms of a synthetic##2##11##(2008-10#2)
shift of pH##2##3##(2008-10#2)
shift of temperature##2##3##(2008-11#2)
shift of the generated##2##4##(2007-12#1)(2008-2#1)
shift of the maximum##2##4##(2008-10#2)
shift of the optimum pH##2##5##(1990-7#1)(2008-9#1)
shift of the##32##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#2)(1993-12#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)
shift of##86##2##(1990-5#1)(1990-7#2)(1991-12#2)(1991-5#1)(1992-12#3)(1993-11#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(2007-11#5)(2007-12#5)(2008-10#19)(2008-11#5)(2008-2#7)(2008-3#12)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#3)(2009-2#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-1#1)
shift parameter##2##2##(1991-9#1)(1996-3#1)
shift parameters##2##2##(2008-2#1)(2008-3#1)
shift reagent##3##2##(1994-3#1)(1997-7#1)(2008-10#1)
shift relative to##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
shift selectivity##2##2##(2007-12#2)
shift some of their##2##4##(1995-1#1)(2008-11#1)
shift that##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
shift the potential of Uf more##2##6##(1991-8#2)
shift the##16##2##(1991-8#2)(1992-4#1)(1994-2#2)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2009-5#1)(2013-8#1)
shift to a more##2##4##(1993-2#1)(2008-10#1)
shift to a##5##3##(1992-2#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
shift to be##2##3##(2007-11#1)(2008-10#1)
shift to the##5##3##(1994-5#1)(2007-12#2)(2008-10#1)(2008-5#1)
shift to##27##2##(1990-5#1)(1992-2#1)(1993-2#1)(1994-5#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)
shift toward##7##2##(1993-12#1)(1994-8#1)(1996-2#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
shift towards##2##2##(2008-9#1)(2009-4#1)
shift type##4##2##(2011-2#4)
shift was##8##2##(1992-6#1)(2007-11#2)(2008-10#2)(2008-8#1)(2009-5#1)(2010-10#1)
shift with##3##2##(1997-7#1)(2007-11#1)(2007-12#1)
shift work exposure##3##3##(2011-2#3)
shift work##13##2##(1990-2#1)(2008-8#2)(2010-7#3)(2011-2#7)
shift workers##9##2##(2008-8#3)(2010-7#1)(2011-2#5)
shift##652##1##(1990-2#1)(1990-5#6)(1990-7#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#8)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#8)(1993-12#10)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#4)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#6)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#8)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#4)(1996-5#3)(1996-7#1)(1997-1#3)(1997-2#3)(1997-7#9)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#43)(2007-12#46)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#67)(2008-11#30)(2008-12#1)(2008-2#52)(2008-3#67)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#15)(2008-9#15)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#8)(2009-6#5)(2009-7#10)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#7)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#23)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
shift)##3##1##(1990-11#1)(2008-2#1)(2010-4#1)
shift- and scale-invariant optical##2##4##(2008-3#2)
shift-invariant##6##1##(2008-3#6)
shift-multiplexed holographic##3##2##(2008-3#3)
shift?##2##1##(2008-3#1)(2010-12#1)
shifted and##3##2##(2008-2#1)(2008-3#2)
shifted by the##2##3##(2007-12#1)(2008-2#1)
shifted by##7##2##(1990-12#1)(1990-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
shifted from the##2##3##(1995-12#1)(2011-2#1)
shifted from##8##2##(1994-3#2)(1995-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
shifted in##2##2##(2008-10#1)(2008-2#1)
shifted its##2##2##(1997-7#1)(2010-8#1)
shifted linearly##2##2##(2008-10#2)
shifted negatively##3##2##(2008-10#3)
shifted over the past##2##4##(1995-12#1)(2011-2#1)
shifted the##11##2##(1992-3#1)(1992-6#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
shifted to a##5##3##(1991-9#1)(1993-12#1)(1994-8#1)(1995-8#1)(2007-7#1)
shifted to more positive values##2##5##(1993-12#1)(2008-10#1)
shifted to more##3##3##(1993-12#1)(2008-10#2)
shifted to target##2##3##(2010-7#1)(2013-1#1)
shifted to the right##5##4##(1990-12#1)(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)
shifted to the##8##3##(1990-12#1)(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(2010-5#1)(2013-1#1)
shifted to##35##2##(1990-12#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-12#3)(1993-8#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#4)(2007-11#2)(2007-7#1)(2008-10#3)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
shifted toward##3##2##(2008-10#2)(2008-9#1)
shifted towards##2##2##(2008-10#1)(2012-12#1)
shifted##128##1##(1990-12#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#8)(1993-3#1)(1993-8#3)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-5#3)(1995-8#4)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-11#5)(2007-12#4)(2007-7#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#8)(2008-5#2)(2008-7#3)(2008-9#5)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
shifter##12##1##(2007-11#3)(2008-10#1)(2008-3#8)
shifters##7##1##(2008-2#5)(2008-3#2)
shifting and##5##2##(1995-5#1)(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#1)
shifting from##2##2##(1994-8#1)(2010-8#1)
shifting in##4##2##(2008-11#1)(2008-3#2)(2011-1#1)
shifting is##2##2##(2008-10#1)(2008-3#1)
shifting of a##2##3##(2008-2#1)(2008-3#1)
shifting of the##10##3##(1994-11#1)(2007-11#3)(2008-10#1)(2008-3#4)(2008-5#1)
shifting of##14##2##(1994-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)
shifting selectivity of##2##3##(2008-3#2)
shifting selectivity##4##2##(2008-3#4)
shifting the##20##2##(1992-3#1)(1994-3#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#6)(2008-6#1)(2008-8#1)(2011-2#1)
shifting to##3##2##(1992-2#1)(1993-6#1)(2008-8#1)
shifting tolerance of##2##3##(2008-3#2)
shifting tolerance##3##2##(2008-3#3)
shifting##92##1##(1992-2#2)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-11#3)(2007-12#4)(2008-10#7)(2008-11#7)(2008-2#10)(2008-3#30)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
shifts (n =##2##3##(2011-2#2)
shifts and##8##2##(1992-4#1)(1992-8#1)(1993-2#1)(1995-3#1)(2008-10#1)(2010-1#1)(2010-7#1)(2010-8#1)
shifts are##8##2##(1991-8#1)(1992-8#2)(2007-11#1)(2008-10#1)(2008-2#2)(2009-6#1)
shifts as##2##2##(2008-11#1)(2012-2#1)
shifts associated with##2##3##(2007-11#1)(2008-2#1)
shifts between##3##2##(1991-5#1)(1992-2#1)(2007-8#1)
shifts caused by the##2##4##(1995-5#1)(2008-3#1)
shifts for##4##2##(1994-5#1)(1995-5#2)(2010-7#1)
shifts from##7##2##(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2012-2#1)
shifts have##3##2##(2008-2#2)(2008-9#1)
shifts in diversification rates##2##4##(2008-9#2)
shifts in reimbursement##2##3##(1992-1#1)(1995-3#1)
shifts in the##13##3##(1993-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#2)(2012-6#1)(2013-8#1)
shifts in their##3##3##(1995-5#1)(1997-7#1)(2009-10#1)
shifts in women's##2##3##(2008-11#2)
shifts in##46##2##(1992-1#1)(1993-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-6#2)(2013-8#1)
shifts induced by##4##3##(1997-2#1)(1997-7#1)(2008-2#1)(2008-3#1)
shifts induced##5##2##(1997-2#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
shifts is##5##2##(1992-2#1)(1992-8#1)(2008-11#1)(2008-3#2)
shifts observed for##3##3##(1993-8#2)(1997-7#1)
shifts of Co(en)(3)(3+)##2##3##(1997-7#2)
shifts of attention##2##3##(1995-5#1)(2008-7#1)
shifts of the##12##3##(1994-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2009-7#1)(2013-1#1)
shifts of these peaks##2##4##(2008-9#1)(2009-6#1)
shifts of these##3##3##(2008-10#1)(2008-9#1)(2009-6#1)
shifts of##33##2##(1991-8#1)(1993-12#1)(1994-2#1)(1995-2#2)(1995-5#2)(1996-5#1)(1997-7#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)(2013-1#1)
shifts that are##2##3##(1992-8#1)(2007-11#1)
shifts that##7##2##(1992-8#1)(1994-8#1)(2007-11#2)(2007-12#2)(2008-4#1)
shifts the##8##2##(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#2)
shifts to a more##2##4##(1994-3#1)(2008-10#1)
shifts to more##2##3##(2008-10#2)
shifts to##11##2##(1992-12#1)(1994-3#1)(2008-10#6)(2008-3#1)(2010-12#1)(2013-8#1)
shifts toward##3##2##(2007-12#2)(2008-10#1)
shifts towards##3##2##(1992-8#1)(2008-11#1)(2013-8#1)
shifts was##2##2##(2008-3#2)
shifts were##7##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-6#2)
shifts with##3##2##(1996-2#1)(2007-12#1)(2008-10#1)
shifts##256##1##(1991-1#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-8#7)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#6)(1995-3#2)(1995-5#7)(1995-6#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-7#5)(2007-11#12)(2007-12#14)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#18)(2008-12#2)(2008-2#24)(2008-3#26)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#7)(2009-10#2)(2009-5#2)(2009-6#3)(2009-7#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#2)(2013-1#1)(2013-8#4)
shiga toxin##7##2##(2008-8#6)(2013-1#1)
shiitake##5##1##(2008-10#5)
shikimic and quinic##2##3##(2008-10#2)
shikimic##3##1##(2008-10#3)
shikonin production##4##2##(1994-11#4)
shikonin##7##1##(1994-11#7)
shimming by##2##2##(2012-3#2)
shimming##7##1##(2012-3#7)
shining##4##1##(1993-1#1)(2008-1#1)(2008-4#1)(2009-7#1)
shiny##2##1##(2008-5#1)(2008-7#1)
ship and##2##2##(1991-12#1)(2008-3#1)
ship of##2##2##(2008-10#1)(2009-7#1)
ship##16##1##(1990-6#2)(1991-12#1)(1992-6#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-7#3)(2011-2#2)
shipboard##3##1##(2008-10#3)
shipped##2##1##(2007-5#1)(2008-10#1)
shipping##3##1##(1993-6#1)(2008-11#1)(2008-6#1)
ships and the##2##3##(2008-11#1)(2011-2#1)
ships and##3##2##(2008-11#2)(2011-2#1)
ships##13##1##(2008-10#1)(2008-11#6)(2008-2#1)(2009-7#1)(2011-2#4)
shipyard workers##2##2##(1991-12#1)(2008-7#1)
shipyard##5##1##(1991-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
shipyards##2##1##(2008-10#1)(2008-11#1)
shiver##3##1##(1997-6#2)(2013-1#1)
shivering##15##1##(1991-8#1)(2007-10#2)(2010-4#1)(2010-7#11)
shoal##2##1##(2010-8#2)
shock absorption##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
shock after##4##2##(1997-5#1)(2007-9#2)(2012-3#1)
shock and the##3##3##(2007-7#1)(2008-1#1)(2009-8#1)
shock and##13##2##(1994-11#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
shock as##2##2##(1994-11#1)(2011-2#1)
shock due to##2##3##(1994-2#1)(2008-1#1)
shock element##3##2##(1993-8#2)(1994-8#1)
shock in the##2##3##(1996-9#1)(2009-4#1)
shock in##11##2##(1990-11#1)(1991-9#1)(1994-8#1)(1995-2#2)(1996-9#1)(2007-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
shock is##3##2##(1994-11#1)(1995-11#1)(2011-2#1)
shock on a##2##3##(2008-2#1)(2008-7#1)
shock on##3##2##(1994-5#1)(2008-2#1)(2008-7#1)
shock protein (HSP)##4##3##(1993-8#1)(1994-11#1)(2008-7#1)(2013-1#1)
shock protein 56##2##3##(1992-11#1)(1993-8#1)
shock protein 60 (HSP60)##2##4##(2008-4#2)
shock protein 60##3##3##(2008-4#2)(2008-7#1)
shock protein##54##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-8#3)(1994-11#4)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#4)(1996-9#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#4)(2010-12#2)(2010-2#1)(2012-1#5)(2012-12#1)(2013-1#2)(2013-8#1)
shock proteins and##2##3##(1994-11#1)(2008-7#1)
shock proteins in immune response##2##5##(1994-11#2)
shock proteins in the##3##4##(1994-11#2)(2008-5#1)
shock proteins in##5##3##(1994-11#4)(2008-5#1)
shock proteins##23##2##(1990-11#1)(1991-9#1)(1993-8#2)(1994-11#9)(1996-9#1)(1997-4#1)(2008-5#2)(2008-7#3)(2009-5#2)(2012-12#1)
shock requiring##2##2##(2007-9#1)(2013-1#1)
shock response##15##2##(1993-8#1)(1994-11#4)(1994-6#1)(1994-8#3)(2008-5#1)(2008-7#3)(2010-2#2)
shock syndrome toxin-1 (TSST-1)##2##4##(1993-3#1)(1997-2#1)
shock syndrome toxin-1##3##3##(1993-3#1)(1997-2#2)
shock syndrome##12##2##(1993-3#2)(1993-6#1)(1994-8#1)(1997-2#2)(2007-12#1)(2007-2#1)(2008-5#1)(2011-2#3)
shock to the##2##3##(1996-2#1)(1996-3#1)
shock was##3##2##(1995-2#1)(1996-2#1)(2008-4#1)
shock wave lithotripsy (ESWL)##3##4##(1990-11#1)(2007-7#1)(2009-5#1)
shock wave lithotripsy##10##3##(1990-11#1)(1990-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
shock wave therapy##3##3##(1997-6#2)(2013-8#1)
shock wave##15##2##(1990-11#1)(1990-8#1)(1997-6#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
shock waves##3##2##(1994-5#2)(1997-5#1)
shock were##2##2##(2007-8#1)(2008-7#1)
shock with##4##2##(1991-8#1)(1993-12#1)(2008-8#1)(2013-1#1)
shock##340##1##(1990-11#8)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#11)(1994-11#27)(1994-2#1)(1994-5#6)(1994-6#1)(1994-8#23)(1995-11#4)(1995-12#1)(1995-2#10)(1995-5#1)(1995-6#2)(1996-12#7)(1996-2#3)(1996-3#6)(1996-9#3)(1997-2#3)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#6)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#11)(2008-5#8)(2008-6#2)(2008-7#27)(2008-8#2)(2009-10#2)(2009-4#1)(2009-5#5)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#4)(2010-5#3)(2010-9#1)(2011-1#4)(2011-2#24)(2012-1#6)(2012-12#4)(2012-3#6)(2013-1#11)(2013-8#5)
shock-induced##2##1##(1994-5#1)(2013-1#1)
shock-probe##7##1##(1993-3#5)(1994-2#2)
shock-wave##2##1##(2007-12#1)(2008-10#1)
shock]##2##1##(1992-11#1)(2013-1#1)
shocked##7##1##(1995-12#3)(1997-5#1)(2008-5#1)(2008-6#2)
shocking the cells with glycerol or DMSO improves transfection efficiency##2##10##(2008-1#1)(2008-2#1)
shocking##4##1##(2007-11#1)(2008-1#1)(2008-2#1)(2010-8#1)
shocks in##2##2##(1996-4#2)
shocks##17##1##(1994-3#1)(1996-4#5)(1997-1#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#4)
shockwave lithotripsy##5##2##(2007-7#1)(2013-1#4)
shockwave##11##1##(1997-6#1)(2007-7#1)(2008-11#5)(2013-1#4)
shoe##8##1##(1990-6#1)(1994-12#1)(1997-4#2)(2007-2#1)(2008-10#1)(2010-11#1)(2013-1#1)
shoe-surface##5##1##(2013-1#5)
shoes and##2##2##(1990-6#1)(2010-11#1)
shoes##6##1##(1990-6#1)(2008-10#1)(2010-11#1)(2010-3#1)(2013-1#1)(2013-8#1)
shook##2##1##(1993-5#1)(2012-12#1)
shoot and root stem##2##4##(2009-8#2)
shoot and root##6##3##(2008-10#1)(2008-12#1)(2009-8#4)
shoot and##8##2##(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#4)
shoot apex##2##2##(2008-10#1)(2008-5#1)
shoot apical meristem (SAM)##3##4##(2009-8#2)(2012-2#1)
shoot apical meristem##4##3##(2009-8#3)(2012-2#1)
shoot blight##14##2##(2008-10#14)
shoot buds##3##2##(2013-1#3)
shoot competition##3##2##(2008-9#3)
shoot dieback##2##2##(2008-10#2)
shoot growth or##2##3##(2008-10#1)(2008-11#1)
shoot growth##4##2##(2008-10#3)(2008-11#1)
shoot tip and##2##3##(2008-10#1)(2008-12#1)
shoot tip meristems##2##3##(2008-8#1)(2008-9#1)
shoot tip##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
shoot tips##5##2##(2008-10#1)(2008-8#4)
shoot##96##1##(2008-10#49)(2008-11#1)(2008-12#8)(2008-5#3)(2008-8#8)(2008-9#8)(2009-8#9)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#6)
shoot)##2##1##(2008-10#2)
shoot/root ratio##2##2##(2008-10#1)(2008-12#1)
shooting##8##1##(1991-3#1)(1995-11#2)(2008-12#2)(2009-2#1)(2011-2#1)(2013-1#1)
shoots and roots##5##3##(2008-10#2)(2008-12#3)
shoots and##10##2##(2008-10#5)(2008-12#3)(2009-8#2)
shoots are##2##2##(2008-10#1)(2008-12#1)
shoots as##3##2##(2008-10#2)(2008-9#1)
shoots by##3##2##(2008-10#3)
shoots contained##2##2##(2008-10#2)
shoots for##3##2##(2008-10#3)
shoots in the##2##3##(2008-10#1)(2008-12#1)
shoots increased##2##2##(2008-10#1)(2008-12#1)
shoots m(-2) in##2##3##(2008-5#2)
shoots was##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2009-8#1)(2012-8#1)
shoots were##4##2##(2008-10#3)(2008-12#1)
shoots##76##1##(1996-10#1)(2008-10#49)(2008-11#1)(2008-12#14)(2008-5#3)(2008-9#1)(2009-10#1)(2009-8#3)(2012-8#1)(2013-1#2)
shoots)##4##1##(2008-10#1)(2011-2#1)(2013-1#2)
shop##7##1##(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#2)(1994-3#1)(1997-1#1)
shopper##2##1##(1994-1#1)(1996-5#1)
shopping for##2##2##(2008-1#1)(2013-1#1)
shopping##13##1##(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#3)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
shops##2##1##(1993-1#1)(1997-3#1)
shore crab##2##2##(1994-11#1)(2007-12#1)
shore flies##2##2##(2008-10#2)
shore##11##1##(1994-1#1)(1994-11#1)(1995-5#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-5#3)(2013-7#1)
shorebirds##4##1##(2013-7#4)
shoreline##3##1##(2008-10#2)(2008-5#1)
shores of the##2##3##(1996-6#1)(2010-1#1)
shores##3##1##(1996-6#1)(2008-10#1)(2010-1#1)
short (6##2##2##(2008-10#1)(2008-7#1)
short (approximately##2##2##(2008-3#1)(2009-8#1)
short (mev-1) life##2##3##(2008-3#2)
short Barrett's esophagus##2##3##(2013-8#2)
short CDSs##4##2##(1996-12#4)
short DNA and fibrous DNA##2##5##(2008-11#2)
short DNA strands##2##3##(2009-6#1)(2010-7#1)
short DNA##10##2##(2008-10#1)(2008-11#5)(2008-3#1)(2009-6#1)(2010-7#1)(2012-3#1)
short ORFs##2##2##(1995-12#1)(2008-10#1)
short acting beta agonist use but only among children who##2##10##(2012-1#2)
short acting beta agonist use even after adjusting for##2##9##(2012-1#2)
short acting beta agonist use##9##5##(2012-1#9)
short acting##10##2##(2008-8#1)(2012-1#9)
short analysis time##4##3##(2008-10#4)
short analysis##5##2##(2008-10#5)
short and long term treatment##3##5##(2007-12#1)(2008-1#1)(2008-8#1)
short and long term##8##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#3)
short and long##13##3##(1992-11#1)(1993-12#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2012-12#1)
short and long-term##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
short and medium-term##2##3##(2011-2#2)
short and##33##2##(1991-3#1)(1992-11#1)(1993-12#1)(1994-11#2)(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#3)(2009-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
short and/or##2##2##(1997-3#1)(2007-12#1)
short arm##28##2##(1996-2#1)(1997-2#1)(2008-10#16)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-10#1)(2012-3#2)
short arms of chromosome##2##4##(2008-5#1)(2009-10#1)
short arms##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)
short as##22##2##(2007-11#8)(2007-12#7)(2008-2#4)(2008-3#3)
short bowel syndrome##6##3##(1991-12#3)(1993-5#1)(1994-3#1)(2008-10#1)
short bowel##7##2##(1991-12#3)(1993-5#1)(1994-3#1)(2008-10#2)
short but##2##2##(1995-1#1)(2008-7#1)
short calls##2##2##(1994-8#1)(2008-8#1)
short capillary and##2##3##(2008-10#2)
short cattle tendons##3##3##(2008-5#3)
short chain fatty##2##3##(1990-6#1)(2008-7#1)
short chain##3##2##(1990-6#1)(2008-7#1)(2009-6#1)
short coherence length##3##3##(2007-11#3)
short compared with the##2##4##(2007-12#1)(2008-2#1)
short course##4##2##(1993-3#1)(1994-1#1)(2006-10#1)(2011-1#1)
short cut##2##2##(2010-4#1)(2010-8#1)
short delays##2##2##(1993-12#2)
short deletions##2##2##(1993-2#1)(1997-7#1)
short description of the##4##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-4#1)
short discussion##2##2##(1992-3#1)(2007-11#1)
short distance##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
short distances##8##2##(2008-10#5)(2008-3#1)(2008-4#1)(2013-8#1)
short duration and##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
short duration of follow-up##2##4##(2008-1#1)(2009-10#1)
short duration of##5##3##(2008-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2012-2#1)
short duration##14##2##(1990-2#1)(1992-8#1)(1995-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#2)
short exposure to##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
short exposure##5##2##(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#1)
short exposures##2##2##(2008-10#1)(2008-7#1)
short external##2##2##(2008-3#1)(2008-8#1)
short fibers##3##2##(2008-3#1)(2009-11#1)(2009-7#1)
short for##3##2##(1990-12#1)(1995-6#1)(2008-10#1)
short fragments of##2##3##(1993-5#1)(2008-7#1)
short fragments##3##2##(1993-5#1)(2008-7#1)(2013-1#1)
short galls##2##2##(2008-10#2)
short gaps##2##2##(2011-2#2)
short generation time##2##3##(2008-4#1)(2013-1#1)
short generation times##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
short generation##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
short glass fibers##2##3##(2009-7#2)
short hairpin RNA##2##3##(2011-2#1)(2013-1#1)
short half-life##5##2##(1991-8#1)(2008-11#1)(2008-4#1)(2009-11#1)(2010-7#1)
short half-lives##2##2##(2007-11#1)(2010-10#1)
short homologies##2##2##(1993-6#2)
short in##2##2##(1997-5#1)(2013-1#1)
short interfering RNA##2##3##(2008-2#1)(2011-2#1)
short interfering##3##2##(2008-2#2)(2011-2#1)
short interruption of the##2##4##(1991-3#1)(2008-1#1)
short laser pulses##2##3##(2007-11#1)(2008-3#1)
short laser##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
short lasting##2##2##(1992-6#1)(1994-2#1)
short latency##4##2##(1996-2#2)(1996-5#2)
short length scales##3##3##(2008-2#1)(2008-7#2)
short length##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#2)
short lengths of stay##2##4##(1992-3#1)(1995-1#1)
short lengths of##4##3##(1992-3#1)(1995-1#1)(2008-3#1)(2008-7#1)
short lengths##5##2##(1992-3#1)(1995-1#1)(2008-1#1)(2008-3#1)(2008-7#1)
short life##2##2##(2012-3#1)(2013-7#1)
short linear##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
short loop##3##2##(1993-11#1)(1994-11#2)
short of the##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
short of##13##2##(1991-3#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-4#1)(2012-12#1)
short or long##3##3##(2007-12#1)(2008-5#1)(2009-2#1)
short or##7##2##(1992-5#1)(1994-2#1)(2007-12#1)(2008-5#1)(2009-2#1)(2013-1#2)
short path length##2##3##(2008-10#1)(2008-3#1)
short peptide sequence##2##3##(1992-8#1)(1995-2#1)
short peptide##3##2##(1992-8#1)(1995-2#1)(2012-12#1)
short peptides##5##2##(2008-10#1)(2008-4#2)(2010-11#1)(2011-3#1)
short period of time##14##4##(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
short period of##21##3##(1992-6#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#3)
short period##29##2##(1990-6#1)(1990-8#1)(1992-6#2)(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#2)(2013-1#3)(2013-8#1)
short periods of time##2##4##(1992-5#1)(2011-2#1)
short periods##5##2##(1992-5#1)(1996-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
short plasma half-life of##2##4##(1993-8#1)(2008-3#1)
short plasma half-life##5##3##(1993-8#1)(2008-3#1)(2008-5#2)(2012-2#1)
short propagation##2##2##(2008-3#2)
short pulse##9##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#1)
short pulses##7##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
short range##2##2##(2008-10#1)(2008-3#1)
short reaction times##2##3##(2008-10#1)(2008-6#1)
short reaction##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
short regions of##2##3##(2008-4#1)(2012-3#1)
short regions##4##2##(1995-5#1)(2008-10#1)(2008-4#1)(2012-3#1)
short relative##2##2##(1993-8#1)(2010-8#1)
short response time##13##3##(2008-10#12)(2010-5#1)
short response##14##2##(1997-3#1)(2008-10#12)(2010-5#1)
short review of##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
short review##11##2##(1995-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2009-3#1)(2012-12#1)
short rods##2##2##(2008-7#1)(2011-2#1)
short segment##2##2##(1992-8#1)(2012-2#1)
short segments##2##2##(1991-8#2)
short separation time##2##3##(2008-10#1)(2008-4#1)
short sequence##2##2##(2008-8#1)(2009-6#1)
short solarization##2##2##(2008-10#2)
short stature in##2##3##(1993-6#1)(1996-6#1)
short stature##20##2##(1993-6#1)(1996-6#1)(2007-11#1)(2008-1#1)(2010-3#1)(2010-6#1)(2011-1#4)(2012-2#3)(2012-3#2)(2013-1#5)
short stay##3##2##(1997-4#1)(2008-3#1)(2013-1#1)
short stretches of##5##3##(1992-3#1)(1993-6#1)(2008-2#1)(2008-4#2)
short supply of##2##3##(2007-2#1)(2010-12#1)
short supply##6##2##(1996-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
short survival##4##2##(1994-6#1)(1996-9#1)(2008-9#1)(2010-5#1)
short tandem repeat (STR) loci##3##5##(1995-11#1)(2008-12#2)
short tandem repeat (STR)##6##4##(1995-11#1)(2008-12#5)
short tandem repeat##9##3##(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#6)
short tandem repeats##2##3##(2008-12#1)(2008-4#1)
short tandem##11##2##(1994-9#1)(1995-11#1)(2008-11#1)(2008-12#7)(2008-4#1)
short term event##3##3##(2013-1#3)
short term memory status in##3##5##(2012-2#3)
short term##27##2##(1992-2#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#5)(2013-1#5)(2013-8#1)
short term&quot##2##2##(1992-6#2)
short terrestrial duathlon##4##3##(2008-5#4)
short time and##2##3##(2008-10#1)(2008-11#1)
short time intervals##2##3##(2008-3#1)(2012-12#1)
short time of##2##3##(2008-10#1)(2009-4#1)
short time period##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
short time##46##2##(1990-12#1)(1990-9#1)(1991-3#1)(1994-8#1)(1995-11#2)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#9)(2008-5#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
short times##3##2##(2008-11#1)(2008-2#2)
short to##2##2##(1992-3#1)(2008-3#1)
short treatment##3##2##(2008-12#1)(2008-5#1)(2010-11#1)
short version of##2##3##(2006-10#1)(2008-7#1)
short volatile##2##2##(2008-7#2)
short wavelengths##3##2##(2008-3#3)
short##868##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#4)(1991-3#5)(1991-5#1)(1991-6#2)(1991-8#3)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#6)(1992-8#4)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#6)(1993-5#2)(1993-6#6)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#7)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#2)(1996-1#3)(1996-12#7)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#7)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#3)(1997-9#1)(2006-10#2)(2007-10#1)(2007-11#28)(2007-12#39)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#14)(2008-10#119)(2008-11#34)(2008-12#16)(2008-2#36)(2008-3#50)(2008-4#18)(2008-5#30)(2008-6#8)(2008-7#35)(2008-8#13)(2008-9#23)(2009-10#5)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#27)(2011-3#2)(2012-1#9)(2012-12#7)(2012-2#28)(2012-3#10)(2012-8#1)(2013-1#34)(2013-7#1)(2013-8#7)
short&quot##3##1##(2008-4#3)
short)##3##1##(2008-5#2)(2008-8#1)
short- and long-term##17##3##(1991-6#1)(1993-12#1)(1994-2#2)(1995-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
short- and##26##2##(1991-11#1)(1991-6#1)(1993-12#2)(1994-2#2)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
short- or long-term##2##3##(2011-2#1)(2012-5#1)
short-##33##1##(1991-11#1)(1991-6#1)(1993-12#2)(1994-2#2)(1995-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#2)(2012-5#1)(2013-1#4)(2013-8#1)
short-acting versus long-acting##2##3##(2009-9#2)
short-acting##4##1##(1997-4#2)(2009-9#2)
short-chain alcohol##3##2##(1995-5#2)(2008-10#1)
short-chain alcohols##3##2##(1990-12#1)(1992-6#1)(2008-6#1)
short-chain and##2##2##(1991-5#1)(1994-8#1)
short-chain carboxylic acid##2##3##(2007-12#2)
short-chain fatty acid##2##3##(2008-5#1)(2009-4#1)
short-chain fatty acids##2##3##(2008-5#1)(2012-1#1)
short-chain fatty##4##2##(2008-5#2)(2009-4#1)(2012-1#1)
short-chain##27##1##(1990-12#1)(1990-8#1)(1991-5#3)(1992-6#1)(1993-8#1)(1994-8#1)(1995-5#2)(1995-6#1)(1997-4#1)(2007-12#3)(2008-10#4)(2008-5#5)(2008-6#1)(2009-4#1)(2012-1#1)
short-circuit current##4##2##(1990-5#1)(1991-5#1)(2008-5#1)(2008-6#1)
short-circuit##5##1##(1990-5#1)(1991-5#1)(2008-5#1)(2008-6#1)(2013-8#1)
short-cutter##2##1##(1994-12#2)
short-distance##5##1##(1990-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
short-duration##2##1##(2007-11#1)(2008-3#1)
short-exposure##4##1##(2008-2#1)(2008-3#3)
short-form##2##1##(2008-10#1)(2011-2#1)
short-lasting##3##1##(1990-5#1)(1994-2#1)(1995-5#1)
short-lived and##2##2##(1992-12#1)(1995-5#1)
short-lived##13##1##(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#2)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2009-9#1)(2012-12#1)(2012-3#1)(2012-4#1)
short-path##2##1##(2008-10#1)(2008-2#1)
short-pitch ferroelectric liquid##2##3##(2008-3#2)
short-pulse laser##4##2##(2007-11#3)(2012-2#1)
short-pulse##16##1##(1993-5#1)(2007-11#7)(2007-12#1)(2008-2#2)(2008-3#4)(2012-2#1)
short-pulse-duration##3##1##(2007-11#1)(2008-2#2)
short-range##9##1##(1990-4#1)(1992-5#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-5#1)
short-run##2##1##(1992-2#1)(1994-12#1)
short-stay hospital inpatient##2##3##(1991-1#1)(1991-3#1)
short-stay hospital services##3##3##(1991-1#1)(1991-3#1)(1992-2#1)
short-stay hospital##6##2##(1991-1#2)(1991-3#2)(1992-2#2)
short-stay hospitals##2##2##(1992-2#2)
short-stay##8##1##(1991-1#2)(1991-3#2)(1992-2#4)
short-term and long-term memory##3##4##(1992-11#2)(2007-8#1)
short-term and long-term##13##3##(1992-11#2)(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#2)
short-term and##16##2##(1992-11#2)(1994-2#1)(1996-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#2)
short-term antibiotic##2##2##(1990-6#1)(1994-3#1)
short-term assays##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
short-term benefits##4##2##(1995-5#1)(2007-11#1)(2011-2#2)
short-term central venous catheter##3##4##(2007-7#3)
short-term changes##2##2##(1994-12#1)(2008-2#1)
short-term chaos##2##2##(2008-9#2)
short-term clinical##2##2##(2007-8#1)(2008-8#1)
short-term colony assays##2##3##(2008-11#2)
short-term control##2##2##(2008-8#1)(2013-8#1)
short-term culture##2##2##(2008-6#2)
short-term cultured astrocytes##3##3##(1995-5#3)
short-term effect##5##2##(1997-1#1)(2008-5#1)(2008-6#1)(2012-1#2)
short-term effects of EGF on##2##5##(1994-6#2)
short-term effects of##7##3##(1994-6#2)(1995-12#1)(1997-1#1)(2008-9#1)(2013-1#2)
short-term effects##8##2##(1994-6#2)(1995-12#1)(1997-1#1)(1997-3#1)(2008-9#1)(2013-1#2)
short-term efficacy of##3##3##(1991-2#1)(2011-2#2)
short-term exposure to##2##3##(1992-8#1)(2008-2#1)
short-term exposure##3##2##(1992-8#1)(2008-10#1)(2008-2#1)
short-term feeding##2##2##(1992-9#1)(1996-2#1)
short-term goals##2##2##(1993-12#1)(2008-11#1)
short-term in vitro##2##3##(1995-11#1)(1995-3#1)
short-term inpatient##2##2##(1992-3#1)(1993-12#1)
short-term longitudinal study##2##3##(2008-3#1)(2009-7#1)
short-term longitudinal##3##2##(2008-3#1)(2009-7#2)
short-term memory and##2##3##(1991-10#1)(2009-8#1)
short-term memory in monkeys##2##4##(1992-11#1)(1993-12#1)
short-term memory in##3##3##(1992-11#1)(1993-12#1)(2008-11#1)
short-term memory##11##2##(1991-10#1)(1992-11#4)(1993-12#2)(2007-8#2)(2008-11#1)(2009-8#1)
short-term or long-term##2##3##(1991-9#1)(1996-3#1)
short-term or##3##2##(1991-9#1)(1996-3#1)(2012-12#1)
short-term outcome of##2##3##(2008-6#1)(2012-12#1)
short-term outcome##3##2##(2008-1#1)(2008-6#1)(2012-12#1)
short-term outcomes##3##2##(2008-12#1)(2009-7#1)(2012-3#1)
short-term pain##2##2##(2013-1#2)
short-term potentiation##3##2##(1995-12#3)
short-term prediction##2##2##(1996-4#2)
short-term predictions##2##2##(1996-4#1)(2008-11#1)
short-term relief of##2##3##(2008-10#1)(2010-8#1)
short-term results##4##2##(1993-3#1)(2008-7#1)(2011-2#2)
short-term stability##4##2##(2007-12#1)(2008-9#1)(2010-3#2)
short-term standard##2##2##(2008-10#1)(2012-3#1)
short-term success##2##2##(1995-3#1)(2008-10#1)
short-term survival##4##2##(1992-9#3)(2007-12#1)
short-term##230##1##(1990-2#1)(1990-6#2)(1991-10#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-11#6)(1992-3#1)(1992-8#1)(1992-9#5)(1993-12#6)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-11#5)(1995-12#8)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#1)(1996-2#2)(1996-3#2)(1996-4#6)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-8#1)(2007-11#1)(2007-12#5)(2007-7#5)(2007-8#7)(2008-1#7)(2008-10#18)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#4)(2008-8#7)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#5)
short-time##2##1##(2007-12#1)(2012-2#1)
short-wave##4##1##(2007-5#1)(2008-2#1)(2008-3#2)
short-wavelength##11##1##(1991-9#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)
shortage in##5##2##(1994-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-4#1)
shortage of donor organs##2##4##(2009-3#1)(2010-6#1)
shortage of organs##3##3##(1993-2#1)(2006-10#1)(2008-1#1)
shortage of##40##2##(1990-3#1)(1991-2#1)(1992-1#2)(1993-2#1)(1993-6#1)(1994-1#2)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-5#1)
shortage##66##1##(1990-3#1)(1991-1#1)(1991-2#2)(1992-1#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-5#2)(1995-2#2)(1996-11#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-3#2)(2007-4#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#4)(2008-4#1)(2008-7#2)(2009-3#2)(2009-4#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-5#1)(2012-7#1)
shortages in##2##2##(2008-11#1)(2011-1#1)
shortages of##2##2##(1991-3#1)(2008-1#1)
shortages##9##1##(1991-3#1)(1997-1#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
shortcoming##2##1##(2008-10#1)(2008-2#1)
shortcomings in adipose tissue##2##4##(2012-8#2)
shortcomings in the##2##3##(2008-3#1)(2013-7#1)
shortcomings in##9##2##(1994-11#1)(1994-12#1)(1995-3#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-8#2)(2013-7#1)
shortcomings of##5##2##(1994-3#1)(2008-3#2)(2011-2#1)(2013-1#1)
shortcomings to##2##2##(2008-10#2)
shortcomings were##2##2##(1993-1#1)(2007-12#1)
shortcomings##33##1##(1991-1#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-4#1)(2012-8#2)(2013-1#3)(2013-7#1)
shorten the duration of the##2##5##(2008-12#1)(2012-3#1)
shorten the duration of treatment##2##5##(2007-8#1)(2011-1#1)
shorten the duration of##4##4##(2007-8#1)(2008-12#1)(2011-1#1)(2012-3#1)
shorten the time##2##3##(2008-8#1)(2011-2#1)
shorten the##15##2##(1991-1#1)(1992-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)
shorten time to##2##3##(2007-9#1)(2012-3#1)
shorten##31##1##(1990-5#1)(1991-1#1)(1992-1#1)(1992-11#1)(1992-5#1)(1994-3#1)(1994-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2012-8#1)
shortened by##2##2##(2008-10#1)(2010-8#1)
shortened from##2##2##(2008-10#1)(2008-5#1)
shortened hospital##2##2##(2008-12#1)(2013-1#1)
shortened postpartum stays##2##3##(2007-2#2)
shortened the time##3##3##(1990-7#1)(2008-10#1)(2008-9#1)
shortened the##8##2##(1990-2#1)(1990-7#1)(1991-12#1)(1994-9#1)(2008-10#3)(2008-9#1)
shortened to##2##2##(1993-9#1)(2007-8#1)
shortened##50##1##(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-9#1)(1994-9#1)(1997-2#1)(2007-11#5)(2007-2#3)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#4)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
shortening and##4##2##(2007-11#1)(2012-2#2)(2013-1#1)
shortening is##3##2##(1996-9#1)(2012-2#2)
shortening of the##9##3##(1992-5#1)(1994-3#1)(1995-6#1)(1997-8#1)(2007-11#2)(2008-2#1)(2012-1#1)(2012-7#1)
shortening of##15##2##(1992-5#1)(1994-3#1)(1995-6#1)(1997-8#1)(2007-11#4)(2007-8#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-8#1)
shortening or##3##2##(1994-3#1)(1997-4#1)(2007-8#1)
shortening the##6##2##(2007-8#2)(2008-10#2)(2008-2#1)(2012-12#1)
shortening was##3##2##(1995-12#1)(2007-8#1)(2013-1#1)
shortening##66##1##(1992-5#2)(1993-9#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-11#9)(2007-12#1)(2007-8#7)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-7#1)(2013-1#7)(2013-8#2)
shortenings##3##1##(1995-5#2)(2007-8#1)
shortens the##5##2##(1992-3#1)(1996-12#1)(2007-8#1)(2010-6#1)(2011-2#1)
shortens##7##1##(1992-3#1)(1996-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-2#1)
shorter RNA molecules##2##3##(2008-7#2)
shorter VEP##2##2##(1995-12#2)
shorter analysis time##4##3##(2008-10#4)
shorter and less##2##3##(2008-5#1)(2008-9#1)
shorter and lighter##2##3##(2008-11#1)(2010-6#1)
shorter and##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#2)
shorter at##2##2##(1995-8#1)(2008-10#1)
shorter chain##2##2##(2008-5#1)(2013-1#1)
shorter disease-free##2##2##(1993-11#1)(1995-4#1)
shorter distances##3##2##(2008-8#1)(2009-9#1)(2012-2#1)
shorter duration of##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
shorter duration##8##2##(1995-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)
shorter for##3##2##(1996-3#1)(2007-6#1)(2008-10#1)
shorter hospital stay (3##2##4##(1996-2#2)
shorter hospital stay##3##3##(1993-2#1)(1996-2#2)
shorter hospitalization##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
shorter in the##2##3##(2011-2#1)(2012-2#1)
shorter in##9##2##(2007-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
shorter leaf wetness##2##3##(2008-10#2)
shorter length##4##2##(2008-12#1)(2008-9#1)(2013-1#2)
shorter or longer##2##3##(1996-6#1)(2008-3#1)
shorter overall##2##2##(2011-2#1)(2012-2#1)
shorter peptide##3##2##(1992-5#1)(1995-2#1)(1996-5#1)
shorter periods of##2##3##(1990-12#1)(2008-10#1)
shorter periods##5##2##(1990-12#1)(1994-6#1)(2008-10#2)(2008-3#1)
shorter postoperative##2##2##(1996-3#1)(2009-2#1)
shorter survival##2##2##(2008-4#1)(2012-3#1)
shorter than 1##2##3##(2008-3#2)
shorter than that of the##3##5##(1993-3#1)(2008-5#1)(2010-4#1)
shorter than that of##7##4##(1991-3#1)(1993-3#1)(2008-5#1)(2010-2#2)(2010-4#1)(2010-8#1)
shorter than that##8##3##(1991-3#1)(1993-3#1)(2008-5#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)
shorter than the acoustic relaxation time##2##6##(2007-12#2)
shorter than the##10##3##(1991-12#1)(1995-11#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-8#1)(2010-10#1)
shorter than those##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
shorter than##40##2##(1991-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(2007-11#4)(2007-12#5)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2010-10#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2013-1#1)(2013-8#1)
shorter time (p##2##3##(1990-2#1)(2007-8#1)
shorter time of##3##3##(1991-3#1)(2008-4#1)(2009-4#1)
shorter time##10##2##(1990-2#1)(1991-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
shorter times##3##2##(1990-5#1)(2008-10#2)
shorter wavelength##4##2##(1992-8#1)(2007-11#1)(2008-2#2)
shorter wavelengths##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
shorter##244##1##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-8#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#7)(2007-12#9)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#10)(2008-9#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#2)
shorter-lived##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
shorter-living##2##1##(2009-5#2)
shorter-than-average calls##2##2##(2009-9#2)
shorter-than-average##3##1##(2009-9#3)
shorter-wavelength##2##1##(2007-12#1)(2008-3#1)
shortest paths##2##2##(2008-4#1)(2008-6#1)
shortest##34##1##(1990-12#2)(1991-2#1)(1992-12#2)(1995-12#1)(1995-2#1)(1996-6#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-8#2)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
shortfall in##2##2##(1991-11#1)(2008-8#1)
shortfall##3##1##(1991-11#1)(2008-12#1)(2008-8#1)
shortfalls##2##1##(2009-3#1)(2010-6#1)
shortly after the initiation of##2##5##(2011-1#1)(2012-3#1)
shortly after the##6##3##(2008-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
shortly after##36##2##(1990-11#1)(1990-6#1)(1991-12#1)(1995-12#1)(1995-2#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
shortly following##2##2##(1995-8#1)(2010-12#1)
shortly thereafter##2##2##(2007-6#1)(2013-1#1)
shortly##48##1##(1990-11#1)(1990-6#1)(1991-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
shortness of breath on##2##4##(2008-1#1)(2008-7#1)
shortness of breath##12##3##(2007-12#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#3)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
shortness of##13##2##(2007-12#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#3)(2009-5#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
shortwave radiometers##2##2##(2008-3#2)
shortwave##3##1##(2008-3#3)
shot noise that is##2##4##(2008-3#2)
shot noise##14##2##(2007-11#1)(2008-2#1)(2008-3#11)(2008-4#1)
shot per shot##2##3##(2008-2#2)
shot to##2##2##(2007-11#1)(2011-2#1)
shot wounds##2##2##(1995-11#1)(2013-1#1)
shot##40##1##(1995-11#3)(1997-8#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#18)(2008-4#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
shot-by-shot##2##1##(2007-12#1)(2008-3#1)
shot-noise-limited detection##3##2##(2007-12#1)(2008-3#2)
shot-noise-limited##9##1##(2007-12#1)(2008-2#4)(2008-3#4)
shot-to-shot##3##1##(2008-2#1)(2008-3#2)
shotgun metagenomics##2##2##(2011-2#2)
shotgun sequencing##2##2##(1996-6#1)(2011-2#1)
shotgun##7##1##(1996-6#1)(2008-7#1)(2010-12#2)(2011-2#3)
shots in##2##2##(1995-11#1)(2011-2#1)
shots with a##2##3##(2011-2#2)
shots##15##1##(1995-11#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2011-2#5)
shots)##2##1##(2008-10#1)(2011-2#1)
should I##2##2##(1995-3#1)(2010-12#1)
should abandon##2##2##(2008-8#1)(2008-9#1)
should accelerate##2##2##(2007-11#1)(2008-11#1)
should acquire##2##2##(1994-2#1)(2007-12#1)
should act##3##2##(1991-9#1)(1995-5#1)(2009-2#1)
should actively##2##2##(1995-12#1)(2008-11#1)
should address##4##2##(2008-4#1)(2008-8#1)(2010-11#1)(2010-8#1)
should adopt a##4##3##(1996-2#1)(1997-7#1)(2009-5#1)(2013-1#1)
should adopt##7##2##(1993-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-3#1)(2009-5#1)(2013-1#1)
should advocate for##2##3##(2009-7#1)(2012-2#1)
should aid##2##2##(1993-11#1)(1995-6#1)
should aim to##2##3##(2008-8#1)(2012-12#1)
should alert the clinician to##2##5##(2006-10#1)(2008-12#1)
should alert##3##2##(1996-2#1)(2006-10#1)(2008-12#1)
should allow for the##4##4##(1991-8#1)(1992-12#1)(1995-3#1)(2008-10#1)
should allow them to##2##4##(1995-2#1)(2008-4#1)
should allow##12##2##(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
should also be applicable to##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
should also be considered##3##4##(1995-12#1)(2008-6#1)(2008-7#1)
should also be referred##2##4##(2008-3#1)(2013-8#1)
should also be taken into account##2##6##(1992-6#1)(2013-7#1)
should also be taken into##3##5##(1992-4#1)(1992-6#1)(2013-7#1)
should also be##27##3##(1990-3#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
should also play a##2##4##(1997-3#1)(2008-3#1)
should also##44##2##(1990-3#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-7#1)(2013-8#2)
should always be considered when##2##5##(2008-10#1)(2011-2#1)
should always be considered##4##4##(2007-10#1)(2008-10#1)(2011-2#1)(2012-3#1)
should always be performed##2##4##(2011-1#1)(2012-2#1)
should always be##18##3##(1990-2#1)(1996-6#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)
should always##23##2##(1990-2#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
should apply to##2##3##(2008-10#1)(2008-3#1)
should apply##4##2##(1996-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
should ask##3##2##(1995-1#1)(2006-10#1)(2007-7#1)
should assist##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
should avoid##4##2##(1993-1#1)(1995-12#1)(2008-10#1)(2010-12#1)
should be &gt##2##3##(1995-6#1)(2007-7#1)
should be a central##2##4##(1995-2#1)(2012-2#1)
should be a part of##2##5##(1994-2#1)(2008-1#1)
should be a useful##2##4##(1993-9#1)(2008-10#1)
should be a##31##3##(1992-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-2#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#6)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
should be able to achieve##2##5##(2008-9#1)(2011-2#1)
should be able to##14##4##(1992-3#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)
should be accompanied by##2##4##(2008-12#1)(2009-7#1)
should be accomplished##2##3##(2008-10#1)(2008-7#1)
should be adapted to the##3##5##(2007-8#1)(2008-3#1)(2008-9#1)
should be added to the list of##2##7##(2009-1#1)(2009-3#1)
should be added to the##5##5##(1996-1#1)(2008-2#1)(2009-1#1)(2009-3#1)(2011-2#1)
should be added##6##3##(1996-1#1)(2008-2#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-12#1)
should be addressed in##2##4##(2013-1#2)
should be addressed##9##3##(1991-9#1)(1992-12#1)(2008-1#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)
should be adequately##3##3##(2008-11#1)(2009-5#1)(2012-5#1)
should be adjusted to##2##4##(2008-2#1)(2008-7#1)
should be adjusted##6##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#2)(2012-3#1)
should be administered##3##3##(1996-3#1)(2008-3#1)(2009-4#1)
should be adopted##3##3##(1990-6#1)(1994-1#1)(2008-12#1)
should be advised to##2##4##(1996-11#1)(2011-2#1)
should be advised##4##3##(1994-3#1)(1996-11#1)(2007-2#1)(2011-2#1)
should be advocated##2##3##(2008-4#1)(2010-10#1)
should be aimed##2##3##(2008-5#1)(2011-2#1)
should be alerted to the##2##5##(2008-12#1)(2008-7#1)
should be allowed to##3##4##(1991-2#1)(2007-7#1)(2008-12#1)
should be also##3##3##(1990-3#1)(1991-3#1)(2011-2#1)
should be always##2##3##(2008-5#1)(2009-4#1)
should be amenable to##2##4##(1997-7#1)(2008-10#1)
should be an appropriate##2##4##(1997-4#1)(2013-1#1)
should be an important part of##2##6##(2013-1#2)
should be an important##4##4##(2008-8#1)(2012-3#1)(2013-1#2)
should be an##12##3##(1991-9#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#3)
should be analyzed in##2##4##(1994-8#1)(2011-1#1)
should be analyzed##6##3##(1990-3#1)(1994-8#1)(1997-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
should be anticipated##2##3##(2008-7#1)(2012-2#1)
should be applicable for##2##4##(1991-2#1)(1996-8#1)
should be applicable to a range of##2##7##(2008-10#2)
should be applicable to the##2##5##(1990-5#1)(2008-10#1)
should be applicable to##7##4##(1990-5#1)(1991-5#1)(1996-2#1)(2008-10#3)(2010-12#1)
should be applicable##11##3##(1990-5#1)(1991-2#1)(1991-5#1)(1994-3#1)(1996-2#1)(1996-8#1)(2008-1#1)(2008-10#3)(2010-12#1)
should be applied in##4##4##(1997-6#1)(2008-10#1)(2008-5#1)(2010-8#1)
should be applied to##3##4##(1992-12#1)(2007-10#1)(2008-10#1)
should be applied with caution##2##5##(2008-2#1)(2008-9#1)
should be applied##12##3##(1992-12#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-8#2)
should be approached##4##3##(1993-3#1)(1995-12#1)(1996-2#1)(2008-6#1)
should be as##4##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
should be ascribed to the##2##5##(2008-10#2)
should be assessed##4##3##(1997-8#1)(2008-11#1)(2010-12#1)(2010-8#1)
should be at##2##3##(1997-1#1)(2008-10#1)
should be attempted##2##3##(2008-7#1)(2012-2#1)
should be attractive##3##3##(2008-10#2)(2008-7#1)
should be available to##2##4##(1991-12#1)(2012-2#1)
should be available##5##3##(1991-12#1)(1994-3#1)(2007-12#1)(2008-8#1)(2012-2#1)
should be avoided and##2##4##(2008-1#2)
should be avoided in##2##4##(2008-10#1)(2008-7#1)
should be avoided##17##3##(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-9#1)(2013-1#1)
should be aware of the possible##2##6##(2011-2#2)
should be aware of the##11##5##(1991-8#1)(1992-11#1)(2007-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#1)
should be aware of this##2##5##(2008-12#2)
should be aware of##22##4##(1991-2#1)(1991-8#1)(1992-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#2)
should be aware that##7##4##(1991-3#2)(2008-1#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#1)
should be aware##32##3##(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-2#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
should be based on a combination of##2##7##(2008-7#1)(2011-2#1)
should be based on a thorough##2##6##(2008-3#1)(2010-5#1)
should be based on a##5##5##(1992-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
should be based on an##2##5##(1990-6#1)(2008-7#1)
should be based on the##7##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-12#1)
should be based on##18##4##(1990-6#1)(1991-7#1)(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
should be based##19##3##(1990-6#1)(1991-7#1)(1992-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
should be capable of##4##4##(1992-3#1)(1994-2#1)(2007-12#1)(2008-2#1)
should be careful##2##3##(1992-3#1)(2008-5#1)
should be carefully considered##2##4##(1995-12#1)(2008-7#1)
should be carefully evaluated##2##4##(2008-1#1)(2013-1#1)
should be carefully followed##2##4##(1991-2#1)(2008-7#1)
should be carefully monitored in##2##5##(1991-8#1)(2011-1#1)
should be carefully monitored##3##4##(1991-8#1)(2011-1#1)(2012-2#1)
should be carefully##12##3##(1991-2#1)(1991-8#1)(1995-12#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
should be carried out in order to##2##7##(1994-6#1)(2007-11#1)
should be carried out on##4##5##(1992-5#1)(2007-2#1)(2010-11#1)(2013-8#1)
should be carried out##14##4##(1992-5#1)(1994-3#1)(1994-6#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
should be cautioned##2##3##(1996-3#1)(2013-1#1)
should be cautious##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
should be changed##3##3##(1991-6#1)(2007-12#1)(2008-10#1)
should be chosen##2##3##(1990-11#1)(2008-2#1)
should be classified as##2##4##(1993-1#1)(2008-10#1)
should be classified##5##3##(1993-1#1)(2008-10#3)(2011-2#1)
should be combined with##6##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
should be combined##7##3##(1992-11#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
should be communicated##2##3##(2008-7#1)(2010-12#1)
should be compared##2##3##(2007-11#1)(2007-4#1)
should be completed##2##3##(2007-10#1)(2008-5#1)
should be conducted in##4##4##(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
should be conducted to##2##4##(2009-12#1)(2010-8#1)
should be conducted##10##3##(1991-3#1)(2008-1#1)(2009-12#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
should be confirmed by##6##4##(1996-2#1)(2007-11#1)(2007-8#2)(2008-10#2)
should be confirmed in larger##2##5##(1995-11#1)(2008-7#1)
should be confirmed##8##3##(1995-11#1)(1996-2#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-7#1)
should be considered a##7##4##(1993-1#1)(1997-3#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
should be considered an##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
should be considered as a differential diagnosis##2##7##(2006-10#1)(2011-1#1)
should be considered as a possible##2##6##(2008-12#1)(2012-12#1)
should be considered as a##13##5##(2006-10#1)(2007-10#1)(2007-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)
should be considered as an alternative to##2##7##(2011-2#2)
should be considered as an##3##5##(2008-4#1)(2011-2#2)
should be considered as##24##4##(2006-10#2)(2007-10#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)
should be considered at##2##4##(2009-7#1)(2012-6#1)
should be considered for a##2##5##(1993-11#1)(2008-10#1)
should be considered for patients##2##5##(1996-9#1)(2008-7#1)
should be considered for the##3##5##(2008-10#1)(2008-12#1)(2008-7#1)
should be considered for##17##4##(1992-5#1)(1992-9#1)(1993-11#1)(1995-3#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#2)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
should be considered if##4##4##(1996-6#1)(2008-9#1)(2009-12#1)(2009-3#1)
should be considered in any##2##5##(2007-11#1)(2013-1#1)
should be considered in cases##2##5##(2008-7#1)(2011-1#1)
should be considered in patients##4##5##(2006-10#1)(2007-10#1)(2009-8#1)(2011-2#1)
should be considered in the differential diagnosis of##11##8##(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
should be considered in the differential diagnosis##14##7##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
should be considered in the##24##5##(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
should be considered in young##2##5##(1990-3#1)(2011-2#1)
should be considered in##62##4##(1990-3#1)(1991-8#2)(1992-12#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#2)
should be considered the##2##4##(2008-8#1)(2012-2#1)
should be considered when choosing##2##5##(2008-8#1)(2011-1#1)
should be considered when designing##2##5##(1996-3#1)(2011-1#1)
should be considered when##17##4##(1992-4#1)(1993-3#1)(1993-6#1)(1995-1#2)(1996-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#2)(2011-1#2)(2013-8#1)
should be considered with##2##4##(1993-1#1)(2008-10#1)
should be considered##190##3##(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-3#1)(1995-1#3)(1995-3#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#2)(2006-10#3)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#3)(2008-12#6)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#6)(2011-2#21)(2012-12#4)(2012-2#4)(2012-3#5)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#7)
should be continued for##3##4##(1990-9#1)(1992-11#1)(2009-12#1)
should be defined##4##3##(1991-12#1)(2008-7#1)(2008-8#2)
should be designed##3##3##(1996-1#1)(2007-10#1)(2012-3#1)
should be determined##4##3##(1990-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
should be developed and##2##4##(2008-3#1)(2010-3#1)
should be developed to##2##4##(1992-12#1)(2013-1#1)
should be developed##13##3##(1991-12#1)(1992-12#1)(1993-2#1)(1995-5#1)(1997-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
should be diagnosed##2##3##(1997-8#1)(2008-1#1)
should be differentiated from##2##4##(2010-6#1)(2011-2#1)
should be differentiated##3##3##(1991-2#1)(2010-6#1)(2011-2#1)
should be directed at##2##4##(2007-7#1)(2013-8#1)
should be directed towards##2##4##(1995-8#1)(2008-1#1)
should be directed##7##3##(1995-8#1)(1996-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
should be discouraged in##2##4##(1992-3#1)(2007-12#1)
should be discouraged##4##3##(1992-3#2)(2007-12#1)(2008-10#1)
should be distinguished from##2##4##(1992-2#1)(2013-1#1)
should be done in##2##4##(1991-4#1)(1996-8#1)
should be done to##2##4##(2007-7#1)(2008-10#1)
should be done##16##3##(1991-11#1)(1991-4#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-11#2)(1996-8#1)(1997-3#2)(2007-7#1)(2008-10#2)(2012-2#2)(2013-1#1)
should be effective##3##3##(1994-6#1)(2008-10#2)
should be emphasized##6##3##(1992-6#1)(1993-12#1)(1996-12#1)(1996-3#1)(2008-4#1)(2011-2#1)
should be employed in##2##4##(1990-12#1)(1991-12#1)
should be employed##7##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1997-2#1)(2008-10#1)(2008-4#1)
should be encouraged to##6##4##(1993-1#1)(1993-2#1)(1994-1#1)(1995-3#1)(2008-11#1)(2012-3#1)
should be encouraged##9##3##(1993-1#1)(1993-2#1)(1994-1#1)(1995-3#1)(1996-3#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
should be enrolled in##2##4##(1994-2#1)(2008-11#1)
should be entitled to##2##4##(1991-3#1)(1994-3#1)
should be especially##2##3##(2008-5#1)(2009-2#1)
should be established##2##3##(1990-6#1)(2011-2#1)
should be evaluated as##2##4##(2008-3#1)(2013-1#1)
should be evaluated before##2##4##(2008-8#1)(2011-2#1)
should be evaluated for##2##4##(2010-6#1)(2012-12#1)
should be evaluated in##3##4##(1992-2#1)(2008-10#1)(2013-7#1)
should be evaluated##19##3##(1992-2#1)(1996-2#1)(1997-8#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
should be examined##2##3##(1996-4#1)(2013-1#1)
should be exercised in##2##4##(1991-6#1)(1993-6#1)
should be expanded to include##2##5##(1991-9#1)(2013-1#1)
should be expanded##4##3##(1991-9#1)(1993-1#1)(2010-7#1)(2013-1#1)
should be expected##2##3##(2007-8#1)(2008-9#1)
should be facilitated##2##3##(1990-11#1)(1997-8#1)
should be familiar##2##3##(1994-5#1)(2012-12#1)
should be feasible##3##3##(2007-11#1)(2008-8#1)(2011-1#1)
should be focused on these##2##5##(1991-5#1)(1996-3#1)
should be focused on##6##4##(1991-5#1)(1996-3#1)(2008-10#2)(2011-2#1)(2012-3#1)
should be followed by##3##4##(1994-2#1)(2008-10#1)(2008-9#1)
should be followed up##2##4##(1997-8#1)(2008-10#1)
should be followed##10##3##(1994-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-9#1)
should be further investigated##2##4##(1990-8#1)(2008-11#1)
should be further strengthened##2##4##(2012-3#2)
should be further##6##3##(1990-8#1)(2008-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
should be given in##2##4##(2007-11#1)(2008-4#1)
should be given to##10##4##(1990-11#1)(1992-11#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
should be given##27##3##(1990-11#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-9#3)(1996-11#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
should be guided by##4##4##(1992-4#1)(1993-3#1)(2011-2#1)(2012-12#1)
should be helpful in##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
should be helpful##4##3##(1992-12#1)(2008-10#2)(2011-2#1)
should be highly##4##3##(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)
should be identified as##2##4##(2008-10#1)(2008-7#1)
should be identified##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
should be implemented in##2##4##(2010-5#1)(2013-1#1)
should be implemented##4##3##(1995-5#1)(1996-12#1)(2010-5#1)(2013-1#1)
should be important in##2##4##(2008-11#1)(2008-8#1)
should be important##3##3##(2008-11#1)(2008-8#1)(2010-6#1)
should be improved by##2##4##(1993-1#1)(2010-7#1)
should be improved##3##3##(1993-1#1)(2008-5#1)(2010-7#1)
should be in##4##3##(1991-2#1)(2008-11#1)(2012-12#2)
should be included in the differential diagnosis of##5##8##(1990-11#1)(1997-7#1)(2007-12#1)(2008-12#1)(2013-1#1)
should be included in the differential diagnosis##8##7##(1990-11#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-12#1)(2009-3#1)(2010-11#1)(2013-1#1)
should be included in the##16##5##(1990-11#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2012-12#1)(2013-1#1)
should be included in##21##4##(1990-11#1)(1996-11#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2012-12#1)(2013-1#1)
should be included##23##3##(1990-11#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2012-12#1)(2013-1#1)
should be incorporated in##2##4##(1995-1#1)(2007-7#1)
should be incorporated into the##3##5##(1992-12#1)(2007-4#1)(2008-5#1)
should be incorporated into##7##4##(1992-12#1)(1997-3#2)(2007-11#1)(2007-4#1)(2008-5#1)(2010-3#1)
should be incorporated##10##3##(1992-12#1)(1995-1#1)(1997-3#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-5#1)(2010-3#1)(2012-12#1)
should be individualized##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
should be individually##2##3##(2008-10#1)(2011-2#1)
should be informed##3##3##(2008-6#1)(2008-8#1)(2011-2#1)
should be initiated immediately in##2##5##(1994-9#1)(2008-10#1)
should be initiated to##2##4##(1992-12#1)(2011-2#1)
should be initiated##9##3##(1992-12#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#2)(2012-1#1)
should be instituted##2##3##(1996-11#1)(2013-8#1)
should be integrated into##2##4##(1993-6#1)(2013-1#1)
should be integrated##4##3##(1993-6#1)(1995-12#1)(2008-6#1)(2013-1#1)
should be intensified##3##3##(1992-11#1)(1994-2#1)(2009-7#1)
should be interpreted cautiously##2##4##(1995-5#1)(2008-8#1)
should be interpreted with caution##3##5##(1994-12#1)(1997-1#1)(2011-1#1)
should be interpreted##10##3##(1994-12#1)(1995-5#1)(1997-1#2)(2008-10#1)(2008-5#1)(2008-8#2)(2010-3#1)(2011-1#1)
should be introduced as##2##4##(2007-10#1)(2007-8#1)
should be introduced##3##3##(2007-10#1)(2007-8#1)(2010-3#1)
should be involved##3##3##(1994-3#1)(2008-11#1)(2008-8#1)
should be kept in mind##7##5##(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
should be kept##9##3##(1996-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
should be known##2##3##(2008-10#1)(2008-7#1)
should be less##2##3##(1997-8#1)(2008-2#1)
should be limited to##3##4##(1991-6#1)(1991-9#1)(2008-11#1)
should be made at##2##4##(2008-3#2)
should be made available##3##4##(2007-4#1)(2013-1#2)
should be made between##2##4##(2008-9#1)(2011-1#1)
should be made to##4##4##(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
should be made##22##3##(1990-3#1)(1992-9#1)(1994-2#1)(1997-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
should be maintained##8##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2013-1#1)
should be managed##2##3##(2008-1#1)(2008-3#1)
should be mandatory##2##3##(2011-2#2)
should be measured##5##3##(1991-3#1)(1994-9#1)(2008-3#1)(2008-8#2)
should be minimized to##2##4##(2008-2#1)(2008-3#1)
should be minimized##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
should be monitored in##3##4##(2008-5#1)(2008-8#1)(2013-8#1)
should be monitored##7##3##(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
should be more##9##3##(1994-2#1)(1997-8#1)(2008-1#3)(2008-11#1)(2008-5#1)(2008-9#2)
should be noted that the##4##5##(2008-10#2)(2008-11#1)(2010-6#1)
should be noted that##9##4##(1991-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
should be noted##10##3##(1991-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-6#1)(2011-2#1)(2012-3#1)
should be observed##4##3##(1993-2#2)(2007-11#1)(2008-9#1)
should be obtained##5##3##(1994-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)
should be of great##2##4##(1997-2#1)(2008-9#1)
should be of value##2##4##(2007-11#1)(2012-3#1)
should be of##7##3##(1990-9#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2012-3#1)
should be offered##8##3##(1992-9#2)(1994-3#1)(1994-9#1)(2007-12#1)(2010-10#1)(2010-5#1)(2013-1#1)
should be on##3##3##(1992-2#1)(1997-2#1)(2008-7#1)
should be one of##2##4##(1996-1#1)(2008-7#1)
should be one##3##3##(1996-1#1)(2008-7#1)(2012-2#1)
should be operated##2##3##(1996-11#1)(2007-11#1)
should be paid to the##3##5##(1993-12#1)(2008-9#1)(2012-2#1)
should be paid to##9##4##(1990-2#1)(1991-11#1)(1992-12#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
should be paid##12##3##(1990-2#1)(1991-11#1)(1992-12#1)(1993-12#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
should be part of the##2##5##(1997-3#1)(2007-12#1)
should be part of##4##4##(1997-3#1)(2007-12#2)(2009-1#1)
should be particularly useful to##2##5##(1993-3#1)(2008-2#1)
should be particularly useful##3##4##(1993-3#1)(2008-10#1)(2008-2#1)
should be performed as##3##4##(2008-7#1)(2010-5#1)(2013-1#1)
should be performed before##2##4##(1996-11#1)(2010-6#1)
should be performed for##3##4##(2008-7#1)(2010-3#1)(2012-12#1)
should be performed in the##2##5##(1990-12#1)(2007-11#1)
should be performed in##8##4##(1990-12#1)(1990-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
should be performed on##2##4##(2008-10#1)(2008-4#1)
should be performed only##4##4##(1994-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
should be performed regularly##2##4##(2007-11#1)(2010-10#1)
should be performed to##6##4##(1991-9#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)
should be performed under##2##4##(2007-4#1)(2012-3#1)
should be performed whenever##2##4##(1990-10#1)(2008-6#1)
should be performed##45##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#1)(1994-3#1)(1994-9#1)(1996-11#2)(2007-11#2)(2007-4#1)(2007-8#3)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
should be placed on the##2##5##(1997-3#1)(2013-1#1)
should be placed on##5##4##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
should be placed##6##3##(1996-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
should be planned##3##3##(1991-12#1)(2008-8#1)(2013-1#1)
should be pointed out##2##4##(1991-8#1)(2007-8#1)
should be possible to##10##4##(1994-12#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-2#1)
should be possible##12##3##(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-2#1)
should be preferred##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
should be prepared for##2##4##(2008-10#1)(2008-9#1)
should be prepared##4##3##(1991-8#1)(2008-10#1)(2008-9#1)(2010-11#1)
should be prescribed##2##3##(2007-11#1)(2008-8#1)
should be present##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
should be presented##2##3##(1993-3#2)
should be promoted##2##3##(2008-1#1)(2008-10#1)
should be promptly##3##3##(1993-12#1)(2012-12#1)(2012-2#1)
should be provided with##2##4##(1992-3#1)(2010-8#1)
should be provided##8##3##(1992-10#1)(1992-3#1)(1994-12#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
should be pursued##3##3##(2006-10#1)(2010-4#1)(2013-1#1)
should be put in place##2##5##(1991-3#1)(2012-12#1)
should be put##3##3##(1991-3#1)(2012-12#2)
should be quantified##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
should be raised in##2##4##(2008-9#2)
should be raised##4##3##(1997-8#1)(2007-11#1)(2008-9#2)
should be re-evaluated##2##3##(1995-3#1)(2010-2#1)
should be readily##4##3##(2008-1#1)(2008-3#1)(2008-9#1)(2010-11#1)
should be recognized and##2##4##(2009-8#1)(2010-3#1)
should be recognized as##2##4##(1996-1#1)(2008-10#1)
should be recognized##5##3##(1996-1#1)(2008-10#1)(2009-8#1)(2010-3#1)(2011-2#1)
should be recommended##2##3##(2007-7#1)(2013-8#1)
should be reduced##2##3##(1995-6#1)(1996-6#1)
should be referred to a specialist##2##6##(2008-11#1)(2013-8#1)
should be referred to a##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
should be referred to##6##4##(1990-6#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-8#1)
should be referred##7##3##(1990-6#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-8#2)
should be reflected##2##3##(2008-1#1)(2011-2#1)
should be regarded as a##3##5##(1992-8#1)(2007-8#1)(2008-10#1)
should be regarded as##9##4##(1991-4#1)(1992-8#2)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#2)(2012-2#1)
should be regarded##10##3##(1990-2#1)(1991-4#1)(1992-8#2)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#2)(2012-2#1)
should be regularly##2##3##(2013-1#2)
should be related to##2##4##(2007-11#1)(2010-6#1)
should be replaced by##2##4##(1997-6#1)(2008-11#1)
should be replaced with##2##4##(1994-12#1)(2010-7#1)
should be replaced##4##3##(1994-12#1)(1997-6#1)(2008-11#1)(2010-7#1)
should be reported##2##3##(2008-11#1)(2010-6#1)
should be required##3##3##(1992-6#1)(2008-9#2)
should be reserved for patients with##2##6##(2011-2#1)(2012-3#1)
should be reserved for patients##5##5##(1990-6#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-3#1)
should be reserved for##8##4##(1990-6#1)(1993-11#1)(1997-3#1)(2007-7#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
should be responsible for the##2##5##(2008-3#1)(2008-6#1)
should be retained as##2##4##(2008-10#2)
should be retrieved##2##3##(2008-3#1)(2008-7#1)
should be revised##3##3##(1994-2#1)(1996-3#1)(1996-5#1)
should be routinely##4##3##(2007-7#1)(2008-10#1)(2012-2#1)(2013-8#1)
should be safe##2##3##(1996-12#1)(2010-7#1)
should be screened for##2##4##(1990-2#1)(2008-11#1)
should be screened##5##3##(1990-2#1)(2006-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
should be seen##3##3##(1991-9#1)(1996-3#1)(2010-5#1)
should be selected##3##3##(2009-8#1)(2012-12#1)(2012-3#1)
should be sent to##2##4##(1994-3#1)(1997-2#1)
should be separated##3##3##(1991-3#1)(2008-10#2)
should be seriously considered as##2##5##(1991-2#1)(1994-6#1)
should be seriously considered##3##4##(1991-2#1)(1994-6#1)(2010-1#1)
should be simplified##2##3##(1994-2#1)(1997-3#1)
should be specifically##2##3##(1996-6#1)(2008-11#1)
should be standard##2##3##(2007-8#1)(2011-2#1)
should be started##6##3##(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
should be stimulated##2##3##(1991-11#1)(1991-6#1)
should be stopped##4##3##(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
should be strengthened##2##3##(2012-3#1)(2013-1#1)
should be stressed##2##3##(2008-1#1)(2008-10#1)
should be structured##2##3##(1996-2#1)(2008-8#1)
should be studied in##2##4##(2008-10#1)(2011-2#1)
should be studied##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
should be subject to##2##4##(1992-11#1)(1997-3#1)
should be suspected if##2##4##(1997-4#1)(2012-2#1)
should be suspected in##3##4##(2006-10#1)(2009-10#1)(2010-10#1)
should be suspected##7##3##(1997-4#1)(2006-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
should be taken in##2##4##(2008-7#1)(2009-12#1)
should be taken into account in##7##6##(1992-3#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2013-1#1)
should be taken into account when##3##6##(2008-2#1)(2013-7#1)(2013-8#1)
should be taken into account##15##5##(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2009-8#1)(2010-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
should be taken into consideration in##2##6##(2008-7#1)(2013-8#1)
should be taken into consideration when using##2##7##(2010-5#1)(2013-1#1)
should be taken into consideration when##5##6##(2008-10#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
should be taken into consideration##12##5##(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
should be taken into##28##4##(1991-12#1)(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#2)(2013-7#2)(2013-8#2)
should be taken seriously##2##4##(1996-6#1)(2008-4#1)
should be taken to##6##4##(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
should be taken##47##3##(1990-3#1)(1991-12#1)(1992-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-2#1)(1996-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#3)
should be targeted for##2##4##(2010-12#1)(2010-4#1)
should be targeted##4##3##(2008-10#1)(2010-12#1)(2010-4#1)(2011-1#1)
should be tested in##2##4##(1990-3#1)(2011-1#1)
should be tested##4##3##(1990-3#1)(1994-8#1)(2007-5#1)(2011-1#1)
should be the first##3##4##(1990-2#1)(1993-6#1)(2010-11#1)
should be the focus of##2##5##(2008-11#1)(2012-2#1)
should be the goal of##3##5##(1992-3#1)(2013-1#2)
should be the initial##2##4##(1990-9#1)(2011-2#1)
should be the##26##3##(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-1#1)(1996-8#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
should be to##4##3##(1993-12#1)(2008-11#1)(2008-4#1)(2010-12#1)
should be trained in##2##4##(1997-8#1)(2008-1#1)
should be trained##3##3##(1997-8#1)(2008-1#1)(2012-3#1)
should be treated by##3##4##(1997-4#1)(1997-8#1)(2007-8#1)
should be treated in##2##4##(1991-3#1)(1993-3#1)
should be treated with##11##4##(1991-6#1)(1996-11#1)(1997-2#1)(2008-3#1)(2008-8#2)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
should be treated##21##3##(1990-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
should be understood##2##3##(1991-1#1)(2013-8#1)
should be undertaken at##2##4##(1996-6#1)(2008-5#1)
should be undertaken##7##3##(1992-12#1)(1993-1#1)(1993-6#1)(1996-6#1)(2008-5#1)(2009-11#1)(2012-3#1)
should be used as a first-line##2##6##(2008-2#1)(2011-2#1)
should be used as##4##4##(2008-2#1)(2008-9#1)(2010-1#1)(2011-2#1)
should be used cautiously##2##4##(1996-12#1)(2012-12#1)
should be used for##6##4##(1990-2#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
should be used in the##4##5##(1990-11#1)(2008-6#1)(2010-11#1)(2013-8#1)
should be used in##11##4##(1990-11#2)(1991-2#1)(1992-11#1)(1996-6#1)(1996-9#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
should be used instead of##2##5##(1995-12#1)(2008-7#1)
should be used only##3##4##(1993-2#1)(1994-12#1)(2007-7#1)
should be used to##6##4##(1995-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
should be used when##2##4##(2008-10#1)(2010-3#1)
should be used with caution##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
should be used##55##3##(1990-11#2)(1990-2#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#2)(2010-1#1)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#3)(2013-8#1)
should be useful as##2##4##(1992-6#1)(2008-5#1)
should be useful for the##2##5##(2008-10#1)(2008-5#1)
should be useful for##10##4##(1992-1#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2013-7#1)
should be useful in studying the##2##6##(1993-6#1)(1996-12#1)
should be useful in the##5##5##(1993-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2010-4#1)
should be useful in##20##4##(1993-12#2)(1993-6#1)(1993-8#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2010-4#2)
should be useful to##3##4##(1994-1#1)(2008-10#1)(2008-8#1)
should be useful##37##3##(1991-9#1)(1992-1#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2010-4#2)(2013-7#1)
should be utilized to##2##4##(2012-3#1)(2013-1#1)
should be vaccinated##2##3##(1990-11#1)(2008-4#1)
should be valuable##2##3##(1995-12#1)(2008-9#1)
should be very useful for##3##5##(1997-2#1)(1997-8#1)(2008-10#1)
should be very##4##3##(1997-2#1)(1997-8#1)(2008-10#2)
should be viewed as a##2##5##(1995-2#1)(1995-3#1)
should be viewed as##3##4##(1995-2#1)(1995-3#1)(2013-1#1)
should be viewed##4##3##(1991-2#1)(1995-2#1)(1995-3#1)(2013-1#1)
should be weighed##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
should be well informed##2##4##(2008-9#1)(2011-2#1)
should be well##4##3##(1997-8#1)(2007-7#1)(2008-9#1)(2011-2#1)
should be##1683##2##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#10)(1990-3#6)(1990-5#2)(1990-6#6)(1990-8#2)(1990-9#6)(1991-1#4)(1991-11#4)(1991-12#10)(1991-2#10)(1991-3#14)(1991-4#2)(1991-5#3)(1991-6#9)(1991-7#1)(1991-8#8)(1991-9#10)(1992-1#3)(1992-10#1)(1992-11#8)(1992-12#18)(1992-2#5)(1992-3#10)(1992-4#2)(1992-5#5)(1992-6#8)(1992-8#5)(1992-9#5)(1993-1#8)(1993-11#3)(1993-12#9)(1993-2#9)(1993-3#10)(1993-6#9)(1993-8#1)(1993-9#1)(1994-1#6)(1994-11#1)(1994-12#10)(1994-2#11)(1994-3#17)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#9)(1995-1#4)(1995-11#2)(1995-12#9)(1995-2#8)(1995-3#6)(1995-5#5)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#6)(1996-11#14)(1996-12#10)(1996-2#6)(1996-3#15)(1996-4#2)(1996-5#1)(1996-6#9)(1996-8#7)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#13)(1997-4#12)(1997-5#4)(1997-6#7)(1997-7#4)(1997-8#18)(2006-10#7)(2006-5#1)(2007-10#10)(2007-11#31)(2007-12#24)(2007-2#8)(2007-4#7)(2007-5#2)(2007-6#1)(2007-7#17)(2007-8#23)(2007-9#1)(2008-1#31)(2008-10#154)(2008-11#52)(2008-12#20)(2008-2#20)(2008-3#35)(2008-4#31)(2008-5#38)(2008-6#13)(2008-7#69)(2008-8#39)(2008-9#56)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#9)(2009-4#11)(2009-5#7)(2009-6#7)(2009-7#4)(2009-8#14)(2009-9#1)(2010-1#6)(2010-10#7)(2010-11#18)(2010-12#13)(2010-2#2)(2010-3#10)(2010-4#8)(2010-5#10)(2010-6#10)(2010-7#4)(2010-8#19)(2010-9#1)(2011-1#24)(2011-2#102)(2011-3#1)(2011-4#1)(2011-7#1)(2011-8#1)(2012-1#3)(2012-12#34)(2012-2#31)(2012-3#33)(2012-5#1)(2012-6#1)(2013-1#64)(2013-7#6)(2013-8#32)
should become a##2##3##(2008-10#1)(2013-1#1)
should become##5##2##(2008-10#2)(2008-11#2)(2013-1#1)
should begin with##2##3##(2007-12#1)(2013-1#1)
should begin##8##2##(1993-2#1)(1994-8#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
should benefit from##2##3##(1996-6#1)(2010-5#1)
should benefit##5##2##(1996-6#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)
should block##3##2##(1992-12#1)(1997-7#2)
should bring##2##2##(2008-10#1)(2009-5#1)
should carefully##2##2##(1994-3#1)(2010-6#1)
should carry##2##2##(1994-5#1)(2008-11#1)
should change##3##2##(1994-2#1)(2008-8#1)(2009-10#1)
should clarify##2##2##(1996-12#1)(2008-6#1)
should collect information from##2##4##(1997-3#1)(2008-10#1)
should consider the##6##3##(2008-10#2)(2011-2#2)(2012-2#1)(2013-1#1)
should consider##34##2##(1991-1#1)(1992-3#2)(1993-1#1)(1995-3#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-9#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)
should consist of##3##3##(1997-2#1)(2008-12#1)(2008-5#1)
should continue to be monitored##2##5##(1997-4#1)(2008-11#1)
should continue to be##4##4##(1997-4#1)(2008-11#1)(2008-8#1)(2009-5#1)
should continue to##6##3##(1997-4#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2013-8#1)
should continue##8##2##(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-4#1)(2009-5#1)(2013-8#1)
should contribute##2##2##(1991-5#1)(2012-2#1)
should decrease the##2##3##(2007-11#1)(2008-5#1)
should decrease##3##2##(2007-11#1)(2008-5#1)(2008-8#1)
should design##2##2##(1997-2#1)(2008-7#1)
should determine##2##2##(2008-5#1)(2012-3#1)
should develop a##2##3##(1994-1#1)(1996-3#1)
should develop##4##2##(1994-1#1)(1996-3#1)(2008-8#1)(2011-2#1)
should do##2##2##(1991-3#1)(1993-12#1)
should elicit##2##2##(1992-12#1)(1995-5#1)
should employ##2##2##(1990-2#1)(2008-10#1)
should enable the##2##3##(1992-9#1)(2011-2#1)
should enable##7##2##(1992-9#1)(2008-10#1)(2008-2#2)(2011-2#2)(2013-8#1)
should encourage##6##2##(1994-2#1)(1994-3#1)(1996-2#1)(2010-10#1)(2013-1#2)
should enhance the##2##3##(1992-2#1)(2013-1#1)
should enhance##4##2##(1992-2#1)(1994-9#1)(2008-8#1)(2013-1#1)
should ensure that the##2##4##(1992-11#1)(2011-2#1)
should ensure that##7##3##(1992-11#1)(1993-12#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-2#2)
should evolve##2##2##(2008-9#1)(2010-10#1)
should examine the##3##3##(2008-8#1)(2009-9#1)(2011-2#1)
should examine##4##2##(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
should exclude##2##2##(1991-11#1)(2008-1#1)
should exist##2##2##(2008-2#1)(2009-8#1)
should expect##2##2##(1996-2#1)(2013-1#1)
should facilitate the development of##2##5##(1996-9#1)(2008-7#1)
should facilitate the##5##3##(1995-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
should facilitate##16##2##(1992-8#1)(1993-2#2)(1993-3#1)(1995-6#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)
should favor##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
should find a wide range of##2##6##(2008-10#2)
should find##5##2##(2008-10#3)(2008-11#1)(2008-3#1)
should first##2##2##(1996-12#1)(2010-5#1)
should focus on the##3##4##(2010-11#1)(2012-12#1)(2012-2#1)
should focus on##16##3##(1994-12#1)(1995-11#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-11#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)
should focus##21##2##(1994-12#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
should follow##7##2##(1994-12#1)(1997-1#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
should forage##2##2##(2008-9#2)
should form the##2##3##(1996-12#1)(2008-10#1)
should foster##2##2##(2008-3#1)(2008-8#1)
should further enhance##2##3##(1992-12#1)(2008-7#1)
should further##4##2##(1992-12#1)(1992-2#1)(2008-7#1)(2012-3#1)
should gain##3##2##(1995-3#1)(2007-8#1)(2008-1#1)
should generally be avoided##2##4##(2008-9#1)(2010-8#1)
should give##2##2##(1995-3#1)(1996-3#1)
should greatly##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
should have a##14##3##(1995-5#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#2)
should have an##2##3##(2007-12#1)(2008-10#1)
should have at##2##3##(1992-12#1)(1993-3#1)
should have been##3##3##(1992-11#1)(2007-11#1)(2011-2#1)
should have higher##2##3##(1994-3#1)(2012-2#1)
should have in##2##3##(1993-12#1)(1996-6#1)
should have positive##2##3##(2008-7#1)(2011-1#1)
should have the##6##3##(1992-4#1)(1993-11#2)(1995-11#1)(1997-3#1)(2008-8#1)
should have their##3##3##(1996-12#1)(2007-12#1)(2011-1#1)
should have##64##2##(1990-6#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2010-10#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
should help to guide##2##4##(2012-2#1)(2013-1#1)
should help to##9##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should help us to##2##4##(1993-5#1)(2007-8#1)
should help##20##2##(1991-12#1)(1993-5#1)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should ideally##2##2##(2007-12#1)(2009-10#1)
should implement##2##2##(2007-10#1)(2013-1#1)
should improve the##2##3##(2008-1#1)(2008-5#1)
should improve##8##2##(1992-12#1)(1993-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#1)
should in##2##2##(2008-11#1)(2008-8#1)
should include a##3##3##(2009-12#1)(2010-7#1)(2013-1#1)
should include an##2##3##(1997-5#1)(2008-10#1)
should include both##2##3##(1997-8#1)(2008-10#1)
should include the##4##3##(1994-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
should include##30##2##(1990-3#1)(1991-1#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
should incorporate##7##2##(1994-3#1)(1995-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-6#1)(2013-1#1)
should increase the##2##3##(1992-12#1)(2010-3#1)
should increase##6##2##(1992-12#1)(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#2)
should induce##2##2##(1995-5#1)(2009-4#1)
should inform future##2##3##(2011-3#1)(2012-12#1)
should inform##4##2##(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
should initially be##3##3##(1990-11#1)(1990-3#1)(2011-2#1)
should initially##4##2##(1990-11#1)(1990-3#1)(2008-9#1)(2011-2#1)
should involve##2##2##(1993-3#1)(1994-3#1)
should it be treated?##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
should it##5##2##(1993-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
should keep in mind that##2##5##(2010-8#1)(2012-12#1)
should keep in mind##3##4##(2010-8#1)(2012-1#1)(2012-12#1)
should keep##6##2##(2006-10#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
should know about##4##3##(1995-1#1)(2008-4#1)(2012-12#1)(2012-3#1)
should know##11##2##(1995-1#1)(1996-11#3)(2008-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
should lead to a##3##4##(2008-5#2)(2012-2#1)
should lead to the development of novel deodorant systems##2##9##(2008-5#2)
should lead to the##5##4##(2008-10#2)(2008-5#2)(2010-12#1)
should lead to##19##3##(1992-6#1)(1994-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-8#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)
should learn##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
should look##3##2##(1994-12#1)(2008-7#1)(2013-1#1)
should maintain##2##2##(2007-12#1)(2011-2#1)
should make it possible to##2##5##(2007-12#1)(2008-10#1)
should make it##4##3##(2007-12#3)(2008-10#1)
should make standardizing CS a high priority for targeted funding##2##10##(2013-1#2)
should make##10##2##(1995-1#1)(2007-12#3)(2008-10#2)(2008-5#2)(2013-1#2)
should measure##2##2##(1995-3#1)(2008-8#1)
should meet##3##2##(1997-8#1)(2011-2#2)
should move##2##2##(1997-2#1)(2008-3#1)
should never be##3##3##(1996-1#1)(1996-6#1)(2007-2#1)
should no##2##2##(1997-5#1)(2006-10#1)
should not be applied##2##4##(1997-3#1)(2008-9#1)
should not be confused with##6##5##(1992-11#1)(1992-4#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)
should not be considered a##2##5##(2008-10#1)(2008-11#1)
should not be considered##9##4##(1991-2#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#2)(2012-3#1)
should not be continued##2##4##(1990-11#1)(2009-12#1)
should not be dismissed##2##4##(2008-1#1)(2008-12#1)
should not be overlooked##2##4##(1997-3#1)(2010-6#1)
should not be recommended##2##4##(2007-2#1)(2007-7#1)
should not be the##3##4##(1997-3#1)(2008-10#1)(2011-2#1)
should not be used in##4##5##(1992-6#1)(1993-2#1)(2007-8#1)(2008-8#1)
should not be used##9##4##(1992-6#1)(1993-2#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-12#1)
should not be##89##3##(1990-11#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-8#3)(2008-9#2)(2009-12#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
should not have##2##3##(2008-11#1)(2008-2#1)
should not only##5##3##(1993-11#1)(2007-12#1)(2007-8#1)(2009-9#1)(2010-4#1)
should not rely##2##3##(1992-6#1)(2008-8#1)
should not underestimate the importance of##2##6##(2007-9#1)(2008-9#1)
should not##131##2##(1990-11#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#5)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
should now be##3##3##(1996-12#1)(1997-7#1)(2010-12#1)
should occur in the##2##4##(1991-6#1)(2008-9#1)
should occur##4##2##(1991-6#1)(1994-9#1)(2008-9#1)(2012-2#1)
should only be applied##2##4##(2008-10#1)(2013-1#1)
should only be used##5##4##(1994-8#1)(2008-10#1)(2008-2#1)(2012-2#2)
should only be##11##3##(1994-8#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-11#1)(2012-2#2)(2013-1#1)
should optimize##3##2##(1997-3#2)(2012-2#1)
should or should not be##2##5##(1990-11#1)(2008-9#1)
should participate in##3##3##(1994-2#1)(2007-7#1)(2011-2#1)
should pay more attention to##2##5##(2008-1#1)(2010-1#1)
should pay##4##2##(1993-7#1)(2008-1#1)(2008-9#1)(2010-1#1)
should perform##5##2##(1995-11#3)(2008-3#1)(2011-2#1)
should permit the##2##3##(2008-11#1)(2009-6#1)
should permit##3##2##(2007-12#1)(2008-11#1)(2009-6#1)
should play##2##2##(1993-1#1)(2008-3#1)
should preferably be##2##3##(1993-2#1)(1993-6#1)
should preferably##5##2##(1991-2#1)(1993-2#1)(1993-6#1)(2008-8#2)
should prepare##2##2##(1996-3#1)(2007-2#1)
should probably be##5##3##(1990-9#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
should produce##3##2##(1993-3#1)(2008-7#1)(2008-8#1)
should promote##2##2##(1994-1#1)(2009-3#1)
should prompt##5##2##(1997-3#1)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
should protect them##2##3##(1993-12#1)(2008-5#1)
should protect##3##2##(1993-12#1)(1997-5#1)(2008-5#1)
should prove to be##2##4##(1993-11#1)(1994-6#1)
should prove useful as a##2##5##(2008-10#2)
should prove useful for researchers and clinicians interested in##2##9##(2007-12#2)
should prove useful for##5##4##(2007-12#3)(2008-10#2)
should prove useful in##2##4##(1994-8#1)(2012-2#1)
should prove useful##11##3##(1992-12#1)(1994-8#1)(2007-12#3)(2008-10#4)(2008-3#1)(2012-2#1)
should prove##14##2##(1992-12#1)(1993-11#1)(1994-6#1)(1994-8#1)(2007-12#3)(2008-10#4)(2008-3#1)(2008-4#1)(2012-2#1)
should provide a##4##3##(1993-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
should provide an##2##3##(2008-10#1)(2008-3#1)
should provide further##2##3##(1993-12#1)(2008-7#1)
should provide the##2##3##(2008-3#1)(2011-2#1)
should provide##25##2##(1991-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(2007-2#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should raise the suspicion of##2##5##(2011-1#1)(2012-1#1)
should raise the##3##3##(2011-1#1)(2012-1#1)(2013-1#1)
should raise##4##2##(2007-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
should read as##2##3##(2007-12#2)
should receive greater##3##3##(1997-8#1)(2013-1#2)
should receive##14##2##(1992-12#2)(1993-11#1)(1993-12#1)(1994-9#1)(1995-8#1)(1997-8#2)(2008-11#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#2)
should recognize##2##2##(1994-2#1)(2008-3#1)
should reduce##4##2##(1993-11#1)(1994-12#1)(2008-10#1)(2008-8#1)
should reflect the##2##3##(1991-12#1)(2008-3#1)
should rely on##2##3##(2008-8#1)(2010-7#1)
should remain in##2##3##(1995-1#1)(2008-12#1)
should remain##4##2##(1992-3#1)(1995-1#1)(1997-8#1)(2008-12#1)
should remove##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
should replace##2##2##(1991-8#1)(2008-2#1)
should result in##6##3##(1995-5#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
should seek##3##2##(1992-6#1)(2008-5#1)(2008-7#1)
should serve as##2##3##(2012-2#2)
should serve to##2##3##(2008-12#1)(2013-8#1)
should serve##4##2##(2008-12#1)(2012-2#2)(2013-8#1)
should significantly##2##2##(2008-7#1)(2010-10#1)
should start in##2##3##(1993-2#1)(2008-3#1)
should start##5##2##(1990-2#1)(1993-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
should still be##2##3##(1994-2#1)(2011-2#1)
should stop##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
should strengthen the##3##3##(2012-3#3)
should strengthen##5##2##(2009-7#1)(2011-2#1)(2012-3#3)
should support a##2##3##(2008-2#1)(2008-9#1)
should support##3##2##(2008-2#1)(2008-9#1)(2012-12#1)
should take an active role in##2##6##(1994-1#1)(1995-3#1)
should take into account##2##4##(2008-7#1)(2009-4#1)
should take into##3##3##(1996-6#1)(2008-7#1)(2009-4#1)
should take place##3##3##(1992-4#1)(1996-11#1)(2008-8#1)
should take##17##2##(1992-4#1)(1994-1#3)(1995-3#1)(1996-11#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)
should target the##2##3##(2010-8#1)(2011-2#1)
should target##5##2##(1995-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
should terminate the##2##3##(2008-4#2)
should the##8##2##(1991-3#1)(1992-1#1)(1992-2#1)(1994-11#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-3#1)
should therefore be considered##2##4##(2008-8#1)(2009-3#1)
should therefore be given##2##4##(1996-11#1)(1997-3#1)
should therefore be##11##3##(1993-11#1)(1996-11#1)(1997-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)
should therefore##17##2##(1993-11#1)(1996-11#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
should they##5##2##(1991-12#1)(1992-12#1)(1992-5#1)(2007-2#1)(2012-3#1)
should thus##4##2##(1994-2#1)(2006-6#1)(2011-1#1)(2013-1#1)
should undergo further##2##3##(2011-8#1)(2013-1#1)
should undergo##9##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
should understand##2##2##(2008-7#1)(2010-8#1)
should use##6##2##(2007-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-2#1)
should usually be##2##3##(2006-5#1)(2008-8#1)
should vary##3##2##(1994-1#1)(2008-9#2)
should we not##2##3##(1993-2#1)(2010-3#1)
should we use?##2##3##(2008-7#1)(2008-8#1)
should we##17##2##(1993-2#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#3)(2008-8#2)(2010-3#1)(2013-7#1)
should work in##2##3##(2008-7#1)(2012-12#1)
should work##4##2##(1995-2#1)(2008-7#1)(2010-9#1)(2012-12#1)
should##2851##1##(1990-10#1)(1990-11#10)(1990-12#3)(1990-2#15)(1990-3#12)(1990-5#4)(1990-6#7)(1990-7#1)(1990-8#2)(1990-9#8)(1991-1#6)(1991-11#5)(1991-12#20)(1991-2#14)(1991-3#19)(1991-4#2)(1991-5#4)(1991-6#11)(1991-7#1)(1991-8#11)(1991-9#11)(1992-1#4)(1992-10#1)(1992-11#12)(1992-12#33)(1992-2#11)(1992-3#16)(1992-4#6)(1992-5#8)(1992-6#15)(1992-8#6)(1992-9#6)(1993-1#12)(1993-11#18)(1993-12#18)(1993-2#18)(1993-3#16)(1993-5#2)(1993-6#10)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#13)(1994-11#3)(1994-12#17)(1994-2#21)(1994-3#31)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#5)(1994-9#12)(1995-1#11)(1995-11#8)(1995-12#16)(1995-2#12)(1995-3#16)(1995-5#11)(1995-6#6)(1995-8#2)(1995-9#5)(1996-1#13)(1996-11#24)(1996-12#17)(1996-2#13)(1996-3#23)(1996-4#2)(1996-5#3)(1996-6#17)(1996-8#9)(1996-9#5)(1997-1#9)(1997-2#15)(1997-3#31)(1997-4#17)(1997-5#11)(1997-6#8)(1997-7#10)(1997-8#28)(2006-10#13)(2006-5#2)(2006-6#1)(2007-10#16)(2007-11#43)(2007-12#53)(2007-2#20)(2007-4#7)(2007-5#2)(2007-6#1)(2007-7#23)(2007-8#31)(2007-9#2)(2008-1#49)(2008-10#240)(2008-11#98)(2008-12#36)(2008-2#31)(2008-3#67)(2008-4#52)(2008-5#57)(2008-6#26)(2008-7#108)(2008-8#96)(2008-9#95)(2009-1#3)(2009-10#4)(2009-11#6)(2009-12#8)(2009-2#5)(2009-3#12)(2009-4#15)(2009-5#16)(2009-6#10)(2009-7#10)(2009-8#16)(2009-9#4)(2010-1#8)(2010-10#17)(2010-11#23)(2010-12#25)(2010-2#4)(2010-3#16)(2010-4#12)(2010-5#13)(2010-6#15)(2010-7#9)(2010-8#33)(2010-9#3)(2011-1#41)(2011-2#165)(2011-3#3)(2011-4#1)(2011-7#1)(2011-8#2)(2012-1#7)(2012-12#47)(2012-2#56)(2012-3#60)(2012-5#1)(2012-6#1)(2013-1#111)(2013-7#11)(2013-8#47)
shoulder abduction loading##3##3##(2010-7#3)
shoulder abduction##4##2##(2010-7#3)(2013-1#1)
shoulder and##6##2##(1990-12#1)(1997-5#1)(1997-8#1)(2008-7#1)(2008-9#1)(2009-7#1)
shoulder arthrodesis##2##2##(2008-6#2)
shoulder arthroplasty##2##2##(2007-8#2)
shoulder arthroscopy##3##2##(2007-11#3)
shoulder discomfort##2##2##(1995-3#1)(1996-9#1)
shoulder diseases##2##2##(2007-11#2)
shoulder dislocation##4##2##(2007-11#1)(2007-8#1)(2008-8#2)
shoulder dislocations##6##2##(2007-11#6)
shoulder during##3##2##(2009-1#1)(2009-3#1)(2013-1#1)
shoulder flexion##6##2##(2010-9#6)
shoulder function##7##2##(2007-8#1)(2008-9#4)(2012-2#1)(2013-1#1)
shoulder girdle##2##2##(2012-2#2)
shoulder in##2##2##(1997-6#1)(2008-10#1)
shoulder instability##6##2##(2007-11#6)
shoulder is##2##2##(2007-11#2)
shoulder joint##8##2##(1991-4#1)(2007-11#4)(2007-8#1)(2008-7#1)(2008-8#1)
shoulder muscles in##2##3##(2010-9#1)(2012-2#1)
shoulder muscles##6##2##(2008-12#1)(2010-9#2)(2012-2#3)
shoulder of##4##2##(1997-5#1)(2007-10#1)(2008-12#2)
shoulder pain and##4##3##(1992-9#1)(2007-11#1)(2008-10#1)(2009-1#1)
shoulder pain##13##2##(1992-9#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-9#1)(2012-1#1)
shoulder surgery##3##2##(2007-11#3)
shoulder##164##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-4#1)(1992-9#3)(1994-8#1)(1995-3#3)(1996-2#1)(1996-3#1)(1996-9#2)(1997-5#4)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#51)(2007-8#11)(2008-10#7)(2008-11#1)(2008-12#7)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#7)(2009-1#3)(2009-3#2)(2009-7#1)(2010-5#1)(2010-7#3)(2010-9#10)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#10)
shoulder-hand syndrome in##2##3##(2007-8#1)(2013-1#1)
shoulder-hand syndrome##3##2##(2007-8#2)(2013-1#1)
shoulders##14##1##(1994-2#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-12#2)(2008-7#1)(2009-5#2)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#1)
shovelers##3##1##(2008-6#3)
show a characteristic##3##3##(1997-7#1)(2008-11#1)(2012-2#1)
show a clear##6##3##(1990-5#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)
show a considerable##2##3##(1996-5#1)(2008-4#1)
show a consistent##3##3##(1994-2#1)(2007-11#1)(2008-5#1)
show a decline##2##3##(2008-7#1)(2009-12#1)
show a decrease in##2##4##(1996-11#1)(2008-10#1)
show a decrease##3##3##(1996-11#1)(2008-10#1)(2008-3#1)
show a different##2##3##(2008-9#1)(2011-2#1)
show a good##2##3##(1995-12#1)(2008-11#1)
show a greater##2##3##(1990-11#1)(1990-6#1)
show a high degree of##4##5##(1990-11#1)(1993-3#1)(2007-11#1)(2008-5#1)
show a high prevalence of##2##5##(2008-11#1)(2011-1#1)
show a high##10##3##(1990-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
show a higher incidence of##2##5##(1990-5#1)(2011-2#1)
show a higher##3##3##(1990-5#1)(1997-8#1)(2011-2#1)
show a highly##2##3##(1995-12#1)(2008-10#1)
show a homology##2##3##(1992-5#1)(2008-11#1)
show a large increase##2##4##(2007-12#1)(2008-10#1)
show a linear##2##3##(2008-10#1)(2011-2#1)
show a low level of agreement between the participants'##2##9##(2011-2#2)
show a low##5##3##(1990-6#1)(2008-10#1)(2008-9#1)(2011-2#2)
show a maximum##3##3##(1994-5#1)(2008-10#2)
show a more##3##3##(2008-4#1)(2012-3#1)(2013-8#1)
show a new##2##3##(1997-6#1)(2008-12#1)
show a potential##2##3##(2008-2#1)(2012-12#1)
show a reduction in their##2##5##(2008-7#1)(2011-2#1)
show a reduction##3##3##(2008-7#2)(2011-2#1)
show a relatively##3##3##(1991-6#1)(1997-6#1)(2009-11#1)
show a significant change in##2##5##(2008-11#1)(2011-2#1)
show a significant effect##2##4##(2008-12#1)(2008-3#1)
show a significant improvement##2##4##(2007-11#1)(2008-5#1)
show a significant##20##3##(1993-1#1)(1994-12#2)(1995-2#1)(1996-12#2)(1996-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2011-2#2)(2012-3#1)(2012-5#1)
show a similar##2##3##(1997-7#1)(2008-6#1)
show a strong correlation between##2##5##(2008-3#1)(2009-10#1)
show a strong correlation##3##4##(2008-3#2)(2009-10#1)
show a strong##7##3##(1990-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-12#1)
show a sufficient antimicrobial effect##3##5##(2008-5#3)
show a trend##2##3##(2008-7#1)(2013-8#1)
show a very##2##3##(2007-12#1)(2013-8#1)
show a wide range of##2##5##(2008-1#1)(2011-2#1)
show a wide##3##3##(2008-1#1)(2011-2#2)
show a##215##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-6#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-7#1)(2008-1#2)(2008-10#27)(2008-11#10)(2008-12#6)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#10)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#2)(2013-8#6)
show activity against##2##3##(1992-6#1)(2008-5#1)
show additional##2##2##(1993-8#1)(2009-8#1)
show agonist##2##2##(1990-8#1)(1992-3#1)
show also that##2##3##(2007-11#1)(2008-10#1)
show also##3##2##(1997-3#1)(2007-11#1)(2008-10#1)
show altered##2##2##(2008-3#1)(2009-6#1)
show an almost##2##3##(2007-11#1)(2008-12#1)
show an association between##4##4##(1990-8#1)(2008-2#1)(2011-2#1)(2013-8#1)
show an association##5##3##(1990-8#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
show an average##2##3##(2008-10#1)(2008-2#1)
show an important##2##3##(1995-12#1)(2008-10#1)
show an increase in##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
show an increase##4##3##(2008-10#1)(2008-3#2)(2008-8#1)
show an increased##2##3##(2008-4#1)(2008-6#1)
show an overall##4##3##(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
show an##53##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#2)
show analytically##2##2##(2007-11#1)(2008-8#1)
show any##46##2##(1990-2#2)(1990-6#1)(1992-6#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
show areas of##2##3##(2007-10#1)(2010-12#1)
show better##2##2##(2008-10#1)(2013-1#1)
show by##7##2##(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
show clearly that##2##3##(2007-11#1)(2008-5#1)
show clinical##2##2##(2010-6#1)(2011-2#1)
show complete##2##2##(1995-6#1)(2008-2#1)
show considerable##3##2##(1995-2#1)(2008-5#1)(2012-2#1)
show consistent##3##2##(2010-10#2)(2011-1#1)
show differences in##2##3##(1997-3#1)(2008-10#1)
show differences##3##2##(1997-3#1)(2008-10#2)
show different##11##2##(2008-10#2)(2008-12#1)(2008-5#2)(2008-9#2)(2009-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
show directional##2##2##(2007-12#1)(2008-10#1)
show distinct##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
show dramatic##3##2##(1992-12#1)(1996-3#1)(2013-1#1)
show either##4##2##(1996-3#1)(1997-1#1)(2008-10#1)(2008-9#1)
show elevated##2##2##(1997-5#1)(2008-11#1)
show enhanced##5##2##(1994-3#1)(2007-12#1)(2008-9#1)(2009-11#1)(2011-2#1)
show evidence for##2##3##(2008-2#1)(2013-1#1)
show evidence of##6##3##(1990-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
show evidence##8##2##(1990-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
show excellent agreement##2##3##(2008-3#2)
show excellent##8##2##(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
show experimentally that the##2##4##(2007-11#1)(2007-12#1)
show experimentally that##4##3##(2007-11#2)(2007-12#1)(2009-11#1)
show experimentally##5##2##(2007-11#2)(2007-12#2)(2009-11#1)
show feasibility##2##2##(2007-8#1)(2013-1#1)
show for the first time that##2##6##(2009-8#1)(2011-2#1)
show for the first time##4##5##(1995-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
show for##5##2##(1992-10#1)(1995-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
show further that##2##3##(2008-8#1)(2011-2#1)
show good agreement for##2##4##(2008-2#2)
show good agreement of##2##4##(2008-10#1)(2008-3#1)
show good agreement with the measured##2##6##(1996-12#1)(2008-2#1)
show good agreement with the##7##5##(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
show good agreement with##11##4##(1996-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#1)
show good agreement##21##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#7)(2008-7#1)
show good correlation with##2##4##(2007-12#1)(2008-10#1)
show good##29##2##(1994-9#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#8)(2008-3#7)(2008-7#1)(2010-6#1)
show great##4##2##(1994-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
show greater##3##2##(1990-2#1)(2008-11#1)(2008-5#1)
show here that##20##3##(1990-12#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-12#2)(2012-2#1)
show here##21##2##(1990-12#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-2#1)(2012-12#2)(2012-2#1)
show high##10##2##(1991-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
show higher##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
show how a WDM##2##4##(2008-2#2)
show how a##8##3##(1996-3#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)
show how an##2##3##(2008-2#1)(2008-3#1)
show how it is##2##4##(2008-10#1)(2008-11#1)
show how it##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
show how migration##2##3##(2008-8#2)
show how such##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
show how the##24##3##(1991-1#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-2#3)
show how these##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
show how they##2##3##(1991-3#1)(2007-12#1)
show how this##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)
show how to use##3##4##(1993-12#1)(1997-3#1)(2008-3#1)
show how to##18##3##(1993-12#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-6#1)
show how##94##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#10)(2008-3#20)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#3)(2009-11#1)(2009-5#2)(2010-1#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#5)(2013-1#1)(2013-8#1)
show identical##2##2##(1994-8#1)(1995-3#1)
show improvement in##2##3##(2007-8#1)(2008-3#1)
show improvement##3##2##(2007-8#1)(2008-11#1)(2008-3#1)
show in##10##2##(1990-10#1)(1991-9#1)(1995-12#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-12#1)
show increased##11##2##(1992-2#1)(1992-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#2)(2010-11#2)(2010-4#1)(2011-10#1)
show ionic##2##2##(1992-3#1)(2008-10#1)
show large##3##2##(1994-2#1)(2012-2#1)(2013-8#1)
show less than##2##3##(1995-12#1)(2008-2#1)
show less##6##2##(1995-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-2#1)
show little##4##2##(1991-8#1)(1995-11#2)(2009-10#1)
show low##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
show lower##2##2##(2008-7#1)(2012-2#1)
show marked##4##2##(1992-9#1)(2007-11#1)(2008-7#1)(2010-3#1)
show more##4##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
show much lower##2##3##(1990-11#1)(1990-12#1)
show much##6##2##(1990-11#1)(1990-12#1)(1995-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
show negligible##3##2##(1990-8#1)(2008-10#2)
show no evidence of##5##4##(1993-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-8#1)
show no evidence##6##3##(1993-11#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-8#1)
show no significant##3##3##(1995-9#1)(1997-4#1)(2008-5#1)
show no##31##2##(1990-2#1)(1990-5#1)(1993-11#2)(1993-6#1)(1994-12#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
show non-linear##2##2##(2008-10#1)(2008-7#1)
show normal##3##2##(1993-6#1)(1994-12#1)(2007-8#1)
show on##2##2##(1996-3#1)(2007-11#1)
show overlap##2##2##(2008-10#1)(2011-2#1)
show positive##2##2##(2008-5#1)(2013-7#1)
show potent##2##2##(2007-11#1)(2011-3#1)
show potential for##2##3##(2008-3#1)(2012-2#1)
show potential##4##2##(2008-10#1)(2008-3#1)(2009-1#1)(2012-2#1)
show promise as##2##3##(2009-5#1)(2010-5#1)
show promise for##2##3##(2008-2#1)(2008-7#1)
show promise##6##2##(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-5#1)
show promising##2##2##(1993-3#1)(2008-2#1)
show rapid##3##2##(2008-4#1)(2008-7#1)(2009-10#1)
show rather##2##2##(1991-11#1)(2010-4#1)
show reduced##4##2##(2008-4#2)(2008-7#1)(2010-2#1)
show relative standard deviations##2##4##(1997-2#1)(2008-10#1)
show relatively##4##2##(2008-5#1)(2010-12#3)
show remarkable##2##2##(1990-7#1)(2008-10#1)
show resistance to##2##3##(2008-10#1)(2011-1#1)
show severe##2##2##(1997-2#1)(2008-11#1)
show significant changes##3##3##(1992-3#1)(1996-1#1)(2012-2#1)
show significant difference##2##3##(2008-10#1)(2008-4#1)
show significant differences in##2##4##(2008-10#1)(2009-9#1)
show significant differences##6##3##(1995-12#1)(2007-10#1)(2008-10#1)(2009-9#1)(2011-2#1)(2013-7#1)
show significant improvement##2##3##(2007-12#1)(2008-2#1)
show significant##44##2##(1990-6#1)(1991-12#1)(1992-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-9#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#9)
show significantly##3##2##(1997-7#1)(2008-5#2)
show signs of##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)
show similar patterns of##2##4##(1996-12#1)(2012-3#1)
show similar##8##2##(1992-6#1)(1995-11#1)(1996-12#1)(1997-6#1)(2008-5#1)(2012-3#1)(2012-8#1)(2013-1#1)
show similarity##3##2##(1995-2#1)(1995-5#1)(1995-6#1)
show simple##2##2##(1995-2#1)(2008-2#1)
show slight##2##2##(1994-5#1)(2008-5#1)
show small event complexity##2##4##(1996-4#2)
show some similarities to##3##4##(1992-12#1)(1996-10#1)(1996-2#1)
show some##17##2##(1990-11#1)(1990-8#1)(1992-12#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)
show spontaneous resolution##2##3##(2008-12#2)
show spontaneous##4##2##(2008-11#1)(2008-12#2)(2010-8#1)
show stable##2##2##(2008-3#2)
show strong##9##2##(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2009-5#2)(2009-6#1)(2011-2#1)
show strongly##2##2##(1995-8#1)(2008-8#1)
show substantial##2##2##(1990-5#1)(2008-3#1)
show such##3##2##(1991-10#1)(1992-3#1)(1995-2#1)
show superior##3##2##(2009-8#1)(2012-2#1)(2012-3#1)
show symptoms##2##2##(2007-8#1)(2011-2#1)
show that (1)##2##3##(1996-3#1)(2008-3#1)
show that (a)##2##3##(2007-12#1)(2009-6#1)
show that 2##2##3##(2008-8#1)(2011-2#1)
show that A##2##3##(2008-10#1)(2008-5#1)
show that C##2##3##(2008-10#1)(2013-1#1)
show that CBF-C##2##3##(1995-2#2)
show that CsA##2##3##(1994-8#2)
show that G##3##3##(1992-9#1)(1996-2#1)(2008-3#1)
show that GC7##2##3##(1997-1#2)
show that HLH-29##2##3##(2012-12#2)
show that I##2##3##(1995-2#1)(2008-10#1)
show that T##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
show that a critical##2##4##(1994-2#1)(2010-7#1)
show that a reduction##2##4##(2008-9#1)(2011-2#1)
show that a single##5##4##(1990-11#1)(2006-6#1)(2007-12#1)(2008-7#1)(2011-1#1)
show that a##57##3##(1990-11#3)(1990-12#1)(1993-8#1)(1994-2#2)(1997-3#1)(1997-9#1)(2006-6#2)(2007-11#3)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#10)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
show that activation of##3##4##(1995-2#1)(2008-4#1)(2011-2#1)
show that adipocyte##2##3##(1994-11#1)(2008-3#1)
show that all of##2##4##(1995-9#1)(2007-11#1)
show that all the##3##4##(1992-11#1)(1992-3#1)(2007-12#1)
show that all##9##3##(1992-11#1)(1992-3#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-8#2)(2009-9#1)
show that although##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
show that an##13##3##(1990-5#1)(1994-3#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
show that at least##4##4##(1992-3#1)(1994-3#1)(2008-1#1)(2008-10#1)
show that at##10##3##(1992-3#1)(1994-3#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
show that beta-CD reacts with##2##5##(2008-10#2)
show that both the##4##4##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
show that both##22##3##(1991-9#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-8#1)(2010-3#1)(2012-12#1)
show that by##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
show that certain##2##3##(2008-12#1)(2008-5#1)
show that changes in##2##4##(1995-12#1)(2008-3#1)
show that changes##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
show that differences##2##3##(1993-1#1)(2009-5#1)
show that different##4##3##(1994-2#1)(2008-1#1)(2011-1#1)(2012-3#1)
show that each##3##3##(1996-9#1)(2008-3#1)(2008-6#1)
show that even in the##2##5##(1994-12#1)(2008-9#1)
show that even##6##3##(1994-12#1)(1997-4#1)(2007-12#1)(2008-7#1)(2008-9#1)(2012-1#1)
show that exogenous##2##3##(1990-2#1)(1996-2#1)
show that female##2##3##(1995-3#1)(2012-3#1)
show that for a##2##4##(2008-3#1)(2013-8#1)
show that for##9##3##(2007-12#1)(2008-2#2)(2008-3#4)(2008-9#1)(2013-8#1)
show that good##2##3##(2008-2#1)(2008-3#1)
show that high##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
show that higher##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
show that human##3##3##(1995-11#1)(2008-5#1)(2009-12#1)
show that if the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
show that if##7##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-7#1)(2013-1#1)
show that in a##2##4##(1997-1#1)(2008-3#1)
show that in addition to the##2##6##(2008-10#1)(2012-12#1)
show that in the##4##4##(1994-8#1)(2008-2#1)(2008-3#1)(2008-9#1)
show that in##30##3##(1990-11#1)(1990-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
show that inclusion of##2##4##(1992-5#1)(2008-9#1)
show that increased##2##3##(2008-1#1)(2008-8#1)
show that increases in##2##4##(2008-10#1)(2011-2#1)
show that individuals with##2##4##(2010-2#1)(2012-2#1)
show that it can##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
show that it is possible to##9##6##(1990-5#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-2#1)
show that it is possible##10##5##(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-2#1)
show that it is##18##4##(1990-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
show that it##29##3##(1990-5#1)(1990-6#1)(1993-9#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
show that its##3##3##(2007-11#1)(2009-5#1)(2010-5#1)
show that little or no##2##5##(1992-3#1)(1992-8#1)
show that little##3##3##(1992-3#1)(1992-8#1)(2011-1#1)
show that low##2##3##(2008-3#1)(2008-7#1)
show that male##2##3##(1993-8#1)(2011-2#1)
show that many of the features##2##6##(2007-12#1)(2008-3#1)
show that many of the##4##5##(2007-12#1)(2008-3#3)
show that many##6##3##(1992-6#1)(1997-4#1)(2007-12#1)(2008-3#3)
show that neither##2##3##(1991-3#1)(1993-12#1)
show that no##3##3##(1991-12#1)(1993-8#1)(2008-9#1)
show that not only##2##4##(1992-3#1)(2013-1#1)
show that nurses##2##3##(1992-3#1)(2007-10#1)
show that of##2##3##(2007-12#1)(2013-8#1)
show that only##3##3##(2007-12#1)(2008-3#2)
show that oral##2##3##(2008-11#1)(2008-8#1)
show that our##8##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
show that parasites##2##3##(2008-8#1)(2010-2#1)
show that population##2##3##(2008-8#1)(2010-5#1)
show that positive##3##3##(1994-12#1)(2008-9#1)(2012-3#1)
show that protein##2##3##(1990-7#1)(2009-6#1)
show that rat##2##3##(1993-3#1)(1993-8#1)
show that resveratrol##2##3##(2008-5#1)(2009-12#1)
show that significant##2##3##(2007-11#1)(2008-8#1)
show that single##3##3##(1993-1#1)(2007-12#1)(2008-3#1)
show that some##6##3##(2008-10#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)
show that spatial##4##3##(2008-10#1)(2008-8#3)
show that species##3##3##(2008-8#1)(2009-8#1)(2012-6#1)
show that such a##4##4##(2007-11#1)(2008-11#1)(2008-2#1)(2012-2#1)
show that such##9##3##(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)
show that the STELLS algorithm is##2##6##(2012-3#2)
show that the absorption and scattering##2##6##(2008-3#1)(2009-12#1)
show that the algorithm##3##4##(2008-2#3)
show that the analysis of##2##5##(2008-10#2)
show that the analysis##3##4##(2008-10#2)(2008-3#1)
show that the application of##2##5##(2008-11#1)(2008-3#1)
show that the combination##2##4##(1995-5#1)(2009-6#1)
show that the common##2##4##(1990-11#1)(2007-7#1)
show that the conversion efficiency##2##5##(2007-12#1)(2008-2#1)
show that the crystal##2##4##(2013-1#1)(2013-8#1)
show that the delivered##2##4##(1996-2#1)(2008-11#1)
show that the differences in##2##5##(2008-2#1)(2012-2#1)
show that the differences##3##4##(2008-2#1)(2012-2#1)(2013-8#1)
show that the distribution##2##4##(1997-4#1)(2011-1#1)
show that the dynamic##2##4##(2008-3#1)(2012-2#1)
show that the effect of##2##5##(2007-12#1)(2008-8#1)
show that the effects of##3##5##(2008-2#1)(2008-3#1)(2008-8#1)
show that the effects##4##4##(2008-2#1)(2008-3#2)(2008-8#1)
show that the error##2##4##(2008-2#1)(2008-3#1)
show that the evolution of##2##5##(2008-8#1)(2012-3#1)
show that the experimental##3##4##(1997-7#1)(2008-2#1)(2008-3#1)
show that the extent of##3##5##(2008-10#1)(2008-5#1)(2008-6#1)
show that the far-field##2##4##(2007-11#1)(2008-3#1)
show that the first##3##4##(2007-12#1)(2011-2#1)(2012-2#1)
show that the geometric##2##4##(2008-2#1)(2008-3#1)
show that the initial##2##4##(2007-12#1)(2008-3#1)
show that the interaction##2##4##(1994-6#1)(2008-8#1)
show that the introduction of##2##5##(2008-11#2)
show that the latter##2##4##(2008-3#1)(2011-2#1)
show that the main##3##4##(1996-6#1)(2008-10#1)(2008-3#1)
show that the maximum##4##4##(2007-12#2)(2008-10#1)(2008-2#1)
show that the method is##3##5##(2007-11#1)(2008-10#2)
show that the method##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
show that the model##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
show that the new method##3##5##(2008-2#2)(2008-3#1)
show that the new##4##4##(2008-2#2)(2008-3#1)(2009-6#1)
show that the number of##3##5##(1995-12#1)(2008-3#1)(2011-2#1)
show that the number##4##4##(1995-12#1)(2008-3#2)(2011-2#1)
show that the optical##4##4##(2008-2#2)(2008-3#1)(2013-8#1)
show that the optimal##3##4##(2008-10#1)(2008-3#2)
show that the oxidized##2##4##(2007-12#1)(2008-10#1)
show that the position of##2##5##(2007-11#1)(2007-12#1)
show that the presence of##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
show that the previously##2##4##(1990-5#1)(1995-9#1)
show that the proposed##9##4##(1995-9#1)(2008-3#2)(2009-9#1)(2010-8#3)(2012-3#1)(2013-8#1)
show that the ratio of##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
show that the relationship between##2##5##(1994-2#1)(2008-8#1)
show that the selectivity of the##2##6##(2008-10#2)
show that the sensitivity of##2##5##(2007-11#1)(2008-3#1)
show that the sensor can##2##5##(2008-10#1)(2008-3#1)
show that the sensor##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
show that the spectral##3##4##(2007-12#2)(2013-8#1)
show that the system can##2##5##(2008-2#1)(2008-3#1)
show that the technique##2##4##(2008-3#2)
show that the three##2##4##(2008-10#1)(2012-1#1)
show that the total##4##4##(1997-7#1)(2007-12#1)(2008-2#1)(2012-2#1)
show that the transcriptional##2##4##(1994-9#1)(2011-2#1)
show that the transverse##2##4##(2007-12#1)(2008-3#1)
show that the two##3##4##(1993-1#1)(1994-8#1)(2008-8#1)
show that the use of this##2##6##(2008-3#1)(2013-1#1)
show that the use of##6##5##(1992-2#1)(2007-12#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
show that the##568##3##(1990-11#2)(1990-12#1)(1990-5#4)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#4)(1996-12#4)(1996-2#6)(1996-5#3)(1996-6#1)(1997-2#4)(1997-4#2)(1997-7#6)(2007-1#1)(2007-10#1)(2007-11#25)(2007-12#25)(2007-7#1)(2008-1#2)(2008-10#77)(2008-11#21)(2008-12#2)(2008-2#52)(2008-3#113)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#27)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#15)(2012-3#8)(2013-1#8)(2013-8#21)
show that there are no##2##5##(1994-9#1)(2008-10#1)
show that there are two##3##5##(2008-3#1)(2008-8#1)(2011-3#1)
show that there are##9##4##(1994-9#1)(1996-6#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-9#1)(2011-3#1)
show that there is a##7##5##(1991-9#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
show that there is an##3##5##(1994-5#1)(2008-2#1)(2012-2#1)
show that there is no##4##5##(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
show that there is##21##4##(1991-9#1)(1992-8#1)(1994-5#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#2)
show that there##34##3##(1991-12#1)(1991-9#1)(1992-8#1)(1994-5#1)(1994-9#1)(1996-6#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
show that these##26##3##(1990-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
show that they##6##3##(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2012-3#1)
show that this approach can##2##5##(2008-2#1)(2008-6#1)
show that this approach is##2##5##(1992-9#1)(2007-12#1)
show that this approach##4##4##(1992-9#1)(2007-12#1)(2008-2#1)(2008-6#1)
show that this is a##2##5##(2007-12#1)(2008-10#1)
show that this is##5##4##(1993-1#1)(2007-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
show that this method##2##4##(2008-10#1)(2008-2#1)
show that this model##2##4##(2008-10#1)(2013-8#1)
show that this procedure##2##4##(2009-8#1)(2012-2#1)
show that this technique can##3##5##(2007-11#1)(2008-3#2)
show that this technique is##2##5##(2007-11#1)(2012-2#1)
show that this technique##7##4##(2007-11#3)(2008-3#3)(2012-2#1)
show that this##60##3##(1991-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-9#1)(1995-6#1)(2007-11#7)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
show that transcription of the##2##5##(1990-11#1)(1995-8#1)
show that transmission##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
show that treatment of##2##4##(2008-10#2)
show that using##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
show that when##5##3##(1994-2#1)(2008-12#1)(2008-2#1)(2008-3#2)
show that while##3##3##(1990-5#1)(1991-12#1)(2012-3#1)
show that with##7##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
show that zinc##3##3##(1992-9#1)(1994-6#1)(2008-10#1)
show that##1746##2##(1990-11#9)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#13)(1990-6#3)(1990-7#3)(1990-8#4)(1991-1#1)(1991-12#12)(1991-2#4)(1991-3#3)(1991-5#7)(1991-9#5)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#10)(1992-4#2)(1992-5#1)(1992-6#8)(1992-7#1)(1992-8#6)(1992-9#8)(1993-1#5)(1993-11#2)(1993-12#8)(1993-2#4)(1993-3#6)(1993-6#9)(1993-8#10)(1993-9#3)(1994-1#4)(1994-11#11)(1994-12#9)(1994-2#9)(1994-3#8)(1994-5#5)(1994-6#5)(1994-8#18)(1994-9#11)(1995-11#6)(1995-12#8)(1995-2#17)(1995-3#6)(1995-5#6)(1995-6#11)(1995-8#7)(1995-9#5)(1996-1#2)(1996-12#7)(1996-2#11)(1996-3#3)(1996-5#8)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#8)(1997-3#4)(1997-4#4)(1997-6#5)(1997-7#15)(1997-8#2)(1997-9#1)(2006-6#3)(2007-1#1)(2007-10#2)(2007-11#68)(2007-12#76)(2007-7#3)(2007-8#3)(2008-1#10)(2008-10#188)(2008-11#48)(2008-12#17)(2008-2#104)(2008-3#243)(2008-4#9)(2008-5#35)(2008-6#13)(2008-7#48)(2008-8#80)(2008-9#39)(2009-10#6)(2009-11#3)(2009-12#9)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#8)(2009-7#4)(2009-8#12)(2009-9#12)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#6)(2010-4#1)(2010-5#5)(2010-6#7)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#14)(2011-2#38)(2011-3#3)(2012-1#4)(2012-12#24)(2012-2#45)(2012-3#30)(2012-6#1)(2012-7#1)(2013-1#30)(2013-7#2)(2013-8#54)
show the correct##2##3##(1990-3#1)(2008-3#1)
show the different##2##3##(2008-10#1)(2008-3#1)
show the effect of##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
show the effect##4##3##(2008-1#1)(2008-11#1)(2008-2#1)(2012-2#1)
show the effectiveness of##3##4##(1996-12#1)(2010-4#1)(2012-2#1)
show the effectiveness##4##3##(1996-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
show the excellent##3##3##(2007-7#1)(2008-10#1)(2008-2#1)
show the existence of a##2##5##(2007-12#1)(2010-10#1)
show the existence of##7##4##(1991-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-10#1)(2013-8#1)
show the expected##3##3##(1992-9#1)(2009-11#1)(2012-12#1)
show the expression of##2##4##(1995-3#1)(2008-7#1)
show the feasibility of the##2##5##(2008-3#2)
show the feasibility of##7##4##(2008-10#2)(2008-3#4)(2010-5#1)
show the feasibility##9##3##(2008-10#3)(2008-3#4)(2009-12#1)(2010-5#1)
show the importance of##8##4##(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-2#1)
show the influence of##2##4##(2008-10#1)(2008-8#1)
show the need for##2##4##(2008-10#1)(2008-8#1)
show the need##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
show the possibility of##3##4##(2008-2#1)(2008-3#2)
show the potential of this technique##2##6##(2007-11#1)(2007-12#1)
show the potential##5##3##(2007-11#1)(2007-12#1)(2008-10#3)
show the presence of##3##4##(1990-12#1)(2007-12#1)(2008-7#1)
show the relative##2##3##(2008-10#2)
show the results of##3##4##(2007-12#1)(2008-3#2)
show the results##4##3##(2007-12#1)(2008-3#3)
show the same##2##3##(2008-10#2)
show the usefulness of the##2##5##(2007-11#1)(2008-10#1)
show the usefulness of##3##4##(2007-11#1)(2008-10#2)
show the usefulness##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
show the utility of the##5##5##(2008-3#5)
show the utility##6##3##(2008-10#1)(2008-3#5)
show the validity of##2##4##(2008-5#1)(2009-10#1)
show the##207##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#8)(2007-12#10)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#5)(2008-12#2)(2008-2#15)(2008-3#35)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-8#1)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#2)
show there is##2##3##(2008-10#1)(2012-3#1)
show there##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
show these##2##2##(1991-5#1)(2008-8#1)
show this##4##2##(1997-3#1)(2007-12#1)(2008-5#1)(2008-8#1)
show through##2##2##(2007-12#1)(2009-9#1)
show two##2##2##(2008-10#2)
show up as##2##3##(2007-12#1)(2008-3#1)
show up##7##2##(1992-5#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
show variable##2##2##(2008-5#1)(2011-2#1)
show very good##2##3##(2008-10#1)(2008-3#1)
show very##6##2##(2008-10#2)(2008-3#1)(2008-9#1)(2010-6#1)(2012-2#1)
show weak##2##2##(1997-7#1)(2011-3#1)
show white##2##2##(2008-10#1)(2008-3#1)
show why##2##2##(2009-5#1)(2012-3#1)
show with##2##2##(2008-10#1)(2008-5#1)
show##3135##1##(1990-10#3)(1990-11#16)(1990-12#7)(1990-2#9)(1990-3#4)(1990-5#20)(1990-6#8)(1990-7#5)(1990-8#10)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#13)(1991-2#6)(1991-3#6)(1991-5#13)(1991-6#5)(1991-8#2)(1991-9#11)(1992-1#2)(1992-10#5)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#18)(1992-4#2)(1992-5#4)(1992-6#12)(1992-7#1)(1992-8#8)(1992-9#17)(1993-1#8)(1993-11#7)(1993-12#11)(1993-2#6)(1993-3#11)(1993-6#14)(1993-8#16)(1993-9#3)(1994-1#4)(1994-11#14)(1994-12#16)(1994-2#14)(1994-3#10)(1994-5#11)(1994-6#8)(1994-8#22)(1994-9#16)(1995-1#2)(1995-11#17)(1995-12#21)(1995-2#23)(1995-3#9)(1995-5#7)(1995-6#16)(1995-8#11)(1995-9#6)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#14)(1996-2#18)(1996-3#10)(1996-4#4)(1996-5#13)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#17)(1997-3#19)(1997-4#10)(1997-5#3)(1997-6#10)(1997-7#25)(1997-8#6)(1997-9#1)(2006-6#4)(2007-1#1)(2007-10#9)(2007-11#119)(2007-12#135)(2007-6#2)(2007-7#5)(2007-8#11)(2008-1#19)(2008-10#351)(2008-11#91)(2008-12#34)(2008-2#169)(2008-3#363)(2008-4#23)(2008-5#94)(2008-6#25)(2008-7#98)(2008-8#118)(2008-9#62)(2009-1#2)(2009-10#16)(2009-11#14)(2009-12#13)(2009-2#6)(2009-3#5)(2009-4#6)(2009-5#16)(2009-6#15)(2009-7#6)(2009-8#19)(2009-9#16)(2010-1#4)(2010-10#12)(2010-11#7)(2010-12#14)(2010-2#10)(2010-3#9)(2010-4#10)(2010-5#13)(2010-6#14)(2010-7#5)(2010-8#16)(2010-9#1)(2011-1#25)(2011-10#1)(2011-2#85)(2011-3#6)(2012-1#9)(2012-12#35)(2012-2#81)(2012-3#46)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#57)(2013-3#1)(2013-7#9)(2013-8#86)
showed 100% sensitivity##2##3##(2007-7#2)
showed 100%##4##2##(2007-11#1)(2007-7#2)(2008-10#1)
showed 20##2##2##(2008-7#1)(2013-1#1)
showed 3##3##2##(1990-5#1)(2007-8#1)(2008-7#1)
showed 50%##2##2##(1992-3#1)(2013-1#1)
showed 99%##2##2##(1993-12#1)(2008-10#1)
showed CGPR##2##2##(2010-12#2)
showed NP##2##2##(2013-8#2)
showed a 13##2##3##(1994-9#1)(2008-1#1)
showed a 50-kDa protein##2##4##(1993-6#2)
showed a better##4##3##(1990-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
showed a big##2##3##(1997-8#1)(2008-10#1)
showed a broad##2##3##(1990-11#1)(2008-5#1)
showed a clear##8##3##(1993-3#1)(1997-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2013-1#1)(2013-8#1)
showed a clearly##2##3##(2008-10#1)(2008-5#1)
showed a close association##2##4##(2008-10#2)
showed a close##3##3##(2008-10#2)(2008-11#1)
showed a complete##3##3##(1990-2#1)(1997-6#1)(2012-3#1)
showed a considerable##2##3##(2008-10#1)(2010-4#1)
showed a consistent##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
showed a correlation##3##3##(2007-11#1)(2008-10#2)
showed a decrease in the##3##5##(1994-8#2)(2008-5#1)
showed a decrease in##6##4##(1994-8#2)(2008-10#2)(2008-12#1)(2008-5#1)
showed a decrease of##3##4##(1994-8#1)(1996-6#1)(2008-7#1)
showed a decrease with##2##4##(2008-3#1)(2008-5#1)
showed a decrease##12##3##(1991-1#1)(1994-8#3)(1996-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
showed a decreasing##2##3##(1996-3#1)(2008-10#1)
showed a distinct##2##3##(2007-8#1)(2008-11#1)
showed a dose-dependent##5##3##(1993-6#1)(1995-12#3)(2011-2#1)
showed a dramatic##2##3##(2008-10#1)(2013-1#1)
showed a favourable##2##3##(1991-6#1)(2013-1#1)
showed a good agreement with##2##5##(2008-10#2)
showed a good agreement##5##4##(2008-10#5)
showed a good fit##2##4##(1994-8#1)(2008-8#1)
showed a good linearity##2##4##(2008-10#1)(2011-3#1)
showed a good response to##2##5##(1992-10#1)(2007-7#1)
showed a good##27##3##(1992-10#1)(1993-8#1)(1994-8#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-3#1)(2013-7#1)
showed a great##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
showed a greater##5##3##(1993-11#1)(2007-10#1)(2008-5#1)(2011-10#1)(2013-8#1)
showed a high affinity for the##2##6##(1994-11#1)(1995-11#1)
showed a high degree of homology##3##6##(1990-2#1)(1997-1#1)(2008-10#1)
showed a high degree of similarity##2##6##(1993-9#1)(2008-10#1)
showed a high degree of##11##5##(1990-2#1)(1990-5#1)(1993-9#1)(1996-2#1)(1997-1#1)(2008-10#4)(2010-12#1)(2012-1#1)
showed a high level of##6##5##(1995-11#1)(1997-3#1)(2007-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
showed a high sequence homology with##2##6##(1992-12#1)(1997-4#1)
showed a high##34##3##(1990-2#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-11#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-5#1)(2008-10#8)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-1#2)(2013-1#1)
showed a higher frequency##2##4##(1997-8#1)(2008-7#1)
showed a higher prevalence of##4##5##(1990-12#1)(1996-12#1)(2008-12#1)(2013-1#1)
showed a higher rate of##2##5##(1997-8#1)(2012-12#1)
showed a higher##24##3##(1990-12#1)(1991-12#2)(1994-11#1)(1995-12#1)(1996-12#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2012-12#2)(2013-1#1)(2013-8#1)
showed a highly significant##2##4##(1994-3#1)(2008-7#1)
showed a highly##5##3##(1994-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
showed a homogeneous##2##3##(2008-5#1)(2008-7#1)
showed a huge##5##3##(2007-8#2)(2008-7#1)(2010-3#1)(2012-2#1)
showed a large##3##3##(1990-6#1)(2008-5#1)(2008-7#1)
showed a larger##2##3##(2008-11#1)(2008-7#1)
showed a left##2##3##(2007-8#1)(2010-2#1)
showed a lesion##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
showed a linear calibration curve in the range##2##8##(2008-10#2)
showed a linear range of##2##5##(2008-10#2)
showed a linear range##3##4##(2008-10#3)
showed a linear response##4##4##(2008-10#4)
showed a linear##14##3##(1990-11#1)(2008-10#13)
showed a little##2##3##(2008-10#1)(2008-11#1)
showed a low##5##3##(1991-11#1)(1991-8#1)(1993-6#1)(2008-9#1)(2011-3#1)
showed a lower##10##3##(1991-3#1)(1991-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2012-5#1)(2013-8#1)
showed a major##3##3##(1992-12#1)(1993-1#1)(1993-11#1)
showed a marginally significant##2##4##(1991-8#1)(1994-2#1)
showed a marginally##3##3##(1991-8#1)(1994-2#1)(2011-2#1)
showed a marked increase in##2##5##(1994-8#1)(1995-5#1)
showed a marked##9##3##(1990-12#2)(1994-8#1)(1995-5#1)(2007-10#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
showed a mass##2##3##(2008-1#1)(2011-2#1)
showed a massive##2##3##(1995-3#1)(1995-6#1)
showed a maximum##2##3##(1994-6#1)(2008-3#1)
showed a mean##3##3##(2007-10#2)(2008-10#1)
showed a moderate##2##3##(2008-5#1)(2010-1#1)
showed a modest##3##3##(1997-5#1)(1997-7#1)(2011-1#1)
showed a much lower##2##4##(1995-5#1)(2008-2#1)
showed a much stronger##2##4##(2008-10#1)(2011-1#1)
showed a much##4##3##(1995-5#1)(2008-10#1)(2008-2#1)(2011-1#1)
showed a near-Nernstian response over the##2##6##(2008-10#2)
showed a negative correlation##2##4##(1991-11#1)(2011-2#1)
showed a negative##3##3##(1991-11#1)(2008-11#1)(2011-2#1)
showed a normal##3##3##(1997-3#1)(2008-9#1)(2011-2#1)
showed a novel##2##3##(1992-9#1)(2008-11#1)
showed a pair of well-defined##2##5##(2008-10#2)
showed a partial response##3##4##(2008-6#1)(2010-12#1)(2013-8#1)
showed a partial##5##3##(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
showed a peak##2##3##(1993-11#1)(1996-12#1)
showed a positive##10##3##(1990-7#1)(1991-2#1)(1992-6#1)(1993-5#1)(2007-8#1)(2008-5#2)(2010-1#1)(2013-1#1)(2013-7#1)
showed a posterior##2##3##(1996-5#1)(2013-1#1)
showed a precision##2##3##(2008-10#2)
showed a preference for##3##4##(2007-5#1)(2008-11#2)
showed a profound##2##3##(1993-12#1)(2008-7#1)
showed a prognostic##2##3##(1992-10#1)(1996-9#1)
showed a progressive##2##3##(1995-8#1)(2011-1#1)
showed a raised##2##3##(2007-7#1)(2011-2#1)
showed a range of##4##4##(1997-3#1)(2008-10#2)(2008-7#1)
showed a rapid##2##3##(1996-12#1)(2013-1#1)
showed a reduced##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
showed a reduction in##5##4##(1993-3#1)(1994-12#1)(2009-10#1)(2012-2#1)(2013-8#1)
showed a reduction of##5##4##(1991-11#1)(1994-9#1)(1995-2#1)(2008-10#1)(2011-2#1)
showed a reduction##11##3##(1991-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-2#1)(2008-10#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
showed a relative standard deviation of##2##6##(2008-10#2)
showed a relative##4##3##(1990-2#1)(1996-9#1)(2008-10#2)
showed a relatively##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
showed a remarkable increase##2##4##(2008-8#1)(2012-3#1)
showed a response##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
showed a right##3##3##(2007-8#1)(2008-8#1)(2011-1#1)
showed a round opacity##2##4##(1993-6#1)(2008-1#1)
showed a sensitivity of##2##4##(1994-2#1)(2007-10#1)
showed a severe##2##3##(1993-2#1)(2011-1#1)
showed a significant association with a##2##6##(1992-3#1)(2009-5#1)
showed a significant association##3##4##(1992-3#1)(2009-5#1)(2011-2#1)
showed a significant correlation between##2##5##(1991-5#1)(2010-4#1)
showed a significant correlation with##3##5##(1991-12#1)(1994-9#1)(2013-1#1)
showed a significant correlation##8##4##(1991-12#1)(1991-5#1)(1994-12#1)(1994-9#1)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#1)
showed a significant decrease in total##2##6##(1992-2#1)(2008-12#1)
showed a significant decrease in##3##5##(1992-2#1)(2008-12#1)(2011-2#1)
showed a significant decrease of the##2##6##(1992-6#1)(2008-1#1)
showed a significant decrease of##5##5##(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2009-6#1)
showed a significant decrease##9##4##(1992-2#1)(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2013-8#1)
showed a significant difference in##2##5##(1990-12#1)(2007-8#1)
showed a significant difference##7##4##(1990-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2013-8#1)
showed a significant down-regulation of##2##5##(1994-11#1)(2013-1#1)
showed a significant improvement of##2##5##(2008-10#1)(2013-1#1)
showed a significant improvement##4##4##(1991-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
showed a significant increase in the##5##6##(1995-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-7#1)
showed a significant increase in##13##5##(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-7#1)(2013-7#1)
showed a significant increase##18##4##(1991-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2012-7#1)(2013-7#1)
showed a significant negative##2##4##(2011-2#1)(2012-2#1)
showed a significant positive correlation##2##5##(1991-12#1)(2008-7#1)
showed a significant positive##4##4##(1991-12#1)(2007-5#1)(2008-7#1)(2008-8#1)
showed a significant reduction in##3##5##(1997-2#1)(2008-10#1)(2012-2#1)
showed a significant reduction##4##4##(1997-2#1)(2008-10#2)(2012-2#1)
showed a significant shade change between##2##6##(2009-8#2)
showed a significant##85##3##(1990-12#1)(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
showed a significantly higher level of##2##6##(2008-10#2)
showed a significantly higher##6##4##(2007-10#2)(2008-10#2)(2008-7#1)(2011-2#1)
showed a significantly##8##3##(1990-8#1)(1995-5#1)(2007-10#2)(2008-10#2)(2008-7#1)(2011-2#1)
showed a similar pattern of##2##5##(1996-12#1)(2011-2#1)
showed a similar pattern##4##4##(1990-12#1)(1996-12#1)(2011-2#2)
showed a similar potency to##2##5##(1995-12#1)(2008-5#1)
showed a similar##16##3##(1990-12#1)(1990-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#3)(2012-2#1)
showed a single##5##3##(1991-6#1)(1992-8#1)(1995-5#1)(2008-10#2)
showed a slight increase with##2##5##(2008-2#1)(2008-7#1)
showed a slight increase##3##4##(2008-2#1)(2008-7#1)(2010-5#1)
showed a slight##6##3##(1993-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)
showed a slightly better##2##4##(2008-10#1)(2013-1#1)
showed a slightly##4##3##(1995-3#1)(1997-4#1)(2008-10#1)(2013-1#1)
showed a small##2##3##(2007-5#1)(2013-8#1)
showed a smaller##4##3##(1995-5#1)(2008-5#1)(2008-7#1)(2011-1#1)
showed a stable##2##3##(2008-11#1)(2013-1#1)
showed a statistical significance##2##4##(1994-9#1)(2013-8#1)
showed a statistical##3##3##(1994-9#1)(2012-12#1)(2013-8#1)
showed a statistically significant difference between##2##6##(2008-12#1)(2010-12#1)
showed a statistically significant positive##2##5##(1994-2#1)(2012-3#1)
showed a statistically significant##9##4##(1991-2#1)(1994-2#1)(2008-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
showed a striking##2##3##(1990-11#1)(2008-10#1)
showed a strong##12##3##(1991-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)(2012-2#1)(2013-8#1)
showed a substantial increase in##2##5##(2010-3#1)(2013-1#1)
showed a substantial##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
showed a tendency to##2##4##(1991-1#1)(2010-2#1)
showed a tendency towards##2##4##(1993-3#1)(2011-2#1)
showed a tendency##5##3##(1991-1#1)(1993-3#1)(1993-8#1)(2010-2#1)(2011-2#1)
showed a transient##2##3##(1997-7#1)(2010-11#1)
showed a trend toward##2##4##(1990-5#1)(2011-2#1)
showed a trend towards##2##4##(2008-7#1)(2009-3#1)
showed a trend##6##3##(1990-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-1#1)
showed a typical##8##3##(1994-8#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
showed a variation##2##3##(2012-2#2)
showed a variety of##2##4##(1997-3#1)(2008-11#1)
showed a very good##4##4##(2007-11#1)(2008-10#2)(2008-12#1)
showed a very high##2##4##(2008-10#1)(2012-6#1)
showed a very##9##3##(1997-7#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)(2012-6#1)
showed a##763##2##(1990-11#4)(1990-12#6)(1990-2#3)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#7)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#5)(1991-8#3)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#8)(1993-8#3)(1993-9#2)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#11)(1994-9#4)(1995-11#3)(1995-12#9)(1995-2#4)(1995-3#4)(1995-5#6)(1995-6#2)(1995-8#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#3)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#5)(2006-10#1)(2007-10#8)(2007-11#5)(2007-12#2)(2007-2#3)(2007-5#4)(2007-7#5)(2007-8#11)(2008-1#8)(2008-10#131)(2008-11#38)(2008-12#9)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#29)(2008-6#8)(2008-7#29)(2008-8#14)(2008-9#12)(2009-1#3)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#11)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#8)(2010-5#2)(2010-8#3)(2011-1#13)(2011-10#1)(2011-2#31)(2011-3#3)(2012-1#5)(2012-12#6)(2012-2#13)(2012-3#8)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#33)(2013-7#4)(2013-8#23)
showed abnormal##3##2##(2008-1#1)(2008-5#1)(2008-8#1)
showed abundant##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
showed acceptable agreement##2##3##(2008-10#2)
showed acceptable##3##2##(2008-10#2)(2013-1#1)
showed active##2##2##(2012-12#1)(2013-1#1)
showed activity##4##2##(1995-6#1)(2008-11#1)(2008-7#1)(2010-2#1)
showed also##2##2##(1991-2#1)(1995-3#1)
showed altered##2##2##(2008-10#2)
showed an almost##2##3##(2007-11#1)(2012-3#1)
showed an apparent Km of##2##5##(1992-3#1)(2008-11#1)
showed an apparent##5##3##(1992-3#1)(1997-2#1)(2008-10#2)(2008-11#1)
showed an association##3##3##(2009-2#1)(2011-2#1)(2012-12#1)
showed an average of##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
showed an average##7##3##(1992-3#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
showed an effect##2##3##(1991-9#1)(2008-11#1)
showed an elevation##2##3##(1990-6#1)(2007-11#1)
showed an enhanced##2##3##(2008-10#1)(2008-11#1)
showed an excellent##6##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#2)(2009-4#1)
showed an improvement in##5##4##(1994-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
showed an improvement##7##3##(1994-11#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
showed an increase in the##5##5##(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
showed an increase in##14##4##(1996-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-8#1)
showed an increase of##2##4##(1993-3#1)(2008-3#1)
showed an increase##20##3##(1991-1#1)(1993-3#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-8#1)
showed an increased##4##3##(1990-11#1)(1992-3#1)(1994-8#1)(2008-7#1)
showed an increasing trend##2##4##(1993-6#1)(2008-3#1)
showed an initial##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
showed an intact##2##3##(2008-8#1)(2013-1#1)
showed an interesting##2##3##(1996-1#1)(2012-2#1)
showed an optimum##2##3##(2008-10#2)
showed an overall##2##3##(2008-11#2)
showed an unusual##2##3##(1991-6#1)(2008-9#1)
showed an##136##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#25)(2008-11#11)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#2)(2009-2#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
showed antimicrobial activity against##2##4##(2008-11#1)(2010-5#1)
showed antimicrobial activity##3##3##(2008-11#1)(2010-2#1)(2010-5#1)
showed any significant##2##3##(1990-11#1)(1993-11#1)
showed any##10##2##(1990-11#1)(1991-3#1)(1992-12#1)(1993-11#2)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
showed at least two##2##4##(1994-6#1)(1995-11#1)
showed at least##3##3##(1994-6#1)(1995-11#1)(2008-6#1)
showed better performance##2##3##(2010-8#1)(2013-1#1)
showed better response##2##3##(2007-7#1)(2008-10#1)
showed better##15##2##(1990-3#1)(1993-12#1)(1997-8#2)(2007-7#2)(2008-10#6)(2008-9#1)(2010-8#1)(2013-1#1)
showed bilateral##7##2##(1990-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
showed both##11##2##(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#2)
showed by##3##2##(1991-6#1)(2010-11#1)(2012-2#1)
showed c-Kit##2##2##(2009-12#2)
showed changes in##2##3##(2008-10#1)(2009-6#1)
showed changes##4##2##(1995-12#1)(2007-10#1)(2008-10#1)(2009-6#1)
showed characteristic##3##2##(2006-10#1)(2008-10#1)(2011-1#1)
showed chronic##2##2##(1997-5#1)(2008-1#1)
showed clear##6##2##(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)
showed clinical improvement##2##3##(1990-2#1)(2008-5#1)
showed clinical##8##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-9#1)(2008-5#1)(2009-10#1)(2009-5#1)
showed closest##2##2##(2008-10#2)
showed comparable##7##2##(1991-6#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
showed complete##7##2##(1995-2#1)(2007-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#2)
showed concentrations##2##2##(2008-3#1)(2008-5#1)
showed conclusively that##2##3##(1995-2#1)(2008-10#1)
showed conservation of##2##3##(1993-12#1)(2008-5#1)
showed considerable##6##2##(1992-4#1)(1992-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
showed consistent##2##2##(2008-7#1)(2008-8#1)
showed continuous##2##2##(1991-3#1)(2010-4#1)
showed correlation##2##2##(2008-10#1)(2011-2#1)
showed cytotoxicity against K562 cells##2##5##(2008-11#2)
showed cytotoxicity against##3##3##(2008-11#2)(2011-3#1)
showed cytotoxicity##4##2##(1992-2#1)(2008-11#2)(2011-3#1)
showed damage##2##2##(2008-5#1)(2008-7#1)
showed decreased##8##2##(1991-1#1)(1993-2#1)(1994-6#1)(1996-2#1)(1997-4#1)(2008-4#1)(2008-5#1)(2009-8#1)
showed decreases##2##2##(2008-5#1)(2013-1#1)
showed degradation of##2##3##(2008-7#2)
showed dense##2##2##(2008-11#2)
showed differences in the##2##4##(1993-12#1)(2010-3#1)
showed differences##4##2##(1993-12#2)(2008-11#1)(2010-3#1)
showed different levels of##2##4##(2008-10#2)
showed different##13##2##(1992-8#1)(1994-11#1)(1994-8#1)(2006-6#1)(2008-10#7)(2009-3#1)(2013-1#1)
showed differential expression##3##3##(2010-12#1)(2010-4#1)(2013-8#1)
showed differential##5##2##(2008-10#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
showed diffuse##6##2##(1991-12#1)(1997-8#1)(2008-7#2)(2010-12#1)(2013-1#1)
showed distinct##7##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2013-1#1)
showed dose-dependent inhibition of##2##4##(1990-12#1)(1992-12#1)
showed dose-dependent##3##2##(1990-12#1)(1992-12#1)(2008-10#1)
showed early##2##2##(2007-7#1)(2008-10#1)
showed elevated eIF4E in##2##4##(1997-7#2)
showed elevated##5##2##(1993-6#1)(1993-8#1)(1994-11#1)(1997-7#2)
showed enhanced##10##2##(2008-10#5)(2008-11#2)(2008-5#1)(2010-11#1)(2013-1#1)
showed enzymatic##2##2##(1994-8#1)(2009-8#1)
showed equivalent##3##2##(1992-3#1)(2008-5#1)(2009-5#1)
showed even##2##2##(1994-12#1)(1994-3#1)
showed evidence of a##3##4##(2010-8#1)(2011-2#2)
showed evidence of scarring##2##4##(2008-4#2)
showed evidence of##18##3##(1991-12#1)(1992-8#2)(1997-6#1)(2008-4#3)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
showed evidence##19##2##(1991-12#1)(1992-8#2)(1997-6#1)(2008-4#3)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
showed excellent agreement##2##3##(2007-12#1)(2008-10#1)
showed excellent electrocatalytic##2##3##(2008-10#2)
showed excellent linearity##3##3##(2008-10#2)(2011-3#1)
showed excellent sensitivity##2##3##(2008-10#1)(2012-2#1)
showed excellent##27##2##(1991-2#1)(1992-5#1)(1993-1#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-3#1)(2012-2#2)
showed extensive##7##2##(1990-12#1)(1993-6#1)(1994-12#1)(1995-3#2)(2008-10#1)(2010-12#1)
showed features##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
showed fewer##2##2##(1990-12#1)(2008-3#1)
showed focal##2##2##(2009-8#1)(2012-2#1)
showed for the first time##2##5##(1992-12#1)(2012-2#1)
showed for##6##2##(1992-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
showed formation of##2##3##(2013-1#2)
showed four##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
showed free##2##2##(1993-6#1)(2008-11#1)
showed fungal##2##2##(2008-10#1)(2013-8#1)
showed further##2##2##(1991-12#1)(2008-10#1)
showed generally##2##2##(1991-1#1)(1992-6#1)
showed genotypic##2##2##(2008-10#2)
showed good agreement between the##2##5##(2008-10#2)
showed good agreement between##4##4##(2008-10#3)(2008-5#1)
showed good agreement with the certified value##2##7##(2008-10#2)
showed good agreement with the certified##3##6##(2008-10#3)
showed good agreement with the##4##5##(2008-10#3)(2008-3#1)
showed good agreement with##7##4##(2008-10#6)(2008-3#1)
showed good agreement##18##3##(2008-10#14)(2008-2#1)(2008-3#2)(2008-5#1)
showed good correlation in the concentration##2##6##(2008-10#2)
showed good correlation##5##3##(1992-11#1)(2008-10#4)
showed good linearity in the concentration range##2##7##(2008-10#2)
showed good linearity in the##3##5##(2008-10#2)(2011-1#1)
showed good linearity##8##3##(1993-8#1)(1996-5#1)(2008-10#4)(2011-1#1)(2012-3#1)
showed good precision##2##3##(2008-10#1)(2011-2#1)
showed good response to##4##4##(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#1)
showed good response##5##3##(2008-10#2)(2008-4#1)(2009-2#1)(2013-1#1)
showed good results##3##3##(2008-11#2)(2008-6#1)
showed good sensitivity and##2##4##(2008-10#2)
showed good sensitivity##5##3##(2008-10#4)(2012-2#1)
showed good stability##2##3##(2008-10#1)(2008-3#1)
showed good##80##2##(1990-6#1)(1992-11#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#44)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)
showed gradual##2##2##(2008-11#1)(2013-1#1)
showed great##2##2##(2008-11#1)(2012-12#1)
showed greater improvement in##2##4##(2010-12#1)(2010-4#1)
showed greater improvement##3##3##(2008-9#1)(2010-12#1)(2010-4#1)
showed greater##28##2##(1991-12#1)(1994-3#1)(1997-6#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#2)
showed greatest##2##2##(1992-8#1)(2008-7#1)
showed growth##6##2##(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-6#1)
showed here that##3##3##(1997-7#1)(2008-11#2)
showed here##4##2##(1991-9#1)(1997-7#1)(2008-11#2)
showed high affinity##5##3##(1994-11#1)(1994-8#1)(2008-10#1)(2009-12#1)(2009-6#1)
showed high expression##2##3##(2008-10#1)(2010-3#1)
showed high genetic##2##3##(2008-10#1)(2010-8#1)
showed high homology to##5##4##(1990-5#1)(1993-12#1)(1994-6#1)(1996-8#1)(1997-2#1)
showed high homology with##3##4##(1993-8#1)(2008-10#1)(2008-8#1)
showed high homology##9##3##(1990-5#1)(1993-12#1)(1993-8#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
showed high levels of##4##4##(1996-2#1)(2008-10#1)(2011-10#1)(2013-1#1)
showed high reliability##2##3##(2008-10#1)(2013-1#1)
showed high selectivity##3##3##(2008-10#3)
showed high sensitivity and##2##4##(2008-10#2)
showed high sensitivity##3##3##(2008-10#3)
showed high##56##2##(1990-5#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#18)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
showed higher bond##2##3##(2008-12#1)(2013-1#1)
showed higher expression##2##3##(2008-11#1)(2010-7#1)
showed higher##34##2##(1992-2#1)(1992-8#1)(1994-11#1)(1994-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#3)
showed highest##5##2##(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
showed homology with##2##3##(1996-3#1)(2013-1#1)
showed homology##3##2##(1996-3#1)(1997-2#1)(2013-1#1)
showed how##2##2##(2007-12#1)(2008-12#1)
showed hydrocephalus##2##2##(1990-9#1)(2008-7#1)
showed identical##2##2##(2008-10#1)(2008-7#1)
showed impaired##2##2##(1993-12#1)(1996-7#1)
showed impairment of##2##3##(1990-3#1)(2013-1#1)
showed impressive##2##2##(2008-7#1)(2012-1#1)
showed improved##6##2##(1994-8#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2012-3#1)
showed improvement##3##2##(1996-5#1)(2007-7#1)(2013-1#1)
showed in vitro##2##3##(2008-10#1)(2009-10#1)
showed in##10##2##(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)
showed increase##3##2##(1992-6#1)(2012-3#1)(2013-1#1)
showed increased allele sharing##2##4##(1997-5#2)
showed increased levels of##2##4##(1995-2#1)(2008-1#1)
showed increased##31##2##(1990-12#1)(1990-9#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
showed inhibition of##3##3##(2008-11#1)(2008-5#2)
showed inhibition##4##2##(2008-11#1)(2008-5#3)
showed interstitial##3##2##(1991-8#1)(2007-7#1)(2008-1#1)
showed it to be##2##4##(2008-10#1)(2008-9#1)
showed it to##3##3##(2008-10#2)(2008-9#1)
showed it##4##2##(1990-11#1)(2008-10#2)(2008-9#1)
showed its##2##2##(1993-8#1)(2013-1#1)
showed large differences in##2##4##(1990-2#1)(2008-8#1)
showed large##4##2##(1990-2#1)(1991-6#1)(1995-12#1)(2008-8#1)
showed left##2##2##(2007-7#1)(2009-5#1)
showed lesions##3##2##(2008-7#1)(2013-1#2)
showed less than##2##3##(2008-10#1)(2008-5#1)
showed less##13##2##(1996-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#2)
showed lexical##2##2##(2008-2#1)(2012-1#1)
showed linear calibration within##2##4##(2008-10#2)
showed linear calibration##3##3##(2008-10#3)
showed linear response##2##3##(2008-10#2)
showed linear##9##2##(1993-8#1)(2008-10#8)
showed linearity in the range of##3##6##(2008-10#2)(2012-1#1)
showed little or no##7##4##(1990-11#1)(1990-5#1)(1991-2#2)(1997-2#1)(2008-10#1)(2008-4#1)
showed little variability##2##3##(2008-10#1)(2008-5#1)
showed little variation in##2##4##(1990-9#1)(2008-9#1)
showed little##22##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-2#2)(1993-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#2)
showed low##14##2##(1990-5#1)(1994-11#1)(1996-12#1)(2008-10#6)(2008-11#1)(2010-12#1)(2011-1#1)(2012-9#1)(2013-8#1)
showed lower levels of##2##4##(2008-10#1)(2012-5#1)
showed lower sleep efficiency##2##4##(2012-3#2)
showed lower toxicity##2##3##(1997-4#1)(2012-12#1)
showed lower values than##2##4##(1991-5#1)(1996-3#1)
showed lower values##3##3##(1991-5#1)(1996-3#1)(2008-7#1)
showed lower##24##2##(1990-12#1)(1991-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#1)
showed malignant lymphoma##2##3##(2008-10#1)(2009-1#1)
showed many##2##2##(2008-10#1)(2009-8#1)
showed marked dilation of the##2##5##(2010-10#2)
showed marked improvement in##4##4##(2007-7#2)(2011-1#1)(2013-1#1)
showed marked inhibitory##2##3##(1990-5#1)(1991-12#1)
showed marked reduction##2##3##(1995-12#1)(2013-1#1)
showed marked##22##2##(1990-5#1)(1991-12#1)(1994-8#1)(1995-12#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-6#1)(2008-7#2)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
showed markedly##2##2##(1992-12#1)(1995-5#1)
showed maximal##3##2##(1994-12#1)(2008-11#2)
showed maximum##8##2##(1993-11#1)(2007-7#1)(2008-10#1)(2010-3#2)(2010-5#2)(2013-1#1)
showed mediastinal##2##2##(2008-7#1)(2013-1#1)
showed mild##4##2##(1996-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
showed minimal##5##2##(1992-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
showed minor##2##2##(2008-6#1)(2013-1#1)
showed moderate activity##2##3##(2008-10#1)(2010-3#1)
showed moderate and##2##3##(1990-12#1)(2012-1#1)
showed moderate resistance##2##3##(2008-10#2)
showed moderate to##2##3##(1994-5#1)(2012-12#1)
showed moderate##14##2##(1990-12#1)(1991-3#1)(1993-12#1)(1994-5#1)(1995-3#1)(1997-3#1)(2008-10#5)(2010-3#1)(2012-1#1)(2012-12#1)
showed modest##5##2##(1997-5#1)(2008-5#1)(2009-12#1)(2012-2#1)(2013-1#1)
showed more potent##2##3##(2008-11#1)(2008-5#1)
showed more than##4##3##(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)
showed more##19##2##(1993-12#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
showed most##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
showed much less##2##3##(1994-9#1)(2008-10#1)
showed much##5##2##(1994-9#1)(2008-10#3)(2008-8#1)
showed multiple nodular##2##3##(1990-2#1)(2013-8#1)
showed multiple##5##2##(1990-2#1)(2008-7#1)(2013-7#1)(2013-8#2)
showed negative##7##2##(1992-5#1)(1996-12#1)(1996-9#1)(2008-5#1)(2013-1#1)(2013-7#2)
showed negligible##2##2##(1994-12#1)(2008-2#1)
showed neither##2##2##(2008-5#1)(2009-10#1)
showed no alteration in BT or BB and was insignificantly increased in##2##12##(2007-7#2)
showed no apparent##3##3##(1995-8#1)(2008-11#2)
showed no change in##2##4##(1990-3#1)(2008-11#1)
showed no change##4##3##(1990-3#1)(2008-11#1)(2010-1#1)(2011-1#1)
showed no changes in##4##4##(1990-11#1)(1995-3#1)(2008-10#1)(2008-4#1)
showed no changes##5##3##(1990-11#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-4#1)
showed no clear##2##3##(2008-10#2)
showed no clinical##2##3##(1991-3#1)(1997-3#1)
showed no consistent##2##3##(2008-10#1)(2011-2#1)
showed no correlation between##2##4##(1990-3#1)(1991-5#1)
showed no difference in##3##4##(1995-5#1)(1997-6#1)(2008-5#1)
showed no difference##6##3##(1995-5#1)(1997-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
showed no differences between##2##4##(2008-10#2)
showed no effect on##5##4##(1993-2#1)(1994-3#1)(2008-10#2)(2011-2#1)
showed no effect##8##3##(1990-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
showed no evidence of##10##4##(1991-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#2)
showed no interference##2##3##(2008-10#2)
showed no negative##2##3##(2008-9#2)
showed no obvious##2##3##(2008-10#1)(2011-2#1)
showed no other abnormalities##2##4##(1991-3#1)(2012-3#1)
showed no reflux##2##3##(2008-10#2)
showed no relationship between##2##4##(1996-7#1)(2011-2#1)
showed no response##2##3##(2008-7#1)(2013-1#1)
showed no significant alteration##2##4##(1995-2#1)(2007-7#1)
showed no significant change##2##4##(1997-8#1)(2008-7#1)
showed no significant correlation with##2##5##(2008-8#1)(2010-10#1)
showed no significant difference in##5##5##(1991-8#1)(1994-11#1)(2008-11#1)(2008-12#1)(2013-7#1)
showed no significant difference##8##4##(1991-8#1)(1994-11#1)(1994-5#1)(2008-11#1)(2008-12#2)(2008-2#1)(2013-7#1)
showed no significant differences between##2##5##(2008-10#1)(2013-1#1)
showed no significant differences in the##3##6##(2008-10#1)(2008-12#1)(2013-7#1)
showed no significant differences##7##4##(1993-12#1)(2008-10#2)(2008-12#1)(2013-1#2)(2013-7#1)
showed no significant##35##3##(1991-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-2#2)(1997-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-9#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#2)
showed no signs of##2##4##(2011-2#1)(2012-12#1)
showed no statistically significant difference in##2##6##(2007-7#1)(2009-7#1)
showed no statistically significant##3##4##(2007-7#1)(2007-9#1)(2009-7#1)
showed no such##2##3##(2008-10#1)(2008-5#1)
showed no##160##2##(1990-11#2)(1990-12#1)(1990-3#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-8#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#29)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-4#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
showed normal##9##2##(1992-11#1)(1993-3#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
showed numerous##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
showed one##2##2##(1994-3#1)(2007-7#1)
showed only a partial##2##4##(1997-7#1)(2008-10#1)
showed only a##6##3##(1994-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2010-6#1)(2012-1#1)
showed only minor##2##3##(1997-3#1)(2008-11#1)
showed only one##2##3##(2008-10#1)(2012-3#1)
showed only two##3##3##(1994-2#2)(2007-12#1)
showed only##28##2##(1993-12#1)(1994-2#4)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#1)
showed optimal##2##2##(2008-5#1)(2013-1#1)
showed other##2##2##(2006-10#1)(2008-12#1)
showed overall##2##2##(1991-12#1)(2008-5#1)
showed pH-dependent##2##2##(1992-6#1)(2008-5#1)
showed partial##6##2##(1990-6#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
showed plasma##2##2##(1994-3#1)(1997-7#1)
showed polymorphism##2##2##(2008-10#1)(2013-8#1)
showed poor##4##2##(1995-8#2)(2008-3#1)(2010-2#1)
showed positive results##3##3##(2007-7#1)(2008-10#1)(2010-8#1)
showed positive##17##2##(1992-3#1)(1995-3#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
showed potent##5##2##(1995-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
showed presence of##3##3##(1995-11#1)(2008-10#1)(2012-2#1)
showed primarily##2##2##(1993-11#1)(2008-8#1)
showed profound##2##2##(1995-5#1)(2012-2#1)
showed progression of disease##2##4##(1990-10#1)(1994-8#1)
showed progression of##3##3##(1990-10#1)(1994-8#1)(2008-7#1)
showed progression##4##2##(1990-10#1)(1994-8#1)(2008-7#1)(2011-2#1)
showed proliferation of##2##3##(2011-2#1)(2013-8#1)
showed prolonged##2##2##(2008-7#1)(2010-6#1)
showed prominent##2##2##(1993-11#1)(2008-11#1)
showed promising results##2##3##(2010-7#1)(2013-8#1)
showed protection##2##2##(2008-11#1)(2008-5#1)
showed reduced pathogenicity##2##3##(2008-10#2)
showed reduced##9##2##(1993-6#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-11#2)(2009-11#1)(2012-3#1)
showed reductions in##2##3##(2008-10#1)(2012-3#1)
showed relatively##9##2##(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2010-8#1)(2012-3#1)
showed remarkable##2##2##(2007-12#1)(2011-1#1)
showed residual##2##2##(1993-2#1)(2009-11#1)
showed resistance to the##2##4##(2008-10#1)(2008-9#1)
showed resistance to##11##3##(2007-6#1)(2008-10#6)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
showed resistance##14##2##(2007-6#3)(2008-10#7)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
showed restriction##2##2##(1991-8#1)(2008-10#1)
showed results##2##2##(1997-3#1)(2012-2#1)
showed satisfactory##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
showed selective##3##2##(1997-3#1)(2008-10#1)(2008-3#1)
showed sensitivity##2##2##(1996-12#1)(2012-2#1)
showed serious##2##2##(1990-6#1)(1991-6#1)
showed several clusters of##2##4##(2008-10#1)(2008-11#1)
showed several##7##2##(1993-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-4#1)
showed severe chronic##2##3##(1992-5#1)(2010-10#1)
showed severe toxicity##2##3##(2008-12#1)(2008-7#1)
showed severe##10##2##(1992-5#2)(1993-9#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-6#1)
showed significant association between##2##4##(2008-10#1)(2011-2#1)
showed significant association##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
showed significant correlations##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
showed significant cytotoxicity##2##3##(2008-10#1)(2013-1#1)
showed significant decrease in##2##4##(2008-12#1)(2012-2#1)
showed significant difference (P &lt##3##5##(2013-1#3)
showed significant difference in##2##4##(2008-12#1)(2011-2#1)
showed significant difference##6##3##(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#3)
showed significant differences between the two##2##6##(1995-8#1)(2010-8#1)
showed significant differences between the##3##5##(1995-8#1)(2008-6#1)(2010-8#1)
showed significant differences between##4##4##(1995-8#1)(2008-6#1)(2008-7#1)(2010-8#1)
showed significant differences##7##3##(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2010-9#1)
showed significant homology to##2##4##(1997-7#1)(2008-10#1)
showed significant homology##4##3##(1990-5#1)(1997-7#1)(2008-10#2)
showed significant improvement in the##2##5##(2010-5#1)(2013-1#1)
showed significant improvement in##6##4##(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)
showed significant improvement##8##3##(1996-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
showed significant improvements##2##3##(2009-11#1)(2013-1#1)
showed significant increases in##2##4##(2008-10#1)(2008-12#1)
showed significant increases##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
showed significant positive correlations with##3##5##(2010-10#1)(2011-1#2)
showed significant positive correlations##4##4##(2010-10#1)(2010-8#1)(2011-1#2)
showed significant positive##5##3##(2010-10#1)(2010-8#1)(2011-1#2)(2012-2#1)
showed significant resistance to##2##4##(2008-10#1)(2008-12#1)
showed significant sequence##2##3##(1995-8#1)(1997-6#1)
showed significant##100##2##(1990-3#1)(1990-5#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-3#1)(1997-6#2)(1997-7#1)(2007-12#2)(2007-6#1)(2007-7#2)(2008-10#16)(2008-11#3)(2008-12#5)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#10)
showed significantly better##2##3##(2007-11#1)(2011-2#1)
showed significantly greater##2##3##(2008-10#1)(2008-8#1)
showed significantly higher levels of##3##5##(2008-10#1)(2009-12#1)(2010-3#1)
showed significantly higher##8##3##(2008-10#3)(2008-5#1)(2008-8#1)(2009-12#1)(2010-3#2)
showed significantly less##3##3##(2007-6#1)(2008-7#1)(2013-1#1)
showed significantly lower##5##3##(1991-12#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
showed significantly more##2##3##(1990-12#1)(2007-10#1)
showed significantly##31##2##(1990-12#1)(1991-12#2)(1996-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
showed signs of##9##3##(1991-6#2)(1994-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
showed similar behavior##2##3##(1991-2#1)(1991-6#1)
showed similar changes##2##3##(2013-8#2)
showed similar rates of##2##4##(2010-2#1)(2013-1#1)
showed similar results##3##3##(1991-8#1)(1994-12#1)(2011-2#1)
showed similar toxicity##2##3##(1992-3#1)(2008-7#1)
showed similar##43##2##(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-8#2)(1996-1#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#3)
showed similarities##3##2##(1992-9#1)(2008-5#1)(2010-3#1)
showed similarity to##2##3##(1996-6#2)
showed similarity##3##2##(1996-6#2)(2008-8#1)
showed single##3##2##(1992-8#1)(2008-10#1)(2010-8#1)
showed slight##3##2##(1997-8#1)(2008-10#2)
showed smaller##2##2##(2008-3#1)(2013-8#1)
showed some differences in##2##4##(2008-10#2)
showed some differences##3##3##(2008-10#2)(2008-5#1)
showed some##19##2##(1993-2#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)
showed specific##7##2##(1991-12#1)(1993-6#1)(1997-6#1)(2008-10#2)(2011-2#1)(2012-3#1)
showed staining of##2##3##(1995-11#1)(1995-12#1)
showed statistically significant changes##2##4##(2008-5#1)(2011-2#1)
showed statistically significant differences##4##4##(1990-9#1)(2008-12#1)(2008-7#1)(2011-2#1)
showed statistically significant##7##3##(1990-9#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#2)
showed statistically##8##2##(1990-9#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#2)
showed strong homology##2##3##(1992-8#1)(1995-6#1)
showed strong inhibitory##2##3##(2011-3#1)(2013-1#1)
showed strong positive##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
showed strong resistance##2##3##(2008-10#2)
showed strong##27##2##(1991-9#1)(1992-8#2)(1993-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-3#1)(2012-3#1)(2013-1#3)
showed stronger##2##2##(2008-11#1)(2011-2#1)
showed strongest##2##2##(1991-3#1)(2008-5#1)
showed substrate##2##2##(1994-8#1)(1995-2#1)
showed sufficient##2##2##(2008-5#1)(2008-7#1)
showed superior binding affinity for U(VI) over Th(IV) and##2##9##(2008-10#2)
showed superior extractability of uranium##2##5##(2008-10#2)
showed superior extraction##2##3##(2008-10#2)
showed superior##9##2##(2008-10#8)(2012-2#1)
showed symptomatic##2##2##(2008-10#1)(2008-3#1)
showed symptoms of##3##3##(1995-6#1)(2008-10#1)(2012-1#1)
showed symptoms##5##2##(1995-6#1)(2008-10#3)(2012-1#1)
showed temperature##2##2##(1995-5#1)(1997-6#1)
showed that &gt##2##3##(1994-8#1)(2008-10#1)
showed that 19##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
showed that 21##2##3##(2007-7#1)(2008-6#1)
showed that DNA##2##3##(1995-11#1)(2008-11#1)
showed that FSTRAP##2##3##(2008-8#2)
showed that GH##2##3##(2010-5#1)(2013-7#1)
showed that P##2##3##(2008-10#2)
showed that T##2##3##(2008-10#2)
showed that YY1 was##2##4##(2008-11#2)
showed that a single##2##4##(1991-2#1)(2008-10#1)
showed that a##30##3##(1990-5#1)(1990-9#1)(1991-2#1)(1992-10#1)(1993-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
showed that about##2##3##(1997-2#2)
showed that after##8##3##(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#1)
showed that age##2##3##(2008-1#1)(2008-7#1)
showed that all of the##2##5##(2008-5#1)(2008-9#1)
showed that all of##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
showed that all the##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
showed that all three##2##4##(2007-12#1)(2008-10#1)
showed that all##21##3##(1991-5#1)(1993-8#1)(2007-12#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
showed that almost all##2##4##(1993-6#1)(2012-2#1)
showed that almost##3##3##(1993-6#1)(2007-10#1)(2012-2#1)
showed that an##3##3##(2008-11#1)(2008-3#1)(2012-3#1)
showed that antibody##2##3##(1990-12#1)(1994-3#1)
showed that application of##2##4##(2008-10#1)(2013-8#1)
showed that approximately##2##3##(2008-10#1)(2008-12#1)
showed that as##3##3##(1994-11#1)(2008-10#1)(2011-1#1)
showed that at least##2##4##(1990-2#1)(2008-8#1)
showed that at low##2##4##(2006-6#1)(2010-6#1)
showed that at##8##3##(1990-2#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)
showed that axons##2##3##(2008-11#1)(2011-2#1)
showed that beta##2##3##(1993-12#1)(1997-4#1)
showed that beta-amylase##2##3##(2008-9#2)
showed that beta-galactosidase##2##3##(1990-5#1)(2011-2#1)
showed that both the##6##4##(1990-12#1)(1991-6#1)(2008-10#1)(2008-7#1)(2008-9#2)
showed that both##26##3##(1990-12#1)(1991-6#1)(1991-8#1)(1993-9#1)(1994-8#2)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2010-10#1)
showed that by##2##3##(1993-11#1)(2008-10#1)
showed that cell##3##3##(2008-11#3)
showed that cigarette smoke##2##4##(1991-9#1)(2008-5#1)
showed that cigarette##3##3##(1991-9#1)(2008-12#1)(2008-5#1)
showed that clinical##2##3##(2006-10#1)(2008-12#1)
showed that compared to##2##4##(1992-11#1)(2011-3#1)
showed that daily##2##3##(1990-7#1)(2009-7#1)
showed that deletion of##2##4##(1997-3#1)(2012-2#1)
showed that dietary##2##3##(2008-11#1)(2008-7#1)
showed that different##2##3##(1995-12#1)(2008-12#1)
showed that drug##2##3##(1990-3#1)(2010-5#1)
showed that each of the##2##5##(1991-7#1)(2008-12#1)
showed that each of##3##4##(1991-7#1)(2008-12#1)(2008-7#1)
showed that each##7##3##(1991-7#1)(1994-6#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)
showed that efavirenz##2##3##(2008-5#2)
showed that expression levels of##2##5##(2008-11#1)(2008-9#1)
showed that expression##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
showed that five##2##3##(2008-9#1)(2011-2#1)
showed that for##5##3##(2008-10#3)(2008-8#1)(2013-8#1)
showed that glutathione##2##3##(1996-12#1)(2012-2#1)
showed that higher##2##3##(1995-3#1)(2009-10#1)
showed that host##2##3##(2008-10#2)
showed that human##4##3##(1991-11#1)(1991-2#1)(2008-11#2)
showed that in all##2##4##(1992-3#1)(2008-8#1)
showed that in the##3##4##(1991-5#1)(2008-10#1)(2009-6#1)
showed that in##17##3##(1991-5#1)(1992-3#1)(1993-1#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-1#2)
showed that increasing##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
showed that irradiation power##2##4##(2008-10#1)(2012-1#1)
showed that irradiation##3##3##(1995-6#1)(2008-10#1)(2012-1#1)
showed that isolates##2##3##(2008-10#2)
showed that it contained##2##4##(1991-9#1)(1995-12#1)
showed that it had##2##4##(1994-9#1)(2009-7#1)
showed that it has##2##4##(2008-10#2)
showed that it is the##2##5##(1991-10#1)(1997-2#1)
showed that it is##10##4##(1990-2#1)(1991-10#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#1)
showed that it was a##2##5##(2008-10#1)(2013-7#1)
showed that it was##4##4##(2008-10#2)(2008-8#1)(2013-7#1)
showed that it##23##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-8#1)(2009-7#1)(2013-7#1)
showed that more##2##3##(2008-5#1)(2011-2#1)
showed that most of the##2##5##(2008-10#1)(2010-2#1)
showed that most of##3##4##(1997-2#1)(2008-10#1)(2010-2#1)
showed that most##9##3##(1990-2#1)(1992-4#1)(1992-9#1)(1995-6#1)(1997-2#1)(2008-10#3)(2010-2#1)
showed that neither##3##3##(1991-5#1)(2007-11#1)(2008-6#1)
showed that no significant##2##4##(2008-10#1)(2009-9#1)
showed that no##8##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)
showed that one of##2##4##(1990-5#1)(2009-8#1)
showed that one##6##3##(1990-5#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)
showed that only the##3##4##(2008-10#1)(2009-8#1)(2010-2#1)
showed that only##12##3##(1990-11#1)(1993-11#1)(2008-10#6)(2008-3#1)(2009-8#1)(2010-2#1)(2011-2#1)
showed that our##4##3##(1993-9#1)(2007-7#1)(2008-3#1)(2013-8#1)
showed that patients with##2##4##(2007-10#1)(2011-2#1)
showed that patients##5##3##(1993-2#1)(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
showed that performance##2##3##(1992-12#1)(2009-4#1)
showed that plants##2##3##(2008-10#1)(2012-7#1)
showed that plasma##2##3##(1992-9#1)(2008-12#1)
showed that propranolol##2##3##(2008-10#1)(2009-8#1)
showed that purified##2##3##(1990-11#1)(2012-2#1)
showed that rates of##2##4##(2008-10#1)(2008-7#1)
showed that several##7##3##(1991-6#1)(1991-9#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
showed that significant##2##3##(2008-10#2)
showed that single##2##3##(2008-10#2)
showed that some##9##3##(1990-8#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-11#1)(2013-1#1)(2013-8#1)
showed that species of##2##4##(2008-10#1)(2008-12#1)
showed that specimens##2##3##(2008-10#2)
showed that subjects##2##3##(1995-5#1)(2008-10#1)
showed that such a##2##4##(2008-11#1)(2009-10#1)
showed that the 2##2##4##(2008-10#2)
showed that the C-terminal##2##4##(1990-7#1)(1993-11#1)
showed that the activity##2##4##(1993-2#1)(2008-9#1)
showed that the area##2##4##(2008-10#1)(2008-11#1)
showed that the average##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
showed that the binding##3##4##(1995-2#1)(2008-10#1)(2008-8#1)
showed that the cell##2##4##(2008-9#1)(2012-1#1)
showed that the channel##2##4##(1990-11#1)(1995-5#1)
showed that the combination of##2##5##(2008-5#1)(2008-8#1)
showed that the common##2##4##(2007-12#1)(2008-1#1)
showed that the density##2##4##(1996-5#1)(2008-6#1)
showed that the dominant##2##4##(2008-10#1)(2011-1#1)
showed that the drug##5##4##(2008-10#1)(2008-11#1)(2008-5#3)
showed that the early##2##4##(1990-11#1)(2008-10#1)
showed that the effect of##2##5##(2007-12#1)(2008-2#1)
showed that the effects of##2##5##(1990-7#1)(2008-5#1)
showed that the effects##3##4##(1990-7#1)(1997-1#1)(2008-5#1)
showed that the enzyme was##2##5##(1991-5#1)(1991-8#1)
showed that the enzyme##5##4##(1991-5#1)(1991-8#1)(1992-8#1)(1994-11#1)(2008-7#1)
showed that the expression##4##4##(1994-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
showed that the extract##3##4##(2009-6#1)(2013-7#2)
showed that the extraction##2##4##(2008-10#1)(2012-1#1)
showed that the fungus##3##4##(2008-10#3)
showed that the growth of##2##5##(2008-10#1)(2008-8#1)
showed that the highest##2##4##(2008-10#1)(2008-12#1)
showed that the isolates##2##4##(1996-12#1)(2008-10#1)
showed that the level of##4##5##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
showed that the main##2##4##(2008-11#1)(2012-12#1)
showed that the major##4##4##(1992-2#1)(2008-1#1)(2008-10#1)(2008-6#1)
showed that the majority of the##2##6##(1997-3#1)(2008-6#1)
showed that the majority of##3##5##(1997-3#1)(2008-6#1)(2008-8#1)
showed that the majority##4##4##(1997-3#1)(2008-6#1)(2008-8#1)(2010-8#1)
showed that the mean##5##4##(1992-11#1)(2008-10#1)(2008-3#2)(2010-7#1)
showed that the method was##2##5##(2008-10#1)(2013-8#1)
showed that the method##4##4##(2008-10#2)(2008-9#1)(2013-8#1)
showed that the modified##2##4##(2007-10#1)(2008-10#1)
showed that the most##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
showed that the number of##3##5##(2008-1#1)(2008-8#1)(2013-8#1)
showed that the occurrence of##2##5##(2008-8#1)(2010-5#1)
showed that the optimal##2##4##(1994-11#1)(2008-8#1)
showed that the optimum##2##4##(2008-10#2)
showed that the overall##2##4##(2010-4#1)(2010-6#1)
showed that the presence of##4##5##(1992-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
showed that the procedure##2##4##(2008-10#1)(2008-3#1)
showed that the proposed method could##3##6##(2008-10#2)(2008-5#1)
showed that the proposed method##5##5##(2008-10#4)(2008-5#1)
showed that the proposed##8##4##(2008-10#7)(2008-5#1)
showed that the purified##3##4##(1990-10#1)(2008-9#1)(2012-2#1)
showed that the rate of##2##5##(2008-8#1)(2011-1#1)
showed that the relative##2##4##(2007-11#1)(2013-8#1)
showed that the response##2##4##(2008-10#1)(2008-11#1)
showed that the retention##2##4##(2008-10#2)
showed that the size of##2##5##(1993-11#1)(2011-2#1)
showed that the strong##2##4##(2008-8#1)(2011-1#1)
showed that the structural##2##4##(2007-12#1)(2008-8#1)
showed that the surface##2##4##(2013-8#2)
showed that the three##4##4##(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
showed that the transgene##2##4##(2008-10#1)(2008-12#1)
showed that the tumor##2##4##(2009-8#1)(2013-8#1)
showed that the use of##4##5##(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
showed that the##492##3##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#3)(1995-2#4)(1995-5#1)(1995-6#4)(1995-8#3)(1996-12#3)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#114)(2008-11#19)(2008-12#9)(2008-2#3)(2008-3#13)(2008-4#4)(2008-5#24)(2008-6#7)(2008-7#18)(2008-8#38)(2008-9#20)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#16)(2011-10#1)(2011-2#15)(2011-3#3)(2012-1#4)(2012-12#4)(2012-2#4)(2012-3#7)(2012-8#1)(2013-1#5)(2013-7#4)(2013-8#16)
showed that their##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
showed that there are two##2##5##(1992-3#1)(2008-8#1)
showed that there are##6##4##(1990-12#1)(1992-3#1)(1992-8#1)(2008-5#1)(2008-8#2)
showed that there is##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
showed that there was a significant##2##6##(2008-12#1)(2013-1#1)
showed that there was a##9##5##(1997-3#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
showed that there was an##3##5##(1997-8#1)(2012-2#1)(2013-8#1)
showed that there was no##5##5##(2008-12#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-1#1)
showed that there was##19##4##(1997-3#1)(1997-8#1)(2008-1#1)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
showed that there were no differences in##2##7##(2008-10#1)(2008-7#1)
showed that there were no differences##3##6##(2008-10#1)(2008-7#1)(2008-9#1)
showed that there were no##5##5##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
showed that there were significant differences between##2##7##(2008-10#1)(2008-12#1)
showed that there were significant differences##4##6##(2007-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
showed that there were##15##4##(1994-12#1)(2007-12#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-3#2)
showed that there##44##3##(1990-12#1)(1992-3#1)(1992-8#1)(1994-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
showed that these compounds##3##4##(2008-10#2)(2008-5#1)
showed that these##15##3##(1994-11#1)(1996-1#1)(1996-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-6#1)
showed that they are##4##4##(1992-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
showed that they##8##3##(1992-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)
showed that this new##2##4##(2008-5#1)(2008-8#1)
showed that this##22##3##(1990-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2012-2#2)(2013-7#2)(2013-8#1)
showed that three##2##3##(2008-12#1)(2011-1#1)
showed that treatment of##2##4##(2008-4#2)
showed that treatment##3##3##(2008-4#2)(2011-2#1)
showed that trophic##2##3##(2008-8#1)(2010-8#1)
showed that two##6##3##(1991-2#1)(1992-11#1)(2007-8#1)(2008-10#2)(2008-9#1)
showed that ultrasound##2##3##(2008-10#1)(2008-8#1)
showed that virus replication was##2##5##(1997-3#1)(2008-10#1)
showed that virus##3##3##(1997-3#1)(2008-10#2)
showed that when##7##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-9#1)(2012-2#1)
showed that while##5##3##(1994-6#1)(1997-4#1)(2008-8#1)(2009-7#1)(2011-2#1)
showed that with a##2##4##(1990-12#1)(2008-7#1)
showed that with##5##3##(1990-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
showed that##1549##2##(1990-10#1)(1990-11#7)(1990-12#11)(1990-2#9)(1990-3#3)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#5)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#4)(1992-10#3)(1992-11#3)(1992-12#7)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#5)(1993-1#2)(1993-11#7)(1993-12#3)(1993-2#6)(1993-3#4)(1993-6#6)(1993-8#7)(1993-9#4)(1994-11#8)(1994-12#6)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#9)(1994-9#2)(1995-11#2)(1995-12#11)(1995-2#8)(1995-3#5)(1995-5#6)(1995-6#10)(1995-8#6)(1995-9#1)(1996-1#2)(1996-12#12)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#14)(1997-3#8)(1997-4#7)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#5)(2006-10#1)(2006-6#3)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#15)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#12)(2008-10#344)(2008-11#71)(2008-12#47)(2008-2#5)(2008-3#30)(2008-4#14)(2008-5#57)(2008-6#19)(2008-7#44)(2008-8#101)(2008-9#85)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#3)(2009-6#9)(2009-7#10)(2009-8#12)(2009-9#7)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#9)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#25)(2011-10#2)(2011-2#48)(2011-3#9)(2012-1#12)(2012-12#11)(2012-2#20)(2012-3#26)(2012-7#1)(2012-8#1)(2013-1#33)(2013-7#11)(2013-8#44)
showed the ability to##2##4##(2008-10#1)(2012-2#1)
showed the absence of##2##4##(1992-3#1)(2008-10#1)
showed the best##9##3##(1995-3#1)(2008-10#5)(2008-12#1)(2012-2#1)(2013-8#1)
showed the characteristic##2##3##(1990-11#1)(2008-6#1)
showed the difference##2##3##(2008-11#1)(2008-5#1)
showed the distribution of##2##4##(2008-10#2)
showed the expected##6##3##(1990-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2009-8#2)
showed the following##2##3##(1993-5#1)(2008-10#1)
showed the formation of##2##4##(1994-8#1)(2011-2#1)
showed the greatest##8##3##(1992-8#1)(1992-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-12#1)
showed the higher##2##3##(2008-10#1)(2008-5#1)
showed the highest activity against##2##5##(2009-6#1)(2010-3#1)
showed the highest fluorescence##2##4##(2007-11#2)
showed the highest level of##3##5##(2008-10#1)(2008-8#1)(2010-3#1)
showed the highest rate##2##4##(2011-2#1)(2013-1#1)
showed the highest sensitivity##2##4##(2008-10#1)(2008-11#1)
showed the highest values of##2##5##(2012-12#2)
showed the highest##40##3##(1990-2#1)(1992-11#1)(1997-2#1)(2007-11#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-8#1)(2009-6#2)(2009-7#1)(2010-3#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#5)
showed the influence of the##2##5##(2008-10#1)(2008-5#1)
showed the largest##2##3##(2008-10#1)(2011-2#1)
showed the least##2##3##(2008-12#1)(2011-2#1)
showed the lowest##4##3##(2009-7#1)(2010-5#1)(2013-1#2)
showed the most important##2##4##(2007-8#1)(2013-8#1)
showed the most potent##2##4##(1994-12#1)(2011-1#1)
showed the most##13##3##(1994-12#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-7#1)(2013-8#1)
showed the need for a##2##5##(2011-2#1)(2013-1#1)
showed the need for##4##4##(1992-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
showed the opposite trend##2##4##(2009-10#1)(2009-2#1)
showed the opposite##5##3##(1993-8#1)(1995-6#1)(2009-10#1)(2009-2#1)(2011-1#1)
showed the possibility##2##3##(2008-10#1)(2008-5#1)
showed the presence of a##5##5##(1994-9#1)(1997-1#1)(1997-7#1)(2008-10#2)
showed the presence of##23##4##(1990-9#1)(1994-12#1)(1994-9#2)(1995-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-5#1)(2009-10#1)(2012-12#3)(2013-1#2)(2013-7#1)
showed the presence##24##3##(1990-9#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-5#1)(2009-10#1)(2012-12#3)(2013-1#2)(2013-7#1)
showed the same pattern of##2##5##(2008-10#1)(2008-11#1)
showed the same pattern##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
showed the same##15##3##(1990-12#1)(1991-12#1)(1995-3#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
showed the strongest##3##3##(1995-5#1)(2008-10#1)(2009-6#1)
showed the typical##2##3##(1995-8#1)(2007-12#1)
showed the##260##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#73)(2008-11#9)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#17)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#3)(2009-7#3)(2009-8#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#7)(2011-2#10)(2012-1#1)(2012-12#10)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#4)(2013-8#5)
showed their##4##2##(2007-10#1)(2008-11#2)(2008-4#1)
showed them to be of the##2##6##(1991-12#1)(1991-5#1)
showed there was##2##3##(1991-8#1)(2010-4#1)
showed there##3##2##(1991-8#1)(2008-10#1)(2010-4#1)
showed these##5##2##(1994-11#1)(2008-10#2)(2008-9#1)(2009-4#1)
showed this##3##2##(1996-11#1)(1997-3#1)(2013-8#1)
showed three##2##2##(1997-8#1)(2012-12#1)
showed to be##7##3##(2008-10#6)(2009-4#1)
showed to##9##2##(2008-10#7)(2008-11#1)(2009-4#1)
showed total##2##2##(1992-3#1)(2008-12#1)
showed two distinct##2##3##(1991-8#1)(2008-10#1)
showed two##12##2##(1990-2#1)(1991-8#2)(1993-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
showed typical##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
showed uniform##2##2##(2008-8#1)(2010-3#1)
showed unique##2##2##(2008-11#1)(2012-3#1)
showed unusual##3##2##(2007-12#1)(2008-12#1)(2012-3#1)
showed up as significant##2##4##(2008-10#2)
showed up as##3##3##(1994-3#1)(2008-10#2)
showed up to##2##3##(1992-12#1)(2008-11#1)
showed up##5##2##(1992-12#1)(1994-3#1)(2008-10#2)(2008-11#1)
showed values of##2##3##(1993-3#1)(2008-10#1)
showed values##3##2##(1993-3#1)(2008-10#1)(2008-3#1)
showed variable##3##2##(1994-2#1)(2008-10#2)
showed variations in##2##3##(1992-8#1)(2008-11#1)
showed variations##5##2##(1992-8#1)(1997-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
showed various##3##2##(2008-10#1)(2008-7#1)(2009-2#1)
showed varying degrees of##2##4##(2008-10#1)(2013-8#1)
showed varying##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
showed very good##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
showed very high##3##3##(2008-7#1)(2009-5#1)(2010-8#1)
showed very similar##2##3##(1997-2#1)(2008-12#1)
showed very##14##2##(1997-2#1)(2007-11#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-8#1)
showed weak or##2##3##(1992-5#1)(2011-1#1)
showed weak##11##2##(1990-11#1)(1991-8#1)(1992-5#1)(1994-8#1)(1995-4#1)(1995-8#1)(2008-10#2)(2010-5#1)(2011-1#1)(2011-2#1)
showed##4825##1##(1990-10#4)(1990-11#24)(1990-12#28)(1990-2#22)(1990-3#10)(1990-5#16)(1990-6#10)(1990-7#10)(1990-8#5)(1990-9#8)(1991-1#6)(1991-10#2)(1991-11#5)(1991-12#22)(1991-2#18)(1991-3#12)(1991-4#3)(1991-5#15)(1991-6#22)(1991-7#2)(1991-8#15)(1991-9#10)(1992-1#1)(1992-10#7)(1992-11#11)(1992-12#17)(1992-2#10)(1992-3#28)(1992-4#2)(1992-5#10)(1992-6#13)(1992-7#1)(1992-8#25)(1992-9#12)(1993-1#5)(1993-11#15)(1993-12#26)(1993-2#12)(1993-3#14)(1993-5#3)(1993-6#27)(1993-8#20)(1993-9#10)(1994-1#1)(1994-10#1)(1994-11#32)(1994-12#24)(1994-2#21)(1994-3#16)(1994-5#6)(1994-6#11)(1994-7#8)(1994-8#44)(1994-9#11)(1995-11#18)(1995-12#36)(1995-2#23)(1995-3#23)(1995-4#2)(1995-5#24)(1995-6#23)(1995-8#20)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#29)(1996-2#16)(1996-3#8)(1996-4#2)(1996-5#17)(1996-6#7)(1996-7#4)(1996-8#2)(1996-9#8)(1997-1#10)(1997-2#37)(1997-3#34)(1997-4#26)(1997-5#10)(1997-6#26)(1997-7#18)(1997-8#22)(2006-10#7)(2006-12#2)(2006-6#6)(2007-1#2)(2007-10#25)(2007-11#30)(2007-12#41)(2007-2#5)(2007-4#1)(2007-5#7)(2007-6#8)(2007-7#43)(2007-8#34)(2007-9#2)(2008-1#37)(2008-10#993)(2008-11#220)(2008-12#111)(2008-2#25)(2008-3#65)(2008-4#33)(2008-5#205)(2008-6#56)(2008-7#168)(2008-8#153)(2008-9#133)(2009-1#6)(2009-10#13)(2009-11#7)(2009-12#19)(2009-2#8)(2009-3#12)(2009-4#10)(2009-5#10)(2009-6#21)(2009-7#21)(2009-8#35)(2009-9#10)(2010-1#11)(2010-10#12)(2010-11#13)(2010-12#19)(2010-2#18)(2010-3#25)(2010-4#30)(2010-5#29)(2010-6#15)(2010-7#6)(2010-8#28)(2010-9#2)(2011-1#73)(2011-10#4)(2011-2#188)(2011-3#17)(2012-1#30)(2012-12#56)(2012-2#80)(2012-3#77)(2012-5#2)(2012-6#1)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#186)(2013-7#35)(2013-8#109)
shower curtain effect##2##3##(2008-2#2)
shower gel##2##2##(2008-5#2)
shower##6##1##(2008-2#3)(2008-5#3)
showering##3##1##(2008-5#2)(2009-3#1)
showers##6##1##(1995-6#1)(2008-10#5)
showing CGE##2##2##(2010-4#2)
showing a good##2##3##(2008-10#1)(2012-3#1)
showing a high##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
showing a significant##2##3##(2007-10#1)(2008-9#1)
showing a strong##2##3##(2008-7#1)(2008-9#1)
showing a##58##2##(1991-11#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-12#3)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#4)(2009-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
showing an increase in##2##4##(1992-6#1)(2007-11#1)
showing an increase##3##3##(1992-6#1)(1994-2#1)(2007-11#1)
showing an##13##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-1#1)(2012-2#1)
showing at the##2##3##(1993-8#1)(1994-9#1)
showing at##3##2##(1993-8#1)(1994-9#1)(1996-1#1)
showing better##2##2##(2008-7#1)(2008-9#1)
showing both##3##2##(1991-4#1)(2007-5#1)(2011-2#1)
showing direct##2##2##(1990-5#1)(1997-4#1)
showing either##4##2##(1997-7#1)(2008-10#3)
showing enhanced##2##2##(2008-9#2)
showing evidence##2##2##(2008-9#1)(2013-1#1)
showing for the first time##2##5##(2008-10#1)(2009-2#1)
showing good repeatability##2##3##(2008-10#2)
showing good##5##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
showing greater##2##2##(2008-10#2)
showing high homology##2##3##(1994-6#1)(2008-8#1)
showing high##5##2##(1993-1#1)(1994-6#1)(2008-6#1)(2008-8#1)(2013-1#1)
showing homology to mouse##2##4##(1994-12#1)(1995-2#1)
showing how the##3##3##(1997-2#1)(2008-12#1)(2008-7#1)
showing how to##2##3##(1997-2#1)(2008-8#1)
showing how##9##2##(1997-2#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
showing increased##3##2##(1996-12#1)(2006-10#1)(2008-5#1)
showing intermediate##2##2##(1990-12#1)(1994-8#1)
showing its##2##2##(2008-10#1)(2010-6#1)
showing less##2##2##(2007-12#1)(2008-11#1)
showing little##2##2##(1995-12#1)(2012-12#1)
showing low##2##2##(1993-1#1)(2010-12#1)
showing marked##2##2##(2008-5#1)(2012-2#1)
showing more than##2##3##(1994-6#1)(1996-2#1)
showing more##3##2##(1994-6#1)(1996-12#1)(1996-2#1)
showing no significant##2##3##(2008-10#1)(2008-5#1)
showing no##9##2##(1995-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-9#1)(2013-1#2)
showing promising results##2##3##(2011-2#1)(2012-1#1)
showing reduced##2##2##(2008-11#1)(2011-2#1)
showing severe##2##2##(2008-10#1)(2012-3#1)
showing significant##3##2##(2008-10#1)(2009-3#1)(2013-1#1)
showing some##5##2##(1990-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-6#1)
showing strong##4##2##(2008-10#2)(2011-3#1)(2012-2#1)
showing that a##2##3##(2008-3#1)(2008-7#1)
showing that it is possible##2##5##(1995-5#1)(2008-7#1)
showing that the two##2##4##(1996-2#1)(2008-2#1)
showing that the##26##3##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-2#1)(2010-10#1)(2011-1#1)(2013-1#1)
showing that these##3##3##(2009-8#1)(2011-2#1)(2013-8#1)
showing that this was##2##4##(1995-5#1)(2007-2#1)
showing that this##5##3##(1995-5#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-6#1)
showing that treatment with##2##4##(2008-10#1)(2008-7#1)
showing that treatment##4##3##(1997-5#1)(2008-10#1)(2008-7#1)(2010-8#1)
showing that##101##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2008-10#12)(2008-11#3)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#2)(2010-4#2)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
showing the highest##3##3##(1993-6#1)(2008-3#1)(2013-7#1)
showing the importance of##2##4##(1991-6#1)(2008-10#1)
showing the most significant effect##2##5##(2008-10#1)(2008-11#1)
showing the most significant##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
showing the most##4##3##(2008-1#1)(2008-10#1)(2008-11#2)
showing the possibility of##2##4##(2008-10#1)(2012-2#1)
showing the presence of##2##4##(1992-9#1)(2007-11#1)
showing the##56##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-6#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
showing their##2##2##(2008-10#1)(2008-7#1)
showing two##2##2##(2007-12#1)(2008-5#1)
showing typical##3##2##(2008-10#2)(2009-8#1)
showing up##2##2##(2008-7#1)(2012-3#1)
showing very##2##2##(1997-7#1)(2008-3#1)
showing##486##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#5)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2006-10#2)(2007-10#1)(2007-11#8)(2007-12#13)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2008-1#7)(2008-10#86)(2008-11#17)(2008-12#10)(2008-2#8)(2008-3#16)(2008-4#4)(2008-5#22)(2008-6#6)(2008-7#20)(2008-8#6)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#10)(2013-1#17)(2013-7#3)(2013-8#6)
shown a genetic effect##2##4##(1994-2#2)
shown a positive correlation##3##4##(1995-9#1)(2008-12#1)(2011-2#1)
shown a positive##5##3##(1992-4#1)(1993-3#1)(1995-9#1)(2008-12#1)(2011-2#1)
shown a significant##4##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
shown a##38##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-2#3)(1994-8#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#1)
shown an appreciable##2##3##(2008-10#2)
shown an##13##2##(1991-5#1)(1991-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
shown and discussed##2##3##(2008-2#1)(2008-3#1)
shown and##7##2##(1991-8#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
shown any##3##2##(2008-10#1)(2012-3#2)
shown as a##5##3##(1990-6#1)(1996-12#1)(2008-3#1)(2008-8#1)(2009-5#1)
shown as##10##2##(1990-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)
shown at##6##2##(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#2)
shown between the##3##3##(2008-10#2)(2012-2#1)
shown between##4##2##(2008-10#2)(2011-1#1)(2012-2#1)
shown both##7##2##(2008-12#1)(2008-3#3)(2008-7#1)(2009-5#1)(2010-1#1)
shown by 1-day-old chicks##2##4##(2008-5#2)
shown by FTIR##2##3##(2008-10#2)
shown by a##4##3##(1990-5#1)(2008-10#3)
shown by an increase in##2##5##(1992-8#1)(1996-12#1)
shown by flow cytometry##2##4##(1993-9#1)(1995-8#1)
shown by fluorescence##2##3##(1992-10#1)(1994-3#1)
shown by further##2##3##(2007-11#1)(2008-9#1)
shown by immunoelectron microscopy##2##4##(1996-3#1)(2011-1#1)
shown by its##2##3##(1993-8#1)(1995-12#1)
shown by our##2##3##(1994-8#1)(2008-9#1)
shown by studies##2##3##(1995-5#1)(2011-2#1)
shown by the##24##3##(1990-12#2)(1990-2#1)(1990-9#1)(1991-6#1)(1991-9#1)(1995-12#2)(2008-10#4)(2008-3#1)(2008-5#3)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#1)
shown by use of##2##4##(1994-8#1)(2008-3#1)
shown by##122##2##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-4#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#3)(2013-8#1)
shown enormous potential in##2##4##(2008-10#1)(2009-7#1)
shown experimentally and theoretically that the##2##6##(1997-1#1)(1997-2#1)
shown experimentally and##3##3##(1997-1#1)(1997-2#1)(2007-11#1)
shown experimentally##4##2##(1997-1#1)(1997-2#1)(2007-11#1)(2008-3#1)
shown for several##2##3##(2008-10#1)(2011-2#1)
shown for the first time##4##5##(1996-2#1)(2008-10#2)(2008-3#1)
shown for the##7##3##(1990-11#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#2)
shown for##24##2##(1990-11#1)(1990-3#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1996-2#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2011-2#1)(2013-1#1)
shown here that##5##3##(1992-3#1)(2008-10#2)(2008-3#2)
shown here##12##2##(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(2008-10#3)(2008-3#3)(2009-8#1)
shown higher##2##2##(2008-12#1)(2008-6#1)
shown how the##6##3##(2008-10#1)(2008-3#2)(2008-6#2)(2008-8#1)
shown how##16##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)
shown in a##6##3##(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
shown in both##2##3##(1991-12#1)(2011-2#1)
shown in comparison##2##3##(2008-3#1)(2008-5#1)
shown in the##19##3##(1991-8#1)(1993-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
shown in this study##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
shown in this##5##3##(2007-11#1)(2008-10#2)(2008-7#1)(2013-1#1)
shown in##71##2##(1990-10#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
shown its##2##2##(2010-4#1)(2011-2#1)
shown less##2##2##(2008-5#1)(2011-2#1)
shown little##2##2##(1991-4#1)(1992-3#1)
shown no##6##2##(1992-9#1)(1993-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)
shown not only to##2##4##(2011-2#1)(2012-12#1)
shown not only##3##3##(2008-2#1)(2011-2#1)(2012-12#1)
shown not to##5##3##(1990-12#1)(1990-2#1)(2008-1#1)(2008-3#1)(2008-7#1)
shown not##8##2##(1990-12#1)(1990-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
shown on##2##2##(1997-3#1)(2008-12#1)
shown only##2##2##(2008-8#1)(2011-1#1)
shown previously that##5##3##(1992-9#1)(1994-11#1)(1995-11#1)(2008-2#1)(2009-8#1)
shown previously to##10##3##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-6#1)
shown previously##17##2##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-8#1)
shown promise in##5##3##(2006-10#1)(2008-8#2)(2010-2#1)(2010-4#1)
shown promise##7##2##(2006-10#1)(2008-10#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-4#1)
shown promising activity in##2##4##(2008-7#1)(2009-4#1)
shown promising results in##6##4##(2007-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
shown promising##10##2##(2007-11#1)(2008-7#3)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
shown recently##2##2##(2008-1#1)(2009-8#1)
shown significant##4##2##(1995-1#1)(2007-11#1)(2008-1#1)(2008-3#1)
shown signs of##2##3##(1990-3#1)(1997-5#1)
shown some##5##2##(2008-10#2)(2008-11#2)(2008-3#1)
shown that (i)##2##3##(1993-8#1)(2008-8#1)
shown that a##40##3##(1990-3#1)(1990-8#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-9#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#3)(2008-7#3)(2008-8#2)(2010-12#1)(2010-4#1)(2011-2#3)(2012-3#1)
shown that all##3##3##(1995-8#1)(2007-11#1)(2008-2#1)
shown that an optimal##2##4##(2008-11#1)(2008-3#1)
shown that an##8##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
shown that at least##3##4##(2008-1#2)(2008-3#1)
shown that at##4##3##(2008-1#2)(2008-3#2)
shown that both##9##3##(1995-1#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2013-8#1)
shown that by##2##3##(2008-10#1)(2008-3#1)
shown that children##2##3##(2007-8#1)(2013-7#1)
shown that for##9##3##(2007-12#1)(2008-2#4)(2008-3#3)(2010-12#1)
shown that high##2##3##(1990-12#1)(1990-6#1)
shown that human##3##3##(1990-5#1)(1994-5#1)(2008-5#1)
shown that if##3##3##(2007-6#1)(2008-3#2)
shown that in the##9##4##(1990-5#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2009-9#1)(2012-12#1)(2013-7#1)
shown that in##17##3##(1990-5#1)(1994-8#1)(1996-5#1)(1997-6#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#2)(2009-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
shown that inclusion of##2##4##(1990-11#1)(1995-12#1)
shown that it is possible to##2##6##(2008-10#1)(2008-3#1)
shown that it is possible##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
shown that it is##7##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
shown that it##10##3##(1990-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
shown that loss of##3##4##(2013-1#2)(2013-7#1)
shown that low##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
shown that many##2##3##(2008-10#1)(2009-4#1)
shown that most##3##3##(1995-8#1)(1997-4#1)(2012-2#1)
shown that one of the##2##5##(1990-5#1)(2013-1#1)
shown that one##6##3##(1990-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2013-1#1)
shown that only##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
shown that oral##2##3##(2008-11#1)(2008-5#1)
shown that patients##2##3##(2008-6#1)(2012-3#1)
shown that polar##2##3##(2008-10#1)(2009-8#1)
shown that proteins##2##3##(1996-5#1)(2010-4#1)
shown that removal of##2##4##(2008-4#1)(2008-6#1)
shown that selecting##2##3##(1997-2#1)(2008-3#1)
shown that several##2##3##(2008-10#1)(2011-2#1)
shown that small##2##3##(1994-11#1)(2008-3#1)
shown that some##4##3##(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
shown that the detection##2##4##(2008-10#1)(2008-7#1)
shown that the different##2##4##(2008-11#2)
shown that the distribution of the##2##6##(2008-11#1)(2013-1#1)
shown that the effect##2##4##(1992-6#1)(1993-12#1)
shown that the induction of hsp70 expression by heat shock##2##10##(1994-11#2)
shown that the induction of##3##5##(1994-11#2)(2008-5#1)
shown that the instrument is##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
shown that the method##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2010-6#1)
shown that the molecular##2##4##(1995-3#1)(2012-2#1)
shown that the presence of##5##5##(1995-6#1)(2008-1#1)(2008-3#1)(2009-1#1)(2013-1#1)
shown that the proposed##2##4##(2008-10#1)(2008-2#1)
shown that the relationship between##2##5##(1994-5#1)(2007-12#1)
shown that the same##2##4##(2008-3#1)(2009-8#1)
shown that the temperature##2##4##(2008-10#1)(2008-3#1)
shown that the transfer##2##4##(2008-11#1)(2009-11#1)
shown that the two##3##4##(1993-11#1)(2008-10#1)(2008-2#1)
shown that the use of##4##5##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
shown that the##234##3##(1990-11#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-3#1)(1994-5#4)(1994-8#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-7#1)(2007-11#9)(2007-12#9)(2007-7#2)(2008-1#1)(2008-10#33)(2008-11#9)(2008-12#2)(2008-2#20)(2008-3#42)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#4)
shown that there is a##4##5##(2007-12#1)(2008-2#1)(2008-9#1)(2010-8#1)
shown that there is##6##4##(1991-3#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
shown that there##7##3##(1991-3#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
shown that these##12##3##(1990-11#1)(1990-7#1)(1995-2#1)(1996-5#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
shown that they##3##3##(1992-3#1)(1993-12#1)(1997-4#1)
shown that this##29##3##(1990-10#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-11#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#2)(2009-7#1)(2011-2#3)
shown that three##3##3##(1992-8#1)(2008-12#1)(2008-3#1)
shown that treatment##3##3##(1990-5#1)(1990-6#1)(1996-5#1)
shown that while##2##3##(1996-5#1)(2012-2#1)
shown that with##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
shown that women##3##3##(2007-12#1)(2008-12#1)(2008-4#1)
shown that##850##2##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#4)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-9#5)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#2)(1993-11#7)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#12)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#9)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#7)(1995-9#1)(1996-12#4)(1996-2#6)(1996-3#2)(1996-5#7)(1997-1#3)(1997-2#7)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#24)(2007-12#29)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#14)(2008-10#103)(2008-11#32)(2008-12#7)(2008-2#65)(2008-3#118)(2008-4#9)(2008-5#18)(2008-6#9)(2008-7#31)(2008-8#27)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#4)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#11)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#25)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#11)(2013-1#19)(2013-7#3)(2013-8#10)
shown the best selectivity##2##4##(2008-10#2)
shown the best##3##3##(2008-10#3)
shown the presence of##2##4##(1994-12#1)(2013-8#1)
shown the##28##2##(1990-2#1)(1992-2#1)(1994-12#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
shown theoretically##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
shown these##3##2##(2008-11#1)(2008-6#1)(2011-2#1)
shown through##2##2##(1995-11#1)(2008-10#1)
shown to account for##2##4##(1995-6#1)(2012-12#1)
shown to accumulate##2##3##(2008-11#1)(2012-3#1)
shown to acquire##2##3##(2008-10#2)
shown to activate##11##3##(1992-4#1)(1994-12#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-2#1)
shown to affect the##2##4##(2008-5#1)(2012-2#1)
shown to affect##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
shown to agree with##3##4##(2007-12#1)(2008-3#2)
shown to agree##5##3##(2007-12#1)(2008-3#4)
shown to alter the##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
shown to alter##5##3##(1994-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
shown to arise from##5##4##(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
shown to be a function of##3##6##(2008-10#2)(2008-2#1)
shown to be a good##2##5##(1994-9#1)(2008-3#1)
shown to be a major##3##5##(1990-8#1)(1992-9#1)(1993-11#1)
shown to be a powerful tool for##2##7##(2007-12#1)(2008-10#1)
shown to be a powerful##5##5##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
shown to be a useful##3##5##(1994-12#1)(2010-7#1)(2012-2#1)
shown to be a very##2##5##(1990-11#1)(2007-12#1)
shown to be a##53##4##(1990-11#2)(1990-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-2#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
shown to be able to##2##5##(2008-3#1)(2009-7#1)
shown to be achievable##2##4##(2007-12#1)(2008-2#1)
shown to be an effective##2##5##(1994-11#1)(2008-10#1)
shown to be an important##4##5##(1990-2#1)(1992-1#1)(2008-10#1)(2009-7#1)
shown to be an##13##4##(1990-2#1)(1990-5#1)(1992-1#1)(1994-11#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-7#1)
shown to be approximately##2##4##(2007-12#1)(2008-2#1)
shown to be associated with##10##5##(2007-11#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)
shown to be beneficial##2##4##(2008-3#1)(2013-8#1)
shown to be better than##2##5##(2008-3#2)
shown to be capable of separating##2##6##(2008-10#1)(2008-11#1)
shown to be capable of##8##5##(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
shown to be closely##2##4##(1992-9#1)(1995-6#1)
shown to be compatible with##2##5##(2008-10#2)
shown to be dependent on##4##5##(1991-5#1)(1995-9#1)(2008-10#1)(2008-11#1)
shown to be effective as##2##5##(2008-10#1)(2008-11#1)
shown to be effective for the##2##6##(2008-11#1)(2013-1#1)
shown to be effective for##3##5##(2008-11#1)(2008-2#1)(2013-1#1)
shown to be effective in##5##5##(2008-11#1)(2010-4#1)(2011-2#1)(2012-12#2)
shown to be effective##14##4##(2008-10#1)(2008-11#4)(2008-2#1)(2009-10#1)(2010-4#2)(2011-2#1)(2012-12#2)(2013-1#2)
shown to be efficient##2##4##(2008-10#1)(2008-3#1)
shown to be equal to##2##5##(1991-5#1)(2008-10#1)
shown to be equivalent to##4##5##(2008-10#2)(2008-3#2)
shown to be essential for##4##5##(1993-12#1)(2008-11#1)(2008-5#2)
shown to be essential##5##4##(1993-12#1)(2008-11#1)(2008-5#2)(2010-7#1)
shown to be expressed in##4##5##(1992-3#1)(1995-6#1)(2010-5#2)
shown to be expressed##5##4##(1992-3#1)(1995-6#1)(2008-9#1)(2010-5#2)
shown to be feasible##2##4##(2009-5#1)(2011-2#1)
shown to be highly specific for##2##6##(1990-2#1)(1996-2#1)
shown to be highly##6##4##(1990-2#1)(1993-3#1)(1996-2#1)(1997-6#1)(2007-11#1)(2012-3#1)
shown to be homogeneous as judged by SDS-gel electrophoresis##2##9##(1992-8#1)(1994-6#1)
shown to be important in##2##5##(2010-5#1)(2011-2#1)
shown to be important##6##4##(1995-6#1)(2007-2#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
shown to be in good agreement with##4##7##(2007-11#1)(2008-3#2)(2008-8#1)
shown to be in##6##4##(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2008-8#1)
shown to be increased at##2##5##(1995-8#1)(2008-5#1)
shown to be increased in##2##5##(1992-8#1)(1994-8#1)
shown to be increased##4##4##(1992-8#1)(1994-8#1)(1995-8#1)(2008-5#1)
shown to be independent of the##2##6##(2008-3#1)(2008-7#1)
shown to be independent of##3##5##(2008-3#2)(2008-7#1)
shown to be involved in the##4##6##(2007-8#1)(2008-10#2)(2010-10#1)
shown to be involved in##8##5##(1992-11#1)(1994-5#1)(2007-8#1)(2008-10#2)(2009-10#1)(2010-10#1)(2010-8#1)
shown to be larger##2##4##(2008-1#1)(2008-2#1)
shown to be located##3##4##(1991-7#1)(1994-12#1)(2007-8#1)
shown to be mediated by##2##5##(1996-12#1)(1997-1#1)
shown to be more##9##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
shown to be necessary for##4##5##(1993-9#1)(1994-6#1)(2008-7#1)(2008-9#1)
shown to be negligible##2##4##(2008-10#1)(2008-3#1)
shown to be one of the##2##6##(2012-1#1)(2013-1#1)
shown to be one of##3##5##(1997-3#1)(2012-1#1)(2013-1#1)
shown to be potentially##2##4##(2007-12#1)(2010-1#1)
shown to be preferable to##2##5##(2008-10#1)(2008-7#1)
shown to be preferable##3##4##(2008-10#2)(2008-7#1)
shown to be present as##2##5##(1991-5#1)(1995-2#1)
shown to be present##6##4##(1990-7#1)(1991-5#2)(1995-2#1)(1996-8#1)(2008-4#1)
shown to be proportional to##2##5##(2008-10#1)(2008-2#1)
shown to be quite##2##4##(2008-11#1)(2010-11#1)
shown to be regulated by##4##5##(1991-2#1)(1993-8#1)(1997-2#1)(2008-8#1)
shown to be regulated##7##4##(1991-2#1)(1993-8#1)(1997-2#1)(2008-8#2)(2010-3#1)(2011-2#1)
shown to be related to the##4##6##(1994-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
shown to be related to##6##5##(1991-8#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
shown to be released##4##4##(1992-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
shown to be reliable##3##4##(1992-3#2)(2008-10#1)
shown to be removed##2##4##(2007-12#1)(2008-12#1)
shown to be responsible for##2##5##(2008-10#1)(2009-5#1)
shown to be safe and##2##5##(1995-5#1)(2009-2#1)
shown to be safe##4##4##(1995-5#1)(2008-5#1)(2009-2#1)(2013-1#1)
shown to be sensitive to##3##5##(1994-12#1)(2008-3#1)(2009-4#1)
shown to be significantly##3##4##(1994-7#1)(2008-3#2)
shown to be stable##3##4##(1997-1#1)(2007-11#1)(2008-11#1)
shown to be statistically significant##2##5##(1993-12#1)(2008-5#1)
shown to be suitable for the##2##6##(1990-12#1)(2008-3#1)
shown to be suitable for##3##5##(1990-12#1)(2008-3#2)
shown to be the##10##4##(1991-6#1)(1996-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)
shown to be tolerant##2##4##(2008-10#1)(2008-8#1)
shown to be useful for##6##5##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
shown to be useful in##4##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
shown to be useful##11##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)
shown to be very##5##4##(1990-7#1)(1997-6#1)(1997-8#1)(2008-10#1)(2009-7#1)
shown to be##454##3##(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#4)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#8)(1992-6#3)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#4)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#13)(2007-12#14)(2007-2#2)(2007-8#2)(2008-1#2)(2008-10#67)(2008-11#15)(2008-12#2)(2008-2#20)(2008-3#36)(2008-4#3)(2008-5#17)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#4)(2010-7#3)(2010-8#2)(2011-1#6)(2011-2#14)(2012-1#4)(2012-12#7)(2012-2#11)(2012-3#5)(2013-1#9)(2013-8#5)
shown to belong to the##2##5##(2008-10#1)(2008-5#1)
shown to belong to##3##4##(2008-10#2)(2008-5#1)
shown to bind the##2##4##(1992-8#1)(2011-1#1)
shown to bind to##5##4##(1993-3#1)(1994-5#1)(1995-12#1)(2008-5#1)(2008-6#1)
shown to bind##13##3##(1990-10#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-5#1)(2008-6#1)(2011-1#1)
shown to cause a##2##4##(2008-8#1)(2012-12#1)
shown to cause##11##3##(1993-12#1)(1993-6#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
shown to compare well with##2##5##(2007-11#1)(2008-3#1)
shown to concentrate##2##3##(1990-12#1)(2008-3#1)
shown to contain an##3##4##(1991-2#1)(1992-3#1)(1994-11#1)
shown to contain the##2##4##(1991-6#1)(1995-8#1)
shown to contain##15##3##(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-12#3)(1992-3#1)(1994-11#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-3#1)(2012-12#1)
shown to contribute to##4##4##(1991-9#1)(2008-9#1)(2009-12#1)(2012-12#1)
shown to correlate with##5##4##(1996-12#1)(2009-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
shown to correlate##6##3##(1993-9#1)(1996-12#1)(2009-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
shown to decrease##9##3##(1992-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
shown to depend on the##5##5##(1992-12#1)(1994-11#1)(2008-10#2)(2008-2#1)
shown to depend on##8##4##(1992-12#1)(1994-11#1)(2008-10#2)(2008-2#2)(2008-9#1)(2012-2#1)
shown to depend strongly on the##2##6##(2007-11#1)(2008-2#1)
shown to depend##10##3##(1992-12#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-9#1)(2012-2#1)
shown to differ##2##3##(1991-5#1)(1996-12#1)
shown to directly##2##3##(2008-5#1)(2008-9#1)
shown to display##2##3##(1990-12#1)(2008-10#1)
shown to elicit##2##3##(1992-2#1)(1996-12#1)
shown to encode a##3##4##(1993-12#1)(1997-4#1)(2007-7#1)
shown to encode##4##3##(1993-12#1)(1997-4#1)(2007-7#1)(2008-11#1)
shown to enhance the sensitivity##2##5##(2008-2#1)(2009-4#1)
shown to enhance the##5##4##(1995-3#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
shown to enhance##7##3##(1995-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
shown to exceed##2##3##(2008-10#1)(2008-3#1)
shown to exhibit##7##3##(1990-11#1)(1990-5#1)(2007-11#1)(2008-10#1)(2008-7#2)(2010-5#1)
shown to exist in##4##4##(1993-8#1)(1995-11#1)(2008-9#2)
shown to exist##6##3##(1993-8#1)(1995-11#1)(1995-8#1)(2008-8#1)(2008-9#2)
shown to form##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
shown to function in##2##4##(1994-12#1)(2012-1#1)
shown to function##8##3##(1994-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-1#1)
shown to give##4##3##(1995-5#1)(2008-10#2)(2008-2#1)
shown to grow##2##3##(2007-12#1)(2008-11#1)
shown to have a significant##2##5##(2006-8#1)(2007-12#1)
shown to have a##13##4##(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-7#1)
shown to have an##4##4##(1990-12#1)(1997-1#1)(2008-3#1)(2009-7#1)
shown to have no##3##4##(1993-8#1)(1997-7#1)(2008-10#1)
shown to have strong##3##4##(1992-8#1)(2008-10#1)(2008-8#1)
shown to have the##3##4##(1992-12#1)(2008-4#1)(2008-5#1)
shown to have##59##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#2)(1997-1#1)(1997-6#1)(1997-7#2)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#3)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
shown to imply##2##3##(1997-5#1)(2007-12#1)
shown to improve the accuracy of##2##6##(2008-10#1)(2008-6#1)
shown to improve the##7##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)
shown to improve##14##3##(1994-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
shown to increase the percentage of##2##6##(2008-1#1)(2008-10#1)
shown to increase the##8##4##(1996-2#1)(2008-1#2)(2008-10#1)(2008-2#1)(2010-10#1)(2010-8#1)(2012-3#1)
shown to increase with##2##4##(2007-12#1)(2008-7#1)
shown to increase##21##3##(1990-8#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-10#1)(2010-8#1)(2010-9#1)(2012-3#1)
shown to induce cell##2##4##(2008-8#1)(2013-1#1)
shown to induce##16##3##(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#2)(1996-12#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
shown to influence##5##3##(1991-6#1)(1997-1#1)(2007-12#1)(2008-7#1)(2009-10#1)
shown to inhibit the##3##4##(1990-11#1)(1991-9#1)(2008-11#1)
shown to inhibit##14##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#2)(2008-11#1)(2010-11#1)(2013-1#1)
shown to interact with##7##4##(1993-8#2)(1994-5#1)(1995-2#2)(2008-10#1)(2013-1#1)
shown to interact##8##3##(1993-8#2)(1994-5#1)(1995-2#2)(2008-10#1)(2008-4#1)(2013-1#1)
shown to involve the##3##4##(1990-7#1)(1995-6#1)(1997-8#1)
shown to lead to##2##4##(2007-11#1)(2012-1#1)
shown to lyse##2##3##(1994-3#1)(2009-6#1)
shown to maintain##2##3##(2008-11#1)(2008-3#1)
shown to markedly##4##3##(1991-5#1)(2008-12#1)(2008-3#1)(2013-8#1)
shown to mediate##2##3##(1996-12#1)(2010-6#1)
shown to modulate##7##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
shown to occur in##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
shown to occur##8##3##(1990-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
shown to operate##2##3##(2008-10#1)(2008-3#1)
shown to play a role in##3##6##(2008-10#1)(2008-4#2)
shown to play##11##3##(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-8#1)
shown to possess the##3##4##(1993-8#1)(2008-10#2)
shown to possess##7##3##(1991-12#1)(1992-3#1)(1993-8#1)(2008-10#2)(2008-3#1)(2009-12#1)
shown to predict##5##3##(1995-12#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
shown to prevent##2##3##(1995-5#1)(2008-8#1)
shown to proceed##2##3##(1995-3#1)(1996-2#1)
shown to produce a##5##4##(1991-1#1)(1993-9#2)(1997-7#1)(2008-10#1)
shown to produce##13##3##(1991-1#1)(1993-9#2)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)
shown to promote##5##3##(1990-12#1)(1995-6#1)(1995-8#1)(2008-10#1)(2013-1#1)
shown to provide a##5##4##(1994-12#1)(2008-10#2)(2008-3#1)(2011-1#1)
shown to provide substantial##2##4##(2010-12#1)(2011-1#1)
shown to provide the##2##4##(2008-11#1)(2008-2#1)
shown to provide##18##3##(1994-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#2)(2010-12#1)(2011-1#2)
shown to reduce the incidence of##2##6##(2008-10#1)(2008-8#1)
shown to reduce the##6##4##(1992-4#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)
shown to reduce##18##3##(1992-4#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-5#1)
shown to remain##2##3##(2008-10#1)(2008-7#1)
shown to repress the##2##4##(2008-11#1)(2008-4#1)
shown to result from##2##4##(1994-5#1)(2008-10#1)
shown to result in##2##4##(2008-10#1)(2008-11#1)
shown to result##5##3##(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)
shown to significantly reduce##4##4##(2007-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
shown to significantly##6##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
shown to stimulate the##3##4##(1990-12#1)(1991-6#1)(1997-1#1)
shown to stimulate##7##3##(1990-12#1)(1991-6#1)(1997-1#2)(2008-3#2)(2012-2#1)
shown to strongly##2##3##(2008-9#1)(2012-12#1)
shown to suppress##5##3##(1995-3#1)(2008-10#2)(2008-7#1)(2010-7#1)
shown to transmit##2##3##(2008-10#2)
shown to vary##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
shown to work##4##3##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)
shown to yield##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
shown to##1037##2##(1990-10#2)(1990-11#6)(1990-12#10)(1990-2#6)(1990-3#1)(1990-5#9)(1990-7#5)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#11)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#11)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#9)(1992-9#3)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#8)(1993-6#4)(1993-8#7)(1993-9#8)(1994-11#7)(1994-12#8)(1994-2#4)(1994-3#6)(1994-5#10)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#7)(1995-11#1)(1995-12#8)(1995-2#9)(1995-3#5)(1995-5#7)(1995-6#14)(1995-8#7)(1995-9#1)(1996-12#11)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#8)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#3)(2006-8#1)(2007-10#1)(2007-11#29)(2007-12#29)(2007-2#4)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#135)(2008-11#42)(2008-12#3)(2008-2#37)(2008-3#75)(2008-4#12)(2008-5#35)(2008-6#6)(2008-7#32)(2008-8#24)(2008-9#21)(2009-1#1)(2009-10#9)(2009-11#2)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#8)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#9)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#9)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#13)(2011-2#20)(2012-1#7)(2012-12#20)(2012-2#17)(2012-3#8)(2013-1#20)(2013-8#8)
shown unchanged##2##2##(2008-10#1)(2008-9#1)
shown using##2##2##(1994-12#1)(2008-10#1)
shown with##4##2##(2008-10#1)(2008-3#2)(2008-8#1)
shown##2580##1##(1990-10#7)(1990-11#15)(1990-12#18)(1990-2#12)(1990-3#5)(1990-5#17)(1990-6#5)(1990-7#9)(1990-8#7)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#17)(1991-6#8)(1991-7#2)(1991-8#4)(1991-9#16)(1992-1#1)(1992-10#3)(1992-11#8)(1992-12#15)(1992-2#3)(1992-3#17)(1992-4#4)(1992-5#3)(1992-6#11)(1992-8#17)(1992-9#10)(1993-1#1)(1993-11#15)(1993-12#15)(1993-2#5)(1993-3#13)(1993-6#6)(1993-8#13)(1993-9#12)(1994-11#22)(1994-12#10)(1994-2#10)(1994-3#9)(1994-5#18)(1994-6#12)(1994-7#1)(1994-8#16)(1994-9#12)(1995-1#2)(1995-11#6)(1995-12#20)(1995-2#19)(1995-3#14)(1995-4#1)(1995-5#15)(1995-6#19)(1995-8#16)(1995-9#3)(1996-10#1)(1996-12#17)(1996-2#19)(1996-3#8)(1996-5#11)(1996-6#3)(1996-8#1)(1997-1#15)(1997-2#17)(1997-3#10)(1997-4#9)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#6)(2006-10#5)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#73)(2007-12#75)(2007-2#4)(2007-5#2)(2007-6#5)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#25)(2008-10#336)(2008-11#95)(2008-12#21)(2008-2#129)(2008-3#260)(2008-4#24)(2008-5#80)(2008-6#25)(2008-7#88)(2008-8#68)(2008-9#38)(2009-1#2)(2009-10#15)(2009-11#7)(2009-12#9)(2009-2#4)(2009-3#4)(2009-4#8)(2009-5#15)(2009-6#5)(2009-7#12)(2009-8#22)(2009-9#4)(2010-1#5)(2010-10#8)(2010-11#15)(2010-12#12)(2010-2#7)(2010-3#12)(2010-4#11)(2010-5#14)(2010-6#2)(2010-7#7)(2010-8#14)(2010-9#3)(2011-1#29)(2011-2#69)(2012-1#12)(2012-12#28)(2012-2#38)(2012-3#29)(2012-5#1)(2012-6#1)(2013-1#51)(2013-7#4)(2013-8#30)
shows 100%##2##2##(1995-6#1)(1997-4#1)
shows 84% identity##2##3##(1993-3#1)(1996-12#1)
shows Na(+)##2##2##(2008-10#2)
shows a clear##2##3##(1991-8#1)(2008-2#1)
shows a considerable##2##3##(1990-7#1)(1991-6#1)
shows a decrease##2##3##(2008-10#1)(2008-3#1)
shows a fast response##2##4##(2008-10#2)
shows a fast##3##3##(2008-10#3)
shows a few##2##3##(2008-10#1)(2008-9#1)
shows a good stability##2##4##(2008-10#2)
shows a good##8##3##(2008-10#7)(2008-3#1)
shows a gradual##2##3##(1994-5#1)(1996-5#1)
shows a high##7##3##(1993-2#1)(1995-11#1)(1996-3#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
shows a higher##3##3##(1992-6#1)(2007-10#1)(2008-11#1)
shows a linear range between##4##5##(2008-10#4)
shows a linear response for##3##5##(2008-10#3)
shows a linear response##6##4##(2008-10#5)(2008-3#1)
shows a linear variation##2##4##(2008-10#2)
shows a linear##16##3##(2008-10#14)(2008-3#1)(2009-11#1)
shows a maximum##2##3##(2008-10#2)
shows a reduced##2##3##(2008-10#1)(2008-3#1)
shows a remarkable##2##3##(1997-4#1)(2008-10#1)
shows a significant##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
shows a steady##2##3##(1997-3#1)(2008-3#1)
shows a strong correlation with##2##5##(2007-12#1)(2008-10#1)
shows a strong dependence##2##4##(2008-10#1)(2008-3#1)
shows a strong##7##3##(1994-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)
shows a time dependent##2##4##(1991-9#1)(2013-1#1)
shows a very low##2##4##(1995-8#1)(1997-8#1)
shows a very##4##3##(1991-12#1)(1995-8#1)(1997-8#1)(2008-10#1)
shows a##157##2##(1990-11#2)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-1#3)(2008-10#52)(2008-11#3)(2008-2#3)(2008-3#11)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#4)
shows an absorption maximum at##2##5##(2008-10#2)
shows an excellent##3##3##(1990-6#1)(1995-2#1)(2008-10#1)
shows an##27##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-11#5)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2012-2#1)(2013-7#1)
shows better##3##2##(2007-12#1)(2008-10#2)
shows both##2##2##(2008-12#1)(2008-4#1)
shows characteristic##2##2##(2008-3#1)(2012-12#1)
shows considerable##4##2##(1991-2#1)(2007-10#1)(2008-10#1)(2008-11#1)
shows cooperativity in O2 binding##2##5##(1991-10#2)
shows different##3##2##(1992-12#1)(2008-2#1)(2010-3#1)
shows evidence of##2##3##(2008-3#2)
shows evidence##3##2##(2008-3#2)(2008-9#1)
shows excellent##8##2##(2008-10#6)(2008-3#2)
shows good agreement with the##2##5##(2008-3#2)
shows good agreement with##4##4##(1995-3#1)(2008-3#3)
shows good agreement##5##3##(1995-3#1)(2008-2#1)(2008-3#3)
shows good performance##2##3##(2008-10#2)
shows good repeatability##2##3##(2008-10#2)
shows good results##2##3##(2008-2#1)(2008-5#1)
shows good selectivity for##5##4##(2008-10#5)
shows good selectivity##6##3##(2008-10#6)
shows good sensitivity##2##3##(2008-10#2)
shows good stability##2##3##(2008-10#2)
shows good##33##2##(1995-3#1)(2008-10#22)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
shows great potential for##2##4##(2010-4#1)(2013-1#1)
shows great potential##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
shows greater##2##2##(1996-12#1)(2009-10#1)
shows high homology to##2##4##(1993-12#1)(1994-2#1)
shows high##12##2##(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-12#1)(2012-2#1)
shows homology##2##2##(1995-3#1)(1995-8#1)
shows how the##4##3##(1993-1#1)(1993-2#1)(1996-3#1)(2008-11#1)
shows how##26##2##(1992-1#1)(1993-1#1)(1993-2#2)(1995-12#1)(1996-3#3)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#4)(2009-11#1)(2009-3#2)(2012-12#1)(2013-8#1)
shows improved##3##2##(2008-10#2)(2008-9#1)
shows in##2##2##(2008-12#1)(2008-5#1)
shows interesting##2##2##(1997-6#1)(2007-12#1)
shows its##3##2##(2008-10#2)(2008-3#1)
shows large##3##2##(1996-8#1)(2007-12#1)(2008-3#1)
shows left-side dominance in controlling##2##5##(2008-9#2)
shows low##3##2##(2008-10#2)(2008-3#1)
shows maximum absorbance at##3##4##(2008-10#3)
shows no obvious##2##3##(2008-10#1)(2008-4#1)
shows no significant##3##3##(1990-2#1)(1992-9#1)(2008-10#1)
shows no##21##2##(1990-2#1)(1990-8#1)(1991-2#2)(1992-3#1)(1992-9#1)(1994-12#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
shows only a##3##3##(1990-8#1)(1994-8#1)(2008-3#1)
shows only##9##2##(1990-6#1)(1990-8#1)(1991-12#1)(1992-5#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
shows optimum##2##2##(2008-3#1)(2008-8#1)
shows parallels##2##2##(2008-11#1)(2011-2#1)
shows patterns of##2##3##(1992-6#1)(2008-11#1)
shows poor##2##2##(1991-3#1)(2009-7#1)
shows potential##2##2##(2008-10#1)(2008-12#1)
shows preference for##2##3##(1991-2#1)(1996-12#1)
shows presence of##2##3##(1994-8#1)(2009-3#1)
shows promise for improving##2##4##(2008-3#1)(2011-2#1)
shows promise for##3##3##(2008-3#2)(2011-2#1)
shows promise in##2##3##(1997-2#1)(2007-12#1)
shows promise##6##2##(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#2)(2011-2#1)
shows promising results in##2##4##(2008-7#1)(2010-8#1)
shows resistance to##3##3##(1994-6#1)(2008-10#1)(2011-2#1)
shows satisfactory agreement##2##3##(2008-2#1)(2008-3#1)
shows satisfactory results##2##3##(2007-8#1)(2008-10#1)
shows satisfactory##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
shows significant homology##2##3##(1994-12#1)(1995-8#1)
shows significant improvement##2##3##(2008-3#2)
shows significant##11##2##(1994-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
shows significantly##3##2##(1992-3#1)(2007-12#1)(2008-7#1)
shows similar##3##2##(1994-1#1)(2008-10#2)
shows similarity to##3##3##(1995-2#1)(1997-3#2)
shows similarity##4##2##(1994-11#1)(1995-2#1)(1997-3#2)
shows some##4##2##(1993-8#1)(2008-11#1)(2008-3#1)(2008-6#1)
shows strong potential##2##3##(2008-3#1)(2008-5#1)
shows strong similarities within##2##4##(1993-2#1)(1993-6#1)
shows strong##9##2##(1993-2#1)(1993-6#1)(1996-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-3#1)
shows substantial##2##2##(2008-10#1)(2013-8#1)
shows superior##2##2##(2008-10#1)(2008-2#1)
shows that DDSP##2##3##(2008-3#2)
shows that a##16##3##(1990-12#1)(1991-8#1)(1992-3#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2010-6#1)
shows that an##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
shows that by##4##3##(2007-12#1)(2008-12#1)(2009-3#1)(2010-3#1)
shows that during##2##3##(1996-5#1)(2008-8#1)
shows that each of##2##4##(2008-10#1)(2008-11#1)
shows that for##3##3##(2008-2#1)(2011-2#1)(2013-8#1)
shows that in##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
shows that it is possible to##3##6##(2007-12#1)(2008-11#1)(2008-3#1)
shows that it is##7##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
shows that it##9##3##(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2012-3#1)
shows that many##3##3##(2009-10#1)(2010-12#1)(2013-8#1)
shows that most of the##2##5##(1990-8#1)(1993-3#1)
shows that most##4##3##(1990-8#1)(1993-3#1)(2007-11#1)(2008-11#1)
shows that multiple##2##3##(1997-4#1)(2009-6#1)
shows that our##3##3##(1997-7#1)(2008-3#2)
shows that significant##2##3##(2008-5#1)(2011-2#1)
shows that the dependence of the##2##6##(2008-2#2)
shows that the host shift##2##5##(2008-8#2)
shows that the most##2##4##(2008-10#1)(2012-3#1)
shows that the proposed##3##4##(2010-8#1)(2013-1#1)(2013-8#1)
shows that the risk##2##4##(1994-3#1)(2006-10#1)
shows that the size##2##4##(1992-8#1)(2008-10#1)
shows that the volume##2##4##(2008-3#2)
shows that the##122##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#3)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#2)(2008-1#2)(2008-10#14)(2008-11#4)(2008-2#9)(2008-3#17)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#2)(2013-8#3)
shows that their##2##3##(1991-6#1)(2010-3#1)
shows that there is##2##4##(2009-11#1)(2011-2#1)
shows that there##5##3##(1994-3#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)
shows that these##7##3##(1993-2#1)(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#2)(2011-2#1)
shows that they are##2##4##(1995-2#1)(2008-10#1)
shows that they##4##3##(1995-2#1)(1997-8#1)(2008-10#1)(2008-7#1)
shows that this##7##3##(1990-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
shows that under##2##3##(2008-10#1)(2013-8#1)
shows that with##2##3##(2007-11#1)(2011-2#1)
shows that##414##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#4)(1995-1#3)(1995-11#1)(1995-2#7)(1995-3#2)(1995-5#5)(1995-6#5)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#4)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#9)(2007-12#11)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#14)(2008-12#8)(2008-2#18)(2008-3#44)(2008-4#4)(2008-5#17)(2008-6#3)(2008-7#8)(2008-8#20)(2008-9#11)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#5)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#5)(2012-9#1)(2013-1#7)(2013-8#11)
shows the ability##2##3##(2008-5#1)(2008-7#1)
shows the highest##2##3##(2010-8#1)(2013-1#1)
shows the importance of##5##4##(2007-12#1)(2008-3#1)(2008-8#2)(2012-2#1)
shows the potential##3##3##(1996-2#1)(2008-10#2)
shows the presence of##4##4##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
shows the results##2##3##(2008-10#1)(2008-9#1)
shows the same##6##3##(1990-4#1)(1990-5#1)(1991-9#1)(2007-11#1)(2008-10#1)(2008-11#1)
shows the superiority of the##2##5##(2008-2#1)(2008-3#1)
shows the##77##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#4)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-6#1)(2013-1#2)(2013-7#1)
shows three##2##2##(1993-8#1)(2013-7#1)
shows two potential##2##3##(1993-2#1)(2012-1#1)
shows two##7##2##(1992-12#1)(1992-3#1)(1993-2#1)(1995-9#1)(2008-10#1)(2011-1#1)(2012-1#1)
shows various##2##2##(2008-11#1)(2010-6#1)
shows very good##2##3##(2008-10#1)(2008-3#1)
shows very high##2##3##(2008-10#2)
shows very little##4##3##(1995-11#1)(1995-5#1)(1995-6#1)(2008-10#1)
shows very##8##2##(1995-11#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-3#1)
shows why##3##2##(1991-3#1)(1991-9#1)(1992-2#1)
shows##1107##1##(1990-11#4)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#7)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#2)(1991-6#4)(1991-8#4)(1991-9#5)(1992-1#4)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#12)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#7)(1993-1#2)(1993-11#3)(1993-12#7)(1993-2#10)(1993-3#6)(1993-6#7)(1993-8#4)(1994-1#3)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#8)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#1)(1995-2#12)(1995-3#7)(1995-5#7)(1995-6#8)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#5)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#7)(1997-6#4)(1997-7#6)(1997-8#8)(1997-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#5)(2007-11#22)(2007-12#30)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#222)(2008-11#32)(2008-12#15)(2008-2#36)(2008-3#97)(2008-4#7)(2008-5#33)(2008-6#8)(2008-7#25)(2008-8#39)(2008-9#22)(2009-10#10)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#8)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#6)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#10)(2011-2#31)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#8)(2012-2#15)(2012-3#8)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#18)(2013-7#4)(2013-8#16)
shrimp and##2##2##(2013-7#2)
shrimp##37##1##(1994-8#1)(2007-12#4)(2007-5#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#2)(2010-2#5)(2010-4#7)(2013-7#6)
shrimps from the Pantanal##2##4##(2013-7#2)
shrimps from##3##2##(2013-7#3)
shrimps##7##1##(2008-8#3)(2013-7#4)
shrink film##2##2##(2008-10#2)
shrink##8##1##(1994-8#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
shrinkage and##4##2##(2008-3#1)(2008-8#1)(2012-3#2)
shrinkage due to##2##3##(2010-10#1)(2012-2#1)
shrinkage of##4##2##(1994-8#1)(2009-3#1)(2012-2#2)
shrinkage was##2##2##(2009-3#1)(2012-2#1)
shrinkage##31##1##(1994-8#1)(1995-6#1)(1995-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#7)(2009-3#2)(2010-10#3)(2012-2#7)(2012-3#2)
shrinking##8##1##(1991-5#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#1)(2008-12#1)(2013-1#1)
shrub species##2##2##(2008-8#1)(2010-2#1)
shrub##8##1##(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)
shrubs in##2##2##(2008-10#1)(2010-2#1)
shrubs##8##1##(2008-10#3)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#1)
shrunken##2##1##(2008-12#1)(2013-7#1)
shuffle interconnection##2##2##(2007-12#2)
shuffle##4##1##(2007-12#4)
shuffling##6##1##(1992-3#1)(1996-10#1)(1997-9#1)(2008-5#1)(2008-7#1)(2011-1#1)
shunt and##3##2##(1996-3#1)(2008-11#1)(2011-2#1)
shunt at##2##2##(2008-11#1)(2008-7#1)
shunt by##2##2##(1991-11#1)(1993-3#1)
shunt catheter##2##2##(2012-2#2)
shunt for hydrocephalus##2##3##(2008-7#1)(2012-12#1)
shunt for##4##2##(2007-8#1)(2008-7#1)(2010-5#1)(2012-12#1)
shunt in##3##2##(1991-11#1)(2008-7#2)
shunt insertion##2##2##(2012-12#1)(2012-2#1)
shunt is##2##2##(2012-12#2)
shunt to##2##2##(1996-6#1)(2007-8#1)
shunt vessels##3##2##(2011-2#3)
shunt was##3##2##(2011-2#2)(2012-12#1)
shunt##72##1##(1990-3#1)(1991-11#3)(1991-6#1)(1992-6#1)(1993-3#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#1)(2007-8#10)(2008-11#2)(2008-7#9)(2009-3#3)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#3)(2010-8#1)(2011-2#8)(2012-12#11)(2012-2#4)(2012-3#1)
shunt)##2##1##(1995-10#1)(1996-3#1)
shunted##2##1##(1992-4#1)(1994-8#1)
shunting and##2##2##(2009-10#1)(2013-1#1)
shunting in the##2##3##(1997-6#1)(2011-2#1)
shunting##13##1##(1990-11#1)(1991-9#1)(1996-9#2)(1997-6#1)(2007-10#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
shunts during##2##2##(2007-8#1)(2010-10#1)
shunts in the##2##3##(2008-7#2)
shunts##24##1##(1990-11#1)(1993-6#1)(1995-11#1)(1996-11#1)(1996-3#2)(1996-9#5)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#3)(2009-9#2)(2010-10#1)(2010-6#1)
shut down##2##2##(1991-1#1)(1995-11#1)
shut##3##1##(1990-11#1)(1991-1#1)(1995-11#1)
shutdown periods##2##2##(2008-11#2)
shutdown##5##1##(1995-2#1)(1996-12#1)(2008-11#2)(2008-7#1)
shutdowns##3##1##(2008-11#3)
shutter##7##1##(2008-11#1)(2008-2#1)(2008-3#4)(2010-11#1)
shutters and##2##2##(2008-3#2)
shutters##4##1##(2008-3#4)
shutting down##2##2##(1993-6#1)(2008-11#1)
shutting##4##1##(1993-6#1)(2007-11#1)(2008-11#1)(2009-8#1)
shuttle between the##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
shuttle cloning vectors##2##3##(1993-12#2)
shuttle plasmid##6##2##(1990-12#1)(1995-5#1)(2008-11#2)(2008-8#2)
shuttle vector##6##2##(1990-11#1)(1995-6#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
shuttle vectors for##3##3##(1991-7#1)(1997-4#2)
shuttle vectors##7##2##(1991-7#3)(1993-12#1)(1994-12#1)(1997-4#2)
shuttle##35##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-7#3)(1993-12#3)(1994-12#1)(1995-5#2)(1995-6#1)(1997-4#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
shuttles##3##1##(2008-1#1)(2008-11#1)(2008-9#1)
shuttling in##2##2##(2011-2#2)
shuttling##5##1##(1991-3#1)(1995-2#1)(2011-2#2)(2012-2#1)
shy children with##2##3##(2012-12#2)
shy children##4##2##(2012-12#4)
shy##6##1##(2008-4#1)(2012-12#4)(2013-8#1)
shyness and##3##2##(2008-1#1)(2008-4#2)
shyness##9##1##(2008-1#1)(2008-4#5)(2012-12#3)
siRNA targeting##2##2##(2008-11#1)(2013-1#1)
siRNA##18##1##(2008-11#1)(2008-2#3)(2009-4#1)(2009-9#1)(2010-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
siRNA-mediated##3##1##(2008-11#1)(2012-12#1)(2013-1#1)
siRNAs##3##1##(2008-2#1)(2010-2#1)(2012-12#1)
sialadenitis##4##1##(2011-1#4)
sialic acid and##2##3##(1990-12#1)(2008-5#1)
sialic acid plasma level##2##4##(2008-12#2)
sialic acid residues##6##3##(1992-12#1)(1993-11#1)(1994-11#2)(1994-9#1)(2008-11#1)
sialic acid##33##2##(1990-12#3)(1990-5#2)(1991-9#2)(1992-12#1)(1993-1#2)(1993-11#1)(1994-11#4)(1994-9#1)(1995-12#5)(2008-11#6)(2008-12#3)(2008-5#1)(2008-7#1)(2009-2#1)
sialic acids to IFN##2##4##(2008-11#2)
sialic acids##9##2##(1993-11#2)(1994-11#1)(1997-2#1)(2008-11#4)(2008-7#1)
sialic##44##1##(1990-12#3)(1990-5#2)(1991-9#2)(1992-12#1)(1993-1#2)(1993-11#3)(1994-11#6)(1994-9#2)(1995-12#5)(1997-2#1)(2008-11#10)(2008-12#3)(2008-5#1)(2008-7#2)(2009-2#1)
sialidase activity in##2##3##(2008-11#1)(2008-4#1)
sialidase and the##2##3##(2008-11#2)
sialidase release and##2##3##(2008-11#2)
sialidase##10##1##(1992-9#2)(1993-11#1)(1994-11#1)(2008-11#5)(2008-4#1)
sialidases and##3##2##(1992-12#2)(2008-11#1)
sialidases##4##1##(1992-12#2)(1994-11#1)(2008-11#1)
sialoglycoprotein##3##1##(1993-12#1)(1994-11#2)
sialolithiasis##4##1##(2008-10#1)(2011-2#3)
sialoliths##3##1##(2008-10#3)
sialometaplasia of the##2##3##(1991-11#1)(2009-1#1)
sialometaplasia##5##1##(1991-11#3)(2009-1#2)
sialosyl##2##1##(1991-12#1)(1992-12#1)
sialosyl-Le(x)##2##1##(1991-12#2)
sialyl##5##1##(1992-8#1)(1993-11#1)(1993-8#3)
sialyl-Lewis x##2##2##(1992-8#2)
sialylated##4##1##(1992-12#1)(1992-8#1)(1993-11#1)(2008-7#1)
sialylation and increased##2##3##(1992-6#2)
sialylation of##4##2##(1990-8#1)(2008-11#1)(2008-7#2)
sialylation was observed at##2##4##(2008-7#2)
sialylation was##4##2##(2008-7#3)(2008-8#1)
sialylation##20##1##(1990-8#1)(1992-6#2)(2008-11#9)(2008-7#7)(2008-8#1)
sialyltransferase##3##1##(1991-2#1)(1992-12#1)(2008-11#1)
siamangs##2##1##(2012-12#2)
sib##4##1##(1997-5#3)(2008-10#1)
sib-pair##8##1##(1997-5#5)(2008-4#1)(2012-3#2)
sibiricus##2##1##(2008-10#2)
siblicide in##2##2##(2008-9#2)
siblicide##3##1##(2008-9#3)
sibling cases##2##2##(1990-5#2)
sibling group##2##2##(1993-12#2)
sibling jealousy##2##2##(2008-12#2)
sibling pairs##4##2##(1997-5#3)(2011-2#1)
sibling pathogens with##3##3##(2008-10#3)
sibling pathogens##6##2##(2008-10#6)
sibling species##8##2##(1995-8#1)(2008-10#4)(2008-9#1)(2012-3#1)(2013-7#1)
sibling##44##1##(1990-5#2)(1993-12#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#2)(1997-5#3)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#5)(2008-9#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#1)
siblings and##2##2##(2007-5#1)(2009-5#1)
siblings had##3##2##(1995-12#1)(2007-8#1)(2011-1#1)
siblings in##4##2##(2007-7#1)(2008-8#1)(2008-9#1)(2010-5#1)
siblings of children with##2##4##(1995-3#1)(2013-1#1)
siblings of children##3##3##(1993-12#1)(1995-3#1)(2013-1#1)
siblings of##7##2##(1993-12#2)(1995-12#1)(1995-3#1)(1997-5#1)(2008-8#1)(2013-1#1)
siblings were##4##2##(1993-12#1)(1995-12#1)(2007-8#1)(2008-12#1)
siblings with##3##2##(2007-8#1)(2008-7#1)(2009-3#1)
siblings##59##1##(1993-12#3)(1995-12#6)(1995-2#1)(1995-3#2)(1995-6#2)(1997-5#1)(1997-7#3)(1997-8#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#3)(2011-1#5)(2011-2#2)(2013-1#2)(2013-8#1)
siblings' fertility##2##2##(2011-2#2)
siblings'##7##1##(1995-12#1)(2008-9#1)(2009-7#1)(2011-2#3)(2013-7#1)
siboglinid##3##1##(2009-8#3)
siboglinids##3##1##(2009-8#3)
sibpair##4##1##(1996-2#1)(2008-9#3)
sibships with##2##2##(2008-8#2)
sibships##3##1##(2008-4#1)(2008-8#2)
sibutramine##4##1##(2008-8#1)(2012-3#3)
sicca syndrome and##2##3##(2007-7#2)
sick children##2##2##(1992-3#1)(1994-6#1)
sick leave##5##2##(1991-3#1)(1991-8#3)(2008-7#1)
sick##34##1##(1990-2#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-8#4)(1991-9#2)(1992-12#1)(1992-3#2)(1993-9#1)(1994-6#2)(1995-5#1)(1996-1#2)(1996-6#2)(1996-8#1)(1997-6#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#2)
sick-listed##3##1##(1991-11#1)(1991-9#1)(1992-11#1)
sicker##2##1##(1995-2#1)(1996-3#1)
sickle cell anaemia patients##4##4##(2013-8#4)
sickle cell anaemia##8##3##(2009-10#1)(2009-4#3)(2013-8#4)
sickle cell disease (SCD)##2##4##(2007-7#1)(2009-4#1)
sickle cell disease##16##3##(1991-6#1)(2007-7#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#2)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
sickle cell hemoglobinopathy##3##3##(2013-8#3)
sickle cell trait##4##3##(2007-7#1)(2012-12#1)(2013-1#2)
sickle cell##37##2##(1991-6#1)(1992-6#1)(2007-7#2)(2008-11#1)(2008-8#3)(2009-10#2)(2009-2#1)(2009-4#5)(2010-11#1)(2012-12#4)(2012-2#1)(2013-1#5)(2013-8#10)
sickle##38##1##(1991-6#1)(1992-6#1)(1992-9#1)(2007-7#2)(2008-11#1)(2008-8#3)(2009-10#2)(2009-2#1)(2009-4#5)(2010-11#1)(2012-12#4)(2012-2#1)(2013-1#5)(2013-8#10)
sickle-cell disease##4##2##(2006-5#1)(2008-10#2)(2008-4#1)
sickle-cell##7##1##(1992-2#1)(2006-5#1)(2008-10#2)(2008-4#1)(2009-10#1)(2013-1#1)
sickness and##6##2##(1992-2#3)(1994-6#1)(2010-1#1)(2012-2#1)
sickness funds##2##2##(1992-12#1)(1995-1#1)
sickness is a##2##3##(1991-6#1)(2010-4#1)
sickness##26##1##(1991-2#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1994-6#1)(1995-1#1)(1996-1#1)(1997-6#1)(1997-8#3)(2007-2#1)(2008-8#1)(2010-1#4)(2010-12#1)(2010-4#2)(2012-2#1)
sickness]##3##1##(1991-6#1)(2010-12#2)
side and the##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
side and##21##2##(1993-12#1)(1993-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#4)(2008-7#3)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
side as compared##2##3##(1990-7#1)(1993-12#1)
side as##4##2##(1990-7#1)(1993-12#1)(2011-2#1)(2013-1#1)
side at##3##2##(1992-6#2)(2008-3#1)
side bands##2##2##(2008-10#2)
side branch##4##2##(2007-8#1)(2008-11#3)
side by side and##2##4##(2008-10#1)(2008-7#1)
side by side with the##3##5##(2008-3#1)(2008-8#1)(2013-8#1)
side by side##9##3##(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2013-8#1)
side by##10##2##(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2013-8#1)
side chain and##2##3##(1991-2#1)(1993-11#1)
side chain cleavage##2##3##(1991-9#1)(1997-2#1)
side chain in the##4##4##(1995-5#2)(2008-9#2)
side chain in##6##3##(1995-11#2)(1995-5#2)(2008-9#2)
side chain of dihydrozamoranic acid##2##5##(2007-11#2)
side chain of##9##3##(1992-1#1)(1992-3#2)(1993-2#1)(1994-5#1)(2007-11#2)(2008-10#1)(2008-8#1)
side chain resonances##2##3##(2009-7#2)
side chain size##2##3##(1995-5#2)
side chain##57##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-3#4)(1992-6#1)(1992-8#2)(1993-11#3)(1993-2#1)(1993-6#1)(1993-8#2)(1994-5#3)(1995-11#3)(1995-3#4)(1995-5#5)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#7)(2012-2#1)
side chain-side chain##3##3##(1991-11#1)(2008-10#2)
side chains and##2##3##(2007-11#1)(2008-10#1)
side chains are##2##3##(1992-3#1)(1993-11#1)
side chains at##3##3##(1990-12#1)(1993-11#1)(2008-10#1)
side chains in the##2##4##(1990-8#1)(1991-6#1)
side chains in##3##3##(1990-8#1)(1991-6#1)(2008-4#1)
side chains of subunits##2##4##(1992-8#2)
side chains of the##3##4##(1992-6#1)(2008-3#1)(2009-7#1)
side chains of##12##3##(1990-5#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)
side chains were##3##3##(1990-11#1)(1991-9#1)(1993-11#1)
side chains##52##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#5)(1993-12#3)(1993-8#2)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(2006-12#3)(2007-11#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2009-7#1)(2009-8#2)(2010-5#1)
side compared##2##2##(1994-3#1)(2008-9#1)
side effect frequency and severity##2##5##(2008-6#2)
side effect in##3##3##(1991-2#1)(1997-3#1)(2008-3#1)
side effect is##2##3##(1990-10#1)(2011-1#1)
side effect of##19##3##(1990-6#1)(1993-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#3)(2013-8#1)
side effect profile##3##3##(1996-3#1)(2008-7#1)(2011-1#1)
side effect profiles##4##3##(2008-3#1)(2010-12#1)(2011-10#2)
side effect was##4##3##(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
side effect##55##2##(1990-10#2)(1990-6#1)(1991-2#1)(1993-11#1)(1996-3#2)(1997-2#1)(1997-3#3)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-10#3)(2011-2#3)(2012-12#4)(2013-7#1)(2013-8#2)
side effects after##5##3##(1990-10#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-12#1)
side effects and can##2##4##(1995-5#1)(2007-7#1)
side effects and the##3##4##(1996-1#1)(1997-1#1)(1997-8#1)
side effects and##20##3##(1992-3#1)(1993-2#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-8#1)(2010-1#2)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
side effects and/or events##2##4##(1993-2#2)
side effects and/or##3##3##(1993-2#2)(2008-7#1)
side effects are##8##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#1)
side effects associated with the##2##5##(1997-8#1)(2010-10#1)
side effects associated with##6##4##(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-10#1)
side effects from##2##3##(2008-7#1)(2011-2#1)
side effects has been##2##4##(2008-10#1)(2008-8#1)
side effects have been reported##2##5##(1993-11#1)(1993-3#1)
side effects in the##2##4##(2009-7#1)(2010-7#1)
side effects in##6##3##(1992-11#1)(2008-10#1)(2009-7#1)(2010-7#1)(2011-2#2)
side effects is##6##3##(1995-1#1)(1997-3#1)(2007-7#1)(2008-8#2)(2013-1#1)
side effects limit##2##3##(2009-12#1)(2010-11#1)
side effects of drugs##2##4##(1995-12#1)(1997-3#1)
side effects of immunosuppressive##2##4##(1994-5#1)(2011-3#1)
side effects of the vaccination were##2##6##(2011-2#2)
side effects of the##5##4##(2011-1#1)(2011-2#3)(2013-1#1)
side effects of these##2##4##(2008-9#1)(2013-1#1)
side effects of##32##3##(1991-6#3)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2013-1#2)
side effects on##4##3##(1993-12#1)(2008-9#2)(2011-2#1)
side effects or##5##3##(1995-8#1)(2008-7#2)(2008-8#2)
side effects such as##6##4##(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)
side effects than##3##3##(2007-10#1)(2010-12#1)(2012-12#1)
side effects that##7##3##(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2013-1#1)
side effects were observed##4##4##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)
side effects were##17##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-10#1)(1993-2#1)(1996-11#2)(1996-8#1)(2006-10#1)(2007-11#2)(2012-3#1)(2013-1#1)
side effects which##2##3##(1996-3#1)(2008-8#1)
side effects##261##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1991-2#4)(1991-3#4)(1991-6#7)(1991-8#3)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#6)(1993-3#2)(1993-6#3)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-5#3)(1995-8#1)(1996-1#2)(1996-11#5)(1996-3#3)(1996-5#1)(1996-8#2)(1997-1#2)(1997-3#5)(1997-4#1)(1997-8#2)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#4)(2007-7#6)(2008-1#8)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#6)(2008-4#2)(2008-5#5)(2008-6#7)(2008-7#16)(2008-8#14)(2008-9#4)(2009-12#4)(2009-5#3)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#3)
side for##2##2##(2007-5#1)(2008-3#1)
side groups##5##2##(1991-5#1)(2009-11#3)(2010-4#1)
side in a##2##3##(2008-6#1)(2008-7#1)
side in##7##2##(1996-3#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)
side is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
side modes##2##2##(2008-2#2)
side of a##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
side of an##2##3##(2008-3#1)(2008-8#1)
side of membrane##2##3##(2011-2#2)
side of the body##2##4##(2008-5#1)(2008-7#1)
side of the face##5##4##(2008-5#1)(2011-1#1)(2012-12#3)
side of the membrane##4##4##(1990-11#1)(1991-5#1)(2008-10#1)(2011-2#1)
side of the neck##4##4##(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
side of the slab##2##4##(2008-3#2)
side of the subesophageal ganglion##2##5##(2008-5#2)
side of the triquinacene framework##2##5##(1996-5#2)
side of the##108##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-6#5)(1993-3#2)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-6#2)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-2#1)(2012-3#1)(2013-2#1)(2013-7#1)
side of##148##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#5)(1991-9#1)(1992-3#2)(1992-6#6)(1993-3#2)(1993-6#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#2)(1997-1#1)(1997-4#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#12)(2012-12#4)(2012-2#3)(2012-3#1)(2013-2#1)(2013-7#1)
side or##2##2##(1991-3#1)(1994-7#1)
side peaks##2##2##(2008-2#2)
side population (SP)##2##3##(2008-9#1)(2010-6#1)
side population cells are##2##4##(2010-6#2)
side population cells##8##3##(2010-6#8)
side population##12##2##(2008-9#2)(2010-6#10)
side product##2##2##(2009-12#2)
side pumped by a##2##4##(2007-12#1)(2008-3#1)
side pumped by##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
side reaction of##2##3##(2008-10#2)
side reaction##5##2##(2008-10#4)(2008-12#1)
side reactions##7##2##(2008-10#1)(2008-4#3)(2011-1#1)(2012-2#2)
side showed##2##2##(2008-9#2)
side was##3##2##(1991-2#2)(2013-1#1)
side were##4##2##(1993-3#1)(2008-2#1)(2011-2#1)(2013-1#1)
side when the knee was##2##5##(1997-8#2)
side##870##1##(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#10)(1991-3#7)(1991-5#7)(1991-6#9)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#10)(1992-4#3)(1992-5#2)(1992-6#13)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#12)(1993-12#9)(1993-2#7)(1993-3#5)(1993-6#7)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#8)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#5)(1995-5#11)(1995-6#3)(1995-8#1)(1996-1#4)(1996-11#5)(1996-12#1)(1996-2#3)(1996-3#6)(1996-4#2)(1996-5#8)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#8)(1997-4#2)(1997-8#4)(2006-10#3)(2006-12#6)(2007-10#4)(2007-11#16)(2007-12#20)(2007-5#2)(2007-7#16)(2007-8#10)(2008-1#13)(2008-10#54)(2008-11#14)(2008-12#9)(2008-2#20)(2008-3#26)(2008-4#10)(2008-5#28)(2008-6#17)(2008-7#40)(2008-8#31)(2008-9#24)(2009-10#2)(2009-11#5)(2009-12#6)(2009-2#1)(2009-5#3)(2009-6#6)(2009-7#18)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#9)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#11)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#14)(2011-10#3)(2011-2#46)(2011-3#2)(2012-1#2)(2012-12#14)(2012-2#10)(2012-3#9)(2012-7#1)(2013-1#22)(2013-2#1)(2013-7#4)(2013-8#13)
side) of##2##2##(1993-6#1)(2010-12#1)
side)##10##1##(1993-6#1)(2007-10#2)(2007-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)
side-by-side##6##1##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
side-chain structure at##2##3##(1992-3#2)
side-chain##21##1##(1990-11#2)(1992-3#4)(1992-6#1)(1992-8#1)(1994-5#2)(1994-8#1)(1995-3#1)(1995-5#2)(2008-3#2)(2008-4#1)(2008-8#2)(2009-7#2)
side-chains of##2##2##(1995-3#1)(1996-5#1)
side-chains##3##1##(1995-3#1)(1996-5#1)(2006-4#1)
side-effect profile##2##2##(1992-8#1)(2012-2#1)
side-effect##7##1##(1992-8#1)(1993-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
side-effects and toxicity##3##3##(2008-8#1)(2008-9#2)
side-effects and##5##2##(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
side-effects in##4##2##(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
side-effects of##12##2##(1992-4#1)(1993-12#1)(1995-5#2)(1996-12#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
side-effects that##3##2##(2007-8#1)(2008-7#2)
side-effects were##6##2##(1991-11#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
side-effects##63##1##(1990-2#2)(1991-11#1)(1991-6#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-5#2)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#3)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#11)(2008-7#10)(2008-8#2)(2008-9#2)(2010-1#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-8#2)
side-mode##2##1##(2007-11#1)(2008-3#1)
side-pumped Nd##5##2##(2007-11#1)(2008-2#4)
side-pumped solid-state laser##3##3##(2008-3#3)
side-pumped solid-state lasers##2##3##(2008-3#2)
side-pumped solid-state##5##2##(2008-3#5)
side-pumped##11##1##(2007-11#2)(2008-2#4)(2008-3#5)
side-pumping scheme##2##2##(2007-12#1)(2008-2#1)
side-pumping##5##1##(2007-12#3)(2008-2#2)
side-to-side anastomosis##3##2##(1991-9#1)(2013-1#2)
side-to-side##8##1##(1990-5#1)(1991-9#2)(2012-2#1)(2012-3#1)(2013-1#3)
sidearm##3##1##(2008-10#1)(2008-3#2)
sideband extraction##5##2##(2008-2#5)
sideband generation##3##2##(2007-11#2)(2007-12#1)
sideband##19##1##(2007-11#4)(2007-12#3)(2008-2#8)(2008-3#4)
sidebands in the##2##3##(2007-12#1)(2008-10#1)
sidebands in##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
sidebands that##2##2##(2007-11#1)(2008-3#1)
sidebands##19##1##(2007-11#6)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#4)
sidechain##6##1##(1990-7#2)(1994-11#1)(2008-2#1)(2008-9#1)(2009-7#1)
sided pleural effusion##2##3##(2008-1#1)(2010-11#1)
sided##16##1##(1997-6#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
sidelobe control##2##2##(2008-3#2)
sidelobe suppression##2##2##(2008-3#2)
sidelobe##5##1##(2008-3#4)(2012-3#1)
sidelobes of##2##2##(2008-2#2)
sidelobes##5##1##(2007-11#2)(2008-2#2)(2008-3#1)
siderophore complexation##2##2##(2013-1#2)
siderophore production##3##2##(2008-10#2)(2013-1#1)
siderophore##17##1##(2008-10#9)(2011-2#3)(2013-1#5)
siderophores##2##1##(2008-10#1)(2013-1#1)
siderosis of the central nervous system secondary to a thalamic hamartoma##2##11##(2008-7#2)
siderosis of the central nervous system##3##6##(2007-10#1)(2008-7#2)
siderosis##4##1##(2007-10#1)(2008-7#3)
sides and##2##2##(2006-10#1)(2007-5#1)
sides at##2##2##(2008-10#1)(2013-1#1)
sides of the membrane##3##4##(1990-11#1)(1993-3#1)(2008-10#1)
sides of the root system##2##5##(2008-10#2)
sides of the root##3##4##(2008-10#3)
sides of the spinal cord##2##5##(1990-7#1)(2008-7#1)
sides of the##39##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-4#1)(2013-7#1)(2013-8#1)
sides of##42##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2009-10#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-4#1)(2013-7#1)(2013-8#1)
sides was##2##2##(2007-8#2)
sides with##2##2##(1993-3#1)(2008-3#1)
sides##78##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-2#1)(1995-1#2)(1995-8#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-1#1)(2009-10#2)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
sidewall##4##1##(2007-11#1)(2008-3#3)
sidewalls##6##1##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
sideways##5##1##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)
sieve elements##4##2##(2008-10#4)
sieve##14##1##(2008-10#10)(2008-11#2)(2008-5#1)(2013-7#1)
sieved##4##1##(2008-10#4)
sieving coefficient##3##2##(2010-5#2)(2011-1#1)
sieving structure for##2##3##(2008-7#2)
sieving structure##3##2##(2008-7#3)
sieving##15##1##(2008-10#6)(2008-7#6)(2010-5#2)(2011-1#1)
sight and##2##2##(2010-8#1)(2011-2#1)
sight in##2##2##(1993-11#1)(2011-2#1)
sight of the##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
sight of##9##2##(1993-6#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2012-2#1)
sight threatening##2##2##(2010-10#1)(2011-1#1)
sight##33##1##(1990-3#1)(1991-2#1)(1992-1#1)(1993-11#1)(1993-6#3)(1995-8#1)(1996-11#1)(1996-3#1)(1997-6#1)(2007-12#1)(2007-3#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
sighted##2##1##(1990-11#2)
sigma 1##3##2##(1990-8#2)(1993-9#1)
sigma 35##2##2##(1993-12#2)
sigma 70##3##2##(1993-12#1)(1994-12#1)(1995-2#1)
sigma 70-dependent##2##2##(1995-2#2)
sigma A##2##2##(1993-9#2)
sigma B2 has##2##3##(1996-3#2)
sigma B2##4##2##(1996-3#4)
sigma H##4##2##(1990-12#4)
sigma factor##5##2##(1990-12#1)(1993-12#3)(2012-2#1)
sigma receptor##2##2##(1995-12#1)(1997-7#1)
sigma##56##1##(1990-11#1)(1990-12#6)(1990-7#1)(1990-8#2)(1991-6#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-12#9)(1993-8#1)(1993-9#3)(1994-12#3)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#2)(1996-3#5)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#2)(2012-2#1)
sigma(0)##3##1##(2008-5#3)
sigma(2)##3##1##(2007-12#3)
sigma1 receptor##2##2##(1995-12#2)
sigma1##7##1##(1995-12#7)
sigma2 sites##2##2##(1995-12#2)
sigma2##5##1##(1995-12#5)
sigma3 protein##3##2##(1997-6#3)
sigmoid and##2##2##(1991-6#1)(2008-10#1)
sigmoid colon and rectum##3##4##(1991-6#1)(1993-9#1)(2013-8#1)
sigmoid colon fistula##2##3##(2012-12#2)
sigmoid colon##17##2##(1991-4#2)(1991-6#1)(1993-9#1)(2006-8#1)(2008-10#1)(2008-12#2)(2010-12#2)(2011-2#3)(2012-12#3)(2013-8#1)
sigmoid sinus##3##2##(1996-6#1)(1996-9#1)(2008-7#1)
sigmoid volvulus##2##2##(1993-5#2)
sigmoid##44##1##(1991-4#2)(1991-6#2)(1992-5#1)(1993-5#2)(1993-9#1)(1996-6#1)(1996-9#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#3)(2010-8#3)(2011-2#5)(2012-12#3)(2013-1#1)(2013-8#1)
sigmoidal##10##1##(1990-5#1)(1995-2#1)(1997-6#1)(2008-10#4)(2010-5#1)(2013-8#2)
sigmoidectomy for##2##2##(2008-10#1)(2009-1#1)
sigmoidectomy##4##1##(2008-10#1)(2009-1#3)
sign and##8##2##(1991-8#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-8#1)
sign for##2##2##(2008-10#1)(2012-12#1)
sign in##5##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
sign is a##2##3##(1990-6#1)(2013-7#1)
sign is##6##2##(1990-6#1)(2007-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
sign language##4##2##(1997-5#1)(2010-5#2)(2011-2#1)
sign of a##4##3##(1991-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
sign of an##2##3##(1996-3#1)(2011-2#1)
sign of recurrence##2##3##(2011-2#1)(2012-3#1)
sign of the##13##3##(1997-1#1)(2007-11#2)(2008-3#6)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
sign of##70##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-11#2)(1995-8#1)(1996-3#1)(1997-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
sign rule##2##2##(2007-11#2)
sign score regression method is##2##5##(1995-2#2)
sign score regression method##3##4##(1995-2#3)
sign score regression##5##3##(1995-2#5)
sign to##2##2##(1995-3#1)(2008-9#1)
sign was##3##2##(1991-8#1)(2013-7#2)
sign##135##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-8#4)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-7#1)(1995-11#2)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#11)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-5#3)(2010-6#2)(2011-1#1)(2011-2#7)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#3)
sign&quot##2##1##(1993-9#1)(2012-12#1)
sign)##4##1##(1995-3#1)(2008-3#2)(2009-7#1)
sign-out note content##3##3##(2011-1#3)
sign-out note##4##2##(2011-1#4)
sign-out notes##2##2##(2011-1#2)
sign-out##13##1##(2010-12#4)(2011-1#9)
signal abnormalities##2##2##(2008-7#1)(2009-10#1)
signal amplification##10##2##(1996-2#1)(2008-10#3)(2008-4#2)(2008-9#3)(2011-1#1)
signal amplitude##6##2##(1990-5#1)(1996-2#1)(2008-3#3)(2009-11#1)
signal amplitudes##2##2##(2008-10#1)(2008-2#1)
signal analysis##2##2##(2007-12#1)(2011-1#1)
signal and a##3##3##(2008-3#2)(2011-2#1)
signal and coding##2##3##(1997-7#1)(2013-1#1)
signal and has##2##3##(1992-6#1)(2008-3#1)
signal and idler pulses##2##4##(2007-11#1)(2007-12#1)
signal and idler##9##3##(2007-11#4)(2007-12#4)(2008-2#1)
signal and noise##2##3##(2008-2#1)(2008-3#1)
signal and the idler##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
signal and the##18##3##(2007-11#5)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#5)
signal and##68##2##(1991-12#1)(1992-6#1)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#11)(2007-12#12)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#19)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
signal are##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
signal as a function of##2##5##(2008-2#1)(2008-3#1)
signal as the##2##3##(2007-11#1)(2007-12#1)
signal as##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
signal at 1##2##3##(1997-2#1)(2008-3#1)
signal at a##3##3##(2006-4#1)(2007-12#1)(2008-3#1)
signal at the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
signal at##21##2##(1993-8#1)(1995-12#1)(1997-2#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#7)
signal averaging##2##2##(2008-2#1)(2008-3#1)
signal bandwidth##2##2##(2008-2#1)(2008-3#1)
signal based##2##2##(2008-10#2)
signal beam##7##2##(2007-12#2)(2008-3#5)
signal beams##3##2##(2007-12#2)(2008-2#1)
signal becomes##3##2##(2008-2#1)(2008-3#2)
signal behavior##2##2##(1997-8#1)(2008-3#1)
signal between##2##2##(2007-12#1)(2008-10#1)
signal by the##3##3##(2008-3#2)(2011-2#1)
signal by##7##2##(2007-11#1)(2007-12#1)(2008-3#3)(2008-9#1)(2011-2#1)
signal can be##6##3##(2007-11#1)(2007-12#1)(2008-10#4)
signal can##10##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
signal cascade##2##2##(2009-8#1)(2012-12#1)
signal caused by##2##3##(2007-11#1)(2008-2#1)
signal change##5##2##(1994-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
signal changes##6##2##(2007-10#1)(2008-10#1)(2011-1#1)(2012-12#2)(2013-8#1)
signal characteristics##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
signal collected##2##2##(2008-10#1)(2012-2#1)
signal contains##2##2##(2008-2#1)(2008-3#1)
signal contamination##2##2##(2008-3#2)
signal contrast##2##2##(2007-12#1)(2009-6#1)
signal correction (OSC)##2##3##(2008-10#2)
signal cost is inversely related to the##2##7##(2008-9#2)
signal could be##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
signal could##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
signal data##3##2##(2008-10#1)(2010-8#2)
signal decrease that was due to photobleaching##2##7##(2008-3#2)
signal decreased##2##2##(2008-10#2)
signal delay##2##2##(2008-3#2)
signal depends on##2##3##(2008-10#2)
signal depends##4##2##(2007-12#1)(2008-10#3)
signal detected##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
signal detection theory##2##3##(1992-11#1)(1994-3#1)
signal detection##12##2##(1992-11#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-8#1)
signal deterioration##2##2##(2008-10#2)
signal drift##2##2##(2010-7#1)(2013-8#1)
signal during##3##2##(2008-10#2)(2008-11#1)
signal energy##3##2##(2008-2#3)
signal enhancement##3##2##(2007-12#1)(2008-10#2)
signal evolution##2##2##(1995-5#1)(2008-9#1)
signal exhibits##2##2##(2008-3#2)
signal fidelity##2##2##(2007-12#1)(2008-2#1)
signal fluctuation##3##2##(2008-10#1)(2008-2#2)
signal for the##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
signal for##29##2##(1990-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-7#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
signal frequency##2##2##(2007-12#1)(2008-3#1)
signal from a##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
signal from the sample##3##4##(2007-12#1)(2008-10#2)
signal from the##16##3##(1990-12#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-8#1)(2009-6#1)(2012-12#1)
signal from which##2##3##(2007-11#1)(2008-2#1)
signal from##35##2##(1990-12#1)(1994-12#2)(2007-11#4)(2007-12#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#2)(2010-5#1)(2012-12#1)(2012-2#1)
signal function##2##2##(2008-8#1)(2008-9#1)
signal gain##3##2##(2008-2#2)(2008-3#1)
signal generated by the##4##4##(1991-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
signal generated by##5##3##(1991-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
signal generated##6##2##(1991-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
signal generation##6##2##(1992-12#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-9#1)
signal has been investigated##2##4##(2008-10#1)(2008-3#1)
signal has been##4##3##(2008-10#1)(2008-3#2)(2010-8#1)
signal has##5##2##(2008-10#1)(2008-3#2)(2010-7#1)(2010-8#1)
signal have been##2##3##(2008-4#1)(2012-2#1)
signal height##4##2##(1993-8#1)(2008-10#3)
signal in a##3##3##(2007-11#2)(2013-1#1)
signal in an optical disk drive##2##6##(2008-2#1)(2008-3#1)
signal in an optical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
signal in an##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
signal in the##16##3##(1991-12#1)(1996-12#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-3#5)(2011-1#1)
signal in tissue##2##3##(2012-12#2)
signal in##48##2##(1991-12#2)(1991-2#1)(1993-6#1)(1995-2#2)(1996-12#1)(1996-5#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#5)(2008-2#4)(2008-3#9)(2008-8#3)(2009-5#1)(2009-9#1)(2011-1#1)(2012-12#2)(2013-1#1)
signal increase##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
signal increased##3##2##(1994-8#1)(2008-9#1)(2010-4#1)
signal induced by##2##3##(1994-3#1)(2008-10#1)
signal integration##2##2##(2008-3#1)(2009-8#1)
signal intensities are used to measure##2##6##(2008-3#2)
signal intensities are##4##3##(2008-3#4)
signal intensities##10##2##(2008-10#3)(2008-2#1)(2008-3#4)(2009-11#1)(2012-3#1)
signal intensity (SI) on different pulse sequences##2##7##(1997-8#1)(2012-2#1)
signal intensity and##5##3##(1992-3#1)(2008-3#3)(2013-1#1)
signal intensity at b = 0##2##6##(2009-11#2)
signal intensity enhancement##2##3##(2008-7#2)
signal intensity in the##4##4##(1991-11#2)(2007-10#1)(2009-3#1)
signal intensity in##5##3##(1991-11#2)(2007-10#1)(2009-3#1)(2013-8#1)
signal intensity of##2##3##(2008-3#1)(2012-3#1)
signal intensity on T1-weighted##2##4##(1991-11#1)(2012-2#1)
signal intensity on##10##3##(1991-11#2)(1997-8#3)(2008-2#1)(2009-11#2)(2011-2#1)(2012-2#1)
signal intensity was##2##3##(2008-10#1)(2008-2#1)
signal intensity with##2##3##(2008-3#1)(2013-1#1)
signal intensity##53##2##(1991-11#6)(1992-3#1)(1996-2#1)(1997-8#4)(2007-10#1)(2008-10#6)(2008-2#3)(2008-3#10)(2008-7#4)(2009-11#5)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
signal into##3##2##(1997-3#1)(2008-9#1)(2011-1#1)
signal is a##2##3##(2008-10#2)
signal is also##3##3##(1994-5#1)(2008-2#1)(2008-3#1)
signal is collected##2##3##(2008-3#2)
signal is converted##2##3##(2008-10#1)(2008-3#1)
signal is demonstrated##2##3##(2007-12#1)(2008-3#1)
signal is derived##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
signal is detected by use of a##2##7##(1995-3#1)(2008-3#1)
signal is detected by##3##4##(1995-3#1)(2008-3#2)
signal is detected##6##3##(1995-3#1)(2007-12#2)(2008-2#1)(2008-3#2)
signal is directly##3##3##(2008-10#2)(2008-11#1)
signal is measured##2##3##(2007-11#1)(2008-10#1)
signal is not##3##3##(1994-5#1)(2008-2#2)
signal is obtained##2##3##(2008-10#1)(2008-3#1)
signal is##84##2##(1991-2#1)(1993-6#1)(1994-11#1)(1994-5#3)(1995-3#1)(1997-3#1)(2007-11#6)(2007-12#7)(2007-7#1)(2008-10#13)(2008-11#1)(2008-2#18)(2008-3#23)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2011-1#1)
signal level in##2##3##(2008-3#1)(2009-5#1)
signal levels##7##2##(2008-2#1)(2008-3#6)
signal light##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
signal magnitude##2##2##(2008-10#2)
signal may##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-6#1)
signal measured##2##2##(2008-10#1)(2008-2#1)
signal measurements##3##2##(2008-10#3)
signal modulation##2##2##(2007-11#1)(2009-3#1)
signal molecule##4##2##(1990-7#1)(1996-5#1)(2008-10#1)(2008-9#1)
signal molecules##5##2##(1994-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
signal networks##2##2##(1997-2#2)
signal noise##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
signal obtained##4##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
signal of a##3##3##(2008-2#1)(2009-9#1)(2010-7#1)
signal of an##3##3##(2008-10#2)(2008-2#1)
signal of interfering species##2##4##(2008-2#2)
signal of the##13##3##(1991-2#1)(2008-10#8)(2008-3#1)(2010-2#1)(2010-9#1)(2013-1#1)
signal of##58##2##(1991-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#3)(2008-10#24)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
signal on the##6##3##(2008-10#1)(2008-2#3)(2008-3#1)(2012-3#1)
signal on##11##2##(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)(2010-8#1)(2012-3#1)
signal originating from##2##3##(2008-3#1)(2009-6#1)
signal output##2##2##(2007-11#1)(2008-3#1)
signal over##2##2##(1994-5#1)(2008-2#1)
signal pathway in##4##3##(2011-2#2)(2011-3#2)
signal pathway of##2##3##(2008-3#1)(2013-1#1)
signal pathway##14##2##(1997-2#2)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#3)(2011-3#4)(2013-1#1)(2013-8#1)
signal pathways##3##2##(1996-2#1)(2012-1#1)(2013-7#1)
signal peptidase I##2##3##(1997-7#2)
signal peptidase##6##2##(1991-10#1)(1991-11#1)(1993-12#1)(1997-7#2)(2008-10#1)
signal peptide and a##3##4##(1992-8#1)(2008-11#2)
signal peptide and##10##3##(1990-12#1)(1991-9#1)(1992-8#2)(2008-11#2)(2008-4#1)(2008-8#1)(2010-5#1)(2010-6#1)
signal peptide cleavage##3##3##(1991-9#1)(1994-9#1)(2008-10#1)
signal peptide for##2##3##(1991-12#1)(1995-6#1)
signal peptide of##5##3##(1990-2#1)(1992-8#2)(1993-2#1)(2008-8#1)
signal peptide polymorphism##2##3##(1997-8#2)
signal peptide sequence##2##3##(2010-6#2)
signal peptide##42##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-8#5)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-4#2)(1997-8#2)(2008-10#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-8#2)(2009-2#1)(2010-5#1)(2010-6#4)
signal peptides##7##2##(1991-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#1)
signal per##2##2##(2008-10#1)(2008-3#1)
signal power and##2##3##(2008-2#1)(2008-3#1)
signal power at##2##3##(2007-11#1)(2007-12#1)
signal power is##2##3##(2008-3#2)
signal power over the range gate##2##6##(2008-3#2)
signal power##16##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#9)
signal processing by##2##3##(2007-12#2)
signal processing is##2##3##(2008-2#1)(2008-3#1)
signal processing method##2##3##(1994-12#1)(2012-3#1)
signal processing##41##2##(1994-12#2)(2007-12#6)(2007-7#1)(2008-10#3)(2008-2#7)(2008-3#13)(2008-9#4)(2010-10#1)(2010-8#1)(2011-7#1)(2012-2#1)(2012-3#1)
signal processor##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
signal processors##3##2##(2008-3#2)(2008-9#1)
signal produced by the##3##4##(1994-12#1)(2008-10#2)
signal produced by##4##3##(1994-12#1)(1995-2#1)(2008-10#2)
signal profiles##2##2##(2008-10#2)
signal propagation mechanism##2##3##(2008-1#1)(2011-1#1)
signal propagation##3##2##(2008-1#1)(2008-2#1)(2011-1#1)
signal properties##2##2##(2010-12#1)(2010-9#1)
signal pulse##5##2##(2007-12#3)(2008-3#2)
signal pulses are##2##3##(2007-11#1)(2008-2#1)
signal pulses##10##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)
signal quality##6##2##(2008-10#1)(2008-3#2)(2008-8#1)(2010-5#1)(2010-8#1)
signal radiation is##2##3##(2007-12#1)(2008-3#1)
signal radiation##3##2##(2007-12#1)(2008-3#2)
signal range##2##2##(2008-10#2)
signal rather than##2##3##(2008-3#2)
signal reception##2##2##(2009-6#1)(2009-8#1)
signal recognition particle receptor##2##4##(1995-6#2)
signal recognition particle##5##3##(1994-11#1)(1995-6#2)(2009-7#2)
signal recognition##7##2##(1994-11#1)(1995-6#3)(2009-5#1)(2009-7#2)
signal recording##2##2##(2008-10#1)(2010-12#1)
signal response##5##2##(1992-3#1)(1996-2#1)(2008-10#3)
signal resulting from the##2##4##(1997-4#1)(2008-3#1)
signal results##2##2##(2008-2#1)(2008-3#1)
signal separation##2##2##(2008-3#1)(2008-4#1)
signal sequence and a##4##4##(1994-12#1)(1997-7#2)(2008-11#1)
signal sequence and##9##3##(1991-6#1)(1992-3#1)(1993-9#1)(1994-12#1)(1997-7#2)(2008-11#3)
signal sequence at the##2##4##(1992-8#1)(1993-3#1)
signal sequence of##3##3##(1993-12#1)(1993-9#2)
signal sequence that##2##3##(1991-10#1)(1993-2#1)
signal sequence##40##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#6)(1991-6#4)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#5)(1994-12#2)(1994-9#1)(1997-4#2)(1997-7#2)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
signal sequences##3##2##(1990-5#1)(1993-6#1)(1997-7#1)
signal showed a##3##3##(2008-10#3)
signal size##3##2##(2008-3#3)
signal source##2##2##(2008-2#1)(2010-8#1)
signal spectrum##4##2##(2007-12#1)(2008-3#2)(2010-8#1)
signal statistics##5##2##(2008-2#1)(2008-3#4)
signal strength##3##2##(2008-10#1)(2008-3#2)
signal structure##2##2##(2008-10#1)(2008-2#1)
signal suppression##3##2##(2008-10#3)
signal termination##3##2##(1991-2#3)
signal than##2##2##(1997-4#1)(2008-3#1)
signal that is##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
signal that##21##2##(1994-8#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-5#1)(2012-2#1)
signal the##7##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)(2013-8#1)
signal through##4##2##(1994-2#1)(2008-3#1)(2008-9#2)
signal to be##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
signal to noise ratio of##3##5##(2008-10#2)(2011-1#1)
signal to noise ratio##7##4##(2008-10#4)(2008-9#1)(2011-1#2)
signal to noise##8##3##(2008-10#4)(2008-9#1)(2010-8#1)(2011-1#2)
signal to the##5##3##(2007-12#1)(2007-9#1)(2008-10#3)
signal to##41##2##(1991-12#1)(1991-3#1)(1993-8#1)(1994-11#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#12)(2008-2#2)(2008-3#7)(2008-4#2)(2008-8#3)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#2)(2013-1#1)
signal transducer and activator of transcription##2##6##(2008-8#1)(2012-3#1)
signal transducer and##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
signal transducer of##2##3##(2008-1#1)(2009-5#1)
signal transducer##12##2##(1996-2#2)(1997-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-3#1)
signal transducers and activators of transcription (STAT)##2##7##(2011-2#1)(2012-3#1)
signal transducers and activators of transcription##5##6##(1996-2#1)(2009-3#1)(2011-2#2)(2012-3#1)
signal transducers in##3##3##(1996-12#2)(2012-1#1)
signal transducers that##2##3##(2008-7#1)(2010-4#1)
signal transducers##11##2##(1996-12#3)(1996-2#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)
signal transducing##3##2##(1993-8#1)(1994-11#1)(2009-4#1)
signal transduction and##12##3##(1991-9#1)(1992-8#1)(1995-2#1)(1997-2#1)(2008-11#3)(2008-9#2)(2010-11#1)(2010-4#1)(2012-1#1)
signal transduction by##4##3##(1992-12#1)(1994-12#1)(2008-7#1)(2008-8#1)
signal transduction cascades##3##3##(1996-2#1)(2009-12#1)(2011-1#1)
signal transduction chain##2##3##(2008-4#2)
signal transduction events##2##3##(1994-6#1)(2008-4#1)
signal transduction in response to##2##5##(1996-2#1)(2010-1#1)
signal transduction in the##2##4##(1991-2#1)(2009-12#1)
signal transduction in##16##3##(1991-2#2)(1993-6#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-4#2)(2008-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2013-1#1)
signal transduction leading to the##2##5##(1990-12#1)(1995-6#1)
signal transduction leading to##3##4##(1990-12#1)(1995-2#1)(1995-6#1)
signal transduction mechanism##2##3##(1994-9#1)(2008-4#1)
signal transduction mechanisms##4##3##(1993-8#1)(1995-11#2)(1995-5#1)
signal transduction molecules and##2##4##(1993-8#1)(2008-11#1)
signal transduction network##2##3##(2008-8#1)(2011-2#1)
signal transduction networks##2##3##(2011-3#2)
signal transduction of##8##3##(1991-12#1)(1993-3#1)(1995-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-5#1)
signal transduction pathway is##2##4##(2007-12#1)(2008-7#1)
signal transduction pathway that##2##4##(1997-2#1)(2008-10#1)
signal transduction pathway##19##3##(1991-12#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-8#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2009-4#1)(2011-3#1)
signal transduction pathways by leptin in colorectal cancer##2##8##(2012-3#2)
signal transduction pathways by leptin##3##5##(2012-3#3)
signal transduction pathways by##4##4##(1994-11#1)(2012-3#3)
signal transduction pathways in##4##4##(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)
signal transduction pathways leading to##2##5##(1992-12#1)(2008-4#1)
signal transduction pathways triggered by##2##5##(2008-11#1)(2008-9#1)
signal transduction pathways upon##2##4##(2007-12#1)(2008-8#1)
signal transduction pathways##35##3##(1992-12#1)(1992-2#1)(1994-11#1)(1995-2#2)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
signal transduction through##2##3##(1991-12#1)(2008-7#1)
signal transduction to##2##3##(2010-11#1)(2012-2#1)
signal transduction##176##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-2#3)(1991-9#1)(1992-12#3)(1992-2#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-6#4)(1993-8#3)(1994-11#4)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#8)(2008-11#11)(2008-2#1)(2008-3#2)(2008-4#16)(2008-5#3)(2008-7#6)(2008-8#9)(2008-9#8)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-11#3)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#1)
signal transfer##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
signal transmission##10##2##(1992-10#1)(1993-9#1)(1994-11#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-3#1)(2011-7#1)
signal traveling##2##2##(2008-3#2)
signal using a##2##3##(1994-9#1)(2008-10#1)
signal using##4##2##(1994-9#1)(2008-10#3)
signal was detected##2##3##(1994-6#1)(2008-3#1)
signal was found to be##2##5##(2008-10#1)(2009-8#1)
signal was found to##3##4##(2008-10#2)(2009-8#1)
signal was found##5##3##(1993-12#1)(1997-2#1)(2008-10#2)(2009-8#1)
signal was observed and##2##4##(2008-10#2)
signal was observed in##3##4##(2008-10#1)(2008-11#2)
signal was observed##7##3##(1993-11#1)(2008-10#4)(2008-11#2)
signal was obtained for##4##4##(1996-12#1)(2008-10#3)
signal was obtained##6##3##(1996-12#1)(2008-10#3)(2008-3#1)(2013-8#1)
signal was##50##2##(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#20)(2008-11#2)(2008-2#3)(2008-3#5)(2008-7#2)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
signal wave and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
signal wave in##2##3##(2008-3#2)
signal wave##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
signal wavelengths##3##2##(2007-12#1)(2008-3#2)
signal waves##2##2##(2007-12#1)(2008-3#1)
signal were##5##2##(2008-10#4)(2008-2#1)
signal when##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
signal which##2##2##(1993-3#1)(2010-8#1)
signal while##2##2##(2007-12#1)(2008-10#1)
signal whose amplitude##2##3##(2008-3#1)(2008-9#1)
signal with a##6##3##(2007-11#1)(2008-10#2)(2008-3#3)
signal with an##2##3##(2008-3#2)
signal with only a##2##4##(2008-10#1)(2008-2#1)
signal with the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
signal with##21##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#10)(2008-4#1)(2011-1#1)
signal within##2##2##(2007-11#1)(2008-3#1)
signal without##2##2##(2008-11#1)(2008-3#1)
signal##1794##1##(1990-11#5)(1990-12#8)(1990-2#1)(1990-5#6)(1990-7#1)(1990-8#2)(1991-10#8)(1991-11#7)(1991-12#13)(1991-2#11)(1991-3#2)(1991-5#2)(1991-6#7)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#11)(1993-11#4)(1993-12#6)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#9)(1993-8#7)(1993-9#7)(1994-11#15)(1994-12#12)(1994-2#2)(1994-3#5)(1994-5#7)(1994-6#5)(1994-8#6)(1994-9#6)(1995-11#5)(1995-12#4)(1995-2#13)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#4)(1996-10#1)(1996-12#10)(1996-2#14)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#10)(1997-3#4)(1997-4#12)(1997-5#2)(1997-6#2)(1997-7#11)(1997-8#13)(2006-10#2)(2006-4#1)(2007-10#2)(2007-11#76)(2007-12#106)(2007-7#2)(2007-9#1)(2008-1#8)(2008-10#323)(2008-11#52)(2008-12#3)(2008-2#157)(2008-3#307)(2008-4#38)(2008-5#7)(2008-6#2)(2008-7#29)(2008-8#45)(2008-9#46)(2009-10#3)(2009-11#8)(2009-12#2)(2009-2#5)(2009-3#7)(2009-4#4)(2009-5#6)(2009-6#13)(2009-7#5)(2009-8#17)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#8)(2010-6#6)(2010-7#5)(2010-8#17)(2010-9#6)(2011-1#23)(2011-2#17)(2011-3#8)(2011-7#2)(2012-1#3)(2012-12#14)(2012-2#19)(2012-3#20)(2013-1#11)(2013-7#3)(2013-8#7)
signal)##5##1##(2007-12#1)(2008-10#3)(2008-3#1)
signal-anchor sequence##2##2##(1991-10#1)(1996-3#1)
signal-anchor##4##1##(1991-10#3)(1996-3#1)
signal-dependent##3##1##(2008-3#3)
signal-detection tasks##2##2##(2008-3#2)
signal-detection##3##1##(2008-3#2)(2011-2#1)
signal-gain##2##1##(2007-12#2)
signal-induced noise##3##2##(2008-2#1)(2008-3#2)
signal-induced##6##1##(1990-8#1)(2008-2#1)(2008-3#3)(2013-1#1)
signal-processing##3##1##(2008-2#1)(2008-3#2)
signal-regulated kinases##4##2##(1995-6#1)(2008-4#1)(2011-2#1)(2013-8#1)
signal-regulated##13##1##(1995-6#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-12#2)(2011-2#4)(2013-1#2)(2013-8#1)
signal-related##3##1##(1991-6#2)(2008-7#1)
signal-to-background ratio and##2##3##(2008-2#1)(2010-5#1)
signal-to-background ratio##6##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-5#1)(2013-8#1)
signal-to-background##9##1##(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2013-8#1)
signal-to-noise and##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
signal-to-noise characteristics##2##2##(2008-10#2)
signal-to-noise level##3##2##(2007-12#1)(2008-10#2)
signal-to-noise ratio (SNR) of##3##4##(2008-10#1)(2010-8#1)(2013-8#1)
signal-to-noise ratio (SNR)##14##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
signal-to-noise ratio and the##2##4##(2007-11#1)(2008-3#1)
signal-to-noise ratio and##9##3##(2007-11#2)(2008-2#1)(2008-3#4)(2010-8#1)(2013-8#1)
signal-to-noise ratio as##2##3##(2007-12#1)(2008-3#1)
signal-to-noise ratio for##3##3##(2007-12#1)(2008-3#2)
signal-to-noise ratio in##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
signal-to-noise ratio is##9##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
signal-to-noise ratio of 3##13##4##(1990-8#1)(1991-5#1)(2007-12#1)(2008-10#8)(2008-3#1)(2013-1#1)
signal-to-noise ratio of the##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
signal-to-noise ratio of##38##3##(1990-8#1)(1991-5#1)(2007-12#6)(2008-10#14)(2008-2#2)(2008-3#13)(2013-1#1)
signal-to-noise ratio than##2##3##(2008-2#1)(2008-3#1)
signal-to-noise ratio to be##2##4##(2007-12#1)(2008-2#1)
signal-to-noise ratio with##6##3##(2008-2#2)(2008-3#4)
signal-to-noise ratio##143##2##(1990-8#1)(1991-2#1)(1991-5#1)(1997-8#1)(2007-11#7)(2007-12#20)(2008-1#1)(2008-10#20)(2008-2#22)(2008-3#58)(2008-4#1)(2009-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
signal-to-noise ratios (SNR's)##2##3##(2008-3#2)
signal-to-noise ratios of##3##3##(2008-10#1)(2008-3#2)
signal-to-noise ratios##18##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#9)(2008-4#1)(2008-8#1)(2012-2#1)
signal-to-noise values##2##2##(2008-3#1)(2008-8#1)
signal-to-noise##181##1##(1990-8#1)(1991-2#1)(1991-5#1)(1997-8#1)(2007-11#9)(2007-12#23)(2008-1#1)(2008-10#31)(2008-2#26)(2008-3#71)(2008-4#2)(2008-8#2)(2009-5#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
signal-transduction##5##1##(1994-8#1)(1997-4#2)(2008-4#1)(2008-9#1)
signal-wave##3##1##(2007-11#1)(2007-12#2)
signal/noise##2##1##(1990-12#1)(2008-10#1)
signaled##4##1##(2007-8#1)(2008-10#1)(2010-4#1)(2011-2#1)
signaler##4##1##(2008-9#4)
signalers##4##1##(2008-8#4)
signaling activity##2##2##(2013-1#2)
signaling and the##5##3##(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
signaling and##24##2##(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
signaling are##2##2##(2007-12#1)(2012-3#1)
signaling arrest of##2##3##(2011-1#2)
signaling assemblies##2##2##(2012-12#2)
signaling at##4##2##(2008-10#1)(2008-4#1)(2009-9#1)(2013-1#1)
signaling between neurons and##2##4##(2008-5#1)(2009-3#1)
signaling between##3##2##(2007-12#1)(2008-5#1)(2009-3#1)
signaling but##2##2##(2008-11#1)(2009-4#1)
signaling by P2Y receptors##2##4##(2008-4#1)(2009-3#1)
signaling by the##3##3##(1997-7#1)(2008-5#1)(2008-8#1)
signaling by##16##2##(1993-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#2)(2012-2#1)(2013-1#2)
signaling cascade##7##2##(1997-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#2)
signaling cascades that##3##3##(2008-4#1)(2008-7#1)(2009-8#1)
signaling cascades##10##2##(1997-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#4)(2009-8#1)
signaling complexes##2##2##(2008-7#2)
signaling component##2##2##(1994-8#1)(2010-7#1)
signaling components and##2##3##(2008-11#1)(2009-10#1)
signaling components##6##2##(2008-11#2)(2009-10#1)(2009-6#2)(2009-8#1)
signaling domains##3##2##(1996-12#1)(2012-2#2)
signaling during##7##2##(2008-4#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-9#1)(2012-2#1)
signaling equilibrium##2##2##(2008-9#2)
signaling event in##3##3##(1992-8#1)(1994-8#1)(2011-1#1)
signaling event##5##2##(1992-8#1)(1994-8#1)(2008-10#1)(2011-1#2)
signaling events activated by##2##4##(1995-2#1)(2008-8#1)
signaling events that##2##3##(2008-1#1)(2011-1#1)
signaling events##23##2##(1991-3#2)(1991-5#1)(1994-12#1)(1995-2#1)(1995-6#1)(2008-1#2)(2008-10#3)(2008-4#3)(2008-6#1)(2008-8#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-2#1)
signaling factors in##2##3##(2008-3#1)(2008-4#1)
signaling for##4##2##(1996-9#1)(2010-11#1)(2010-3#1)(2010-7#1)
signaling function##2##2##(2008-4#1)(2008-8#1)
signaling functions of##2##3##(2011-2#1)(2012-2#1)
signaling functions##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
signaling has been##2##3##(2010-2#1)(2012-1#1)
signaling has##5##2##(2008-5#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-1#1)
signaling in plants##2##3##(2008-8#1)(2011-1#1)
signaling in postsynaptic##2##3##(2008-11#1)(2009-8#1)
signaling in response to##2##4##(2008-9#1)(2011-1#1)
signaling in the##10##3##(2007-12#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-1#1)(2013-1#2)
signaling in these##2##3##(2010-3#2)
signaling in vitro##2##3##(2009-9#1)(2012-2#1)
signaling in β-cells##3##3##(2010-11#3)
signaling in##47##2##(1992-5#2)(1994-8#1)(2007-12#4)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#4)(2010-3#3)(2010-5#1)(2011-1#3)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
signaling induces##2##2##(2007-12#1)(2012-3#1)
signaling is##15##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
signaling leads to##2##3##(2007-12#1)(2013-1#1)
signaling leads##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
signaling may##3##2##(2009-8#1)(2010-3#1)(2012-12#1)
signaling mechanisms that##3##3##(2008-10#2)(2010-11#1)
signaling mechanisms##14##2##(1993-5#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-3#1)(2009-6#2)(2010-11#1)(2012-2#1)
signaling mediated by##2##3##(2007-12#1)(2011-2#1)
signaling molecule##6##2##(1997-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
signaling molecules are##2##3##(1994-12#1)(2013-8#1)
signaling molecules in##3##3##(2009-10#1)(2010-1#1)(2010-7#1)
signaling molecules that##3##3##(2008-1#1)(2009-8#1)(2010-1#1)
signaling molecules##25##2##(1993-3#1)(1994-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
signaling network involved in##2##4##(2010-3#1)(2012-12#1)
signaling network##5##2##(2008-11#1)(2009-8#2)(2010-3#1)(2012-12#1)
signaling networks##5##2##(2008-4#1)(2012-12#1)(2012-2#2)(2013-8#1)
signaling of##11##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-9#1)(2010-5#1)
signaling pathway and the##2##4##(2008-11#1)(2008-8#1)
signaling pathway and##5##3##(1994-11#1)(2008-11#2)(2008-8#1)(2013-1#1)
signaling pathway has been##4##4##(2007-12#1)(2010-3#2)(2012-1#1)
signaling pathway in##7##3##(1994-11#2)(2010-3#1)(2011-2#2)(2012-12#1)(2013-8#1)
signaling pathway is##3##3##(2009-8#1)(2012-2#1)(2013-1#1)
signaling pathway may be##2##4##(2009-6#1)(2013-1#1)
signaling pathway might##2##3##(2008-11#1)(2011-2#1)
signaling pathway of apoptosis##2##4##(2008-11#1)(2009-9#1)
signaling pathway of##5##3##(1992-12#2)(1994-11#1)(2008-11#1)(2009-9#1)
signaling pathway plays an important role in##2##7##(2009-5#1)(2011-2#1)
signaling pathway to##2##3##(1997-1#1)(2009-10#1)
signaling pathway##74##2##(1992-12#2)(1993-3#1)(1994-11#6)(1994-8#3)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#3)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#6)(2010-3#4)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
signaling pathways and##10##3##(1991-9#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
signaling pathways are##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
signaling pathways by##2##3##(2008-9#1)(2009-5#1)
signaling pathways contributes to##2##4##(2009-5#1)(2013-7#1)
signaling pathways have##2##3##(2011-2#1)(2013-8#1)
signaling pathways in the##2##4##(2011-2#2)
signaling pathways in##10##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#4)(2013-1#1)
signaling pathways including##2##3##(1995-2#1)(2013-7#1)
signaling pathways involved##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2012-1#1)
signaling pathways may##2##3##(2008-1#1)(2008-4#1)
signaling pathways of##3##3##(1994-8#1)(2011-2#1)(2013-1#1)
signaling pathways that lead to##2##5##(2008-4#1)(2009-5#1)
signaling pathways that##8##3##(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-3#1)(2013-8#1)
signaling pathways to##2##3##(2009-8#1)(2012-2#1)
signaling pathways##122##2##(1991-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-7#2)(2007-12#1)(2008-1#4)(2008-10#6)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#13)(2008-7#3)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#4)(2009-6#2)(2009-8#7)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
signaling plays a##4##3##(2008-10#1)(2012-12#1)(2013-1#2)
signaling process##2##2##(2008-10#1)(2008-8#1)
signaling processes##2##2##(2008-10#1)(2008-5#1)
signaling promotes##2##2##(2008-11#1)(2011-1#1)
signaling properties of##2##3##(2008-4#1)(2010-3#1)
signaling properties##3##2##(2008-4#1)(2010-3#2)
signaling proteins##2##2##(1991-12#1)(2012-2#1)
signaling system##8##2##(1994-8#1)(2008-10#3)(2008-4#1)(2009-5#2)(2012-12#1)
signaling systems in##2##3##(2009-8#1)(2012-2#1)
signaling systems##6##2##(1996-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
signaling through the##2##3##(2012-2#2)
signaling through##4##2##(2008-11#1)(2010-11#1)(2012-2#2)
signaling to the cytoskeleton##2##4##(2012-12#2)
signaling to the##3##3##(1995-6#1)(2012-12#2)
signaling to##7##2##(1995-6#2)(2009-8#1)(2010-3#1)(2012-12#3)
signaling via##3##2##(2008-1#1)(2009-8#2)
signaling was##2##2##(2008-7#1)(2009-12#1)
signaling were##3##2##(2010-5#1)(2013-8#2)
signaling when##2##2##(2009-9#1)(2010-8#1)
signaling with the##2##3##(2008-7#1)(2013-1#1)
signaling with##4##2##(1993-1#1)(2008-1#1)(2008-7#1)(2013-1#1)
signaling##728##1##(1990-11#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-9#2)(1992-12#2)(1992-5#2)(1992-8#2)(1993-1#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1994-11#6)(1994-12#4)(1994-5#1)(1994-6#2)(1994-8#10)(1994-9#1)(1995-11#1)(1995-2#4)(1995-6#5)(1996-12#4)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#3)(1997-7#4)(2006-10#1)(2007-12#25)(2007-8#1)(2008-1#17)(2008-10#37)(2008-11#39)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#51)(2008-5#9)(2008-6#2)(2008-7#22)(2008-8#32)(2008-9#28)(2009-10#9)(2009-11#2)(2009-12#9)(2009-2#2)(2009-3#14)(2009-4#1)(2009-5#10)(2009-6#18)(2009-7#2)(2009-8#46)(2009-9#15)(2010-1#5)(2010-11#13)(2010-12#10)(2010-2#1)(2010-3#21)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#12)(2011-2#45)(2012-1#8)(2012-12#28)(2012-2#35)(2012-3#9)(2013-1#34)(2013-7#5)(2013-8#15)
signaling)##2##1##(2008-7#1)(2008-8#1)
signallers##2##1##(1995-5#2)
signalling a##2##2##(2008-9#2)
signalling and the##2##3##(2008-7#1)(2012-1#1)
signalling and##7##2##(1993-8#1)(2008-7#2)(2011-2#2)(2012-1#1)(2012-2#1)
signalling by##2##2##(1994-6#1)(2012-12#1)
signalling cascades##3##2##(1996-2#1)(2009-3#1)(2011-2#1)
signalling events##4##2##(1995-8#1)(1997-7#1)(2008-1#1)(2009-6#1)
signalling for##2##2##(1997-3#1)(2011-2#1)
signalling in the##5##3##(1994-2#1)(1994-5#1)(2008-4#2)(2009-9#1)
signalling in##12##2##(1994-2#1)(1994-5#1)(2008-4#4)(2008-7#1)(2009-9#1)(2011-2#2)(2012-2#2)
signalling is##4##2##(1995-5#2)(2008-4#1)(2010-10#1)
signalling molecule##3##2##(2008-4#1)(2010-10#1)(2012-2#1)
signalling molecules##7##2##(1995-8#1)(1996-2#1)(2008-1#1)(2008-7#1)(2010-7#1)(2012-6#2)
signalling networks##2##2##(2008-4#1)(2011-2#1)
signalling pathway and##2##3##(1996-3#1)(2011-10#1)
signalling pathway in##2##3##(1997-2#1)(2009-6#1)
signalling pathway##11##2##(1995-8#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-7#1)(2009-6#1)(2011-10#1)(2011-2#2)
signalling pathways and##2##3##(1997-7#1)(2009-6#1)
signalling pathways are##3##3##(1994-11#1)(1996-2#1)(2009-3#1)
signalling pathways in##2##3##(1993-8#1)(1994-11#1)
signalling pathways##16##2##(1993-8#1)(1994-11#2)(1996-2#4)(1996-5#1)(1997-7#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2013-8#1)
signalling proteins which##2##3##(1996-2#2)
signalling proteins##3##2##(1996-2#2)(2009-7#1)
signalling system##5##2##(1993-3#1)(1994-11#1)(1994-6#1)(1995-8#1)(2010-10#1)
signalling to##4##2##(2009-10#2)(2009-8#1)(2010-11#1)
signalling was studied in##2##4##(2009-9#2)
signalling was##3##2##(2009-9#2)(2013-7#1)
signalling##156##1##(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#4)(1995-11#1)(1995-5#4)(1995-8#7)(1996-2#11)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#11)(2008-7#12)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#2)(2009-9#10)(2010-10#8)(2010-11#1)(2010-7#1)(2011-10#2)(2011-2#12)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#1)(2012-6#2)(2013-7#1)(2013-8#2)
signalling)##3##1##(2008-7#2)(2009-9#1)
signals acquired##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
signals across the##2##3##(2009-8#1)(2012-2#1)
signals after##2##2##(2008-2#2)
signals and a##3##3##(1994-8#1)(2008-3#2)
signals and that##2##3##(1994-12#1)(2008-10#1)
signals and the##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
signals and their##2##3##(2010-4#1)(2012-2#1)
signals and##30##2##(1994-12#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
signals are calculated##3##3##(2008-2#2)(2008-3#1)
signals are consistent with##2##4##(1992-6#1)(2008-3#1)
signals are detected##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
signals are integrated##2##3##(2007-9#1)(2008-3#1)
signals are measured##2##3##(2007-12#1)(2008-10#1)
signals are not##2##3##(2008-11#1)(2008-2#1)
signals are obtained for##2##4##(1990-8#1)(2008-10#1)
signals are used to##2##4##(2008-3#2)
signals are used##3##3##(2008-2#1)(2008-3#2)
signals are##46##2##(1990-11#1)(1990-8#1)(1992-6#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#10)(2008-3#10)(2008-4#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-3#1)
signals arising from##2##3##(1995-11#1)(2008-10#1)
signals as##4##2##(2007-11#1)(2008-3#2)(2012-12#1)
signals at the##3##3##(2008-2#2)(2008-3#1)
signals at##13##2##(1990-8#1)(2007-11#1)(2008-10#4)(2008-2#4)(2008-3#2)(2010-1#1)
signals back to##2##3##(2007-12#1)(2008-11#1)
signals based##2##2##(2008-10#1)(2008-2#1)
signals between##2##2##(1997-6#1)(2012-12#1)
signals but##2##2##(2008-3#1)(2010-6#1)
signals by use of##2##4##(2007-12#1)(2008-2#1)
signals by##12##2##(1992-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(2007-12#3)(2008-2#3)(2008-7#1)(2009-8#1)
signals calculated##2##2##(2008-3#2)
signals can be##8##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-2#1)
signals can##12##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-3#1)(2012-2#1)
signals caused by##3##3##(2008-10#3)
signals characterized at##2##3##(2008-10#2)
signals control##2##2##(1995-6#1)(2008-10#1)
signals derived from##2##3##(1994-12#1)(2007-11#1)
signals detected by##2##3##(2008-10#1)(2008-3#1)
signals detected##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
signals during##3##2##(1995-5#1)(2007-8#1)(2011-2#1)
signals elicited##2##2##(2012-12#1)(2013-8#1)
signals for the##8##3##(1992-12#1)(1993-9#1)(2007-12#2)(2008-10#2)(2008-3#1)(2010-8#1)
signals for##29##2##(1992-12#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
signals from a##9##3##(2008-10#1)(2008-3#8)
signals from clouds##2##3##(2008-10#1)(2008-3#1)
signals from different##3##3##(2007-12#1)(2008-3#2)
signals from multiple##2##3##(2008-3#1)(2009-8#1)
signals from the external##2##4##(1997-2#1)(2008-11#1)
signals from the##16##3##(1994-3#1)(1995-2#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-3#2)(2009-8#1)
signals from##59##2##(1994-3#1)(1995-2#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-10#10)(2008-11#2)(2008-2#6)(2008-3#15)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#5)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-8#1)(2013-1#1)
signals generated by##2##3##(2008-10#1)(2013-1#1)
signals generated##5##2##(2007-12#2)(2008-10#1)(2009-3#1)(2013-1#1)
signals have a##2##3##(2008-3#1)(2010-7#1)
signals have been##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
signals have##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
signals in a##5##3##(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
signals in real time##2##4##(2008-3#1)(2012-3#1)
signals in the##15##3##(1992-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
signals in these##2##3##(2008-11#1)(2011-2#1)
signals in wavelength-modulation spectrometry##2##4##(2008-3#2)
signals in##47##2##(1992-3#1)(1992-6#1)(1993-5#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
signals induced by##3##3##(1994-6#2)(1997-7#1)
signals into##3##2##(1994-11#1)(2009-10#1)(2010-4#1)
signals is described##2##3##(2008-2#1)(2008-3#1)
signals is##18##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#5)(2008-9#1)(2009-8#1)(2011-1#1)
signals may##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
signals obtained from##3##3##(2008-10#2)(2008-3#1)
signals obtained in##2##3##(2008-3#1)(2008-4#1)
signals obtained##8##2##(2008-10#5)(2008-3#2)(2008-4#1)
signals of LHR mRNA##2##4##(2008-8#2)
signals of previously unrecognised adverse##2##5##(2008-8#2)
signals of rare##2##3##(2008-10#1)(2012-3#1)
signals of the##12##3##(1993-2#1)(1994-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2010-8#3)
signals of two##2##3##(2007-12#1)(2008-3#1)
signals of##51##2##(1993-2#1)(1994-12#1)(1994-5#1)(2007-12#2)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#8)(2008-8#10)(2008-9#4)(2009-8#1)(2010-8#3)(2012-3#1)
signals on the##3##3##(1996-4#1)(2008-2#1)(2013-1#1)
signals on##8##2##(1996-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
signals provided by##2##3##(2007-8#1)(2008-3#1)
signals received at##2##3##(2007-12#1)(2008-3#1)
signals received##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
signals should be##2##3##(2008-10#1)(2008-8#1)
signals such as##4##3##(1990-3#1)(1995-8#1)(2010-3#1)(2013-7#1)
signals such##5##2##(1990-3#1)(1995-8#1)(2007-11#1)(2010-3#1)(2013-7#1)
signals that are##8##3##(1990-5#1)(1995-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-8#1)
signals that control##2##3##(2008-10#1)(2008-5#1)
signals that drive##2##3##(2008-9#1)(2009-3#1)
signals that##23##2##(1990-5#1)(1991-5#1)(1995-5#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-8#1)
signals the##2##2##(2008-9#1)(2011-2#1)
signals through a##2##3##(1995-2#1)(2008-3#1)
signals through##7##2##(1995-11#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
signals to the##9##3##(1994-11#1)(1994-8#1)(1997-6#3)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
signals to##25##2##(1994-11#1)(1994-8#1)(1995-5#1)(1997-6#3)(2007-11#1)(2007-12#2)(2008-11#2)(2008-3#5)(2008-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
signals using##3##2##(2007-10#1)(2008-10#1)(2008-2#1)
signals was##2##2##(2008-10#1)(2008-3#1)
signals were detected##4##3##(2008-5#1)(2008-8#3)
signals were found##2##3##(1991-12#1)(2007-12#1)
signals were observed in the##2##5##(2008-10#2)
signals were observed in##4##4##(2008-10#3)(2010-8#1)
signals were observed##5##3##(2008-10#3)(2008-11#1)(2010-8#1)
signals were obtained for##2##4##(1996-12#1)(2008-10#1)
signals were obtained##3##3##(1996-12#1)(2008-10#2)
signals were recorded##2##3##(2008-11#1)(2012-2#1)
signals were##34##2##(1991-12#1)(1996-12#2)(2007-12#1)(2008-10#20)(2008-11#2)(2008-5#1)(2008-8#3)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
signals when##5##2##(1991-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-7#1)
signals which##4##2##(1990-7#1)(1994-8#1)(2009-8#1)(2010-5#1)
signals with a##2##3##(2007-12#1)(2008-3#1)
signals with the##2##3##(2008-10#2)
signals with##10##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)
signals within##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
signals##856##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-6#8)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#5)(1994-12#6)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#7)(1995-11#2)(1995-12#3)(1995-2#5)(1995-5#5)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#4)(1997-7#3)(2006-12#1)(2007-10#2)(2007-11#23)(2007-12#46)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#174)(2008-11#38)(2008-12#2)(2008-2#67)(2008-3#147)(2008-4#14)(2008-5#8)(2008-7#13)(2008-8#33)(2008-9#24)(2009-10#3)(2009-12#2)(2009-3#9)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#20)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#1)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#19)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#9)(2012-2#12)(2012-3#8)(2012-9#1)(2013-1#7)(2013-7#6)(2013-8#7)
signature chemicals##5##2##(2008-10#5)
signature for##3##2##(1992-8#1)(2007-11#1)(2008-4#1)
signature of the##2##3##(2008-3#2)
signature of##8##2##(2007-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-1#1)(2011-1#1)(2011-2#1)
signature patterns##3##2##(2008-10#1)(2008-2#2)
signature that##2##2##(2010-3#2)
signature to##2##2##(2008-3#1)(2013-8#1)
signature##47##1##(1990-12#1)(1992-8#1)(1994-12#1)(2007-11#3)(2007-12#1)(2008-10#8)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#4)
signatures as##2##2##(2009-6#1)(2010-11#1)
signatures associated with##2##3##(2008-7#1)(2010-4#1)
signatures for##3##2##(2010-3#1)(2012-1#1)(2013-8#1)
signatures from##4##2##(1997-2#1)(2007-11#1)(2008-10#1)(2010-11#1)
signatures in##2##2##(2008-3#1)(2010-8#1)
signatures is##2##2##(2008-4#1)(2009-6#1)
signatures of the##3##3##(2008-3#1)(2012-2#1)(2012-3#1)
signatures of##8##2##(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
signatures to##3##2##(2009-6#1)(2012-2#1)(2013-8#1)
signatures were##2##2##(2008-10#1)(2008-3#1)
signatures with##2##2##(2008-7#1)(2013-8#1)
signatures##51##1##(1995-9#1)(1997-2#1)(1997-5#3)(2007-11#3)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#6)(2009-3#2)(2009-4#2)(2009-6#4)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
signed into law##6##3##(1991-12#2)(1991-3#1)(1993-1#1)(1994-3#1)(1996-5#1)
signed ranks##2##2##(2008-10#1)(2008-3#1)
signed the##4##2##(1994-1#1)(1996-1#1)(1996-5#1)(2009-4#1)
signed##24##1##(1991-12#2)(1991-3#1)(1991-6#1)(1993-1#1)(1994-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-5#2)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-6#1)(2010-8#1)
signed-digit##6##1##(2008-2#2)(2008-3#4)
signers##2##1##(2010-5#2)
signes##2##1##(2009-4#1)(2011-2#1)
signet ring cell##3##3##(1993-12#3)
signet ring##4##2##(1993-12#3)(2006-8#1)
significance (P &lt##2##3##(2008-10#1)(2012-3#1)
significance (P = 0##2##4##(1992-11#1)(2011-2#1)
significance (P##4##2##(1992-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
significance (p =##2##3##(2008-11#1)(2008-5#1)
significance (p##3##2##(1990-9#1)(2008-11#1)(2008-5#1)
significance and##15##2##(1991-2#1)(1995-8#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-7#1)(2012-1#1)(2013-2#1)
significance as a##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
significance as it##3##3##(2008-3#1)(2013-1#2)
significance as risk##2##3##(1996-8#1)(2008-4#1)
significance as##9##2##(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2012-3#1)(2013-1#2)
significance at##3##2##(1993-9#1)(1995-8#2)
significance because##2##2##(2008-7#1)(2011-2#1)
significance between##5##2##(1990-12#1)(1993-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
significance by##2##2##(1996-5#1)(2009-2#1)
significance for the##7##3##(1990-11#1)(1990-3#1)(1990-9#1)(1995-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
significance for understanding the##2##4##(1992-11#1)(2008-10#1)
significance for##24##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-9#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
significance in the##3##3##(1993-2#1)(2007-11#1)(2008-10#1)
significance in##17##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-8#1)(1993-2#1)(1994-8#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
significance is##5##2##(1994-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-5#1)
significance level of##2##3##(2007-11#1)(2008-10#1)
significance level##9##2##(1997-3#1)(2007-11#1)(2008-10#3)(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
significance of cathepsin-D expression##3##4##(1993-9#3)
significance of differences between##2##4##(2007-10#1)(2008-10#1)
significance of differences##4##3##(2007-10#2)(2008-10#1)(2008-7#1)
significance of difficulties in mobility##2##5##(2008-7#2)
significance of each##2##3##(2008-10#1)(2010-6#1)
significance of flow##2##3##(1993-1#2)
significance of positive##3##3##(1992-11#1)(2011-1#1)(2011-2#1)
significance of several##2##3##(2008-10#1)(2011-2#1)
significance of such##3##3##(1994-3#1)(1994-8#1)(2011-2#1)
significance of the proposed##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
significance of the##50##3##(1991-2#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
significance of their##2##3##(1996-2#1)(2007-11#1)
significance of these results##3##4##(1996-2#1)(2008-10#2)
significance of these##15##3##(1993-11#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)
significance of this##19##3##(1990-11#1)(1990-12#1)(1990-5#1)(1993-1#1)(1993-12#2)(1993-6#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)
significance of various##2##3##(2006-10#1)(2010-3#1)
significance of which##2##3##(2007-11#1)(2011-2#1)
significance of##254##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-5#2)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#25)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#15)(2008-8#4)(2008-9#7)(2009-1#3)(2009-10#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#12)(2013-8#5)
significance should not be##2##4##(1997-4#1)(2010-6#1)
significance tests##3##2##(1994-11#1)(1997-4#1)(2008-10#1)
significance threshold##2##2##(2008-10#1)(2012-2#1)
significance to##10##2##(1992-2#1)(1996-5#1)(2008-10#3)(2008-7#1)(2008-8#2)(2010-12#1)(2012-2#1)
significance was##11##2##(1993-11#1)(1993-3#1)(1994-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
significance##517##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#5)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-11#4)(1992-2#1)(1992-5#2)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#2)(1993-9#5)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#4)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2006-10#1)(2006-12#2)(2007-10#4)(2007-11#8)(2007-12#10)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#56)(2008-11#18)(2008-12#10)(2008-2#4)(2008-3#9)(2008-4#10)(2008-5#11)(2008-6#7)(2008-7#23)(2008-8#11)(2008-9#12)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#10)(2012-2#14)(2012-3#13)(2013-1#24)(2013-2#1)(2013-7#1)(2013-8#11)
significances of##3##2##(1992-8#1)(2008-10#1)(2012-2#1)
significant (&gt##2##2##(2007-10#2)
significant (1##2##2##(1990-3#1)(2008-8#1)
significant (P &lt##32##3##(1993-12#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#2)(2008-10#16)(2008-5#1)(2008-7#2)(2009-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)
significant (P = 0##11##4##(2008-10#10)(2008-8#1)
significant (P less than 0##4##5##(1990-3#1)(1991-5#1)(1992-3#1)(1992-8#1)
significant (P##48##2##(1990-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#2)(2008-10#27)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)
significant (P&gt##5##2##(2008-7#1)(2009-3#2)(2013-1#2)
significant (P&lt##10##2##(1997-6#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#4)(2011-1#1)
significant (chi2 =##2##3##(2008-12#1)(2009-6#1)
significant (p &gt##3##3##(2008-12#3)
significant (p &lt##15##3##(1993-9#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-12#3)(2008-4#2)(2008-6#1)(2010-7#1)(2011-2#2)(2012-2#1)
significant (p = 0##5##4##(1993-1#1)(1997-6#1)(2008-1#1)(2013-1#2)
significant (p =##6##3##(1993-1#1)(1997-6#1)(2008-1#1)(2010-10#1)(2013-1#2)
significant (p less than 0##3##5##(1990-12#1)(1991-11#1)(1992-8#1)
significant (p##29##2##(1990-12#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-9#2)(1995-12#1)(1996-8#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#6)(2008-4#2)(2008-6#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
significant (p&gt##3##2##(2008-12#1)(2008-5#1)(2010-7#1)
significant (p&lt##9##2##(2007-7#1)(2008-12#3)(2010-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
significant ability to##2##3##(2008-9#1)(2012-3#1)
significant accumulation of##3##3##(1991-5#1)(1997-1#1)(2008-4#1)
significant accumulation##5##2##(1991-5#1)(1997-1#1)(2008-3#1)(2008-4#1)(2012-2#1)
significant activating##2##2##(1995-6#1)(2008-10#1)
significant activation##3##2##(2008-2#1)(2008-7#2)
significant activity in##3##3##(2008-5#1)(2009-3#1)(2010-11#1)
significant activity##5##2##(1994-5#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-11#1)
significant additional##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
significant additive##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
significant advance in##3##3##(1997-7#1)(2007-9#1)(2011-2#1)
significant advancement in the##2##4##(2008-10#1)(2009-5#1)
significant advancement in##3##3##(2008-10#1)(2009-5#1)(2010-11#1)
significant advances have been made in##3##6##(1992-12#1)(2008-11#1)(2008-8#1)
significant advances in our##2##4##(2009-3#1)(2013-7#1)
significant advances in the understanding of the##2##7##(2008-9#1)(2009-3#1)
significant advances in the##5##4##(1990-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-3#1)
significant advances in understanding the pathophysiology of##2##7##(2008-1#1)(2011-1#1)
significant advances in##15##3##(1990-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#1)(2013-7#1)
significant advances##19##2##(1990-11#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#1)(2013-7#1)
significant advantage for##2##3##(2007-12#1)(2008-6#1)
significant advantage in the##2##4##(2008-3#1)(2010-9#1)
significant advantage in##3##3##(2007-11#1)(2008-3#1)(2010-9#1)
significant advantage over##5##3##(2007-11#1)(2008-10#2)(2008-9#1)(2010-8#1)
significant advantage##15##2##(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-8#1)(2010-9#1)
significant advantages of##3##3##(2007-12#1)(2008-10#2)
significant advantages over##4##3##(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#1)
significant advantages##10##2##(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#1)
significant adverse effect##2##3##(2008-4#1)(2011-2#1)
significant adverse effects##2##3##(2008-10#1)(2008-12#1)
significant adverse##5##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
significant after adjusting for##2##4##(2012-5#2)
significant after##3##2##(1992-12#1)(2012-5#2)
significant age-dependent##2##2##(1995-8#1)(1996-5#1)
significant age-related##2##2##(1996-5#1)(2008-7#1)
significant alteration of##2##3##(1991-4#1)(1995-2#1)
significant alteration##4##2##(1991-4#1)(1995-2#1)(2007-7#1)(2008-11#1)
significant alterations in the##2##4##(1991-4#1)(1994-3#1)
significant alterations in##3##3##(1991-4#1)(1994-3#1)(1996-12#1)
significant alterations##5##2##(1991-4#1)(1994-3#1)(1996-12#1)(2008-5#1)(2013-1#1)
significant amino acid##2##3##(2008-10#2)
significant among##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
significant amount of the##2##4##(2008-10#1)(2008-9#1)
significant amount of##16##3##(1991-2#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
significant amounts of##16##3##(1990-5#1)(1992-12#2)(1993-11#1)(1994-6#1)(1995-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-8#1)
significant amounts##18##2##(1990-11#1)(1990-5#1)(1992-12#2)(1993-11#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-8#1)
significant and comparable##2##3##(1995-3#1)(2013-1#1)
significant and insignificant##3##3##(2008-10#3)
significant and##40##2##(1990-5#1)(1990-7#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
significant antagonistic effect##2##3##(2008-10#1)(2008-7#1)
significant antibacterial##2##2##(2008-12#1)(2012-3#1)
significant antioxidant activity##2##3##(2008-10#1)(2012-2#1)
significant antitumor##2##2##(1994-5#1)(2011-1#1)
significant areas##2##2##(2008-1#1)(2008-12#1)
significant as##3##2##(2008-10#2)(2008-3#1)
significant association between the##3##4##(2011-2#2)(2013-8#1)
significant association between##21##3##(1994-7#1)(1996-12#1)(2007-10#1)(2008-1#2)(2008-10#3)(2008-5#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#6)(2012-12#1)(2013-8#1)
significant association of##5##3##(1990-6#1)(2008-10#2)(2008-7#1)(2012-2#1)
significant association was found between##2##5##(2011-2#2)
significant association was##4##3##(1991-6#1)(2011-1#1)(2011-2#2)
significant association with##14##3##(1992-2#1)(1992-3#1)(1994-12#1)(1995-8#2)(1997-4#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-5#1)(2010-2#1)(2010-6#1)(2012-2#1)
significant association##47##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-7#1)(1995-8#2)(1996-12#1)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2013-8#1)
significant associations between##9##3##(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
significant associations were found between##2##5##(2010-2#1)(2012-5#1)
significant associations were found with##2##5##(1993-9#1)(2009-5#1)
significant associations were found##4##4##(1993-9#1)(2009-5#1)(2010-2#1)(2012-5#1)
significant associations were##5##3##(1993-9#1)(2009-5#1)(2010-2#1)(2012-5#1)(2013-8#1)
significant associations##17##2##(1993-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
significant at P&lt##2##3##(2008-12#1)(2008-7#1)
significant at the##3##3##(1995-5#1)(2008-6#1)(2010-8#1)
significant at##14##2##(1993-12#1)(1993-9#1)(1995-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#3)
significant atrial##2##2##(1996-6#1)(2012-12#1)
significant attention##4##2##(2009-7#1)(2010-3#1)(2011-2#2)
significant attenuation of##2##3##(2008-4#1)(2011-2#1)
significant attenuation##3##2##(2007-10#1)(2008-4#1)(2011-2#1)
significant background##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
significant barriers to##2##3##(1995-12#1)(1997-1#1)
significant barriers##4##2##(1995-12#2)(1997-1#1)(2008-11#1)
significant because##3##2##(2008-11#1)(2009-10#1)(2010-7#1)
significant behavioral##2##2##(2009-12#1)(2013-8#1)
significant beneficial##2##2##(1991-2#1)(2008-7#1)
significant benefit##4##2##(1991-2#1)(2007-11#1)(2008-1#1)(2008-6#1)
significant benefits from##2##3##(2008-7#1)(2010-8#1)
significant benefits##5##2##(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-3#1)
significant better##2##2##(1990-6#1)(2011-2#1)
significant between the##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
significant between##5##2##(2007-8#1)(2008-10#1)(2011-2#3)
significant between-group##2##2##(2011-2#1)(2013-1#1)
significant bias##2##2##(2008-10#2)
significant biases##2##2##(2008-10#1)(2008-3#1)
significant binding##3##2##(1992-8#1)(1994-6#1)(2009-7#1)
significant body of##2##3##(2008-8#1)(2009-6#1)
significant body##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)
significant bone##2##2##(2007-8#1)(2011-2#1)
significant both in##2##3##(2007-2#1)(2008-10#1)
significant broadening##2##2##(2007-11#1)(2008-10#1)
significant burden of##2##3##(2007-2#1)(2011-1#1)
significant but##9##2##(1993-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
significant by##3##2##(1995-12#1)(2008-9#1)(2012-2#1)
significant carotid##3##2##(2007-8#2)(2008-3#1)
significant cause of##9##3##(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#2)
significant cell loss##2##3##(2008-7#1)(2010-11#1)
significant cell##5##2##(1993-8#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
significant challenge##5##2##(1994-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
significant challenges in##4##3##(1992-1#1)(2007-12#1)(2008-7#1)(2010-12#1)
significant challenges to##2##3##(2008-5#1)(2009-12#1)
significant challenges##13##2##(1992-1#1)(1995-12#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
significant change between##2##3##(2008-7#1)(2013-1#1)
significant change in plasma##2##4##(2008-6#1)(2009-5#1)
significant change in relative##2##4##(2008-3#1)(2011-2#1)
significant change in the##17##4##(1990-3#1)(1991-2#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#2)
significant change in##46##3##(1990-3#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#5)(2013-1#4)(2013-8#1)
significant change of##2##3##(1996-12#1)(2010-5#1)
significant change was observed in the##2##6##(2010-5#1)(2011-1#1)
significant change was observed in##4##5##(1993-12#1)(2007-10#1)(2010-5#1)(2011-1#1)
significant change was##5##3##(1991-1#1)(1993-12#1)(2007-10#1)(2010-5#1)(2011-1#1)
significant change##60##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-9#1)(1993-12#2)(1993-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#3)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#6)(2013-8#1)
significant changes are##2##3##(2008-10#1)(2008-5#1)
significant changes between##2##3##(2008-10#1)(2012-2#1)
significant changes from baseline##2##4##(1993-1#1)(2011-2#1)
significant changes in the##15##4##(1990-7#1)(1992-6#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)
significant changes in##62##3##(1990-7#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)
significant changes occurred in the##2##5##(1992-12#1)(2008-11#1)
significant changes occurred in##3##4##(1992-12#1)(1993-12#1)(2008-11#1)
significant changes of the##2##4##(2008-10#1)(2012-2#1)
significant changes of##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
significant changes were found##4##4##(2009-8#1)(2012-3#2)(2013-1#1)
significant changes were observed in##2##5##(1995-3#1)(1996-2#1)
significant changes were##13##3##(1991-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#2)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
significant changes with##2##3##(2008-7#1)(2009-8#1)
significant changes##95##2##(1990-7#1)(1991-1#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#1)
significant clinical benefits##2##3##(2007-11#1)(2008-7#1)
significant clinical##13##2##(1994-1#1)(1994-2#1)(1995-3#1)(2007-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)
significant commercial##3##2##(2008-4#2)(2008-5#1)
significant complication of##2##3##(2011-2#2)
significant complication##5##2##(2008-6#1)(2011-2#3)(2013-1#1)
significant complications##5##2##(1993-1#1)(2007-7#1)(2008-7#1)(2008-9#1)(2013-1#1)
significant components##2##2##(1995-5#1)(2013-1#1)
significant computation##2##2##(2007-11#1)(2008-2#1)
significant concentration##2##2##(2008-10#2)
significant concentration-dependent##2##2##(1992-2#1)(2008-7#1)
significant consequences of##2##3##(1991-12#1)(1996-2#1)
significant consequences##3##2##(1991-12#1)(1996-2#1)(2013-1#1)
significant contrast##2##2##(2011-1#1)(2012-2#1)
significant contribution of##3##3##(1993-11#1)(1997-5#1)(2009-9#1)
significant contribution to the global##2##5##(2011-2#2)
significant contribution to the##5##4##(1993-11#1)(2011-2#2)(2013-1#2)
significant contribution to##11##3##(1992-12#1)(1993-11#1)(1994-12#1)(2007-11#1)(2008-11#2)(2011-1#1)(2011-2#2)(2013-1#2)
significant contribution##16##2##(1992-12#1)(1993-11#2)(1994-12#1)(1997-5#1)(2007-11#1)(2008-11#2)(2009-9#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
significant contributions##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
significant contributor##2##2##(2008-10#1)(2011-3#1)
significant coronary artery##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
significant correlation (r = 0##3##5##(2008-10#1)(2008-8#1)(2010-2#1)
significant correlation between a##2##4##(2007-10#1)(2007-2#1)
significant correlation between genetic and geographic##2##6##(2008-10#2)
significant correlation between serum##2##4##(1991-5#1)(2013-7#1)
significant correlation between the##12##4##(1992-11#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#2)(2010-3#1)(2011-2#1)(2013-1#2)
significant correlation between##49##3##(1990-5#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#3)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
significant correlation existed between##2##4##(1993-12#1)(2008-12#1)
significant correlation of##7##3##(1996-7#1)(1997-7#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
significant correlation was found between##6##5##(1995-5#1)(2008-10#2)(2008-3#1)(2010-4#1)(2013-1#1)
significant correlation was found##7##4##(1995-5#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
significant correlation was observed between##3##5##(1991-6#1)(2008-10#1)(2008-5#1)
significant correlation was observed##4##4##(1991-6#1)(1995-6#1)(2008-10#1)(2008-5#1)
significant correlation was##14##3##(1990-5#1)(1991-6#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
significant correlation with the##2##4##(2006-6#1)(2010-8#1)
significant correlation with##8##3##(1991-12#1)(1994-9#1)(2006-6#1)(2006-8#1)(2008-8#1)(2010-10#1)(2010-8#1)(2013-1#1)
significant correlation##89##2##(1990-5#2)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#16)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#9)(2013-7#1)(2013-8#1)
significant correlations (p &lt##2##4##(2010-10#1)(2013-1#1)
significant correlations among##2##3##(2008-8#1)(2009-11#1)
significant correlations between the##5##4##(1992-2#1)(2008-10#1)(2011-2#2)(2012-12#1)
significant correlations between##14##3##(1992-2#1)(1994-2#1)(2007-10#1)(2007-2#2)(2008-10#2)(2008-7#1)(2011-2#4)(2012-12#1)(2013-1#1)
significant correlations in##2##3##(2008-8#1)(2013-8#1)
significant correlations of##2##3##(1992-6#1)(1997-7#1)
significant correlations were found between##2##5##(1995-12#1)(2011-1#1)
significant correlations were##3##3##(1995-12#1)(2008-8#1)(2011-1#1)
significant correlations with the##2##4##(2008-11#1)(2012-1#1)
significant correlations with##4##3##(2008-11#1)(2012-1#1)(2012-12#1)(2013-7#1)
significant correlations##30##2##(1992-2#1)(1992-6#1)(1994-2#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2009-11#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
significant cost savings##2##3##(1992-2#1)(1995-12#1)
significant cost##3##2##(1992-2#1)(1995-12#1)(2008-7#1)
significant covariate##2##2##(1994-2#1)(2012-12#1)
significant covariates##2##2##(2008-10#1)(2013-1#1)
significant cytotoxicity against##3##3##(2008-7#2)(2013-1#1)
significant cytotoxicity##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
significant damage to##2##3##(2008-10#2)
significant decline in##2##3##(1995-12#1)(2008-7#1)
significant decline##3##2##(1995-12#1)(2008-7#1)(2011-1#1)
significant decrease in the##17##4##(1990-7#1)(1993-12#2)(1994-6#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
significant decrease in total##3##4##(1992-2#1)(1993-6#1)(2008-12#1)
significant decrease in##71##3##(1990-7#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-3#2)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(2007-7#2)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#6)(2008-3#1)(2008-5#3)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
significant decrease of##14##3##(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
significant decrease##98##2##(1990-7#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-4#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#6)
significant decreases in the##3##4##(1993-6#1)(1994-2#1)(1996-12#1)
significant decreases in##12##3##(1993-6#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-5#3)(2010-12#1)(2010-6#1)
significant decreases##14##2##(1993-6#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-5#4)(2010-12#1)(2010-6#1)(2011-2#1)
significant decreasing##2##2##(2008-10#1)(2012-12#1)
significant deficiencies in##2##3##(2008-10#1)(2008-3#1)
significant degree##5##2##(1990-5#1)(1994-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
significant delays##2##2##(2007-12#1)(2008-10#1)
significant deleterious##2##2##(2010-3#1)(2011-2#1)
significant dependence on##2##3##(2008-10#1)(2010-4#1)
significant depressive symptoms##2##3##(2013-1#1)(2013-8#1)
significant destruction of##2##3##(1990-11#1)(2008-8#1)
significant deterioration##2##2##(1997-8#1)(2008-7#1)
significant development##2##2##(1993-11#1)(2013-1#1)
significant deviation from##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
significant deviation##5##2##(1996-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
significant diagnostic##2##2##(2007-8#1)(2008-10#1)
significant difference (P &lt##4##4##(2011-1#1)(2013-1#3)
significant difference (P = 0##2##5##(2008-10#1)(2013-1#1)
significant difference (P##7##3##(2008-10#1)(2011-1#2)(2013-1#4)
significant difference (P&gt##2##3##(2007-10#1)(2012-2#1)
significant difference (p &lt##3##4##(2008-5#2)(2013-1#1)
significant difference (p##6##3##(2007-2#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
significant difference (p&gt##3##3##(2008-5#1)(2013-1#2)
significant difference among the##4##4##(1994-3#1)(2007-11#1)(2008-10#2)
significant difference among##6##3##(1994-3#1)(2007-11#1)(2008-10#3)(2013-1#1)
significant difference at 95% confidence level was observed##2##8##(2008-10#2)
significant difference at 95% confidence level##4##6##(2008-10#4)
significant difference at the 95% confidence level was observed##3##9##(2008-10#3)
significant difference at##8##3##(2008-10#8)
significant difference between groups regarding##2##5##(2008-12#1)(2013-1#1)
significant difference between patients and##2##5##(1995-5#1)(2013-8#1)
significant difference between patients##3##4##(1995-5#1)(2011-2#1)(2013-8#1)
significant difference between the groups##2##5##(2008-7#1)(2012-3#1)
significant difference between the two groups##5##6##(2007-7#1)(2007-9#1)(2008-12#1)(2010-8#1)(2011-1#1)
significant difference between the two##10##5##(2007-7#1)(2007-9#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)
significant difference between the##40##4##(1991-9#1)(1992-11#1)(1992-2#1)(1993-8#1)(1997-8#2)(1997-9#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#5)(2008-12#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-7#1)(2009-8#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-8#1)
significant difference between##79##3##(1991-11#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-5#1)(1995-8#1)(1997-8#2)(1997-9#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#10)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
significant difference for##6##3##(2008-10#2)(2008-12#1)(2009-7#1)(2011-1#1)(2011-2#1)
significant difference in both##2##4##(2007-8#1)(2013-7#1)
significant difference in the characteristics##2##5##(1996-7#1)(2007-11#1)
significant difference in the prevalence of##2##6##(2008-1#1)(2008-7#1)
significant difference in the##47##4##(1990-7#1)(1991-12#1)(1991-2#2)(1991-8#2)(1991-9#1)(1994-2#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
significant difference in their##2##4##(1996-6#1)(2009-7#1)
significant difference in##120##3##(1990-10#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1995-4#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#4)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#2)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
significant difference observed##3##3##(2008-12#1)(2013-1#2)
significant difference of the##2##4##(2008-10#1)(2008-9#1)
significant difference of##5##3##(1996-7#1)(2008-10#1)(2008-9#1)(2011-2#2)
significant difference only##2##3##(2008-4#1)(2011-1#1)
significant difference to the##2##4##(2008-10#1)(2011-1#1)
significant difference was detected##2##4##(2008-11#1)(2008-7#1)
significant difference was found among##2##5##(2008-7#1)(2013-1#1)
significant difference was found between the##4##6##(1993-2#1)(2008-12#1)(2010-12#1)(2011-2#1)
significant difference was found between##9##5##(1990-3#1)(1990-8#1)(1993-2#1)(2008-10#2)(2008-12#1)(2010-12#1)(2011-2#2)
significant difference was found in the##2##6##(1994-7#1)(2008-10#1)
significant difference was found in##3##5##(1994-7#1)(2008-10#1)(2008-11#1)
significant difference was found##19##4##(1990-3#1)(1990-8#1)(1993-2#1)(1994-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
significant difference was observed in##2##5##(1996-9#1)(2009-11#1)
significant difference was observed##6##4##(1993-1#1)(1993-11#1)(1996-12#1)(1996-9#1)(2009-11#1)(2013-1#1)
significant difference was##30##3##(1990-3#1)(1990-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-7#1)(1996-12#2)(1996-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-8#1)
significant difference##300##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-8#6)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-8#3)(1997-9#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#44)(2008-11#8)(2008-12#12)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#12)(2011-2#25)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#7)(2012-6#1)(2012-7#1)(2013-1#24)(2013-7#3)(2013-8#8)
significant differences (P &lt##2##4##(2008-5#2)
significant differences (P##3##3##(1995-12#1)(2008-5#2)
significant differences (P&lt##2##3##(2008-10#1)(2010-3#1)
significant differences (p &lt##2##4##(2008-5#1)(2011-2#1)
significant differences (p##3##3##(2008-5#2)(2011-2#1)
significant differences (p&lt##2##3##(2008-12#1)(2013-7#1)
significant differences among the three groups##2##6##(2008-9#1)(2013-8#1)
significant differences among##14##3##(1993-2#1)(2008-10#6)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
significant differences are observed##2##4##(2008-10#1)(2008-3#1)
significant differences as##2##3##(2007-10#1)(2010-12#1)
significant differences between all##2##4##(1992-9#1)(2008-10#1)
significant differences between groups##7##4##(1994-5#1)(2011-2#1)(2013-1#4)(2013-8#1)
significant differences between men and women##2##6##(1993-2#2)
significant differences between patients and##2##5##(1995-2#1)(1997-5#1)
significant differences between the groups##3##5##(1995-1#1)(2008-6#1)(2009-12#1)
significant differences between the proposed##2##5##(2008-10#2)
significant differences between the two groups##6##6##(1995-4#1)(2007-9#1)(2008-9#1)(2012-12#1)(2013-1#2)
significant differences between the two##11##5##(1991-3#1)(1993-8#1)(1995-4#1)(1995-8#1)(2007-2#1)(2007-9#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
significant differences between the##32##4##(1991-3#1)(1991-9#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
significant differences between##75##3##(1990-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-8#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#1)
significant differences by##2##3##(1993-11#1)(2011-2#1)
significant differences exist##2##3##(1996-2#1)(1997-4#1)
significant differences for##5##3##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#2)
significant differences found among the 9 fish species##2##8##(2008-12#2)
significant differences found##3##3##(2007-6#1)(2008-12#2)
significant differences from##2##3##(1991-8#1)(2008-7#1)
significant differences in age##2##4##(2012-5#1)(2013-1#1)
significant differences in allele frequencies##2##5##(2008-10#2)
significant differences in allele##3##4##(2008-10#2)(2008-12#1)
significant differences in diagnostic##2##4##(1991-8#1)(2012-2#1)
significant differences in terms of##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
significant differences in the frequency of##4##6##(1991-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
significant differences in the size##2##5##(1991-12#1)(2010-9#1)
significant differences in the##36##4##(1990-7#1)(1991-12#1)(1991-4#1)(1991-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-9#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
significant differences in##124##3##(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-7#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#3)(2008-12#7)(2008-5#3)(2008-7#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#4)
significant differences of##2##3##(2008-6#1)(2008-7#1)
significant differences were also##2##4##(2008-2#1)(2010-1#1)
significant differences were found among##4##5##(1993-2#1)(1997-4#1)(2008-10#1)(2012-3#1)
significant differences were found between the##3##6##(1992-3#1)(1993-2#1)(2008-10#1)
significant differences were found between##11##5##(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-3#1)(2013-1#1)
significant differences were found in the##2##6##(1995-5#1)(2008-10#1)
significant differences were found in##9##5##(1992-12#1)(1995-5#1)(1997-3#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)
significant differences were found##27##4##(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-9#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
significant differences were noted in##2##5##(1996-7#1)(2013-1#1)
significant differences were noted##3##4##(1994-1#1)(1996-7#1)(2013-1#1)
significant differences were observed between the##2##6##(2008-10#1)(2011-2#1)
significant differences were observed between##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
significant differences were observed in the##2##6##(1995-11#1)(2012-3#1)
significant differences were observed in##5##5##(1992-3#1)(1995-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
significant differences were observed##13##4##(1992-3#1)(1995-11#1)(2008-10#6)(2008-5#3)(2011-2#1)(2012-3#1)
significant differences were seen in##6##5##(1997-6#1)(2007-11#1)(2008-12#1)(2008-5#2)(2013-1#1)
significant differences were seen##7##4##(1997-6#1)(2007-11#1)(2008-12#1)(2008-5#3)(2013-1#1)
significant differences were##60##3##(1990-5#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-5#8)(2008-7#1)(2008-8#2)(2010-1#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#4)(2013-7#1)
significant differences when##2##3##(2008-8#1)(2013-1#1)
significant differences with respect to##2##5##(1995-12#1)(2008-12#1)
significant differences with##3##3##(1994-3#1)(1995-12#1)(2008-12#1)
significant differences##352##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#6)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-7#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#64)(2008-11#5)(2008-12#17)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#23)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#16)(2011-3#2)(2012-12#3)(2012-2#10)(2012-3#10)(2012-5#1)(2013-1#29)(2013-7#6)(2013-8#8)
significant different##6##2##(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
significant differential##2##2##(1997-7#1)(2009-6#1)
significant difficulties in##2##3##(2008-11#1)(2013-1#1)
significant digenic##2##2##(2008-10#1)(2008-4#1)
significant direct correlation##2##3##(2008-7#2)
significant disagreement##2##2##(2008-10#1)(2008-6#1)
significant discrepancy between##2##3##(2008-1#1)(2008-3#1)
significant discrepancy##3##2##(1994-2#1)(2008-1#1)(2008-3#1)
significant disease control##2##3##(2008-10#2)
significant disease in##2##3##(1996-6#1)(2013-1#1)
significant disease##9##2##(1996-6#1)(2007-2#1)(2008-10#5)(2011-2#1)(2013-1#1)
significant distortions##2##2##(2008-7#1)(2011-1#1)
significant diversity##2##2##(2008-10#1)(2010-12#1)
significant dose##2##2##(1992-5#1)(2007-7#1)
significant down-regulation of##3##3##(1992-6#1)(1994-11#1)(2013-1#1)
significant drug##2##2##(2008-3#2)
significant dynamic##2##2##(2008-3#1)(2008-7#1)
significant early##2##2##(2007-10#1)(2010-4#1)
significant ecological##2##2##(2008-8#1)(2008-9#1)
significant economic losses##4##3##(2008-10#3)(2010-4#1)
significant economic##9##2##(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-5#1)(2010-4#1)(2012-3#1)
significant effect in##4##3##(1991-8#2)(2008-11#1)(2012-12#1)
significant effect of the##3##4##(1996-12#1)(2008-11#1)(2013-8#1)
significant effect of##17##3##(1990-2#1)(1996-12#2)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
significant effect on LAT cell viability##2##6##(1990-6#2)
significant effect on the rate of 3H-thymidine##2##7##(1995-3#2)
significant effect on the rate of##3##6##(1995-3#2)(2008-10#1)
significant effect on the##41##4##(1990-5#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-3#2)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-8#1)(2011-2#3)(2011-3#1)(2013-1#2)
significant effect on##81##3##(1990-5#1)(1990-6#3)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-5#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#4)(2011-3#2)(2012-2#2)(2013-1#3)
significant effect was observed##3##4##(2007-10#1)(2008-10#1)(2008-5#1)
significant effect was##4##3##(1993-6#1)(2007-10#1)(2008-10#1)(2008-5#1)
significant effect##133##2##(1990-2#1)(1990-5#1)(1990-6#3)(1991-3#1)(1991-6#1)(1991-8#3)(1992-12#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#3)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#32)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
significant effects are##2##3##(1996-3#1)(2011-2#1)
significant effects of##5##3##(1993-2#1)(1994-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
significant effects on the##6##4##(1991-9#1)(1993-6#1)(2008-11#2)(2013-1#1)(2013-8#1)
significant effects on##23##3##(1991-9#1)(1992-11#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(2007-3#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
significant effects were##2##3##(1991-2#1)(2008-7#1)
significant effects##36##2##(1991-2#1)(1991-9#1)(1992-11#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-3#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
significant efficacy##2##2##(2008-9#1)(2011-2#1)
significant efforts##2##2##(2008-10#1)(2012-2#1)
significant elevation in##3##3##(2007-10#1)(2012-2#1)(2013-8#1)
significant elevation of##4##3##(1990-8#1)(1995-3#1)(1996-5#1)(2008-4#1)
significant elevation##7##2##(1990-8#1)(1995-3#1)(1996-5#1)(2007-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
significant elevations in##2##3##(1992-12#1)(2008-10#1)
significant enhancement of the##10##4##(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)
significant enhancement of##12##3##(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-5#1)
significant enhancement##16##2##(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)
significant enzyme##2##2##(1992-11#1)(2008-7#1)
significant error##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
significant errors##4##2##(2008-2#1)(2008-3#2)(2008-6#1)
significant evidence for##3##3##(1994-12#1)(2008-7#1)(2008-9#1)
significant evidence of##3##3##(1997-1#1)(2008-7#1)(2008-8#1)
significant evidence that the##2##4##(2008-3#1)(2008-7#1)
significant evidence##9##2##(1994-12#1)(1997-1#1)(1997-5#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)
significant except##2##2##(2007-2#1)(2008-12#1)
significant excess##5##2##(1990-2#1)(1991-11#1)(1992-2#1)(1993-9#1)(2008-5#1)
significant expression##2##2##(1996-12#1)(2008-11#1)
significant extent##4##2##(1991-6#1)(2008-4#1)(2008-7#1)(2012-3#1)
significant factor in the##3##4##(1996-7#1)(2013-8#2)
significant factor in##7##3##(1995-4#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#2)
significant factor##13##2##(1994-3#1)(1995-4#1)(1996-7#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#2)
significant factors for total inorganic##2##5##(2008-10#2)
significant factors for##4##3##(2008-10#3)(2012-3#1)
significant factors were##2##3##(2008-10#1)(2011-2#1)
significant factors##15##2##(1997-2#1)(2007-10#1)(2008-10#8)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
significant fall in the##2##4##(2010-8#1)(2012-3#1)
significant fall in##6##3##(1990-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
significant features##3##2##(1995-6#1)(2008-10#1)(2009-9#1)
significant finding##5##2##(1997-1#1)(1997-6#1)(2008-12#1)(2008-9#1)(2013-1#1)
significant fit##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
significant for all##2##3##(1991-12#1)(2008-10#1)
significant for the##5##3##(1992-5#1)(2007-10#1)(2007-12#1)(2011-2#1)(2012-3#1)
significant for##37##2##(1990-2#2)(1990-3#1)(1991-1#1)(1991-12#2)(1992-5#1)(1992-6#1)(1995-12#1)(1996-1#1)(1996-5#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#3)
significant fragments##3##2##(1995-6#3)
significant frequency##2##2##(2006-10#1)(2013-1#1)
significant functional##4##2##(1991-5#1)(1997-9#1)(2008-7#1)(2012-2#1)
significant gain##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
significant gains##4##2##(1992-1#1)(1997-4#1)(2008-12#1)(2008-9#1)
significant gaps in##11##3##(2009-10#1)(2013-8#10)
significant gastrointestinal##2##2##(1996-8#1)(2011-2#1)
significant gender difference in##2##4##(2008-1#1)(2008-11#1)
significant gender difference##3##3##(2008-1#1)(2008-11#1)(2010-3#1)
significant gender differences in##2##4##(2008-12#1)(2008-5#1)
significant gender differences##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
significant gender##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-3#1)
significant gene##4##2##(2008-6#1)(2009-2#1)(2010-5#1)(2011-1#1)
significant genes##2##2##(2009-9#1)(2010-4#1)
significant genetic differentiation among##2##4##(2008-10#2)
significant genetic differentiation##3##3##(2008-10#3)
significant genetic effect##3##3##(1994-2#3)
significant genetic##12##2##(1994-2#4)(2007-5#1)(2008-10#4)(2008-12#1)(2012-3#1)(2013-8#1)
significant geographical##2##2##(2008-10#1)(2010-8#1)
significant group differences in##2##4##(1993-3#1)(2012-2#1)
significant group differences were##2##4##(1993-9#1)(2008-2#1)
significant group differences##6##3##(1993-3#1)(1993-9#1)(2007-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
significant growth in##2##3##(1997-2#1)(2011-2#1)
significant growth inhibition of##2##4##(1990-12#1)(2013-7#1)
significant growth was##2##3##(2012-3#2)
significant growth##12##2##(1990-12#1)(1993-1#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#3)(2013-7#1)
significant health and##2##3##(2008-11#1)(2009-8#1)
significant health##7##2##(1996-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
significant hemodynamic##2##2##(2009-8#2)
significant hemolysis##2##2##(1992-12#2)
significant heterogeneity of##2##3##(1990-3#1)(2008-10#1)
significant heterogeneity##4##2##(1990-3#1)(2008-10#2)(2010-2#1)
significant higher##5##2##(1990-8#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
significant homologies##3##2##(1990-11#1)(1991-9#1)(1997-3#1)
significant homology to known proteins##2##5##(1995-12#1)(1995-9#1)
significant homology to the##3##4##(1992-3#1)(1993-12#1)(1995-2#1)
significant homology to##10##3##(1992-3#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#2)(1997-7#2)(2008-10#1)
significant homology with the##4##4##(1990-5#1)(1994-12#1)(1995-2#1)(1997-3#1)
significant homology with##7##3##(1990-5#1)(1994-12#1)(1995-2#1)(1997-3#2)(2008-10#1)(2008-8#1)
significant homology##21##2##(1990-5#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#1)(1997-2#2)(1997-3#2)(1997-7#2)(2008-10#3)(2008-8#1)
significant human##2##2##(2008-10#1)(2013-8#1)
significant immune##2##2##(1997-4#1)(2008-9#1)
significant impact of##3##3##(2008-1#1)(2008-10#2)
significant impact on quality of life##2##6##(2009-5#1)(2010-12#1)
significant impact on the##19##4##(1992-1#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#4)(2013-8#1)
significant impact on##41##3##(1990-2#1)(1992-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
significant impact##48##2##(1990-2#1)(1991-12#1)(1992-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(1997-2#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
significant impacts##4##2##(1991-12#2)(2008-10#1)(2012-2#1)
significant impairment of##2##3##(2012-2#2)
significant implications for##2##3##(2008-7#1)(2009-12#1)
significant implications in the##2##4##(2008-10#2)
significant implications##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
significant improvement in clinical##2##4##(1994-12#1)(2011-2#1)
significant improvement in the##9##4##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
significant improvement in##54##3##(1990-2#2)(1991-3#1)(1991-8#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
significant improvement of the##6##4##(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
significant improvement of##15##3##(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)(2012-7#1)(2013-1#2)
significant improvement over time##2##4##(2008-9#1)(2011-2#1)
significant improvement over##7##3##(1994-1#1)(2008-3#3)(2008-9#1)(2010-5#1)(2011-2#1)
significant improvement##96##2##(1990-2#2)(1991-3#1)(1991-8#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-4#1)(1996-3#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#5)(2008-7#4)(2008-9#2)(2009-1#1)(2009-10#1)(2010-12#2)(2010-5#3)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#10)(2013-8#1)
significant improvements in the##3##4##(1991-2#1)(1996-3#1)(2011-2#1)
significant improvements in##18##3##(1991-2#1)(1993-1#1)(1996-2#2)(1996-3#1)(1996-7#1)(2007-11#1)(2007-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
significant improvements over##2##3##(2008-2#1)(2009-3#1)
significant improvements##27##2##(1991-2#2)(1993-1#1)(1996-2#2)(1996-3#2)(1996-7#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
significant in a##2##3##(2008-10#1)(2009-4#1)
significant in both##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
significant in comparison with##2##4##(1994-11#1)(2008-2#1)
significant in the##12##3##(1990-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#1)
significant in vitro##2##3##(2007-11#1)(2012-12#1)
significant in##45##2##(1990-11#1)(1990-12#1)(1990-2#1)(1994-11#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#2)(2009-4#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
significant increase (by about##2##4##(2009-8#2)
significant increase after##2##3##(1995-12#1)(2013-1#1)
significant increase both##2##3##(2008-7#1)(2012-2#1)
significant increase in cell##2##4##(2008-5#1)(2012-1#1)
significant increase in comet tail length##2##6##(2010-5#2)
significant increase in local##2##4##(1992-10#1)(2008-4#1)
significant increase in the average##2##5##(2007-8#1)(2008-12#1)
significant increase in the frequency of micronucleated##2##7##(1996-12#1)(2008-9#1)
significant increase in the level of##2##6##(2009-8#2)
significant increase in the proportion of##3##6##(1995-11#1)(1995-6#1)(1996-12#1)
significant increase in the##40##4##(1992-11#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#2)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
significant increase in##121##3##(1990-2#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-11#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-7#1)(2013-1#8)(2013-7#4)(2013-8#3)
significant increase of intracellular##2##4##(1995-8#1)(2008-8#1)
significant increase of the signal intensity##2##6##(2008-10#1)(2008-3#1)
significant increase of the##9##4##(1994-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
significant increase of##26##3##(1990-6#1)(1990-9#1)(1994-6#2)(1995-8#1)(1997-1#1)(2006-10#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-8#1)(2011-2#1)(2012-2#2)
significant increase was##3##3##(1995-8#1)(2008-7#1)(2013-1#1)
significant increase##171##2##(1990-2#1)(1990-6#2)(1990-9#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-11#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#2)(1996-12#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-6#1)(2009-8#10)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#5)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#3)
significant increased risk##2##3##(1990-6#2)
significant increased##6##2##(1990-6#2)(2008-6#1)(2008-8#2)(2011-2#1)
significant increases in the##3##4##(1996-12#1)(2008-7#1)(2008-9#1)
significant increases in##29##3##(1990-3#1)(1990-5#1)(1990-7#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-12#3)(1997-2#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-6#1)(2013-1#2)
significant increases of##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
significant increases##37##2##(1990-3#1)(1990-5#1)(1990-7#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#3)(1997-2#1)(1997-4#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
significant independent##4##2##(2009-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
significant influence of##4##3##(1992-9#1)(2008-10#1)(2011-2#1)(2012-6#1)
significant influence on the##10##4##(1990-2#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#2)(2011-3#1)
significant influence on##25##3##(1990-2#1)(1992-8#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#4)(2011-3#1)(2013-1#1)(2013-8#1)
significant influence##30##2##(1990-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#6)(2011-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
significant information##2##2##(2007-11#1)(2008-11#1)
significant inhibition in the##3##4##(1992-6#2)(1994-8#1)
significant inhibition of##4##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
significant inhibition##11##2##(1990-11#1)(1992-6#2)(1994-8#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)
significant inhibitory effect on##2##4##(1994-11#1)(2008-11#1)
significant inhibitory effects##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
significant inhibitory##6##2##(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
significant insight into the roles of##2##6##(2008-7#1)(2011-2#1)
significant interaction between the##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
significant interaction between##6##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-4#1)
significant interaction by##2##3##(2011-2#1)(2013-1#1)
significant interaction for##2##3##(2008-10#1)(2008-12#1)
significant interaction of##2##3##(2008-10#2)
significant interaction was found between##2##5##(2009-2#1)(2011-2#1)
significant interaction##19##2##(1993-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-4#1)(2012-6#2)(2013-1#1)
significant interactions were##2##3##(2008-10#1)(2008-5#1)
significant interactions##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
significant interest##5##2##(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
significant interference from##3##3##(1990-2#1)(2008-10#2)
significant interference in##2##3##(2008-10#1)(2008-3#1)
significant interference##9##2##(1990-2#2)(2008-10#6)(2008-3#1)
significant interferences##3##2##(1990-2#1)(2008-10#2)
significant intracranial hypertension##2##3##(2010-5#2)
significant inverse##6##2##(1991-12#1)(1993-12#1)(1993-2#1)(2008-4#1)(2008-7#2)
significant investment##2##2##(1993-12#1)(2008-11#1)
significant involvement of##2##3##(1996-2#1)(2007-10#1)
significant issues##3##2##(1991-3#1)(2007-10#1)(2008-6#1)
significant lag positions discontinuous from##2##5##(2008-10#2)
significant level of##5##3##(1992-9#1)(1994-8#1)(1996-7#1)(2009-10#1)(2010-4#1)
significant levels of genetic differentiation##2##5##(2008-10#2)
significant levels of##14##3##(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-7#1)(2013-1#1)
significant levels##19##2##(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-8#2)(2013-1#1)
significant linear relationship##2##3##(2008-10#1)(2011-2#1)
significant linkage##2##2##(1997-5#1)(2012-5#1)
significant local##2##2##(1995-6#1)(2007-7#1)
significant loss of##10##3##(1994-2#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
significant loss##11##2##(1994-2#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
significant losses##2##2##(1993-12#1)(2008-10#1)
significant lower##6##2##(1991-6#2)(2010-3#2)(2011-2#1)(2012-2#1)
significant main effects##2##3##(2008-10#1)(2013-1#1)
significant main##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
significant maternal and foetal##2##4##(2007-2#1)(2008-7#1)
significant maternal and##3##3##(2007-2#1)(2008-7#1)(2012-3#1)
significant maternal##4##2##(2007-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
significant mean##2##2##(2008-12#1)(2008-5#1)
significant medical##2##2##(2007-11#1)(2013-1#1)
significant methodological##2##2##(1993-6#1)(2012-2#1)
significant model##2##2##(2008-8#1)(2009-3#1)
significant modification##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
significant morbidity and mortality##10##4##(2006-10#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
significant morbidity and##11##3##(1997-3#1)(2006-10#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
significant morbidity to##2##3##(2008-7#1)(2013-1#1)
significant morbidity##26##2##(1997-3#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
significant morphological##2##2##(1990-11#1)(2008-2#1)
significant mortality and morbidity##2##4##(2007-8#1)(2009-5#1)
significant mortality##7##2##(2007-8#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
significant negative correlation between##7##4##(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-6#1)
significant negative correlation##13##3##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#3)(2008-7#2)(2011-2#2)(2012-6#1)(2013-1#1)
significant negative##20##2##(1990-12#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-6#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)
significant new##3##2##(1995-2#1)(2008-7#1)(2012-3#1)
significant noise##2##2##(2008-2#1)(2008-3#1)
significant nonrandom##2##2##(2008-10#2)
significant number have##2##3##(1993-8#1)(2007-8#1)
significant number of patients##7##4##(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#2)
significant number of the##2##4##(1995-3#1)(2007-11#1)
significant number of##24##3##(1990-5#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-8#1)
significant number##26##2##(1990-5#1)(1993-8#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-8#1)
significant numbers of##4##3##(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)
significant only##2##2##(2008-10#1)(2009-7#1)
significant optical##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
significant or##4##2##(1993-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
significant others##3##2##(2009-5#1)(2010-2#1)(2011-2#1)
significant outcomes##2##2##(2011-1#1)(2012-2#1)
significant output##4##2##(2007-8#2)(2008-2#1)(2008-3#1)
significant pain##3##2##(2007-8#1)(2008-7#1)(2009-3#1)
significant parameter##2##2##(2008-6#1)(2010-8#1)
significant parameters##2##2##(2008-10#1)(2013-1#1)
significant parts##2##2##(1997-2#1)(2010-7#1)
significant pathology##2##2##(2008-9#1)(2012-1#1)
significant patient##2##2##(1995-3#1)(2008-7#1)
significant penetration##2##2##(2008-5#2)
significant perioperative##2##2##(2007-8#1)(2008-7#1)
significant phase##2##2##(2007-12#1)(2008-3#1)
significant population##5##2##(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
significant positive association with##2##4##(2008-8#1)(2012-2#1)
significant positive association##4##3##(1994-2#1)(2008-8#1)(2012-2#2)
significant positive correlation between##3##4##(2008-11#1)(2008-8#1)(2012-3#1)
significant positive correlation with##2##4##(1991-12#1)(2008-1#1)
significant positive correlation##11##3##(1991-12#1)(1992-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
significant positive correlations between##3##4##(2007-6#1)(2010-8#2)
significant positive correlations##6##3##(2007-6#1)(2010-10#1)(2010-8#2)(2011-1#2)
significant positive effect##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
significant positive relationship##5##3##(2007-5#1)(2008-10#2)(2010-11#1)(2013-1#1)
significant positive##37##2##(1991-12#1)(1992-10#1)(1994-2#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
significant potential as##2##3##(2010-8#1)(2011-2#1)
significant potential##8##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#1)
significant potentiation of##2##3##(1992-3#1)(1992-6#1)
significant potentiation##3##2##(1992-3#2)(1992-6#1)
significant predictive##2##2##(1994-2#1)(2007-7#1)
significant predictor for##2##3##(2007-10#1)(2011-2#1)
significant predictor of##11##3##(1991-3#1)(1996-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#2)(2013-1#1)
significant predictor##15##2##(1991-3#1)(1993-1#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#2)(2013-1#1)
significant predictors for##2##3##(2012-2#2)
significant predictors of mortality##3##4##(2008-7#3)
significant predictors of##15##3##(1994-2#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-10#1)(2011-2#2)(2012-2#1)
significant predictors##21##2##(1994-2#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-10#1)(2011-2#3)(2012-2#3)
significant prevalence##2##2##(1990-6#1)(2011-2#1)
significant probability of##2##3##(2008-10#1)(2008-4#1)
significant problem for##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
significant problem##11##2##(1991-1#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-11#1)(2010-12#1)(2012-12#1)
significant problems##4##2##(2008-1#2)(2010-8#1)(2013-1#1)
significant prognostic factors##3##3##(1990-6#1)(1994-7#1)(1995-4#1)
significant prognostic value##2##3##(1994-7#1)(2011-1#1)
significant prognostic##7##2##(1990-6#2)(1994-7#2)(1995-4#1)(2010-9#1)(2011-1#1)
significant progress has been made in##2##6##(2009-12#1)(2009-8#1)
significant progress has been made##4##5##(2008-1#1)(2009-12#1)(2009-8#1)(2013-8#1)
significant progress has##6##3##(2008-1#1)(2008-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-8#1)
significant progress in the##2##4##(2008-10#1)(2012-3#1)
significant progress in##7##3##(2008-10#1)(2008-5#1)(2009-5#1)(2010-10#2)(2010-4#1)(2012-3#1)
significant progress##17##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
significant proliferation##2##2##(2007-12#1)(2010-3#1)
significant prolongation of the CSP duration##2##6##(2011-2#2)
significant prolongation of the##3##4##(1996-9#1)(2011-2#2)
significant proportion of the##8##4##(1993-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)
significant proportion of##18##3##(1990-2#1)(1993-3#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
significant proportion##19##2##(1990-2#1)(1993-3#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
significant protection against##6##3##(1991-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
significant protection to##3##3##(1992-6#1)(2008-10#1)(2009-12#1)
significant protection##12##2##(1991-2#1)(1992-6#1)(1995-12#2)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-12#1)
significant protein##3##2##(1990-5#1)(1995-2#1)(1995-8#1)
significant quantities of##2##3##(1990-5#1)(1996-1#1)
significant recurrence##2##2##(2011-2#2)
significant reduction in febrile##2##4##(2008-10#1)(2008-7#1)
significant reduction in the incidence of##2##6##(1992-9#1)(1993-3#1)
significant reduction in the##25##4##(1990-5#1)(1991-12#1)(1991-3#1)(1992-9#2)(1993-11#2)(1993-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-6#1)(2012-2#1)
significant reduction in their##2##4##(1996-12#1)(2008-7#1)
significant reduction in##75##3##(1990-5#2)(1991-12#2)(1991-3#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#3)(2009-12#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-10#1)(2012-2#5)(2013-1#4)
significant reduction of the##10##4##(1992-1#1)(1992-3#1)(1992-8#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-3#1)(2011-2#3)
significant reduction of##31##3##(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-3#3)(2008-6#1)(2010-12#1)(2011-10#1)(2011-2#3)(2012-2#3)(2013-1#1)
significant reduction##110##2##(1990-5#2)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-3#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#4)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#6)(2008-5#5)(2008-6#4)(2008-7#3)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-10#2)(2011-2#3)(2012-2#9)(2013-1#6)
significant reductions in both##2##4##(2007-10#1)(2008-10#1)
significant reductions in the##4##4##(1995-1#1)(1995-12#1)(1997-2#1)(2008-10#1)
significant reductions in yield##2##4##(2008-10#2)
significant reductions in##18##3##(1993-10#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-2#1)(2007-10#1)(2008-10#9)(2008-3#1)(2008-5#1)
significant reductions of##6##3##(1993-3#1)(1995-5#1)(2008-10#2)(2009-9#1)(2013-1#1)
significant reductions were##2##3##(1997-3#1)(2008-10#1)
significant reductions##28##2##(1993-10#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#12)(2008-3#1)(2008-5#1)(2009-9#1)(2013-1#1)(2013-8#1)
significant regional##3##2##(1996-3#1)(1997-5#1)(2008-10#1)
significant regression of##2##3##(2010-8#1)(2011-2#1)
significant relation##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
significant relationship among the##2##4##(2010-9#1)(2011-2#1)
significant relationship between the##4##4##(1991-8#1)(1996-3#1)(1997-8#1)(2008-8#1)
significant relationship between##17##3##(1991-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#1)
significant relationship was##3##3##(2008-5#1)(2012-12#1)(2012-3#1)
significant relationship##27##2##(1991-8#1)(1992-2#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
significant relationships between##4##3##(2008-9#1)(2009-10#1)(2009-7#1)(2012-2#1)
significant relationships were found between##2##5##(2008-10#1)(2008-8#1)
significant relationships were##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
significant relationships##9##2##(1991-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-2#1)
significant relative##2##2##(2008-3#1)(2010-2#1)
significant release of##2##3##(1995-8#1)(2008-4#1)
significant relief##2##2##(1993-2#1)(2006-10#1)
significant renal##5##2##(1995-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
significant research##2##2##(2008-11#1)(2012-3#1)
significant residual tumour##2##3##(2009-4#2)
significant residual##5##2##(2007-10#1)(2007-12#1)(2008-11#1)(2009-4#2)
significant response##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2012-3#1)
significant results##9##2##(1994-3#1)(2008-10#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
significant rise in the##2##4##(2011-2#1)(2012-2#1)
significant rise in##9##3##(1996-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
significant rise of##2##3##(2007-8#1)(2008-5#1)
significant rise##12##2##(1996-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
significant risk factor for##8##4##(1997-3#1)(2008-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
significant risk factors for##3##4##(2007-11#1)(2012-1#1)(2013-8#1)
significant risk factors##4##3##(2007-11#1)(2008-8#1)(2012-1#1)(2013-8#1)
significant risk for##2##3##(2010-4#1)(2011-2#1)
significant risk of neurological##2##4##(2007-11#1)(2010-8#1)
significant risk of##6##3##(1996-9#1)(2007-11#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
significant risk##21##2##(1996-9#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
significant risks##2##2##(2008-3#1)(2013-1#1)
significant role for reduced##3##4##(2008-10#3)
significant role for##5##3##(1993-12#1)(2008-10#3)(2008-7#1)
significant role of##5##3##(1992-12#1)(1995-6#1)(2008-1#1)(2008-10#1)(2013-8#1)
significant role##52##2##(1992-12#1)(1993-1#1)(1993-12#1)(1995-2#1)(1995-6#2)(2006-10#1)(2006-8#1)(2008-1#2)(2008-10#14)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
significant roles in##6##3##(1990-8#1)(1994-8#1)(1995-2#1)(1997-6#1)(2008-9#1)(2009-8#1)
significant roles##10##2##(1990-8#1)(1994-8#2)(1995-2#1)(1996-1#1)(1997-6#1)(2008-2#1)(2008-9#1)(2009-8#1)(2013-1#1)
significant savings of##2##3##(1994-12#1)(2008-10#1)
significant savings##3##2##(1994-12#1)(1994-3#1)(2008-10#1)
significant seasonal##2##2##(2010-8#1)(2013-1#1)
significant selection##2##2##(2008-3#1)(2008-8#1)
significant selectivity##2##2##(1994-5#1)(1997-2#1)
significant sequence identity##2##3##(1992-4#1)(1994-12#1)
significant sequence similarity##2##3##(1997-6#1)(2008-10#1)
significant sequence##7##2##(1992-4#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#1)(2010-10#1)
significant side effects##6##3##(1991-2#1)(1993-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2013-8#1)
significant side##7##2##(1991-2#1)(1993-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-10#1)(2013-8#1)
significant signal##2##2##(1996-6#1)(2009-2#1)
significant similarity to any##4##4##(1996-12#2)(1996-6#1)(2008-10#1)
significant similarity to##11##3##(1991-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#1)
significant similarity was##2##3##(1994-5#1)(1996-10#1)
significant similarity with##2##3##(1995-9#1)(1997-3#1)
significant similarity##16##2##(1991-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-7#1)(2008-10#1)(2009-8#1)
significant sources of##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
significant spatial##2##2##(2008-10#1)(2008-5#1)
significant standing height##2##3##(2010-3#2)
significant statistical difference was found##3##5##(1994-3#1)(2010-8#1)(2013-8#1)
significant statistical difference##5##3##(1994-3#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
significant statistical differences between the##2##5##(2008-1#1)(2008-7#1)
significant statistical differences##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
significant statistical##8##2##(1994-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
significant stenosis##3##2##(1992-9#1)(1993-8#1)(2011-2#1)
significant stimulation of##2##3##(2008-10#1)(2008-7#1)
significant structural##4##2##(1991-3#1)(1993-8#1)(1996-2#1)(2012-2#1)
significant suppression of##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
significant suppression##4##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
significant surrounding##2##2##(1991-2#1)(2012-2#1)
significant survival advantage##2##3##(2008-7#1)(2009-4#1)
significant survival##6##2##(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#2)(2013-8#1)
significant symptoms of depression##2##4##(2010-7#2)
significant synergistic##2##2##(2008-10#1)(2013-7#1)
significant system##2##2##(2007-11#1)(2009-3#1)
significant technological##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
significant temporal##2##2##(2012-3#1)(2013-1#1)
significant tendency##2##2##(2010-8#1)(2011-2#1)
significant than##4##2##(1992-3#1)(2008-3#2)(2008-9#1)
significant therapeutic##2##2##(1993-9#1)(2010-7#1)
significant threat##3##2##(1994-1#1)(2008-5#1)(2013-8#1)
significant time##4##2##(2008-10#1)(2008-9#1)(2010-5#1)(2013-8#1)
significant titers of##2##3##(1996-11#1)(2012-3#1)
significant to##4##2##(1993-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
significant toxicity##2##2##(2010-12#1)(2011-2#1)
significant treatment##3##2##(2007-11#1)(2008-8#1)(2009-12#1)
significant trend##2##2##(1990-6#1)(2008-8#1)
significant tumor##2##2##(2008-10#1)(2012-2#1)
significant two-way##2##2##(2008-11#1)(2010-2#1)
significant uncertainty##2##2##(2008-8#1)(2009-8#1)
significant up-regulation of##2##3##(2010-12#1)(2012-12#1)
significant using##2##2##(2012-12#2)
significant variability##4##2##(1990-2#1)(2008-10#1)(2010-9#1)(2011-3#1)
significant variables##8##2##(2008-10#6)(2010-1#1)(2011-2#1)
significant variation in the##2##4##(2008-10#1)(2008-11#1)
significant variation in##7##3##(1991-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2013-1#1)
significant variation of##2##3##(2008-10#2)
significant variation##12##2##(1991-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-7#1)(2012-3#1)(2013-1#1)
significant variations in##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
significant variations##9##2##(1991-12#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)
significant ventricular##2##2##(1993-2#1)(1996-3#1)
significant visual loss##2##3##(2011-2#1)(2013-8#1)
significant way##3##2##(1994-6#1)(2008-11#1)(2012-3#1)
significant when##8##2##(1997-5#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
significant whitening##2##2##(2008-5#2)
significant with the##3##3##(1992-5#1)(2008-10#1)(2011-1#1)
significant with##8##2##(1992-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2011-1#1)(2013-1#2)
significant yield losses##2##3##(2008-10#2)
significant##4501##1##(1990-10#2)(1990-11#10)(1990-12#6)(1990-2#16)(1990-3#9)(1990-4#1)(1990-5#21)(1990-6#19)(1990-7#8)(1990-8#6)(1990-9#2)(1991-1#5)(1991-11#6)(1991-12#20)(1991-2#15)(1991-3#9)(1991-4#4)(1991-5#7)(1991-6#12)(1991-8#15)(1991-9#8)(1992-1#5)(1992-10#3)(1992-11#13)(1992-12#21)(1992-2#16)(1992-3#18)(1992-4#4)(1992-5#4)(1992-6#17)(1992-7#2)(1992-8#10)(1992-9#12)(1993-1#16)(1993-10#3)(1993-11#19)(1993-12#35)(1993-2#17)(1993-3#14)(1993-5#2)(1993-6#8)(1993-8#11)(1993-9#15)(1994-1#9)(1994-11#16)(1994-12#21)(1994-2#33)(1994-3#25)(1994-5#14)(1994-6#18)(1994-7#8)(1994-8#15)(1994-9#6)(1995-1#8)(1995-11#10)(1995-12#39)(1995-2#22)(1995-3#17)(1995-4#6)(1995-5#17)(1995-6#19)(1995-8#11)(1995-9#3)(1996-1#20)(1996-10#3)(1996-11#1)(1996-12#42)(1996-2#16)(1996-3#16)(1996-4#2)(1996-5#14)(1996-6#5)(1996-7#12)(1996-8#5)(1996-9#7)(1997-1#15)(1997-2#26)(1997-3#15)(1997-4#20)(1997-5#11)(1997-6#15)(1997-7#16)(1997-8#11)(1997-9#2)(2006-10#9)(2006-12#3)(2006-4#1)(2006-6#2)(2006-8#5)(2007-10#38)(2007-11#67)(2007-12#52)(2007-2#17)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#4)(2007-7#27)(2007-8#45)(2007-9#7)(2008-1#46)(2008-10#688)(2008-11#134)(2008-12#125)(2008-2#39)(2008-3#112)(2008-4#50)(2008-5#148)(2008-6#57)(2008-7#188)(2008-8#103)(2008-9#77)(2009-1#4)(2009-10#11)(2009-11#10)(2009-12#15)(2009-2#10)(2009-3#23)(2009-4#8)(2009-5#19)(2009-6#14)(2009-7#21)(2009-8#36)(2009-9#12)(2010-1#14)(2010-10#19)(2010-11#8)(2010-12#32)(2010-2#13)(2010-3#26)(2010-4#21)(2010-5#22)(2010-6#13)(2010-7#10)(2010-8#34)(2010-9#8)(2011-1#78)(2011-10#4)(2011-2#251)(2011-3#12)(2011-7#1)(2012-1#14)(2012-12#58)(2012-2#116)(2012-3#88)(2012-4#1)(2012-5#8)(2012-6#6)(2012-7#4)(2012-8#1)(2013-1#223)(2013-7#22)(2013-8#102)
significant&quot##4##1##(1993-12#2)(1993-2#1)(2009-11#1)
significant)##9##1##(1992-5#1)(2007-10#1)(2007-8#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
significantly (P &gt##5##3##(2008-10#3)(2010-2#1)(2012-2#1)
significantly (P &lt##55##3##(1993-1#1)(1994-2#1)(1994-8#1)(1996-6#1)(1997-7#1)(2006-6#1)(2008-10#33)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#5)(2010-7#1)(2012-3#2)(2013-1#3)
significantly (P = 0##7##4##(1996-8#1)(2008-10#6)
significantly (P =##8##3##(1996-8#1)(2008-10#6)(2008-8#1)
significantly (P less than 0##3##5##(1990-11#2)(1990-12#1)
significantly (P##71##2##(1990-11#2)(1990-12#1)(1993-1#1)(1994-2#1)(1994-8#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-6#1)(2008-10#42)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#6)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
significantly (P&lt##12##2##(1997-6#1)(2008-10#5)(2008-12#1)(2008-5#1)(2010-4#2)(2012-12#1)(2012-3#1)
significantly (P &lt##2##2##(2012-2#2)
significantly (P = 0##2##2##(2012-2#2)
significantly (p &lt##15##3##(1993-3#1)(1997-4#2)(2008-11#2)(2008-12#5)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)
significantly (p = 0##3##4##(1991-5#1)(2008-12#2)
significantly (p less than 0##2##5##(1990-12#1)(1991-3#1)
significantly (p##20##2##(1990-12#1)(1991-3#1)(1991-5#1)(1993-3#1)(1997-4#2)(2008-11#2)(2008-12#7)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)
significantly (p&lt##8##2##(2008-10#1)(2008-12#1)(2010-4#2)(2012-3#1)(2013-1#3)
significantly (p &lt##4##2##(2012-1#1)(2012-2#1)(2013-1#2)
significantly 8 h after##2##4##(1990-2#1)(1995-12#1)
significantly across##4##2##(1996-7#1)(2008-9#2)(2009-7#1)
significantly affect the##14##3##(1991-9#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-7#1)
significantly affect##23##2##(1991-1#1)(1991-9#1)(1993-5#1)(1994-11#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
significantly affected (P &gt##2##3##(2010-11#2)
significantly affected by gypsum application##2##5##(2008-12#2)
significantly affected by the presence of##2##6##(1993-3#1)(1995-12#1)
significantly affected by the##7##4##(1993-3#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
significantly affected by##37##3##(1990-5#1)(1993-3#2)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#1)
significantly affected the##9##3##(1995-5#1)(1997-5#1)(2008-10#2)(2008-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
significantly affected##67##2##(1990-5#1)(1992-2#1)(1993-3#2)(1994-2#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-12#6)(2008-2#1)(2008-5#2)(2008-6#3)(2010-11#3)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
significantly affecting the##2##3##(2010-3#1)(2011-1#1)
significantly affecting##3##2##(2009-7#1)(2010-3#1)(2011-1#1)
significantly affects the##4##3##(1997-6#1)(2008-3#1)(2008-9#1)(2012-3#1)
significantly affects##5##2##(1997-6#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-3#1)
significantly after the##3##3##(1996-8#1)(2007-8#1)(2011-1#1)
significantly after treatment##3##3##(2011-1#3)
significantly after##16##2##(1991-3#1)(1993-11#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)
significantly alter##12##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-11#2)(1997-2#1)(1997-4#1)(2008-10#2)(2011-2#1)
significantly altered after##2##3##(1996-12#1)(2012-12#1)
significantly altered by##4##3##(1992-1#1)(1992-3#1)(1992-8#1)(1995-12#1)
significantly altered in##5##3##(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
significantly altered##21##2##(1990-12#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
significantly among##7##2##(1997-8#1)(2008-10#4)(2008-3#1)(2011-2#1)
significantly and negatively##2##3##(1996-7#1)(2008-10#1)
significantly and positively##4##3##(2008-1#1)(2008-10#1)(2009-7#1)(2013-8#1)
significantly and the##4##3##(2008-1#1)(2008-8#2)(2008-9#1)
significantly and##20##2##(1992-3#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
significantly as the##2##3##(2008-10#1)(2008-6#1)
significantly as##6##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
significantly assist##2##2##(1994-5#1)(2008-8#1)
significantly associated with a##3##4##(1997-4#1)(2008-12#1)(2013-8#1)
significantly associated with fewer##3##4##(2011-1#1)(2012-2#2)
significantly associated with higher##2##4##(2011-1#1)(2013-1#1)
significantly associated with increased##3##4##(2008-4#1)(2009-7#1)(2012-2#1)
significantly associated with increasing age##2##5##(2012-2#2)
significantly associated with lower##2##4##(2011-1#2)
significantly associated with severe##2##4##(2007-7#1)(2008-10#1)
significantly associated with the increase of##2##6##(2011-1#2)
significantly associated with the##8##4##(2008-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
significantly associated with##76##3##(1990-9#2)(1994-7#1)(1995-11#1)(1997-4#2)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#2)(2011-1#8)(2011-2#6)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#5)(2013-8#4)
significantly associated##84##2##(1990-9#2)(1991-6#1)(1994-7#1)(1995-11#1)(1997-4#2)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#2)(2011-1#8)(2011-2#7)(2012-12#2)(2012-2#11)(2012-3#2)(2013-1#5)(2013-8#4)
significantly at 1##2##3##(1994-9#1)(1995-2#1)
significantly at##11##2##(1994-9#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)
significantly attenuated by##2##3##(1994-9#1)(2008-7#1)
significantly attenuated in wa2##2##4##(2008-7#2)
significantly attenuated the##7##3##(1990-12#1)(1994-11#1)(1995-12#1)(1995-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
significantly attenuated##17##2##(1990-12#1)(1992-3#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#4)(2011-2#1)(2013-1#1)
significantly augmented##7##2##(1990-2#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)
significantly below the##2##3##(2007-12#1)(2011-2#1)
significantly below##3##2##(1997-2#1)(2007-12#1)(2011-2#1)
significantly better for##2##3##(1994-2#1)(2008-7#1)
significantly better outcomes##2##3##(2007-11#1)(2011-2#1)
significantly better performance##2##3##(1993-9#1)(2008-3#1)
significantly better results than##2##4##(1997-7#1)(2007-11#1)
significantly better results##3##3##(1997-7#1)(2007-11#2)
significantly better than the##4##4##(2008-10#1)(2008-7#1)(2009-9#1)(2010-3#1)
significantly better than##9##3##(2008-10#3)(2008-7#1)(2009-9#1)(2010-3#2)(2011-2#1)(2013-8#1)
significantly better with##2##3##(2007-11#1)(2008-2#1)
significantly better##39##2##(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1997-7#1)(2007-11#4)(2008-10#8)(2008-2#2)(2008-3#2)(2008-7#6)(2009-9#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
significantly between age groups##2##4##(2008-7#1)(2012-3#1)
significantly between the groups##3##4##(1997-7#2)(2008-6#1)
significantly between the three groups##3##5##(1996-12#1)(2009-10#2)
significantly between the three##6##4##(1996-12#1)(2008-5#1)(2009-10#3)(2011-1#1)
significantly between the two##4##4##(1993-12#1)(1994-8#1)(2008-6#1)(2011-2#1)
significantly between the##19##3##(1993-12#1)(1994-8#1)(1996-12#1)(1997-7#2)(2007-10#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#4)(2011-1#1)(2011-2#2)(2013-7#2)
significantly between##39##2##(1993-12#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-7#2)(2007-1#2)(2007-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-10#4)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#3)
significantly but##2##2##(2008-10#1)(2011-1#1)
significantly by the##5##3##(2008-10#2)(2008-4#1)(2008-7#2)
significantly by##28##2##(1990-12#1)(1991-12#1)(1992-3#1)(1997-2#1)(1997-7#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-2#1)
significantly canceled the stimulatory actions of L-leucine and KIC on protein synthesis##2##12##(2008-11#2)
significantly change the##5##3##(1994-5#1)(1995-1#1)(1995-12#1)(2007-11#1)(2008-10#1)
significantly change##9##2##(1994-5#1)(1995-1#1)(1995-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2010-8#1)
significantly changed as##2##3##(1992-6#1)(1995-3#1)
significantly changed##13##2##(1992-6#1)(1993-12#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#1)
significantly compared to##3##3##(1997-2#1)(2007-10#1)(2008-10#1)
significantly compared with the##2##4##(2008-10#1)(2011-3#1)
significantly compared with##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2011-3#1)
significantly compared##8##2##(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-3#1)
significantly contribute to##3##3##(1994-9#1)(2008-1#1)(2008-9#1)
significantly contributed to##3##3##(1991-2#1)(2008-10#1)(2012-3#1)
significantly contributes to the##2##4##(1995-12#1)(2007-12#1)
significantly contributes to##3##3##(1995-12#1)(2007-12#1)(2010-8#1)
significantly correlated with geographic distance##2##5##(2008-10#2)
significantly correlated with the presence of##2##6##(1995-5#1)(2011-2#1)
significantly correlated with the##18##4##(1990-8#1)(1993-3#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#3)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-5#1)(2013-8#1)
significantly correlated with##54##3##(1990-8#2)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-1#2)(2008-10#9)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#1)(2013-8#2)
significantly correlated##62##2##(1990-8#3)(1991-8#1)(1992-12#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#11)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#1)(2013-8#2)
significantly declined##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
significantly decrease the##4##3##(1990-5#1)(2008-9#1)(2009-3#1)(2011-1#1)
significantly decrease##11##2##(1990-12#1)(1990-5#1)(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
significantly decreased (P &lt##3##4##(1996-6#1)(2008-10#1)(2008-7#1)
significantly decreased (p &lt##2##4##(2008-11#1)(2008-12#1)
significantly decreased [3H]NE release##2##4##(1992-3#2)
significantly decreased after##4##3##(1994-2#1)(1995-12#1)(2011-2#1)(2013-1#1)
significantly decreased and##2##3##(2008-10#1)(2008-5#1)
significantly decreased as##2##3##(1995-12#1)(2008-9#1)
significantly decreased at##3##3##(1995-12#1)(2008-8#1)(2013-1#1)
significantly decreased by##2##3##(1992-11#1)(1996-2#1)
significantly decreased compared##2##3##(1993-1#1)(1995-6#1)
significantly decreased from##3##3##(2008-4#1)(2011-1#2)
significantly decreased growth##2##3##(1990-7#1)(2012-12#1)
significantly decreased in both##2##4##(2008-10#1)(2013-1#1)
significantly decreased in patients with##2##5##(2007-11#1)(2008-7#1)
significantly decreased in the presence of##2##6##(1996-5#1)(2008-10#1)
significantly decreased in the##8##4##(1990-7#2)(1993-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#2)
significantly decreased in##27##3##(1990-7#2)(1993-12#1)(1993-3#2)(1995-5#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-12#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
significantly decreased platelet##2##3##(2008-3#1)(2008-7#1)
significantly decreased serum##2##3##(1996-12#1)(2012-2#1)
significantly decreased the labeling index of##2##6##(2008-4#2)
significantly decreased the##17##3##(1992-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#1)
significantly decreased with##3##3##(1994-8#1)(2008-11#1)(2010-2#1)
significantly decreased##116##2##(1990-7#3)(1991-12#1)(1991-4#1)(1991-9#2)(1992-11#2)(1992-3#4)(1993-1#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-2#5)(1994-5#2)(1994-6#3)(1994-8#3)(1995-12#4)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#11)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#8)(2009-1#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
significantly decreases the##3##3##(1990-9#1)(2007-8#1)(2008-3#1)
significantly decreases##6##2##(1990-9#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-3#1)(2011-1#1)
significantly degrade##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
significantly delayed in##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
significantly delayed##9##2##(1997-3#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)
significantly depressed##4##2##(1991-9#1)(1992-3#1)(1994-11#1)(2011-1#1)
significantly determined by##2##3##(1996-7#1)(2010-4#1)
significantly differ##9##2##(1995-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
significantly differed##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-12#1)
significantly difference between##3##3##(2008-12#2)(2011-2#1)
significantly different (P &lt##3##4##(2008-10#1)(2011-1#2)
significantly different (P = 0##2##5##(2008-10#2)
significantly different (P##6##3##(2008-10#4)(2011-1#2)
significantly different (p&lt##4##3##(2008-12#2)(2008-5#1)(2013-1#1)
significantly different among concentrations for##2##5##(2008-10#2)
significantly different among the four##2##5##(2008-7#1)(2010-4#1)
significantly different among the##6##4##(2008-10#1)(2008-12#1)(2008-7#2)(2010-4#1)(2013-1#1)
significantly different among##13##3##(2008-10#5)(2008-12#1)(2008-7#2)(2008-9#2)(2010-4#1)(2010-7#1)(2013-1#1)
significantly different between the two groups##2##6##(1995-12#1)(2007-12#1)
significantly different between the two##4##5##(1995-12#1)(2007-12#1)(2008-5#1)(2013-1#1)
significantly different between the##10##4##(1990-7#1)(1995-12#1)(1995-4#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
significantly different between##22##3##(1990-7#1)(1991-8#1)(1993-11#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-7#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2013-1#2)(2013-8#1)
significantly different for##5##3##(1992-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
significantly different from a binomial distribution (P##2##7##(2008-10#2)
significantly different from each other##2##5##(1993-3#1)(2008-10#1)
significantly different from that##9##4##(1990-8#1)(1992-5#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)
significantly different from the results##2##5##(1994-5#1)(2008-10#1)
significantly different from the##18##4##(1992-11#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(2007-7#2)(2008-10#4)(2008-6#2)(2008-8#1)(2012-3#1)(2013-1#1)
significantly different from those of##4##5##(1993-8#1)(1997-6#1)(2010-8#1)(2011-2#1)
significantly different from those##7##4##(1990-12#1)(1993-2#1)(1993-8#1)(1997-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
significantly different from zero (P &lt##3##6##(2008-10#3)
significantly different from zero##5##4##(2008-10#5)
significantly different from##60##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-7#2)(2008-10#26)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
significantly different in the##5##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
significantly different in##14##3##(1992-3#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-5#2)(2011-1#1)(2011-2#1)
significantly different only##2##3##(2008-5#1)(2010-8#1)
significantly different than##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
significantly different to##2##3##(1996-12#1)(2008-10#1)
significantly different with##2##3##(1991-6#1)(2011-1#1)
significantly different##191##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#58)(2008-11#2)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
significantly differentiated##6##2##(2008-10#5)(2012-5#1)
significantly diminished in##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
significantly diminished##9##2##(1991-12#1)(1991-2#1)(1994-2#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
significantly down-regulated##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
significantly during the first##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
significantly during the##9##3##(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
significantly during treatment##3##3##(2008-7#1)(2012-3#2)
significantly during##21##2##(1991-12#1)(1995-3#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)
significantly earlier than##2##3##(1993-12#1)(2011-2#1)
significantly earlier##4##2##(1991-9#1)(1993-12#1)(1995-12#1)(2011-2#1)
significantly elevated in the##4##4##(1995-12#1)(1996-12#1)(2008-10#2)
significantly elevated in##7##3##(1993-8#1)(1995-12#1)(1996-12#2)(2008-10#2)(2008-3#1)
significantly elevated##32##2##(1990-11#1)(1990-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#2)(1996-12#2)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
significantly enhance the##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#1)
significantly enhance##11##2##(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
significantly enhanced by the addition of##2##6##(1992-12#1)(2008-11#1)
significantly enhanced by the##4##4##(1992-12#1)(1995-12#1)(2007-12#1)(2008-11#1)
significantly enhanced by##7##3##(1992-12#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#2)
significantly enhanced growth of##2##4##(1992-8#1)(2008-10#1)
significantly enhanced resistance##2##3##(2008-10#2)
significantly enhanced response towards##2##4##(2008-10#2)
significantly enhanced sensitivity##2##3##(2007-11#1)(2011-1#1)
significantly enhanced the##9##3##(1994-3#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-6#2)(2008-7#1)(2011-2#1)
significantly enhanced##49##2##(1992-12#1)(1992-2#1)(1992-8#1)(1994-11#2)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#4)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
significantly enhances its##2##3##(2007-12#1)(2008-3#1)
significantly enhances##6##2##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
significantly expressed genes##2##3##(2008-8#1)(2010-4#1)
significantly extends the##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
significantly extends##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
significantly faster in##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
significantly faster than##2##3##(2008-10#1)(2008-2#1)
significantly faster##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
significantly fewer##24##2##(1991-3#1)(1992-2#2)(1994-2#2)(1995-12#1)(1995-5#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
significantly following##2##2##(2008-10#1)(2010-7#1)
significantly for RAPD##2##3##(2008-10#2)
significantly for the two##2##4##(1994-5#1)(2008-10#1)
significantly for the##3##3##(1994-5#1)(2008-10#1)(2009-12#1)
significantly for##13##2##(1991-12#1)(1993-12#1)(1994-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2009-12#1)(2010-3#1)
significantly from 97##2##3##(2008-1#1)(2008-12#1)
significantly from a mean##3##4##(2008-1#2)(2013-1#1)
significantly from a##6##3##(2008-1#2)(2008-10#2)(2008-3#1)(2013-1#1)
significantly from baseline##3##3##(2008-1#1)(2012-3#2)
significantly from one##2##3##(2008-10#2)
significantly from that of the##3##5##(1994-2#1)(1996-7#1)(2008-3#1)
significantly from that of##7##4##(1994-2#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)
significantly from that##10##3##(1993-11#1)(1994-2#1)(1994-5#1)(1996-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-3#1)
significantly from the##12##3##(1990-5#1)(1991-6#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)
significantly from those of##3##4##(2008-8#1)(2009-8#1)(2013-1#1)
significantly from those##8##3##(1995-11#1)(1996-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2013-1#1)(2013-8#1)
significantly from##63##2##(1990-5#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-2#1)(2008-1#4)(2008-10#12)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
significantly greater (P &lt##2##4##(2008-10#2)
significantly greater for##5##3##(1993-9#1)(1995-1#1)(1995-2#1)(2009-7#1)(2013-1#1)
significantly greater improvements##2##3##(2008-3#1)(2008-8#1)
significantly greater in mulch##2##4##(2008-10#2)
significantly greater in the##11##4##(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#2)
significantly greater in##22##3##(1992-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2011-2#2)(2013-1#1)
significantly greater number of##2##4##(1996-5#1)(2007-11#1)
significantly greater reduction in##2##4##(1996-12#1)(2007-11#1)
significantly greater than 0 (P &lt##2##6##(2008-10#2)
significantly greater than that in the vehicle control group##2##9##(2008-9#2)
significantly greater than that in the vehicle##3##7##(2008-9#3)
significantly greater than that in the##4##6##(2008-9#4)
significantly greater than that in##5##5##(2008-5#1)(2008-9#4)
significantly greater than that of##2##5##(2008-10#1)(2009-7#1)
significantly greater than that##9##4##(1991-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-7#1)
significantly greater than the##7##4##(1995-1#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-10#1)(2010-9#1)(2012-3#1)
significantly greater than those of##5##5##(2008-5#1)(2008-9#3)(2010-4#1)
significantly greater than those##9##4##(2008-5#1)(2008-9#7)(2010-4#1)
significantly greater than zero##3##4##(1994-2#2)(2008-9#1)
significantly greater than##39##3##(1991-9#1)(1992-5#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#12)(2009-2#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#1)
significantly greater##117##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-9#1)(2007-10#1)(2007-11#3)(2007-6#3)(2007-7#1)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#13)(2009-2#1)(2009-7#2)(2009-8#2)(2010-4#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#6)
significantly high levels of##2##4##(1994-6#1)(2008-10#1)
significantly high levels##3##3##(1994-6#1)(2008-10#1)(2008-11#1)
significantly high##15##2##(1993-12#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
significantly higher (P &lt##3##4##(1996-12#1)(2008-10#1)(2008-4#1)
significantly higher (P##4##3##(1991-8#1)(1996-12#1)(2008-10#1)(2008-4#1)
significantly higher (p &lt##2##4##(2008-6#1)(2011-2#1)
significantly higher (p##3##3##(1993-11#1)(2008-6#1)(2011-2#1)
significantly higher (p&lt##2##3##(2008-7#1)(2013-1#1)
significantly higher among patients with##2##5##(2008-7#1)(2013-1#1)
significantly higher among patients##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
significantly higher among##10##3##(1996-5#1)(1997-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#2)
significantly higher amounts of##2##4##(2008-10#1)(2008-11#1)
significantly higher cell##2##3##(1994-2#1)(2008-10#1)
significantly higher concentration of##2##4##(1994-12#1)(2008-4#1)
significantly higher during##3##3##(1995-11#2)(2008-11#1)
significantly higher for##12##3##(1992-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-1#1)(2010-2#2)(2011-2#3)
significantly higher in cases##3##4##(1990-12#1)(1997-8#1)(2007-10#1)
significantly higher in group##3##4##(2007-8#1)(2008-7#1)(2009-6#1)
significantly higher in obese##2##4##(1995-5#1)(2013-8#1)
significantly higher in patients with##11##5##(1992-12#1)(1993-11#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-4#1)(2013-1#2)
significantly higher in patients##13##4##(1991-6#1)(1992-12#1)(1993-11#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2013-1#2)
significantly higher in the patients##2##5##(1990-3#1)(2008-7#1)
significantly higher in the resistant##2##5##(2008-10#2)
significantly higher in the##43##4##(1990-3#1)(1990-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
significantly higher in these##2##4##(1991-11#1)(2008-4#1)
significantly higher in type 1##2##5##(1993-2#1)(2008-1#1)
significantly higher in##131##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-6#3)(2010-12#1)(2010-4#2)(2011-1#6)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#7)(2012-5#1)(2013-1#5)(2013-8#2)
significantly higher incidence##4##3##(1993-8#1)(1996-8#2)(2008-8#1)
significantly higher levels in##2##4##(2008-10#1)(2010-7#1)
significantly higher levels of##9##4##(1992-2#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
significantly higher levels##12##3##(1992-2#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
significantly higher mean age##2##4##(2008-10#1)(2013-8#1)
significantly higher mean##4##3##(1993-11#1)(1997-4#1)(2008-10#1)(2013-8#1)
significantly higher number of##6##4##(2008-5#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
significantly higher numbers of##2##4##(2008-10#1)(2008-12#1)
significantly higher numbers##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
significantly higher on##8##3##(1992-5#1)(2008-10#2)(2008-5#2)(2009-5#1)(2011-2#1)(2012-9#1)
significantly higher percentage of##11##4##(1991-2#1)(1994-6#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-5#1)(2011-2#1)
significantly higher risk for##2##4##(2008-10#1)(2008-7#1)
significantly higher risk of##3##4##(1990-2#1)(2007-7#1)(2013-1#1)
significantly higher risk##5##3##(1990-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
significantly higher scores for##2##4##(1996-12#1)(2008-8#1)
significantly higher scores in##2##4##(2007-2#1)(2009-4#1)
significantly higher scores##7##3##(1996-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2013-1#1)
significantly higher serum##2##3##(2008-11#1)(2011-1#1)
significantly higher than control##3##4##(2008-11#1)(2008-5#1)(2009-11#1)
significantly higher than in controls##3##5##(2011-1#2)(2012-1#1)
significantly higher than in the control group##2##7##(1991-4#1)(2011-2#1)
significantly higher than in the##5##5##(1991-4#2)(1991-5#1)(1997-8#1)(2011-2#1)
significantly higher than in##20##4##(1990-11#1)(1991-11#1)(1991-4#2)(1991-5#2)(1992-10#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#1)
significantly higher than on##2##4##(1993-11#1)(1995-11#1)
significantly higher than that in healthy##2##6##(2008-10#1)(2011-1#1)
significantly higher than that in the control group##2##8##(2007-8#1)(2012-2#1)
significantly higher than that in the control##3##7##(1995-3#1)(2007-8#1)(2012-2#1)
significantly higher than that in the##4##6##(1995-3#1)(2007-10#1)(2007-8#1)(2012-2#1)
significantly higher than that in##10##5##(1995-3#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-1#3)(2012-2#1)
significantly higher than that##19##4##(1992-3#1)(1994-11#1)(1995-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
significantly higher than the##9##4##(1991-5#1)(1993-3#1)(1995-12#1)(2008-10#3)(2009-10#1)(2010-8#1)(2011-2#1)
significantly higher than those of##10##5##(1994-12#1)(1994-6#1)(2008-10#2)(2008-12#2)(2009-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
significantly higher than those##18##4##(1990-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-7#2)(2008-10#3)(2008-12#2)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
significantly higher than##98##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-5#3)(1992-10#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-3#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-7#4)(1997-7#1)(1997-8#1)(2007-10#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-8#3)(2011-1#8)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
significantly higher total##2##3##(2008-12#1)(2008-5#1)
significantly higher under##2##3##(2008-10#2)
significantly higher values of##2##4##(2008-4#1)(2008-7#1)
significantly higher values##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
significantly higher with##4##3##(2007-11#1)(2008-9#1)(2009-4#1)(2010-12#1)
significantly higher##455##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#5)(1994-7#1)(1994-8#1)(1995-11#4)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#6)(1996-5#2)(1996-6#1)(1996-7#7)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2007-10#8)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#7)(2007-8#6)(2008-1#6)(2008-10#67)(2008-11#13)(2008-12#11)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#11)(2008-6#7)(2008-7#23)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#18)(2011-2#36)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#13)(2012-5#2)(2012-9#1)(2013-1#21)(2013-7#1)(2013-8#6)
significantly highest with##2##3##(2008-12#2)
significantly if##3##2##(1993-3#1)(1997-2#1)(2008-2#1)
significantly impact on##2##3##(2008-1#1)(2013-1#1)
significantly impact##4##2##(2008-1#1)(2008-8#1)(2010-12#1)(2013-1#1)
significantly impair##2##2##(1990-12#1)(2008-3#1)
significantly impaired##11##2##(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-8#1)(1997-2#1)(2008-10#1)(2010-11#1)(2013-1#1)
significantly improve patient##2##3##(1994-2#1)(2013-8#1)
significantly improve the##4##3##(1997-1#1)(2008-12#1)(2008-8#1)(2013-1#1)
significantly improve##14##2##(1994-2#1)(1995-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#3)(2013-8#1)
significantly improved by##5##3##(2008-2#1)(2008-3#2)(2008-5#1)(2011-3#1)
significantly improved compared with##2##4##(2008-3#1)(2010-7#1)
significantly improved in the##3##4##(2008-7#1)(2012-1#2)
significantly improved in##5##3##(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#2)
significantly improved its##2##3##(2008-10#1)(2008-3#1)
significantly improved the##7##3##(2007-8#1)(2008-10#2)(2008-3#2)(2009-2#1)(2012-12#1)
significantly improved##53##2##(1990-7#1)(1991-8#1)(1993-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#9)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
significantly improves the##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
significantly improves##11##2##(1991-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
significantly improving##3##2##(2008-2#1)(2010-5#1)(2012-12#1)
significantly in all##3##3##(2007-8#1)(2008-7#1)(2011-3#1)
significantly in any of the##2##5##(1996-1#1)(2013-7#1)
significantly in both##2##3##(2009-3#1)(2011-2#1)
significantly in patients with##2##4##(2007-10#1)(2007-11#1)
significantly in rats##2##3##(2008-9#1)(2012-2#1)
significantly in response to##2##4##(2008-10#1)(2010-11#1)
significantly in the past##2##4##(2008-8#1)(2013-8#1)
significantly in the presence of##3##5##(1993-6#1)(2008-10#1)(2008-9#1)
significantly in the##24##3##(1990-11#1)(1992-11#1)(1993-12#1)(1993-6#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
significantly in their##2##3##(2008-10#1)(2010-8#1)
significantly in##74##2##(1990-11#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-2#2)(1994-3#1)(1995-11#1)(1996-1#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
significantly increase the##15##3##(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
significantly increase##22##2##(1991-12#1)(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#1)
significantly increased (P&lt##2##3##(2007-3#1)(2009-10#1)
significantly increased after##8##3##(1991-6#1)(1995-3#2)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
significantly increased and##2##3##(1996-6#1)(2008-7#1)
significantly increased arthropod##2##3##(2008-9#2)
significantly increased at##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
significantly increased body weight##2##4##(2008-5#1)(2013-1#1)
significantly increased by##14##3##(1992-3#1)(1992-8#1)(1995-12#2)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-6#1)(2013-1#2)
significantly increased cell##2##3##(2008-7#1)(2012-1#1)
significantly increased during##3##3##(1992-12#2)(1995-5#1)
significantly increased from 1##2##4##(2008-10#1)(2009-11#1)
significantly increased from##6##3##(1994-3#1)(2008-10#2)(2009-11#1)(2011-2#1)(2013-1#1)
significantly increased in 256 mg/kg males at##2##7##(2008-9#2)
significantly increased in 800 mg/L##2##5##(2008-9#2)
significantly increased in all##3##4##(1995-11#1)(2008-9#2)
significantly increased in both##4##4##(1994-11#1)(1994-3#1)(2008-10#1)(2008-9#1)
significantly increased in the##12##4##(1991-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-6#1)(2013-8#1)
significantly increased in those##2##4##(2008-11#1)(2011-2#1)
significantly increased in##56##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#17)(2010-11#1)(2011-2#3)(2012-1#1)(2012-6#1)(2013-8#1)
significantly increased incidences##4##3##(2008-9#4)
significantly increased on day##2##4##(1994-5#2)
significantly increased on##3##3##(1993-12#1)(1994-5#2)
significantly increased over##2##3##(2008-10#1)(2012-2#1)
significantly increased resistance to M##2##5##(2008-10#2)
significantly increased response##2##3##(1992-11#1)(2010-8#1)
significantly increased risk of##3##4##(1992-10#1)(2008-1#1)(2011-2#1)
significantly increased risk##5##3##(1992-10#1)(1994-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
significantly increased the final##2##4##(2007-11#1)(2008-10#1)
significantly increased the frequency##2##4##(1995-9#1)(2010-3#1)
significantly increased the maximum##2##4##(2013-1#2)
significantly increased the number of##3##5##(2008-10#1)(2008-6#1)(2012-3#1)
significantly increased the##33##3##(1990-3#1)(1990-5#1)(1992-12#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)
significantly increased##256##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1995-11#4)(1995-12#11)(1995-2#1)(1995-3#5)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#10)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#8)(2008-9#34)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#4)(2012-4#1)(2012-6#2)(2013-1#12)(2013-8#1)
significantly increases the risk of##2##5##(1992-4#1)(2011-2#1)
significantly increases the##9##3##(1992-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
significantly increases##15##2##(1992-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)
significantly increasing the##3##3##(2008-3#1)(2012-2#2)
significantly increasing##4##2##(2008-3#1)(2012-2#3)
significantly induced in##2##3##(2008-10#1)(2008-9#1)
significantly induced the##2##3##(2011-10#1)(2011-3#1)
significantly induced##8##2##(1992-5#1)(2008-10#3)(2008-9#1)(2011-10#2)(2011-3#1)
significantly influence the##12##3##(1992-9#1)(1993-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)
significantly influence##20##2##(1991-2#1)(1992-9#1)(1993-1#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-7#1)(2012-2#1)
significantly influenced by the##7##4##(1990-11#1)(1992-5#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-2#2)
significantly influenced by##10##3##(1990-11#1)(1992-5#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
significantly influenced the##5##3##(1992-2#1)(1995-5#1)(2008-10#1)(2009-5#1)(2009-8#1)
significantly influenced##20##2##(1990-11#1)(1990-3#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-10#3)(2008-11#1)(2009-5#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
significantly influences the##2##3##(2007-12#1)(2009-5#1)
significantly influences##4##2##(1990-8#1)(2007-12#1)(2008-1#1)(2009-5#1)
significantly inhibit the##2##3##(1991-11#1)(2008-5#1)
significantly inhibit##9##2##(1991-11#1)(1997-4#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2012-2#1)
significantly inhibited by##3##3##(1990-7#1)(1992-3#1)(2008-4#1)
significantly inhibited in##3##3##(1992-3#1)(1995-6#1)(2010-8#1)
significantly inhibited the##12##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
significantly inhibited##46##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-11#2)(1993-9#2)(1994-11#2)(1994-2#1)(1995-11#3)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
significantly involved in##2##3##(2010-3#1)(2011-2#1)
significantly larger in the group of subjects with PD##2##9##(2008-7#2)
significantly larger in the##3##4##(2008-7#2)(2011-1#1)
significantly larger in##6##3##(2007-10#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
significantly larger than that##4##4##(1990-7#1)(2008-2#1)(2008-9#1)(2009-2#1)
significantly larger than##8##3##(1990-7#1)(1991-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-2#1)
significantly larger##33##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-3#3)(1993-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
significantly less disease##5##3##(2008-10#5)
significantly less effective in##2##4##(2008-10#2)
significantly less frequent in##2##4##(2011-2#2)
significantly less frequent##3##3##(2007-8#1)(2011-2#2)
significantly less frequently##2##3##(2008-12#1)(2011-2#1)
significantly less in##5##3##(1996-3#1)(2008-10#2)(2010-7#1)(2012-2#1)
significantly less likely##3##3##(1995-12#1)(2007-11#1)(2013-1#1)
significantly less than in##4##4##(1992-9#1)(1995-12#1)(2008-10#2)
significantly less than that##3##4##(1994-12#1)(1997-4#1)(1997-6#1)
significantly less than the##4##4##(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
significantly less than##28##3##(1991-11#1)(1992-9#1)(1994-12#1)(1995-12#1)(1997-4#1)(1997-6#1)(2008-10#6)(2008-9#12)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
significantly less toxic than##2##4##(2008-8#1)(2013-1#1)
significantly less##92##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-3#1)(1996-5#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#13)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#3)
significantly lesser##2##2##(2009-6#1)(2010-7#1)
significantly longer in##6##3##(1996-5#1)(2007-8#1)(2008-5#1)(2009-4#2)(2011-2#1)
significantly longer than the##2##4##(2008-10#1)(2013-8#1)
significantly longer than##3##3##(1994-11#1)(2008-10#1)(2013-8#1)
significantly longer##18##2##(1993-1#1)(1994-11#1)(1994-3#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
significantly low##5##2##(1994-8#2)(2007-12#1)(2008-2#1)(2012-3#1)
significantly lower (P##2##3##(1993-12#1)(2008-10#1)
significantly lower among white##2##4##(2012-12#2)
significantly lower among##5##3##(2008-10#1)(2011-1#1)(2012-12#2)(2013-8#1)
significantly lower at##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
significantly lower compared with##3##4##(2007-10#1)(2011-2#2)
significantly lower disease##2##3##(2008-10#2)
significantly lower flux##2##3##(2008-7#2)
significantly lower for##8##3##(1990-12#2)(1993-11#1)(2008-10#4)(2011-2#1)
significantly lower fraction of##2##4##(1991-11#2)
significantly lower in gamblers##2##4##(2008-3#2)
significantly lower in patients with##3##5##(1990-2#1)(2008-7#1)(2012-3#1)
significantly lower in the##9##4##(1990-3#1)(1993-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-7#1)
significantly lower in women##2##4##(1992-3#1)(2009-11#1)
significantly lower in##41##3##(1990-2#2)(1990-3#1)(1991-12#2)(1992-2#1)(1992-3#1)(1993-10#1)(1995-5#1)(1996-7#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-7#1)
significantly lower incidence of##2##4##(2008-10#2)
significantly lower incidence##3##3##(1992-9#1)(2008-10#2)
significantly lower levels of##7##4##(1995-2#1)(1996-1#1)(2008-10#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
significantly lower mean values of##2##5##(1990-2#1)(1991-12#1)
significantly lower on##4##3##(2008-10#1)(2010-8#3)
significantly lower scores##2##3##(2010-10#1)(2013-1#1)
significantly lower than in control subjects##2##6##(1991-11#1)(1996-7#1)
significantly lower than in control##4##5##(1991-11#1)(1996-7#1)(2007-10#1)(2010-1#1)
significantly lower than in patients##2##5##(1993-2#1)(2008-7#1)
significantly lower than in the##7##5##(1995-11#1)(1995-8#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
significantly lower than in##20##4##(1990-11#1)(1991-11#2)(1993-2#1)(1995-11#1)(1995-8#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-7#3)(2008-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)
significantly lower than that in##4##5##(1995-4#1)(1995-8#1)(2012-2#1)(2013-1#1)
significantly lower than that of##4##5##(1990-8#1)(1994-8#1)(2008-10#1)(2008-9#1)
significantly lower than that##13##4##(1990-8#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
significantly lower than the calculated##2##5##(2008-10#2)
significantly lower than the##10##4##(1990-7#1)(1991-11#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-7#1)
significantly lower than those of##3##5##(2008-10#1)(2008-12#1)(2011-2#1)
significantly lower than those##7##4##(2008-10#2)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
significantly lower than##56##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#3)(1991-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
significantly lower values##2##3##(2008-12#1)(2008-7#1)
significantly lower##223##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#2)(1991-11#5)(1991-12#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#44)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#13)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#4)
significantly lowered##9##2##(1992-8#1)(1994-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
significantly modified by##2##3##(1991-9#1)(2013-1#1)
significantly modified the relationship between##2##5##(2009-7#2)
significantly modified the##3##3##(2008-10#1)(2009-7#2)
significantly modified##10##2##(1991-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2009-7#2)(2013-1#1)
significantly modify the##3##3##(1994-5#1)(2008-8#1)(2011-10#1)
significantly more and##2##3##(1990-8#1)(2012-2#1)
significantly more common among##2##4##(2011-1#1)(2012-3#1)
significantly more common in##5##4##(2008-7#2)(2010-12#1)(2010-4#1)(2011-2#1)
significantly more common##7##3##(2008-7#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
significantly more disabled##2##3##(2007-10#1)(2013-8#1)
significantly more effective at##2##4##(2008-10#1)(2008-5#1)
significantly more effective##6##3##(1992-2#1)(2008-10#3)(2008-5#1)(2013-1#1)
significantly more efficient##3##3##(2008-10#2)(2011-2#1)
significantly more efficiently than##2##4##(2011-2#1)(2012-2#1)
significantly more frequent in##2##4##(2007-8#1)(2011-1#1)
significantly more frequent than##2##4##(1994-3#1)(2012-2#1)
significantly more frequent##6##3##(1994-3#1)(2007-8#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
significantly more in##3##3##(1992-12#1)(2007-7#1)(2012-2#1)
significantly more likely to have##2##5##(2007-11#1)(2010-9#1)
significantly more likely to##7##4##(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-9#1)
significantly more likely##9##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2013-1#1)
significantly more new##2##3##(2008-5#1)(2012-2#1)
significantly more often than##2##4##(1992-2#1)(1996-12#1)
significantly more often##5##3##(1992-2#1)(1996-12#1)(1997-3#1)(2007-2#1)(2011-2#1)
significantly more patients##2##3##(1990-5#1)(1991-2#1)
significantly more potent##2##3##(1997-7#1)(2008-7#1)
significantly more resistant to##2##4##(2008-10#1)(2009-4#1)
significantly more satisfied with their life##2##6##(2007-1#2)
significantly more satisfied with their##3##5##(1993-3#1)(2007-1#2)
significantly more sensitive than##3##4##(1991-9#1)(1997-4#1)(2008-10#1)
significantly more than did##2##4##(2008-10#1)(2009-11#1)
significantly more than##6##3##(2008-10#2)(2008-2#1)(2009-11#1)(2011-2#2)
significantly more##145##2##(1990-12#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#3)(1993-2#1)(1993-3#3)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#5)(2013-8#2)
significantly narrowed##2##2##(2007-12#1)(2012-12#1)
significantly negative##2##2##(2010-8#1)(2011-2#1)
significantly negatively##2##2##(2010-1#1)(2012-3#1)
significantly older##3##2##(1996-9#1)(2010-11#1)(2011-2#1)
significantly on the##2##3##(2008-11#1)(2008-12#1)
significantly on##8##2##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
significantly only##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
significantly over the##2##3##(2008-6#1)(2012-12#1)
significantly over time##5##3##(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
significantly over##8##2##(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)
significantly poorer##6##2##(1991-2#1)(1994-3#1)(1996-2#1)(2007-8#1)(2008-11#1)(2013-1#1)
significantly potentiated##4##2##(1990-12#1)(1992-8#1)(1996-2#2)
significantly predict##3##2##(2007-9#1)(2008-12#1)(2009-6#1)
significantly predicted##5##2##(2008-8#1)(2012-1#3)(2013-1#1)
significantly predictive of##2##3##(1996-3#1)(2008-5#1)
significantly prevented increases in the urinary excretion of protein##2##9##(1994-5#2)
significantly prevented the##2##3##(1994-5#1)(2013-1#1)
significantly prevented##6##2##(1994-5#3)(1995-2#1)(1996-12#1)(2013-1#1)
significantly prevents the##2##3##(2008-5#1)(2010-6#1)
significantly prolonged the##2##3##(1996-2#1)(2008-8#1)
significantly prolonged##4##2##(1992-3#1)(1995-2#1)(1996-2#1)(2008-8#1)
significantly raised##5##2##(1990-12#1)(1991-12#1)(1992-12#1)(1993-8#1)(2007-10#1)
significantly reduce the risk##2##4##(2006-10#1)(2012-2#1)
significantly reduce the##13##3##(1992-8#1)(1995-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
significantly reduce##26##2##(1992-8#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
significantly reduced after##2##3##(1990-9#1)(2008-10#1)
significantly reduced at##4##3##(2008-10#3)(2008-7#1)
significantly reduced both##2##3##(1995-12#1)(2008-10#1)
significantly reduced by the##2##4##(1996-12#1)(2008-2#1)
significantly reduced by##25##3##(1991-2#1)(1992-12#1)(1995-11#1)(1995-12#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-10#1)(2012-12#1)(2012-3#1)
significantly reduced compared to##2##4##(1992-10#1)(2008-4#1)
significantly reduced compared with the##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
significantly reduced compared with##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
significantly reduced compared##6##3##(1992-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)
significantly reduced disease severity##2##4##(2008-10#2)
significantly reduced disease##5##3##(2008-10#5)
significantly reduced from##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
significantly reduced if##2##3##(1996-8#1)(2008-7#1)
significantly reduced in hippocampus and##2##5##(1997-2#1)(2007-8#1)
significantly reduced in the##5##4##(1990-5#1)(1995-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
significantly reduced in##37##3##(1990-5#2)(1991-12#1)(1991-5#1)(1993-11#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#5)(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
significantly reduced levels##2##3##(2008-10#1)(2011-2#1)
significantly reduced pain##2##3##(2008-7#1)(2013-1#1)
significantly reduced the EFS-evoked contractile response in##2##7##(2008-2#2)
significantly reduced the development of lesions caused by##2##8##(2008-10#2)
significantly reduced the extent of##2##5##(1990-11#1)(2008-10#1)
significantly reduced the incidence of##3##5##(2008-10#2)(2008-6#1)
significantly reduced the infarct size##2##5##(2011-2#2)
significantly reduced the infarct##3##4##(1995-12#1)(2011-2#2)
significantly reduced the number of##3##5##(1993-11#1)(2008-10#2)
significantly reduced the number##4##4##(1993-11#1)(2008-10#2)(2008-4#1)
significantly reduced the severity of##2##5##(2008-10#2)
significantly reduced the##56##3##(1990-11#1)(1990-2#1)(1990-7#3)(1991-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#2)(1995-5#1)(1997-2#2)(2008-10#18)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#2)
significantly reduced to##3##3##(2008-5#1)(2010-8#1)(2012-2#1)
significantly reduced when##2##3##(2008-7#1)(2011-2#1)
significantly reduced##252##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-9#1)(1991-12#4)(1991-2#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-8#3)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#8)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#10)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#75)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-10#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#1)
significantly reduces the incidence of##2##5##(1992-9#1)(1994-6#1)
significantly reduces the time required##2##5##(1997-4#1)(2008-10#1)
significantly reduces the##11##3##(1991-11#1)(1992-9#1)(1994-6#1)(1995-11#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
significantly reduces##16##2##(1991-11#1)(1992-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
significantly reducing##8##2##(1996-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-9#1)(2013-8#1)
significantly related to Medicaid##2##4##(1996-1#2)
significantly related to the presence of##2##6##(2007-7#1)(2008-10#1)
significantly related to the##4##4##(1996-12#1)(2007-7#1)(2008-10#1)(2011-1#1)
significantly related to##24##3##(1991-8#1)(1993-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
significantly restored##2##2##(2013-1#2)
significantly retarded##3##2##(2008-10#3)
significantly shorter than the##2##4##(2008-10#1)(2008-8#1)
significantly shorter than##3##3##(2008-10#1)(2008-8#2)
significantly shorter##17##2##(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#3)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
significantly similar to##2##3##(2008-10#2)
significantly since##3##2##(2008-7#1)(2011-2#1)(2011-3#1)
significantly slowed the##2##3##(2008-10#1)(2008-8#1)
significantly slower than##2##3##(2008-10#1)(2008-9#1)
significantly slower##8##2##(1992-9#1)(2008-10#4)(2008-9#2)(2011-2#1)
significantly smaller for##2##3##(2008-5#1)(2012-3#1)
significantly smaller in##7##3##(1991-11#1)(1991-12#1)(1995-12#1)(1996-7#1)(1997-2#1)(2007-11#1)(2011-2#1)
significantly smaller than in##2##4##(1995-12#1)(2013-8#1)
significantly smaller than that of##2##5##(2008-10#1)(2008-11#1)
significantly smaller than that##4##4##(2008-10#2)(2008-11#1)(2012-12#1)
significantly smaller than##10##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
significantly smaller##30##2##(1991-11#1)(1991-12#2)(1995-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
significantly sooner than##2##3##(1991-8#1)(2008-9#1)
significantly steeper##2##2##(2008-10#1)(2008-8#1)
significantly stimulated##2##2##(1990-8#1)(2009-12#1)
significantly superior to##2##3##(2008-3#1)(2010-3#1)
significantly superior##5##2##(2008-3#1)(2008-5#2)(2010-3#1)(2011-2#1)
significantly suppress##2##2##(2008-10#1)(2008-11#1)
significantly suppressed the##4##3##(1994-2#1)(1994-8#1)(2008-10#2)
significantly suppressed##17##2##(1994-2#2)(1994-8#3)(1995-12#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
significantly suppressing##2##2##(1990-2#1)(2007-12#1)
significantly the##30##2##(1992-5#1)(1993-11#1)(1994-2#1)(1996-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
significantly to the##14##3##(1993-6#1)(1995-2#1)(1996-12#1)(1997-2#2)(2008-10#3)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
significantly to##29##2##(1993-2#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-7#1)(2007-7#2)(2008-10#6)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
significantly under##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
significantly upfield##2##2##(1992-3#1)(2008-10#1)
significantly upon##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
significantly upregulated##3##2##(2008-10#2)(2013-1#1)
significantly weaker##2##2##(1991-12#1)(2008-8#1)
significantly when compared##2##3##(2008-11#1)(2011-2#1)
significantly when the##2##3##(1991-3#1)(2008-2#1)
significantly when##9##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#1)
significantly with a##2##3##(2008-12#1)(2008-3#1)
significantly with age in##2##4##(1990-3#1)(1994-11#1)
significantly with age##7##3##(1990-3#2)(1991-9#1)(1994-11#1)(2008-7#2)(2013-7#1)
significantly with both atorvastatin and rosuvastatin##2##6##(2011-1#2)
significantly with duration of##2##4##(2011-2#2)
significantly with increasing##3##3##(1992-6#1)(2008-2#1)(2008-9#1)
significantly with the##11##3##(1991-2#1)(1992-3#1)(1992-6#1)(1995-11#1)(2008-10#2)(2008-12#2)(2008-6#1)(2010-2#2)
significantly with##65##2##(1990-3#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-12#4)(1994-11#2)(1994-12#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-6#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#1)(2010-2#3)(2010-8#1)(2011-1#4)(2011-2#2)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#2)
significantly worse in##2##3##(2008-1#1)(2013-8#1)
significantly worse##7##2##(1996-7#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
significantly##3928##1##(1990-11#10)(1990-12#21)(1990-2#14)(1990-3#8)(1990-5#11)(1990-6#4)(1990-7#15)(1990-8#12)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#13)(1991-12#30)(1991-2#14)(1991-3#7)(1991-4#4)(1991-5#10)(1991-6#9)(1991-8#10)(1991-9#16)(1992-1#2)(1992-10#3)(1992-11#9)(1992-12#20)(1992-2#13)(1992-3#32)(1992-4#1)(1992-5#10)(1992-6#7)(1992-8#11)(1992-9#7)(1993-1#8)(1993-10#1)(1993-11#17)(1993-12#25)(1993-2#12)(1993-3#26)(1993-5#2)(1993-6#7)(1993-8#15)(1993-9#14)(1994-1#1)(1994-11#17)(1994-12#9)(1994-2#30)(1994-3#20)(1994-5#17)(1994-6#19)(1994-7#3)(1994-8#21)(1994-9#4)(1995-1#6)(1995-11#24)(1995-12#54)(1995-2#16)(1995-3#20)(1995-4#3)(1995-5#14)(1995-6#6)(1995-8#10)(1995-9#1)(1996-1#9)(1996-11#1)(1996-12#40)(1996-2#18)(1996-3#8)(1996-5#17)(1996-6#10)(1996-7#21)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#31)(1997-3#12)(1997-4#25)(1997-5#3)(1997-6#18)(1997-7#22)(1997-8#9)(1997-9#1)(2006-10#3)(2006-6#1)(2007-1#4)(2007-10#29)(2007-11#35)(2007-12#39)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#7)(2007-7#23)(2007-8#31)(2007-9#3)(2008-1#37)(2008-10#735)(2008-11#113)(2008-12#105)(2008-2#52)(2008-3#98)(2008-4#37)(2008-5#97)(2008-6#43)(2008-7#161)(2008-8#82)(2008-9#131)(2009-1#2)(2009-10#14)(2009-11#11)(2009-12#10)(2009-2#5)(2009-3#9)(2009-4#11)(2009-5#12)(2009-6#13)(2009-7#20)(2009-8#15)(2009-9#8)(2010-1#8)(2010-10#10)(2010-11#12)(2010-12#11)(2010-2#24)(2010-3#17)(2010-4#25)(2010-5#8)(2010-6#6)(2010-7#19)(2010-8#28)(2010-9#11)(2011-1#88)(2011-10#4)(2011-2#181)(2011-3#10)(2012-1#26)(2012-12#35)(2012-2#88)(2012-3#68)(2012-4#2)(2012-5#7)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#149)(2013-7#19)(2013-8#53)
significative##7##1##(1990-9#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)
signify##2##1##(1993-12#1)(2013-8#1)
signifying that##2##2##(2008-8#1)(2012-3#1)
signifying##5##1##(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-7#1)
signing##11##1##(1996-1#1)(1996-3#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
signouts##2##1##(1991-12#1)(1993-12#1)
signs and symptoms and##4##4##(1990-6#1)(1991-8#1)(1997-8#1)(2008-7#1)
signs and symptoms are##2##4##(2012-2#1)(2013-1#1)
signs and symptoms of leprosy##2##5##(2007-7#2)
signs and symptoms of##20##4##(1992-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#5)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2011-2#2)(2013-1#1)
signs and symptoms##53##3##(1990-6#1)(1991-8#1)(1992-1#1)(1992-9#1)(1997-2#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#7)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
signs and the##2##3##(1992-5#1)(2008-7#1)
signs and##65##2##(1990-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#7)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#3)(2008-9#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
signs are##4##2##(1993-2#1)(2007-7#1)(2011-1#1)(2012-3#1)
signs at##2##2##(2008-7#1)(2010-4#1)
signs could be observed##2##4##(2008-5#2)
signs could be##3##3##(2008-5#2)(2010-8#1)
signs for##3##2##(1995-1#1)(2011-2#1)(2012-12#1)
signs from##3##2##(2008-10#1)(2009-9#1)(2010-8#1)
signs in patients with malaria##2##5##(2012-12#2)
signs in patients with##3##4##(2012-12#2)(2013-1#1)
signs in##7##2##(1995-2#1)(2008-5#1)(2010-11#1)(2012-12#2)(2013-1#2)
signs included##3##2##(1997-3#1)(1997-5#1)(2011-1#1)
signs of a##3##3##(1994-6#1)(1994-9#1)(2013-1#1)
signs of acute##4##3##(1991-11#2)(2007-7#1)(2013-1#1)
signs of an##2##3##(2008-10#1)(2010-5#1)
signs of apoptosis and##2##4##(2008-4#1)(2008-7#1)
signs of cerebral##2##3##(2008-6#1)(2011-2#1)
signs of depression##2##3##(2008-7#1)(2013-1#1)
signs of heart##2##3##(2008-3#2)
signs of herniation##2##3##(2006-7#1)(2008-7#1)
signs of improvement##2##3##(2011-2#1)(2012-3#1)
signs of infection##5##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
signs of inflammation##4##3##(2007-7#1)(2007-8#1)(2008-10#1)(2012-3#1)
signs of left##2##3##(2008-3#1)(2008-7#1)
signs of local##2##3##(1993-1#1)(2009-4#1)
signs of recurrence##5##3##(1991-9#1)(2008-6#3)(2012-12#1)
signs of secondary##2##3##(1993-8#1)(2013-1#1)
signs of severe##2##3##(1997-5#1)(2012-2#1)
signs of skin ageing##2##4##(2008-5#2)
signs of skin##3##3##(2008-5#3)
signs of spinal cord##2##4##(1991-6#1)(2008-10#1)
signs of the##5##3##(1996-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
signs of toxicity##2##3##(1996-12#1)(2008-10#1)
signs of##176##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#6)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-2#2)(1995-3#3)(1996-12#2)(1996-5#1)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#5)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#11)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#14)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#2)(2012-3#9)(2013-1#13)(2013-8#2)
signs or symptoms of##3##4##(1991-8#1)(2008-7#2)
signs or symptoms##4##3##(1991-8#1)(2008-7#2)(2011-2#1)
signs or##6##2##(1991-8#1)(2007-10#1)(2008-7#2)(2010-6#1)(2011-2#1)
signs related to##2##3##(2006-10#1)(2011-1#1)
signs suggestive of##2##3##(1994-2#1)(2011-1#1)
signs than##2##2##(1996-8#1)(2008-5#1)
signs that##4##2##(1993-2#1)(2007-10#1)(2008-12#1)(2009-9#1)
signs to##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
signs were not##2##3##(2007-11#1)(2011-1#1)
signs were##11##2##(1992-5#1)(1993-2#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#2)(2013-1#2)
signs##381##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#6)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#7)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#4)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#4)(1996-1#1)(1996-12#2)(1996-5#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#5)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#8)(2006-10#4)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#8)(2007-12#1)(2007-2#2)(2007-7#11)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#19)(2008-6#5)(2008-7#24)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#9)(2011-2#26)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#4)(2012-3#16)(2013-1#24)(2013-8#5)
sika deer##4##2##(2008-5#4)
silage preparation##2##2##(2012-2#2)
silage quality at##2##3##(2012-2#2)
silage##25##1##(1990-6#2)(2008-10#6)(2008-12#4)(2012-2#11)(2013-1#2)
silane and##3##2##(2008-10#1)(2008-12#2)
silane film##4##2##(2008-10#4)
silane##17##1##(2007-12#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-5#1)(2009-7#4)
silanization##5##1##(2008-10#1)(2008-8#3)(2009-8#1)
silanized##4##1##(2008-10#4)
silanol##6##1##(2008-1#3)(2008-10#2)(2009-5#1)
silanols##3##1##(2008-1#1)(2008-10#2)
silastic tube##2##2##(2008-7#2)
silastic##4##1##(1996-3#1)(2006-12#1)(2008-7#2)
sildenafil##8##1##(2008-10#5)(2008-11#2)(2009-10#1)
silence##9##1##(2008-2#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
silenced dataset##3##2##(2008-7#3)
silenced genes##3##2##(2007-11#1)(2008-5#1)(2009-4#1)
silenced imprinted genes##2##3##(2008-7#2)
silenced imprinted##3##2##(2008-7#3)
silenced##22##1##(2007-11#2)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
silencer elements##2##2##(1995-8#2)
silencer##4##1##(1994-12#1)(1995-8#2)(2008-2#1)
silences##3##1##(2008-9#1)(2009-3#1)(2012-12#1)
silencing and##8##2##(2007-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
silencing as##2##2##(2010-2#1)(2011-2#1)
silencing by##4##2##(2008-2#1)(2009-3#1)(2012-2#1)(2012-3#1)
silencing in##6##2##(2008-2#3)(2008-9#1)(2011-1#1)(2013-1#1)
silencing of the##3##3##(2009-3#1)(2011-1#2)
silencing of##12##2##(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)
silencing suppression##3##2##(2008-10#3)
silencing the##2##2##(2008-2#1)(2011-1#1)
silencing triggering##3##2##(2011-1#3)
silencing##99##1##(2007-11#2)(2008-10#13)(2008-11#1)(2008-2#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#9)(2009-3#8)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#16)(2011-2#10)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#4)
silent ST segment depression##2##4##(2008-7#2)
silent amino acid substitutions##5##4##(2008-4#5)
silent and##2##2##(1991-11#1)(2008-1#1)
silent behavior##2##2##(2009-8#2)
silent circulation##2##2##(2007-10#2)
silent mating loci##2##3##(2008-8#2)
silent mutations##2##2##(1997-9#1)(2008-10#1)
silent myocardial ischemia##4##3##(1992-6#1)(2008-7#3)
silent myocardial##5##2##(1992-6#1)(2008-12#1)(2008-7#3)
silent##58##1##(1991-11#2)(1991-9#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-9#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
silent&quot##4##1##(1990-11#2)(1991-12#1)(1992-3#1)
silica and a##2##3##(2008-10#1)(2008-2#1)
silica and##19##2##(1990-8#1)(2007-12#3)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#5)(2009-12#1)(2010-7#1)
silica as the shell##2##4##(2008-10#1)(2010-5#1)
silica as the##3##3##(2008-10#2)(2010-5#1)
silica as##5##2##(2007-11#1)(2008-10#3)(2010-5#1)
silica at##3##2##(2008-10#1)(2008-3#2)
silica based##2##2##(2008-10#2)
silica beads##3##2##(2008-10#3)
silica binding##2##2##(2008-12#2)
silica by##6##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#1)
silica can##2##2##(2008-10#1)(2008-2#1)
silica capillaries##2##2##(2008-10#2)
silica capillary and##2##3##(2008-10#2)
silica capillary columns##2##3##(2008-10#2)
silica capillary##6##2##(2008-10#6)
silica cartridge##2##2##(2008-10#2)
silica chromatography##3##2##(2008-10#3)
silica column##10##2##(1996-5#1)(2008-10#8)(2008-4#1)
silica columns##3##2##(2008-10#3)
silica content##3##2##(2008-10#3)
silica core##3##2##(2007-12#1)(2008-2#2)
silica exposure##3##2##(2008-10#3)
silica fiber and##2##3##(2007-11#1)(2008-2#1)
silica fiber laser##4##3##(2007-11#2)(2008-2#2)
silica fiber##15##2##(2007-11#5)(2007-12#2)(2008-2#8)
silica fibers##4##2##(2007-11#3)(2008-2#1)
silica fillers##3##2##(2009-7#3)
silica films for##2##3##(2007-11#1)(2008-2#1)
silica films##6##2##(2007-11#3)(2008-2#3)
silica for##3##2##(2008-10#1)(2008-2#2)
silica fume##3##2##(2008-10#3)
silica gel 60##2##3##(1994-3#1)(2008-10#1)
silica gel TLC##2##3##(2008-11#1)(2010-4#1)
silica gel and estimated##2##4##(2008-10#2)
silica gel and##15##3##(2008-10#12)(2008-5#1)(2011-2#1)(2013-8#1)
silica gel as a solid##2##5##(2008-10#2)
silica gel as a##4##4##(2008-10#4)
silica gel as##5##3##(2008-10#5)
silica gel chemically modified with zirconium##2##6##(2008-10#2)
silica gel column chromatography##2##4##(2008-11#1)(2008-5#1)
silica gel column##6##3##(1991-5#1)(2008-10#2)(2008-11#1)(2008-5#2)
silica gel for the##2##4##(2008-10#2)
silica gel for##4##3##(2008-10#4)
silica gel has been##2##4##(2008-10#2)
silica gel in##2##3##(2008-10#2)
silica gel modified with##8##4##(2008-10#8)
silica gel phases##4##3##(2008-10#4)
silica gel stationary phase##9##4##(2008-10#9)
silica gel surface##3##3##(2008-10#3)
silica gel was investigated##2##4##(2008-10#2)
silica gel was##8##3##(2008-10#8)
silica gel with##3##3##(2008-10#3)
silica gel##138##2##(1991-5#1)(1992-12#1)(1994-3#1)(1996-5#2)(2007-11#1)(2008-10#119)(2008-11#3)(2008-5#3)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
silica gel)##2##2##(2008-10#2)
silica gels modified with##2##4##(2008-10#2)
silica gels##13##2##(1990-8#1)(2008-10#11)(2010-4#1)
silica glass and##2##3##(2007-12#1)(2008-3#1)
silica glass##10##2##(2007-11#2)(2007-12#5)(2008-10#1)(2008-3#2)
silica glasses##3##2##(2007-12#3)
silica in aqueous##2##3##(2008-10#2)
silica in the##2##3##(2007-12#1)(2008-10#1)
silica in##9##2##(2007-12#1)(2008-10#7)(2012-2#1)
silica incorporated##2##2##(2008-5#2)
silica is##5##2##(2007-11#2)(2008-10#3)
silica matrix##3##2##(1990-7#1)(2008-10#2)
silica membrane disks modified with##5##5##(2008-10#5)
silica membrane disks modified##10##4##(2008-10#10)
silica membrane##11##2##(2008-10#11)
silica microspheres##3##2##(2007-11#1)(2007-12#2)
silica modified by organofunctional silane##2##5##(2009-7#2)
silica modified by##3##3##(2007-11#1)(2009-7#2)
silica modified with N-propylsalicylaldimine##2##4##(2008-10#2)
silica modified with##4##3##(2008-10#4)
silica modified##7##2##(2007-11#1)(2008-10#4)(2009-7#2)
silica monoliths##4##2##(2007-12#1)(2008-10#3)
silica nanoparticle##2##2##(2008-7#1)(2011-1#1)
silica nanoparticles##11##2##(2008-7#2)(2009-2#1)(2010-12#4)(2010-4#3)(2011-1#1)
silica on##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
silica optical##2##2##(2007-11#2)
silica or##2##2##(2007-12#1)(2008-10#1)
silica particles##6##2##(1990-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)
silica samples##2##2##(2007-12#1)(2008-10#1)
silica slabs##2##2##(2008-3#2)
silica sol-gel modified##2##3##(2008-10#2)
silica sol-gel##4##2##(2008-10#4)
silica sol-gels##2##2##(2010-7#2)
silica substrate##5##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
silica substrates##2##2##(2007-11#1)(2008-2#1)
silica support##5##2##(1990-8#1)(1997-2#1)(2008-10#3)
silica surface were obtained##2##4##(2008-10#2)
silica surface were##3##3##(2008-10#3)
silica surface##13##2##(1997-2#1)(2008-10#11)(2008-3#1)
silica surfaces##4##2##(2008-10#3)(2010-7#1)
silica to##2##2##(1996-5#1)(2008-3#1)
silica was##5##2##(2008-10#4)(2008-3#1)
silica with##5##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)
silica##535##1##(1990-7#1)(1990-8#5)(1991-5#1)(1992-10#1)(1992-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-5#4)(1997-2#2)(2007-11#41)(2007-12#36)(2008-1#1)(2008-10#310)(2008-11#3)(2008-12#5)(2008-2#26)(2008-3#32)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#5)(2009-12#4)(2009-2#1)(2009-6#1)(2009-7#8)(2009-8#3)(2010-12#4)(2010-4#10)(2010-5#1)(2010-7#4)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#5)(2013-1#2)(2013-8#1)
silica)##2##1##(2008-10#1)(2008-2#1)
silica-based##7##1##(1997-2#2)(2008-10#4)(2008-4#1)
silica-coated##5##1##(2008-10#4)(2009-8#1)
silica-fiber##2##1##(2007-12#1)(2008-10#1)
silica-immobilized##2##1##(2008-10#2)
silicagel##3##1##(2008-10#2)(2008-5#1)
silicalite##2##1##(2008-10#2)
silicas##6##1##(1990-8#2)(1992-7#1)(2008-1#2)(2008-10#1)
silicate film##3##2##(2008-10#3)
silicate glass##5##2##(2007-12#2)(2008-3#3)
silicate glasses##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
silicate in##2##2##(2008-10#2)
silicate interference in##2##3##(2008-10#2)
silicate interference##4##2##(2008-10#4)
silicate##45##1##(1995-6#1)(2007-11#1)(2007-12#8)(2008-10#26)(2008-2#1)(2008-3#5)(2008-6#1)(2009-7#2)
silicates in##2##2##(2008-10#2)
silicates##5##1##(1992-7#1)(2008-10#4)
siliceous##3##1##(2008-10#2)(2012-2#1)
silicic acid##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
silico and in vitro##2##4##(2008-10#1)(2013-1#1)
silico methods##2##2##(2009-8#1)(2009-9#1)
silico prediction##4##2##(2008-4#2)(2012-3#2)
silico##28##1##(2008-10#2)(2008-4#2)(2008-7#5)(2008-8#1)(2009-8#2)(2009-9#4)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
silicon (Si)##7##2##(2008-10#4)(2008-3#1)(2008-9#1)(2012-2#1)
silicon CCD camera##2##3##(2007-11#2)
silicon CCD##3##2##(2007-11#3)
silicon and alkali##2##3##(2013-8#2)
silicon and silicon##2##3##(2008-2#1)(2008-3#1)
silicon and##12##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2013-8#2)
silicon are##2##2##(2007-12#1)(2008-2#1)
silicon as##2##2##(2008-3#2)
silicon atom##2##2##(2010-12#2)
silicon atoms##2##2##(2010-12#2)
silicon by##3##2##(2008-10#2)(2012-2#1)
silicon content##3##2##(2008-10#3)
silicon dioxide##4##2##(1992-7#1)(2008-2#1)(2008-3#1)(2008-7#1)
silicon has##2##2##(2008-10#1)(2012-12#1)
silicon in##7##2##(2008-10#5)(2008-2#1)(2012-12#1)
silicon is##2##2##(2008-10#1)(2008-2#1)
silicon layers##2##2##(2008-10#2)
silicon microlenses##3##2##(2008-2#3)
silicon micromachined##2##2##(2007-11#1)(2008-3#1)
silicon mirror##2##2##(2008-2#1)(2008-3#1)
silicon nanowires##4##2##(2008-7#2)(2010-3#2)
silicon nitride##4##2##(2008-10#1)(2008-3#2)(2009-2#1)
silicon oil##4##2##(2008-10#3)(2008-5#1)
silicon on##3##2##(2008-10#2)(2008-9#1)
silicon oxide##9##2##(2007-12#2)(2008-10#3)(2008-3#3)(2008-7#1)
silicon photodetector##3##2##(2007-11#1)(2008-3#2)
silicon photodetectors##2##2##(2008-2#1)(2008-3#1)
silicon photodiode##5##2##(2008-2#2)(2008-3#3)
silicon photodiodes##2##2##(2007-11#1)(2008-2#1)
silicon substrate by##2##3##(2007-12#2)
silicon substrate##10##2##(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
silicon substrates##6##2##(2007-12#3)(2008-10#1)(2009-11#2)
silicon surface##2##2##(2008-10#1)(2012-2#1)
silicon surfaces##5##2##(2008-10#1)(2008-7#4)
silicon tethers##2##2##(2008-8#2)
silicon tetrafluoride##3##2##(2008-10#3)
silicon wafer##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
silicon wafers##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
silicon were##4##2##(2008-10#3)(2009-10#1)
silicon##270##1##(1991-5#1)(1991-9#1)(1992-11#2)(1992-7#1)(1994-2#1)(1997-6#1)(2006-4#1)(2007-11#16)(2007-12#21)(2007-7#1)(2008-10#90)(2008-11#3)(2008-12#1)(2008-2#27)(2008-3#49)(2008-4#1)(2008-5#3)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#7)(2009-2#1)(2009-5#1)(2010-12#5)(2010-3#2)(2010-4#2)(2011-2#1)(2012-12#5)(2012-2#7)(2013-1#1)(2013-8#2)
silicon-based technologies##2##2##(2008-7#1)(2012-2#1)
silicon-based##5##1##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
silicon-on-insulator (SOI)##2##2##(2007-12#1)(2013-8#1)
silicon-on-insulator##7##1##(2007-11#2)(2007-12#3)(2008-3#1)(2013-8#1)
silicon-treated plants##3##2##(2008-10#3)
silicone and##2##2##(2008-10#1)(2011-2#1)
silicone catheter##4##2##(2013-1#4)
silicone intraocular##2##2##(2008-3#2)
silicone oil##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
silicone rubber##5##2##(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)
silicone##52##1##(1995-12#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-2#2)(2008-3#4)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#7)(2009-4#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#7)
silicones##5##1##(1996-3#1)(2008-5#3)(2013-1#1)
silicosis and##3##2##(2009-12#3)
silicosis##10##1##(1992-11#1)(2008-7#4)(2009-12#3)(2012-2#2)
silicotungstic acid##4##2##(2008-10#4)
silk emergence##2##2##(2008-10#2)
silk fibroin##9##2##(2008-11#2)(2008-5#2)(2012-2#1)(2012-8#4)
silk glands##2##2##(2007-12#2)
silk##45##1##(1990-9#2)(1991-2#1)(2007-12#6)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#1)(2012-2#16)(2012-8#4)
silk-producing##3##1##(2007-12#3)
silks were inoculated##2##3##(2008-10#2)
silks##7##1##(2008-10#7)
silkworm eclosion hormone##5##3##(1990-12#5)
silkworm larvae##3##2##(1997-3#1)(1997-4#1)(2008-11#1)
silkworm##23##1##(1990-12#6)(1995-11#5)(1997-3#1)(1997-4#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#2)(2012-2#1)
sill values##2##2##(2008-10#2)
sill##4##1##(2008-10#4)
silorane##2##1##(2011-2#2)
siloxane##4##1##(2008-10#1)(2008-3#1)(2009-5#1)(2011-1#1)
silt (0##2##2##(2008-10#2)
silt + leaf mold##3##4##(2008-12#3)
silt loam soil##3##3##(2008-10#3)
silt loam##7##2##(2008-10#7)
silt##16##1##(2008-10#11)(2008-12#5)
silty clay loam##3##3##(2008-10#3)
silty clay##5##2##(2008-10#3)(2012-12#2)
silty##6##1##(2008-10#4)(2012-12#2)
silvanus##3##1##(2011-2#3)
silver (Ag)##2##2##(2008-10#1)(2008-3#1)
silver and copper##2##3##(2008-10#2)
silver and manganese##3##3##(2008-10#3)
silver and##11##2##(1992-12#1)(2007-12#1)(2008-10#7)(2008-3#1)(2012-2#1)
silver as##3##2##(2008-10#3)
silver at##3##2##(2008-10#3)
silver bromide crystals##3##3##(2008-2#3)
silver by##3##2##(2008-10#2)(2008-3#1)
silver chloride activated surface-silver##2##4##(2008-10#2)
silver chloride##4##2##(2008-10#4)
silver coating##2##2##(2007-12#2)
silver colloidal##2##2##(2008-10#2)
silver deposits##2##2##(2008-7#2)
silver diethyldithiocarbamate##4##2##(2008-10#4)
silver electrode##7##2##(2008-10#7)
silver enhancement##2##2##(2008-10#2)
silver film##4##2##(2008-2#1)(2008-3#3)
silver films##2##2##(2008-3#1)(2009-5#1)
silver grains##3##2##(2008-3#2)(2008-5#1)
silver halide sensitized gelatin##2##4##(2007-11#1)(2008-3#1)
silver halide##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
silver hollow glass waveguides##2##4##(2008-2#2)
silver impregnation and sequence specific fluorochromes CMA3 and DAPI##2##9##(2008-12#2)
silver impregnation##3##2##(2008-12#2)(2008-7#1)
silver in environmental samples##2##4##(2008-10#2)
silver in environmental##3##3##(2008-10#3)
silver in##11##2##(2008-10#11)
silver ion##6##2##(2008-10#6)
silver ions##11##2##(2008-10#11)
silver island##4##2##(2008-3#4)
silver mirror reaction glass##2##4##(2009-4#2)
silver mottle virus##10##3##(2008-10#10)
silver nanocubes##6##2##(2008-5#3)(2013-1#3)
silver nanoparticles in##2##3##(2008-10#1)(2011-2#1)
silver nanoparticles##11##2##(2008-10#5)(2008-3#1)(2011-2#5)
silver nitrate and##2##3##(2008-10#2)
silver nitrate##6##2##(2008-10#5)(2013-1#1)
silver or##2##2##(2008-10#1)(2008-4#1)
silver oxide##3##2##(2008-10#3)
silver particles##2##2##(2008-10#2)
silver pomfret##2##2##(2008-12#2)
silver preconcentration##2##2##(2008-10#2)
silver scurf of##3##3##(2008-10#3)
silver sea bream##3##3##(2009-5#1)(2010-5#2)
silver solution##2##2##(2008-10#1)(2008-2#1)
silver stain##2##2##(2008-4#1)(2012-3#1)
silver staining and##3##3##(1992-8#1)(1994-6#1)(2008-7#1)
silver staining in the##2##4##(1992-8#1)(1994-6#1)
silver staining methods##2##3##(1997-3#1)(2008-2#1)
silver staining##26##2##(1992-8#2)(1994-6#3)(1995-12#1)(1997-3#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#3)(2010-3#1)
silver stains##2##2##(1991-1#2)
silver surface##2##2##(2008-10#2)
silver were##3##2##(2008-10#3)
silver##257##1##(1991-1#2)(1992-12#5)(1992-8#3)(1994-6#3)(1995-12#1)(1996-2#1)(1997-3#3)(2007-11#1)(2007-12#7)(2008-10#139)(2008-12#6)(2008-2#15)(2008-3#21)(2008-4#9)(2008-5#5)(2008-7#6)(2008-8#4)(2009-4#2)(2009-5#2)(2010-3#1)(2010-5#2)(2011-2#7)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#1)
silver(I) and##3##2##(2008-10#3)
silver(I) at##2##2##(2008-10#2)
silver(I) by##2##2##(2008-10#2)
silver(I) was##2##2##(2008-10#2)
silver(I)##23##1##(2008-10#23)
silver-coated##3##1##(2008-2#1)(2008-3#2)
silver-cysteine##3##1##(1992-12#3)
silver-nitrate##2##1##(1992-12#2)
silvicultural##2##1##(2008-5#1)(2011-2#1)
silybin##2##1##(2008-11#1)(2008-5#1)
silyl acetal##2##2##(2008-4#2)
silyl##5##1##(2008-4#4)(2009-5#1)
silylated##7##1##(1996-5#5)(2008-5#1)(2012-3#1)
silylation##6##1##(1996-5#1)(2008-10#3)(2008-5#1)(2010-11#1)
simazine and##2##2##(2008-10#2)
simazine##14##1##(2008-10#12)(2008-2#2)
simian immunodeficiency virus (SIV)##4##4##(1992-6#1)(1995-2#2)(1997-3#1)
simian immunodeficiency virus protease##2##4##(1991-9#1)(1992-6#1)
simian immunodeficiency virus##10##3##(1991-9#1)(1992-6#2)(1995-2#4)(1997-3#2)(2013-7#1)
simian immunodeficiency##11##2##(1991-9#1)(1992-6#2)(1995-2#4)(1997-3#2)(1997-6#1)(2013-7#1)
simian virus 40 large##2##4##(2008-11#1)(2013-1#1)
simian virus 40##10##3##(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-11#2)(2013-1#1)
simian##25##1##(1991-9#1)(1992-6#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#5)(1995-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
simii in a##3##3##(2008-5#3)
simii##5##1##(2008-5#5)
similar DNA##4##2##(2008-4#1)(2008-5#1)(2008-9#2)
similar EC50 values##2##3##(1995-12#2)
similar Km values##2##3##(1994-6#1)(1995-5#1)
similar Km##3##2##(1992-6#1)(1994-6#1)(1995-5#1)
similar P##2##2##(2008-10#1)(2012-3#1)
similar according to##2##3##(2010-12#1)(2013-1#1)
similar across different##2##3##(2008-5#1)(2013-8#1)
similar across##8##2##(1991-3#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
similar activity##2##2##(1996-2#1)(2008-5#1)
similar affinities##2##2##(1994-2#1)(1995-6#1)
similar affinity##4##2##(1992-6#1)(1993-8#1)(1995-2#1)(2008-5#1)
similar age##5##2##(1994-11#1)(1996-5#1)(2009-12#1)(2010-2#1)(2013-1#1)
similar amino acids##2##3##(1995-9#2)
similar among the##2##3##(1994-11#1)(2008-10#1)
similar among##9##2##(1994-11#1)(1995-11#1)(2008-10#3)(2008-11#2)(2009-9#1)(2013-8#1)
similar amounts of##6##3##(1994-8#1)(2007-2#1)(2008-11#2)(2008-5#1)(2010-2#1)
similar and the##4##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
similar and##16##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
similar antibody##2##2##(1996-12#1)(2011-2#1)
similar approach##5##2##(1993-11#2)(2008-3#1)(2008-7#1)(2009-8#1)
similar approaches to##2##3##(2010-3#1)(2010-6#1)
similar approaches##4##2##(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#1)
similar at the##2##3##(1995-12#1)(2011-2#1)
similar at##4##2##(1990-5#1)(1995-12#1)(2008-4#1)(2011-2#1)
similar banding pattern##2##3##(2008-10#1)(2008-12#1)
similar behavior##4##2##(1991-2#1)(1991-6#1)(2008-11#1)(2008-3#1)
similar benefit##2##2##(1993-11#1)(2008-3#1)
similar between the two groups##2##5##(2007-8#1)(2008-8#1)
similar between the##6##3##(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
similar between treatment groups##2##4##(2010-4#1)(2012-12#1)
similar between treatment##3##3##(2010-4#1)(2012-12#1)(2012-3#1)
similar between##27##2##(1991-9#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-8#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#4)
similar binding##5##2##(1991-5#1)(1993-6#1)(1997-6#1)(2008-10#1)(2012-2#1)
similar biochemical##2##2##(1994-8#1)(1995-11#1)
similar biological properties##2##3##(1993-8#1)(2008-5#1)
similar biological##3##2##(1991-2#1)(1993-8#1)(2008-5#1)
similar biomechanical##2##2##(2008-9#1)(2009-1#1)
similar but##12##2##(1991-9#1)(1993-5#1)(1994-5#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)(2012-12#1)
similar case reports##2##3##(2008-7#1)(2011-2#1)
similar case##4##2##(2007-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
similar cases in the##2##4##(1997-3#1)(2012-12#1)
similar cases in##3##3##(1997-3#1)(2012-12#2)
similar cases##6##2##(1992-2#1)(1997-3#1)(2008-10#1)(2008-12#1)(2012-12#2)
similar cell##3##2##(1994-11#1)(2008-11#2)
similar change in##2##3##(1990-3#1)(1994-5#1)
similar change##3##2##(1990-3#1)(1994-3#1)(1994-5#1)
similar changes to##2##3##(1991-6#1)(2013-1#1)
similar changes were##2##3##(2010-11#1)(2010-12#1)
similar changes##8##2##(1991-6#1)(1995-2#1)(2008-10#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#2)
similar characteristics##6##2##(1990-2#1)(1992-6#1)(1994-12#1)(1995-11#1)(2007-5#1)(2009-9#1)
similar chemical##4##2##(2008-10#4)
similar circumstances##2##2##(1991-3#1)(1993-3#1)
similar clinical##5##2##(1995-2#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
similar composition##2##2##(2008-10#2)
similar compounds##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
similar concentrations of##2##3##(1994-6#1)(2008-10#1)
similar concentrations##3##2##(1992-9#1)(1994-6#1)(2008-10#1)
similar concerning mortality##2##3##(2007-8#2)
similar conclusions##2##2##(2008-5#1)(2008-7#1)
similar conditions of##2##3##(1997-4#1)(2008-10#1)
similar conditions##18##2##(1990-9#1)(1995-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-8#1)(2009-7#2)(2010-12#1)
similar configurations##2##2##(2008-10#1)(2009-8#1)
similar criteria##2##2##(1995-6#1)(2008-7#1)
similar culture##2##2##(2008-2#1)(2008-7#1)
similar data from##2##3##(1991-12#1)(2008-4#1)
similar data##3##2##(1991-12#1)(1996-2#1)(2008-4#1)
similar decrease##3##2##(1990-3#1)(2008-11#1)(2008-2#1)
similar degree of##3##3##(1992-10#1)(1992-3#1)(1994-8#1)
similar degree##9##2##(1992-10#1)(1992-3#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
similar developmental##2##2##(2007-12#1)(2010-6#1)
similar dimensions##2##2##(2009-2#1)(2013-8#1)
similar disease##5##2##(1991-2#1)(2007-8#1)(2008-10#3)
similar disorder##2##2##(2008-10#1)(2012-3#1)
similar distribution patterns##2##3##(2008-9#1)(2010-1#1)
similar distribution##6##2##(1990-12#1)(1991-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
similar distributions##2##2##(2008-5#2)
similar dose##2##2##(2006-6#1)(2008-11#1)
similar educational##2##2##(2008-9#2)
similar effect as##3##3##(1992-6#1)(2008-10#1)(2008-12#1)
similar effect##15##2##(1991-5#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#2)
similar effects in##2##3##(1995-2#1)(2008-2#1)
similar effects on morning peak##2##5##(1996-1#1)(1996-2#1)
similar effects on##4##3##(1996-1#1)(1996-2#1)(2008-8#1)(2011-2#1)
similar effects##10##2##(1992-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
similar efficacy##5##2##(1994-3#1)(2008-10#1)(2008-5#2)(2009-8#1)
similar experiment##2##2##(2008-10#1)(2008-7#1)
similar experimental##3##2##(1990-2#1)(2008-11#1)(2008-4#1)
similar experiments##2##2##(1995-8#1)(2008-8#1)
similar expression##5##2##(1996-12#1)(2008-2#2)(2008-3#1)(2008-8#1)
similar extent##6##2##(1990-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(2009-12#1)(2013-8#1)
similar fashion##11##2##(1990-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
similar features##2##2##(2008-10#1)(2012-8#1)
similar findings##2##2##(1997-3#1)(2012-3#1)
similar for all##10##3##(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)
similar for both##11##3##(1991-1#1)(1995-8#1)(1996-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-11#1)(2010-12#1)
similar for men and women##2##5##(2012-12#2)
similar for the three##3##4##(1992-1#1)(2008-10#1)(2008-8#1)
similar for the##6##3##(1992-1#1)(2008-10#3)(2008-8#1)(2010-3#1)
similar for##46##2##(1990-2#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-3#1)(1995-3#2)(1995-8#1)(1996-1#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#1)(2010-3#1)(2011-10#1)(2011-2#3)(2012-12#3)(2013-8#1)
similar frequencies##2##2##(2008-10#1)(2012-2#1)
similar frequency##4##2##(1990-8#1)(1996-6#1)(2008-10#1)(2012-2#1)
similar function##3##2##(1995-3#1)(2008-9#1)(2009-5#1)
similar functions##2##2##(1995-12#1)(2009-8#1)
similar gene##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2010-5#1)
similar genetic##4##2##(1996-8#1)(2008-10#2)(2008-2#1)
similar genomic##2##2##(2008-5#1)(2009-5#1)
similar group of##2##3##(1990-6#1)(2009-10#1)
similar growth##2##2##(2008-11#1)(2009-4#1)
similar if not##2##3##(1993-9#1)(1995-3#1)
similar improvement in##2##3##(2007-12#1)(2008-7#1)
similar in all##5##3##(1994-8#1)(2008-10#2)(2008-4#1)(2008-7#1)
similar in both groups##14##4##(1990-8#1)(1991-12#1)(1991-5#1)(1994-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#2)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#1)
similar in both populations##2##4##(2007-10#1)(2013-7#1)
similar in both sexes##2##4##(2008-3#1)(2010-12#1)
similar in both the##3##4##(2007-8#1)(2011-2#1)(2012-3#1)
similar in both##32##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
similar in composition to##2##4##(2008-10#1)(2008-11#1)
similar in magnitude to##2##4##(2010-4#1)(2011-2#1)
similar in magnitude##3##3##(2008-9#1)(2010-4#1)(2011-2#1)
similar in many##2##3##(1991-5#1)(2008-11#1)
similar in shape and##2##4##(2007-11#1)(2012-2#1)
similar in size to the##2##5##(1995-2#1)(2008-5#1)
similar in size##4##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
similar in terms of##4##4##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
similar in that##2##3##(1990-11#1)(1993-8#1)
similar in the 2##2##4##(1991-11#1)(2008-10#1)
similar in the two groups##8##5##(1990-12#1)(1992-2#1)(1992-3#1)(2007-8#3)(2011-1#1)(2012-2#1)
similar in the two##11##4##(1990-12#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(2007-8#3)(2011-1#1)(2012-2#1)(2012-3#1)
similar in the##27##3##(1990-12#1)(1991-11#2)(1991-12#1)(1992-2#2)(1992-3#1)(1993-3#1)(1995-12#1)(2007-8#3)(2008-10#7)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
similar in their##2##3##(2010-10#1)(2011-2#1)
similar in these##2##3##(2008-7#1)(2010-2#1)
similar in##149##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#4)(1991-5#2)(1991-7#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#3)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
similar increases in##2##3##(1990-8#1)(2008-7#1)
similar inhibitory effects##2##3##(1990-7#1)(2008-10#1)
similar irrespective of##2##3##(1990-12#1)(2008-3#1)
similar isolates##2##2##(2008-10#2)
similar kinetic##3##2##(1994-6#1)(1997-2#1)(2008-6#1)
similar lesion##2##2##(1993-3#1)(2008-10#1)
similar lesions##3##2##(1995-2#1)(2009-12#1)(2012-3#1)
similar level of##4##3##(1994-5#1)(2008-10#2)(2008-11#1)
similar levels in##3##3##(1991-6#1)(2008-10#2)
similar levels of##8##3##(1992-12#1)(1995-2#1)(1995-8#2)(1997-1#1)(2008-10#2)(2009-12#1)
similar levels##13##2##(1991-6#1)(1992-12#1)(1995-2#1)(1995-8#2)(1997-1#1)(2008-10#4)(2008-11#1)(2009-12#1)(2011-2#1)
similar ligand##2##2##(1997-2#1)(1997-4#1)
similar light##3##2##(1996-5#1)(2008-11#1)(2008-9#1)
similar locations##2##2##(2008-10#1)(2008-9#1)
similar low levels of##2##4##(2008-10#1)(2009-7#1)
similar magnitude and##2##3##(1997-4#1)(2008-10#1)
similar magnitude##7##2##(1992-8#1)(1997-4#1)(2008-10#3)(2008-11#2)
similar mean##2##2##(2008-7#1)(2013-1#1)
similar mechanism##5##2##(1990-12#1)(1995-3#1)(2008-6#1)(2008-7#1)(2009-10#1)
similar mechanisms of##4##3##(1991-9#1)(2008-10#2)(2012-2#1)
similar mechanisms##8##2##(1991-9#2)(1997-2#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
similar methods##2##2##(2008-11#1)(2008-2#1)
similar molecular mass##2##3##(1993-9#1)(2008-10#1)
similar molecular weight and##2##4##(1990-12#1)(1995-11#1)
similar molecular##6##2##(1990-12#2)(1993-9#1)(1994-6#1)(1995-11#1)(2008-10#1)
similar morphological##2##2##(2008-10#1)(2008-9#1)
similar nature##2##2##(2008-10#1)(2012-3#1)
similar numbers of##2##3##(1991-12#1)(2008-5#1)
similar numbers##4##2##(1991-12#2)(2008-5#2)
similar on the##2##3##(2008-10#1)(2008-8#1)
similar on##5##2##(1992-3#1)(2008-10#3)(2008-8#1)
similar or enhanced##2##3##(2008-11#1)(2009-5#1)
similar or##14##2##(1991-5#1)(1995-11#1)(1995-5#1)(2006-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#1)
similar organization##2##2##(2008-8#1)(2008-9#1)
similar over##2##2##(2008-3#1)(2011-2#1)
similar pattern of##8##3##(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(2011-2#1)
similar pattern##18##2##(1990-12#1)(1990-8#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-2#2)(2012-12#1)
similar patterns of##8##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2012-3#1)
similar patterns##16##2##(1993-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#4)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
similar percentages of##2##3##(2008-10#1)(2013-8#1)
similar performance to##2##3##(2008-10#1)(2013-1#1)
similar performance##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
similar perturbations##2##2##(1992-6#1)(2011-2#1)
similar phenomena##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)
similar polypeptide##3##2##(1990-7#1)(1992-6#1)(2008-12#1)
similar populations##4##2##(1994-1#1)(1996-2#1)(1996-3#1)(2010-4#1)
similar positions##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
similar potency and##3##3##(1993-8#2)(1997-1#1)
similar potency to##4##3##(1994-8#1)(1995-12#1)(2008-5#1)(2008-9#1)
similar potency##10##2##(1991-3#1)(1993-8#2)(1994-8#1)(1995-12#2)(1997-1#1)(2008-12#1)(2008-5#1)(2008-9#1)
similar pregnancy rates##2##3##(1991-12#1)(1991-3#1)
similar principles##2##2##(2008-1#1)(2008-4#1)
similar problems##4##2##(1997-3#1)(2008-7#1)(2009-3#1)(2009-9#1)
similar procedures##2##2##(2007-11#1)(2012-3#1)
similar properties##4##2##(1994-8#1)(1997-6#1)(2008-10#2)
similar quantities##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
similar rates of##5##3##(1992-10#1)(2008-8#1)(2010-2#1)(2013-1#2)
similar rates##8##2##(1992-10#1)(1994-11#1)(1995-6#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-1#2)
similar reaction##2##2##(1996-5#1)(2008-6#1)
similar records of##3##3##(1990-6#1)(2008-12#2)
similar reduction##3##2##(1993-12#1)(1994-8#1)(2008-5#1)
similar regions##2##2##(2008-4#1)(2010-3#1)
similar regulatory##3##2##(1992-12#1)(1993-6#1)(2008-7#1)
similar resolution##2##2##(1994-12#1)(2010-7#1)
similar response##5##2##(1995-12#1)(2008-10#2)(2008-3#1)(2009-5#1)
similar responses##3##2##(1990-5#1)(2008-10#1)(2013-8#1)
similar result##3##2##(1991-9#1)(2008-11#2)
similar results and##2##3##(2008-10#1)(2008-3#1)
similar results in##6##3##(1990-6#1)(1996-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
similar results were obtained with##3##5##(1990-8#1)(2008-10#2)
similar results were obtained##5##4##(1990-8#1)(2008-10#3)(2008-11#1)
similar results were##7##3##(1990-8#1)(1992-3#1)(2008-10#3)(2008-11#1)(2013-1#1)
similar results##39##2##(1990-6#1)(1990-8#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2011-2#1)(2012-12#3)(2012-7#1)(2013-1#3)
similar risk##4##2##(2008-3#2)(2008-7#1)(2011-1#1)
similar sample##2##2##(2008-10#2)
similar sensitivity and specificity##2##4##(1992-5#1)(2012-1#1)
similar sensitivity##3##2##(1992-5#1)(1997-1#1)(2012-1#1)
similar sequences##3##2##(1994-6#1)(1995-2#1)(2008-4#1)
similar set of##5##3##(1996-1#1)(2008-10#1)(2009-8#1)(2010-3#1)(2013-1#1)
similar side##2##2##(1993-11#1)(2008-10#1)
similar sites##3##2##(1993-6#1)(2007-5#2)
similar size##12##2##(1993-12#1)(1994-11#1)(1994-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2010-2#1)
similar species##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
similar spectral##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
similar spectrum of##2##3##(1994-6#1)(2008-10#1)
similar stability ([Gdn##2##3##(1992-6#2)
similar stability##3##2##(1992-6#2)(2008-10#1)
similar stimulation##2##2##(1990-5#1)(1995-8#1)
similar structural##2##2##(2008-10#2)
similar structures##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
similar studies##7##2##(2008-10#3)(2008-11#2)(2008-5#2)
similar study was##2##3##(1992-5#1)(2008-9#1)
similar study##4##2##(1992-5#1)(1996-11#1)(2008-9#1)(2012-12#1)
similar symptoms##5##2##(1993-8#1)(1997-3#1)(2008-10#3)
similar systems##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
similar technique##3##2##(1991-3#1)(2008-3#1)(2008-5#1)
similar tendency##2##2##(2007-11#1)(2008-10#1)
similar texture##2##2##(2007-12#1)(2012-6#1)
similar thickness##2##2##(2008-10#1)(2009-7#1)
similar time##4##2##(1995-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
similar to F##2##3##(2008-10#2)
similar to P##2##3##(2008-10#1)(2010-3#1)
similar to V##2##3##(2008-10#2)
similar to a##16##3##(1990-11#1)(1991-7#1)(1992-9#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-9#3)(2010-9#1)(2012-2#1)
similar to acute##3##3##(1995-3#1)(2008-3#1)(2013-1#1)
similar to an##6##3##(1994-6#1)(1995-12#1)(2008-10#3)(2008-2#1)
similar to and##3##3##(1994-6#1)(2008-10#1)(2012-3#1)
similar to apoptosis##2##3##(2013-1#2)
similar to control##2##3##(1997-2#1)(2012-6#1)
similar to conventional##2##3##(2008-3#1)(2009-12#1)
similar to each other and##2##5##(2008-10#2)
similar to each other##11##4##(1993-6#1)(1994-6#1)(1997-8#1)(2008-10#7)(2008-9#1)
similar to either##2##3##(2008-10#1)(2008-5#1)
similar to findings##2##3##(1994-12#1)(2012-3#1)
similar to gunshot residue##2##4##(2012-2#2)
similar to human##5##3##(1991-2#1)(1992-11#1)(1992-9#1)(2008-6#1)(2013-1#1)
similar to its##3##3##(2008-10#3)
similar to known##3##3##(1991-11#1)(2008-10#2)
similar to one another##3##4##(1995-6#1)(2008-1#1)(2008-10#1)
similar to one##4##3##(1995-6#1)(1997-3#1)(2008-1#1)(2008-10#1)
similar to or##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
similar to other rodents##2##4##(2010-11#2)
similar to other##22##3##(1990-11#1)(1990-7#1)(1991-9#1)(1994-12#2)(1994-9#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-8#1)(2011-2#1)
similar to patients with##2##4##(2011-2#1)(2013-1#1)
similar to previous##3##3##(2007-5#1)(2008-6#1)(2011-1#1)
similar to previously reported##2##4##(1993-1#1)(2008-10#1)
similar to previously##4##3##(1993-1#1)(2008-10#1)(2009-10#1)(2009-12#1)
similar to results##4##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
similar to some##2##3##(1991-12#1)(1992-8#1)
similar to that associated with##2##5##(2008-10#1)(2008-2#1)
similar to that by##8##4##(2008-8#2)(2008-9#6)
similar to that described for the##2##6##(1990-5#1)(2008-10#1)
similar to that for##3##4##(1993-8#1)(2008-10#1)(2008-9#1)
similar to that found in##4##5##(1994-8#1)(2008-7#2)(2012-12#1)
similar to that found##7##4##(1991-3#1)(1994-3#1)(1994-8#1)(2007-11#1)(2008-7#2)(2012-12#1)
similar to that in the##3##5##(1994-11#1)(2008-7#1)(2008-9#1)
similar to that in##14##4##(1990-8#1)(1991-11#1)(1994-11#1)(1995-9#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-9#2)(2010-11#1)
similar to that induced by the##2##6##(1993-3#1)(2008-10#1)
similar to that induced by##4##5##(1993-3#1)(1995-9#1)(2008-10#1)(2009-10#1)
similar to that measured##2##4##(1992-9#1)(2013-1#1)
similar to that observed during the##2##6##(1993-11#1)(2009-5#1)
similar to that observed for##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
similar to that observed in the##3##6##(1991-6#1)(1995-12#1)(2008-10#1)
similar to that observed in##13##5##(1991-12#1)(1991-2#1)(1991-6#1)(1993-8#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
similar to that observed with##3##5##(1994-8#1)(2008-10#1)(2008-7#1)
similar to that observed##22##4##(1991-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#5)(2008-7#3)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
similar to that obtained with##2##5##(1995-12#1)(2008-10#1)
similar to that obtained##6##4##(1992-6#1)(1995-12#1)(2008-10#3)(2008-5#1)
similar to that of a##3##5##(1992-8#1)(2008-10#1)(2008-3#1)
similar to that of chicken##2##5##(1993-2#1)(2008-5#1)
similar to that of other##8##5##(1990-11#1)(1993-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
similar to that of the control##7##6##(1994-8#1)(2008-8#1)(2008-9#5)
similar to that of the human##2##6##(1990-12#1)(2008-4#1)
similar to that of the intact##2##6##(1993-6#1)(1995-5#1)
similar to that of the##49##5##(1990-12#1)(1991-7#1)(1991-9#2)(1992-6#3)(1992-9#1)(1993-3#1)(1993-6#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-6#1)(1997-2#2)(1997-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#5)(2008-9#11)(2010-5#1)
similar to that of##121##4##(1990-11#1)(1990-12#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#4)(1995-8#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#14)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#16)(2009-10#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-10#1)(2012-2#1)(2013-1#1)
similar to that reported for##4##5##(1992-12#1)(2007-12#1)(2008-11#1)(2008-7#1)
similar to that reported in##2##5##(2008-1#1)(2012-12#1)
similar to that reported##7##4##(1990-2#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-12#1)
similar to that seen in patients with##2##7##(2008-11#1)(2012-3#1)
similar to that seen in##5##5##(1994-5#2)(2008-10#1)(2008-11#1)(2012-3#1)
similar to that seen with##2##5##(1993-8#1)(1997-3#1)
similar to that seen##7##4##(1993-8#1)(1994-5#2)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
similar to that##226##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#5)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-12#3)(1995-2#2)(1995-5#4)(1995-8#1)(1995-9#2)(1996-12#3)(1996-2#3)(1996-5#3)(1996-6#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#33)(2008-11#6)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#9)(2008-9#25)(2009-10#2)(2009-11#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
similar to the characteristic##2##4##(1990-11#1)(1997-4#1)
similar to the common alphabeta type##2##6##(2009-8#2)
similar to the control##3##4##(2008-11#2)(2010-4#1)
similar to the counts##2##4##(2008-12#1)(2013-8#1)
similar to the distribution##2##4##(1997-2#1)(2008-5#1)
similar to the human##2##4##(1992-3#1)(2008-9#1)
similar to the hypersensitive##2##4##(2008-10#1)(2008-11#1)
similar to the one##2##4##(1992-1#1)(2010-7#1)
similar to the ones##2##4##(2008-11#1)(2008-4#1)
similar to the original##2##4##(2008-11#1)(2013-1#1)
similar to the other##3##4##(1990-12#1)(2006-12#1)(2008-10#1)
similar to the previously identified##2##5##(1996-12#1)(2008-10#1)
similar to the previously##3##4##(1996-12#1)(2008-10#2)
similar to the primary##2##4##(2008-8#1)(2013-8#1)
similar to the recently##2##4##(1993-12#1)(2010-9#1)
similar to the value##3##4##(1990-8#1)(1995-11#1)(1996-12#1)
similar to the##174##3##(1990-11#5)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-2#3)(1997-4#3)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-2#1)(2009-4#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
similar to their##3##3##(1990-12#1)(2009-7#1)(2013-1#1)
similar to this##2##3##(2008-12#1)(2011-2#1)
similar to those at##2##4##(1994-12#1)(1995-9#1)
similar to those based on##2##5##(2008-10#1)(2008-5#1)
similar to those being##2##4##(2008-3#1)(2010-5#1)
similar to those caused by##2##5##(2008-10#2)
similar to those described##2##4##(1994-3#1)(2006-10#1)
similar to those for##3##4##(2008-3#1)(2011-1#1)(2012-1#1)
similar to those found in the##2##6##(1993-12#1)(2008-7#1)
similar to those found in##6##5##(1993-1#1)(1993-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
similar to those found##8##4##(1993-1#1)(1993-12#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
similar to those in the##4##5##(1993-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
similar to those in##12##4##(1993-12#1)(1993-6#1)(1994-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)
similar to those induced by##3##5##(2008-10#2)(2011-2#1)
similar to those observed for##2##5##(2008-5#1)(2009-11#1)
similar to those observed in the field##3##7##(2008-10#3)
similar to those observed in the##4##6##(1997-8#1)(2008-10#3)
similar to those observed in##15##5##(1993-11#1)(1994-5#1)(1997-8#2)(2008-10#7)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
similar to those observed##20##4##(1992-12#1)(1993-11#1)(1994-5#1)(1997-8#2)(2008-10#8)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#1)
similar to those obtained by the##2##6##(2008-10#2)
similar to those obtained by##3##5##(2008-10#3)
similar to those obtained in##5##5##(1990-5#1)(1990-8#1)(2007-12#1)(2008-10#2)
similar to those obtained with##5##5##(1992-6#1)(1996-8#1)(2008-10#3)
similar to those obtained##15##4##(1990-5#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-8#1)(2007-12#1)(2008-10#8)
similar to those of other##3##5##(1994-5#1)(1997-2#1)(2008-10#1)
similar to those of the 25 degrees C-grown C##2##9##(2008-5#2)
similar to those of the control##2##6##(2008-9#1)(2012-2#1)
similar to those of the wild-type##2##6##(1990-10#1)(1993-8#1)
similar to those of the##33##5##(1990-10#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-5#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#12)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
similar to those of wild-type##2##5##(1993-11#1)(1995-2#1)
similar to those of##94##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-2#1)(1995-5#3)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#16)(2009-8#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#1)
similar to those previously described in##2##6##(2011-2#1)(2012-3#1)
similar to those previously described##3##5##(1991-6#1)(2011-2#1)(2012-3#1)
similar to those previously##4##4##(1991-12#1)(1991-6#1)(2011-2#1)(2012-3#1)
similar to those produced##2##4##(1997-7#1)(2008-10#1)
similar to those provided by the BLAST package##2##8##(2008-4#2)
similar to those reported in##4##5##(1995-12#1)(1997-2#2)(2007-12#1)
similar to those reported##7##4##(1995-12#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-3#1)(2013-1#1)
similar to those seen in the##2##6##(1996-12#1)(2012-3#1)
similar to those seen in##3##5##(1995-12#1)(1996-12#1)(2012-3#1)
similar to those seen with##4##5##(2006-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
similar to those seen##7##4##(1995-12#1)(1996-12#1)(2006-10#1)(2008-5#1)(2011-2#1)(2012-3#2)
similar to those that are##2##5##(2007-11#1)(2007-12#1)
similar to those that##4##4##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
similar to those used for##2##5##(1990-11#1)(2011-2#1)
similar to those used##3##4##(1990-11#1)(2008-3#1)(2011-2#1)
similar to those##226##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#5)(1995-12#2)(1995-2#3)(1995-5#3)(1995-9#1)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-7#3)(1997-8#2)(2006-10#2)(2007-11#4)(2007-12#5)(2007-7#1)(2007-8#3)(2008-10#45)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#6)(2008-5#11)(2008-7#4)(2008-8#3)(2008-9#20)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#2)
similar to what is##2##4##(1995-12#1)(2008-8#1)
similar to what##4##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-8#1)
similar to wild-type##2##3##(1994-5#1)(1995-5#1)
similar to##934##2##(1990-10#1)(1990-11#10)(1990-12#7)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#3)(1991-11#4)(1991-12#3)(1991-2#5)(1991-3#3)(1991-5#4)(1991-6#5)(1991-7#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#2)(1992-3#10)(1992-4#1)(1992-6#8)(1992-8#5)(1992-9#7)(1993-1#3)(1993-11#7)(1993-12#6)(1993-2#5)(1993-3#6)(1993-5#1)(1993-6#8)(1993-8#12)(1993-9#2)(1994-11#1)(1994-12#13)(1994-2#3)(1994-3#4)(1994-5#8)(1994-6#6)(1994-8#9)(1994-9#1)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#3)(1995-5#11)(1995-6#7)(1995-8#3)(1995-9#3)(1996-1#1)(1996-12#11)(1996-2#6)(1996-3#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#12)(1997-3#5)(1997-4#5)(1997-6#2)(1997-7#6)(1997-8#3)(2006-10#3)(2006-12#1)(2007-10#2)(2007-11#9)(2007-12#17)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#185)(2008-11#25)(2008-12#10)(2008-2#14)(2008-3#30)(2008-4#11)(2008-5#36)(2008-6#7)(2008-7#28)(2008-8#26)(2008-9#58)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#2)(2010-11#4)(2010-12#2)(2010-3#3)(2010-4#7)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#7)(2011-10#1)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#14)(2012-3#12)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#5)
similar topologies##3##2##(2008-10#3)
similar treatment##2##2##(2007-10#1)(2008-9#1)
similar trend##2##2##(2008-3#1)(2008-7#1)
similar trends##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
similar trials##2##2##(2008-5#1)(2010-1#1)
similar under##2##2##(1991-2#1)(2008-10#1)
similar values##2##2##(2008-10#1)(2013-1#1)
similar way##11##2##(1990-12#1)(1991-9#1)(1992-11#1)(1995-11#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)
similar ways##2##2##(1990-10#1)(2010-6#1)
similar with respect to##3##4##(1991-2#1)(2007-8#1)(2008-10#1)
similar with##9##2##(1990-2#1)(1991-2#1)(1993-5#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#1)
similar within##2##2##(2008-10#1)(2012-2#1)
similar yields##2##2##(2008-11#1)(2008-7#1)
similar##2588##1##(1990-10#3)(1990-11#14)(1990-12#17)(1990-2#11)(1990-3#5)(1990-5#11)(1990-6#6)(1990-7#14)(1990-8#15)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#7)(1991-12#16)(1991-2#14)(1991-3#10)(1991-5#15)(1991-6#11)(1991-7#4)(1991-8#6)(1991-9#15)(1992-1#4)(1992-10#5)(1992-11#10)(1992-12#13)(1992-2#6)(1992-3#19)(1992-4#3)(1992-5#3)(1992-6#19)(1992-8#9)(1992-9#10)(1993-1#5)(1993-11#12)(1993-12#14)(1993-2#5)(1993-3#10)(1993-5#4)(1993-6#17)(1993-8#25)(1993-9#7)(1994-1#5)(1994-10#1)(1994-11#12)(1994-12#24)(1994-2#9)(1994-3#12)(1994-5#20)(1994-6#15)(1994-7#1)(1994-8#25)(1994-9#3)(1995-1#1)(1995-11#19)(1995-12#24)(1995-2#30)(1995-3#14)(1995-5#22)(1995-6#16)(1995-8#11)(1995-9#5)(1996-1#8)(1996-11#1)(1996-12#25)(1996-2#19)(1996-3#7)(1996-4#2)(1996-5#16)(1996-6#6)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#28)(1997-3#17)(1997-4#11)(1997-5#2)(1997-6#11)(1997-7#11)(1997-8#7)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#13)(2007-11#27)(2007-12#42)(2007-2#3)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#18)(2007-9#1)(2008-1#12)(2008-10#504)(2008-11#86)(2008-12#39)(2008-2#40)(2008-3#70)(2008-4#30)(2008-5#83)(2008-6#20)(2008-7#90)(2008-8#65)(2008-9#91)(2009-1#1)(2009-10#12)(2009-11#5)(2009-12#11)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#10)(2009-6#7)(2009-7#8)(2009-8#17)(2009-9#6)(2010-1#3)(2010-10#7)(2010-11#8)(2010-12#11)(2010-2#5)(2010-3#13)(2010-4#22)(2010-5#9)(2010-6#5)(2010-7#3)(2010-8#9)(2010-9#4)(2011-1#19)(2011-10#2)(2011-2#69)(2011-3#1)(2012-1#6)(2012-12#28)(2012-2#29)(2012-3#32)(2012-5#1)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#66)(2013-7#4)(2013-8#28)
similar)##2##1##(1997-3#1)(2009-6#1)
similar-sized##3##1##(1995-3#1)(2009-5#1)(2010-4#1)
similarities and differences between the##6##5##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
similarities and differences between##10##4##(1997-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
similarities and differences in the##2##5##(1994-12#1)(2007-2#1)
similarities and differences in##3##4##(1994-12#1)(2007-2#1)(2008-8#1)
similarities and differences of##2##4##(2007-12#1)(2008-2#1)
similarities and differences##21##3##(1991-3#1)(1993-3#1)(1994-12#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-5#1)(2013-1#1)
similarities and dissimilarities##2##3##(1996-5#1)(2008-10#1)
similarities and##27##2##(1991-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-5#1)(2013-1#1)
similarities are##3##2##(1990-5#1)(1991-5#1)(1992-8#1)
similarities between the##9##3##(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-3#1)
similarities between these##3##3##(1993-3#1)(2007-11#1)(2008-7#1)
similarities between##24##2##(1990-4#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#2)(1993-3#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)
similarities for##2##2##(1991-6#1)(2008-10#1)
similarities in structure##2##3##(1997-7#1)(2008-4#1)
similarities in the##4##3##(1991-1#1)(1996-12#1)(1996-5#1)(2008-7#1)
similarities in their##3##3##(1992-7#1)(2008-1#1)(2008-3#1)
similarities in##21##2##(1990-7#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-7#1)(1992-8#2)(1996-12#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)
similarities include the##2##3##(1993-3#1)(2008-5#1)
similarities of the##3##3##(2008-10#2)(2008-5#1)
similarities of##7##2##(1997-3#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
similarities or##2##2##(1997-1#1)(2008-11#1)
similarities that##2##2##(2008-3#1)(2008-7#1)
similarities to human##3##3##(1995-9#1)(2008-10#1)(2008-9#1)
similarities to known##4##3##(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)
similarities to the##10##3##(1991-6#1)(1992-12#2)(1992-9#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)
similarities to##32##2##(1990-5#2)(1991-6#1)(1992-12#2)(1992-9#1)(1993-8#1)(1994-9#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-9#1)
similarities were found between the##2##5##(2008-10#1)(2010-5#1)
similarities were found between##3##4##(2008-10#2)(2010-5#1)
similarities were##6##2##(1995-2#1)(2008-10#4)(2010-5#1)
similarities with a##3##3##(1992-9#1)(1996-10#1)(2009-2#1)
similarities with the##5##3##(1991-2#1)(1992-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
similarities with those##2##3##(1995-2#1)(2008-5#1)
similarities with##20##2##(1991-2#1)(1992-6#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-9#2)(1996-10#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
similarities within the##2##3##(1993-2#1)(2008-10#1)
similarities within##4##2##(1993-2#1)(1993-6#1)(2008-10#1)(2010-5#1)
similarities##180##1##(1990-12#1)(1990-4#1)(1990-5#4)(1990-7#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#4)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#3)(1995-9#3)(1996-10#2)(1996-12#2)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#25)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#3)(2008-7#13)(2008-8#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-2#1)(2012-5#1)(2012-9#1)(2013-1#3)(2013-8#2)
similarity (&gt##2##2##(2008-10#1)(2010-6#1)
similarity among isolates of##2##4##(2008-10#2)
similarity among strains##2##3##(2008-10#2)
similarity among##8##2##(2008-10#6)(2008-3#1)(2008-8#1)
similarity analysis##3##2##(2008-10#1)(2012-2#2)
similarity and low##2##3##(2008-7#1)(2008-9#1)
similarity and##9##2##(1996-10#1)(1996-6#1)(2008-10#2)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)
similarity at##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
similarity between EAS and ENA##2##5##(2008-8#2)
similarity between EAS##3##3##(2008-8#3)
similarity between the##11##3##(1990-11#1)(1990-4#1)(1991-6#1)(1992-8#1)(1995-3#1)(2008-10#3)(2008-2#1)(2009-3#1)(2012-2#1)
similarity between this##2##3##(1992-8#1)(2008-2#1)
similarity between##34##2##(1990-11#1)(1990-4#1)(1991-6#1)(1992-8#3)(1993-2#1)(1993-3#1)(1995-3#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-8#5)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
similarity coefficient##2##2##(2008-10#2)
similarity coefficients##2##2##(2008-10#1)(2013-7#1)
similarity for two##2##3##(1996-6#1)(2008-10#1)
similarity in properties##2##3##(2008-10#1)(2008-8#1)
similarity in the##4##3##(1995-2#1)(2008-10#2)(2008-8#1)
similarity in##21##2##(1992-8#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-8#4)(2011-2#2)(2013-8#1)
similarity index##2##2##(2008-10#1)(2010-8#1)
similarity is##2##2##(1992-4#1)(2008-7#1)
similarity matrix##2##2##(2008-10#1)(2008-4#1)
similarity of the##13##3##(1994-6#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
similarity of these##2##3##(1996-4#1)(2007-12#1)
similarity of##41##2##(1990-7#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-6#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-12#3)(2008-2#1)(2008-3#1)(2008-9#3)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
similarity search##2##2##(1996-6#1)(2008-4#1)
similarity searches##3##2##(2008-4#1)(2009-10#1)(2013-1#1)
similarity searching##6##2##(2008-4#4)(2008-9#1)(2013-8#1)
similarity to a##7##3##(1992-11#1)(1994-5#1)(1996-6#1)(1997-7#2)(2008-10#1)(2009-11#1)
similarity to any other##4##4##(1996-12#2)(1996-6#1)(2008-7#1)
similarity to any##9##3##(1995-8#1)(1996-12#2)(1996-6#2)(1997-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
similarity to genes in other##2##5##(2008-7#2)
similarity to genes##4##3##(1993-9#1)(2008-7#3)
similarity to human skin##2##4##(2008-5#2)
similarity to known genes were also predicted##2##7##(1997-6#1)(1997-8#1)
similarity to known genes##3##4##(1995-12#1)(1997-6#1)(1997-8#1)
similarity to known##7##3##(1995-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-10#1)
similarity to lipoprotein##2##3##(1995-2#1)(2010-10#1)
similarity to other##3##3##(1994-12#1)(1995-2#1)(1997-6#1)
similarity to proteins##2##3##(1993-9#1)(1995-6#1)
similarity to sequences##3##3##(1997-3#1)(2008-10#2)
similarity to that of the yeast##2##6##(1991-6#1)(1996-2#1)
similarity to that of##4##4##(1991-6#1)(1993-12#1)(1993-6#1)(1996-2#1)
similarity to that##5##3##(1991-6#1)(1993-12#1)(1993-6#1)(1996-2#1)(2007-10#1)
similarity to the##19##3##(1990-11#1)(1991-6#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#1)(2008-10#3)(2008-7#1)(2012-3#1)(2013-8#1)
similarity to those of##2##4##(1991-5#1)(1995-6#1)
similarity to vinculin##2##3##(1991-5#2)
similarity to##98##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#3)(1991-6#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#3)(1994-5#1)(1994-6#3)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#6)(1996-8#1)(1997-3#3)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#1)(2008-10#16)(2008-5#2)(2008-7#6)(2009-11#1)(2010-10#3)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
similarity values##2##2##(2008-10#1)(2011-3#1)
similarity was found between##2##4##(1991-9#1)(1994-5#1)
similarity was found##4##3##(1991-9#1)(1994-5#2)(2008-10#1)
similarity was observed between##2##4##(1994-12#1)(2008-10#1)
similarity was##8##2##(1991-9#1)(1994-12#1)(1994-5#2)(1996-10#1)(2008-10#3)
similarity with a##2##3##(1994-11#1)(2008-10#1)
similarity with amino acid sequences##2##5##(1994-11#1)(1995-9#1)
similarity with isolates from##2##4##(2008-10#2)
similarity with strains##2##3##(2008-10#1)(2008-5#1)
similarity with the##7##3##(1990-2#1)(1990-5#1)(1992-3#1)(1995-6#2)(2008-5#1)(2010-3#1)
similarity with##33##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#2)(1994-8#3)(1995-6#2)(1995-9#1)(1997-3#1)(1997-7#1)(2008-10#10)(2008-4#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
similarity##356##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#4)(1991-6#5)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#6)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#5)(1994-11#2)(1994-12#5)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#5)(1995-6#8)(1995-8#3)(1995-9#1)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#12)(1996-8#1)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#6)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#80)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#16)(2008-9#11)(2009-10#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-10#3)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#9)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#7)
similarity)##3##1##(1994-12#1)(2008-10#1)(2013-8#1)
similarly affected by##2##3##(1994-12#1)(2008-11#1)
similarly as##2##2##(2008-10#2)
similarly declined during##2##3##(2008-7#1)(2010-2#1)
similarly effective in##2##3##(1990-11#1)(2007-11#1)
similarly effective##3##2##(1990-11#1)(2007-11#1)(2011-2#1)
similarly high##3##2##(1997-2#1)(2008-12#1)(2012-3#1)
similarly increased##2##2##(1991-5#1)(1994-6#1)
similarly inhibited by##2##3##(1990-8#1)(1993-3#1)
similarly inhibited##3##2##(1990-8#1)(1993-3#1)(1995-8#1)
similarly injected##2##2##(1993-5#1)(2013-1#1)
similarly on##2##2##(2008-12#1)(2013-1#1)
similarly reduced the##2##3##(1996-2#1)(2008-10#1)
similarly regulated##2##2##(1991-5#1)(2009-3#1)
similarly stimulated##2##2##(1992-8#1)(2013-1#1)
similarly tested##2##2##(2009-7#1)(2012-3#1)
similarly to a##3##3##(1994-5#1)(2008-11#1)(2009-9#1)
similarly to the##4##3##(1996-5#2)(2007-11#1)(2008-10#1)
similarly to those##2##3##(1997-4#1)(2008-10#1)
similarly to##28##2##(1990-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#2)(1996-4#1)(1996-5#2)(1997-4#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#1)
similarly treated##2##2##(1997-6#1)(2008-3#1)
similarly##129##1##(1990-11#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-5#3)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-5#3)(1994-6#1)(1995-2#2)(1995-8#2)(1995-9#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-2#6)(2012-1#1)(2012-3#3)(2013-1#7)(2013-8#1)
similis##3##1##(2008-10#3)
similitude##4##1##(2008-10#1)(2013-7#3)
simple DNA##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
simple Fabry-Perot##2##2##(2007-11#2)
simple RT##3##2##(2008-7#1)(2010-1#2)
simple adaptive##2##2##(2008-11#1)(2010-4#1)
simple addition of##2##3##(2008-10#1)(2008-7#1)
simple alternative##2##2##(1994-7#1)(2008-10#1)
simple analyses##2##2##(1994-11#1)(1995-12#1)
simple analysis of the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
simple analytic##2##2##(2007-11#1)(2008-2#1)
simple analytical formulas##2##3##(2008-2#1)(2008-3#1)
simple analytical model##3##3##(2007-11#1)(2008-3#2)
simple analytical technique##2##3##(2008-10#2)
simple analytical##15##2##(2007-11#3)(2008-10#5)(2008-2#1)(2008-3#6)
simple and accurate method for measuring the##2##7##(2008-2#1)(2008-3#1)
simple and accurate method for##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
simple and accurate##4##3##(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
simple and automated##2##3##(1995-2#1)(2008-10#1)
simple and can be##3##4##(2008-10#2)(2008-3#1)
simple and can##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
simple and compact##3##3##(2007-12#1)(2008-2#2)
simple and complex reaction##2##4##(2010-1#1)(2012-1#1)
simple and complex##6##3##(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#1)
simple and convenient##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
simple and direct##4##3##(1995-12#1)(2007-12#1)(2008-10#2)
simple and easy to##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
simple and easy##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
simple and economical##2##3##(2008-10#2)
simple and effective chromatographic##2##4##(1990-5#1)(2008-10#1)
simple and effective tool##2##4##(2008-10#1)(2010-5#1)
simple and effective##9##3##(1990-5#1)(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-5#1)(2010-5#1)
simple and efficient method for the##4##6##(1995-6#1)(2007-11#1)(2008-9#1)(2010-3#1)
simple and efficient method##5##4##(1990-11#1)(1995-6#1)(2007-11#1)(2008-9#1)(2010-3#1)
simple and efficient##14##3##(1990-11#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-9#3)(2009-5#1)(2010-2#1)(2010-3#1)
simple and fast method for the##3##6##(2008-10#3)
simple and fast method for##5##5##(2008-10#4)(2008-11#1)
simple and fast method is proposed##2##6##(2008-10#2)
simple and fast method##7##4##(2008-10#6)(2008-11#1)
simple and fast procedure##2##4##(2008-10#1)(2008-6#1)
simple and fast##24##3##(2008-10#17)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
simple and general##3##3##(1996-5#1)(2008-4#1)(2008-8#1)
simple and highly selective##3##4##(2008-10#3)
simple and highly##6##3##(2008-10#5)(2008-3#1)
simple and inexpensive##9##3##(1991-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2013-8#1)
simple and is##2##3##(2007-7#1)(2008-3#1)
simple and low-cost##4##3##(2008-10#3)(2008-3#1)
simple and non-invasive##2##3##(1996-2#1)(2006-6#1)
simple and practical##7##3##(1993-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
simple and rapid method for the##2##6##(2008-10#2)
simple and rapid method for##6##5##(1995-2#1)(2008-10#5)
simple and rapid method##11##4##(1995-2#1)(2008-10#8)(2008-4#1)(2008-5#1)
simple and rapid procedure##4##4##(1994-8#1)(1996-12#1)(2008-10#2)
simple and rapid spectrophotometric##3##4##(2008-10#3)
simple and rapid##37##3##(1990-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#26)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
simple and relatively##2##3##(2008-10#2)
simple and reliable method for the##2##6##(2008-10#2)
simple and reliable method for##6##5##(2008-10#4)(2008-2#1)(2008-8#1)
simple and reliable method##10##4##(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
simple and reliable##16##3##(2008-10#10)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
simple and reproducible##6##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2013-8#1)
simple and robust and##2##4##(2008-10#1)(2008-3#1)
simple and robust##7##3##(2008-10#4)(2008-11#1)(2008-3#2)
simple and safe##3##3##(1994-9#1)(2008-10#1)(2008-7#1)
simple and selective method for##3##5##(2008-10#3)
simple and selective method##5##4##(2008-10#5)
simple and selective##7##3##(2008-10#7)
simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells##2##18##(1990-12#2)
simple and sensitive flow##4##4##(1990-12#2)(2008-10#2)
simple and sensitive fluorometric method##2##5##(2008-10#2)
simple and sensitive method for the##5##6##(2008-10#5)
simple and sensitive method of nonaqueous capillary electrophoresis with laser-induced native fluorescence##2##12##(2008-10#2)
simple and sensitive method##11##4##(1991-3#1)(2008-10#9)(2011-1#1)
simple and sensitive spectrophotometric##2##4##(2008-10#2)
simple and sensitive visible spectrophotometric methods##3##6##(2008-10#3)
simple and sensitive##44##3##(1990-12#2)(1991-3#1)(2008-10#35)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)
simple and straightforward##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
simple and the##2##3##(2008-10#2)
simple and understandable##2##3##(1995-12#1)(1996-3#1)
simple and useful##2##3##(1997-3#1)(2008-10#1)
simple and versatile##3##3##(2008-10#3)
simple and##313##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-7#1)(2008-10#161)(2008-11#11)(2008-12#1)(2008-2#11)(2008-3#21)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#7)(2009-2#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#3)
simple application of##3##3##(2008-10#2)(2008-8#1)
simple approach to the##2##4##(2008-11#1)(2012-2#1)
simple approach to##6##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-2#1)
simple approach##10##2##(1994-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2012-2#1)
simple aqueous solutions##2##3##(2008-7#1)(2008-8#1)
simple aqueous##6##2##(2008-10#4)(2008-7#1)(2008-8#1)
simple as it##2##3##(2008-10#1)(2008-6#1)
simple as##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
simple assay##3##2##(1996-12#1)(2008-7#1)(2008-9#1)
simple associations##2##2##(1995-2#1)(2010-8#1)
simple bead injection##2##3##(2008-10#2)
simple bromophenols in fish meat##2##5##(2008-10#2)
simple bromophenols in##3##3##(2008-10#3)
simple but effective##2##3##(2008-3#2)
simple but##8##2##(2007-12#1)(2008-10#2)(2008-3#3)(2013-1#1)(2013-8#1)
simple calculation##3##2##(2007-12#1)(2009-11#1)(2011-2#1)
simple calibration##2##2##(2008-10#2)
simple carbohydrates##2##2##(2008-10#1)(2012-12#1)
simple cell##3##2##(2008-5#1)(2008-8#2)
simple cells in##4##3##(1996-2#1)(2008-11#1)(2008-8#2)
simple cells##6##2##(1996-2#1)(2008-11#1)(2008-8#4)
simple chemical##2##2##(1995-5#1)(2008-10#1)
simple classification system of##2##4##(2008-12#2)
simple classification##5##2##(2008-12#2)(2008-2#1)(2008-7#2)
simple closure##3##2##(1990-6#3)
simple communities##2##2##(2008-10#1)(2008-8#1)
simple concentration##2##2##(2008-2#1)(2009-6#1)
simple construction##2##2##(2008-10#1)(2008-4#1)
simple counts##3##2##(2007-11#3)
simple cysts##2##2##(1990-10#1)(2011-1#1)
simple data##2##2##(1990-8#1)(2008-3#1)
simple design##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
simple determination of##4##3##(1992-3#1)(2008-10#3)
simple device for##2##3##(2008-10#1)(2008-3#1)
simple device##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
simple dilution of##2##3##(2008-10#2)
simple dilution##4##2##(2008-10#4)
simple disjoining solid-state##2##3##(2008-10#2)
simple electronic##2##2##(2007-11#1)(2008-3#1)
simple emulsion##2##2##(2008-5#2)
simple equation##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
simple equipment##2##2##(2008-10#1)(2008-3#1)
simple example of##2##3##(2007-12#1)(2013-8#1)
simple example##5##2##(2007-12#3)(2008-10#1)(2013-8#1)
simple experiment##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
simple experimental setup##2##3##(2008-2#1)(2008-3#1)
simple experimental##8##2##(2007-12#2)(2008-2#2)(2008-3#2)(2012-12#1)(2012-2#1)
simple experiments##2##2##(2008-3#1)(2008-9#1)
simple explanation##2##2##(2008-2#1)(2008-9#1)
simple exposure##3##2##(2008-4#3)
simple extension##3##2##(2007-11#1)(2008-12#1)(2008-3#1)
simple extraction procedure and##2##4##(2008-10#2)
simple extraction##4##2##(1996-5#1)(2008-10#3)
simple fabrication##4##2##(2008-2#2)(2008-3#1)(2009-5#1)
simple firing-rate model##2##3##(2009-8#2)
simple flow cytometry##2##3##(2008-9#1)(2012-2#1)
simple flow injection (FI)##2##4##(2008-10#2)
simple flow injection##9##3##(2008-10#9)
simple flow##14##2##(2008-10#10)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
simple fluorescence##2##2##(2008-10#1)(2008-3#1)
simple form of##3##3##(1995-12#1)(2008-9#1)(2009-6#1)
simple formulas##2##2##(2007-12#1)(2008-3#1)
simple frequency##2##2##(1991-12#1)(2008-9#1)
simple geometric##2##2##(2008-2#1)(2010-9#1)
simple geometrical##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
simple graphic##2##2##(2007-12#1)(2008-3#1)
simple grid##2##2##(2008-7#1)(2009-11#1)
simple harvest##2##2##(2008-11#2)
simple in##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
simple inheritance##2##2##(1994-9#1)(2008-10#1)
simple instrumentation##2##2##(2008-10#1)(2010-11#1)
simple interpolation##2##2##(2008-3#2)
simple interrupted##2##2##(1991-2#2)
simple kinetic method##2##3##(2008-10#2)
simple kinetic##3##2##(2008-10#2)(2012-12#1)
simple linear regression##3##3##(2008-10#1)(2012-3#2)
simple linear##10##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-5#1)(2012-3#2)
simple manner##2##2##(2008-2#1)(2008-3#1)
simple mathematical model##6##3##(1994-8#1)(2007-12#1)(2008-9#2)(2009-8#1)(2013-1#1)
simple mathematical models of the##2##5##(2008-2#1)(2008-3#1)
simple mathematical##12##2##(1994-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#2)(2009-8#1)(2013-1#1)
simple means for##2##3##(2006-6#1)(2008-8#1)
simple means##5##2##(2006-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)
simple measures##2##2##(2008-7#1)(2009-9#1)
simple mechanical##3##2##(2007-12#1)(2008-10#2)
simple method for determining the##4##5##(1997-7#1)(2008-10#2)(2008-3#1)
simple method for estimation of##2##5##(1997-3#1)(2008-10#1)
simple method for rapid##2##4##(2008-10#2)
simple method for the##12##4##(1995-3#1)(2007-11#1)(2008-10#9)(2008-2#1)
simple method for##45##3##(1995-3#1)(1997-3#1)(1997-7#1)(2007-11#5)(2008-10#19)(2008-2#4)(2008-3#9)(2008-6#1)(2008-8#1)(2010-6#1)(2012-2#1)(2012-3#1)
simple method has been developed for the##3##7##(2008-10#3)
simple method has been developed for##4##6##(2008-10#4)
simple method has been##6##4##(1997-7#1)(2008-10#4)(2010-8#1)
simple method is proposed for##2##5##(2008-10#2)
simple method is##6##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)
simple method of##17##3##(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)
simple method to detect##2##4##(2008-12#1)(2008-5#1)
simple method to determine the##2##5##(2008-2#1)(2008-8#1)
simple method to##14##3##(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)
simple method was developed for the##4##6##(2008-10#4)
simple method was developed##5##4##(2008-10#5)
simple method was used to##2##5##(2008-10#1)(2008-5#1)
simple method was##7##3##(2008-10#6)(2008-5#1)
simple method##104##2##(1992-3#1)(1995-12#1)(1995-3#2)(1996-5#1)(1997-3#1)(1997-7#3)(2007-11#7)(2007-12#3)(2008-1#1)(2008-10#41)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#17)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
simple methodology to##2##3##(1996-3#1)(2008-10#1)
simple methodology##5##2##(1993-6#1)(1996-3#1)(2008-10#2)(2008-7#1)
simple methods##3##2##(2008-2#2)(2013-1#1)
simple model and##2##3##(2007-11#1)(2009-8#1)
simple model describing the##2##4##(2008-10#1)(2009-10#1)
simple model for solvation in mixed solvents##2##7##(1990-8#2)
simple model for the##2##4##(1992-9#1)(2008-9#1)
simple model for##9##3##(1990-8#2)(1992-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
simple model is presented to##2##5##(2008-2#2)
simple model is presented##3##4##(2008-11#1)(2008-2#2)
simple model is##4##3##(2008-11#1)(2008-2#3)
simple model of##14##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
simple model that##4##3##(1994-2#1)(2008-7#2)(2008-8#1)
simple model to##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
simple model##49##2##(1990-8#2)(1992-4#1)(1992-9#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#5)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
simple models##3##2##(2008-10#1)(2008-8#2)
simple modification of##2##3##(1995-3#1)(2009-7#1)
simple modification##3##2##(1995-3#1)(2009-7#1)(2011-2#1)
simple molecular##3##2##(1994-5#1)(2012-2#2)
simple needle aspiration##2##3##(2008-5#1)(2009-6#1)
simple network##2##2##(2008-11#1)(2013-8#1)
simple networks of##2##3##(1996-4#1)(1997-7#1)
simple neural##3##2##(1997-7#1)(2007-12#1)(2008-4#1)
simple nonlinear##2##2##(2007-11#1)(2008-10#1)
simple numerical##3##2##(1993-9#1)(2008-3#2)
simple one-step##4##2##(1992-11#1)(2008-3#1)(2009-11#1)(2013-1#1)
simple optical##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
simple or##3##2##(1991-4#1)(2008-5#1)(2008-9#1)
simple organisms##2##2##(2008-10#2)
simple patch##2##2##(2008-5#1)(2008-8#1)
simple pathotypes##2##2##(2008-10#2)
simple pattern##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
simple photoreceptors##2##2##(2008-9#2)
simple physical##3##2##(1996-12#1)(2007-11#1)(2008-10#1)
simple preparation##2##2##(2008-10#2)
simple procedure for the determination of##3##6##(2008-10#3)
simple procedure for the##5##4##(2008-10#5)
simple procedure for##6##3##(2008-10#5)(2008-3#1)
simple procedure is##3##3##(2008-10#3)
simple procedure to##3##3##(2008-2#2)(2008-4#1)
simple procedure##20##2##(1990-11#1)(1993-3#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-4#4)
simple procedures for##2##3##(2008-2#1)(2008-4#1)
simple procedures##5##2##(1997-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
simple process##3##2##(1992-12#1)(1996-2#1)(2008-10#1)
simple protocol for##2##3##(2008-10#1)(2008-11#1)
simple protocol##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)
simple quantitative##4##2##(2008-10#2)(2008-5#1)(2009-6#1)
simple random##2##2##(1992-6#1)(1996-1#1)
simple recycling##2##2##(2008-11#1)(2013-1#1)
simple reflex##2##2##(1995-6#1)(2008-7#1)
simple repeat##2##2##(2008-6#2)
simple route to the##2##4##(1996-5#1)(2008-8#1)
simple rules can##2##3##(1995-5#1)(2008-8#1)
simple rules##4##2##(1995-5#1)(2008-2#1)(2008-8#1)(2011-2#1)
simple sample##2##2##(2008-10#2)
simple scheme for##2##3##(2007-12#2)
simple scheme##4##2##(2007-11#2)(2007-12#2)
simple screening##2##2##(2008-10#1)(2008-3#1)
simple sensor##2##2##(2010-4#1)(2010-5#1)
simple sequence repeat (SSR) markers in##2##6##(2008-10#1)(2008-9#1)
simple sequence repeat (SSR) markers##5##5##(2008-10#3)(2008-9#2)
simple sequence repeat (SSR)##6##4##(2008-10#4)(2008-9#2)
simple sequence repeat markers##2##4##(2008-10#2)
simple sequence repeat##13##3##(2008-10#10)(2008-9#2)(2010-10#1)
simple sequence repeats (SSRs)##2##4##(1996-8#1)(2008-10#1)
simple sequence repeats database##2##4##(2008-7#2)
simple sequence repeats##7##3##(1996-8#2)(2008-10#2)(2008-7#3)
simple sequence##22##2##(1992-6#1)(1996-5#1)(1996-8#2)(2008-10#12)(2008-7#3)(2008-9#2)(2010-10#1)
simple setup##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
simple single-step##2##2##(2008-3#1)(2012-12#1)
simple solutions##2##2##(2008-10#1)(2008-3#1)
simple spatial##2##2##(2008-3#1)(2008-8#1)
simple spectrophotometer##2##2##(2008-10#2)
simple spectrophotometric method##4##3##(1990-8#2)(2008-10#2)
simple spectrophotometric##6##2##(1990-8#2)(2008-10#4)
simple strategy for##2##3##(2008-10#2)
simple strategy to##3##3##(1990-12#1)(2007-8#1)(2013-7#1)
simple strategy##5##2##(1990-12#1)(2007-8#1)(2008-10#2)(2013-7#1)
simple structure##4##2##(2008-10#1)(2008-2#1)(2009-5#1)(2010-9#1)
simple sugars##3##2##(2008-10#3)
simple synchronous fluorimetric method##2##4##(2008-10#2)
simple system for##5##3##(1997-6#1)(2007-8#1)(2008-2#1)(2008-3#2)
simple system of##2##3##(2008-2#1)(2008-3#1)
simple system##12##2##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#2)
simple taste analyzing system##2##4##(2008-10#2)
simple technique for##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2011-2#1)
simple technique##17##2##(1994-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#1)(2009-2#1)(2011-2#1)
simple techniques##3##2##(1997-4#1)(2008-4#1)(2011-1#1)
simple test##2##2##(1990-11#1)(2008-3#1)
simple theoretical##8##2##(1990-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
simple threshold##2##2##(2008-2#1)(2008-3#1)
simple thresholding##3##2##(2008-3#1)(2010-4#1)(2011-1#1)
simple to be##2##3##(2008-10#1)(2010-8#1)
simple to implement##2##3##(2008-10#1)(2008-3#1)
simple to use and##2##4##(2008-4#1)(2010-5#1)
simple to use##4##3##(1993-1#1)(2008-10#1)(2008-4#1)(2010-5#1)
simple to##24##2##(1990-2#1)(1990-5#1)(1993-1#1)(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)
simple tool for##3##3##(2008-10#2)(2011-2#1)
simple tools that are##2##4##(2009-10#1)(2010-2#1)
simple transcriptional##2##2##(1993-2#1)(2008-11#1)
simple visual##3##2##(1995-12#1)(2008-10#2)
simple way to##12##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
simple way##18##2##(1993-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
simple with##2##2##(2007-10#1)(2008-10#1)
simple##1929##1##(1990-10#2)(1990-11#6)(1990-12#10)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#8)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#4)(1995-11#2)(1995-12#9)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#4)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#9)(1996-3#3)(1996-4#3)(1996-5#7)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#7)(1997-4#5)(1997-6#3)(1997-7#7)(1997-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#3)(2007-11#69)(2007-12#62)(2007-2#1)(2007-5#4)(2007-7#2)(2007-8#17)(2007-9#1)(2008-1#11)(2008-10#661)(2008-11#49)(2008-12#12)(2008-2#101)(2008-3#208)(2008-4#48)(2008-5#34)(2008-6#15)(2008-7#49)(2008-8#54)(2008-9#51)(2009-10#5)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#9)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#7)(2010-3#5)(2010-4#4)(2010-5#16)(2010-6#4)(2010-7#6)(2010-8#4)(2010-9#2)(2011-1#17)(2011-2#22)(2012-1#4)(2012-12#11)(2012-2#25)(2012-3#12)(2012-7#1)(2013-1#21)(2013-7#3)(2013-8#16)
simple)##2##1##(2008-3#1)(2009-9#1)
simple-repeat##2##1##(2008-10#2)
simpler and less##2##3##(1993-9#1)(2008-2#1)
simpler and more##4##3##(2008-10#1)(2008-3#1)(2011-2#2)
simpler and##10##2##(1993-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#2)
simpler for##2##2##(2008-10#1)(2008-9#1)
simpler technique##2##2##(2008-2#1)(2009-8#1)
simpler than the##3##3##(2008-10#2)(2008-9#1)
simpler than##10##2##(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)
simpler##60##1##(1991-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-11#2)(2008-2#4)(2008-3#9)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)
simples##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
simplest version##2##2##(2008-4#1)(2010-3#1)
simplest##31##1##(1990-5#1)(1993-1#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#2)(2009-5#2)(2009-8#1)(2010-3#1)(2013-8#1)
simplex algorithm was##2##3##(2008-10#2)
simplex algorithm##4##2##(2008-10#3)(2008-3#1)
simplex and##2##2##(2008-10#1)(2011-2#1)
simplex centroid##2##2##(2008-5#1)(2010-5#1)
simplex in##2##2##(1997-7#1)(2008-10#1)
simplex method to##2##3##(2008-10#2)
simplex method was used##2##4##(2008-10#1)(2008-5#1)
simplex method were##2##3##(2008-10#2)
simplex method##12##2##(2008-10#11)(2008-5#1)
simplex optimization##3##2##(2008-10#3)
simplex virus (HSV)##5##3##(1996-12#1)(1996-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
simplex virus type 1 (HSV-1) and##2##6##(2008-10#2)
simplex virus type 1 (HSV-1)##3##5##(2007-12#1)(2008-10#2)
simplex virus type 1##7##4##(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
simplex virus type##9##3##(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2013-1#1)
simplex virus type-specific serology##2##4##(2008-10#2)
simplex virus##31##2##(1995-2#3)(1996-12#2)(1996-5#1)(1996-6#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#5)(2008-4#3)(2008-8#1)(2008-9#3)(2009-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
simplex was##2##2##(2008-10#1)(2008-5#1)
simplex##89##1##(1991-12#2)(1994-11#1)(1995-2#5)(1996-12#2)(1996-5#1)(1996-6#2)(1997-7#1)(2007-12#7)(2007-2#2)(2007-7#1)(2008-10#34)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#7)(2008-8#1)(2008-9#3)(2009-4#3)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#2)
simplicity and high sensitivity##2##4##(2008-10#2)
simplicity and rapidity##3##3##(1990-7#1)(2008-10#2)
simplicity and##28##2##(1990-2#1)(1990-7#1)(1994-12#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-8#1)(2013-7#1)
simplicity in##2##2##(2007-8#1)(2008-10#1)
simplicity makes##2##2##(2008-3#1)(2012-3#1)
simplicity of implementation##2##3##(2007-12#1)(2008-3#1)
simplicity of preparation##2##3##(2008-10#2)
simplicity of the##14##3##(1995-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#2)(2010-10#1)(2010-5#1)(2011-2#1)
simplicity of this##3##3##(2008-10#3)
simplicity of##30##2##(1995-5#1)(1996-12#1)(1997-7#1)(2007-12#2)(2008-10#12)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#4)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
simplicity##111##1##(1990-2#1)(1990-5#2)(1990-7#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#44)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
simplification is##2##2##(2008-6#1)(2011-2#1)
simplification of##3##2##(1992-6#1)(2008-2#1)(2011-2#1)
simplification##13##1##(1992-6#1)(1992-9#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-6#3)(2009-8#1)(2011-2#3)
simplified by##4##2##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
simplified chemical##2##2##(1995-6#1)(2008-10#1)
simplified conditions##2##2##(2008-2#1)(2011-2#1)
simplified device##2##2##(2007-11#1)(2008-3#1)
simplified dose regimen##2##3##(1994-2#2)
simplified form##2##2##(2008-3#2)
simplified if##2##2##(1997-3#1)(2008-3#1)
simplified in##3##2##(1990-6#1)(2008-3#1)(2008-5#1)
simplified method##5##2##(1992-12#1)(2007-11#1)(2008-2#2)(2008-3#1)
simplified model##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#1)
simplified preventative disclosure of TTM##2##5##(2007-12#2)
simplified procedure##2##2##(2008-11#1)(2008-4#1)
simplified to##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
simplified version of the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
simplified version##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
simplified##95##1##(1990-12#1)(1990-6#1)(1991-12#1)(1992-12#1)(1992-8#1)(1994-2#5)(1994-3#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-6#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#11)(2008-3#22)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
simplifies the analytical procedure and##2##5##(2008-10#2)
simplifies the##14##2##(1992-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#2)
simplifies##22##1##(1992-2#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#2)(2011-2#1)(2012-2#1)
simplify the##16##2##(1994-9#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2010-8#1)
simplify##36##1##(1990-8#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#6)(2008-3#2)(2008-5#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#4)
simplifying assumptions##2##2##(2008-10#1)(2008-2#1)
simplifying the##8##2##(1991-2#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#2)
simplifying##20##1##(1991-2#1)(1994-12#1)(1996-1#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2011-2#2)
simplistic##2##1##(1997-2#1)(2010-6#1)
simply a##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#2)
simply an##2##2##(1996-3#1)(2009-7#1)
simply and effectively##2##3##(2008-10#1)(2013-1#1)
simply and rapidly##3##3##(2008-10#3)
simply and##7##2##(2008-10#5)(2011-2#1)(2013-1#1)
simply as##2##2##(2008-10#1)(2010-1#1)
simply be##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
simply because##2##2##(1994-12#1)(2008-5#1)
simply being##2##2##(2009-6#1)(2011-2#1)
simply by##13##2##(1992-9#1)(1994-1#1)(1994-8#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-7#1)(2008-9#1)(2010-5#1)
simply caused by##2##3##(2008-7#1)(2011-2#1)
simply explained##2##2##(1990-11#1)(2009-12#1)
simply increases##2##2##(1996-11#1)(2012-2#1)
simply increasing the##2##3##(1996-5#1)(2009-12#1)
simply involved##2##2##(2008-4#1)(2013-1#1)
simply not##2##2##(1995-1#1)(2008-2#1)
simply on##2##2##(1991-12#1)(2008-3#1)
simply reflect the##2##3##(2008-10#1)(2009-4#1)
simply reflect##3##2##(2008-10#1)(2009-4#1)(2012-1#1)
simply represent##2##2##(2008-4#1)(2008-7#1)
simply to##4##2##(1990-6#1)(1991-12#1)(1995-8#1)(1997-3#1)
simply##144##1##(1990-11#2)(1990-6#1)(1991-12#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#5)(2008-10#34)(2008-11#4)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)
simulans##8##1##(2012-3#8)
simulant##6##1##(2008-10#5)(2010-1#1)
simulants##3##1##(2008-10#3)
simulate a##3##2##(2008-9#1)(2009-7#1)(2013-8#1)
simulate different##2##2##(1995-3#1)(2008-8#1)
simulate natural##2##2##(2009-5#1)(2011-2#1)
simulate the effects##3##3##(1994-1#1)(2008-3#2)
simulate the##54##2##(1992-3#1)(1994-1#1)(1996-12#1)(1996-4#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#5)(2008-2#5)(2008-3#20)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)
simulate##117##1##(1990-11#1)(1991-11#1)(1991-5#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#9)(2008-2#12)(2008-3#27)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#4)(2009-11#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
simulated I/R##2##2##(2013-7#2)
simulated action potential of the##2##5##(2008-11#2)
simulated and experimental data##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)
simulated and experimental##8##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-7#1)
simulated and real data##3##4##(2008-10#1)(2008-3#1)(2009-9#1)
simulated and real##7##3##(2008-10#3)(2008-3#2)(2008-7#1)(2009-9#1)
simulated and##20##2##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#7)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
simulated annealing algorithm##3##3##(2008-2#1)(2008-3#2)
simulated annealing and##2##3##(2008-2#1)(2008-3#1)
simulated annealing optimization algorithm##2##4##(2008-3#2)
simulated annealing optimization##3##3##(2008-3#2)(2012-1#1)
simulated annealing with##2##3##(2008-2#1)(2008-3#1)
simulated annealing##25##2##(1991-11#1)(1994-5#3)(1995-5#1)(1995-8#1)(2008-2#4)(2008-3#12)(2008-4#1)(2011-1#1)(2012-1#1)
simulated by a##4##3##(2008-3#4)
simulated by computer##2##3##(2008-2#2)
simulated by use of the##2##5##(2007-11#1)(2008-2#1)
simulated by##18##2##(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
simulated clinical##2##2##(1997-7#1)(2008-11#1)
simulated curves##2##2##(1990-9#1)(2008-10#1)
simulated data and##2##3##(2008-7#1)(2011-1#1)
simulated data from##3##3##(2008-3#1)(2012-3#2)
simulated data in##2##3##(2010-2#1)(2011-2#1)
simulated data##24##2##(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-3#3)
simulated epidemics##3##2##(2008-10#3)
simulated field temperatures##2##3##(2008-10#2)
simulated for##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
simulated fusions##2##2##(2008-8#2)
simulated images##2##2##(2008-2#1)(2008-3#1)
simulated in##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
simulated internal##2##2##(2008-2#2)
simulated ischemia##6##2##(1994-2#6)
simulated lidar##2##2##(2008-3#2)
simulated microgravity conditions##2##3##(2009-7#2)
simulated microgravity##9##2##(2008-9#7)(2009-7#2)
simulated numerically##2##2##(2007-11#1)(2008-9#1)
simulated on##2##2##(1993-9#1)(2008-3#1)
simulated quenching##2##2##(2008-3#2)
simulated radiances##2##2##(2008-2#2)
simulated rain##3##2##(2008-10#3)
simulated rainfall##2##2##(2008-10#2)
simulated results showed that##2##4##(2007-12#1)(2008-2#1)
simulated results##6##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)
simulated retrieval##2##2##(2008-3#1)(2013-8#1)
simulated samples##2##2##(2008-10#2)
simulated solar##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
simulated spectra##2##2##(1994-3#1)(2008-3#1)
simulated sunlight##5##2##(2008-11#3)(2008-3#1)(2008-5#1)
simulated temperature##3##2##(1996-12#1)(2008-10#1)(2009-11#1)
simulated the##7##2##(1990-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
simulated under##2##2##(2008-7#1)(2008-9#1)
simulated using a##4##3##(2008-10#3)(2013-1#1)
simulated using the##2##3##(2009-8#1)(2013-1#1)
simulated using##8##2##(2008-10#3)(2008-7#1)(2009-8#1)(2013-1#2)(2013-8#1)
simulated van't Hoff plots##2##4##(1997-2#2)
simulated with a##3##3##(2008-3#2)(2011-1#1)
simulated with##10##2##(1996-2#1)(2008-3#4)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
simulated##340##1##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-2#7)(1994-3#1)(1994-5#3)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#6)(2008-10#62)(2008-11#19)(2008-12#3)(2008-2#24)(2008-3#70)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#14)(2009-1#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#4)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#4)
simulates a##4##2##(1996-3#1)(2008-10#2)(2011-2#1)
simulates the##8##2##(1994-6#1)(2008-10#5)(2008-8#1)(2009-10#1)
simulates##19##1##(1994-6#1)(1996-3#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#2)(2011-1#1)(2011-2#1)(2013-8#2)
simulating a##5##2##(1993-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)
simulating the##8##2##(1993-3#1)(1994-3#1)(2008-10#2)(2008-3#3)(2011-2#1)
simulating##48##1##(1990-3#2)(1991-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#6)(2008-8#1)(2009-5#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
simulation and a##2##3##(2008-3#1)(2008-9#1)
simulation and empirical studies##2##4##(2012-12#1)(2013-1#1)
simulation and experimental results are presented##2##6##(2008-2#1)(2008-3#1)
simulation and experimental results##5##4##(2008-2#1)(2008-3#3)(2008-7#1)
simulation and experimental##6##3##(2008-2#1)(2008-3#4)(2008-7#1)
simulation and experiments##2##3##(2008-3#1)(2008-7#1)
simulation and optical##2##3##(2008-2#1)(2008-3#1)
simulation and the##4##3##(2008-2#2)(2008-3#1)(2010-6#1)
simulation and##33##2##(2008-10#1)(2008-2#7)(2008-3#16)(2008-6#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
simulation approach##4##2##(2008-3#1)(2010-8#1)(2013-1#2)
simulation are##2##2##(2008-2#1)(2008-3#1)
simulation based on the##2##4##(2008-3#2)
simulation by##2##2##(2007-11#1)(2008-2#1)
simulation code##3##2##(2008-3#3)
simulation data##3##2##(2008-3#1)(2009-2#1)(2012-3#1)
simulation experiments##8##2##(1995-9#1)(2008-10#4)(2008-8#1)(2010-2#1)(2012-3#1)
simulation for the##2##3##(2008-10#1)(2008-3#1)
simulation for##5##2##(1993-11#1)(2008-10#1)(2008-3#3)
simulation has been##3##3##(2008-3#1)(2008-7#1)(2010-8#1)
simulation has##4##2##(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
simulation in##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
simulation is based on##2##4##(2008-3#1)(2013-8#1)
simulation is##11##2##(2008-11#1)(2008-2#4)(2008-3#3)(2008-9#1)(2010-7#1)(2013-8#1)
simulation method##3##2##(1994-3#1)(2008-3#2)
simulation methods##5##2##(1995-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)
simulation model for##2##3##(2012-12#2)
simulation model to##2##3##(2008-9#1)(2010-8#1)
simulation model##20##2##(2007-12#2)(2008-10#5)(2008-2#1)(2008-8#5)(2008-9#3)(2010-8#1)(2012-12#2)(2012-2#1)
simulation models to##2##3##(2008-9#2)
simulation models##6##2##(2008-8#2)(2008-9#3)(2010-8#1)
simulation of a##7##3##(1996-12#1)(2008-10#2)(2008-3#3)(2008-4#1)
simulation of an##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
simulation of atmospheric##2##3##(2008-2#1)(2008-3#1)
simulation of large##3##3##(2008-11#1)(2008-5#1)(2009-5#1)
simulation of light scattering##3##4##(2008-3#3)
simulation of light##4##3##(2008-3#4)
simulation of such##2##3##(1997-6#1)(2007-12#1)
simulation of the##24##3##(1992-3#1)(1992-8#1)(1996-12#1)(1997-4#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#7)(2009-11#1)(2010-3#1)(2010-8#1)
simulation of##93##2##(1992-3#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-8#2)(1995-2#1)(1996-12#2)(1997-4#4)(1997-6#1)(2007-11#3)(2007-12#5)(2008-10#11)(2008-11#2)(2008-2#9)(2008-3#32)(2008-4#2)(2008-5#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-8#1)(2011-1#3)(2012-2#1)(2013-1#1)
simulation output##2##2##(2008-10#2)
simulation packages##3##2##(2008-2#1)(2013-1#2)
simulation platform##2##2##(2008-11#1)(2009-9#1)
simulation program##2##2##(1995-2#1)(2008-3#1)
simulation result##2##2##(2011-1#1)(2013-8#1)
simulation results are given to##2##5##(2007-12#1)(2008-2#1)
simulation results are##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
simulation results show that the##4##5##(2008-3#3)(2012-3#1)
simulation results show that##6##4##(2008-3#4)(2011-1#1)(2012-3#1)
simulation results##29##2##(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#14)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
simulation show that the##2##4##(2007-11#1)(2008-7#1)
simulation show that##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
simulation shows that the##2##4##(2007-11#1)(2011-1#1)
simulation shows that##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
simulation shows##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2011-1#1)
simulation studies and##3##3##(2009-12#1)(2012-12#1)(2012-3#1)
simulation studies of##2##3##(2008-3#1)(2010-3#1)
simulation studies that##2##3##(2008-3#1)(2009-9#1)
simulation studies##18##2##(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
simulation study of the##2##4##(2008-2#1)(2012-2#1)
simulation study##22##2##(1992-9#1)(1994-11#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-3#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
simulation techniques##2##2##(2008-4#1)(2008-7#1)
simulation technologies##2##2##(2008-11#2)
simulation that##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
simulation the##2##2##(2007-11#1)(2008-2#1)
simulation to be##2##3##(2008-2#1)(2008-3#1)
simulation to##8##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)
simulation tool for##2##3##(2008-2#2)
simulation tool##4##2##(2008-2#3)(2008-3#1)
simulation tools##2##2##(2008-2#1)(2009-5#1)
simulation training##2##2##(2008-11#2)
simulation using a##5##3##(1992-6#1)(2007-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
simulation using the##4##3##(1992-6#1)(2008-3#2)(2008-7#1)
simulation using##10##2##(1992-6#2)(2007-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
simulation was used to##2##4##(1995-1#1)(2008-3#1)
simulation was##6##2##(1995-1#1)(2008-3#2)(2009-6#1)(2011-2#1)(2013-1#1)
simulation with##4##2##(2008-3#2)(2008-8#1)(2008-9#1)
simulation##486##1##(1990-12#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#4)(1993-2#2)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#2)(1996-12#2)(1996-3#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-6#2)(2007-11#14)(2007-12#12)(2008-10#49)(2008-11#21)(2008-12#3)(2008-2#61)(2008-3#123)(2008-4#4)(2008-5#1)(2008-6#7)(2008-7#10)(2008-8#19)(2008-9#11)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-12#1)(2010-2#1)(2010-3#4)(2010-6#1)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#9)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#14)(2013-8#5)
simulation-based##6##1##(2009-10#1)(2009-5#1)(2010-8#1)(2012-2#2)(2013-8#1)
simulations agree with experimental##2##4##(1993-11#1)(2008-2#1)
simulations agree##3##2##(1993-11#1)(2008-2#1)(2008-3#1)
simulations also##2##2##(2008-3#2)
simulations and a sensitivity analysis##2##5##(2008-3#2)
simulations and experimental results##4##4##(2008-2#1)(2008-3#3)
simulations and experimental##6##3##(2008-2#2)(2008-3#3)(2009-9#1)
simulations and experiments##5##3##(2008-3#5)
simulations and field##2##3##(2008-3#2)
simulations and goniometric measurements##2##4##(2008-3#2)
simulations and the##3##3##(2008-3#2)(2010-2#1)
simulations and##43##2##(1994-9#1)(2007-12#1)(2008-11#1)(2008-2#6)(2008-3#20)(2008-8#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)
simulations are able to##2##4##(2008-11#1)(2013-8#1)
simulations are performed to##2##4##(2008-3#2)
simulations are performed##3##3##(2008-3#3)
simulations are presented##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
simulations are used to##3##4##(1992-2#1)(2007-12#1)(2008-3#1)
simulations are used##4##3##(1992-2#1)(2007-12#1)(2008-3#2)
simulations are##22##2##(1992-2#1)(1992-3#1)(1993-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#7)(2008-8#1)(2013-8#2)
simulations based on the##3##4##(1992-6#1)(2007-12#1)(2008-2#1)
simulations based on##9##3##(1992-6#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-7#1)
simulations can be##2##3##(2008-12#1)(2008-8#1)
simulations carried out##2##3##(2008-2#1)(2008-3#1)
simulations confirm the##2##3##(2008-11#1)(2008-2#1)
simulations demonstrate that##2##3##(2007-12#1)(2008-3#1)
simulations demonstrate##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-12#1)
simulations for##8##2##(2008-10#1)(2008-2#2)(2008-3#2)(2013-1#2)(2013-8#1)
simulations has been##2##3##(2008-10#1)(2008-12#1)
simulations have been##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
simulations have##4##2##(1993-11#1)(2007-11#1)(2008-11#1)(2008-3#1)
simulations in##7##2##(2007-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-11#1)(2011-1#1)
simulations indicate that the##3##4##(1994-2#1)(2008-3#1)(2008-4#1)
simulations indicate that##9##3##(1994-2#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
simulations of a##2##3##(2012-2#1)(2013-8#1)
simulations of alternative##2##3##(1993-12#1)(1996-1#1)
simulations of an##2##3##(1993-11#1)(2008-2#1)
simulations of light scattering##3##4##(2008-2#3)
simulations of nonlinear##2##3##(2007-12#1)(2008-2#1)
simulations of several##2##3##(2008-10#1)(2008-3#1)
simulations of the##19##3##(1990-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1995-5#2)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#8)
simulations of##69##2##(1990-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-5#1)(1995-3#2)(1995-5#3)(1995-6#1)(1996-1#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#12)(2008-3#18)(2009-12#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
simulations on##3##2##(1996-4#1)(2007-12#1)(2008-2#1)
simulations predict##3##2##(2008-2#1)(2008-3#2)
simulations provide##2##2##(1993-11#1)(2008-12#1)
simulations revealed that##2##3##(2008-2#1)(2012-2#1)
simulations show that the##6##4##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)
simulations show that##16##3##(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#5)(2008-8#1)
simulations show##20##2##(1997-2#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#7)(2008-8#1)
simulations showed that##4##3##(2008-3#2)(2008-8#1)(2012-2#1)
simulations suggest that the##2##4##(2007-12#1)(2008-8#1)
simulations suggest that##6##3##(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
simulations support##2##2##(2007-11#1)(2008-3#1)
simulations that a##2##3##(2007-11#1)(2007-12#1)
simulations that demonstrate the##2##4##(2008-3#2)
simulations that##16##2##(1995-2#1)(2007-11#3)(2007-12#4)(2008-3#5)(2009-8#1)(2010-9#1)(2012-2#1)
simulations the##3##2##(2008-3#3)
simulations to investigate the##2##4##(2008-8#1)(2009-6#1)
simulations to##15##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#1)(2011-3#1)
simulations using the##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
simulations using##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
simulations was##3##2##(1992-11#1)(2008-10#1)(2008-11#1)
simulations we##5##2##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
simulations were carried out##3##4##(2008-10#1)(2008-3#1)(2009-6#1)
simulations were judged to be##2##5##(2008-11#2)
simulations were performed to##2##4##(2008-2#1)(2012-3#1)
simulations were used to##2##4##(1997-2#1)(2008-10#1)
simulations were##14##2##(1993-11#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2009-6#1)(2012-3#1)
simulations with the##5##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
simulations with##14##2##(1992-3#1)(1993-11#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-2#1)
simulations##459##1##(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#12)(1993-12#1)(1993-5#1)(1994-2#1)(1994-9#2)(1995-2#3)(1995-3#4)(1995-5#5)(1995-6#1)(1996-1#1)(1996-4#2)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#22)(2007-12#35)(2008-10#23)(2008-11#16)(2008-12#8)(2008-2#59)(2008-3#130)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#15)(2008-9#6)(2009-12#1)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#17)(2013-8#10)
simulator equipped with##2##3##(2008-11#1)(2008-3#1)
simulator for the##2##3##(1994-12#1)(2008-10#1)
simulator for##3##2##(1994-12#1)(2008-10#1)(2008-2#1)
simulator predicts the##2##3##(2008-2#2)
simulator training##2##2##(2011-2#2)
simulator##36##1##(1994-12#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
simulators are##2##2##(2008-11#2)
simulators for##3##2##(2008-2#2)(2011-2#1)
simulators in##2##2##(2008-5#1)(2011-2#1)
simulators##14##1##(1996-12#1)(2008-11#2)(2008-2#2)(2008-5#1)(2009-5#1)(2011-2#5)(2012-2#1)(2012-3#1)
simultaneous EEG and near infrared optical tomography##2##7##(2011-1#2)
simultaneous action of two##2##4##(2007-11#1)(2007-12#1)
simultaneous activation of PPARalpha##2##4##(2008-1#2)
simultaneous addition of##8##3##(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)(2009-8#1)
simultaneous administration of the##2##4##(1991-1#1)(1992-5#1)
simultaneous administration of##6##3##(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1995-5#1)
simultaneous administration##7##2##(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1995-5#2)
simultaneous amplification##2##2##(2007-10#1)(2008-10#1)
simultaneous analysis of several##2##4##(2008-10#1)(2008-4#1)
simultaneous analysis of the##2##4##(2008-10#1)(2012-2#1)
simultaneous analysis of three##2##4##(2008-10#2)
simultaneous analysis of##26##3##(1990-8#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
simultaneous analysis##27##2##(1990-8#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
simultaneous and quantitative##2##3##(2008-10#1)(2008-5#1)
simultaneous and##9##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
simultaneous atomic absorption spectrometry (SIMAAS)##2##5##(2008-10#2)
simultaneous atomic absorption spectrometry##3##4##(2008-10#3)
simultaneous changes in##2##3##(1991-9#1)(2013-1#1)
simultaneous changes##3##2##(1991-9#1)(2008-3#1)(2013-1#1)
simultaneous cochlear implantation in children##2##5##(2012-2#2)
simultaneous cochlear implantation in##4##4##(2008-9#2)(2012-2#2)
simultaneous cochlear##5##2##(2008-9#2)(2012-2#3)
simultaneous confidence##3##2##(1997-7#1)(2009-5#1)(2010-11#1)
simultaneous detection and##3##3##(2008-10#2)(2010-6#1)
simultaneous detection of multiple##2##4##(2008-2#1)(2008-9#1)
simultaneous detection of the##3##4##(2008-10#2)(2011-1#1)
simultaneous detection of two##2##4##(2007-12#1)(2013-8#1)
simultaneous detection of##24##3##(2007-12#2)(2008-10#14)(2008-2#2)(2008-3#1)(2008-9#2)(2010-11#1)(2011-1#1)(2013-8#1)
simultaneous detection##33##2##(2007-12#2)(2008-10#19)(2008-2#2)(2008-3#1)(2008-9#3)(2009-11#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
simultaneous determination method##2##3##(2008-10#2)
simultaneous determination of 19##2##4##(2008-10#2)
simultaneous determination of As##5##4##(2008-10#5)
simultaneous determination of Fe(II)##5##4##(2008-10#5)
simultaneous determination of Fe(III) and Fe(II)##2##6##(2008-10#2)
simultaneous determination of Pb(2+) and Cd(2+)##2##6##(2008-10#2)
simultaneous determination of V(V) and##2##5##(2008-10#2)
simultaneous determination of all##3##4##(2008-10#3)
simultaneous determination of ammonium##4##4##(2008-10#4)
simultaneous determination of arsenic##3##4##(2008-10#3)
simultaneous determination of both organic and inorganic anions in##2##9##(2008-10#2)
simultaneous determination of both##5##4##(2008-10#5)
simultaneous determination of caffeine##3##4##(2008-10#3)
simultaneous determination of cobalt##2##4##(2008-10#2)
simultaneous determination of copper and iron##2##6##(2008-10#2)
simultaneous determination of copper and##3##5##(2008-10#3)
simultaneous determination of cyclosporine A##2##5##(2008-10#2)
simultaneous determination of direct and total##2##6##(2008-10#2)
simultaneous determination of four##5##4##(2008-10#5)
simultaneous determination of honokiol and magnolol in rat plasma##2##9##(2008-10#2)
simultaneous determination of iron and##3##5##(2008-10#3)
simultaneous determination of iron##4##4##(2008-10#4)
simultaneous determination of iron(III) and copper(II) and of iron(III) and palladium(II) based on##2##13##(2008-10#2)
simultaneous determination of iron(III) and##3##5##(2008-10#3)
simultaneous determination of nitrite and nitrate in##6##7##(2008-10#6)
simultaneous determination of nitrite and nitrate##9##6##(2008-10#9)
simultaneous determination of nitroaniline isomers##2##5##(2008-10#2)
simultaneous determination of nitroaniline##3##4##(2008-10#3)
simultaneous determination of organic##2##4##(2008-10#2)
simultaneous determination of oxidizable amino acids##2##6##(2008-10#2)
simultaneous determination of periodate-bromate and iodate-bromate##2##6##(2008-10#2)
simultaneous determination of selenium(IV) and##2##5##(2008-10#2)
simultaneous determination of seven##3##4##(2008-10#2)(2012-3#1)
simultaneous determination of some##4##4##(2008-10#4)
simultaneous determination of the compounds##2##5##(2008-10#2)
simultaneous determination of the##17##4##(2008-10#15)(2008-2#1)(2008-3#1)
simultaneous determination of these##4##4##(2008-10#4)
simultaneous determination of three##4##4##(2008-10#4)
simultaneous determination of trace##7##4##(2008-10#7)
simultaneous determination of two##2##4##(2008-10#2)
simultaneous determination of##244##3##(1990-8#3)(1995-3#2)(2008-10#226)(2008-2#2)(2008-3#1)(2008-5#3)(2009-6#1)(2011-1#3)(2011-3#1)(2012-2#1)(2012-3#1)
simultaneous determination##251##2##(1990-8#3)(1995-3#2)(2008-10#233)(2008-2#2)(2008-3#1)(2008-5#3)(2009-6#1)(2011-1#3)(2011-3#1)(2012-2#1)(2012-3#1)
simultaneous determinations of##2##3##(2008-10#2)
simultaneous determinations##4##2##(2008-10#4)
simultaneous dilution##2##2##(2008-10#2)
simultaneous direct##2##2##(2008-10#2)
simultaneous electrochemical##3##2##(2008-10#2)(2010-2#1)
simultaneous equations##2##2##(2008-3#1)(2010-5#1)
simultaneous estimation##4##2##(2008-10#3)(2010-3#1)
simultaneous exposure of##2##3##(1992-2#1)(1993-8#1)
simultaneous exposure to##2##3##(1991-12#1)(2010-4#1)
simultaneous exposure##4##2##(1991-12#1)(1992-2#1)(1993-8#1)(2010-4#1)
simultaneous expression##2##2##(2008-1#1)(2011-3#1)
simultaneous extraction##2##2##(2008-10#2)
simultaneous flow injection##2##3##(2008-10#2)
simultaneous handling of##2##3##(2008-10#2)
simultaneous identification and##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
simultaneous imaging##3##2##(2007-11#1)(2008-3#1)(2009-11#1)
simultaneous intracavity##2##2##(2007-12#2)
simultaneous kinetic##2##2##(2008-10#2)
simultaneous manipulation##2##2##(2007-11#1)(2008-7#1)
simultaneous measurement of temperature and##3##5##(2007-11#2)(2008-3#1)
simultaneous measurement of temperature##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
simultaneous measurement of the##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
simultaneous measurement of##24##3##(1994-9#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#9)(2008-4#2)
simultaneous measurement##25##2##(1994-9#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#10)(2008-4#2)
simultaneous measurements of##7##3##(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)
simultaneous measurements with lidar##2##4##(2008-2#2)
simultaneous measurements with##3##3##(2008-2#2)(2008-3#1)
simultaneous measurements##11##2##(2008-10#3)(2008-2#4)(2008-3#3)(2008-7#1)
simultaneous monitoring of##3##3##(2008-10#2)(2008-3#1)
simultaneous multielement determination of##2##4##(2008-10#2)
simultaneous multielement determination##3##3##(2008-10#3)
simultaneous multielement flame atomic absorption spectrometry##2##6##(2008-10#2)
simultaneous multielement##5##2##(2008-10#5)
simultaneous multiple injection##2##3##(2008-10#2)
simultaneous multiple##3##2##(2008-10#3)
simultaneous occurrence of##4##3##(1992-10#1)(1992-2#1)(2008-2#1)(2013-1#1)
simultaneous operation##2##2##(2008-10#1)(2008-11#1)
simultaneous optical wavelength interchange##2##4##(2007-12#2)
simultaneous optical##4##2##(2007-12#3)(2008-3#1)
simultaneous optimization of##2##3##(2008-10#1)(2008-3#1)
simultaneous optimization##3##2##(2008-10#2)(2008-3#1)
simultaneous or sequential##2##3##(2008-10#2)
simultaneous preconcentration##2##2##(2008-10#2)
simultaneous presence of##5##3##(1991-12#1)(1991-8#1)(1996-5#1)(2006-10#1)(2008-11#1)
simultaneous quantification of##7##3##(2008-10#2)(2008-11#1)(2010-12#2)(2011-3#1)(2012-2#1)
simultaneous quantitation of##3##3##(2008-10#2)(2008-9#1)
simultaneous quantitative##2##2##(2008-10#2)
simultaneous saccharification and fermentation (SSF)##3##5##(2008-6#2)(2013-1#1)
simultaneous saccharification and fermentation##8##4##(2008-6#6)(2013-1#2)
simultaneous saccharification and##9##3##(2008-6#7)(2013-1#2)
simultaneous saccharification##10##2##(2008-6#8)(2013-1#2)
simultaneous scores monitoring and residuals tracking (SMART)##2##7##(2008-10#2)
simultaneous second-harmonic generation and##3##4##(2007-12#3)
simultaneous second-harmonic generation##4##3##(2007-12#4)
simultaneous separation and determination of different##2##6##(2008-10#2)
simultaneous separation and determination of##3##5##(2008-10#3)
simultaneous separation and##6##3##(2008-10#6)
simultaneous separation of##5##3##(1990-8#1)(2008-10#4)
simultaneous separation##12##2##(1990-8#1)(2008-10#11)
simultaneous spectrophotometric determination of copper(II) and nickel(II) in##2##8##(2008-10#2)
simultaneous spectrophotometric determination of trace amounts of##2##7##(2008-10#2)
simultaneous spectrophotometric determination of##18##4##(2008-10#18)
simultaneous spectrophotometric##19##2##(2008-10#19)
simultaneous staining##2##2##(1996-12#1)(2008-11#1)
simultaneous strain and temperature##2##4##(2007-12#1)(2008-3#1)
simultaneous sunphotometer##2##2##(2008-2#1)(2008-3#1)
simultaneous system##2##2##(2008-10#2)
simultaneous thermal lens and beam deflection phenomena##2##7##(2008-3#2)
simultaneous thermal##3##2##(2008-3#2)(2011-2#1)
simultaneous to##2##2##(2008-12#2)
simultaneous triple ENBD insertion##2##4##(2013-1#2)
simultaneous triple ENBD##3##3##(2013-1#3)
simultaneous triple##4##2##(2013-1#4)
simultaneous use of##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
simultaneous utilization of##2##3##(2008-7#1)(2008-9#1)
simultaneous visualization of##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
simultaneous visualization##4##2##(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)
simultaneous with##2##2##(1992-8#1)(2008-3#1)
simultaneous##827##1##(1990-12#2)(1990-5#1)(1990-8#6)(1991-1#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#2)(1993-2#1)(1993-5#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#23)(2007-12#32)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#419)(2008-11#10)(2008-12#5)(2008-2#29)(2008-3#54)(2008-4#11)(2008-5#12)(2008-6#14)(2008-7#17)(2008-8#9)(2008-9#20)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2011-1#9)(2011-2#6)(2011-3#3)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#2)(2013-1#12)(2013-8#7)
simultaneously a##2##2##(2008-10#1)(2008-5#1)
simultaneously acquired##4##2##(2007-12#1)(2008-1#1)(2008-3#1)(2011-1#1)
simultaneously amplified##3##2##(2007-11#1)(2008-10#2)
simultaneously and in##2##3##(2007-12#1)(2008-10#1)
simultaneously and##9##2##(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
simultaneously applied##2##2##(1996-12#1)(2012-1#1)
simultaneously are##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
simultaneously as a##3##3##(2007-11#1)(2008-3#1)(2009-12#1)
simultaneously as##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2009-12#1)
simultaneously at##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
simultaneously by the##2##3##(2008-10#2)
simultaneously by use of##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
simultaneously by using##2##3##(2007-9#1)(2008-10#1)
simultaneously by##21##2##(1994-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2011-2#1)
simultaneously compensated##2##2##(1992-11#1)(1995-3#1)
simultaneously detect##4##2##(2008-10#2)(2008-9#1)(2013-8#1)
simultaneously detected in the##2##4##(1994-7#1)(2008-10#1)
simultaneously detected in##3##3##(1994-7#1)(2008-10#1)(2008-4#1)
simultaneously detected##8##2##(1994-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#2)
simultaneously determined by##4##3##(2008-10#4)
simultaneously determined in##5##3##(2008-10#5)
simultaneously determined##13##2##(1996-8#1)(2008-10#11)(2008-2#1)
simultaneously determining##3##2##(1994-3#1)(2008-10#2)
simultaneously employs##2##2##(2008-3#1)(2010-8#1)
simultaneously estimates##2##2##(2008-2#1)(2008-3#1)
simultaneously exposed to##2##3##(1995-12#1)(2009-9#1)
simultaneously extracted and##2##3##(1990-8#1)(2008-10#1)
simultaneously extracted##4##2##(1990-8#1)(2007-11#1)(2008-10#2)
simultaneously fitted to##2##3##(1997-2#1)(2008-3#1)
simultaneously fitting##2##2##(2008-2#1)(2008-3#1)
simultaneously for##6##2##(2007-11#1)(2008-10#2)(2008-2#3)
simultaneously from both##2##3##(2008-2#1)(2008-3#1)
simultaneously from the##5##3##(1996-2#1)(1997-7#1)(2008-3#3)
simultaneously from##13##2##(1991-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#6)(2011-2#1)
simultaneously imaged##2##2##(2007-10#1)(2009-10#1)
simultaneously imaging##2##2##(2008-3#2)
simultaneously in a##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
simultaneously in combined dosage form##2##5##(2010-3#1)(2010-5#1)
simultaneously in the blood##2##4##(2008-5#1)(2009-2#1)
simultaneously in the same##5##4##(1994-10#1)(1995-5#1)(2008-10#2)(2008-9#1)
simultaneously in the##16##3##(1992-12#1)(1994-10#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#2)(2011-1#1)
simultaneously in##34##2##(1992-12#1)(1994-10#1)(1994-12#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
simultaneously increased##3##2##(1996-6#1)(2008-8#1)(2009-6#1)
simultaneously infected##2##2##(2008-10#1)(2012-12#1)
simultaneously into##4##2##(2008-10#1)(2008-11#1)(2009-11#1)(2010-8#1)
simultaneously measure##4##2##(1994-2#1)(2008-3#1)(2008-9#2)
simultaneously measured##4##2##(2007-11#1)(2008-10#1)(2011-2#2)
simultaneously monitored##2##2##(2008-10#2)
simultaneously observed##6##2##(1995-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
simultaneously obtained##3##2##(2008-10#2)(2008-8#1)
simultaneously on a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
simultaneously on the##2##3##(2008-10#1)(2008-4#1)
simultaneously on##10##2##(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)
simultaneously over a##3##3##(2008-2#1)(2008-3#2)
simultaneously over the##2##3##(2007-12#1)(2011-1#1)
simultaneously over##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-1#1)
simultaneously phase-matched##2##2##(2007-11#1)(2007-12#1)
simultaneously present##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
simultaneously presented with##2##3##(2009-11#1)(2013-8#1)
simultaneously recorded##8##2##(1995-11#1)(1997-6#1)(2007-12#2)(2008-2#2)(2008-3#1)(2010-8#1)
simultaneously the##7##2##(1995-5#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)
simultaneously to the##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
simultaneously to##9##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
simultaneously using##3##2##(2008-10#2)(2008-3#1)
simultaneously with a##7##3##(1990-8#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-2#2)(2008-3#1)
simultaneously with an##2##3##(1990-12#1)(2008-10#1)
simultaneously with one##2##3##(1990-2#1)(2007-11#1)
simultaneously with the##14##3##(1992-3#1)(1993-2#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-3#2)
simultaneously with##54##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#1)(1995-2#2)(1995-5#2)(1995-6#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-7#1)(2013-7#1)
simultaneously##573##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#4)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#4)(1994-7#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#7)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#23)(2007-12#29)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#139)(2008-11#10)(2008-12#3)(2008-2#34)(2008-3#78)(2008-4#11)(2008-5#7)(2008-6#5)(2008-7#17)(2008-8#12)(2008-9#18)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#7)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#4)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#4)
simvastatin in##2##2##(2008-12#1)(2012-2#1)
simvastatin significantly reduced##2##3##(2011-2#1)(2012-2#1)
simvastatin##20##1##(1991-12#2)(1991-6#5)(1997-5#1)(2008-12#5)(2008-5#1)(2011-2#3)(2012-2#3)
sinapic acid##3##2##(2008-5#1)(2013-1#2)
since 1969##2##2##(1990-2#1)(1996-8#1)
since 1970 has##2##3##(1990-11#2)
since 1970##6##2##(1990-11#2)(1992-2#1)(1995-3#1)(2010-8#1)(2013-1#1)
since 1974##2##2##(2007-8#1)(2008-10#1)
since 1975##4##2##(1990-9#1)(1991-4#1)(1992-2#1)(1997-5#1)
since 1979##2##2##(1992-3#1)(1995-2#1)
since 1980##7##2##(1992-3#1)(1994-3#1)(1994-9#1)(2008-10#2)(2010-8#1)(2013-1#1)
since 1981##2##2##(1990-12#1)(1991-1#1)
since 1983##3##2##(1992-2#1)(1992-3#1)(2011-2#1)
since 1985##9##2##(1990-2#2)(1991-3#1)(1992-12#1)(1992-4#1)(1992-9#1)(1997-2#1)(1997-3#1)(2008-7#1)
since 1986##2##2##(1996-4#1)(2008-1#1)
since 1988##2##2##(1992-11#1)(2008-10#1)
since 1989##2##2##(2008-2#1)(2009-3#1)
since 1990##6##2##(1994-1#1)(1995-6#1)(1996-2#1)(1997-5#1)(2008-10#1)(2011-2#1)
since 1991##3##2##(2007-8#1)(2008-1#1)(2008-9#1)
since 1992##7##2##(1996-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
since 1993##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
since 1994##2##2##(2008-1#1)(2010-7#1)
since 1996##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
since 1997##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
since 1998##4##2##(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#1)
since 1999##3##2##(2008-5#1)(2010-8#1)(2011-2#1)
since 2000##8##2##(2007-12#1)(2008-10#3)(2008-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
since 2001##3##2##(2008-10#1)(2008-7#1)(2009-11#1)
since 2004##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
since 2005##2##2##(2009-8#1)(2011-2#1)
since 2006##3##2##(2011-2#1)(2011-3#1)(2013-1#1)
since 2007##2##2##(2012-3#1)(2013-8#1)
since 2012##2##2##(2013-8#2)
since August##3##2##(1995-6#1)(1996-8#1)(2012-12#1)
since January##2##2##(1990-12#1)(1995-12#1)
since March##4##2##(1995-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
since September##2##2##(1991-2#1)(1996-3#1)
since a##11##2##(1990-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
since all##3##2##(1991-8#1)(1995-6#1)(2008-10#1)
since an##4##2##(2007-10#1)(2008-10#1)(2009-3#1)(2011-1#1)
since ancient times##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
since at least##2##3##(1993-6#1)(2008-10#1)
since at##3##2##(1993-6#1)(2008-10#1)(2008-6#1)
since been##8##2##(1990-11#1)(1992-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-9#1)(2012-3#1)(2013-8#1)
since birth##7##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-3#1)(2010-6#1)
since both##5##2##(1994-8#1)(1995-5#1)(2007-12#1)(2008-10#1)(2010-5#1)
since childhood##2##2##(2012-2#1)(2013-1#1)
since diagnosis##5##2##(1993-9#1)(1996-2#1)(2008-9#2)(2011-2#1)
since early childhood##2##3##(2006-8#1)(2008-9#1)
since early##5##2##(1993-2#1)(2006-8#1)(2007-11#1)(2008-9#1)(2012-2#1)
since environmental##2##2##(2008-7#1)(2010-11#1)
since evolved##2##2##(2008-10#1)(2011-1#1)
since his##2##2##(2007-8#1)(2013-1#1)
since in the##2##3##(1990-9#1)(1995-11#1)
since in this##3##3##(1994-8#1)(2008-3#2)
since in##7##2##(1990-9#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-11#1)(2008-3#2)
since initial##2##2##(2008-3#1)(2013-8#1)
since it can also##2##4##(2008-8#1)(2012-12#1)
since it can be##4##4##(1992-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
since it can##7##3##(1992-2#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
since it does not require##3##5##(2007-11#1)(2008-3#1)(2009-7#1)
since it does not##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2009-7#1)
since it has been##2##4##(2008-1#1)(2008-10#1)
since it has##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
since it is a##2##4##(1997-8#1)(2007-7#1)
since it is likely##2##4##(2007-11#1)(2008-4#1)
since it is##21##3##(1992-12#1)(1994-12#2)(1997-8#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-3#1)(2011-2#1)
since it may be##2##4##(2010-7#1)(2013-1#1)
since it may##5##3##(1995-5#1)(1996-9#1)(2008-5#1)(2010-7#1)(2013-1#1)
since it provides##2##3##(2008-10#2)
since it was reversed##2##4##(1994-2#1)(1997-7#1)
since it was##10##3##(1992-2#1)(1994-2#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2010-12#1)
since it##81##2##(1990-5#2)(1990-6#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
since its first##3##3##(1990-9#1)(2008-10#1)(2011-1#1)
since its inception in##2##4##(1995-12#1)(2010-8#1)
since its inception##6##3##(1995-12#1)(1996-3#1)(2008-1#1)(2008-6#1)(2010-8#1)(2011-2#1)
since its##20##2##(1990-3#1)(1990-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
since long##2##2##(2008-10#1)(2012-3#1)
since many years##2##3##(1990-9#1)(1991-4#1)
since many##8##2##(1990-9#1)(1991-4#1)(1992-6#1)(1994-2#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
since more##2##2##(2008-4#1)(2011-2#1)
since most of##2##3##(2008-10#1)(2008-4#1)
since most##6##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
since neither##3##2##(1994-11#1)(1994-5#1)(1995-12#1)
since new##2##2##(1990-11#1)(2011-2#1)
since no statistical differences were found after applying the paired t-test at the 95%##2##14##(2008-10#2)
since no##6##2##(1991-8#1)(1994-8#1)(2007-7#1)(2008-10#2)(2012-12#1)
since one##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
since only patients##2##3##(1990-8#1)(1991-6#1)
since only##4##2##(1990-8#1)(1991-6#2)(2013-8#1)
since oxidative##2##2##(1994-9#1)(2013-1#1)
since recent##2##2##(2011-2#1)(2012-12#1)
since reduction of##2##3##(1995-2#1)(2008-11#1)
since remained##2##2##(1996-11#1)(2013-8#1)
since some##3##2##(1994-3#1)(2008-11#1)(2008-2#1)
since such##3##2##(1991-1#1)(1995-3#1)(2008-7#1)
since surgical##3##2##(2007-11#2)(2011-2#1)
since that time##2##3##(1996-3#1)(2008-12#1)
since the 1960s##2##3##(2010-10#1)(2010-5#1)
since the 1970s##3##3##(1994-12#1)(2008-10#2)
since the 1990s##3##3##(2010-8#1)(2013-8#2)
since the beginning of##3##4##(1992-2#1)(2007-8#1)(2008-10#1)
since the discovery of##3##4##(1996-5#1)(2008-4#1)(2009-6#1)
since the discovery##4##3##(1996-5#1)(2008-4#1)(2009-6#1)(2010-3#1)
since the early 1990s##2##4##(2008-10#1)(2012-1#1)
since the early##5##3##(1997-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
since the end of##2##4##(2007-11#1)(2011-2#1)
since the first##7##3##(1992-5#1)(1993-6#1)(1997-8#1)(2008-5#1)(2008-7#1)(2013-8#2)
since the founding of the##2##5##(1997-2#1)(2008-7#1)
since the inception of the##2##5##(2007-8#1)(2011-2#1)
since the inception of##4##4##(1995-12#1)(2007-2#1)(2007-8#1)(2011-2#1)
since the initial##2##3##(2008-10#1)(2008-2#1)
since the initiation of##2##4##(2007-12#1)(2007-7#1)
since the introduction of the##2##5##(1997-5#1)(2011-1#1)
since the introduction of##8##4##(1991-9#1)(1997-5#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-3#1)
since the last##2##3##(1991-12#1)(2013-1#1)
since the late 1990s##2##4##(2008-10#1)(2013-1#1)
since the late##6##3##(1993-12#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
since the latter is##2##4##(1990-3#1)(2008-10#1)
since the mid##2##3##(2008-7#1)(2013-7#1)
since the original##2##3##(2008-11#1)(2008-12#1)
since the remaining##2##3##(1994-5#1)(2011-2#1)
since the results##2##3##(1994-2#1)(2008-11#1)
since the seventeenth century##2##4##(2009-7#1)(2010-1#1)
since the use of##2##4##(1997-3#1)(2008-6#1)
since the widespread use of##2##5##(2008-7#2)
since the##217##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#3)(1993-6#3)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#4)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#4)(2008-10#35)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#5)
since their introduction##2##3##(2007-11#1)(2007-12#1)
since their##13##2##(1993-1#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-7#1)(2010-3#1)(2010-5#2)(2012-3#1)
since then##5##2##(1991-3#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
since there are##2##3##(1994-3#1)(1995-5#1)
since there is##2##3##(1993-1#1)(2010-2#1)
since there##6##2##(1990-11#1)(1993-1#1)(1994-3#1)(1995-5#1)(2008-10#1)(2010-2#1)
since these are##2##3##(2008-10#2)
since these diseases have##2##4##(2011-2#1)(2012-2#1)
since these variables##2##3##(1993-1#1)(2013-1#1)
since these##19##2##(1990-8#1)(1991-6#1)(1992-10#1)(1993-1#1)(2008-10#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
since they are##4##3##(1994-9#1)(2008-1#1)(2008-6#1)(2012-3#1)
since they can##2##3##(2008-4#1)(2009-7#1)
since they exhibit##2##3##(2008-11#1)(2013-1#1)
since they have to##2##4##(1997-6#1)(2008-2#1)
since they have##5##3##(1990-12#1)(1997-6#1)(2008-2#1)(2010-11#1)(2010-3#1)
since they may##3##3##(1992-1#1)(1992-6#1)(1997-6#1)
since they were##2##3##(1995-3#1)(2008-11#1)
since they##39##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-3#2)(1994-9#1)(1995-3#1)(1997-1#1)(1997-6#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
since this is##4##3##(1994-3#1)(1997-1#1)(2008-10#2)
since this##15##2##(1990-5#1)(1991-5#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
since we##6##2##(1990-12#1)(1991-4#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-8#1)
since##915##1##(1990-10#1)(1990-11#9)(1990-12#7)(1990-2#4)(1990-3#4)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#7)(1991-1#2)(1991-11#1)(1991-12#11)(1991-2#4)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#7)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#4)(1992-11#3)(1992-12#2)(1992-2#12)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#6)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#9)(1994-5#2)(1994-6#2)(1994-8#10)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#10)(1995-2#8)(1995-3#6)(1995-5#5)(1995-6#7)(1995-8#3)(1996-11#2)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#8)(1996-6#5)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#4)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#10)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#5)(2007-7#11)(2007-8#10)(2008-1#20)(2008-10#127)(2008-11#19)(2008-12#12)(2008-2#11)(2008-3#18)(2008-4#21)(2008-5#23)(2008-6#13)(2008-7#30)(2008-8#11)(2008-9#16)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#5)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#7)(2010-1#5)(2010-10#5)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#11)(2010-4#3)(2010-5#9)(2010-6#3)(2010-7#3)(2010-8#10)(2011-1#12)(2011-2#41)(2011-3#4)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#14)(2013-1#36)(2013-7#7)(2013-8#18)
sincere##3##1##(1992-2#1)(2008-11#1)(2009-4#1)
sindbis##3##1##(1997-8#2)(2013-1#1)
sine and##2##2##(2007-12#1)(2008-3#1)
sine oculis##2##2##(2007-12#2)
sine wave##5##2##(2006-12#3)(2011-2#2)
sine##12##1##(2006-12#3)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)
sinensis##11##1##(2008-10#2)(2008-6#2)(2008-7#3)(2008-8#2)(2011-2#1)(2013-8#1)
sinensis)##8##1##(2008-10#7)(2012-12#1)
sinensis]##2##1##(2012-3#1)(2013-8#1)
sing##5##1##(1991-3#1)(1991-8#1)(2008-2#1)(2008-8#1)(2013-8#1)
singing males##2##2##(2008-8#2)
singing##4##1##(2008-8#3)(2008-9#1)
single African##2##2##(1994-3#2)
single Cys##3##2##(1994-5#2)(1995-6#1)
single DNA molecule##2##3##(2008-10#1)(2008-12#1)
single DNA##6##2##(1993-11#1)(2008-10#2)(2008-12#1)(2008-9#2)
single IV##2##2##(1996-9#1)(2012-2#1)
single P##3##2##(2008-10#3)
single QTL##3##2##(2008-10#2)(2012-3#1)
single RNA##3##2##(2007-12#1)(2008-7#1)(2009-3#1)
single U##2##2##(2008-10#1)(2011-2#1)
single academic##2##2##(2007-10#1)(2010-12#1)
single access retroperitoneoscopic adrenalectomy##2##4##(2012-12#2)
single access retroperitoneoscopic##4##3##(2012-12#4)
single administration of##3##3##(1990-7#1)(1995-3#1)(1997-7#1)
single administration##6##2##(1990-7#1)(1995-3#2)(1997-7#1)(2012-2#1)(2013-1#1)
single agent in pretreated##2##4##(1991-6#1)(1994-8#1)
single agent in##4##3##(1991-6#2)(1994-8#2)
single agent##10##2##(1991-6#2)(1994-8#3)(2008-10#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-4#1)
single agents##3##2##(2007-5#1)(2008-10#1)(2009-12#1)
single amino acid change in the##2##6##(2008-10#1)(2012-3#1)
single amino acid change##4##4##(1995-2#1)(1997-2#1)(2008-10#1)(2012-3#1)
single amino acid mutations##2##4##(1997-2#1)(2008-10#1)
single amino acid substitution##5##4##(1990-11#1)(1991-12#1)(1995-8#1)(2008-10#1)(2008-8#1)
single amino acid##20##3##(1990-11#1)(1991-12#1)(1991-8#2)(1993-11#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-2#2)(1997-4#1)(2008-10#3)(2008-8#2)(2009-9#1)(2012-3#1)
single amino##21##2##(1990-11#1)(1991-12#1)(1991-8#2)(1993-11#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-2#2)(1997-4#1)(2008-10#4)(2008-8#2)(2009-9#1)(2012-3#1)
single analysis##6##2##(1990-8#1)(1994-9#1)(1997-3#1)(2008-10#1)(2009-11#1)(2012-12#1)
single ancestral##2##2##(2007-11#1)(2008-8#1)
single and combined##2##3##(1993-3#1)(2011-1#1)
single and double##2##3##(1990-5#1)(1991-9#1)
single and dual##3##3##(1997-2#1)(2011-1#1)(2013-1#1)
single and mixed##4##3##(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
single and multiple##9##3##(1992-8#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-1#1)
single and repeated##2##3##(2012-1#1)(2013-1#1)
single and##36##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
single antibody-secreting cells##2##3##(2008-4#2)
single application of##7##3##(2008-10#6)(2013-1#1)
single application##9##2##(2008-10#8)(2013-1#1)
single approach is##2##3##(1994-12#1)(2008-7#1)
single approach##3##2##(1994-12#1)(2008-7#1)(2013-8#1)
single assay##4##2##(1991-5#1)(1992-3#1)(2008-10#2)
single atoms##2##2##(2007-11#1)(2008-10#1)
single bacterial##2##2##(1995-2#1)(2008-10#1)
single band in##4##3##(1990-11#1)(1993-2#1)(1996-5#1)(2008-10#1)
single band##18##2##(1990-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#2)(1996-5#1)(1997-2#1)(2008-10#2)
single base deletion##3##3##(1992-8#3)
single base pair mutation##2##4##(2008-10#2)
single base pair##5##3##(1990-5#1)(2007-10#1)(2007-7#1)(2008-10#2)
single base##14##2##(1990-5#2)(1992-8#3)(1993-3#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)
single bead string##3##3##(2008-10#3)
single bead##4##2##(2008-10#3)(2008-11#1)
single beam##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
single biological##2##2##(2007-11#1)(2008-5#1)
single biomolecules##2##2##(2010-7#1)(2012-2#1)
single blind##2##2##(2008-5#1)(2012-2#1)
single cancer##2##2##(2009-12#1)(2010-12#1)
single carbon source##2##3##(2008-10#1)(2008-8#1)
single carbon##3##2##(2008-10#2)(2008-8#1)
single case studies##2##3##(2008-12#1)(2010-5#1)
single case study##3##3##(1993-9#1)(2008-9#1)(2013-1#1)
single case##14##2##(1990-6#1)(1993-9#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-9#1)(2013-1#3)
single cause of##2##3##(1992-5#1)(1992-6#1)
single cause##4##2##(1992-5#1)(1992-6#1)(2007-7#1)(2008-11#1)
single cell analysis##2##3##(2007-12#1)(2009-12#1)
single cell gel electrophoresis##3##4##(1996-2#1)(1997-4#2)
single cell gel##4##3##(1996-2#1)(1997-4#2)(2013-1#1)
single cell##43##2##(1990-12#2)(1992-12#1)(1993-6#1)(1993-9#1)(1994-8#2)(1996-2#2)(1996-5#1)(1997-4#4)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
single cells from##3##3##(2008-11#1)(2008-2#1)(2009-2#1)
single cells##28##2##(1991-5#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#7)(2008-9#1)(2009-12#2)(2009-2#1)(2011-1#1)
single center##9##2##(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)
single centre##2##2##(1993-2#1)(2012-2#1)
single chain T cell receptor##2##5##(1994-6#2)
single chain antibodies##2##3##(2008-10#2)
single chain antibody to vascular endothelial growth factor##2##8##(2008-8#2)
single chain antibody##5##3##(1992-6#2)(2008-8#3)
single chain insulin##6##3##(2008-9#6)
single chain##20##2##(1990-11#1)(1992-6#2)(1994-3#1)(1994-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#6)
single channel##14##2##(1994-12#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2011-3#2)(2012-3#1)
single chemical##2##2##(2008-10#1)(2008-7#1)
single chirality##2##2##(2010-12#2)
single clone##2##2##(1994-9#1)(1995-2#1)
single colonies##3##2##(1994-11#1)(2008-10#2)
single colony##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
single column##2##2##(1997-2#1)(2008-10#1)
single component of the##2##4##(2008-2#1)(2008-3#1)
single component of##4##3##(1992-12#1)(2008-2#1)(2008-3#2)
single component##8##2##(1992-12#1)(1993-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
single components in##2##3##(2008-10#2)
single components##4##2##(2008-10#3)(2011-2#1)
single compound##8##2##(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-8#1)
single copy##30##2##(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#4)(1997-4#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#4)(2009-10#1)(2012-2#1)
single coronary artery##2##3##(2007-8#1)(2008-12#1)
single coronary##3##2##(2007-8#1)(2008-12#1)(2009-11#1)
single crown##3##2##(1990-5#1)(2013-1#2)
single crystal X-ray diffraction##2##4##(2007-11#1)(2011-1#1)
single crystal X-ray##3##3##(2007-11#2)(2011-1#1)
single crystal of##5##3##(1997-7#1)(2008-10#1)(2008-2#1)(2013-1#2)
single crystal##25##2##(1990-4#1)(1992-8#1)(1997-7#2)(2007-11#5)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#1)(2009-11#2)(2011-1#1)(2013-1#3)
single crystalline titanium dioxide##2##4##(2009-11#2)
single crystalline##6##2##(1997-4#1)(2006-4#1)(2009-11#4)
single crystals and##2##3##(1992-8#1)(2008-3#1)
single crystals as##2##3##(2006-4#1)(2008-3#1)
single crystals of##5##3##(1996-2#1)(2008-10#2)(2012-2#2)
single crystals##17##2##(1992-8#1)(1996-2#1)(1997-7#1)(2006-4#1)(2007-11#2)(2008-10#2)(2008-3#6)(2009-5#1)(2012-2#2)
single cystosorus isolates##2##3##(2008-10#2)
single cystosorus##3##2##(2008-10#3)
single daily dose##5##3##(1990-11#2)(1991-11#1)(2008-11#1)(2011-2#1)
single daily##6##2##(1990-11#2)(1991-11#1)(2007-7#1)(2008-11#1)(2011-2#1)
single data point##2##3##(2008-2#1)(2009-9#1)
single day##5##2##(1991-2#1)(2008-12#1)(2010-10#2)(2013-8#1)
single difference##2##2##(2008-3#1)(2009-6#1)
single digital micromirror##2##3##(2008-3#2)
single digital##3##2##(2008-3#3)
single dominant avirulence genes##2##4##(2008-10#2)
single dominant avirulence##3##3##(2008-10#3)
single dominant gene for##2##4##(2008-10#1)(2008-5#1)
single dominant gene##18##3##(2008-10#17)(2008-5#1)
single dominant##29##2##(2008-10#28)(2008-5#1)
single dose of##19##3##(1990-6#2)(1991-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-5#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
single dose##35##2##(1990-6#2)(1991-2#1)(1992-12#2)(1993-2#2)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-5#1)(2006-6#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#4)(2010-1#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
single doses of##2##3##(1994-5#1)(2008-11#1)
single ectopic ureteric##2##3##(2008-10#2)
single ectopic ureters with hypoplastic bladder##3##6##(2008-10#3)
single ectopic##5##2##(2008-10#5)
single electrical##2##2##(2008-1#1)(2009-8#1)
single element##4##2##(2008-10#2)(2008-9#1)(2009-5#1)
single eukaryotic##2##2##(1995-9#1)(2009-12#1)
single experimental##2##2##(2007-11#1)(2012-3#1)
single exponential##5##2##(1990-7#1)(1991-12#1)(1996-5#1)(2008-3#1)(2008-5#1)
single exposure##4##2##(2007-12#1)(2008-3#2)(2008-7#1)
single extract of##2##3##(2008-10#2)
single extraction##8##2##(2008-10#8)
single factor##3##2##(2008-10#1)(2008-11#2)
single factors##2##2##(1990-9#1)(1993-1#1)
single family##2##2##(2007-7#1)(2011-2#1)
single fiber optic sensor##2##4##(2008-10#2)
single fiber##12##2##(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#4)
single fields##3##2##(2008-10#3)
single fluorescent##2##2##(1997-6#1)(2008-3#1)
single fraction 8Gy##3##3##(2008-10#3)
single fraction##5##2##(1990-2#1)(2008-10#4)
single frequency##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
single gene control of##3##4##(2008-10#3)
single gene disorders##2##3##(2008-8#2)
single gene##40##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1993-2#1)(1994-9#1)(1995-6#3)(1995-8#1)(1996-2#1)(1997-3#1)(2008-10#17)(2008-4#1)(2008-7#2)(2008-8#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
single genes for##2##3##(2008-10#2)
single genes##5##2##(2008-10#3)(2008-6#1)(2012-12#1)
single genetic##3##2##(1990-8#1)(1991-11#1)(2010-4#1)
single genome##2##2##(2008-1#1)(2013-8#1)
single genotype stands##2##3##(2008-10#2)
single genotype##5##2##(2008-10#5)
single genotypes##2##2##(2008-10#1)(2008-12#1)
single genotypic infections##2##3##(2008-12#2)
single genotypic##3##2##(2008-12#3)
single glycerinated##2##2##(1991-12#2)
single graphene##2##2##(2008-7#1)(2009-11#1)
single habitat##2##2##(2008-8#1)(2008-9#1)
single haplotype##2##2##(2008-10#2)
single helical##2##2##(1994-2#1)(1995-5#1)
single hologram##2##2##(2008-2#1)(2008-3#1)
single i##4##2##(1990-11#1)(1992-5#2)(2008-4#1)
single image##9##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)
single implants inserted##2##3##(2013-1#2)
single implants##4##2##(2013-1#4)
single individual##3##2##(2008-10#2)(2013-1#1)
single individuals##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
single infarct##2##2##(2007-10#2)
single infection with##2##3##(2008-10#1)(2011-2#1)
single infection##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
single infections##4##2##(2008-10#3)(2008-8#1)
single injection of##5##3##(1995-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
single injection##9##2##(1992-10#1)(1995-11#1)(1997-3#1)(2008-10#3)(2008-8#1)(2010-8#1)(2013-1#1)
single institution experience##2##3##(2007-5#1)(2011-2#1)
single institution##7##2##(1993-6#1)(2007-5#1)(2007-8#2)(2008-6#1)(2011-2#2)
single institutions##4##2##(1996-12#1)(2008-6#2)(2011-2#1)
single instrument##2##2##(1997-8#1)(2008-10#1)
single interaction##2##2##(2008-10#1)(2012-12#1)
single interphase##2##2##(2008-4#2)
single intervention##2##2##(2008-3#1)(2013-8#1)
single intradermal##3##2##(1997-8#2)(2008-9#1)
single intraperitoneal##7##2##(1992-12#1)(1994-5#2)(1994-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
single intravenous##3##2##(1991-12#1)(2011-1#1)(2012-3#1)
single isolate##5##2##(2008-10#5)
single joint##3##2##(2008-4#1)(2008-7#1)(2013-1#1)
single large##6##2##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)
single laser pulse##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
single laser##15##2##(1990-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#5)
single layer##9##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)
single layers##3##2##(2008-2#2)(2008-3#1)
single left##4##2##(2007-8#1)(2008-1#1)(2013-1#1)(2013-2#1)
single leg##2##2##(2007-12#2)
single lens##2##2##(2008-3#2)
single lesion halo naevus##2##4##(2007-7#2)
single lesion##3##2##(2007-7#2)(2008-10#1)
single line##5##2##(2008-10#4)(2008-3#1)
single lineage##2##2##(2008-10#1)(2008-6#1)
single linear##2##2##(2008-10#1)(2009-10#1)
single liquid##2##2##(1992-3#1)(2008-2#1)
single live##2##2##(2009-2#1)(2010-8#1)
single loci##2##2##(2008-12#1)(2013-1#1)
single locus##6##2##(1995-8#1)(2008-10#4)(2008-8#1)
single longitudinal mode with a##3##5##(2007-12#2)(2008-3#1)
single longitudinal mode##5##3##(2007-12#3)(2008-3#2)
single longitudinal##6##2##(2007-12#3)(2008-3#2)(2009-11#1)
single lung##2##2##(2011-3#2)
single major##6##2##(1995-12#1)(1995-2#1)(2008-10#4)
single mandibular##3##2##(2013-1#3)
single mass##3##2##(1990-5#1)(1992-1#1)(2010-6#1)
single measure##2##2##(2010-11#1)(2011-2#1)
single measurements##2##2##(1990-8#2)
single men##2##2##(2010-8#2)
single method##2##2##(2007-11#1)(2008-9#1)
single microaperture-per-channel##2##2##(2008-3#2)
single mirror##3##2##(2007-11#1)(2008-2#1)(2008-6#1)
single mode and##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
single mode##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
single model##4##2##(1995-2#1)(1997-5#1)(2008-11#1)(2010-6#1)
single molecule##17##2##(1992-3#1)(1997-6#1)(2008-10#1)(2008-5#2)(2009-5#2)(2009-9#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
single molecules and##2##3##(2008-4#1)(2008-7#1)
single molecules with##2##3##(2007-12#1)(2008-7#1)
single molecules##12##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#6)(2012-2#1)
single morning urine##2##3##(1996-12#2)
single most important factor in##2##5##(1990-8#1)(2011-1#1)
single most important factor##3##4##(1990-8#1)(2008-9#1)(2011-1#1)
single most important##4##3##(1990-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
single most##10##2##(1990-8#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
single mutant receptors##2##3##(1995-6#2)
single mutant##8##2##(1993-9#1)(1995-6#3)(2008-8#2)(2011-2#1)(2013-8#1)
single mutants##2##2##(1995-6#1)(2012-2#1)
single mutation##2##2##(1997-3#1)(2008-11#1)
single neuron##4##2##(1992-11#2)(1996-12#1)(2008-10#1)
single neurons and##2##3##(2007-8#1)(2008-11#1)
single neurons##8##2##(1993-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)
single nucleolus##2##2##(2008-12#1)(2008-5#1)
single nucleotide polymorphism (SNP) markers##2##5##(2008-7#1)(2012-5#1)
single nucleotide polymorphism (SNP)##8##4##(2008-4#1)(2008-7#2)(2009-7#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
single nucleotide polymorphism##16##3##(2008-1#1)(2008-4#1)(2008-7#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
single nucleotide polymorphisms (SNP)##3##4##(2008-4#1)(2011-1#1)(2013-1#1)
single nucleotide polymorphisms (SNPs) and##2##5##(2008-10#1)(2013-1#1)
single nucleotide polymorphisms (SNPs) of the##3##6##(2008-11#1)(2009-8#1)(2011-1#1)
single nucleotide polymorphisms (SNPs)##13##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
single nucleotide polymorphisms and##3##4##(2008-7#1)(2010-6#1)(2013-8#1)
single nucleotide polymorphisms of##3##4##(2008-10#1)(2011-1#2)
single nucleotide polymorphisms##28##3##(1997-9#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
single nucleotide##53##2##(1990-12#1)(1995-8#1)(1996-12#1)(1997-9#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#2)(2011-1#6)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
single optical##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
single or dual##2##3##(2008-3#1)(2011-1#1)
single or few##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
single or in##2##3##(2008-12#1)(2008-8#1)
single or multiple##7##3##(1994-2#2)(2007-10#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#1)
single or repeated##2##3##(2008-5#1)(2012-2#1)
single or##28##2##(1994-2#2)(1995-6#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)
single oral administration of##2##4##(2008-10#1)(2010-11#1)
single oral dose##4##3##(2007-7#1)(2008-10#2)(2008-7#1)
single oral##8##2##(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)
single out##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
single output##4##2##(2008-10#2)(2008-3#1)(2008-6#1)
single pair of##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
single parameter##4##2##(1994-9#1)(2008-10#1)(2008-3#1)(2008-9#1)
single particle analysis##3##3##(2008-10#3)
single particle##13##2##(1990-12#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)
single particles##3##2##(2008-10#2)(2008-5#1)
single patient with##2##3##(1990-3#1)(2013-8#1)
single patient##10##2##(1990-12#1)(1990-3#1)(1994-7#1)(2006-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
single peak##7##2##(1990-8#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-8#1)
single peptides##2##2##(2007-11#1)(2008-4#1)
single phase##4##2##(1990-7#1)(1992-6#1)(2008-5#1)(2009-11#1)
single photon emission computed tomography (SPECT)##6##6##(1996-12#1)(1996-5#1)(1996-7#1)(2008-8#1)(2009-12#1)(2009-8#1)
single photon emission computed tomography in##2##6##(1994-1#1)(1996-5#1)
single photon emission computed tomography##13##5##(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(2007-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
single photon emission computed##14##4##(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#1)(2007-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
single photon emission##17##3##(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#1)(2007-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
single photon##20##2##(1994-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#3)(1996-7#1)(2007-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
single plants##3##2##(2008-10#2)(2008-5#1)
single point mutation##3##3##(2008-10#3)
single point##12##2##(1995-12#1)(1997-6#1)(2008-10#8)(2008-2#1)(2008-6#1)
single polypeptide chain##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
single polypeptide##6##2##(1990-5#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2010-5#1)
single population of##3##3##(1990-8#1)(1996-2#1)(2007-9#1)
single population##5##2##(1990-8#1)(1996-2#1)(2007-9#1)(2008-10#1)(2011-2#1)
single primary##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
single primer##2##2##(2008-8#2)
single psychiatric occupational therapy##2##4##(2012-1#2)
single pulse##4##2##(1997-4#1)(2007-12#1)(2008-5#1)(2013-7#1)
single pulsed##4##2##(2007-12#1)(2008-10#1)(2008-9#2)
single pyramidal cells in the hippocampal CA1##2##7##(2008-11#2)
single pyramidal cells##4##3##(2008-11#4)
single quantum dots##2##3##(2007-11#1)(2007-12#1)
single random##2##2##(2008-10#1)(2008-3#1)
single rare##2##2##(2008-10#1)(2012-3#1)
single rat##3##2##(1991-9#1)(1996-12#2)
single recessive gene##8##3##(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)
single recessive##10##2##(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)
single reference##2##2##(2008-10#1)(2008-3#1)
single resistance##5##2##(2008-10#5)
single response##4##2##(1997-7#2)(2008-10#2)
single restriction site##2##3##(2008-10#1)(2008-5#1)
single run##3##2##(2008-10#2)(2008-11#1)
single scan##3##2##(2008-10#2)(2012-2#1)
single scattering##7##2##(2008-2#2)(2008-3#4)(2009-11#1)
single scoliosis##2##2##(2007-8#2)
single secretory##3##2##(1991-12#1)(1997-7#1)(2008-6#1)
single seed##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
single sensory##4##2##(1996-12#1)(2007-12#1)(2009-5#1)(2010-11#1)
single sequence##2##2##(2008-4#1)(2010-8#1)
single sequences##2##2##(2008-4#1)(2011-2#1)
single serum##2##2##(1991-11#1)(1996-12#1)
single set of##5##3##(1994-12#1)(1997-7#1)(2008-1#1)(2008-3#1)(2012-12#1)
single shot##4##2##(2007-12#2)(2008-3#1)(2009-4#1)
single side##2##2##(2007-8#1)(2013-8#1)
single site##11##2##(1990-8#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-4#2)(2008-10#3)(2008-11#1)(2008-7#1)
single social##2##2##(2010-10#1)(2010-2#1)
single sound##2##2##(2008-9#1)(2013-8#1)
single source##5##2##(1992-1#2)(1993-2#1)(2008-10#1)(2008-2#1)
single spatial##2##2##(2008-2#1)(2008-3#1)
single species of##2##3##(1995-12#1)(1996-12#1)
single species##14##2##(1993-12#1)(1995-12#1)(1996-12#1)(2007-5#1)(2008-10#8)(2009-6#1)(2011-2#1)
single spectral line##2##3##(2008-2#2)
single sperm##2##2##(2007-12#1)(2008-9#1)
single stage##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
single stance##2##2##(2007-10#2)
single standard addition##2##3##(2008-10#2)
single standard##4##2##(2008-10#3)(2008-7#1)
single stem##2##2##(2008-10#1)(2011-2#1)
single step##20##2##(1992-11#1)(1993-6#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#3)(2010-5#1)(2013-1#1)(2013-8#1)
single strain##5##2##(2008-10#2)(2009-6#1)(2012-3#2)
single strand##8##2##(1992-2#1)(1993-12#1)(2008-10#2)(2008-12#2)(2008-8#1)(2011-1#1)
single stranded DNA##2##3##(2008-10#2)
single stranded##5##2##(2008-10#4)(2011-2#1)
single study##2##2##(2008-8#1)(2009-10#1)
single subcutaneous injection of##2##4##(1993-1#1)(2008-7#1)
single substrate##4##2##(1991-5#1)(2008-3#3)
single subunit##2##2##(1991-12#1)(1992-8#1)
single surgical##2##2##(1994-8#1)(2008-11#1)
single target##2##2##(1993-11#1)(2008-3#1)
single telia##2##2##(2008-10#2)
single test in##2##3##(2008-6#1)(2008-8#1)
single test##6##2##(1997-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-2#1)
single time##4##2##(1995-12#1)(1996-9#1)(2011-2#1)(2012-3#1)
single to##2##2##(2008-3#1)(2011-1#1)
single tooth##3##2##(2007-12#3)
single topical application of##2##4##(1992-8#2)
single training##2##2##(2008-2#1)(2013-8#1)
single transverse mode##5##3##(2007-12#1)(2008-3#4)
single treatment##4##2##(1995-12#1)(2008-12#1)(2010-5#1)(2010-9#1)
single treatments##2##2##(2008-10#1)(2013-1#1)
single trees##3##2##(2008-10#3)
single tropocollagen##2##2##(2009-7#2)
single tryptophan##2##2##(1992-6#1)(1995-5#1)
single tumor cells##2##3##(2011-2#2)
single tumor##3##2##(1994-12#1)(2011-2#2)
single two-dimensional synthetic##2##3##(2008-3#2)
single two-dimensional##4##2##(2007-11#2)(2008-3#2)
single type of##3##3##(2007-7#1)(2009-8#1)(2010-8#1)
single type##4##2##(1994-2#1)(2007-7#1)(2009-8#1)(2010-8#1)
single unit activity##2##3##(1994-2#1)(2008-4#1)
single unit##5##2##(1994-2#1)(1994-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
single units##3##2##(1996-2#1)(2008-1#1)(2008-8#1)
single versus multiple##4##3##(2008-10#3)(2012-3#1)
single vesicle##2##2##(1997-7#1)(2012-2#1)
single vessel##3##2##(2007-8#3)
single wave of##2##3##(1995-11#1)(1996-5#1)
single wavelength modulation##2##3##(2008-10#2)
single wavelength##10##2##(2006-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
single zoospore isolates##6##3##(2008-10#6)
single##2563##1##(1990-10#1)(1990-11#13)(1990-12#10)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#11)(1990-6#3)(1990-7#12)(1990-8#17)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#13)(1991-2#9)(1991-4#1)(1991-5#6)(1991-6#9)(1991-7#1)(1991-8#5)(1991-9#8)(1992-1#5)(1992-10#1)(1992-11#9)(1992-12#11)(1992-2#3)(1992-3#12)(1992-4#1)(1992-5#6)(1992-6#11)(1992-8#15)(1992-9#1)(1993-1#3)(1993-11#14)(1993-12#11)(1993-2#14)(1993-3#7)(1993-5#1)(1993-6#9)(1993-8#6)(1993-9#5)(1994-1#1)(1994-11#7)(1994-12#11)(1994-2#10)(1994-3#10)(1994-5#12)(1994-6#8)(1994-7#2)(1994-8#13)(1994-9#4)(1995-11#7)(1995-12#10)(1995-2#14)(1995-3#5)(1995-5#16)(1995-6#21)(1995-8#6)(1995-9#3)(1996-1#2)(1996-12#26)(1996-2#11)(1996-3#1)(1996-5#10)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#14)(1997-3#14)(1997-4#13)(1997-5#4)(1997-6#9)(1997-7#21)(1997-8#4)(1997-9#1)(2006-10#1)(2006-12#2)(2006-4#5)(2006-6#2)(2007-10#12)(2007-11#73)(2007-12#90)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#16)(2007-8#21)(2007-9#1)(2008-1#14)(2008-10#549)(2008-11#72)(2008-12#33)(2008-2#97)(2008-3#177)(2008-4#49)(2008-5#44)(2008-6#21)(2008-7#69)(2008-8#58)(2008-9#58)(2009-1#1)(2009-10#14)(2009-11#13)(2009-12#17)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#15)(2009-6#4)(2009-7#5)(2009-8#15)(2009-9#9)(2010-1#1)(2010-10#7)(2010-11#7)(2010-12#11)(2010-2#6)(2010-3#7)(2010-4#5)(2010-5#12)(2010-6#7)(2010-7#4)(2010-8#15)(2010-9#3)(2011-1#38)(2011-10#1)(2011-2#72)(2011-3#6)(2011-7#1)(2012-1#8)(2012-12#19)(2012-2#40)(2012-3#27)(2012-5#1)(2012-6#2)(2013-1#69)(2013-2#1)(2013-7#4)(2013-8#31)
single- and two-laser##2##3##(2008-2#2)
single- and##12##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)(2009-4#1)
single- or##9##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
single-##25##1##(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)
single-agent chemotherapy##2##2##(2008-6#2)
single-agent##4##1##(2008-6#3)(2013-1#1)
single-amino-acid##2##1##(1993-12#1)(2011-1#1)
single-arc RapidArc##2##2##(2013-1#2)
single-arc##3##1##(2013-1#3)
single-arm clinical trials##2##3##(1995-2#2)
single-arm##9##1##(1995-2#3)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
single-band##5##1##(2008-3#5)
single-base mismatch in##2##3##(2008-10#2)
single-base mismatch##3##2##(1993-11#1)(2008-10#2)
single-base mismatches##2##2##(2008-10#1)(2008-4#1)
single-base##16##1##(1990-8#2)(1992-3#1)(1993-11#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-9#3)
single-beam gradient force##2##3##(2007-12#1)(2008-2#1)
single-beam##8##1##(2007-12#1)(2008-2#5)(2008-3#2)
single-blind phase##2##2##(2008-6#2)
single-blind study##2##2##(1990-6#1)(2010-8#1)
single-blind##9##1##(1990-3#1)(1990-6#1)(1990-8#1)(2008-6#2)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
single-blinded##2##1##(2012-12#1)(2013-1#1)
single-carbon metabolism##2##2##(1992-10#2)
single-case research##3##2##(2009-11#3)
single-case##6##1##(2009-11#3)(2009-5#1)(2013-1#1)(2013-8#1)
single-cell gel electrophoresis assay##2##4##(1996-2#1)(1997-4#1)
single-cell gel electrophoresis##4##3##(1996-2#1)(1997-4#3)
single-cell level##5##2##(2008-10#2)(2008-11#1)(2008-9#2)
single-cell reproduction##2##2##(2008-8#2)
single-cell suspension##2##2##(2008-11#1)(2008-9#1)
single-cell suspensions of##3##3##(2008-4#2)(2008-9#1)
single-cell suspensions##4##2##(2008-4#3)(2008-9#1)
single-cell##28##1##(1993-9#1)(1994-8#1)(1996-2#1)(1997-4#3)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#4)(2008-8#3)(2008-9#5)(2009-12#2)(2009-2#1)(2012-12#1)
single-celled##3##1##(1995-2#1)(2008-1#1)(2012-3#1)
single-center experience##5##2##(2007-12#3)(2008-11#1)(2011-2#1)
single-center##6##1##(2007-12#3)(2008-11#1)(2011-2#2)
single-centre##4##1##(2007-5#1)(2007-8#1)(2008-11#1)(2010-12#1)
single-chain Fv##6##2##(1993-8#1)(2008-10#1)(2008-8#2)(2010-12#2)
single-chain antibodies (scFvs) against##2##4##(2008-10#2)
single-chain antibodies (scFvs)##3##3##(2008-10#2)(2008-4#1)
single-chain antibody fragment##2##3##(1997-4#1)(2009-2#1)
single-chain antibody##7##2##(1993-8#1)(1994-8#1)(1997-4#1)(2008-4#1)(2008-8#2)(2009-2#1)
single-chain precursor##3##2##(1992-10#1)(1992-12#2)
single-chain variable fragment antibodies (scFv) that bind##2##7##(2008-10#2)
single-chain variable fragment antibodies##3##4##(2008-10#3)
single-chain variable##4##2##(2008-10#4)
single-chain##36##1##(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-8#1)(1993-8#2)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#1)(1997-4#1)(2008-10#8)(2008-4#2)(2008-8#7)(2009-2#1)(2010-12#2)
single-channel conductance##3##2##(1993-3#1)(1994-12#1)(2008-8#1)
single-channel transmission##2##2##(2007-12#1)(2008-3#1)
single-channel##16##1##(1990-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1997-6#2)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
single-charged##6##1##(2008-10#6)
single-color##2##1##(1997-6#1)(2008-4#1)
single-copy DNA##3##2##(1994-12#1)(2008-10#2)
single-copy gene##11##2##(1991-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1996-6#1)(2008-7#1)(2008-8#1)
single-copy restriction fragment length polymorphism##2##5##(2008-10#2)
single-copy##26##1##(1990-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#3)(1995-6#1)(1995-8#2)(1996-6#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)
single-crystal X-ray diffraction##5##3##(1996-2#1)(1997-7#3)(2010-5#1)
single-crystal quartz##3##2##(2008-3#2)(2009-11#1)
single-crystal##26##1##(1992-7#1)(1996-2#1)(1997-7#6)(2006-4#1)(2007-12#6)(2008-2#4)(2008-3#4)(2008-7#1)(2009-11#1)(2010-5#1)
single-cycle electromagnetic pulses##2##3##(2007-12#2)
single-cycle##7##1##(2007-12#7)
single-domain##3##1##(1993-12#1)(2007-11#1)(2008-2#1)
single-dose##9##1##(1992-9#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
single-drop microextraction (SDME)##4##3##(2008-10#4)
single-drop microextraction##6##2##(2008-10#6)
single-drop##10##1##(2008-10#9)(2008-3#1)
single-electron reduction##3##2##(1995-8#3)
single-electron##5##1##(1995-8#3)(1996-5#1)(2008-11#1)
single-electron-transferring##2##1##(1995-8#2)
single-element##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
single-ended distributed##2##2##(2007-11#1)(2007-12#1)
single-ended##3##1##(2007-11#2)(2007-12#1)
single-female-derived lines##2##2##(2008-10#2)
single-fiber##6##1##(2008-3#5)(2010-4#1)
single-field##2##1##(2008-2#2)
single-frame##2##1##(2008-2#2)
single-frequency 532-nm##2##2##(2007-12#1)(2008-3#1)
single-frequency green output##2##3##(2008-3#2)
single-frequency idler##2##2##(2007-11#1)(2007-12#1)
single-frequency laser##2##2##(2007-11#1)(2008-2#1)
single-frequency operation is##2##3##(2008-2#1)(2008-3#1)
single-frequency operation##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
single-frequency oscillations on different transitions##2##5##(2007-12#2)
single-frequency radiation at##2##3##(2007-12#2)
single-frequency radiation##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
single-frequency##43##1##(2007-11#7)(2007-12#14)(2008-2#10)(2008-3#12)
single-gene##7##1##(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#2)(2010-7#1)
single-genotype plots##4##2##(2008-10#4)
single-genotype##5##1##(2008-10#5)
single-grating##3##1##(2007-12#3)
single-group##3##1##(1993-1#1)(2010-7#1)(2013-1#1)
single-hTREK1-channel##2##1##(2012-2#2)
single-image codebook##2##2##(2008-3#2)
single-image##4##1##(2008-2#1)(2008-3#3)
single-institution##4##1##(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)
single-instruction multiple-data##2##2##(2008-2#1)(2008-3#1)
single-instruction##3##1##(2008-2#2)(2008-3#1)
single-instruction-multiple-data##2##1##(2008-3#2)
single-ion##4##1##(2007-12#1)(2008-10#1)(2010-7#1)(2012-2#1)
single-joint strength##2##2##(2010-7#2)
single-joint##3##1##(2008-7#1)(2010-7#2)
single-knob tuning##2##2##(2008-2#2)
single-laser##5##1##(2008-2#2)(2008-3#1)(2008-9#2)
single-laser-shot##2##1##(2008-2#1)(2008-3#1)
single-layer viscous##2##2##(2009-10#2)
single-layer##12##1##(1997-4#1)(2007-12#2)(2008-2#3)(2008-3#2)(2009-10#2)(2009-11#1)(2009-7#1)
single-layered##2##1##(2007-12#1)(2008-3#1)
single-lens##2##1##(2008-2#1)(2008-3#1)
single-level C-ADR with##2##3##(2012-12#2)
single-level C-ADR##4##2##(2012-12#4)
single-level##10##1##(2010-1#2)(2012-12#7)(2012-3#1)
single-line##3##1##(2008-10#2)(2008-3#1)
single-locus##5##1##(2008-10#1)(2008-4#2)(2010-6#1)(2012-3#1)
single-longitudinal##2##1##(2007-12#1)(2008-3#1)
single-longitudinal- and##2##2##(2007-11#1)(2008-2#1)
single-longitudinal-mode (SLM)##2##2##(2007-12#1)(2008-3#1)
single-longitudinal-mode erbium-doped fiber##2##3##(2008-3#2)
single-longitudinal-mode operation##2##2##(2007-11#1)(2008-2#1)
single-longitudinal-mode##8##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
single-lung ventilation##3##2##(2006-10#3)
single-lung##4##1##(2006-10#3)(2012-1#1)
single-mode Nd##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
single-mode behavior##2##2##(2007-11#1)(2008-2#1)
single-mode cavity ringdown spectroscopy##2##4##(2008-3#2)
single-mode class B lasers##2##4##(2007-11#2)
single-mode continuous-wave##4##2##(2008-2#2)(2008-3#2)
single-mode diode lasers##3##3##(2008-3#3)
single-mode fiber collimators##2##3##(2008-3#2)
single-mode fiber coupler##2##3##(2007-11#1)(2007-12#1)
single-mode fiber coupling##3##3##(2008-2#2)(2008-3#1)
single-mode fiber depolarizer##2##3##(2008-2#2)
single-mode fiber with a##2##4##(2008-2#2)
single-mode fiber with##5##3##(2008-2#3)(2008-3#2)
single-mode fiber##40##2##(2007-11#8)(2007-12#9)(2008-2#12)(2008-3#11)
single-mode fibers are##2##3##(2007-11#1)(2007-12#1)
single-mode fibers##10##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#2)
single-mode gain margin##2##3##(2008-3#2)
single-mode laser##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
single-mode operation of a##2##4##(2008-3#2)
single-mode operation of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
single-mode operation##9##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)
single-mode optical fiber##16##3##(2007-11#6)(2007-12#4)(2008-2#3)(2008-3#3)
single-mode optical fibers were##2##4##(2007-11#2)
single-mode optical fibers##9##3##(2007-11#3)(2007-12#1)(2008-3#5)
single-mode optical##27##2##(2007-11#9)(2007-12#6)(2008-2#3)(2008-3#9)
single-mode output power##2##3##(2008-3#2)
single-mode output##4##2##(2008-2#2)(2008-3#2)
single-mode polarization-maintaining##2##2##(2008-3#2)
single-mode quantum cascade##2##3##(2007-11#2)
single-mode regime##2##2##(2007-11#2)
single-mode slab waveguides##2##3##(2008-2#2)
single-mode tuning of##2##3##(2007-11#1)(2008-3#1)
single-mode tuning##3##2##(2007-11#2)(2008-3#1)
single-mode vertical-cavity surface-emitting laser with##2##5##(2007-12#2)
single-mode vertical-cavity surface-emitting laser##3##4##(2007-12#3)
single-mode waveguides##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
single-mode##186##1##(2007-11#44)(2007-12#48)(2008-2#37)(2008-3#56)(2008-7#1)
single-molecule detection##2##2##(2008-2#1)(2012-2#1)
single-molecule fluorescence experiments##2##3##(2009-4#2)
single-molecule fluorescence##9##2##(2007-12#2)(2008-10#2)(2008-2#1)(2009-4#4)
single-molecule imaging of oxidation catalysis##2##5##(2008-7#2)
single-molecule imaging##3##2##(2008-7#2)(2010-2#1)
single-molecule##27##1##(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-7#5)(2009-4#5)(2009-9#1)(2010-10#1)(2010-2#2)(2012-2#4)(2013-8#1)
single-neuron##2##1##(1994-2#1)(2009-8#1)
single-nucleotide polymorphism (SNP)##2##3##(2008-10#1)(2009-5#1)
single-nucleotide polymorphism##5##2##(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#2)
single-nucleotide polymorphisms (SNPs)##4##3##(2009-7#1)(2012-3#2)(2013-1#1)
single-nucleotide polymorphisms##12##2##(2008-10#1)(2008-4#1)(2009-7#1)(2012-3#7)(2013-1#2)
single-nucleotide##21##1##(1993-6#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#7)(2013-1#2)
single-order##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
single-parent families##2##2##(2008-11#1)(2008-9#1)
single-particle detection##2##2##(2008-3#2)
single-particle##4##1##(2008-2#1)(2008-3#3)
single-pass amplification##2##2##(2007-12#2)
single-pass and##2##2##(2007-12#1)(2008-3#1)
single-pass compression##2##2##(2008-2#2)
single-pass frequency doubling##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
single-pass pumping##2##2##(2007-12#1)(2008-2#1)
single-pass##33##1##(1997-2#1)(2007-11#3)(2007-12#13)(2008-2#6)(2008-3#8)(2011-3#2)
single-path##2##1##(2007-12#2)
single-payer##2##1##(1995-1#1)(1996-12#1)
single-peaked##2##1##(2007-11#1)(2007-12#1)
single-phase extraction##2##2##(2008-10#2)
single-phase solution##2##2##(2008-10#2)
single-phase##5##1##(2008-10#4)(2010-4#1)
single-photon and two-photon excitation##2##4##(2008-3#2)
single-photon and two-photon##3##3##(2008-3#3)
single-photon counting##5##2##(2007-11#1)(2008-3#4)
single-photon emission computed tomography##2##4##(1995-5#1)(2012-2#1)
single-photon excitation##2##2##(2008-3#2)
single-photon photolysis##2##2##(2008-4#2)
single-photon##22##1##(1995-5#1)(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#10)(2008-4#2)(2012-2#1)
single-photon-counting##2##1##(2007-11#1)(2008-2#1)
single-point mutants##3##2##(1993-11#2)(2008-9#1)
single-point##12##1##(1991-5#1)(1993-11#3)(1993-8#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-9#2)(2013-1#1)
single-projection##2##1##(2008-2#2)
single-pulse energy##2##2##(2008-3#2)
single-pulse##14##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#9)
single-pump scheme##2##2##(2007-11#2)
single-resistance##2##1##(2008-10#2)
single-ring##2##1##(2007-11#1)(2010-2#1)
single-round##2##1##(2008-10#2)
single-scan##3##1##(2008-3#1)(2012-8#2)
single-scatter albedo was 0##3##4##(2008-3#3)
single-scatter##5##1##(2008-3#5)
single-scattering albedo and##3##3##(2008-2#3)
single-scattering albedo at##2##3##(2008-3#2)
single-scattering albedo of the hexagonal column##2##6##(2008-3#2)
single-scattering albedo of##4##3##(2008-3#4)
single-scattering albedo##19##2##(2008-2#6)(2008-3#13)
single-scattering##28##1##(2008-2#8)(2008-3#20)
single-seed descent##2##2##(2008-10#2)
single-shot autocorrelator##2##2##(2007-11#2)
single-shot measurement of the##3##4##(2007-11#2)(2007-12#1)
single-shot measurement##4##2##(2007-11#2)(2007-12#2)
single-shot measurements of##2##3##(2007-12#1)(2008-3#1)
single-shot measurements##5##2##(2007-12#2)(2008-3#3)
single-shot##37##1##(2007-11#11)(2007-12#10)(2008-2#1)(2008-3#12)(2011-1#3)
single-side##2##1##(2012-2#2)
single-sideband##5##1##(2007-12#2)(2008-3#3)
single-sided##2##1##(2008-2#2)
single-site mutations in the catalytic##2##5##(1990-8#2)
single-site mutations in##3##3##(1990-8#2)(2008-11#1)
single-site surgery##2##2##(2009-2#2)
single-site##7##1##(1990-8#2)(2008-11#1)(2008-3#1)(2009-2#2)(2012-2#1)
single-spore isolates##3##2##(2008-10#3)
single-spore##4##1##(2008-10#4)
single-spot multianalyte##2##2##(2008-10#2)
single-stage bilateral##3##2##(2008-10#2)(2008-8#1)
single-stage ultrafast laser amplifier system##2##5##(2007-11#2)
single-stage##15##1##(2007-11#4)(2008-10#5)(2008-2#2)(2008-3#2)(2008-8#1)(2012-3#1)
single-step fabrication##2##2##(2007-11#1)(2008-2#1)
single-step phase modulation##2##3##(2008-3#2)
single-step##14##1##(1995-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#2)(2012-12#1)
single-strand breaks and##2##3##(1994-5#1)(1994-8#1)
single-strand breaks in##3##3##(1993-3#2)(1997-4#1)
single-strand breaks were##2##3##(1993-8#1)(2008-11#1)
single-strand breaks##18##2##(1992-3#1)(1993-3#4)(1993-8#1)(1994-5#1)(1994-8#4)(1996-2#1)(1997-4#3)(2008-11#2)(2008-3#1)
single-strand conformation polymorphism (SSCP) analysis##2##5##(2008-10#2)
single-strand conformation polymorphism analysis##2##4##(1992-8#1)(2011-2#1)
single-strand conformation polymorphism##6##3##(1992-8#1)(2008-10#4)(2011-2#1)
single-strand conformational polymorphism##2##3##(2008-10#2)
single-strand##29##1##(1992-3#1)(1992-8#1)(1993-3#4)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#4)(1996-2#1)(1997-4#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2011-2#1)(2013-1#1)
single-stranded (ss) DNA##2##3##(1997-2#1)(2008-2#1)
single-stranded (ss)##3##2##(1997-2#1)(2008-10#1)(2008-2#1)
single-stranded DNA (msDNA)##2##3##(1997-6#1)(2008-4#1)
single-stranded DNA (ssDNA)##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
single-stranded DNA binding protein##6##4##(1992-3#1)(1992-6#1)(1992-9#2)(1997-3#2)
single-stranded DNA binding##7##3##(1992-3#1)(1992-6#1)(1992-9#2)(1997-2#1)(1997-3#2)
single-stranded DNA virus##2##3##(2008-10#1)(2008-9#1)
single-stranded DNA##28##2##(1991-3#1)(1991-5#2)(1992-3#1)(1992-6#2)(1992-9#2)(1994-12#2)(1995-2#2)(1997-2#1)(1997-3#3)(1997-6#2)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#2)
single-stranded DNA-binding##2##2##(2008-10#1)(2010-10#1)
single-stranded RNA molecules##2##3##(2008-10#1)(2011-2#1)
single-stranded RNA##8##2##(2008-10#5)(2008-4#1)(2011-2#1)(2012-2#1)
single-stranded and double-stranded DNA##2##4##(2008-10#1)(2008-9#1)
single-stranded and double-stranded##3##3##(2008-10#1)(2008-9#2)
single-stranded and##4##2##(2008-10#2)(2008-9#2)
single-stranded deoxyribonucleic acid##2##3##(2008-10#2)
single-stranded nucleic##3##2##(1991-5#1)(2008-10#1)(2008-9#1)
single-stranded nucleotides##2##2##(1993-1#2)
single-stranded##80##1##(1990-11#1)(1990-5#2)(1991-3#1)(1991-5#4)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-8#2)(1994-12#3)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#2)(2008-4#4)(2008-7#1)(2008-9#5)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
single-stripe##2##1##(2007-11#1)(2007-12#1)
single-subject##2##1##(2009-9#1)(2011-2#1)
single-tone##2##1##(2007-11#2)
single-tooth##5##1##(1996-3#1)(2013-1#4)
single-tube##3##1##(2008-12#1)(2011-1#1)(2012-12#1)
single-unit##2##1##(1995-12#1)(2008-1#1)
single-uredinial isolates##2##2##(2008-10#2)
single-uredinial##3##1##(2008-10#3)
single-use phosphorimetric##2##2##(2008-10#2)
single-use##5##1##(2008-10#4)(2011-2#1)
single-valued function##2##2##(2008-2#1)(2008-3#1)
single-wall carbon nanotubes##4##3##(2007-11#1)(2008-10#2)(2008-12#1)
single-walled carbon nanotube##4##3##(2008-10#1)(2008-7#3)
single-walled carbon nanotubes (SWNTs) are##2##5##(2008-7#1)(2009-11#1)
single-walled carbon nanotubes (SWNTs)##5##4##(2008-7#4)(2009-11#1)
single-walled carbon nanotubes##14##3##(2008-10#3)(2008-7#7)(2009-11#2)(2010-2#1)(2013-1#1)
single-walled carbon##18##2##(2008-10#4)(2008-7#10)(2009-11#2)(2010-2#1)(2013-1#1)
single-walled nanotubes##3##2##(2008-7#3)
single-walled##23##1##(2008-10#4)(2008-7#15)(2009-11#2)(2010-2#1)(2013-1#1)
single-wavelength##3##1##(2007-11#2)(2008-2#1)
single-well potential##5##2##(2008-10#5)
single-well##7##1##(2007-12#2)(2008-10#5)
single-zoospore progeny##2##2##(2008-10#2)
single-zoospore##3##1##(2008-10#3)
singlehood##2##1##(2011-2#2)
singlet and triplet##2##3##(1996-5#1)(2009-10#1)
singlet oxygen and##3##3##(2008-5#2)(2008-8#1)
singlet oxygen quencher##2##3##(2008-3#1)(2008-5#1)
singlet oxygen##25##2##(1990-11#3)(1991-9#1)(1992-12#2)(1994-12#1)(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#8)(2008-8#1)(2009-4#1)(2010-4#1)
singlet states##2##2##(1997-7#1)(2008-10#1)
singlet##38##1##(1990-11#3)(1991-9#1)(1992-12#2)(1992-9#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-11#3)(2008-10#5)(2008-2#1)(2008-3#4)(2008-5#8)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#2)(2010-4#1)
singlet-singlet##2##1##(1993-11#1)(2008-3#1)
singlet-triplet##2##1##(2012-2#2)
singleton##7##1##(1993-10#1)(2007-11#2)(2008-12#1)(2011-1#1)(2012-3#2)
singletons##2##1##(1995-6#1)(2008-11#1)
singly and doubly protonated##3##4##(1996-7#3)
singly and in combination##2##4##(1990-6#1)(2012-6#1)
singly and in##6##3##(1990-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-6#1)
singly and##11##2##(1990-6#1)(1996-7#3)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-6#1)
singly immunoprecipitated##2##2##(2008-2#2)
singly occupied##2##2##(1996-2#2)
singly or in##4##3##(1996-5#1)(2008-5#1)(2010-1#1)(2012-12#1)
singly or##6##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-12#1)
singly protonated##4##2##(1996-7#4)
singly resonant OPO##4##3##(2007-11#3)(2007-12#1)
singly resonant optical parametric oscillator##6##5##(2007-11#1)(2007-12#4)(2008-3#1)
singly resonant optical parametric oscillators##3##5##(2007-12#2)(2008-3#1)
singly resonant optical parametric##9##4##(2007-11#1)(2007-12#6)(2008-3#2)
singly resonant##22##2##(2007-11#7)(2007-12#10)(2008-3#5)
singly scattered light##2##3##(2008-2#1)(2008-3#1)
singly to##2##2##(1995-11#1)(2008-5#1)
singly##69##1##(1990-5#1)(1990-6#1)(1990-8#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#7)(2007-11#7)(2007-12#11)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-6#1)
singly-doped and doubly-doped##2##3##(2008-3#2)
singly-doped##3##1##(2008-3#3)
singular points of##2##3##(2007-11#1)(2008-3#1)
singular points##3##2##(2007-11#1)(2008-3#2)
singular value decomposition (SVD)##2##4##(1990-8#1)(1994-11#1)
singular value decomposition##8##3##(1990-8#1)(1994-11#1)(2008-10#5)(2010-10#1)
singular##28##1##(1990-8#1)(1992-6#1)(1994-11#1)(1994-3#1)(1997-5#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
singular-value decomposition##3##2##(2008-2#1)(2008-3#2)
singularities are##2##2##(2008-2#1)(2008-3#1)
singularities in##2##2##(2007-11#2)
singularities##13##1##(2007-11#8)(2007-12#2)(2008-2#1)(2008-3#2)
singularity##12##1##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#4)(2008-6#1)(2009-10#1)(2013-1#1)
singularly perturbed##2##2##(2013-8#2)
sinica##5##1##(2008-10#4)(2008-5#1)
sink for##4##2##(1997-4#1)(2008-10#1)(2008-11#2)
sink populations##3##2##(2013-1#3)
sink##35##1##(1995-6#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#14)(2008-9#1)(2013-1#4)
sinking phytoplankton species##2##3##(2008-8#2)
sinking phytoplankton##4##2##(2008-8#4)
sinking##9##1##(2008-10#1)(2008-3#1)(2008-8#6)(2008-9#1)
sinks planted to##2##3##(2008-10#2)
sinks planted##4##2##(2008-10#4)
sinks to##2##2##(2008-10#1)(2008-9#1)
sinks##15##1##(1995-3#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-8#3)(2008-9#1)(2013-1#1)
sinoatrial blocks##4##2##(1996-3#4)
sinogram##3##1##(2012-1#3)
sinomenine##2##1##(1994-8#2)
sinonasal epithelial cells##2##3##(2012-1#2)
sinonasal malignancies##3##2##(2008-3#1)(2011-1#1)(2012-1#1)
sinonasal symptoms following##2##3##(2011-2#2)
sinonasal symptoms##3##2##(2011-2#3)
sinonasal tract##2##2##(1993-6#1)(2009-1#1)
sinonasal undifferentiated carcinoma##2##3##(2008-3#2)
sinonasal##21##1##(1990-6#1)(1993-6#1)(2008-11#1)(2008-3#3)(2008-8#2)(2009-1#1)(2011-1#1)(2011-2#4)(2012-1#7)
sins##2##1##(1996-12#1)(2008-11#1)
sintered##5##1##(2008-11#2)(2009-7#3)
sintering and##2##2##(2008-3#1)(2013-8#1)
sintering process##2##2##(2008-11#1)(2009-7#1)
sintering##10##1##(2008-11#1)(2008-3#4)(2009-7#3)(2013-8#2)
sinus access##2##2##(2012-1#2)
sinus and the##2##3##(1993-12#1)(1996-6#1)
sinus and##17##2##(1990-12#1)(1993-12#1)(1996-6#1)(1996-9#2)(1997-3#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#4)(2012-3#1)(2012-8#1)(2013-1#1)
sinus are##3##2##(2006-12#1)(2008-7#1)(2013-1#1)
sinus beats##2##2##(1996-6#2)
sinus but##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
sinus disease##2##2##(2013-8#2)
sinus dural arteriovenous malformations##4##4##(2006-12#2)(2008-7#2)
sinus dural##5##2##(1996-9#1)(2006-12#2)(2008-7#2)
sinus floor augmentation##2##3##(2007-12#1)(2013-1#1)
sinus floor##4##2##(2007-12#2)(2008-11#1)(2013-1#1)
sinus gland##6##2##(2007-12#1)(2008-5#2)(2008-6#3)
sinus in an##2##3##(1996-6#1)(2013-7#1)
sinus in##4##2##(1996-6#1)(2008-10#1)(2008-5#1)(2013-7#1)
sinus is an##2##3##(1996-9#1)(2013-1#1)
sinus is##9##2##(1996-9#2)(2006-12#1)(2008-7#2)(2010-11#1)(2013-1#3)
sinus lift##3##2##(2007-12#1)(2010-5#2)
sinus mucocele##2##2##(2013-1#2)
sinus mucosa of##2##3##(2012-1#1)(2013-1#1)
sinus of Valsalva##7##3##(1997-5#3)(2007-8#2)(2010-5#1)(2011-2#1)
sinus of##10##2##(1997-5#3)(2007-8#4)(2010-5#1)(2011-2#2)
sinus or paced rhythm##2##4##(2007-8#2)
sinus or##6##2##(2007-8#2)(2008-4#1)(2011-2#1)(2011-7#1)(2012-3#1)
sinus pressure##3##2##(1993-1#2)(2007-8#1)
sinus rhythm and##2##3##(1990-3#1)(1995-12#1)
sinus rhythm showed##2##3##(2008-11#1)(2012-3#1)
sinus rhythm with##2##3##(1996-6#1)(2007-8#1)
sinus rhythm##24##2##(1990-3#1)(1990-9#1)(1994-3#1)(1995-12#2)(1996-6#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-11#2)(2008-7#2)(2009-10#1)(2010-12#3)(2012-3#2)(2013-1#1)
sinus showed##2##2##(2007-10#1)(2008-7#1)
sinus surgery##4##2##(2008-5#1)(2012-1#3)
sinus system##2##2##(1996-9#1)(2011-2#1)
sinus that##3##2##(1996-9#1)(2008-2#1)(2008-3#1)
sinus thrombosis##12##2##(1997-3#1)(1997-6#2)(2007-10#2)(2008-7#5)(2012-12#1)(2012-3#1)
sinus tract##4##2##(2013-1#1)(2013-8#3)
sinus was performed##2##3##(2006-12#1)(2007-8#1)
sinus was##6##2##(1996-6#1)(1996-9#1)(2006-12#2)(2007-8#1)(2008-7#1)
sinus with detachable##2##3##(2006-12#2)
sinus with##6##2##(1996-9#1)(2006-12#2)(2008-7#2)(2013-1#1)
sinus##267##1##(1990-12#3)(1990-3#1)(1990-5#2)(1990-9#2)(1991-10#1)(1992-4#1)(1992-6#1)(1993-1#3)(1993-12#2)(1993-9#2)(1994-3#1)(1995-12#2)(1996-6#8)(1996-9#27)(1997-3#5)(1997-5#3)(1997-6#2)(2006-12#13)(2007-10#5)(2007-12#5)(2007-8#13)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#33)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#2)(2010-11#2)(2010-12#3)(2010-5#3)(2010-6#1)(2011-2#27)(2011-7#1)(2012-1#8)(2012-12#3)(2012-2#3)(2012-3#7)(2012-8#3)(2013-1#20)(2013-7#1)(2013-8#9)
sinuses and the##2##3##(2013-1#1)(2013-8#1)
sinuses and##5##2##(2007-7#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
sinuses are##2##2##(1996-9#2)
sinuses in##3##2##(1992-10#1)(2007-12#1)(2010-5#1)
sinuses##42##1##(1990-6#1)(1991-6#1)(1992-10#2)(1993-12#1)(1996-9#4)(2006-12#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2010-5#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
sinusitis and##2##2##(1997-3#1)(2008-5#1)
sinusitis in pregnancy##2##3##(2012-8#2)
sinusitis in##5##2##(1991-6#1)(2011-1#2)(2012-8#2)
sinusitis is##3##2##(2011-1#1)(2013-1#2)
sinusitis##45##1##(1990-10#1)(1991-6#4)(1993-2#8)(1995-8#1)(1996-1#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-8#3)(2013-1#7)
sinusoid##4##1##(2006-12#1)(2008-2#2)(2008-5#1)
sinusoidal GSH##4##2##(1995-2#4)
sinusoidal and##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
sinusoidal fringe##3##2##(2008-3#3)
sinusoidal function##2##2##(2008-3#2)
sinusoidal grating##2##2##(2008-3#2)
sinusoidal gratings##4##2##(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
sinusoidal phase##2##2##(2007-11#1)(2008-3#1)
sinusoidal phase-modulating##3##2##(2008-3#3)
sinusoidal signal##2##2##(2008-3#2)
sinusoidal wavelength-scanning##2##2##(2008-3#2)
sinusoidal##62##1##(1990-12#2)(1992-6#1)(1992-9#1)(1995-2#5)(1996-2#1)(1996-5#3)(2006-10#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#30)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2013-1#1)
sinusoidally modulated laser diodes##2##4##(2008-3#2)
sinusoidally modulated##3##2##(2008-2#1)(2008-3#2)
sinusoidally##8##1##(1995-12#1)(2007-11#1)(2008-2#1)(2008-3#5)
sinusoids##5##1##(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)
sion##2##1##(2008-11#1)(2012-1#1)
siphon##3##1##(2008-10#1)(2008-5#2)
sir1 cells##3##2##(2008-8#3)
sir1##4##1##(2008-8#4)
sire lines of Japanese Black cattle##2##6##(2012-2#2)
sire lines of##3##3##(2012-2#3)
sire##6##1##(2012-2#6)
sired by##3##2##(2008-8#1)(2010-8#2)
sires in##2##2##(2012-2#2)
sires##5##1##(2008-9#1)(2012-1#1)(2012-2#3)
siring success##2##2##(2008-8#1)(2008-9#1)
siring##3##1##(2008-8#1)(2008-9#2)
siro##4##1##(2011-2#4)
siroheme##3##1##(1993-8#3)
sirolimus##7##1##(2007-11#3)(2008-11#1)(2013-1#3)
sirolimus-eluting##3##1##(2008-11#2)(2009-5#1)
sirtuin##3##1##(2008-7#1)(2010-1#1)(2010-12#1)
sirtuins are##2##2##(2008-10#2)
sirtuins##5##1##(2008-10#5)
sister chromatid exchange (SCE)##2##4##(1992-8#1)(2008-11#1)
sister chromatid exchange##4##3##(1992-8#1)(1992-9#1)(1993-12#1)(2008-11#1)
sister chromatid exchanges (SCEs)##3##4##(1996-2#1)(1997-7#1)(2008-11#1)
sister chromatid exchanges in human##2##5##(2008-11#2)
sister chromatid exchanges##7##3##(1993-12#1)(1996-2#1)(1997-7#2)(2008-11#3)
sister chromatid##13##2##(1992-8#1)(1992-9#1)(1993-12#2)(1996-2#1)(1997-7#2)(2008-11#4)(2008-7#1)(2012-2#1)
sister clades##2##2##(2008-8#2)
sister group of##2##3##(2010-2#1)(2010-3#1)
sister group##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-3#1)
sister of##3##2##(1991-5#1)(2008-1#1)(2012-2#1)
sister species##2##2##(2008-8#1)(2012-3#1)
sister taxa##3##2##(2008-10#2)(2009-2#1)
sister who##2##2##(1996-6#1)(2011-2#1)
sister##41##1##(1990-7#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1994-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
sisters had##3##2##(1996-5#1)(2007-10#1)(2008-1#1)
sisters with##2##2##(2008-9#1)(2011-2#1)
sisters##18##1##(1990-6#1)(1991-12#1)(1996-5#1)(2007-10#1)(2008-1#3)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#5)
sit in a##2##3##(2010-4#1)(2011-7#1)
sit in##3##2##(1995-3#1)(2010-4#1)(2011-7#1)
sit without support##3##3##(1995-8#3)
sit##10##1##(1990-3#1)(1995-3#1)(1995-8#3)(2008-6#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-3#1)
site (STS) markers##6##3##(1996-10#1)(1996-12#2)(1997-8#1)(2008-10#2)
site (STS)##7##2##(1994-12#1)(1996-10#1)(1996-12#2)(1997-8#1)(2008-10#2)
site (mean daily minimum##2##4##(2013-1#2)
site 2##3##2##(2008-8#3)
site 8 O-acetylated sialomucins##3##4##(1990-2#3)
site A##4##2##(1996-2#3)(2013-8#1)
site I##3##2##(1991-5#1)(2008-10#2)
site II##3##2##(2008-10#3)
site after##3##2##(1990-6#1)(1994-9#1)(2011-2#1)
site agents are##2##3##(1995-5#2)
site agents##8##2##(1995-5#8)
site agonists##3##2##(1996-5#3)
site analysis of##3##3##(1994-12#1)(1996-4#1)(2008-8#1)
site and a##4##3##(1992-3#1)(1993-3#1)(2007-6#1)(2008-2#1)
site and in##2##3##(2008-7#1)(2010-6#1)
site and is##2##3##(1990-5#1)(2008-8#1)
site and size##2##3##(2007-10#1)(2008-6#1)
site and the##7##3##(1991-12#1)(1992-12#1)(1994-5#1)(2007-6#1)(2008-12#1)(2008-9#1)(2011-1#1)
site and##62##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-3#2)(1994-5#2)(1995-2#1)(1995-5#3)(1995-8#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-5#2)(2007-6#2)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-8#3)
site are##5##2##(1995-5#1)(2007-12#2)(2008-6#1)(2008-8#1)
site areas##2##2##(2008-10#1)(2008-12#1)
site as the##2##3##(1990-5#1)(1996-12#1)
site as well as##2##4##(1992-3#1)(2007-7#1)
site as##11##2##(1990-5#3)(1992-3#1)(1995-2#1)(1995-6#1)(1996-12#2)(2007-7#1)(2008-10#1)(2008-9#1)
site at the##3##3##(1992-9#1)(1994-8#1)(1995-11#1)
site at##12##2##(1990-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1996-5#1)(2008-10#2)
site availability##3##2##(2008-11#2)(2012-2#1)
site available to##2##3##(1992-6#2)
site between##3##2##(1995-11#1)(1995-6#1)(2008-8#1)
site bleeding##3##2##(1997-8#1)(2007-8#1)(2011-2#1)
site but##5##2##(1990-5#1)(1990-7#1)(1997-3#1)(2008-10#1)(2012-2#1)
site by the##2##3##(1995-3#1)(1995-6#1)
site by##10##2##(1990-7#1)(1991-6#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#4)(2013-8#1)
site can##3##2##(2007-12#1)(2007-2#1)(2008-4#1)
site changes##2##2##(2008-10#1)(2008-5#1)
site characterization##4##2##(1994-12#1)(2008-10#3)
site complications but##3##3##(2011-2#2)(2013-1#1)
site complications##7##2##(2011-2#5)(2013-1#2)
site contact##2##2##(1991-8#2)
site cooperativity##3##2##(1997-2#2)(2012-2#1)
site could##2##2##(2008-11#1)(2008-9#1)
site defined##2##2##(1993-11#1)(2013-8#1)
site development##6##2##(2007-12#6)
site did not##3##3##(1994-5#1)(1995-2#1)(2008-4#1)
site directed mutagenesis##3##3##(1992-12#1)(1992-9#1)(2008-1#1)
site directed##5##2##(1992-12#1)(1992-3#1)(1992-9#1)(2008-1#1)(2011-2#1)
site distribution##2##2##(2007-12#1)(2010-12#1)
site duplex##2##2##(1993-11#2)
site environment##2##2##(2008-3#1)(2013-7#1)
site fidelity##2##2##(2010-4#2)
site flanked by##2##3##(1995-8#1)(1997-3#1)
site for a##4##3##(1993-8#1)(1995-11#1)(1997-6#1)(2008-10#1)
site for the##19##3##(1990-5#2)(1990-7#1)(1991-5#1)(1991-6#1)(1992-8#3)(1993-12#1)(1993-3#2)(1995-5#1)(1995-6#1)(1997-7#1)(2008-10#2)(2009-8#1)(2010-7#1)(2012-2#1)
site for##72##2##(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1991-6#2)(1992-8#4)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-7#1)(2011-2#5)(2012-2#2)
site from##4##2##(1990-11#1)(1995-5#1)(1997-7#1)(2008-11#1)
site gastric cancer after##3##4##(2008-12#3)
site had##3##2##(2008-10#2)(2012-12#1)
site has been##4##3##(1991-3#1)(1994-12#1)(1995-2#1)(2013-8#1)
site has##5##2##(1991-3#1)(1994-12#1)(1995-2#1)(2013-1#1)(2013-8#1)
site identified##3##2##(1991-9#1)(1995-2#1)(2013-8#1)
site in a##5##3##(1990-5#2)(1990-7#1)(1991-9#1)(2008-8#1)
site in the regulation of##2##5##(1990-8#1)(1991-12#1)
site in the same##2##4##(1996-2#1)(2007-12#1)
site in the##36##3##(1990-5#3)(1990-7#2)(1990-8#2)(1991-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-2#1)(2007-12#3)(2007-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-6#1)
site in vitro##2##3##(1991-12#1)(1996-3#1)
site in which##2##3##(1995-3#1)(1996-2#1)
site in##84##2##(1990-2#1)(1990-5#6)(1990-7#5)(1990-8#4)(1991-12#2)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-5#1)(2007-12#3)(2007-5#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
site infection##6##2##(2008-8#2)(2009-3#1)(2010-12#2)(2012-3#1)
site infections##12##2##(2007-8#1)(2008-10#4)(2009-3#2)(2010-8#2)(2012-3#3)
site into##2##2##(1994-5#1)(1995-6#1)
site is a##4##3##(1990-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
site is contained within a##2##5##(1995-2#1)(1995-5#1)
site is located in the##3##5##(1995-2#1)(2008-11#1)(2010-10#1)
site is located##6##3##(1990-7#1)(1991-12#1)(1993-8#1)(1995-2#1)(2008-11#1)(2010-10#1)
site is not##2##3##(2008-5#1)(2012-2#1)
site is presented##2##3##(2007-5#1)(2008-3#1)
site is responsible for the##2##5##(1990-5#2)
site is the##2##3##(1991-3#1)(1997-4#1)
site is##47##2##(1990-5#5)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-8#1)(1994-5#1)(1995-2#4)(1995-5#2)(1995-6#3)(1997-4#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
site lies##2##2##(1992-6#1)(2008-4#1)
site ligands were##2##3##(1995-11#2)
site ligands##7##2##(1991-12#1)(1995-11#4)(1995-12#1)(1995-5#1)
site located at##2##3##(2008-10#2)
site located##3##2##(2008-10#2)(2008-11#1)
site may be##4##3##(1995-2#2)(1995-5#1)(1997-3#1)
site may##7##2##(1991-12#1)(1991-2#1)(1995-2#2)(1995-5#1)(1997-3#1)(2010-11#1)
site near##2##2##(1993-9#1)(2008-10#1)
site observed##2##2##(1993-6#1)(1995-11#1)
site occupancy##2##2##(1995-2#1)(1995-5#1)
site of Bacillus##2##3##(1992-3#1)(1995-2#1)
site of S##2##3##(2008-12#1)(2011-2#1)
site of a##8##3##(1990-11#1)(1993-2#1)(1995-3#1)(1995-8#1)(2010-6#3)(2011-2#1)
site of action of##2##4##(1996-2#1)(2011-2#1)
site of action##6##3##(1990-11#1)(1991-2#1)(1994-2#1)(1996-2#1)(2008-10#1)(2011-2#1)
site of an##4##3##(1992-3#1)(1995-3#1)(2006-4#1)(2012-2#1)
site of application##43##3##(2007-7#1)(2008-10#1)(2008-9#41)
site of attachment##2##3##(1990-8#1)(2008-7#1)
site of care##3##3##(2007-12#1)(2009-4#2)
site of disease##2##3##(1990-9#1)(2008-6#1)
site of human##2##3##(1990-12#1)(1994-11#1)
site of implantation##3##3##(2008-10#1)(2010-10#1)(2012-1#1)
site of infection and##2##4##(2008-10#1)(2011-1#1)
site of infection##13##3##(1996-8#1)(1997-1#1)(2008-10#4)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#3)
site of injury##5##3##(1996-5#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
site of insulin resistance in Type 2##2##7##(2008-1#2)
site of integration##2##3##(1991-9#1)(2008-4#1)
site of involvement##2##3##(2011-2#1)(2012-2#1)
site of long##3##3##(2007-11#1)(2007-7#2)
site of metastatic disease##2##4##(2008-1#1)(2008-6#1)
site of metastatic##3##3##(2008-1#2)(2008-6#1)
site of occurrence##2##3##(2007-5#2)
site of origin of##2##4##(2008-6#1)(2012-2#1)
site of origin##6##3##(1993-8#1)(2008-11#1)(2008-6#1)(2009-9#1)(2012-2#1)(2013-7#1)
site of phosphorylation##4##3##(1991-2#3)(1997-2#1)
site of plasminogen##2##3##(1990-12#1)(1997-2#1)
site of rat liver##2##4##(1990-10#1)(1992-8#1)
site of stimulation##2##3##(1992-12#2)
site of the enzyme##10##4##(1990-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-8#1)(2008-4#1)(2008-5#1)(2009-9#1)
site of the human##2##4##(1990-12#1)(1995-6#1)
site of the mutation##2##4##(1993-8#1)(1994-11#1)
site of the protein##2##4##(1992-8#1)(2008-10#1)
site of the##71##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#3)(1993-8#1)(1994-11#4)(1994-5#4)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-2#2)(2006-6#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-9#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
site of their##2##3##(1996-6#1)(2008-9#1)
site of this##5##3##(1990-5#2)(1991-9#1)(1995-5#1)(2008-6#1)
site of transcription##2##3##(1991-5#1)(1997-7#1)
site of##364##2##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#3)(1991-9#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#9)(1992-4#1)(1992-6#5)(1992-8#5)(1992-9#1)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#4)(1993-9#2)(1994-11#6)(1994-2#1)(1994-3#1)(1994-5#15)(1994-8#4)(1994-9#1)(1995-11#2)(1995-2#8)(1995-3#3)(1995-5#10)(1995-6#4)(1995-8#4)(1996-2#4)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#7)(2008-10#20)(2008-11#7)(2008-12#2)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#6)(2008-8#4)(2008-9#51)(2009-4#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#3)(2012-9#1)(2013-1#2)(2013-7#3)
site on a##2##3##(1995-11#1)(2008-7#1)
site on the##10##3##(1990-7#1)(1991-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-4#1)
site on##25##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-8#2)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-4#1)
site or##6##2##(1997-2#1)(1997-6#1)(2008-10#1)(2010-2#2)(2010-8#1)
site peptide##4##2##(1991-8#2)(1992-11#1)(1992-5#1)
site polymorphism##5##2##(2008-10#2)(2008-5#3)
site preparation##2##2##(2007-12#1)(2008-10#1)
site preservation##2##2##(2007-12#2)
site reactions##4##2##(1996-8#1)(2008-8#3)
site represents a##2##3##(1995-5#1)(2009-5#1)
site residue##3##2##(1993-11#1)(1993-6#1)(1994-6#1)
site residues are##2##3##(1992-8#1)(2012-2#1)
site residues##9##2##(1992-11#2)(1992-8#1)(1995-2#1)(1997-4#1)(2009-9#1)(2012-2#3)
site resulting##2##2##(1991-9#1)(2008-11#1)
site selection##3##2##(1995-8#1)(2008-12#1)(2008-8#1)
site sequence##4##2##(1993-6#1)(1994-12#1)(2008-8#1)(2009-9#1)
site specific##2##2##(1995-5#1)(2008-9#1)
site structures##2##2##(1992-8#1)(1995-5#1)
site that had been##2##4##(2008-10#2)
site that had##3##3##(2008-10#2)(2013-1#1)
site that is##3##3##(1991-12#1)(1994-5#2)
site that##14##2##(1991-12#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
site tissues##2##2##(2013-1#2)
site to be##2##3##(2007-12#1)(2008-10#1)
site to the##2##3##(1992-6#1)(2008-3#1)
site to##23##2##(1991-11#1)(1991-8#1)(1992-6#2)(1994-5#2)(1995-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
site used to##2##3##(1994-11#1)(2008-4#1)
site variation##2##2##(2008-10#1)(2008-5#1)
site visits to##2##3##(1993-1#1)(2007-5#1)
site visits##3##2##(1993-1#1)(1995-12#1)(2007-5#1)
site was identified##5##3##(1991-7#2)(2007-8#1)(2008-8#1)(2013-8#1)
site was localized##2##3##(1994-11#1)(1995-6#1)
site was located##3##3##(1997-6#1)(2008-9#2)
site was##37##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-7#3)(1991-9#1)(1992-6#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#3)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#4)(2013-8#2)
site were found##2##3##(1991-6#1)(1995-5#1)
site were measured##3##3##(1993-11#1)(2008-10#1)(2008-9#1)
site were obtained##2##3##(1991-3#1)(2008-10#1)
site were used##2##3##(1995-2#1)(2008-10#1)
site were##20##2##(1990-6#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#1)(1995-2#1)(1995-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#2)(2012-3#2)(2013-8#1)
site where##5##2##(1992-3#1)(2007-12#2)(2008-4#1)(2013-1#1)
site which was##3##3##(1990-7#1)(1996-5#1)(1997-7#1)
site which##8##2##(1990-7#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-7#1)
site while##2##2##(1992-6#1)(1993-11#1)
site with a##2##3##(1997-4#1)(2008-5#1)
site with two##2##3##(1993-11#1)(2011-2#1)
site with##21##2##(1990-2#1)(1990-5#2)(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#2)(1994-5#1)(1995-2#1)(1995-5#2)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
site within the##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
site within##6##2##(1995-5#2)(1997-7#1)(2008-10#2)(2008-8#1)
site##1757##1##(1990-10#2)(1990-11#17)(1990-12#8)(1990-2#10)(1990-5#39)(1990-6#2)(1990-7#22)(1990-8#18)(1990-9#4)(1991-1#1)(1991-10#5)(1991-11#3)(1991-12#18)(1991-2#14)(1991-3#9)(1991-5#13)(1991-6#13)(1991-7#4)(1991-8#8)(1991-9#11)(1992-10#3)(1992-11#9)(1992-12#11)(1992-2#5)(1992-3#32)(1992-4#3)(1992-5#7)(1992-6#32)(1992-7#1)(1992-8#14)(1992-9#7)(1993-1#1)(1993-11#26)(1993-12#9)(1993-2#4)(1993-3#13)(1993-6#8)(1993-8#13)(1993-9#6)(1994-11#16)(1994-12#21)(1994-2#2)(1994-3#8)(1994-5#39)(1994-6#4)(1994-8#17)(1994-9#6)(1995-11#19)(1995-12#17)(1995-2#50)(1995-3#11)(1995-5#64)(1995-6#31)(1995-8#16)(1995-9#1)(1996-10#2)(1996-12#9)(1996-2#19)(1996-3#2)(1996-4#1)(1996-5#16)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#15)(1997-3#7)(1997-4#13)(1997-5#2)(1997-6#10)(1997-7#12)(1997-8#8)(2006-4#3)(2006-6#1)(2007-10#4)(2007-11#8)(2007-12#35)(2007-2#2)(2007-5#11)(2007-6#4)(2007-7#17)(2007-8#8)(2008-1#9)(2008-10#178)(2008-11#36)(2008-12#18)(2008-2#8)(2008-3#16)(2008-4#16)(2008-5#44)(2008-6#18)(2008-7#34)(2008-8#44)(2008-9#71)(2009-10#5)(2009-11#1)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#9)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#8)(2010-7#2)(2010-8#7)(2011-1#13)(2011-2#65)(2012-1#4)(2012-12#13)(2012-2#30)(2012-3#28)(2012-5#1)(2012-9#1)(2013-1#28)(2013-7#9)(2013-8#21)
site's##2##1##(2008-10#1)(2009-3#1)
site(s) of##4##2##(1991-2#1)(1993-3#1)(1994-8#1)(1995-5#1)
site(s)##20##1##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-5#1)(2009-10#1)(2012-2#1)
site) of the##2##3##(1993-12#1)(1995-6#1)
site) was##2##2##(1992-12#1)(1995-5#1)
site)##17##1##(1990-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)(2012-9#1)
site-binding##2##1##(1994-5#1)(2008-10#1)
site-dependent##2##1##(2008-5#1)(2012-1#1)
site-directed mutagenesis and##5##3##(1992-3#2)(1993-3#1)(1994-5#1)(1995-2#1)
site-directed mutagenesis at##2##3##(1992-1#1)(2008-9#1)
site-directed mutagenesis in##2##3##(1990-5#1)(1995-2#1)
site-directed mutagenesis of the##2##4##(1990-5#1)(1994-12#1)
site-directed mutagenesis of##6##3##(1990-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#2)
site-directed mutagenesis to##4##3##(1992-1#1)(1993-11#1)(1995-5#1)(2008-10#1)
site-directed mutagenesis using##3##3##(1990-11#2)(2008-10#1)
site-directed mutagenesis was##4##3##(1995-2#1)(1995-5#1)(2008-4#1)(2008-9#1)
site-directed mutagenesis##66##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#4)(1992-6#2)(1992-8#2)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#4)(1994-8#1)(1995-2#8)(1995-5#6)(1995-8#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#6)(2010-5#1)(2011-2#1)
site-directed mutants of##4##3##(1994-11#1)(1995-6#1)(1997-9#1)(2008-10#1)
site-directed mutants##7##2##(1994-11#1)(1995-2#2)(1995-6#2)(1997-9#1)(2008-10#1)
site-directed mutation of##2##3##(2008-8#2)
site-directed mutation##3##2##(1997-3#1)(2008-8#2)
site-directed mutations of##3##3##(1990-7#1)(1995-2#1)(1995-6#1)
site-directed mutations##5##2##(1990-7#1)(1991-5#1)(1995-2#2)(1995-6#1)
site-directed##92##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#5)(1992-6#2)(1992-8#2)(1993-11#2)(1993-3#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-5#4)(1994-8#1)(1995-11#1)(1995-2#13)(1995-5#6)(1995-6#4)(1995-8#1)(1997-2#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#6)(2010-5#1)(2011-2#1)
site-specific TFs##2##2##(2008-9#2)
site-specific cancers##2##2##(2010-1#1)(2011-2#1)
site-specific mutagenesis##6##2##(1990-11#1)(1991-10#1)(1992-3#1)(1993-6#1)(2008-8#1)(2010-4#1)
site-specific mutations##3##2##(1991-8#2)(2008-11#1)
site-specific recombination##4##2##(1995-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
site-specific transcription##2##2##(1994-3#1)(2008-9#1)
site-specific##47##1##(1990-11#1)(1990-8#3)(1991-10#1)(1991-8#2)(1992-3#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2010-1#3)(2010-4#1)(2011-2#1)(2012-2#2)
site-specifically modified##2##2##(2008-4#1)(2010-7#1)
site-specifically##5##1##(1990-7#1)(1994-12#1)(1995-5#1)(2008-4#1)(2010-7#1)
site-to-site##2##1##(2007-11#1)(2007-12#1)
site-years##2##1##(2008-10#2)
sited##4##1##(2008-10#2)(2008-7#1)(2009-6#1)
siteof##2##1##(2008-11#1)(2009-8#1)
sites (D2##2##2##(1993-9#2)
sites (assessed by displacement of##2##5##(1995-12#2)
sites (e##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
sites across the##2##3##(2008-2#1)(2013-8#1)
sites along the##2##3##(1994-9#1)(2008-10#1)
sites along##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2009-5#1)
sites also##5##2##(1992-3#1)(1993-11#1)(1993-12#2)(1994-3#1)
sites among##2##2##(2008-10#1)(2008-11#1)
sites and an##2##3##(2008-10#1)(2013-1#1)
sites and by##2##3##(1990-12#1)(2009-6#1)
sites and in##3##3##(2008-10#2)(2011-2#1)
sites and that##2##3##(1995-6#1)(2008-11#1)
sites and the##7##3##(1990-12#1)(1992-3#1)(1994-2#1)(2008-10#3)(2008-9#1)
sites and their##2##3##(1990-11#1)(1992-1#1)
sites and were##2##3##(1991-3#1)(2008-10#1)
sites and##63##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-2#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
sites are found in##2##4##(1993-11#1)(2008-8#1)
sites are found##3##3##(1993-11#1)(1995-11#1)(2008-8#1)
sites are located in the##2##5##(1993-8#1)(2008-10#1)
sites are of the##3##4##(1994-5#2)(1995-8#1)
sites are present in##2##4##(1994-11#1)(2008-11#1)
sites are present##4##3##(1994-11#1)(1997-4#1)(2008-11#1)(2008-7#1)
sites are the##2##3##(2007-5#1)(2010-3#1)
sites are##51##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#2)(1994-11#1)(1994-5#2)(1995-11#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-9#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
sites around##2##2##(2008-10#1)(2010-5#1)
sites as##4##2##(1991-9#1)(1997-2#1)(2008-5#1)(2009-11#1)
sites assigned##2##2##(1996-8#1)(2008-4#1)
sites associated with the##3##4##(1991-1#1)(1992-3#1)(2013-8#1)
sites at the##3##3##(1990-8#1)(2008-9#1)(2013-8#1)
sites at which##4##3##(1993-6#1)(1994-3#1)(1994-6#1)(2008-5#1)
sites at##14##2##(1990-8#1)(1992-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-7#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-8#1)
sites but##3##2##(1990-11#1)(1994-5#1)(2008-10#1)
sites by##8##2##(1993-8#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-5#1)(2008-10#2)(2011-2#1)
sites can##4##2##(1995-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
sites containing wild##2##3##(2008-10#2)
sites containing##3##2##(1995-8#1)(2008-10#2)
sites covered##2##2##(2008-10#2)
sites distant##2##2##(2008-10#1)(2013-7#1)
sites dominated the##2##3##(1993-12#2)
sites due to the##2##4##(1990-12#1)(2009-5#1)
sites during##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
sites exhibited##2##2##(1993-12#1)(2008-3#1)
sites exhibiting##2##2##(2008-10#1)(2008-8#1)
sites for 5-methyl-urapidil##3##3##(1995-12#3)
sites for SH2##2##3##(1995-6#1)(1996-2#1)
sites for a##3##3##(1993-2#1)(1997-6#1)(2008-7#1)
sites for the##6##3##(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-8#1)(2008-10#1)
sites for two##2##3##(1991-5#1)(1992-10#1)
sites for##91##2##(1990-11#1)(1990-12#3)(1990-5#3)(1990-8#6)(1990-9#1)(1991-2#1)(1991-5#5)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-2#2)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
sites found##3##2##(1991-9#1)(2007-12#1)(2008-10#1)
sites from##7##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-6#1)
sites had##4##2##(1991-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
sites have been##3##3##(1994-12#1)(1994-2#1)(2010-12#1)
sites have##6##2##(1992-3#1)(1994-12#1)(1994-2#1)(2008-8#1)(2008-9#1)(2010-12#1)
sites in Switzerland##2##3##(2008-10#1)(2008-2#1)
sites in a##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
sites in both##3##3##(1990-12#1)(1994-3#1)(2011-2#1)
sites in four##2##3##(2007-12#1)(2008-10#1)
sites in rat##5##3##(1990-7#2)(1993-11#1)(1993-5#1)(2008-11#1)
sites in significant##2##3##(2012-5#2)
sites in the United States##2##5##(2007-10#1)(2008-10#1)
sites in the beta-subunit##2##4##(1994-6#2)
sites in the genome##3##4##(1997-3#1)(2008-10#1)(2009-3#1)
sites in the##50##3##(1990-2#2)(1990-5#1)(1991-1#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-8#1)(2011-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
sites in this##2##3##(2008-11#1)(2010-8#1)
sites in various##2##3##(1990-5#1)(2012-2#1)
sites in##143##2##(1990-12#1)(1990-2#2)(1990-5#4)(1990-7#3)(1991-1#1)(1991-5#2)(1992-5#1)(1992-6#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-5#2)(1995-6#4)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#35)(2008-11#8)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-3#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#2)(2013-7#1)(2013-8#2)
sites include##2##2##(1996-12#1)(2013-1#1)
sites included##2##2##(1995-2#1)(2008-6#1)
sites including the##2##3##(1993-6#1)(1994-10#1)
sites including##4##2##(1993-6#1)(1994-10#1)(2008-12#1)(2010-4#1)
sites indicated that##2##3##(2008-10#1)(2008-8#1)
sites indicated##3##2##(2008-10#2)(2008-8#1)
sites involved in##2##3##(2008-4#1)(2012-3#1)
sites is##10##2##(1992-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
sites located##2##2##(1991-2#1)(1993-3#1)
sites lost##2##2##(1992-3#1)(1997-1#1)
sites may occur##2##3##(1995-5#1)(2011-2#1)
sites may##4##2##(1990-12#1)(1995-5#1)(2011-2#1)(2013-7#1)
sites might##3##2##(1991-12#1)(2008-10#1)(2012-12#1)
sites not##2##2##(2008-8#1)(2013-7#1)
sites of DNA##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
sites of action of##2##4##(1994-5#1)(1997-4#1)
sites of action##6##3##(1990-5#1)(1993-3#1)(1994-5#1)(1997-4#1)(2008-11#1)(2008-8#1)
sites of bacterial##2##3##(1992-2#1)(1992-3#1)
sites of both##2##3##(1993-8#1)(2008-10#1)
sites of cell##2##3##(1996-5#1)(2009-10#1)
sites of disease##3##3##(2008-11#1)(2008-6#1)(2012-2#1)
sites of high affinity##2##4##(1992-6#1)(1995-12#1)
sites of high##3##3##(1992-6#1)(1995-12#1)(2008-3#1)
sites of human##3##3##(1990-12#1)(1993-8#1)(2008-11#1)
sites of infection##2##3##(2008-10#1)(2013-1#1)
sites of origin##4##3##(1995-2#1)(2008-1#1)(2008-2#1)(2013-1#1)
sites of potential pathogen##2##4##(2008-10#2)
sites of potential##5##3##(2008-10#5)
sites of proteins##2##3##(1993-11#1)(2008-8#1)
sites of proteolysis##2##3##(1991-2#2)
sites of tau##2##3##(1995-12#2)
sites of the HA1 gene##2##5##(1994-8#2)
sites of the##35##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#4)(1997-6#1)(1997-8#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#2)(2011-1#1)(2012-2#1)
sites of thrombosis##2##3##(2008-7#2)
sites of vascular injury##2##4##(1992-12#1)(1994-5#1)
sites of##187##2##(1990-11#2)(1990-12#2)(1990-5#4)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#4)(1993-11#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#4)(1994-11#2)(1994-12#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#4)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#6)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#2)(1997-9#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#28)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#9)(2009-10#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-3#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#3)
sites often##2##2##(2007-2#1)(2011-2#1)
sites on MAP kinase##2##4##(1995-2#2)
sites on a##2##3##(1997-5#1)(2008-9#1)
sites on the cell surface##2##5##(1990-12#1)(2008-11#1)
sites on the##25##3##(1990-11#1)(1990-12#2)(1990-7#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-1#1)
sites on##49##2##(1990-11#1)(1990-12#3)(1990-5#3)(1990-7#2)(1991-2#2)(1991-3#1)(1991-5#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-2#4)(1995-5#1)(1996-12#3)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)
sites per cell##2##3##(1993-9#1)(2008-11#1)
sites per##8##2##(1990-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(2008-11#1)(2008-4#1)
sites related to##2##3##(1997-7#1)(2012-12#1)
sites represented##3##2##(1994-2#2)(2008-10#1)
sites responsible for the##2##4##(2008-10#2)
sites resulted in##3##3##(1993-8#1)(1997-4#1)(2012-2#1)
sites revealed##4##2##(2007-12#1)(2008-7#1)(2008-8#2)
sites situated##2##2##(1990-5#1)(2008-6#1)
sites such as##5##3##(1994-11#1)(2008-1#1)(2008-5#1)(2009-3#1)(2011-2#1)
sites suggests##2##2##(1991-5#1)(1996-2#1)
sites that are##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
sites that##24##2##(1992-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(2007-12#2)(2007-2#4)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
sites throughout the United States##2##5##(1996-12#1)(2012-12#1)
sites throughout the##3##3##(1996-12#1)(2010-8#1)(2012-12#1)
sites throughout##6##2##(1994-9#1)(1996-12#1)(2008-10#2)(2010-8#1)(2012-12#1)
sites to recruit##2##3##(2007-12#1)(2009-5#1)
sites to the##2##3##(1994-8#1)(1997-9#1)
sites to##16##2##(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1997-9#1)(2007-12#2)(2008-10#1)(2008-4#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
sites using the##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
sites using##7##2##(1996-2#1)(1997-5#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-3#1)
sites varied##2##2##(1992-3#1)(2007-12#1)
sites was also##2##3##(1994-11#1)(2012-3#1)
sites was##27##2##(1990-5#4)(1992-3#2)(1993-9#1)(1994-11#3)(1994-7#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#2)(2012-12#1)(2012-3#2)
sites were accessible to##2##4##(1991-8#1)(1994-5#1)
sites were also##4##3##(1992-6#1)(1995-5#1)(2008-5#1)(2008-7#1)
sites were analyzed##2##3##(1993-12#1)(2008-10#1)
sites were detected##3##3##(1993-3#1)(1994-2#1)(2008-3#1)
sites were identified##4##3##(1995-8#1)(1996-5#1)(2008-11#2)
sites were not##2##3##(1995-6#1)(1997-6#1)
sites were predicted##3##3##(1997-6#1)(2008-12#2)
sites were predominant##2##3##(1994-2#2)
sites were##61##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-6#4)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#1)(2013-7#2)
sites when##2##2##(2008-10#2)
sites where disease pressure was##2##5##(2008-10#2)
sites where the##3##3##(1995-4#1)(1996-10#1)(2009-10#1)
sites where##16##2##(1992-12#1)(1994-12#1)(1995-4#1)(1996-10#1)(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#1)
sites which are##2##3##(1990-8#1)(1996-2#1)
sites which contain##2##3##(1991-9#1)(1995-5#1)
sites which##7##2##(1990-5#1)(1990-8#1)(1991-9#1)(1995-5#1)(1996-2#1)(1997-4#1)(2012-2#1)
sites with an##2##3##(1990-5#1)(2008-10#1)
sites with different##2##3##(2008-10#1)(2008-8#1)
sites with high##2##3##(1993-1#1)(2008-10#1)
sites with##27##2##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#2)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
sites within an##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
sites within the##11##3##(1990-7#1)(1991-8#2)(1992-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
sites within##22##2##(1990-7#1)(1991-8#2)(1992-9#1)(1994-11#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sites##1586##1##(1990-11#12)(1990-12#18)(1990-2#6)(1990-5#31)(1990-6#1)(1990-7#15)(1990-8#19)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#10)(1991-2#11)(1991-3#5)(1991-5#12)(1991-6#5)(1991-7#2)(1991-8#5)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#11)(1992-2#7)(1992-3#31)(1992-4#4)(1992-5#3)(1992-6#12)(1992-8#9)(1992-9#4)(1993-1#3)(1993-11#18)(1993-12#20)(1993-2#8)(1993-3#19)(1993-5#2)(1993-6#16)(1993-8#19)(1993-9#11)(1994-1#2)(1994-10#2)(1994-11#17)(1994-12#17)(1994-2#15)(1994-3#6)(1994-5#11)(1994-6#8)(1994-7#6)(1994-8#20)(1994-9#3)(1995-11#10)(1995-12#25)(1995-2#19)(1995-3#9)(1995-4#1)(1995-5#13)(1995-6#30)(1995-8#15)(1996-1#9)(1996-10#2)(1996-12#14)(1996-2#21)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#15)(1997-3#7)(1997-4#9)(1997-5#7)(1997-6#12)(1997-7#12)(1997-8#4)(1997-9#3)(2006-10#1)(2006-4#2)(2007-10#2)(2007-11#3)(2007-12#23)(2007-2#5)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#259)(2008-11#49)(2008-12#14)(2008-2#11)(2008-3#10)(2008-4#30)(2008-5#43)(2008-6#18)(2008-7#26)(2008-8#52)(2008-9#22)(2009-10#7)(2009-11#3)(2009-3#4)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#3)(2010-11#7)(2010-12#4)(2010-2#1)(2010-3#8)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#16)(2011-2#36)(2011-3#3)(2012-1#4)(2012-12#18)(2012-2#31)(2012-3#22)(2012-5#2)(2012-6#1)(2013-1#24)(2013-7#18)(2013-8#13)
sites) was##2##2##(1991-5#1)(2010-11#1)
sites)##10##1##(1991-5#1)(1992-4#1)(1993-12#2)(1994-1#1)(1996-2#2)(2008-10#1)(2008-8#1)(2010-11#1)
sites/cell##3##1##(1993-12#1)(1994-8#1)(1995-8#1)
sites/cell)##2##1##(1994-8#1)(1996-5#1)
sitosterol##2##1##(1991-5#1)(2007-11#1)
sits between##2##2##(1995-3#1)(1997-6#1)
sits##4##1##(1995-3#1)(1996-2#1)(1997-6#1)(2008-11#1)
sitting and##3##2##(1995-8#1)(2010-3#1)(2013-1#1)
sitting height##2##2##(2011-2#2)
sitting in##2##2##(2008-10#1)(2008-8#1)
sitting on##2##2##(2008-10#1)(2008-11#1)
sitting position##9##2##(1993-10#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#4)
sitting positions##4##2##(1993-10#1)(2011-2#3)
sitting unsupported and##2##3##(1995-8#2)
sitting##43##1##(1991-8#1)(1993-10#4)(1995-8#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-7#1)(2010-3#3)(2010-9#3)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)
situ and in##6##3##(1993-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-7#1)
situ and##21##2##(1990-2#1)(1992-3#1)(1993-5#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
situ by##13##2##(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(2007-12#1)(2008-10#6)(2008-2#1)(2013-8#1)
situ combustion measurements##2##3##(2008-2#1)(2008-3#1)
situ combustion##3##2##(2008-2#1)(2008-3#2)
situ conservation##4##2##(2008-8#3)(2013-7#1)
situ detection of##4##3##(1993-12#1)(2008-11#1)(2008-9#1)(2010-5#1)
situ detection##5##2##(1993-12#1)(2008-11#1)(2008-9#2)(2010-5#1)
situ determination of##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
situ end labelling##2##3##(1994-10#2)
situ end##4##2##(1994-10#2)(2008-7#2)
situ extraction##6##2##(1990-11#1)(1994-11#5)
situ from##3##2##(1996-5#1)(2007-12#1)(2008-2#1)
situ gel##4##2##(2010-5#1)(2011-3#3)
situ generated##5##2##(2008-10#3)(2010-2#2)
situ hybridisation##7##2##(1994-12#1)(1995-12#1)(1996-12#2)(2008-12#2)(2009-8#1)
situ hybridization (FISH)##20##3##(1993-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)
situ hybridization analysis##8##3##(1991-5#1)(1992-9#1)(1994-12#1)(1996-12#1)(1997-4#2)(2008-5#1)(2008-9#1)
situ hybridization and immunocytochemical techniques##2##5##(1991-12#1)(1997-3#1)
situ hybridization and##11##3##(1990-11#1)(1991-12#1)(1991-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-5#1)
situ hybridization combined with##2##4##(1992-8#1)(1995-12#1)
situ hybridization of the##2##4##(1995-11#1)(1996-12#1)
situ hybridization of##7##3##(1995-11#1)(1996-12#3)(2008-10#1)(2008-9#1)(2010-3#1)
situ hybridization performed##2##3##(2008-8#1)(2010-3#1)
situ hybridization showed##4##3##(1996-12#1)(1997-1#1)(1997-2#1)(2008-5#1)
situ hybridization studies##3##3##(1996-12#1)(2008-4#1)(2009-8#1)
situ hybridization technique##3##3##(2008-11#1)(2008-8#1)(2010-12#1)
situ hybridization to##5##3##(1991-2#1)(1995-12#1)(1997-7#1)(2008-4#2)
situ hybridization using##4##3##(1990-12#1)(1991-5#1)(1993-5#1)(2008-10#1)
situ hybridization##167##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#3)(1992-12#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-11#2)(1995-12#5)(1995-2#2)(1995-6#2)(1996-12#19)(1996-2#2)(1996-5#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#2)(2008-1#3)(2008-10#5)(2008-11#4)(2008-4#15)(2008-5#10)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#16)(2009-1#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#2)(2010-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#1)
situ hybridization)##4##2##(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)
situ images of##2##3##(2007-11#2)
situ light-scattering measurements##2##3##(2008-3#2)
situ localization of##3##3##(1996-12#1)(1997-6#1)(2008-10#1)
situ measurement##5##2##(2008-2#1)(2008-3#4)
situ measurements of CO##2##4##(2008-2#1)(2008-3#1)
situ measurements of##15##3##(2008-10#1)(2008-2#4)(2008-3#9)(2008-6#1)
situ measurements##25##2##(2008-10#1)(2008-2#7)(2008-3#16)(2008-6#1)
situ monitoring of##7##3##(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#4)
situ monitoring##11##2##(1991-5#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)
situ mutagenesis##2##2##(2008-6#2)
situ nick##4##2##(2008-4#3)(2008-9#1)
situ observation of##2##3##(2008-10#1)(2008-11#1)
situ prepared BiFE##2##3##(2008-10#2)
situ surface-enhanced Raman spectroscopy (SERS)##2##5##(2007-12#1)(2013-1#1)
situ surface-enhanced Raman spectroscopy##3##4##(2007-12#2)(2013-1#1)
situ##665##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#4)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#3)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-5#3)(1993-6#2)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#9)(1994-12#4)(1994-2#1)(1994-8#6)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#4)(1995-4#2)(1995-6#3)(1996-12#25)(1996-2#2)(1996-5#4)(1996-6#1)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#6)(1997-6#3)(1997-7#3)(1997-8#3)(2006-4#3)(2007-11#6)(2007-12#14)(2007-5#4)(2007-8#2)(2008-1#7)(2008-10#123)(2008-11#12)(2008-12#2)(2008-2#30)(2008-3#78)(2008-4#27)(2008-5#18)(2008-6#8)(2008-7#15)(2008-8#21)(2008-9#29)(2009-1#1)(2009-11#1)(2009-12#6)(2009-5#1)(2009-7#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#6)(2010-5#7)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#7)(2011-3#3)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#6)(2013-1#7)(2013-7#4)(2013-8#7)
situ)##4##1##(2008-10#1)(2008-3#2)(2008-5#1)
situated at##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
situated between##5##2##(1990-5#1)(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
situated close to the##2##4##(2011-1#1)(2012-2#1)
situated in the northern part of##2##6##(1990-6#1)(2011-2#1)
situated in the##17##3##(1990-6#2)(1990-9#1)(1991-3#1)(1991-6#1)(1993-8#1)(1995-6#1)(1997-2#1)(1997-9#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
situated in##25##2##(1990-6#2)(1990-9#1)(1991-3#1)(1991-6#2)(1993-8#1)(1995-6#1)(1997-2#1)(1997-9#1)(2007-11#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
situated on##2##2##(1997-3#1)(2008-3#1)
situated within##3##2##(1996-8#1)(2008-12#1)(2008-7#1)
situated##60##1##(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
situating##2##1##(2010-6#1)(2012-2#1)
situation a##2##2##(2008-11#1)(2008-2#1)
situation and in##2##3##(1993-1#1)(1996-9#1)
situation and##15##2##(1990-11#1)(1990-12#3)(1991-3#1)(1993-1#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-7#1)
situation at##2##2##(2008-1#1)(2008-10#1)
situation by##2##2##(1994-8#1)(2012-3#1)
situation for##5##2##(1991-5#1)(1994-12#2)(1997-5#1)(2008-2#1)
situation in Brazil##2##3##(1991-6#2)
situation in the##6##3##(1990-6#1)(1991-11#1)(1991-6#1)(1993-12#1)(1996-3#1)(2008-1#1)
situation in##35##2##(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#3)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
situation is more##2##3##(1996-2#1)(2009-7#1)
situation is observed##2##3##(2008-7#1)(2008-8#1)
situation is the##2##3##(1993-6#1)(1994-12#1)
situation is##20##2##(1990-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-2#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)
situation model##3##2##(2013-1#3)
situation of a##2##3##(2008-3#1)(2010-4#1)
situation of the##5##3##(1990-8#1)(1994-2#1)(1996-9#1)(2011-2#1)(2012-2#1)
situation of##29##2##(1990-12#1)(1990-8#1)(1992-3#1)(1992-5#1)(1994-2#1)(1996-2#1)(1996-9#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-11#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
situation should##2##2##(2008-10#1)(2008-8#1)
situation that is##2##3##(1995-3#1)(2008-8#1)
situation that##8##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-12#1)
situation the##5##2##(1990-6#1)(1995-5#1)(2008-10#1)(2008-3#2)
situation was found##2##3##(2008-11#1)(2012-12#1)
situation was##5##2##(1997-5#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-3#1)
situation when##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)
situation where##4##2##(2008-8#2)(2012-2#1)(2012-3#1)
situation will##2##2##(1992-6#1)(1993-11#1)
situation with##4##2##(2008-12#2)(2010-10#1)(2012-2#1)
situation##318##1##(1990-11#1)(1990-12#14)(1990-2#2)(1990-3#3)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#3)(1992-1#1)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#2)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#1)(2008-1#6)(2008-10#14)(2008-11#15)(2008-12#7)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#8)(2008-7#11)(2008-8#11)(2008-9#3)(2009-10#2)(2009-11#5)(2009-12#1)(2009-3#1)(2009-5#5)(2009-7#4)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#18)(2012-12#7)(2012-2#4)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#4)
situational and##2##2##(1993-12#1)(1994-2#1)
situational context##2##2##(1994-2#1)(2009-7#1)
situational factors##5##2##(1996-3#1)(2007-12#1)(2008-12#1)(2008-7#2)
situational##14##1##(1993-12#1)(1994-2#2)(1996-3#1)(1997-8#1)(2007-12#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-7#2)(2013-8#1)
situations and to##2##3##(2008-12#1)(2009-6#1)
situations and##13##2##(1990-6#1)(1992-9#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#1)
situations are##6##2##(2008-2#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
situations as well##2##3##(2008-5#1)(2013-1#1)
situations as##5##2##(1996-12#1)(2008-5#1)(2009-6#1)(2013-1#2)
situations at##2##2##(2008-11#1)(2008-3#1)
situations can be##2##3##(2008-11#1)(2008-3#1)
situations exist##2##2##(1993-1#2)
situations has been##2##3##(1994-6#1)(2008-3#1)
situations in the hospital##2##4##(1991-1#1)(2011-1#1)
situations in the##3##3##(1990-9#1)(1991-1#1)(2011-1#1)
situations in which##14##3##(1993-10#1)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
situations in##25##2##(1990-9#1)(1991-1#1)(1993-10#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
situations include##2##2##(2008-9#1)(2010-3#1)
situations involving##4##2##(1992-12#1)(1993-12#1)(1996-3#1)(2008-10#1)
situations is##3##2##(2007-12#1)(2008-3#2)
situations may##2##2##(2007-12#1)(2009-6#1)
situations of##8##2##(1990-3#1)(1991-9#1)(1993-12#1)(1996-1#1)(2007-12#1)(2008-1#1)(2012-3#2)
situations or##3##2##(1993-11#1)(2008-12#1)(2011-2#1)
situations such as##2##3##(2008-11#1)(2010-5#1)
situations that are##2##3##(2008-2#2)
situations that may##2##3##(1995-8#1)(2010-11#1)
situations that##11##2##(1990-6#1)(1995-8#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)
situations the##2##2##(1994-9#1)(2007-11#1)
situations to##2##2##(1995-3#1)(2009-3#1)
situations was##2##2##(2007-12#1)(2010-11#1)
situations were##3##2##(1990-12#1)(2007-12#1)(2008-10#1)
situations when##4##2##(1992-11#1)(1995-3#1)(2007-11#1)(2008-9#1)
situations where a##4##3##(1993-8#1)(2008-10#1)(2010-7#1)(2012-12#1)
situations where the##5##3##(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)
situations where##23##2##(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#2)(1997-3#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2010-3#1)(2010-7#1)(2012-12#1)
situations with##7##2##(1991-12#1)(1993-9#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-8#1)
situations##293##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#2)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-3#4)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#17)(2008-12#6)(2008-2#7)(2008-3#20)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#8)(2009-10#2)(2009-11#4)(2009-12#1)(2009-3#2)(2009-5#5)(2009-6#11)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#15)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#10)(2013-8#1)
situations]##2##1##(1990-12#1)(1993-2#1)
situs inversus totalis##2##3##(1993-9#2)
situs inversus##7##2##(1993-9#2)(2008-7#2)(2009-8#3)
situs##8##1##(1993-9#2)(2007-8#1)(2008-7#2)(2009-8#3)
sive non specificata)##2##3##(1990-12#2)
six (20%)##2##2##(2011-2#2)
six (3##2##2##(1990-3#1)(2008-1#1)
six (9%)##2##2##(1994-6#1)(2008-10#1)
six Cys residues##2##3##(1991-6#1)(1993-2#1)
six active##2##2##(2008-10#1)(2008-5#1)
six additional##4##2##(1992-7#1)(2008-10#2)(2008-6#1)
six alkaloids##2##2##(2008-10#1)(2011-3#1)
six amino acids##3##3##(1992-8#1)(1994-6#2)
six amplified fragment length polymorphism markers##2##6##(2008-10#2)
six analytes##2##2##(2008-10#1)(2008-3#1)
six and four##2##3##(2008-10#1)(2012-1#1)
six and##10##2##(1995-11#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2012-1#1)
six animals##3##2##(1994-8#1)(1996-12#1)(1996-3#1)
six areas of##2##3##(2008-1#1)(2008-10#1)
six areas##6##2##(1991-12#1)(1993-3#1)(2008-1#2)(2008-10#1)(2011-2#1)
six articles##4##2##(2008-5#3)(2008-6#1)
six cases of##3##3##(2007-8#1)(2008-7#1)(2008-9#1)
six cases##17##2##(1991-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-3#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)
six children who had received##2##5##(2008-9#1)(2010-10#1)
six children##4##2##(1997-3#1)(2008-11#1)(2008-9#1)(2010-10#1)
six classes##4##2##(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
six clinical isolates##2##3##(2008-5#2)
six clinical##4##2##(1992-1#1)(2007-10#1)(2008-5#2)
six clusters##2##2##(1991-5#1)(2008-5#1)
six combinations##2##2##(2008-5#1)(2008-8#1)
six compounds##2##2##(2008-10#1)(2013-7#1)
six countries##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2012-2#2)
six courses of##2##3##(2008-6#2)
six critical points of intervention##2##5##(1997-2#2)
six cultivars##2##2##(2008-10#2)
six cycles of##3##3##(1994-5#1)(2011-1#1)(2011-2#1)
six databases##2##2##(1992-12#1)(1996-12#1)
six days after##3##3##(1996-5#1)(2007-12#1)(2012-3#1)
six days of##2##3##(1993-2#1)(2008-11#1)
six days##7##2##(1993-2#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-3#1)
six derivatives of##2##3##(1990-8#1)(2008-10#1)
six different commercial##2##3##(2008-10#2)
six different##21##2##(1991-6#1)(1993-2#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-2#1)(2008-10#8)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2013-8#1)
six dimensions of##2##3##(1992-3#1)(2010-3#1)
six dimensions##4##2##(1991-3#2)(1992-3#1)(2010-3#1)
six distinct##2##2##(1993-3#1)(2008-6#1)
six donors##2##2##(2008-11#1)(2012-2#1)
six electron equivalents##2##3##(1995-3#2)
six examples##2##2##(1992-11#1)(2008-3#1)
six exons##2##2##(1991-6#2)
six female tigers (Panthera tigris)##2##5##(2009-4#2)
six females##2##2##(1990-2#1)(2009-12#1)
six for##2##2##(2008-10#1)(2008-9#1)
six fresh frozen##2##3##(2008-9#2)
six genes##3##2##(1996-10#1)(1996-6#1)(2012-3#1)
six genotypes##2##2##(2008-10#2)
six groups of##2##3##(1994-7#1)(2010-5#1)
six groups##5##2##(1994-7#1)(2008-11#1)(2010-4#1)(2010-5#1)(2011-2#1)
six had##2##2##(1995-12#1)(2011-2#1)
six healthy volunteers##2##3##(1995-11#1)(2008-5#1)
six healthy##3##2##(1995-11#1)(2008-5#1)(2008-6#1)
six highly##2##2##(1997-8#1)(2009-5#1)
six hours after##2##3##(1991-6#1)(1995-5#1)
six hours##6##2##(1991-11#1)(1991-6#1)(1992-6#1)(1995-5#1)(2007-10#1)(2008-5#1)
six human##2##2##(1991-6#1)(1997-4#1)
six in##3##2##(2008-10#2)(2011-2#1)
six indigenous communities residing in the city of Cali##2##9##(2012-12#2)
six indigenous communities residing in##3##5##(2012-12#3)
six introns##3##2##(1991-9#1)(1994-8#1)(1997-2#1)
six isolates##5##2##(2008-10#4)(2008-5#1)
six key##5##2##(1993-12#1)(1994-2#1)(1995-3#1)(2010-4#1)(2012-2#1)
six known compounds##2##3##(2010-2#2)
six known##4##2##(2008-10#1)(2008-4#1)(2010-2#2)
six locations##2##2##(2008-10#1)(2013-8#1)
six major##4##2##(1995-2#1)(2008-10#1)(2008-12#1)(2010-8#1)
six media##4##2##(2008-12#4)
six members of the##2##4##(1994-2#1)(2008-7#1)
six methods##2##2##(2008-10#2)
six mismatched##2##2##(2010-11#2)
six month period##2##3##(1992-5#1)(2008-12#1)
six month##5##2##(1992-5#1)(1996-11#1)(2008-12#1)(2008-6#1)(2012-12#1)
six months after an##2##4##(2013-1#2)
six months after embolisation##2##4##(1997-3#2)
six months after surgery##2##4##(1993-3#2)
six months after the event##2##5##(1991-3#1)(2013-8#1)
six months after the procedure##2##5##(2008-11#1)(2011-2#1)
six months after the##6##4##(1991-3#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
six months after##17##3##(1990-2#1)(1990-5#1)(1991-3#1)(1993-3#2)(1997-3#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2011-2#1)(2013-1#4)(2013-8#1)
six months and one year##2##5##(1991-11#1)(2009-10#1)
six months and##3##3##(1991-11#1)(2008-11#1)(2009-10#1)
six months at -20 degreeC##3##5##(2013-7#3)
six months at -20##4##4##(2013-7#4)
six months before##2##3##(2012-12#1)(2013-8#1)
six months in##2##3##(1993-2#1)(2008-1#1)
six months of age##5##4##(1991-11#1)(1991-6#1)(2008-1#1)(2008-10#1)(2010-11#1)
six months of treatment##2##4##(2008-5#1)(2013-1#1)
six months of##11##3##(1991-11#1)(1991-6#1)(1996-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#3)
six months or##3##3##(1990-5#1)(1991-11#1)(2013-1#1)
six months to##3##3##(1990-5#1)(2008-1#1)(2013-1#1)
six months##94##2##(1990-12#1)(1990-2#1)(1990-5#6)(1990-6#1)(1991-11#5)(1991-2#1)(1991-3#1)(1991-6#2)(1993-2#1)(1993-3#3)(1993-6#1)(1996-11#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-7#4)(2008-1#6)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#4)
six more##3##2##(1997-8#1)(2008-10#2)
six multimember VCGs##2##3##(2008-10#2)
six multimember##3##2##(2008-10#3)
six new##7##2##(1991-8#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
six of the##9##3##(1990-12#1)(1993-12#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)
six of them##2##3##(2011-2#1)(2013-7#1)
six of these##4##3##(1995-5#1)(1996-3#1)(2008-10#1)(2008-7#1)
six of##22##2##(1990-12#1)(1991-2#1)(1993-12#1)(1995-5#1)(1996-3#1)(1996-9#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#2)(2013-7#1)
six open reading frames##2##4##(1995-9#2)
six or more##2##3##(2008-2#1)(2008-6#1)
six or##3##2##(1990-5#1)(2008-2#1)(2008-6#1)
six orders of magnitude##2##4##(2007-12#1)(2008-10#1)
six orders##3##2##(2007-12#1)(2008-10#1)(2013-7#1)
six organic##2##2##(2008-10#1)(2013-8#1)
six other members of the SCMV subgroup##2##7##(2008-10#2)
six other##7##2##(1996-6#1)(2008-10#4)(2011-2#2)
six out of##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
six patients treated##2##3##(1991-3#1)(2008-10#1)
six patients with##10##3##(2007-7#1)(2008-6#2)(2008-7#2)(2008-9#2)(2011-2#1)(2013-1#2)
six patients##35##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-2#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-9#4)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
six peptides##2##2##(1993-6#1)(1994-9#1)
six percent of the##2##4##(2008-10#1)(2013-1#1)
six percent of##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
six plates##2##2##(2008-9#2)
six populations##2##2##(2008-10#2)
six potential##2##2##(1994-12#1)(1997-7#1)
six primary##3##2##(1990-12#1)(2013-8#2)
six proteins##2##2##(1995-5#1)(2010-12#1)
six putative##2##2##(1997-9#1)(2008-10#1)
six pyrethroids##3##2##(2008-10#3)
six races##2##2##(2008-10#2)
six receptor-centered gene networks##2##4##(2013-1#2)
six regions##2##2##(2008-10#2)
six replicate##5##2##(2008-10#5)
six replicates##3##2##(2008-10#3)
six rounds##3##2##(1997-4#3)
six samples##5##2##(2008-10#4)(2013-7#1)
six scales##2##2##(2008-10#1)(2008-3#1)
six sections##2##2##(2012-3#2)
six selected##2##2##(2008-10#2)
six series of six samples were analyzed along 5 months##2##10##(2008-10#2)
six series of##3##3##(2008-10#2)(2008-8#1)
six species##9##2##(1993-12#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-8#1)(2008-9#3)
six spectral##2##2##(2008-3#1)(2008-6#1)
six states##5##2##(1995-12#1)(2008-10#3)(2012-2#1)
six structural##2##2##(1994-5#1)(2008-10#1)
six students##2##2##(1997-2#1)(2008-11#1)
six subjects were##2##3##(2008-7#2)
six subjects##4##2##(2008-3#1)(2008-7#2)(2010-1#1)
six successive##2##2##(2008-10#2)
six such##2##2##(2007-8#1)(2008-9#1)
six times higher than that##2##5##(2007-11#1)(2007-12#1)
six times higher##3##3##(1995-12#1)(2007-11#1)(2007-12#1)
six times more##2##3##(2008-1#1)(2008-9#1)
six times##14##2##(1993-1#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)
six to eight copies##2##4##(2008-10#2)
six to eight##4##3##(2008-10#3)(2008-5#1)
six to##7##2##(1991-12#1)(2008-1#1)(2008-10#4)(2008-5#1)
six transmembrane##2##2##(1996-12#1)(2009-9#1)
six tumor cell lines##2##4##(1991-6#2)
six types of##2##3##(2008-10#1)(2011-2#1)
six variables##5##2##(1990-9#1)(1995-1#1)(2008-10#2)(2008-7#1)
six volunteers##3##2##(1992-3#1)(2008-5#1)(2008-9#1)
six weeks after##3##3##(2007-12#1)(2007-5#1)(2008-7#1)
six weeks and three months##2##5##(1991-11#2)
six weeks and##5##3##(1990-5#1)(1990-6#1)(1991-11#2)(1991-6#1)
six weeks later##2##3##(2008-10#1)(2012-8#1)
six weeks of##2##3##(1997-5#1)(2011-1#1)
six weeks##24##2##(1990-5#1)(1990-6#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1997-5#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2012-8#1)(2013-1#1)(2013-7#1)
six were##6##2##(1991-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-5#1)
six with##2##2##(1994-6#1)(2008-3#1)
six year##5##2##(1990-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
six years of age##2##4##(2011-1#1)(2011-2#1)
six years of##4##3##(2008-1#1)(2008-2#1)(2011-1#1)(2011-2#1)
six years to##2##3##(2008-3#1)(2008-7#1)
six years with##2##3##(2007-7#1)(2007-8#1)
six years##23##2##(1991-2#1)(1993-1#1)(1995-1#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#3)(2011-1#3)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
six young##2##2##(1991-12#1)(1991-6#1)
six##1035##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#5)(1990-5#9)(1990-6#3)(1990-8#3)(1990-9#1)(1991-11#10)(1991-12#5)(1991-2#8)(1991-3#5)(1991-5#2)(1991-6#12)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#7)(1993-6#4)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#7)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#4)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#6)(1995-5#8)(1995-6#3)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#13)(1996-2#5)(1996-3#9)(1996-5#3)(1996-6#2)(1996-9#3)(1997-1#3)(1997-2#8)(1997-3#10)(1997-4#10)(1997-5#3)(1997-7#3)(1997-8#3)(1997-9#1)(2007-10#3)(2007-11#9)(2007-12#15)(2007-2#3)(2007-5#6)(2007-6#1)(2007-7#18)(2007-8#11)(2008-1#27)(2008-10#223)(2008-11#21)(2008-12#19)(2008-2#8)(2008-3#27)(2008-4#8)(2008-5#54)(2008-6#26)(2008-7#30)(2008-8#20)(2008-9#22)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#31)(2011-3#4)(2012-1#1)(2012-12#10)(2012-2#19)(2012-3#12)(2012-8#1)(2013-1#31)(2013-7#11)(2013-8#20)
six-arm##2##1##(2008-3#2)
six-component##3##1##(2008-10#2)(2012-3#1)
six-hour##2##1##(1996-8#1)(2007-10#1)
six-membered##3##1##(1996-2#1)(1997-7#2)
six-month sampling##2##2##(2007-5#2)
six-month survival##2##2##(1994-12#2)
six-month##9##1##(1994-12#2)(1996-11#1)(1997-3#1)(2007-5#3)(2008-5#1)(2008-6#1)
six-monthly##2##1##(2008-6#1)(2008-9#1)
six-months follow-up##2##2##(2007-8#2)
six-phase strategy##2##2##(1996-1#1)(1996-2#1)
six-point##2##1##(2010-6#1)(2013-1#1)
six-way valve##2##2##(2008-10#2)
six-year period##3##2##(1995-5#1)(1996-1#1)(2011-2#1)
six-year time##2##2##(2011-2#2)
six-year##5##1##(1995-5#1)(1996-1#1)(2011-2#3)
six-year-old boy##2##2##(1997-7#1)(2008-11#1)
sixfold##8##1##(1993-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-8#1)
sixteen##10##1##(1991-5#1)(1993-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
sixteenth##3##1##(2008-11#1)(2008-8#1)(2012-2#1)
sixteenth-century##6##1##(2008-11#4)(2008-2#1)(2012-2#1)
sixth decade##2##2##(1997-7#1)(2008-9#1)
sixth ligand##2##2##(1997-7#1)(2008-10#1)
sixth month##3##2##(1990-6#1)(1997-8#2)
sixth nerve##2##2##(2011-2#1)(2012-3#1)
sixth##41##1##(1990-12#1)(1990-6#1)(1991-1#1)(1992-1#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-7#2)(1997-8#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
sixth-order##6##1##(2007-12#2)(2008-2#1)(2008-3#1)(2010-12#2)
sixties##4##1##(1992-10#1)(1992-8#1)(1997-8#1)(2007-8#1)
sixty (65%)##2##2##(1997-3#2)
sixty five##2##2##(2007-11#1)(2012-12#1)
sixty patients##2##2##(2011-2#2)
sixty##17##1##(1991-12#1)(1992-11#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-5#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
sixty-five##3##1##(1991-1#1)(2008-11#1)(2008-7#1)
sizable##4##1##(1995-2#1)(2008-10#2)(2009-9#1)
size &lt##2##2##(2008-10#1)(2008-2#1)
size (&gt##2##2##(2008-9#1)(2012-2#1)
size (8##2##2##(1993-9#1)(2008-10#1)
size (diameter)##2##2##(2008-10#1)(2008-11#1)
size (typically##2##2##(2008-1#1)(2008-10#1)
size 50##2##2##(1996-9#1)(2009-12#1)
size N##2##2##(2008-10#1)(2008-8#1)
size VLDL##4##2##(1993-8#4)
size a##2##2##(1993-12#1)(2012-3#1)
size affected##2##2##(2008-10#1)(2009-8#1)
size among##3##2##(1991-8#1)(1993-9#1)(2008-8#1)
size analysis##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
size and a##3##3##(2008-10#1)(2008-3#2)
size and age at settlement##2##5##(2007-5#2)
size and age##3##3##(2007-5#2)(2008-8#1)
size and cell##2##3##(2008-11#1)(2008-8#1)
size and charge distribution##2##4##(1997-2#1)(2008-10#1)
size and charge##5##3##(1992-8#1)(1993-9#1)(1997-2#1)(2008-10#2)
size and composition##2##3##(2009-8#2)
size and compression##2##3##(2007-8#1)(2008-2#1)
size and concentration of##2##4##(1995-3#1)(2008-10#1)
size and concentration##8##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#4)(2011-2#1)
size and density##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
size and expression level##2##4##(1997-8#1)(2008-10#1)
size and initial##2##3##(2008-10#1)(2008-11#1)
size and intensity##3##3##(1993-12#2)(2008-9#1)
size and location of the##2##5##(1995-2#1)(2011-2#1)
size and mass##2##3##(2007-12#1)(2012-12#1)
size and mature height##2##4##(2008-9#2)
size and number of##9##4##(2007-12#3)(2008-10#4)(2008-7#1)(2008-8#1)
size and number##13##3##(1991-5#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#2)
size and optical##2##3##(2008-2#1)(2008-3#1)
size and position of the##2##5##(2007-12#1)(2008-2#1)
size and power##5##3##(1994-2#1)(1994-9#1)(1997-3#2)(2007-7#1)
size and purity of##2##4##(2009-5#2)
size and rate##2##3##(2008-7#1)(2011-2#1)
size and refractive index##2##4##(2008-2#1)(2008-3#1)
size and sample##3##3##(2008-10#2)(2010-4#1)
size and shape is##2##4##(2008-10#1)(2008-3#1)
size and shape of the##5##5##(2007-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2013-8#1)
size and shape of##10##4##(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-12#2)(2013-8#1)
size and shape##22##3##(1993-9#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#2)(2010-7#1)(2013-7#3)(2013-8#1)
size and strength##2##3##(2008-5#1)(2009-12#1)
size and structure##2##3##(1997-6#1)(2008-10#1)
size and that##4##3##(2008-3#1)(2008-8#2)(2008-9#1)
size and the shape of##2##5##(2008-3#2)
size and the shape##3##4##(2008-3#3)
size and the##27##3##(1994-11#1)(1996-3#2)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#7)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2013-8#1)
size and type##3##3##(1994-2#1)(1996-1#1)(2010-8#1)
size and was##2##3##(2009-7#1)(2011-1#1)
size and weight##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
size and##311##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#3)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-1#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#8)(2007-12#14)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#52)(2008-11#3)(2008-12#2)(2008-2#13)(2008-3#26)(2008-4#5)(2008-5#7)(2008-7#7)(2008-8#24)(2008-9#13)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-2#13)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#4)(2013-8#5)
size are##9##2##(1992-4#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)
size as a##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
size as the##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
size as##12##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
size asymmetric##2##2##(2008-8#2)
size asymmetry of competition##3##4##(2008-8#3)
size asymmetry##5##2##(2008-8#5)
size at maturity##7##3##(2008-8#2)(2008-9#5)
size at the##2##3##(2008-1#1)(2008-2#1)
size at##16##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#5)(2008-9#6)(2012-3#1)(2013-8#1)
size based##3##2##(1995-9#1)(2008-10#2)
size before##2##2##(1996-6#1)(2008-7#1)
size below which##2##3##(2008-10#2)
size below##4##2##(2008-10#2)(2008-8#2)
size between##3##2##(1993-9#1)(1995-6#1)(2011-1#1)
size bias in##2##3##(2008-8#2)
size bias##4##2##(2008-8#4)
size but##8##2##(1993-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#2)(2013-7#1)
size by##10##2##(1991-8#1)(1996-9#1)(2008-10#1)(2008-3#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
size calculations##3##2##(1992-6#1)(2012-3#2)
size can##5##2##(1992-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
size change##2##2##(2008-7#1)(2013-8#1)
size characteristics of##2##3##(1992-12#1)(1992-3#1)
size characteristics##3##2##(1992-12#1)(1992-3#1)(2008-3#1)
size classes##9##2##(1992-6#1)(1996-12#2)(2008-10#3)(2010-8#1)(2013-7#2)
size constraints##2##2##(2008-1#1)(2010-10#1)
size could##2##2##(1995-3#1)(2008-10#1)
size decreases with##2##3##(2008-2#1)(2008-8#1)
size dependence##2##2##(2008-10#1)(2008-3#1)
size dependent##3##2##(1991-2#1)(1997-1#1)(2008-3#1)
size determination##4##2##(1994-2#1)(1995-9#1)(2008-10#1)(2008-3#1)
size differences##2##2##(2007-12#1)(2008-8#1)
size disparity##2##2##(2007-8#1)(2010-8#1)
size distribution and##11##3##(1996-12#1)(2008-10#3)(2008-2#3)(2008-3#3)(2013-1#1)
size distribution as##2##3##(2007-12#1)(2008-7#1)
size distribution at##2##3##(1995-3#1)(2008-5#1)
size distribution from##3##3##(2008-2#2)(2008-3#1)
size distribution in the##2##4##(2008-9#1)(2013-8#1)
size distribution is##5##3##(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)
size distribution of the##6##4##(1992-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
size distribution of##16##3##(1991-12#1)(1992-2#1)(1995-2#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
size distribution were##2##3##(2008-10#1)(2008-3#1)
size distribution##87##2##(1990-3#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#17)(2008-3#20)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#4)(2009-11#3)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#2)
size distributions are presented##2##4##(2008-10#1)(2008-3#1)
size distributions are##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
size distributions of##6##3##(1992-3#1)(1997-2#1)(2008-2#3)(2008-3#1)
size distributions##34##2##(1992-3#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-2#8)(2008-3#18)(2008-9#3)(2009-11#1)
size does not##2##3##(2007-12#1)(2008-10#1)
size does##3##2##(1992-6#1)(2007-12#1)(2008-10#1)
size due to##2##3##(2008-10#1)(2008-11#1)
size during the##5##3##(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)
size during##7##2##(1995-9#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#1)
size effect##2##2##(2008-10#1)(2010-7#1)
size effects##5##2##(1993-5#1)(2008-3#1)(2008-8#3)
size estimate of##2##3##(1990-8#1)(2010-4#1)
size estimate##3##2##(1990-8#1)(1994-9#1)(2010-4#1)
size estimates##3##2##(1992-2#1)(1996-6#1)(2007-12#1)
size evolution##3##2##(2012-3#3)
size exclusion chromatography (SEC) with##2##5##(2008-10#2)
size exclusion chromatography (SEC)##3##4##(2008-10#3)
size exclusion chromatography with##2##4##(2008-10#2)
size exclusion chromatography##11##3##(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#7)(2011-2#1)
size exclusion##14##2##(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#10)(2011-2#1)
size following##2##2##(1992-9#1)(2012-2#1)
size for a##3##3##(1995-9#1)(2008-8#1)(2011-1#1)
size for each##2##3##(1993-9#1)(2013-1#1)
size for the##2##3##(1996-3#1)(2009-11#1)
size for##25##2##(1993-9#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-3#1)(2007-7#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#2)(2009-11#3)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
size formulae##3##2##(2012-3#3)
size fractionated##2##2##(1992-3#1)(2008-10#1)
size fractionation of##4##3##(2008-10#4)
size fractionation##5##2##(2008-10#5)
size from 4##2##3##(1991-5#1)(2008-10#1)
size from##15##2##(1990-12#2)(1991-5#1)(1992-12#1)(1992-8#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-4#1)(2012-3#2)
size had##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
size has been##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
size has##4##2##(2007-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
size have been##2##3##(2008-10#1)(2009-5#1)
size have##3##2##(2008-10#1)(2008-9#1)(2009-5#1)
size heterogeneity##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
size in a##3##3##(1990-8#1)(2008-7#2)
size in the##6##3##(1995-6#1)(1997-5#1)(2008-10#2)(2008-9#1)(2012-2#1)
size in this##2##3##(1994-11#1)(2008-3#1)
size in##45##2##(1990-8#1)(1991-11#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-7#3)(2008-8#6)(2008-9#8)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-7#1)
size increase##5##2##(1995-9#2)(2008-8#2)(2008-9#1)
size increased##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
size increases##3##2##(2008-10#2)(2008-2#1)
size information##3##2##(2007-11#1)(2007-12#1)(2011-2#1)
size is 6##2##3##(2009-8#1)(2011-2#1)
size is determined##2##3##(2008-10#1)(2008-8#1)
size is more closely related to host size##2##8##(2008-9#2)
size is not##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
size is possible##2##3##(2008-5#1)(2008-8#1)
size is small##2##3##(2008-7#1)(2008-8#1)
size is the##3##3##(2008-10#1)(2008-11#2)
size is##55##2##(1996-8#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-7#3)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#5)(2009-11#2)(2009-8#2)(2010-7#1)(2011-2#2)(2012-3#3)(2013-7#1)(2013-8#2)
size less than##2##3##(2008-10#1)(2009-11#1)
size limit##3##2##(1991-5#1)(2008-1#1)(2013-7#1)
size may be##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
size may##6##2##(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)
size measurement##2##2##(1991-9#2)
size measurements of##2##3##(1991-9#1)(2011-2#1)
size measurements##4##2##(1991-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
size observed##2##2##(1992-12#1)(2013-7#1)
size obtained##2##2##(2008-10#2)
size occurred##2##2##(1992-3#1)(2008-10#1)
size occurs##2##2##(2008-5#1)(2008-8#1)
size of 0##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
size of 1##7##3##(1990-6#1)(1992-6#1)(1995-3#1)(1995-4#1)(2008-8#1)(2009-2#1)(2011-2#1)
size of 20##2##3##(1993-12#1)(2008-5#1)
size of 3##5##3##(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#2)
size of P##3##3##(2008-10#3)
size of PSD-95 clusters##2##4##(2012-3#2)
size of a##18##3##(1992-5#1)(1992-6#1)(1994-11#2)(1994-3#2)(2007-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-9#1)(2010-3#1)(2013-1#1)
size of about##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
size of an##2##3##(1992-3#1)(1994-11#1)
size of approximately##5##3##(1993-3#1)(1993-6#1)(2007-11#1)(2008-3#1)(2008-9#1)
size of both##4##3##(1996-5#1)(2008-3#1)(2008-9#1)(2011-2#1)
size of cells##2##3##(2008-10#1)(2008-11#1)
size of colonies##2##3##(1995-2#1)(1995-6#1)
size of crown##2##3##(2008-10#1)(2013-7#1)
size of detectable populations of##2##5##(2008-10#2)
size of detectable populations##3##4##(2008-10#3)
size of fragments##2##3##(1991-12#1)(1993-2#1)
size of hospital##2##3##(1997-3#1)(2011-2#1)
size of more than##2##4##(2008-7#1)(2008-8#1)
size of pancreas##2##3##(2012-3#2)
size of particles##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
size of the Golgi##2##4##(1993-12#2)
size of the areas##2##4##(1996-4#1)(2010-9#1)
size of the cloned##2##4##(1994-12#1)(2008-8#1)
size of the field##2##4##(2008-10#1)(2008-2#1)
size of the inoculum##2##4##(1991-11#1)(2008-5#1)
size of the lesions##2##4##(1995-4#1)(2007-8#1)
size of the nutrient foramen was##2##6##(2013-8#2)
size of the nutrient foramen##3##5##(2013-8#3)
size of the optical##2##4##(2007-12#1)(2013-8#1)
size of the orifice##2##4##(1995-11#1)(2013-1#1)
size of the polar headgroup of##2##6##(1990-11#1)(2008-10#1)
size of the probe##2##4##(2008-2#2)
size of the referred pain area##2##6##(2010-9#2)
size of the source##3##4##(2006-4#1)(2008-10#1)(2008-11#1)
size of the tumor##2##4##(2009-3#1)(2010-3#1)
size of the##220##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-11#5)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-6#1)(1997-1#2)(1997-2#3)(2006-4#1)(2007-10#4)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#13)(2008-3#15)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#7)
size of these##5##3##(1994-2#1)(1996-1#1)(1997-3#1)(2008-9#1)(2009-3#1)
size of this##4##3##(1991-2#1)(2008-6#1)(2008-8#1)(2010-4#1)
size of tumour##2##3##(2008-6#2)
size of##451##2##(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#5)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#8)(1997-3#3)(1997-5#1)(1997-6#2)(1997-9#1)(2006-4#1)(2007-10#4)(2007-11#9)(2007-12#11)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#70)(2008-11#7)(2008-12#2)(2008-2#19)(2008-3#30)(2008-4#4)(2008-5#23)(2008-6#7)(2008-7#13)(2008-8#18)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#6)(2010-4#3)(2010-5#3)(2010-8#6)(2010-9#3)(2011-1#8)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#11)(2013-7#8)(2013-8#11)
size on the##5##3##(1996-5#1)(2008-3#1)(2008-8#2)(2009-2#1)
size on##19##2##(1996-5#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#3)(2008-9#3)(2009-2#1)
size or sex##2##3##(2007-12#1)(2008-8#1)
size or##13##2##(1995-1#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#4)
size parameter of 20##3##4##(2008-3#3)
size parameter of##7##3##(2008-2#3)(2008-3#4)
size parameter##16##2##(2008-2#7)(2008-3#9)
size parameters of##2##3##(2008-2#1)(2008-3#1)
size parameters up to##2##4##(2008-2#1)(2008-3#1)
size parameters##15##2##(2007-11#1)(2008-2#4)(2008-3#10)
size phenotype##2##2##(2008-3#2)
size polydispersity##3##2##(2008-10#1)(2013-8#2)
size polymorphism##2##2##(1993-2#1)(2008-10#1)
size range between##2##3##(2008-3#1)(2013-7#1)
size range of##11##3##(1993-8#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-12#1)
size range##21##2##(1993-8#1)(1994-11#1)(1995-3#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-9#1)(2010-12#1)(2013-7#1)
size ranges##2##2##(1997-2#1)(2008-10#1)
size ratio##2##2##(2008-9#1)(2011-2#1)
size ratios##3##2##(2008-3#3)
size reduction##6##2##(2007-11#1)(2008-10#1)(2008-7#3)(2012-3#1)
size required##3##2##(1992-9#1)(1995-9#1)(2008-10#1)
size requirement##2##2##(2008-3#1)(2008-8#1)
size should##2##2##(2008-10#1)(2013-7#1)
size smaller than##3##3##(2008-10#2)(2008-5#1)
size standards##3##2##(1991-9#1)(2008-4#2)
size structure##2##2##(2008-5#2)
size structuring##2##2##(2008-8#2)
size than##2##2##(1996-2#1)(2007-12#1)
size that was##2##3##(1994-6#1)(2008-10#1)
size that##8##2##(1994-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-6#1)
size through##2##2##(2007-12#1)(2008-8#1)
size to be##3##3##(1997-2#1)(2008-3#1)(2008-8#1)
size to the##4##3##(1992-10#1)(1995-2#1)(2008-10#1)(2008-5#1)
size to##21##2##(1992-10#1)(1993-12#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)
size using##2##2##(2009-8#1)(2012-3#1)
size variable##3##2##(2011-2#3)
size variants##2##2##(1995-11#2)
size variation and##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
size variation in##2##3##(2008-8#2)
size variation within##2##3##(2008-8#2)
size variation##13##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#8)(2009-5#1)(2010-5#1)
size was around##2##3##(1990-7#1)(1992-4#1)
size was calculated using##2##4##(2008-11#1)(2012-12#1)
size was calculated##4##3##(2008-10#2)(2008-11#1)(2012-12#1)
size was determined##2##3##(2008-10#1)(2008-7#1)
size was measured##2##3##(2010-12#1)(2013-8#1)
size was not##3##3##(1992-2#1)(1993-8#1)(2008-10#1)
size was significantly##2##3##(1993-11#1)(2008-10#1)
size was the##2##3##(1995-5#1)(2008-11#1)
size was##52##2##(1990-7#1)(1991-1#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#2)(2009-3#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
size were##12##2##(1992-4#1)(1996-7#1)(2007-12#1)(2008-10#5)(2008-6#1)(2009-10#1)(2012-3#1)(2013-7#1)
size when##7##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
size while##2##2##(2008-10#1)(2008-9#1)
size will be##2##3##(1996-2#1)(2008-3#1)
size will##5##2##(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
size with##9##2##(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-5#1)
size within##2##2##(2008-8#2)
size ≥50 mm##2##2##(2011-2#2)
size##2329##1##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#6)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#2)(1991-5#9)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#7)(1992-1#1)(1992-10#4)(1992-11#4)(1992-12#8)(1992-2#6)(1992-3#16)(1992-4#4)(1992-5#5)(1992-6#11)(1992-8#4)(1992-9#8)(1993-10#1)(1993-11#5)(1993-12#11)(1993-2#9)(1993-3#2)(1993-5#2)(1993-6#4)(1993-8#9)(1993-9#11)(1994-11#9)(1994-12#7)(1994-2#8)(1994-3#7)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#7)(1995-1#2)(1995-11#7)(1995-12#3)(1995-2#13)(1995-3#13)(1995-4#4)(1995-5#11)(1995-6#7)(1995-8#6)(1995-9#9)(1996-1#7)(1996-10#2)(1996-12#12)(1996-2#13)(1996-3#13)(1996-4#10)(1996-5#4)(1996-6#7)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#7)(1997-2#20)(1997-3#11)(1997-4#2)(1997-5#4)(1997-6#5)(1997-7#2)(1997-8#6)(1997-9#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#14)(2007-11#35)(2007-12#56)(2007-4#1)(2007-5#3)(2007-7#11)(2007-8#11)(2008-1#17)(2008-10#380)(2008-11#46)(2008-12#18)(2008-2#119)(2008-3#209)(2008-4#24)(2008-5#73)(2008-6#23)(2008-7#74)(2008-8#179)(2008-9#112)(2009-1#1)(2009-10#7)(2009-11#15)(2009-12#15)(2009-2#7)(2009-3#3)(2009-4#3)(2009-5#12)(2009-6#2)(2009-7#1)(2009-8#12)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#11)(2010-2#11)(2010-3#9)(2010-4#6)(2010-5#8)(2010-6#5)(2010-7#6)(2010-8#27)(2010-9#6)(2011-1#27)(2011-2#58)(2012-1#2)(2012-12#18)(2012-2#29)(2012-3#44)(2012-5#4)(2012-9#2)(2013-1#38)(2013-7#29)(2013-8#35)
size) and the##2##3##(2008-9#1)(2011-2#1)
size) and##6##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
size) in##2##2##(1996-6#1)(2008-11#1)
size) were##2##2##(1994-12#1)(2008-5#1)
size)##27##1##(1993-12#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#3)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#2)
size-abundance relationships among##3##3##(2008-9#3)
size-asymmetric##3##1##(2008-8#3)
size-based##3##1##(2008-1#1)(2008-10#1)(2008-7#1)
size-dependent optical properties##2##3##(2008-10#1)(2008-7#1)
size-dependent##7##1##(2008-10#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#1)
size-exclusion and##3##2##(1991-9#1)(1993-11#1)(2008-10#1)
size-exclusion chromatography (SEC)##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
size-exclusion chromatography##15##2##(1992-9#2)(1993-11#2)(1993-6#1)(1993-8#1)(1996-5#2)(1997-2#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
size-exclusion##23##1##(1990-8#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-11#3)(1993-6#1)(1993-8#1)(1995-6#1)(1996-5#2)(1997-2#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
size-fractionated by##2##2##(1994-8#1)(1995-8#1)
size-fractionated##6##1##(1990-11#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#2)
size-related##4##1##(1996-12#1)(2009-5#1)(2010-8#2)
size-selected##2##1##(1992-8#1)(2008-2#1)
size-selective##2##1##(2008-1#1)(2008-5#1)
size/BMR##2##1##(2008-8#2)
sizeable##5##1##(1995-11#1)(1996-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
sized and##2##2##(2007-9#1)(2008-10#1)
sized particles##2##2##(2008-10#2)
sized##36##1##(1990-12#1)(1992-3#1)(1992-9#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
sizer##3##1##(1993-2#2)(2008-3#1)
sizes and in##2##3##(2008-9#1)(2010-8#1)
sizes and numbers of##2##4##(1997-6#1)(2007-12#1)
sizes and the##3##3##(2008-3#1)(2011-2#1)(2013-7#1)
sizes and##40##2##(1995-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
sizes are##8##2##(1994-5#1)(1997-8#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-3#2)
sizes as##4##2##(2008-2#2)(2008-8#2)
sizes below##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
sizes between##2##2##(2008-10#1)(2010-6#1)
sizes by electron microscopy##2##4##(1997-3#1)(2008-3#1)
sizes by##3##2##(1997-3#1)(2008-3#2)
sizes can be##2##3##(1995-5#1)(2009-5#1)
sizes can##3##2##(1995-5#1)(2009-5#1)(2012-3#1)
sizes compared with##2##3##(2008-10#1)(2012-12#1)
sizes for##7##2##(1995-12#1)(2008-10#1)(2008-3#2)(2012-12#1)(2012-3#1)(2013-1#1)
sizes in the##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
sizes in this##2##3##(2008-10#1)(2008-9#1)
sizes in##20##2##(1992-9#1)(2006-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
sizes increased##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
sizes is##2##2##(1993-9#1)(2008-12#1)
sizes of 0##3##3##(2008-10#2)(2008-6#1)
sizes of Eh252##2##3##(2008-10#2)
sizes of the##19##3##(2007-7#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2010-7#1)(2011-2#1)(2013-8#2)
sizes of these##3##3##(2008-10#3)
sizes of##67##2##(1990-11#1)(1990-7#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-2#1)(1994-6#1)(1996-4#1)(1997-2#2)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#29)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
sizes on##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
sizes or##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
sizes ranged from##2##3##(2008-10#1)(2011-1#1)
sizes ranging from##4##3##(1992-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
sizes tested##6##2##(2008-10#5)(2013-7#1)
sizes that were##2##3##(2007-7#1)(2008-10#1)
sizes that##4##2##(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
sizes up to##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
sizes was##2##2##(2007-12#1)(2008-10#1)
sizes were obtained##3##3##(2008-10#2)(2008-3#1)
sizes were##17##2##(1991-6#1)(1995-8#1)(2008-10#5)(2008-3#3)(2008-6#1)(2008-7#2)(2010-6#1)(2011-2#3)
sizes when##2##2##(2007-12#1)(2008-11#1)
sizes with##2##2##(2008-1#1)(2008-3#1)
sizes##353##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-4#3)(1996-6#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#1)(2006-4#1)(2007-11#5)(2007-12#14)(2007-4#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#87)(2008-11#7)(2008-12#2)(2008-2#17)(2008-3#35)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#22)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#6)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#11)(2012-1#3)(2012-12#3)(2012-2#8)(2012-3#10)(2013-1#6)(2013-7#2)(2013-8#4)
sizes)##3##1##(2008-10#2)(2013-8#1)
sizing and##2##2##(2008-10#1)(2008-3#1)
sizing in##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
sizing of##2##2##(2008-2#1)(2008-3#1)
sizing systems##2##2##(1992-3#2)
sizing##41##1##(1992-3#3)(1995-3#2)(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#14)(2008-3#18)(2011-2#1)
sizzled##7##1##(2012-12#7)
siècle##3##1##(1995-1#1)(2009-4#1)(2011-2#1)
skate Leucoraja##2##2##(2010-8#2)
skate species##2##2##(2009-4#2)
skate##15##1##(2008-11#1)(2008-4#1)(2009-4#6)(2010-8#7)
skates##3##1##(2009-4#2)(2010-8#1)
skeletal Ca##2##2##(1997-4#2)
skeletal Class III##2##3##(2009-7#1)(2013-1#1)
skeletal abnormalities##4##2##(1992-6#1)(1997-3#1)(2011-1#1)(2012-2#1)
skeletal abnormality##2##2##(2007-7#1)(2012-3#1)
skeletal actin [alpha]##2##3##(1990-5#2)
skeletal actin##3##2##(1990-5#3)
skeletal and cardiac muscle development##2##5##(2010-7#2)
skeletal and cardiac muscle##4##4##(1997-8#1)(2010-7#2)(2012-3#1)
skeletal and cardiac##6##3##(1997-8#1)(2010-7#2)(2012-3#3)
skeletal and soft tissue##2##4##(1991-2#1)(2011-2#1)
skeletal and##12##2##(1990-2#1)(1991-2#1)(1997-8#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-3#4)(2013-1#1)
skeletal anomalies were##2##3##(1993-12#2)
skeletal anomalies##3##2##(1993-12#3)
skeletal bone##2##2##(1994-7#1)(2012-2#1)
skeletal bones##2##2##(2008-12#1)(2011-1#1)
skeletal changes##2##2##(2009-7#1)(2011-1#1)
skeletal complications and##3##3##(2007-11#1)(2008-7#2)
skeletal complications in patients with##2##5##(2008-7#2)
skeletal complications##10##2##(2007-11#3)(2008-7#7)
skeletal defects##4##2##(1995-3#1)(2009-7#1)(2010-6#2)
skeletal deformities##2##2##(2007-12#1)(2012-2#1)
skeletal demineralization observed##2##3##(1997-4#2)
skeletal demineralization##4##2##(1997-4#3)(2008-6#1)
skeletal development and##2##3##(2008-11#1)(2012-2#1)
skeletal development##4##2##(2008-11#2)(2012-12#1)(2012-2#1)
skeletal discrepancy##2##2##(2007-12#2)
skeletal disease##4##2##(2007-11#2)(2011-1#1)(2012-2#1)
skeletal dysplasia was##2##3##(2011-1#2)
skeletal dysplasia##7##2##(2008-11#1)(2011-1#6)
skeletal fluorosis##2##2##(2012-1#2)
skeletal fractures##2##2##(2008-8#2)
skeletal growth##2##2##(2007-12#1)(2008-4#1)
skeletal hyperostosis##2##2##(2006-10#1)(2007-8#1)
skeletal integrity##3##2##(1997-4#1)(2007-7#1)(2010-9#1)
skeletal maturation##2##2##(2008-1#1)(2012-12#1)
skeletal maturity##3##2##(2007-12#1)(2007-8#1)(2008-6#1)
skeletal metastases from soft tissue sarcomas##4##6##(2008-6#4)
skeletal metastases from##5##3##(2007-11#1)(2008-6#4)
skeletal metastases##15##2##(1994-7#1)(2007-11#4)(2008-1#1)(2008-6#5)(2008-7#3)(2011-2#1)
skeletal muscle and testis##2##4##(1994-11#1)(1997-8#1)
skeletal muscle and##12##3##(1990-11#1)(1990-2#1)(1990-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-3#1)(2012-3#1)
skeletal muscle are##3##3##(1994-8#1)(2008-3#1)(2009-3#1)
skeletal muscle by##4##3##(1992-6#1)(1995-2#1)(2008-1#1)(2008-4#1)
skeletal muscle cells##5##3##(2008-11#2)(2008-8#1)(2008-9#2)
skeletal muscle differentiation##3##3##(1991-6#1)(1994-11#1)(2013-1#1)
skeletal muscle during##3##3##(1991-2#2)(2008-10#1)
skeletal muscle fiber##3##3##(1991-12#2)(1993-5#1)
skeletal muscle fibers##4##3##(1991-12#1)(1994-6#1)(2009-8#1)(2010-1#1)
skeletal muscle from##3##3##(1990-8#1)(1995-2#2)
skeletal muscle growth##2##3##(2008-5#1)(2012-12#1)
skeletal muscle in##3##3##(1993-2#1)(1997-7#1)(2007-6#1)
skeletal muscle insulin resistance in##2##5##(2008-1#1)(2008-3#1)
skeletal muscle is a##2##4##(2008-1#1)(2011-1#1)
skeletal muscle is##13##3##(1990-8#1)(1991-9#1)(1993-2#1)(1997-2#1)(1997-3#1)(2008-1#6)(2009-3#1)(2011-1#1)
skeletal muscle lineage##2##3##(1992-5#2)
skeletal muscle nebulin##2##3##(2008-6#2)
skeletal muscle of##2##3##(2008-8#1)(2013-1#1)
skeletal muscle sodium channel gene##3##5##(1991-12#1)(1992-3#2)
skeletal muscle that##2##3##(2008-11#1)(2008-5#1)
skeletal muscle tissue##6##3##(2007-11#1)(2008-10#1)(2008-2#4)
skeletal muscle to##3##3##(1991-12#1)(1995-8#1)(2010-2#1)
skeletal muscle was##3##3##(1995-11#1)(2008-3#1)(2013-1#1)
skeletal muscle##198##2##(1990-11#3)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#8)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-6#3)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-2#7)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#5)(1997-8#1)(2007-11#2)(2007-6#1)(2008-1#14)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#7)(2009-12#2)(2009-3#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#4)(2012-7#1)(2013-1#5)(2013-8#4)
skeletal muscle-specific##4##2##(1993-12#1)(1995-2#2)(2008-8#1)
skeletal muscles in##2##3##(1993-5#1)(2012-1#1)
skeletal muscles of##3##3##(1995-8#1)(2008-11#1)(2008-7#1)
skeletal muscles under##2##3##(1995-2#1)(2008-3#1)
skeletal muscles##22##2##(1990-8#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#5)(1995-8#2)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-1#3)
skeletal myoblasts##3##2##(1990-12#1)(1993-12#1)(2009-9#1)
skeletal myopathy##2##2##(2008-7#2)
skeletal survey##3##2##(2011-1#3)
skeletal system##5##2##(2007-11#3)(2007-8#2)
skeletal tissues##2##2##(1990-11#1)(1994-12#1)
skeletal##397##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-5#6)(1990-7#1)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-5#1)(1991-6#2)(1991-9#3)(1992-3#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#8)(1993-12#11)(1993-2#3)(1993-3#2)(1993-5#2)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#4)(1994-5#1)(1994-6#3)(1994-7#3)(1994-8#1)(1994-9#6)(1995-11#1)(1995-12#2)(1995-2#14)(1995-3#1)(1995-6#4)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#8)(1997-7#5)(1997-8#2)(2006-10#2)(2007-11#18)(2007-12#10)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#17)(2008-10#4)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#12)(2008-7#20)(2008-8#9)(2008-9#8)(2009-12#3)(2009-3#3)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-6#4)(2010-7#2)(2010-9#1)(2011-1#18)(2011-2#7)(2012-1#5)(2012-12#4)(2012-2#6)(2012-3#9)(2012-7#1)(2013-1#11)(2013-8#7)
skeletal-related events##2##2##(2008-7#1)(2013-7#1)
skeletally immature##6##2##(2008-6#1)(2009-3#1)(2010-3#1)(2013-1#3)
skeletally##7##1##(2008-6#1)(2009-3#1)(2010-3#2)(2013-1#3)
skeleton and##6##2##(1991-11#1)(1993-11#1)(2012-12#1)(2012-2#3)
skeleton for the synthesis of##2##5##(2008-5#2)
skeleton is a##2##3##(2007-11#1)(2007-12#1)
skeleton is##5##2##(1993-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2011-2#1)
skeleton of##4##2##(1991-5#1)(2008-8#3)
skeleton##63##1##(1990-2#1)(1991-11#1)(1991-5#2)(1992-4#1)(1993-11#5)(1994-12#1)(1995-11#1)(1996-5#3)(2007-11#5)(2007-12#5)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#9)(2009-10#1)(2009-7#1)(2010-3#1)(2010-6#4)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)
skeleton-muscle##2##1##(2007-12#2)
skeletonization##4##1##(2007-8#2)(2008-7#1)(2010-8#1)
skeletonized IMA##2##2##(2007-8#2)
skeletonized arterial graft##2##3##(2007-8#2)
skeletonized arterial##3##2##(2007-8#3)
skeletonized##7##1##(2007-8#6)(2010-8#1)
skeletons##6##1##(1995-2#1)(1995-6#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-3#1)
skeptical##2##1##(1990-10#1)(2009-11#1)
skepticism##7##1##(1991-12#1)(1995-2#1)(2008-4#1)(2009-1#1)(2009-10#1)(2011-2#2)
skerries##2##1##(2008-3#2)
sketch##5##1##(1993-3#1)(2008-11#1)(2009-3#1)(2010-10#1)(2013-1#1)
skew foot deformity in a patient with##2##7##(2012-3#2)
skew foot deformity##3##3##(2012-3#3)
skew in##5##2##(2008-8#3)(2008-9#2)
skew models##4##2##(2008-8#3)(2008-9#1)
skew or##2##2##(2008-8#1)(2008-9#1)
skew was associated with##2##4##(2008-9#2)
skew##35##1##(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#20)(2008-9#7)(2012-3#3)
skewed toward##3##2##(2008-10#3)
skewed##14##1##(1993-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)
skewing of##2##2##(2008-10#1)(2008-11#1)
skewing##6##1##(2008-10#1)(2008-11#1)(2008-3#3)(2012-1#1)
skewness##3##1##(2008-10#2)(2008-3#1)
skews##2##1##(2008-8#2)
skies##6##1##(2008-1#1)(2008-2#2)(2008-3#3)
skiing##3##1##(1992-6#1)(2007-12#1)(2013-1#1)
skill acquisition##4##2##(1994-2#1)(2008-11#1)(2011-1#2)
skill and##7##2##(1990-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-2#1)
skill development##6##2##(1993-2#1)(1994-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
skill for##5##2##(1992-2#1)(1997-3#1)(2008-11#2)(2008-12#1)
skill in##4##2##(1992-11#1)(1995-12#1)(2008-11#2)
skill is##2##2##(2007-8#1)(2008-11#1)
skill learning##5##2##(2007-8#3)(2009-6#1)(2012-2#1)
skill level##3##2##(1996-12#1)(2007-11#1)(2009-2#1)
skill mix##4##2##(1995-2#1)(1997-2#2)(2013-8#1)
skill of##6##2##(2007-11#1)(2008-11#4)(2010-4#1)
skill or##2##2##(1992-11#1)(2008-11#1)
skill set##4##2##(2007-12#4)
skill that##5##2##(1995-1#1)(2008-11#1)(2008-12#2)(2013-1#1)
skill##99##1##(1990-12#2)(1990-3#1)(1991-3#2)(1992-11#3)(1992-2#2)(1993-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-2#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#2)(2007-12#6)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#16)(2008-12#5)(2008-7#1)(2008-8#2)(2009-2#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
skilled and##6##2##(1992-12#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
skilled attendance at delivery##2##4##(2011-1#2)
skilled attendance##4##2##(2010-12#1)(2011-1#3)
skilled birth attendance##2##3##(2010-12#1)(2011-1#1)
skilled nursing facilities##4##3##(1991-2#1)(1992-2#1)(2012-12#1)(2012-3#1)
skilled nursing facility (SNF)##3##4##(1994-12#1)(1994-2#1)(1995-3#1)
skilled nursing facility benefit##2##4##(1992-1#1)(1994-2#1)
skilled nursing facility services##3##4##(1991-1#1)(1992-1#2)
skilled nursing facility##10##3##(1991-1#2)(1992-1#3)(1994-12#1)(1994-2#2)(1995-3#2)
skilled nursing##16##2##(1991-1#2)(1991-2#1)(1992-1#3)(1992-2#1)(1994-12#2)(1994-2#3)(1995-3#2)(2012-12#1)(2012-3#1)
skilled reaching##2##2##(1992-10#1)(1994-3#1)
skilled use of##2##3##(2007-10#1)(2008-12#1)
skilled##49##1##(1990-10#1)(1991-1#2)(1991-2#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-3#2)(1995-5#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#2)(2011-1#6)(2012-12#1)(2012-2#1)(2012-3#1)
skillful##4##1##(1991-2#1)(1994-6#1)(1997-1#1)(2007-12#1)
skills acquisition##3##2##(2008-11#2)(2011-2#1)
skills and abilities##2##3##(1993-1#1)(2008-12#1)
skills and attitudes##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
skills and confidence##2##3##(2008-11#1)(2008-12#1)
skills and knowledge of##2##4##(2008-10#1)(2011-2#1)
skills and knowledge##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
skills and the##5##3##(1992-3#1)(1993-2#1)(1995-6#1)(2008-11#1)(2011-2#1)
skills and##59##2##(1992-11#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#13)(2008-12#6)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
skills are the##2##3##(2008-11#1)(2012-3#1)
skills are##12##2##(1993-12#1)(1996-1#1)(2008-11#2)(2008-12#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
skills as a##2##3##(2008-11#1)(2009-10#1)
skills as##7##2##(1992-12#1)(1995-12#1)(1995-3#1)(2008-11#3)(2009-10#1)
skills at##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
skills by##3##2##(2008-11#2)(2008-12#1)
skills course##2##2##(2008-11#1)(2013-1#1)
skills explained##2##2##(2009-5#2)
skills for people who will##2##5##(1994-1#2)
skills for##13##2##(1990-12#1)(1992-1#1)(1992-12#1)(1994-1#2)(1997-3#1)(2008-1#1)(2008-12#4)(2011-2#1)(2012-12#1)
skills from##3##2##(1992-6#1)(1996-3#1)(2013-1#1)
skills have been##2##3##(1997-3#1)(2012-3#1)
skills have##3##2##(1997-3#1)(2012-2#1)(2012-3#1)
skills in caring for##2##4##(2007-10#1)(2013-8#1)
skills in standard and non-standard entry diploma students##2##8##(2008-11#2)
skills in the##6##3##(1994-8#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-2#1)(2011-2#1)
skills in their##2##3##(2008-11#1)(2012-12#1)
skills in##44##2##(1993-12#2)(1994-8#1)(1995-1#2)(1995-3#1)(1996-2#1)(1997-3#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#11)(2008-12#5)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
skills into##2##2##(2008-11#1)(2008-12#1)
skills is##3##2##(1995-5#1)(2007-8#1)(2008-11#1)
skills may be##3##3##(1992-6#1)(2008-11#1)(2010-5#1)
skills may##4##2##(1992-6#1)(2008-11#1)(2010-5#1)(2011-2#1)
skills necessary to##3##3##(1993-2#1)(2008-1#1)(2008-5#1)
skills needed for##3##3##(1993-12#1)(2008-12#1)(2012-3#1)
skills needed to##2##3##(2010-5#1)(2012-12#1)
skills needed##6##2##(1993-12#1)(1995-2#1)(2008-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
skills of a##3##3##(2008-6#1)(2008-9#2)
skills of children with cochlear implants##2##6##(2008-9#2)
skills of the##3##3##(2008-11#1)(2009-8#1)(2010-11#1)
skills of##33##2##(1991-12#1)(1992-3#1)(1994-2#1)(1996-3#2)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#7)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
skills on##2##2##(2008-4#1)(2010-3#1)
skills remained within##2##3##(1997-5#1)(2008-6#1)
skills required for##3##3##(1991-1#1)(2008-11#1)(2009-12#1)
skills should be##2##3##(1992-6#1)(2008-10#1)
skills that##7##2##(1992-2#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-11#2)
skills to a##2##3##(2008-11#2)
skills to provide##2##3##(2008-11#1)(2011-1#1)
skills to##21##2##(1990-11#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
skills training to##2##3##(2008-11#1)(2013-1#1)
skills training##6##2##(1996-2#1)(2008-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
skills was##4##2##(1994-3#1)(1995-6#1)(2009-10#1)(2012-2#1)
skills were##6##2##(2008-11#1)(2008-12#3)(2008-6#1)(2008-9#1)
skills which##2##2##(1994-2#1)(2012-2#1)
skills with##2##2##(2009-9#1)(2012-1#1)
skills##454##1##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#2)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#4)(1992-6#4)(1993-1#5)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#3)(1994-12#6)(1994-2#8)(1994-3#5)(1994-8#1)(1995-1#8)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#7)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#9)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#1)(2007-10#3)(2007-12#12)(2007-3#1)(2007-8#5)(2008-1#8)(2008-10#4)(2008-11#80)(2008-12#43)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-9#19)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#4)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#15)(2012-1#5)(2012-12#11)(2012-2#11)(2012-3#24)(2013-1#13)(2013-8#7)
skills-based##5##1##(1997-7#1)(2008-11#1)(2008-6#2)(2012-2#1)
skills?##4##1##(1992-2#1)(2007-12#1)(2008-11#1)(2009-11#1)
skills]##2##1##(1992-6#1)(2009-5#1)
skim milk##9##2##(1991-9#1)(2008-10#1)(2010-2#6)(2013-1#1)
skim##11##1##(1991-9#1)(2008-10#1)(2010-2#6)(2013-1#3)
skimmed##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
skimmer interface and ion attachment mass spectrometry##2##7##(2008-10#2)
skimmer interface and##3##3##(2008-10#3)
skimmer interface##6##2##(2008-10#6)
skimmer##8##1##(2008-10#8)
skimming##3##1##(1994-3#1)(2013-1#2)
skimping##2##1##(1993-1#2)
skin -##3##2##(2008-5#1)(2012-3#2)
skin abscesses in##2##3##(2012-2#2)
skin abscesses##3##2##(2012-2#3)
skin according to##2##3##(2008-5#2)
skin after##4##2##(2008-5#3)(2012-3#1)
skin against##4##2##(2008-5#3)(2009-6#1)
skin ageing##10##2##(2008-5#10)
skin aging##16##2##(2008-5#12)(2009-9#2)(2011-2#2)
skin ailments##2##2##(2008-4#1)(2008-5#1)
skin and a##4##3##(2008-5#2)(2010-8#1)(2013-8#1)
skin and hair##2##3##(2008-5#1)(2008-9#1)
skin and lung##2##3##(2008-10#1)(2013-1#1)
skin and measuring##2##3##(2008-5#2)
skin and mucous membranes##2##4##(2010-1#1)(2012-12#1)
skin and muscle##2##3##(1992-9#2)
skin and on##2##3##(2008-3#1)(2008-5#1)
skin and peripheral blood##3##4##(2012-2#3)
skin and soft tissue infections in##2##6##(2008-10#1)(2009-4#1)
skin and soft tissue infections##3##5##(2007-12#1)(2008-10#1)(2009-4#1)
skin and subcutaneous##2##3##(2013-1#1)(2013-8#1)
skin and the##10##3##(1991-8#1)(2008-10#1)(2008-5#6)(2011-3#2)
skin and underlying##2##3##(2008-2#1)(2009-4#1)
skin and veins##3##3##(1995-12#3)
skin and##96##2##(1990-3#2)(1991-11#1)(1991-8#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-3#1)(1995-12#5)(1995-8#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#35)(2008-6#1)(2008-9#3)(2009-4#2)(2010-1#1)(2010-3#1)(2010-8#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
skin appendages##2##2##(1990-12#1)(2010-5#1)
skin are##9##2##(1992-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#5)
skin areas##4##2##(1995-5#1)(1996-6#1)(2008-5#1)(2010-8#1)
skin as a##2##3##(1993-3#1)(2008-5#1)
skin as well as##2##4##(2008-10#1)(2012-2#1)
skin as##5##2##(1993-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)
skin at the##6##3##(1992-6#1)(2008-9#5)
skin at##7##2##(1992-6#1)(2008-3#1)(2008-9#5)
skin barrier function##4##3##(2008-5#4)
skin barrier##10##2##(2008-5#10)
skin before and after##3##4##(2007-11#1)(2008-10#2)
skin biology##2##2##(2008-5#2)
skin biopsies##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)
skin biopsy##8##2##(1992-2#1)(1992-5#1)(2007-7#1)(2007-9#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
skin blood flow##2##3##(1992-3#1)(2007-12#1)
skin blood##3##2##(1992-3#1)(2007-12#1)(2008-5#1)
skin but##7##2##(1991-6#1)(1992-6#1)(2008-5#2)(2010-8#1)(2012-2#1)(2012-3#1)
skin by##9##2##(1994-9#1)(1995-9#1)(2008-10#1)(2008-5#3)(2009-6#1)(2011-2#1)(2013-1#1)
skin can##4##2##(1995-11#1)(2008-5#1)(2008-9#1)(2009-5#1)
skin cancer and##2##3##(1994-5#1)(2012-3#1)
skin cancer has been##2##4##(2007-12#1)(2008-8#1)
skin cancer is##4##3##(2007-12#2)(2011-2#2)
skin cancer##32##2##(1991-11#1)(1991-6#3)(1994-5#1)(2007-12#11)(2008-4#2)(2008-8#2)(2010-6#1)(2010-8#2)(2011-2#4)(2012-3#4)(2013-1#1)
skin cancers in##2##3##(2010-8#1)(2012-3#1)
skin cancers##15##2##(2007-12#3)(2008-4#1)(2008-5#1)(2010-8#3)(2011-2#2)(2011-3#1)(2012-3#3)(2013-1#1)
skin carcinogenesis in##2##3##(1990-11#1)(1993-9#1)
skin carcinogenesis##5##2##(1990-11#1)(1993-9#2)(1994-6#2)
skin care formulation##2##3##(2008-5#2)
skin care product##2##3##(2008-5#2)
skin care##14##2##(2006-5#1)(2008-5#12)(2013-8#1)
skin cells##11##2##(2008-4#1)(2008-5#6)(2008-9#1)(2012-3#3)
skin changes##3##2##(2007-8#1)(2010-6#1)(2011-2#1)
skin characteristics##2##2##(2008-5#2)
skin chronic##2##2##(2012-3#2)
skin color##4##2##(2008-5#3)(2008-6#1)
skin coloration##3##2##(2008-5#1)(2008-6#2)
skin colors##2##2##(1995-6#1)(2008-5#1)
skin colour##7##2##(1991-6#1)(2008-5#6)
skin compared with##2##3##(2008-5#2)
skin compatibility of##4##3##(2008-10#1)(2008-5#3)
skin compatibility##7##2##(2008-10#2)(2008-5#5)
skin condition##8##2##(2007-7#1)(2008-12#1)(2008-5#5)(2011-2#1)
skin conductance level##2##3##(2008-7#2)
skin conductance##3##2##(2008-7#3)
skin cream##2##2##(2008-5#2)
skin damage caused by##2##4##(2008-5#1)(2011-2#1)
skin damage##7##2##(1995-11#1)(2008-5#4)(2009-9#1)(2011-2#1)
skin defects##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
skin delivery##2##2##(2008-5#1)(2012-2#1)
skin depth##2##2##(2008-2#1)(2008-3#1)
skin disease##12##2##(1995-1#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
skin diseases##10##2##(1991-6#1)(1995-11#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)
skin disorder##5##2##(2008-10#1)(2008-5#3)(2013-7#1)
skin disorders in##2##3##(2011-2#2)
skin disorders##10##2##(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2011-2#3)
skin doses##2##2##(2007-10#2)
skin dryness##4##2##(2008-5#4)
skin due to##2##3##(2008-6#1)(2008-7#1)
skin effects##4##2##(2008-10#1)(2008-5#3)
skin elasticity is##2##3##(2008-5#2)
skin elasticity##5##2##(2008-5#5)
skin electron##2##2##(1993-9#1)(1995-9#1)
skin equivalent model##6##3##(2008-5#6)
skin equivalent##8##2##(2008-5#8)
skin equivalents##3##2##(2008-5#3)
skin eruption##4##2##(2007-12#1)(2008-8#1)(2012-3#1)(2013-7#1)
skin erythema##2##2##(2008-5#1)(2012-1#1)
skin erythemal response##2##3##(2008-5#2)
skin exposure to##2##3##(2008-5#2)
skin fibroblast and##2##3##(1995-3#1)(2012-3#1)
skin fibroblast cells##2##3##(2008-11#1)(2008-9#1)
skin fibroblast##7##2##(1990-3#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-9#2)(2012-3#1)
skin fibroblasts and the##2##4##(2008-5#2)
skin fibroblasts and##9##3##(1991-12#1)(1993-12#1)(1994-6#1)(1995-3#1)(2008-5#3)(2008-8#1)(2009-8#1)
skin fibroblasts from##6##3##(1990-3#1)(1991-5#1)(1993-3#1)(1995-8#1)(1996-7#2)
skin fibroblasts in culture##2##4##(1993-9#1)(1994-6#1)
skin fibroblasts##45##2##(1990-3#3)(1991-12#2)(1991-5#3)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-6#4)(1995-3#1)(1995-8#1)(1996-7#2)(2008-11#1)(2008-2#2)(2008-5#14)(2008-7#2)(2008-8#3)(2009-8#1)
skin flap in##2##3##(2008-9#1)(2013-8#1)
skin flap##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
skin flaps##2##2##(2008-9#1)(2009-5#1)
skin flora##2##2##(1994-11#1)(2007-7#1)
skin fold thickness (r = -0##2##6##(2012-2#2)
skin fold thickness##3##3##(2012-2#3)
skin folds##2##2##(2008-5#1)(2009-5#1)
skin following##2##2##(1992-2#1)(2008-10#1)
skin for##3##2##(2008-5#3)
skin from the##2##3##(2008-10#1)(2008-5#1)
skin from##6##2##(2008-10#1)(2008-3#1)(2008-5#3)(2011-2#1)
skin function##3##2##(2008-5#2)(2008-9#1)
skin graft##11##2##(2008-9#4)(2009-1#1)(2009-6#1)(2012-3#2)(2013-1#2)(2013-8#1)
skin grafting##5##2##(2007-12#1)(2008-9#1)(2013-8#3)
skin grafts##9##2##(2007-12#1)(2007-8#1)(2009-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
skin has an##2##3##(2008-5#1)(2009-4#1)
skin has been##3##3##(2008-5#3)
skin has##5##2##(2008-5#4)(2009-4#1)
skin have##2##2##(2008-5#2)
skin health##2##2##(2008-5#1)(2012-3#1)
skin homeostasis##2##2##(2008-5#1)(2008-9#1)
skin hydration and##5##3##(2008-5#5)
skin hydration state##2##3##(2008-5#2)
skin hydration##21##2##(2008-10#1)(2008-5#18)(2010-8#2)
skin impedance at##2##3##(2008-10#2)
skin impedance##6##2##(2008-10#6)
skin improvement##5##2##(2008-5#5)
skin in terms of##2##4##(2008-5#2)
skin in the##4##3##(1996-12#1)(2008-5#3)
skin in vivo##8##3##(1990-11#1)(2008-3#1)(2008-5#5)(2012-3#1)
skin in##24##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-8#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#14)(2011-3#1)(2012-3#1)
skin incision##3##2##(1991-12#1)(2007-8#1)(2008-10#1)
skin incisions##3##2##(2007-8#2)(2008-9#1)
skin infection were##2##3##(1992-2#1)(2008-12#1)
skin infection##10##2##(1991-3#1)(1992-2#1)(1997-3#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#2)
skin infections##3##2##(1991-6#1)(2008-5#1)(2011-2#1)
skin inflammation##2##2##(2008-10#1)(2008-5#1)
skin injury##2##2##(2008-5#1)(2010-8#1)
skin involvement##2##2##(2006-10#1)(2013-1#1)
skin irritation##9##2##(2008-10#3)(2008-5#5)(2009-6#1)
skin is a##4##3##(2008-5#2)(2008-9#1)(2011-2#1)
skin is described##2##3##(2008-3#2)
skin is the##2##3##(2008-5#2)
skin is##31##2##(1994-5#1)(2008-3#2)(2008-5#20)(2008-9#2)(2009-6#1)(2011-2#3)(2013-1#1)(2013-8#1)
skin keratinocytes##3##2##(1997-4#2)(2008-7#1)
skin layers##8##2##(2008-10#1)(2008-11#5)(2008-5#2)
skin lesion##7##2##(2007-10#2)(2008-9#1)(2011-2#3)(2013-8#1)
skin lesions and##2##3##(2007-7#1)(2013-8#1)
skin lesions are##2##3##(1997-8#1)(2012-3#1)
skin lesions at the site of application##4##7##(2008-9#4)
skin lesions at the site of##5##6##(1992-6#1)(2008-9#4)
skin lesions in##3##3##(2011-2#2)(2012-3#1)
skin lesions##43##2##(1990-3#3)(1990-6#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-6#1)(1996-12#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-9#5)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#2)
skin lightening##2##2##(2008-5#2)
skin lipids##4##2##(2008-5#4)
skin loss##2##2##(2007-8#1)(2013-8#1)
skin lotion##6##2##(2008-5#6)
skin markers can be##2##4##(2013-1#2)
skin markers for##2##3##(2011-2#1)(2013-1#1)
skin markers##6##2##(2011-2#1)(2013-1#5)
skin may##2##2##(2008-5#1)(2012-2#1)
skin measurements##2##2##(2007-12#2)
skin melanoma in##3##3##(1994-12#1)(1994-8#1)(2011-2#1)
skin microflora##4##2##(2008-5#1)(2012-3#3)
skin microrelief##3##2##(2008-5#3)
skin model##13##2##(2008-5#6)(2008-6#2)(2011-1#1)(2012-2#1)(2012-3#3)
skin moisture and##2##3##(2008-5#2)
skin moisture##3##2##(2008-5#3)
skin moisturisation##4##2##(2008-5#4)
skin moisturization##3##2##(2008-5#3)
skin moisturizing##2##2##(2008-5#2)
skin necrosis and sloughing##3##4##(1991-8#3)
skin necrosis##6##2##(1990-8#1)(1991-8#3)(2008-9#1)(2009-1#1)
skin nodules##2##2##(1997-6#2)
skin of an operator##2##4##(2008-5#2)
skin of colour##4##3##(2008-5#4)
skin of the##9##3##(1990-6#1)(1994-5#1)(2008-12#1)(2008-5#4)(2008-7#1)(2011-2#1)
skin of##39##2##(1990-6#1)(1990-7#2)(1992-2#1)(1992-3#1)(1992-8#2)(1993-3#1)(1994-11#2)(1994-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#14)(2008-6#1)(2008-7#2)(2008-9#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
skin often##2##2##(2008-5#1)(2012-12#1)
skin on the##2##3##(1995-11#1)(2008-5#1)
skin or##12##2##(1992-6#1)(1993-11#1)(1995-3#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#4)
skin over time##2##3##(2008-10#1)(2008-5#1)
skin over##3##2##(2008-10#1)(2008-5#2)
skin overlying##3##2##(2008-3#2)(2010-11#1)
skin pH##3##2##(2008-5#3)
skin papules##2##2##(2013-8#2)
skin parameters##4##2##(2008-5#4)
skin penetration and##2##3##(2008-3#1)(2008-5#1)
skin penetration of the##2##4##(2008-3#1)(2008-5#1)
skin penetration of##3##3##(2008-3#2)(2008-5#1)
skin penetration##8##2##(2008-3#3)(2008-5#4)(2013-1#1)
skin permeation##4##2##(2008-5#4)
skin photoprotection##2##2##(2008-5#2)
skin photoreceptors##2##2##(1993-3#2)
skin phototype##2##2##(2008-5#2)
skin physiology##5##2##(2008-5#4)(2009-8#1)
skin pigmentation##9##2##(1997-3#1)(2008-5#4)(2008-9#2)(2009-5#2)
skin preparation##2##2##(2007-12#1)(2007-7#1)
skin prick test (SPT)##2##4##(2008-10#1)(2012-3#1)
skin prick testing##4##3##(1996-8#1)(2007-2#1)(2012-12#1)(2013-1#1)
skin prick tests##3##3##(1992-9#1)(2008-10#1)(2012-3#1)
skin prick##10##2##(1992-9#1)(1996-8#1)(1997-6#1)(2007-2#1)(2008-10#2)(2012-12#1)(2012-3#2)(2013-1#1)
skin problems##4##2##(1994-11#1)(2007-7#1)(2008-5#1)(2009-12#1)
skin properties##2##2##(2008-5#2)
skin protection##3##2##(2008-5#2)(2009-6#1)
skin rash##9##2##(1997-8#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
skin reaction was##2##3##(1992-12#1)(2008-5#1)
skin reaction##7##2##(1992-12#1)(1994-1#1)(2008-5#4)(2013-1#1)
skin reactions##6##2##(1992-8#1)(1996-11#1)(2007-2#1)(2007-7#1)(2008-7#1)(2010-8#1)
skin recurrences##2##2##(1991-12#2)
skin response to##2##3##(2008-5#2)
skin response##5##2##(2008-5#3)(2012-3#2)
skin samples were##2##3##(2008-5#2)
skin samples##4##2##(2008-5#3)(2011-2#1)
skin scaliness##2##2##(2008-5#2)
skin sections##2##2##(2012-3#2)
skin segmentation##2##2##(2008-6#2)
skin self-examination##2##2##(2013-1#2)
skin sensitivity##3##2##(2008-5#3)
skin sensitization##5##2##(1997-2#1)(2008-10#1)(2008-5#3)
skin sensitizing potency of##4##4##(2008-5#4)
skin sensitizing potency##5##3##(2008-5#5)
skin sites##3##2##(2008-5#3)
skin smoothness##3##2##(2008-5#3)
skin specimens##2##2##(2008-5#1)(2012-1#1)
skin squamous cell carcinomas##2##4##(1994-6#2)
skin structure and##4##3##(2008-5#2)(2010-8#1)(2011-2#1)
skin surface cellular morphology##2##4##(2008-5#2)
skin surface is##2##3##(2008-5#2)
skin surface pH and##2##4##(2008-5#2)
skin surface pH are##3##4##(2008-5#3)
skin surface pH is on average##3##6##(2008-5#3)
skin surface pH##16##3##(2008-5#16)
skin surface##58##2##(2008-10#1)(2008-3#1)(2008-5#55)(2010-8#1)
skin temperature##4##2##(1990-6#1)(2008-3#1)(2008-5#2)
skin test and##3##3##(2008-5#1)(2008-7#2)
skin test was positive##2##4##(1997-4#1)(2007-7#1)
skin test was##3##3##(1997-4#1)(2007-7#1)(2013-1#1)
skin test##14##2##(1990-6#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#4)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
skin testing##4##2##(1996-3#2)(2007-2#1)(2013-1#1)
skin tests##8##2##(1990-3#1)(1991-11#1)(1991-4#1)(1996-11#1)(2007-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
skin that##5##2##(2008-5#2)(2011-2#1)(2012-12#1)(2012-3#1)
skin thickness##2##2##(2008-5#2)
skin tissue phantom##2##3##(2008-3#2)
skin tissue##15##2##(1992-9#1)(1995-11#1)(2007-8#1)(2008-3#6)(2008-6#2)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
skin tissues##3##2##(1992-9#1)(2008-5#2)
skin to UV##2##3##(2008-5#2)
skin to the##2##3##(2008-3#1)(2008-5#1)
skin to##15##2##(2008-11#1)(2008-3#1)(2008-5#10)(2010-8#1)(2011-2#1)(2012-3#1)
skin tone bias##2##3##(2008-11#2)
skin tone##5##2##(2008-11#5)
skin toxicity##2##2##(2008-5#1)(2008-8#1)
skin treated with##2##3##(1992-8#1)(2008-5#1)
skin tumor promotion##3##3##(1992-8#2)(1993-8#1)
skin tumor##5##2##(1992-8#2)(1993-3#1)(1993-8#1)(2008-10#1)
skin tumorigenesis##2##2##(1992-2#1)(1992-8#1)
skin tumors##4##2##(1991-6#1)(1992-8#1)(2008-7#1)(2011-2#1)
skin tumour##4##2##(1992-2#1)(2008-5#2)(2013-1#1)
skin tumours##5##2##(1992-2#1)(1997-4#1)(1997-6#1)(2008-8#1)(2011-2#1)
skin type##11##2##(2008-4#1)(2008-5#7)(2010-8#2)(2011-2#1)
skin types##14##2##(2008-5#12)(2010-8#1)(2011-2#1)
skin using##6##2##(2008-5#4)(2008-6#1)(2012-2#1)
skin was analyzed##2##3##(2008-5#1)(2012-3#1)
skin was investigated##2##3##(2008-10#1)(2008-11#1)
skin was observed##2##3##(2008-5#1)(2011-3#1)
skin was##18##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#10)(2011-3#2)(2012-3#1)(2012-8#1)(2013-1#1)
skin water##2##2##(2008-3#1)(2008-5#1)
skin were##9##2##(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#2)
skin which##2##2##(2008-5#1)(2008-9#1)
skin whitening agents##2##3##(2008-5#2)
skin whitening##6##2##(2008-5#6)
skin with pH values##2##4##(2008-5#2)
skin with##12##2##(1992-8#2)(2007-12#1)(2008-5#7)(2008-9#1)(2012-2#1)
skin wrinkling and sagging##2##4##(2008-5#1)(2010-8#1)
skin wrinkling##3##2##(2008-5#2)(2010-8#1)
skin##1797##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#11)(1990-6#5)(1990-7#4)(1990-8#4)(1990-9#1)(1991-11#4)(1991-12#7)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#4)(1991-6#15)(1991-8#6)(1992-12#1)(1992-2#12)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#11)(1992-8#16)(1992-9#8)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#9)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#5)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#9)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#8)(1995-12#7)(1995-3#8)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#9)(1996-7#2)(1996-8#1)(1997-2#3)(1997-3#10)(1997-4#5)(1997-5#1)(1997-6#8)(1997-7#2)(1997-8#6)(2006-10#4)(2006-5#1)(2007-10#9)(2007-11#6)(2007-12#34)(2007-2#8)(2007-7#13)(2007-8#12)(2007-9#1)(2008-1#2)(2008-10#60)(2008-11#25)(2008-12#11)(2008-2#6)(2008-3#36)(2008-4#12)(2008-5#830)(2008-6#20)(2008-7#23)(2008-8#13)(2008-9#57)(2009-1#4)(2009-11#3)(2009-12#1)(2009-4#3)(2009-5#8)(2009-6#7)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#11)(2010-7#3)(2010-8#28)(2010-9#1)(2011-1#4)(2011-2#72)(2011-3#10)(2012-1#5)(2012-12#7)(2012-2#32)(2012-3#59)(2012-8#1)(2013-1#37)(2013-7#3)(2013-8#26)
skin&quot##3##1##(2008-10#1)(2008-5#1)(2010-5#1)
skin)##7##1##(1993-3#1)(2008-5#3)(2008-9#1)(2009-5#1)(2011-1#1)
skin-associated##2##1##(2008-10#1)(2012-2#1)
skin-care##2##1##(2008-5#2)
skin-contact thermometer##2##2##(2010-5#2)
skin-lightening##3##1##(2008-5#3)
skin-resident bacteria##2##2##(2008-5#2)
skin-whitening##3##1##(2008-5#3)
skinfold measurements##2##2##(1997-7#1)(2009-11#1)
skinks##2##1##(2010-3#2)
skinned##2##1##(1991-12#1)(1995-2#1)
skinning##4##1##(1997-5#3)(2008-4#1)
skins and##2##2##(1997-4#1)(2010-8#1)
skins of##2##2##(2008-10#1)(2011-3#1)
skins##7##1##(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-3#1)
skip##2##1##(2007-12#1)(2010-8#1)
skipped##2##1##(1993-8#2)
skipping the##3##2##(1993-6#1)(1993-8#2)
skipping##7##1##(1993-6#2)(1993-8#4)(2011-2#1)
skull and##8##2##(1994-3#1)(1995-6#1)(2007-11#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-2#1)
skull base are##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
skull base fracture##2##3##(2008-9#1)(2011-2#1)
skull base in##3##3##(2008-1#2)(2011-2#1)
skull base lesions##4##3##(2006-12#2)(2011-2#1)(2013-1#1)
skull base malignancies##2##3##(2011-2#2)
skull base model##3##3##(2011-2#3)
skull base surgery##9##3##(2011-2#8)(2012-3#1)
skull base tumors##2##3##(2011-2#1)(2012-3#1)
skull base##57##2##(2006-12#12)(2007-12#1)(2008-1#4)(2008-7#4)(2008-9#1)(2011-2#30)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
skull fracture##6##2##(1992-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#2)
skull in##3##2##(1995-6#2)(2012-12#1)
skull was##2##2##(1995-6#2)
skull##116##1##(1991-3#1)(1992-6#2)(1994-2#1)(1994-3#2)(1995-6#9)(2006-12#14)(2007-11#3)(2007-12#1)(2008-1#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#3)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#34)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)
skull-base surgery##4##2##(2008-9#1)(2012-1#3)
skull-base##6##1##(2008-9#1)(2011-2#1)(2012-1#4)
skull-image superimposition##2##2##(1995-6#2)
skulls##7##1##(1995-6#1)(1995-9#1)(2006-12#1)(2011-2#1)(2013-1#3)
sky conditions##2##2##(2007-12#1)(2008-3#1)
sky optical phenomena##3##3##(2008-2#3)
sky radiance over##2##3##(2008-2#2)
sky radiance##9##2##(2008-2#6)(2008-3#3)
sky##43##1##(1993-3#1)(2007-12#4)(2008-2#22)(2008-3#15)(2012-2#1)
skylight in##2##2##(2008-3#2)
skylight polarization is##2##3##(2008-2#2)
skylight polarization##7##2##(2008-2#7)
skylight##19##1##(2008-2#11)(2008-3#8)
skyrocketing##2##1##(1996-12#1)(2010-7#1)
sl##2##1##(1994-12#1)(2008-5#1)
slab PC##2##2##(2007-11#2)
slab Ti##2##2##(2008-3#2)
slab and##3##2##(2008-2#1)(2008-3#2)
slab gel##4##2##(2008-2#2)(2008-4#2)
slab is##8##2##(1995-6#2)(2008-3#6)
slab laser##4##2##(2007-11#1)(2008-3#3)
slab lasers##3##2##(2007-11#2)(2008-2#1)
slab of##2##2##(2008-3#1)(2009-5#1)
slab optical waveguide (SOWG)##3##4##(2008-10#3)
slab optical waveguide spectroscopy##2##4##(2008-10#2)
slab optical waveguide##6##3##(2008-10#6)
slab structure##2##2##(2007-11#1)(2008-2#1)
slab waveguide##7##2##(2007-11#3)(2007-12#4)
slab waveguides are##2##3##(2007-11#2)
slab waveguides##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
slab with##4##2##(2008-3#4)
slab##86##1##(1992-3#1)(1995-6#4)(2007-11#17)(2007-12#9)(2008-10#6)(2008-2#11)(2008-3#33)(2008-4#3)(2009-5#1)(2013-8#1)
slab)##2##1##(2007-11#1)(2008-2#1)
slabs of##2##2##(1997-7#1)(2008-3#1)
slabs##14##1##(1997-7#1)(2007-11#3)(2008-10#2)(2008-2#4)(2008-3#4)
slag filters##3##2##(2013-1#3)
slag samples##3##2##(2008-10#3)
slag##15##1##(2008-10#11)(2013-1#4)
slags##2##1##(2008-10#1)(2013-1#1)
slalom chromatography##4##2##(2008-10#4)
slant##3##1##(1993-6#1)(2008-2#2)
slanted volume holographic gratings##2##4##(2008-3#2)
slanted##4##1##(2008-3#3)(2011-1#1)
slash and burn##2##3##(2010-7#2)
slash and loblolly pine##2##4##(2008-10#2)
slash and loblolly##3##3##(2008-10#3)
slash and##5##2##(2008-10#3)(2010-7#2)
slash##8##1##(2008-10#6)(2010-7#2)
slaughter and##2##2##(1990-3#1)(2007-6#1)
slaughter line##2##2##(1997-4#1)(1997-5#1)
slaughter##20##1##(1990-3#3)(1993-2#2)(1994-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-6#1)(2008-12#1)(2008-5#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-3#1)
slaughtered at##8##2##(1994-7#1)(1996-12#1)(2010-4#3)(2011-1#1)(2012-2#1)(2013-1#1)
slaughtered in##2##2##(1994-7#1)(2011-2#1)
slaughtered pigs in##2##3##(2011-2#2)
slaughtered pigs##3##2##(1991-8#1)(2011-2#2)
slaughtered##23##1##(1991-8#1)(1994-7#2)(1996-12#2)(1997-5#1)(2008-12#3)(2008-9#1)(2010-2#1)(2010-4#4)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#1)
slaughterhouse##6##1##(1994-7#1)(2008-12#2)(2010-4#1)(2013-1#2)
slave laser##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
slave model of autobiographical memory##2##5##(2008-2#2)
slave##8##1##(1991-3#1)(2007-11#1)(2008-2#3)(2008-3#3)
sledge##2##1##(2008-4#1)(2008-5#1)
sleep EEG##5##2##(2009-8#3)(2010-8#2)
sleep after##2##2##(1995-12#1)(2012-12#1)
sleep and health##2##3##(2011-2#1)(2012-1#1)
sleep and its##2##3##(2008-7#1)(2009-8#1)
sleep and obesity##2##3##(2013-1#2)
sleep and sleep##2##3##(1994-8#1)(2007-8#1)
sleep and##29##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-7#2)(2007-8#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
sleep apnea (OSA) and##2##4##(2009-9#1)(2010-5#1)
sleep apnea (OSA)##3##3##(2009-9#1)(2010-5#1)(2012-2#1)
sleep apnea##28##2##(1992-5#1)(2007-12#10)(2007-2#2)(2009-4#1)(2009-9#2)(2010-5#5)(2012-2#3)(2013-1#1)(2013-7#3)
sleep apnoea syndrome##3##3##(2010-6#2)(2012-2#1)
sleep apnoea##7##2##(1992-11#1)(1997-8#1)(2008-7#1)(2008-9#1)(2010-6#2)(2012-2#1)
sleep are##2##2##(2007-6#1)(2009-8#1)
sleep at##2##2##(1990-5#1)(2010-7#1)
sleep deprivation##8##2##(1995-12#1)(1997-6#1)(2008-4#1)(2011-2#4)(2013-1#1)
sleep diaries##2##2##(2012-12#2)
sleep disorders are##2##3##(2007-10#1)(2013-7#1)
sleep disorders in##2##3##(2008-11#1)(2013-8#1)
sleep disorders##10##2##(1993-2#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-11#1)(2012-2#2)(2013-7#2)(2013-8#1)
sleep disorders]##2##2##(1997-6#2)
sleep disturbance##3##2##(1990-6#1)(2011-2#2)
sleep disturbances in##2##3##(2008-7#1)(2009-9#1)
sleep disturbances##7##2##(2008-7#3)(2009-7#1)(2009-9#1)(2012-3#2)
sleep duration and##3##3##(1996-7#2)(2009-7#1)
sleep duration was##2##3##(1996-7#1)(2011-2#1)
sleep duration##13##2##(1995-12#4)(1996-7#3)(2009-7#1)(2011-2#5)
sleep during##3##2##(1991-1#1)(2008-5#1)(2008-9#1)
sleep efficiency##3##2##(2011-2#1)(2012-3#2)
sleep fragmentation##2##2##(2010-5#1)(2012-3#1)
sleep in a##2##3##(2012-12#1)(2013-1#1)
sleep in the##4##3##(1992-8#1)(1994-8#1)(2008-11#1)(2011-1#1)
sleep in##8##2##(1992-8#1)(1993-12#1)(1994-8#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
sleep latency##3##2##(2007-6#2)(2011-2#1)
sleep loss##7##2##(1995-12#2)(2013-1#5)
sleep onset time##2##3##(1990-5#2)
sleep onset##6##2##(1990-5#3)(1990-7#1)(1996-7#1)(2010-7#1)
sleep parameters##2##2##(1996-7#1)(2012-12#1)
sleep patterns##2##2##(2008-7#1)(2009-8#1)
sleep position##3##2##(2008-9#1)(2011-1#2)
sleep problems##7##2##(1997-3#1)(2008-11#1)(2008-9#1)(2013-1#3)(2013-7#1)
sleep quality##5##2##(2009-11#1)(2009-3#3)(2013-7#1)
sleep spindles and##2##3##(2009-8#2)
sleep spindles##3##2##(2009-8#3)
sleep stage##2##2##(2009-8#2)
sleep stages##4##2##(1997-4#1)(2010-8#3)
sleep states##2##2##(2009-8#2)
sleep time##4##2##(1992-8#1)(1994-8#1)(2010-7#1)(2012-12#1)
sleep##299##1##(1990-5#6)(1990-6#1)(1990-7#8)(1991-1#1)(1991-5#4)(1991-9#4)(1992-11#2)(1992-5#1)(1992-8#4)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1994-3#1)(1994-8#10)(1995-12#10)(1996-7#10)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#6)(1997-8#1)(2007-10#1)(2007-12#14)(2007-2#2)(2007-6#3)(2007-8#4)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#9)(2009-11#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#17)(2009-9#4)(2010-12#1)(2010-5#6)(2010-6#4)(2010-7#8)(2010-8#7)(2011-1#4)(2011-10#1)(2011-2#18)(2012-1#2)(2012-12#11)(2012-2#14)(2012-3#10)(2013-1#21)(2013-7#8)(2013-8#8)
sleep/wake##2##1##(1997-6#1)(2008-6#1)
sleepiness and##4##2##(1991-5#1)(2010-7#3)
sleepiness##10##1##(1991-5#1)(2008-7#1)(2010-7#7)(2011-2#1)
sleeping and##3##2##(2007-11#1)(2012-2#2)
sleeping on##2##2##(2011-1#1)(2011-2#1)
sleeping position##9##2##(1992-11#4)(1992-4#4)(2008-1#1)
sleeping positions and other possible risk factors##2##7##(1992-11#2)
sleeping positions at the age of one##2##7##(1992-11#2)
sleeping positions##9##2##(1992-11#9)
sleeping prone##2##2##(1992-4#1)(2011-1#1)
sleeping sickness##4##2##(2010-1#4)
sleeping time##4##2##(1990-10#1)(1995-12#2)(2008-12#1)
sleeping##41##1##(1990-10#1)(1990-2#1)(1991-5#1)(1992-11#13)(1992-4#6)(1995-12#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-1#4)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#2)
sleeve gastrectomy##2##2##(2013-1#2)
sleeve##11##1##(1991-12#2)(2007-8#2)(2008-11#2)(2008-5#1)(2010-4#1)(2012-1#1)(2013-1#2)
slender##7##1##(1996-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-7#1)
slender&quot##2##1##(2007-12#1)(2009-8#1)
slept in##2##2##(1990-2#2)
slept##4##1##(1990-2#2)(1997-4#1)(2012-1#1)
slice of##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
slice preparation of the retina##2##5##(2008-8#2)
slice preparation##7##2##(1996-2#1)(2008-4#3)(2008-7#1)(2008-8#2)
slice preparations##3##2##(2008-4#2)(2008-7#1)
slice thickness##3##2##(1995-5#1)(1997-8#1)(2012-12#1)
slice was##3##2##(2008-6#1)(2008-8#1)(2013-1#1)
slice##43##1##(1994-8#1)(1995-11#2)(1995-5#2)(1995-8#1)(1996-2#5)(1996-7#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-6#2)(2008-7#5)(2008-8#4)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
sliced and##2##2##(2008-11#1)(2008-3#1)
sliced dry fermented sausage##2##4##(2013-1#2)
sliced dry fermented##3##3##(2013-1#3)
sliced inverse regression##3##3##(2012-3#3)
sliced##14##1##(1991-1#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-1#1)(2010-4#2)(2012-3#3)(2013-1#3)
slices after##3##2##(1990-7#1)(1995-11#1)(2008-2#1)
slices and the##2##3##(1992-3#1)(1995-5#1)
slices and##8##2##(1992-3#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
slices are##2##2##(2008-7#1)(2013-8#1)
slices as##2##2##(1994-11#1)(2008-7#1)
slices by##3##2##(1991-11#1)(1993-6#1)(1994-5#1)
slices containing##2##2##(1995-12#1)(2008-7#1)
slices during##2##2##(1993-12#1)(1996-5#1)
slices from the##2##3##(1995-12#2)
slices from##11##2##(1995-11#1)(1995-12#4)(1995-2#1)(1996-5#1)(2008-1#2)(2008-11#1)(2013-8#1)
slices in a##2##3##(1991-12#1)(1994-8#1)
slices in vitro##2##3##(1990-7#1)(1993-12#1)
slices in##6##2##(1990-7#1)(1991-12#1)(1993-12#2)(1994-8#1)(2010-8#1)
slices obtained from##2##3##(1995-12#2)
slices obtained##3##2##(1994-11#1)(1995-12#2)
slices of##9##2##(1995-12#5)(1996-5#2)(2008-3#1)(2013-8#1)
slices prepared from PND##2##4##(1996-5#2)
slices prepared from##3##3##(1996-5#3)
slices to##3##2##(1994-6#1)(2008-7#1)(2011-3#1)
slices was investigated##2##3##(1992-3#1)(1996-5#1)
slices was##7##2##(1992-3#1)(1994-5#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-2#1)
slices were##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
slices with##3##2##(1996-7#1)(1997-2#1)(2008-7#1)
slices without##2##2##(2007-12#1)(2008-10#1)
slices##133##1##(1990-12#2)(1990-7#5)(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#2)(1993-12#3)(1993-5#1)(1993-6#1)(1994-11#2)(1994-5#3)(1994-6#2)(1994-8#4)(1995-11#4)(1995-12#21)(1995-2#2)(1995-5#1)(1996-2#1)(1996-5#15)(1996-7#2)(1997-1#2)(1997-2#5)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#2)(2009-12#2)(2009-9#2)(2010-8#1)(2011-1#1)(2011-3#2)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#3)
slicing of a##2##3##(2007-12#1)(2012-2#1)
slicing##7##1##(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#2)
slide and##3##2##(2008-11#1)(2008-9#2)
slide glass##3##2##(1991-5#2)(2007-11#1)
slide glasses##2##2##(1991-5#1)(2008-12#1)
slide##34##1##(1990-12#1)(1991-5#3)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
slide-mounted##2##1##(1993-9#1)(2008-4#1)
slider##9##1##(2007-12#2)(2007-7#2)(2008-3#4)(2009-3#1)
slides for##2##2##(2008-4#1)(2008-9#1)
slides of made up##2##4##(2008-5#2)
slides was##2##2##(2008-10#2)
slides were##4##2##(2008-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
slides with##3##2##(2008-10#1)(2008-4#2)
slides##44##1##(1995-11#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#10)(2008-5#7)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
sliding and##2##2##(2009-7#1)(2010-11#1)
sliding of the##2##3##(1990-9#1)(2007-8#1)
sliding of##5##2##(1990-9#1)(1991-2#1)(1995-3#1)(2007-11#1)(2007-8#1)
sliding##24##1##(1990-9#1)(1991-2#2)(1993-9#1)(1995-2#2)(1995-3#1)(1996-4#4)(2007-11#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#3)
sliding-frequency##2##1##(2007-12#2)
slight and##2##2##(1990-2#1)(1996-2#1)
slight but significant##5##3##(1991-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
slight but##7##2##(1991-4#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
slight changes in##2##3##(2008-1#1)(2008-5#1)
slight decrease of the##2##4##(2008-10#1)(2008-7#1)
slight decrease##8##2##(1990-11#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
slight difference in##2##3##(2012-2#1)(2013-8#1)
slight difference##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
slight differences##3##2##(1991-2#1)(2008-10#1)(2008-5#1)
slight excess##2##2##(1996-3#1)(2008-10#1)
slight hemiparesis##2##2##(1991-6#1)(2008-7#1)
slight improvement in##2##3##(2007-11#1)(2008-10#1)
slight improvement##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
slight increase in##13##3##(1991-12#1)(1991-6#1)(1992-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-5#1)(2013-1#2)
slight increase##18##2##(1991-12#1)(1991-6#1)(1992-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)(2013-1#2)
slight interference##2##2##(2008-10#2)
slight loss##3##2##(1997-4#1)(2007-11#2)
slight or##3##2##(2008-10#2)(2008-7#1)
slight reduction in##2##3##(2008-10#1)(2008-9#1)
slight reduction##4##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-9#1)
slight trend##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
slight variations in##2##3##(2008-10#1)(2008-3#1)
slight##152##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#8)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#8)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#5)(2013-8#2)
slightly acidic##5##2##(2008-10#4)(2011-2#1)
slightly affected##2##2##(2008-10#1)(2008-3#1)
slightly asynchronous##2##2##(2008-5#1)(2008-7#1)
slightly below the##2##3##(1995-11#1)(2008-11#1)
slightly below##3##2##(1995-11#1)(2007-11#1)(2008-11#1)
slightly better for##2##3##(2008-10#1)(2008-11#1)
slightly better##9##2##(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)
slightly but significantly##4##3##(1991-6#1)(2007-8#1)(2008-10#2)
slightly but##7##2##(1990-7#1)(1991-6#1)(1993-6#1)(1995-12#1)(2007-8#1)(2008-10#2)
slightly decreased##5##2##(1995-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)
slightly degraded##2##2##(1990-5#1)(2008-2#1)
slightly different from##4##3##(1996-6#1)(2008-10#2)(2008-11#1)
slightly different##19##2##(1991-8#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2012-12#1)
slightly elevated in##3##3##(1990-2#1)(1990-9#1)(2012-12#1)
slightly elevated##6##2##(1990-2#1)(1990-9#1)(1991-2#1)(2008-10#1)(2010-3#1)(2012-12#1)
slightly enhanced##3##2##(1992-12#1)(1995-11#1)(2008-5#1)
slightly from the##2##3##(2008-10#1)(2008-3#1)
slightly from those##2##3##(2008-1#1)(2008-10#1)
slightly from##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
slightly greater in##2##3##(2009-4#1)(2009-9#1)
slightly greater than the##2##4##(1996-2#1)(2008-10#1)
slightly greater than##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
slightly greater##7##2##(1996-2#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#1)
slightly higher and##2##3##(1992-12#1)(1997-6#1)
slightly higher in the##5##4##(1992-9#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
slightly higher in##8##3##(1992-9#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
slightly higher than that of##2##5##(2010-8#1)(2013-1#1)
slightly higher than that##4##4##(1994-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
slightly higher than the##5##4##(1993-6#1)(1995-11#1)(1995-2#1)(1996-8#1)(2008-2#1)
slightly higher than those##5##4##(1994-8#1)(1995-3#1)(2008-10#2)(2008-6#1)
slightly higher than##19##3##(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-3#1)(2010-8#1)(2013-1#1)
slightly higher##51##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-6#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
slightly improved##7##2##(1991-8#1)(1995-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)
slightly in##6##2##(1995-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)
slightly increased in the##2##4##(2008-10#1)(2013-1#1)
slightly increased in##4##3##(1993-12#1)(2008-10#1)(2011-1#1)(2013-1#1)
slightly increased##15##2##(1990-11#1)(1992-11#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
slightly increases the##2##3##(1994-11#1)(2007-12#1)
slightly inhibited by##2##3##(1996-2#1)(2008-5#1)
slightly inhibited##7##2##(1992-9#1)(1993-9#1)(1995-11#1)(1996-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
slightly larger than##2##3##(2008-10#1)(2008-3#1)
slightly larger##7##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)
slightly less than 3##2##4##(2008-3#1)(2011-2#1)
slightly less than##4##3##(2008-3#3)(2011-2#1)
slightly less##13##2##(1994-2#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)
slightly longer##3##2##(1997-5#1)(2008-3#1)(2008-5#1)
slightly lower in##4##3##(1990-3#1)(1994-2#1)(1996-12#1)(2008-3#1)
slightly lower than that##4##4##(1992-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
slightly lower than those##2##4##(1995-5#1)(2008-10#1)
slightly lower than##9##3##(1992-6#1)(1995-5#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-8#1)
slightly lower##22##2##(1990-12#1)(1990-3#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)
slightly modified##5##2##(1993-11#1)(1994-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
slightly more common##2##3##(1991-11#1)(2008-10#1)
slightly more effective than##6##4##(1990-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
slightly more effective##8##3##(1990-12#1)(1993-12#1)(1994-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
slightly more than##2##3##(1992-5#1)(2009-7#1)
slightly more##28##2##(1990-12#2)(1990-7#1)(1991-11#1)(1992-11#1)(1992-5#2)(1993-12#1)(1994-3#1)(1995-11#1)(1995-5#2)(1996-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-5#1)(2013-1#1)
slightly nonspherical##2##2##(2007-11#1)(2008-2#1)
slightly older##3##2##(1991-11#1)(2008-10#1)(2010-3#1)
slightly on##2##2##(2008-3#2)
slightly or##2##2##(1996-7#1)(2008-10#1)
slightly over##3##2##(2007-12#1)(2007-8#1)(2008-2#1)
slightly reduced##10##2##(1995-2#1)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
slightly shifted##3##2##(2008-10#3)
slightly shorter##2##2##(1991-3#1)(2008-8#1)
slightly smaller than the##2##4##(2007-12#1)(2008-5#1)
slightly smaller than##4##3##(1992-3#1)(2007-12#1)(2008-5#1)(2012-3#1)
slightly smaller##5##2##(1992-2#1)(1992-3#1)(2007-12#1)(2008-5#1)(2012-3#1)
slightly soluble##2##2##(2008-10#2)
slightly stimulated##2##2##(2008-11#2)
slightly the##5##2##(1990-8#1)(1996-2#1)(2007-11#1)(2008-10#2)
slightly tilted##2##2##(2008-2#1)(2008-5#1)
slightly to##2##2##(1990-7#1)(2008-4#1)
slightly with##6##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
slightly##403##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#6)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#2)(2007-11#10)(2007-12#10)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#79)(2008-11#22)(2008-12#3)(2008-2#15)(2008-3#18)(2008-4#5)(2008-5#15)(2008-6#6)(2008-7#11)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#3)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#5)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#4)(2012-5#2)(2013-1#9)(2013-8#1)
slim##3##1##(1990-9#1)(2007-12#1)(2012-2#1)
slime molds##3##2##(1993-2#1)(2008-8#2)
slime production##2##2##(1991-3#2)
slime##13##1##(1991-3#3)(1993-2#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-8#2)(2012-2#3)
slime-producing##2##1##(1991-3#2)
slimming##3##1##(1990-4#1)(2008-5#2)
sling##3##1##(2007-10#1)(2007-8#2)
slingshot##3##1##(2008-1#3)
slip and##2##2##(1990-11#1)(1996-4#1)
slip of the##3##3##(2008-8#1)(2008-9#2)
slip on the##3##3##(1990-11#1)(1996-4#2)
slip on##4##2##(1990-11#1)(1996-4#3)
slip was##2##2##(2007-11#1)(2008-3#1)
slip weakening##2##2##(1996-4#2)
slip##36##1##(1990-11#2)(1996-4#23)(2007-11#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2012-2#1)
slipped capital femoral epiphysis##2##4##(2008-8#2)
slipped femoral##2##2##(2008-8#1)(2013-8#1)
slipped##5##1##(2008-8#3)(2011-1#1)(2013-8#1)
slipping##3##1##(1992-5#1)(2007-10#1)(2008-11#1)
slips##5##1##(1996-4#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
slit diaphragm##3##2##(2007-7#3)
slit function##2##2##(2008-3#2)
slit in##2##2##(2008-2#1)(2008-3#1)
slit lamp##2##2##(2008-9#1)(2013-1#1)
slit width##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
slit widths##2##2##(2008-3#2)
slit##43##1##(2007-11#2)(2007-12#4)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#17)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
slits##8##1##(1995-12#1)(2008-11#1)(2008-2#1)(2008-3#5)
slogans##2##1##(2008-9#2)
slope =##2##2##(2008-10#2)
slope analysis##2##2##(2008-10#2)
slope and intercept for##2##4##(2008-10#2)
slope and intercept were 0##2##5##(2008-10#2)
slope and intercept were##3##4##(2008-10#3)
slope and intercept##7##3##(2008-10#7)
slope and##12##2##(2008-10#10)(2008-7#1)(2011-1#1)
slope area##2##2##(2010-8#2)
slope at##2##2##(1995-3#1)(2008-10#1)
slope between##2##2##(2011-2#1)(2013-1#1)
slope distribution##3##2##(2008-3#3)
slope efficiencies of##2##3##(2007-11#1)(2007-12#1)
slope efficiencies##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
slope efficiency and##2##3##(2007-12#1)(2008-2#1)
slope efficiency increased by##2##4##(2008-3#2)
slope efficiency increased##3##3##(2008-2#1)(2008-3#2)
slope efficiency is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
slope efficiency of 55%##2##4##(2007-11#1)(2008-2#1)
slope efficiency of##29##3##(2007-11#9)(2007-12#7)(2008-2#10)(2008-3#3)
slope efficiency with respect to##2##5##(2007-11#1)(2008-2#1)
slope efficiency##49##2##(2007-11#13)(2007-12#12)(2008-2#17)(2008-3#7)
slope equal to##2##3##(2008-10#1)(2008-9#1)
slope facet##2##2##(2008-3#2)
slope for##4##2##(1992-3#1)(1995-5#2)(2008-10#1)
slope from the##2##3##(2008-10#2)
slope in the##3##3##(1990-9#1)(2008-3#2)
slope in##5##2##(1990-9#1)(2008-10#1)(2008-3#3)
slope is obtained##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
slope is##5##2##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#2)
slope method##4##2##(2008-3#4)
slope of -55##2##3##(2008-10#2)
slope of -59##2##3##(2008-10#2)
slope of 0##6##3##(2008-10#5)(2008-2#1)
slope of 19##4##3##(2008-10#4)
slope of 28##4##3##(2008-10#4)
slope of 29 mV##3##4##(2008-10#3)
slope of 29##12##3##(2008-10#12)
slope of 30##2##3##(2008-10#2)
slope of 30+/-1 mV per decade##2##6##(2008-10#2)
slope of 56##4##3##(2008-10#4)
slope of 57##2##3##(2008-10#2)
slope of the electrode##2##4##(2008-10#2)
slope of the linear portion##2##5##(2008-10#2)
slope of the response##2##4##(1997-2#1)(2008-10#1)
slope of the survival curve##2##5##(1995-3#2)
slope of the##45##3##(1993-12#1)(1995-3#2)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#22)(2008-2#4)(2008-3#8)(2008-8#3)(2008-9#1)
slope of this##3##3##(1991-5#1)(1993-12#1)(2007-11#1)
slope of##145##2##(1991-2#1)(1991-5#1)(1993-12#2)(1994-12#1)(1995-3#2)(1996-2#2)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#108)(2008-2#6)(2008-3#9)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
slope or##2##2##(1994-9#1)(2008-10#1)
slope over a##2##3##(2007-11#1)(2008-10#1)
slope was##5##2##(1995-8#1)(2008-10#4)
slope were##2##2##(2008-10#1)(2008-5#1)
slope##322##1##(1990-11#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#2)(1994-12#1)(1994-9#1)(1995-3#5)(1995-5#2)(1995-8#2)(1996-2#2)(1996-5#1)(1997-2#2)(2007-11#19)(2007-12#18)(2008-10#163)(2008-11#1)(2008-12#1)(2008-2#35)(2008-3#37)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-6#1)(2009-8#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
slope/bias correction##2##2##(2007-12#1)(2008-10#1)
sloped##2##1##(2008-2#2)
slopes 0##2##2##(2008-10#2)
slopes and##7##2##(2008-10#2)(2012-1#3)(2013-1#1)(2013-7#1)
slopes can be##2##3##(2007-12#1)(2012-1#1)
slopes for##2##2##(2008-10#1)(2013-1#1)
slopes in##2##2##(2008-10#1)(2008-3#1)
slopes of the##12##3##(1990-11#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-8#1)(2012-3#1)
slopes of##27##2##(1990-11#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#4)(2008-9#1)(2012-3#1)
slopes were not significantly##2##4##(2008-10#2)
slopes were##6##2##(1990-7#1)(2008-10#5)
slopes##77##1##(1990-11#1)(1990-7#1)(1996-5#2)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#32)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-8#5)(2008-9#5)(2009-6#1)(2012-1#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)
sloppy##2##1##(1996-5#1)(2008-9#1)
slot blot assay to determine the infectious titer of the purified HDAd##2##12##(2008-2#1)(2008-4#1)
slot blot##3##2##(1990-11#1)(2008-2#1)(2008-4#1)
slot of##2##2##(1996-2#1)(2007-8#1)
slot or##3##2##(1996-2#1)(2008-4#2)
slot##11##1##(1990-11#1)(1990-2#1)(1996-2#2)(2007-8#2)(2008-2#1)(2008-4#3)(2012-1#1)
slough##3##1##(2008-10#2)(2010-11#1)
sloughed##3##1##(2008-10#3)
sloughing of##2##2##(1991-8#1)(2011-2#1)
sloughing##5##1##(1991-8#4)(2011-2#1)
slovaca##8##1##(1995-12#3)(2009-2#5)
slow K(+)##2##2##(2008-8#2)
slow accumulation of##2##3##(1990-2#1)(1996-10#1)
slow and fast##4##3##(1997-2#1)(2007-12#1)(2008-4#1)(2011-2#1)
slow and##15##2##(1990-7#1)(1993-12#1)(1994-2#1)(1996-7#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
slow axis##2##2##(2007-11#1)(2007-12#1)
slow binding##2##2##(1992-5#1)(2006-6#1)
slow but##3##2##(1991-2#1)(1994-5#1)(2008-3#1)
slow channel##2##2##(2013-1#2)
slow components##2##2##(2008-3#2)
slow cooling##2##2##(1996-8#1)(2008-3#1)
slow down the process of##2##5##(2008-12#1)(2008-9#1)
slow down the##6##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#2)
slow down##11##2##(1991-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)
slow evolution##2##2##(2007-11#1)(2008-10#1)
slow flow##3##2##(1996-9#1)(2008-7#1)(2013-8#1)
slow folding##2##2##(1992-3#1)(1992-6#1)
slow growing and##2##3##(2008-10#1)(2013-7#1)
slow growing##7##2##(1994-11#1)(1997-4#1)(2008-10#1)(2008-9#2)(2010-3#1)(2013-7#1)
slow growth in##2##3##(1992-12#1)(1997-3#1)
slow growth##12##2##(1992-12#1)(1993-3#1)(1997-2#1)(1997-3#1)(2010-12#1)(2010-2#3)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
slow in coming##2##3##(1996-1#1)(2008-8#1)
slow in##6##2##(1991-12#1)(1996-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)
slow increase##2##2##(2008-11#1)(2009-8#1)
slow kinetics##2##2##(1995-11#1)(2008-10#1)
slow loss of the##2##4##(1993-5#1)(2008-10#1)
slow onset##3##2##(1994-9#1)(1995-12#1)(2012-2#1)
slow oscillations##2##2##(2008-1#1)(2009-8#1)
slow phase##5##2##(1991-12#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-5#1)
slow potential shift##2##3##(1996-5#2)
slow process##6##2##(1991-12#1)(1992-3#1)(1993-11#1)(2008-1#1)(2008-10#1)(2009-8#1)
slow processes##2##2##(1990-5#1)(2009-8#1)
slow progression##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
slow rate##9##2##(1993-8#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#3)(2012-3#1)
slow rates##4##2##(2008-8#3)(2008-9#1)
slow reaction##2##2##(2008-10#2)
slow recovery##2##2##(2008-3#1)(2008-5#1)
slow release##2##2##(1996-12#1)(2010-5#1)
slow rusting resistance to leaf rust##2##6##(2008-10#2)
slow skeletal muscles##2##3##(1995-2#2)
slow the growth of##2##4##(1992-2#1)(2012-2#1)
slow the growth##3##3##(1992-2#2)(2012-2#1)
slow the progression of##3##4##(2012-12#2)(2013-8#1)
slow the rate of##2##4##(2007-7#1)(2008-10#1)
slow the##11##2##(1992-2#2)(1996-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
slow to##10##2##(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
slow wave activity##2##3##(1991-2#1)(2008-7#1)
slow wave##5##2##(1990-7#1)(1991-2#1)(1991-9#1)(2008-7#1)(2012-12#1)
slow waves##2##2##(1991-9#1)(2009-8#1)
slow##311##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#4)(1990-9#1)(1991-12#9)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-5#2)(1993-8#3)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-6#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#12)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#44)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#16)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#15)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#6)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#4)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#5)
slow&quot##2##1##(1993-11#1)(2007-12#1)
slow)##2##1##(2008-2#1)(2008-8#1)
slow- and##2##2##(1993-11#1)(1994-9#1)
slow-##3##1##(1993-11#1)(1994-9#2)
slow-binding##3##1##(1992-3#1)(1994-6#1)(2012-12#1)
slow-canker-growth (SCG)##2##2##(2008-10#2)
slow-growing##11##1##(1991-12#1)(1993-9#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2010-3#2)(2012-3#1)
slow-grown##2##1##(1996-12#2)
slow-onset potentiation##3##2##(1995-12#3)
slow-onset##4##1##(1995-12#3)(2010-4#1)
slow-release##5##1##(1991-2#1)(1994-6#1)(1996-12#1)(2008-11#1)(2008-8#1)
slow-rusting resistance to leaf rust in wheat##2##7##(2008-10#2)
slow-rusting resistance to leaf rust##3##5##(2008-10#3)
slow-rusting resistance##5##2##(2008-10#5)
slow-rusting##6##1##(2008-10#6)
slow-wave activity##2##2##(1992-12#1)(1994-8#1)
slow-wave sleep##3##2##(1992-8#2)(2012-3#1)
slow-wave##6##1##(1992-12#1)(1992-8#2)(1994-8#1)(2008-11#1)(2012-3#1)
slowdown of##2##2##(2007-12#2)
slowdown##4##1##(2007-12#2)(2008-12#1)(2013-8#1)
slowed by the##2##3##(2009-5#1)(2010-3#1)
slowed by##3##2##(2008-1#1)(2009-5#1)(2010-3#1)
slowed down the##2##3##(1997-2#1)(2008-11#1)
slowed down##8##2##(1991-2#1)(1992-3#1)(1997-2#1)(2008-11#2)(2010-1#1)(2012-2#2)
slowed the##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#1)
slowed##36##1##(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1994-11#1)(1996-2#1)(1996-3#1)(1997-2#3)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
slower and##3##2##(1993-8#1)(1994-5#1)(2007-12#1)
slower decrease##2##2##(2008-7#2)
slower in##9##2##(1990-11#1)(1995-12#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
slower learning##2##2##(1993-12#1)(2008-9#1)
slower rate##3##2##(1990-11#1)(1992-8#1)(1995-2#1)
slower rates##3##2##(1992-2#1)(2008-6#1)(2012-12#1)
slower responses##2##2##(2008-2#1)(2011-1#1)
slower than that of##4##4##(1990-5#1)(1990-7#1)(2007-11#1)(2008-10#1)
slower than that##8##3##(1990-5#1)(1990-7#2)(2007-11#1)(2008-10#3)(2008-2#1)
slower than the rate of##2##5##(1993-11#1)(2008-10#1)
slower than the##11##3##(1992-6#2)(1992-9#1)(1993-11#1)(2008-10#5)(2008-7#1)(2010-10#1)
slower than##27##2##(1990-5#1)(1990-7#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2011-3#1)
slower to##5##2##(1993-6#1)(1995-12#1)(2008-10#1)(2009-8#1)(2012-3#1)
slower with##2##2##(1990-9#1)(2008-10#1)
slower##100##1##(1990-11#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-6#2)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#22)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
slower)##2##1##(2008-10#2)
slowest##14##1##(1990-7#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
slowing down of the##4##4##(1994-3#1)(2008-10#2)(2012-2#1)
slowing down of##5##3##(1994-3#1)(2007-12#1)(2008-10#2)(2012-2#1)
slowing down the##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
slowing down##11##2##(1994-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
slowing in##3##2##(1991-2#1)(1995-3#1)(2008-7#1)
slowing of the##5##3##(1991-11#1)(1991-12#1)(2007-12#1)(2008-11#1)(2012-3#1)
slowing of##12##2##(1991-11#2)(1991-12#2)(1993-6#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2012-3#1)
slowing the progression of myopia##2##5##(2012-12#2)
slowing the##11##2##(1991-12#1)(1992-2#1)(1995-3#1)(1996-11#1)(2007-8#2)(2008-10#2)(2011-2#1)(2012-12#2)
slowing##50##1##(1991-11#2)(1991-12#4)(1991-2#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-3#2)(1995-5#1)(1996-11#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
slowly and##2##2##(2008-10#1)(2011-2#1)
slowly as##2##2##(2007-11#1)(2008-10#1)
slowly but##2##2##(2008-10#2)
slowly growing##4##2##(1997-2#1)(2008-10#1)(2011-2#2)
slowly hydrolyzed##2##2##(1992-6#1)(2008-4#1)
slowly in the##3##3##(1996-12#1)(2008-10#2)
slowly in##9##2##(1992-3#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)
slowly increased##3##2##(2008-10#2)(2008-12#1)
slowly migrating species##2##3##(1993-12#2)
slowly on##4##2##(1991-11#1)(2008-10#2)(2008-9#1)
slowly over a##2##3##(1991-2#1)(2010-8#1)
slowly over the##2##3##(1991-2#1)(2008-11#1)
slowly over##5##2##(1991-2#2)(2008-11#1)(2008-2#1)(2010-8#1)
slowly progressive CES##2##3##(2012-3#2)
slowly progressive##9##2##(1990-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-7#1)(2012-3#3)(2013-1#1)
slowly to##2##2##(1991-5#1)(1991-6#1)
slowly until##2##2##(2008-11#1)(2011-2#1)
slowly varying##5##2##(2007-11#2)(2008-3#1)(2008-8#2)
slowly with the##3##3##(1995-2#1)(2008-3#2)
slowly with##5##2##(1995-2#1)(2008-3#3)(2008-8#1)
slowly##130##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#4)(1992-6#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-5#2)(1994-7#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#2)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-3#4)(2013-1#2)
slowness##2##1##(1991-12#1)(2012-12#1)
slows down##2##2##(2008-10#2)
slows the##2##2##(2009-6#1)(2012-2#1)
slows##11##1##(1994-2#1)(2008-10#4)(2008-7#1)(2008-8#2)(2009-6#1)(2012-2#1)(2013-8#1)
sludge and##5##2##(2008-12#1)(2008-6#1)(2010-12#1)(2012-12#2)
sludge can##2##2##(1997-4#1)(2012-12#1)
sludge in##4##2##(1997-4#3)(2008-5#1)
sludge or##2##2##(2007-12#1)(2010-12#1)
sludge samples##2##2##(2012-12#2)
sludge treatment##2##2##(1997-4#1)(2008-11#1)
sludge was##2##2##(2008-12#1)(2012-3#1)
sludge were##2##2##(2008-6#2)
sludge##71##1##(1997-4#14)(2007-12#2)(2008-10#15)(2008-11#4)(2008-12#14)(2008-5#1)(2008-6#4)(2008-9#1)(2010-12#2)(2011-2#1)(2012-12#6)(2012-3#3)(2013-1#4)
sludges##12##1##(2008-10#8)(2008-11#3)(2008-6#1)
slug##4##1##(2008-10#1)(2008-6#2)(2008-7#1)
slum of##2##2##(2008-7#1)(2009-10#1)
slum##5##1##(1991-6#1)(2007-7#1)(2008-7#1)(2009-10#1)(2012-2#1)
slump test##3##2##(2008-12#3)
slump##6##1##(1992-11#1)(2008-12#4)(2011-2#1)
slurried in##2##2##(2008-10#2)
slurried##5##1##(2008-10#5)
slurries (2%##2##2##(2008-10#2)
slurries and##2##2##(2008-10#2)
slurries of##4##2##(2008-10#4)
slurries were prepared by##3##4##(2008-10#3)
slurries were##7##2##(2008-10#7)
slurries##23##1##(2008-10#22)(2008-11#1)
slurry analysis##3##2##(2008-10#3)
slurry and##3##2##(2008-10#3)
slurry formation##3##2##(2008-10#3)
slurry preparation##4##2##(2008-10#4)
slurry sample introduction##2##3##(2008-10#2)
slurry sample##3##2##(2008-10#3)
slurry samples##6##2##(2008-10#6)
slurry sampling ETAAS##3##3##(2008-10#3)
slurry sampling and##2##3##(2008-10#2)
slurry sampling electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
slurry sampling electrothermal atomic absorption##3##5##(2008-10#3)
slurry sampling electrothermal vaporisation##2##4##(2008-10#2)
slurry sampling electrothermal##6##3##(2008-10#6)
slurry sampling##27##2##(2008-10#27)
slurry technique##3##2##(2008-10#3)
slurry was##7##2##(2008-10#5)(2008-3#1)(2012-12#1)
slurry##81##1##(2008-10#73)(2008-3#2)(2008-6#1)(2008-7#3)(2012-12#1)(2013-1#1)
small (&lt##9##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
small (0##2##2##(2007-11#1)(2008-10#1)
small (1##2##2##(1991-11#1)(2008-3#1)
small DNA##4##2##(1995-2#1)(2008-10#2)(2008-7#1)
small GTP binding proteins##2##4##(1997-4#2)
small GTP binding##4##3##(1997-4#4)
small GTP-binding protein##5##3##(1991-12#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-9#1)
small GTP-binding proteins by##2##4##(1992-3#1)(1995-8#1)
small GTP-binding proteins##7##3##(1992-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-8#1)(1997-1#1)(2008-6#1)
small GTP-binding##12##2##(1991-12#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-11#2)(1994-6#1)(1994-9#1)(1995-8#1)(1997-1#1)(2008-6#1)
small GTPase##3##2##(2008-7#1)(2011-2#2)
small GTPases and##2##3##(1997-7#1)(2008-11#1)
small GTPases##8##2##(1996-2#1)(1997-7#1)(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
small LDL##2##2##(2008-3#1)(2012-2#1)
small PTTH##2##2##(1995-11#2)
small PTTH-stimulated ecdysteroid secretion##2##4##(1995-11#2)
small RNA and##2##3##(2008-10#1)(2010-5#1)
small RNA##9##2##(1993-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-3#2)(2010-5#1)
small RNAs that##2##3##(2009-3#1)(2013-1#1)
small RNAs##13##2##(1991-2#2)(1994-12#1)(2008-1#1)(2008-2#3)(2008-9#2)(2009-3#3)(2013-1#1)
small aberrations##2##2##(2008-3#2)
small absorbers##2##2##(2007-11#1)(2008-3#1)
small amount of the##2##4##(2008-10#1)(2008-6#1)
small amount of##38##3##(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
small amount##39##2##(1991-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
small amounts of a##3##4##(2008-10#1)(2010-4#2)
small amounts of the##4##4##(1990-5#1)(1995-11#1)(2007-11#1)(2008-10#1)
small amounts of##32##3##(1990-5#1)(1993-6#1)(1993-8#1)(1995-11#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#2)(2012-1#1)(2012-2#2)(2013-8#1)
small amounts##36##2##(1990-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#2)(2012-1#1)(2012-2#2)(2013-8#1)
small amplitude##7##2##(1993-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
small analyte##3##2##(2008-4#1)(2008-7#2)
small analytes##2##2##(2008-10#2)
small and asymptomatic##2##3##(2013-1#1)(2013-8#1)
small and isolated patches##2##4##(2008-9#2)
small and large bowel##2##4##(2008-4#1)(2008-7#1)
small and large subunits##2##4##(1990-11#2)
small and large##12##3##(1990-11#2)(1993-12#1)(1994-11#1)(1996-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2011-2#1)
small and medium##5##3##(1996-12#1)(1997-3#1)(2006-10#1)(2008-10#1)(2012-12#1)
small and the##4##3##(1995-9#1)(2008-10#1)(2008-6#1)(2012-3#1)
small and transient##2##3##(2007-8#1)(2011-10#1)
small and##56##2##(1990-11#2)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
small angle X-ray##2##3##(2008-11#1)(2008-5#1)
small angle neutron scattering##2##4##(2008-10#2)
small angle##10##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-6#1)
small angles##5##2##(2007-12#1)(2008-3#4)
small angular##2##2##(2006-4#1)(2008-3#1)
small animal imaging##3##3##(2009-8#1)(2011-1#1)(2012-12#1)
small animal model system##2##4##(2008-11#2)
small animal model##3##3##(1994-12#1)(2008-11#2)
small animal##14##2##(1994-12#1)(1996-12#2)(2008-11#2)(2009-8#2)(2011-1#1)(2012-12#6)
small animals##7##2##(1990-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
small antral follicles##3##3##(2008-8#2)(2008-9#1)
small apertures##3##2##(2007-11#2)(2008-2#1)
small applied##2##2##(2007-11#1)(2008-10#1)
small aqueous pore##3##3##(1990-2#3)
small area##6##2##(1990-8#1)(1991-8#1)(1993-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
small areas of##2##3##(2008-10#2)
small areas##5##2##(1990-8#1)(2008-10#3)(2008-3#1)
small aromatic molecules##2##3##(2010-11#2)
small arteries and##3##3##(1996-8#1)(2007-10#1)(2007-9#1)
small arteries##5##2##(1996-8#1)(2007-10#1)(2007-9#2)(2009-1#1)
small artery disease##2##3##(2007-10#2)
small artery##7##2##(2007-10#4)(2009-1#2)(2013-8#1)
small as##35##2##(1997-5#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#14)(2009-12#1)(2010-11#1)(2011-1#1)
small astatic##2##2##(2008-5#2)
small average##2##2##(2007-11#2)
small basic##2##2##(1991-5#1)(1993-6#1)
small beam##4##2##(2008-3#4)
small biological networks##2##3##(2008-11#1)(2010-10#1)
small biological##4##2##(2008-1#1)(2008-11#1)(2010-10#2)
small blood##2##2##(2008-12#1)(2008-3#1)
small blue copper##2##3##(1993-11#2)
small bowel disorders##3##3##(2012-2#3)
small bowel juice##2##3##(1990-12#2)
small bowel lesions##2##3##(2010-12#2)
small bowel obstruction##6##3##(2008-12#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
small bowel resection##3##3##(1992-5#2)(2008-10#1)
small bowel##63##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-5#4)(1992-9#1)(1993-8#1)(1995-10#1)(1995-12#2)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-12#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#11)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#1)
small boxes##3##2##(1995-3#3)
small but significant increases in##2##5##(1990-3#1)(2008-10#1)
small but significant##15##3##(1990-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)
small but##27##2##(1990-3#1)(1990-6#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#2)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)
small case series of##2##4##(2008-8#1)(2013-1#1)
small case series##3##3##(2008-8#1)(2010-5#1)(2013-1#1)
small case##4##2##(2008-11#1)(2008-8#1)(2010-5#1)(2013-1#1)
small cell carcinoma of the bladder##2##6##(1992-12#2)
small cell carcinoma of the gallbladder##3##6##(2009-3#3)
small cell carcinoma of the##9##5##(1992-12#2)(1995-9#1)(1997-5#1)(2007-7#1)(2009-3#3)(2009-8#1)
small cell carcinoma##18##3##(1991-6#1)(1992-12#2)(1995-9#1)(1997-5#1)(2007-5#1)(2007-7#2)(2008-1#1)(2009-1#2)(2009-3#5)(2009-8#2)
small cell lung cancer##10##4##(1990-2#1)(1991-6#1)(1993-2#1)(1995-8#1)(1996-2#1)(2008-10#2)(2009-1#2)(2010-8#1)
small cell lung carcinoma cell line##2##6##(1994-8#1)(1996-12#1)
small cell lung carcinoma##5##4##(1990-12#1)(1994-8#2)(1996-12#2)
small cell lung##16##3##(1990-12#1)(1990-2#1)(1991-6#1)(1993-2#1)(1994-8#2)(1995-8#1)(1996-12#2)(1996-2#1)(2008-10#2)(2008-4#1)(2009-1#2)(2010-8#1)
small cell##41##2##(1990-12#1)(1990-2#1)(1991-6#2)(1992-12#2)(1993-2#1)(1994-8#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-1#4)(2009-3#5)(2009-8#2)(2010-8#2)(2011-2#2)(2012-3#1)
small cells##2##2##(1991-6#1)(2008-11#1)
small change in the##4##4##(1994-8#1)(2007-11#1)(2008-3#2)
small change in##6##3##(1994-8#1)(2007-11#3)(2008-3#2)
small changes in the##7##4##(1995-5#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-7#1)(2013-1#1)
small changes in##14##3##(1995-5#1)(1996-7#1)(2008-2#1)(2008-3#4)(2008-8#3)(2009-11#1)(2010-7#1)(2012-1#1)(2013-1#1)
small changes##16##2##(1995-5#1)(1996-7#1)(2008-2#1)(2008-3#5)(2008-8#3)(2009-11#1)(2010-7#1)(2012-1#1)(2013-1#2)
small children treated##2##3##(1992-4#1)(1996-11#1)
small children with##2##3##(2008-1#1)(2008-10#1)
small children##10##2##(1990-11#1)(1992-4#1)(1994-2#1)(1996-11#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-9#1)(2012-12#1)
small chromosomes##3##2##(2008-10#1)(2008-8#2)
small clinical##2##2##(1993-12#1)(2008-5#1)
small clusters of##3##3##(1991-9#1)(1996-5#1)(2007-12#1)
small communities##4##2##(1994-11#1)(2008-10#1)(2010-9#2)
small compared to##4##3##(1996-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
small compared with##6##3##(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#2)
small compared##10##2##(1995-3#1)(1996-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)
small concentration##2##2##(2008-10#2)
small decrease in##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
small decrease##4##2##(1997-7#1)(2008-10#2)(2008-7#1)
small decreases in##2##3##(1990-7#1)(1997-4#1)
small deformation##2##2##(2007-11#1)(2008-8#1)
small deformations##3##2##(2008-2#1)(2008-3#2)
small degree##2##2##(1991-6#1)(1992-10#1)
small deletion##4##2##(1990-5#1)(1993-8#1)(2008-4#1)(2008-9#1)
small dense LDL##3##3##(2008-1#1)(2008-3#2)
small dense##6##2##(2008-1#1)(2008-3#4)(2011-1#1)
small dependence on##2##3##(1993-8#1)(1997-6#1)
small diameter##5##2##(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)
small difference in##2##3##(2012-3#1)(2013-8#1)
small difference##3##2##(2010-2#1)(2012-3#1)(2013-8#1)
small differences between##2##3##(2008-11#1)(2011-2#1)
small differences in##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
small differences##10##2##(1992-8#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
small dimensions##2##2##(2008-10#2)
small dispersal rates##2##3##(2008-8#2)
small distances##8##2##(1990-8#1)(2007-11#3)(2007-12#2)(2008-3#2)
small domain##2##2##(2008-3#1)(2009-7#1)
small doses of##3##3##(1997-7#1)(2007-8#1)(2008-7#1)
small doses##5##2##(1997-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
small droplets##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
small dsRNA##2##2##(2008-10#2)
small effect on##4##3##(1990-2#1)(1995-3#2)(2008-8#1)
small effect##8##2##(1990-2#1)(1995-3#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
small effective##2##2##(2007-12#2)
small effects##2##2##(1991-12#1)(2008-10#1)
small electric##2##2##(2008-2#1)(2011-2#1)
small employers##2##2##(1994-3#2)
small enough to##6##3##(1994-1#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-3#2)
small enough##8##2##(1994-1#1)(1994-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
small error##2##2##(2008-3#2)
small extent##2##2##(1995-3#1)(2008-10#1)
small family##2##2##(1994-7#1)(2008-8#1)
small fiber##2##2##(2010-1#1)(2012-3#1)
small field sizes##2##3##(2008-3#2)
small field##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
small focal##2##2##(2011-1#1)(2012-2#1)
small foci of##2##3##(2008-11#1)(2011-2#1)
small for gestational age (SGA)##4##5##(1994-3#1)(2011-1#2)(2013-1#1)
small for gestational age##5##4##(1990-12#1)(1994-3#1)(2011-1#2)(2013-1#1)
small for the##2##3##(2008-3#2)
small for##10##2##(1990-12#1)(1991-12#1)(1994-3#1)(2008-2#1)(2008-3#3)(2011-1#2)(2013-1#1)
small fraction of##16##3##(1991-12#1)(1991-5#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-11#2)(2010-5#1)(2013-1#1)
small fraction##17##2##(1991-12#1)(1991-5#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-11#2)(2010-5#1)(2013-1#1)
small fragment##3##2##(1993-3#1)(2008-8#1)(2012-3#1)
small fruit##2##2##(2008-10#2)
small genetic##2##2##(2008-10#2)
small genomic##3##2##(2008-9#1)(2009-7#1)(2013-1#1)
small geographical##3##2##(2008-10#2)(2012-3#1)
small globular##2##2##(1995-5#1)(2008-8#1)
small grains##6##2##(2008-10#5)(2008-9#1)
small grazing##3##2##(2007-11#2)(2008-2#1)
small group of##8##3##(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2013-1#2)
small group process##2##3##(2008-12#2)
small group##15##2##(1994-12#1)(1995-12#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
small groups of##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
small groups##7##2##(1995-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)
small hairpin##2##2##(2010-11#1)(2013-1#1)
small heat capacity changes##2##4##(1997-2#2)
small heat capacity##3##3##(1997-2#3)
small heat shock##2##3##(2008-7#1)(2013-1#1)
small heat##6##2##(1997-2#3)(2008-7#1)(2013-1#2)
small heat-shock protein##3##3##(1993-6#3)
small hospitals##8##2##(1991-12#1)(1991-6#1)(1994-2#4)(2008-4#1)(2008-8#1)
small impact on##2##3##(1996-11#1)(2012-12#1)
small in comparison with the##2##5##(2008-3#1)(2008-7#1)
small in comparison##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
small in number##3##3##(1990-6#1)(1997-5#1)(2008-10#1)
small in size##2##3##(1991-12#1)(2010-7#1)
small in##13##2##(1990-12#1)(1990-6#1)(1991-12#1)(1993-8#1)(1997-5#1)(2008-10#3)(2008-3#1)(2008-7#2)(2010-7#1)(2010-8#1)
small inclination misalignment##2##3##(2008-3#2)
small inclination##9##2##(2008-3#9)
small inclined angle##2##3##(2008-3#2)
small increase in the##4##4##(1992-8#1)(1997-8#1)(2008-10#1)(2008-3#1)
small increase in##9##3##(1990-12#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-1#1)
small increase##10##2##(1990-12#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)
small increases##2##2##(1991-12#1)(1997-4#1)
small inducible##2##2##(1994-9#2)
small influence##3##2##(1993-8#1)(2008-4#1)(2008-5#1)
small interference##3##2##(2008-10#2)(2013-8#1)
small interfering RNA (siRNA)##3##4##(2009-3#1)(2010-2#1)(2012-3#1)
small interfering RNA##4##3##(2009-3#1)(2010-2#1)(2010-5#1)(2012-3#1)
small interfering RNAs (siRNAs)##4##4##(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
small interfering RNAs##5##3##(2008-10#2)(2008-2#1)(2011-2#1)(2012-2#1)
small interfering##9##2##(2008-10#2)(2008-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
small internal##2##2##(2008-3#2)
small intestinal##15##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#2)(1992-6#1)(1996-6#1)(2007-2#1)(2008-5#2)(2010-6#1)(2012-2#1)(2013-1#2)
small intestine and colon##2##4##(1991-12#1)(2012-2#1)
small intestine and##8##3##(1991-12#1)(1995-3#1)(1997-6#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
small intestine in##3##3##(1990-11#1)(2007-2#1)(2007-8#1)
small intestine metastases##2##3##(1995-12#2)
small intestine with##2##3##(1990-11#1)(2008-5#1)
small intestine##71##2##(1990-11#4)(1990-12#2)(1990-7#1)(1990-8#1)(1991-12#5)(1991-5#2)(1992-11#4)(1992-5#2)(1992-6#3)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#3)(1997-3#2)(1997-6#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#2)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#4)(2013-1#6)(2013-7#1)
small intestines##5##2##(1993-11#1)(1993-9#3)(1997-3#1)
small inverse##2##2##(2008-4#1)(2012-2#1)
small island##4##2##(1996-6#1)(2008-1#2)(2012-12#1)
small lateral##2##2##(2008-12#1)(2008-3#1)
small lesions##7##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
small lipid##2##2##(1995-3#1)(2008-7#1)
small loss##2##2##(2008-7#1)(2013-1#1)
small lung vessels##2##3##(1991-8#2)
small lymphocytes and##3##3##(1991-8#1)(1997-6#2)
small lymphocytes##5##2##(1991-8#1)(1997-6#4)
small lymphoid##2##2##(1997-6#1)(2009-8#1)
small males##2##2##(2009-9#1)(2012-3#1)
small mammals##2##2##(1996-6#1)(2009-12#1)
small marks##2##2##(2007-11#1)(2008-3#1)
small membrane##2##2##(1992-9#1)(1994-12#1)
small metal##2##2##(1992-8#1)(2008-9#1)
small model##2##2##(1993-11#1)(2008-11#1)
small molecular compounds##2##3##(2009-12#1)(2011-3#1)
small molecular weight##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
small molecular##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2011-2#1)(2011-3#1)
small molecule inhibitors##3##3##(2008-4#1)(2010-3#1)(2011-2#1)
small molecule##26##2##(1992-8#1)(1994-2#1)(1994-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#2)
small molecules for##2##3##(2008-4#1)(2011-2#1)
small molecules have##2##3##(1992-9#1)(2008-9#1)
small molecules in the##2##4##(2008-8#1)(2010-11#1)
small molecules in##3##3##(2008-10#1)(2008-8#1)(2010-11#1)
small molecules such as##2##4##(1992-12#1)(1994-2#1)
small molecules that##4##3##(2008-4#1)(2009-4#1)(2009-7#1)(2012-3#1)
small molecules##40##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
small municipalities##2##2##(1994-11#2)
small neutral amino##2##3##(1994-5#2)
small non-coding RNAs that##2##4##(2008-11#1)(2010-7#1)
small normal##2##2##(2008-10#1)(2008-5#1)
small nuclear RNA##3##3##(1990-5#1)(1993-8#1)(1996-3#1)
small nuclear ribonucleoprotein particle##2##4##(1993-8#1)(2007-12#1)
small nuclear ribonucleoprotein##3##3##(1991-6#1)(1993-8#1)(2007-12#1)
small nuclear##10##2##(1990-5#1)(1991-6#1)(1993-8#2)(1995-6#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#1)
small nucleolar##2##2##(1997-7#1)(2008-11#1)
small number of cases##5##4##(1994-9#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
small number of genes##3##4##(1997-7#1)(2008-7#1)(2008-9#1)
small number of patients##8##4##(1994-6#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-5#2)
small number of reported cases##2##5##(2008-11#1)(2008-6#1)
small number of samples##2##4##(2008-10#1)(2008-11#1)
small number of##66##3##(1990-2#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
small number##73##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#4)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
small numbers of patients##3##4##(2008-1#1)(2008-12#1)(2008-9#1)
small numbers of##10##3##(1991-12#1)(1993-12#1)(1995-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-2#1)
small numbers##13##2##(1991-12#2)(1993-12#1)(1994-6#1)(1995-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
small objects##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
small open reading##2##3##(1993-12#1)(2008-9#1)
small open##3##2##(1993-12#1)(2008-9#1)(2013-7#1)
small optical##3##2##(2007-12#1)(2008-3#2)
small or large##4##3##(1992-11#1)(1994-11#1)(2008-9#1)(2011-2#1)
small or moderate##2##3##(1995-9#1)(2008-8#1)
small or##13##2##(1992-11#1)(1993-9#2)(1994-11#1)(1995-9#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
small organic molecules and##2##4##(1994-2#1)(2010-2#1)
small organic molecules##9##3##(1994-2#1)(1997-6#2)(2008-9#2)(2009-11#2)(2010-11#1)(2010-2#1)
small part of the##6##4##(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(2008-3#1)(2010-5#1)
small part of##7##3##(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1997-6#1)(2008-3#1)(2010-5#1)
small particle size##3##3##(2008-5#2)(2013-8#1)
small particle##4##2##(2008-2#1)(2008-5#2)(2013-8#1)
small particles in##2##3##(2008-3#2)
small particles##13##2##(1991-12#1)(1995-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
small pelvis##2##2##(2007-11#1)(2012-3#1)
small peptides and##2##3##(1990-11#1)(1994-8#1)
small peptides##10##2##(1990-11#1)(1991-5#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-3#1)
small percent of##2##3##(2008-5#1)(2012-2#1)
small percent##3##2##(1990-2#1)(2008-5#1)(2012-2#1)
small percentage of the##3##4##(1991-3#1)(1993-3#1)(2007-5#1)
small percentage of##10##3##(1991-3#1)(1992-12#1)(1993-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
small percentage##12##2##(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
small peripheral##4##2##(1990-2#1)(2008-1#2)(2011-2#1)
small perturbation##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
small phase##2##2##(2008-3#1)(2008-5#1)
small piece of##2##3##(1992-3#1)(2008-12#1)
small population and##2##3##(2008-1#1)(2008-12#1)
small population##11##2##(1991-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)
small populations of##2##3##(2008-1#1)(2013-1#1)
small populations##5##2##(1996-6#1)(2008-1#1)(2008-9#2)(2013-1#1)
small portion of the##4##4##(1992-3#1)(1994-11#1)(2008-10#1)(2009-5#1)
small portion of##8##3##(1992-3#1)(1994-11#1)(2007-10#1)(2008-10#1)(2008-4#2)(2009-5#1)(2010-3#1)
small portion##9##2##(1992-3#1)(1994-11#1)(2007-10#1)(2008-10#2)(2008-4#2)(2009-5#1)(2010-3#1)
small proportion of cases##2##4##(1991-11#1)(1996-5#1)
small proportion of the##8##4##(1991-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
small proportion of##18##3##(1991-11#1)(1991-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
small proportion##22##2##(1991-11#1)(1991-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
small protein##3##2##(2008-7#1)(2009-10#1)(2010-8#1)
small proteins##3##2##(2008-10#2)(2008-2#1)
small quantities of##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
small quantities##11##2##(2007-10#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-9#1)
small quantity of##3##3##(1992-9#1)(1996-1#1)(2008-10#1)
small radial diameters##2##3##(2011-2#2)
small radial##3##2##(2011-2#3)
small reaction##2##2##(2008-10#2)
small recurrent carcinomas##2##3##(1991-4#2)
small regions##2##2##(1990-12#1)(2013-1#1)
small regulatory RNAs##2##3##(2008-2#1)(2010-7#1)
small relative to##3##3##(1992-5#1)(2008-2#1)(2008-8#1)
small relative##5##2##(1992-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)
small ribosomal subunit##3##3##(2009-11#1)(2009-9#2)
small right##2##2##(2007-12#1)(2011-2#1)
small role in##4##3##(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
small round cell tumor (DSRCT)##2##5##(2008-10#1)(2008-6#1)
small round cell tumor##3##4##(2008-10#2)(2008-6#1)
small round cell##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
small round##7##2##(1990-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-6#1)
small ruminant strains##2##3##(1991-8#2)
small ruminant##3##2##(1991-8#3)
small ruminants##3##2##(1991-8#1)(1997-7#1)(2013-1#1)
small rural hospitals##4##3##(1991-1#1)(1992-2#1)(1996-3#1)(2008-11#1)
small rural##6##2##(1991-1#1)(1992-2#1)(1994-11#1)(1996-3#1)(2008-11#1)(2010-5#1)
small sample size##9##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
small sample sizes##6##3##(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
small sample##25##2##(1997-5#1)(2007-4#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
small samples##8##2##(2008-10#5)(2008-12#1)(2008-4#1)(2009-2#1)
small scale##15##2##(1996-4#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
small segments of##2##3##(1994-12#1)(2010-8#1)
small segments##3##2##(1994-12#1)(2008-10#1)(2010-8#1)
small series of##2##3##(1996-9#1)(2011-2#1)
small series##3##2##(1996-9#1)(2011-2#2)
small set of##2##3##(2008-10#2)
small sets of##2##3##(2008-7#1)(2008-9#1)
small share of##2##3##(1994-1#1)(1996-1#1)
small shears##2##2##(2008-3#2)
small shocks##2##2##(1996-4#2)
small signal##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
small size and##2##3##(1994-2#1)(2008-10#1)
small size of the##6##4##(1991-5#1)(1992-12#1)(2007-12#1)(2008-12#1)(2009-3#1)(2010-2#1)
small size of##11##3##(1991-5#1)(1992-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)
small size##23##2##(1991-5#1)(1992-12#1)(1993-8#2)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#1)
small skin##2##2##(1991-12#1)(2008-3#1)
small solid##2##2##(2008-3#1)(2012-12#1)
small source-detector separations##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
small source-detector##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
small spatial extent of##2##4##(2008-2#1)(2008-3#1)
small spatial extent##3##3##(2008-2#2)(2008-3#1)
small spatial##6##2##(2008-2#2)(2008-3#1)(2008-9#1)(2010-6#1)(2010-8#1)
small spectral##2##2##(2008-3#2)
small spot##3##2##(2007-12#1)(2008-3#2)
small studies##4##2##(1995-12#1)(2008-6#2)(2013-8#1)
small study##5##2##(1990-11#1)(1990-2#1)(2007-10#1)(2008-11#2)
small subset of all##2##4##(2008-6#1)(2010-2#1)
small subset of##10##3##(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-12#1)
small subunit of##2##3##(1993-12#1)(1994-8#1)
small subunit##11##2##(1990-11#1)(1993-12#2)(1994-8#1)(2008-10#5)(2008-8#1)(2013-8#1)
small subunits##2##2##(1997-6#1)(2009-11#1)
small surface area##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
small surface##5##2##(1990-8#1)(2008-2#1)(2008-3#2)(2010-4#1)
small to large numbers of##2##5##(1997-8#1)(2008-4#1)
small to large##3##3##(1997-8#1)(2008-10#1)(2008-4#1)
small to##14##2##(1990-8#2)(1991-3#2)(1993-3#1)(1994-12#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2012-2#1)
small trials##3##2##(1993-12#2)(2007-12#1)
small unilamellar vesicles##5##3##(1994-5#1)(1997-7#1)(2008-10#2)(2009-12#1)
small unilamellar##8##2##(1992-3#2)(1993-8#1)(1994-5#1)(1997-7#1)(2008-10#2)(2009-12#1)
small user##2##2##(2008-7#2)
small values of the##2##4##(1990-8#1)(2008-2#1)
small values of##6##3##(1990-8#1)(2008-2#3)(2008-3#1)(2013-8#1)
small variation##3##2##(1990-8#1)(2007-12#1)(2008-9#1)
small variations in the##3##4##(1991-9#1)(1994-12#1)(2008-2#1)
small variations in##6##3##(1991-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(2008-2#1)(2013-8#1)
small variations##7##2##(1991-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(2007-12#1)(2008-2#1)(2013-8#1)
small vesicles##3##2##(1992-12#1)(2007-12#2)
small vessel disease##5##3##(2007-10#2)(2008-8#2)(2009-10#1)
small vessel##10##2##(1997-8#2)(2007-10#2)(2008-10#1)(2008-8#2)(2009-10#1)(2011-2#1)(2013-8#1)
small vessels##6##2##(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
small vibration amplitudes of a rough surface##2##7##(2008-3#2)
small volume of##14##3##(2008-10#13)(2008-8#1)
small volume##20##2##(2008-10#17)(2008-11#1)(2008-2#1)(2008-8#1)
small volumes of##5##3##(2008-10#4)(2008-9#1)
small volumes##13##2##(1996-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#2)(2009-7#2)
small water##3##2##(2007-11#1)(2008-2#2)
small with##2##2##(2009-7#1)(2009-8#1)
small##2307##1##(1990-11#17)(1990-12#16)(1990-2#13)(1990-3#4)(1990-5#11)(1990-6#7)(1990-7#5)(1990-8#19)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#23)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#8)(1991-6#13)(1991-7#1)(1991-8#10)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#11)(1992-12#13)(1992-2#5)(1992-3#10)(1992-4#1)(1992-5#10)(1992-6#4)(1992-8#9)(1992-9#6)(1993-11#9)(1993-12#14)(1993-2#5)(1993-3#4)(1993-6#9)(1993-8#15)(1993-9#6)(1994-1#4)(1994-11#13)(1994-12#12)(1994-2#17)(1994-3#4)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#15)(1994-9#8)(1995-10#1)(1995-11#16)(1995-12#14)(1995-2#5)(1995-3#16)(1995-5#12)(1995-6#2)(1995-8#5)(1995-9#4)(1996-1#3)(1996-11#4)(1996-12#16)(1996-2#7)(1996-3#5)(1996-4#8)(1996-5#9)(1996-6#6)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#4)(1997-2#7)(1997-3#16)(1997-4#11)(1997-5#4)(1997-6#17)(1997-7#8)(1997-8#8)(2006-10#1)(2006-12#3)(2006-4#1)(2007-10#15)(2007-11#43)(2007-12#55)(2007-2#2)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#2)(2008-1#28)(2008-10#317)(2008-11#71)(2008-12#27)(2008-2#91)(2008-3#206)(2008-4#42)(2008-5#55)(2008-6#29)(2008-7#74)(2008-8#63)(2008-9#63)(2009-1#10)(2009-10#6)(2009-11#14)(2009-12#7)(2009-2#4)(2009-3#15)(2009-4#2)(2009-5#11)(2009-6#4)(2009-7#9)(2009-8#13)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#14)(2010-12#23)(2010-2#7)(2010-3#7)(2010-4#10)(2010-5#16)(2010-6#10)(2010-7#9)(2010-8#19)(2010-9#4)(2011-1#19)(2011-10#1)(2011-2#59)(2011-3#2)(2012-1#11)(2012-12#20)(2012-2#35)(2012-3#27)(2013-1#57)(2013-7#8)(2013-8#27)
small)##2##1##(1990-7#1)(2008-7#1)
small-##5##1##(2006-10#1)(2007-12#1)(2008-2#1)(2008-9#2)
small-angle X-ray scattering (SAXS)##2##4##(2008-10#2)
small-angle X-ray scattering##3##3##(2008-10#3)
small-angle X-ray##4##2##(2008-10#3)(2008-5#1)
small-angle approximation to##2##3##(2008-3#2)
small-angle approximation##8##2##(2008-2#3)(2008-3#5)
small-angle measurement##4##2##(2008-3#4)
small-angle measurements##2##2##(2008-3#2)
small-angle scattering is##2##3##(2008-2#1)(2008-3#1)
small-angle scattering##7##2##(2008-2#3)(2008-3#3)(2011-2#1)
small-angle x-ray scattering##2##3##(2008-3#1)(2008-5#1)
small-angle##34##1##(2008-10#3)(2008-2#9)(2008-3#18)(2008-5#2)(2009-12#1)(2011-2#1)
small-animal imaging##3##2##(2009-8#1)(2012-2#2)
small-animal##5##1##(2008-4#1)(2009-8#1)(2012-2#2)(2013-1#1)
small-artery disease with##2##3##(2007-10#2)
small-bore##5##1##(2007-12#2)(2008-2#3)
small-bowel##3##1##(1993-9#1)(2008-12#1)(2013-1#1)
small-breasted patients##2##2##(2013-1#2)
small-breasted##3##1##(2013-1#3)
small-caliber##3##1##(2010-6#1)(2011-3#2)
small-cell carcinoma of the##2##4##(1992-12#1)(1994-11#1)
small-cell carcinoma##3##2##(1992-12#1)(1994-11#1)(1997-1#1)
small-cell lung cancer##9##3##(1994-11#1)(1996-8#2)(2008-7#3)(2010-12#3)
small-cell lung##10##2##(1994-11#1)(1996-8#2)(1997-8#1)(2008-7#3)(2010-12#3)
small-cell##13##1##(1992-12#1)(1994-11#2)(1996-8#2)(1997-1#1)(1997-8#1)(2008-7#3)(2010-12#3)
small-diameter##8##1##(1991-2#2)(2007-12#1)(2008-10#1)(2008-3#2)(2010-1#1)(2013-1#1)
small-event complexity##2##2##(1996-4#2)
small-fiber neuropathy##2##2##(2013-1#2)
small-field##2##1##(2008-2#1)(2008-3#1)
small-intestine##2##1##(1992-2#1)(1994-3#1)
small-molecule crystallography##2##2##(2006-4#2)
small-molecule##12##1##(1997-3#1)(1997-4#1)(2006-4#3)(2008-12#1)(2008-3#1)(2010-11#1)(2010-12#2)(2010-4#1)(2013-1#1)
small-particle##2##1##(1996-1#1)(2008-2#1)
small-plot##2##1##(2011-2#2)
small-scale experiments##2##2##(2008-11#1)(2008-3#1)
small-scale studies##2##2##(2011-1#1)(2013-1#1)
small-scale##33##1##(1994-8#2)(1995-6#1)(2007-12#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-7#1)
small-signal gain##3##2##(2007-12#2)(2008-3#1)
small-signal gains##2##2##(2007-11#1)(2008-3#1)
small-signal##13##1##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#4)
small-size##3##1##(1990-5#1)(2008-10#1)(2008-6#1)
small-sized##4##1##(1994-10#1)(2007-11#1)(2008-10#2)
small-solute##3##1##(2007-12#2)(2011-2#1)
small-spored Alternaria##3##2##(2008-10#3)
small-vessel##4##1##(2007-10#2)(2007-8#1)(2010-6#1)
small-volume##4##1##(2007-12#1)(2008-3#2)(2009-9#1)
small-world##4##1##(2008-11#4)
smaller adult##2##2##(2008-8#1)(2010-2#1)
smaller amounts of##2##3##(1996-5#1)(2008-2#1)
smaller amounts##4##2##(1992-9#1)(1996-5#1)(1997-1#1)(2008-2#1)
smaller and more##3##3##(1996-2#1)(2008-4#1)(2013-7#1)
smaller and##12##2##(1995-3#1)(1996-2#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
smaller at##2##2##(2007-5#1)(2008-6#1)
smaller brains##2##2##(1996-5#1)(2012-3#1)
smaller breeds##2##2##(1996-12#2)
smaller but##5##2##(1991-5#1)(1994-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
smaller changes##2##2##(1994-6#1)(2012-3#1)
smaller companies##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
smaller compared##2##2##(2008-3#1)(2012-12#1)
smaller difference between##2##3##(2008-10#1)(2011-1#1)
smaller field of view##2##4##(2008-2#1)(2008-3#1)
smaller for##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
smaller genomes##2##2##(2008-8#2)
smaller geographic areas##2##3##(1994-3#1)(2008-10#1)
smaller geographic##3##2##(1994-3#1)(1994-6#1)(2008-10#1)
smaller head circumference##2##3##(2008-11#1)(2008-12#1)
smaller hospitals##3##2##(1990-11#1)(1992-6#1)(1993-6#1)
smaller in the##4##3##(1996-2#1)(1996-7#1)(2008-7#1)(2012-2#1)
smaller in##17##2##(1991-11#1)(1991-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
smaller increases in##3##3##(1993-3#1)(2008-12#1)(2010-6#1)
smaller lesions##3##2##(1997-3#1)(2008-10#2)
smaller loss##2##2##(2008-3#1)(2008-5#1)
smaller mRNA species##2##3##(1990-11#1)(1992-12#1)
smaller number of##3##3##(1993-12#1)(2011-2#1)(2012-2#1)
smaller numbers##3##2##(1990-12#1)(1991-12#1)(1996-5#1)
smaller ones##4##2##(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#1)
smaller particles##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
smaller peaks##2##2##(2008-10#1)(2009-11#1)
smaller population##2##2##(1996-5#1)(1997-2#1)
smaller pore##2##2##(2008-5#1)(2008-7#1)
smaller propagule size##2##3##(2008-8#2)
smaller proportion of the##2##4##(1994-3#1)(2008-10#1)
smaller protein##2##2##(1993-12#1)(2008-9#1)
smaller sample volumes##2##3##(2008-10#1)(2008-9#1)
smaller sample##4##2##(2008-10#3)(2008-9#1)
smaller segments##2##2##(2008-10#1)(2008-5#1)
smaller size##5##2##(1992-6#1)(1993-2#1)(2008-7#1)(2008-9#1)(2010-6#1)
smaller species##3##2##(2008-8#1)(2008-9#2)
smaller test##2##2##(1995-2#1)(2008-10#1)
smaller than 0##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
smaller than 1##5##3##(2007-12#1)(2008-10#3)(2008-2#1)
smaller than 2##2##3##(1995-4#1)(2008-10#1)
smaller than 5##2##3##(2008-10#1)(2010-12#1)
smaller than a##2##3##(2008-3#1)(2008-9#1)
smaller than approximately##2##3##(2008-3#2)
smaller than at pH##2##4##(2008-10#2)
smaller than for##2##3##(1993-8#1)(2008-11#1)
smaller than half of the##2##5##(2008-3#2)
smaller than half##3##3##(2008-2#1)(2008-3#2)
smaller than in the##3##4##(2008-5#1)(2009-6#1)(2013-8#1)
smaller than in##6##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-8#1)
smaller than one##2##3##(1997-1#1)(2008-10#1)
smaller than that between##2##4##(2008-10#1)(2011-1#1)
smaller than that for a##2##5##(2008-2#1)(2008-3#1)
smaller than that for##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
smaller than that in##3##4##(1993-8#1)(2008-10#1)(2012-12#1)
smaller than that obtained##2##4##(2008-10#2)
smaller than that of the##6##5##(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
smaller than that of##12##4##(1995-6#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)
smaller than that##25##3##(1992-3#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#3)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
smaller than the center wavelength of##2##6##(2007-11#2)
smaller than the extension of the##2##6##(2013-7#2)
smaller than the ligand##2##4##(2008-10#2)
smaller than the##31##3##(1990-7#1)(1992-10#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-7#3)(2013-8#1)
smaller than those of##4##4##(1994-5#1)(2008-3#2)(2008-5#1)
smaller than those##10##3##(1994-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#1)
smaller than##140##2##(1990-11#1)(1990-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-8#3)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#6)(2007-12#4)(2007-7#2)(2007-8#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#20)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
smaller units were caring for##2##5##(2011-2#2)
smaller units##6##2##(1990-7#1)(2011-2#3)(2012-3#2)
smaller values##2##2##(2008-12#1)(2008-6#1)
smaller volumes##2##2##(2008-10#1)(2009-7#1)
smaller voxel##2##2##(2008-7#2)
smaller when##2##2##(2008-11#1)(2008-3#1)
smaller with##2##2##(2009-3#1)(2012-2#1)
smaller##498##1##(1990-11#3)(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#4)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#5)(1993-9#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#5)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#8)(2007-12#15)(2007-5#2)(2007-7#3)(2007-8#1)(2008-10#92)(2008-11#9)(2008-12#4)(2008-2#21)(2008-3#42)(2008-4#7)(2008-5#16)(2008-6#5)(2008-7#19)(2008-8#13)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#3)(2010-8#3)(2011-1#4)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#10)(2013-1#6)(2013-7#6)(2013-8#6)
smallest chromosome##2##2##(2008-10#2)
smallest spatial##3##2##(2008-10#2)(2008-2#1)
smallest volume##2##2##(2008-7#1)(2009-7#1)
smallest##52##1##(1991-9#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#5)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#2)(2010-11#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#2)
smallpox epidemic##3##2##(1993-6#1)(2007-12#2)
smallpox##11##1##(1993-12#1)(1993-6#5)(1994-9#1)(1996-12#1)(2007-12#2)(2010-8#1)
smaragdinae##3##1##(2011-2#3)
smart cannula was##2##3##(2007-8#2)
smart cannula##5##2##(2007-8#5)
smart materials that##2##3##(2009-7#1)(2011-1#1)
smart materials##3##2##(2008-7#1)(2009-7#1)(2011-1#1)
smart pixel##3##2##(2008-3#3)
smart pixels##4##2##(2008-2#3)(2008-3#1)
smart##34##1##(1994-1#2)(1994-3#1)(1996-3#2)(1997-1#1)(2007-11#2)(2007-8#5)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#3)(2009-7#2)(2010-12#1)(2010-2#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
smart&quot##3##1##(2009-11#1)(2010-2#1)(2010-4#1)
smart-pixel array##8##2##(2008-2#5)(2008-3#3)
smart-pixel arrays##2##2##(2008-2#1)(2008-3#1)
smart-pixel devices##2##2##(2008-2#2)
smart-pixel technology##2##2##(2008-3#2)
smart-pixel##18##1##(2007-12#1)(2008-2#11)(2008-3#6)
smear and##2##2##(1990-6#1)(2007-7#1)
smear images##3##2##(2008-3#3)
smear is##3##2##(1992-3#1)(2007-8#1)(2011-2#1)
smear of##3##2##(1996-12#1)(2008-3#1)(2008-5#1)
smear screening##6##2##(2008-3#1)(2011-2#5)
smear within##2##2##(1992-8#1)(2011-2#1)
smear##50##1##(1990-3#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-6#4)(1992-1#2)(1992-3#4)(1992-8#3)(1995-3#1)(1996-12#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2011-2#10)(2012-3#2)(2013-1#1)
smear-positive PTB cases##2##3##(2013-8#2)
smear-positive##4##1##(1991-11#1)(2013-8#3)
smeared##2##1##(2008-2#1)(2013-8#1)
smearing##2##1##(2008-2#1)(2008-3#1)
smears and##8##2##(1990-12#1)(1990-6#1)(1992-10#1)(1992-3#1)(2007-7#2)(2008-9#1)(2013-8#1)
smears of##3##2##(1996-12#1)(2008-7#1)(2010-5#1)
smears were##2##2##(1990-6#1)(1992-3#1)
smears##32##1##(1990-12#2)(1990-6#5)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-3#3)(1992-8#1)(1996-12#1)(2007-7#4)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
smectic##3##1##(2007-11#3)
smectite##2##1##(2008-10#2)
smell of##2##2##(1995-6#1)(2008-2#1)
smell##16##1##(1992-5#1)(1995-5#2)(1995-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#6)
smelter##6##1##(1992-3#1)(1995-11#3)(2008-11#1)(2012-1#1)
smelting##4##1##(1997-6#1)(2008-10#3)
smile##6##1##(2008-7#1)(2012-3#5)
smiles and eyebrow raises##3##4##(2010-3#3)
smiles##5##1##(2010-3#4)(2012-3#1)
smoke and those##2##3##(1994-2#1)(2008-1#1)
smoke and##9##2##(1993-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-2#1)
smoke caused##3##2##(2008-5#3)
smoke control##3##2##(1996-12#3)
smoke from##2##2##(1996-12#2)
smoke generating##2##2##(2007-11#2)
smoke in##5##2##(1991-12#1)(1991-4#1)(1993-8#1)(1996-12#1)(2008-11#1)
smoke is##4##2##(1991-12#1)(1992-9#1)(1996-12#2)
smoke on##6##2##(1991-4#2)(1991-9#1)(2008-5#2)(2012-12#1)
smoke or##2##2##(1991-12#1)(1993-8#1)
smoke production##2##2##(1993-12#1)(1996-12#1)
smoke toxicity testing##2##3##(1996-12#2)
smoke toxicity##5##2##(1996-12#5)
smoke was##2##2##(2008-5#1)(2011-1#1)
smoke while##2##2##(1991-11#1)(2010-5#1)
smoke##120##1##(1991-11#4)(1991-12#3)(1991-3#1)(1991-4#5)(1991-9#3)(1992-3#1)(1992-5#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-8#5)(1994-2#2)(1994-3#1)(1995-6#1)(1996-12#30)(1996-3#2)(1996-6#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#8)(2008-3#1)(2008-5#12)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#8)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
smoke-free##7##1##(1990-6#1)(1991-5#3)(1995-6#2)(1996-12#1)
smoke-induced##2##1##(1991-9#1)(2008-5#1)
smoke?##2##1##(2010-9#1)(2011-2#1)
smoked more##2##2##(1991-11#1)(1993-11#1)
smoked##23##1##(1990-6#1)(1991-1#1)(1991-11#3)(1993-11#1)(1996-6#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
smokeless powders##2##2##(2008-10#2)
smokeless tobacco use##2##3##(2008-4#2)
smokeless tobacco using patients enrolled)##2##5##(2008-4#2)
smokeless tobacco##7##2##(2008-4#7)
smokeless##9##1##(2008-10#2)(2008-4#7)
smoker (n =##2##3##(2008-12#2)
smoker##19##1##(1991-4#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-12#4)(2008-6#1)(2012-12#3)(2012-3#1)(2013-1#2)
smokers (N =##2##3##(2007-12#1)(2012-3#1)
smokers and non-smokers##5##3##(2008-10#1)(2008-12#3)(2008-7#1)
smokers and nonsmokers##3##3##(2008-10#2)(2009-5#1)
smokers and##18##2##(2008-10#6)(2008-11#1)(2008-12#5)(2008-7#2)(2009-5#1)(2013-1#3)
smokers are##3##2##(1996-3#1)(1996-9#1)(2008-12#1)
smokers by##3##2##(1993-8#3)
smokers continue to##2##3##(2010-2#1)(2013-1#1)
smokers had##3##2##(2008-10#1)(2008-12#1)(2010-7#1)
smokers in the##2##3##(2008-10#1)(2010-11#1)
smokers in##6##2##(2008-10#1)(2008-12#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
smokers or ex-smokers##2##3##(1991-3#2)
smokers or##3##2##(1991-3#2)(2008-4#1)
smokers than non-smokers##3##3##(1992-9#1)(2008-10#2)
smokers using##2##2##(2009-7#1)(2010-11#1)
smokers was##2##2##(2009-5#1)(2011-2#1)
smokers were##2##2##(1994-6#1)(2010-11#1)
smokers who##4##2##(1997-4#1)(2013-1#3)
smokers with##3##2##(1992-9#1)(2008-6#1)(2013-1#1)
smokers##146##1##(1990-2#1)(1990-6#2)(1991-1#1)(1991-3#2)(1991-4#5)(1991-9#2)(1992-2#1)(1992-9#5)(1993-1#1)(1993-11#1)(1993-2#4)(1993-6#2)(1993-8#3)(1994-6#6)(1995-12#1)(1995-6#1)(1996-3#7)(1996-8#2)(1996-9#1)(1997-4#1)(2006-10#1)(2007-12#8)(2007-7#1)(2008-10#15)(2008-11#2)(2008-12#11)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-5#5)(2009-7#2)(2010-11#5)(2010-2#2)(2010-7#1)(2011-2#7)(2012-3#6)(2013-1#14)(2013-8#5)
smokers'##4##1##(1993-8#1)(1995-6#1)(2008-11#1)(2011-2#1)
smoking abstinence##5##2##(2010-11#3)(2010-4#1)(2013-1#1)
smoking among##10##2##(1991-11#3)(1991-4#1)(1991-9#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#2)
smoking and ethnicity##2##3##(2008-1#1)(2013-8#1)
smoking and its##2##3##(2009-5#1)(2013-1#1)
smoking and lung cancer##4##4##(1996-3#1)(2013-1#3)
smoking and the risk of##2##5##(2008-12#1)(2011-2#1)
smoking and the##5##3##(1995-6#1)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)
smoking and##29##2##(1991-11#1)(1991-5#2)(1991-9#1)(1992-6#1)(1995-6#2)(1996-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#4)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#6)(2013-8#1)
smoking are##5##2##(1994-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
smoking at Wave 1 were##2##5##(2013-8#2)
smoking at##7##2##(1991-11#1)(1991-9#1)(1997-3#1)(1997-4#1)(2010-11#1)(2013-8#2)
smoking behavior##5##2##(1991-1#1)(2008-8#2)(2010-2#1)(2010-9#1)
smoking behaviour##3##2##(1990-9#1)(1995-6#1)(2010-12#1)
smoking by doctors##2##3##(2008-10#2)
smoking cessation among##2##3##(2007-12#1)(2010-4#1)
smoking cessation and##5##3##(1991-4#1)(2007-12#1)(2008-7#1)(2013-1#2)
smoking cessation education##4##3##(2012-3#4)
smoking cessation in##5##3##(2008-6#1)(2009-7#2)(2011-1#1)(2011-2#1)
smoking cessation interventions##5##3##(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
smoking cessation programs##2##3##(1991-12#1)(2008-8#1)
smoking cessation rate##2##3##(1991-11#1)(2008-11#1)
smoking cessation rates##2##3##(2008-11#2)
smoking cessation training##2##3##(2011-2#2)
smoking cessation##61##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1994-11#1)(1994-2#1)(1995-3#1)(1997-4#2)(2007-12#3)(2008-11#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-7#6)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#7)(2012-3#9)(2013-1#11)
smoking during pregnancy##5##3##(1991-11#1)(1995-6#1)(1997-7#2)(2012-2#1)
smoking during##6##2##(1991-11#2)(1995-6#1)(1997-7#2)(2012-2#1)
smoking for##3##2##(1995-6#2)(2012-12#1)
smoking habit##5##2##(1991-12#1)(1993-6#1)(2008-12#1)(2009-5#1)(2011-1#1)
smoking habits in##2##3##(1993-2#1)(1995-6#1)
smoking habits##17##2##(1990-2#4)(1991-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-6#3)(1996-3#1)(2008-8#1)(2009-5#2)(2012-12#1)(2013-1#1)
smoking histories##2##2##(1991-12#1)(1992-6#1)
smoking history##5##2##(1993-1#1)(1996-3#2)(2009-4#1)(2009-5#1)
smoking in pregnancy##5##3##(1992-11#1)(1995-6#3)(2010-6#1)
smoking in public places##2##4##(1991-5#1)(1996-1#1)
smoking in the##3##3##(1991-5#1)(2008-1#1)(2013-1#1)
smoking in##20##2##(1990-6#1)(1991-5#2)(1991-9#1)(1992-11#1)(1995-6#3)(1996-1#1)(1996-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-6#1)(2013-1#1)
smoking initiation##2##2##(2008-8#1)(2010-11#1)
smoking is a##2##3##(2011-1#1)(2013-1#1)
smoking is associated with a##2##5##(2008-4#1)(2011-2#1)
smoking is associated with##3##4##(2008-12#1)(2008-4#1)(2011-2#1)
smoking is##10##2##(2008-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#3)
smoking maintenance##2##2##(2010-2#2)
smoking norms and##2##3##(2010-2#1)(2013-1#1)
smoking on##13##2##(1990-6#1)(1992-3#1)(1992-9#1)(1995-6#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2009-12#1)(2012-3#2)
smoking or##4##2##(1990-9#1)(2008-7#1)(2009-5#1)(2013-8#1)
smoking prevalence##9##2##(1994-6#3)(1996-3#3)(2008-7#1)(2011-2#2)
smoking rate##3##2##(2007-7#1)(2008-2#1)(2009-5#1)
smoking rates and##2##3##(2011-2#1)(2013-1#1)
smoking rates##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
smoking related##2##2##(1997-7#1)(2010-2#1)
smoking status and##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
smoking status of##5##3##(2008-12#1)(2009-5#4)
smoking status##17##2##(2007-12#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-5#5)(2011-2#5)(2012-12#1)(2013-1#1)
smoking was##11##2##(1992-10#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-7#1)(2010-2#2)(2011-2#1)(2013-1#2)
smoking were##7##2##(1996-3#1)(2007-10#1)(2009-5#1)(2010-11#1)(2010-2#2)(2013-8#1)
smoking##425##1##(1990-12#1)(1990-2#6)(1990-6#7)(1990-9#2)(1991-1#4)(1991-11#12)(1991-12#8)(1991-4#3)(1991-5#4)(1991-6#1)(1991-9#10)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#5)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#7)(1995-3#1)(1995-6#15)(1996-1#2)(1996-3#12)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-10#1)(2007-10#4)(2007-12#6)(2007-2#2)(2007-7#5)(2007-8#1)(2008-1#7)(2008-10#14)(2008-11#10)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#14)(2008-8#12)(2009-12#2)(2009-4#3)(2009-5#22)(2009-7#10)(2010-11#6)(2010-12#2)(2010-2#15)(2010-4#5)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#9)(2011-2#30)(2012-12#4)(2012-2#2)(2012-3#11)(2013-1#48)(2013-8#11)
smoking-negative samples##2##2##(2010-4#2)
smoking-related TP53 mutation##2##3##(2011-2#2)
smoking?##2##1##(2006-10#1)(2007-2#1)
smoking]##6##1##(1991-4#1)(1995-12#1)(1996-3#2)(2008-10#1)(2013-8#1)
smooth and the##2##3##(2007-12#1)(2008-7#1)
smooth and##8##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)
smooth as##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
smooth endoplasmic reticulum and##2##4##(2007-12#2)
smooth muscle actin and##2##4##(2008-11#1)(2010-12#1)
smooth muscle actin##7##3##(1994-12#1)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
smooth muscle and##8##3##(1990-8#1)(1991-12#1)(1991-8#1)(1992-3#1)(1995-12#1)(1997-4#1)(1997-7#1)(2011-2#1)
smooth muscle are##2##3##(1994-8#1)(2010-1#1)
smooth muscle by##3##3##(1990-8#1)(1993-6#1)(1994-11#1)
smooth muscle cell proliferation##5##4##(1990-7#2)(2008-10#1)(2008-7#1)(2010-12#1)
smooth muscle cell##16##3##(1990-7#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
smooth muscle cells (SMC)##3##4##(1994-11#1)(2008-4#2)
smooth muscle cells and fibroblasts##3##5##(1990-2#2)(1997-1#1)
smooth muscle cells and##4##4##(1990-2#2)(1995-2#1)(1997-1#1)
smooth muscle cells are##2##4##(1990-12#1)(2009-7#1)
smooth muscle cells from##4##4##(1990-2#1)(1991-12#1)(1994-11#1)(1995-11#1)
smooth muscle cells in the media##2##6##(1995-12#1)(2009-1#1)
smooth muscle cells in the##3##5##(1993-2#1)(1995-12#1)(2009-1#1)
smooth muscle cells in##4##4##(1993-2#1)(1995-12#1)(2008-7#1)(2009-1#1)
smooth muscle cells is##3##4##(1990-12#1)(1990-8#1)(1992-9#1)
smooth muscle cells stimulated##2##4##(1990-7#1)(1995-2#1)
smooth muscle cells to##3##4##(1990-12#1)(1993-8#1)(1995-11#1)
smooth muscle cells was##3##4##(1990-7#1)(1994-11#1)(2008-11#1)
smooth muscle cells were##3##4##(1990-8#2)(1992-8#1)
smooth muscle cells##100##3##(1990-12#5)(1990-2#4)(1990-7#6)(1990-8#5)(1991-12#2)(1991-5#1)(1992-12#2)(1992-3#1)(1992-8#3)(1992-9#3)(1993-2#2)(1993-3#4)(1993-8#2)(1994-11#7)(1994-6#2)(1994-9#2)(1995-11#7)(1995-12#5)(1995-2#8)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-4#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
smooth muscle cells]##2##3##(2010-12#1)(2011-2#1)
smooth muscle contraction in##2##4##(1990-12#1)(1991-12#1)
smooth muscle contraction##5##3##(1990-12#1)(1991-12#2)(1994-8#1)(1997-7#1)
smooth muscle fibres##2##3##(2007-8#1)(2008-10#1)
smooth muscle is##2##3##(1994-8#1)(1995-8#1)
smooth muscle myosin light chain kinase##5##6##(1991-2#2)(1992-9#1)(1993-8#2)
smooth muscle myosin##6##3##(1991-2#2)(1991-5#1)(1992-9#1)(1993-8#2)
smooth muscle of the##2##4##(1991-5#1)(1997-4#1)
smooth muscle of##6##3##(1991-5#1)(1993-8#2)(1994-9#1)(1997-4#1)(2012-3#1)
smooth muscle relaxant##2##3##(1992-9#1)(1997-4#1)
smooth muscle relaxation##4##3##(1991-9#1)(1992-6#2)(1993-6#1)
smooth muscle tumor##2##3##(1990-10#1)(1994-6#1)
smooth muscle##226##2##(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#4)(1990-7#8)(1990-8#8)(1991-12#5)(1991-2#3)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#3)(1992-12#4)(1992-3#2)(1992-6#3)(1992-8#4)(1992-9#10)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#3)(1993-8#8)(1993-9#1)(1994-11#11)(1994-12#1)(1994-6#5)(1994-8#6)(1994-9#4)(1995-11#8)(1995-12#12)(1995-2#8)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#4)(1997-3#1)(1997-4#4)(1997-7#2)(1997-8#1)(2006-6#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#2)(2009-7#1)(2010-1#2)(2010-12#5)(2010-3#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
smooth muscle-specific##2##2##(2008-6#1)(2009-2#1)
smooth muscles##5##2##(1994-5#1)(1995-12#2)(1997-4#1)(1997-7#1)
smooth or##2##2##(2008-3#2)
smooth pursuit##3##2##(2008-7#1)(2009-8#2)
smooth septate junctions##4##3##(2008-7#4)
smooth surface##6##2##(1994-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
smooth tongue sole##2##3##(2013-8#2)
smooth transition##2##2##(2008-6#1)(2013-1#1)
smooth tuning of the##3##4##(2007-11#1)(2007-12#2)
smooth##344##1##(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#4)(1990-7#10)(1990-8#8)(1991-12#5)(1991-2#3)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#3)(1992-12#4)(1992-3#2)(1992-6#3)(1992-8#4)(1992-9#10)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#3)(1993-8#8)(1993-9#2)(1994-11#11)(1994-12#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#4)(1995-11#8)(1995-12#15)(1995-2#8)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#4)(1997-3#1)(1997-4#5)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#11)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#6)(2008-6#12)(2008-7#14)(2008-8#6)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-7#3)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#4)
smoothed##4##1##(1995-2#1)(2008-10#1)(2008-2#1)(2009-12#1)
smoother##7##1##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
smoothing factor gamma##2##3##(2008-2#2)
smoothing in##3##2##(2007-11#1)(2008-3#1)(2009-7#1)
smoothing of##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
smoothing parameter for##2##3##(2009-10#2)
smoothing parameter##5##2##(2009-10#4)(2010-5#1)
smoothing##43##1##(1990-8#1)(1994-11#1)(1997-3#1)(2007-11#5)(2008-10#3)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2009-10#6)(2009-12#1)(2009-7#3)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#3)
smoothly over##2##2##(2008-2#1)(2008-3#1)
smoothly tunable##2##2##(2008-2#2)
smoothly with##2##2##(2008-7#1)(2010-4#1)
smoothly##18##1##(1996-2#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2010-1#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
smoothness and##5##2##(2008-3#1)(2008-5#2)(2008-6#2)
smoothness of##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2010-6#1)
smoothness##16##1##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2010-6#1)(2011-2#2)
smut fungi##3##2##(2008-10#3)
smut##13##1##(2008-10#11)(2008-8#1)(2009-8#1)
sn-1##6##1##(1990-2#1)(1990-7#2)(1992-8#1)(1995-8#1)(2012-2#1)
sn-2 of##2##2##(1994-12#1)(2013-1#1)
sn-2##7##1##(1990-2#2)(1990-7#1)(1994-12#2)(2012-2#1)(2013-1#1)
sn-glycerol-3-phosphate##2##1##(1990-5#1)(1995-6#1)
snRNA##5##1##(1995-6#1)(2008-1#1)(2008-2#1)(2008-9#1)(2013-8#1)
snRNAs##2##1##(1995-6#1)(2007-12#1)
snRNP##9##1##(1991-6#1)(1993-6#1)(1993-8#1)(1995-6#2)(1997-9#1)(2007-12#2)(2013-8#1)
snRNP-specific##3##1##(1991-6#3)
snRNPs##7##1##(1993-8#3)(1995-6#3)(2013-8#1)
snack##2##1##(2008-3#1)(2010-10#1)
snacks##5##1##(2007-10#1)(2008-10#1)(2011-1#1)(2012-1#2)
snail and oyster samples##2##4##(1997-4#2)
snail and##7##2##(1997-4#3)(2007-12#1)(2008-12#2)(2008-8#1)
snail areas##2##2##(2012-3#2)
snail control##2##2##(2012-3#2)
snail habitats##3##2##(2008-8#3)
snail species##3##2##(2008-8#3)
snail surveillance is##2##3##(2012-3#2)
snail##50##1##(1991-5#1)(1993-11#1)(1993-6#2)(1994-6#1)(1995-5#2)(1997-4#5)(2007-12#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-7#1)(2008-8#14)(2009-8#1)(2011-2#1)(2012-3#9)
snails Helix##2##2##(2008-12#2)
snails and##3##2##(2010-4#1)(2012-3#2)
snails in##2##2##(2008-5#1)(2012-3#1)
snails were##3##2##(2008-11#1)(2008-12#1)(2012-3#1)
snails##37##1##(1997-6#1)(2007-5#1)(2008-11#4)(2008-12#10)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-4#3)(2011-2#2)(2012-2#1)(2012-3#7)(2013-8#1)
snake muscle fructose-1##3##3##(2008-9#3)
snake venom##8##2##(1992-3#1)(1993-3#3)(1995-5#1)(1997-2#1)(2008-5#2)
snake##46##1##(1991-6#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-3#3)(1995-5#2)(1996-12#2)(1997-2#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#4)(2009-7#1)(2010-3#8)(2010-8#1)(2012-2#3)(2013-1#1)
snake-bite##2##1##(1991-8#1)(2008-4#1)
snakes and##3##2##(2008-8#1)(2010-3#1)(2012-2#1)
snakes as##2##2##(2010-3#1)(2012-2#1)
snakes based on##2##3##(1996-12#1)(2008-6#1)
snakes fed##2##2##(1996-12#2)
snakes##25##1##(1996-12#7)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-3#6)(2010-8#1)(2012-2#3)
snap and dry bean##2##4##(2008-10#2)
snap bean##11##2##(2008-10#11)
snap##17##1##(1996-2#1)(2008-10#15)(2012-3#1)
snapper##2##1##(2008-10#1)(2010-8#1)
snapping##3##1##(2008-8#1)(2009-10#2)
snapshot of the##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
snapshot##10##1##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-6#1)(2011-2#1)(2012-3#1)
snapshots of##2##2##(2008-2#1)(2008-3#1)
snare##3##1##(2008-5#1)(2013-8#2)
sneezing##7##1##(2008-3#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
sniffing##4##1##(1995-12#1)(1997-2#1)(2008-10#1)(2012-1#1)
snoRNA gene##4##2##(2008-8#4)
snoRNA genes##3##2##(1997-7#1)(2008-8#2)
snoRNA##10##1##(1997-7#1)(1997-8#1)(2008-8#8)
snoRNAs in##2##2##(1997-7#2)
snoRNAs##6##1##(1997-7#4)(2008-1#1)(2008-8#1)
snook##5##1##(2013-7#5)
snorted cocaine##2##2##(2013-8#2)
snout##2##1##(2013-7#2)
snow albedo##2##2##(2008-3#2)
snow and lake water samples##2##5##(2008-10#2)
snow and##3##2##(2008-10#3)
snow cover by##2##3##(2008-10#1)(2008-3#1)
snow cover##8##2##(2008-10#4)(2008-3#4)
snow molds##6##2##(2008-10#6)
snow##38##1##(1993-3#3)(2008-10#18)(2008-3#13)(2011-2#1)(2012-6#1)(2013-8#2)
snow-covered##2##1##(2008-3#2)
snow-field site##2##2##(2008-3#2)
snowball sampling##2##2##(2011-1#1)(2013-8#1)
so a##8##2##(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-3#1)(2011-2#2)
so and##4##2##(1990-2#1)(1996-3#1)(2007-12#1)(2008-5#1)
so are the##3##3##(1994-11#1)(1997-8#1)(2008-3#1)
so are##5##2##(1994-11#1)(1997-8#1)(2008-3#1)(2011-1#1)(2013-8#1)
so as not to##4##4##(1992-6#2)(2008-12#1)(2008-2#1)
so as to avoid##3##4##(1996-11#1)(2008-3#1)(2013-8#1)
so as to better##2##4##(2008-12#1)(2013-8#1)
so as to have##3##4##(2006-6#1)(2008-12#1)(2010-8#1)
so as to improve##2##4##(2008-5#1)(2009-10#1)
so as to optimize##2##4##(2008-10#1)(2008-3#1)
so as to preserve##2##4##(2007-7#1)(2010-1#1)
so as to prevent##2##4##(2008-1#1)(2008-3#1)
so as to provide##3##4##(1995-3#1)(2011-1#1)(2012-3#1)
so as to##60##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2010-1#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-7#1)(2013-8#2)
so as##65##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#2)(1993-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#6)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2010-1#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#5)(2012-6#1)(2013-7#1)(2013-8#2)
so at 12 months##2##4##(2012-2#2)
so at the##2##3##(2008-5#1)(2008-9#1)
so at##5##2##(2007-12#1)(2008-5#1)(2008-9#1)(2012-2#2)
so called &quot##6##3##(1990-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-3#1)(2013-1#1)
so called##20##2##(1990-3#1)(1991-12#1)(1992-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#2)
so clear##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
so common##2##2##(2009-3#1)(2011-2#1)
so created##2##2##(2008-11#1)(2011-2#1)
so did##2##2##(1997-3#1)(2008-8#1)
so different##4##2##(1996-1#2)(2007-4#2)
so does the##4##3##(1994-1#1)(1995-2#1)(1996-1#1)(2008-10#1)
so each##2##2##(2008-5#1)(2008-8#1)
so far and##4##3##(2008-11#1)(2008-7#2)(2008-9#1)
so far as##4##3##(1990-10#1)(1990-9#1)(1997-6#1)(2009-8#1)
so far been reported##2##4##(1990-11#1)(1992-2#1)
so far been##15##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-2#1)(2007-12#1)(2008-1#2)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
so far developed##2##3##(1993-3#1)(2008-10#1)
so far examined##2##3##(2006-12#1)(2013-7#1)
so far has##2##3##(2007-12#1)(2008-12#1)
so far have##5##3##(1996-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2013-8#1)
so far identified##2##3##(1992-7#1)(2012-2#1)
so far in the literature##3##5##(2012-12#1)(2012-2#1)(2013-1#1)
so far in the##6##4##(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
so far in##7##3##(2007-11#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
so far investigated##2##3##(2008-12#1)(2011-1#1)
so far is##2##3##(2008-7#1)(2013-8#1)
so far not##3##3##(1991-11#1)(2008-10#1)(2010-3#1)
so far only##4##3##(1990-11#1)(2008-7#1)(2012-12#2)
so far proposed##2##3##(1996-11#1)(2008-8#1)
so far the##2##3##(1990-5#1)(2008-10#1)
so far there##2##3##(2010-5#1)(2013-8#1)
so far to##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
so far unknown##2##3##(1992-8#1)(1994-6#1)
so far##151##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-6#2)(1991-8#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#5)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#6)
so fast##2##2##(2008-3#1)(2008-9#1)
so high that##3##3##(2008-10#2)(2008-8#1)
so important in##2##3##(2008-5#1)(2008-8#1)
so important##4##2##(1990-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
so in the##5##3##(1994-2#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
so in##14##2##(1994-12#1)(1994-2#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
so is the##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
so is##5##2##(1993-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
so it can##2##3##(2008-10#2)
so it is important to##2##5##(2008-5#1)(2011-2#1)
so it is important##3##4##(2008-2#1)(2008-5#1)(2011-2#1)
so it is##9##3##(1994-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#1)
so it may##2##3##(2010-8#1)(2013-1#1)
so it was##3##3##(1996-4#1)(2008-10#1)(2008-11#1)
so it##25##2##(1994-9#1)(1995-3#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#2)(2013-1#2)
so little##2##2##(1995-6#1)(1995-9#1)
so long as##4##3##(1992-3#1)(1993-8#1)(2008-1#1)(2008-4#1)
so long to##2##3##(2007-9#1)(2008-10#1)
so long##6##2##(1992-3#1)(1993-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
so low##4##2##(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)
so many##14##2##(1992-2#2)(1993-1#2)(1994-12#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#2)(2012-12#1)
so may##2##2##(2008-7#1)(2010-10#1)
so more quickly##2##3##(2008-11#1)(2008-9#1)
so much##10##2##(1991-6#1)(1993-3#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-3#1)(2007-7#1)(2008-4#1)(2009-10#1)
so obtained can be used for##2##6##(2008-2#1)(2009-8#1)
so obtained##5##2##(2008-10#3)(2008-2#1)(2009-8#1)
so on##14##2##(1997-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-3#1)(2011-4#1)(2012-3#1)
so rapid##2##2##(2010-12#1)(2012-12#1)
so rapidly##2##2##(2008-9#1)(2011-2#1)
so severe that##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
so strong##2##2##(1992-4#1)(2008-11#1)
so strongly##3##2##(2008-10#1)(2008-8#2)
so that a##17##3##(1991-8#1)(1992-2#1)(1993-1#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
so that all##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
so that an##3##3##(1995-2#1)(2008-3#2)
so that appropriate##2##3##(1993-6#1)(2008-4#1)
so that at##2##3##(1994-2#1)(2008-7#1)
so that both##5##3##(1994-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
so that by##2##3##(2007-12#1)(2008-10#1)
so that different##2##3##(2008-10#1)(2008-3#1)
so that in##4##3##(1992-9#1)(2008-10#1)(2008-11#2)
so that it becomes##2##4##(2008-10#1)(2008-11#1)
so that it can be used##2##6##(2008-10#1)(2008-3#1)
so that it can be##4##5##(1990-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
so that it can##6##4##(1990-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)(2013-8#1)
so that it is##5##4##(1995-3#1)(2008-10#1)(2008-8#2)(2011-2#1)
so that it##23##3##(1990-9#1)(1991-8#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
so that long-term##2##3##(1992-11#1)(2008-11#1)
so that more##5##3##(2009-11#1)(2010-7#1)(2012-2#2)(2013-8#1)
so that no##2##3##(2008-11#1)(2011-2#1)
so that only##2##3##(1993-6#1)(2008-3#1)
so that possible##2##3##(1990-9#1)(1992-11#1)
so that quantitative##2##3##(2008-10#2)
so that some##2##3##(1994-2#1)(2008-10#1)
so that the model##2##4##(1996-4#1)(2008-11#1)
so that the number of##2##5##(2008-10#1)(2008-2#1)
so that the##67##3##(1991-1#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-6#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-1#1)(2011-2#6)(2012-3#1)(2013-1#1)
so that their##8##3##(2007-12#2)(2008-1#1)(2008-2#2)(2010-3#1)(2012-2#1)(2013-8#1)
so that there is##2##4##(2008-12#1)(2008-4#1)
so that these##4##3##(1992-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
so that they are##3##4##(1994-5#2)(2010-4#1)
so that they become##2##4##(2008-7#1)(2010-4#1)
so that they can be##4##5##(1994-3#1)(2008-9#2)(2011-2#1)
so that they can##7##4##(1994-3#1)(2007-2#1)(2008-9#3)(2011-1#1)(2011-2#1)
so that they were##2##4##(2008-10#2)
so that they will be more##2##6##(1997-3#1)(1997-7#1)
so that they##20##3##(1994-3#1)(1994-5#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-4#2)(2011-1#1)(2011-2#1)
so that this##2##3##(1990-6#1)(2008-2#1)
so that we##2##3##(2008-3#1)(2013-8#1)
so that##287##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-3#2)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#7)(2007-2#1)(2008-1#4)(2008-10#42)(2008-11#11)(2008-12#2)(2008-2#14)(2008-3#28)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#10)(2008-9#9)(2009-11#1)(2009-2#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#6)
so thatthe##2##2##(2008-11#2)
so the treatment##2##3##(2008-3#1)(2008-7#1)
so the##43##2##(1991-12#1)(1993-2#1)(1996-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#2)
so their analysis may require microdissection##2##6##(2008-2#1)(2008-4#1)
so their##3##2##(1995-2#1)(2008-2#1)(2008-4#1)
so these##2##2##(2008-10#1)(2010-5#1)
so they are##3##3##(1992-3#1)(2008-4#1)(2013-8#1)
so they can be##2##4##(2008-4#1)(2008-8#1)
so they can##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
so they##7##2##(1992-3#1)(1997-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-8#1)
so this##5##2##(1996-1#1)(2007-11#1)(2007-5#1)(2008-9#1)(2009-6#1)
so through##2##2##(1994-6#1)(1996-2#1)
so to##9##2##(1990-12#1)(1992-5#1)(1993-3#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-10#1)
so too have##2##3##(1996-1#1)(2008-7#1)
so too##6##2##(1996-1#2)(2008-7#3)(2012-1#1)
so was##4##2##(2008-10#1)(2008-9#2)(2011-1#1)
so we##9##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-7#1)
so well##2##2##(1991-6#1)(2008-11#1)
so when##5##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
so will##2##2##(2007-12#1)(2008-9#1)
so with the##2##3##(2007-10#1)(2008-11#1)
so with##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
so without##2##2##(1992-1#1)(2009-10#1)
so would be##3##3##(2008-7#1)(2013-1#2)
so##1053##1##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#5)(1991-1#2)(1991-11#4)(1991-12#9)(1991-2#3)(1991-3#2)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#4)(1993-11#5)(1993-12#5)(1993-2#3)(1993-3#8)(1993-6#3)(1993-8#4)(1993-9#1)(1994-1#3)(1994-11#3)(1994-12#8)(1994-2#8)(1994-3#5)(1994-5#3)(1994-6#5)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#8)(1996-11#2)(1996-12#7)(1996-2#7)(1996-3#5)(1996-4#3)(1996-5#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#7)(1997-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#3)(2007-11#11)(2007-12#29)(2007-2#2)(2007-4#3)(2007-5#2)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#13)(2008-10#133)(2008-11#42)(2008-12#17)(2008-2#30)(2008-3#48)(2008-4#16)(2008-5#24)(2008-6#13)(2008-7#52)(2008-8#38)(2008-9#34)(2009-1#3)(2009-10#12)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#12)(2010-9#2)(2011-1#11)(2011-2#43)(2011-3#3)(2011-4#1)(2012-1#2)(2012-12#16)(2012-2#14)(2012-3#14)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#27)(2013-7#4)(2013-8#27)
so-Gal4##3##1##(2007-12#3)
so-called &quot##18##2##(1990-6#1)(1990-8#2)(1991-2#1)(1991-3#2)(1993-3#1)(1993-6#1)(1994-8#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#2)
so-called DNA##2##2##(1995-5#1)(2010-8#1)
so-called fusiform##2##2##(2007-8#1)(2008-10#1)
so-called hairy length##2##3##(2008-7#2)
so-called individual##2##2##(2008-2#1)(2008-5#1)
so-called natural##2##2##(2008-3#1)(2008-5#1)
so-called nerve endings##2##3##(1990-11#2)
so-called##142##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#3)(1991-2#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#6)(2009-11#3)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#6)(2012-3#1)(2012-5#1)
soaked in a##3##3##(2008-10#3)
soaked in##4##2##(1993-8#1)(2008-10#3)
soaked##12##1##(1993-8#1)(2008-10#8)(2008-12#1)(2011-2#1)(2012-3#1)
soaking in##3##2##(2006-11#1)(2008-12#1)(2008-2#1)
soaking##9##1##(2006-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-8#1)(2013-1#1)
soap and water##2##3##(2007-12#1)(2008-5#1)
soap and##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
soap##13##1##(2007-12#2)(2008-10#6)(2008-5#4)(2012-12#1)
soapnut##5##1##(2009-3#5)
soaps and##2##2##(2008-5#2)
soaps##7##1##(2008-10#2)(2008-5#5)
soapy##2##1##(1990-3#1)(2008-5#1)
soar##2##1##(1991-9#1)(1996-8#1)
soccer player##5##2##(2006-10#2)(2008-9#1)(2011-2#2)
soccer players##6##2##(1996-6#1)(2008-5#4)(2010-3#1)
soccer##19##1##(1996-6#7)(2006-10#2)(2008-5#4)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-3#1)
sociability##3##1##(2008-1#1)(2008-5#1)(2011-2#1)
social Hymenoptera##3##2##(2008-8#3)
social acceptance##2##2##(2010-4#1)(2013-8#1)
social action in##2##3##(1996-1#1)(2009-11#1)
social action##3##2##(1996-1#1)(2008-5#1)(2009-11#1)
social activities##2##2##(1996-3#1)(2010-11#1)
social adjustment##2##2##(1990-2#1)(1996-1#1)
social and academic##5##3##(1993-1#1)(2008-12#4)
social and behavioral##2##3##(1996-2#1)(1996-4#1)
social and communication##2##3##(2008-6#1)(2012-2#1)
social and cultural##7##3##(1990-3#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
social and demographic##2##3##(2008-9#1)(2013-1#1)
social and economic development##3##4##(1994-9#1)(2008-11#1)(2009-7#1)
social and economic impact##2##4##(2008-7#1)(2011-2#1)
social and economic##17##3##(1991-3#1)(1992-12#1)(1994-9#1)(1996-1#1)(1996-4#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
social and economical practice opportunity benefits associated with our rural location##2##11##(1994-1#2)
social and emotional##5##3##(2008-11#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-8#1)
social and environmental factors##2##4##(2008-11#1)(2011-2#1)
social and environmental##3##3##(2008-11#2)(2011-2#1)
social and health##2##3##(2011-2#1)(2013-1#1)
social and nonsocial##2##3##(2008-11#1)(2009-8#1)
social and past-temporal##2##3##(2009-5#2)
social and physical##2##3##(2012-2#2)
social and political##6##3##(1991-12#1)(1991-6#1)(1993-11#1)(2008-11#1)(2010-12#1)(2013-1#1)
social and professional##3##3##(2009-10#1)(2012-12#1)(2013-1#1)
social and psychological##5##3##(1992-5#1)(1994-3#1)(2007-12#1)(2008-4#1)(2008-5#1)
social and##90##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#2)(1994-1#2)(1994-3#1)(1994-9#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#4)(2009-10#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#4)(2013-1#5)(2013-8#1)
social and/or##2##2##(2011-2#2)
social animals##2##2##(2008-9#1)(2009-8#1)
social anxiety disorder##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
social anxiety##5##2##(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#2)
social aspects of##3##3##(1993-11#1)(1996-11#1)(2007-10#1)
social aspects##6##2##(1990-12#1)(1993-11#1)(1996-11#1)(2007-10#1)(2011-2#1)(2012-12#1)
social awareness##2##2##(2008-12#1)(2013-1#1)
social behavior in##3##3##(1992-6#1)(2008-8#1)(2009-4#1)
social behavior is##3##3##(2008-10#2)(2008-8#1)
social behavior##22##2##(1992-6#1)(1995-12#1)(2008-10#5)(2008-11#4)(2008-8#3)(2009-4#1)(2009-9#2)(2010-3#1)(2010-4#1)(2012-12#2)(2012-3#1)
social behaviors##3##2##(2008-10#1)(2009-4#2)
social behaviour##2##2##(1991-5#1)(2010-10#1)
social benefits to##2##3##(2008-9#1)(2010-7#1)
social capital##10##2##(2008-7#3)(2010-2#2)(2011-2#1)(2012-12#3)(2012-3#1)
social care##19##2##(1992-11#1)(1992-2#1)(1992-5#1)(1995-11#1)(1996-8#1)(2007-8#1)(2008-11#8)(2008-12#3)(2008-5#1)(2013-8#1)
social change##4##2##(2008-1#3)(2008-12#1)
social class##8##2##(1992-8#4)(1996-9#1)(1997-3#1)(2007-2#1)(2010-8#1)
social classes##5##2##(1990-12#1)(1991-9#3)(2008-9#1)
social climate##3##2##(2007-10#1)(2008-7#1)(2009-7#1)
social cognition in##2##3##(2012-1#1)(2012-12#1)
social cognition##10##2##(2008-11#5)(2009-9#1)(2012-1#2)(2012-12#1)(2013-1#1)
social cognitive##5##2##(2008-11#2)(2012-12#1)(2013-1#2)
social cohesion##3##2##(2008-7#1)(2009-9#1)(2012-1#1)
social communication##2##2##(1995-5#1)(2009-10#1)
social comparison##3##2##(2007-12#2)(2012-2#1)
social comparisons with##2##3##(2007-12#2)
social comparisons##4##2##(2007-12#4)
social competence and self-regulation##2##4##(2008-12#2)
social competence and##4##3##(2008-12#2)(2010-11#2)
social competence##9##2##(1996-1#1)(2008-11#1)(2008-12#3)(2008-9#1)(2010-11#3)
social complexity##3##2##(2009-8#3)
social concerns##2##2##(2008-12#1)(2011-1#1)
social condition##2##2##(1991-6#1)(2007-11#1)
social conditions##3##2##(1994-6#1)(1995-11#1)(2010-12#1)
social connectedness##2##2##(2013-1#2)
social consequences of##2##3##(2012-2#1)(2013-1#1)
social consequences##6##2##(1990-3#1)(1991-12#1)(1995-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
social contact with##2##3##(1997-1#1)(1997-2#1)
social contact##4##2##(1997-1#1)(1997-2#1)(2011-2#1)(2012-1#1)
social contacts##2##2##(1996-11#1)(2007-1#1)
social context in which##2##4##(1992-1#1)(2009-10#1)
social context of##2##3##(1993-1#1)(2008-11#1)
social context##13##2##(1992-1#1)(1993-1#1)(2008-11#2)(2009-10#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2013-1#1)
social contexts##2##2##(2008-4#1)(2010-4#1)
social contract&quot##2##2##(1995-1#1)(2008-9#1)
social contracts##2##2##(2008-9#2)
social control##8##2##(1996-1#1)(2009-7#3)(2009-9#1)(2010-7#1)(2011-2#2)
social cost##2##2##(2010-11#1)(2010-5#1)
social costs##3##2##(1991-6#1)(2008-11#1)(2012-12#1)
social desirability##2##2##(1990-6#1)(2013-1#1)
social determinants of health##4##4##(2011-1#1)(2011-2#1)(2013-1#2)
social determinants of##5##3##(2011-1#1)(2011-2#2)(2013-1#2)
social determinants##7##2##(2011-1#3)(2011-2#2)(2013-1#2)
social development and##4##3##(2008-8#1)(2009-9#2)(2012-2#1)
social development##8##2##(2008-8#1)(2009-9#4)(2011-2#1)(2012-12#1)(2012-2#1)
social dominance is##2##3##(2008-8#2)
social dominance##7##2##(2008-11#1)(2008-8#5)(2010-1#1)
social effects##3##2##(2008-8#2)(2009-10#1)
social environment##7##2##(2008-10#2)(2008-6#1)(2009-6#2)(2009-9#1)(2010-11#1)
social environments##4##2##(2008-1#1)(2008-9#1)(2009-5#1)(2012-12#1)
social ethic##2##2##(1992-2#1)(1992-3#1)
social events and##2##3##(2010-2#2)
social events##4##2##(2010-11#1)(2010-2#2)(2010-4#1)
social evolution and##2##3##(2008-8#1)(2010-4#1)
social evolution in##2##3##(2008-8#2)
social evolution##10##2##(2008-8#5)(2010-4#1)(2012-3#4)
social experiences##3##2##(1993-1#1)(2008-11#1)(2012-2#1)
social fabric##2##2##(1997-5#1)(2008-11#1)
social factors in stuttering##2##4##(2008-2#2)
social factors in##4##3##(1991-6#1)(2008-2#2)(2008-7#1)
social factors such as religion##2##5##(2009-6#2)
social factors such as##3##4##(2009-6#2)(2009-7#1)
social factors##15##2##(1991-6#1)(1995-9#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-7#3)(2011-2#1)(2012-12#1)
social function in##3##3##(2013-1#3)
social function##8##2##(2008-11#1)(2009-5#1)(2013-1#5)(2013-8#1)
social functioning and##3##3##(1992-5#1)(1996-1#1)(2007-11#1)
social functioning of patients##2##4##(2007-12#1)(2013-1#1)
social functioning of##4##3##(1996-1#1)(2007-12#1)(2011-2#1)(2013-1#1)
social functioning##18##2##(1992-5#1)(1996-1#5)(2007-11#2)(2007-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
social group##2##2##(2008-9#1)(2009-7#1)
social groups##8##2##(1990-12#1)(1993-1#1)(2008-11#1)(2008-8#2)(2010-4#1)(2013-1#2)
social health maintenance organization##3##4##(1991-3#1)(1992-1#1)(1997-1#1)
social health maintenance##4##3##(1991-3#2)(1992-1#1)(1997-1#1)
social health##5##2##(1991-3#2)(1992-1#1)(1997-1#1)(2008-7#1)
social hierarchy##2##2##(2008-11#2)
social identity performance can##2##4##(2008-5#2)
social identity performance##3##3##(2008-5#3)
social identity##6##2##(2008-10#1)(2008-5#5)
social impact of##2##3##(2009-10#1)(2009-5#1)
social impact##4##2##(2008-11#1)(2008-8#1)(2009-10#1)(2009-5#1)
social importance##2##2##(1991-5#1)(2010-1#1)
social inequalities##2##2##(2011-1#1)(2012-3#1)
social influences##2##2##(2009-7#1)(2012-2#1)
social information##2##2##(2007-8#1)(2008-11#1)
social insect colonies##3##3##(2008-10#1)(2008-8#2)
social insect##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
social insects##3##2##(2008-8#2)(2008-9#1)
social institutions##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
social insurance##6##2##(1995-5#3)(1996-12#1)(1996-8#1)(2008-1#1)
social intelligence##4##2##(2009-8#1)(2010-1#3)
social interaction##16##2##(1995-3#1)(1996-11#1)(1996-2#1)(2007-12#1)(2008-11#2)(2008-4#1)(2011-2#5)(2012-2#1)(2012-3#3)
social interactions and##2##3##(2010-4#2)
social interactions in##2##3##(2010-4#1)(2010-8#1)
social interactions##26##2##(1996-2#1)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-4#6)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
social isolation##7##2##(1991-2#1)(1994-12#1)(2008-11#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
social issues##3##2##(2008-12#2)(2008-4#1)
social justice##2##2##(1990-12#1)(2013-1#1)
social learning##4##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
social life##5##2##(1991-6#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-2#1)
social marketing techniques##2##3##(1997-3#2)
social marketing##4##2##(1997-3#2)(2012-1#1)(2012-3#1)
social meanings and##2##3##(2007-12#2)
social media technologies##2##3##(2012-2#2)
social media##3##2##(2012-2#3)
social memory/recognition##3##2##(1994-3#3)
social network##11##2##(1995-1#1)(2010-1#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
social networking##4##2##(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
social networks and##3##3##(2009-12#1)(2009-5#1)(2010-10#1)
social networks##7##2##(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2012-12#1)(2013-8#1)
social norms##4##2##(1993-3#1)(2007-2#1)(2012-12#1)(2013-1#1)
social or##4##2##(2008-12#1)(2008-6#1)(2009-6#1)(2011-2#1)
social organization in##2##3##(2008-11#1)(2012-2#1)
social organization##6##2##(2007-12#1)(2008-11#1)(2008-9#1)(2010-1#1)(2012-2#2)
social outcome following paediatric traumatic brain injury##2##7##(2009-10#2)
social outcome##6##2##(2009-10#6)
social participation##4##2##(2008-12#1)(2008-5#1)(2009-5#1)(2013-8#1)
social partners##3##2##(2008-8#1)(2012-3#2)
social perception##3##2##(2008-11#1)(2013-8#2)
social phenotypes##3##2##(2008-11#3)
social phobia and##2##3##(2008-4#2)
social phobia subtypes##2##3##(2008-4#1)(2010-2#1)
social phobia##30##2##(2008-1#1)(2008-4#18)(2010-2#6)(2012-12#1)(2012-2#2)(2013-1#2)
social policy##7##2##(1996-12#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
social practice##2##2##(2012-3#2)
social problem##4##2##(2007-11#2)(2008-11#1)(2009-10#1)
social problem-solving skills##3##3##(2009-10#3)
social problem-solving##4##2##(2008-11#1)(2009-10#3)
social problems such as##2##4##(1996-11#1)(2013-1#1)
social problems##6##2##(1990-11#1)(1996-11#1)(2008-1#1)(2008-10#1)(2009-7#1)(2013-1#1)
social process##2##2##(2007-11#1)(2008-12#1)
social programs##2##2##(1994-2#1)(1997-2#1)
social proximity##3##2##(2009-4#3)
social psychology##4##2##(2008-12#1)(2008-2#1)(2008-5#2)
social rank##2##2##(2008-11#2)
social recognition##3##2##(2008-11#2)(2008-4#1)
social reintegration of##2##3##(1992-1#1)(1994-5#1)
social relations##3##2##(1995-3#2)(2009-9#1)
social relationships##3##2##(2009-4#1)(2010-1#1)(2011-2#1)
social representation##6##2##(2008-9#1)(2011-2#4)(2012-3#1)
social representations of the##2##4##(2011-2#1)(2012-12#1)
social representations of##3##3##(2011-2#1)(2012-12#2)
social representations##4##2##(2011-2#1)(2012-12#2)(2012-3#1)
social research##2##2##(1997-1#1)(2011-1#1)
social resources##2##2##(1994-6#1)(2011-2#1)
social responsibility of the##2##4##(1991-6#1)(2008-10#1)
social responsibility##5##2##(1991-6#1)(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
social risk factors##2##3##(1993-3#2)
social risk##3##2##(1993-3#3)
social roles##3##2##(2008-5#2)(2012-12#1)
social science##6##2##(1995-2#1)(1996-3#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-10#1)
social sciences##11##2##(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#3)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#2)
social scientists##2##2##(1994-3#1)(2010-4#1)
social security##6##2##(1995-5#5)(2012-12#1)
social selection##6##2##(2008-8#2)(2012-3#4)
social service organizations##2##3##(1991-12#2)
social service##7##2##(1991-12#2)(1994-2#2)(1995-3#1)(1996-3#1)(2011-2#1)
social services with##2##3##(1996-12#1)(2011-2#1)
social services##26##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-11#1)(1992-12#1)(1994-1#2)(1994-12#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#4)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
social signals##2##2##(2007-8#1)(2008-11#1)
social situation##2##2##(1995-5#1)(2008-11#1)
social situations##3##2##(2008-6#1)(2010-2#1)(2010-4#1)
social skills##8##2##(2008-11#2)(2008-12#1)(2009-12#1)(2009-7#1)(2010-5#1)(2013-1#2)
social spacing##2##2##(2010-8#2)
social species##5##2##(2008-6#1)(2008-8#2)(2008-9#2)
social spending##3##2##(2013-1#3)
social spider##3##2##(2008-9#3)
social status and##3##3##(1997-2#1)(2008-11#1)(2010-8#1)
social status in##2##3##(2008-12#1)(2010-8#1)
social status##13##2##(1994-6#1)(1997-2#1)(2008-11#2)(2008-12#2)(2008-8#1)(2010-8#4)(2011-2#1)(2012-12#1)
social stress##3##2##(2008-8#1)(2010-8#1)(2011-1#1)
social structure and##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
social structure##5##2##(2008-12#3)(2008-5#1)(2013-1#1)
social structures in##2##3##(1995-6#1)(2012-12#1)
social structures##4##2##(1995-6#1)(2008-1#1)(2012-12#1)(2012-2#1)
social support and##15##3##(1992-3#3)(1996-3#1)(2009-7#4)(2010-1#2)(2010-10#1)(2010-3#2)(2012-1#1)(2013-8#1)
social support for##5##3##(1995-1#1)(2008-6#1)(2010-10#1)(2010-11#1)(2011-2#1)
social support from##5##3##(1992-3#1)(2008-12#1)(2009-7#3)
social support in##4##3##(1992-3#2)(2009-7#1)(2009-8#1)
social support networks of##2##4##(1992-3#2)
social support networks##3##3##(1992-3#2)(2009-5#1)
social support with##2##3##(2009-7#1)(2012-2#1)
social support##77##2##(1990-10#1)(1991-1#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#13)(1993-1#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#4)(1996-3#4)(2007-4#1)(2008-12#3)(2008-4#1)(2008-6#2)(2009-10#1)(2009-5#5)(2009-7#11)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
social supports##2##2##(2008-3#1)(2011-1#1)
social systems##6##2##(2008-8#1)(2010-5#1)(2012-2#4)
social ties##2##2##(2012-12#1)(2013-1#1)
social validity##3##2##(1993-1#1)(2009-11#2)
social welfare and##2##3##(2008-11#1)(2008-9#1)
social welfare##5##2##(1994-1#1)(1995-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
social withdrawal##3##2##(1996-1#1)(2008-6#1)(2012-1#1)
social work consultation##2##3##(1992-12#2)
social work##14##2##(1991-12#1)(1992-12#2)(1996-1#1)(2008-1#1)(2008-12#1)(2009-12#1)(2010-10#2)(2010-3#1)(2012-12#3)(2013-1#1)
social worker##6##2##(1991-6#1)(1993-12#1)(1995-11#1)(1996-1#1)(2012-3#1)(2013-1#1)
social workers and##3##3##(1994-3#1)(2008-1#1)(2013-1#1)
social workers##7##2##(1994-3#1)(1995-11#1)(2007-8#1)(2008-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
social##1193##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#12)(1991-9#4)(1992-1#10)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#17)(1992-5#3)(1992-6#1)(1992-8#4)(1993-1#6)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#1)(1994-1#5)(1994-11#2)(1994-12#8)(1994-2#5)(1994-3#6)(1994-5#3)(1994-6#3)(1994-9#2)(1995-1#6)(1995-11#5)(1995-12#3)(1995-2#5)(1995-3#9)(1995-4#1)(1995-5#13)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#17)(1996-11#6)(1996-12#10)(1996-2#7)(1996-3#14)(1996-4#2)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#7)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#2)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#18)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#22)(2008-10#20)(2008-11#90)(2008-12#48)(2008-2#12)(2008-3#1)(2008-4#30)(2008-5#18)(2008-6#19)(2008-7#19)(2008-8#48)(2008-9#32)(2009-10#27)(2009-11#5)(2009-12#4)(2009-4#14)(2009-5#16)(2009-6#8)(2009-7#32)(2009-8#12)(2009-9#13)(2010-1#18)(2010-10#11)(2010-11#12)(2010-12#6)(2010-2#13)(2010-3#7)(2010-4#19)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#12)(2011-1#13)(2011-2#63)(2012-1#9)(2012-12#38)(2012-2#33)(2012-3#38)(2013-1#68)(2013-8#17)
social-cognitive processing##2##2##(2008-11#2)
social-cognitive##4##1##(2008-11#3)(2012-12#1)
social-emotional growth fostering##2##3##(1990-12#2)
social-emotional##3##1##(1990-12#2)(1992-3#1)
social/health maintenance organization (S/HMO)##2##4##(1995-2#1)(1997-1#1)
social/health maintenance organization##3##3##(1995-2#2)(1997-1#1)
social/health maintenance##4##2##(1993-12#1)(1995-2#2)(1997-1#1)
sociality##12##1##(2008-8#9)(2013-1#3)
socialization and##6##2##(2008-12#1)(2009-7#4)(2010-10#1)
socialization in##2##2##(2007-4#1)(2012-12#1)
socialization of##3##2##(1991-3#1)(1992-6#1)(2010-10#1)
socialization process##2##2##(2008-5#1)(2010-10#1)
socialization##24##1##(1991-3#1)(1992-6#1)(2007-4#1)(2008-12#1)(2008-5#1)(2009-7#7)(2010-10#6)(2011-2#1)(2012-12#4)(2012-3#1)
socially constructed##2##2##(2010-7#1)(2013-1#1)
socially disadvantaged populations##2##3##(2011-2#2)
socially disadvantaged##3##2##(2010-12#1)(2011-2#2)
socially marginalized##2##2##(1993-6#1)(2012-12#1)
socially relevant##2##2##(2007-8#1)(2008-11#1)
socially##38##1##(1991-2#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-5#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-11#6)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
societal and##2##2##(1995-12#1)(2008-3#1)
societal benefit##2##2##(2007-12#1)(2008-8#1)
societal impacts##2##2##(2007-12#1)(2010-12#1)
societal pressure##2##2##(2007-12#1)(2008-1#1)
societal##34##1##(1995-12#1)(1996-3#1)(1997-1#1)(2007-12#6)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)
societies and##2##2##(2009-12#1)(2009-4#1)
societies is##3##2##(2008-10#1)(2009-12#1)(2010-12#1)
societies##61##1##(1992-1#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-11#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#5)(2009-12#3)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2011-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
society and the##4##3##(1992-6#1)(2007-8#1)(2008-12#1)(2012-2#1)
society and##17##2##(1992-6#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-2#3)(2013-1#1)(2013-8#2)
society as a whole##4##4##(1994-3#1)(1995-5#1)(2007-12#1)(2008-1#1)
society as a##5##3##(1994-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2012-1#1)
society as##7##2##(1994-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-6#1)(2012-1#1)
society at large##2##3##(1993-12#1)(2012-2#1)
society by##2##2##(2008-11#1)(2008-8#1)
society for##2##2##(2008-11#1)(2013-8#1)
society held##2##2##(1990-12#1)(2008-5#1)
society in the##2##3##(2008-8#1)(2012-2#1)
society in##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
society is##5##2##(1996-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)
society of##11##2##(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-1#1)(2012-2#2)(2012-3#1)
society that##3##2##(1993-1#1)(2008-1#1)(2008-3#1)
society to##6##2##(1991-3#1)(1992-3#1)(1992-4#1)(2007-7#1)(2008-8#1)(2008-9#1)
society##205##1##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#3)(1991-6#4)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#12)(2008-10#26)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#7)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2011-3#2)(2012-1#5)(2012-12#2)(2012-2#10)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
society's##7##1##(1990-12#1)(1992-1#1)(1993-12#1)(1995-12#1)(2008-8#1)(2012-2#2)
society]##2##1##(1993-3#1)(1996-6#1)
socio-cultural factors##2##2##(2007-12#1)(2012-12#1)
socio-cultural##8##1##(1991-6#1)(2007-12#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
socio-demographic characteristics##3##2##(2008-1#1)(2008-8#1)(2011-2#1)
socio-demographic factors##2##2##(2008-8#1)(2013-1#1)
socio-demographic variables##3##2##(2009-7#1)(2010-6#1)(2011-1#1)
socio-demographic##15##1##(2008-1#1)(2008-10#1)(2008-8#2)(2009-7#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
socio-ecological##2##1##(1997-4#1)(2012-12#1)
socio-economic and##4##2##(2008-10#1)(2010-6#2)(2012-12#1)
socio-economic development##3##2##(2007-12#2)(2013-7#1)
socio-economic factors##3##2##(2008-12#1)(2010-4#1)(2012-12#1)
socio-economic level##2##2##(2008-1#1)(2009-10#1)
socio-economic situations##2##2##(1996-12#1)(2008-7#1)
socio-economic status##7##2##(1992-2#1)(1995-6#1)(2008-1#1)(2010-11#1)(2010-6#2)(2012-3#1)
socio-economic##38##1##(1992-2#1)(1995-6#1)(1996-12#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-12#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#4)(2010-4#1)(2010-6#4)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#1)
socio-economical model##2##2##(1994-1#2)
socio-economical##3##1##(1990-12#1)(1994-1#2)
socio-economically distinct populations##2##3##(2007-12#2)
socio-emotional##3##1##(2008-11#1)(2009-11#1)(2009-9#1)
socio-occupational and health insurance##2##4##(2013-1#2)
socio-occupational##3##1##(2013-1#3)
socio-political##3##1##(2008-11#2)(2008-4#1)
sociobiology##4##1##(2010-4#4)
sociocultural##11##1##(1991-8#1)(1997-7#1)(2007-12#5)(2008-11#1)(2009-10#1)(2011-1#1)(2013-1#1)
sociodemographic and psychosocial##2##3##(2011-2#2)
sociodemographic and##6##2##(2009-5#1)(2011-2#4)(2013-1#1)
sociodemographic characteristics of##2##3##(2011-2#1)(2012-3#1)
sociodemographic characteristics##5##2##(1994-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
sociodemographic factors##4##2##(1997-4#1)(2011-2#2)(2012-2#1)
sociodemographic##25##1##(1994-1#1)(1997-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
socioeconomic and demographic factors##2##4##(2012-12#1)(2013-1#1)
socioeconomic and demographic##3##3##(1992-12#1)(2012-12#1)(2013-1#1)
socioeconomic and##8##2##(1992-12#1)(1996-3#1)(1997-3#1)(2008-1#1)(2009-5#1)(2012-12#1)(2013-1#2)
socioeconomic burden##3##2##(2010-10#1)(2012-12#1)(2012-2#1)
socioeconomic change##4##2##(1991-12#1)(2008-12#3)
socioeconomic classes##2##2##(2008-10#1)(2013-7#1)
socioeconomic condition##2##2##(2013-1#2)
socioeconomic conditions##2##2##(1994-6#1)(1997-5#1)
socioeconomic factors##3##2##(2011-2#1)(2012-12#2)
socioeconomic groups##5##2##(1995-1#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-1#1)
socioeconomic level##3##2##(1997-5#1)(2012-2#1)(2013-8#1)
socioeconomic status (SES)##4##3##(2011-1#2)(2012-12#1)(2012-2#1)
socioeconomic status and##5##3##(1993-3#1)(2007-12#1)(2009-11#1)(2011-1#2)
socioeconomic status##37##2##(1990-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-6#2)(2006-10#1)(2007-12#2)(2008-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
socioeconomic strata##5##2##(2008-1#1)(2009-12#1)(2013-1#3)
socioeconomic##113##1##(1990-2#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#2)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#4)(1995-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-5#2)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#6)(2008-10#2)(2008-11#2)(2008-12#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#5)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#7)(2011-2#7)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#5)
socioeconomically disadvantaged##2##2##(1995-2#1)(2013-8#1)
socioeconomically##3##1##(1995-2#1)(2013-1#1)(2013-8#1)
sociological##8##1##(1991-9#1)(1994-7#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
sociologists##6##1##(2008-12#6)
sociology and##2##2##(1996-1#1)(2008-12#1)
sociology of##2##2##(2008-12#2)
sociology##8##1##(1993-2#1)(1996-1#1)(2008-12#4)(2008-2#1)(2009-10#1)
sociometric popularity##2##2##(2010-1#2)
sociometric##4##1##(2010-1#2)(2013-1#2)
sociopolitical##2##1##(1993-2#1)(2011-1#1)
sociotechnical systems theory and##2##4##(1993-12#2)
sociotechnical systems##3##2##(1993-12#2)(2010-8#1)
socket##7##1##(2007-12#1)(2008-10#1)(2009-5#1)(2010-11#1)(2013-1#3)
sockeye salmon##2##2##(2008-5#1)(2010-8#1)
sockeye##3##1##(2008-5#2)(2010-8#1)
socotrana##2##1##(2008-10#2)
sod-2 was##2##2##(1996-6#2)
soda##5##1##(2008-10#5)
soda-lime##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
sodalites##7##1##(2008-10#7)
sodefrin##4##1##(2008-6#4)
sodium (Na(+))##4##2##(2008-10#1)(2008-3#1)(2010-7#1)(2012-2#1)
sodium 1##2##2##(2008-10#2)
sodium L-ascorbate##2##2##(1992-3#2)
sodium acetate and##2##3##(2008-10#2)
sodium acetate buffer##3##3##(2008-10#3)
sodium acetate##12##2##(1990-9#1)(1991-7#1)(1997-4#1)(2008-10#8)(2012-2#1)
sodium acetate-acetic acid buffer##2##4##(2008-10#2)
sodium acetate-acetic##3##2##(2008-10#2)(2009-10#1)
sodium alginate##7##2##(1992-8#1)(2010-5#4)(2011-1#1)(2011-2#1)
sodium and glucose##3##3##(1994-6#3)
sodium and potassium picrates##4##4##(2008-10#4)
sodium and potassium sensing##2##4##(2008-10#2)
sodium and potassium##13##3##(1995-8#1)(2008-10#11)(2008-4#1)
sodium and sulfate##2##3##(2008-10#1)(2008-6#1)
sodium and water retention##3##4##(1997-7#3)
sodium and water##6##3##(1997-7#3)(2008-1#2)(2013-8#1)
sodium and##39##2##(1990-5#1)(1990-6#1)(1994-6#3)(1995-8#1)(1997-7#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-2#1)(2008-4#1)(2008-6#1)(2010-2#1)(2010-3#2)(2010-5#1)(2012-2#1)(2013-8#1)
sodium arsenite##2##2##(1994-11#1)(1995-11#1)
sodium as##2##2##(1995-12#1)(2010-5#1)
sodium ascorbate##5##2##(1997-4#3)(2008-11#1)(2009-9#1)
sodium at##2##2##(2008-10#2)
sodium atom##4##2##(1996-2#4)
sodium atoms##2##2##(1996-2#1)(2007-11#1)
sodium azide##11##2##(1990-11#1)(1991-8#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
sodium balance##2##2##(2008-1#2)
sodium benzoate and##2##3##(2008-6#1)(2008-8#1)
sodium benzoate##7##2##(2008-10#1)(2008-6#1)(2008-8#3)(2012-2#2)
sodium bicarbonate and##4##3##(2008-10#1)(2010-3#3)
sodium bicarbonate##7##2##(1991-1#1)(2008-10#1)(2008-4#1)(2010-3#4)
sodium borate glasses##2##3##(2007-12#2)
sodium borate##7##2##(1990-3#3)(2007-12#2)(2008-10#2)
sodium borohydride and##2##3##(1991-12#1)(2008-10#1)
sodium borohydride flow##2##3##(2008-10#2)
sodium borohydride reduction##3##3##(2008-10#2)(2010-6#1)
sodium borohydride##14##2##(1990-7#1)(1991-12#1)(1995-11#1)(2008-10#9)(2010-6#1)(2013-8#1)
sodium bromate in##4##3##(2008-9#4)
sodium bromate##15##2##(2008-10#1)(2008-9#14)
sodium bromide##3##2##(1991-5#1)(1994-5#1)(2008-9#1)
sodium butyrate##12##2##(1990-6#1)(1992-2#2)(1992-3#2)(1993-9#2)(2008-11#5)
sodium carbonate##3##2##(2008-10#3)
sodium caseinates##2##2##(2010-4#2)
sodium channel activity##2##3##(1995-3#1)(2013-1#1)
sodium channel alpha-subunit mRNAs##2##4##(1996-12#2)
sodium channel blocker##3##3##(2009-3#1)(2012-3#1)(2013-1#1)
sodium channel blockers##3##3##(2008-8#1)(2012-3#2)
sodium channel mRNA##2##3##(1996-12#2)
sodium channel mRNAs##2##3##(1996-12#2)
sodium channel##45##2##(1991-12#2)(1992-3#3)(1994-12#2)(1995-3#2)(1996-12#9)(1997-3#3)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#3)
sodium channels are##3##3##(1995-3#1)(2008-8#1)(2012-3#1)
sodium channels in##3##3##(1994-12#1)(1995-3#2)
sodium channels##15##2##(1992-11#1)(1994-12#1)(1995-3#5)(2008-5#1)(2008-8#4)(2012-3#3)
sodium chloride (NaCl)##2##3##(1992-3#1)(2007-3#1)
sodium chloride aerosol##3##3##(1996-3#2)(2008-2#1)
sodium chloride and##2##3##(1994-8#1)(1997-2#1)
sodium chloride at##3##3##(2008-10#2)(2008-2#1)
sodium chloride concentration##5##3##(2008-10#4)(2011-2#1)
sodium chloride in##4##3##(1990-8#1)(2008-10#2)(2011-2#1)
sodium chloride solution##2##3##(2008-10#1)(2008-3#1)
sodium chloride was##2##3##(2008-10#2)
sodium chloride##47##2##(1990-8#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#2)(1994-5#2)(1994-8#1)(1996-3#3)(1997-2#1)(2007-3#1)(2008-10#21)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2011-2#2)
sodium cholate##5##2##(1990-2#1)(1993-11#1)(1994-9#3)
sodium citrate 40 mg/mL (4%)##3##5##(2010-3#3)
sodium citrate and##4##3##(1997-4#1)(2008-10#1)(2010-3#2)
sodium citrate concentrations##2##3##(2010-3#2)
sodium citrate##21##2##(1990-12#1)(1997-4#1)(2008-10#5)(2010-3#11)(2011-2#2)(2012-2#1)
sodium concentration##5##2##(1992-11#1)(1994-3#1)(1995-8#1)(2010-1#2)
sodium content##2##2##(1994-3#1)(2008-10#1)
sodium currents##2##2##(1996-12#1)(2008-11#1)
sodium cyclamate##4##2##(2008-10#2)(2011-1#2)
sodium deoxycholate##9##2##(1990-7#1)(1992-9#1)(1993-8#1)(2008-10#3)(2011-2#3)
sodium depletion##3##2##(1993-12#3)
sodium dichloroisocyanurate##2##2##(2008-10#2)
sodium diethyldithiocarbamate##6##2##(2008-10#6)
sodium dihydrogen##2##2##(1996-5#1)(2011-1#1)
sodium dodecyl sulfate (SDS) micellar##2##5##(2008-10#2)
sodium dodecyl sulfate (SDS)##22##4##(1990-11#1)(1994-9#2)(1995-5#1)(1996-5#1)(2008-10#14)(2008-2#1)(2008-4#1)(2012-2#1)
sodium dodecyl sulfate polyacrylamide gel electrophoresis##6##6##(1990-10#1)(1991-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
sodium dodecyl sulfate to##2##4##(1991-3#1)(2008-10#1)
sodium dodecyl sulfate##49##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-3#1)(1992-3#1)(1994-9#2)(1995-5#2)(1996-12#1)(1996-5#3)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#2)(2008-4#1)(2010-11#1)(2012-2#2)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and##2##6##(1990-11#1)(2008-11#1)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis of##4##6##(2008-10#4)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis##17##5##(1990-10#1)(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(2008-10#11)(2008-11#1)
sodium dodecyl sulfate-polyacrylamide-gel electrophoresis##2##4##(1990-5#1)(1997-4#1)
sodium dodecyl sulphate (SDS) and##3##5##(1994-9#1)(2008-10#2)
sodium dodecyl sulphate (SDS)##4##4##(1994-9#1)(2008-10#3)
sodium dodecyl sulphate##9##3##(1993-3#1)(1994-9#1)(2008-10#6)(2008-5#1)
sodium dodecyl sulphate-polyacrylamide gel electrophoresis##2##5##(1994-2#1)(2008-10#1)
sodium dodecyl##86##2##(1990-10#2)(1990-11#2)(1990-5#2)(1990-7#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-9#3)(1995-5#2)(1996-12#1)(1996-5#4)(1997-4#1)(2008-1#1)(2008-10#47)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2010-11#1)(2012-2#2)
sodium dodecylsulfate (SDS) and##2##4##(2008-10#2)
sodium dodecylsulfate (SDS) in##2##4##(2008-10#2)
sodium dodecylsulfate (SDS)##8##3##(2008-10#7)(2013-8#1)
sodium dodecylsulfate##14##2##(1991-12#1)(2008-10#11)(2008-5#1)(2013-8#1)
sodium efflux##3##2##(1992-12#3)
sodium excretion##2##2##(1997-7#1)(2011-2#1)
sodium fluoride (NaF)##4##3##(2008-10#3)(2013-1#1)
sodium fluoride in##2##3##(1996-2#1)(2008-12#1)
sodium fluoride pollution##2##3##(2008-12#2)
sodium fluoride was##2##3##(1995-12#1)(2008-10#1)
sodium fluoride##24##2##(1990-2#2)(1991-11#2)(1993-11#2)(1995-12#4)(1996-2#1)(2008-10#6)(2008-11#1)(2008-12#4)(2010-3#1)(2013-1#1)
sodium hexadecane-sulfonate##2##2##(2008-10#2)
sodium hyaluronan##3##2##(2011-2#3)
sodium hydroxide and##9##3##(2008-10#7)(2013-1#2)
sodium hydroxide in##3##3##(2008-10#2)(2009-5#1)
sodium hydroxide solution##5##3##(2008-10#5)
sodium hydroxide##33##2##(1991-7#1)(1994-9#1)(2008-10#26)(2008-6#1)(2009-5#1)(2013-1#3)
sodium hypochlorite (NaOCl)##2##3##(2013-1#2)
sodium hypochlorite and##2##3##(2008-10#2)
sodium hypochlorite solution##5##3##(2008-10#3)(2008-5#2)
sodium hypochlorite##11##2##(2008-10#7)(2008-5#2)(2013-1#2)
sodium in##11##2##(1994-3#1)(2008-10#10)
sodium influx##2##2##(1992-12#2)
sodium intake when injected##2##4##(1997-4#2)
sodium intake##8##2##(1997-4#4)(2011-1#4)
sodium ion##9##2##(1990-11#1)(1993-3#1)(2008-10#7)
sodium ions##7##2##(1991-8#3)(1992-3#1)(2008-10#3)
sodium is##2##2##(1994-6#1)(2008-10#1)
sodium lactate##2##2##(2008-4#2)
sodium lauryl ether sulfate##2##4##(2008-10#1)(2008-5#1)
sodium lauryl ether sulphate##3##4##(2008-5#3)
sodium lauryl ether##5##3##(2008-10#1)(2008-5#4)
sodium lauryl sulphate##3##3##(2008-5#2)(2010-3#1)
sodium lauryl##9##2##(2008-10#2)(2008-5#6)(2010-3#1)
sodium metabisulfite##3##2##(2008-10#3)
sodium metaperiodate##2##2##(2008-10#2)
sodium molybdate##4##2##(1993-8#1)(2008-10#3)
sodium n-vanadate##3##2##(2008-8#3)
sodium nitrate in##2##3##(2008-10#2)
sodium nitrate##6##2##(2008-10#6)
sodium nitrilotriacetate##2##2##(2008-10#2)
sodium nitrite##2##2##(2008-10#2)
sodium nitroprusside (SNP)##4##3##(1995-11#1)(2008-10#1)(2008-11#2)
sodium nitroprusside##17##2##(1990-12#1)(1991-9#1)(1995-11#1)(1995-8#3)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2012-3#1)(2013-7#2)
sodium or potassium##2##3##(2008-10#2)
sodium or##3##2##(1993-8#1)(2008-10#2)
sodium orthovanadate##2##2##(1994-11#1)(2008-10#1)
sodium oxalate##3##2##(2008-10#3)
sodium pentanesulphonate##3##2##(2008-10#3)
sodium pentobarbital##2##2##(2008-4#2)
sodium perchlorate solutions##2##3##(2008-10#2)
sodium perchlorate##6##2##(1994-8#1)(2008-10#5)
sodium periodate##2##2##(1996-12#1)(2007-11#1)
sodium phenolate complexes##3##3##(1996-2#3)
sodium phosphate buffer##3##3##(2008-10#3)
sodium phosphate##13##2##(1991-1#1)(1992-3#1)(1997-2#1)(2008-10#6)(2009-8#1)(2011-2#3)
sodium piperacillin##2##2##(1990-2#2)
sodium polypectate##2##2##(2008-10#2)
sodium polystyrenesulfonate (NaPSS)##2##3##(2008-10#2)
sodium potassium##2##2##(1995-8#1)(2008-10#1)
sodium pyruvate##3##2##(1991-8#3)
sodium retention##4##2##(1994-2#1)(1997-7#1)(2006-10#1)(2008-7#1)
sodium saccharin##3##2##(1992-11#1)(2011-1#2)
sodium salicylate##2##2##(2008-10#2)
sodium salt##10##2##(1990-6#1)(1993-8#2)(1995-11#2)(1995-3#1)(2008-10#2)(2008-11#1)(2010-3#1)
sodium salts of##2##3##(2008-10#1)(2008-11#1)
sodium salts##6##2##(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2012-7#1)
sodium selenite and##2##3##(1995-11#1)(2008-10#1)
sodium selenite##8##2##(1995-11#1)(1996-2#1)(2008-10#2)(2010-11#1)(2011-1#3)
sodium signal##2##2##(1994-3#2)
sodium starch glycolate##2##3##(2010-3#2)
sodium sulfacetamide 10%-sulfur 5% emollient foam##3##6##(2010-8#3)
sodium sulfacetamide 10%-sulfur 5%##4##4##(2010-8#4)
sodium sulfide in##2##3##(2008-10#1)(2013-1#1)
sodium sulfide##6##2##(2008-10#3)(2008-5#2)(2013-1#1)
sodium sulfite as##2##3##(2008-10#2)
sodium sulfite##7##2##(2008-10#7)
sodium sulphate##6##2##(1990-8#1)(2008-10#5)
sodium tartrate##4##2##(2008-10#4)
sodium tetrahydroborate solution##2##3##(2007-12#1)(2008-10#1)
sodium tetrahydroborate##10##2##(2007-12#1)(2008-10#9)
sodium tetrahydroborate(III)##2##2##(2008-10#2)
sodium tetrakis (4-fluorophenyl) borate##2##4##(2008-10#2)
sodium tetraphenyl borate (NaTPB) as##2##5##(2008-10#2)
sodium tetraphenyl borate##4##3##(2008-10#4)
sodium tetraphenylborate (NaTPB) as##4##4##(2008-10#4)
sodium tetraphenylborate (NaTPB)##5##3##(2008-10#5)
sodium tetraphenylborate##10##2##(2008-10#10)
sodium thiocyanate in##2##3##(2008-10#2)
sodium thiocyanate##3##2##(2008-10#3)
sodium to##3##2##(1990-7#1)(2007-12#1)(2008-10#1)
sodium transport##4##2##(1992-12#1)(1992-6#1)(1994-6#1)(2008-7#1)
sodium tripolyphosphate##2##2##(1997-4#1)(2008-10#1)
sodium valproate##6##2##(1995-12#4)(2008-3#1)(2008-6#1)
sodium was##2##2##(2008-10#2)
sodium##983##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#3)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#6)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#8)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#8)(1991-9#1)(1992-10#1)(1992-11#8)(1992-12#7)(1992-2#2)(1992-3#11)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#6)(1993-3#2)(1993-8#6)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#8)(1994-5#7)(1994-6#6)(1994-8#3)(1994-9#11)(1995-11#7)(1995-12#9)(1995-2#1)(1995-3#11)(1995-5#2)(1995-8#8)(1996-12#12)(1996-2#10)(1996-3#3)(1996-5#5)(1996-7#1)(1997-2#4)(1997-3#3)(1997-4#13)(1997-5#1)(1997-7#5)(2006-10#1)(2007-11#4)(2007-12#8)(2007-3#1)(2007-7#5)(2007-8#2)(2008-1#10)(2008-10#421)(2008-11#20)(2008-12#16)(2008-2#5)(2008-3#12)(2008-4#11)(2008-5#26)(2008-6#5)(2008-7#7)(2008-8#15)(2008-9#20)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#22)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#9)(2011-1#16)(2011-2#18)(2011-3#2)(2012-12#3)(2012-2#12)(2012-3#8)(2012-7#1)(2013-1#12)(2013-7#2)(2013-8#4)
sodium)##4##1##(1991-3#1)(2008-10#3)
sodium-dependent and##2##2##(1992-3#2)
sodium-dependent##6##1##(1992-3#2)(1993-3#1)(1994-8#1)(1995-11#1)(2008-11#1)
sodium-depleted rats##2##2##(1997-4#2)
sodium-lithium counter-transport activity##5##3##(1992-6#5)
sodium-selective electrodes##3##2##(2008-10#3)
sodium-selective##4##1##(2008-10#4)
sodiumindependent##2##1##(2008-11#2)
soft X-ray##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
soft agar and##2##3##(2008-11#1)(2008-8#1)
soft agar##9##2##(1990-5#1)(1991-12#2)(1995-2#1)(2008-11#3)(2008-8#2)
soft and hard tissue##2##4##(2007-12#2)
soft and hard tissues##2##4##(1990-10#1)(2008-5#1)
soft and hard##6##3##(1990-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
soft and##11##2##(1990-10#1)(1991-2#2)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
soft biological##2##2##(2008-2#1)(2012-2#1)
soft bottoms from##2##3##(2008-5#2)
soft bottoms##3##2##(2008-5#3)
soft contact and adhesion##2##4##(2011-1#2)
soft contact lenses##2##3##(1993-11#1)(2012-12#1)
soft contact##4##2##(1993-11#1)(2011-1#2)(2012-12#1)
soft dough stage##2##3##(2008-10#2)
soft dough##3##2##(2008-10#3)
soft drink powders##2##3##(2008-10#2)
soft drink sample##2##3##(2008-10#2)
soft drink samples##2##3##(2008-10#2)
soft drink##9##2##(2008-10#9)
soft drinks##15##2##(2008-10#15)
soft gel##4##2##(1991-5#1)(1997-2#1)(2008-5#1)(2010-3#1)
soft hydrated tissues##2##3##(2008-7#2)
soft ice cream##3##3##(2011-2#3)
soft independent modeling of class analogy (SIMCA)##2##7##(2008-10#1)(2013-8#1)
soft independent modeling of class##3##5##(2008-10#2)(2013-8#1)
soft independent modelling of class analogy (SIMCA)##2##7##(2008-10#2)
soft independent modelling of class analogy##4##6##(2008-10#4)
soft independent##7##2##(2008-10#6)(2013-8#1)
soft ionization##2##2##(2008-10#1)(2010-7#1)
soft lithography##3##2##(2007-5#1)(2008-3#1)(2008-7#1)
soft matter cell model##2##4##(2011-1#2)
soft matter model##2##3##(2011-1#2)
soft matter##4##2##(2011-1#4)
soft modeling##2##2##(2008-10#2)
soft palate is##2##3##(1991-2#1)(1991-3#1)
soft palate##6##2##(1990-6#1)(1991-2#1)(1991-3#1)(2009-8#1)(2010-5#2)
soft part sarcoma##2##3##(1990-2#2)
soft red winter wheat##3##4##(2008-10#1)(2008-5#2)
soft rot##5##2##(2008-10#5)
soft sensors##2##2##(2013-1#2)
soft spherical##2##2##(2008-3#2)
soft tick strains##2##3##(2008-12#2)
soft tissue and bone##3##4##(2008-11#1)(2010-6#1)(2013-8#1)
soft tissue and##10##3##(2007-12#1)(2008-11#1)(2008-12#2)(2008-6#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#2)
soft tissue as##2##3##(2007-7#1)(2009-7#1)
soft tissue by##3##3##(2008-10#2)(2012-2#1)
soft tissue contrast##4##3##(2007-4#1)(2008-1#1)(2008-8#1)(2010-12#1)
soft tissue coverage##3##3##(2008-6#1)(2013-8#2)
soft tissue defect##3##3##(2008-9#2)(2011-2#1)
soft tissue defects##4##3##(2007-8#1)(2010-6#1)(2011-2#1)(2012-12#1)
soft tissue dissection##2##3##(2011-2#1)(2012-2#1)
soft tissue envelope##2##3##(2008-8#2)
soft tissue healing##2##3##(2009-8#2)
soft tissue imaging##2##3##(2008-10#1)(2008-7#1)
soft tissue in the##2##4##(2008-2#1)(2008-3#1)
soft tissue in##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
soft tissue infection##2##3##(2008-9#1)(2011-2#1)
soft tissue infections##8##3##(2007-12#2)(2008-10#2)(2009-4#2)(2013-1#2)
soft tissue inflammation of##2##4##(2008-12#2)
soft tissue injury##2##3##(2007-8#1)(2010-3#1)
soft tissue lesions of the##3##5##(2007-11#1)(2012-2#2)
soft tissue lesions##5##3##(2007-11#1)(2008-6#1)(2012-2#3)
soft tissue mass##2##3##(2011-1#2)
soft tissue reconstruction##3##3##(2010-11#1)(2012-2#1)(2012-8#1)
soft tissue sarcoma (STS)##7##4##(2008-6#7)
soft tissue sarcoma and##2##4##(2008-6#1)(2009-3#1)
soft tissue sarcoma in##3##4##(2008-6#2)(2008-7#1)
soft tissue sarcoma of the extremities##2##6##(2008-6#2)
soft tissue sarcoma of the##4##5##(1992-12#1)(2008-6#3)
soft tissue sarcoma specimens##2##4##(2008-6#2)
soft tissue sarcoma##34##3##(1992-12#1)(2008-6#30)(2008-7#1)(2009-3#1)(2010-3#1)
soft tissue sarcomas in adults##2##5##(1992-12#1)(2008-6#1)
soft tissue sarcomas is##2##4##(1992-12#1)(2008-6#1)
soft tissue sarcomas##32##3##(1992-12#3)(1993-9#1)(2008-6#27)(2011-2#1)
soft tissue treatment##2##3##(2009-6#1)(2013-8#1)
soft tissue tumors##4##3##(1994-6#1)(2007-8#1)(2011-2#2)
soft tissue tumour##3##3##(2008-6#2)(2013-7#1)
soft tissue tumours##8##3##(2008-6#5)(2012-2#3)
soft tissue##226##2##(1990-6#1)(1991-2#1)(1992-1#1)(1992-12#4)(1992-2#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#10)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#70)(2008-7#5)(2008-8#5)(2008-9#7)(2009-3#4)(2009-4#7)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#4)(2010-6#4)(2010-9#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#14)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#7)
soft tissues and##5##3##(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
soft tissues in the##2##4##(2008-2#1)(2012-2#1)
soft tissues in##6##3##(2007-11#1)(2008-12#1)(2008-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
soft tissues of the##6##4##(2007-7#1)(2008-12#2)(2009-5#1)(2010-6#1)(2010-9#1)
soft tissues##51##2##(1995-3#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2012-12#2)(2012-2#4)(2013-1#5)
soft x rays##2##3##(2007-12#2)
soft##454##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-6#2)(1991-12#2)(1991-2#7)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#4)(1992-2#3)(1993-11#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#7)(2007-12#21)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#59)(2008-11#5)(2008-12#20)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#9)(2008-6#73)(2008-7#14)(2008-8#8)(2008-9#14)(2009-11#4)(2009-3#6)(2009-4#9)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#9)(2010-4#3)(2010-5#4)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#13)(2011-2#13)(2012-1#2)(2012-12#7)(2012-2#23)(2012-3#1)(2012-8#1)(2013-1#19)(2013-7#3)(2013-8#9)
soft&quot##2##1##(1990-4#1)(1991-3#1)
soft-agar##3##1##(1992-9#2)(1995-2#1)
soft-tissue coverage##2##2##(2008-9#2)
soft-tissue defects##2##2##(2007-8#1)(2008-9#1)
soft-tissue reconstruction##3##2##(2008-9#1)(2010-12#1)(2010-3#1)
soft-tissue sarcoma who##2##3##(1991-8#1)(2008-6#1)
soft-tissue sarcoma##10##2##(1991-8#1)(2008-6#8)(2008-7#1)
soft-tissue sarcomas##3##2##(2008-6#3)
soft-tissue thickening##2##2##(2011-2#1)(2013-7#1)
soft-tissue tumors##2##2##(2007-8#1)(2012-2#1)
soft-tissue tumours##3##2##(2008-6#2)(2012-2#1)
soft-tissue##41##1##(1991-8#1)(1992-2#1)(1992-6#1)(1994-6#1)(2007-12#2)(2007-8#3)(2008-2#1)(2008-3#1)(2008-6#14)(2008-7#2)(2008-9#6)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
soft-x-ray laser##4##2##(2007-12#4)
soft-x-ray lasers##2##2##(2007-12#1)(2008-3#1)
soft-x-ray performance##2##2##(2007-11#2)
soft-x-ray synchrotron radiation##2##3##(2008-2#1)(2008-3#1)
soft-x-ray##29##1##(2007-11#3)(2007-12#9)(2008-2#8)(2008-3#9)
softening during##2##2##(2008-10#1)(2010-4#1)
softening or##2##2##(2009-5#1)(2010-4#1)
softening##9##1##(1993-5#1)(2008-10#2)(2009-5#1)(2009-7#1)(2010-4#2)(2011-2#2)
softer##5##1##(2007-12#1)(2008-5#2)(2008-8#1)(2008-9#1)
softly##2##1##(2007-11#1)(2010-12#1)
softness of the##2##3##(2007-12#2)
softness##3##1##(2007-12#2)(2013-1#1)
software and hardware##3##3##(1994-3#1)(2008-7#1)(2012-2#1)
software and the##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
software and##19##2##(1991-2#1)(1993-3#1)(1994-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
software applications##3##2##(2007-12#1)(2008-7#1)(2009-12#1)
software based on##3##3##(2007-8#1)(2008-2#1)(2012-3#1)
software by##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
software compensation##3##2##(2008-9#3)
software correlator##2##2##(2008-3#2)
software developed in##2##3##(2008-10#2)
software developed##3##2##(2008-10#3)
software development##2##2##(2008-11#1)(2011-2#1)
software for 3D reconstruction##2##4##(2009-1#1)(2012-2#1)
software for the##5##3##(2008-10#3)(2008-2#1)(2008-5#1)
software for##19##2##(1992-9#1)(1994-2#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-1#1)(2011-1#1)(2012-1#1)(2012-2#1)
software has##5##2##(1991-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2011-2#1)
software in a##3##3##(1992-3#1)(2008-7#1)(2012-1#1)
software in##10##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
software is available##2##3##(2011-2#2)
software is##13##2##(1993-3#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2011-2#3)(2012-3#1)(2013-1#1)
software method##2##2##(2008-9#1)(2012-1#1)
software of##2##2##(2010-8#1)(2011-2#1)
software package for##2##3##(2008-4#1)(2011-1#1)
software package##13##2##(1991-3#1)(1992-12#1)(1992-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-8#1)(2011-1#2)(2012-3#1)
software packages##4##2##(1992-12#1)(1992-2#1)(2008-10#1)(2008-4#1)
software permits##2##2##(1991-12#1)(2008-10#1)
software platform to support##2##4##(1994-2#1)(1994-3#1)
software product##2##2##(1997-2#1)(2008-10#1)
software program based on graph theory##2##6##(1995-6#2)
software program##13##2##(1992-2#1)(1995-6#3)(1996-2#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
software programs##3##2##(2008-4#1)(2008-9#1)(2009-3#1)
software requirements##2##2##(1994-2#1)(2008-4#1)
software that is##2##3##(1992-12#1)(2011-1#1)
software that##10##2##(1991-12#1)(1992-12#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
software to obtain##2##3##(2012-12#1)(2012-3#1)
software to produce##2##3##(1992-9#1)(2013-7#1)
software to##13##2##(1992-3#1)(1992-9#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
software tool##2##2##(2008-2#1)(2008-4#1)
software tools for##3##3##(2010-11#1)(2011-3#1)(2012-2#1)
software tools##5##2##(2008-4#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-2#1)
software used in##2##3##(2008-10#1)(2012-2#1)
software vendors##2##2##(1994-2#1)(2011-2#1)
software version##3##2##(2008-4#1)(2011-2#2)
software was used for##3##4##(2008-10#2)(2012-12#1)
software was used in order to##2##6##(2008-10#1)(2008-12#1)
software was used to##2##4##(2008-1#1)(2008-10#1)
software was used##7##3##(2008-1#1)(2008-10#4)(2008-12#1)(2012-12#1)
software was##11##2##(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2012-12#1)
software written in##3##3##(2008-10#3)
software##356##1##(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1992-12#5)(1992-2#4)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#1)(1994-2#8)(1994-3#2)(1995-12#1)(1995-3#1)(1995-6#5)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#56)(2008-11#14)(2008-12#4)(2008-2#13)(2008-3#20)(2008-4#19)(2008-5#6)(2008-6#2)(2008-7#17)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#4)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#15)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#5)(2012-2#9)(2012-3#10)(2013-1#10)(2013-7#1)(2013-8#7)
software)##3##1##(2007-10#1)(2007-7#1)(2008-10#1)
software-based##4##1##(1994-1#1)(2006-12#1)(2008-4#1)(2008-6#1)
softwood##2##1##(2008-10#1)(2008-6#1)
softwoods##2##1##(2008-10#1)(2008-6#1)
soil (P &lt##3##3##(2008-10#2)(2008-6#1)
soil 2##2##2##(2008-10#1)(2008-11#1)
soil GHG fluxes##4##3##(2012-2#4)
soil GHG##5##2##(2012-2#5)
soil acidification##2##2##(2008-10#2)
soil after##2##2##(2008-10#2)
soil amended with##2##3##(2008-10#2)
soil amendment##2##2##(2008-10#2)
soil and a##2##3##(2008-10#2)
soil and airborne##2##3##(2008-10#1)(2008-11#1)
soil and fruit##2##3##(2008-10#2)
soil and groundwater##2##3##(2008-10#1)(2008-2#1)
soil and infected##2##3##(2008-10#2)
soil and marine##2##3##(2008-10#1)(2011-2#1)
soil and on##3##3##(2008-10#3)
soil and plant processes##2##4##(1990-9#2)
soil and plant##6##3##(1990-9#2)(2008-10#3)(2008-11#1)
soil and root##2##3##(2008-10#2)
soil and sediment certified##2##4##(2008-10#2)
soil and sediment samples##7##4##(2008-10#7)
soil and sediment##16##3##(2008-10#16)
soil and the##4##3##(2008-10#4)
soil and vegetation cover##2##4##(2008-12#2)
soil and vegetation##4##3##(2008-10#1)(2008-12#2)(2008-9#1)
soil and water##8##3##(2008-10#4)(2008-11#2)(2008-9#1)(2013-8#1)
soil and##103##2##(1990-9#3)(1993-11#1)(2008-10#80)(2008-11#6)(2008-12#3)(2008-2#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
soil applications of##2##3##(2008-10#1)(2008-12#1)
soil applications##3##2##(2008-10#2)(2008-12#1)
soil are##2##2##(2008-10#2)
soil around##2##2##(2008-10#1)(2011-2#1)
soil as a##2##3##(1993-8#1)(2008-10#1)
soil as well as##2##4##(2008-10#2)
soil as##7##2##(1993-8#1)(2008-10#6)
soil at 5##2##3##(2008-10#2)
soil at the end of##2##5##(2008-10#2)
soil at the##3##3##(2008-10#3)
soil at##17##2##(2008-10#15)(2008-5#2)
soil bacteria##4##2##(1996-5#1)(2008-10#1)(2009-3#1)(2012-3#1)
soil bacterial##2##2##(2013-7#2)
soil bacterium##3##2##(2008-11#2)(2011-1#1)
soil block##4##2##(2008-10#4)
soil bulk density##4##3##(2008-12#3)(2013-7#1)
soil but##4##2##(2008-10#3)(2008-12#1)
soil by##12##2##(2008-10#9)(2008-11#1)(2011-2#1)(2012-12#1)
soil can##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
soil carbon##2##2##(2013-7#1)(2013-8#1)
soil caused##3##2##(2008-10#3)
soil characteristics##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
soil chemical##4##2##(2008-10#4)
soil compared with##3##3##(2008-10#3)
soil compartment##2##2##(2008-10#1)(2008-11#1)
soil compounds##3##2##(2010-3#3)
soil concentrations##2##2##(2008-12#1)(2008-5#1)
soil conditioners##2##2##(2008-10#2)
soil conditions##3##2##(2008-10#3)
soil containing##3##2##(2008-10#2)(2008-11#1)
soil contamination##2##2##(1995-11#1)(2008-10#1)
soil core samples##2##3##(2011-1#2)
soil core##3##2##(2008-10#1)(2011-1#2)
soil cores##3##2##(2008-10#2)(2013-7#1)
soil could##2##2##(2008-10#1)(2008-6#1)
soil depths##2##2##(2008-10#1)(2008-12#1)
soil disinfestation##2##2##(2008-10#2)
soil drought##6##2##(2012-5#2)(2012-6#3)(2012-8#1)
soil during root mineralisation##2##4##(2010-5#2)
soil during##4##2##(2008-10#2)(2010-5#2)
soil extract containing##2##3##(2008-10#2)
soil extract##3##2##(2008-10#3)
soil extracts and##3##3##(1996-5#1)(2008-10#2)
soil extracts using a##2##4##(2008-10#2)
soil extracts using##4##3##(2008-10#4)
soil extracts was##2##3##(2008-10#2)
soil extracts were##2##3##(2008-10#2)
soil extracts##29##2##(1996-5#1)(2008-10#27)(2008-12#1)
soil factors##3##2##(2008-10#3)
soil fertility##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2013-7#2)
soil formation##2##2##(2008-12#2)
soil fractions##3##2##(2008-10#3)
soil from the##7##3##(2008-10#4)(2008-11#1)(2008-5#2)
soil from##17##2##(1990-9#1)(2008-10#12)(2008-11#1)(2008-5#3)
soil fulvic acid##3##3##(2008-10#3)
soil fumigant##2##2##(2008-10#2)
soil fumigants##3##2##(2008-10#3)
soil fungi##3##2##(2008-10#3)
soil had significantly##3##3##(2008-10#3)
soil had##8##2##(2008-10#8)
soil in a##2##3##(2008-10#2)
soil in the##4##3##(2008-10#4)
soil in##21##2##(1996-3#1)(2008-10#15)(2008-5#1)(2011-1#1)(2011-2#3)
soil infestation##4##2##(2008-10#4)
soil infested with T##2##4##(2008-10#2)
soil infested with##7##3##(2008-10#7)
soil inoculum##2##2##(2008-10#2)
soil is##8##2##(1990-9#1)(1992-12#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
soil isolates##2##2##(2008-10#2)
soil layer##2##2##(2008-10#2)
soil layers##4##2##(2008-10#4)
soil leachates##3##2##(2008-10#3)
soil lead##2##2##(1995-11#1)(2012-12#1)
soil management##3##2##(2008-10#1)(2008-5#1)(2010-7#1)
soil material##2##2##(2008-11#2)
soil matric potential##2##3##(2008-10#2)
soil matrices##2##2##(2008-10#2)
soil microbes were##2##3##(2008-10#1)(2008-11#1)
soil microbes##6##2##(2008-10#3)(2008-11#3)
soil microbial communities and##2##4##(2008-10#2)
soil microbial communities##4##3##(2008-10#4)
soil microbial community structure##2##4##(2008-10#2)
soil microbial community##8##3##(2008-10#8)
soil microbial##18##2##(1990-9#1)(2008-10#17)
soil microcosm experiments##3##3##(2008-10#3)
soil microflora##6##2##(2008-10#6)
soil mixtures##2##2##(2008-10#2)
soil moisture and temperature##4##4##(2008-10#4)
soil moisture and##8##3##(2008-10#6)(2008-9#1)(2012-7#1)
soil moisture content##5##3##(2008-10#1)(2008-12#1)(2012-7#2)(2013-7#1)
soil moisture##26##2##(1995-3#1)(2008-10#16)(2008-12#1)(2008-9#1)(2011-1#3)(2012-7#3)(2013-7#1)
soil nutrients##2##2##(2008-5#2)
soil of the##2##3##(2008-10#1)(2008-5#1)
soil of##9##2##(2008-10#5)(2008-5#3)(2010-3#1)
soil on the##2##3##(1993-2#1)(2008-10#1)
soil on##5##2##(1993-2#1)(2008-10#3)(2008-11#1)
soil or##7##2##(2008-10#5)(2008-11#1)(2008-6#1)
soil organic carbon##5##3##(2008-12#5)
soil organic matter##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
soil organic##13##2##(2008-10#5)(2008-12#7)(2013-8#1)
soil organisms##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
soil pH##13##2##(1995-3#1)(2008-10#9)(2008-12#1)(2010-5#1)(2012-6#1)
soil parameters##3##2##(2008-10#1)(2008-2#1)(2013-7#1)
soil particles##2##2##(2008-10#2)
soil pasteurization##2##2##(2008-10#2)
soil pathogen##2##2##(2010-10#1)(2013-8#1)
soil physical##2##2##(2008-12#2)
soil pollution##2##2##(2008-10#1)(2008-11#1)
soil population##2##2##(2008-10#2)
soil populations of Pythium spp##2##5##(2008-10#2)
soil populations of##6##3##(2008-10#6)
soil populations##12##2##(2008-10#12)
soil prior to##2##3##(2008-10#2)
soil properties and##4##3##(2008-10#2)(2008-12#2)
soil properties in##2##3##(2008-10#2)
soil properties##8##2##(2008-10#5)(2008-12#2)(2010-5#1)
soil quality##2##2##(2008-12#1)(2008-5#1)
soil ranged##2##2##(2008-10#1)(2013-8#1)
soil reduced the##2##3##(2008-10#2)
soil reference materials##3##3##(2008-10#3)
soil respiration##2##2##(2008-11#2)
soil sample in##2##3##(2008-10#1)(2011-1#1)
soil sample with##2##3##(2008-10#2)
soil sample##9##2##(2008-10#8)(2011-1#1)
soil samples by##5##3##(2008-10#5)
soil samples collected from##7##4##(2008-10#7)
soil samples collected##8##3##(2008-10#8)
soil samples from an intensive horticulture area##2##7##(2008-10#2)
soil samples from##4##3##(2008-10#4)
soil samples of##3##3##(2008-10#1)(2008-11#2)
soil samples taken from an##2##5##(2008-10#2)
soil samples that##4##3##(2008-10#4)
soil samples using##2##3##(2008-10#2)
soil samples was developed##2##4##(2008-10#2)
soil samples was##3##3##(2008-10#3)
soil samples were collected from##2##5##(2008-12#1)(2013-8#1)
soil samples were collected##3##4##(2008-10#1)(2008-12#1)(2013-8#1)
soil samples were##12##3##(2008-10#8)(2008-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
soil samples with##4##3##(1994-3#1)(2008-10#3)
soil samples##87##2##(1994-3#1)(2008-10#74)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
soil solarization##2##2##(2008-10#2)
soil solution##7##2##(1992-3#2)(2008-10#4)(2008-11#1)
soil surface of##2##3##(2008-10#2)
soil surface temperature##2##3##(2011-1#2)
soil surface##20##2##(2008-10#12)(2008-11#1)(2008-6#3)(2010-5#2)(2011-1#2)
soil suspensions##2##2##(2008-10#2)
soil temperature and##4##3##(2008-10#4)
soil temperature##10##2##(2008-10#9)(2013-7#1)
soil temperatures##5##2##(2008-10#5)
soil texture##8##2##(2008-10#8)
soil than in##3##3##(2008-10#3)
soil than##5##2##(2008-10#4)(2008-11#1)
soil that##5##2##(1990-9#1)(2008-10#4)
soil to##15##2##(1992-3#1)(1994-9#1)(2008-10#12)(2012-12#1)
soil transplant experiment##2##3##(2008-9#2)
soil treatments and##2##3##(2008-10#2)
soil treatments##8##2##(2008-10#8)
soil type##9##2##(2008-10#4)(2012-6#1)(2012-9#4)
soil types and##2##3##(2008-10#1)(2012-2#1)
soil types of##2##3##(2008-10#1)(2012-9#1)
soil types##8##2##(1993-8#1)(2008-10#3)(2012-2#1)(2012-5#1)(2012-9#2)
soil using##6##2##(2007-12#1)(2008-10#4)(2011-1#1)
soil was inoculated with##2##4##(2008-10#2)
soil was investigated##2##3##(2008-10#1)(2008-5#1)
soil was##34##2##(2008-10#26)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-12#1)
soil water content##3##3##(2008-7#1)(2012-8#2)
soil water infiltration##2##3##(2008-12#2)
soil water potential##2##3##(2008-10#2)
soil water##12##2##(2008-10#3)(2008-12#2)(2008-7#1)(2008-8#1)(2012-5#1)(2012-6#1)(2012-8#2)(2013-7#1)
soil were not##2##3##(2008-10#2)
soil were##20##2##(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#2)(2013-7#1)
soil with##17##2##(2008-10#14)(2008-12#1)(2008-6#1)(2010-5#1)
soil within##2##2##(2008-10#1)(2008-11#1)
soil without##3##2##(2008-10#1)(2010-5#2)
soil##1267##1##(1990-9#11)(1991-7#1)(1992-12#3)(1992-3#8)(1993-11#1)(1993-2#1)(1993-8#4)(1994-3#1)(1994-9#1)(1995-11#2)(1995-3#4)(1996-3#1)(1996-5#2)(2006-12#1)(2007-12#1)(2008-10#896)(2008-11#68)(2008-12#45)(2008-2#3)(2008-3#1)(2008-5#24)(2008-6#17)(2008-7#5)(2008-8#2)(2008-9#11)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-3#8)(2010-5#15)(2010-7#3)(2010-8#1)(2011-1#18)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#13)(2012-3#3)(2012-5#4)(2012-6#10)(2012-7#3)(2012-8#3)(2012-9#8)(2013-1#3)(2013-7#22)(2013-8#11)
soil)##15##1##(2008-10#14)(2008-12#1)
soil-borne##2##1##(2008-8#1)(2012-3#1)
soil-plant##2##1##(1992-3#2)
soil-to-solvent ratios##2##2##(2008-10#2)
soil-transmitted##3##1##(1994-11#2)(2008-7#1)
soilborne disease of##2##3##(2008-10#2)
soilborne disease##5##2##(2008-10#5)
soilborne diseases##4##2##(2008-10#4)
soilborne fungal pathogens##3##3##(2008-10#3)
soilborne fungus##5##2##(2008-10#5)
soilborne pathogen##6##2##(2008-10#6)
soilborne pathogens under##2##3##(2008-10#2)
soilborne pathogens##15##2##(2008-10#15)
soilborne pests in fresh market vegetable production systems##2##8##(2008-10#2)
soilborne pests##4##2##(2008-10#4)
soilborne plant pathogen##2##3##(2008-10#2)
soilborne plant pathogens##6##3##(2008-10#6)
soilborne plant##9##2##(2008-10#9)
soilborne##69##1##(2008-10#69)
soiled##3##1##(1996-12#1)(1997-5#2)
soiling##7##1##(1990-3#1)(1991-8#1)(1997-5#2)(2008-3#1)(2011-2#1)(2012-12#1)
soilless container##2##2##(2008-10#2)
soilless potting##2##2##(2008-10#2)
soilless##9##1##(2008-10#9)
soils after##2##2##(2008-10#2)
soils amended with##6##3##(2008-10#6)
soils and sediments##6##3##(2008-10#6)
soils and the##3##3##(2008-10#2)(2008-11#1)
soils and vegetation##2##3##(2008-10#2)
soils and wastes##2##3##(2008-10#2)
soils and##34##2##(2008-10#32)(2008-11#1)(2013-8#1)
soils are a##3##3##(2008-11#2)(2012-2#1)
soils are##7##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2012-2#1)(2013-7#1)
soils at##2##2##(2008-10#1)(2008-6#1)
soils by##6##2##(2008-10#5)(2008-12#1)
soils collected##2##2##(2008-10#2)
soils containing the##2##3##(2008-10#2)
soils contaminated with##3##3##(2008-10#1)(2008-6#2)
soils exhibited##2##2##(2008-10#2)
soils from##12##2##(2008-10#11)(2013-7#1)
soils had higher##2##3##(2013-7#1)(2013-8#1)
soils had##4##2##(2008-10#2)(2013-7#1)(2013-8#1)
soils in a##2##3##(2008-10#2)
soils in the##3##3##(2008-12#1)(2012-6#1)(2013-8#1)
soils in which##5##3##(2008-10#5)
soils in##17##2##(2008-10#14)(2008-12#1)(2012-6#1)(2013-8#1)
soils infested with##5##3##(2008-10#5)
soils is##3##2##(2008-10#3)
soils may be##2##3##(2008-10#1)(2008-11#1)
soils of##3##2##(2008-10#1)(2008-12#2)
soils on the##3##3##(2008-10#1)(2008-12#2)
soils over##3##2##(2008-10#3)
soils prior to planting##2##4##(2008-10#2)
soils prior to##3##3##(2008-10#3)
soils tested##2##2##(2008-10#2)
soils under##2##2##(2008-10#2)
soils was##7##2##(2008-10#7)
soils were infested with##2##4##(2008-10#2)
soils were infested##3##3##(2008-10#3)
soils were##12##2##(2008-10#11)(2013-7#1)
soils with different##2##3##(2008-10#2)
soils with##17##2##(1995-3#1)(2008-10#13)(2011-1#1)(2012-2#1)(2012-6#1)
soils##336##1##(1992-3#3)(1993-8#1)(1995-3#1)(2008-10#274)(2008-11#8)(2008-12#11)(2008-2#2)(2008-5#1)(2008-6#7)(2008-7#1)(2008-9#3)(2009-8#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-2#2)(2012-6#3)(2013-7#8)(2013-8#4)
soils)##3##1##(2008-10#1)(2009-8#1)(2012-6#1)
soit##2##1##(2008-5#1)(2011-2#1)
sojae and##2##2##(2008-10#2)
sojae f##4##2##(1997-6#4)
sojae from##2##2##(2008-10#2)
sojae in soil##2##3##(2008-10#2)
sojae in the##2##3##(2008-10#2)
sojae in##8##2##(2008-10#8)
sojae is##3##2##(2008-10#3)
sojae isolates were##2##3##(2008-10#2)
sojae isolates##4##2##(2008-10#4)
sojae was##4##2##(2008-10#4)
sojae were##2##2##(2008-10#2)
sojae##44##1##(1997-6#4)(2008-10#40)
sol is##2##2##(2008-10#2)
sol was##2##2##(2008-10#2)
sol##15##1##(2008-10#11)(2008-2#1)(2008-8#2)(2010-5#1)
sol-gel and self-assembly##3##3##(2008-10#3)
sol-gel carbon composite##2##3##(2008-10#2)
sol-gel carbon##3##2##(2008-10#3)
sol-gel chemistry##2##2##(2008-10#1)(2010-7#1)
sol-gel coating##2##2##(2008-10#2)
sol-gel derived##4##2##(2008-10#4)
sol-gel film with##2##3##(2008-10#2)
sol-gel film##10##2##(2008-10#10)
sol-gel films##2##2##(2008-10#2)
sol-gel glass##4##2##(2008-10#4)
sol-gel layer with##2##3##(2008-10#2)
sol-gel material##2##2##(2008-10#2)
sol-gel matrix##4##2##(2008-10#4)
sol-gel membranes##2##2##(2008-10#2)
sol-gel method and characterized by##2##5##(2008-10#2)
sol-gel method and##3##3##(2008-10#3)
sol-gel method##9##2##(2008-10#8)(2009-8#1)
sol-gel process##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2009-7#1)
sol-gel technique is##2##3##(2008-10#2)
sol-gel technique##8##2##(2008-10#8)
sol-gel was##3##2##(2008-10#3)
sol-gel##91##1##(2008-10#83)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)
sol-gel-imprinted##2##1##(2008-10#2)
sol-gels##3##1##(2008-10#1)(2010-7#2)
solanacearum 1609##3##2##(2008-10#3)
solanacearum and##2##2##(2008-10#2)
solanacearum biovar 2##3##3##(2008-10#3)
solanacearum cells##4##2##(2008-10#4)
solanacearum growth##2##2##(2008-10#2)
solanacearum is##4##2##(2008-10#4)
solanacearum population##3##2##(2008-10#3)
solanacearum race 3##2##3##(2008-10#2)
solanacearum race##3##2##(2008-10#3)
solanacearum strains from ginger in Hawaii##2##6##(2008-10#2)
solanacearum strains from##3##3##(2008-10#3)
solanacearum strains##6##2##(2008-10#6)
solanacearum##71##1##(2008-10#71)
solanaceous crops##2##2##(2008-10#1)(2008-6#1)
solanaceous hosts##2##2##(2008-10#2)
solanaceous species##2##2##(2008-10#2)
solanaceous##8##1##(2008-10#7)(2008-6#1)
solani AG-3##4##2##(2008-10#3)(2008-12#1)
solani AG-4##2##2##(2008-10#2)
solani AG-5##3##2##(2008-10#3)
solani AG1-1A##2##2##(2008-10#2)
solani AGs##2##2##(2008-10#2)
solani anastomosis group##8##3##(2008-10#8)
solani and BNR##2##3##(2008-12#2)
solani and##12##2##(2008-10#8)(2008-12#4)
solani at##2##2##(2008-10#2)
solani by##5##2##(2008-10#5)
solani cutinase##2##2##(2008-7#2)
solani f##27##2##(2008-10#27)
solani from##3##2##(2008-10#3)
solani in##9##2##(2008-10#9)
solani is##2##2##(2008-10#2)
solani isolates from coffee##2##4##(2008-10#2)
solani isolates from##4##3##(2008-10#4)
solani isolates##5##2##(2008-10#5)
solani on soybean##2##3##(2008-10#2)
solani on the surface of##2##5##(2008-10#2)
solani on##8##2##(2008-10#8)
solani only##2##2##(2008-10#2)
solani or##3##2##(2008-10#3)
solani pisi##3##2##(1995-3#1)(2008-7#2)
solani resulted in##2##3##(2008-10#2)
solani showed##2##2##(2008-10#2)
solani to##2##2##(2008-10#2)
solani was##5##2##(2008-10#5)
solani were##7##2##(2008-10#7)
solani##213##1##(1992-8#1)(1995-3#1)(2008-10#198)(2008-12#6)(2008-7#4)(2010-10#3)
solani)##2##1##(2008-10#2)
solar UV radiation##2##3##(2008-10#1)(2013-8#1)
solar UV##6##2##(2008-10#1)(2008-2#1)(2008-5#2)(2011-2#1)(2013-8#1)
solar UV-B##2##2##(1991-5#2)
solar UVB##2##2##(2008-10#1)(2012-3#1)
solar absorptance is##2##3##(2008-3#2)
solar absorptance##7##2##(2008-2#1)(2008-3#6)
solar absorption##3##2##(2008-3#3)
solar and##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
solar angle##3##2##(2008-2#1)(2008-3#2)
solar aureole##3##2##(2008-2#1)(2008-3#2)
solar background##6##2##(2008-2#1)(2008-3#5)
solar cells and##2##3##(2008-7#1)(2009-11#1)
solar cells##5##2##(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#2)
solar elevation##4##2##(2008-2#1)(2008-3#3)
solar elevations##2##2##(2008-3#2)
solar energy##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
solar exposure was##2##3##(2008-5#2)
solar exposure##7##2##(2008-5#6)(2011-2#1)
solar irradiance##11##2##(2008-10#1)(2008-2#6)(2008-3#2)(2008-7#2)
solar light##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
solar measurements##3##2##(2008-3#3)
solar occultation##5##2##(2008-2#4)(2008-3#1)
solar polarimetry##3##2##(2008-3#3)
solar radiance##2##2##(2008-3#2)
solar radiation and cancer mortality##2##5##(2010-1#2)
solar radiation and##4##3##(2008-10#1)(2008-2#1)(2010-1#2)
solar radiation in##2##3##(1990-9#1)(2008-2#1)
solar radiation on##4##3##(2008-10#1)(2008-2#1)(2010-1#2)
solar radiation##33##2##(1990-9#1)(1992-7#1)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#6)(2008-5#2)(2010-1#7)(2011-2#1)
solar radiative##2##2##(2008-2#1)(2008-3#1)
solar simulator##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
solar spectra##4##2##(2008-3#4)
solar spectral irradiance##2##3##(2008-3#2)
solar spectral##3##2##(2008-3#3)
solar spectrum##6##2##(2008-11#1)(2008-2#3)(2008-3#2)
solar transmittance##2##2##(2008-3#2)
solar ultraviolet##4##2##(2008-2#2)(2011-2#2)
solar zenith angle and##3##4##(2008-3#3)
solar zenith angle##10##3##(2008-2#4)(2008-3#6)
solar zenith angles as##2##4##(2008-2#1)(2008-3#1)
solar zenith angles##9##3##(2008-2#5)(2008-3#4)
solar zenith##19##2##(2008-2#9)(2008-3#10)
solar##204##1##(1990-9#1)(1991-5#2)(1992-11#1)(1992-7#1)(1995-5#1)(1997-5#1)(2007-12#2)(2008-10#17)(2008-11#6)(2008-2#44)(2008-3#89)(2008-5#12)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#7)(2011-2#9)(2012-3#1)(2013-8#2)
solar-blind Raman lidars##2##3##(2007-12#1)(2008-3#1)
solar-blind##3##1##(2007-12#2)(2008-3#1)
solar-imaging spectroscopy##2##2##(2008-3#2)
solar-selective##2##1##(2008-3#2)
solarization for##2##2##(2008-10#2)
solarization of##2##2##(2008-10#2)
solarization was##2##2##(2008-10#2)
solarization##12##1##(2008-10#12)
solasodine glycosides##4##2##(2008-11#4)
sold##9##1##(1990-6#1)(1991-9#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2009-10#1)(2010-2#1)
solder##5##1##(2008-2#1)(2008-3#4)
soldering##5##1##(1991-4#1)(2008-2#1)(2008-3#3)
soldiers and##3##2##(2007-12#1)(2007-8#2)
soldiers in##2##2##(1992-4#1)(1993-2#1)
soldiers##15##1##(1992-4#1)(1993-2#2)(1995-6#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#3)
sole carbohydrate source##2##3##(2008-10#2)
sole carbon source and##2##4##(2008-10#1)(2011-1#1)
sole carbon source##17##3##(2008-10#7)(2008-11#1)(2008-6#5)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
sole possibility##2##2##(1990-3#1)(1991-5#1)
sole source of##7##3##(1991-12#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)
sole species##2##2##(2011-2#2)
sole##96##1##(1990-3#1)(1990-5#2)(1990-9#1)(1991-12#4)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-7#1)(2007-11#1)(2007-7#2)(2008-10#20)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
solely by the##3##3##(1991-4#1)(2008-10#1)(2008-2#1)
solely by##11##2##(1991-4#1)(1993-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
solely dependent on##2##3##(2008-10#1)(2009-3#1)
solely due to##3##3##(1993-3#1)(1996-12#1)(2012-2#1)
solely from the##5##3##(1994-8#1)(2007-11#1)(2008-3#2)(2013-1#1)
solely from##14##2##(1994-2#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-3#4)(2011-2#1)(2013-1#1)
solely in the##2##3##(1995-8#1)(2008-10#1)
solely in##6##2##(1995-8#1)(2008-10#3)(2008-11#1)(2009-12#1)
solely of##2##2##(2008-10#1)(2013-8#1)
solely on the basis of##2##5##(1995-6#1)(2008-9#1)
solely on the##7##3##(1995-6#1)(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-2#1)
solely on##23##2##(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#2)(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
solely responsible for the##2##4##(1997-9#1)(2008-5#1)
solely responsible for##3##3##(1991-2#1)(1997-9#1)(2008-5#1)
solely the##5##2##(1996-5#1)(2008-2#1)(2008-7#1)(2013-1#2)
solely through##2##2##(2008-3#1)(2012-3#1)
solely to##9##2##(1990-9#1)(1992-9#1)(1993-1#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
solely##111##1##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
solenoid micro-pumps##2##2##(2008-10#2)
solenoid valve was##2##3##(2008-10#2)
solenoid valve##3##2##(2007-12#1)(2008-10#2)
solenoid valves and##3##3##(2008-10#3)
solenoid valves assembled to##3##4##(2008-10#3)
solenoid valves for##2##3##(2008-10#2)
solenoid valves##14##2##(2008-10#14)
solenoid##21##1##(2007-12#1)(2008-10#20)
soles and##2##2##(1997-3#1)(2008-5#1)
soles of the feet##2##4##(1996-3#1)(2012-3#1)
soles##6##1##(1996-3#1)(1997-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-3#1)
soleus H-reflex##3##2##(1993-12#2)(2013-1#1)
soleus and##2##2##(1993-12#1)(2013-8#1)
soleus motor##2##2##(1993-12#1)(1993-9#1)
soleus muscle##4##2##(1991-12#1)(1993-9#1)(1995-12#1)(2012-7#1)
soleus muscles##3##2##(1991-2#1)(1995-12#1)(2012-7#1)
soleus##18##1##(1991-12#1)(1991-2#1)(1993-12#6)(1993-9#2)(1995-12#4)(2012-7#2)(2013-1#1)(2013-8#1)
solgel fiber##2##2##(2007-11#2)
solgel glasses##3##2##(2008-3#3)
solgel material##2##2##(2007-12#2)
solgel silica lasers##2##3##(2008-3#2)
solgel silica##3##2##(2008-3#3)
solgel waveguide##2##2##(2008-3#2)
solgel##17##1##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#10)
solgel-derived##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
solicit##4##1##(1992-12#1)(1995-3#1)(2007-12#1)(2008-3#1)
solicitation##2##1##(1993-12#1)(2010-12#1)
solicited a##2##2##(1995-12#1)(1996-2#1)
solicited##3##1##(1995-12#1)(1996-1#1)(1996-2#1)
soliciting##2##1##(1996-3#1)(2008-8#1)
solid acid##5##2##(2008-10#2)(2008-5#1)(2010-12#2)
solid adsorbents##2##2##(2008-10#2)
solid amalgam electrode##3##3##(2008-10#3)
solid amalgam##5##2##(2008-10#5)
solid and liquid##5##3##(2008-10#4)(2008-2#1)
solid and the##2##3##(2008-10#1)(2010-4#1)
solid and##17##2##(2008-10#9)(2008-12#1)(2008-2#3)(2010-3#1)(2010-4#1)(2013-1#2)
solid angle of##3##3##(2008-2#2)(2008-3#1)
solid angle##6##2##(2008-10#1)(2008-2#2)(2008-3#3)
solid angles##2##2##(2008-3#2)
solid arthrodesis from##2##3##(2008-8#2)
solid bony##2##2##(2007-12#1)(2008-6#1)
solid cancers##2##2##(1993-8#1)(2013-1#1)
solid carbon##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
solid contact electrodes##4##3##(2008-10#4)
solid contact sensor for the determination of doxycycline hydrochloride##2##9##(2008-10#2)
solid contact were##2##3##(2008-10#2)
solid contact##11##2##(2008-10#11)
solid crystals##2##2##(2008-2#1)(2008-5#1)
solid data##2##2##(1990-8#1)(1996-1#1)
solid dispersion##5##2##(2011-1#2)(2012-2#3)
solid dispersions##3##2##(2012-2#3)
solid electrodes##2##2##(2008-10#2)
solid explosive##2##2##(2008-10#2)
solid fermentation##3##2##(2008-10#3)
solid fusion##3##2##(2008-11#1)(2012-3#2)
solid immersion lens (SIL)##3##4##(2008-3#3)
solid immersion lens##7##3##(2007-12#2)(2008-3#5)
solid immersion##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
solid iodine##2##2##(2008-10#2)
solid lipid nanoparticle##2##3##(2008-5#2)
solid lipid nanoparticles##2##3##(2008-5#2)
solid lipid##4##2##(2008-5#4)
solid mass is##3##3##(2008-10#3)
solid mass##7##2##(2008-10#7)
solid masses##2##2##(1990-10#1)(2007-5#1)
solid material##2##2##(2008-10#2)
solid materials##4##2##(2008-10#3)(2008-5#1)
solid matrices##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
solid matrix##5##2##(2008-10#4)(2008-2#1)
solid media##10##2##(1994-6#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#3)
solid medium##4##2##(1993-9#1)(1994-6#1)(1997-2#1)(2008-7#1)
solid mercury##2##2##(2008-10#2)
solid mixture##3##2##(2008-10#3)
solid nodules##2##2##(2012-12#1)(2013-1#1)
solid or liquid media##4##4##(1991-11#1)(2008-10#3)
solid or liquid particles##2##4##(1992-3#2)
solid or liquid##6##3##(1991-11#1)(1992-3#2)(2008-10#3)
solid or##9##2##(1991-11#1)(1992-3#2)(2008-10#4)(2008-9#1)(2010-4#1)
solid organ transplantation##2##3##(2007-11#1)(2008-1#1)
solid organ transplants##2##3##(2010-12#1)(2010-8#1)
solid organ##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#1)
solid organs##3##2##(2007-12#1)(2011-2#1)(2013-8#1)
solid pancreatic hamartoma##2##3##(2013-1#2)
solid pancreatic hamartomas##3##3##(2013-1#3)
solid pancreatic##5##2##(2013-1#5)
solid particles##3##2##(1990-12#1)(1996-3#1)(2008-10#1)
solid phantoms##2##2##(2007-10#1)(2008-2#1)
solid phase and##3##3##(1990-12#1)(1997-3#1)(2008-10#1)
solid phase degradation of l-ascorbic acid##4##6##(2008-10#4)
solid phase extractant for##2##4##(2008-10#2)
solid phase extractant##4##3##(2008-10#4)
solid phase extraction (SPE) and##4##5##(2008-10#3)(2008-11#1)
solid phase extraction (SPE) cartridges##2##5##(2008-10#2)
solid phase extraction (SPE) method##2##5##(2008-10#2)
solid phase extraction (SPE) procedure was##2##6##(2008-10#2)
solid phase extraction (SPE) procedure##4##5##(2008-10#4)
solid phase extraction (SPE) systems##2##5##(2008-10#2)
solid phase extraction (SPE)##32##4##(2008-10#30)(2008-11#1)(2011-1#1)
solid phase extraction and##5##4##(2008-10#5)
solid phase extraction cartridges##2##4##(2008-10#2)
solid phase extraction followed by##2##5##(2008-10#2)
solid phase extraction of##8##4##(2008-10#8)
solid phase extraction procedure##3##4##(2008-10#3)
solid phase extraction system##2##4##(2008-10#2)
solid phase extraction using##3##4##(2008-10#3)
solid phase extraction with##2##4##(2008-10#2)
solid phase extraction##84##3##(2008-10#80)(2008-11#1)(2009-8#1)(2011-1#1)(2013-1#1)
solid phase extractive preconcentration and separation of##2##7##(2008-10#2)
solid phase extractive preconcentration of##3##5##(2008-10#3)
solid phase extractive preconcentration##6##4##(2008-10#6)
solid phase extractor for##3##4##(2008-10#3)
solid phase extractor##4##3##(2008-10#4)
solid phase micro extraction##2##4##(2008-10#2)
solid phase micro-extraction##3##3##(2008-10#3)
solid phase microextraction (HSSPME)##2##4##(2008-10#2)
solid phase microextraction (SPME) to##2##5##(2008-10#2)
solid phase microextraction (SPME)##8##4##(2008-10#7)(2012-1#1)
solid phase microextraction coupled##2##4##(2008-10#2)
solid phase microextraction##17##3##(2008-10#16)(2012-1#1)
solid phase protein A##2##4##(1996-12#2)
solid phase spectrophotometric##3##3##(2008-10#3)
solid phase spectrophotometry##3##3##(2008-10#3)
solid phase##203##2##(1990-12#4)(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-2#2)(1994-8#1)(1995-6#1)(1996-12#2)(1997-3#1)(1997-4#2)(2006-12#1)(2008-10#166)(2008-11#2)(2008-4#4)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
solid propellants##2##2##(2008-10#2)
solid sample##10##2##(2008-10#9)(2008-3#1)
solid samples and##4##3##(2008-10#4)
solid samples by##2##3##(2008-10#2)
solid samples has##2##3##(2008-10#2)
solid samples using the##2##4##(2008-10#2)
solid samples was##4##3##(2008-1#1)(2008-10#3)
solid samples were##2##3##(2008-10#2)
solid samples##28##2##(2008-1#2)(2008-10#25)(2012-1#1)
solid sampling electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
solid sampling##7##2##(2008-10#7)
solid sensing zone##2##3##(2008-10#2)
solid sensing##3##2##(2008-10#3)
solid solution##9##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#2)(2012-2#1)
solid sorbents##3##2##(2008-10#3)
solid state (13)C NMR##3##4##(2008-10#3)
solid state bioprocessing of##2##4##(1997-2#2)
solid state bioprocessing##3##3##(1997-2#3)
solid state structures##2##3##(1996-2#2)
solid state##25##2##(1993-3#1)(1996-2#3)(1997-2#4)(1997-7#2)(2007-11#1)(2008-10#9)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#2)
solid substrate inoculum##2##3##(2008-10#2)
solid substrate room temperature phosphorescence (SS-RTP)##2##6##(2008-10#2)
solid substrate room temperature phosphorescence##3##5##(2008-10#3)
solid substrate##14##2##(1997-2#1)(2008-10#11)(2008-5#1)(2008-7#1)
solid substrate-room temperature phosphorimetry##2##4##(2008-10#2)
solid substrates##5##2##(2008-10#3)(2008-4#1)(2009-6#1)
solid support and##4##3##(2008-10#2)(2008-4#2)
solid support is##2##3##(2008-10#2)
solid support was##2##3##(2008-10#2)
solid support##36##2##(2008-10#26)(2008-4#7)(2008-5#1)(2008-6#1)(2009-12#1)
solid supports##8##2##(1997-3#1)(1997-4#2)(2008-10#4)(2013-8#1)
solid surface fluorescence##2##3##(2008-10#2)
solid surface fluorescence-based sensing##2##4##(2008-10#2)
solid surface is##2##3##(2008-10#2)
solid surface##10##2##(2008-10#8)(2008-11#1)(2008-7#1)
solid surfaces for##2##3##(2008-10#1)(2009-11#1)
solid surfaces##8##2##(1990-7#1)(1994-6#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-7#1)
solid tissues##3##2##(2007-12#1)(2008-2#2)
solid to##2##2##(1996-4#1)(2013-1#1)
solid tubular carcinoma##2##3##(1995-4#2)
solid tubular##5##2##(1995-4#5)
solid tumor##9##2##(1993-6#1)(1994-12#1)(1994-3#1)(1995-9#1)(2008-11#1)(2008-9#1)(2010-7#1)(2012-12#2)
solid tumors and##6##3##(2007-7#1)(2008-4#1)(2008-7#3)(2011-1#1)
solid tumors by##2##3##(2008-9#1)(2011-2#1)
solid tumors in##2##3##(1990-2#1)(1996-7#1)
solid tumors is##2##3##(1991-9#1)(2008-7#1)
solid tumors with##2##3##(2008-7#2)
solid tumors##51##2##(1990-2#3)(1991-9#1)(1992-10#2)(1992-9#1)(1996-10#1)(1996-7#1)(2007-7#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#20)(2008-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#4)
solid tumour##2##2##(2008-1#1)(2008-11#1)
solid tumours##8##2##(1994-10#3)(1997-4#1)(2008-11#1)(2009-4#1)(2010-9#1)(2013-7#1)
solid waste disposal##3##3##(2008-12#2)(2008-6#1)
solid waste##10##2##(2008-10#4)(2008-12#4)(2008-6#2)
solid##814##1##(1990-10#3)(1990-12#6)(1990-2#4)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#3)(1994-12#1)(1994-3#1)(1994-6#5)(1994-8#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#5)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#7)(1997-7#4)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#12)(2007-5#1)(2007-7#3)(2008-1#6)(2008-10#425)(2008-11#16)(2008-12#8)(2008-2#18)(2008-3#23)(2008-4#17)(2008-5#22)(2008-6#4)(2008-7#32)(2008-8#3)(2008-9#12)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#6)(2012-1#4)(2012-12#5)(2012-2#13)(2012-3#3)(2013-1#27)(2013-7#1)(2013-8#7)
solid&quot##3##1##(1994-5#2)(2008-10#1)
solid-contact##4##1##(2008-10#4)
solid-liquid extraction of##2##3##(2008-10#2)
solid-liquid extraction##12##2##(2008-10#12)
solid-liquid##19##1##(2008-10#16)(2008-7#1)(2012-1#1)(2013-1#1)
solid-matrix luminescence##3##2##(2008-10#3)
solid-matrix phosphorescence##2##2##(2008-10#2)
solid-matrix##6##1##(2008-10#6)
solid-phase PbO(2)##2##2##(2008-10#2)
solid-phase assay##2##2##(1990-12#1)(2008-1#1)
solid-phase extraction (SPE) using##2##4##(2008-10#2)
solid-phase extraction (SPE)##16##3##(1997-2#1)(2008-10#15)
solid-phase extraction and gas chromatography-mass spectrometry##2##6##(2008-10#2)
solid-phase extraction and gas chromatography-mass##3##5##(2008-10#3)
solid-phase extraction and##14##3##(1992-11#1)(1997-2#2)(2008-10#10)(2008-11#1)
solid-phase extraction by##2##3##(2008-10#2)
solid-phase extraction device##2##3##(1997-2#2)
solid-phase extraction of the##2##4##(2008-10#2)
solid-phase extraction of##8##3##(1997-2#1)(2008-10#7)
solid-phase extraction support##2##3##(2008-10#2)
solid-phase extraction system##2##3##(2008-10#2)
solid-phase extraction technique##3##3##(1992-11#1)(2008-10#1)(2013-8#1)
solid-phase extraction using##4##3##(2008-10#4)
solid-phase extraction was##2##3##(2008-10#2)
solid-phase extraction with##4##3##(2008-10#4)
solid-phase extraction##82##2##(1992-11#4)(1996-5#1)(1997-2#9)(2008-10#64)(2008-11#1)(2008-5#2)(2013-8#1)
solid-phase immunoassay##2##2##(1990-12#1)(1990-8#1)
solid-phase method##2##2##(1995-6#1)(2008-9#1)
solid-phase microextraction (HS-SPME)##5##3##(2008-10#4)(2012-1#1)
solid-phase microextraction (SPME) fiber##2##4##(2008-10#2)
solid-phase microextraction (SPME) with##2##4##(2008-10#2)
solid-phase microextraction (SPME)##14##3##(2008-10#14)
solid-phase microextraction and##3##3##(2008-10#3)
solid-phase microextraction coupled with high-performance liquid chromatography##2##7##(2008-10#2)
solid-phase microextraction coupled with##3##4##(2008-10#3)
solid-phase microextraction coupled##4##3##(2008-10#4)
solid-phase microextraction using calix[4]arene fiber##2##5##(2008-10#2)
solid-phase microextraction with##2##3##(2008-10#2)
solid-phase microextraction##47##2##(1997-2#1)(2008-10#43)(2012-1#2)(2012-12#1)
solid-phase organic synthesis##2##3##(1997-4#2)
solid-phase organic##3##2##(1997-3#1)(1997-4#2)
solid-phase peptide synthesis##3##3##(2008-2#1)(2008-4#2)
solid-phase reactor##2##2##(2008-10#2)
solid-phase spectrofluorimetry##2##2##(2008-10#2)
solid-phase spectrophotometric##2##2##(2008-10#2)
solid-phase spectrophotometry##3##2##(2008-10#3)
solid-phase synthesis of oligosaccharides##2##4##(1997-4#2)
solid-phase synthesis of##9##3##(1997-3#1)(1997-4#2)(2008-4#6)
solid-phase synthesis##15##2##(1993-11#1)(1997-3#1)(1997-4#5)(2008-4#8)
solid-phase techniques##3##2##(1992-3#1)(2008-2#1)(2008-4#1)
solid-phase##216##1##(1990-12#3)(1990-8#1)(1991-3#1)(1992-11#4)(1992-3#1)(1992-6#2)(1993-11#1)(1995-6#2)(1995-8#1)(1996-5#1)(1997-2#11)(1997-3#4)(1997-4#8)(2007-12#1)(2008-1#3)(2008-10#141)(2008-11#1)(2008-2#4)(2008-4#17)(2008-5#2)(2008-9#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
solid-state NMR##3##2##(1991-11#2)(2010-12#1)
solid-state and##5##2##(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
solid-state contact##3##2##(2008-10#3)
solid-state dye laser##4##3##(2008-2#2)(2008-3#2)
solid-state dye lasers##5##3##(2008-2#2)(2008-3#3)
solid-state dye##10##2##(2007-12#1)(2008-2#4)(2008-3#5)
solid-state electrochemiluminescence##2##2##(2008-10#2)
solid-state electrodes##3##2##(2008-10#3)
solid-state fermentation##2##2##(2011-2#2)
solid-state gain medium##3##3##(2007-11#1)(2008-2#2)
solid-state laser is##2##3##(2007-11#1)(2007-12#1)
solid-state laser with a##3##4##(2007-12#1)(2008-3#2)
solid-state laser##23##2##(2007-11#7)(2007-12#9)(2008-2#1)(2008-3#6)
solid-state lasers based on##2##4##(2007-12#1)(2008-3#1)
solid-state lasers with##3##3##(2007-11#2)(2008-2#1)
solid-state lasers##19##2##(2007-11#6)(2007-12#6)(2008-2#3)(2008-3#4)
solid-state nanopore##3##2##(2008-7#3)
solid-state nanopores##2##2##(2008-7#2)
solid-state saturable##3##2##(2008-2#1)(2008-3#2)
solid-state##128##1##(1991-11#2)(1992-1#1)(1996-2#1)(2007-11#14)(2007-12#25)(2008-10#24)(2008-2#21)(2008-3#25)(2008-7#7)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#3)
solid-support assisted on-line derivatization##2##4##(2008-10#2)
solid-support assisted##3##2##(2008-10#3)
solid-surface fluorescence##2##2##(2008-10#2)
solid-surface##4##1##(2008-10#4)
solidarity##6##1##(2008-12#1)(2008-7#3)(2009-10#1)(2011-2#1)
solidified in a##2##3##(2008-10#1)(2010-2#1)
solidified wastes##2##2##(2008-10#2)
solidified##6##1##(2007-11#1)(2008-10#3)(2008-5#1)(2010-2#1)
solidifying##3##1##(2008-12#1)(2008-5#2)
solidity##2##1##(1990-3#1)(2008-5#1)
solidphase##2##1##(2008-7#1)(2012-12#1)
solids and liquids##2##3##(2008-3#2)
solids and##6##2##(2008-10#2)(2008-3#2)(2011-2#1)(2012-2#1)
solids have been##2##3##(2008-10#2)
solids in the##2##3##(2007-5#1)(2008-10#1)
solids such as##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
solids##49##1##(1994-12#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#25)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-7#1)
solitarily##2##1##(2008-8#1)(2008-9#1)
solitary and##3##2##(1997-1#1)(2008-9#1)(2012-3#1)
solitary cells##2##2##(1994-6#1)(2008-10#1)
solitary extramedullary plasmacytoma##2##3##(2009-3#2)
solitary fibrous tumour of##2##4##(2011-1#2)
solitary fibrous##3##2##(2007-8#1)(2011-1#2)
solitary foragers##2##2##(2008-9#2)
solitary kidney in##2##3##(2012-12#1)(2012-2#1)
solitary kidney##5##2##(2012-12#3)(2012-2#2)
solitary metastases of##2##3##(1990-8#1)(2007-11#1)
solitary metastases##4##2##(1990-8#1)(1992-12#1)(2007-11#1)(2008-10#1)
solitary nodules##2##2##(2012-3#2)
solitary nonparasitic cyst of the##2##5##(1991-3#2)
solitary plasmacytoma##2##2##(2012-12#2)
solitary pulmonary nodule##3##3##(2007-8#2)(2008-1#1)
solitary pulmonary##4##2##(1991-3#1)(2007-8#2)(2008-1#1)
solitary solid##2##2##(1993-6#1)(2013-1#1)
solitary species##2##2##(2008-6#1)(2008-9#1)
solitary wasps and bees##4##4##(2008-6#4)
solitary waves in##3##3##(2007-12#3)
solitary waves##9##2##(2007-11#1)(2007-12#8)
solitary##100##1##(1990-11#1)(1990-12#1)(1990-8#3)(1991-3#4)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-6#1)(1996-1#1)(1996-5#1)(1997-1#1)(2007-11#2)(2007-12#9)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#7)(2009-3#4)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#5)
soliton and##2##2##(2007-11#1)(2007-12#1)
soliton at##2##2##(2007-12#2)
soliton can be##2##3##(2007-12#2)
soliton collisions##2##2##(2007-12#2)
soliton compressor##2##2##(2007-12#2)
soliton fiber laser##2##3##(2007-11#1)(2007-12#1)
soliton fiber##3##2##(2007-11#1)(2007-12#2)
soliton formation##4##2##(2007-11#1)(2007-12#3)
soliton generation##4##2##(2007-11#2)(2007-12#2)
soliton in a##3##3##(2007-11#1)(2007-12#2)
soliton in##5##2##(2007-11#2)(2007-12#3)
soliton induces a##2##3##(2007-11#1)(2008-3#1)
soliton interactions##2##2##(2007-11#1)(2007-12#1)
soliton is##2##2##(2007-11#1)(2007-12#1)
soliton laser##2##2##(2007-12#2)
soliton mode locking##2##3##(2007-11#1)(2007-12#1)
soliton pixels##2##2##(2007-11#2)
soliton propagation##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
soliton pulse##4##2##(2007-11#4)
soliton pulses##4##2##(2007-11#2)(2007-12#2)
soliton self-frequency shift by##2##4##(2007-11#2)
soliton self-frequency shift##4##3##(2007-11#4)
soliton switching in a##2##4##(2008-3#2)
soliton systems##6##2##(2007-11#4)(2007-12#2)
soliton transmission##5##2##(2007-11#1)(2007-12#4)
soliton##115##1##(1992-11#1)(2007-11#47)(2007-12#59)(2008-2#2)(2008-3#6)
soliton-induced waveguides##2##2##(2007-11#1)(2007-12#1)
soliton-induced##3##1##(2007-11#2)(2007-12#1)
solitonlike pulses##2##2##(2007-11#1)(2007-12#1)
solitons and##9##2##(2007-11#5)(2007-12#4)
solitons are observed##2##3##(2007-11#1)(2007-12#1)
solitons are##9##2##(2007-11#5)(2007-12#4)
solitons can##2##2##(2007-11#1)(2007-12#1)
solitons exist##2##2##(2007-11#2)
solitons in a bulk##2##4##(2007-12#2)
solitons in a##6##3##(2007-11#3)(2007-12#3)
solitons in centrosymmetric##2##3##(2007-12#2)
solitons in photorefractive##3##3##(2007-11#1)(2007-12#2)
solitons in##28##2##(2007-11#11)(2007-12#14)(2008-2#2)(2008-3#1)
solitons is##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
solitons with a##2##3##(2007-11#1)(2008-3#1)
solitons with##7##2##(2007-11#3)(2007-12#2)(2008-3#2)
solitons##119##1##(1994-2#1)(2007-11#48)(2007-12#63)(2008-2#3)(2008-3#4)
solium##3##1##(1991-8#2)(1995-12#1)
solo##2##1##(1991-1#1)(2012-1#1)
solstitialis##2##1##(2008-10#2)
solubilisation##5##1##(1990-2#1)(2008-10#2)(2008-5#1)(2010-4#1)
solubilities and##2##2##(2008-10#2)
solubilities##7##1##(2008-10#7)
solubility and##12##2##(1991-2#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-4#1)(2010-4#1)(2010-5#1)(2013-1#1)
solubility constant##2##2##(2008-10#2)
solubility data##2##2##(2008-10#1)(2010-3#1)
solubility in molten##2##3##(2008-10#2)
solubility in the##4##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
solubility in water##7##3##(2008-10#5)(2008-9#1)(2009-12#1)
solubility in##18##2##(1991-12#1)(1993-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)
solubility is##2##2##(1991-12#1)(2008-10#1)
solubility of furosemide##2##3##(2012-2#2)
solubility of the##7##3##(2008-10#6)(2013-1#1)
solubility of toluene##3##3##(2008-10#3)
solubility of##39##2##(1994-8#1)(1995-2#1)(2008-10#23)(2008-11#1)(2008-4#1)(2008-5#3)(2010-4#1)(2010-5#2)(2011-1#1)(2012-2#4)(2013-1#1)
solubility on##2##2##(2008-10#2)
solubility parameter##3##2##(2008-10#3)
solubility parameters##5##2##(2008-10#5)
solubility product##2##2##(2008-10#2)
solubility properties##2##2##(1997-2#1)(2008-10#1)
solubility was##4##2##(2008-11#1)(2010-5#1)(2012-2#2)
solubility##148##1##(1991-12#2)(1991-2#1)(1992-8#1)(1993-1#1)(1993-8#2)(1994-8#1)(1995-2#1)(1995-3#3)(1995-5#1)(1997-1#4)(1997-2#1)(2007-11#3)(2008-1#1)(2008-10#72)(2008-11#4)(2008-3#1)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#5)(2010-5#5)(2011-1#1)(2011-2#1)(2012-2#8)(2013-1#8)
solubility)##2##1##(2008-10#1)(2008-5#1)
solubilization and##4##2##(2008-11#1)(2008-4#1)(2008-5#2)
solubilization in##5##2##(1994-5#1)(2008-10#2)(2008-11#1)(2013-1#1)
solubilization is##2##2##(1994-12#1)(2008-4#1)
solubilization of the protein##2##4##(2008-4#2)
solubilization of the##6##3##(1990-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)
solubilization of##16##2##(1990-2#1)(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#1)(2008-7#1)(2013-1#3)
solubilization with##3##2##(1990-11#1)(2008-10#1)(2008-4#1)
solubilization##56##1##(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1992-12#2)(1994-12#3)(1994-5#1)(1994-6#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-4#12)(2008-5#4)(2008-7#1)(2012-2#2)(2013-1#6)
solubilize##5##1##(2008-10#1)(2009-10#2)(2012-2#1)(2013-1#1)
solubilized and##4##2##(1990-12#1)(1994-11#1)(2008-10#1)(2008-11#1)
solubilized brush border##2##3##(1990-11#2)
solubilized by##2##2##(1990-8#1)(1991-10#1)
solubilized enzyme##3##2##(1990-5#2)(1994-8#1)
solubilized from the##2##3##(1994-8#1)(2008-5#1)
solubilized from##3##2##(1994-12#1)(1994-8#1)(2008-5#1)
solubilized in##6##2##(1990-2#2)(1995-11#1)(2008-10#3)
solubilized into##2##2##(1994-11#1)(2008-10#1)
solubilized membrane##4##2##(1990-2#1)(1991-5#2)(2008-1#1)
solubilized membranes##2##2##(1990-2#1)(1990-5#1)
solubilized tonoplast proteins##2##3##(2008-11#2)
solubilized with##7##2##(1990-11#1)(1990-2#1)(1991-5#1)(1994-11#1)(1994-12#1)(2008-10#2)
solubilized##52##1##(1990-11#4)(1990-12#1)(1990-2#6)(1990-5#3)(1990-8#1)(1991-10#1)(1991-5#3)(1992-3#1)(1993-11#2)(1994-11#3)(1994-12#3)(1994-8#3)(1995-11#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2013-1#2)
solubilizing agent for##2##3##(2010-5#1)(2013-1#1)
solubilizing the##2##2##(2008-10#1)(2008-11#1)
solubilizing##8##1##(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2013-1#1)(2013-7#2)
soluble A beta##2##3##(1994-11#1)(1996-5#1)
soluble Cr##3##2##(2008-10#3)
soluble FMN phosphatase##2##3##(1992-12#2)
soluble IL-6 receptor##3##3##(1997-7#2)(2008-4#1)
soluble Mn (IV)-formaldehyde-indomethacin##2##3##(2008-10#2)
soluble TNF receptors (sTNF-Rs)##2##4##(2008-4#2)
soluble and exchangeable cations and##2##5##(2011-2#2)
soluble and exchangeable##3##3##(2011-2#3)
soluble and insoluble##6##3##(1996-1#1)(1997-4#1)(2008-10#3)(2008-4#1)
soluble and microsomal b5##2##4##(1992-6#2)
soluble and microsomal##4##3##(1992-6#4)
soluble and##24##2##(1992-12#1)(1992-3#1)(1992-6#4)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-4#1)(2008-10#5)(2008-4#2)(2009-7#1)(2010-2#1)(2011-2#3)
soluble antigens##5##2##(1997-9#1)(2008-11#3)(2008-9#1)
soluble carbohydrate##2##2##(2008-10#1)(2013-7#1)
soluble chemicals##2##2##(2008-11#1)(2008-7#1)
soluble complexes##3##2##(2008-10#3)
soluble components##4##2##(2008-10#3)(2008-9#1)
soluble cytokines##2##2##(2008-9#2)
soluble even##2##2##(2008-10#2)
soluble extract##4##2##(1990-2#2)(1990-5#1)(1994-12#1)
soluble extracts from##2##3##(1994-8#1)(2008-10#1)
soluble factors##9##2##(2007-11#1)(2008-4#2)(2008-9#2)(2009-12#1)(2012-4#1)(2013-1#1)(2013-8#1)
soluble form of RGP##2##4##(1995-2#2)
soluble form of furin##3##4##(1992-12#3)
soluble form of the##4##4##(1992-11#1)(1993-8#1)(1994-8#1)(1997-2#1)
soluble form of##9##3##(1992-11#1)(1992-12#3)(1993-8#1)(1994-8#1)(1995-2#2)(1997-2#1)
soluble form##18##2##(1992-11#1)(1992-12#3)(1992-6#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-2#3)(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#2)
soluble forms in##2##3##(2009-4#1)(2010-5#1)
soluble forms of##2##3##(1994-11#1)(1995-12#1)
soluble forms##5##2##(1994-11#1)(1995-12#1)(2008-10#1)(2009-4#1)(2010-5#1)
soluble fraction of##5##3##(1990-6#1)(1991-7#1)(1991-9#1)(1992-9#1)(1996-12#1)
soluble fraction##8##2##(1990-2#2)(1990-6#1)(1991-7#1)(1991-9#1)(1992-9#1)(1996-12#1)(2008-10#1)
soluble fractions##5##2##(1990-11#3)(1993-11#1)(1997-2#1)
soluble glucose oxidase##2##3##(2008-10#2)
soluble guanylate cyclase##3##3##(1991-9#1)(2008-4#1)(2008-6#1)
soluble human##2##2##(2008-11#2)
soluble in a##2##3##(2008-10#2)
soluble in aqueous##2##3##(1990-7#1)(2008-10#1)
soluble in the##7##3##(1997-7#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)
soluble in water##5##3##(1994-3#1)(2008-10#2)(2008-5#1)(2010-3#1)
soluble in##22##2##(1990-7#1)(1994-3#1)(1996-1#1)(1997-7#1)(2008-10#11)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)
soluble insulin##2##2##(1991-8#2)
soluble interleukin-2##2##2##(1990-2#1)(1990-6#1)
soluble magnesium##2##2##(2008-10#2)
soluble manganese(IV)##2##2##(2008-10#2)
soluble mediators##2##2##(1990-9#1)(1995-2#1)
soluble or##4##2##(1995-2#1)(2008-4#3)
soluble oxalate##2##2##(2012-2#2)
soluble phenolic compounds##4##3##(2008-10#4)
soluble polymer##4##2##(2008-10#3)(2008-6#1)
soluble product##2##2##(2008-10#1)(2008-5#1)
soluble protein in the##3##4##(1994-5#1)(1995-2#1)(2013-1#1)
soluble protein in##4##3##(1993-9#1)(1994-5#1)(1995-2#1)(2013-1#1)
soluble protein##15##2##(1990-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-9#1)(2013-1#1)
soluble proteins and##2##3##(1995-12#1)(2008-6#1)
soluble proteins##17##2##(1992-6#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-4#8)(2008-6#2)(2012-1#1)
soluble receptor##2##2##(1994-2#1)(1994-8#1)
soluble recombinant##2##2##(1995-11#1)(2013-8#1)
soluble salts##2##2##(1990-5#1)(2008-10#1)
soluble solids##4##2##(2008-10#1)(2011-2#1)(2012-2#2)
soluble species of##2##3##(2008-10#2)
soluble starch##4##2##(2008-6#1)(2008-9#1)(2013-8#2)
soluble sugars was##2##3##(2008-12#2)
soluble sugars##4##2##(2008-12#3)(2008-9#1)
soluble type##2##2##(1993-3#1)(2008-11#1)
soluble##378##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#8)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#10)(1992-3#4)(1992-6#10)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#10)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#15)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#4)(1997-9#1)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#96)(2008-11#19)(2008-12#4)(2008-3#1)(2008-4#27)(2008-5#4)(2008-6#6)(2008-7#8)(2008-8#3)(2008-9#11)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-2#7)(2012-1#1)(2012-2#6)(2012-4#1)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#7)
solublized##2##1##(2008-10#1)(2008-11#1)
soluflazine##2##1##(1994-8#2)
solute and##7##2##(1990-8#1)(2008-10#4)(2008-7#1)(2011-2#1)
solute clearances##2##2##(2011-2#2)
solute dielectric##2##2##(2008-4#1)(2013-1#1)
solute distribution##3##2##(2008-7#1)(2011-2#2)
solute in##4##2##(2008-10#3)(2008-7#1)
solute is##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
solute particles##2##2##(2008-7#2)
solute retention and##2##3##(2008-10#2)
solute##63##1##(1990-8#1)(1991-6#1)(1993-11#2)(1994-9#1)(1996-5#1)(2007-12#2)(2008-10#26)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#6)(2009-10#1)(2009-12#1)(2010-2#4)(2011-2#7)(2012-7#1)(2013-1#4)
solute-solute##2##1##(2008-10#1)(2010-2#1)
solute-solvent interactions##3##2##(2008-10#3)
solute-solvent##6##1##(2008-10#4)(2010-2#2)
solutes and##5##2##(2008-10#2)(2008-7#1)(2011-2#2)
solutes are##2##2##(2008-10#2)
solutes from##2##2##(2008-10#2)
solutes in##5##2##(1993-11#2)(1996-5#1)(2008-10#1)(2012-7#1)
solutes on##2##2##(2008-10#2)
solutes was##2##2##(1996-5#1)(2008-10#1)
solutes were separated in parallel##2##5##(2008-10#2)
solutes were##3##2##(2008-10#3)
solutes##50##1##(1990-5#2)(1993-11#4)(1994-9#1)(1996-5#4)(1997-2#1)(2008-10#23)(2008-12#1)(2008-4#1)(2008-7#4)(2010-2#1)(2011-1#1)(2011-2#4)(2012-7#2)(2013-1#1)
solution (0##6##2##(1992-3#1)(2008-10#5)
solution (1##2##2##(2008-10#2)
solution (100##2##2##(2008-10#1)(2008-7#1)
solution (2##3##2##(2008-10#3)
solution (31)P-NMR##2##2##(2008-10#2)
solution (5##2##2##(2008-10#2)
solution (NaNO(3) 0##2##3##(2008-10#2)
solution (in##2##2##(1993-8#1)(2008-10#1)
solution (pH 12)##2##3##(2008-10#2)
solution (pH 4##7##3##(2008-10#6)(2008-3#1)
solution (pH 7##4##3##(2008-10#4)
solution (pH 8##2##3##(2008-10#1)(2008-11#1)
solution (pH##28##2##(2008-10#26)(2008-11#1)(2008-3#1)
solution 0##2##2##(2008-10#2)
solution NMR##2##2##(1991-11#1)(2008-9#1)
solution acidity##6##2##(2008-10#6)
solution adjusted to pH##3##4##(2008-10#3)
solution after each##2##3##(2008-10#2)
solution after##10##2##(1991-12#1)(2008-10#7)(2008-2#1)(2009-7#1)
solution also##2##2##(2008-10#1)(2008-5#1)
solution and a##5##3##(2008-10#5)
solution and at##2##3##(2008-10#1)(2008-12#1)
solution and crystal##2##3##(1992-8#2)
solution and for##2##3##(2008-10#1)(2008-3#1)
solution and in##9##3##(1990-2#1)(1997-7#1)(2008-10#6)(2009-9#1)
solution and liquid##2##3##(1995-6#1)(2008-5#1)
solution and subsequently##2##3##(2008-10#2)
solution and the##18##3##(2008-10#15)(2008-2#1)(2008-3#1)(2008-9#1)
solution and then##2##3##(2008-10#2)
solution and to##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
solution and was##2##3##(2008-10#2)
solution and were##2##3##(2008-10#1)(2008-12#1)
solution and##129##2##(1990-2#1)(1990-5#1)(1991-3#2)(1992-8#3)(1994-3#1)(1995-6#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#96)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-9#3)(2009-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
solution are described##2##3##(2008-10#1)(2008-2#1)
solution are##12##2##(1990-8#1)(1991-8#1)(1992-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
solution as a titrant##2##4##(2008-10#2)
solution as a##10##3##(1990-7#1)(2008-10#7)(2008-3#1)(2009-11#1)
solution as eluent##2##3##(2008-10#2)
solution as mobile phase##2##4##(2008-10#2)
solution as the##3##3##(2008-10#2)(2008-5#1)
solution as##26##2##(1990-7#1)(1994-9#1)(2008-10#19)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)
solution at a flow-rate of##2##5##(2008-10#2)
solution at a##8##3##(2008-10#8)
solution at an##2##3##(2008-10#2)
solution at different##2##3##(2008-10#2)
solution at pH 3##3##4##(2008-10#3)
solution at pH 5##2##4##(2008-10#2)
solution at pH 6##3##4##(2008-10#3)
solution at pH 7##3##4##(2008-10#3)
solution at pH 8##3##4##(2008-10#3)
solution at pH##17##3##(2008-10#17)
solution at the##2##3##(1994-3#1)(2008-10#1)
solution at##48##2##(1991-6#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-10#39)(2008-8#1)(2009-12#1)(2009-6#1)
solution based on the##2##4##(2007-11#1)(2011-1#1)
solution based on##4##3##(2007-11#1)(2008-6#1)(2011-1#1)(2011-3#1)
solution between##2##2##(2008-10#2)
solution binding##2##2##(1992-6#1)(2008-10#1)
solution by means of##3##4##(2008-10#3)
solution by the##2##3##(2008-10#2)
solution by using##2##3##(2008-10#2)
solution by##24##2##(1990-2#1)(1991-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#17)(2008-5#1)(2009-9#1)
solution calorimetry##5##2##(2008-10#5)
solution can be##8##3##(1991-3#1)(2008-10#5)(2008-2#2)
solution can##13##2##(1991-3#1)(2008-10#8)(2008-2#2)(2008-6#1)(2013-8#1)
solution carrier##2##2##(2008-10#2)
solution casting##3##2##(2008-10#2)(2008-5#1)
solution caused##2##2##(2008-10#1)(2008-8#1)
solution causes##2##2##(1994-9#1)(2008-10#1)
solution chemistry##2##2##(1993-12#1)(2008-5#1)
solution composition##2##2##(2008-10#2)
solution concentration##4##2##(2008-10#3)(2009-7#1)
solution conditions##5##2##(1997-2#2)(2008-10#2)(2010-4#1)
solution conformation of the##2##4##(1991-12#1)(1991-8#1)
solution conformation##3##2##(1991-12#1)(1991-8#1)(2008-9#1)
solution containing 0##10##3##(2008-10#9)(2008-12#1)
solution containing 1##2##3##(2008-10#1)(2008-8#1)
solution containing 2##3##3##(2008-10#3)
solution containing 7##2##3##(2008-10#2)
solution containing a##3##3##(2008-10#3)
solution containing both##2##3##(2008-10#2)
solution containing the##3##3##(2008-10#3)
solution containing various##2##3##(2008-10#1)(2008-12#1)
solution containing##85##2##(1997-6#1)(2007-11#1)(2008-10#72)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2011-2#1)
solution could be##4##3##(1997-2#1)(2008-10#2)(2013-1#1)
solution could##5##2##(1997-2#1)(2008-10#2)(2008-2#1)(2013-1#1)
solution culture##2##2##(2008-8#1)(2008-9#1)
solution decreased##2##2##(1996-2#1)(2008-10#1)
solution depends on##2##3##(1997-2#1)(2011-2#1)
solution does not##2##3##(1996-3#1)(2008-10#1)
solution during the##2##3##(2008-10#1)(2009-12#1)
solution during##3##2##(2008-10#2)(2009-12#1)
solution equilibria of##3##3##(2008-10#3)
solution followed by##3##3##(2008-10#2)(2008-11#1)
solution for a##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
solution for an##2##3##(1993-8#1)(1994-1#1)
solution for light scattering by nonspherical##2##6##(2008-3#2)
solution for light scattering by##3##5##(2008-3#3)
solution for the##18##3##(1993-11#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-5#1)(2009-7#1)(2011-7#1)(2012-12#1)
solution for##67##2##(1990-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#2)(2011-7#1)(2012-12#1)
solution from the##4##3##(2008-10#3)(2008-3#1)
solution from##13##2##(1993-11#1)(2006-4#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#1)
solution gave a mean absorbance of 0##3##7##(2008-10#3)
solution gave a mean##4##4##(2008-10#4)
solution gave a##6##3##(2008-10#6)
solution generated##2##2##(2008-10#2)
solution had##5##2##(1996-2#1)(2008-10#4)
solution has been carried out##2##5##(2008-10#2)
solution has been described##2##4##(2008-10#2)
solution has been investigated##2##4##(2008-10#2)
solution has been##10##3##(2008-10#8)(2008-3#1)(2010-5#1)
solution has##11##2##(2007-7#1)(2008-10#8)(2008-3#1)(2010-5#1)
solution have been##6##3##(1990-9#1)(1995-6#1)(2008-10#3)(2008-5#1)
solution have##7##2##(1990-9#1)(1995-6#1)(2008-10#4)(2008-5#1)
solution hybridisation-RNase protection assay##3##4##(1996-12#3)
solution hybridisation-RNase protection##4##3##(1996-12#4)
solution hybridization assay##3##3##(1991-9#3)
solution hybridization##6##2##(1991-9#3)(1995-8#1)(2008-10#1)(2008-4#1)
solution in a##11##3##(2008-10#8)(2009-9#1)(2011-2#2)
solution in order to##3##4##(2008-10#3)
solution in the presence of##4##5##(1995-11#1)(2008-10#3)
solution in the range##2##4##(2008-10#2)
solution in the##15##3##(1991-1#1)(1995-11#1)(1995-3#2)(2007-12#2)(2008-10#9)
solution in which the##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
solution in##59##2##(1991-1#1)(1991-9#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-3#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#38)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-2#3)
solution including##2##2##(2008-10#2)
solution increased##2##2##(1990-5#1)(2008-11#1)
solution instead of##2##3##(2008-10#1)(2008-11#1)
solution into a##3##3##(2008-10#3)
solution into the##5##3##(1990-7#1)(2008-10#4)
solution into##9##2##(1990-7#1)(2008-10#8)
solution is added to##2##4##(2008-10#2)
solution is derived##2##3##(2007-11#1)(2008-2#1)
solution is determined##2##3##(2008-10#2)
solution is injected into##3##4##(2008-10#3)
solution is mixed##2##3##(2008-10#2)
solution is presented##4##3##(2008-10#1)(2008-3#3)
solution is required##2##3##(2008-10#2)
solution is to##2##3##(1994-3#1)(2011-2#1)
solution is used to##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
solution is used##5##3##(2008-1#1)(2008-10#3)(2008-2#1)
solution is##80##2##(1994-3#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#44)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#3)
solution leaving##2##2##(2008-10#2)
solution may##2##2##(2008-3#1)(2010-7#1)
solution measurements##2##2##(1993-8#1)(2008-10#1)
solution method##3##2##(2008-3#1)(2013-8#2)
solution must be##2##3##(2008-10#2)
solution obtained by##2##3##(2008-10#1)(2011-2#1)
solution obtained##3##2##(2008-10#2)(2011-2#1)
solution of 0##9##3##(2008-10#9)
solution of 2##3##3##(2008-10#3)
solution of a##14##3##(1991-5#1)(1995-2#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#2)(2009-10#1)(2009-11#1)
solution of an inverse##2##4##(2007-11#1)(2008-3#1)
solution of light scattering##3##4##(2008-3#3)
solution of pH 8##2##4##(2008-10#2)
solution of pH##6##3##(2008-10#6)
solution of potassium phosphate dibasic (pH 7##2##7##(2008-10#2)
solution of potassium##3##3##(2007-7#1)(2008-10#2)
solution of sodium##3##3##(2008-10#3)
solution of the diffusion equation##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
solution of the diffusion##5##4##(2007-11#1)(2008-2#3)(2008-3#1)
solution of the radiative transfer equation##2##6##(2008-2#2)
solution of the reagent##2##4##(2008-10#2)
solution of the two-frequency lidar inversion##2##6##(2008-3#2)
solution of the##53##3##(1991-11#1)(1991-9#1)(1997-2#1)(2007-11#3)(2007-12#3)(2008-10#13)(2008-11#1)(2008-2#8)(2008-3#12)(2008-5#2)(2008-7#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
solution of##195##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-2#4)(1997-2#1)(2007-11#6)(2007-12#5)(2007-7#1)(2008-10#92)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#25)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#4)
solution on the##9##3##(2008-10#8)(2013-8#1)
solution on##18##2##(2008-10#11)(2008-11#1)(2008-2#1)(2010-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
solution only##2##2##(2008-10#1)(2008-12#1)
solution onto##3##2##(2008-10#2)(2008-11#1)
solution or the##2##3##(2008-10#2)
solution or##15##2##(1990-5#1)(1990-8#1)(1993-12#2)(1994-9#1)(2008-10#10)
solution orientation##2##2##(2011-2#2)
solution over a##2##3##(1994-3#1)(2008-10#1)
solution over##3##2##(1994-3#1)(2008-10#2)
solution pH and##4##3##(2008-10#3)(2008-6#1)
solution pH on the##3##4##(2008-10#2)(2008-5#1)
solution pH##28##2##(1995-2#1)(2008-10#25)(2008-5#1)(2008-6#1)
solution phase sensing##2##3##(2008-10#2)
solution phase##10##2##(2008-10#8)(2008-5#1)(2010-5#1)
solution precipitation##2##2##(2009-11#2)
solution preparation##2##2##(2008-10#1)(2008-9#1)
solution prior to##3##3##(1994-3#1)(1996-2#1)(2010-5#1)
solution procedure##2##2##(1992-6#1)(2009-10#1)
solution provides##3##2##(2008-10#2)(2008-3#1)
solution ranged from##2##3##(2008-10#2)
solution results in##4##3##(1990-2#1)(1996-5#1)(2009-6#1)(2010-5#1)
solution samples##11##2##(2008-10#11)
solution should be##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
solution showed##3##2##(2008-10#2)(2010-3#1)
solution shows##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
solution structure of a##2##4##(1992-4#1)(1995-8#1)
solution structure of##11##3##(1991-11#1)(1992-4#1)(1994-5#5)(1995-2#1)(1995-3#1)(1995-8#1)(2011-2#1)
solution structure##16##2##(1991-11#1)(1992-4#1)(1994-5#8)(1995-2#1)(1995-3#1)(1995-8#1)(2009-7#2)(2011-2#1)
solution such##2##2##(2009-4#1)(2010-12#1)
solution temperature##3##2##(2008-10#3)
solution than##2##2##(2008-10#2)
solution that contained##3##3##(2008-10#2)(2008-6#1)
solution that##12##2##(1992-12#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2009-6#1)(2010-8#1)
solution the##5##2##(1994-8#1)(2007-12#1)(2008-10#3)
solution through the##3##3##(2008-10#3)
solution through##5##2##(2008-10#4)(2008-11#1)
solution to a##3##3##(2008-10#1)(2008-6#1)(2010-3#1)
solution to an##2##3##(2008-10#2)
solution to enhance the##2##4##(2007-12#1)(2008-10#1)
solution to form the##2##4##(1994-12#1)(2008-10#1)
solution to form##4##3##(1994-12#1)(2008-10#3)
solution to give##2##3##(2008-10#2)
solution to the problem of##3##5##(1991-9#1)(2008-10#1)(2008-12#1)
solution to the problem##8##4##(1991-9#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)
solution to the##27##3##(1990-5#1)(1991-9#1)(1994-9#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-7#1)
solution to these problems##2##4##(2008-8#1)(2008-9#1)
solution to these##3##3##(2008-6#1)(2008-8#1)(2008-9#1)
solution to this problem##5##4##(1990-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
solution to this##10##3##(1990-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2012-1#1)
solution to##86##2##(1990-11#1)(1990-5#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-4#1)(1997-5#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
solution under##8##2##(1995-2#1)(2008-10#5)(2008-2#2)
solution upon##2##2##(2008-10#2)
solution used for##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
solution used in##3##3##(2008-10#3)
solution used##8##2##(2008-10#6)(2008-3#1)(2009-9#1)
solution using a##4##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
solution using the##2##3##(1996-12#1)(2010-3#1)
solution using##13##2##(1992-8#1)(1994-2#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-11#1)(2010-3#1)
solution volume of##2##3##(2008-10#2)
solution was 0##5##3##(2008-10#5)
solution was adjusted to##2##4##(1990-8#1)(2008-10#1)
solution was also##3##3##(2008-10#2)(2008-5#1)
solution was analyzed##2##3##(2008-10#1)(2011-3#1)
solution was carried out##2##4##(2008-10#2)
solution was carried##3##3##(2008-10#3)
solution was determined##2##3##(2008-10#2)
solution was directly##3##3##(2008-10#3)
solution was employed##2##3##(2008-10#1)(2010-5#1)
solution was evaluated##2##3##(2008-10#2)
solution was found to be##2##5##(2008-10#1)(2012-2#1)
solution was found##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
solution was heated##2##3##(2008-10#2)
solution was injected and##2##4##(2008-10#1)(2012-1#1)
solution was injected in to##2##5##(2008-10#2)
solution was injected into the##3##5##(2008-10#3)
solution was injected into##4##4##(2008-10#3)(2008-9#1)
solution was injected##12##3##(2008-10#10)(2008-9#1)(2012-1#1)
solution was investigated##2##3##(1996-5#1)(2008-10#1)
solution was linear##2##3##(2008-10#2)
solution was measured##4##3##(2008-10#3)(2013-1#1)
solution was obtained##3##3##(2008-10#3)
solution was passed through##2##4##(2008-10#2)
solution was performed by##2##4##(2008-10#2)
solution was performed##3##3##(2008-10#3)
solution was studied##3##3##(2008-10#3)
solution was to##2##3##(1995-1#1)(2008-7#1)
solution was used as a##2##5##(2008-10#2)
solution was used as##5##4##(2008-10#5)
solution was used to##5##4##(2008-10#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
solution was used##12##3##(2008-10#8)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
solution was##135##2##(1990-8#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#101)(2008-11#3)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#1)
solution were carried out##2##4##(1991-5#1)(2008-10#1)
solution were determined##2##3##(2008-10#2)
solution were introduced##2##3##(2008-10#2)
solution were investigated##2##3##(2008-10#1)(2008-5#1)
solution were measured##2##3##(2008-10#1)(2008-3#1)
solution were obtained##3##3##(2008-10#3)
solution were performed##2##3##(2008-3#1)(2008-8#1)
solution were studied##3##3##(2008-10#3)
solution were##40##2##(1991-5#1)(2007-9#1)(2008-10#32)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)
solution when##2##2##(2008-3#1)(2009-5#1)
solution which was##2##3##(2008-10#2)
solution which##5##2##(1992-3#1)(2008-10#4)
solution while##2##2##(2008-10#1)(2009-10#1)
solution with a correlation coefficient of 0##3##7##(2008-10#3)
solution with a detection limit of##2##6##(2008-10#2)
solution with a detection limit##3##5##(2008-10#3)
solution with a##9##3##(2008-10#9)
solution with an##2##3##(1992-3#1)(2007-12#1)
solution with low##2##3##(2008-10#1)(2011-2#1)
solution with pH##2##3##(2008-10#2)
solution with the##6##3##(2008-10#5)(2008-2#1)
solution with##46##2##(1990-12#1)(1992-3#1)(1995-11#1)(2007-12#1)(2008-10#32)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
solution within the##4##3##(1990-5#1)(2008-10#3)
solution without##4##2##(2008-10#3)(2008-12#1)
solution yielding a##2##3##(2008-10#2)
solution##2409##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#8)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#5)(1991-5#4)(1991-6#1)(1991-8#4)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#8)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#5)(1993-3#2)(1993-6#3)(1993-8#6)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#11)(1994-5#10)(1994-6#4)(1994-8#2)(1994-9#7)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#10)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#2)(1996-12#11)(1996-2#20)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#15)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#2)(2006-12#3)(2006-4#1)(2007-11#28)(2007-12#37)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#5)(2008-1#7)(2008-10#1464)(2008-11#26)(2008-12#13)(2008-2#69)(2008-3#98)(2008-4#25)(2008-5#48)(2008-6#23)(2008-7#22)(2008-8#17)(2008-9#33)(2009-10#5)(2009-11#10)(2009-12#5)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#7)(2009-8#2)(2009-9#7)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#9)(2010-4#2)(2010-5#8)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#37)(2011-3#3)(2011-7#1)(2012-1#8)(2012-12#2)(2012-2#16)(2012-3#3)(2012-7#1)(2012-8#1)(2013-1#23)(2013-7#2)(2013-8#8)
solution) and##2##2##(2008-10#2)
solution) were##3##2##(2008-10#2)(2008-5#1)
solution)##18##1##(1994-2#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#2)(2010-12#1)(2013-1#1)
solution-based##2##1##(2012-2#2)
solution-phase reaction work-up##2##3##(2008-10#2)
solution-phase##5##1##(1997-4#1)(2008-10#2)(2008-4#2)
solution?##5##1##(1995-1#2)(1995-2#1)(2008-10#1)(2008-8#1)
solutions (0##2##2##(2008-10#2)
solutions after##4##2##(2008-10#3)(2011-3#1)
solutions and for##3##3##(2008-10#2)(2008-4#1)
solutions and in the##3##4##(2008-10#2)(2008-11#1)
solutions and in##9##3##(2008-10#7)(2008-11#1)(2008-8#1)
solutions and its##3##3##(2008-10#2)(2013-1#1)
solutions and the##7##3##(1995-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-6#1)
solutions and to##2##3##(1997-2#1)(2008-10#1)
solutions and##61##2##(1995-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#39)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
solutions are described##2##3##(1992-11#1)(2008-10#1)
solutions are found for##2##4##(2007-12#1)(2008-3#1)
solutions are found##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
solutions are possible##2##3##(1994-9#1)(2008-3#1)
solutions are presented for the##2##5##(2008-2#2)
solutions are##32##2##(1992-11#1)(1992-5#1)(1994-9#1)(1996-12#1)(2007-12#3)(2008-1#1)(2008-10#12)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
solutions as a function of##2##5##(2008-10#2)
solutions as well##2##3##(2008-10#1)(2008-3#1)
solutions as##7##2##(2008-10#6)(2008-3#1)
solutions at concentrations of##2##4##(2008-10#1)(2012-3#1)
solutions at different##2##3##(2008-10#2)
solutions at pH##2##3##(2008-10#2)
solutions at##17##2##(2007-11#1)(2008-10#14)(2008-6#1)(2012-3#1)
solutions based on##6##3##(2008-10#4)(2008-3#1)(2009-11#1)
solutions by##14##2##(2007-12#1)(2008-10#11)(2008-3#2)
solutions can be##6##3##(1993-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-2#1)
solutions contained##2##2##(1991-9#1)(2008-10#1)
solutions containing 0##2##3##(2008-10#2)
solutions containing 20##2##3##(2008-10#1)(2009-6#1)
solutions containing a##3##3##(2008-10#3)
solutions containing acetic##2##3##(2008-10#2)
solutions containing both##2##3##(2008-10#2)
solutions containing only##2##3##(2008-10#2)
solutions containing up to##2##4##(2008-10#2)
solutions containing##57##2##(1991-8#1)(1991-9#1)(1992-8#1)(1996-2#1)(1996-5#1)(2008-10#46)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#2)
solutions could be##2##3##(2008-10#1)(2013-1#1)
solutions could##4##2##(1994-9#1)(2008-10#1)(2008-2#1)(2013-1#1)
solutions did not##3##3##(2008-10#2)(2011-2#1)
solutions due to##2##3##(2008-10#1)(2011-2#1)
solutions due##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
solutions exist##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)
solutions for a##5##3##(2008-11#1)(2008-2#2)(2010-4#1)(2013-8#1)
solutions for all##2##3##(2008-10#1)(2013-8#1)
solutions for extraction##2##3##(2008-10#2)
solutions for the##4##3##(2008-2#1)(2008-3#2)(2013-8#1)
solutions for##39##2##(1993-2#1)(1995-2#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-6#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#4)
solutions from##3##2##(2008-10#2)(2010-11#1)
solutions had##2##2##(1991-7#1)(2007-10#1)
solutions has been investigated##2##4##(2008-10#2)
solutions has been studied using##2##5##(2008-10#2)
solutions has been studied##3##4##(1996-2#1)(2008-10#2)
solutions has been##8##3##(1996-2#1)(2008-10#7)
solutions have been##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
solutions have##9##2##(1994-11#1)(2008-10#4)(2008-12#2)(2009-11#1)(2011-2#1)
solutions in the treatment of##2##5##(1994-2#1)(1997-3#1)
solutions in the##12##3##(1991-1#1)(1992-2#1)(1994-2#1)(1997-3#1)(2008-10#7)(2008-5#1)
solutions in view of##2##4##(2008-10#2)
solutions in##34##2##(1991-1#1)(1992-2#1)(1994-2#1)(1997-3#1)(2008-10#21)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
solutions including##3##2##(2008-10#3)
solutions increased the##2##3##(1995-5#1)(2008-10#1)
solutions into a##2##3##(2008-10#2)
solutions into##5##2##(2008-10#5)
solutions is described##2##3##(2008-10#2)
solutions is proposed##3##3##(2008-10#3)
solutions is##17##2##(1997-5#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-5#1)
solutions may##3##2##(2007-12#2)(2008-3#1)
solutions need to be##2##4##(1995-1#1)(2008-2#1)
solutions needed for##2##3##(2008-10#1)(2008-9#1)
solutions obtained from the##2##4##(2008-10#1)(2008-3#1)
solutions obtained from##4##3##(2008-10#2)(2008-3#2)
solutions obtained##10##2##(2007-12#1)(2008-10#6)(2008-3#3)
solutions of 0##3##3##(2008-10#3)
solutions of 10##2##3##(2008-10#2)
solutions of 2##2##3##(2008-10#2)
solutions of 5##2##3##(2008-10#2)
solutions of As(III)##2##3##(2008-10#2)
solutions of different##4##3##(1990-12#1)(2008-10#3)
solutions of mixed salts##2##4##(2008-10#2)
solutions of pH 2##2##4##(1990-8#1)(2008-10#1)
solutions of pH##4##3##(1990-8#1)(2008-10#3)
solutions of sodium##3##3##(1997-4#1)(2008-10#2)
solutions of the single molecule magnet Ni(4)##2##7##(2009-5#2)
solutions of the##22##3##(1992-8#1)(1993-5#1)(1995-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-2#1)(2008-4#1)(2009-5#2)
solutions of various##5##3##(2008-10#4)(2008-5#1)
solutions of##135##2##(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#3)(1991-5#2)(1992-8#1)(1993-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-4#2)(1997-7#4)(2007-11#4)(2007-12#2)(2008-10#83)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-5#2)(2010-1#1)(2013-8#1)
solutions on the##3##3##(2008-10#2)(2012-7#1)
solutions on##7##2##(1993-1#1)(2008-10#4)(2012-7#1)(2013-1#1)
solutions onto##3##2##(2008-10#2)(2008-4#1)
solutions or for##2##3##(2008-10#2)
solutions or##5##2##(1994-2#1)(2008-10#3)(2011-1#1)
solutions over##3##2##(2008-10#3)
solutions prepared in##3##3##(1992-11#2)(2008-10#1)
solutions prepared##4##2##(1992-11#3)(2008-10#1)
solutions previously##3##2##(2008-10#3)
solutions resulted in##3##3##(1994-6#1)(2008-10#2)
solutions resulting from##2##3##(2008-10#1)(2009-9#1)
solutions show that##2##3##(2008-10#1)(2008-3#1)
solutions show##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
solutions showed##3##2##(1990-7#1)(2008-10#2)
solutions shows##3##2##(2008-10#2)(2008-2#1)
solutions that are##4##3##(2007-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
solutions that became available##2##4##(2008-11#1)(2008-3#1)
solutions that##17##2##(2007-5#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2010-7#1)(2011-2#2)(2013-1#1)
solutions through##2##2##(2008-10#1)(2008-6#1)
solutions to be developed##2##4##(2012-2#1)(2012-3#1)
solutions to be##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
solutions to common##2##3##(1992-1#1)(1994-12#1)
solutions to the diffusion equation##2##5##(2008-3#2)
solutions to the##9##3##(1996-1#1)(1997-7#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)
solutions to these##5##3##(1990-2#1)(2009-6#1)(2011-1#1)(2011-2#2)
solutions to this##2##3##(1997-3#1)(2008-3#1)
solutions to##57##2##(1990-2#1)(1992-1#2)(1994-12#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-3#3)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-1#2)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
solutions under##4##2##(2007-11#1)(2008-10#3)
solutions using a##3##3##(2008-10#3)
solutions using##12##2##(1994-3#1)(2008-10#10)(2012-2#1)
solutions via##2##2##(2008-10#1)(2009-6#1)
solutions was determined##2##3##(2008-10#2)
solutions was developed##3##3##(2008-10#3)
solutions was##24##2##(1990-2#1)(1993-1#1)(1995-3#1)(2008-10#19)(2008-5#1)(2008-6#1)
solutions were determined##5##3##(1990-8#1)(2008-10#2)(2013-8#2)
solutions were introduced##2##3##(2008-10#2)
solutions were measured##2##3##(2008-3#2)
solutions were mixed and##2##4##(2008-10#1)(2009-9#1)
solutions were observed##2##3##(2008-10#2)
solutions were studied##2##3##(2008-10#2)
solutions were used to##2##4##(2008-10#1)(2008-3#1)
solutions were used##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
solutions were##46##2##(1990-8#1)(1991-5#1)(2008-10#35)(2008-3#3)(2009-9#1)(2010-3#1)(2011-2#2)(2013-8#2)
solutions when##3##2##(2008-10#1)(2009-5#1)(2011-1#1)
solutions which##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
solutions will be##2##3##(1993-12#1)(2008-6#1)
solutions will##3##2##(1993-12#1)(2008-6#2)
solutions with different##3##3##(2008-10#3)
solutions with low##3##3##(2008-10#2)(2011-2#1)
solutions with the##2##3##(2008-10#1)(2008-6#1)
solutions with##29##2##(1992-5#1)(1994-1#1)(2008-10#20)(2008-2#2)(2008-5#1)(2008-6#2)(2011-2#2)
solutions without##3##2##(2008-10#2)(2008-5#1)
solutions##1092##1##(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#2)(1990-8#8)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#5)(1995-5#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-5#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#1)(1997-7#5)(1997-8#1)(2007-10#2)(2007-11#7)(2007-12#16)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#629)(2008-11#10)(2008-12#6)(2008-2#36)(2008-3#62)(2008-4#6)(2008-5#14)(2008-6#17)(2008-7#14)(2008-8#7)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#4)(2009-3#2)(2009-5#5)(2009-6#7)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#23)(2011-3#1)(2012-12#4)(2012-2#7)(2012-3#6)(2012-7#1)(2013-1#13)(2013-8#10)
solutions)##6##1##(2007-10#1)(2008-10#3)(2008-11#1)(2009-12#1)
solvate)##2##1##(1996-2#2)
solvated##11##1##(1992-6#2)(1993-11#1)(1995-5#1)(2007-12#2)(2008-10#3)(2012-2#1)(2013-1#1)
solvating##8##1##(1992-9#1)(1995-2#2)(2008-10#5)
solvation and the##3##3##(2008-10#2)(2008-4#1)
solvation and##4##2##(2008-10#3)(2008-4#1)
solvation energy##2##2##(2008-10#1)(2011-3#1)
solvation free##2##2##(2010-2#1)(2012-2#1)
solvation in##3##2##(1990-8#3)
solvation is##2##2##(2009-12#1)(2010-7#1)
solvation of the##2##3##(1990-5#1)(2008-10#1)
solvation of##3##2##(1990-5#1)(2008-10#1)(2010-2#1)
solvation##36##1##(1990-5#1)(1990-8#4)(1993-8#1)(1994-9#1)(2008-10#8)(2008-4#3)(2009-12#2)(2009-5#1)(2009-9#1)(2010-2#4)(2010-4#1)(2010-7#5)(2011-3#1)(2012-2#2)(2013-1#1)
solve a##8##2##(1992-12#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)
solve both##2##2##(2008-9#1)(2012-2#1)
solve some##2##2##(2008-10#2)
solve the problem of##5##4##(1992-9#1)(2008-10#2)(2008-3#2)
solve the problem##12##3##(1992-9#1)(1997-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2009-3#1)
solve the##40##2##(1992-9#3)(1994-6#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-2#3)(2008-3#10)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
solve their##2##2##(1997-7#1)(2006-10#1)
solve these problems##3##3##(2008-10#2)(2008-5#1)
solve these##4##2##(2008-10#2)(2008-5#1)(2009-2#1)
solve this problem##10##3##(1997-1#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
solve##97##1##(1990-12#1)(1992-12#1)(1992-9#3)(1994-12#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#4)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#18)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
solved analytically##2##2##(2008-10#1)(2008-2#1)
solved by a##3##3##(1992-9#1)(2008-2#1)(2011-2#1)
solved by single-crystal##2##3##(1996-2#1)(1997-7#1)
solved by the##2##3##(1992-12#1)(2008-3#1)
solved by use of##5##4##(2008-3#4)(2008-8#1)
solved by using##2##3##(2008-10#1)(2013-1#1)
solved by##22##2##(1992-12#1)(1992-4#1)(1992-8#2)(1992-9#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-8#1)(2011-2#1)(2013-1#1)
solved for##2##2##(1990-2#1)(2008-3#1)
solved in##5##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
solved structures##2##2##(1997-7#1)(2008-7#1)
solved the##6##2##(1992-11#1)(2008-10#2)(2010-1#2)(2011-2#1)
solved to##3##2##(1995-2#1)(2008-3#1)(2010-10#1)
solved using a##2##3##(2007-9#1)(2009-12#1)
solved using the##2##3##(2008-7#1)(2009-6#1)
solved using##8##2##(1991-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-6#1)
solved with a##2##3##(2008-10#1)(2008-7#1)
solved with the##2##3##(2008-11#1)(2010-10#1)
solved with##8##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#1)(2011-3#1)
solved##94##1##(1990-2#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-7#3)(1997-8#1)(1997-9#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#8)(2008-3#14)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#3)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
solvent B##2##2##(2008-10#1)(2012-12#1)
solvent access to##2##3##(1992-4#2)
solvent addition##2##2##(1994-11#1)(2008-10#1)
solvent and of##2##3##(1996-5#1)(2008-10#1)
solvent and the##7##3##(1996-5#1)(2008-10#5)(2009-9#1)
solvent and##27##2##(1996-5#2)(2008-10#20)(2008-4#1)(2008-8#1)(2009-6#1)(2009-9#1)(2012-2#1)
solvent are##5##2##(2007-12#1)(2008-10#4)
solvent composition and##2##3##(2008-10#1)(2008-5#1)
solvent composition##6##2##(1994-9#1)(2008-10#4)(2008-5#1)
solvent concentration##2##2##(2008-10#1)(2008-4#1)
solvent consumption and##3##3##(2008-10#3)
solvent consumption##10##2##(2008-10#10)
solvent containing##2##2##(1994-12#1)(2008-10#1)
solvent content##2##2##(1992-9#1)(2008-10#1)
solvent dependence of##2##3##(2008-7#1)(2009-9#1)
solvent dependence##4##2##(2008-10#1)(2008-7#1)(2009-9#2)
solvent dependent##2##2##(1996-2#1)(2008-10#1)
solvent dielectric relaxation##2##3##(1994-8#2)
solvent dielectric##3##2##(1994-8#2)(2013-1#1)
solvent effect on the##2##4##(2007-11#1)(2008-10#1)
solvent effect on##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
solvent effects##3##2##(2008-10#2)(2008-3#1)
solvent evaporation and cogrinding##2##4##(2011-1#2)
solvent evaporation##6##2##(2007-12#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
solvent exchange##4##2##(1996-2#2)(2008-10#2)
solvent extraction and##7##3##(2008-10#7)
solvent extraction combined with solid-phase microextraction##2##6##(2008-10#2)
solvent extraction in##2##3##(2008-10#1)(2008-7#1)
solvent extraction method and##2##4##(2008-10#2)
solvent extraction method##5##3##(2008-10#5)
solvent extraction of Pb(II)##2##4##(2008-10#2)
solvent extraction of##11##3##(2008-10#11)
solvent extraction or##2##3##(2008-10#2)
solvent extraction procedure##3##3##(2008-10#3)
solvent extraction separation of##2##4##(2008-10#2)
solvent extraction step##2##3##(2008-10#2)
solvent extraction techniques##2##3##(2008-10#2)
solvent extraction using##2##3##(2008-10#2)
solvent extraction##68##2##(1995-2#1)(2008-10#63)(2008-5#2)(2008-7#1)(2008-9#1)
solvent extracts of##2##3##(2008-10#1)(2013-8#1)
solvent flow##2##2##(2008-10#2)
solvent for the##3##3##(2008-10#2)(2008-3#1)
solvent for##11##2##(2008-10#9)(2008-3#1)(2008-5#1)
solvent from##2##2##(2008-10#2)
solvent has been developed##2##4##(2008-10#2)
solvent has been##4##3##(2008-10#3)(2010-11#1)
solvent has##5##2##(2008-10#3)(2008-11#1)(2010-11#1)
solvent in##8##2##(1996-2#1)(2008-10#7)
solvent is##5##2##(2008-10#3)(2008-7#2)
solvent kinetic isotope effect##2##4##(1992-3#2)
solvent kinetic isotope effects of 0##2##6##(1992-3#2)
solvent kinetic isotope effects##4##4##(1991-9#1)(1992-3#3)
solvent kinetic isotope##6##3##(1991-9#1)(1992-3#5)
solvent media and##2##3##(2008-10#2)
solvent media##7##2##(2008-10#7)
solvent mediator##4##2##(2008-10#4)
solvent mediators##5##2##(2008-10#5)
solvent microextraction##6##2##(2008-10#6)
solvent mixture of##2##3##(2008-10#1)(2008-2#1)
solvent mixture##11##2##(1992-4#1)(2008-10#8)(2008-2#1)(2008-7#1)
solvent mixtures##6##2##(2008-10#5)(2008-5#1)
solvent molecules in the##2##4##(2007-12#1)(2008-10#1)
solvent molecules##8##2##(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#4)(2010-7#1)
solvent of##6##2##(2008-10#4)(2008-2#1)(2010-12#1)
solvent on the##4##3##(2008-10#4)
solvent or##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
solvent polymeric membrane electrodes##2##4##(2008-10#2)
solvent polymeric membrane##4##3##(2008-10#4)
solvent polymeric membranes##3##3##(2008-10#3)
solvent polymeric##11##2##(2008-10#11)
solvent precipitation##3##2##(2008-10#3)
solvent properties of##2##3##(2010-5#1)(2012-2#1)
solvent properties##4##2##(1991-5#1)(2008-10#1)(2010-5#1)(2012-2#1)
solvent relaxation##4##2##(2013-1#4)
solvent stable##3##2##(2013-1#3)
solvent sublation##3##2##(2008-10#3)
solvent system##14##2##(2008-10#10)(2011-1#3)(2012-3#1)
solvent systems##8##2##(2007-11#1)(2008-10#4)(2008-6#2)(2011-1#1)
solvent that##2##2##(2007-12#1)(2008-10#1)
solvent to##3##2##(1994-8#1)(2008-10#2)
solvent under##2##2##(1996-5#1)(2008-10#1)
solvent used##5##2##(2008-10#3)(2008-7#1)(2010-4#1)
solvent vapor##2##2##(2008-10#1)(2008-7#1)
solvent volume and##2##3##(2008-10#2)
solvent volume##7##2##(2008-10#7)
solvent was optimized##2##3##(2008-10#2)
solvent was##12##2##(2007-11#1)(2008-10#10)(2009-9#1)
solvent water##3##2##(1992-4#1)(1993-11#1)(2009-8#1)
solvent were##3##2##(2008-10#3)
solvent with##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
solvent##546##1##(1990-5#4)(1990-8#5)(1991-5#1)(1991-9#1)(1992-3#9)(1992-4#5)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-2#6)(1995-3#2)(1995-5#1)(1996-2#5)(1996-5#4)(1997-1#1)(1997-2#2)(1997-7#1)(2007-11#7)(2007-12#5)(2008-10#362)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-11#1)(2010-12#1)(2010-2#6)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#9)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#13)(2013-8#2)
solvent)##6##1##(1995-3#1)(2008-10#4)(2011-2#1)
solvent-accessible surface area##2##3##(1994-5#1)(1997-2#1)
solvent-accessible##4##1##(1994-5#2)(1995-2#1)(1997-2#1)
solvent-based##5##1##(2008-10#3)(2008-5#1)(2008-9#1)
solvent-cage##3##1##(1994-8#3)
solvent-dependent##4##1##(1995-3#1)(2008-10#1)(2009-11#1)(2009-9#1)
solvent-exposed##6##1##(1993-11#1)(1995-5#1)(1997-2#2)(2008-7#1)(2013-1#1)
solvent-free##10##1##(2007-11#2)(2008-10#3)(2008-5#4)(2011-2#1)
solvent-soluble conducting##2##2##(2008-10#2)
solventless##3##1##(2008-10#2)(2012-3#1)
solvents (e##2##2##(1995-2#1)(2008-10#1)
solvents (water##2##2##(1997-7#1)(2008-10#1)
solvents and##10##2##(2007-11#1)(2008-10#5)(2008-11#2)(2008-5#1)(2011-1#1)
solvents are##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
solvents as##5##2##(2008-10#4)(2008-2#1)
solvents but not##2##3##(1990-7#1)(1995-2#1)
solvents compared with##2##3##(2008-10#2)
solvents for the##2##3##(2008-10#1)(2011-2#1)
solvents for##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
solvents have been##2##3##(2008-10#2)
solvents in the##2##3##(2008-10#2)
solvents in##4##2##(1996-5#1)(2008-10#3)
solvents is##3##2##(1995-2#1)(2008-10#1)(2008-2#1)
solvents like##2##2##(2008-10#1)(2010-5#1)
solvents of##2##2##(2008-10#2)
solvents on the##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
solvents on##6##2##(2008-10#4)(2008-3#1)(2011-1#1)
solvents revealed##2##2##(2008-10#2)
solvents such as n-hexane##2##4##(2008-10#2)
solvents such as##5##3##(2008-10#2)(2008-3#1)(2009-9#1)(2013-1#1)
solvents that##5##2##(2008-3#3)(2008-7#1)(2009-11#1)
solvents to##4##2##(1995-3#1)(2008-10#3)
solvents used##2##2##(2008-10#1)(2010-10#1)
solvents using##2##2##(1991-5#1)(2008-10#1)
solvents were used##2##3##(2008-10#2)
solvents were##9##2##(1991-1#1)(2008-10#6)(2008-3#1)(2012-2#1)
solvents with##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
solvents##232##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#6)(1991-1#1)(1991-5#1)(1992-4#1)(1994-3#2)(1994-8#4)(1994-9#1)(1995-2#5)(1995-3#2)(1995-5#1)(1996-2#1)(1996-5#4)(1997-7#2)(2007-11#7)(2008-10#123)(2008-11#6)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#15)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-2#3)(2013-1#5)(2013-8#1)
solvents)##2##1##(1993-8#1)(2008-10#1)
solver is##2##2##(2008-2#1)(2009-11#1)
solver##7##1##(1992-2#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-11#2)
solves the problem of##2##4##(1995-6#1)(2012-2#1)
solves the##6##2##(1992-5#1)(1995-6#1)(2007-11#1)(2008-2#1)(2009-12#1)(2012-2#1)
solves two##2##2##(2008-2#1)(2008-3#1)
solves##9##1##(1992-5#1)(1995-6#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2012-1#1)(2012-2#1)
solving a##7##2##(2008-2#3)(2008-6#1)(2008-7#1)(2010-7#1)(2010-8#1)
solving and##4##2##(1994-2#1)(2008-11#1)(2008-6#1)(2010-10#1)
solving problems##2##2##(1994-2#1)(2008-10#1)
solving the equations##2##3##(1996-12#1)(2008-7#1)
solving the health care problems##2##5##(1997-8#1)(2008-7#1)
solving the problem of##2##4##(2008-12#1)(2009-10#1)
solving the radiative transfer equation##2##5##(2008-2#1)(2008-3#1)
solving the##21##2##(1996-12#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2012-1#1)
solving this problem##3##3##(2008-7#1)(2009-3#1)(2013-1#1)
solving this##4##2##(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
solving##78##1##(1991-2#1)(1992-1#2)(1992-2#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#13)(2008-3#3)(2008-4#1)(2008-6#4)(2008-7#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)
solvolysis##2##1##(2011-1#2)
solvothermal##2##1##(2009-11#2)
soma in##2##2##(1991-12#1)(2008-6#1)
soma of##3##2##(1990-7#1)(1991-10#1)(1995-12#1)
soma##10##1##(1990-7#1)(1991-10#1)(1991-12#1)(1993-12#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)
soman intoxication##3##2##(1995-12#2)(1997-7#1)
soman poisoning##2##2##(1997-7#2)
soman##6##1##(1995-12#2)(1997-7#4)
somata and##2##2##(1997-3#1)(2008-9#1)
somata are##2##2##(2007-12#2)
somata of the##2##3##(1995-12#1)(2009-8#1)
somata of##4##2##(1992-11#1)(1993-12#1)(1995-12#1)(2009-8#1)
somata showed##2##2##(1995-12#2)
somata were##3##2##(1997-3#2)(2008-7#1)
somata##23##1##(1992-11#1)(1993-12#1)(1995-12#7)(1996-12#2)(1997-3#3)(2007-12#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)
somatic and##4##2##(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
somatic cell count##3##3##(1992-2#1)(1996-8#1)(2012-2#1)
somatic cell counts##2##3##(1993-2#1)(1996-3#1)
somatic cell gene targeting##4##4##(2008-2#4)
somatic cell hybrid##2##3##(1994-11#1)(1994-9#1)
somatic cell hybrids##4##3##(1991-6#2)(1991-9#1)(1997-9#1)
somatic cell##23##2##(1991-6#2)(1991-9#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-7#1)(2008-9#3)(2009-10#1)(2012-2#1)(2013-1#1)
somatic cells and##5##3##(1994-11#1)(1994-8#1)(2008-5#1)(2009-10#2)
somatic cells of##3##3##(1994-11#2)(2007-12#1)
somatic cells##30##2##(1991-11#1)(1993-6#2)(1994-11#3)(1994-8#1)(1997-4#1)(2007-12#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#3)(2009-10#3)(2009-3#3)(2010-7#1)(2011-2#2)
somatic compatibility##2##2##(2008-10#2)
somatic complaints##6##2##(1995-12#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#2)
somatic differentiation##2##2##(1993-9#1)(2009-3#1)
somatic embryo##4##2##(2008-9#3)(2009-8#1)
somatic embryogenesis##5##2##(2008-12#2)(2008-9#1)(2009-8#2)
somatic embryos##2##2##(2008-10#1)(2008-12#1)
somatic gene therapy##4##3##(1994-5#1)(1995-8#1)(2008-5#1)(2008-8#1)
somatic genetic##2##2##(2008-4#1)(2009-6#1)
somatic health##3##2##(1996-6#2)(2011-2#1)
somatic hybridization between##2##3##(2008-8#1)(2008-9#1)
somatic hybrids##2##2##(2008-5#1)(2008-9#1)
somatic incompatibility types##3##3##(2008-10#3)
somatic mutations in##2##3##(2010-5#1)(2012-2#1)
somatic mutations##13##2##(1995-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2012-2#2)
somatic nucleus##2##2##(2008-9#2)
somatic profiles##2##2##(1997-2#2)
somatic sexual differentiation##2##3##(2007-12#2)
somatic symptoms##5##2##(1990-2#1)(1995-5#1)(2009-6#2)(2009-9#1)
somatic treatments##2##2##(2008-4#1)(2008-7#1)
somatic##175##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#4)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(1997-9#1)(2007-12#9)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#7)(2008-8#7)(2008-9#25)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-6#3)(2009-8#4)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#8)(2013-1#2)(2013-8#3)
somatically##2##1##(2008-10#1)(2008-7#1)
somatization disorders in##2##3##(1995-6#1)(2012-12#1)
somatization disorders##3##2##(1995-6#1)(2012-12#2)
somatization##9##1##(1995-1#1)(1995-6#3)(2008-6#1)(2012-1#1)(2012-12#3)
somatodendritic 5-HT release##2##3##(2008-7#2)
somatodendritic##6##1##(1992-3#1)(2008-4#1)(2008-7#3)(2012-3#1)
somatoform disorders##2##2##(1997-8#2)
somatoform##4##1##(1995-6#1)(1997-8#3)
somatomedin##3##1##(1992-11#1)(2008-7#2)
somatometry##2##1##(1993-9#1)(1995-6#1)
somatosensory and motor-evoked##2##3##(2010-7#1)(2011-2#1)
somatosensory and##4##2##(1991-5#1)(1995-12#1)(2010-7#1)(2011-2#1)
somatosensory area##2##2##(1994-3#1)(1995-8#1)
somatosensory cortex##7##2##(1993-12#1)(1994-3#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-5#1)
somatosensory evoked##2##2##(1991-1#1)(2011-2#1)
somatosensory##29##1##(1991-1#1)(1991-2#1)(1991-5#1)(1993-12#4)(1993-6#1)(1994-3#3)(1994-8#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-5#6)(2010-7#1)(2011-2#2)
somatostatin (SRIF)##2##2##(1997-2#1)(2008-4#1)
somatostatin (SS)##2##2##(1996-5#1)(2011-2#1)
somatostatin analogs##3##2##(1994-11#1)(2011-2#1)(2012-3#1)
somatostatin analogue RC-160##2##3##(1995-2#2)
somatostatin analogue##6##2##(1995-2#2)(2007-8#1)(2008-7#2)(2013-8#1)
somatostatin and##2##2##(1990-5#1)(1997-4#1)
somatostatin gene in##2##3##(1995-8#2)
somatostatin gene##5##2##(1995-8#5)
somatostatin in##3##2##(1994-11#1)(1997-2#2)
somatostatin or##2##2##(1993-1#1)(1997-4#1)
somatostatin receptor subtype##2##3##(1993-3#2)
somatostatin receptor subtypes##3##3##(1994-11#1)(1995-2#2)
somatostatin receptor##13##2##(1993-3#3)(1994-11#5)(1995-2#2)(1997-8#1)(2010-9#1)(2012-3#1)
somatostatin receptors##4##2##(1997-2#2)(2008-7#1)(2012-3#1)
somatostatin##67##1##(1990-12#1)(1990-5#1)(1992-6#1)(1993-1#1)(1993-3#3)(1994-11#9)(1995-2#5)(1995-8#5)(1996-5#2)(1997-1#1)(1997-2#5)(1997-4#8)(1997-8#3)(2006-12#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-7#4)(2008-8#1)(2010-11#4)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
somatostatin-14##3##1##(1994-11#1)(1995-2#2)
somatosympathetic reflexes##2##2##(1993-12#2)
somatosympathetic##3##1##(1993-12#3)
somatotopic##5##1##(1997-3#3)(2009-8#2)
somatotropes##4##1##(1992-6#3)(1994-9#1)
somatotroph##2##1##(2007-7#2)
somatotropic axis##3##2##(2010-5#2)(2011-2#1)
somatotropic##5##1##(2008-1#1)(2008-7#1)(2010-5#2)(2011-2#1)
some &quot##3##2##(1992-3#1)(1995-3#2)
some 150##2##2##(1996-6#1)(2007-5#1)
some 2-acetamido-2-deoxyaldono(1----4)lactones##2##2##(1990-5#2)
some 3##4##2##(1995-3#1)(2008-5#1)(2010-3#1)(2013-1#1)
some 70##2##2##(2008-11#2)
some G##2##2##(1997-1#1)(2010-8#1)
some abnormalities##2##2##(2010-1#1)(2012-2#1)
some accessions##2##2##(2008-10#1)(2008-5#1)
some active##3##2##(1994-5#1)(2008-10#2)
some additional##8##2##(1990-5#1)(2008-10#2)(2008-4#2)(2009-8#1)(2012-2#1)(2013-8#1)
some advantage##2##2##(2008-5#1)(2012-1#1)
some advantages over##2##3##(1993-3#1)(2008-10#1)
some advantages##9##2##(1993-3#1)(2008-10#6)(2008-3#1)(2009-2#1)
some adverse##2##2##(2008-10#1)(2008-8#1)
some alcoholic##2##2##(2008-10#1)(2009-7#1)
some alternative##3##2##(1990-9#1)(2008-10#1)(2009-12#1)
some amines##2##2##(2008-10#2)
some amino acid##2##3##(1996-10#1)(1997-2#1)
some amino acids##3##3##(2008-10#2)(2012-1#1)
some amino##5##2##(1996-10#1)(1997-2#1)(2008-10#2)(2012-1#1)
some amino-alcohols##2##2##(2008-10#2)
some amount of##3##3##(2007-10#1)(2007-12#1)(2012-2#1)
some analytes##2##2##(2008-10#2)
some analytical##6##2##(2008-10#6)
some animal protein sources##2##4##(2008-10#2)
some animals were##2##3##(1994-9#1)(2008-12#1)
some animals##3##2##(1992-11#1)(1994-9#1)(2008-12#1)
some answers##2##2##(1992-12#1)(1997-2#1)
some antioxidants##2##2##(1993-2#1)(2008-10#1)
some applications##6##2##(1992-9#1)(2008-10#4)(2008-4#1)
some are more##2##3##(2008-5#1)(2008-9#1)
some are##13##2##(1991-3#1)(1991-9#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-3#1)
some areas of##3##3##(2007-12#1)(2011-1#1)(2013-1#1)
some areas##13##2##(1993-3#1)(1994-2#1)(1994-3#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)(2013-1#1)
some aromatic amines##6##3##(1990-8#2)(2007-11#2)(2008-10#2)
some aromatic amino acids##2##4##(2008-10#2)
some aromatic##14##2##(1990-8#2)(2007-11#2)(2008-10#7)(2008-5#2)(2011-3#1)
some articles##3##2##(2009-8#1)(2013-1#2)
some as##5##2##(1990-6#2)(1995-3#1)(2007-7#1)(2008-11#1)
some aspect of##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
some aspects of its##2##4##(2013-7#1)(2013-8#1)
some aspects of the##6##4##(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)
some aspects of##27##3##(1995-12#1)(1996-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
some aspects##28##2##(1995-12#1)(1996-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#1)
some assistance##2##2##(1991-12#1)(1994-1#1)
some at##2##2##(2008-10#1)(2011-2#1)
some attempts##2##2##(2008-11#1)(2013-1#1)
some attention##2##2##(1991-1#1)(2012-3#1)
some authors have##2##3##(1990-5#1)(2013-1#1)
some authors##12##2##(1990-5#1)(1992-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#2)
some avian species##2##3##(1994-5#1)(2008-3#1)
some avian##4##2##(1994-5#1)(1997-6#1)(2008-3#1)(2008-5#1)
some bacteria##2##2##(1994-2#1)(2007-11#1)
some bacterial species##2##3##(1994-8#1)(2008-8#1)
some bacterial##7##2##(1994-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)
some bands##2##2##(1992-8#1)(1996-2#1)
some basic##13##2##(1990-8#1)(1991-12#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-3#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)
some being##2##2##(1992-3#1)(2007-7#1)
some beneficial##2##2##(2008-10#1)(2013-7#1)
some benefit##2##2##(2008-5#1)(2008-8#1)
some benefits##4##2##(2007-11#1)(2011-1#1)(2012-3#1)(2013-7#1)
some biochemical##3##2##(2008-10#1)(2008-12#2)
some biological characteristics of##2##4##(2008-6#1)(2013-8#1)
some biological fluids##2##3##(2008-10#2)
some biological##10##2##(2008-10#6)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
some biologically important##2##3##(2008-10#1)(2008-12#1)
some biologically##4##2##(2007-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
some blood##4##2##(1991-6#1)(1992-9#1)(2008-12#1)(2008-8#1)
some boys##2##2##(2007-12#1)(2008-10#1)
some but not all##2##4##(2008-10#1)(2008-6#1)
some cancer##2##2##(1990-12#1)(2008-11#1)
some cancers and##2##3##(2008-5#1)(2013-8#1)
some cancers##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
some cardiovascular##2##2##(1994-3#1)(2008-7#1)
some case##2##2##(1995-2#1)(2008-11#1)
some cases for##4##3##(1990-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
some cases of##8##3##(1991-12#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
some cases the##8##3##(1991-2#1)(1991-8#1)(1994-11#1)(2008-10#3)(2008-11#1)(2010-4#1)
some cases##130##2##(1990-2#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-3#3)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-4#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
some caution##3##2##(1992-5#1)(1993-11#1)(2008-1#1)
some cell lines##4##3##(1992-3#1)(2008-11#2)(2008-8#1)
some cell##6##2##(1992-3#1)(1996-12#1)(2008-11#2)(2008-8#1)(2011-2#1)
some cells in##2##3##(1992-6#1)(2008-8#1)
some cells##10##2##(1990-2#1)(1992-3#1)(1992-6#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
some cellular##2##2##(1994-6#1)(1997-3#1)
some centres##2##2##(2007-12#1)(2007-8#1)
some challenges##3##2##(2008-11#2)(2012-3#1)
some changes in##2##3##(1992-2#1)(1994-3#1)
some changes##3##2##(1992-2#1)(1994-3#1)(2013-8#1)
some characteristics of##4##3##(1990-11#1)(1997-3#1)(2008-8#1)(2010-3#1)
some characteristics##6##2##(1990-11#1)(1997-3#1)(2008-8#1)(2010-3#1)(2011-2#2)
some chemical##2##2##(1995-6#1)(2008-10#1)
some children##4##2##(2007-11#1)(2008-1#1)(2008-12#1)(2013-8#1)
some circumstances##6##2##(1996-1#1)(2008-10#2)(2010-10#1)(2011-1#1)(2012-3#1)
some clear##2##2##(2008-10#1)(2008-4#1)
some clinical##11##2##(1990-8#1)(2008-1#3)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#2)(2012-2#1)
some clinically##2##2##(2008-11#1)(2013-8#1)
some clues to##2##3##(2008-5#1)(2012-2#1)
some clues##4##2##(1991-6#1)(2007-12#1)(2008-5#1)(2012-2#1)
some combination of these##2##4##(2007-11#1)(2008-6#1)
some combination of##9##3##(2007-11#1)(2008-10#2)(2008-4#1)(2008-6#2)(2009-9#1)(2010-11#1)(2010-2#1)
some combinations of##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
some commercial##3##2##(2008-10#3)
some common pharmaceutical species##2##4##(2008-10#2)
some common##13##2##(1992-11#1)(1993-6#1)(1995-2#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
some commonly used##3##3##(2007-7#1)(2008-4#1)(2008-9#1)
some complications##2##2##(2007-8#2)
some components of the##4##4##(1993-5#1)(1996-12#2)(2008-10#1)
some components of##5##3##(1993-5#1)(1996-12#2)(2008-10#2)
some components##8##2##(1993-5#1)(1994-3#1)(1996-12#2)(2008-10#4)
some compounds##2##2##(1995-3#1)(2008-10#1)
some concerns##3##2##(2008-3#2)(2010-11#1)
some conditions##5##2##(1990-2#1)(1992-3#1)(2008-10#1)(2008-9#1)(2010-5#1)
some confusion in##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
some confusion##6##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
some considerations on the##2##4##(1991-12#1)(1994-9#1)
some considerations on##3##3##(1991-12#1)(1994-9#1)(2013-1#1)
some considerations##6##2##(1990-2#1)(1991-12#1)(1994-9#1)(2008-7#1)(2010-11#1)(2013-1#1)
some cooperative##2##2##(1993-11#1)(1995-12#1)
some cosmetic##2##2##(2008-5#2)
some cost##2##2##(2007-11#1)(2008-8#1)
some costs##2##2##(2008-11#1)(2012-3#1)
some countries##12##2##(1993-11#1)(1993-3#1)(1996-2#1)(2007-2#3)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)
some critical##6##2##(1991-3#1)(1994-11#1)(2008-1#1)(2008-11#2)(2012-3#1)
some current##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
some data##4##2##(1991-12#1)(1994-12#1)(2008-10#1)(2012-12#1)
some decrease##2##2##(1994-3#1)(2009-8#1)
some degree of recovery##2##4##(2008-10#1)(2008-7#1)
some degree of success##2##4##(2008-1#1)(2013-1#1)
some degree of##9##3##(1995-1#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#1)
some degree##17##2##(1992-2#1)(1993-12#1)(1995-1#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
some design##2##2##(2008-3#1)(2008-6#1)
some diagnostic##3##2##(1991-2#1)(1993-5#1)(2008-6#1)
some difference##2##2##(2008-10#1)(2011-2#1)
some differences between the##2##4##(1994-11#1)(2008-3#1)
some differences between##6##3##(1994-11#1)(2007-2#1)(2008-3#1)(2009-7#1)(2012-12#1)(2013-1#1)
some differences in the##4##4##(2007-12#1)(2008-5#1)(2012-3#2)
some differences in##9##3##(1991-6#1)(1993-3#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#1)(2012-3#2)
some differences##17##2##(1991-6#1)(1993-3#1)(1994-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
some different##2##2##(2008-10#1)(2010-10#1)
some dipeptides##3##2##(2008-10#3)
some direct##2##2##(2008-5#1)(2008-9#1)
some disadvantages of the##2##4##(2008-3#1)(2010-8#1)
some disadvantages##4##2##(2008-3#1)(2009-2#1)(2010-8#1)(2012-2#1)
some disagreement##3##2##(2008-11#1)(2008-2#1)(2013-1#1)
some discussion##2##2##(2006-10#1)(2012-1#1)
some diseases##7##2##(1992-8#1)(1993-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2013-1#2)
some distinct##3##2##(1992-2#1)(1993-8#1)(2009-9#1)
some doubt##2##2##(1993-3#1)(2010-3#1)
some drug##4##2##(1996-12#1)(2008-10#1)(2011-3#2)
some drugs and##2##3##(2007-11#1)(2008-10#1)
some drugs##11##2##(1991-1#2)(1997-4#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
some dyes##2##2##(2008-10#2)
some early##2##2##(1990-4#1)(1996-7#1)
some earthquakes##2##2##(1996-4#2)
some effect on##3##3##(1996-2#1)(2007-6#1)(2011-1#1)
some efficiency##2##2##(2008-3#1)(2008-7#1)
some empirical##4##2##(1993-1#1)(2008-11#1)(2008-6#1)(2012-2#1)
some endocrine##2##2##(1990-2#1)(2008-10#1)
some environmental samples##2##3##(2008-10#2)
some environmental##5##2##(1990-6#1)(2008-10#3)(2013-7#1)
some enzymes##3##2##(1990-8#1)(1991-4#1)(2008-10#1)
some epidemiological##2##2##(2008-10#1)(2011-2#1)
some errors##2##2##(2008-3#1)(2009-5#1)
some essential##8##2##(1993-8#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)
some evidence for##3##3##(2008-5#1)(2008-7#1)(2009-6#1)
some evidence of##11##3##(1991-1#1)(1994-12#1)(1995-5#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-2#1)
some evidence that the##4##4##(1994-5#1)(1996-2#1)(2008-10#1)(2008-5#1)
some evidence that##9##3##(1990-2#1)(1993-1#1)(1994-5#1)(1996-2#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
some evidence to suggest that##3##5##(1994-3#1)(2008-3#1)(2013-1#1)
some evidence##30##2##(1990-2#1)(1991-1#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
some examples of such##3##4##(2012-2#1)(2013-1#2)
some examples of the##2##4##(2008-8#1)(2009-10#1)
some examples of##10##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
some examples##14##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
some exceptions##3##2##(2008-6#1)(2010-8#1)(2012-12#1)
some experiences##2##2##(1996-12#1)(2010-2#1)
some experimental results are shown##2##5##(2008-2#2)
some experimental results are##3##4##(2008-2#2)(2008-3#1)
some experimental results##4##3##(2008-2#2)(2008-3#2)
some experimental##11##2##(1990-2#1)(1997-6#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#1)
some experiments##6##2##(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
some explanatory variables##2##3##(2008-10#2)
some extent##30##2##(1990-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
some factors associated with##3##4##(2008-10#1)(2011-2#1)(2012-1#1)
some factors controlling##2##3##(2007-5#1)(2008-10#1)
some factors##10##2##(2007-5#1)(2008-10#3)(2008-4#2)(2008-6#1)(2011-2#2)(2012-1#1)
some families##3##2##(2008-8#2)(2011-1#1)
some features##4##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
some field##2##2##(2007-12#1)(2008-10#1)
some findings##2##2##(1997-3#1)(1997-8#1)
some form of##17##3##(1991-3#1)(1992-12#1)(1993-2#1)(1994-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-11#1)(2012-3#2)(2013-1#1)
some form##19##2##(1991-3#1)(1992-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-11#1)(2012-3#2)(2013-1#1)
some forms of##4##3##(1991-11#1)(1991-12#1)(2008-11#1)(2008-7#1)
some formulations##2##2##(1993-11#1)(2010-4#1)
some fragments##2##2##(1994-2#1)(2010-5#1)
some functional##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
some fungal##2##2##(2008-10#1)(2012-2#1)
some further##2##2##(1991-5#1)(1992-2#1)
some future##4##2##(1991-6#1)(2008-1#1)(2008-3#1)(2010-12#1)
some general guidelines for##2##4##(1993-12#1)(2008-9#1)
some general##5##2##(1991-2#1)(1993-12#1)(1996-6#1)(2008-9#1)(2010-5#1)
some genes##4##2##(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)
some genetic##3##2##(1994-11#1)(1995-6#1)(2008-10#1)
some groups##7##2##(1991-12#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-4#2)(2010-7#1)
some growth##2##2##(2008-12#1)(2010-8#1)
some hard and soft metals##2##5##(2008-10#2)
some have##9##2##(1991-9#1)(1996-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-3#2)
some health care##2##3##(1997-1#1)(2009-6#1)
some health##4##2##(1997-1#1)(2008-10#2)(2009-6#1)
some heavy metal ions##3##4##(2008-10#3)
some heavy metals##3##3##(2008-10#2)(2010-11#1)
some heavy##6##2##(2008-10#5)(2010-11#1)
some heteropoly##3##2##(2008-10#3)
some higher##3##2##(1995-8#1)(2008-8#1)(2010-4#1)
some highlights##2##2##(1997-7#1)(2008-11#1)
some hospital##3##2##(1991-2#1)(2011-1#1)(2012-2#1)
some hospitals##3##2##(1993-12#1)(1997-8#1)(2008-10#1)
some host##2##2##(2008-10#2)
some human##2##2##(1993-9#1)(2008-7#1)
some ideas on##2##3##(1995-2#1)(2009-10#1)
some ideas##5##2##(1992-2#1)(1995-2#1)(2009-10#1)(2011-3#1)(2012-1#1)
some implications of##2##3##(1991-1#1)(2008-11#1)
some important differences##2##3##(1994-5#1)(2009-12#1)
some important##21##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-5#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2011-2#1)(2012-2#1)
some improvements##5##2##(1991-9#1)(1993-12#1)(2008-3#2)(2010-2#1)
some in vitro##3##3##(2008-10#2)(2008-4#1)
some in##4##2##(2008-10#2)(2008-4#1)(2010-3#1)
some inconsistencies##2##2##(1995-12#1)(2008-10#1)
some inconsistency##2##2##(2008-3#2)
some increase of##2##3##(2008-3#1)(2010-7#1)
some increase##3##2##(1990-6#1)(2008-3#1)(2010-7#1)
some indication##2##2##(2008-9#2)
some indications##2##2##(2008-5#2)
some indicators##3##2##(1994-9#1)(2008-9#1)(2012-12#1)
some individual##7##2##(1992-12#1)(1993-12#1)(1995-9#1)(1997-3#1)(2008-10#2)(2008-12#1)
some individuals##15##2##(1992-11#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#2)(2010-5#1)(2012-2#1)(2013-1#1)
some industrial waste waters##2##4##(2008-10#2)
some industrial##4##2##(2008-10#3)(2008-3#1)
some inflammatory diseases##2##3##(2008-10#1)(2013-1#1)
some information##3##2##(1991-12#1)(1992-12#1)(1997-3#1)
some inorganic##2##2##(2008-10#2)
some insects##3##2##(1990-5#1)(2008-10#1)(2008-6#1)
some insight into##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
some insights into the##2##4##(1992-9#1)(2008-7#1)
some insights##3##2##(1992-9#1)(2008-7#1)(2013-1#1)
some instances##16##2##(1990-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#2)(2011-1#1)
some instrumental parameters##2##3##(2008-10#2)
some instrumental##4##2##(2008-10#4)
some insulin##2##2##(1995-8#1)(2010-11#1)
some interesting##4##2##(2008-2#1)(2008-5#1)(2010-11#1)(2013-1#1)
some internal##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
some international##2##2##(2008-10#2)
some invasive##2##2##(2008-10#1)(2012-12#1)
some investigators##2##2##(1994-3#1)(2008-8#1)
some ions##5##2##(2008-10#5)
some isolates of V##2##4##(2008-10#2)
some isolates of##3##3##(2008-10#3)
some isolates##11##2##(1997-3#1)(2008-10#10)
some issues##4##2##(2008-11#1)(2009-10#1)(2012-2#1)(2013-8#1)
some key issues##2##3##(2008-12#1)(2012-2#1)
some key lessons##3##3##(1995-12#1)(2008-12#2)
some key##12##2##(1994-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-12#4)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)
some kind of##10##3##(1991-12#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#1)(2009-5#1)(2013-8#1)
some lanthanide metal ions##2##4##(2008-10#2)
some large##2##2##(1991-3#1)(2008-10#1)
some lead##2##2##(2008-10#1)(2012-3#1)
some lesions##2##2##(1997-3#1)(2010-12#1)
some level of##5##3##(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)
some level##6##2##(2008-10#1)(2008-4#3)(2008-9#1)(2011-2#1)
some ligands##2##2##(2010-11#1)(2012-2#1)
some light on the##2##4##(2008-10#1)(2008-11#1)
some light on##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
some light##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
some limitations##8##2##(1994-12#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
some lines##4##2##(2008-10#3)(2008-9#1)
some local##2##2##(2008-10#1)(2008-12#1)
some locations##3##2##(2008-10#3)
some long-term##2##2##(1993-12#1)(2008-11#1)
some loss of##4##3##(2008-10#3)(2008-3#1)
some maize##2##2##(2008-10#1)(2008-5#1)
some major##5##2##(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
some malignancies##2##2##(2010-12#1)(2012-12#1)
some malignant##2##2##(2010-1#1)(2011-2#1)
some managers##2##2##(1993-2#1)(2008-11#1)
some markers##2##2##(2007-7#1)(2008-5#1)
some materials##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
some measure of##4##3##(1993-3#1)(1995-5#1)(2008-12#1)(2008-2#1)
some measurement##2##2##(2007-11#1)(2008-3#1)
some measures##3##2##(2007-12#1)(2008-11#1)(2010-8#1)
some mechanisms##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
some members of the##2##4##(1994-9#1)(1997-3#1)
some members##4##2##(1993-3#1)(1994-9#1)(1997-3#1)(2009-10#1)
some metabolic##2##2##(2008-2#1)(2008-9#1)
some metabolites##2##2##(2008-10#1)(2012-1#1)
some metal ions and##3##4##(2008-10#3)
some metal ions##11##3##(2008-10#11)
some metal##12##2##(2008-10#11)(2008-3#1)
some metals##8##2##(2007-11#1)(2008-10#6)(2008-12#1)
some methods of##2##3##(1994-9#1)(2008-10#1)
some methods##4##2##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
some microanatomical##2##2##(1994-6#2)
some might##2##2##(1991-6#2)
some migration##2##2##(2008-8#1)(2008-9#1)
some minor##3##2##(1995-2#1)(2008-2#1)(2011-1#1)
some model##2##2##(2008-7#1)(2011-1#1)
some models##3##2##(1996-4#1)(2008-10#1)(2008-3#1)
some modifications##2##2##(2007-2#1)(2008-10#1)
some molecules##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
some months##3##2##(1991-11#1)(1994-6#1)(2008-2#1)
some more##2##2##(2007-11#1)(2007-7#1)
some morphological##4##2##(1990-11#1)(2007-7#1)(2008-10#1)(2008-2#1)
some native##2##2##(1991-12#1)(2008-10#1)
some natural compounds##2##3##(2011-3#2)
some natural##7##2##(2008-10#4)(2008-3#1)(2011-3#2)
some ncRNAs##2##2##(2012-3#2)
some neurons##4##2##(1996-12#1)(2008-8#1)(2009-10#2)
some new##15##2##(1990-11#1)(1991-9#1)(1997-2#1)(2007-11#5)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
some newly##2##2##(1996-5#1)(2008-12#1)
some normal##2##2##(1995-2#1)(2010-11#1)
some novel##6##2##(1990-11#1)(1996-5#1)(2007-11#3)(2012-2#1)
some nuclear proteins##3##3##(1994-9#2)(2008-9#1)
some nucleotides##2##2##(1995-11#1)(2008-9#1)
some observations##4##2##(1991-9#1)(1992-6#1)(1997-3#1)(2008-10#1)
some of its##14##3##(1990-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-8#1)
some of our##2##3##(2008-12#1)(2012-2#1)
some of the advantages##2##4##(1993-2#1)(2007-12#1)
some of the adverse##2##4##(2008-7#1)(2013-1#1)
some of the areas##2##4##(1991-2#1)(2008-7#1)
some of the barriers##2##4##(1994-1#1)(1997-2#1)
some of the basic##3##4##(2008-4#2)(2008-6#1)
some of the causes##3##4##(1991-6#1)(1996-2#1)(2007-11#1)
some of the challenges and##2##5##(1996-2#1)(2008-1#1)
some of the challenges##5##4##(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)
some of the characteristic##2##4##(2008-11#1)(2009-12#1)
some of the clinical##2##4##(2007-12#1)(2008-4#1)
some of the common##3##4##(2008-4#3)
some of the complications##2##4##(2008-6#1)(2011-2#1)
some of the critical##2##4##(1992-12#1)(2008-8#1)
some of the current##6##4##(2008-11#2)(2008-8#1)(2009-4#2)(2012-3#1)
some of the data##4##4##(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)
some of the diagnostic##2##4##(1997-2#1)(2008-1#1)
some of the difficulties##2##4##(2008-7#1)(2008-9#1)
some of the early##2##4##(2008-11#1)(2011-2#1)
some of the effects of##2##5##(2008-3#1)(2009-12#1)
some of the existing##3##4##(2008-3#1)(2008-5#1)(2009-1#1)
some of the factors that##2##5##(1997-1#1)(2008-4#1)
some of the factors##5##4##(1991-3#1)(1992-6#1)(1997-1#1)(2008-4#1)(2008-5#1)
some of the features##2##4##(1994-1#1)(1996-3#1)
some of the first##2##4##(2008-10#1)(2008-9#1)
some of the following##2##4##(1995-12#1)(2008-10#1)
some of the future##2##4##(1994-2#1)(2008-2#1)
some of the gaps##2##4##(1997-1#1)(2012-12#1)
some of the genes##2##4##(2008-10#1)(2008-9#1)
some of the health##2##4##(1994-3#1)(2010-3#1)
some of the important##4##4##(1992-3#1)(2008-4#1)(2009-7#1)(2010-7#1)
some of the inherent##2##4##(2008-11#1)(2008-12#1)
some of the issues involved in##2##6##(1991-12#2)
some of the issues that##3##5##(1991-3#1)(2008-4#2)
some of the issues##10##4##(1991-12#2)(1991-3#1)(1992-3#1)(1993-11#1)(2008-11#1)(2008-4#2)(2009-6#1)(2013-8#1)
some of the key##7##4##(1992-1#1)(1992-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
some of the legal##3##4##(1991-12#1)(1992-3#1)(2008-11#1)
some of the limitations and##2##5##(2008-10#2)
some of the limitations of##2##5##(2008-10#1)(2008-5#1)
some of the limitations##6##4##(2008-1#1)(2008-10#3)(2008-5#1)(2013-1#1)
some of the main##5##4##(1991-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
some of the major problems##2##5##(1997-2#1)(2008-12#1)
some of the major##4##4##(1997-2#1)(2008-11#1)(2008-12#1)(2011-2#1)
some of the mechanisms underlying##2##5##(1993-8#1)(2008-1#1)
some of the mechanisms##3##4##(1993-8#1)(2007-8#1)(2008-1#1)
some of the methods##3##4##(2008-10#1)(2008-11#1)(2009-9#1)
some of the molecular##3##4##(2008-7#2)(2010-5#1)
some of the more common##4##5##(2008-9#2)(2009-9#1)(2012-2#1)
some of the more##9##4##(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#2)(2009-9#1)(2012-2#1)
some of the most common##3##5##(2008-10#1)(2008-11#1)(2009-10#1)
some of the most important##5##5##(1995-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)
some of the most recent findings##2##6##(2008-5#1)(2009-2#1)
some of the most recent##3##5##(2008-5#2)(2009-2#1)
some of the most##26##4##(1995-1#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
some of the new##2##4##(1996-5#1)(2012-2#1)
some of the obstacles##2##4##(1993-2#1)(1995-3#1)
some of the other##2##4##(2008-9#1)(2010-3#1)
some of the participating##2##4##(2008-11#1)(2008-12#1)
some of the philosophical##2##4##(2008-4#1)(2008-7#1)
some of the potential##2##4##(2008-10#1)(2008-11#1)
some of the practical##2##4##(1995-3#1)(2008-8#1)
some of the problems##4##4##(1992-12#1)(1993-3#1)(2008-11#1)(2008-4#1)
some of the properties of##2##5##(2008-10#1)(2008-7#1)
some of the questions##2##4##(2008-2#1)(2008-7#1)
some of the real##2##4##(1997-7#1)(2008-3#1)
some of the reasons for the##2##6##(1996-2#1)(2013-1#1)
some of the reasons why##3##5##(2009-11#1)(2009-6#1)(2012-2#1)
some of the reasons##6##4##(1994-3#1)(1996-2#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
some of the recent##3##4##(2008-10#1)(2008-7#2)
some of the relevant##2##4##(1992-1#1)(2008-7#1)
some of the resources available##2##5##(2008-4#2)
some of the same##2##4##(2008-10#1)(2008-3#1)
some of the strategies##2##4##(1991-12#1)(1992-1#1)
some of the studies##2##4##(1990-6#1)(2008-7#1)
some of the symptoms##2##4##(2008-11#1)(2009-11#1)
some of the techniques##2##4##(2008-1#1)(2008-9#1)
some of the unique##3##4##(1991-1#1)(2008-11#2)
some of the##446##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#2)(1991-12#8)(1991-2#2)(1991-3#2)(1991-6#2)(1991-9#1)(1992-1#3)(1992-12#5)(1992-2#1)(1992-3#6)(1992-4#2)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#4)(1993-12#4)(1993-2#7)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#4)(1996-6#2)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#1)(1997-7#5)(1997-8#1)(2007-11#5)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#14)(2008-10#39)(2008-11#29)(2008-12#15)(2008-2#7)(2008-3#13)(2008-4#22)(2008-5#13)(2008-6#3)(2008-7#29)(2008-8#8)(2008-9#11)(2009-1#2)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#12)(2012-12#5)(2012-2#9)(2012-3#3)(2012-7#1)(2013-1#10)(2013-8#3)
some of their##9##3##(1991-12#1)(1995-1#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
some of them may##2##4##(2011-1#1)(2013-1#1)
some of them were##3##4##(2007-11#1)(2011-1#1)(2012-1#1)
some of them##28##3##(1994-3#1)(1996-2#1)(1996-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
some of these agents##2##4##(1994-6#1)(2008-5#1)
some of these are##2##4##(1996-3#1)(2009-12#1)
some of these compounds##2##4##(1990-3#1)(2008-5#1)
some of these isolates##2##4##(2008-10#1)(2010-4#1)
some of these issues##3##4##(1990-6#1)(2007-7#1)(2008-1#1)
some of these problems##2##4##(2008-10#1)(2008-11#1)
some of these products##2##4##(2008-10#2)
some of these##70##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-8#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-3#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
some of this##5##3##(1991-12#1)(1992-11#1)(1993-12#1)(2008-8#1)(2013-1#1)
some of those##3##3##(1991-3#1)(2008-5#1)(2009-8#1)
some of which are currently##2##5##(2008-12#1)(2008-5#1)
some of which are##16##4##(1991-12#1)(1992-10#1)(1992-6#1)(1993-11#1)(1994-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
some of which have been##2##5##(1997-5#1)(2008-10#1)
some of which have##4##4##(1995-1#1)(1995-6#1)(1997-5#1)(2008-10#1)
some of which result##2##4##(1994-11#1)(2011-1#1)
some of which were##2##4##(2009-4#1)(2013-1#1)
some of which##41##3##(1991-12#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#2)
some of##633##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#3)(1990-7#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#12)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#6)(1992-4#2)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#5)(1993-12#6)(1993-2#7)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#16)(2008-10#64)(2008-11#36)(2008-12#21)(2008-2#9)(2008-3#16)(2008-4#29)(2008-5#23)(2008-6#4)(2008-7#39)(2008-8#11)(2008-9#13)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#16)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#5)(2012-7#1)(2013-1#16)(2013-8#6)
some older##2##2##(1996-2#1)(2013-1#1)
some operons##2##2##(2008-8#2)
some or all##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
some organic compounds of##2##4##(2008-10#1)(2011-2#1)
some organic compounds##3##3##(2008-10#2)(2011-2#1)
some organic solvents##2##3##(1995-3#1)(2008-10#1)
some organic##11##2##(1990-9#1)(1995-3#1)(2008-10#8)(2011-2#1)
some organisms##3##2##(1997-3#1)(2008-3#1)(2012-3#1)
some other properties##3##3##(2007-11#1)(2008-11#2)
some other##38##2##(1990-8#1)(1991-12#1)(1992-9#1)(1994-2#1)(1996-12#1)(1997-3#2)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
some others##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
some overall##2##2##(2008-10#1)(2010-9#1)
some parallels##2##2##(2008-6#1)(2012-2#1)
some parameters of##2##3##(2008-12#1)(2012-1#1)
some parameters such as##2##4##(2008-10#2)
some parameters##7##2##(2008-10#3)(2008-12#1)(2010-3#1)(2012-1#1)(2013-8#1)
some part##2##2##(2008-12#2)
some participants##3##2##(2009-7#2)(2013-1#1)
some particular##2##2##(2008-10#1)(2008-9#1)
some parts of the##5##4##(1997-6#1)(2007-12#1)(2008-11#1)(2010-12#1)(2012-2#1)
some patients the##2##3##(1992-8#1)(2011-2#1)
some patients who##2##3##(1992-3#1)(2010-3#1)
some patients with acute##2##4##(2007-9#1)(2010-12#1)
some patients with##15##3##(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-2#1)
some patients##51##2##(1991-1#2)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-12#1)(1996-2#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#2)
some patterns##2##2##(1990-12#1)(2013-1#1)
some peculiarities of##2##3##(2008-2#1)(2008-3#1)
some peculiarities##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
some people##8##2##(1993-3#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2013-8#1)
some peptides##2##2##(1991-3#1)(2010-10#1)
some peripheral##2##2##(1992-6#1)(1995-12#1)
some persistent##2##2##(1994-3#1)(2008-7#1)
some perspectives##2##2##(2012-12#1)(2012-2#1)
some pharmaceutical formulations##2##3##(2008-10#2)
some pharmaceutical##7##2##(2008-10#6)(2008-11#1)
some pharmacological##2##2##(1992-10#1)(2008-5#1)
some physical##6##2##(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
some physicians##3##2##(1993-1#1)(2008-4#1)(2013-7#1)
some physicochemical conditions##2##3##(2013-7#2)
some physicochemical##3##2##(2009-3#1)(2013-7#2)
some physiological growth parameters##2##4##(2008-12#2)
some physiological parameters##2##3##(2008-12#2)
some physiological##8##2##(1997-4#1)(2008-12#5)(2008-7#1)(2012-2#1)
some pigments##2##2##(2008-10#2)
some plant##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
some plants##6##2##(2008-10#5)(2013-1#1)
some point##6##2##(1991-12#1)(2008-9#1)(2009-5#2)(2013-1#2)
some polymeric##3##2##(2008-10#1)(2008-11#2)
some populations##4##2##(2008-1#1)(2010-11#2)(2011-2#1)
some positive##2##2##(2010-2#1)(2013-1#1)
some possible##5##2##(1992-12#1)(1994-3#1)(2008-3#1)(2008-6#1)(2009-8#1)
some potential for##2##3##(2008-10#1)(2008-7#1)
some potential##8##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
some practical advice##2##3##(1992-12#1)(2008-1#1)
some practical##9##2##(1992-12#1)(1992-5#1)(1993-2#1)(1995-1#1)(1995-5#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
some preliminary data##2##3##(1995-12#1)(2011-2#1)
some preliminary results##2##3##(1996-4#1)(2009-3#1)
some preliminary##7##2##(1995-12#1)(1996-4#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)
some previous reports##2##3##(1991-3#1)(1991-8#1)
some previous studies##2##3##(2008-11#1)(2008-9#1)
some previous##8##2##(1991-3#1)(1991-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2012-1#1)
some previously##3##2##(1994-11#1)(1997-5#1)(2013-1#1)
some primary##2##2##(2007-11#1)(2009-5#1)
some prior##2##2##(1991-12#1)(2008-10#1)
some problems in##4##3##(2008-10#2)(2013-1#2)
some problems##6##2##(1992-11#1)(2008-10#2)(2012-2#1)(2013-1#2)
some products##3##2##(1995-2#1)(2008-11#1)(2008-5#1)
some promise##2##2##(1994-3#1)(2012-3#1)
some properties of the##2##4##(2007-11#1)(2008-11#1)
some properties of##5##3##(1990-7#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-3#1)
some properties##10##2##(1990-6#1)(1990-7#2)(1995-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
some protection against##2##3##(1997-6#1)(2010-8#1)
some protective##2##2##(1992-12#1)(1993-5#1)
some protein##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)
some proteins##6##2##(1993-11#1)(1995-6#1)(2008-10#3)(2009-9#1)
some protocols##2##2##(2008-4#1)(2008-6#1)
some psychiatric disorders##2##3##(2008-4#1)(2008-5#1)
some psychiatric##4##2##(1996-5#1)(2008-3#1)(2008-4#1)(2008-5#1)
some psychological##3##2##(2008-11#1)(2008-12#1)(2010-8#1)
some purposes##2##2##(1997-8#1)(2008-1#1)
some putative##2##2##(2008-7#1)(2009-10#1)
some questions##4##2##(1992-2#1)(1993-6#1)(2007-12#1)(2013-1#1)
some rare cases##2##3##(1993-3#1)(2008-9#1)
some reactions##2##2##(2007-11#1)(2008-11#1)
some real##2##2##(2008-10#1)(2008-2#1)
some recent developments##4##3##(1991-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
some recent results##2##3##(2008-10#2)
some recent##16##2##(1991-2#1)(1997-3#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2011-2#2)
some recently synthesized##4##3##(2008-10#4)
some recommendations##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
some reduction in##2##3##(1991-8#1)(2008-6#1)
some regions##4##2##(1990-5#1)(1994-2#1)(2008-8#1)(2011-2#1)
some related##3##2##(1993-6#1)(2008-10#1)(2010-7#1)
some relation to##2##3##(1992-8#1)(2008-7#1)
some relief from##2##3##(2008-5#1)(2011-3#1)
some remaining##2##2##(1995-5#1)(1997-4#1)
some renal##2##2##(2008-12#1)(2011-2#1)
some reported##2##2##(2008-5#1)(2011-1#1)
some reports##4##2##(2008-7#1)(2009-2#1)(2010-3#1)(2013-1#1)
some representative##2##2##(2008-3#1)(2008-8#1)
some require##3##2##(1996-2#1)(2008-7#1)(2009-11#1)
some research##3##2##(1991-2#1)(2008-5#1)(2010-7#1)
some researchers##3##2##(2010-5#1)(2012-12#1)(2012-2#1)
some residual##3##2##(1993-2#1)(2006-6#1)(2008-11#1)
some resistant##2##2##(2008-10#2)
some results of##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
some results##4##2##(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
some risk factors##3##3##(2007-11#1)(2008-1#1)(2013-8#1)
some risk##5##2##(1995-11#1)(2007-11#1)(2008-1#1)(2009-4#1)(2013-8#1)
some role in##4##3##(2008-7#2)(2008-8#1)(2012-12#1)
some rural areas##2##3##(1991-6#1)(2013-1#1)
some samples with##2##3##(2008-10#2)
some samples##9##2##(2008-10#6)(2008-3#1)(2008-4#1)(2011-2#1)
some schizophrenic##2##2##(1995-11#1)(2007-8#1)
some scientific##3##2##(1994-8#1)(2010-12#1)(2013-8#1)
some selected##4##2##(2006-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
some sequence##2##2##(2008-10#1)(2008-8#1)
some series##2##2##(2010-12#1)(2011-2#1)
some short##2##2##(2011-3#1)(2013-1#1)
some shortcomings##2##2##(2012-2#1)(2013-1#1)
some significant##2##2##(1995-2#1)(2008-6#1)
some similarities to known genes##3##5##(1995-8#1)(1996-10#1)(1996-2#1)
some similarities to##5##3##(1992-12#1)(1993-8#1)(1995-8#1)(1996-10#1)(1996-2#1)
some similarities##7##2##(1991-1#1)(1992-12#1)(1993-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#1)
some similarity##2##2##(1992-8#1)(1997-7#1)
some simple##6##2##(1995-12#1)(1995-5#1)(1997-4#1)(2008-3#2)(2008-8#1)
some situations##6##2##(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)
some skin##2##2##(1992-6#1)(2013-1#1)
some small##6##2##(1990-6#1)(1993-12#1)(1997-6#1)(2007-8#1)(2008-8#1)(2008-9#1)
some smaller##2##2##(1995-2#1)(2008-11#1)
some social##2##2##(2009-7#2)
some soils##2##2##(2008-10#2)
some solid##3##2##(1992-9#1)(2008-12#1)(2012-12#1)
some sort of##5##3##(1996-9#1)(2008-1#1)(2008-3#2)(2012-12#1)
some sort##6##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-12#1)
some species of##4##3##(1995-3#1)(2008-12#1)(2008-8#1)(2011-2#1)
some species##14##2##(1995-3#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-9#1)(2011-2#1)(2012-2#1)
some specific activities##2##3##(2008-4#1)(2008-9#1)
some specific##17##2##(1990-6#1)(1994-2#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-3#1)(2012-2#1)
some specificity##3##2##(1994-2#1)(1994-8#1)(1995-12#1)
some standard##8##2##(2008-10#3)(2008-2#1)(2008-4#1)(2013-1#3)
some strains of##2##3##(2008-10#1)(2008-2#1)
some strains##11##2##(1991-3#1)(1995-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
some strategic##2##2##(1992-8#1)(1993-2#1)
some strategies##2##2##(1991-1#1)(2008-10#1)
some structural##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
some students##2##2##(2008-11#1)(2012-3#1)
some studies have##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)
some studies indicate that##2##4##(2011-2#1)(2013-1#1)
some studies may##2##3##(2008-1#1)(2012-2#1)
some studies##16##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-12#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#1)
some subjects##3##2##(1990-3#1)(1994-3#1)(1995-5#1)
some success in##2##3##(1993-2#1)(2008-11#1)
some success##6##2##(1991-9#1)(1993-2#1)(2008-11#1)(2009-5#1)(2010-6#1)(2012-3#1)
some such##2##2##(1996-4#1)(2013-8#1)
some suggestions for##2##3##(1991-2#1)(2008-5#1)
some suggestions##3##2##(1991-2#1)(2008-5#1)(2012-3#1)
some support for the##2##4##(1991-12#1)(2011-1#1)
some support for##4##3##(1991-12#1)(2009-10#1)(2011-1#1)(2013-1#1)
some surfactants##2##2##(2008-10#2)
some surgical##2##2##(2008-4#1)(2009-7#1)
some symptoms##2##2##(2011-2#1)(2012-12#1)
some synthetic mixtures##3##3##(2008-10#3)
some synthetic##5##2##(2008-10#5)
some systems##2##2##(2008-10#1)(2013-8#1)
some taxonomic##2##2##(2008-6#1)(2011-2#1)
some ten##2##2##(1990-6#1)(1997-4#1)
some tens##2##2##(2008-10#1)(2008-3#1)
some tests##2##2##(2008-10#1)(2008-11#1)
some theoretical##3##2##(1990-12#1)(2008-10#1)(2008-4#1)
some time after##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
some time and##2##3##(1995-9#1)(1996-11#1)
some time in##3##3##(1992-3#1)(1997-1#1)(2010-1#1)
some time##22##2##(1992-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)
some tissue##2##2##(2008-3#1)(2008-7#1)
some tissues of##2##3##(2008-12#2)
some tissues##3##2##(1992-9#1)(2008-12#2)
some topological##2##2##(2007-11#1)(2008-7#1)
some trace elements##3##3##(2008-10#3)
some transition metal ions##3##4##(2008-10#3)
some transition metals##3##3##(2008-10#3)
some transition##7##2##(2008-10#7)
some treatments##3##2##(2008-12#1)(2008-5#1)(2008-8#1)
some trophic##2##2##(2008-1#1)(2008-5#1)
some tumor cell lines##2##4##(1991-2#1)(2008-8#1)
some tumor##4##2##(1991-2#1)(1992-2#1)(2007-11#1)(2008-8#1)
some tumors##3##2##(1993-8#1)(2008-9#1)(2010-3#1)
some type of##5##3##(2008-10#2)(2008-12#1)(2009-9#1)(2013-1#1)
some types of samples##2##4##(2008-10#2)
some types of##11##3##(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-3#1)
some types##12##2##(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2011-3#1)
some typical##4##2##(2007-11#1)(2008-10#2)(2009-10#1)
some uncertainties##2##2##(1995-1#1)(2008-10#1)
some uncertainty##2##2##(1996-11#1)(2008-10#1)
some unique##2##2##(2008-10#1)(2009-8#1)
some unresolved##2##2##(1996-1#1)(2011-3#1)
some unusual##2##2##(2008-10#1)(2008-11#1)
some useful##3##2##(1994-3#1)(1997-4#1)(2008-11#1)
some users##2##2##(1991-3#1)(2009-5#1)
some utility in the##2##4##(2008-5#1)(2011-2#1)
some variables##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
some variation##2##2##(2008-10#2)
some variations in##3##3##(1994-3#1)(2008-3#1)(2008-7#1)
some variations##6##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
some very##4##2##(1991-1#1)(1993-12#1)(2008-10#1)(2013-8#1)
some viral##2##2##(1997-4#1)(2008-11#1)
some viruses##4##2##(2008-10#1)(2008-11#2)(2010-1#1)
some visual##2##2##(1993-12#1)(2011-2#1)
some way##4##2##(1991-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
some ways##2##2##(1990-6#1)(2012-3#1)
some weeks##4##2##(1991-3#1)(1991-8#1)(1996-9#1)(1997-6#1)
some weight##2##2##(1992-8#1)(2010-1#1)
some well known##2##3##(2008-10#1)(2009-5#1)
some well##3##2##(2008-10#2)(2009-5#1)
some well-known##2##2##(1993-3#1)(2009-2#1)
some were even##2##3##(2008-3#1)(2008-9#1)
some were##3##2##(1997-2#1)(2008-3#1)(2008-9#1)
some what##2##2##(1990-5#1)(2008-8#1)
some with##3##2##(2007-11#1)(2008-11#1)(2013-1#1)
some women##3##2##(1990-6#1)(1994-9#1)(2007-1#1)
some years##6##2##(1997-5#1)(2008-10#4)(2011-2#1)
some##3749##1##(1990-10#1)(1990-11#11)(1990-12#10)(1990-2#12)(1990-3#6)(1990-4#1)(1990-5#14)(1990-6#16)(1990-7#5)(1990-8#10)(1990-9#3)(1991-1#15)(1991-10#2)(1991-11#4)(1991-12#39)(1991-2#15)(1991-3#14)(1991-4#1)(1991-5#4)(1991-6#13)(1991-8#9)(1991-9#8)(1992-1#7)(1992-10#3)(1992-11#10)(1992-12#18)(1992-2#15)(1992-3#23)(1992-4#4)(1992-5#3)(1992-6#12)(1992-7#1)(1992-8#13)(1992-9#12)(1993-1#12)(1993-10#1)(1993-11#12)(1993-12#32)(1993-2#21)(1993-3#22)(1993-5#6)(1993-6#11)(1993-8#14)(1993-9#4)(1994-1#10)(1994-11#14)(1994-12#15)(1994-2#21)(1994-3#21)(1994-5#8)(1994-6#12)(1994-8#11)(1994-9#15)(1995-1#16)(1995-11#8)(1995-12#27)(1995-2#17)(1995-3#29)(1995-5#11)(1995-6#11)(1995-8#8)(1995-9#5)(1996-1#4)(1996-10#4)(1996-11#6)(1996-12#19)(1996-2#21)(1996-3#8)(1996-4#11)(1996-5#18)(1996-6#9)(1996-7#4)(1996-8#3)(1996-9#5)(1997-1#8)(1997-2#17)(1997-3#35)(1997-4#15)(1997-5#7)(1997-6#16)(1997-7#17)(1997-8#9)(1997-9#2)(2006-10#2)(2006-4#2)(2006-6#5)(2007-1#2)(2007-10#6)(2007-11#59)(2007-12#50)(2007-2#11)(2007-3#1)(2007-4#5)(2007-5#6)(2007-6#2)(2007-7#11)(2007-8#15)(2007-9#2)(2008-1#53)(2008-10#728)(2008-11#148)(2008-12#98)(2008-2#63)(2008-3#108)(2008-4#84)(2008-5#116)(2008-6#40)(2008-7#129)(2008-8#104)(2008-9#111)(2009-1#2)(2009-10#31)(2009-11#8)(2009-12#18)(2009-2#9)(2009-3#8)(2009-4#11)(2009-5#21)(2009-6#13)(2009-7#10)(2009-8#17)(2009-9#12)(2010-1#12)(2010-10#13)(2010-11#22)(2010-12#22)(2010-2#11)(2010-3#22)(2010-4#11)(2010-5#14)(2010-6#8)(2010-7#13)(2010-8#22)(2010-9#5)(2011-1#34)(2011-2#115)(2011-3#15)(2012-1#19)(2012-12#43)(2012-2#61)(2012-3#52)(2012-7#2)(2013-1#89)(2013-7#19)(2013-8#38)
someday##2##1##(1994-5#1)(2013-1#1)
somehow##3##1##(1990-5#1)(1995-11#1)(2008-10#1)
someone else##4##2##(1996-3#1)(2008-11#1)(2010-11#1)(2012-12#1)
someone##13##1##(1994-2#1)(1995-9#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
something of##3##2##(1995-6#1)(2008-4#1)(2013-1#1)
something that##3##2##(1996-2#1)(2008-12#1)(2008-5#1)
something to##3##2##(1996-11#1)(1997-2#1)(2008-7#1)
something##19##1##(1991-1#1)(1991-3#1)(1992-6#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
sometime during the##2##3##(2007-2#1)(2008-10#1)
sometime##5##1##(1990-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
sometimes accompanied by##2##3##(1997-3#1)(2008-3#1)
sometimes also##2##2##(1997-4#1)(1997-8#1)
sometimes associated with##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
sometimes be##11##2##(1993-11#1)(1993-9#1)(1994-12#1)(2008-1#1)(2008-10#2)(2009-6#1)(2011-2#2)(2013-1#2)
sometimes conflicting##2##2##(2008-4#1)(2009-5#1)
sometimes contradictory##3##2##(1996-12#1)(2012-2#2)
sometimes even##3##2##(1994-1#1)(2007-2#1)(2008-2#1)
sometimes fatal##3##2##(1997-4#1)(2008-11#1)(2012-2#1)
sometimes in the##3##3##(2010-1#1)(2012-12#2)
sometimes it is##2##3##(1990-5#1)(2012-3#1)
sometimes refer##2##2##(1994-2#1)(2007-2#1)
sometimes referred to as##2##4##(2008-10#1)(2011-2#1)
sometimes severely##2##2##(2008-10#2)
sometimes the##6##2##(1991-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
sometimes this##2##2##(2012-2#2)
sometimes treated##2##2##(2008-8#1)(2008-9#1)
sometimes were##2##2##(2008-10#2)
sometimes with##3##2##(2008-8#1)(2009-10#1)(2012-2#1)
sometimes##201##1##(1990-3#2)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-5#1)(1993-9#2)(1994-1#3)(1994-12#5)(1994-2#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#3)(1997-8#2)(2006-4#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#5)(2009-10#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#10)
somewhat different from##2##3##(1994-9#1)(1995-6#1)
somewhat different##10##2##(1994-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-6#1)(2013-1#1)
somewhat greater##2##2##(2007-11#1)(2008-10#1)
somewhat higher##4##2##(1996-9#1)(2008-10#1)(2008-2#1)(2012-1#1)
somewhat larger##2##2##(1991-6#1)(2008-10#1)
somewhat less##10##2##(1995-12#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2010-5#1)(2011-2#1)
somewhat lower##5##2##(1997-8#1)(2007-8#1)(2008-10#2)(2008-7#1)
somewhat more##6##2##(1991-1#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2011-1#1)
somewhat reduced##2##2##(1997-2#1)(2008-11#1)
somewhat smaller##2##2##(1992-6#1)(2013-8#1)
somewhat with##2##2##(2008-2#1)(2008-9#1)
somewhat##101##1##(1990-12#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
somewhere in the##2##3##(1994-5#1)(1996-11#1)
somewhere##6##1##(1994-5#1)(1996-11#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-11#1)
somite##4##1##(1993-12#1)(1994-12#3)
somites##6##1##(1994-12#4)(1995-8#1)(1996-5#1)
somitic mesoderm##2##2##(1994-12#2)
somnolence##4##1##(1991-2#1)(1994-3#1)(2008-5#1)(2008-8#1)
son and##2##2##(2008-12#2)
son was##2##2##(2008-7#2)
son##16##1##(1992-3#1)(1994-12#1)(1994-7#1)(1995-6#1)(2007-10#1)(2008-12#4)(2008-5#1)(2008-7#3)(2009-4#1)(2013-1#2)
sonar##2##1##(2009-8#2)
song rate##4##2##(2008-9#4)
song sparrows##4##2##(2008-8#2)(2008-9#2)
song was highly##2##3##(2008-9#2)
song##27##1##(1996-3#1)(1997-2#4)(2007-6#2)(2008-8#8)(2008-9#9)(2009-2#1)(2011-1#2)
songbird##2##1##(2008-9#1)(2009-2#1)
songbirds##8##1##(1995-3#1)(2008-8#1)(2008-9#6)
songs of C##2##3##(2008-8#2)
songs of##3##2##(2008-8#3)
songs##15##1##(1994-3#1)(2007-6#3)(2008-8#11)
sonic hedgehog##2##2##(1993-12#1)(2013-1#1)
sonic##4##1##(1993-12#1)(2008-3#1)(2013-1#2)
sonicated in##2##2##(2008-10#2)
sonicated##13##1##(1990-2#1)(1992-3#1)(1994-5#3)(2008-10#5)(2008-11#2)(2013-1#1)
sonicating##2##1##(2008-10#2)
sonication amplitude##3##2##(2008-10#3)
sonication and##5##2##(1993-12#1)(2008-10#4)
sonication for##2##2##(2008-10#2)
sonication in##2##2##(2008-10#2)
sonication step##2##2##(1992-9#1)(2008-10#1)
sonication time and##2##3##(2008-10#2)
sonication time##13##2##(2008-10#13)
sonication were##3##2##(2008-10#2)(2011-2#1)
sonication##51##1##(1990-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(2008-10#43)(2008-11#1)(2008-5#2)(2011-2#1)
sonication-assisted##2##1##(2008-10#2)
sonnei strain##2##2##(2008-9#2)
sonnei##6##1##(2008-10#1)(2008-9#4)(2012-2#1)
sonogel-carbon electrode is##2##3##(2008-10#2)
sonogel-carbon electrode##4##2##(2008-10#4)
sonogram trace##2##2##(2007-11#2)
sonogram##7##1##(2007-11#6)(2007-12#1)
sonographic evaluation##2##2##(2007-11#1)(2012-2#1)
sonographic findings##5##2##(1991-8#1)(2011-8#1)(2012-2#1)(2013-1#2)
sonographic##15##1##(1990-8#1)(1991-8#1)(1994-9#1)(2007-11#2)(2008-8#1)(2010-8#1)(2011-8#1)(2012-2#5)(2013-1#2)
sonographically##2##1##(1990-9#1)(1991-11#1)
sonography and MR##2##3##(1997-8#1)(2008-1#1)
sonography and a CT##2##4##(1990-6#1)(1992-5#1)
sonography and##9##2##(1990-6#1)(1991-3#1)(1992-5#2)(1997-8#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-1#1)
sonography are##2##2##(1990-9#1)(1995-6#1)
sonography as a##2##3##(1990-9#1)(2008-8#1)
sonography in the##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
sonography in##8##2##(1990-9#1)(1991-3#1)(1994-3#1)(1997-8#1)(2011-2#3)(2013-1#1)
sonography is a##2##3##(1992-5#1)(2012-12#1)
sonography is##5##2##(1992-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
sonography of##3##2##(1991-6#1)(1993-6#1)(1995-6#1)
sonography or##2##2##(1990-12#1)(2010-5#1)
sonography permits##2##2##(1992-5#1)(1993-6#1)
sonography revealed##2##2##(2012-12#1)(2013-1#1)
sonography was##2##2##(2011-2#1)(2012-12#1)
sonography##62##1##(1990-10#2)(1990-12#1)(1990-6#1)(1990-9#5)(1991-11#1)(1991-3#2)(1991-6#1)(1992-5#4)(1993-6#3)(1994-3#1)(1995-6#2)(1996-6#1)(1997-8#7)(2006-10#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#3)(2010-5#2)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#1)
sonolinear sweep voltammetry##2##3##(2008-10#2)
sonoluminescence##2##1##(1994-2#2)
sonorensis and M##2##3##(2010-2#2)
sonorensis##6##1##(2010-2#6)
sonothrombolysis##2##1##(2013-1#2)
sons or##2##2##(1995-1#2)
sons that they##2##3##(2008-8#2)
sons##10##1##(1995-1#2)(1997-3#1)(2008-12#1)(2008-7#1)(2008-8#3)(2012-3#2)
sont decrits##3##2##(2008-5#3)
sont des##5##2##(2008-5#2)(2011-2#1)(2013-1#2)
sont##20##1##(2008-11#1)(2008-5#7)(2011-2#5)(2013-1#7)
soon after birth##2##3##(1993-12#1)(2009-12#1)
soon after the insult##2##4##(1996-5#1)(2008-7#1)
soon after the##6##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
soon after##27##2##(1991-12#1)(1993-12#1)(1996-5#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#2)(2012-3#1)(2013-1#1)
soon as the##7##3##(1990-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-6#1)
soon as##36##2##(1990-5#1)(1990-9#2)(1991-12#3)(1991-6#1)(1994-3#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-8#1)(2013-1#2)
soon be used for##2##4##(2008-3#1)(2012-2#1)
soon be##6##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
soon become##2##2##(2008-10#1)(2011-2#1)
soon##93##1##(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#4)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)
sooner than##4##2##(1991-8#1)(2008-10#1)(2008-9#2)
sooner##11##1##(1991-8#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-9#2)(2012-12#2)(2012-3#1)(2013-8#1)
soot concentration##2##2##(2008-3#2)
soot diagnostic##2##2##(2008-3#2)
soot distribution##4##2##(2008-2#1)(2008-3#3)
soot in the##2##3##(2008-3#2)
soot in##4##2##(2008-3#4)
soot volume fraction and##2##4##(2008-3#2)
soot volume fraction##6##3##(2008-2#3)(2008-3#3)
soot volume##7##2##(2008-2#4)(2008-3#3)
soot with##2##2##(2008-10#1)(2008-3#1)
soot##55##1##(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#16)(2008-3#29)
sooting##3##1##(2008-2#2)(2008-3#1)
sooty##5##1##(1995-2#1)(2008-10#3)(2008-3#1)
sophisticated and##7##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
sophisticated data##2##2##(1995-12#1)(2008-4#1)
sophisticated information systems##2##3##(1997-2#1)(2008-10#1)
sophisticated mechanisms to##2##3##(2011-10#1)(2012-1#1)
sophisticated mechanisms##3##2##(2011-1#1)(2011-10#1)(2012-1#1)
sophisticated processes##2##2##(1997-6#1)(2010-12#1)
sophisticated techniques##2##2##(2008-11#1)(2008-8#1)
sophisticated technology##2##2##(1994-12#1)(1996-1#1)
sophisticated##80##1##(1991-12#1)(1991-3#2)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-12#2)(1996-7#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)
sophistication##6##1##(1995-2#1)(1996-2#2)(1997-4#1)(2008-11#1)(2009-10#1)
sophomore##2##1##(2008-12#2)
sophoridine##2##1##(2008-10#2)
sorafenib##4##1##(2008-8#2)(2011-1#1)(2011-2#1)
sorbate##2##1##(1996-5#1)(2008-10#1)
sorbed on the##3##3##(2008-10#3)
sorbed on##6##2##(2008-10#6)
sorbed onto activated##2##3##(2008-10#2)
sorbed onto the resin##2##4##(2008-10#2)
sorbed onto the##3##3##(2008-10#3)
sorbed onto##8##2##(2008-10#8)
sorbed##30##1##(2008-10#30)
sorbent and##3##2##(2008-10#3)
sorbent column##2##2##(2008-10#2)
sorbent extraction preconcentration system##2##4##(2008-10#2)
sorbent extraction preconcentration##4##3##(2008-10#4)
sorbent extraction##8##2##(2008-10#8)
sorbent for the##2##3##(2008-10#2)
sorbent for##9##2##(2008-10#9)
sorbent has been developed for##2##5##(2008-10#2)
sorbent has been developed##4##4##(2008-10#4)
sorbent has##5##2##(2008-10#5)
sorbent is##2##2##(2008-10#2)
sorbent material##3##2##(2008-10#3)
sorbent phase##2##2##(2008-10#2)
sorbent tube for##2##3##(2008-10#2)
sorbent was##8##2##(2008-10#8)
sorbent with##2##2##(2008-10#1)(2009-8#1)
sorbent##95##1##(1997-2#1)(2008-10#93)(2009-8#1)
sorbents for##5##2##(2008-10#5)
sorbents##16##1##(2008-10#16)
sorbic acid##10##2##(1996-5#1)(2008-10#6)(2011-2#3)
sorbic##11##1##(1996-5#1)(2008-10#6)(2011-2#4)
sorbing solids##5##2##(2008-10#5)
sorbing##8##1##(2008-10#7)(2008-11#1)
sorbinil##5##1##(1994-8#5)
sorbitan##2##1##(2008-5#1)(2009-11#1)
sorbitol and##5##2##(1996-2#1)(2008-12#1)(2008-6#2)(2011-1#1)
sorbitol dehydrogenase (SDH)##2##3##(1996-12#1)(2008-11#1)
sorbitol dehydrogenase##6##2##(1996-12#1)(1996-2#3)(2008-11#1)(2008-8#1)
sorbitol or##2##2##(1994-8#1)(2008-11#1)
sorbitol were##2##2##(2008-6#1)(2008-8#1)
sorbitol##21##1##(1994-8#1)(1996-12#1)(1996-2#5)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#5)(2008-8#2)(2011-1#1)(2012-7#1)
sore throat and##2##3##(1992-6#1)(2008-1#1)
sore throat##4##2##(1992-6#1)(1995-11#1)(1996-9#1)(2008-1#1)
sore##10##1##(1992-6#1)(1995-11#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2012-2#1)
sorghi and##2##2##(2008-10#2)
sorghi##14##1##(2008-10#14)
sorghum and millet##3##3##(2008-10#3)
sorghum and##4##2##(1995-8#1)(2008-10#3)
sorghum ergot##3##2##(2008-10#3)
sorghum mosaic virus##3##3##(2008-10#2)(2008-9#1)
sorghum pathogen##3##2##(2008-10#3)
sorghum was##2##2##(2008-10#2)
sorghum##44##1##(1995-8#1)(2008-10#35)(2008-9#4)(2009-10#4)
sorokiniana conidia on##2##3##(2008-10#2)
sorokiniana conidia##3##2##(2008-10#3)
sorokiniana on##2##2##(2008-10#2)
sorokiniana##25##1##(2008-10#25)
sorption and preconcentration for the off-line determination of##2##8##(2008-10#2)
sorption and recovery of##2##4##(2008-10#2)
sorption and##10##2##(2008-10#7)(2008-5#1)(2013-1#2)
sorption capacities##2##2##(2008-10#2)
sorption capacity of the impregnated resin##2##6##(2008-10#2)
sorption capacity of the##9##4##(2008-10#9)
sorption capacity of##14##3##(2008-10#14)
sorption capacity values##2##3##(2008-10#2)
sorption capacity was##2##3##(2008-10#2)
sorption capacity##29##2##(2008-10#29)
sorption characteristics##2##2##(2008-10#1)(2010-4#1)
sorption conditions##2##2##(2008-10#2)
sorption data##4##2##(2008-10#4)
sorption efficiency##2##2##(2008-10#2)
sorption equilibria##3##2##(2008-10#3)
sorption is##3##2##(2008-10#3)
sorption isotherms##7##2##(2008-10#1)(2008-6#3)(2010-4#3)
sorption kinetics##4##2##(2008-10#4)
sorption mechanism##3##2##(2008-10#3)
sorption of Hg(II)##2##3##(2008-10#2)
sorption of Pb(II)##2##3##(2008-10#2)
sorption of metal ions##2##4##(2008-10#2)
sorption of metal##3##3##(2008-10#3)
sorption of silver ions onto PUF##2##6##(2008-10#2)
sorption of silver##3##3##(2008-10#3)
sorption of the##5##3##(2008-10#4)(2008-2#1)
sorption of uranium(VI)##2##3##(2008-10#2)
sorption of##49##2##(2008-10#48)(2008-2#1)
sorption on a##6##3##(2008-10#6)
sorption on activated carbon##2##4##(2008-10#2)
sorption on octadecyl silica membrane disks modified with##2##8##(2008-10#2)
sorption on##12##2##(2008-10#12)
sorption onto##5##2##(2008-10#5)
sorption preconcentration##5##2##(2008-10#5)
sorption properties of##2##3##(2008-10#2)
sorption properties##4##2##(2008-10#4)
sorption rate##2##2##(2008-10#2)
sorption was##3##2##(2008-10#3)
sorption were##2##2##(2008-10#1)(2010-4#1)
sorption with##5##2##(2008-10#5)
sorption##210##1##(2008-10#192)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#5)(2010-3#1)(2010-4#6)(2013-1#2)
sorption-spectroscopic##3##1##(2008-10#3)
sorptive##6##1##(2008-10#6)
sorrow##4##1##(1993-11#1)(2009-9#3)
sort of##11##2##(1990-7#1)(1992-3#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#2)(2012-12#1)
sort##22##1##(1990-7#1)(1991-12#1)(1992-3#1)(1995-3#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)
sorted chromosomes##2##2##(2008-9#2)
sorted from##2##2##(2008-10#1)(2008-11#1)
sorted into the regulated##2##4##(1990-5#1)(1992-12#1)
sorted into##7##2##(1990-5#1)(1992-12#2)(2007-10#1)(2008-10#1)(2008-9#1)(2012-3#1)
sorted out##2##2##(1994-2#1)(2011-2#1)
sorted with##2##2##(1996-12#1)(2008-10#1)
sorted##24##1##(1990-5#2)(1992-11#1)(1992-12#2)(1994-2#1)(1996-12#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2011-2#2)(2012-3#1)
sorting and##9##2##(1995-11#1)(1996-9#1)(2008-7#2)(2008-8#2)(2008-9#2)(2012-3#1)
sorting by##2##2##(2010-6#1)(2012-3#1)
sorting defect##3##2##(1990-5#3)
sorting in##2##2##(1993-9#1)(2008-5#1)
sorting nexin AtSNX2b##2##3##(2009-10#2)
sorting of the##2##3##(1995-8#1)(2012-2#1)
sorting of##18##2##(1995-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#5)(2009-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
sorting out##2##2##(2008-7#2)
sorting system##2##2##(2008-8#1)(2008-9#1)
sorting the data##2##3##(1992-11#2)
sorting the##3##2##(1992-11#2)(2008-9#1)
sorting##80##1##(1990-5#4)(1992-11#2)(1992-6#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-6#3)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-8#1)
sorts of##3##2##(2007-12#1)(2010-9#1)(2012-12#1)
sorts the##2##2##(2007-12#1)(2008-10#1)
sorts##8##1##(1996-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-12#1)
sotalol##4##1##(1992-3#1)(1995-6#1)(2008-10#1)(2010-8#1)
sought by##3##2##(1994-8#1)(2008-7#1)(2009-6#1)
sought for##2##2##(2009-5#1)(2011-2#1)
sought from##3##2##(1992-2#1)(2007-12#1)(2012-12#1)
sought in##4##2##(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
sought medical advice for##3##4##(2007-7#3)
sought medical##4##2##(1994-9#1)(2007-7#3)
sought solutions to##2##3##(2011-2#1)(2012-2#1)
sought the##2##2##(1993-9#1)(2011-2#1)
sought to address##2##3##(2008-7#1)(2008-9#1)
sought to determine if##6##4##(1992-11#1)(1993-6#1)(1994-2#1)(2008-10#1)(2010-11#1)(2012-2#1)
sought to determine the##4##4##(1994-11#1)(2007-10#1)(2008-6#1)(2012-3#1)
sought to determine whether the##2##5##(1993-11#1)(2008-11#1)
sought to determine whether##6##4##(1991-2#1)(1993-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2010-2#1)
sought to determine##19##3##(1991-2#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#1)
sought to develop##3##3##(2008-12#1)(2013-1#2)
sought to evaluate the##4##4##(2007-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
sought to evaluate##5##3##(2007-10#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-3#1)
sought to examine the##3##4##(2007-11#1)(2009-10#1)(2012-2#1)
sought to examine##4##3##(2007-11#1)(2008-6#1)(2009-10#1)(2012-2#1)
sought to explore##3##3##(1993-12#1)(2008-11#1)(2010-10#1)
sought to identify##4##3##(2008-10#1)(2008-9#2)(2011-1#1)
sought to investigate##3##3##(2008-11#1)(2008-5#1)(2012-3#1)
sought to test the hypothesis that##2##6##(1994-6#1)(2008-7#1)
sought to##75##2##(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)
sought treatment at a##2##4##(2009-9#1)(2011-1#1)
sought##132##1##(1991-1#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#11)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#1)
soul##2##1##(2008-11#1)(2013-8#1)
sound and##7##2##(2008-10#1)(2008-11#1)(2008-3#3)(2008-9#1)(2012-3#1)
sound arguments##2##2##(2012-2#2)
sound can##2##2##(2008-11#1)(2012-2#1)
sound clinical##2##2##(2008-12#1)(2010-10#1)
sound condition##2##2##(2013-8#2)
sound condition)##2##2##(2013-8#2)
sound decisions##2##2##(1993-3#1)(2010-1#1)
sound evidence##4##2##(1993-12#2)(2010-12#1)(2010-5#1)
sound in##2##2##(2008-8#1)(2008-9#1)
sound intensity##5##2##(1994-8#1)(2008-8#1)(2008-9#3)
sound is##5##2##(2007-12#1)(2008-3#2)(2008-8#1)(2012-3#1)
sound localization##2##2##(2008-9#2)
sound of##2##2##(2008-2#1)(2010-2#1)
sound on fishes##2##3##(2010-8#2)
sound perception##2##2##(2008-9#2)
sound pressure##4##2##(1995-12#1)(2008-3#1)(2010-2#2)
sound production##2##2##(1992-2#1)(2007-12#1)
sound scientific##2##2##(2009-11#1)(2010-5#1)
sound source segregation##2##3##(2009-5#2)
sound source##3##2##(2008-2#1)(2009-5#2)
sound speed and##2##3##(2007-12#1)(2008-3#1)
sound speed measurements##2##3##(2007-12#1)(2008-3#1)
sound speed##8##2##(2007-12#2)(2008-2#4)(2008-3#2)
sound stimuli##2##2##(2008-9#1)(2012-2#1)
sound stress##4##2##(1992-3#4)
sound wave##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
sound when##2##2##(2007-12#1)(2008-9#1)
sound with##2##2##(2008-4#1)(2008-9#1)
sound##164##1##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#6)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-5#5)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#8)(2008-10#7)(2008-11#4)(2008-12#4)(2008-2#15)(2008-3#11)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#20)(2009-11#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#3)(2011-8#1)(2012-2#9)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#11)
sounded##5##1##(2008-3#3)(2009-10#2)
sounder##9##1##(1996-8#1)(2008-2#3)(2008-3#5)
sounding board##2##2##(1992-2#1)(2010-4#1)
sounding rocket##6##2##(2008-3#6)
sounding##21##1##(1992-2#1)(2008-2#3)(2008-3#15)(2008-8#1)(2010-4#1)
soundings##2##1##(2008-2#1)(2008-3#1)
soundness##2##1##(1991-6#1)(1993-3#1)
sounds by##2##2##(2008-11#2)
sounds in a##2##3##(1993-12#1)(2008-11#1)
sounds in##7##2##(1993-12#2)(1993-9#1)(2008-11#1)(2008-9#2)(2012-12#1)
sounds was##2##2##(1993-12#1)(2008-9#1)
sounds##35##1##(1993-12#7)(1993-9#1)(2006-10#1)(2008-11#5)(2008-4#2)(2008-9#7)(2009-2#1)(2009-9#2)(2010-2#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
sour orange##7##2##(2008-10#7)
sour##10##1##(2008-10#9)(2008-9#1)
source analysis##4##2##(1992-8#1)(2008-11#2)(2008-3#1)
source and a##8##3##(2007-11#1)(2008-10#6)(2008-2#1)
source and an##2##3##(2008-3#1)(2012-2#1)
source and culture##2##3##(2008-11#1)(2008-5#1)
source and detector##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2009-5#1)
source and is##2##3##(1993-6#1)(1996-1#1)
source and the##15##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#5)(2008-8#1)(2012-2#1)
source and##63##2##(1993-6#1)(1994-3#1)(1996-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#15)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
source are necessary##2##3##(2008-3#2)
source are##10##2##(2008-2#4)(2008-3#5)(2009-9#1)
source area##2##2##(1996-4#1)(2008-10#1)
source areas##2##2##(2008-10#2)
source at 3##2##3##(2007-12#1)(2008-2#1)
source at##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
source based on a##6##4##(2007-12#3)(2008-3#3)
source based on##11##3##(2007-11#3)(2007-12#5)(2008-3#3)
source based##12##2##(2007-11#3)(2007-12#5)(2008-10#1)(2008-3#3)
source by##6##2##(2007-11#1)(2008-10#3)(2008-6#1)(2011-2#1)
source can be##4##3##(2007-12#1)(2008-2#1)(2010-1#1)(2013-8#1)
source can##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)(2013-8#1)
source code##3##2##(1996-2#1)(2008-10#1)(2010-5#1)
source control##3##2##(2011-2#3)
source distance##2##2##(2008-2#2)
source during the##2##3##(2008-10#1)(2008-6#1)
source emitting##2##2##(2007-12#1)(2008-3#1)
source for a##5##3##(2007-11#1)(2008-11#1)(2008-3#2)(2010-2#1)
source for all##2##3##(1993-12#1)(2008-4#1)
source for coherent laser radar##2##5##(2007-12#2)
source for fungicidal preparations against##2##5##(2008-10#2)
source for optical##2##3##(2007-11#1)(2007-12#1)
source for the##13##3##(1991-12#1)(1994-8#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2013-1#1)
source for##78##2##(1991-11#1)(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-6#1)(2007-11#7)(2007-12#5)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#3)
source from##2##2##(2007-12#1)(2008-2#1)
source generated##2##2##(2007-12#1)(2008-3#1)
source habitats##2##2##(2008-8#1)(2010-6#1)
source has##2##2##(2007-11#1)(2008-8#1)
source having##2##2##(2007-12#1)(2008-3#1)
source in a##8##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
source in the##12##3##(1995-1#1)(1995-8#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-3#5)(2008-6#1)(2013-1#1)
source in##29##2##(1993-5#1)(1995-1#1)(1995-8#1)(1996-4#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#7)(2008-6#1)(2008-7#1)(2013-1#1)
source is a##2##3##(2007-12#1)(2008-3#1)
source is also##2##3##(2007-12#1)(2008-2#1)
source is located##2##3##(2008-3#2)
source is not##2##3##(2008-3#1)(2011-2#1)
source is used to##2##4##(2007-11#1)(2008-3#1)
source is used##3##3##(2007-11#1)(2008-3#2)
source is##38##2##(1994-11#1)(2007-11#5)(2007-12#5)(2008-10#4)(2008-2#4)(2008-3#17)(2011-2#1)(2012-3#1)
source located##2##2##(2008-3#2)
source may be##2##3##(2008-3#2)
source near##2##2##(2007-11#1)(2008-3#1)
source of C##2##3##(1990-3#1)(2010-3#1)
source of DNA##2##3##(1991-11#1)(1995-11#1)
source of MSCs for##2##4##(2009-10#1)(2012-12#1)
source of a##6##3##(1994-12#1)(2008-10#1)(2008-3#2)(2010-9#1)(2013-1#1)
source of advice on##2##4##(2007-12#1)(2011-1#1)
source of advice##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
source of animal protein consumed##2##5##(2013-7#2)
source of asbestos exposure##2##4##(1991-12#2)
source of carbon##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
source of cells for##2##4##(2008-9#1)(2013-1#1)
source of cells##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
source of data##2##3##(1995-2#1)(2008-4#1)
source of dietary##2##3##(2008-4#1)(2012-2#1)
source of drinking water##2##4##(2008-5#1)(2013-1#1)
source of error in##2##4##(2008-10#1)(2008-3#1)
source of error##4##3##(2008-10#2)(2008-3#2)
source of estrogens##2##3##(2012-2#1)(2013-1#1)
source of free##2##3##(2008-5#1)(2009-9#1)
source of functional##2##3##(2012-2#1)(2013-1#1)
source of funding##2##3##(1992-1#1)(2008-7#1)
source of gender differences in##2##5##(2008-12#2)
source of health##4##3##(2008-10#3)(2012-12#1)
source of infection##4##3##(1997-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
source of information##5##3##(1993-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
source of injury##2##3##(2008-12#2)
source of inoculum and##2##4##(2008-10#2)
source of inoculum for##3##4##(2008-10#3)
source of inoculum##8##3##(2008-10#8)
source of light##4##3##(1993-3#2)(2008-2#1)(2008-3#1)
source of many##2##3##(2008-4#2)
source of microbial##2##3##(2008-5#1)(2012-2#1)
source of morbidity##2##3##(2010-6#1)(2012-3#1)
source of new##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
source of noise##2##3##(2008-3#1)(2010-10#1)
source of nutrition##2##3##(1991-3#1)(2008-10#1)
source of organic carbon##2##4##(2008-10#2)
source of polyphenol oxidase##2##4##(2008-10#2)
source of primary inoculum##6##4##(2008-10#5)(2008-12#1)
source of primary##8##3##(2008-10#5)(2008-12#1)(2008-8#1)(2010-3#1)
source of progestin did not##2##5##(2008-12#2)
source of progestin##3##3##(2008-12#3)
source of protein##2##3##(1997-4#1)(2013-7#1)
source of recurrent##2##3##(1994-5#1)(2011-2#1)
source of resistance##6##3##(2008-10#6)
source of stem rust resistance in oat breeding##2##8##(2008-10#2)
source of stem##3##3##(2008-10#2)(2008-9#1)
source of superoxide##2##3##(1995-3#1)(2008-1#1)
source of the##21##3##(1991-12#1)(1991-2#1)(1995-1#1)(1995-11#2)(1996-4#1)(1996-5#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#1)
source of this factor##2##4##(1991-8#1)(2009-3#1)
source of this##7##3##(1991-8#1)(1991-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-3#1)
source of variation##2##3##(2008-10#2)
source of##357##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-8#3)(1993-1#1)(1993-2#2)(1993-3#3)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#9)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#73)(2008-11#13)(2008-12#17)(2008-2#5)(2008-3#14)(2008-4#12)(2008-5#10)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#15)(2013-7#5)(2013-8#5)
source on##2##2##(2008-12#1)(2008-3#1)
source or##4##2##(1995-2#1)(2008-10#1)(2008-6#1)(2010-11#1)
source phase##3##2##(2008-10#3)
source plant##4##2##(2008-10#4)
source plants 21##2##3##(2008-10#2)
source plants displaying##2##3##(2008-10#2)
source plants##12##2##(2008-10#12)
source population##4##2##(2008-10#3)(2013-1#1)
source populations in##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
source produces##2##2##(2008-3#2)
source reduction and##2##3##(2008-12#1)(2013-8#1)
source reduction##3##2##(2008-12#2)(2013-8#1)
source size is##2##3##(2008-3#2)
source size##5##2##(2008-2#3)(2008-3#2)
source software##2##2##(2010-2#1)(2011-1#1)
source spectra##2##2##(2007-11#2)
source strength##2##2##(2008-10#1)(2008-2#1)
source such as##2##3##(2008-1#1)(2008-2#1)
source such##3##2##(2008-1#1)(2008-2#2)
source terms##2##2##(2008-3#2)
source that is##2##3##(1994-11#1)(2008-3#1)
source that was##3##3##(2008-3#3)
source that##9##2##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#6)
source through##2##2##(2007-11#1)(2008-3#1)
source tissue##3##2##(1991-8#1)(2008-10#2)
source to the##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
source to##17##2##(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
source used was##2##3##(2008-10#1)(2008-3#1)
source used##5##2##(1995-9#1)(2007-4#1)(2008-10#1)(2008-3#2)
source was a##4##3##(2007-12#2)(2008-3#1)(2008-5#1)
source was investigated##2##3##(2008-10#1)(2008-6#1)
source was used##4##3##(2008-3#1)(2010-4#1)(2011-3#2)
source was##23##2##(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#2)(2011-2#2)(2011-3#2)(2013-1#1)
source wavelength##2##2##(2008-2#1)(2011-7#1)
source were compared##2##3##(2008-3#2)
source were##7##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)
source which##2##2##(2008-10#1)(2012-2#1)
source with a##4##3##(2007-12#1)(2008-3#3)
source with##11##2##(2007-11#2)(2007-12#2)(2008-12#1)(2008-3#5)(2012-12#1)
source##1244##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#4)(1993-1#1)(1993-12#3)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#7)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#2)(1996-1#2)(1996-2#2)(1996-3#3)(1996-4#5)(1996-5#2)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#2)(1997-7#1)(2006-10#1)(2006-4#1)(2007-10#3)(2007-11#60)(2007-12#82)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#9)(2008-10#268)(2008-11#33)(2008-12#26)(2008-2#81)(2008-3#209)(2008-4#16)(2008-5#21)(2008-6#28)(2008-7#20)(2008-8#15)(2008-9#14)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#1)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#5)(2010-4#6)(2010-5#7)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#16)(2011-2#28)(2011-3#3)(2011-7#1)(2012-1#4)(2012-12#9)(2012-2#18)(2012-3#13)(2012-9#1)(2013-1#26)(2013-7#6)(2013-8#12)
source)##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
source-detector configurations##2##2##(2008-3#2)
source-detector distance##2##2##(2008-2#1)(2008-3#1)
source-detector distances##2##2##(2008-2#1)(2008-3#1)
source-detector separation##3##2##(2008-3#3)
source-detector separations and##2##3##(2007-12#1)(2008-3#1)
source-detector separations##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
source-detector##16##1##(2007-12#2)(2008-2#3)(2008-3#10)(2011-1#1)
source-sink dynamics##4##2##(2008-8#4)
source-sink##11##1##(2008-8#9)(2008-9#2)
sourced##2##1##(2008-11#1)(2008-8#1)
sources (e##4##2##(2008-10#1)(2008-4#2)(2008-5#1)
sources and detectors##2##3##(2008-3#2)
sources and is##2##3##(1992-6#1)(2008-11#1)
sources and methods##2##3##(1991-2#1)(2013-1#1)
sources and sinks##4##3##(2008-11#2)(2008-8#1)(2008-9#1)
sources and##49##2##(1991-2#1)(1992-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(2007-10#1)(2007-12#4)(2007-2#1)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#8)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
sources are used##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
sources are##27##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)
sources as##4##2##(1996-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
sources at##6##2##(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)
sources based on##2##3##(2007-12#1)(2012-2#1)
sources by##2##2##(2008-2#2)
sources can be##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
sources can##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
sources for biomedical##2##3##(1993-3#1)(2010-1#1)
sources for the production of bioplastics by##2##7##(2008-6#2)
sources for the##5##3##(2008-4#1)(2008-6#3)(2008-9#1)
sources for##32##2##(1993-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-9#4)(2009-10#1)(2009-3#1)(2010-1#1)(2010-6#1)(2013-1#1)
sources from##4##2##(1990-11#1)(1997-6#1)(2008-10#1)(2010-1#1)
sources has##3##2##(1996-2#1)(2006-4#1)(2012-12#1)
sources have been##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
sources have##8##2##(1992-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
sources in the##15##3##(1991-9#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-9#1)(2011-7#1)(2012-3#1)
sources in##26##2##(1991-9#1)(1992-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#1)(2009-9#1)(2010-10#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
sources include##3##2##(2007-5#1)(2008-9#1)(2012-2#1)
sources included##2##2##(1997-3#1)(2008-12#1)
sources including##6##2##(1995-3#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)
sources is presented##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
sources is##8##2##(1991-12#1)(2007-12#2)(2008-10#1)(2008-3#3)(2012-12#1)
sources like##2##2##(2008-2#1)(2008-6#1)
sources located##3##2##(2007-12#1)(2008-3#2)
sources of a##2##3##(2008-11#1)(2011-1#1)
sources of bias##3##3##(1992-6#1)(2008-10#2)
sources of contamination##3##3##(1994-3#1)(2008-10#1)(2012-2#1)
sources of data##4##3##(2008-1#2)(2008-7#1)(2011-3#1)
sources of dietary##2##3##(2011-2#1)(2012-2#1)
sources of diverted##2##3##(2012-1#2)
sources of error in the##2##5##(2008-2#1)(2008-3#1)
sources of error##5##3##(2008-2#2)(2008-3#3)
sources of errors##2##3##(2008-10#1)(2008-3#1)
sources of funding##7##3##(1993-2#2)(1994-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
sources of health information##2##4##(2012-3#1)(2013-7#1)
sources of health##3##3##(2012-3#2)(2013-7#1)
sources of heterogeneity##2##3##(2008-12#1)(2008-8#1)
sources of infection##4##3##(2008-10#1)(2008-7#1)(2012-3#2)
sources of information about##2##4##(1996-11#1)(2008-1#1)
sources of information are##2##4##(1995-12#1)(2011-2#1)
sources of information available##2##4##(1995-3#1)(2008-11#1)
sources of information##11##3##(1990-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(2008-1#1)(2008-11#2)(2009-7#1)(2011-2#1)
sources of inoculum and##2##4##(2008-10#2)
sources of inoculum for##3##4##(2008-10#3)
sources of inoculum##11##3##(2008-10#11)
sources of input##2##3##(1991-3#1)(2008-9#1)
sources of leaf rust resistance##2##5##(2008-10#2)
sources of measurement error##2##4##(2008-3#2)
sources of noise##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
sources of nutrition##2##3##(1991-3#2)
sources of perceived##2##3##(2010-1#2)
sources of pollution##2##3##(2007-5#2)
sources of potential##2##3##(2008-12#1)(2011-2#1)
sources of resistance and##2##4##(2008-10#2)
sources of resistance to##3##4##(2008-10#3)
sources of resistance##8##3##(2008-10#7)(2011-2#1)
sources of support##3##3##(2009-7#1)(2010-1#1)(2010-10#1)
sources of systematic##2##3##(2008-3#2)
sources of the##5##3##(1990-5#1)(1990-8#1)(1992-3#1)(2008-10#1)(2008-3#1)
sources of uncertainty##3##3##(2008-10#1)(2008-3#2)
sources of variability##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
sources of variation##3##3##(1992-6#1)(2008-10#1)(2011-2#1)
sources of##227##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#4)(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#3)(1993-12#1)(1993-2#3)(1993-6#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-5#4)(2008-1#3)(2008-10#48)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#17)(2008-4#3)(2008-5#9)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#3)(2012-1#4)(2012-12#3)(2012-2#8)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#1)
sources on the##2##3##(2008-10#1)(2012-3#1)
sources on##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
sources previously##2##2##(2008-10#2)
sources such as##6##3##(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#2)(2008-3#1)
sources that##4##2##(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
sources to identify##2##3##(2010-11#1)(2011-8#1)
sources to the##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
sources to##14##2##(1991-3#1)(1992-1#1)(1995-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-10#1)(2010-11#1)(2011-2#2)(2011-8#1)(2012-1#1)
sources used to##2##3##(1991-2#1)(2010-11#1)
sources used##4##2##(1991-2#1)(2008-3#1)(2010-11#1)(2012-12#1)
sources was##4##2##(2008-10#3)(2013-1#1)
sources were determined##3##3##(2008-10#2)(2008-8#1)
sources were used##4##3##(1995-1#1)(1996-2#1)(2013-1#2)
sources were##15##2##(1992-1#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-2#1)(2008-10#4)(2008-8#1)(2010-2#2)(2013-1#2)
sources when##2##2##(2008-10#1)(2008-2#1)
sources which are##2##3##(1995-9#1)(2007-8#1)
sources which##3##2##(1992-1#1)(1995-9#1)(2007-8#1)
sources with##8##2##(1991-8#1)(1992-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
sources within the##2##3##(1996-2#1)(2008-10#1)
sources##750##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#7)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-3#8)(1992-5#2)(1992-6#7)(1993-12#2)(1993-2#6)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1995-1#5)(1995-12#3)(1995-2#3)(1995-3#7)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#4)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2006-4#4)(2007-10#2)(2007-11#11)(2007-12#28)(2007-2#4)(2007-5#8)(2007-8#5)(2008-1#6)(2008-10#142)(2008-11#29)(2008-12#8)(2008-2#32)(2008-3#89)(2008-4#14)(2008-5#19)(2008-6#7)(2008-7#16)(2008-8#11)(2008-9#20)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#4)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#21)(2011-3#4)(2011-7#2)(2011-8#1)(2012-1#6)(2012-12#12)(2012-2#15)(2012-3#14)(2013-1#17)(2013-7#3)(2013-8#3)
sources)##8##1##(1992-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2013-1#1)
sourcing##3##1##(2008-11#2)(2011-1#1)
soursop (guanábana)##3##2##(2012-12#3)
south India##7##2##(1992-11#1)(2007-7#2)(2007-8#1)(2008-3#1)(2010-10#1)(2012-2#1)
south Indian population##2##3##(2012-2#1)(2012-3#1)
south London##3##2##(1996-8#3)
south and##2##2##(1991-4#1)(2008-10#1)
south of the##5##3##(2008-10#3)(2009-5#1)(2012-2#1)
south of##17##2##(1990-12#2)(2008-10#9)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
south than in##2##3##(2008-10#2)
south to##3##2##(2008-10#2)(2008-9#1)
south zone##2##2##(2011-2#2)
south##56##1##(1990-12#2)(1991-11#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-3#2)(1995-9#1)(1996-8#3)(2007-1#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
south-eastern##4##1##(2008-8#2)(2010-8#1)(2013-1#1)
south-west##4##1##(1993-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
southeast Asia##2##2##(1994-9#1)(2008-6#1)
southeast of##2##2##(2008-12#1)(2012-2#1)
southeast##17##1##(1991-11#1)(1994-9#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
southeastern Brazil##4##2##(2008-5#1)(2008-6#3)
southeastern Spain##2##2##(2008-10#2)
southeastern United States##15##3##(1992-8#1)(1993-1#1)(1994-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2011-2#5)
southeastern state##2##2##(1996-12#1)(1996-2#1)
southeastern##34##1##(1992-8#1)(1993-1#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#4)(2009-4#1)(2011-2#7)(2013-8#1)
southern Africa##5##2##(2008-10#1)(2010-1#2)(2011-2#1)(2013-1#1)
southern Arizona##5##2##(2008-10#1)(2008-9#1)(2009-8#2)(2011-2#1)
southern California##10##2##(1996-4#2)(2008-10#5)(2011-2#1)(2012-1#2)
southern Californian soil##2##3##(2008-10#2)
southern Egypt##2##2##(1994-9#1)(2008-10#1)
southern Europe##3##2##(2010-1#1)(2011-2#2)
southern New Jersey##2##3##(1997-3#1)(2008-10#1)
southern New##3##2##(1997-3#1)(2008-10#2)
southern Somalia##4##2##(2011-2#4)
southern Spain##9##2##(2008-10#9)
southern Taiwan##4##2##(2008-10#1)(2010-8#1)(2013-8#2)
southern United States##2##3##(2008-10#1)(2008-11#1)
southern and northern##4##3##(2008-8#3)(2013-1#1)
southern and##8##2##(2008-10#3)(2008-11#1)(2008-8#3)(2013-1#1)
southern blight##4##2##(2008-10#4)
southern corn##2##2##(2008-10#2)
southern division meeting##8##3##(2008-11#8)
southern ocean islands##3##3##(2008-8#1)(2008-9#2)
southern##167##1##(1990-6#1)(1991-6#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#4)(1996-8#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-10#57)(2008-11#10)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#11)(2008-9#3)(2009-5#1)(2009-8#3)(2010-1#4)(2010-10#1)(2010-3#2)(2010-8#9)(2011-2#13)(2012-1#2)(2012-3#3)(2013-1#7)(2013-8#4)
southernmost##2##1##(2008-5#1)(2009-8#1)
southward##3##1##(2008-10#2)(2010-1#1)
southwest France##2##2##(2008-10#2)
southwest of##3##2##(2008-12#1)(2008-9#1)(2010-5#1)
southwest##16##1##(1997-6#2)(2007-5#1)(2008-10#8)(2008-12#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)
southwestern Ontario##3##2##(1996-12#1)(1997-3#1)(2008-10#1)
southwestern##19##1##(1990-8#3)(1992-7#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-10#8)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
souvent##4##1##(2011-2#3)(2013-1#1)
sow##2##1##(1990-9#1)(2013-8#1)
sowing and##3##2##(2008-10#2)(2008-12#1)
sowing date##9##2##(2008-10#9)
sowing distances##7##2##(2008-12#7)
sowing##28##1##(1992-3#1)(2008-10#14)(2008-12#13)
sowings##3##1##(2008-10#2)(2012-7#1)
sown with##3##2##(2008-10#1)(2008-12#2)
sown##6##1##(2008-10#4)(2008-12#2)
sows fed the##4##3##(2010-2#4)
sows fed##5##2##(2010-2#5)
sows were##6##2##(1990-3#2)(2010-2#4)
sows##21##1##(1990-3#2)(1991-11#1)(2008-8#3)(2010-2#15)
soxhlet extraction##3##2##(2008-10#3)
soy hydrolysate##4##2##(2008-11#4)
soy isoflavones##2##2##(2008-10#2)
soy protein##4##2##(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)
soy sauce and hot-pepper paste##2##5##(2010-4#2)
soy sauce and##3##3##(2008-10#1)(2010-4#2)
soy sauce##8##2##(1996-2#4)(2008-10#1)(2010-4#3)
soy##33##1##(1996-2#4)(1996-8#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-7#3)(2010-1#2)(2010-12#1)(2010-4#4)(2012-2#2)(2013-1#4)
soya bean##3##2##(1990-3#2)(2008-5#1)
soya beans##2##2##(2008-3#2)
soya biopeptide##3##2##(2008-5#3)
soya peptide##2##2##(2008-5#2)
soya##19##1##(1990-3#2)(1993-12#2)(1997-2#1)(2008-10#3)(2008-3#2)(2008-5#7)(2008-8#1)(2013-8#1)
soybean (Glycine max L##3##4##(1990-5#1)(1997-6#1)(2008-12#1)
soybean (Glycine max) plants##2##4##(2008-10#2)
soybean (Glycine max)##10##3##(1990-7#1)(1991-12#1)(2008-10#5)(2008-11#1)(2013-1#2)
soybean (Glycine##14##2##(1990-5#1)(1990-7#1)(1991-12#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-11#1)(2013-1#2)
soybean (diet##2##2##(2008-12#2)
soybean Bowman-Birk inhibitor##2##3##(1996-12#2)
soybean Sclerotinia stem rot (SSR)##2##5##(2008-10#2)
soybean after##3##2##(2008-10#2)(2013-1#1)
soybean agglutinin##4##2##(1995-11#4)
soybean and the##3##3##(2008-10#2)(2008-12#1)
soybean and##15##2##(2008-10#10)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)
soybean by##3##2##(2008-10#3)
soybean cultivar response to S##2##5##(2008-10#2)
soybean cultivar##3##2##(2008-10#3)
soybean cultivars##4##2##(2008-10#4)
soybean cvs##2##2##(2008-10#2)
soybean cyst nematode##2##3##(2008-10#2)
soybean dwarf##2##2##(2008-10#2)
soybean fields in##4##3##(2008-10#4)
soybean fields##7##2##(2008-10#7)
soybean genotypes carrying##2##3##(2008-10#2)
soybean genotypes##3##2##(2008-10#3)
soybean hull flour##4##3##(2012-2#4)
soybean hull##5##2##(2008-10#1)(2012-2#4)
soybean hypocotyls##4##2##(1997-6#3)(2008-10#1)
soybean is##3##2##(2008-10#2)(2011-2#1)
soybean leaves##2##2##(2008-10#2)
soybean oil##7##2##(2008-10#4)(2008-5#1)(2008-6#2)
soybean peroxygenase##2##2##(1990-12#2)
soybean plants in##2##3##(2008-10#2)
soybean plants were##2##3##(2008-10#2)
soybean plants##13##2##(2008-10#12)(2010-11#1)
soybean production##3##2##(2008-10#3)
soybean resulted in##2##3##(2008-10#2)
soybean resulted##3##2##(2008-10#2)(2008-12#1)
soybean roots##3##2##(2008-10#3)
soybean rust epidemics##2##3##(2008-10#2)
soybean rust##18##2##(2008-10#18)
soybean seed##3##2##(2008-10#3)
soybean seedlings##5##2##(2008-10#3)(2008-8#2)
soybean stem##5##2##(2008-10#5)
soybean stems and##3##3##(2008-10#1)(2011-2#2)
soybean stems##6##2##(2008-10#4)(2011-2#2)
soybean tissue##4##2##(2008-10#4)
soybean trypsin inhibitor##3##3##(1990-12#1)(1992-8#1)(1994-6#1)
soybean varieties##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
soybean variety##3##2##(2008-12#2)(2011-2#1)
soybean were##2##2##(2008-10#2)
soybean##268##1##(1990-12#4)(1990-2#1)(1990-5#3)(1990-7#1)(1991-12#2)(1992-8#3)(1994-6#1)(1995-11#4)(1995-3#1)(1995-8#2)(1996-12#2)(1997-6#6)(1997-7#1)(2007-11#1)(2008-10#170)(2008-11#4)(2008-12#13)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#6)(2009-10#1)(2010-10#2)(2010-11#2)(2010-3#1)(2011-10#1)(2011-2#13)(2012-2#12)(2013-1#5)
soybeans in##2##2##(2008-10#1)(2011-2#1)
soybeans##15##1##(2008-10#10)(2008-7#1)(2009-10#1)(2011-2#3)
sp##652##1##(1990-12#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#3)(1993-3#2)(1994-12#2)(1994-3#3)(1995-12#2)(1995-3#3)(1995-6#4)(1995-8#2)(1996-12#3)(1996-5#1)(1996-6#5)(1996-8#2)(1997-2#1)(1997-6#17)(2007-12#1)(2008-10#412)(2008-11#2)(2008-12#23)(2008-5#39)(2008-6#24)(2008-7#5)(2008-8#7)(2008-9#5)(2009-10#2)(2009-2#4)(2009-4#1)(2009-6#5)(2009-9#1)(2010-10#3)(2010-3#2)(2010-4#11)(2010-8#3)(2011-1#8)(2011-2#11)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#10)
sp3-hybridized##2##1##(2007-11#2)
spa therapy with Politzer##2##4##(2008-4#2)
spa therapy with##3##3##(2008-4#3)
spa therapy##5##2##(2008-4#5)
spa##7##1##(1992-11#1)(2008-4#5)(2008-7#1)
space acquisition##3##2##(2008-8#2)(2008-9#1)
space after##2##2##(1993-10#1)(2007-10#1)
space analysis##3##2##(2007-12#1)(2008-5#1)(2009-8#1)
space and are##3##3##(1994-3#2)(2008-2#1)
space and in##2##3##(1992-2#1)(2008-3#1)
space and the##5##3##(2008-1#1)(2008-3#1)(2008-7#1)(2013-8#2)
space and time##19##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-8#1)(2013-1#5)(2013-8#1)
space and##62##2##(1991-12#1)(1992-11#1)(1992-2#1)(1993-6#1)(1993-9#3)(1994-3#2)(1994-9#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-11#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-8#2)(2009-9#1)(2010-7#1)(2010-8#1)(2011-7#1)(2012-2#1)(2013-1#7)(2013-8#5)
space applications##2##2##(2008-2#1)(2008-3#1)
space are##6##2##(1993-10#1)(2007-12#2)(2008-11#1)(2008-3#2)
space as##3##2##(1991-12#1)(2008-7#1)(2013-8#1)
space at the##2##3##(1993-10#1)(2008-5#1)
space at##6##2##(1993-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#2)
space available##2##2##(2008-9#1)(2011-2#1)
space between the##5##3##(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
space between##7##2##(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
space by##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)
space can##3##2##(2007-11#1)(2008-11#1)(2013-1#1)
space code-division multiple access##2##4##(2008-2#2)
space code-division##3##2##(2008-2#3)
space environment##2##2##(2008-3#2)
space exploration##4##2##(2012-3#4)
space for the##3##3##(2008-2#1)(2008-8#1)(2010-8#1)
space for##8##2##(1991-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-8#1)
space from##2##2##(2009-8#2)
space group C2/c##3##3##(1996-2#3)
space group P&amp##6##3##(1996-2#4)(1997-7#2)
space group P2(1)/a##2##3##(1997-7#2)
space group P2(1)/c with a =##2##6##(1996-2#1)(2007-11#1)
space group P2(1)/c##8##3##(1996-2#6)(1997-7#1)(2007-11#1)
space group P2(1)/n with a =##2##6##(1997-7#2)
space group P2(1)/n##5##3##(1996-2#2)(1996-5#1)(1997-7#2)
space group P2(1)2(1)2(1) with a =##2##6##(1996-2#2)
space group P6(1)##3##3##(1992-8#1)(1995-2#1)(2008-9#1)
space group of##2##3##(2008-8#1)(2013-1#1)
space group##54##2##(1992-11#1)(1992-12#1)(1992-8#3)(1993-8#2)(1995-2#1)(1996-2#22)(1996-5#1)(1997-7#11)(2007-11#3)(2008-4#1)(2008-8#3)(2008-9#3)(2010-10#1)(2013-1#1)
space has been##2##3##(2007-11#1)(2008-10#1)
space in the##2##3##(1990-5#1)(2007-11#1)
space in##11##2##(1990-5#1)(1991-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2013-8#1)
space infrared##2##2##(2008-3#2)
space inside##2##2##(2007-11#1)(2008-11#1)
space into the##2##3##(2008-3#1)(2008-8#1)
space into##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
space is##16##2##(1991-2#1)(1992-11#1)(1994-12#1)(1997-3#1)(1997-6#1)(2007-11#4)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
space models##6##2##(2008-11#6)
space occupying lesion##3##3##(1993-12#1)(2011-2#1)(2012-2#1)
space of the##14##3##(1990-12#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#2)(2009-7#1)(2013-1#1)(2013-8#1)
space of##23##2##(1990-12#1)(1991-6#1)(1997-6#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
space offers an##2##3##(2008-4#1)(2008-9#1)
space or##3##2##(2008-3#1)(2008-6#1)(2012-3#1)
space other than##2##3##(2008-8#1)(2011-2#1)
space repellents##2##2##(2011-2#2)
space structure of##5##3##(2008-8#5)
space telescope##3##2##(2008-3#3)
space that##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
space the##2##2##(2008-2#1)(2008-9#1)
space to##9##2##(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2013-8#1)
space use of##2##3##(2008-8#1)(2008-9#1)
space use patterns##2##3##(2008-8#1)(2008-9#1)
space use##6##2##(2008-8#3)(2008-9#2)(2012-2#1)
space vehicle##3##2##(2007-11#1)(2008-2#2)
space was##7##2##(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-7#1)
space where##4##2##(1991-2#1)(2008-5#1)(2008-8#1)(2011-2#1)
space whose##2##2##(2009-6#1)(2011-2#1)
space with an##2##3##(1997-7#1)(2008-2#1)
space with##7##2##(1994-2#1)(1997-7#1)(2008-12#1)(2008-2#2)(2008-7#1)(2012-1#1)
space within##2##2##(2008-6#1)(2012-2#1)
space without##2##2##(2008-10#1)(2008-7#1)
space##591##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#5)(1991-2#9)(1991-6#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-10#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#5)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#22)(1996-4#3)(1996-5#3)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#8)(1997-7#14)(1997-8#1)(2007-10#3)(2007-11#26)(2007-12#20)(2008-1#10)(2008-10#27)(2008-11#24)(2008-12#6)(2008-2#26)(2008-3#58)(2008-4#9)(2008-5#10)(2008-6#11)(2008-7#22)(2008-8#46)(2008-9#31)(2009-10#5)(2009-11#5)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#5)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#16)(2011-7#1)(2012-1#4)(2012-12#1)(2012-2#11)(2012-3#17)(2013-1#16)(2013-7#1)(2013-8#13)
space)##5##1##(1996-12#1)(1996-5#1)(2007-11#1)(2012-12#2)
space-bandwidth product of the##2##4##(2008-2#2)
space-bandwidth product##6##2##(2008-2#2)(2008-3#4)
space-bandwidth##7##1##(2008-2#2)(2008-3#5)
space-based lidar##2##2##(2008-2#1)(2008-3#1)
space-based##10##1##(2007-12#1)(2008-2#3)(2008-3#6)
space-charge field##8##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
space-charge##13##1##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#1)(2012-2#2)
space-consuming##2##1##(1994-11#1)(2012-12#1)
space-dependent rate equation##3##3##(2008-3#3)
space-filling curve##2##2##(2008-6#2)
space-invariant and space-variant##3##3##(2008-3#3)
space-invariant##6##1##(2008-2#1)(2008-3#5)
space-occupying lesion##2##2##(2008-1#1)(2008-4#1)
space-occupying##8##1##(1991-3#1)(2006-7#2)(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)
space-time analogies##2##2##(2007-12#2)
space-time coupling caused##2##3##(2008-3#2)
space-time coupling##5##2##(2007-11#3)(2008-3#2)
space-time##18##1##(1996-4#1)(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#5)(2008-8#1)(2009-2#1)
space-variant operations##3##2##(2008-3#3)
space-variant optical##3##2##(2008-2#2)(2008-3#1)
space-variant subwavelength dielectric grating##2##4##(2007-11#2)
space-variant subwavelength dielectric##3##3##(2007-11#3)
space-variant subwavelength##4##2##(2007-11#3)(2007-12#1)
space-variant##27##1##(2007-11#10)(2007-12#6)(2008-2#5)(2008-3#6)
spaceborne lidar##3##2##(2008-3#3)
spaceborne sensors##2##2##(2008-3#2)
spaceborne##26##1##(2007-12#1)(2008-2#6)(2008-3#19)
spacecraft##11##1##(1991-8#1)(2008-2#1)(2008-3#8)(2012-3#1)
spaced polyps and##2##3##(2009-8#2)
spaced samples##2##2##(2008-3#2)
spaced##43##1##(1992-2#1)(2007-11#5)(2007-12#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#2)(2010-6#1)(2012-3#1)
spaceflight##9##1##(1991-2#2)(2008-3#1)(2009-7#3)(2012-3#3)
spacer and##3##2##(2008-10#2)(2010-6#1)
spacer arm##2##2##(1994-11#1)(2008-4#1)
spacer arm)##2##2##(1994-11#2)
spacer between##3##2##(1997-3#1)(2008-10#2)
spacer layer##3##2##(2008-3#1)(2009-11#2)
spacer length##3##2##(2008-5#1)(2013-1#2)
spacer of the##4##3##(2007-12#1)(2008-10#3)
spacer of##5##2##(2007-12#1)(2008-10#4)
spacer rDNA##2##2##(2008-10#2)
spacer region between the##2##4##(1991-6#1)(2008-10#1)
spacer region between##3##3##(1991-6#1)(2008-10#2)
spacer region of##4##3##(2008-10#4)
spacer region were##3##3##(2008-10#3)
spacer region##29##2##(1991-6#1)(2008-10#26)(2008-9#1)(2011-2#1)
spacer regions of##5##3##(2008-10#5)
spacer regions##7##2##(2008-10#7)
spacer sequence analysis and##2##4##(2008-9#1)(2010-10#1)
spacer sequence analysis##3##3##(2008-8#1)(2008-9#1)(2010-10#1)
spacer was##2##2##(2008-5#1)(2008-8#1)
spacer##172##1##(1990-7#1)(1991-6#1)(1993-12#1)(1994-11#3)(1995-8#3)(1996-1#3)(1996-2#3)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#122)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-8#3)(2008-9#3)(2009-11#2)(2010-10#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#3)
spacers in##2##2##(2008-10#1)(2008-6#1)
spacers##14##1##(1992-3#2)(2008-10#4)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2013-1#1)
spaces and the##3##3##(2008-8#1)(2009-7#1)(2012-3#1)
spaces and##6##2##(2008-10#3)(2008-8#1)(2009-7#1)(2012-3#1)
spaces between##3##2##(2007-5#1)(2008-5#2)
spaces for##2##2##(2009-5#1)(2012-12#1)
spaces from##2##2##(2008-11#1)(2009-5#1)
spaces in##2##2##(2008-5#1)(2008-7#1)
spaces of the##5##3##(1997-3#1)(2008-10#4)
spaces of##9##2##(1997-3#1)(2008-10#6)(2009-6#1)(2011-2#1)
spaces were##2##2##(2008-7#1)(2012-1#1)
spaces##69##1##(1993-12#2)(1993-2#1)(1995-11#1)(1997-3#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
spacing and##10##2##(1992-4#1)(1995-5#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-2#1)(2011-2#1)
spacing between the##5##3##(2007-11#1)(2008-3#4)
spacing between##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
spacing in the##2##3##(2010-8#1)(2012-2#1)
spacing in##3##2##(1992-3#1)(2010-8#1)(2012-2#1)
spacing increases##2##2##(2007-11#1)(2008-3#1)
spacing is##6##2##(1992-6#1)(2007-12#1)(2008-2#2)(2008-3#2)
spacing of all possible stopbands##2##5##(2008-3#2)
spacing of the##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
spacing of##19##2##(1995-2#1)(2007-12#2)(2008-2#4)(2008-3#11)(2008-9#1)
spacing on the##4##3##(2008-12#2)(2008-3#2)
spacing or##2##2##(1995-2#2)
spacing to##5##2##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
spacing##104##1##(1990-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1994-11#1)(1995-2#3)(1995-5#1)(1996-2#3)(1997-5#1)(2007-11#6)(2007-12#5)(2008-11#1)(2008-12#9)(2008-2#14)(2008-3#36)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
spacings between##2##2##(2008-2#2)
spacings of the##2##3##(2008-2#1)(2010-11#1)
spacings of##5##2##(1997-7#1)(2008-2#2)(2008-5#1)(2010-11#1)
spacings##10##1##(1992-8#1)(1997-7#1)(2008-2#4)(2008-3#2)(2008-5#1)(2010-11#1)
span and##7##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
span in##6##2##(1994-5#1)(1996-6#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-8#1)
span is##3##2##(1992-2#1)(1996-3#1)(2008-10#1)
span of the##9##3##(1991-12#1)(1991-5#1)(1993-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
span of##32##2##(1990-3#1)(1991-12#1)(1991-5#1)(1992-5#1)(1993-8#3)(1994-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#5)(2008-7#4)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
span the range of##2##4##(1996-2#1)(2008-10#1)
span the##11##2##(1991-9#1)(1993-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-7#1)(2012-3#1)
span##125##1##(1990-3#6)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-5#5)(1994-6#5)(1995-6#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#15)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#6)(2008-9#6)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
spanish##2##1##(2008-5#1)(2011-1#1)
spanned by##2##2##(1997-6#1)(2008-3#1)
spanned##7##1##(1992-11#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)
spanning a##2##2##(1990-5#1)(2008-3#1)
spanning approximately##2##2##(1996-8#1)(2008-10#1)
spanning from##5##2##(1992-3#1)(2008-11#1)(2008-3#1)(2010-4#1)(2013-1#1)
spanning more than##2##3##(1997-7#1)(2007-12#1)
spanning several##3##2##(1994-5#1)(2008-12#1)(2009-11#1)
spanning the##16##2##(1990-11#1)(1990-8#1)(1992-1#1)(1994-12#2)(1994-5#1)(1995-6#1)(1996-6#1)(1997-5#2)(2008-10#6)
spanning two##2##2##(2007-12#1)(2009-6#1)
spanning##63##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-5#3)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
spans about##2##2##(1991-5#1)(2008-5#1)
spans of##2##2##(2007-12#1)(2011-2#1)
spans the##4##2##(1991-5#2)(2008-12#1)(2008-5#1)
spans##28##1##(1991-5#3)(1993-12#2)(1993-2#1)(1993-3#2)(1994-11#1)(1996-6#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
spare the##3##2##(2007-11#1)(2008-10#1)(2012-3#1)
spare##7##1##(1991-4#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
spared from##2##2##(1992-3#1)(2013-1#1)
spared in##2##2##(1991-4#1)(2009-10#1)
spared##11##1##(1991-4#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2006-10#1)(2009-10#1)(2009-2#1)(2010-6#1)(2013-1#1)
spares##3##1##(2008-5#1)(2008-7#1)(2010-8#1)
sparfloxacin##4##1##(2007-7#2)(2008-7#2)
sparge##2##1##(2008-10#1)(2008-11#1)
sparged##2##1##(1994-3#1)(2008-6#1)
sparging##3##1##(1994-3#2)(2008-11#1)
sparing of brain##2##3##(2008-11#2)
sparing of##11##2##(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1996-5#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)
sparing surgery##3##2##(1990-12#1)(2009-4#1)(2011-1#1)
sparing the##5##2##(1990-6#1)(1993-12#1)(1994-2#1)(2007-8#1)(2012-3#1)
sparing treatment##2##2##(2008-6#1)(2012-3#1)
sparing##37##1##(1990-12#1)(1990-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-5#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-4#1)(2011-1#3)(2012-2#2)(2012-3#2)(2013-1#1)
sparingly soluble and insoluble Cr(VI) from##2##6##(2008-10#2)
sparingly soluble##5##2##(2008-10#5)
sparingly##7##1##(2008-10#7)
spark ablation vessel##3##3##(2008-10#3)
spark ablation##7##2##(2008-10#7)
spark source##3##2##(2008-10#3)
spark##16##1##(2008-1#2)(2008-10#14)
spark-ignition##2##1##(2008-2#2)
sparked an##2##2##(1995-1#1)(1997-1#1)
sparked##8##1##(1993-12#1)(1994-11#1)(1995-1#1)(1997-1#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
sparking##2##1##(2008-11#1)(2010-12#1)
sparkling wines##4##2##(2008-10#4)
sparkling##5##1##(2008-10#5)
sparks##6##1##(1996-3#1)(2008-1#4)(2009-10#1)
sparrows (Passer##3##2##(2008-5#3)
sparrows##9##1##(2008-5#5)(2008-8#2)(2008-9#2)
sparse data##2##2##(2008-5#1)(2012-2#1)
sparse in##2##2##(2013-1#1)(2013-7#1)
sparse matrix approximation method##2##4##(2008-3#2)
sparse matrix##3##2##(2008-3#3)
sparse##45##1##(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
sparse-data pages##2##2##(2008-3#2)
sparsely ionizing radiation##2##3##(2008-7#2)
sparsely ionizing##3##2##(2008-7#3)
sparsely##9##1##(1991-1#1)(1994-8#1)(2008-11#1)(2008-7#3)(2009-6#1)(2012-12#1)(2012-3#1)
sparseness of##2##2##(2008-10#1)(2008-11#1)
sparser##2##1##(2008-6#1)(2013-8#1)
sparsity##5##1##(1995-5#1)(2008-2#1)(2008-3#3)
spasm and##5##2##(1992-6#2)(2008-7#2)(2011-2#1)
spasm during##2##2##(2011-2#1)(2012-2#1)
spasm in the##2##3##(1991-9#1)(2007-8#1)
spasm in##4##2##(1991-9#1)(2007-8#1)(2008-7#2)
spasm##34##1##(1991-3#1)(1991-9#1)(1992-6#3)(1994-11#1)(2007-8#5)(2008-10#1)(2008-12#2)(2008-7#9)(2011-1#1)(2011-2#8)(2012-2#1)(2012-3#1)
spasmodic##5##1##(1991-8#1)(1996-2#3)(2008-2#1)
spasmolytic##3##1##(1990-12#2)(2011-2#1)
spasms and##4##2##(1991-3#1)(1992-5#1)(2009-11#1)(2011-2#1)
spasms##15##1##(1990-8#1)(1990-9#1)(1991-3#1)(1992-5#1)(2008-12#1)(2009-11#5)(2011-1#2)(2011-2#2)(2012-12#1)
spastic foot drop##2##3##(2009-11#2)
spastic paraparesis##6##2##(1991-11#1)(2007-10#1)(2008-7#1)(2012-12#3)
spastic##15##1##(1991-11#1)(1995-6#1)(1996-2#2)(1997-6#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-11#2)(2011-2#1)(2012-12#3)(2012-2#1)
spasticity and##2##2##(2009-9#1)(2011-2#1)
spasticity in##2##2##(2010-8#1)(2010-9#1)
spasticity##9##1##(2008-7#1)(2009-4#1)(2009-9#2)(2010-8#1)(2010-9#1)(2011-2#3)
spat##9##1##(1995-3#1)(2007-5#5)(2008-5#2)(2010-11#1)
spataceum##2##1##(2012-2#2)
spatial Fourier transform##2##3##(2008-2#2)
spatial abilities##2##2##(2008-11#2)
spatial ability##5##2##(1994-8#1)(2008-11#3)(2008-7#1)
spatial adaptation##3##2##(2013-8#3)
spatial aggregation##6##2##(2008-10#4)(2008-8#2)
spatial analysis by distance indices (SADIE)##3##6##(2008-10#3)
spatial analysis by distance indices##4##5##(2008-10#4)
spatial analysis##10##2##(2008-10#5)(2008-3#1)(2008-8#4)
spatial and angular correlations in beams of any state of spatial coherence##2##12##(2007-11#2)
spatial and angular##3##3##(2007-11#2)(2008-2#1)
spatial and contextual learning##2##4##(1993-12#2)
spatial and contextual##3##3##(1993-12#2)(2011-2#1)
spatial and spectral data##3##4##(2008-2#2)(2008-3#1)
spatial and spectral##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
spatial and temporal changes in##3##5##(2008-11#1)(2010-4#1)(2013-7#1)
spatial and temporal characteristics##3##4##(2007-12#1)(2008-8#2)
spatial and temporal distribution of##2##5##(2007-11#1)(2007-5#1)
spatial and temporal distribution##3##4##(2007-11#1)(2007-5#1)(2008-10#1)
spatial and temporal dynamics##2##4##(2008-9#1)(2009-8#1)
spatial and temporal patterns of the##2##6##(2008-7#2)
spatial and temporal patterns of##3##5##(2008-10#1)(2008-7#2)
spatial and temporal patterns##5##4##(2008-10#2)(2008-7#3)
spatial and temporal resolution in##2##5##(2008-11#1)(2011-2#1)
spatial and temporal resolution##8##4##(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
spatial and temporal scales##2##4##(2008-9#1)(2013-1#1)
spatial and temporal##59##3##(1996-6#1)(1997-2#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
spatial and the temporal##6##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
spatial and the##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
spatial and##93##2##(1992-10#1)(1993-12#3)(1993-5#1)(1994-2#2)(1994-8#1)(1996-6#1)(1997-2#1)(2007-11#5)(2007-12#7)(2007-5#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#10)(2008-3#11)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#3)
spatial architecture##2##2##(2008-8#2)
spatial arrangement of##9##3##(1993-8#1)(1994-9#1)(2008-10#2)(2008-3#2)(2013-1#1)(2013-7#2)
spatial arrangement##13##2##(1993-8#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-9#1)(2013-1#1)(2013-7#2)
spatial aspects of disease incidence data##2##6##(2008-10#2)
spatial assimilation##2##2##(2011-2#2)
spatial attention##6##2##(1994-3#1)(1995-5#2)(2008-4#2)(2010-5#1)
spatial autocorrelation##13##2##(2008-10#7)(2008-2#1)(2008-7#1)(2008-8#2)(2009-11#1)(2013-7#1)
spatial beam profile##5##3##(2007-12#1)(2008-3#4)
spatial beam##6##2##(2007-12#2)(2008-3#4)
spatial carrier##5##2##(2008-2#3)(2008-3#2)
spatial characteristics of##2##3##(2007-12#1)(2011-1#1)
spatial characteristics##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
spatial coherence and##6##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
spatial coherence in##2##3##(2008-2#1)(2008-3#1)
spatial coherence is not##2##4##(2007-12#2)
spatial coherence is##3##3##(2007-12#2)(2008-3#1)
spatial coherence of light influenced by turbulence##2##7##(2008-3#2)
spatial coherence of light##3##4##(2008-3#3)
spatial coherence of the##3##4##(2007-12#1)(2008-3#2)
spatial coherence of##9##3##(2007-12#1)(2008-2#3)(2008-3#5)
spatial coherence##34##2##(2007-11#6)(2007-12#7)(2008-2#6)(2008-3#15)
spatial component##2##2##(1993-5#1)(1995-5#1)
spatial configuration of##2##3##(2007-7#1)(2008-2#1)
spatial conformation of the##2##4##(2008-8#2)
spatial conformation##3##2##(2008-8#3)
spatial control##2##2##(2007-12#1)(2008-7#1)
spatial coordinate##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
spatial correlation##9##2##(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#3)
spatial correlations##4##2##(1994-8#3)(2008-3#1)
spatial correlator##2##2##(2008-3#2)
spatial covariance##2##2##(2008-8#2)
spatial data##4##2##(2008-10#1)(2008-8#1)(2009-9#2)
spatial delayed##3##2##(1991-2#1)(1993-3#1)(1994-8#1)
spatial dependence##7##2##(2007-11#1)(2008-10#4)(2008-3#1)(2009-7#1)
spatial dependence)##2##2##(2008-10#2)
spatial dependency##2##2##(2008-10#1)(2008-3#1)
spatial differences##2##2##(2007-5#1)(2008-5#1)
spatial dimensions##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
spatial directions##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
spatial dispersion##2##2##(2008-2#1)(2008-3#1)
spatial displacement##2##2##(2007-11#1)(2007-12#1)
spatial distribution and##2##3##(2008-10#1)(2008-8#1)
spatial distribution during##2##3##(2008-3#1)(2008-8#1)
spatial distribution in##2##3##(1991-6#1)(2008-2#1)
spatial distribution of the optical##2##5##(2007-12#1)(2008-2#1)
spatial distribution of the quantum dots##2##6##(1995-3#1)(2007-11#1)
spatial distribution of the##14##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#2)(2011-1#1)(2013-8#1)
spatial distribution of##48##3##(1990-7#1)(1994-9#1)(1995-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#6)(2008-5#2)(2008-8#5)(2009-10#4)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#3)(2013-8#1)
spatial distribution##72##2##(1990-7#2)(1991-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#12)(2008-11#2)(2008-2#7)(2008-3#10)(2008-5#3)(2008-8#10)(2009-10#5)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#4)(2013-8#2)
spatial distributions of##2##3##(2008-10#1)(2008-2#1)
spatial distributions##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
spatial dynamics of the##2##4##(2008-10#2)
spatial dynamics of##8##3##(1995-5#1)(2008-10#6)(2011-2#1)
spatial dynamics##11##2##(1995-5#1)(2008-10#6)(2008-8#2)(2009-2#1)(2011-2#1)
spatial expression of##3##3##(1995-3#1)(2008-10#1)(2012-2#1)
spatial expression##5##2##(1993-2#1)(1995-3#1)(1996-12#1)(2008-10#1)(2012-2#1)
spatial extent of##4##3##(1996-5#1)(2008-2#2)(2008-3#1)
spatial extent##7##2##(1996-5#1)(2007-5#2)(2008-2#3)(2008-3#1)
spatial filter##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
spatial filtering in##2##3##(2007-12#1)(2008-3#1)
spatial filtering is##2##3##(2008-2#2)
spatial filtering of##2##3##(2007-12#1)(2008-2#1)
spatial filtering##16##2##(2007-12#2)(2008-2#9)(2008-3#5)
spatial filters##2##2##(2008-2#1)(2008-3#1)
spatial frame##2##2##(2012-2#2)
spatial frequencies in##2##3##(2008-3#2)
spatial frequencies that##2##3##(2007-11#1)(2008-2#1)
spatial frequencies##19##2##(2007-11#2)(2007-12#2)(2008-2#6)(2008-3#7)(2008-7#1)(2011-1#1)
spatial frequency and the##2##4##(2008-3#2)
spatial frequency and##3##3##(2008-3#3)
spatial frequency of##6##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)
spatial frequency##20##2##(1994-8#1)(2007-12#1)(2008-2#7)(2008-3#7)(2008-8#2)(2009-10#2)
spatial gradients##3##2##(2007-5#1)(2008-10#1)(2009-7#1)
spatial heterodyne##4##2##(2007-11#2)(2013-8#2)
spatial heterogeneity in##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
spatial heterogeneity of##5##3##(1996-2#1)(2008-10#4)
spatial heterogeneity##15##2##(1996-2#1)(2008-10#6)(2008-3#2)(2008-8#4)(2008-9#2)
spatial hierarchy##6##2##(2008-10#6)
spatial hole burning is##2##4##(2008-3#2)
spatial hole burning##10##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)
spatial image of##2##3##(2008-3#2)
spatial image##5##2##(2008-3#4)(2008-6#1)
spatial imaging##2##2##(2007-11#2)
spatial information on##2##3##(2008-11#1)(2008-3#1)
spatial information##13##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-7#1)(2008-9#1)
spatial interactions##2##2##(2009-8#2)
spatial interpolation##2##2##(2007-5#1)(2008-3#1)
spatial issues##2##2##(2008-8#2)
spatial learning and memory##3##4##(1994-8#1)(2011-2#1)(2012-2#1)
spatial learning and##4##3##(1991-7#1)(1994-8#1)(2011-2#1)(2012-2#1)
spatial learning by##3##3##(1993-12#1)(1994-3#1)(2012-2#1)
spatial learning deficit##5##3##(1991-7#1)(1993-12#4)
spatial learning in the##3##4##(1993-12#1)(1994-8#1)(2008-9#1)
spatial learning in##6##3##(1993-12#1)(1993-3#1)(1994-8#1)(2008-9#3)
spatial learning##35##2##(1991-7#4)(1993-12#10)(1993-3#3)(1994-3#2)(1994-8#3)(1996-2#2)(1996-5#2)(2008-7#1)(2008-9#4)(2011-2#1)(2012-2#2)(2013-8#1)
spatial light modulator (SLM)##9##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
spatial light modulator for##2##4##(2008-3#2)
spatial light modulator in##2##4##(2007-12#1)(2008-2#1)
spatial light modulator that uses electroabsorption##2##6##(2008-2#2)
spatial light modulator that##3##4##(2008-2#2)(2008-3#1)
spatial light modulator##53##3##(2007-11#6)(2007-12#6)(2008-2#14)(2008-3#27)
spatial light modulators (SLM's)##3##4##(2008-2#2)(2008-3#1)
spatial light modulators##27##3##(2007-12#4)(2008-2#12)(2008-3#11)
spatial light##82##2##(2007-11#7)(2007-12#10)(2008-2#27)(2008-3#38)
spatial light-scattering##2##2##(2008-3#2)
spatial location##9##2##(1994-3#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-5#1)
spatial locations##2##2##(2009-8#1)(2009-9#1)
spatial mapping of##2##3##(2007-12#1)(2008-2#1)
spatial maps##2##2##(2008-3#1)(2011-2#1)
spatial memory deficits##3##3##(1997-2#2)(2013-1#1)
spatial memory function##3##3##(1993-12#3)
spatial memory task##2##3##(1993-5#1)(2008-7#1)
spatial memory tasks##2##3##(1993-12#1)(2011-2#1)
spatial memory##24##2##(1993-12#5)(1993-5#2)(1994-8#3)(1997-2#3)(2008-11#1)(2008-4#1)(2008-7#6)(2011-2#2)(2013-1#1)
spatial mismatch##5##2##(2009-9#4)(2012-12#1)
spatial mode##3##2##(2007-11#2)(2008-3#1)
spatial model##2##2##(2008-8#2)
spatial modelling##2##2##(2009-9#1)(2010-10#1)
spatial models##4##2##(2008-8#3)(2009-9#1)
spatial modes of lasers##2##4##(2008-3#2)
spatial modes##4##2##(2007-12#1)(2008-3#3)
spatial modulation##3##2##(2007-11#2)(2008-3#1)
spatial movements##2##2##(2009-8#2)
spatial navigation##3##2##(1993-12#1)(1994-3#1)(2008-11#1)
spatial nonuniformity##2##2##(2008-2#2)
spatial optical##3##2##(2007-11#2)(2007-12#1)
spatial or temporal##2##3##(2008-9#1)(2009-10#1)
spatial or##3##2##(1994-2#1)(2008-9#1)(2009-10#1)
spatial organisation##3##2##(2010-10#3)
spatial organization of##5##3##(1991-2#1)(2008-1#1)(2008-7#1)(2009-5#2)
spatial organization##7##2##(1991-2#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-5#2)
spatial pattern of disease##2##4##(2008-10#1)(2008-8#1)
spatial pattern of spore deposition##2##5##(2008-10#2)
spatial pattern of##16##3##(2008-10#13)(2008-8#3)
spatial pattern##29##2##(2008-10#18)(2008-11#1)(2008-8#10)
spatial patterns at##2##3##(2008-10#1)(2008-8#1)
spatial patterns of ACC##2##4##(2008-10#2)
spatial patterns of##17##3##(1996-12#1)(2007-12#1)(2008-10#13)(2008-2#1)(2008-3#1)
spatial patterns##28##2##(1996-12#1)(2007-12#2)(2008-10#16)(2008-2#1)(2008-3#1)(2008-8#5)(2008-9#1)(2011-2#1)
spatial performance##2##2##(1994-8#1)(2008-3#1)
spatial phase modulation##2##3##(2007-12#2)
spatial phase##10##2##(1991-12#1)(2007-11#1)(2007-12#3)(2008-3#5)
spatial point##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
spatial population structure##2##3##(2008-8#2)
spatial population##3##2##(2008-8#3)
spatial position##4##2##(1993-12#1)(2007-12#1)(2008-3#2)
spatial power##2##2##(2008-3#1)(2010-7#1)
spatial prediction##3##2##(2007-5#2)(2008-8#1)
spatial prior##2##2##(2011-1#2)
spatial problems##2##2##(1991-2#1)(2008-8#1)
spatial processes##3##2##(1993-5#1)(2008-10#1)(2008-8#1)
spatial processing##3##2##(1994-3#3)
spatial profile of##2##3##(2008-3#1)(2008-4#1)
spatial profile##4##2##(2008-2#2)(2008-3#1)(2008-4#1)
spatial profiles##4##2##(2007-12#3)(2008-2#1)
spatial quality##2##2##(2007-11#1)(2007-12#1)
spatial reasoning##2##2##(2008-11#2)
spatial recognition memory##2##3##(1992-10#1)(1994-3#1)
spatial recognition##4##2##(1992-10#3)(1994-3#1)
spatial redistribution of surface water##2##5##(2008-8#2)
spatial redistribution of##5##3##(1995-6#1)(1996-9#1)(2007-12#1)(2008-8#2)
spatial redistribution##6##2##(1995-6#1)(1996-9#1)(2007-12#1)(2008-8#3)
spatial reference memory##2##3##(1993-12#2)
spatial reference##3##2##(1993-12#2)(2012-3#1)
spatial region##2##2##(2008-3#1)(2008-8#1)
spatial relationship of##2##3##(2008-10#1)(2008-4#1)
spatial relationships among##3##3##(1996-5#1)(2007-5#1)(2008-9#1)
spatial relationships of##2##3##(1997-3#1)(2012-2#1)
spatial relationships##8##2##(1996-5#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-9#2)(2011-7#1)(2012-2#1)
spatial release from masking##2##4##(2009-5#2)
spatial representation##3##2##(1995-5#1)(2009-8#1)(2013-8#1)
spatial representations##2##2##(1995-12#1)(2009-8#1)
spatial resolution along the##2##4##(2007-12#1)(2008-7#1)
spatial resolution and##10##3##(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2012-12#1)(2012-2#1)
spatial resolution at##3##3##(2008-3#2)(2009-5#1)
spatial resolution better than##2##4##(2008-3#1)(2008-7#1)
spatial resolution for##2##3##(2008-10#1)(2008-3#1)
spatial resolution in optical diffusion tomography##2##6##(2008-3#2)
spatial resolution in##10##3##(2007-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2012-12#2)
spatial resolution is the##2##4##(2012-12#2)
spatial resolution is##6##3##(2007-12#2)(2008-2#1)(2008-7#1)(2012-12#2)
spatial resolution of 0##2##4##(2008-2#1)(2008-3#1)
spatial resolution of a##2##4##(2007-12#1)(2008-9#1)
spatial resolution of the##5##4##(2007-12#1)(2008-10#1)(2008-3#3)
spatial resolution of##25##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
spatial resolution that##3##3##(2008-10#2)(2008-3#1)
spatial resolution were##2##3##(2007-12#1)(2008-3#1)
spatial resolution with##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
spatial resolution##119##2##(1995-11#1)(2007-11#6)(2007-12#14)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#12)(2008-3#38)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#2)(2009-11#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#3)(2013-8#1)
spatial reversal##2##2##(1993-3#2)
spatial sampling##2##2##(2008-2#1)(2008-3#1)
spatial scale is essential##2##4##(2008-10#1)(2009-2#1)
spatial scale of the##2##4##(2008-8#2)
spatial scale of##5##3##(2008-2#1)(2008-8#4)
spatial scale##20##2##(2008-10#4)(2008-2#1)(2008-8#7)(2009-2#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#3)
spatial scale)##3##2##(2013-7#3)
spatial scales##29##2##(2007-11#1)(2008-10#7)(2008-3#2)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#3)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#2)
spatial segregation of the sexes may be##2##7##(2008-9#2)
spatial segregation of the sexes##3##5##(2008-9#3)
spatial segregation of##5##3##(2008-9#3)(2010-10#1)(2013-8#1)
spatial separation of the spectral components##2##6##(2007-11#1)(2007-12#1)
spatial separation of the##3##4##(2007-11#1)(2007-12#2)
spatial separation of##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
spatial separation##8##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2009-9#1)
spatial shaping of##2##3##(2007-11#1)(2008-2#1)
spatial shearing##2##2##(2007-11#2)
spatial signal##3##2##(2008-3#3)
spatial smoothing##2##2##(2009-7#2)
spatial solitary waves##2##3##(2007-12#2)
spatial soliton##7##2##(2007-11#5)(2007-12#2)
spatial solitons and##2##3##(2007-11#1)(2007-12#1)
spatial solitons are##2##3##(2007-12#2)
spatial solitons in bulk nematic liquid crystals##2##7##(2007-12#2)
spatial solitons in photorefractive##2##4##(2007-12#2)
spatial solitons in##10##3##(2007-11#2)(2007-12#8)
spatial solitons##24##2##(2007-11#7)(2007-12#16)(2008-3#1)
spatial spread of##6##3##(2008-10#5)(2011-3#1)
spatial spread##7##2##(2008-10#5)(2008-9#1)(2011-3#1)
spatial statistics of##4##3##(2008-10#1)(2008-3#3)
spatial statistics##8##2##(2008-10#1)(2008-3#3)(2008-8#3)(2013-1#1)
spatial structure and##2##3##(2008-10#1)(2008-11#1)
spatial structure of the##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
spatial structure of##11##3##(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#4)(2009-2#1)(2013-1#1)
spatial structure##20##2##(1990-5#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-8#8)(2009-2#2)(2013-1#1)
spatial structures##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)
spatial task##5##2##(1994-8#4)(1996-5#1)
spatial tasks##2##2##(1994-3#1)(2008-11#1)
spatial terms##2##2##(2009-7#2)
spatial transfer functions##2##3##(2008-2#2)
spatial trends##2##2##(2008-10#1)(2011-2#1)
spatial uniformity##4##2##(2007-12#1)(2008-3#3)
spatial variability of##2##3##(2008-2#2)
spatial variability##3##2##(2008-2#2)(2010-8#1)
spatial variance in fitness##2##4##(2008-8#2)
spatial variance##3##2##(2008-8#2)(2009-5#1)
spatial variation in habitat quality##2##5##(2008-8#2)
spatial variation in##8##3##(2008-8#4)(2010-8#2)(2012-3#1)(2013-7#1)
spatial variation of##4##3##(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
spatial variation##17##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#4)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
spatial variations##2##2##(2008-10#1)(2008-2#1)
spatial vector solitons##2##3##(2007-11#2)
spatial vector##3##2##(2007-11#3)
spatial water-maze##2##2##(1994-8#2)
spatial working memory task##3##4##(1994-8#3)
spatial working memory##8##3##(1992-11#1)(1993-12#1)(1994-8#4)(2008-11#2)
spatial working##9##2##(1992-11#1)(1993-12#1)(1994-8#4)(2008-11#3)
spatial##1391##1##(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#4)(1992-10#4)(1992-11#1)(1992-4#1)(1992-8#2)(1993-12#23)(1993-2#1)(1993-3#8)(1993-5#5)(1993-6#1)(1993-8#1)(1994-2#4)(1994-3#15)(1994-8#24)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#7)(1995-6#2)(1996-12#3)(1996-2#4)(1996-5#6)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#92)(2007-12#109)(2007-5#13)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#167)(2008-11#26)(2008-2#146)(2008-3#254)(2008-4#8)(2008-5#9)(2008-6#4)(2008-7#35)(2008-8#126)(2008-9#29)(2009-1#2)(2009-10#14)(2009-11#3)(2009-12#1)(2009-2#7)(2009-5#10)(2009-6#1)(2009-7#8)(2009-8#13)(2009-9#20)(2010-1#1)(2010-10#5)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#10)(2011-2#20)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#11)(2012-2#16)(2012-3#3)(2013-1#9)(2013-7#20)(2013-8#22)
spatial&quot##2##1##(1993-5#2)
spatial-filtering method##3##2##(2008-2#2)(2008-3#1)
spatial-filtering##8##1##(2008-2#5)(2008-3#3)
spatial-frequency##8##1##(2007-12#5)(2008-2#1)(2008-3#2)
spatial-response##2##1##(2008-3#2)
spatial-soliton##4##1##(2007-12#1)(2008-3#3)
spatial-spectral##2##1##(2007-12#2)
spatial-temporal converters##3##2##(2008-2#1)(2008-3#2)
spatially aggregated within##2##3##(2008-10#2)
spatially aggregated##4##2##(2008-10#4)
spatially and spectrally##2##3##(2007-12#1)(2008-2#1)
spatially and temporally regulated##5##4##(1994-2#1)(2009-3#2)(2009-8#1)(2011-2#1)
spatially and temporally##10##3##(1994-2#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-3#1)(2011-2#1)
spatially and##15##2##(1994-2#1)(1994-8#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-2#2)(2008-9#2)(2009-3#2)(2009-8#1)(2010-3#1)(2011-2#1)
spatially autocorrelated##2##2##(2008-10#1)(2008-8#1)
spatially characterized##2##2##(2008-5#2)
spatially coherent##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
spatially continuous##2##2##(2008-8#2)
spatially correlated##10##2##(2008-10#3)(2008-11#1)(2008-8#4)(2008-9#2)
spatially dependent##2##2##(2008-2#1)(2009-9#1)
spatially discrete##2##2##(2008-8#2)
spatially distant##2##2##(2010-3#1)(2012-2#1)
spatially distinct##2##2##(2007-12#2)
spatially distributed##3##2##(1995-11#1)(2007-12#1)(2008-3#1)
spatially encrypted signal##3##3##(2008-3#3)
spatially explicit models##4##3##(2008-8#1)(2008-9#3)
spatially explicit##13##2##(2008-10#2)(2008-8#6)(2008-9#4)(2013-8#1)
spatially filtered##2##2##(2008-3#2)
spatially heterogeneous##6##2##(2006-10#1)(2008-10#3)(2008-8#1)(2013-1#1)
spatially homogeneous##7##2##(2007-12#1)(2008-8#6)
spatially incoherent light##3##3##(2007-11#2)(2008-3#1)
spatially incoherent signals##2##3##(2008-3#2)
spatially incoherent source##2##3##(2007-12#2)
spatially incoherent sources##2##3##(2007-12#2)
spatially incoherent##17##2##(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#7)
spatially integrated##2##2##(2011-2#2)
spatially localized##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
spatially modulated##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2011-1#1)(2012-2#1)
spatially multiplexed##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
spatially nonoverlapping white##2##3##(2008-2#2)
spatially nonoverlapping##3##2##(2008-2#3)
spatially nonuniform nonlinear coefficients##2##4##(2007-11#2)
spatially nonuniform##3##2##(2007-11#2)(2008-2#1)
spatially organized##2##2##(1995-11#1)(2007-11#1)
spatially periodic##2##2##(2007-12#1)(2008-2#1)
spatially realistic metapopulation model##4##4##(2008-8#3)(2008-9#1)
spatially resolved diffuse reflectance##2##4##(2008-2#1)(2008-3#1)
spatially resolved measurements of the##3##5##(2007-12#1)(2008-3#2)
spatially resolved measurements##4##3##(2007-12#1)(2008-3#2)(2013-8#1)
spatially resolved probe##2##3##(2008-3#2)
spatially resolved reflectance##2##3##(2008-2#1)(2008-3#1)
spatially resolved##33##2##(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#15)(2008-5#1)(2012-2#1)(2013-8#1)
spatially restricted epileptiform activity##2##4##(1996-5#2)
spatially segregated##3##2##(2008-10#1)(2008-9#2)
spatially selective##3##2##(2007-11#1)(2008-3#2)
spatially separate##2##2##(1990-7#1)(2007-12#1)
spatially separated from##2##3##(2009-5#2)
spatially separated##9##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-5#2)(2009-9#1)(2012-2#1)
spatially structured##3##2##(2008-8#2)(2008-9#1)
spatially uniform##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2008-9#1)
spatially variable pest management##2##4##(2008-10#2)
spatially variable##5##2##(2008-10#2)(2008-8#2)(2009-8#1)
spatially varying##5##2##(2008-3#2)(2008-9#1)(2011-1#1)(2013-1#1)
spatially##267##1##(1990-7#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-2#1)(1996-5#2)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#19)(2007-12#26)(2007-5#3)(2008-10#29)(2008-11#3)(2008-2#28)(2008-3#46)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#40)(2008-9#14)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#1)(2010-3#2)(2010-4#2)(2011-1#2)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
spatially-resolved##2##1##(1997-6#1)(2008-10#1)
spatio-temporal organization##2##2##(1995-6#1)(2011-2#1)
spatio-temporal pattern##2##2##(2007-12#1)(2013-8#1)
spatio-temporal##18##1##(1992-12#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
spatiotemporal analysis of##2##3##(2008-10#1)(2008-3#1)
spatiotemporal data##2##2##(1995-5#1)(2009-9#1)
spatiotemporal digital holography##2##3##(2007-12#2)
spatiotemporal dynamics of##4##3##(2008-10#2)(2008-11#2)
spatiotemporal expression##2##2##(1996-12#1)(2008-7#1)
spatiotemporal maps##2##2##(2008-10#2)
spatiotemporal parameters##2##2##(2013-7#2)
spatiotemporal patterns of activity##2##4##(1990-5#1)(2009-8#1)
spatiotemporal patterns of##3##3##(1990-5#1)(2009-8#1)(2013-1#1)
spatiotemporal patterns##5##2##(1990-5#1)(1996-2#1)(2009-8#1)(2013-1#2)
spatiotemporal resolution##3##2##(1994-3#1)(2008-2#1)(2009-7#1)
spatiotemporal variation in##2##3##(2008-8#2)
spatiotemporal variation##3##2##(2008-8#3)
spatiotemporal##65##1##(1990-5#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#5)(2007-12#4)(2008-10#10)(2008-11#7)(2008-2#1)(2008-3#6)(2008-7#2)(2008-8#6)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#2)
spatiotemporally##2##1##(2007-11#1)(2008-5#1)
spatula##2##1##(2008-7#1)(2009-6#1)
spawn##2##1##(1994-9#1)(2008-8#1)
spawned##6##1##(1995-1#1)(1996-3#1)(2008-1#1)(2008-5#2)(2010-8#1)
spawners##3##1##(2008-8#2)(2010-8#1)
spawning and##3##2##(2008-12#1)(2010-8#2)
spawning habitat##2##2##(2010-8#2)
spawning number##3##2##(2010-8#3)
spawning of##3##2##(1991-8#1)(2008-11#1)(2008-12#1)
spawning period##2##2##(2010-8#1)(2013-7#1)
spawning rhythm##2##2##(2010-8#2)
spawning rhythms##2##2##(2010-8#2)
spawning season from##2##3##(2008-12#1)(2010-8#1)
spawning season##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
spawning with##2##2##(2010-8#2)
spawning##45##1##(1991-8#1)(2008-11#1)(2008-12#7)(2008-7#3)(2008-8#1)(2010-8#31)(2013-7#1)
spawnings##7##1##(2008-5#1)(2010-8#6)
speA gene##2##2##(1992-2#2)
speA##3##1##(1992-2#3)
speC gene##3##2##(1994-12#3)
speak English##2##2##(1996-2#1)(2008-4#1)
speak to##2##2##(1993-12#1)(2008-11#1)
speak##18##1##(1991-2#1)(1993-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
speaker from prosody##2##3##(2009-10#2)
speaker from##3##2##(2009-10#2)(2011-1#1)
speaker sounded##2##2##(2009-10#2)
speaker##22##1##(1993-9#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#6)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-8#3)
speaker's##4##1##(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#1)
speakers and##3##2##(2008-11#1)(2008-2#2)
speakers for the##2##3##(1995-12#1)(2007-11#1)
speakers of##3##2##(2008-2#1)(2013-8#2)
speakers to##3##2##(2008-2#3)
speakers who stammer##6##3##(2008-2#3)(2008-4#3)
speakers who stutter##5##3##(2008-2#5)
speakers who##12##2##(2008-2#8)(2008-4#4)
speakers##46##1##(1995-1#1)(1995-12#2)(1995-6#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#18)(2008-4#5)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
speakers'##3##1##(1995-1#1)(2011-1#1)(2013-8#1)
speaking the##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
speaking##29##1##(1991-6#1)(1992-2#1)(1996-5#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-5#1)(2008-7#2)(2009-11#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#3)
speaking)##2##1##(2010-12#1)(2012-12#1)
speaks for##2##2##(1991-6#1)(1993-1#1)
speaks##6##1##(1991-6#1)(1992-11#1)(1993-1#1)(2011-2#2)(2012-3#1)
special alignment##2##2##(2008-3#2)
special attention is given to##2##5##(2008-3#1)(2010-10#1)
special attention should be paid to##3##6##(1990-2#1)(1991-11#1)(2012-2#1)
special attention to the##5##4##(1993-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
special attention to##18##3##(1993-12#1)(1993-3#1)(1996-6#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
special attention was##2##3##(2007-11#1)(2009-5#1)
special attention##29##2##(1990-2#1)(1991-11#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
special care is##2##3##(2008-3#1)(2010-3#1)
special care nursery##2##3##(1993-3#2)
special care##9##2##(1993-3#2)(1994-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)
special case of the##4##4##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
special case of##12##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#1)
special case##21##2##(1992-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-8#8)(2008-9#1)(2012-3#1)
special cases of the##2##4##(2008-10#1)(2008-2#1)
special cases of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
special cases##12##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
special challenges##2##2##(1996-12#1)(2011-2#1)
special characteristics##2##2##(2008-11#1)(2008-6#1)
special circumstances##2##2##(2008-12#1)(2009-8#1)
special clinics##2##2##(1995-2#2)
special concern##2##2##(2008-11#1)(2011-1#1)
special conditions##2##2##(1996-2#1)(2008-11#1)
special consideration##7##2##(1990-6#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2013-8#1)
special considerations in Asia##2##4##(2012-3#2)
special considerations in##3##3##(2010-6#1)(2012-3#2)
special considerations##5##2##(2008-4#1)(2010-6#1)(2010-8#1)(2012-3#2)
special criteria##2##2##(1990-6#1)(2010-3#1)
special edition##2##2##(1997-1#1)(2008-12#1)
special education##6##2##(1993-1#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-12#1)(2011-2#1)
special emphasis on the##7##4##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
special emphasis on##28##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
special emphasis##31##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
special experiences##2##2##(2012-2#2)
special features of the##3##4##(2008-10#3)
special features of##5##3##(1994-3#1)(2008-10#3)(2008-12#1)
special features##7##2##(1991-1#1)(1994-3#1)(2008-10#4)(2008-12#1)
special focus on##5##3##(1990-6#1)(2008-4#1)(2009-7#1)(2011-2#2)
special focus##7##2##(1990-6#1)(1994-3#2)(2008-4#1)(2009-7#1)(2011-2#2)
special form##2##2##(2008-10#1)(2012-12#1)
special health care needs##17##4##(1991-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2008-11#1)(2010-11#2)(2011-1#1)
special health##20##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1996-12#1)(1997-2#2)(2008-11#1)(2010-11#2)(2011-1#1)
special importance in##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
special importance##4##2##(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
special indications##2##2##(1991-11#1)(2009-8#1)
special interest because of##3##4##(1997-3#1)(2011-2#2)
special interest because##4##3##(1997-3#1)(2011-2#3)
special interest for##5##3##(2007-11#1)(2008-10#1)(2011-2#3)
special interest groups##2##3##(1996-11#1)(1996-3#1)
special interest in##4##3##(2007-2#1)(2011-1#2)(2013-1#1)
special interest##24##2##(1990-6#1)(1990-9#1)(1991-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#8)(2013-1#1)
special issue of##4##3##(1994-3#1)(2009-8#1)(2009-9#1)(2013-8#1)
special issue on##2##3##(2008-8#1)(2013-1#1)
special issue##10##2##(1993-6#1)(1994-3#1)(2008-4#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
special issues##3##2##(2008-12#1)(2009-9#1)(2010-5#1)
special list health journals##3##4##(1991-12#3)
special measures##2##2##(1991-11#1)(1997-8#1)
special mention##2##2##(2008-8#1)(2013-1#1)
special needs and##5##3##(1991-3#1)(1996-3#1)(2008-5#1)(2012-3#2)
special needs of##4##3##(1997-2#1)(1997-8#1)(2012-12#1)(2013-1#1)
special needs##19##2##(1991-12#1)(1991-3#2)(1995-1#2)(1996-3#1)(1997-2#3)(1997-8#1)(2008-12#2)(2008-5#1)(2012-12#1)(2012-3#4)(2013-1#1)
special orthopedic##2##2##(2008-12#1)(2011-2#1)
special population##3##2##(1996-3#1)(2008-2#1)(2008-6#1)
special populations##4##2##(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)
special precautions##2##2##(1992-3#1)(2007-2#1)
special preparation##2##2##(1997-2#1)(2007-11#1)
special probe##2##2##(2008-9#2)
special problem##2##2##(1993-3#1)(1994-8#1)
special properties##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
special quadrature scheme##2##3##(2008-3#2)
special reactor##2##2##(2008-11#2)
special reagent##2##2##(2008-10#2)
special reference to##16##3##(1990-9#1)(1991-2#1)(1991-5#1)(1993-8#1)(1996-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
special regard to the##5##4##(1991-6#1)(1994-5#1)(2008-10#2)(2013-8#1)
special regard to##7##3##(1991-6#1)(1994-5#1)(2007-11#2)(2008-10#2)(2013-8#1)
special relativity effects##2##3##(2008-3#2)
special relativity##3##2##(2008-3#3)
special report##2##2##(1994-12#1)(2008-8#1)
special requirements##2##2##(2009-3#1)(2013-1#1)
special role##3##2##(1990-11#1)(1991-6#1)(2009-12#1)
special section of##2##3##(2008-7#1)(2011-2#1)
special section##5##2##(2008-7#1)(2011-2#2)(2012-2#2)
special situations##3##2##(2007-12#1)(2010-12#1)(2010-5#1)
special structure of the##2##4##(1992-6#1)(2012-3#1)
special structure##3##2##(1992-6#1)(2008-10#1)(2012-3#1)
special surgical##2##2##(1996-12#2)
special teachers##2##2##(1993-6#2)
special test##2##2##(2008-2#1)(2013-1#1)
special tests are##2##3##(2008-12#2)
special treatment##4##2##(1992-12#1)(1995-2#2)(2011-2#1)
special type##3##2##(1992-4#1)(2007-5#2)
special##522##1##(1990-11#3)(1990-2#3)(1990-5#1)(1990-6#6)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#6)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#4)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#5)(1995-12#8)(1995-2#8)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#6)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(2007-11#14)(2007-12#9)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#59)(2008-11#17)(2008-12#14)(2008-2#14)(2008-3#26)(2008-4#7)(2008-5#8)(2008-6#6)(2008-7#11)(2008-8#16)(2008-9#10)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#30)(2011-3#1)(2012-12#6)(2012-2#11)(2012-3#12)(2013-1#16)(2013-8#7)
special-needs children##2##2##(1994-3#2)
special-needs##3##1##(1994-3#3)
specialisation in##2##2##(1994-12#1)(1994-3#1)
specialisation##3##1##(1994-12#1)(1994-3#1)(1997-8#1)
specialised##14##1##(1992-9#1)(1993-11#2)(1994-9#1)(1995-5#1)(1995-9#1)(2007-12#1)(2007-2#2)(2008-11#2)(2009-3#1)(2011-2#1)(2011-3#1)
specialising in##2##2##(1991-11#1)(2008-1#1)
specialist and##3##2##(1996-11#1)(2008-8#1)(2009-8#1)
specialist center##4##2##(2008-3#4)
specialist centres##2##2##(1994-11#1)(2009-8#1)
specialist clinics##2##2##(1993-2#1)(1994-11#1)
specialist education in##2##3##(2010-10#2)
specialist education##5##2##(1992-11#1)(2010-10#4)
specialist health##2##2##(1993-6#2)
specialist in endocrinology##2##3##(2013-1#2)
specialist in##10##2##(1992-2#1)(1993-2#1)(1993-5#1)(1995-6#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-1#2)
specialist or##2##2##(1992-5#1)(2010-9#1)
specialist practice##2##2##(2008-11#2)
specialist services##2##2##(1991-6#1)(1993-12#1)
specialist to##2##2##(1993-12#2)
specialist training##4##2##(1991-3#1)(1992-9#1)(1993-2#1)(1993-6#1)
specialist##103##1##(1990-11#1)(1990-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-5#2)(1992-9#1)(1993-12#3)(1993-2#3)(1993-5#1)(1993-6#4)(1994-11#2)(1994-12#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-11#1)(1997-7#1)(1997-8#3)(2007-11#3)(2007-12#3)(2008-11#7)(2008-3#5)(2008-7#4)(2008-8#8)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
specialistic##2##1##(2007-11#2)
specialists and the##2##3##(2008-7#1)(2011-2#1)
specialists and##6##2##(1993-6#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
specialists can##2##2##(1992-12#1)(1997-1#1)
specialists in the##2##3##(2008-12#1)(2011-1#1)
specialists in##19##2##(1991-12#1)(1991-2#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
specialists is##2##2##(2008-7#1)(2012-12#1)
specialists should##2##2##(1993-2#1)(2013-1#1)
specialists to##6##2##(1993-2#1)(1996-2#1)(2007-8#1)(2008-5#1)(2011-1#1)(2012-3#1)
specialists##80##1##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-2#5)(1993-3#1)(1993-6#3)(1994-1#2)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-2#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#3)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
specialities##3##1##(2008-11#2)(2009-4#1)
speciality##5##1##(1990-2#1)(2008-11#1)(2008-2#1)(2009-10#1)(2012-2#1)
specialization (such as##2##3##(2008-8#2)
specialization and##9##2##(1993-6#1)(2008-10#1)(2008-8#7)
specialization in the##2##3##(1993-12#1)(2008-10#1)
specialization in##11##2##(1993-12#1)(1993-2#1)(2008-10#4)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#1)
specialization is##4##2##(1995-5#1)(2008-5#1)(2008-8#2)
specialization of the##2##3##(1996-12#1)(2008-10#1)
specialization of##7##2##(1996-12#1)(2008-10#1)(2008-8#3)(2008-9#1)(2012-3#1)
specialization within the##2##3##(2008-10#1)(2008-12#1)
specialization##75##1##(1991-9#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-12#2)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#25)(2008-9#7)(2009-10#1)(2012-2#4)(2012-3#2)(2013-7#1)
specializations in the##3##3##(2007-12#3)
specializations##10##1##(1995-6#1)(2007-12#4)(2008-7#1)(2008-9#3)(2009-10#1)
specialize in##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
specialize##6##1##(2007-11#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)
specialized and##4##2##(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#1)
specialized antigen-presenting cells##2##3##(2008-4#1)(2010-5#1)
specialized care##3##2##(1992-12#1)(1993-12#1)(2013-1#1)
specialized cells##2##2##(2008-4#1)(2009-5#1)
specialized centers##2##2##(2008-4#1)(2009-5#1)
specialized centres##3##2##(1992-6#2)(2007-11#1)
specialized chromatin##2##2##(1994-5#1)(1995-2#1)
specialized clinics##5##2##(1995-11#1)(2008-2#4)
specialized equipment##4##2##(2008-4#2)(2008-9#1)(2013-8#1)
specialized feeding##2##2##(2008-10#2)
specialized for##7##2##(2007-12#1)(2008-11#4)(2008-7#1)(2009-2#1)
specialized form##2##2##(2008-10#1)(2012-2#1)
specialized geriatric##2##2##(1990-5#1)(1991-2#1)
specialized health care##3##3##(1993-1#1)(2008-11#2)
specialized health##4##2##(1992-9#1)(1993-1#1)(2008-11#2)
specialized home care team##2##4##(1993-3#2)
specialized host races##2##3##(2008-9#2)
specialized in the##2##3##(1995-12#1)(2008-7#1)
specialized in##4##2##(1995-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
specialized infection##3##2##(2008-10#3)
specialized information##4##2##(1995-1#3)(1996-2#1)
specialized knowledge##3##2##(1991-12#1)(1993-12#1)(2008-11#1)
specialized laboratories##3##2##(2011-2#1)(2013-1#2)
specialized medicine##2##2##(1992-9#1)(1997-3#1)
specialized metabolism##2##2##(2011-2#2)
specialized metabolites##3##2##(2011-2#3)
specialized nature##2##2##(2008-1#1)(2008-4#1)
specialized on different##2##3##(2008-10#1)(2008-8#1)
specialized on##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
specialized psychiatric##2##2##(2008-2#2)
specialized retinal##3##2##(1990-3#1)(2008-5#1)(2011-2#1)
specialized services for##2##3##(1996-1#1)(1997-1#1)
specialized services##11##2##(1993-2#2)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#2)(2008-7#1)(2008-9#1)
specialized structures##3##2##(1990-5#1)(2008-11#2)
specialized tests##2##2##(2008-12#1)(2013-1#1)
specialized to##4##2##(2008-10#3)(2013-1#1)
specialized training##3##2##(1994-12#1)(1996-11#1)(2010-8#1)
specialized units##4##2##(1994-8#2)(1995-11#1)(2008-11#1)
specialized##204##1##(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-6#2)(1992-9#3)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#4)(1996-11#1)(1996-2#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#15)(2008-11#15)(2008-12#1)(2008-2#9)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#13)(2009-10#2)(2009-2#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#2)
specializing in##3##2##(1992-8#1)(1996-1#1)(2008-12#1)
specializing on the##2##3##(2008-9#2)
specializing on##3##2##(2008-8#1)(2008-9#2)
specializing##8##1##(1992-8#1)(1996-1#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
specially adapted##3##2##(2008-10#1)(2008-3#1)(2010-2#1)
specially designed for##2##3##(2008-10#1)(2008-5#1)
specially designed to##2##3##(2008-10#1)(2008-5#1)
specially designed##33##2##(1993-2#1)(1994-12#1)(1995-8#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)
specially developed##2##2##(2007-10#1)(2008-3#1)
specially in##3##2##(1991-9#1)(2008-11#1)(2008-4#1)
specially modified##2##2##(1997-6#1)(2008-5#1)
specially on##2##2##(2007-11#1)(2008-12#1)
specially prepared##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
specially suited for##2##3##(2007-12#1)(2008-11#1)
specially##80##1##(1990-8#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#5)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#8)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)
specialties and subspecialties##2##3##(1991-6#1)(1995-1#1)
specialties and##12##2##(1991-11#2)(1991-6#1)(1992-4#2)(1993-6#1)(1994-1#2)(1995-1#1)(1995-3#1)(2013-1#2)
specialties##43##1##(1991-11#2)(1991-6#5)(1992-11#1)(1992-12#2)(1992-4#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#3)(1995-1#1)(1995-3#1)(1996-1#2)(1996-7#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
specialty and##5##2##(1993-6#2)(1994-12#1)(2006-10#1)(2010-12#1)
specialty boards##5##2##(1994-12#1)(2008-4#4)
specialty care##3##2##(1997-1#1)(1997-2#1)(2008-9#1)
specialty choices##2##2##(2007-4#2)
specialty group##2##2##(1993-1#1)(1994-12#1)
specialty health##2##2##(1993-2#1)(1994-3#1)
specialty in##3##2##(1997-8#1)(2008-9#1)(2012-2#1)
specialty ingredients##2##2##(2010-7#2)
specialty of##2##2##(1995-9#2)
specialty physician##4##2##(1994-1#2)(1997-1#1)(2009-9#1)
specialty physicians in##2##3##(1994-12#1)(1997-1#1)
specialty services##2##2##(1991-2#1)(1994-3#1)
specialty that##2##2##(2007-12#1)(2010-8#1)
specialty##89##1##(1991-2#1)(1991-6#4)(1992-11#1)(1992-3#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#6)(1994-12#5)(1994-3#4)(1995-12#1)(1995-3#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-4#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#10)(2008-6#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
speciated and##2##2##(2008-6#1)(2008-7#1)
speciated simultaneously##2##2##(2008-10#2)
speciated##8##1##(1996-4#1)(2008-10#4)(2008-6#1)(2008-7#2)
speciation analysis by##2##3##(2008-10#1)(2009-6#1)
speciation analysis in##4##3##(2008-10#4)
speciation analysis is##2##3##(2008-10#2)
speciation analysis of iron in##2##5##(2008-10#2)
speciation analysis of this element##2##5##(2008-10#2)
speciation analysis of##10##3##(2008-10#8)(2009-6#1)(2010-11#1)
speciation analysis##25##2##(2008-10#22)(2009-6#2)(2010-11#1)
speciation and determination##3##3##(2008-10#3)
speciation and preconcentration##2##3##(2008-10#2)
speciation and##14##2##(2008-10#11)(2008-9#1)(2010-3#1)(2013-7#1)
speciation approaches##2##2##(2008-10#2)
speciation are##2##2##(2008-10#1)(2008-8#1)
speciation as a function of##2##5##(2008-10#2)
speciation based on##2##3##(2008-10#1)(2010-3#1)
speciation by##9##2##(2008-10#8)(2008-9#1)
speciation calculations##2##2##(2008-10#2)
speciation continuum##2##2##(2013-1#2)
speciation events##2##2##(2008-8#2)
speciation for##2##2##(1996-6#1)(2008-10#1)
speciation in angiosperms##2##3##(2009-2#2)
speciation in aqueous solutions##2##4##(2008-10#2)
speciation in environmental samples##4##4##(2008-10#4)
speciation in environmental##6##3##(2008-10#6)
speciation in phylogenesis##2##3##(2010-3#2)
speciation in water by##2##4##(2008-10#2)
speciation in water##3##3##(2008-10#3)
speciation in##35##2##(1996-6#2)(2008-10#29)(2009-2#2)(2010-3#2)
speciation is##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
speciation measurements##2##2##(2008-10#2)
speciation method##4##2##(2008-10#4)
speciation methods##2##2##(2008-10#2)
speciation models##2##2##(1996-6#1)(2008-10#1)
speciation of As(III) and As(V)##3##5##(2008-10#3)
speciation of Cr(VI)##2##3##(2008-10#2)
speciation of Fe(II) and Fe(III)##2##5##(2008-10#2)
speciation of arsenic in environmental and biological samples##2##8##(2008-10#2)
speciation of arsenic in##7##4##(2008-10#7)
speciation of arsenic##14##3##(2008-10#14)
speciation of chromium in##7##4##(2008-10#7)
speciation of chromium##13##3##(2008-10#13)
speciation of different forms using##2##5##(2008-10#2)
speciation of inorganic##7##3##(2008-10#7)
speciation of iron##2##3##(2008-10#2)
speciation of mercury##2##3##(2008-10#2)
speciation of selenium in##2##4##(2008-10#2)
speciation of selenium##3##3##(2008-10#3)
speciation of the##2##3##(2008-10#2)
speciation of this group##2##4##(2008-10#1)(2008-9#1)
speciation of##95##2##(2008-10#93)(2008-9#2)
speciation on##3##2##(1996-6#1)(2008-10#1)(2010-5#1)
speciation or##2##2##(2008-10#1)(2008-8#1)
speciation scheme##2##2##(2008-10#2)
speciation studies##4##2##(2008-10#4)
speciation study in##2##3##(2008-10#2)
speciation study of##2##3##(2008-10#2)
speciation study##4##2##(2008-10#4)
speciation was assessed by performing multiple analyses of the spiked samples##2##11##(2008-10#2)
speciation was##8##2##(2008-10#7)(2010-11#1)
speciation##318##1##(1996-6#9)(2008-1#1)(2008-10#248)(2008-6#2)(2008-8#19)(2008-9#9)(2009-2#5)(2009-6#2)(2010-11#4)(2010-3#5)(2010-5#1)(2010-6#2)(2012-3#4)(2013-1#4)(2013-7#3)
specie of##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
specie##9##1##(2007-10#1)(2008-10#2)(2008-5#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
species (A##2##2##(1997-6#1)(2008-10#1)
species (C##2##2##(2013-7#2)
species (Diptera##2##2##(2007-12#1)(2011-2#1)
species (H##2##2##(2009-9#2)
species (Q##4##2##(2012-5#3)(2012-6#1)
species (e##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
species (i##4##2##(2008-10#2)(2012-9#1)(2013-1#1)
species (the##2##2##(2008-10#1)(2012-3#1)
species B##2##2##(2008-10#2)
species C##3##2##(2008-10#3)
species P##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
species X##2##2##(2008-10#2)
species able to##2##3##(2008-10#1)(2013-7#1)
species abundance distribution##2##3##(2008-8#2)
species abundance distributions##3##3##(2008-8#3)
species abundance##10##2##(2008-5#1)(2008-8#8)(2013-7#1)
species abundances##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
species across##2##2##(2009-8#1)(2011-1#1)
species after##4##2##(2008-10#3)(2013-1#1)
species also##3##2##(2008-10#2)(2008-9#1)
species analysis##6##2##(2008-10#5)(2013-7#1)
species and a##4##3##(1996-2#1)(2008-8#1)(2011-3#1)(2013-8#1)
species and between##2##3##(2008-10#1)(2008-9#1)
species and could##2##3##(2008-10#1)(2010-3#1)
species and for##2##3##(2008-8#1)(2010-8#1)
species and in some##2##4##(2008-8#1)(2010-3#1)
species and in##3##3##(2007-12#1)(2008-8#1)(2010-3#1)
species and its##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
species and one##2##3##(2008-10#1)(2013-1#1)
species and other morphologically##2##4##(2008-10#1)(2011-2#1)
species and oxidation##2##3##(1996-2#1)(2012-2#1)
species and shows##2##3##(1997-7#1)(2008-10#1)
species and subsequently##2##3##(2008-2#1)(2010-2#1)
species and subspecies##4##3##(2008-10#1)(2008-12#1)(2012-2#2)
species and that##2##3##(2008-10#1)(2008-8#1)
species and the##13##3##(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
species and their hybrids##2##4##(2008-10#1)(2008-9#1)
species and their##4##3##(2008-10#3)(2008-9#1)
species and this##2##3##(1993-3#1)(1997-9#1)
species and to##2##3##(2008-8#1)(2010-3#1)
species and two##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
species and##175##2##(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-9#1)(2007-12#2)(2007-5#2)(2007-7#1)(2008-10#64)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#13)(2008-9#6)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#5)(2012-6#2)(2013-1#4)(2013-8#4)
species are also##2##3##(2008-5#1)(2010-8#1)
species are collected##2##3##(2007-5#2)
species are determined by##2##4##(2008-10#2)
species are determined##3##3##(2008-10#3)
species are discussed##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
species are formed##3##3##(2008-10#3)
species are found##2##3##(2008-10#1)(2011-2#1)
species are known##3##3##(2008-5#1)(2008-9#1)(2012-5#1)
species are new reports for##2##5##(2008-5#2)
species are new##3##3##(2008-5#3)
species are not##3##3##(2008-8#2)(2013-1#1)
species are often##2##3##(2008-10#1)(2008-12#1)
species are present in the##2##5##(2008-10#2)
species are present in##3##4##(2008-1#1)(2008-10#2)
species are present##5##3##(2008-1#2)(2008-10#3)
species are reported##2##3##(2008-10#1)(2008-5#1)
species are separated##3##3##(2008-10#2)(2008-6#1)
species are similar##2##3##(1997-4#1)(2008-10#1)
species are the##3##3##(2008-1#1)(2008-8#1)(2009-8#1)
species are very##3##3##(2008-10#2)(2008-7#1)
species are##120##2##(1991-9#2)(1992-6#1)(1994-8#1)(1994-9#1)(1997-4#2)(2007-10#1)(2007-12#3)(2007-5#2)(2008-1#6)(2008-10#32)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#7)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-8#2)(2011-2#5)(2012-2#2)(2012-5#1)(2013-1#4)(2013-7#3)(2013-8#1)
species as a function##2##4##(2008-10#2)
species as well as the##3##5##(1995-2#1)(2008-10#2)
species as well as to##3##5##(1997-7#1)(2008-10#1)(2008-4#1)
species as well as##11##4##(1993-8#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-7#1)
species as##23##2##(1993-11#1)(1993-8#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#1)
species associated with##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
species at a##3##3##(2008-8#1)(2008-9#2)
species at the##3##3##(2008-10#2)(2008-7#1)
species at##16##2##(1997-5#1)(2008-10#9)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-2#1)
species based on##3##3##(2008-10#3)
species because##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
species becoming##2##2##(2008-8#2)
species belong to##2##3##(2008-8#1)(2011-2#1)
species belonging to the genus##2##5##(2008-10#1)(2008-5#1)
species belonging to the##6##4##(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)
species belonging to##17##3##(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-7#2)
species both##2##2##(1997-1#1)(2008-10#1)
species boundaries##3##2##(2008-7#1)(2010-6#1)(2012-3#1)
species but not##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
species but remain##2##3##(2008-10#2)
species but##12##2##(1997-6#1)(2007-12#1)(2008-10#3)(2008-8#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-8#1)
species by employing##2##3##(2008-7#1)(2012-2#1)
species by##27##2##(1996-11#1)(1996-12#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)
species can be##12##3##(1991-9#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)
species can##20##2##(1991-9#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-2#1)(2011-2#2)
species cannot be##2##3##(1990-8#1)(2008-6#1)
species cannot##3##2##(1990-8#1)(2008-6#1)(2008-8#1)
species capable of##2##3##(2008-10#2)
species captured##2##2##(2008-10#1)(2008-5#1)
species cause##2##2##(2008-10#1)(2013-8#1)
species causing##4##2##(2008-10#3)(2008-5#1)
species coexistence##3##2##(2008-8#2)(2008-9#1)
species collected from##2##3##(2008-10#1)(2011-1#1)
species collected in##2##3##(2008-10#1)(2008-8#1)
species collected##4##2##(2008-10#2)(2008-8#1)(2011-1#1)
species common##2##2##(2008-10#1)(2008-5#1)
species compete##2##2##(2008-10#1)(2008-8#1)
species complex##12##2##(2008-10#6)(2008-12#1)(2009-9#2)(2010-10#1)(2011-2#1)(2013-1#1)
species composed of##2##3##(1996-2#2)
species composition and##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
species composition of##7##3##(1990-2#2)(1995-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
species composition##20##2##(1990-2#4)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2011-1#1)(2013-1#1)(2013-7#5)
species concentration##2##2##(2008-2#1)(2008-3#1)
species concept in##3##3##(2008-10#3)
species concept##4##2##(2008-10#4)
species concepts##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#1)
species contain##2##2##(1995-12#1)(2008-5#1)
species containing##3##2##(1990-2#1)(1995-8#1)(1996-2#1)
species correlations##2##2##(1997-4#2)
species could be##5##3##(1993-8#1)(2008-10#3)(2011-2#1)
species could##9##2##(1993-8#1)(1994-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)
species delimitation##3##2##(2012-3#3)
species delineation##2##2##(2008-10#1)(2010-6#1)
species dependent##2##2##(2008-10#2)
species depends on##2##3##(2007-12#1)(2008-7#1)
species designation##2##2##(2008-5#1)(2012-3#1)
species detected in##2##3##(2008-10#1)(2010-11#1)
species detected##6##2##(2008-10#3)(2010-11#1)(2013-1#1)(2013-7#1)
species detection##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
species determination##4##2##(2008-10#4)
species did not##3##3##(1991-7#1)(2008-10#2)
species differ##2##2##(2008-8#1)(2009-8#1)
species difference##5##2##(1996-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)
species differences in##4##3##(1990-6#1)(1995-12#1)(2007-12#1)(2008-9#1)
species differences##7##2##(1990-6#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
species differentiation##3##2##(2008-10#3)
species discovery##2##2##(2010-6#2)
species display##2##2##(2008-3#1)(2009-9#1)
species distributed##2##2##(2010-3#1)(2013-7#1)
species distribution##5##2##(2008-10#1)(2008-5#3)(2013-7#1)
species divergence##2##2##(2012-3#2)
species diversification##4##2##(1996-4#1)(2008-8#1)(2010-3#2)
species diversity and##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
species diversity in##4##3##(2008-8#2)(2009-2#1)(2012-3#1)
species diversity of fruit flies##2##5##(2013-8#2)
species diversity of##3##3##(2012-3#1)(2013-8#2)
species diversity##22##2##(2008-5#4)(2008-8#6)(2008-9#4)(2009-2#1)(2010-3#1)(2012-3#3)(2013-7#1)(2013-8#2)
species do not##4##3##(1997-3#1)(2008-1#1)(2008-8#1)(2011-2#1)
species dominant under##2##3##(2008-8#2)
species during the##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
species during##6##2##(2008-10#3)(2008-5#2)(2010-12#1)
species endemic to##3##3##(2008-5#2)(2013-7#1)
species evaluated##2##2##(2008-10#1)(2009-4#1)
species examined##9##2##(1993-12#1)(1993-2#1)(1996-5#2)(2008-10#3)(2008-7#1)(2009-5#1)
species except##2##2##(2008-10#2)
species exhibit##3##2##(2008-8#2)(2008-9#1)
species exhibited an##2##3##(2008-10#1)(2010-8#1)
species exhibited##7##2##(1993-12#1)(1997-2#1)(2008-10#2)(2008-8#1)(2010-3#1)(2010-8#1)
species exist##2##2##(1995-11#1)(2008-10#1)
species existing in##2##3##(2008-10#2)
species extinctions##2##2##(2008-8#2)
species followed by##2##3##(2008-10#1)(2008-2#1)
species for the##7##3##(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
species for which##3##3##(1993-12#1)(1994-7#1)(2008-8#1)
species for##28##2##(1990-2#1)(1992-6#1)(1993-12#1)(1994-7#1)(1995-2#2)(2008-10#8)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
species formed by##3##3##(2007-12#1)(2008-10#2)
species formed in##2##3##(2008-10#2)
species formed##15##2##(2007-12#1)(2008-10#12)(2008-6#1)(2009-9#1)
species found in##6##3##(1992-6#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)
species found##11##2##(1992-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
species from a##2##3##(2008-10#1)(2008-9#1)
species from different##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
species from five##2##3##(2011-2#1)(2012-3#1)
species from the##16##3##(2008-10#4)(2008-5#6)(2008-8#1)(2009-2#1)(2011-2#1)(2012-3#2)(2013-7#1)
species from##62##2##(1990-8#1)(1995-2#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-5#10)(2008-6#1)(2008-8#4)(2008-9#2)(2009-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#4)(2013-7#5)(2013-8#1)
species generally##2##2##(2008-5#1)(2012-5#1)
species generated by##2##3##(1993-11#1)(2010-11#1)
species generation##2##2##(2007-12#1)(2009-12#1)
species group by##2##3##(2013-7#2)
species group##5##2##(2008-5#2)(2013-7#3)
species grouped##2##2##(2008-10#1)(2013-7#1)
species groups##3##2##(2008-6#1)(2010-4#2)
species growing in the##2##4##(2008-10#1)(2008-9#1)
species growing in##3##3##(2008-10#1)(2008-9#1)(2012-5#1)
species growing##4##2##(2008-10#1)(2008-9#1)(2012-5#1)(2012-6#1)
species had a##2##3##(1993-8#1)(2008-8#1)
species had##7##2##(1993-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-7#1)
species has been##10##3##(1994-12#1)(1995-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)
species has##20##2##(1992-10#1)(1994-12#1)(1995-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#4)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#1)
species have a##4##3##(1993-6#1)(2007-12#1)(2008-12#1)(2008-5#1)
species have become##2##3##(2012-3#1)(2013-7#1)
species have been determined##2##4##(2008-10#2)
species have been used##2##4##(2008-10#1)(2011-1#1)
species have been##22##3##(1994-6#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-5#2)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2013-1#1)
species have##48##2##(1993-6#1)(1994-6#1)(1996-12#1)(1996-2#1)(2007-12#3)(2007-5#2)(2007-7#1)(2008-10#15)(2008-12#2)(2008-5#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
species identification and Halal authentication##2##5##(2010-4#2)
species identification and##6##3##(2008-3#1)(2008-9#1)(2010-4#3)(2011-2#1)
species identification##10##2##(2008-10#1)(2008-3#1)(2008-9#2)(2010-3#1)(2010-4#3)(2011-2#1)(2013-7#1)
species identifications##2##2##(2008-9#1)(2010-4#1)
species identified in##2##3##(2008-10#1)(2011-2#1)
species identified##5##2##(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
species if##2##2##(2008-9#1)(2012-1#1)
species in a single##2##4##(2008-10#2)
species in a##19##3##(1991-8#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-8#5)(2008-9#1)(2012-3#1)
species in aqueous##3##3##(2008-10#3)
species in both##4##3##(1996-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
species in brain##2##3##(1994-11#1)(1996-5#1)
species in deep##2##3##(2008-10#1)(2008-8#1)
species in different##2##3##(2008-8#1)(2013-1#1)
species in each of##2##4##(1991-5#1)(2008-10#1)
species in each##3##3##(1991-5#1)(2008-10#1)(2008-2#1)
species in environmental samples##2##4##(2008-10#2)
species in environmental##5##3##(2008-10#5)
species in fish##2##3##(2008-10#2)
species in human##3##3##(2008-10#2)(2009-11#1)
species in natural waters##3##4##(2008-10#3)
species in natural##5##3##(2008-10#5)
species in regard to##2##4##(2008-6#1)(2011-2#1)
species in response to drought##2##5##(2012-8#2)
species in river##2##3##(2008-10#2)
species in six##2##3##(2008-10#2)
species in solution##3##3##(2008-10#3)
species in spiked##2##3##(2008-10#2)
species in the family##2##4##(2008-10#2)
species in the genus Tospovirus##2##5##(2008-10#2)
species in the genus##10##4##(2008-10#7)(2008-8#1)(2011-2#2)
species in the system##2##4##(2008-11#1)(2008-5#1)
species in the##86##3##(1990-2#1)(1990-5#3)(1990-8#1)(1991-6#1)(1992-3#1)(1994-3#1)(1995-3#1)(1996-5#2)(1996-6#2)(1997-4#1)(2007-12#4)(2008-1#1)(2008-10#28)(2008-11#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-2#1)(2013-7#7)
species in these##3##3##(2008-5#1)(2008-8#2)
species in this##6##3##(1992-6#1)(2008-10#3)(2009-10#1)(2012-5#1)
species in tropical##2##3##(2008-8#1)(2013-7#1)
species in two##2##3##(2008-10#1)(2008-5#1)
species in various##2##3##(2008-2#2)
species in water samples##3##4##(2008-10#3)
species in water##5##3##(2008-10#5)
species in which##5##3##(2008-10#1)(2008-8#3)(2013-1#1)
species in##276##2##(1990-2#1)(1990-5#3)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-11#2)(1994-3#3)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-4#1)(1997-6#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#120)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#3)(2008-8#25)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#2)(2013-1#4)(2013-7#8)(2013-8#2)
species include##4##2##(2007-12#1)(2008-1#1)(2008-12#1)(2012-3#1)
species including##11##2##(1997-2#1)(2008-10#8)(2008-8#1)(2010-1#1)
species indicates that##2##3##(1993-12#1)(1993-6#1)
species indicates##3##2##(1993-12#1)(1993-6#1)(2008-10#1)
species infected with##2##3##(2008-10#1)(2012-3#1)
species infecting##3##2##(2008-10#3)
species infection##2##2##(1996-6#1)(2009-4#1)
species inhabiting##2##2##(2008-8#1)(2011-2#1)
species interactions in##2##3##(2008-9#2)
species interactions##10##2##(2008-8#2)(2008-9#8)
species into##6##2##(2008-10#5)(2008-5#1)
species investigated##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2012-5#1)
species involved in the##3##4##(1993-6#1)(1994-11#1)(2008-10#1)
species involved##7##2##(1993-6#1)(1994-11#1)(2008-10#5)
species is a##7##3##(1993-11#1)(2008-10#1)(2008-8#1)(2011-2#4)
species is also##2##3##(2008-10#2)
species is characterized by a##2##5##(2008-8#1)(2011-2#1)
species is characterized by##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
species is discussed##2##3##(2008-10#1)(2010-10#1)
species is not##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
species is now##2##3##(2008-10#1)(2008-12#1)
species is of interest because##3##5##(2011-2#3)
species is of interest##4##4##(2011-2#4)
species is of##5##3##(2008-11#1)(2011-2#4)
species is possible by##2##4##(2008-10#2)
species is presented##2##3##(2008-10#1)(2013-7#1)
species is the##3##3##(2008-10#2)(2013-1#1)
species is##98##2##(1990-11#2)(1993-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-6#1)(2008-10#38)(2008-11#2)(2008-12#4)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#11)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#3)
species isolated from cases of##2##5##(2007-7#1)(2008-7#1)
species isolated from##7##3##(1996-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
species isolated in##2##3##(2008-10#1)(2008-5#1)
species isolated##11##2##(1993-8#1)(1996-3#1)(2007-7#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
species known to be##2##4##(1990-11#1)(2012-6#1)
species known to##3##3##(1990-11#1)(2008-8#1)(2012-6#1)
species lacking##2##2##(1995-12#1)(2008-11#1)
species leading to##2##3##(1992-12#1)(1995-5#1)
species level##13##2##(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-6#1)
species life history##2##3##(2008-8#2)
species life##3##2##(2008-5#1)(2008-8#2)
species mate##3##2##(2008-8#1)(2008-9#2)
species may be##11##3##(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#2)(2012-3#1)
species may have been##2##4##(2008-10#2)
species may##24##2##(1992-8#1)(1993-6#1)(1995-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
species might have##2##3##(2008-7#1)(2009-8#1)
species mixtures##2##2##(2008-10#2)
species native to##2##3##(2008-10#1)(2008-8#1)
species nesting##2##2##(2008-6#1)(2008-9#1)
species not##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
species occur##2##2##(1992-9#1)(2008-10#1)
species occurs##3##2##(2007-5#1)(2008-8#1)(2011-2#1)
species of &quot##2##3##(2011-2#2)
species of Aspergillus##2##3##(1993-12#1)(1994-3#1)
species of Drosophila##4##3##(1993-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
species of Fusarium##2##3##(2008-10#2)
species of Gemella##2##3##(2007-12#2)
species of Gracilaria##2##3##(2008-11#2)
species of Hyphessobrycon from the Pacific Coast of Colombia##2##9##(2013-7#2)
species of Hyphessobrycon##3##3##(2013-7#3)
species of Hypocrea##2##3##(2008-10#2)
species of IFN##2##3##(2008-4#2)
species of Mentha##2##3##(2013-1#2)
species of Neotibilis Grazia &amp##2##5##(2008-6#2)
species of Nicotiana##2##3##(2008-10#2)
species of Phytophthora##7##3##(2008-10#7)
species of Trichoderma##2##3##(2008-10#2)
species of approximately##3##3##(2008-10#3)
species of bacteria##2##3##(2006-6#1)(2011-2#1)
species of bats##3##3##(1994-11#2)(2013-1#1)
species of birds##7##3##(1997-3#1)(1997-4#1)(1997-6#1)(2008-3#1)(2008-8#1)(2008-9#2)
species of bitterling##2##3##(2010-8#2)
species of cerebroside sulfate##2##4##(1993-8#2)
species of copper(II)##2##3##(2008-10#2)
species of cyanobacteria##2##3##(1996-12#1)(2008-10#1)
species of different##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
species of fish from##2##4##(2008-11#1)(2013-1#1)
species of fish##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
species of forest##2##3##(1995-3#1)(2008-9#1)
species of freshwater##2##3##(2008-11#1)(2008-5#1)
species of fungi##3##3##(2008-10#2)(2008-5#1)
species of parasites##2##3##(2011-2#1)(2013-1#1)
species of pathogenic fungi##2##4##(2008-10#2)
species of pathogens##2##3##(2008-10#2)
species of phosphatidylcholine (PC)##2##4##(1993-8#1)(1994-12#1)
species of plants##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
species of plasma##3##3##(1994-12#2)(1995-8#1)
species of poikilothermic vertebrates##2##4##(2008-7#2)
species of sand flies##2##4##(2013-1#2)
species of serogroup IV##2##4##(2008-10#2)
species of similar##2##3##(1994-6#1)(2008-8#1)
species of skate (Rajidae)##2##4##(2010-8#2)
species of tRNA genes##2##4##(1995-8#1)(2008-9#1)
species of the Paramecium aurelia complex##3##6##(2008-12#3)
species of the family##3##4##(2008-10#2)(2011-2#1)
species of the genera##2##4##(1997-4#1)(2008-5#1)
species of the genus Squatina##2##5##(2008-5#2)
species of the genus##49##4##(1997-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#3)(2009-5#1)(2010-8#2)(2011-2#26)(2013-1#1)(2013-7#2)(2013-8#1)
species of the obscura group##2##5##(2013-1#2)
species of the order##2##4##(2008-5#1)(2008-8#1)
species of the##83##3##(1994-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#5)(2008-5#9)(2008-6#6)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#2)(2011-2#30)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
species of this genus##3##4##(2008-5#2)(2013-1#1)
species of this##5##3##(2008-10#2)(2008-5#2)(2013-1#1)
species of ungulates##2##3##(2008-5#1)(2008-8#1)
species of wild##3##3##(2007-2#1)(2008-12#1)(2013-7#1)
species of##432##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#4)(1994-11#4)(1994-12#3)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2006-6#1)(2007-12#14)(2007-2#1)(2007-5#2)(2008-10#111)(2008-11#7)(2008-12#16)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#45)(2008-6#14)(2008-7#6)(2008-8#16)(2008-9#14)(2009-10#1)(2009-2#3)(2009-5#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#1)(2010-8#9)(2011-1#1)(2011-2#45)(2012-12#1)(2012-3#4)(2013-1#17)(2013-7#9)(2013-8#5)
species often##2##2##(2007-6#1)(2008-10#1)
species on the##5##3##(2008-10#5)
species on##23##2##(2007-12#1)(2008-10#16)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-6#2)
species only##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
species or a##2##3##(2008-8#1)(2008-9#1)
species or genera##2##3##(2008-10#2)
species or##16##2##(1991-3#1)(2008-10#9)(2008-11#1)(2008-8#4)(2008-9#1)
species other than##2##3##(2008-10#1)(2011-2#1)
species over a##3##3##(2008-10#2)(2008-3#1)
species over##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
species pairs##2##2##(2009-2#1)(2013-7#1)
species play##2##2##(2008-10#1)(2009-6#1)
species possess##2##2##(2008-9#1)(2012-3#1)
species presence##2##2##(2008-5#1)(2008-8#1)
species present in the##2##4##(1997-2#1)(2008-10#1)
species present in these samples##2##5##(2008-10#2)
species present in these##3##4##(1990-2#1)(2008-10#2)
species present in##9##3##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#6)
species present##14##2##(1990-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-4#1)(2010-12#1)
species presented##2##2##(2007-6#1)(2013-7#1)
species provide##2##2##(2008-8#2)
species provided##2##2##(2008-10#1)(2008-5#1)
species ranged from##2##3##(2008-10#1)(2008-12#1)
species rather than##2##3##(2008-8#1)(2009-8#1)
species recovered from##2##3##(2010-3#1)(2011-1#1)
species reported##3##2##(2008-10#1)(2008-5#2)
species representing##3##2##(2008-10#1)(2008-9#1)(2010-3#1)
species represents##2##2##(1990-7#1)(2011-2#1)
species responded to##2##3##(2008-7#1)(2008-8#1)
species responded##3##2##(2008-7#1)(2008-8#2)
species responsible for##2##3##(2010-11#1)(2011-2#1)
species retained on##2##3##(2008-10#2)
species reveal##2##2##(2008-10#1)(2011-1#1)
species revealed that##3##3##(1997-7#1)(2008-8#1)(2008-9#1)
species revealed##5##2##(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
species richness along##2##3##(2008-8#2)
species richness and abundance##4##4##(2008-5#1)(2013-7#3)
species richness and plant functional group richness had##2##8##(2008-8#2)
species richness and plant functional group richness##3##7##(2008-8#3)
species richness and plant functional group##4##6##(2008-8#4)
species richness and plant functional##5##5##(2008-8#4)(2008-9#1)
species richness and##15##3##(2008-5#3)(2008-8#5)(2008-9#2)(2013-1#1)(2013-7#4)
species richness is##5##3##(2008-8#4)(2008-9#1)
species richness of##3##3##(2008-8#1)(2008-9#2)
species richness on##2##3##(2008-8#2)
species richness was##2##3##(2008-9#1)(2013-7#1)
species richness##63##2##(2008-5#5)(2008-8#31)(2008-9#14)(2011-2#1)(2013-1#1)(2013-7#11)
species sampled##2##2##(2008-10#2)
species separation##3##2##(2008-10#3)
species share##2##2##(1994-6#1)(2008-8#1)
species should be considered##2##4##(2009-4#1)(2010-11#1)
species show a##2##3##(2008-12#1)(2012-5#1)
species show##6##2##(1993-12#1)(2008-10#1)(2008-12#2)(2011-2#1)(2012-5#1)
species showed a##2##3##(2012-5#1)(2013-1#1)
species showed distinct##2##3##(2008-10#1)(2008-8#1)
species showed significant##2##3##(1995-8#1)(2008-5#1)
species showed that##6##3##(1990-11#1)(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)
species showed##18##2##(1990-11#1)(1992-3#1)(1993-12#1)(1995-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-8#1)(2012-5#1)(2013-1#1)
species shows##6##2##(2008-10#2)(2008-3#1)(2008-8#2)(2009-2#1)
species so far##2##3##(2008-10#1)(2013-7#1)
species specific primer-probe##2##3##(2010-4#2)
species specific##7##2##(1991-2#1)(2008-10#3)(2010-4#2)(2012-3#1)
species specificity of##2##3##(2008-10#2)
species specificity##9##2##(2008-1#2)(2008-10#4)(2008-12#2)(2008-7#1)
species studied are##2##3##(2012-5#1)(2013-7#1)
species studied were##2##3##(2008-10#1)(2013-8#1)
species studied##10##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-5#1)(2012-5#1)(2013-7#1)(2013-8#1)
species such as ascorbic acid##2##5##(2008-10#2)
species such as the##2##4##(1994-11#1)(1997-8#1)
species such as##22##3##(1992-10#1)(1992-12#1)(1994-11#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-5#1)
species suggest that##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
species suggests that##5##3##(1993-11#1)(1996-5#1)(2008-9#1)(2010-3#1)(2010-8#1)
species survival##2##2##(1997-9#1)(2013-1#1)
species tend to be##2##4##(2008-1#1)(2008-10#1)
species tested were##3##3##(2008-10#2)(2008-6#1)
species tested##11##2##(2008-10#8)(2008-12#1)(2008-5#1)(2008-6#1)
species than##4##2##(1990-8#1)(2008-10#2)(2008-9#1)
species that are##16##3##(1992-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-3#1)(2011-2#1)(2013-7#1)
species that belong to##2##4##(2008-10#1)(2008-3#1)
species that can##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
species that causes##2##3##(2008-10#2)
species that exhibit##3##3##(2008-8#1)(2008-9#1)(2009-5#1)
species that have been##2##4##(2008-10#1)(2013-7#1)
species that have##6##3##(2007-7#2)(2008-10#1)(2008-8#1)(2010-8#1)(2013-7#1)
species that may##2##3##(2011-1#1)(2013-7#1)
species that probably##2##3##(1993-3#1)(2008-6#1)
species that produce##2##3##(1997-4#1)(2008-10#1)
species that provide##2##3##(2008-10#1)(2008-6#1)
species that vary in##2##4##(2008-12#1)(2008-8#1)
species that were##3##3##(2008-10#1)(2010-1#1)(2012-2#1)
species that##83##2##(1992-10#3)(1993-3#1)(1997-4#1)(2007-5#1)(2007-7#2)(2008-10#17)(2008-12#1)(2008-3#3)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#17)(2008-9#4)(2009-10#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#5)
species the##6##2##(1994-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-3#1)
species through##3##2##(1995-2#1)(2008-8#1)(2008-9#1)
species to be##8##3##(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
species to neighbors##2##3##(2008-8#2)
species to possess##2##3##(1993-3#1)(2010-3#1)
species to regenerate##2##3##(2008-5#1)(2008-8#1)
species to the##5##3##(2008-10#1)(2008-8#2)(2013-1#1)(2013-8#1)
species to##53##2##(1990-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#9)(2008-9#3)(2009-2#1)(2009-8#3)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#4)(2012-6#1)(2013-1#1)(2013-8#1)
species tree inference##2##3##(2012-3#2)
species tree##4##2##(2012-3#4)
species trees##3##2##(2008-4#1)(2012-3#2)
species under the##2##3##(2008-10#1)(2009-8#1)
species under##4##2##(1993-9#1)(2008-10#1)(2008-4#1)(2009-8#1)
species undergoing##2##2##(2008-7#1)(2009-8#1)
species use##2##2##(2008-8#1)(2012-2#1)
species used##5##2##(2008-10#2)(2010-11#3)
species using a##2##3##(1990-8#1)(2008-10#1)
species using##16##2##(1990-8#1)(1994-11#1)(1997-4#1)(2008-10#9)(2008-5#1)(2011-2#1)(2012-3#2)
species usually##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
species values##2##2##(1997-4#2)
species via##2##2##(2008-10#1)(2012-2#1)
species was carried out using##2##5##(2008-5#1)(2010-3#1)
species was carried out##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
species was demonstrated##2##3##(2008-10#2)
species was detected##2##3##(2008-10#1)(2010-11#1)
species was determined##2##3##(2008-10#2)
species was estimated##2##3##(2008-10#2)
species was first##3##3##(2008-5#1)(2011-2#2)
species was found to##2##4##(2008-12#1)(2011-2#1)
species was found##3##3##(2008-12#1)(2011-2#1)(2012-12#1)
species was not##3##3##(1990-8#1)(2008-10#1)(2012-12#1)
species was observed##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
species was performed##3##3##(1996-12#1)(2008-10#2)
species was present in##2##4##(2008-10#1)(2008-5#1)
species was present##3##3##(1992-9#1)(2008-10#1)(2008-5#1)
species was reduced##2##3##(2007-6#1)(2008-10#1)
species was studied##2##3##(2008-10#1)(2008-12#1)
species was the##2##3##(2008-10#2)
species was##88##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-7#1)(1992-10#1)(1992-9#1)(1993-12#1)(1996-12#1)(1997-2#1)(2007-5#1)(2007-6#1)(2008-10#41)(2008-12#3)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#5)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-5#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
species we##3##2##(2008-5#1)(2008-8#1)(2009-8#1)
species were analyzed##2##3##(2008-10#1)(2008-11#1)
species were carried##2##3##(2008-5#1)(2013-8#1)
species were chosen##2##3##(2007-12#1)(2008-10#1)
species were collected from##3##4##(2008-10#1)(2011-1#2)
species were collected##5##3##(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#2)
species were detected##2##3##(1993-11#1)(2008-10#1)
species were determined in##2##4##(2008-10#2)
species were determined##5##3##(2008-10#5)
species were evaluated##2##3##(2008-10#1)(2009-10#1)
species were found in##3##4##(2007-5#1)(2009-10#1)(2012-2#1)
species were found to be##3##5##(2008-10#3)
species were found to##5##4##(2008-10#4)(2009-2#1)
species were found##12##3##(2007-5#1)(2008-10#5)(2008-5#2)(2009-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
species were identified##10##3##(1996-2#1)(2008-10#2)(2008-12#1)(2008-5#3)(2011-2#1)(2013-1#1)(2013-7#1)
species were investigated##2##3##(1990-8#1)(2008-10#1)
species were isolated from##2##4##(2008-10#1)(2008-5#1)
species were isolated##3##3##(2008-10#2)(2008-5#1)
species were measured##2##3##(2008-10#2)
species were more##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-7#1)
species were not##3##3##(2008-10#1)(2008-9#1)(2010-12#1)
species were observed##5##3##(1991-7#1)(2008-10#2)(2008-12#1)(2012-6#1)
species were obtained##2##3##(2008-5#2)
species were placed in##2##4##(2008-10#2)
species were placed##3##3##(2008-10#2)(2008-8#1)
species were recorded##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
species were recovered from##2##4##(2008-10#1)(2011-2#1)
species were reduced##2##3##(2008-10#1)(2012-6#1)
species were separated from##2##4##(2008-10#2)
species were separated##4##3##(2008-10#4)
species were shown to##2##4##(2008-10#2)
species were studied by##2##4##(2008-10#1)(2008-12#1)
species were studied##5##3##(2007-10#1)(2008-10#3)(2008-12#1)
species were tested and in##2##5##(2008-8#2)
species were tested for##2##4##(2008-10#2)
species were tested##4##3##(2008-10#2)(2008-8#2)
species were used##2##3##(2008-10#1)(2008-8#1)
species were very##2##3##(2008-10#1)(2012-8#1)
species were##161##2##(1990-8#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#1)(1996-2#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#66)(2008-11#3)(2008-12#8)(2008-5#23)(2008-6#3)(2008-8#7)(2008-9#2)(2009-10#2)(2009-2#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-2#2)(2012-6#2)(2012-8#1)(2012-9#1)(2013-1#3)(2013-7#7)(2013-8#1)
species when##5##2##(2008-10#3)(2008-5#1)(2008-8#1)
species where##2##2##(2008-10#1)(2008-8#1)
species which is##2##3##(1996-2#1)(2011-2#1)
species which were##2##3##(2008-10#2)
species which##12##2##(1990-7#1)(1993-11#1)(1995-3#1)(1996-2#1)(2008-10#3)(2010-2#1)(2010-4#1)(2011-2#2)(2013-7#1)
species whose##2##2##(2008-10#1)(2008-8#1)
species widely distributed##2##3##(2008-10#1)(2013-7#1)
species will##4##2##(2008-9#1)(2011-2#1)(2013-1#2)
species with a large##2##4##(2008-9#1)(2013-7#1)
species with a##5##3##(1997-7#1)(2008-10#1)(2008-9#1)(2009-12#1)(2013-7#1)
species with different##2##3##(2008-8#2)
species with high##3##3##(2008-8#1)(2010-5#1)(2011-1#1)
species with low##2##3##(2008-9#2)
species with the highest##2##4##(2008-10#2)
species with the##4##3##(2008-10#4)
species with##61##2##(1990-5#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#8)(2008-9#7)(2009-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-7#2)
species within a##2##3##(2008-8#2)
species within the family##2##4##(2008-10#2)
species within the##11##3##(1997-6#1)(2008-10#6)(2008-5#1)(2010-3#1)(2011-2#2)
species within##16##2##(1997-6#1)(2008-10#6)(2008-5#1)(2008-8#3)(2010-10#2)(2010-3#1)(2011-2#2)
species without defined importance to eucalyptus##2##6##(2008-5#2)
species without##5##2##(2008-10#3)(2008-5#2)
species##4418##1##(1990-11#12)(1990-12#1)(1990-2#13)(1990-3#1)(1990-5#11)(1990-6#2)(1990-7#4)(1990-8#14)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#2)(1991-5#6)(1991-6#5)(1991-7#3)(1991-8#7)(1991-9#11)(1992-10#10)(1992-11#5)(1992-12#9)(1992-3#7)(1992-4#1)(1992-6#11)(1992-8#4)(1992-9#6)(1993-11#11)(1993-12#19)(1993-2#8)(1993-3#5)(1993-6#7)(1993-8#13)(1993-9#1)(1994-11#18)(1994-12#12)(1994-2#1)(1994-3#11)(1994-5#6)(1994-6#10)(1994-7#1)(1994-8#8)(1994-9#6)(1995-11#5)(1995-12#11)(1995-2#16)(1995-3#6)(1995-5#5)(1995-6#5)(1995-8#11)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#14)(1996-2#21)(1996-3#1)(1996-4#1)(1996-5#11)(1996-6#9)(1996-9#3)(1997-1#2)(1997-2#15)(1997-3#6)(1997-4#23)(1997-5#2)(1997-6#10)(1997-7#10)(1997-8#1)(1997-9#2)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#78)(2007-2#1)(2007-5#20)(2007-6#4)(2007-7#11)(2007-8#1)(2008-1#27)(2008-10#1420)(2008-11#66)(2008-12#88)(2008-2#28)(2008-3#43)(2008-4#27)(2008-5#314)(2008-6#49)(2008-7#85)(2008-8#370)(2008-9#208)(2009-10#15)(2009-11#2)(2009-12#11)(2009-2#23)(2009-3#4)(2009-4#14)(2009-5#13)(2009-6#9)(2009-8#49)(2009-9#9)(2010-1#6)(2010-10#12)(2010-11#17)(2010-12#18)(2010-2#18)(2010-3#60)(2010-4#21)(2010-5#11)(2010-6#14)(2010-7#3)(2010-8#42)(2010-9#2)(2011-1#27)(2011-10#2)(2011-2#209)(2011-3#6)(2012-1#7)(2012-12#16)(2012-2#56)(2012-3#84)(2012-5#20)(2012-6#17)(2012-7#1)(2012-8#5)(2012-9#10)(2013-1#78)(2013-7#130)(2013-8#38)
species' range##4##2##(2008-10#1)(2008-9#1)(2009-2#1)(2013-1#1)
species' ranges##2##2##(2008-8#2)
species' responses to disturbance##4##4##(2008-8#4)
species'##23##1##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#12)(2008-9#4)(2009-2#1)(2009-8#1)(2010-8#1)(2013-1#1)
species)##26##1##(1994-5#1)(2007-5#2)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#2)(2012-2#1)(2012-5#1)(2012-9#2)(2013-7#2)(2013-8#1)
species- and##2##2##(1990-8#1)(2012-5#1)
species-area##5##1##(2008-8#4)(2008-9#1)
species-dependent##3##1##(1991-2#1)(1993-3#2)
species-group##3##1##(2008-10#2)(2013-1#1)
species-groups##4##1##(2008-10#4)
species-specific characteristic##2##2##(2008-10#1)(2009-5#1)
species-specific database##2##2##(2008-4#2)
species-specific differences in##2##3##(2010-4#1)(2011-10#1)
species-specific differences##4##2##(1991-1#1)(2008-10#1)(2010-4#1)(2011-10#1)
species-specific polymerase chain reaction (PCR)##2##5##(2008-10#2)
species-specific primer pair##3##3##(2008-10#3)
species-specific primer##5##2##(1995-12#1)(2008-10#3)(2011-2#1)
species-specific primers and TaqMan probes##2##5##(2008-10#2)
species-specific primers and##3##3##(2008-10#3)
species-specific primers for##2##3##(2008-10#1)(2008-12#1)
species-specific primers##13##2##(2008-10#12)(2008-12#1)
species-specific probes##2##2##(1994-12#1)(2012-2#1)
species-specific##66##1##(1991-1#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-12#3)(2007-12#1)(2008-10#33)(2008-12#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-2#3)(2012-3#2)(2012-8#1)(2013-7#1)(2013-8#1)
specific &quot##2##2##(1994-2#1)(2012-3#1)
specific 1H##3##2##(2009-7#3)
specific AT receptors##2##3##(1993-8#2)
specific CAT activity##2##3##(2008-7#2)
specific DNA binding##3##3##(1990-11#1)(1995-11#1)(1995-8#1)
specific DNA fragment##2##3##(2008-10#1)(2008-8#1)
specific DNA probe##2##3##(1991-2#1)(1993-9#1)
specific DNA probes##2##3##(2008-10#1)(2008-5#1)
specific DNA sequence##2##3##(1997-2#1)(2008-8#1)
specific DNA##16##2##(1990-11#1)(1991-2#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#1)
specific IgE in##3##3##(1990-12#2)(2008-10#1)
specific IgE##7##2##(1990-12#3)(1990-3#1)(2008-10#3)
specific IgG##2##2##(1995-11#1)(2012-12#1)
specific Low-density lipoprotein##2##3##(1990-2#2)
specific NADPH##2##2##(1990-2#1)(1994-8#1)
specific PCR##7##2##(1992-3#1)(1996-8#1)(1997-3#1)(2008-10#4)
specific [3H]5-HT##2##2##(1994-2#2)
specific absorption##2##2##(2008-2#1)(2008-3#1)
specific action##4##2##(1992-8#1)(1993-5#1)(2008-4#1)(2011-2#1)
specific actions##3##2##(1994-1#1)(1995-2#1)(1996-11#1)
specific activities of##2##3##(1991-12#1)(1997-6#1)
specific activities##13##2##(1991-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
specific activity and##5##3##(1991-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(2008-5#1)
specific activity in the##3##4##(1995-12#1)(1997-4#1)(2008-7#1)
specific activity in##4##3##(1995-12#1)(1997-4#2)(2008-7#1)
specific activity of brain##2##4##(1994-8#1)(2008-7#1)
specific activity of the##6##4##(1994-8#1)(1997-6#1)(2008-10#3)(2008-4#1)
specific activity of##21##3##(1990-7#1)(1991-12#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)
specific activity was##3##3##(1997-4#1)(1997-6#1)(2008-7#1)
specific activity##52##2##(1990-11#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1997-2#1)(1997-4#5)(1997-6#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
specific adhesion##3##2##(1990-2#1)(1992-9#1)(1996-12#1)
specific admission##2##2##(1995-3#1)(1997-3#1)
specific adsorption of##2##3##(2008-10#2)
specific adsorption##3##2##(2008-10#3)
specific affinity##2##2##(1990-11#1)(2008-9#1)
specific alterations in##2##3##(1995-5#1)(2010-1#1)
specific alterations##3##2##(1995-5#1)(1995-8#1)(2010-1#1)
specific amino acid substitutions##2##4##(2008-8#1)(2009-8#1)
specific amino acid##5##3##(1990-7#1)(1991-9#1)(1993-6#1)(2008-8#1)(2009-8#1)
specific amino##6##2##(1990-7#1)(1991-9#1)(1993-6#1)(1995-5#1)(2008-8#1)(2009-8#1)
specific analysis##2##2##(2008-9#2)
specific anatomic##2##2##(2010-12#1)(2010-8#1)
specific and effective##2##3##(1991-5#1)(1997-2#1)
specific and general symptoms##2##4##(2008-4#2)
specific and irreversible##3##3##(1990-2#1)(2008-11#1)(2008-4#1)
specific and not##2##3##(1995-11#1)(2008-5#1)
specific and reproducible##2##3##(1991-9#1)(1993-9#1)
specific and sensitive##7##3##(1991-11#1)(1997-3#1)(2008-10#4)(2010-3#1)
specific and showed##2##3##(1994-8#1)(2008-10#1)
specific and stable##2##3##(2008-4#1)(2011-3#1)
specific and##68##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#3)(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#2)(1996-12#2)(1997-2#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
specific antibodies against##3##3##(1997-9#1)(2008-4#1)(2008-7#1)
specific antibodies and##2##3##(1997-8#1)(2008-1#1)
specific antibodies##17##2##(1990-12#2)(1990-5#1)(1992-11#1)(1992-7#1)(1996-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-7#1)
specific antibody to##2##3##(1995-12#1)(2008-9#1)
specific antibody was##2##3##(1996-12#1)(2008-10#1)
specific antibody##25##2##(1990-12#1)(1991-2#2)(1992-12#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-4#2)(2008-8#1)(2008-9#2)(2012-2#1)
specific anticancer##2##2##(2007-5#1)(2008-11#1)
specific antigen (PSA)##3##3##(1994-12#1)(2008-12#1)(2011-2#1)
specific antigen##10##2##(1994-12#2)(1994-8#1)(1995-12#1)(2008-12#1)(2008-4#2)(2011-2#1)(2013-8#2)
specific antigens##6##2##(1991-5#1)(2006-6#1)(2008-4#4)
specific antisera##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
specific application##2##2##(1997-2#1)(2008-10#1)
specific applications##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)
specific approach##3##2##(2008-10#1)(2010-3#1)(2012-2#1)
specific area##2##2##(1994-2#1)(2008-10#1)
specific areas of##5##3##(1990-7#1)(1991-12#1)(1996-12#1)(2009-10#1)(2011-2#1)
specific as##2##2##(2008-4#1)(2008-5#1)
specific aspects of the##3##4##(1992-2#2)(2008-8#1)
specific aspects of##11##3##(1991-3#1)(1992-2#2)(1996-6#1)(1996-7#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-9#1)
specific aspects##12##2##(1991-3#1)(1992-2#2)(1996-6#1)(1996-7#1)(2008-11#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-3#1)(2010-9#1)
specific assays##2##2##(2008-4#1)(2010-3#1)
specific association##2##2##(1991-12#1)(1993-8#1)
specific associations##3##2##(1994-8#1)(2010-7#1)(2011-1#1)
specific attachment##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
specific bacteria and##2##3##(2008-5#1)(2008-9#1)
specific bacterial##2##2##(2008-10#1)(2011-1#1)
specific band##4##2##(2008-4#1)(2008-8#1)(2010-3#1)(2013-1#1)
specific behavior##4##2##(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
specific behavioral##2##2##(1993-12#1)(2008-4#1)
specific behaviors that##3##3##(2007-12#1)(2010-11#1)(2011-2#1)
specific behaviors##9##2##(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
specific binding capacity of##2##4##(1990-11#1)(1993-3#1)
specific binding of##15##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)
specific binding sites for [3H]-staurosporine on##2##6##(1990-8#2)
specific binding sites for##3##4##(1990-5#1)(1990-8#2)
specific binding sites in##2##4##(1990-5#2)
specific binding sites##9##3##(1990-5#4)(1990-8#2)(1993-8#2)(1996-3#1)
specific binding to##6##3##(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-10#1)(2009-7#1)
specific binding##41##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-8#1)(1995-11#3)(1995-12#3)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-7#1)
specific bioassay##2##2##(1990-12#1)(2008-10#1)
specific biological activity##4##3##(1990-12#2)(1990-8#1)(2011-2#1)
specific biological##8##2##(1990-12#2)(1990-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)
specific biomarkers##2##2##(2008-10#1)(2010-5#1)
specific brain regions##3##3##(1994-6#1)(2008-4#2)
specific brain##10##2##(1993-8#1)(1994-2#1)(1994-6#1)(1997-2#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-6#1)(2009-7#1)
specific cDNA clones##2##3##(1996-10#1)(2008-11#1)
specific cDNA##5##2##(1990-2#1)(1993-9#1)(1996-10#1)(2008-11#2)
specific cDNAs##2##2##(1993-8#1)(1994-12#1)
specific capacity##3##2##(2008-10#3)
specific carcinogens##2##2##(1991-11#1)(1992-3#1)
specific cardiac##2##2##(2007-8#2)
specific case##5##2##(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)(2012-2#1)
specific cases##2##2##(2009-11#1)(2013-8#1)
specific categories of##2##3##(1993-1#1)(2009-8#1)
specific categories##3##2##(1992-8#1)(1993-1#1)(2009-8#1)
specific causal##2##2##(2008-11#1)(2011-2#1)
specific cause##3##2##(1997-2#1)(2008-1#1)(2008-2#1)
specific causes##2##2##(2009-3#1)(2010-4#1)
specific cell types from##2##4##(2008-4#1)(2009-3#1)
specific cell types##7##3##(1997-4#1)(2008-11#1)(2008-4#3)(2009-3#1)(2013-7#1)
specific cell##17##2##(1990-2#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2013-7#1)
specific cells##3##2##(2008-7#1)(2008-9#1)(2010-5#1)
specific cellular##7##2##(1991-2#1)(1992-11#1)(1992-9#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
specific changes at##2##3##(1995-5#1)(2008-2#1)
specific changes in the##4##4##(2008-10#2)(2008-3#1)(2010-12#1)
specific changes in##6##3##(1994-6#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-2#1)
specific changes##10##2##(1994-6#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)
specific channel##3##2##(2007-11#1)(2008-8#1)(2010-12#1)
specific characteristics and##4##3##(1991-3#1)(2008-10#1)(2008-8#1)(2011-1#1)
specific characteristics of##5##3##(1990-11#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-8#1)
specific characteristics##12##2##(1990-11#1)(1991-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
specific chemical##3##2##(1993-11#1)(2008-10#1)(2010-7#1)
specific chemicals##2##2##(2008-10#1)(2008-5#1)
specific chromosomes##2##2##(2008-7#1)(2009-12#1)
specific chronic diseases##2##3##(1994-5#1)(2012-2#1)
specific circumstances##3##2##(2008-2#1)(2008-4#1)(2011-1#1)
specific class of##2##3##(1994-12#1)(2008-10#1)
specific classes of##2##3##(2008-10#2)
specific cleavage of##2##3##(1991-9#1)(2008-9#1)
specific cleavage##3##2##(1991-9#1)(2008-9#2)
specific clinical and##2##3##(1996-1#1)(2008-12#1)
specific clinical##13##2##(1996-1#1)(1997-3#1)(1997-4#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-12#1)
specific combinations of##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
specific community##2##2##(1992-1#1)(2012-2#1)
specific complexes##2##2##(1990-5#1)(2008-7#1)
specific complications##2##2##(2007-8#1)(2013-1#1)
specific components of##2##3##(2007-6#1)(2008-4#1)
specific compounds##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)
specific computer##2##2##(1996-2#1)(2008-12#1)
specific condition##2##2##(2007-11#1)(2013-1#1)
specific conditions##10##2##(1996-2#1)(1996-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-6#1)(2011-3#1)(2012-12#1)(2013-1#1)
specific conductivity##3##2##(2008-5#1)(2012-2#2)
specific configurations of##2##3##(1997-2#1)(2008-11#1)
specific context##2##2##(2008-7#1)(2013-8#1)
specific contribution of##2##3##(2008-11#1)(2013-1#1)
specific conversion##2##2##(1995-3#1)(2008-6#1)
specific criteria##3##2##(1991-2#1)(2011-7#1)(2012-1#1)
specific critical##2##2##(1996-5#1)(2008-5#1)
specific cytotoxic##2##2##(2008-4#1)(2008-8#1)
specific defects##2##2##(2007-11#1)(2012-12#1)
specific deficits in##2##3##(1991-8#1)(1996-7#1)
specific deficits##3##2##(1991-8#1)(1996-7#1)(2013-1#1)
specific degradation of the##2##4##(2008-5#1)(2011-2#1)
specific density##2##2##(2008-10#1)(2008-5#1)
specific design##4##2##(2008-3#3)(2013-1#1)
specific detection of P##3##4##(2008-10#3)
specific detection of the##3##4##(2008-10#2)(2010-10#1)
specific detection of##10##3##(2008-10#8)(2010-10#1)(2010-5#1)
specific detection##14##2##(1991-2#1)(2008-10#10)(2010-10#1)(2010-5#1)(2013-8#1)
specific determination of hydrogen peroxide##2##5##(2008-10#2)
specific determination of l-ascorbic acid##2##5##(2008-10#2)
specific determination of##5##3##(2008-10#5)
specific developmental##4##2##(2008-7#1)(2008-9#2)(2012-1#1)
specific diagnosis##5##2##(1993-5#1)(1996-6#1)(2011-2#1)(2012-2#2)
specific diagnostic procedures##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
specific diagnostic##13##2##(1991-2#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
specific dietary##2##2##(1990-8#1)(2008-10#1)
specific differences in##2##3##(1995-11#1)(2008-8#1)
specific differences##3##2##(1995-11#1)(2008-8#1)(2013-1#1)
specific dimensions##3##2##(2009-7#1)(2013-1#2)
specific direction##3##2##(1996-2#1)(2008-11#1)(2008-4#1)
specific directions##2##2##(2007-11#1)(2009-5#1)
specific disease##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
specific diseases##4##2##(2008-4#1)(2009-5#1)(2011-2#1)(2013-1#1)
specific domains##3##2##(1992-6#1)(1993-12#1)(2011-1#1)
specific dose-dependent##2##2##(1995-2#1)(2008-2#1)
specific drug delivery##2##3##(2008-11#2)
specific drug##5##2##(2008-11#3)(2011-3#1)(2013-8#1)
specific duties##2##2##(1992-1#1)(2008-11#1)
specific effect##3##2##(1996-5#1)(2008-5#1)(2012-2#1)
specific effects##2##2##(2008-1#1)(2008-11#1)
specific electrical##2##2##(2008-10#1)(2012-2#1)
specific elements of##2##3##(1996-5#1)(2010-1#1)
specific elements##3##2##(1996-5#1)(2006-4#1)(2010-1#1)
specific emphasis##2##2##(1994-1#1)(1995-11#1)
specific energy dissipation rate##9##4##(2008-7#9)
specific energy dissipation rates##2##4##(2008-7#2)
specific energy dissipation##12##3##(2008-7#12)
specific energy##13##2##(1990-11#1)(2008-7#12)
specific enolase (NSE) in##2##4##(1990-2#1)(1990-6#1)
specific enolase##5##2##(1990-2#3)(1990-6#1)(2012-2#1)
specific enough to##2##3##(2007-4#1)(2010-1#1)
specific environmental##6##2##(1995-9#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-1#1)
specific enzymatic activity##2##3##(1995-6#1)(2008-11#1)
specific enzymatic##4##2##(1995-6#1)(1997-7#1)(2008-11#1)(2011-1#1)
specific enzyme##8##2##(1990-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(2008-4#1)(2008-7#1)
specific enzymes##4##2##(2008-4#1)(2008-5#1)(2012-1#1)(2013-8#1)
specific etiology##2##2##(1991-2#1)(2011-2#1)
specific example of##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
specific example##5##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
specific examples of##2##3##(2008-4#2)
specific examples##11##2##(1990-8#1)(1992-2#1)(1994-12#1)(2008-1#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
specific exercise##3##2##(2008-12#3)
specific expectations of##2##3##(2013-1#2)
specific experimental conditions##2##3##(1996-2#2)
specific experiments##2##2##(2008-10#1)(2008-3#1)
specific expression and##2##3##(2008-11#1)(2012-3#1)
specific expression of HOX##2##4##(1992-3#2)
specific expression of##5##3##(1992-3#2)(1994-11#1)(1994-6#1)(1995-2#1)
specific expression##15##2##(1991-9#1)(1992-3#2)(1993-11#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-11#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
specific extraction##2##2##(2008-10#2)
specific factors##5##2##(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
specific features of the##2##4##(2008-10#2)
specific features of##7##3##(2008-10#3)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
specific features that##2##3##(2007-11#1)(2010-8#1)
specific features##11##2##(2007-11#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
specific findings##2##2##(2013-1#2)
specific focus##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
specific for 2##2##3##(1991-9#1)(2008-10#1)
specific for P##5##3##(2008-10#5)
specific for a particular##2##4##(1993-11#1)(1994-8#1)
specific for a##7##3##(1990-12#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-4#1)
specific for each of the##2##5##(1991-5#1)(2008-10#1)
specific for each##7##3##(1991-5#1)(2007-12#1)(2008-10#5)
specific for either##4##3##(2008-10#2)(2013-8#2)
specific for glycoprotein IIb-IIIa##2##4##(1990-5#2)
specific for human##4##3##(1991-6#1)(1997-6#1)(2008-4#1)(2008-7#1)
specific for individual##2##3##(2008-10#2)
specific for the highly##2##4##(1992-2#1)(2008-10#1)
specific for the##37##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#3)(1995-2#3)(1996-2#1)(1996-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
specific for these##2##3##(1995-12#1)(2008-10#1)
specific for##168##2##(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#4)(1990-7#3)(1990-8#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#4)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#45)(2008-11#8)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-11#2)(2010-11#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#6)
specific force##2##2##(2008-3#2)
specific fragments##2##2##(1991-2#1)(2013-8#1)
specific frequency##2##2##(1993-2#1)(2010-8#1)
specific functional exercise##2##3##(2007-10#1)(2012-1#1)
specific functional##9##2##(1996-2#1)(1997-7#1)(2007-10#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#1)
specific functions of##3##3##(1992-9#1)(2008-11#1)(2009-5#1)
specific functions##7##2##(1992-9#1)(1994-8#2)(1996-12#1)(2008-11#2)(2009-5#1)
specific gene in##2##3##(2008-8#2)
specific gene##12##2##(1995-11#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#2)
specific genes##17##2##(1990-11#1)(1991-12#1)(1992-8#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-2#1)
specific genetic background##3##3##(2007-10#2)(2008-7#1)
specific genetic factors##2##3##(2007-10#1)(2007-9#1)
specific genetic##11##2##(1997-4#1)(2007-10#3)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
specific genome##2##2##(2008-10#1)(2008-7#1)
specific genomic regions##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
specific genomic##4##2##(2008-10#1)(2008-2#2)(2011-2#1)
specific geographical##2##2##(2008-10#1)(2012-5#1)
specific geometry##2##2##(2008-3#2)
specific glucose consumption rate##3##4##(2008-11#3)
specific glucose consumption##4##3##(2008-11#4)
specific glucose uptake rate##5##4##(1994-5#5)
specific glucose uptake##6##3##(1994-5#6)
specific glucose##12##2##(1994-5#6)(2008-11#4)(2008-7#2)
specific goals##2##2##(1994-3#1)(1995-5#1)
specific gravity##2##2##(1991-1#2)
specific growth and##3##3##(1993-9#1)(2008-11#1)(2008-7#1)
specific growth factor##2##3##(1993-9#1)(2008-9#1)
specific growth rate (mu)##2##4##(2008-11#2)
specific growth rate and##2##4##(2008-11#2)
specific growth rate of 0##5##5##(2008-11#3)(2008-6#1)(2011-2#1)
specific growth rate of##11##4##(1995-9#1)(2008-11#4)(2008-6#1)(2008-7#3)(2010-11#1)(2011-2#1)
specific growth rate remained##2##4##(1994-5#1)(2008-11#1)
specific growth rate was##2##4##(2008-11#1)(2010-11#1)
specific growth rate##37##3##(1994-3#2)(1994-5#1)(1995-9#2)(2008-10#1)(2008-11#14)(2008-6#1)(2008-7#11)(2008-9#1)(2010-11#2)(2010-8#1)(2011-2#1)
specific growth rates##5##3##(2008-11#4)(2008-7#1)
specific growth##50##2##(1991-6#1)(1993-9#2)(1994-3#2)(1994-5#1)(1995-9#2)(2008-10#1)(2008-11#21)(2008-6#1)(2008-7#13)(2008-9#2)(2010-11#2)(2010-8#1)(2011-2#1)
specific guidelines##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
specific hMab productivity in##2##4##(2008-11#2)
specific hMab productivity##3##3##(2008-11#3)
specific health care##2##3##(2008-8#1)(2010-10#1)
specific health##6##2##(1995-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2012-12#1)
specific heat##2##2##(1993-12#1)(2008-3#1)
specific hospital##2##2##(1994-12#1)(2008-11#1)
specific host##2##2##(2008-10#2)
specific human monoclonal##2##3##(2008-11#2)
specific human##6##2##(2008-11#5)(2008-8#1)
specific hyperfine##2##2##(2007-12#2)
specific identification##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
specific imaging##3##2##(2007-11#1)(2010-6#1)(2011-1#1)
specific immune responses##2##3##(2008-10#1)(2008-9#1)
specific immune##9##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#2)(2012-3#1)
specific immunoassay##2##2##(2008-10#2)
specific in the##2##3##(2009-8#1)(2011-2#1)
specific in##11##2##(1990-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(2007-10#1)(2008-10#2)(2009-8#1)(2011-2#1)(2013-1#2)
specific incorporation of##3##3##(1992-3#1)(1994-5#1)(2008-4#1)
specific indication##2##2##(1990-6#1)(1997-5#1)
specific indications##4##2##(1996-9#1)(1997-6#1)(2007-8#1)(2010-6#1)
specific indicators##2##2##(2007-4#1)(2008-11#1)
specific induction##2##2##(1994-12#1)(2008-10#1)
specific infections##2##2##(2009-5#1)(2011-1#1)
specific information concerning##2##3##(1992-11#1)(1995-3#1)
specific information##6##2##(1992-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
specific inhibition##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
specific inhibitor of protein##3##4##(1990-11#1)(1994-11#1)(1997-7#1)
specific inhibitor of##18##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#3)(1994-6#1)(1994-8#2)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-10#1)
specific inhibitor##20##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#3)(1994-6#1)(1994-8#3)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2009-10#1)(2009-6#1)
specific inhibitors of the##3##4##(1992-6#1)(1995-3#1)(1996-2#1)
specific inhibitors of##8##3##(1992-6#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
specific inhibitors##13##2##(1992-6#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-2#2)(2013-1#1)
specific initiatives##2##2##(1992-1#1)(1992-12#1)
specific input##3##2##(2008-11#1)(2008-3#2)
specific interaction between##2##3##(2008-10#2)
specific interaction of guanidine hydrochloride with##2##6##(1993-3#1)(1993-6#1)
specific interaction of##4##3##(1993-3#1)(1993-6#1)(2008-10#1)(2008-3#1)
specific interaction with##2##3##(2008-10#1)(2008-7#1)
specific interaction##11##2##(1990-5#1)(1993-3#1)(1993-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)
specific interactions between##3##3##(2008-12#1)(2008-3#1)(2013-1#1)
specific interactions##6##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
specific interest##2##2##(2008-11#1)(2012-2#1)
specific intervention##2##2##(2011-2#1)(2013-8#1)
specific interventions##3##2##(1993-12#1)(1995-6#1)(2012-12#1)
specific intracellular##3##2##(1993-2#1)(1995-11#1)(2010-9#1)
specific investigations##2##2##(2012-3#1)(2013-8#1)
specific ion interaction##2##3##(2008-10#2)
specific isolates##2##2##(2008-10#2)
specific issues related to##2##4##(2009-7#1)(2013-1#1)
specific issues##5##2##(2008-9#1)(2009-7#1)(2010-6#1)(2013-1#2)
specific labeling of##5##3##(1991-12#1)(1992-3#1)(1992-9#1)(1996-12#1)(2012-3#1)
specific labeling##7##2##(1991-12#1)(1992-3#1)(1992-9#1)(1994-8#1)(1996-12#1)(2008-7#1)(2012-3#1)
specific labelling of the##3##4##(1993-9#1)(2009-8#2)
specific laboratory##2##2##(2011-2#1)(2012-2#1)
specific language impairment (SLI)##3##4##(2009-8#1)(2012-3#2)
specific leaf area##3##3##(2008-8#1)(2012-5#1)(2013-7#1)
specific leaf##7##2##(2008-10#3)(2008-12#1)(2008-8#1)(2012-5#1)(2013-7#1)
specific life##2##2##(1993-11#1)(2013-8#1)
specific ligand of##2##3##(1995-8#1)(2008-9#1)
specific ligand##4##2##(1995-8#1)(2008-6#1)(2008-9#1)(2010-1#1)
specific ligands##3##2##(1993-11#1)(2007-11#1)(2008-4#1)
specific limitations##2##2##(2008-7#1)(2009-10#1)
specific local##3##2##(1994-1#1)(1995-5#1)(2013-1#1)
specific localization##2##2##(1990-12#1)(1996-12#1)
specific location##5##2##(1995-5#1)(2007-12#1)(2007-7#1)(2008-8#1)(2009-9#1)
specific locations##6##2##(2008-10#2)(2008-5#1)(2008-7#2)(2011-1#1)
specific locus##2##2##(1995-2#1)(1997-3#1)
specific lysine##2##2##(2008-4#1)(2008-9#1)
specific mRNA##2##2##(1990-8#1)(2008-8#1)
specific manner##11##2##(1990-12#1)(1990-2#1)(1993-11#1)(1993-8#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-7#1)
specific marker for##4##3##(1995-11#1)(1996-12#1)(1997-7#1)(2008-12#1)
specific marker of##2##3##(1994-8#1)(2008-4#1)
specific marker##9##2##(1994-11#1)(1994-8#1)(1995-11#2)(1996-12#1)(1997-7#1)(2008-12#1)(2008-4#1)(2008-8#1)
specific markers for##3##3##(2008-10#1)(2008-9#2)
specific markers##9##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#2)(2013-8#1)
specific materials##2##2##(1994-3#1)(1995-6#1)
specific measurement##2##2##(2008-5#1)(2013-1#1)
specific measures of##2##3##(2007-12#1)(2008-6#1)
specific measures##3##2##(1995-12#1)(2007-12#1)(2008-6#1)
specific mechanism of##3##3##(1992-9#1)(1995-5#1)(2008-10#1)
specific mechanism##4##2##(1992-9#1)(1995-5#1)(2008-10#1)(2010-5#1)
specific mechanisms of##2##3##(2008-10#1)(2010-8#1)
specific mechanisms##4##2##(2008-1#1)(2008-10#2)(2010-8#1)
specific medical##4##2##(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
specific medication##2##2##(2008-12#1)(2008-4#1)
specific membrane markers##2##3##(2013-1#2)
specific membrane##3##2##(2008-8#1)(2013-1#2)
specific memory##4##2##(1991-6#1)(2009-8#3)
specific metabolism##2##2##(1995-3#1)(2009-5#1)
specific method for the determination of##2##6##(2008-10#2)
specific method for the##3##4##(2008-10#3)
specific method for##7##3##(2008-10#6)(2011-3#1)
specific method##12##2##(1996-3#1)(2008-10#7)(2008-5#1)(2011-3#1)(2013-1#2)
specific methods of##2##3##(2008-3#1)(2013-8#1)
specific methods##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
specific miRNA##2##2##(2011-1#1)(2011-2#1)
specific mind-body##2##2##(2010-12#2)
specific modality##2##2##(2010-3#1)(2013-1#1)
specific modifications##2##2##(2007-12#1)(2008-4#1)
specific molecular##10##2##(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-1#1)
specific molecules in##2##3##(2008-3#1)(2008-9#1)
specific molecules##6##2##(2008-1#2)(2008-3#1)(2008-4#2)(2008-9#1)
specific monoclonal antibodies##7##3##(1990-11#1)(1992-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
specific monoclonal antibody production##4##4##(2008-11#4)
specific monoclonal antibody##7##3##(1993-8#1)(1994-10#1)(2008-10#1)(2008-11#4)
specific monoclonal##14##2##(1990-11#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-10#1)(2008-10#2)(2008-11#5)(2008-9#1)(2012-3#1)
specific morphological##2##2##(1994-3#1)(2008-9#1)
specific multiple##2##2##(2008-10#1)(2009-3#1)
specific mutations in the##2##4##(1994-8#1)(2011-1#1)
specific mutations##3##2##(1994-8#1)(2008-4#1)(2011-1#1)
specific nature of##4##3##(1996-5#1)(2007-7#1)(2008-2#1)(2010-2#1)
specific nature##6##2##(1994-8#1)(1996-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-2#1)
specific needs##8##2##(1995-1#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
specific neural##3##2##(1996-5#1)(2008-3#1)(2008-4#1)
specific neuronal##3##2##(1991-12#1)(1995-5#1)(2007-12#1)
specific nor##2##2##(1991-9#1)(2008-9#1)
specific nuclear##2##2##(1991-12#1)(2008-8#1)
specific nuclease##2##2##(1991-7#1)(1997-7#1)
specific nucleic acid##3##3##(1990-11#1)(2008-2#2)
specific nucleotide##3##2##(1993-11#1)(1995-8#1)(2008-10#1)
specific nutrients##2##2##(1995-6#1)(2012-1#1)
specific of##5##2##(1991-8#1)(1992-6#1)(1992-8#1)(1994-5#1)(2009-2#1)
specific oligonucleotide primers##2##3##(2008-10#2)
specific oligonucleotide probe##2##3##(1996-2#1)(1997-8#1)
specific oligonucleotide##7##2##(1996-2#1)(1997-8#3)(2008-10#3)
specific optical##2##2##(2008-2#2)
specific or##5##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-6#1)
specific organic##3##2##(1990-3#1)(1995-9#1)(2008-10#1)
specific orientation##2##2##(1995-11#1)(2010-3#1)
specific oxygen uptake##2##3##(2008-11#2)
specific pH##2##2##(2008-10#1)(2008-4#1)
specific parameters##3##2##(1990-3#1)(1991-5#1)(2008-10#1)
specific parasitism##2##2##(2008-10#2)
specific parts of##3##3##(2008-11#1)(2008-5#2)
specific pathogen free hens##2##4##(1991-11#2)
specific pathogen##4##2##(1991-11#2)(2008-10#1)(2011-2#1)
specific pathway##3##2##(1994-8#1)(2008-1#1)(2008-7#1)
specific patient##2##2##(1996-3#1)(2010-6#1)
specific patients##3##2##(1990-12#1)(2008-7#1)(2010-8#1)
specific pattern of##3##3##(1993-6#1)(2009-1#1)(2011-2#1)
specific pattern##4##2##(1993-6#1)(2008-3#1)(2009-1#1)(2011-2#1)
specific patterns of gene##2##4##(2008-7#1)(2008-8#1)
specific patterns of##4##3##(1995-11#1)(2008-7#1)(2008-8#1)(2010-2#1)
specific peptide##4##2##(1993-11#1)(1997-3#1)(2008-4#2)
specific perfusion rates##4##3##(2008-11#4)
specific perfusion##5##2##(2008-11#5)
specific personality##3##2##(2008-6#1)(2009-10#1)(2013-7#1)
specific phases of##2##3##(2009-5#1)(2012-2#1)
specific phenotypic##2##2##(1997-6#1)(2011-2#1)
specific phosphoprotein##3##2##(1994-9#1)(2008-2#1)(2008-4#1)
specific physical##2##2##(2008-11#1)(2013-8#1)
specific physiological##6##2##(1995-6#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#1)
specific points in##3##3##(1992-1#1)(1995-6#1)(2008-11#1)
specific polyclonal antibodies##3##3##(1995-12#2)(2008-10#1)
specific polyclonal antibody##2##3##(1992-11#1)(2008-10#1)
specific polyclonal##6##2##(1992-11#1)(1995-12#2)(2008-10#3)
specific polymerase chain reaction##4##4##(2008-10#4)
specific population##3##2##(1990-7#1)(1995-12#1)(2011-2#1)
specific populations##2##2##(1992-1#1)(2013-8#1)
specific power##2##2##(2008-3#1)(2008-6#1)
specific practice##2##2##(2008-11#1)(2011-2#1)
specific predictions##4##2##(2008-11#1)(2008-8#2)(2008-9#1)
specific prescriptions##2##2##(1991-1#1)(1995-6#1)
specific primer sets##2##3##(2008-10#2)
specific primer##6##2##(2008-10#4)(2009-3#1)(2011-1#1)
specific primers for##4##3##(1994-11#1)(2008-10#2)(2008-7#1)
specific primers were designed##2##4##(2008-10#1)(2013-8#1)
specific primers were##4##3##(2008-10#3)(2013-8#1)
specific primers##22##2##(1992-9#1)(1994-11#1)(1997-8#1)(2008-10#12)(2008-12#2)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
specific probe##6##2##(1990-12#1)(1991-12#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-9#1)
specific probes##3##2##(1991-5#1)(1993-6#1)(1997-7#1)
specific problem##4##2##(1994-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
specific problems##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-11#1)
specific procedures##5##2##(1993-2#1)(1995-8#1)(2006-10#1)(2009-5#1)(2010-12#1)
specific product##2##2##(1992-8#1)(2008-5#1)
specific production rate##3##3##(2008-11#2)(2011-2#1)
specific production##6##2##(2008-10#1)(2008-11#4)(2011-2#1)
specific productivity of##8##3##(2008-11#5)(2008-6#2)(2008-7#1)
specific productivity##17##2##(2008-11#13)(2008-6#2)(2008-7#2)
specific products##2##2##(2007-8#1)(2008-7#1)
specific programming##2##2##(1996-5#1)(2013-8#1)
specific promoter in##2##3##(2008-11#1)(2008-9#1)
specific promoter##4##2##(2008-11#3)(2008-9#1)
specific properties##2##2##(2008-10#1)(2008-7#1)
specific protease##2##2##(2008-9#1)(2012-3#1)
specific protection##2##2##(1990-5#1)(2013-1#1)
specific protein binding to##2##4##(1992-11#2)
specific protein binding##3##3##(1992-11#2)(1992-6#1)
specific protein kinase##2##3##(1992-6#1)(2008-11#1)
specific protein##20##2##(1990-8#1)(1991-9#2)(1992-11#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
specific protein-protein interactions##2##3##(2008-4#1)(2009-9#1)
specific protein-protein##3##2##(2008-2#1)(2008-4#1)(2009-9#1)
specific proteins in##3##3##(1993-11#1)(2008-1#1)(2010-11#1)
specific proteins that##2##3##(2010-11#2)
specific proteins##20##2##(1991-6#1)(1993-11#1)(1996-12#2)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#2)(2009-12#1)(2010-11#3)
specific protocols##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
specific psychiatric##2##2##(1991-2#1)(1994-2#1)
specific questions are##2##3##(1996-3#1)(2012-2#1)
specific questions##4##2##(1996-3#2)(2012-2#2)
specific radioactivity##4##2##(1990-12#3)(1991-3#1)
specific rat##2##2##(1995-11#2)
specific rate##2##2##(2007-11#1)(2008-11#1)
specific rates of##4##3##(2008-11#3)(2011-1#1)
specific rates##6##2##(2008-11#4)(2011-1#1)(2013-1#1)
specific reagents##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
specific receptor on##2##3##(1994-11#1)(1994-6#1)
specific receptor##11##2##(1990-12#1)(1990-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-7#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
specific receptors on the##2##4##(1991-12#1)(2010-10#1)
specific receptors on##3##3##(1991-12#1)(2010-10#1)(2013-7#1)
specific receptors##11##2##(1990-7#1)(1991-12#1)(1994-6#1)(1996-5#1)(2008-4#2)(2008-5#1)(2008-8#2)(2010-10#1)(2013-7#1)
specific recognition of the##2##4##(1991-9#1)(2008-10#1)
specific recognition of##4##3##(1991-9#1)(2008-10#3)
specific recognition##6##2##(1991-2#1)(1991-9#1)(2008-10#4)
specific recombinant##3##2##(2008-11#2)(2013-8#1)
specific recommendations for##2##3##(2008-5#1)(2009-11#1)
specific recommendations##3##2##(1990-6#1)(2008-5#1)(2009-11#1)
specific reference to the##2##4##(1993-10#1)(2008-10#1)
specific reference to##5##3##(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)(2008-10#1)
specific region of##2##3##(1994-11#1)(2011-2#1)
specific region##7##2##(1993-3#1)(1993-9#1)(1994-11#1)(1996-1#1)(2008-4#1)(2011-2#1)(2013-8#1)
specific regions of interest##2##4##(2008-6#1)(2012-1#1)
specific regions of the genome##2##5##(2008-4#1)(2008-9#1)
specific regions of the##5##4##(1993-6#1)(1995-3#1)(1996-12#1)(2008-4#1)(2008-9#1)
specific regions of##9##3##(1993-6#1)(1995-3#2)(1995-5#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-1#1)
specific regions##12##2##(1993-6#1)(1995-3#2)(1995-5#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)
specific relationship##2##2##(2007-12#1)(2008-10#1)
specific relationships##2##2##(2007-12#1)(2010-7#1)
specific repair##2##2##(2008-11#1)(2008-9#1)
specific requirements##4##2##(1991-12#1)(1992-11#1)(2008-4#1)(2013-8#1)
specific research##6##2##(1996-1#1)(1996-2#1)(2008-4#1)(2008-7#1)(2012-2#2)
specific resistance##6##2##(2008-10#6)
specific response of##2##3##(1995-8#1)(2008-10#1)
specific response##5##2##(1990-5#1)(1992-10#1)(1995-8#1)(2008-10#1)(2008-7#1)
specific richness##2##2##(2008-5#2)
specific risk factors and##2##4##(2008-1#2)
specific risk factors##4##3##(2008-1#3)(2009-8#1)
specific risk##6##2##(1996-12#1)(2008-1#3)(2009-10#1)(2009-8#1)
specific role for##2##3##(1996-2#1)(2011-2#1)
specific role in##4##3##(1997-2#1)(2008-11#1)(2008-6#1)(2008-8#1)
specific role of##7##3##(1991-9#1)(1993-6#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-2#1)
specific role##16##2##(1991-9#1)(1993-6#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
specific roles in##2##3##(1992-12#1)(2008-11#1)
specific roles of##2##3##(1993-8#1)(1996-2#1)
specific roles##8##2##(1992-12#1)(1993-8#1)(1996-2#1)(2008-11#2)(2008-2#1)(2008-8#1)(2013-8#1)
specific rotation##3##2##(2008-10#2)(2008-3#1)
specific sample##2##2##(1990-8#1)(2008-10#1)
specific scoring##2##2##(2008-11#2)
specific screening##2##2##(1994-2#1)(2008-3#1)
specific secretory##2##2##(1990-5#1)(2013-1#1)
specific sensitivity##2##2##(2008-11#1)(2011-2#1)
specific sensory##2##2##(2007-12#2)
specific sequence##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-1#1)(2013-8#1)
specific sets of##3##3##(1990-5#1)(1995-2#1)(2009-12#1)
specific signal##3##2##(2007-12#1)(2008-9#1)(2010-4#1)
specific signaling pathways##2##3##(2009-3#1)(2009-8#1)
specific signaling##4##2##(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
specific signalling##2##2##(2008-7#1)(2011-2#1)
specific signatures##2##2##(2012-2#1)(2012-3#1)
specific sites in the##2##4##(1995-11#1)(2009-3#1)
specific sites in##4##3##(1994-12#1)(1995-11#1)(2009-3#1)(2010-8#1)
specific sites of##3##3##(1991-2#1)(2011-1#1)(2012-2#1)
specific sites##9##2##(1991-2#1)(1994-12#1)(1995-11#1)(1996-2#1)(2008-10#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
specific situation##4##2##(1990-3#1)(2009-11#1)(2010-12#1)(2011-2#1)
specific social##2##2##(2010-2#1)(2013-1#1)
specific soluble antigen##2##3##(2008-11#2)
specific somatic##2##2##(2008-4#1)(2008-9#1)
specific spatial##2##2##(2008-7#1)(2013-8#1)
specific spectral##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
specific stages##3##2##(2008-6#1)(2010-5#1)(2012-2#1)
specific statistical##2##2##(2008-10#1)(2008-6#1)
specific stem##2##2##(2008-10#1)(2008-11#1)
specific steps##4##2##(2008-11#1)(2008-2#1)(2011-3#1)(2012-2#1)
specific strains of##2##3##(2008-10#2)
specific strategies##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
specific structural##3##2##(1994-5#1)(2009-12#1)(2012-3#1)
specific structure##3##2##(1995-5#1)(2008-10#1)(2012-2#1)
specific structures##2##2##(2008-7#1)(2010-4#1)
specific subsets of##2##3##(2008-2#1)(2008-7#1)
specific substrate##2##2##(1993-11#1)(2008-6#1)
specific substrates##4##2##(2006-6#1)(2008-9#1)(2010-12#1)(2012-12#1)
specific subtypes of##2##3##(2008-3#1)(2008-8#1)
specific subtypes##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
specific sugar##3##2##(1994-6#2)(2011-1#1)
specific surface area was synthesized##2##5##(2008-10#2)
specific surface area##4##3##(1990-8#1)(2008-10#2)(2013-1#1)
specific surface areas##2##3##(1990-8#1)(2008-10#1)
specific surface##10##2##(1990-8#2)(2008-10#4)(2008-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
specific symptoms and##2##3##(2008-9#1)(2010-12#1)
specific symptoms##5##2##(1996-4#1)(1997-2#1)(2008-9#1)(2010-12#1)(2012-1#1)
specific target##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
specific targeting of##2##3##(1995-12#1)(2012-3#1)
specific targeting##4##2##(1994-8#1)(1995-12#1)(2011-2#1)(2012-3#1)
specific targets##4##2##(2008-3#1)(2009-9#1)(2012-3#1)(2013-8#1)
specific task##2##2##(2008-4#1)(2013-7#1)
specific tasks##2##2##(1996-1#1)(2008-10#1)
specific test##3##2##(1996-3#1)(2008-2#1)(2011-2#1)
specific tests##2##2##(1993-2#1)(2008-5#1)
specific therapeutic##4##2##(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
specific therapies to##2##3##(2009-1#1)(2010-7#1)
specific therapies##4##2##(2008-2#1)(2009-1#1)(2009-4#1)(2010-7#1)
specific therapy for##2##3##(1990-2#1)(2008-10#1)
specific therapy##3##2##(1990-2#1)(2008-10#1)(2010-1#1)
specific thioredoxins##2##2##(1990-12#1)(2009-10#1)
specific time points##2##3##(2010-4#2)
specific time##5##2##(1997-4#1)(2008-10#2)(2010-4#2)
specific tissue##2##2##(1995-6#1)(2008-10#1)
specific tissues##5##2##(1993-12#1)(1994-5#1)(2008-11#1)(2010-5#1)(2011-2#1)
specific to DRB1*0406##2##3##(1997-8#2)
specific to V##3##3##(2008-10#2)(2009-8#1)
specific to a##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
specific to each##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
specific to the particular##2##4##(1995-8#1)(2008-10#1)
specific to the##35##3##(1990-7#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
specific to this##6##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)
specific to##110##2##(1990-11#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
specific training##2##2##(1991-12#1)(2012-12#1)
specific treatment and##2##3##(2007-2#1)(2011-2#1)
specific treatment for##3##3##(1994-9#1)(1996-11#1)(2013-1#1)
specific treatment of##2##3##(2008-1#1)(2008-8#1)
specific treatment##25##2##(1993-1#1)(1993-2#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
specific treatments##3##2##(1995-12#1)(2009-4#1)(2013-1#1)
specific tumor##2##2##(2008-10#1)(2008-7#1)
specific type of##3##3##(1990-8#1)(1992-2#1)(2008-10#1)
specific type##5##2##(1990-8#1)(1991-5#1)(1992-2#1)(2008-10#1)(2011-1#1)
specific types of##4##3##(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
specific tyrosine-phosphorylated peptides##3##3##(2008-1#2)(2008-4#1)
specific uptake##2##2##(1996-5#2)
specific use##2##2##(1994-1#1)(2012-12#1)
specific uses##2##2##(1991-12#1)(2008-6#1)
specific vaccination##2##2##(2012-12#2)
specific value for##2##3##(1993-2#1)(1995-9#1)
specific virulence on##2##3##(2008-10#2)
specific virulence##6##2##(2008-10#6)
specific volume##4##2##(2008-10#3)(2009-7#1)
specific warnings##2##2##(2013-1#2)
specific way##2##2##(1997-7#1)(2008-12#1)
specific ways##4##2##(1996-1#1)(2008-10#2)(2008-11#1)
specific wheat cultivars##2##3##(2008-10#2)
specific yeast artificial chromosome##2##4##(1996-8#1)(2008-5#1)
specific##3242##1##(1990-11#22)(1990-12#32)(1990-2#25)(1990-3#6)(1990-5#28)(1990-6#6)(1990-7#11)(1990-8#14)(1990-9#2)(1991-1#3)(1991-11#6)(1991-12#21)(1991-2#25)(1991-3#6)(1991-5#18)(1991-6#8)(1991-7#1)(1991-8#4)(1991-9#13)(1992-1#7)(1992-10#2)(1992-11#13)(1992-12#12)(1992-2#9)(1992-3#22)(1992-5#4)(1992-6#13)(1992-7#2)(1992-8#11)(1992-9#19)(1993-1#7)(1993-10#1)(1993-11#20)(1993-12#16)(1993-2#10)(1993-3#9)(1993-5#4)(1993-6#22)(1993-8#27)(1993-9#12)(1994-1#8)(1994-10#1)(1994-11#23)(1994-12#17)(1994-2#21)(1994-3#18)(1994-5#15)(1994-6#16)(1994-8#37)(1994-9#6)(1995-1#3)(1995-11#33)(1995-12#30)(1995-2#24)(1995-3#18)(1995-5#17)(1995-6#16)(1995-8#14)(1995-9#8)(1996-1#7)(1996-10#1)(1996-11#5)(1996-12#25)(1996-2#24)(1996-3#14)(1996-4#4)(1996-5#26)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#21)(1997-3#10)(1997-4#15)(1997-5#1)(1997-6#14)(1997-7#17)(1997-8#11)(1997-9#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-10#9)(2007-11#19)(2007-12#44)(2007-2#7)(2007-4#3)(2007-5#5)(2007-6#4)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#40)(2008-10#442)(2008-11#242)(2008-12#31)(2008-2#54)(2008-3#61)(2008-4#109)(2008-5#69)(2008-6#32)(2008-7#142)(2008-8#81)(2008-9#80)(2009-1#3)(2009-10#16)(2009-11#11)(2009-12#9)(2009-2#3)(2009-3#13)(2009-4#6)(2009-5#20)(2009-6#10)(2009-7#14)(2009-8#21)(2009-9#10)(2010-1#8)(2010-10#6)(2010-11#19)(2010-12#14)(2010-2#8)(2010-3#11)(2010-4#17)(2010-5#11)(2010-6#13)(2010-7#8)(2010-8#19)(2010-9#4)(2011-1#35)(2011-10#1)(2011-2#113)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#11)(2012-12#35)(2012-2#72)(2012-3#35)(2012-5#2)(2012-7#2)(2012-8#1)(2013-1#75)(2013-7#5)(2013-8#51)
specific-pathogen-free##3##1##(2008-5#3)
specifically a##2##2##(1994-11#1)(1995-12#1)
specifically address##2##2##(2008-11#1)(2008-7#1)
specifically addressing##2##2##(2011-2#1)(2013-1#1)
specifically affect the##2##3##(2008-11#1)(2008-7#1)
specifically affect##3##2##(1995-6#1)(2008-11#1)(2008-7#1)
specifically against##2##2##(1996-12#1)(2012-3#1)
specifically amplified##3##2##(1993-12#1)(2008-10#2)
specifically and directly##2##3##(1992-8#1)(2010-1#1)
specifically and stably##2##3##(1994-8#2)
specifically and##8##2##(1992-8#1)(1993-8#1)(1994-8#2)(1997-2#1)(2008-10#1)(2010-1#1)(2010-11#1)
specifically antagonized by##2##3##(1992-8#1)(1993-11#1)
specifically as it##2##3##(2008-1#1)(2013-8#1)
specifically as##3##2##(2008-1#1)(2013-8#2)
specifically associated with##4##3##(1990-8#1)(2007-8#1)(2011-2#1)(2013-8#1)
specifically associated##6##2##(1990-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
specifically at the##2##3##(2008-5#1)(2013-8#1)
specifically be##2##2##(2006-10#1)(2008-10#1)
specifically between##2##2##(2008-8#1)(2011-1#1)
specifically bind the##2##3##(1993-6#1)(2008-10#1)
specifically bind to the##2##4##(1992-6#1)(2008-7#1)
specifically bind to##4##3##(1992-6#1)(1992-8#1)(2008-10#1)(2008-7#1)
specifically bind##7##2##(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-7#1)
specifically binds BMP-2 and BMP-4##2##5##(1994-12#2)
specifically binds to##8##3##(1990-12#1)(1991-5#1)(1993-3#1)(1993-8#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
specifically binds##14##2##(1990-12#2)(1991-5#1)(1993-3#1)(1993-8#1)(1994-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
specifically bound to the##3##4##(1993-6#1)(2008-11#1)(2008-8#1)
specifically bound to##5##3##(1993-3#1)(1993-6#1)(2008-11#1)(2008-8#2)
specifically bound##9##2##(1991-5#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#2)
specifically by##7##2##(1990-11#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#2)
specifically cleave##2##2##(1993-9#1)(2008-8#1)
specifically cleaved##3##2##(1991-5#1)(1992-11#1)(1994-8#1)
specifically competed##2##2##(1993-6#1)(1996-12#1)
specifically cytotoxic##2##2##(1995-2#1)(2008-9#1)
specifically designed for the##3##4##(1991-1#1)(2007-12#1)(2008-3#1)
specifically designed for use##2##4##(2007-11#1)(2008-4#1)
specifically designed for##11##3##(1991-1#1)(1993-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
specifically designed to##10##3##(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-3#2)(2008-4#1)(2009-11#1)(2011-2#1)(2012-2#1)
specifically designed##24##2##(1990-3#1)(1991-1#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2009-11#1)(2011-2#1)(2012-2#1)
specifically detect##5##2##(2008-10#3)(2008-4#1)(2011-2#1)
specifically detected##6##2##(1993-3#1)(2008-10#4)(2008-4#1)
specifically developed for##3##3##(1996-3#1)(2008-10#1)(2008-4#1)
specifically developed to##2##3##(2008-3#1)(2011-1#1)
specifically developed##7##2##(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-1#1)
specifically directed against##2##3##(2008-6#1)(2009-2#1)
specifically evaluated##2##2##(1997-4#1)(2008-3#1)
specifically examined##2##2##(2008-11#2)
specifically expressed in a##2##4##(1996-10#1)(2008-7#1)
specifically expressed in testis##2##4##(1995-6#1)(2008-8#1)
specifically expressed in the##3##4##(1992-9#1)(2008-11#1)(2008-8#1)
specifically expressed in##16##3##(1992-9#1)(1995-6#1)(1996-10#1)(2008-11#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-7#1)
specifically expressed##20##2##(1991-5#1)(1991-9#1)(1992-9#1)(1995-6#1)(1996-10#1)(2008-11#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-8#1)(2010-7#1)
specifically focusing on##2##3##(2010-4#1)(2012-12#1)
specifically for the##3##3##(2007-6#1)(2008-3#1)(2008-5#1)
specifically for##30##2##(1990-11#1)(1992-1#1)(1995-6#1)(1996-1#1)(1997-2#1)(2007-12#1)(2007-6#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
specifically from the##2##3##(2008-10#1)(2013-1#1)
specifically from##8##2##(1995-2#1)(1995-3#1)(2008-10#4)(2008-3#1)(2013-1#1)
specifically in the testis##2##4##(1993-12#1)(1995-6#1)
specifically in the##11##3##(1990-11#1)(1990-12#1)(1993-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-7#1)
specifically in##30##2##(1990-11#2)(1990-12#1)(1990-8#1)(1993-12#2)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
specifically increased##2##2##(1991-5#1)(1996-2#1)
specifically increases cytosolic##2##3##(1993-8#1)(1994-6#1)
specifically induced by wounding##2##4##(1997-2#2)
specifically induced by##3##3##(1997-2#2)(2008-10#1)
specifically inhibit##3##2##(1991-7#1)(1993-3#1)(2009-12#1)
specifically inhibited##4##2##(1992-3#2)(1994-9#1)(2008-10#1)
specifically interact with##3##3##(1994-12#1)(1997-7#1)(2009-6#1)
specifically involved in##3##3##(1992-9#1)(2009-10#1)(2009-8#1)
specifically labeled##3##2##(1992-8#1)(2008-10#1)(2009-5#1)
specifically linked to##2##3##(1997-3#1)(2011-1#1)
specifically on the##3##3##(1991-12#1)(1994-12#1)(2008-8#1)
specifically on##8##2##(1991-12#1)(1993-3#1)(1994-12#1)(1996-5#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
specifically prevents the##2##3##(1990-11#1)(1994-8#1)
specifically reacted with##2##3##(1995-11#1)(2008-10#1)
specifically recognize##6##2##(1992-8#1)(1994-6#1)(1996-5#1)(2008-10#2)(2009-5#1)
specifically recognized a single##2##4##(1991-9#1)(1995-6#1)
specifically recognized a##3##3##(1991-9#1)(1995-6#1)(2008-11#1)
specifically recognized the##2##3##(1995-8#1)(1996-2#1)
specifically recognized##11##2##(1991-9#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)
specifically reduced##2##2##(1992-12#1)(2008-10#1)
specifically regulate##2##2##(1991-9#1)(2009-8#1)
specifically related to##4##3##(1992-3#1)(1995-8#1)(2008-11#1)(2009-11#1)
specifically removes##2##2##(1992-9#1)(1993-12#1)
specifically stimulated##2##2##(1993-1#1)(2008-11#1)
specifically target the##2##3##(2008-12#1)(2010-4#1)
specifically target##5##2##(2008-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)
specifically targeted##2##2##(1990-6#1)(1995-12#1)
specifically targeting the##2##3##(2010-7#1)(2012-3#1)
specifically the##15##2##(1992-12#1)(1993-1#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-11#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
specifically through the##2##3##(1997-7#1)(2008-10#1)
specifically to address##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
specifically to the##9##3##(1992-5#1)(1992-8#1)(1995-11#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-9#1)(2010-11#1)(2011-1#1)
specifically to##38##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1997-8#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#4)(2012-3#1)(2013-1#1)
specifically upregulated##2##2##(2008-11#1)(2010-12#1)
specifically with a##2##3##(1991-12#1)(1994-8#1)
specifically with the##6##3##(1992-8#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
specifically with##20##2##(1991-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
specifically##584##1##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#6)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#8)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#9)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#7)(1994-2#2)(1994-6#4)(1994-8#12)(1994-9#5)(1995-11#5)(1995-12#5)(1995-2#13)(1995-3#1)(1995-5#2)(1995-6#10)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#11)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#57)(2008-11#32)(2008-12#8)(2008-2#6)(2008-3#17)(2008-4#22)(2008-5#16)(2008-6#5)(2008-7#15)(2008-8#15)(2008-9#19)(2009-10#6)(2009-11#4)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#3)(2011-1#10)(2011-2#20)(2012-1#1)(2012-12#5)(2012-2#17)(2012-3#5)(2012-6#1)(2013-1#11)(2013-8#8)
specification and##5##2##(1994-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
specification for##2##2##(2007-11#1)(2010-8#1)
specification in##2##2##(1994-9#1)(2009-4#1)
specification is##3##2##(1994-3#1)(2009-3#1)(2013-8#1)
specification of the##9##3##(1995-2#1)(1996-4#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-8#2)(2010-5#1)(2013-1#1)
specification of##22##2##(1990-11#1)(1990-12#1)(1991-1#1)(1994-3#1)(1995-2#2)(1996-4#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-8#2)(2010-5#1)(2012-2#1)(2013-1#1)
specification##50##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#1)(1994-12#1)(1994-3#5)(1994-9#1)(1995-2#2)(1996-4#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#2)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
specifications and##2##2##(2011-2#1)(2012-2#1)
specifications are##5##2##(1993-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
specifications can be##2##3##(2008-2#1)(2011-2#1)
specifications for a##2##3##(1997-6#1)(2008-3#1)
specifications for##5##2##(1994-1#1)(1997-6#1)(2008-3#3)
specifications of the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
specifications of##6##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
specifications##40##1##(1991-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#7)(2008-3#10)(2008-8#1)(2009-11#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#1)
specificities and##4##2##(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)
specificities in##2##2##(2007-7#1)(2008-10#1)
specificities of the##2##3##(1994-12#2)
specificities of##12##2##(1990-7#1)(1991-12#2)(1991-2#1)(1994-12#2)(1994-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#2)
specificities towards##2##2##(2008-10#1)(2012-2#1)
specificities##42##1##(1990-7#1)(1991-12#2)(1991-2#2)(1991-9#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-3#2)(2011-1#3)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
specificity (0##2##2##(2006-10#1)(2012-3#1)
specificity 91##2##2##(1997-4#1)(2011-2#1)
specificity 95%)##2##2##(1997-8#2)
specificity against##2##2##(1997-7#1)(2008-10#1)
specificity and accuracy of##2##4##(2011-2#1)(2013-8#1)
specificity and mechanism##2##3##(1992-11#1)(1997-7#1)
specificity and sensitivity of##3##4##(2008-10#2)(2008-11#1)
specificity and sensitivity##8##3##(1996-9#1)(1997-2#1)(2008-10#5)(2008-11#1)
specificity and the##3##3##(1990-3#1)(1993-6#1)(2008-10#1)
specificity and##51##2##(1990-3#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-2#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
specificity are##2##2##(1991-9#1)(2008-4#1)
specificity as well as##3##4##(1991-9#1)(2008-4#1)(2010-4#1)
specificity as##5##2##(1991-12#1)(1991-9#1)(2008-4#1)(2009-9#1)(2010-4#1)
specificity between##2##2##(1993-3#1)(1995-5#1)
specificity by##5##2##(1990-7#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
specificity could##2##2##(1995-2#1)(2008-10#1)
specificity during##2##2##(2008-6#1)(2012-2#1)
specificity for DNA##2##3##(2008-11#2)
specificity for a##3##3##(1990-11#1)(1992-12#1)(2012-3#1)
specificity for aspartate##2##3##(1995-6#1)(2008-4#1)
specificity for the diagnosis of##2##5##(2008-3#1)(2011-2#1)
specificity for the##5##3##(1990-7#1)(1994-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
specificity for##46##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
specificity in the##4##3##(1992-9#1)(1996-8#1)(2008-10#1)(2011-2#1)
specificity in##21##2##(1990-12#1)(1992-11#1)(1992-9#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
specificity is##3##2##(1991-5#1)(1994-9#1)(1997-2#1)
specificity of 100% and##2##4##(1997-3#1)(2007-7#1)
specificity of 100%##3##3##(1997-3#1)(2007-7#1)(2007-8#1)
specificity of 85##2##3##(2011-1#1)(2013-8#1)
specificity of 95%##2##3##(1997-8#1)(2013-1#1)
specificity of PSA##2##3##(2008-9#1)(2012-12#1)
specificity of a##7##3##(1991-9#1)(1992-9#1)(2008-10#2)(2008-2#1)(2012-3#1)(2013-1#1)
specificity of action##2##3##(1990-12#1)(1992-5#1)
specificity of binding##3##3##(1990-5#1)(1995-2#1)(2008-4#1)
specificity of human##2##3##(1994-3#1)(2012-12#1)
specificity of the TDX system##2##5##(1993-8#2)
specificity of the assay##3##4##(1997-2#1)(1997-4#1)(2008-10#1)
specificity of the immobilized##2##4##(2008-10#1)(2008-7#1)
specificity of the##69##3##(1990-11#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-4#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
specificity of these##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
specificity of this##8##3##(1990-9#1)(1991-5#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-11#1)
specificity of##207##2##(1990-11#2)(1990-12#1)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#3)(1991-12#1)(1991-2#3)(1991-5#2)(1991-9#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#3)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-8#2)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#3)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#6)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#3)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#2)
specificity on##3##2##(2008-10#3)
specificity protein 1##2##3##(2013-1#2)
specificity remains##2##2##(2008-11#1)(2012-2#1)
specificity than##2##2##(1992-12#1)(2008-10#1)
specificity to a##2##3##(1994-8#1)(2008-8#1)
specificity to the##4##3##(1991-9#1)(1997-4#1)(2008-10#1)(2011-2#1)
specificity to##13##2##(1990-2#1)(1991-9#2)(1992-6#1)(1994-2#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
specificity was##21##2##(1992-3#1)(1995-12#1)(1995-2#1)(1996-12#5)(1997-3#1)(2007-8#1)(2008-10#4)(2008-8#2)(2010-6#1)(2011-2#3)(2013-1#1)
specificity were##5##2##(1990-6#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
specificity with##4##2##(1997-3#2)(2011-1#1)(2012-12#1)
specificity##643##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#9)(1990-6#2)(1990-7#11)(1990-8#2)(1990-9#3)(1991-12#4)(1991-2#3)(1991-4#1)(1991-5#4)(1991-8#1)(1991-9#8)(1992-10#1)(1992-11#4)(1992-12#4)(1992-3#10)(1992-5#4)(1992-6#5)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#5)(1993-8#7)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#7)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#4)(1996-12#8)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#10)(1997-3#8)(1997-4#6)(1997-7#3)(1997-8#5)(2006-10#3)(2007-10#4)(2007-11#7)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#110)(2008-11#19)(2008-12#6)(2008-2#5)(2008-3#2)(2008-4#19)(2008-5#7)(2008-6#5)(2008-7#17)(2008-8#13)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#8)(2011-1#16)(2011-2#38)(2012-1#2)(2012-12#16)(2012-2#18)(2012-3#14)(2013-1#20)(2013-7#1)(2013-8#7)
specificity) and##2##2##(1991-12#1)(2011-2#1)
specificity)##4##1##(1991-12#2)(2008-10#1)(2011-2#1)
specificity?##4##1##(1992-11#1)(1994-6#1)(2008-12#1)(2009-5#1)
specifics##4##1##(1996-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
specified a##3##2##(1997-2#1)(2008-10#1)(2013-1#1)
specified and##2##2##(1996-9#1)(2009-7#1)
specified as a function of##2##5##(2008-11#1)(2008-2#1)
specified as##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
specified by a##5##3##(1992-3#1)(1994-11#1)(1995-6#1)(2008-10#1)(2013-1#1)
specified by the##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
specified by##11##2##(1992-3#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
specified conditions##2##2##(2008-10#2)
specified for a##2##3##(2007-7#1)(2010-11#1)
specified for##5##2##(1991-12#1)(2007-7#1)(2008-10#1)(2010-11#1)(2013-1#1)
specified in the##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
specified in##5##2##(1996-9#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
specified intervals##2##2##(1996-4#1)(2007-10#1)
specified time##3##2##(2008-10#1)(2008-12#2)
specified##116##1##(1990-2#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#3)(1996-4#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#10)(2008-5#1)(2008-7#5)(2008-8#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
specifies the##6##2##(1991-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)
specifies##12##1##(1990-11#1)(1991-9#1)(1993-9#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#2)
specifity##3##1##(2007-2#1)(2008-10#1)(2011-2#1)
specify a##4##2##(2007-2#1)(2008-10#1)(2009-5#1)(2011-1#1)
specify the relationship between##2##4##(1997-1#1)(2010-11#1)
specify the##21##2##(1994-12#1)(1995-2#1)(1996-4#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
specify##35##1##(1990-8#1)(1991-5#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-4#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#3)(2008-10#5)(2008-2#3)(2008-3#2)(2008-7#1)(2009-10#2)(2009-5#1)(2010-11#1)(2011-1#2)(2013-1#1)(2013-8#1)
specifying a##2##2##(2008-3#1)(2013-8#1)
specifying the##10##2##(1991-9#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(2008-2#1)(2008-6#1)(2011-2#2)
specifying##21##1##(1991-1#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
specimen and##2##2##(2011-2#1)(2013-7#1)
specimen collection##3##2##(2009-5#1)(2010-6#2)
specimen for##3##2##(2007-12#1)(2008-9#1)(2009-8#1)
specimen in rectal##2##3##(2008-10#2)
specimen in##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
specimen is##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
specimen of the##3##3##(2008-10#2)(2008-5#1)
specimen of##7##2##(1995-3#1)(2008-10#2)(2008-5#1)(2011-2#2)(2013-1#1)
specimen revealed##5##2##(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
specimen showed##7##2##(2007-7#1)(2007-9#1)(2008-10#1)(2009-5#2)(2009-8#1)(2011-2#1)
specimen using##2##2##(2009-8#1)(2011-1#1)
specimen volume##3##2##(2009-7#3)
specimen was##12##2##(1992-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
specimen were##4##2##(1991-1#1)(2008-11#1)(2011-1#1)(2012-3#1)
specimen with##3##2##(2008-2#1)(2008-7#1)(2012-2#1)
specimen##134##1##(1991-1#1)(1991-6#1)(1992-6#1)(1992-8#2)(1994-9#1)(1995-3#2)(1996-1#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#2)(2009-5#3)(2009-7#11)(2009-8#3)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#4)(2010-9#1)(2011-1#5)(2011-2#12)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#5)
specimen-specific pelvic FE##2##3##(2013-1#2)
specimen-specific##3##1##(2013-1#3)
specimens after##2##2##(2006-8#1)(2011-2#1)
specimens analyzed##2##2##(2007-12#1)(2008-5#1)
specimens and##11##2##(1992-12#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)
specimens are##4##2##(1992-6#1)(2008-6#1)(2009-7#1)(2011-2#1)
specimens at the##2##3##(2008-11#1)(2008-12#1)
specimens at##4##2##(1993-8#1)(2008-11#1)(2008-12#1)(2010-4#1)
specimens by##6##2##(2008-10#4)(2008-2#1)(2011-2#1)
specimens can be##3##3##(2008-9#2)(2011-1#1)
specimens caught##2##2##(2013-7#2)
specimens collected via##2##3##(2011-1#2)
specimens collected##5##2##(2007-12#1)(2008-6#1)(2011-1#2)(2013-7#1)
specimens demonstrated##2##2##(2008-1#1)(2013-1#1)
specimens during##3##2##(2008-3#1)(2009-4#1)(2010-8#1)
specimens ex vivo##2##3##(2007-11#1)(2008-6#1)
specimens examined##3##2##(1994-8#1)(2008-5#1)(2008-6#1)
specimens exhibited##2##2##(2008-8#1)(2013-1#1)
specimens for##4##2##(1992-4#1)(2008-10#1)(2008-12#1)(2013-8#1)
specimens from patients in##2##4##(2007-12#1)(2008-5#1)
specimens from patients##5##3##(2007-12#1)(2008-5#1)(2009-11#1)(2012-1#2)
specimens from the##3##3##(2008-12#1)(2008-5#1)(2013-7#1)
specimens from##36##2##(1990-9#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1996-12#2)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-5#6)(2008-9#1)(2009-11#1)(2009-8#2)(2011-2#1)(2012-1#2)(2012-3#2)(2012-9#1)(2013-7#1)(2013-8#2)
specimens has##2##2##(2010-5#1)(2011-2#1)
specimens in##5##2##(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-8#1)
specimens increased##2##2##(2011-2#1)(2012-2#1)
specimens is##2##2##(1994-3#1)(2010-5#1)
specimens obtained at##2##3##(1994-7#1)(1997-8#1)
specimens obtained from##3##3##(1994-3#1)(2012-1#1)(2012-3#1)
specimens obtained##5##2##(1994-3#1)(1994-7#1)(1997-8#1)(2012-1#1)(2012-3#1)
specimens of C##2##3##(2008-10#1)(2008-6#1)
specimens of Pimelodus##2##3##(2008-12#2)
specimens of patients##2##3##(2008-12#1)(2010-11#1)
specimens of the##6##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
specimens of##37##2##(1991-11#1)(1991-12#1)(1992-3#1)(1996-10#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
specimens on##2##2##(2008-10#1)(2010-8#1)
specimens prepared from##2##3##(2008-1#1)(2008-10#1)
specimens received##2##2##(2008-12#1)(2012-3#1)
specimens revealed##7##2##(1991-11#1)(2008-1#3)(2010-10#1)(2011-2#1)(2012-12#1)
specimens showed##3##2##(2008-5#2)(2011-2#1)
specimens that##2##2##(1993-12#1)(2008-9#1)
specimens to the##2##3##(1994-3#1)(2007-5#1)
specimens to##4##2##(1994-3#1)(2007-12#1)(2007-5#1)(2008-10#1)
specimens using##4##2##(2007-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
specimens was##3##2##(2008-12#1)(2008-7#1)(2009-7#1)
specimens were analyzed and##2##4##(2013-7#2)
specimens were analyzed##5##3##(2007-7#1)(2013-1#1)(2013-7#3)
specimens were collected from##2##4##(1991-7#1)(2008-12#1)
specimens were collected##4##3##(1991-7#1)(2008-12#1)(2008-5#1)(2011-2#1)
specimens were identified##2##3##(2008-5#1)(2011-2#1)
specimens were prepared##2##3##(2008-12#1)(2011-2#1)
specimens were randomly##2##3##(2013-1#2)
specimens were subjected to##2##4##(2013-1#2)
specimens were taken##2##3##(2008-5#1)(2013-7#1)
specimens were tested in##2##4##(2008-12#1)(2012-2#1)
specimens were tested##4##3##(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)
specimens were then##2##3##(2008-3#1)(2009-7#1)
specimens were used##3##3##(1994-12#1)(2008-12#1)(2013-1#1)
specimens were##48##2##(1990-2#1)(1991-7#1)(1994-12#1)(1996-12#1)(2007-10#1)(2007-7#2)(2008-10#3)(2008-12#8)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#7)(2013-7#4)
specimens with##8##2##(2008-10#2)(2008-3#2)(2008-4#1)(2009-8#2)(2012-2#1)
specimens##381##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#5)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#5)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-10#1)(1996-12#4)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#3)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#8)(2007-5#2)(2007-7#4)(2007-8#1)(2008-1#8)(2008-10#30)(2008-11#4)(2008-12#29)(2008-2#2)(2008-3#10)(2008-4#10)(2008-5#25)(2008-6#9)(2008-7#6)(2008-8#3)(2008-9#19)(2009-11#1)(2009-4#3)(2009-7#10)(2009-8#8)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#4)(2010-4#3)(2010-5#3)(2010-8#5)(2011-1#5)(2011-2#25)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#10)(2012-3#9)(2012-7#1)(2012-9#1)(2013-1#19)(2013-7#10)(2013-8#12)
specimens) in##2##2##(2008-12#1)(2008-6#1)
specimens)##3##1##(2008-12#1)(2008-6#1)(2011-2#1)
speciosa extract##2##2##(2008-5#1)(2010-3#1)
speciosa##11##1##(2008-12#1)(2008-5#3)(2010-3#5)(2011-2#1)(2013-8#1)
speck of tomato##2##3##(2008-10#2)
speck##12##1##(2008-10#12)
speckle and##3##2##(2007-12#1)(2008-3#2)
speckle correlation method##2##3##(2008-3#2)
speckle correlation##3##2##(2008-3#3)
speckle effects in##2##3##(2008-2#1)(2008-3#1)
speckle field##4##2##(2007-12#2)(2008-3#2)
speckle fields##4##2##(2008-2#1)(2008-3#3)
speckle intensity##2##2##(2008-2#1)(2008-3#1)
speckle interferometer##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
speckle interferometric##2##2##(2008-2#2)
speckle interferometry##8##2##(2008-2#3)(2008-3#5)
speckle is##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
speckle modulation##3##2##(2007-11#1)(2007-12#2)
speckle noise##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
speckle pattern fluctuations##2##3##(2007-11#2)
speckle pattern interferometry (ESPI)##2##4##(2008-2#1)(2009-7#1)
speckle pattern interferometry##13##3##(2008-2#6)(2008-3#5)(2008-8#1)(2009-7#1)
speckle pattern##25##2##(2007-11#3)(2007-12#2)(2008-2#10)(2008-3#8)(2008-8#1)(2009-7#1)
speckle patterns scattered##2##3##(2008-2#1)(2008-3#1)
speckle patterns##9##2##(2008-2#5)(2008-3#4)
speckle photography and##2##3##(2008-2#1)(2008-3#1)
speckle photography technique##2##3##(2007-11#1)(2008-3#1)
speckle photography##17##2##(2007-11#2)(2008-2#1)(2008-3#14)
speckle signal##3##2##(2008-3#3)
speckle signals##2##2##(2008-3#2)
speckle size##4##2##(2008-2#1)(2008-3#3)
speckle statistics in##2##3##(2008-2#1)(2008-3#1)
speckle statistics##4##2##(2008-2#2)(2008-3#2)
speckle velocimeter with two self-mixing laser diodes##2##7##(2008-3#2)
speckle velocimeter with##3##3##(2008-3#3)
speckle velocimeter##6##2##(2008-3#6)
speckle##160##1##(2007-11#11)(2007-12#14)(2008-1#2)(2008-2#44)(2008-3#85)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#1)
speckle-field-based##2##1##(2007-11#2)
speckle-free##2##1##(2007-12#1)(2008-3#1)
speckle-pattern illumination##2##2##(2008-2#2)
speckle-pattern interferometry##11##2##(2008-2#3)(2008-3#8)
speckle-pattern##15##1##(2008-2#5)(2008-3#10)
speckle-tracking echocardiography##2##2##(2011-2#2)
speckled images##2##2##(2007-12#1)(2008-3#1)
speckled leaf blotch##6##3##(2008-10#6)
speckled speckles##2##2##(2008-3#2)
speckled##15##1##(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#4)
speckles and##2##2##(2007-12#1)(2008-2#1)
speckles are##2##2##(2007-12#2)
speckles in##3##2##(2008-2#2)(2008-3#1)
speckles##17##1##(2007-12#4)(2008-2#8)(2008-3#4)(2013-1#1)
speckling##2##1##(2008-3#2)
spectabilis##2##1##(2010-3#2)
spectacle corrected visual##2##3##(2011-2#1)(2012-3#1)
spectacle independence##2##2##(2011-2#2)
spectacle##5##1##(2011-2#3)(2012-12#1)(2012-3#1)
spectacles##2##1##(1993-11#1)(2011-2#1)
spectacular##8##1##(1991-2#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#1)
spectators##3##1##(1996-3#2)(2012-2#1)
specter##2##1##(1995-12#1)(2013-1#1)
spectra and a##2##3##(2008-10#2)
spectra and electrochemical properties of##2##5##(1996-5#1)(2008-8#1)
spectra and the##6##3##(2007-12#2)(2008-10#3)(2010-9#1)
spectra and their##4##3##(2008-10#4)
spectra and##46##2##(1992-1#1)(1993-11#1)(1994-3#1)(1994-5#1)(1996-5#2)(1997-7#1)(2007-11#1)(2007-12#5)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#2)(2013-8#1)
spectra are in good agreement##2##5##(2008-2#1)(2008-3#1)
spectra are measured at##2##4##(2008-10#1)(2008-3#1)
spectra are obtained in##2##4##(2008-10#1)(2012-8#1)
spectra are obtained##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2012-8#1)
spectra are presented##2##3##(2008-10#1)(2008-2#1)
spectra are recorded##3##3##(1997-2#1)(2008-3#1)(2012-2#1)
spectra are used##2##3##(2008-3#2)
spectra are##33##2##(1997-2#1)(2006-4#2)(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#4)(2008-3#6)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-8#1)
spectra as a function of the##2##6##(2008-2#1)(2008-3#1)
spectra as a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
spectra as well as##4##4##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
spectra as##13##2##(2008-10#7)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)
spectra at##5##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
spectra between##4##2##(2008-10#3)(2008-3#1)
spectra by a##3##3##(2008-3#3)
spectra by use of##4##4##(2007-12#1)(2008-3#3)
spectra by using a##2##4##(2008-2#1)(2008-3#1)
spectra by using##3##3##(2008-2#1)(2008-3#2)
spectra by##15##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#11)
spectra can be##3##3##(2008-10#1)(2008-3#2)
spectra can##4##2##(2008-10#2)(2008-3#2)
spectra confirmed the##2##3##(1997-2#1)(2008-10#1)
spectra demonstrated##2##2##(2007-12#1)(2008-10#1)
spectra derivative##6##2##(2008-10#6)
spectra derived##2##2##(2008-10#1)(2008-2#1)
spectra directly##2##2##(2007-11#1)(2008-10#1)
spectra do not##2##3##(2008-3#1)(2008-5#1)
spectra do##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
spectra due to##3##3##(2008-10#2)(2012-2#1)
spectra during the##2##3##(1996-12#1)(2007-12#1)
spectra exhibit##2##2##(1997-7#1)(2007-1#1)
spectra for the##7##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-11#1)
spectra for##19##2##(1990-8#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-5#1)(2010-11#1)
spectra from a##3##3##(1990-8#1)(2008-2#1)(2008-8#1)
spectra from the##2##3##(2007-12#1)(2008-2#1)
spectra from##16##2##(1990-8#1)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#2)(2008-5#1)(2008-8#1)
spectra generated##2##2##(2007-11#1)(2008-10#1)
spectra has been##2##3##(2008-10#2)
spectra have been##3##3##(1990-8#1)(2007-12#1)(2008-10#1)
spectra have##5##2##(1990-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
spectra in the visible##2##4##(2008-10#1)(2008-2#1)
spectra in the wavelength##2##4##(2008-3#2)
spectra in the##14##3##(1992-6#1)(1992-8#1)(2008-10#5)(2008-2#2)(2008-3#5)
spectra in##24##2##(1992-6#1)(1992-8#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#10)
spectra indicate a##2##3##(1996-2#1)(2010-12#1)
spectra indicate that##2##3##(1991-11#1)(2008-10#1)
spectra indicate##4##2##(1991-11#1)(1996-2#1)(2008-10#1)(2010-12#1)
spectra indicated that the##2##4##(1997-7#1)(2008-10#1)
spectra indicated that##3##3##(1997-7#1)(2008-10#1)(2013-8#1)
spectra indicated##5##2##(1992-6#1)(1997-7#1)(2008-10#2)(2013-8#1)
spectra into##2##2##(2008-10#1)(2008-7#1)
spectra is demonstrated##2##3##(2008-10#1)(2008-3#1)
spectra is presented##2##3##(1994-3#1)(2008-3#1)
spectra is##20##2##(1994-3#1)(1995-5#1)(2008-10#5)(2008-2#3)(2008-3#7)(2008-4#1)(2008-9#1)(2010-2#1)
spectra measured##3##2##(2008-3#3)
spectra obtained from##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)
spectra obtained with##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
spectra obtained##19##2##(1990-7#1)(2007-11#2)(2008-10#7)(2008-2#2)(2008-3#3)(2008-4#1)(2010-5#3)
spectra of 12##2##3##(2008-10#2)
spectra of HA##3##3##(2008-10#1)(2013-8#2)
spectra of a##8##3##(1991-5#1)(1997-7#1)(2008-10#2)(2008-3#3)(2008-9#1)
spectra of ammonia##2##3##(2007-12#2)
spectra of aqueous##3##3##(2008-10#2)(2008-3#1)
spectra of biological##4##3##(1995-12#1)(2008-10#1)(2011-1#2)
spectra of calcified human heart-valve##2##5##(2008-3#2)
spectra of calcified##3##3##(2008-3#3)
spectra of human sera##2##4##(2008-3#2)
spectra of human##4##3##(2008-3#4)
spectra of individual##3##3##(2008-10#2)(2009-9#1)
spectra of mixtures##3##3##(2008-10#3)
spectra of molecular##2##3##(1996-2#1)(2012-2#1)
spectra of n-component solid mixtures##2##5##(2008-10#2)
spectra of nitric oxide##2##4##(2008-2#2)
spectra of pure chlorophenols##2##4##(2008-10#2)
spectra of pure##3##3##(2008-10#3)
spectra of six##2##3##(2008-10#2)
spectra of the analytes##2##4##(2008-10#2)
spectra of the complex##2##4##(1994-11#1)(2008-10#1)
spectra of the##75##3##(1990-2#1)(1990-5#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-11#2)(1994-3#2)(1995-5#2)(1996-2#1)(1997-7#2)(2007-11#3)(2007-12#5)(2008-10#25)(2008-2#8)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2013-1#1)(2013-8#3)
spectra of their##2##3##(2008-10#2)
spectra of these compounds##3##4##(2008-10#3)
spectra of these##8##3##(2008-10#6)(2008-3#1)(2009-10#1)
spectra of turbid media##2##4##(2008-3#2)
spectra of##270##2##(1990-2#3)(1990-5#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#5)(1993-11#3)(1993-5#1)(1993-8#1)(1994-11#4)(1994-3#3)(1994-5#2)(1995-12#1)(1995-5#3)(1996-2#5)(1996-7#1)(1997-7#6)(2007-1#1)(2007-11#8)(2007-12#12)(2008-1#1)(2008-10#92)(2008-11#1)(2008-12#1)(2008-2#16)(2008-3#46)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#11)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-5#3)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#14)
spectra on the##3##3##(2007-12#1)(2008-10#2)
spectra on##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
spectra or##2##2##(2007-12#1)(2008-7#1)
spectra over##2##2##(2008-10#1)(2008-3#1)
spectra produced##2##2##(2008-10#1)(2008-8#1)
spectra provided##2##2##(2007-12#1)(2008-10#1)
spectra recorded at##2##3##(2008-10#1)(2008-3#1)
spectra recorded by##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
spectra recorded##12##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#1)
spectra reveal that##2##3##(1994-8#1)(2008-10#1)
spectra reveal the##2##3##(2008-10#1)(2008-3#1)
spectra reveal##4##2##(1994-8#1)(2008-10#2)(2008-3#1)
spectra revealed##6##2##(1992-5#2)(1992-6#1)(1994-3#1)(2008-10#2)
spectra show that the##4##4##(2007-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
spectra show that##6##3##(2007-1#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-6#1)
spectra show##9##2##(1996-2#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-8#1)(2009-6#1)
spectra showed that##4##3##(1995-3#1)(2007-12#1)(2013-8#2)
spectra showed the##3##3##(1995-5#1)(2008-10#2)
spectra showed##13##2##(1990-2#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-5#1)(2013-8#2)
spectra similar to##2##3##(1993-12#1)(1994-12#1)
spectra suggest##2##2##(1996-2#1)(2008-10#1)
spectra that are##2##3##(2007-12#1)(2008-3#1)
spectra that cover##2##3##(2008-3#2)
spectra that##10##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)
spectra to be##3##3##(2008-10#1)(2008-3#2)
spectra to the##2##3##(2008-3#2)
spectra to##13##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#7)(2011-1#1)
spectra using##3##2##(2008-10#3)
spectra was##4##2##(2008-10#3)(2013-1#1)
spectra were acquired##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
spectra were analysed by principal component analysis (PCA) and the relevant principal components (PCs) were used for constructing multivariate Shewhart##2##20##(2008-10#2)
spectra were analysed##3##3##(2008-10#3)
spectra were analyzed##2##3##(2008-10#1)(2008-3#1)
spectra were collected from##2##4##(2007-11#1)(2008-3#1)
spectra were collected##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-8#1)
spectra were measured for##2##4##(1996-5#1)(2008-2#1)
spectra were measured##5##3##(1996-5#1)(2007-11#1)(2008-2#3)
spectra were observed##2##3##(2007-11#1)(2008-10#1)
spectra were obtained##3##3##(1990-7#1)(2008-10#2)
spectra were recorded at various##2##5##(2008-10#2)
spectra were recorded for##2##4##(2008-10#2)
spectra were recorded##7##3##(2008-10#7)
spectra were used##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
spectra were##49##2##(1990-7#1)(1992-8#1)(1995-2#2)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#24)(2008-2#7)(2008-3#6)(2008-6#1)(2011-1#1)(2013-8#1)
spectra which##2##2##(1994-3#1)(2008-2#1)
spectra with a##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
spectra with the##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
spectra with those of##2##4##(1990-5#1)(2008-10#1)
spectra with##15##2##(1990-5#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#2)(2010-4#1)(2013-1#1)(2013-8#1)
spectra without##3##2##(2008-10#2)(2008-3#1)
spectra##989##1##(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#5)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#2)(1991-5#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#7)(1993-11#5)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#4)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#7)(1996-12#1)(1996-2#13)(1996-5#6)(1996-7#1)(1997-2#4)(1997-6#1)(1997-7#10)(2006-4#3)(2007-1#3)(2007-11#42)(2007-12#63)(2008-1#4)(2008-10#337)(2008-11#7)(2008-12#4)(2008-2#85)(2008-3#177)(2008-4#11)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#13)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#7)(2010-9#1)(2011-1#7)(2011-2#7)(2012-12#1)(2012-2#5)(2012-8#2)(2013-1#7)(2013-8#32)
spectra)##8##1##(2008-10#7)(2008-3#1)
spectral EEG characteristics of##3##4##(2008-7#3)
spectral absorption data##2##3##(2008-10#1)(2008-3#1)
spectral absorption##6##2##(2008-10#1)(2008-3#5)
spectral amplitude##2##2##(2007-12#1)(2008-3#1)
spectral amplitudes##2##2##(2008-3#2)
spectral analysis and##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
spectral analysis in##2##3##(1991-12#1)(2008-7#1)
spectral analysis is##2##3##(2008-10#1)(2011-2#1)
spectral analysis of##9##3##(1990-5#1)(1991-10#1)(2007-12#2)(2008-3#2)(2009-9#1)(2012-2#1)(2013-1#1)
spectral analysis was##2##3##(1995-2#1)(1996-5#1)
spectral analysis##28##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-8#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
spectral and polarization##2##3##(2007-12#1)(2008-3#1)
spectral and spatial##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
spectral and##17##2##(1994-3#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#8)(2009-9#1)(2010-3#1)
spectral angle##4##2##(2007-12#1)(2013-8#3)
spectral asymmetry of TEA CO2 laser pulses##2##7##(2008-3#2)
spectral atmospheric transmission and##2##4##(2008-2#2)
spectral band##11##2##(2008-10#1)(2008-3#7)(2008-7#2)(2012-2#1)
spectral bandpass##2##2##(2007-11#1)(2008-10#1)
spectral bands of##2##3##(2008-10#2)
spectral bands##10##2##(2007-12#1)(2008-10#3)(2008-3#5)(2008-7#1)
spectral bandwidth and##2##3##(2007-11#1)(2008-2#1)
spectral bandwidth calibration##2##3##(2008-3#2)
spectral bandwidth of the##2##4##(2008-2#1)(2008-3#1)
spectral bandwidth of##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
spectral bandwidth standard##3##3##(2008-3#3)
spectral bandwidth##20##2##(2007-11#4)(2007-12#1)(2008-2#3)(2008-3#12)
spectral bandwidths##5##2##(2007-12#2)(2008-3#3)
spectral behavior of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
spectral behavior##6##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
spectral broadening is##3##3##(2007-12#3)
spectral broadening##9##2##(2007-11#5)(2007-12#4)
spectral calibration accuracy##2##3##(2008-2#2)
spectral calibration##5##2##(2008-2#5)
spectral change##2##2##(1990-2#1)(1995-2#1)
spectral changes##9##2##(1992-3#1)(1992-6#1)(1995-2#1)(1995-5#2)(2007-11#1)(2008-10#2)(2008-7#1)
spectral channel response functions of##2##5##(2008-2#1)(2008-3#1)
spectral channel##3##2##(2008-2#2)(2008-3#1)
spectral characteristics and##4##3##(2007-11#1)(2008-3#2)(2009-4#1)
spectral characteristics of the##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
spectral characteristics of##11##3##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#4)(2013-8#2)
spectral characteristics##25##2##(1991-12#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-9#1)(2009-4#1)(2013-8#2)
spectral characterization of##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
spectral classification library##2##3##(2013-8#2)
spectral classification##6##2##(2013-8#6)
spectral coherence##2##2##(2007-12#2)
spectral collapse##2##2##(2007-12#2)
spectral components##4##2##(1990-8#1)(2007-11#1)(2007-12#2)
spectral cone types##2##3##(2007-5#2)
spectral continuum##2##2##(2007-12#1)(2008-3#1)
spectral correction##3##2##(2008-10#3)
spectral coverage##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
spectral curves##2##2##(2008-2#1)(2008-3#1)
spectral data obtained##2##3##(2008-10#2)
spectral data##40##2##(1991-1#1)(1993-11#1)(2007-11#2)(2008-10#19)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2009-2#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
spectral decay##2##2##(2009-12#2)
spectral deconvolution##4##2##(2008-10#3)(2011-2#1)
spectral density of the##2##4##(2007-11#1)(2008-3#1)
spectral density of##6##3##(2007-11#1)(2007-12#3)(2008-3#2)
spectral density##19##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#7)(2010-8#2)(2012-2#1)
spectral dependences of the##2##4##(2008-3#2)
spectral dependences##3##2##(2008-3#3)
spectral diffusion##3##2##(2008-2#3)
spectral discrimination##6##2##(2007-11#2)(2007-12#2)(2008-2#2)
spectral dispersion##9##2##(2007-11#3)(2008-2#1)(2008-3#5)
spectral distribution of the Raman-scattering##2##5##(2008-2#2)
spectral distribution of the##6##4##(2007-11#1)(2008-2#4)(2008-3#1)
spectral distribution of##9##3##(2007-11#1)(2008-2#5)(2008-3#3)
spectral distribution##13##2##(2007-11#1)(2008-10#1)(2008-2#6)(2008-3#5)
spectral domain optical coherence tomography##3##5##(2011-1#2)(2012-12#1)
spectral domain##14##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#3)(2011-1#2)(2012-12#1)(2013-8#1)
spectral emission##2##2##(2008-10#1)(2008-2#1)
spectral evolution##2##2##(2007-11#2)
spectral extinction and backscatter##2##4##(2008-3#2)
spectral extinction measurements##2##3##(2008-3#2)
spectral extinction##11##2##(2008-3#11)
spectral feature##4##2##(2008-10#1)(2008-3#3)
spectral features and##2##3##(1994-5#1)(2008-3#1)
spectral features of the##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
spectral features of##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)
spectral features##18##2##(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-7#1)
spectral filter##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
spectral filtering##8##2##(2007-11#4)(2007-12#3)(2008-3#1)
spectral filters that##2##3##(2007-12#1)(2008-6#1)
spectral filters##7##2##(2007-11#2)(2007-12#1)(2008-6#1)(2013-1#3)
spectral fluorescence##3##2##(2008-2#3)
spectral focusing##2##2##(2008-3#2)
spectral grating##4##2##(2007-12#4)
spectral hole burning (PSHB)##2##4##(2007-12#2)
spectral hole burning##8##3##(2007-11#2)(2007-12#6)
spectral hole##9##2##(2007-11#2)(2007-12#7)
spectral hole-burning##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
spectral holography##5##2##(2008-2#1)(2008-3#4)
spectral identity##2##2##(2007-12#2)
spectral image data##2##3##(2007-12#2)
spectral image of the##2##4##(2008-2#1)(2008-5#1)
spectral image##6##2##(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#1)
spectral imager operates based on##2##5##(2013-8#2)
spectral imager##6##2##(2008-2#1)(2008-3#1)(2013-8#4)
spectral images##8##2##(2008-3#1)(2013-8#7)
spectral imaging##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
spectral information in##3##3##(2008-3#3)
spectral information##12##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-9#1)
spectral intensities##3##2##(2007-11#2)(2013-8#1)
spectral intensity##4##2##(2007-11#2)(2013-8#2)
spectral interference##9##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)
spectral interferences of##2##3##(2008-10#2)
spectral interferences##13##2##(2008-10#11)(2011-1#2)
spectral interfering elements##2##3##(2008-10#2)
spectral interferometry##8##2##(2007-11#5)(2007-12#3)
spectral interval##5##2##(2007-12#2)(2008-3#3)
spectral intervals##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
spectral inversion and##2##3##(2007-12#1)(2008-3#1)
spectral inversion##4##2##(2007-12#3)(2008-3#1)
spectral irradiance measurements##2##3##(2008-2#1)(2008-3#1)
spectral irradiance##8##2##(2008-2#3)(2008-3#5)
spectral karyotyping##2##2##(2008-1#2)
spectral leakage##2##2##(2008-3#2)
spectral library##2##2##(2008-10#1)(2011-2#1)
spectral line and##2##3##(2008-3#1)(2013-8#1)
spectral line##14##2##(2008-10#1)(2008-2#3)(2008-3#2)(2013-8#8)
spectral line-shape##2##2##(2007-11#1)(2008-2#1)
spectral lines##8##2##(2007-12#1)(2008-3#4)(2011-2#1)(2013-8#2)
spectral linewidth of##2##3##(2008-3#2)
spectral linewidth##4##2##(2007-12#1)(2008-3#3)
spectral measurement##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
spectral measurements of##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
spectral measurements##10##2##(2007-11#2)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#2)
spectral method for the determination of trace##2##7##(2008-10#2)
spectral method for##3##3##(2008-10#3)
spectral method##6##2##(2008-10#4)(2008-2#1)(2012-2#1)
spectral model##2##2##(2008-2#2)
spectral models for##2##3##(2007-12#1)(2008-2#1)
spectral narrowing##2##2##(2007-11#1)(2007-12#1)
spectral optical##3##2##(2007-11#2)(2008-3#1)
spectral output##2##2##(2007-11#1)(2008-10#1)
spectral overlap was##3##3##(2008-10#3)
spectral overlap##10##2##(2007-12#1)(2008-10#9)
spectral overlapping of##2##3##(2008-10#2)
spectral overlapping##6##2##(2008-10#6)
spectral parameters##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
spectral patterns##2##2##(2008-3#1)(2009-9#1)
spectral peak##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
spectral peaks##4##2##(2008-10#1)(2008-2#1)(2009-6#1)(2010-6#1)
spectral performance##3##2##(2008-2#1)(2008-3#2)
spectral phase and##2##3##(2007-12#2)
spectral phase conjugation##2##3##(2007-12#2)
spectral phase interferometry for direct electric-field reconstruction (SPIDER)##2##8##(2007-12#2)
spectral phase interferometry for direct electric-field reconstruction##5##7##(2007-12#5)
spectral phase interferometry for direct##6##5##(2007-11#1)(2007-12#5)
spectral phase##15##2##(2007-11#2)(2007-12#12)(2008-3#1)
spectral polarization optical imaging##2##4##(2007-12#2)
spectral power##4##2##(1991-1#1)(2008-2#1)(2008-3#2)
spectral profile of##2##3##(2007-11#1)(2008-10#1)
spectral profiles##8##2##(1992-12#1)(2007-11#1)(2008-10#5)(2008-3#1)
spectral properties and##2##3##(2008-2#1)(2008-5#1)
spectral properties of the##4##4##(1992-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
spectral properties of##14##3##(1992-1#1)(1994-11#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#5)(2008-7#1)(2012-2#1)(2013-1#1)
spectral properties were evaluated##2##4##(2008-10#2)
spectral properties##24##2##(1992-1#2)(1994-11#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#1)
spectral purity##6##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
spectral radiance##9##2##(2008-2#5)(2008-3#4)
spectral radiances##2##2##(2008-2#1)(2008-3#1)
spectral range and##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
spectral range from the ultraviolet##2##5##(2007-11#1)(2008-3#1)
spectral range from##10##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#1)
spectral range is##2##3##(2008-2#1)(2008-3#1)
spectral range of the##2##4##(2007-11#1)(2008-10#1)
spectral range of##11##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)
spectral range was##2##3##(2008-10#1)(2008-3#1)
spectral range with##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
spectral range##79##2##(2007-11#10)(2007-12#12)(2008-10#9)(2008-2#11)(2008-3#33)(2008-5#1)(2009-12#1)(2010-4#1)(2013-8#1)
spectral ranges##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2009-12#1)
spectral reflectance##13##2##(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#2)(2013-8#1)
spectral reflectivity##2##2##(2008-2#2)
spectral region and number of factors##2##6##(2008-10#2)
spectral region are##2##3##(2008-3#2)
spectral region because of##2##4##(2008-2#1)(2008-3#1)
spectral region between##2##3##(2008-2#2)
spectral region for##2##3##(1994-8#1)(2008-2#1)
spectral region from 49##2##4##(2008-3#2)
spectral region from##5##3##(2008-2#2)(2008-3#3)
spectral region near##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
spectral region where##2##3##(2007-12#1)(2008-3#1)
spectral region##59##2##(1991-5#1)(1992-6#1)(1994-8#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#13)(2008-3#33)(2009-12#1)
spectral regions are##2##3##(2008-3#2)
spectral regions with##3##3##(2008-3#2)(2008-6#1)
spectral regions##19##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#13)(2008-6#1)
spectral representation of##2##3##(2007-11#1)(2008-3#1)
spectral representation##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
spectral requirements##2##2##(2008-3#2)
spectral resolution and##5##3##(2007-12#3)(2008-2#2)
spectral resolution for##2##3##(2008-2#1)(2008-3#1)
spectral resolution is##3##3##(2007-12#1)(2008-3#2)
spectral resolution of approximately##2##4##(2008-2#1)(2008-3#1)
spectral resolution of##7##3##(1991-5#1)(2007-12#3)(2008-2#1)(2008-3#2)
spectral resolution was##3##3##(2007-12#1)(2008-3#2)
spectral resolution##50##2##(1991-5#1)(2007-11#2)(2007-12#13)(2008-2#13)(2008-3#18)(2008-9#1)(2012-2#1)(2013-8#1)
spectral response linewidth##2##3##(2008-3#2)
spectral response of the##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
spectral response of##9##3##(2007-12#3)(2008-2#3)(2008-3#3)
spectral response##23##2##(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#12)
spectral responses of##2##3##(2007-11#1)(2008-10#1)
spectral responses##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
spectral responsivity of##2##3##(2007-11#1)(2008-3#1)
spectral responsivity##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
spectral sampling##2##2##(2008-3#2)
spectral sculpting##2##2##(2007-11#2)
spectral selectivities##3##2##(2008-2#3)
spectral sensitivity##4##2##(2007-11#1)(2008-3#1)(2008-8#2)
spectral separation##2##2##(2008-2#1)(2009-10#1)
spectral shape of##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
spectral shape##11##2##(1994-6#1)(2007-12#2)(2008-2#3)(2008-3#5)
spectral shapes##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
spectral shaping##3##2##(2007-11#2)(2008-3#1)
spectral shift of the##2##4##(1992-12#1)(2008-2#1)
spectral shift##3##2##(1992-12#1)(2008-2#2)
spectral shifts of##2##3##(2008-11#1)(2009-6#1)
spectral shifts##10##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-6#2)(2010-12#1)
spectral signatures##3##2##(2007-11#1)(2008-3#2)
spectral spacing of##3##3##(2008-3#3)
spectral spacing##4##2##(2008-3#4)
spectral structure##2##2##(2008-3#2)
spectral studies##4##2##(2008-10#2)(2008-5#2)
spectral transmission factor##2##3##(2008-3#2)
spectral transmission function and optical thickness##2##6##(2008-2#2)
spectral transmission##8##2##(2008-2#3)(2008-3#3)(2008-5#2)
spectral transmittance##2##2##(2008-3#1)(2008-5#1)
spectral width and##2##3##(2007-11#2)
spectral width of the##4##4##(2007-12#2)(2008-3#2)
spectral width##8##2##(2007-11#2)(2007-12#3)(2008-3#2)(2012-8#1)
spectral window##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
spectral##1210##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-5#2)(1991-8#2)(1992-1#3)(1992-12#2)(1992-3#1)(1992-6#2)(1993-11#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-5#3)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#117)(2007-12#162)(2007-5#2)(2008-1#5)(2008-10#155)(2008-11#7)(2008-12#3)(2008-2#195)(2008-3#363)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#5)(2009-2#1)(2009-4#2)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#8)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#9)(2012-7#1)(2012-8#1)(2013-1#6)(2013-8#45)
spectral-curvature algorithms##2##2##(2008-3#2)
spectral-domain OCT in the diagnosis and management of##2##8##(2011-7#2)
spectral-domain OCT##7##2##(2011-7#6)(2013-1#1)
spectral-domain##11##1##(2008-3#2)(2011-7#8)(2013-1#1)
spectrally broadened by self-phase modulation##2##5##(2008-2#2)
spectrally broadened##3##2##(2008-2#3)
spectrally continuous##2##2##(2008-3#2)
spectrally decomposed##2##2##(2007-12#2)
spectrally disperse##2##2##(2007-12#1)(2008-2#1)
spectrally distinct##4##2##(2008-2#2)(2008-4#1)(2008-9#1)
spectrally encoded confocal scanning laser##2##5##(2011-1#2)
spectrally encoded##5##2##(2007-11#1)(2008-2#2)(2011-1#2)
spectrally narrow##2##2##(2007-12#1)(2008-2#1)
spectrally resolved fluorescence##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
spectrally resolved two-beam coupling##2##4##(2007-12#2)
spectrally resolved##15##2##(2007-11#2)(2007-12#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-8#1)(2011-1#1)
spectrally uniform##2##2##(2008-3#2)
spectrally##63##1##(1995-3#1)(1995-5#1)(1997-7#1)(2007-11#8)(2007-12#13)(2008-12#1)(2008-2#18)(2008-3#13)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#3)
spectre##2##1##(1991-6#1)(2013-1#1)
spectrin and##2##2##(1990-5#1)(1996-12#1)
spectrin is##2##2##(1990-5#2)
spectrin##9##1##(1990-5#4)(1993-11#2)(1996-12#2)(2008-10#1)
spectroanalytical##2##1##(2008-10#2)
spectrochemical analysis##3##2##(2007-12#1)(2010-2#2)
spectrochemical##6##1##(1997-7#1)(2007-12#1)(2008-10#1)(2010-2#3)
spectroelectrochemical cell##3##2##(2008-10#3)
spectroelectrochemical characterization of##2##3##(2008-10#2)
spectroelectrochemical##11##1##(2008-10#11)
spectroelectrochemistry##4##1##(2007-12#1)(2008-10#2)(2009-9#1)
spectrofluorimeter##9##1##(1995-3#1)(2008-10#7)(2008-4#1)
spectrofluorimetric determination of acetylsalicylic acid##2##5##(2008-10#2)
spectrofluorimetric determination of the##2##4##(2008-10#2)
spectrofluorimetric determination of trace amounts of##2##6##(2008-10#2)
spectrofluorimetric determination of trace##5##4##(2008-10#5)
spectrofluorimetric determination of##25##3##(2008-10#25)
spectrofluorimetric determination##26##2##(2008-10#26)
spectrofluorimetric method for the determination of##9##6##(2008-10#9)
spectrofluorimetric method for the##11##4##(2008-10#11)
spectrofluorimetric method for##13##3##(2008-10#13)
spectrofluorimetric method##21##2##(2008-10#21)
spectrofluorimetric system is##2##3##(2008-10#2)
spectrofluorimetric##58##1##(2008-10#58)
spectrofluorimetrically##4##1##(2008-10#4)
spectrofluorimetry of ultra trace##2##4##(2008-10#2)
spectrofluorimetry of##3##2##(2008-10#3)
spectrofluorimetry##25##1##(1990-8#1)(2008-10#23)(2008-11#1)
spectrofluorometer##9##1##(1995-3#1)(2008-1#1)(2008-10#7)
spectrofluorometric##6##1##(2008-10#4)(2008-11#2)
spectrogram##3##1##(2008-2#1)(2013-7#1)(2013-8#1)
spectrograms and##2##2##(2008-10#1)(2008-9#1)
spectrograms##4##1##(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)
spectrograph and a##2##3##(2007-12#1)(2008-10#1)
spectrograph and##3##2##(2007-12#1)(2008-10#2)
spectrograph for##2##2##(2008-2#1)(2008-3#1)
spectrograph with a##2##3##(2007-12#1)(2008-3#1)
spectrograph with##3##2##(2007-12#1)(2008-3#2)
spectrograph##20##1##(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#12)
spectrographic##2##1##(1993-11#1)(2012-12#1)
spectrographs##10##1##(2008-2#2)(2008-3#8)
spectrometer (FTS)##3##2##(2008-2#1)(2008-3#2)
spectrometer (ICP-MS)##4##2##(2008-10#4)
spectrometer and the##2##3##(2008-10#1)(2008-3#1)
spectrometer and##8##2##(1992-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)
spectrometer are##4##2##(2008-10#1)(2008-3#3)
spectrometer based on##9##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#2)
spectrometer by using##2##3##(2008-2#2)
spectrometer by##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
spectrometer capable of##2##3##(2008-3#2)
spectrometer designed to##2##3##(2008-2#1)(2008-3#1)
spectrometer devoted to the in situ##2##6##(2008-3#2)
spectrometer equipped with a##3##4##(2008-10#2)(2009-2#1)
spectrometer equipped with##5##3##(2008-10#3)(2009-2#1)(2011-3#1)
spectrometer for dual wavelength##2##4##(2007-12#2)
spectrometer for##20##2##(2007-12#3)(2008-10#6)(2008-2#3)(2008-3#6)(2008-4#1)(2010-6#1)
spectrometer has been used##2##4##(2008-10#1)(2008-2#1)
spectrometer has been##4##3##(2008-10#3)(2008-2#1)
spectrometer in##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2011-1#1)
spectrometer is demonstrated by##2##4##(2007-12#1)(2008-3#1)
spectrometer is presented##2##3##(2008-10#1)(2008-3#1)
spectrometer is used##2##3##(2008-10#2)
spectrometer is##16##2##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#5)(2010-7#1)(2013-8#2)
spectrometer may be##2##3##(2008-3#2)
spectrometer position##2##2##(2007-12#2)
spectrometer systems##2##2##(2008-10#2)
spectrometer that was##2##3##(2008-3#2)
spectrometer that##6##2##(2008-2#2)(2008-3#4)
spectrometer to##3##2##(2008-10#2)(2008-3#1)
spectrometer was calibrated##2##3##(2008-10#1)(2008-3#1)
spectrometer was used to##2##4##(2008-2#1)(2010-9#1)
spectrometer was##13##2##(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2010-9#1)(2011-1#1)
spectrometer with a##8##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)
spectrometer with the##2##3##(2008-3#2)
spectrometer with##19##2##(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#8)
spectrometer##301##1##(1991-8#1)(1992-3#2)(1996-7#1)(1997-8#1)(2007-11#3)(2007-12#20)(2008-1#1)(2008-10#121)(2008-11#1)(2008-2#39)(2008-3#86)(2008-4#5)(2009-2#1)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#2)(2011-3#1)(2013-8#10)
spectrometer's##5##1##(2008-10#2)(2008-3#3)
spectrometer-detector parameters##3##2##(2007-12#3)
spectrometer]##3##1##(2013-8#3)
spectrometers Coronal Diagnostic Spectrometer (CDS) and Solar Ultraviolet Measurements of Emitted Radiation (SUMER)##2##13##(2008-3#2)
spectrometers are##2##2##(2008-10#1)(2013-8#1)
spectrometers can be##2##3##(2008-3#1)(2008-4#1)
spectrometers for##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
spectrometers has been##2##3##(2008-2#1)(2008-3#1)
spectrometers is##3##2##(2008-10#2)(2008-3#1)
spectrometers to##3##2##(2008-1#1)(2008-3#2)
spectrometers with##3##2##(2008-2#2)(2008-3#1)
spectrometers##51##1##(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#7)(2008-3#23)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#2)(2011-2#2)(2013-8#3)
spectrometric analysis of##3##3##(1995-5#1)(2008-10#2)
spectrometric analysis##6##2##(1990-7#1)(1995-5#1)(2008-10#3)(2008-11#1)
spectrometric data##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
spectrometric detection has been developed##3##5##(2008-10#3)
spectrometric detection in the##3##4##(2008-10#3)
spectrometric detection##27##2##(2008-10#23)(2008-4#1)(2008-5#2)(2012-1#1)
spectrometric detector##3##2##(2008-10#3)
spectrometric determination of trace##2##4##(2008-10#2)
spectrometric determination of##29##3##(2007-12#1)(2008-10#28)
spectrometric determination##31##2##(2007-12#1)(2008-10#30)
spectrometric determinations##5##2##(2008-10#5)
spectrometric identification##4##2##(2008-10#3)(2008-4#1)
spectrometric measurements##4##2##(1992-8#1)(2008-10#2)(2010-11#1)
spectrometric method##9##2##(2008-10#8)(2011-1#1)
spectrometric methods for the##2##4##(2008-10#1)(2008-7#1)
spectrometric methods##6##2##(1992-12#1)(2008-10#2)(2008-7#1)(2013-1#2)
spectrometric microtitration set up##2##4##(2008-10#2)
spectrometric microtitration##4##2##(2008-10#4)
spectrometric procedure##5##2##(2008-10#5)
spectrometric system##3##2##(2008-10#2)(2008-2#1)
spectrometric techniques is##3##3##(2008-10#2)(2008-3#1)
spectrometric techniques##7##2##(2008-10#6)(2008-3#1)
spectrometric##154##1##(1990-7#2)(1992-12#1)(1992-8#2)(1993-8#1)(1995-5#1)(2007-12#1)(2008-10#119)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#3)
spectrometrically##2##1##(2008-10#2)
spectrometry (ESI-MS)##8##2##(2008-10#4)(2008-5#1)(2011-1#3)
spectrometry (FAAS##2##2##(2008-10#2)
spectrometry (GC##4##2##(2008-10#4)
spectrometry (GC-MS)##27##2##(1990-5#1)(1992-5#1)(1993-12#1)(1995-2#1)(2008-10#19)(2008-4#1)(2008-5#1)(2012-1#2)
spectrometry (GC/MS)##6##2##(1995-11#1)(2008-10#4)(2013-1#1)
spectrometry (ICP-MS) and##2##3##(2008-10#2)
spectrometry (ICP-MS)##34##2##(2008-10#32)(2013-8#2)
spectrometry (LA-ICP-MS)##5##2##(2008-10#3)(2010-11#2)
spectrometry (LC-ESI-MS)##3##2##(2008-10#1)(2010-4#2)
spectrometry (LC-MS)##5##2##(2008-10#2)(2010-4#1)(2011-1#1)(2012-1#1)
spectrometry (LOQ=0##2##2##(2008-10#2)
spectrometry (MS) and##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
spectrometry (MS)##9##2##(1997-2#1)(2008-10#3)(2008-4#2)(2008-8#1)(2010-7#1)(2011-2#1)
spectrometry (MS)-based##2##2##(2008-9#1)(2013-8#1)
spectrometry after preconcentration##2##3##(2008-10#1)(2013-8#1)
spectrometry after##22##2##(1992-3#1)(1995-12#1)(2008-10#19)(2013-8#1)
spectrometry analysis##10##2##(1992-8#1)(1996-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2013-1#1)
spectrometry and cyclic voltammetry##2##4##(2008-10#2)
spectrometry and inductively coupled plasma##2##5##(2008-10#2)
spectrometry and temperature-constrained cascade correlation networks##2##6##(2008-10#2)
spectrometry and the##2##3##(2008-10#2)
spectrometry and##46##2##(1995-12#1)(1997-2#2)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
spectrometry as a##5##3##(1997-2#1)(2008-10#2)(2008-2#1)(2011-2#1)
spectrometry as an alternative##2##4##(2008-10#2)
spectrometry as an##4##3##(2008-10#3)(2012-1#1)
spectrometry as##14##2##(1995-2#1)(1997-2#1)(2008-10#9)(2008-2#1)(2011-2#1)(2012-1#1)
spectrometry at##7##2##(1990-5#1)(2008-10#4)(2008-5#2)
spectrometry can be used##2##4##(2008-10#2)
spectrometry can be##3##3##(2008-10#2)(2008-4#1)
spectrometry coupled with##3##3##(2008-10#3)
spectrometry detection##15##2##(2008-10#14)(2010-5#1)
spectrometry determination of Malathion in pesticide##2##6##(2008-10#2)
spectrometry determination of##7##3##(2008-10#7)
spectrometry determination##9##2##(2008-10#9)
spectrometry for determination of##2##4##(2008-10#2)
spectrometry for quantitative##2##3##(2008-10#2)
spectrometry for the determination of##5##5##(2008-1#1)(2008-10#4)
spectrometry for the##16##3##(2008-1#1)(2008-10#13)(2008-4#1)(2010-9#1)
spectrometry for trace##2##3##(2008-10#2)
spectrometry for##33##2##(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-3#1)(2008-4#1)(2010-9#1)
spectrometry has become##2##3##(2008-10#2)
spectrometry has been##8##3##(1990-12#1)(1997-2#1)(2008-10#6)
spectrometry has##11##2##(1990-12#1)(1997-2#1)(2008-10#9)
spectrometry in terms of##3##4##(2008-3#2)(2010-7#1)
spectrometry in the##2##3##(2008-10#2)
spectrometry in##22##2##(1992-3#1)(2008-10#16)(2008-3#2)(2010-5#1)(2010-7#2)
spectrometry is described##9##3##(1992-3#1)(2008-10#7)(2008-11#1)
spectrometry is used for##2##4##(2008-10#2)
spectrometry is##23##2##(1992-3#1)(2008-10#19)(2008-11#1)(2008-9#1)(2011-1#1)
spectrometry method for##3##3##(2008-10#3)
spectrometry method was developed for the##2##6##(2008-10#1)(2011-1#1)
spectrometry method was developed##3##4##(2008-10#2)(2011-1#1)
spectrometry method##9##2##(2007-10#1)(2008-10#7)(2011-1#1)
spectrometry methods##3##2##(2008-10#2)(2010-5#1)
spectrometry of the##3##3##(1990-7#1)(1990-8#1)(1993-11#1)
spectrometry of##13##2##(1990-7#1)(1990-8#1)(1992-6#1)(1993-11#1)(1994-3#1)(2008-10#6)(2008-9#1)(2010-7#1)
spectrometry results##2##2##(2008-10#2)
spectrometry technique is##2##3##(2008-10#1)(2008-3#1)
spectrometry technique##6##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
spectrometry techniques##3##2##(2008-10#3)
spectrometry that##2##2##(2008-3#2)
spectrometry to determine##2##3##(2008-10#1)(2008-8#1)
spectrometry to##12##2##(1991-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
spectrometry using a##6##3##(2008-10#5)(2008-4#1)
spectrometry using solid##2##3##(2008-10#2)
spectrometry using the##2##3##(2008-10#2)
spectrometry using##28##2##(2008-10#24)(2008-4#1)(2008-5#2)(2010-5#1)
spectrometry was applied##3##3##(2008-10#2)(2011-3#1)
spectrometry was employed##2##3##(2008-10#1)(2012-12#1)
spectrometry was used for the##3##5##(2008-10#3)
spectrometry was used for##5##4##(2008-10#5)
spectrometry was used to##5##4##(1997-3#1)(2008-10#4)
spectrometry was used##12##3##(1997-3#1)(2008-10#11)
spectrometry was##23##2##(1993-11#1)(1997-3#1)(2008-10#19)(2011-3#1)(2012-12#1)
spectrometry were##6##2##(2008-10#6)
spectrometry with a##3##3##(2008-10#3)
spectrometry with both##2##3##(2008-10#2)
spectrometry with high performance liquid chromatography for the analysis of##2##10##(2008-10#2)
spectrometry with the##2##3##(1994-2#1)(2009-6#1)
spectrometry with##35##2##(1994-2#1)(2008-10#28)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
spectrometry without##2##2##(1994-5#1)(2008-10#1)
spectrometry##1364##1##(1990-12#2)(1990-5#3)(1990-7#3)(1990-8#6)(1991-12#2)(1991-2#2)(1991-5#3)(1992-12#1)(1992-3#7)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#1)(1995-11#5)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#1)(1996-5#1)(1997-2#11)(1997-3#1)(1997-4#4)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#1059)(2008-11#12)(2008-2#10)(2008-3#16)(2008-4#18)(2008-5#13)(2008-6#1)(2008-7#16)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#2)(2010-11#6)(2010-2#2)(2010-4#4)(2010-5#11)(2010-6#3)(2010-7#12)(2010-8#2)(2010-9#2)(2011-1#16)(2011-2#10)(2011-3#1)(2012-1#8)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#8)
spectrometry)##6##1##(2008-10#3)(2008-12#1)(2008-7#2)
spectrometry-based##5##1##(2008-10#2)(2010-5#1)(2010-7#2)
spectrometry]##10##1##(2011-1#7)(2012-3#1)(2013-8#2)
spectrophotometer and##3##2##(2008-10#2)(2008-3#1)
spectrophotometer as detector##2##3##(2008-10#2)
spectrophotometer assay##3##2##(2008-10#3)
spectrophotometer at##3##2##(1994-3#1)(2008-10#2)
spectrophotometer for##3##2##(2008-10#3)
spectrophotometer in##2##2##(1997-4#1)(2008-2#1)
spectrophotometer is used to##2##4##(2008-3#1)(2008-4#1)
spectrophotometer is##3##2##(2008-3#2)(2008-4#1)
spectrophotometer to##2##2##(2008-10#2)
spectrophotometer was##2##2##(2008-10#2)
spectrophotometer with##4##2##(2008-10#2)(2008-3#2)
spectrophotometer##67##1##(1994-3#1)(1997-4#1)(2008-10#44)(2008-2#4)(2008-3#9)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
spectrophotometeric##2##1##(2008-10#2)
spectrophotometers##5##1##(2008-2#2)(2008-3#2)(2008-5#1)
spectrophotometric FI system with a column##2##6##(2008-10#2)
spectrophotometric FI##3##2##(2008-10#3)
spectrophotometric analyses##3##2##(2008-10#2)(2008-5#1)
spectrophotometric analysis of##3##3##(2008-10#3)
spectrophotometric analysis##4##2##(2008-10#4)
spectrophotometric and inductively coupled plasma atomic emission##2##7##(2008-10#2)
spectrophotometric and spectrofluorimetric analysis##2##4##(2008-10#2)
spectrophotometric and spectrofluorimetric determination of##2##5##(2008-10#2)
spectrophotometric and spectrofluorimetric##4##3##(2008-10#4)
spectrophotometric and##20##2##(2008-1#1)(2008-10#18)(2011-1#1)
spectrophotometric assay##5##2##(2008-10#5)
spectrophotometric assays##2##2##(2008-10#2)
spectrophotometric data in##3##3##(2008-10#3)
spectrophotometric data##14##2##(1993-8#1)(2008-10#11)(2008-3#1)(2011-1#1)
spectrophotometric detection at##3##3##(2008-10#3)
spectrophotometric detection has been developed for the##2##7##(2008-10#2)
spectrophotometric detection in##2##3##(2008-10#2)
spectrophotometric detection is proposed##2##4##(2008-10#2)
spectrophotometric detection is##3##3##(2008-10#3)
spectrophotometric detection of##3##3##(2008-10#3)
spectrophotometric detection was##4##3##(1996-5#1)(2008-10#3)
spectrophotometric detection##38##2##(1996-5#1)(2008-10#37)
spectrophotometric determination method##2##3##(2008-10#2)
spectrophotometric determination of Fe and Ni##2##6##(2008-10#2)
spectrophotometric determination of Fe##3##4##(2008-10#3)
spectrophotometric determination of Fe(II) and Fe(III)##2##6##(2008-10#2)
spectrophotometric determination of ascorbic acid based on##2##7##(2008-10#2)
spectrophotometric determination of ascorbic acid##5##5##(2008-10#5)
spectrophotometric determination of boron in##4##5##(2008-10#4)
spectrophotometric determination of boron##5##4##(2008-10#5)
spectrophotometric determination of calcium using murexide##2##6##(2008-10#2)
spectrophotometric determination of calcium##3##4##(2008-10#3)
spectrophotometric determination of captopril##2##4##(2008-10#2)
spectrophotometric determination of chromium (VI) with diphenylcarbazide##2##7##(2008-10#2)
spectrophotometric determination of chromium##3##4##(2008-10#3)
spectrophotometric determination of chromium(VI) in##2##5##(2008-10#2)
spectrophotometric determination of chromium(VI)##3##4##(2008-10#3)
spectrophotometric determination of cobalt##3##4##(2008-10#3)
spectrophotometric determination of cobalt(II)##2##4##(2008-10#2)
spectrophotometric determination of copper and iron##2##6##(2008-10#2)
spectrophotometric determination of copper##4##4##(2008-10#4)
spectrophotometric determination of copper(II) in##2##5##(2008-10#2)
spectrophotometric determination of copper(II)##6##4##(2008-10#6)
spectrophotometric determination of europium##2##4##(2008-10#2)
spectrophotometric determination of free chlorine##2##5##(2008-10#2)
spectrophotometric determination of hydrazine##2##4##(2008-10#2)
spectrophotometric determination of hydrosoluble vitamins##2##5##(2008-10#2)
spectrophotometric determination of iron##2##4##(2008-10#2)
spectrophotometric determination of manganese##4##4##(2008-10#4)
spectrophotometric determination of molybdenum in##2##5##(2008-10#2)
spectrophotometric determination of molybdenum##3##4##(2008-10#3)
spectrophotometric determination of nickel in##3##5##(2008-10#3)
spectrophotometric determination of nickel##7##4##(2008-10#7)
spectrophotometric determination of nitrite##4##4##(2008-10#4)
spectrophotometric determination of the##4##4##(2008-10#4)
spectrophotometric determination of total##4##4##(2008-10#4)
spectrophotometric determination of trace amount of##2##6##(2008-10#2)
spectrophotometric determination of trace amounts of copper##2##7##(2008-10#2)
spectrophotometric determination of trace amounts of##7##6##(2008-10#7)
spectrophotometric determination of trace##13##4##(2008-10#13)
spectrophotometric determination of tungsten##3##4##(2008-10#3)
spectrophotometric determination of vanillin##3##4##(2008-10#3)
spectrophotometric determination of zinc in##2##5##(2008-10#2)
spectrophotometric determination of zinc##3##4##(2008-10#3)
spectrophotometric determination of##202##3##(1990-12#1)(2008-10#199)(2009-8#1)(2010-5#1)
spectrophotometric determination##213##2##(1990-12#1)(2008-10#210)(2009-8#1)(2010-5#1)
spectrophotometric determinations of##3##3##(2008-10#3)
spectrophotometric determinations##4##2##(2008-10#4)
spectrophotometric estimation of##2##3##(2008-10#1)(2010-5#1)
spectrophotometric estimation##3##2##(2008-10#2)(2010-5#1)
spectrophotometric flow injection##3##3##(2008-10#3)
spectrophotometric flow-injection method is##2##4##(2008-10#2)
spectrophotometric flow-injection##3##2##(2008-10#3)
spectrophotometric measurement of##2##3##(2008-10#1)(2008-3#1)
spectrophotometric measurement##6##2##(2008-10#5)(2008-3#1)
spectrophotometric measurements in##2##3##(2008-10#2)
spectrophotometric measurements##10##2##(2008-10#7)(2008-2#3)
spectrophotometric method and##2##3##(2008-10#2)
spectrophotometric method at##2##3##(2008-10#1)(2013-8#1)
spectrophotometric method based on the##2##5##(2008-10#2)
spectrophotometric method based on##5##4##(2008-10#5)
spectrophotometric method for determination of acidity constants##2##7##(2008-10#2)
spectrophotometric method for determination of##7##5##(2008-10#7)
spectrophotometric method for determining##2##4##(2008-10#1)(2013-8#1)
spectrophotometric method for the analysis of##2##6##(2008-10#2)
spectrophotometric method for the determination of hydrogen peroxide##2##8##(2008-10#2)
spectrophotometric method for the determination of trace##3##7##(2008-10#3)
spectrophotometric method for the determination of##23##6##(2008-10#23)
spectrophotometric method for the simultaneous##2##5##(2008-10#2)
spectrophotometric method for the##32##4##(2008-10#32)
spectrophotometric method for##51##3##(2008-10#49)(2008-5#1)(2013-8#1)
spectrophotometric method has been developed for the determination of##5##9##(2008-10#5)
spectrophotometric method has been developed for the##9##7##(2008-10#9)
spectrophotometric method has been developed##10##5##(2008-10#10)
spectrophotometric method in the##2##4##(2008-10#2)
spectrophotometric method in##3##3##(2008-10#3)
spectrophotometric method is described for the determination of trace amounts of##2##11##(2008-10#2)
spectrophotometric method is described for the determination of##4##8##(2008-10#4)
spectrophotometric method is described for##5##5##(2008-10#5)
spectrophotometric method is proposed for the determination of##4##8##(2008-10#4)
spectrophotometric method is proposed for the simultaneous determination of##2##9##(2008-10#2)
spectrophotometric method is proposed for the##7##6##(2008-10#7)
spectrophotometric method is##14##3##(2008-10#14)
spectrophotometric method of##3##3##(2008-10#2)(2008-5#1)
spectrophotometric method using##3##3##(2008-10#3)
spectrophotometric method was developed for the determination of##2##8##(2008-10#2)
spectrophotometric method was proposed for the determination of##2##8##(2008-10#2)
spectrophotometric method was proposed for##3##5##(2008-10#3)
spectrophotometric method was##10##3##(2008-10#10)
spectrophotometric method##147##2##(1990-8#2)(1991-2#1)(1996-12#1)(2008-10#137)(2008-5#2)(2010-5#1)(2013-8#3)
spectrophotometric methodology##2##2##(2008-10#2)
spectrophotometric methods are described for the##2##6##(2008-10#2)
spectrophotometric methods are described##3##4##(2008-10#3)
spectrophotometric methods are##4##3##(1996-12#1)(2008-10#3)
spectrophotometric methods for the determination of##3##6##(2008-10#3)
spectrophotometric methods for the##4##4##(2008-10#4)
spectrophotometric methods##21##2##(1996-12#1)(2008-10#20)
spectrophotometric monitoring of the##3##4##(2008-10#3)
spectrophotometric monitoring of##4##3##(2008-10#4)
spectrophotometric monitoring##5##2##(2008-10#5)
spectrophotometric multicomponent analysis of##2##4##(2008-10#2)
spectrophotometric procedure and##2##3##(2008-10#2)
spectrophotometric procedure for DNA assay##2##5##(2008-10#2)
spectrophotometric procedure for##5##3##(2008-10#5)
spectrophotometric procedure is proposed for the determination of##2##8##(2008-10#2)
spectrophotometric procedure is proposed for##3##5##(2008-10#3)
spectrophotometric procedure##16##2##(1993-9#1)(2008-10#15)
spectrophotometric procedures##2##2##(2008-10#2)
spectrophotometric reaction##2##2##(2008-10#2)
spectrophotometric reagent##4##2##(2008-10#4)
spectrophotometric reference method##4##3##(2008-10#4)
spectrophotometric studies##3##2##(2008-10#3)
spectrophotometric study on##2##3##(2008-10#2)
spectrophotometric study##4##2##(2008-10#4)
spectrophotometric system##2##2##(2008-10#2)
spectrophotometric technique for the##2##4##(1990-2#1)(2008-10#1)
spectrophotometric technique##3##2##(1990-2#1)(2008-10#2)
spectrophotometric titration method##2##3##(1995-2#1)(2008-10#1)
spectrophotometric titration##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
spectrophotometric##599##1##(1990-12#1)(1990-2#1)(1990-8#2)(1991-2#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-12#2)(1996-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#560)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2009-8#2)(2010-5#3)(2011-1#4)(2011-2#1)(2013-8#4)
spectrophotometrically and##2##2##(2008-10#2)
spectrophotometrically as##4##2##(2008-10#4)
spectrophotometrically at##21##2##(1993-12#1)(2008-10#20)
spectrophotometrically by##13##2##(2008-10#13)
spectrophotometrically in aqueous##2##3##(2008-10#2)
spectrophotometrically using##4##2##(2008-10#3)(2012-2#1)
spectrophotometrically with##3##2##(2008-10#3)
spectrophotometrically##77##1##(1992-3#1)(1993-12#1)(1996-9#1)(2008-10#72)(2012-1#1)(2012-2#1)
spectrophotometry and by##2##3##(2008-10#2)
spectrophotometry and flame atomic absorption spectrometry##2##6##(2008-10#2)
spectrophotometry and multivariate calibration##2##4##(2008-10#2)
spectrophotometry and##22##2##(1993-1#1)(1995-2#1)(2008-10#20)
spectrophotometry at##2##2##(2008-10#2)
spectrophotometry for determination of##2##4##(2008-10#2)
spectrophotometry for##9##2##(2008-10#8)(2009-5#1)
spectrophotometry has been developed##2##4##(2008-10#2)
spectrophotometry has been##3##3##(2008-10#3)
spectrophotometry has the advantage of high sensitivity than normal##2##9##(2008-10#2)
spectrophotometry has##5##2##(2008-10#5)
spectrophotometry in##4##2##(2008-10#4)
spectrophotometry is##6##2##(2008-10#5)(2008-9#1)
spectrophotometry of##3##2##(2008-10#3)
spectrophotometry using##5##2##(2008-10#5)
spectrophotometry was used to determine##2##5##(1997-4#1)(2008-10#1)
spectrophotometry was used to##3##4##(1997-4#1)(2008-10#2)
spectrophotometry was used##5##3##(1997-4#1)(2008-10#4)
spectrophotometry was##6##2##(1997-4#1)(2008-10#5)
spectrophotometry were##2##2##(2008-10#2)
spectrophotometry with flow injection##2##4##(2008-10#2)
spectrophotometry with##9##2##(2008-10#9)
spectrophotometry##179##1##(1993-1#1)(1995-2#1)(1997-4#2)(2006-10#2)(2008-1#1)(2008-10#165)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)
spectropolarimeter##2##1##(2008-3#2)
spectropolarimetric imager##2##2##(2008-3#2)
spectropolarimetric##6##1##(1994-5#1)(2008-10#1)(2008-3#4)
spectroradiometer for##2##2##(2008-2#2)
spectroradiometer##18##1##(2008-2#5)(2008-3#13)
spectroradiometers##5##1##(2008-2#1)(2008-3#4)
spectroradiometry##2##1##(2008-3#2)
spectroscope##2##1##(2007-12#1)(2008-11#1)
spectroscopic analyses##4##2##(1992-8#1)(2008-10#1)(2008-7#2)
spectroscopic analysis and##2##3##(2008-10#1)(2013-1#1)
spectroscopic analysis of##2##3##(1990-5#1)(1990-7#1)
spectroscopic analysis##12##2##(1990-5#1)(1990-7#2)(1997-4#2)(2008-10#5)(2010-6#1)(2013-1#1)
spectroscopic and electrochemical methods##2##4##(1996-2#1)(2010-7#1)
spectroscopic and##14##2##(1991-8#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-7#1)(2012-12#1)
spectroscopic applications##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
spectroscopic characterization of##2##3##(2008-10#1)(2008-3#1)
spectroscopic characterization##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
spectroscopic data and##2##3##(1990-7#1)(2007-11#1)
spectroscopic data##12##2##(1990-2#1)(1990-7#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
spectroscopic detection of##2##3##(2008-10#1)(2008-3#1)
spectroscopic detection##6##2##(2008-10#5)(2008-3#1)
spectroscopic determination of##4##3##(2008-10#3)(2012-2#1)
spectroscopic ellipsometer##5##2##(2008-2#1)(2008-3#4)
spectroscopic ellipsometry (SE)##2##3##(2008-2#1)(2008-3#1)
spectroscopic ellipsometry##12##2##(2007-11#1)(2008-2#4)(2008-3#7)
spectroscopic evidence for##2##3##(1991-5#1)(1995-5#1)
spectroscopic experiments##3##2##(2009-3#1)(2010-2#2)
spectroscopic features##2##2##(2008-10#1)(2008-2#1)
spectroscopic imaging##3##2##(2007-12#2)(2010-12#1)
spectroscopic investigation of##2##3##(2007-12#1)(2008-10#1)
spectroscopic measurements of##4##3##(1995-5#1)(2007-11#1)(2008-2#1)(2013-8#1)
spectroscopic measurements to##2##3##(2007-12#1)(2008-5#1)
spectroscopic measurements##17##2##(1992-12#1)(1995-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-5#1)(2013-8#1)
spectroscopic method for##2##3##(2008-10#2)
spectroscopic method to##2##3##(2008-10#1)(2008-5#1)
spectroscopic method was##2##3##(2008-10#2)
spectroscopic method##9##2##(2008-10#8)(2008-5#1)
spectroscopic methods including##2##3##(1996-2#1)(2007-1#1)
spectroscopic methods##9##2##(1996-2#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-4#1)
spectroscopic parameters##3##2##(2008-10#1)(2008-3#2)
spectroscopic probe##4##2##(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)
spectroscopic probes##2##2##(2008-10#1)(2008-12#1)
spectroscopic properties and##2##3##(2007-12#1)(2008-10#1)
spectroscopic properties of##5##3##(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#2)
spectroscopic properties##10##2##(1994-11#1)(1994-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)
spectroscopic resolution##2##2##(1994-8#1)(2008-7#1)
spectroscopic studies of##4##3##(1992-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
spectroscopic studies on##2##3##(1994-12#1)(2008-10#1)
spectroscopic studies##9##2##(1992-3#1)(1994-12#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-1#1)
spectroscopic study of##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)
spectroscopic study##9##2##(1994-8#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#2)
spectroscopic technique##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2013-8#1)
spectroscopic techniques and##2##3##(1997-2#1)(2007-11#1)
spectroscopic techniques##14##2##(1997-2#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
spectroscopic units##3##2##(2008-10#3)
spectroscopic##239##1##(1990-2#1)(1990-5#1)(1990-7#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#2)(1994-8#2)(1995-5#3)(1995-6#2)(1996-2#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-1#1)(2007-11#9)(2007-12#13)(2008-1#1)(2008-10#80)(2008-11#1)(2008-12#1)(2008-2#23)(2008-3#35)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
spectroscopical##2##1##(2008-10#2)
spectroscopically##6##1##(1992-8#1)(1994-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
spectroscopies to##2##2##(1993-11#1)(2010-4#1)
spectroscopies##11##1##(1992-3#1)(1992-8#1)(1993-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2010-4#1)(2010-7#1)
spectroscopy (CRDS)##2##2##(2008-2#1)(2010-7#1)
spectroscopy (EDS)##3##2##(2008-10#1)(2008-11#2)
spectroscopy (FTIR) and##3##3##(2008-10#3)
spectroscopy (FTIR)##11##2##(2008-10#7)(2008-5#1)(2011-1#1)(2013-8#2)
spectroscopy (IR)##2##2##(2008-10#1)(2009-8#1)
spectroscopy (LIBS)##3##2##(2008-10#2)(2013-8#1)
spectroscopy (NIRS) technology together with a remote reflectance fibre-optic probe##2##10##(2008-10#2)
spectroscopy (NIRS) was##2##3##(2008-10#2)
spectroscopy (NIRS)##9##2##(2008-10#8)(2008-3#1)
spectroscopy after##2##2##(2008-10#1)(2008-7#1)
spectroscopy analysis##3##2##(2008-10#1)(2008-6#1)(2010-9#1)
spectroscopy and X-ray photoelectron spectroscopy##2##5##(2008-10#2)
spectroscopy and X-ray##5##3##(1994-3#1)(1996-5#1)(2008-10#3)
spectroscopy and atomic force##2##4##(2008-10#1)(2008-6#1)
spectroscopy and chemical##2##3##(1992-3#1)(2008-7#1)
spectroscopy and chemometrics##2##3##(2007-12#2)
spectroscopy and fast##2##3##(1994-3#1)(2008-2#1)
spectroscopy and imaging##2##3##(1993-3#1)(2008-11#1)
spectroscopy and in##2##3##(2010-7#1)(2012-2#1)
spectroscopy and molecular##2##3##(1992-4#1)(1994-11#1)
spectroscopy and multivariate calibration##5##4##(2008-10#5)
spectroscopy and multivariate control charts##3##5##(2008-10#3)
spectroscopy and multivariate##10##3##(2008-10#9)(2013-8#1)
spectroscopy and the##4##3##(1994-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
spectroscopy and##93##2##(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-3#4)(1995-2#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-9#1)(2012-2#2)(2013-8#4)
spectroscopy applied to##2##3##(1997-6#1)(2008-10#1)
spectroscopy are discussed##2##3##(2007-12#1)(2008-3#1)
spectroscopy are##7##2##(1990-7#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-11#1)
spectroscopy as a tool for##2##5##(2008-4#1)(2010-11#1)
spectroscopy as a##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-11#1)
spectroscopy as an##2##3##(2008-10#1)(2010-4#1)
spectroscopy as##9##2##(2008-10#4)(2008-2#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-4#1)
spectroscopy at##13##2##(1990-9#1)(1993-11#1)(2008-10#4)(2008-3#6)(2011-1#1)
spectroscopy by use of##3##4##(2008-3#3)
spectroscopy by##4##2##(2008-3#4)
spectroscopy can be##2##3##(2008-10#1)(2008-3#1)
spectroscopy can##4##2##(1994-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
spectroscopy combined with##5##3##(1994-5#1)(1995-5#1)(2007-12#1)(2008-6#1)(2013-8#1)
spectroscopy coupled to multivariate##2##4##(2008-10#2)
spectroscopy coupled to##3##3##(2008-10#3)
spectroscopy coupled##4##2##(2008-10#4)
spectroscopy determinations##2##2##(2008-10#2)
spectroscopy experiment##3##2##(2007-11#1)(2008-3#2)
spectroscopy for in situ##3##4##(2008-10#3)
spectroscopy for in##4##3##(2008-10#3)(2011-1#1)
spectroscopy for quantitative##2##3##(2007-11#1)(2008-3#1)
spectroscopy for the##10##3##(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2010-4#1)(2012-12#1)
spectroscopy for##27##2##(2007-11#3)(2008-10#10)(2008-2#2)(2008-3#6)(2008-4#1)(2010-4#1)(2011-1#1)(2012-12#3)
spectroscopy from##3##2##(1992-8#1)(2007-11#1)(2008-3#1)
spectroscopy gives##2##2##(2008-3#1)(2008-5#1)
spectroscopy has been applied##2##4##(2008-10#1)(2013-8#1)
spectroscopy has been used to investigate the##2##7##(1990-8#1)(1994-5#1)
spectroscopy has been used to study##3##6##(1991-12#1)(1994-8#1)(2007-11#1)
spectroscopy has been used to##8##5##(1990-8#1)(1991-12#1)(1992-3#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-7#1)(2010-5#1)
spectroscopy has been##14##3##(1990-8#1)(1991-12#1)(1992-3#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-9#1)(2010-5#1)(2013-8#1)
spectroscopy has##20##2##(1990-8#1)(1991-12#1)(1992-3#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-5#1)(2013-8#2)
spectroscopy have been##5##3##(1992-3#1)(2008-10#2)(2008-3#1)(2008-7#1)
spectroscopy have##6##2##(1992-3#1)(2008-10#2)(2008-3#2)(2008-7#1)
spectroscopy in a##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
spectroscopy in combination with##2##4##(2008-10#1)(2008-6#1)
spectroscopy in order to##3##4##(2008-10#2)(2008-5#1)
spectroscopy in the##9##3##(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
spectroscopy in turbid media##2##4##(2008-3#2)
spectroscopy in##45##2##(1990-5#1)(1990-9#1)(1996-5#1)(1997-6#1)(2006-12#1)(2007-11#4)(2007-12#4)(2008-10#16)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)
spectroscopy indicated that##2##3##(2008-10#1)(2013-8#1)
spectroscopy indicated##3##2##(2008-10#2)(2013-8#1)
spectroscopy is also##2##3##(2007-11#1)(2007-12#1)
spectroscopy is an important tool##2##5##(2008-4#1)(2010-12#1)
spectroscopy is an##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
spectroscopy is applied to##2##4##(2008-2#1)(2008-3#1)
spectroscopy is demonstrated##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
spectroscopy is presented##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
spectroscopy is used to study##2##5##(2008-10#1)(2008-3#1)
spectroscopy is used to##4##4##(1995-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
spectroscopy is##30##2##(1995-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#6)(2008-3#7)(2008-4#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-8#1)
spectroscopy measurements of##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
spectroscopy measurements##9##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
spectroscopy method for##2##3##(2008-10#1)(2008-3#1)
spectroscopy method##3##2##(2008-10#2)(2008-3#1)
spectroscopy methods##3##2##(2008-10#2)(2008-9#1)
spectroscopy of anisotropic surfaces and films##2##6##(2007-12#2)
spectroscopy of human##3##3##(2007-11#1)(2008-3#2)
spectroscopy of the skin##2##4##(2008-5#2)
spectroscopy of the##14##3##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2010-11#1)(2010-5#1)
spectroscopy of##62##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(2007-11#7)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#15)(2008-4#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-2#2)(2010-5#2)(2013-8#1)
spectroscopy on##2##2##(2008-2#1)(2008-3#1)
spectroscopy or##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
spectroscopy provides##2##2##(2008-3#1)(2010-11#1)
spectroscopy show##2##2##(1997-7#1)(2013-8#1)
spectroscopy studies##5##2##(1991-9#1)(1993-11#1)(2008-10#1)(2008-3#2)
spectroscopy study of the##2##4##(2008-10#1)(2013-8#1)
spectroscopy study##4##2##(1992-6#1)(1997-7#1)(2008-10#1)(2013-8#1)
spectroscopy system##6##2##(2007-12#2)(2008-2#1)(2013-8#3)
spectroscopy technique##8##2##(2008-10#2)(2008-2#3)(2008-3#2)(2013-8#1)
spectroscopy techniques##10##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2012-12#1)
spectroscopy the##2##2##(2008-10#2)
spectroscopy to determine the##2##4##(1993-11#1)(2010-9#1)
spectroscopy to study the##2##4##(1990-12#1)(1997-7#1)
spectroscopy to study##3##3##(1990-12#1)(1994-11#1)(1997-7#1)
spectroscopy to the##5##3##(2008-10#2)(2008-2#1)(2013-8#2)
spectroscopy to##27##2##(1990-12#1)(1991-5#1)(1993-11#1)(1994-11#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-9#1)(2013-8#2)
spectroscopy using an##3##3##(1997-1#1)(2008-10#1)(2010-4#1)
spectroscopy using##14##2##(1990-11#1)(1994-11#1)(1994-5#1)(1997-1#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)
spectroscopy was used to investigate the##3##6##(2008-10#2)(2008-8#1)
spectroscopy was used to investigate##4##5##(2008-10#2)(2008-8#1)(2010-5#1)
spectroscopy was used to study##2##5##(1990-2#1)(1994-11#1)
spectroscopy was used to##14##4##(1990-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)
spectroscopy was used##15##3##(1990-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2013-8#1)
spectroscopy was##21##2##(1990-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-2#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2013-8#2)
spectroscopy were used to##2##4##(2008-10#2)
spectroscopy were##4##2##(2008-10#3)(2008-3#1)
spectroscopy with a 1##2##4##(2008-2#1)(2008-3#1)
spectroscopy with a continuous-wave##2##4##(2007-12#1)(2008-2#1)
spectroscopy with a##13##3##(2007-12#3)(2008-10#2)(2008-2#6)(2008-3#2)
spectroscopy with##31##2##(2007-11#2)(2007-12#8)(2008-10#3)(2008-2#9)(2008-3#7)(2013-8#2)
spectroscopy##1078##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#1)(1990-9#5)(1991-1#1)(1991-12#3)(1991-3#3)(1991-5#5)(1991-9#3)(1992-11#2)(1992-12#2)(1992-3#8)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#13)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#5)(1994-6#6)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#9)(1995-5#6)(1995-6#1)(1996-12#1)(1996-2#9)(1996-3#1)(1996-5#3)(1997-1#2)(1997-6#4)(1997-7#5)(2006-12#2)(2007-10#3)(2007-11#48)(2007-12#62)(2008-1#2)(2008-10#357)(2008-11#14)(2008-2#84)(2008-3#130)(2008-4#11)(2008-5#25)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#9)(2010-11#6)(2010-12#5)(2010-2#6)(2010-4#9)(2010-5#11)(2010-7#6)(2010-8#1)(2010-9#4)(2011-1#13)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#9)(2013-1#10)(2013-8#42)
spectroscopy) to##2##2##(2008-3#2)
spectroscopy)##7##1##(2008-10#1)(2008-3#3)(2010-3#2)(2010-7#1)
spectroscopy]##3##1##(2013-8#3)
spectrotemporal##2##1##(2007-12#1)(2008-2#1)
spectrum (340-640 nm) of##2##4##(2008-2#2)
spectrum -lactamase##2##2##(2007-7#2)
spectrum also##2##2##(2007-11#1)(2008-3#1)
spectrum analysis##6##2##(1991-12#1)(2007-11#1)(2008-3#2)(2009-8#1)(2013-8#1)
spectrum analyzer##3##2##(2007-11#1)(2008-3#2)
spectrum and a##2##3##(2007-12#1)(2008-3#1)
spectrum and mode of action##2##5##(2008-6#2)
spectrum and the##3##3##(2008-1#1)(2008-3#2)
spectrum and##32##2##(1990-12#1)(1990-8#1)(1991-8#1)(1993-6#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-8#2)
spectrum are##11##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2009-12#1)(2013-8#1)
spectrum as a##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
spectrum as well as##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
spectrum as##8##2##(2007-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)
spectrum at a##2##3##(2007-11#1)(2008-3#1)
spectrum at##8##2##(2007-11#2)(2008-10#3)(2008-3#3)
spectrum beta##3##2##(2007-7#1)(2008-3#1)(2012-2#1)
spectrum between##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
spectrum by##8##2##(1990-5#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
spectrum can be##2##3##(2008-10#1)(2013-8#1)
spectrum can##4##2##(2008-10#1)(2013-1#1)(2013-8#2)
spectrum change##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
spectrum could##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
spectrum disorder##7##2##(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
spectrum disorders##17##2##(2008-11#3)(2008-6#2)(2010-12#1)(2011-2#5)(2012-1#1)(2012-2#5)
spectrum displays four peaks##2##4##(2008-8#2)
spectrum displays##5##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-8#2)
spectrum for##10##2##(1991-1#1)(1992-5#2)(1995-5#1)(2007-12#1)(2008-2#4)(2011-1#1)
spectrum from a##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
spectrum from the##2##3##(1992-3#1)(2008-3#1)
spectrum from##11##2##(1992-3#1)(2007-12#3)(2008-2#1)(2008-3#5)(2008-8#1)
spectrum has##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
spectrum in the visible##2##4##(1993-11#1)(2007-12#1)
spectrum in the##9##3##(1993-11#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2011-1#1)
spectrum in##17##2##(1993-11#3)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2011-1#1)
spectrum is acquired by##2##4##(2008-10#1)(2008-3#1)
spectrum is acquired in##2##4##(2008-10#1)(2008-3#1)
spectrum is acquired##4##3##(2008-10#2)(2008-3#2)
spectrum is measured##2##3##(2007-11#1)(2008-10#1)
spectrum is presented##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
spectrum is used##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
spectrum is##37##2##(1994-6#1)(1995-1#1)(1997-3#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#12)
spectrum measured##2##2##(2008-3#2)
spectrum obtained by##2##3##(2008-2#2)
spectrum obtained##3##2##(1990-5#1)(2008-2#2)
spectrum of a fiber optical parametric amplifier##2##7##(2007-11#2)
spectrum of a single##2##4##(2008-10#1)(2010-7#1)
spectrum of a##16##3##(2007-11#4)(2007-12#5)(2008-10#4)(2008-3#2)(2010-7#1)
spectrum of action##4##3##(1990-5#1)(1994-6#1)(2010-6#1)(2013-8#1)
spectrum of activities##2##3##(2011-2#1)(2013-7#1)
spectrum of activity and##4##4##(2008-10#2)(2008-5#1)(2012-3#1)
spectrum of activity##11##3##(1992-2#1)(2008-10#4)(2008-5#3)(2008-7#1)(2011-2#1)(2012-3#1)
spectrum of an extreme-ultraviolet##2##4##(2007-11#2)
spectrum of an##6##3##(2007-11#3)(2008-3#3)
spectrum of antibiotics##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
spectrum of biological##4##3##(1990-4#1)(1994-6#1)(2008-10#1)(2010-4#1)
spectrum of both##2##3##(2008-10#1)(2012-2#1)
spectrum of clinical##4##3##(1996-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
spectrum of congenital##2##3##(2008-11#1)(2008-8#1)
spectrum of differential##2##3##(1993-8#1)(2008-12#1)
spectrum of each##5##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
spectrum of free##3##3##(2008-10#2)(2008-5#1)
spectrum of illness##3##3##(2008-5#1)(2011-2#2)
spectrum of light transmitted through turbid##2##6##(2008-3#2)
spectrum of light##3##3##(2008-3#3)
spectrum of liquid water##4##4##(2008-2#1)(2008-3#3)
spectrum of native##2##3##(1993-11#1)(2008-10#1)
spectrum of neurological##2##3##(2008-8#1)(2010-9#1)
spectrum of plane waves##2##4##(2008-3#2)
spectrum of potential##2##3##(2007-12#1)(2008-11#1)
spectrum of products##2##3##(2008-5#1)(2008-6#1)
spectrum of pure##5##3##(2008-2#3)(2008-3#2)
spectrum of reduced##2##3##(1991-2#1)(1993-11#1)
spectrum of resistance to##2##4##(2008-10#1)(2011-2#1)
spectrum of symptoms##2##3##(2008-7#2)
spectrum of the product##2##4##(1990-8#1)(2008-10#1)
spectrum of the##41##3##(1990-5#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-11#2)(2007-12#4)(2008-10#8)(2008-11#1)(2008-3#8)(2008-5#1)(2008-8#2)(2009-5#1)(2009-6#1)(2011-2#2)(2012-2#1)
spectrum of therapeutic##2##3##(1990-6#1)(2011-1#1)
spectrum of these##2##3##(2007-12#1)(2008-2#1)
spectrum of three##2##3##(1991-9#1)(2012-2#1)
spectrum of##283##2##(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-8#5)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#4)(1995-2#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2007-11#11)(2007-12#14)(2008-1#4)(2008-10#38)(2008-11#8)(2008-12#3)(2008-2#9)(2008-3#35)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#5)
spectrum phase##3##2##(2008-3#2)(2013-8#1)
spectrum ranging from##3##3##(1995-1#1)(2007-11#1)(2008-5#1)
spectrum resolution of the##2##4##(2013-8#2)
spectrum resolution##4##2##(2013-8#4)
spectrum shows##2##2##(1992-3#1)(2008-10#1)
spectrum that is##2##3##(2008-2#1)(2008-3#1)
spectrum that##4##2##(2008-2#1)(2008-3#3)
spectrum to##3##2##(1995-11#1)(2008-2#1)(2008-3#1)
spectrum using##3##2##(2008-10#1)(2010-8#1)(2012-1#1)
spectrum was used to##2##4##(2007-12#1)(2008-10#1)
spectrum was##13##2##(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2013-8#2)
spectrum were##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
spectrum with a##2##3##(2007-12#1)(2008-10#1)
spectrum with##8##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-2#1)(2012-3#1)
spectrum without##2##2##(1992-4#1)(2007-11#1)
spectrum##825##1##(1990-12#4)(1990-4#3)(1990-5#8)(1990-6#1)(1990-8#4)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#1)(1993-11#10)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#7)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#5)(1994-6#6)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#5)(1995-6#1)(1995-9#2)(1996-12#2)(1996-2#3)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#1)(2007-11#50)(2007-12#51)(2007-5#1)(2007-7#7)(2007-8#1)(2008-1#12)(2008-10#105)(2008-11#20)(2008-12#3)(2008-2#67)(2008-3#159)(2008-4#13)(2008-5#22)(2008-6#7)(2008-7#13)(2008-8#18)(2008-9#6)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#30)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#19)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#41)
spectrum)##2##1##(2007-11#1)(2008-10#1)
specular component##2##2##(2008-2#1)(2008-3#1)
specular direction##5##2##(2007-11#3)(2008-3#2)
specular microscope##2##2##(2011-2#2)
specular reflection and##2##3##(2008-3#2)
specular reflection##6##2##(2008-2#1)(2008-3#4)(2010-4#1)
specular##23##1##(2007-11#4)(2008-2#4)(2008-3#12)(2010-4#1)(2011-2#2)
speculate about##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
speculate on the possible##2##4##(2007-12#1)(2008-11#1)
speculate on the##6##3##(1996-3#1)(2007-12#1)(2008-11#1)(2009-5#1)(2012-12#1)(2012-3#1)
speculate on##12##2##(1994-1#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-11#3)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
speculate that the##6##3##(1990-11#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-4#1)
speculate that these##2##3##(2008-10#1)(2008-7#1)
speculate that this##2##3##(2008-11#1)(2012-3#1)
speculate that##29##2##(1990-11#1)(1990-5#1)(1991-9#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
speculate##48##1##(1990-11#1)(1990-5#1)(1991-9#1)(1994-1#1)(1994-2#2)(1995-8#1)(1996-3#2)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
speculated that a##2##3##(2008-9#1)(2009-6#1)
speculated that the##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
speculated that this##2##3##(1992-3#1)(2008-2#1)
speculated that##21##2##(1992-3#2)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
speculated to be the##3##4##(2008-3#1)(2008-5#1)(2012-2#1)
speculated to be##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)
speculated##27##1##(1992-3#2)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
speculation that##3##2##(1993-12#1)(2008-4#1)(2013-8#1)
speculation##7##1##(1993-12#1)(1993-5#1)(2008-11#1)(2008-4#2)(2011-1#1)(2013-8#1)
speculations about##3##2##(1992-3#1)(1996-9#1)(2012-2#1)
speculations##7##1##(1992-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
speculative##11##1##(1990-11#1)(1992-2#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-7#1)
speech and language disturbances##4##4##(2007-8#4)
speech and language##11##3##(2007-8#5)(2008-9#3)(2011-1#1)(2011-2#1)(2012-3#1)
speech and phonological awareness##2##4##(2011-1#2)
speech and##22##2##(1993-9#1)(2007-10#1)(2007-7#1)(2007-8#5)(2008-9#4)(2009-2#1)(2011-1#6)(2011-2#1)(2012-1#1)(2012-3#1)
speech at##2##2##(1994-1#1)(2008-2#1)
speech control##2##2##(2008-2#2)
speech discrimination##2##2##(2008-9#1)(2012-2#1)
speech in##4##2##(2009-5#1)(2011-1#3)
speech intelligibility##2##2##(2008-9#2)
speech on##2##2##(2011-1#1)(2012-12#1)
speech or##2##2##(2007-12#1)(2009-5#1)
speech perception and production##2##4##(2008-11#1)(2008-4#1)
speech perception and##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
speech perception in adult##2##4##(2008-9#2)
speech perception in##3##3##(2008-9#2)(2012-2#1)
speech perception performance in##3##4##(2008-9#1)(2012-2#2)
speech perception performance##7##3##(2008-9#5)(2012-2#2)
speech perception scores##2##3##(2008-9#2)
speech perception##30##2##(2008-11#2)(2008-4#1)(2008-9#20)(2009-2#1)(2009-9#1)(2012-2#5)
speech performance##2##2##(2008-9#2)
speech processing##3##2##(1993-9#1)(2008-9#2)
speech processor##12##2##(2008-9#12)
speech processors##2##2##(2008-9#2)
speech production and##2##3##(2008-9#1)(2012-12#1)
speech production##7##2##(2008-9#4)(2011-1#2)(2012-12#1)
speech rate##4##2##(2008-2#1)(2009-11#3)
speech recognition for##2##3##(2007-7#1)(2008-9#1)
speech recognition in noise##2##4##(2008-9#2)
speech recognition in##4##3##(2007-7#1)(2008-9#3)
speech recognition##15##2##(2007-12#1)(2007-7#5)(2008-9#9)
speech signal##2##2##(2007-7#1)(2009-2#1)
speech sounds##4##2##(1993-9#1)(2008-9#3)
speech therapy##3##2##(1995-1#1)(2009-7#1)(2011-2#1)
speech to##2##2##(2011-1#1)(2013-8#1)
speech was##2##2##(2007-7#1)(2011-1#1)
speech##204##1##(1990-12#1)(1990-3#1)(1991-3#1)(1993-9#3)(1994-1#3)(1994-3#1)(1995-1#1)(1995-12#1)(1997-8#1)(2007-10#4)(2007-12#5)(2007-7#12)(2007-8#5)(2008-10#1)(2008-11#2)(2008-2#9)(2008-4#5)(2008-9#77)(2009-10#6)(2009-11#3)(2009-2#4)(2009-3#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#25)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#5)
speech-coding##2##1##(2008-9#2)
speech-perception performance in##3##3##(2008-9#3)
speech-perception performance##4##2##(2008-9#4)
speech-processing##3##1##(2008-9#3)
speech-production##2##1##(2008-9#2)
speech-recognition performance##2##2##(2008-9#2)
speech-recognition technology##3##2##(2007-12#3)
speech-recognition##6##1##(2007-12#3)(2008-9#3)
speeches##3##1##(1997-2#1)(2008-9#1)(2010-10#1)
speed (0##2##2##(2007-10#1)(2008-10#1)
speed and accuracy of##2##4##(2008-11#1)(2008-3#1)
speed and accuracy##5##3##(2008-11#1)(2008-3#2)(2009-12#1)(2011-2#1)
speed and is##2##3##(2008-10#1)(2011-1#1)
speed and memory##2##3##(2008-2#1)(2008-3#1)
speed and resolution##3##3##(2008-7#1)(2008-9#1)(2011-7#1)
speed and the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
speed and time##6##3##(2008-10#1)(2008-5#5)
speed and##51##2##(1990-5#1)(1991-12#1)(1993-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
speed as well##2##3##(1994-3#1)(2010-8#1)
speed decreases##4##2##(2007-11#1)(2009-6#3)
speed during##2##2##(2008-7#1)(2012-12#1)
speed for##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
speed in a##2##3##(1994-8#1)(2008-3#1)
speed in the##5##3##(2007-12#1)(2008-12#2)(2008-2#2)
speed in##10##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
speed is required##2##3##(2008-3#2)
speed is##7##2##(1995-2#1)(2008-2#1)(2008-3#3)(2009-11#1)(2013-8#1)
speed of 5##2##3##(2008-12#1)(2008-3#1)
speed of analysis##3##3##(2008-10#2)(2008-9#1)
speed of propagation of##3##4##(2007-11#1)(2008-5#2)
speed of sound##5##3##(2008-3#5)
speed of the##12##3##(1990-12#1)(1993-8#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
speed of##76##2##(1990-12#1)(1992-2#2)(1993-12#3)(1993-8#2)(1994-5#1)(1994-8#2)(1997-7#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-10#12)(2008-12#3)(2008-2#2)(2008-3#15)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
speed on##2##2##(1994-8#1)(2008-7#1)
speed the##2##2##(1990-4#1)(2010-7#1)
speed to##3##2##(1991-3#1)(1992-6#1)(2008-10#1)
speed up##11##2##(1990-11#1)(1994-9#1)(1997-2#1)(2008-10#4)(2008-3#4)
speed was##6##2##(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#2)
speed were##4##2##(2008-12#2)(2008-3#1)(2011-2#1)
speed##323##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#2)(1992-2#2)(1992-3#1)(1992-6#2)(1993-12#7)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#8)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#2)(2007-11#11)(2007-12#11)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#51)(2008-11#5)(2008-12#7)(2008-2#20)(2008-3#51)(2008-4#8)(2008-5#9)(2008-6#6)(2008-7#8)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#4)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#5)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#12)(2011-7#2)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#4)
speeds and##6##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
speeds are##2##2##(1996-12#1)(2008-4#1)
speeds of##6##2##(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)
speeds revealed differences from##2##4##(1997-2#2)
speeds up##2##2##(1993-6#1)(2012-2#1)
speeds##44##1##(1992-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-2#3)(2007-10#4)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-1#2)
speedup##7##1##(2007-9#2)(2008-2#1)(2008-6#1)(2012-2#3)
speedy and accurate##2##3##(2008-3#1)(2010-8#1)
speedy##9##1##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
spell##3##1##(2008-10#1)(2009-5#1)(2010-4#1)
spelling errors##2##2##(2012-3#2)
spelling out##2##2##(2008-2#1)(2008-9#1)
spelling##12##1##(1990-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#3)(2011-1#2)(2012-3#2)
speltoides##9##1##(2008-10#9)
spend a##2##2##(1996-12#1)(2011-2#1)
spend compared to##2##3##(2009-4#2)
spend less##3##2##(1992-3#1)(1992-5#1)(2008-2#1)
spend more time in##2##4##(2008-7#1)(2012-2#1)
spend more time##7##3##(1996-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
spend more##9##2##(1994-2#1)(1996-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
spend on##4##2##(1990-2#2)(1995-6#1)(2009-4#1)
spend their##2##2##(1997-1#1)(2009-10#1)
spend##40##1##(1990-2#2)(1991-2#1)(1992-12#1)(1992-3#2)(1992-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#5)(2010-3#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-7#1)(2013-8#2)
spend-down##2##1##(1994-2#2)
spending and##6##2##(1992-3#1)(1993-3#1)(1995-1#1)(1996-1#1)(2008-11#1)(2012-3#1)
spending by state##2##3##(1995-12#1)(1997-3#1)
spending by##5##2##(1992-3#1)(1994-1#2)(1995-12#1)(1997-3#1)
spending for##7##2##(1991-2#3)(1995-3#1)(1997-1#2)(1997-3#1)
spending growth##2##2##(1993-1#1)(1996-2#1)
spending in the##2##3##(1992-12#1)(1995-3#1)
spending in##3##2##(1992-12#1)(1995-3#1)(2013-1#1)
spending is##2##2##(2012-3#1)(2013-8#1)
spending more time##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
spending more##4##2##(1991-3#1)(2008-11#1)(2009-8#1)(2011-1#1)
spending on health##2##3##(1992-2#1)(1996-8#1)
spending on##3##2##(1991-12#1)(1992-2#1)(1996-8#1)
spending per capita##2##3##(1994-1#1)(2008-7#1)
spending per##3##2##(1994-1#1)(1996-3#1)(2008-7#1)
spending the##2##2##(1995-12#1)(2012-2#1)
spending time##3##2##(1991-2#2)(2009-9#1)
spending to##2##2##(1995-3#1)(1996-1#1)
spending##109##1##(1991-12#2)(1991-2#6)(1991-3#2)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#5)(1993-1#1)(1993-2#1)(1993-3#3)(1994-1#9)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#5)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#6)(2008-11#10)(2008-7#2)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
spends##2##1##(1990-2#1)(1991-2#1)
spent CAPD fluids by##2##4##(2008-10#2)
spent CAPD fluids##4##3##(2008-10#4)
spent CAPD##5##2##(2008-10#5)
spent an##2##2##(2008-5#1)(2008-7#1)
spent by photons inside a##2##5##(2007-12#2)
spent by##3##2##(2007-12#2)(2008-2#1)
spent in the##4##3##(1993-2#1)(2008-9#1)(2011-2#2)
spent in##15##2##(1990-5#1)(1993-2#1)(2007-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#4)(2013-1#1)
spent ion exchange##2##3##(2008-10#2)
spent less##2##2##(1993-6#1)(2008-5#1)
spent male and female buffalo meat##2##6##(2010-4#2)
spent male and##3##3##(2010-4#3)
spent male##4##2##(2010-4#4)
spent medium was##3##3##(1994-5#1)(2008-11#2)
spent medium##5##2##(1994-5#2)(2008-11#3)
spent more time in##3##4##(2009-7#3)
spent more time##8##3##(2008-5#1)(2009-7#4)(2009-9#2)(2012-3#1)
spent on the##5##3##(1992-4#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
spent on##15##2##(1990-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#2)
spent##116##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#4)(1995-11#2)(1995-12#2)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#4)(1997-3#2)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#16)(2008-11#9)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#5)(2009-9#3)(2010-3#2)(2010-4#5)(2010-8#4)(2011-2#8)(2012-2#4)(2012-3#1)(2013-1#6)
spent-sulfidic caustic##3##2##(2008-6#3)
sperm DNA is##2##3##(1993-6#1)(2008-9#1)
sperm DNA##16##2##(1993-6#1)(2008-10#12)(2008-4#1)(2008-9#2)
sperm acrosome reaction##4##3##(1992-8#1)(2008-4#1)(2008-8#2)
sperm acrosome##7##2##(1992-8#1)(1995-6#1)(2008-4#1)(2008-8#4)
sperm allocation##4##2##(2013-1#4)
sperm and microbes##2##3##(1996-9#2)
sperm and##9##2##(1996-9#3)(1997-4#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
sperm are##6##2##(1992-8#2)(1994-8#1)(2007-12#1)(2008-8#2)
sperm binding to ZP and##2##5##(2013-1#2)
sperm can##3##2##(1994-5#1)(1994-8#1)(2007-12#1)
sperm cell##4##2##(1993-6#1)(2007-12#2)(2008-12#1)
sperm cells and##2##3##(2008-12#2)
sperm cells of##2##3##(2007-12#1)(2008-8#1)
sperm cells were##5##3##(1997-4#1)(2008-12#4)
sperm cells##22##2##(1993-6#3)(1997-4#2)(1997-6#3)(2007-12#2)(2008-12#9)(2008-8#1)(2009-8#1)(2012-2#1)
sperm chromatin##2##2##(1990-7#1)(2012-3#1)
sperm competition##7##2##(2008-6#1)(2008-8#4)(2009-6#1)(2013-1#1)
sperm concentration and##2##3##(2008-7#1)(2008-8#1)
sperm concentration##3##2##(2008-7#2)(2008-8#1)
sperm flagella##3##2##(1991-2#2)(2007-12#1)
sperm from##5##2##(1996-11#1)(1997-4#1)(2007-12#1)(2008-6#1)(2012-12#1)
sperm head shape abnormality test##2##5##(1992-5#2)
sperm head shape abnormality##4##4##(1992-5#4)
sperm head##9##2##(1992-5#4)(1994-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
sperm in the##2##3##(1997-4#1)(2008-6#1)
sperm in##6##2##(1994-5#1)(1997-4#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)
sperm insemination##2##2##(1996-9#1)(2012-3#1)
sperm is##2##2##(1994-8#1)(2009-2#1)
sperm limitation and polyspermy##2##4##(2008-8#2)
sperm limitation##4##2##(2008-8#4)
sperm maturation and##2##3##(1997-6#1)(2011-1#1)
sperm maturation##4##2##(1997-6#2)(2011-1#2)
sperm morphology##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
sperm motility##6##2##(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#3)
sperm movement##2##2##(2007-12#1)(2008-12#1)
sperm nucleus##2##2##(2008-7#1)(2012-2#1)
sperm of##3##2##(1997-5#1)(2007-12#1)(2008-8#1)
sperm parameters##3##2##(2008-12#3)
sperm penetration##2##2##(2013-1#2)
sperm precedence##3##2##(2008-8#2)(2012-12#1)
sperm production##4##2##(1992-12#2)(1994-8#1)(2009-10#1)
sperm quality and##3##3##(2008-12#1)(2009-10#1)(2011-1#1)
sperm quality##6##2##(1996-6#1)(2008-12#1)(2009-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
sperm release##3##2##(2008-5#1)(2008-8#1)(2009-10#1)
sperm storage and##2##3##(2007-12#2)
sperm storage organs##3##3##(2007-12#3)
sperm storage##8##2##(2007-12#6)(2008-6#1)(2008-7#1)
sperm stored##3##2##(2008-8#2)(2012-12#1)
sperm to##3##2##(2008-8#1)(2009-2#1)(2013-1#1)
sperm transfer and storage##2##4##(2007-12#2)
sperm transfer##3##2##(1995-2#1)(2007-12#2)
sperm ultrastructure of##2##3##(2008-7#2)
sperm viability##2##2##(2008-12#1)(2008-9#1)
sperm was##2##2##(1997-4#1)(2008-4#1)
sperm were alive##2##3##(2008-12#2)
sperm were##5##2##(2008-12#4)(2008-4#1)
sperm whale myoglobin##2##3##(1993-11#1)(1994-5#1)
sperm whale##5##2##(1993-11#1)(1994-5#2)(1995-2#1)(1995-3#1)
sperm when stimulated with##2##4##(2008-8#2)
sperm##282##1##(1990-7#3)(1990-9#1)(1991-11#2)(1991-2#3)(1991-5#1)(1992-12#2)(1992-5#4)(1992-8#6)(1993-11#1)(1993-6#5)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#9)(1995-2#2)(1995-3#1)(1995-6#4)(1996-11#1)(1996-6#1)(1996-9#6)(1997-4#8)(1997-5#1)(1997-6#6)(2007-12#25)(2008-10#13)(2008-11#1)(2008-12#30)(2008-4#12)(2008-5#4)(2008-6#6)(2008-7#17)(2008-8#37)(2008-9#8)(2009-10#4)(2009-2#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#14)(2013-8#1)
sperm)##2##1##(1997-8#1)(2008-8#1)
sperm-ZP interactions##3##2##(2013-1#3)
sperm-egg membrane fusion##2##3##(2008-8#2)
sperm-egg##5##1##(2008-6#1)(2008-8#4)
sperm-oocyte adhesion##3##2##(2012-2#3)
sperm-oocyte##4##1##(1995-6#1)(2012-2#3)
spermatheca##13##1##(2008-5#1)(2008-6#5)(2008-8#1)(2012-12#6)
spermathecae and##2##2##(2007-12#2)
spermathecae##10##1##(2007-12#5)(2008-12#1)(2008-7#2)(2008-8#2)
spermathecal ducts##4##2##(2007-12#2)(2008-8#2)
spermathecal sperm##3##2##(2008-8#3)
spermathecal##11##1##(2007-12#3)(2008-5#3)(2008-8#5)
spermatia##2##1##(2008-10#2)
spermatic cord torsion##3##3##(2008-10#3)
spermatic cord##8##2##(2008-10#4)(2008-6#4)
spermatic##12##1##(1990-9#2)(2007-5#1)(2008-10#4)(2008-5#1)(2008-6#4)
spermatid differentiation##2##2##(2008-7#2)
spermatid nuclei##2##2##(1991-9#1)(2012-2#1)
spermatid##13##1##(1991-9#2)(2008-7#4)(2009-12#1)(2012-2#6)
spermatids and spermatozoa##2##3##(2008-5#1)(2008-7#1)
spermatids and##3##2##(2008-5#1)(2008-7#2)
spermatids that##2##2##(2008-7#1)(2012-2#1)
spermatids##21##1##(1990-9#1)(1991-9#1)(1992-12#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#3)(2012-2#4)(2013-1#1)
spermatocystes##2##1##(2008-12#2)
spermatocyte##6##1##(2008-7#1)(2009-10#3)(2011-2#1)(2012-2#1)
spermatocytes and##3##2##(2009-10#1)(2010-5#1)(2012-2#1)
spermatocytes##16##1##(1990-10#1)(2008-5#2)(2008-7#2)(2009-10#2)(2009-7#1)(2010-5#2)(2012-2#5)(2013-1#1)
spermatodesm##2##1##(2008-7#2)
spermatodesms##5##1##(2008-7#5)
spermatogenesis and male fertility##2##4##(2009-10#1)(2012-2#1)
spermatogenesis and##8##2##(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-1#1)(2012-2#2)
spermatogenesis are##4##2##(2009-10#1)(2010-5#1)(2012-2#2)
spermatogenesis in the##2##3##(2010-5#1)(2013-7#1)
spermatogenesis in##4##2##(2009-7#1)(2010-5#1)(2012-2#1)(2013-7#1)
spermatogenesis##66##1##(1992-12#4)(1993-12#2)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#17)(2009-7#1)(2010-5#4)(2011-1#1)(2012-1#1)(2012-2#17)(2012-3#1)(2013-7#1)(2013-8#3)
spermatogenic cells##4##2##(2008-5#2)(2009-10#1)(2012-2#1)
spermatogenic##16##1##(2008-10#1)(2008-5#3)(2008-9#1)(2009-10#3)(2012-2#8)
spermatogonia and##6##2##(2008-5#2)(2008-9#1)(2009-10#1)(2013-1#1)(2013-7#1)
spermatogonia##20##1##(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#4)(2009-7#1)(2010-5#2)(2012-2#5)(2013-1#2)(2013-7#1)
spermatogonial and spermatocyte##2##3##(2009-10#1)(2011-2#1)
spermatogonial stem cell##2##3##(2012-2#2)
spermatogonial stem##3##2##(2009-10#1)(2012-2#2)
spermatogonial##11##1##(2008-7#2)(2009-10#2)(2011-2#1)(2012-2#6)
spermatological##2##1##(2008-7#2)
spermatology##3##1##(2007-12#2)(2008-7#1)
spermatophore##2##1##(2008-7#2)
spermatozoa and##2##2##(2008-5#1)(2008-8#1)
spermatozoa are##2##2##(2007-12#1)(2012-2#1)
spermatozoa during##4##2##(2007-12#1)(2008-7#1)(2011-1#2)
spermatozoa from##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
spermatozoa is##2##2##(2007-12#1)(2008-6#1)
spermatozoa of all the species##3##5##(2007-12#2)(2008-7#1)
spermatozoa of the rove beetle Aleochara bilineata##2##7##(2008-7#2)
spermatozoa of the rove beetle Aleochara##3##6##(2007-12#1)(2008-7#2)
spermatozoa of the##5##3##(2007-12#1)(2008-7#4)
spermatozoa of##14##2##(2007-12#5)(2008-7#8)(2008-8#1)
spermatozoa on##2##2##(2009-4#1)(2012-3#1)
spermatozoa stored in the##3##4##(2008-7#3)
spermatozoa to##3##2##(2011-1#1)(2013-1#2)
spermatozoa were##3##2##(2008-12#1)(2008-8#2)
spermatozoa##84##1##(1991-6#1)(1996-9#1)(2007-12#10)(2008-10#1)(2008-12#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#25)(2008-8#10)(2009-10#2)(2009-4#1)(2010-5#1)(2011-1#7)(2011-2#1)(2012-2#3)(2012-3#5)(2013-1#6)
spermatozoal function##2##2##(2011-1#2)
spermatozoal##5##1##(2008-7#1)(2008-9#1)(2011-1#3)
spermatozoon##7##1##(2007-12#1)(2008-7#4)(2008-8#2)
spermiation##5##1##(2012-2#5)
spermidine and spermine##5##3##(1992-11#1)(2008-10#2)(2008-8#1)(2009-8#1)
spermidine and spermine)##2##3##(1991-5#1)(2009-8#1)
spermidine and##12##2##(1991-5#1)(1992-11#1)(2008-10#4)(2008-8#2)(2009-6#2)(2009-8#2)
spermidine as##2##2##(1995-2#1)(2009-8#1)
spermidine importer##2##2##(2009-6#2)
spermidine synthase##2##2##(2009-8#1)(2013-8#1)
spermidine was##2##2##(1995-2#2)
spermidine##28##1##(1991-12#1)(1991-5#1)(1992-11#1)(1995-2#4)(2008-10#7)(2008-8#4)(2009-6#4)(2009-8#4)(2013-8#2)
spermidine/spermine N1-acetyltransferase (SSAT)##2##3##(1992-10#1)(1995-2#1)
spermidine/spermine N1-acetyltransferase##6##2##(1991-9#2)(1992-10#2)(1995-2#2)
spermine and##3##2##(1990-7#1)(1991-5#1)(1995-2#1)
spermine##41##1##(1990-3#6)(1990-7#4)(1991-12#1)(1991-5#3)(1992-11#2)(1993-8#1)(1994-11#1)(1995-2#1)(1996-2#3)(2008-10#5)(2008-8#10)(2009-8#4)
spermiogenesis and spermiation##3##3##(2012-2#3)
spermiogenesis and##4##2##(2012-2#4)
spermiogenesis in two##2##3##(2007-12#1)(2008-7#1)
spermiogenesis in##3##2##(2007-12#1)(2008-7#2)
spermiogenesis##17##1##(1991-9#1)(2007-12#3)(2008-7#4)(2008-9#1)(2011-1#1)(2012-2#7)
spermogonia##4##1##(2008-10#4)
sperms are##2##2##(2007-12#1)(2008-8#1)
sperms##8##1##(2007-12#2)(2008-8#2)(2008-9#3)(2012-2#1)
sphaericus##6##1##(2008-10#1)(2008-6#5)
sphaeroides reaction##2##2##(1992-6#1)(1993-11#1)
sphaeroides were##2##2##(1993-11#1)(2008-8#1)
sphaeroides##19##1##(1992-6#2)(1993-11#4)(1995-2#1)(1995-8#1)(2008-10#2)(2008-8#4)(2008-9#2)(2010-2#3)
sphagnum peat mix##2##3##(2008-10#2)
sphagnum peat##4##2##(2008-10#4)
spheno-clival region##3##2##(2011-2#3)
sphenoid ridge##2##2##(2008-7#2)
sphenoid sinus and##2##3##(2011-2#1)(2012-3#1)
sphenoid sinus##11##2##(1990-9#1)(1993-12#1)(2008-7#3)(2011-2#3)(2012-3#3)
sphenoid##18##1##(1990-9#1)(1993-12#1)(2008-10#3)(2008-7#5)(2011-2#4)(2012-3#3)(2013-1#1)
sphenopalatine##2##1##(2008-8#1)(2012-1#1)
sphenoparietal sinus##4##2##(1996-9#4)
sphere and##3##2##(2008-2#2)(2008-3#1)
sphere of the##2##3##(1997-7#1)(2008-10#1)
sphere of##7##2##(1990-7#1)(1991-6#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-2#2)
sphere radius##2##2##(2007-12#1)(2008-2#1)
sphere size##2##2##(2008-3#2)
sphere suspensions##3##2##(2007-12#1)(2008-3#2)
sphere##72##1##(1990-3#1)(1990-7#1)(1991-6#3)(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#21)(2008-3#27)(2008-6#1)(2009-11#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#4)
spheres and##9##2##(2007-11#1)(2008-2#2)(2008-3#5)(2008-7#1)
spheres are##4##2##(1997-7#1)(2007-11#1)(2008-3#2)
spheres can##2##2##(2008-2#1)(2008-3#1)
spheres containing##3##2##(2008-11#2)(2008-3#1)
spheres in the##2##3##(2008-2#2)
spheres in##7##2##(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#2)
spheres is##2##2##(2008-2#1)(2008-3#1)
spheres of##5##2##(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)
spheres that##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
spheres with a##2##3##(2008-3#2)
spheres with the##2##3##(2008-3#2)
spheres with##8##2##(2008-2#2)(2008-3#6)
spheres##102##1##(1990-2#2)(1994-12#1)(1997-7#1)(2007-11#8)(2007-12#1)(2008-11#7)(2008-2#24)(2008-3#49)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#2)
spherical aberration and##4##3##(2008-2#1)(2008-3#3)
spherical aberration of the##2##4##(2008-2#1)(2008-3#1)
spherical aberration of##3##3##(2008-2#1)(2008-3#2)
spherical aberration on the##2##4##(2008-2#1)(2008-3#1)
spherical aberration on##4##3##(2008-2#2)(2008-3#2)
spherical aberration##32##2##(2007-12#3)(2008-2#9)(2008-3#19)(2009-5#1)
spherical aberrations##4##2##(2008-2#2)(2008-3#2)
spherical and##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
spherical beads##2##2##(2008-11#1)(2013-1#1)
spherical bioparticle##3##2##(2008-6#1)(2008-7#2)
spherical ceramic##2##2##(2010-11#2)
spherical coordinates##2##2##(2008-2#1)(2008-3#1)
spherical drop##2##2##(2008-10#2)
spherical end##2##2##(2008-10#2)
spherical holographic gratings##2##3##(2008-3#2)
spherical illumination##4##2##(2008-2#4)
spherical in shape##2##3##(2008-2#1)(2008-5#1)
spherical interference##3##2##(2008-3#3)
spherical macroporous epoxy-dicyandiamide chelating resin##2##5##(2008-10#2)
spherical micelles##4##2##(2008-10#3)(2008-12#1)
spherical microparticles##2##2##(2007-11#2)
spherical mirror##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
spherical mirrors are##3##3##(2008-2#1)(2008-3#2)
spherical mirrors##7##2##(2008-2#1)(2008-3#6)
spherical multicellular aggregates (spheroids)##2##4##(2008-11#2)
spherical object##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
spherical or##2##2##(1997-8#1)(2007-12#1)
spherical particle##9##2##(2008-2#4)(2008-3#4)(2011-2#1)
spherical particles in##2##3##(2008-3#1)(2008-7#1)
spherical particles with##2##3##(2008-3#1)(2008-7#1)
spherical particles##11##2##(2008-10#1)(2008-2#2)(2008-3#6)(2008-7#2)
spherical primary##3##2##(2008-3#3)
spherical shape##4##2##(2008-10#1)(2008-2#2)(2009-5#1)
spherical surface##6##2##(2008-3#5)(2008-7#1)
spherical surfaces and##3##3##(2008-2#1)(2008-3#2)
spherical surfaces##4##2##(2008-2#1)(2008-3#3)
spherical symmetry##2##2##(2008-3#2)
spherical variable-line-spaced grating##2##3##(2008-3#2)
spherical variable-line-spaced##3##2##(2008-3#3)
spherical vesicles##3##2##(1990-2#1)(1997-2#1)(2008-10#1)
spherical virus##4##2##(2008-10#4)
spherical wave##4##2##(2007-12#1)(2008-3#3)
spherical##222##1##(1990-2#1)(1990-5#1)(1990-8#1)(1992-12#2)(1992-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-11#6)(2007-12#13)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#36)(2008-3#97)(2008-5#2)(2008-6#1)(2008-7#8)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#3)
spherically symmetric##2##2##(2008-2#1)(2008-3#1)
spherically##4##1##(2008-11#1)(2008-2#1)(2008-3#2)
sphericity##7##1##(2008-2#3)(2008-3#1)(2009-4#2)(2010-5#1)
sphering##3##1##(2008-2#3)
spherochromatism##3##1##(2008-3#3)
spheroid assay##2##2##(2013-1#2)
spheroid culture##4##2##(2008-11#4)
spheroid cultures##2##2##(2008-11#2)
spheroid##21##1##(2008-11#11)(2008-2#4)(2008-3#3)(2013-1#3)
spheroidal coordinates##4##2##(2007-12#1)(2008-2#3)
spheroidal particles##2##2##(2008-2#2)
spheroidal shape##2##2##(2008-2#2)
spheroidal##14##1##(1992-8#1)(2007-12#1)(2008-2#10)(2008-3#1)(2008-7#1)
spheroidene##2##1##(2010-2#2)
spheroids and##2##2##(1997-4#1)(2008-11#1)
spheroids disaggregated after 1 week##2##5##(1992-9#2)
spheroids disaggregated##4##2##(1992-9#4)
spheroids formed##2##2##(2008-11#2)
spheroids of##3##2##(1995-12#1)(2008-11#1)(2008-2#1)
spheroids on a##2##3##(2008-11#2)
spheroids were##2##2##(2008-11#2)
spheroids with##5##2##(2008-3#5)
spheroids##45##1##(1991-6#1)(1992-9#6)(1995-12#2)(1997-4#3)(2008-11#21)(2008-2#2)(2008-3#7)(2011-2#3)
spheroplasts##2##1##(2008-4#2)
spherule recovered from##2##3##(2008-10#2)
sphincter and##2##2##(1990-3#1)(2013-8#1)
sphincter mechanism##2##2##(1996-11#2)
sphincter##28##1##(1990-3#1)(1990-9#1)(1992-6#1)(1992-9#1)(1994-2#1)(1996-11#2)(2008-10#3)(2008-3#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#4)(2013-8#4)
sphincterotomy was##2##2##(2007-8#2)
sphincterotomy##14##1##(1990-2#1)(1990-3#4)(1991-3#1)(1993-2#1)(2007-8#4)(2008-5#2)(2013-1#1)
sphinganine##2##1##(2008-10#1)(2008-5#1)
sphingoid##3##1##(1990-5#1)(1990-7#1)(2008-5#1)
sphingolipid metabolism in##2##3##(2008-5#1)(2009-9#1)
sphingolipid metabolism##4##2##(2008-5#2)(2009-9#2)
sphingolipid##13##1##(1994-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#3)(2008-8#4)(2009-9#2)
sphingolipids##4##1##(1994-12#1)(1994-6#1)(1997-7#1)(2008-5#1)
sphingomyelin (SPM)##2##2##(2008-10#1)(2012-2#1)
sphingomyelin##18##1##(1992-10#1)(1992-6#1)(1992-9#1)(1993-9#3)(1994-5#3)(1995-12#2)(1995-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#2)
sphingomyelinase##8##1##(1992-6#3)(1995-12#2)(2008-6#1)(2008-8#1)(2009-9#1)
sphingosine levels were##2##3##(1992-8#1)(1994-3#1)
sphingosine levels##3##2##(1992-8#1)(1994-3#2)
sphingosine production##3##2##(1994-3#3)
sphingosine treatment##2##2##(1994-3#2)
sphingosine##19##1##(1992-11#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-3#12)(1995-2#1)(2009-9#2)
sphingosine)##2##1##(2008-5#2)
sphingosine-1-phosphate##2##1##(2009-9#2)
sphingosine-dependent##2##1##(1994-3#2)
sphingosines##2##1##(1990-5#2)
sphygmomanometer##5##1##(1990-8#1)(1991-3#1)(1992-6#1)(2008-1#1)(2008-11#1)
spi gene in##2##3##(1997-7#2)
spi gene##3##2##(1997-7#3)
spica##4##1##(2008-9#3)(2013-7#1)
spicata##3##1##(2008-10#1)(2008-9#2)
spice##9##1##(2008-10#1)(2008-2#4)(2008-5#1)(2011-1#1)(2012-3#2)
spices and##2##2##(2008-10#1)(2013-1#1)
spices##6##1##(1997-4#1)(2008-10#2)(2009-11#1)(2011-2#1)(2013-1#1)
spicifera##5##1##(2008-10#1)(2008-11#3)(2008-5#1)
spicules##5##1##(1992-3#1)(2007-12#3)(2008-1#1)
spider Misumenops pallidus##2##3##(2008-5#2)
spider and##2##2##(1993-11#1)(2008-9#1)
spider dragline silk##2##3##(2008-7#1)(2012-2#1)
spider mite##4##2##(2008-12#1)(2008-8#2)(2011-2#1)
spider monkey##3##2##(2008-5#1)(2011-2#2)
spider silk##2##2##(2008-7#2)
spider##44##1##(1990-5#2)(1993-11#2)(2007-12#10)(2008-10#1)(2008-12#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#5)(2009-9#3)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#1)
spiders##17##1##(2007-12#5)(2008-5#1)(2008-9#2)(2009-9#3)(2012-2#2)(2012-3#4)
spiders)##2##1##(2008-9#2)
spike activity##3##2##(1995-12#1)(1996-2#1)(2008-11#1)
spike and a##2##3##(2007-12#1)(2008-8#1)
spike characteristics##2##2##(2008-10#2)
spike firing##2##2##(1993-12#1)(1996-2#1)
spike gene##5##2##(1997-3#5)
spike in##5##2##(1991-12#2)(1997-3#1)(2008-8#1)(2011-2#1)
spike of##3##2##(1994-6#1)(2008-7#2)
spike protein##3##2##(1997-3#1)(2008-5#2)
spike recovery##4##2##(1995-12#1)(2008-10#3)
spike train##7##2##(2008-1#1)(2008-11#2)(2009-8#3)(2013-8#1)
spike trains##10##2##(2008-11#5)(2009-8#3)(2013-8#2)
spike was##3##2##(2008-10#2)(2008-3#1)
spike##104##1##(1990-7#1)(1991-12#3)(1992-3#4)(1993-12#3)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#5)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#8)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#15)(2008-12#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#8)(2011-2#1)(2012-3#1)(2013-8#4)
spike) and##2##2##(2008-10#2)
spike)##3##1##(2008-10#3)
spike-burst##3##1##(2008-11#3)
spiked and unspiked##2##3##(2008-10#2)
spiked and##4##2##(2008-10#4)
spiked artificial##2##2##(2008-10#2)
spiked at##3##2##(2008-10#2)(2011-2#1)
spiked environmental samples##2##3##(2008-10#1)(2011-1#1)
spiked human urine and serum##2##5##(2008-10#2)
spiked human urine and##4##4##(2008-10#4)
spiked human urine##6##3##(2008-10#6)
spiked human##11##2##(1995-3#1)(2008-10#10)
spiked in a##2##3##(2008-10#2)
spiked in##5##2##(2008-1#1)(2008-10#3)(2008-5#1)
spiked into##4##2##(2008-10#3)(2011-2#1)
spiked levels##3##2##(2011-1#3)
spiked matrices and##2##3##(2008-10#2)
spiked matrices##3##2##(2008-10#3)
spiked natural water##3##3##(2008-10#3)
spiked natural##5##2##(2008-10#5)
spiked on the surface of the##2##6##(2008-10#2)
spiked plasma samples##4##3##(2008-10#4)
spiked recoveries of##2##3##(2008-10#1)(2011-1#1)
spiked recoveries##3##2##(2008-10#2)(2011-1#1)
spiked sample##2##2##(2008-10#1)(2008-9#1)
spiked samples are in##2##4##(2008-10#2)
spiked samples are##3##3##(2008-10#3)
spiked samples of##3##3##(2008-10#3)
spiked samples were over##2##4##(2008-10#2)
spiked samples were##8##3##(2008-10#8)
spiked samples##34##2##(2008-10#34)
spiked seawater samples##2##3##(2008-10#2)
spiked serum##2##2##(2008-10#2)
spiked soil##2##2##(2008-10#1)(2008-12#1)
spiked tap water##2##3##(2008-10#2)
spiked tap##4##2##(2008-10#4)
spiked to##2##2##(2008-10#2)
spiked urine samples##4##3##(1995-2#1)(2008-10#3)
spiked urine##7##2##(1995-2#1)(1996-5#1)(2008-10#5)
spiked vegetable##2##2##(2008-10#2)
spiked water and##3##3##(2008-10#3)
spiked water samples##9##3##(2008-10#9)
spiked water##14##2##(2008-10#14)
spiked with 1##2##3##(2008-10#2)
spiked with 10##2##3##(2008-10#2)
spiked with Au##2##3##(2008-10#2)
spiked with Hg(II)##2##3##(2008-10#2)
spiked with a mixture of##2##5##(2008-10#2)
spiked with a##3##3##(2008-10#3)
spiked with different concentrations of##2##5##(2008-10#2)
spiked with different##5##3##(2008-10#5)
spiked with known amounts of##4##5##(2008-10#4)
spiked with known##7##3##(2008-10#7)
spiked with the##4##3##(2008-10#3)(2012-1#1)
spiked with##67##2##(1990-12#1)(1993-9#1)(2008-10#59)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-12#1)
spiked##258##1##(1990-12#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#232)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-12#1)
spiked)##2##1##(2008-10#2)
spikelet differentiation in rice##2##4##(2008-9#2)
spikelet differentiation##4##2##(2008-9#4)
spikelet##14##1##(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#4)
spikelets##11##1##(2008-10#10)(2008-9#1)
spikes added to the##2##4##(2008-10#2)
spikes and##2##2##(1996-5#1)(2009-8#1)
spikes are##2##2##(2008-4#1)(2009-8#1)
spikes can##3##2##(2008-10#1)(2008-11#2)
spikes in the##2##3##(2008-10#1)(2008-3#1)
spikes in##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
spikes of##4##2##(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)
spikes or##2##2##(1994-6#1)(2009-5#1)
spikes that##2##2##(2008-10#1)(2008-11#1)
spikes were##3##2##(2008-10#2)(2008-3#1)
spikes##50##1##(1991-5#1)(1992-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#5)(2010-8#1)(2012-4#1)
spikes)##3##1##(2008-10#3)
spiking activity in##2##3##(2009-8#1)(2013-8#1)
spiking activity##4##2##(2009-8#3)(2013-8#1)
spiking fever##2##2##(1995-11#1)(2011-2#1)
spiking level##2##2##(2008-10#2)
spiking neuron models##2##3##(2008-11#2)
spiking neuron##3##2##(2008-11#3)
spiking procedure##3##2##(2008-10#3)
spiking with##3##2##(2008-10#2)(2009-5#1)
spiking##44##1##(1991-5#1)(1995-11#1)(2008-10#25)(2008-11#6)(2008-7#2)(2009-5#1)(2009-8#3)(2011-1#1)(2011-2#2)(2013-8#2)
spill##11##1##(1997-4#4)(2008-10#2)(2008-11#2)(2008-3#1)(2009-7#1)(2013-1#1)
spillage##2##1##(1994-9#1)(2008-11#1)
spilled##3##1##(2008-10#2)(2012-2#1)
spillovers##2##1##(1997-1#2)
spills##3##1##(2008-11#3)
spin axis##2##2##(2008-2#2)
spin blockade##4##2##(2012-2#4)
spin coating method##2##3##(2008-10#2)
spin coating##5##2##(2008-10#4)(2008-2#1)
spin delocalization from##2##3##(2007-11#1)(2010-7#1)
spin delocalization##4##2##(2007-11#2)(2010-7#2)
spin density wave##2##3##(2012-2#2)
spin density##7##2##(1993-8#1)(1994-5#2)(1996-2#1)(2009-10#1)(2012-2#2)
spin echo##3##2##(1993-11#1)(2008-1#1)(2011-2#1)
spin excitations in##2##3##(2012-2#2)
spin excitations##3##2##(2012-2#3)
spin filter perfusion##2##3##(2008-11#2)
spin filter##4##2##(2008-10#1)(2008-11#3)
spin fluctuations##2##2##(2008-7#1)(2012-2#1)
spin label##2##2##(1990-12#1)(1993-8#1)
spin labels##5##2##(1990-2#1)(1993-8#4)
spin probe##3##2##(2008-10#3)
spin profiles##2##2##(2007-11#2)
spin relaxation##3##2##(2008-7#3)
spin resonance##14##2##(1990-5#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#1)
spin state##2##2##(2008-7#1)(2012-12#1)
spin states##3##2##(2009-5#1)(2012-2#2)
spin trap##2##2##(1990-12#1)(1993-3#1)
spin trapping##3##2##(1994-11#1)(2008-10#1)(2008-5#1)
spin valve##3##2##(2008-10#1)(2008-7#2)
spin##121##1##(1990-12#2)(1990-2#1)(1990-5#6)(1992-11#1)(1993-11#2)(1993-3#1)(1993-8#6)(1994-11#1)(1994-5#2)(1994-6#1)(1996-2#3)(1997-7#1)(2007-11#15)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#6)(2008-5#2)(2008-7#12)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#3)(2009-6#1)(2010-7#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#13)
spin-allowed##2##1##(1997-7#2)
spin-coated films##2##2##(2008-10#2)
spin-coated##5##1##(2008-10#4)(2009-11#1)
spin-coating##2##1##(2008-10#1)(2010-8#1)
spin-echo sequence##2##2##(1995-8#1)(2008-10#1)
spin-echo##4##1##(1992-3#1)(1995-8#1)(1997-8#1)(2008-10#1)
spin-flip##3##1##(2007-12#2)(2012-2#1)
spin-forbidden##3##1##(1997-7#3)
spin-labeled##3##1##(1994-5#3)
spin-lattice relaxation time##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
spin-lattice relaxation##6##2##(1991-5#1)(1994-11#1)(2008-10#3)(2008-9#1)
spin-orbit mixing##2##2##(1997-7#2)
spin-orbit##3##1##(1997-7#3)
spin-polarized##2##1##(2008-10#1)(2008-2#1)
spin-spin##2##1##(1997-7#1)(2007-11#1)
spin-trapping##5##1##(1990-12#1)(1995-5#1)(1996-2#1)(2008-5#1)(2008-8#1)
spin-traps##2##1##(1993-6#2)
spina bifida and##2##3##(1990-9#1)(2012-2#1)
spina bifida##5##2##(1990-9#1)(1997-3#1)(2008-10#1)(2010-12#1)(2012-2#1)
spina##6##1##(1990-9#1)(1996-12#1)(1997-3#1)(2008-10#1)(2010-12#1)(2012-2#1)
spinach (Spinacia oleracea) tissue##2##4##(2008-10#2)
spinach and##3##2##(2008-10#3)
spinach chloroplasts##3##2##(1992-3#1)(1995-2#1)(2008-4#1)
spinach leaves##4##2##(1990-5#1)(1994-11#2)(2008-10#1)
spinach tissue homogenate##2##3##(2008-10#2)
spinach##35##1##(1990-5#2)(1991-9#1)(1992-3#2)(1994-11#2)(1995-2#1)(1997-7#1)(2008-10#19)(2008-4#2)(2008-9#4)(2012-2#1)
spinaciae in##2##2##(2008-10#2)
spinaciae##4##1##(2008-10#4)
spinal AVMs##2##2##(2008-7#2)
spinal accessory nerve##2##3##(2008-7#1)(2008-9#1)
spinal anaesthesia for caesarean section##2##5##(2006-10#1)(2009-7#1)
spinal anaesthesia##5##2##(1992-11#2)(1993-10#1)(2006-10#1)(2009-7#1)
spinal and rib##2##3##(2007-11#2)
spinal and##7##2##(1992-12#1)(1995-12#1)(2007-11#3)(2007-8#1)(2008-7#1)
spinal anesthesia for##2##3##(2011-2#1)(2012-12#1)
spinal anesthesia in##3##3##(2012-3#3)
spinal anesthesia with isobaric bypivacain##2##5##(2012-3#2)
spinal anesthesia with##3##3##(2012-12#1)(2012-3#2)
spinal anesthesia##14##2##(1996-12#1)(2011-2#3)(2012-12#2)(2012-3#8)
spinal angiomas##2##2##(2007-11#2)
spinal arteriovenous malformation (AVM)##3##4##(1991-3#1)(2008-7#1)(2013-1#1)
spinal arteriovenous malformation##4##3##(1991-3#1)(2008-7#2)(2013-1#1)
spinal arteriovenous malformations##3##3##(2008-7#3)
spinal arteriovenous##8##2##(1991-3#1)(1995-11#1)(2008-7#5)(2013-1#1)
spinal axis##3##2##(1997-6#1)(2007-8#1)(2008-12#1)
spinal bone mineral##2##3##(1993-11#2)
spinal bone##3##2##(1993-11#2)(2007-11#1)
spinal canal involvement##3##3##(2007-8#3)
spinal canal##16##2##(2006-12#1)(2007-11#3)(2007-8#7)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#1)
spinal column##6##2##(2007-11#2)(2007-8#1)(2008-11#1)(2008-7#1)(2009-6#1)
spinal conditions##2##2##(2008-8#2)
spinal cord after##2##3##(1993-12#1)(2011-2#1)
spinal cord and RT##2##4##(1990-11#2)
spinal cord and in##2##4##(1990-7#1)(2013-7#1)
spinal cord and telencephalon##2##4##(1996-5#2)
spinal cord and##21##3##(1990-11#2)(1990-7#1)(1991-1#1)(1992-1#1)(1992-12#1)(1994-8#2)(1995-12#2)(1996-12#1)(1996-2#2)(1996-5#2)(2007-11#1)(2008-7#2)(2009-3#1)(2013-7#1)(2013-8#1)
spinal cord arteriovenous malformations (SCAVMs)##2##5##(1995-11#1)(1997-6#1)
spinal cord but not in##2##5##(1996-12#1)(1997-2#1)
spinal cord by##3##3##(1994-8#1)(1995-12#1)(2008-7#1)
spinal cord cells##2##3##(1993-5#2)
spinal cord compression and##2##4##(2007-11#2)
spinal cord compression in patients with##2##6##(1996-9#1)(2007-11#1)
spinal cord compression in pregnancy##2##5##(2008-7#2)
spinal cord compression in##4##4##(1996-9#1)(2007-11#1)(2008-7#2)
spinal cord compression is##3##4##(1996-9#1)(2007-11#2)
spinal cord compression##39##3##(1991-9#2)(1992-12#4)(1993-9#1)(1996-9#5)(2007-11#11)(2007-5#1)(2008-10#1)(2008-6#4)(2008-7#8)(2009-3#1)(2012-3#1)
spinal cord contusion##2##3##(2009-12#2)
spinal cord dysfunction##3##3##(1991-6#1)(2007-7#1)(2013-8#1)
spinal cord in##4##3##(1990-5#1)(1996-5#1)(2008-5#1)(2008-7#1)
spinal cord injured##2##3##(2012-12#1)(2013-1#1)
spinal cord injuries##9##3##(1991-6#3)(1992-6#2)(2007-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
spinal cord injury (SCI)##3##4##(2008-7#1)(2009-12#1)(2013-1#1)
spinal cord injury in##2##4##(1995-11#1)(2008-5#1)
spinal cord injury##24##3##(1991-12#1)(1993-12#2)(1993-2#1)(1995-11#2)(2007-11#4)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#5)
spinal cord is##4##3##(1992-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
spinal cord ischemia##2##3##(2010-8#2)
spinal cord lesion##3##3##(1995-11#1)(2007-11#1)(2013-8#1)
spinal cord lesion]##2##3##(1997-8#1)(2013-8#1)
spinal cord of the##4##4##(1991-1#1)(1995-5#1)(1996-5#1)(1997-2#1)
spinal cord of##10##3##(1991-1#1)(1993-12#1)(1995-5#1)(1996-5#1)(1997-2#4)(1997-3#1)(2008-7#1)
spinal cord or##2##3##(2007-11#1)(2008-7#1)
spinal cord stimulation##5##3##(1997-2#3)(2013-1#2)
spinal cord tumor##2##3##(2007-2#1)(2008-12#1)
spinal cord was##3##3##(1996-5#1)(2008-5#2)
spinal cord##277##2##(1990-11#3)(1990-5#4)(1990-7#4)(1991-1#2)(1991-12#1)(1991-5#5)(1991-6#7)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#5)(1992-6#3)(1993-11#1)(1993-12#12)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-8#5)(1995-11#4)(1995-12#7)(1995-3#1)(1995-5#4)(1995-9#1)(1996-12#4)(1996-2#7)(1996-5#14)(1996-9#6)(1997-2#11)(1997-3#4)(1997-6#1)(1997-8#2)(2007-10#3)(2007-11#18)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#35)(2008-9#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#5)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#6)
spinal cords##2##2##(1990-5#1)(1995-12#1)
spinal curvature##4##2##(2008-11#1)(2008-12#3)
spinal deformities##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
spinal deformity##4##2##(2008-11#1)(2008-7#1)(2008-8#2)
spinal dorsal horn##4##3##(1992-6#1)(1994-2#1)(1997-2#2)
spinal dural arteriovenous##2##3##(2008-7#2)
spinal dural##3##2##(1991-3#1)(2008-7#2)
spinal dysraphism##2##2##(2012-2#1)(2013-1#1)
spinal epidural abscess##2##3##(2009-5#1)(2012-3#1)
spinal epidural haematoma##3##3##(2008-7#3)
spinal epidural hematoma##2##3##(2008-7#2)
spinal epidural##12##2##(1992-12#2)(2007-8#1)(2008-7#6)(2009-5#1)(2011-2#1)(2012-3#1)
spinal field##2##2##(2007-10#2)
spinal fixation##2##2##(2008-8#1)(2012-3#1)
spinal fluid##2##2##(1997-3#1)(2008-7#1)
spinal fractures##5##2##(2007-11#2)(2007-8#1)(2012-12#2)
spinal fusion with##3##3##(2008-8#3)
spinal fusion##14##2##(2008-8#6)(2012-12#1)(2012-3#7)
spinal glial##2##2##(2008-7#2)
spinal injures##3##2##(2007-8#3)
spinal injuries##2##2##(2008-10#1)(2012-12#1)
spinal injury##3##2##(2012-2#3)
spinal instability and##2##3##(2007-11#1)(2012-12#1)
spinal instability##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2012-12#1)
spinal instrumentation##2##2##(2008-8#2)
spinal involvement##2##2##(2007-11#2)
spinal ischaemia##2##2##(2012-1#2)
spinal lesions##3##2##(2007-11#1)(2007-8#1)(2012-3#1)
spinal manipulative therapy##2##3##(2013-1#2)
spinal metastases##12##2##(2007-11#10)(2008-7#2)
spinal metastasis##3##2##(1994-7#1)(2008-7#2)
spinal metastatic tumors##2##3##(2007-11#2)
spinal metastatic##3##2##(2007-11#3)
spinal microglia##2##2##(2008-4#2)
spinal motor neurons##2##3##(2008-7#2)
spinal muscular atrophy##2##3##(1996-12#1)(2012-2#1)
spinal muscular##3##2##(1996-12#1)(2012-2#1)(2012-3#1)
spinal needle##2##2##(2012-3#2)
spinal neoplasms##3##2##(2007-11#2)(2011-2#1)
spinal nerve roots##3##3##(2006-12#2)(2013-1#1)
spinal nerve##7##2##(2006-12#3)(2008-4#1)(2011-2#1)(2013-1#2)
spinal nerves##3##2##(2008-7#2)(2011-2#1)
spinal pain and related disorders##3##5##(2008-12#3)
spinal pain and related##5##4##(2008-12#5)
spinal pain##6##2##(2008-12#6)
spinal puncture##2##2##(1991-6#1)(1995-11#1)
spinal reconstruction##3##2##(2007-8#1)(2008-7#2)
spinal roots##3##2##(2007-11#1)(2008-9#2)
spinal segments##3##2##(1993-12#1)(2008-7#1)(2008-9#1)
spinal stability##5##2##(2007-11#3)(2010-12#2)
spinal stabilization##2##2##(2007-11#2)
spinal stenosis##7##2##(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#2)(2012-2#1)(2013-1#1)
spinal subdural haematoma##4##3##(2008-7#4)
spinal subdural hematoma##2##3##(2012-12#2)
spinal subdural##7##2##(2008-7#4)(2012-12#3)
spinal surgery##12##2##(1994-7#1)(2007-11#1)(2007-8#3)(2008-8#4)(2012-12#1)(2012-3#2)
spinal tract of##3##3##(1996-5#3)
spinal trauma##3##2##(2007-11#2)(2012-12#1)
spinal##622##1##(1990-11#4)(1990-12#1)(1990-5#5)(1990-7#4)(1990-9#1)(1991-1#3)(1991-12#1)(1991-3#2)(1991-5#5)(1991-6#8)(1991-9#2)(1992-1#2)(1992-11#5)(1992-12#8)(1992-6#4)(1993-10#2)(1993-11#3)(1993-12#13)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-2#4)(1994-3#1)(1994-7#3)(1994-8#5)(1995-11#6)(1995-12#11)(1995-3#1)(1995-5#4)(1995-9#1)(1996-12#6)(1996-2#8)(1996-3#1)(1996-5#22)(1996-9#6)(1997-2#13)(1997-3#6)(1997-6#2)(1997-8#5)(2006-10#1)(2006-12#5)(2007-10#5)(2007-11#69)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#25)(2008-1#1)(2008-10#4)(2008-11#11)(2008-12#19)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#11)(2008-6#6)(2008-7#85)(2008-8#20)(2008-9#6)(2009-11#2)(2009-12#4)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#9)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#20)(2012-1#3)(2012-12#20)(2012-2#14)(2012-3#30)(2013-1#22)(2013-7#1)(2013-8#7)
spinal-pelvic sagittal##2##2##(2013-8#2)
spinally##3##1##(1992-12#1)(1992-3#1)(1995-11#1)
spindle and##2##2##(1995-6#1)(2010-5#1)
spindle cell carcinoma and apocrine carcinoma##2##6##(2008-10#2)
spindle cell carcinoma##5##3##(2008-10#5)
spindle cell lipoma##2##3##(1990-12#2)
spindle cell neoplasm##2##3##(2010-12#1)(2011-2#1)
spindle cell nodules##3##3##(2008-11#3)
spindle cell sarcoma##2##3##(2008-6#1)(2011-2#1)
spindle cell##19##2##(1990-12#3)(1991-8#1)(2008-10#6)(2008-11#3)(2008-6#2)(2010-12#1)(2011-2#3)
spindle cells were##2##3##(2013-1#1)(2013-8#1)
spindle cells##12##2##(1990-12#1)(2008-7#1)(2010-6#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
spindle in##2##2##(2009-3#1)(2011-2#1)
spindle pole##2##2##(1991-5#1)(2010-5#1)
spindle poles##2##2##(2009-10#1)(2011-2#1)
spindle shaped##2##2##(2008-10#1)(2008-11#1)
spindle streak mosaic virus (WSSMV)##3##5##(2008-10#2)(2008-8#1)
spindle streak mosaic##4##3##(2008-10#3)(2008-8#1)
spindle##67##1##(1990-12#4)(1991-12#2)(1991-5#1)(1991-8#1)(1994-8#1)(1995-6#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#5)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#2)(2010-6#3)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
spindle-shaped cells##2##2##(1991-8#1)(1994-6#1)
spindle-shaped##5##1##(1991-8#1)(1994-6#1)(2008-6#1)(2009-5#1)(2011-2#1)
spindled##2##1##(2008-11#1)(2010-12#1)
spindles and##3##2##(1997-3#1)(2009-8#2)
spindles##7##1##(1991-9#1)(1997-3#1)(2009-10#1)(2009-8#3)(2011-2#1)
spine -##2##2##(2007-11#1)(2007-7#1)
spine and femur##3##3##(1991-11#1)(2011-2#2)
spine and proximal femur##2##4##(2011-2#2)
spine and the##2##3##(2007-11#1)(2008-8#1)
spine and##21##2##(1991-11#2)(1993-11#1)(1993-12#1)(1995-11#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-3#1)(2008-8#3)(2010-1#1)(2010-5#1)(2011-2#4)(2012-2#1)
spine are##3##2##(1997-4#1)(2007-11#1)(2011-2#1)
spine at##3##2##(2007-11#1)(2008-8#1)(2011-2#1)
spine correction##2##2##(2007-8#2)
spine curve##6##2##(2007-8#6)
spine dynamics##2##2##(2012-2#2)
spine for##2##2##(2008-7#1)(2012-3#1)
spine fractures##2##2##(2007-11#1)(2009-8#1)
spine fusion##4##2##(2008-8#2)(2012-12#1)(2012-3#1)
spine have##2##2##(2007-11#1)(2012-3#1)
spine in a##3##3##(1990-12#1)(2008-12#1)(2011-2#1)
spine in##10##2##(1990-12#1)(1991-11#1)(2007-11#1)(2008-12#1)(2009-10#1)(2011-2#3)(2012-1#2)
spine is a rare##2##4##(2011-2#2)
spine is##4##2##(2007-7#1)(2008-8#1)(2011-2#2)
spine metastatic tumours##2##3##(2007-11#2)
spine morphologies##2##2##(2008-11#2)
spine movement##2##2##(2007-11#1)(2013-1#1)
spine of##2##2##(1991-6#1)(1995-8#1)
spine revealed a##2##3##(2009-3#1)(2012-2#1)
spine revealed##4##2##(2009-3#2)(2012-12#1)(2012-2#1)
spine scoliosis##2##2##(2007-8#2)
spine stabilization##2##2##(2007-11#2)
spine surgeons##2##2##(2011-2#1)(2012-12#1)
spine surgery##24##2##(2007-11#1)(2007-8#2)(2008-7#4)(2008-8#1)(2011-2#1)(2012-12#8)(2012-2#3)(2012-3#4)
spine synostosis##2##2##(2013-1#2)
spine trauma in children and adults##2##6##(2007-11#2)
spine trauma in##3##3##(2007-11#3)
spine trauma##6##2##(2007-11#6)
spine was##3##2##(1993-12#1)(2007-8#1)(2012-2#1)
spine##257##1##(1990-12#2)(1990-6#2)(1991-11#4)(1991-6#1)(1993-11#2)(1993-12#3)(1995-11#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#58)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#25)(2008-1#1)(2008-11#8)(2008-12#13)(2008-3#1)(2008-4#1)(2008-7#7)(2008-8#12)(2009-10#1)(2009-3#3)(2009-4#4)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#4)(2010-3#5)(2010-5#1)(2010-6#1)(2011-2#22)(2012-1#4)(2012-12#22)(2012-2#15)(2012-3#11)(2013-1#8)(2013-8#1)
spine)##2##1##(2007-11#1)(2011-1#1)
spinel##2##1##(2008-10#1)(2008-3#1)
spinel-type manganese oxide##2##3##(2008-10#2)
spinel-type##4##1##(2008-10#4)
spines and##2##2##(2007-12#1)(2008-5#1)
spines are##2##2##(2008-11#1)(2012-2#1)
spines in##2##2##(1995-8#1)(2009-8#1)
spines of##4##2##(1995-8#1)(1996-2#1)(2008-5#1)(2012-2#1)
spines on the##2##3##(2007-12#1)(2008-4#1)
spines were##3##2##(2008-8#3)
spines##37##1##(1995-12#1)(1995-8#2)(1996-2#5)(1996-6#1)(1997-2#1)(2007-10#1)(2007-12#4)(2008-11#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#4)(2009-8#1)(2012-2#3)(2012-3#1)
spinfilter##8##1##(2008-11#8)
spinner bottle##2##2##(2008-11#2)
spinner culture##3##2##(2008-11#3)
spinner flask to##2##3##(2008-11#2)
spinner flask##9##2##(2008-11#9)
spinner flasks##3##2##(2008-11#2)(2008-7#1)
spinner##21##1##(2008-11#19)(2008-3#1)(2008-7#1)
spinning disc##2##2##(2008-9#1)(2010-11#1)
spinning nuclear magnetic resonance spectroscopy##2##5##(2008-10#1)(2013-8#1)
spinning nuclear magnetic resonance##3##4##(2008-10#2)(2013-8#1)
spinning nuclear magnetic##5##3##(2008-1#2)(2008-10#2)(2013-8#1)
spinning rates##3##2##(2008-10#3)
spinning##17##1##(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-8#1)
spinocerebellar ataxia in South Africa##2##5##(1997-5#2)
spinocerebellar ataxia type##2##3##(1997-5#1)(1997-8#1)
spinocerebellar ataxia##4##2##(1997-5#3)(1997-8#1)
spinocerebellar ataxias (SCAs)##2##3##(2008-6#1)(2008-7#1)
spinocerebellar ataxias##5##2##(2008-6#4)(2008-7#1)
spinocerebellar axons##2##2##(1996-5#2)
spinocerebellar##12##1##(1996-5#3)(1997-5#3)(1997-8#1)(2008-6#4)(2008-7#1)
spinopelvic parameters##2##2##(2013-8#2)
spinosad##2##1##(2011-2#2)
spinous##3##1##(2008-5#1)(2011-2#1)(2013-1#1)
spins with##3##2##(2008-7#3)
spins##9##1##(2007-12#1)(2008-10#1)(2008-7#6)(2012-2#1)
spiny mice##2##2##(2010-11#2)
spiny mouse)##3##2##(2010-11#3)
spiny neurons##4##2##(2008-1#1)(2008-4#1)(2013-8#2)
spiny##16##1##(1995-12#1)(2007-12#3)(2008-1#1)(2008-11#2)(2008-4#1)(2010-11#5)(2010-3#1)(2013-8#2)
spiracles and##2##2##(1995-12#1)(2007-12#1)
spiracles##4##1##(1995-12#1)(2007-12#2)(2008-5#1)
spiraecola##2##1##(2008-10#2)
spiral CT##4##2##(1997-8#1)(2007-10#1)(2012-2#2)
spiral arteries##2##2##(1994-9#1)(2012-3#1)
spiral cell##3##2##(2008-10#3)
spiral computed tomography##2##3##(2008-7#2)
spiral computed##3##2##(2008-7#2)(2013-8#1)
spiral ganglion##2##2##(2008-9#2)
spiral optical##2##2##(2008-2#2)
spiral waves##2##2##(1997-3#2)
spiral##45##1##(1991-11#1)(1994-9#1)(1995-5#1)(1997-3#3)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2010-10#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
spiral&quot##3##1##(2011-2#3)
spiralin##4##1##(2008-10#4)
spiraling##4##1##(2007-12#3)(2009-4#1)
spiralis (T1)##2##2##(1996-12#2)
spiralis##3##1##(1990-12#1)(1996-12#2)
spiralling##2##1##(2009-11#1)(2009-5#1)
spiramycin##3##1##(1990-9#1)(2008-10#2)
spirit of##6##2##(1992-12#1)(1994-11#1)(1996-1#1)(1997-8#1)(2009-10#1)(2012-2#1)
spirit to##2##2##(1994-11#1)(1995-2#1)
spirit##21##1##(1992-12#1)(1994-11#2)(1995-2#2)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-12#2)(2009-10#3)(2010-7#1)(2012-2#2)(2012-3#2)(2013-1#2)
spirits##4##1##(2008-10#3)(2009-7#1)
spiritual and religious involvement##2##4##(2009-7#2)
spiritual and religious##4##3##(2008-4#2)(2009-7#2)
spiritual and##8##2##(2008-1#1)(2008-4#3)(2008-7#1)(2009-7#2)(2013-8#1)
spiritual belief##3##2##(2009-7#1)(2010-2#2)
spiritual care in Hong Kong##4##5##(2010-11#4)
spiritual care in##7##3##(2008-4#1)(2009-11#1)(2010-11#5)
spiritual care##15##2##(2008-4#2)(2009-11#2)(2010-11#8)(2011-1#3)
spiritual education session##2##3##(2011-1#2)
spiritual experience##3##2##(2009-11#2)(2010-2#1)
spiritual experiences##6##2##(2009-11#2)(2013-1#4)
spiritual journey##2##2##(1994-1#1)(2008-12#1)
spiritual needs##7##2##(1990-10#1)(1993-2#1)(2008-11#3)(2011-1#2)
spiritual themes##2##2##(2008-4#2)
spiritual##77##1##(1990-10#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-5#2)(1997-2#1)(2007-2#1)(2007-5#2)(2008-1#3)(2008-11#3)(2008-12#5)(2008-4#11)(2008-7#1)(2009-11#7)(2009-7#5)(2010-11#8)(2010-2#5)(2011-1#8)(2011-2#1)(2013-1#4)(2013-8#6)
spirituality and spiritual care in Hong Kong##2##7##(2010-11#2)
spirituality and spiritual##4##3##(2010-11#2)(2013-1#2)
spirituality and##11##2##(1991-6#1)(2008-12#1)(2008-4#2)(2010-11#2)(2011-1#1)(2013-1#4)
spirituality as a tool for recovery##2##6##(2008-4#2)
spirituality as a##3##3##(2008-12#1)(2008-4#2)
spirituality in nursing##4##3##(2008-4#4)
spirituality in##12##2##(2008-12#2)(2008-4#8)(2013-1#1)(2013-8#1)
spirituality to##3##2##(1997-2#1)(2009-11#1)(2010-8#1)
spirituality##58##1##(1991-6#1)(1994-1#1)(1997-2#2)(2008-11#3)(2008-12#7)(2008-4#23)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-8#1)(2011-1#1)(2013-1#11)(2013-8#2)
spirituality&quot##2##1##(2013-1#2)
spiritually based##3##2##(2008-4#1)(2010-10#2)
spiritually##4##1##(2008-4#1)(2009-11#1)(2010-10#2)
spirituous beverages##4##2##(2008-10#4)
spirituous##5##1##(2008-10#5)
spiro##7##1##(1996-5#1)(2007-11#2)(2008-10#2)(2008-11#1)(2011-1#1)
spirobenzylisoquinoline##2##1##(2008-11#2)
spirochetal##2##1##(2008-9#1)(2011-2#1)
spirochete##9##1##(1990-2#1)(1997-4#1)(2008-9#4)(2010-6#2)(2011-2#1)
spirochetes##11##1##(1990-2#2)(1997-4#6)(2008-9#3)
spirodioxanyl oligosaccharides##2##2##(1992-12#2)
spirodioxanyl##3##1##(1992-12#3)
spiroforme##5##1##(1991-8#5)
spirometer##3##1##(2009-11#1)(2012-2#1)(2012-3#1)
spirometric parameters##3##2##(2008-1#2)(2008-7#1)
spirometric pulmonary function test##2##4##(2010-8#2)
spirometric##12##1##(1990-9#2)(1997-3#1)(2008-1#2)(2008-7#1)(2010-8#3)(2011-2#3)
spirometry and##2##2##(1990-9#1)(1996-1#1)
spirometry in##2##2##(2008-1#2)
spirometry parameters##2##2##(2007-8#2)
spirometry##15##1##(1990-9#1)(1991-4#1)(1996-1#2)(2007-8#2)(2008-1#3)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
spiromustine##2##1##(2008-4#2)
spironolactone##7##1##(2008-10#7)
spiroplas-mas##2##1##(2008-10#2)
spiroplasma membrane##2##2##(2008-10#2)
spiroplasma##11##1##(2008-10#11)
spiroplasmas to##2##2##(2008-10#2)
spiroplasmas with##2##2##(2008-10#2)
spiroplasmas##6##1##(2008-10#6)
spiropyran in##2##2##(2008-10#1)(2008-3#1)
spiroxatrine##2##1##(1995-12#2)
spite of a##10##3##(1990-5#1)(1991-8#1)(1992-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-10#1)(2012-12#1)
spite of an##3##3##(1995-11#1)(2007-8#1)(2009-3#1)
spite of high##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
spite of its prevalence##2##4##(2008-6#1)(2013-8#1)
spite of its##14##3##(1992-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
spite of large##2##3##(2007-8#1)(2008-10#1)
spite of many##4##3##(1996-9#1)(2008-10#2)(2008-8#1)
spite of numerous##2##3##(1992-12#1)(1993-2#1)
spite of remarkable##2##3##(2008-1#1)(2008-12#1)
spite of some##2##3##(1995-12#1)(2008-3#1)
spite of the fact that##9##5##(1991-2#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2009-8#1)(2011-1#1)
spite of the many##2##4##(2007-11#1)(2008-5#1)
spite of the small##2##4##(1994-3#1)(2009-3#1)
spite of the##53##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-5#2)(1996-8#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
spite of their##4##3##(1996-4#1)(2008-10#1)(2008-5#1)(2010-12#1)
spite of##150##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-8#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(2006-12#1)(2007-11#5)(2007-8#6)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
spite##151##1##(1990-11#1)(1990-5#1)(1991-2#1)(1991-8#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(2006-12#1)(2007-11#5)(2007-8#6)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
splanchnic##5##1##(1996-3#2)(1997-7#1)(2008-6#1)(2012-2#1)
splash dispersal of three##2##4##(2008-10#2)
splash dispersal of##5##3##(2008-10#5)
splash dispersal##13##2##(2008-10#13)
splash in##2##2##(2008-10#2)
splash##22##1##(2008-10#22)
splash-dispersed##2##1##(2008-10#2)
splashed rain intensity and##2##4##(2008-10#2)
splashed rain##5##2##(2008-10#5)
splashed##6##1##(2008-10#6)
splashing##5##1##(2008-10#5)
spleen and bone marrow##2##4##(1991-9#1)(2008-5#1)
spleen and bone##3##3##(1991-9#1)(1995-11#1)(2008-5#1)
spleen and liver##5##3##(1994-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
spleen and lymph##2##3##(2008-10#1)(2008-4#1)
spleen and testis##2##3##(2008-8#2)
spleen and##33##2##(1990-12#2)(1990-3#1)(1991-9#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-6#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
spleen cell##2##2##(1991-12#2)
spleen cells##6##2##(1994-2#1)(1996-12#1)(2007-2#2)(2008-11#1)(2008-7#1)
spleen ferritin##2##2##(1996-2#1)(2012-1#1)
spleen in the##2##3##(1990-5#1)(1992-3#1)
spleen in##5##2##(1990-5#1)(1992-2#1)(1992-3#1)(2008-10#1)(2010-8#1)
spleen is a##2##3##(1990-9#1)(2008-11#1)
spleen is##3##2##(1990-9#1)(1992-12#1)(2008-11#1)
spleen mass##2##2##(2008-9#2)
spleen of##2##2##(2008-9#1)(2012-2#1)
spleen or thymus##2##3##(2008-10#1)(2008-4#1)
spleen or##4##2##(1996-12#1)(2008-10#1)(2008-4#2)
spleen weight##4##2##(1991-6#1)(1996-12#2)(2008-10#1)
spleen were significantly##2##3##(1993-3#1)(1995-12#1)
spleen were##5##2##(1993-3#1)(1995-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
spleen##154##1##(1990-11#2)(1990-12#4)(1990-3#1)(1990-5#4)(1990-7#3)(1990-9#2)(1991-12#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-3#1)(1996-12#6)(1996-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#9)(2008-4#3)(2008-5#10)(2008-7#8)(2008-8#4)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#2)
spleen)##2##1##(2008-9#1)(2009-8#1)
spleen]##2##1##(1994-9#1)(2009-5#1)
spleens of immunized##2##3##(1995-2#1)(2008-4#1)
spleens of##4##2##(1995-2#1)(2008-10#2)(2008-4#1)
spleens##9##1##(1990-12#1)(1993-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-4#1)
splendens##4##1##(2008-5#1)(2008-8#1)(2009-12#2)
splenectomized individuals##2##2##(1994-9#2)
splenectomized patient with systemic lupus erythematosus##2##6##(2006-10#2)
splenectomized patients##5##2##(1990-9#2)(1994-9#2)(2009-4#1)
splenectomized##14##1##(1990-9#2)(1994-9#8)(2006-10#2)(2009-4#1)(2012-3#1)
splenectomy and##3##2##(1997-8#1)(2010-12#1)(2013-8#1)
splenectomy with##2##2##(2012-12#1)(2012-2#1)
splenectomy##20##1##(1990-9#1)(1994-9#3)(1997-8#1)(2007-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
splenic CD4 T cells##3##4##(2008-11#3)
splenic DCs##3##2##(2008-11#3)
splenic T-cells##2##2##(2008-10#2)
splenic T-lymphocytes##4##2##(2008-10#3)(2008-7#1)
splenic artery aneurysm##4##3##(2011-2#4)
splenic artery##7##2##(1990-3#1)(2008-7#1)(2011-2#5)
splenic cellularity##2##2##(2008-10#2)
splenic culture for Leishmania##4##4##(2008-7#4)
splenic cyst##7##2##(1993-5#1)(1997-8#5)(2007-12#1)
splenic cysts##2##2##(1993-5#1)(2008-7#1)
splenic flexure##5##2##(1993-9#1)(2008-12#2)(2013-8#2)
splenic hematoma##3##2##(2011-2#3)
splenic lymphocyte##2##2##(2008-10#1)(2012-3#1)
splenic lymphocytes##2##2##(1991-12#1)(2008-10#1)
splenic metastasis of##2##3##(1992-2#1)(2011-2#1)
splenic metastasis##7##2##(1992-2#1)(1993-9#2)(2007-8#2)(2011-2#2)
splenic rupture in##4##3##(1992-2#2)(1993-9#1)(2011-2#1)
splenic rupture##8##2##(1992-2#4)(1993-9#1)(2007-5#1)(2011-2#2)
splenic tumor##2##2##(2011-2#2)
splenic##95##1##(1990-3#1)(1991-12#1)(1992-11#1)(1992-2#6)(1993-12#4)(1993-5#2)(1993-9#5)(1995-12#2)(1997-8#5)(2007-12#1)(2007-5#2)(2007-8#3)(2008-10#13)(2008-11#9)(2008-12#2)(2008-7#10)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#16)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
splenocyte proliferation##4##2##(2008-10#4)
splenocyte subsets##2##2##(2008-10#1)(2011-2#1)
splenocyte##17##1##(1991-12#1)(1993-11#1)(1993-12#1)(1996-12#1)(1997-4#2)(2008-10#10)(2011-2#1)
splenocytes from##2##2##(1996-12#1)(2008-10#1)
splenocytes immunized with##2##3##(2008-11#2)
splenocytes of##2##2##(1990-2#1)(2008-8#1)
splenocytes to##2##2##(1991-1#1)(1991-12#1)
splenocytes was##3##2##(1995-12#1)(2008-10#2)
splenocytes were##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
splenocytes with##3##2##(1991-1#1)(2008-11#2)
splenocytes##29##1##(1990-2#1)(1990-5#1)(1991-1#3)(1991-12#1)(1991-9#1)(1995-12#1)(1996-12#2)(1997-4#1)(2008-10#7)(2008-11#4)(2008-5#4)(2008-8#1)(2008-9#1)(2013-1#1)
splenomegaly and##5##2##(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
splenomegaly was##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
splenomegaly##17##1##(1990-6#1)(1994-11#1)(2006-10#2)(2007-12#2)(2008-10#3)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#3)(2012-2#1)
splice acceptor site##3##3##(1993-11#1)(1995-12#2)
splice donor##2##2##(1994-11#1)(2011-1#1)
splice forms##2##2##(1994-9#1)(1996-12#1)
splice junction sequences##2##3##(1992-6#1)(1994-12#1)
splice junction##3##2##(1992-6#1)(1994-12#1)(2008-4#1)
splice mutation##2##2##(2008-4#1)(2010-4#1)
splice signals##2##2##(1994-8#2)
splice site in##2##3##(1994-9#1)(2008-8#1)
splice site variants##2##3##(2011-1#2)
splice site##11##2##(1991-5#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#2)(2008-8#2)(2011-1#2)
splice sites##4##2##(1992-6#1)(1993-6#1)(1995-8#1)(2008-4#1)
splice variant of##2##3##(1997-1#1)(2008-8#1)
splice variant##4##2##(1996-12#1)(1997-1#1)(2008-8#2)
splice variants in##2##3##(2012-2#2)
splice variants##8##2##(1996-12#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)
splice##47##1##(1991-5#3)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-12#4)(1995-8#1)(1996-12#3)(1997-1#1)(2007-11#1)(2008-4#5)(2008-8#5)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)
splice-site##5##1##(1993-6#5)
spliced mRNA##4##2##(1990-7#2)(1993-6#1)(2012-2#1)
spliced mRNAs##2##2##(1993-6#1)(2012-2#1)
spliced out in##2##3##(1993-8#1)(1995-12#1)
spliced transcripts##3##2##(1991-9#1)(1994-11#1)(1994-12#1)
spliced viral transcripts##2##3##(1994-8#1)(2011-3#1)
spliced##39##1##(1990-12#1)(1990-7#3)(1990-8#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-8#2)(1995-12#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2011-3#1)(2012-2#3)
spliceosome##5##1##(1995-6#2)(2008-2#3)
spliceosomes##3##1##(1995-6#1)(2008-2#1)(2013-8#1)
splices##2##1##(1995-6#1)(2008-2#1)
splicing and##9##2##(1993-2#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-7#1)
splicing at##2##2##(1993-9#1)(1995-6#1)
splicing by##3##2##(1991-5#1)(1991-9#1)(1993-12#1)
splicing events##5##2##(1992-6#1)(1993-8#1)(2008-4#1)(2010-12#2)
splicing factor##4##2##(1993-8#1)(1995-6#2)(1997-4#1)
splicing in the##3##3##(1990-7#1)(1992-6#1)(2008-12#1)
splicing in##4##2##(1990-7#1)(1992-6#1)(2008-12#1)(2008-2#1)
splicing is##2##2##(1993-12#1)(1993-8#1)
splicing of a##5##3##(1991-5#1)(1993-11#1)(1994-6#1)(1994-9#1)(2008-8#1)
splicing of exon##2##3##(1990-7#1)(1991-12#1)
splicing of purified precursor##2##4##(1993-12#2)
splicing of the##7##3##(1990-5#1)(1991-5#1)(1993-6#1)(1993-8#2)(1994-12#1)(2008-7#1)
splicing of##32##2##(1990-12#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#3)(1991-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#4)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-6#2)(2008-4#2)(2008-7#1)(2008-8#1)(2012-2#2)
splicing or##2##2##(1993-12#1)(2008-9#1)
splicing process and##2##3##(1991-9#1)(1993-11#1)
splicing process##3##2##(1991-9#2)(1993-11#1)
splicing was##2##2##(1993-12#1)(2012-2#1)
splicing##126##1##(1990-12#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-9#5)(1992-12#1)(1992-6#3)(1993-11#2)(1993-12#8)(1993-2#1)(1993-6#5)(1993-8#10)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-6#12)(1995-8#1)(1996-2#2)(1997-4#1)(1997-7#1)(2007-12#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#7)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-2#3)(2009-7#1)(2010-12#6)(2011-1#2)(2011-3#1)(2012-2#4)(2013-8#1)
spline wavelet##4##2##(2008-10#4)
spline##12##1##(1995-9#2)(2008-10#5)(2008-3#3)(2008-6#1)(2012-12#1)
splines##5##1##(2008-11#1)(2008-6#4)
splint bone##3##2##(1991-6#3)
splint##14##1##(1991-6#4)(2007-11#1)(2007-8#3)(2008-10#2)(2010-6#3)(2012-12#1)
splints in##2##2##(2008-10#2)
splints##8##1##(2007-11#1)(2008-10#3)(2008-11#2)(2010-6#2)
split CFTR##2##2##(2011-3#2)
split by a##2##3##(2008-10#1)(2008-3#1)
split by##5##2##(1995-6#1)(2008-10#3)(2008-3#1)
split common fixed point problem##2##5##(2011-2#2)
split decomposition##2##2##(2008-4#1)(2008-5#1)
split from##2##2##(2008-6#1)(2009-10#1)
split into three##2##3##(1996-6#1)(2008-7#1)
split into two beams##2##4##(2007-12#2)
split into two##9##3##(2007-12#3)(2008-10#3)(2008-3#1)(2008-5#1)(2013-8#1)
split into##23##2##(1993-12#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-8#2)
split of the##2##3##(1995-3#1)(2010-5#1)
split of##7##2##(1992-10#1)(1995-3#1)(2007-12#2)(2008-1#1)(2009-10#1)(2010-5#1)
split plot##4##2##(2007-11#1)(2008-12#3)
split rice spikelet##3##3##(2008-8#3)
split root##2##2##(2008-10#2)
split the##2##2##(2007-12#1)(2008-10#1)
split window##2##2##(2013-8#2)
split with##2##2##(1997-2#1)(2007-11#1)
split##100##1##(1990-5#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2007-11#4)(2007-12#10)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2009-10#2)(2009-4#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-10#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#2)(2013-8#7)
split-face##2##1##(2008-5#2)
split-fovea processing##2##2##(2009-2#2)
split-mouth##5##1##(2012-12#1)(2013-1#4)
split-plot##2##1##(2008-10#1)(2008-12#1)
split-root tests##2##2##(2008-10#2)
split-root##3##1##(2008-10#3)
split-signal##3##1##(2009-8#3)
split-step reconstruction technique##3##3##(2008-3#3)
split-step##5##1##(2007-11#1)(2008-3#4)
split-thickness##2##1##(2008-11#1)(2008-9#1)
splitless##3##1##(2008-10#1)(2013-1#2)
splits##7##1##(1990-5#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-4#2)(2010-4#1)
splitter for##4##2##(2007-12#1)(2008-2#3)
splitter layer##2##2##(2008-2#2)
splitter operating at##2##3##(2007-11#1)(2008-3#1)
splitter##50##1##(2007-11#5)(2007-12#6)(2008-10#1)(2008-2#17)(2008-3#21)
splitting and focusing##3##3##(2007-11#1)(2008-3#2)
splitting and##8##2##(2007-11#1)(2008-3#7)
splitting angle##2##2##(2007-11#1)(2008-3#1)
splitting in##3##2##(1994-5#1)(2007-12#1)(2012-7#1)
splitting is##2##2##(2007-12#1)(2008-2#1)
splitting of the##6##3##(1996-2#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-5#1)
splitting of##13##2##(1990-5#1)(1996-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-5#2)(2012-2#1)
splitting ratio##3##2##(2007-12#1)(2008-2#2)
splitting the##2##2##(2008-2#1)(2008-3#1)
splitting##66##1##(1990-5#2)(1993-11#1)(1994-5#4)(1996-2#1)(1997-7#5)(1997-8#1)(2007-11#7)(2007-12#8)(2008-10#5)(2008-2#8)(2008-3#11)(2008-5#3)(2008-8#1)(2009-9#1)(2010-4#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-8#1)
splitting&quot##2##1##(2008-8#1)(2009-11#1)
splittings##2##1##(1990-7#1)(2009-5#1)
splénectomie##2##1##(2011-2#2)
splénique##4##1##(2011-2#4)
spoOA##3##1##(1997-4#3)
spoil##2##1##(2008-7#1)(2009-9#1)
spoilage and##4##2##(1997-4#1)(2011-2#3)
spoilage microorganisms##3##2##(2008-10#2)(2012-2#1)
spoilage##25##1##(1997-4#4)(2008-10#9)(2008-7#1)(2011-2#10)(2012-2#1)
spoiled##5##1##(1997-8#4)(2008-10#1)
spoke Arabic##2##2##(2008-1#2)
spoke at the##2##3##(1992-3#1)(1993-12#1)
spoke channels##4##2##(2007-12#2)(2008-7#2)
spoke##17##1##(1990-6#1)(1992-3#1)(1993-12#2)(1996-1#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-7#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
spoken in the##2##3##(2013-8#2)
spoken in##3##2##(2013-1#1)(2013-8#2)
spoken language##2##2##(2008-9#1)(2009-10#1)
spoken word recognition in Spanish##2##5##(2008-11#2)
spoken word recognition##3##3##(2008-11#3)
spoken##18##1##(1993-9#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
spokes##2##1##(2007-11#2)
spokesman##4##1##(1995-6#3)(1996-8#1)
spokespersons##2##1##(1997-3#2)
spoligotyping##2##1##(2011-2#1)(2012-12#1)
spondarthritides##6##1##(1990-6#6)
spondylitis##24##1##(1990-6#5)(2006-10#6)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#4)(2010-5#1)(2011-2#2)(2012-3#2)
spondyloarthritis##4##1##(2010-12#1)(2012-12#3)
spondyloarthropathies##7##1##(1990-11#2)(2006-10#2)(2008-9#1)(2011-2#2)
spondyloarthropathy##4##1##(2006-10#3)(2012-3#1)
spondylodesis##9##1##(2007-11#6)(2007-8#3)
spondylodiscitis##4##1##(1996-8#1)(2007-8#1)(2012-3#2)
spondylolistesis##3##1##(2007-11#3)
spondylolisthesis##12##1##(1996-6#1)(2007-11#7)(2008-11#1)(2012-12#2)(2013-8#1)
spondylolysis##3##1##(1996-6#2)(2007-11#1)
spondylosis##3##1##(2007-11#2)(2013-1#1)
sponge and##2##2##(2008-9#1)(2009-11#1)
sponge species##2##2##(2011-2#1)(2012-2#1)
sponge##14##1##(1994-3#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)
sponge-like mycelial mass was##2##4##(2008-10#2)
sponge-like mycelial mass##3##3##(2008-10#3)
sponges to##2##2##(2010-7#1)(2012-2#1)
sponges##21##1##(1994-3#4)(2008-5#4)(2010-12#1)(2010-7#2)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)
spongiform encephalopathies##2##2##(1996-5#1)(2008-11#1)
spongiform encephalopathy##15##2##(1990-3#1)(1990-9#1)(1992-5#1)(1996-3#2)(1997-3#1)(1997-8#1)(2008-11#1)(2008-5#1)(2010-4#2)(2011-2#4)
spongiform##20##1##(1990-3#1)(1990-9#1)(1992-5#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-8#1)(2008-11#3)(2008-5#2)(2010-12#1)(2010-4#2)(2011-2#4)
spongy##5##1##(2008-10#2)(2008-2#1)(2012-12#1)(2012-2#1)
sponsor##8##1##(1991-12#1)(1991-2#1)(1991-3#1)(1994-1#2)(1995-5#1)(2008-1#1)(2008-6#1)
sponsored by a##2##3##(1994-1#1)(2012-12#1)
sponsored by the##7##3##(1990-2#1)(1996-4#1)(1997-2#2)(1997-8#1)(2008-11#1)(2008-5#1)
sponsored by##15##2##(1990-2#1)(1992-3#1)(1994-1#1)(1994-3#1)(1996-4#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-11#1)(2009-6#1)(2012-12#1)
sponsored##20##1##(1990-2#1)(1991-3#1)(1992-3#1)(1994-1#1)(1994-3#1)(1996-4#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-6#2)(2011-2#1)(2012-12#2)
sponsoring##4##1##(1992-2#1)(1993-1#1)(2008-11#1)(2013-1#1)
sponsors##5##1##(1992-1#1)(1993-1#1)(2008-11#1)(2009-6#1)(2013-8#1)
sponsorship to##3##2##(2008-12#3)
sponsorship##11##1##(1992-3#1)(1995-12#1)(1995-3#1)(2008-12#4)(2008-7#2)(2012-2#2)
sponsorships##2##1##(2008-12#2)
spontaneous Brillouin backscattered light##4##4##(2008-3#4)
spontaneous Brillouin scattering##4##3##(2007-11#2)(2007-12#2)
spontaneous Brillouin##8##2##(2007-11#2)(2007-12#2)(2008-3#4)
spontaneous HCV clearance##3##3##(2012-2#3)
spontaneous Raman##2##2##(2008-2#1)(2008-3#1)
spontaneous abortion rate##3##3##(1994-3#1)(2008-10#2)
spontaneous abortion##8##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1994-3#2)(2008-10#2)
spontaneous abortions and##4##3##(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
spontaneous abortions##5##2##(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#2)
spontaneous activity in the absence of##2##6##(1996-2#1)(2013-8#1)
spontaneous activity in the##3##4##(1996-2#1)(2008-11#1)(2013-8#1)
spontaneous activity in##5##3##(1996-2#1)(2008-11#2)(2013-8#2)
spontaneous activity##18##2##(1996-2#2)(1997-7#1)(2007-12#1)(2008-11#6)(2008-8#1)(2009-3#1)(2013-1#1)(2013-8#5)
spontaneous alternation##2##2##(1994-8#1)(2012-2#1)
spontaneous and cytokine-dependent##2##3##(2006-6#2)
spontaneous and induced##3##3##(1994-6#1)(2008-7#1)(2013-1#1)
spontaneous and intentional trait inferences##2##5##(2008-11#2)
spontaneous and intentional##3##3##(2008-11#3)
spontaneous and##12##2##(1990-3#1)(1992-6#1)(1994-6#1)(2006-6#2)(2008-11#3)(2008-7#2)(2012-12#1)(2013-1#1)
spontaneous asymptomatic urinoma##2##3##(2008-10#2)
spontaneous bacterial peritonitis and##2##4##(2011-2#2)
spontaneous bacterial peritonitis##5##3##(2009-8#1)(2011-2#2)(2013-1#2)
spontaneous behavior##2##2##(2011-2#2)
spontaneous bladder contractions##2##3##(1995-12#2)
spontaneous bloody##2##2##(1990-11#2)
spontaneous calcium oscillations##2##3##(1994-11#2)
spontaneous cancer##2##2##(2008-7#1)(2011-2#1)
spontaneous cerebrospinal fluid##2##3##(2011-2#1)(2012-1#1)
spontaneous chloride-channel activity##2##3##(1995-11#2)
spontaneous clearance of HCV##2##4##(2012-2#2)
spontaneous clearance of##4##3##(2012-2#4)
spontaneous emission (ASE) in##2##4##(2007-12#1)(2008-2#1)
spontaneous emission (ASE)##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
spontaneous emission from##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
spontaneous emission in a##2##4##(2007-11#2)
spontaneous emission in the##2##4##(2008-2#1)(2008-3#1)
spontaneous emission in##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
spontaneous emission of##2##3##(2007-11#1)(2008-2#1)
spontaneous emission rates##4##3##(2007-11#4)
spontaneous emission##36##2##(1993-5#1)(2007-11#12)(2007-12#12)(2008-2#6)(2008-3#5)
spontaneous emulsion##2##2##(2008-5#2)
spontaneous evolution of##3##3##(1996-9#1)(1997-8#1)(2008-7#1)
spontaneous firing##5##2##(2008-6#4)(2013-1#1)
spontaneous haemothorax##4##2##(2007-8#1)(2011-2#2)(2013-7#1)
spontaneous hyperplastic foci##2##3##(2013-1#2)
spontaneous hypertensive##2##2##(1990-7#1)(2011-1#1)
spontaneous improvement##2##2##(1993-5#1)(2008-7#1)
spontaneous inferences##2##2##(2008-11#2)
spontaneous intracerebral hemorrhage##2##3##(2007-10#1)(2008-8#1)
spontaneous locomotion##2##2##(1993-3#1)(2011-2#1)
spontaneous lung##3##2##(1990-8#1)(2008-11#1)(2013-1#1)
spontaneous metastasis&quot##2##2##(1990-6#1)(2008-1#1)
spontaneous motor activity##4##3##(1994-2#1)(1995-12#1)(2008-12#2)
spontaneous motor##5##2##(1994-2#1)(1995-12#1)(2008-12#2)(2008-4#1)
spontaneous neural activity##2##3##(2009-3#1)(2013-8#1)
spontaneous neural##3##2##(2009-3#2)(2013-8#1)
spontaneous or radiation-induced##2##3##(2008-7#2)
spontaneous or##8##2##(1990-9#1)(1991-5#1)(1992-3#1)(1992-9#1)(2008-11#1)(2008-7#2)(2012-12#1)
spontaneous oscillations##3##2##(1992-12#1)(1994-11#2)
spontaneous pain##2##2##(2008-6#1)(2008-9#1)
spontaneous parametric downconversion##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
spontaneous perforation of the##3##4##(1993-8#1)(2011-2#1)(2013-1#1)
spontaneous platelet aggregation in##3##4##(1990-5#1)(1991-11#2)
spontaneous platelet aggregation##5##3##(1990-5#2)(1991-11#3)
spontaneous pneumothorax in##2##3##(2007-8#1)(2008-7#1)
spontaneous pneumothorax##23##2##(1991-6#2)(2006-10#4)(2007-8#6)(2008-1#1)(2008-10#1)(2008-7#8)(2010-8#1)
spontaneous pneumothorax]##2##2##(2008-1#1)(2008-10#1)
spontaneous polarization##4##2##(2008-2#2)(2008-3#2)
spontaneous polymerization##2##2##(1994-8#1)(1995-6#1)
spontaneous rearrangement##2##2##(2008-10#2)
spontaneous recovery##4##2##(1995-12#1)(1995-5#1)(1996-6#1)(1997-2#1)
spontaneous regression of##3##3##(1991-12#1)(2008-1#2)
spontaneous regression##5##2##(1991-12#1)(2007-8#1)(2008-1#2)(2010-8#1)
spontaneous remission##2##2##(2008-10#1)(2013-7#1)
spontaneous reporting##3##2##(2008-8#3)
spontaneous reports##2##2##(1996-11#1)(2008-11#1)
spontaneous resolution##3##2##(2008-10#1)(2008-12#2)
spontaneous rupture of the intestine and large vessels##2##8##(1990-2#2)
spontaneous rupture of the##4##4##(1990-2#3)(1993-9#1)
spontaneous rupture##5##2##(1990-2#3)(1993-9#1)(1996-6#1)
spontaneous seizures##2##2##(2008-4#1)(2009-8#1)
spontaneous speech##4##2##(1993-9#1)(2008-10#1)(2008-4#1)(2011-1#1)
spontaneous splenic rupture in##3##4##(1992-2#1)(1993-9#1)(2011-2#1)
spontaneous splenic rupture##5##3##(1992-2#2)(1993-9#1)(2007-5#1)(2011-2#1)
spontaneous theta rhythm in##3##4##(1993-9#3)
spontaneous theta##4##2##(1993-9#4)
spontaneous transfer##4##2##(1992-3#3)(1992-6#1)
spontaneous vaginal##2##2##(2011-1#1)(2013-1#1)
spontaneous##449##1##(1990-11#5)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#3)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#9)(1994-11#4)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#4)(1995-12#8)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-11#2)(1996-2#3)(1996-5#3)(1996-6#3)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#6)(1997-8#1)(2006-10#4)(2006-6#2)(2007-10#3)(2007-11#18)(2007-12#21)(2007-5#1)(2007-7#1)(2007-8#11)(2007-9#1)(2008-1#9)(2008-10#29)(2008-11#26)(2008-12#4)(2008-2#12)(2008-3#14)(2008-4#9)(2008-5#5)(2008-6#7)(2008-7#32)(2008-8#11)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-3#4)(2010-4#1)(2010-8#3)(2011-1#8)(2011-2#19)(2012-1#2)(2012-12#6)(2012-2#10)(2012-3#3)(2013-1#17)(2013-7#2)(2013-8#6)
spontaneous-emission##5##1##(2007-11#4)(2007-12#1)
spontaneously active##3##2##(1993-12#1)(1996-6#1)(2008-11#1)
spontaneously after##3##2##(1995-5#1)(2007-8#1)(2008-7#1)
spontaneously and##5##2##(1990-2#1)(1994-7#1)(1996-1#1)(1996-3#1)(2008-11#1)
spontaneously beating##2##2##(1994-11#1)(2009-3#1)
spontaneously breathing##3##2##(1996-5#1)(2007-9#1)(2012-3#1)
spontaneously detach##2##2##(2011-2#2)
spontaneously develop##5##2##(2008-10#2)(2008-4#2)(2012-2#1)
spontaneously developed##3##2##(1990-11#1)(1997-3#2)
spontaneously diabetic##2##2##(1994-12#2)
spontaneously hypertensive rats (SHR) and##2##5##(1990-7#1)(1997-6#1)
spontaneously hypertensive rats (SHR)##5##4##(1990-7#1)(1994-2#1)(1997-6#1)(2010-2#1)(2011-1#1)
spontaneously hypertensive rats (SHRSP)##2##4##(1991-6#1)(1995-12#1)
spontaneously hypertensive rats##18##3##(1990-7#1)(1991-5#1)(1991-6#1)(1994-2#2)(1995-11#2)(1995-12#4)(1997-2#1)(1997-6#2)(2010-2#1)(2011-1#3)
spontaneously hypertensive##24##2##(1990-7#1)(1991-5#1)(1991-6#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#4)(1996-5#1)(1997-2#2)(1997-6#2)(2008-3#1)(2009-9#1)(2010-2#1)(2011-1#3)(2013-8#1)
spontaneously immortalized##2##2##(1997-7#1)(2008-11#1)
spontaneously in the##2##3##(1997-5#1)(2013-8#1)
spontaneously in##6##2##(1995-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2013-8#1)
spontaneously occurring##3##2##(1994-11#1)(1995-8#1)(2010-3#1)
spontaneously or##5##2##(1990-2#1)(1997-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
spontaneously resolved##4##2##(1993-9#1)(2007-8#1)(2008-10#1)(2008-7#1)
spontaneously through##2##2##(2008-7#2)
spontaneously transformed rat-liver##2##3##(1992-9#2)
spontaneously transformed##3##2##(1992-9#2)(2008-11#1)
spontaneously without##2##2##(1997-4#1)(2011-1#1)
spontaneously##141##1##(1990-11#1)(1990-2#3)(1990-5#3)(1990-7#1)(1991-5#1)(1991-6#2)(1992-9#2)(1993-12#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#11)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#1)(2009-10#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-8#3)
spoonful##2##1##(1993-9#2)
sporadic AD##5##2##(1994-8#3)(1996-5#2)
sporadic and##4##2##(2007-12#1)(2009-12#1)(2013-1#2)
sporadic breast cancer##2##3##(1994-6#1)(1995-12#1)
sporadic cases of##2##3##(2008-7#2)
sporadic cases##6##2##(2007-12#1)(2007-2#1)(2007-7#1)(2008-7#2)(2011-2#1)
sporadic forms##2##2##(2007-10#1)(2008-7#1)
sporadic medullary thyroid carcinoma##3##4##(2008-1#3)
sporadic paraganglioma##2##2##(2012-2#1)(2013-1#1)
sporadic tumors##2##2##(2011-2#1)(2013-8#1)
sporadic##69##1##(1990-12#1)(1990-2#1)(1990-3#2)(1991-8#1)(1993-12#1)(1993-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1996-2#1)(1996-5#2)(1997-3#1)(2006-10#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#7)(2009-11#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
sporadically or as part of##2##5##(2007-5#1)(2012-3#1)
sporadically or as##3##3##(2007-5#1)(2008-7#1)(2012-3#1)
sporadically##13##1##(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2012-3#1)
sporamin##4##1##(2008-6#4)
sporangia and mycelia##3##3##(2008-10#3)
sporangia and zoospores of P##2##5##(2008-10#2)
sporangia and zoospores of##3##4##(2008-10#3)
sporangia and zoospores##7##3##(2008-10#7)
sporangia and##13##2##(2008-10#13)
sporangia of##6##2##(2008-10#6)
sporangia on##2##2##(2008-10#2)
sporangia or##2##2##(2008-10#2)
sporangia production##3##2##(2008-10#3)
sporangia released##2##2##(2008-10#2)
sporangia was##3##2##(2008-10#3)
sporangia were##2##2##(2008-10#2)
sporangia##63##1##(2008-10#62)(2010-3#1)
sporangiiferum##2##1##(2008-10#2)
sporangiophores and sporangia##2##3##(2008-10#2)
sporangiophores##5##1##(2008-10#5)
sporangiospores##3##1##(2008-10#1)(2008-5#1)(2008-8#1)
spore adhesion##5##2##(2008-10#5)
spore and##2##2##(2008-10#1)(2008-3#1)
spore attachment##3##2##(2008-10#3)
spore coat##3##2##(2008-10#3)
spore concentration##3##2##(2008-10#2)(2008-5#1)
spore concentrations##4##2##(2008-10#1)(2008-5#2)(2010-5#1)
spore densities##2##2##(2008-10#2)
spore density##4##2##(2008-10#4)
spore deposition of G##2##4##(2008-10#2)
spore deposition of##3##3##(2008-10#3)
spore deposition##11##2##(2008-10#11)
spore dispersal gradient##4##3##(2008-10#4)
spore dispersal##10##2##(2008-10#10)
spore efficacy on##2##3##(2008-10#2)
spore efficacy##5##2##(2008-10#5)
spore flux density was##2##4##(2008-10#2)
spore flux density##4##3##(2008-10#4)
spore formation##4##2##(2008-8#1)(2010-2#2)(2012-2#1)
spore germination and germ tube growth of##2##7##(2008-10#2)
spore germination and outgrowth##3##4##(2011-2#3)
spore germination and##9##3##(1997-6#1)(2008-10#5)(2011-2#3)
spore germination fluid##2##3##(2008-10#2)
spore germination frequency##2##3##(2008-10#2)
spore germination in##4##3##(2008-10#3)(2011-2#1)
spore germination##30##2##(1997-6#1)(1997-7#1)(2008-10#21)(2011-2#7)
spore maturation##2##2##(2008-10#1)(2012-2#1)
spore morphology##2##2##(2008-10#2)
spore movement##2##2##(2008-10#2)
spore outgrowth##2##2##(2011-2#2)
spore pigment##3##2##(2008-8#3)
spore precipitator in##2##3##(2008-10#2)
spore precipitator##4##2##(2008-10#4)
spore production per lesion##2##4##(2008-10#2)
spore production per##3##3##(2008-10#3)
spore production was##2##3##(2008-10#2)
spore production##15##2##(2008-10#12)(2010-10#2)(2012-3#1)
spore release of##3##3##(2008-10#3)
spore release##11##2##(2008-10#11)
spore samplers##3##2##(2008-10#3)
spore suspension and irrigation water samples##2##6##(2008-10#2)
spore suspension##9##2##(2008-10#8)(2008-5#1)
spore suspensions##2##2##(2008-10#2)
spore traps##5##2##(2008-10#4)(2010-5#1)
spore types##3##2##(2008-10#3)
spore##209##1##(1995-3#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-7#2)(2008-10#152)(2008-3#4)(2008-5#5)(2008-8#6)(2010-1#1)(2010-10#2)(2010-2#2)(2010-5#2)(2011-2#23)(2012-2#2)(2012-3#1)(2013-8#1)
spore-forming bacteria and##3##3##(2011-2#3)
spore-forming bacteria##8##2##(2011-2#8)
spore-forming##11##1##(2011-2#11)
spores and the##2##3##(2011-2#2)
spores and##11##2##(2008-10#4)(2008-5#2)(2008-8#1)(2010-2#1)(2011-2#3)
spores are##5##2##(2008-10#2)(2008-5#2)(2008-8#1)
spores by##2##2##(2011-2#2)
spores can##2##2##(2008-10#1)(2011-2#1)
spores deposited##2##2##(2008-10#2)
spores dispersed##2##2##(2008-10#2)
spores has been##2##3##(2011-2#2)
spores have##2##2##(2010-5#1)(2011-2#1)
spores in##6##2##(1997-4#1)(2008-10#3)(2008-5#1)(2011-2#1)
spores is##4##2##(2008-10#3)(2010-1#1)
spores m(-3) day(-1)) was##2##4##(2010-5#2)
spores m(-3)##3##2##(2008-5#1)(2010-5#2)
spores of A##2##3##(2008-10#2)
spores of G##2##3##(2008-10#2)
spores of the##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
spores of##19##2##(1997-4#1)(2008-10#9)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#5)
spores on##2##2##(2008-10#2)
spores per##5##2##(2008-10#5)
spores produced at##2##3##(2011-2#2)
spores produced##3##2##(2008-10#1)(2011-2#2)
spores to##2##2##(2010-1#1)(2011-2#1)
spores was##3##2##(2008-10#3)
spores were##16##2##(1997-3#1)(2008-10#10)(2010-5#4)(2011-2#1)
spores with##3##2##(2008-10#1)(2010-10#2)
spores##176##1##(1991-5#1)(1993-6#1)(1994-9#1)(1997-3#1)(1997-4#3)(2007-5#1)(2007-7#2)(2008-10#93)(2008-3#3)(2008-5#9)(2008-8#7)(2008-9#2)(2009-8#1)(2010-1#3)(2010-10#4)(2010-2#1)(2010-3#1)(2010-5#8)(2011-1#2)(2011-2#31)(2013-1#1)
spores)##2##1##(1992-8#1)(2008-10#1)
sporidia##5##1##(2008-10#5)
sporocysts of S##2##3##(1996-12#2)
sporocysts of##3##2##(1996-12#3)
sporocysts##4##1##(1996-12#4)
sporopollenin##5##1##(2011-2#5)
sporotrichioides enzyme##2##2##(1995-2#2)
sporotrichioides##3##1##(1995-2#2)(2008-10#1)
sporotrichosis##4##1##(2007-7#4)
sporozoites##4##1##(1991-5#1)(1996-12#1)(1997-4#1)(2008-3#1)
sport and##2##2##(2010-7#1)(2011-2#1)
sport orientation##3##2##(2009-7#3)
sport participation##4##2##(2009-7#1)(2010-1#1)(2010-7#2)
sport performance##3##2##(2008-5#2)(2009-1#1)
sport##50##1##(1993-3#2)(1995-6#1)(1996-9#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#4)(2008-6#1)(2009-1#2)(2009-11#3)(2009-3#1)(2009-5#2)(2009-7#8)(2009-9#1)(2010-1#1)(2010-11#2)(2010-4#2)(2010-7#4)(2011-1#4)(2011-2#2)(2013-1#2)
sport-related concussion##3##2##(2010-1#3)
sporting##4##1##(1990-9#1)(1991-3#1)(1993-3#1)(2008-8#1)
sports activity##2##2##(2008-9#2)
sports and##8##2##(1995-5#1)(2007-11#1)(2007-2#1)(2008-11#1)(2009-7#2)(2013-1#2)
sports background##2##2##(2007-11#2)
sports in##2##2##(1996-6#1)(2007-11#1)
sports injuries and illnesses##2##4##(1993-3#2)
sports injuries##5##2##(1993-3#2)(2010-1#2)(2013-1#1)
sports medicine##5##2##(1993-3#2)(1994-3#2)(2013-1#1)
sports nutrition##3##2##(2008-5#3)
sports participation##2##2##(2009-7#1)(2010-7#1)
sports performance##6##2##(2008-5#6)
sports##67##1##(1990-9#1)(1991-6#2)(1993-3#7)(1994-3#2)(1995-5#1)(1995-6#1)(1996-6#4)(2007-11#8)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#9)(2008-9#3)(2009-7#5)(2010-1#3)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-6#1)(2013-1#8)
sportsmen##4##1##(1995-6#2)(1996-3#1)(2007-11#1)
sporulated##6##1##(1997-3#1)(2008-10#4)(2011-2#1)
sporulates##2##1##(2008-10#2)
sporulating colonies##2##2##(2008-10#1)(2008-8#1)
sporulating lesions on##2##3##(2008-10#2)
sporulating lesions##6##2##(2008-10#6)
sporulating surface area##2##3##(2008-10#2)
sporulating surface##3##2##(2008-10#3)
sporulating##20##1##(1997-3#1)(2008-10#16)(2008-7#1)(2008-8#2)
sporulation and##7##2##(1993-3#1)(2008-10#4)(2011-2#2)
sporulation capacity on##2##3##(2008-10#2)
sporulation capacity##6##2##(2008-10#6)
sporulation curve##5##2##(2008-10#5)
sporulation from##2##2##(2008-10#2)
sporulation in##6##2##(1995-9#1)(2008-10#4)(2008-8#1)
sporulation medium##2##2##(1997-3#1)(2011-2#1)
sporulation occurred##2##2##(2008-10#2)
sporulation of B##2##3##(2008-10#2)
sporulation of the##6##3##(2008-10#5)(2008-6#1)
sporulation of##13##2##(2008-10#12)(2008-6#1)
sporulation on necrotic##2##3##(2008-10#2)
sporulation on##6##2##(2008-10#6)
sporulation per lesion##2##3##(2008-10#2)
sporulation per##3##2##(2008-10#3)
sporulation rate##5##2##(2008-10#5)
sporulation was observed##2##3##(2008-10#2)
sporulation was##9##2##(2008-10#9)
sporulation##117##1##(1990-12#1)(1990-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-6#2)(1995-9#4)(1997-3#1)(2008-10#94)(2008-6#3)(2008-8#1)(2011-2#5)(2012-2#2)
sporulation-specific##2##1##(1995-6#1)(2012-2#1)
spot analysis##2##2##(1997-6#1)(2013-1#1)
spot and Stagonospora blotch##2##4##(2008-10#2)
spot and the##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
spot and##16##2##(2008-10#10)(2008-2#2)(2008-3#2)(2013-1#2)
spot are##2##2##(2008-10#1)(2008-3#1)
spot arrays##4##2##(2007-11#1)(2008-3#3)
spot as##3##2##(2008-10#2)(2008-3#1)
spot at##2##2##(2008-2#1)(2008-3#1)
spot blotch disease##2##3##(2008-10#2)
spot blotch resistance##3##3##(2008-10#3)
spot blotch##7##2##(2008-10#7)
spot by##5##2##(2007-11#1)(2008-10#3)(2013-8#1)
spot caused by##3##3##(2008-10#3)
spot development##6##2##(2008-10#6)
spot diameter##2##2##(2008-2#1)(2008-3#1)
spot diameters##2##2##(2007-11#1)(2008-3#1)
spot disease of##2##3##(2008-10#2)
spot disease on##2##3##(2008-10#2)
spot disease##12##2##(2008-10#11)(2010-3#1)
spot epidemics##6##2##(2008-10#6)
spot from##2##2##(2008-10#1)(2008-3#1)
spot has##3##2##(2007-11#1)(2008-10#2)
spot in each##2##3##(2007-12#1)(2008-4#1)
spot in the##2##3##(2007-11#2)
spot in##12##2##(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-4#1)(2011-2#1)
spot incidence##3##2##(2008-10#3)
spot is##9##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)
spot lesions on##3##3##(2008-10#3)
spot lesions##7##2##(2008-10#6)(2009-7#1)
spot of wheat##5##3##(2008-10#5)
spot of##41##2##(2008-10#36)(2008-3#2)(2008-9#1)(2010-12#1)(2012-2#1)
spot on the##3##3##(1995-2#1)(2008-3#1)(2013-7#1)
spot on##17##2##(1995-2#1)(2008-10#12)(2008-3#2)(2008-9#1)(2013-7#1)
spot pathogen##5##2##(2008-10#5)
spot produced by a##2##4##(2007-11#1)(2008-3#1)
spot produced by##3##3##(2007-11#1)(2008-3#2)
spot recording##2##2##(2008-3#2)
spot resistance##8##2##(2008-10#8)
spot sample##2##2##(2012-2#1)(2013-1#1)
spot scanning##2##2##(2010-9#2)
spot severity##6##2##(2008-10#6)
spot size and##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
spot size for##3##3##(2008-10#2)(2008-3#1)
spot size##29##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#7)(2008-3#10)(2008-9#3)(2010-1#1)(2012-2#1)
spot sizes and##2##3##(2008-2#1)(2008-3#1)
spot sizes##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
spot symptoms##3##2##(2008-10#3)
spot test analysis##2##3##(2008-10#2)
spot test##8##2##(2007-7#1)(2008-10#6)(2012-2#1)
spot that##2##2##(2007-11#1)(2008-2#1)
spot virus and##2##3##(2008-10#2)
spot virus##29##2##(2008-10#29)
spot was##3##2##(2008-10#2)(2008-11#1)
spot welding##2##2##(1996-1#1)(2008-2#1)
spot were##3##2##(2008-10#2)(2008-3#1)
spot with##5##2##(1990-11#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
spot##419##1##(1990-11#1)(1993-11#2)(1995-2#1)(1995-8#1)(1996-1#1)(1997-6#1)(2007-11#12)(2007-12#9)(2007-7#1)(2008-10#267)(2008-11#1)(2008-2#24)(2008-3#53)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-7#5)(2010-1#2)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#5)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
spot)##8##1##(1991-5#2)(2008-10#5)(2008-2#1)
spot-array generator##2##2##(2008-3#2)
spot-array##3##1##(2007-11#1)(2008-3#2)
spot-resistant##2##1##(2008-10#2)
spot-size and numerical-aperture conversion##2##4##(2007-12#2)
spot-size mismatch##2##2##(2008-3#2)
spot-size##7##1##(2007-11#1)(2007-12#3)(2008-3#3)
spotlight on##3##2##(2008-11#1)(2010-5#1)(2012-2#1)
spotlight##13##1##(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-2#3)(2008-7#1)(2009-7#1)(2010-5#1)(2012-2#1)
spots and##5##2##(1994-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2010-3#1)
spots are##2##2##(2011-2#1)(2012-3#1)
spots for##3##2##(2008-10#2)(2009-10#1)
spots in the##2##3##(2008-3#1)(2008-7#1)
spots in##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
spots of##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
spots on the##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2011-3#1)
spots on##13##2##(1991-8#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-3#1)
spots or##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
spots to##2##2##(1997-6#1)(2008-3#1)
spots was##4##2##(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#1)
spots were##7##2##(1996-8#1)(2008-10#3)(2009-4#1)(2010-12#1)(2010-8#1)
spots##116##1##(1990-11#1)(1990-5#1)(1991-2#2)(1991-8#2)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1996-8#1)(1997-6#2)(2007-11#2)(2007-12#9)(2007-5#1)(2008-10#38)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#4)(2010-12#4)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
spotted fever group Rickettsiae##2##4##(1991-8#2)
spotted fever group##3##3##(1991-8#2)(1995-12#1)
spotted fever##6##2##(1991-8#2)(1995-12#1)(2009-2#1)(2013-8#2)
spotted onto a##2##3##(2008-10#1)(2012-3#1)
spotted wilt tospovirus (TSWV)##3##4##(2008-10#3)
spotted wilt virus (TSWV)##16##4##(2008-10#16)
spotted wilt virus##31##3##(2008-10#31)
spotted wilt##35##2##(2008-10#35)
spotted##53##1##(1991-8#2)(1994-12#1)(1995-12#1)(2007-12#1)(2007-2#1)(2008-10#39)(2008-7#3)(2009-2#1)(2012-3#2)(2013-8#2)
spotting##9##1##(1994-12#4)(2008-10#4)(2010-4#1)
spotty##3##1##(1990-5#1)(1995-4#1)(2008-7#1)
spouse and##3##2##(1993-12#1)(2008-1#1)(2009-5#1)
spouse##13##1##(1990-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-11#1)(2008-1#1)(2009-5#2)(2010-4#1)(2011-2#1)(2012-12#1)
spouses in##4##2##(2008-10#1)(2012-12#3)
spouses##10##1##(1991-4#1)(1997-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#4)(2013-8#1)
spouses'##2##1##(2011-2#2)
spout was##2##2##(1990-7#2)
spout##12##1##(1990-7#9)(2008-4#2)(2013-1#1)
spp and##5##2##(2008-10#1)(2009-9#1)(2011-2#2)(2013-1#1)
spp##624##1##(1990-3#1)(1990-6#4)(1991-11#1)(1994-3#1)(1996-12#4)(1997-3#1)(1997-4#1)(1997-6#3)(2007-10#1)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#17)(2008-10#422)(2008-11#1)(2008-12#4)(2008-5#37)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#4)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#2)(2010-2#1)(2010-4#9)(2010-6#2)(2010-8#2)(2011-1#7)(2011-10#1)(2011-2#24)(2012-12#16)(2012-2#10)(2012-3#3)(2012-5#4)(2013-1#16)(2013-7#4)(2013-8#3)
sprague-dawley rats##2##2##(2008-10#1)(2012-1#1)
sprain##10##1##(2007-11#3)(2008-12#2)(2011-2#1)(2012-3#1)(2013-1#3)
sprains and##2##2##(2013-1#2)
sprains##4##1##(2013-1#4)
spray and##6##2##(2007-11#1)(2008-10#5)
spray by##2##2##(2008-10#1)(2008-3#1)
spray drying##2##2##(2008-10#2)
spray inoculation##4##2##(2008-10#3)(2008-9#1)
spray is##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
spray of validamycin##2##3##(2008-10#2)
spray of##5##2##(1996-2#1)(2008-10#4)
spray or##2##2##(2008-10#2)
spray pyrolysis##2##2##(2008-11#2)
spray to##2##2##(1992-2#1)(2008-10#1)
spray##95##1##(1991-12#1)(1992-12#1)(1992-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-11#1)(2008-10#53)(2008-11#4)(2008-2#3)(2008-3#9)(2008-5#5)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#4)(2013-8#1)
spray-inoculated onto##3##2##(2008-10#3)
sprayed and##2##2##(2008-10#2)
sprayed in##3##2##(2008-10#3)
sprayed on##4##2##(2008-10#4)
sprayed with a##3##3##(2008-10#3)
sprayed with the##3##3##(2008-10#3)
sprayed with##16##2##(2008-10#14)(2008-8#1)(2011-2#1)
sprayed##32##1##(2008-10#28)(2008-3#1)(2008-8#1)(2011-2#2)
spraying and##2##2##(2008-10#1)(2009-4#1)
spraying of##3##2##(1997-7#1)(2011-2#1)(2013-8#1)
spraying the##2##2##(2008-10#1)(2008-9#1)
spraying##22##1##(1997-7#1)(2008-10#9)(2008-6#1)(2008-9#2)(2009-4#3)(2011-2#4)(2013-8#2)
sprays is##2##2##(2008-10#2)
sprays of the##2##3##(2008-10#2)
sprays of##3##2##(1996-2#1)(2008-10#2)
sprays with##4##2##(2008-10#4)
sprays##28##1##(1996-2#1)(1997-8#1)(2008-10#19)(2008-3#5)(2008-5#1)(2011-2#1)
spread all over the##2##4##(1996-6#1)(2008-10#1)
spread along##2##2##(2008-1#1)(2012-3#1)
spread among##2##2##(2007-12#1)(2012-1#1)
spread and the##3##3##(2008-8#1)(2010-9#1)(2011-2#1)
spread and##20##2##(1991-6#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-9#1)(2011-2#2)(2013-1#1)
spread as##4##2##(1996-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
spread at a##2##3##(2008-3#1)(2013-1#1)
spread at##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
spread beyond##2##2##(2008-7#1)(2010-7#1)
spread by##6##2##(1992-6#1)(2008-10#4)(2010-10#1)
spread from a##2##3##(2008-10#1)(2008-6#1)
spread from the##2##3##(2008-10#1)(2011-2#1)
spread from##9##2##(2008-10#4)(2008-6#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)
spread function##3##2##(2008-3#1)(2008-6#1)(2011-1#1)
spread has##2##2##(2008-10#1)(2008-12#1)
spread in the##7##3##(1992-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-3#1)
spread in##30##2##(1991-12#1)(1991-8#2)(1992-8#1)(1992-9#1)(1996-10#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
spread into##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
spread is##3##2##(1992-9#1)(2008-9#1)(2012-2#1)
spread more slowly than##2##4##(2007-7#1)(2008-10#1)
spread more slowly##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
spread occurred##2##2##(2008-10#1)(2008-9#1)
spread of AIDS and other sexually transmitted diseases##2##8##(1993-6#1)(1993-9#1)
spread of AIDS##8##3##(1990-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1997-6#3)
spread of HIV##11##3##(1996-11#3)(1997-5#2)(1997-6#3)(2008-1#1)(2008-8#1)(2011-1#1)
spread of P##3##3##(2008-10#3)
spread of SMV strain G-5##2##5##(2008-10#2)
spread of SMV strain##3##4##(2008-10#3)
spread of SMV##5##3##(2008-10#5)
spread of TSWV##3##3##(2008-10#3)
spread of a##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
spread of an##2##3##(1997-3#1)(2008-10#1)
spread of antimicrobial resistance in bacteria##2##6##(2010-4#2)
spread of blueberry shock ilarvirus##2##5##(2008-10#2)
spread of breast cancer##2##4##(1993-9#2)
spread of carcinoma##2##3##(1990-8#1)(1995-11#1)
spread of disease from##2##4##(2008-10#1)(2010-3#1)
spread of disease##12##3##(2008-10#10)(2008-8#1)(2010-3#1)
spread of infection##9##3##(1995-8#1)(2007-6#1)(2007-7#1)(2009-6#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-3#1)
spread of infectious diseases##4##4##(2010-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
spread of plant diseases##2##4##(2008-10#2)
spread of soybean mosaic virus##2##5##(2008-10#2)
spread of the disease from##2##5##(2008-10#1)(2010-4#1)
spread of the disease##6##4##(2007-7#1)(2008-10#3)(2010-4#1)(2011-2#1)
spread of the fungus##2##4##(2008-10#2)
spread of the infection##2##4##(2011-2#2)
spread of the pathogen##4##4##(2008-10#4)
spread of the virus##2##4##(2007-8#1)(2008-10#1)
spread of the##28##3##(1990-6#1)(1993-8#1)(1994-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#14)(2008-8#1)(2010-4#1)(2011-2#5)
spread of these##3##3##(1997-3#1)(2008-9#1)(2013-1#1)
spread of this disease##2##4##(1995-1#1)(2008-12#1)
spread of this##5##3##(1995-1#1)(2008-10#3)(2008-12#1)
spread of##211##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-3#1)(1997-3#2)(1997-5#2)(1997-6#7)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#87)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#5)(2009-2#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#13)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
spread on##5##2##(1993-9#1)(1994-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
spread out##3##2##(2007-12#1)(2008-11#1)(2009-10#1)
spread over the##2##3##(1996-5#1)(2008-10#1)
spread over##8##2##(1996-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)
spread rapidly##6##2##(1990-3#1)(1990-5#1)(1990-6#1)(1996-11#1)(1997-6#1)(2008-11#1)
spread rate##3##2##(2008-8#2)(2011-2#1)
spread rates##2##2##(2008-8#2)
spread systemically##2##2##(2008-10#2)
spread the word##4##3##(1993-1#1)(1993-2#1)(1993-3#1)(2008-4#1)
spread the##5##2##(1993-1#1)(1993-2#1)(1993-3#1)(1997-6#1)(2008-4#1)
spread through##4##2##(1992-5#1)(2008-10#2)(2013-8#1)
spread throughout the##2##3##(2008-10#2)
spread throughout##3##2##(2008-10#3)
spread to other parts of Malaysia##3##6##(2008-12#1)(2011-1#2)
spread to other##5##3##(2008-12#2)(2008-9#1)(2011-1#2)
spread to the##7##3##(1992-10#2)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
spread to##26##2##(1992-10#2)(1994-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#1)(2013-8#1)
spread was possible##2##3##(2008-10#2)
spread was##8##2##(1990-8#1)(1995-5#1)(2008-10#4)(2009-2#1)(2010-9#1)
spread when##2##2##(2008-10#1)(2008-8#1)
spread widely##2##2##(2007-7#1)(2011-2#1)
spread with##3##2##(2008-10#2)(2008-8#1)
spread within the##5##3##(2008-1#1)(2008-10#3)(2008-6#1)
spread within##8##2##(2008-1#1)(2008-10#6)(2008-6#1)
spread worldwide##2##2##(2007-7#1)(2011-2#1)
spread##516##1##(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#7)(1996-12#1)(1996-3#2)(1996-5#3)(1996-6#1)(1997-3#3)(1997-5#2)(1997-6#9)(1997-8#2)(2007-11#1)(2007-12#13)(2007-2#2)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#2)(2008-1#16)(2008-10#201)(2008-11#5)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#7)(2008-7#8)(2008-8#26)(2008-9#18)(2009-10#1)(2009-2#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#23)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#11)(2013-8#7)
spreaders##3##1##(2008-2#1)(2012-2#2)
spreading a##3##2##(1995-12#1)(2008-2#1)(2008-9#1)
spreading and##3##2##(2008-3#2)(2008-9#1)
spreading broadly##2##2##(2007-12#1)(2008-11#1)
spreading depression##7##2##(1993-12#2)(1996-5#3)(2007-10#2)
spreading epidemic##2##2##(1997-2#1)(2008-2#1)
spreading from the##2##3##(2012-3#2)
spreading in##3##2##(2007-12#1)(2008-7#1)(2008-8#1)
spreading of the pulse in##2##5##(2007-12#2)
spreading of the##8##3##(1991-3#1)(1997-3#1)(2007-12#3)(2008-2#1)(2008-7#1)(2011-1#1)
spreading of##18##2##(1990-12#1)(1991-3#1)(1993-3#1)(1993-9#1)(1994-6#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)
spreading panicle was##2##3##(2009-10#2)
spreading panicle##6##2##(2009-10#6)
spreading rapidly##2##2##(1990-3#1)(2008-10#1)
spreading through##2##2##(2008-7#1)(2008-8#1)
spreading to the##2##3##(2008-3#1)(2011-2#1)
spreading##97##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-5#2)(1991-8#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-6#3)(1995-12#1)(1996-5#3)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#8)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#4)(2012-5#1)(2013-8#1)
spreads epidemically##2##2##(2008-10#2)
spreads from##2##2##(2008-10#1)(2008-4#1)
spreads to##2##2##(1991-6#1)(2008-9#1)
spreads##15##1##(1991-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)
spreadsheet##6##1##(1992-12#1)(1993-1#1)(2008-11#2)(2011-2#1)(2013-1#1)
spring 1999##2##2##(2008-10#2)
spring and autumn##5##3##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
spring and early summer##2##4##(2008-10#1)(2011-2#1)
spring and fall##4##3##(2008-10#4)
spring and summer season##2##4##(2012-3#2)
spring and summer##4##3##(2008-9#1)(2011-2#1)(2012-3#2)
spring and the##2##3##(2008-10#2)
spring and winter barley##2##4##(2008-10#2)
spring and winter wheat##2##4##(2008-10#2)
spring and winter##5##3##(2008-10#4)(2008-12#1)
spring and##24##2##(2008-10#14)(2008-12#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#1)
spring barley cv##2##3##(2008-10#2)
spring barley##9##2##(2008-10#4)(2008-12#5)
spring cotton and fall corn every year##2##7##(2008-10#2)
spring cotton and fall corn##3##5##(2008-10#3)
spring crop##2##2##(2008-10#2)
spring in##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
spring infections##4##2##(2008-10#4)
spring is##3##2##(2008-12#2)(2008-6#1)
spring of 2003##2##3##(2008-11#2)
spring of##21##2##(1992-4#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-3#1)
spring samples##2##2##(2008-10#1)(2011-2#1)
spring season##4##2##(2008-10#3)(2012-3#1)
spring systems##3##2##(2012-2#3)
spring water##8##2##(1991-11#1)(2008-10#7)
spring wheat cultivars##4##3##(2008-10#4)
spring wheat##12##2##(2008-10#12)
spring##166##1##(1990-8#1)(1991-11#1)(1992-4#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#91)(2008-11#4)(2008-12#13)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#5)(2011-2#11)(2011-9#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#2)(2013-7#1)(2013-8#2)
spring)##2##1##(2008-10#1)(2008-12#1)
springiness##2##1##(2011-2#2)
springs associated with the##2##4##(1990-8#2)
springs##8##1##(1990-12#1)(1990-8#2)(2007-8#1)(2008-6#1)(2011-2#2)(2012-2#1)
sprinkler irrigation##2##2##(2008-10#2)
sprinklers##3##1##(2008-10#3)
sprint##2##1##(2008-5#1)(2011-2#1)
sprinters##3##1##(2011-2#3)
sprout##5##1##(1997-3#3)(2008-11#1)(2008-7#1)
sprouted##2##1##(1997-3#1)(2008-5#1)
sprouting and##2##2##(1996-12#1)(2008-7#1)
sprouting is##2##2##(1993-12#1)(1997-3#1)
sprouting of##6##2##(1993-12#3)(1997-3#1)(2008-5#2)
sprouting was##2##2##(1997-3#2)
sprouting##19##1##(1993-12#4)(1996-12#1)(1997-3#4)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#5)(2011-2#1)
sprouts##6##1##(2008-10#3)(2008-11#2)(2008-5#1)
spruce (Picea##3##2##(2008-10#2)(2012-2#1)
spruce seedlings##4##2##(2008-10#4)
spruce wood##5##2##(2008-10#1)(2012-2#1)(2013-1#3)
spruce##20##1##(2008-10#15)(2012-2#2)(2013-1#3)
spun fiber##2##2##(2007-11#1)(2007-12#1)
spun fibers##6##2##(2007-11#6)
spun out of##2##3##(2008-8#1)(2012-3#1)
spun##15##1##(1990-12#1)(2007-11#8)(2007-12#3)(2008-8#2)(2012-3#1)
spur##6##1##(1990-11#1)(1992-2#1)(1997-2#1)(2008-8#1)(2012-2#1)(2013-1#1)
spurious evidence for##2##3##(1997-5#2)
spurious evidence##3##2##(1997-5#3)
spurious##14##1##(1996-11#1)(1997-5#3)(1997-7#1)(2008-10#1)(2008-3#5)(2008-7#1)(2009-8#2)
spurred##9##1##(1990-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
spurs##3##1##(2008-10#1)(2008-8#1)(2010-10#1)
spurt##4##1##(1996-5#1)(2008-10#1)(2010-3#2)
sputter deposition of##2##3##(2008-2#2)
sputter##7##1##(2008-2#4)(2008-3#1)(2009-10#2)
sputtered##11##1##(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)
sputtering and##2##2##(2007-11#1)(2008-3#1)
sputtering of##2##2##(2008-3#1)(2009-5#1)
sputtering techniques##3##2##(2008-3#2)(2012-2#1)
sputtering##21##1##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#9)(2009-5#2)(2012-2#1)
sputum analysis##2##2##(2008-3#2)
sputum and##4##2##(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
sputum culture##3##2##(2007-2#1)(2013-1#2)
sputum from##3##2##(1997-1#2)(2012-2#1)
sputum in##4##2##(2007-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
sputum samples for##2##3##(2007-8#1)(2013-1#1)
sputum samples##4##2##(2007-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
sputum##46##1##(1991-11#1)(1992-5#1)(1997-1#8)(2007-2#1)(2007-8#3)(2008-1#6)(2008-11#1)(2008-3#7)(2008-5#3)(2008-7#1)(2010-5#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#2)
squads##3##1##(1996-3#3)
squalane in##2##2##(1991-5#1)(2008-10#1)
squalane##5##1##(1991-5#2)(2008-10#3)
squalene 2##2##2##(1994-3#2)
squalene derivatives##2##2##(1994-3#2)
squalene from##2##2##(2008-10#1)(2008-5#1)
squalene hydroperoxide##2##2##(2008-5#2)
squalene monohydroperoxide##2##2##(2008-5#2)
squalene peroxidation during##2##3##(2008-5#2)
squalene peroxidation##4##2##(2008-5#4)
squalene##23##1##(1994-3#7)(1995-2#1)(1995-5#1)(2008-10#2)(2008-5#12)
squalida##5##1##(2008-5#5)
squamate##3##1##(2010-3#3)
squamometry index##2##2##(2008-5#2)
squamometry tests##2##2##(2008-5#2)
squamometry##12##1##(2008-5#12)
squamosa##2##1##(2008-10#1)(2008-8#1)
squamosissimus##3##1##(2008-7#3)
squamous and##3##2##(1996-9#2)(2009-6#1)
squamous carcinoma cells##3##3##(1992-9#3)
squamous carcinoma##5##2##(1992-8#1)(1992-9#3)(2010-12#1)
squamous cell carcinoma (OSCC)##3##4##(2010-12#1)(2013-1#2)
squamous cell carcinoma and the##2##5##(1993-8#1)(2012-2#1)
squamous cell carcinoma and##5##4##(1991-8#2)(1993-8#1)(2010-12#1)(2012-2#1)
squamous cell carcinoma arising##2##4##(2010-7#1)(2013-8#1)
squamous cell carcinoma cell##2##4##(2008-2#1)(2012-2#1)
squamous cell carcinoma in##2##4##(2012-1#1)(2013-1#1)
squamous cell carcinoma of the appendix##2##6##(1993-12#2)
squamous cell carcinoma of the cervix##2##6##(1996-12#1)(2013-7#1)
squamous cell carcinoma of the esophagus##5##6##(1993-8#1)(2013-8#4)
squamous cell carcinoma of the head and neck##3##8##(1990-6#1)(1993-8#1)(2007-11#1)
squamous cell carcinoma of the##18##5##(1990-6#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-8#3)(1993-9#1)(1996-12#1)(2007-11#1)(2008-4#1)(2009-5#1)(2013-7#1)(2013-8#4)
squamous cell carcinoma of##20##4##(1990-6#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-8#3)(1993-9#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-5#1)(2012-12#1)(2013-7#1)(2013-8#4)
squamous cell carcinoma##69##3##(1990-6#1)(1991-6#2)(1991-8#2)(1992-3#1)(1993-12#2)(1993-8#4)(1993-9#1)(1996-12#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#9)
squamous cell carcinoma]##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
squamous cell carcinomas of the##4##5##(1991-8#1)(1992-2#1)(2012-3#2)
squamous cell carcinomas of##5##4##(1991-8#1)(1992-2#2)(2012-3#2)
squamous cell carcinomas##19##3##(1991-11#1)(1991-8#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-6#3)(1997-3#2)(2008-4#2)(2008-9#2)(2010-8#1)(2012-3#3)
squamous cell lung cancer##3##4##(2012-2#3)
squamous cell lung##4##3##(2012-2#4)
squamous cell papilloma of the forestomach in##3##7##(2008-9#3)
squamous cell papilloma of the##4##5##(2008-9#4)
squamous cell papilloma##9##3##(2008-9#9)
squamous cell papillomas at##2##4##(2008-9#2)
squamous cell papillomas of the##2##5##(2008-9#2)
squamous cell papillomas##4##3##(2008-9#4)
squamous cell##113##2##(1990-6#1)(1991-11#1)(1991-6#2)(1991-8#3)(1992-2#3)(1992-3#2)(1993-12#2)(1993-8#4)(1993-9#2)(1994-6#3)(1996-12#1)(1997-3#3)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#4)(2008-9#17)(2009-10#1)(2009-5#2)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#9)
squamous cells##2##2##(1997-5#1)(2008-11#1)
squamous differentiation##2##2##(2011-2#1)(2013-7#1)
squamous epithelium##4##2##(1990-6#1)(2009-3#2)(2013-1#1)
squamous intraepithelial lesions##2##3##(1994-1#1)(1994-12#1)
squamous intraepithelial##3##2##(1994-1#1)(1994-12#1)(2008-11#1)
squamous lesions##2##2##(1994-1#2)
squamous metaplasia##3##2##(1991-2#1)(1994-9#1)(2008-1#1)
squamous##144##1##(1990-6#3)(1991-11#1)(1991-2#2)(1991-6#2)(1991-8#3)(1992-2#3)(1992-3#2)(1992-8#1)(1992-9#3)(1993-12#2)(1993-8#5)(1993-9#2)(1994-1#3)(1994-12#1)(1994-6#3)(1994-9#2)(1996-12#1)(1996-9#2)(1997-3#3)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#4)(2008-9#17)(2009-10#1)(2009-3#2)(2009-5#2)(2009-6#2)(2010-12#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#9)
squamous-cell carcinoma##7##2##(1990-8#1)(1991-12#1)(1992-10#1)(1993-9#3)(2012-12#1)
squamous-cell carcinomas##2##2##(1992-12#1)(1993-9#1)
squamous-cell##10##1##(1990-8#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-9#5)(2012-12#1)
squamulosa##3##1##(2013-7#3)
squaraine##2##1##(2008-10#2)
square analysis##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
square and##7##2##(2007-10#1)(2008-10#1)(2008-3#1)(2011-2#3)(2012-2#1)
square area##3##2##(2012-12#3)
square array##4##2##(1994-11#2)(2008-3#2)
square beam##3##2##(2008-2#3)
square capillaries##3##2##(2007-8#3)
square centimeter##9##2##(1991-5#1)(2007-12#2)(2008-10#5)(2008-2#1)
square error of prediction##7##4##(2008-10#7)
square error of##10##3##(2008-1#1)(2008-10#9)
square error##14##2##(2008-1#1)(2008-10#10)(2010-8#1)(2011-2#1)(2012-1#1)
square fit##2##2##(2008-10#1)(2012-2#1)
square foot##3##2##(1991-2#1)(1992-2#1)(2012-2#1)
square grid##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
square meter##6##2##(1995-8#1)(2008-10#4)(2008-5#1)
square miles##3##2##(2008-1#2)(2013-1#1)
square of the##13##3##(1990-7#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#6)
square of##16##2##(1990-7#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#7)(2012-3#1)
square pyramidal##2##2##(1997-7#1)(2008-10#1)
square regression##3##2##(2008-10#1)(2013-8#2)
square root of the Allan variance##2##6##(2007-12#1)(2008-2#1)
square root of the##8##4##(1994-9#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)
square root of##15##3##(1993-8#1)(1994-9#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)
square wave adsorptive stripping voltammetry##7##5##(2008-10#7)
square wave adsorptive stripping##8##4##(2008-10#8)
square wave and##2##3##(2008-10#2)
square wave anodic stripping voltammetry##4##5##(2008-10#4)
square wave cathodic stripping voltammetry (SWCSV)##2##6##(2008-10#2)
square wave cathodic stripping voltammetry##4##5##(2008-10#4)
square wave pattern##2##3##(2011-2#2)
square wave voltammetric##11##3##(2008-10#11)
square wave voltammetry (SWV) with##2##5##(2008-10#2)
square wave voltammetry (SWV)##6##4##(2008-10#6)
square wave voltammetry was##2##4##(2008-10#1)(2008-8#1)
square wave voltammetry with##2##4##(2008-10#2)
square wave voltammetry##26##3##(2008-10#24)(2008-8#2)
square wave##67##2##(2007-12#2)(2008-10#61)(2008-8#2)(2011-2#2)
square##238##1##(1990-3#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#105)(2008-12#1)(2008-2#15)(2008-3#27)(2008-5#3)(2008-8#5)(2008-9#2)(2009-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#4)
square)##3##1##(2008-2#1)(2008-7#1)(2011-2#1)
square-law##4##1##(2007-11#2)(2008-2#2)
square-pulse##2##1##(2007-12#2)
square-root##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
square-shaped##3##1##(2007-12#2)(2008-3#1)
square-wave (SW)##4##2##(2008-10#4)
square-wave adsorptive cathodic stripping voltammetric procedure was##2##7##(2008-10#2)
square-wave adsorptive cathodic stripping##3##4##(2008-10#3)
square-wave adsorptive stripping##2##3##(2008-10#2)
square-wave adsorptive##5##2##(2008-10#5)
square-wave and adsorptive stripping square-wave##2##5##(2008-10#2)
square-wave and##4##2##(2008-10#4)
square-wave anodic stripping voltammetry##8##4##(2008-10#8)
square-wave anodic##9##2##(2008-10#9)
square-wave stripping voltammetry (SWSV)##2##4##(2008-10#2)
square-wave stripping voltammetry##4##3##(2008-10#4)
square-wave techniques##2##2##(2008-10#2)
square-wave voltammetric (SWV) method##2##4##(2008-10#2)
square-wave voltammetric scan##3##3##(2008-10#3)
square-wave voltammetric##6##2##(2008-10#6)
square-wave voltammetry##8##2##(2008-10#8)
square-wave was 2##2##3##(2008-10#2)
square-wave##51##1##(2007-12#1)(2008-10#48)(2008-3#2)
squared##12##1##(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2011-3#1)
squared-grating deflectograms##2##2##(2008-3#2)
squares of##5##2##(1995-12#1)(2007-11#1)(2008-6#1)(2008-8#1)(2013-1#1)
squares regression analysis##4##3##(1993-12#1)(2008-10#2)(2008-11#1)
squares regression##26##2##(1993-12#1)(2008-10#22)(2008-11#2)(2011-2#1)
squares##154##1##(1990-3#1)(1992-6#3)(1993-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-10#117)(2008-11#3)(2008-2#2)(2008-3#4)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
squaring##2##1##(2008-3#2)
squarylium dye##2##2##(2008-10#2)
squarylium##3##1##(2007-11#1)(2008-10#2)
squash and melon plants##2##4##(2008-10#2)
squash and##4##2##(2008-10#4)
squash leaf curl virus##2##4##(2008-10#2)
squash leaf curl##3##3##(2008-10#3)
squash plants##2##2##(2008-10#2)
squash##22##1##(2008-10#21)(2008-5#1)
squat##6##1##(1995-2#1)(2008-5#2)(2011-2#3)
squatting postures##3##2##(2008-6#3)
squatting##8##1##(2008-6#6)(2010-9#1)(2012-2#1)
squeeze##5##1##(1990-4#1)(1992-3#1)(1993-9#1)(1994-8#1)(2008-7#1)
squeezed##3##1##(1993-5#1)(2007-11#1)(2008-2#1)
squeezing by##2##2##(2007-12#2)
squeezing in##3##2##(2007-11#1)(2007-12#2)
squeezing of##3##2##(2007-11#1)(2007-12#2)
squeezing##10##1##(2007-11#3)(2007-12#6)(2008-12#1)
squid##7##1##(2008-12#3)(2008-7#1)(2010-9#2)(2013-8#1)
squirrel monkeys##4##2##(1991-1#2)(2008-4#1)(2012-3#1)
squirrel##24##1##(1990-5#3)(1991-1#2)(1994-5#1)(1997-8#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#9)(2010-6#1)(2012-3#1)
squirrels##11##1##(1995-12#3)(2008-5#3)(2008-8#2)(2010-6#3)
sr##2##1##(2007-11#1)(2008-3#1)
sr(-1) for the##3##3##(2008-3#3)
sr(-1)##11##1##(2008-2#4)(2008-3#7)
src##4##1##(1990-12#1)(1990-8#1)(1991-11#1)(1994-8#1)
src-family##2##1##(1993-3#2)
srebf1a##5##1##(2012-2#5)
srs-1 gene##3##2##(2008-8#3)
srs-1##6##1##(2008-8#6)
ss##4##1##(2007-11#3)(2011-2#1)
ss-DNA probe##2##2##(2008-10#2)
ss-DNA##7##1##(1997-2#4)(2008-10#3)
ssDNA and dsDNA##2##3##(2008-10#2)
ssDNA and##3##2##(1995-2#1)(2008-10#2)
ssDNA##27##1##(1991-5#9)(1995-2#1)(2008-10#11)(2008-4#2)(2008-7#1)(2012-3#3)
ssRNA##3##1##(1991-5#1)(2008-10#2)
ssh7a and ssh7b##2##3##(2008-9#2)
ssp##19##1##(1997-2#2)(2008-11#2)(2008-5#2)(2008-9#7)(2009-10#3)(2011-1#2)(2012-2#1)
st##8##1##(1995-12#7)(1997-1#1)
stab agar##2##2##(2008-2#1)(2008-9#1)
stab wounds##2##2##(1990-2#2)
stab##4##1##(1990-2#2)(2008-2#1)(2008-9#1)
stabile fixation##2##2##(2007-11#2)
stabile##3##1##(1997-8#1)(2007-11#2)
stabilisation of IL-2 receptor alpha subunit mRNA by##2##8##(1991-2#2)
stabilisation of the##4##3##(1991-5#1)(1997-5#1)(2007-11#1)(2007-8#1)
stabilisation of##12##2##(1991-2#3)(1991-5#1)(1997-5#1)(2007-11#3)(2007-8#1)(2008-10#1)(2009-1#1)(2012-2#1)
stabilisation was##3##2##(2007-11#2)(2008-6#1)
stabilisation with##4##2##(2007-11#1)(2007-8#2)(2008-7#1)
stabilisation##42##1##(1991-2#3)(1991-5#1)(1997-5#1)(2007-11#16)(2007-12#1)(2007-8#6)(2008-10#6)(2008-6#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
stabilise IL-2R alpha mRNA##2##4##(1991-2#2)
stabilise##4##1##(1991-2#2)(1991-6#1)(2008-10#1)
stabilised by##3##2##(1995-3#1)(2007-11#1)(2011-2#1)
stabilised with##2##2##(2007-11#1)(2012-2#1)
stabilised##14##1##(1990-11#1)(1991-5#1)(1995-3#1)(1997-4#1)(2007-11#4)(2007-7#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
stabiliser##3##1##(2008-10#3)
stabilises##2##1##(1990-5#1)(2010-5#1)
stabilising##3##1##(1992-9#1)(2008-10#1)(2013-1#1)
stabilities and##3##2##(2008-10#2)(2008-5#1)
stabilities of##7##2##(1993-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2011-1#1)
stabilities##22##1##(1993-11#1)(1995-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-9#1)(2011-1#1)(2012-3#3)
stability (at##2##2##(2008-10#1)(2010-3#1)
stability (up to##2##3##(2008-10#2)
stability against##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#2)
stability analysis of##2##3##(2008-3#1)(2008-9#1)
stability analysis##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
stability and a##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
stability and ability to##3##4##(1994-12#1)(2008-10#1)(2011-2#1)
stability and energy##2##3##(1992-11#1)(2008-6#1)
stability and for##2##3##(2008-10#1)(2012-2#1)
stability and its##2##3##(2008-10#1)(2008-5#1)
stability and long-life##2##3##(2008-10#2)
stability and no##2##3##(2008-10#1)(2008-7#1)
stability and reproducibility of the##4##5##(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)
stability and reproducibility of##5##4##(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)
stability and reproducibility##14##3##(2008-10#11)(2008-12#1)(2008-2#1)(2008-8#1)
stability and selectivity##2##3##(2008-10#2)
stability and structure of DNA##2##5##(1995-5#2)
stability and structure of##4##4##(1991-8#1)(1995-5#2)(2007-11#1)
stability and the##8##3##(1991-1#1)(1993-11#1)(1994-3#1)(2008-10#3)(2008-3#1)(2011-2#1)
stability and to##2##3##(2008-10#1)(2008-5#1)
stability and##133##2##(1990-10#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-3#2)(1994-8#3)(1995-3#1)(1995-5#3)(2007-11#5)(2008-10#44)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#3)
stability are##6##2##(1991-6#1)(1994-6#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-2#1)
stability as well as##2##4##(2008-10#1)(2011-2#1)
stability as##3##2##(2008-10#2)(2011-2#1)
stability at##7##2##(1990-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-5#1)(2011-2#1)
stability because of the##2##4##(2008-10#2)
stability between##2##2##(2008-10#1)(2008-8#1)
stability but##4##2##(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
stability by##7##2##(1990-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-4#1)(2011-2#1)
stability compared##2##2##(2008-10#1)(2010-4#1)
stability constant for##3##3##(2008-10#3)
stability constant of##7##3##(2008-10#7)
stability constant values##2##3##(2008-10#2)
stability constant##20##2##(2008-10#20)
stability constants (logK) were##2##4##(2008-10#2)
stability constants are##2##3##(2008-10#2)
stability constants determination##2##3##(2008-10#2)
stability constants for metal-ligand complexes##2##5##(2008-10#2)
stability constants for the##3##4##(2008-10#2)(2008-5#1)
stability constants for##10##3##(2008-10#9)(2008-5#1)
stability constants of Fe(II)##2##4##(2008-10#2)
stability constants of complexes##3##4##(2008-10#3)
stability constants of praseodymium carbonate complexes##2##6##(2008-10#2)
stability constants of the complexes##2##5##(2008-10#2)
stability constants of the##15##4##(2008-10#15)
stability constants of##35##3##(1992-9#1)(2008-10#34)
stability constants were##2##3##(2008-10#2)
stability constants##82##2##(1992-9#1)(2008-10#78)(2008-5#3)
stability criteria##2##2##(2008-2#1)(2010-4#1)
stability domain##2##2##(1992-10#1)(2007-11#1)
stability during##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
stability even##2##2##(2008-10#1)(2011-1#1)
stability for a##2##3##(2008-10#1)(2008-3#1)
stability for at least 3 months##2##6##(2008-10#2)
stability for at least##4##4##(1992-5#1)(2008-10#3)
stability for up to##2##4##(2008-10#2)
stability for##19##2##(1992-5#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)
stability from the##2##3##(1992-5#1)(2008-3#1)
stability from##3##2##(1992-5#1)(2008-3#1)(2010-4#1)
stability has been##4##3##(1996-3#1)(2008-10#2)(2008-2#1)
stability in aqueous##3##3##(2008-10#2)(2008-5#1)
stability in patients##2##3##(2008-1#1)(2012-2#1)
stability in the##9##3##(1992-12#1)(1994-12#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-10#1)(2010-4#1)
stability in##42##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-8#1)(1996-6#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
stability indicating##6##2##(2008-10#5)(2011-1#1)
stability is one of the##2##5##(2006-10#1)(2008-5#1)
stability is##14##2##(2006-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)
stability level##2##2##(2008-3#2)
stability may##2##2##(2008-5#1)(2011-1#1)
stability observed##3##2##(1992-6#1)(2009-9#1)(2012-2#1)
stability of a model##2##4##(1993-11#1)(1995-8#1)
stability of a##14##3##(1993-11#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-9#2)(2012-2#1)
stability of adriamycin##2##3##(2008-10#2)
stability of complexes formed##2##4##(2008-10#2)
stability of complexes##3##3##(2008-10#2)(2012-2#1)
stability of gentamicin and sodium citrate##2##6##(2010-3#2)
stability of pGP1 was##2##4##(1995-8#2)
stability of protein##3##3##(1991-6#1)(1997-4#1)(2008-11#1)
stability of real##2##3##(1995-2#1)(2008-10#1)
stability of recombinant##3##3##(1994-11#1)(1994-3#1)(2011-2#1)
stability of such##3##3##(1992-2#1)(2008-5#2)
stability of the PB##3##4##(2008-10#3)
stability of the algorithm##2##4##(2008-3#1)(2012-2#1)
stability of the complex##3##4##(2008-10#3)
stability of the electrode##3##4##(2008-10#3)
stability of the enzyme##2##4##(1996-12#1)(1997-6#1)
stability of the film##2##4##(2008-10#2)
stability of the films and the##2##6##(2008-10#2)
stability of the free##2##4##(2007-11#1)(2008-6#1)
stability of the product##2##4##(1995-5#1)(2008-10#1)
stability of the protein##5##4##(1993-11#1)(1994-5#1)(1997-2#2)(2008-5#1)
stability of the sensor##2##4##(2008-10#1)(2008-3#1)
stability of the system is##2##5##(2008-11#1)(2008-8#1)
stability of the system##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
stability of the##160##3##(1990-2#1)(1990-5#2)(1990-7#2)(1991-11#1)(1992-6#6)(1993-11#5)(1993-2#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#2)(2007-11#5)(2007-12#3)(2007-8#4)(2008-10#54)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
stability of their##2##3##(2007-2#1)(2008-10#1)
stability of these##16##3##(1991-12#1)(1995-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
stability of this##8##3##(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
stability of transgene##2##3##(2008-12#1)(2008-5#1)
stability of various##2##3##(1992-5#1)(2010-3#1)
stability of vesicles##2##3##(1990-2#1)(2013-7#1)
stability of vitamin##2##3##(2008-5#2)
stability of##405##2##(1990-2#3)(1990-5#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#8)(1992-8#1)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#8)(1995-5#5)(1995-8#7)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#3)(2007-11#11)(2007-12#11)(2007-2#1)(2007-8#5)(2008-10#110)(2008-11#14)(2008-12#4)(2008-2#12)(2008-3#20)(2008-4#2)(2008-5#18)(2008-6#4)(2008-7#9)(2008-8#15)(2008-9#8)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#5)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#4)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#3)(2012-6#1)(2012-7#2)(2013-1#8)(2013-7#2)(2013-8#1)
stability on##3##2##(2008-11#1)(2008-12#2)
stability or##3##2##(1993-11#1)(2008-10#1)(2012-8#1)
stability over a##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
stability over time##2##3##(2008-10#1)(2011-2#1)
stability over##7##2##(2008-10#4)(2008-2#1)(2011-2#1)(2013-1#1)
stability range##2##2##(2007-12#1)(2008-3#1)
stability showed that##2##3##(2008-5#1)(2011-1#1)
stability so that##2##3##(2007-12#1)(2008-10#1)
stability studies##8##2##(1993-11#1)(2008-10#5)(2010-3#2)
stability study##3##2##(2008-5#2)(2010-3#1)
stability testing##2##2##(2008-5#1)(2011-1#1)
stability tests##6##2##(2008-10#2)(2008-5#2)(2008-6#1)(2012-12#1)
stability than##5##2##(1997-4#2)(2008-10#1)(2008-2#1)(2008-3#1)
stability that##3##2##(1990-8#1)(1992-6#1)(2008-3#1)
stability through##4##2##(2007-12#1)(2008-8#1)(2012-2#2)
stability to##10##2##(1992-6#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)
stability under##5##2##(1992-12#1)(2008-2#1)(2008-5#3)
stability upon##2##2##(2008-10#1)(2008-11#1)
stability was found##3##3##(2008-10#1)(2008-5#2)
stability was observed##2##3##(2008-10#1)(2008-5#1)
stability was##18##2##(1990-11#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#6)
stability were##8##2##(2008-10#6)(2008-6#1)(2008-7#1)
stability when##3##2##(2008-10#2)(2008-4#1)
stability which measures##2##3##(1991-6#1)(2013-8#1)
stability which##3##2##(1991-6#1)(1992-5#1)(2013-8#1)
stability will##3##2##(2008-9#1)(2009-7#1)(2013-8#1)
stability with##2##2##(2008-5#1)(2008-6#1)
stability##1183##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#5)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#4)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#7)(1992-6#15)(1992-8#1)(1992-9#1)(1993-11#12)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#8)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#6)(1995-1#1)(1995-11#3)(1995-2#12)(1995-3#3)(1995-5#9)(1995-6#1)(1995-8#9)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#6)(1997-6#4)(2006-10#1)(2007-11#39)(2007-12#23)(2007-2#1)(2007-8#10)(2008-1#5)(2008-10#407)(2008-11#31)(2008-12#11)(2008-2#35)(2008-3#48)(2008-4#12)(2008-5#72)(2008-6#13)(2008-7#27)(2008-8#32)(2008-9#27)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#9)(2010-4#13)(2010-5#4)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#12)(2011-2#24)(2012-1#2)(2012-12#7)(2012-2#29)(2012-3#9)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#25)(2013-7#2)(2013-8#9)
stability-diversity relationships##2##2##(2008-9#2)
stability-diversity##3##1##(2008-9#3)
stability-indicating HPLC##2##2##(2010-3#1)(2011-1#1)
stability-indicating##7##1##(2008-10#2)(2010-3#1)(2011-1#2)(2012-12#2)
stability]##2##1##(2012-3#1)(2013-1#1)
stabilization and destabilization##2##3##(1990-8#2)
stabilization and##17##2##(1990-8#2)(1995-5#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
stabilization at##2##2##(1992-1#1)(1995-5#1)
stabilization by means of##2##4##(2008-3#2)
stabilization by##10##2##(1994-5#1)(1997-2#1)(2007-11#4)(2008-1#1)(2008-3#2)(2008-6#1)
stabilization effect##4##2##(1994-11#3)(2008-10#1)
stabilization for##2##2##(1992-3#1)(2008-3#1)
stabilization in the##2##3##(2007-8#1)(2008-3#1)
stabilization in##4##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)
stabilization is##3##2##(2008-10#1)(2008-3#2)
stabilization mechanism##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
stabilization of a higher-order mode-locked##2##5##(2007-11#2)
stabilization of a##9##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)(2009-11#1)
stabilization of an##2##3##(1992-3#1)(2008-3#1)
stabilization of infrequently used##2##4##(1994-8#2)
stabilization of neural circuitry##2##4##(1994-8#2)
stabilization of tellurium in##3##4##(2008-10#3)
stabilization of the##25##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-3#1)(1994-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
stabilization of this##2##3##(1991-5#1)(1994-11#1)
stabilization of##77##2##(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
stabilization system##3##2##(2008-2#3)
stabilization was done##3##3##(2007-11#3)
stabilization was##5##2##(2007-11#4)(2009-3#1)
stabilization with##4##2##(2007-11#1)(2007-8#1)(2012-2#1)(2013-1#1)
stabilization##183##1##(1990-8#4)(1991-12#1)(1991-5#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#2)(1992-8#1)(1993-3#1)(1994-11#4)(1994-12#1)(1994-5#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-5#4)(1996-3#1)(1997-2#3)(1997-3#1)(2007-11#29)(2007-12#9)(2007-8#5)(2008-1#3)(2008-10#19)(2008-12#6)(2008-2#8)(2008-3#18)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#1)
stabilization)##2##1##(2007-8#2)
stabilizations##2##1##(2007-11#1)(2013-1#1)
stabilize the##26##2##(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#4)(2010-8#1)(2012-3#1)(2013-8#1)
stabilize this##2##2##(2011-2#1)(2011-3#1)
stabilize##65##1##(1990-2#1)(1990-8#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-11#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-5#2)(1996-2#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#8)(2008-9#2)(2009-12#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
stabilized and##2##2##(1992-3#1)(1992-6#1)
stabilized at##2##2##(2008-10#1)(2013-1#1)
stabilized by a##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
stabilized by the C-terminal##2##4##(1995-5#1)(2013-8#1)
stabilized by the interaction##2##4##(1995-5#1)(2008-4#1)
stabilized by the##9##3##(1991-3#1)(1994-11#1)(1995-5#2)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
stabilized by##32##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-5#2)(1995-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
stabilized in the##3##3##(2008-2#1)(2008-4#1)(2009-12#1)
stabilized in##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)
stabilized laser##2##2##(2007-11#1)(2008-3#1)
stabilized microtubules##2##2##(1993-8#1)(2012-4#1)
stabilized on##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
stabilized phosphate##2##2##(2008-10#2)
stabilized the##7##2##(1990-5#1)(1992-5#1)(1992-6#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-4#1)
stabilized to##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2011-1#1)
stabilized with a cervical plate##2##5##(2009-10#2)
stabilized with##7##2##(2007-12#1)(2007-8#1)(2008-10#1)(2009-10#2)(2011-2#1)(2013-1#1)
stabilized within##2##2##(2008-10#1)(2012-3#1)
stabilized##121##1##(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-11#5)(2007-12#7)(2007-8#4)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#3)(2013-8#1)
stabilizer of the##2##3##(1994-8#1)(2008-9#1)
stabilizer of##3##2##(1994-8#1)(2008-7#1)(2008-9#1)
stabilizer was##2##2##(2007-8#1)(2008-10#1)
stabilizer##12##1##(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#2)
stabilizers in##2##2##(2008-10#2)
stabilizers of the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
stabilizers##22##1##(1992-11#2)(2007-11#1)(2007-8#6)(2008-10#6)(2008-3#1)(2008-7#2)(2008-8#1)(2010-8#2)(2011-2#1)
stabilizes and##3##2##(1996-2#1)(1997-2#1)(2011-2#1)
stabilizes the##5##2##(1992-6#1)(1993-11#1)(2008-1#1)(2008-10#2)
stabilizes##22##1##(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-6#1)(2011-2#2)(2013-8#1)
stabilizing and destabilizing##2##3##(1995-5#1)(1997-4#1)
stabilizing and##3##2##(1995-5#1)(1997-4#1)(2008-9#1)
stabilizing drug##2##2##(2008-6#1)(2011-2#1)
stabilizing effect of##5##3##(1990-5#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-1#1)
stabilizing effect##7##2##(1990-5#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)
stabilizing or destabilizing influences##2##4##(2008-8#1)(2008-9#1)
stabilizing selection on##2##3##(2008-8#1)(2008-9#1)
stabilizing selection##13##2##(2008-10#1)(2008-8#9)(2008-9#3)
stabilizing the membrane##2##3##(2007-12#1)(2013-8#1)
stabilizing the##14##2##(1993-11#1)(1993-6#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
stabilizing##78##1##(1990-5#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#2)(1993-11#2)(1993-6#1)(1993-8#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#4)(1995-8#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#13)(2008-9#10)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
stable (II##2##2##(2012-3#2)
stable 1##4##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
stable 100% control##3##3##(2012-2#3)
stable BC1F4 line (denominated##2##4##(2008-10#2)
stable Chinese hamster ovary##2##4##(2008-11#2)
stable HbA1C##2##2##(1990-6#2)
stable after##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
stable along##2##2##(1990-5#1)(2007-5#1)
stable amperometric##2##2##(2008-10#2)
stable analogues##2##2##(1997-7#1)(2008-4#1)
stable and dynamic motion##2##4##(2010-8#2)
stable and highly productive##3##4##(2008-11#3)
stable and homogeneous##3##3##(2008-10#2)(2008-4#1)
stable and reliable##2##3##(2008-10#1)(2008-3#1)
stable and reproducible##3##3##(2008-10#3)
stable and showed##2##3##(2008-10#2)
stable and the##2##3##(2008-10#1)(2013-8#1)
stable and unstable##5##3##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-3#1)
stable and##72##2##(1990-9#1)(1991-12#1)(1993-11#1)(1994-11#1)(1994-8#3)(1997-1#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#4)(2010-8#2)(2011-2#2)(2012-3#2)(2012-4#1)(2013-1#2)(2013-8#2)
stable angina##10##2##(1996-6#1)(2008-10#3)(2008-3#2)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
stable as the##3##3##(1995-5#1)(2008-2#1)(2008-3#1)
stable at 4 degrees C for##2##6##(1991-5#1)(2008-11#1)
stable at around##2##3##(1993-3#1)(1995-5#1)
stable at least##2##3##(2008-10#1)(2011-1#1)
stable at room temperature##2##4##(2007-11#1)(2008-10#1)
stable at##18##2##(1991-12#1)(1991-5#1)(1993-3#1)(1995-5#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#2)
stable biosensor for##2##3##(2008-10#2)
stable bound##2##2##(2007-11#1)(2007-12#1)
stable but##2##2##(1997-6#1)(2008-4#1)
stable carbon##3##2##(2008-10#2)(2012-9#1)
stable cell line##2##3##(2008-2#2)
stable cell lines##9##3##(1997-4#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-7#1)(2009-6#1)
stable cell##13##2##(1997-4#1)(2008-1#1)(2008-11#3)(2008-2#5)(2008-7#1)(2008-8#1)(2009-6#1)
stable chelating resin was##2##4##(2008-10#2)
stable chelating resin##3##3##(2008-10#3)
stable chronic##2##2##(1997-1#1)(2012-3#1)
stable coating##2##2##(2008-10#1)(2008-3#1)
stable complex with##3##3##(2008-10#2)(2008-8#1)
stable complex##8##2##(1990-12#1)(1992-3#1)(1994-8#1)(2008-10#4)(2008-8#1)
stable complexes with##8##3##(1994-8#1)(1995-5#1)(2008-10#5)(2010-11#1)
stable conditions##2##2##(1997-8#1)(2008-11#1)
stable coronary##2##2##(2008-5#1)(2008-7#1)
stable cyclic##2##2##(1994-2#1)(2008-10#1)
stable cylindrical##2##2##(2008-3#2)
stable dimeric##2##2##(1993-11#1)(2008-10#1)
stable dioxin-responsive cell line##2##4##(2008-11#2)
stable disease and the##2##4##(2008-10#1)(2008-6#1)
stable disease and##5##3##(1991-6#1)(1992-12#1)(2008-10#1)(2008-6#2)
stable disease in##2##3##(1992-12#1)(2008-6#1)
stable disease##19##2##(1990-2#3)(1991-6#1)(1991-8#1)(1992-12#3)(1993-8#1)(1994-8#1)(2008-10#1)(2008-6#7)(2011-2#1)
stable diseases##2##2##(1991-2#1)(1992-8#1)
stable drug##2##2##(1992-8#1)(2013-1#1)
stable duplexes with##2##3##(1991-8#1)(2008-4#1)
stable during the##2##3##(2008-12#1)(2011-2#1)
stable during##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
stable enough to be##2##4##(2008-10#1)(2013-8#1)
stable enough to##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
stable environment##5##2##(1997-7#1)(2008-4#2)(2011-2#1)(2013-7#1)
stable enzyme##3##2##(1992-3#1)(1994-11#1)(2008-10#1)
stable equilibria##5##2##(1995-3#1)(2008-8#4)
stable equilibrium##6##2##(2008-8#4)(2008-9#1)(2012-2#1)
stable even##3##2##(2008-10#1)(2009-4#1)(2013-8#1)
stable expression of##4##3##(1997-4#1)(2008-11#3)
stable expression##5##2##(1992-9#1)(1997-4#1)(2008-11#3)
stable fixation of##2##3##(2007-11#1)(2012-2#1)
stable fixation##3##2##(2007-11#1)(2010-3#1)(2012-2#1)
stable flow##3##2##(2008-10#3)
stable fly##5##2##(2011-2#5)
stable folding##3##2##(1990-7#1)(1992-6#1)(1997-6#1)
stable for 24 h##4##4##(2008-10#3)(2008-7#1)
stable for 3##3##3##(2008-10#2)(2010-4#1)
stable for at least 2##2##5##(2008-10#2)
stable for at least 24h##2##5##(2008-10#2)
stable for at least one##2##5##(1993-8#1)(2008-7#1)
stable for at least two months##2##6##(2008-10#1)(2008-6#1)
stable for at least##11##4##(1993-8#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#1)
stable for more than 2##2##5##(2008-10#1)(2008-11#1)
stable for more than##6##4##(2008-10#5)(2008-11#1)
stable for one##2##3##(1993-2#1)(1997-6#1)
stable for over##2##3##(1993-9#1)(2008-10#1)
stable for several##2##3##(1997-8#1)(2007-11#1)
stable for##54##2##(1992-9#1)(1993-2#2)(1993-8#1)(1993-9#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#28)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
stable form of##2##3##(1996-7#1)(2008-7#1)
stable form##4##2##(1994-11#1)(1996-7#1)(2007-12#1)(2008-7#1)
stable free##2##2##(1992-12#2)
stable geometric isomers of carotenoids is needed to understand if a relationship between stereochemistry and biological function exists##2##18##(2010-2#2)
stable host##2##2##(2008-8#1)(2010-4#1)
stable in common##2##3##(1994-3#1)(2008-10#1)
stable in the presence of##2##5##(2008-10#2)
stable in the##8##3##(1992-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2013-8#1)
stable in their##2##3##(1991-2#1)(1995-2#1)
stable in##32##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#2)(1993-12#1)(1994-3#1)(1995-2#2)(1995-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#3)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
stable inclusion complex##2##3##(2007-11#1)(2008-10#1)
stable integration of##3##3##(1995-5#1)(2006-12#1)(2008-11#1)
stable intermediate##2##2##(1995-5#1)(2008-10#1)
stable intramedullary##3##2##(2009-3#1)(2011-2#2)
stable isotope##8##2##(1990-5#1)(1991-5#1)(2008-6#2)(2008-8#1)(2010-8#1)(2012-3#2)
stable karyotype##2##2##(1996-2#1)(2008-12#1)
stable level##2##2##(1992-11#1)(2008-11#1)
stable lines##3##2##(1995-6#1)(2008-2#1)(2011-2#1)
stable local##2##2##(2007-5#1)(2008-10#1)
stable mammalian cell lines##2##4##(2008-11#1)(2012-2#1)
stable measurements##2##2##(2008-10#1)(2008-3#1)
stable metabolite of##2##3##(1991-5#1)(2008-10#1)
stable on##3##2##(2008-10#2)(2008-2#1)
stable ones##3##2##(1997-7#1)(2009-5#1)(2013-8#1)
stable only if##2##3##(2008-8#2)
stable only##3##2##(1997-4#1)(2008-8#2)
stable operation##5##2##(2007-11#2)(2008-3#2)(2008-6#1)
stable optical##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
stable or##4##2##(1994-8#1)(1995-12#1)(2012-4#1)(2013-8#1)
stable organic##2##2##(2008-10#2)
stable over a 2-week period##2##5##(2007-12#1)(2009-11#1)
stable over a wide pH range##2##6##(2008-10#2)
stable over a wide##4##4##(2007-12#1)(2008-10#2)(2008-8#1)
stable over a##8##3##(2007-12#3)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)
stable over the##3##3##(1996-2#1)(2008-10#1)(2013-1#1)
stable over##17##2##(1996-2#1)(1997-2#1)(2007-12#3)(2008-10#7)(2008-11#2)(2008-8#1)(2009-11#1)(2013-1#1)
stable patients##6##2##(2007-8#2)(2008-10#1)(2011-2#2)(2013-8#1)
stable phase##3##2##(2008-6#1)(2012-2#2)
stable population##5##2##(2008-11#1)(2008-9#4)
stable protein##2##2##(1993-6#1)(2009-8#1)
stable region##2##2##(1993-11#1)(2008-8#1)
stable renal##4##2##(2008-1#3)(2013-1#1)
stable resonator##3##2##(2008-2#1)(2008-3#2)
stable resonators##2##2##(2007-11#1)(2008-3#1)
stable response##4##2##(2008-10#4)
stable secondary##2##2##(2008-10#1)(2011-2#1)
stable simple##2##2##(2008-5#2)
stable single##2##2##(2007-12#1)(2012-2#1)
stable species with##2##3##(2008-10#2)
stable state##2##2##(2007-7#1)(2008-9#1)
stable structure##2##2##(1992-4#1)(2008-3#1)
stable than##17##2##(1992-11#1)(1994-11#1)(1994-6#2)(1995-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)
stable through##2##2##(2008-10#1)(2008-11#1)
stable throughout the##4##3##(1994-6#1)(2008-8#1)(2009-8#1)(2012-1#1)
stable to hydrolysis##2##3##(1991-5#1)(2008-5#1)
stable to within##2##3##(2008-2#1)(2011-1#1)
stable to##13##2##(1991-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#2)
stable toward##2##2##(1995-5#1)(2008-10#1)
stable towards##3##2##(2006-12#2)(2008-5#1)
stable transfectants##4##2##(1994-3#1)(2008-11#2)(2008-2#1)
stable transfection of##2##3##(1992-7#1)(1997-1#1)
stable transfection##4##2##(1992-7#1)(1997-1#1)(2008-11#1)(2008-2#1)
stable transformants##4##2##(1993-12#1)(1997-8#1)(2008-1#1)(2008-10#1)
stable transformation##5##2##(2008-1#2)(2008-2#2)(2012-2#1)
stable transgenic##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
stable under##5##2##(1995-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-9#1)
stable up to##3##3##(1992-8#1)(2008-10#1)(2010-8#1)
stable value##2##2##(2007-11#1)(2008-5#1)
stable when##3##2##(1997-1#1)(2008-9#1)(2010-2#1)
stable with respect to##3##4##(1996-2#2)(2008-3#1)
stable with##11##2##(1992-12#1)(1993-12#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)
stable within##3##2##(2008-2#1)(2008-8#1)(2009-1#1)
stable##1054##1##(1990-11#3)(1990-12#4)(1990-2#6)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#5)(1991-2#6)(1991-5#6)(1991-6#1)(1991-8#4)(1992-11#2)(1992-12#10)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#7)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#4)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#9)(1994-9#3)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#14)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#10)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#4)(2006-12#3)(2007-10#1)(2007-11#41)(2007-12#33)(2007-5#5)(2007-7#3)(2007-8#11)(2008-1#18)(2008-10#223)(2008-11#52)(2008-12#5)(2008-2#42)(2008-3#38)(2008-4#26)(2008-5#34)(2008-6#18)(2008-7#26)(2008-8#45)(2008-9#32)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#7)(2011-1#8)(2011-2#26)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#22)(2012-3#15)(2012-4#3)(2012-9#1)(2013-1#25)(2013-7#2)(2013-8#14)
stables##3##1##(2008-6#1)(2010-4#2)
stably and##3##2##(1994-3#1)(2008-11#1)(2008-8#1)
stably coexist##3##2##(2008-8#3)
stably express##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
stably expressed in##3##3##(1990-12#1)(1994-12#1)(2008-4#1)
stably expressed##7##2##(1990-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(2008-11#2)(2008-4#1)
stably expressing the##2##3##(1995-11#1)(2008-8#1)
stably expressing##7##2##(1992-8#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
stably in##2##2##(1993-9#1)(2008-9#1)
stably integrated##2##2##(2008-2#1)(2008-9#1)
stably maintained in##2##3##(1993-9#1)(1994-3#1)
stably maintained##5##2##(1993-9#1)(1994-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
stably transfected by##2##3##(2008-9#2)
stably transfected cell lines##3##4##(1994-2#1)(2008-2#2)
stably transfected into##2##3##(2008-4#1)(2008-8#1)
stably transfected with the##2##4##(2008-11#1)(2013-1#1)
stably transfected with##6##3##(1992-9#2)(2008-11#2)(2012-3#1)(2013-1#1)
stably transfected##19##2##(1992-9#2)(1994-2#1)(1995-2#1)(1997-7#1)(2008-11#5)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-3#1)(2013-1#1)
stably transformed with##2##3##(1993-2#1)(2008-10#1)
stably transformed##4##2##(1993-2#2)(2008-10#1)(2008-11#1)
stably##87##1##(1990-12#1)(1992-8#1)(1992-9#3)(1993-2#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-11#1)(1995-2#1)(1996-5#2)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#13)(2008-2#7)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#9)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
stachyose##7##1##(2008-10#6)(2010-2#1)
stack and##2##2##(2007-12#1)(2012-2#1)
stack as a##2##3##(2007-12#1)(2008-3#1)
stack of##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
stack structure##2##2##(1996-2#1)(2007-12#1)
stack with##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
stack##34##1##(1993-1#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#14)(2008-4#1)(2008-7#1)(2012-2#3)
stacked around##2##2##(2008-7#2)
stacked stems##2##2##(2008-10#2)
stacked##26##1##(1991-5#1)(1993-8#1)(1994-5#1)(2007-11#2)(2008-10#6)(2008-2#3)(2008-3#6)(2008-4#2)(2008-7#4)
stacking action##2##2##(2008-10#2)
stacking in##2##2##(1991-5#1)(1993-8#1)
stacking interactions##2##2##(2008-8#1)(2009-6#1)
stacking is##3##2##(1993-11#1)(2008-10#1)(2008-3#1)
stacking of##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
stacking procedure##2##2##(1994-12#2)
stacking##41##1##(1991-5#4)(1993-11#4)(1993-8#2)(1994-12#2)(1996-5#2)(2007-11#1)(2008-10#12)(2008-2#2)(2008-3#3)(2008-8#3)(2009-11#1)(2009-12#1)(2009-6#3)(2009-7#1)
stacks by##2##2##(2008-3#2)
stacks of##6##2##(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)
stacks##21##1##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#11)(2008-5#1)(2008-7#3)(2009-10#1)(2009-8#1)
stackup effects in free-space optical interconnects##2##6##(2008-3#2)
stadium##4##1##(1992-8#1)(2007-12#2)(2011-3#1)
staff about the##2##3##(1991-12#1)(2008-11#1)
staff about##3##2##(1991-12#1)(1995-12#1)(2008-11#1)
staff and hospital##3##3##(1991-12#1)(1993-2#1)(1994-1#1)
staff and managers##2##3##(1994-3#1)(1996-3#1)
staff and may##2##3##(2008-12#1)(2013-1#1)
staff and others##2##3##(1991-3#1)(2007-12#1)
staff and patients##3##3##(1992-3#1)(1993-2#1)(2011-2#1)
staff and students##2##3##(2008-12#2)
staff and the##5##3##(1992-12#1)(1996-2#1)(1997-3#1)(2008-11#2)
staff and to##2##3##(1991-2#1)(2007-2#1)
staff and##61##2##(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#2)(1993-2#2)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#3)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#4)(1997-1#1)(1997-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-12#6)(2008-6#1)(2009-3#1)(2010-10#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#2)
staff appointment and##2##3##(1991-12#1)(1994-3#1)
staff are##7##2##(1993-2#1)(1995-3#1)(1996-12#2)(1997-5#1)(2009-3#1)(2012-12#1)
staff as##4##2##(1991-3#1)(1994-3#1)(2007-10#1)(2012-1#1)
staff at all##2##3##(2008-11#1)(2010-3#1)
staff at##8##2##(1992-2#1)(1993-12#2)(1995-8#1)(2008-11#2)(2008-4#1)(2010-3#1)
staff awareness##2##2##(2013-8#2)
staff by##3##2##(1994-3#1)(2008-7#1)(2010-12#1)
staff bylaws##4##2##(1991-2#3)(1991-3#1)
staff can##5##2##(1991-12#1)(1992-2#1)(1994-2#1)(2008-6#1)(2011-2#1)
staff credentialing and##2##3##(1992-2#1)(1993-1#1)
staff credentialing##7##2##(1992-2#1)(1993-1#1)(1993-12#3)(1994-3#1)(1997-2#1)
staff development##10##2##(1993-12#2)(1994-1#3)(1996-2#1)(2008-11#2)(2008-9#1)(2010-9#1)
staff education##4##2##(1994-2#1)(1997-1#1)(2010-9#1)(2011-2#1)
staff for##6##2##(1991-11#1)(1993-3#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-11#1)
staff from the##2##3##(1995-3#1)(2007-5#1)
staff from##6##2##(1994-1#1)(1995-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2010-4#1)
staff had##3##2##(2008-11#2)(2010-10#1)
staff has##2##2##(1995-1#1)(2010-11#1)
staff hours per##2##3##(2007-8#2)
staff in a##2##3##(2008-11#1)(2010-10#1)
staff in the##8##3##(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-1#1)
staff in##30##2##(1991-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-5#1)(2007-2#1)(2008-11#4)(2008-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
staff incentive program##2##3##(1992-3#2)
staff involved in##2##3##(1992-3#1)(2012-2#1)
staff is##7##2##(1991-1#1)(1991-2#1)(1994-1#1)(1994-2#2)(2008-11#1)(2008-12#1)
staff may be##3##3##(1991-12#1)(1995-2#1)(2007-8#1)
staff may##4##2##(1991-12#1)(1995-2#1)(2007-8#1)(2012-3#1)
staff members can##2##3##(1996-1#1)(2008-9#1)
staff members in##2##3##(1995-1#1)(2010-10#1)
staff members regarding the##2##4##(1991-12#1)(1994-12#1)
staff members who##3##3##(1995-1#1)(1995-3#1)(2010-11#1)
staff members##19##2##(1991-12#1)(1991-5#1)(1993-1#2)(1994-12#1)(1995-1#2)(1995-3#2)(1996-1#1)(2008-9#2)(2010-10#3)(2010-11#1)(2012-12#1)(2013-1#2)
staff members'##6##2##(2008-11#1)(2010-10#5)
staff membership##2##2##(1992-2#2)
staff morale##3##2##(1993-2#1)(1997-3#2)
staff must##2##2##(1991-12#1)(1992-2#1)
staff need##2##2##(1997-5#1)(2011-2#1)
staff needs##3##2##(1995-3#1)(2012-3#1)(2013-1#1)
staff numbers##2##2##(2008-12#1)(2012-12#1)
staff nurse##3##2##(2010-11#1)(2013-8#2)
staff of the##4##3##(1991-12#1)(1995-1#1)(1996-1#1)(2010-4#1)
staff of##5##2##(1991-12#1)(1991-2#1)(1995-1#1)(1996-1#1)(2010-4#1)
staff on##2##2##(1996-12#1)(2008-12#1)
staff or##2##2##(1993-1#1)(1997-2#1)
staff participation##2##2##(1993-1#1)(2008-10#1)
staff privileges##6##2##(1991-12#1)(1992-12#1)(1993-1#2)(1993-3#1)(1994-1#1)
staff reductions##2##2##(1993-1#1)(1996-12#1)
staff regarding##3##2##(2007-11#1)(2010-10#1)(2012-3#1)
staff relationship##2##2##(1994-1#1)(1994-2#1)
staff resources##2##2##(1995-1#1)(2008-4#1)
staff responsibilities in##2##3##(1991-12#1)(1992-2#1)
staff scheduling##4##2##(1994-2#4)
staff support##4##2##(1991-12#1)(2008-11#1)(2008-9#1)(2010-2#1)
staff throughout##2##2##(1994-12#1)(1997-3#1)
staff time##5##2##(1992-12#1)(1992-2#1)(1995-3#2)(2013-8#1)
staff to##11##2##(1992-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)
staff training and##2##3##(2008-12#1)(2008-6#1)
staff training##5##2##(1991-12#1)(2007-9#1)(2008-12#1)(2008-6#1)(2010-8#1)
staff use##2##2##(1993-12#1)(2010-10#1)
staff utilization##3##2##(1994-1#1)(1994-2#1)(1994-3#1)
staff was##4##2##(1995-2#1)(2008-8#1)(2013-1#2)
staff were##4##2##(1994-12#1)(2008-12#1)(2010-10#1)(2012-12#1)
staff while##2##2##(1995-3#2)
staff who##7##2##(2008-1#1)(2008-11#4)(2010-8#1)(2013-8#1)
staff will##2##2##(1994-1#1)(2008-11#1)
staff with the##2##3##(2010-3#1)(2013-8#1)
staff with##5##2##(1991-12#1)(1992-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
staff within##2##2##(1995-2#1)(2012-12#1)
staff##552##1##(1990-3#1)(1991-1#5)(1991-11#1)(1991-12#20)(1991-2#10)(1991-3#5)(1991-5#1)(1991-9#2)(1992-1#6)(1992-11#1)(1992-12#6)(1992-2#16)(1992-3#8)(1993-1#18)(1993-12#13)(1993-2#7)(1993-3#7)(1994-1#21)(1994-12#8)(1994-2#21)(1994-3#14)(1994-6#2)(1995-1#7)(1995-12#3)(1995-2#10)(1995-3#19)(1995-8#1)(1995-9#1)(1996-1#13)(1996-12#8)(1996-2#8)(1996-3#11)(1996-6#1)(1996-7#1)(1997-1#6)(1997-2#7)(1997-3#7)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-5#2)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#6)(2007-5#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#37)(2008-12#21)(2008-4#2)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#7)(2009-11#1)(2009-3#3)(2009-7#1)(2010-10#19)(2010-11#6)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#6)(2010-9#3)(2011-1#10)(2011-2#12)(2012-1#4)(2012-12#11)(2012-2#2)(2012-3#6)(2013-1#13)(2013-8#20)
staff's##4##1##(1993-12#1)(1993-2#1)(1993-3#1)(2010-10#1)
staff)##4##1##(1990-3#1)(2008-1#1)(2013-1#2)
staff- and group-model HMOs##2##4##(1994-1#2)
staff-led behavioral management##2##3##(2008-3#2)
staff?##3##1##(1991-3#1)(1994-12#1)(2011-2#1)
staff]##3##1##(1991-6#1)(1994-3#1)(1994-5#1)
staffed by##4##2##(1997-8#1)(2008-3#1)(2010-10#1)(2012-12#1)
staffing and scheduling##2##3##(2012-3#2)
staffing and##9##2##(1993-12#1)(1994-12#1)(1996-1#2)(1996-11#1)(1997-2#1)(2012-3#2)(2013-8#1)
staffing in##2##2##(1990-3#1)(1994-3#1)
staffing levels in##2##3##(2008-11#1)(2008-7#1)
staffing levels##4##2##(1996-1#1)(2008-11#1)(2008-7#1)(2012-2#1)
staffing patterns##5##2##(1991-12#1)(1993-1#3)(1996-3#1)
staffing practices##2##2##(2012-3#2)
staffing##48##1##(1990-2#1)(1990-3#1)(1991-1#3)(1991-12#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(2008-11#5)(2008-7#1)(2009-6#1)(2012-2#2)(2012-3#6)(2013-8#4)
staffs##16##1##(1991-12#1)(1991-2#3)(1992-1#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1997-2#1)
stage (P##2##2##(2009-11#1)(2013-1#1)
stage (lesions in the mucosa##2##5##(2013-1#2)
stage (lesions##3##2##(2013-1#3)
stage (n =##2##3##(1990-5#2)
stage (p = 0##3##4##(2008-12#1)(2011-2#2)
stage (p##4##2##(2006-10#1)(2008-12#1)(2011-2#2)
stage 1##2##2##(2008-6#2)
stage 2##6##2##(1991-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
stage 3##6##2##(1991-4#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
stage 4 of disease was##2##5##(2011-2#2)
stage 4##8##2##(1991-4#1)(1995-2#1)(1995-8#1)(2011-2#5)
stage 5##4##2##(1996-12#1)(2008-10#1)(2010-4#1)(2012-3#1)
stage 6 oocytes##3##3##(1995-2#3)
stage B##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
stage C and##2##3##(1992-8#1)(2006-8#1)
stage D##2##2##(1992-8#1)(2006-8#1)
stage I NSCLC##2##3##(2007-8#2)
stage I and##6##3##(1995-12#1)(2011-2#2)(2012-3#1)(2013-8#2)
stage I endometrial##2##3##(1993-12#1)(2013-1#1)
stage I lung cancer##2##4##(1990-2#2)
stage I was##2##3##(2007-8#2)
stage I##35##2##(1990-10#1)(1990-2#3)(1990-6#1)(1990-9#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-2#2)(2007-8#10)(2008-10#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
stage I-II##3##2##(2007-8#1)(2009-12#2)
stage II and##2##3##(1994-7#1)(2011-2#1)
stage II included tumors##2##4##(2007-8#2)
stage II or IIIa patients##2##5##(1993-11#2)
stage II##25##2##(1990-6#1)(1990-9#1)(1991-4#1)(1992-2#1)(1993-11#2)(1994-7#1)(1997-7#2)(2006-10#3)(2007-8#6)(2008-7#1)(2009-10#3)(2011-2#1)(2013-8#2)
stage III NSCLC##2##3##(2008-10#1)(2012-3#1)
stage III and above##2##4##(2011-2#2)
stage III and##4##3##(1990-6#1)(1997-3#1)(2011-2#2)
stage III non small cell lung cancer##2##7##(1993-2#1)(2008-10#1)
stage III##27##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-4#1)(1991-8#2)(1992-9#1)(1993-2#1)(1994-8#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#2)(2011-2#3)(2012-3#1)
stage III-IV##2##2##(1990-6#2)
stage IIIA-IIIB non-small-cell lung cancer##2##5##(1992-12#2)
stage IIIC##6##2##(1995-12#1)(2011-2#5)
stage IIa##2##2##(2008-8#2)
stage IIb##2##2##(2008-8#2)
stage IV and##3##3##(1991-8#1)(2008-1#1)(2011-2#1)
stage IV ovarian carcinoma treated with##2##6##(1990-6#2)
stage IV ovarian##3##3##(1990-6#3)
stage IV##19##2##(1990-6#4)(1990-9#1)(1991-11#1)(1991-8#1)(1995-12#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-2#1)
stage Ia##2##2##(1991-2#1)(2007-8#1)
stage T1 urothelial carcinoma of the bladder##2##7##(2013-1#2)
stage T1##4##2##(1990-2#1)(2013-1#3)
stage V##4##2##(2011-1#2)(2012-2#2)
stage according to##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
stage and a##4##3##(1992-3#1)(2008-10#1)(2008-12#2)
stage and may##2##3##(1997-6#1)(2008-11#1)
stage and the expression##2##4##(1997-8#1)(2008-5#1)
stage and the##7##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)
stage and##60##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
stage are##5##2##(1995-1#1)(2008-3#1)(2008-8#2)(2012-3#1)
stage at diagnosis##4##3##(1990-12#3)(2012-3#1)
stage at presentation##2##3##(2008-6#1)(2013-1#1)
stage at which the##2##4##(1997-3#1)(2008-10#1)
stage at which##4##3##(1997-3#1)(2008-10#3)
stage at##15##2##(1990-12#3)(1997-3#1)(2008-10#6)(2008-6#1)(2010-8#1)(2012-3#1)(2013-1#2)
stage between##2##2##(2008-5#1)(2009-10#1)
stage breast cancer##3##3##(1994-8#1)(1995-9#1)(2008-4#1)
stage breast##4##2##(1994-8#1)(1995-9#1)(2007-10#1)(2008-4#1)
stage but was##2##3##(1991-8#1)(1994-3#1)
stage but##3##2##(1991-8#1)(1994-3#1)(2010-8#1)
stage by##4##2##(2007-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
stage c)##2##2##(2008-7#2)
stage can##2##2##(2007-5#1)(2012-1#1)
stage chronic renal failure##2##4##(1991-11#1)(2008-1#1)
stage chronic renal##3##3##(1991-11#1)(2008-1#1)(2008-10#1)
stage distribution##3##2##(1994-8#1)(2012-12#1)(2013-1#1)
stage due to##2##3##(2008-10#1)(2009-5#1)
stage embryos##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
stage following##2##2##(2008-10#1)(2013-1#1)
stage for the##6##3##(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
stage for##16##2##(1990-9#1)(1996-2#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
stage from##3##2##(2008-10#1)(2013-7#2)
stage grouping##2##2##(2011-2#2)
stage has##2##2##(1991-8#1)(1997-7#1)
stage in the##10##3##(2007-11#2)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#2)
stage in##26##2##(1990-8#1)(1990-9#1)(1991-9#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#3)
stage involves##3##2##(2012-12#2)(2012-3#1)
stage is a##2##3##(1992-1#1)(2011-2#1)
stage is##11##2##(1992-1#1)(2007-8#1)(2008-10#4)(2008-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
stage larvae##2##2##(2007-5#1)(2008-8#1)
stage malaria parasites##2##3##(2012-2#2)
stage of DR##2##3##(2008-1#1)(2010-8#1)
stage of P##2##3##(2010-4#1)(2011-2#1)
stage of a##3##3##(2008-10#2)(2008-2#1)
stage of advanced CHF##2##4##(2009-10#2)
stage of an##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
stage of change##2##3##(2008-11#1)(2013-1#1)
stage of development of##2##4##(1996-8#1)(2008-10#1)
stage of development##15##3##(1991-1#1)(1996-2#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#1)
stage of disease and##2##4##(1993-11#1)(1995-5#1)
stage of disease##6##3##(1990-12#1)(1993-11#1)(1995-5#1)(2011-2#2)(2013-1#1)
stage of evolution##3##3##(1996-1#1)(2008-1#1)(2008-5#1)
stage of exercise##2##3##(2008-10#1)(2013-1#1)
stage of flower##2##3##(1997-8#1)(2008-8#1)
stage of fruit development##2##4##(2008-10#1)(2008-9#1)
stage of illness##2##3##(1995-5#1)(2009-6#1)
stage of infection##5##3##(1997-6#1)(2008-10#2)(2008-5#2)
stage of kernel development##2##4##(2008-10#2)
stage of lag##2##3##(2011-2#2)
stage of life##4##3##(1992-5#1)(1993-12#1)(2010-1#2)
stage of organ##2##3##(2008-7#1)(2008-9#1)
stage of severe##2##3##(2013-1#1)(2013-8#1)
stage of the disease and##2##5##(1991-6#1)(1995-9#1)
stage of the disease##14##4##(1990-6#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-2#1)(1995-2#1)(1995-8#1)(1995-9#1)(2008-10#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
stage of the illness##2##4##(2007-11#1)(2012-3#1)
stage of the luteal phase##2##5##(1990-8#1)(1994-9#1)
stage of the program##2##4##(1991-12#2)
stage of the##61##3##(1990-6#1)(1990-8#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1994-9#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-3#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
stage of their##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
stage of this##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
stage of treatment##2##3##(2012-3#2)
stage of weaning##2##3##(2013-1#2)
stage of##249##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#3)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#9)(2008-12#6)(2008-2#4)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#6)(2008-9#12)(2009-10#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#5)(2012-8#1)(2013-1#16)(2013-8#7)
stage or the##2##3##(2008-10#1)(2008-5#1)
stage or##5##2##(1991-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
stage ranged from##2##3##(2008-10#1)(2011-2#1)
stage renal disease (ESRD)##12##4##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#1)(2007-7#3)(2008-1#1)(2008-4#1)(2012-2#1)
stage renal disease and##3##4##(2010-11#1)(2011-2#1)(2013-1#1)
stage renal disease in##2##4##(2008-1#1)(2010-4#1)
stage renal disease patients##2##4##(2008-1#1)(2010-7#1)
stage renal disease##26##3##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(2007-7#4)(2008-1#4)(2008-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
stage renal failure##4##3##(1997-8#2)(2008-1#2)
stage renal##30##2##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(1997-8#2)(2007-7#4)(2008-1#6)(2008-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
stage significantly##3##2##(1994-11#1)(2008-10#1)(2012-1#1)
stage specific embryonic##2##3##(2008-11#2)
stage specific##5##2##(1992-3#1)(2008-11#2)(2008-9#1)(2009-10#1)
stage structure##4##2##(2008-8#4)
stage than##3##2##(1994-7#1)(1997-2#1)(2008-4#1)
stage that##3##2##(2007-12#1)(2011-3#1)(2012-1#1)
stage the##6##2##(1990-3#1)(1995-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-6#1)
stage through##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
stage to##13##2##(1992-6#1)(1994-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#2)(2009-11#1)(2011-2#1)
stage tumours##2##2##(2011-2#2)
stage using a##2##3##(1993-9#1)(2011-2#1)
stage using##3##2##(1993-9#1)(2008-12#1)(2011-2#1)
stage was##18##2##(1991-8#1)(1994-11#1)(1996-9#1)(2008-10#7)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
stage were##5##2##(1990-12#1)(1990-3#1)(1991-12#1)(2008-1#1)(2008-10#1)
stage when the##2##3##(2008-11#1)(2008-6#1)
stage when##5##2##(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)
stage with##2##2##(1997-3#1)(2008-3#1)
stage##1130##1##(1990-10#2)(1990-11#2)(1990-12#10)(1990-2#4)(1990-3#6)(1990-5#6)(1990-6#10)(1990-8#3)(1990-9#11)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#3)(1991-4#5)(1991-5#1)(1991-6#3)(1991-8#13)(1991-9#3)(1992-1#1)(1992-12#6)(1992-2#4)(1992-3#3)(1992-5#3)(1992-6#5)(1992-8#4)(1992-9#4)(1993-1#3)(1993-11#7)(1993-12#7)(1993-2#5)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#4)(1994-7#3)(1994-8#5)(1994-9#6)(1995-1#5)(1995-12#8)(1995-2#9)(1995-3#2)(1995-4#4)(1995-5#6)(1995-6#2)(1995-8#3)(1995-9#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#7)(1996-5#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#6)(1997-7#8)(1997-8#6)(2006-10#4)(2006-6#1)(2006-8#5)(2007-10#3)(2007-11#8)(2007-12#17)(2007-5#4)(2007-7#5)(2007-8#31)(2007-9#1)(2008-1#20)(2008-10#181)(2008-11#32)(2008-12#31)(2008-2#16)(2008-3#5)(2008-4#12)(2008-5#27)(2008-6#24)(2008-7#32)(2008-8#45)(2008-9#26)(2009-10#8)(2009-11#2)(2009-12#6)(2009-3#2)(2009-5#8)(2009-6#4)(2009-7#4)(2009-8#4)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#10)(2010-9#3)(2011-1#6)(2011-2#82)(2011-3#1)(2012-1#6)(2012-12#9)(2012-2#22)(2012-3#27)(2012-8#1)(2013-1#58)(2013-7#5)(2013-8#20)
stage) and##3##2##(1992-12#1)(2008-10#2)
stage)##12##1##(1990-6#1)(1991-6#1)(1992-12#1)(2008-10#6)(2008-6#1)(2010-2#1)(2011-2#1)
stage-IV disease in##4##3##(2012-12#4)
stage-dependent##3##1##(1990-12#1)(2012-2#2)
stage-related##3##1##(1992-3#1)(2008-8#1)(2008-9#1)
stage-specific manner##2##2##(1995-12#1)(2008-8#1)
stage-specific##8##1##(1995-12#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2012-2#1)
stage-structured populations##2##2##(2012-2#2)
stage-structured##4##1##(2008-8#2)(2012-2#2)
stage]##2##1##(2008-1#1)(2013-1#1)
staged 4##2##2##(1995-8#2)
staged according to##3##3##(1990-8#1)(2008-6#1)(2012-3#1)
staged and##2##2##(2006-8#1)(2008-7#1)
staged approach##2##2##(2009-5#1)(2010-11#1)
staged based on the##2##4##(2007-12#1)(2011-2#1)
staged operation##2##2##(2008-10#1)(2008-7#1)
staged operations##2##2##(2008-7#2)
staged surgery##3##2##(2008-7#3)
staged therapy##2##2##(2012-3#2)
staged with##2##2##(1992-6#1)(2012-2#1)
staged##44##1##(1990-8#1)(1992-6#1)(1993-12#1)(1995-8#2)(1996-3#1)(1997-3#3)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-6#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
stages 2##2##2##(2008-10#1)(2008-11#1)
stages I and II##2##4##(1993-9#1)(2007-8#1)
stages I and##4##3##(1990-8#1)(1993-9#1)(2007-8#1)(2008-1#1)
stages I##7##2##(1990-8#1)(1993-9#1)(1997-4#1)(2007-8#1)(2008-1#2)(2008-5#1)
stages III##2##2##(2008-5#1)(2011-2#1)
stages and in##2##3##(1993-6#1)(1997-7#1)
stages and the##4##3##(2008-10#3)(2008-4#1)
stages and##31##2##(1993-6#1)(1994-8#1)(1995-1#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
stages are##6##2##(1995-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2012-12#1)
stages as##3##2##(2007-11#1)(2008-10#1)(2010-8#1)
stages based on##2##3##(2008-6#1)(2010-8#1)
stages by##3##2##(1993-6#1)(2010-8#1)(2011-2#1)
stages can be##2##3##(2008-11#1)(2008-4#1)
stages can##3##2##(2008-11#1)(2008-4#1)(2011-3#1)
stages during##5##2##(1994-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
stages for##3##2##(1993-6#1)(2008-4#1)(2010-8#1)
stages from##2##2##(2008-10#2)
stages in the development of##3##5##(1996-5#1)(2007-11#1)(2010-8#1)
stages in the life cycles of these pathogens##2##8##(2008-10#2)
stages in the##12##3##(1991-2#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
stages in##19##2##(1991-2#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2011-2#2)
stages increased##2##2##(2008-10#1)(2008-9#1)
stages of Alzheimer's##2##3##(1992-12#2)
stages of BPD##2##3##(2009-8#2)
stages of Plasmodium##2##3##(2010-12#1)(2010-2#1)
stages of adult##2##3##(2007-12#1)(2012-3#1)
stages of biofilm formation##3##4##(2008-9#1)(2013-8#2)
stages of both##2##3##(2008-10#1)(2008-9#1)
stages of cell death##2##4##(2008-11#1)(2008-9#1)
stages of cell division##2##4##(1997-4#1)(2012-12#1)
stages of cell##5##3##(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
stages of change##2##3##(2008-12#1)(2008-4#1)
stages of colonization##2##3##(2008-10#1)(2008-8#1)
stages of data##3##3##(1994-2#1)(2008-4#1)(2008-7#1)
stages of development ranging from##2##5##(1991-7#1)(2008-10#1)
stages of development##21##3##(1990-5#1)(1991-7#1)(1993-2#1)(1994-12#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
stages of diabetic##2##3##(1997-8#2)
stages of disease development##2##4##(2008-10#2)
stages of disease##3##3##(2008-10#2)(2012-12#1)
stages of embryonic development##4##4##(2007-12#2)(2008-11#1)(2012-3#1)
stages of embryos##2##3##(1992-12#1)(1997-8#1)
stages of epidemics##2##3##(2008-10#2)
stages of follicular atresia##2##4##(2008-7#2)
stages of germ##3##3##(2008-7#1)(2009-10#1)(2009-3#1)
stages of growth##4##3##(1990-7#1)(2008-1#1)(2008-10#1)(2010-7#1)
stages of human##2##3##(1997-8#1)(2010-8#1)
stages of implementation##2##3##(1995-3#2)
stages of infection##7##3##(2008-10#4)(2008-2#1)(2010-6#1)(2011-10#1)
stages of lag##2##3##(2011-2#2)
stages of life##4##3##(1997-7#1)(2008-10#1)(2009-5#1)(2013-1#1)
stages of mammalian##2##3##(2008-10#1)(2008-9#1)
stages of ovarian cancer##2##4##(2011-2#2)
stages of physical activity##3##4##(2013-1#3)
stages of plant development##4##4##(2008-10#4)
stages of pregnancy##3##3##(1995-12#1)(2008-9#1)(2009-3#1)
stages of rehabilitation##2##3##(2007-11#1)(2007-8#1)
stages of reward##2##3##(2013-8#2)
stages of sexual##2##3##(2008-5#2)
stages of the disease were studied##2##6##(2008-5#1)(2008-7#1)
stages of the disease##7##4##(1990-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
stages of the life cycle##2##5##(1995-2#1)(2008-12#1)
stages of the parasite##2##4##(1997-6#1)(2010-2#1)
stages of the process##3##4##(2007-7#1)(2008-10#1)(2008-2#1)
stages of the##55##3##(1990-11#1)(1990-12#1)(1990-8#1)(1992-6#2)(1993-9#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-2#1)(2011-2#2)(2011-3#3)(2012-2#1)(2013-1#1)
stages of their##3##3##(2008-5#1)(2009-10#1)(2009-8#1)
stages of treatment##3##3##(1995-2#1)(1997-4#1)(2012-3#1)
stages of tumor##3##3##(1993-8#1)(2009-6#1)(2012-2#1)
stages of##333##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-6#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-6#5)(1997-7#1)(1997-8#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#12)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#53)(2008-11#4)(2008-12#13)(2008-2#7)(2008-3#4)(2008-4#9)(2008-5#11)(2008-6#2)(2008-7#15)(2008-8#7)(2008-9#8)(2009-10#5)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#2)(2009-8#7)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#16)(2011-3#3)(2012-12#4)(2012-2#9)(2012-3#7)(2012-7#1)(2013-1#16)(2013-8#5)
stages on##2##2##(2008-10#2)
stages or##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
stages that##2##2##(1994-12#1)(2010-12#1)
stages to##2##2##(2011-2#1)(2012-8#1)
stages was##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
stages were examined##2##3##(1997-4#1)(2011-2#1)
stages were##7##2##(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)
stages with a##2##3##(2008-10#2)
stages with##4##2##(2008-10#3)(2008-12#1)
stages##683##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#1)(1993-9#6)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#6)(1997-6#6)(1997-7#3)(1997-8#5)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#20)(2007-5#1)(2007-7#3)(2007-8#9)(2008-1#7)(2008-10#130)(2008-11#15)(2008-12#25)(2008-2#9)(2008-3#11)(2008-4#17)(2008-5#20)(2008-6#12)(2008-7#20)(2008-8#20)(2008-9#14)(2009-1#1)(2009-10#9)(2009-12#2)(2009-2#4)(2009-3#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#9)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#8)(2010-2#6)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#19)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#45)(2011-3#5)(2012-12#10)(2012-2#17)(2012-3#12)(2012-7#1)(2012-8#1)(2013-1#25)(2013-8#15)
stages)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
staggered##7##1##(1997-7#2)(2007-11#2)(2008-8#1)(2009-12#1)(2013-1#1)
staggering##3##1##(1994-9#1)(2008-2#1)(2008-5#1)
staghorn stone##2##2##(2007-7#1)(2008-10#1)
staghorn##5##1##(2007-7#3)(2008-10#1)(2013-1#1)
staging and monitoring##2##3##(2008-2#1)(2010-3#1)
staging and risk##2##3##(1995-1#1)(2011-2#1)
staging and the##2##3##(2010-3#1)(2011-2#1)
staging and##21##2##(1990-3#1)(1990-9#3)(1995-1#1)(1995-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-6#2)(2010-3#5)(2011-2#3)(2012-12#1)
staging in patients with##2##4##(2007-9#1)(2009-5#1)
staging method in##2##3##(1990-9#2)
staging of rectal##2##3##(1990-9#1)(2013-1#1)
staging of the##2##3##(2006-8#1)(2007-4#1)
staging of##18##2##(1990-9#1)(1992-9#1)(2006-8#1)(2007-11#1)(2007-4#2)(2008-1#3)(2008-2#3)(2009-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
staging procedure##3##2##(1990-12#1)(1994-12#1)(1997-8#1)
staging system and##3##3##(2011-2#3)
staging system for##2##3##(2007-8#1)(2008-9#1)
staging system##18##2##(1990-8#1)(2006-10#1)(2007-12#1)(2007-4#3)(2007-8#2)(2008-12#1)(2008-9#3)(2011-1#1)(2011-2#4)(2012-3#1)
staging systems##4##2##(2007-8#1)(2008-9#1)(2011-2#2)
staging the##2##2##(2007-12#1)(2010-8#1)
staging was##2##2##(2008-10#2)
staging##123##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#12)(1991-1#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#6)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#5)(2008-12#1)(2008-2#7)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#7)(2009-12#1)(2009-5#2)(2010-12#5)(2010-3#8)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
stagnant##4##1##(1992-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
stagnation point##3##2##(2008-3#3)
stagnation##7##1##(1992-1#1)(1997-7#1)(2008-3#3)(2008-7#1)(2013-1#1)
stagonospora##2##1##(2008-10#2)
stain and##5##2##(1992-2#1)(1995-12#1)(2007-7#1)(2010-5#1)(2012-3#1)
stain cells##2##2##(2008-11#1)(2008-9#1)
stain for##2##2##(1991-1#1)(1995-12#1)
stain in##2##2##(2007-8#1)(2012-12#1)
stain of##2##2##(2011-2#2)
stain solution##2##2##(2008-9#1)(2012-8#1)
stain was##4##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-12#1)
stain with##2##2##(1991-12#1)(1992-2#1)
stain##61##1##(1990-2#1)(1990-3#2)(1991-1#1)(1991-12#2)(1992-2#3)(1992-6#1)(1995-12#3)(1997-2#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#7)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-3#2)(2012-8#1)
stained after##2##2##(2008-2#1)(2008-7#1)
stained and the##3##3##(2008-5#3)
stained and##7##2##(1990-2#1)(2008-11#1)(2008-5#3)(2008-9#1)(2011-3#1)
stained by the##3##3##(1997-2#1)(2008-10#2)
stained by##11##2##(1992-12#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
stained cells##3##2##(2008-9#2)(2013-1#1)
stained for##6##2##(1992-6#1)(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
stained gels##4##2##(2008-2#1)(2008-4#3)
stained in##3##2##(1996-5#1)(2008-12#2)
stained nuclei##2##2##(1996-2#1)(2008-11#1)
stained positive for##2##3##(1997-8#1)(2012-3#1)
stained positive##3##2##(1997-8#1)(2007-8#1)(2012-3#1)
stained positively for##2##3##(2008-7#1)(2013-8#1)
stained positively##4##2##(1996-12#1)(2008-7#1)(2012-1#1)(2013-8#1)
stained sections##3##2##(2007-5#1)(2008-11#1)(2009-11#1)
stained with Coomassie##2##3##(1993-8#1)(2008-4#1)
stained with Evans blue##3##4##(2012-2#3)
stained with hematoxylin and eosin##2##5##(2011-2#1)(2013-1#1)
stained with one##2##3##(1990-12#1)(2008-5#1)
stained with the##8##3##(1991-12#1)(1991-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
stained with##38##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
stained##137##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#3)(1991-11#1)(1991-12#3)(1991-5#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1995-12#3)(1995-4#1)(1996-12#4)(1996-2#2)(1996-5#3)(1997-2#4)(1997-8#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#6)(2008-5#7)(2008-7#7)(2008-8#4)(2008-9#9)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
staining (e##2##2##(2006-6#1)(2008-4#1)
staining after##4##2##(2008-10#1)(2008-11#1)(2010-6#1)(2012-12#1)
staining and DNA##2##3##(2008-8#1)(2009-4#1)
staining and confocal##2##3##(2007-12#1)(2011-2#1)
staining and flow cytometry##2##4##(2008-10#2)
staining and the##2##3##(2008-7#1)(2013-8#1)
staining and##33##2##(1991-2#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-6#1)(1995-6#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
staining assay##2##2##(2008-10#1)(2008-2#1)
staining at##2##2##(1995-12#1)(2012-12#1)
staining cells##3##2##(2008-11#1)(2008-9#2)
staining for##23##2##(1990-7#1)(1995-12#3)(1997-3#2)(1997-7#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#4)
staining in both telomeres##2##4##(2008-12#2)
staining in the##5##3##(1990-7#1)(1992-8#1)(1994-6#1)(2012-3#1)(2013-1#1)
staining in##14##2##(1990-7#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2012-3#2)(2013-1#1)
staining indicated that##2##3##(2008-4#1)(2008-8#1)
staining intensity to##2##3##(1991-5#1)(2011-2#1)
staining intensity##6##2##(1991-5#2)(1996-2#1)(2009-4#1)(2011-2#2)
staining is a##2##3##(2008-2#1)(2008-9#1)
staining is##6##2##(2008-2#1)(2008-5#1)(2008-9#4)
staining method##8##2##(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)
staining methods##4##2##(1996-5#1)(1997-3#1)(2007-12#1)(2008-2#1)
staining of DNA and##2##4##(2008-11#1)(2008-9#1)
staining of cells##2##3##(1990-12#1)(2008-9#1)
staining of the device##2##4##(2010-7#2)
staining of the##11##3##(1991-2#1)(1991-5#1)(1992-1#1)(1993-12#1)(1995-11#1)(2008-4#1)(2008-9#1)(2010-7#2)(2011-2#1)(2012-7#1)
staining of##53##2##(1990-12#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#2)(1995-11#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#8)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-7#1)(2013-8#1)
staining on##5##2##(1990-12#1)(1995-4#1)(2008-8#1)(2011-1#2)
staining or##4##2##(2008-11#1)(2008-2#1)(2008-4#2)
staining pattern##3##2##(1996-5#1)(1996-6#1)(2008-10#1)
staining procedure##3##2##(2007-8#1)(2008-11#1)(2008-9#1)
staining procedures for##2##3##(2008-9#2)
staining procedures##8##2##(2008-2#2)(2008-4#2)(2008-9#3)(2012-2#1)
staining protocol##3##2##(2008-9#3)
staining reaction##2##2##(1997-7#1)(2008-9#1)
staining reagents##2##2##(2008-4#1)(2013-8#1)
staining revealed that##2##3##(2008-12#1)(2008-8#1)
staining revealed##3##2##(2006-12#1)(2008-12#1)(2008-8#1)
staining technique##4##2##(1991-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
staining techniques##2##2##(2007-7#1)(2011-2#1)
staining to##2##2##(1991-2#1)(2008-8#1)
staining was seen in the##2##5##(1992-11#1)(1997-2#1)
staining was seen in##3##4##(1992-11#1)(1995-8#1)(1997-2#1)
staining was seen##4##3##(1992-11#1)(1995-8#1)(1997-2#2)
staining was used to##2##4##(1992-8#1)(2008-5#1)
staining was##13##2##(1990-5#1)(1992-11#2)(1992-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
staining were##3##2##(2007-10#1)(2008-11#1)(2011-2#1)
staining with 4'##2##3##(2008-10#1)(2008-11#1)
staining with a second fluorochrome (propidium iodide) after incubation of effector and target cells##2##14##(1990-12#2)
staining with a##5##3##(1990-12#2)(2008-11#1)(2008-5#1)(2008-9#1)
staining with ethidium bromide##2##4##(1990-7#1)(2006-8#1)
staining with##35##2##(1990-12#2)(1990-7#1)(1993-12#1)(1994-2#3)(1994-9#1)(1995-8#1)(1997-8#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2013-8#2)
staining##419##1##(1990-12#6)(1990-5#1)(1990-7#5)(1991-2#4)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1993-12#5)(1993-3#2)(1993-8#1)(1993-9#2)(1994-2#4)(1994-6#3)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#7)(1995-3#1)(1995-4#3)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#3)(1996-5#4)(1996-6#2)(1997-2#5)(1997-3#4)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#29)(2008-11#32)(2008-12#14)(2008-2#11)(2008-4#35)(2008-5#16)(2008-7#12)(2008-8#19)(2008-9#51)(2009-10#1)(2009-12#3)(2009-4#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#6)(2011-2#11)(2012-12#8)(2012-2#3)(2012-3#4)(2012-7#2)(2013-1#7)(2013-7#1)(2013-8#11)
staining)##3##1##(2008-10#1)(2008-11#1)(2012-1#1)
stainings##3##1##(1990-12#1)(1996-12#1)(1997-8#1)
stainless steel (SS)##2##3##(2010-4#1)(2013-8#1)
stainless steel and titanium##2##4##(2008-3#1)(2008-5#1)
stainless steel and##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
stainless steel housing##2##3##(2008-7#2)
stainless steel welding fume##2##4##(2008-10#2)
stainless steel welding##3##3##(2008-10#3)
stainless steel wire##3##3##(2008-10#1)(2009-3#1)(2012-1#1)
stainless steel##39##2##(1992-1#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-4#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
stainless##42##1##(1992-1#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-4#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
stainless-steel cone pinhole##2##3##(2008-3#2)
stainless-steel##7##1##(1992-8#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-6#1)
stains and##5##2##(1990-7#1)(2008-5#1)(2008-9#2)(2013-1#1)
stains used##2##2##(2008-9#1)(2012-2#1)
stains was##2##2##(2008-12#1)(2013-1#1)
stains were##2##2##(1992-2#1)(2008-9#1)
stains##40##1##(1990-7#4)(1991-1#2)(1992-2#1)(1993-6#1)(1996-11#2)(1997-3#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#7)(2009-1#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
stair##3##1##(2013-1#3)
staircase effect##2##2##(2008-2#2)
staircase procedure##3##2##(1990-11#3)
staircase##9##1##(1990-11#4)(2007-10#1)(2008-2#3)(2013-1#1)
stairs##4##1##(2008-7#2)(2008-9#1)(2013-1#1)
stake in##4##2##(1990-4#1)(1993-5#1)(2009-10#1)(2012-1#1)
stake##7##1##(1990-4#1)(1992-4#1)(1993-5#1)(1995-2#1)(2009-10#1)(2010-8#1)(2012-1#1)
stakeholder alignment##3##2##(2013-1#3)
stakeholder analysis##3##2##(1995-1#3)
stakeholder group participation##2##3##(1996-12#2)
stakeholder group##3##2##(1995-1#1)(1996-12#2)
stakeholder groups##5##2##(1995-1#1)(1996-12#2)(2012-2#1)(2012-3#1)
stakeholder management##3##2##(1991-3#1)(1993-3#1)(2008-1#1)
stakeholder##29##1##(1991-3#2)(1992-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#5)(1996-12#4)(2007-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#5)
stakeholders and##6##2##(1996-3#1)(1997-1#1)(2007-6#1)(2008-12#1)(2008-7#1)(2013-1#1)
stakeholders from##4##2##(1993-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
stakeholders in the##2##3##(2008-12#1)(2011-2#1)
stakeholders in##10##2##(1993-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#3)
stakeholders involved##3##2##(1991-12#1)(1992-1#1)(1997-2#1)
stakeholders was##2##2##(2008-11#1)(2010-3#1)
stakeholders##61##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#5)(2008-6#3)(2008-7#4)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#9)(2013-8#2)
stakeholders'##3##1##(1994-1#1)(1995-3#1)(2008-11#1)
stakes##2##1##(1993-12#1)(2008-12#1)
stalk and##2##2##(2008-8#1)(2011-2#1)
stalk pieces##3##2##(2008-10#3)
stalk was##3##2##(1997-8#1)(2011-2#2)
stalk##30##1##(1995-6#1)(1997-3#3)(1997-8#2)(2008-10#7)(2008-11#1)(2008-8#3)(2009-9#2)(2011-2#7)(2013-8#4)
stalker##2##1##(2009-9#2)
stalking##2##1##(2009-9#2)
stalks##8##1##(2007-12#1)(2008-10#6)(2008-6#1)
stall##3##1##(1991-9#1)(1997-3#1)(2011-2#1)
stalled in##2##2##(1995-2#1)(2012-12#1)
stalled##8##1##(1991-9#1)(1993-3#1)(1994-8#1)(1995-2#1)(2008-9#1)(2011-2#1)(2012-12#2)
stalling##2##1##(2011-2#2)
stallions was##2##2##(2012-3#2)
stamens and##2##2##(2008-8#2)
staminate ear tip##3##3##(2012-3#3)
staminate ear tips##2##3##(2012-3#2)
staminate ear##5##2##(2012-3#5)
staminate##9##1##(2012-3#9)
stammering##3##1##(2008-2#2)(2008-4#1)
stamp##2##1##(2008-10#1)(2008-3#1)
stamped##2##1##(2007-11#1)(2008-8#1)
stamping element is##2##3##(2008-3#2)
stamping of multilayer##2##3##(2008-3#2)
stamping##4##1##(2008-3#4)
stamping-out##2##1##(2007-6#2)
stance on##3##2##(2008-11#1)(2008-12#2)
stance phase##2##2##(2013-1#2)
stance was##2##2##(1994-9#1)(2007-10#1)
stance##24##1##(1991-12#1)(1992-1#1)(1993-3#2)(1994-1#3)(1994-9#1)(1996-3#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-11#2)(2008-12#3)(2009-10#1)(2010-12#1)(2010-9#1)(2013-1#2)
stanchions and handrails in buses##2##5##(2008-6#2)
stanchions and handrails##3##3##(2008-6#3)
stanchions##4##1##(2008-6#4)
stand against##2##2##(1990-6#1)(2012-3#1)
stand and##3##2##(2008-10#2)(2009-11#1)
stand as##2##2##(2009-10#1)(2009-7#1)
stand establishment##2##2##(2008-10#1)(2008-12#1)
stand for##4##2##(2008-10#2)(2008-5#1)(2009-7#1)
stand in##2##2##(1990-2#1)(2008-11#1)
stand##41##1##(1990-2#1)(1990-6#1)(1994-12#1)(1995-6#1)(1997-8#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#2)(2010-10#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
stand-alone##14##1##(1993-2#1)(2007-12#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
stand-by therapy##3##2##(1993-8#3)
stand-by##4##1##(1993-8#3)(2007-2#1)
stand-off detection and##2##3##(2008-3#2)
standalone##2##1##(1992-4#1)(2010-8#1)
standard &quot##2##2##(2008-8#1)(2011-2#1)
standard 2##2##2##(1992-9#1)(2009-3#1)
standard CT##2##2##(1995-11#1)(2007-11#1)
standard DNA##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
standard EVAR##2##2##(2012-2#2)
standard GDx VCC##2##3##(2010-8#2)
standard LPA using PBMC##2##4##(2011-2#2)
standard LPA using##3##3##(2011-2#3)
standard LPA##4##2##(2011-2#4)
standard OCT##2##2##(2007-12#1)(2008-3#1)
standard Papanicolaou smear##2##3##(1992-1#2)
standard SeaWiFS##2##2##(2008-3#2)
standard VAS##4##2##(2009-3#4)
standard acid##2##2##(2008-10#2)
standard addition and##5##3##(2008-10#5)
standard addition approach##2##3##(2008-10#2)
standard addition calibration##6##3##(2008-10#6)
standard addition method and##4##4##(2008-10#4)
standard addition method for##2##4##(2008-10#2)
standard addition method or##2##4##(2008-10#2)
standard addition method to##2##4##(2008-10#2)
standard addition method was##3##4##(2008-10#3)
standard addition method were##2##4##(2008-10#2)
standard addition method##55##3##(2008-10#55)
standard addition methodology##5##3##(2008-10#5)
standard addition technique was##2##4##(2008-10#2)
standard addition technique##10##3##(1991-12#1)(2008-10#9)
standard addition##107##2##(1990-8#1)(1991-12#1)(2008-10#104)(2013-8#1)
standard additions method was##2##4##(2008-10#2)
standard additions method##17##3##(2008-10#17)
standard additions methods##3##3##(2008-10#3)
standard additions##33##2##(2008-10#33)
standard alloy##2##2##(2008-10#2)
standard alloys and environmental samples##5##5##(2008-10#5)
standard alloys and##8##3##(2008-10#8)
standard alloys##12##2##(2008-10#12)
standard and a##3##3##(1990-12#1)(1995-5#1)(2008-5#1)
standard and deviant##2##3##(1995-5#1)(2013-8#1)
standard and the##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
standard and##40##2##(1990-12#1)(1991-5#1)(1994-3#1)(1995-5#2)(1996-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-5#1)(2008-7#3)(2009-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#3)
standard approach in##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
standard approach to##2##3##(1994-1#1)(2008-11#1)
standard approach##12##2##(1990-6#1)(1994-1#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#2)
standard approaches##3##2##(2010-3#1)(2010-6#1)(2013-1#1)
standard are##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
standard assays##2##2##(1996-5#1)(2008-11#1)
standard at##3##2##(2007-12#1)(2008-10#2)
standard atmospheric##2##2##(2008-2#1)(2008-3#1)
standard bacteriological##4##2##(2008-12#3)(2012-3#1)
standard base solution##2##3##(2008-10#2)
standard benefits##2##2##(1994-12#1)(1997-3#1)
standard biochemical##2##2##(1990-7#1)(2011-2#1)
standard by##2##2##(2008-3#1)(2011-1#1)
standard calibrated##2##2##(2008-10#1)(2008-3#1)
standard calibration technique##2##3##(2008-10#2)
standard calibration##4##2##(2008-10#4)
standard care##5##2##(2008-3#1)(2008-4#1)(2010-4#3)
standard cell culture##2##3##(1993-12#1)(2008-11#1)
standard cell##3##2##(1993-12#1)(2008-11#1)(2011-1#1)
standard cell-based##2##2##(2008-3#2)
standard challenge##2##2##(2008-5#2)
standard chemical##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
standard chemotherapy##2##2##(2008-6#2)
standard clinical##5##2##(1994-3#1)(2007-10#1)(2008-10#1)(2009-10#1)(2013-8#1)
standard coals##2##2##(2008-10#2)
standard colorimetric##2##2##(2008-10#2)
standard commercial##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
standard compounds##3##2##(2008-10#3)
standard criteria##3##2##(2008-5#1)(2010-11#1)(2011-1#1)
standard culture##2##2##(1993-2#1)(2010-8#1)
standard curve##9##2##(1996-12#1)(2008-1#1)(2008-10#6)(2010-11#1)
standard curves##6##2##(1995-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
standard derivative##2##2##(2008-10#2)
standard derivatives##2##2##(2008-10#2)
standard deviation &lt##3##3##(2008-10#2)(2008-3#1)
standard deviation (R##82##3##(2008-10#82)
standard deviation (S##5##3##(2008-10#5)
standard deviation (n=10)##6##3##(2008-10#6)
standard deviation (n=6) was##2##4##(2008-10#2)
standard deviation (n=6)##3##3##(2008-10#3)
standard deviation =##2##3##(2008-10#2)
standard deviation about##2##3##(2008-10#1)(2008-2#1)
standard deviation and the##2##4##(2008-10#1)(2013-1#1)
standard deviation and##4##3##(2008-10#3)(2013-1#1)
standard deviation being##2##3##(2008-10#2)
standard deviation between##4##3##(2008-10#3)(2013-8#1)
standard deviation for the##9##4##(2008-10#9)
standard deviation for##42##3##(2008-10#41)(2010-9#1)
standard deviation in the##6##4##(2008-10#2)(2008-3#4)
standard deviation in##10##3##(2008-10#5)(2008-3#4)(2010-5#1)
standard deviation is 0##2##4##(2008-10#2)
standard deviation is##22##3##(2008-10#21)(2008-2#1)
standard deviation less than##2##4##(2008-10#2)
standard deviation of +/-0##4##4##(2008-10#4)
standard deviation of 0##11##4##(2008-10#9)(2008-3#1)(2009-2#1)
standard deviation of 10##2##4##(2008-10#2)
standard deviation of 5##4##4##(2008-10#3)(2011-1#1)
standard deviation of less than##9##5##(2008-10#8)(2008-2#1)
standard deviation of the blank signal##2##6##(2008-10#2)
standard deviation of the blank##9##5##(2008-10#9)
standard deviation of the mean##2##5##(2008-3#2)
standard deviation of the method was##2##6##(2008-10#2)
standard deviation of the method##4##5##(2008-10#4)
standard deviation of the proposed method calculated from##2##8##(2008-10#2)
standard deviation of the proposed method##3##6##(2008-10#3)
standard deviation of the proposed##5##5##(2008-10#5)
standard deviation of the##46##4##(1994-11#1)(2007-11#1)(2008-10#32)(2008-2#3)(2008-3#9)
standard deviation of three independent##2##5##(2008-10#2)
standard deviation of three##4##4##(2008-10#4)
standard deviation of##165##3##(1994-11#1)(1994-9#1)(1996-8#1)(2007-11#1)(2008-10#144)(2008-2#4)(2008-3#11)(2009-2#1)(2011-1#1)
standard deviation score (SDS)##2##4##(2011-1#2)
standard deviation was 3##5##4##(2008-10#5)
standard deviation was 5##3##4##(2008-10#3)
standard deviation was##44##3##(1990-8#1)(2008-10#43)
standard deviation##531##2##(1990-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-8#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#464)(2008-11#1)(2008-2#8)(2008-3#18)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-2#1)(2012-5#1)(2013-1#4)(2013-8#5)
standard deviation)##13##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
standard deviations (R##19##3##(2008-10#19)
standard deviations between##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
standard deviations for##21##3##(2008-10#20)(2008-5#1)
standard deviations from##2##3##(2008-8#2)
standard deviations of the results##3##5##(2008-10#2)(2008-5#1)
standard deviations of the##13##4##(2008-10#11)(2008-12#1)(2008-5#1)
standard deviations of##36##3##(1992-1#1)(1993-9#1)(2008-10#32)(2008-12#1)(2008-5#1)
standard deviations were 0##2##4##(2008-10#2)
standard deviations were less than##2##5##(2008-10#2)
standard deviations were lower than##3##5##(2008-10#3)
standard deviations were##27##3##(2008-10#22)(2011-1#2)(2011-2#3)
standard deviations##159##2##(1991-5#1)(1992-1#1)(1993-9#1)(1994-9#1)(1997-2#1)(2008-10#126)(2008-12#2)(2008-3#1)(2008-5#5)(2008-8#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#9)(2011-2#3)(2012-1#1)(2012-12#1)
standard diagnostic##3##2##(2011-2#1)(2011-3#1)(2013-1#1)
standard dietary##2##2##(1992-3#1)(2010-10#1)
standard dose##5##2##(1990-6#1)(1994-6#1)(2007-11#1)(2008-6#1)(2008-7#1)
standard doses##3##2##(1997-3#1)(2009-5#1)(2010-3#1)
standard drink##4##2##(2009-7#4)
standard drinks##3##2##(2009-7#3)
standard drug##2##2##(2008-10#1)(2012-2#1)
standard dural##2##2##(2012-3#1)(2013-8#1)
standard electrode##2##2##(2008-10#1)(2008-9#1)
standard error (R##4##3##(2008-10#4)
standard error for##3##3##(2008-10#2)(2008-3#1)
standard error of estimate##2##4##(2007-11#1)(2008-10#1)
standard error of prediction##3##4##(2008-10#2)(2013-8#1)
standard error of##12##3##(2007-11#1)(2008-10#6)(2008-2#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
standard error was##2##3##(2008-10#2)
standard error##27##2##(1997-3#1)(2007-10#1)(2007-11#2)(2008-10#17)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
standard errors of MLE##2##4##(2008-7#2)
standard errors of prediction##2##4##(2008-10#2)
standard errors of the##2##4##(2008-10#2)
standard errors of##7##3##(2008-10#5)(2008-7#2)
standard errors##12##2##(1995-9#1)(1997-4#1)(2008-10#6)(2008-3#1)(2008-7#2)(2008-8#1)
standard ethanol##2##2##(1997-7#1)(2008-9#1)
standard ethanolic deodorant##2##3##(2008-5#2)
standard fiber by##2##3##(2007-12#2)
standard fiber##8##2##(2007-12#7)(2008-3#1)
standard fibers with##2##3##(2007-12#2)
standard fibers##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
standard first-line chemotherapy##2##3##(2010-12#2)
standard first-line##3##2##(2010-12#2)(2013-1#1)
standard for the diagnosis of##4##5##(2008-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
standard for the##13##3##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
standard for##52##2##(1991-1#1)(1993-5#1)(1995-2#1)(1995-6#1)(1996-12#4)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2010-4#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
standard format##2##2##(2008-7#2)
standard free##3##2##(2008-10#2)(2011-1#1)
standard from##2##2##(2008-10#2)
standard growth##2##2##(1992-12#1)(2012-3#1)
standard health##2##2##(1997-3#1)(2008-1#1)
standard imaging##2##2##(2008-10#1)(2008-3#1)
standard in vitro##3##3##(2008-4#1)(2008-5#1)(2009-12#1)
standard in##14##2##(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#3)(2011-3#1)(2012-12#1)
standard infection control##2##3##(2007-7#1)(2008-1#1)
standard interferon##2##2##(2009-8#1)(2010-11#1)
standard interview##3##2##(2008-12#2)(2011-2#1)
standard intravenous##2##2##(1996-8#1)(2012-12#1)
standard iodine solution##2##3##(2008-10#2)
standard is##7##2##(1997-8#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#2)
standard laboratory##8##2##(1992-11#1)(1993-6#1)(2007-7#2)(2008-10#2)(2008-8#1)(2008-9#1)
standard lamp##3##2##(2008-2#1)(2008-3#2)
standard laparoscopic##2##2##(2008-10#2)
standard least-squares##3##2##(2008-3#3)
standard length (L(S))##4##3##(2010-8#4)
standard length of##2##3##(2010-8#2)
standard length##9##2##(2008-5#1)(2010-8#6)(2013-7#2)
standard linear correlation##2##3##(2008-3#2)
standard linear##3##2##(2008-3#2)(2011-1#1)
standard liquid##2##2##(1994-5#1)(2008-9#1)
standard management##3##2##(2012-12#1)(2013-1#2)
standard market formula##2##3##(2008-5#2)
standard market##3##2##(2008-5#3)
standard material##3##2##(2008-10#3)
standard materials##3##2##(2008-10#3)
standard means##2##2##(1995-12#1)(2008-1#1)
standard measurements##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
standard medical##4##2##(2008-4#1)(2009-10#1)(2011-1#1)(2012-2#1)
standard metal##3##2##(2008-10#2)(2008-7#1)
standard method and##2##3##(2008-10#2)
standard method for##6##3##(1997-4#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-3#1)
standard method in##3##3##(1996-3#1)(2008-10#1)(2010-12#1)
standard method of treatment##2##4##(2007-8#1)(2013-1#1)
standard method of##4##3##(2007-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
standard method used##2##3##(2008-10#1)(2012-2#1)
standard method##41##2##(1992-12#1)(1993-3#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-10#19)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
standard methodology for##3##3##(1992-12#1)(1996-6#1)(2008-10#1)
standard methodology##5##2##(1992-12#1)(1996-6#1)(2008-10#1)(2012-12#1)(2012-3#1)
standard methods for##6##3##(1994-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-8#1)
standard methods of analysis##2##4##(1994-9#1)(2008-10#1)
standard methods of##6##3##(1994-9#1)(1997-6#1)(2008-10#2)(2008-4#1)(2011-2#1)
standard methods##29##2##(1994-11#1)(1994-3#1)(1994-9#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
standard microbiological##3##2##(2011-1#2)(2012-3#1)
standard mixtures of##3##3##(2008-10#3)
standard mixtures##7##2##(2008-10#7)
standard multidish##2##2##(2008-11#2)
standard of care (SOC)##2##4##(2008-7#1)(2012-12#1)
standard of care and##2##4##(1993-2#1)(2012-3#1)
standard of care for##5##4##(1993-12#1)(2007-10#1)(2007-12#1)(2008-6#1)(2009-12#1)
standard of care in##5##4##(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#1)(2012-3#1)
standard of care##25##3##(1990-11#1)(1991-12#1)(1993-12#1)(1993-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)
standard of care&quot##3##3##(2010-3#1)(2012-12#1)(2012-3#1)
standard of society##2##3##(1995-5#2)
standard of the##2##3##(2008-11#1)(2011-2#1)
standard of treatment##2##3##(2007-12#1)(2008-6#1)
standard of##54##2##(1990-11#3)(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1995-3#1)(1995-5#2)(1996-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#6)(2013-1#3)(2013-8#1)
standard on the##2##3##(1993-2#1)(2008-10#1)
standard on##4##2##(1993-2#1)(2008-10#2)(2011-2#1)
standard operating procedures (SOPs)##2##4##(2007-7#1)(2010-3#1)
standard operating procedures##4##3##(2007-7#1)(2010-11#1)(2010-3#1)(2011-2#1)
standard operating##6##2##(2007-7#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-2#2)
standard operation procedure##2##3##(2008-10#2)
standard optical##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
standard or##6##2##(2007-11#1)(2008-10#4)(2009-8#1)
standard oral glucose tolerance test (OGTT)##2##6##(2011-1#1)(2011-2#1)
standard osmolality##2##2##(2008-11#2)
standard pellet diet##3##3##(2013-1#3)
standard peritoneal permeability analysis##3##4##(2011-2#3)
standard phase-sensitive detection##2##3##(2008-3#2)
standard phase-sensitive##3##2##(2008-2#1)(2008-3#2)
standard photolithography##2##2##(2007-12#1)(2008-10#1)
standard populations##2##2##(2011-1#1)(2013-1#1)
standard potential##2##2##(2008-10#1)(2008-8#1)
standard practice##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#1)
standard practices##2##2##(2010-5#1)(2013-7#1)
standard preparation##3##2##(1992-9#1)(2008-4#1)(2008-7#1)
standard procedure to##2##3##(2008-10#1)(2008-7#1)
standard procedure##13##2##(2007-11#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
standard procedures and optimization##2##4##(2008-2#1)(2008-9#1)
standard procedures and##3##3##(2008-2#1)(2008-9#1)(2010-8#1)
standard procedures to##2##3##(1990-11#1)(2011-2#1)
standard procedures##13##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
standard protocol##6##2##(1996-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
standard random effects##2##3##(1996-3#1)(1997-4#1)
standard reference material and##3##4##(2008-10#3)
standard reference material##18##3##(2008-10#18)
standard reference materials and##4##4##(2008-10#4)
standard reference materials##31##3##(2008-10#31)
standard reference serum##2##3##(2011-2#2)
standard reference##61##2##(2008-1#1)(2008-10#56)(2010-3#1)(2011-1#1)(2011-2#2)
standard regimen##3##2##(2008-7#1)(2010-12#2)
standard resection##2##2##(1990-2#2)
standard sample and##2##3##(2008-10#2)
standard sample##3##2##(2008-10#3)
standard samples of##2##3##(2008-10#2)
standard samples##11##2##(2008-10#10)(2013-8#1)
standard scale##2##2##(2008-8#1)(2011-2#1)
standard scientific##2##2##(2006-12#1)(2009-11#1)
standard screening##3##2##(1990-8#1)(2008-10#1)(2008-11#1)
standard serum##2##2##(1993-9#1)(1995-2#1)
standard set of##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
standard set##4##2##(2008-10#1)(2008-4#1)(2012-2#2)
standard setting##7##2##(1996-2#1)(2011-2#2)(2012-2#4)
standard short##2##2##(2008-10#1)(2008-9#1)
standard simulation##2##2##(2008-12#1)(2011-1#1)
standard single-mode fiber##4##3##(2007-11#3)(2007-12#1)
standard slurries were##3##3##(2008-10#3)
standard slurries##4##2##(2008-10#4)
standard solution and in##2##4##(2008-10#2)
standard solution and##5##3##(2008-10#5)
standard solution containing##5##3##(2008-10#5)
standard solution of##5##3##(2008-10#5)
standard solution was##3##3##(2008-10#3)
standard solution##37##2##(2008-10#36)(2008-8#1)
standard solutions and##2##3##(2008-10#2)
standard solutions containing##3##3##(2008-10#3)
standard solutions in##2##3##(2008-10#2)
standard solutions of##6##3##(2008-10#6)
standard solutions was##2##3##(2008-10#2)
standard solutions were##4##3##(2008-10#4)
standard solutions##38##2##(2008-1#1)(2008-10#37)
standard spectrophotometric procedure##2##3##(2008-10#2)
standard spectrophotometric##3##2##(2008-10#3)
standard stimuli##2##2##(2008-8#2)
standard strains##4##2##(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)
standard surgical resection##2##3##(2009-4#2)
standard surgical##4##2##(2008-7#1)(2009-4#2)(2011-2#1)
standard technique##5##2##(2008-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
standard techniques##4##2##(2007-7#1)(2008-10#1)(2008-4#1)(2010-7#1)
standard telecom fiber##2##3##(2007-11#2)
standard telecommunication fiber##2##3##(2007-11#1)(2008-2#1)
standard ten##2##2##(2013-1#2)
standard test##8##2##(2008-12#1)(2011-2#6)(2012-3#1)
standard testing procedures##2##3##(2008-12#1)(2008-5#1)
standard tests##2##2##(2012-2#1)(2013-1#1)
standard that is##2##3##(2008-7#1)(2011-2#1)
standard that##4##2##(1991-3#1)(1992-2#1)(2008-7#1)(2011-2#1)
standard therapy for##4##3##(1994-12#1)(1997-8#1)(2010-8#1)(2011-2#1)
standard therapy of##2##3##(1994-7#1)(2013-7#1)
standard therapy##16##2##(1992-10#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-2#1)(1997-8#2)(2009-4#2)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-7#1)
standard tissue culture plasticware##2##4##(2008-11#2)
standard tissue##3##2##(2008-11#2)(2008-4#1)
standard to##12##2##(1995-10#1)(2008-1#1)(2008-10#8)(2008-9#1)(2010-8#1)
standard treatment for##9##3##(2007-10#1)(2007-8#1)(2008-3#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
standard treatment is##3##3##(1990-2#1)(1995-9#1)(1997-5#1)
standard treatment##25##2##(1990-2#1)(1991-8#1)(1995-9#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
standard treatments##4##2##(2008-3#1)(2013-1#3)
standard uncertainty of##4##3##(2008-2#2)(2008-3#2)
standard uncertainty##5##2##(2008-2#2)(2008-3#3)
standard values##3##2##(2008-10#2)(2008-5#1)
standard was prepared##2##3##(1994-2#1)(2008-5#1)
standard was##15##2##(1992-12#1)(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2012-12#1)
standard were##6##2##(1990-5#1)(1992-8#1)(1996-5#1)(2008-10#3)
standard wheat##2##2##(2008-10#1)(2010-8#1)
standard with##4##2##(2008-10#2)(2009-6#1)(2011-1#1)
standard x-ray##2##2##(1992-11#1)(2007-11#1)
standard##2537##1##(1990-11#7)(1990-12#4)(1990-2#5)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#4)(1991-1#2)(1991-11#2)(1991-12#11)(1991-2#2)(1991-3#3)(1991-5#4)(1991-8#2)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#8)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-8#1)(1992-9#3)(1993-12#6)(1993-2#8)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#3)(1994-11#3)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#2)(1994-7#2)(1994-9#6)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#6)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#3)(1996-5#4)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#9)(2006-12#1)(2006-5#1)(2007-10#6)(2007-11#39)(2007-12#37)(2007-2#5)(2007-7#10)(2007-8#15)(2007-9#1)(2008-1#16)(2008-10#1277)(2008-11#53)(2008-12#29)(2008-2#61)(2008-3#124)(2008-4#26)(2008-5#42)(2008-6#8)(2008-7#47)(2008-8#22)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#4)(2009-2#4)(2009-3#12)(2009-4#7)(2009-5#4)(2009-6#1)(2009-7#8)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#11)(2010-2#1)(2010-3#10)(2010-4#9)(2010-5#13)(2010-6#1)(2010-7#7)(2010-8#29)(2010-9#4)(2011-1#42)(2011-2#78)(2011-3#4)(2011-7#1)(2012-1#11)(2012-12#22)(2012-2#30)(2012-3#34)(2012-5#1)(2013-1#54)(2013-7#7)(2013-8#33)
standard&quot##16##1##(1992-3#1)(1993-2#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-4#1)
standard)##10##1##(1990-5#1)(1990-8#1)(1995-2#1)(1996-5#1)(2008-10#4)(2008-2#1)(2011-3#1)
standard-dose chemotherapy##2##2##(2008-7#2)
standard-dose##3##1##(2008-7#2)(2012-2#1)
standard/sample##2##1##(2008-10#2)
standard?##2##1##(1992-3#1)(2008-10#1)
standardisation of the##2##3##(1991-2#1)(2010-4#1)
standardisation of##4##2##(1991-2#1)(1992-3#1)(2008-10#1)(2010-4#1)
standardisation##9##1##(1990-3#1)(1991-2#1)(1992-3#1)(1997-7#1)(2008-10#3)(2010-4#1)(2012-12#1)
standardised methods##2##2##(2008-10#1)(2008-11#1)
standardised protocol##2##2##(2009-8#2)
standardised##27##1##(1993-2#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#3)(2010-6#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-8#1)
standardization and validation of##2##4##(2008-10#1)(2008-5#1)
standardization and##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)
standardization efforts##2##2##(1994-12#1)(2008-7#1)
standardization evaluation system##2##3##(2012-3#2)
standardization evaluation##3##2##(2012-3#3)
standardization for##3##2##(2008-10#2)(2012-3#1)
standardization in##2##2##(1993-1#1)(2008-9#1)
standardization method##2##2##(2008-10#1)(2011-1#1)
standardization methods##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
standardization of the##5##3##(1992-5#1)(2006-6#1)(2008-10#1)(2008-8#1)(2012-3#1)
standardization of##21##2##(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#5)(2008-8#2)(2009-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
standardization process##2##2##(2008-10#2)
standardization##73##1##(1991-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-8#2)(2006-6#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-6#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#2)
standardize and##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
standardize our##2##2##(2008-3#2)
standardize the##5##2##(1997-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
standardize##16##1##(1996-1#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
standardized and##6##2##(1993-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
standardized area under DII progress curve##2##6##(2008-10#2)
standardized area under DII progress##3##5##(2008-10#3)
standardized area under##4##3##(2008-10#4)
standardized by##2##2##(2008-10#2)
standardized conditions##2##2##(1991-12#1)(2008-10#1)
standardized data##4##2##(1993-2#1)(1996-12#1)(2008-11#1)(2010-8#1)
standardized evaluation##2##2##(2008-5#1)(2008-7#1)
standardized in##2##2##(2008-5#1)(2010-8#1)
standardized incidence ratio (SIR)##2##4##(1993-9#2)
standardized incidence##4##2##(1993-2#1)(1993-9#2)(2006-8#1)
standardized mean square##2##3##(2012-2#2)
standardized measures of##2##3##(1996-2#1)(2010-12#1)
standardized mortality or morbidity##2##4##(2008-7#2)
standardized mortality##3##2##(1995-2#1)(2008-7#2)
standardized or##2##2##(1992-3#1)(2011-2#1)
standardized patients##2##2##(1994-2#1)(2012-3#1)
standardized procedure##3##2##(1995-2#1)(2008-12#1)(2012-3#1)
standardized protocol for##3##3##(1990-12#1)(1997-1#1)(2008-11#1)
standardized protocol##4##2##(1990-12#1)(1997-1#2)(2008-11#1)
standardized protocols##2##2##(1997-8#1)(2013-8#1)
standardized questionnaire##8##2##(1993-6#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#2)
standardized test scores##2##3##(2008-12#1)(2009-7#1)
standardized test##4##2##(2008-12#2)(2008-5#1)(2009-7#1)
standardized tests##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
standardized to##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
standardized tool##2##2##(2008-6#1)(2013-1#1)
standardized##208##1##(1990-12#1)(1990-3#1)(1991-11#2)(1991-12#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-1#2)(1993-12#2)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-7#1)(1997-1#2)(1997-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-6#1)(2008-1#1)(2008-10#26)(2008-11#13)(2008-12#7)(2008-3#7)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#3)(2009-11#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-8#5)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2012-4#1)(2013-1#19)(2013-7#1)(2013-8#5)
standardizing the##2##2##(2008-10#2)
standardizing##13##1##(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#4)
standardless FP method##2##3##(2008-10#2)
standards across the##2##3##(2010-8#1)(2011-1#1)
standards and from##2##3##(1992-11#1)(2008-10#1)
standards and requirements##2##3##(2007-8#1)(2012-3#1)
standards and samples##2##3##(2008-10#2)
standards and the##2##3##(1995-2#1)(2008-10#1)
standards and##42##2##(1992-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#3)(1996-1#1)(1996-9#1)(2007-12#2)(2007-8#2)(2008-10#14)(2008-11#2)(2008-12#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-3#1)(2013-1#2)
standards are##8##2##(1993-12#1)(1993-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-11#1)(2011-2#1)
standards as##3##2##(1993-12#1)(1995-3#1)(2008-10#1)
standards by##2##2##(2007-12#1)(2008-11#1)
standards can be##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
standards can##6##2##(2006-5#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
standards containing##2##2##(2008-10#2)
standards could##2##2##(2008-10#1)(2013-8#1)
standards for data##3##3##(2008-7#3)
standards for patient handling##2##4##(1997-7#2)
standards for prevention and##2##4##(2007-11#2)
standards for quality##2##3##(1991-12#1)(1991-2#1)
standards for the##8##3##(1995-12#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-8#1)(2012-12#1)
standards for##54##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-7#3)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
standards from##4##2##(2008-3#1)(2008-4#1)(2013-1#2)
standards have been##2##3##(1996-1#1)(2012-3#1)
standards have##3##2##(1996-1#1)(2011-1#1)(2012-3#1)
standards in papers published in##2##5##(2013-1#2)
standards in reversed-phase##3##3##(1990-8#2)(1993-11#1)
standards in the##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
standards in##20##2##(1990-8#2)(1993-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
standards is##7##2##(1993-12#1)(1994-3#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
standards may##2##2##(1995-2#1)(2008-3#1)
standards needed##2##2##(2008-10#1)(2008-9#1)
standards of care and##2##4##(1991-1#1)(2008-3#1)
standards of care during##2##4##(2013-1#2)
standards of care for##2##4##(2008-3#1)(2013-1#1)
standards of care##15##3##(1991-1#1)(1991-3#1)(1994-3#1)(2008-3#3)(2008-5#1)(2011-1#1)(2013-1#3)(2013-8#4)
standards of health##2##3##(2007-2#1)(2008-1#1)
standards of practice##4##3##(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
standards of quality##3##3##(1996-12#2)(2009-7#1)
standards of the##3##3##(1991-8#1)(1993-2#1)(2011-2#1)
standards of##54##2##(1991-1#1)(1991-3#2)(1991-8#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#3)(1995-3#1)(1996-11#1)(1996-12#2)(1997-8#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#4)
standards on##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
standards or##3##2##(2008-7#1)(2009-9#1)(2010-8#1)
standards regarding##2##2##(2007-12#1)(2011-2#1)
standards such as##3##3##(2008-11#1)(2008-2#1)(2012-3#1)
standards that##3##2##(1994-3#1)(2007-11#1)(2009-6#1)
standards to##6##2##(1995-6#1)(2008-10#4)(2013-1#1)
standards was##5##2##(1996-5#1)(1997-7#1)(2008-10#2)(2011-1#1)
standards well##2##2##(2008-10#2)
standards were not##2##3##(1992-4#1)(2008-10#1)
standards were used for quantification##2##5##(2008-10#1)(2008-7#1)
standards were used##3##3##(2008-10#2)(2008-7#1)
standards were##15##2##(1992-4#1)(2008-10#11)(2008-7#1)(2010-10#1)(2013-1#1)
standards which##3##2##(2008-11#1)(2009-6#1)(2013-1#1)
standards will##3##2##(1993-2#1)(1995-1#1)(2008-3#1)
standards##450##1##(1990-8#3)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#11)(1993-2#7)(1993-3#4)(1994-12#3)(1994-3#11)(1994-5#1)(1995-1#1)(1995-12#4)(1995-2#8)(1995-3#2)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#2)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#6)(1997-8#1)(2006-5#4)(2007-11#5)(2007-12#10)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#5)(2008-10#121)(2008-11#20)(2008-12#9)(2008-2#4)(2008-3#10)(2008-4#10)(2008-5#4)(2008-6#3)(2008-7#12)(2008-9#7)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-8#6)(2011-1#11)(2011-2#18)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#8)(2013-1#18)(2013-8#7)
standards)##4##1##(1991-5#1)(2008-10#2)(2011-2#1)
standing and##4##2##(2008-10#1)(2008-7#2)(2012-2#1)
standing height changes##2##3##(2010-3#2)
standing height gains##2##3##(2010-3#2)
standing height##4##2##(2010-3#4)
standing horses##2##2##(2013-8#2)
standing in##5##2##(1992-3#1)(2008-10#1)(2010-9#1)(2013-1#2)
standing position##3##2##(1990-6#1)(1997-4#1)(2007-8#1)
standing spore crop was##2##4##(2008-10#2)
standing spore crop##3##3##(2008-10#3)
standing surface plasmon##3##3##(2007-12#3)
standing wave##2##2##(1992-8#1)(2007-11#1)
standing waves##2##2##(2008-2#2)
standing##72##1##(1990-6#1)(1992-3#2)(1992-8#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-11#2)(2010-10#2)(2010-3#6)(2010-9#2)(2012-2#3)(2013-1#10)(2013-8#3)
standing-wave##2##1##(2007-11#1)(2008-3#1)
standoff##4##1##(2008-2#2)(2008-3#2)
standpoint of##9##2##(1995-12#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)
standpoint##20##1##(1990-2#1)(1991-6#2)(1994-12#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#3)
standpoints##4##1##(1996-2#1)(2008-5#1)(2008-9#1)(2010-3#1)
stands and##8##2##(2008-10#8)
stands as the##2##3##(2008-10#1)(2012-2#1)
stands as##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
stands for the##2##3##(1990-11#1)(2013-8#1)
stands for##8##2##(1990-11#1)(2008-10#4)(2008-2#1)(2012-3#1)(2013-8#1)
stands in southern##2##3##(2008-10#2)
stands in##8##2##(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#3)(2010-8#1)(2011-1#1)
stands of##7##2##(2008-10#5)(2008-12#2)
stands that##2##2##(1995-3#1)(2008-9#1)
stands with##4##2##(2008-10#4)
stands##59##1##(1990-11#1)(1991-3#1)(1991-9#1)(1994-3#1)(1995-3#2)(1996-12#1)(2007-12#2)(2008-10#39)(2008-12#2)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
standstill##2##1##(1993-6#1)(1997-5#1)
stannous chloride##5##2##(2008-10#5)
stannous##6##1##(2007-10#1)(2008-10#5)
stapedius##6##1##(2008-9#6)
staphylocoagulase##3##1##(2010-6#3)
staphylococcal enterotoxin B##2##3##(1994-8#1)(2008-10#1)
staphylococcal enterotoxin##3##2##(1993-3#1)(1994-8#1)(2008-10#1)
staphylococcal infections##2##2##(1990-10#1)(2008-11#1)
staphylococcal nuclease##4##2##(1992-6#3)(1997-2#1)
staphylococcal plasmids##6##2##(1991-9#1)(1995-8#1)(2012-3#4)
staphylococcal protein A##4##3##(1990-12#1)(1994-12#1)(1994-6#1)(2008-10#1)
staphylococcal##27##1##(1990-10#1)(1990-12#1)(1991-9#1)(1992-6#3)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#4)
staphylococci and##2##2##(1997-3#1)(2007-12#1)
staphylococci isolated##2##2##(2008-7#1)(2012-3#1)
staphylococci##18##1##(1990-6#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-5#2)(2008-7#4)(2010-12#1)(2010-4#3)(2011-2#1)(2012-3#2)
staphylococcus aureus##3##2##(2010-12#1)(2010-8#1)(2013-1#1)
staphylococcus##7##1##(1991-3#1)(2007-12#1)(2007-8#1)(2010-12#1)(2010-8#1)(2013-1#2)
staple##6##1##(1991-12#2)(2008-9#1)(2009-10#1)(2009-12#1)(2012-1#1)
stapled side-to-side anastomosis##2##3##(2013-1#2)
stapled side-to-side##3##2##(2013-1#3)
stapled##9##1##(2009-2#2)(2013-1#7)
stapler and##2##2##(1995-3#1)(2010-8#1)
stapler##9##1##(1992-9#2)(1995-1#1)(1995-3#1)(2007-8#1)(2010-8#4)
staplers from##2##2##(2010-8#2)
staplers##4##1##(1995-1#1)(2007-8#1)(2010-8#2)
staples##2##1##(1995-1#1)(2012-2#1)
stapling device##4##2##(1993-12#1)(1995-3#1)(1996-2#2)
stapling##8##1##(1991-12#1)(1993-12#1)(1995-3#2)(1996-2#2)(2007-8#1)(2013-1#1)
star##20##1##(1991-8#1)(1994-2#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#9)(2013-8#1)
star)##2##1##(2011-2#2)
starch 4##4##2##(2008-5#4)
starch accumulation##2##2##(2008-10#2)
starch and##6##2##(1990-12#1)(1990-7#1)(2008-10#1)(2009-12#1)(2013-7#1)(2013-8#1)
starch at##2##2##(2008-7#1)(2008-8#1)
starch breakdown##2##2##(2008-9#2)
starch by##2##2##(2008-6#1)(2008-7#1)
starch concentrations##2##2##(2008-10#1)(2008-9#1)
starch degradation##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
starch granules##5##2##(2008-1#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
starch hydrolysis##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
starch in##7##2##(2008-10#2)(2008-5#2)(2008-8#2)(2010-8#1)
starch metabolism##2##2##(2008-10#1)(2009-5#1)
starch to##3##2##(1990-12#1)(2007-11#1)(2008-10#1)
starch with##2##2##(2008-10#1)(2010-8#1)
starch##106##1##(1990-12#2)(1990-7#1)(1991-12#2)(1993-6#2)(1995-6#2)(1997-4#1)(1997-5#2)(2007-11#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-5#16)(2008-6#14)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-3#3)(2010-8#3)(2011-2#2)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#6)
starches##3##1##(2007-11#1)(2012-1#2)
starchy##5##1##(1995-6#1)(2008-6#3)(2012-1#1)
starfish##6##1##(1992-8#3)(2007-5#2)(2008-9#1)
staring##3##1##(2008-2#1)(2008-3#2)
stark contrast##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
starlight nulling##2##2##(2008-3#2)
starlings##5##1##(2008-3#1)(2008-8#2)(2008-9#2)
stars are##2##2##(2008-2#1)(2013-8#1)
stars##14##1##(1991-1#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#3)(2011-2#1)(2012-2#1)(2013-8#3)
start an##2##2##(2007-6#1)(2007-8#1)
start and##2##2##(2012-12#1)(2013-8#1)
start at the level of the##2##6##(2010-9#2)
start at the##3##3##(2007-12#1)(2010-9#2)
start at##5##2##(1990-2#1)(1995-12#1)(2007-12#1)(2010-9#2)
start codon##12##2##(1990-11#1)(1990-5#1)(1991-6#3)(1991-9#1)(1992-3#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
start from##2##2##(2008-11#1)(2008-9#1)
start in life##2##3##(2008-11#1)(2010-5#1)
start in##5##2##(1993-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)
start of the study##5##4##(1992-5#1)(2008-5#1)(2010-11#1)(2010-3#1)(2012-2#1)
start of the##25##3##(1990-6#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
start of##76##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)
start or##3##2##(1993-12#1)(1995-3#1)(2009-8#1)
start performance##3##2##(2011-2#3)
start point##21##2##(1990-11#1)(1990-5#2)(1991-6#3)(1991-9#2)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#2)(1994-12#3)(1997-4#1)(1997-6#1)
start position##4##2##(1993-12#1)(2008-6#3)
start signals##2##2##(1990-5#1)(2010-5#1)
start site of the##2##4##(1992-8#1)(1995-6#1)
start site of##6##3##(1991-5#1)(1992-3#1)(1992-8#1)(1995-6#1)(2008-9#2)
start site was##5##3##(1991-7#2)(1994-11#1)(1997-6#1)(2008-9#1)
start site##25##2##(1991-11#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-8#2)(1995-11#2)(1995-2#2)(1995-6#3)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-9#3)
start site)##2##2##(1991-2#1)(2012-2#1)
start sites and##2##3##(1990-11#1)(1994-11#1)
start sites##8##2##(1990-11#1)(1993-3#1)(1993-8#1)(1994-11#3)(2008-4#2)
start smoking##2##2##(1990-2#2)
start the program##2##3##(2008-6#1)(2008-9#1)
start the##3##2##(2007-11#1)(2008-6#1)(2008-9#1)
start their##2##2##(2009-12#1)(2011-2#1)
start to be##2##3##(2008-7#1)(2011-2#1)
start to##7##2##(1996-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
start up##3##2##(1992-1#1)(2008-10#1)(2008-6#1)
start with a##3##3##(2008-3#1)(2008-7#1)(2010-8#1)
start with the##3##3##(1990-2#1)(1994-12#1)(2008-2#1)
start with##8##2##(1990-2#1)(1993-12#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-8#1)
start##258##1##(1990-11#7)(1990-2#6)(1990-5#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#9)(1991-7#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#2)(1993-12#10)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#9)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#11)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
start-site##2##1##(1991-9#1)(1993-3#1)
start-up##9##1##(1991-12#1)(1991-3#4)(1997-2#1)(2008-2#1)(2008-5#1)(2008-7#1)
start/stop##2##1##(2011-1#2)
started ART##2##2##(2010-8#2)
started after##2##2##(2008-10#2)
started and##3##2##(1993-12#1)(2008-12#1)(2011-1#1)
started as a##2##3##(2011-2#1)(2012-1#1)
started at the##5##3##(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
started at##6##2##(1993-11#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
started before the##2##3##(1990-6#1)(2013-1#1)
started before##3##2##(1990-6#1)(2013-1#2)
started by##4##2##(1990-3#1)(1990-6#1)(2007-12#1)(2008-5#1)
started from##3##2##(2007-11#1)(2008-11#1)(2010-2#1)
started immediately after##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
started in##17##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-6#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#3)(2012-12#2)(2013-8#1)
started on##16##2##(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#2)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
started the##2##2##(2010-1#1)(2010-11#1)
started to be##5##3##(2007-12#1)(2008-11#2)(2010-8#1)(2012-1#1)
started to decline##2##3##(1997-2#1)(2012-3#1)
started to decrease##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
started to develop##2##3##(1992-11#1)(1995-6#1)
started to increase##7##3##(1994-6#1)(1995-3#5)(2010-8#1)
started to##37##2##(1992-11#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-3#5)(1995-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-7#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-3#1)(2012-1#1)(2012-3#1)
started treatment##2##2##(1997-6#1)(2011-2#1)
started with a##2##3##(1991-6#1)(2012-2#1)
started with##12##2##(1990-11#1)(1991-2#2)(1991-6#1)(1995-2#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
started within 24 h##2##4##(2011-2#2)
started within 24##3##3##(2011-2#3)
started within##4##2##(1992-2#1)(2011-2#3)
started##186##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-6#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-1#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#1)(1996-12#1)(1996-6#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#3)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#11)
starter##4##1##(2008-3#1)(2008-7#2)(2010-4#1)
starters##4##1##(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)
starting 2##2##2##(2008-10#1)(2008-7#1)
starting after##2##2##(1990-7#1)(2012-2#1)
starting and##3##2##(2008-10#3)
starting at 1##2##3##(1995-12#1)(2013-8#1)
starting at a##3##3##(1993-6#1)(2008-3#1)(2011-2#1)
starting at the##3##3##(2008-10#1)(2008-5#2)
starting at##21##2##(1991-6#1)(1992-11#1)(1993-6#1)(1995-12#2)(1996-5#1)(1997-3#1)(2008-10#5)(2008-3#1)(2008-5#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
starting compound for##2##3##(2008-11#1)(2008-5#1)
starting concentrations of##2##3##(1997-3#1)(2012-2#1)
starting concentrations##3##2##(1994-5#1)(1997-3#1)(2012-2#1)
starting dose of##3##3##(2008-6#1)(2008-7#2)
starting dose##4##2##(1992-10#1)(2008-6#1)(2008-7#2)
starting from 12##2##3##(2008-7#1)(2011-1#1)
starting from 3 months##2##4##(1992-5#1)(2008-4#1)
starting from a##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
starting from the##10##3##(1995-2#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#2)(2010-10#1)(2012-2#1)
starting from##31##2##(1990-8#1)(1992-5#1)(1993-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(2007-11#5)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
starting hemodialysis##2##2##(1991-11#1)(2012-3#1)
starting in 1997##2##3##(1994-12#1)(2013-7#1)
starting in the##3##3##(1993-8#1)(1996-3#1)(2012-3#1)
starting in##15##2##(1991-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
starting material and##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
starting material for##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
starting material##19##2##(1990-12#1)(1996-5#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#2)
starting materials##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)
starting molar##3##2##(2008-10#3)
starting on the##2##3##(2007-12#1)(2007-8#1)
starting on##4##2##(1991-2#1)(2007-12#1)(2007-8#1)(2010-7#1)
starting point for the##5##4##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
starting point for understanding the##2##5##(1992-12#1)(1994-2#1)
starting point for##20##3##(1992-12#1)(1992-3#1)(1994-2#1)(1996-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
starting point is##2##3##(1994-12#1)(2008-11#1)
starting point##34##2##(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#2)
starting points for##3##3##(1997-8#1)(2008-4#1)(2008-8#1)
starting the##8##2##(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)
starting time of##2##3##(2008-10#2)
starting time##5##2##(2008-10#2)(2010-8#2)(2011-2#1)
starting to##5##2##(1994-3#1)(2010-12#1)(2011-1#2)(2013-8#1)
starting treatment with##3##3##(1993-2#1)(2011-2#1)(2012-3#1)
starting treatment##5##2##(1991-9#1)(1993-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
starting values for##3##3##(2008-10#1)(2008-2#2)
starting values##5##2##(1993-8#1)(2008-10#1)(2008-2#3)
starting with a##2##3##(2008-10#1)(2008-4#1)
starting with the##2##3##(2010-4#2)
starting with##15##2##(1993-3#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-4#4)(2008-6#1)(2008-9#1)(2010-1#1)(2010-4#2)(2011-2#1)(2012-2#1)
starting##264##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#5)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#4)(2007-11#6)(2007-12#7)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#42)(2008-11#11)(2008-12#2)(2008-2#11)(2008-3#4)(2008-4#10)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#6)(2011-1#8)(2011-2#6)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#3)
startle and##2##2##(2008-11#1)(2008-4#1)
startle in mice##3##3##(2008-4#3)
startle response##8##2##(1996-2#2)(1996-5#1)(2008-11#2)(2008-4#3)
startle responses##3##2##(1996-2#2)(2008-4#1)
startle##32##1##(1991-12#1)(1996-2#5)(1996-5#2)(2008-11#11)(2008-4#13)
starts at##3##2##(1992-3#1)(1992-6#1)(2011-1#1)
starts by##4##2##(1997-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
starts from the##2##3##(2008-7#1)(2009-10#1)
starts from##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
starts in the##3##3##(1994-11#1)(2008-10#1)(2013-8#1)
starts in##6##2##(1994-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
starts the##2##2##(2008-10#2)
starts to##9##2##(1994-3#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-2#1)
starts with a##4##3##(2007-7#1)(2009-7#1)(2010-10#1)(2011-2#1)
starts with the##3##3##(1995-5#1)(2008-7#1)(2010-11#1)
starts with##15##2##(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#1)
starts##51##1##(1990-7#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-2#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
startup##5##1##(2008-11#4)(2010-8#1)
starvation in##2##2##(2008-7#2)
starvation of##4##2##(1993-6#1)(2008-9#3)
starvation period##2##2##(2008-6#1)(2008-7#1)
starvation resistance in##3##3##(2008-6#3)
starvation resistance##5##2##(2008-6#5)
starvation was##2##2##(2008-7#2)
starvation##49##1##(1990-11#2)(1990-2#1)(1990-7#1)(1992-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(2008-10#1)(2008-11#6)(2008-12#2)(2008-4#4)(2008-6#7)(2008-7#12)(2008-9#4)(2010-10#1)(2012-12#2)
starved##8##1##(1993-12#1)(1994-11#1)(1995-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
starving##3##1##(2008-5#1)(2009-8#1)(2011-2#1)
stasis in##2##2##(1994-3#1)(2013-1#1)
stasis of##2##2##(1995-5#1)(2012-3#1)
stasis ulcers##6##2##(2008-5#1)(2013-1#5)
stasis##16##1##(1994-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#7)(2013-8#2)
state III respiration rates##2##4##(1994-8#2)
state III respiration##4##3##(1994-8#4)
state III##5##2##(1994-8#5)
state III/DNP##3##2##(1994-8#3)
state Medicaid programs##2##3##(1995-12#1)(1997-2#1)
state Medicaid##3##2##(1995-12#1)(1995-3#1)(1997-2#1)
state abortion restrictions##2##3##(1994-2#2)
state according##2##2##(2008-10#1)(2011-1#1)
state activities##2##2##(1997-3#1)(1997-7#1)
state after##2##2##(2008-6#1)(2008-7#1)
state agencies##4##2##(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#1)
state analog##2##2##(1991-5#2)
state and can##2##3##(2008-2#1)(2008-3#1)
state and federal##7##3##(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#2)(1997-3#1)(2010-9#1)
state and future##3##3##(2007-4#1)(2010-3#1)(2011-2#1)
state and in##2##3##(2008-10#1)(2008-2#1)
state and its##3##3##(1995-3#1)(2009-8#1)(2013-1#1)
state and local governments##2##4##(1993-2#1)(1995-1#1)
state and local health##3##4##(1996-3#1)(1997-3#1)(2011-9#1)
state and local public health##5##5##(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)
state and local##17##3##(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#3)(1997-3#1)(2008-6#1)(2011-9#3)
state and of##2##3##(1997-2#1)(2007-6#1)
state and on##2##3##(1990-3#1)(1996-3#1)
state and the##8##3##(1996-1#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
state and##92##2##(1990-2#1)(1990-3#3)(1991-5#1)(1991-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#3)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#2)(2011-9#3)(2012-3#1)(2013-1#4)(2013-8#2)
state anxiety##2##2##(2010-6#2)
state are##4##2##(1996-2#1)(1997-7#2)(2008-7#1)
state as well as##3##4##(1997-2#1)(2008-3#1)(2011-2#1)
state as##8##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
state associated with##2##3##(2010-12#1)(2012-3#1)
state at pH##4##3##(1990-8#2)(1993-8#2)
state at##9##2##(1990-8#2)(1993-8#2)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
state attorneys general##2##3##(2008-11#2)
state by the##3##3##(2008-1#2)(2011-2#1)
state by##12##2##(1990-11#1)(1993-6#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
state can be##4##3##(1990-2#1)(1997-2#1)(2008-7#1)(2009-6#1)
state does not##3##3##(1993-3#1)(1996-12#1)(1996-3#1)
state due to##2##3##(1996-3#1)(2008-1#1)
state during##4##2##(1992-6#1)(1994-9#1)(2010-12#1)(2012-3#1)
state energy##4##2##(2009-12#1)(2009-9#1)(2010-2#2)
state evaluations##2##2##(1993-2#1)(1997-3#1)
state examination (MMSE)##2##3##(2008-7#2)
state fluorescence##3##2##(1995-3#1)(2008-10#2)
state following##2##2##(1990-11#1)(1991-2#1)
state for##7##2##(1994-2#1)(1995-2#2)(1997-3#1)(2007-11#1)(2008-11#1)(2009-5#1)
state free##2##2##(2010-8#1)(2011-2#1)
state from##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
state government##3##2##(1994-12#1)(1997-1#1)(1997-3#1)
state governments##5##2##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#1)
state has##3##2##(1995-5#1)(2008-6#1)(2009-9#1)
state have been##3##3##(2008-10#2)(2013-1#1)
state health agencies to##3##4##(1997-1#3)
state health agencies##5##3##(1995-12#1)(1997-1#4)
state health agency##3##3##(1996-2#1)(1997-1#1)(1997-2#1)
state health departments##4##3##(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
state health reform##2##3##(1994-2#1)(1997-3#1)
state health services commissions##3##4##(1996-12#1)(1997-2#2)
state health##26##2##(1991-12#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(2013-8#1)
state hospital##3##2##(1996-3#1)(1996-9#1)(2008-11#1)
state hospitals##3##2##(1992-8#1)(1995-1#1)(2008-12#1)
state in a##3##3##(2007-11#1)(2008-3#1)(2009-10#1)
state in the presence of##2##5##(1993-6#2)
state in the##12##3##(1993-6#2)(1996-3#1)(1996-5#1)(1997-2#2)(2008-10#1)(2008-7#2)(2009-3#1)(2011-2#1)(2013-1#1)
state in vivo##2##3##(1995-12#1)(2008-9#1)
state in which##2##3##(1995-11#1)(2011-1#1)
state in##48##2##(1990-3#2)(1991-8#1)(1991-9#1)(1993-6#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
state is at##2##3##(2007-12#1)(2008-7#1)
state is##25##2##(1990-8#2)(1991-2#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-5#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)
state itself##2##2##(2007-12#1)(2008-1#1)
state known as##2##3##(2008-5#1)(2008-9#1)
state law##4##2##(1996-2#1)(1996-5#1)(1997-7#1)(2008-4#1)
state legislation##4##2##(2008-11#4)
state legislators##2##2##(2008-11#2)
state legislatures##3##2##(2008-12#1)(2008-4#1)(2012-2#1)
state level##4##2##(1994-12#1)(2008-6#1)(2008-8#2)
state management##3##2##(1996-3#1)(2008-1#2)
state may##4##2##(1992-8#1)(1994-3#1)(1996-5#1)(2008-9#1)
state mental health##3##3##(1993-1#1)(1995-2#2)
state mental##5##2##(1993-1#1)(1995-2#3)(1996-9#1)
state model##2##2##(1996-12#1)(2010-8#1)
state name##2##2##(1990-11#2)
state nursing##2##2##(1996-3#1)(2012-3#1)
state observed##2##2##(1995-5#1)(1997-7#1)
state of Bahia##3##3##(2008-8#1)(2009-10#2)
state of São Paulo##3##4##(1996-12#1)(2008-10#2)
state of a##13##3##(1991-9#1)(1993-11#1)(1996-2#1)(2007-11#3)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#2)
state of affairs##4##3##(1991-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
state of an##3##3##(1996-4#1)(2007-12#1)(2008-3#1)
state of art##3##3##(1993-2#1)(2008-11#1)(2013-1#1)
state of differentiation##3##3##(1990-5#1)(1992-3#1)(2008-11#1)
state of health##5##3##(1992-3#1)(1993-11#1)(1994-9#1)(1997-1#1)(2011-2#1)
state of its##2##3##(1992-8#1)(2009-11#1)
state of knowledge and##2##4##(2007-11#1)(2010-5#1)
state of knowledge of##2##4##(2008-10#1)(2010-3#1)
state of knowledge on the##2##5##(1990-8#1)(1995-11#1)
state of knowledge on##3##4##(1990-8#1)(1995-11#1)(2012-2#1)
state of knowledge##14##3##(1990-8#1)(1991-3#1)(1995-11#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-6#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)
state of mind##2##3##(1994-2#1)(2013-1#1)
state of oxidative stress##2##4##(2008-5#2)
state of polarization of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
state of polarization##14##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#7)
state of rebalance##2##3##(2013-1#2)
state of some##2##3##(1991-12#1)(1993-11#1)
state of stress##2##3##(1996-4#1)(2008-4#1)
state of the animal##2##4##(1996-2#1)(2007-12#1)
state of the art for##2##5##(1995-2#1)(2008-4#1)
state of the art in##6##5##(2007-8#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#1)(2010-9#1)
state of the art##25##4##(1991-9#1)(1993-3#2)(1994-8#1)(1995-2#1)(1995-5#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#2)(2010-8#1)(2010-9#1)(2012-2#2)
state of the art]##2##4##(1996-11#1)(2013-8#1)
state of the cell##4##4##(1993-8#1)(1995-9#1)(2008-7#1)(2012-3#1)
state of the enzyme##2##4##(1994-3#1)(1997-2#1)
state of the laser##2##4##(2007-12#1)(2008-2#1)
state of the literature##2##4##(2008-5#1)(2009-7#1)
state of the science##4##4##(1992-3#1)(2009-5#2)(2010-9#1)
state of the system##2##4##(1992-6#1)(2008-8#1)
state of the##111##3##(1990-2#1)(1990-5#1)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#2)(1997-2#3)(1997-4#1)(1997-7#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#2)(2009-7#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
state of these##2##3##(1990-12#1)(1997-6#1)
state of##364##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#7)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#2)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#5)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#2)(1997-1#2)(1997-2#7)(1997-4#1)(1997-6#1)(1997-7#3)(2007-10#3)(2007-11#11)(2007-12#7)(2007-8#2)(2008-1#11)(2008-10#42)(2008-11#11)(2008-12#2)(2008-2#11)(2008-3#19)(2008-4#5)(2008-5#13)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-9#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#5)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#10)(2013-8#12)
state on##4##2##(1990-8#1)(2008-2#1)(2008-7#1)(2012-2#1)
state or local##2##3##(1995-2#1)(2011-9#1)
state or##7##2##(1990-9#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-2#1)(2011-9#1)(2013-8#1)
state policy##2##2##(2008-12#1)(2013-1#1)
state public health##3##3##(1995-2#2)(1997-3#1)
state public##4##2##(1995-2#2)(1997-3#1)(2012-3#1)
state regulations##3##2##(1995-2#2)(2008-3#1)
state response##2##2##(1997-3#1)(2008-10#1)
state restrictions on##3##3##(1994-2#3)
state resulting##2##2##(1991-9#1)(1996-3#1)
state space models in##2##4##(2008-11#2)
state space models##5##3##(2008-11#5)
state space##11##2##(2008-11#8)(2008-8#1)(2008-9#2)
state than in the##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
state than##5##2##(1994-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
state that can##2##3##(2007-11#1)(2008-12#1)
state that is##3##3##(1996-4#1)(2010-8#1)(2013-8#1)
state that the##2##3##(1997-3#1)(2007-11#1)
state that they##3##3##(1993-2#2)(2012-2#1)
state that##19##2##(1990-2#1)(1993-2#2)(1994-1#1)(1994-2#1)(1995-9#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
state the##2##2##(1995-11#1)(2011-2#1)
state to a##2##3##(2007-12#1)(2008-3#1)
state to another##2##3##(2007-12#1)(2008-10#1)
state to##15##2##(1992-12#1)(1992-5#1)(1995-12#1)(1995-8#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
state using##2##2##(2008-10#1)(2010-6#1)
state variables are##2##3##(2008-11#1)(2013-1#1)
state variables##4##2##(2008-11#3)(2013-1#1)
state was##16##2##(1991-6#1)(1992-5#1)(1993-12#2)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
state were##2##2##(2008-7#1)(2011-2#1)
state when##3##2##(1996-8#1)(2007-6#1)(2008-9#1)
state which##4##2##(1992-6#1)(1993-12#1)(2008-9#1)(2011-1#1)
state with a##4##3##(1995-5#1)(2007-2#1)(2008-3#1)(2008-7#1)
state with##14##2##(1991-3#1)(1995-5#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#3)(2010-7#1)(2012-12#1)
state##1399##1##(1990-10#1)(1990-11#9)(1990-12#6)(1990-2#8)(1990-3#8)(1990-5#7)(1990-7#1)(1990-8#19)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#9)(1991-2#6)(1991-3#5)(1991-5#7)(1991-6#1)(1991-8#4)(1991-9#7)(1992-1#5)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#9)(1992-8#10)(1992-9#3)(1993-1#2)(1993-11#15)(1993-12#9)(1993-2#9)(1993-3#5)(1993-5#2)(1993-6#6)(1993-8#9)(1994-1#1)(1994-11#4)(1994-12#8)(1994-2#15)(1994-3#8)(1994-5#7)(1994-6#1)(1994-8#14)(1994-9#5)(1995-1#6)(1995-11#4)(1995-12#16)(1995-2#23)(1995-3#16)(1995-5#9)(1995-6#7)(1995-8#1)(1995-9#2)(1996-1#12)(1996-11#1)(1996-12#13)(1996-2#17)(1996-3#22)(1996-4#4)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#15)(1997-2#35)(1997-3#22)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#15)(1997-8#4)(2007-1#2)(2007-10#6)(2007-11#26)(2007-12#31)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#6)(2008-1#27)(2008-10#158)(2008-11#60)(2008-12#10)(2008-2#30)(2008-3#48)(2008-4#20)(2008-5#27)(2008-6#12)(2008-7#51)(2008-8#27)(2008-9#22)(2009-1#1)(2009-10#6)(2009-11#6)(2009-12#8)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#10)(2009-7#10)(2009-8#7)(2009-9#8)(2010-1#3)(2010-11#4)(2010-12#14)(2010-2#8)(2010-3#3)(2010-4#5)(2010-5#4)(2010-6#10)(2010-7#3)(2010-8#7)(2010-9#5)(2011-1#12)(2011-2#37)(2011-3#1)(2011-9#5)(2012-1#1)(2012-12#9)(2012-2#29)(2012-3#13)(2013-1#30)(2013-8#29)
state&quot##3##1##(1995-3#1)(2008-9#2)
state's##9##1##(1991-8#1)(1992-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
state)##6##1##(1995-3#1)(2007-10#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
state-by-state##3##1##(1994-12#1)(1995-2#1)(1995-3#1)
state-dependent##4##1##(1996-4#2)(2008-1#1)(2008-8#1)
state-of-the-art of##3##2##(2008-10#1)(2008-9#1)(2011-7#1)
state-of-the-art##40##1##(1991-1#1)(1992-11#1)(1992-2#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
state-run##3##1##(1991-1#1)(2008-9#1)(2012-3#1)
state-specific##2##1##(2008-2#2)
state-wide##2##1##(1996-2#1)(2008-8#1)
state]##3##1##(1996-11#1)(2010-4#1)(2013-1#1)
stated as##2##2##(1992-6#1)(2007-2#1)
stated by##4##2##(1991-6#2)(1992-2#1)(2010-5#1)
stated in##3##2##(1995-2#1)(2007-11#2)
stated that the##11##3##(1990-11#1)(1992-11#1)(1993-3#1)(1995-6#2)(1996-9#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
stated that their##3##3##(1996-1#1)(2010-6#1)(2013-1#1)
stated that there is##2##4##(2008-3#1)(2010-10#1)
stated that they had##2##4##(2008-11#1)(2011-2#1)
stated that they##6##3##(1991-3#1)(2007-2#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#1)
stated that##41##2##(1990-11#1)(1991-3#1)(1992-11#2)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-9#2)(1997-1#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-8#2)(2010-10#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
stated##78##1##(1990-11#1)(1991-3#1)(1991-6#2)(1992-11#2)(1992-2#4)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-1#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-2#3)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-8#2)(2010-10#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
statement by the##2##3##(1996-3#1)(2012-12#1)
statement for the##2##3##(2008-12#1)(2010-6#1)
statement for##3##2##(1996-8#1)(2008-12#1)(2010-6#1)
statement of the##5##3##(1996-1#1)(2007-9#2)(2008-3#1)(2009-11#1)
statement of##9##2##(1990-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-4#1)(2007-9#2)(2008-3#1)(2009-11#1)
statement on the##4##3##(1991-3#1)(2009-10#1)(2009-8#2)
statement on##19##2##(1991-3#1)(1993-3#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#2)(2012-2#1)
statement regarding the##2##3##(1995-12#1)(2011-1#1)
statement that##2##2##(1997-1#1)(2008-11#1)
statement to##2##2##(1993-11#1)(2008-6#1)
statement were##2##2##(2008-10#1)(2009-8#1)
statement##73##1##(1990-2#1)(1991-11#1)(1991-3#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-8#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
statements and##3##2##(1992-12#1)(1992-2#1)(2008-10#1)
statements in the##2##3##(2007-4#1)(2008-9#1)
statements of##3##2##(2008-5#1)(2013-1#2)
statements regarding##2##2##(1997-1#1)(2008-11#1)
statements that##5##2##(1992-2#1)(2008-11#2)(2011-2#2)
statements were##3##2##(1992-12#1)(1993-1#1)(2008-9#1)
statements##39##1##(1990-11#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#2)(1997-1#2)(1997-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-9#2)(2009-4#1)(2011-2#6)(2012-1#1)(2013-1#4)
states (e##2##2##(2008-4#2)
states (the##2##2##(2008-8#1)(2009-8#1)
states and the##6##3##(2008-2#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-5#1)(2013-1#1)
states and##31##2##(1992-12#1)(1993-5#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2009-1#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-5#1)(2012-3#2)(2013-1#1)
states and/or##2##2##(2008-11#1)(2010-7#1)
states are##16##2##(1991-12#1)(1993-11#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2013-8#1)
states as##3##2##(2008-10#2)(2008-11#1)
states at##2##2##(2008-10#2)
states but also##2##3##(2008-12#1)(2009-10#1)
states but##4##2##(2008-12#1)(2009-10#1)(2011-1#1)(2012-3#1)
states by##2##2##(1996-5#1)(2009-11#1)
states can be##3##3##(2007-11#1)(2012-2#1)(2012-3#1)
states can##5##2##(1994-2#1)(2007-11#2)(2012-2#1)(2012-3#1)
states characterized by##2##3##(2008-3#1)(2008-4#1)
states during##4##2##(1991-6#1)(2007-11#1)(2007-12#1)(2009-5#1)
states following##2##2##(2008-3#1)(2008-7#1)
states for##8##2##(1991-9#1)(1992-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
states have been##3##3##(2007-11#2)(2007-5#1)
states have##6##2##(1997-3#1)(2007-11#2)(2007-2#1)(2007-5#1)(2010-4#1)
states in a##2##3##(1995-3#1)(2007-11#1)
states in the##11##3##(1996-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2013-1#1)(2013-8#1)
states in##43##2##(1990-8#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#3)(1997-3#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
states is##6##2##(1991-8#1)(1994-1#2)(2008-3#1)(2008-7#1)(2013-1#1)
states may##2##2##(1992-2#1)(2008-1#1)
states of a##2##3##(1993-5#1)(2007-11#1)
states of different##2##3##(2006-4#1)(2012-2#1)
states of fac-Re(CO)(3)(dpknph)Cl##2##3##(2008-10#2)
states of interest##2##3##(2008-11#1)(2011-2#1)
states of polarization##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
states of the neurons##2##4##(2008-11#1)(2009-8#1)
states of the##19##3##(1990-8#2)(1991-6#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-8#1)(2013-8#1)
states of##77##2##(1990-2#1)(1990-8#3)(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-5#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1997-7#3)(1997-8#1)(2006-4#1)(2007-11#5)(2007-12#5)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#7)(2008-5#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-4#1)(2013-7#1)(2013-8#2)
states on##3##2##(1996-4#1)(2008-4#1)(2009-5#1)
states should be##2##3##(2008-3#1)(2010-4#1)
states should##3##2##(1996-12#1)(2008-3#1)(2010-4#1)
states that it is##2##4##(1995-6#1)(1996-1#1)
states that the##3##3##(1996-5#1)(2007-11#1)(2008-4#1)
states that##24##2##(1993-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
states to##8##2##(1995-12#1)(1995-3#1)(1997-1#2)(1997-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
states under##4##2##(1997-2#1)(2006-6#1)(2008-11#1)(2011-2#1)
states was##4##2##(1990-10#1)(1996-5#1)(2008-10#1)(2008-7#1)
states were measured##2##3##(2007-12#1)(2008-6#1)
states were##11##2##(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
states where##3##2##(1996-12#1)(2008-11#1)(2010-12#1)
states which do not##2##4##(1994-2#1)(1996-1#1)
states which##4##2##(1994-2#2)(1996-1#1)(2008-7#1)
states with the##2##3##(2008-10#1)(2008-7#1)
states with##14##2##(1994-2#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#3)(2009-7#1)(2012-1#1)(2012-2#1)
states within##2##2##(2008-10#1)(2009-3#1)
states without##2##2##(1994-12#1)(1994-2#1)
states##550##1##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#4)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-8#6)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#3)(1993-8#3)(1994-1#4)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#5)(1995-5#8)(1995-6#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#6)(1997-2#6)(1997-3#6)(1997-5#1)(1997-7#6)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#27)(2007-12#19)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#62)(2008-11#21)(2008-12#7)(2008-2#8)(2008-3#36)(2008-4#16)(2008-5#10)(2008-6#1)(2008-7#31)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#14)(2012-3#9)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#9)
states'##4##1##(1997-1#2)(2008-11#1)(2012-3#1)
states)##6##1##(1993-1#1)(1994-2#3)(2008-10#1)(2009-5#1)
statesman##2##1##(2008-12#1)(2009-10#1)
statewide##23##1##(1991-2#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-1#2)(1995-12#2)(1996-1#2)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(2008-6#3)(2008-9#1)(2012-12#1)(2012-2#1)
static Fourier-transform spectrometer##2##3##(2008-2#1)(2008-3#1)
static Fourier-transform##4##2##(2008-2#2)(2008-3#2)
static SDME##2##2##(2008-10#2)
static and dynamic light scattering##2##5##(1994-3#1)(2008-2#1)
static and dynamic modes##2##4##(2008-10#1)(2010-7#1)
static and dynamic##25##3##(1990-6#1)(1990-7#1)(1993-12#1)(1994-3#1)(1995-3#1)(2007-11#3)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#5)(2008-9#1)(2010-7#1)(2011-2#1)
static and time-varying##2##3##(2008-2#1)(2008-3#1)
static and##38##2##(1990-6#1)(1990-7#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-3#1)(2007-11#3)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#8)(2008-9#1)(2009-1#2)(2010-7#1)(2011-2#1)(2012-1#1)
static biofilm systems##2##3##(2008-9#2)
static biofilm##3##2##(2008-9#3)
static case##2##2##(1997-6#1)(2008-11#1)
static cell##3##2##(2008-2#1)(2008-3#2)
static compliance##2##2##(1991-9#2)
static conditions##3##2##(2008-11#1)(2008-4#1)(2009-12#1)
static culture##3##2##(2008-11#2)(2008-6#1)
static cytometry##2##2##(1991-6#1)(2008-9#1)
static extraction time##2##3##(2008-10#2)
static extraction##4##2##(2008-10#4)
static friction##2##2##(2008-5#2)
static headspace (HS)##2##3##(2008-10#2)
static headspace gas chromatographic##2##4##(2008-10#2)
static headspace gas##3##3##(2008-10#3)
static headspace##5##2##(2008-10#5)
static images##4##2##(2013-1#4)
static imaging method##2##3##(2008-10#2)
static imaging##3##2##(2008-10#3)
static interference##3##2##(2007-12#1)(2013-8#2)
static light scattering##2##3##(2008-10#1)(2008-3#1)
static light-scattering instrument##2##3##(2007-11#2)
static light-scattering##5##2##(2007-11#3)(2008-3#2)
static magnetic field##3##3##(2007-12#2)(2010-2#1)
static magnetic fields##2##3##(1992-3#1)(1994-5#1)
static magnetic##5##2##(1992-3#1)(1994-5#1)(2007-12#2)(2010-2#1)
static mercury drop electrode (SMDE)##4##5##(2008-10#4)
static mercury drop electrode##10##4##(2008-10#10)
static mode sampling##2##3##(2008-10#2)
static mode##3##2##(2008-10#3)
static or##4##2##(1992-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
static phase##3##2##(2008-3#3)
static quenching effect##2##3##(2008-10#2)
static quenching##3##2##(2008-10#3)
static seeding##3##2##(2011-2#3)
static tester##2##2##(2008-3#2)
static time##2##2##(2008-10#2)
static ultrasonic##3##2##(2008-10#3)
static##226##1##(1990-6#1)(1990-7#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#2)(1993-12#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#7)(2007-12#10)(2007-8#2)(2008-10#58)(2008-11#11)(2008-12#1)(2008-2#11)(2008-3#34)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#9)(2009-1#3)(2009-12#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#8)
statically##5##1##(1990-8#1)(2008-10#1)(2008-3#2)(2011-2#1)
statin dose##2##2##(2013-1#2)
statin therapy in##2##3##(2008-11#1)(2008-3#1)
statin therapy is##2##3##(2008-3#1)(2008-7#1)
statin therapy##15##2##(2008-11#1)(2008-3#4)(2008-7#1)(2010-12#2)(2011-2#2)(2013-1#2)(2013-8#3)
statin treatment##3##2##(2011-2#2)(2013-8#1)
statin##29##1##(1991-6#1)(2008-11#1)(2008-3#5)(2008-7#1)(2009-4#1)(2010-12#4)(2011-2#5)(2012-3#1)(2013-1#5)(2013-8#5)
stating that##5##2##(1995-6#2)(1996-5#1)(2011-1#1)(2013-1#1)
stating##8##1##(1995-6#2)(1996-5#2)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
statins and fibrates##2##3##(2011-1#1)(2012-2#1)
statins and##6##2##(2008-10#1)(2008-12#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
statins in##2##2##(2008-5#1)(2012-1#1)
statins to##2##2##(2008-1#1)(2010-12#1)
statins##37##1##(2008-1#5)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-6#3)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#7)(2013-8#2)
station 3 was##2##3##(2007-8#2)
station 3##3##2##(2007-8#3)
station in the##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
station in##4##2##(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
station of the##2##3##(2008-10#1)(2010-1#1)
station of##4##2##(1993-12#1)(2008-10#1)(2008-12#1)(2010-1#1)
station##33##1##(1993-12#1)(2007-5#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#5)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
stationary and##2##2##(1996-5#1)(2008-3#1)
stationary phase Chromosorb 105##2##4##(2008-10#2)
stationary phase and a##2##4##(2008-10#2)
stationary phase and an##2##4##(2008-10#1)(2008-5#1)
stationary phase and##12##3##(1996-5#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)
stationary phase at##3##3##(2008-10#2)(2008-11#1)
stationary phase by HPLC##3##4##(2008-10#3)
stationary phase by##4##3##(2008-10#4)
stationary phase for the##2##4##(2008-10#2)
stationary phase for##8##3##(1991-5#2)(2008-10#6)
stationary phase in the##4##4##(1990-8#1)(2008-10#3)
stationary phase in##9##3##(1990-8#2)(1997-2#1)(2008-10#6)
stationary phase is##2##3##(2007-11#1)(2008-10#1)
stationary phase of the##2##4##(1997-4#1)(2008-10#1)
stationary phase of##6##3##(1997-4#1)(2008-10#4)(2008-11#1)
stationary phase surface##2##3##(2008-10#1)(2008-11#1)
stationary phase was##6##3##(2008-10#5)(2008-7#1)
stationary phase with##2##3##(2008-10#2)
stationary phase##134##2##(1990-7#1)(1990-8#2)(1991-5#3)(1995-3#1)(1995-8#2)(1996-5#1)(1997-2#2)(1997-4#1)(2007-11#1)(2008-10#95)(2008-11#8)(2008-4#1)(2008-5#2)(2008-7#6)(2009-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
stationary phases and##3##3##(2008-10#3)
stationary phases for steroids were##2##5##(2008-10#2)
stationary phases for##7##3##(2008-10#6)(2011-1#1)
stationary phases in##2##3##(1996-5#1)(2008-10#1)
stationary phases were##5##3##(2008-10#3)(2008-11#1)(2010-11#1)
stationary phases with the##2##4##(2008-10#2)
stationary phases with##3##3##(2008-10#2)(2011-1#1)
stationary phases##39##2##(1990-8#1)(1996-5#1)(1997-2#2)(2008-10#27)(2008-11#2)(2009-8#1)(2010-11#1)(2011-1#4)
stationary points##2##2##(2007-11#2)
stationary signal wave##2##3##(2008-3#2)
stationary##227##1##(1990-7#1)(1990-8#3)(1991-5#3)(1995-3#3)(1995-8#2)(1996-5#4)(1997-2#4)(1997-4#1)(2007-11#7)(2007-12#5)(2008-10#128)(2008-11#16)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)
stations and##2##2##(1992-7#1)(2009-4#1)
stations during##3##2##(1997-4#1)(2011-2#2)
stations in the##2##3##(2008-10#1)(2008-3#1)
stations in##7##2##(1991-12#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-3#1)
stations were established##2##3##(2007-5#1)(2011-2#1)
stations were##4##2##(1997-4#1)(2007-5#1)(2008-10#1)(2011-2#1)
stations##43##1##(1990-3#1)(1991-12#1)(1992-7#1)(1993-3#1)(1996-2#1)(1997-4#2)(2007-5#2)(2008-10#16)(2008-11#2)(2008-3#5)(2009-4#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-7#2)
statistic based on##2##3##(1995-2#1)(1996-3#1)
statistic for##4##2##(1996-3#1)(1997-3#1)(2008-12#1)(2012-3#1)
statistic is##6##2##(1992-9#1)(1996-3#1)(1997-3#2)(2008-10#1)(2013-8#1)
statistic that##2##2##(2008-10#1)(2008-8#1)
statistic was##2##2##(2008-10#2)
statistic##56##1##(1990-3#1)(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-9#3)(1995-2#3)(1995-9#1)(1996-3#6)(1997-3#5)(2008-10#13)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#4)
statistic)##2##1##(2008-7#2)
statistical agreement with##2##3##(2008-10#2)
statistical agreement##3##2##(2008-10#3)
statistical analyses are##2##3##(1992-12#1)(2010-7#1)
statistical analyses of##3##3##(2008-7#2)(2008-8#1)
statistical analyses##14##2##(1992-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2013-7#1)
statistical analysis and##2##3##(2008-1#1)(2008-7#1)
statistical analysis are##2##3##(2008-10#1)(2008-8#1)
statistical analysis is##3##3##(1990-5#1)(2008-2#1)(2008-4#1)
statistical analysis of the data##2##5##(2008-10#2)
statistical analysis of the results##3##5##(1991-12#1)(2008-10#2)
statistical analysis of the##18##4##(1990-3#2)(1990-9#1)(1991-12#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-9#1)(2009-11#1)(2013-1#2)
statistical analysis of##32##3##(1990-3#2)(1990-9#1)(1991-12#1)(1993-9#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
statistical analysis showed that##3##4##(1995-5#1)(2008-7#1)(2011-2#1)
statistical analysis showed##5##3##(1990-9#1)(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
statistical analysis was done by##2##5##(2013-8#2)
statistical analysis was performed using##2##5##(2011-2#2)
statistical analysis was performed##3##4##(2011-2#2)(2013-1#1)
statistical analysis was##7##3##(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)(2013-8#2)
statistical analysis##85##2##(1990-3#2)(1990-5#1)(1990-9#3)(1991-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-11#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
statistical and analytical##2##3##(2008-11#1)(2008-8#1)
statistical and##9##2##(1993-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)
statistical applications##2##2##(2008-10#2)
statistical approach to##2##3##(2008-3#1)(2008-4#1)
statistical approach##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-5#1)
statistical approaches##5##2##(2008-10#1)(2008-7#2)(2008-9#1)(2009-5#1)
statistical artifact##3##2##(2008-8#3)
statistical artifacts##2##2##(2008-8#2)
statistical association##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
statistical assumptions##2##2##(1997-4#1)(2010-9#1)
statistical averaging##3##2##(2008-9#3)
statistical characteristics##4##2##(2008-3#3)(2010-3#1)
statistical classification strategy gave##2##4##(2008-6#2)
statistical classification strategy##4##3##(2008-6#4)
statistical comparison of##4##3##(2008-10#2)(2011-1#1)(2013-1#1)
statistical comparison##7##2##(2008-10#4)(2010-11#1)(2011-1#1)(2013-1#1)
statistical considerations##2##2##(2008-10#2)
statistical correction##2##2##(2007-12#1)(2013-1#1)
statistical correlation between##4##3##(1992-12#1)(2007-11#1)(2008-10#1)(2013-1#1)
statistical correlation with the##2##4##(2008-7#2)
statistical correlation##8##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-4#1)(2013-1#1)
statistical data##4##2##(1995-1#1)(1997-8#1)(2008-10#1)(2008-7#1)
statistical description of##2##3##(2009-11#1)(2010-10#1)
statistical description##3##2##(2009-11#1)(2009-3#1)(2010-10#1)
statistical design##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
statistical difference between##9##3##(1996-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
statistical difference in the##3##4##(1991-5#1)(2011-1#1)(2011-2#1)
statistical difference in##4##3##(1990-12#1)(1991-5#1)(2011-1#1)(2011-2#1)
statistical difference was##4##3##(1994-3#1)(2008-10#1)(2010-8#1)(2013-8#1)
statistical difference##22##2##(1990-12#1)(1991-5#1)(1994-3#1)(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
statistical differences between##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
statistical differences in##4##3##(2012-12#1)(2013-1#3)
statistical differences were found##3##4##(2008-10#2)(2012-12#1)
statistical differences were##6##3##(2008-10#2)(2008-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
statistical differences##16##2##(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
statistical distribution##3##2##(2008-1#1)(2008-3#1)(2009-10#1)
statistical error##4##2##(2008-2#2)(2008-3#1)(2008-6#1)
statistical errors##3##2##(2008-3#3)
statistical evaluation of the##2##4##(2008-10#1)(2011-3#1)
statistical evaluation of##4##3##(1994-2#1)(2008-10#1)(2008-7#1)(2011-3#1)
statistical evaluation##9##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
statistical evidence##5##2##(1996-3#1)(2011-1#1)(2011-2#3)
statistical geometry##3##2##(1997-6#3)
statistical independence##2##2##(2008-8#1)(2010-1#1)
statistical inevitability##2##2##(2008-9#2)
statistical inference##5##2##(2007-7#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-2#1)
statistical measures##2##2##(2008-10#2)
statistical mechanics##2##2##(1994-2#1)(2008-3#1)
statistical method has##2##3##(2008-2#1)(2013-8#1)
statistical method##8##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
statistical methodology used##2##3##(1997-8#1)(2013-8#1)
statistical methodology##6##2##(1997-8#1)(2008-10#2)(2008-12#1)(2009-9#1)(2013-8#1)
statistical methods for##3##3##(1997-4#2)(2012-3#1)
statistical methods to##2##3##(2008-10#1)(2008-3#1)
statistical methods##28##2##(1990-2#1)(1990-9#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-4#2)(2008-10#8)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-5#1)(2012-2#1)(2012-3#1)
statistical model for##2##3##(1995-12#1)(2008-10#1)
statistical model of##2##3##(1992-2#1)(2009-11#1)
statistical model##15##2##(1992-2#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2013-8#2)
statistical models for##3##3##(1996-3#1)(2008-4#1)(2010-1#1)
statistical models##5##2##(1996-3#1)(2008-10#2)(2008-4#1)(2010-1#1)
statistical package##2##2##(2008-7#1)(2012-2#1)
statistical parameters that##2##3##(2008-10#1)(2008-3#1)
statistical parameters##6##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)
statistical power##10##2##(1992-9#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#3)(2012-2#1)(2012-3#1)(2013-1#1)
statistical problems##2##2##(1995-2#1)(2011-2#1)
statistical procedures for##2##3##(1996-6#1)(2008-10#1)
statistical procedures##3##2##(1995-6#1)(1996-6#1)(2008-10#1)
statistical process control (SPC)##2##4##(1996-1#1)(2008-10#1)
statistical process control##5##3##(1995-2#1)(1996-1#1)(2008-10#1)(2008-3#2)
statistical process##7##2##(1995-2#1)(1996-1#1)(2008-10#1)(2008-3#2)(2013-8#2)
statistical proof##2##2##(2008-10#2)
statistical properties of the##7##4##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#2)(2012-3#1)
statistical properties of##12##3##(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#2)(2010-10#1)(2012-3#1)
statistical properties##14##2##(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2010-10#1)(2012-3#1)
statistical regression##4##2##(2008-10#2)(2011-1#1)(2013-8#1)
statistical relation##2##2##(2007-11#1)(2008-11#1)
statistical relevance##3##2##(1991-2#1)(1996-2#1)(2011-2#1)
statistical results##5##2##(1992-4#1)(1996-12#1)(2008-12#2)(2008-7#1)
statistical sampling##5##2##(1992-2#5)
statistical scoring procedures##2##3##(2009-11#2)
statistical significance (P=0##2##3##(2008-11#1)(2008-7#1)
statistical significance between##2##3##(1990-12#1)(2011-2#1)
statistical significance in##2##3##(1990-12#1)(1991-8#1)
statistical significance was##6##3##(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
statistical significance when##2##3##(1992-11#1)(2013-1#1)
statistical significance##55##2##(1990-12#2)(1990-6#2)(1991-2#2)(1991-8#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#2)(2006-12#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#1)(2009-2#2)(2009-4#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
statistical significant decrease##2##3##(2013-8#2)
statistical significant##4##2##(1995-5#1)(2008-11#1)(2013-8#2)
statistical software##6##2##(1997-7#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-12#1)
statistical study of##2##3##(2008-10#1)(2008-6#1)
statistical study##5##2##(2008-1#1)(2008-10#3)(2008-6#1)
statistical support##4##2##(1997-7#1)(2008-8#2)(2012-3#1)
statistical techniques to##2##3##(2007-12#1)(2008-10#1)
statistical techniques##8##2##(1996-3#1)(2007-12#1)(2008-10#3)(2008-4#1)(2012-3#2)
statistical test##2##2##(2008-10#1)(2008-4#1)
statistical tests that##2##3##(1997-3#1)(2008-10#1)
statistical tests##8##2##(1994-1#1)(1997-3#2)(2008-10#3)(2011-1#1)(2012-3#1)
statistical theory##3##2##(2008-10#3)
statistical thermodynamic##3##2##(1990-8#1)(1997-2#2)
statistical thermodynamics##2##2##(2008-3#2)
statistical tools##6##2##(1993-3#1)(1996-3#1)(2008-10#2)(2010-8#1)(2013-8#1)
statistical treatment of##2##3##(2008-10#2)
statistical treatment##4##2##(2008-10#3)(2008-3#1)
statistical uncertainty##3##2##(2008-10#2)(2008-3#1)
statistical viewpoint##2##2##(1994-11#1)(2013-8#1)
statistical##622##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#5)(1991-12#1)(1991-2#3)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#6)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#5)(2006-12#1)(2006-6#1)(2007-11#9)(2007-12#8)(2007-7#6)(2008-1#6)(2008-10#109)(2008-11#23)(2008-12#10)(2008-2#16)(2008-3#44)(2008-4#15)(2008-5#9)(2008-6#13)(2008-7#34)(2008-8#24)(2008-9#21)(2009-10#2)(2009-11#9)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-5#5)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#13)(2011-2#18)(2011-3#1)(2012-12#10)(2012-2#13)(2012-3#14)(2012-4#1)(2013-1#20)(2013-7#1)(2013-8#18)
statistically analysed##2##2##(2008-10#1)(2008-9#1)
statistically analyzed##6##2##(1994-8#1)(2008-10#1)(2010-5#1)(2010-8#1)(2012-3#2)
statistically and##6##2##(2008-10#1)(2010-5#4)(2012-2#1)
statistically associated with##3##3##(1990-3#1)(2008-8#1)(2010-3#1)
statistically better##3##2##(2007-7#1)(2008-3#1)(2010-7#1)
statistically by##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
statistically comparable##3##2##(2008-10#3)
statistically compared with those##2##4##(2008-10#2)
statistically compared with##5##3##(2008-10#5)
statistically compared##6##2##(2008-10#6)
statistically different from the##2##4##(2008-10#1)(2010-3#1)
statistically different from##6##3##(1992-5#1)(2008-10#3)(2010-3#1)(2012-3#1)
statistically different##17##2##(1990-3#1)(1991-12#1)(1992-5#1)(1994-2#1)(1997-8#1)(2008-10#5)(2009-1#1)(2010-3#1)(2011-2#2)(2012-3#3)
statistically equivalent to##3##3##(2008-10#3)
statistically equivalent##4##2##(2008-10#3)(2011-2#1)
statistically evaluated for its accuracy and precision##2##7##(2008-10#2)
statistically evaluated using##2##3##(2008-12#2)
statistically evaluated##10##2##(1990-8#1)(2008-10#4)(2008-12#2)(2008-7#1)(2009-1#1)(2013-1#1)
statistically higher than##2##3##(2008-11#1)(2010-8#1)
statistically higher##7##2##(1995-12#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-8#2)
statistically important influence##2##3##(2008-5#2)
statistically important##3##2##(2007-11#1)(2008-5#2)
statistically in##4##2##(1997-8#1)(2008-10#1)(2008-12#1)(2013-7#1)
statistically independent##6##2##(1996-12#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#1)
statistically indistinguishable##2##2##(2008-10#2)
statistically insignificant##4##2##(1992-10#1)(1992-3#1)(1993-6#1)(2008-2#1)
statistically less##2##2##(1992-2#1)(1997-3#1)
statistically non-significant##3##2##(1992-11#1)(2008-10#2)
statistically not##3##2##(2007-9#1)(2008-1#1)(2008-7#1)
statistically processed##3##2##(1995-6#1)(2008-8#1)(2013-1#1)
statistically related to##2##3##(1992-2#1)(2008-9#1)
statistically reliable##2##2##(1997-2#1)(2008-11#1)
statistically satisfactory##2##2##(2008-10#2)
statistically separated##2##2##(2008-10#2)
statistically significant (P &lt##6##4##(1994-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
statistically significant (P##8##3##(1990-3#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)
statistically significant (p &lt##8##4##(1993-9#1)(1995-12#1)(1996-8#1)(2008-12#2)(2010-7#1)(2011-2#2)
statistically significant (p = 0##3##5##(1997-6#1)(2008-1#1)(2013-1#1)
statistically significant (p##14##3##(1990-12#1)(1993-9#2)(1995-12#1)(1996-8#1)(1997-6#1)(2008-1#1)(2008-12#3)(2010-7#1)(2011-2#2)(2013-1#1)
statistically significant and##2##3##(2008-10#1)(2008-8#1)
statistically significant association between##2##4##(2008-1#1)(2011-2#1)
statistically significant association##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
statistically significant associations##2##3##(2012-5#1)(2013-1#1)
statistically significant at##3##3##(2008-12#1)(2008-6#1)(2013-1#1)
statistically significant between##2##3##(2011-2#2)
statistically significant change in##2##4##(2007-10#1)(2010-3#1)
statistically significant change##4##3##(2007-10#2)(2010-3#1)(2013-1#1)
statistically significant changes in the##2##5##(2008-11#1)(2008-5#1)
statistically significant changes were found##2##5##(2009-8#1)(2012-3#1)
statistically significant changes##5##3##(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
statistically significant correlation between##4##4##(1994-3#1)(1996-8#1)(2013-1#1)(2013-7#1)
statistically significant correlation##8##3##(1994-3#1)(1995-5#1)(1996-8#1)(2007-8#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
statistically significant decreases##2##3##(2008-5#1)(2011-2#1)
statistically significant difference (p##2##4##(2011-1#1)(2013-1#1)
statistically significant difference (p&gt##2##4##(2013-1#2)
statistically significant difference between the two groups##2##7##(2007-7#1)(2008-12#1)
statistically significant difference between the two##4##6##(2007-7#1)(2008-12#2)(2009-8#1)
statistically significant difference between the##9##5##(1992-11#1)(2007-6#1)(2007-7#1)(2008-12#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
statistically significant difference between##13##4##(1992-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
statistically significant difference in the##3##5##(2008-11#1)(2013-1#1)(2013-8#1)
statistically significant difference in##11##4##(1994-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
statistically significant difference was found##3##5##(2008-10#1)(2011-1#1)(2011-2#1)
statistically significant difference was observed##2##5##(2009-11#1)(2013-1#1)
statistically significant difference was##6##4##(2008-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
statistically significant difference##39##3##(1992-11#1)(1993-2#1)(1994-2#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
statistically significant differences between the##6##5##(2007-9#1)(2008-10#1)(2009-10#1)(2011-1#1)(2013-1#2)
statistically significant differences between##14##4##(1997-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
statistically significant differences in the##3##5##(1991-4#1)(2008-7#1)(2012-3#1)
statistically significant differences in##14##4##(1991-4#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
statistically significant differences were##7##4##(1992-12#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
statistically significant differences##49##3##(1990-6#1)(1990-9#1)(1991-4#1)(1992-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-7#2)(1997-4#1)(1997-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#8)
statistically significant effect on the##3##5##(1994-6#1)(2009-1#1)(2009-8#1)
statistically significant effect on##4##4##(1994-6#1)(2008-7#1)(2009-1#1)(2009-8#1)
statistically significant effect##10##3##(1994-6#1)(1994-9#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-8#1)
statistically significant evidence##2##3##(1997-1#1)(2008-9#1)
statistically significant for##7##3##(1990-2#2)(1991-1#1)(1996-5#1)(2006-12#1)(2011-2#1)(2013-1#1)
statistically significant higher##2##3##(1990-8#1)(2013-1#1)
statistically significant improvement in##2##4##(1994-12#1)(2007-8#1)
statistically significant improvement##4##3##(1994-12#1)(2007-8#1)(2008-12#1)(2013-1#1)
statistically significant improvements in##2##4##(1991-2#1)(1993-1#1)
statistically significant improvements##4##3##(1991-2#2)(1993-1#1)(2008-7#1)
statistically significant in the##3##4##(2008-6#1)(2008-7#1)(2010-1#1)
statistically significant in##7##3##(2008-11#1)(2008-6#1)(2008-7#2)(2010-1#1)(2011-2#1)(2013-8#1)
statistically significant increase in the##4##5##(2007-8#1)(2008-5#1)(2009-8#2)
statistically significant increase in##9##4##(1992-11#1)(1992-2#1)(1992-3#1)(1994-3#1)(2007-8#1)(2008-5#1)(2009-8#3)
statistically significant increase##12##3##(1992-11#1)(1992-2#1)(1992-3#1)(1994-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-8#3)(2011-2#1)(2013-1#1)
statistically significant increases in##2##4##(1990-7#1)(2006-12#1)
statistically significant influence on##2##4##(2011-2#2)
statistically significant influence##3##3##(2011-2#3)
statistically significant lower##2##3##(2010-3#1)(2012-2#1)
statistically significant pre- to post-intervention##2##5##(2008-12#2)
statistically significant reduction in the##3##5##(1992-9#1)(1996-9#1)(2007-8#1)
statistically significant reduction in##4##4##(1992-9#1)(1996-9#1)(2007-8#2)
statistically significant reduction##6##3##(1992-9#1)(1996-1#1)(1996-9#1)(2007-8#2)(2013-1#1)
statistically significant relationship between##2##4##(2008-11#1)(2011-2#1)
statistically significant relationship##5##3##(2008-11#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
statistically significant results##2##3##(2008-10#1)(2012-12#1)
statistically significant##370##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#4)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#33)(2008-11#10)(2008-12#14)(2008-3#1)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#7)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#7)(2010-1#1)(2010-12#4)(2010-3#4)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#36)(2011-7#1)(2012-1#1)(2012-12#9)(2012-2#9)(2012-3#8)(2012-5#1)(2012-6#1)(2013-1#36)(2013-7#1)(2013-8#7)
statistically significant)##3##2##(2007-10#1)(2008-9#1)(2013-1#1)
statistically significantly different##2##3##(2010-10#1)(2011-2#1)
statistically significantly higher##4##3##(2008-12#1)(2008-7#1)(2013-1#2)
statistically significantly##16##2##(1997-5#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-8#1)
statistically similar to##2##3##(2008-10#1)(2013-1#1)
statistically similar##5##2##(2008-10#1)(2013-1#4)
statistically superior to##2##3##(2008-12#1)(2012-12#1)
statistically that the##2##3##(2008-1#1)(2008-8#1)
statistically the most significant##2##4##(2008-10#1)(2009-3#1)
statistically the##3##2##(2008-10#1)(2008-3#1)(2009-3#1)
statistically using one-way ANOVA##2##4##(2008-12#1)(2013-1#1)
statistically##571##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#5)(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-12#2)(2007-10#7)(2007-11#4)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#2)(2008-1#5)(2008-10#81)(2008-11#15)(2008-12#22)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#17)(2008-6#4)(2008-7#19)(2008-8#17)(2008-9#11)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#9)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#5)(2010-3#7)(2010-5#6)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#43)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#11)(2012-3#14)(2012-5#1)(2012-6#1)(2013-1#53)(2013-7#2)(2013-8#8)
statistician##2##1##(1995-12#1)(2009-11#1)
statisticians##5##1##(1995-2#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-2#1)
statistics also##2##2##(1996-3#1)(2008-9#1)
statistics and##15##2##(1991-3#1)(1992-9#1)(1993-12#1)(1995-9#1)(2008-1#1)(2008-10#2)(2008-4#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
statistics are##9##2##(1992-2#1)(2007-12#1)(2008-3#3)(2008-9#1)(2010-12#1)(2010-7#1)(2012-12#1)
statistics as##3##2##(1996-12#1)(2008-1#1)(2008-2#1)
statistics by##2##2##(1991-3#1)(2008-1#1)
statistics for##14##2##(1992-2#1)(1992-9#1)(1995-1#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2011-3#1)(2012-3#1)
statistics in the##6##3##(1990-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
statistics in##11##2##(1990-11#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2012-12#1)
statistics is##2##2##(2008-8#1)(2013-8#1)
statistics of a##2##3##(2008-3#1)(2010-3#1)
statistics of the##10##3##(1990-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#1)(2013-8#1)
statistics of##28##2##(1990-7#1)(1990-9#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#9)(2008-8#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
statistics on the##2##3##(1994-12#1)(2008-11#1)
statistics on##4##2##(1994-12#1)(2008-11#1)(2010-7#1)(2012-12#1)
statistics provide##2##2##(1992-6#1)(2008-9#1)
statistics that##4##2##(1992-11#1)(1992-6#1)(2011-1#1)(2013-1#1)
statistics to##6##2##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
statistics were calculated to##2##4##(2008-10#1)(2012-12#1)
statistics were calculated##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
statistics were evaluated##2##3##(1997-3#1)(2008-11#1)
statistics were used for##2##4##(2012-12#2)
statistics were used to##2##4##(2010-3#1)(2013-1#1)
statistics were used##5##3##(2010-3#1)(2012-12#2)(2013-1#2)
statistics were##12##2##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-3#1)(2012-12#3)(2013-1#2)
statistics##246##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-11#2)(1992-2#3)(1992-6#3)(1992-9#3)(1993-12#3)(1993-2#3)(1994-12#2)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-1#1)(1997-3#8)(1997-4#1)(2007-11#6)(2007-12#7)(2007-4#1)(2007-8#2)(2008-1#4)(2008-10#23)(2008-11#10)(2008-12#2)(2008-2#13)(2008-3#31)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#3)(2012-12#17)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
statistics]##2##1##(1990-12#1)(2013-8#1)
statolith removal##5##2##(2008-5#5)
stature with##3##2##(2012-2#1)(2013-1#2)
stature##30##1##(1993-6#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-3#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#8)
status (ECOG) was##2##3##(1992-2#1)(1992-8#1)
status (OR##2##2##(2012-12#1)(2012-3#1)
status (SES)##5##2##(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)
status (p##3##2##(1990-2#1)(2010-12#1)(2010-8#1)
status affects##2##2##(2009-7#1)(2011-2#1)
status after##5##2##(1991-12#1)(1994-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
status against##2##2##(1993-9#1)(2008-10#1)
status among immediately adjacent trees##2##5##(2008-10#2)
status among##9##2##(1992-12#1)(1994-2#1)(1996-6#1)(2008-10#2)(2011-1#2)(2011-2#2)
status and family##2##3##(2009-8#1)(2013-8#1)
status and future perspectives##2##4##(1994-9#1)(2012-3#1)
status and future##8##3##(1994-9#1)(1997-3#1)(2006-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-3#1)
status and health##3##3##(1990-12#1)(1996-2#1)(2009-5#1)
status and quality of life##2##5##(1997-1#1)(2009-12#1)
status and risk factors##2##4##(2011-1#1)(2013-1#1)
status and risk##3##3##(1993-11#1)(2011-1#1)(2013-1#1)
status and the##8##3##(1997-1#1)(2008-11#2)(2008-7#2)(2011-1#1)(2012-12#1)(2013-1#1)
status and##116##2##(1990-12#1)(1990-6#2)(1991-12#2)(1991-6#1)(1992-3#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2008-1#5)(2008-10#3)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#6)(2011-2#8)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#2)
status are##2##2##(2009-10#1)(2011-1#1)
status as a##3##3##(1995-2#1)(2012-12#1)(2012-3#1)
status as well as##2##4##(2008-5#1)(2012-12#1)
status as##11##2##(1994-12#1)(1995-12#1)(1995-2#1)(1997-3#2)(2007-11#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
status assessment for##2##3##(1992-9#1)(2012-3#1)
status assessment in##2##3##(2012-3#1)(2013-1#1)
status assessment##5##2##(1992-9#1)(2008-3#1)(2012-3#2)(2013-1#1)
status at the##4##3##(1991-7#1)(1992-8#1)(1995-5#2)
status at##8##2##(1991-6#1)(1991-7#1)(1992-8#1)(1994-1#1)(1995-5#3)(2013-1#1)
status between the##2##3##(1994-1#1)(1997-4#1)
status between##5##2##(1994-1#1)(1997-4#1)(2008-1#1)(2008-6#1)(2012-12#1)
status by##2##2##(2009-5#1)(2010-5#1)
status can##2##2##(1996-12#1)(2008-2#1)
status data##2##2##(1996-12#1)(2010-5#1)
status did not##4##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-7#1)
status during the##4##3##(1990-6#3)(2010-9#1)
status during##5##2##(1990-6#3)(1995-9#1)(2010-9#1)
status epilepticus##6##2##(1994-11#1)(2008-7#2)(2010-11#1)(2012-2#2)
status exchange##3##2##(2012-12#3)
status for both##2##3##(2008-10#1)(2012-12#1)
status for##8##2##(1993-2#1)(1994-1#1)(2008-10#1)(2009-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)
status from the##2##3##(1996-5#1)(2012-12#1)
status from##9##2##(1991-3#1)(1996-11#1)(1996-5#1)(2007-8#2)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
status has##2##2##(2007-7#1)(2011-1#1)
status improved##2##2##(1990-6#1)(2007-8#1)
status in Asian##2##3##(2007-12#1)(2010-10#1)
status in a##3##3##(1991-12#1)(1992-9#1)(2008-12#1)
status in patients with##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
status in patients##5##3##(2007-10#1)(2008-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
status in rats##3##3##(2008-12#1)(2009-6#2)
status in the elderly##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
status in the##13##3##(1992-3#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-7#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-1#2)
status in##72##2##(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-12#1)(1996-5#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
status information##4##2##(1996-1#2)(2008-10#1)(2010-3#1)
status is a##3##3##(1996-5#1)(2010-10#1)(2010-2#1)
status is##21##2##(1991-12#1)(1995-2#1)(1996-5#2)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
status may##5##2##(1994-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2013-8#1)
status of 12##2##3##(1993-9#1)(2012-3#1)
status of HIV##2##3##(2010-9#1)(2013-1#1)
status of Medicare##2##3##(1993-3#1)(1997-2#1)
status of a##9##3##(1993-2#1)(1996-3#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
status of an##2##3##(2008-11#1)(2011-2#1)
status of children##5##3##(1996-1#1)(2007-3#1)(2008-11#1)(2010-5#1)(2010-6#1)
status of displaced persons##2##4##(1994-9#2)
status of experiential learning##2##4##(1995-1#2)
status of patients in##2##4##(1992-3#1)(1995-3#1)
status of patients with##5##4##(1992-3#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
status of patients##10##3##(1992-3#2)(1995-3#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#1)
status of populations##2##3##(1995-12#2)
status of subjects##2##3##(2008-12#1)(2012-2#1)
status of the cell##2##4##(2008-9#1)(2012-1#1)
status of the patient##3##4##(1991-6#1)(1992-8#1)(2008-7#1)
status of the patients##3##4##(1995-11#1)(2008-1#1)(2008-6#1)
status of the##82##3##(1990-6#2)(1990-8#2)(1991-12#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
status of their##6##3##(1995-2#1)(2007-2#1)(2009-5#1)(2011-2#1)(2013-1#2)
status of these##6##3##(1994-1#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)
status of women##3##3##(1993-6#1)(2010-4#1)(2013-1#1)
status of##292##2##(1990-11#1)(1990-2#1)(1990-6#3)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#4)(1992-8#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2006-10#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#2)(2008-1#9)(2008-10#28)(2008-11#16)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#10)(2008-9#7)(2009-12#3)(2009-2#1)(2009-5#6)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#12)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#9)(2013-1#16)(2013-8#2)
status on the##2##3##(1993-3#1)(2012-12#1)
status on##9##2##(1993-12#1)(1993-2#1)(1993-3#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
status or##7##2##(1990-12#1)(1991-12#1)(1993-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
status over the##2##3##(2008-11#1)(2012-12#1)
status quo##3##2##(1994-12#1)(2008-7#1)(2010-12#1)
status showed##2##2##(1992-10#1)(1993-11#1)
status than##3##2##(2010-2#1)(2010-6#1)(2013-8#1)
status to the##2##3##(2007-8#1)(2008-10#1)
status to##10##2##(1992-9#1)(1994-3#1)(1995-12#1)(1997-6#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-3#1)(2010-4#1)(2013-1#1)
status was assessed by##2##4##(1993-3#1)(2008-7#1)
status was assessed##6##3##(1991-12#1)(1991-2#1)(1993-3#1)(2008-1#1)(2008-7#1)(2008-9#1)
status was determined by##2##4##(1993-11#1)(2008-8#1)
status was determined##3##3##(1993-11#1)(2008-11#1)(2008-8#1)
status was evaluated##2##3##(2008-10#1)(2011-1#1)
status was found##2##3##(2007-12#1)(2013-1#1)
status was identified##2##3##(2009-4#1)(2012-12#1)
status was not##2##3##(2008-10#1)(2013-8#1)
status was##32##2##(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-7#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
status were assessed##3##3##(1997-4#1)(2008-12#1)(2012-3#1)
status were evaluated##2##3##(2008-6#1)(2012-2#1)
status were##10##2##(1992-10#1)(1997-4#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
status while##3##2##(1995-2#1)(2010-3#1)(2011-2#1)
status with##9##2##(1997-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
status within##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
status##1132##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#3)(1990-6#9)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#13)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#8)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-12#5)(1992-2#4)(1992-3#7)(1992-6#1)(1992-8#4)(1992-9#8)(1993-1#7)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#10)(1993-6#5)(1993-9#3)(1994-1#5)(1994-11#2)(1994-12#12)(1994-2#7)(1994-3#14)(1994-5#4)(1994-6#4)(1994-7#4)(1994-8#1)(1994-9#4)(1995-1#4)(1995-11#1)(1995-12#12)(1995-2#11)(1995-3#5)(1995-4#2)(1995-5#6)(1995-6#2)(1995-9#4)(1996-1#6)(1996-11#1)(1996-12#9)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#11)(1997-4#9)(1997-5#9)(1997-6#2)(1997-7#7)(1997-8#7)(2006-10#5)(2006-5#1)(2006-9#1)(2007-10#3)(2007-11#13)(2007-12#17)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#6)(2007-8#6)(2008-1#29)(2008-10#75)(2008-11#40)(2008-12#25)(2008-2#3)(2008-3#6)(2008-4#15)(2008-5#18)(2008-6#13)(2008-7#43)(2008-8#9)(2008-9#20)(2009-10#3)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#15)(2009-6#2)(2009-7#9)(2009-8#11)(2009-9#4)(2010-1#1)(2010-10#13)(2010-11#4)(2010-12#13)(2010-2#10)(2010-3#6)(2010-4#11)(2010-5#7)(2010-6#6)(2010-7#3)(2010-8#12)(2010-9#3)(2011-1#35)(2011-2#61)(2011-3#2)(2011-7#2)(2012-1#4)(2012-12#39)(2012-2#34)(2012-3#29)(2013-1#59)(2013-7#5)(2013-8#22)
status) were##2##2##(2008-6#1)(2009-4#1)
status)##8##1##(1992-12#1)(1993-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-4#1)(2013-1#1)
status?##2##1##(2006-10#1)(2009-6#1)
status]##2##1##(1991-3#1)(1993-11#1)
statuses##7##1##(2007-8#1)(2009-5#2)(2009-7#1)(2012-12#1)(2013-8#2)
statute and##3##2##(1993-1#2)(1994-2#1)
statute of limitations##2##3##(1996-5#2)
statute of##3##2##(1996-5#3)
statute that##2##2##(1996-5#1)(1997-5#1)
statute##27##1##(1992-12#2)(1992-3#1)(1993-1#6)(1993-2#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#2)(1996-5#5)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#2)
statutes##7##1##(1992-12#1)(1993-12#1)(1994-1#2)(1996-1#1)(1997-6#1)(2007-3#1)
statutory and##3##2##(1991-12#1)(1992-12#1)(2008-11#1)
statutory health insurance##2##3##(1992-12#1)(2008-11#1)
statutory health##3##2##(1992-12#2)(2008-11#1)
statutory provisions##2##2##(1993-1#1)(2012-3#1)
statutory##27##1##(1991-12#1)(1991-7#1)(1992-12#6)(1992-2#1)(1992-3#2)(1993-1#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#4)(2012-1#1)(2012-3#1)(2013-8#1)
staufen##4##1##(1994-12#4)
staurosporin##2##1##(1990-8#1)(1997-1#1)
staurosporine and##2##2##(1991-2#2)
staurosporine##26##1##(1990-12#2)(1990-8#3)(1991-2#2)(1992-12#1)(1992-9#3)(1993-3#2)(1993-6#2)(1995-11#2)(1995-12#5)(2008-10#1)(2008-11#2)(2008-4#1)
stave off##2##2##(1993-9#1)(2013-7#1)
stavudine##7##1##(2008-10#3)(2008-5#2)(2008-7#2)
stay (median##2##2##(2007-8#2)
stay and a##2##3##(1995-12#1)(2008-10#1)
stay and##15##2##(1993-3#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-3#1)(2008-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
stay for the##2##3##(1992-2#1)(2008-10#1)
stay for##8##2##(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#2)(2007-8#1)(2008-10#1)
stay in hospital##9##3##(1990-6#1)(1992-5#1)(1996-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-4#1)(2013-1#1)
stay in the##8##3##(1991-12#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2009-8#1)
stay in##21##2##(1990-6#1)(1991-12#1)(1992-5#1)(1994-12#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
stay of the##2##3##(1990-9#1)(1997-6#1)
stay of##8##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#1)(1997-6#1)(2011-2#2)(2013-1#1)
stay on the##2##3##(1995-12#1)(1997-2#1)
stay on##6##2##(1991-1#1)(1992-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(2013-1#1)
stay than##2##2##(1993-2#1)(2010-8#1)
stay was##13##2##(1992-12#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-3#1)(2012-2#2)(2013-1#2)
stay were similar##2##3##(1994-3#1)(2007-8#1)
stay were##5##2##(1990-9#1)(1994-1#1)(1994-3#1)(1996-3#1)(2007-8#1)
stay##221##1##(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#8)(1991-3#1)(1992-1#3)(1992-12#11)(1992-2#3)(1992-3#4)(1992-5#1)(1993-1#3)(1993-12#9)(1993-2#5)(1993-3#2)(1994-1#2)(1994-12#5)(1994-3#7)(1994-5#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#7)(1996-1#5)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#3)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#4)(2007-5#1)(2007-7#2)(2007-8#12)(2008-1#2)(2008-10#8)(2008-11#2)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#14)(2012-2#14)(2012-3#5)(2013-1#20)(2013-8#3)
stayed in##3##2##(2007-1#1)(2008-10#1)(2012-3#1)
stayed##15##1##(1995-3#1)(1997-8#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-4#1)(2012-2#1)(2012-3#2)(2013-1#1)
staying in the##2##3##(2008-10#1)(2009-12#1)
staying in##5##2##(2008-10#1)(2009-12#1)(2010-10#2)(2013-1#1)
staying##12##1##(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-12#1)(2010-10#2)(2011-3#1)(2012-3#1)(2013-1#1)
stays and##2##2##(1993-3#1)(2011-2#1)
stays are##3##2##(1993-1#1)(2010-8#2)
stays for##3##2##(1996-1#2)(1997-1#1)
stays in a##2##3##(2010-8#1)(2013-1#1)
stays in##4##2##(2008-11#1)(2010-8#1)(2013-1#2)
stays##34##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#1)(2007-2#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-8#5)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
ste11##2##1##(1997-4#2)
ste7##2##1##(1997-4#2)
steadily from 2##2##3##(1994-12#1)(2008-10#1)
steadily from##3##2##(1992-4#1)(1994-12#1)(2008-10#1)
steadily in##2##2##(1997-2#1)(2008-5#1)
steadily increased##3##2##(1995-3#1)(2008-10#1)(2012-2#1)
steadily increases##2##2##(2007-10#1)(2008-5#1)
steadily increasing in##2##3##(2011-2#2)
steadily increasing##6##2##(1991-11#1)(1997-6#2)(2008-3#1)(2011-2#2)
steadily with##3##2##(1993-6#1)(1997-7#1)(2008-5#1)
steadily##41##1##(1990-5#2)(1991-11#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-6#2)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#5)(2008-7#2)(2011-2#3)(2012-2#2)(2013-8#1)
steady and unsteady##4##3##(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
steady and##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
steady decline##2##2##(1994-6#1)(2011-2#1)
steady in##2##2##(2008-11#2)
steady increase in the##2##4##(2009-7#1)(2012-2#1)
steady increase in##4##3##(2008-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
steady increase##5##2##(1997-3#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
steady state and##7##3##(2008-1#1)(2008-10#4)(2008-7#2)
steady state concentrations##2##3##(1990-5#1)(2008-10#1)
steady state conditions##2##3##(2008-10#2)
steady state experiments##2##3##(2008-7#2)
steady state fluorescence##2##3##(1995-3#1)(2008-10#1)
steady state fluxes##2##3##(2008-7#2)
steady state is##3##3##(2008-10#2)(2008-7#1)
steady state isotopomer##2##3##(2008-7#2)
steady state levels of##6##4##(1991-12#1)(1991-5#1)(1992-8#1)(1994-9#1)(1997-2#1)(2008-11#1)
steady state levels##7##3##(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-9#1)(1997-2#1)(2008-11#1)
steady state of##2##3##(2007-12#1)(2008-6#1)
steady state was##2##3##(1993-12#2)
steady state##74##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#2)(1993-12#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#14)(2009-5#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#2)
steady states##5##2##(1992-11#1)(1992-8#1)(1996-8#1)(2007-11#1)(2007-12#1)
steady swimming##2##2##(2010-8#2)
steady##138##1##(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#3)(1993-12#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#10)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#17)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#4)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
steady-state DO concentration##3##3##(2008-10#3)
steady-state Young's relaxation modulus##2##4##(2009-7#2)
steady-state and time-resolved fluorescence##2##4##(1990-2#1)(2008-8#1)
steady-state and##3##2##(1990-2#1)(1993-11#1)(2008-8#1)
steady-state concentration of##2##3##(1992-11#1)(2008-6#1)
steady-state concentration##4##2##(1992-11#1)(2008-10#2)(2008-6#1)
steady-state distribution##3##2##(2008-3#2)(2009-5#1)
steady-state fluorescence emission##2##3##(1992-6#1)(2008-10#1)
steady-state fluorescence polarization##2##3##(1990-12#1)(1991-5#1)
steady-state fluorescence spectra##2##3##(2008-10#1)(2009-2#1)
steady-state fluorescence spectroscopy##2##3##(2008-10#1)(2008-4#1)
steady-state fluorescence##10##2##(1990-12#1)(1991-5#1)(1992-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-2#1)
steady-state growth##5##2##(1993-9#2)(2008-11#1)(2008-6#1)(2008-7#1)
steady-state kinetic##5##2##(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-2#1)
steady-state kinetics##2##2##(1993-11#1)(1995-2#1)
steady-state level of the mRNA##2##5##(1990-11#1)(1992-1#1)
steady-state level of##10##3##(1990-11#1)(1992-1#1)(1992-9#1)(1993-6#1)(1995-6#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-4#1)
steady-state level##11##2##(1990-11#1)(1992-1#1)(1992-9#1)(1993-6#1)(1995-6#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
steady-state levels of##12##3##(1992-11#1)(1992-12#1)(1994-5#1)(1994-6#3)(1995-12#2)(1995-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
steady-state light distribution##2##3##(2008-3#2)
steady-state mRNA levels of##2##4##(1992-9#1)(2008-9#1)
steady-state mRNA levels##4##3##(1992-10#1)(1992-9#1)(1997-7#1)(2008-9#1)
steady-state mRNA##5##2##(1992-10#1)(1992-9#1)(1997-7#1)(2008-8#1)(2008-9#1)
steady-state measurements##2##2##(2008-3#1)(2008-7#1)
steady-state photorefractive##2##2##(2007-11#1)(2007-12#1)
steady-state response was##2##3##(2007-9#1)(2008-10#1)
steady-state response##4##2##(2007-9#2)(2008-10#1)(2008-9#1)
steady-state responses##2##2##(2007-9#1)(2008-9#1)
steady-state results##2##2##(1994-5#1)(2009-5#1)
steady-state##146##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-8#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#4)(1992-9#2)(1993-11#3)(1993-6#1)(1993-9#2)(1994-5#3)(1994-6#3)(1995-12#2)(1995-2#3)(1995-6#2)(1997-1#3)(1997-2#1)(1997-7#3)(2007-11#3)(2007-12#9)(2007-8#1)(2007-9#3)(2008-10#22)(2008-11#5)(2008-2#6)(2008-3#14)(2008-4#3)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#3)(2009-7#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
steadystate##2##1##(2008-7#1)(2013-1#1)
steal syndrome##5##2##(1993-3#1)(2007-7#2)(2008-1#2)
steal##6##1##(1993-3#1)(2007-7#2)(2008-1#2)(2010-5#1)
steam explosion##2##2##(2008-6#1)(2013-1#1)
steam generator##3##2##(2008-10#1)(2009-10#2)
steam##19##1##(1993-2#1)(2007-7#1)(2008-10#8)(2008-6#4)(2008-7#1)(2009-10#2)(2011-2#1)(2013-1#1)
steam-exploded poplar##3##2##(2008-6#3)
steam-pretreated willow##2##2##(2008-6#2)
steam-pretreated##3##1##(2008-6#2)(2011-2#1)
steamed potting mix##2##3##(2008-10#2)
steaming and Al##2##3##(2008-10#2)
steaming##3##1##(2008-1#1)(2008-10#2)
stearate (18##2##2##(1990-2#1)(1995-8#1)
stearate##7##1##(1990-2#1)(1995-8#1)(2008-10#2)(2008-5#1)(2010-5#1)(2013-8#1)
stearates##2##1##(2008-5#2)
stearic acid##7##2##(1991-3#2)(2008-10#5)
stearic##14##1##(1991-3#2)(1993-6#1)(1994-8#2)(2008-10#8)(2008-7#1)
stearothermophilus is##3##2##(1992-3#1)(1993-11#1)(1995-5#1)
stearothermophilus spores##2##2##(2007-7#2)
stearothermophilus##21##1##(1990-11#3)(1990-7#1)(1992-3#4)(1993-11#3)(1995-2#2)(1995-5#2)(2007-7#2)(2008-6#2)(2008-7#1)(2011-2#1)
stearylamine##2##1##(2008-10#1)(2008-8#1)
steato-hepatitis##2##1##(2008-1#1)(2013-1#1)
steatocystoma multiplex##2##2##(2012-3#2)
steatohepatitis##7##1##(2006-10#1)(2007-8#2)(2013-1#4)
steatorrhea##3##1##(1992-5#1)(2013-1#1)(2013-7#1)
steatosis##10##1##(2007-8#1)(2009-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#3)
steel and brass##2##3##(2008-10#2)
steel and##10##2##(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)
steel by##2##2##(2008-10#1)(2010-4#1)
steel pin##2##2##(2008-10#1)(2012-2#1)
steel plate##2##2##(2008-12#2)
steel plates##2##2##(2008-12#2)
steel production##2##2##(2008-10#2)
steel sample##3##2##(2008-10#3)
steel samples##7##2##(2007-12#1)(2008-10#6)
steel slag filters##2##3##(2013-1#2)
steel standards##2##2##(2008-10#2)
steel wire and##3##3##(2009-3#3)
steel wire##6##2##(2008-10#1)(2009-3#4)(2012-1#1)
steel wires##2##2##(2007-8#1)(2008-10#1)
steel##100##1##(1990-11#1)(1991-12#1)(1992-1#1)(1996-12#4)(1996-3#3)(2007-12#3)(2007-8#1)(2008-10#50)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2009-3#4)(2010-4#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#2)
steel)##3##1##(2008-10#2)(2011-2#1)
steelmaking##2##1##(2008-10#2)
steels by##2##2##(2007-12#1)(2008-10#1)
steels is##2##2##(2008-10#2)
steels##12##1##(2007-12#1)(2008-10#11)
steels)##4##1##(2008-10#4)
steep decrease in##3##3##(1992-6#1)(2008-3#1)(2008-8#1)
steep learning##2##2##(2008-11#2)
steep trajectory##2##2##(1995-12#2)
steep##32##1##(1992-6#1)(1995-12#3)(1995-5#1)(1995-6#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2013-1#1)(2013-7#1)
steep)##2##1##(2008-10#1)(2008-8#1)
steeper than##2##2##(2008-8#2)
steeper##9##1##(1993-8#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-6#2)
steeply##7##1##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-1#1)
steepness##4##1##(1995-3#1)(2008-10#1)(2008-3#2)
steered and rotated##2##3##(2008-3#2)
steered molecular dynamics##2##3##(2009-9#2)
steered##7##1##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#2)
steering committee for##2##3##(1993-3#1)(1995-12#1)
steering committee##3##2##(1993-3#1)(1995-12#1)(1997-3#1)
steering in##3##2##(2007-11#3)
steering is##2##2##(2008-2#1)(2008-3#1)
steering of##2##2##(2007-12#2)
steering the##2##2##(2008-3#1)(2008-5#1)
steering##22##1##(1993-3#1)(1995-12#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2013-8#1)
steers of##2##2##(2012-2#2)
steers were##2##2##(2010-4#1)(2012-2#1)
steers##9##1##(1996-12#2)(1997-5#1)(2010-4#1)(2012-2#4)(2013-1#1)
stele##4##1##(2008-10#4)
stellar coronagraph##4##2##(2007-11#4)
stellar interferometer with##2##3##(2007-11#1)(2008-3#1)
stellar interferometer##5##2##(2007-11#2)(2008-3#3)
stellar occultation##2##2##(2008-2#1)(2008-3#1)
stellar##19##1##(1997-8#1)(2006-10#1)(2007-11#7)(2008-2#2)(2008-3#8)
stellate cell line##2##3##(2008-11#2)
stellate cell##4##2##(2008-11#4)
stellate cells were##2##3##(1993-12#1)(2008-11#1)
stellate cells##10##2##(1993-12#1)(1997-3#1)(2006-10#1)(2008-11#5)(2009-7#1)(2013-8#1)
stellate##16##1##(1993-12#1)(1997-3#1)(2006-10#1)(2008-11#10)(2008-7#1)(2009-7#1)(2013-8#1)
stem (ES) cells##15##3##(1992-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)
stem (ES)##17##2##(1992-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#6)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)
stem and leaf##2##3##(2008-10#2)
stem and loop##2##3##(2008-8#1)(2011-3#1)
stem and progenitor cells##4##4##(2008-9#2)(2010-11#1)(2012-12#1)
stem and progenitor##5##3##(2008-4#1)(2008-9#2)(2010-11#1)(2012-12#1)
stem and##25##2##(1990-9#1)(2008-10#8)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
stem bark of##2##3##(2008-8#1)(2010-5#1)
stem base tissue##2##3##(2008-10#2)
stem base##4##2##(2008-10#4)
stem can be##2##3##(2008-10#2)
stem canker of##4##3##(2008-10#4)
stem canker##6##2##(2008-10#6)
stem cell (MSC)##2##3##(2012-12#1)(2012-7#1)
stem cell application##2##3##(2012-12#1)(2012-5#1)
stem cell banks##2##3##(2008-11#2)
stem cell behavior##2##3##(2008-11#1)(2009-3#1)
stem cell biology and##2##4##(2008-11#1)(2009-12#1)
stem cell biology##10##3##(2008-11#4)(2008-5#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-4#1)
stem cell compartment##2##3##(2008-7#1)(2010-4#1)
stem cell culture##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
stem cell deficiency and##2##4##(2010-10#1)(2010-11#1)
stem cell differentiation into##2##4##(2008-11#1)(2012-7#1)
stem cell differentiation##11##3##(2008-11#4)(2008-7#1)(2009-3#3)(2011-2#1)(2012-7#1)(2013-7#1)
stem cell factor##3##3##(1996-5#1)(2011-2#1)(2012-12#1)
stem cell fate##5##3##(2008-11#4)(2009-3#1)
stem cell function##2##3##(2009-3#1)(2009-8#1)
stem cell is##4##3##(2008-10#1)(2008-7#1)(2010-8#1)(2012-12#1)
stem cell line##6##3##(1997-6#2)(2008-11#2)(2008-8#1)(2013-1#1)
stem cell lineages##3##3##(2008-6#1)(2009-3#2)
stem cell lines##5##3##(1994-12#1)(2008-8#2)(2008-9#2)
stem cell maintenance and##2##4##(2009-8#1)(2013-8#1)
stem cell marker##3##3##(2009-10#1)(2010-11#1)(2012-5#1)
stem cell markers##2##3##(2009-12#1)(2012-5#1)
stem cell niche##5##3##(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2012-2#1)
stem cell niches##2##3##(2010-10#2)
stem cell pool##4##3##(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
stem cell population and##2##4##(2010-4#1)(2012-12#1)
stem cell population in Aplastic##2##5##(2010-11#2)
stem cell population in the##2##5##(2008-11#1)(2010-7#1)
stem cell population in##4##4##(2008-11#1)(2010-11#2)(2010-7#1)
stem cell population##14##3##(2008-11#6)(2010-11#2)(2010-4#1)(2010-7#3)(2012-12#2)
stem cell populations##5##3##(2008-11#1)(2009-8#1)(2010-11#2)(2010-6#1)
stem cell research##11##3##(2008-10#1)(2008-11#3)(2008-9#3)(2009-3#1)(2010-11#1)(2012-12#1)(2013-8#1)
stem cell state##2##3##(2009-3#2)
stem cell support##2##3##(1996-11#1)(2010-3#1)
stem cell systems biology##2##4##(2009-3#2)
stem cell systems##3##3##(2008-11#1)(2009-3#2)
stem cell therapy##8##3##(2008-10#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-4#1)(2013-1#2)
stem cell to##2##3##(2007-12#1)(2008-7#1)
stem cell transplant##4##3##(2008-10#1)(2009-10#1)(2010-11#1)(2012-12#1)
stem cell transplantation (HSCT)##4##4##(2006-10#1)(2010-11#1)(2010-5#1)(2011-2#1)
stem cell transplantation in a##2##5##(2006-10#1)(2011-2#1)
stem cell transplantation in##5##4##(2006-10#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
stem cell transplantation is##3##4##(1997-8#1)(2012-12#2)
stem cell transplantation##36##3##(1997-3#2)(1997-8#1)(2006-10#2)(2008-10#1)(2008-11#3)(2008-7#2)(2009-10#1)(2010-11#5)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#5)(2012-2#2)(2013-1#1)
stem cell transplantation]##3##3##(1997-3#1)(2011-2#1)(2012-2#1)
stem cell types##2##3##(2008-9#1)(2012-5#1)
stem cell##250##2##(1992-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-3#3)(1997-6#2)(1997-8#1)(2006-10#2)(2007-12#1)(2008-10#9)(2008-11#48)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#9)(2009-10#4)(2009-12#5)(2009-3#20)(2009-8#5)(2009-9#2)(2010-10#6)(2010-11#15)(2010-12#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#4)(2011-1#1)(2011-2#17)(2012-1#1)(2012-12#18)(2012-2#12)(2012-3#1)(2012-4#1)(2012-5#5)(2012-7#3)(2013-1#10)(2013-7#2)(2013-8#2)
stem cell)##2##2##(2008-11#1)(2010-11#1)
stem cell-based therapeutic products##2##4##(2012-12#2)
stem cell-based therapeutics##2##3##(2012-12#2)
stem cell-based##6##2##(2012-12#5)(2013-8#1)
stem cell-derived##2##2##(2011-2#2)
stem cell-like##2##2##(2012-5#1)(2013-1#1)
stem cells (ADSCs)##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
stem cells (CSCs)##3##3##(2009-9#1)(2011-2#1)(2012-12#1)
stem cells (ESC)##3##3##(2008-10#1)(2008-11#2)
stem cells (HSCs)##5##3##(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)
stem cells (MSCs)##9##3##(2008-11#2)(2008-5#2)(2008-9#1)(2010-8#1)(2012-12#2)(2012-7#1)
stem cells and their##2##4##(2011-2#1)(2012-4#1)
stem cells and##13##3##(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-4#1)(2013-1#1)
stem cells are##8##3##(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)
stem cells as##3##3##(2008-9#1)(2009-6#1)(2011-2#1)
stem cells because they##2##4##(2009-3#1)(2012-12#1)
stem cells both##2##3##(2008-11#2)
stem cells but##2##3##(2008-11#1)(2009-3#1)
stem cells can be##5##4##(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
stem cells can##8##3##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)
stem cells could##2##3##(2009-12#1)(2012-2#1)
stem cells for the treatment of##2##6##(2008-11#1)(2010-6#1)
stem cells for tissue engineering##2##5##(2008-5#1)(2012-5#1)
stem cells for##7##3##(2008-11#2)(2008-5#1)(2010-6#1)(2012-12#2)(2012-5#1)
stem cells from human cord blood##2##6##(2008-9#2)
stem cells from human##3##4##(2008-9#2)(2012-1#1)
stem cells from the##2##4##(2008-9#1)(2012-1#1)
stem cells from##15##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#4)(2009-12#1)(2010-7#1)(2012-1#2)(2012-2#2)(2013-8#1)
stem cells have##6##3##(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
stem cells in a##3##4##(2008-11#1)(2010-10#1)(2012-12#1)
stem cells in hepatic repair##2##5##(2012-2#2)
stem cells in the bone marrow##2##6##(2012-12#1)(2012-3#1)
stem cells in the##4##4##(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
stem cells in vitro##2##4##(2009-10#1)(2010-2#1)
stem cells in wound##2##4##(2008-9#1)(2012-12#1)
stem cells in##28##3##(2008-11#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-3#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-1#3)(2012-12#5)(2012-2#2)(2012-3#2)(2012-5#1)(2013-8#2)
stem cells into##6##3##(2008-11#5)(2008-9#1)
stem cells involved in the##2##5##(2007-12#1)(2012-1#1)
stem cells is##4##3##(2008-9#1)(2009-3#1)(2012-1#1)(2012-2#1)
stem cells isolated from##2##4##(2012-2#1)(2013-1#1)
stem cells may##2##3##(2012-2#1)(2013-1#1)
stem cells or their##2##4##(2008-11#1)(2008-7#1)
stem cells or##6##3##(2008-11#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-1#1)
stem cells that##2##3##(2009-3#1)(2012-12#1)
stem cells to##8##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)
stem cells transplantation##2##3##(2008-5#1)(2013-8#1)
stem cells was##2##3##(1992-5#1)(1995-2#1)
stem cells were##3##3##(2008-11#1)(2009-12#1)(2010-6#1)
stem cells will##4##3##(2008-11#2)(2009-3#1)(2010-12#1)
stem cells with a##2##4##(2008-11#2)
stem cells##342##2##(1991-11#1)(1992-12#1)(1992-5#1)(1993-2#2)(1993-8#2)(1994-11#3)(1994-5#1)(1995-2#4)(1997-8#1)(2006-10#1)(2007-12#3)(2008-10#11)(2008-11#70)(2008-4#7)(2008-5#12)(2008-7#7)(2008-8#5)(2008-9#39)(2009-10#3)(2009-11#1)(2009-12#9)(2009-3#24)(2009-6#4)(2009-8#1)(2009-9#1)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#4)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#13)(2012-1#16)(2012-10#1)(2012-12#23)(2012-2#17)(2012-3#6)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#2)(2013-1#9)(2013-7#1)(2013-8#5)
stem colonization##2##2##(2008-10#2)
stem contraction##2##2##(2009-6#2)
stem diameter##9##2##(2008-10#5)(2008-9#1)(2013-7#3)
stem elongation##2##2##(2008-10#2)
stem for##2##2##(2008-10#1)(2013-1#1)
stem from the fact that the##2##6##(2008-7#1)(2011-3#1)
stem from the##8##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-3#1)
stem from##17##2##(1990-11#1)(1991-2#1)(1993-12#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-1#1)
stem gall##9##2##(2008-10#9)
stem girdling##2##2##(2008-10#2)
stem grooving##3##2##(2008-10#3)
stem height##2##2##(2008-10#1)(2012-5#1)
stem hydration##2##2##(2008-10#2)
stem in##3##2##(2008-10#1)(2013-1#2)
stem infection##5##2##(2008-10#5)
stem infections##2##2##(2008-10#2)
stem inoculation##2##2##(2008-10#2)
stem is##2##2##(2010-3#1)(2013-1#1)
stem lesions##6##2##(2008-10#5)(2008-7#1)
stem necrosis##2##2##(2008-10#2)
stem of##7##2##(1995-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-6#1)(2013-1#1)
stem or progenitor cells##2##4##(2009-6#2)
stem or##3##2##(2009-6#2)(2011-2#1)
stem pieces##3##2##(2008-10#3)
stem pitting virus##4##3##(2008-10#4)
stem pitting##6##2##(2008-10#6)
stem rot caused by##2##4##(2008-10#2)
stem rot in##5##3##(2008-10#5)
stem rot of soybean##5##4##(2008-10#5)
stem rot of soybeans##2##4##(2008-10#2)
stem rot of##8##3##(2008-10#8)
stem rot or##2##3##(2008-10#2)
stem rot prevalence##2##3##(2008-10#2)
stem rot was##6##3##(2008-10#6)
stem rot##44##2##(2008-10#44)
stem rust of perennial ryegrass##2##5##(2008-10#2)
stem rust races##2##3##(2008-10#2)
stem rust resistance genes##2##4##(2008-10#2)
stem rust resistance in the##2##5##(2008-10#2)
stem rust resistance in##4##4##(2008-10#4)
stem rust resistance##9##3##(2008-10#9)
stem rust##23##2##(2008-10#23)
stem rust)##2##2##(2008-10#2)
stem samples##6##2##(2008-10#6)
stem segments##3##2##(2008-10#3)
stem tissue##8##2##(2008-10#7)(2008-11#1)
stem tissues##4##2##(2008-10#4)
stem to##4##2##(2008-10#4)
stem was##2##2##(1990-9#1)(1995-3#1)
stem with##2##2##(2011-2#2)
stem##987##1##(1990-11#1)(1990-5#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-3#3)(1997-6#2)(1997-8#3)(2006-10#3)(2007-11#3)(2007-12#6)(2007-5#1)(2008-10#235)(2008-11#130)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#17)(2008-6#2)(2008-7#25)(2008-8#16)(2008-9#55)(2009-10#7)(2009-11#2)(2009-12#16)(2009-3#47)(2009-4#3)(2009-5#2)(2009-6#14)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#12)(2010-11#18)(2010-12#6)(2010-2#2)(2010-3#6)(2010-4#7)(2010-5#2)(2010-6#5)(2010-7#6)(2010-8#7)(2011-1#6)(2011-2#43)(2011-3#2)(2012-1#20)(2012-10#1)(2012-12#47)(2012-2#29)(2012-3#8)(2012-4#3)(2012-5#14)(2012-6#1)(2012-7#5)(2013-1#37)(2013-7#6)(2013-8#9)
stem-and-loop region##2##2##(1993-6#2)
stem-cell-fate specification##2##2##(2009-3#2)
stem-cell-fate##3##1##(2009-3#3)
stem-loop at##2##2##(1995-8#2)
stem-loop##11##1##(1994-12#1)(1995-12#1)(1995-8#4)(1997-6#2)(2008-10#2)(2013-1#1)
stem-loops##2##1##(1995-8#1)(2008-10#1)
stem-pitting##3##1##(2008-10#3)
stem/progenitor##3##1##(2008-11#2)(2010-11#1)
stemmed from a##2##3##(1990-11#1)(1990-9#1)
stemmed from##3##2##(1990-11#1)(1990-9#1)(2008-1#1)
stemmed##4##1##(1990-11#1)(1990-9#1)(1995-5#1)(2008-1#1)
stemming from the##5##3##(1991-3#1)(2007-7#2)(2009-12#1)(2011-2#1)
stemming from##11##2##(1991-3#2)(2007-12#1)(2007-7#2)(2008-11#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-2#2)
stemming##13##1##(1991-1#1)(1991-3#2)(2007-12#1)(2007-7#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-2#2)
stemness##2##1##(2008-5#1)(2011-2#1)
stems after##2##2##(2008-10#1)(2011-10#1)
stems and leaves of##3##4##(2008-10#2)(2008-5#1)
stems and leaves##8##3##(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
stems and roots##3##3##(2008-10#1)(2011-10#2)
stems and##18##2##(2008-10#10)(2008-12#1)(2008-5#2)(2011-10#2)(2011-2#2)(2013-8#1)
stems are##2##2##(1993-11#1)(2009-4#1)
stems as##3##2##(2008-10#2)(2008-7#1)
stems by##2##2##(2008-10#2)
stems from##5##2##(1990-6#1)(1996-3#1)(2008-3#1)(2008-8#1)(2012-2#1)
stems in##2##2##(2008-10#1)(2010-12#1)
stems is##2##2##(2008-10#1)(2008-11#1)
stems of peach##2##3##(2008-10#2)
stems of##14##2##(2008-10#10)(2008-11#2)(2010-10#1)(2011-2#1)
stems were##4##2##(2008-10#4)
stems with##10##2##(2008-10#10)
stems##125##1##(1990-6#1)(1991-7#1)(1993-11#1)(1996-3#1)(2008-10#87)(2008-11#5)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-4#5)(2010-10#1)(2010-12#1)(2011-10#4)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
stenophagy##6##1##(2012-3#6)
stenosed##2##1##(2008-7#2)
stenoses in##2##2##(1992-5#1)(2008-10#1)
stenoses of the##4##3##(1992-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
stenoses of##6##2##(1990-8#1)(1992-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)
stenoses were##2##2##(2008-7#2)
stenoses##22##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-5#2)(1993-6#1)(1996-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#1)(2009-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
stenoses]##2##1##(1991-3#1)(1994-9#1)
stenosing##7##1##(1992-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#3)
stenosis (CAS)##2##2##(2011-2#2)
stenosis (n =##3##3##(1993-8#2)(1997-8#1)
stenosis and membranous##2##3##(2007-9#1)(2013-8#1)
stenosis and occlusion##2##3##(1996-2#1)(2008-7#1)
stenosis and the##2##3##(1990-2#1)(2008-8#1)
stenosis and##21##2##(1990-2#1)(1993-8#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-8#1)
stenosis as##2##2##(1992-5#1)(2007-8#1)
stenosis by##2##2##(2012-2#1)(2013-1#1)
stenosis caused by##3##3##(1990-3#1)(2007-8#1)(2008-1#1)
stenosis detected##2##2##(2007-8#1)(2008-7#1)
stenosis during##2##2##(1990-9#1)(2013-8#1)
stenosis has##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
stenosis in one##2##3##(2008-1#1)(2013-8#1)
stenosis in patients##2##3##(2008-7#1)(2009-10#1)
stenosis in the##5##3##(1997-8#1)(2007-10#1)(2007-8#1)(2008-8#1)(2011-2#1)
stenosis in##22##2##(1992-9#1)(1993-8#1)(1997-8#1)(2007-10#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
stenosis is a##3##3##(2007-8#1)(2013-1#2)
stenosis is an##2##3##(2008-8#2)
stenosis is usually##2##3##(2008-1#2)
stenosis is##13##2##(1996-2#1)(1997-2#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-7#2)(2008-8#2)(2013-1#3)
stenosis of the vertebral arteries##2##5##(1995-3#2)
stenosis of the vertebral##3##4##(1991-8#1)(1995-3#2)
stenosis of the##12##3##(1991-8#1)(1993-3#1)(1994-3#1)(1995-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#2)
stenosis of##22##2##(1991-11#1)(1991-8#1)(1993-3#1)(1994-3#1)(1995-3#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#3)
stenosis or##6##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)
stenosis treated with##2##3##(1990-9#1)(2009-12#1)
stenosis was##7##2##(1993-8#1)(1997-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2013-1#2)
stenosis were##6##2##(1993-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
stenosis with##6##2##(1996-9#1)(2007-8#2)(2012-2#1)(2013-1#2)
stenosis##244##1##(1990-2#1)(1990-3#4)(1990-6#1)(1990-9#3)(1991-11#1)(1991-8#1)(1992-1#1)(1992-5#2)(1992-9#3)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#7)(1994-11#2)(1994-3#2)(1995-3#3)(1996-2#2)(1996-9#1)(1997-2#1)(1997-8#6)(2007-10#8)(2007-5#1)(2007-7#6)(2007-8#23)(2007-9#1)(2008-1#19)(2008-10#2)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#20)(2008-8#15)(2009-10#1)(2009-12#1)(2009-3#3)(2009-5#3)(2009-8#1)(2010-12#3)(2010-5#1)(2011-2#18)(2012-12#1)(2012-2#12)(2012-3#6)(2013-1#22)(2013-8#8)
stenosis)##2##1##(2012-3#1)(2013-8#1)
stenosis]##5##1##(1990-8#1)(1990-9#1)(1995-3#1)(2008-7#1)(2013-1#1)
stenotic arterial##2##2##(1997-8#1)(2008-12#1)
stenotic canal##2##2##(2013-1#2)
stenotic lesions of##2##3##(1994-5#1)(2008-7#1)
stenotic lesions##5##2##(1994-5#1)(2008-12#1)(2008-7#2)(2011-2#1)
stenotic##15##1##(1990-9#1)(1994-5#1)(1996-6#1)(1997-8#1)(2007-10#1)(2008-12#2)(2008-3#1)(2008-7#2)(2011-2#1)(2013-1#3)(2013-7#1)
stent and##3##2##(2008-1#1)(2008-11#1)(2009-5#1)
stent deployment##2##2##(1994-11#1)(1997-8#1)
stent for##5##2##(1992-4#1)(2009-5#1)(2013-1#3)
stent graft##7##2##(2007-8#1)(2008-1#1)(2008-11#2)(2010-12#2)(2011-3#1)
stent grafts have been developed and##2##6##(2010-12#1)(2010-8#1)
stent grafts##8##2##(2008-11#1)(2010-12#3)(2010-8#3)(2011-2#1)
stent implantation in##2##3##(2008-11#1)(2009-5#1)
stent implantation##11##2##(1994-11#1)(1996-8#1)(2008-11#4)(2009-11#1)(2009-5#2)(2011-2#2)
stent in a patient with##2##5##(2007-8#1)(2010-5#1)
stent in##4##2##(1990-8#1)(2007-8#1)(2008-11#1)(2010-5#1)
stent insertion##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
stent material##2##2##(2009-7#2)
stent migration##2##2##(2008-12#1)(2013-1#1)
stent or graft thrombosis##2##4##(2011-2#2)
stent or##3##2##(2011-2#3)
stent placement and##2##3##(2008-12#1)(2008-2#1)
stent placement##6##2##(2007-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-1#1)
stent thrombosis after##2##3##(2008-11#1)(2011-2#1)
stent thrombosis##4##2##(2008-11#2)(2011-2#1)(2013-8#1)
stent was##4##2##(2007-8#2)(2008-11#2)
stent##129##1##(1990-8#3)(1992-4#1)(1994-11#4)(1996-8#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-8#9)(2008-1#3)(2008-10#2)(2008-11#24)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#10)(2008-8#2)(2009-1#1)(2009-11#1)(2009-5#5)(2009-7#5)(2010-12#7)(2010-5#4)(2010-8#3)(2011-2#16)(2011-3#1)(2012-2#2)(2013-1#10)(2013-7#1)(2013-8#3)
stent-assisted coiling##2##2##(2011-2#1)(2012-3#1)
stent-assisted##4##1##(2011-2#1)(2012-3#2)(2013-8#1)
stent-graft##4##1##(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
stented##5##1##(2008-1#1)(2008-12#1)(2008-4#1)(2010-8#1)(2013-1#1)
stentgraft##2##1##(2011-3#2)
stenting in##5##2##(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#2)
stenting is##2##2##(2008-12#1)(2013-1#1)
stenting of the##5##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
stenting of##7##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
stenting or##2##2##(2008-11#1)(2012-3#1)
stenting prior to coronary artery bypass##2##6##(2008-11#2)
stenting versus gastrojejunostomy##2##3##(2012-2#2)
stenting with##2##2##(2009-5#1)(2011-2#1)
stenting##47##1##(1992-4#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#4)(2008-3#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#7)(2012-2#3)(2012-3#1)(2013-1#5)
stents and##6##2##(2008-5#1)(2011-2#5)
stents are##4##2##(2008-11#1)(2008-7#1)(2013-1#2)
stents for##2##2##(2009-12#1)(2009-5#1)
stents has##3##2##(1994-11#1)(2008-11#1)(2008-12#1)
stents have been##2##3##(2008-12#1)(2008-7#1)
stents have##4##2##(2008-11#2)(2008-12#1)(2008-7#1)
stents in the##2##3##(2008-12#1)(2009-5#1)
stents in##11##2##(1990-8#1)(1994-11#1)(2008-11#3)(2008-12#1)(2009-12#1)(2009-5#1)(2012-2#3)
stents is a##2##3##(2008-11#1)(2011-2#1)
stents were##2##2##(1990-8#2)
stents##88##1##(1990-8#4)(1994-11#4)(1994-9#1)(1996-2#1)(2007-8#1)(2008-11#18)(2008-12#7)(2008-5#1)(2008-7#4)(2009-11#1)(2009-12#10)(2009-5#5)(2009-7#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#2)
stents]##2##1##(1991-3#1)(1991-5#1)
step and the##4##3##(2008-10#3)(2008-3#1)
step and##15##2##(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-6#1)(2011-1#1)(2012-3#1)
step are##3##2##(1997-1#1)(2008-10#2)
step associated with##2##3##(1991-9#1)(2008-10#1)
step at the##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
step at##6##2##(1997-7#1)(2008-10#3)(2008-3#1)(2012-2#1)
step before##4##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
step between##2##2##(2008-3#1)(2008-4#1)
step beyond##2##2##(1992-11#1)(2012-12#1)
step by step##2##3##(1997-1#1)(2008-11#1)
step by##14##2##(1992-6#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)
step can be##5##3##(1991-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
step can##8##2##(1991-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
step closer to##3##3##(2007-9#1)(2008-10#1)(2008-6#1)
step consisting of##2##3##(1990-12#1)(2008-10#1)
step consists##2##2##(2008-10#1)(2011-2#1)
step cycle in##2##3##(2007-12#2)
step cycle##3##2##(1997-2#1)(2007-12#2)
step during##3##2##(2007-8#1)(2008-7#1)(2012-12#1)
step followed by##2##3##(2008-10#2)
step following the##2##3##(2008-10#1)(2008-3#1)
step following##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
step for the development of##2##5##(2008-3#1)(2012-2#1)
step for the##8##3##(1992-6#1)(1993-6#1)(1994-11#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
step for##27##2##(1992-6#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1995-6#1)(1996-3#1)(2007-10#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
step forward in the##2##4##(2008-5#1)(2008-7#1)
step forward in##7##3##(1993-6#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2012-2#1)
step forward##10##2##(1993-1#1)(1993-6#1)(1994-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-2#1)
step from a##2##3##(1991-9#1)(2008-10#1)
step from the##2##3##(1994-12#1)(2008-10#1)
step from##5##2##(1991-9#1)(1994-12#1)(2006-12#1)(2008-10#2)
step further##5##2##(1994-2#1)(2008-7#1)(2008-9#2)(2009-9#1)
step gives##2##2##(2008-10#1)(2008-4#1)
step gradient##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
step has been##2##3##(1992-9#1)(2008-10#1)
step has##3##2##(1992-9#1)(2008-1#1)(2008-10#1)
step height measurement##2##3##(2007-11#1)(2008-3#1)
step height##4##2##(2007-11#2)(2008-3#2)
step in a##5##3##(1995-12#1)(2008-10#2)(2008-4#1)(2008-9#1)
step in analyzing##2##3##(1996-10#1)(2008-3#1)
step in colonization##2##3##(2008-5#1)(2008-9#1)
step in cytokinesis##2##3##(2009-8#2)
step in de novo pyrimidine biosynthesis##2##6##(1990-7#1)(1995-5#1)
step in establishing##2##3##(2007-8#1)(2010-9#1)
step in plant##2##3##(2009-8#1)(2011-1#1)
step in the development of##2##5##(1994-12#1)(1996-6#1)
step in the development##3##4##(1994-12#1)(1996-6#1)(2009-7#1)
step in the preparation of##2##5##(1992-3#1)(2008-7#1)
step in the process of##3##5##(1994-1#1)(2008-10#1)(2010-4#1)
step in the study of##3##5##(2008-11#1)(2008-2#1)(2008-4#1)
step in the##51##3##(1990-2#1)(1990-5#3)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#2)(1994-1#1)(1994-12#2)(1994-3#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
step in their##2##3##(1994-2#1)(2008-1#1)
step in this process##2##4##(1992-3#1)(2008-4#1)
step in this##9##3##(1992-3#1)(1992-8#1)(1996-2#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-2#1)
step in understanding the evolution of##2##6##(2012-2#1)(2013-1#1)
step in##138##2##(1990-2#1)(1990-5#5)(1990-7#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#8)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#2)(2009-7#2)(2009-8#5)(2010-11#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#3)(2013-8#1)
step includes an##2##3##(2008-10#2)
step into##2##2##(1991-3#1)(2011-1#1)
step is a##2##3##(2007-11#1)(2008-10#1)
step is required##2##3##(2008-11#1)(2008-2#1)
step is the##2##3##(1995-2#1)(1996-5#1)
step is to##7##3##(1995-12#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
step is##28##2##(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-8#1)
step of a##3##3##(1995-2#1)(1997-5#1)(2008-10#1)
step of chiral inversion##2##4##(1994-8#2)
step of chiral##3##3##(1994-8#3)
step of glucose##2##3##(1990-11#1)(1994-11#1)
step of hepatic##2##3##(1993-8#1)(2008-6#1)
step of its##3##3##(1992-12#1)(1992-6#1)(1994-12#1)
step of steroidogenesis##3##3##(1991-9#1)(2012-2#2)
step of the reaction##3##4##(1993-3#1)(2008-10#2)
step of the##19##3##(1992-5#1)(1992-8#1)(1993-3#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2008-9#1)(2010-6#1)(2013-8#1)
step of##70##2##(1990-11#1)(1990-4#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-9#3)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
step on##3##2##(1992-11#1)(2009-11#1)(2012-3#1)
step or##4##2##(1991-9#1)(2008-10#1)(2008-5#1)(2008-9#1)
step potential##2##2##(2008-10#2)
step prior to the##2##4##(1994-12#1)(2008-10#1)
step prior to##4##3##(1994-12#1)(2008-10#3)
step procedure##2##2##(1991-5#1)(2010-11#1)
step process##4##2##(1997-2#1)(2008-1#1)(2008-5#1)(2010-3#1)
step purification##3##2##(1992-12#1)(2008-7#1)(2013-1#1)
step required##2##2##(1990-8#1)(2008-10#1)
step sequential extraction procedure##3##4##(2008-10#3)
step size##8##2##(1995-3#1)(2008-3#4)(2009-2#2)(2011-2#1)
step sizes##2##2##(2008-6#1)(2011-2#1)
step test##4##2##(1996-3#3)(2012-2#1)
step that##4##2##(1993-11#1)(1995-5#1)(2008-3#1)(2008-4#1)
step the##4##2##(2008-10#1)(2008-11#1)(2008-3#2)
step to##30##2##(1992-12#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
step toward a##4##3##(1992-6#1)(2007-12#1)(2012-12#1)(2012-3#1)
step toward identifying##2##3##(1997-2#1)(2008-11#1)
step toward the##8##3##(1992-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-1#1)(2009-4#1)(2009-7#1)(2012-2#1)
step toward##34##2##(1991-12#1)(1992-3#1)(1992-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
step towards developing a##2##4##(1994-12#1)(2009-7#1)
step towards developing##3##3##(1994-12#1)(2008-11#1)(2009-7#1)
step towards the##2##3##(2008-10#2)
step towards##15##2##(1994-11#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-2#2)(2013-1#1)
step was carried out using##3##5##(2008-10#3)
step was carried out##5##4##(2008-10#5)
step was performed##3##3##(1996-5#1)(2008-10#2)
step was to##2##3##(1990-12#1)(2009-12#1)
step was##21##2##(1990-12#1)(1993-9#1)(1996-5#1)(2007-8#1)(2008-10#13)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)
step were##2##2##(2008-10#2)
step with a##3##3##(2008-10#2)(2010-12#1)
step with the##4##3##(2008-1#1)(2008-10#2)(2008-9#1)
step with##13##2##(1996-3#1)(2008-1#1)(2008-10#8)(2008-6#1)(2008-9#1)(2010-12#1)
step##810##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#6)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#5)(1991-9#10)(1992-1#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#2)(1994-1#3)(1994-11#8)(1994-12#9)(1994-2#4)(1994-3#7)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#8)(1995-3#5)(1995-5#3)(1995-6#9)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#9)(1996-3#6)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#13)(1997-3#7)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-10#3)(2007-11#15)(2007-12#10)(2007-5#1)(2007-8#8)(2007-9#1)(2008-1#15)(2008-10#223)(2008-11#31)(2008-12#2)(2008-2#13)(2008-3#50)(2008-4#18)(2008-5#13)(2008-6#16)(2008-7#16)(2008-8#7)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#11)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#15)(2012-1#3)(2012-12#4)(2012-2#16)(2012-3#8)(2013-1#15)(2013-8#6)
step(s)##3##1##(1997-1#2)(2008-10#1)
step)##2##1##(2008-10#2)
step-by-step##30##1##(1992-1#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#6)(2008-7#2)(2008-9#3)(2009-2#1)(2011-1#1)(2011-2#1)
step-down##4##1##(2009-9#4)
step-gradient##3##1##(2008-4#1)(2011-3#2)
step-index POF's##2##2##(2008-3#2)
step-index fiber##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
step-index##16##1##(2007-12#4)(2008-2#3)(2008-3#9)
step-scan##5##1##(2007-12#3)(2008-2#2)
step-through##2##1##(1994-3#2)
step-to-step transition types##3##3##(2012-12#3)
step-to-step transition##4##2##(2012-12#4)
step-to-step##5##1##(2012-12#5)
step-wise##4##1##(2008-10#2)(2010-7#1)(2011-2#1)
stepless##2##1##(2011-2#2)
steplike##3##1##(2007-12#1)(2008-3#2)
stepped##10##1##(1990-3#1)(1992-8#1)(1997-5#2)(2008-3#3)(2008-6#2)(2011-1#1)
stepper motor##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
stepper##5##1##(2007-12#1)(2008-10#1)(2008-3#3)
stepping motors##2##2##(2008-3#1)(2009-8#1)
stepping##14##1##(1993-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-3#2)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#4)
stepping-stone##2##1##(2008-11#1)(2008-9#1)
steps 1 and 2##4##4##(2008-12#1)(2012-3#3)
steps 1 and##6##3##(2008-12#1)(2008-4#2)(2012-3#3)
steps a##2##2##(1995-3#1)(1996-2#1)
steps and the##7##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-1#1)
steps and##22##2##(1992-8#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)
steps are quite##2##3##(2008-10#1)(2008-4#1)
steps are required##2##3##(2008-10#1)(2010-11#1)
steps are##19##2##(1991-12#1)(1994-2#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)
steps based on##2##3##(2008-10#2)
steps by##2##2##(1993-9#1)(2008-3#1)
steps can##2##2##(2008-7#1)(2013-7#1)
steps during##2##2##(1992-3#1)(2012-12#1)
steps for each##2##3##(2008-2#1)(2008-4#1)
steps for the##2##3##(2008-4#1)(2012-3#1)
steps for##20##2##(1991-3#1)(1997-7#1)(2008-10#3)(2008-2#5)(2008-3#1)(2008-4#4)(2008-8#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
steps forward in##2##3##(2012-12#2)
steps forward##3##2##(2008-8#1)(2012-12#2)
steps from##7##2##(1993-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-6#1)(2012-2#1)
steps in a##3##3##(2007-12#1)(2008-10#1)(2011-3#1)
steps in the development of##2##5##(2008-8#1)(2009-12#1)
steps in the process##2##4##(1993-12#1)(2008-9#1)
steps in the##22##3##(1993-12#1)(1994-8#1)(1995-2#1)(2008-1#2)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
steps in this##4##3##(1992-1#1)(1997-7#1)(2008-2#1)(2009-4#1)
steps in##52##2##(1990-11#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-2#1)(1996-6#1)(1997-7#1)(2007-12#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
steps include##2##2##(2008-3#1)(2008-6#1)
steps involve##2##2##(1991-6#1)(1997-7#1)
steps involved in the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
steps involved in##10##3##(1992-3#1)(1994-2#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#1)
steps involved##11##2##(1992-3#1)(1994-2#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#1)
steps necessary to##2##3##(1997-1#1)(2009-8#1)
steps necessary##3##2##(1997-1#1)(2008-4#1)(2009-8#1)
steps of the##20##3##(1992-6#1)(1993-11#1)(1995-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)
steps of##65##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)
steps or##2##2##(1990-12#1)(2008-10#1)
steps required for##2##3##(2008-1#1)(2010-3#1)
steps required##3##2##(2008-1#1)(2008-11#1)(2010-3#1)
steps starting with##2##3##(2008-4#2)
steps taken##4##2##(1993-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
steps that##8##2##(1992-1#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#1)(2012-3#1)
steps to follow##2##3##(2009-11#1)(2011-2#1)
steps to improve##2##3##(1994-2#1)(1996-2#1)
steps to##38##2##(1991-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-6#3)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
steps toward a##2##3##(1994-1#1)(2008-6#1)
steps toward##5##2##(1994-1#1)(1996-1#2)(2008-11#1)(2008-6#1)
steps using##4##2##(2008-10#3)(2008-4#1)
steps were also##2##3##(1993-3#1)(2008-10#1)
steps were required##2##3##(2008-10#2)
steps were##18##2##(1993-3#2)(2008-10#13)(2008-3#1)(2011-2#1)(2013-8#1)
steps with a##2##3##(2008-10#1)(2008-3#1)
steps with##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
steps##482##1##(1990-11#1)(1990-12#3)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#5)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#6)(2007-10#5)(2007-11#6)(2007-12#8)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#8)(2008-10#98)(2008-11#15)(2008-12#3)(2008-2#18)(2008-3#27)(2008-4#39)(2008-5#3)(2008-6#6)(2008-7#10)(2008-8#14)(2008-9#8)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#17)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#10)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#2)
steps/day##2##1##(2013-1#2)
stepwise and##2##2##(2008-10#1)(2010-4#1)
stepwise approach##3##2##(1996-7#1)(2008-4#1)(2012-3#1)
stepwise elution with##2##3##(1991-5#1)(1995-11#1)
stepwise elution##3##2##(1991-5#1)(1995-11#1)(2008-10#1)
stepwise evolution##2##2##(2008-10#1)(2010-4#1)
stepwise increase in##2##3##(2008-11#1)(2011-2#1)
stepwise increase##3##2##(2008-11#2)(2011-2#1)
stepwise increases##2##2##(2008-7#1)(2012-3#1)
stepwise linear discriminant analysis##2##4##(2008-10#2)
stepwise linear discriminant##3##3##(2008-10#3)
stepwise linear##6##2##(2008-10#3)(2008-11#1)(2010-5#2)
stepwise logistic regression analysis##2##4##(2008-10#1)(2012-2#1)
stepwise logistic regression##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
stepwise manner##3##2##(2007-12#1)(2008-10#2)
stepwise multiple regression analysis##2##4##(1992-9#1)(1994-9#1)
stepwise pattern##3##2##(2008-10#3)
stepwise procedure##3##2##(1996-5#1)(2008-10#1)(2012-12#1)
stepwise reduction of##2##3##(2008-7#1)(2009-5#1)
stepwise regression analysis##5##3##(1995-6#2)(1996-3#1)(1996-5#1)(2011-1#1)
stepwise regression##11##2##(1995-6#2)(1996-3#1)(1996-5#1)(2008-10#2)(2008-6#1)(2008-9#2)(2011-1#1)(2012-12#1)
stepwise##85##1##(1990-11#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#24)(2008-11#7)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
stercoralis##4##1##(1997-3#1)(2007-7#2)(2012-2#1)
stereo image##2##2##(2008-2#2)
stereo microscope##2##2##(2008-3#2)
stereo vision##3##2##(2008-3#2)(2008-9#1)
stereo##16##1##(1994-8#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#2)(2008-9#1)(2010-8#1)(2013-7#1)
stereo-specific##2##1##(2009-10#1)(2012-2#1)
stereocamera for particle image velocimetry##2##5##(2008-2#2)
stereocamera##4##1##(2008-2#4)
stereocenter##2##1##(2008-6#1)(2009-10#1)
stereocenters of the##2##3##(2008-6#1)(2010-2#1)
stereocenters##3##1##(2008-6#1)(2010-2#1)(2010-7#1)
stereochemical course of##3##3##(1990-7#1)(1992-7#1)(1996-5#1)
stereochemical outcome##3##2##(1995-5#1)(2008-7#2)
stereochemical outcomes##2##2##(1996-5#1)(2008-9#1)
stereochemical##14##1##(1990-7#3)(1992-7#1)(1992-8#1)(1995-5#1)(1996-5#2)(2008-10#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-2#1)
stereochemically##5##1##(1990-6#1)(1992-12#1)(1992-4#1)(1995-3#1)(1996-2#1)
stereochemistry of the##3##3##(1990-8#1)(1995-5#1)(2009-7#1)
stereochemistry of##12##2##(1990-12#1)(1990-8#1)(1992-11#1)(1992-8#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-2#1)
stereochemistry##22##1##(1990-12#1)(1990-8#1)(1992-11#1)(1992-8#2)(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-2#3)(2011-2#1)
stereodefined PS-oligos##3##2##(2008-4#3)
stereodefined##4##1##(2008-4#4)
stereoelectronic control##2##2##(1992-12#1)(2009-8#1)
stereogenic##2##1##(2008-8#1)(2013-1#1)
stereoisomer##4##1##(1994-8#1)(1995-2#1)(2007-11#1)(2009-12#1)
stereoisomers##11##1##(1992-9#1)(1995-3#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-2#6)
stereolithographic##4##1##(2008-3#2)(2013-1#2)
stereological##11##1##(1995-5#1)(1995-8#1)(2007-12#4)(2008-12#1)(2008-5#3)(2011-2#1)
stereology##3##1##(1992-12#1)(1995-5#1)(1996-9#1)
stereomicroscopy##3##1##(2008-10#2)(2013-1#1)
stereopsis##4##1##(1994-8#1)(2008-9#2)(2012-12#1)
stereoscopic image##2##2##(2008-2#2)
stereoscopic vision##2##2##(2008-3#1)(2012-1#1)
stereoscopic##11##1##(1990-8#1)(2008-2#4)(2008-3#2)(2008-9#1)(2011-2#1)(2011-7#1)(2012-1#1)
stereoselective synthesis of##2##3##(2009-12#1)(2010-2#1)
stereoselective##20##1##(1991-1#1)(1991-5#1)(1993-9#1)(1994-5#1)(1994-8#2)(1996-5#5)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-12#2)(2010-2#2)(2010-4#1)
stereoselectively##2##1##(1996-5#1)(2007-11#1)
stereoselectivity of##3##2##(1991-12#1)(1995-5#1)(2008-10#1)
stereoselectivity##13##1##(1990-6#1)(1991-12#2)(1992-12#1)(1992-7#1)(1995-3#1)(1995-5#2)(1996-5#1)(2008-10#1)(2009-2#2)(2009-5#1)
stereospecific##10##1##(1992-12#1)(1993-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-11#1)
stereospecificity##5##1##(1990-5#1)(1991-1#1)(1991-5#1)(1994-11#1)(1996-5#1)
stereotactic aspirations##2##2##(2008-7#2)
stereotactic biopsy##4##2##(2006-10#1)(2008-7#2)(2013-1#1)
stereotactic pallidotomy##3##2##(2008-7#3)
stereotactic procedures##2##2##(2008-7#2)
stereotactic radiosurgery##8##2##(1995-8#1)(2008-7#2)(2011-2#5)
stereotactic radiotherapy##3##2##(1994-3#1)(2008-3#1)(2008-7#1)
stereotactic##36##1##(1993-9#1)(1994-3#1)(1995-8#1)(1995-9#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#19)(2008-9#1)(2010-12#1)(2011-2#5)(2013-1#2)
stereotaxic##4##1##(1993-6#1)(1997-4#1)(2008-7#2)
stereotype group was exposed to##2##5##(2008-11#2)
stereotype group was##3##3##(2008-11#3)
stereotype group##4##2##(2008-11#4)
stereotype of a##2##3##(2012-3#2)
stereotype of##3##2##(2008-11#1)(2012-3#2)
stereotype that##2##2##(2008-11#1)(2009-9#1)
stereotype##12##1##(1993-2#1)(2008-11#8)(2009-9#1)(2012-3#2)
stereotyped##9##1##(1993-12#1)(1995-12#1)(1996-2#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
stereotypes of##2##2##(1990-2#1)(2012-3#1)
stereotypes##17##1##(1990-2#1)(1994-12#1)(2007-8#1)(2008-11#2)(2010-11#1)(2011-2#2)(2012-12#3)(2012-3#6)
stereotypic##2##1##(2007-12#2)
stereotypical##2##1##(2008-10#1)(2010-3#1)
stereotypies##3##1##(2008-11#3)
stereotypy performance##3##2##(2008-11#3)
stereotypy##7##1##(1995-12#2)(1995-3#2)(2008-11#3)
stereovision##4##1##(2008-2#2)(2008-6#1)(2011-2#1)
steric accessibility of##2##3##(1995-2#1)(2008-10#1)
steric accessibility##3##2##(1995-2#1)(2008-10#2)
steric and electronic##2##3##(1992-10#1)(1996-5#1)
steric and##4##2##(1990-7#1)(1992-10#1)(1996-5#1)(2010-12#1)
steric bulk of the##2##4##(1997-7#1)(2009-11#1)
steric effects##2##2##(2008-10#2)
steric factors##2##2##(2007-11#1)(2012-12#1)
steric hindrance and##2##3##(2008-10#1)(2012-1#1)
steric hindrance between the##2##4##(1990-8#1)(2011-2#1)
steric hindrance##13##2##(1990-8#1)(1994-11#1)(1994-9#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
steric hindrances##2##2##(1990-11#1)(2008-9#1)
steric influence on the##2##4##(1994-5#1)(2008-10#1)
steric repulsion##2##2##(1997-2#1)(1997-7#1)
steric repulsions##2##2##(2008-10#1)(2010-5#1)
steric requirements##3##2##(1996-2#1)(2012-3#1)(2013-1#1)
steric restriction##2##2##(2008-10#2)
steric##56##1##(1990-11#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-5#2)(1992-10#1)(1992-11#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-7#3)(2007-11#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
sterically demanding##2##2##(1996-5#1)(2008-11#1)
sterically hindered##4##2##(1991-8#1)(1994-9#1)(1996-5#1)(2008-10#1)
sterically##10##1##(1991-8#1)(1991-9#1)(1994-9#2)(1995-2#1)(1996-5#2)(2008-10#1)(2008-11#1)(2009-8#1)
sterile and fertile##3##3##(2008-8#2)(2013-7#1)
sterile and##4##2##(2007-12#1)(2008-8#2)(2013-7#1)
sterile anther##3##2##(2008-8#3)
sterile because##2##2##(2012-2#1)(2012-3#1)
sterile distilled water##2##3##(2008-10#1)(2008-5#1)
sterile fungus StFCh1-1##3##3##(2008-12#3)
sterile fungus##4##2##(2008-10#1)(2008-12#3)
sterile in##2##2##(2006-10#1)(2008-10#1)
sterile leaves##2##2##(2013-7#2)
sterile males to##2##3##(2011-2#1)(2012-12#1)
sterile males##3##2##(2011-2#1)(2012-12#2)
sterile phenotype##2##2##(1994-12#1)(1996-10#1)
sterile production##3##2##(2012-2#3)
sterile technique##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
sterile water##4##2##(1996-12#2)(2007-10#2)
sterile##77##1##(1990-12#1)(1994-12#2)(1994-5#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-12#2)(2008-10#12)(2008-11#1)(2008-12#7)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#7)(2008-9#2)(2011-2#5)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
sterilis##6##1##(2008-10#6)
sterilisation##2##1##(1996-8#1)(2007-7#1)
sterility and##6##2##(1993-8#1)(1995-8#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-3#1)
sterility mosaic disease##2##3##(2008-10#2)
sterility mosaic##4##2##(2008-10#4)
sterility of the final product##2##5##(2012-2#2)
sterility of the##4##3##(2008-11#1)(2012-2#3)
sterility of##6##2##(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#3)
sterility testing##2##2##(2012-2#2)
sterility##42##1##(1990-2#1)(1993-8#1)(1994-12#3)(1995-8#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2010-3#1)(2011-2#6)(2012-12#1)(2012-2#8)(2012-3#1)
sterilization and##2##2##(2010-7#1)(2011-2#1)
sterilization by##2##2##(2011-2#2)
sterilization of the##2##3##(2008-1#1)(2011-2#1)
sterilization of##7##2##(1992-12#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-3#1)(2009-5#1)(2011-2#1)
sterilization procedure##3##2##(1991-3#1)(1995-1#1)(1996-8#1)
sterilization status##2##2##(2013-8#2)
sterilization##43##1##(1991-11#1)(1991-3#5)(1991-6#1)(1992-12#3)(1993-3#2)(1994-3#1)(1995-1#6)(1996-3#4)(1996-8#2)(1997-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#1)(2013-8#2)
sterilized##11##1##(1990-3#1)(1991-3#1)(1995-3#1)(2008-10#5)(2008-11#1)(2012-2#1)(2013-1#1)
sterilizing pathogens##3##2##(2008-8#3)
sterilizing##5##1##(2008-7#1)(2008-8#3)(2010-7#1)
steriod##3##1##(1990-11#1)(1997-1#1)(2007-11#1)
steris##2##1##(2011-2#2)
sternal nonunion##5##2##(2012-2#5)
sternal notch##3##2##(2007-8#3)
sternal recumbency##2##2##(1994-7#2)
sternal wound infection##5##3##(2007-8#2)(2012-2#3)
sternal wound##7##2##(2007-8#4)(2012-2#3)
sternal##28##1##(1994-2#1)(1994-7#2)(1995-11#1)(2007-8#12)(2012-2#11)(2013-8#1)
sternite##3##1##(2007-12#3)
sternites##4##1##(2007-12#4)
sternoclavicular##4##1##(2007-8#2)(2009-6#1)(2012-2#1)
sternocleidomastoid##3##1##(2010-9#2)(2011-2#1)
sternotomy between##2##2##(2007-8#2)
sternotomy in##6##2##(2007-8#5)(2007-9#1)
sternotomy or##2##2##(2008-11#1)(2012-2#1)
sternotomy with##2##2##(2007-8#1)(2010-6#1)
sternotomy##42##1##(1993-3#1)(2007-8#32)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
sternum##13##1##(1995-6#4)(2007-8#6)(2012-1#1)(2012-2#2)
steroid - TSPO interactions##2##4##(2012-2#2)
steroid 21-hydroxylase##2##2##(1992-8#2)
steroid 5##5##2##(1990-11#3)(1994-11#1)(1995-9#1)
steroid 9alpha-hydroxylase##4##2##(2008-11#4)
steroid administration##2##2##(2008-7#1)(2009-3#1)
steroid and##5##2##(1990-11#1)(1994-12#1)(2008-1#1)(2010-2#1)(2012-2#1)
steroid binding##5##2##(1990-12#1)(1991-12#3)(1992-12#1)
steroid cells##2##2##(1996-5#2)
steroid consumption##2##2##(2009-3#2)
steroid dependent nephrotic syndrome##3##4##(2007-7#2)(2007-8#1)
steroid dependent##5##2##(2007-7#3)(2007-8#1)(2008-1#1)
steroid dosage##4##2##(2006-10#3)(2007-11#1)
steroid drugs##3##2##(1996-5#1)(2008-10#2)
steroid hormone receptor##3##3##(1995-6#1)(2007-4#1)(2008-4#1)
steroid hormone##13##2##(1991-8#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#4)(2009-4#1)
steroid hormones and##2##3##(1994-9#1)(2008-4#1)
steroid hormones are##2##3##(1995-2#1)(2008-3#1)
steroid hormones##14##2##(1990-11#1)(1994-6#1)(1994-9#4)(1995-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-4#1)(2012-3#1)
steroid in##3##2##(1990-11#1)(2007-7#1)(2008-10#1)
steroid induced##2##2##(2007-7#1)(2009-3#1)
steroid injection##2##2##(2010-3#1)(2012-2#1)
steroid injections##4##2##(2007-11#1)(2007-7#1)(2008-8#1)(2008-9#1)
steroid molecules##2##2##(1990-2#1)(1991-8#1)
steroid nucleus##2##2##(2008-11#2)
steroid production##3##2##(1995-12#1)(2012-2#1)(2013-1#1)
steroid receptor complexes##2##3##(1992-11#2)
steroid receptor##7##2##(1991-12#1)(1992-11#2)(1993-2#1)(1994-6#1)(2008-4#1)(2011-2#1)
steroid receptors and##3##3##(1992-11#1)(1993-8#1)(1997-4#1)
steroid receptors##7##2##(1991-12#1)(1992-11#1)(1993-8#2)(1997-4#1)(2008-4#1)(2008-7#1)
steroid resistant nephrotic syndrome##2##4##(2007-7#1)(2007-8#1)
steroid resistant##7##2##(2007-7#5)(2007-8#2)
steroid secretion and##2##3##(2008-12#1)(2010-8#1)
steroid secretion by##2##3##(2008-12#2)
steroid secretion##4##2##(2008-12#3)(2010-8#1)
steroid side##2##2##(2007-7#2)
steroid structure##2##2##(1996-2#1)(2008-10#1)
steroid substrates##2##2##(1990-11#2)
steroid synthesis##2##2##(2008-4#1)(2008-5#1)
steroid therapy##17##2##(1990-11#1)(1994-6#1)(2007-11#1)(2007-7#3)(2008-1#2)(2008-4#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#3)
steroid treatment##5##2##(1992-12#1)(1996-11#1)(1996-5#1)(2008-4#2)
steroid use##2##2##(2009-3#2)
steroid was##2##2##(1990-11#1)(2008-10#1)
steroid##215##1##(1990-11#16)(1990-12#2)(1990-2#1)(1991-12#5)(1991-5#3)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#4)(1992-8#2)(1993-1#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#4)(1995-12#4)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#1)(1997-1#3)(1997-4#1)(2006-10#3)(2007-11#3)(2007-4#1)(2007-7#20)(2007-8#5)(2008-1#6)(2008-10#10)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#17)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#1)(2009-3#6)(2009-4#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#2)
steroid-binding domain##3##2##(1990-11#3)
steroid-binding##4##1##(1990-11#4)
steroid-dependent##2##1##(2010-12#2)
steroid-induced##2##1##(2008-7#2)
steroid-sparing##3##1##(2008-3#1)(2010-12#1)(2012-3#1)
steroidal anti-inflammatory drug##2##3##(1997-1#1)(2012-12#1)
steroidal anti-inflammatory##3##2##(1997-1#1)(2010-4#1)(2012-12#1)
steroidal saponin##2##2##(1992-8#1)(2008-10#1)
steroidal saponins##3##2##(2008-11#3)
steroidal##17##1##(1990-11#1)(1990-9#1)(1991-8#1)(1992-8#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
steroidogenesis in rat adrenal##2##4##(1996-2#2)
steroidogenesis in##3##2##(1996-2#3)
steroidogenesis##15##1##(1991-3#2)(1991-9#1)(1992-3#1)(1995-12#1)(1996-2#3)(2012-2#6)(2013-1#1)
steroidogenic acute regulatory protein##2##4##(1995-12#1)(2008-4#1)
steroidogenic acute regulatory##3##3##(1995-12#2)(2008-4#1)
steroidogenic##10##1##(1990-11#1)(1991-3#1)(1995-12#3)(1995-2#1)(2008-4#2)(2008-7#1)(2012-2#1)
steroids and a##2##3##(1991-12#1)(1995-10#1)
steroids and cytotoxic##2##3##(2007-7#1)(2008-1#1)
steroids and other##3##3##(1990-11#1)(1991-3#1)(2007-7#1)
steroids and tamoxifen##2##3##(2011-2#2)
steroids and##23##2##(1990-11#1)(1991-12#1)(1991-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(2006-10#1)(2007-7#4)(2008-1#1)(2008-5#2)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
steroids are also##2##3##(2010-6#1)(2012-2#1)
steroids are##8##2##(2007-10#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-6#1)(2012-2#1)
steroids at the##2##3##(1995-10#1)(2008-7#1)
steroids for##2##2##(2010-12#1)(2010-2#1)
steroids having##3##2##(1990-8#1)(1997-1#2)
steroids in the##2##3##(1994-5#1)(1996-3#1)
steroids in##14##2##(1994-5#2)(1994-9#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#2)(2008-10#2)(2008-4#1)(2010-11#1)(2011-1#1)(2012-3#1)
steroids on##4##2##(1993-5#1)(1997-6#1)(2008-7#1)(2012-2#1)
steroids or##2##2##(2010-4#1)(2011-2#1)
steroids such as##2##3##(1991-12#1)(2009-3#1)
steroids tested##4##2##(1990-11#2)(1994-9#1)(1996-2#1)
steroids to##5##2##(1990-11#1)(1997-1#2)(2009-6#1)(2012-2#1)
steroids was##2##2##(1996-5#1)(1997-8#1)
steroids were found in##2##4##(1990-11#2)
steroids were found##3##3##(1990-11#2)(1991-5#1)
steroids were##7##2##(1990-11#3)(1991-5#1)(2008-10#2)(2008-11#1)
steroids with##4##2##(1990-11#2)(1997-1#1)(2008-5#1)
steroids##173##1##(1990-11#16)(1990-2#4)(1990-8#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-3#2)(1992-5#4)(1993-5#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#5)(1995-10#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#6)(1997-2#1)(1997-6#2)(1997-8#4)(2006-10#5)(2007-10#1)(2007-12#1)(2007-7#7)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#1)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#7)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#6)
sterol 27-hydroxylase##2##2##(1994-8#2)
sterol and##3##2##(2008-10#1)(2008-6#1)(2009-3#1)
sterol delta 14-reductase##3##3##(1991-5#3)
sterol demethylation inhibitors (DMIs)##2##4##(2008-10#2)
sterol demethylation##4##2##(1992-11#1)(2008-10#3)
sterol of##2##2##(1997-2#2)
sterol side##2##2##(1990-11#1)(2007-11#1)
sterol##40##1##(1990-11#1)(1990-12#1)(1991-5#4)(1992-11#1)(1992-3#4)(1992-6#2)(1993-6#1)(1994-8#2)(1997-2#2)(2007-11#4)(2008-10#10)(2008-12#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
sterols having##2##2##(1992-3#2)
sterols in the##2##3##(1997-2#1)(2008-10#1)
sterols in##4##2##(1992-11#1)(1997-2#1)(2008-10#2)
sterols##27##1##(1990-11#2)(1992-11#2)(1992-3#2)(1992-6#2)(1994-11#2)(1994-2#1)(1997-2#4)(2008-10#6)(2008-12#2)(2008-6#1)(2009-7#3)
stethoscope##7##1##(1993-12#1)(2009-6#1)(2010-2#3)(2010-8#1)(2012-3#1)
stethoscopes##4##1##(2009-6#4)
stevia##2##1##(2008-10#2)
stewardship and##3##2##(2009-8#2)(2011-2#1)
stewardship in##8##2##(2009-5#1)(2012-2#3)(2013-1#4)
stewardship programs (ASPs)##3##3##(2013-1#3)
stewardship programs##6##2##(2013-1#6)
stewardship##29##1##(2009-5#1)(2009-8#2)(2011-2#1)(2012-2#6)(2013-1#19)
stewartii ranged from 0##3##4##(2008-10#3)
stewartii##6##1##(2008-10#6)
stewartii-infested corn flea beetles##2##4##(2008-10#2)
stewartii-infested corn flea##3##3##(2008-10#3)
stewartii-infested##5##1##(2008-10#5)
stibine generation##2##2##(2008-10#2)
stibine##4##1##(2008-10#4)
stick injuries##3##2##(2007-7#2)(2012-12#1)
stick insect Carausius morosus##2##4##(1992-12#1)(2007-12#1)
stick insect##6##2##(1992-12#2)(2007-12#4)
stick to##2##2##(1996-3#1)(2008-10#1)
stick##26##1##(1992-12#2)(1995-8#1)(1996-3#1)(1997-7#1)(2007-10#3)(2007-12#4)(2007-7#2)(2008-10#2)(2008-5#3)(2009-11#1)(2009-2#3)(2010-8#2)(2012-12#1)
sticking to##2##2##(2008-10#1)(2012-12#1)
sticking##8##1##(1995-9#1)(2008-10#1)(2009-11#1)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
sticks##6##1##(1994-12#1)(2008-12#1)(2009-11#1)(2009-2#3)
sticky platelet syndrome##2##3##(1997-6#2)
sticky platelet##4##2##(1997-6#3)(2010-3#1)
sticky##10##1##(1997-6#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
stiff backing##2##2##(2008-5#2)
stiff##12##1##(1997-5#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)
stiffening##4##1##(2008-7#1)(2009-5#1)(2012-2#2)
stiffer and less##2##3##(2008-5#1)(2010-4#1)
stiffer tissue##2##2##(2009-8#1)(2010-8#1)
stiffer##9##1##(1995-2#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)
stiffness and##11##2##(2007-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-7#1)
stiffness as##2##2##(2008-9#1)(2009-7#1)
stiffness coefficient##2##2##(2013-1#2)
stiffness coefficients##2##2##(1992-7#1)(2013-1#1)
stiffness in##3##2##(1994-6#1)(2009-6#1)(2013-8#1)
stiffness is##2##2##(2008-9#1)(2013-7#1)
stiffness of alveolar##2##3##(2011-2#2)
stiffness of the##5##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-7#1)
stiffness of##10##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#2)(2013-7#1)
stiffness##78##1##(1992-5#1)(1992-7#1)(1994-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#6)(2008-6#7)(2008-7#1)(2008-8#2)(2008-9#9)(2009-3#3)(2009-4#1)(2009-6#6)(2009-7#7)(2009-9#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-3#2)(2013-7#5)(2013-8#1)
stifle##4##1##(1996-1#1)(2012-3#3)
stigma and##9##2##(2008-10#2)(2008-12#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
stigma in Chinese immigrants##2##4##(2012-1#2)
stigma in##6##2##(2007-7#1)(2008-10#1)(2009-5#1)(2011-1#1)(2012-1#2)
stigma instrument##3##2##(2012-1#3)
stigma is##4##2##(2008-10#1)(2011-1#1)(2012-1#2)
stigma items##2##2##(2012-1#2)
stigma scores##2##2##(2012-1#2)
stigma was##2##2##(2008-10#1)(2011-1#1)
stigma##61##1##(1996-5#1)(2007-7#2)(2008-1#1)(2008-10#9)(2008-12#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-5#6)(2009-7#3)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#10)(2011-10#1)(2012-1#14)(2012-12#2)(2012-2#2)(2012-3#2)
stigmas and##2##2##(2008-10#2)
stigmas of detached crab apple blossoms##2##6##(2008-10#2)
stigmas##11##1##(2008-10#11)
stigmasterol and beta-sitosterol##2##3##(2008-12#2)
stigmasterol and##3##2##(1990-2#1)(2008-12#2)
stigmasterol##5##1##(1990-2#2)(2008-11#1)(2008-12#2)
stigmata and##2##2##(1991-2#1)(2007-12#1)
stigmata of bleeding##3##3##(2007-8#3)
stigmata of##5##2##(2007-8#3)(2008-3#1)(2010-6#1)
stigmata were inoculated##2##3##(2008-10#2)
stigmata##13##1##(1991-12#1)(1991-2#1)(2007-12#1)(2007-8#3)(2008-10#5)(2008-3#1)(2010-6#1)
stigmatic##7##1##(2008-10#2)(2008-2#2)(2008-3#2)(2013-1#1)
stigmatization of##4##2##(2008-9#2)(2011-2#2)
stigmatization##7##1##(1997-6#1)(2008-9#3)(2011-2#2)(2012-12#1)
stigmatized##5##1##(2008-9#2)(2009-7#1)(2012-2#2)
stigmatizing##3##1##(1996-5#1)(2008-9#1)(2010-4#1)
stigonocarpa##3##1##(2008-5#3)
stilbene oxidase##2##2##(2008-10#2)
stilbene##8##1##(1992-12#2)(1993-3#1)(2007-12#1)(2008-10#4)
stilbenes##4##1##(2007-11#1)(2008-10#2)(2012-2#1)
still a challenge##2##3##(2008-6#1)(2013-7#1)
still a concern##2##3##(1991-12#1)(2006-10#1)
still a matter of debate##2##5##(1990-8#1)(2008-5#1)
still a matter of##4##4##(1990-8#1)(2008-1#1)(2008-5#1)(2011-1#1)
still a matter##5##3##(1990-8#1)(1997-7#1)(2008-1#1)(2008-5#1)(2011-1#1)
still a##56##2##(1990-6#1)(1990-8#2)(1991-12#2)(1993-6#1)(1994-6#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-2#1)(2009-5#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
still able to##6##3##(1993-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
still active##2##2##(1991-6#1)(2011-2#1)
still alive in##2##3##(1992-9#1)(1997-2#1)
still alive##14##2##(1990-6#1)(1990-9#1)(1992-6#1)(1992-9#2)(1995-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
still an important##2##3##(2007-8#1)(2008-12#1)
still an##7##2##(1992-9#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
still apparent##2##2##(1994-2#1)(1996-12#1)
still apply##2##2##(2008-3#1)(2011-2#1)
still as##2##2##(1996-11#1)(2013-1#1)
still at##2##2##(1991-3#1)(2008-11#1)
still be##28##2##(1990-3#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-2#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
still been##2##2##(1996-3#1)(2008-11#1)
still being##9##2##(1991-5#1)(1991-8#1)(1997-5#1)(2008-11#2)(2008-7#2)(2010-1#2)
still bind and respond to##2##5##(2008-4#2)
still birth##2##2##(1996-11#1)(2012-3#1)
still can##2##2##(2007-12#1)(2008-9#1)
still caused##2##2##(1992-5#1)(2008-10#1)
still clearly##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
still complains of##2##3##(2006-12#1)(2013-1#1)
still considered##4##2##(1993-2#1)(1995-2#1)(1995-5#1)(2011-2#1)
still constitutes##2##2##(2011-2#1)(2012-1#1)
still contained##2##2##(1992-10#1)(1997-7#1)
still continues##2##2##(1994-7#1)(2008-9#1)
still controversial##13##2##(1990-12#1)(1992-6#1)(1992-8#1)(1995-2#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
still debated##5##2##(1992-8#2)(2011-2#2)(2012-3#1)
still dependent##2##2##(1993-12#1)(1994-11#1)
still detectable in the##2##4##(1996-12#1)(2008-4#1)
still did##3##2##(1993-12#1)(2012-2#2)
still discussed##3##2##(1993-6#1)(2008-8#1)(2009-1#1)
still do not##3##3##(2007-4#1)(2008-12#1)(2010-12#1)
still dominated by##2##3##(2008-10#1)(2011-1#1)
still elevated##2##2##(1996-7#1)(2008-10#1)
still elusive##2##2##(2009-5#1)(2010-11#1)
still engage in##2##3##(2010-7#1)(2011-2#1)
still evident##2##2##(2008-10#1)(2013-1#1)
still exhibited##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
still exist##5##2##(2008-12#1)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)
still exists##8##2##(1991-8#1)(1992-12#1)(1993-8#1)(1994-8#1)(2007-2#1)(2008-11#1)(2008-8#1)(2012-3#1)
still experience##2##2##(2007-12#1)(2008-7#1)
still expressed##3##2##(1991-2#1)(1995-6#1)(2008-8#1)
still face##3##2##(1997-3#1)(2013-8#2)
still fail to##2##3##(2008-10#1)(2011-2#1)
still far from##2##3##(2008-5#1)(2012-2#1)
still free##2##2##(1997-3#1)(2013-1#1)
still functional##4##2##(1994-9#1)(1995-2#1)(2008-6#1)(2008-7#1)
still growing##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2010-3#1)
still had##6##2##(1990-11#1)(1991-9#1)(1992-5#1)(1994-2#1)(1995-9#1)(2008-7#1)
still has a##2##3##(1997-3#1)(2010-8#1)
still has##6##2##(1997-3#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
still have a##3##3##(1996-8#1)(2008-9#1)(2009-6#1)
still have the##2##3##(1993-12#1)(2008-10#1)
still have to be##2##4##(2012-2#2)
still have##17##2##(1991-12#1)(1991-3#1)(1993-12#1)(1994-9#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
still high##5##2##(1996-11#1)(2007-8#1)(2008-1#1)(2010-5#1)(2011-1#1)
still higher than the##2##4##(2008-7#1)(2008-8#1)
still higher than##5##3##(1997-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
still higher##6##2##(1990-7#1)(1997-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
still highly##4##2##(1990-10#1)(1993-6#1)(1996-12#1)(2007-7#1)
still in its infancy##4##4##(1995-5#1)(1996-2#1)(1996-4#1)(2008-10#1)
still in its##6##3##(1995-5#1)(1996-2#1)(1996-4#1)(2007-7#1)(2008-10#1)(2011-2#1)
still in the##2##3##(1991-12#1)(2006-7#1)
still in use##2##3##(1995-12#1)(2009-5#1)
still in##21##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(2006-7#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#1)
still incompletely understood##3##3##(2008-7#1)(2010-11#1)(2011-2#1)
still incompletely##5##2##(1993-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
still increasing##5##2##(1990-12#1)(1997-8#1)(2008-5#1)(2011-2#1)(2013-7#1)
still insufficient##3##2##(2006-10#1)(2009-7#1)(2012-2#1)
still intact##2##2##(2008-10#1)(2011-2#1)
still is##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
still lacking##11##2##(1992-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-2#1)(2012-3#1)
still largely##8##2##(1990-6#1)(1994-12#1)(1996-12#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#1)
still leave##2##2##(1991-2#1)(1995-12#1)
still led to##2##3##(1997-7#1)(2008-10#1)
still maintained##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
still major##2##2##(2008-11#1)(2011-1#1)
still makes it##2##3##(2008-8#1)(2010-5#1)
still markedly##2##2##(1992-8#1)(1993-3#1)
still more##6##2##(1994-1#1)(1994-5#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
still much##5##2##(1990-9#1)(1996-2#1)(2007-12#1)(2008-11#1)(2009-1#1)
still necessary##2##2##(1990-3#1)(2012-3#1)
still need to be##8##4##(1992-10#1)(1993-3#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2013-1#1)
still need to##11##3##(1992-10#1)(1993-3#1)(1994-1#1)(1995-9#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2013-1#1)
still need##13##2##(1992-10#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-9#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#1)(2013-1#1)
still needed to##2##3##(2007-9#1)(2009-3#1)
still needed##5##2##(2007-9#1)(2008-10#1)(2009-2#1)(2009-3#1)(2010-12#1)
still needs to be##4##4##(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
still needs to##5##3##(1994-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
still needs##8##2##(1994-12#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-7#1)
still no##6##2##(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
still not available##2##3##(2008-5#1)(2011-2#1)
still not clear and##2##4##(2007-8#1)(2011-2#1)
still not clear##9##3##(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#2)(2013-7#1)
still not completely elucidated##3##4##(2008-10#1)(2009-12#1)(2010-7#1)
still not completely##5##3##(2008-10#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-1#1)
still not fully understood##6##4##(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)
still not known##2##3##(2008-12#1)(2013-1#1)
still not statistically significant##2##4##(2007-10#1)(2008-10#1)
still not understood##2##3##(2006-6#1)(2008-7#1)
still not##50##2##(1993-6#1)(1994-11#1)(1996-5#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
still obscure##2##2##(1990-12#1)(2008-6#1)
still observed##3##2##(2008-3#1)(2008-9#1)(2009-12#1)
still obtained##2##2##(2008-10#1)(2008-2#1)
still occur##4##2##(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)
still occurs##3##2##(1996-5#1)(2008-10#1)(2010-4#1)
still of##3##2##(2011-2#1)(2011-3#1)(2012-3#1)
still on the##2##3##(1995-2#1)(2008-4#1)
still on##5##2##(1994-6#1)(1995-2#1)(1995-5#1)(2007-7#1)(2008-4#1)
still other##3##2##(1995-3#1)(1995-8#1)(2012-12#1)
still over##3##2##(2008-10#3)
still persist##2##2##(2008-11#1)(2008-4#1)
still plays a##2##3##(1990-8#1)(2013-1#1)
still plays##3##2##(1990-8#1)(2012-3#1)(2013-1#1)
still poor##2##2##(2008-5#1)(2013-1#1)
still poorly characterized##2##3##(2008-11#1)(2008-4#1)
still poorly understood##7##3##(1991-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
still poorly##10##2##(1991-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
still potentially##2##2##(2011-2#1)(2012-3#1)
still present in the##5##4##(1995-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-9#1)
still present in##7##3##(1991-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-9#1)
still present##17##2##(1991-3#1)(1991-5#1)(1992-8#1)(1994-9#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-9#1)(2013-1#1)
still presents a##2##3##(2008-1#1)(2010-12#1)
still presents##3##2##(2008-1#1)(2008-10#1)(2010-12#1)
still produced##2##2##(2008-5#1)(2013-8#1)
still provide##2##2##(2008-4#1)(2010-9#1)
still regarded as##2##3##(2007-8#1)(2012-2#1)
still relatively##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
still remain about##2##3##(2008-11#1)(2012-12#1)
still remain##11##2##(1992-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-3#1)(2012-12#2)(2012-3#1)
still remained##4##2##(1994-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
still remains a challenge##3##4##(2008-7#1)(2009-8#1)(2012-2#1)
still remains a##5##3##(2008-7#2)(2009-8#1)(2010-6#1)(2012-2#1)
still remains the most##2##4##(2008-7#1)(2012-2#1)
still remains the##4##3##(2007-8#1)(2008-4#1)(2008-7#1)(2012-2#1)
still remains to be##2##4##(1994-2#1)(2009-5#1)
still remains unknown##2##3##(2008-9#1)(2012-3#1)
still remains##24##2##(1993-5#1)(1994-2#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)
still represent the##2##3##(2008-10#1)(2010-11#1)
still represent##3##2##(1997-5#1)(2008-10#1)(2010-11#1)
still represents##3##2##(1993-3#1)(1995-1#1)(2008-11#1)
still require##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-12#1)
still required to##3##3##(2009-10#1)(2010-11#1)(2011-2#1)
still required##8##2##(1997-1#1)(1997-4#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-8#1)(2011-2#2)
still requires##2##2##(2008-3#1)(2008-7#1)
still retain a##2##3##(2008-10#1)(2008-11#1)
still significant##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
still significantly##3##2##(1991-9#1)(1994-5#1)(2008-4#1)
still some##4##2##(1996-11#1)(2008-10#1)(2008-7#1)(2011-3#1)
still subject to##3##3##(2008-5#1)(2010-10#1)(2013-1#1)
still sufficiently##3##2##(2007-8#1)(2008-1#1)(2008-11#1)
still tend to##2##3##(2008-12#1)(2008-5#1)
still the##15##2##(1990-5#1)(1991-10#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
still there##2##2##(2008-7#1)(2012-3#1)
still to be##6##3##(1990-12#1)(1991-12#1)(1993-3#1)(1997-8#1)(2008-3#1)(2010-12#1)
still to##7##2##(1990-12#1)(1991-12#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2010-12#1)
still uncertain##4##2##(2008-8#1)(2011-2#1)(2013-1#2)
still unclear##26##2##(1992-2#1)(1994-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
still under debate##2##3##(2007-8#1)(2008-7#1)
still under investigation##5##3##(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
still under##10##2##(1992-5#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
still unknown##26##2##(1991-3#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-9#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
still unresolved##2##2##(1995-8#1)(2008-11#1)
still unsolved##2##2##(1990-12#1)(2008-12#1)
still use##3##2##(1996-2#2)(2008-1#1)
still used##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
still valid##7##2##(1992-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#2)
still very##9##2##(1991-1#1)(1994-2#1)(1997-7#1)(2008-10#2)(2010-3#1)(2011-2#2)(2013-8#1)
still was##2##2##(2008-10#1)(2008-12#1)
still water##2##2##(2008-10#1)(2011-1#1)
still widely##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
still within##2##2##(2007-12#1)(2008-5#1)
still##1054##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#2)(1991-3#5)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#3)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#4)(1992-6#7)(1992-8#5)(1992-9#4)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#7)(1993-8#2)(1993-9#2)(1994-1#6)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#3)(1994-5#2)(1994-6#6)(1994-7#2)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#8)(1995-3#5)(1995-5#4)(1995-6#6)(1995-8#4)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#7)(1996-12#5)(1996-2#5)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#8)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#9)(2006-10#7)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#18)(2007-2#3)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#18)(2007-9#1)(2008-1#21)(2008-10#87)(2008-11#46)(2008-12#13)(2008-2#11)(2008-3#29)(2008-4#19)(2008-5#26)(2008-6#11)(2008-7#50)(2008-8#33)(2008-9#19)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#9)(2009-5#9)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#11)(2010-11#10)(2010-12#12)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#2)(2011-1#18)(2011-2#56)(2011-3#7)(2011-7#1)(2012-1#5)(2012-12#20)(2012-2#40)(2012-3#25)(2012-9#1)(2013-1#38)(2013-7#8)(2013-8#13)
stillage##6##1##(2008-6#1)(2011-2#5)
stillbirth##6##1##(1992-4#1)(1995-6#1)(1996-11#1)(2007-10#1)(2008-12#1)(2013-1#1)
stillbirths##5##1##(2008-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
stillborn##4##1##(1995-8#1)(2008-11#1)(2008-7#1)(2009-3#1)
stillness##2##1##(2008-2#1)(2010-12#1)
stimulability##2##1##(1990-6#1)(2008-9#1)
stimulant effects##3##2##(1991-5#1)(1993-12#1)(1993-6#1)
stimulant medication##3##2##(1995-1#1)(1996-6#2)
stimulant##17##1##(1991-5#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-1#1)(1996-6#2)(2008-10#3)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#2)
stimulants and##2##2##(2008-3#1)(2008-8#1)
stimulants in##4##2##(2008-10#3)(2008-6#1)
stimulants were##2##2##(2008-10#1)(2013-8#1)
stimulants##18##1##(1991-1#1)(2006-10#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-6#2)(2008-8#2)(2009-7#1)(2013-8#1)
stimulate DNA synthesis##7##3##(1990-11#1)(1990-12#1)(1992-3#1)(1992-9#1)(1997-7#1)(2008-8#1)(2009-8#1)
stimulate DNA##8##2##(1990-11#1)(1990-12#1)(1992-3#1)(1992-9#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-8#1)
stimulate a##6##2##(1993-6#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
stimulate adenylate cyclase##2##3##(1991-9#1)(1997-7#1)
stimulate an increase##2##3##(2008-12#1)(2008-4#1)
stimulate an##4##2##(2008-12#1)(2008-4#1)(2009-5#1)(2010-1#1)
stimulate any##2##2##(1992-9#1)(2008-10#1)
stimulate ascospore##2##2##(2008-10#2)
stimulate bone##2##2##(1997-7#1)(2008-8#1)
stimulate both##4##2##(1992-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
stimulate cell growth##2##3##(1992-11#1)(2008-11#1)
stimulate cell##3##2##(1992-11#1)(2008-11#1)(2008-3#1)
stimulate channel##2##2##(2008-8#2)
stimulate further##2##2##(2009-3#1)(2013-1#1)
stimulate fusion##2##2##(1992-6#2)
stimulate glucose uptake##2##3##(2008-11#1)(2008-8#1)
stimulate glucose##3##2##(1994-8#1)(2008-11#1)(2008-8#1)
stimulate growth of normal##2##4##(2008-11#2)
stimulate growth##3##2##(2008-11#2)(2008-3#1)
stimulate or##3##2##(1994-8#1)(1995-2#1)(2008-9#1)
stimulate plant##2##2##(2008-10#2)
stimulate proliferation##2##2##(1994-3#1)(2008-4#1)
stimulate protein synthesis##4##3##(2008-11#2)(2008-5#2)
stimulate protein##5##2##(1992-2#1)(2008-11#2)(2008-5#2)
stimulate secretion of##2##3##(1990-2#1)(2008-7#1)
stimulate the ATPase##2##3##(1992-6#1)(1994-12#1)
stimulate the cell##2##3##(1994-9#1)(2009-8#1)
stimulate the expression of##2##4##(1997-6#1)(2008-10#1)
stimulate the formation of##2##4##(1990-12#1)(2012-1#1)
stimulate the growth##2##3##(2008-4#1)(2011-2#1)
stimulate the immune##2##3##(1997-2#1)(2008-7#1)
stimulate the phosphorylation of the##2##5##(1990-10#1)(1996-2#1)
stimulate the phosphorylation of##4##4##(1990-10#1)(1992-9#1)(1996-2#2)
stimulate the production of##3##4##(2008-11#1)(2008-6#1)(2008-7#1)
stimulate the proliferation and##2##4##(1995-2#1)(2008-5#1)
stimulate the proliferation of the##3##5##(1993-9#1)(2008-4#2)
stimulate the proliferation of##6##4##(1993-9#1)(2008-11#1)(2008-4#3)(2008-8#1)
stimulate the proliferation##8##3##(1993-9#1)(1995-2#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)
stimulate the synthesis of##2##4##(1993-12#1)(2008-5#1)
stimulate the transcription of the##2##5##(1994-9#1)(1995-6#1)
stimulate the##67##2##(1990-10#1)(1990-12#3)(1990-3#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-8#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
stimulate transcription##4##2##(1993-8#1)(1994-2#1)(1996-2#1)(2011-1#1)
stimulate##266##1##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#1)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#4)(1994-8#4)(1994-9#3)(1995-2#7)(1995-3#2)(1995-6#2)(1995-8#4)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#6)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#5)(2007-11#1)(2008-1#3)(2008-10#14)(2008-11#16)(2008-12#4)(2008-3#4)(2008-4#18)(2008-5#16)(2008-6#2)(2008-7#11)(2008-8#13)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
stimulate(s)##2##1##(1992-9#2)
stimulated B cells##2##3##(1993-11#2)
stimulated Brillouin scattering (SBS) in##2##5##(2007-11#1)(2007-12#1)
stimulated Brillouin scattering (SBS)##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
stimulated Brillouin scattering in a##2##5##(2007-12#1)(2008-2#1)
stimulated Brillouin scattering in optical fiber##2##6##(2007-11#2)
stimulated Brillouin scattering in##5##4##(2007-11#3)(2007-12#1)(2008-2#1)
stimulated Brillouin scattering##13##3##(2007-11#7)(2007-12#2)(2008-2#4)
stimulated DNA synthesis in##3##4##(1992-9#1)(1994-9#1)(1996-12#1)
stimulated GTH-II release##2##3##(1994-8#2)
stimulated Raman scattering and##3##4##(2007-12#1)(2008-2#1)(2010-7#1)
stimulated Raman scattering in##5##4##(2007-11#1)(2007-12#4)
stimulated Raman scattering##18##3##(2007-11#4)(2007-12#8)(2008-2#3)(2008-3#1)(2010-7#2)
stimulated Raman##21##2##(2007-11#6)(2007-12#8)(2008-2#3)(2008-3#2)(2010-7#2)
stimulated T##2##2##(1997-8#1)(2008-4#1)
stimulated T-lymphocytes##2##2##(1997-5#1)(2008-7#1)
stimulated a##10##2##(1990-2#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-4#3)(2012-2#1)
stimulated an increase in##2##4##(1991-9#1)(2008-10#1)
stimulated an##8##2##(1991-9#1)(1996-12#1)(2008-10#1)(2008-4#1)(2011-2#4)
stimulated animals##2##2##(1992-8#1)(2008-7#1)
stimulated anti-Stokes-Raman scattering##2##3##(2008-2#2)
stimulated at##2##2##(1990-4#1)(1995-11#1)
stimulated by Na+##2##3##(1990-11#2)
stimulated by a##3##3##(1995-8#2)(2008-5#1)
stimulated by all##2##3##(1995-12#1)(1997-1#1)
stimulated by phorbol##2##3##(1990-12#1)(1995-6#1)
stimulated by tetrachlorohydroquinone##2##3##(2009-3#2)
stimulated by the##11##3##(1990-5#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-3#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)
stimulated by these##2##3##(1995-11#1)(2008-6#1)
stimulated by various##3##3##(1990-7#1)(1994-6#1)(1995-6#1)
stimulated by##87##2##(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#6)(1996-5#3)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2012-2#2)(2013-8#1)
stimulated cAMP formation##2##3##(1994-9#1)(1995-6#1)
stimulated cAMP##3##2##(1994-9#1)(1995-6#1)(1996-5#1)
stimulated cell proliferation##3##3##(1992-5#1)(1994-2#1)(2008-11#1)
stimulated cell##4##2##(1992-5#1)(1994-2#1)(2007-11#1)(2008-11#1)
stimulated cells##2##2##(1992-12#1)(2012-2#1)
stimulated emission and##2##3##(2007-11#1)(2008-3#1)
stimulated emission from##2##3##(2007-11#1)(2008-3#1)
stimulated emission##8##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#3)
stimulated for##5##2##(1990-7#1)(1993-6#1)(1994-6#1)(1997-3#1)(2013-8#1)
stimulated four-wave mixing##3##3##(2007-11#3)
stimulated glucose transport##2##3##(1992-11#1)(1997-1#1)
stimulated glucose uptake##3##3##(1990-8#1)(1994-12#1)(2008-1#1)
stimulated glucose##6##2##(1990-8#1)(1992-11#1)(1994-12#1)(1994-6#1)(1997-1#1)(2008-1#1)
stimulated human##3##2##(1991-9#1)(1993-11#1)(2008-5#1)
stimulated in the##3##3##(1990-12#1)(2008-6#1)(2008-9#1)
stimulated in##8##2##(1990-12#1)(1990-8#1)(1993-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#1)
stimulated inositol trisphosphate production##2##4##(1990-8#1)(1993-3#1)
stimulated insulin secretion##2##3##(1990-12#1)(1991-7#1)
stimulated insulin##3##2##(1990-12#1)(1991-7#1)(1995-8#1)
stimulated luminescence##2##2##(2008-10#2)
stimulated lymphocytes##2##2##(1991-9#1)(2008-11#1)
stimulated macrophages##2##2##(1990-2#1)(1992-9#1)
stimulated muscle##2##2##(1995-3#1)(1995-8#1)
stimulated peripheral blood##2##3##(1995-2#1)(2010-6#1)
stimulated phosphorylation of##2##3##(1993-1#1)(1993-3#1)
stimulated photon echoes##3##3##(2007-11#1)(2007-12#2)
stimulated proliferation of##2##3##(1994-2#1)(2008-11#1)
stimulated protein synthesis##3##3##(2008-11#3)
stimulated protein##4##2##(1995-11#1)(2008-11#3)
stimulated release##4##2##(1993-3#1)(1995-12#3)
stimulated synthesis##2##2##(1994-6#1)(1994-9#1)
stimulated the expression of##2##4##(1997-2#1)(2008-11#1)
stimulated the growth of##2##4##(1993-9#1)(2008-11#1)
stimulated the production of##3##4##(2008-10#2)(2008-3#1)
stimulated the proliferation##3##3##(2008-11#3)
stimulated the release of##5##4##(1993-8#1)(1994-8#1)(1995-3#2)(2008-5#1)
stimulated the##44##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#3)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
stimulated thermal scattering##2##3##(2008-2#2)
stimulated through##2##2##(2008-4#2)
stimulated to a##2##3##(1990-5#1)(1991-6#1)
stimulated to proliferate##3##3##(1990-12#1)(2008-4#1)(2008-7#1)
stimulated to##12##2##(1990-12#1)(1990-5#1)(1991-6#2)(1992-2#1)(1993-11#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-7#1)
stimulated two##2##2##(1991-2#1)(1994-2#1)
stimulated vortex gyration##2##3##(2012-2#2)
stimulated with hVEGF(165)##2##3##(2008-8#2)
stimulated with opsonized zymosan##2##4##(1991-2#1)(1992-8#1)
stimulated with phorbol##2##3##(1994-6#1)(1994-8#1)
stimulated with the##5##3##(1991-5#1)(2008-5#1)(2008-8#2)(2012-12#1)
stimulated with thrombin##2##3##(1992-6#1)(1997-7#1)
stimulated with##44##2##(1990-2#2)(1990-7#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-9#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1997-2#1)(1997-7#2)(2008-10#3)(2008-11#5)(2008-5#2)(2008-8#5)(2011-2#1)(2012-12#1)
stimulated##494##1##(1990-11#7)(1990-12#7)(1990-2#7)(1990-3#3)(1990-4#2)(1990-5#8)(1990-7#8)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-5#5)(1991-6#2)(1991-7#1)(1991-9#7)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#7)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#9)(1993-12#2)(1993-3#8)(1993-6#5)(1993-8#3)(1993-9#4)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#9)(1994-8#8)(1994-9#5)(1995-11#8)(1995-12#8)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#4)(1995-8#10)(1996-12#2)(1996-2#5)(1996-5#6)(1996-9#1)(1997-1#8)(1997-2#6)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(2007-10#2)(2007-11#23)(2007-12#15)(2007-8#1)(2008-1#4)(2008-10#32)(2008-11#33)(2008-2#14)(2008-3#10)(2008-4#13)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#14)(2008-9#8)(2009-12#2)(2009-2#2)(2009-3#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#7)(2012-6#1)(2013-1#5)(2013-8#3)
stimulated-Brillouin-scattering resonator##2##2##(2007-12#2)
stimulates 45Ca2+ uptake in##2##4##(1990-7#2)
stimulates DNA synthesis in##3##4##(1994-3#1)(1995-11#1)(1997-1#1)
stimulates a##2##2##(2008-8#1)(2012-3#1)
stimulates angiogenesis##2##2##(1992-9#1)(2012-1#1)
stimulates bone##2##2##(1997-7#1)(2010-10#1)
stimulates calcium##2##2##(1993-11#1)(1997-1#1)
stimulates cardiac##2##2##(1992-3#1)(2010-8#1)
stimulates cell proliferation##2##3##(1990-11#1)(2008-4#1)
stimulates expression##2##2##(1994-9#1)(2012-12#1)
stimulates food##2##2##(2008-3#1)(2013-8#1)
stimulates glucose##3##2##(1994-11#1)(1994-12#1)(2008-3#1)
stimulates growth##2##2##(1993-9#1)(2008-4#1)
stimulates human##2##2##(1994-11#1)(1995-2#1)
stimulates mitochondrial##2##2##(1991-2#1)(2012-3#1)
stimulates mitogenesis in##2##3##(1993-8#2)
stimulates mitogenesis##3##2##(1993-8#2)(1997-7#1)
stimulates osteoblast mitogenesis and##2##4##(1993-8#2)
stimulates osteoblasts##2##2##(1997-7#1)(2007-11#1)
stimulates proliferation##2##2##(2008-11#1)(2008-6#1)
stimulates protein##2##2##(1995-11#1)(1997-8#1)
stimulates pyruvate kinase activity in confluent-phase##2##6##(1995-12#2)
stimulates the activity of##2##4##(1994-8#1)(1996-2#1)
stimulates the expression of##2##4##(1994-11#1)(1994-9#1)
stimulates the formation of##2##4##(1993-8#1)(2008-8#1)
stimulates the growth of##2##4##(1991-2#1)(1992-11#1)
stimulates the mitochondrial metabolism transmitted by the##2##7##(1994-8#2)
stimulates the phosphorylation of##2##4##(1996-2#1)(2009-3#1)
stimulates the release of##2##4##(1995-11#1)(2011-1#1)
stimulates the secretion of##2##4##(1990-12#1)(1996-12#1)
stimulates the##41##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-6#1)(1997-8#1)(2008-5#1)(2008-8#3)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
stimulates tyrosine phosphorylation of##2##4##(1992-10#2)
stimulates##152##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1991-12#1)(1991-2#5)(1991-5#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#2)(1993-6#3)(1993-8#6)(1993-9#1)(1994-11#7)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#4)(1995-11#5)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#1)(1997-6#1)(1997-7#5)(1997-8#2)(2007-11#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-3#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
stimulating a##2##2##(1996-12#1)(2012-2#1)
stimulating activity of##3##3##(1991-5#1)(2008-11#2)
stimulating activity##6##2##(1990-7#1)(1991-5#1)(1992-9#2)(2008-11#2)
stimulating agents##2##2##(2008-11#1)(2008-4#1)
stimulating and##2##2##(1997-6#1)(2008-4#1)
stimulating antigen##2##2##(2008-4#2)
stimulating concentrations of##2##3##(1990-5#2)
stimulating effect of ET-1##2##4##(1994-8#2)
stimulating effect of##6##3##(1992-12#1)(1993-5#1)(1994-8#2)(1996-2#1)(2008-11#1)
stimulating effect on antibody production##2##5##(2008-11#2)
stimulating effect on##4##3##(1995-11#1)(1997-2#1)(2008-11#2)
stimulating effect##11##2##(1992-12#1)(1993-5#1)(1994-8#2)(1995-11#1)(1996-2#1)(1997-2#1)(2008-11#3)(2012-3#1)
stimulating effects##5##2##(1994-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2012-3#1)
stimulating factor (M-CSF)##2##3##(1991-5#1)(2008-11#1)
stimulating factor##17##2##(1990-5#1)(1991-5#1)(1992-3#3)(1992-8#1)(1994-3#1)(1996-5#1)(2007-10#1)(2008-11#3)(2008-6#1)(2011-2#1)(2012-2#3)
stimulating factors##2##2##(2008-10#1)(2008-11#1)
stimulating glucose##2##2##(1993-8#1)(2008-11#1)
stimulating hormone##11##2##(1990-11#1)(1990-8#1)(1993-11#2)(1994-9#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)
stimulating sound-pulses##4##2##(2008-8#4)
stimulating the development of##2##4##(2008-7#1)(2008-9#1)
stimulating the##21##2##(1990-9#2)(1992-10#1)(1992-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
stimulating##164##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-12#3)(1991-5#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#4)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#15)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#4)(2009-12#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#2)
stimulation (0##2##2##(1994-6#1)(2008-9#1)
stimulation (P&lt##2##2##(2009-10#2)
stimulation also##3##2##(1992-8#1)(1994-6#1)(2012-2#1)
stimulation and inhibition of##2##4##(2008-11#1)(2008-8#1)
stimulation and##29##2##(1991-1#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-2#1)(1997-1#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#2)(2009-9#1)(2012-2#1)(2013-1#1)
stimulation as##2##2##(1992-8#1)(1995-8#1)
stimulation assays##2##2##(2008-4#2)
stimulation associated with##2##3##(1991-12#1)(1994-9#1)
stimulation at##4##2##(1993-12#1)(1994-8#1)(1995-12#1)(1996-5#1)
stimulation both##2##2##(1994-6#1)(2008-6#1)
stimulation by a##2##3##(1990-5#1)(2008-8#1)
stimulation by both##2##3##(1990-5#1)(1995-8#1)
stimulation by extracellular##2##3##(2008-4#2)
stimulation by the##2##3##(1992-3#1)(1994-11#1)
stimulation by##31##2##(1990-5#2)(1990-8#2)(1992-11#2)(1992-3#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-2#1)(1997-6#1)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)
stimulation causes##2##2##(1992-12#1)(1997-1#1)
stimulation could##3##2##(1991-2#1)(1993-8#1)(2008-9#1)
stimulation decreased##2##2##(1993-3#1)(2009-10#1)
stimulation depended on the##2##4##(1994-9#1)(2013-1#1)
stimulation encoding strategy for##2##4##(2009-12#2)
stimulation encoding strategy##3##3##(2009-12#3)
stimulation for##11##2##(1990-7#1)(1997-2#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-1#1)(2013-1#1)
stimulation has been##2##3##(2007-10#1)(2008-4#1)
stimulation improves##3##2##(1992-8#2)(2012-2#1)
stimulation in a##4##3##(1990-12#1)(1994-5#1)(1994-6#1)(2009-9#1)
stimulation in humans##2##3##(1993-12#1)(2010-7#1)
stimulation in the##4##3##(1992-9#1)(1994-8#1)(2008-1#1)(2008-7#1)
stimulation in##39##2##(1990-12#2)(1990-5#1)(1991-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-9#3)(2009-9#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)
stimulation increased##3##2##(1993-3#1)(2009-6#1)(2011-2#1)
stimulation index (SI)##2##3##(2008-5#1)(2011-2#1)
stimulation index of##2##3##(2008-10#2)
stimulation index##6##2##(2008-10#2)(2008-5#1)(2010-4#2)(2011-2#1)
stimulation induced##2##2##(1997-3#1)(2008-4#1)
stimulation is not##2##3##(1991-12#1)(1993-12#1)
stimulation is##10##2##(1990-12#1)(1991-12#1)(1993-12#1)(1994-2#1)(1995-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2013-1#2)
stimulation mapping##2##2##(2008-9#2)
stimulation may##5##2##(1991-12#2)(2008-1#1)(2008-9#1)(2013-8#1)
stimulation mode##2##2##(1992-5#1)(2008-9#1)
stimulation of 125I-IGF-II binding by Man6P##2##6##(1990-5#2)
stimulation of Ca2+##3##3##(1996-2#2)(1996-5#1)
stimulation of DNA synthesis##2##4##(1997-1#1)(1997-7#1)
stimulation of GTH-II and GH release##2##6##(1994-8#2)
stimulation of NAT##2##3##(1994-2#2)
stimulation of PLD##2##3##(1995-8#2)
stimulation of T cell##3##4##(1994-9#1)(2008-11#1)(2008-4#1)
stimulation of T cells##2##4##(1995-5#1)(2008-9#1)
stimulation of T##5##3##(1994-9#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
stimulation of a##5##3##(1994-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
stimulation of acetylcholine##3##3##(1992-3#1)(2013-1#2)
stimulation of adenylate cyclase##2##4##(1992-6#1)(1994-8#1)
stimulation of antibody production##3##4##(2008-11#3)
stimulation of both##3##3##(1993-12#1)(1993-3#1)(2010-1#1)
stimulation of cell growth##3##4##(1994-2#1)(2008-11#2)
stimulation of cell##5##3##(1994-2#1)(2008-11#4)
stimulation of collagen synthesis##2##4##(2008-5#2)
stimulation of collagen##3##3##(2008-5#3)
stimulation of corticosterone synthesis##2##4##(1996-2#2)
stimulation of cultured##2##3##(2008-11#2)
stimulation of ecdysteroid secretion##2##4##(1995-11#2)
stimulation of either##3##3##(1990-5#1)(1995-8#1)(2009-8#1)
stimulation of expression##3##3##(1994-8#1)(2011-1#2)
stimulation of glucose transport into L6##2##6##(1994-11#2)
stimulation of glucose##6##3##(1994-11#2)(1994-8#3)(1997-6#1)
stimulation of growth##4##3##(1992-3#1)(1993-6#1)(1994-8#1)(1995-2#1)
stimulation of human##3##3##(1992-3#1)(1994-11#1)(1997-1#1)
stimulation of immunity by##2##4##(2008-7#2)
stimulation of intestinal##4##3##(1992-12#1)(1996-5#1)(1997-6#1)(2008-11#1)
stimulation of lipid peroxidation by##2##5##(1995-6#2)
stimulation of lipogenesis##2##3##(2010-4#1)(2012-2#1)
stimulation of mu-opioid receptors##2##4##(1997-2#2)
stimulation of osteoblast##2##3##(1991-12#1)(2008-8#1)
stimulation of platelets##2##3##(1992-6#1)(2008-8#1)
stimulation of protein synthesis##2##4##(2008-11#1)(2008-5#1)
stimulation of steroidogenesis##2##3##(1991-3#1)(1996-2#1)
stimulation of the activity of##2##5##(1997-2#1)(2008-8#1)
stimulation of the brain##3##4##(1992-11#1)(2008-1#2)
stimulation of the cells with 8-BrcAMP##2##6##(1994-11#2)
stimulation of the hypothalamic paraventricular##3##5##(1993-12#1)(1994-8#2)
stimulation of the hypothalamus##2##4##(1993-12#1)(1996-2#1)
stimulation of the neuron##2##4##(1993-12#2)
stimulation of the posterior##2##4##(1991-2#1)(1993-12#1)
stimulation of the##85##3##(1990-2#1)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-12#17)(1994-11#3)(1994-2#2)(1994-5#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#4)(1997-2#2)(1997-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2010-6#1)(2010-7#3)(2012-2#1)(2013-1#1)(2013-7#2)
stimulation of this##2##3##(1996-12#1)(2008-12#1)
stimulation of##313##2##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#9)(1990-7#3)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#7)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#21)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#10)(1994-12#2)(1994-2#7)(1994-3#3)(1994-5#3)(1994-8#14)(1994-9#1)(1995-11#4)(1995-12#10)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#5)(1996-12#1)(1996-2#11)(1996-5#7)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#3)(1997-7#6)(1997-8#1)(2006-10#1)(2007-10#1)(2008-1#2)(2008-10#8)(2008-11#24)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#7)(2009-10#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#5)(2013-7#4)(2013-8#1)
stimulation on the##2##3##(1994-2#1)(2011-1#1)
stimulation on##13##2##(1990-7#1)(1992-8#1)(1994-2#2)(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
stimulation or##7##2##(1992-5#1)(1993-12#1)(1994-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-7#1)
stimulation parameters##2##2##(1994-3#1)(2012-2#1)
stimulation produced##2##2##(2011-2#2)
stimulation rate on##2##3##(2008-9#2)
stimulation rate##5##2##(2008-9#5)
stimulation rates##3##2##(2008-9#3)
stimulation reduces##2##2##(1991-5#1)(2009-8#1)
stimulation resulted in##3##3##(1997-3#1)(2008-5#1)(2009-4#1)
stimulation technique##2##2##(1993-12#1)(1995-12#1)
stimulation test##5##2##(2008-1#1)(2008-9#2)(2012-3#1)(2013-1#1)
stimulation testing##2##2##(2008-4#1)(2012-3#1)
stimulation tests##2##2##(1996-11#2)
stimulation that##3##2##(1993-12#1)(2008-10#1)(2010-6#1)
stimulation through the##2##3##(1991-2#1)(2008-7#1)
stimulation through##3##2##(1991-2#1)(2008-10#1)(2008-7#1)
stimulation to the##4##3##(1993-8#1)(2008-8#1)(2008-9#1)(2010-7#1)
stimulation to##8##2##(1993-8#1)(1997-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)
stimulation under##3##2##(1996-6#1)(2008-9#1)(2011-1#1)
stimulation via the##2##3##(2011-1#1)(2013-8#1)
stimulation was abolished##2##3##(1990-5#1)(1995-12#1)
stimulation was significantly##2##3##(2008-7#2)
stimulation was used##2##3##(2008-7#2)
stimulation was##30##2##(1990-2#1)(1990-5#3)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-2#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-7#7)(2009-12#1)(2012-2#1)(2013-1#1)
stimulation wave##4##2##(2008-7#4)
stimulation were##6##2##(1993-1#1)(1993-12#1)(2008-10#1)(2008-7#3)
stimulation with a##4##3##(1990-5#1)(1992-6#1)(1994-3#1)(2011-2#1)
stimulation with bradykinin##2##3##(1991-12#2)
stimulation with the##7##3##(1994-9#1)(2008-11#1)(2008-5#1)(2008-9#3)(2013-8#1)
stimulation with##55##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#2)(1991-5#2)(1992-6#3)(1992-8#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-12#1)(2009-4#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
stimulation##987##1##(1990-11#2)(1990-12#6)(1990-2#4)(1990-4#1)(1990-5#21)(1990-7#8)(1990-8#8)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#18)(1991-2#12)(1991-3#4)(1991-5#9)(1991-6#2)(1992-10#2)(1992-11#8)(1992-12#17)(1992-3#12)(1992-4#1)(1992-5#5)(1992-6#10)(1992-8#12)(1992-9#4)(1993-1#2)(1993-11#7)(1993-12#42)(1993-2#1)(1993-3#12)(1993-5#1)(1993-6#8)(1993-8#6)(1993-9#1)(1994-11#13)(1994-12#2)(1994-2#17)(1994-3#8)(1994-5#4)(1994-6#5)(1994-8#19)(1994-9#4)(1995-11#13)(1995-12#25)(1995-2#8)(1995-3#2)(1995-5#3)(1995-6#10)(1995-8#12)(1996-11#3)(1996-12#6)(1996-2#18)(1996-5#17)(1996-6#2)(1997-1#7)(1997-2#15)(1997-3#5)(1997-4#2)(1997-6#6)(1997-7#10)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#5)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#14)(2008-10#28)(2008-11#48)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#20)(2008-5#23)(2008-6#5)(2008-7#47)(2008-8#16)(2008-9#50)(2009-1#1)(2009-10#10)(2009-12#7)(2009-2#1)(2009-4#8)(2009-5#1)(2009-6#1)(2009-8#12)(2009-9#8)(2010-1#4)(2010-10#5)(2010-12#5)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#26)(2010-8#4)(2011-1#19)(2011-2#21)(2012-1#5)(2012-12#2)(2012-2#24)(2012-3#10)(2012-7#1)(2013-1#24)(2013-7#4)(2013-8#11)
stimulation-induced feeding in the##3##4##(1994-3#3)
stimulation-induced feeding##5##2##(1994-3#5)
stimulation-induced##9##1##(1992-3#1)(1994-3#5)(1994-8#1)(1997-1#1)(2008-9#1)
stimulation?##2##1##(2008-11#1)(2010-7#1)
stimulations and##2##2##(1994-3#1)(2008-4#1)
stimulations of##2##2##(1993-8#1)(2008-11#1)
stimulations were##2##2##(1993-3#1)(1995-8#1)
stimulations##14##1##(1992-11#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-4#2)(2013-1#2)
stimulative effects##2##2##(1995-8#1)(2008-11#1)
stimulator and##2##2##(2007-7#1)(2008-7#1)
stimulator of##8##2##(1990-11#1)(1992-3#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-6#1)(2008-7#1)
stimulator was##2##2##(2012-3#2)
stimulator##27##1##(1990-11#1)(1992-3#1)(1993-12#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#2)(2010-12#1)(2010-7#1)(2012-3#5)
stimulators of##2##2##(1997-2#1)(2008-4#1)
stimulators##9##1##(1994-3#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-1#1)(2013-1#1)
stimulatory ability##5##2##(2008-8#5)
stimulatory action of L-histidine on protein synthesis in L6 myotubes##2##10##(2008-11#2)
stimulatory action of L-histidine on protein synthesis##3##7##(2008-11#3)
stimulatory action of##4##3##(1990-2#1)(2008-11#3)
stimulatory actions of L-leucine and KIC on protein synthesis##4##9##(2008-11#4)
stimulatory actions of L-leucine and KIC##5##6##(2008-11#5)
stimulatory actions of L-leucine and##6##5##(2008-11#6)
stimulatory actions of##8##3##(2008-11#6)(2010-11#2)
stimulatory actions##10##2##(2008-11#8)(2010-11#2)
stimulatory activity of##2##3##(1991-6#1)(1993-6#1)
stimulatory activity##3##2##(1991-6#1)(1993-6#2)
stimulatory and##3##2##(1991-5#1)(1994-3#1)(1996-2#1)
stimulatory effect of##11##3##(1991-12#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-6#1)(1997-8#1)(2010-11#1)
stimulatory effect on##9##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1997-7#1)(1997-8#1)(2008-5#1)
stimulatory effect##23##2##(1990-12#1)(1991-12#2)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-11#1)(2008-5#1)(2010-11#1)
stimulatory effects of##2##3##(2008-6#1)(2008-7#1)
stimulatory effects on##2##3##(2008-8#1)(2011-2#1)
stimulatory effects##7##2##(1990-12#1)(1990-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
stimulatory guanine nucleotide binding##2##4##(1992-3#1)(1994-2#1)
stimulatory or inhibitory##2##3##(1997-7#1)(2013-1#1)
stimulatory or##3##2##(1994-8#1)(1997-7#1)(2013-1#1)
stimulatory##84##1##(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-10#4)(2008-11#13)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#6)(2010-11#3)(2010-12#1)(2011-2#1)(2013-1#2)
stimuli (e##2##2##(2008-4#1)(2012-12#1)
stimuli activate##4##2##(2006-12#3)(2009-9#1)
stimuli and the##3##3##(1990-9#1)(2008-9#1)(2009-9#1)
stimuli and##29##2##(1990-11#1)(1990-9#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-1#1)(2012-2#1)(2012-7#1)(2013-8#1)
stimuli applied to the##2##4##(1992-11#1)(2008-7#1)
stimuli applied to##3##3##(1992-11#1)(2008-7#1)(2009-9#1)
stimuli are##5##2##(1995-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-5#1)
stimuli as##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
stimuli at##3##2##(1992-11#2)(1995-12#1)
stimuli before##2##2##(1993-12#1)(2010-1#1)
stimuli by##2##2##(1992-6#1)(2013-1#1)
stimuli can##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
stimuli comprised of##2##3##(2013-8#2)
stimuli during##2##2##(1992-10#1)(2013-8#1)
stimuli for##3##2##(1993-12#1)(2008-11#1)(2008-5#1)
stimuli from##4##2##(1997-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
stimuli have##2##2##(2008-1#1)(2009-12#1)
stimuli in a##3##3##(1993-12#1)(1996-5#1)(2009-12#1)
stimuli in the##2##3##(2008-5#1)(2009-2#1)
stimuli in##21##2##(1990-11#1)(1991-1#1)(1993-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#2)
stimuli may##3##2##(1993-6#1)(1996-5#1)(2012-12#1)
stimuli of different##2##3##(1996-2#1)(2013-1#1)
stimuli of##5##2##(1996-2#1)(1996-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
stimuli on the##5##3##(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)
stimuli on##8##2##(1996-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#3)
stimuli presented##3##2##(1994-8#2)(1996-2#1)
stimuli should##2##2##(1993-12#2)
stimuli such as##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2010-12#1)
stimuli that are##2##3##(1992-6#1)(2008-4#1)
stimuli that were##2##3##(2008-4#1)(2010-5#1)
stimuli that##12##2##(1990-12#1)(1991-5#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-1#2)(2008-4#2)(2008-8#1)(2010-5#1)(2011-9#1)
stimuli to be##3##3##(1992-11#1)(1993-12#1)(2009-2#1)
stimuli to##12##2##(1992-11#1)(1993-12#2)(1993-6#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-2#1)(2012-12#1)
stimuli under##2##2##(1995-5#1)(2008-8#1)
stimuli using##2##2##(2009-10#1)(2012-12#1)
stimuli was##5##2##(1990-12#1)(1991-2#1)(2008-11#1)(2008-8#2)
stimuli were applied##2##3##(2008-8#1)(2008-9#1)
stimuli were introduced##2##3##(1993-12#1)(1993-3#1)
stimuli were used to##2##4##(2008-9#1)(2009-2#1)
stimuli were used##3##3##(2008-9#1)(2009-2#2)
stimuli were##24##2##(1990-11#1)(1990-5#1)(1992-11#1)(1993-12#2)(1993-3#2)(1995-11#2)(1996-5#3)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
stimuli which##3##2##(1990-6#1)(1996-5#1)(2012-1#1)
stimuli with##5##2##(1996-8#1)(2008-11#1)(2008-9#2)(2013-8#1)
stimuli within the##2##3##(1993-6#1)(2008-1#1)
stimuli within##3##2##(1993-6#1)(1995-11#1)(2008-1#1)
stimuli##377##1##(1990-11#9)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#4)(1992-11#8)(1992-5#1)(1992-6#3)(1993-12#13)(1993-3#5)(1993-6#9)(1994-11#1)(1994-2#3)(1994-3#2)(1994-8#2)(1995-11#4)(1995-12#7)(1995-5#3)(1995-8#4)(1996-12#3)(1996-2#9)(1996-5#14)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-7#4)(2006-12#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#9)(2008-11#16)(2008-2#7)(2008-4#26)(2008-5#10)(2008-6#4)(2008-7#19)(2008-8#18)(2008-9#15)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#9)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#13)(2011-9#2)(2012-1#2)(2012-12#10)(2012-2#15)(2012-3#1)(2012-7#1)(2013-1#7)(2013-8#12)
stimuli-responsive##3##1##(1995-11#1)(2008-8#1)(2010-4#1)
stimulus (e##2##2##(2008-5#2)
stimulus and##4##2##(1992-12#1)(1993-12#1)(1993-3#1)(2007-9#1)
stimulus at##2##2##(2006-12#1)(2008-4#1)
stimulus conditions##3##2##(1995-11#1)(1996-2#1)(2008-11#1)
stimulus configuration##3##2##(1993-12#1)(2008-9#2)
stimulus control##2##2##(2011-2#2)
stimulus duration and the##2##4##(2009-2#2)
stimulus duration and##5##3##(2008-9#2)(2009-2#3)
stimulus duration##7##2##(2008-9#2)(2009-2#5)
stimulus during##3##2##(2008-5#2)(2010-4#1)
stimulus effects of##3##3##(1991-1#2)(1997-7#1)
stimulus effects##6##2##(1991-1#3)(1991-12#2)(1997-7#1)
stimulus features##2##2##(1990-5#1)(2008-11#1)
stimulus for##7##2##(1993-1#1)(1993-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-4#1)(2013-8#1)
stimulus had##2##2##(1994-8#1)(2010-5#1)
stimulus intensities##3##2##(1993-12#2)(2011-2#1)
stimulus intensity on##2##3##(2011-2#2)
stimulus intensity##10##2##(1991-12#1)(2008-7#3)(2011-2#6)
stimulus is##4##2##(1995-12#1)(1997-4#1)(1997-6#1)(2008-11#1)
stimulus may##2##2##(1994-2#1)(1997-2#1)
stimulus of##6##2##(1995-8#1)(2007-12#1)(2008-5#2)(2010-4#1)(2013-1#1)
stimulus on##3##2##(1991-12#1)(2008-6#1)(2010-5#1)
stimulus onset##2##2##(2008-2#1)(2012-2#1)
stimulus preexposure##3##2##(2008-10#2)(2008-4#1)
stimulus presentation##2##2##(2008-5#2)
stimulus properties##4##2##(1993-12#2)(1997-7#2)
stimulus rate##4##2##(2008-9#4)
stimulus significantly##2##2##(1997-2#1)(2008-7#1)
stimulus specific##2##2##(2008-5#1)(2009-2#1)
stimulus tends to be identified as a##2##7##(2013-8#2)
stimulus that##2##2##(1993-12#1)(1997-7#1)
stimulus to##6##2##(1994-12#1)(1995-5#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
stimulus train##2##2##(1993-12#1)(1997-2#1)
stimulus was##11##2##(1990-5#1)(1992-11#1)(1996-2#1)(1997-2#1)(2008-5#3)(2009-11#1)(2010-5#3)
stimulus when##2##2##(2007-12#1)(2012-12#1)
stimulus with##2##2##(1993-6#1)(2008-5#1)
stimulus##236##1##(1990-12#1)(1990-5#4)(1990-8#1)(1990-9#2)(1991-1#3)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#10)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-8#2)(1995-11#2)(1995-12#5)(1995-5#5)(1995-8#1)(1996-12#2)(1996-2#6)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#7)(2006-12#1)(2007-12#3)(2007-8#2)(2007-9#8)(2008-1#3)(2008-10#4)(2008-11#14)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#18)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#7)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#4)(2010-5#8)(2010-6#1)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#7)
stimulus)##2##1##(1993-11#1)(2013-1#1)
stimulus--reward learning##2##2##(1993-6#2)
stimulus--reward##3##1##(1993-6#3)
stimulus-evoked##4##1##(1992-12#1)(1993-12#1)(1996-5#1)(2007-9#1)
stimulus-frequency##3##1##(2009-5#3)
stimulus-induced activity##3##2##(2013-8#3)
stimulus-induced##5##1##(1996-5#1)(2010-12#1)(2013-8#3)
stimulus-specific##2##1##(1991-5#1)(2013-8#1)
sting##6##1##(2012-3#6)
stinging##2##1##(2008-5#2)
stingray##2##1##(1995-12#1)(2011-2#1)
stings##2##1##(2006-5#1)(2012-3#1)
stink bug (Hemiptera##2##3##(2011-2#2)
stink bug feeding##2##3##(2011-2#2)
stink bug number##3##3##(2011-2#3)
stink bug##11##2##(2011-2#11)
stink##12##1##(2011-2#12)
stipes and apothecia##2##3##(2008-10#2)
stipes##5##1##(2008-10#4)(2013-7#1)
stir bar sorptive extraction (SBSE)##2##5##(2008-10#2)
stir bar##4##2##(2008-10#4)
stir##5##1##(2007-2#1)(2008-10#4)
stirred at##2##2##(2008-10#1)(2008-11#1)
stirred bioreactors##2##2##(2008-11#1)(2008-7#1)
stirred reactor##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
stirred sample##2##2##(2008-10#2)
stirred tank bioreactor##10##3##(2008-11#10)
stirred tank reactor##7##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#4)
stirred tank##20##2##(1997-2#1)(2008-10#1)(2008-11#13)(2008-7#5)
stirred tankreactor##2##2##(2008-11#2)
stirred##55##1##(1996-3#1)(1997-2#1)(2008-10#12)(2008-11#30)(2008-7#8)(2011-2#1)(2013-1#2)
stirred-tank reactor##2##2##(2008-10#1)(2008-11#1)
stirred-tank##3##1##(2008-10#1)(2008-11#1)(2008-6#1)
stirrer##4##1##(2008-10#1)(2008-11#2)(2010-5#1)
stirring for##3##2##(2008-10#3)
stirring of##2##2##(2008-10#2)
stirring rate##10##2##(2008-10#10)
stirring rates##2##2##(2008-11#2)
stirring speed##3##2##(2008-10#1)(2008-11#2)
stirring time from##2##3##(2008-10#2)
stirring time of##2##3##(2008-10#2)
stirring time##11##2##(2008-10#11)
stirring##46##1##(2006-6#1)(2008-10#38)(2008-11#6)(2008-5#1)
stitch##8##1##(1991-2#6)(2008-6#1)(2013-1#1)
stitches##4##1##(1993-9#1)(1996-3#1)(1997-7#1)(2007-8#1)
stitching##3##1##(2008-2#1)(2008-3#2)
stochastic component##2##2##(1997-4#1)(2008-8#1)
stochastic differential equations##3##3##(2007-11#1)(2008-6#2)
stochastic effects##8##2##(1996-6#4)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
stochastic effects)##2##2##(2008-12#1)(2008-7#1)
stochastic extinction##3##2##(2008-8#3)
stochastic fluctuations##2##2##(2008-7#1)(2010-10#1)
stochastic harvesting in##2##3##(2008-8#2)
stochastic juvenile survival##2##3##(2008-8#2)
stochastic kinetic models##2##3##(2010-7#1)(2011-2#1)
stochastic model for##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
stochastic model##10##2##(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)
stochastic modeling##3##2##(2008-10#2)(2008-11#1)
stochastic models of##3##3##(2008-8#2)(2013-8#1)
stochastic models##5##2##(1995-5#1)(2008-11#1)(2008-8#2)(2013-8#1)
stochastic parallel##3##2##(2007-11#1)(2008-3#2)
stochastic process##3##2##(2008-2#1)(2009-12#1)(2010-8#1)
stochastic processes##2##2##(2009-8#2)
stochastic resonance##7##2##(2008-10#7)
stochastic simulation##3##2##(1994-3#1)(1997-3#1)(2010-7#1)
stochastic simulations##2##2##(2008-10#1)(2008-8#1)
stochastic spatial##2##2##(2008-8#2)
stochastic threshold##2##2##(2008-7#2)
stochastic transition##2##2##(2008-7#2)
stochastic transitions##3##2##(2008-7#3)
stochastic two-stage cancer model##2##4##(2008-7#2)
stochastic##136##1##(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-5#2)(1995-6#1)(1996-6#4)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#14)(2008-6#3)(2008-7#18)(2008-8#25)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-8#3)
stochastically##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
stochasticity and##2##2##(2008-8#1)(2008-9#1)
stochasticity in##2##2##(2008-8#1)(2008-9#1)
stochasticity##12##1##(2008-8#6)(2008-9#5)(2013-8#1)
stock and##7##2##(2007-12#1)(2008-10#1)(2008-9#2)(2010-1#1)(2010-3#2)
stock control##2##2##(2010-3#2)
stock for##2##2##(2008-10#1)(2008-9#1)
stock of##7##2##(1991-1#1)(1996-12#1)(1997-2#1)(2007-6#2)(2008-12#2)
stock solutions of##2##3##(2008-10#1)(2008-4#1)
stock solutions##4##2##(1990-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
stock structure of E##2##4##(2010-8#2)
stock types##2##2##(2008-10#2)
stock##66##1##(1990-12#1)(1991-1#1)(1993-5#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-6#4)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#6)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-3#7)(2010-8#3)(2011-2#6)(2013-7#1)(2013-8#1)
stocking rate##10##2##(1996-12#10)
stocking##13##1##(1996-12#10)(2011-3#1)(2012-2#1)(2013-7#1)
stocks and##3##2##(2008-10#1)(2008-4#1)(2013-7#1)
stocks are##4##2##(2008-9#2)(2009-5#1)(2012-2#1)
stocks in##2##2##(2008-9#1)(2009-5#1)
stocks of##8##2##(2008-4#1)(2008-9#1)(2009-5#1)(2010-8#3)(2012-12#1)(2012-2#1)
stocks##52##1##(2008-10#8)(2008-11#2)(2008-2#3)(2008-4#7)(2008-5#1)(2008-9#9)(2009-2#2)(2009-5#6)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
stoichiometric LiTaO(3)##2##2##(2007-12#2)
stoichiometric amounts of##3##3##(1990-11#1)(1991-5#1)(1995-6#1)
stoichiometric binding##3##2##(1990-8#2)(1997-2#1)
stoichiometric data##2##2##(1994-3#1)(2008-10#1)
stoichiometric model##2##2##(2008-11#1)(2008-7#1)
stoichiometric quantities of##2##3##(1996-2#1)(2008-10#1)
stoichiometric ratio##3##2##(2008-10#2)(2008-11#1)
stoichiometric##57##1##(1990-11#1)(1990-8#2)(1991-5#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-6#1)(1996-2#3)(1997-2#3)(2007-11#1)(2007-12#5)(2008-10#18)(2008-11#7)(2008-7#6)(2009-5#1)(2010-12#1)(2012-2#1)(2013-7#1)
stoichiometrically##6##1##(1991-5#1)(1992-11#1)(1993-12#1)(1995-2#1)(2008-10#2)
stoichiometries and##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
stoichiometries of##2##2##(2008-10#1)(2009-9#1)
stoichiometries##10##1##(1997-2#1)(2008-10#6)(2008-4#1)(2009-9#1)(2011-1#1)
stoichiometry and distance##2##3##(2010-5#2)
stoichiometry and##10##2##(1994-5#1)(1995-2#1)(2008-10#4)(2008-11#1)(2010-5#2)(2012-2#1)
stoichiometry for##2##2##(1992-12#1)(1996-2#1)
stoichiometry in##3##2##(1992-3#2)(2008-10#1)
stoichiometry of the complex##3##4##(2008-10#3)
stoichiometry of the species##2##4##(2008-10#2)
stoichiometry of the##12##3##(1993-8#1)(2008-10#10)(2008-7#1)
stoichiometry of##32##2##(1990-2#1)(1990-7#1)(1991-5#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-4#2)(2008-7#1)(2012-2#1)
stoichiometry was##3##2##(1991-5#1)(1992-3#1)(2008-10#1)
stoichiometry were##2##2##(2008-10#2)
stoichiometry with##2##2##(1995-11#1)(2008-10#1)
stoichiometry##79##1##(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#3)(1992-12#1)(1992-2#1)(1992-3#4)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#36)(2008-11#2)(2008-2#1)(2008-4#4)(2008-7#1)(2010-5#3)(2012-2#2)
stokes##2##1##(2008-2#1)(2008-3#1)
stolbur phytoplasma##4##2##(2008-10#4)
stolbur##5##1##(2008-10#5)
stolon connections##2##2##(2009-8#2)
stolon regression and##2##3##(2009-8#2)
stolon regression##4##2##(2009-8#4)
stolon##9##1##(2008-10#1)(2009-8#8)
stolonifer##2##1##(2008-5#2)
stolons of##2##2##(2008-10#2)
stolons##4##1##(2008-10#3)(2009-8#1)
stoma##6##1##(1993-6#1)(2007-8#3)(2008-10#1)(2011-2#1)
stomach (p = 0##2##4##(2008-7#2)
stomach and intestine##4##3##(2008-12#1)(2008-5#2)(2013-8#1)
stomach and##22##2##(1990-12#1)(1990-9#1)(1991-4#1)(1992-5#2)(1994-2#1)(1996-12#2)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
stomach are##3##2##(1992-8#1)(2012-2#1)(2012-3#1)
stomach cancer cells##3##3##(2008-8#1)(2009-9#2)
stomach cancer##12##2##(1990-12#2)(1990-9#1)(1992-12#1)(1995-9#1)(2008-8#1)(2009-9#2)(2012-12#3)(2012-3#1)
stomach compartment##2##2##(2011-2#2)
stomach contents##5##2##(1992-12#1)(1995-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
stomach in##7##2##(1990-8#1)(1991-6#1)(1993-9#1)(1997-1#1)(2011-2#1)(2013-8#2)
stomach is##3##2##(1997-1#1)(2008-5#1)(2012-3#1)
stomach lavage and cloacal##2##4##(1996-12#2)
stomach lavage##3##2##(1996-12#3)
stomach mucosa##7##2##(1992-8#1)(1992-9#2)(1993-11#3)(1997-7#1)
stomach samples##3##2##(1996-12#3)
stomach ulcer##2##2##(1990-3#1)(1990-9#1)
stomach##183##1##(1990-11#1)(1990-12#3)(1990-3#2)(1990-8#2)(1990-9#4)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#4)(1992-6#3)(1992-8#4)(1992-9#7)(1993-11#5)(1993-6#1)(1993-9#3)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-9#1)(1996-12#8)(1996-3#1)(1997-1#6)(1997-4#2)(1997-7#5)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#15)(2008-8#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-6#1)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#5)
stomachs##6##1##(2008-12#3)(2008-5#1)(2010-8#2)
stomata were##3##2##(2008-10#2)(2011-10#1)
stomata##21##1##(2008-10#18)(2011-10#1)(2013-7#2)
stomatal aperture##2##2##(2008-10#2)
stomatal closure and##2##3##(2008-10#2)
stomatal closure##3##2##(2008-10#2)(2012-6#1)
stomatal conductance##3##2##(2008-10#1)(2008-12#1)(2012-7#1)
stomatal movement##4##2##(2008-8#4)
stomatal opening##4##2##(2008-10#1)(2008-8#2)(2012-6#1)
stomatal##25##1##(1994-11#1)(2008-10#11)(2008-12#1)(2008-8#6)(2009-8#1)(2012-6#2)(2012-7#1)(2013-7#2)
stomatitis##21##1##(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-4#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-1#1)
stomatologic##2##1##(2008-10#1)(2011-1#1)
stomatopod##4##1##(2007-12#4)
stone disease##2##2##(1997-8#1)(2012-12#1)
stone formation is##2##3##(1992-9#1)(2007-7#1)
stone formation##6##2##(1992-9#3)(1993-6#1)(1996-3#1)(2007-7#1)
stone formers##6##2##(1991-12#6)
stone fruit trees##3##3##(2008-10#3)
stone fruit##12##2##(2008-10#12)
stone fruits##4##2##(2008-10#4)
stone in##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
stone of##2##2##(2007-7#1)(2009-1#1)
stone part to the##3##4##(1997-4#3)
stone recurrence##7##2##(2007-7#2)(2008-5#4)(2013-7#1)
stone removal##4##2##(2008-5#2)(2013-7#2)
stone##78##1##(1990-12#1)(1991-12#6)(1992-9#3)(1993-12#1)(1993-6#2)(1994-5#1)(1994-9#1)(1995-8#1)(1996-3#1)(1997-4#4)(1997-8#1)(2007-7#5)(2008-1#2)(2008-10#19)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-8#2)(2009-1#1)(2009-4#1)(2009-5#1)(2010-12#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#3)(2013-8#3)
stone-fruit-growing##2##1##(2008-10#2)
stones and##10##2##(1991-9#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-2#2)(2013-7#2)(2013-8#2)
stones in the##2##3##(1992-5#1)(2010-12#1)
stones in##6##2##(1991-3#1)(1992-5#1)(1994-6#1)(2007-7#1)(2010-12#1)(2013-8#1)
stones was##2##2##(1994-5#1)(2010-12#1)
stones were removed##2##3##(1991-3#1)(2011-2#1)
stones were##6##2##(1991-3#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
stones with##2##2##(1993-6#1)(2011-2#1)
stones##58##1##(1990-5#1)(1990-6#1)(1991-3#4)(1991-9#1)(1992-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-3#1)(1997-8#2)(2007-7#5)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-7#1)(2010-12#4)(2010-8#1)(2011-2#7)(2013-1#1)(2013-7#3)(2013-8#8)
stones)##2##1##(2008-10#1)(2011-2#1)
stony##3##1##(1997-5#2)(2013-1#1)
stood at##2##2##(2008-5#1)(2011-2#1)
stood out##2##2##(2006-10#1)(2008-5#1)
stood##5##1##(2006-10#1)(2008-10#1)(2008-5#2)(2011-2#1)
stool and##2##2##(2011-2#1)(2013-8#1)
stool as##2##2##(1993-3#1)(2011-2#1)
stool bed cuttings##2##3##(2008-10#2)
stool examination##2##2##(1995-10#1)(2012-3#1)
stool height##4##2##(2008-6#4)
stool samples and##2##3##(2011-1#2)
stool samples examined##3##3##(2009-10#1)(2011-2#1)(2012-3#1)
stool samples from##2##3##(2007-12#1)(2013-1#1)
stool samples were##3##3##(2007-7#1)(2011-1#1)(2012-2#1)
stool samples##16##2##(2007-12#1)(2007-7#4)(2008-10#2)(2009-10#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
stool specimens##5##2##(1993-8#1)(2012-2#3)(2013-8#1)
stool##45##1##(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-8#1)(1995-10#1)(2007-12#2)(2007-7#4)(2007-8#1)(2008-10#4)(2008-6#4)(2008-7#1)(2009-10#2)(2011-1#4)(2011-2#4)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#3)
stools and##3##2##(1990-3#1)(2013-1#1)(2013-8#1)
stools##9##1##(1990-3#1)(1991-6#1)(2007-12#1)(2009-1#1)(2009-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
stop at##2##2##(1994-12#1)(2011-2#1)
stop band of the grating##2##5##(2007-12#1)(2008-3#1)
stop band##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
stop codon (UAA)##3##3##(1990-11#1)(1990-7#1)(1992-11#1)
stop codon##21##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-6#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#2)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-9#2)(2013-1#1)
stop codons##3##2##(1993-12#1)(1993-2#1)(2008-11#1)
stop drinking##2##2##(1995-11#1)(2007-9#1)
stop smoking##4##2##(1990-6#1)(1996-8#1)(2011-1#1)(2011-2#1)
stop the##6##2##(1995-6#1)(1996-9#1)(1997-6#1)(2008-5#1)(2010-2#1)(2012-2#1)
stop using##2##2##(1996-11#1)(2008-7#1)
stop##92##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-11#2)(1996-8#1)(1996-9#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-12#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-8#1)
stop-band##2##1##(2007-11#1)(2008-3#1)
stopband##2##1##(2008-3#2)
stopbands##5##1##(2008-3#5)
stopgaps##3##1##(2007-11#3)
stopped after the##2##3##(1996-11#1)(2008-10#1)
stopped and##4##2##(1993-1#1)(2008-7#1)(2010-12#1)(2011-3#1)
stopped at##2##2##(1990-8#1)(2008-8#1)
stopped before##2##2##(2008-1#1)(2009-5#1)
stopped by##3##2##(1996-6#1)(2008-7#2)
stopped flow##7##2##(2008-10#7)
stopped for##2##2##(1996-3#1)(2008-8#1)
stopped in##2##2##(2007-7#1)(2008-10#1)
stopped smoking##2##2##(1996-8#1)(1997-3#1)
stopped the##3##2##(1996-9#1)(2008-12#1)(2008-8#1)
stopped##60##1##(1990-8#1)(1991-12#1)(1992-1#1)(1993-1#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#4)(2009-5#1)(2010-1#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
stopped-FI##3##1##(2008-10#3)
stopped-flow fluorescence polarization immunoassay##2##4##(2008-10#2)
stopped-flow fluorescence##4##2##(1994-5#1)(2008-10#2)(2008-4#1)
stopped-flow injection##4##2##(2008-10#4)
stopped-flow mixing technique##7##3##(2008-10#7)
stopped-flow spectrophotometric##2##2##(2008-10#2)
stopped-flow technique##2##2##(2008-10#2)
stopped-flow##32##1##(1994-5#1)(1995-2#1)(2008-10#28)(2008-4#2)
stopping power##2##2##(2012-12#2)
stopping the##4##2##(1992-3#1)(2008-10#1)(2008-7#1)(2010-2#1)
stopping##28##1##(1992-3#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-6#1)(1997-4#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-12#3)(2013-1#1)(2013-8#2)
stops##7##1##(1996-2#1)(1997-5#1)(1997-6#1)(2008-5#1)(2009-12#1)(2010-1#2)
storage (&gt##2##2##(2008-10#1)(2013-1#1)
storage and preparation##2##3##(2012-2#2)
storage and release##2##3##(1995-12#1)(2008-10#1)
storage and transportation##2##3##(2012-2#1)(2013-1#1)
storage and use##2##3##(1997-6#1)(2007-12#1)
storage and##43##2##(1991-5#1)(1992-3#1)(1994-11#1)(1994-3#2)(1995-12#1)(1997-6#1)(2007-12#8)(2008-10#5)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2010-4#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
storage are##2##2##(1994-8#1)(2011-2#1)
storage area at Vikuge##2##4##(2008-10#2)
storage at -80##2##3##(1993-12#1)(2008-10#1)
storage at 4 degrees C and##2##6##(2008-10#2)
storage at 4 degrees C##6##5##(2008-10#5)(2012-2#1)
storage at 4##7##3##(2008-10#5)(2012-2#1)(2013-1#1)
storage at room temperature and##2##5##(2008-10#1)(2008-5#1)
storage at room temperature##6##4##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)
storage at##26##2##(1993-12#1)(1997-4#1)(2007-11#1)(2007-3#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
storage based on##2##3##(2007-12#1)(2008-3#1)
storage because##2##2##(1995-6#1)(2010-8#1)
storage by##7##2##(1995-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)
storage capacity and##3##3##(2007-12#1)(2008-3#2)
storage capacity of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
storage capacity##13##2##(2007-12#2)(2008-2#4)(2008-3#7)
storage condition##2##2##(1996-12#1)(2011-2#1)
storage conditions##5##2##(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
storage densities##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
storage density in##2##3##(2007-12#1)(2008-2#1)
storage density of##2##3##(2008-3#2)
storage density##9##2##(2007-12#3)(2008-2#1)(2008-3#5)
storage disease##9##2##(1992-10#1)(1993-12#1)(2007-7#1)(2008-7#2)(2010-8#3)(2012-2#1)
storage diseases##8##2##(1993-9#2)(1996-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
storage disorder##4##2##(1990-8#1)(1996-8#1)(2006-10#1)(2008-10#1)
storage due to##2##3##(2007-12#1)(2008-10#1)
storage facility##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
storage for a##2##3##(1993-12#1)(1995-6#1)
storage for six months at -20##2##6##(2013-7#2)
storage for##8##2##(1993-12#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2013-7#2)
storage in a##6##3##(2008-10#2)(2008-3#3)(2008-5#1)
storage in liquid nitrogen##2##4##(1992-2#1)(2010-8#1)
storage in the##6##3##(1992-3#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-5#1)
storage in which##2##3##(2007-7#1)(2008-3#1)
storage in##32##2##(1992-2#1)(1992-3#1)(1995-12#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-10#5)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#2)(2012-5#1)
storage media##3##2##(2007-12#3)
storage medium##8##2##(2008-12#1)(2008-3#3)(2013-1#4)
storage of glycogen##2##3##(2008-7#1)(2012-2#1)
storage of samples##3##3##(1992-3#1)(2008-10#2)
storage of the##6##3##(1990-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
storage of##49##2##(1990-2#1)(1990-9#1)(1991-3#1)(1992-3#1)(1993-12#3)(1994-3#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#9)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
storage on##3##2##(1992-6#1)(2008-3#1)(2011-2#1)
storage or##6##2##(1994-8#1)(2008-10#2)(2008-3#2)(2008-8#1)
storage organ##3##2##(2007-12#2)(2010-8#1)
storage period at##2##3##(2008-5#1)(2012-2#1)
storage period in##3##3##(2007-3#1)(2008-5#1)(2012-2#1)
storage period##8##2##(2007-3#1)(2008-11#1)(2008-5#2)(2012-2#4)
storage pixels##2##2##(2008-3#2)
storage protein##4##2##(1993-11#1)(1995-8#1)(2008-10#1)(2008-9#1)
storage proteins##3##2##(1991-12#1)(2008-10#1)(2010-4#1)
storage protocols##4##2##(2008-10#4)
storage roots##2##2##(2008-10#2)
storage sites##4##2##(1991-12#1)(1994-8#1)(1995-12#1)(2008-7#1)
storage stability at 4 degrees C##2##6##(2008-10#1)(2010-5#1)
storage stability of the##3##4##(2008-10#2)(2008-5#1)
storage stability of##6##3##(2008-10#5)(2008-5#1)
storage stability##24##2##(2008-10#18)(2008-5#3)(2008-6#1)(2008-7#1)(2010-5#1)
storage system##7##2##(1994-3#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
storage systems##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
storage tanks##2##2##(1995-2#1)(2009-10#1)
storage that##2##2##(2007-12#1)(2008-3#1)
storage time of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
storage time##10##2##(1993-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
storage times##2##2##(2007-12#1)(2011-3#1)
storage was##2##2##(1997-4#1)(2012-2#1)
storage with##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
storage##542##1##(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#8)(1993-9#2)(1994-11#1)(1994-3#10)(1994-8#3)(1995-12#4)(1995-2#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#2)(1996-8#1)(1997-4#3)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#5)(2007-12#50)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#9)(2008-1#1)(2008-10#117)(2008-11#12)(2008-12#5)(2008-2#19)(2008-3#86)(2008-4#7)(2008-5#12)(2008-6#3)(2008-7#15)(2008-8#8)(2008-9#26)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#13)(2011-2#17)(2011-3#1)(2012-12#2)(2012-2#22)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#1)
store and##6##2##(1991-8#1)(1993-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-11#1)
store employee##2##2##(1996-5#2)
store in##2##2##(1996-5#1)(2011-2#1)
store information##2##2##(2008-11#1)(2008-4#1)
store it##2##2##(2008-1#1)(2008-6#1)
store the##5##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
store their##2##2##(2008-7#2)
store##48##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-8#1)(1993-8#2)(1994-3#1)(1995-12#1)(1996-5#4)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
store-operated##2##1##(1996-12#2)
stored LH##2##2##(1996-2#2)
stored and##5##2##(1995-12#1)(2008-10#1)(2010-8#1)(2011-9#1)(2013-1#1)
stored apples##2##2##(2008-10#2)
stored as##6##2##(2008-10#2)(2008-3#3)(2008-7#1)
stored at -20 degrees C##3##5##(2008-10#2)(2010-3#1)
stored at 20##2##3##(2008-10#2)
stored at 4 degrees C##8##5##(1990-12#1)(1991-11#1)(1993-8#1)(1997-4#1)(2008-10#4)
stored at room temperature##3##4##(1994-7#1)(2008-10#1)(2010-9#1)
stored at##28##2##(1990-12#1)(1991-11#1)(1993-8#1)(1994-7#1)(1996-12#1)(1997-4#1)(2008-10#13)(2008-2#1)(2008-6#1)(2010-3#3)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
stored by##2##2##(1991-2#1)(2012-12#1)
stored data##2##2##(2008-9#2)
stored energy##3##2##(2008-3#2)(2010-8#1)
stored for 6##2##3##(2008-10#1)(2008-11#1)
stored for##9##2##(1990-12#1)(1993-12#2)(2008-10#3)(2008-11#1)(2008-9#2)
stored frozen##2##2##(2008-4#1)(2011-2#1)
stored holographically in a photorefractive material##2##6##(2007-12#1)(2008-3#1)
stored holographically in a photorefractive##3##5##(2007-12#1)(2008-3#2)
stored holographically in a##4##4##(2007-12#1)(2008-3#3)
stored holographically##5##2##(2007-12#1)(2008-3#4)
stored in a##11##3##(1994-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-8#1)
stored in the volume##2##4##(2008-3#1)(2008-6#1)
stored in the##19##3##(1992-4#1)(1994-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#2)(2013-1#1)
stored in##57##2##(1990-11#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-6#1)(1994-8#2)(1997-1#1)(1997-6#2)(2007-11#3)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2012-3#1)(2013-1#1)
stored pollen samples##2##3##(2011-2#2)
stored pollen##4##2##(2011-2#4)
stored reference signal##2##3##(2008-2#2)
stored six months at -20 degreeC##2##6##(2013-7#2)
stored sperm##2##2##(1994-8#1)(2008-6#1)
stored under##4##2##(1993-3#1)(2008-10#2)(2008-7#1)
stored##187##1##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-6#1)(1994-7#1)(1994-8#5)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(1997-6#3)(1997-7#1)(2007-11#5)(2007-12#8)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#7)(2008-12#5)(2008-2#5)(2008-3#23)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#6)(2009-7#1)(2009-8#1)(2010-3#4)(2010-4#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-2#9)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
stores and the##2##3##(1996-5#1)(2012-2#1)
stores and##11##2##(1990-12#1)(1992-9#1)(1996-5#2)(2007-11#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
stores in rat##2##3##(1996-5#1)(1997-7#1)
stores in##5##2##(1996-5#1)(1997-7#1)(2007-12#1)(2008-1#2)
stores is##3##2##(1994-8#1)(1995-3#1)(2008-4#1)
stores of##3##2##(1992-3#1)(1996-5#1)(2009-3#1)
stores to##2##2##(1990-12#1)(2012-3#1)
stores##54##1##(1990-12#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-3#1)(1996-12#1)(1996-5#5)(1997-7#3)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
stories about##5##2##(2009-5#3)(2010-10#1)(2012-2#1)
stories and##3##2##(2008-11#1)(2008-2#1)(2009-3#1)
stories of##3##2##(2008-7#1)(2009-7#1)(2009-9#1)
stories were##2##2##(2008-12#1)(2010-10#1)
stories##33##1##(1992-12#1)(1992-3#2)(1993-1#1)(1996-3#2)(1997-3#1)(2008-11#4)(2008-12#5)(2008-2#1)(2008-7#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
storing data##2##2##(2008-3#1)(2008-4#1)
storing the##2##2##(2008-3#1)(2010-8#1)
storing##17##1##(1992-12#1)(1994-3#3)(1994-8#1)(1996-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)
storm over##2##2##(1990-11#1)(2008-11#1)
storm##24##1##(1990-11#1)(1993-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#10)(2008-9#1)(2011-2#3)(2012-12#4)(2013-8#1)
story of a##2##3##(2008-11#1)(2012-2#1)
story of the##2##3##(2007-10#1)(2008-8#1)
story of##17##2##(1995-12#1)(1996-3#1)(1997-9#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
story that##2##2##(2007-2#1)(2011-2#1)
story##60##1##(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-3#2)(1997-3#1)(1997-9#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#2)(2009-4#3)(2010-1#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2013-8#5)
storytelling and narrative##3##3##(2008-11#3)
storytelling as a##3##3##(2008-11#2)(2008-12#1)
storytelling##11##1##(1992-3#1)(2008-11#6)(2008-12#4)
stover##5##1##(2008-10#1)(2008-6#1)(2011-2#2)(2013-1#1)
str##3##1##(2008-3#1)(2008-5#1)(2011-2#1)
straddling patent foramen ovale thrombus##2##5##(2011-2#2)
straddling##4##1##(2006-10#1)(2008-2#1)(2011-2#2)
straight and##3##2##(2008-2#1)(2009-7#1)(2010-7#1)
straight line##9##2##(1991-5#1)(2008-10#7)(2008-3#1)
straight loss of##2##3##(2007-12#1)(2008-3#1)
straight to##2##2##(2008-6#1)(2011-2#1)
straight tube##2##2##(2008-7#1)(2009-6#1)
straight tubules##2##2##(1992-8#2)
straight waveguide##2##2##(2007-11#1)(2008-10#1)
straight when the knee was##2##5##(1997-8#2)
straight wire##4##2##(2009-7#4)
straight##61##1##(1991-5#1)(1992-3#1)(1992-8#2)(1993-12#3)(1995-3#1)(1996-5#1)(1996-6#1)(1997-8#2)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#3)(2008-6#3)(2008-7#1)(2008-9#2)(2009-6#2)(2009-7#5)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
straight-line##2##1##(2008-10#2)
straightforward and##7##2##(1995-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-3#1)
straightforward procedure##2##2##(2008-9#1)(2011-2#1)
straightforward synthesis of##2##3##(2008-8#1)(2009-10#1)
straightforward to determine##2##3##(2008-3#1)(2008-8#1)
straightforward to##5##2##(2008-3#2)(2008-4#1)(2008-8#1)(2009-7#1)
straightforward##80##1##(1990-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
straightness##2##1##(2008-3#2)
strain (ATCC##2##2##(2008-12#1)(2011-2#1)
strain (H8)##3##2##(1997-6#3)
strain (designated##2##2##(2008-10#2)
strain 1##5##2##(1991-8#4)(2008-10#1)
strain 10##2##2##(2008-10#2)
strain 1295-22##3##2##(2008-10#3)
strain 1609##4##2##(2008-10#4)
strain 2##5##2##(1991-8#3)(2008-10#2)
strain 2308##4##2##(1996-12#4)
strain 4/4 was##2##3##(2008-10#2)
strain 4/4##4##2##(2008-10#4)
strain 50##4##2##(2008-10#2)(2008-5#2)
strain 70T01 was##2##3##(2008-10#2)
strain 70T01##9##2##(2008-10#9)
strain 90-166##3##2##(2008-10#3)
strain A mice##2##3##(1994-2#2)
strain A1##2##2##(2011-2#2)
strain A506##12##2##(2008-10#12)
strain AAV-2##4##2##(2008-8#4)
strain AF2240##2##2##(2008-11#2)
strain ATCC##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
strain BK18 of##2##3##(2008-10#2)
strain BK18##3##2##(2008-10#3)
strain BV-15##4##2##(2008-10#4)
strain C##3##2##(1994-6#1)(2008-10#2)
strain C3 produces##2##3##(2008-10#2)
strain C3##8##2##(2008-10#8)
strain C9-1##3##2##(2008-10#3)
strain DC3000##2##2##(2008-10#2)
strain E278Ar##2##2##(2008-10#2)
strain Fo47##5##2##(2008-10#5)
strain G-5##3##2##(2008-10#3)
strain H46A##2##2##(2012-2#2)
strain IFO##3##2##(1993-12#2)(2008-6#1)
strain IL-Cb1##2##2##(2008-10#2)
strain JC1 and Hydrogenophaga pseudoflava##2##5##(1997-6#2)
strain JJ45##2##2##(2009-6#2)
strain K##7##2##(2008-10#7)
strain K84##4##2##(2008-10#4)
strain Kh5##2##2##(2008-10#2)
strain Kluyveromyces##2##2##(2008-10#1)(2008-6#1)
strain Liaoning##2##2##(2008-9#2)
strain M##2##2##(2008-10#2)
strain M41##3##2##(1997-6#2)(2008-5#1)
strain MKB 158##4##3##(2008-10#4)
strain MKB##5##2##(2008-10#5)
strain PAV##2##2##(2008-10#2)
strain PCC 6301##2##3##(1996-6#2)
strain PCC 6803##2##3##(1996-12#2)
strain PCC##4##2##(1996-12#2)(1996-6#2)
strain PCC6803 by amino-terminal##2##4##(1996-8#1)(1997-6#1)
strain PCC6803 by##3##3##(1996-8#1)(1997-6#2)
strain PCC6803##14##2##(1995-12#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-6#2)
strain Q2-87##2##2##(2008-10#2)
strain Q8r1-96##3##2##(2008-10#3)
strain RT37-1##2##2##(2008-10#2)
strain SHZH98##3##2##(2008-8#3)
strain SSB17##2##2##(2008-10#2)
strain T32##2##2##(2008-9#2)
strain W260##2##2##(2008-10#2)
strain amplitude##3##2##(2008-10#2)(2012-7#1)
strain and a##3##3##(2008-6#1)(2009-12#1)(2011-2#1)
strain and forskolin##3##3##(1993-3#3)
strain and its associated factors among lecturers##2##7##(2008-10#2)
strain and its##5##3##(2008-10#5)
strain and mutant##2##3##(1997-2#1)(1997-3#1)
strain and temperature measurement##2##4##(2007-12#1)(2008-3#1)
strain and temperature sensor##2##4##(2007-12#1)(2008-3#1)
strain and temperature with##2##4##(2008-3#2)
strain and temperature##16##3##(2007-12#4)(2008-3#12)
strain and the##6##3##(1996-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-8#1)
strain and##58##2##(1992-2#1)(1993-3#3)(1994-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#4)(2008-10#8)(2008-11#1)(2008-3#12)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
strain are##2##2##(2008-8#1)(2011-1#1)
strain as##2##2##(2008-10#1)(2008-5#1)
strain at 60##2##3##(1990-8#1)(1994-11#1)
strain at fracture##2##3##(2008-7#2)
strain at the##2##3##(2009-11#1)(2013-1#1)
strain at##9##2##(1990-8#1)(1994-11#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-7#2)(2009-11#1)(2013-1#1)
strain but not in the reference or##2##7##(2011-2#2)
strain but##4##2##(2008-10#1)(2011-2#3)
strain by##2##2##(1995-8#1)(2008-9#1)
strain can be##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
strain can##6##2##(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
strain carrying##2##2##(1991-6#1)(1993-3#1)
strain caused by the##2##4##(1996-5#1)(2009-1#1)
strain caused##3##2##(1996-5#1)(1997-3#1)(2009-1#1)
strain changes##3##2##(1996-4#2)(2008-10#1)
strain characterization##2##2##(2008-10#1)(2008-3#1)
strain clustered##2##2##(2008-10#1)(2013-8#1)
strain compared##2##2##(1996-12#1)(2008-10#1)
strain constitutes##2##2##(1991-2#1)(2008-10#1)
strain containing##2##2##(1990-5#1)(1994-12#1)
strain correlates with##2##3##(2011-1#1)(2013-7#1)
strain could##4##2##(1990-5#1)(1993-8#1)(2012-2#1)(2013-8#1)
strain decreased##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
strain deleted for the##3##4##(1997-3#2)(2008-7#1)
strain deleted for##4##3##(1991-7#1)(1997-3#2)(2008-7#1)
strain deleted##5##2##(1991-7#1)(1997-3#3)(2008-7#1)
strain did not##3##3##(2010-9#1)(2011-1#1)(2011-2#1)
strain differences##4##2##(1992-11#1)(1994-8#2)(1996-12#1)
strain distribution profiles##2##3##(2008-3#2)
strain distribution##5##2##(2008-12#1)(2008-3#3)(2010-8#1)
strain distributions##10##2##(2007-12#1)(2008-8#4)(2009-7#2)(2013-1#3)
strain diversity##2##2##(2008-10#1)(2008-9#1)
strain due to##2##3##(2007-10#1)(2009-7#1)
strain expressing##2##2##(2008-8#1)(2011-2#1)
strain failed to##5##3##(2008-10#3)(2008-8#1)(2012-3#1)
strain for##4##2##(2008-10#3)(2013-1#1)
strain from##7##2##(1991-2#1)(1996-12#1)(1996-2#1)(2008-10#3)(2011-1#1)
strain gages##2##2##(2008-2#2)
strain gauge##2##2##(2007-12#1)(2008-3#1)
strain group##2##2##(2008-10#2)
strain had##3##2##(2008-10#2)(2013-8#1)
strain has been##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
strain has##5##2##(1996-5#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
strain in a##2##3##(1992-11#1)(2008-7#1)
strain in the##3##3##(1994-11#1)(2008-9#1)(2009-7#1)
strain in##27##2##(1990-5#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
strain induced##2##2##(1993-3#1)(2009-7#1)
strain is##13##2##(1993-3#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#1)
strain isolated from a commercial##2##5##(2012-2#2)
strain isolated from##7##3##(2008-10#3)(2012-2#3)(2013-8#1)
strain isolated in##2##3##(2013-8#2)
strain isolated##9##2##(2008-10#3)(2012-2#3)(2013-8#3)
strain isolates##13##2##(2008-10#13)
strain lacking##4##2##(1992-10#1)(1995-11#1)(2009-10#1)(2009-8#1)
strain m6418##2##2##(2008-10#2)
strain maintained##2##2##(2008-10#1)(2013-8#1)
strain measurement##7##2##(2007-11#1)(2008-2#1)(2008-3#2)(2013-8#3)
strain measurements##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-8#1)
strain microscope##2##2##(2008-3#2)
strain of A##5##3##(1991-12#1)(2008-10#4)
strain of B##2##3##(2008-10#2)
strain of BYDV##2##3##(2008-10#2)
strain of Bean common mosaic necrosis virus (BCMNV)##2##8##(2008-10#2)
strain of C##3##3##(2008-10#3)
strain of E##6##3##(1997-7#3)(2008-10#1)(2008-5#1)(2008-6#1)
strain of H##2##3##(1997-3#1)(2011-2#1)
strain of HIV-1##2##3##(1991-9#1)(1992-8#1)
strain of Japanese##2##3##(1997-3#2)
strain of M##2##3##(1993-11#1)(2008-10#1)
strain of P##5##3##(1997-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
strain of Pseudomonas aeruginosa##3##4##(2008-6#1)(2012-2#1)(2012-3#1)
strain of Pseudomonas##4##3##(2008-6#1)(2012-2#2)(2012-3#1)
strain of S##6##3##(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#3)
strain of X##2##3##(2008-10#2)
strain of a##3##3##(2008-10#1)(2011-2#2)
strain of group##2##3##(2008-8#1)(2012-2#1)
strain of infectious bronchitis virus (IBV)##3##6##(1997-6#2)(2008-5#1)
strain of infectious bronchitis virus##4##5##(1997-6#3)(2008-5#1)
strain of mice##3##3##(1993-12#1)(1997-8#1)(2008-12#1)
strain of rats##2##3##(1993-12#1)(2007-10#1)
strain of the##14##3##(1993-3#1)(1995-2#1)(2008-10#4)(2008-9#2)(2010-1#1)(2011-2#5)
strain of virus##2##3##(2008-5#2)
strain of yeast##2##3##(1994-6#1)(2008-8#1)
strain of##148##2##(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#1)(1994-12#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-6#5)(1997-7#4)(1997-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#56)(2008-11#1)(2008-12#2)(2008-5#7)(2008-6#4)(2008-8#6)(2008-9#5)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#9)(2012-2#5)(2012-3#3)(2013-8#2)
strain on##9##2##(1996-6#1)(1997-2#1)(2008-10#4)(2009-1#1)(2009-6#1)(2011-2#1)
strain or##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
strain produced##2##2##(2008-10#1)(2008-8#1)
strain profile##2##2##(2007-12#2)
strain rate and##2##3##(2009-7#2)
strain rate##6##2##(1996-4#1)(2009-10#1)(2009-7#4)
strain rates##2##2##(2009-7#2)
strain relaxation in the##2##4##(2007-11#1)(2008-3#1)
strain relaxation##3##2##(2007-11#2)(2008-3#1)
strain resolution of##3##3##(2007-12#2)(2008-3#1)
strain resolution##4##2##(2007-12#2)(2008-3#2)
strain sensing##3##2##(2007-12#2)(2008-3#1)
strain sensitivities##2##2##(2007-11#1)(2008-3#1)
strain sensitivity of the##2##4##(2008-3#2)
strain sensitivity of##4##3##(2007-12#1)(2008-3#3)
strain sensitivity##6##2##(2007-12#1)(2008-3#4)(2013-8#1)
strain sensor##6##2##(2007-12#3)(2008-3#3)
strain sensors##2##2##(2008-2#2)
strain showed##3##2##(1997-6#1)(2008-12#2)
strain specific##3##2##(2008-10#2)(2011-2#1)
strain stimulates##2##2##(1994-11#2)
strain structure can##2##3##(2008-8#2)
strain structure##3##2##(2008-8#3)
strain subgroups##2##2##(2008-10#2)
strain that was susceptible to##2##5##(2011-2#2)
strain that was##4##3##(2008-10#1)(2011-1#1)(2011-2#2)
strain that##12##2##(1994-9#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
strain to be##2##3##(1991-7#1)(1992-5#1)
strain to##9##2##(1991-7#1)(1992-5#1)(1993-9#1)(1997-3#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
strain under##5##2##(1997-1#1)(2007-10#1)(2008-10#1)(2008-7#2)
strain used##3##2##(2008-10#2)(2008-6#1)
strain using##2##2##(2011-2#1)(2012-3#1)
strain was able to##2##4##(2008-10#1)(2008-6#1)
strain was also##2##3##(2008-10#2)
strain was found to be##2##5##(2008-6#1)(2013-1#1)
strain was found to##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
strain was isolated from a##2##5##(1991-8#1)(2008-9#1)
strain was isolated from##3##4##(1991-8#1)(2008-9#1)(2011-2#1)
strain was isolated##4##3##(1991-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
strain was obtained##2##3##(2008-10#1)(2013-8#1)
strain was significantly##2##3##(2008-10#1)(2009-7#1)
strain was##50##2##(1991-3#1)(1991-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#14)(2008-12#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#4)
strain were##15##2##(1991-9#1)(1994-12#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-3#1)
strain when##3##2##(2008-10#2)(2009-7#1)
strain which##6##2##(1991-7#1)(1995-3#1)(2008-10#1)(2008-8#1)(2011-3#1)(2013-1#1)
strain whose##2##2##(2008-3#1)(2008-5#1)
strain with##2##2##(2008-10#1)(2008-8#1)
strain##1432##1##(1990-11#1)(1990-2#2)(1990-5#4)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-6#1)(1991-7#3)(1991-8#10)(1991-9#8)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#3)(1993-11#2)(1993-12#12)(1993-3#10)(1993-5#1)(1993-8#1)(1993-9#12)(1994-11#8)(1994-12#9)(1994-2#3)(1994-3#6)(1994-6#6)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#8)(1996-12#15)(1996-2#6)(1996-4#4)(1996-5#4)(1996-6#8)(1996-8#2)(1997-1#1)(1997-2#8)(1997-3#12)(1997-4#4)(1997-6#18)(1997-7#6)(1997-8#6)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#12)(2007-11#10)(2007-12#32)(2007-2#3)(2007-6#5)(2007-7#3)(2008-1#1)(2008-10#502)(2008-11#14)(2008-12#16)(2008-2#13)(2008-3#43)(2008-4#3)(2008-5#23)(2008-6#32)(2008-7#29)(2008-8#58)(2008-9#29)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#11)(2009-7#26)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-6#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#124)(2011-3#3)(2012-12#6)(2012-2#27)(2012-3#19)(2012-7#1)(2013-1#37)(2013-7#4)(2013-8#34)
strain) and##3##2##(2007-10#1)(2008-3#1)(2011-1#1)
strain)##18##1##(1991-8#1)(1992-8#1)(1997-3#1)(2007-10#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
strain-based plasticity##2##2##(2013-1#2)
strain-based##4##1##(2013-1#4)
strain-dependent##2##1##(1994-2#1)(2008-10#1)
strain-induced##6##1##(1994-11#1)(1995-2#3)(2008-3#2)
strain-specific monoclonal antibodies##2##3##(2008-10#2)
strain-specific monoclonal##3##2##(2008-10#3)
strain-specific##18##1##(1994-5#1)(1996-12#1)(2008-10#9)(2008-12#3)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
strain]##3##1##(2010-12#1)(2011-2#1)(2013-8#1)
strained##9##1##(1990-8#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
straining##3##1##(2007-12#1)(2007-8#1)(2012-3#1)
strains (F##2##2##(2008-10#2)
strains ER##2##2##(2008-10#2)
strains TA98##2##2##(2008-8#1)(2008-9#1)
strains able to##2##3##(1991-3#1)(2008-10#1)
strains after##3##2##(2008-10#2)(2008-11#1)
strains against##2##2##(2008-10#1)(2012-2#1)
strains also##4##2##(1994-12#1)(2008-10#2)(2013-8#1)
strains among##2##2##(2008-10#1)(2011-2#1)
strains and a##4##3##(2008-10#2)(2011-1#1)(2012-2#1)
strains and clinical isolates of##2##5##(2007-7#1)(2008-8#1)
strains and in##2##3##(2008-10#2)
strains and isolates##3##3##(2008-10#2)(2008-5#1)
strains and other##2##3##(2008-10#2)
strains and the##9##3##(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-12#1)(2013-1#1)
strains and their##4##3##(2008-12#4)
strains and##64##2##(1993-12#1)(1994-3#1)(1994-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#29)(2008-11#1)(2008-12#6)(2008-2#1)(2008-5#5)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
strains appear to##2##3##(1991-1#1)(2007-6#1)
strains are able to##2##4##(2008-10#2)
strains are discussed##2##3##(1993-9#1)(1995-12#1)
strains are##23##2##(1990-5#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-8#1)(2008-10#10)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#1)
strains as X##2##3##(2008-10#2)
strains as well as##2##4##(2008-10#1)(2008-12#1)
strains as##11##2##(2008-10#8)(2008-12#1)(2008-2#1)(2008-9#1)
strains associated with diseased##2##4##(2008-10#2)
strains associated with##3##3##(2008-10#3)
strains at the##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
strains at##6##2##(1996-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
strains based on##4##3##(1997-3#1)(2008-10#2)(2013-1#1)
strains became##2##2##(2008-10#1)(2010-7#1)
strains belonged to##4##3##(1993-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
strains belonging to genomospecies 1##2##5##(2008-10#2)
strains belonging to genomospecies##3##4##(2008-10#3)
strains belonging to other##2##4##(2008-10#2)
strains belonging to##5##3##(2008-10#5)
strains but##2##2##(2008-10#2)
strains by##14##2##(1992-11#1)(1997-3#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-9#1)(2012-2#1)
strains can##7##2##(2008-10#5)(2008-5#1)(2008-8#1)
strains carried##3##2##(1990-5#1)(2012-12#1)(2012-3#1)
strains carry multiple##2##3##(2008-10#1)(2012-3#1)
strains carry##3##2##(1996-6#1)(2008-10#1)(2012-3#1)
strains carrying multiple##2##3##(1995-8#1)(2008-10#1)
strains carrying##5##2##(1990-11#1)(1990-5#1)(1992-10#1)(1995-8#1)(2008-10#1)
strains caused##3##2##(2008-10#3)
strains causing##3##2##(2007-12#1)(2008-12#1)(2013-8#1)
strains clearly##2##2##(2008-10#1)(2008-5#1)
strains clustered##4##2##(2008-10#3)(2013-8#1)
strains collected from##4##3##(2008-10#4)
strains collected##7##2##(2008-10#7)
strains contain##2##2##(1993-11#1)(1995-8#1)
strains containing the##2##3##(1995-5#1)(2008-10#1)
strains containing##6##2##(1993-9#1)(1995-5#1)(2008-10#2)(2009-2#1)(2011-2#1)
strains could be##7##3##(1993-2#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-7#1)
strains could##10##2##(1993-2#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-8#1)
strains derived from##2##3##(2008-10#2)
strains detected##2##2##(1996-6#1)(2008-10#1)
strains did not##6##3##(2007-10#1)(2008-10#4)(2008-5#1)
strains displaying##2##2##(2008-10#2)
strains do not##3##3##(1995-8#1)(2008-10#1)(2008-9#1)
strains during##2##2##(1995-6#1)(2008-10#1)
strains evaluated##2##2##(1997-3#1)(2008-10#1)
strains examined##4##2##(1990-7#1)(2008-10#3)
strains except##2##2##(2008-5#1)(2010-3#1)
strains exhibited##3##2##(2008-10#3)
strains expressing##3##2##(2010-11#1)(2012-3#1)(2013-1#1)
strains for##6##2##(1996-12#1)(2008-10#3)(2010-7#1)(2011-2#1)
strains formed a##2##3##(1996-12#1)(2008-10#1)
strains from Costa Rica##6##4##(2008-10#6)
strains from São Paulo##2##4##(2008-10#2)
strains from a##2##3##(2008-10#2)
strains from all other##2##4##(2008-10#2)
strains from all##6##3##(2008-10#6)
strains from cantaloupe and##2##4##(2008-10#2)
strains from citrus##2##3##(2008-10#2)
strains from different geographical##2##4##(2008-10#2)
strains from different regions##2##4##(2008-10#1)(2009-2#1)
strains from different##7##3##(2008-10#6)(2009-2#1)
strains from each##2##3##(2008-10#1)(2008-7#1)
strains from ginger##4##3##(2008-10#4)
strains from hazelnut##3##3##(2008-10#3)
strains from ornamental##2##3##(2008-10#1)(2011-2#1)
strains from other##3##3##(2008-10#3)
strains from the##6##3##(2008-10#5)(2008-5#1)
strains from tomato##2##3##(2008-10#2)
strains from various other##2##4##(1997-3#1)(2011-2#1)
strains from various##3##3##(1993-3#1)(1997-3#1)(2011-2#1)
strains from##87##2##(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#74)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#3)(2013-1#1)(2013-8#1)
strains grew##5##2##(1991-8#1)(2008-10#3)(2010-4#1)
strains grouped##3##2##(2008-10#3)
strains had##8##2##(1997-6#1)(2008-10#4)(2008-5#1)(2010-4#1)(2013-8#1)
strains has been##2##3##(1995-6#1)(2008-10#1)
strains has##3##2##(1995-6#1)(1995-9#1)(2008-10#1)
strains have been obtained##2##4##(2008-10#1)(2008-8#1)
strains have been##7##3##(1996-12#1)(2008-10#3)(2008-6#1)(2008-8#1)(2012-3#1)
strains have not##2##3##(2008-10#1)(2008-5#1)
strains have##16##2##(1991-1#1)(1996-12#1)(1997-6#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
strains identified##2##2##(2008-10#2)
strains in a##5##3##(2008-10#4)(2011-2#1)
strains in all##2##3##(2008-10#1)(2013-8#1)
strains in cucurbits##2##3##(2008-10#2)
strains in culture##2##3##(1991-2#1)(2008-10#1)
strains in the exoskeleton##2##4##(2007-12#2)
strains in the##13##3##(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-9#3)(2013-8#1)
strains in which##3##3##(1995-2#2)(2008-10#1)
strains in##59##2##(1991-2#1)(1995-2#2)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#1)(2008-10#28)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#5)(2009-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#4)
strains increased##3##2##(2008-10#3)
strains indicated that##2##3##(1995-8#1)(2008-10#1)
strains induced##3##2##(2008-10#2)(2008-2#1)
strains infecting##2##2##(2008-10#2)
strains into three##3##3##(2008-10#3)
strains into two distinct groups##2##5##(2008-10#2)
strains into##11##2##(2008-10#10)(2012-3#1)
strains investigated##2##2##(1997-4#1)(2010-6#1)
strains is a##3##3##(1996-6#1)(2008-9#1)(2012-12#1)
strains is##9##2##(1990-5#1)(1994-12#1)(1996-6#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-12#1)
strains isolated from patients##3##4##(2007-12#1)(2008-5#1)(2011-1#1)
strains isolated from the##3##4##(2008-10#1)(2008-5#2)
strains isolated from##33##3##(2007-12#1)(2008-10#21)(2008-12#2)(2008-5#4)(2009-5#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
strains isolated in the##3##4##(1990-2#1)(2008-12#1)(2011-1#1)
strains isolated in##6##3##(1990-2#1)(2008-10#1)(2008-12#2)(2011-1#2)
strains isolated##45##2##(1990-2#1)(2007-12#1)(2008-10#23)(2008-12#4)(2008-5#8)(2009-5#1)(2009-6#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
strains lacked##2##2##(2008-10#2)
strains lacking##2##2##(1992-10#1)(2009-10#1)
strains may be##2##3##(2008-10#2)
strains may##4##2##(1997-3#1)(2008-10#2)(2008-5#1)
strains not##2##2##(2008-10#1)(2008-12#1)
strains of A##4##3##(2008-1#3)(2008-10#1)
strains of Bacillus##3##3##(1994-2#1)(2008-10#2)
strains of C##6##3##(2007-6#1)(2008-10#2)(2009-10#1)(2009-2#1)(2010-8#1)
strains of Chlamydia psittaci##2##4##(1990-5#1)(1993-2#1)
strains of Clostridium spiroforme##2##4##(1991-8#2)
strains of Clostridium##4##3##(1991-8#2)(1997-4#1)(2008-5#1)
strains of E##7##3##(2007-7#1)(2008-10#4)(2008-12#1)(2012-3#1)
strains of F##5##3##(2008-10#4)(2013-1#1)
strains of Fusarium oxysporum##3##4##(2008-10#3)
strains of H contortus##2##4##(1991-8#2)
strains of H##8##3##(1990-5#1)(1991-8#2)(1997-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
strains of HIV-1##5##3##(1991-9#1)(1994-6#3)(2013-7#1)
strains of Helicobacter pylori##2##4##(1997-8#1)(2008-12#1)
strains of M##3##3##(1997-3#2)(2008-10#1)
strains of Mycobacterium##2##3##(1991-8#1)(2011-2#1)
strains of P##11##3##(2007-2#1)(2008-10#8)(2008-5#1)(2010-3#1)
strains of Pantoea agglomerans##2##4##(2008-10#2)
strains of Pantoea##3##3##(2008-10#3)
strains of Pseudomonas##5##3##(2008-10#4)(2008-7#1)
strains of R##4##3##(1991-8#1)(2008-10#3)
strains of S##13##3##(1996-11#1)(1997-3#2)(2008-10#5)(2008-7#2)(2008-9#1)(2012-3#2)
strains of SCMV and SrMV##2##5##(2008-10#2)
strains of Salmonella##3##3##(1990-6#1)(1995-5#1)(2013-8#1)
strains of T##3##3##(1992-8#2)(2008-10#1)
strains of Trichoderma##2##3##(2008-10#2)
strains of V##2##3##(2008-10#2)
strains of X##11##3##(2008-10#11)
strains of Xanthomonas albilineans from##2##5##(2008-10#2)
strains of Xanthomonas axonopodis pv##3##5##(2008-10#3)
strains of Xanthomonas campestris pv##2##5##(2008-10#2)
strains of Xanthomonas oryzae pv##2##5##(2008-10#2)
strains of Xanthomonas##12##3##(2008-10#11)(2008-8#1)
strains of Xylella fastidiosa##3##4##(2008-10#3)
strains of a##2##3##(2008-10#2)
strains of avian##2##3##(1997-6#1)(2007-6#1)
strains of bacteria and##2##4##(2008-8#1)(2010-2#1)
strains of bacteria##5##3##(1990-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)
strains of beet##2##3##(2008-10#2)
strains of binucleate Rhizoctonia##2##4##(2008-10#2)
strains of coagulase-negative staphylococci##2##4##(2008-7#1)(2010-4#1)
strains of each species##2##4##(2008-10#1)(2008-12#1)
strains of infectious bronchitis virus isolated from the##2##8##(2008-5#2)
strains of infectious bronchitis virus##3##5##(1996-11#1)(2008-5#2)
strains of mice were##2##4##(1991-12#1)(2008-10#1)
strains of mice##18##3##(1991-12#3)(1993-12#1)(1994-5#2)(1996-12#1)(1996-5#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2013-1#1)
strains of mutant mice##2##4##(2008-8#2)
strains of other##4##3##(2008-10#4)
strains of plant growth-promoting rhizobacteria (PGPR)##2##6##(2008-10#2)
strains of race##2##3##(2008-10#2)
strains of rat##2##3##(1994-2#1)(2008-11#1)
strains of rats##4##3##(1993-12#1)(1997-7#2)(2008-10#1)
strains of the bacterial##2##4##(2008-10#2)
strains of the bacterium##2##4##(2008-1#1)(2008-10#1)
strains of the fungus##2##4##(1991-5#1)(2008-10#1)
strains of the pathogen##7##4##(2008-10#7)
strains of the same species##2##5##(2008-10#1)(2012-2#1)
strains of the same##4##4##(2008-10#2)(2008-4#1)(2012-2#1)
strains of the species##3##4##(2008-10#3)
strains of the virus##2##4##(2008-10#2)
strains of the##38##3##(1991-5#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
strains of this##2##3##(2008-10#1)(2008-9#1)
strains of##296##2##(1990-3#1)(1990-5#3)(1990-6#1)(1991-12#4)(1991-5#1)(1991-8#7)(1991-9#1)(1992-8#3)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-6#3)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#147)(2008-11#3)(2008-12#13)(2008-2#1)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#3)
strains on the basis of##2##5##(2008-10#2)
strains on the##3##3##(2008-10#2)(2011-2#1)
strains on##11##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
strains or##3##2##(2008-10#2)(2008-9#1)
strains originating from##2##3##(1991-2#1)(2008-10#1)
strains pathogenic to##3##3##(2008-10#3)
strains pathogenic##4##2##(2008-10#4)
strains persisted##2##2##(2008-10#1)(2008-5#1)
strains produced##10##2##(1991-8#1)(2007-8#1)(2008-10#8)
strains producing##3##2##(2008-10#2)(2008-5#1)
strains represent##2##2##(2008-10#2)
strains representing the##2##3##(2008-10#2)
strains representing##3##2##(2008-10#3)
strains required##2##2##(2008-10#1)(2012-3#1)
strains revealed that the##2##4##(1997-2#1)(2009-6#1)
strains revealed##6##2##(1997-2#1)(2008-10#2)(2008-5#1)(2009-6#2)
strains reveals##2##2##(1993-2#1)(2011-2#1)
strains selected only for their bioremediation properties##2##7##(2008-6#2)
strains selected##3##2##(2008-6#3)
strains sensitive##3##2##(2008-10#3)
strains showed##11##2##(2007-6#1)(2008-10#6)(2008-12#1)(2008-5#3)
strains significantly reduced##2##3##(2008-10#2)
strains such as##2##3##(2009-12#1)(2010-3#1)
strains tested were##2##3##(2008-10#1)(2009-5#1)
strains tested##11##2##(2008-10#8)(2008-5#1)(2009-5#1)(2011-2#1)
strains that are##4##3##(2008-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
strains that differ in##2##4##(1996-12#1)(2008-10#1)
strains that might##2##3##(1992-12#1)(2011-2#1)
strains that were isolated##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
strains that were##10##3##(2008-10#7)(2008-12#1)(2008-6#1)(2011-2#1)
strains that##36##2##(1992-12#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-10#20)(2008-12#1)(2008-6#2)(2008-8#2)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)
strains to the##2##3##(1993-12#1)(2008-2#1)
strains to##17##2##(1991-12#1)(1993-12#1)(1995-6#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-2#1)(2009-5#1)(2011-2#2)
strains used##4##2##(2008-10#3)(2013-8#1)
strains using##9##2##(1990-8#1)(2008-10#6)(2008-7#1)(2011-2#1)
strains varied significantly##2##3##(2008-10#1)(2008-12#1)
strains was analyzed##2##3##(2008-10#2)
strains was evaluated##2##3##(2007-10#1)(2008-10#1)
strains was found##2##3##(2008-10#1)(2008-12#1)
strains was revealed by RFLP##2##5##(2008-10#2)
strains was##26##2##(1991-3#2)(1991-8#1)(1997-7#2)(2007-10#1)(2008-10#18)(2008-12#1)(2012-3#1)
strains were also##4##3##(1991-3#1)(1993-11#1)(1996-12#1)(2008-10#1)
strains were collected from##2##4##(2008-10#1)(2008-12#1)
strains were compared with##2##4##(2008-10#1)(2008-6#1)
strains were compared##5##3##(1996-5#1)(2008-10#3)(2008-6#1)
strains were constructed##2##3##(1995-8#1)(2008-10#1)
strains were detected##2##3##(2008-10#2)
strains were divided into two##2##5##(2008-10#2)
strains were divided into##4##4##(2008-10#4)
strains were established##2##3##(1993-11#1)(2008-10#1)
strains were evaluated##2##3##(2008-10#2)
strains were examined##2##3##(2008-10#1)(2008-5#1)
strains were found##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
strains were further##2##3##(2008-10#2)
strains were grouped into##2##4##(2008-5#2)
strains were grouped##5##3##(2008-10#3)(2008-5#2)
strains were grown##2##3##(2008-10#1)(2008-6#1)
strains were highly pathogenic on Andean##2##6##(2008-10#2)
strains were highly pathogenic on##3##5##(2008-10#3)
strains were identified as##4##4##(2008-10#3)(2009-6#1)
strains were identified##9##3##(2008-10#7)(2008-11#1)(2009-6#1)
strains were inoculated##3##3##(1992-2#1)(2008-10#2)
strains were isolated from##6##4##(2008-10#5)(2008-5#1)
strains were isolated##8##3##(1994-3#1)(2008-10#5)(2008-5#1)(2011-2#1)
strains were less##2##3##(2008-10#2)
strains were more##3##3##(2008-10#2)(2011-1#1)
strains were mostly in serotype##2##5##(1993-2#2)
strains were not##5##3##(2008-10#3)(2008-5#1)(2011-1#1)
strains were pathogenic on##2##4##(2008-10#2)
strains were pathogenic##3##3##(2008-10#3)
strains were placed in##2##4##(2008-10#2)
strains were placed##3##3##(2008-10#3)
strains were present##2##3##(2008-10#2)
strains were selected##2##3##(2008-10#1)(2008-6#1)
strains were sensitive to##3##4##(1990-6#1)(2007-10#1)(2008-10#1)
strains were separated##2##3##(2008-10#2)
strains were significantly##2##3##(2008-10#1)(2008-12#1)
strains were similar##2##3##(2008-10#1)(2011-2#1)
strains were tested for##3##4##(2007-8#1)(2008-10#2)
strains were tested##4##3##(2007-8#1)(2008-10#3)
strains were the most##2##4##(2008-10#1)(2011-2#1)
strains were then##2##3##(2008-10#1)(2011-2#1)
strains were used to##4##4##(2008-10#2)(2010-8#1)(2012-12#1)
strains were##159##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-11#2)(1993-2#2)(1994-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#101)(2008-11#1)(2008-12#6)(2008-5#6)(2008-6#3)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#7)(2012-12#1)(2013-8#3)
strains which were##2##3##(2008-6#1)(2011-1#1)
strains which##3##2##(2008-5#1)(2008-6#1)(2011-1#1)
strains with##29##2##(1991-12#2)(1993-8#1)(1993-9#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#4)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)
strains within this##2##3##(2008-10#1)(2008-5#1)
strains within##6##2##(2008-10#5)(2008-5#1)
strains without##3##2##(2008-10#3)
strains##1769##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#14)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#4)(1991-12#9)(1991-2#2)(1991-3#7)(1991-5#2)(1991-8#10)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#3)(1992-8#3)(1993-11#3)(1993-12#12)(1993-2#7)(1993-3#1)(1993-8#1)(1993-9#9)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#4)(1994-5#5)(1994-6#3)(1994-8#6)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#5)(1995-8#14)(1995-9#1)(1996-11#2)(1996-12#15)(1996-2#2)(1996-5#4)(1996-6#5)(1997-2#2)(1997-3#13)(1997-4#4)(1997-6#8)(1997-7#8)(1997-8#4)(1997-9#2)(2006-6#1)(2007-10#14)(2007-11#5)(2007-12#10)(2007-2#1)(2007-6#10)(2007-7#9)(2007-8#3)(2008-1#6)(2008-10#935)(2008-11#11)(2008-12#47)(2008-2#15)(2008-3#4)(2008-4#3)(2008-5#77)(2008-6#21)(2008-7#22)(2008-8#30)(2008-9#33)(2009-10#4)(2009-12#3)(2009-2#6)(2009-4#1)(2009-5#4)(2009-6#6)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#4)(2010-4#11)(2010-5#1)(2010-6#2)(2010-7#7)(2010-8#5)(2011-1#35)(2011-2#56)(2011-3#1)(2012-1#1)(2012-12#12)(2012-2#21)(2012-3#40)(2013-1#19)(2013-7#1)(2013-8#34)
strains) and##4##2##(1991-8#1)(1993-2#1)(2008-10#2)
strains) were##2##2##(1991-8#1)(2008-10#1)
strains)##16##1##(1991-8#2)(1993-2#2)(1996-12#1)(2008-10#6)(2008-7#1)(2010-8#1)(2011-1#2)(2013-8#1)
strains]##2##1##(2012-12#1)(2013-8#1)
straminea##4##1##(1993-6#4)
stramineus##2##1##(2007-12#1)(2008-5#1)
stramonium SPDS1##2##2##(2013-8#2)
stramonium##8##1##(2008-10#5)(2008-7#1)(2013-8#2)
strand DNA##2##2##(2008-10#1)(2011-1#1)
strand RNA##2##2##(1990-11#1)(2008-10#1)
strand and##3##2##(1990-5#1)(1990-7#1)(2009-9#1)
strand as##2##2##(1990-5#1)(2008-10#1)
strand break##4##2##(1996-2#2)(2011-1#1)(2013-1#1)
strand breaks##25##2##(1991-12#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#3)(1995-6#1)(1996-2#1)(1997-4#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-3#1)
strand cDNA##3##2##(1994-11#1)(1994-9#1)(2008-9#1)
strand conformation polymorphism##4##3##(1992-2#2)(1992-3#1)(2008-8#1)
strand displacement##2##2##(1990-5#1)(2008-12#1)
strand encodes a protein of##2##5##(2008-10#2)
strand in##2##2##(2008-4#1)(2011-2#1)
strand is##4##2##(1994-8#2)(2008-4#1)(2008-8#1)
strand of the##11##3##(1992-8#2)(1993-12#1)(1994-8#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-2#1)
strand of##19##2##(1992-8#2)(1993-12#1)(1994-8#3)(1997-7#1)(1997-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2009-2#1)(2010-5#1)(2011-1#1)
strand scission##2##2##(1990-5#1)(1995-6#1)
strand transfer##2##2##(2009-11#2)
strand with the##2##3##(2008-10#1)(2008-4#1)
strand##126##1##(1990-11#3)(1990-5#6)(1990-7#1)(1991-12#2)(1992-2#2)(1992-3#3)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-8#9)(1994-9#2)(1995-6#3)(1996-2#3)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#1)(1997-9#1)(2008-1#1)(2008-10#17)(2008-11#7)(2008-12#3)(2008-2#2)(2008-4#6)(2008-7#1)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#5)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
strand)##3##1##(1993-11#2)(2008-2#1)
strand-loop&quot##2##1##(1992-11#2)
strand-specific##3##1##(1994-8#1)(2008-10#1)(2012-3#1)
stranded DNA##8##2##(1990-12#1)(2007-11#1)(2008-10#5)(2013-8#1)
stranded in##2##2##(2012-2#2)
stranded nucleic##2##2##(2008-10#2)
stranded oligonucleotides##2##2##(2008-10#2)
stranded##26##1##(1990-12#1)(1990-5#1)(1994-8#1)(2007-11#1)(2008-10#15)(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
strands and##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
strands are##4##2##(1993-11#1)(2008-4#1)(2008-8#1)(2010-7#1)
strands from##2##2##(2008-10#1)(2008-2#1)
strands of DNA##2##3##(1995-3#1)(1996-6#1)
strands of the##2##3##(1994-12#1)(1994-8#1)
strands of##11##2##(1991-1#1)(1992-8#1)(1994-12#1)(1994-8#2)(1995-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-9#1)
strands were##3##2##(1992-6#1)(1994-8#2)
strands##45##1##(1991-1#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-8#9)(1995-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#1)(2010-7#1)(2012-2#3)
strange##6##1##(1990-11#2)(2008-10#2)(2012-2#1)(2013-1#1)
strangers##3##1##(2009-6#1)(2011-1#1)(2011-2#1)
strangulation##3##1##(1995-3#2)(2012-12#1)
straps##2##1##(2008-6#1)(2009-1#1)
strata and##3##2##(1991-6#1)(2013-1#1)(2013-8#1)
strata children##2##2##(2013-1#2)
strata in##2##2##(2008-1#1)(2008-9#1)
strata of##4##2##(1993-9#1)(1994-6#1)(2008-1#1)(2008-8#1)
strata##31##1##(1990-8#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-9#1)(1994-6#1)(1995-9#1)(2008-1#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#7)(2013-7#4)(2013-8#1)
strategic alliances##3##2##(1992-1#2)(1997-3#1)
strategic and##5##2##(2008-11#2)(2008-12#2)(2012-12#1)
strategic approach to##2##3##(1992-12#1)(2008-11#1)
strategic approach##3##2##(1992-12#1)(1996-3#1)(2008-11#1)
strategic choices##4##2##(1995-12#1)(1996-3#2)(1997-1#1)
strategic considerations##3##2##(1995-12#1)(1997-1#1)(2012-3#1)
strategic decision##4##2##(1996-12#1)(1997-3#1)(2007-4#1)(2013-1#1)
strategic decisions##2##2##(2010-8#2)
strategic directions##2##2##(1994-2#1)(2011-2#1)
strategic effectiveness##2##2##(1992-1#1)(1994-2#1)
strategic environmental assessment##2##3##(2013-1#2)
strategic goals##5##2##(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)
strategic impact##3##2##(2012-3#3)
strategic issues##2##2##(2008-11#1)(2012-12#1)
strategic management of##3##3##(1992-12#1)(2011-2#2)
strategic management##10##2##(1992-12#1)(1992-3#1)(1993-12#3)(1993-2#1)(1994-3#1)(1997-3#1)(2011-2#2)
strategic marketing##2##2##(1994-2#2)
strategic objectives##2##2##(1995-12#1)(1995-3#1)
strategic or##2##2##(1994-3#1)(1997-1#1)
strategic plan are##3##3##(1991-2#1)(1992-3#1)(1993-3#1)
strategic plan for##3##3##(1992-3#1)(1994-2#1)(1995-2#1)
strategic plan to##2##3##(1995-2#1)(2011-1#1)
strategic plan with##2##3##(1992-3#1)(2011-1#1)
strategic plan##19##2##(1991-2#2)(1992-3#5)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1995-2#2)(1997-1#1)(2011-1#3)
strategic planning and management##2##4##(1993-2#1)(1994-1#1)
strategic planning and##6##3##(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-3#1)(2008-10#1)
strategic planning in##4##3##(1991-1#1)(1992-1#1)(1995-1#1)(2008-11#1)
strategic planning process at##2##4##(1993-3#1)(1994-2#1)
strategic planning process used by##2##5##(1991-2#1)(1992-2#1)
strategic planning process used##3##4##(1991-2#1)(1992-2#1)(1994-2#1)
strategic planning process##16##3##(1991-2#2)(1992-2#1)(1993-3#2)(1994-2#6)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#2)
strategic planning##52##2##(1991-1#2)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#10)(1994-3#4)(1995-1#5)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
strategic plans##2##2##(1994-2#1)(1995-1#1)
strategic position##2##2##(1994-11#1)(1996-1#1)
strategic purposes##2##2##(1992-8#1)(2008-12#1)
strategic quality planning##2##3##(1994-2#2)
strategic quality##3##2##(1994-2#2)(1997-3#1)
strategic response##2##2##(1996-3#1)(1997-2#1)
strategic use of##2##3##(1991-8#2)
strategic##206##1##(1991-1#2)(1991-2#5)(1991-3#2)(1991-8#3)(1992-1#4)(1992-12#3)(1992-2#2)(1992-3#9)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#6)(1993-3#8)(1994-1#5)(1994-11#1)(1994-12#3)(1994-2#22)(1994-3#10)(1994-8#1)(1995-1#6)(1995-12#3)(1995-2#5)(1995-3#4)(1996-1#6)(1996-12#3)(1996-2#3)(1996-3#8)(1997-1#12)(1997-2#2)(1997-3#4)(2007-4#1)(2008-10#3)(2008-11#9)(2008-12#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-9#2)(2010-8#3)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
strategically located at##2##3##(2009-10#1)(2009-6#1)
strategically##15##1##(1994-12#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
strategies (i##2##2##(2008-8#1)(2011-2#1)
strategies adopted by##2##3##(2008-6#1)(2012-12#1)
strategies adopted##5##2##(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
strategies against##5##2##(2007-12#1)(2008-10#2)(2010-7#1)(2011-2#1)
strategies aimed at##3##3##(2007-5#1)(2008-4#1)(2013-1#1)
strategies and methods##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
strategies and programs to##2##4##(1996-1#1)(2012-12#1)
strategies and tactics to##2##4##(1994-12#1)(2013-1#1)
strategies and tactics##3##3##(1994-12#1)(2008-9#1)(2013-1#1)
strategies and the##2##3##(2009-12#1)(2010-11#1)
strategies and their##2##3##(2008-7#1)(2012-3#1)
strategies and to##2##3##(1995-9#1)(2008-8#1)
strategies and##61##2##(1992-3#2)(1993-1#1)(1993-12#3)(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#3)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-7#1)(2006-5#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
strategies are also##2##3##(2008-10#1)(2008-4#1)
strategies are an##2##3##(2009-9#1)(2011-2#1)
strategies are available for##2##4##(2010-11#1)(2012-2#1)
strategies are based on##3##4##(1993-11#1)(1996-11#1)(2010-11#1)
strategies are being##2##3##(2010-5#1)(2011-1#1)
strategies are discussed in##2##4##(1995-8#1)(2008-4#1)
strategies are discussed##7##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
strategies are needed to##2##4##(1994-3#1)(2009-12#1)
strategies are needed##3##3##(1994-3#1)(2008-6#1)(2009-12#1)
strategies are##52##2##(1992-1#1)(1992-3#1)(1993-11#1)(1994-3#3)(1995-8#2)(1996-11#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#6)(2009-12#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
strategies as well as##2##4##(2010-8#1)(2011-2#1)
strategies as##4##2##(1997-4#1)(2010-8#1)(2011-2#2)
strategies at##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
strategies based on##7##3##(1991-8#1)(2006-10#1)(2007-6#1)(2008-10#2)(2010-8#1)(2011-2#1)
strategies based##8##2##(1991-8#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)
strategies because##2##2##(2008-10#1)(2008-4#1)
strategies become##2##2##(1994-3#1)(2012-3#1)
strategies by##3##2##(1996-1#1)(2007-10#1)(2012-2#1)
strategies can be##8##3##(1993-11#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-4#1)
strategies can##14##2##(1993-11#1)(1995-1#1)(1996-12#1)(1997-3#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-4#1)
strategies designed to##2##3##(2008-7#1)(2011-2#1)
strategies emerge##2##2##(1997-4#1)(2006-5#1)
strategies employed by##2##3##(2010-12#1)(2012-2#1)
strategies employed in##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
strategies employed to facilitate the detection##2##6##(2008-10#2)
strategies employed to##3##3##(2008-10#2)(2011-2#1)
strategies employed##9##2##(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#2)
strategies for attaining##2##3##(2008-10#1)(2008-9#1)
strategies for communicating##2##3##(1997-3#1)(2010-4#1)
strategies for control##2##3##(2007-12#1)(2007-6#1)
strategies for detection##2##3##(2010-11#1)(2010-7#1)
strategies for early##2##3##(2009-4#1)(2010-5#1)
strategies for enhancing##2##3##(2008-11#1)(2011-1#1)
strategies for future##3##3##(1991-1#1)(2008-10#2)
strategies for implementing these##2##4##(1994-1#1)(1996-2#1)
strategies for implementing##3##3##(1994-1#2)(1996-2#1)
strategies for improving the##2##4##(1993-2#1)(2008-6#1)
strategies for improving##8##3##(1993-2#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
strategies for inducing##2##3##(1994-6#1)(1996-9#1)
strategies for integrating##2##3##(2008-10#1)(2008-6#1)
strategies for management of##2##4##(2008-1#1)(2008-10#1)
strategies for management##3##3##(1994-1#1)(2008-1#1)(2008-10#1)
strategies for managing##2##3##(2011-1#1)(2012-2#1)
strategies for nurses##2##3##(2010-7#1)(2011-1#1)
strategies for preventing##2##3##(2011-1#1)(2013-1#1)
strategies for protecting##2##3##(2008-1#1)(2008-9#1)
strategies for the control of##2##5##(2007-6#1)(2011-2#1)
strategies for the management of##2##5##(2008-1#1)(2008-4#1)
strategies for the prevention##2##4##(2008-3#1)(2010-2#1)
strategies for the primary##2##4##(2008-11#1)(2010-3#1)
strategies for the treatment of##3##5##(2011-2#1)(2013-1#1)(2013-8#1)
strategies for the##22##3##(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
strategies for their##2##3##(2008-8#1)(2009-10#1)
strategies for these##3##3##(2008-6#1)(2009-5#1)(2012-3#1)
strategies for this##2##3##(2008-6#1)(2009-7#1)
strategies for tissue##2##3##(2010-10#2)
strategies for treating##2##3##(1994-5#1)(2008-3#1)
strategies for treatment##2##3##(2008-4#1)(2010-5#1)
strategies for use##2##3##(2010-5#1)(2013-1#1)
strategies for##222##2##(1991-1#2)(1991-9#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-1#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#6)(2008-10#21)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#11)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#5)(2009-10#5)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#5)(2010-7#4)(2011-1#6)(2011-10#1)(2011-2#10)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#1)
strategies from##2##2##(1995-5#1)(2008-8#1)
strategies has been##2##3##(2007-6#1)(2012-3#1)
strategies has##3##2##(2007-6#1)(2008-7#1)(2012-3#1)
strategies have been investigated##2##4##(2008-7#1)(2009-11#1)
strategies have been proposed##2##4##(1993-11#1)(2010-11#1)
strategies have been used##2##4##(2009-12#1)(2011-1#1)
strategies have been##17##3##(1990-6#1)(1993-11#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
strategies have focused##2##3##(2010-3#1)(2011-2#1)
strategies have##23##2##(1990-6#1)(1993-11#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
strategies implemented##2##2##(2011-1#1)(2011-2#1)
strategies in a##3##3##(1994-3#1)(2010-12#2)
strategies in order to##3##4##(2008-11#2)(2012-3#1)
strategies in reducing##2##3##(2010-10#2)
strategies in the##15##3##(1993-2#1)(1993-3#1)(1994-1#1)(1997-3#2)(2007-6#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-12#1)(2012-3#1)
strategies in which current investments##2##5##(2008-8#2)
strategies in which##3##3##(2008-8#2)(2010-12#1)
strategies in##63##2##(1990-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-11#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-6#1)(2007-12#1)(2007-6#3)(2007-8#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-12#1)(2009-5#2)(2010-10#3)(2010-11#2)(2010-12#4)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)
strategies include##4##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
strategies included##4##2##(1994-12#1)(2007-10#1)(2008-5#1)(2010-8#1)
strategies into##4##2##(1994-2#1)(2008-11#1)(2008-12#1)(2009-9#1)
strategies is critical##2##3##(2008-10#1)(2010-5#1)
strategies is provided##2##3##(2010-10#1)(2013-8#1)
strategies is##12##2##(1990-6#1)(1991-6#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-10#1)(2010-3#1)(2010-5#1)(2013-8#1)
strategies may be##2##3##(2008-6#1)(2012-2#1)
strategies may##8##2##(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#2)(2012-3#2)
strategies more##2##2##(2008-11#1)(2009-9#1)
strategies must be##2##3##(2008-10#1)(2013-1#1)
strategies must##3##2##(2008-10#1)(2010-3#1)(2013-1#1)
strategies need to be##2##4##(1994-2#1)(2008-3#1)
strategies need to##4##3##(1994-2#1)(1995-5#1)(2008-3#2)
strategies of measurement instruments and their validity as adopted in##4##10##(2013-1#4)
strategies of the##4##3##(1990-8#1)(1996-9#1)(2009-8#1)(2010-8#1)
strategies of these##2##3##(2012-2#1)(2012-3#1)
strategies of##39##2##(1990-8#1)(1993-12#1)(1993-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
strategies on a wide scale##2##5##(2010-6#1)(2013-8#1)
strategies on the##4##3##(1993-1#2)(2013-1#2)
strategies on##10##2##(1993-1#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-1#2)(2013-8#1)
strategies or##2##2##(2010-11#1)(2012-1#1)
strategies related to##2##3##(1995-12#1)(2008-12#1)
strategies should be##2##3##(1991-6#1)(2008-11#1)
strategies should##6##2##(1991-6#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-11#2)
strategies showed##2##2##(1997-2#1)(2010-10#1)
strategies such as the##2##4##(1996-3#1)(2008-10#1)
strategies such as##5##3##(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
strategies support##2##2##(2008-12#1)(2011-2#1)
strategies targeted##2##2##(2007-5#1)(2011-2#1)
strategies targeting##3##2##(1994-2#1)(2012-2#1)(2013-1#1)
strategies than##3##2##(2008-11#1)(2008-8#2)
strategies that are##2##3##(2008-9#1)(2010-3#1)
strategies that can be used##2##5##(2008-4#1)(2011-2#1)
strategies that can be##4##4##(2008-4#2)(2009-3#1)(2011-2#1)
strategies that can##7##3##(1997-2#1)(2008-4#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
strategies that have been evaluated##2##5##(1992-2#1)(2009-1#1)
strategies that have been##3##4##(1992-2#1)(2009-1#1)(2010-7#1)
strategies that may##4##3##(1993-2#1)(1994-2#1)(2008-10#1)(2013-8#1)
strategies that rely on##2##4##(1996-2#1)(2009-9#1)
strategies that use##2##3##(1994-5#1)(2008-11#1)
strategies that##52##2##(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#3)(1994-5#1)(1996-2#2)(1997-2#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
strategies the##2##2##(1997-2#1)(2012-12#1)
strategies these pathogens##2##3##(2012-2#2)
strategies they##3##2##(2008-5#1)(2010-6#1)(2012-3#1)
strategies to address##2##3##(2009-8#1)(2012-3#1)
strategies to be##2##3##(1997-6#1)(2010-3#1)
strategies to combat##4##3##(2007-2#1)(2008-1#1)(2008-7#1)(2010-6#1)
strategies to compete##2##3##(1993-12#1)(2008-10#1)
strategies to control##4##3##(1997-2#1)(2008-8#1)(2009-12#1)(2009-4#1)
strategies to deal with##3##4##(1997-5#1)(2008-11#1)(2008-8#1)
strategies to decrease##2##3##(2007-12#1)(2008-6#1)
strategies to determine##2##3##(2007-10#1)(2008-4#1)
strategies to enhance##3##3##(1997-8#1)(2008-1#1)(2008-11#1)
strategies to ensure##2##3##(1995-2#1)(2008-11#1)
strategies to help##4##3##(1991-1#1)(2007-7#1)(2008-10#1)(2010-1#1)
strategies to identify##3##3##(2008-10#1)(2008-7#2)
strategies to improve the##2##4##(1991-11#1)(2008-10#1)
strategies to improve##8##3##(1991-11#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2013-1#1)
strategies to increase##4##3##(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
strategies to meet the##2##4##(1994-2#1)(2010-3#1)
strategies to minimize the##2##4##(1996-9#1)(2011-2#1)
strategies to minimize##3##3##(1996-9#1)(2008-7#1)(2011-2#1)
strategies to optimize##2##3##(2008-10#1)(2009-8#1)
strategies to overcome##3##3##(2008-11#1)(2009-5#1)(2010-10#1)
strategies to prevent or##3##4##(2008-5#1)(2010-10#1)(2011-1#1)
strategies to prevent##6##3##(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
strategies to protect##2##3##(1994-3#1)(1996-12#1)
strategies to reduce##7##3##(1994-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
strategies to retain##2##3##(1994-3#1)(2011-1#1)
strategies to treat##2##3##(1996-1#1)(2010-5#1)
strategies to##113##2##(1991-1#1)(1991-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#8)(2008-11#12)(2008-12#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)
strategies used by the##2##4##(2008-7#1)(2010-11#1)
strategies used by##9##3##(1994-12#1)(1996-12#1)(2008-7#1)(2010-10#2)(2010-11#1)(2010-7#1)(2013-1#1)(2013-8#1)
strategies used in##2##3##(2010-11#1)(2012-3#1)
strategies used to##6##3##(1990-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2013-1#1)
strategies used##20##2##(1990-5#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-10#2)(2010-11#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
strategies using##7##2##(1994-5#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#2)
strategies we##2##2##(1993-2#1)(2010-10#1)
strategies were also##2##3##(2009-9#1)(2011-1#1)
strategies were##15##2##(1994-12#1)(1995-1#1)(1997-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#2)(2009-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
strategies which are##2##3##(2010-3#1)(2013-8#1)
strategies which##6##2##(1991-6#1)(2008-10#1)(2008-11#2)(2010-3#1)(2013-8#1)
strategies will be##3##3##(1992-3#1)(1994-3#1)(2011-3#1)
strategies will##4##2##(1992-3#1)(1994-3#1)(2008-1#1)(2011-3#1)
strategies with##4##2##(1991-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
strategies within the##2##3##(2008-10#1)(2012-3#1)
strategies within##3##2##(1996-3#1)(2008-10#1)(2012-3#1)
strategies##1195##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#5)(1992-3#8)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#5)(1993-12#11)(1993-2#8)(1993-3#4)(1993-6#1)(1994-1#9)(1994-11#1)(1994-12#9)(1994-2#12)(1994-3#15)(1994-5#5)(1994-6#2)(1994-9#3)(1995-1#5)(1995-12#5)(1995-2#10)(1995-3#7)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#6)(1996-4#1)(1996-6#2)(1996-9#3)(1997-1#4)(1997-2#11)(1997-3#11)(1997-4#8)(1997-5#1)(1997-6#8)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-5#2)(2007-10#9)(2007-11#4)(2007-12#13)(2007-2#6)(2007-4#1)(2007-5#2)(2007-6#10)(2007-7#3)(2007-8#6)(2008-1#18)(2008-10#102)(2008-11#76)(2008-12#25)(2008-2#9)(2008-3#17)(2008-4#26)(2008-5#14)(2008-6#16)(2008-7#38)(2008-8#49)(2008-9#31)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#11)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#11)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#13)(2010-1#3)(2010-10#19)(2010-11#17)(2010-12#16)(2010-2#4)(2010-3#12)(2010-4#3)(2010-5#12)(2010-6#7)(2010-7#12)(2010-8#12)(2010-9#2)(2011-1#33)(2011-10#2)(2011-2#66)(2011-3#5)(2011-9#1)(2012-1#6)(2012-12#22)(2012-2#30)(2012-3#44)(2012-4#1)(2013-1#52)(2013-7#6)(2013-8#14)
strategies)##3##1##(2008-8#1)(2009-7#1)(2010-6#1)
strategy against##2##2##(2013-1#2)
strategy aimed at##2##3##(2008-1#1)(2008-11#1)
strategy allowed##2##2##(2008-10#2)
strategy allows##2##2##(2008-5#1)(2009-9#1)
strategy and a##2##3##(1991-6#1)(1996-1#1)
strategy and implementation##4##3##(1996-1#2)(1996-2#1)(2013-8#1)
strategy and precisely located on the physical map of chromosome 5##2##11##(1997-6#1)(1997-8#1)
strategy and the##4##3##(1991-11#1)(1992-12#1)(1992-9#1)(2008-8#1)
strategy and##32##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1995-12#1)(1996-1#3)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-7#1)(2013-8#2)
strategy are discussed##2##3##(2008-2#2)
strategy are##9##2##(1991-5#1)(1996-2#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)
strategy as##4##2##(2008-10#1)(2008-5#1)(2009-4#1)(2009-9#1)
strategy based on the##6##4##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
strategy based on##11##3##(2007-11#1)(2007-6#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)
strategy because##2##2##(2008-7#2)
strategy by##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
strategy can be##2##3##(2008-3#1)(2008-7#1)
strategy can##6##2##(1994-1#1)(2008-3#2)(2008-7#2)(2009-12#1)
strategy combining##2##2##(2008-10#1)(2008-5#1)
strategy consists in##2##3##(2008-3#1)(2013-1#1)
strategy consists##3##2##(1994-2#1)(2008-3#1)(2013-1#1)
strategy could be##4##3##(2008-5#1)(2010-10#1)(2011-3#1)(2012-12#1)
strategy designed to##2##3##(1996-2#1)(2008-7#1)
strategy designed##3##2##(1996-2#1)(2008-12#1)(2008-7#1)
strategy during##2##2##(1997-8#1)(2008-12#1)
strategy entailed##2##2##(1996-3#1)(2008-10#1)
strategy facilitates##2##2##(1992-1#1)(1992-11#1)
strategy for a##2##3##(2008-9#1)(2012-3#1)
strategy for creating##2##3##(2008-7#1)(2013-8#1)
strategy for detection of##2##4##(2008-1#1)(2008-10#1)
strategy for determining##2##3##(2008-10#2)
strategy for developing##2##3##(2008-10#1)(2008-9#1)
strategy for effective##3##3##(1992-1#1)(1993-12#1)(1996-4#1)
strategy for enhanced##2##3##(1996-12#1)(2008-7#1)
strategy for implementing##2##3##(2008-11#1)(2008-9#1)
strategy for improving the##2##4##(2008-10#1)(2013-1#1)
strategy for improving##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
strategy for increasing##2##3##(1997-2#1)(2013-8#1)
strategy for patients##3##3##(2008-3#2)(2013-8#1)
strategy for preventing##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
strategy for prevention##2##3##(2011-2#2)
strategy for reducing the##2##4##(2008-10#1)(2008-11#1)
strategy for reducing##5##3##(2008-10#2)(2008-11#1)(2008-6#1)(2012-2#1)
strategy for the determination of##2##5##(2008-10#2)
strategy for the management of##2##5##(2008-10#1)(2011-1#1)
strategy for the treatment of##5##5##(1992-8#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
strategy for the##34##3##(1990-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
strategy for##188##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#32)(2008-11#10)(2008-12#3)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#7)(2009-12#3)(2009-3#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#6)(2013-8#4)
strategy formulation##2##2##(1993-2#1)(1993-3#1)
strategy from##5##2##(2008-10#1)(2008-11#2)(2009-6#1)(2013-1#1)
strategy has been developed and##2##5##(1996-1#1)(2008-11#1)
strategy has been developed##3##4##(1996-1#1)(2008-10#1)(2008-11#1)
strategy has been##8##3##(1994-9#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
strategy has##13##2##(1994-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-10#1)(2011-2#1)
strategy if##2##2##(2008-10#1)(2008-8#1)
strategy in a##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
strategy in the##9##3##(1993-3#1)(1994-9#1)(2008-10#2)(2009-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
strategy in this##2##3##(2011-3#1)(2012-3#1)
strategy in##37##2##(1991-2#1)(1991-5#1)(1992-1#1)(1993-3#1)(1994-9#2)(1995-3#1)(1996-3#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#4)(2009-2#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-3#1)(2013-8#2)
strategy involving##2##2##(2008-12#1)(2011-1#1)
strategy is also##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
strategy is based on the##2##5##(2008-5#1)(2008-6#1)
strategy is based on##3##4##(1991-6#1)(2008-5#1)(2008-6#1)
strategy is proposed##2##3##(1997-7#1)(2012-12#1)
strategy is the##4##3##(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#1)
strategy is to##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
strategy is##36##2##(1991-6#1)(1992-9#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-12#2)(2012-2#1)
strategy may be##3##3##(1997-3#1)(2008-1#1)(2008-6#1)
strategy of an##2##3##(2008-10#1)(2008-8#1)
strategy of gene##3##3##(2008-8#2)(2008-9#1)
strategy of introducing##2##3##(1997-4#1)(2008-8#1)
strategy of the##4##3##(2008-4#2)(2008-7#2)
strategy of this##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
strategy of##46##2##(1990-6#1)(1991-1#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
strategy offers##2##2##(1995-12#1)(2008-10#1)
strategy on the##2##3##(1994-11#1)(2008-8#1)
strategy on##4##2##(1994-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
strategy provides##2##2##(2008-10#1)(2011-2#1)
strategy represents##2##2##(2008-8#1)(2010-5#1)
strategy should be##3##3##(1991-6#1)(2008-4#1)(2012-3#1)
strategy than##2##2##(2010-12#1)(2010-8#1)
strategy that can be used##2##5##(2008-12#1)(2012-2#1)
strategy that can be##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
strategy that combines##2##3##(2008-6#1)(2012-12#1)
strategy that is##2##3##(1993-2#1)(1997-2#1)
strategy that##30##2##(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#3)(1995-3#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
strategy to a##2##3##(1997-4#1)(2010-11#1)
strategy to control##2##3##(1991-3#1)(2008-10#1)
strategy to create##3##3##(1993-9#1)(2007-7#1)(2010-10#1)
strategy to enhance##3##3##(2008-7#1)(2010-10#1)(2013-8#1)
strategy to identify##3##3##(1995-1#1)(2008-10#1)(2009-5#1)
strategy to improve the##4##4##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
strategy to improve##10##3##(1991-1#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#2)(2013-1#1)
strategy to increase##2##3##(2008-11#1)(2008-12#1)
strategy to integrate##2##3##(1993-1#1)(2008-10#1)
strategy to obtain##4##3##(1993-12#1)(2008-2#1)(2010-12#1)(2012-3#1)
strategy to optimize##2##3##(2008-3#1)(2013-7#1)
strategy to overcome##2##3##(1991-2#1)(1997-3#1)
strategy to prevent##5##3##(2008-1#2)(2008-10#1)(2011-2#1)(2013-8#1)
strategy to reduce##4##3##(2007-8#1)(2009-4#1)(2010-2#1)(2011-2#1)
strategy to treat##2##3##(2012-12#2)
strategy to##92##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
strategy use##2##2##(2008-9#1)(2009-5#1)
strategy used##3##2##(2008-3#1)(2008-9#1)(2012-3#1)
strategy using##2##2##(2008-2#1)(2008-9#1)
strategy was employed##2##3##(1995-5#1)(2010-5#1)
strategy was proposed##3##3##(2008-10#2)(2013-1#1)
strategy was used to##2##4##(2008-10#1)(2009-11#1)
strategy was used##3##3##(1995-2#1)(2008-10#1)(2009-11#1)
strategy was##24##2##(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
strategy we##2##2##(2008-11#1)(2010-12#1)
strategy were##2##2##(2008-10#1)(2008-9#1)
strategy where##2##2##(1995-2#1)(2008-10#1)
strategy which##3##2##(1993-2#1)(2011-2#1)(2012-3#1)
strategy will##2##2##(1994-6#1)(1997-3#1)
strategy with##11##2##(1992-3#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-3#3)(2013-1#1)
strategy would allow the##2##4##(2008-3#1)(2008-7#1)
strategy would##4##2##(1993-1#1)(2008-3#1)(2008-7#1)(2011-1#1)
strategy##898##1##(1990-12#2)(1990-6#2)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#5)(1992-1#5)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#4)(1993-11#1)(1993-12#9)(1993-2#11)(1993-3#4)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#6)(1994-2#10)(1994-3#5)(1994-6#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#8)(1995-5#2)(1995-6#2)(1996-1#9)(1996-12#6)(1996-2#9)(1996-3#7)(1996-4#2)(1996-7#1)(1997-1#4)(1997-2#7)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2007-10#2)(2007-11#5)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#13)(2008-1#10)(2008-10#111)(2008-11#63)(2008-12#27)(2008-2#19)(2008-3#28)(2008-4#14)(2008-5#19)(2008-6#16)(2008-7#40)(2008-8#34)(2008-9#35)(2009-10#2)(2009-11#2)(2009-12#9)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#8)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#7)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#5)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#10)(2010-8#8)(2011-1#12)(2011-2#38)(2011-3#4)(2012-1#2)(2012-12#17)(2012-2#20)(2012-3#23)(2012-7#1)(2013-1#27)(2013-7#8)(2013-8#16)
stratification and##6##2##(2008-3#2)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
stratification as##2##2##(2008-8#1)(2009-9#1)
stratification for estrogen receptor status##2##5##(1994-7#1)(1995-4#1)
stratification for##4##2##(1994-7#1)(1995-4#1)(2008-8#1)(2012-2#1)
stratification has##2##2##(2008-8#1)(2009-9#1)
stratification in##4##2##(2006-11#1)(2008-8#1)(2010-5#1)(2010-9#1)
stratification is##5##2##(2008-3#2)(2008-7#1)(2011-1#1)(2012-2#1)
stratification model##2##2##(2008-3#1)(2009-9#1)
stratification of patients into##2##4##(2008-7#1)(2013-8#1)
stratification of patients##4##3##(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
stratification of the##6##3##(1994-9#1)(2007-10#1)(2008-3#1)(2010-12#1)(2011-2#2)
stratification of##21##2##(1994-9#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#6)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
stratification to##3##2##(2009-9#2)(2011-2#1)
stratification with##2##2##(2012-3#1)(2013-8#1)
stratification##80##1##(1991-6#1)(1992-10#1)(1992-12#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-4#1)(2006-11#2)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-9#5)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#12)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
stratified according to##4##3##(1990-5#1)(1994-12#1)(2010-3#1)(2011-2#1)
stratified analysis##2##2##(1991-8#1)(2012-12#1)
stratified and##2##2##(2007-12#1)(2011-1#1)
stratified as##2##2##(1995-11#1)(2007-12#1)
stratified by gender##2##3##(2008-3#1)(2009-5#1)
stratified by sex##2##3##(1992-6#1)(2008-7#1)
stratified by the##3##3##(1995-2#1)(2007-7#1)(2013-1#1)
stratified by##16##2##(1992-3#1)(1992-6#1)(1995-1#1)(1995-2#2)(2007-7#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-9#1)(2012-12#1)(2013-1#1)
stratified epithelium##2##2##(2010-3#1)(2010-7#1)
stratified group##2##2##(2013-1#2)
stratified into##8##2##(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#3)(2012-2#1)
stratified on##2##2##(2008-10#1)(2010-11#1)
stratified random sampling##2##3##(2012-12#1)(2013-1#1)
stratified random##5##2##(1996-8#1)(1997-3#1)(2008-2#1)(2012-12#1)(2013-1#1)
stratified sample of##3##3##(1994-6#1)(2008-10#1)(2011-1#1)
stratified sample##4##2##(1994-6#1)(2008-10#1)(2010-1#1)(2011-1#1)
stratified structures##2##2##(2008-3#2)
stratified water body##2##3##(2008-2#2)
stratified water##3##2##(2008-2#3)
stratified##85##1##(1990-11#1)(1990-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-9#2)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-9#2)(2012-12#3)(2012-2#3)(2012-5#1)(2013-1#5)(2013-8#1)
stratifies##2##1##(2008-10#1)(2010-11#1)
stratify the##2##2##(2008-10#1)(2008-11#1)
stratify##7##1##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#2)(2012-2#1)(2013-1#1)
stratifying by##2##2##(2011-2#2)
stratifying##7##1##(2008-3#1)(2011-1#1)(2011-2#5)
stratigraphic##5##1##(1990-8#1)(1997-5#3)(2010-6#1)
stratosphere from##2##2##(2008-3#2)
stratosphere was##2##2##(2008-2#1)(2008-3#1)
stratosphere##22##1##(1991-5#4)(1991-6#1)(2008-2#4)(2008-3#13)
stratospheric aerosol##10##2##(2008-2#8)(2008-3#2)
stratospheric aerosols##6##2##(2008-2#5)(2008-3#1)
stratospheric ozone##6##2##(1995-3#1)(1996-1#1)(2008-10#2)(2008-3#1)(2012-2#1)
stratospheric sulfuric##2##2##(2008-3#2)
stratospheric temperature##2##2##(2008-2#1)(2008-3#1)
stratospheric##49##1##(1991-5#3)(1995-3#1)(1996-1#2)(2008-10#2)(2008-11#1)(2008-2#19)(2008-3#18)(2012-2#3)
stratum corneum (SC)##9##3##(2008-10#1)(2008-5#8)
stratum corneum and##4##3##(2008-5#4)
stratum corneum barrier function##2##4##(2008-5#2)
stratum corneum by##2##3##(2008-5#2)
stratum corneum hydration and##2##4##(2008-5#1)(2012-2#1)
stratum corneum hydration##5##3##(2008-5#3)(2012-2#2)
stratum corneum lipid##3##3##(2008-10#1)(2008-5#2)
stratum corneum lipids##8##3##(2008-5#8)
stratum corneum maturation##2##3##(2008-5#2)
stratum corneum samples##2##3##(2008-5#2)
stratum corneum tryptic enzyme##2##4##(2008-5#2)
stratum corneum water barrier##2##4##(2008-5#2)
stratum corneum water##3##3##(2008-5#3)
stratum corneum were##4##3##(2008-5#3)(2012-2#1)
stratum corneum##124##2##(1992-8#2)(2008-10#3)(2008-5#114)(2010-8#2)(2012-2#3)
stratum granulosum##3##2##(2008-5#3)
stratum radiatum##3##2##(1994-2#1)(1995-12#1)(2008-7#1)
stratum##139##1##(1990-5#1)(1992-8#2)(1994-2#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#119)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-12#1)(2012-2#3)
straw pretreated by##3##3##(2013-1#3)
straw##22##1##(1992-10#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#10)(2013-8#3)
strawberry and##9##2##(2008-10#9)
strawberry fields##6##2##(2008-10#6)
strawberry isolates##4##2##(2008-10#4)
strawberry leaf blight##3##3##(2008-10#3)
strawberry leaf##4##2##(2008-10#4)
strawberry leaflets##4##2##(2008-10#4)
strawberry leaves and##2##3##(2008-10#2)
strawberry leaves##9##2##(2008-10#9)
strawberry plants##5##2##(2008-10#5)
strawberry production fields##2##3##(2008-10#2)
strawberry production##5##2##(2008-10#5)
strawberry tree honey##2##3##(2008-10#2)
strawberry was##3##2##(2008-10#3)
strawberry##103##1##(2008-10#101)(2008-12#1)(2008-8#1)
stray dogs##4##2##(1996-12#1)(2008-7#1)(2011-1#2)
stray light and the##2##4##(2008-3#2)
stray light##10##2##(2008-2#2)(2008-3#8)
stray##19##1##(1996-12#3)(2008-12#1)(2008-2#2)(2008-3#9)(2008-7#1)(2011-1#2)(2013-8#1)
stray-light##4##1##(2008-2#1)(2008-3#3)
streak camera with a##3##4##(2007-11#1)(2008-3#2)
streak camera##8##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)
streak disease##2##2##(2008-10#2)
streak method##2##2##(2008-11#1)(2012-2#1)
streak mosaic virus (WSMV)##3##4##(2008-10#3)
streak mosaic virus##10##3##(2008-10#9)(2008-8#1)
streak mosaic##12##2##(2008-10#11)(2008-8#1)
streak virus (MSV)##3##3##(2008-10#3)
streak virus Isolates from##2##4##(2008-10#2)
streak virus##11##2##(2008-10#11)
streak##40##1##(2007-11#3)(2007-12#1)(2008-10#25)(2008-11#1)(2008-2#4)(2008-3#4)(2008-8#1)(2012-2#1)
streaking##3##1##(2008-2#1)(2008-8#1)(2008-9#1)
streaks##8##1##(1995-3#1)(2008-10#7)
stream (flow rate##3##3##(2008-10#3)
stream and passed through the##2##5##(2008-10#2)
stream and the##3##3##(2008-10#3)
stream and##8##2##(2008-10#7)(2008-3#1)
stream at##2##2##(2008-10#1)(2008-6#1)
stream by##2##2##(2008-10#1)(2008-3#1)
stream containing 0##4##3##(2008-10#4)
stream containing##9##2##(2008-10#9)
stream flow##2##2##(2008-10#1)(2011-2#1)
stream formation##3##2##(1997-3#1)(2009-8#2)
stream from##2##2##(1991-2#1)(2008-6#1)
stream in##3##2##(2008-1#1)(2008-10#2)
stream into##2##2##(1995-3#1)(2008-10#1)
stream is##5##2##(2007-12#1)(2008-10#3)(2013-8#1)
stream of N(2)##2##3##(2008-10#2)
stream of a##2##3##(2007-11#1)(2008-10#1)
stream of sodium##2##3##(2008-10#2)
stream of the##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
stream of##41##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-10#4)(2011-2#1)
stream sediment##4##2##(2008-10#4)
stream that##2##2##(2008-7#1)(2008-8#1)
stream then returns to the reservoir##2##6##(2008-10#2)
stream to be##3##3##(2008-10#3)
stream to##7##2##(2008-10#6)(2008-6#1)
stream was monitored##2##3##(2008-10#2)
stream was##9##2##(2008-10#9)
stream water##3##2##(2008-10#3)
stream with a##2##3##(2008-10#2)
stream with##5##2##(2008-10#3)(2009-9#1)(2013-1#1)
stream##183##1##(1991-2#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#129)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#5)(2008-9#2)(2009-2#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-8#4)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
stream)##2##1##(1992-5#1)(2008-10#1)
streaming##9##1##(1994-9#2)(1997-3#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#2)
streamline the##2##2##(1994-3#1)(2010-10#1)
streamline##7##1##(1994-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-1#1)
streamlined##11##1##(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
streamlining the process##2##3##(1997-2#1)(2007-11#1)
streamlining the##3##2##(1997-2#2)(2007-11#1)
streamlining##8##1##(1992-8#1)(1993-1#1)(1995-3#1)(1997-2#2)(2007-11#1)(2012-12#1)(2012-3#1)
streams and##6##2##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#2)
streams at the##2##3##(2008-10#1)(2008-3#1)
streams from##2##2##(1996-1#1)(2008-6#1)
streams of##13##2##(1996-1#1)(1997-3#1)(2008-10#5)(2008-2#3)(2008-8#2)(2009-8#1)
streams that##4##2##(2008-3#1)(2010-8#1)(2012-2#2)
streams was##2##2##(2008-10#2)
streams were##2##2##(1993-6#1)(2008-10#1)
streams with##3##2##(2008-10#2)(2008-8#1)
streams##64##1##(1993-6#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#1)(1997-3#1)(2008-10#23)(2008-11#2)(2008-2#5)(2008-3#4)(2008-6#4)(2008-8#5)(2008-9#1)(2009-8#3)(2010-8#3)(2012-2#5)
streamwater##3##1##(2008-10#3)
street air##2##2##(2008-11#2)
street children##3##2##(1992-5#1)(1997-6#2)
street dust samples##2##3##(2008-10#2)
street dust##3##2##(2008-10#3)
street##15##1##(1992-5#1)(1996-5#1)(1997-6#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
street-involved youth##4##2##(2007-4#1)(2013-1#3)
street-involved##5##1##(2007-4#1)(2013-1#4)
streets in walking##2##3##(2007-11#1)(2007-12#1)
streets##6##1##(1992-5#1)(1995-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2012-2#1)
strength (quadriceps##2##2##(2013-1#2)
strength and endurance##3##3##(2010-12#2)(2011-2#1)
strength and function##3##3##(2013-1#3)
strength and functional##2##3##(2010-1#1)(2013-1#1)
strength and in##2##3##(1993-3#1)(2010-5#1)
strength and microhardness of a composite resin##2##7##(2008-12#2)
strength and pH of##3##4##(2008-10#3)
strength and pH##6##3##(1990-12#1)(2008-10#5)
strength and the##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
strength and##87##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-3#1)(1994-8#1)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
strength are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
strength at##2##2##(1993-11#1)(2008-2#1)
strength but##3##2##(1993-11#1)(2007-12#1)(2008-10#1)
strength by##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)
strength compared##2##2##(1995-2#1)(2008-3#1)
strength data##2##2##(2008-3#1)(2009-11#1)
strength exerted##2##2##(2008-6#2)
strength for##5##2##(1990-2#1)(1993-5#1)(2008-12#1)(2008-6#1)(2009-8#1)
strength has##2##2##(1992-3#1)(1992-4#1)
strength in the##3##3##(2007-8#2)(2008-10#1)
strength in##15##2##(1997-6#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-9#2)(2009-3#1)(2009-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
strength increased to##3##3##(2007-11#2)(2007-8#1)
strength increases##2##2##(2007-12#1)(2008-3#1)
strength interphase results in##2##4##(2009-6#2)
strength is reported##2##3##(2008-3#1)(2008-9#1)
strength is##15##2##(1990-12#1)(1996-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#3)(2013-1#1)(2013-8#2)
strength necessary##2##2##(1995-2#1)(2009-9#1)
strength of a##3##3##(1991-2#1)(2012-2#1)(2013-1#1)
strength of an##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
strength of evidence for##2##4##(2011-1#1)(2012-12#1)
strength of evidence##8##3##(2009-6#1)(2011-1#1)(2012-12#6)
strength of experimentally filled resins##2##5##(2009-7#2)
strength of local density regulation##2##5##(2008-8#2)
strength of selection on##3##4##(2008-8#1)(2008-9#2)
strength of selection##8##3##(2008-8#4)(2008-9#2)(2010-4#1)(2013-1#1)
strength of the composite##2##4##(2008-5#1)(2009-7#1)
strength of the evidence##3##4##(2008-3#1)(2008-7#1)(2008-8#1)
strength of the feedback##2##4##(2008-2#1)(2008-8#1)
strength of the##64##3##(1990-5#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-11#3)(2007-12#3)(2007-8#3)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#9)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-10#1)(2010-2#2)(2010-4#3)(2011-2#1)(2013-1#1)
strength of##175##2##(1990-12#1)(1990-5#2)(1991-2#2)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-7#2)(1997-8#4)(2007-11#4)(2007-12#6)(2007-8#4)(2008-10#19)(2008-11#3)(2008-12#7)(2008-2#5)(2008-3#14)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#16)(2008-9#7)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#9)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#5)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
strength on the##3##3##(2007-11#1)(2008-10#2)
strength on##7##2##(2007-11#1)(2008-10#3)(2008-9#1)(2009-9#1)(2010-9#1)
strength or##3##2##(1994-9#1)(2008-10#1)(2009-3#1)
strength scores##2##2##(2008-12#1)(2013-1#1)
strength test was performed##2##4##(2009-7#1)(2013-1#1)
strength test##3##2##(2008-5#1)(2009-7#1)(2013-1#1)
strength tests were performed##2##4##(2008-12#2)
strength to##4##2##(1993-12#1)(2008-4#1)(2008-7#1)(2010-6#1)
strength training##5##2##(2007-12#1)(2008-8#1)(2010-1#1)(2013-8#2)
strength values of the##2##4##(2008-10#1)(2008-5#1)
strength values##6##2##(2008-10#1)(2008-5#2)(2009-3#1)(2009-7#1)(2013-1#1)
strength was measured##2##3##(2009-7#1)(2011-2#1)
strength was##15##2##(1997-2#2)(2007-11#2)(2008-10#1)(2008-7#1)(2008-9#2)(2009-7#4)(2010-6#1)(2011-2#1)(2013-1#1)
strength were##10##2##(2007-11#1)(2008-10#3)(2008-12#1)(2008-9#2)(2012-2#3)
strength when##6##2##(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#2)
strength with##5##2##(2008-10#1)(2008-12#1)(2009-11#1)(2012-1#1)(2012-2#1)
strength##641##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#7)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-8#3)(1993-1#1)(1993-11#5)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#7)(1995-5#2)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2007-11#19)(2007-12#17)(2007-4#1)(2007-8#10)(2008-1#1)(2008-10#108)(2008-11#9)(2008-12#30)(2008-2#13)(2008-3#29)(2008-4#9)(2008-5#21)(2008-6#7)(2008-7#17)(2008-8#21)(2008-9#32)(2009-1#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#9)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#32)(2009-8#6)(2009-9#4)(2010-1#4)(2010-10#2)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#7)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#13)(2012-1#2)(2012-12#8)(2012-2#19)(2012-3#2)(2013-1#46)(2013-7#1)(2013-8#10)
strength)##7##1##(1992-3#1)(1992-8#1)(2008-10#4)(2010-4#1)
strength/power athletes##4##2##(2008-5#4)
strengthen and##3##2##(1992-3#1)(1997-1#1)(2008-7#1)
strengthen the concept of##2##4##(1995-2#1)(2008-7#1)
strengthen the immune system##2##4##(2008-12#1)(2008-5#1)
strengthen the public health##3##4##(1995-12#1)(1996-2#1)(1997-2#1)
strengthen the##36##2##(1992-6#1)(1993-12#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#6)(2013-7#1)(2013-8#2)
strengthen their##5##2##(1991-2#1)(1992-3#1)(1997-2#1)(2010-3#1)(2012-12#1)
strengthen##66##1##(1991-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-10#1)(2009-7#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#7)(2012-2#2)(2012-3#7)(2013-7#1)(2013-8#2)
strengthened by##4##2##(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#1)
strengthened through##3##2##(1995-3#1)(2008-10#1)(2009-11#1)
strengthened##22##1##(1995-3#1)(1996-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#2)
strengthening Shen'##2##2##(2013-8#2)
strengthening and##3##2##(1996-2#1)(2009-6#1)(2013-1#1)
strengthening civil registration and vital statistics##2##6##(2012-12#2)
strengthening exercise##4##2##(2011-2#3)(2013-1#1)
strengthening of the##5##3##(1997-8#1)(2008-1#1)(2008-10#1)(2012-1#2)
strengthening of##9##2##(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-1#2)
strengthening the hypothesis that##2##4##(2008-10#2)
strengthening the##8##2##(1991-3#1)(1992-6#1)(2008-10#3)(2008-4#1)(2009-5#1)(2012-12#1)
strengthening##60##1##(1991-12#1)(1991-3#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#2)(2009-5#3)(2009-6#1)(2009-7#3)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#5)
strengthens its##2##2##(1991-2#1)(1992-6#1)
strengthens the##3##2##(1993-1#1)(1994-6#1)(2012-12#1)
strengthens##6##1##(1991-2#1)(1992-6#1)(1993-1#1)(1994-6#1)(2008-12#1)(2012-12#1)
strengths and limitations of##4##4##(1993-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
strengths and limitations##5##3##(1993-1#1)(1996-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
strengths and weaknesses and##2##4##(1996-2#1)(2008-9#1)
strengths and weaknesses of##6##4##(1992-12#1)(1994-1#1)(1997-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
strengths and weaknesses within##2##4##(1994-1#1)(2008-11#1)
strengths and weaknesses##19##3##(1992-12#1)(1993-2#1)(1994-1#2)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#1)(2011-2#1)
strengths and##37##2##(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#2)(1994-3#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
strengths has been##2##3##(1995-2#1)(1997-6#1)
strengths in##7##2##(1991-12#1)(2008-10#3)(2008-3#1)(2013-1#1)(2013-8#1)
strengths of the##9##3##(1995-2#1)(1995-9#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#2)
strengths of##23##2##(1995-2#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)
strengths ranging from 0##2##4##(2008-10#1)(2009-7#1)
strengths such as##2##3##(2010-8#1)(2011-2#1)
strengths than##3##2##(2008-11#1)(2008-12#1)(2009-7#1)
strengths that##2##2##(2008-12#1)(2011-1#1)
strengths were##2##2##(2008-10#1)(2008-6#1)
strengths##120##1##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-2#1)(1994-1#2)(1994-3#2)(1994-5#1)(1995-2#5)(1995-5#1)(1995-9#2)(1996-1#2)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#1)
strenuous##8##1##(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2013-1#2)(2013-8#1)
streptavidin modified screen-printed carbon electrodes##2##5##(2008-10#2)
streptavidin moves to the##2##4##(2009-12#2)
streptavidin to##4##2##(1990-2#1)(1995-11#1)(2008-11#1)(2008-7#1)
streptavidin was##3##2##(1993-6#1)(2008-10#2)
streptavidin##39##1##(1990-12#1)(1990-2#2)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-8#1)(2008-10#13)(2008-11#1)(2008-4#3)(2008-7#2)(2008-9#3)(2009-12#8)
streptavidin)##2##1##(1995-8#1)(2008-4#1)
streptavidin-biotin##4##1##(1995-2#2)(2008-10#1)(2011-2#1)
streptavidin-coated magnetic beads##3##3##(1995-6#3)
streptavidin-coated##4##1##(1995-6#3)(2008-9#1)
streptococcal binding##3##2##(1990-12#3)
streptococcal infection##3##2##(2011-2#3)
streptococcal infections##4##2##(1992-2#1)(1995-6#1)(2007-12#1)(2011-2#1)
streptococcal species##4##2##(2010-12#1)(2011-1#2)(2012-2#1)
streptococcal##24##1##(1990-12#3)(1991-8#2)(1992-2#1)(1995-6#1)(1995-8#1)(2007-12#4)(2008-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-2#1)
streptococci##14##1##(1990-12#1)(1991-11#1)(1993-10#1)(1995-11#1)(1995-8#1)(1997-4#1)(2006-10#1)(2006-6#2)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
streptococcus mutans##2##2##(2013-1#2)
streptococcus##12##1##(1991-2#1)(1995-5#1)(2007-12#4)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
streptokinase and##5##2##(1990-3#1)(1995-6#1)(1997-4#1)(2007-11#1)(2012-2#1)
streptokinase by##3##2##(1990-3#1)(2012-2#2)
streptokinase##26##1##(1990-3#3)(1991-9#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#10)
streptolysin-O permeabilized##2##2##(1992-12#2)
streptomycete##3##1##(2008-10#3)
streptomycetes were##2##2##(2008-10#2)
streptomycetes##6##1##(2008-10#5)(2011-1#1)
streptomycin or##2##2##(2008-10#2)
streptomycin sulfate##8##2##(2008-10#6)(2008-6#1)(2008-8#1)
streptomycin##22##1##(1993-12#1)(2008-10#17)(2008-6#1)(2008-8#2)(2010-3#1)
streptomycin-resistant##2##1##(2008-10#2)
streptozotocin (STZ)##3##2##(1996-12#1)(2010-11#1)(2011-3#1)
streptozotocin (STZ)-induced diabetic##2##3##(1991-12#1)(2008-4#1)
streptozotocin (STZ)-induced##3##2##(1991-12#1)(2008-10#1)(2008-4#1)
streptozotocin##21##1##(1990-2#1)(1991-12#1)(1991-6#1)(1996-12#1)(2008-10#4)(2008-12#2)(2008-4#1)(2009-11#1)(2010-11#3)(2010-2#1)(2011-2#1)(2011-3#1)(2012-3#3)
streptozotocin-diabetic rats##2##2##(1994-8#1)(1996-12#1)
streptozotocin-induced diabetic rats##3##3##(2008-12#1)(2011-3#2)
streptozotocin-induced diabetic##6##2##(2008-12#2)(2011-1#1)(2011-3#3)
streptozotocin-induced##9##1##(1994-11#1)(2008-12#3)(2011-1#1)(2011-3#3)(2012-3#1)
stress -##2##2##(2008-11#1)(2008-7#1)
stress adaptation##2##2##(2009-6#1)(2011-2#1)
stress affecting##2##2##(2012-12#1)(2013-8#1)
stress also##2##2##(2008-11#1)(2009-11#1)
stress among##4##2##(1992-12#1)(2008-11#1)(2010-10#1)(2012-2#1)
stress analysis##2##2##(2008-3#1)(2009-4#1)
stress and aging##2##3##(2009-5#2)
stress and antioxidant##3##3##(2008-7#2)(2012-12#1)
stress and anxiety##2##3##(2008-5#1)(2013-7#1)
stress and burnout##2##3##(1996-2#1)(2010-7#1)
stress and coping model##2##4##(1995-1#2)
stress and coping##8##3##(1992-1#1)(1995-1#2)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#2)
stress and energy##2##3##(2008-8#1)(2009-8#1)
stress and have##2##3##(2007-12#1)(2008-7#1)
stress and hypertension##2##3##(2008-7#1)(2013-7#1)
stress and injury##2##3##(2008-11#1)(2011-2#1)
stress and its##5##3##(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)
stress and other##2##3##(2008-10#1)(2009-7#1)
stress and somatic##2##3##(2008-2#1)(2011-2#1)
stress and strain distributions##2##4##(2013-1#2)
stress and strain##6##3##(1996-4#1)(2008-7#1)(2009-4#2)(2013-1#2)
stress and the##7##3##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
stress and to##3##3##(1994-2#1)(2008-7#2)
stress and##135##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#2)(1996-9#2)(1997-6#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#11)(2008-11#8)(2008-2#2)(2008-3#2)(2008-5#7)(2008-7#13)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-10#4)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#5)(2012-5#2)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#2)
stress and/or##3##2##(1995-12#2)(2008-1#1)
stress anisotropy##2##2##(2008-3#2)
stress are##8##2##(1994-6#1)(1995-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
stress as##2##2##(2008-5#1)(2009-9#1)
stress associated with##3##3##(2008-8#3)
stress at fracture##5##3##(2008-7#5)
stress at the##5##3##(1997-8#1)(2007-11#2)(2008-3#1)(2009-6#1)
stress at##12##2##(1997-8#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#5)(2009-6#1)
stress behaviors##3##2##(1991-12#3)
stress biomarkers##2##2##(2010-5#1)(2011-2#1)
stress birefringence##2##2##(2007-12#1)(2008-3#1)
stress by##14##2##(1991-9#1)(1994-6#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
stress can be##3##3##(2008-1#1)(2008-2#1)(2010-10#1)
stress can##9##2##(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)
stress caused by##2##3##(2008-10#1)(2008-7#1)
stress caused##4##2##(2008-10#1)(2008-7#1)(2011-10#1)(2012-1#1)
stress changes##2##2##(1996-4#2)
stress conditions##16##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-7#1)(2013-7#2)
stress could##4##2##(2008-10#2)(2008-12#1)(2011-10#1)
stress decreased##2##2##(2011-1#1)(2012-1#1)
stress defense##2##2##(2009-8#1)(2010-11#1)
stress disorder (PTSD) is##3##4##(1996-7#1)(2008-6#2)
stress disorder (PTSD)##13##3##(1996-7#1)(2008-6#3)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
stress disorder and##3##3##(1991-2#1)(2009-9#1)(2013-8#1)
stress disorder in##2##3##(2008-11#1)(2009-6#1)
stress disorder patients##3##3##(1996-5#2)(2008-6#1)
stress disorder##37##2##(1991-2#1)(1996-5#2)(1996-7#2)(2008-11#1)(2008-6#6)(2008-8#1)(2009-11#3)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-1#5)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#5)
stress distribution##4##2##(1996-4#1)(2008-11#1)(2008-3#1)(2013-1#1)
stress does not##2##3##(1991-9#1)(2008-2#1)
stress drop##5##2##(1996-4#5)
stress due to##2##3##(2007-11#1)(2008-7#1)
stress during##2##2##(2008-10#1)(2008-12#1)
stress dynamic##3##2##(1992-12#3)
stress echocardiography##2##2##(1994-11#2)
stress experienced by##4##3##(1991-12#1)(1992-2#1)(2008-11#1)(2009-8#1)
stress exposure and##2##3##(2009-7#1)(2012-3#1)
stress exposure##4##2##(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
stress factors##4##2##(1990-6#1)(1990-9#1)(2008-10#1)(2008-12#1)
stress fiber formation##2##3##(1997-6#2)
stress fibers were##2##3##(2008-6#1)(2008-7#1)
stress fibers##8##2##(1994-8#1)(2008-6#5)(2008-7#2)
stress field##5##2##(1996-4#1)(2008-2#1)(2008-7#1)(2009-7#2)
stress for##4##2##(1992-9#1)(2008-11#1)(2009-6#1)(2010-10#1)
stress fracture##2##2##(1996-6#1)(2007-11#1)
stress fractures of the##3##4##(1991-11#3)
stress fractures##7##2##(1991-11#5)(2007-11#1)(2010-4#1)
stress from##3##2##(2008-10#1)(2008-3#2)
stress granules##2##2##(2012-12#1)(2012-2#1)
stress has been##3##3##(2008-10#2)(2012-3#1)
stress has##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
stress hormones##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
stress in a##2##3##(2008-2#1)(2008-5#1)
stress in the##21##3##(1992-8#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#3)(2009-10#1)(2009-7#3)(2010-11#2)(2010-12#1)(2012-2#1)(2013-1#2)
stress in##70##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-1#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-9#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-2#3)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-5#1)(2012-7#1)(2013-1#7)(2013-8#1)
stress incontinence##3##2##(1994-3#2)(2008-1#1)
stress increases##5##2##(1992-11#1)(1993-11#1)(1995-12#1)(2009-5#2)
stress induced by##4##3##(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
stress induced##9##2##(1994-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#2)(2012-3#2)(2013-1#1)
stress is a##4##3##(1995-6#1)(2008-5#1)(2010-2#1)(2013-1#1)
stress is an important##2##4##(1992-9#1)(2012-2#1)
stress is an##3##3##(1992-9#1)(2012-2#1)(2013-8#1)
stress is laid on the importance of##2##7##(1990-3#1)(2007-7#1)
stress is laid on##3##4##(1990-3#2)(2007-7#1)
stress is one of the##2##5##(2008-12#1)(2011-2#1)
stress is one##3##3##(2008-12#1)(2009-9#1)(2011-2#1)
stress is thought to##2##4##(1995-12#1)(2013-1#1)
stress is##25##2##(1990-3#2)(1990-5#1)(1992-9#1)(1994-2#1)(1995-12#2)(1995-6#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
stress led to##2##3##(2008-10#1)(2013-1#1)
stress level##2##2##(1996-9#1)(2010-10#1)
stress levels as a##2##4##(2008-8#1)(2009-5#1)
stress levels of##3##3##(2008-7#1)(2010-10#1)(2012-1#1)
stress levels##12##2##(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#3)(2011-1#1)(2012-1#1)
stress management##6##2##(1994-2#1)(1996-2#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
stress markers in##3##3##(2009-6#1)(2010-5#1)(2011-2#1)
stress markers##8##2##(2009-6#1)(2010-5#2)(2011-2#2)(2012-5#2)(2013-1#1)
stress may be##2##3##(1994-11#1)(2008-9#1)
stress may##6##2##(1991-9#1)(1992-12#1)(1994-11#1)(2008-2#1)(2008-9#1)(2012-1#1)
stress measurements##2##2##(2008-3#2)
stress measures##2##2##(2009-7#1)(2012-3#1)
stress model##3##2##(2007-10#1)(2008-11#1)(2010-8#1)
stress occurring##2##2##(2008-3#1)(2009-4#1)
stress of the##4##3##(2007-12#1)(2008-7#2)(2012-3#1)
stress of workers##2##3##(2008-2#1)(2010-12#1)
stress of##23##2##(1990-7#1)(1994-12#1)(1995-1#1)(1995-12#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-1#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
stress on cell##2##3##(2008-11#1)(2009-12#1)
stress on the##15##3##(1990-8#1)(1991-6#1)(1991-9#1)(1995-12#1)(1997-4#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-3#1)
stress on##42##2##(1990-8#1)(1991-6#1)(1991-9#2)(1993-11#1)(1994-2#1)(1995-12#2)(1997-4#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-2#1)(2008-6#3)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#4)(2010-8#1)(2012-2#2)(2012-3#5)(2013-1#2)
stress or##8##2##(1995-5#1)(1996-5#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)
stress play##2##2##(2008-7#1)(2012-2#1)
stress produced##2##2##(2009-8#2)
stress profiles##2##2##(2009-11#2)
stress protein##5##2##(1993-6#1)(1994-11#1)(2008-7#1)(2009-7#2)
stress proteins in##6##3##(1992-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-7#2)
stress proteins##14##2##(1992-5#3)(1993-6#1)(1994-11#2)(1994-8#1)(1995-6#1)(1996-9#1)(2008-11#1)(2008-4#1)(2008-7#3)
stress reaction##6##2##(2006-9#1)(2008-5#3)(2011-2#2)
stress reactions and##2##3##(1993-6#1)(2011-2#1)
stress reactions##3##2##(1993-6#1)(2008-11#1)(2011-2#1)
stress related##2##2##(2008-7#1)(2011-2#1)
stress relaxation##3##2##(2008-3#1)(2008-5#1)(2013-7#1)
stress relief proteins in##2##4##(1996-9#2)
stress relief proteins##3##3##(1996-9#3)
stress resistance##4##2##(2008-6#1)(2008-8#1)(2011-2#2)
stress response behaviors##2##3##(2008-7#2)
stress response by##2##3##(2008-7#2)
stress response genes##2##3##(1994-5#1)(2012-2#1)
stress response has##2##3##(2008-10#1)(2011-2#1)
stress response in##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
stress response protein##3##3##(1997-7#2)(2011-2#1)
stress response to##6##3##(1995-8#3)(1997-2#1)(2008-11#2)
stress response##48##2##(1992-12#1)(1994-5#1)(1995-8#3)(1996-9#1)(1997-2#3)(1997-7#2)(2008-10#4)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-8#4)(2010-11#1)(2011-1#2)(2011-2#6)(2012-2#4)(2012-3#2)(2013-7#1)
stress responses in##5##3##(1997-8#2)(2008-7#2)(2011-2#1)
stress responses##20##2##(1997-8#2)(2008-10#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
stress resulting##2##2##(1994-8#1)(2008-11#1)
stress shielding##3##2##(2008-5#2)(2009-7#1)
stress signals##2##2##(2009-8#1)(2011-2#1)
stress symptoms##13##2##(2008-11#1)(2008-7#1)(2009-11#2)(2009-7#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#3)
stress tensor##6##2##(2007-11#3)(2008-3#1)(2009-10#2)
stress test##7##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#2)
stress testing of##2##3##(1997-8#1)(2011-1#1)
stress testing##6##2##(1997-8#1)(2008-3#2)(2008-7#2)(2011-1#1)
stress tests##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
stress thallium cardiac imaging services##2##5##(1992-12#2)
stress than##5##2##(1992-11#1)(2008-4#2)(2011-2#1)(2012-7#1)
stress that in turn##2##4##(1991-9#1)(1996-4#1)
stress that the##2##3##(2009-9#1)(2013-1#1)
stress that##10##2##(1991-9#1)(1993-9#1)(1996-4#1)(2008-1#1)(2008-5#1)(2009-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
stress the importance of##4##4##(1990-9#1)(2008-11#1)(2008-3#1)(2008-9#1)
stress the need##2##3##(2008-10#1)(2008-7#1)
stress the##18##2##(1990-12#2)(1990-2#1)(1990-9#2)(1992-5#1)(1993-2#1)(1994-2#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)
stress they##2##2##(1996-4#1)(2008-1#1)
stress to##8##2##(1996-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)
stress tolerance in plants##2##4##(2011-2#2)
stress tolerance##8##2##(2008-10#3)(2008-11#1)(2011-2#3)(2012-7#1)
stress transfer between##2##3##(2009-6#1)(2012-2#1)
stress ulcer##2##2##(2012-3#2)
stress under##2##2##(2008-10#1)(2013-1#1)
stress urinary incontinence##5##3##(1991-3#1)(1994-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
stress using##3##2##(2008-11#1)(2008-9#1)(2009-10#1)
stress was studied in##2##4##(2008-12#1)(2008-8#1)
stress was##9##2##(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
stress were##7##2##(1990-5#1)(1994-12#1)(2007-6#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
stress with##5##2##(1994-11#2)(2011-2#2)(2012-1#1)
stress words##3##2##(2009-11#3)
stress##1415##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#10)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#9)(1992-1#2)(1992-11#2)(1992-12#10)(1992-2#1)(1992-3#10)(1992-5#7)(1992-6#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-6#7)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#13)(1994-12#5)(1994-2#15)(1994-3#3)(1994-5#3)(1994-6#8)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#5)(1995-12#21)(1995-2#2)(1995-3#2)(1995-5#8)(1995-6#3)(1995-8#3)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#17)(1996-5#5)(1996-6#1)(1996-7#3)(1996-9#14)(1997-2#3)(1997-3#2)(1997-4#6)(1997-6#4)(1997-7#6)(1997-8#7)(2006-9#1)(2007-10#1)(2007-11#15)(2007-12#5)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#19)(2008-10#81)(2008-11#96)(2008-12#29)(2008-2#26)(2008-3#36)(2008-4#20)(2008-5#58)(2008-6#21)(2008-7#111)(2008-8#22)(2008-9#21)(2009-1#2)(2009-10#13)(2009-11#18)(2009-12#7)(2009-3#2)(2009-4#6)(2009-5#7)(2009-6#12)(2009-7#31)(2009-8#28)(2009-9#8)(2010-1#4)(2010-10#17)(2010-11#4)(2010-12#9)(2010-2#3)(2010-4#14)(2010-5#10)(2010-6#1)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#15)(2011-10#2)(2011-2#93)(2011-3#2)(2012-1#37)(2012-12#20)(2012-2#45)(2012-3#22)(2012-5#5)(2012-6#2)(2012-7#5)(2013-1#55)(2013-7#16)(2013-8#21)
stress&quot##2##1##(1991-9#1)(1994-5#1)
stress)##6##1##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
stress-##2##1##(2008-11#1)(2008-4#1)
stress-based##3##1##(1991-2#1)(2013-1#2)
stress-induced ABA accumulation##5##3##(2008-8#5)
stress-induced analgesia##3##2##(1990-7#3)
stress-induced anxiety##2##2##(2011-2#1)(2013-8#1)
stress-induced birefringence##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
stress-induced changes in##2##3##(2008-11#1)(2008-7#1)
stress-induced##45##1##(1990-11#1)(1990-7#3)(1992-3#1)(1993-11#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#1)(2008-8#5)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-8#2)
stress-inducible protein##2##2##(1997-7#2)
stress-inducible proteins##2##2##(1997-7#1)(2008-7#1)
stress-inducible##8##1##(1997-7#3)(1997-8#2)(2008-7#1)(2009-6#2)
stress-mediated##2##1##(2008-7#1)(2009-8#1)
stress-related changes##2##2##(1992-1#1)(2012-1#1)
stress-related hormone##2##2##(2008-10#1)(2009-8#1)
stress-related parameters in##2##3##(2010-12#2)
stress-related parameters##3##2##(2010-12#3)
stress-related symptoms##2##2##(1991-2#2)
stress-related##18##1##(1991-2#2)(1992-1#1)(1995-8#1)(2008-10#3)(2008-4#1)(2008-6#2)(2008-9#1)(2009-8#2)(2010-12#3)(2011-1#1)(2012-1#1)
stress-response##3##1##(2010-12#1)(2011-1#1)(2012-12#1)
stress-responsive genes##2##2##(2008-9#1)(2011-2#1)
stress-responsive##4##1##(1996-2#1)(2008-9#1)(2009-10#1)(2011-2#1)
stress/strain##2##1##(2008-5#1)(2011-2#1)
stress? What##2##2##(2012-12#2)
stress?##3##1##(2009-6#1)(2012-12#2)
stress]##4##1##(1991-6#1)(1993-3#1)(2010-12#1)(2012-3#1)
stressed and##4##2##(1997-7#1)(2008-5#1)(2011-1#1)(2011-2#1)
stressed animals##2##2##(2008-7#1)(2013-1#1)
stressed in the##2##3##(1996-9#1)(2008-5#1)
stressed mice##2##2##(2008-7#2)
stressed that##9##2##(1990-11#1)(1990-9#1)(1991-5#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)
stressed the importance of##3##4##(1992-6#1)(2008-1#1)(2010-10#1)
stressed the need##2##3##(2008-11#1)(2009-4#1)
stressed the##8##2##(1992-6#1)(1997-6#1)(2008-1#2)(2008-11#1)(2009-4#1)(2010-10#1)(2011-2#1)
stressed volumes##2##2##(2009-7#2)
stressed word##2##2##(2008-2#2)
stressed##97##1##(1990-11#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-6#2)(1993-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-4#1)(2008-1#3)(2008-10#6)(2008-11#10)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#5)(2008-9#5)(2009-10#2)(2009-4#1)(2009-7#3)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
stresses and##8##2##(1996-9#1)(2008-7#1)(2009-4#1)(2009-7#4)(2011-2#1)
stresses are##5##2##(2009-4#1)(2009-6#1)(2009-7#3)
stresses associated with##2##3##(2008-10#1)(2008-7#1)
stresses how##2##2##(1992-2#1)(1995-12#1)
stresses in##5##2##(2008-3#1)(2008-7#2)(2009-8#1)(2010-10#1)
stresses of##4##2##(1997-4#3)(2008-10#1)
stresses on##3##2##(2008-2#1)(2009-3#1)(2009-7#1)
stresses such as drought##2##4##(1997-2#1)(2011-2#1)
stresses such as##4##3##(1996-2#1)(1997-2#1)(2008-1#1)(2011-2#1)
stresses the importance of##7##4##(1993-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(2008-11#1)(2012-2#1)(2013-1#1)
stresses the need for##2##4##(2008-11#1)(2011-2#1)
stresses the need##4##3##(2007-7#1)(2008-11#1)(2011-2#1)(2012-2#1)
stresses the##11##2##(1993-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(2007-7#1)(2008-11#2)(2011-2#1)(2012-2#2)(2013-1#1)
stresses were##2##2##(2008-7#1)(2009-7#1)
stresses##107##1##(1991-1#2)(1991-12#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-11#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-4#3)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#12)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#15)(2009-8#3)(2010-10#4)(2010-5#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#3)(2013-8#1)
stressful and##2##2##(2008-11#2)
stressful conditions##3##2##(1995-12#1)(2012-3#2)
stressful effects##2##2##(2008-11#1)(2008-7#1)
stressful events having a negative impact##2##6##(1992-1#2)
stressful events##5##2##(1992-1#3)(1996-12#1)(2008-2#1)
stressful life events and##2##4##(2011-2#2)
stressful life events##6##3##(2008-11#1)(2011-2#5)
stressful life##7##2##(2008-11#1)(2011-2#5)(2012-1#1)
stressful##39##1##(1992-1#3)(1992-2#2)(1994-12#5)(1994-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-3#3)(2013-1#1)
stressing the need for##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
stressing the##8##2##(1990-6#1)(1993-9#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
stressing##12##1##(1990-6#1)(1993-9#1)(1994-2#1)(1995-11#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-7#1)
stressor is##2##2##(1993-6#1)(1995-12#1)
stressor of##2##2##(2008-2#1)(2010-2#1)
stressor##29##1##(1993-6#2)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#10)(2008-2#1)(2008-4#3)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
stressors and distress##2##3##(2012-3#2)
stressors and##12##2##(1990-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-3#2)(2013-8#1)
stressors are##3##2##(2009-8#1)(2010-2#1)(2012-1#1)
stressors compared to##2##3##(2008-4#2)
stressors for##2##2##(2010-10#1)(2012-1#1)
stressors in the##2##3##(1993-6#1)(2012-3#1)
stressors in##5##2##(1993-6#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
stressors is##2##2##(2008-4#1)(2010-12#1)
stressors on##2##2##(2008-11#1)(2012-2#1)
stressors such as##2##3##(2008-5#1)(2011-2#1)
stressors that##3##2##(2008-2#1)(2011-2#1)(2012-12#1)
stressors##67##1##(1990-5#1)(1993-6#1)(1996-12#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#3)(2008-2#3)(2008-4#6)(2008-5#1)(2008-7#2)(2009-11#1)(2009-6#1)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#4)(2011-2#5)(2012-1#7)(2012-12#1)(2012-2#2)(2012-3#6)(2012-6#1)(2013-1#2)(2013-8#1)
stressosome##7##1##(2009-8#7)
stretch and##3##2##(2008-12#1)(2011-1#1)(2012-2#1)
stretch may be##2##3##(1990-2#1)(1990-7#1)
stretch may##3##2##(1990-12#1)(1990-2#1)(1990-7#1)
stretch of##11##2##(1990-11#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1995-8#2)(1996-3#1)(1997-3#1)(2009-10#1)(2013-7#1)
stretch on the##2##3##(1990-12#1)(2008-6#1)
stretch##58##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#3)(1990-8#5)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-6#2)(1995-8#2)(1996-3#2)(1997-3#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-12#2)(2008-3#6)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#1)
stretch-induced##6##1##(1990-11#2)(1990-12#2)(1990-8#1)(2008-6#1)
stretched and##2##2##(2008-12#1)(2008-3#1)
stretched at##2##2##(1990-8#1)(2012-7#1)
stretched exponential##2##2##(2007-12#1)(2012-2#1)
stretched pulse##2##2##(2008-3#2)
stretched##27##1##(1990-8#1)(1992-7#1)(1992-9#1)(1993-11#1)(1995-6#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-7#3)(2013-8#1)
stretched-pulse fiber laser with a nonlinear optical loop mirror##2##9##(2007-11#2)
stretched-pulse fiber laser##4##3##(2007-11#3)(2007-12#1)
stretched-pulse fiber##5##2##(2007-11#4)(2007-12#1)
stretched-pulse##9##1##(2007-11#7)(2007-12#2)
stretcher##5##1##(2007-11#3)(2007-12#1)(2008-2#1)
stretchers##2##1##(2008-3#1)(2011-1#1)
stretches of##10##2##(1992-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-5#1)
stretches##15##1##(1990-11#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)
stretching and##2##2##(2008-10#1)(2008-2#1)
stretching band##8##2##(1990-2#2)(2008-10#4)(2008-2#2)
stretching bands##4##2##(1996-2#1)(2008-10#3)
stretching exercises##2##2##(2009-1#2)
stretching force##2##2##(1996-2#1)(2008-10#1)
stretching frequencies of the##2##4##(1990-2#1)(1994-3#1)
stretching frequencies##8##2##(1990-2#1)(1994-3#2)(1995-5#3)(1996-2#1)(2008-5#1)
stretching frequency measurements##2##3##(1994-3#2)
stretching frequency##3##2##(1994-3#2)(2008-2#1)
stretching mode of##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
stretching mode##6##2##(1990-8#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)
stretching modes##3##2##(1996-2#1)(2008-3#1)(2008-5#1)
stretching of a##2##3##(2007-11#1)(2009-7#1)
stretching of the##9##3##(1990-2#2)(2008-10#1)(2008-12#1)(2008-2#2)(2009-3#1)(2009-7#2)
stretching of##17##2##(1990-11#1)(1990-2#2)(1990-8#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2009-3#1)(2009-7#3)
stretching region##2##2##(2008-8#1)(2010-2#1)
stretching techniques##2##2##(2009-1#2)
stretching the##2##2##(1995-8#1)(2012-7#1)
stretching vibration mode##2##3##(2008-10#2)
stretching vibration of##2##3##(2008-10#2)
stretching vibration##7##2##(1996-2#1)(2008-10#5)(2008-2#1)
stretching vibrational##2##2##(1995-5#1)(2007-12#1)
stretching vibrations##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
stretching##102##1##(1990-11#1)(1990-2#7)(1990-8#2)(1993-11#2)(1994-11#1)(1994-3#4)(1995-5#5)(1995-8#2)(1996-2#5)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#20)(2008-12#1)(2008-2#9)(2008-3#6)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2009-1#7)(2009-3#1)(2009-7#5)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-7#1)(2013-1#1)
stria vascularis##2##2##(2009-8#2)
stria##5##1##(1993-12#1)(1994-2#1)(2008-9#1)(2009-8#2)
striae##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
striata##2##1##(1995-8#1)(1996-12#1)
striatal D-2 receptor##2##3##(1993-12#2)
striatal D-2##3##2##(1993-12#3)
striatal D2 receptor##2##3##(1996-7#2)
striatal DA##2##2##(1993-12#1)(1997-2#1)
striatal and##3##2##(1990-7#1)(1991-6#1)(1994-8#1)
striatal cells##2##2##(1993-12#1)(1995-5#1)
striatal dopamine receptor##2##3##(1994-5#1)(1995-2#1)
striatal dopamine release##2##3##(1995-12#1)(2008-2#1)
striatal dopamine transporter##4##3##(1996-2#4)
striatal dopamine##14##2##(1993-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-2#4)(2008-11#1)(2008-2#1)(2008-7#1)
striatal dopaminergic##2##2##(2008-7#1)(2013-8#1)
striatal glutamate##2##2##(1995-12#1)(2008-7#1)
striatal hyperactivity##2##2##(2013-8#2)
striatal interactions##2##2##(1993-6#2)
striatal neurons that##2##3##(2008-5#1)(2011-1#1)
striatal neurons##5##2##(1991-6#1)(1994-5#1)(1995-12#1)(2008-5#1)(2011-1#1)
striatal projection##2##2##(1996-12#1)(1996-2#1)
striatal regions##2##2##(1996-5#2)
striatal slices##5##2##(1993-12#1)(1995-12#4)
striatal synaptosomes##3##2##(1995-11#2)(1996-2#1)
striatal uptake##2##2##(1993-9#1)(2008-7#1)
striatal##86##1##(1990-7#4)(1991-2#1)(1991-6#2)(1992-10#1)(1993-12#10)(1993-6#2)(1993-9#1)(1994-2#1)(1994-5#3)(1994-8#3)(1995-11#3)(1995-12#12)(1995-2#2)(1995-5#4)(1995-8#1)(1996-12#2)(1996-2#7)(1996-5#4)(1996-7#2)(1997-2#3)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#6)(2011-1#2)(2013-1#1)(2013-8#4)
striate cortex##3##2##(1994-8#2)(2008-11#1)
striate cortical cells in the monkey##2##6##(2008-8#2)
striate##7##1##(1994-8#2)(2008-10#2)(2008-11#1)(2008-8#2)
striated muscle myosin of Xenopus laevis##2##6##(1995-12#2)
striated muscle##5##2##(1992-6#1)(1994-5#1)(1995-12#2)(1995-6#1)
striated skeletal muscle##3##3##(1993-12#2)(2010-6#1)
striated##12##1##(1990-7#1)(1992-6#1)(1993-12#2)(1994-5#1)(1995-12#3)(1995-6#1)(2009-9#2)(2010-6#1)
striations##2##1##(2008-5#2)
striatum &gt##2##2##(1993-9#1)(1997-2#1)
striatum after dopamine##2##3##(1996-12#1)(1996-2#1)
striatum and motor cortex##3##4##(1991-6#3)
striatum and nucleus accumbens##4##4##(1993-12#1)(1994-8#3)
striatum and spinal cord##2##4##(1996-2#1)(1997-2#1)
striatum and##21##2##(1991-6#3)(1993-12#1)(1994-8#4)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-7#2)(2008-11#1)(2008-7#2)
striatum but##2##2##(1993-12#1)(1997-2#1)
striatum by##2##2##(1992-7#1)(1997-2#1)
striatum compared##2##2##(1996-2#1)(1997-2#1)
striatum in the##2##3##(1993-6#1)(1996-5#1)
striatum in##4##2##(1993-6#1)(1993-9#1)(1995-5#1)(1996-5#1)
striatum of rats##2##3##(1996-5#1)(1997-2#1)
striatum of the##3##3##(1993-6#1)(2008-10#1)(2008-7#1)
striatum of##13##2##(1993-12#1)(1993-6#1)(1995-12#2)(1996-5#1)(1997-2#3)(2008-10#1)(2008-7#2)(2009-8#1)(2012-3#1)
striatum to##2##2##(1996-5#1)(2008-11#1)
striatum was##3##2##(1992-7#1)(1993-12#1)(1995-11#1)
striatum##133##1##(1990-9#1)(1991-1#1)(1991-4#1)(1991-6#5)(1991-9#1)(1992-7#3)(1993-12#4)(1993-6#7)(1993-9#3)(1994-2#7)(1994-6#2)(1994-8#6)(1995-11#3)(1995-12#6)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#8)(1996-2#8)(1996-5#12)(1997-2#11)(1997-3#2)(1997-6#2)(1997-7#5)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#11)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#7)
striatum)##3##1##(1993-12#1)(1996-12#1)(2012-2#1)
striatus##5##1##(2008-10#5)
stricken##2##1##(1996-5#1)(2009-6#1)
strict and##2##2##(2007-8#1)(2008-12#1)
strict control of##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
strict genetic##2##2##(2008-11#1)(2008-6#1)
strict regulation##2##2##(1990-11#1)(2013-7#1)
strict requirements##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
strict selection##3##2##(1990-3#1)(1996-6#1)(1996-8#1)
strict specificity##2##2##(2008-4#1)(2008-8#1)
strict temporal##2##2##(2012-2#1)(2012-3#1)
strict##60##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-9#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
stricter##3##1##(1992-12#1)(1995-6#1)(2007-2#1)
strictly anaerobic and##2##3##(2011-2#2)
strictly anaerobic##5##2##(2011-2#5)
strictly by the##2##3##(1992-3#1)(1994-12#1)
strictly by##3##2##(1992-3#1)(1994-12#1)(1996-5#1)
strictly clonal##3##2##(2008-10#3)
strictly conserved##5##2##(1991-5#1)(1995-2#2)(1995-5#1)(2008-10#1)
strictly controlled##7##2##(1995-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
strictly dependent on##6##3##(1990-9#1)(1993-11#1)(1993-5#1)(1994-8#1)(2008-10#1)(2010-11#1)
strictly limited##2##2##(1997-3#1)(2008-11#1)
strictly on##2##2##(2008-8#1)(2012-2#1)
strictly regulated##2##2##(1997-6#1)(2011-2#1)
strictly related to##6##3##(1990-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-7#2)
strictly symmetric initial##2##3##(2007-8#2)
strictly##97##1##(1990-6#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-11#2)(1992-3#2)(1993-1#1)(1993-11#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
strictum##9##1##(2008-10#9)
stricture and##2##2##(1996-3#1)(2009-1#1)
stricture is not a##2##4##(2008-11#1)(2013-1#1)
stricture is##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
stricture of##2##2##(2010-12#1)(2013-1#1)
stricture was##3##2##(2010-12#1)(2013-1#1)(2013-7#1)
stricture##33##1##(1995-10#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-1#1)(2009-4#1)(2009-5#4)(2010-12#2)(2010-4#1)(2011-2#1)(2013-1#8)(2013-7#6)(2013-8#2)
strictures of##2##2##(2008-10#2)
strictures##22##1##(1993-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2010-12#4)(2012-3#1)(2013-1#7)(2013-8#3)
stride length##4##2##(1994-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
stride##6##1##(1994-12#1)(1994-8#1)(2008-7#1)(2010-8#1)(2013-1#2)
strides have been made in##3##5##(1995-12#1)(2008-11#1)(2013-1#1)
strides have been made##4##4##(1995-12#1)(2008-11#2)(2013-1#1)
strides in##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
strides##14##1##(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#1)(2012-12#3)(2012-3#1)(2013-1#1)
stridor and##2##2##(1991-11#1)(2008-11#1)
stridor##6##1##(1991-11#2)(2008-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
stridulation##3##1##(2007-12#3)
strife##3##1##(1993-12#1)(1995-9#1)(2008-7#1)
striga emergence##4##2##(2008-10#4)
striga per host plant##2##4##(2008-10#2)
striga##14##1##(2008-10#14)
striiformis f##30##2##(2008-10#30)
striiformis in##2##2##(2008-10#2)
striiformis##41##1##(2008-10#41)
strike is##2##2##(2007-12#2)
strike slip##2##2##(1990-11#2)
strike the##2##2##(1996-5#1)(2010-1#1)
strike##13##1##(1990-11#2)(1991-11#1)(1993-12#1)(1996-11#1)(1996-5#2)(2007-12#3)(2008-10#1)(2010-1#1)(2010-3#1)
strikes##6##1##(1992-9#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
striking difference between##2##3##(2008-10#2)
striking difference##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)
striking differences in##3##3##(2008-10#2)(2012-3#1)
striking feature of##2##3##(1994-5#1)(2008-10#1)
striking feature##4##2##(1991-5#1)(1994-5#1)(1996-6#1)(2008-10#1)
striking finding##3##2##(1992-5#1)(2008-7#1)(2008-8#1)
striking in the##2##3##(1991-8#1)(1993-5#1)
striking in##3##2##(1991-8#1)(1993-5#1)(2007-12#1)
striking increase in##3##3##(1991-12#1)(1992-8#1)(2008-10#1)
striking reduction in##2##3##(1993-11#1)(2011-2#1)
striking similarities##2##2##(2009-3#1)(2009-4#1)
striking similarity to a##2##4##(1994-5#1)(1996-6#1)
striking similarity to##3##3##(1993-3#1)(1994-5#1)(1996-6#1)
striking similarity##5##2##(1993-3#1)(1994-5#1)(1996-6#1)(2007-12#2)
striking##89##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-3#1)(1997-7#2)(2007-11#1)(2007-12#8)(2007-6#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
strikingly different##5##2##(1992-3#1)(2008-11#2)(2008-7#1)(2008-9#1)
strikingly increased in##2##3##(1991-8#1)(1993-2#1)
strikingly increased##3##2##(1990-5#1)(1991-8#1)(1993-2#1)
strikingly similar to##4##3##(1994-12#1)(2008-5#2)(2012-2#1)
strikingly similar##8##2##(1994-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)
strikingly##28##1##(1990-5#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
string quartets##2##2##(2013-1#2)
string test##4##2##(2007-7#4)
string##25##1##(1990-4#1)(1994-3#1)(2007-11#2)(2007-7#4)(2008-10#3)(2008-12#2)(2008-7#7)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#2)
stringency of##3##2##(1995-5#1)(1996-2#1)(2010-12#1)
stringency##12##1##(1991-5#1)(1993-11#1)(1994-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#1)(2008-10#1)(2010-12#1)(2013-1#2)
stringent environmental##2##2##(1990-9#1)(2008-10#1)
stringent in##2##2##(1995-6#1)(2008-11#1)
stringent requirements for##2##3##(1996-1#1)(2008-8#1)
stringent requirements##4##2##(1996-1#1)(2008-3#1)(2008-8#1)(2009-5#1)
stringent##43##1##(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
strings and##2##2##(2008-3#1)(2008-5#1)
strings of##3##2##(1990-8#1)(1997-6#1)(2008-5#1)
strings##15##1##(1990-8#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#7)(2008-7#3)
strip agent##2##2##(2008-10#2)
strip coating material##2##3##(2008-3#2)
strip electrode##2##2##(2008-10#2)
strip mask##2##2##(2008-2#2)
strip of##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
strip test##3##2##(2012-3#3)
strip tillage##3##2##(2008-10#3)
strip##48##1##(1990-7#1)(1996-12#3)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#24)(2008-2#5)(2008-3#4)(2008-5#3)(2012-3#5)
stripe rust and##2##3##(2008-10#2)
stripe rust epidemics##2##3##(2008-10#2)
stripe rust in##3##3##(2008-10#3)
stripe rust pathogen##2##3##(2008-10#2)
stripe rust resistance gene##2##4##(2008-10#2)
stripe rust resistance##6##3##(2008-10#6)
stripe rust severity and infection type##2##6##(2008-10#2)
stripe rust severity##5##3##(2008-10#5)
stripe rust was##4##3##(2008-10#4)
stripe rust when introgressed into##2##5##(2008-10#2)
stripe rust##46##2##(2008-10#46)
stripe virus##4##2##(2008-10#4)
stripe wear##3##2##(2009-7#3)
stripe width of##2##3##(2008-3#2)
stripe##68##1##(1993-12#1)(1997-3#1)(2007-12#4)(2008-10#54)(2008-2#1)(2008-3#4)(2009-7#3)
striped##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
stripes##11##1##(1993-2#1)(2007-12#1)(2008-2#1)(2008-3#4)(2011-2#4)
striping##4##1##(2008-10#3)(2008-2#1)
stripped and##2##2##(2008-10#1)(2008-4#1)
stripped from organic phase with##2##5##(2008-10#2)
stripped from the organic phase with##2##6##(2008-10#2)
stripped from the##9##3##(1993-1#1)(2008-10#8)
stripped from##11##2##(1993-1#1)(2008-10#10)
stripped##21##1##(1993-1#1)(2008-10#16)(2008-3#1)(2008-4#2)(2008-5#1)
stripping analysis (PSA)##2##3##(2008-10#2)
stripping analysis##8##2##(2008-10#8)
stripping and##7##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)
stripping chronopotentiometric##3##2##(2008-10#3)
stripping current##4##2##(2008-10#4)
stripping differential pulse voltammetry##2##4##(2008-10#2)
stripping differential pulse##4##3##(2008-10#4)
stripping method for the##2##4##(2008-10#2)
stripping method##3##2##(2008-10#3)
stripping mode with an accumulation time##2##6##(2008-10#2)
stripping mode##3##2##(2008-10#3)
stripping of the##4##3##(2008-10#4)
stripping of##10##2##(2008-10#10)
stripping peak current##4##3##(2008-10#4)
stripping peak was##2##3##(2008-10#2)
stripping peak##8##2##(2008-10#8)
stripping peaks##2##2##(2008-10#2)
stripping performance##2##2##(2008-10#2)
stripping potentiometry##3##2##(2008-10#3)
stripping procedure for##2##3##(2008-10#2)
stripping response is##2##3##(2008-10#2)
stripping response##5##2##(2008-10#5)
stripping square-wave voltammetry##3##3##(2008-10#3)
stripping square-wave##6##2##(2008-10#6)
stripping step##3##2##(2008-10#3)
stripping technique##4##2##(2008-10#4)
stripping voltammetric assay of##2##4##(2008-10#2)
stripping voltammetric detection##5##3##(2008-10#5)
stripping voltammetric determination of the##2##5##(2008-10#2)
stripping voltammetric determination of##12##4##(2008-10#12)
stripping voltammetric determination##13##3##(2008-10#13)
stripping voltammetric measurement##2##3##(2008-10#2)
stripping voltammetric measurements##3##3##(2008-10#3)
stripping voltammetric method for the##2##5##(2008-10#2)
stripping voltammetric method is##2##4##(2008-10#2)
stripping voltammetric method##4##3##(2008-10#4)
stripping voltammetric procedure for##2##4##(2008-10#2)
stripping voltammetric procedure##7##3##(2008-10#7)
stripping voltammetric##45##2##(2008-10#45)
stripping voltammetry (CSV)##3##3##(2008-10#3)
stripping voltammetry (DPASV)##5##3##(2008-10#5)
stripping voltammetry and##4##3##(2008-10#4)
stripping voltammetry at a##4##4##(2008-10#4)
stripping voltammetry at##8##3##(2008-10#8)
stripping voltammetry in##2##3##(2008-10#2)
stripping voltammetry is##3##3##(2008-10#2)(2010-2#1)
stripping voltammetry of cysteine##2##4##(2008-10#2)
stripping voltammetry of##12##3##(2008-10#12)
stripping voltammetry on a##4##4##(2008-10#4)
stripping voltammetry on##6##3##(2008-10#6)
stripping voltammetry the##2##3##(2008-10#2)
stripping voltammetry using##7##3##(2008-10#7)
stripping voltammetry with a mercury##2##5##(2008-10#2)
stripping voltammetry with a##5##4##(2008-10#5)
stripping voltammetry with##10##3##(2008-10#10)
stripping voltammetry##150##2##(2008-10#149)(2010-2#1)
stripping was##2##2##(2008-10#2)
stripping with##3##2##(2008-10#2)(2008-5#1)
stripping##320##1##(2008-10#308)(2008-11#1)(2008-4#1)(2008-5#9)(2010-2#1)
strips in##3##2##(1990-8#1)(1992-6#1)(1996-12#1)
strips of##5##2##(1991-12#1)(1994-11#1)(2007-11#1)(2008-11#1)(2008-3#1)
strips were##2##2##(2007-10#1)(2009-7#1)
strips##31##1##(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1994-11#1)(1996-12#2)(2007-10#2)(2007-11#2)(2008-10#7)(2008-11#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)
strive for##2##2##(2008-10#1)(2012-1#1)
strive to##8##2##(1991-12#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-3#1)(2008-7#1)(2008-9#1)
strive##11##1##(1991-12#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)
strived##2##1##(2010-5#1)(2013-1#1)
strives to##5##2##(1992-12#1)(2006-9#1)(2007-5#1)(2008-7#1)(2013-7#1)
strives##6##1##(1992-12#1)(1994-1#1)(2006-9#1)(2007-5#1)(2008-7#1)(2013-7#1)
striving for##2##2##(1997-2#1)(2010-9#1)
striving to improve##3##3##(1993-1#1)(2010-8#1)(2011-2#1)
striving to##5##2##(1993-1#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
striving##10##1##(1993-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-2#1)
strobilurin resistance in##2##3##(2008-10#2)
strobilurin##4##1##(2008-10#4)
stroboscopic##6##1##(2007-12#3)(2008-3#3)
strobus##2##1##(2008-10#2)
stroke (n =##2##3##(2008-7#1)(2010-7#1)
stroke and death##2##3##(1991-11#1)(2006-7#1)
stroke and other##3##3##(1996-6#1)(2008-8#2)
stroke and peripheral embolism##2##4##(2008-7#1)(2008-8#1)
stroke and stroke##2##3##(2007-10#1)(2013-1#1)
stroke and their##3##3##(2007-10#2)(2011-1#1)
stroke and to##2##3##(2008-8#1)(2010-12#1)
stroke and##62##2##(1990-3#3)(1991-11#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-7#1)(2007-10#16)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#9)(2009-11#2)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
stroke are##9##2##(2007-10#3)(2008-8#5)(2013-1#1)
stroke at young age##2##4##(2007-10#2)
stroke at##5##2##(2007-10#5)
stroke attack rates in rural##2##5##(2007-10#2)
stroke attack rates in##3##4##(2007-10#3)
stroke attack rates##4##3##(2007-10#4)
stroke attack##6##2##(2007-10#5)(2008-8#1)
stroke awareness##2##2##(2007-10#1)(2010-10#1)
stroke but##3##2##(2008-7#1)(2008-8#2)
stroke by##4##2##(2007-10#2)(2008-8#1)(2011-2#1)
stroke can##3##2##(2007-10#1)(2008-12#1)(2008-8#1)
stroke care##4##2##(2007-10#2)(2008-8#1)(2013-8#1)
stroke cases##4##2##(2007-10#2)(2009-9#1)(2011-1#1)
stroke caused by##6##3##(2007-10#5)(2008-12#1)
stroke center##2##2##(2007-9#1)(2013-8#1)
stroke centers##2##2##(2007-9#2)
stroke dementia patients##2##3##(1990-3#2)
stroke dementia##4##2##(1990-3#4)
stroke discharge##2##2##(2007-10#2)
stroke during cardiac surgery?##2##4##(2007-8#2)
stroke during the##2##3##(2007-8#1)(2008-8#1)
stroke during##6##2##(2007-10#2)(2007-8#3)(2008-8#1)
stroke event##2##2##(2008-9#1)(2009-10#1)
stroke events##3##2##(2007-10#1)(2008-8#1)(2009-11#1)
stroke for##2##2##(2008-8#1)(2008-9#1)
stroke from##3##2##(2007-10#2)(2008-8#1)
stroke had##2##2##(2007-10#1)(2008-7#1)
stroke has declined##2##3##(1995-5#2)
stroke has##5##2##(1995-5#2)(2007-10#1)(2008-8#1)(2012-3#1)
stroke have##3##2##(2007-10#2)(2008-8#1)
stroke in China##2##3##(2008-8#2)
stroke in a##2##3##(2007-10#1)(2009-9#1)
stroke in patients with##5##4##(2007-10#1)(2007-7#1)(2007-8#2)(2008-8#1)
stroke in the##6##3##(1992-2#1)(2007-8#2)(2008-8#1)(2009-7#1)(2013-1#1)
stroke in these##3##3##(1991-6#1)(2007-10#1)(2010-5#1)
stroke in##49##2##(1991-6#1)(1992-2#1)(1995-5#1)(2007-10#11)(2007-7#1)(2007-8#4)(2008-7#2)(2008-8#16)(2009-7#1)(2009-9#3)(2010-5#1)(2011-1#4)(2012-3#1)(2013-1#2)
stroke incidence##6##2##(2007-10#2)(2007-9#1)(2008-8#3)
stroke is common##2##3##(2007-10#1)(2008-8#1)
stroke is now##2##3##(2006-7#1)(2007-10#1)
stroke is##12##2##(2006-7#1)(2007-10#3)(2007-11#1)(2008-8#2)(2008-9#3)(2009-11#1)(2012-2#1)
stroke management##3##2##(2007-9#1)(2008-8#2)
stroke mechanism##4##2##(2007-10#4)
stroke models##2##2##(2007-9#1)(2008-2#1)
stroke number##2##2##(2008-7#2)
stroke occurrence##2##2##(2007-10#2)
stroke of##5##2##(2007-10#1)(2007-11#1)(2008-8#2)(2010-10#1)
stroke onset is##2##3##(2007-10#2)
stroke onset##13##2##(2007-10#6)(2007-9#2)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
stroke or brain injury##2##4##(2008-2#2)
stroke or transient ischemic attacks##2##5##(1994-6#1)(2007-7#1)
stroke or transient ischemic##4##4##(1994-6#1)(2007-10#1)(2007-7#1)(2008-8#1)
stroke or##17##2##(1991-11#2)(1993-12#1)(1994-6#2)(2007-10#3)(2007-11#1)(2007-7#1)(2008-2#2)(2008-8#3)(2011-2#1)(2013-8#1)
stroke over the##2##3##(2007-10#1)(2011-2#1)
stroke patient##3##2##(1995-5#1)(2007-10#1)(2007-9#1)
stroke patients admitted##3##3##(2007-10#3)
stroke patients presenting##2##3##(2007-10#2)
stroke patients who##2##3##(2007-10#2)
stroke patients with##4##3##(2007-10#4)
stroke patients##46##2##(1995-3#1)(1995-5#1)(2007-10#22)(2007-2#2)(2007-9#1)(2008-2#3)(2008-3#2)(2008-8#10)(2010-3#1)(2011-2#1)(2012-12#2)
stroke prevalence##2##2##(2007-10#1)(2008-8#1)
stroke prevention but##2##3##(2008-8#1)(2012-12#1)
stroke prevention with##2##3##(2008-8#1)(2012-12#1)
stroke prevention##16##2##(1993-9#1)(1994-9#1)(2006-7#1)(2007-10#2)(2008-8#5)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
stroke probability##2##2##(2007-10#2)
stroke published##2##2##(2007-10#1)(2008-8#1)
stroke recovery##2##2##(2008-8#1)(2013-1#1)
stroke registry##2##2##(2007-10#1)(2008-8#1)
stroke rehabilitation##3##2##(2007-10#1)(2011-2#1)(2013-1#1)
stroke related##2##2##(2007-10#1)(2012-2#1)
stroke research##5##2##(2008-8#4)(2013-1#1)
stroke risk factors##9##3##(2007-10#6)(2007-9#1)(2008-2#2)
stroke risk in##2##3##(2007-10#1)(2008-8#1)
stroke risk was##2##3##(2007-10#2)
stroke risk##20##2##(2007-10#11)(2007-9#1)(2008-2#3)(2008-8#3)(2010-5#1)(2012-2#1)
stroke scale##2##2##(2007-10#2)
stroke services##4##2##(2008-8#3)(2013-8#1)
stroke severity##4##2##(2007-10#2)(2008-3#2)
stroke subtype##4##2##(2007-10#4)
stroke subtypes##2##2##(2007-10#2)
stroke survivors in##2##3##(2007-10#1)(2013-1#1)
stroke survivors##9##2##(2007-10#6)(2010-7#1)(2013-1#2)
stroke survivors'##2##2##(2013-1#2)
stroke syndrome##2##2##(2007-10#2)
stroke than those##2##3##(2007-10#2)
stroke therapy##3##2##(2007-10#2)(2007-9#1)
stroke to##3##2##(2007-10#2)(2008-7#1)
stroke treatment##7##2##(2007-10#2)(2007-9#3)(2008-8#2)
stroke trial##3##2##(2008-8#3)
stroke type##4##2##(2007-10#4)
stroke unit##4##2##(1995-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
stroke units##6##2##(2008-8#1)(2011-1#5)
stroke volume##4##2##(2012-2#2)(2012-3#2)
stroke was##5##2##(1991-11#1)(2007-10#1)(2008-3#1)(2011-2#1)(2012-1#1)
stroke were##5##2##(2007-10#4)(2009-9#1)
stroke who##4##2##(2007-10#3)(2009-4#1)
stroke will##2##2##(1995-5#1)(2011-1#1)
stroke with##2##2##(2007-10#1)(2008-8#1)
stroke##854##1##(1990-3#9)(1991-11#10)(1991-6#1)(1992-2#4)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#12)(1996-11#3)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-7#8)(2007-10#301)(2007-11#3)(2007-2#2)(2007-7#3)(2007-8#11)(2007-9#24)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#17)(2008-3#11)(2008-5#2)(2008-7#30)(2008-8#169)(2008-9#10)(2009-1#3)(2009-10#4)(2009-11#13)(2009-4#3)(2009-6#3)(2009-7#1)(2009-9#8)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#22)(2011-2#16)(2012-1#3)(2012-12#17)(2012-2#11)(2012-3#10)(2013-1#25)(2013-7#2)(2013-8#20)
stroke)##2##1##(2008-7#1)(2009-11#1)
stroke-induced##2##1##(2007-10#1)(2008-8#1)
stroke-like##3##1##(1990-12#1)(2007-10#1)(2008-8#1)
stroke-prone spontaneously hypertensive rats##4##4##(1995-12#4)
stroke-prone##5##1##(1991-6#1)(1995-12#4)
stroke-related disability##2##2##(2007-10#2)
stroke-related##3##1##(1992-8#1)(2007-10#2)
stroke?##6##1##(1995-5#1)(1997-5#2)(2008-8#1)(2009-10#1)(2010-12#1)
stroke]##4##1##(1995-5#1)(1995-8#1)(1997-3#1)(2010-12#1)
strokectomy##3##1##(2012-3#3)
strokes and##3##2##(1995-5#1)(2007-10#1)(2013-1#1)
strokes in##4##2##(2007-10#1)(2008-7#2)(2011-2#1)
strokes that occurred##2##3##(2007-10#2)
strokes##31##1##(1990-11#1)(1990-3#1)(1991-11#1)(1995-5#1)(2007-10#12)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
stroma and##5##2##(1994-2#1)(2008-11#1)(2013-1#2)(2013-8#1)
stroma in the##2##3##(1992-12#1)(2008-10#1)
stroma of the##2##3##(1997-3#1)(2008-11#1)
stroma of##3##2##(1994-2#1)(1997-3#1)(2008-11#1)
stroma with##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
stroma##49##1##(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-2#5)(1994-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#4)(2008-12#5)(2008-2#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#9)(2013-8#2)
stromal cell cultures##2##3##(1994-9#2)
stromal cell line##9##3##(1994-6#2)(2008-10#1)(2008-11#4)(2008-8#2)
stromal cell types##2##3##(2011-1#1)(2012-3#1)
stromal cell##24##2##(1994-6#2)(1994-9#4)(2008-10#1)(2008-11#6)(2008-8#4)(2009-10#1)(2009-4#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-3#1)
stromal cells from##3##3##(1994-9#1)(2011-2#2)
stromal cells or##2##3##(2008-11#1)(2008-4#1)
stromal cells##39##2##(1993-11#1)(1993-9#4)(1994-9#7)(1995-12#2)(2008-11#6)(2008-4#2)(2008-8#6)(2009-10#1)(2009-3#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#2)
stromal elements##3##2##(1993-9#1)(2009-3#1)(2011-1#1)
stromal fibroblast##2##2##(1995-11#1)(2013-1#1)
stromal fibroblasts##8##2##(2011-1#2)(2013-1#6)
stromal sarcoma##7##2##(1994-7#4)(2009-5#3)
stromal stem cells##2##3##(2012-1#2)
stromal stem##3##2##(2012-1#3)
stromal tumor (GIST)##2##3##(2008-7#1)(2009-7#1)
stromal tumor##8##2##(2007-4#2)(2008-10#1)(2008-7#1)(2009-7#2)(2010-12#1)(2012-12#1)
stromal tumors##10##2##(1992-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
stromal tumours##3##2##(2008-6#2)(2013-7#1)
stromal vascular fraction##2##3##(2008-11#1)(2012-12#1)
stromal vascular##3##2##(2008-11#2)(2012-12#1)
stromal##128##1##(1992-9#1)(1993-11#1)(1993-9#5)(1994-6#2)(1994-7#4)(1994-9#12)(1995-11#1)(1995-12#2)(2007-11#1)(2007-4#2)(2008-10#2)(2008-11#17)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#11)(2009-10#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-7#2)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#7)(2011-2#6)(2012-1#7)(2012-12#3)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#1)
stromata##5##1##(2008-10#5)
stromaticum##13##1##(2008-10#13)
stromatoporoids##3##1##(1990-11#3)
strong O(3)##3##2##(2008-2#2)(2008-3#1)
strong RTP##2##2##(2008-10#2)
strong Raman##2##2##(2008-10#2)
strong ability to##2##3##(2008-10#1)(2010-11#1)
strong absorption and##2##3##(2007-12#1)(2008-10#1)
strong absorption##10##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#3)
strong acid##7##2##(1990-6#1)(2008-10#6)
strong acidic##6##2##(2008-10#5)(2008-11#1)
strong acids##3##2##(2008-10#3)
strong activation of##3##3##(2008-11#1)(2008-4#1)(2009-8#1)
strong adsorption of##3##3##(2008-10#3)
strong affinity for the##2##4##(2008-10#2)
strong affinity for##3##3##(2008-10#3)
strong affinity of##2##3##(2008-10#1)(2011-2#1)
strong affinity##6##2##(1995-8#1)(2008-10#4)(2011-2#1)
strong alkaline##2##2##(2008-10#2)
strong and broad##2##3##(2008-10#1)(2008-3#1)
strong and important##2##3##(2008-3#2)
strong and stable electrocatalytic##2##4##(2008-10#2)
strong and that##2##3##(1995-5#1)(2008-8#1)
strong and##22##2##(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
strong anion exchange##2##3##(2008-10#2)
strong anion exchanger##2##3##(2008-10#2)
strong anion##6##2##(1991-7#1)(2008-10#5)
strong anisotropy of##2##3##(2008-2#2)
strong anisotropy##3##2##(2008-10#1)(2008-2#2)
strong antifungal activities against##2##4##(1994-2#1)(2013-1#1)
strong antifungal activities##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
strong antifungal##4##2##(1994-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
strong antimicrobial activity##2##3##(2008-10#1)(2010-2#1)
strong antimicrobial##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)
strong antioxidant##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)
strong argument##2##2##(1994-11#1)(2008-9#1)
strong association between the##2##4##(2008-1#1)(2008-8#1)
strong association between##8##3##(1990-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
strong association of##3##3##(2008-10#1)(2008-3#2)
strong association##17##2##(1990-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
strong associations##3##2##(1990-8#1)(1997-2#1)(2013-8#1)
strong background in##2##3##(1995-1#1)(2008-9#1)
strong background##3##2##(1995-1#1)(2008-10#1)(2008-9#1)
strong base##4##2##(2007-11#1)(2008-10#3)
strong binding of##2##3##(2008-10#1)(2010-6#1)
strong binding##3##2##(2008-10#1)(2009-5#1)(2010-6#1)
strong bootstrap support##3##3##(2008-10#3)
strong but##5##2##(1997-2#1)(2008-10#1)(2008-8#2)(2009-8#1)
strong candidates##3##2##(1996-8#1)(2008-11#1)(2008-7#1)
strong case##2##2##(1994-1#1)(2008-6#1)
strong cation exchange##2##3##(1992-3#1)(2008-10#1)
strong cation##3##2##(1991-7#1)(1992-3#1)(2008-10#1)
strong cell-mediated immune responses##2##4##(1995-2#1)(2013-8#1)
strong clinical suspicion##2##3##(2009-11#1)(2013-1#1)
strong clinical##4##2##(1997-2#1)(2009-11#1)(2010-10#1)(2013-1#1)
strong competition for##2##3##(2008-7#1)(2008-8#1)
strong contribution##2##2##(2008-11#1)(2008-3#1)
strong contributions##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
strong correlated##2##2##(2008-8#2)
strong correlation (r = 0##3##5##(1993-8#1)(2008-10#1)(2008-11#1)
strong correlation between the##7##4##(1991-6#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
strong correlation between##18##3##(1991-6#1)(1994-6#1)(1997-1#1)(1997-3#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
strong correlation##34##2##(1991-6#1)(1993-8#2)(1994-6#1)(1994-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-3#4)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
strong correlations##2##2##(2008-10#1)(2010-4#1)
strong coupling between##3##3##(2008-3#2)(2009-8#1)
strong coupling##4##2##(2007-12#1)(2008-3#2)(2009-8#1)
strong cultural##2##2##(2009-11#1)(2012-3#1)
strong decrease##2##2##(2008-10#1)(2009-8#1)
strong dependence of the##3##4##(2007-11#1)(2008-2#1)(2012-2#1)
strong dependence of##5##3##(2007-11#2)(2008-2#2)(2012-2#1)
strong dependence##10##2##(2007-11#3)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
strong dispersion management##2##3##(2007-12#2)
strong dispersion##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
strong divergent##2##2##(2008-10#1)(2009-9#1)
strong earthquakes##4##2##(1996-4#4)
strong effect on##7##3##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)(2011-3#1)
strong effect##9##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-10#1)(2011-3#1)(2013-8#1)
strong effects##3##2##(2008-8#1)(2010-4#1)(2012-3#1)
strong electron##2##2##(2008-10#2)
strong emphasis on the##4##4##(1993-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
strong emphasis##5##2##(1993-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
strong enhancement##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
strong enough to##5##3##(1997-7#1)(2008-3#1)(2008-7#1)(2012-2#2)
strong enough##7##2##(1997-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#2)
strong environmental##2##2##(2008-8#1)(2008-9#1)
strong evidence for the##2##4##(1990-11#1)(2013-1#1)
strong evidence for##8##3##(1990-11#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
strong evidence of##2##3##(1993-3#1)(2009-5#1)
strong evidence that this##2##4##(2007-8#1)(2008-1#1)
strong evidence that##12##3##(1990-2#1)(1994-1#1)(1994-9#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#3)(2011-1#1)(2012-3#1)
strong evidence to suggest##2##4##(2008-8#2)
strong evidence to##3##3##(2008-8#2)(2012-2#1)
strong evidence##29##2##(1990-11#1)(1990-2#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#6)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
strong expression of##8##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
strong expression##9##2##(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
strong fluorescence##6##2##(2008-10#5)(2008-2#1)
strong for##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
strong functional##2##2##(1993-12#1)(2012-3#1)
strong genetic##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
strong growth##2##2##(1992-12#1)(2008-11#1)
strong health##2##2##(2011-1#1)(2012-12#1)
strong homology to##3##3##(1995-6#1)(1996-6#1)(1997-7#1)
strong homology with##3##3##(1992-8#1)(1996-6#1)(1997-4#1)
strong homology##7##2##(1992-8#1)(1993-2#1)(1995-6#1)(1996-6#2)(1997-4#1)(1997-7#1)
strong hybridization signals##2##3##(1991-6#1)(2008-8#1)
strong hybridization##3##2##(1991-12#1)(1991-6#1)(2008-8#1)
strong hydrogen bonding##3##3##(1991-8#2)(2008-10#1)
strong hydrogen##4##2##(1991-8#2)(2008-10#2)
strong hydrophobicity##2##2##(2008-10#1)(2008-8#1)
strong impact on##4##3##(2008-11#1)(2010-8#1)(2011-1#1)(2012-3#1)
strong implications##3##2##(2010-10#1)(2011-2#1)(2013-1#1)
strong in the##2##3##(1996-12#1)(2009-7#1)
strong in##3##2##(1996-12#1)(2008-8#1)(2009-7#1)
strong increase in##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
strong increase of the##2##4##(2008-10#1)(2009-12#1)
strong increase##6##2##(1991-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)
strong independent##2##2##(1993-2#1)(2008-2#1)
strong induction of##2##3##(1992-8#1)(1996-12#1)
strong inflammatory##3##2##(2008-10#1)(2008-11#1)(2009-11#1)
strong influence of the##2##4##(2008-3#1)(2009-7#1)
strong influence of##8##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2012-3#1)
strong influence on the##4##4##(2008-10#3)(2012-8#1)
strong influence on##9##3##(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)(2012-8#1)
strong influence##18##2##(1990-2#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2012-8#1)
strong inhibition##5##2##(1992-12#1)(2008-10#1)(2008-8#2)(2009-10#1)
strong inhibitory activities##3##3##(2011-3#3)
strong inhibitory activity##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
strong inhibitory##8##2##(1994-11#1)(1995-3#1)(2008-10#2)(2011-3#3)(2013-1#1)
strong interaction##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)
strong intermolecular##2##2##(2008-10#1)(2008-5#1)
strong inverse##3##2##(2008-11#1)(2008-3#2)
strong ionic##2##2##(1992-6#1)(2008-10#1)
strong is##2##2##(2008-8#1)(2011-2#1)
strong leadership##3##2##(1995-2#1)(1997-3#1)(2008-12#1)
strong light scattering##3##3##(2008-10#2)(2008-8#1)
strong light##5##2##(1991-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
strong linkage disequilibrium##3##3##(1997-8#1)(2012-3#2)
strong linkage##4##2##(1997-8#1)(2008-12#1)(2012-3#2)
strong matrix##2##2##(2008-10#2)
strong metabolic##2##2##(2008-10#1)(2012-3#1)
strong mode##2##2##(2007-11#1)(2008-3#1)
strong morphological##2##2##(2011-1#1)(2011-2#1)
strong negative##9##2##(1994-12#2)(1994-3#1)(1997-7#1)(2008-10#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-2#1)
strong optical##2##2##(2008-2#1)(2008-3#1)
strong periodic##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
strong polarization##2##2##(2007-11#1)(2008-3#1)
strong positive correlation of##2##4##(2008-11#1)(2009-9#1)
strong positive correlation##4##3##(2008-11#1)(2009-9#1)(2010-8#1)(2013-8#1)
strong positive results##2##3##(2012-2#2)
strong positive##16##2##(1994-3#1)(1994-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
strong potential##4##2##(2008-3#2)(2008-5#1)(2010-5#1)
strong predictor of##5##3##(1996-8#1)(2007-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
strong predictors of##5##3##(1992-4#1)(1993-1#1)(2007-7#1)(2008-2#1)(2008-7#1)
strong preference##3##2##(1990-11#1)(1990-7#1)(1994-12#1)
strong premating##2##2##(2008-8#1)(2008-9#1)
strong promoter activity in Escherichia coli##2##6##(1991-9#2)
strong promoter activity in##3##4##(1991-9#2)(2008-9#1)
strong promoter##4##2##(1991-9#2)(2008-9#2)
strong psychometric properties##2##3##(2010-10#1)(2010-9#1)
strong pump beam##2##3##(2007-11#1)(2007-12#1)
strong reaction##2##2##(1993-6#1)(2008-8#1)
strong reactivity with##2##3##(1992-8#1)(2008-5#1)
strong reduction of the##2##4##(2007-11#2)
strong reduction of##3##3##(1997-3#1)(2007-11#2)
strong reduction##4##2##(1997-3#1)(2007-11#2)(2010-11#1)
strong relation between##2##3##(2008-12#1)(2008-3#1)
strong relation##3##2##(1994-6#1)(2008-12#1)(2008-3#1)
strong relationship between##2##3##(2007-10#1)(2008-9#1)
strong relationship##5##2##(2007-10#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
strong relationships##2##2##(1993-11#1)(2010-5#1)
strong resistance to##4##3##(2008-10#3)(2012-2#1)
strong resistance##6##2##(2008-10#4)(2008-8#1)(2012-2#1)
strong retention of##2##3##(2008-10#2)
strong risk factor##2##3##(1993-11#1)(2008-3#1)
strong room temperature phosphorescence (RTP)##2##5##(2008-10#2)
strong selective pressure to##2##4##(1991-2#1)(2008-7#1)
strong selective##5##2##(1991-2#1)(2008-7#1)(2008-8#2)(2013-1#1)
strong short-term##2##2##(2008-9#2)
strong similarities##4##2##(1990-5#1)(1991-2#1)(1993-2#1)(1993-6#1)
strong similarity to##2##3##(1996-6#1)(2008-7#1)
strong similarity##5##2##(1994-8#1)(1996-6#1)(1997-4#1)(2008-2#1)(2008-7#1)
strong spatial##2##2##(2007-12#1)(2008-10#1)
strong spectral##3##2##(2008-10#3)
strong statistical##2##2##(1997-4#1)(2008-8#1)
strong stimulation of##2##3##(1994-8#1)(1997-7#1)
strong support for the##3##4##(2008-11#1)(2009-11#1)(2012-3#1)
strong support for##6##3##(1991-1#1)(1992-2#1)(2008-1#1)(2008-11#1)(2009-11#1)(2012-3#1)
strong support to the##2##4##(1990-11#1)(2012-3#1)
strong support##9##2##(1990-11#1)(1991-1#1)(1992-2#1)(2008-1#1)(2008-11#1)(2009-11#2)(2012-3#2)
strong suspicion of##3##3##(2008-3#2)(2012-3#1)
strong suspicion##4##2##(2008-3#2)(2012-3#1)(2013-1#1)
strong synergistic##3##2##(1993-8#1)(2008-10#1)(2012-12#1)
strong temporal##2##2##(2008-11#1)(2008-8#1)
strong variation##2##2##(2008-5#1)(2009-5#1)
strong visible##2##2##(2008-8#1)(2011-2#1)
strong water vapor absorption##2##4##(2008-2#1)(2008-3#1)
strong##1032##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#5)(1991-1#1)(1991-12#4)(1991-2#2)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#7)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#3)(1992-8#8)(1992-9#2)(1993-1#2)(1993-11#4)(1993-12#6)(1993-2#3)(1993-3#3)(1993-6#6)(1993-8#4)(1994-1#3)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#6)(1996-5#1)(1996-6#6)(1996-7#1)(1996-8#4)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#8)(1997-5#3)(1997-7#7)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#38)(2007-12#32)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#212)(2008-11#39)(2008-12#10)(2008-2#35)(2008-3#59)(2008-4#5)(2008-5#22)(2008-6#7)(2008-7#26)(2008-8#58)(2008-9#28)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#3)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#7)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#9)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#20)(2011-3#6)(2012-1#1)(2012-12#9)(2012-2#15)(2012-3#21)(2012-6#1)(2012-8#1)(2012-9#1)(2013-1#27)(2013-7#1)(2013-8#11)
stronger affinity for##2##3##(1997-1#1)(2008-10#1)
stronger and##7##2##(1990-5#1)(1997-6#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
stronger delayed absorbable suture materials##2##5##(1991-1#2)
stronger effect on the action threshold##2##6##(2008-4#2)
stronger effect on##4##3##(2008-4#2)(2008-8#2)
stronger effects on##2##3##(1995-1#1)(2008-2#1)
stronger for##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-1#1)(2013-1#1)
stronger in the##2##3##(1995-11#1)(2011-2#1)
stronger in##9##2##(1993-9#1)(1995-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-8#1)
stronger or##3##2##(1992-7#1)(2008-8#1)(2008-9#1)
stronger relationship##2##2##(1993-12#1)(1993-2#1)
stronger resonance scattering##2##3##(2008-10#2)
stronger rhythms##2##2##(2008-6#2)
stronger signal##3##2##(1997-4#1)(2008-3#1)(2013-8#1)
stronger than any##2##3##(1997-8#1)(2011-2#1)
stronger than that of##6##4##(1996-2#1)(2008-10#1)(2008-8#3)(2009-8#1)
stronger than that##7##3##(1996-2#1)(2008-10#1)(2008-8#4)(2009-8#1)
stronger than the##6##3##(2008-10#2)(2008-3#1)(2012-2#2)(2013-1#1)
stronger than##27##2##(1990-5#1)(1993-2#1)(1993-5#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-8#6)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
stronger when##3##2##(2008-9#1)(2009-10#1)(2010-5#1)
stronger with##2##2##(2008-10#2)
stronger##169##1##(1990-5#2)(1991-1#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#4)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#30)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#3)(2008-5#4)(2008-6#3)(2008-8#13)(2008-9#8)(2009-10#1)(2009-11#1)(2009-7#2)(2009-8#5)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#4)(2013-8#6)
strongest evidence##2##2##(2007-8#1)(2008-6#1)
strongest for##2##2##(1991-5#1)(2010-5#1)
strongest in##2##2##(2008-10#1)(2008-11#1)
strongest predictors##3##2##(1992-12#1)(2007-12#1)(2012-12#1)
strongest##80##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1995-5#2)(1996-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
strongly a##2##2##(2008-10#1)(2008-2#1)
strongly aberrated##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
strongly absorbing aerosols##4##3##(2008-2#3)(2008-3#1)
strongly absorbing##11##2##(2007-12#1)(2008-2#5)(2008-3#5)
strongly acidic resins##2##3##(2008-10#2)
strongly acidic solution##3##3##(2008-10#3)
strongly acidic##11##2##(1994-5#1)(2008-10#10)
strongly adsorbed##2##2##(2008-10#2)
strongly affected by the##5##4##(1990-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
strongly affected by##9##3##(1990-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
strongly affected the##2##3##(2008-10#1)(2008-9#1)
strongly affected##15##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)
strongly affects the##2##3##(1993-9#1)(2008-10#1)
strongly aggregated##2##2##(2008-10#2)
strongly and irreversibly##2##3##(2008-10#2)
strongly and##9##2##(1992-4#1)(1994-11#1)(1995-5#1)(2008-10#3)(2008-5#1)(2010-3#1)(2013-1#1)
strongly associated to##2##3##(1991-6#1)(2011-1#1)
strongly associated with suicidal risk##2##5##(2009-7#2)
strongly associated with the occurrence of##2##6##(1995-2#1)(2010-12#1)
strongly associated with the##4##4##(1995-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
strongly associated with##29##3##(1991-11#1)(1995-2#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#1)(2009-4#1)(2009-7#3)(2009-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-3#1)(2013-1#1)
strongly associated##32##2##(1991-11#1)(1991-6#1)(1995-2#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-7#3)(2009-9#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-3#1)(2013-1#1)
strongly attached##3##2##(2008-10#1)(2008-11#2)
strongly believe##2##2##(2008-7#1)(2012-2#1)
strongly birefringent##2##2##(2007-11#1)(2008-3#1)
strongly blocked##2##2##(1990-12#1)(2008-11#1)
strongly bound##2##2##(2010-7#1)(2011-2#1)
strongly by##2##2##(1992-4#1)(2009-9#1)
strongly competing species##2##3##(2008-8#2)
strongly conserved##2##2##(1993-6#1)(2013-8#1)
strongly coordinates with the##2##4##(2008-10#2)
strongly correlated (r = 0##2##5##(1991-12#1)(2008-10#1)
strongly correlated with the##4##4##(1990-2#1)(2008-7#1)(2008-9#1)(2009-3#1)
strongly correlated with##18##3##(1990-2#1)(1991-8#1)(1992-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-3#3)(2013-1#1)
strongly correlated##26##2##(1990-2#1)(1991-12#1)(1991-8#1)(1992-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#2)(2012-3#3)(2013-1#1)
strongly coupled##7##2##(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#1)(2009-9#1)
strongly decreased##7##2##(1990-12#1)(1992-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
strongly depend on the##3##4##(1993-11#1)(2008-10#1)(2008-5#1)
strongly depend on##6##3##(1990-11#1)(1993-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
strongly depended on the##2##4##(2008-10#1)(2011-2#1)
strongly depended on##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
strongly dependent on both##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
strongly dependent on the##19##4##(1990-8#1)(1995-6#1)(1995-8#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#1)
strongly dependent on##31##3##(1990-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(2007-11#2)(2008-10#7)(2008-2#2)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
strongly dependent upon##2##3##(2008-10#2)
strongly dependent##34##2##(1990-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(2007-11#2)(2008-10#10)(2008-2#2)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
strongly depends on the##5##4##(1990-5#1)(2008-3#2)(2008-6#1)(2009-3#1)
strongly depends on##6##3##(1990-5#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)
strongly differed between##2##3##(2008-11#1)(2008-8#1)
strongly differentiated##2##2##(1997-7#1)(2008-10#1)
strongly dispersion-managed##8##2##(2007-11#5)(2007-12#3)
strongly enhance the##3##3##(2007-12#1)(2008-10#2)
strongly enhance##4##2##(1995-2#1)(2007-12#1)(2008-10#2)
strongly enhanced by##4##3##(1995-3#1)(2008-10#2)(2008-3#1)
strongly enhanced##10##2##(1991-2#1)(1994-11#1)(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
strongly expressed in the##2##4##(1994-9#1)(1996-2#1)
strongly expressed in##5##3##(1992-12#1)(1994-9#1)(1996-2#1)(2012-12#1)(2012-2#1)
strongly expressed##6##2##(1992-12#1)(1994-9#1)(1996-2#1)(2008-9#1)(2012-12#1)(2012-2#1)
strongly favor##2##2##(1997-5#1)(2012-12#1)
strongly fluorescent##2##2##(2008-10#2)
strongly focused on##2##3##(2009-5#1)(2011-2#1)
strongly focused##5##2##(2007-11#2)(2007-12#1)(2009-5#1)(2011-2#1)
strongly from##3##2##(2007-12#2)(2008-2#1)
strongly immunostained##2##2##(2008-6#1)(2008-9#1)
strongly improved##2##2##(2007-11#1)(2011-1#1)
strongly in the##2##3##(1994-8#1)(2008-10#1)
strongly in##5##2##(1994-8#1)(1995-5#1)(2008-10#1)(2010-12#1)(2012-2#1)
strongly increased##5##2##(1993-8#1)(1995-12#1)(1995-3#1)(2012-2#1)(2013-1#1)
strongly indicate##3##2##(1991-12#1)(1993-8#1)(2008-10#1)
strongly indicated##2##2##(2008-10#1)(2008-3#1)
strongly indicates that##3##3##(1990-2#1)(2011-2#1)(2013-1#1)
strongly indicates##4##2##(1990-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
strongly indicating that the##2##4##(1994-7#1)(2008-10#1)
strongly indicating that##3##3##(1994-7#1)(2008-10#2)
strongly induced##2##2##(2008-10#2)
strongly influence the##6##3##(2008-10#2)(2008-3#1)(2008-9#2)(2009-2#1)
strongly influence##10##2##(1992-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)
strongly influenced by the##3##4##(1996-4#1)(2008-11#1)(2008-8#1)
strongly influenced by##15##3##(1991-9#1)(1995-3#1)(1996-4#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#3)(2010-4#1)(2013-1#1)
strongly influenced the##2##3##(1993-3#1)(2008-10#1)
strongly influenced##17##2##(1991-9#1)(1993-3#1)(1995-3#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#3)(2010-4#1)(2013-1#1)
strongly influences the##2##3##(2008-9#1)(2012-12#1)
strongly influences##4##2##(2007-11#1)(2008-2#1)(2008-9#1)(2012-12#1)
strongly inhibited by##10##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-12#1)(1993-9#2)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)
strongly inhibited growth##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
strongly inhibited in##2##3##(1995-2#1)(1996-2#1)
strongly inhibited the growth of##2##5##(1992-8#1)(2010-6#1)
strongly inhibited the##6##3##(1992-8#2)(1995-6#2)(1997-7#1)(2010-6#1)
strongly inhibited##35##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#4)(2010-6#1)(2011-2#1)(2013-1#1)
strongly interacting##2##2##(1990-12#1)(2008-9#1)
strongly linked to##4##3##(1991-12#1)(2009-7#1)(2009-8#1)(2010-5#1)
strongly linked##5##2##(1991-12#1)(2007-8#1)(2009-7#1)(2009-8#1)(2010-5#1)
strongly localized##3##2##(2007-11#1)(2009-5#1)(2012-12#1)
strongly on the##18##3##(1992-8#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#3)(2008-9#1)
strongly on##23##2##(1992-8#1)(2007-11#6)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-9#1)(2010-7#1)(2013-1#1)
strongly overlapped##2##2##(2008-10#2)
strongly overlapping##2##2##(2008-10#2)
strongly pH-dependent##2##2##(2008-10#1)(2012-2#1)
strongly positive for##4##3##(1991-9#1)(1993-8#1)(2007-5#1)(2008-5#1)
strongly positive##9##2##(1991-9#1)(1993-12#1)(1993-8#1)(1994-7#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
strongly predicted##3##2##(2009-9#1)(2013-1#2)
strongly preferred to##2##3##(2008-10#1)(2009-5#1)
strongly promote##2##2##(2008-8#1)(2009-8#1)
strongly recommended##6##2##(2008-11#2)(2008-7#2)(2010-8#1)(2011-2#1)
strongly reduce the##2##3##(2008-2#1)(2008-3#1)
strongly reduced by##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
strongly reduced in##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
strongly reduced##17##2##(1992-6#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-8#1)
strongly reduces the##2##3##(2008-10#1)(2011-1#1)
strongly reduces##5##2##(1994-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
strongly reducing##4##2##(2008-10#3)(2008-3#1)
strongly related to the##8##4##(1991-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2011-2#1)
strongly related to##15##3##(1991-12#1)(2007-10#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#2)(2013-8#1)
strongly retained##2##2##(2008-10#1)(2010-5#1)
strongly scattering media##2##3##(1992-8#1)(2008-2#1)
strongly scattering##3##2##(1992-8#1)(2007-11#1)(2008-2#1)
strongly stabilizing##3##2##(1991-7#1)(2008-9#2)
strongly stimulated the##2##3##(1994-9#1)(1997-2#1)
strongly stimulated##5##2##(1993-8#1)(1994-8#1)(1994-9#1)(1997-2#2)
strongly stimulates##2##2##(2007-7#1)(2010-11#1)
strongly suggest a##2##3##(1993-12#1)(2009-2#1)
strongly suggest an##3##3##(1991-2#1)(2008-2#1)(2009-12#1)
strongly suggest that Si##2##4##(2008-10#2)
strongly suggest that the##9##4##(1991-12#1)(1993-6#1)(1994-6#1)(1996-5#1)(1997-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
strongly suggest that##32##3##(1990-4#1)(1990-7#1)(1991-12#3)(1992-12#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-4#2)(2008-10#4)(2008-11#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-1#1)
strongly suggest the##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2010-11#1)
strongly suggest##42##2##(1990-4#1)(1990-7#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-4#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
strongly suggested that##5##3##(1990-5#1)(1993-9#1)(2008-10#1)(2008-7#1)(2010-12#1)
strongly suggested##9##2##(1990-5#1)(1993-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
strongly suggestive of##2##3##(2008-7#1)(2008-8#1)
strongly suggests that both##2##4##(2008-8#1)(2009-3#1)
strongly suggests that the##5##4##(1990-12#1)(1993-6#1)(1995-5#1)(1995-8#1)(2008-5#1)
strongly suggests that these##2##4##(1995-2#1)(2008-12#1)
strongly suggests that##15##3##(1990-12#1)(1993-6#1)(1995-2#1)(1995-5#2)(1995-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2012-3#1)
strongly suggests the##2##3##(1990-5#1)(1994-12#1)
strongly suggests##18##2##(1990-12#1)(1990-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2012-3#1)
strongly support the hypothesis that##2##5##(1994-8#1)(1995-12#1)
strongly support the##12##3##(1992-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
strongly support##16##2##(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-5#1)(1997-7#2)(1997-8#1)(2008-10#3)(2008-5#1)(2012-3#1)(2013-1#1)
strongly supported##8##2##(1993-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
strongly supports##2##2##(1997-2#1)(2012-2#1)
strongly suppressed##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
strongly suppresses##2##2##(1992-6#1)(2009-12#1)
strongly that the##2##3##(1991-8#1)(2008-7#1)
strongly that##7##2##(1991-8#1)(1992-3#1)(1995-1#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
strongly the##4##2##(1991-9#1)(2008-10#2)(2008-5#1)
strongly to the##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
strongly to##10##2##(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#2)(2010-6#1)(2011-2#1)(2012-2#1)
strongly toxic##2##2##(1992-3#1)(2008-8#1)
strongly turbid suspensions##2##3##(2008-3#2)
strongly warranted##2##2##(2007-6#1)(2011-2#1)
strongly with a##2##3##(1993-6#1)(2008-10#1)
strongly with an##2##3##(1993-6#1)(2008-3#1)
strongly with depression##2##3##(2010-2#1)(2012-1#1)
strongly with the##5##3##(1990-5#1)(2007-12#1)(2008-10#2)(2008-11#1)
strongly with##32##2##(1990-5#1)(1992-12#1)(1993-2#2)(1993-6#2)(1994-2#1)(1994-5#1)(1997-3#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-4#1)
strongly##796##1##(1990-11#4)(1990-12#5)(1990-2#2)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#3)(1991-11#1)(1991-12#7)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-11#1)(1992-12#6)(1992-3#6)(1992-4#2)(1992-6#4)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#5)(1993-8#8)(1993-9#4)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#4)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#4)(1995-5#6)(1995-6#6)(1995-8#5)(1996-1#2)(1996-12#1)(1996-2#6)(1996-4#2)(1996-5#2)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#2)(2006-6#1)(2007-10#4)(2007-11#29)(2007-12#21)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#156)(2008-11#34)(2008-12#5)(2008-2#23)(2008-3#42)(2008-4#7)(2008-5#16)(2008-6#5)(2008-7#16)(2008-8#39)(2008-9#24)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#5)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#8)(2011-2#24)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#16)(2012-3#11)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#8)
strongylocentrotid##2##1##(2009-2#2)
strontium 89##7##2##(2007-11#7)
strontium and lanthanum##2##3##(2008-10#2)
strontium barium niobate crystal##4##4##(2007-11#2)(2008-3#2)
strontium barium niobate##9##3##(2007-11#2)(2007-12#1)(2008-3#6)
strontium ion##4##2##(2008-10#4)
strontium or lanthanum was##2##4##(2008-10#2)
strontium or lanthanum##4##3##(2008-10#4)
strontium##44##1##(1993-11#1)(2007-11#10)(2007-12#1)(2008-10#24)(2008-3#6)(2012-2#2)
strontium(II)##2##1##(2008-10#2)
strontium-89##2##1##(2007-11#2)
strontium/calcium ratios##2##2##(1992-7#2)
struck a##2##2##(2008-7#1)(2009-10#1)
struck by the##2##3##(1993-6#1)(1997-4#1)
struck by##4##2##(1993-6#1)(1997-4#1)(2008-12#1)(2008-2#1)
struck##8##1##(1993-3#1)(1993-6#1)(1997-4#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)
structural RNA##2##2##(1995-8#1)(2013-1#1)
structural abnormalities of the##3##4##(1996-2#1)(2007-12#1)(2010-8#1)
structural abnormalities##9##2##(1996-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-8#1)(2013-1#1)(2013-7#1)
structural abnormality##2##2##(1996-12#1)(2008-7#1)
structural alignment of##2##3##(1997-6#1)(2011-2#1)
structural alignments##2##2##(2011-3#2)
structural alteration of the##2##4##(1992-9#1)(1995-12#1)
structural alteration##4##2##(1992-9#1)(1995-12#1)(1995-2#1)(2013-8#1)
structural alterations##4##2##(1993-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
structural analogues##2##2##(1992-6#1)(2010-1#1)
structural analysis and##2##3##(2008-5#1)(2010-11#1)
structural analysis of the Yersinia##2##5##(2013-8#2)
structural analysis of the##3##4##(2008-11#1)(2013-8#2)
structural analysis of##9##3##(1993-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-1#2)(2013-8#3)
structural analysis##19##2##(1993-8#1)(1994-6#1)(1997-9#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#3)
structural and biochemical##2##3##(2008-10#1)(2012-1#1)
structural and expressional##2##3##(1993-11#1)(2008-8#1)
structural and functional analyses##2##4##(1995-6#1)(2012-2#1)
structural and functional analysis##3##4##(1993-6#1)(2008-10#1)(2008-9#1)
structural and functional changes##2##4##(2008-5#2)
structural and functional plasticity##2##4##(2008-1#1)(2012-12#1)
structural and functional properties of##2##5##(2008-5#1)(2008-8#1)
structural and functional properties##3##4##(2008-5#1)(2008-8#1)(2009-10#1)
structural and functional##32##3##(1990-5#1)(1993-6#2)(1995-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
structural and magnetic##2##3##(1996-2#1)(2007-11#1)
structural and material##2##3##(2007-12#1)(2009-7#1)
structural and##61##2##(1990-12#1)(1990-5#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-6#2)(1995-12#2)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#1)
structural anisotropy##2##2##(2008-2#1)(2008-7#1)
structural anomalies##2##2##(2008-1#1)(2008-2#1)
structural aspects of##2##3##(2009-12#1)(2013-1#1)
structural aspects##3##2##(2008-8#1)(2009-12#1)(2013-1#1)
structural basis for the##3##4##(1992-10#1)(1993-11#2)
structural basis for##6##3##(1992-10#1)(1992-4#1)(1993-11#2)(1995-2#1)(1997-4#1)
structural basis##14##2##(1992-10#1)(1992-4#1)(1993-11#2)(1993-8#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-9#2)(2008-4#2)(2008-9#1)(2009-7#1)
structural brain##2##2##(1996-5#1)(2008-4#1)
structural carbohydrates##2##2##(2008-10#1)(2010-2#1)
structural cardiac disease##2##3##(2010-8#1)(2011-2#1)
structural change of##4##3##(2008-10#2)(2008-8#2)
structural change##14##2##(1991-5#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#3)(2009-5#1)(2011-2#1)
structural changes as##2##3##(1993-8#1)(2008-9#1)
structural changes at the##3##4##(1995-5#1)(2009-8#1)(2013-1#1)
structural changes in the##13##4##(1990-7#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-5#2)(1996-3#1)(2008-10#3)(2012-1#1)(2013-1#1)
structural changes in##21##3##(1990-7#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-6#1)(1995-5#4)(1996-3#1)(2008-10#4)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
structural changes occurring##3##3##(1991-3#1)(1994-2#1)(2008-5#1)
structural changes of the##3##4##(1992-3#1)(2010-4#1)(2011-2#1)
structural changes of##7##3##(1992-3#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)
structural changes that##3##3##(1997-1#1)(2008-3#1)(2012-12#1)
structural changes##66##2##(1990-7#2)(1991-12#1)(1991-3#2)(1991-5#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#6)(1996-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
structural characteristics of the##3##4##(2008-11#1)(2008-8#1)(2013-7#1)
structural characteristics of##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
structural characteristics##12##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
structural characterization by##2##3##(1990-2#1)(2008-10#1)
structural characterization of the##6##4##(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-4#1)
structural characterization of##10##3##(1993-8#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-4#1)
structural characterization##15##2##(1990-2#1)(1993-11#1)(1993-8#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-4#1)(2009-9#1)
structural classes##3##2##(1993-6#1)(2008-11#1)(2008-4#1)
structural comparison##3##2##(1992-11#1)(1992-8#1)(2008-7#1)
structural component of##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
structural component##7##2##(1992-3#1)(1995-2#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#2)
structural components of the##2##4##(1997-8#1)(2008-8#1)
structural components of##4##3##(1992-5#1)(1997-8#1)(2008-8#1)(2013-1#1)
structural components##7##2##(1992-5#1)(1997-8#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2013-1#1)
structural composition of##2##3##(2008-10#1)(2008-3#1)
structural composition##3##2##(2008-10#2)(2008-3#1)
structural constraints on the##2##4##(1994-5#1)(2009-5#1)
structural constraints##4##2##(1994-5#2)(2008-7#1)(2009-5#1)
structural crisis##2##2##(2013-1#2)
structural damage in##2##3##(1990-7#2)
structural damage##5##2##(1990-7#2)(2010-5#1)(2013-8#2)
structural data on complexes between##2##5##(2009-2#1)(2013-1#1)
structural data##10##2##(1990-12#1)(1990-7#1)(2007-11#1)(2008-10#1)(2008-7#2)(2009-11#1)(2009-2#1)(2011-2#1)(2013-1#1)
structural database##2##2##(2008-10#2)
structural defects in the##2##4##(1995-3#1)(2012-12#1)
structural defects in##3##3##(1995-3#1)(2008-2#1)(2012-12#1)
structural defects##6##2##(1995-3#1)(1996-12#2)(1997-6#1)(2008-2#1)(2012-12#1)
structural defense responses##2##3##(2008-10#2)
structural defense##3##2##(2008-10#3)
structural deficit in the##2##4##(1996-7#2)
structural definition of##2##3##(2008-4#2)
structural definition##3##2##(2008-10#1)(2008-4#2)
structural derivative of##2##3##(1996-9#1)(2008-10#1)
structural design of cemented doublets##2##5##(2008-3#2)
structural design##3##2##(2008-3#3)
structural detail##3##2##(1994-5#1)(1997-2#1)(2008-7#1)
structural details of the##2##4##(1993-8#1)(2007-7#1)
structural details##4##2##(1992-6#1)(1993-8#1)(1994-2#1)(2007-7#1)
structural determinants for##2##3##(2008-8#1)(2013-1#1)
structural determinants of##2##3##(1992-12#1)(2008-4#1)
structural determinants##5##2##(1992-12#2)(2008-4#1)(2008-8#1)(2013-1#1)
structural determination of##2##3##(1994-5#1)(1995-11#1)
structural determination##3##2##(1994-5#1)(1995-11#1)(1997-7#1)
structural differences among the##2##4##(1993-11#1)(2012-3#1)
structural differences among##3##3##(1991-8#1)(1993-11#1)(2012-3#1)
structural differences between##2##3##(2008-10#1)(2008-5#1)
structural differences of##2##3##(2007-11#1)(2008-7#1)
structural differences##16##2##(1991-2#1)(1991-8#1)(1993-11#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-5#3)(2008-7#2)(2012-2#1)(2012-3#1)(2013-7#1)
structural diversity of the##2##4##(1992-6#1)(2008-7#1)
structural diversity of##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
structural diversity##5##2##(1992-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)
structural domains of##2##3##(1990-8#1)(1995-6#1)
structural domains##5##2##(1990-5#1)(1990-8#1)(1995-6#2)(2009-7#1)
structural dynamics##6##2##(1990-8#1)(2008-10#2)(2008-4#2)(2008-7#1)
structural effects##2##2##(1994-3#1)(2008-10#1)
structural elements and##2##3##(1995-5#1)(1997-4#1)
structural elements of the tooth##2##5##(1997-4#2)
structural elements of the##4##4##(1994-5#1)(1996-5#1)(1997-4#2)
structural elements of##6##3##(1992-4#1)(1994-5#1)(1996-5#1)(1997-4#2)(2012-12#1)
structural elements##17##2##(1991-12#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-5#2)(1996-5#1)(1997-4#4)(2008-9#1)(2009-3#1)(2010-4#1)(2012-12#2)
structural elucidation of##2##3##(2008-10#1)(2011-2#1)
structural elucidation##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
structural equation modeling (SEM)##2##4##(2009-7#1)(2010-2#1)
structural equation modeling approach##2##4##(2013-8#2)
structural equation modeling##11##3##(2008-11#1)(2008-12#1)(2009-11#1)(2009-7#2)(2010-2#2)(2010-6#1)(2012-3#1)(2013-8#2)
structural equation##14##2##(2008-11#1)(2008-12#2)(2009-11#1)(2009-7#2)(2010-2#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#3)
structural factors##5##2##(1990-9#1)(1996-1#1)(2008-10#1)(2009-3#1)(2012-12#1)
structural failure##2##2##(2008-6#1)(2009-7#1)
structural families##2##2##(1994-9#1)(2008-8#1)
structural feature##5##2##(1991-8#1)(1994-11#1)(1995-3#1)(1995-8#1)(2008-4#1)
structural features of this##2##4##(1993-1#1)(1996-10#1)
structural features of##9##3##(1992-10#1)(1993-1#1)(1994-11#1)(1996-10#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
structural features that are##2##4##(1994-5#1)(2010-10#1)
structural features##30##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-5#2)(1994-8#1)(1996-10#1)(1997-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
structural functions##3##2##(2006-4#2)(2010-11#1)
structural gene encoding##3##3##(1993-9#1)(1995-8#1)(2008-5#1)
structural gene for##2##3##(1992-3#1)(1994-12#1)
structural gene of##3##3##(1995-6#1)(2008-8#2)
structural gene##20##2##(1990-5#2)(1990-8#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#2)(1995-6#2)(1995-8#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#3)
structural genes were isolated##2##4##(1990-11#1)(2008-8#1)
structural genes were##3##3##(1990-11#1)(1993-9#1)(2008-8#1)
structural genes##11##2##(1990-11#2)(1990-5#1)(1993-9#1)(1994-8#1)(2008-11#1)(2008-8#2)(2008-9#2)(2011-2#1)
structural genomics effort##2##3##(2008-4#1)(2008-7#1)
structural genomics##7##2##(2008-4#1)(2008-7#5)(2010-11#1)
structural heterogeneity##3##2##(1993-11#1)(2008-11#1)(2010-11#1)
structural homology to##2##3##(1993-8#1)(1994-8#1)
structural homology with##3##3##(1993-3#1)(1993-9#1)(1995-2#1)
structural homology##5##2##(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)
structural imaging##2##2##(2008-1#1)(2010-12#1)
structural inequalities##2##2##(2008-11#1)(2011-1#1)
structural information about the##3##4##(1990-12#1)(2008-7#1)(2008-8#1)
structural information available##2##3##(1991-11#1)(2013-1#1)
structural information on##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
structural information##19##2##(1990-12#1)(1991-11#1)(1991-6#1)(1993-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
structural injury##2##2##(2007-10#1)(2011-2#1)
structural integrity of##4##3##(1990-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
structural integrity##7##2##(1990-12#1)(2008-4#1)(2008-7#1)(2008-9#3)(2010-10#1)
structural interactions##3##2##(1995-5#1)(2012-2#2)
structural interpretation of the##2##4##(2007-11#2)
structural isomers##2##2##(1996-2#1)(2008-10#1)
structural mimic##2##2##(1995-3#1)(2012-12#1)
structural model of PBS##2##4##(2008-8#2)
structural model of the##2##4##(1991-9#1)(1995-2#1)
structural model of##5##3##(1991-9#1)(1995-2#1)(2008-8#2)(2011-1#1)
structural model was##3##3##(2008-4#1)(2008-6#1)(2012-2#1)
structural model##13##2##(1991-9#1)(1992-9#1)(1993-11#2)(1994-5#1)(1995-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-1#1)(2012-2#1)
structural models##3##2##(2009-4#1)(2010-12#1)(2010-4#1)
structural modification of##2##3##(1992-9#1)(2008-9#1)
structural modification##4##2##(1992-3#1)(1992-9#1)(1995-3#1)(2008-9#1)
structural modifications of##2##3##(2008-10#1)(2012-3#1)
structural modifications##7##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-3#2)
structural motif##3##2##(1992-6#1)(1993-2#1)(1995-6#1)
structural motifs of##2##3##(1997-8#1)(2013-1#1)
structural motifs##6##2##(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#1)(1997-9#1)(2013-1#1)
structural or##2##2##(1997-3#1)(2008-4#1)
structural organization of the##6##4##(1991-6#1)(1993-9#1)(2008-10#1)(2008-5#2)(2009-8#1)
structural organization of##12##3##(1991-6#1)(1993-2#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-8#1)(2012-12#1)
structural organization##19##2##(1990-5#1)(1991-6#1)(1993-2#1)(1993-9#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-8#2)(2010-8#1)(2012-12#1)
structural origin of##2##3##(1994-5#1)(2007-11#1)
structural parameterization##2##2##(1997-2#2)
structural parameters for the##2##4##(2008-10#2)
structural parameters of##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
structural parameters##12##2##(1990-4#1)(1995-5#1)(2007-12#4)(2008-10#4)(2008-3#1)(2011-1#1)
structural pattern##2##2##(1994-12#1)(1994-3#1)
structural patterns##2##2##(1996-3#1)(2012-2#1)
structural plasticity##2##2##(2008-7#1)(2012-2#1)
structural properties that##2##3##(1991-6#1)(2012-1#1)
structural properties##13##2##(1990-2#1)(1991-6#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2010-11#1)(2010-2#2)(2012-1#1)(2012-2#1)
structural protein Gag and##3##4##(2011-3#3)
structural protein##13##2##(1993-12#2)(1993-9#1)(1995-2#1)(2008-10#2)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#3)
structural proteins of##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
structural proteins##9##2##(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
structural rearrangements##4##2##(1993-9#2)(1995-5#1)(2008-10#1)
structural regions##2##2##(1993-6#1)(2008-7#1)
structural relaxation##2##2##(1995-3#1)(2008-10#1)
structural remodeling##2##2##(2008-7#1)(2012-12#1)
structural reorganization of the##2##4##(2011-2#1)(2013-1#1)
structural reorganization##4##2##(1995-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
structural requirements for##5##3##(1990-5#1)(1992-9#1)(1994-12#1)(1994-6#1)(2011-2#1)
structural requirements##6##2##(1990-5#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(2011-2#1)
structural response##2##2##(2008-10#2)
structural rigidity##2##2##(2008-10#1)(2009-12#1)
structural role in the##2##4##(1993-8#1)(2008-10#1)
structural role in##3##3##(1993-8#1)(1995-6#1)(2008-10#1)
structural role of##3##3##(1992-3#2)(2008-10#1)
structural role##9##2##(1992-3#2)(1993-8#1)(1995-6#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
structural similarities##6##2##(1990-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(2008-10#1)(2009-4#1)
structural similarity between the##2##4##(1990-4#1)(1995-3#1)
structural similarity of##3##3##(1990-7#1)(1991-6#1)(2008-10#1)
structural similarity to##4##3##(1992-6#1)(1996-2#1)(2010-10#2)
structural similarity##12##2##(1990-4#1)(1990-7#1)(1991-6#1)(1992-5#1)(1992-6#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-10#2)(2010-8#1)(2011-1#1)
structural solarization##4##2##(2008-10#4)
structural stability of##5##3##(1995-8#4)(2008-10#1)
structural stability##11##2##(1993-12#1)(1995-2#1)(1995-8#4)(2007-11#1)(2008-10#2)(2008-11#1)(2009-8#1)
structural states##2##2##(1992-6#2)
structural studies by##2##3##(1993-11#1)(2012-2#1)
structural studies of##5##3##(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
structural studies##11##2##(1993-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
structural study##2##2##(1991-12#1)(2009-8#1)
structural support##2##2##(2010-6#1)(2012-2#1)
structural types##2##2##(1992-6#1)(1996-2#1)
structural variants##3##2##(1994-8#1)(1997-9#1)(2013-1#1)
structural variation of##2##3##(2009-11#1)(2013-8#1)
structural variation##3##2##(2009-11#1)(2012-12#1)(2013-8#1)
structural variations##2##2##(1992-4#1)(2009-12#1)
structural##957##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#7)(1990-7#7)(1990-8#4)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-5#5)(1991-6#8)(1991-8#4)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#7)(1992-3#12)(1992-4#4)(1992-5#4)(1992-6#13)(1992-8#5)(1992-9#7)(1993-1#2)(1993-11#15)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#7)(1993-8#13)(1993-9#10)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#3)(1994-5#14)(1994-6#3)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#14)(1995-3#9)(1995-5#18)(1995-6#10)(1995-8#8)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#9)(1996-3#4)(1996-5#5)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#14)(1997-6#8)(1997-7#3)(1997-8#4)(1997-9#6)(2006-4#2)(2007-10#1)(2007-11#14)(2007-12#17)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#100)(2008-11#20)(2008-12#4)(2008-2#16)(2008-3#14)(2008-4#29)(2008-5#24)(2008-6#5)(2008-7#52)(2008-8#29)(2008-9#20)(2009-10#6)(2009-11#5)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#8)(2009-6#1)(2009-7#9)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#7)(2010-12#2)(2010-2#10)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#8)(2011-1#8)(2011-2#23)(2011-3#8)(2012-1#7)(2012-12#13)(2012-2#30)(2012-3#6)(2012-9#1)(2013-1#23)(2013-7#4)(2013-8#18)
structural-functional##2##1##(2010-8#1)(2011-7#1)
structurally and functionally##6##3##(1993-3#1)(1993-6#1)(2007-12#2)(2008-11#1)(2009-9#1)
structurally and##10##2##(1993-3#1)(1993-6#1)(1996-2#1)(1997-7#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-9#1)(2010-10#1)
structurally characterized##6##2##(1994-5#3)(1996-2#1)(1997-7#1)(2008-10#1)
structurally complex##2##2##(2011-1#1)(2012-2#1)
structurally defined##2##2##(2010-4#2)
structurally different from##2##3##(2007-12#1)(2013-7#1)
structurally different##6##2##(2007-12#2)(2008-10#1)(2009-12#2)(2013-7#1)
structurally dissimilar##4##2##(1992-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
structurally distinct##6##2##(1990-8#1)(1992-8#1)(1995-2#1)(1996-2#1)(2008-5#1)(2009-12#1)
structurally diverse##2##2##(1992-8#1)(2008-11#1)
structurally heterogeneous##2##2##(2008-1#1)(2010-4#1)
structurally homologous##2##2##(1992-8#1)(1993-2#1)
structurally mimic##2##2##(1995-3#1)(2012-2#1)
structurally normal heart##6##3##(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#1)
structurally normal##8##2##(1994-8#1)(2008-12#2)(2008-7#1)(2009-5#2)(2009-7#1)(2011-2#1)
structurally novel##2##2##(1991-1#1)(1992-8#1)
structurally related to the AGL2 family and##2##7##(1997-2#1)(1997-8#1)
structurally related to the##3##4##(1994-8#1)(1997-2#1)(1997-8#1)
structurally related to##9##3##(1991-12#1)(1994-8#1)(1995-5#2)(1997-2#2)(1997-8#1)(2008-11#1)(2008-4#1)
structurally related##27##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#3)
structurally similar compounds##2##3##(2007-11#1)(2008-10#1)
structurally similar to the##2##4##(1991-6#1)(2010-10#1)
structurally similar to##6##3##(1991-6#1)(1993-8#1)(2007-12#1)(2010-10#1)(2011-1#1)(2012-2#1)
structurally similar##14##2##(1990-5#1)(1990-8#1)(1991-6#1)(1993-8#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
structurally unique##3##2##(1995-11#1)(1995-6#1)(2010-7#1)
structurally unrelated##2##2##(2008-11#1)(2010-8#1)
structurally##133##1##(1990-5#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-8#5)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#3)(1996-2#3)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#8)(2008-8#2)(2009-12#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)
structurally-related##2##1##(1990-9#1)(2008-5#1)
structure according to##2##3##(2008-10#2)
structure across##4##2##(1992-6#1)(2009-2#1)(2012-3#1)(2013-1#1)
structure activity relationship##2##3##(2007-11#1)(2011-1#1)
structure activity##3##2##(2007-11#1)(2011-1#1)(2012-2#1)
structure affects insect herbivore species richness and abundance##2##8##(2013-7#2)
structure affects##3##2##(2010-3#1)(2013-7#2)
structure after##2##2##(2007-8#1)(2010-8#1)
structure against##2##2##(2008-4#1)(2011-3#1)
structure allow##2##2##(1995-5#1)(2011-1#1)
structure allows the##2##3##(1992-12#1)(2008-3#1)
structure allows##4##2##(1992-12#1)(2008-3#2)(2008-8#1)
structure among##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
structure analyses##2##2##(2008-10#1)(2010-2#1)
structure analysis of##6##3##(1993-8#1)(1996-5#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-8#1)
structure analysis##15##2##(1993-8#1)(1994-8#1)(1996-5#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#3)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
structure and a##4##3##(1992-12#1)(1992-8#1)(2012-2#1)(2013-1#1)
structure and activity##2##3##(2008-2#1)(2013-1#1)
structure and an##2##3##(1991-6#1)(2008-7#1)
structure and are##2##3##(1990-6#1)(1992-8#1)
structure and behavior of##2##4##(2008-2#1)(2008-5#1)
structure and biological##2##3##(2008-5#1)(2010-4#1)
structure and can##3##3##(1990-12#1)(2008-7#1)(2012-1#1)
structure and characteristics of a##2##5##(1993-3#1)(2008-10#1)
structure and chemical composition##2##4##(2008-3#1)(2009-7#1)
structure and chemical##3##3##(2008-3#1)(2009-7#1)(2012-2#1)
structure and composition##5##3##(1997-2#1)(2008-3#1)(2009-10#1)(2010-7#1)(2012-2#1)
structure and distribution##2##3##(2007-12#1)(2008-11#1)
structure and dynamics of the##4##5##(1991-5#1)(2007-12#1)(2008-10#1)(2008-4#1)
structure and dynamics of##9##4##(1991-5#2)(1992-3#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#1)
structure and dynamics##14##3##(1991-5#2)(1992-3#1)(2007-12#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-9#1)(2009-8#1)(2012-3#1)
structure and enzymatic activity##2##4##(1992-11#1)(2008-7#1)
structure and expression of the##4##5##(1990-11#1)(1991-9#1)(1992-6#1)(1993-12#1)
structure and expression##8##3##(1990-11#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#1)(1997-6#1)(1997-7#1)(1997-9#1)
structure and folding##2##3##(2008-4#1)(2008-7#1)
structure and function in the##3##5##(1995-2#1)(2009-5#2)
structure and function in##7##4##(1995-2#1)(2008-5#2)(2009-1#1)(2009-5#2)(2012-12#1)
structure and function of proteins##4##5##(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
structure and function of the##7##5##(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-12#1)
structure and function of##27##4##(1992-11#1)(1992-3#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
structure and function##60##3##(1991-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-2#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
structure and hydration##2##3##(1994-3#2)
structure and in##4##3##(2008-1#1)(2008-12#1)(2008-6#1)(2012-3#1)
structure and interactions##2##3##(1992-9#1)(2008-4#1)
structure and is##2##3##(2008-7#1)(2013-1#1)
structure and its##3##3##(1995-2#1)(2011-1#1)(2012-2#1)
structure and mechanism##2##3##(2008-5#2)
structure and metabolism##2##3##(1993-9#1)(2011-1#1)
structure and performance of##2##4##(2006-4#1)(2013-8#1)
structure and process##4##3##(1994-3#1)(2008-9#3)
structure and reactivity##3##3##(1995-5#1)(2007-11#1)(2009-10#1)
structure and regulation of the##2##5##(1990-5#1)(1993-2#1)
structure and regulation##3##3##(1990-5#1)(1993-2#1)(2008-4#1)
structure and sequence of##3##4##(1991-6#1)(1993-6#2)
structure and sequence##5##3##(1991-6#1)(1993-6#3)(2008-10#1)
structure and stability of##2##4##(1996-2#1)(2007-11#1)
structure and that##2##3##(2008-2#1)(2008-5#1)
structure and the##26##3##(1990-8#1)(1991-11#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-6#2)(1997-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
structure and thereby##2##3##(1993-8#1)(2012-2#1)
structure and underlying##2##3##(1995-1#1)(2008-9#1)
structure and##339##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#3)(1991-6#3)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#5)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-7#1)(1997-2#3)(1997-4#4)(1997-6#1)(1997-7#4)(1997-9#1)(2006-4#1)(2007-11#8)(2007-12#9)(2007-5#1)(2008-1#4)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#16)(2008-5#16)(2008-6#4)(2008-7#20)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#3)(2009-2#1)(2009-5#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#2)(2010-7#3)(2010-8#5)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#10)(2012-3#8)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#5)
structure and/or##2##2##(1997-3#1)(2008-10#1)
structure are important##2##3##(2008-10#2)
structure are##18##2##(1990-2#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-1#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#2)(2008-4#1)(2012-3#1)(2013-1#1)
structure around##2##2##(1991-6#1)(2008-10#1)
structure as a##4##3##(1990-11#1)(2007-12#1)(2008-2#1)(2010-2#1)
structure as determined by##2##4##(1993-11#1)(1995-6#1)
structure as the##3##3##(1990-2#1)(2008-11#1)(2008-2#1)
structure as well as##5##4##(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
structure as##21##2##(1990-11#1)(1990-2#1)(1993-11#1)(1993-6#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
structure at one##2##3##(1993-2#1)(2008-10#1)
structure at positions##2##3##(1992-3#2)
structure at the##4##3##(1990-7#1)(2008-11#1)(2008-3#1)(2012-2#1)
structure at##15##2##(1990-7#1)(1992-3#3)(1993-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)
structure based on##6##3##(1992-5#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-7#1)
structure based##8##2##(1992-12#1)(1992-5#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-7#2)
structure being##3##2##(1995-12#1)(2008-11#1)(2010-8#1)
structure between the##2##3##(1990-2#1)(1993-12#1)
structure between##5##2##(1990-2#1)(1991-5#1)(1992-9#1)(1993-12#1)(2008-11#1)
structure by the##2##3##(1996-2#1)(2008-10#1)
structure by using##2##3##(1993-11#1)(2008-3#1)
structure by##14##2##(1991-5#1)(1993-11#3)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)
structure can be used##3##4##(2008-2#2)(2009-7#1)
structure can be##13##3##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)
structure can##21##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)
structure caused by##2##3##(2008-10#1)(2008-2#1)
structure changes##2##2##(1991-5#1)(2008-7#1)
structure common to##3##3##(2008-4#2)(2008-8#1)
structure composed of##2##3##(2008-3#1)(2008-8#1)
structure consistent with##2##3##(2008-10#1)(2012-12#1)
structure consisting of a##4##4##(1993-2#1)(2007-12#1)(2008-3#1)(2008-7#1)
structure consisting of##6##3##(1993-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
structure consists of a##2##4##(1991-5#1)(1997-7#1)
structure could##2##2##(1990-5#1)(2010-4#1)
structure data##3##2##(1990-7#1)(1996-2#1)(2008-4#1)
structure determination of the##3##4##(1991-11#1)(1993-8#1)(2009-7#1)
structure determination of##6##3##(1991-11#1)(1993-8#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-8#1)
structure determination##18##2##(1991-11#2)(1992-8#1)(1993-8#2)(2008-4#3)(2008-9#2)(2009-11#1)(2009-7#5)(2010-7#1)(2012-8#1)
structure determined by##2##3##(1997-7#1)(2008-2#1)
structure determined##4##2##(1991-3#1)(1995-11#1)(1997-7#1)(2008-2#1)
structure does not##4##3##(1995-5#1)(2007-11#1)(2008-2#1)(2008-8#1)
structure does##5##2##(1995-5#1)(2007-11#2)(2008-2#1)(2008-8#1)
structure due to##2##3##(2008-8#2)
structure during the##2##3##(1997-9#1)(2011-1#1)
structure during##4##2##(1997-9#1)(2008-11#1)(2008-5#1)(2011-1#1)
structure elements##2##2##(1995-2#1)(2013-1#1)
structure elucidation of a##2##4##(1997-2#1)(2007-11#1)
structure elucidation of small molecules##2##5##(2011-2#2)
structure elucidation of the##2##4##(2008-12#1)(2008-9#1)
structure elucidation of##6##3##(1997-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2011-2#2)
structure elucidation##7##2##(1997-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2011-2#2)
structure factor##3##2##(2008-2#1)(2008-3#1)(2010-8#1)
structure features##2##2##(2008-4#1)(2013-1#1)
structure following##2##2##(1994-8#1)(1995-2#1)
structure for a##3##3##(1993-12#1)(2007-11#2)
structure for an##2##3##(2008-7#1)(2010-5#1)
structure for the##10##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
structure for##38##2##(1993-12#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-9#1)(2007-11#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
structure form##3##2##(1995-5#1)(1997-6#1)(2008-10#1)
structure formation##5##2##(1995-2#1)(2008-10#1)(2008-4#1)(2010-11#1)(2013-8#1)
structure formed by##2##3##(2008-10#1)(2012-2#1)
structure from a sample##2##4##(1994-9#1)(2007-12#1)
structure from a##4##3##(1994-9#1)(2007-12#1)(2008-3#1)(2008-5#1)
structure from##11##2##(1993-8#1)(1994-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#3)(2008-5#1)
structure has been determined for##2##5##(1993-3#1)(1994-5#1)
structure has been determined##4##4##(1992-4#1)(1993-3#1)(1994-5#1)(1996-2#1)
structure has been reported##2##4##(2007-11#1)(2010-10#1)
structure has been##13##3##(1992-4#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-4#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)(2012-3#1)
structure has##21##2##(1992-4#1)(1992-5#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-4#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-3#1)
structure have been##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
structure have##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2009-7#1)
structure in a##4##3##(1993-2#1)(2007-11#2)(2008-5#1)
structure in an##4##3##(2007-12#2)(2008-3#2)
structure in the presence of##2##5##(1995-3#1)(2009-7#1)
structure in the##30##3##(1990-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-2#1)
structure in this##2##3##(1992-6#1)(2008-11#1)
structure in which the##4##4##(1996-2#1)(1997-6#1)(2007-12#1)(2008-7#1)
structure in which##6##3##(1994-12#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-7#1)
structure in##77##2##(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-6#1)(2007-11#5)(2007-12#9)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#3)
structure includes##2##2##(1993-2#1)(2008-7#1)
structure into##2##2##(2008-7#1)(2012-3#1)
structure is a##3##3##(1994-12#1)(2008-10#1)(2008-7#1)
structure is also##3##3##(1997-5#1)(2007-11#1)(2008-10#1)
structure is formed##2##3##(2008-3#1)(2011-2#1)
structure is found##4##3##(2007-12#1)(2008-3#1)(2008-4#2)
structure is not##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
structure is presented##3##3##(1991-7#1)(2008-11#1)(2008-3#1)
structure is similar to that of##2##6##(1992-12#1)(2008-5#1)
structure is similar##4##3##(1992-12#1)(1992-4#1)(1993-8#1)(2008-5#1)
structure is the##2##3##(1994-5#1)(1995-11#1)
structure is typical##2##3##(1997-7#1)(2008-12#1)
structure is used##2##3##(2008-3#1)(2008-7#1)
structure is very similar to that##2##6##(1993-8#1)(1994-5#1)
structure is very similar to##4##5##(1993-8#1)(1994-12#1)(1994-5#1)(2010-11#1)
structure is very##5##3##(1993-8#1)(1994-12#1)(1994-5#1)(1997-2#1)(2010-11#1)
structure is##87##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-5#2)(1991-7#1)(1992-12#2)(1992-4#2)(1993-2#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#3)(2010-11#2)(2010-4#1)(2011-2#2)(2013-1#1)
structure may be##2##3##(1990-5#1)(2008-8#1)
structure may##4##2##(1990-5#1)(1996-12#1)(1996-6#1)(2008-8#1)
structure modeling##2##2##(2008-4#2)
structure near the##2##3##(2007-12#1)(2007-8#1)
structure near##3##2##(2007-12#1)(2007-8#1)(2008-8#1)
structure of A##4##3##(2008-10#1)(2011-2#2)(2013-8#1)
structure of APPI##2##3##(1991-11#2)
structure of DNA and##2##4##(2008-4#1)(2011-2#1)
structure of DNA##7##3##(1995-5#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
structure of E##3##3##(1990-5#1)(2010-8#2)
structure of Escherichia coli##2##4##(1993-8#1)(1997-6#1)
structure of Heterobasidion annosum##2##4##(2008-10#2)
structure of Jann_2411##2##3##(2010-10#2)
structure of P##4##3##(2008-10#2)(2011-2#2)
structure of PBS##2##3##(2008-8#2)
structure of Phytophthora infestans##3##4##(2008-10#3)
structure of S##4##3##(2008-10#4)
structure of X##4##3##(1993-6#1)(2008-10#3)
structure of a natural alternating d(TA)n sequence##2##7##(1997-3#2)
structure of a new##2##4##(2007-11#1)(2010-2#1)
structure of a surface##2##4##(2008-7#1)(2010-7#1)
structure of a##43##3##(1990-7#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1994-8#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-8#2)
structure of an##6##3##(1990-9#1)(1991-12#1)(1992-3#1)(1995-11#1)(2008-10#1)(2009-5#1)
structure of biological##2##3##(1994-5#1)(2010-4#1)
structure of bovine##2##3##(1991-5#1)(1993-6#1)
structure of brazzein##2##3##(2008-9#2)
structure of complex##2##3##(2007-12#1)(2011-2#1)
structure of compounds##2##3##(2008-10#2)
structure of each of the##2##5##(2007-11#1)(2010-8#1)
structure of each##4##3##(2007-11#1)(2008-10#1)(2009-5#1)(2010-8#1)
structure of employee##2##3##(1994-3#2)
structure of eukaryotic##2##3##(2008-10#1)(2008-8#1)
structure of goat##4##3##(2010-4#4)
structure of horse heart ferrocytochrome c##2##6##(1994-5#2)
structure of human recombinant interleukin-4##2##5##(1992-8#2)
structure of human##11##3##(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#2)(1994-9#1)(1995-8#1)(2008-6#1)(2009-7#1)
structure of information##2##3##(1994-2#1)(2011-1#1)
structure of inorganic##2##3##(1997-6#1)(2008-11#1)
structure of membrane##3##3##(2008-8#3)
structure of natural##2##3##(2008-8#1)(2012-3#1)
structure of neural##2##3##(1990-5#1)(2008-10#1)
structure of nucleic##2##3##(2008-10#1)(2012-2#1)
structure of nursing research programs##2##5##(2010-9#2)
structure of other##2##3##(1993-11#1)(1994-9#1)
structure of oxidized##3##3##(1993-9#1)(1994-5#2)
structure of paper##2##3##(2008-3#1)(2008-9#1)
structure of populations of##4##4##(2008-10#3)(2011-2#1)
structure of populations##6##3##(2008-10#5)(2011-2#1)
structure of rat##2##3##(1992-8#1)(1993-12#1)
structure of silk##3##3##(2012-2#3)
structure of the 5'##2##4##(1991-11#1)(1991-9#1)
structure of the N-terminal##2##4##(1990-7#1)(1992-8#1)
structure of the Peruvian scallop Argopecten purpuratus##2##7##(2013-8#2)
structure of the Ras-binding domain of##2##6##(1995-5#2)
structure of the annexin XII hexamer##2##6##(1995-11#2)
structure of the azobenzene arsonic acid compound##2##7##(2008-10#2)
structure of the brain##2##4##(2007-12#1)(2009-7#1)
structure of the chicken##2##4##(1991-6#1)(1993-2#1)
structure of the complex##2##4##(1990-5#1)(1991-5#1)
structure of the complexes##2##4##(2008-10#2)
structure of the compound##3##4##(2007-12#1)(2009-10#1)(2009-6#1)
structure of the data##2##4##(2008-3#1)(2008-6#1)
structure of the enzyme##2##4##(1990-5#1)(1997-2#1)
structure of the expressed##3##4##(1993-8#1)(1997-4#1)(2008-2#1)
structure of the first##4##4##(1993-6#1)(2010-10#2)(2013-1#1)
structure of the fungal##2##4##(2008-10#2)
structure of the gene and##2##5##(1996-2#1)(1996-8#1)
structure of the gene##3##4##(1993-2#1)(1996-2#1)(1996-8#1)
structure of the human##4##4##(1991-9#1)(1994-9#1)(2008-11#1)(2008-7#1)
structure of the inner##3##4##(2008-8#2)(2013-8#1)
structure of the liquid##2##4##(2007-11#1)(2010-8#1)
structure of the mammalian##2##4##(1990-7#1)(2008-11#1)
structure of the modified##2##4##(1997-2#1)(2008-5#1)
structure of the molecule##5##4##(1990-5#1)(1990-7#1)(1992-3#1)(2008-10#1)(2008-4#1)
structure of the natural##2##4##(2008-5#1)(2009-10#1)
structure of the new##2##4##(1997-7#1)(2007-1#1)
structure of the peptide cycle##2##5##(1994-2#2)
structure of the peptide##3##4##(1992-6#1)(1994-2#2)
structure of the planarian CNS##2##5##(2008-5#2)
structure of the protein##9##4##(1992-11#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-2#2)
structure of the rat##2##4##(2009-5#1)(2011-2#1)
structure of the trp operator##2##5##(1994-3#2)
structure of the trp##3##4##(1994-3#3)
structure of the##289##3##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#5)(1990-7#6)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#4)(1991-6#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#2)(2007-1#1)(2007-11#4)(2007-12#12)(2007-8#2)(2007-9#1)(2008-10#34)(2008-11#12)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#15)(2008-6#3)(2008-7#6)(2008-8#11)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#6)
structure of their##4##3##(2007-11#1)(2011-2#1)(2012-12#2)
structure of thermostable alpha-amylase from Bacillus licheniformis##2##7##(1997-4#2)
structure of these##11##3##(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
structure of this protein##2##4##(1991-9#1)(2009-3#1)
structure of this##8##3##(1991-9#1)(1992-3#1)(1992-8#1)(1997-3#1)(2008-10#2)(2009-3#1)(2011-2#1)
structure of viral##2##3##(2008-10#2)
structure of##783##2##(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#9)(1990-7#9)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#10)(1991-6#4)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#12)(1992-2#2)(1992-3#10)(1992-4#5)(1992-5#3)(1992-6#5)(1992-8#12)(1992-9#4)(1993-1#1)(1993-11#11)(1993-12#2)(1993-2#5)(1993-3#2)(1993-5#1)(1993-6#5)(1993-8#9)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#9)(1994-5#12)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#8)(1995-5#11)(1995-6#1)(1995-8#6)(1995-9#2)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#5)(1997-3#6)(1997-4#6)(1997-6#6)(1997-7#5)(1997-8#3)(1997-9#1)(2007-1#1)(2007-11#12)(2007-12#26)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#119)(2008-11#25)(2008-12#8)(2008-2#10)(2008-3#17)(2008-4#12)(2008-5#21)(2008-6#5)(2008-7#17)(2008-8#44)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#6)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#2)(2010-10#10)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#10)(2010-5#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#29)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#12)(2012-3#7)(2013-1#11)(2013-7#5)(2013-8#14)
structure on the##8##3##(1994-11#1)(2007-12#1)(2008-10#4)(2009-9#1)(2013-1#1)
structure on##21##2##(1994-11#1)(1995-11#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-1#1)(2013-1#2)
structure or function##4##3##(1991-5#1)(1993-11#1)(2007-12#1)(2012-2#1)
structure or the##3##3##(1992-8#1)(1994-11#1)(2008-10#1)
structure or##11##2##(1991-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
structure parameter##2##2##(2008-2#2)
structure parameters##5##2##(2008-10#2)(2008-6#1)(2013-7#1)(2013-8#1)
structure prediction##6##2##(1990-4#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
structure remains##2##2##(2009-7#1)(2012-2#1)
structure requirements for##2##3##(2008-10#1)(2008-8#1)
structure reveals that##2##3##(1991-12#1)(2010-10#1)
structure reveals##4##2##(1991-12#1)(1995-8#1)(1996-2#1)(2010-10#1)
structure should be##2##3##(2008-3#1)(2008-8#1)
structure showed##2##2##(2008-8#1)(2008-9#1)
structure shows that the##2##4##(1995-11#1)(2010-4#1)
structure shows that##4##3##(1995-11#1)(1995-5#2)(2010-4#1)
structure shows##5##2##(1995-11#1)(1995-5#2)(2007-12#1)(2010-4#1)
structure similar to that of human##2##6##(1993-11#1)(2008-6#1)
structure similar to that of the##3##6##(1992-6#1)(2008-2#1)(2008-5#1)
structure similar to that of##6##5##(1992-6#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
structure similar to##12##3##(1990-11#1)(1990-7#1)(1992-6#1)(1993-11#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)
structure solution##2##2##(1997-7#1)(2006-4#1)
structure suggests that##3##3##(1995-2#1)(1997-7#1)(2008-8#1)
structure suggests##4##2##(1995-2#1)(1997-7#1)(2008-6#1)(2008-8#1)
structure termed##2##2##(2008-7#1)(2008-8#1)
structure than##4##2##(2008-10#2)(2008-4#1)(2012-2#1)
structure that enables##2##3##(2007-11#1)(2012-12#1)
structure that is##6##3##(1993-12#1)(1994-5#1)(2007-12#1)(2008-3#1)(2009-9#1)(2011-2#1)
structure that##36##2##(1991-9#2)(1993-12#1)(1994-1#1)(1994-5#1)(1996-2#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
structure the##5##2##(2007-12#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)
structure they##2##2##(2007-12#1)(2008-10#1)
structure through##3##2##(2008-8#2)(2011-2#1)
structure throughout##2##2##(2007-12#1)(2010-5#1)
structure to facilitate##2##3##(1996-1#1)(2010-10#1)
structure to produce##2##3##(2008-5#1)(2008-9#1)
structure to##25##2##(1990-5#2)(1991-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-1#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-3#1)(2012-3#1)(2012-5#1)
structure under##3##2##(2008-3#1)(2009-9#1)(2012-2#1)
structure underlying##2##2##(2006-6#1)(2008-11#1)
structure upon##4##2##(1992-11#1)(1994-2#1)(2007-11#1)(2013-7#1)
structure using a##2##3##(2008-9#1)(2013-7#1)
structure using##11##2##(1991-9#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#2)(2012-1#1)(2013-7#1)
structure was designed to##2##4##(1992-2#1)(2007-11#1)
structure was determined by##6##4##(1990-5#1)(1992-3#1)(1992-8#1)(1996-5#1)(2008-8#1)(2009-10#1)
structure was determined##9##3##(1990-5#1)(1992-3#1)(1992-8#1)(1996-5#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)
structure was examined##2##3##(2008-10#1)(2013-1#1)
structure was investigated##2##3##(2007-12#1)(2008-10#1)
structure was not##2##3##(2008-7#2)
structure was produced##2##3##(2008-10#2)
structure was solved by##3##4##(1992-12#1)(1997-7#1)(2008-8#1)
structure was##56##2##(1990-5#2)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-7#2)(2007-11#4)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#2)(2011-2#2)(2013-1#1)
structure were investigated##2##3##(2008-10#1)(2008-12#1)
structure were##14##2##(1992-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2009-7#1)(2010-2#1)(2012-3#2)(2013-8#1)
structure when##11##2##(1990-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
structure where##2##2##(1997-3#1)(2012-2#1)
structure which##7##2##(1993-11#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-7#1)
structure while##2##2##(1995-3#1)(2012-5#1)
structure with a##8##3##(1990-7#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2013-1#1)
structure with an##2##3##(2007-11#1)(2008-2#1)
structure with the##5##3##(1996-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
structure with##35##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1995-2#1)(1995-5#1)(1996-2#2)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#1)
structure within the##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
structure without##2##2##(2008-2#1)(2008-6#1)
structure##2720##1##(1990-11#8)(1990-12#8)(1990-2#9)(1990-3#1)(1990-4#5)(1990-5#24)(1990-6#1)(1990-7#20)(1990-8#7)(1990-9#2)(1991-1#4)(1991-11#12)(1991-12#6)(1991-2#7)(1991-3#5)(1991-5#25)(1991-6#11)(1991-7#2)(1991-8#2)(1991-9#9)(1992-1#5)(1992-11#7)(1992-12#28)(1992-2#6)(1992-3#27)(1992-4#11)(1992-5#11)(1992-6#20)(1992-7#1)(1992-8#22)(1992-9#7)(1993-1#3)(1993-11#26)(1993-12#9)(1993-2#13)(1993-3#5)(1993-5#1)(1993-6#13)(1993-8#28)(1993-9#4)(1994-1#6)(1994-11#11)(1994-12#15)(1994-2#18)(1994-3#20)(1994-5#29)(1994-6#4)(1994-8#10)(1994-9#9)(1995-1#4)(1995-11#19)(1995-12#5)(1995-2#26)(1995-3#22)(1995-5#32)(1995-6#15)(1995-8#11)(1995-9#2)(1996-1#6)(1996-10#1)(1996-12#16)(1996-2#27)(1996-3#4)(1996-5#5)(1996-6#3)(1996-7#6)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#16)(1997-3#11)(1997-4#19)(1997-5#1)(1997-6#15)(1997-7#26)(1997-8#3)(1997-9#4)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#93)(2007-12#107)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#10)(2008-10#311)(2008-11#77)(2008-12#20)(2008-2#68)(2008-3#130)(2008-4#115)(2008-5#81)(2008-6#26)(2008-7#105)(2008-8#121)(2008-9#66)(2009-1#1)(2009-10#12)(2009-11#13)(2009-12#11)(2009-2#7)(2009-3#2)(2009-4#2)(2009-5#14)(2009-6#5)(2009-7#30)(2009-8#9)(2009-9#9)(2010-1#1)(2010-10#17)(2010-11#9)(2010-12#6)(2010-2#12)(2010-3#6)(2010-4#23)(2010-5#12)(2010-7#9)(2010-8#19)(2010-9#5)(2011-1#19)(2011-2#67)(2011-3#4)(2012-1#16)(2012-12#7)(2012-2#45)(2012-3#30)(2012-5#2)(2012-7#1)(2012-8#2)(2013-1#46)(2013-7#14)(2013-8#38)
structure&quot##2##1##(1996-9#1)(2008-9#1)
structure's##3##1##(2008-2#1)(2009-7#1)(2011-2#1)
structure) of##2##2##(1990-5#1)(2007-12#1)
structure)##5##1##(1990-5#2)(2007-12#1)(2008-10#1)(2008-5#1)
structure-activity relationship studies##2##3##(1994-5#1)(1995-3#1)
structure-activity relationship##11##2##(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-3#1)
structure-activity relationships (SAR)##3##3##(2008-7#1)(2013-1#2)
structure-activity relationships for##2##3##(1991-3#1)(1995-6#1)
structure-activity relationships of##4##3##(1992-6#1)(1995-3#1)(2008-10#1)(2012-3#1)
structure-activity relationships##19##2##(1991-3#1)(1992-6#1)(1993-12#2)(1995-3#2)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#2)
structure-activity##33##1##(1991-3#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#3)(1995-6#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
structure-antioxidant activity##2##2##(2007-11#2)
structure-based##7##1##(1992-8#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
structure-chromatographic retention relationship study##2##4##(1996-5#2)
structure-function analyses##2##2##(1991-2#1)(2011-2#1)
structure-function analysis##2##2##(1991-2#1)(1997-4#1)
structure-function relationships in##3##3##(1990-7#1)(1994-8#1)(2008-11#1)
structure-function relationships##6##2##(1990-5#1)(1990-7#1)(1992-8#1)(1994-8#1)(2008-11#2)
structure-function studies##3##2##(1991-12#1)(2008-11#1)(2008-8#1)
structure-function##19##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-11#4)(2008-5#2)(2008-8#2)(2011-2#1)
structure-property correlations##2##2##(2009-8#2)
structure-property relationship study##2##3##(2008-10#2)
structure-property relationship##4##2##(2008-10#3)(2009-7#1)
structure-property relationships##2##2##(2007-11#2)
structure-property##11##1##(2007-11#2)(2008-10#4)(2009-7#1)(2009-8#2)(2013-1#2)
structure-retention relationship (QSRR)##3##3##(2008-10#3)
structure/function##5##1##(1990-12#1)(1990-5#1)(1992-4#1)(2011-2#1)(2012-3#1)
structure]##2##1##(1991-9#1)(2012-3#1)
structured and##7##2##(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(2008-8#1)(2010-8#1)(2011-1#1)
structured approach##2##2##(1996-3#1)(2011-2#1)
structured arrays##2##2##(2008-9#1)(2009-10#1)
structured as a##2##3##(2007-7#1)(2008-8#1)
structured as##3##2##(2007-7#1)(2008-3#1)(2008-8#1)
structured assessments##2##2##(2008-11#2)
structured by a##2##3##(2008-5#1)(2009-2#1)
structured by##5##2##(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)
structured clinical##6##2##(1994-2#2)(2008-11#3)(2011-1#1)
structured data##2##2##(1992-4#1)(2008-8#1)
structured educational##2##2##(2007-7#1)(2008-11#1)
structured electronic##2##2##(2012-12#1)(2013-1#1)
structured illumination##3##2##(2007-12#1)(2008-3#2)
structured in##3##2##(1991-1#1)(2008-1#1)(2009-4#1)
structured interview on##2##3##(2008-1#1)(2011-2#1)
structured interview##7##2##(1993-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-3#1)
structured interviews##8##2##(2007-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#3)(2013-8#1)
structured into##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
structured light##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
structured metapopulation models##2##3##(2008-8#2)
structured model##2##2##(2008-7#2)
structured patient##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
structured populations##3##2##(2008-8#3)
structured questionnaire##12##2##(1995-10#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-3#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
structured questionnaires##4##2##(2008-8#1)(2010-2#1)(2010-3#1)(2012-12#1)
structured student tutorial support##3##4##(2008-11#3)
structured to##7##2##(1992-2#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
structured training and##2##3##(1995-1#1)(2012-2#1)
structured training##3##2##(1995-1#1)(2010-3#1)(2012-2#1)
structured trees##2##2##(2008-7#2)
structured tutorial support##2##3##(2008-11#2)
structured vocabularies##3##2##(2008-9#3)
structured##207##1##(1990-5#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-1#4)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#13)(2008-1#4)(2008-10#7)(2008-11#20)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#8)(2008-8#17)(2008-9#9)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-2#1)(2010-3#7)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#7)(2012-12#9)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
structures among##2##2##(2008-11#1)(2010-1#1)
structures and experiments##2##3##(2010-7#2)
structures and functions##2##3##(1992-11#1)(2008-9#1)
structures and processes##3##3##(2008-12#2)(2008-6#1)
structures and properties##2##3##(2008-10#1)(2010-12#1)
structures and the##7##3##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)
structures and their##4##3##(1993-9#1)(1995-3#1)(2008-10#1)(2012-12#1)
structures and##95##2##(1990-6#1)(1990-8#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#4)(1993-9#2)(1994-7#1)(1995-1#2)(1995-3#2)(1996-2#2)(1996-3#1)(1997-6#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#4)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#3)
structures are a##2##3##(1990-11#1)(2008-11#1)
structures are known##2##3##(1997-5#1)(2008-7#1)
structures are presented##4##3##(2008-3#3)(2009-9#1)
structures are produced by##2##4##(1990-11#1)(2008-3#1)
structures are used##2##3##(1997-6#1)(2008-12#1)
structures are##47##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#2)(1997-5#4)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#9)(2008-5#1)(2008-7#5)(2009-9#1)(2011-2#1)(2012-2#1)
structures as##3##2##(2006-12#1)(2007-12#1)(2011-2#1)
structures associated with##2##3##(1995-3#1)(2008-10#1)
structures at the##4##3##(2008-11#1)(2011-2#2)(2013-1#1)
structures at##9##2##(1996-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#2)(2013-1#1)
structures based on##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2009-3#1)
structures based##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)
structures by##18##2##(1992-5#1)(1992-8#1)(1993-11#1)(1994-8#2)(2007-11#1)(2008-10#1)(2008-3#5)(2008-4#4)(2011-2#1)(2013-1#1)
structures can be##5##3##(1990-11#1)(2008-1#1)(2008-3#1)(2009-12#1)(2010-7#1)
structures can##9##2##(1990-11#1)(1992-9#1)(1997-3#1)(2008-1#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-7#1)
structures close to##2##3##(2008-3#2)
structures composed of##4##3##(1990-5#1)(2008-3#1)(2008-8#1)(2009-7#1)
structures consist of##2##3##(2007-12#1)(2008-2#1)
structures containing##5##2##(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
structures derived from##2##3##(1996-5#1)(2009-10#1)
structures derived##3##2##(1996-5#1)(2009-10#1)(2012-2#1)
structures during##4##2##(2007-12#1)(2007-8#1)(2008-5#1)(2013-1#1)
structures embedded in##2##3##(2008-2#1)(2008-3#1)
structures for the##5##3##(1994-9#1)(1996-2#2)(2008-11#1)(2008-7#1)
structures for use##2##3##(2008-2#2)
structures for##24##2##(1994-9#1)(1995-6#1)(1996-2#3)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
structures form##2##2##(1997-3#1)(2011-2#1)
structures from##14##2##(1993-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-2#1)
structures has##3##2##(1993-3#1)(2008-7#1)(2009-7#1)
structures have been elucidated##3##4##(1995-9#1)(2008-10#1)(2012-2#1)
structures have been##8##3##(1995-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2012-2#1)
structures have##15##2##(1994-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2012-2#3)
structures having##2##2##(2007-11#1)(2007-12#1)
structures in a##5##3##(1990-5#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
structures in order to##2##4##(1994-2#1)(2012-12#1)
structures in the##25##3##(1991-1#1)(1992-11#1)(1993-5#1)(1995-3#1)(1996-7#1)(1997-5#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-8#2)
structures in vivo##2##3##(2009-10#1)(2010-12#1)
structures in which##2##3##(2008-1#1)(2012-2#1)
structures in##76##2##(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-5#1)(2007-11#1)(2007-12#9)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#4)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
structures including the##2##3##(2007-8#1)(2013-8#1)
structures including##3##2##(2007-8#1)(2009-11#1)(2013-8#1)
structures increased##2##2##(2008-10#2)
structures into##4##2##(1990-8#1)(2007-12#1)(2008-12#1)(2013-8#1)
structures involved in##2##3##(2008-11#1)(2008-5#1)
structures involved##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
structures is a##2##3##(1991-2#1)(2008-10#1)
structures is an##2##3##(1997-1#1)(2007-8#1)
structures is##12##2##(1991-2#1)(1997-1#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)
structures like##3##2##(1997-6#1)(2007-8#1)(2009-8#1)
structures located in the##2##4##(1992-8#1)(2008-3#1)
structures located in##3##3##(1992-8#1)(2008-3#2)
structures located##4##2##(1992-8#1)(1993-9#1)(2008-3#2)
structures made from##2##3##(2007-11#1)(2009-5#1)
structures may be##2##3##(1990-7#1)(2008-3#1)
structures may contribute to##2##4##(2008-1#1)(2008-10#1)
structures may##8##2##(1990-7#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
structures must##2##2##(2008-11#2)
structures observed in the##2##4##(1992-4#1)(2008-8#1)
structures observed in##3##3##(1992-4#1)(1995-3#1)(2008-8#1)
structures observed##5##2##(1992-4#1)(1992-8#2)(1995-3#1)(2008-8#1)
structures obtained by##2##3##(2007-11#1)(2009-9#1)
structures obtained##4##2##(2007-11#1)(2008-3#1)(2009-7#1)(2009-9#1)
structures of Escherichia coli dihydrofolate reductase##2##6##(1995-2#2)
structures of a##3##3##(2008-1#1)(2010-2#2)
structures of all##6##3##(1991-6#1)(1996-2#1)(2007-11#2)(2010-6#1)(2012-2#1)
structures of both the##2##4##(1992-3#1)(1992-9#1)
structures of both##4##3##(1992-3#1)(1992-9#1)(1993-11#1)(2008-10#1)
structures of the isolated##2##4##(1994-5#1)(2008-11#1)
structures of the knee##2##4##(2012-2#1)(2013-1#1)
structures of the two##2##4##(1990-7#1)(1991-12#1)
structures of the##50##3##(1990-7#3)(1990-9#1)(1991-12#2)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
structures of these two##3##4##(1990-5#1)(1995-3#1)(1997-7#1)
structures of these##10##3##(1990-5#1)(1995-3#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-1#1)
structures of two##3##3##(1990-7#1)(1995-5#1)(1996-5#1)
structures of##165##2##(1990-5#1)(1990-7#6)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-5#5)(1994-8#3)(1995-11#1)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#4)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-11#10)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#8)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
structures on the surface of##2##5##(2008-5#2)
structures on the##4##3##(1997-5#1)(2008-5#2)(2008-8#1)
structures on##10##2##(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#2)(2012-2#1)(2013-8#1)
structures or##5##2##(1992-2#1)(1994-2#1)(1995-3#1)(2006-12#1)(2008-3#1)
structures placed on##2##3##(2007-12#1)(2008-12#1)
structures produced##2##2##(2008-10#1)(2008-3#1)
structures remains##2##2##(1996-2#1)(2011-2#1)
structures resembling##3##2##(1990-11#1)(2008-10#1)(2009-8#1)
structures show##3##2##(1994-5#1)(2009-6#1)(2012-2#1)
structures shows##2##2##(1991-12#1)(2008-3#1)
structures significantly##2##2##(1993-6#1)(2012-2#1)
structures such as the##3##4##(1993-12#1)(2008-3#1)(2008-6#1)
structures such as##17##3##(1992-6#1)(1993-12#1)(1995-11#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)
structures suggest that##2##3##(1990-8#1)(1996-12#1)
structures that are not##2##4##(2007-12#1)(2008-3#1)
structures that are##5##3##(2007-12#1)(2008-3#2)(2008-7#1)(2012-2#1)
structures that consist of##2##4##(2008-3#2)
structures that regulate##2##3##(1992-9#1)(2008-12#1)
structures that##35##2##(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#6)(2008-6#1)(2008-7#4)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#2)
structures to the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
structures to##14##2##(1990-5#1)(1991-2#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#1)
structures using##3##2##(1990-7#1)(1991-12#1)(1994-2#1)
structures was##7##2##(1993-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2009-9#1)(2010-4#1)(2013-1#1)
structures were confirmed##3##3##(2010-2#1)(2011-1#1)(2011-3#1)
structures were determined##4##3##(1997-2#1)(1997-7#1)(2008-12#1)(2010-6#1)
structures were elucidated by##3##4##(1995-11#1)(2007-1#1)(2011-3#1)
structures were elucidated##5##3##(1995-11#1)(2007-1#1)(2008-10#1)(2011-2#1)(2011-3#1)
structures were established##5##3##(2007-11#3)(2008-11#1)(2013-1#1)
structures were found##2##3##(2008-10#1)(2008-8#1)
structures were then##2##3##(1995-3#1)(2008-7#1)
structures were##46##2##(1990-6#1)(1991-7#1)(1994-5#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
structures when##2##2##(1992-5#1)(1997-8#1)
structures which##4##2##(1994-12#1)(1994-5#1)(2008-10#1)(2009-5#1)
structures while##3##2##(1990-7#1)(2008-11#1)(2012-2#1)
structures with a##6##3##(1996-3#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#2)
structures with an##2##3##(2007-12#1)(2012-2#1)
structures with different##2##3##(2008-3#1)(2008-7#1)
structures with only a##2##4##(2008-5#1)(2011-2#1)
structures with the##2##3##(2008-3#1)(2008-8#1)
structures with##37##2##(1990-7#1)(1992-3#1)(1994-5#1)(1996-3#1)(2007-11#2)(2007-12#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-2#3)(2013-1#3)
structures within the##2##3##(1996-12#1)(2008-12#1)
structures within##5##2##(1995-2#2)(1996-12#1)(2008-12#2)
structures without##2##2##(2007-11#1)(2008-7#1)
structures##1250##1##(1990-11#7)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#9)(1990-6#2)(1990-7#11)(1990-8#6)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-5#4)(1991-6#3)(1991-7#3)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#3)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#10)(1992-8#11)(1992-9#5)(1993-11#8)(1993-12#11)(1993-2#1)(1993-3#10)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#5)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#5)(1994-5#13)(1994-7#1)(1994-8#8)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#11)(1995-3#17)(1995-5#9)(1995-6#6)(1995-8#2)(1995-9#1)(1996-1#3)(1996-12#6)(1996-2#17)(1996-3#2)(1996-4#1)(1996-5#9)(1996-7#3)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#11)(1997-6#5)(1997-7#6)(1997-8#3)(1997-9#1)(2006-12#7)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#46)(2007-12#65)(2007-5#4)(2007-6#1)(2007-8#14)(2008-1#9)(2008-10#90)(2008-11#44)(2008-12#18)(2008-2#41)(2008-3#110)(2008-4#30)(2008-5#32)(2008-6#10)(2008-7#60)(2008-8#27)(2008-9#9)(2009-10#5)(2009-11#8)(2009-12#6)(2009-2#2)(2009-3#2)(2009-5#8)(2009-6#3)(2009-7#9)(2009-8#11)(2009-9#8)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#4)(2010-7#9)(2010-8#6)(2010-9#2)(2011-1#14)(2011-2#37)(2011-3#8)(2011-7#1)(2012-1#5)(2012-12#8)(2012-2#48)(2012-3#11)(2013-1#21)(2013-7#4)(2013-8#18)
structures)##3##1##(2008-8#1)(2009-11#1)(2010-7#1)
structures/organs##4##1##(2007-8#4)
structuring of##8##2##(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(2007-12#1)(2008-10#1)(2010-8#1)
structuring##29##1##(1991-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#3)(2009-9#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)
struggle for##2##2##(1995-2#1)(2008-6#1)
struggle over health care##2##4##(1995-1#1)(1997-3#1)
struggle over##3##2##(1995-1#1)(1997-3#1)(2008-10#1)
struggle to##6##2##(1991-12#1)(1992-10#1)(1996-1#2)(2008-6#1)(2013-1#1)
struggle with the##2##3##(2008-4#1)(2008-9#1)
struggle with##5##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
struggle##20##1##(1991-12#1)(1992-10#1)(1993-11#1)(1995-1#1)(1995-2#1)(1996-1#2)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)
struggled to##3##2##(1995-1#1)(2008-7#1)(2013-1#1)
struggled##5##1##(1995-1#1)(1996-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
struggles to##3##2##(1996-1#2)(1996-12#1)
struggles##7##1##(1996-1#2)(1996-12#1)(1997-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
struggling to##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
struggling##4##1##(1995-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
struma ovarii##3##2##(1994-12#2)(2009-5#1)
struma##4##1##(1990-6#1)(1994-12#2)(2009-5#1)
strut bone##2##2##(2012-3#2)
strut##4##1##(2011-2#2)(2012-3#2)
struts##3##1##(2008-7#2)(2010-8#1)
strychnine-insensitive glycine receptors##2##3##(1995-11#2)
stubble##6##1##(2008-10#6)
stuck in##2##2##(2008-10#1)(2010-9#1)
stuck##4##1##(2008-10#3)(2010-9#1)
stud##2##1##(2008-11#1)(2012-3#1)
student achievement##2##2##(2008-12#1)(2009-7#1)
student and##4##2##(2008-11#2)(2013-1#2)
student applicants##2##2##(2012-3#2)
student assessment##2##2##(1996-2#1)(2008-11#1)
student at##2##2##(2010-8#1)(2013-1#1)
student attitudes##2##2##(2008-11#1)(2012-12#1)
student clinical##2##2##(2008-12#1)(2012-3#1)
student cohorts##2##2##(2008-12#2)
student evaluation##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
student exchange##2##2##(2008-12#1)(2010-3#1)
student experience of##2##3##(2008-11#1)(2013-1#1)
student experience##7##2##(2008-11#6)(2013-1#1)
student feedback##3##2##(2008-11#1)(2013-1#2)
student group##2##2##(2008-11#1)(2008-12#1)
student groups##2##2##(2008-11#1)(2012-12#1)
student in##2##2##(1994-3#1)(2008-11#1)
student interaction##2##2##(2007-5#1)(2008-11#1)
student journal club##3##3##(2008-12#3)
student learning in##2##3##(2008-12#1)(2009-12#1)
student learning outcomes##2##3##(2007-10#1)(2008-12#1)
student learning##15##2##(1994-2#1)(2007-10#1)(2008-11#4)(2008-12#6)(2009-12#1)(2012-1#1)(2012-12#1)
student math aptitude and success on a medication calculation assessment##2##10##(2010-3#2)
student midwives##3##2##(2008-11#3)
student nurse anesthetist##2##3##(2011-2#2)
student nurse education##2##3##(2008-12#1)(2013-8#1)
student nurse##11##2##(2008-11#6)(2008-12#2)(2011-2#2)(2013-8#1)
student nurses and##2##3##(2008-11#1)(2008-12#1)
student nurses at the##2##4##(2008-11#1)(2012-3#1)
student nurses at##3##3##(2008-11#2)(2012-3#1)
student nurses on##4##3##(2008-11#1)(2008-12#3)
student nurses to##5##3##(2008-11#3)(2008-12#1)(2013-8#1)
student nurses who##5##3##(2008-11#4)(2010-3#1)
student nurses##43##2##(2008-11#27)(2008-12#9)(2010-3#4)(2012-3#1)(2013-8#2)
student nurses' attitudes towards older people##2##6##(2012-3#2)
student nurses'##4##2##(2008-11#2)(2012-3#2)
student perceptions of##2##3##(2008-12#1)(2012-1#1)
student perceptions##3##2##(2008-12#1)(2012-1#1)(2013-1#1)
student performance##3##2##(2008-11#1)(2008-12#1)(2010-3#1)
student population##2##2##(2008-11#1)(2008-12#1)
student projects##2##2##(1995-1#1)(1996-2#1)
student psychiatric nurses##2##3##(2008-11#1)(2008-12#1)
student psychiatric nurses'##2##3##(2008-11#1)(2008-12#1)
student psychiatric##4##2##(2008-11#2)(2008-12#2)
student research##2##2##(2010-9#1)(2013-1#1)
student response system##3##3##(2010-3#3)
student responses##2##2##(2008-11#1)(2008-12#1)
student stress##4##2##(2008-11#4)
student support##5##2##(2008-11#4)(2008-12#1)
student survey##2##2##(1996-1#1)(2008-12#1)
student symposium##3##2##(2008-10#2)(2008-5#1)
student to##4##2##(2008-11#2)(2008-12#1)(2012-2#1)
student voice##4##2##(2008-11#1)(2013-1#3)
student##259##1##(1990-12#2)(1990-8#1)(1991-1#1)(1992-3#1)(1992-6#2)(1993-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#5)(1996-1#4)(1996-2#3)(1997-2#2)(1997-3#1)(2007-10#3)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#104)(2008-12#44)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#3)(2009-8#1)(2010-12#1)(2010-3#16)(2010-6#2)(2010-8#1)(2010-9#2)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#13)(2013-8#4)
student's##18##1##(2008-11#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2012-3#1)
student-centered##2##1##(2008-12#2)
student-centred##2##1##(2008-11#2)
student-focused##2##1##(2011-2#2)
students &quot##2##2##(1992-6#1)(2012-3#1)
students about their##3##3##(2008-11#2)(2012-12#1)
students about##8##2##(1992-6#1)(1995-12#2)(2008-11#2)(2009-8#1)(2012-12#1)(2012-3#1)
students and Practice Nurses##2##4##(2008-11#2)
students and academics##2##3##(2008-11#2)
students and factory workers##2##4##(2008-11#2)
students and faculty##2##3##(2008-11#1)(2008-12#1)
students and graduates##3##3##(2013-1#2)(2013-8#1)
students and lecturers##2##3##(2008-11#2)
students and nurse##3##3##(2008-11#2)(2008-12#1)
students and research]##2##3##(1992-6#2)
students and staff##3##3##(1993-1#1)(2008-12#1)(2008-9#1)
students and teachers##6##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
students and their##3##3##(2008-11#1)(2009-7#1)(2013-8#1)
students and##64##2##(1990-12#2)(1991-6#1)(1992-6#2)(1993-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#18)(2008-12#10)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
students are also##2##3##(2008-11#1)(2008-12#1)
students are##18##2##(1990-2#1)(1996-1#1)(1997-3#1)(1997-5#1)(2008-11#9)(2008-12#3)(2008-4#1)(2010-3#1)
students as##6##2##(2008-11#1)(2008-12#1)(2012-1#1)(2012-12#1)(2013-8#2)
students at a##4##3##(2008-12#1)(2009-5#1)(2011-2#1)(2012-3#1)
students at the University of##4##5##(1992-6#2)(1996-1#1)(2009-12#1)
students at the##8##3##(1992-6#2)(1996-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-9#1)(2011-2#1)
students at##24##2##(1991-6#1)(1992-3#1)(1992-6#2)(1993-3#1)(1996-1#2)(1996-2#1)(2008-10#1)(2008-11#3)(2008-12#3)(2009-12#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-3#1)
students attending##2##2##(2008-5#2)
students can##4##2##(1996-12#1)(2008-11#2)(2012-1#1)
students choose##2##2##(2007-4#1)(2008-12#1)
students completed an##2##3##(1991-9#1)(2013-8#1)
students completed##5##2##(1991-9#1)(1997-2#1)(2007-12#1)(2008-12#1)(2013-8#1)
students delivered between##3##3##(2013-1#3)
students delivered##4##2##(2013-1#4)
students demonstrated##2##2##(2008-11#1)(2012-12#1)
students developed##2##2##(2008-12#2)
students due to##2##3##(2010-12#1)(2010-3#1)
students during their clinical placements##2##5##(1995-3#1)(2010-3#1)
students during their clinical##3##4##(1995-3#1)(2007-10#1)(2010-3#1)
students during their##4##3##(1995-3#1)(2007-10#1)(2008-11#1)(2010-3#1)
students during##6##2##(1995-3#1)(2007-10#1)(2008-11#2)(2010-3#2)
students early in their##2##4##(2012-12#1)(2012-3#1)
students enrolled in##5##3##(1992-1#1)(1996-1#1)(2008-11#1)(2011-1#1)(2012-2#1)
students expressed##2##2##(1992-6#1)(2012-1#1)
students for##3##2##(1995-2#1)(2008-12#1)(2010-10#1)
students found##4##2##(1996-1#1)(2008-11#1)(2008-12#1)(2010-10#1)
students from 15##2##3##(2007-5#1)(2013-1#1)
students from non-English speaking backgrounds##3##5##(2008-11#1)(2008-12#2)
students from the##2##3##(1990-2#1)(2008-10#1)
students from##29##2##(1990-2#1)(1992-6#2)(1993-6#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-11#5)(2008-12#6)(2009-7#1)(2010-3#1)(2011-2#3)(2013-1#4)(2013-8#2)
students had a positive##2##4##(1997-2#1)(2008-11#1)
students had##12##2##(1991-9#1)(1992-6#1)(1997-2#1)(2008-11#5)(2011-2#1)(2013-1#2)(2013-8#1)
students has been##2##3##(2008-11#2)
students has##4##2##(2008-11#4)
students have experienced##2##3##(1996-1#2)
students have##11##2##(1996-1#2)(1997-2#2)(2008-1#1)(2008-11#3)(2010-3#1)(2012-12#1)(2013-8#1)
students identified##2##2##(2008-11#2)
students in India##3##3##(2013-1#3)
students in Years##2##3##(2008-12#1)(2011-1#1)
students in a##5##3##(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
students in developing##2##3##(2008-11#1)(2010-3#1)
students in faculty research##2##4##(2008-12#1)(2010-3#1)
students in grades K - 12##2##6##(2012-12#2)
students in the##21##3##(1991-1#1)(1996-1#1)(2008-11#5)(2008-12#5)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
students in this study##2##4##(2008-11#1)(2013-8#1)
students in##73##2##(1991-1#1)(1992-6#1)(1993-3#1)(1996-1#1)(2007-7#1)(2008-1#1)(2008-11#13)(2008-12#12)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-3#5)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#5)(2012-2#3)(2013-1#11)(2013-7#1)(2013-8#2)
students is##4##2##(2007-12#1)(2008-11#2)(2013-1#1)
students learn##5##2##(1992-12#1)(2008-11#3)(2013-8#1)
students learning##2##2##(2008-11#1)(2012-1#1)
students may##3##2##(2007-2#1)(2008-12#1)(2012-1#1)
students might##3##2##(2007-12#1)(2008-11#1)(2009-5#1)
students must be##3##3##(2008-11#1)(2008-12#1)(2010-3#1)
students must##5##2##(1992-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2010-3#1)
students need to achieve##2##4##(2008-11#2)
students need to##4##3##(1996-1#1)(2008-11#3)
students need##5##2##(1996-1#1)(2008-11#3)(2008-12#1)
students of nursing to##2##4##(2008-12#2)
students of nursing##4##3##(2008-11#1)(2008-12#3)
students of the##3##3##(2012-3#1)(2013-1#1)(2013-8#1)
students of##20##2##(1993-12#1)(1994-5#1)(1997-3#1)(2008-11#2)(2008-12#3)(2008-6#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
students on##3##2##(1995-3#1)(1997-1#1)(2008-11#1)
students or##2##2##(1991-3#1)(2008-4#1)
students perceived##2##2##(2008-11#1)(2012-3#1)
students receive##2##2##(2008-11#2)
students reported that##4##3##(1993-3#1)(2008-11#1)(2012-12#2)
students reported##12##2##(1991-9#1)(1993-3#1)(2008-11#1)(2008-12#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
students should be##3##3##(1992-6#1)(2008-11#1)(2008-6#1)
students studied##2##2##(2008-12#1)(2012-3#1)
students than black##2##3##(2012-12#2)
students that##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2012-1#1)(2012-3#1)
students the##3##2##(1990-2#1)(1995-3#1)(2013-8#1)
students through##2##2##(2010-9#1)(2011-2#1)
students to apply##2##3##(1996-1#1)(2008-11#1)
students to be##2##3##(2008-11#1)(2008-3#1)
students to become##2##3##(1997-2#1)(2013-8#1)
students to develop##4##3##(1991-3#1)(2008-11#3)
students to participate in##2##4##(1992-6#1)(2010-3#1)
students to take##2##3##(2008-11#1)(2013-8#1)
students to the##4##3##(1992-2#1)(1992-6#1)(1997-1#1)(2009-8#1)
students to##51##2##(1991-3#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1993-1#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#21)(2008-12#5)(2008-3#1)(2009-8#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#3)
students towards##2##2##(2009-7#1)(2012-1#1)
students trained with the##2##4##(2012-3#2)
students undertaking a##3##3##(2008-11#3)
students undertaking##7##2##(2008-11#6)(2008-12#1)
students used##3##2##(2009-12#1)(2013-1#1)(2013-8#1)
students volunteered to##2##3##(2008-11#1)(2008-12#1)
students was##5##2##(1995-3#1)(2009-5#1)(2011-2#1)(2013-1#2)
students were also asked to##2##5##(2008-11#1)(2013-8#1)
students were asked to##2##4##(2008-11#1)(2008-12#1)
students were randomly assigned to##3##5##(1992-12#1)(2008-12#1)(2009-11#1)
students were satisfied with##2##4##(2008-12#1)(2010-3#1)
students were##36##2##(1992-12#1)(1997-2#1)(2008-1#1)(2008-11#7)(2008-12#12)(2009-11#1)(2010-3#4)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
students whilst##2##2##(2008-11#1)(2008-12#1)
students who are##5##3##(1996-2#1)(2008-11#1)(2008-12#1)(2011-2#2)
students who failed##2##3##(2008-11#2)
students who had just completed##2##5##(2008-11#2)
students who had##5##3##(1992-1#1)(2008-11#3)(2013-1#1)
students who have##3##3##(1996-1#1)(2008-11#1)(2009-5#1)
students who studied##2##3##(2008-10#1)(2008-9#1)
students who were##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
students who##33##2##(1992-1#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#14)(2008-12#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
students whose mothers were##2##4##(2009-5#2)
students whose##3##2##(2008-11#1)(2009-5#2)
students with dyslexia##3##3##(2008-12#3)
students with limited##2##3##(1996-2#1)(2008-12#1)
students with similar records of achievement##2##6##(2008-12#2)
students with the##3##3##(2008-11#1)(2013-1#2)
students with##24##2##(1996-2#2)(1997-2#1)(2008-11#3)(2008-12#9)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
students without##2##2##(2010-3#1)(2013-1#1)
students worked in##2##3##(1992-6#1)(2008-12#1)
students would##4##2##(1993-3#2)(2008-11#2)
students##888##1##(1990-12#2)(1990-2#5)(1990-3#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-6#2)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#19)(1992-7#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#9)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#9)(1996-1#19)(1996-12#3)(1996-2#7)(1996-7#1)(1997-1#2)(1997-2#13)(1997-3#3)(1997-5#2)(2007-10#3)(2007-12#11)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#7)(2008-10#11)(2008-11#224)(2008-12#140)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#4)(2008-9#4)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#10)(2009-6#3)(2009-7#6)(2009-8#3)(2010-1#5)(2010-10#7)(2010-12#1)(2010-2#3)(2010-3#30)(2010-4#2)(2010-7#1)(2010-9#7)(2011-1#10)(2011-2#34)(2012-1#9)(2012-12#41)(2012-2#19)(2012-3#24)(2013-1#56)(2013-7#4)(2013-8#44)
students' ability to##2##3##(2008-11#1)(2008-12#1)
students' academic performance##3##3##(2011-2#1)(2012-3#2)
students' access to##2##3##(2008-11#1)(2008-12#1)
students' and##5##2##(2008-11#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
students' approaches to learning##3##4##(2011-1#2)(2011-2#1)
students' clinical learning##2##3##(2008-11#1)(2008-12#1)
students' clinical##3##2##(2008-11#1)(2008-12#2)
students' competence and confidence##2##4##(2008-11#1)(2008-12#1)
students' competence and##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
students' competence##5##2##(1993-1#1)(2008-11#2)(2008-12#1)(2012-3#1)
students' evaluation of##2##3##(2008-11#1)(2010-3#1)
students' experiences of##2##3##(2008-11#1)(2008-12#1)
students' experiences##7##2##(2008-11#3)(2008-12#3)(2009-8#1)
students' learning##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
students' needs for##2##3##(1995-1#1)(2010-2#1)
students' needs##5##2##(1995-1#1)(2008-12#2)(2010-2#1)(2012-3#1)
students' perception of##2##3##(2008-12#1)(2012-12#1)
students' perceptions and##2##3##(2008-11#1)(2009-7#1)
students' perceptions of ethical behavior in##2##6##(2008-12#2)
students' perceptions of their learning##2##5##(2008-11#1)(2013-1#1)
students' perceptions of their##3##4##(2008-11#2)(2013-1#1)
students' perceptions of##13##3##(2007-12#1)(2008-1#1)(2008-11#5)(2008-12#2)(2009-12#1)(2012-3#2)(2013-1#1)
students' perceptions##16##2##(2007-12#1)(2008-1#1)(2008-11#6)(2008-12#2)(2009-12#1)(2009-7#1)(2012-3#2)(2013-1#2)
students' perspectives on##2##3##(2008-11#1)(2012-2#1)
students' perspectives##5##2##(2008-11#2)(2010-3#1)(2012-2#1)(2013-1#1)
students' self-esteem##2##2##(2008-11#1)(2008-12#1)
students' successful##2##2##(2011-1#1)(2012-3#1)
students' theoretical##2##2##(2008-11#1)(2010-10#1)
students'##131##1##(1993-1#1)(1995-1#1)(1995-3#1)(1996-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#37)(2008-12#29)(2009-12#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#7)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#11)(2013-1#6)(2013-7#1)(2013-8#5)
students)##4##1##(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
students]##4##1##(1995-2#1)(1997-8#1)(2008-9#1)(2010-5#1)
studied 14##2##2##(1991-5#1)(2008-4#1)
studied 43 patients##2##3##(2008-7#2)
studied 60##2##2##(1997-8#1)(2010-7#1)
studied a##13##2##(1990-3#1)(1992-8#1)(1997-3#1)(1997-5#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-6#1)(2011-1#1)(2012-2#1)
studied after##5##2##(1993-12#1)(1995-12#2)(1996-5#1)(2012-1#1)
studied and a##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
studied and compared to##2##4##(2008-10#1)(2011-2#1)
studied and compared with a##2##5##(2008-2#1)(2008-3#1)
studied and compared with those of##2##6##(2008-10#1)(2008-3#1)
studied and compared with those##3##5##(2008-10#2)(2008-3#1)
studied and compared with##8##4##(1992-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)
studied and compared##15##3##(1992-6#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2011-3#1)
studied and correlated with##2##4##(1990-12#1)(2008-10#1)
studied and evaluated##3##3##(2008-10#3)
studied and is##2##3##(2008-3#1)(2008-9#1)
studied and it was##2##4##(2008-10#2)
studied and its##2##3##(2008-7#1)(2013-8#1)
studied and optimized##13##3##(2008-10#13)
studied and reported##3##3##(2008-10#2)(2008-5#1)
studied and the##14##3##(2008-10#13)(2008-12#1)
studied and to##2##3##(1991-9#1)(2008-3#1)
studied and##111##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-6#1)(1994-2#2)(1994-5#1)(1995-5#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#66)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#8)(2008-5#1)(2008-7#5)(2008-9#1)(2009-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
studied are##8##2##(2008-10#2)(2008-3#2)(2008-9#1)(2010-10#1)(2012-5#1)(2013-7#1)
studied as a function of the##4##6##(2007-11#1)(2008-10#2)(2009-10#1)
studied as a function of##11##5##(1990-5#1)(1993-11#1)(2007-11#1)(2008-10#3)(2008-3#4)(2009-10#1)
studied as a##22##3##(1990-5#1)(1992-6#1)(1993-11#1)(2007-11#2)(2008-10#9)(2008-3#5)(2008-4#1)(2008-9#1)(2009-10#1)
studied as##42##2##(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-6#1)(2007-11#2)(2008-10#17)(2008-2#1)(2008-3#6)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-4#2)(2011-1#1)(2013-1#1)(2013-8#1)
studied at 1##4##3##(2008-10#3)(2010-5#1)
studied at 25 degrees C##4##5##(1997-7#1)(2008-10#3)
studied at King##2##3##(2008-1#2)
studied at a##4##3##(2007-11#1)(2008-10#3)
studied at pH##4##3##(1991-2#1)(1995-5#1)(2008-10#2)
studied at the##9##3##(2007-10#1)(2007-12#1)(2008-10#3)(2011-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
studied at##49##2##(1990-6#1)(1990-8#1)(1991-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#19)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
studied because of##3##3##(1990-12#1)(2008-10#1)(2013-7#1)
studied between##2##2##(2008-10#1)(2008-3#1)
studied both in##2##3##(2008-11#1)(2008-2#1)
studied both##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
studied by ID##2##3##(2008-5#2)
studied by X-ray##3##3##(2008-10#2)(2013-8#1)
studied by a##3##3##(2008-10#2)(2008-3#1)
studied by applying##4##3##(2008-10#4)
studied by both##2##3##(2008-10#2)
studied by comparing the##2##4##(1994-5#1)(2010-4#1)
studied by comparing##3##3##(1994-5#1)(2008-10#1)(2010-4#1)
studied by confocal##2##3##(2008-10#2)
studied by conventional##2##3##(2008-10#1)(2008-5#1)
studied by cyclic voltammetry (CV)##4##5##(2008-10#4)
studied by cyclic voltammetry##9##4##(2008-10#9)
studied by cyclic##10##3##(2008-10#10)
studied by differential scanning calorimetry##4##5##(1993-8#2)(1997-2#1)(2011-2#1)
studied by flow cytometry##2##4##(1993-11#1)(2012-1#1)
studied by flow##4##3##(1993-11#1)(1994-5#1)(2008-10#1)(2012-1#1)
studied by immunohistochemistry##2##3##(1996-5#1)(2013-8#1)
studied by in situ hybridization##2##5##(1993-5#1)(2012-1#1)
studied by in situ##3##4##(1993-5#1)(2008-10#1)(2012-1#1)
studied by in vivo##2##4##(1991-5#2)
studied by in##5##3##(1991-5#2)(1993-5#1)(2008-10#1)(2012-1#1)
studied by light and##2##4##(2007-7#1)(2008-10#1)
studied by liquid chromatography##2##4##(2008-10#2)
studied by means of the##2##5##(2008-10#2)
studied by means of##8##4##(1995-12#1)(2008-10#5)(2008-5#1)(2013-8#1)
studied by measurement of##3##4##(2007-11#1)(2008-2#1)(2008-5#1)
studied by measuring##5##3##(1990-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
studied by molecular##2##3##(2008-10#1)(2008-8#1)
studied by optical##2##3##(1994-12#1)(1995-2#1)
studied by pulsed-field gradient##2##4##(2008-3#2)
studied by quantitative##2##3##(2008-7#1)(2009-2#1)
studied by spectrofluorimetry##2##3##(2008-10#2)
studied by spectrophotometry##3##3##(2008-10#3)
studied by the##13##3##(1990-5#1)(1994-12#1)(1995-2#1)(1996-2#1)(2008-10#7)(2013-1#1)(2013-8#1)
studied by use of##3##4##(1993-8#1)(2007-12#1)(2008-2#1)
studied by using a##5##4##(1997-2#1)(2008-10#3)(2008-3#1)
studied by using different##2##4##(2008-10#1)(2010-5#1)
studied by using##19##3##(1992-7#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-5#1)(2013-1#1)
studied by##262##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#5)(1994-11#2)(1994-12#2)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-2#2)(1996-5#3)(1997-1#1)(1997-2#5)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#111)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#8)(2008-7#1)(2008-8#9)(2008-9#4)(2009-11#2)(2009-2#1)(2009-5#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#7)
studied can##2##2##(2008-10#2)
studied cases##4##2##(1993-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
studied compounds were##2##3##(2008-10#2)
studied compounds##8##2##(2008-10#7)(2008-5#1)
studied could be##2##3##(2008-10#1)(2011-1#1)
studied countries##2##2##(2010-8#2)
studied directly##2##2##(1994-11#1)(2007-12#1)
studied do not##4##3##(2008-10#3)(2013-1#1)
studied drug in##2##3##(2008-10#2)
studied drug##5##2##(2008-10#5)
studied drugs in##3##3##(2008-10#3)
studied drugs##6##2##(2008-10#6)
studied during the##4##3##(1994-12#1)(1996-4#1)(2008-2#1)(2008-5#1)
studied during##10##2##(1994-12#1)(1996-4#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2012-2#1)(2013-7#1)
studied either##2##2##(2008-4#1)(2010-11#1)
studied elements##2##2##(2008-10#2)
studied employing##3##2##(1991-10#1)(2008-10#1)(2008-6#1)
studied even##2##2##(2008-10#2)
studied experimentally##9##2##(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-9#1)
studied extensively as##2##3##(2008-10#1)(2010-5#1)
studied extensively##13##2##(1995-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#2)
studied following##2##2##(1994-11#1)(2008-10#1)
studied for a##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
studied for comparison##2##3##(1994-8#1)(2008-10#1)
studied for different##2##3##(2008-10#1)(2008-3#1)
studied for serological##2##3##(2007-7#1)(2008-1#1)
studied for several##2##3##(2008-10#1)(2013-1#1)
studied for the first time##6##5##(1993-2#1)(2008-10#2)(2008-12#1)(2010-3#1)(2010-4#1)
studied for the presence of##2##5##(1991-2#1)(2008-10#1)
studied for the##23##3##(1990-8#1)(1991-2#1)(1992-3#1)(1993-2#1)(2008-10#10)(2008-12#1)(2008-2#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#2)
studied for their##5##3##(1992-2#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)
studied for##78##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-8#2)(1995-12#2)(1995-3#1)(1996-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#3)
studied from the##2##3##(2008-10#1)(2013-1#1)
studied from##14##2##(1991-5#1)(1991-8#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2013-1#1)
studied further##3##2##(1992-9#1)(2008-7#1)(2008-9#1)
studied groups##3##2##(1995-12#1)(2013-8#2)
studied have been##2##3##(2008-10#2)
studied have##4##2##(2008-10#3)(2008-11#1)
studied here##7##2##(1993-11#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
studied histopathologically##2##2##(1994-12#1)(2011-2#1)
studied in 13##2##3##(1993-12#1)(1995-11#1)
studied in 15##2##3##(2008-10#1)(2010-6#1)
studied in a group of##2##5##(1991-8#1)(1996-7#1)
studied in a patient##2##4##(1993-12#1)(2008-7#1)
studied in a series of##2##5##(1997-4#1)(2008-7#1)
studied in a##40##3##(1990-11#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-12#1)(1996-7#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2009-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)
studied in an##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
studied in aqueous solution##4##4##(1996-2#1)(2008-10#3)
studied in aqueous##7##3##(1996-2#1)(2008-10#6)
studied in batch##3##3##(2008-10#2)(2008-11#1)
studied in both##2##3##(2008-10#1)(2012-2#1)
studied in cells##3##3##(1995-11#1)(2007-11#1)(2007-12#1)
studied in chloroform solutions##2##4##(1994-3#1)(2007-11#1)
studied in comparison##2##3##(2008-10#1)(2013-7#1)
studied in cultured##3##3##(1994-6#1)(1995-11#1)(2008-11#1)
studied in detail by##2##4##(2008-10#2)
studied in detail to optimize the conditions for their##2##9##(2008-10#2)
studied in detail to optimize the conditions for##7##8##(2008-10#7)
studied in detail to optimize the conditions##8##7##(2008-10#8)
studied in detail##37##3##(1991-12#1)(1992-3#1)(2007-11#1)(2008-10#29)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)
studied in fibroblasts##2##3##(1993-8#1)(2012-12#1)
studied in five##2##3##(1993-9#1)(1996-5#1)
studied in humans##2##3##(1995-12#1)(2008-8#1)
studied in male##3##3##(1992-12#1)(2008-7#1)(2011-1#1)
studied in order to increase##2##5##(1995-6#1)(2008-10#1)
studied in order to##10##4##(1994-11#1)(1995-6#1)(2008-10#7)(2013-1#1)
studied in other##2##3##(2008-2#1)(2008-4#1)
studied in rats and##2##4##(1991-5#1)(2011-1#1)
studied in rats##4##3##(1991-5#1)(1993-2#1)(1994-5#1)(2011-1#1)
studied in recent years##2##4##(2008-11#1)(2008-8#1)
studied in relation to##8##4##(1995-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)
studied in several##2##3##(2010-8#1)(2012-3#1)
studied in solution by##2##4##(1994-5#1)(2008-10#1)
studied in terms of##5##4##(2008-10#2)(2008-2#1)(2009-9#1)(2010-2#1)
studied in the context of##2##5##(1994-2#1)(2008-7#1)
studied in the field and##2##5##(2008-10#1)(2008-5#1)
studied in the field##3##4##(2008-10#2)(2008-5#1)
studied in the liver of##2##5##(1990-3#1)(2008-5#1)
studied in the past##2##4##(2008-1#1)(2012-7#1)
studied in the presence and absence of##2##7##(2008-10#2)
studied in the presence of##3##5##(2008-10#3)
studied in the presence##5##4##(2008-10#5)
studied in the range of##3##5##(1990-5#1)(2008-10#2)
studied in the rat##4##4##(1996-12#2)(1996-2#1)(1997-2#1)
studied in the##61##3##(1990-11#1)(1990-3#1)(1990-5#3)(1990-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-2#2)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#2)(1997-2#2)(1997-3#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-9#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
studied in this paper##4##4##(1993-6#1)(2008-10#3)
studied in this work##2##4##(2010-7#1)(2011-1#1)
studied in this##8##3##(1993-6#1)(2007-7#1)(2008-10#3)(2008-12#1)(2010-7#1)(2011-1#1)
studied in three##2##3##(1996-2#1)(2010-8#1)
studied in two##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
studied in vitro and##2##4##(1996-5#1)(2008-11#1)
studied in vitro using##2##4##(2008-10#1)(2009-10#1)
studied in vitro##11##3##(1990-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)
studied in##408##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-5#6)(1990-7#4)(1991-12#4)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#7)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-12#4)(1996-2#7)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#121)(2008-11#16)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#19)(2008-6#8)(2008-7#15)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#3)(2013-7#5)(2013-8#1)
studied include the##2##3##(2008-10#2)
studied include##3##2##(2008-10#2)(2012-2#1)
studied included##4##2##(1992-3#1)(1994-3#1)(2008-1#1)(2008-10#1)
studied including##2##2##(2008-9#1)(2013-1#1)
studied is the##2##3##(2008-10#1)(2008-2#1)
studied is##6##2##(1994-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
studied its##10##2##(1991-2#1)(1991-6#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-9#2)(2012-3#2)
studied mainly##2##2##(2008-10#1)(2010-5#1)
studied methods##2##2##(2008-10#2)
studied more##3##2##(2008-10#2)(2009-3#1)
studied nine##2##2##(1997-5#1)(2008-1#1)
studied numerically##2##2##(2007-11#1)(2007-12#1)
studied of##3##2##(1990-9#1)(1993-6#1)(2008-11#1)
studied on a##6##3##(2008-10#5)(2010-4#1)
studied on five##2##3##(2008-10#1)(2009-8#1)
studied on the##6##3##(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
studied on##29##2##(1990-8#1)(1991-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#14)(2008-11#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#1)(2013-8#1)
studied only in##2##3##(1997-7#1)(2010-1#1)
studied over a period of##2##5##(1991-6#1)(2008-1#1)
studied over a##6##3##(1991-6#1)(1994-7#1)(1997-2#1)(2008-1#1)(2008-3#2)
studied over the range##2##4##(1995-2#1)(2008-10#1)
studied over the##5##3##(1995-2#1)(1995-5#1)(2008-10#1)(2008-6#1)(2009-2#1)
studied over##13##2##(1991-6#1)(1994-7#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-2#1)
studied pH range##2##3##(2008-10#2)
studied pairs of##2##3##(2009-12#1)(2009-8#1)
studied parameters##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)
studied patients##3##2##(1990-6#1)(2008-1#1)(2013-1#1)
studied population was##2##3##(2008-3#1)(2011-2#1)
studied population##6##2##(2008-10#1)(2008-3#1)(2009-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
studied potentiometrically (H(+)-glass electrode)##3##4##(2008-10#3)
studied potentiometrically##6##2##(2008-10#6)
studied previously##3##2##(1990-5#1)(2008-7#1)(2012-7#1)
studied prospectively##6##2##(1990-9#1)(1991-4#1)(1994-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
studied quantitatively##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
studied ranged from##2##3##(2011-2#1)(2012-1#1)
studied retrospectively##8##2##(1990-9#1)(1994-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)
studied separately##2##2##(1996-2#1)(2009-8#1)
studied so far##3##3##(1997-6#1)(2008-7#2)
studied soils##2##2##(2008-10#2)
studied species##4##2##(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)
studied spectrophotometrically##6##2##(2008-10#6)
studied strains and##2##3##(2007-10#1)(2012-12#1)
studied strains##4##2##(2007-10#1)(2010-2#1)(2012-12#2)
studied subjects##2##2##(2011-1#1)(2013-1#1)
studied systematically##2##2##(2008-10#2)
studied the association of##2##4##(1991-12#1)(2008-10#1)
studied the association##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
studied the effect of a##2##5##(1992-6#1)(1997-8#1)
studied the effect of##23##4##(1990-2#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#3)(1995-12#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)
studied the effects of the##3##5##(1994-8#1)(1995-3#1)(2008-3#1)
studied the effects of##17##4##(1990-11#1)(1993-1#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-10#1)(2013-1#1)(2013-8#1)
studied the effects##18##3##(1990-11#1)(1993-1#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-10#1)(2013-1#1)(2013-8#1)
studied the evolution of##2##4##(2008-9#1)(2012-3#1)
studied the expression of##6##4##(1993-8#1)(1996-12#1)(2008-7#1)(2008-9#2)(2013-8#1)
studied the expression##7##3##(1993-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2013-8#1)
studied the function of##2##4##(2008-8#1)(2012-2#1)
studied the impact of two##2##5##(2008-5#1)(2013-1#1)
studied the impact of##3##4##(2008-5#1)(2008-7#1)(2013-1#1)
studied the influence of##7##4##(1994-8#1)(2008-3#2)(2008-5#3)(2011-1#1)
studied the molecular##2##3##(1993-6#1)(2008-8#1)
studied the relationship between##2##4##(1992-9#1)(2008-5#1)
studied the role of##5##4##(1992-5#1)(1995-12#2)(1996-12#1)(1997-6#1)
studied the##184##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#3)(1994-11#4)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#3)(2013-7#3)(2013-8#7)
studied their##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
studied theoretically##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
studied this##2##2##(1990-2#1)(2008-4#1)
studied through a##2##3##(2008-3#1)(2008-7#1)
studied through##7##2##(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#2)
studied thus far##2##3##(2007-12#1)(2012-2#1)
studied to assess the##2##4##(1991-9#1)(2008-10#1)
studied to assess##5##3##(1991-9#1)(1995-2#2)(2008-10#2)
studied to date##3##3##(1993-2#1)(2010-3#1)(2012-3#1)
studied to determine the##4##4##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
studied to determine##9##3##(1993-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
studied to ensure##2##3##(2008-10#2)
studied to estimate##2##3##(1995-10#1)(2008-3#1)
studied to test##2##3##(2008-10#2)
studied to##48##2##(1991-1#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1995-10#1)(1995-11#1)(1995-2#2)(2007-10#1)(2007-7#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#2)
studied two##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
studied under different##3##3##(2008-10#3)
studied under laboratory conditions##2##4##(2008-12#1)(2011-2#1)
studied under the same##2##4##(1990-8#1)(2009-5#1)
studied under the##4##3##(1990-8#1)(2008-10#1)(2008-9#1)(2009-5#1)
studied under various##2##3##(1995-3#1)(1996-6#1)
studied under##22##2##(1990-8#1)(1991-2#1)(1992-8#1)(1995-3#1)(1996-6#1)(1997-2#1)(2008-10#7)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
studied upon##2##2##(1991-2#1)(2008-3#1)
studied using a bioluminescent strain##2##5##(2008-10#2)
studied using a##11##3##(2008-10#8)(2008-9#1)(2010-10#1)(2010-6#1)
studied using cyclic##2##3##(2008-10#2)
studied using immersion tests##2##4##(2012-2#2)
studied using methanol##2##3##(1994-9#1)(2008-10#1)
studied using scanning electron##2##4##(1995-6#1)(2009-3#1)
studied using the##11##3##(1990-3#1)(1993-3#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-8#1)
studied using two##2##3##(2008-10#1)(2009-8#1)
studied using##119##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#3)(1991-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#4)(1995-12#2)(1995-2#1)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-1#1)(2008-10#50)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
studied variables##2##2##(2007-8#1)(2011-2#1)
studied was##6##2##(1991-12#1)(1993-6#1)(2008-10#3)(2008-6#1)
studied were also##2##3##(1997-4#1)(2008-2#1)
studied were higher than##2##4##(2008-10#1)(2008-5#1)
studied were the##3##3##(1994-5#1)(1996-5#1)(2008-10#1)
studied were##29##2##(1994-5#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-7#1)(2013-8#1)
studied when##3##2##(1990-9#1)(2008-10#1)(2008-3#1)
studied whether##2##2##(1992-12#1)(2012-3#1)
studied with Monte Carlo##2##4##(2008-3#2)
studied with a##5##3##(1997-4#1)(2007-12#2)(2008-10#1)(2008-3#1)
studied with regard to##2##4##(2008-10#2)
studied with respect to##2##4##(1993-6#1)(2008-10#1)
studied with the##13##3##(1993-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
studied with##59##2##(1990-5#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-12#3)(1993-6#1)(1994-6#1)(1995-2#1)(1996-7#1)(1997-4#1)(2007-12#4)(2008-10#14)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
studied##2955##1##(1990-11#11)(1990-12#11)(1990-2#9)(1990-3#10)(1990-5#17)(1990-6#5)(1990-7#12)(1990-8#12)(1990-9#6)(1991-1#1)(1991-10#2)(1991-11#7)(1991-12#17)(1991-2#11)(1991-3#3)(1991-4#2)(1991-5#12)(1991-6#8)(1991-8#6)(1991-9#11)(1992-10#3)(1992-11#5)(1992-12#8)(1992-2#5)(1992-3#15)(1992-4#1)(1992-5#7)(1992-6#10)(1992-7#1)(1992-8#13)(1992-9#7)(1993-1#6)(1993-10#2)(1993-11#7)(1993-12#22)(1993-2#9)(1993-3#6)(1993-5#2)(1993-6#10)(1993-8#11)(1993-9#5)(1994-1#1)(1994-11#15)(1994-12#7)(1994-2#10)(1994-3#8)(1994-5#16)(1994-6#9)(1994-7#3)(1994-8#13)(1994-9#7)(1995-1#1)(1995-10#2)(1995-11#15)(1995-12#27)(1995-2#12)(1995-3#10)(1995-5#11)(1995-6#10)(1995-8#8)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#16)(1996-2#18)(1996-3#2)(1996-4#1)(1996-5#18)(1996-6#3)(1996-7#5)(1996-8#2)(1997-1#7)(1997-2#20)(1997-3#10)(1997-4#11)(1997-5#7)(1997-6#2)(1997-7#5)(1997-8#9)(2006-10#3)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#17)(2007-11#44)(2007-12#42)(2007-2#2)(2007-6#1)(2007-7#18)(2007-8#25)(2007-9#2)(2008-1#31)(2008-10#1022)(2008-11#65)(2008-12#39)(2008-2#60)(2008-3#124)(2008-4#25)(2008-5#94)(2008-6#29)(2008-7#74)(2008-8#58)(2008-9#49)(2009-1#2)(2009-10#4)(2009-11#11)(2009-12#6)(2009-2#5)(2009-3#5)(2009-5#5)(2009-6#3)(2009-7#7)(2009-8#16)(2009-9#6)(2010-1#4)(2010-10#7)(2010-11#10)(2010-12#7)(2010-2#6)(2010-3#14)(2010-4#9)(2010-5#9)(2010-6#2)(2010-7#8)(2010-8#8)(2011-1#23)(2011-10#4)(2011-2#59)(2011-3#5)(2012-1#18)(2012-12#16)(2012-2#45)(2012-3#36)(2012-5#2)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#47)(2013-7#18)(2013-8#44)
studies (e##2##2##(1991-8#1)(2008-4#1)
studies (i##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
studies (up to##2##3##(2008-10#1)(2011-2#1)
studies - a##2##3##(2008-10#2)
studies a##3##2##(2008-10#2)(2013-1#1)
studies about the##3##3##(2008-10#1)(2012-3#2)
studies about##7##2##(2008-10#2)(2008-9#1)(2012-3#2)(2013-1#2)
studies addressing##6##2##(2007-11#1)(2007-2#1)(2008-8#2)(2010-10#1)(2012-2#1)
studies agree##2##2##(1996-2#1)(2008-3#1)
studies aimed at understanding the##3##5##(1995-6#1)(2008-7#1)(2009-6#1)
studies aimed at understanding##4##4##(1995-6#1)(2008-7#2)(2009-6#1)
studies aimed at##11##3##(1991-5#1)(1995-6#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#2)
studies also showed that##2##4##(1996-12#1)(2008-5#1)
studies also suggest that the##2##5##(2011-2#1)(2013-8#1)
studies also suggest that##3##4##(2008-8#1)(2011-2#1)(2013-8#1)
studies also##22##2##(1991-1#1)(1994-10#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies analyzing##2##2##(2008-11#1)(2008-2#1)
studies and a##3##3##(1996-11#1)(2008-7#1)(2012-12#1)
studies and are##2##3##(1991-2#1)(2007-11#1)
studies and by##3##3##(1990-8#1)(2007-6#1)(2008-10#1)
studies and clinical trials##3##4##(1993-11#1)(2008-8#1)(2010-8#1)
studies and clinical##5##3##(1993-11#1)(1997-1#1)(2008-8#1)(2010-8#1)(2012-3#1)
studies and experimental##2##3##(2009-10#1)(2010-10#1)
studies and have##2##3##(2008-2#1)(2008-5#1)
studies and in##5##3##(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)
studies and new##3##3##(2008-1#2)(2013-1#1)
studies and other##2##3##(2007-11#1)(2008-8#1)
studies and our##2##3##(1997-2#1)(2009-2#1)
studies and provides##2##3##(2008-4#1)(2009-5#1)
studies and publications##2##3##(2011-2#1)(2012-12#1)
studies and studies##2##3##(2008-11#1)(2008-7#1)
studies and the##11##3##(1991-12#1)(1994-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
studies and to##3##3##(2008-9#1)(2009-5#1)(2012-3#1)
studies and two##2##3##(2008-5#1)(2012-12#1)
studies and##160##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-6#1)(2008-1#4)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#10)(2012-12#7)(2012-2#3)(2012-3#7)(2013-1#6)(2013-8#3)
studies applied##2##2##(2008-7#1)(2009-6#1)
studies are also##4##3##(2007-12#1)(2009-6#1)(2009-8#1)(2012-3#1)
studies are available##2##3##(2011-2#1)(2013-8#1)
studies are based on the##2##5##(2012-2#1)(2012-3#1)
studies are based on##3##4##(2008-7#1)(2012-2#1)(2012-3#1)
studies are carried out##2##4##(2009-12#1)(2010-11#1)
studies are conducted to##2##4##(2008-10#1)(2009-10#1)
studies are consistent with the##3##5##(1997-1#1)(2007-8#1)(2008-10#1)
studies are consistent with##4##4##(1995-12#1)(1997-1#1)(2007-8#1)(2008-10#1)
studies are described##2##3##(2009-11#1)(2010-2#1)
studies are descriptive##2##3##(2011-2#1)(2012-2#1)
studies are discussed##6##3##(1993-12#1)(1996-3#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-1#1)
studies are essential##2##3##(1993-12#1)(2011-2#1)
studies are examined##2##3##(2008-8#1)(2011-2#1)
studies are generally##2##3##(2008-2#1)(2010-11#1)
studies are identified##2##3##(2011-2#2)
studies are in progress##2##4##(1993-11#1)(2008-12#1)
studies are in##4##3##(1991-9#1)(1993-11#1)(2008-12#1)(2008-9#1)
studies are limited##2##3##(2007-5#1)(2008-1#1)
studies are necessary in##3##4##(2007-10#2)(2013-8#1)
studies are necessary to confirm##2##5##(2012-12#1)(2013-1#1)
studies are necessary to determine the##2##6##(2009-12#1)(2011-2#1)
studies are necessary to determine##3##5##(2009-12#1)(2011-2#1)(2013-8#1)
studies are necessary to##12##4##(2007-10#1)(2007-8#1)(2008-1#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
studies are necessary##16##3##(2007-10#3)(2007-8#1)(2008-1#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
studies are needed to clarify the effects of##2##8##(2010-12#1)(2012-3#1)
studies are needed to clarify the##3##6##(2010-12#1)(2012-3#1)(2013-8#1)
studies are needed to clarify##4##5##(1991-3#1)(2010-12#1)(2012-3#1)(2013-8#1)
studies are needed to confirm##4##5##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
studies are needed to establish the##3##6##(2007-10#1)(2012-2#2)
studies are needed to establish##5##5##(2007-10#1)(2008-5#1)(2012-2#2)(2012-3#1)
studies are needed to evaluate the##2##6##(2009-5#1)(2009-8#1)
studies are needed to evaluate##3##5##(2008-3#1)(2009-5#1)(2009-8#1)
studies are needed to##32##4##(1991-3#1)(1991-6#1)(1993-8#1)(1995-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
studies are needed##40##3##(1991-12#1)(1991-3#1)(1991-6#1)(1993-8#1)(1995-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
studies are not##2##3##(1990-6#1)(1997-3#1)
studies are now##2##3##(1997-3#1)(2008-9#1)
studies are often##4##3##(1997-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
studies are performed##3##3##(1992-12#1)(1997-3#1)(2008-7#1)
studies are planned to##2##4##(2008-11#1)(2008-6#1)
studies are presented##5##3##(1990-5#1)(1995-5#1)(2008-3#2)(2011-2#1)
studies are reported for##2##4##(2008-10#2)
studies are reported##6##3##(2008-10#3)(2008-12#1)(2008-5#1)(2012-12#1)
studies are required to clarify the##2##6##(2010-8#1)(2012-2#1)
studies are required to clarify##3##5##(1994-9#1)(2010-8#1)(2012-2#1)
studies are required to elucidate the##2##6##(2008-6#1)(2012-2#1)
studies are required to##13##4##(1990-6#1)(1993-11#1)(1993-2#1)(1994-9#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
studies are required##20##3##(1990-6#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
studies are reviewed##2##3##(2012-2#2)
studies are still lacking##2##4##(2008-10#1)(2008-3#1)
studies are still##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
studies are the##2##3##(1995-5#1)(2008-5#1)
studies are undertaken##2##3##(2012-2#1)(2012-3#1)
studies are used to##2##4##(2008-4#1)(2010-5#1)
studies are used##3##3##(1990-3#1)(2008-4#1)(2010-5#1)
studies are warranted to##4##4##(2008-10#1)(2008-5#1)(2008-7#2)
studies are warranted##6##3##(2008-10#1)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)
studies are##219##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#3)(2010-8#2)(2011-1#5)(2011-2#14)(2012-1#1)(2012-12#7)(2012-2#15)(2012-3#8)(2013-1#8)(2013-8#7)
studies as a##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
studies as well as gene##2##5##(1996-6#1)(1996-9#1)
studies as well as##3##4##(1996-6#1)(1996-9#1)(2008-11#1)
studies as well##5##3##(1995-9#1)(1996-6#1)(1996-9#1)(2008-11#1)(2013-1#1)
studies as##13##2##(1995-9#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#3)(2009-12#1)(2010-8#1)(2012-5#1)(2013-1#1)
studies at the##2##3##(1994-2#1)(2008-7#1)
studies at##10##2##(1992-11#1)(1994-2#1)(2008-10#5)(2008-7#1)(2008-9#1)(2011-2#1)
studies based on the##7##4##(1991-4#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-1#1)
studies based on##13##3##(1991-4#1)(1992-9#2)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2009-7#1)(2012-1#1)
studies because##2##2##(2008-2#1)(2011-2#1)
studies before##2##2##(2008-6#1)(2012-2#1)
studies between##5##2##(2008-10#2)(2008-6#1)(2008-7#1)(2010-9#1)
studies but##3##2##(2008-11#1)(2009-6#1)(2012-3#1)
studies by incorporating##3##3##(1992-9#1)(2012-2#2)
studies by##19##2##(1990-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#3)
studies can be applied##2##4##(2008-10#1)(2008-11#1)
studies can be##8##3##(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
studies can##14##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies carried out in the##3##5##(2008-10#2)(2008-7#1)
studies carried out in##5##4##(1996-7#1)(2008-10#3)(2008-7#1)
studies carried out on##2##4##(2008-10#1)(2013-7#1)
studies carried out through##2##4##(2008-10#1)(2012-2#1)
studies carried out to##2##4##(2008-10#2)
studies carried out##12##3##(1990-5#1)(1996-7#1)(2008-10#7)(2008-7#1)(2012-2#1)(2013-7#1)
studies clearly##2##2##(1990-7#1)(1996-2#1)
studies compared##7##2##(2008-2#1)(2008-6#1)(2008-7#2)(2012-12#2)(2012-2#1)
studies comparing the##2##3##(1990-2#1)(2009-7#1)
studies comparing##8##2##(1990-2#1)(1992-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-12#1)
studies concerning##5##2##(1992-9#1)(1995-8#1)(2008-8#1)(2013-1#1)(2013-7#1)
studies conducted by the authors##2##5##(1995-1#1)(2012-3#1)
studies conducted during##2##3##(2008-10#1)(2008-11#1)
studies conducted for##2##3##(2008-10#1)(2008-2#1)
studies conducted in the##2##4##(1990-8#1)(1994-9#1)
studies conducted in##9##3##(1990-8#1)(1994-9#1)(1996-1#1)(2008-10#2)(2008-7#1)(2009-1#1)(2011-2#2)
studies conducted on the##2##4##(2011-2#1)(2013-1#1)
studies conducted on##3##3##(1997-4#1)(2011-2#1)(2013-1#1)
studies conducted with##2##3##(2008-5#2)
studies conducted##30##2##(1990-8#1)(1992-10#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
studies confirm that##3##3##(1993-6#1)(1995-2#1)(2010-1#1)
studies confirm the##2##3##(2008-5#2)
studies confirm##8##2##(1993-2#1)(1993-6#1)(1995-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)
studies confirmed##5##2##(1992-6#1)(1994-11#1)(1997-8#1)(2008-10#1)(2008-8#1)
studies consider the##2##3##(1992-3#1)(2007-12#1)
studies consider##3##2##(1992-3#1)(2007-12#1)(2009-5#1)
studies covering##2##2##(2008-1#1)(2008-4#1)
studies dealing with##3##3##(1996-5#1)(2011-2#1)(2012-7#1)
studies define##2##2##(2008-3#1)(2012-12#1)
studies demonstrate a##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
studies demonstrate that it##2##4##(1994-10#1)(2008-7#1)
studies demonstrate that the##6##4##(1990-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
studies demonstrate that these##2##4##(2010-2#1)(2010-7#1)
studies demonstrate that##24##3##(1990-2#1)(1991-12#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-8#1)(1995-2#2)(1996-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#2)(2013-1#1)
studies demonstrate the##5##3##(1990-12#1)(1991-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
studies demonstrate##35##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
studies demonstrated a high##2##4##(2008-10#1)(2010-11#1)
studies demonstrated a##5##3##(2006-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
studies demonstrated that all##2##4##(1991-9#1)(2009-8#1)
studies demonstrated that the##5##4##(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
studies demonstrated that##18##3##(1991-2#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
studies demonstrated the feasibility of##2##5##(2007-8#1)(2011-2#1)
studies demonstrated the##6##3##(1994-2#1)(1994-3#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-3#1)
studies demonstrated##36##2##(1990-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
studies demonstrating that##2##3##(2008-11#1)(2008-12#1)
studies demonstrating##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
studies describe##2##2##(2007-12#1)(2011-2#1)
studies described in this report##2##5##(1993-6#1)(2008-11#1)
studies described##6##2##(1993-6#1)(1994-8#1)(1996-1#1)(2007-12#1)(2008-11#1)(2008-7#1)
studies describing the##2##3##(1994-2#1)(2008-11#1)
studies describing##4##2##(1994-2#1)(2008-11#1)(2012-3#2)
studies designed to##5##3##(1992-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
studies did not##5##3##(1992-11#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
studies directly##2##2##(1995-2#1)(2008-3#1)
studies do not##4##3##(1991-12#1)(1992-9#1)(2008-11#1)(2012-2#1)
studies done in##3##3##(1992-12#1)(2008-10#2)
studies done##4##2##(1992-12#1)(2008-10#2)(2008-8#1)
studies during the##2##3##(1995-5#1)(2010-12#1)
studies during##5##2##(1995-5#1)(2008-3#1)(2008-7#2)(2010-12#1)
studies employ##2##2##(1996-9#1)(2008-8#1)
studies employing##6##2##(1994-5#1)(2008-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
studies establish##2##2##(1995-2#1)(2009-11#1)
studies established##2##2##(1994-8#1)(1996-8#1)
studies evaluated##2##2##(2008-2#1)(2012-3#1)
studies evaluating the##5##3##(2006-10#1)(2007-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
studies evaluating##11##2##(1995-1#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-2#1)(2008-7#1)(2010-1#2)(2010-12#1)(2012-1#1)(2013-1#1)
studies examined musculoskeletal injuries in the##2##6##(2013-1#2)
studies examined musculoskeletal injuries##3##4##(2013-1#3)
studies examined##6##2##(2007-12#1)(2008-2#1)(2010-4#1)(2013-1#3)
studies examining the##3##3##(1994-9#1)(2008-7#1)(2013-1#1)
studies examining##12##2##(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
studies exist##2##2##(1993-9#1)(2007-11#1)
studies exploring the##2##3##(2010-2#1)(2011-1#1)
studies exploring##3##2##(2009-4#1)(2010-2#1)(2011-1#1)
studies failed to##6##3##(2008-10#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-1#1)
studies focused on the##2##4##(2008-1#1)(2008-11#1)
studies focused on##4##3##(2008-1#1)(2008-11#1)(2009-7#1)(2010-11#1)
studies focusing on this##2##4##(2008-9#1)(2011-2#1)
studies focusing on##6##3##(1993-12#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
studies focusing##7##2##(1993-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
studies for a##3##3##(1995-3#1)(1997-2#1)(2009-3#1)
studies for stem cell-based##2##4##(2012-12#2)
studies for tebuconazole effect on##2##5##(2008-10#2)
studies for the##5##3##(2008-10#3)(2009-7#1)(2012-2#1)
studies for##34##2##(1992-9#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#1)
studies found no##2##3##(2009-4#1)(2011-2#1)
studies found that##4##3##(2007-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
studies found##12##2##(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#4)(2012-1#1)(2013-7#1)(2013-8#1)
studies from our##2##3##(1995-5#1)(2008-10#1)
studies from the##2##3##(1992-1#1)(2007-8#1)
studies from this laboratory##3##4##(1990-11#1)(1991-3#1)(1995-12#1)
studies from##23##2##(1990-11#1)(1991-3#1)(1992-1#1)(1993-11#1)(1995-12#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2009-2#1)(2011-2#3)(2012-12#1)(2012-2#2)
studies further##4##2##(1990-10#1)(1996-12#1)(2013-1#1)(2013-8#1)
studies gave##2##2##(1994-9#1)(2008-10#1)
studies has been##3##3##(1994-1#1)(1996-9#1)(2008-10#1)
studies has varied##2##3##(1996-12#1)(2008-1#1)
studies has##9##2##(1994-1#1)(1996-12#1)(1996-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)
studies have already##3##3##(1995-8#1)(1997-4#1)(2007-7#1)
studies have also shown that##2##5##(1993-12#1)(2008-10#1)
studies have also shown##3##4##(1993-12#1)(2007-8#1)(2008-10#1)
studies have also##5##3##(1993-12#1)(2007-8#1)(2008-10#2)(2008-6#1)
studies have been carried out in##2##6##(1994-5#1)(2008-11#1)
studies have been carried out on the##3##7##(1993-9#1)(2007-6#1)(2008-10#1)
studies have been carried out##10##5##(1993-3#1)(1993-9#1)(1994-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)(2012-3#1)
studies have been conducted in##3##5##(2008-7#1)(2013-1#2)
studies have been conducted on the##2##6##(2011-2#1)(2012-12#1)
studies have been conducted to##2##5##(2012-2#1)(2013-1#1)
studies have been conducted##11##4##(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
studies have been limited to##2##5##(2008-11#1)(2011-1#1)
studies have been performed to##3##5##(2007-10#1)(2008-11#1)(2008-4#1)
studies have been performed##9##4##(1996-2#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
studies have been published##6##4##(1995-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)
studies have been reported##3##4##(1990-11#1)(1990-8#1)(2008-5#1)
studies have been undertaken to##3##5##(2008-7#1)(2012-3#1)(2013-1#1)
studies have been##60##3##(1990-11#1)(1990-8#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-5#2)(1996-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#4)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)
studies have begun to##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
studies have claimed that##3##4##(2007-5#1)(2009-2#1)(2010-8#1)
studies have clearly shown that the##3##6##(1990-6#1)(1995-12#1)(2007-7#1)
studies have compared the##2##4##(2011-2#1)(2013-1#1)
studies have compared##5##3##(1991-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
studies have confirmed that##3##4##(2007-10#1)(2008-12#1)(2008-8#1)
studies have confirmed the##4##4##(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)
studies have confirmed##9##3##(1995-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-8#1)(2011-2#1)
studies have considered##2##3##(2009-2#1)(2013-7#1)
studies have demonstrated a##2##4##(2008-3#1)(2008-4#1)
studies have demonstrated that the##7##5##(1990-3#1)(1994-8#2)(2008-7#2)(2011-1#1)(2011-3#1)
studies have demonstrated that##24##4##(1990-12#1)(1990-3#1)(1992-8#1)(1993-12#2)(1994-8#2)(1996-2#1)(2008-1#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)
studies have demonstrated the##8##4##(1992-1#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-5#2)(2012-2#1)
studies have demonstrated##37##3##(1990-12#1)(1990-3#1)(1992-1#1)(1992-8#1)(1993-12#2)(1994-8#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
studies have described##2##3##(2008-12#1)(2008-9#1)
studies have emphasized##2##3##(2009-2#1)(2013-1#1)
studies have established a##2##4##(2009-12#1)(2010-12#1)
studies have established##3##3##(2008-5#1)(2009-12#1)(2010-12#1)
studies have evaluated the##5##4##(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
studies have evaluated##8##3##(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)
studies have examined the impact of##2##6##(2007-10#1)(2013-1#1)
studies have examined the##11##4##(1993-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
studies have examined##16##3##(1993-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
studies have explored the##3##4##(2008-2#1)(2009-10#1)(2010-1#1)
studies have failed to##2##4##(1994-2#1)(2008-7#1)
studies have focused on the##3##5##(2008-4#1)(2008-8#1)(2008-9#1)
studies have focused on##8##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
studies have focused##9##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-3#1)
studies have found##9##3##(1990-9#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
studies have identified the##2##4##(2008-10#1)(2008-6#1)
studies have identified##13##3##(1995-6#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies have implicated the##2##4##(1994-3#1)(2013-1#1)
studies have implicated##7##3##(1993-11#1)(1994-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-1#1)
studies have indicated that the##4##5##(1995-6#1)(2008-9#1)(2010-11#1)(2012-2#1)
studies have indicated that##16##4##(1992-12#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)
studies have indicated the##2##4##(2008-11#1)(2013-1#1)
studies have indicated##22##3##(1992-12#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
studies have investigated female##2##4##(2009-9#1)(2012-3#1)
studies have investigated the##3##4##(2007-11#1)(2008-12#1)(2013-1#1)
studies have investigated##6##3##(2007-11#1)(2008-12#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
studies have led to##2##4##(1997-8#1)(2008-3#1)
studies have localized##2##3##(1993-6#1)(1995-12#1)
studies have measured##2##3##(2008-8#1)(2010-6#1)
studies have not been##2##4##(2008-11#1)(2012-2#1)
studies have not provided##2##4##(1991-2#1)(1992-3#1)
studies have not##6##3##(1991-2#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
studies have now demonstrated that##3##5##(1997-1#1)(2008-11#1)(2009-2#1)
studies have now##4##3##(1993-2#1)(1997-1#1)(2008-11#1)(2009-2#1)
studies have proved that the##2##5##(2008-10#1)(2013-8#1)
studies have provided a##3##4##(1992-8#1)(2007-12#1)(2007-8#1)
studies have provided##10##3##(1992-8#1)(1992-9#1)(1996-5#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
studies have quantified##2##3##(2008-9#1)(2012-2#1)
studies have reported a##3##4##(1992-9#1)(2007-10#1)(2008-9#1)
studies have reported that the##3##5##(2008-11#1)(2008-3#1)(2009-11#1)
studies have reported that##5##4##(2008-11#1)(2008-3#1)(2009-11#1)(2012-3#1)(2013-1#1)
studies have reported the##2##4##(2008-11#1)(2013-8#1)
studies have reported##22##3##(1992-9#1)(1996-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
studies have revealed that##11##4##(1992-10#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-2#1)
studies have revealed##17##3##(1992-10#1)(1993-12#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#1)
studies have shown that a##3##5##(1994-8#1)(2011-2#2)
studies have shown that some##2##5##(2008-3#1)(2008-9#1)
studies have shown that the##21##5##(1990-11#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1996-12#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies have shown that this##5##5##(1993-6#1)(2008-7#2)(2011-2#2)
studies have shown that##93##4##(1990-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
studies have shown the##5##4##(1990-2#1)(1992-2#1)(2008-2#1)(2009-11#1)(2013-7#1)
studies have shown##117##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#3)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#5)(2008-7#8)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
studies have suggested a possible##2##5##(2013-1#2)
studies have suggested a##4##4##(2008-5#1)(2013-1#3)
studies have suggested that##9##4##(1992-2#1)(1994-2#1)(1994-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
studies have suggested##15##3##(1992-2#1)(1994-2#1)(1994-6#1)(1997-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#4)
studies have supported the##2##4##(2007-12#1)(2008-3#1)
studies have tested##2##3##(2008-11#1)(2008-9#1)
studies have uncovered##2##3##(2009-9#1)(2012-3#1)
studies have used##5##3##(2008-2#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
studies have yielded##2##3##(1990-8#1)(2013-1#1)
studies have##505##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-12#2)(1996-2#4)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#6)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#19)(2008-11#25)(2008-12#10)(2008-2#10)(2008-3#14)(2008-4#8)(2008-5#19)(2008-6#5)(2008-7#26)(2008-8#15)(2008-9#19)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#8)(2011-2#35)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#21)(2012-3#10)(2013-1#29)(2013-7#4)(2013-8#7)
studies however##2##2##(1993-11#1)(2010-1#1)
studies identified the##2##3##(2006-10#1)(2012-2#1)
studies identified##4##2##(2006-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
studies illustrate the##2##3##(1996-3#1)(2008-7#1)
studies illustrate##5##2##(1992-11#1)(1994-10#1)(1996-3#1)(2008-10#1)(2008-7#1)
studies in Drosophila##2##3##(2008-10#1)(2008-9#1)
studies in a##4##3##(1992-8#1)(2008-10#1)(2008-9#1)(2010-5#1)
studies in animal models##5##4##(2006-6#1)(2009-11#1)(2009-5#1)(2010-10#1)(2012-3#1)
studies in bovine##2##3##(2008-10#1)(2008-11#1)
studies in children##3##3##(2007-11#1)(2008-8#1)(2009-5#1)
studies in different##3##3##(1996-5#1)(2008-12#1)(2013-1#1)
studies in health##2##3##(1992-2#1)(2011-2#1)
studies in human##2##3##(2008-10#1)(2013-1#1)
studies in humans##3##3##(2008-7#1)(2009-12#1)(2009-8#1)
studies in mice##2##3##(2011-2#1)(2012-1#1)
studies in order to##3##4##(2008-11#1)(2011-1#1)(2013-1#1)
studies in other##3##3##(1995-3#1)(2008-5#1)(2009-4#1)
studies in our##3##3##(1991-2#1)(2008-7#1)(2009-6#1)
studies in patients with##6##4##(1996-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-2#1)
studies in rat##2##3##(1992-11#1)(2012-1#1)
studies in rats##4##3##(1991-12#1)(1997-1#1)(2008-5#1)(2008-7#1)
studies in recent years##2##4##(2008-3#1)(2008-9#1)
studies in the absence##2##4##(1992-6#1)(2008-11#1)
studies in the context of##2##5##(2008-11#1)(2013-8#1)
studies in the field##3##4##(2009-10#2)(2013-8#1)
studies in the presence of##2##5##(1994-8#1)(2008-10#1)
studies in the##31##3##(1992-2#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2009-10#3)(2009-12#1)(2009-8#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#2)
studies in these##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)
studies in this area##2##4##(2008-11#1)(2012-12#1)
studies in this##5##3##(2008-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
studies in vivo##4##3##(1995-9#1)(1996-5#2)(2008-5#1)
studies in which the##3##4##(2008-7#1)(2013-1#1)(2013-8#1)
studies in which##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
studies in##200##2##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#3)(1996-6#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#16)(2008-11#9)(2008-12#5)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2011-1#7)(2011-2#8)(2011-8#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#6)
studies include##2##2##(2008-8#1)(2010-7#1)
studies including a##2##3##(1991-11#1)(2008-1#1)
studies including##9##2##(1991-11#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
studies increased##2##2##(2008-5#2)
studies indicate a novel##2##4##(2008-1#1)(2008-3#1)
studies indicate a##3##3##(2008-1#1)(2008-3#1)(2009-12#1)
studies indicate that both##3##4##(1990-9#1)(1991-5#1)(1995-11#1)
studies indicate that in##2##4##(2008-10#1)(2008-3#1)
studies indicate that the##13##4##(1990-11#2)(1991-12#1)(1993-9#1)(1995-2#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)
studies indicate that##63##3##(1990-11#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-7#2)(1997-8#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
studies indicate##69##2##(1990-11#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(2008-1#4)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
studies indicated a##3##3##(1994-10#1)(1994-2#2)
studies indicated that the##7##4##(1993-12#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
studies indicated that##18##3##(1990-11#1)(1993-12#1)(1995-3#1)(1996-12#2)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#1)
studies indicated the##4##3##(1992-3#1)(2008-10#2)(2012-1#1)
studies indicated##25##2##(1990-11#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-2#2)(1995-3#1)(1996-12#2)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#2)(2012-1#1)(2013-1#1)
studies indicating that##5##3##(1994-5#1)(1995-6#1)(2011-2#2)(2013-1#1)
studies intended to##2##3##(1993-5#1)(2008-7#1)
studies into the##4##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
studies into##10##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
studies investigated the##2##3##(2009-9#1)(2012-3#1)
studies investigated##4##2##(1995-12#1)(2008-10#1)(2009-9#1)(2012-3#1)
studies investigating the##9##3##(1995-12#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-1#1)
studies investigating##16##2##(1995-12#1)(2007-10#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
studies involved##2##2##(1997-5#1)(2011-2#1)
studies involving the##4##3##(2008-10#3)(2008-5#1)
studies involving##22##2##(1994-3#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
studies is described##2##3##(2008-2#1)(2008-9#1)
studies is discussed##2##3##(1993-11#1)(2008-4#1)
studies is that##4##3##(1990-8#1)(1997-2#1)(2008-7#1)(2008-9#1)
studies is the##5##3##(2008-10#3)(2008-7#1)(2013-1#1)
studies is to##3##3##(2008-6#1)(2009-6#1)(2010-12#1)
studies is##31##2##(1990-8#1)(1993-11#1)(1994-2#1)(1995-9#1)(1996-9#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
studies it may be##2##4##(2008-3#1)(2008-8#1)
studies it##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
studies leading to##3##3##(2008-8#1)(2008-9#1)(2010-7#1)
studies looking at##2##3##(2008-7#1)(2013-8#1)
studies may be##6##3##(1991-6#1)(1992-9#1)(2007-2#1)(2008-1#1)(2008-2#1)(2012-2#1)
studies may provide##2##3##(2008-7#1)(2009-3#1)
studies may reflect##2##3##(1995-11#1)(2012-3#1)
studies may##19##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-5#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-2#1)(2012-3#1)
studies met inclusion criteria##3##4##(2007-12#1)(2012-12#2)
studies met the##2##3##(2007-11#1)(2013-1#1)
studies met##8##2##(2007-11#1)(2007-12#2)(2012-12#3)(2013-1#2)
studies might##2##2##(2008-11#1)(2011-2#1)
studies must be##2##3##(2007-6#1)(2010-11#1)
studies must##3##2##(2007-6#1)(2008-4#1)(2010-11#1)
studies need to be##2##4##(2008-9#1)(2010-12#1)
studies not##2##2##(1996-9#1)(2010-11#1)
studies now##2##2##(1994-5#1)(2009-3#1)
studies of DNA##2##3##(1993-8#1)(2008-7#1)
studies of a novel##2##4##(2007-12#1)(2008-8#1)
studies of a##10##3##(1990-6#1)(1992-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-11#1)(2012-3#1)
studies of acesulfame potassium##2##4##(2008-9#2)
studies of adult##2##3##(1996-9#1)(2007-12#1)
studies of alkali metal##2##4##(2008-2#1)(2012-2#1)
studies of an##2##3##(2008-10#1)(2008-3#1)
studies of anaphor comprehension##2##4##(2007-12#2)
studies of aspartame##3##3##(2008-8#3)
studies of bromodichloromethane##2##3##(2008-9#2)
studies of cancer##3##3##(2008-7#1)(2009-4#1)(2012-12#1)
studies of cell##2##3##(2008-11#1)(2008-2#1)
studies of cellular##2##3##(1997-4#1)(2008-9#1)
studies of children##2##3##(1991-1#1)(2010-5#1)
studies of chronic##2##3##(1991-1#1)(2007-7#1)
studies of complex##3##3##(1992-4#1)(2008-10#1)(2008-9#1)
studies of dichloroacetic acid##2##4##(2008-9#2)
studies of different##3##3##(1996-6#1)(2008-10#2)
studies of disease##2##3##(1997-3#1)(2012-2#1)
studies of each##2##3##(1993-11#1)(1997-2#1)
studies of efficacy##2##3##(1995-1#1)(2011-1#1)
studies of enzymes##2##3##(1996-12#1)(2008-4#1)
studies of gene expression##3##4##(2008-1#1)(2008-7#2)
studies of genes##2##3##(1991-12#1)(2008-8#1)
studies of how##2##3##(2008-10#2)
studies of human##4##3##(1995-6#1)(2008-11#1)(2008-4#1)(2012-2#1)
studies of humans##3##3##(1997-5#2)(2012-2#1)
studies of hydrogen##2##3##(1991-6#1)(2010-4#1)
studies of hydrozoans##2##3##(2010-2#2)
studies of its##2##3##(2008-10#1)(2008-7#1)
studies of laser##2##3##(2008-2#1)(2008-3#1)
studies of many##2##3##(2008-10#1)(2008-9#1)
studies of methylphenidate##2##3##(1995-11#2)
studies of natural##2##3##(2008-10#1)(2008-9#1)
studies of nickel and chromium in wastewater from##2##8##(2008-10#2)
studies of other##2##3##(1991-5#1)(2008-5#1)
studies of patients with##3##4##(1990-12#1)(2007-8#1)(2008-10#1)
studies of plant##2##3##(2008-9#1)(2009-8#1)
studies of population##2##3##(2008-9#1)(2010-12#1)
studies of prenatal##2##3##(2008-2#2)
studies of primary##2##3##(1997-3#1)(2007-10#1)
studies of protein-protein interactions##2##4##(2008-11#1)(2008-7#1)
studies of receptor##3##3##(1993-3#1)(2011-1#1)(2012-2#1)
studies of reverse-correlation have##2##4##(2013-8#2)
studies of selected##2##3##(2007-11#1)(2008-11#1)
studies of several##2##3##(1994-6#1)(2009-12#1)
studies of sexual selection##2##4##(2008-8#1)(2009-9#1)
studies of six##2##3##(1991-12#2)
studies of sodium bromate##2##4##(2008-9#2)
studies of stroke incidence##2##4##(2008-8#2)
studies of stroke##5##3##(2007-10#1)(2008-8#4)
studies of such##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
studies of the binary and ternary complexes involving##2##8##(2008-10#2)
studies of the biosensor##4##4##(2008-10#4)
studies of the development of##2##5##(1992-12#1)(2008-11#1)
studies of the effect of##3##5##(2008-10#2)(2008-9#1)
studies of the effect##4##4##(2008-10#2)(2008-3#1)(2008-9#1)
studies of the effects of##3##5##(1996-2#1)(2007-11#1)(2009-11#1)
studies of the function of##2##5##(1993-11#1)(2008-8#1)
studies of the interaction##3##4##(1993-11#1)(2008-10#2)
studies of the reaction##2##4##(2008-10#1)(2009-8#1)
studies of the##117##3##(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-12#3)(1992-3#2)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#2)(1997-7#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#26)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#6)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#6)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
studies of these##5##3##(1993-12#1)(1994-9#1)(2008-8#1)(2009-5#1)(2010-11#1)
studies of this pathogen##3##4##(2008-10#3)
studies of this##12##3##(1991-12#1)(1994-11#1)(1997-2#1)(2008-1#1)(2008-10#6)(2008-5#2)
studies of two##2##3##(1994-12#1)(2008-12#1)
studies of utilization##2##3##(1995-1#1)(2012-12#1)
studies of ventricular brain CSF in assorted psychiatric and##2##9##(1993-1#2)
studies of##611##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#2)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#6)(1993-12#6)(1993-3#4)(1993-6#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#2)(1994-9#2)(1995-1#2)(1995-11#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#4)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#3)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#8)(1997-6#4)(1997-7#2)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#4)(2007-11#11)(2007-12#13)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#8)(2008-10#101)(2008-11#30)(2008-12#5)(2008-2#11)(2008-3#15)(2008-4#15)(2008-5#16)(2008-6#4)(2008-7#27)(2008-8#31)(2008-9#39)(2009-10#1)(2009-11#3)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#9)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#8)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#12)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#10)(2012-4#1)(2012-9#1)(2013-1#4)(2013-7#2)(2013-8#5)
studies offer##2##2##(2008-11#1)(2008-8#1)
studies often##2##2##(1996-6#1)(2008-7#1)
studies on a##2##3##(2008-1#1)(2011-2#1)
studies on human##3##3##(1990-11#1)(1995-8#1)(2008-11#1)
studies on incidence##2##3##(1995-5#2)
studies on its##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
studies on natural##3##3##(2008-10#3)
studies on other##2##3##(2008-10#1)(2009-6#1)
studies on social support##2##4##(1992-3#2)
studies on the development of##2##5##(2008-10#1)(2009-6#1)
studies on the effects of##3##5##(2008-11#1)(2008-5#1)(2009-9#1)
studies on the effects##4##4##(2007-12#1)(2008-11#1)(2008-5#1)(2009-9#1)
studies on the expression of##2##5##(1994-8#1)(2013-8#1)
studies on the immune##3##4##(1993-8#1)(1997-4#1)(2007-2#1)
studies on the interaction##2##4##(2008-11#1)(2012-12#1)
studies on the mechanism of##2##5##(2007-11#1)(2007-12#1)
studies on the molecular mechanisms##2##5##(2008-9#1)(2012-12#1)
studies on the molecular##3##4##(2008-9#1)(2011-3#1)(2012-12#1)
studies on the role of##2##5##(2008-7#1)(2009-8#1)
studies on the##100##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#1)
studies on these##3##3##(2008-7#2)(2013-8#1)
studies on this issue##2##4##(2008-11#2)
studies on this##8##3##(1990-7#1)(1997-8#1)(2008-1#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-1#1)
studies on virus##2##3##(2007-12#1)(2008-10#1)
studies on##269##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#5)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-6#1)(1993-8#2)(1994-12#4)(1994-2#3)(1994-6#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#31)(2008-11#11)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#3)
studies or##7##2##(1992-6#1)(2007-10#1)(2008-2#1)(2008-4#2)(2010-5#1)(2013-1#1)
studies performed for U(VI) and Th(IV)##2##6##(2008-10#2)
studies performed for U(VI)##3##4##(2008-10#3)
studies performed on##2##3##(1994-6#1)(2008-10#1)
studies performed over the##2##4##(2008-7#1)(2009-4#1)
studies performed over##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
studies performed with##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
studies performed##15##2##(1994-6#1)(2008-10#8)(2008-7#3)(2009-4#1)(2012-12#1)(2013-8#1)
studies predict##2##2##(2008-10#1)(2008-8#1)
studies presented##6##2##(1994-9#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
studies proved that the##2##4##(1992-2#1)(2008-10#1)
studies proved##4##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-9#1)
studies provide a##5##3##(1993-11#1)(2008-10#2)(2008-2#1)(2013-8#1)
studies provide evidence that##2##4##(1991-9#1)(1994-6#1)
studies provide evidence##3##3##(1991-9#1)(1994-6#1)(2007-12#1)
studies provide further support for##2##5##(1991-9#1)(2008-8#1)
studies provide the first##2##4##(2010-11#1)(2010-4#1)
studies provide the##3##3##(1992-8#1)(2010-11#1)(2010-4#1)
studies provide##21##2##(1991-9#2)(1992-11#1)(1992-8#1)(1993-11#1)(1994-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-11#2)(2010-4#1)(2011-2#1)(2013-8#1)
studies provided##2##2##(2008-10#1)(2009-10#1)
studies published between##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
studies published in##3##3##(1993-12#1)(2008-3#1)(2008-7#1)
studies published##10##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
studies regarding the##3##3##(2008-11#1)(2008-7#2)
studies regarding##7##2##(1994-5#1)(2008-1#1)(2008-11#1)(2008-7#2)(2012-3#2)
studies related to##8##3##(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
studies report the##2##3##(1993-9#1)(2008-5#1)
studies report##5##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-8#1)
studies reported here##3##3##(1995-8#1)(2008-10#1)(2009-2#1)
studies reported in the literature##2##5##(1993-11#1)(2008-11#1)
studies reported to date##2##4##(1991-12#1)(2011-2#1)
studies reported##16##2##(1990-5#1)(1990-6#1)(1991-12#1)(1993-11#2)(1995-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-5#2)(2011-2#1)(2012-3#1)(2013-1#1)
studies reporting a##2##3##(2008-7#1)(2011-2#1)
studies reporting long-term (≥ 48 months)##2##6##(2012-12#2)
studies reporting##9##2##(2008-10#2)(2008-7#2)(2011-2#2)(2012-12#2)(2013-1#1)
studies resulted in##2##3##(1990-8#1)(2008-10#1)
studies resulted##3##2##(1990-8#1)(2008-10#1)(2008-4#1)
studies reveal a##2##3##(1996-2#1)(2012-12#1)
studies reveal that the##2##4##(2008-11#1)(2012-3#1)
studies reveal that##11##3##(1990-7#1)(1992-6#1)(1993-3#1)(1994-5#1)(2008-11#2)(2008-8#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
studies reveal##17##2##(1990-7#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-5#1)(1996-2#1)(2008-11#2)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
studies revealed a##5##3##(1992-1#1)(1992-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
studies revealed that both##3##4##(1994-12#1)(1995-8#1)(2012-3#1)
studies revealed that most##2##4##(1997-2#1)(2009-4#1)
studies revealed that the##8##4##(2007-12#1)(2008-10#5)(2010-5#1)(2012-2#1)
studies revealed that##32##3##(1990-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
studies revealed the presence of##3##5##(1994-10#1)(1994-8#1)(2008-7#1)
studies revealed the##6##3##(1994-10#1)(1994-8#1)(2008-10#1)(2008-7#2)(2008-8#1)
studies revealed##55##2##(1990-12#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
studies revealing##3##2##(2008-6#1)(2011-1#1)(2011-2#1)
studies reviewed##4##2##(1994-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
studies seem to##2##3##(1991-6#1)(2008-10#1)
studies should be carried out##2##5##(1994-6#1)(2008-5#1)
studies should be undertaken##2##4##(1992-12#1)(1993-6#1)
studies should be##11##3##(1990-6#1)(1992-12#1)(1993-6#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#2)
studies should##23##2##(1990-3#1)(1990-6#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-6#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#3)(2011-2#3)(2012-3#2)
studies show a##7##3##(1991-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-1#1)
studies show that the##17##4##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
studies show that there##3##4##(1996-6#1)(2008-5#1)(2012-12#1)
studies show that##48##3##(1990-11#1)(1991-12#1)(1992-4#1)(1994-6#1)(1995-6#2)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
studies show the##4##3##(1991-5#1)(2007-11#1)(2009-11#1)(2013-1#1)
studies show##68##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1994-6#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-1#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
studies showed a##10##3##(1990-11#1)(1994-2#1)(2008-10#3)(2008-7#2)(2009-8#1)(2010-11#1)(2011-2#1)
studies showed an##2##3##(1992-11#1)(2009-2#1)
studies showed no##2##3##(1993-6#1)(2011-2#1)
studies showed that a##2##4##(2008-10#1)(2010-5#1)
studies showed that in##2##4##(1991-5#1)(2008-7#1)
studies showed that the##11##4##(1991-8#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)
studies showed that they are##2##5##(2007-11#1)(2008-1#1)
studies showed that##46##3##(1990-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-5#2)(2012-1#1)(2012-12#1)(2013-1#1)
studies showed the##3##3##(2008-5#3)
studies showed##76##2##(1990-11#2)(1990-5#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#2)(1995-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
studies showing improvement##2##3##(2006-10#1)(2007-12#1)
studies showing positive##2##3##(1997-5#1)(2008-9#1)
studies showing that the##2##4##(1991-11#1)(1993-6#1)
studies showing that##7##3##(1991-11#1)(1993-6#1)(1995-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2012-3#1)
studies showing##12##2##(1991-11#1)(1993-6#1)(1995-12#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)
studies so far have##2##4##(2008-1#1)(2008-3#1)
studies so far##3##3##(2008-1#1)(2008-3#1)(2010-12#1)
studies so##5##2##(1997-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-12#1)
studies strongly suggest##2##3##(2008-10#1)(2009-12#1)
studies suggest a##4##3##(1991-8#1)(1994-9#1)(2008-6#1)(2012-3#1)
studies suggest that PKC##2##4##(1990-5#1)(1992-8#1)
studies suggest that the##13##4##(1991-9#1)(1992-8#1)(1992-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies suggest that these##3##4##(1990-8#1)(1995-2#1)(2010-5#1)
studies suggest that##71##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
studies suggest the possibility of##2##5##(1990-6#1)(1995-11#1)
studies suggest the##4##3##(1990-6#1)(1995-11#1)(2007-8#1)(2008-4#1)
studies suggest##86##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#2)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
studies suggested that the##2##4##(1993-12#1)(2013-1#1)
studies suggested that##3##3##(1993-12#1)(2008-11#1)(2013-1#1)
studies suggested##6##2##(1990-6#1)(1993-12#1)(2008-11#1)(2011-2#2)(2013-1#1)
studies suggesting that##4##3##(2007-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
studies suggesting##7##2##(1996-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-6#1)(2012-3#1)
studies suggests that##3##3##(1996-5#1)(2009-7#1)(2012-2#1)
studies support a##2##3##(1994-2#1)(2011-2#1)
studies support the notion that##2##5##(2008-5#1)(2011-2#1)
studies support the notion##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
studies support the##11##3##(1995-12#1)(1996-5#1)(1997-8#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
studies support##14##2##(1994-2#1)(1995-12#1)(1996-5#1)(1997-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#2)
studies supporting##2##2##(1990-12#1)(2010-5#1)
studies tested##2##2##(2008-10#1)(2009-9#1)
studies that can##2##3##(2008-7#1)(2010-9#1)
studies that compare##3##3##(2008-10#1)(2010-12#1)(2010-6#1)
studies that describe##2##3##(2009-6#1)(2013-1#1)
studies that employ##2##3##(2008-3#1)(2008-8#1)
studies that evaluated##3##3##(2008-2#1)(2012-3#1)(2013-1#1)
studies that examine the##4##4##(2008-11#1)(2008-7#2)(2012-2#1)
studies that examine##6##3##(2008-11#1)(2008-7#2)(2009-5#1)(2009-9#1)(2012-2#1)
studies that examined##2##3##(2007-8#1)(2008-4#1)
studies that fail to##2##4##(2008-9#1)(2009-10#1)
studies that focused on##2##4##(2008-11#1)(2008-7#1)
studies that found##2##3##(2011-2#2)
studies that have evaluated##2##4##(2008-7#1)(2012-2#1)
studies that have examined##2##4##(1992-3#1)(2008-2#1)
studies that have led to##2##5##(1997-2#1)(2010-10#1)
studies that have used##2##4##(2012-2#1)(2012-3#1)
studies that have##17##3##(1991-8#1)(1992-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
studies that investigate##2##3##(1997-8#1)(2007-10#1)
studies that met##3##3##(2007-10#1)(2013-1#2)
studies that reported relevant data##3##5##(2009-2#3)
studies that show##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
studies that support##2##3##(1994-3#1)(2010-11#1)
studies that the##3##3##(1994-12#1)(2008-10#1)(2009-9#1)
studies that we##2##3##(2007-8#1)(2008-7#1)
studies that were##3##3##(2008-11#1)(2008-5#1)(2010-4#1)
studies that##106##2##(1991-2#1)(1991-8#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-10#3)(2007-2#1)(2007-8#3)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#1)(2009-10#3)(2009-2#4)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
studies the##20##2##(1990-6#1)(1994-2#1)(1994-9#1)(1995-12#2)(1996-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
studies to assess the##2##4##(2008-10#1)(2008-5#1)
studies to assess##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
studies to be##3##3##(1994-11#1)(2008-2#1)(2008-4#1)
studies to date have examined##2##5##(2012-1#1)(2013-1#1)
studies to date have##3##4##(2008-11#1)(2012-1#1)(2013-1#1)
studies to date##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
studies to determine the##3##4##(1990-7#1)(2008-10#1)(2010-3#1)
studies to determine##8##3##(1990-7#1)(1991-11#1)(1994-12#1)(1997-5#1)(2008-10#2)(2010-3#1)(2012-2#1)
studies to evaluate##8##3##(1993-8#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-6#1)(2012-3#1)
studies to examine##3##3##(1992-6#1)(2008-5#1)(2013-1#1)
studies to prevent##2##3##(2008-3#1)(2008-7#1)
studies to support##2##3##(2008-10#1)(2012-12#1)
studies to##70##2##(1990-7#1)(1991-11#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
studies toward##2##2##(2009-11#1)(2010-6#1)
studies under##3##2##(2008-10#2)(2008-11#1)
studies used a##2##3##(2008-10#1)(2008-2#1)
studies used##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
studies using a##2##3##(1997-7#1)(2008-10#1)
studies using novel##2##3##(2009-2#1)(2012-12#1)
studies using the##9##3##(1994-6#1)(1995-6#1)(1997-2#1)(2008-11#1)(2008-3#2)(2009-10#1)(2009-2#1)(2011-2#1)
studies using##76##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
studies utilizing##6##2##(2008-10#2)(2008-11#2)(2010-11#1)(2012-2#1)
studies via##2##2##(1990-11#1)(2008-9#1)
studies was to##2##3##(2008-10#1)(2008-5#1)
studies was##15##2##(1992-11#1)(1993-6#1)(1994-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
studies we examined##3##3##(1993-3#1)(2008-3#1)(2013-1#1)
studies we have shown that##2##5##(2008-7#2)
studies we have##4##3##(2008-10#1)(2008-7#2)(2012-12#1)
studies we##13##2##(1991-2#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
studies were also##3##3##(1994-10#1)(2008-10#1)(2008-5#1)
studies were carried out on the##2##6##(2007-6#1)(2008-10#1)
studies were carried out on##5##5##(1994-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
studies were carried out to##4##5##(2008-10#2)(2008-5#2)
studies were carried out using##3##5##(2008-5#1)(2010-5#1)(2013-1#1)
studies were carried out##17##4##(1994-5#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
studies were compared##2##3##(2008-7#1)(2010-1#1)
studies were conducted by##2##4##(2008-10#1)(2008-11#1)
studies were conducted in##11##4##(2008-1#1)(2008-8#1)(2008-9#6)(2012-2#1)(2013-1#1)(2013-8#1)
studies were conducted to determine##2##5##(1995-2#1)(2011-2#1)
studies were conducted to##8##4##(1995-2#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#2)
studies were conducted with##3##4##(1991-8#1)(2007-12#1)(2008-5#1)
studies were conducted##29##3##(1991-8#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
studies were designed to##2##4##(1990-11#1)(1991-3#1)
studies were done##4##3##(1994-9#1)(1996-12#1)(2008-10#2)
studies were found##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
studies were identified and##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
studies were identified##6##3##(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#3)
studies were included in the##2##5##(2008-8#1)(2009-11#1)
studies were included in##3##4##(2008-10#1)(2008-8#1)(2009-11#1)
studies were included##8##3##(2008-10#2)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies were not##2##3##(1994-12#1)(2012-12#1)
studies were performed by##3##4##(1994-8#1)(2008-10#1)(2008-5#1)
studies were performed in order to##2##6##(1990-8#1)(1995-12#1)
studies were performed in##7##4##(1990-8#1)(1995-12#1)(1997-8#1)(2006-10#2)(2008-10#1)(2008-7#1)
studies were performed on##5##4##(1990-5#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-12#1)
studies were performed to determine##3##5##(1997-1#1)(1997-6#1)(2008-10#1)
studies were performed to##7##4##(1997-1#1)(1997-6#1)(2008-10#3)(2008-3#1)(2011-2#1)
studies were performed with##2##4##(1994-5#1)(2008-10#1)
studies were performed##30##3##(1990-5#1)(1990-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-5#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-10#1)(2011-2#1)
studies were reviewed##2##3##(2008-10#1)(2013-1#1)
studies were undertaken to##4##4##(1993-11#1)(1994-11#1)(1994-6#1)(1997-7#1)
studies were undertaken##5##3##(1993-11#1)(1994-11#1)(1994-6#1)(1997-7#1)(2013-1#1)
studies were used to##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
studies were##152##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#1)(2010-1#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#3)
studies where##4##2##(2008-7#1)(2009-12#1)(2012-3#1)(2013-8#1)
studies which have shown##2##4##(1997-1#1)(2012-2#1)
studies which have##5##3##(1990-8#1)(1994-2#1)(1997-1#1)(1997-8#1)(2012-2#1)
studies which##13##2##(1990-8#1)(1994-2#2)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
studies will allow##2##3##(2010-4#1)(2012-2#1)
studies will be necessary##2##4##(2009-5#1)(2009-8#1)
studies will be needed to##2##5##(1991-12#1)(2008-7#1)
studies will be##5##3##(1991-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)
studies will##24##2##(1991-12#1)(1993-2#1)(1994-9#1)(1996-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
studies with a total of##2##5##(2007-12#1)(2013-8#1)
studies with a##11##3##(1994-12#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#2)(2013-8#1)
studies with different##2##3##(1994-2#1)(2008-10#1)
studies with larger##4##3##(2007-10#1)(2008-12#1)(2010-5#1)(2012-3#1)
studies with long-term follow-up##2##4##(2012-12#2)
studies with other##2##3##(1991-12#1)(2008-4#1)
studies with targeted toxins##2##4##(2008-5#2)
studies with the##8##3##(1990-12#1)(2008-10#2)(2008-8#1)(2009-3#2)(2012-1#1)(2013-8#1)
studies with##124##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-8#2)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#2)(1997-6#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-8#2)
studies would be##3##3##(1992-2#1)(1994-9#1)(2011-3#1)
studies would##5##2##(1990-2#1)(1992-2#1)(1994-9#1)(2010-12#1)(2011-3#1)
studies##5050##1##(1990-10#2)(1990-11#19)(1990-12#13)(1990-2#10)(1990-3#10)(1990-5#16)(1990-6#16)(1990-7#10)(1990-8#25)(1990-9#5)(1991-1#12)(1991-11#10)(1991-12#33)(1991-2#16)(1991-3#7)(1991-4#4)(1991-5#11)(1991-6#7)(1991-7#2)(1991-8#12)(1991-9#18)(1992-1#6)(1992-10#5)(1992-11#18)(1992-12#16)(1992-2#9)(1992-3#35)(1992-4#5)(1992-5#7)(1992-6#18)(1992-8#18)(1992-9#18)(1993-1#9)(1993-11#30)(1993-12#29)(1993-2#11)(1993-3#11)(1993-5#5)(1993-6#16)(1993-8#18)(1993-9#6)(1994-1#4)(1994-10#8)(1994-11#14)(1994-12#24)(1994-2#41)(1994-3#19)(1994-5#18)(1994-6#20)(1994-7#3)(1994-8#19)(1994-9#21)(1995-1#9)(1995-11#17)(1995-12#28)(1995-2#29)(1995-3#15)(1995-4#2)(1995-5#25)(1995-6#25)(1995-8#14)(1995-9#10)(1996-1#9)(1996-10#2)(1996-11#4)(1996-12#25)(1996-2#24)(1996-3#9)(1996-4#3)(1996-5#14)(1996-6#11)(1996-7#7)(1996-8#2)(1996-9#19)(1997-1#17)(1997-2#19)(1997-3#14)(1997-4#23)(1997-5#17)(1997-6#18)(1997-7#17)(1997-8#25)(1997-9#2)(2006-10#17)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#33)(2007-11#51)(2007-12#57)(2007-2#9)(2007-4#4)(2007-5#10)(2007-6#9)(2007-7#20)(2007-8#20)(2007-9#1)(2008-1#76)(2008-10#639)(2008-11#218)(2008-12#71)(2008-2#80)(2008-3#109)(2008-4#94)(2008-5#175)(2008-6#50)(2008-7#248)(2008-8#174)(2008-9#164)(2009-1#4)(2009-10#24)(2009-11#26)(2009-12#27)(2009-2#25)(2009-3#13)(2009-4#13)(2009-5#28)(2009-6#30)(2009-7#30)(2009-8#42)(2009-9#23)(2010-1#16)(2010-10#21)(2010-11#31)(2010-12#36)(2010-2#17)(2010-3#20)(2010-4#14)(2010-5#46)(2010-6#16)(2010-7#11)(2010-8#27)(2010-9#8)(2011-1#65)(2011-10#1)(2011-2#241)(2011-3#6)(2011-7#1)(2011-8#1)(2012-1#36)(2012-12#96)(2012-2#131)(2012-3#125)(2012-4#2)(2012-5#2)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#168)(2013-7#21)(2013-8#71)
studies&quot##2##1##(2008-10#2)
studies) and carcinogenicity studies of##3##5##(2008-9#3)
studies) and##4##2##(2008-9#3)(2012-2#1)
studies) were##2##2##(2009-2#1)(2012-2#1)
studies)##21##1##(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#10)(2009-2#2)(2012-2#2)(2013-8#1)
studies?##6##1##(1991-3#1)(1993-11#1)(2007-11#2)(2009-4#1)(2009-6#1)
studies]##7##1##(1990-3#2)(1995-5#1)(1996-6#1)(2008-4#1)(2012-3#1)(2013-8#1)
study (N =##4##3##(2008-5#1)(2008-8#1)(2010-10#1)(2013-8#1)
study (age##2##2##(1993-6#1)(2008-3#1)
study (n = 4)##2##4##(2008-5#1)(2009-2#1)
study (n =##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-5#1)
study a new##2##3##(2008-7#1)(2010-3#1)
study a simple##2##3##(1996-4#1)(2008-8#1)
study a##32##2##(1990-12#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-4#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
study about the##2##3##(2008-10#1)(2013-1#1)
study about##7##2##(1995-3#1)(2008-10#1)(2009-1#1)(2009-5#1)(2013-1#3)
study addresses the##7##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)
study addresses##10##2##(1992-1#1)(1994-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-4#1)
study adds##3##2##(2010-5#1)(2011-2#1)(2013-1#1)
study adopts##2##2##(2008-6#1)(2010-5#1)
study after##2##2##(2007-11#1)(2008-3#1)
study aimed at investigating the##2##5##(2012-3#1)(2013-8#1)
study aimed at##11##3##(1992-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-12#1)(2012-3#3)(2013-8#1)
study aimed to assess the##3##5##(1991-5#1)(2011-2#1)(2012-3#1)
study aimed to describe the##3##5##(2010-3#1)(2012-12#1)(2012-3#1)
study aimed to describe##6##4##(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
study aimed to determine the##3##5##(2007-10#1)(2009-5#1)(2012-3#1)
study aimed to determine##6##4##(2007-10#1)(2007-11#1)(2009-5#1)(2011-1#2)(2012-3#1)
study aimed to evaluate the##7##5##(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
study aimed to evaluate##8##4##(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
study aimed to explore##4##4##(2007-10#1)(2009-10#1)(2011-1#1)(2013-1#1)
study aimed to find##2##4##(2007-7#1)(2008-12#1)
study aimed to identify risk factors##2##6##(2010-10#1)(2011-2#1)
study aimed to identify##7##4##(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-8#1)
study aimed to investigate##6##4##(2008-10#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
study aimed to##61##3##(1991-5#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#10)(2012-6#1)(2012-8#1)(2013-1#6)(2013-7#2)(2013-8#3)
study aimed##72##2##(1991-5#1)(1992-9#1)(1995-3#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#13)(2012-6#1)(2012-8#1)(2013-1#6)(2013-7#2)(2013-8#4)
study aiming to##2##3##(2009-4#1)(2011-1#1)
study aiming##3##2##(2008-2#1)(2009-4#1)(2011-1#1)
study aims at##5##3##(1994-6#1)(2009-11#1)(2009-12#1)(2011-1#1)(2013-8#1)
study aims to assess the##2##5##(2010-6#1)(2012-3#1)
study aims to assess##3##4##(2010-6#1)(2012-3#1)(2013-8#1)
study aims to compare the##2##5##(2008-7#1)(2011-2#1)
study aims to determine the##3##5##(2011-1#2)(2011-2#1)
study aims to identify##3##4##(2010-10#1)(2010-2#1)(2013-1#1)
study aims to##25##3##(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
study aims##30##2##(1994-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
study all##2##2##(2008-12#1)(2012-3#1)
study allowed##3##2##(2008-5#1)(2010-4#1)(2012-3#1)
study allows##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
study also demonstrates that##4##4##(2008-10#2)(2008-3#1)(2009-4#1)
study also describes the experimental conditions and the##2##8##(2008-10#2)
study also found##3##3##(1997-3#1)(2009-7#1)(2010-3#1)
study also indicated##2##3##(1995-5#1)(2011-1#1)
study also indicates##2##3##(2008-10#1)(2008-9#1)
study also revealed##2##3##(1997-7#1)(2008-10#1)
study also shows##2##3##(2008-5#1)(2010-8#1)
study also suggests that##2##4##(2008-8#1)(2011-3#1)
study also suggests##3##3##(2008-8#1)(2010-3#1)(2011-3#1)
study also##50##2##(1991-12#2)(1992-12#1)(1992-3#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
study among##11##2##(1991-6#1)(1993-3#1)(1995-1#1)(1995-6#2)(2007-2#1)(2008-3#1)(2008-4#1)(2011-2#2)(2013-1#1)
study an##3##2##(1990-6#1)(2008-11#1)(2009-9#1)
study analysed##3##2##(2008-12#1)(2011-2#1)(2012-1#1)
study analyses the##2##3##(2009-12#1)(2013-8#1)
study analyses##3##2##(1990-11#1)(2009-12#1)(2013-8#1)
study analytically##2##2##(2007-12#1)(2009-9#1)
study analyzed the##5##3##(2009-7#1)(2013-1#3)(2013-7#1)
study analyzed##10##2##(1995-12#1)(2008-11#1)(2009-7#1)(2010-6#1)(2013-1#5)(2013-7#1)
study analyzes the##7##3##(1992-5#1)(1993-3#1)(1996-3#1)(2008-2#2)(2011-1#1)(2013-1#1)
study analyzes##11##2##(1992-5#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-3#2)(2008-2#2)(2011-1#1)(2011-2#1)(2013-1#1)
study and a##5##3##(1990-9#1)(1995-3#1)(2007-2#1)(2007-6#1)(2010-1#1)
study and analysis of##3##4##(2008-10#2)(2012-3#1)
study and analytical applications of##2##5##(2008-10#2)
study and application of##3##4##(2008-10#2)(2008-5#1)
study and compare##3##3##(1992-3#1)(2007-11#1)(2007-7#1)
study and implications for##2##4##(1997-8#1)(2008-12#1)
study and literature##2##3##(2012-12#1)(2013-1#1)
study and report##2##3##(1993-2#1)(2011-2#1)
study and suggests that##2##4##(1995-3#1)(2008-9#1)
study and the##15##3##(1990-6#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(1996-2#1)(2008-10#3)(2008-5#2)(2008-6#1)(2009-11#1)(2009-2#1)(2012-3#1)
study and those##2##3##(2008-1#1)(2008-9#1)
study and were divided##2##4##(2007-6#1)(2008-11#1)
study and were##5##3##(1991-2#1)(2007-6#1)(2008-11#1)(2011-2#2)
study and##122##2##(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#1)(2010-1#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
study applies##2##2##(2008-10#2)
study are also##2##3##(2008-10#1)(2008-2#1)
study are discussed##4##3##(1993-1#1)(2007-11#1)(2008-3#1)(2013-8#1)
study are encouraging##2##3##(1996-12#1)(2010-12#1)
study are presented##4##3##(1992-2#1)(2008-11#1)(2008-3#1)(2009-12#1)
study are to##6##3##(1997-8#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
study are##55##2##(1992-2#1)(1992-8#1)(1993-1#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
study area and##2##3##(2008-10#1)(2008-12#1)
study area##20##2##(1995-9#2)(2008-10#2)(2008-12#6)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
study areas##4##2##(1995-3#1)(2008-10#2)(2013-1#1)
study as a##6##3##(1997-5#1)(2008-11#3)(2008-9#1)(2011-2#1)
study as well##2##3##(2008-5#1)(2012-3#1)
study as##12##2##(1992-11#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#2)
study asks##2##2##(1993-3#1)(2009-11#1)
study assessed the effects of##3##5##(1993-3#1)(1996-2#1)(2008-7#1)
study assessed the##20##3##(1991-9#1)(1993-3#1)(1996-2#1)(1996-7#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)
study assessed##29##2##(1991-9#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
study assesses the##6##3##(2008-11#3)(2008-3#1)(2008-9#1)(2012-2#1)
study assesses##8##2##(1997-3#1)(2008-11#3)(2008-3#1)(2008-9#1)(2010-3#1)(2012-2#1)
study assessing##4##2##(2008-5#2)(2008-9#1)(2013-1#1)
study at a##4##3##(1991-11#1)(1995-2#1)(2009-10#1)(2013-1#1)
study at the##7##3##(1991-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)
study at##19##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-11#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-6#1)(2009-10#1)(2012-12#2)(2013-1#1)
study attempted to##6##3##(1990-2#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
study attempts to##7##3##(1992-1#1)(1993-12#1)(1994-6#1)(2008-2#1)(2008-9#1)(2010-5#1)(2011-2#1)
study based on a##2##4##(2007-7#1)(2010-12#1)
study based on the##5##4##(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
study based on##13##3##(1991-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
study because of the##2##4##(2008-1#1)(2008-9#1)
study because##6##2##(2008-1#2)(2008-10#1)(2008-9#1)(2010-1#1)(2013-1#1)
study before and##2##3##(2008-10#2)
study between a##2##3##(1997-5#1)(2008-10#1)
study between the##2##3##(2008-8#1)(2009-12#1)
study between##11##2##(1997-5#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#1)
study but##2##2##(2008-12#1)(2008-5#1)
study by the##5##3##(1991-4#1)(1992-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
study by##21##2##(1991-4#1)(1992-1#1)(1993-11#1)(1996-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)
study can be used##4##4##(1997-7#1)(2008-12#1)(2008-2#1)(2013-1#1)
study can be##7##3##(1992-6#1)(1994-3#1)(1995-9#1)(1997-7#1)(2008-12#1)(2008-2#1)(2013-1#1)
study can provide a##2##4##(2008-11#1)(2013-1#1)
study can##13##2##(1990-3#1)(1992-6#1)(1993-2#1)(1994-3#1)(1995-9#1)(1997-7#1)(2008-11#1)(2008-12#2)(2008-2#1)(2011-1#1)(2013-1#2)
study carried out in the##2##5##(2008-12#1)(2008-2#1)
study carried out in##5##4##(1993-3#1)(1996-7#1)(2008-12#1)(2008-2#1)(2012-3#1)
study carried out on 16##2##5##(2008-11#1)(2008-5#1)
study carried out on##5##4##(1991-6#1)(1997-4#1)(2008-11#1)(2008-5#2)
study carried out##14##3##(1991-6#1)(1993-3#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2010-3#1)(2012-3#1)
study cell##4##2##(2008-10#1)(2008-4#1)(2009-12#1)(2011-1#1)
study changes in##2##3##(1995-5#1)(2008-10#1)
study characterized the##3##3##(2010-1#1)(2010-11#1)(2013-1#1)
study characterized##4##2##(2008-10#1)(2010-1#1)(2010-11#1)(2013-1#1)
study characterizes the##2##3##(2008-10#2)
study characterizes##3##2##(1993-6#1)(2008-10#2)
study clearly showed that the##2##5##(2008-10#2)
study clearly showed##3##3##(1992-9#1)(2008-10#2)
study clearly##10##2##(1992-9#1)(2008-10#4)(2008-11#4)(2012-2#1)
study clinical##3##2##(2007-8#2)(2012-3#1)
study cohort##5##2##(2009-10#4)(2010-2#1)
study combined##2##2##(2007-10#1)(2008-5#1)
study compared a##2##3##(2009-11#1)(2012-12#1)
study compared the effects of##2##5##(1993-3#1)(2010-1#1)
study compared the efficacy##2##4##(1993-1#1)(2012-3#1)
study compared the results of##2##5##(2009-3#1)(2011-2#1)
study compared the##18##3##(1993-1#1)(1993-3#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#3)(2010-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
study compared##36##2##(1993-1#1)(1993-3#2)(1994-3#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#4)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
study compares the##6##3##(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(2009-4#1)(2012-1#1)
study compares##10##2##(1992-12#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(2008-10#1)(2009-4#1)(2009-7#1)(2012-1#1)(2012-3#1)
study comparing a##2##3##(1994-3#2)
study comparing the##4##3##(1994-3#1)(1996-1#1)(2008-10#1)(2008-6#1)
study comparing three##2##3##(1992-3#1)(2008-5#1)
study comparing##16##2##(1992-3#1)(1994-3#3)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2012-3#2)(2013-1#1)
study comprised##3##2##(1997-3#1)(2013-1#1)(2013-8#1)
study concerning##5##2##(1990-3#1)(1990-5#1)(1994-5#1)(2008-3#1)(2011-2#1)
study concerns the##2##3##(1996-1#1)(1997-2#1)
study concerns##4##2##(1994-6#1)(1996-1#1)(1997-2#1)(2008-11#1)
study concluded that##6##3##(1997-4#1)(2008-11#2)(2010-9#1)(2011-1#2)
study concludes that##7##3##(1991-2#1)(1996-1#2)(2008-11#1)(2009-4#1)(2012-3#1)(2013-1#1)
study concludes##8##2##(1991-2#1)(1995-12#1)(1996-1#2)(2008-11#1)(2009-4#1)(2012-3#1)(2013-1#1)
study conducted at##2##3##(1991-11#1)(2008-2#1)
study conducted by the##2##4##(1994-12#1)(1997-5#1)
study conducted by##3##3##(1994-12#1)(1996-12#1)(1997-5#1)
study conducted in the##3##4##(1990-8#1)(2007-2#1)(2008-6#1)
study conducted in##16##3##(1990-8#1)(1993-9#1)(1995-11#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-10#2)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
study conducted on##3##3##(1992-5#1)(2008-5#1)(2009-5#1)
study conducted##33##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-5#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-10#2)(2009-4#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
study confirm the##2##3##(2009-1#1)(2012-3#1)
study confirmed that##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
study confirmed the##4##3##(1993-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
study confirmed##8##2##(1993-12#1)(1993-2#1)(2008-10#2)(2010-3#1)(2011-2#2)(2012-12#1)
study confirms that##7##3##(1990-2#1)(1996-1#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-2#1)
study confirms the##6##3##(1992-8#1)(1995-2#1)(2008-10#3)(2008-7#1)
study confirms##16##2##(1990-2#1)(1992-8#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(2007-7#1)(2008-10#5)(2008-7#2)(2008-9#1)(2009-2#1)
study consisted of##11##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#2)(2010-8#1)(2011-2#2)(2012-1#1)(2013-8#1)
study contains##2##2##(2008-10#1)(2012-3#1)
study contributes##4##2##(2008-10#1)(2010-10#1)(2013-1#2)
study could also be##2##4##(2010-7#1)(2013-8#1)
study could be##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
study could##13##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#2)
study current##2##2##(1996-2#1)(2008-8#1)
study data##6##2##(2007-10#1)(2008-11#2)(2010-5#1)(2012-2#1)(2012-3#1)
study data)##2##2##(1993-11#2)
study deals with a##2##4##(1995-12#1)(2008-10#1)
study deals with the##7##4##(2007-7#1)(2008-10#2)(2008-5#2)(2012-2#1)(2013-1#1)
study deals with##11##3##(1995-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#2)(2012-2#2)(2013-1#1)
study deals##12##2##(1995-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-2#2)(2013-1#1)
study demonstrate that##6##3##(1994-6#1)(2008-10#3)(2008-12#1)(2008-5#1)
study demonstrate the##4##3##(1997-3#1)(2006-12#1)(2008-5#1)(2012-1#1)
study demonstrate##12##2##(1994-6#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-1#1)
study demonstrated a##2##3##(2008-7#1)(2011-2#1)
study demonstrated that the##7##4##(1994-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
study demonstrated that##30##3##(1990-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#2)(2009-3#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#1)(2013-8#1)
study demonstrated the##5##3##(1997-1#1)(2008-10#1)(2008-6#1)(2009-1#1)(2013-1#1)
study demonstrated##41##2##(1990-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-1#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-3#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#1)
study demonstrates a##5##3##(1990-11#1)(1995-12#1)(1996-3#1)(2008-10#2)
study demonstrates that the##5##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
study demonstrates that this##2##4##(2013-1#1)(2013-8#1)
study demonstrates that##30##3##(1991-12#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
study demonstrates the feasibility of##2##5##(2008-11#1)(2008-6#1)
study demonstrates the importance of##2##5##(2008-6#1)(2009-5#1)
study demonstrates the##23##3##(1990-5#1)(1992-1#1)(1992-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
study demonstrates##66##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(2007-11#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
study demonstrating the##2##3##(2008-10#1)(2008-3#1)
study described in this article##2##5##(1991-2#1)(1996-3#1)
study described##6##2##(1991-2#1)(1993-3#1)(1996-3#1)(2007-2#1)(2008-11#1)(2013-1#1)
study describes a case of##2##5##(2008-10#1)(2012-3#1)
study describes a##10##3##(2008-10#4)(2008-11#1)(2008-6#1)(2009-6#1)(2012-12#1)(2012-3#2)
study describes how##4##3##(1991-1#1)(2010-10#1)(2010-4#1)(2010-9#1)
study describes the##20##3##(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
study describes##50##2##(1990-7#1)(1991-1#1)(1991-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
study describing the##2##3##(2008-10#1)(2011-1#1)
study design and##10##3##(1992-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
study design is##2##3##(2008-11#1)(2011-2#1)
study design to##2##3##(2011-1#1)(2011-2#1)
study design was used to##2##5##(2007-10#1)(2011-2#1)
study design was used##4##4##(2007-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
study design was##6##3##(1994-3#1)(2007-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
study design##40##2##(1992-3#1)(1994-12#1)(1994-3#1)(1997-7#1)(2007-10#3)(2007-7#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#7)(2012-2#3)(2013-1#4)(2013-8#1)
study designed to##5##3##(1990-12#1)(1996-12#1)(2007-12#1)(2008-11#2)
study designs##8##2##(1995-9#1)(1996-3#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
study determined the##4##3##(1993-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
study determined##12##2##(1993-2#1)(1996-12#1)(1997-7#1)(2007-10#2)(2008-10#1)(2010-6#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#1)
study developed##2##2##(1997-1#1)(2008-10#1)
study did not find##2##4##(2009-10#1)(2013-1#1)
study did not show any##2##5##(1997-8#1)(2010-8#1)
study did not##10##3##(1992-1#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
study different types of##2##4##(2008-2#1)(2009-7#1)
study different##4##2##(2007-10#1)(2007-2#1)(2008-2#1)(2009-7#1)
study directly##2##2##(1994-3#1)(2008-11#1)
study discusses the role of##2##5##(2008-12#1)(2008-7#1)
study do not##4##3##(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
study documents the##2##3##(2008-6#1)(2012-3#1)
study documents##5##2##(1993-9#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-3#1)
study does not support the##4##5##(1992-5#1)(1993-3#1)(2007-11#1)(2008-9#1)
study does not support##6##4##(1991-8#1)(1992-5#1)(1993-3#1)(2007-11#1)(2008-9#1)(2010-5#1)
study does not##7##3##(1991-8#1)(1992-12#1)(1992-5#1)(1993-3#1)(2007-11#1)(2008-9#1)(2010-5#1)
study done in a##2##4##(1993-3#1)(2008-3#1)
study done in##4##3##(1993-3#1)(1996-11#1)(2008-3#1)(2008-7#1)
study done##5##2##(1993-3#1)(1996-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
study due to##2##3##(2008-9#1)(2012-2#1)
study duration##4##2##(2012-3#4)
study emphasizes##3##2##(2008-11#1)(2009-3#1)(2013-8#1)
study employed a##4##3##(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)
study employed##5##2##(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2013-1#1)
study end##2##2##(2007-11#1)(2008-10#1)
study entry##2##2##(2010-11#1)(2011-1#1)
study established##3##2##(2008-11#1)(2008-3#1)(2012-3#1)
study evaluated a range of##2##5##(2008-9#1)(2012-2#1)
study evaluated the acute##2##4##(2008-10#1)(2008-6#1)
study evaluated the effect of##3##5##(1991-2#1)(2008-12#1)(2011-1#1)
study evaluated the effects of##2##5##(1995-11#1)(1995-12#1)
study evaluated the use##2##4##(2008-10#1)(2013-1#1)
study evaluated the##32##3##(1991-2#1)(1993-1#1)(1995-11#1)(1995-12#2)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#6)
study evaluated whether##2##3##(2009-11#1)(2013-1#1)
study evaluated##50##2##(1991-2#1)(1993-1#1)(1995-11#1)(1995-12#2)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)
study evaluates the effect of##2##5##(2008-7#1)(2013-8#1)
study evaluates the##13##3##(1993-2#1)(1993-3#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2013-8#1)
study evaluates##17##2##(1993-2#1)(1993-3#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2013-8#1)
study evaluating##6##2##(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
study examined differences##2##3##(2009-5#1)(2010-10#1)
study examined how##2##3##(1997-8#1)(2010-10#1)
study examined the association##2##4##(2007-12#1)(2013-1#1)
study examined the effect of##5##5##(1991-2#2)(1995-12#1)(2011-2#1)(2013-1#1)
study examined the effectiveness of##2##5##(2008-12#1)(2008-5#1)
study examined the effects of##10##5##(1990-9#1)(1994-8#1)(1996-12#1)(1997-6#1)(2008-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)
study examined the relationship between##8##5##(2007-12#1)(2008-7#1)(2009-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
study examined the relationship##9##4##(2007-12#1)(2008-7#1)(2009-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
study examined the##69##3##(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-11#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#2)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#3)(2009-9#2)(2010-1#3)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
study examined whether##12##3##(1992-12#1)(1996-2#1)(1996-5#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
study examined##127##2##(1990-2#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#8)(2009-9#4)(2010-1#4)(2010-10#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
study examines and##2##3##(2008-11#1)(2008-9#1)
study examines how##5##3##(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)
study examines the effect##2##4##(1994-2#1)(2008-12#1)
study examines the effects of##3##5##(1991-5#1)(1993-3#1)(2008-5#1)
study examines the impact of##2##5##(1994-2#1)(2008-11#1)
study examines the importance##2##4##(1993-6#1)(1995-1#1)
study examines the relationship between the##2##6##(1997-3#1)(2009-5#1)
study examines the relationship between##3##5##(1995-12#1)(1997-3#1)(2009-5#1)
study examines the##41##3##(1991-1#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
study examines whether##3##3##(1993-3#1)(1994-12#1)(2010-7#1)
study examines##68##2##(1991-1#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#4)(2009-7#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
study examining##3##2##(1997-7#1)(2011-2#1)(2012-3#1)
study explored how##2##3##(2008-11#1)(2013-1#1)
study explored the perceptions##2##4##(2010-11#1)(2010-9#1)
study explored the relation##2##4##(1994-3#1)(2008-9#1)
study explored the##10##3##(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)
study explored##18##2##(1993-12#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
study explores how the##2##4##(2009-5#1)(2013-8#1)
study explores how##3##3##(2009-5#1)(2010-9#1)(2013-8#1)
study explores the relationship##2##4##(1996-2#1)(2007-2#1)
study explores the##11##3##(1995-1#1)(1996-2#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
study explores##22##2##(1994-2#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-8#3)
study exploring the##4##3##(2007-10#1)(2008-11#3)
study exploring##5##2##(2007-10#1)(2008-11#3)(2013-8#1)
study extended##3##2##(1994-2#1)(2008-9#1)(2010-8#1)
study extends previous##3##3##(1994-3#1)(2010-2#1)(2013-8#1)
study extends##7##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-8#1)
study failed to##2##3##(2007-7#1)(2008-5#1)
study findings##9##2##(1991-12#2)(1991-2#1)(1993-1#1)(1993-12#1)(1995-1#1)(2008-3#1)(2008-7#1)(2009-5#1)
study finds##2##2##(1994-2#1)(2008-11#1)
study focused on the##5##4##(2008-10#1)(2010-4#1)(2013-1#3)
study focused on##9##3##(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)(2013-1#4)(2013-7#1)
study focuses on the##6##4##(1990-6#1)(1992-8#1)(2008-10#1)(2008-11#2)(2008-3#1)
study focuses on##12##3##(1990-6#1)(1992-8#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-3#2)(2009-11#1)(2010-12#1)
study followed the##2##3##(2008-9#1)(2013-1#1)
study followed##4##2##(1994-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
study for a##2##3##(1992-3#1)(2008-3#1)
study for each##2##3##(2008-10#1)(2008-7#1)
study for sexually transmitted diseases in patients attending STD clinics in##2##11##(2007-7#2)
study for the analysis of##2##5##(2008-10#1)(2010-6#1)
study for the first time##2##5##(2008-10#1)(2010-12#1)
study for the##13##3##(1993-3#1)(1994-12#1)(2007-2#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
study for##47##2##(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-8#1)
study found no##2##3##(1997-8#1)(2008-7#1)
study found that the##3##4##(1995-2#1)(2008-11#1)(2012-12#1)
study found that##11##3##(1995-2#1)(1995-3#1)(1997-3#1)(2008-11#2)(2009-11#1)(2009-9#1)(2010-10#1)(2012-12#2)(2013-8#1)
study found##19##2##(1995-2#1)(1995-3#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
study four-wave mixing##2##3##(2007-11#1)(2007-12#1)
study from a##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
study from the##2##3##(1993-6#1)(1995-3#1)
study from##22##2##(1992-11#1)(1993-6#1)(1995-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#2)(2009-3#2)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
study further revealed##2##3##(1993-6#1)(2009-8#1)
study further##9##2##(1993-6#1)(1994-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)
study gives the##2##3##(2007-8#1)(2008-10#1)
study gives##4##2##(2007-8#1)(2008-10#3)
study group and##5##3##(2009-10#1)(2009-8#2)(2011-1#1)(2011-2#1)
study group as##2##3##(2007-7#1)(2008-6#1)
study group comprised##3##3##(1991-12#1)(2009-6#1)(2013-1#1)
study group was##5##3##(2007-7#3)(2008-1#1)(2008-10#1)
study group##43##2##(1990-11#1)(1991-12#2)(1992-11#1)(1994-3#1)(1996-7#1)(2007-11#1)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#2)(2008-7#2)(2009-10#5)(2009-6#1)(2009-8#2)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
study groups##10##2##(1991-11#1)(1991-8#1)(2007-7#2)(2007-8#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2013-8#1)
study had##6##2##(1990-6#1)(1991-5#1)(1992-2#1)(1994-3#1)(2013-1#1)(2013-8#1)
study has a##2##3##(2012-3#1)(2013-8#1)
study has been carried out on##2##6##(2008-3#1)(2011-2#1)
study has been carried out##7##5##(1990-9#1)(2008-10#2)(2008-3#2)(2010-3#1)(2011-2#1)
study has been made of##2##5##(1992-3#1)(2007-12#1)
study has been made##4##4##(1992-3#1)(2007-12#2)(2008-10#1)
study has been##21##3##(1990-9#1)(1992-3#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#3)(2009-5#1)(2010-3#1)(2011-2#2)(2013-1#1)
study has demonstrated##2##3##(2011-2#2)
study has found##3##3##(1997-2#1)(2008-8#1)(2011-2#1)
study has provided##4##3##(2007-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
study has revealed that##2##4##(1993-11#1)(1997-1#1)
study has revealed##4##3##(1992-6#1)(1993-11#1)(1997-1#1)(1997-3#1)
study has shown that the##2##5##(2008-10#1)(2012-3#1)
study has shown that##9##4##(1990-6#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)
study has shown##11##3##(1990-6#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-3#1)
study has##83##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#2)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
study have shown that the##2##5##(2008-1#1)(2008-10#1)
study have shown that##3##4##(2008-1#2)(2008-10#1)
study have subsequently##2##3##(2010-12#1)(2011-2#1)
study have##19##2##(1991-1#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-10#5)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
study highlights the importance of##3##5##(2008-10#2)(2008-5#1)
study highlights the##7##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
study highlights##13##2##(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
study hospitals##2##2##(1991-3#1)(1996-3#1)
study how the##2##3##(2008-5#1)(2008-8#1)
study how##7##2##(1994-11#1)(1995-11#1)(2008-10#2)(2008-5#1)(2008-8#2)
study human##2##2##(1992-6#1)(2008-10#1)
study hypothesis##2##2##(2008-8#1)(2011-1#1)
study identified a number of##2##5##(2008-9#1)(2011-1#1)
study identified a##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
study identified that##2##3##(2009-4#1)(2012-2#1)
study identified##11##2##(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)
study identifies##4##2##(1996-1#1)(1997-2#1)(2008-12#1)(2008-4#1)
study identify##2##2##(1993-2#1)(2011-2#1)
study illustrates##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
study in 3##2##3##(1991-11#1)(1993-11#1)
study in 31##2##3##(1990-9#1)(2008-5#1)
study in Korea##2##3##(2009-8#1)(2010-6#1)
study in Okinawa##2##3##(2008-10#1)(2009-7#1)
study in a##12##3##(1990-11#1)(1993-5#1)(1996-7#1)(2007-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
study in an##3##3##(1992-5#1)(2008-6#1)(2008-8#1)
study in children with##2##4##(2007-11#1)(2011-2#1)
study in children##3##3##(2007-11#1)(2009-8#1)(2011-2#1)
study in detail the##2##4##(2008-2#1)(2008-3#1)
study in healthy##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
study in order to##4##4##(1994-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
study in patients with##3##4##(1997-8#1)(2007-9#1)(2008-7#1)
study in patients##5##3##(1992-2#1)(1997-8#1)(2007-9#1)(2008-7#1)(2012-12#1)
study in rural##3##3##(2008-12#1)(2008-3#1)(2010-12#1)
study in the rat##5##4##(1992-8#1)(1993-12#1)(1995-12#2)(1997-2#1)
study in the##16##3##(1990-6#1)(1992-8#1)(1993-12#1)(1995-12#2)(1997-2#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)
study in this##3##3##(2008-3#1)(2008-6#1)(2013-8#1)
study in three##3##3##(1995-3#1)(2008-10#1)(2008-9#1)
study in two##2##3##(2008-11#1)(2012-2#1)
study in which the##2##4##(1994-11#1)(2008-9#1)
study in which we##4##4##(2008-6#1)(2008-7#1)(2010-11#1)(2010-9#1)
study in which##15##3##(1994-11#1)(1996-2#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
study in##179##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-11#4)(1991-3#1)(1991-6#4)(1991-8#1)(1992-2#2)(1992-5#2)(1992-8#1)(1993-11#2)(1993-12#3)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1995-12#4)(1995-2#2)(1995-3#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-8#2)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#10)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#3)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#6)
study include##4##2##(2008-12#1)(2008-8#2)(2012-3#1)
study included 100##2##3##(1993-11#1)(2008-11#1)
study included a##2##3##(1991-1#1)(2013-1#1)
study included patients##2##3##(2011-2#1)(2012-2#1)
study included the##2##3##(1993-1#1)(2010-4#1)
study included##49##2##(1990-2#2)(1991-1#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-6#1)(1996-1#2)(1997-8#1)(2007-11#4)(2007-8#2)(2008-10#1)(2008-11#4)(2008-12#3)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
study includes##9##2##(2007-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2011-2#1)
study including##2##2##(1990-8#1)(2010-10#1)
study indicate that the##6##4##(1996-3#1)(2006-6#1)(2008-10#2)(2008-12#1)(2009-7#1)
study indicate that##27##3##(1990-5#1)(1990-6#1)(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#6)(2008-12#2)(2008-6#2)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
study indicate the##3##3##(2008-11#1)(2008-12#2)
study indicate##30##2##(1990-5#1)(1990-6#1)(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-6#2)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
study indicated some##2##3##(2007-2#1)(2008-10#1)
study indicated that in##2##4##(1993-12#1)(2008-9#1)
study indicated that the##10##4##(1994-3#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-6#2)(2008-9#2)
study indicated that##20##3##(1993-12#1)(1993-8#1)(1994-3#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#3)(2012-3#1)
study indicated the##2##3##(1992-8#1)(2008-10#1)
study indicated##28##2##(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#2)(2008-9#4)(2010-8#1)(2011-2#1)(2012-3#1)
study indicates that the##6##4##(1994-2#1)(1996-12#1)(2008-3#1)(2008-5#1)(2013-1#2)
study indicates that##39##3##(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#2)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#2)
study indicates the##3##3##(1990-2#1)(1995-11#1)(1995-2#1)
study indicates##49##2##(1990-2#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#2)(2007-1#1)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#6)(2013-8#3)
study indicating##2##2##(2007-6#1)(2008-10#1)
study intended to##2##3##(2008-7#1)(2011-2#1)
study into##2##2##(2007-10#1)(2008-10#1)
study investigated the effects of##5##5##(1991-9#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
study investigated the possible##4##4##(1994-11#1)(1995-12#1)(2011-2#1)(2012-3#1)
study investigated the relationship between##2##5##(2008-7#1)(2010-10#1)
study investigated the role of##2##5##(2008-12#1)(2008-4#1)
study investigated the##49##3##(1991-9#1)(1992-1#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#2)(1996-2#1)(1997-4#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-7#3)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
study investigated whether##7##3##(1994-8#1)(2008-6#1)(2008-9#2)(2009-10#1)(2012-1#1)(2012-2#1)
study investigated##73##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
study investigates the##19##3##(1991-12#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
study investigates whether##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
study investigates##28##2##(1991-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
study investigating the##2##3##(2008-11#1)(2010-7#1)
study investigating##4##2##(2008-11#1)(2009-7#1)(2010-7#1)(2011-2#1)
study involved a##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
study involved##16##2##(1991-9#1)(1995-1#1)(1996-1#1)(1996-9#1)(1997-4#1)(2008-11#3)(2008-2#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-4#1)
study involves the##2##3##(1997-2#1)(2011-3#1)
study involves##4##2##(1997-2#1)(2008-3#1)(2008-5#1)(2011-3#1)
study involving a##2##3##(1991-2#1)(2008-10#1)
study involving##16##2##(1991-2#1)(1992-11#1)(1994-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#2)(2013-1#4)
study is a retrospective##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
study is a##12##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
study is an extension of##2##5##(2008-10#1)(2008-2#1)
study is an##13##3##(1990-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
study is available##2##3##(1992-6#1)(2008-1#1)
study is based on##7##4##(1991-12#1)(1997-3#1)(2008-12#1)(2008-2#2)(2010-10#1)(2011-2#1)
study is being conducted##2##4##(2008-5#1)(2010-8#1)
study is conducted##6##3##(1992-2#1)(2008-3#2)(2008-9#1)(2010-8#1)(2013-1#1)
study is focused on##3##4##(1994-5#1)(2008-11#1)(2008-9#1)
study is focused##4##3##(1994-5#1)(2008-11#1)(2008-3#1)(2008-9#1)
study is limited by##2##4##(1991-3#1)(2008-12#1)
study is made##2##3##(2008-10#2)
study is needed to##5##4##(1996-12#1)(2007-8#1)(2008-9#1)(2010-10#1)(2012-3#1)
study is needed##8##3##(1996-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
study is on the##2##4##(2008-8#1)(2010-10#1)
study is one of the##2##5##(2012-3#1)(2013-7#1)
study is part of a##2##5##(1992-1#1)(2008-10#1)
study is part of##4##4##(1992-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
study is presented##3##3##(1990-8#1)(1997-5#1)(2008-10#1)
study is reported##2##3##(1990-8#1)(2010-12#1)
study is required to##3##4##(1992-12#1)(2008-1#1)(2011-2#1)
study is required##4##3##(1992-12#1)(2008-1#1)(2011-2#2)
study is still##3##3##(2007-11#1)(2007-9#1)(2008-8#1)
study is that##8##3##(1995-11#1)(1997-8#1)(2008-2#1)(2008-3#2)(2009-6#1)(2013-1#1)(2013-8#1)
study is the first attempt##2##5##(2010-2#1)(2013-8#1)
study is the first to demonstrate##2##6##(1994-11#1)(2009-12#1)
study is the first to show##2##6##(2011-2#1)(2013-3#1)
study is the first to##9##5##(1993-1#1)(1994-11#1)(2008-11#1)(2008-6#1)(2009-12#2)(2010-11#1)(2011-2#1)(2013-3#1)
study is the first##14##4##(1993-1#1)(1994-11#1)(1997-7#1)(2008-11#1)(2008-6#1)(2009-12#2)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-3#1)(2013-8#2)
study is the##28##3##(1991-11#1)(1993-1#1)(1994-11#1)(1994-6#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#2)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-3#1)(2013-8#2)
study is to analyze the##3##5##(2007-8#1)(2011-7#1)(2013-1#1)
study is to analyze##4##4##(2007-8#1)(2009-2#1)(2011-7#1)(2013-1#1)
study is to assess the##5##5##(2008-11#2)(2008-5#1)(2012-3#2)
study is to assess##8##4##(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#2)
study is to clarify##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
study is to compare efficiency and safety of##2##8##(2012-3#2)
study is to compare##7##4##(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#2)
study is to describe the##4##5##(1993-1#1)(1995-4#1)(2010-7#1)(2011-2#1)
study is to describe##5##4##(1993-1#1)(1995-4#1)(2008-11#1)(2010-7#1)(2011-2#1)
study is to determine the##4##5##(2008-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
study is to determine##8##4##(2008-11#1)(2008-5#1)(2011-2#3)(2013-1#2)(2013-7#1)
study is to discover##2##4##(2012-1#1)(2012-3#1)
study is to discuss the##2##5##(2008-12#1)(2013-8#1)
study is to discuss##3##4##(2008-12#1)(2011-2#1)(2013-8#1)
study is to evaluate the##13##5##(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#3)(2011-2#4)(2013-1#1)
study is to evaluate whether##2##5##(2008-4#1)(2011-2#1)
study is to evaluate##20##4##(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#3)(2011-2#6)(2013-1#2)
study is to examine##5##4##(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
study is to explore the##4##5##(2008-11#1)(2010-10#1)(2011-3#1)(2012-12#1)
study is to explore##5##4##(2008-11#1)(2010-10#1)(2011-3#1)(2012-1#1)(2012-12#1)
study is to illustrate##2##4##(2008-7#1)(2013-1#1)
study is to investigate the effects##2##6##(2008-10#1)(2011-3#1)
study is to investigate the##10##5##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-3#2)(2012-2#1)
study is to investigate##15##4##(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-3#2)(2012-2#1)(2012-3#1)
study is to observe the##2##5##(2008-12#1)(2011-3#1)
study is to present##7##4##(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
study is to review##2##4##(2009-10#1)(2009-11#1)
study is to show##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
study is to##138##3##(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1995-4#1)(1996-1#1)(1997-3#1)(2007-10#3)(2007-11#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-2#19)(2011-3#5)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#6)
study is warranted##2##3##(2007-11#1)(2007-7#1)
study is##315##2##(1990-2#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-6#1)(1993-1#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-4#1)(1996-1#2)(1996-12#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#4)(2007-11#7)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#28)(2008-11#11)(2008-12#10)(2008-2#5)(2008-3#12)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#2)(2011-1#5)(2011-2#30)(2011-3#6)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#14)(2012-5#1)(2013-1#16)(2013-3#1)(2013-7#2)(2013-8#12)
study it is##3##3##(1990-12#1)(2008-11#1)(2008-2#1)
study it was found that##3##5##(1992-4#1)(2008-2#1)(2012-2#1)
study it was##5##3##(1992-4#1)(1994-11#1)(1996-12#1)(2008-2#1)(2012-2#1)
study it##11##2##(1990-12#1)(1992-4#1)(1992-6#1)(1994-11#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2012-2#2)
study its performance##2##3##(1994-9#1)(2008-6#1)
study its##12##2##(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-7#1)
study kinetic##2##2##(2008-10#1)(2009-9#1)
study limitations##2##2##(2007-11#1)(2007-2#1)
study looked##2##2##(2008-8#1)(2011-2#1)
study made##2##2##(1990-3#1)(2008-10#1)
study may be used##2##4##(2008-10#1)(2013-1#1)
study may be##5##3##(1996-2#1)(2008-10#2)(2008-2#1)(2013-1#1)
study may provide##2##3##(1997-4#1)(2013-1#1)
study may##14##2##(1996-2#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
study measured the effect of##2##5##(1995-1#1)(2008-12#1)
study measured the##3##3##(1995-1#1)(1996-2#1)(2008-12#1)
study measured##8##2##(1995-1#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-6#1)(2013-1#1)
study mechanisms involved in##2##4##(2008-1#1)(2008-7#1)
study mechanisms of##5##3##(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#2)
study mechanisms##7##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#2)
study medication##2##2##(2007-8#1)(2011-2#1)
study methodology##2##2##(2008-12#1)(2009-9#1)
study methods##2##2##(1992-5#1)(1996-9#1)
study model##2##2##(2008-10#1)(2010-5#1)
study monitored the##2##3##(1997-4#1)(2007-5#1)
study monitored##3##2##(1994-11#1)(1997-4#1)(2007-5#1)
study more##2##2##(1997-3#1)(2008-2#1)
study no##2##2##(2008-6#1)(2008-7#1)
study objective was to determine##2##5##(2008-5#1)(2009-5#1)
study objective was##3##3##(2007-11#1)(2008-5#1)(2009-5#1)
study of 10##5##3##(1993-2#1)(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#1)
study of 16##3##3##(2008-12#1)(2013-1#2)
study of 2##2##3##(1992-6#1)(1993-6#1)
study of 25##2##3##(2007-7#1)(2010-11#1)
study of 30##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
study of 36##3##3##(1995-5#1)(2007-11#2)
study of 38##2##3##(2008-7#1)(2011-2#1)
study of 45##2##3##(1990-6#1)(2008-7#1)
study of 4771 patients##2##4##(2008-6#2)
study of 70##2##3##(1990-2#1)(1996-3#1)
study of B cell development##3##5##(2008-4#3)
study of Cd(II)##2##3##(2008-10#2)
study of QTLs##2##3##(2008-9#2)
study of a new##4##4##(2008-2#2)(2008-4#1)(2010-12#1)
study of a school-based##2##4##(2010-12#1)(2012-2#1)
study of a##48##3##(1990-7#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-2#2)(2007-11#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)
study of acute##2##3##(1994-3#1)(2010-12#1)
study of adaptive radiations##2##4##(2008-8#2)
study of adolescent##2##3##(2009-9#1)(2010-10#1)
study of aging##2##3##(2008-3#1)(2009-12#1)
study of all##5##3##(1995-1#1)(2007-12#1)(2008-1#1)(2010-3#1)(2012-2#1)
study of an##14##3##(1991-1#1)(1994-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
study of antihypertensive##2##3##(2010-5#1)(2011-1#1)
study of any##2##3##(2008-10#1)(2013-8#1)
study of apoptosis##2##3##(2008-9#1)(2013-1#1)
study of body##2##3##(1990-5#1)(2007-12#1)
study of bone##2##3##(2008-6#1)(2012-3#1)
study of both##2##3##(2008-2#1)(2008-4#1)
study of cancer##3##3##(1992-10#1)(2008-9#1)(2009-5#1)
study of cell##5##3##(1995-11#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-1#1)
study of children##3##3##(1994-6#1)(1996-2#1)(2013-1#1)
study of clinical##3##3##(1994-12#1)(2007-8#1)(2010-11#1)
study of critical##2##3##(2008-11#2)
study of different##2##3##(2008-10#2)
study of diispropylcarbodiimide##2##3##(2008-9#2)
study of dissolved##2##3##(2008-10#1)(2008-3#1)
study of drug##2##3##(2008-11#1)(2008-6#1)
study of dynamics of##2##4##(2008-8#1)(2011-1#1)
study of efficacy##2##3##(2008-7#1)(2011-2#1)
study of eight##2##3##(2008-11#1)(2011-2#1)
study of environmental##2##3##(1996-3#1)(2013-1#1)
study of ethics##3##3##(1993-1#1)(1994-1#2)
study of filgrastim##2##3##(2008-7#2)
study of five##2##3##(1991-8#1)(2009-5#1)
study of four patients##2##4##(1993-5#1)(2010-12#1)
study of four##4##3##(1993-5#1)(2008-7#2)(2010-12#1)
study of gene##5##3##(2007-6#1)(2008-4#2)(2008-9#2)
study of genetic##2##3##(1990-12#1)(1997-5#1)
study of growth##2##3##(1993-8#1)(2010-8#1)
study of health##2##3##(1995-2#1)(2009-6#1)
study of hepatitis##2##3##(2007-7#1)(2008-12#1)
study of how##3##3##(1995-3#1)(1997-2#1)(2008-8#1)
study of human##11##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2012-2#1)(2012-3#2)
study of interferences##2##3##(2008-10#2)
study of interfering##2##3##(2008-10#2)
study of its##8##3##(1990-7#1)(1990-9#1)(1992-3#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
study of local##3##3##(2007-7#1)(2008-7#1)(2013-8#1)
study of long-term##3##3##(1991-12#1)(1992-2#1)(2007-9#1)
study of matrix##2##3##(2008-10#1)(2008-4#1)
study of molecular##3##3##(2008-7#2)(2011-2#1)
study of natural##2##3##(1991-12#1)(2008-9#1)
study of nine##2##3##(2007-8#1)(2008-7#1)
study of normal##2##3##(1996-11#1)(1997-5#1)
study of nursing##3##3##(1990-2#1)(2008-12#1)(2010-10#1)
study of oral##3##3##(1993-8#1)(2007-7#2)
study of ovarian cancer##3##4##(1993-9#2)(1994-6#1)
study of pain##2##3##(1992-2#1)(2010-10#1)
study of patients with##6##4##(1992-9#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
study of patients##9##3##(1992-9#1)(1993-11#1)(2008-7#2)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
study of patients'##2##3##(1997-5#1)(2008-11#1)
study of persons##2##3##(2008-7#1)(2013-1#1)
study of plant##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#2)
study of pretreatment methods for the determination of##2##8##(2008-10#2)
study of proteinaceous binding media##2##5##(2008-10#2)
study of reaction between##2##4##(2008-10#2)
study of reaction##3##3##(2008-10#2)(2008-7#1)
study of risk##2##3##(1994-2#1)(2008-10#1)
study of robustness##2##3##(2008-10#2)
study of six##2##3##(1996-5#1)(2009-5#1)
study of soft##2##3##(2008-6#1)(2010-3#1)
study of some##4##3##(2008-10#1)(2008-12#1)(2009-7#1)(2012-2#1)
study of specific##4##3##(1995-11#1)(1995-6#1)(2007-2#1)(2008-7#1)
study of synaptic plasticity in##2##5##(2008-4#2)
study of synaptic plasticity##3##4##(2008-4#3)
study of temporal##2##3##(2007-11#1)(2008-1#1)
study of the adsorption##3##4##(2008-10#3)
study of the analytical##3##4##(2008-10#3)
study of the association##2##4##(2008-8#1)(2012-2#1)
study of the best##2##4##(2008-10#1)(2008-3#1)
study of the characteristics##2##4##(2008-10#1)(2008-7#1)
study of the dependence of##2##5##(2007-12#1)(2008-3#1)
study of the development of##2##5##(2008-10#1)(2008-12#1)
study of the development##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
study of the dynamic##2##4##(2008-3#1)(2011-1#1)
study of the effect of##10##5##(1991-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
study of the effects of##9##5##(1990-5#1)(1994-10#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
study of the effects##11##4##(1990-5#1)(1994-10#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
study of the enhanced##2##4##(2007-12#1)(2008-10#1)
study of the enzyme##2##4##(1995-6#1)(2008-10#1)
study of the evolution of the##2##6##(2008-2#1)(2008-3#1)
study of the evolution of##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
study of the experiences of##3##5##(2008-11#1)(2008-9#1)(2013-1#1)
study of the first##2##4##(1990-3#1)(2008-3#1)
study of the health##2##4##(1992-5#1)(2010-9#1)
study of the impact of##2##5##(1995-6#1)(2012-2#1)
study of the inclusion##2##4##(2008-10#2)
study of the influence of##2##5##(2008-10#1)(2010-10#1)
study of the interaction between##2##5##(1992-12#1)(2008-10#1)
study of the interaction of##2##5##(2008-10#2)
study of the interaction##4##4##(1992-12#1)(2008-10#3)
study of the main##3##4##(2008-10#3)
study of the mechanism of##3##5##(1991-5#1)(2007-11#1)(2008-9#1)
study of the mechanisms of##2##5##(1994-11#1)(2009-10#1)
study of the molecular##4##4##(1997-7#1)(2008-10#2)(2009-3#1)
study of the optical##5##4##(2007-11#1)(2008-3#4)
study of the oxidation##2##4##(2008-10#2)
study of the physiological##2##4##(2008-5#2)
study of the psychobiological##2##4##(2008-1#1)(2008-4#1)
study of the quality of##2##5##(1993-3#1)(2008-9#1)
study of the reaction##2##4##(2008-10#2)
study of the reduction of##2##5##(2008-10#2)
study of the reduction##3##4##(2008-10#2)(2008-8#1)
study of the relation##2##4##(1996-2#1)(2009-5#1)
study of the relationship between##6##5##(1994-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-10#1)(2012-3#1)
study of the relationship##7##4##(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-10#1)(2012-3#1)
study of the relationships between##2##5##(1991-6#1)(2008-9#1)
study of the retention behaviour in##2##6##(1996-5#1)(2008-10#1)
study of the sensitivity##2##4##(1990-7#1)(2008-3#1)
study of the simultaneous##2##4##(2008-10#1)(2009-7#1)
study of the use of##3##5##(2008-10#1)(2008-6#1)(2009-3#1)
study of the works of##2##5##(2009-10#1)(2009-7#1)
study of the##342##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#91)(2008-11#8)(2008-12#2)(2008-2#15)(2008-3#20)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#10)(2009-10#2)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#5)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-10#2)(2011-2#8)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#3)
study of thermal##2##3##(2008-10#2)
study of these complexes##2##4##(1994-8#1)(2008-10#1)
study of these##13##3##(1993-9#1)(1994-8#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
study of this##5##3##(1990-5#1)(1997-7#1)(2008-2#1)(2008-3#1)(2009-6#1)
study of three##3##3##(2007-11#1)(2008-7#1)(2012-12#1)
study of treatment##2##3##(1990-2#1)(1993-2#1)
study of tumor##2##3##(1995-10#1)(2008-11#1)
study of two##11##3##(1990-3#1)(1991-12#1)(1993-5#1)(1993-8#1)(2007-12#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
study of various##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
study of vascular##2##3##(1991-6#1)(1994-5#1)
study of women's##2##3##(1996-3#1)(2009-5#1)
study of##1400##2##(1990-11#2)(1990-12#6)(1990-2#7)(1990-3#6)(1990-5#8)(1990-6#7)(1990-7#6)(1990-8#3)(1990-9#5)(1991-1#2)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#7)(1991-6#7)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#1)(1992-10#5)(1992-11#2)(1992-12#4)(1992-2#6)(1992-3#3)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#6)(1993-11#4)(1993-12#4)(1993-2#6)(1993-3#7)(1993-5#2)(1993-6#3)(1993-8#4)(1993-9#7)(1994-1#3)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#5)(1994-3#8)(1994-5#4)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#6)(1995-3#5)(1995-5#4)(1995-6#8)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#6)(1996-3#11)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#3)(1997-4#4)(1997-5#8)(1997-6#2)(1997-7#7)(1997-8#2)(2006-10#3)(2006-4#1)(2006-6#1)(2007-10#7)(2007-11#21)(2007-12#29)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#9)(2007-9#2)(2008-1#17)(2008-10#254)(2008-11#44)(2008-12#24)(2008-2#33)(2008-3#63)(2008-4#30)(2008-5#29)(2008-6#14)(2008-7#61)(2008-8#30)(2008-9#44)(2009-1#4)(2009-10#7)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#10)(2009-6#6)(2009-7#6)(2009-8#7)(2009-9#6)(2010-1#2)(2010-10#8)(2010-11#7)(2010-12#6)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#7)(2010-6#6)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#21)(2011-10#2)(2011-2#38)(2011-3#7)(2012-1#9)(2012-12#13)(2012-2#27)(2012-3#31)(2012-8#1)(2013-1#41)(2013-7#4)(2013-8#23)
study offers a##3##3##(1996-6#1)(2010-12#1)(2012-2#1)
study offers##4##2##(1996-6#1)(2010-12#1)(2010-5#1)(2012-2#1)
study on a##10##3##(1993-6#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#2)(2009-3#1)(2013-1#1)
study on effects of##2##4##(1994-5#1)(2013-8#1)
study on healthy##2##3##(2008-5#1)(2010-12#1)
study on primary##2##3##(2008-8#1)(2013-8#1)
study on the determination of##2##5##(2008-10#2)
study on the effect of##6##5##(1990-12#1)(2007-10#1)(2008-10#1)(2010-3#1)(2011-1#1)(2012-3#1)
study on the effects of##2##5##(1990-3#1)(2009-11#1)
study on the interaction of##3##5##(2008-10#2)(2008-9#1)
study on the interaction##4##4##(2008-10#3)(2008-9#1)
study on the##70##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1991-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-6#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
study on their##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
study on women's journey of recovery##2##6##(2010-3#2)
study on##213##2##(1990-10#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#28)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#15)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#4)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#5)(2012-2#6)(2012-3#8)(2013-1#11)(2013-8#7)
study opens##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
study or clinical##2##3##(1991-1#1)(2008-10#1)
study or##7##2##(1991-1#2)(1997-7#1)(2008-10#1)(2010-11#1)(2010-3#1)(2013-1#1)
study over##6##2##(1992-11#1)(1996-11#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
study participants were##2##3##(2007-7#1)(2008-12#1)
study participants##16##2##(1994-2#1)(1997-3#1)(2007-7#1)(2008-12#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)
study participants'##2##2##(2011-2#1)(2012-3#1)
study participation##3##2##(2008-3#1)(2009-4#1)(2013-1#1)
study patients were##7##3##(2007-7#3)(2008-1#4)
study patients##22##2##(1993-12#1)(2007-7#5)(2008-1#13)(2010-12#1)(2013-1#2)
study performed in##2##3##(1990-6#1)(2008-5#1)
study performed##7##2##(1990-6#1)(1990-9#1)(2007-8#1)(2008-12#2)(2008-5#2)
study period for##3##3##(2006-8#2)(2008-11#1)
study period had##2##3##(2007-10#1)(2008-7#1)
study period was##4##3##(2006-8#2)(2010-3#1)(2012-12#1)
study period##62##2##(1992-5#1)(1993-3#1)(1994-12#1)(1997-5#1)(2006-8#9)(2007-10#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2010-11#1)(2010-3#3)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#5)(2013-8#2)
study periods##3##2##(2007-10#1)(2010-11#1)(2011-2#1)
study phase##2##2##(1991-3#1)(2008-3#1)
study points out##2##3##(1992-8#1)(2013-7#1)
study points##3##2##(1992-8#1)(1994-6#1)(2013-7#1)
study population of##2##3##(1990-2#1)(2011-2#1)
study population was##5##3##(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#1)(2013-1#1)
study population##32##2##(1990-2#2)(1993-9#1)(1996-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#3)
study populations##4##2##(1992-11#1)(2008-11#1)(2008-8#1)(2009-7#1)
study present##2##2##(2007-11#1)(2008-10#1)
study presented##3##2##(1995-3#1)(2008-12#1)(2008-4#1)
study presents a##8##3##(2007-11#1)(2008-10#3)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)
study presents the##8##3##(1991-3#1)(2007-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#2)
study presents##24##2##(1991-3#1)(1991-6#1)(1994-8#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#2)
study produced##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
study proposed a##2##3##(2011-2#1)(2013-1#1)
study proposed##4##2##(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
study proposes a new##2##4##(2008-10#1)(2008-5#1)
study proposes##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
study protocol##4##2##(1997-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
study protocols##3##2##(2008-5#1)(2008-6#1)(2010-3#1)
study provide##8##2##(2007-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
study provided a##2##3##(2008-7#1)(2008-8#1)
study provided evidence that##3##4##(1992-12#1)(2009-11#1)(2010-1#1)
study provided##16##2##(1991-12#1)(1992-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2012-1#1)(2013-1#1)
study provides a##10##3##(2007-7#1)(2008-10#2)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
study provides an##2##3##(2013-1#2)
study provides evidence for##4##4##(1994-8#1)(1995-12#1)(2013-1#1)(2013-8#1)
study provides evidence that##3##4##(1994-6#1)(2008-10#1)(2008-9#1)
study provides evidence##9##3##(1990-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-9#1)(2013-1#1)(2013-8#1)
study provides for the first time##2##6##(2011-2#1)(2012-2#1)
study provides insight into##2##4##(2010-12#1)(2013-1#1)
study provides novel##2##3##(2008-10#1)(2013-1#1)
study provides##55##2##(1990-3#1)(1990-7#1)(1993-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#1)
study quantifies##2##2##(1992-1#1)(2009-11#1)
study question##3##2##(1996-9#1)(2012-12#2)
study questions the##2##3##(1997-7#1)(2011-2#1)
study questions##3##2##(1994-2#1)(1997-7#1)(2011-2#1)
study rats were##2##3##(2008-9#2)
study rats##3##2##(2008-9#3)
study received##2##2##(2010-4#1)(2010-8#1)
study recommends##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
study replicates##4##2##(1993-6#1)(1994-2#1)(1996-2#1)(2009-8#1)
study reported here was##3##4##(2008-12#1)(2008-5#2)
study reported here##7##3##(1992-3#1)(2008-12#1)(2008-5#2)(2010-5#1)(2011-2#1)(2013-8#1)
study reported that##4##3##(1991-12#1)(1994-3#1)(1997-2#1)(2008-5#1)
study reported##14##2##(1991-12#1)(1992-3#1)(1994-3#1)(1997-2#1)(2008-12#1)(2008-5#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
study reports a##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
study reports on the##5##4##(1993-1#1)(1994-2#1)(2007-7#1)(2008-7#1)(2008-9#1)
study reports on##9##3##(1993-1#2)(1994-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-5#1)
study reports the##11##3##(1997-7#1)(2007-7#1)(2008-10#4)(2008-11#1)(2010-12#1)(2010-5#1)(2012-7#1)(2013-1#1)
study reports##32##2##(1990-12#1)(1991-2#1)(1993-1#2)(1994-2#1)(1995-2#1)(1995-6#2)(1997-7#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-7#1)(2013-1#3)
study represents a first##2##4##(2009-7#1)(2012-2#1)
study represents a##4##3##(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
study represents the first##4##4##(1995-12#1)(2008-10#1)(2008-9#1)(2010-3#1)
study represents##10##2##(1995-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
study resulted in##3##3##(2008-10#1)(2012-1#1)(2013-7#1)
study results##16##2##(1992-12#1)(1993-12#3)(1995-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#2)(2010-7#1)
study retrospectively##2##2##(2008-3#1)(2012-3#1)
study reveal that the##2##4##(2008-12#1)(2009-10#1)
study reveal##4##2##(2008-12#1)(2008-7#1)(2009-10#1)(2009-9#1)
study revealed a##5##3##(1994-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2013-7#1)
study revealed higher##3##3##(2007-8#1)(2012-1#1)(2013-8#1)
study revealed no##2##3##(2007-2#1)(2008-10#1)
study revealed that both##2##4##(2008-10#1)(2012-3#1)
study revealed that the##6##4##(1995-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)
study revealed that##29##3##(1991-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
study revealed the##3##3##(2007-7#1)(2008-7#1)(2012-3#1)
study revealed three##2##3##(1994-12#1)(2012-3#1)
study revealed##54##2##(1991-2#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
study reveals a##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
study reveals that the##6##4##(1991-3#1)(2008-1#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#1)
study reveals that##11##3##(1991-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
study reveals the##4##3##(1994-3#1)(1997-4#1)(2007-12#1)(2013-1#1)
study reveals##21##2##(1991-3#1)(1994-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#4)
study reviews##4##2##(1995-2#1)(1996-1#1)(2012-2#2)
study sample##9##2##(1995-1#1)(1996-9#1)(1997-5#1)(2007-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-6#1)(2012-3#1)
study samples##3##2##(2010-11#2)(2010-4#1)
study seeks to##3##3##(1995-12#1)(2007-11#1)(2013-8#1)
study selection##2##2##(2007-7#1)(2012-3#1)
study several##2##2##(2008-10#1)(2009-11#1)
study should be##7##3##(1991-12#1)(1993-1#1)(1995-5#1)(1996-8#1)(2008-1#1)(2008-10#1)(2010-4#1)
study should prove useful##2##4##(2008-10#1)(2012-2#1)
study should##14##2##(1991-12#1)(1993-1#1)(1995-5#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
study show a##2##3##(2008-3#1)(2011-2#1)
study show that##15##3##(1990-12#1)(1991-5#1)(1994-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
study show##22##2##(1990-12#1)(1991-5#1)(1994-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
study showed a high##2##4##(2006-10#1)(2010-4#1)
study showed a##11##3##(1997-4#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-6#1)(2013-1#1)
study showed an##2##3##(2007-8#1)(2011-2#1)
study showed no##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
study showed that a##2##4##(2007-2#1)(2008-5#1)
study showed that all##2##4##(2008-9#1)(2012-3#1)
study showed that both##2##4##(2008-5#1)(2008-7#1)
study showed that no##2##4##(2008-1#1)(2008-10#1)
study showed that the##20##4##(1990-11#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#3)(2013-8#2)
study showed that there was a##2##6##(2008-12#1)(2011-1#1)
study showed that there was##3##5##(2008-12#1)(2011-1#1)(2013-8#1)
study showed that there##4##4##(2008-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
study showed that##70##3##(1990-11#1)(1990-2#1)(1992-6#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#12)(2008-12#4)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#4)
study showed the##2##3##(1997-7#1)(2011-1#1)
study showed##113##2##(1990-11#1)(1990-2#1)(1990-6#1)(1992-12#1)(1992-6#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#17)(2008-11#1)(2008-12#6)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#8)(2013-8#6)
study showing that##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
study showing##4##2##(1995-12#1)(2008-10#1)(2010-5#1)(2011-2#1)
study shows a##4##3##(1991-8#1)(1993-12#1)(1996-3#1)(2012-12#1)
study shows how oral##2##4##(2008-5#2)
study shows how##5##3##(1993-2#1)(2008-5#2)(2008-7#1)(2009-11#1)
study shows that a##2##4##(2008-10#1)(2010-6#1)
study shows that by##2##4##(2008-12#1)(2009-3#1)
study shows that the proposed##2##5##(2013-1#1)(2013-8#1)
study shows that the##19##4##(1990-7#1)(1995-6#2)(2007-10#1)(2008-1#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2012-3#1)(2013-1#2)(2013-8#1)
study shows that this##3##4##(2008-10#1)(2008-5#1)(2010-5#1)
study shows that##64##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-6#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
study shows the##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2013-7#1)
study shows##83##2##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#2)(1995-1#1)(1995-6#3)(1996-12#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-8#1)(2007-10#2)(2007-7#2)(2008-1#2)(2008-10#6)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
study since##2##2##(2008-10#1)(2008-7#1)
study site##4##2##(2008-10#2)(2008-5#2)
study sites##9##2##(2008-10#3)(2008-12#2)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
study sought to determine##2##4##(1992-11#1)(2012-3#1)
study sought to examine the##2##5##(2007-11#1)(2012-2#1)
study sought to examine##3##4##(2007-11#1)(2008-6#1)(2012-2#1)
study sought to##16##3##(1992-11#1)(2007-11#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
study strongly##4##2##(1994-3#1)(2008-10#2)(2008-7#1)
study subjects were##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
study subjects##13##2##(1990-8#1)(1992-12#1)(1994-2#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
study suggest that the##7##4##(1990-2#1)(1992-12#1)(1992-6#1)(1994-2#1)(1996-5#1)(2011-2#2)
study suggest that these##2##4##(2007-12#1)(2008-10#1)
study suggest that##40##3##(1990-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-5#1)(2013-1#1)
study suggest##44##2##(1990-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#4)(2012-3#1)(2012-5#1)(2013-1#1)
study suggested that an##2##4##(1992-12#1)(1992-2#1)
study suggested that the##2##4##(2008-5#1)(2008-6#1)
study suggested that##11##3##(1992-12#1)(1992-2#1)(1994-2#1)(1995-4#1)(1995-8#1)(2006-12#1)(2008-5#1)(2008-6#1)(2011-3#1)(2013-1#1)(2013-8#1)
study suggested##12##2##(1992-12#1)(1992-2#1)(1994-2#1)(1995-4#1)(1995-8#1)(2006-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-3#1)(2013-1#1)(2013-8#1)
study suggests a##2##3##(2008-5#2)
study suggests that a##5##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
study suggests that routine##2##4##(1990-2#1)(1990-8#1)
study suggests that the##15##4##(1990-7#1)(1991-3#1)(1995-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#3)(2013-1#1)
study suggests that there##2##4##(2008-9#1)(2011-2#1)
study suggests that##65##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-6#1)(1993-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-7#4)(2008-1#4)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2011-1#2)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
study suggests the##4##3##(1990-3#1)(1992-12#1)(2008-1#1)(2008-10#1)
study suggests##73##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-7#4)(2008-1#5)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
study support the##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
study support##4##2##(1991-12#1)(1991-9#1)(2008-10#1)(2008-5#1)
study supports the hypothesis that##3##5##(1993-6#1)(2010-10#1)(2013-1#1)
study supports the##9##3##(1990-5#1)(1993-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
study supports##14##2##(1990-5#1)(1993-6#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-7#2)(2010-10#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
study takes##2##2##(2008-3#1)(2011-2#1)
study tested the hypothesis that##5##5##(1993-6#1)(1995-12#1)(2008-3#2)(2008-5#1)
study tested the##9##3##(1993-6#1)(1995-12#1)(1996-5#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#1)
study tested##12##2##(1993-6#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)
study tests##5##2##(1995-2#1)(2008-9#1)(2010-10#1)(2010-2#1)(2013-8#1)
study than in##2##3##(1992-6#1)(2008-6#1)
study than##3##2##(1992-6#1)(1994-12#1)(2008-6#1)
study that explored the##3##4##(2007-10#1)(2008-12#1)(2011-1#1)
study that explored##4##3##(2007-10#1)(2008-12#1)(2009-5#1)(2011-1#1)
study that had##2##3##(2008-10#1)(2012-1#1)
study that included##2##3##(2008-10#1)(2011-2#1)
study that investigated the##2##4##(2007-10#1)(2010-3#1)
study that investigated##3##3##(1996-3#1)(2007-10#1)(2010-3#1)
study that the##2##3##(1995-12#1)(2011-2#1)
study that was##2##3##(2009-11#1)(2010-3#1)
study that##49##2##(1990-11#1)(1991-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#1)(2007-10#4)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
study the activity##2##3##(1991-5#1)(2013-1#1)
study the association between##2##4##(1993-12#1)(2011-1#1)
study the association of##2##4##(2008-10#1)(2008-5#1)
study the association##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
study the authors##2##3##(1991-6#1)(2007-8#1)
study the chemical##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
study the consequences of##2##4##(2008-10#1)(2008-8#1)
study the correlation between##2##4##(2008-8#1)(2012-3#1)
study the coupling##2##3##(2007-12#1)(2009-11#1)
study the development of##2##4##(2007-8#1)(2008-12#1)
study the development##3##3##(1995-9#1)(2007-8#1)(2008-12#1)
study the effect of a##3##5##(1991-6#1)(2008-7#1)(2008-9#1)
study the effect of##40##4##(1990-11#1)(1990-2#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)
study the effect##41##3##(1990-11#1)(1990-2#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)
study the effects of##30##4##(1992-6#1)(1993-1#1)(1993-11#1)(1996-7#1)(1997-3#1)(1997-7#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
study the effects##32##3##(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1996-7#1)(1997-3#1)(1997-7#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
study the efficacy of##3##4##(1991-11#1)(2008-12#1)(2008-5#1)
study the efficacy##4##3##(1991-11#1)(2007-10#1)(2008-12#1)(2008-5#1)
study the evolution of##4##4##(2008-6#1)(2008-8#3)
study the expression of##3##4##(1992-3#1)(2008-9#1)(2013-8#1)
study the expression##4##3##(1992-3#1)(2008-9#2)(2013-8#1)
study the factors##2##3##(2008-1#1)(2008-7#1)
study the feasibility of##2##4##(2008-10#1)(2008-3#1)
study the feasibility##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
study the frequency##2##3##(2007-12#1)(2008-10#1)
study the function of##7##4##(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#2)
study the functional##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
study the gene##2##3##(2008-10#1)(2008-9#1)
study the genetic##5##3##(2008-10#2)(2008-7#1)(2010-4#1)(2011-1#1)
study the influence of the##3##5##(2008-10#1)(2008-2#2)
study the influence of##16##4##(1991-8#1)(1992-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-5#2)(2011-1#1)(2012-2#1)(2013-8#1)
study the molecular##6##3##(1991-6#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)
study the origin and##2##4##(1995-11#1)(2008-10#1)
study the performance of##3##4##(2008-3#1)(2009-9#1)(2010-5#1)
study the physiology##2##3##(1992-9#1)(2008-9#1)
study the possible mechanism of##3##5##(2008-10#2)(2009-12#1)
study the possible##6##3##(1991-9#1)(1992-12#1)(2007-12#1)(2008-10#2)(2009-12#1)
study the prevalence##3##3##(1990-9#1)(2007-10#1)(2013-8#1)
study the relationship between the##4##5##(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)
study the relationship between##6##4##(1991-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)
study the relationship##9##3##(1991-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#1)
study the relative##3##3##(1994-2#1)(2008-3#1)(2008-4#1)
study the role of##15##4##(1990-5#1)(1992-9#1)(1993-12#1)(1993-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
study the use of##3##4##(2008-10#2)(2008-2#1)
study the##498##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#4)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#6)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-5#4)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#4)(1997-8#1)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#10)(2007-12#10)(2007-2#1)(2007-8#3)(2008-1#9)(2008-10#96)(2008-11#18)(2008-12#9)(2008-2#23)(2008-3#20)(2008-4#13)(2008-5#17)(2008-6#8)(2008-7#15)(2008-8#23)(2008-9#16)(2009-1#1)(2009-11#2)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-11#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#9)(2011-10#1)(2011-2#8)(2011-3#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#11)(2012-3#7)(2013-1#6)(2013-7#4)(2013-8#11)
study their##8##2##(1994-6#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2013-7#1)
study there##2##2##(2006-10#1)(2008-2#1)
study therefore##3##2##(1992-4#1)(2008-11#1)(2010-3#1)
study these##7##2##(1992-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-11#1)
study this effect##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
study this##20##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
study through##2##2##(2007-12#1)(2012-2#1)
study thus##4##2##(1994-8#1)(1995-11#1)(2008-10#2)
study to assess the effect of##2##6##(2009-6#1)(2012-3#1)
study to assess the effect##3##5##(2009-6#1)(2012-3#1)(2013-7#1)
study to assess the##8##4##(1996-12#1)(2007-7#1)(2009-12#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
study to assess##11##3##(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
study to be##2##3##(2008-10#2)
study to compare the##3##4##(1996-3#1)(2007-7#1)(2008-1#1)
study to compare##5##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2013-1#1)
study to determine the##7##4##(1990-10#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-7#1)(2012-12#1)
study to determine whether##2##4##(2010-3#1)(2010-4#1)
study to determine##17##3##(1990-10#1)(1993-12#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
study to develop##2##3##(2008-10#1)(2009-10#1)
study to evaluate the effect of##4##6##(1993-3#1)(1994-11#1)(2007-7#1)(2010-7#1)
study to evaluate the##14##4##(1990-2#1)(1991-3#1)(1993-3#1)(1994-11#1)(2007-7#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
study to evaluate##22##3##(1990-2#2)(1991-3#1)(1993-3#1)(1994-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-7#1)
study to examine the effects of##2##6##(2008-10#1)(2010-8#1)
study to examine the##4##4##(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
study to examine##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)
study to explore##2##3##(2010-8#1)(2011-2#1)
study to identify##4##3##(1990-11#1)(2008-10#1)(2008-12#1)(2010-11#1)
study to inform##2##3##(2011-1#1)(2012-3#1)
study to investigate the##2##4##(1996-12#1)(2011-2#1)
study to measure##2##3##(1991-6#1)(2011-2#1)
study to monitor the##2##4##(2008-10#1)(2010-4#1)
study to test##3##3##(1997-3#1)(2008-11#1)(2010-5#1)
study to the##2##3##(2008-10#1)(2011-2#1)
study to##125##2##(1990-10#1)(1990-11#1)(1990-2#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-3#1)(2007-10#2)(2007-11#1)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#3)
study took place in##2##4##(1991-3#1)(2011-2#1)
study took place##3##3##(1991-3#1)(2010-3#1)(2011-2#1)
study two##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
study type##12##2##(2007-8#11)(2008-10#1)
study undertaken##2##2##(2008-11#1)(2008-7#1)
study used a mixed method##2##5##(2013-1#2)
study used a qualitative methodology##2##5##(2007-12#1)(2009-4#1)
study used a qualitative##3##4##(2007-12#1)(2009-4#1)(2013-1#1)
study used a##13##3##(1993-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#3)(2012-12#1)(2013-1#3)
study used qualitative##2##3##(2012-3#1)(2013-1#1)
study used the##4##3##(2008-5#1)(2010-7#1)(2011-1#2)
study used##32##2##(1990-6#1)(1993-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#3)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#5)
study uses a##2##3##(2009-5#1)(2010-7#1)
study uses##11##2##(1995-2#2)(1997-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)
study using a##6##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
study using an##2##3##(1995-5#1)(2008-11#1)
study using data from##2##4##(2006-4#1)(2011-2#1)
study using focus groups was##2##5##(2008-11#1)(2008-12#1)
study using focus##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
study using the##4##3##(1997-2#1)(2008-7#1)(2008-8#1)(2013-7#1)
study using##38##2##(1990-11#1)(1991-9#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
study utilized##4##2##(1993-2#1)(1994-2#1)(2009-7#1)(2009-8#1)
study utilizing##4##2##(1993-3#1)(2008-10#1)(2008-11#1)(2010-9#1)
study vascular##2##2##(2008-11#2)
study was a retrospective##2##4##(2007-8#1)(2008-9#1)
study was a##12##3##(1992-8#2)(1993-3#1)(1995-9#1)(2007-11#1)(2007-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
study was aimed at investigating the##3##6##(2010-12#1)(2012-12#2)
study was aimed at investigating##4##5##(1990-6#1)(2010-12#1)(2012-12#2)
study was aimed at##11##4##(1990-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
study was aimed to assess##2##5##(1991-6#1)(2008-3#1)
study was aimed to investigate the##2##6##(2010-8#1)(2012-3#1)
study was aimed to##12##4##(1991-6#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
study was aimed##23##3##(1990-6#1)(1991-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(2008-12#1)(2008-3#3)(2009-12#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
study was also##4##3##(1994-8#1)(2008-10#2)(2011-2#1)
study was an evaluation of##2##5##(2007-11#1)(2008-11#1)
study was an##3##3##(2007-10#1)(2007-11#1)(2008-11#1)
study was based on a##2##5##(1990-9#1)(2010-11#1)
study was based on the##2##5##(2008-4#1)(2012-12#1)
study was based on##8##4##(1990-9#1)(1992-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
study was based##9##3##(1990-9#1)(1992-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
study was carried out at##5##5##(2007-7#1)(2008-12#1)(2011-2#1)(2013-8#2)
study was carried out by##3##5##(1991-12#1)(1994-11#1)(2008-10#1)
study was carried out for##2##5##(2008-5#1)(2010-2#1)
study was carried out in##9##5##(1992-5#1)(1996-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
study was carried out on a##3##6##(2008-2#1)(2008-7#1)(2013-1#1)
study was carried out on##11##5##(1992-12#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2011-2#2)(2013-1#1)
study was carried out to assess##2##6##(1996-6#1)(2011-2#1)
study was carried out to determine the prevalence of##2##9##(2010-8#1)(2011-2#1)
study was carried out to determine the##6##7##(1994-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
study was carried out to determine##7##6##(1994-3#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
study was carried out to evaluate the##2##7##(1990-2#1)(1992-6#1)
study was carried out to evaluate##3##6##(1990-11#1)(1990-2#1)(1992-6#1)
study was carried out to investigate the##5##7##(1991-6#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#1)
study was carried out to investigate##6##6##(1991-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#1)
study was carried out to##26##5##(1990-11#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-6#1)(1994-3#1)(1995-12#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
study was carried out using##2##5##(2008-11#1)(2012-2#1)
study was carried out with##4##5##(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
study was carried out##72##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-12#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
study was carried##73##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-12#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
study was closed##2##3##(1990-12#1)(1992-2#1)
study was completed##3##3##(1991-12#1)(1994-3#1)(2008-11#1)
study was comprised of##3##4##(2008-10#2)(2013-1#1)
study was concerned##2##3##(2010-8#1)(2012-1#1)
study was conducted among##4##4##(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
study was conducted at the##4##5##(1994-1#1)(2007-7#1)(2008-12#1)(2008-9#1)
study was conducted at##6##4##(1994-1#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
study was conducted between##2##4##(2011-2#1)(2013-8#1)
study was conducted during##2##4##(2007-11#1)(2013-7#1)
study was conducted from##3##4##(2008-8#1)(2008-9#1)(2013-7#1)
study was conducted in a##3##5##(2009-12#1)(2009-5#1)(2012-2#1)
study was conducted in order to##4##6##(1997-7#1)(2008-12#1)(2008-9#2)
study was conducted in the##4##5##(1992-2#1)(2008-1#2)(2011-2#1)
study was conducted in##27##4##(1992-2#1)(1993-1#1)(1997-7#2)(2008-1#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
study was conducted on a##2##5##(2008-5#1)(2012-5#1)
study was conducted on##13##4##(1997-6#1)(2007-7#2)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-5#1)(2013-8#1)
study was conducted to assess the##3##6##(2007-7#1)(2008-10#1)(2010-5#1)
study was conducted to assess##4##5##(2007-7#1)(2008-10#2)(2010-5#1)
study was conducted to compare the##3##6##(1993-1#1)(2012-12#1)(2012-2#1)
study was conducted to determine the##8##6##(1994-6#1)(1995-1#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
study was conducted to determine whether##2##6##(1995-8#1)(2008-10#1)
study was conducted to determine##15##5##(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
study was conducted to evaluate the##9##6##(2008-10#2)(2008-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
study was conducted to evaluate##11##5##(2008-10#2)(2008-11#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
study was conducted to examine##3##5##(1994-1#1)(2008-10#1)(2008-11#1)
study was conducted to explore##2##5##(2008-11#1)(2009-5#1)
study was conducted to identify the##2##6##(1995-10#1)(2008-10#1)
study was conducted to identify##3##5##(1995-10#1)(2008-10#1)(2010-11#1)
study was conducted to investigate the effect of##2##8##(2008-12#1)(2011-2#1)
study was conducted to investigate the##6##6##(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#2)(2013-1#1)
study was conducted to investigate##7##5##(1991-3#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#2)(2013-1#1)
study was conducted to provide##2##5##(1990-12#1)(2008-10#1)
study was conducted to study##2##5##(2007-7#1)(2008-3#1)
study was conducted to test the hypothesis##2##7##(1991-2#1)(2012-2#1)
study was conducted to test##3##5##(1991-2#1)(2008-10#1)(2012-2#1)
study was conducted to##65##4##(1990-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#12)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
study was conducted using a##2##5##(2008-10#1)(2013-1#1)
study was conducted using##5##4##(2008-10#2)(2009-5#1)(2011-2#1)(2013-1#1)
study was conducted with##5##4##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
study was conducted##144##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#2)(1994-1#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#3)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#6)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#3)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-8#3)(2011-1#3)(2011-2#13)(2012-12#5)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#4)(2013-8#4)
study was designed as a##3##5##(2010-3#1)(2011-2#1)(2013-1#1)
study was designed in##2##4##(1994-2#1)(2010-8#1)
study was designed to assess the##3##6##(1994-6#1)(2011-2#2)
study was designed to assess whether##2##6##(1994-3#1)(2007-10#1)
study was designed to assess##5##5##(1994-3#1)(1994-6#1)(2007-10#1)(2011-2#2)
study was designed to compare the##6##6##(1991-12#1)(1994-12#1)(1996-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
study was designed to compare##8##5##(1991-12#1)(1994-12#1)(1996-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
study was designed to determine if##2##6##(1994-2#1)(2008-7#1)
study was designed to determine the##4##6##(1990-5#1)(2008-10#1)(2008-6#1)(2012-3#1)
study was designed to determine##7##5##(1990-5#1)(1992-11#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)
study was designed to develop##2##5##(2008-10#1)(2011-2#1)
study was designed to estimate the##2##6##(2008-12#1)(2010-3#1)
study was designed to evaluate the effects of##2##8##(2011-1#1)(2011-2#1)
study was designed to evaluate the##8##6##(1995-8#1)(2007-7#2)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
study was designed to evaluate##12##5##(1995-8#1)(2007-7#2)(2008-10#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#4)
study was designed to examine the relationship between##2##8##(1992-2#1)(2011-2#1)
study was designed to examine the##7##6##(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
study was designed to examine##8##5##(1992-2#1)(1992-8#1)(1993-12#2)(1994-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
study was designed to investigate the effect of##3##8##(2008-12#1)(2010-5#1)(2012-12#1)
study was designed to investigate the##11##6##(1993-12#1)(1993-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#1)
study was designed to investigate##13##5##(1993-12#1)(1993-3#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-12#1)
study was designed to##77##4##(1990-5#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
study was designed##86##3##(1990-5#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#1)
study was developed##2##3##(2008-10#1)(2012-3#1)
study was done in##6##4##(1990-10#1)(1997-1#1)(1997-8#1)(2008-12#1)(2011-2#1)(2013-7#1)
study was done to compare the##2##6##(2007-7#1)(2010-7#1)
study was done to##6##4##(2007-7#1)(2008-12#1)(2008-5#1)(2010-7#1)(2013-8#2)
study was done##18##3##(1990-10#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
study was initiated##3##3##(2008-10#3)
study was made of##3##4##(1992-5#1)(2008-10#1)(2012-12#1)
study was made on the##2##5##(2008-10#1)(2008-8#1)
study was made on##3##4##(2008-10#2)(2008-8#1)
study was made##13##3##(1990-2#1)(1992-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
study was performed by##2##4##(1996-12#1)(2008-12#1)
study was performed in order to##3##6##(2007-12#1)(2008-7#1)(2009-7#1)
study was performed in##9##4##(1991-6#1)(1996-5#1)(2007-12#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-5#1)(2013-1#1)
study was performed on the##2##5##(2008-10#1)(2013-1#1)
study was performed on##12##4##(1990-6#1)(1991-6#1)(1996-5#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-3#1)(2013-1#2)(2013-8#1)
study was performed to assess the##2##6##(2008-5#1)(2013-1#1)
study was performed to evaluate the##4##6##(1994-9#1)(2008-1#1)(2008-10#1)(2011-2#1)
study was performed to evaluate##5##5##(1994-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
study was performed to investigate the##2##6##(1992-8#1)(1997-6#1)
study was performed to##20##4##(1992-8#1)(1994-9#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
study was performed using##2##4##(2007-10#1)(2008-10#1)
study was performed with##3##4##(1991-6#1)(2008-10#2)
study was performed##56##3##(1990-6#1)(1991-6#3)(1992-12#1)(1992-8#1)(1994-9#1)(1996-12#1)(1996-5#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#5)(2009-1#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#4)(2013-8#2)
study was planned as##2##4##(1990-6#1)(2010-7#1)
study was planned to##4##4##(1994-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
study was planned##8##3##(1990-3#1)(1990-6#1)(1994-11#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
study was seen##2##3##(2007-7#1)(2008-10#1)
study was set##3##3##(1990-3#1)(2011-2#1)(2012-3#1)
study was started##2##3##(1991-6#1)(2008-11#1)
study was the determination of##2##5##(1994-7#1)(2010-5#1)
study was the##14##3##(1994-7#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#2)(2013-1#1)
study was therefore to##2##4##(1990-5#1)(2009-6#1)
study was therefore##4##3##(1990-5#1)(1994-12#1)(2009-6#1)(2010-10#1)
study was to analyse the##7##5##(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2013-8#1)
study was to analyse##10##4##(2007-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
study was to analyze the##11##5##(1995-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-3#1)
study was to analyze##20##4##(1995-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
study was to ascertain the##2##5##(1991-12#1)(2008-9#1)
study was to ascertain##3##4##(1991-12#1)(1992-3#1)(2008-9#1)
study was to asses the##3##5##(2007-11#1)(2008-12#1)(2008-7#1)
study was to assess the feasibility of##2##7##(1997-8#1)(2007-8#1)
study was to assess the feasibility##3##6##(1997-8#1)(2007-10#1)(2007-8#1)
study was to assess the influence of##2##7##(2008-5#1)(2009-2#1)
study was to assess the prevalence of##2##7##(2011-2#1)(2012-3#1)
study was to assess the##32##5##(1990-6#1)(1992-10#1)(1992-12#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#3)(2009-2#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
study was to assess whether##3##5##(1991-6#1)(2008-7#1)(2012-2#1)
study was to assess##45##4##(1990-6#1)(1991-6#1)(1992-10#1)(1992-12#1)(1994-3#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#5)(2009-2#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
study was to characterize and##2##5##(2008-11#1)(2008-5#1)
study was to characterize the##3##5##(2007-8#1)(2008-11#1)(2008-5#1)
study was to characterize##7##4##(1993-1#1)(2007-8#1)(2008-11#2)(2008-5#2)(2012-3#1)
study was to clarify the mechanism of##2##7##(2007-10#1)(2011-2#1)
study was to clarify the##3##5##(2007-10#1)(2011-2#1)(2012-2#1)
study was to compare clinical##2##5##(2008-12#1)(2012-12#1)
study was to compare the accuracy of##2##7##(2007-10#1)(2013-8#1)
study was to compare the results of##2##7##(2007-8#1)(2008-12#1)
study was to compare the results##3##6##(2007-8#1)(2008-12#1)(2013-1#1)
study was to compare the##25##5##(1992-10#1)(1997-8#1)(2007-10#2)(2007-8#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#2)(2013-1#4)(2013-8#2)
study was to compare##49##4##(1990-2#1)(1992-10#1)(1993-12#1)(1994-12#1)(1994-2#1)(1997-8#2)(2007-10#2)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#2)
study was to confirm##2##4##(2008-10#1)(2012-2#1)
study was to define##4##4##(1991-5#1)(1995-2#1)(2008-9#1)(2011-2#1)
study was to describe the##11##5##(1993-12#1)(2007-2#1)(2008-11#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-1#3)(2013-7#1)
study was to describe##16##4##(1993-12#1)(1996-9#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-5#2)(2011-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
study was to design a##2##5##(2008-10#1)(2008-5#1)
study was to determine if a##3##6##(1997-3#1)(2008-12#1)(2008-9#1)
study was to determine if##11##5##(1995-2#1)(1996-5#2)(1997-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)
study was to determine the effect of##5##7##(1991-8#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
study was to determine the effects of##9##7##(2008-10#1)(2008-5#3)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#2)
study was to determine the influence of##3##7##(2007-11#1)(2011-2#2)
study was to determine the prevalence of##4##7##(2008-12#2)(2010-2#1)(2013-1#1)
study was to determine the##74##5##(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-5#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#6)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#4)(2013-3#1)(2013-8#5)
study was to determine whether the##2##6##(1990-8#1)(1995-12#1)
study was to determine whether##21##5##(1990-10#1)(1990-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-8#1)(2007-10#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
study was to determine which##4##5##(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
study was to determine##118##4##(1990-10#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#6)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#8)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#5)(2009-5#3)(2009-6#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#6)(2013-3#1)(2013-8#6)
study was to develop a##8##5##(2007-10#1)(2008-10#1)(2008-5#3)(2008-6#1)(2010-2#1)(2012-4#1)
study was to develop##27##4##(2007-10#1)(2008-10#5)(2008-11#4)(2008-5#6)(2008-6#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-4#1)(2013-1#1)
study was to document the##2##5##(2008-10#1)(2009-2#1)
study was to elucidate##4##4##(1995-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
study was to establish a##2##5##(2010-6#1)(2013-1#1)
study was to establish the##4##5##(1994-2#1)(2007-11#1)(2012-3#1)(2013-7#1)
study was to establish##9##4##(1994-2#1)(2007-11#2)(2008-11#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
study was to estimate the##7##5##(1996-1#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#1)
study was to estimate##8##4##(1996-1#1)(2007-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#1)
study was to evaluate a##5##5##(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-8#1)
study was to evaluate effects of##2##6##(2008-12#1)(2010-7#1)
study was to evaluate the effect of##6##7##(1992-8#1)(2008-1#1)(2008-5#1)(2012-2#2)(2013-1#1)
study was to evaluate the effectiveness of##2##7##(2008-9#1)(2013-1#1)
study was to evaluate the efficacy of##5##7##(2007-7#2)(2008-5#1)(2009-8#1)(2013-1#1)
study was to evaluate the influence##4##6##(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
study was to evaluate the reliability##2##6##(2007-12#1)(2010-10#1)
study was to evaluate the results of##3##7##(1997-8#1)(2008-9#1)(2011-2#1)
study was to evaluate the role of##3##7##(2007-7#1)(2011-2#1)(2013-1#1)
study was to evaluate the##87##5##(1990-11#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-1#1)(1997-8#4)(2007-11#4)(2007-12#1)(2007-7#3)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#3)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#15)
study was to evaluate this##2##5##(1993-6#1)(1994-5#1)
study was to evaluate whether##6##5##(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
study was to evaluate##128##4##(1990-11#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#6)(2007-11#5)(2007-12#1)(2007-7#3)(2007-8#9)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#10)(2008-3#1)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#7)(2008-9#4)(2009-11#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#16)(2013-8#4)
study was to examine the effect of##3##7##(2008-5#1)(2008-7#1)(2010-6#1)
study was to examine the effects of a##2##8##(2007-12#1)(2013-8#1)
study was to examine the effects of##5##7##(1991-12#1)(2007-12#1)(2008-5#1)(2013-8#2)
study was to examine the relationship##2##6##(2011-2#2)
study was to examine the##42##5##(1991-12#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#3)
study was to examine whether##2##5##(2007-6#1)(2013-1#1)
study was to examine##59##4##(1991-12#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#3)
study was to explore the##8##5##(1996-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
study was to explore##21##4##(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
study was to find##3##4##(1990-2#1)(2008-6#1)(2012-12#1)
study was to further##4##4##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
study was to identify the##13##5##(1994-5#1)(1996-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#2)
study was to identify##24##4##(1990-2#1)(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#4)(2013-1#1)
study was to investigate the effect of##15##7##(1994-6#1)(1995-3#1)(2007-10#2)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-2#1)
study was to investigate the effectiveness of##2##7##(2013-1#2)
study was to investigate the effects of##8##7##(1990-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
study was to investigate the effects##9##6##(1990-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
study was to investigate the efficacy of##2##7##(2008-10#1)(2013-1#1)
study was to investigate the influence of##4##7##(1995-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
study was to investigate the relationship between the##2##8##(2008-8#1)(2009-7#1)
study was to investigate the relationship between##5##7##(2008-8#1)(2009-7#2)(2013-1#1)(2013-8#1)
study was to investigate the##82##5##(1990-9#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#4)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#8)(2013-7#1)(2013-8#2)
study was to investigate whether the##3##6##(1997-7#1)(2008-5#1)(2012-12#1)
study was to investigate whether##12##5##(1997-7#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
study was to investigate##117##4##(1990-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
study was to localize the##2##5##(1993-8#1)(1995-2#1)
study was to measure the##3##5##(2008-5#1)(2010-10#1)(2011-2#1)
study was to obtain##4##4##(1993-1#1)(1997-3#1)(2008-10#1)(2008-6#1)
study was to present##5##4##(1994-2#1)(2008-10#2)(2008-6#1)(2011-2#1)
study was to provide a##2##5##(1995-2#1)(2012-1#1)
study was to provide##3##4##(1995-2#1)(2011-2#1)(2012-1#1)
study was to quantify##4##4##(1996-6#1)(2007-10#1)(2008-10#1)(2009-5#1)
study was to report##4##4##(2008-9#2)(2012-1#1)(2013-1#1)
study was to review the##2##5##(2008-10#1)(2008-9#1)
study was to review##3##4##(2008-10#1)(2008-9#1)(2012-1#1)
study was to search for##4##5##(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)
study was to see##2##4##(2008-12#1)(2011-2#1)
study was to show##2##4##(2007-11#1)(2008-12#1)
study was to specify##2##4##(2007-8#2)
study was to test the hypothesis that##3##7##(1990-8#1)(1993-12#1)(1996-9#1)
study was to test the##5##5##(1990-8#1)(1993-12#1)(1996-9#1)(2008-8#1)(2010-3#1)
study was to test##10##4##(1990-8#1)(1993-12#2)(1995-3#1)(1996-9#1)(2007-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-3#1)
study was to validate the##2##5##(2008-12#1)(2013-1#1)
study was to validate##3##4##(2008-12#1)(2008-8#1)(2013-1#1)
study was to verify##6##4##(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-9#1)
study was to##822##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-8#2)(1993-1#3)(1993-12#8)(1993-2#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#2)(1996-9#3)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#12)(2006-8#2)(2007-10#20)(2007-11#14)(2007-12#5)(2007-2#3)(2007-6#5)(2007-7#9)(2007-8#32)(2008-1#5)(2008-10#52)(2008-11#28)(2008-12#45)(2008-3#4)(2008-4#8)(2008-5#52)(2008-6#14)(2008-7#32)(2008-8#9)(2008-9#27)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#4)(2009-5#10)(2009-6#2)(2009-7#7)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#7)(2010-11#4)(2010-12#2)(2010-2#5)(2010-3#11)(2010-4#5)(2010-5#6)(2010-6#6)(2010-7#3)(2010-8#4)(2010-9#5)(2011-1#18)(2011-2#60)(2011-7#1)(2012-1#8)(2012-12#11)(2012-2#22)(2012-3#22)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#59)(2013-3#1)(2013-7#9)(2013-8#23)
study was undertaken in the##2##5##(2008-5#1)(2009-6#1)
study was undertaken in##7##4##(1992-3#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-6#1)
study was undertaken on##2##4##(2012-2#1)(2012-3#1)
study was undertaken to assess the##4##6##(1991-12#1)(1994-6#1)(2008-10#1)(2013-7#1)
study was undertaken to assess##5##5##(1991-12#1)(1993-12#1)(1994-6#1)(2008-10#1)(2013-7#1)
study was undertaken to compare##3##5##(1992-3#1)(2008-5#1)(2011-2#1)
study was undertaken to determine the##7##6##(1996-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-12#1)
study was undertaken to determine whether##3##6##(1993-6#1)(2008-10#1)(2008-6#1)
study was undertaken to determine##11##5##(1993-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-6#1)(2012-12#1)
study was undertaken to establish##3##5##(2008-10#1)(2012-2#2)
study was undertaken to evaluate the efficacy of##2##8##(2007-7#1)(2008-7#1)
study was undertaken to evaluate the##7##6##(1991-4#1)(1996-1#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
study was undertaken to examine##4##5##(2008-5#1)(2009-12#1)(2011-2#2)
study was undertaken to investigate the##5##6##(1994-12#1)(2008-7#1)(2010-3#1)(2012-2#2)
study was undertaken to test the##2##6##(1994-1#1)(2008-10#1)
study was undertaken to##48##4##(1991-12#1)(1991-4#1)(1992-3#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-2#1)(2007-7#3)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-3#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)
study was undertaken##62##3##(1990-12#1)(1991-12#1)(1991-4#1)(1992-3#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-7#5)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2009-12#1)(2009-3#1)(2009-6#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
study was used##3##3##(2007-12#1)(2010-3#1)(2011-1#1)
study was##1453##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#7)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#5)(1992-5#2)(1992-6#1)(1992-8#6)(1993-1#5)(1993-12#14)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#4)(1994-11#4)(1994-12#7)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#6)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#5)(1996-5#5)(1996-6#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#5)(1997-7#3)(1997-8#13)(2006-10#2)(2006-8#2)(2007-10#26)(2007-11#25)(2007-12#7)(2007-2#5)(2007-6#6)(2007-7#30)(2007-8#38)(2008-1#11)(2008-10#117)(2008-11#44)(2008-12#70)(2008-2#2)(2008-3#19)(2008-4#14)(2008-5#77)(2008-6#18)(2008-7#57)(2008-8#12)(2008-9#35)(2009-1#3)(2009-10#3)(2009-11#3)(2009-12#8)(2009-2#5)(2009-3#5)(2009-4#4)(2009-5#14)(2009-6#5)(2009-7#10)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#10)(2010-11#7)(2010-12#3)(2010-2#7)(2010-3#21)(2010-4#9)(2010-5#15)(2010-6#7)(2010-7#5)(2010-8#16)(2010-9#6)(2011-1#29)(2011-2#119)(2011-7#1)(2012-1#10)(2012-12#27)(2012-2#41)(2012-3#43)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#89)(2013-3#1)(2013-7#16)(2013-8#41)
study we aimed to##3##4##(2007-8#1)(2008-1#1)(2012-3#1)
study we compared the##5##4##(1993-11#1)(1994-2#1)(1995-11#1)(2007-8#1)(2008-7#1)
study we compared##6##3##(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2007-8#1)(2008-7#1)
study we conducted##4##3##(2008-11#1)(2009-9#1)(2012-2#1)(2013-1#1)
study we confirm that##2##4##(1994-8#1)(2012-12#1)
study we describe##3##3##(1994-12#1)(1994-6#1)(2007-8#1)
study we evaluated the##5##4##(1992-12#1)(1994-8#1)(1997-2#1)(2008-4#1)(2013-1#1)
study we evaluated##6##3##(1992-12#1)(1994-8#1)(1997-2#1)(2008-4#1)(2009-6#1)(2013-1#1)
study we examined the effects of##3##6##(1995-8#1)(1996-12#1)(2009-7#1)
study we examined##5##3##(1995-8#1)(1996-12#1)(2009-7#1)(2010-7#1)(2012-1#1)
study we have identified##2##4##(2010-11#1)(2011-2#1)
study we have investigated the##3##5##(1995-12#1)(2008-12#1)(2012-2#1)
study we have investigated##5##4##(1994-2#1)(1995-12#1)(1995-6#1)(2008-12#1)(2012-2#1)
study we have isolated##2##4##(1991-2#1)(1992-10#1)
study we have used##4##4##(1996-12#2)(2008-7#1)(2011-2#1)
study we have##30##3##(1991-2#2)(1992-10#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-12#2)(1997-2#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
study we identified##4##3##(2007-2#1)(2008-10#1)(2008-6#1)(2012-3#1)
study we investigated the##7##4##(1991-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)(2009-2#1)(2013-8#1)
study we investigated whether##3##4##(1995-8#1)(1997-7#1)(2010-6#1)
study we investigated##15##3##(1991-2#1)(1993-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-6#1)(2011-2#2)(2012-7#1)(2013-8#1)
study we present a##2##4##(1997-3#1)(2013-7#1)
study we present##4##3##(1991-9#1)(1997-3#1)(2008-5#1)(2013-7#1)
study we report that##2##4##(1997-2#1)(2012-2#1)
study we reviewed##2##3##(1996-11#1)(2007-2#1)
study we show that the##4##5##(1994-11#1)(1994-9#1)(1995-9#1)(1997-2#1)
study we show that##9##4##(1990-5#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-9#1)(1997-2#1)(2008-7#1)(2012-2#1)
study we showed that##2##4##(1995-12#1)(2009-8#1)
study we used##5##3##(2008-12#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)
study we wanted to compare##2##5##(2011-2#1)(2013-1#1)
study we wanted to##5##4##(1995-5#1)(2008-10#1)(2011-2#2)(2013-1#1)
study we##160##2##(1990-11#2)(1990-5#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#2)
study were (i)##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
study were as follows##3##4##(1990-10#1)(1991-2#1)(1997-2#1)
study were obtained##2##3##(1990-10#1)(2012-12#1)
study were similar to those of the vehicle control groups##2##10##(2008-9#2)
study were to characterize##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
study were to describe the##3##5##(1996-3#1)(2008-6#1)(2013-1#1)
study were to describe##4##4##(1996-3#1)(2008-6#1)(2009-5#1)(2013-1#1)
study were to determine the prevalence of##4##7##(2008-12#1)(2008-3#1)(2008-8#2)
study were to determine the##10##5##(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2011-2#1)
study were to determine##12##4##(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
study were to evaluate the repeatability (r) and reproducibility (R) when different laboratories conduct the test##2##16##(2008-10#2)
study were to evaluate the##6##5##(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#2)
study were to evaluate##9##4##(2008-10#3)(2008-12#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-3#2)
study were to examine the##3##5##(2008-11#1)(2010-11#1)(2012-2#1)
study were to identify##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
study were to##57##3##(1996-1#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#7)
study were##123##2##(1990-10#4)(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-11#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-8#2)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#9)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#1)(2009-5#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#9)
study when##3##2##(2008-3#1)(2008-7#1)(2013-1#1)
study where##4##2##(1991-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
study whether##2##2##(2008-7#1)(2011-2#1)
study which was##3##3##(1991-5#1)(1996-1#1)(2013-8#1)
study which##18##2##(1991-5#1)(1993-1#1)(1993-12#2)(1996-1#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-11#4)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
study will be##9##3##(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#2)(2009-9#1)(2010-11#1)(2012-3#1)
study will enroll##2##3##(2008-5#2)
study will show that##3##4##(1994-3#2)(2008-5#1)
study will##30##2##(1994-3#3)(1994-8#1)(1996-3#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-4#1)(2008-5#7)(2009-9#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
study with a##7##3##(1990-6#1)(1992-2#1)(1996-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
study with an##2##3##(1991-3#1)(2008-3#1)
study with emphasis on##2##4##(1990-12#1)(2013-1#1)
study with healthy##3##3##(1991-8#2)(2008-5#1)
study with the##4##3##(1990-7#1)(1994-5#1)(2008-1#1)(2008-11#1)
study with two##2##3##(1994-11#1)(2013-8#1)
study with##77##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
study would##7##2##(1993-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-3#1)(2009-10#1)(2011-7#1)
study years##3##2##(1993-3#2)(2013-7#1)
study yielded##2##2##(1994-12#1)(2007-7#1)
study##11079##1##(1990-10#11)(1990-11#24)(1990-12#33)(1990-2#35)(1990-3#31)(1990-4#1)(1990-5#32)(1990-6#33)(1990-7#13)(1990-8#24)(1990-9#25)(1991-1#24)(1991-11#21)(1991-12#59)(1991-2#46)(1991-3#31)(1991-4#7)(1991-5#16)(1991-6#30)(1991-7#4)(1991-8#26)(1991-9#17)(1992-1#15)(1992-10#11)(1992-11#17)(1992-12#45)(1992-2#27)(1992-3#31)(1992-4#4)(1992-5#17)(1992-6#26)(1992-7#1)(1992-8#19)(1992-9#16)(1993-1#38)(1993-11#21)(1993-12#68)(1993-2#34)(1993-3#51)(1993-5#7)(1993-6#31)(1993-8#25)(1993-9#30)(1994-1#19)(1994-10#2)(1994-11#36)(1994-12#40)(1994-2#61)(1994-3#50)(1994-5#21)(1994-6#35)(1994-7#1)(1994-8#41)(1994-9#11)(1995-1#27)(1995-10#4)(1995-11#24)(1995-12#64)(1995-2#57)(1995-3#32)(1995-4#2)(1995-5#20)(1995-6#29)(1995-8#21)(1995-9#16)(1996-1#43)(1996-10#1)(1996-11#9)(1996-12#57)(1996-2#45)(1996-3#48)(1996-4#2)(1996-5#40)(1996-6#15)(1996-7#13)(1996-8#8)(1996-9#15)(1997-1#20)(1997-2#50)(1997-3#57)(1997-4#38)(1997-5#24)(1997-6#25)(1997-7#35)(1997-8#46)(2006-10#16)(2006-12#4)(2006-4#3)(2006-5#1)(2006-6#3)(2006-8#15)(2007-1#3)(2007-10#117)(2007-11#128)(2007-12#107)(2007-2#44)(2007-4#6)(2007-5#14)(2007-6#16)(2007-7#174)(2007-8#131)(2007-9#6)(2008-1#146)(2008-10#1352)(2008-11#454)(2008-12#341)(2008-2#125)(2008-3#262)(2008-4#126)(2008-5#393)(2008-6#143)(2008-7#378)(2008-8#203)(2008-9#304)(2009-1#16)(2009-10#59)(2009-11#50)(2009-12#41)(2009-2#28)(2009-3#44)(2009-4#32)(2009-5#81)(2009-6#37)(2009-7#75)(2009-8#61)(2009-9#40)(2010-1#42)(2010-10#72)(2010-11#59)(2010-12#54)(2010-2#45)(2010-3#107)(2010-4#61)(2010-5#65)(2010-6#49)(2010-7#43)(2010-8#97)(2010-9#32)(2011-1#211)(2011-10#5)(2011-2#565)(2011-3#24)(2011-7#5)(2012-1#66)(2012-12#166)(2012-2#262)(2012-3#292)(2012-4#3)(2012-5#8)(2012-6#5)(2012-7#5)(2012-8#2)(2012-9#1)(2013-1#572)(2013-3#2)(2013-7#68)(2013-8#231)
study's findings##3##2##(1995-1#1)(2008-11#1)(2012-3#1)
study's purpose was to##2##4##(1993-2#1)(2013-1#1)
study's purpose##3##2##(1993-2#1)(2012-3#1)(2013-1#1)
study's results##2##2##(1996-1#1)(2011-2#1)
study's##15##1##(1993-2#1)(1995-1#2)(1996-1#1)(2007-10#1)(2007-12#2)(2008-11#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
study) and##2##2##(2008-10#1)(2013-1#1)
study)##21##1##(1991-3#1)(1992-2#1)(1993-11#1)(1995-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#4)
study-specific##3##1##(1995-12#1)(2008-10#1)(2013-1#1)
study]##58##1##(1990-3#3)(1990-5#2)(1990-6#2)(1990-9#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-11#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-11#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-5#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
studying a##3##2##(2007-12#1)(2009-5#1)(2012-3#1)
studying and##3##2##(2008-12#1)(2009-7#1)(2010-3#1)
studying both##2##2##(2008-10#1)(2012-2#1)
studying cell##2##2##(1990-5#1)(2008-11#1)
studying changes in##2##3##(2008-10#1)(2008-8#1)
studying gene function##3##3##(1993-9#1)(2008-2#1)(2008-7#1)
studying gene##4##2##(1993-9#1)(2008-2#1)(2008-4#1)(2008-7#1)
studying how##2##2##(1993-12#1)(1995-2#1)
studying human##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
studying its##2##2##(2008-10#2)
studying living##2##2##(2007-12#1)(2012-2#1)
studying mechanisms of##4##3##(1995-3#1)(2006-10#1)(2008-11#1)(2008-4#1)
studying population dynamics##2##3##(2008-10#1)(2008-8#1)
studying protein##3##2##(2008-10#1)(2008-9#1)(2009-5#1)
studying the behavior of##2##4##(2008-11#1)(2008-3#1)
studying the biological##3##3##(2008-4#2)(2008-9#1)
studying the dynamics of##2##4##(2008-3#1)(2013-8#1)
studying the effect of##5##4##(1991-8#1)(1995-11#1)(2008-10#3)
studying the effects of##7##4##(1994-11#1)(1995-2#1)(2008-11#1)(2008-2#2)(2008-6#1)(2012-12#1)
studying the impact of##2##4##(2012-12#1)(2012-3#1)
studying the isoform##2##3##(1996-12#2)
studying the regulation of##2##4##(1991-6#1)(1993-6#1)
studying the role of##2##4##(1992-12#1)(2012-12#1)
studying the role##3##3##(1990-5#1)(1992-12#1)(2012-12#1)
studying the structure##2##3##(1992-6#1)(1993-11#1)
studying the time##2##3##(1996-2#1)(2008-1#1)
studying the##118##2##(1990-5#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#2)(1996-12#2)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#17)(2008-11#6)(2008-2#5)(2008-3#7)(2008-4#8)(2008-5#5)(2008-6#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
studying their##3##2##(2007-6#1)(2008-1#1)(2008-10#1)
studying these##2##2##(2008-1#1)(2008-4#1)
studying##282##1##(1990-12#1)(1990-5#4)(1990-8#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-6#1)(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#7)(1995-3#2)(1996-12#3)(1996-2#3)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#7)(2007-5#2)(2007-6#2)(2007-8#1)(2008-1#7)(2008-10#38)(2008-11#12)(2008-12#4)(2008-2#8)(2008-3#12)(2008-4#20)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#13)(2008-9#15)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-5#4)(2009-7#2)(2009-8#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#5)(2013-8#4)
stuff##3##1##(1994-1#1)(2008-10#1)(2012-3#1)
stuffed##2##1##(1992-3#2)
stumbling block##2##2##(1995-11#1)(2009-9#1)
stumbling blocks##3##2##(2010-3#1)(2012-3#2)
stumbling##5##1##(1995-11#1)(2009-9#1)(2010-3#1)(2012-3#2)
stump neuroma##2##2##(2009-3#2)
stump of the##2##3##(2007-8#1)(2008-12#1)
stump of##3##2##(1991-6#1)(2007-8#1)(2008-12#1)
stump##18##1##(1991-6#3)(1992-6#1)(1992-9#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-3#2)(2010-3#1)(2010-8#1)(2012-12#1)
stumps and##2##2##(2008-10#1)(2008-5#1)
stumps##10##1##(2008-10#6)(2008-5#1)(2008-9#3)
stung##2##1##(1991-6#1)(2012-3#1)
stunned myocardium&quot##2##2##(1991-3#1)(2013-1#1)
stunned##5##1##(1991-3#1)(1996-9#2)(2013-1#2)
stunning and##2##2##(2008-3#1)(2011-1#1)
stunning following##2##2##(1996-9#2)
stunning in##3##2##(1996-9#2)(2011-1#1)
stunning##27##1##(1990-9#3)(1991-3#3)(1996-8#1)(1996-9#7)(2007-8#1)(2008-10#1)(2008-3#3)(2010-2#1)(2011-1#7)
stunning&quot##4##1##(1990-9#1)(1991-3#2)(1996-9#1)
stunt viroid##4##2##(2008-10#4)
stunt virus (PSV)##3##3##(2008-10#3)
stunt virus##17##2##(2008-10#17)
stunt##25##1##(2008-10#23)(2008-8#2)
stunted growth##2##2##(2008-10#2)
stunted##8##1##(2008-10#3)(2008-5#1)(2010-6#3)(2011-1#1)
stunting and##6##2##(2008-1#1)(2008-10#4)(2010-6#1)
stunting##22##1##(1990-12#1)(2008-1#1)(2008-10#16)(2009-8#1)(2010-6#2)(2011-1#1)
stupor##3##1##(1994-2#1)(1996-11#1)(1996-6#1)
sturdy##2##1##(1991-7#1)(1993-5#1)
stuttering in##2##2##(2008-2#2)
stuttering##12##1##(2008-2#8)(2012-12#4)
style and##13##2##(1992-2#1)(2008-10#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-5#2)(2010-8#1)(2012-3#1)
style are##2##2##(2008-7#1)(2009-7#1)
style is##3##2##(1990-6#1)(2008-11#1)(2013-8#1)
style of##9##2##(1992-1#1)(1996-4#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
style that##5##2##(1992-11#1)(1994-2#1)(2007-5#1)(2008-6#1)(2012-2#1)
style to##2##2##(1993-12#1)(2008-9#1)
style was##6##2##(1992-3#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#1)
style##104##1##(1990-6#2)(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#5)(1992-3#2)(1993-12#3)(1994-1#1)(1994-2#1)(1995-3#1)(1996-4#2)(1997-3#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#6)(2009-7#5)(2009-8#1)(2010-1#11)(2010-10#7)(2010-11#2)(2010-5#4)(2010-8#1)(2011-1#1)(2012-2#4)(2012-3#7)(2013-1#2)(2013-8#1)
styles and theories##3##3##(2013-8#3)
styles and##10##2##(1997-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#4)
styles of##10##2##(1995-2#1)(1997-6#1)(2008-10#2)(2008-7#2)(2009-11#1)(2012-3#1)(2013-8#2)
styles##50##1##(1990-9#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#2)(1997-6#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#3)(2009-7#3)(2009-8#1)(2010-10#1)(2010-5#2)(2010-9#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#9)
stylet##10##1##(2007-12#2)(2008-10#6)(2010-8#2)
stylets##3##1##(2007-12#2)(2008-10#1)
styling##4##1##(2008-5#4)
stylo (Stylosanthes guianensis Sw##2##4##(2012-2#2)
stylo silage##2##2##(2012-2#2)
stylo##4##1##(2012-2#4)
styloconic sensilla##3##2##(2010-11#3)
styloconicum##6##1##(2008-8#6)
stymied by##2##2##(1997-2#1)(2007-10#1)
stymied##4##1##(1997-2#1)(2007-10#3)
styrene##24##1##(1994-8#1)(1996-5#3)(2008-10#6)(2008-11#1)(2008-12#5)(2008-3#2)(2009-9#1)(2010-2#2)(2010-4#2)(2010-5#1)
styrene-butadiene-styrene (SBS)##2##2##(2008-10#1)(2009-11#1)
styrene-divinyl benzene##3##2##(2008-10#3)
styrene-divinylbenzene copolymer##2##2##(2008-10#2)
styrene-divinylbenzene##4##1##(2008-10#4)
styryl dye##2##2##(2007-12#1)(2008-8#1)
styryl##3##1##(2007-11#1)(2007-12#1)(2008-8#1)
styryl-based##2##1##(1991-11#2)
stysi##4##1##(2013-8#4)
su(f)##2##1##(1995-6#2)
suPAR levels in##2##3##(2013-1#2)
suPAR levels##6##2##(2013-1#6)
sub classification##2##2##(2007-2#1)(2010-3#1)
sub group##3##2##(2007-8#1)(2008-11#2)
sub groups##2##2##(1997-1#1)(2008-11#1)
sub mug l(-1)##2##3##(2008-10#2)
sub##25##1##(1990-12#1)(1994-9#1)(1997-1#1)(2007-2#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2009-11#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
sub-10-fs pulse##2##2##(2007-11#1)(2007-12#1)
sub-10-fs pulses##5##2##(2007-11#1)(2007-12#4)
sub-10-fs##10##1##(2007-11#2)(2007-12#8)
sub-100-fs##6##1##(2007-11#4)(2007-12#2)
sub-6-fs##2##1##(2007-12#2)
sub-Doppler lines##3##2##(2008-2#3)
sub-Doppler##7##1##(2007-11#1)(2007-12#3)(2008-2#3)
sub-Nernstian##3##1##(2008-10#3)
sub-Saharan Africa##18##2##(1995-12#1)(1996-8#1)(1997-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
sub-Saharan##20##1##(1995-12#1)(1996-8#1)(1997-4#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#1)
sub-acute and chronic##2##3##(2008-10#1)(2012-2#1)
sub-acute##4##1##(2008-10#2)(2008-12#1)(2012-2#1)
sub-boiling distillation##3##2##(2008-10#3)
sub-cellular compartments##3##2##(2010-2#3)
sub-cellular localization##3##2##(2009-10#1)(2010-2#2)
sub-cellular location##2##2##(2008-7#1)(2012-2#1)
sub-cellular##17##1##(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-2#6)(2011-1#1)(2012-2#2)
sub-chronic##4##1##(1991-12#1)(1996-12#2)(2008-5#1)
sub-classes of##2##2##(1995-12#1)(2008-1#1)
sub-clinical##5##1##(1992-5#1)(2008-2#1)(2008-9#1)(2010-4#1)(2012-1#1)
sub-cutaneous##3##1##(2008-8#2)(2012-2#1)
sub-diffraction-limit-sized##2##1##(2007-12#2)
sub-evergreen##2##1##(2013-7#2)
sub-formulations##2##1##(2008-5#2)
sub-group of patients##2##3##(1993-9#1)(1995-11#1)
sub-group of the##2##3##(2008-10#1)(2008-5#1)
sub-group of##4##2##(1993-9#1)(1995-11#1)(2008-10#1)(2008-5#1)
sub-groups of##2##2##(2007-11#1)(2008-10#1)
sub-groups##11##1##(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)
sub-injection##2##1##(2008-10#2)
sub-isoforms##3##1##(2008-10#3)
sub-lethal##4##1##(1996-12#1)(2007-12#1)(2008-7#1)(2013-1#1)
sub-microgram##2##1##(1990-2#1)(1993-8#1)
sub-micron##3##1##(2008-10#1)(2010-4#1)(2011-1#1)
sub-nanogram levels##3##2##(2008-10#3)
sub-nanogram per liter##3##3##(2008-10#3)
sub-nanogram per##4##2##(2008-10#4)
sub-nanogram##9##1##(2008-10#9)
sub-nanogram/gram##2##1##(2008-10#2)
sub-nephrotic proteinuria##2##2##(2008-1#2)
sub-ng##3##1##(2008-10#3)
sub-optimal##3##1##(2008-11#2)(2008-5#1)
sub-part per trillion levels##2##4##(2008-10#2)
sub-physiological##3##1##(2008-11#3)
sub-population of##3##2##(1992-8#1)(1993-8#1)(2008-11#1)
sub-population##5##1##(1992-8#1)(1993-8#1)(2008-11#2)(2013-1#1)
sub-populations##8##1##(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)
sub-sample##11##1##(2008-10#7)(2008-12#1)(2010-8#1)(2013-1#2)
sub-samples##2##1##(2008-10#2)
sub-scale##2##1##(1992-1#1)(2008-11#1)
sub-surface##4##1##(2008-11#1)(2009-7#3)
sub-type##2##1##(1993-9#2)
sub-unit of##3##2##(1992-12#1)(1993-11#2)
sub-unit##7##1##(1992-12#2)(1993-11#2)(2008-10#2)(2008-7#1)
subacromial impingement##2##2##(2007-11#1)(2008-12#1)
subacromial##7##1##(2007-11#5)(2008-12#1)(2010-9#1)
subacute and chronic occlusions##2##4##(2011-2#2)
subacute and chronic##4##3##(2008-7#1)(2011-2#3)
subacute bacterial endocarditis##2##3##(1991-3#1)(2007-11#1)
subacute combined degeneration of the spinal cord##2##7##(2008-7#2)
subacute intestinal##2##2##(1990-6#1)(2009-5#1)
subacute or chronic##3##3##(2007-11#1)(2011-2#2)
subacute stage##2##2##(1997-3#1)(2008-12#1)
subacute##38##1##(1990-6#3)(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-9#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
subadult##4##1##(1997-9#1)(2008-5#1)(2010-4#2)
subadventitial layer of##3##3##(2011-2#3)
subadventitial##4##1##(2008-7#1)(2011-2#3)
subaperture##2##1##(2008-3#2)
subapertures##2##1##(2007-12#1)(2008-3#1)
subapical##5##1##(1995-2#1)(2008-10#2)(2008-7#1)(2010-11#1)
subarachnoid and##2##2##(2007-10#1)(2007-8#1)
subarachnoid haemorrhage (SAH)##6##3##(2008-7#6)
subarachnoid haemorrhage and##3##3##(2008-7#3)
subarachnoid haemorrhage on computed tomography##2##5##(2008-7#2)
subarachnoid haemorrhage##30##2##(1995-11#1)(1995-9#1)(1996-9#3)(1997-3#1)(2008-7#24)
subarachnoid hemorrhage (SAH)##5##3##(2007-10#2)(2012-3#2)(2013-8#1)
subarachnoid hemorrhage##24##2##(1991-8#1)(1995-11#4)(1995-5#1)(2007-10#5)(2008-2#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
subarachnoid or##2##2##(2008-7#1)(2009-6#1)
subarachnoid space and##2##3##(2008-12#1)(2008-7#1)
subarachnoid space##12##2##(2008-12#2)(2008-7#9)(2009-6#1)
subarachnoid##85##1##(1991-8#1)(1995-11#6)(1995-5#1)(1995-9#1)(1996-9#3)(1997-3#1)(2007-10#8)(2007-8#2)(2008-12#3)(2008-2#1)(2008-7#39)(2008-9#1)(2009-4#3)(2009-6#2)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#6)(2013-8#1)
subarachnoid-extradural anesthesia##2##2##(2007-8#2)
subband of##2##2##(1997-8#1)(2007-12#1)
subband##3##1##(1997-8#2)(2007-12#1)
subcapital growth plate of the##2##5##(2007-11#2)
subcapital growth plate##3##3##(2007-11#3)
subcapital##4##1##(2007-11#3)(2007-8#1)
subcapsular hematoma##3##2##(2010-11#2)(2012-3#1)
subcapsular##12##1##(1990-5#1)(2008-11#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
subcardinal##2##1##(2008-7#1)(2010-11#1)
subcategories##3##1##(1990-12#2)(1991-12#1)
subcategory##4##1##(1990-12#2)(1991-12#1)(2010-5#1)
subcellular compartments##4##2##(1990-5#1)(1997-7#1)(2008-4#1)(2008-9#1)
subcellular distribution in##3##3##(1991-2#1)(2008-9#2)
subcellular distribution of the##3##4##(1993-9#1)(1995-6#1)(1996-5#1)
subcellular distribution of##7##3##(1990-2#1)(1993-9#1)(1994-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)
subcellular distribution##10##2##(1990-2#1)(1991-2#1)(1993-9#1)(1994-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-9#2)
subcellular distributions of##2##3##(1991-2#1)(2008-4#1)
subcellular fractionation studies##2##3##(1994-10#1)(1995-6#1)
subcellular fractionation##6##2##(1990-5#2)(1994-10#1)(1995-6#2)(2008-4#1)
subcellular fractions of##2##3##(1993-12#1)(1993-6#1)
subcellular fractions##8##2##(1990-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-2#1)
subcellular level##2##2##(2008-4#2)
subcellular localization of the##2##4##(1997-2#1)(2009-8#1)
subcellular localization of##11##3##(1992-6#1)(1993-5#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#1)
subcellular localization##26##2##(1992-11#1)(1992-6#1)(1993-5#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-6#2)(1997-2#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#4)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)
subcellular location of##2##3##(1992-11#1)(2010-11#1)
subcellular locations##3##2##(2008-1#1)(2008-4#1)(2011-2#1)
subcellular organelles##3##2##(1990-11#1)(1996-9#1)(2008-4#1)
subcellular##94##1##(1990-11#2)(1990-2#1)(1990-5#4)(1991-2#2)(1992-11#2)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-2#3)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#2)(1997-7#1)(2007-12#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#10)(2008-7#6)(2008-9#5)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#6)
subcentimeter pulmonary nodules##2##3##(2008-6#2)
subchannel##3##1##(2007-11#2)(2008-3#1)
subchannel-multiplexed##2##1##(2007-11#2)
subchondral bone##3##2##(2007-11#2)(2011-2#1)
subchondral erosions in##2##3##(2011-2#2)
subchondral erosions##3##2##(2011-2#3)
subchondral##8##1##(2007-11#3)(2011-2#5)
subchronic##6##1##(1995-3#3)(2008-10#1)(2008-8#1)(2013-8#1)
subclades##2##1##(2008-10#2)
subclass and##2##2##(2008-8#1)(2009-4#1)
subclass of##3##2##(1997-1#1)(2008-3#1)(2009-9#1)
subclass##19##1##(1991-5#1)(1993-12#1)(1993-6#1)(1995-3#1)(1997-1#1)(2007-2#1)(2008-3#4)(2008-4#2)(2008-8#3)(2009-4#1)(2009-9#2)(2011-2#1)
subclasses of##3##2##(1996-2#1)(2008-11#1)(2008-4#1)
subclasses##12##1##(1994-11#1)(1994-12#2)(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-10#1)(2009-6#1)
subclassification##4##1##(2008-8#3)(2009-11#1)
subclassified as##2##2##(1991-11#1)(2013-8#1)
subclavian arteries##2##2##(2011-2#2)
subclavian artery and##3##3##(2007-7#1)(2009-3#1)(2010-7#1)
subclavian artery aneurysm##2##3##(2010-5#2)
subclavian artery##19##2##(1993-3#3)(1997-8#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-7#5)(2009-3#2)(2010-5#2)(2010-7#1)
subclavian vein##7##2##(2008-1#2)(2008-12#2)(2012-2#2)(2013-1#1)
subclavian##36##1##(1993-3#3)(1997-8#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#4)(2008-12#3)(2008-7#7)(2009-3#2)(2010-5#2)(2010-7#1)(2011-2#4)(2012-2#2)(2013-1#1)
subclinical cryptosporidiosis##4##2##(1996-12#4)
subclinical hypothyroidism (TSH##2##3##(2012-3#2)
subclinical lesions##2##2##(1991-2#1)(2012-3#1)
subclinical##40##1##(1990-12#1)(1991-2#3)(1993-2#1)(1996-12#5)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#5)
subcloned and##3##2##(1991-11#1)(1991-9#1)(1993-11#1)
subcloned in the expression vector##2##5##(1990-5#1)(1997-6#1)
subcloned into the expression vector pT7-7##2##6##(1994-5#2)
subcloned into the##4##3##(1994-5#2)(2008-10#1)(2008-11#1)
subcloned into##7##2##(1991-2#1)(1994-5#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
subcloned##15##1##(1990-5#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#2)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
subclones##6##1##(1993-1#1)(2008-10#1)(2008-11#3)(2008-8#1)
subcloning##6##1##(1990-5#1)(1991-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
subclusters##4##1##(2008-10#2)(2008-5#1)(2013-8#1)
subcommissural##2##1##(1993-6#1)(2007-8#1)
subcommittee##3##1##(1995-12#1)(1995-6#1)(1997-3#1)
subcompartments##2##1##(1994-8#1)(2008-1#1)
subcomplexes##2##1##(2011-2#2)
subcomponent of the##2##3##(1997-3#1)(2008-11#1)
subcomponent##3##1##(1997-3#1)(2008-11#1)(2009-11#1)
subconfluent##2##1##(1992-3#1)(1994-9#1)
subconjunctival application##3##2##(2008-12#3)
subconjunctival##4##1##(2008-12#3)(2012-3#1)
subcontinent##7##1##(1996-8#1)(2007-12#1)(2007-2#1)(2008-10#3)(2011-2#1)
subcortical areas##5##2##(2008-11#1)(2009-6#4)
subcortical lesions##2##2##(1993-9#2)
subcortical structures##2##2##(1993-9#1)(2010-9#1)
subcortical##27##1##(1993-12#1)(1993-9#3)(1996-3#1)(1996-5#1)(2007-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-6#4)(2010-12#1)(2010-9#1)(2013-1#2)
subcritical water extraction##3##3##(2008-10#3)
subcritical water##4##2##(2008-10#4)
subcritical##6##1##(1994-2#1)(2008-10#4)(2010-10#1)
subcultivation##3##1##(2008-11#3)
subculture and##2##2##(2008-9#1)(2010-8#1)
subculture##12##1##(1991-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2009-10#1)(2010-8#1)(2013-1#2)(2013-8#1)
subcultured in##2##2##(2008-10#1)(2013-8#1)
subcultured on##2##2##(2008-10#2)
subcultured##12##1##(1996-5#1)(2008-10#8)(2008-8#1)(2010-3#1)(2013-8#1)
subcultures and##2##2##(1991-1#1)(2008-10#1)
subcultures##5##1##(1991-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
subculturing##7##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-8#1)
subcutaneous LMS##2##2##(2008-6#2)
subcutaneous administration of##4##3##(1992-3#1)(1995-2#1)(1997-7#1)(2012-2#1)
subcutaneous administration##6##2##(1992-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-7#1)(2012-2#1)
subcutaneous alemtuzumab##3##2##(2009-12#3)
subcutaneous and intravenous##2##3##(2007-11#1)(2009-5#1)
subcutaneous and visceral##2##3##(2008-7#2)
subcutaneous and##5##2##(2007-11#1)(2008-11#1)(2008-7#2)(2009-5#1)
subcutaneous atrophy##3##2##(2011-2#3)
subcutaneous connective tissue##2##3##(1997-3#2)
subcutaneous continuous infusion##2##3##(2012-3#2)
subcutaneous drug delivery##2##3##(1991-3#1)(1992-5#1)
subcutaneous emphysema following##2##3##(1991-5#1)(2011-2#1)
subcutaneous emphysema##3##2##(1991-5#1)(2011-2#2)
subcutaneous fat and##2##3##(2010-4#1)(2011-1#1)
subcutaneous fat##17##2##(1996-3#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-4#1)
subcutaneous heparin##3##2##(1993-5#1)(1994-3#1)(1997-5#1)
subcutaneous immunotherapy##3##2##(1993-12#1)(2008-8#1)(2013-1#1)
subcutaneous implantation##2##2##(2008-11#2)
subcutaneous infusion in terminal##2##4##(1990-3#1)(1992-5#1)
subcutaneous infusion##5##2##(1990-3#1)(1992-5#1)(1996-5#1)(2011-2#2)
subcutaneous injection of a##2##4##(1993-1#1)(2008-6#1)
subcutaneous injection of##9##3##(1993-1#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
subcutaneous injection##12##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#4)(2013-7#1)
subcutaneous injections of either##2##4##(1993-11#1)(1996-5#1)
subcutaneous injections of##4##3##(1992-5#1)(1993-11#1)(1995-6#1)(1996-5#1)
subcutaneous inoculation##2##2##(1992-2#1)(2008-8#1)
subcutaneous insulin##4##2##(1997-8#1)(2008-1#1)(2008-7#1)(2009-11#1)
subcutaneous interleukin-2##3##2##(1991-6#1)(1992-2#1)(1994-12#1)
subcutaneous mass in the right##2##5##(1994-8#1)(2012-1#1)
subcutaneous mass in the##3##4##(1994-8#1)(2012-1#1)(2013-1#1)
subcutaneous mass##5##2##(1994-8#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
subcutaneous nodules##7##2##(1990-2#2)(2007-10#1)(2013-1#3)(2013-8#1)
subcutaneous or##2##2##(1997-6#1)(2013-1#1)
subcutaneous therapy##2##2##(1991-6#1)(1993-8#1)
subcutaneous tissue of##2##3##(1997-3#1)(2008-5#1)
subcutaneous tissue##9##2##(1997-3#1)(2008-5#2)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
subcutaneous tissues##4##2##(1990-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
subcutaneous tumor##2##2##(2008-8#1)(2012-3#1)
subcutaneous##164##1##(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#5)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#4)(2007-11#1)(2007-7#5)(2008-1#2)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#3)(2009-5#3)(2010-2#2)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#12)(2012-3#4)(2012-4#1)(2013-1#14)(2013-7#1)(2013-8#5)
subcutaneously every##3##2##(1990-2#1)(2008-7#1)(2010-5#1)
subcutaneously implanted##2##2##(1997-4#1)(2008-5#1)
subcutaneously into nude mice##2##4##(2008-11#1)(2008-8#1)
subcutaneously once##2##2##(2008-7#1)(2008-8#1)
subcutaneously with##4##2##(1991-6#1)(1995-11#1)(1996-12#1)(2012-3#1)
subcutaneously##26##1##(1990-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-12#1)(2010-5#1)(2010-6#2)(2012-3#1)
subcutaneously)##3##1##(2007-10#2)(2012-3#1)
subcuticular hyphae##2##2##(2008-10#2)
subcuticular##4##1##(2007-12#1)(2008-10#3)
subcutis##2##1##(2010-6#2)
subcycle pulses##2##2##(2007-11#2)
subcycle##4##1##(2007-11#3)(2007-12#1)
subdiaphragmatic##5##1##(1992-6#1)(1993-12#2)(1995-12#1)(2011-2#1)
subdivide the##4##2##(1995-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
subdivided by##2##2##(2007-12#1)(2008-10#1)
subdivided into four##4##3##(1997-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
subdivided into three##2##3##(2009-2#1)(2013-8#1)
subdivided into two##4##3##(1995-11#1)(2008-10#1)(2008-12#1)(2012-1#1)
subdivided into##26##2##(1991-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
subdivided##35##1##(1991-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
subdivision among all##2##3##(2008-10#2)
subdivision and##2##2##(2008-10#1)(2009-2#1)
subdivision hierarchy##2##2##(2008-6#2)
subdivision of##4##2##(2008-10#3)(2008-8#1)
subdivision##20##1##(2008-10#7)(2008-6#5)(2008-8#3)(2008-9#3)(2009-2#2)
subdivisions##7##1##(1993-12#1)(1994-2#1)(1997-2#3)(2008-3#1)(2012-3#1)
subdomain and##3##2##(1992-11#1)(1992-6#2)
subdomain of the CPAP protein##2##5##(2009-7#2)
subdomain##8##1##(1992-11#2)(1992-4#1)(1992-6#2)(1996-12#1)(2009-7#2)
subdomains are##2##2##(1992-11#1)(1992-6#1)
subdomains##14##1##(1992-11#4)(1992-6#3)(1995-2#2)(1997-4#1)(1997-7#1)(2008-10#2)(2008-7#1)
subduction zone##3##2##(1990-11#3)
subduction##4##1##(1990-11#3)(1995-6#1)
subdural electrode##2##2##(2008-11#1)(2010-7#1)
subdural haematoma##5##2##(2008-7#5)
subdural hematoma in a##2##4##(2012-2#2)
subdural hematoma on the##2##4##(2008-7#2)
subdural hematoma##20##2##(1995-3#1)(1996-11#1)(2008-7#11)(2010-11#1)(2012-12#2)(2012-2#4)
subdural hematomas##2##2##(2008-9#2)
subdural##37##1##(1990-5#1)(1995-3#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#18)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-12#3)(2012-2#4)
subendocardial##7##1##(1991-3#2)(2008-7#2)(2009-12#1)(2013-7#2)
subendothelial##4##1##(1996-6#1)(2008-11#2)(2008-8#1)
subependymal##2##1##(1996-3#1)(2008-11#1)
subepidermal##4##1##(2008-10#2)(2008-8#1)(2009-6#1)
subepithelial lymphocytic infiltrates##2##3##(2013-1#2)
subepithelial##8##1##(1996-7#1)(1997-1#1)(2008-11#1)(2009-8#1)(2013-1#3)(2013-8#1)
suberate##2##1##(1992-2#1)(1994-2#1)
suberized##2##1##(2008-10#2)
suberoylanilide hydroxamic acid##3##3##(2008-5#1)(2010-12#1)(2012-12#1)
subesophageal##5##1##(2007-12#1)(2008-5#3)(2008-9#1)
subfamilies of##3##2##(1995-3#1)(1995-6#1)(2008-4#1)
subfamilies were##2##2##(1995-3#2)
subfamilies##22##1##(1992-8#1)(1993-9#1)(1995-3#8)(1995-6#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2013-8#1)
subfamily in##3##2##(1994-8#1)(1995-8#1)(2011-2#1)
subfamily of##6##2##(1993-2#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-12#2)
subfamily that##2##2##(1994-12#1)(2011-3#1)
subfamily##40##1##(1991-5#1)(1993-2#1)(1993-6#2)(1994-12#4)(1994-5#1)(1994-8#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#2)(2013-8#1)
subfertility##6##1##(1991-11#1)(1995-8#1)(2007-7#1)(2008-4#1)(2011-1#2)
subfield of##3##2##(1995-3#1)(1995-5#1)(2008-12#1)
subfield##8##1##(1990-5#2)(1995-3#1)(1995-5#1)(1996-7#1)(2008-12#1)(2008-3#1)(2013-1#1)
subfields CA##2##2##(1995-3#2)
subfields##5##1##(1995-3#5)
subform##2##1##(1991-2#2)
subfornical organ##4##2##(1993-12#1)(1994-2#2)(2008-4#1)
subfraction##3##1##(1995-2#2)(2010-6#1)
subfractionated##2##1##(1993-8#1)(1995-11#1)
subfractions##3##1##(1995-11#1)(1995-5#1)(2008-10#1)
subfragment 1##5##2##(1992-4#2)(1994-5#1)(1994-8#2)
subfragment##6##1##(1991-9#1)(1992-4#2)(1994-5#1)(1994-8#2)
subfrontal##2##1##(2006-12#1)(2011-2#1)
subgenera##3##1##(2008-6#1)(2011-2#2)
subgenogroup B5##3##2##(2008-12#3)
subgenogroup##4##1##(2008-12#4)
subgenogroups (C1##2##2##(2008-12#2)
subgenogroups##3##1##(2008-12#3)
subgenomic RNA##5##2##(1994-8#1)(2008-10#4)
subgenomic library##2##2##(1997-8#1)(2008-10#1)
subgenomic##12##1##(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#6)(2008-9#2)(2013-1#1)
subgenotype##3##1##(2009-3#1)(2013-8#2)
subgenus##8##1##(2008-6#3)(2011-2#1)(2013-1#3)(2013-8#1)
subgingival##4##1##(2008-12#2)(2008-5#1)(2012-2#1)
subglobal scales##2##2##(2008-8#2)
subglottic larynx##2##2##(2013-1#2)
subglottic##5##1##(2011-2#3)(2013-1#2)
subglutinans from##2##2##(2008-10#2)
subglutinans in##2##2##(2008-10#2)
subglutinans##12##1##(2008-10#12)
subgraphs##3##1##(2008-2#1)(2010-10#2)
subgroup 16SrI-A phytoplasma strains##2##4##(2008-10#2)
subgroup 16SrI-A##4##2##(2008-10#4)
subgroup 16SrI-B##2##2##(2008-10#2)
subgroup C##2##2##(2008-5#2)
subgroup I and##3##3##(2008-10#3)
subgroup I strains##3##3##(2008-10#3)
subgroup I##15##2##(2008-10#15)
subgroup II strains##4##3##(2008-10#4)
subgroup II##16##2##(2008-10#16)
subgroup III##4##2##(2008-10#3)(2008-9#1)
subgroup analyses##3##2##(2008-4#1)(2011-2#2)
subgroup analysis##2##2##(2007-8#1)(2011-2#1)
subgroup and the other##2##4##(2008-10#2)
subgroup and the##3##3##(1990-5#1)(2008-10#2)
subgroup and##8##2##(1990-5#1)(1994-11#1)(2008-10#3)(2009-12#1)(2009-2#1)(2010-12#1)
subgroup are##2##2##(2008-10#2)
subgroup had##2##2##(1991-11#1)(2008-10#1)
subgroup in the##2##3##(2008-10#2)
subgroup in##3##2##(1994-12#1)(2008-10#2)
subgroup of children##2##3##(2011-1#1)(2011-2#1)
subgroup of patients with##4##4##(1992-9#1)(2008-4#1)(2008-6#1)(2008-8#1)
subgroup of patients##7##3##(1992-9#1)(1993-1#1)(2008-4#1)(2008-6#3)(2008-8#1)
subgroup of the##5##3##(1993-11#1)(1994-12#1)(1997-5#1)(1997-7#1)(2013-8#1)
subgroup of##32##2##(1990-2#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-12#1)(1996-7#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
subgroup specific##2##2##(2008-10#2)
subgroup that##3##2##(2008-10#3)
subgroup within##3##2##(2008-10#3)
subgroup##154##1##(1990-2#1)(1990-5#3)(1991-11#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#3)(1995-12#2)(1996-2#1)(1996-7#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#82)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
subgrouping##2##1##(2008-10#2)
subgroups A and B##2##4##(2008-5#2)
subgroups I and II##4##4##(2008-10#4)
subgroups I##5##2##(2008-10#5)
subgroups according to the##4##4##(1993-2#1)(1994-5#1)(2008-10#1)(2011-2#1)
subgroups according to##5##3##(1993-2#1)(1994-5#1)(2008-10#1)(2009-8#1)(2011-2#1)
subgroups and##2##2##(2007-10#1)(2008-10#1)
subgroups are more##2##3##(2013-1#2)
subgroups are##3##2##(2008-2#1)(2013-1#2)
subgroups based on##2##3##(2008-10#1)(2008-12#1)
subgroups based##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
subgroups in##3##2##(2007-8#1)(2008-10#1)(2010-8#1)
subgroups is##2##2##(1997-1#2)
subgroups may##2##2##(2008-7#1)(2011-1#1)
subgroups of isolates##2##3##(2008-10#2)
subgroups of patients who##2##4##(1994-3#1)(2008-7#1)
subgroups of patients##5##3##(1991-3#1)(1994-3#1)(2008-10#1)(2008-7#2)
subgroups of the population##2##4##(1994-9#1)(1997-1#1)
subgroups of the##4##3##(1994-9#1)(1996-2#1)(1997-1#1)(2008-7#1)
subgroups of##23##2##(1991-3#2)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-4#1)(2008-7#7)(2009-2#1)(2013-1#1)
subgroups that are##2##3##(1995-12#1)(2008-10#1)
subgroups that##3##2##(1995-12#1)(2008-10#1)(2013-8#1)
subgroups were##3##2##(1990-8#1)(2008-10#2)
subgroups with##5##2##(1996-9#1)(2008-12#3)(2008-2#1)
subgroups within the##4##3##(1994-1#1)(1996-3#1)(2008-10#2)
subgroups within##5##2##(1994-1#1)(1996-3#1)(2008-10#3)
subgroups##142##1##(1990-8#2)(1991-3#2)(1991-6#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#5)(1995-5#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-8#2)(2008-10#47)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#13)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
subheading information##2##2##(1995-1#2)
subheading##3##1##(1995-1#3)
subheadings##5##1##(1993-3#1)(1995-1#3)(2011-2#1)
subicular##3##1##(1992-11#1)(1993-12#2)
subiculum and##3##2##(1993-6#2)(2008-1#1)
subiculum##9##1##(1991-10#1)(1991-12#1)(1993-6#5)(1994-2#1)(2008-1#1)
subimage##2##1##(2008-3#2)
subimages##2##1##(2008-3#2)
subisoforms##5##1##(2008-10#5)
subisolates obtained##2##2##(2008-10#2)
subisolates##3##1##(2008-10#3)
subjacent##4##1##(1992-12#1)(1995-2#1)(1997-3#1)(2008-1#1)
subject and to##2##3##(2008-11#1)(2008-4#1)
subject and##9##2##(1992-12#1)(1993-11#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
subject are##2##2##(2008-3#1)(2008-4#1)
subject area##4##2##(1996-12#1)(2008-11#1)(2008-3#1)(2008-9#1)
subject areas##2##2##(2008-1#1)(2013-1#1)
subject chipmunks##2##2##(2008-5#2)
subject during##2##2##(2008-5#1)(2010-9#1)
subject for##4##2##(1990-10#1)(1994-2#1)(1996-6#1)(2010-2#1)
subject has##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
subject in##6##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)
subject is##9##2##(1994-11#1)(1996-12#1)(1997-4#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-8#1)(2013-8#1)
subject matter##4##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
subject of a##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
subject of intense##3##3##(2008-5#1)(2008-9#1)(2010-3#1)
subject of intensive##2##3##(1990-6#1)(2008-5#1)
subject of the study##2##4##(2008-10#1)(2008-12#1)
subject of the##11##3##(1992-2#1)(1993-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-2#1)
subject of this##3##3##(1992-6#1)(2008-10#1)(2011-2#1)
subject of##62##2##(1990-2#1)(1990-6#1)(1991-1#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-6#1)(1995-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
subject or##4##2##(1996-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
subject should be##2##3##(1990-6#1)(2007-11#1)
subject to a precipitation/dissolution process##2##5##(2008-10#2)
subject to a##9##3##(1991-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
subject to an##2##3##(2008-12#1)(2013-1#1)
subject to both##2##3##(2010-5#1)(2012-3#1)
subject to certain##2##3##(1992-2#1)(2008-5#1)
subject to constraints##2##3##(1997-8#1)(2008-8#1)
subject to interference from##2##4##(2008-10#2)
subject to the##9##3##(2008-2#1)(2008-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2011-2#2)(2013-1#1)
subject to this##3##3##(2008-5#1)(2008-8#1)(2009-2#1)
subject to##125##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1993-12#1)(1995-12#4)(1995-6#1)(1996-10#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2007-11#4)(2007-12#4)(2007-4#1)(2007-9#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)
subject was a##2##3##(2012-12#1)(2013-1#1)
subject was##17##2##(1990-3#1)(1990-8#1)(1991-3#1)(1995-11#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)
subject who##3##2##(1991-3#1)(2008-10#1)(2013-1#1)
subject with##5##2##(1992-9#1)(1995-8#2)(1996-5#1)(2011-1#1)
subject##374##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#3)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#28)(2008-11#24)(2008-12#10)(2008-2#8)(2008-3#18)(2008-4#9)(2008-5#15)(2008-6#2)(2008-7#15)(2008-8#8)(2008-9#11)(2009-1#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#8)(2010-9#2)(2011-1#4)(2011-2#11)(2012-1#3)(2012-12#7)(2012-2#9)(2012-3#8)(2012-7#1)(2013-1#16)(2013-7#2)(2013-8#5)
subject's##17##1##(1992-1#1)(1992-2#1)(1994-8#1)(1997-5#2)(2007-6#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
subject-based##2##1##(1997-6#2)
subject-specific##4##1##(1997-3#1)(2008-6#1)(2013-1#2)
subject]##2##1##(2008-10#1)(2009-5#1)
subjected in##3##2##(1993-3#1)(2008-12#1)(2009-12#1)
subjected to 30 min##2##4##(1995-12#1)(2013-1#1)
subjected to SDS-PAGE##3##3##(1992-8#1)(2008-10#1)(2008-12#1)
subjected to a high static electric field##2##7##(2007-12#2)
subjected to a high##3##4##(2007-12#2)(2010-7#1)
subjected to a##33##3##(1990-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-7#1)(2012-12#2)(2013-1#4)
subjected to acid##4##3##(2008-10#4)
subjected to an##10##3##(1993-6#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
subjected to bilateral##2##3##(2009-12#1)(2013-1#1)
subjected to both##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
subjected to cyclic##3##3##(2008-4#1)(2008-6#1)(2009-7#1)
subjected to different##9##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2010-2#1)(2012-12#1)(2013-1#2)
subjected to either##2##3##(2008-8#1)(2010-3#1)
subjected to external optical injection##2##5##(2007-11#2)
subjected to four different##2##4##(2007-8#1)(2008-10#1)
subjected to four##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
subjected to global##2##3##(1996-9#1)(2013-7#1)
subjected to one of##2##4##(2009-7#1)(2012-9#1)
subjected to rigorous##3##3##(1992-1#1)(2012-3#2)
subjected to the##18##3##(1993-8#1)(1997-4#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
subjected to various##2##3##(2008-3#1)(2008-5#1)
subjected to##317##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1991-12#3)(1991-5#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#5)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-6#1)(2007-7#9)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#63)(2008-11#20)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#7)(2009-8#2)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#7)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#7)(2012-7#1)(2012-9#1)(2013-1#22)(2013-7#6)(2013-8#4)
subjected##326##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#3)(1990-8#2)(1991-12#3)(1991-5#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-6#1)(2007-7#9)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#66)(2008-11#20)(2008-12#10)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#7)(2009-8#2)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#7)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#7)(2012-7#1)(2012-9#1)(2013-1#22)(2013-7#6)(2013-8#4)
subjecting the##5##2##(1992-3#1)(2008-10#1)(2009-11#1)(2010-5#1)(2010-8#1)
subjecting##7##1##(1992-3#1)(1995-12#1)(2008-10#1)(2009-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
subjective SA##4##2##(2011-2#4)
subjective and objective##11##3##(1992-9#2)(1997-6#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#1)
subjective and##16##2##(1991-1#1)(1992-9#2)(1997-6#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-5#1)(2010-7#1)(2013-1#1)
subjective aspects of##4##3##(1992-5#1)(2008-10#1)(2013-1#2)
subjective assessment##3##2##(2010-4#1)(2012-3#1)(2013-1#1)
subjective day##2##2##(1995-12#1)(2008-5#1)
subjective evaluation of##3##3##(1990-3#1)(2008-10#1)(2008-6#1)
subjective evaluations##2##2##(1993-1#2)
subjective experiences##2##2##(2008-6#1)(2009-7#1)
subjective feelings##2##2##(2008-5#1)(2013-1#1)
subjective global assessment##2##3##(2007-12#1)(2013-1#1)
subjective health status##2##3##(2012-12#1)(2013-1#1)
subjective health##7##2##(2008-7#2)(2010-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
subjective improvement in##3##3##(1992-8#1)(2006-10#1)(2007-8#1)
subjective judgement and##2##3##(2008-5#1)(2008-9#1)
subjective knee##2##2##(2013-1#2)
subjective measures of##2##3##(2007-11#1)(2011-1#1)
subjective memory##3##2##(2009-11#3)
subjective night##5##2##(1994-2#1)(1995-12#1)(2008-5#3)
subjective norm and##2##3##(1993-12#2)
subjective norm##3##2##(1993-12#3)
subjective opinion##2##2##(2007-11#1)(2013-1#1)
subjective pain##3##2##(2007-11#1)(2008-9#2)
subjective perception during landing##2##4##(2011-2#2)
subjective perception##5##2##(2011-2#4)(2013-1#1)
subjective quality of life##2##4##(1997-1#1)(2012-12#1)
subjective rating of##2##3##(1996-12#1)(2012-1#1)
subjective ratings##4##2##(1995-12#1)(2007-12#1)(2008-5#2)
subjective report##2##2##(1996-3#1)(2012-1#1)
subjective responses to##2##3##(2009-6#1)(2011-2#1)
subjective results were##2##3##(1996-9#2)
subjective results##3##2##(1996-9#2)(2012-2#1)
subjective scoring##2##2##(1992-9#1)(2012-1#1)
subjective sense of##2##3##(1996-5#1)(2008-5#1)
subjective symptoms##3##2##(1990-8#1)(1991-6#1)(2010-1#1)
subjective well-being##8##2##(1990-2#2)(2008-12#2)(2008-7#3)(2013-1#1)
subjective##196##1##(1990-2#2)(1990-3#2)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-6#4)(1991-8#2)(1992-12#3)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#6)(1994-2#1)(1995-12#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#2)(2006-10#1)(2007-11#5)(2007-12#9)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#18)(2008-6#3)(2008-7#15)(2008-9#8)(2009-10#1)(2009-11#4)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#16)(2013-8#3)
subjectively rated##3##2##(2007-12#2)(2013-8#1)
subjectively##14##1##(1995-1#1)(1997-3#1)(1997-6#1)(2007-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
subjectivity##4##1##(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
subjects &gt##2##2##(2008-7#2)
subjects (11##2##2##(1995-5#2)
subjects (19##2##2##(1992-3#1)(2013-1#1)
subjects (5##2##2##(1990-6#1)(2010-3#1)
subjects (P##2##2##(1994-12#1)(1994-3#1)
subjects (P&lt##2##2##(2008-7#1)(2012-2#1)
subjects (aged##3##2##(1992-12#1)(2007-6#1)(2008-5#1)
subjects (group##3##2##(1996-6#1)(2008-1#1)(2011-1#1)
subjects (mean age##3##3##(2008-12#1)(2008-4#1)(2008-7#1)
subjects (mean##4##2##(1993-12#1)(2008-12#1)(2008-4#1)(2008-7#1)
subjects (n =##11##3##(1993-12#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-7#2)(2008-10#1)(2008-5#2)(2009-8#1)(2013-8#1)
subjects (n=10)##2##2##(2009-12#1)(2013-1#1)
subjects (n=5) were cooled using##2##5##(2007-10#2)
subjects affected by##3##3##(1990-9#1)(1993-12#1)(2008-1#1)
subjects after##4##2##(1992-6#1)(1996-1#1)(2008-10#1)(2008-7#1)
subjects aged##9##2##(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
subjects also##2##2##(2008-5#2)
subjects and healthy controls##2##4##(1992-12#1)(2011-2#1)
subjects and in##3##3##(2008-4#2)(2013-1#1)
subjects and patients with##3##4##(2008-10#1)(2010-12#2)
subjects and patients##4##3##(1996-1#1)(2008-10#1)(2010-12#2)
subjects and the##6##3##(1990-8#1)(1991-2#1)(1996-1#1)(2009-6#1)(2011-2#2)
subjects and to##2##3##(2012-2#1)(2013-8#1)
subjects and with##2##3##(1990-6#1)(1991-3#1)
subjects and##54##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1994-6#1)(1995-12#1)(1996-1#4)(1996-12#1)(1996-5#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
subjects appears to be##2##4##(1997-1#1)(2013-1#1)
subjects are required##2##3##(2008-11#1)(2012-3#1)
subjects are##14##2##(1990-6#1)(1991-3#1)(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
subjects as well as in##2##5##(1990-11#1)(1992-3#1)
subjects as well as##6##4##(1990-11#1)(1992-3#1)(2008-11#1)(2008-3#1)(2009-8#2)
subjects as##11##2##(1990-11#1)(1992-3#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-1#2)(2009-4#1)(2009-8#2)(2012-12#1)
subjects at risk##2##3##(2011-2#1)(2012-3#1)
subjects at##8##2##(1994-1#1)(2008-10#3)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
subjects before and##2##3##(1990-5#1)(1991-8#1)
subjects belonging to##2##3##(2008-1#1)(2009-12#1)
subjects between##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
subjects but##5##2##(1990-5#1)(1996-7#1)(2006-8#1)(2008-5#1)(2012-2#1)
subjects can be classified as##2##5##(1991-3#1)(2008-10#1)
subjects can##7##2##(1991-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#2)
subjects completed##6##2##(1996-7#1)(2007-7#1)(2008-3#1)(2008-4#1)(2009-3#1)(2013-8#1)
subjects did not perform any##2##5##(2009-1#1)(2009-3#1)
subjects did not##3##3##(2008-5#1)(2009-1#1)(2009-3#1)
subjects displayed##2##2##(1990-12#1)(2008-7#1)
subjects during##4##2##(1990-6#1)(1991-2#1)(1995-12#1)(1996-5#1)
subjects employed in##2##3##(1994-9#1)(2008-11#1)
subjects excreted##2##2##(1991-12#1)(1993-9#1)
subjects exposed to##3##3##(1992-3#1)(2011-2#1)(2012-2#1)
subjects exposed##4##2##(1992-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
subjects expressed##2##2##(1994-2#1)(2012-12#1)
subjects following##3##2##(1995-9#1)(2011-2#1)(2012-2#1)
subjects for##9##2##(1990-6#1)(1991-2#1)(1993-12#1)(1996-3#1)(1997-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
subjects from Crikvenica##2##3##(2011-2#2)
subjects from Kostrena##2##3##(2011-2#2)
subjects from a##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
subjects from##11##2##(1997-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#4)(2011-3#1)(2013-1#1)
subjects had a##2##3##(1996-12#1)(2008-11#1)
subjects had high##2##3##(2008-1#2)
subjects had reduced##2##3##(1994-12#1)(2008-6#1)
subjects had significantly##2##3##(2008-3#1)(2011-2#1)
subjects had##22##2##(1991-8#1)(1992-6#1)(1994-12#1)(1996-12#1)(1996-5#1)(1996-8#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-1#1)(2011-2#2)(2012-12#1)
subjects have##5##2##(1992-12#1)(1992-3#2)(2008-1#1)(2008-3#1)
subjects homozygous##2##2##(1996-5#2)
subjects in The Netherlands]##2##4##(1992-5#2)
subjects in a##5##3##(1995-5#1)(1995-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
subjects in clinical trials of##2##5##(2009-11#2)
subjects in each group##2##4##(1995-5#1)(2008-5#1)
subjects in group 1##2##4##(2008-1#2)
subjects in the##12##3##(1992-3#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2010-11#1)(2011-2#3)(2012-2#1)
subjects in##36##2##(1992-3#1)(1992-5#2)(1993-9#1)(1995-5#3)(1995-9#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-2#1)(2013-1#1)
subjects included##2##2##(2009-8#1)(2013-1#1)
subjects initially##2##2##(2013-1#2)
subjects is##3##2##(1995-6#1)(1995-9#1)(1997-1#1)
subjects it was found that##2##5##(1990-10#1)(2008-7#1)
subjects it##3##2##(1990-10#1)(1992-9#1)(2008-7#1)
subjects listening to##3##3##(2007-6#3)
subjects living in the##2##4##(1992-8#1)(2011-2#1)
subjects living in##3##3##(1990-8#1)(1992-8#1)(2011-2#1)
subjects may##3##2##(2008-10#1)(2008-6#1)(2013-7#1)
subjects meeting##3##2##(2008-6#1)(2009-10#1)(2011-2#1)
subjects might##2##2##(1990-9#1)(1994-2#1)
subjects not##4##2##(1990-10#1)(2007-6#1)(2008-12#1)(2013-1#1)
subjects of the study were##4##5##(1990-10#1)(1991-1#1)(2007-10#1)(2008-8#1)
subjects of the##7##3##(1990-10#1)(1990-11#1)(1991-1#1)(1991-8#1)(2007-10#1)(2008-5#1)(2008-8#1)
subjects of this##3##3##(1994-5#1)(2007-7#2)
subjects of##24##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-11#1)(1991-8#1)(1994-5#1)(1996-7#1)(2007-10#1)(2007-7#2)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#1)
subjects on a##2##3##(2008-5#1)(2011-2#1)
subjects on the##4##3##(1991-6#1)(1996-3#1)(1996-7#1)(2008-7#1)
subjects on##10##2##(1990-3#1)(1991-6#1)(1996-3#1)(1996-7#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)
subjects or##2##2##(2008-11#1)(2012-3#1)
subjects over##2##2##(1996-7#1)(2008-7#1)
subjects participated in##4##3##(2007-10#1)(2008-9#1)(2010-10#1)(2013-1#1)
subjects perceived##2##2##(1991-2#1)(2008-5#1)
subjects performed voluntary##2##3##(1992-8#1)(2008-11#1)
subjects performed##7##2##(1992-8#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-5#1)(2013-8#1)
subjects performing##2##2##(1994-8#1)(2007-10#1)
subjects randomized to##2##3##(2008-3#1)(2010-11#1)
subjects randomly selected from##2##4##(2008-12#1)(2008-7#1)
subjects rated their##2##3##(2008-5#1)(2008-7#1)
subjects received##7##2##(1996-12#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
subjects receiving##5##2##(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-1#1)
subjects reported##2##2##(2008-5#1)(2008-7#1)
subjects responded to##2##3##(1991-5#1)(2007-9#1)
subjects revealed##3##2##(1993-8#1)(1997-7#1)(2013-1#1)
subjects showed a##4##3##(1992-6#1)(1995-12#1)(2008-5#1)(2008-7#1)
subjects showed##8##2##(1990-3#1)(1991-12#1)(1992-6#1)(1995-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
subjects studied##3##2##(1994-12#1)(2008-12#1)(2012-1#1)
subjects such as##2##3##(1996-1#2)
subjects tend to##2##3##(2008-11#1)(2009-11#1)
subjects tested##2##2##(1990-3#1)(1991-3#1)
subjects than##4##2##(1991-11#1)(2008-10#1)(2008-5#1)(2009-2#1)
subjects that##4##2##(1990-6#1)(1991-8#1)(1996-7#1)(1997-6#1)
subjects the##4##2##(1993-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
subjects to##9##2##(1990-5#1)(1994-12#1)(1997-5#1)(2007-10#1)(2008-2#1)(2008-7#1)(2010-2#2)(2012-12#1)
subjects took##2##2##(1990-3#1)(2008-7#1)
subjects treated with##4##3##(1991-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
subjects treated##5##2##(1991-1#1)(1991-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
subjects under the effect of##2##5##(2013-8#2)
subjects under the##3##3##(1991-12#1)(2013-8#2)
subjects under##5##2##(1991-12#1)(1991-3#1)(2011-2#1)(2013-8#2)
subjects undergoing##5##2##(1990-6#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
subjects underwent a##2##3##(2008-7#1)(2013-8#1)
subjects underwent##7##2##(2008-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
subjects until##2##2##(1995-9#1)(1996-3#1)
subjects used##4##2##(1992-2#1)(1996-7#1)(2008-11#1)(2008-2#1)
subjects using cochlear implants##2##4##(2008-9#2)
subjects using##6##2##(1991-12#1)(1992-2#1)(1996-2#1)(2007-11#1)(2008-9#2)
subjects viewed##2##2##(1996-5#1)(2008-11#1)
subjects was 0##2##3##(1991-5#2)
subjects was found##2##3##(2008-7#1)(2012-3#1)
subjects was##19##2##(1991-5#2)(1992-6#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
subjects we##2##2##(2008-7#1)(2012-12#1)
subjects were asked to##3##4##(1996-2#1)(2008-6#1)(2013-1#1)
subjects were assigned to##2##4##(1991-3#1)(2008-5#1)
subjects were compared with##2##4##(2008-3#1)(2011-2#1)
subjects were compared##3##3##(1995-4#1)(2008-3#1)(2011-2#1)
subjects were either##2##3##(1992-11#1)(1993-6#1)
subjects were examined by##2##4##(2008-4#1)(2008-7#1)
subjects were examined##5##3##(2008-4#1)(2008-7#2)(2012-3#1)(2013-1#1)
subjects were found to be##2##5##(1996-2#1)(2008-7#1)
subjects were found to##3##4##(1996-2#1)(2008-7#1)(2012-2#1)
subjects were found##4##3##(1996-2#1)(2008-7#2)(2012-2#1)
subjects were given##2##3##(1996-5#1)(2008-10#1)
subjects were in##2##3##(2008-1#1)(2008-12#1)
subjects were included in the study##2##6##(1997-8#1)(2008-7#1)
subjects were included in the##3##5##(1997-8#1)(2008-7#1)(2008-8#1)
subjects were instructed to##2##4##(2008-9#1)(2012-2#1)
subjects were interviewed##2##3##(2008-7#1)(2011-2#1)
subjects were male##2##3##(2010-1#1)(2011-2#1)
subjects were randomly assigned to##3##5##(2008-11#1)(2008-12#1)(2011-2#1)
subjects were recruited##5##3##(2008-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
subjects were tested##3##3##(2008-12#1)(2008-7#2)
subjects were treated##2##3##(2008-5#1)(2011-2#1)
subjects were##112##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#3)(1995-11#2)(1995-4#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#15)(2008-8#2)(2008-9#1)(2009-2#1)(2010-1#2)(2010-12#2)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#3)
subjects when compared to##2##4##(2008-1#1)(2008-7#1)
subjects when##3##2##(1997-4#1)(2008-1#1)(2008-7#1)
subjects while##2##2##(2008-3#1)(2013-1#1)
subjects who had##6##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)
subjects who reported##2##3##(1993-9#1)(2008-11#1)
subjects who were given##2##4##(2007-12#1)(2012-2#1)
subjects who were##9##3##(1994-3#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2011-1#1)(2012-2#1)
subjects who##33##2##(1991-3#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2009-11#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
subjects whose##2##2##(2008-7#1)(2010-11#1)
subjects with BMI##2##3##(2008-6#2)
subjects with PD showed more fluctuations in their##2##8##(2008-7#2)
subjects with PD##9##3##(2008-7#9)
subjects with Parkinson's disease (PD)##3##5##(2008-7#2)(2013-1#1)
subjects with Parkinson's disease##4##4##(2008-7#3)(2013-1#1)
subjects with SI joint dysfunction##4##5##(2012-2#4)
subjects with Type 2 diabetes##2##5##(1994-12#2)
subjects with a##7##3##(1992-3#1)(2007-11#3)(2008-5#1)(2008-7#1)(2008-9#1)
subjects with and without##5##4##(1991-3#1)(2008-12#1)(2012-2#1)(2013-1#2)
subjects with chronic##5##3##(1996-6#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
subjects with clinically##2##3##(1996-12#1)(2008-7#1)
subjects with coronary##2##3##(2008-3#1)(2008-7#1)
subjects with diabetes##3##3##(2008-3#1)(2012-3#2)
subjects with different##3##3##(1994-11#1)(2008-7#1)(2010-10#1)
subjects with either##2##3##(1997-5#1)(2008-11#1)
subjects with high##2##3##(2008-7#1)(2009-1#1)
subjects with impaired##2##3##(2008-7#2)
subjects with insulin resistance##2##4##(2008-1#1)(2009-7#1)
subjects with mild acne vulgaris##2##5##(2008-5#2)
subjects with no##3##3##(2008-1#1)(2012-2#2)
subjects with normal skin##2##4##(2008-5#2)
subjects with normal##7##3##(1990-8#1)(1992-11#1)(1996-2#1)(2008-5#2)(2011-1#1)(2012-7#1)
subjects with persistent MAP psychosis##2##5##(1996-7#2)
subjects with primary##2##3##(1996-11#1)(2012-2#1)
subjects with significant##2##3##(2008-3#1)(2011-2#1)
subjects with skin of colour##2##5##(2008-5#2)
subjects with the##6##3##(1991-12#1)(1991-5#1)(1991-8#1)(1997-7#1)(2008-3#1)(2009-9#1)
subjects with type 2 diabetes##2##5##(2008-7#1)(2013-7#1)
subjects with type##3##3##(2008-7#1)(2012-12#1)(2013-7#1)
subjects with xerotic skin##2##4##(2008-5#2)
subjects with##169##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-5#4)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#29)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#11)(2012-3#5)(2012-7#2)(2013-1#12)(2013-7#1)(2013-8#1)
subjects without##11##2##(1997-5#3)(2008-12#1)(2008-7#3)(2012-3#2)(2013-1#2)
subjects##1346##1##(1990-10#6)(1990-11#3)(1990-12#4)(1990-2#5)(1990-3#9)(1990-5#5)(1990-6#8)(1990-8#7)(1990-9#3)(1991-1#4)(1991-11#6)(1991-12#11)(1991-2#15)(1991-3#13)(1991-4#1)(1991-5#9)(1991-6#5)(1991-7#1)(1991-8#9)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#6)(1992-2#4)(1992-3#12)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#3)(1993-1#4)(1993-12#13)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#8)(1994-1#3)(1994-11#4)(1994-12#16)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#2)(1995-11#7)(1995-12#11)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#22)(1995-6#5)(1995-8#3)(1995-9#7)(1996-1#10)(1996-11#1)(1996-12#7)(1996-2#9)(1996-3#5)(1996-5#26)(1996-6#2)(1996-7#26)(1996-8#3)(1997-1#4)(1997-3#1)(1997-4#1)(1997-5#9)(1997-6#2)(1997-7#7)(1997-8#5)(2006-6#1)(2006-8#3)(2007-10#15)(2007-11#7)(2007-12#6)(2007-2#3)(2007-5#1)(2007-6#7)(2007-7#7)(2007-9#1)(2008-1#22)(2008-10#47)(2008-11#49)(2008-12#36)(2008-2#13)(2008-3#32)(2008-4#15)(2008-5#85)(2008-6#18)(2008-7#127)(2008-8#12)(2008-9#20)(2009-1#5)(2009-10#3)(2009-11#9)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#10)(2009-5#1)(2009-6#5)(2009-7#3)(2009-8#11)(2009-9#1)(2010-1#7)(2010-10#3)(2010-11#5)(2010-12#9)(2010-2#3)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#5)(2011-1#11)(2011-2#62)(2011-3#1)(2012-1#4)(2012-12#32)(2012-2#42)(2012-3#33)(2012-7#2)(2013-1#73)(2013-7#4)(2013-8#29)
subjects'##9##1##(1992-12#1)(1995-3#1)(2008-4#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
subjects)##8##1##(1994-12#2)(1995-5#2)(1996-1#1)(2008-7#1)(2011-3#1)(2012-2#1)
subjugated##2##1##(2008-11#1)(2008-12#1)
sublethal concentrations of##2##3##(1991-12#1)(2011-1#1)
sublethal concentrations##4##2##(1991-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
sublethal##16##1##(1991-12#1)(1993-12#1)(1994-5#1)(1995-2#2)(1996-6#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)
sublethally injured##2##2##(2008-10#1)(2009-6#1)
sublevels##2##1##(2007-12#1)(2008-2#1)
sublibraries##2##1##(1994-12#1)(1997-3#1)
sublimation##2##1##(1997-7#1)(2007-11#1)
subliminal##4##1##(1990-9#1)(2008-1#1)(2010-5#1)(2012-12#1)
subline##5##1##(1990-2#2)(1992-9#1)(1997-4#1)(2008-11#1)
sublineages##4##1##(1995-3#4)
sublinear##2##1##(1990-4#1)(2007-12#1)
sublineolum##6##1##(2008-10#6)
sublineolum)##2##1##(2008-10#2)
sublines of##2##2##(1991-4#1)(1997-4#1)
sublines##21##1##(1991-4#1)(1992-9#3)(1997-4#7)(2008-11#6)(2008-4#3)(2008-9#1)
sublingual##4##1##(1991-1#1)(2008-3#2)(2008-8#1)
sublittoral##2##1##(2012-2#2)
sublocalized##2##1##(1992-11#1)(1997-3#1)
subluxated##2##1##(2007-11#1)(2012-2#1)
subluxation##2##1##(2007-11#1)(2012-3#1)
subluxations##3##1##(2007-11#2)(2008-6#1)
sublytic##2##1##(1990-2#1)(1994-2#1)
submandibular gland and##2##3##(1996-2#1)(2011-1#1)
submandibular gland##5##2##(1990-12#1)(1996-2#1)(2008-8#1)(2011-1#1)(2011-2#1)
submandibular salivary gland##4##3##(1990-5#3)(1995-11#1)
submandibular sialadenitis##2##2##(2011-1#2)
submandibular##14##1##(1990-12#1)(1990-5#3)(1995-11#1)(1996-2#1)(2008-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2013-8#1)
submaxillary##5##1##(1993-11#2)(1994-9#3)
submaximal stimulus##2##2##(1993-12#2)
submaximal sustained##2##2##(2013-8#2)
submaximal##16##1##(1991-8#1)(1991-9#1)(1993-12#3)(1994-11#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#4)
submaximally##2##1##(1990-5#1)(1997-4#1)
submerged fermentation##2##2##(2008-7#1)(2008-8#1)
submerged in a##2##3##(2008-10#1)(2008-8#1)
submerged in##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
submerged##20##1##(1990-7#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#2)(2011-2#1)
submersible flow##2##2##(2008-10#2)
submersible##3##1##(2008-10#3)
submicellar##5##1##(1996-5#4)(2008-10#1)
submicrometer resolution##4##2##(2007-12#1)(2008-3#2)(2008-4#1)
submicrometer structures##3##2##(2007-11#1)(2008-3#2)
submicrometer##25##1##(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#13)(2008-4#1)
submicrometer-sized##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
submicrometer-thick optical polarizing films##2##4##(2008-3#2)
submicromolar##7##1##(1994-11#1)(2008-10#3)(2008-7#1)(2013-1#2)
submicron##3##1##(2008-10#1)(2008-11#1)(2009-11#1)
submicroscopic##5##1##(1997-3#2)(2008-1#1)(2008-3#1)(2012-12#1)
submillimeter radiometer##2##2##(2008-3#2)
submillimeter##15##1##(2007-12#3)(2008-2#5)(2008-3#7)
submillimetric##3##1##(2008-3#3)
submillisecond##3##1##(2007-10#1)(2007-11#1)(2008-3#1)
submission of##2##2##(2008-11#1)(2008-5#1)
submission to##3##2##(1992-3#1)(1993-2#1)(1996-1#1)
submission##15##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-2#1)(1996-1#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
submissions to the##2##3##(1994-1#1)(2008-4#1)
submissions to##4##2##(1994-1#1)(2007-11#1)(2008-4#2)
submissions##7##1##(1994-1#1)(1996-1#1)(2007-11#1)(2008-4#2)(2008-7#1)(2011-2#1)
submissive##2##1##(2008-11#2)
submit the##2##2##(2008-10#1)(2008-5#1)
submit their##3##2##(2008-11#1)(2008-7#2)
submit##15##1##(1992-1#1)(1996-12#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#4)(2008-8#1)(2012-2#1)(2013-8#1)
submitochondrial particles##5##2##(1990-5#1)(1992-6#2)(1994-11#2)
submits##4##1##(1990-11#2)(1993-5#1)(2009-6#1)
submitted a##2##2##(1995-6#1)(2012-12#1)
submitted by##2##2##(1992-5#1)(1994-3#1)
submitted for##10##2##(1992-3#1)(1992-5#1)(1994-2#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#1)
submitted in##2##2##(1993-3#1)(2009-7#1)
submitted the##2##2##(1992-5#1)(2012-2#1)
submitted to a##10##3##(1991-12#1)(1993-6#1)(1994-2#1)(2007-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
submitted to adjuvant##2##3##(1992-12#1)(1993-9#1)
submitted to an##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
submitted to different##2##3##(2008-12#1)(2008-5#1)
submitted to esophagectomy alone##2##4##(2013-8#2)
submitted to esophagectomy##3##3##(2013-8#3)
submitted to neoadjuvant chemoradiotherapy##2##4##(2013-8#2)
submitted to neoadjuvant radiotherapy##2##4##(2013-8#2)
submitted to neoadjuvant##4##3##(2013-8#4)
submitted to surgical##2##3##(1990-3#1)(2011-2#1)
submitted to the##12##3##(1992-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
submitted to three##2##3##(2008-10#1)(2013-1#1)
submitted to##91##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-2#1)(1995-1#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-6#2)(2011-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#7)
submitted##131##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#6)(2008-2#1)(2008-5#12)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#7)
submitted)##2##1##(1991-2#1)(1991-9#1)
submitting data##4##2##(2008-4#3)(2008-7#1)
submitting##9##1##(2008-1#2)(2008-4#3)(2008-7#2)(2011-2#1)(2013-7#1)
submucosa##6##1##(1990-9#1)(1992-2#1)(1993-12#1)(1995-3#1)(2008-1#1)(2011-2#1)
submucosal dissection (ESD)##2##3##(2012-2#1)(2013-8#1)
submucosal dissection##7##2##(2009-3#2)(2012-2#2)(2013-1#2)(2013-8#1)
submucosal hematoma of the esophagus##3##5##(2011-2#3)
submucosal tumor##6##2##(2008-12#5)(2012-2#1)
submucosal tumors##2##2##(1992-9#1)(2013-1#1)
submucosal##34##1##(1990-5#1)(1992-2#2)(1992-9#1)(1993-8#1)(1993-9#3)(1994-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-12#5)(2008-7#1)(2009-3#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
submucous fibrosis and##2##3##(2009-6#1)(2013-1#1)
submucous fibrosis is##2##3##(2013-1#2)
submucous fibrosis##7##2##(1996-6#1)(2009-6#1)(2013-1#5)
submucous leiomyomas##4##2##(1991-2#4)
submucous##12##1##(1991-2#5)(1996-6#1)(2009-6#1)(2013-1#5)
subnanometer##7##1##(2007-11#1)(2007-12#2)(2008-3#4)
subnanomolar##2##1##(1995-2#1)(2008-10#1)
subnanosecond##4##1##(2007-12#2)(2008-3#2)
suboccipital craniotomy##3##2##(2008-7#2)(2012-3#1)
suboccipital muscles##2##2##(2010-9#2)
suboccipital##10##1##(2008-7#4)(2010-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
suboptimal dietary##2##2##(2012-2#2)
suboptimal intake##2##2##(2008-5#1)(2012-2#1)
suboptimal##28##1##(1991-6#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-3#1)(2012-2#4)(2012-3#1)(2013-1#1)
suborder##5##1##(1993-3#1)(2008-7#1)(2010-3#1)(2011-2#2)
subordinate male##3##2##(1992-1#1)(2008-8#2)
subordinate to##4##2##(1990-3#1)(1996-11#1)(2008-11#1)(2008-8#1)
subordinate##19##1##(1990-3#1)(1992-1#2)(1996-11#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-8#7)(2008-9#1)(2010-8#3)
subordinates##14##1##(1992-1#2)(2008-8#4)(2010-8#8)
subpattern##2##1##(2008-3#2)
subpatterns##2##1##(2008-3#2)
subperiosteal abscess and##2##3##(2011-1#1)(2012-8#1)
subperiosteal##8##1##(1991-11#1)(2008-4#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-8#1)
subperitoneal space##3##2##(2008-1#3)
subphase##10##1##(1991-3#1)(1992-6#1)(1994-3#3)(1994-5#1)(1994-6#1)(1997-2#2)(2012-2#1)
subpicosecond laser pulses##2##3##(2008-2#1)(2008-3#1)
subpicosecond laser##3##2##(2008-2#1)(2008-3#2)
subpicosecond pulses##3##2##(2007-11#2)(2007-12#1)
subpicosecond terahertz##2##2##(2007-11#2)
subpicosecond##15##1##(1996-2#1)(2007-11#5)(2007-12#6)(2008-2#1)(2008-3#2)
subpixel##3##1##(2008-2#2)(2008-3#1)
subpleural##7##1##(1991-6#1)(2006-10#2)(2008-1#4)
subplots##7##1##(2008-10#3)(2008-12#3)(2008-9#1)
subpopulation (clusters##2##2##(2008-10#2)
subpopulation of cells##2##3##(2008-7#2)
subpopulation of neuronal##2##3##(1991-12#1)(1995-12#1)
subpopulation of##23##2##(1991-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-12#2)(1995-5#1)(2008-10#3)(2008-11#2)(2008-7#3)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-3#1)
subpopulation that##4##2##(2008-4#1)(2010-11#1)(2011-2#2)
subpopulation##62##1##(1990-12#1)(1991-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1997-5#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#5)(2012-3#1)(2013-1#1)
subpopulations and##5##2##(1990-6#1)(1991-5#1)(2008-10#2)(2008-9#1)
subpopulations are##2##2##(2007-12#1)(2008-10#1)
subpopulations from##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
subpopulations have been##2##3##(2008-7#1)(2013-1#1)
subpopulations have##3##2##(2008-7#2)(2013-1#1)
subpopulations in the##3##3##(2008-10#3)
subpopulations in##14##2##(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#1)
subpopulations of cells that##2##4##(1994-8#1)(2008-4#1)
subpopulations of cells##4##3##(1994-8#1)(1997-4#1)(2008-4#1)(2010-6#1)
subpopulations of the##3##3##(1991-12#1)(2008-10#2)
subpopulations of##24##2##(1990-12#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#2)(2009-8#1)(2010-6#1)
subpopulations using##2##2##(2008-4#1)(2008-9#1)
subpopulations were##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
subpopulations with##2##2##(2008-11#1)(2008-4#1)
subpopulations within##4##2##(2008-10#4)
subpopulations##140##1##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-12#6)(1995-6#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#60)(2008-11#9)(2008-4#13)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#2)(2013-1#3)
subpulmonary infundibulum##2##2##(2007-8#2)
subpupil forms##3##2##(2008-3#3)
subregion##3##1##(2008-3#1)(2008-5#1)(2008-8#1)
subregional##3##1##(1995-5#2)(2013-1#1)
subregions of##3##2##(1994-12#1)(2007-8#1)(2008-7#1)
subregions##11##1##(1994-12#1)(1996-12#1)(2007-8#1)(2008-3#4)(2008-7#1)(2008-8#2)(2012-1#1)
subretinal fluid##2##2##(2011-7#1)(2013-8#1)
subretinal##6##1##(2008-4#2)(2011-7#3)(2013-8#1)
subsample of##5##2##(2008-10#2)(2008-4#1)(2012-3#1)(2013-8#1)
subsample##7##1##(2008-10#3)(2008-4#1)(2009-8#1)(2012-3#1)(2013-8#1)
subsamples of##3##2##(2008-10#1)(2010-12#1)(2012-12#1)
subsamples##6##1##(2008-10#3)(2009-12#1)(2010-12#1)(2012-12#1)
subsarcolemmal##2##1##(1995-12#1)(2009-7#1)
subscale##12##1##(2007-12#3)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-6#1)(2010-8#2)(2012-2#1)(2013-1#1)
subscales and##2##2##(2008-11#1)(2010-6#1)
subscales of the##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
subscales##24##1##(1994-6#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2009-5#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#5)
subscapular artery##2##2##(2008-7#2)
subscapular##3##1##(2008-7#3)
subscapularis##4##1##(2012-12#3)(2013-1#1)
subscore##2##1##(2008-7#1)(2009-10#1)
subscriber##4##1##(1994-12#2)(1996-3#1)(2011-3#1)
subscribers##3##1##(1994-1#2)(1997-1#1)
subscription##2##1##(1991-12#2)
subsensitivity of striatal##2##3##(1995-12#2)
subsensitivity of##3##2##(1995-12#3)
subsensitivity##5##1##(1992-11#1)(1995-11#1)(1995-12#3)
subsequent CT##2##2##(1994-2#1)(2012-3#1)
subsequent DHAA reduction##2##3##(1993-3#2)
subsequent activation##3##2##(1994-6#1)(2009-8#1)(2012-2#1)
subsequent acute##4##2##(2008-7#1)(2009-9#1)(2012-1#1)(2012-2#1)
subsequent administration of##4##3##(1992-5#1)(1995-2#1)(1997-6#1)(2007-7#1)
subsequent age group##2##3##(1991-6#2)
subsequent age##3##2##(1990-6#1)(1991-6#2)
subsequent analyses##2##2##(1996-7#1)(2008-4#1)
subsequent analysis of##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
subsequent analysis##13##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#3)(2011-2#1)
subsequent attachment of##3##3##(1993-6#1)(2008-10#2)
subsequent challenge##2##2##(2008-3#1)(2008-4#1)
subsequent changes in##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
subsequent chemical##3##2##(1997-5#1)(2009-12#1)(2010-12#1)
subsequent chromium##2##2##(2008-10#2)
subsequent clinical##5##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-8#1)
subsequent complex formation##2##3##(2008-10#2)
subsequent conditioned performance##2##3##(1993-12#2)
subsequent day##2##2##(1994-8#1)(2010-3#1)
subsequent decrease in the##3##4##(1995-12#1)(2008-10#1)(2009-6#1)
subsequent decrease in##5##3##(1992-2#1)(1995-12#1)(2008-10#1)(2009-6#1)(2012-3#1)
subsequent decrease##6##2##(1991-9#1)(1992-2#1)(1995-12#1)(2008-10#1)(2009-6#1)(2012-3#1)
subsequent detection of##4##3##(2008-10#1)(2008-3#2)(2008-7#1)
subsequent detection##6##2##(2008-10#3)(2008-3#2)(2008-7#1)
subsequent determination by##4##3##(2008-10#4)
subsequent determination of##2##3##(2008-10#2)
subsequent determination##8##2##(2008-10#8)
subsequent development of##11##3##(1991-12#1)(1992-10#1)(1993-6#1)(1994-2#1)(1997-6#1)(2008-10#5)(2008-7#1)
subsequent development##13##2##(1991-12#1)(1992-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-6#1)(2008-10#5)(2008-5#1)(2008-7#1)
subsequent disease##2##2##(1990-3#1)(2008-10#1)
subsequent displacement##2##2##(1990-12#1)(2008-2#1)
subsequent elution of##4##3##(2008-10#4)
subsequent elution##5##2##(2008-10#5)
subsequent evaluation##4##2##(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
subsequent events in##2##3##(1994-8#1)(2008-7#1)
subsequent events##3##2##(1994-8#1)(2008-7#2)
subsequent exams##2##2##(1991-3#2)
subsequent experiments##2##2##(2008-10#1)(2008-5#1)
subsequent exposure to##2##3##(2008-10#2)
subsequent expression of##2##3##(1992-3#1)(2008-10#1)
subsequent fractures##2##2##(1993-11#2)
subsequent gene##2##2##(2008-1#1)(2012-3#1)
subsequent generations##3##2##(1992-2#1)(2008-2#1)(2010-4#1)
subsequent germination##2##2##(2008-10#2)
subsequent health##4##2##(1993-1#1)(2009-10#1)(2009-5#2)
subsequent immune##3##2##(2008-1#1)(2008-4#2)
subsequent increase in##4##3##(1991-12#1)(2008-5#1)(2012-2#1)(2013-7#1)
subsequent increase##5##2##(1991-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-7#1)
subsequent inhibition of the##2##4##(1993-6#1)(2010-12#1)
subsequent injection##2##2##(2008-10#1)(2008-4#1)
subsequent isolation of##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
subsequent large##2##2##(2008-7#1)(2010-2#1)
subsequent leaching##2##2##(2008-10#1)(2008-11#1)
subsequent maintenance of##2##3##(1996-12#1)(2008-10#1)
subsequent maintenance##3##2##(1996-12#1)(1997-3#1)(2008-10#1)
subsequent management##5##2##(1994-5#1)(2008-9#1)(2009-8#1)(2012-2#2)
subsequent measurement by##2##3##(2008-10#2)
subsequent measurement of##3##3##(2008-10#2)(2008-4#1)
subsequent measurement##5##2##(2008-10#4)(2008-4#1)
subsequent measurements##2##2##(2008-10#1)(2008-7#1)
subsequent medical##2##2##(1993-11#1)(2008-12#1)
subsequent memory##2##2##(1993-12#1)(2013-1#1)
subsequent migration##2##2##(1996-5#1)(2007-7#1)
subsequent miscarriage##2##2##(1990-2#1)(1994-9#1)
subsequent nuclear##2##2##(1994-11#1)(1994-6#1)
subsequent occurrence of##2##3##(1993-9#1)(2012-12#1)
subsequent oxidation##3##2##(2008-10#3)
subsequent oxidative stress##2##3##(1991-9#1)(2008-11#1)
subsequent oxidative##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
subsequent papers##2##2##(2008-10#2)
subsequent pregnancies##2##2##(2008-11#1)(2011-2#1)
subsequent primary##2##2##(2011-2#1)(2013-7#1)
subsequent processes##2##2##(2008-10#1)(2008-3#1)
subsequent pseudothecium##2##2##(2008-10#2)
subsequent rapid##2##2##(2008-10#2)
subsequent rate##2##2##(1990-11#2)
subsequent reaction with##3##3##(2008-10#3)
subsequent reaction##8##2##(1991-11#1)(1992-8#1)(1993-3#1)(2008-10#5)
subsequent reactions##2##2##(1991-3#1)(2008-10#1)
subsequent reconstruction##2##2##(2007-12#1)(2010-6#1)
subsequent relapses##2##2##(2010-11#1)(2011-2#1)
subsequent release of##2##3##(1995-5#1)(2008-11#1)
subsequent release##4##2##(1991-9#1)(1995-5#1)(1997-4#1)(2008-11#1)
subsequent removal##2##2##(2008-2#1)(2010-12#1)
subsequent space use##2##3##(2008-9#2)
subsequent staining##2##2##(1995-12#1)(2008-2#1)
subsequent steps of##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
subsequent steps##5##2##(1991-12#1)(1992-11#1)(1992-5#1)(1995-3#1)(2008-10#1)
subsequent stimulation##2##2##(1993-3#1)(2011-2#1)
subsequent surgery##3##2##(2007-5#1)(2008-9#1)(2013-1#1)
subsequent surgical##2##2##(2007-11#1)(2012-12#1)
subsequent time points##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
subsequent to a##2##3##(1991-6#1)(1994-2#1)
subsequent to the##7##3##(1990-5#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-5#1)
subsequent to##26##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#2)(1995-10#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
subsequent treatment##7##2##(1990-8#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)
subsequent use##5##2##(1994-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#1)
subsequent years##4##2##(2008-10#3)(2011-2#1)
subsequent##763##1##(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#4)(1991-6#4)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#5)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#7)(1993-3#5)(1993-6#8)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#4)(1994-2#6)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#5)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#5)(2007-11#17)(2007-12#10)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#7)(2008-10#167)(2008-11#22)(2008-12#11)(2008-2#15)(2008-3#13)(2008-4#26)(2008-5#17)(2008-6#4)(2008-7#30)(2008-8#14)(2008-9#25)(2009-10#4)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#9)(2011-2#27)(2011-3#1)(2012-1#4)(2012-12#14)(2012-2#17)(2012-3#12)(2013-1#17)(2013-7#5)(2013-8#14)
subsequently analysed by##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
subsequently analyzed##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
subsequently be##3##2##(1990-12#1)(2008-10#1)(2013-8#1)
subsequently became infected##2##3##(2006-10#1)(2008-10#1)
subsequently became##3##2##(2006-10#1)(2008-10#1)(2010-1#1)
subsequently been##4##2##(1995-8#1)(2010-12#2)(2011-2#1)
subsequently by##2##2##(2008-11#1)(2009-11#1)
subsequently characterized##2##2##(2008-3#2)
subsequently cloned##2##2##(1993-6#1)(1996-6#1)
subsequently compared to the##2##4##(2008-5#1)(2010-8#1)
subsequently confirmed##4##2##(1993-11#1)(1994-7#1)(2008-7#1)(2012-3#1)
subsequently delivered##2##2##(1994-3#1)(2008-10#1)
subsequently detected##3##2##(1994-5#1)(2007-12#1)(2008-10#1)
subsequently determined by##2##3##(2008-10#2)
subsequently determined with##2##3##(2008-10#2)
subsequently determined##5##2##(2008-10#5)
subsequently developed##6##2##(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#1)
subsequently died##2##2##(1994-3#1)(2006-10#1)
subsequently discovered##2##2##(2010-3#1)(2012-3#1)
subsequently eluted with##5##3##(2008-10#5)
subsequently eluted##6##2##(2008-10#6)
subsequently examined##2##2##(1995-6#1)(1997-3#1)
subsequently exposed##2##2##(2008-10#1)(2008-3#1)
subsequently forms##2##2##(2008-10#1)(2008-11#1)
subsequently had##2##2##(1995-8#1)(2009-6#1)
subsequently introduced##2##2##(1990-5#1)(2008-10#1)
subsequently investigated##3##2##(1997-4#1)(2010-4#1)(2010-5#1)
subsequently measured##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)
subsequently modified by##2##3##(1997-2#1)(2008-10#1)
subsequently placed##2##2##(2008-11#1)(2011-2#1)
subsequently received##3##2##(1993-6#1)(1994-12#1)(2010-1#1)
subsequently reduced##2##2##(1995-12#1)(2008-12#1)
subsequently released##2##2##(2008-10#1)(2011-2#1)
subsequently separated on##2##3##(1996-5#1)(2008-10#1)
subsequently separated##4##2##(1996-5#2)(2008-10#2)
subsequently shown to##4##3##(1990-10#1)(1991-2#1)(2008-10#1)(2008-7#1)
subsequently shown##5##2##(1990-10#1)(1991-2#1)(1992-6#1)(2008-10#1)(2008-7#1)
subsequently subjected to##2##3##(2008-10#1)(2013-1#1)
subsequently tested##3##2##(1991-2#1)(1991-7#1)(2008-5#1)
subsequently the##6##2##(1993-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
subsequently to the##2##3##(2008-2#1)(2009-12#1)
subsequently to##8##2##(1990-12#1)(1991-8#1)(1991-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)
subsequently treated with##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2010-7#1)
subsequently treated##6##2##(1993-6#1)(1993-8#1)(2008-10#2)(2008-11#1)(2010-7#1)
subsequently underwent a##2##3##(1994-12#1)(2008-9#1)
subsequently underwent##8##2##(1994-12#1)(1995-11#1)(2007-5#1)(2008-9#2)(2013-1#3)
subsequently used in##2##3##(2008-3#1)(2008-8#1)
subsequently used to##3##3##(1996-2#1)(2008-10#2)
subsequently used##8##2##(1993-3#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-6#1)
subsequently validated##2##2##(2008-10#1)(2012-2#1)
subsequently was##2##2##(1996-8#1)(2008-10#1)
subsequently were##2##2##(2008-10#1)(2012-12#1)
subsequently with##3##2##(2008-10#3)
subsequently##332##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#3)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(2006-10#3)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#77)(2008-11#15)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#13)(2008-8#10)(2008-9#10)(2009-1#1)(2009-11#4)(2009-12#1)(2009-6#2)(2009-7#2)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#4)(2012-2#10)(2012-3#2)(2012-7#1)(2013-1#13)(2013-8#4)
subserosal##2##1##(1993-9#1)(1994-2#1)
subserve##4##1##(1991-5#1)(1993-3#1)(2008-11#1)(2008-4#1)
subserving##7##1##(1992-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-8#1)(2008-11#1)(2008-4#1)
subset composition##2##2##(2008-11#2)
subset of T cells##2##4##(2008-4#1)(2012-2#1)
subset of all##3##3##(2008-6#1)(2010-10#1)(2010-2#1)
subset of cells##2##3##(1991-5#1)(2009-5#1)
subset of patients who##2##4##(2008-9#1)(2011-2#1)
subset of patients with##4##4##(1995-5#1)(2006-7#1)(2007-10#1)(2008-7#1)
subset of patients##12##3##(1995-5#1)(1997-1#1)(1997-8#1)(2006-7#1)(2007-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)
subset of the##16##3##(1996-7#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
subset of these##5##3##(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#2)
subset of this##3##3##(2007-12#1)(2008-6#1)(2008-9#1)
subset of##117##2##(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#2)(2006-7#1)(2007-10#2)(2007-12#3)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
subset partitioning##3##2##(2008-10#2)(2013-8#1)
subset selection##2##2##(2008-11#1)(2008-6#1)
subset##153##1##(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#3)(1995-8#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#2)(2006-7#1)(2007-10#2)(2007-12#3)(2008-10#25)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#7)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
subsets in the##3##3##(1993-12#1)(1993-8#1)(2012-2#1)
subsets in##8##2##(1990-2#1)(1991-6#1)(1993-12#1)(1993-8#1)(1997-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
subsets of AG-2 were##2##4##(2008-10#2)
subsets of AG-2##4##3##(2008-10#4)
subsets of neurons##2##3##(1993-12#1)(1997-3#1)
subsets of patients##2##3##(2007-11#1)(2009-6#1)
subsets of the population##2##4##(1995-12#1)(2006-10#1)
subsets of the##3##3##(1995-12#1)(2006-10#1)(2009-8#1)
subsets of##38##2##(1992-10#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-3#1)(2012-3#2)
subsets##91##1##(1990-11#1)(1990-2#1)(1991-6#3)(1992-10#1)(1993-12#3)(1993-8#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-6#1)(2008-7#4)(2008-9#10)(2009-12#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
subside##2##1##(1995-6#1)(2007-11#1)
subsided##9##1##(1990-12#1)(1996-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
subsidence of##2##2##(1990-12#1)(2007-11#1)
subsidence##3##1##(1990-12#1)(2007-11#1)(2010-5#1)
subsidiary of U##2##3##(1996-12#1)(1997-1#1)
subsidiary of##5##2##(1990-2#1)(1996-12#1)(1997-1#1)(2008-5#2)
subsidiary##6##1##(1990-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#2)
subsidies##13##1##(1992-12#1)(1992-5#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-5#1)(2013-8#1)
subsiding##2##1##(1992-11#1)(1997-4#1)
subsidized##5##1##(1991-12#1)(1997-5#1)(2008-7#1)(2009-10#1)(2012-12#1)
subsidy##8##1##(1994-2#1)(1996-2#2)(2008-11#1)(2008-12#1)(2008-7#3)
subsistence##7##1##(1991-12#1)(2008-1#1)(2008-10#2)(2010-6#1)(2013-7#2)
subsite##6##1##(1990-7#2)(1991-6#2)(1992-12#1)(2010-12#1)
subsites##3##1##(1991-6#1)(1992-12#1)(1992-8#1)
subsonic##4##1##(2008-3#4)
subsp##116##1##(1990-5#2)(1993-12#2)(1994-12#2)(1994-6#2)(1995-8#2)(2007-6#2)(2008-10#76)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#6)(2012-3#5)(2013-1#3)(2013-7#2)
subspace##6##1##(2007-11#1)(2008-7#2)(2009-9#3)
subspecialists##2##1##(2008-11#1)(2013-1#1)
subspecialization##2##1##(1994-12#1)(2007-8#1)
subspecialties##4##1##(1991-6#1)(1994-12#1)(1995-1#1)(2008-11#1)
subspecialty##9##1##(1993-12#1)(1994-12#1)(1994-3#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-8#1)(2012-3#1)
subspecies level##2##2##(2008-10#1)(2011-1#1)
subspecies of##3##2##(2008-10#1)(2008-5#2)
subspecies##28##1##(1990-8#2)(2008-10#10)(2008-11#1)(2008-12#3)(2008-5#3)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
subspecies-specific##3##1##(2008-10#2)(2011-1#1)
subspecific groups##2##2##(2008-10#2)
subspecific##4##1##(2008-10#4)
substance (TBARS)##3##2##(1994-6#1)(2012-2#1)(2012-5#1)
substance P (SP) and calcitonin gene-related peptide (CGRP)##2##8##(1997-3#1)(2007-2#1)
substance P (SP) and##4##4##(1992-3#1)(1992-9#1)(1997-3#1)(2007-2#1)
substance P and bronchoalveolar lavage##2##5##(1992-3#2)
substance P and##4##3##(1992-3#2)(1993-12#1)(1993-8#1)
substance P in##3##3##(1994-8#1)(1995-12#1)(2009-11#1)
substance P or##2##3##(1991-12#1)(1994-8#1)
substance P##33##2##(1991-12#2)(1992-3#4)(1992-9#1)(1993-12#1)(1993-8#1)(1994-8#8)(1995-11#2)(1995-12#2)(1997-1#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-8#2)(2008-4#3)(2008-7#1)(2009-11#1)(2013-8#1)
substance P-##2##2##(1994-8#1)(1997-3#1)
substance abuse and comorbid##2##4##(2008-6#1)(2009-5#1)
substance abuse and mental health##5##5##(1995-1#1)(2008-6#1)(2013-8#3)
substance abuse and##11##3##(1991-1#1)(1994-2#1)(1995-1#1)(2008-6#2)(2009-5#1)(2009-9#2)(2013-8#3)
substance abuse diagnosis##2##3##(1994-2#1)(1995-1#1)
substance abuse in##2##3##(1994-3#1)(2013-8#1)
substance abuse or dependence##2##4##(1992-1#1)(2008-6#1)
substance abuse patients##2##3##(1991-1#1)(2008-6#1)
substance abuse treatment and##3##4##(2008-6#2)(2010-6#1)
substance abuse treatment programs##2##4##(2008-6#1)(2009-9#1)
substance abuse treatment##10##3##(2008-6#3)(2009-9#2)(2010-11#3)(2010-6#1)(2012-12#1)
substance abuse##64##2##(1991-1#3)(1991-2#1)(1992-1#2)(1993-2#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#3)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-4#3)(2008-6#15)(2008-9#1)(2009-5#1)(2009-9#6)(2010-11#3)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#5)
substance abusers##9##2##(1991-1#6)(1994-2#2)(2011-1#1)
substance abusing##2##2##(2009-9#1)(2013-7#1)
substance and volume loss were##2##5##(2011-2#2)
substance and volume loss##3##4##(2011-2#3)
substance and##5##2##(2007-12#1)(2010-4#1)(2011-2#3)
substance as##2##2##(2008-10#2)
substance by##2##2##(2008-10#1)(2008-5#1)
substance can##2##2##(1997-6#1)(2008-3#1)
substance code##2##2##(2010-8#2)
substance dependence##5##2##(1991-1#1)(2012-2#2)(2013-8#2)
substance did not##2##3##(1997-6#1)(2008-10#1)
substance for##2##2##(1994-11#1)(2011-1#1)
substance from##3##2##(2008-12#1)(2008-5#2)
substance have been##2##3##(2008-10#2)
substance in the##3##3##(1992-6#1)(2008-11#1)(2008-9#1)
substance in##9##2##(1991-12#1)(1992-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)
substance inhibited##3##2##(1993-3#1)(1995-12#1)(1997-6#1)
substance is##3##2##(1990-7#1)(2008-10#1)(2010-5#1)
substance misuse##4##2##(2008-12#1)(2009-9#2)(2012-12#1)
substance of##6##2##(1993-12#2)(2008-10#2)(2008-5#1)(2013-1#1)
substance that appears to##2##4##(2008-11#2)
substance that##5##2##(1991-9#1)(1994-5#1)(1997-6#1)(2008-11#2)
substance use across##2##3##(2008-5#1)(2009-7#1)
substance use among##4##3##(2008-5#3)(2009-7#1)
substance use and##7##3##(2008-5#1)(2008-6#1)(2009-7#1)(2010-7#1)(2013-1#2)(2013-8#1)
substance use disorder in##2##4##(2012-12#1)(2012-3#1)
substance use disorder##5##3##(2008-6#1)(2009-11#2)(2012-12#1)(2012-3#1)
substance use disorders in##2##4##(2008-6#1)(2012-12#1)
substance use disorders##8##3##(2008-6#2)(2009-10#1)(2009-9#1)(2010-6#3)(2012-12#1)
substance use in##5##3##(2008-6#2)(2009-7#2)(2012-3#1)
substance use##61##2##(1994-2#1)(2008-11#1)(2008-4#3)(2008-5#7)(2008-6#7)(2009-10#1)(2009-11#3)(2009-5#3)(2009-7#13)(2009-9#1)(2010-10#2)(2010-6#3)(2010-7#1)(2012-12#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
substance used in##2##3##(1990-6#1)(2008-5#1)
substance users##5##2##(1991-1#2)(2008-5#3)
substance using##2##2##(2009-7#1)(2012-12#1)
substance was##7##2##(1990-12#1)(1990-5#1)(1990-6#1)(2008-11#2)(2008-5#1)(2008-8#1)
substance were##2##2##(2008-11#1)(2008-5#1)
substance which##2##2##(1992-8#1)(1997-7#1)
substance##343##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#5)(1990-7#1)(1991-1#13)(1991-12#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#12)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#9)(1995-1#3)(1995-11#3)(1995-12#5)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#4)(1997-7#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#32)(2008-11#24)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#10)(2008-5#25)(2008-6#26)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#5)(2009-4#2)(2009-5#4)(2009-7#15)(2009-9#10)(2010-10#2)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#9)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#8)(2013-7#3)(2013-8#10)
substance(s)##4##1##(1992-8#1)(2008-10#2)(2008-5#1)
substance-P immunoreactivity in##2##3##(1995-12#2)
substance-P immunoreactivity##3##2##(1995-12#3)
substance-P##5##1##(1995-12#5)
substance-abusing##2##1##(2008-6#1)(2012-3#1)
substance-related disorders##3##2##(2009-7#3)
substance-specific##2##1##(2008-3#1)(2008-4#1)
substances (HS) and##2##3##(2008-10#2)
substances (HS)##5##2##(2008-10#5)
substances (TBARS)##7##2##(1993-2#1)(1995-3#1)(2008-10#2)(2010-4#1)(2011-2#2)
substances and the##4##3##(2008-11#1)(2008-5#2)(2008-7#1)
substances and their##4##3##(1996-12#1)(2008-10#3)
substances and##28##2##(1990-11#1)(1992-1#1)(1992-3#1)(1992-5#1)(1996-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#5)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-8#1)
substances are responsible for##2##4##(2008-10#1)(2008-11#1)
substances are##9##2##(1991-3#1)(1993-11#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-7#2)(2012-1#1)
substances as well as##3##4##(1997-2#1)(2009-10#1)(2010-5#1)
substances as##4##2##(1997-2#1)(2008-11#1)(2009-10#1)(2010-5#1)
substances by##3##2##(2008-10#3)
substances contained in the##2##4##(2008-10#1)(2008-11#1)
substances existing in##2##3##(2008-11#1)(2009-11#1)
substances for the##4##3##(2008-11#3)(2013-1#1)
substances for##8##2##(1992-3#1)(2008-11#3)(2008-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
substances from the##4##3##(2007-12#1)(2008-5#1)(2008-7#2)
substances from##6##2##(1997-1#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-1#1)
substances have been##2##3##(1996-5#1)(2007-11#1)
substances have##6##2##(1995-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-5#1)(2008-7#1)
substances having a##2##3##(2008-10#1)(2008-11#1)
substances in biological##2##3##(2008-10#1)(2010-11#1)
substances in human##2##3##(2008-10#1)(2010-11#1)
substances in plasma##3##3##(1992-3#1)(2008-10#2)
substances in the##10##3##(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2013-8#2)
substances in##36##2##(1992-3#1)(1992-5#1)(1994-8#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#2)(2010-11#4)(2013-8#4)
substances including##2##2##(1994-8#1)(1997-4#1)
substances is##4##2##(1990-3#1)(1995-11#1)(2008-5#1)(2013-1#1)
substances may##2##2##(2008-11#1)(2010-4#1)
substances of##5##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
substances on the##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
substances or##2##2##(2008-2#1)(2008-4#1)
substances present in the##2##4##(1994-3#1)(2008-10#1)
substances present in##3##3##(1994-3#1)(2008-10#2)
substances produced by##3##3##(2010-1#1)(2010-10#1)(2010-7#1)
substances produced##4##2##(2008-10#1)(2010-1#1)(2010-10#1)(2010-7#1)
substances such as nitric oxide##2##5##(2008-3#1)(2011-2#1)
substances such as vitamin C##2##5##(1992-9#1)(2008-1#1)
substances such as##9##3##(1992-9#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-3#1)(2011-2#1)
substances tested##2##2##(1993-12#1)(2008-11#1)
substances that are##5##3##(2008-10#1)(2008-3#1)(2008-5#2)(2013-1#1)
substances that can##2##3##(2008-5#1)(2013-8#1)
substances that have##2##3##(1990-2#2)
substances that##16##2##(1990-2#2)(1991-12#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-9#1)(2013-1#2)(2013-8#1)
substances to##2##2##(2008-10#1)(2008-5#1)
substances used for##2##3##(2008-10#1)(2008-7#1)
substances used##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
substances was studied##2##3##(2008-10#1)(2008-8#1)
substances was##6##2##(2008-10#5)(2008-8#1)
substances were studied##2##3##(1996-8#1)(2008-10#1)
substances were##14##2##(1992-5#1)(1995-12#1)(1995-2#1)(1996-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2013-1#1)
substances which can##2##3##(2008-10#1)(2013-8#1)
substances which##9##2##(1994-2#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-8#1)
substances with##5##2##(1993-2#1)(2008-10#3)(2011-1#1)
substances##389##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#5)(1992-5#5)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#138)(2008-11#35)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#30)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#5)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#9)
substantia nigra and##8##3##(1995-12#1)(1996-12#2)(2008-7#5)
substantia nigra has##2##3##(1990-5#2)
substantia nigra##41##2##(1990-5#4)(1991-12#1)(1992-10#1)(1993-12#2)(1994-2#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#6)(1997-3#1)(1997-7#1)(2008-12#1)(2008-7#10)(2012-12#1)(2012-2#1)
substantia##43##1##(1990-5#4)(1991-12#1)(1992-10#1)(1993-12#2)(1994-2#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#6)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-7#10)(2012-12#1)(2012-2#1)
substantial advances##3##2##(1995-5#1)(2010-5#1)(2011-2#1)
substantial amino acid##2##3##(1993-3#1)(2008-9#1)
substantial amount of##5##3##(1995-1#1)(1997-3#1)(2008-11#1)(2008-8#1)(2012-1#1)
substantial amounts of##5##3##(1991-12#2)(1991-5#1)(1992-11#1)(2008-10#1)
substantial and##3##2##(2008-3#1)(2008-7#1)(2010-3#1)
substantial benefit##2##2##(2010-12#1)(2012-3#1)
substantial benefits##2##2##(2007-8#1)(2011-2#1)
substantial bone##2##2##(2007-7#1)(2011-1#1)
substantial change##2##2##(1994-12#1)(2013-8#1)
substantial changes in##6##3##(1997-1#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-1#1)
substantial changes of##2##3##(2008-10#2)
substantial changes##9##2##(1993-3#1)(1997-1#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-1#1)
substantial decrease in##2##3##(1991-6#1)(2008-10#1)
substantial differences in the##2##4##(1996-1#1)(2009-10#1)
substantial differences in##3##3##(1996-1#1)(2008-3#1)(2009-10#1)
substantial differences##5##2##(1995-3#1)(1996-1#1)(2008-3#1)(2009-10#1)(2010-12#1)
substantial effects on##2##3##(2008-10#1)(2012-2#1)
substantial effort to##2##3##(2008-3#1)(2011-2#1)
substantial effort##3##2##(2008-3#1)(2011-2#2)
substantial enhancement##3##2##(1997-3#1)(2008-10#1)(2008-3#1)
substantial evidence that##2##3##(1992-5#1)(2008-11#1)
substantial evidence##5##2##(1991-8#1)(1992-5#1)(2008-11#1)(2008-12#1)(2008-8#1)
substantial financial##2##2##(2007-11#1)(2012-12#1)
substantial gains##2##2##(2008-3#1)(2012-3#1)
substantial impact on##2##3##(2008-5#1)(2012-12#1)
substantial impact##5##2##(1995-1#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-12#1)
substantial improvement in the##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
substantial improvement##6##2##(1995-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)
substantial improvements in the##2##4##(1991-4#1)(2009-11#1)
substantial improvements in##6##3##(1991-4#1)(1994-12#1)(2009-11#1)(2011-1#1)(2012-1#1)(2013-1#1)
substantial increase in the##5##4##(1992-2#1)(1997-3#1)(2008-10#2)(2011-2#1)
substantial increase in##12##3##(1992-2#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
substantial increase##15##2##(1991-6#1)(1992-2#1)(1994-12#1)(1997-3#1)(2008-10#4)(2008-11#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
substantial increases in##2##3##(2008-8#1)(2012-2#1)
substantial influence##2##2##(2008-10#1)(2009-7#1)
substantial inhibition##2##2##(1992-8#1)(1993-8#1)
substantial levels of##3##3##(1990-12#1)(1995-12#1)(2007-11#1)
substantial morbidity and mortality##2##4##(2008-7#1)(2008-8#1)
substantial numbers of##3##3##(1995-12#1)(1996-9#1)(2008-12#1)
substantial numbers##4##2##(1995-12#1)(1996-9#1)(2007-8#1)(2008-12#1)
substantial part of the##3##4##(1990-5#1)(1995-1#1)(2008-7#1)
substantial part of##4##3##(1990-5#1)(1995-1#1)(2008-7#1)(2011-2#1)
substantial part##5##2##(1990-5#1)(1995-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
substantial percentage of##2##3##(2007-7#1)(2013-1#1)
substantial proportion of##5##3##(1991-9#1)(2006-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
substantial proportion##7##2##(1991-9#1)(2006-8#1)(2008-12#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
substantial protection against##3##3##(1990-11#1)(1990-8#1)(2008-5#1)
substantial public health##3##3##(1993-12#1)(2011-2#1)(2013-8#1)
substantial reduction in##4##3##(1991-12#1)(2007-9#1)(2008-10#1)(2008-11#1)
substantial reduction##5##2##(1991-12#1)(1991-8#1)(2007-9#1)(2008-10#1)(2008-11#1)
substantial reductions in##4##3##(1992-2#1)(2008-10#1)(2011-3#1)(2012-3#1)
substantial savings in##2##3##(1993-3#1)(2008-3#1)
substantial suppression of##2##3##(2007-11#1)(2008-1#1)
substantial uncertainty##2##2##(2011-2#2)
substantial variation in##4##3##(1992-12#1)(1995-6#1)(2008-10#1)(2010-3#1)
substantial variations##2##2##(1991-1#1)(1997-1#1)
substantial##330##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#13)(2008-12#7)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#14)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#7)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#13)(2013-8#9)
substantially affect##2##2##(2007-11#1)(2012-2#1)
substantially affected by the##2##4##(1990-8#1)(2008-10#1)
substantially affected by##3##3##(1990-8#1)(2008-10#1)(2012-3#1)
substantially alter##4##2##(1993-12#1)(1995-1#1)(2010-3#1)(2012-1#1)
substantially altered##2##2##(1997-3#1)(2008-10#1)
substantially at##2##2##(1990-5#1)(2008-9#1)
substantially better results than##2##4##(1991-6#1)(2007-12#1)
substantially better##4##2##(1991-6#1)(2007-12#2)(2011-2#1)
substantially between##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
substantially by##2##2##(1992-6#1)(2008-3#1)
substantially decreased##5##2##(1992-2#1)(1992-5#1)(1995-11#1)(2008-4#1)(2009-10#1)
substantially delayed##2##2##(1997-3#2)
substantially different from##2##3##(1992-12#1)(2007-11#1)
substantially different##4##2##(1992-12#1)(2007-11#1)(2008-10#1)(2009-12#1)
substantially during the##2##3##(2008-3#1)(2009-3#1)
substantially from those##2##3##(1994-1#1)(2008-7#1)
substantially from##9##2##(1994-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
substantially greater than##3##3##(1994-3#1)(2008-2#1)(2010-10#1)
substantially greater##5##2##(1994-3#1)(1996-12#1)(2008-2#1)(2010-10#1)(2012-12#1)
substantially high##2##2##(2007-12#1)(2008-10#1)
substantially higher than those in##2##5##(1995-8#1)(2008-6#1)
substantially higher than those##3##4##(1995-8#1)(2008-6#1)(2011-1#1)
substantially higher than##4##3##(1995-8#1)(2008-6#1)(2011-1#1)(2012-2#1)
substantially higher##10##2##(1993-1#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
substantially improve the performance of##2##5##(2007-12#1)(2008-10#1)
substantially improve the performance##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
substantially improve##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
substantially improved and##2##3##(1992-3#1)(2008-3#1)
substantially improved##7##2##(1992-3#1)(1993-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
substantially improves the##2##3##(2007-11#2)
substantially in recent##2##3##(1994-6#1)(2012-2#1)
substantially in##5##2##(1994-6#1)(2008-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
substantially increase the##3##3##(2007-12#1)(2007-8#1)(2008-8#1)
substantially increased##8##2##(1992-8#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#2)(2013-8#1)
substantially increases the##3##3##(1992-9#1)(2007-11#1)(2008-2#1)
substantially increases##4##2##(1992-9#1)(2007-11#1)(2008-2#1)(2008-8#1)
substantially influence the aging process##2##5##(1994-6#1)(2009-12#1)
substantially influence##3##2##(1994-6#1)(1996-3#1)(2009-12#1)
substantially inhibited##2##2##(1995-2#1)(2008-6#1)
substantially less##5##2##(1994-5#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-3#1)
substantially lower than##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
substantially lower##10##2##(1993-12#1)(1993-3#2)(1994-6#1)(1995-5#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-3#1)
substantially more##4##2##(1990-12#1)(1993-12#1)(2008-10#2)
substantially normal##2##2##(1991-2#1)(2009-2#1)
substantially on##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
substantially reduce the##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
substantially reduced##14##2##(1991-12#1)(1994-3#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
substantially reduces the##2##3##(1995-2#1)(2008-6#1)
substantially reduces##3##2##(1995-2#1)(2008-3#1)(2008-6#1)
substantially reducing##2##2##(1992-9#1)(2008-10#1)
substantially the##5##2##(1993-3#1)(1994-9#1)(2008-8#1)(2011-2#1)(2012-2#1)
substantially to the##3##3##(1991-8#1)(1997-2#1)(2008-3#1)
substantially to##6##2##(1991-8#1)(1997-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)
substantially with##2##2##(1991-3#1)(1994-6#1)
substantially##245##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-3#3)(1993-8#1)(1994-1#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-7#1)(2007-8#3)(2008-10#31)(2008-11#6)(2008-2#11)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#13)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#5)(2013-8#3)
substantiate the##6##2##(1992-12#1)(2008-11#2)(2008-7#2)(2009-9#1)
substantiate##10##1##(1992-12#1)(1992-5#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2012-12#1)
substantiated by##9##2##(1990-5#1)(1994-11#1)(1994-2#1)(1995-3#1)(2007-12#1)(2008-10#4)
substantiated with##2##2##(2008-5#1)(2010-5#1)
substantiated##18##1##(1990-5#1)(1991-10#1)(1992-11#1)(1994-11#1)(1994-2#1)(1995-3#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-2#1)(2010-5#1)(2012-2#1)
substantiates the##4##2##(1994-12#1)(2008-10#2)(2009-3#1)
substantiates##6##1##(1991-2#1)(1994-12#1)(2008-10#2)(2008-8#1)(2009-3#1)
substantiating##2##1##(2008-10#1)(2009-3#1)
substantive##9##1##(1996-1#1)(1996-3#1)(2007-10#2)(2008-1#1)(2008-5#1)(2009-11#1)(2009-12#1)(2013-1#1)
substantively##3##1##(2011-1#1)(2013-1#2)
substantivity to##2##2##(2008-5#2)
substantivity##8##1##(2008-5#8)
substituent at the##3##3##(1995-2#1)(1995-3#1)(2009-8#1)
substituent at##4##2##(1995-2#1)(1995-3#1)(1996-5#1)(2009-8#1)
substituent effects##2##2##(2007-11#1)(2009-5#1)
substituent in the##2##3##(2007-11#1)(2008-10#1)
substituent in##3##2##(2007-11#1)(2008-10#2)
substituent is##3##2##(1995-3#1)(1996-5#1)(2008-10#1)
substituent of##4##2##(1992-11#1)(1996-2#2)(2010-11#1)
substituent on the##2##3##(1992-6#1)(2007-11#1)
substituent on##3##2##(1991-5#1)(1992-6#1)(2007-11#1)
substituent to##2##2##(1995-3#1)(1996-2#1)
substituent was##2##2##(2008-10#2)
substituent##43##1##(1991-5#1)(1992-11#1)(1992-6#1)(1994-5#1)(1995-2#3)(1995-3#6)(1996-2#4)(1996-5#3)(2007-11#5)(2007-12#1)(2008-10#10)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-8#1)(2012-3#1)
substituent's##2##1##(2008-10#2)
substituents and##2##2##(2007-11#1)(2008-3#1)
substituents are##2##2##(1993-12#1)(2008-10#1)
substituents at the##2##3##(1995-3#1)(2009-10#1)
substituents at##3##2##(1995-3#1)(2009-10#2)
substituents in the##3##3##(1990-11#1)(1995-5#2)
substituents in##7##2##(1990-11#1)(1992-8#1)(1995-5#2)(2008-10#2)(2010-5#1)
substituents is##2##2##(2007-11#1)(2009-7#1)
substituents on the##3##3##(1992-8#1)(2009-10#1)(2009-9#1)
substituents##46##1##(1990-11#1)(1991-5#1)(1992-11#1)(1992-8#2)(1993-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#3)(1996-2#3)(1996-5#2)(1997-7#3)(2006-12#1)(2007-11#5)(2008-10#6)(2008-3#1)(2008-4#1)(2009-10#3)(2009-5#1)(2009-7#1)(2009-9#3)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
substitutable##3##1##(1996-3#1)(2008-8#2)
substitute for a##2##3##(2008-10#1)(2008-3#1)
substitute for inpatient##2##3##(1991-1#1)(1996-3#1)
substitute for soybean meal##2##4##(2012-2#2)
substitute for the##7##3##(1993-3#1)(1993-9#1)(1995-11#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
substitute for##43##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-11#2)(1995-2#4)(1995-3#1)(1996-3#2)(1997-7#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#1)
substitute the##5##2##(1997-2#1)(2008-11#2)(2008-8#1)(2010-11#1)
substitute##71##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-2#4)(1995-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
substituted amino acid##2##3##(1996-5#1)(2011-2#1)
substituted aromatic##2##2##(2008-10#1)(2011-1#1)
substituted at position##5##3##(1992-6#2)(1994-11#1)(1996-5#1)(1997-6#1)
substituted at##7##2##(1992-6#2)(1994-11#1)(1995-2#2)(1996-5#1)(1997-6#1)
substituted benzamides##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
substituted benzenes##2##2##(2008-10#2)
substituted by a##3##3##(1992-8#1)(1996-9#1)(2008-10#1)
substituted by##14##2##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1995-6#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-8#2)
substituted consent##3##2##(1995-2#3)
substituted for the##6##3##(1990-12#2)(2007-12#1)(2008-10#2)(2008-2#1)
substituted for##16##2##(1990-12#2)(1990-2#1)(1992-6#1)(1993-8#1)(1994-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2011-2#3)
substituted in the##4##3##(1992-6#1)(1997-2#1)(2008-4#1)(2008-7#1)
substituted in##5##2##(1992-6#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#1)
substituted into##2##2##(2008-10#1)(2008-3#1)
substituted or##2##2##(2008-10#1)(2008-2#1)
substituted the##2##2##(1994-8#1)(2008-8#1)
substituted with a##6##3##(1992-6#1)(1993-6#1)(1994-5#1)(1995-11#1)(2008-10#1)(2009-5#1)
substituted with the##2##3##(2008-10#1)(2011-2#1)
substituted with##15##2##(1992-6#2)(1993-6#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(2008-10#4)(2009-5#1)(2009-6#1)(2009-9#1)(2011-2#1)
substituted##149##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#7)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#3)(1996-2#2)(1996-5#7)(1996-9#1)(1997-2#3)(1997-6#2)(1997-7#1)(2006-12#1)(2006-4#1)(2007-11#9)(2007-12#1)(2008-10#33)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#11)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#5)(2010-11#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#5)(2012-3#1)
substitutes are##2##2##(1991-11#1)(2008-7#1)
substitutes for##9##2##(1992-3#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#2)
substitutes in##2##2##(1994-3#1)(2008-11#1)
substitutes the##2##2##(1994-12#1)(2008-10#1)
substitutes##35##1##(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#2)(1994-12#1)(1994-3#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#7)(2008-7#2)(2008-8#5)(2008-9#1)(2009-7#2)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#2)
substituting the##4##2##(1997-4#1)(2008-10#2)(2012-3#1)
substituting##21##1##(1990-2#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(1997-4#1)(2008-10#5)(2008-5#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
substitution abolished the##2##3##(1995-3#1)(1995-5#1)
substitution abolished##3##2##(1995-3#1)(1995-5#2)
substitution and##7##2##(1990-7#1)(1991-7#1)(1994-6#1)(2008-7#2)(2008-9#1)(2011-1#1)
substitution at position##2##3##(1992-8#1)(2006-6#1)
substitution at##8##2##(1992-6#1)(1992-8#1)(1993-12#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)
substitution by##2##2##(1992-3#2)
substitution for ethanol##2##3##(1997-7#2)
substitution for##3##2##(1997-7#2)(2008-4#1)
substitution gradients##2##2##(2010-3#2)
substitution has##2##2##(1990-12#1)(2008-10#1)
substitution in the##11##3##(1991-1#1)(1991-2#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#3)(2008-6#1)(2008-9#1)
substitution in##19##2##(1990-11#1)(1991-1#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-6#1)(2008-9#2)(2010-4#1)
substitution is##3##2##(1993-11#1)(2008-2#1)(2008-9#1)
substitution line##10##2##(2008-10#7)(2008-5#1)(2008-8#2)
substitution lines##3##2##(2008-10#3)
substitution mutant##2##2##(1991-2#1)(2008-10#1)
substitution of a##5##3##(1991-12#1)(1993-3#1)(1993-8#1)(2008-10#1)(2011-2#1)
substitution of lysine for##2##4##(1991-8#2)
substitution of one of the##2##5##(1995-5#1)(2009-9#1)
substitution of one##3##3##(1995-5#1)(1997-7#1)(2009-9#1)
substitution of the##11##3##(1990-12#1)(1990-8#1)(1993-11#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)
substitution of##61##2##(1990-12#5)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#2)(1994-11#4)(1994-5#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)
substitution on##4##2##(1992-12#1)(2008-10#1)(2008-8#2)
substitution pattern##4##2##(1995-3#1)(1996-5#1)(2008-10#2)
substitution process##4##2##(1991-2#3)(2010-3#1)
substitution rates##3##2##(1997-6#1)(2008-8#1)(2010-3#1)
substitution reaction in metallic complex##2##5##(2008-10#2)
substitution reaction##6##2##(1990-8#1)(2008-10#4)(2008-6#1)
substitution results in##2##3##(1993-6#1)(2008-10#1)
substitution that##2##2##(1990-8#1)(1994-6#1)
substitution therapy##4##2##(1996-8#1)(2012-1#2)(2013-8#1)
substitution to##2##2##(1992-3#1)(2008-4#1)
substitution was##3##2##(1992-6#1)(1993-3#1)(1993-8#1)
substitution were##2##2##(2008-10#1)(2008-7#1)
substitution with##2##2##(2008-10#1)(2011-1#1)
substitution within the##2##3##(1991-2#1)(2008-10#1)
substitution##243##1##(1990-11#2)(1990-12#6)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#5)(1991-2#7)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#6)(1992-4#1)(1992-6#3)(1992-8#2)(1993-11#4)(1993-12#2)(1993-3#5)(1993-6#3)(1993-8#4)(1994-1#1)(1994-11#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#1)(1995-2#1)(1995-3#3)(1995-5#5)(1995-6#2)(1995-8#2)(1996-2#4)(1996-5#4)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#7)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#45)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#13)(2008-9#6)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#1)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
substitutional##2##1##(2008-10#1)(2009-3#1)
substitutions and##7##2##(1993-11#1)(1994-5#1)(1995-6#2)(2008-10#1)(2008-4#1)(2008-8#1)
substitutions are##3##2##(1996-5#1)(1997-9#1)(2013-1#1)
substitutions at the##4##3##(1994-9#1)(1995-3#1)(2008-4#1)(2009-3#1)
substitutions at##14##2##(1990-8#1)(1993-11#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-4#2)(2009-3#1)
substitutions between##3##2##(1993-6#1)(2008-6#1)(2009-8#1)
substitutions for##2##2##(1993-11#1)(2008-7#1)
substitutions in the##6##3##(1991-2#1)(1991-6#1)(1993-6#1)(2008-10#2)(2013-8#1)
substitutions in##14##2##(1990-11#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-10#2)(2008-8#2)(2008-9#1)(2011-1#1)(2013-8#1)
substitutions of##7##2##(1992-3#1)(1992-6#2)(1995-5#1)(2008-10#1)(2008-6#1)(2010-5#1)
substitutions on the##4##3##(1990-8#1)(1994-11#1)(1994-8#1)(1995-2#1)
substitutions that##2##2##(1990-8#1)(2011-1#1)
substitutions were##4##2##(1993-2#1)(1997-9#1)(2008-10#1)(2008-5#1)
substitutions##105##1##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#7)(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(1997-9#3)(2007-11#1)(2008-10#11)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-8#2)(2010-4#2)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#5)(2013-8#1)
substitutive hormonal##2##2##(1991-11#1)(1993-2#1)
substitutive noise##3##2##(2008-3#3)
substitutive therapy##2##2##(2013-1#2)
substitutive##8##1##(1991-11#1)(1992-3#1)(1993-2#1)(2008-3#3)(2013-1#2)
substoichiometric##2##1##(2008-10#2)
substomatal chambers##2##2##(2008-10#2)
substomatal##4##1##(2008-10#4)
substrain##3##1##(1995-8#2)(2008-6#1)
substrains##2##1##(1993-3#1)(2008-7#1)
substrata and##2##2##(1994-8#2)
substrata for##2##2##(2008-5#1)(2010-8#1)
substrata##13##1##(1992-9#1)(1994-8#6)(2008-10#2)(2008-5#2)(2008-7#1)(2010-8#1)
substrate (Km##2##2##(1992-3#1)(1992-9#1)
substrate (e##3##2##(2008-10#1)(2008-5#1)(2010-6#1)
substrate (i##2##2##(1990-5#1)(2008-3#1)
substrate (kcat/Km =##2##3##(1992-12#1)(1994-5#1)
substrate RC3/neurogranin##2##2##(1997-2#2)
substrate affinities##2##2##(1995-2#1)(1995-6#1)
substrate analog##4##2##(1990-8#2)(1994-9#1)(1997-4#1)
substrate analogue##4##2##(1992-5#1)(1992-6#1)(1993-11#1)(2008-4#1)
substrate analogues##2##2##(1990-5#1)(2009-9#1)
substrate and a##3##3##(1990-2#1)(1992-11#1)(2010-2#1)
substrate and an##3##3##(1990-7#1)(1991-5#1)(2008-10#1)
substrate and metabolite##2##3##(1991-3#1)(2008-11#1)
substrate and product##2##3##(1994-5#1)(2008-6#1)
substrate and the##5##3##(1994-5#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-8#1)
substrate and##56##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-8#3)(1994-5#3)(1994-6#1)(1995-2#3)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
substrate are##7##2##(1992-3#1)(2007-12#1)(2008-2#2)(2008-3#3)
substrate as##3##2##(1995-2#1)(2008-10#1)(2008-2#1)
substrate assisted##2##2##(1995-3#2)
substrate at the##2##3##(1991-9#1)(2011-2#1)
substrate at##7##2##(1991-9#1)(1997-4#1)(2008-10#2)(2008-3#1)(2011-2#2)
substrate binding and##3##3##(1993-8#1)(1995-5#1)(2009-9#1)
substrate binding is##2##3##(1994-8#1)(1995-6#1)
substrate binding site##3##3##(1992-11#1)(1992-3#1)(1994-5#1)
substrate binding##22##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-5#4)(1994-8#1)(1995-5#2)(1995-6#2)(1997-2#1)(2008-4#1)(2009-9#1)
substrate by a##2##3##(2008-2#2)
substrate by use of##2##4##(2007-11#1)(2008-3#1)
substrate by##13##2##(1990-8#1)(1992-3#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
substrate can##2##2##(2007-11#1)(2008-11#1)
substrate colonization##3##2##(2008-10#3)
substrate concentration and##2##3##(2008-7#1)(2010-10#1)
substrate concentration##11##2##(1992-3#1)(1995-11#1)(2008-5#2)(2008-6#2)(2008-7#4)(2010-10#1)
substrate concentrations##11##2##(1990-5#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2011-1#1)
substrate consumption rate##2##3##(2008-7#2)
substrate consumption##8##2##(2008-11#1)(2008-7#7)
substrate containing##2##2##(1991-12#1)(1992-3#1)
substrate conversion##3##2##(2008-6#2)(2008-7#1)
substrate deprivation and simulated ischemia##2##5##(1994-2#2)
substrate discrimination##2##2##(2011-1#2)
substrate during##4##2##(1992-3#1)(2008-2#1)(2008-5#1)(2008-7#1)
substrate exposed to##2##3##(2008-10#1)(2008-11#1)
substrate for a##2##3##(1992-1#1)(1995-5#1)
substrate for both##2##3##(1994-11#1)(2012-2#1)
substrate for producing##2##3##(2008-6#1)(2008-7#1)
substrate for protein##4##3##(1994-11#1)(1995-11#1)(2008-7#1)(2009-9#1)
substrate for the preparation of##2##5##(2008-10#2)
substrate for the##16##3##(1990-5#1)(1991-5#4)(1992-9#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-6#1)(2008-10#6)
substrate for tyrosine##2##3##(1992-7#1)(1993-9#1)
substrate for##70##2##(1990-5#1)(1991-5#6)(1991-9#2)(1992-1#1)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
substrate has##2##2##(1995-5#1)(2008-7#1)
substrate hydrolysis##2##2##(1990-8#1)(1993-8#1)
substrate in a##3##3##(1990-5#1)(1995-2#1)(2011-2#1)
substrate in an##2##3##(1993-8#1)(1995-2#1)
substrate in the##8##3##(1990-10#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2013-1#1)
substrate in##22##2##(1990-10#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-5#2)(1995-2#2)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
substrate inhibition in ATCase##2##4##(1997-2#2)
substrate inhibition in##3##3##(1997-2#2)(2008-7#1)
substrate inhibition##15##2##(1991-12#1)(1992-3#1)(1992-6#1)(1997-2#9)(2008-6#1)(2008-7#2)
substrate into##4##2##(1990-5#1)(1994-11#2)(1994-6#1)
substrate is made##2##3##(2008-3#1)(2012-2#1)
substrate is rotated##2##3##(2008-3#2)
substrate is##25##2##(1992-11#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#6)(2012-2#1)(2012-3#1)
substrate levels##2##2##(1996-8#2)
substrate luciferin##2##2##(1997-4#1)(2008-10#1)
substrate material for##2##3##(2008-10#1)(2008-3#1)
substrate material##4##2##(2008-10#2)(2008-3#2)
substrate materials##2##2##(2008-3#2)
substrate metabolism##2##2##(1997-8#1)(2012-3#1)
substrate molecule##3##2##(1992-3#1)(1995-5#1)(2008-11#1)
substrate molecules and##2##3##(1992-3#2)
substrate molecules##5##2##(1992-3#5)
substrate of protein kinase C##3##5##(1990-11#1)(1990-5#1)(1992-6#1)
substrate of the##3##3##(1994-12#1)(1994-8#1)(2008-10#1)
substrate of##24##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
substrate on##3##2##(2007-11#1)(2008-5#1)(2010-4#1)
substrate or product##2##3##(1995-5#1)(2008-7#1)
substrate or##8##2##(1993-6#1)(1995-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)
substrate oxidation##2##2##(2008-7#1)(2009-11#1)
substrate properties of##2##3##(1994-8#2)
substrate properties##3##2##(1994-8#2)(2008-3#1)
substrate protein##2##2##(1990-10#1)(2008-4#1)
substrate proteins##3##2##(1995-2#1)(2009-6#1)(2009-7#1)
substrate ranges##2##2##(1994-12#1)(2011-2#1)
substrate reaction##2##2##(1990-8#1)(1992-3#1)
substrate reactivity##4##2##(2008-7#4)
substrate recognition by##3##3##(1992-3#1)(1995-6#1)(2007-11#1)
substrate recognition##6##2##(1992-3#1)(1992-6#1)(1995-6#1)(1997-4#2)(2007-11#1)
substrate recycling##2##2##(2008-10#2)
substrate resulted in a##2##4##(2011-2#2)
substrate roughness##3##2##(2008-2#1)(2008-3#2)
substrate samples##4##2##(2008-10#1)(2008-3#3)
substrate showed##2##2##(1992-3#1)(2008-7#1)
substrate solution##4##2##(2008-10#2)(2008-4#2)
substrate specificities and##2##3##(2010-3#1)(2011-2#1)
substrate specificities of monoamine oxidase##2##5##(1991-12#2)
substrate specificities of##3##3##(1991-12#2)(1994-12#1)
substrate specificities##9##2##(1991-12#2)(1994-12#1)(1995-2#1)(2008-4#2)(2010-3#2)(2011-2#1)
substrate specificity and##5##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-9#1)
substrate specificity for##3##3##(1994-11#1)(1997-4#1)(2007-11#1)
substrate specificity of the##4##4##(1992-3#1)(1992-8#1)(1995-2#1)(1996-2#1)
substrate specificity of##12##3##(1990-11#1)(1990-5#1)(1990-8#2)(1992-3#1)(1992-8#1)(1995-2#1)(1996-2#1)(2008-4#1)(2008-7#2)(2013-1#1)
substrate specificity##45##2##(1990-11#2)(1990-5#3)(1990-7#1)(1990-8#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1994-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#2)(2007-11#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#5)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
substrate syntide 2##2##3##(1993-6#1)(1994-8#1)
substrate temperature##5##2##(2008-2#1)(2008-3#4)
substrate temperatures##2##2##(2008-3#2)
substrate than##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
substrate that##3##2##(1992-11#1)(1993-3#1)(2008-3#1)
substrate thickness##2##2##(2008-2#2)
substrate thicknesses##2##2##(2008-2#1)(2008-3#1)
substrate through##2##2##(2008-3#1)(2008-5#1)
substrate to a##3##3##(1994-8#1)(1996-8#1)(2009-5#1)
substrate to form a##2##4##(2008-10#2)
substrate to form##4##3##(1996-12#1)(2008-10#2)(2013-8#1)
substrate to##24##2##(1991-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-8#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2009-5#1)(2013-1#1)(2013-8#1)
substrate transport##2##2##(1990-11#1)(2008-11#1)
substrate turnover##2##2##(2008-12#1)(2008-6#1)
substrate types##2##2##(2008-9#1)(2009-2#1)
substrate uptake##5##2##(1992-6#2)(2008-7#3)
substrate used##2##2##(2008-10#2)
substrate using##5##2##(2008-10#1)(2008-11#2)(2010-12#1)(2013-1#1)
substrate utilisation##2##2##(2008-10#2)
substrate utilization and##2##3##(2008-10#1)(2008-7#1)
substrate utilization in##2##3##(2008-8#1)(2010-8#1)
substrate utilization patterns##3##3##(2008-10#2)(2008-7#1)
substrate utilization##12##2##(2008-10#7)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)
substrate was 5##2##3##(2008-2#1)(2008-6#1)
substrate was##17##2##(1990-10#1)(1990-7#1)(1993-3#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2011-1#1)
substrate were##2##2##(2008-10#1)(2013-1#1)
substrate will give##2##3##(2008-5#1)(2009-7#1)
substrate with a##4##3##(1991-12#1)(2007-11#1)(2008-3#2)
substrate with the##2##3##(2008-10#1)(2013-1#1)
substrate with##14##2##(1990-7#1)(1991-12#1)(1996-5#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
substrate within##3##2##(1993-1#1)(2008-10#1)(2008-4#1)
substrate##1025##1##(1990-10#5)(1990-11#7)(1990-12#3)(1990-2#3)(1990-5#18)(1990-7#8)(1990-8#12)(1990-9#3)(1991-12#12)(1991-2#1)(1991-3#1)(1991-5#18)(1991-6#2)(1991-8#1)(1991-9#10)(1992-1#1)(1992-11#8)(1992-12#5)(1992-3#34)(1992-5#1)(1992-6#14)(1992-7#2)(1992-8#7)(1992-9#6)(1993-1#1)(1993-11#9)(1993-12#2)(1993-3#6)(1993-5#1)(1993-6#6)(1993-8#16)(1993-9#1)(1994-11#8)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#23)(1994-6#3)(1994-8#12)(1994-9#5)(1995-11#3)(1995-12#1)(1995-2#33)(1995-3#4)(1995-5#10)(1995-6#11)(1995-8#2)(1996-12#5)(1996-2#3)(1996-5#3)(1996-8#4)(1997-1#1)(1997-2#20)(1997-3#2)(1997-4#7)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#18)(2007-12#20)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#143)(2008-11#32)(2008-12#5)(2008-2#29)(2008-3#91)(2008-4#25)(2008-5#23)(2008-6#21)(2008-7#78)(2008-8#4)(2008-9#2)(2009-11#7)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#7)(2009-9#7)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#14)(2011-2#22)(2012-12#1)(2012-2#19)(2012-3#4)(2013-1#16)(2013-8#2)
substrate)##5##1##(1991-9#1)(1992-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
substrate-GFP fusion protein##2##3##(2008-4#2)
substrate-binding domain##2##2##(1991-9#1)(2008-6#1)
substrate-binding##8##1##(1991-9#1)(1992-6#1)(1992-8#2)(1995-3#3)(2008-6#1)
substrate-bound##2##1##(1994-5#2)
substrate-induced##2##1##(1992-12#1)(1993-3#1)
substrate-reduced trimethylamine dehydrogenase##2##3##(1995-2#2)
substrate/product##6##1##(1995-5#6)
substrates and cofactors##2##3##(2008-10#2)
substrates and electrolytes##2##3##(2008-10#2)
substrates and inhibitors##4##3##(1991-5#1)(1994-8#2)(1995-8#1)
substrates and products##2##3##(1991-3#1)(2008-4#1)
substrates and the##4##3##(1992-3#1)(1992-6#1)(1993-9#1)(2008-3#1)
substrates and##44##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)
substrates and/or##4##2##(1992-8#1)(2008-4#1)(2009-2#2)
substrates are##13##2##(1990-11#1)(1993-3#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)
substrates as##5##2##(1990-7#1)(1995-2#1)(2007-12#1)(2008-3#1)(2013-1#1)
substrates at##4##2##(1990-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
substrates because of##2##3##(2008-11#1)(2008-2#1)
substrates by the##2##3##(1990-8#1)(2008-2#1)
substrates by thermolysin##2##3##(1994-5#2)
substrates by##15##2##(1990-8#2)(1992-8#1)(1994-5#2)(1995-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2012-2#1)
substrates capable of##2##3##(1990-5#1)(1994-5#1)
substrates containing##5##2##(1992-3#1)(1994-5#1)(1995-5#1)(2007-11#1)(2013-1#1)
substrates for the##8##3##(1990-2#2)(1994-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#1)
substrates for##54##2##(1990-2#2)(1991-2#2)(1991-5#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#4)(1995-3#1)(1995-8#1)(1996-12#1)(1997-3#2)(2007-11#2)(2008-10#8)(2008-3#2)(2008-7#3)(2008-8#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
substrates have been##3##3##(2008-3#1)(2008-4#1)(2010-4#1)
substrates have##4##2##(1992-11#1)(2008-3#1)(2008-4#1)(2010-4#1)
substrates in a##4##3##(1994-5#2)(2008-7#2)
substrates in cactophilic Drosophila mojavensis##2##5##(2008-8#1)(2008-9#1)
substrates in human##2##3##(1992-9#1)(1993-12#1)
substrates in the##7##3##(1991-5#2)(1993-6#2)(2008-10#1)(2008-3#1)(2008-7#1)
substrates in##30##2##(1990-9#1)(1991-5#3)(1992-10#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-5#2)(1996-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#1)(2013-1#1)
substrates is of##2##3##(2008-7#1)(2012-3#1)
substrates is##10##2##(1990-7#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-7#3)(2011-1#1)(2012-3#1)
substrates of the##5##3##(1992-12#1)(1994-9#1)(1997-2#1)(2008-10#2)
substrates of##21##2##(1992-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-9#1)(2012-2#1)
substrates on the##2##3##(2008-3#1)(2010-3#1)
substrates on##3##2##(1992-11#1)(2008-3#1)(2010-3#1)
substrates or inhibitors of##2##4##(2009-2#1)(2012-3#1)
substrates or##6##2##(1994-5#1)(2008-2#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-3#1)
substrates should be##2##3##(1992-3#1)(2008-7#1)
substrates such as glucose##2##4##(2008-10#1)(2011-1#1)
substrates such as##8##3##(1990-12#1)(1990-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#1)
substrates tested##4##2##(1992-11#1)(2008-10#2)(2008-11#1)
substrates that are##4##3##(1996-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
substrates that can##2##3##(1995-5#1)(2008-10#1)
substrates that##10##2##(1995-5#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-2#1)
substrates through##2##2##(2009-5#1)(2012-12#1)
substrates to produce##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
substrates to the##2##3##(1994-5#1)(1994-6#1)
substrates to##12##2##(1991-5#1)(1992-8#1)(1994-5#3)(1994-6#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)
substrates up to##2##3##(2008-2#1)(2008-3#1)
substrates used##2##2##(1994-8#1)(2007-12#1)
substrates via##2##2##(2009-11#1)(2010-4#1)
substrates was##6##2##(1992-6#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
substrates were &quot##2##3##(1991-9#2)
substrates were prepared by##2##4##(2007-11#1)(2007-12#1)
substrates were tested##2##3##(2008-11#1)(2011-2#1)
substrates were##17##2##(1991-9#2)(1992-6#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)
substrates with##8##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-7#1)(2012-1#1)
substrates##545##1##(1990-10#1)(1990-11#7)(1990-12#1)(1990-2#2)(1990-5#8)(1990-7#8)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#9)(1991-8#1)(1991-9#16)(1992-10#3)(1992-11#6)(1992-12#3)(1992-3#10)(1992-5#1)(1992-6#12)(1992-8#11)(1992-9#4)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#5)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#24)(1994-6#4)(1994-8#13)(1994-9#3)(1995-2#3)(1995-3#1)(1995-5#6)(1995-6#3)(1995-8#2)(1996-12#7)(1996-2#1)(1996-5#5)(1996-9#1)(1997-2#3)(1997-3#4)(1997-7#2)(2006-6#1)(2007-11#12)(2007-12#13)(2008-1#2)(2008-10#79)(2008-11#16)(2008-12#1)(2008-2#23)(2008-3#36)(2008-4#13)(2008-5#7)(2008-6#6)(2008-7#31)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#5)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#6)(2013-8#1)
substrates)##2##1##(1990-11#1)(2012-2#1)
substratum and##2##2##(2007-5#1)(2008-11#1)
substratum##9##1##(1990-12#1)(1994-8#1)(1995-8#1)(2007-5#1)(2008-11#4)(2008-9#1)
substructure and##2##2##(2008-12#1)(2013-1#1)
substructure##8##1##(2007-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
substructures##2##1##(2007-12#1)(2008-3#1)
substructuring##2##1##(2008-10#2)
substudy##3##1##(2008-3#2)(2009-5#1)
subsurface defects##2##2##(2008-2#2)
subsurface drip irrigation##7##3##(2008-10#7)
subsurface drip##9##2##(2008-10#9)
subsurface soil##2##2##(2008-10#2)
subsurface water##3##2##(2007-5#1)(2009-8#2)
subsurface##29##1##(1997-5#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-10#12)(2008-2#5)(2008-3#3)(2008-8#1)(2009-8#2)
subsurface-drip irrigation##5##2##(2008-10#5)
subsurface-drip##6##1##(2008-10#6)
subsynovial connective tissue##4##3##(2008-9#4)
subsynovial##5##1##(2008-9#4)(2009-3#1)
subsystem is based on##2##4##(2008-10#1)(2008-3#1)
subsystem##10##1##(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#4)
subsystems and the analysis of##2##5##(2008-11#2)
subsystems and##4##2##(2008-11#2)(2008-2#1)(2012-1#1)
subsystems##14##1##(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#2)(2010-8#1)(2012-1#1)
subtalar dislocation##3##2##(2008-12#2)(2010-3#1)
subtalar joint##4##2##(2010-3#1)(2012-2#3)
subtalar##11##1##(2008-12#3)(2009-10#1)(2010-3#3)(2012-2#4)
subtelocentric##2##1##(2010-3#2)
subtelomere##3##1##(1996-3#1)(2008-9#1)(2009-10#1)
subtelomeric DNA sequence probe were observed at the telomeres of HSA##2##11##(1997-6#2)
subtelomeric DNA##5##2##(1991-7#1)(1997-6#4)
subtelomeric region##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
subtelomeric repeat##2##2##(1997-6#2)
subtelomeric##13##1##(1991-7#2)(1997-6#6)(2008-10#1)(2009-10#1)(2009-5#2)(2012-3#1)
subtemporal##3##1##(2008-7#2)(2008-8#1)
subtending##2##1##(2008-10#1)(2009-8#1)
subterahertz##2##1##(2007-11#2)
subterminal##2##1##(1995-8#1)(2008-5#1)
subterranea f##8##2##(2008-10#8)
subterranea##14##1##(2008-10#14)
subterranea-specific##2##1##(2008-10#2)
subterranean termite##3##2##(2009-5#1)(2011-2#2)
subterranean termites (Isoptera##2##3##(2011-2#2)
subterranean termites##3##2##(2009-5#1)(2011-2#2)
subterranean##12##1##(2008-10#2)(2009-5#2)(2011-2#5)(2012-3#3)
subterraneus##3##1##(2012-3#3)
subtests##4##1##(1995-11#1)(2008-9#1)(2009-10#1)(2012-3#1)
subtext##2##1##(2007-11#2)
subthalamic nuclei##2##2##(1996-12#2)
subthalamic nucleus in##2##3##(2008-12#1)(2008-2#1)
subthalamic nucleus##6##2##(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)
subthalamic##9##1##(1996-12#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-2#1)
subthemes##2##1##(2012-3#1)(2013-1#1)
subthreshold##9##1##(1990-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-6#2)(2009-8#1)(2010-5#1)(2011-1#1)
subtidal##3##1##(2008-5#1)(2013-7#2)
subtilis GB03##2##2##(2008-10#2)
subtilis MBI 600##4##3##(2008-10#4)
subtilis and##10##2##(1991-9#2)(1994-8#1)(1995-3#1)(1996-6#1)(1997-2#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
subtilis cells##3##2##(2008-6#2)(2009-8#1)
subtilis cloning##2##2##(1991-9#2)
subtilis genome##6##2##(1995-12#2)(1996-8#2)(1997-7#1)(2008-7#1)
subtilis of a##3##3##(1990-11#1)(1991-6#2)
subtilis strains were##2##3##(1995-8#1)(2011-2#1)
subtilis strains##4##2##(1995-8#1)(2008-10#2)(2011-2#1)
subtilis##102##1##(1990-11#6)(1990-12#3)(1991-5#1)(1991-6#2)(1991-9#5)(1992-3#1)(1993-12#3)(1993-6#2)(1993-9#1)(1994-12#5)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-6#1)(1996-8#2)(1997-2#3)(1997-4#2)(1997-7#2)(2007-11#1)(2008-10#19)(2008-11#1)(2008-3#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-3#2)(2011-1#3)(2011-2#5)(2012-2#1)
subtilis)##4##1##(2008-10#3)(2008-5#1)
subtilisin Carlsberg##3##2##(1994-6#1)(2008-7#2)
subtilisin E##3##2##(1992-11#1)(2009-7#2)
subtilisin##20##1##(1992-11#2)(1992-4#1)(1992-8#1)(1993-8#3)(1994-5#1)(1994-6#2)(1995-3#2)(2008-7#5)(2009-7#2)(2011-2#1)
subtle alterations##2##2##(1991-2#1)(1996-12#1)
subtle and##5##2##(1993-9#1)(1994-9#1)(1996-12#1)(2010-11#1)(2012-12#1)
subtle balance between##2##3##(2007-12#1)(2013-8#1)
subtle but##3##2##(1993-12#1)(1993-3#1)(2008-10#1)
subtle changes in the##3##4##(2007-8#1)(2011-2#1)(2012-1#1)
subtle changes in##6##3##(1993-8#1)(1994-9#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-1#1)
subtle changes##9##2##(1992-6#1)(1993-8#1)(1994-9#1)(1995-6#1)(2007-8#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-1#1)
subtle differences in the##3##4##(1992-8#1)(2008-5#1)(2008-6#1)
subtle differences in their##2##4##(2008-10#1)(2008-7#1)
subtle differences in##11##3##(1990-2#1)(1992-8#1)(1994-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-8#1)
subtle differences##15##2##(1990-2#1)(1992-8#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#2)(2010-3#1)(2012-1#1)(2013-8#1)
subtle genetic##2##2##(1994-12#1)(2009-12#1)
subtle variations##2##2##(2009-10#1)(2009-5#1)
subtle##78##1##(1990-2#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#5)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#2)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
subtleties##2##1##(1992-12#1)(2009-5#1)
subtotal and##2##2##(1990-6#1)(2008-7#1)
subtotal occlusion##2##2##(1997-3#1)(2013-1#1)
subtotal parathyroidectomy##3##2##(1991-5#1)(1993-3#2)
subtotal resection##2##2##(2008-7#1)(2011-2#1)
subtotal thyroidectomy##2##2##(2013-1#2)
subtotal vertebrectomy##2##2##(2008-7#2)
subtotal##29##1##(1990-6#2)(1991-5#2)(1991-8#2)(1993-3#2)(1994-12#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-7#7)(2008-8#1)(2009-7#1)(2010-12#2)(2011-2#2)(2013-1#3)
subtracted component##2##2##(2008-2#2)
subtracted fragments##2##2##(2008-10#2)
subtracted from the corresponding##2##4##(2008-10#1)(2008-5#1)
subtracted from the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
subtracted from##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
subtracted##15##1##(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-5#1)(2011-2#1)
subtracting the##7##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)
subtracting##12##1##(1992-3#1)(1995-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#3)(2009-12#1)
subtraction and odour detection##2##4##(2008-7#2)
subtraction and##4##2##(2008-3#1)(2008-7#3)
subtraction angiography##11##2##(1993-8#2)(2008-12#1)(2008-7#5)(2011-2#2)(2012-2#1)
subtraction images##2##2##(1995-4#2)
subtraction of the##4##3##(2008-3#3)(2013-8#1)
subtraction of these##2##3##(2007-11#1)(2008-5#1)
subtraction of##10##2##(2007-11#1)(2008-3#7)(2008-5#1)(2013-8#1)
subtraction##51##1##(1990-4#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-12#1)(1995-4#3)(1997-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#10)(2008-8#1)(2008-9#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-8#2)
subtractive enrichment of##2##3##(1995-12#2)
subtractive hybridization (SSH)##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
subtractive hybridization##11##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#2)(2008-9#1)(2010-4#1)
subtractive##21##1##(1990-11#1)(1995-11#1)(1995-12#2)(2008-10#3)(2008-11#2)(2008-2#5)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)
subtractor##3##1##(2008-3#3)
subtrochanteric femoral##3##2##(2013-1#3)
subtrochanteric##5##1##(2009-3#1)(2013-1#4)
subtropical##13##1##(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#2)(2010-5#1)(2013-1#2)
subtropics##4##1##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
subtype C##2##2##(2007-7#1)(2008-12#1)
subtype and a##2##3##(1995-12#1)(2013-1#1)
subtype and##5##2##(1995-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2013-1#1)
subtype family IIa##3##3##(2013-1#3)
subtype family IId##2##3##(2013-1#2)
subtype family##5##2##(2013-1#5)
subtype has a##2##3##(1992-8#1)(2008-2#1)
subtype has##3##2##(1992-8#1)(1993-3#1)(2008-2#1)
subtype in##2##2##(1991-11#1)(1993-12#1)
subtype is##6##2##(1993-12#2)(1993-3#1)(1995-11#1)(2007-12#1)(2008-2#1)
subtype of attention-deficit/hyperactivity disorder##2##4##(2008-2#2)
subtype of cystosarcoma phyllodes##2##4##(2011-3#2)
subtype of schizophrenia##2##3##(1996-7#1)(2008-3#1)
subtype of##35##2##(1992-8#1)(1993-11#1)(1993-12#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#3)(2013-1#1)
subtype was##3##2##(1991-9#1)(1996-5#1)(2007-10#1)
subtype were##2##2##(1993-12#1)(2013-8#1)
subtype##165##1##(1991-11#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-8#2)(1993-11#1)(1993-12#7)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#5)(1995-11#8)(1995-12#9)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#4)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#6)(2007-12#3)(2007-7#1)(2008-10#3)(2008-12#3)(2008-2#10)(2008-3#4)(2008-4#9)(2008-6#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#5)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#12)(2013-8#7)
subtype)##5##1##(1994-8#3)(1996-6#2)
subtype-selective##6##1##(1994-6#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
subtype-specific##2##1##(2007-10#1)(2008-4#1)
subtyped##2##1##(1994-2#2)
subtypes and##6##2##(1995-12#1)(1995-6#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
subtypes are##6##2##(1990-5#1)(1991-12#1)(1995-12#2)(2011-2#1)(2012-12#1)
subtypes based on##3##3##(1994-2#2)(2008-9#1)
subtypes expressed##2##2##(1997-2#2)
subtypes have been described##3##4##(2010-6#1)(2011-2#1)(2011-3#1)
subtypes have been##5##3##(1993-12#1)(1995-11#1)(2010-6#1)(2011-2#1)(2011-3#1)
subtypes have##6##2##(1993-12#1)(1994-6#1)(1995-11#1)(2010-6#1)(2011-2#1)(2011-3#1)
subtypes in human##2##3##(1991-11#1)(1997-7#1)
subtypes in the##5##3##(1991-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-8#1)
subtypes in##11##2##(1990-11#1)(1991-11#1)(1991-9#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-7#1)(2008-3#1)(2008-8#1)(2010-12#1)
subtypes of neuronal nicotinic acetylcholine receptors##2##6##(1995-11#2)
subtypes of receptors##2##3##(1993-11#1)(2008-5#1)
subtypes of stroke##2##3##(2007-10#2)
subtypes of the##4##3##(1991-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
subtypes of##38##2##(1990-5#1)(1991-11#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-11#2)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#3)
subtypes were##4##2##(1993-12#1)(1997-3#1)(2012-2#1)(2013-1#1)
subtypes with##2##2##(2007-12#1)(2008-8#1)
subtypes##166##1##(1990-11#2)(1990-5#2)(1991-11#6)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#6)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#7)(1994-6#4)(1995-11#5)(1995-12#8)(1995-2#2)(1995-6#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#3)(2006-10#1)(2007-10#7)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
subtypes)##4##1##(1990-5#1)(1996-7#1)(2008-3#1)(2013-8#1)
subtyping##4##1##(1997-8#1)(2008-1#1)(2011-2#2)
subumbilical incision##3##2##(2011-2#3)
subungual##6##1##(2007-7#1)(2008-9#3)(2010-6#2)
subunit 4##3##2##(1995-11#3)
subunit A##2##2##(1993-2#1)(1994-12#1)
subunit I of cytochrome##3##4##(1993-2#1)(1997-7#2)
subunit I of##5##3##(1993-2#2)(1995-2#1)(1997-7#2)
subunit I##9##2##(1993-2#2)(1995-2#1)(1997-7#2)(2010-4#3)(2011-2#1)
subunit VIb of cytochrome c oxidase##2##6##(1991-6#2)
subunit VIb##8##2##(1991-6#8)
subunit alone##3##2##(1993-9#1)(1995-2#1)(2008-9#1)
subunit and the##3##3##(1993-8#1)(1995-5#1)(1995-8#1)
subunit and##23##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-8#2)(2010-12#1)(2011-1#1)(2013-8#1)
subunit as##2##2##(1994-11#1)(1995-6#1)
subunit assembly in##3##3##(1990-8#1)(1997-2#1)(2008-8#1)
subunit assembly reactions##2##3##(1990-8#1)(1997-2#1)
subunit assembly##8##2##(1990-8#3)(1997-2#4)(2008-8#1)
subunit but##3##2##(1993-11#1)(1995-8#1)(2008-7#1)
subunit by##3##2##(1993-11#1)(2006-6#1)(2008-8#1)
subunit combination Pb2+##2##3##(1995-11#2)
subunit combination##3##2##(1995-11#3)
subunit combinations##2##2##(1990-8#1)(1995-11#1)
subunit composition##4##2##(1990-5#1)(1991-10#1)(1995-11#1)(2008-4#1)
subunit contains##3##2##(1990-12#1)(1990-7#1)(1995-8#1)
subunit does not##3##3##(1994-6#1)(1994-8#1)(1995-2#1)
subunit from the##3##3##(1991-6#1)(1994-8#1)(2009-7#1)
subunit from##9##2##(1991-6#1)(1993-12#1)(1993-8#2)(1994-8#1)(1997-4#1)(2008-11#1)(2009-7#2)
subunit gene##11##2##(1992-10#1)(1992-9#1)(1993-11#1)(1995-6#2)(1996-2#2)(1997-4#1)(2008-10#1)(2008-8#2)
subunit genes##7##2##(1990-8#1)(1991-2#4)(1996-2#1)(2008-8#1)
subunit has been##2##3##(1992-9#1)(1996-2#1)
subunit homologue##2##2##(1993-12#1)(1996-12#1)
subunit in the##6##3##(1993-8#1)(1995-12#3)(1995-2#1)(1997-7#1)
subunit in##17##2##(1990-5#1)(1992-8#1)(1993-8#2)(1995-12#3)(1995-2#2)(1995-6#2)(1995-8#1)(1997-7#3)(2008-8#2)
subunit interactions##6##2##(1990-8#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(2008-9#1)
subunit is labeled upon modification of##2##6##(1995-6#2)
subunit is##14##2##(1991-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(2008-8#4)
subunit mRNA levels##2##3##(1996-12#2)
subunit mRNA##5##2##(1991-2#2)(1995-5#1)(1996-12#2)
subunit mRNAs##2##2##(1996-12#2)
subunit molecular weight##2##3##(1991-9#1)(1995-5#1)
subunit molecular##3##2##(1991-9#1)(1994-8#1)(1995-5#1)
subunit of PKA##2##3##(1994-8#1)(2008-8#1)
subunit of cAMP-dependent protein kinase##2##5##(1990-2#1)(1995-2#1)
subunit of human##4##3##(1993-6#1)(1994-8#2)(2008-11#1)
subunit of phosphatase 2A##2##4##(1995-3#2)
subunit of the enzyme##3##4##(1992-8#2)(1995-11#1)
subunit of the human platelet fibrinogen receptor##2##7##(2006-6#2)
subunit of the human##3##4##(1995-11#1)(2006-6#2)
subunit of the##40##3##(1991-5#1)(1992-11#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#6)(1997-3#2)(1997-4#1)(1997-7#1)(2006-6#2)(2008-10#1)(2008-8#3)(2009-7#3)(2009-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
subunit of##102##2##(1990-2#2)(1991-12#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#2)(1994-8#9)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#1)(1995-6#9)(1995-8#3)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#2)(2006-6#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#3)(2009-8#1)(2010-6#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
subunit protein##4##2##(1990-5#1)(1991-12#1)(1992-8#1)(1995-5#1)
subunit recombination##3##2##(1991-3#3)
subunit ribosomal##5##2##(1991-6#1)(1994-12#2)(2008-10#1)(2010-4#1)
subunit structure##3##2##(1990-11#1)(1990-7#1)(2009-9#1)
subunit that##2##2##(1995-2#1)(2012-3#1)
subunit to the##2##3##(1990-8#1)(1995-6#1)
subunit to##4##2##(1990-8#1)(1995-2#1)(1995-6#1)(2009-2#1)
subunit vaccine against##2##3##(1995-12#1)(1995-2#1)
subunit vaccine##4##2##(1995-12#1)(1995-2#1)(2007-11#2)
subunit vaccines##4##2##(1991-5#1)(1995-5#1)(2007-2#1)(2009-8#1)
subunit was found##2##3##(1990-7#1)(1992-9#1)
subunit was##8##2##(1990-2#1)(1990-5#2)(1990-7#1)(1992-9#2)(1993-8#1)(1995-2#1)
subunit were##2##2##(1990-2#1)(1992-11#1)
subunit with##4##2##(1993-8#1)(1994-6#2)(1995-11#1)
subunit would##2##2##(1993-11#2)
subunit α##4##2##(2010-11#1)(2010-12#3)
subunit##518##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#7)(1990-5#13)(1990-7#8)(1990-8#13)(1991-10#1)(1991-12#7)(1991-2#6)(1991-3#5)(1991-5#2)(1991-6#11)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#8)(1992-6#4)(1992-8#9)(1992-9#15)(1993-11#13)(1993-12#9)(1993-2#4)(1993-3#4)(1993-6#1)(1993-8#11)(1993-9#5)(1994-11#8)(1994-12#9)(1994-2#1)(1994-5#7)(1994-6#7)(1994-8#17)(1994-9#3)(1995-11#18)(1995-12#10)(1995-2#34)(1995-3#4)(1995-5#7)(1995-6#28)(1995-8#16)(1996-12#11)(1996-2#10)(1996-5#2)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#4)(1997-7#10)(2006-6#4)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#33)(2008-9#6)(2009-11#2)(2009-2#4)(2009-7#6)(2009-8#2)(2009-9#4)(2010-11#2)(2010-12#5)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#4)
subunit)##4##1##(1991-5#1)(1992-3#1)(1995-6#1)(2008-9#1)
subunits (Gs##2##2##(1995-6#1)(2008-7#1)
subunits C##3##2##(1993-11#3)
subunits alpha##2##2##(1994-6#1)(2010-8#1)
subunits and the two##2##4##(1990-8#1)(1993-6#1)
subunits and the##3##3##(1990-8#1)(1993-6#1)(1996-2#1)
subunits and their##2##3##(1997-6#1)(2008-9#1)
subunits and three##2##3##(1990-8#1)(1993-11#1)
subunits and##20##2##(1990-7#1)(1990-8#3)(1991-12#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-6#1)(2008-7#1)(2008-8#2)(2008-9#2)
subunits are catalytically##2##3##(1992-3#2)
subunits are##9##2##(1992-3#2)(1994-8#1)(1995-11#1)(1995-5#1)(2008-10#2)(2009-11#1)(2012-3#1)
subunits by##3##2##(1992-6#1)(1995-11#1)(2009-7#1)
subunits differentially##2##2##(1992-2#1)(2008-8#1)
subunits encoded##2##2##(1995-6#1)(1997-7#1)
subunits from other##2##3##(1993-8#1)(1994-12#1)
subunits from##4##2##(1993-8#1)(1994-12#1)(1996-2#1)(2008-8#1)
subunits have been##2##3##(1992-3#1)(1994-8#1)
subunits have##4##2##(1992-3#1)(1994-8#1)(1995-6#1)(2013-8#1)
subunits in a##2##3##(1995-6#1)(2008-7#1)
subunits in the##6##3##(1991-12#1)(1992-8#2)(1995-5#1)(2008-8#2)
subunits in##18##2##(1991-10#1)(1991-12#1)(1992-6#1)(1992-8#2)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-7#1)(2008-8#4)(2008-9#3)
subunits into##2##2##(1990-11#1)(2009-2#1)
subunits is##2##2##(1994-6#1)(1994-8#1)
subunits occurred in##2##3##(1990-5#1)(2008-8#1)
subunits of G-proteins##2##3##(1993-3#1)(2008-8#1)
subunits of a##2##3##(1996-5#1)(2008-10#1)
subunits of human##2##3##(1992-6#1)(2009-2#1)
subunits of the enzyme##2##4##(1990-11#1)(1992-6#1)
subunits of the##15##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#2)
subunits of##65##2##(1990-11#1)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#2)(1992-10#1)(1992-11#1)(1992-6#3)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-6#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-2#1)(2009-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
subunits show##2##2##(1992-9#1)(2009-6#1)
subunits that##2##2##(2008-9#1)(2012-2#1)
subunits to##5##2##(1991-3#1)(1992-6#1)(1993-11#1)(1997-6#1)(2008-1#1)
subunits was##2##2##(1992-3#1)(1995-5#1)
subunits were##5##2##(1990-5#1)(1992-11#1)(2008-10#1)(2008-8#2)
subunits whose##2##2##(1990-8#1)(1995-6#1)
subunits with##3##2##(1993-9#1)(1997-2#1)(2008-8#1)
subunits within the##2##3##(1990-8#2)
subunits within##3##2##(1990-8#2)(1991-10#1)
subunits##288##1##(1990-11#3)(1990-2#4)(1990-5#6)(1990-7#5)(1990-8#12)(1991-10#8)(1991-12#5)(1991-3#1)(1991-7#3)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#8)(1992-6#9)(1992-8#3)(1992-9#5)(1993-11#10)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#4)(1994-8#6)(1995-11#10)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#13)(1995-8#2)(1996-1#1)(1996-2#7)(1996-5#1)(1996-8#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-6#5)(1997-7#5)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#10)(2008-8#29)(2008-9#10)(2009-10#3)(2009-11#2)(2009-2#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#7)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
subunits)##2##1##(1992-3#1)(2009-7#1)
suburban area of##2##3##(2008-11#1)(2008-3#1)
suburban areas##3##2##(2008-11#1)(2011-2#2)
suburban##10##1##(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-2#2)(2013-1#1)
suburbs of##2##2##(2007-9#1)(2008-3#1)
suburbs##3##1##(2007-9#1)(2008-2#1)(2008-3#1)
subvalvular##3##1##(1992-9#1)(2013-8#2)
subventricular zone##2##2##(2008-7#2)
subventricular##4##1##(1995-12#1)(2008-7#2)(2008-9#1)
subversion of##2##2##(1992-8#1)(2013-1#1)
subvert##2##1##(2008-9#1)(2009-6#1)
subverted##2##1##(2008-11#1)(2013-1#1)
subwavelength aperture##4##2##(2007-12#3)(2008-7#1)
subwavelength dielectric gratings##2##3##(2007-11#2)
subwavelength dielectric##5##2##(2007-11#4)(2008-3#1)
subwavelength gratings and##2##3##(2008-3#2)
subwavelength gratings##10##2##(2007-11#3)(2007-12#1)(2008-3#6)
subwavelength holes##2##2##(2007-12#2)
subwavelength metal-stripe##2##2##(2007-12#2)
subwavelength optical##2##2##(2007-11#1)(2008-3#1)
subwavelength period##4##2##(2007-12#1)(2008-3#3)
subwavelength resolution##2##2##(2007-12#1)(2008-3#1)
subwavelength structures##3##2##(2007-11#2)(2008-3#1)
subwavelength##54##1##(2007-11#14)(2007-12#15)(2008-2#2)(2008-3#21)(2008-7#2)
subzero temperatures##3##2##(1995-2#1)(2008-10#2)
suc1##2##1##(1995-8#2)
succeed in##13##2##(1990-2#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#2)
succeed##26##1##(1990-2#1)(1992-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#3)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
succeeded in##24##2##(1992-12#1)(1993-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#2)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
succeeded##32##1##(1992-12#1)(1993-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-4#1)(2012-12#1)(2013-1#1)
succeeding##7##1##(1992-6#1)(1993-1#1)(1994-5#1)(1995-5#1)(2007-5#1)(2008-1#1)(2008-10#1)
succeeds in predicting mothers'##2##4##(2011-1#2)
succeeds##5##1##(2008-2#1)(2011-1#4)
succesfull##3##1##(2007-11#3)
success among##2##2##(1993-2#1)(2008-6#1)
success and safety##2##3##(2008-7#2)
success and the##3##3##(1995-12#1)(1997-6#1)(2008-9#1)
success and##29##2##(1994-3#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-9#1)(2010-11#2)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
success as a##3##3##(2009-5#1)(2009-7#1)(2012-3#1)
success as##5##2##(1994-2#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-3#1)
success at the##2##3##(1996-12#1)(2008-8#1)
success at##6##2##(1996-1#1)(1996-12#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)
success between##3##2##(2009-12#2)(2011-2#1)
success but##2##2##(2008-8#1)(2013-1#1)
success can##2##2##(1996-8#1)(2008-5#1)
success factor##2##2##(1996-1#1)(1997-1#1)
success factors for##2##3##(1993-3#1)(1994-2#1)
success factors##9##2##(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1996-12#1)(2008-12#1)(2008-9#1)(2010-8#1)
success for the##2##3##(1992-11#1)(2009-12#1)
success for##11##2##(1992-11#1)(1994-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)
success has##5##2##(1993-12#1)(2010-10#1)(2011-3#1)(2012-12#1)(2013-8#1)
success in a##4##3##(1995-2#1)(2007-8#1)(2008-9#1)(2012-3#1)
success in managing##2##3##(1995-12#1)(2013-1#1)
success in obtaining a dietetic internship##2##6##(1993-3#2)
success in obtaining##3##3##(1992-2#1)(1993-3#2)
success in the##7##3##(1993-2#1)(1996-3#1)(2008-1#2)(2008-9#1)(2010-8#1)(2011-1#1)
success in this##2##3##(1996-12#1)(2008-12#1)
success in##49##2##(1992-2#2)(1993-2#3)(1993-3#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#6)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)
success is dependent##2##3##(2008-11#1)(2008-5#1)
success is the##2##3##(1994-9#1)(2008-7#1)
success is##10##2##(1994-2#1)(1994-3#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
success may##2##2##(1997-3#1)(2008-8#1)
success of a health care##2##5##(1995-1#1)(2013-1#1)
success of a##8##3##(1991-2#1)(1994-2#1)(1995-1#1)(2006-5#1)(2008-12#1)(2008-9#1)(2013-1#2)
success of any##3##3##(2008-11#2)(2008-9#1)
success of percutaneous##3##3##(1990-8#1)(2008-11#1)(2008-12#1)
success of the##29##3##(1990-9#1)(1991-5#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
success of their##4##3##(1991-8#1)(1992-3#1)(1994-12#1)(2012-2#1)
success of these strategies##2##4##(2008-11#1)(2008-4#1)
success of these##6##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
success of this approach##3##4##(2008-1#1)(2008-11#1)(2009-6#1)
success of this##17##3##(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-1#1)(2012-2#1)(2013-8#1)
success of treatment##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
success of##170##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1996-1#1)(1996-12#3)(1996-3#5)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#10)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#12)(2012-3#6)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#3)
success or failure of the##2##5##(1996-2#1)(2008-12#1)
success or failure of##5##4##(1996-2#1)(2008-10#2)(2008-12#1)(2008-4#1)
success or failure##7##3##(1996-2#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-9#1)
success or##9##2##(1996-2#1)(1996-3#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-9#1)
success rate and##2##3##(1996-11#1)(2010-7#1)
success rate for##8##3##(1991-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
success rate in##6##3##(1990-6#1)(1994-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
success rate is##2##3##(2008-10#1)(2012-2#1)
success rate of##13##3##(1991-3#1)(1994-5#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-12#1)(2010-7#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
success rate##49##2##(1990-6#2)(1991-12#1)(1991-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-3#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
success rates of##2##3##(2008-8#1)(2010-7#1)
success rates##15##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
success stories##2##2##(1996-3#1)(1997-3#1)
success story##5##2##(2008-10#1)(2009-12#1)(2009-4#3)
success than##3##2##(2008-8#1)(2008-9#2)
success that##5##2##(1993-3#2)(1995-1#1)(2008-8#1)(2011-1#1)
success through##2##2##(1993-3#1)(1997-1#1)
success to##4##2##(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
success was related##2##3##(1994-3#1)(2012-3#1)
success was##14##2##(1991-2#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
success were##2##2##(1992-11#1)(2008-8#1)
success will be##2##3##(1996-1#1)(1996-3#1)
success will depend on##2##4##(1995-12#1)(2010-12#1)
success will##4##2##(1995-12#1)(1996-1#1)(1996-3#1)(2010-12#1)
success with##9##2##(1994-1#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
success!##2##1##(1992-1#1)(2006-5#1)
success##610##1##(1990-11#1)(1990-12#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-9#2)(1993-12#2)(1993-2#9)(1993-3#10)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#8)(1994-2#13)(1994-3#6)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#9)(1995-2#3)(1995-3#8)(1995-5#1)(1996-1#7)(1996-11#1)(1996-12#9)(1996-2#3)(1996-3#16)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(2006-5#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#36)(2008-11#32)(2008-12#18)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#7)(2008-7#16)(2008-8#46)(2008-9#43)(2009-10#1)(2009-12#9)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#2)(2010-3#5)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#12)(2011-1#8)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#22)(2012-3#23)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#9)
successes and challenges##2##3##(2007-7#1)(2012-3#1)
successes and failures##4##3##(1994-3#1)(2008-10#1)(2008-5#1)(2010-11#1)
successes and##8##2##(1994-12#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)(2012-3#1)
successes in##4##2##(1994-12#1)(2007-9#1)(2012-2#1)(2013-1#1)
successes of##3##2##(1995-1#1)(2009-7#1)(2010-11#1)
successes with##2##2##(1993-2#1)(1995-12#1)
successes##25##1##(1990-3#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-11#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
successful PTCA##3##2##(2007-8#3)
successful adaptation##3##2##(1995-5#1)(2008-12#1)(2008-7#1)
successful aging##2##2##(2007-12#1)(2011-1#1)
successful alternative##2##2##(2008-2#1)(2009-9#1)
successful amplification of##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
successful and##14##2##(1990-9#1)(1992-2#1)(1994-1#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-10#1)(2012-2#2)(2013-1#1)(2013-8#1)
successful angioplasty##2##2##(1996-8#1)(2011-2#1)
successful application of a##3##4##(1995-11#1)(2008-2#1)(2008-9#1)
successful application of##9##3##(1995-1#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-9#2)(2012-3#1)
successful applications of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
successful applications##4##2##(2008-10#1)(2008-3#1)(2012-2#2)
successful approaches to##2##3##(2009-2#1)(2011-1#1)
successful approaches##3##2##(2009-2#1)(2009-3#1)(2011-1#1)
successful at##7##2##(1990-3#1)(1994-3#1)(1997-2#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
successful attempt##3##2##(2008-10#3)
successful because##2##2##(2008-10#1)(2008-2#1)
successful biological control##2##3##(2008-10#2)
successful cannulation##2##2##(2008-1#1)(2011-2#1)
successful cardiopulmonary##2##2##(1990-9#1)(2008-3#1)
successful cases##2##2##(2007-8#1)(2011-1#1)
successful change##3##2##(1994-2#1)(1995-12#1)(1996-1#1)
successful clinical##6##2##(2007-12#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-3#1)
successful closed reduction of##2##4##(2013-7#2)
successful closed reduction##4##3##(2013-7#4)
successful collaborative##2##2##(1995-2#1)(1996-2#1)
successful compensation##2##2##(1991-2#1)(1995-12#1)
successful completion of##4##3##(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
successful completion##5##2##(2008-12#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)
successful condom use##2##3##(2008-11#2)
successful condom users were more likely to##2##7##(2008-11#2)
successful condom users##3##3##(2008-11#3)
successful condom##5##2##(2008-11#5)
successful control of##2##3##(2007-12#1)(2009-5#1)
successful culture##2##2##(2013-1#2)
successful defense of##3##3##(1991-1#1)(1992-2#1)(1993-12#1)
successful detection of##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
successful development##2##2##(1995-5#1)(2008-12#1)
successful eradication of##2##3##(1992-6#1)(1993-12#1)
successful establishment of##2##3##(2008-10#1)(2008-11#1)
successful execution##2##2##(2008-2#1)(2009-2#1)
successful experimental##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
successful exploitation##2##2##(2008-11#1)(2008-8#1)
successful extraction##2##2##(2008-10#1)(2008-9#1)
successful for the determination of the enantiopurity of Mtx as raw material##2##12##(2008-10#2)
successful for the##3##3##(2008-10#3)
successful for two##2##3##(2008-9#1)(2013-7#1)
successful for##10##2##(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-7#1)
successful gene##2##2##(2008-11#1)(2008-4#1)
successful health##3##2##(1994-3#1)(1995-12#1)(1996-3#1)
successful hospital##4##2##(1991-2#1)(1995-1#1)(1996-2#1)(2012-3#1)
successful human##2##2##(1997-2#1)(2007-7#1)
successful implementation of a##2##4##(1994-3#1)(2007-12#1)
successful implementation of the##2##4##(1992-1#1)(2010-3#1)
successful implementation of##10##3##(1992-1#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#2)
successful implementation##13##2##(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#2)(2013-8#1)
successful implementations of##2##3##(2008-2#1)(2012-3#1)
successful in all##4##3##(1991-2#1)(2007-12#1)(2011-2#1)(2012-2#1)
successful in many##2##3##(2008-10#1)(2013-1#1)
successful in obtaining##2##3##(1992-2#1)(1993-3#1)
successful in preventing fungal ingress##2##5##(2008-10#2)
successful in preventing##4##3##(1994-12#1)(2008-10#2)(2009-3#1)
successful in reducing##5##3##(2008-11#3)(2012-1#1)(2012-2#1)
successful in resolving##2##3##(2007-11#1)(2008-10#1)
successful in the##6##3##(2007-8#2)(2008-10#2)(2011-2#1)(2012-2#1)
successful in this##2##3##(2008-1#1)(2008-10#1)
successful in##68##2##(1990-8#1)(1991-2#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-9#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
successful integration##2##2##(1992-3#1)(1995-2#1)
successful isolation of##3##3##(2008-10#2)(2008-7#1)
successful learners##2##2##(2008-6#1)(2013-8#1)
successful management of##10##3##(1994-3#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#3)(2012-12#1)
successful management##12##2##(1994-3#1)(2007-8#2)(2008-10#1)(2008-7#2)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)
successful medical management##2##3##(2007-10#1)(2010-8#1)
successful medical##4##2##(1995-8#1)(2007-10#1)(2008-10#1)(2010-8#1)
successful only##2##2##(2008-5#1)(2008-7#1)
successful open##2##2##(2013-1#1)(2013-8#1)
successful operation##7##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2010-8#1)
successful organization##2##2##(1994-12#1)(2007-9#1)
successful outcome of the##2##4##(2008-11#1)(2012-12#1)
successful outcome of##3##3##(1991-6#1)(2008-11#1)(2012-12#1)
successful outcome##13##2##(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#2)
successful outcomes##4##2##(1991-12#1)(1996-12#1)(2013-1#1)(2013-8#1)
successful past##2##2##(2008-8#1)(2011-2#1)
successful practice in##2##3##(1991-1#1)(2007-2#1)
successful practice##3##2##(1991-1#1)(1993-1#1)(2007-2#1)
successful pregnancy##4##2##(1991-3#1)(1996-12#1)(2010-8#1)(2012-3#1)
successful process##2##2##(1995-1#1)(2008-11#1)
successful production##2##2##(1991-3#1)(2012-12#1)
successful recovery##2##2##(2011-1#1)(2012-3#1)
successful rehabilitation##2##2##(1992-3#1)(2008-9#1)
successful repair##2##2##(2007-12#1)(2011-2#1)
successful research##3##2##(2007-4#1)(2008-8#1)(2010-5#1)
successful resection of##2##3##(2008-10#1)(2011-2#1)
successful restructuring##2##2##(1994-3#1)(1995-1#1)
successful results##3##2##(2008-5#1)(2013-1#2)
successful strategy##2##2##(2008-3#1)(2009-9#1)
successful surgical treatment##2##3##(1997-7#1)(2007-8#1)
successful surgical##4##2##(1997-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
successful synthesis of##2##3##(1997-3#1)(2012-2#1)
successful than##2##2##(1993-2#1)(1996-3#1)
successful therapeutic##4##2##(1992-8#1)(1996-11#1)(2008-1#1)(2013-1#1)
successful therapy##7##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
successful thrombolysis##2##2##(1990-3#2)
successful to##2##2##(2008-10#1)(2008-11#1)
successful transition##3##2##(1991-12#1)(2010-10#1)(2011-1#1)
successful transmission##2##2##(2008-10#2)
successful treatment by##3##3##(2008-7#1)(2009-5#1)(2010-12#1)
successful treatment of the##2##4##(1997-3#1)(2008-1#1)
successful treatment of##13##3##(1991-4#1)(1993-5#1)(1993-6#1)(1994-6#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
successful treatment using##2##3##(2006-10#1)(2007-8#1)
successful treatment##25##2##(1991-4#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-5#1)(1997-3#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
successful use of the##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
successful use of##8##3##(1990-8#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)
successful users to##2##3##(2008-11#2)
successful volunteer##2##2##(1997-2#2)
successful when##2##2##(1993-1#1)(1993-8#1)
successful with a##2##3##(1993-9#1)(2008-10#1)
successful with##5##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
successful##758##1##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#4)(1991-1#5)(1991-12#4)(1991-2#7)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#8)(1992-2#7)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#7)(1993-12#6)(1993-2#7)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-12#7)(1994-2#5)(1994-3#9)(1994-6#1)(1994-7#1)(1994-9#5)(1995-1#7)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#10)(1996-2#6)(1996-3#8)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#17)(2007-2#4)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#26)(2007-9#2)(2008-1#10)(2008-10#100)(2008-11#40)(2008-12#15)(2008-2#12)(2008-3#20)(2008-4#8)(2008-5#8)(2008-6#4)(2008-7#21)(2008-8#12)(2008-9#20)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#10)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#7)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#9)(2010-4#3)(2010-5#7)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#9)(2011-2#18)(2011-3#2)(2012-1#2)(2012-12#11)(2012-2#17)(2012-3#23)(2013-1#22)(2013-7#7)(2013-8#12)
successfully achieved##5##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
successfully adopted##2##2##(1992-3#1)(2008-8#1)
successfully amplified by##2##3##(2008-10#2)
successfully amplified polymorphic##2##3##(2008-5#2)
successfully amplified##4##2##(2008-10#2)(2008-5#2)
successfully analyzed by##2##3##(2008-10#1)(2011-1#1)
successfully analyzed##7##2##(2008-10#5)(2010-5#1)(2011-1#1)
successfully and##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
successfully applied for determination of##4##5##(2008-10#4)
successfully applied for simultaneous determination of##2##6##(2008-10#2)
successfully applied for the analysis of##3##6##(2008-10#3)
successfully applied for the assay of##3##6##(2008-10#3)
successfully applied for the determination of trace##2##7##(2008-10#2)
successfully applied for the determination of##16##6##(2008-10#16)
successfully applied for the##36##4##(2008-10#33)(2009-11#1)(2009-6#1)(2009-8#1)
successfully applied for##51##3##(2008-10#48)(2009-11#1)(2009-6#1)(2009-8#1)
successfully applied in the##4##4##(2007-8#1)(2008-10#3)
successfully applied in##10##3##(2007-8#1)(2008-10#8)(2011-3#1)
successfully applied to analysis of##2##5##(2008-10#2)
successfully applied to analyze##3##4##(2008-10#3)
successfully applied to determination of the##2##6##(2008-10#2)
successfully applied to determination of##5##5##(2008-10#5)
successfully applied to determine the##2##5##(2008-10#2)
successfully applied to determine##12##4##(2008-10#12)
successfully applied to different##2##4##(2008-10#2)
successfully applied to on-line##2##4##(2008-10#2)
successfully applied to real##2##4##(2008-10#2)
successfully applied to the analysis of the##2##7##(2008-10#2)
successfully applied to the analysis of##15##6##(2008-10#14)(2013-1#1)
successfully applied to the determination of atrazine in##2##8##(2008-10#2)
successfully applied to the determination of chromium in##2##8##(2008-10#2)
successfully applied to the determination of glucose in human##2##9##(2008-10#1)(2010-5#1)
successfully applied to the determination of glucose in##3##8##(2008-10#2)(2010-5#1)
successfully applied to the determination of lead in##3##8##(2008-10#3)
successfully applied to the determination of nickel in##2##8##(2008-10#2)
successfully applied to the determination of nickel##3##7##(2008-10#3)
successfully applied to the determination of nitrite in##2##8##(2008-10#2)
successfully applied to the determination of the drug in##2##9##(2008-10#2)
successfully applied to the determination of the##4##7##(2008-10#4)
successfully applied to the determination of these##2##7##(2008-10#2)
successfully applied to the determination of trace amount of##3##9##(2008-10#3)
successfully applied to the determination of trace##7##7##(2008-10#7)
successfully applied to the determination of vanadium in##4##8##(2008-10#4)
successfully applied to the determination of##93##6##(1994-9#1)(1996-5#1)(2008-10#90)(2010-5#1)
successfully applied to the determination##94##5##(1994-9#1)(1996-5#1)(2008-10#91)(2010-5#1)
successfully applied to the pharmacokinetic study of##2##7##(2008-10#2)
successfully applied to the simultaneous determination of##12##7##(2008-10#12)
successfully applied to the simultaneous##16##5##(2008-10#15)(2008-5#1)
successfully applied to the##152##4##(1991-12#1)(1994-9#1)(1996-5#1)(2008-10#144)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
successfully applied to##213##3##(1991-12#1)(1992-11#1)(1994-7#1)(1994-9#2)(1996-5#1)(2007-12#2)(2008-10#193)(2008-11#1)(2008-3#2)(2008-5#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
successfully applied##281##2##(1991-12#1)(1992-11#1)(1994-7#1)(1994-9#2)(1996-5#1)(2007-12#2)(2007-8#1)(2008-10#253)(2008-11#1)(2008-3#3)(2008-5#2)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
successfully as##2##2##(2008-10#2)
successfully be##4##2##(2007-8#1)(2008-10#2)(2013-8#1)
successfully been##4##2##(2008-1#1)(2008-10#2)(2008-7#1)
successfully by this##2##3##(2008-2#1)(2008-3#1)
successfully by##11##2##(1990-9#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-8#1)(2011-2#1)(2012-2#1)
successfully cloned##3##2##(2008-8#1)(2010-11#1)(2010-6#1)
successfully combined##2##2##(2007-11#1)(2008-10#1)
successfully completed##6##2##(2007-8#1)(2008-10#3)(2011-2#1)(2012-3#1)
successfully conducting a##2##3##(1992-12#1)(1992-3#1)
successfully confirmed by##2##3##(2008-10#1)(2010-4#1)
successfully contained the growth of public expenditures on##2##8##(1994-2#2)
successfully controlled##3##2##(2008-3#1)(2008-7#1)(2011-1#1)
successfully coupled with##2##3##(2008-1#1)(2008-10#1)
successfully cultivated##3##2##(1994-5#1)(2008-11#2)
successfully demonstrate##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
successfully demonstrated by use of##2##5##(2007-12#1)(2008-2#1)
successfully demonstrated for##2##3##(2008-10#2)
successfully demonstrated that##2##3##(1997-4#1)(2010-5#1)
successfully demonstrated the##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
successfully demonstrated##16##2##(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#1)(2010-5#1)
successfully detect##3##2##(2008-10#2)(2011-2#1)
successfully detected by##3##3##(2008-10#2)(2008-5#1)
successfully detected##6##2##(1996-12#1)(2008-10#4)(2008-5#1)
successfully determined by##3##3##(2008-10#3)
successfully determined##8##2##(1990-8#1)(2008-10#6)(2008-3#1)
successfully develop##2##2##(1996-3#1)(2010-2#1)
successfully developed a##2##3##(2009-7#1)(2012-3#1)
successfully developed##8##2##(1993-3#1)(2008-10#3)(2008-11#1)(2009-7#1)(2010-4#1)(2012-3#1)
successfully done##3##2##(2008-1#1)(2008-12#1)(2008-6#1)
successfully employed for the##4##4##(2008-10#4)
successfully employed for##6##3##(2008-10#5)(2012-12#1)
successfully employed in the##3##4##(1990-12#1)(2008-10#2)
successfully employed##15##2##(1990-12#1)(2008-10#10)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)
successfully established##3##2##(2008-10#1)(2008-11#1)(2010-9#1)
successfully explained##2##2##(2008-3#2)
successfully expressed##3##2##(2008-11#1)(2008-7#2)
successfully extracted##4##2##(1992-9#1)(2007-8#1)(2008-10#1)(2008-4#1)
successfully fabricated##3##2##(2007-11#1)(2008-10#2)
successfully for the analysis of##2##5##(1997-2#1)(2008-10#1)
successfully for the##11##3##(1997-2#1)(2008-10#8)(2008-7#1)(2009-11#1)
successfully for##17##2##(1997-2#1)(2008-10#10)(2008-2#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)
successfully from##2##2##(2008-10#1)(2008-8#1)
successfully generate##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
successfully generated##4##2##(1997-4#1)(2007-12#2)(2008-11#1)
successfully identified##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
successfully implement##5##2##(1994-1#2)(1994-2#1)(2008-10#1)(2008-3#1)
successfully implemented##2##2##(1994-12#1)(2008-3#1)
successfully in the determination of##2##5##(2008-10#2)
successfully in the##7##3##(2008-10#4)(2008-4#1)(2009-10#1)(2009-4#1)
successfully in##17##2##(2007-12#1)(2008-10#9)(2008-4#2)(2008-6#1)(2009-10#1)(2009-4#1)(2010-11#1)(2012-1#1)
successfully incorporated into a##3##4##(2008-10#1)(2009-12#1)(2009-9#1)
successfully incorporated into##6##3##(1996-1#1)(2008-10#2)(2009-12#1)(2009-9#1)(2012-2#1)
successfully inserted##3##2##(1993-11#1)(1997-6#1)(2010-7#1)
successfully integrated##3##2##(1997-8#1)(2007-12#1)(2010-8#1)
successfully into##2##2##(2008-10#1)(2008-5#1)
successfully introduced##2##2##(2008-11#1)(2013-8#1)
successfully isolated and##2##3##(2008-7#1)(2011-1#1)
successfully isolated##7##2##(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)
successfully lased##2##2##(2007-12#1)(2008-2#1)
successfully managed with##2##3##(2010-10#1)(2012-2#1)
successfully managed##5##2##(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
successfully mapped##2##2##(1995-8#1)(2008-8#1)
successfully measured##2##2##(2008-10#1)(2008-2#1)
successfully obtained from##2##3##(2010-4#1)(2011-1#1)
successfully obtained##10##2##(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)
successfully on##3##2##(1994-2#1)(1995-6#1)(2008-3#1)
successfully operated##3##2##(1990-9#1)(2008-6#1)(2008-7#1)
successfully overcome by##2##3##(1994-3#1)(2008-3#1)
successfully performed in##3##3##(2007-7#1)(2008-7#1)(2012-3#1)
successfully performed using##2##3##(2007-8#1)(2008-11#1)
successfully performed##16##2##(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2012-3#1)(2013-1#2)
successfully placed in##2##3##(2008-7#1)(2013-7#1)
successfully placed##3##2##(1990-11#1)(2008-7#1)(2013-7#1)
successfully plan##2##2##(2010-7#1)(2013-8#1)
successfully prepared##2##2##(1996-2#1)(2013-1#1)
successfully produced##3##2##(2008-5#1)(2012-6#1)(2013-8#1)
successfully recovered##2##2##(2008-10#2)
successfully reduced##4##2##(2007-11#1)(2007-8#1)(2008-3#1)(2013-1#1)
successfully removed##5##2##(2008-5#1)(2008-7#2)(2011-2#1)(2013-8#1)
successfully repaired##2##2##(2011-1#1)(2011-2#1)
successfully reproduced with##2##3##(1991-8#1)(1997-7#1)
successfully resected##3##2##(2007-8#1)(2008-6#1)(2013-1#1)
successfully separated##5##2##(1997-2#1)(2008-10#4)
successfully tested for##3##3##(2008-10#3)
successfully tested in##2##3##(1991-1#1)(2008-3#1)
successfully tested on##2##3##(2008-10#1)(2009-2#1)
successfully tested##10##2##(1991-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)
successfully to determine##3##3##(2008-10#2)(2008-3#1)
successfully to##44##2##(1991-5#1)(2008-10#31)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-10#1)(2010-8#1)(2012-2#1)
successfully transduced##2##2##(1994-5#1)(2008-9#1)
successfully transferred##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
successfully treat##4##2##(1991-3#1)(2008-11#1)(2008-6#1)(2008-7#1)
successfully treated by endoscopic##2##4##(2008-12#1)(2008-5#1)
successfully treated by##12##3##(1991-8#1)(1992-9#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
successfully treated in##2##3##(1993-5#1)(2008-11#1)
successfully treated patients##2##3##(2008-11#1)(2010-10#1)
successfully treated with a##2##4##(2013-1#2)
successfully treated with antibiotics##2##4##(2007-12#1)(2007-7#1)
successfully treated with itraconazole##3##4##(2007-7#1)(2008-5#2)
successfully treated with oral##2##4##(2010-12#1)(2012-12#1)
successfully treated with##39##3##(1990-8#1)(1995-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#4)(2008-5#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#1)
successfully treated##67##2##(1990-8#1)(1991-8#1)(1992-9#2)(1993-5#1)(1995-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#4)(2008-7#3)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#2)(2013-1#4)(2013-8#3)
successfully underwent##5##2##(2008-11#2)(2008-5#1)(2008-8#1)(2012-1#1)
successfully used as a##3##4##(1994-2#1)(2008-10#1)(2009-10#1)
successfully used as an indicator electrode in the potentiometric titration of##2##11##(2008-10#2)
successfully used as an indicator electrode in##3##7##(2008-10#3)
successfully used as##8##3##(1994-2#1)(2007-11#1)(2008-10#5)(2009-10#1)
successfully used for both##2##4##(2007-2#1)(2008-10#1)
successfully used for determination of##2##5##(2008-10#2)
successfully used for the assay of##2##6##(2008-10#2)
successfully used for the separation##2##5##(2008-10#2)
successfully used for the##14##4##(2008-10#12)(2008-5#1)(2011-1#1)
successfully used for##26##3##(2007-11#1)(2007-2#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
successfully used in a##2##4##(2008-10#2)
successfully used in the##5##4##(1994-5#1)(2007-12#1)(2007-8#1)(2008-10#2)
successfully used in##12##3##(1990-9#1)(1994-5#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2011-3#1)
successfully used the##2##3##(2009-3#1)(2013-8#1)
successfully used to determine##6##4##(2008-10#3)(2010-3#1)(2010-5#1)(2012-2#1)
successfully used to##32##3##(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
successfully used##86##2##(1990-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#39)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
successfully using a##2##3##(1993-3#1)(2008-10#1)
successfully utilized for##3##3##(2008-10#3)
successfully utilized##4##2##(1997-8#1)(2008-10#3)
successfully with a combination of##2##5##(1991-6#1)(2007-7#1)
successfully with a##4##3##(1991-6#1)(2007-7#1)(2008-3#1)(2009-8#1)
successfully with##15##2##(1991-12#1)(1991-6#1)(1995-11#1)(1995-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#1)(2013-1#1)
successfully##1037##1##(1990-11#1)(1990-12#1)(1990-8#4)(1990-9#3)(1991-1#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#4)(1994-5#5)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#2)(2007-11#11)(2007-12#20)(2007-2#1)(2007-4#1)(2007-7#7)(2007-8#19)(2008-1#11)(2008-10#475)(2008-11#36)(2008-12#9)(2008-2#21)(2008-3#39)(2008-4#9)(2008-5#19)(2008-6#9)(2008-7#26)(2008-8#18)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#11)(2011-2#27)(2011-3#2)(2012-1#5)(2012-12#6)(2012-2#14)(2012-3#8)(2012-6#1)(2012-8#1)(2013-1#17)(2013-7#1)(2013-8#10)
succession of##7##2##(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)
succession##15##1##(1990-2#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#4)
successional diversity##3##2##(2008-9#3)
successional##8##1##(2008-8#1)(2008-9#7)
successive additions of##3##3##(1993-8#1)(2008-10#2)
successive cultures of human##2##4##(2008-11#2)
successive cultures##3##2##(2008-11#3)
successive cycles of##3##3##(2008-10#3)
successive cycles##4##2##(2008-10#4)
successive days##4##2##(1992-5#1)(1993-6#1)(2008-10#2)
successive determination of##5##3##(2008-10#5)
successive determinations of##2##3##(2008-10#2)
successive determinations##3##2##(2008-10#3)
successive divisions##2##2##(2008-7#2)
successive generation of##2##3##(2007-12#1)(2008-7#1)
successive generations##9##2##(1997-5#2)(2007-10#3)(2008-10#2)(2008-2#1)(2008-9#1)
successive images##2##2##(2007-11#1)(2008-3#1)
successive increase##2##2##(2011-2#1)(2013-1#1)
successive injections of##3##3##(2008-10#2)(2012-12#1)
successive injections##8##2##(2008-10#7)(2012-12#1)
successive measurements##2##2##(2008-10#2)
successive reaction##2##2##(1995-6#1)(1996-5#1)
successive stages of##2##3##(1995-2#1)(2007-8#1)
successive stages##3##2##(1995-2#1)(2007-8#1)(2008-8#1)
successive steps of##2##3##(1990-12#1)(2008-3#1)
successive steps##3##2##(1990-12#1)(1994-2#1)(2008-3#1)
successive years##7##2##(2008-10#5)(2010-4#1)(2011-2#1)
successive##148##1##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-3#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#51)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#5)(2012-12#1)(2013-1#3)
successively by##3##2##(1996-2#1)(2008-10#1)(2010-11#1)
successively in##2##2##(1995-11#1)(1997-6#1)
successively presented##2##2##(1992-8#1)(1993-6#1)
successively with##2##2##(2008-10#1)(2008-2#1)
successively within##2##2##(2007-12#1)(2008-11#1)
successively##39##1##(1990-12#1)(1990-8#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-11#2)(1996-2#2)(1997-4#5)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#1)(2009-8#1)(2010-11#1)(2011-3#1)(2012-12#1)(2013-1#1)
successor##8##1##(1994-5#1)(2008-11#1)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#1)
succinate cytochrome c reductase##2##4##(1990-11#2)
succinate dehydrogenase##5##2##(1990-7#1)(1993-11#1)(1996-8#1)(2009-11#2)
succinate##21##1##(1990-11#2)(1990-7#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-3#1)(1996-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#2)
succinct overview of##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
succinct##5##1##(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2013-8#1)
succinctly##2##1##(1996-12#1)(2011-2#1)
succinic acid by##2##3##(2008-10#1)(2008-6#1)
succinic acid##18##2##(1990-5#1)(1990-8#1)(2008-10#8)(2008-5#1)(2008-6#7)
succinic semialdehyde reductase in rat brain##2##6##(1997-2#2)
succinic semialdehyde reductase##3##3##(1997-2#3)
succinic semialdehyde##5##2##(1997-2#4)(2008-11#1)
succinic##31##1##(1990-5#1)(1990-8#1)(1994-9#1)(1995-11#1)(1997-2#4)(2008-10#14)(2008-11#1)(2008-5#1)(2008-6#7)
succinimide ester of biotin##2##4##(1993-6#1)(1993-8#1)
succinimide##5##1##(1993-6#4)(1993-8#1)
succinimidyl ester##3##2##(2008-9#1)(2012-3#1)(2013-8#1)
succinimidyl##4##1##(2008-9#1)(2012-3#1)(2013-8#2)
succinoyl trehalose##3##2##(2008-11#3)
succinyl concanavalin A##4##3##(1995-11#4)
succinyl dehydrogenase##2##2##(2012-2#2)
succinyl##6##1##(1995-11#4)(2012-2#2)
succumb to##3##2##(2007-7#1)(2008-1#1)(2009-5#1)
succumb##6##1##(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-5#1)
succumbed to death##2##3##(2008-12#1)(2012-3#1)
succumbed to##4##2##(2008-12#1)(2008-6#1)(2010-3#1)(2012-3#1)
suceptibility##2##1##(2008-11#1)(2008-4#1)
such &quot##2##2##(2008-10#1)(2012-2#1)
such DNA##2##2##(2008-10#1)(2012-12#1)
such a bias##2##3##(2013-1#2)
such a case with##2##4##(2012-3#2)
such a case##6##3##(2009-10#1)(2010-6#1)(2012-12#1)(2012-3#2)(2013-8#1)
such a change##4##3##(1994-2#1)(1994-3#1)(1995-1#1)(2008-10#1)
such a clinical##2##3##(1997-2#1)(2008-4#1)
such a combined##3##3##(1990-6#1)(1992-9#2)
such a complex##3##3##(1997-6#1)(2008-10#1)(2009-5#1)
such a component##2##3##(2007-12#1)(2008-3#1)
such a condition##2##3##(1994-6#1)(2008-5#1)
such a coupler also##2##4##(2008-2#2)
such a crisis##2##3##(1993-12#1)(2012-3#1)
such a critical##3##3##(2007-4#1)(2008-8#2)
such a device##6##3##(2006-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
such a distinction##2##3##(1991-2#1)(1992-9#1)
such a drug##2##3##(2008-1#1)(2008-11#1)
such a fiber##2##3##(2007-12#1)(2008-2#1)
such a filter##2##3##(2008-2#1)(2008-3#1)
such a grating is##2##4##(2008-3#2)
such a high##2##3##(2008-12#1)(2008-3#1)
such a laser##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
such a lesion##4##3##(2008-1#2)(2008-7#1)(2010-7#1)
such a level##2##3##(2008-12#1)(2008-3#1)
such a manner as to##2##5##(2008-9#1)(2009-9#1)
such a manner##4##3##(2008-10#1)(2008-9#1)(2009-9#1)(2010-8#1)
such a method##5##3##(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
such a model##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
such a network##2##3##(2008-3#1)(2013-8#1)
such a parameter##2##3##(1992-10#1)(2009-10#1)
such a procedure##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
such a process##3##3##(1991-3#1)(1996-2#1)(2012-2#1)
such a program in##2##4##(1992-3#1)(2012-12#1)
such a program##6##3##(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#1)(2012-12#1)
such a protocol##2##3##(2012-1#1)(2012-3#1)
such a reaction##2##3##(1997-3#1)(2010-12#1)
such a relationship##2##3##(2007-8#1)(2008-10#1)
such a setting##3##3##(1992-1#1)(1993-1#1)(2009-6#1)
such a signal##2##3##(2008-2#1)(2008-8#1)
such a simple##2##3##(1990-11#1)(2008-3#1)
such a situation##5##3##(1992-3#1)(1992-4#1)(2008-3#1)(2008-5#1)(2011-1#1)
such a structure##3##3##(1994-12#1)(2008-3#1)(2008-7#1)
such a system is##2##4##(1992-3#1)(2008-2#1)
such a system##14##3##(1992-2#1)(1992-3#1)(1993-3#2)(1993-8#1)(1994-1#1)(2007-12#1)(2008-2#4)(2008-3#3)
such a test##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
such a trial##2##3##(1991-11#1)(1995-5#1)
such a type##2##3##(2008-10#2)
such a waveguide##2##3##(2007-11#1)(2010-8#1)
such a way##34##3##(1990-12#2)(1991-9#1)(1997-4#1)(1997-5#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
such a wide range of##2##5##(1990-11#1)(2008-10#1)
such a young##2##3##(1990-12#1)(2008-12#1)
such a##352##2##(1990-11#3)(1990-12#6)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#7)(2007-12#16)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#33)(2008-11#15)(2008-12#11)(2008-2#20)(2008-3#44)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#17)(2008-8#12)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#7)(2013-8#4)
such abnormalities##2##2##(1996-3#1)(2008-3#1)
such actions##2##2##(1993-3#1)(1997-7#1)
such activities##6##2##(1991-12#2)(1996-11#1)(2008-11#2)(2010-8#1)
such activity##4##2##(1990-12#1)(1993-1#1)(2008-10#1)(2012-2#1)
such algorithms##2##2##(2008-3#1)(2008-6#1)
such alterations##4##2##(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
such an action##2##3##(1994-1#1)(2008-7#1)
such an analysis##2##3##(1991-2#1)(2008-2#1)
such an application##2##3##(2008-10#1)(2008-12#1)
such an approach is##2##4##(1992-8#1)(2013-1#1)
such an approach##9##3##(1992-8#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
such an arrangement##2##3##(1993-1#1)(1995-6#1)
such an assessment##3##3##(1995-11#1)(2008-11#2)
such an association##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
such an effect##2##3##(1990-5#1)(2007-12#1)
such an event##5##3##(1991-2#1)(1997-5#2)(2007-12#1)(2008-11#1)
such an injury##2##3##(2009-3#2)
such an instrument##2##3##(2008-3#1)(2013-1#1)
such an integrated##2##3##(1995-2#1)(2013-8#1)
such an##84##2##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#2)(1992-2#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-5#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
such analyses##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2010-11#1)
such analysis##3##2##(1995-5#1)(2008-11#1)(2011-3#1)
such analytes##2##2##(2008-10#2)
such antibodies##3##2##(2008-10#1)(2008-4#2)
such applications##5##2##(1992-9#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-8#1)
such approaches##5##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-8#1)
such areas as##2##3##(1993-1#1)(2008-1#1)
such areas##4##2##(1993-1#1)(2007-2#1)(2008-1#1)(2013-8#1)
such arrays##2##2##(2009-12#1)(2012-2#1)
such as &quot##12##3##(1993-11#1)(1993-12#2)(1997-3#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
such as 1##2##3##(2008-10#2)
such as 2##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
such as African##2##3##(2008-1#1)(2009-5#1)
such as Al##2##3##(2008-10#1)(2009-8#1)
such as Alzheimer's and##2##4##(2008-7#1)(2013-7#1)
such as Alzheimer's disease##5##4##(1994-9#1)(1996-12#1)(2008-11#1)(2009-8#1)(2011-2#1)
such as Alzheimer's##8##3##(1994-9#1)(1996-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
such as B##2##3##(2011-2#1)(2013-7#1)
such as BrdU##2##3##(2008-9#2)
such as C##2##3##(2008-10#1)(2008-3#1)
such as CO(2)##2##3##(2008-2#1)(2008-7#1)
such as Crohn's disease##2##4##(2008-11#1)(2009-8#1)
such as Cu(II)##4##3##(2008-10#4)
such as DNA and##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)
such as DNA##8##3##(1992-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)
such as EDTA##2##3##(2008-10#2)
such as Escherichia coli##5##4##(1994-8#1)(1995-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
such as Fe##2##3##(2008-12#1)(2013-8#1)
such as Gaussian##2##3##(2012-1#1)(2012-2#1)
such as H+##2##3##(1990-8#1)(2013-8#1)
such as HF##2##3##(2007-8#1)(2008-10#1)
such as HIV##3##3##(2007-4#1)(2008-8#1)(2012-1#1)
such as HIV/AIDS##2##3##(1995-9#1)(2009-4#1)
such as IL-1##2##3##(1992-3#1)(1995-5#1)
such as MR##2##3##(2010-12#2)
such as MRI##2##3##(2012-2#1)(2013-1#1)
such as Mg(II)##2##3##(2008-10#2)
such as Mg2+##2##3##(1995-2#1)(2008-6#1)
such as Mycobacterium##2##3##(2008-7#1)(2011-1#1)
such as NH(3)##2##3##(2008-10#2)
such as Na(+)##2##3##(2008-10#2)
such as New##2##3##(2012-12#1)(2013-7#1)
such as P##2##3##(2008-10#1)(2012-1#1)
such as PKC##2##3##(1992-12#1)(1994-2#1)
such as Parkinson's##2##3##(2008-4#1)(2013-1#1)
such as Pseudomonas##2##3##(2007-7#1)(2010-4#1)
such as Pythium##2##3##(2008-10#2)
such as R##2##3##(2008-10#1)(2012-2#1)
such as RNAi##2##3##(2008-4#1)(2012-2#1)
such as T##2##3##(2008-9#1)(2010-3#1)
such as UV##2##3##(2008-5#1)(2011-2#1)
such as X-Ray##2##3##(2008-7#1)(2013-1#1)
such as a laser##3##4##(2008-3#3)
such as a tumor##2##4##(2008-3#1)(2009-10#1)
such as a##52##3##(1990-8#1)(1994-6#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#13)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
such as accuracy##3##3##(2008-10#2)(2013-1#1)
such as acetonitrile##2##3##(1994-9#1)(2008-10#1)
such as acetylsalicylic acid##2##4##(2008-10#2)
such as acidity##3##3##(2008-10#3)
such as actin##2##3##(1993-8#1)(2008-9#1)
such as advanced##2##3##(1994-3#1)(2009-5#1)
such as adverse##2##3##(2009-7#1)(2011-2#1)
such as age and##4##4##(1990-3#1)(1994-3#1)(2012-12#1)(2013-8#1)
such as age##13##3##(1990-3#1)(1990-8#1)(1992-8#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
such as aggressive##2##3##(2007-12#1)(2008-11#1)
such as aging##2##3##(2008-10#1)(2009-5#1)
such as air##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
such as alcohol##3##3##(2010-4#1)(2010-5#1)(2013-8#1)
such as alkaline##2##3##(1993-11#1)(2008-11#1)
such as amphetamine and##2##4##(1993-3#1)(2008-10#1)
such as an aircraft##2##4##(1996-12#1)(2008-2#1)
such as an##15##3##(1995-11#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-2#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
such as angiotensin##2##3##(1991-5#1)(2008-4#1)
such as antibiotics##3##3##(1992-3#1)(2008-11#1)(2011-1#1)
such as antibodies or##2##4##(2008-11#1)(2008-4#1)
such as antimicrobial##2##3##(2008-10#1)(2013-1#1)
such as antitumor##2##3##(2011-3#1)(2012-3#1)
such as anxiety##3##3##(1990-3#1)(2008-11#2)
such as apoptosis##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
such as applied##3##3##(2008-10#2)(2008-12#1)
such as are##2##3##(1997-3#1)(2008-9#1)
such as aromatic##2##3##(2008-10#1)(2010-7#1)
such as arthritis##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
such as ascorbate##2##3##(2008-10#2)
such as ascorbic acid and##2##5##(1993-2#1)(2008-10#1)
such as ascorbic acid##3##4##(1993-2#1)(2008-10#2)
such as asthma##4##3##(1994-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
such as atherosclerosis and##3##4##(2008-3#1)(2010-5#1)(2012-12#1)
such as atherosclerosis##8##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)
such as atmospheric##2##3##(2008-11#1)(2008-3#1)
such as atopic dermatitis##2##4##(2008-3#1)(2011-1#1)
such as auxin##2##3##(2011-1#2)
such as balanced##2##3##(2010-8#1)(2013-8#1)
such as bcl-2##3##3##(2008-11#2)(2008-7#1)
such as being##5##3##(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
such as bending##2##3##(2008-3#1)(2009-7#1)
such as benzene and##2##4##(2008-10#2)
such as binder##2##3##(2008-1#1)(2008-10#1)
such as biomass##2##3##(2008-5#1)(2008-9#1)
such as bisphosphonates##2##3##(1996-11#1)(2008-8#1)
such as bladder##2##3##(2008-5#1)(2010-3#1)
such as blood##5##3##(2008-10#3)(2010-4#1)(2012-2#1)
such as body mass index##2##5##(2008-7#2)
such as body##3##3##(2008-7#2)(2010-5#1)
such as bone##4##3##(2008-9#1)(2011-7#1)(2012-12#1)(2012-2#1)
such as bovine##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
such as brain##5##3##(2008-10#1)(2008-6#1)(2011-2#2)(2012-12#1)
such as breast cancer##3##4##(1997-3#1)(1997-8#1)(2012-2#1)
such as breast##4##3##(1994-6#1)(1997-3#1)(1997-8#1)(2012-2#1)
such as by##3##3##(1997-3#1)(2008-10#1)(2010-11#1)
such as cadmium##2##3##(2008-10#2)
such as calibration##2##3##(2007-12#1)(2008-10#1)
such as cancer and##2##4##(2010-11#1)(2012-2#1)
such as cancer##7##3##(1992-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
such as candidate##2##3##(2008-8#1)(2012-3#1)
such as carbon##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
such as cardiovascular diseases##2##4##(1991-11#1)(2008-10#1)
such as cardiovascular##4##3##(1991-11#1)(2008-10#1)(2008-7#1)(2010-7#1)
such as cell cycle##2##4##(2009-6#1)(2012-12#1)
such as cell proliferation##4##4##(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)
such as cell signaling##2##4##(2008-9#1)(2011-2#1)
such as cell##17##3##(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-5#1)(2013-8#1)
such as cells##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
such as cellular##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
such as cellulose##2##3##(2008-10#1)(2011-2#1)
such as central##2##3##(2008-10#1)(2011-1#1)
such as cetyltrimethylammonium##2##3##(2008-10#2)
such as changes in##6##4##(1992-12#1)(1992-5#1)(1997-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
such as chemical##3##3##(1994-5#1)(1995-11#1)(2008-3#1)
such as chest pain##3##4##(2007-8#1)(2010-1#1)(2012-3#1)
such as chest##4##3##(2007-8#1)(2008-1#1)(2010-1#1)(2012-3#1)
such as chestnut blight##2##4##(2008-10#2)
such as chloride##2##3##(1994-5#2)
such as chlorophyll##2##3##(2008-12#2)
such as chronic##3##3##(2008-3#1)(2008-5#1)(2010-10#1)
such as citrate##2##3##(2008-10#1)(2010-4#1)
such as cleft##2##3##(1993-12#1)(2007-12#1)
such as clinical##4##3##(1994-12#1)(1997-4#1)(2007-4#1)(2008-11#1)
such as cluster##3##3##(2008-10#2)(2009-11#1)
such as cognitive##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
such as collagen##3##3##(2008-5#1)(2008-9#1)(2012-2#1)
such as collateral##2##3##(2007-10#1)(2010-6#1)
such as commercial##3##3##(2008-10#2)(2009-7#1)
such as communication##2##3##(1994-2#1)(2008-12#1)
such as competition##3##3##(2008-10#1)(2008-9#2)
such as computed tomography and magnetic resonance imaging##2##8##(2008-2#1)(2008-7#1)
such as concentration of##2##4##(2008-10#2)
such as confocal##2##3##(2007-11#1)(2008-9#1)
such as continuous##3##3##(1997-7#1)(2007-12#1)(2011-1#1)
such as controlled##2##3##(2008-10#1)(2008-2#1)
such as corn##2##3##(2008-5#1)(2008-6#1)
such as critical##3##3##(2008-2#1)(2008-5#1)(2010-8#1)
such as crude oil##2##4##(2008-10#2)
such as cucumber##2##3##(2008-10#1)(2013-8#1)
such as cystic fibrosis##2##4##(2008-5#1)(2011-3#1)
such as deep##2##3##(1994-3#1)(2012-3#1)
such as deposition##2##3##(2008-10#1)(2008-3#1)
such as depression and##2##4##(2008-11#1)(2012-2#1)
such as depression##6##3##(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
such as detection limit##2##4##(2008-10#2)
such as detection##3##3##(2008-10#3)
such as detector##2##3##(2008-10#1)(2008-2#1)
such as diabetes##6##3##(1995-2#1)(1996-12#1)(2007-7#1)(2011-3#1)(2012-2#1)(2013-8#1)
such as diabetic##2##3##(2007-8#1)(2008-1#1)
such as diazepam##2##3##(1991-12#1)(1992-3#1)
such as different##2##3##(1997-2#1)(1997-4#1)
such as diffractive optical elements##2##5##(2008-3#2)
such as direct##4##3##(1997-3#1)(2008-2#1)(2008-6#1)(2012-12#1)
such as disease##6##3##(1995-12#1)(1995-2#1)(1996-3#1)(2008-10#2)(2011-2#1)
such as dopamine##5##3##(1995-11#1)(1995-8#1)(2008-10#3)
such as drug##3##3##(1994-5#1)(2009-5#1)(2011-2#1)
such as dual##2##3##(2008-1#1)(2013-8#1)
such as dynamic##2##3##(2007-8#1)(2008-7#1)
such as education##2##3##(2011-1#2)
such as effect of##2##4##(2008-10#2)
such as egg##2##3##(2008-8#1)(2008-9#1)
such as elevated##4##3##(2007-9#1)(2008-7#1)(2010-4#1)(2012-2#1)
such as energy##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
such as enhanced##3##3##(2008-8#1)(2009-6#1)(2012-2#1)
such as environmental##2##3##(2008-10#2)
such as ethanol##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
such as evaporation##2##3##(2008-10#1)(2009-11#1)
such as exercise##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
such as facial##2##3##(2008-12#1)(2008-9#1)
such as family##3##3##(1992-1#1)(2011-1#1)(2012-2#1)
such as fatigue and##2##4##(2009-1#1)(2012-1#1)
such as feeding##2##3##(2008-10#1)(2009-9#1)
such as fetal##2##3##(1996-2#1)(2010-3#1)
such as fever##2##3##(2009-4#1)(2012-2#1)
such as film##3##3##(2008-10#2)(2008-2#1)
such as flame##3##3##(2008-10#2)(2008-3#1)
such as flavonoids##2##3##(2008-10#1)(2011-2#1)
such as flow cytometry and##2##5##(2008-9#1)(2010-7#1)
such as flow injection analysis (FIA)##2##6##(2008-10#2)
such as flow##8##3##(2008-10#5)(2008-9#1)(2010-7#1)(2011-1#1)
such as fluorescence##3##3##(2007-12#1)(2008-2#1)(2010-7#1)
such as fluoride##2##3##(1990-2#1)(2008-10#1)
such as food##2##3##(1994-3#1)(2012-12#1)
such as for##2##3##(2007-11#1)(2008-10#1)
such as freshwater##2##3##(2008-12#1)(2008-8#1)
such as from##3##3##(2008-1#1)(2008-3#1)(2011-1#1)
such as fructose and##2##4##(1995-11#1)(2008-7#1)
such as gastrointestinal##5##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-7#1)
such as gender##2##3##(1993-12#1)(2007-7#1)
such as gene expression##3##4##(2008-8#1)(2010-11#1)(2011-3#1)
such as gene therapy##2##4##(2008-11#1)(2013-8#1)
such as gene##8##3##(2008-11#1)(2008-3#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-3#1)(2013-8#1)
such as genes##2##3##(2009-11#1)(2010-11#1)
such as genetic##6##3##(1995-1#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-8#2)
such as genetically##2##3##(2008-11#1)(2008-7#1)
such as geographic##2##3##(1997-1#1)(2008-10#1)
such as glass##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
such as glucose##6##3##(1992-12#1)(1994-8#1)(2008-10#2)(2008-6#1)(2011-1#1)
such as glutathione##3##3##(1992-9#1)(2008-5#2)
such as glycerol##2##3##(2008-11#1)(2008-6#1)
such as growth##3##3##(2008-5#1)(2010-5#1)(2011-2#1)
such as head##2##3##(2007-12#1)(2011-2#1)
such as health care##2##4##(1995-1#1)(2008-11#1)
such as health##4##3##(1995-1#1)(1996-3#1)(2008-11#1)(2010-12#1)
such as healthy##2##3##(2008-10#1)(2011-2#1)
such as heart attack##2##4##(2008-5#1)(2013-8#1)
such as heart##5##3##(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
such as heat##2##3##(1996-12#1)(1996-2#1)
such as heavy##2##3##(2008-11#1)(2008-12#1)
such as hemoglobin##2##3##(1990-8#1)(2008-1#1)
such as high##10##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
such as histidine##2##3##(1990-11#1)(2008-1#1)
such as honey##2##3##(2008-10#2)
such as hospital##5##3##(1993-2#1)(1995-3#1)(1996-3#1)(2008-11#1)(2012-12#1)
such as hospitals and##2##4##(1992-3#1)(2012-12#1)
such as hospitals##3##3##(1992-3#1)(2007-12#1)(2012-12#1)
such as host##2##3##(1997-7#1)(2008-10#1)
such as how##3##3##(1993-11#1)(2007-12#1)(2009-5#1)
such as human immunodeficiency virus (HIV)##3##6##(1992-12#1)(2008-4#1)(2008-9#1)
such as human immunodeficiency virus##4##5##(1992-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
such as human##12##3##(1992-10#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2011-2#1)
such as hydrogen##5##3##(2007-11#1)(2008-10#2)(2010-12#1)(2010-5#1)
such as hydrophobic interaction##2##4##(2008-10#2)
such as hypertension and diabetes##4##5##(1996-11#1)(2007-8#1)(2008-1#1)(2008-4#1)
such as hypertension or##2##4##(2007-10#1)(2009-5#1)
such as hypertension##11##3##(1996-11#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-2#1)
such as image##2##3##(2008-6#2)
such as impact##2##3##(1997-3#1)(2008-3#1)
such as improved##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
such as in the##5##4##(2008-10#2)(2008-7#2)(2011-2#1)
such as in##21##3##(1994-8#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#3)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
such as increased##8##3##(1997-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-8#1)(2012-12#1)(2013-8#1)
such as individual##2##3##(2009-9#1)(2011-2#1)
such as infection and##2##4##(2008-10#1)(2012-2#1)
such as infection##5##3##(1994-11#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-2#1)
such as infectious##2##3##(1992-2#1)(2013-1#1)
such as inflammation##2##3##(2009-11#1)(2011-2#1)
such as influenza##2##3##(2008-8#1)(2013-8#1)
such as injection##2##3##(2008-10#2)
such as insects##2##3##(2009-8#1)(2010-3#1)
such as insulin and##2##4##(1990-8#1)(2008-4#1)
such as insulin##3##3##(1990-8#1)(2008-4#1)(2008-8#1)
such as internal##3##3##(1994-12#1)(2010-5#1)(2011-2#1)
such as iron and##2##4##(1995-3#1)(2008-10#1)
such as iron##3##3##(1995-3#1)(2008-10#2)
such as ischemic heart disease##2##5##(1992-9#1)(2008-1#1)
such as ischemic##3##3##(1992-9#1)(2008-1#1)(2008-7#1)
such as its##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)
such as joint##2##3##(2007-7#1)(2012-2#1)
such as kin##2##3##(2010-4#1)(2013-1#1)
such as lead##2##3##(1995-3#1)(2008-10#1)
such as learning##2##3##(1995-1#1)(2008-10#1)
such as length##3##3##(1995-12#1)(1995-6#1)(2010-9#1)
such as leukotriene modifiers##2##4##(2010-1#2)
such as leukotriene##3##3##(2010-1#2)(2012-12#1)
such as leukotrienes##2##3##(1992-2#1)(2010-1#1)
such as ligand##2##3##(2008-4#1)(2008-5#1)
such as light##2##3##(2007-12#1)(2010-12#1)
such as linear discriminant analysis##2##5##(2008-10#2)
such as linear##4##3##(1995-12#1)(2008-10#2)(2008-3#1)
such as linearity##2##3##(2008-10#1)(2009-8#1)
such as liquid-liquid extraction##2##4##(2008-10#2)
such as local##2##3##(1996-4#1)(2008-7#1)
such as long##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
such as long-term##2##3##(1995-2#1)(2012-3#1)
such as loss##2##3##(2008-11#2)
such as low##4##3##(2008-10#2)(2008-2#1)(2013-1#1)
such as lower##2##3##(2008-10#1)(2010-9#1)
such as lung##2##3##(2008-6#1)(2010-8#1)
such as lupus erythematosus##2##4##(1992-5#1)(2011-2#1)
such as lupus##3##3##(1992-5#1)(2007-5#1)(2011-2#1)
such as macrophages##3##3##(1995-5#1)(2008-10#1)(2008-4#1)
such as magnetic resonance imaging##2##5##(2008-8#1)(2009-11#1)
such as magnetic##4##3##(2008-1#1)(2008-8#1)(2009-11#1)(2013-1#1)
such as major##2##3##(2008-7#1)(2010-8#1)
such as mammography##2##3##(2010-8#1)(2011-1#1)
such as mass##2##3##(2008-10#1)(2011-2#1)
such as maternal##2##3##(1996-12#1)(2010-6#1)
such as meat and##2##4##(2008-10#2)
such as mechanical##2##3##(1994-3#1)(2009-12#1)
such as medical##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
such as metabolic##2##3##(2010-1#1)(2011-2#1)
such as metal##2##3##(2008-10#2)
such as metalaxyl##2##3##(2008-10#2)
such as methanol content##3##4##(2008-10#3)
such as methanol##4##3##(1994-9#1)(2008-10#3)
such as methicillin-resistant Staphylococcus aureus##2##5##(2008-12#1)(2008-3#1)
such as methyl##2##3##(2008-10#1)(2008-3#1)
such as microarrays##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
such as mitochondria##2##3##(2008-7#1)(2009-8#1)
such as molecular##3##3##(2008-3#1)(2010-4#1)(2010-7#1)
such as monitoring##2##3##(2008-3#1)(2008-7#1)
such as mood##2##3##(2008-1#1)(2010-8#1)
such as morphine##2##3##(2008-11#1)(2008-7#1)
such as motion##2##3##(2007-2#1)(2010-8#1)
such as multiple sclerosis##4##4##(2008-12#1)(2011-2#2)(2012-3#1)
such as multiple##8##3##(2008-10#1)(2008-12#1)(2011-2#4)(2012-3#1)(2013-1#1)
such as muscle##4##3##(1992-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
such as myocardial infarction##2##4##(1997-5#1)(2013-8#1)
such as naltrexone##2##3##(2008-2#1)(2009-7#1)
such as natural##2##3##(2008-10#2)
such as nausea##2##3##(1995-5#1)(1997-8#1)
such as neural##2##3##(1990-11#1)(2011-2#1)
such as neurons##3##3##(2008-11#2)(2008-8#1)
such as nickel##2##3##(2008-10#1)(2008-3#1)
such as nitrate##2##3##(2008-10#2)
such as nitric oxide##3##4##(1994-8#1)(2008-3#1)(2011-2#1)
such as nucleic acids##2##4##(1996-9#1)(2010-5#1)
such as number of##3##4##(1993-12#1)(2008-9#1)(2012-9#1)
such as nutrients and##2##4##(2008-10#1)(2009-8#1)
such as obesity##2##3##(2008-10#1)(2011-2#1)
such as on##2##3##(2008-2#1)(2011-2#1)
such as optical##7##3##(2008-3#4)(2009-12#1)(2010-5#1)(2012-2#1)
such as oral##3##3##(2008-7#2)(2011-1#1)
such as organic matter##2##4##(2008-10#1)(2010-5#1)
such as organic##5##3##(2008-10#3)(2008-12#1)(2010-5#1)
such as osteoblasts and##2##4##(2008-11#2)
such as oxygen##2##3##(2008-10#1)(2010-4#1)
such as oxytocin##2##3##(2008-4#2)
such as pH and the##2##5##(2008-10#2)
such as pH and##5##4##(2008-10#4)(2011-1#1)
such as pH of##3##4##(2008-10#3)
such as pH value##2##4##(2008-10#2)
such as pH##30##3##(1995-11#1)(2008-10#27)(2008-6#1)(2011-1#1)
such as partial##2##3##(2008-10#2)
such as particle##2##3##(2008-5#1)(2012-2#1)
such as patient##2##3##(2010-8#1)(2013-8#1)
such as patients with##2##4##(2010-8#1)(2011-2#1)
such as peptides and##2##4##(2008-10#1)(2010-12#1)
such as percutaneous##2##3##(1995-2#1)(2010-8#1)
such as phosphorylation##2##3##(2008-5#1)(2009-5#1)
such as physical##3##3##(1994-8#1)(2008-11#1)(2011-2#1)
such as physician##2##3##(1996-1#1)(1997-3#1)
such as plant##2##3##(2008-10#1)(2008-12#1)
such as polychlorinated##2##3##(2008-10#1)(2008-7#1)
such as poor##2##3##(2008-11#1)(2012-3#1)
such as population##4##3##(2008-11#1)(2008-5#2)(2008-8#1)
such as pore##2##3##(2008-7#1)(2010-10#1)
such as pork##2##3##(2007-12#1)(2008-10#1)
such as positron emission tomography##2##5##(2008-2#1)(2008-8#1)
such as potassium##4##3##(2006-4#1)(2008-10#3)
such as predation##2##3##(2008-9#1)(2012-3#1)
such as preeclampsia##2##3##(2008-10#1)(2013-1#1)
such as presence of##4##4##(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
such as prevention of##2##4##(2013-7#1)(2013-8#1)
such as price##2##3##(1996-3#1)(2008-12#1)
such as primary##3##3##(1992-12#1)(2010-12#1)(2011-1#1)
such as principal component analysis##2##5##(2008-10#1)(2013-1#1)
such as principal##3##3##(2008-10#2)(2013-1#1)
such as propylene glycol##2##4##(1991-5#1)(2008-5#1)
such as protecting##2##3##(1994-9#1)(2008-7#1)
such as protein##6##3##(1994-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
such as proteins and##2##4##(2007-11#1)(2009-8#1)
such as proteins##6##3##(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#1)
such as providing##3##3##(2011-1#1)(2012-12#1)(2012-3#1)
such as psoriasis##2##3##(2011-2#1)(2013-1#1)
such as public##3##3##(1991-12#1)(1996-1#1)(1996-3#1)
such as pulmonary##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
such as pyridine##2##3##(2009-9#1)(2012-12#1)
such as quality##2##3##(1995-1#1)(2008-3#1)
such as quercetin##2##3##(2008-10#1)(2008-4#1)
such as radiotherapy##2##3##(2007-11#1)(2010-8#1)
such as ranging##2##3##(2008-3#2)
such as rates of##2##4##(2007-12#1)(2009-8#1)
such as rats##2##3##(2009-10#2)
such as reactive##2##3##(2008-5#1)(2008-7#1)
such as reagent##2##3##(2008-10#2)
such as real-time##2##3##(2008-7#1)(2010-6#1)
such as receptor##2##3##(2008-7#1)(2009-9#1)
such as recurrent##3##3##(2008-8#2)(2011-3#1)
such as reduced##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
such as reduction of##2##4##(1991-12#1)(2008-11#1)
such as refractive##2##3##(2008-2#2)
such as religion##3##3##(2009-6#2)(2009-7#1)
such as renal##3##3##(1992-8#1)(2007-7#1)(2008-7#1)
such as reproducibility##3##3##(2008-10#3)
such as resolution##2##3##(2007-11#1)(2011-2#1)
such as respiratory##2##3##(1997-8#1)(2012-2#1)
such as restriction##2##3##(2008-10#1)(2008-2#1)
such as rhesus macaques##2##4##(2008-4#1)(2012-3#1)
such as rheumatoid arthritis##3##4##(1993-11#1)(2010-5#1)(2013-1#1)
such as rhodamine##2##3##(2008-10#1)(2008-9#1)
such as rigidity and##2##4##(2008-12#1)(2008-7#1)
such as sample volume##2##4##(2008-10#2)
such as sample##7##3##(2008-10#6)(2008-2#1)
such as scanning electron microscopy (SEM) and##2##7##(2008-10#1)(2009-7#1)
such as scanning##4##3##(2008-10#3)(2009-7#1)
such as schizophrenia##3##3##(1991-2#1)(2008-5#1)(2009-6#1)
such as seawater##2##3##(2008-10#2)
such as selection##2##3##(1992-12#1)(2008-10#1)
such as selective##2##3##(1990-3#1)(2008-10#1)
such as sensitivity##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
such as serum##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
such as service##2##3##(1993-3#1)(2008-12#1)
such as severe##2##3##(2007-12#1)(2009-6#1)
such as sex##4##3##(1993-11#1)(2008-7#1)(2010-3#1)(2013-7#1)
such as shape##2##3##(1992-2#1)(2008-3#1)
such as signal##2##3##(2008-3#1)(2010-9#1)
such as skin##9##3##(2008-3#2)(2008-5#6)(2010-8#1)
such as sleep##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)
such as social##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
such as sodium (Na(+))##2##4##(2008-10#1)(2010-7#1)
such as sodium##8##3##(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#1)(2010-7#1)(2012-2#1)
such as solar##2##3##(2008-2#1)(2008-5#1)
such as solubility##2##3##(1992-8#1)(2013-1#1)
such as solution pH##2##4##(2008-10#2)
such as solution##3##3##(1991-11#1)(2008-10#2)
such as some##2##3##(2006-6#1)(2008-3#1)
such as sonication time##5##4##(2008-10#5)
such as sonication##6##3##(2008-10#5)(2008-11#1)
such as squirrel monkeys##2##4##(2008-4#1)(2012-3#1)
such as starch##2##3##(1990-12#1)(2008-10#1)
such as stress##2##3##(2007-12#1)(2008-11#1)
such as superoxide dismutase (SOD)##2##5##(1991-9#1)(2008-7#1)
such as superoxide dismutase##4##4##(1991-9#1)(1992-9#1)(2008-10#1)(2008-7#1)
such as superoxide##6##3##(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(2008-10#1)(2008-7#1)
such as systemic##2##3##(2008-12#1)(2013-1#1)
such as tannins##2##3##(2008-12#1)(2013-8#1)
such as temperature##9##3##(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2013-8#1)
such as that in##2##4##(1990-7#1)(2008-1#1)
such as that of##2##4##(2008-4#1)(2008-7#1)
such as that##8##3##(1990-6#1)(1990-7#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
such as the European##2##4##(1995-6#1)(2008-10#1)
such as the International##3##4##(2008-10#1)(2010-11#1)(2013-7#1)
such as the Sun##2##4##(2008-2#2)
such as the Wolf method##2##5##(2013-1#2)
such as the availability of##2##5##(2007-7#1)(2008-1#1)
such as the chemical##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
such as the concentration##2##4##(2008-10#2)
such as the detection of##5##5##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#2)
such as the dorsal##2##4##(1993-12#2)
such as the existence of##2##5##(2007-12#1)(2008-7#1)
such as the flow##2##4##(2008-10#1)(2008-7#1)
such as the formation of##3##5##(1992-12#1)(2007-12#1)(2012-2#1)
such as the green##2##4##(2008-1#1)(2012-2#1)
such as the orbitofrontal cortex and amygdala that##2##8##(2009-10#2)
such as the pH value##2##5##(2008-10#2)
such as the pH##4##4##(2008-10#4)
such as the potential##2##4##(1997-2#1)(2009-12#1)
such as the presence of##3##5##(1996-3#1)(2008-10#1)(2008-11#1)
such as the presence##4##4##(1996-3#1)(2007-5#1)(2008-10#1)(2008-11#1)
such as the role of##2##5##(2008-1#1)(2008-4#1)
such as the selection of##2##5##(2008-10#1)(2009-8#1)
such as the skin##2##4##(1994-3#1)(2008-10#1)
such as the study##2##4##(1991-12#1)(2012-12#1)
such as the thickness##2##4##(1994-11#1)(2008-3#1)
such as the use of##7##5##(1993-6#1)(2008-10#4)(2011-1#1)(2012-3#1)
such as the##349##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#11)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#8)(2008-10#61)(2008-11#11)(2008-12#3)(2008-2#20)(2008-3#23)(2008-4#6)(2008-5#9)(2008-6#7)(2008-7#16)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#4)(2010-1#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#2)(2011-4#1)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#3)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#6)
such as their##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
such as thermal##2##3##(2008-2#2)
such as these##4##3##(2008-11#1)(2008-6#1)(2008-8#1)(2010-11#1)
such as this##3##3##(1992-6#1)(2008-11#1)(2008-8#1)
such as those in the##3##5##(1991-12#1)(2010-1#1)(2012-12#1)
such as those of##2##4##(2008-11#1)(2013-1#1)
such as those on##2##4##(1996-11#1)(2008-3#1)
such as those with##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
such as those##28##3##(1990-6#1)(1991-12#1)(1992-6#1)(1993-5#1)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-4#1)(2012-12#1)(2012-2#3)(2013-1#2)
such as time##4##3##(1997-8#1)(2008-11#2)(2010-9#1)
such as tissue##3##3##(2007-12#1)(2008-1#1)(2009-8#1)
such as to##3##3##(1993-11#1)(2008-11#1)(2008-6#1)
such as tobacco##4##3##(1991-4#1)(1992-9#1)(2008-10#1)(2012-12#1)
such as total##2##3##(2011-2#1)(2013-1#1)
such as toxicity##2##3##(2008-10#1)(2008-8#1)
such as transcription factors##2##4##(2008-11#1)(2011-2#1)
such as transcription##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
such as transepidermal water loss##2##5##(2008-5#2)
such as trauma##4##3##(1991-2#1)(1996-3#1)(2009-5#1)(2010-9#1)
such as treatment of##2##4##(2011-2#2)
such as treatment##4##3##(2011-1#1)(2011-2#2)(2012-2#1)
such as tryptophan##2##3##(2008-4#1)(2010-6#1)
such as tuberculosis##2##3##(2009-7#1)(2012-2#1)
such as tumor##3##3##(1991-12#1)(2008-11#1)(2010-2#1)
such as tumour necrosis factor-alpha##2##5##(2007-11#2)
such as tumour##3##3##(1996-12#1)(2007-11#2)
such as type 2 diabetes##3##5##(2008-4#1)(2009-11#1)(2010-8#1)
such as type##4##3##(2008-4#2)(2009-11#1)(2010-8#1)
such as types of##4##4##(1994-12#2)(2008-10#2)
such as uncertainty and##2##4##(2008-2#1)(2013-1#1)
such as uncertainty##3##3##(2008-2#1)(2009-5#1)(2013-1#1)
such as understanding##2##3##(1997-3#1)(2007-12#1)
such as unwanted##2##3##(2007-12#1)(2008-1#1)
such as vascular endothelial growth factor (VEGF)##3##7##(2008-1#2)(2010-7#1)
such as vascular##4##3##(2008-1#2)(2008-4#1)(2010-7#1)
such as ventricular##3##3##(2010-6#1)(2010-8#1)(2012-3#1)
such as vertical##2##3##(1997-2#1)(2011-2#1)
such as viscosity##2##3##(2008-7#1)(2011-2#1)
such as vitamin E##2##4##(1991-9#1)(2008-1#1)
such as vitamin##4##3##(1991-9#1)(1992-9#1)(2008-1#2)
such as vitiligo##2##3##(1996-3#1)(2011-2#1)
such as water##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
such as whole##2##3##(2008-4#1)(2009-11#1)
such as with glucose and fructose##2##6##(2008-10#2)
such as with##3##3##(2007-11#1)(2008-10#2)
such as women##2##3##(1996-5#1)(2008-1#1)
such as working##2##3##(1991-12#1)(2008-10#1)
such as##3533##2##(1990-11#9)(1990-12#2)(1990-2#7)(1990-3#8)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#12)(1990-9#2)(1991-1#3)(1991-11#3)(1991-12#19)(1991-2#5)(1991-3#7)(1991-4#2)(1991-5#8)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#11)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#14)(1992-2#6)(1992-3#9)(1992-4#1)(1992-5#7)(1992-6#6)(1992-8#11)(1992-9#11)(1993-1#2)(1993-11#13)(1993-12#11)(1993-2#13)(1993-3#6)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#11)(1994-12#15)(1994-2#16)(1994-3#19)(1994-5#13)(1994-6#7)(1994-8#18)(1994-9#13)(1995-1#6)(1995-11#18)(1995-12#14)(1995-2#12)(1995-3#13)(1995-5#11)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#9)(1996-11#6)(1996-12#19)(1996-2#10)(1996-3#16)(1996-4#3)(1996-5#10)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#14)(1997-2#12)(1997-3#16)(1997-4#9)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#10)(2006-10#2)(2006-4#2)(2006-6#1)(2007-10#6)(2007-11#39)(2007-12#57)(2007-2#6)(2007-4#6)(2007-5#7)(2007-6#1)(2007-7#16)(2007-8#18)(2007-9#2)(2008-1#65)(2008-10#678)(2008-11#149)(2008-12#51)(2008-2#104)(2008-3#158)(2008-4#78)(2008-5#124)(2008-6#51)(2008-7#163)(2008-8#92)(2008-9#76)(2009-1#3)(2009-10#15)(2009-11#16)(2009-12#15)(2009-2#6)(2009-3#7)(2009-4#9)(2009-5#22)(2009-6#12)(2009-7#18)(2009-8#41)(2009-9#15)(2010-1#13)(2010-10#6)(2010-11#18)(2010-12#34)(2010-2#8)(2010-3#22)(2010-4#23)(2010-5#25)(2010-6#11)(2010-7#19)(2010-8#43)(2010-9#7)(2011-1#62)(2011-2#145)(2011-3#18)(2011-4#1)(2011-7#3)(2012-1#16)(2012-12#61)(2012-2#80)(2012-3#46)(2012-5#2)(2012-6#1)(2012-9#2)(2013-1#87)(2013-7#16)(2013-8#47)
such assays##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
such association##3##2##(2008-10#2)(2008-9#1)
such atmospheres##2##2##(1996-12#1)(2011-2#1)
such beams##2##2##(2007-11#1)(2008-3#1)
such behavior##3##2##(1993-11#1)(2008-3#1)(2008-8#1)
such behaviour##2##2##(1996-11#1)(2008-11#1)
such binding##2##2##(1991-12#1)(2009-12#1)
such biological##2##2##(2011-2#1)(2013-1#1)
such building##2##2##(1991-12#1)(2008-2#1)
such candidate##2##2##(1996-2#1)(2008-2#1)
such case in a##2##4##(2010-5#1)(2011-1#1)
such case in##3##3##(2008-7#1)(2010-5#1)(2011-1#1)
such case##11##2##(2007-7#2)(2008-11#1)(2008-7#3)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
such cases can##2##3##(2011-1#1)(2013-8#1)
such cases have##3##3##(2010-6#2)(2013-1#1)
such cases is##3##3##(1996-11#1)(2010-12#1)(2013-1#1)
such cases##50##2##(1990-9#1)(1991-11#1)(1991-5#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
such cells##6##2##(1992-2#1)(1994-10#1)(1995-11#1)(2008-10#1)(2008-11#2)
such challenges##2##2##(2010-7#1)(2011-2#1)
such change##2##2##(2007-7#1)(2013-1#1)
such changes##11##2##(1990-6#1)(1993-3#1)(1994-1#2)(1995-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)(2013-1#1)
such children##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
such circumstances##6##2##(1994-2#1)(1997-3#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
such claims##3##2##(2008-5#1)(2009-5#1)(2013-8#1)
such collaboration##2##2##(1992-1#1)(2008-11#1)
such combination##2##2##(2008-10#1)(2011-2#1)
such common##4##2##(1995-12#1)(2008-1#1)(2008-10#2)
such complex##4##2##(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
such complications##3##2##(2009-6#1)(2011-2#1)(2012-8#1)
such compounds##3##2##(1991-12#1)(1993-12#1)(2008-11#1)
such conditions it is##2##4##(1997-4#1)(2008-3#1)
such conditions##11##2##(1990-12#1)(1994-12#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2013-8#1)
such contexts##2##2##(2008-7#1)(2010-12#1)
such correlation##2##2##(2008-11#1)(2008-8#1)
such correlations were##2##3##(2008-10#2)
such correlations##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
such critical##2##2##(1994-2#1)(2008-6#1)
such damage##3##2##(1991-2#1)(1995-6#1)(2008-10#1)
such data are##2##3##(1992-6#1)(2008-10#1)
such data for##2##3##(1997-4#1)(2008-8#1)
such data to##2##3##(1996-12#1)(2013-1#1)
such data##19##2##(1991-12#2)(1992-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-1#1)
such databases##2##2##(1997-1#1)(2008-3#1)
such deaths in##2##3##(1997-8#1)(2010-1#1)
such determinations##2##2##(1993-3#1)(2008-10#1)
such developments##2##2##(2009-8#1)(2013-8#1)
such devices is##3##3##(2008-10#1)(2009-11#1)(2010-5#1)
such devices##9##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#3)(2009-11#2)(2010-5#1)
such difference##3##2##(1996-3#1)(2008-5#1)(2013-1#1)
such differences##5##2##(1992-8#1)(1997-2#1)(2008-10#1)(2009-7#1)(2013-1#1)
such difficulties##2##2##(1993-2#1)(2008-12#1)
such diseases as##2##3##(2009-5#1)(2013-1#1)
such diseases##5##2##(2008-4#2)(2009-5#1)(2013-1#1)(2013-8#1)
such diverse##4##2##(2007-8#1)(2008-10#1)(2009-8#1)(2010-7#1)
such drugs##4##2##(1992-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
such dynamic##2##2##(2008-5#1)(2009-5#1)
such effects were##2##3##(1995-3#1)(2008-5#1)
such effects##11##2##(1991-5#1)(1995-3#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
such efforts##3##2##(1993-2#1)(1994-12#1)(1995-1#1)
such enhancement##2##2##(1991-12#1)(2008-9#1)
such environments##3##2##(2008-3#1)(2008-8#1)(2012-5#1)
such estimates of##2##3##(1994-11#1)(1997-7#1)
such estimates##4##2##(1992-3#1)(1994-11#1)(1997-7#1)(2008-8#1)
such events##3##2##(2009-10#1)(2011-2#1)(2013-7#1)
such evidence##2##2##(2008-8#1)(2011-2#1)
such examples##3##2##(2008-11#1)(2009-11#1)(2013-8#1)
such experience##3##2##(1992-12#1)(1993-12#1)(2008-11#1)
such experiences##4##2##(1991-12#1)(1992-2#1)(2008-11#1)(2009-7#1)
such experimental##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
such expression##2##2##(2008-10#1)(2013-1#1)
such factors as the##2##4##(1990-2#1)(2008-8#1)
such factors as##6##3##(1990-2#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-8#1)(2013-1#1)
such factors##7##2##(1990-2#1)(1995-2#1)(2007-11#2)(2008-11#1)(2008-8#1)(2013-1#1)
such family##3##2##(1995-2#1)(2008-3#1)(2008-7#1)
such fibers##3##2##(2007-11#3)
such films##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
such filters##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
such findings##5##2##(1992-12#1)(1995-11#1)(2008-2#1)(2008-8#1)(2013-1#1)
such flow##2##2##(1996-12#1)(2008-7#1)
such food##4##2##(2008-1#2)(2008-10#1)(2008-11#1)
such functional##2##2##(2008-7#1)(2009-5#1)
such functions##3##2##(1990-11#1)(1992-9#1)(1997-6#1)
such gene##2##2##(1997-3#1)(1997-7#1)
such gratings##2##2##(2007-12#1)(2008-3#1)
such groups##4##2##(1991-3#1)(1993-3#1)(2008-3#1)(2008-8#1)
such health care##2##3##(1994-12#1)(2010-3#1)
such high##4##2##(2008-3#2)(2009-6#1)(2012-2#1)
such images##4##2##(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)
such implants##2##2##(1992-4#1)(1996-3#1)
such important##3##2##(1995-5#1)(1996-1#1)(2008-7#1)
such in##3##2##(2008-7#1)(2009-7#1)(2012-2#1)
such infections##4##2##(1996-12#1)(2009-2#1)(2011-1#1)(2013-8#1)
such information is##2##3##(2008-4#1)(2013-1#1)
such information##10##2##(1995-1#1)(1997-3#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-2#1)(2013-1#1)
such inhibition##2##2##(1991-9#1)(1995-2#1)
such inhibitory##2##2##(1995-12#1)(2009-12#1)
such initiatives##2##2##(2010-12#1)(2011-1#1)
such injuries are##2##3##(2007-11#1)(2011-1#1)
such injuries##8##2##(1990-2#1)(1990-9#1)(1993-3#1)(2007-11#1)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
such interactions##8##2##(1995-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2010-10#1)
such interventions to##2##3##(2008-11#1)(2010-12#1)
such interventions##5##2##(2008-11#1)(2008-2#1)(2010-12#1)(2010-5#1)(2012-2#1)
such investigations##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2013-7#1)
such issues as##2##3##(1996-1#1)(1996-12#1)
such issues##6##2##(1992-3#1)(1996-1#1)(1996-12#1)(2008-7#1)(2008-9#1)(2009-5#1)
such it is##3##3##(2007-11#1)(2010-10#1)(2012-12#1)
such knowledge##2##2##(1997-6#1)(2008-10#1)
such lasers##6##2##(2007-11#3)(2007-12#1)(2008-3#1)(2008-9#1)
such lesions##9##2##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
such libraries##2##2##(2008-4#2)
such lines##3##2##(2007-12#1)(2008-11#2)
such links##2##2##(2008-2#1)(2010-3#1)
such low concentrations##2##3##(2008-10#1)(2013-1#1)
such low##7##2##(1993-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)(2013-7#1)
such materials##5##2##(2008-10#2)(2008-7#1)(2009-11#1)(2010-10#1)
such measurements are##2##3##(1992-12#1)(2007-12#1)
such measurements##7##2##(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#2)
such measures##6##2##(1992-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2013-1#1)
such mechanism##2##2##(2008-8#1)(2012-3#1)
such medical##2##2##(2007-10#1)(2008-11#1)
such men##2##2##(1993-8#2)
such methods##6##2##(1992-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
such model##4##2##(1997-3#1)(2008-1#1)(2008-9#1)(2013-1#1)
such models are##3##3##(1994-3#1)(2008-7#2)
such models##14##2##(1994-3#1)(1996-4#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2012-12#1)
such modifications##3##2##(2008-10#1)(2009-5#1)(2013-8#1)
such modified##2##2##(1997-3#1)(1997-4#1)
such mutants##2##2##(1990-11#1)(2008-10#1)
such mutations##2##2##(1990-5#1)(2009-5#1)
such new##2##2##(1997-1#1)(2008-10#1)
such noise##2##2##(2008-2#1)(2008-7#1)
such nonlinear JFTCs##2##3##(2008-3#2)
such observations##2##2##(2008-8#1)(2012-2#1)
such occurrences##2##2##(1991-3#1)(1992-2#1)
such online health communities##2##4##(2011-2#2)
such operations##2##2##(2008-11#1)(2008-4#1)
such parameters##2##2##(2008-10#1)(2008-11#1)
such particle##2##2##(2008-3#1)(2012-2#1)
such patients have##2##3##(1994-3#1)(2007-10#1)
such patients is a##2##4##(2007-8#1)(2008-9#1)
such patients is##5##3##(1995-11#1)(2007-11#1)(2007-8#2)(2008-9#1)
such patients with##4##3##(2008-7#2)(2010-12#1)(2011-2#1)
such patients##47##2##(1990-2#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-11#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#4)
such patterns##3##2##(1996-4#1)(2010-12#1)(2012-3#1)
such peptide##3##2##(1990-2#1)(2008-10#1)(2009-6#1)
such phenotypes##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
such populations##2##2##(2010-12#1)(2012-2#1)
such practices##3##2##(1991-12#1)(2008-5#1)(2012-3#1)
such predictions##4##2##(1996-4#2)(2008-11#1)(2013-8#1)
such problems##4##2##(1993-2#1)(2007-12#1)(2008-10#1)(2013-1#1)
such procedures##2##2##(1997-6#1)(2007-8#1)
such processes##4##2##(2007-12#1)(2007-4#1)(2008-7#1)(2013-1#1)
such processing##3##2##(1990-8#1)(2008-11#2)
such programs are##2##3##(1992-3#1)(1996-1#1)
such programs##15##2##(1991-1#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-5#1)(2012-12#4)
such projections##2##2##(1994-5#1)(2007-11#1)
such protective##2##2##(2008-5#1)(2013-1#1)
such proteins is##2##3##(1993-9#1)(2009-8#1)
such proteins##3##2##(1993-9#1)(2008-4#1)(2009-8#1)
such purposes##3##2##(2008-10#2)(2008-2#1)
such questions##2##2##(1997-6#1)(2008-11#1)
such rare##2##2##(2011-1#2)
such regions##2##2##(1992-6#1)(2012-1#1)
such relationships##2##2##(1991-3#1)(2009-4#1)
such research##2##2##(2007-11#1)(2011-3#1)
such residues##2##2##(1995-2#1)(2008-10#1)
such resistance##2##2##(2008-10#1)(2008-3#1)
such samples##7##2##(2008-10#3)(2008-11#3)(2008-12#1)
such secondary##2##2##(2008-10#1)(2008-6#1)
such selection##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
such sensors##3##2##(2007-11#1)(2008-10#2)
such sequences##5##2##(1990-11#1)(1997-4#3)(2007-11#1)
such services and##2##3##(1992-12#1)(2012-12#1)
such services##5##2##(1992-12#1)(1992-3#1)(1996-1#1)(2011-2#1)(2012-12#1)
such sets of##2##3##(2008-10#1)(2008-4#1)
such side effects##2##3##(1996-11#1)(2008-7#1)
such signals##3##2##(2008-9#1)(2010-7#1)(2013-8#1)
such significant##2##2##(2008-1#1)(2011-2#1)
such simulations##2##2##(2012-12#1)(2013-1#1)
such sites##2##2##(2008-7#1)(2009-5#1)
such situations##4##2##(2008-10#1)(2008-12#1)(2011-2#2)
such small##2##2##(2009-2#1)(2013-8#1)
such smoke##2##2##(1992-3#1)(2008-8#1)
such solutions##2##2##(2008-10#1)(2008-5#1)
such sources##2##2##(2007-12#2)
such species##3##2##(2008-10#2)(2008-9#1)
such strains##2##2##(2008-10#2)
such strategies are##2##3##(1994-3#1)(2008-8#1)
such strategies##4##2##(1994-3#1)(1997-2#1)(2008-1#1)(2008-8#1)
such studies have##3##3##(2008-4#1)(2009-10#1)(2013-1#1)
such studies is the##2##4##(2008-10#1)(2013-1#1)
such studies is to##2##4##(2008-6#1)(2010-12#1)
such studies is##4##3##(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#1)
such studies##21##2##(1993-6#1)(1994-12#2)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#4)
such substances##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
such support##2##2##(2008-11#1)(2011-2#1)
such system##4##2##(2008-12#1)(2008-2#1)(2008-5#1)(2013-8#1)
such systems is##3##3##(2008-3#1)(2008-9#1)(2013-8#1)
such systems##17##2##(1992-12#1)(1993-3#1)(1996-1#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-9#1)(2009-8#1)(2013-8#1)
such techniques##7##2##(1994-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-3#1)
such technologies##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
such technology##2##2##(2008-12#1)(2008-3#1)
such testing##4##2##(2007-7#1)(2008-12#1)(2012-12#1)(2013-8#1)
such tests##2##2##(2008-10#1)(2008-12#1)
such that a large##2##4##(2007-12#1)(2008-11#1)
such that a##11##3##(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-7#1)(2013-7#1)
such that each##3##3##(2008-8#1)(2009-2#1)(2010-12#1)
such that higher##2##3##(2008-10#1)(2010-6#1)
such that it becomes##2##4##(2007-10#1)(2008-8#1)
such that it is##2##4##(2008-2#1)(2012-12#1)
such that it##7##3##(2007-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-12#1)
such that one##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
such that only a##2##4##(2008-2#1)(2008-7#1)
such that only##4##3##(1997-2#1)(2008-2#2)(2008-7#1)
such that the overall##2##4##(2012-2#2)
such that the##33##3##(1990-7#1)(1994-5#2)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#8)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#2)
such that their##2##3##(2008-10#1)(2012-1#1)
such that these##2##3##(2008-1#1)(2011-2#1)
such that they are##2##4##(2008-12#1)(2010-5#1)
such that they##3##3##(2008-12#1)(2010-5#1)(2013-8#1)
such that we##2##3##(1997-3#1)(2008-8#1)
such that##134##2##(1990-7#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#26)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
such the##2##2##(2008-4#1)(2013-8#1)
such therapies##4##2##(1995-1#1)(2008-8#2)(2012-12#1)
such therapy##5##2##(1991-9#1)(2007-10#1)(2007-7#1)(2008-6#1)(2013-8#1)
such things as##3##3##(1995-1#1)(2007-11#1)(2012-3#1)
such tools##3##2##(1993-12#1)(1994-1#1)(2013-1#1)
such topics as##3##3##(1994-1#1)(2008-9#2)
such training##6##2##(1991-1#1)(1993-1#1)(1997-1#1)(2007-2#1)(2010-10#1)(2012-3#1)
such traits##4##2##(2007-12#1)(2008-8#3)
such translocations##2##2##(2008-6#2)
such treatment and##2##3##(1995-1#1)(2008-9#1)
such treatment have not##2##4##(2008-7#1)(2012-2#1)
such treatment##13##2##(1995-1#1)(1996-9#1)(1997-3#2)(2008-10#2)(2008-7#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
such treatments##4##2##(1994-5#1)(1997-4#1)(2007-3#1)(2008-5#1)
such trials##4##2##(1994-9#1)(2008-11#1)(2010-3#1)(2013-7#1)
such units##4##2##(1994-9#2)(2007-11#1)(2008-11#1)
such usage##2##2##(1991-4#1)(2008-3#1)
such use##3##2##(1995-11#1)(2008-7#1)(2012-1#1)
such variability##2##2##(2012-2#1)(2012-3#1)
such variables##2##2##(2009-8#1)(2013-8#1)
such variance##3##2##(1994-3#1)(2007-8#1)(2010-2#1)
such variation##2##2##(2008-7#2)
such##5740##1##(1990-10#2)(1990-11#18)(1990-12#11)(1990-2#13)(1990-3#10)(1990-5#6)(1990-6#6)(1990-7#7)(1990-8#16)(1990-9#5)(1991-1#6)(1991-10#1)(1991-11#10)(1991-12#34)(1991-2#12)(1991-3#15)(1991-4#4)(1991-5#11)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#17)(1992-1#8)(1992-10#2)(1992-11#4)(1992-12#27)(1992-2#18)(1992-3#22)(1992-4#3)(1992-5#8)(1992-6#13)(1992-8#19)(1992-9#22)(1993-1#9)(1993-11#17)(1993-12#20)(1993-2#23)(1993-3#18)(1993-5#4)(1993-6#4)(1993-8#7)(1993-9#6)(1994-1#11)(1994-10#3)(1994-11#16)(1994-12#32)(1994-2#28)(1994-3#29)(1994-5#19)(1994-6#10)(1994-8#25)(1994-9#23)(1995-1#15)(1995-11#26)(1995-12#21)(1995-2#28)(1995-3#22)(1995-5#22)(1995-6#12)(1995-8#7)(1995-9#2)(1996-1#17)(1996-11#15)(1996-12#30)(1996-2#15)(1996-3#23)(1996-4#11)(1996-5#14)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#7)(1997-1#20)(1997-2#19)(1997-3#31)(1997-4#26)(1997-5#7)(1997-6#15)(1997-7#10)(1997-8#12)(2006-10#4)(2006-4#4)(2006-6#2)(2007-10#18)(2007-11#88)(2007-12#115)(2007-2#10)(2007-3#2)(2007-4#8)(2007-5#10)(2007-6#3)(2007-7#30)(2007-8#37)(2007-9#3)(2008-1#96)(2008-10#895)(2008-11#259)(2008-12#90)(2008-2#172)(2008-3#314)(2008-4#115)(2008-5#170)(2008-6#72)(2008-7#267)(2008-8#172)(2008-9#124)(2009-1#3)(2009-10#31)(2009-11#25)(2009-12#24)(2009-2#11)(2009-3#19)(2009-4#12)(2009-5#42)(2009-6#24)(2009-7#26)(2009-8#56)(2009-9#26)(2010-1#19)(2010-10#15)(2010-11#23)(2010-12#52)(2010-2#13)(2010-3#36)(2010-4#26)(2010-5#40)(2010-6#19)(2010-7#29)(2010-8#54)(2010-9#7)(2011-1#91)(2011-2#202)(2011-3#23)(2011-4#1)(2011-7#3)(2012-1#25)(2012-12#99)(2012-2#135)(2012-3#73)(2012-5#3)(2012-6#1)(2012-8#4)(2012-9#2)(2013-1#160)(2013-7#23)(2013-8#87)
suck##3##1##(2009-6#3)
sucker##2##1##(2007-12#1)(2008-5#1)
sucking instinct##3##2##(2007-10#3)
sucking the##3##2##(2008-7#3)
sucking##13##1##(1995-12#1)(2007-10#6)(2008-10#2)(2008-7#3)(2012-12#1)
suckling to##2##2##(2013-1#2)
suckling##5##1##(1990-11#1)(2008-8#1)(2013-1#3)
sucralfate##3##1##(1991-3#1)(2007-11#1)(2008-7#1)
sucrase-isomaltase mRNA##2##2##(1990-12#2)
sucrase-isomaltase##6##1##(1990-12#6)
sucrose (2%)##2##2##(2013-1#2)
sucrose and 0##2##3##(1993-12#1)(2008-10#1)
sucrose and glucose##2##3##(1990-8#1)(2010-2#1)
sucrose and raffinose##2##3##(1997-2#1)(2008-10#1)
sucrose and##20##2##(1990-8#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-10#8)(2008-8#1)(2010-2#1)(2011-2#3)(2012-2#1)
sucrose biosensor##2##2##(2008-10#2)
sucrose density gradient centrifugation##3##4##(1991-11#1)(1994-8#1)(1997-3#1)
sucrose density gradient##7##3##(1990-8#1)(1991-11#1)(1993-11#1)(1994-8#1)(1995-2#1)(1997-3#1)(2010-12#1)
sucrose density gradients##5##3##(1992-12#1)(1995-6#1)(2008-1#1)(2008-4#1)(2008-8#1)
sucrose density##12##2##(1990-8#1)(1991-11#1)(1992-12#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-12#1)
sucrose gap##2##2##(1990-5#1)(1997-4#1)
sucrose gradient##4##2##(1990-7#1)(1997-6#1)(2008-11#1)(2008-8#1)
sucrose gradients##3##2##(1997-3#1)(2008-1#2)
sucrose in##6##2##(1990-11#1)(2008-10#4)(2011-2#1)
sucrose is##2##2##(2008-10#2)
sucrose or##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
sucrose reinforcement##2##2##(1993-6#2)
sucrose solution##3##2##(1993-12#1)(1996-2#1)(2008-10#1)
sucrose synthase##3##2##(1995-3#1)(2011-2#2)
sucrose was##2##2##(2008-5#1)(2008-6#1)
sucrose##125##1##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-5#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#3)(1993-9#1)(1994-11#1)(1994-8#5)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#5)(2008-10#35)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-8#5)(2008-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-2#10)(2012-2#1)(2012-7#1)(2013-1#4)
sucrose)##3##1##(2007-8#1)(2010-11#2)
suction##24##1##(1990-11#1)(1991-3#5)(1992-12#2)(1995-3#1)(1995-8#2)(2007-8#1)(2008-10#1)(2008-5#2)(2009-3#1)(2011-2#5)(2012-2#1)(2013-1#2)
suctorial proboscis in pollen wasps##2##5##(2007-12#2)
sudangrass##3##1##(2008-10#3)
sudden and unexpected##3##3##(1990-11#1)(2007-11#1)(2008-12#1)
sudden and##7##2##(1990-11#2)(2007-11#1)(2007-12#1)(2008-12#1)(2010-11#1)(2011-2#1)
sudden cardiac arrest##2##3##(2010-1#1)(2013-8#1)
sudden cardiac death in young##2##5##(2008-12#1)(2012-3#1)
sudden cardiac death in##3##4##(2007-2#1)(2008-12#1)(2012-3#1)
sudden cardiac death is##2##4##(2011-2#2)
sudden cardiac death##19##3##(1992-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-10#1)(2009-5#2)(2009-9#1)(2011-2#5)(2012-3#1)(2013-8#1)
sudden cardiac##21##2##(1992-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-10#1)(2009-5#2)(2009-9#1)(2010-1#1)(2011-2#5)(2012-3#1)(2013-8#2)
sudden changes in##2##3##(2007-11#1)(2012-12#1)
sudden contractions##2##2##(2008-7#2)
sudden coronary deaths##2##3##(2010-12#2)
sudden deafness##4##2##(1994-9#3)(2011-2#1)
sudden death in##4##3##(1992-11#1)(2008-1#1)(2008-12#2)
sudden death syndrome##4##3##(2008-10#4)
sudden death##23##2##(1992-11#1)(1994-11#1)(2008-1#1)(2008-10#6)(2008-12#2)(2010-12#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
sudden decrease##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
sudden gains##6##2##(2009-11#6)
sudden hearing loss##3##3##(1995-6#1)(2008-4#1)(2008-7#1)
sudden increase in##2##3##(1991-12#1)(2013-1#1)
sudden infant death syndrome (SIDS) and##2##6##(1991-11#1)(1993-12#1)
sudden infant death syndrome (SIDS)##7##5##(1991-11#3)(1992-11#1)(1993-12#1)(2011-1#1)(2013-1#1)
sudden infant death syndrome##17##4##(1991-11#5)(1991-8#1)(1991-9#3)(1992-11#1)(1993-12#2)(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#2)
sudden infant death##22##3##(1991-11#5)(1991-3#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-4#2)(1993-12#2)(1996-9#1)(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#2)
sudden infant##23##2##(1991-11#5)(1991-3#1)(1991-8#1)(1991-9#5)(1992-11#1)(1992-4#2)(1993-12#2)(1996-9#1)(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#2)
sudden jumps##2##2##(2007-11#1)(2008-7#1)
sudden loss of##2##3##(1995-3#1)(2012-12#1)
sudden oak death pathogen Phytophthora ramorum##2##6##(2008-10#1)(2009-2#1)
sudden oak death##6##3##(2008-10#5)(2009-2#1)
sudden oak##7##2##(2008-10#6)(2009-2#1)
sudden onset of##7##3##(2007-12#1)(2008-10#2)(2008-7#3)(2009-12#1)
sudden onset##10##2##(1993-8#1)(2007-12#1)(2008-10#2)(2008-7#4)(2009-12#1)(2013-1#1)
sudden sensorineural hearing loss##4##4##(2008-4#4)
sudden severe anorexia##2##3##(2012-3#2)
sudden severe##3##2##(1993-9#1)(2012-3#2)
sudden unexplained##2##2##(1991-11#1)(1992-11#1)
sudden##176##1##(1990-11#4)(1991-11#7)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#6)(1992-11#5)(1992-12#1)(1992-4#2)(1992-6#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-9#4)(1995-3#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-9#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#9)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#11)(2008-9#2)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#15)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#4)
suddenly and##2##2##(1991-9#1)(2008-5#1)
suddenly##10##1##(1991-8#1)(1991-9#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-12#1)
sudomotor##3##1##(2009-12#3)
sue the##3##2##(1995-12#1)(1996-5#1)(2008-11#1)
sue##8##1##(1995-12#2)(1996-5#3)(1997-5#2)(2008-11#1)
suecica##2##1##(2011-2#2)
sued##11##1##(1993-12#1)(1995-12#3)(1995-6#3)(1997-5#2)(2008-1#1)(2008-11#1)
suf-1##2##1##(1995-6#2)
sufentanil and nitrous oxide##2##4##(1996-6#2)
sufentanil in##2##2##(1991-1#1)(2013-7#1)
sufentanil##5##1##(1991-1#2)(1996-6#2)(2013-7#1)
suffer a##5##2##(2006-7#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)
suffer from CI##2##3##(2007-10#2)
suffer from a##6##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)
suffer from chronic##5##3##(1997-2#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
suffer from the##2##3##(1990-11#1)(2007-11#1)
suffer from this##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
suffer from##66##2##(1990-11#1)(1990-5#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
suffer more##2##2##(1991-4#1)(2008-8#1)
suffer serious##2##2##(1993-6#1)(2008-7#1)
suffer the##4##2##(2008-11#1)(2008-8#2)(2009-6#1)
suffer##109##1##(1990-11#1)(1990-5#1)(1990-6#2)(1991-4#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-4#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-2#3)(1997-7#1)(2006-7#1)(2007-10#3)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
suffered a fracture##2##3##(2008-11#1)(2008-12#1)
suffered a significant##2##3##(2008-12#1)(2012-2#1)
suffered a##21##2##(1990-9#1)(1993-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
suffered an##4##2##(1991-3#1)(1995-12#1)(1997-6#1)(2013-8#1)
suffered cerebral infarction##2##3##(2007-10#2)
suffered frequent##2##2##(2008-7#1)(2013-1#1)
suffered from a malignant##3##4##(1991-8#1)(1993-2#1)(1995-12#1)
suffered from a##5##3##(1991-8#1)(1993-2#1)(1993-6#1)(1995-12#1)(2008-7#1)
suffered from acute##2##3##(1991-8#1)(2013-1#1)
suffered from chronic##2##3##(1990-3#1)(2011-1#1)
suffered from dizziness##2##3##(2007-10#1)(2012-2#1)
suffered from severe##3##3##(1991-2#1)(1995-2#1)(2007-8#1)
suffered from the##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
suffered from these##2##3##(2008-10#1)(2011-2#1)
suffered from##58##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#3)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-7#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2007-10#3)(2007-11#4)(2007-2#2)(2007-5#1)(2007-8#4)(2008-10#3)(2008-12#1)(2008-7#3)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
suffered major##2##2##(1992-9#1)(2008-7#1)
suffered severe##2##2##(1996-11#1)(2013-1#1)
suffered the##2##2##(1995-3#1)(2008-5#1)
suffered##131##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#4)(1992-5#1)(1992-9#2)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(2007-10#8)(2007-11#8)(2007-2#2)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#6)(2008-2#3)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-1#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2012-9#1)(2013-1#10)(2013-8#2)
sufferer##3##1##(1993-6#1)(2013-1#2)
sufferers of##2##2##(2008-10#1)(2008-8#1)
sufferers##11##1##(1994-2#3)(1996-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-12#1)(2010-8#1)
suffering and##6##2##(1994-12#1)(2007-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
suffering for##2##2##(1995-5#1)(2008-11#1)
suffering from Alzheimer's disease##2##4##(1994-12#1)(2008-7#1)
suffering from MMD and##2##4##(2013-1#2)
suffering from a##7##3##(1990-9#1)(1992-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2012-12#1)(2012-3#1)
suffering from acute##5##3##(1992-9#1)(2006-7#1)(2010-1#1)(2011-2#2)
suffering from both##2##3##(2007-8#1)(2008-2#1)
suffering from breast carcinoma##2##4##(1993-11#1)(2008-7#1)
suffering from chronic renal##2##4##(2008-10#1)(2013-1#1)
suffering from chronic##8##3##(1991-2#1)(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
suffering from clinical depression##2##4##(1991-2#1)(2008-10#1)
suffering from coxarthrosis##4##3##(2007-11#4)
suffering from diabetes##2##3##(2008-7#1)(2010-8#1)
suffering from mental##3##3##(1996-1#2)(2008-7#1)
suffering from osteoarthritis##2##3##(2010-12#1)(2013-1#1)
suffering from primary##3##3##(1990-11#2)(1990-8#1)
suffering from recurrent##3##3##(1992-11#1)(2008-12#1)(2010-6#1)
suffering from rheumatoid arthritis##2##4##(2013-1#2)
suffering from severe##2##3##(2006-8#1)(2012-3#1)
suffering from surgical diseases##2##4##(1990-5#1)(1991-3#1)
suffering from the##5##3##(1991-12#1)(1993-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
suffering from this##3##3##(2008-6#1)(2010-10#1)(2013-8#1)
suffering from##175##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#1)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#3)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-4#1)(2007-8#5)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#15)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#1)
suffering in##3##2##(1992-5#1)(2009-7#1)(2012-3#1)
suffering of the##2##3##(2008-6#1)(2010-8#1)
suffering of##5##2##(1991-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)
suffering##232##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#1)(1991-8#4)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#3)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#17)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#1)(2009-5#1)(2009-7#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#3)(2012-3#12)(2013-1#17)(2013-7#2)(2013-8#4)
suffers from a##2##3##(1992-10#1)(2008-5#1)
suffers from the##2##3##(2008-5#1)(2008-6#1)
suffers from##14##2##(1991-1#1)(1992-10#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2012-2#2)(2013-1#1)
suffers##21##1##(1991-1#1)(1992-10#1)(1996-2#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2012-2#2)(2013-1#1)
suffice to##2##2##(1990-11#1)(1995-2#1)
suffice##7##1##(1990-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
suffices##4##1##(1990-11#1)(2007-12#1)(2008-10#1)(2009-4#1)
sufficiency##4##1##(1990-4#1)(1996-12#1)(2007-11#2)
sufficient DNA##2##2##(1997-4#1)(2008-12#1)
sufficient amounts of##6##3##(1990-5#1)(2008-10#1)(2008-11#3)(2011-2#1)
sufficient amounts##8##2##(1990-5#1)(2008-10#1)(2008-11#4)(2010-4#1)(2011-2#1)
sufficient and##7##2##(1993-1#1)(1994-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
sufficient attention##2##2##(2008-7#1)(2008-9#1)
sufficient blood##2##2##(2007-9#1)(2008-7#1)
sufficient concentrations##2##2##(2008-3#1)(2010-10#1)
sufficient condition##2##2##(1992-9#1)(2008-7#1)
sufficient data for##2##3##(1992-11#1)(2012-12#1)
sufficient data##5##2##(1992-11#1)(1994-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
sufficient epidemiological##2##2##(2008-11#1)(2008-7#1)
sufficient evidence for##2##3##(2008-1#1)(2008-11#1)
sufficient evidence##5##2##(1990-6#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
sufficient follow-up##2##2##(1993-11#1)(2008-10#1)
sufficient for a##3##3##(1991-2#1)(2007-12#1)(2008-3#1)
sufficient for detecting##2##3##(2008-10#1)(2008-3#1)
sufficient for management of##3##4##(2009-12#1)(2013-1#2)
sufficient for the##12##3##(1991-2#2)(1992-8#1)(1993-11#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
sufficient for##76##2##(1990-11#1)(1991-2#3)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#6)(1995-4#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
sufficient information for##3##3##(1991-12#1)(2008-10#1)(2013-8#1)
sufficient information##4##2##(1991-12#1)(2007-10#1)(2008-10#1)(2013-8#1)
sufficient interactions##2##2##(1993-6#1)(2013-8#1)
sufficient levels of##2##3##(2008-11#1)(2008-5#1)
sufficient levels##3##2##(1997-7#1)(2008-11#1)(2008-5#1)
sufficient numbers of##4##3##(2008-11#1)(2008-7#1)(2008-9#2)
sufficient numbers##5##2##(2008-11#2)(2008-7#1)(2008-9#2)
sufficient or##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
sufficient precision##2##2##(2008-10#1)(2013-1#1)
sufficient quantities of##3##3##(2008-10#2)(2008-11#1)
sufficient rats##2##2##(1994-5#2)
sufficient selectivity##3##2##(2008-10#3)
sufficient sensitivity to##2##3##(2008-10#1)(2008-8#1)
sufficient sensitivity##5##2##(1992-6#1)(2008-10#2)(2008-3#1)(2008-8#1)
sufficient time##2##2##(1994-12#1)(2012-3#1)
sufficient to account for the##3##5##(1991-3#1)(1995-3#1)(2008-7#1)
sufficient to account for##6##4##(1991-3#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-7#2)
sufficient to activate transcription##2##4##(1994-8#1)(1995-2#1)
sufficient to activate##3##3##(1994-8#1)(1995-2#1)(2008-4#1)
sufficient to allow##5##3##(1992-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)
sufficient to cause##6##3##(1993-12#1)(1995-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)
sufficient to complete##2##3##(2008-5#1)(2008-9#1)
sufficient to confer##3##3##(1994-12#1)(1995-5#1)(1997-3#1)
sufficient to determine##4##3##(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
sufficient to elicit##2##3##(1991-2#1)(1996-12#1)
sufficient to explain the##5##4##(1997-5#1)(2007-11#1)(2007-12#1)(2008-11#2)
sufficient to explain##6##3##(1997-5#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-8#1)
sufficient to give##2##3##(1997-6#1)(2008-10#1)
sufficient to identify##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
sufficient to induce##11##3##(1990-7#1)(1991-5#1)(1992-5#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-11#1)(2012-12#1)
sufficient to justify##2##3##(2008-2#1)(2008-7#1)
sufficient to maintain##2##3##(1991-12#1)(1992-12#1)
sufficient to make##2##3##(2008-2#1)(2009-8#1)
sufficient to mediate##2##3##(1993-8#1)(1994-6#1)
sufficient to promote##3##3##(1992-3#1)(2008-5#1)(2013-1#1)
sufficient to provide##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
sufficient to raise##2##3##(1996-12#1)(2008-7#1)
sufficient to reach##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
sufficient to rescue##2##3##(2008-3#1)(2008-9#1)
sufficient to##134##2##(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1996-12#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#7)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#5)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
sufficient##444##1##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#5)(1991-3#3)(1991-5#1)(1992-11#2)(1992-12#3)(1992-3#5)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#4)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#10)(1994-6#2)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#12)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#2)(2006-12#1)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#67)(2008-11#28)(2008-12#5)(2008-2#13)(2008-3#39)(2008-4#6)(2008-5#17)(2008-6#2)(2008-7#18)(2008-8#9)(2008-9#15)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#3)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#10)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#9)(2013-8#2)
sufficiently accurate##4##2##(2008-2#1)(2008-3#2)(2009-3#1)
sufficiently demonstrated##2##2##(2008-10#1)(2008-7#1)
sufficiently flexible to##2##3##(2008-10#1)(2008-11#1)
sufficiently high or##2##3##(2008-3#1)(2008-8#1)
sufficiently high to##2##3##(2008-1#1)(2008-9#1)
sufficiently high##15##2##(1992-12#1)(1994-3#1)(1995-2#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#3)(2008-9#1)
sufficiently intense##2##2##(2007-12#1)(2012-2#1)
sufficiently large##11##2##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)
sufficiently low to allow##2##4##(2008-10#1)(2008-3#1)
sufficiently low to##4##3##(2008-10#3)(2008-3#1)
sufficiently low##5##2##(2008-10#4)(2008-3#1)
sufficiently reliable to##2##3##(1990-9#1)(1996-11#1)
sufficiently reliable##4##2##(1990-9#1)(1996-11#1)(2008-10#1)(2013-1#1)
sufficiently rigid to##2##3##(2007-12#1)(2009-7#1)
sufficiently selective##2##2##(2008-10#1)(2008-5#1)
sufficiently sensitive##4##2##(2008-10#2)(2008-11#2)
sufficiently separated##2##2##(2008-10#1)(2008-3#1)
sufficiently similar##2##2##(1995-5#1)(2008-3#1)
sufficiently simple##2##2##(1997-6#1)(2008-3#1)
sufficiently small##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
sufficiently stable##2##2##(2008-10#1)(2008-11#1)
sufficiently to##5##2##(1992-6#1)(1997-2#1)(2008-10#2)(2013-1#1)
sufficiently weak##2##2##(1994-5#1)(2007-11#1)
sufficiently##126##1##(1990-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#30)(2008-11#7)(2008-2#8)(2008-3#16)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2012-2#3)(2013-1#2)
suffocation##2##1##(2008-10#1)(2008-11#1)
suffruticosa##3##1##(2008-10#1)(2008-5#1)(2011-1#1)
sugammadex##2##1##(2012-2#2)
sugar and##11##2##(1993-9#1)(1995-11#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
sugar as##2##2##(1992-12#1)(2008-10#1)
sugar beet (Beta##2##3##(2008-10#1)(2012-3#1)
sugar beet and wheat##3##4##(2008-10#3)
sugar beet and##4##3##(2008-10#4)
sugar beet cv##2##3##(2008-12#2)
sugar beet cyst nematode##2##4##(2008-10#1)(2008-12#1)
sugar beet genotypes##2##3##(2008-12#2)
sugar beet plant##2##3##(2008-12#2)
sugar beet plants##3##3##(2008-10#1)(2008-12#2)
sugar beet seedlings##3##3##(2008-10#3)
sugar beet##46##2##(2008-10#29)(2008-12#12)(2008-5#3)(2012-3#2)
sugar beets and##2##3##(2008-10#2)
sugar beets##4##2##(2008-10#4)
sugar bound pK(a)##2##3##(2008-10#2)
sugar cane juices using##2##4##(2008-10#2)
sugar cane##5##2##(2008-10#3)(2008-6#2)
sugar chain##3##2##(2007-11#1)(2008-11#2)
sugar chains were##4##3##(1993-11#4)
sugar chains##16##2##(1992-9#1)(1993-11#10)(1994-9#2)(2008-11#1)(2008-4#2)
sugar content##6##2##(2008-10#3)(2010-7#1)(2013-1#2)
sugar cultivars##2##2##(2011-2#2)
sugar in the##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
sugar in##6##2##(1990-2#1)(1992-12#1)(1993-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
sugar level##2##2##(1994-8#1)(2008-10#1)
sugar levels##6##2##(1993-11#1)(2008-1#1)(2008-10#3)(2008-3#1)
sugar moieties##2##2##(1991-8#1)(2009-8#1)
sugar moiety##6##2##(1990-7#1)(1992-6#1)(1993-6#1)(1995-12#1)(1996-5#1)(2008-4#1)
sugar phosphate##2##2##(2008-7#2)
sugar recovery from##2##3##(2013-1#2)
sugar recovery##4##2##(2013-1#4)
sugar residues##2##2##(1994-11#1)(1995-2#1)
sugar retention##2##2##(2008-10#2)
sugar spheres##6##2##(2008-11#6)
sugar syrup##2##2##(1992-3#1)(2012-2#1)
sugar to##2##2##(1993-9#1)(2011-1#1)
sugar units##3##2##(1994-3#1)(2008-10#1)(2009-10#1)
sugar utilization##3##2##(2008-6#3)
sugar water##2##2##(2009-8#1)(2012-12#1)
sugar##228##1##(1990-2#2)(1990-7#2)(1991-12#3)(1991-8#2)(1992-12#5)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#12)(1993-6#1)(1993-9#8)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#67)(2008-11#9)(2008-12#19)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#11)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#11)
sugar)##3##1##(2008-10#2)(2008-6#1)
sugar/salt##2##1##(1991-9#2)
sugarcane and##4##2##(2008-10#4)
sugarcane bagasse hemicellulosic hydrolysate##2##4##(2008-6#2)
sugarcane bagasse##6##2##(2008-6#2)(2013-1#4)
sugarcane cultivars##3##2##(2008-10#1)(2011-2#2)
sugarcane cv##2##2##(2008-10#2)
sugarcane in##2##2##(2008-10#2)
sugarcane mosaic virus##3##3##(2008-10#1)(2008-9#2)
sugarcane mosaic##4##2##(2008-10#2)(2008-9#2)
sugarcane rust##2##2##(2008-10#2)
sugarcane straw##2##2##(2013-1#2)
sugarcane##49##1##(2007-12#2)(2008-10#33)(2008-6#2)(2008-9#2)(2011-2#4)(2013-1#6)
sugars and##13##2##(1990-8#1)(2008-10#8)(2008-12#1)(2008-6#1)(2008-7#1)(2012-1#1)
sugars are##2##2##(2008-10#1)(2008-5#1)
sugars for##2##2##(2008-10#1)(2011-1#1)
sugars in the##4##3##(1990-2#1)(1993-11#1)(2008-10#2)
sugars in##10##2##(1990-2#1)(1993-11#1)(2008-10#5)(2010-4#1)(2011-1#1)(2011-2#1)
sugars of##4##2##(2009-7#2)(2011-2#1)(2013-1#1)
sugars or##3##2##(1990-2#1)(1992-12#1)(2008-7#1)
sugars that##2##2##(2011-2#1)(2012-2#1)
sugars to##3##2##(1990-2#1)(1991-12#1)(2008-10#1)
sugars was##3##2##(2008-12#2)(2008-6#1)
sugars were##2##2##(1992-8#1)(2008-6#1)
sugars##107##1##(1990-2#3)(1990-8#1)(1990-9#1)(1991-12#2)(1992-12#3)(1992-8#1)(1993-11#2)(1993-8#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-1#2)(2008-10#34)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#2)(2010-4#1)(2011-1#2)(2011-2#10)(2012-1#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#1)
sugary drinks##2##2##(2010-8#2)
sugary##4##1##(1997-6#1)(2010-8#3)
suggest a complex##3##3##(2008-4#1)(2009-11#1)(2009-12#1)
suggest a crucial role of##2##5##(2008-11#1)(2010-5#1)
suggest a functional##2##3##(1991-5#1)(2008-8#1)
suggest a genetic##2##3##(2007-2#1)(2008-10#1)
suggest a mechanism of##2##4##(1991-9#1)(1992-3#1)
suggest a mechanism##3##3##(1991-9#1)(1992-3#1)(1994-9#1)
suggest a model##3##3##(1995-2#1)(2007-12#1)(2009-8#1)
suggest a molecular basis for the##2##6##(1996-12#1)(2008-8#1)
suggest a need##2##3##(2010-4#1)(2011-1#1)
suggest a negative##2##3##(2010-11#1)(2011-2#1)
suggest a new##4##3##(2007-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
suggest a novel##4##3##(2007-11#3)(2011-1#1)
suggest a possible mechanism##2##4##(1993-6#1)(2011-2#1)
suggest a possible role for##3##5##(1991-1#1)(1992-3#1)(2012-2#1)
suggest a possible role##4##4##(1990-11#1)(1991-1#1)(1992-3#1)(2012-2#1)
suggest a possible##14##3##(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1997-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
suggest a potential role for##2##5##(1993-3#1)(2008-10#1)
suggest a potential##4##3##(1990-8#1)(1993-3#1)(1994-9#1)(2008-10#1)
suggest a role for##15##4##(1990-6#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-6#1)(2009-10#1)(2012-3#1)
suggest a role of the##2##5##(1992-6#1)(2010-4#1)
suggest a role of##4##4##(1990-7#1)(1992-6#1)(1993-11#1)(2010-4#1)
suggest a role##19##3##(1990-6#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-4#1)(2012-3#1)
suggest a secondary##3##3##(2008-9#2)(2009-9#1)
suggest a simple##2##3##(2007-11#1)(2008-9#1)
suggest a specific##2##3##(1996-2#1)(2012-2#1)
suggest a##145##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-6#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#3)(1997-5#1)(1997-7#1)(2007-11#5)(2007-12#8)(2007-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#1)
suggest an important role for##3##5##(1996-5#1)(2008-10#1)(2010-11#1)
suggest an important##4##3##(1996-5#1)(2008-10#1)(2008-9#1)(2010-11#1)
suggest an increased##3##3##(1990-6#1)(2008-2#1)(2008-7#1)
suggest an inhibitory##3##3##(1991-2#1)(1993-12#1)(2008-5#1)
suggest an interaction##3##3##(1990-6#1)(1995-12#1)(2008-4#1)
suggest an inverse relationship between##2##5##(2008-3#1)(2010-8#1)
suggest an involvement of##4##4##(1992-12#1)(1992-5#1)(2008-11#2)
suggest an##41##2##(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#1)
suggest any##3##2##(1990-12#1)(1990-6#1)(2008-9#1)
suggest areas##2##2##(1997-5#1)(2012-2#1)
suggest different patterns##2##3##(2008-10#1)(2013-7#1)
suggest different##6##2##(1997-7#1)(2007-10#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
suggest diminished atherosclerotic progression in cavernous tissue##2##7##(2009-5#2)
suggest direct##2##2##(1992-6#1)(2011-2#1)
suggest further##3##2##(2007-12#1)(2008-12#1)(2008-9#1)
suggest future##2##2##(1991-3#1)(2007-10#1)
suggest high##2##2##(2008-7#1)(2010-11#1)
suggest higher##2##2##(2009-9#1)(2011-1#1)
suggest how##5##2##(1993-2#1)(1994-11#1)(2008-12#1)(2008-8#1)(2010-3#1)
suggest important differences##2##3##(1992-4#1)(2011-2#1)
suggest increased##2##2##(2008-10#2)
suggest increasing##2##2##(1994-3#1)(1995-5#1)
suggest it is##2##3##(2008-10#1)(2008-7#1)
suggest it##5##2##(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
suggest its possible##2##3##(2008-12#1)(2013-1#1)
suggest its##7##2##(1993-6#1)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#2)(2013-7#1)
suggest many##2##2##(2008-5#1)(2009-4#1)
suggest marked##2##2##(2007-10#1)(2008-5#1)
suggest more##2##2##(2008-10#1)(2010-12#1)
suggest new##2##2##(2008-7#2)
suggest novel##2##2##(2008-2#1)(2008-4#1)
suggest possible##6##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-3#1)
suggest potential##2##2##(2008-5#1)(2010-6#1)
suggest some##5##2##(1990-6#1)(1992-2#1)(2008-11#1)(2010-2#1)(2010-5#1)
suggest strongly##3##2##(1991-8#1)(1992-3#1)(1996-2#1)
suggest that (1)##3##3##(1994-5#1)(2007-9#1)(2011-2#1)
suggest that (a)##4##3##(1994-2#1)(1997-8#1)(2008-2#1)(2008-4#1)
suggest that (i)##3##3##(1993-9#1)(2008-10#1)(2008-9#1)
suggest that B##2##3##(2008-10#2)
suggest that C##2##3##(2008-10#1)(2012-1#1)
suggest that CC-516##2##3##(2008-5#2)
suggest that DNA##3##3##(1990-6#1)(1992-9#1)(2010-5#1)
suggest that ET-1##2##3##(1991-2#1)(1993-3#1)
suggest that G##2##3##(2008-4#1)(2010-3#1)
suggest that IL-1##2##3##(1990-12#1)(1994-9#1)
suggest that IVC may##2##4##(1990-10#1)(1990-2#1)
suggest that L-PHP may##2##4##(2013-7#2)
suggest that L-PHP##3##3##(2013-7#3)
suggest that LHRH##2##3##(1995-12#1)(2008-4#1)
suggest that M##2##3##(2008-10#2)
suggest that NO##3##3##(1992-12#1)(1995-11#1)(2012-2#1)
suggest that P##6##3##(2008-10#4)(2008-12#1)(2012-12#1)
suggest that P2##2##3##(2008-11#1)(2008-4#1)
suggest that PKC##5##3##(1990-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-2#1)
suggest that TCDD##2##3##(1995-3#1)(2008-10#1)
suggest that a combination of##2##5##(2008-5#1)(2008-6#1)
suggest that a high##4##4##(1993-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
suggest that a low##2##4##(1993-8#1)(2008-7#1)
suggest that a single##4##4##(1996-2#1)(2008-10#2)(2009-10#1)
suggest that a small##2##4##(1992-12#1)(2008-1#1)
suggest that a##63##3##(1990-12#1)(1990-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#2)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
suggest that activation of##2##4##(1991-2#1)(2008-3#1)
suggest that activation##3##3##(1991-2#1)(2008-3#1)(2008-9#1)
suggest that additional##4##3##(1991-9#2)(1993-12#1)(2012-3#1)
suggest that all##3##3##(1997-6#1)(2008-12#1)(2008-8#1)
suggest that alternative##3##3##(1991-5#1)(2008-6#1)(2009-10#1)
suggest that although##5##3##(1991-10#1)(1991-4#1)(1997-3#1)(2007-12#1)(2010-3#1)
suggest that ampicillin##2##3##(2008-10#1)(2009-12#1)
suggest that an##18##3##(1990-2#1)(1990-9#1)(1991-9#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-6#1)(2012-2#2)(2013-8#1)
suggest that analysis##2##3##(1991-1#1)(1995-12#1)
suggest that antibodies against the##2##5##(1991-12#1)(2008-4#1)
suggest that artificial turf##2##4##(2013-1#2)
suggest that as##2##3##(1990-11#1)(2008-8#1)
suggest that at least some of##2##6##(2008-10#1)(2012-2#1)
suggest that at least##4##4##(1991-3#1)(1991-5#1)(2008-10#1)(2012-2#1)
suggest that at##5##3##(1991-3#1)(1991-5#1)(1995-12#1)(2008-10#1)(2012-2#1)
suggest that binding of##2##4##(1993-1#1)(1995-6#1)
suggest that binding##3##3##(1993-1#1)(1993-3#1)(1995-6#1)
suggest that body##2##3##(2007-12#1)(2013-7#1)
suggest that both the##3##4##(1991-12#1)(1994-3#1)(2013-1#1)
suggest that both##17##3##(1990-12#1)(1991-12#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
suggest that bullying##2##3##(2009-7#2)
suggest that c-myc##2##3##(1993-11#1)(2008-11#1)
suggest that cAMP##2##3##(1991-3#1)(1994-11#1)
suggest that certain##5##3##(1994-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
suggest that chronic##2##3##(1992-3#1)(2013-1#1)
suggest that combination therapy##2##4##(2010-10#1)(2011-2#1)
suggest that concomitant##2##3##(2011-2#1)(2012-12#1)
suggest that cyclic##2##3##(1994-11#1)(2012-7#1)
suggest that dietary##4##3##(1992-10#1)(2008-10#1)(2008-11#1)(2010-2#1)
suggest that different##6##3##(1990-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
suggest that diffuse##2##3##(2008-3#1)(2008-7#1)
suggest that direct##2##3##(1992-9#1)(2008-10#1)
suggest that distinct##2##3##(1992-3#1)(2008-5#1)
suggest that during##3##3##(1990-7#1)(1992-5#1)(1994-9#1)
suggest that early##4##3##(1993-12#1)(2008-12#1)(2009-1#1)(2012-12#1)
suggest that either##3##3##(1993-12#1)(2009-12#1)(2010-2#1)
suggest that endogenous##3##3##(1995-12#1)(2008-3#2)
suggest that enhanced##2##3##(2008-10#1)(2013-1#1)
suggest that evaluation##2##3##(2006-10#1)(2008-10#1)
suggest that even##3##3##(2007-2#1)(2008-3#1)(2013-1#1)
suggest that exposure to##5##4##(1997-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)
suggest that extracellular##3##3##(1990-8#1)(1994-11#1)(2008-8#1)
suggest that factors##3##3##(1993-6#1)(2008-8#1)(2011-2#1)
suggest that family##2##3##(2011-2#1)(2013-1#1)
suggest that females##2##3##(2008-8#1)(2009-9#1)
suggest that for some##2##4##(2008-7#1)(2012-12#1)
suggest that for##7##3##(1990-3#1)(1992-11#1)(1995-2#1)(1996-12#1)(2008-7#1)(2009-7#1)(2012-12#1)
suggest that functional##3##3##(1995-2#1)(2008-11#1)(2008-5#1)
suggest that further studies##2##4##(1990-12#1)(2009-8#1)
suggest that further##7##3##(1990-12#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
suggest that genetic##3##3##(2008-10#3)
suggest that glucose##2##3##(2007-11#1)(2007-8#1)
suggest that growth##3##3##(1991-12#1)(1993-9#1)(2008-7#1)
suggest that high levels of##2##5##(2008-10#1)(2013-8#1)
suggest that high##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
suggest that higher##2##3##(2008-7#1)(2012-3#1)
suggest that hippocampal##2##3##(2008-11#1)(2008-7#1)
suggest that homologous##2##3##(1994-8#1)(1995-6#1)
suggest that human##4##3##(1990-12#1)(1994-2#1)(2008-2#1)(2008-8#1)
suggest that in addition to##3##5##(1992-9#1)(1993-3#1)(2008-4#1)
suggest that in the absence of##2##6##(1990-2#1)(2009-8#1)
suggest that in the##5##4##(1990-2#1)(1990-5#1)(1992-3#1)(2008-10#1)(2009-8#1)
suggest that in##24##3##(1990-2#1)(1990-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-8#2)(1994-6#1)(1995-12#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#2)(2012-1#1)(2013-8#1)
suggest that increased##5##3##(1992-3#1)(1995-11#1)(1995-3#1)(2009-12#1)(2011-2#1)
suggest that increasing##2##3##(2008-11#1)(2008-6#1)
suggest that individual differences##2##4##(2008-11#1)(2013-8#1)
suggest that individual##3##3##(2008-1#1)(2008-11#1)(2013-8#1)
suggest that induced resistance is the##2##6##(2008-10#2)
suggest that induced##4##3##(2008-10#3)(2008-8#1)
suggest that induction of##2##4##(1995-5#1)(1995-6#1)
suggest that inhibition of##2##4##(1992-9#1)(1994-11#1)
suggest that inoculum##2##3##(2008-10#2)
suggest that insulin##2##3##(1990-7#1)(2008-7#1)
suggest that interactions##3##3##(1994-8#1)(2008-10#1)(2008-8#1)
suggest that intracellular##3##3##(1993-6#1)(1995-8#1)(2008-10#1)
suggest that it is##4##4##(1990-2#1)(1994-11#1)(1996-12#1)(2008-10#1)
suggest that it may be##5##5##(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
suggest that it may##6##4##(1993-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
suggest that it##15##3##(1990-2#1)(1993-2#1)(1994-11#1)(1996-12#1)(1996-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
suggest that large##4##3##(1994-5#1)(1996-4#1)(2008-11#1)(2008-8#1)
suggest that limited##2##3##(1994-8#1)(2009-10#1)
suggest that local##5##3##(1996-12#1)(2008-9#1)(2009-10#1)(2011-2#2)
suggest that long-term##4##3##(1994-5#1)(1994-6#1)(2008-6#1)(2008-8#1)
suggest that low##3##3##(1994-5#1)(2008-11#1)(2008-8#1)
suggest that many of the##2##5##(2008-6#1)(2008-9#1)
suggest that many##5##3##(1992-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
suggest that maternal##2##3##(1996-11#1)(2010-8#1)
suggest that membrane##2##3##(1994-8#1)(2008-4#1)
suggest that metabolic##2##3##(2010-2#1)(2011-2#1)
suggest that miRNAs##2##3##(2010-11#1)(2011-2#1)
suggest that mild##2##3##(2008-5#1)(2008-7#1)
suggest that molecular##3##3##(1995-3#1)(2008-9#1)(2012-2#1)
suggest that monkeys##2##3##(1992-11#2)
suggest that more##2##3##(2008-4#1)(2011-2#1)
suggest that most##3##3##(1992-12#1)(1997-2#1)(2007-12#1)
suggest that mu##2##3##(1993-12#1)(2009-7#1)
suggest that multiple##4##3##(1991-6#1)(1992-6#1)(1997-3#1)(2008-10#1)
suggest that music##2##3##(2008-11#1)(2008-5#1)
suggest that neither##2##3##(1994-8#1)(2008-10#1)
suggest that neurons##2##3##(1995-12#1)(2012-2#1)
suggest that new##2##3##(2007-12#1)(2008-10#1)
suggest that not only##2##4##(1991-9#1)(2008-12#1)
suggest that not##3##3##(1991-9#1)(1992-3#1)(2008-12#1)
suggest that older##2##3##(2009-7#1)(2012-12#1)
suggest that one##4##3##(1991-12#1)(1994-9#1)(1995-6#1)(2013-8#1)
suggest that other##3##3##(1990-2#1)(2013-1#1)(2013-8#1)
suggest that our##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
suggest that overexpression of##2##4##(2008-10#2)
suggest that p72syk is a##2##5##(1992-6#1)(1993-11#1)
suggest that parental##2##3##(2008-11#1)(2010-1#1)
suggest that participants##2##3##(2012-2#1)(2013-8#1)
suggest that patients with##3##4##(1993-11#1)(1996-7#1)(2011-2#1)
suggest that patients##4##3##(1993-11#1)(1996-7#1)(2008-10#1)(2011-2#1)
suggest that patterns of##2##4##(2008-8#1)(2009-9#1)
suggest that peripheral##2##3##(1990-7#1)(1997-2#1)
suggest that poor##3##3##(2008-11#1)(2009-5#1)(2013-1#1)
suggest that previous##2##3##(1994-2#1)(2013-8#1)
suggest that problem-solving therapies##2##4##(1993-2#2)
suggest that protein kinase##2##4##(1992-12#1)(1995-6#1)
suggest that protein##6##3##(1990-7#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-6#1)
suggest that rather than##2##4##(2008-10#2)
suggest that recognition##2##3##(1993-3#1)(2007-12#1)
suggest that regulation of##3##4##(1995-11#1)(1995-12#1)(2008-8#1)
suggest that regulation##4##3##(1995-11#1)(1995-12#1)(2008-8#1)(2009-10#1)
suggest that researchers##2##3##(2010-6#1)(2012-12#1)
suggest that retinoids##2##3##(1993-12#1)(2008-4#1)
suggest that schools of nursing##2##5##(2008-11#1)(2010-8#1)
suggest that selection##2##3##(2008-10#2)
suggest that sequences##2##3##(1992-12#1)(1995-2#1)
suggest that several##5##3##(1993-1#1)(1994-9#1)(1997-7#1)(2008-10#1)(2010-6#1)
suggest that sex##2##3##(1991-12#1)(2008-9#1)
suggest that sexting is##2##4##(2013-1#2)
suggest that signal##2##3##(1997-8#1)(2008-10#1)
suggest that significant##2##3##(1996-2#1)(1997-2#1)
suggest that similar##2##3##(2008-4#1)(2008-8#1)
suggest that single##2##3##(1997-2#1)(2012-1#1)
suggest that skin##2##3##(1994-9#1)(2008-5#1)
suggest that some of the##4##5##(1995-8#1)(1996-6#1)(2008-7#1)(2008-9#1)
suggest that some##8##3##(1993-12#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)
suggest that species##3##3##(2008-8#2)(2009-4#1)
suggest that specific##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
suggest that stimulation of##3##4##(1994-2#1)(1997-7#2)
suggest that strategies##2##3##(2009-7#1)(2012-2#1)
suggest that strong##2##3##(1996-12#1)(2009-8#1)
suggest that such##5##3##(1993-3#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-12#1)
suggest that sugarcane##2##3##(2008-10#2)
suggest that suppression of##2##4##(2008-10#1)(2008-11#1)
suggest that surfactant##2##3##(1994-5#1)(2008-10#1)
suggest that systemic##2##3##(1995-2#1)(2008-10#1)
suggest that the &quot##3##4##(1991-1#1)(2008-10#1)(2008-11#1)
suggest that the C-terminal##2##4##(1996-5#1)(2008-9#1)
suggest that the ability to##2##5##(1990-11#1)(1992-10#1)
suggest that the ability##3##4##(1990-11#1)(1992-10#1)(2008-10#1)
suggest that the abnormal##2##4##(1991-12#1)(2008-8#1)
suggest that the above##2##4##(1991-6#1)(1994-9#1)
suggest that the activation of the##2##6##(1995-2#1)(1997-2#1)
suggest that the altered##3##4##(1992-10#1)(1997-1#1)(2008-10#1)
suggest that the barrier##3##4##(2008-10#2)(2008-7#1)
suggest that the cardiac##2##4##(1993-3#1)(2012-3#1)
suggest that the cell##2##4##(1990-2#1)(1992-9#1)
suggest that the combination of##2##5##(2008-5#1)(2008-9#1)
suggest that the contribution of##2##5##(1991-5#1)(2008-6#1)
suggest that the cytoplasm of teosinte##2##6##(2008-5#2)
suggest that the descending##2##4##(2007-10#1)(2008-5#1)
suggest that the disease##2##4##(2008-4#1)(2012-12#1)
suggest that the early phase of##2##6##(1992-3#1)(2008-9#1)
suggest that the early##5##4##(1992-3#1)(1996-12#1)(2007-12#1)(2008-9#1)(2013-8#1)
suggest that the effect of##5##5##(1993-3#1)(1994-11#1)(1994-3#1)(1996-12#1)(2008-8#1)
suggest that the effects of##2##5##(2009-11#1)(2010-8#1)
suggest that the expression of##2##5##(1993-8#2)
suggest that the formation of##2##5##(1994-8#1)(2008-5#1)
suggest that the functional##3##4##(2007-10#1)(2008-10#1)(2012-2#1)
suggest that the gene##3##4##(1990-5#1)(2008-11#1)(2008-9#1)
suggest that the genes##2##4##(1991-9#1)(1994-8#1)
suggest that the genetic##2##4##(1994-12#1)(2008-8#1)
suggest that the high##2##4##(1991-12#1)(2008-6#1)
suggest that the host##2##4##(1992-10#1)(2008-10#1)
suggest that the human##3##4##(1993-6#1)(1997-7#1)(2008-11#1)
suggest that the increase in##2##5##(1995-12#1)(2008-11#1)
suggest that the increased##3##4##(1992-8#1)(2008-11#1)(2008-9#1)
suggest that the influence##2##4##(2007-12#1)(2011-2#1)
suggest that the initial##2##4##(1995-6#1)(2008-3#1)
suggest that the lack of##2##5##(1994-7#1)(2009-10#1)
suggest that the local##2##4##(1992-6#1)(1995-2#1)
suggest that the mechanism##3##4##(1993-3#1)(1997-2#1)(2013-1#1)
suggest that the mechanisms of##3##5##(2008-5#1)(2010-3#1)(2011-2#1)
suggest that the mechanisms##4##4##(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
suggest that the medial##2##4##(2008-11#1)(2008-7#1)
suggest that the membrane##2##4##(1991-9#1)(1992-9#1)
suggest that the migratory##2##4##(1997-4#1)(2012-3#1)
suggest that the most likely##2##5##(1996-4#1)(2008-10#1)
suggest that the most##3##4##(1996-4#1)(2008-10#1)(2008-9#1)
suggest that the observed##7##4##(1992-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(2007-12#1)(2008-7#1)(2013-7#1)
suggest that the overall##2##4##(1993-2#1)(2007-12#1)
suggest that the parasite##2##4##(2007-6#1)(2008-8#1)
suggest that the patient##2##4##(1994-12#1)(1996-5#1)
suggest that the patients##2##4##(1994-12#1)(2007-7#1)
suggest that the presence of##8##5##(1990-5#2)(1992-9#1)(1993-3#1)(2008-10#2)(2008-5#1)(2013-7#1)
suggest that the prevalence of##3##5##(2007-12#1)(2008-8#1)(2009-3#1)
suggest that the primary##3##4##(1991-5#1)(2008-7#1)(2009-5#1)
suggest that the process of##2##5##(2008-11#1)(2008-9#1)
suggest that the process##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
suggest that the proposed##2##4##(2008-10#1)(2013-1#1)
suggest that the protein##3##4##(1990-11#1)(1990-12#1)(2008-9#1)
suggest that the reduction in##2##5##(1995-3#1)(2007-10#1)
suggest that the reduction##3##4##(1995-3#1)(2007-10#1)(2011-2#1)
suggest that the regulation of##3##5##(1991-2#1)(1992-8#1)(1994-9#1)
suggest that the release of##2##5##(1992-6#1)(2008-10#1)
suggest that the resistance of##3##5##(2008-10#3)
suggest that the response##2##4##(1997-3#1)(2006-10#1)
suggest that the role of##4##5##(1991-5#1)(1995-3#1)(1996-12#1)(2010-1#1)
suggest that the role##5##4##(1991-5#1)(1995-3#1)(1996-12#1)(2010-1#1)(2013-1#1)
suggest that the second##2##4##(2008-2#1)(2009-8#1)
suggest that the structure of##2##5##(1992-6#1)(1993-6#1)
suggest that the synthesis##2##4##(1990-11#1)(1995-11#1)
suggest that the three-dimensional##2##4##(1993-6#1)(1995-2#1)
suggest that the two##5##4##(1990-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
suggest that the type##2##4##(1995-2#1)(1995-3#1)
suggest that the use of##4##5##(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
suggest that the vascular##2##4##(1991-9#1)(2008-5#1)
suggest that the##536##3##(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-12#7)(1991-2#4)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#5)(1992-6#4)(1992-8#8)(1992-9#6)(1993-12#3)(1993-2#1)(1993-3#8)(1993-6#7)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#6)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#4)(1995-12#10)(1995-2#7)(1995-3#5)(1995-5#2)(1995-6#5)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-4#2)(1996-5#9)(1996-7#1)(1997-1#3)(1997-2#8)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#3)(2007-12#10)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#52)(2008-11#30)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#19)(2008-6#8)(2008-7#12)(2008-8#25)(2008-9#19)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#25)(2012-12#4)(2012-2#13)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#4)
suggest that their##4##3##(1991-9#1)(1995-12#1)(1995-3#1)(2008-10#1)
suggest that there are many##2##5##(1994-2#1)(2007-12#1)
suggest that there are some##2##5##(1992-3#1)(2008-11#1)
suggest that there are##9##4##(1992-3#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
suggest that there is a##6##5##(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)
suggest that there is no##3##5##(2008-10#1)(2008-11#2)
suggest that there is##16##4##(1994-3#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#2)
suggest that there may be##4##5##(1995-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
suggest that there may##6##4##(1995-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
suggest that there##34##3##(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#3)(2013-8#2)
suggest that these two##5##4##(1990-8#1)(1995-11#1)(2007-12#1)(2008-9#1)(2012-1#1)
suggest that these##29##3##(1990-7#1)(1990-8#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-1#1)(2012-2#1)
suggest that they may##2##4##(2008-10#1)(2008-7#1)
suggest that they##7##3##(1992-2#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
suggest that this compound##2##4##(1991-8#1)(1993-9#1)
suggest that this is##3##4##(2006-10#1)(2008-11#1)(2008-3#1)
suggest that this new##2##4##(2008-3#1)(2011-7#1)
suggest that this##46##3##(1990-11#1)(1990-5#2)(1991-8#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-6#1)(2010-11#1)(2011-7#1)(2012-2#1)(2012-3#2)
suggest that thyroid##2##3##(1993-3#1)(2011-1#1)
suggest that timing of##2##4##(2008-10#1)(2010-7#1)
suggest that translocation of##2##4##(1991-12#1)(1994-8#1)
suggest that treatment with##2##4##(1996-12#1)(2008-11#1)
suggest that urinary##2##3##(1991-12#1)(1992-3#1)
suggest that use of##4##4##(2008-10#3)(2010-7#1)
suggest that vascular##2##3##(1990-12#1)(2009-1#1)
suggest that vertical transmission##2##4##(2008-8#1)(2008-9#1)
suggest that virus##2##3##(2008-10#2)
suggest that visual##2##3##(1996-2#1)(2011-1#1)
suggest that vitamin##2##3##(2008-11#1)(2008-8#1)
suggest that we##3##3##(2008-9#1)(2012-12#1)(2012-2#1)
suggest that when##8##3##(1992-10#1)(1992-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-2#1)
suggest that with##3##3##(1992-2#1)(1994-8#1)(1995-2#1)
suggest that young##2##3##(2010-4#1)(2012-12#1)
suggest that zinc##3##3##(2008-10#1)(2008-4#1)(2013-7#1)
suggest that##2215##2##(1990-10#1)(1990-11#16)(1990-12#15)(1990-2#22)(1990-3#5)(1990-4#1)(1990-5#21)(1990-6#4)(1990-7#16)(1990-8#6)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#29)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#12)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#16)(1992-1#2)(1992-10#6)(1992-11#9)(1992-12#27)(1992-2#9)(1992-3#24)(1992-4#1)(1992-5#3)(1992-6#14)(1992-7#2)(1992-8#22)(1992-9#17)(1993-1#7)(1993-11#9)(1993-12#23)(1993-2#7)(1993-3#23)(1993-5#2)(1993-6#19)(1993-8#19)(1993-9#10)(1994-1#3)(1994-11#29)(1994-12#18)(1994-2#11)(1994-3#15)(1994-5#11)(1994-6#15)(1994-7#3)(1994-8#20)(1994-9#16)(1995-1#1)(1995-11#20)(1995-12#34)(1995-2#26)(1995-3#17)(1995-4#2)(1995-5#10)(1995-6#14)(1995-8#7)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#19)(1996-2#19)(1996-3#7)(1996-4#5)(1996-5#18)(1996-6#3)(1996-7#3)(1996-9#2)(1997-1#10)(1997-2#20)(1997-3#10)(1997-4#11)(1997-5#3)(1997-6#8)(1997-7#14)(1997-8#5)(2006-10#6)(2006-7#1)(2007-10#8)(2007-11#8)(2007-12#31)(2007-2#1)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#255)(2008-11#112)(2008-12#21)(2008-2#20)(2008-3#34)(2008-4#26)(2008-5#54)(2008-6#27)(2008-7#65)(2008-8#87)(2008-9#61)(2009-1#5)(2009-10#16)(2009-11#3)(2009-12#10)(2009-2#3)(2009-3#4)(2009-4#8)(2009-5#5)(2009-6#6)(2009-7#13)(2009-8#18)(2009-9#10)(2010-1#4)(2010-10#9)(2010-11#6)(2010-12#8)(2010-2#7)(2010-3#15)(2010-4#7)(2010-5#11)(2010-6#7)(2010-7#3)(2010-8#9)(2010-9#5)(2011-1#14)(2011-10#1)(2011-2#76)(2011-7#2)(2012-1#7)(2012-12#26)(2012-2#50)(2012-3#29)(2012-5#2)(2012-7#1)(2013-1#55)(2013-7#11)(2013-8#24)
suggest the diagnosis##2##3##(1990-5#1)(1997-3#1)
suggest the existence of a##4##5##(1990-8#1)(1991-2#1)(1992-8#1)(2008-4#1)
suggest the existence of##10##4##(1990-8#1)(1991-2#1)(1992-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
suggest the following##2##3##(1994-5#1)(1996-12#1)
suggest the importance of##3##4##(1992-8#1)(1994-8#1)(2008-7#1)
suggest the involvement of PKC in##2##6##(1997-1#1)(2008-4#1)
suggest the involvement of##4##4##(1996-5#1)(1997-1#1)(2008-10#1)(2008-4#1)
suggest the need for##9##4##(1992-2#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)
suggest the need to##3##4##(1991-3#1)(2007-10#1)(2010-4#1)
suggest the need##12##3##(1991-3#1)(1992-2#1)(1995-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
suggest the possibility of a##3##5##(1993-12#1)(1994-8#1)(1995-11#1)
suggest the possibility of##12##4##(1990-5#1)(1990-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)
suggest the possibility that##8##4##(1990-12#1)(1991-12#1)(1994-11#1)(1994-3#1)(1996-12#1)(2008-11#1)(2011-1#1)(2012-2#1)
suggest the possibility##20##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)
suggest the possible use of##3##5##(2008-10#1)(2008-5#1)(2009-8#1)
suggest the possible##8##3##(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2009-8#1)(2010-11#1)
suggest the potential##7##3##(1993-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
suggest the presence of a##8##5##(1991-2#1)(1992-8#1)(1994-11#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-9#1)
suggest the presence of##11##4##(1991-2#1)(1992-8#1)(1994-11#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
suggest the use of##4##4##(2008-2#1)(2008-3#2)(2008-8#1)
suggest the usefulness of##3##4##(1990-5#1)(2008-5#1)(2010-8#1)
suggest the##140##2##(1990-12#1)(1990-5#3)(1990-6#2)(1990-8#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-8#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#4)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
suggest their##4##2##(1995-11#1)(2007-12#1)(2009-10#1)(2011-2#1)
suggest there is a##2##4##(1995-11#1)(2008-10#1)
suggest there##4##2##(1995-11#1)(2008-10#1)(2010-6#1)(2012-2#1)
suggest these##3##2##(2008-1#1)(2009-12#1)(2013-1#1)
suggest they##2##2##(1994-11#1)(2008-10#1)
suggest this##4##2##(2008-10#1)(2009-8#1)(2012-3#2)
suggest two##4##2##(1991-8#1)(1995-2#1)(2012-2#1)(2012-3#1)
suggest using a##2##3##(2008-3#1)(2009-8#1)
suggest using##4##2##(1996-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
suggest what##2##2##(2008-3#1)(2009-4#1)
suggest##2775##1##(1990-10#1)(1990-11#17)(1990-12#17)(1990-2#23)(1990-3#6)(1990-4#2)(1990-5#26)(1990-6#11)(1990-7#17)(1990-8#11)(1990-9#2)(1991-1#6)(1991-10#2)(1991-11#4)(1991-12#35)(1991-2#14)(1991-3#6)(1991-4#3)(1991-5#14)(1991-6#5)(1991-7#1)(1991-8#7)(1991-9#18)(1992-1#2)(1992-10#9)(1992-11#11)(1992-12#31)(1992-2#14)(1992-3#32)(1992-4#2)(1992-5#4)(1992-6#21)(1992-7#2)(1992-8#28)(1992-9#19)(1993-1#8)(1993-11#12)(1993-12#27)(1993-2#8)(1993-3#31)(1993-5#2)(1993-6#22)(1993-8#22)(1993-9#11)(1994-1#3)(1994-11#34)(1994-12#20)(1994-2#12)(1994-3#25)(1994-5#14)(1994-6#18)(1994-7#3)(1994-8#24)(1994-9#18)(1995-1#2)(1995-11#24)(1995-12#42)(1995-2#33)(1995-3#17)(1995-4#2)(1995-5#12)(1995-6#16)(1995-8#8)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#27)(1996-2#23)(1996-3#10)(1996-4#5)(1996-5#20)(1996-6#3)(1996-7#3)(1996-9#3)(1997-1#12)(1997-2#20)(1997-3#16)(1997-4#11)(1997-5#6)(1997-6#8)(1997-7#18)(1997-8#7)(2006-10#8)(2006-6#1)(2006-7#1)(2007-10#14)(2007-11#16)(2007-12#49)(2007-2#3)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#11)(2008-10#296)(2008-11#134)(2008-12#31)(2008-2#26)(2008-3#50)(2008-4#34)(2008-5#68)(2008-6#33)(2008-7#86)(2008-8#99)(2008-9#75)(2009-1#5)(2009-10#21)(2009-11#6)(2009-12#14)(2009-2#5)(2009-3#4)(2009-4#14)(2009-5#8)(2009-6#7)(2009-7#15)(2009-8#22)(2009-9#12)(2010-1#5)(2010-10#9)(2010-11#11)(2010-12#11)(2010-2#10)(2010-3#18)(2010-4#11)(2010-5#13)(2010-6#11)(2010-7#3)(2010-8#14)(2010-9#5)(2011-1#21)(2011-10#1)(2011-2#89)(2011-7#2)(2012-1#9)(2012-12#31)(2012-2#68)(2012-3#39)(2012-5#2)(2012-7#2)(2013-1#66)(2013-7#14)(2013-8#31)
suggested a diagnosis of##2##4##(2007-7#1)(2013-8#1)
suggested a possible involvement of##2##5##(1997-2#2)
suggested a possible##7##3##(1990-5#1)(1990-6#1)(1997-2#2)(2008-10#1)(2013-1#2)
suggested a potential role##2##4##(1993-9#1)(1994-6#1)
suggested a potential##3##3##(1993-9#1)(1994-6#1)(2008-10#1)
suggested a role for##2##4##(2008-5#1)(2008-8#1)
suggested a role##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
suggested a##62##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1997-2#2)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#2)
suggested aggregation of##2##3##(2008-10#2)
suggested an##6##2##(1991-5#1)(1993-12#1)(1995-3#1)(2008-1#1)(2009-6#1)(2012-3#1)
suggested and##6##2##(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-12#2)
suggested approach##2##2##(1990-5#1)(1997-2#1)
suggested as a possible mechanism##2##5##(2007-8#1)(2008-5#1)
suggested as a possible##5##4##(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#1)
suggested as a strategy to##2##5##(1997-3#1)(2008-3#1)
suggested as a##17##3##(1997-3#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#2)
suggested as possible##4##3##(1990-11#1)(1992-11#1)(2008-4#1)(2010-6#1)
suggested as the##6##3##(1992-8#1)(1995-5#1)(2007-12#1)(2008-7#2)(2012-3#1)
suggested as##42##2##(1990-11#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
suggested based on##2##3##(1994-6#1)(2011-2#1)
suggested by Vitruvius (De Architectura)##2##5##(2008-10#2)
suggested by a##3##3##(1992-6#1)(2008-12#1)(2013-1#1)
suggested by its##2##3##(1990-5#1)(2009-12#1)
suggested by the observation##2##4##(1991-9#1)(1992-9#1)
suggested by the##15##3##(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)
suggested by##56##2##(1990-3#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-3#2)(1997-5#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#2)
suggested could be##2##3##(2008-11#1)(2008-9#1)
suggested design##2##2##(2008-10#1)(2008-3#1)
suggested earlier##3##2##(1991-11#1)(2008-3#1)(2009-12#1)
suggested for the##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#1)
suggested for##31##2##(1990-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
suggested here##2##2##(1997-2#1)(2008-1#1)
suggested improvements##2##2##(1994-9#1)(2010-4#1)
suggested in order to##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
suggested in the##4##3##(2009-11#1)(2011-1#1)(2012-2#2)
suggested in this##2##3##(1991-11#1)(2008-12#1)
suggested in##15##2##(1991-11#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-6#1)(2009-11#1)(2011-1#1)(2012-2#2)(2013-1#1)
suggested interventions##2##2##(1995-2#1)(2013-1#1)
suggested method is##2##3##(2008-2#1)(2010-8#1)
suggested method uses##2##3##(2008-10#2)
suggested method##6##2##(2008-10#3)(2008-2#2)(2010-8#1)
suggested more##2##2##(1994-3#1)(2008-8#1)
suggested on the basis of##2##5##(1990-3#1)(2007-11#1)
suggested on##4##2##(1990-3#1)(1994-12#1)(2007-11#1)(2008-10#1)
suggested stage-IV disease in##2##4##(2012-12#2)
suggested system##3##2##(2008-3#1)(2013-1#2)
suggested technique##2##2##(2008-3#2)
suggested that a single##4##4##(1992-1#1)(1997-2#1)(2008-10#2)
suggested that a##19##3##(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-6#1)(2013-1#2)
suggested that active##2##3##(1991-5#1)(2008-10#1)
suggested that additional##2##3##(1991-12#1)(2008-5#1)
suggested that all##4##3##(1990-3#1)(1992-3#1)(2008-10#2)
suggested that an important##2##4##(1992-2#1)(2010-12#1)
suggested that an##7##3##(1992-12#1)(1992-2#1)(1994-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
suggested that at##2##3##(2008-10#2)
suggested that both of##2##4##(1993-12#1)(2008-9#1)
suggested that both##7##3##(1991-12#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
suggested that chromosome##2##3##(1996-6#1)(2008-10#1)
suggested that each##2##3##(1991-5#1)(2008-10#1)
suggested that for##2##3##(2013-1#2)
suggested that health##2##3##(2008-11#1)(2010-7#1)
suggested that improved##2##3##(1995-6#1)(2008-10#1)
suggested that in the##2##4##(2008-4#1)(2013-1#1)
suggested that in##5##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-6#1)(2013-1#1)
suggested that iron##2##3##(1992-8#1)(1996-2#1)
suggested that it is##2##4##(1992-3#1)(2008-10#1)
suggested that it was##2##4##(1994-11#1)(2011-2#1)
suggested that it##9##3##(1990-11#1)(1990-6#1)(1992-3#1)(1994-11#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
suggested that many##2##3##(1994-6#1)(2007-8#1)
suggested that not##2##3##(2008-10#2)
suggested that nuclear##2##3##(1994-8#1)(2008-8#1)
suggested that one##2##3##(2008-10#1)(2008-11#1)
suggested that patients##4##3##(1997-8#1)(2008-11#1)(2008-5#1)(2008-6#1)
suggested that resistance##4##3##(2008-10#4)
suggested that some##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)
suggested that specific##2##3##(1994-12#1)(2008-8#1)
suggested that students##2##3##(2008-11#1)(2009-7#1)
suggested that the activity##2##4##(1992-2#1)(1994-2#1)
suggested that the cell##2##4##(1997-3#1)(2008-11#1)
suggested that the conformation of##2##5##(2008-10#1)(2008-8#1)
suggested that the efe gene##2##5##(2008-10#2)
suggested that the effects observed##2##5##(1991-5#1)(2011-1#1)
suggested that the increase in##4##5##(1992-9#1)(1993-12#1)(2008-11#1)(2008-4#1)
suggested that the initial##2##4##(2008-10#1)(2008-12#1)
suggested that the three##2##4##(1991-9#1)(2008-10#1)
suggested that the##158##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1991-2#5)(1991-3#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#13)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#6)(2009-2#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)
suggested that there are##3##4##(2007-6#1)(2008-10#1)(2008-5#1)
suggested that there is##3##4##(2008-12#1)(2011-2#1)(2012-12#1)
suggested that there##10##3##(1991-12#1)(1996-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
suggested that these findings##2##4##(2008-10#1)(2011-1#1)
suggested that these##15##3##(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-2#1)(1996-12#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#1)
suggested that they##5##3##(1992-12#1)(1996-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
suggested that this combination##2##4##(1997-7#1)(2013-1#1)
suggested that this virus##2##4##(2008-10#2)
suggested that this##24##3##(1990-12#1)(1990-2#1)(1990-5#3)(1993-6#2)(1995-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
suggested that three##2##3##(2008-10#1)(2012-3#1)
suggested that two##2##3##(1992-8#1)(1995-5#1)
suggested that##596##2##(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#6)(1991-2#6)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#6)(1992-5#3)(1992-6#2)(1992-8#7)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#6)(1994-3#1)(1994-6#5)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#7)(1995-8#3)(1996-12#7)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#6)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#93)(2008-11#43)(2008-12#10)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#19)(2008-8#34)(2008-9#22)(2009-10#6)(2009-11#1)(2009-2#3)(2009-3#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#16)(2011-3#3)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#29)(2013-7#1)(2013-8#8)
suggested the existence of##6##4##(1995-2#1)(1997-6#2)(2008-11#1)(2010-8#1)(2012-7#1)
suggested the following##2##3##(2008-10#1)(2008-9#1)
suggested the formation of##2##4##(2007-7#1)(2008-5#1)
suggested the involvement of##2##4##(1990-11#1)(2008-6#1)
suggested the occurrence of##2##4##(2008-10#2)
suggested the possibility##2##3##(2009-5#1)(2011-2#1)
suggested the possible##2##3##(2010-12#1)(2011-1#1)
suggested the presence of a##3##5##(1993-2#1)(1995-6#1)(1997-5#1)
suggested the presence of two##2##5##(1992-6#1)(1995-2#1)
suggested the presence of##12##4##(1992-12#1)(1992-6#1)(1993-2#1)(1995-2#1)(1995-6#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
suggested the use of##3##4##(1994-8#1)(2008-12#1)(2012-3#1)
suggested the##51##2##(1990-11#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#2)(1997-5#1)(1997-6#2)(2007-5#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)
suggested to be a##4##4##(1995-3#1)(2008-9#2)(2010-12#1)
suggested to be an##3##4##(1991-2#1)(1994-8#1)(2009-11#1)
suggested to be involved in##4##5##(1995-6#1)(2008-10#1)(2009-9#1)(2011-2#1)
suggested to be responsible for##2##5##(2008-7#1)(2011-2#1)
suggested to be##35##3##(1990-11#2)(1991-2#2)(1993-1#1)(1993-11#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
suggested to contribute to##2##4##(1994-11#1)(2008-10#1)
suggested to have##2##3##(1993-12#1)(2008-4#1)
suggested to occur via##3##4##(1990-5#1)(2013-1#2)
suggested to play a##2##4##(1994-12#1)(2008-11#1)
suggested to play##7##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)
suggested to##77##2##(1990-11#2)(1990-5#1)(1991-2#2)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#5)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
suggested##1168##1##(1990-11#9)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#11)(1990-6#4)(1990-7#3)(1990-8#6)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#8)(1991-3#5)(1991-5#8)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-11#4)(1992-12#14)(1992-2#3)(1992-3#10)(1992-5#3)(1992-6#9)(1992-8#12)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#12)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#5)(1993-8#5)(1993-9#5)(1994-11#6)(1994-12#6)(1994-2#10)(1994-3#2)(1994-5#1)(1994-6#7)(1994-7#3)(1994-8#7)(1994-9#10)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#10)(1995-3#7)(1995-4#1)(1995-5#6)(1995-6#10)(1995-8#3)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#12)(1997-3#9)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#11)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#15)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#8)(2008-10#191)(2008-11#66)(2008-12#24)(2008-2#19)(2008-3#33)(2008-4#8)(2008-5#26)(2008-6#12)(2008-7#37)(2008-8#47)(2008-9#39)(2009-10#7)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#4)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#13)(2011-2#34)(2011-3#4)(2011-4#1)(2011-7#1)(2012-1#3)(2012-12#15)(2012-2#20)(2012-3#9)(2012-4#1)(2012-7#2)(2013-1#52)(2013-7#3)(2013-8#15)
suggestedthat the##2##2##(2008-11#2)
suggesting a common evolutionary origin##2##5##(1990-5#2)
suggesting a common##4##3##(1990-5#2)(1995-5#1)(2008-10#1)
suggesting a complex##2##3##(1993-12#1)(2008-7#1)
suggesting a direct action of the drug##2##7##(1990-11#1)(1994-8#1)
suggesting a direct##3##3##(1990-11#1)(1993-6#1)(1994-8#1)
suggesting a functional##2##3##(1994-9#1)(1997-7#1)
suggesting a high##2##3##(2008-8#1)(2010-5#1)
suggesting a more##2##3##(1997-7#1)(2008-5#1)
suggesting a new##2##3##(2008-11#1)(2008-3#1)
suggesting a physiologic role for LIF##2##6##(2008-4#2)
suggesting a possible role for##3##5##(2008-10#2)(2009-12#1)
suggesting a possible##13##3##(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2009-12#1)(2010-12#1)(2010-3#1)(2013-7#1)
suggesting a potential##4##3##(2008-11#1)(2008-9#1)(2011-2#2)
suggesting a role for##9##4##(1992-12#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-3#1)(2012-2#1)
suggesting a role of##2##4##(2009-9#1)(2012-3#1)
suggesting a role##11##3##(1992-12#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
suggesting a##111##2##(1990-11#2)(1990-5#3)(1990-7#1)(1991-10#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#3)(2006-10#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#4)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
suggesting an alternative##2##3##(1995-2#2)
suggesting an important role for##2##5##(1991-8#1)(2012-3#1)
suggesting an important role##3##4##(1991-8#1)(2009-11#1)(2012-3#1)
suggesting an increased flux##2##4##(2008-11#2)
suggesting an increased##4##3##(2008-11#2)(2008-7#2)
suggesting an involvement of phosphatidylinositol degradation and activation of protein kinase C##2##12##(2008-11#2)
suggesting an##22##2##(1991-6#1)(1991-8#1)(1992-8#1)(1995-2#3)(2007-8#1)(2008-11#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)
suggesting different##3##2##(1991-5#1)(1993-8#1)(2008-11#1)
suggesting either that##2##3##(2008-10#2)
suggesting involvement##2##2##(1996-5#1)(2008-11#1)
suggesting it##4##2##(1995-6#1)(1996-6#1)(2008-10#1)(2013-8#1)
suggesting its##7##2##(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
suggesting multiple##3##2##(1993-11#1)(2008-10#1)(2012-2#1)
suggesting neurotransmitter##2##2##(1990-5#1)(1993-3#1)
suggesting no involvement of arachidonic acid metabolism##2##7##(2008-11#2)
suggesting no##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
suggesting possible##6##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)
suggesting potential##2##2##(1995-3#1)(2013-1#1)
suggesting recent##2##2##(1997-6#1)(2009-10#1)
suggesting reduced##2##2##(2009-10#1)(2013-7#1)
suggesting secretion##2##2##(1995-6#1)(2008-10#1)
suggesting sensitization of##2##3##(1995-12#2)
suggesting several##2##2##(1991-3#1)(1994-12#1)
suggesting similar##2##2##(1997-2#1)(2009-8#1)
suggesting some##2##2##(1993-12#1)(2008-7#1)
suggesting specificity##2##2##(1996-5#1)(2012-3#1)
suggesting that P##2##3##(2009-9#1)(2010-8#1)
suggesting that a single##3##4##(2008-10#2)(2012-3#1)
suggesting that a##23##3##(1991-2#1)(1992-11#1)(1992-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-2#2)(2008-6#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
suggesting that additional##3##3##(1992-12#1)(2008-10#2)
suggesting that an##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
suggesting that at least some##2##5##(1990-12#1)(2008-10#1)
suggesting that at least two##2##5##(1992-10#1)(1997-6#1)
suggesting that at least##4##4##(1990-12#1)(1992-10#1)(1997-6#1)(2008-10#1)
suggesting that at##6##3##(1990-12#1)(1992-10#1)(1994-5#1)(1997-6#1)(2008-1#1)(2008-10#1)
suggesting that both##6##3##(1991-5#1)(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
suggesting that differences##2##3##(1994-12#1)(2008-10#1)
suggesting that different##3##3##(1993-8#1)(2011-2#1)(2012-12#1)
suggesting that either the##3##4##(1992-9#1)(1997-4#1)(1997-7#1)
suggesting that either##4##3##(1992-9#1)(1997-4#1)(1997-7#1)(2013-7#1)
suggesting that in the##2##4##(2008-1#1)(2008-11#1)
suggesting that in##4##3##(2008-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
suggesting that it is##3##4##(1992-12#1)(1994-6#1)(2011-2#1)
suggesting that it may play a##2##6##(1993-3#1)(2008-10#1)
suggesting that it may play##3##5##(1993-3#1)(2008-10#2)
suggesting that it may##5##4##(1993-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
suggesting that it##14##3##(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-2#1)
suggesting that its##2##3##(1995-8#1)(2008-10#1)
suggesting that migration##2##3##(2008-10#2)
suggesting that new##2##3##(1995-2#1)(2008-10#1)
suggesting that no##3##3##(1994-8#1)(1996-12#1)(2010-2#1)
suggesting that not all##2##4##(2007-11#1)(2008-11#1)
suggesting that one of the##2##5##(1993-8#1)(2008-4#1)
suggesting that one##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
suggesting that only##2##3##(2008-10#1)(2009-12#1)
suggesting that other mechanisms##2##4##(2008-4#1)(2010-12#1)
suggesting that other##6##3##(1991-9#1)(1992-7#1)(1995-2#1)(2008-10#1)(2008-4#1)(2010-12#1)
suggesting that protein##2##3##(1991-5#1)(1997-1#1)
suggesting that sex##2##3##(2008-5#1)(2008-8#1)
suggesting that some##6##3##(1993-6#1)(1995-5#1)(1997-3#2)(2008-10#2)
suggesting that the amino terminus##2##5##(1991-8#2)
suggesting that the bacterial##2##4##(1994-6#1)(1995-2#1)
suggesting that the effect of##2##5##(1992-6#1)(2010-8#1)
suggesting that the effect##3##4##(1992-6#1)(2008-11#1)(2010-8#1)
suggesting that the endogenous##2##4##(1990-5#1)(2008-5#1)
suggesting that the gene##2##4##(1993-2#1)(1994-12#1)
suggesting that the increased##2##4##(1990-12#1)(1995-2#1)
suggesting that the inhibitory effect##2##5##(1991-9#2)
suggesting that the interaction##2##4##(2008-8#1)(2008-9#1)
suggesting that the modulation##2##4##(1994-6#1)(2012-2#1)
suggesting that the presence of##2##5##(1992-3#1)(1995-2#1)
suggesting that the release of##2##5##(2008-11#1)(2008-4#1)
suggesting that the resistance##2##4##(2008-10#2)
suggesting that the two##3##4##(1995-6#1)(2008-10#1)(2008-11#1)
suggesting that the various##2##4##(1994-8#1)(1995-6#1)
suggesting that the##152##3##(1990-12#1)(1990-2#1)(1990-5#4)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#6)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-9#1)(2007-12#2)(2007-6#1)(2008-10#25)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-8#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
suggesting that their##2##3##(2008-8#1)(2010-4#1)
suggesting that there is##3##4##(1991-5#1)(1996-2#1)(1997-9#1)
suggesting that there may be##2##5##(2007-12#1)(2008-8#1)
suggesting that there##7##3##(1991-5#1)(1996-2#1)(1997-9#1)(2007-12#1)(2008-8#2)(2008-9#1)
suggesting that these two##4##4##(1992-2#1)(1993-11#1)(2008-10#1)(2008-11#1)
suggesting that these##14##3##(1990-7#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-8#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-2#1)
suggesting that they are##3##4##(2007-12#1)(2008-7#1)(2008-9#1)
suggesting that they may##3##4##(1991-2#1)(1992-3#1)(2010-4#1)
suggesting that they share##2##4##(1995-2#1)(1997-4#1)
suggesting that they were derived from##2##6##(2008-10#2)
suggesting that they were##3##4##(2008-10#2)(2008-8#1)
suggesting that they##16##3##(1991-2#1)(1992-3#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)
suggesting that this##26##3##(1991-11#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#2)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)
suggesting that##599##2##(1990-11#3)(1990-12#4)(1990-2#3)(1990-5#6)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#6)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#7)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#10)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#7)(1994-8#8)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#7)(1995-2#16)(1995-3#1)(1995-5#4)(1995-6#9)(1995-8#7)(1995-9#2)(1996-12#3)(1996-2#5)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#6)(1997-4#6)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-6#2)(2008-1#3)(2008-10#115)(2008-11#28)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#14)(2008-5#17)(2008-6#7)(2008-7#13)(2008-8#30)(2008-9#9)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#14)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#13)(2013-1#6)(2013-7#3)(2013-8#3)
suggesting the effect##2##3##(2011-2#1)(2012-2#1)
suggesting the existence of a##2##5##(2008-5#1)(2013-1#1)
suggesting the existence of##9##4##(1994-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
suggesting the importance of the##2##5##(2008-10#1)(2010-6#1)
suggesting the importance of##7##4##(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-2#1)
suggesting the involvement of a##2##5##(1994-3#1)(2008-11#1)
suggesting the involvement of##10##4##(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)
suggesting the need##2##3##(1991-3#1)(2009-6#1)
suggesting the occurrence of##5##4##(1994-6#2)(2008-10#3)
suggesting the possibility of##2##4##(2008-6#1)(2008-8#1)
suggesting the possibility that the##2##5##(1995-9#1)(2011-2#1)
suggesting the possibility that##3##4##(1994-3#1)(1995-9#1)(2011-2#1)
suggesting the possibility##5##3##(1994-3#1)(1995-9#1)(2008-6#1)(2008-8#1)(2011-2#1)
suggesting the possible involvement##2##4##(1994-8#1)(2008-11#1)
suggesting the possible##3##3##(1994-8#1)(2007-12#1)(2008-11#1)
suggesting the potential for##2##4##(2008-10#2)
suggesting the potential##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
suggesting the presence of##9##4##(1994-11#1)(1994-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-6#1)
suggesting the use of##2##4##(2008-6#1)(2008-8#1)
suggesting the##92##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-12#1)(2007-7#1)(2008-10#17)(2008-11#6)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
suggesting this##3##2##(1994-2#1)(1997-4#1)(2008-8#1)
suggesting##973##1##(1990-11#7)(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#10)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#8)(1991-3#4)(1991-4#1)(1991-5#7)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#7)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#10)(1993-2#3)(1993-3#8)(1993-6#7)(1993-8#15)(1993-9#3)(1994-10#1)(1994-11#11)(1994-12#8)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#11)(1994-8#11)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#12)(1995-2#19)(1995-3#3)(1995-5#7)(1995-6#13)(1995-8#7)(1995-9#3)(1996-10#1)(1996-12#8)(1996-2#7)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#7)(1997-4#8)(1997-6#5)(1997-7#7)(1997-8#3)(1997-9#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#15)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#172)(2008-11#51)(2008-12#4)(2008-2#10)(2008-3#8)(2008-4#20)(2008-5#30)(2008-6#12)(2008-7#25)(2008-8#41)(2008-9#12)(2009-10#4)(2009-11#2)(2009-12#7)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#5)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#7)(2010-2#6)(2010-3#7)(2010-4#6)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#4)(2011-1#5)(2011-10#1)(2011-2#23)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#24)(2012-3#19)(2012-6#1)(2013-1#15)(2013-7#6)(2013-8#6)
suggestion for##2##2##(1994-2#1)(2008-1#1)
suggestion is made that##2##4##(1990-11#1)(2009-10#1)
suggestion is made##4##3##(1990-11#1)(2008-10#1)(2008-3#1)(2009-10#1)
suggestion is##6##2##(1990-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-8#1)(2012-3#1)
suggestion of a##2##3##(1995-9#1)(2008-1#1)
suggestion of##7##2##(1995-11#1)(1995-9#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
suggestion that the##4##3##(1990-11#1)(1993-12#1)(1995-6#1)(1996-2#1)
suggestion that##20##2##(1990-11#1)(1991-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
suggestion##39##1##(1990-11#2)(1991-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
suggestions and##3##2##(1990-12#1)(1994-2#1)(2008-12#1)
suggestions are given##2##3##(2008-4#1)(2009-5#1)
suggestions are##9##2##(1996-2#1)(2007-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2009-5#1)(2012-2#1)
suggestions as to how##2##4##(1994-3#1)(2008-8#1)
suggestions for a##4##3##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
suggestions for developing##2##3##(1995-1#1)(2007-12#1)
suggestions for future action##2##4##(2012-12#2)
suggestions for future research##5##4##(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)
suggestions for future##8##3##(2008-12#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2012-12#2)
suggestions for improving##4##3##(1991-3#1)(1995-1#1)(1996-11#1)(2008-9#1)
suggestions for physicians##2##3##(1991-2#1)(1992-2#1)
suggestions for practice##2##3##(2010-11#1)(2011-1#1)
suggestions for the##3##3##(1990-2#1)(2008-3#1)(2008-6#1)
suggestions for their##2##3##(1991-2#1)(2012-3#1)
suggestions for##50##2##(1990-2#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-1#2)(1996-1#2)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
suggestions from##3##2##(1992-2#1)(1994-3#1)(1997-3#1)
suggestions on the##4##3##(1995-12#1)(2008-6#1)(2008-9#1)(2012-2#1)
suggestions on which##2##3##(2008-1#1)(2008-6#1)
suggestions on##8##2##(1993-2#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2012-2#1)
suggestions that##4##2##(1997-3#1)(2008-6#1)(2008-7#1)(2009-8#1)
suggestions to improve##2##3##(2008-10#1)(2011-1#1)
suggestions to##4##2##(1992-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
suggestions were##3##2##(2010-8#1)(2012-2#1)(2012-3#1)
suggestions##107##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)
suggestive for a relationship between increased##2##6##(2013-8#2)
suggestive for an inverse relationship between##2##6##(2013-8#2)
suggestive for##5##2##(2013-8#5)
suggestive of a##13##3##(1990-11#1)(1992-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-6#1)(2010-8#1)
suggestive of acute##2##3##(2007-7#1)(2011-1#1)
suggestive of an##4##3##(1990-5#1)(1995-12#1)(2011-2#1)(2013-1#1)
suggestive of genital##2##3##(2008-10#1)(2013-1#1)
suggestive of the##2##3##(1995-3#1)(2012-1#1)
suggestive of this##2##3##(1994-2#1)(2009-9#1)
suggestive of##72##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-2#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#7)(2008-8#2)(2009-1#2)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
suggestive##86##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#1)(1992-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#2)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#10)
suggests a framework##2##3##(2008-5#1)(2012-2#1)
suggests a functional##2##3##(1991-7#1)(1995-12#1)
suggests a general##2##3##(1996-1#1)(2008-10#1)
suggests a genetic##2##3##(2008-7#1)(2009-12#1)
suggests a mechanism by which##2##5##(1994-8#1)(1995-9#1)
suggests a mechanism for##2##4##(1997-8#1)(2011-2#1)
suggests a mechanism##5##3##(1991-9#1)(1994-8#1)(1995-9#1)(1997-8#1)(2011-2#1)
suggests a need##2##3##(2008-12#1)(2008-9#1)
suggests a new##3##3##(2007-11#1)(2008-3#1)(2010-10#1)
suggests a number of##2##4##(1991-3#1)(1992-12#1)
suggests a possible role in the##2##6##(1995-12#1)(1996-3#1)
suggests a possible role in##3##5##(1993-12#1)(1995-12#1)(1996-3#1)
suggests a possible role##5##4##(1992-6#1)(1993-12#1)(1995-12#1)(1996-3#1)(2011-2#1)
suggests a possible##9##3##(1992-1#1)(1992-6#1)(1993-12#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
suggests a potential##4##3##(1996-2#1)(2008-10#1)(2008-12#1)(2013-7#1)
suggests a relationship between##2##4##(1994-11#1)(2013-8#1)
suggests a role of##2##4##(1992-6#1)(2007-8#1)
suggests a role##4##3##(1992-6#1)(2007-8#1)(2009-6#1)(2010-10#1)
suggests a##84##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-6#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
suggests an important##2##3##(1990-2#1)(1997-5#1)
suggests an##16##2##(1990-2#1)(1990-7#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2013-1#1)
suggests different##2##2##(1995-12#1)(1997-3#1)
suggests either that##2##3##(1990-8#1)(1992-11#1)
suggests either##3##2##(1990-8#1)(1992-11#1)(2008-10#1)
suggests how##4##2##(1993-12#1)(1995-3#1)(1997-7#1)(2009-11#1)
suggests involvement of##2##3##(1994-9#1)(2012-2#1)
suggests involvement##3##2##(1994-9#1)(2010-10#1)(2012-2#1)
suggests it##3##2##(1997-2#1)(2008-6#1)(2013-8#1)
suggests its##4##2##(1996-2#1)(2008-2#1)(2010-10#1)(2010-5#1)
suggests possible##2##2##(2008-3#1)(2008-7#1)
suggests several##2##2##(1991-3#1)(2012-1#1)
suggests some##3##2##(1994-3#1)(1995-2#1)(2008-5#1)
suggests strategies##3##2##(1993-2#1)(1997-1#1)(2008-4#1)
suggests that S##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
suggests that a##20##3##(1990-9#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-5#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
suggests that additional##2##3##(2008-10#1)(2008-3#1)
suggests that although##2##3##(1990-12#1)(2012-12#1)
suggests that an##8##3##(1993-2#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2011-3#1)
suggests that at##3##3##(1995-11#1)(2008-10#1)(2010-3#1)
suggests that both##11##3##(1991-4#1)(1991-6#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-1#1)
suggests that chronic##2##3##(2008-11#1)(2011-2#1)
suggests that comparative##2##3##(1991-9#1)(2008-10#1)
suggests that even##2##3##(1997-4#1)(2009-8#1)
suggests that factors##2##3##(1990-5#1)(1997-2#1)
suggests that fatty acids##2##4##(1995-6#1)(2008-8#1)
suggests that for##2##3##(1993-11#1)(2008-11#1)
suggests that further##3##3##(1996-8#1)(2008-9#1)(2009-5#1)
suggests that genetic##3##3##(2008-10#2)(2008-11#1)
suggests that horizontal##2##3##(2008-10#1)(2009-6#1)
suggests that in the##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
suggests that in##8##3##(1993-2#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
suggests that increasing altitude##2##4##(2009-5#2)
suggests that it is not##2##5##(1996-2#1)(2008-10#1)
suggests that it is##11##4##(1991-8#1)(1993-6#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
suggests that it may be##2##5##(1997-2#1)(2009-9#1)
suggests that it may##4##4##(1991-5#1)(1992-12#1)(1997-2#1)(2009-9#1)
suggests that it might be##2##5##(2008-2#1)(2013-8#1)
suggests that it might##3##4##(2008-2#1)(2012-2#1)(2013-8#1)
suggests that it##23##3##(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
suggests that its##2##3##(1992-3#1)(1995-2#1)
suggests that many##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
suggests that most##3##3##(1996-2#1)(2008-5#1)(2013-1#1)
suggests that natural##3##3##(2008-11#1)(2008-8#2)
suggests that no##2##3##(1992-3#1)(2008-11#1)
suggests that one##3##3##(1997-7#1)(2008-10#1)(2009-10#1)
suggests that only##3##3##(1991-7#1)(1992-4#1)(2008-8#1)
suggests that other##4##3##(1997-3#1)(2008-8#1)(2012-2#1)(2012-3#1)
suggests that outcomes##2##3##(2009-5#1)(2012-12#1)
suggests that parasites##2##3##(2008-8#1)(2009-2#1)
suggests that selection##2##3##(2008-8#1)(2008-9#1)
suggests that several##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
suggests that sexual reproduction##2##4##(2008-10#2)
suggests that some##5##3##(2008-8#2)(2010-11#1)(2013-1#2)
suggests that such##2##3##(1992-12#1)(2009-10#1)
suggests that the ability of##2##5##(2008-4#1)(2012-2#1)
suggests that the effects of##2##5##(2008-10#1)(2008-8#1)
suggests that the genetic##3##4##(1991-2#1)(2008-10#1)(2009-8#1)
suggests that the human##5##4##(1991-2#1)(1991-6#1)(1992-11#1)(2008-10#1)(2008-6#1)
suggests that the immunophilin-heat shock##2##5##(1993-8#2)
suggests that the increase in##2##5##(1993-6#1)(1995-6#1)
suggests that the initial##2##4##(2008-10#1)(2013-1#1)
suggests that the mechanism##2##4##(1993-11#1)(2008-8#1)
suggests that the mutation##2##4##(1990-12#1)(2008-12#1)
suggests that the pathogen##2##4##(2008-10#2)
suggests that the prevalence of##2##5##(2007-12#1)(2011-1#1)
suggests that the rate##2##4##(2008-10#1)(2013-1#1)
suggests that the two conditions##2##5##(1990-2#1)(2008-4#1)
suggests that the two##4##4##(1990-2#1)(1991-2#1)(2008-4#1)(2009-8#1)
suggests that the use of##3##5##(1990-8#1)(2006-10#1)(2013-1#1)
suggests that the##189##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#7)(2007-7#2)(2008-10#26)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#11)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#6)(2012-2#4)(2013-1#4)(2013-7#1)
suggests that therapeutic##2##3##(2008-6#1)(2009-6#1)
suggests that there are##8##4##(1992-8#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)
suggests that there is a##5##5##(1991-2#1)(2008-6#1)(2010-5#1)(2011-2#2)
suggests that there is no##2##5##(1994-5#1)(2009-2#1)
suggests that there is##7##4##(1991-2#1)(1994-5#1)(2008-6#1)(2009-2#1)(2010-5#1)(2011-2#2)
suggests that there may be##2##5##(2008-9#1)(2009-11#1)
suggests that there##19##3##(1991-2#1)(1991-9#1)(1992-8#1)(1994-5#1)(1996-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#2)
suggests that these two##3##4##(1992-12#1)(1992-5#1)(1995-2#1)
suggests that these##23##3##(1990-12#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1995-11#1)(1995-12#1)(1995-2#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)
suggests that they are##7##4##(1991-12#1)(1991-5#1)(1993-6#1)(1995-12#1)(1997-2#1)(2008-5#1)(2008-7#1)
suggests that they do not##2##5##(1993-8#1)(1995-5#1)
suggests that they have##3##4##(1992-12#1)(2008-10#2)
suggests that they may be##2##5##(1993-8#1)(2008-11#1)
suggests that they may##3##4##(1993-8#1)(2008-11#1)(2008-7#1)
suggests that they##20##3##(1990-2#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-6#1)(1993-8#2)(1995-12#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2013-1#1)
suggests that this new##2##4##(2007-12#1)(2007-7#1)
suggests that this protein might##2##5##(1996-12#1)(2008-10#1)
suggests that this##31##3##(1990-2#1)(1990-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
suggests that two##2##3##(1991-12#1)(2008-4#1)
suggests that##832##2##(1990-11#1)(1990-12#7)(1990-2#7)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#7)(1991-2#10)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#6)(1992-11#5)(1992-12#8)(1992-2#1)(1992-3#9)(1992-4#3)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#6)(1993-6#6)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#13)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#5)(1995-12#8)(1995-2#8)(1995-3#4)(1995-4#1)(1995-5#7)(1995-6#10)(1995-8#7)(1996-1#5)(1996-12#11)(1996-2#4)(1996-3#1)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#2)(1997-9#2)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#18)(2007-2#2)(2007-7#6)(2007-8#1)(2008-1#13)(2008-10#88)(2008-11#36)(2008-12#14)(2008-2#3)(2008-3#15)(2008-4#13)(2008-5#27)(2008-6#8)(2008-7#23)(2008-8#45)(2008-9#19)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#2)(2009-5#6)(2009-6#5)(2009-7#6)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#11)(2011-2#23)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#21)(2012-3#7)(2012-6#1)(2013-1#27)(2013-7#5)(2013-8#7)
suggests the existence of a##3##5##(1990-5#1)(1992-6#1)(2012-2#1)
suggests the existence of##9##4##(1990-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
suggests the involvement of##2##4##(1995-2#1)(2008-10#1)
suggests the need for##6##4##(2008-1#1)(2008-3#2)(2008-8#1)(2010-3#1)(2012-12#1)
suggests the need##7##3##(2008-1#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-8#1)(2012-12#1)
suggests the possibility of##3##4##(1995-11#1)(2007-12#1)(2012-3#1)
suggests the possibility##4##3##(1995-11#1)(2007-12#2)(2012-3#1)
suggests the possible##2##3##(2008-7#1)(2009-8#1)
suggests the potential##4##3##(1995-6#1)(2008-6#1)(2008-7#1)(2012-3#1)
suggests the presence of##3##4##(1993-8#1)(2008-3#1)(2013-1#1)
suggests the usefulness of##4##4##(1994-12#1)(1994-7#1)(2008-10#1)(2011-2#1)
suggests the##58##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
suggests these##3##2##(1992-6#1)(1993-3#1)(2011-1#1)
suggests this##7##2##(1996-10#1)(1997-7#1)(2008-1#1)(2008-9#1)(2009-9#1)(2013-1#1)(2013-8#1)
suggests two##2##2##(1993-6#1)(2013-1#1)
suggests ways##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
suggests where##2##2##(2010-10#1)(2013-1#1)
suggests##1132##1##(1990-11#1)(1990-12#7)(1990-2#9)(1990-3#3)(1990-5#7)(1990-6#2)(1990-7#8)(1990-8#6)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#10)(1991-2#12)(1991-3#4)(1991-4#1)(1991-5#7)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#8)(1992-1#1)(1992-11#6)(1992-12#12)(1992-2#3)(1992-3#10)(1992-4#3)(1992-5#2)(1992-6#8)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#5)(1993-3#8)(1993-6#8)(1993-8#8)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#7)(1994-2#15)(1994-3#6)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#5)(1995-11#6)(1995-12#11)(1995-2#11)(1995-3#6)(1995-4#1)(1995-5#8)(1995-6#11)(1995-8#7)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#10)(1996-3#3)(1996-5#10)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#8)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#5)(1997-9#2)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#24)(2007-2#2)(2007-4#2)(2007-7#7)(2007-8#2)(2008-1#18)(2008-10#107)(2008-11#48)(2008-12#19)(2008-2#7)(2008-3#21)(2008-4#16)(2008-5#34)(2008-6#11)(2008-7#34)(2008-8#50)(2008-9#29)(2009-10#7)(2009-11#6)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#7)(2009-7#6)(2009-8#13)(2009-9#3)(2010-1#2)(2010-10#10)(2010-11#5)(2010-12#1)(2010-2#4)(2010-3#7)(2010-4#3)(2010-5#9)(2010-6#3)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#13)(2011-2#30)(2011-3#1)(2012-1#3)(2012-12#13)(2012-2#31)(2012-3#11)(2012-6#1)(2013-1#38)(2013-7#8)(2013-8#15)
suicidal behavior in a##2##4##(2010-7#1)(2013-1#1)
suicidal behavior##10##2##(2008-7#1)(2009-7#1)(2010-7#1)(2013-1#7)
suicidal behaviors##5##2##(2008-11#1)(2012-12#3)(2013-1#1)
suicidal hanging##2##2##(2010-7#2)
suicidal ideation and planning##2##4##(2013-1#2)
suicidal ideation and##4##3##(1996-3#1)(2010-8#1)(2013-1#2)
suicidal ideation##13##2##(1992-1#2)(1996-3#1)(2008-11#1)(2010-6#2)(2010-8#4)(2012-1#1)(2013-1#2)
suicidal intent##2##2##(2009-2#1)(2012-2#1)
suicidal motives##3##2##(1996-3#3)
suicidal patients##2##2##(2010-6#1)(2010-8#1)
suicidal thoughts and behaviors##2##4##(2008-11#2)
suicidal thoughts and##3##3##(2008-11#2)(2009-7#1)
suicidal thoughts##5##2##(2008-11#2)(2008-6#1)(2009-7#1)(2010-8#1)
suicidal##67##1##(1992-1#5)(1992-5#1)(1993-2#2)(1995-11#2)(1996-3#6)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#4)(2010-6#11)(2010-7#4)(2010-8#6)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#11)
suicidality##7##1##(2008-6#1)(2009-7#4)(2010-7#1)(2011-2#1)
suicide and##3##2##(2010-12#2)(2011-2#1)
suicide as##2##2##(2009-5#1)(2010-12#1)
suicide attempt##9##2##(1992-1#1)(1995-11#1)(2009-3#2)(2010-7#2)(2010-8#1)(2011-1#1)(2013-1#1)
suicide attempts and##2##3##(2010-6#1)(2013-1#1)
suicide attempts##5##2##(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#2)
suicide between##2##2##(1991-12#1)(2009-7#1)
suicide by burning in##2##4##(2011-2#2)
suicide by self-burning##2##3##(2011-2#2)
suicide by##9##2##(1991-8#2)(2007-8#1)(2009-2#1)(2009-7#1)(2011-2#4)
suicide cases##2##2##(1996-1#2)
suicide in older##3##3##(2009-5#3)
suicide in##17##2##(1996-1#2)(1996-3#1)(1997-3#1)(2008-11#1)(2009-10#1)(2009-5#4)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
suicide is##2##2##(2010-6#1)(2013-1#1)
suicide prevention centers##3##3##(1991-12#3)
suicide prevention measures among##2##4##(2011-2#2)
suicide prevention##7##2##(1991-12#3)(2009-5#1)(2011-2#2)(2012-12#1)
suicide rates in##3##3##(1991-12#1)(1996-1#1)(2013-1#1)
suicide rates tend to##2##4##(2013-1#2)
suicide rates##13##2##(1990-6#1)(1991-12#2)(1996-1#1)(2009-5#1)(2011-2#1)(2013-1#7)
suicide risk##3##2##(2009-7#2)(2013-1#1)
suicide substrate##2##2##(1990-8#1)(1992-8#1)
suicide was##3##2##(1991-8#2)(1992-1#1)
suicide##157##1##(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#9)(1991-2#1)(1991-8#9)(1992-1#5)(1992-2#1)(1992-8#1)(1993-3#1)(1993-9#3)(1994-3#1)(1995-11#1)(1996-1#10)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#8)(2009-7#13)(2009-9#1)(2010-12#10)(2010-5#1)(2010-6#6)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#12)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#16)(2013-8#1)
suicide?##2##1##(1991-12#1)(1992-1#1)
suicide]##2##1##(1991-3#1)(2009-10#1)
suicides##6##1##(1991-12#1)(1991-6#1)(1995-11#1)(1995-2#1)(2007-1#1)(2011-2#1)
suillus##4##1##(2011-2#4)
suing##4##1##(1991-7#1)(1994-2#1)(1996-5#1)(1997-5#1)
suis serotype 2##4##3##(2009-6#4)
suis type 2##4##3##(1991-8#4)
suis##17##1##(1991-8#4)(1996-12#2)(2007-12#2)(2009-6#9)
suit against the##2##3##(1995-12#1)(1997-5#1)
suit against##4##2##(1993-12#1)(1995-12#2)(1997-5#1)
suit over##3##2##(1996-2#1)(1996-5#2)
suit the##6##2##(1996-6#1)(2009-5#1)(2010-3#2)(2012-12#1)(2013-1#1)
suit to##2##2##(1992-2#1)(2008-8#1)
suit##37##1##(1991-3#1)(1992-2#1)(1993-12#3)(1994-3#1)(1995-12#8)(1995-6#5)(1996-2#1)(1996-5#4)(1996-6#1)(1997-5#2)(2008-10#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#1)(2012-12#1)(2013-1#2)
suitability and##4##2##(1996-5#1)(2008-5#2)(2008-8#1)
suitability as##3##2##(2008-10#2)(2009-7#1)
suitability for##18##2##(1992-4#1)(1992-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2013-1#1)
suitability in##2##2##(1996-12#1)(2008-8#1)
suitability of potential##2##3##(2008-8#2)
suitability of the proposed method for##2##6##(2008-10#2)
suitability of the##24##3##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2013-1#1)
suitability of these##3##3##(1996-3#1)(2007-2#1)(2008-2#1)
suitability of##66##2##(1992-6#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
suitability to##2##2##(2008-10#2)
suitability##107##1##(1992-4#1)(1992-6#2)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#37)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#4)(2013-8#1)
suitable alternative to##4##3##(1993-1#1)(1996-1#1)(2008-10#1)(2009-2#1)
suitable alternative##11##2##(1993-1#1)(1996-1#3)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-7#1)(2012-3#1)
suitable amount of##2##3##(2008-10#2)
suitable analytical##3##2##(2008-10#3)
suitable and##2##2##(2008-10#2)
suitable approach for##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
suitable approaches##2##2##(2008-10#1)(2008-8#1)
suitable as a##4##3##(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)
suitable as an##2##3##(2008-10#1)(2008-5#1)
suitable as##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)
suitable candidate##2##2##(2008-11#1)(2008-3#1)
suitable candidates for##2##3##(2008-7#1)(2011-1#1)
suitable characteristics##2##2##(2008-10#1)(2012-1#1)
suitable combinations of##2##3##(2007-11#1)(2008-3#1)
suitable conditions for##2##3##(2008-10#2)
suitable conditions##8##2##(2007-11#1)(2008-10#5)(2010-1#1)(2013-1#1)
suitable detection##2##2##(2008-10#1)(2012-2#1)
suitable ends on the##2##4##(2008-2#2)
suitable for a variety of##3##5##(2007-12#1)(2008-4#2)
suitable for a##9##3##(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#2)(2011-2#1)
suitable for active##2##3##(2007-11#1)(2008-10#1)
suitable for analysis of##3##4##(1997-2#1)(2008-10#1)(2010-12#1)
suitable for analysis##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2010-12#1)
suitable for analyzing##2##3##(2008-10#1)(2008-3#1)
suitable for application in skin and##2##6##(2008-5#2)
suitable for application in##5##4##(2008-10#3)(2008-5#2)
suitable for application##7##3##(2008-10#5)(2008-5#2)
suitable for applications in##2##4##(2007-12#1)(2008-11#1)
suitable for applications##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
suitable for automatic and continuous analysis##4##6##(2008-10#4)
suitable for biomimetic bone tissue engineering##2##6##(2009-7#2)
suitable for both##4##3##(1994-12#1)(2008-3#2)(2011-2#1)
suitable for clinical##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
suitable for determination of the##2##5##(2008-10#2)
suitable for determination of##6##4##(1992-3#1)(2008-10#5)
suitable for field##3##3##(2008-10#2)(2008-3#1)
suitable for flow##2##3##(2008-5#2)
suitable for high throughput##3##4##(2008-10#1)(2009-9#1)(2010-12#1)
suitable for high##5##3##(2008-10#2)(2009-9#1)(2010-12#1)(2013-8#1)
suitable for high-power##2##3##(2008-2#2)
suitable for imaging##2##3##(2008-2#1)(2009-8#1)
suitable for in vivo##2##4##(1994-12#1)(2010-6#1)
suitable for in##3##3##(1994-12#1)(1996-12#1)(2010-6#1)
suitable for industrial##3##3##(1991-5#1)(2008-10#1)(2011-2#1)
suitable for inertial confinement fusion##2##5##(2007-11#1)(2008-3#1)
suitable for local##2##3##(1992-6#1)(2008-1#1)
suitable for many##4##3##(1995-2#1)(1996-2#1)(2008-6#1)(2009-8#1)
suitable for measuring##4##3##(2008-10#3)(2008-2#1)
suitable for medical##2##3##(2010-4#1)(2010-9#1)
suitable for most##2##3##(2008-10#1)(2011-2#1)
suitable for neonatal screening##2##4##(1991-2#2)
suitable for practical##2##3##(2008-10#1)(2008-2#1)
suitable for processing##3##3##(2008-3#1)(2010-4#2)
suitable for qualitative##2##3##(2008-10#1)(2012-3#1)
suitable for quantification of##2##4##(2008-10#2)
suitable for quantitating iodate##2##4##(2008-10#2)
suitable for rapid##2##3##(2008-11#1)(2008-9#1)
suitable for real-time##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
suitable for routine##6##3##(1996-12#1)(2008-10#4)(2008-5#1)
suitable for screening##5##3##(2008-10#3)(2011-1#1)(2011-2#1)
suitable for simultaneous##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
suitable for studying##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
suitable for the analysis of##5##5##(1993-11#1)(1996-2#1)(2008-10#1)(2011-1#2)
suitable for the assay of##2##5##(2008-10#2)
suitable for the assay##3##4##(2008-10#2)(2008-11#1)
suitable for the detection of##3##5##(1990-12#1)(2008-10#1)(2010-4#1)
suitable for the determination of##13##5##(1991-5#1)(2008-10#10)(2009-8#1)(2011-1#1)
suitable for the expression of##2##5##(2008-8#2)
suitable for the identification##2##4##(2008-10#1)(2011-2#1)
suitable for the quality control of##4##6##(2011-1#3)(2012-3#1)
suitable for the salivary gland##2##5##(2008-11#2)
suitable for the separation##2##4##(2008-10#2)
suitable for the simultaneous##4##4##(2008-10#4)
suitable for the##86##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#37)(2008-11#8)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
suitable for their##2##3##(2008-10#1)(2012-12#1)
suitable for thin##2##3##(2008-3#1)(2008-9#1)
suitable for this##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
suitable for treatment##2##3##(1991-2#1)(2010-9#1)
suitable for use at##2##4##(1990-12#1)(2008-3#1)
suitable for use in##5##4##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
suitable for use on##2##4##(2008-3#2)
suitable for use with##6##4##(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#1)
suitable for use##18##3##(1990-12#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
suitable for##423##2##(1990-12#2)(1990-2#3)(1990-8#2)(1991-12#1)(1991-2#4)(1991-5#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#3)(1994-3#3)(1994-8#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#2)(2007-11#10)(2007-12#10)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#135)(2008-11#23)(2008-12#3)(2008-2#22)(2008-3#45)(2008-4#16)(2008-5#11)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#9)(2009-12#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#12)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#3)
suitable habitat##2##2##(2008-10#1)(2008-11#1)
suitable habitats for##2##3##(2008-8#2)
suitable habitats##3##2##(2008-8#3)
suitable hosts##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
suitable in##4##2##(2008-10#1)(2009-10#1)(2010-12#1)(2011-1#1)
suitable material for##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
suitable mathematical##2##2##(2008-1#1)(2008-10#1)
suitable medium for##3##3##(2008-10#2)(2008-3#1)
suitable method for##4##3##(2008-10#4)
suitable method##8##2##(2008-10#6)(2008-5#1)(2010-4#1)
suitable methodology##2##2##(2008-10#2)
suitable model##10##2##(1992-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2013-1#2)
suitable models##3##2##(1990-8#1)(1991-5#1)(2013-1#1)
suitable new##2##2##(1996-6#1)(2011-2#1)
suitable not only for##2##4##(1996-5#1)(2008-3#1)
suitable or##2##2##(2008-10#1)(2008-9#1)
suitable pH for##2##3##(2008-10#2)
suitable pH##4##2##(2008-10#3)(2008-5#1)
suitable replacement for##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
suitable sampling##2##2##(1994-9#1)(2012-12#1)
suitable source##2##2##(2007-11#1)(2012-2#1)
suitable substrate for##2##3##(2008-10#1)(2012-2#1)
suitable substrate##3##2##(2008-10#2)(2012-2#1)
suitable substrates##3##2##(1991-9#1)(2008-10#1)(2009-11#1)
suitable technique for##2##3##(2007-12#1)(2008-10#1)
suitable technique##4##2##(2007-12#1)(2008-10#2)(2009-12#1)
suitable temperature##2##2##(2008-8#1)(2010-3#1)
suitable to a##2##3##(2008-10#1)(2008-8#1)
suitable to be##2##3##(2012-2#1)(2013-8#1)
suitable to study##2##3##(1991-6#1)(2008-5#1)
suitable to##23##2##(1990-3#1)(1991-6#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-8#2)
suitable tool for##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
suitable tool to##2##3##(2008-10#1)(2008-3#1)
suitable tool##6##2##(1993-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
suitable treatment##4##2##(1994-2#1)(1995-11#1)(2008-10#1)(2012-1#1)
suitable##820##1##(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#5)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2007-11#19)(2007-12#19)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#10)(2008-10#270)(2008-11#48)(2008-12#7)(2008-2#32)(2008-3#68)(2008-4#22)(2008-5#30)(2008-6#9)(2008-7#7)(2008-8#20)(2008-9#16)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#6)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#15)(2011-2#18)(2011-3#2)(2012-1#3)(2012-12#6)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#13)(2013-8#6)
suitably chosen##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
suitably designed##2##2##(2008-3#2)
suitably packed medications##2##3##(2012-12#2)
suitably protected##4##2##(1992-12#1)(2008-4#2)(2009-12#1)
suitably##36##1##(1990-11#1)(1990-12#1)(1992-12#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-2#2)(2008-3#8)(2008-4#3)(2009-12#1)(2009-7#1)(2010-5#1)(2010-6#1)(2012-12#2)(2013-1#1)(2013-7#1)
suite of traits##2##3##(2008-8#2)
suite of##18##2##(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2012-3#1)(2013-1#2)
suite##28##1##(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-11#2)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#3)
suited as##4##2##(1990-8#1)(1996-5#1)(2007-12#1)(2008-10#1)
suited for rapid##2##3##(2008-2#1)(2008-3#1)
suited for the analysis of##2##5##(2008-10#2)
suited for the##13##3##(1990-12#1)(1990-8#1)(1997-6#1)(2008-10#7)(2008-3#1)(2011-1#1)(2011-2#1)
suited for this##5##3##(1995-2#1)(2008-10#2)(2008-4#1)(2012-2#1)
suited for use as##2##4##(2008-10#1)(2008-11#1)
suited for use##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
suited for##72##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1993-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#8)(2008-8#1)(2008-9#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
suited to analyzing##2##3##(2008-2#1)(2008-4#1)
suited to study##2##3##(2008-7#1)(2012-12#1)
suited to the measurement of##2##5##(2007-12#1)(2008-3#1)
suited to the##15##3##(1990-9#1)(1991-5#1)(1993-12#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#1)
suited to##59##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#2)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
suited##138##1##(1990-11#1)(1990-12#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#3)(1991-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#2)(2009-4#1)(2009-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
suites of##2##2##(2007-12#1)(2008-9#1)
suites##5##1##(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#2)
suits and##2##2##(1992-2#1)(2012-3#1)
suits##7##1##(1991-12#1)(1992-2#1)(1995-12#1)(1996-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
sujet âgé##2##2##(2013-1#2)
sulcal prefrontal cortex##4##3##(1994-3#4)
sulcal prominence in##2##3##(1996-7#2)
sulcal prominence##6##2##(1996-7#6)
sulcal##12##1##(1994-3#4)(1996-5#1)(1996-7#6)(2008-6#1)
sulci##3##1##(1991-12#1)(2008-7#1)(2008-9#1)
sulcus and##3##2##(2008-11#1)(2010-5#1)(2013-1#1)
sulcus hemorrhage##3##2##(2013-1#3)
sulcus##16##1##(1991-3#1)(1994-8#1)(2007-10#1)(2007-8#1)(2008-11#3)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-5#1)(2013-1#4)
sulfabenzamide##2##1##(2008-10#2)
sulfacetamide 10%-sulfur 5%##5##3##(2010-8#5)
sulfacetamide##6##1##(2008-10#1)(2010-8#5)
sulfadiazine##5##1##(2008-10#5)
sulfadimethoxine##4##1##(2008-10#4)
sulfaguanidine##8##1##(2008-10#8)
sulfamate derivatives##2##2##(1993-1#2)
sulfamate##4##1##(1993-1#3)(2008-10#1)
sulfamerazine##7##1##(2008-10#7)
sulfamethazine##4##1##(2008-10#4)
sulfamethizole##2##1##(2008-10#2)
sulfamethoxazole##9##1##(2008-10#7)(2008-7#1)(2010-12#1)
sulfamide##2##1##(2007-11#1)(2008-10#1)
sulfamonomethoxine##4##1##(2008-10#4)
sulfanilamide and##3##2##(2008-10#3)
sulfanilamide##6##1##(2008-10#5)(2011-3#1)
sulfanilic acid##5##2##(2008-10#5)
sulfapyridine##3##1##(2008-10#3)
sulfaquinoxaline##2##1##(2008-10#2)
sulfasalazine##10##1##(1990-6#1)(2006-10#2)(2008-10#3)(2008-8#1)(2010-12#2)(2010-5#1)
sulfatase##7##1##(2009-4#1)(2012-2#4)(2013-8#2)
sulfate (SLES)##2##2##(2008-10#1)(2008-5#1)
sulfate aerosols##3##2##(2008-3#3)
sulfate and 0##2##3##(1990-11#1)(2008-10#1)
sulfate and ammonium##2##3##(2008-10#1)(2008-8#1)
sulfate and it##2##3##(2008-10#1)(2008-6#1)
sulfate and##23##2##(1990-11#2)(1992-12#1)(1992-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#9)(2008-6#2)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
sulfate anions##2##2##(1992-12#1)(1997-7#1)
sulfate as##3##2##(2008-10#2)(2008-5#1)
sulfate assimilation##2##2##(2008-7#1)(2009-8#1)
sulfate charring##2##2##(2009-7#2)
sulfate droplets##2##2##(2008-3#2)
sulfate groups##4##2##(2008-10#4)
sulfate in the presence of##2##5##(2008-10#1)(2013-1#1)
sulfate in the##3##3##(2008-10#2)(2013-1#1)
sulfate in##8##2##(1995-12#2)(1995-6#1)(1997-7#1)(2008-10#3)(2013-1#1)
sulfate into##2##2##(1990-11#1)(1990-8#1)
sulfate ion and##2##3##(2008-10#2)
sulfate ion in##2##3##(2008-10#2)
sulfate ion##9##2##(2008-10#9)
sulfate ion-selective##2##2##(2008-10#2)
sulfate ions in##2##3##(2008-10#2)
sulfate ions##4##2##(2008-10#4)
sulfate is##3##2##(2008-10#2)(2008-8#1)
sulfate on##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
sulfate reduction##2##2##(2008-10#1)(2013-8#1)
sulfate to the##2##3##(1991-5#1)(2008-10#1)
sulfate to##5##2##(1991-3#1)(1991-5#1)(2008-10#2)(2008-11#1)
sulfate treatment##2##2##(1990-10#1)(2008-6#1)
sulfate was##8##2##(1994-9#1)(1997-6#1)(2008-10#2)(2008-6#3)(2011-2#1)
sulfate with##2##2##(1993-8#1)(1996-2#1)
sulfate##281##1##(1990-10#2)(1990-11#11)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#5)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#5)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#3)(1996-12#2)(1996-2#11)(1996-5#3)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-1#2)(2008-10#122)(2008-11#6)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#10)(2008-7#4)(2008-8#5)(2008-9#1)(2009-7#2)(2009-8#2)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-2#2)(2013-1#6)(2013-8#2)
sulfate)##9##1##(1995-12#1)(2008-10#7)(2008-6#1)
sulfate-carbon##2##1##(2008-3#2)
sulfate-induced##2##1##(1996-12#1)(1996-2#1)
sulfate-reducing bacteria##2##2##(1994-5#1)(2011-1#1)
sulfate-reducing##3##1##(1994-5#1)(2011-1#1)(2011-2#1)
sulfate/glucosamine ratio##2##2##(1994-9#2)
sulfated Asn-linked oligosaccharides##2##3##(1992-10#2)
sulfated GAGs##2##2##(1993-12#2)
sulfated gangliosides##3##2##(1991-2#3)
sulfated glycans##3##2##(1991-12#3)
sulfated polysaccharide##2##2##(1995-2#1)(2008-11#1)
sulfated##29##1##(1991-12#3)(1991-2#4)(1992-10#4)(1992-12#5)(1992-8#1)(1993-12#5)(1995-2#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#2)
sulfathiazole and##2##2##(2008-10#2)
sulfathiazole##7##1##(2008-10#7)
sulfatide##4##1##(1993-9#1)(1994-12#1)(1996-5#2)
sulfation##6##1##(1991-12#1)(1993-12#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-4#1)
sulfentrazone##2##1##(2008-10#2)
sulfhydryl and amino groups##2##4##(2008-7#1)(2009-8#1)
sulfhydryl compounds##4##2##(1992-8#1)(1992-9#1)(1994-8#1)(1995-6#1)
sulfhydryl group of the##2##4##(1993-11#1)(1995-5#1)
sulfhydryl group of##5##3##(1992-5#1)(1993-11#2)(1995-5#1)(2009-11#1)
sulfhydryl group##11##2##(1992-5#1)(1993-11#2)(1995-5#1)(1995-6#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-11#1)
sulfhydryl groups in the##4##4##(1991-5#1)(1992-6#3)
sulfhydryl groups in##5##3##(1991-5#1)(1992-6#3)(1993-6#1)
sulfhydryl groups##12##2##(1990-12#1)(1991-5#1)(1992-5#1)(1992-6#4)(1992-8#2)(1993-6#1)(1995-5#1)(2013-1#1)
sulfhydryl reagent##3##2##(1993-11#1)(1995-8#2)
sulfhydryl##49##1##(1990-12#1)(1991-5#1)(1992-12#2)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#1)(1993-11#4)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#4)(1995-6#3)(1995-8#3)(2006-6#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
sulfide and mercaptans##2##3##(2008-10#1)(2008-6#1)
sulfide and nitrite##2##3##(1993-8#1)(2008-10#1)
sulfide and##9##2##(1993-8#1)(2008-10#6)(2008-11#1)(2008-6#1)
sulfide at##2##2##(2008-10#2)
sulfide based on##2##3##(2008-10#2)
sulfide by##2##2##(2008-10#2)
sulfide can##2##2##(2008-10#1)(2012-2#1)
sulfide concentration##2##2##(2008-10#2)
sulfide determination in##3##3##(2008-10#3)
sulfide determination##6##2##(2008-10#6)
sulfide in different##2##3##(2008-10#2)
sulfide in environmental##2##3##(2008-10#2)
sulfide in the##2##3##(2008-10#1)(2013-1#1)
sulfide in##19##2##(1992-5#1)(1996-5#1)(2008-10#14)(2011-1#1)(2013-1#2)
sulfide is determined by##2##4##(2008-10#2)
sulfide is##3##2##(2008-10#3)
sulfide on##2##2##(2008-10#1)(2013-8#1)
sulfide solution##2##2##(2008-10#2)
sulfide with##3##2##(2008-10#3)
sulfide##118##1##(1991-8#1)(1992-5#3)(1993-11#1)(1993-8#1)(1994-6#3)(1995-3#1)(1996-5#3)(2007-11#2)(2007-12#2)(2008-10#85)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#3)(2009-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
sulfides to##2##2##(2008-10#1)(2008-6#1)
sulfides##11##1##(2008-10#9)(2008-6#2)
sulfidic##3##1##(2008-10#2)(2011-2#1)
sulfinyl##2##1##(1995-2#2)
sulfisoxazole##7##1##(2008-10#1)(2008-12#6)
sulfite and sulfide##3##3##(2008-10#3)
sulfite and##5##2##(1993-8#1)(2008-10#4)
sulfite in##6##2##(2008-10#6)
sulfite ions in##2##3##(2008-10#2)
sulfite ions##5##2##(2008-10#5)
sulfite is used##2##3##(2008-10#2)
sulfite is##3##2##(2008-10#3)
sulfite reductase hemeprotein subunit##2##4##(1990-5#2)
sulfite reductase##5##2##(1990-5#2)(1993-8#2)(1994-8#1)
sulfite solution##3##2##(2008-10#3)
sulfite##50##1##(1990-5#2)(1993-8#4)(1994-8#1)(1997-7#1)(2008-10#42)
sulfobromophthalein##3##1##(1992-3#2)(1995-2#1)
sulfonamide compounds in a mixture##2##5##(2008-10#2)
sulfonamide compounds##3##2##(2008-10#3)
sulfonamide##12##1##(1996-2#1)(2006-12#1)(2008-10#7)(2009-3#2)(2009-8#1)
sulfonamides and quinolones##4##3##(2008-10#4)
sulfonamides and##5##2##(2008-10#4)(2011-2#1)
sulfonamides##21##1##(1991-5#1)(2008-10#16)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
sulfonate (SDBS)##2##2##(2008-10#2)
sulfonate and##2##2##(2008-10#2)
sulfonate##20##1##(1994-5#1)(2007-12#2)(2008-10#14)(2010-12#1)(2010-2#1)(2010-6#1)
sulfonate)##6##1##(2008-10#5)(2008-12#1)
sulfonate)]##2##1##(2007-11#1)(2007-12#1)
sulfonated##6##1##(1992-9#1)(2008-10#5)
sulfonates in##2##2##(2008-10#2)
sulfonates##8##1##(1994-9#1)(2008-10#6)(2010-12#1)
sulfonephthalein##2##1##(2008-10#2)
sulfonic acid##11##2##(1994-9#1)(1995-5#1)(2008-10#7)(2010-6#2)
sulfonic acids##3##2##(2008-10#3)
sulfonic##16##1##(1994-9#1)(1995-5#1)(2008-10#12)(2010-6#2)
sulfonium##4##1##(1994-8#3)(2008-4#1)
sulfonyl chlorides##2##2##(2010-12#2)
sulfonyl##8##1##(1990-5#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-12#3)
sulfonylurea agents on##2##3##(1994-8#2)
sulfonylurea herbicides##2##2##(2008-10#2)
sulfonylurea##8##1##(1990-7#1)(1991-7#1)(1992-3#2)(1994-8#2)(2008-10#2)
sulfonylureas or##2##2##(2008-3#1)(2008-8#1)
sulfonylureas##10##1##(1991-12#2)(1992-3#6)(2008-3#1)(2008-8#1)
sulforhodamine B##2##2##(2008-10#2)
sulfotransferase##11##1##(1991-12#2)(1992-10#1)(1992-8#2)(1993-12#2)(1993-8#3)(1994-8#1)
sulfotransferases##2##1##(1992-8#1)(2008-4#1)
sulfoxide (DMSO)##6##2##(1994-8#1)(2008-10#5)
sulfoxide and##5##2##(1993-3#2)(2008-10#2)(2009-5#1)
sulfoxide##25##1##(1990-9#1)(1993-3#2)(1994-8#1)(1995-5#3)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#11)(2008-5#1)(2008-9#1)(2009-5#1)(2010-1#1)
sulfoximine##5##1##(1992-11#1)(1992-3#1)(1995-11#1)(2009-10#1)(2012-2#1)
sulfoximine)##2##1##(2007-11#1)(2008-2#1)
sulfoximines##2##1##(2007-11#2)
sulfur amino acids##2##3##(2008-10#1)(2011-2#1)
sulfur and##8##2##(1996-2#1)(2008-10#5)(2008-9#1)(2013-1#1)
sulfur atom##3##2##(1992-12#1)(2008-4#1)(2010-2#1)
sulfur by##2##2##(2008-10#1)(2008-11#1)
sulfur colloid##2##2##(1994-2#1)(1997-1#1)
sulfur compounds in##3##3##(2008-10#3)
sulfur compounds##13##2##(2008-10#11)(2011-2#1)(2013-1#1)
sulfur containing diesel fuels##2##4##(2008-10#2)
sulfur containing##3##2##(2008-10#3)
sulfur content##2##2##(2008-10#2)
sulfur dioxide in air by##2##5##(2008-10#2)
sulfur dioxide in air##3##4##(2008-10#3)
sulfur dioxide in##9##3##(2008-10#9)
sulfur dioxide##19##2##(1996-12#1)(2008-10#17)(2008-2#1)
sulfur donors is##3##3##(1997-7#3)
sulfur donors##4##2##(1997-7#4)
sulfur in the##2##3##(2008-10#2)
sulfur in##4##2##(2008-10#4)
sulfur solids##2##2##(2008-10#2)
sulfur to##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
sulfur##124##1##(1990-12#1)(1992-12#1)(1992-3#1)(1994-11#2)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-7#4)(2007-12#2)(2008-1#1)(2008-10#76)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#9)(2013-1#4)
sulfur-containing##4##1##(1990-8#1)(2008-10#2)(2008-3#1)
sulfuric acid and##2##3##(2008-10#2)
sulfuric acid as##2##3##(2008-10#1)(2010-6#1)
sulfuric acid media##4##3##(2008-10#4)
sulfuric acid medium##10##3##(2008-10#10)
sulfuric acid solution##3##3##(2008-10#3)
sulfuric acid were##2##3##(2008-10#1)(2013-1#1)
sulfuric acid with##2##3##(2008-10#2)
sulfuric acid##49##2##(1991-12#1)(2008-10#38)(2008-2#1)(2008-3#4)(2010-6#3)(2013-1#2)
sulfuric acid-assisted continuous twin screw-driven reactor##2##6##(2013-1#2)
sulfuric##55##1##(1991-12#1)(2008-10#40)(2008-2#1)(2008-3#5)(2010-6#3)(2013-1#5)
sulfuric-acid-water##2##1##(2008-3#2)
sulfurreducens##3##1##(2011-1#3)
sulindac (Clinoril)##2##2##(1992-4#1)(1992-9#1)
sulindac##7##1##(1992-3#1)(1992-4#2)(1992-9#2)(1995-9#1)(2009-12#1)
sulisobenzone was##2##2##(2008-5#2)
sulisobenzone##5##1##(2008-5#5)
sulodexide on the##2##3##(2013-8#2)
sulodexide##3##1##(2013-8#3)
sulpha-drug##2##1##(2008-10#2)
sulphadiazine##2##1##(2011-2#1)(2013-7#1)
sulphamethoxazole##4##1##(1990-12#2)(2008-10#2)
sulphamidase gene##3##2##(1996-8#3)
sulphamidase##4##1##(1996-8#4)
sulphanilamide##3##1##(2008-10#2)(2008-5#1)
sulphanilic acid to##2##3##(2008-10#2)
sulphanilic acid##3##2##(2008-10#3)
sulphate (SDS)##6##2##(1994-9#1)(2008-10#4)(2008-5#1)
sulphate and chloride##2##3##(2008-10#2)
sulphate and sodium##2##3##(2008-5#2)
sulphate and sulphite reduction##2##4##(2008-7#2)
sulphate and##13##2##(1990-11#1)(2008-10#6)(2008-5#3)(2008-7#2)(2012-6#1)
sulphate as##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
sulphate conjugated CA##3##3##(1997-7#3)
sulphate conjugated DA and NA##2##5##(1997-7#2)
sulphate conjugated DA and##3##4##(1997-7#3)
sulphate conjugated NA and Ad##2##5##(1997-7#2)
sulphate conjugated NA##4##3##(1997-7#4)
sulphate conjugated##12##2##(1997-7#12)
sulphate conjugated)##3##2##(1997-7#3)
sulphate conversion##2##2##(2008-7#2)
sulphate fractionation##2##2##(1990-11#1)(1990-7#1)
sulphate hydrate##2##2##(2008-10#2)
sulphate in##10##2##(2008-10#8)(2010-3#1)(2011-2#1)
sulphate ion##3##2##(2008-10#2)(2012-7#1)
sulphate matrix##3##2##(2008-10#3)
sulphate media##2##2##(2008-10#2)
sulphate or##3##2##(1990-8#1)(2008-10#1)(2010-4#1)
sulphate to##2##2##(1990-12#1)(1996-7#1)
sulphate was##3##2##(1995-9#1)(1996-7#1)(2008-5#1)
sulphate with##4##2##(2008-10#2)(2013-1#2)
sulphate##129##1##(1990-11#3)(1990-12#7)(1990-5#6)(1990-7#1)(1990-8#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-9#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-7#15)(2006-6#1)(2008-10#48)(2008-5#11)(2008-7#5)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-6#3)(2012-7#2)(2013-1#4)
sulphate)##3##1##(1994-12#1)(2008-10#2)
sulphated##5##1##(1992-9#2)(1993-6#1)(1994-8#1)(2011-10#1)
sulphates##5##1##(1990-11#1)(1992-9#1)(2008-10#2)(2008-5#1)
sulphatide concentration##2##2##(1994-3#2)
sulphide and##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
sulphide at##3##2##(2008-10#3)
sulphide in##2##2##(2008-10#2)
sulphide is##2##2##(2008-10#2)
sulphide##36##1##(1996-7#7)(1997-4#2)(2008-10#24)(2008-7#1)(2012-2#1)(2013-8#1)
sulphides##5##1##(2008-10#5)
sulphite##8##1##(2008-10#5)(2008-7#3)
sulphonate formaldehyde##2##2##(2008-10#2)
sulphonate##6##1##(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#3)
sulphonated azo dyes in##2##4##(2008-10#2)
sulphonated azo dyes##3##3##(2008-10#3)
sulphonated##6##1##(1994-5#1)(2008-10#5)
sulphonic acid##2##2##(1996-5#1)(2010-5#1)
sulphonic acid)##2##2##(2008-10#2)
sulphonic##7##1##(1996-5#1)(2008-10#5)(2010-5#1)
sulphonylurea##5##1##(1994-12#2)(1994-8#3)
sulphonylureas##5##1##(1994-8#4)(2010-4#1)
sulphosalicylic##2##1##(1991-5#1)(2008-10#1)
sulphotransferase##5##1##(1994-11#4)(1994-3#1)
sulphur and##3##2##(2008-10#3)
sulphur compounds##7##2##(1992-8#1)(1997-4#1)(2008-10#5)
sulphur content##3##2##(2008-10#2)(2008-11#1)
sulphur dioxide in ambient air##2##5##(2008-10#2)
sulphur dioxide in##3##3##(2008-10#3)
sulphur dioxide were##2##3##(2008-10#2)
sulphur dioxide##12##2##(1996-12#1)(2008-10#11)
sulphur in##6##2##(2008-10#6)
sulphur is##2##2##(2008-10#2)
sulphur were##3##2##(2008-10#3)
sulphur##57##1##(1992-8#1)(1996-12#1)(1997-4#2)(2008-10#47)(2008-11#1)(2008-4#4)(2008-8#1)
sulphur-containing compounds##4##2##(1997-4#2)(2008-10#2)
sulphur-containing##6##1##(1997-4#3)(2008-10#2)(2008-11#1)
sulphureum and##2##2##(2008-10#2)
sulphureum##6##1##(2008-10#6)
sulphuric acid and permanganate##2##4##(2008-10#2)
sulphuric acid and##6##3##(2008-10#4)(2008-5#1)(2009-10#1)
sulphuric acid concentration##3##3##(2008-10#3)
sulphuric acid in the##2##4##(2008-10#1)(2009-10#1)
sulphuric acid media was##2##4##(2008-10#2)
sulphuric acid media##3##3##(2008-10#3)
sulphuric acid medium##4##3##(2008-10#4)
sulphuric acid to##2##3##(2008-10#2)
sulphuric acid with##2##3##(2008-10#2)
sulphuric acid##37##2##(2008-10#33)(2008-5#1)(2009-10#3)
sulphuric##42##1##(2008-10#38)(2008-5#1)(2009-10#3)
sulphydryl compounds##3##2##(1992-8#3)
sulphydryl##7##1##(1991-2#1)(1992-8#3)(1993-2#1)(2008-10#2)
sulpiride##7##1##(1991-1#1)(1992-3#1)(1992-9#2)(1996-2#1)(2008-10#2)
sultanate of oman##2##3##(2008-4#1)(2012-2#1)
sultone##2##1##(2008-10#2)
sultopride##2##1##(2008-10#2)
sum frequency generation##2##3##(2008-2#1)(2009-7#1)
sum frequency##4##2##(2007-12#1)(2008-2#2)(2009-7#1)
sum of squares of##2##4##(1995-12#1)(2013-1#1)
sum of squares##5##3##(1995-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
sum of the##26##3##(1990-12#1)(1990-6#1)(1991-12#2)(1995-12#1)(1996-6#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#2)(2010-3#1)(2010-8#1)
sum of##73##2##(1990-12#4)(1990-6#1)(1991-12#3)(1993-2#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
sum rule##2##2##(2008-3#2)
sum rules##2##2##(1993-5#1)(2007-12#1)
sum score##3##2##(1996-7#1)(2010-3#2)
sum to##2##2##(2008-10#1)(2008-3#1)
sum up##3##2##(2007-8#1)(2008-11#1)(2008-3#1)
sum##115##1##(1990-12#4)(1990-6#1)(1991-12#3)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#31)(2008-11#3)(2008-2#7)(2008-3#21)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2010-3#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
sum- and difference-frequency##3##3##(2007-12#1)(2008-3#2)
sum-frequency generation with##2##3##(2007-12#2)
sum-frequency generation##9##2##(2007-12#7)(2008-3#2)
sum-frequency mixing in##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
sum-frequency mixing of the##2##4##(2007-12#1)(2008-2#1)
sum-frequency mixing##9##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)
sum-frequency##20##1##(2007-11#2)(2007-12#11)(2008-2#3)(2008-3#4)
sumatriptan##5##1##(1995-12#2)(2008-6#2)(2008-8#1)
summaries in##2##2##(1993-2#1)(1994-3#1)
summaries of the##3##3##(1991-12#1)(1993-12#1)(1994-3#1)
summaries of##8##2##(1991-12#1)(1992-12#1)(1993-12#2)(1994-3#1)(1996-6#1)(2008-10#1)(2010-11#1)
summaries##19##1##(1991-12#2)(1992-12#1)(1993-12#2)(1993-2#2)(1994-3#2)(1996-6#1)(1997-8#1)(2008-10#1)(2010-11#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
summarily##3##1##(1996-4#2)(2008-7#1)
summarise the results##2##3##(1996-11#1)(2009-5#1)
summarise the##10##2##(1996-11#1)(1996-8#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
summarise##13##1##(1996-11#1)(1996-8#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
summarised and##2##2##(2008-11#2)
summarised in this##2##3##(2008-7#1)(2011-3#1)
summarised##8##1##(1994-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
summarises recent##2##2##(2007-5#1)(2008-11#1)
summarises the##6##2##(1997-7#1)(2007-5#1)(2008-10#2)(2011-10#1)(2011-2#1)
summarises##14##1##(1994-3#1)(1997-7#1)(2007-5#2)(2008-10#3)(2008-11#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)
summarize a##2##2##(2010-7#1)(2011-2#1)
summarize findings##3##2##(2008-11#2)(2008-3#1)
summarize our current##2##3##(2007-12#1)(2013-8#1)
summarize our##7##2##(2007-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
summarize recent##10##2##(1996-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)
summarize some of the##3##4##(2008-11#1)(2008-4#1)(2009-10#1)
summarize some##4##2##(2008-11#1)(2008-4#1)(2009-10#2)
summarize studies##2##2##(1996-4#1)(2008-7#1)
summarize the current knowledge of##2##5##(2011-2#1)(2013-7#1)
summarize the current##5##3##(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
summarize the evidence on##2##4##(1995-5#1)(2013-1#1)
summarize the evidence##4##3##(1995-5#1)(2010-1#1)(2010-11#1)(2013-1#1)
summarize the most##2##3##(2009-7#1)(2012-12#1)
summarize the results##2##3##(2008-10#1)(2009-2#1)
summarize the role of##3##4##(2008-2#1)(2008-4#2)
summarize the various##2##3##(1993-12#1)(2011-2#1)
summarize the##45##2##(1993-12#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)
summarize these##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
summarize##108##1##(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-4#3)(1997-2#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#11)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#4)
summarized and compared to the##2##5##(1993-2#1)(1995-12#1)
summarized and compared##3##3##(1993-2#1)(1995-12#1)(2008-10#1)
summarized and##7##2##(1993-2#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
summarized as follows##6##3##(1990-9#1)(1995-9#2)(2008-10#1)(2008-11#1)(2008-5#1)
summarized as##8##2##(1990-9#1)(1992-11#1)(1995-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
summarized by the##2##3##(2008-10#1)(2008-5#1)
summarized by##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
summarized in a##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
summarized in the##3##3##(2008-10#1)(2008-8#1)(2009-4#1)
summarized in this review##3##4##(1995-5#1)(2008-10#1)(2008-5#1)
summarized in this##5##3##(1995-5#1)(2008-10#2)(2008-5#2)
summarized in two##2##3##(1990-11#1)(2013-1#1)
summarized in##18##2##(1990-11#1)(1995-5#1)(1996-3#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-4#1)(2012-12#1)(2013-1#1)
summarized the##7##2##(1996-12#1)(1996-2#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-3#1)
summarized to##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
summarized##99##1##(1990-11#1)(1990-9#1)(1991-12#2)(1992-11#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2011-9#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
summarizes a##5##2##(1992-3#1)(2008-10#2)(2008-7#1)(2012-2#1)
summarizes aspects##2##2##(2008-11#1)(2008-4#1)
summarizes current##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
summarizes findings##3##2##(1994-9#1)(2009-8#1)(2012-2#1)
summarizes key##2##2##(2008-11#1)(2010-4#1)
summarizes new##2##2##(2008-11#2)
summarizes our##7##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
summarizes recent##5##2##(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#1)
summarizes research##3##2##(1994-1#1)(2008-6#1)(2009-11#1)
summarizes several examples##2##3##(2008-10#2)
summarizes some of the##3##4##(1993-6#1)(2008-5#1)(2009-3#1)
summarizes the advantages and##2##4##(2007-5#1)(2008-10#1)
summarizes the clinical and##2##4##(2007-5#1)(2008-1#1)
summarizes the current knowledge##2##4##(2008-4#2)
summarizes the current##6##3##(2008-11#1)(2008-4#2)(2008-7#2)(2012-3#1)
summarizes the evidence supporting##3##4##(2008-9#1)(2009-10#1)(2009-12#1)
summarizes the literature on##2##4##(1992-12#1)(2011-2#1)
summarizes the literature##3##3##(1992-12#1)(2009-5#1)(2011-2#1)
summarizes the most recent##2##4##(2008-10#1)(2010-5#1)
summarizes the most##5##3##(2006-10#1)(2007-10#1)(2008-10#2)(2010-5#1)
summarizes the recent##3##3##(2010-11#1)(2010-8#1)(2012-12#1)
summarizes the results of##2##4##(1992-12#1)(1994-11#1)
summarizes the##75##2##(1992-12#3)(1992-3#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#2)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#7)(2011-9#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
summarizes their##2##2##(2008-4#1)(2008-9#1)
summarizes these##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
summarizes##153##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#3)(1992-3#2)(1992-4#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-11#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-1#3)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#3)(2006-10#2)(2007-10#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#13)(2008-11#7)(2008-12#1)(2008-4#10)(2008-5#5)(2008-6#7)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#9)(2011-9#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#4)
summarizing the##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
summarizing##11##1##(1996-3#1)(2007-5#2)(2008-10#3)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)
summary and##4##2##(1991-1#1)(2007-11#1)(2008-2#1)(2008-5#1)
summary data##2##2##(1993-12#1)(2012-12#1)
summary measure of##2##3##(2008-9#1)(2013-1#1)
summary of an##2##3##(1991-1#1)(2010-5#1)
summary of initial##2##3##(1994-11#1)(1996-1#1)
summary of published##2##3##(2008-9#1)(2011-2#1)
summary of recent##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
summary of the analytical##2##4##(2008-10#1)(2010-11#1)
summary of the##35##3##(1991-3#2)(1992-3#1)(1992-6#1)(1993-1#1)(1994-1#1)(1996-8#1)(1997-3#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#2)(2009-12#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
summary of##67##2##(1990-2#1)(1991-1#2)(1991-2#1)(1991-3#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-1#2)(1996-8#1)(1997-3#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#4)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
summary statistic##4##2##(1994-9#3)(1997-3#1)
summary statistics##3##2##(1992-9#3)
summary suspension##2##2##(1993-12#1)(1994-2#1)
summary##214##1##(1990-12#2)(1990-2#1)(1991-1#3)(1991-12#2)(1991-2#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#5)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#3)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-9#3)(1995-1#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#10)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#4)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
summation of the##3##3##(1990-5#1)(2007-11#2)
summation of##12##2##(1990-5#1)(1995-12#1)(2007-11#2)(2008-10#3)(2008-2#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
summation operatorDDT##2##2##(2008-10#2)
summation operatorHCH##2##2##(2008-10#2)
summation technique##2##2##(1992-6#1)(2008-2#1)
summation##34##1##(1990-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1995-12#1)(1995-2#1)(2007-11#2)(2008-10#7)(2008-2#3)(2008-3#3)(2008-5#6)(2009-8#1)(2010-9#1)(2012-2#2)(2013-1#3)
summations##2##1##(1994-3#1)(2008-3#1)
summative##3##1##(1993-12#1)(1996-11#1)(2008-11#1)
summed to##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
summed up##3##2##(1997-6#1)(2008-3#1)(2013-7#1)
summed##13##1##(1994-8#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
summer (July and August)##2##4##(2008-10#1)(2011-2#1)
summer and autumn##3##3##(2008-10#2)(2011-2#1)
summer and spring##2##3##(2008-11#1)(2008-5#1)
summer and winter##4##3##(1994-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
summer and##14##2##(1994-12#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#4)(2011-2#1)(2013-1#1)(2013-8#1)
summer epidemic progress of apple scab##2##6##(2008-10#2)
summer months##5##2##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
summer of##15##2##(1990-9#1)(1991-1#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-1#1)(2011-2#1)
summer season##3##2##(2012-2#1)(2012-3#2)
summer temperatures##2##2##(2008-10#1)(2008-7#1)
summer to##2##2##(2008-10#1)(2008-8#1)
summer##107##1##(1990-11#1)(1990-9#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-11#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#10)(2008-7#5)(2008-8#5)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
summer)##4##1##(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
summers##3##1##(2008-11#1)(2008-8#1)(2009-12#1)
summing these##2##2##(1993-9#1)(2008-10#1)
summing##7##1##(1993-9#1)(1995-11#1)(2008-10#3)(2008-3#1)(2008-8#1)
summit##5##1##(1991-9#1)(2008-11#1)(2010-3#1)(2010-5#1)(2013-1#1)
summit-to-sea maps##2##2##(2007-5#2)
sumoylated##2##1##(2008-4#2)
sumoylation##5##1##(2008-4#5)
sump##2##1##(1991-3#1)(1996-6#1)
sums up the##2##3##(1995-3#1)(1996-11#1)
sums##8##1##(1994-3#1)(1995-3#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-4#1)
sun care##4##2##(2008-5#4)
sun damage##3##2##(2011-2#3)
sun dried##2##2##(2008-10#2)
sun exposure and##3##3##(2008-5#2)(2011-2#1)
sun exposure##20##2##(2008-10#1)(2008-5#10)(2010-8#1)(2011-2#8)
sun glint contamination##3##3##(2008-3#3)
sun glint correction##3##3##(2008-3#3)
sun glint##11##2##(2008-3#11)
sun parlour##2##2##(2008-5#2)
sun protection factor (SPF)##3##4##(2008-5#3)
sun protection factor##6##3##(1991-6#1)(2008-5#5)
sun protection factors (SPF) of##2##5##(2008-5#2)
sun protection factors (SPF)##3##4##(2008-5#3)
sun protection factors##7##3##(2008-5#7)
sun protection##16##2##(1991-6#1)(2008-4#1)(2008-5#12)(2011-2#2)
sun radiation##6##2##(2011-2#6)
sun reactive skin type##2##4##(2008-5#2)
sun reactive skin##3##3##(1991-6#1)(2008-5#2)
sun valley forum##2##3##(2008-8#2)
sun##99##1##(1991-6#10)(1992-7#1)(1993-3#2)(1994-3#2)(1994-6#1)(2008-10#5)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#32)(2008-8#2)(2010-8#1)(2011-2#26)(2013-8#1)
sun-exposed areas of the##3##4##(2010-6#1)(2010-8#1)(2011-2#1)
sun-exposed areas##4##2##(2010-6#2)(2010-8#1)(2011-2#1)
sun-exposed skin in the summer##2##5##(2008-5#2)
sun-exposed skin##4##2##(2008-5#2)(2011-2#2)
sun-exposed##8##1##(2008-5#2)(2010-6#2)(2010-8#1)(2011-2#3)
sunburn##10##1##(1991-6#1)(1992-6#1)(2008-4#1)(2008-5#7)
sunburns##4##1##(2011-2#4)
suncare products##2##2##(2008-10#2)
suncare##4##1##(2008-10#3)(2008-5#1)
sunfish##2##1##(2008-10#1)(2008-8#1)
sunflower (Helianthus annuus)##2##3##(2008-10#2)
sunflower (Helianthus##3##2##(2008-10#3)
sunflower and##2##2##(2008-10#2)
sunflower oil##4##2##(2008-10#2)(2013-1#2)
sunflower stem##5##2##(2008-10#4)(2009-6#1)
sunflower##41##1##(1991-5#3)(2008-10#29)(2008-5#3)(2008-8#1)(2009-6#1)(2011-2#2)(2013-1#2)
sunflowers (Helianthus##3##2##(2008-10#1)(2008-8#2)
sunflowers##4##1##(2008-10#1)(2008-8#3)
sunitinib##4##1##(2013-1#4)
sunken##3##1##(2008-10#3)
sunlight and the##2##3##(2008-2#1)(2008-5#1)
sunlight and##5##2##(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#2)
sunlight in##2##2##(2008-10#1)(2011-2#1)
sunlight intensity was##2##3##(2008-6#2)
sunlight intensity##8##2##(2008-6#7)(2008-8#1)
sunlight##55##1##(1991-5#1)(1994-1#1)(1997-1#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#9)(2008-6#8)(2008-8#3)(2011-2#14)
sunlight-induced##2##1##(1994-6#1)(2008-11#1)
sunn hemp pollen##2##3##(2008-6#2)
sunn hemp##4##2##(2008-6#4)
sunny##10##1##(1993-3#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2012-3#1)
sunphotometer and##2##2##(2008-3#2)
sunphotometer measurements##2##2##(2008-3#2)
sunphotometer##9##1##(2008-2#4)(2008-3#5)
sunrise and##2##2##(2008-10#2)
sunrise##6##1##(2008-10#6)
sunscreen agent##2##2##(2008-3#1)(2008-5#1)
sunscreen agents in##2##3##(2008-10#2)
sunscreen agents##3##2##(2008-10#2)(2008-5#1)
sunscreen and##2##2##(2008-5#2)
sunscreen application##2##2##(2008-5#2)
sunscreen chemicals##2##2##(2008-3#2)
sunscreen derived from Chinese herbs##2##5##(2008-5#2)
sunscreen derived from natural Chinese herbs##2##6##(2008-5#2)
sunscreen derived from##4##3##(2008-5#4)
sunscreen films##6##2##(2008-5#6)
sunscreen formulation##3##2##(2008-5#3)
sunscreen formulations##4##2##(2008-5#4)
sunscreen from##2##2##(2008-5#2)
sunscreen lotions containing##3##3##(2008-10#1)(2008-5#2)
sunscreen lotions with##2##3##(2008-5#2)
sunscreen lotions##7##2##(2008-10#1)(2008-5#6)
sunscreen preparations##2##2##(2008-5#2)
sunscreen products in the##2##4##(2008-5#2)
sunscreen products in##3##3##(2008-5#3)
sunscreen products##13##2##(2008-10#1)(2008-3#1)(2008-5#11)
sunscreen system##2##2##(2008-5#2)
sunscreen use##3##2##(2008-4#1)(2010-8#1)(2012-2#1)
sunscreen##90##1##(2008-10#6)(2008-3#4)(2008-4#1)(2008-5#76)(2008-8#1)(2010-8#1)(2012-2#1)
sunscreening##4##1##(1991-6#1)(2008-5#3)
sunscreens are##2##2##(2008-5#2)
sunscreens in##4##2##(2008-5#4)
sunscreens is##3##2##(2008-5#3)
sunscreens should be##2##3##(2008-5#2)
sunscreens were##2##2##(2008-5#2)
sunscreens##41##1##(1991-6#3)(2008-11#1)(2008-3#1)(2008-5#36)
sunset to##2##2##(2008-10#2)
sunset yellow FCF##2##3##(2008-10#2)
sunset yellow##5##2##(2008-10#5)
sunset##11##1##(2008-10#7)(2008-2#3)(2011-2#1)
sunshine##6##1##(1993-3#4)(2008-10#1)(2013-8#1)
super disintegrants##2##2##(2010-3#1)(2012-2#1)
super family##5##2##(1996-12#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-8#1)
super high##2##2##(2008-3#1)(2008-9#1)
super high-yielding##2##2##(2008-9#2)
super modified simplex##3##3##(2008-10#3)
super splines##2##2##(2008-6#2)
super##28##1##(1991-12#1)(1992-10#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
super&quot##2##1##(1991-12#2)
super-Gaussian and square-shaped beams##2##4##(2007-12#2)
super-Gaussian beam##2##2##(2007-11#2)
super-Gaussian intensity##3##2##(2008-3#3)
super-Gaussian##11##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#5)
super-family##2##1##(1997-6#1)(2008-11#1)
super-imposition##2##1##(1995-6#1)(2008-7#1)
super-ordinate themes##2##2##(2013-1#2)
superabsorbent polymers##2##2##(2008-11#2)
superabsorbent##5##1##(2008-11#2)(2008-12#3)
superantigen##8##1##(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(2007-11#3)
superb##4##1##(2008-10#1)(2008-4#1)(2010-5#1)(2010-6#1)
superceded##2##1##(2008-10#1)(2010-3#1)
superchannel##2##1##(2011-2#2)
supercoiled DNA##4##2##(1992-11#1)(1995-3#1)(1996-2#1)(2008-9#1)
supercoiled DNA-modified mercury##2##3##(2008-10#2)
supercoiled and##2##2##(1993-8#1)(2008-9#1)
supercoiled topoisomers##3##2##(1990-11#3)
supercoiled##14##1##(1990-11#3)(1992-11#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-9#2)(2013-1#1)
supercoiling factor##3##2##(1995-6#3)
supercoiling in##2##2##(1995-2#1)(1995-8#1)
supercoiling##14##1##(1994-5#1)(1995-2#3)(1995-6#4)(1995-8#4)(2008-8#1)(2008-9#1)
supercoils into##2##2##(1995-6#1)(1996-2#1)
supercoils##4##1##(1995-6#1)(1996-2#1)(2008-9#2)
supercomputers##2##1##(2008-3#1)(2009-11#1)
superconducting quantum interference device##2##4##(2008-7#2)
superconducting##20##1##(1990-12#1)(1990-4#1)(1992-8#3)(2008-10#1)(2008-3#4)(2008-7#5)(2010-7#1)(2012-2#3)(2013-8#1)
superconductive edge-transition##2##2##(2008-3#2)
superconductivity in##3##2##(1993-5#1)(2008-7#1)(2012-2#1)
superconductivity##6##1##(1993-5#1)(2008-7#2)(2012-2#3)
superconductor##3##1##(1990-12#1)(2012-2#2)
superconductors##11##1##(1990-4#2)(1992-8#3)(1993-5#1)(1994-9#1)(2008-10#4)
supercontinuum generation in photonic crystal##2##5##(2007-11#1)(2007-12#1)
supercontinuum generation in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
supercontinuum generation##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
supercontinuum##19##1##(2007-11#9)(2007-12#9)(2008-3#1)
supercooled##2##1##(1995-3#1)(2008-2#1)
supercritical CO(2)##16##2##(2008-10#16)
supercritical carbon dioxide (SC-CO(2))##2##4##(2008-10#1)(2010-4#1)
supercritical carbon dioxide has been##2##5##(2008-10#2)
supercritical carbon dioxide##23##3##(2008-10#16)(2008-3#4)(2008-7#1)(2010-4#2)
supercritical fluid CO(2)##2##3##(2008-10#2)
supercritical fluid and##2##3##(2008-10#2)
supercritical fluid chromatography (SFC)##3##4##(2008-10#3)
supercritical fluid chromatography##9##3##(2008-10#9)
supercritical fluid extraction (SFE) has##2##5##(2008-10#2)
supercritical fluid extraction (SFE)##10##4##(2008-10#10)
supercritical fluid extraction of##3##4##(2008-10#2)(2012-3#1)
supercritical fluid extraction##18##3##(2008-10#16)(2008-11#1)(2012-3#1)
supercritical fluid extractor##2##3##(2008-10#2)
supercritical fluid##41##2##(2008-10#38)(2008-11#1)(2012-2#1)(2012-3#1)
supercritical fluids and their##2##4##(2012-2#2)
supercritical fluids##5##2##(2008-10#2)(2012-2#3)
supercritical##91##1##(2008-10#74)(2008-11#1)(2008-3#4)(2008-7#1)(2009-6#1)(2010-10#1)(2010-4#2)(2012-2#5)(2012-3#1)(2013-1#1)
superfamilies##3##1##(2008-7#1)(2009-5#1)(2011-1#1)
superfamily and is##2##3##(1995-6#1)(2011-2#1)
superfamily and##3##2##(1995-6#1)(2008-5#1)(2011-2#1)
superfamily of proteins##6##3##(1991-5#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)
superfamily of small GTP-binding proteins##2##5##(1994-6#1)(2008-6#1)
superfamily of small##3##3##(1994-6#1)(1994-9#1)(2008-6#1)
superfamily of##19##2##(1991-5#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-11#4)(2008-6#1)(2009-2#1)(2010-5#1)
superfamily or fold##3##3##(2008-7#3)
superfamily were##2##2##(1997-6#1)(2011-1#1)
superfamily##75##1##(1991-5#2)(1992-11#3)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#6)(1994-6#1)(1994-9#2)(1995-12#2)(1995-2#8)(1995-5#1)(1995-6#3)(1995-8#1)(1996-2#2)(1997-6#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#7)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#2)
superficial LMS##5##2##(2008-6#5)
superficial and deep##7##3##(1993-12#2)(2007-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
superficial and##11##2##(1993-12#2)(2007-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
superficial bladder cancer##3##3##(1993-11#1)(2007-10#1)(2008-11#1)
superficial bladder carcinoma##2##3##(1993-9#2)
superficial bladder tumours##3##3##(1991-6#3)
superficial bladder##10##2##(1991-6#3)(1993-11#1)(1993-9#3)(2007-10#1)(2008-1#1)(2008-11#1)
superficial brachial##2##2##(2008-7#2)
superficial categorical##2##2##(2008-11#2)
superficial cervical plexus##2##3##(2010-7#1)(2012-3#1)
superficial chronic gastritis##2##3##(2008-5#2)
superficial chronic##3##2##(2008-5#3)
superficial corneocytes##2##2##(2008-5#2)
superficial dorsal horn##3##3##(1990-7#1)(1994-2#1)(1996-5#1)
superficial fascia##2##2##(2009-9#2)
superficial femoral artery##2##3##(2011-2#2)
superficial femoral vein##5##3##(2007-7#1)(2008-1#2)(2011-3#2)
superficial femoral##8##2##(2007-7#1)(2008-1#2)(2011-2#3)(2011-3#2)
superficial laminae##3##2##(1993-12#3)
superficial layer##5##2##(1996-12#1)(2008-2#3)(2008-3#1)
superficial layers of the stratum corneum##2##6##(2008-5#2)
superficial layers of the##4##4##(1997-2#1)(2008-5#3)
superficial layers of##5##3##(1997-2#1)(2008-11#1)(2008-5#3)
superficial layers##14##2##(1993-12#2)(1997-2#2)(2008-11#2)(2008-2#1)(2008-5#6)(2013-1#1)
superficial lesions##3##2##(1990-9#1)(2008-7#1)(2011-1#1)
superficial mycoses##2##2##(2008-5#2)
superficial porokeratosis##5##2##(2007-7#3)(2010-6#2)
superficial scarring##2##2##(2007-7#2)
superficial siderosis##2##2##(2008-7#2)
superficial skin##2##2##(1992-2#1)(2012-3#1)
superficial small##2##2##(1990-6#1)(2007-10#1)
superficial structures##2##2##(2008-5#1)(2011-2#1)
superficial temporal##3##2##(2008-12#2)(2012-3#1)
superficial to##2##2##(2008-9#1)(2013-8#1)
superficial trunk##4##2##(1993-9#1)(2008-6#3)
superficial vein##2##2##(2013-8#2)
superficial veins##2##2##(2008-9#1)(2013-8#1)
superficial velocity##2##2##(2008-6#2)
superficial##177##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-6#3)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#7)(1993-9#4)(1994-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-12#2)(2007-10#3)(2007-5#1)(2007-7#10)(2008-1#5)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-5#31)(2008-6#15)(2008-7#7)(2008-9#6)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#4)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#4)
superficially##5##1##(1996-2#1)(2007-8#2)(2008-10#1)(2008-9#1)
superfluous##4##1##(1991-6#1)(1996-9#1)(2007-12#1)(2008-9#1)
superfused carp retina##2##3##(2008-8#1)(2008-9#1)
superfused isolated##2##2##(1992-8#1)(1994-3#1)
superfused##7##1##(1992-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
superfusion with##3##2##(1995-11#1)(1995-12#2)
superfusion##6##1##(1995-11#1)(1995-12#3)(2008-11#1)(2010-2#1)
superheated hexane extraction##2##3##(2008-10#2)
superheated hexane##3##2##(2008-10#3)
superheated water extraction and##2##4##(2008-10#2)
superheated water extraction##5##3##(2008-10#5)
superheated water##8##2##(2008-10#8)
superheated##12##1##(2008-10#12)
superhelical stress##2##2##(1997-3#2)
superhelical##3##1##(1995-6#1)(1997-3#2)
superhelicity in##3##2##(1994-6#3)
superhelicity##4##1##(1994-6#4)
superhigh-reflectivity##2##1##(2007-12#2)
superhigh-yield rice##3##2##(2008-9#3)
superimposable##2##1##(1992-10#1)(1995-8#1)
superimpose on##2##2##(1992-9#1)(2008-6#1)
superimposed by##4##2##(1993-12#2)(2008-3#1)(2013-1#1)
superimposed on a##2##3##(2008-11#1)(2008-2#1)
superimposed on the##7##3##(1995-2#1)(2008-2#2)(2008-3#3)(2008-5#1)
superimposed on##17##2##(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)
superimposed preeclampsia##2##2##(1997-8#1)(2008-11#1)
superimposed##41##1##(1993-12#2)(1995-2#1)(1995-3#1)(1996-5#1)(1997-8#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#10)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#2)(2013-1#2)
superimposing a##2##2##(2008-3#1)(2012-2#1)
superimposing##4##1##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
superimposition images##2##2##(1995-6#2)
superimposition##11##1##(1995-6#5)(2008-2#1)(2008-6#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-2#1)
superinduction##3##1##(1991-2#1)(1992-8#2)
superinfection##6##1##(1991-6#1)(1993-8#1)(2008-8#2)(2009-4#1)(2013-1#1)
superinfections##4##1##(1991-2#1)(2008-8#2)(2012-2#1)
superior ability##3##2##(2008-10#2)(2008-8#1)
superior and inferior##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
superior at##2##2##(2008-10#1)(2008-8#1)
superior attributes##2##2##(1997-3#1)(2011-2#1)
superior binding affinity##3##3##(2008-10#3)
superior cerebellar##2##2##(1992-11#1)(2008-7#1)
superior cervical ganglion##4##3##(1994-5#1)(1996-2#1)(1996-5#1)(2008-8#1)
superior cervical##5##2##(1991-12#1)(1994-5#1)(1996-2#1)(1996-5#1)(2008-8#1)
superior clinical##2##2##(2008-10#1)(2008-3#1)
superior colliculus and##2##3##(1991-5#1)(2008-7#1)
superior colliculus##9##2##(1991-5#4)(1993-12#1)(1993-3#1)(2008-7#3)
superior compared with##3##3##(2007-10#1)(2008-5#2)
superior competitor##5##2##(2008-8#4)(2010-2#1)
superior control of##2##3##(2008-10#2)
superior efficacy and tolerability of##2##5##(2012-3#2)
superior efficacy##4##2##(2008-8#1)(2011-2#1)(2012-3#2)
superior for##5##2##(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#1)
superior frontal##2##2##(1996-12#2)
superior image quality##2##3##(2007-12#1)(2010-8#1)
superior in terms of##6##4##(2008-10#2)(2008-11#1)(2009-2#1)(2010-8#1)(2011-2#1)
superior in##15##2##(1990-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
superior mesenteric artery##10##3##(1991-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2013-1#6)
superior mesenteric##14##2##(1990-3#1)(1991-5#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#6)
superior method since##2##3##(2008-9#1)(2011-2#1)
superior oblique muscle##2##3##(2010-9#1)(2011-2#1)
superior oblique##4##2##(2010-9#3)(2011-2#1)
superior outcomes##4##2##(1992-11#1)(1995-3#1)(2010-6#1)(2012-1#1)
superior pancreaticoduodenal##2##2##(1991-6#2)
superior parietal cortex##2##3##(2013-8#2)
superior parietal lobule##3##3##(1996-2#1)(1996-5#1)(2008-11#1)
superior parietal##5##2##(1996-2#1)(1996-5#1)(2008-11#1)(2013-8#2)
superior performance over##2##3##(2011-1#1)(2012-3#1)
superior performance##6##2##(1997-3#1)(2007-8#1)(2008-2#2)(2011-1#1)(2012-3#1)
superior potency##2##2##(2007-11#1)(2012-12#1)
superior results##2##2##(2008-10#1)(2008-7#1)
superior sagittal sinus thrombosis##2##4##(1997-3#1)(2007-10#1)
superior sagittal sinus##5##3##(1997-3#3)(2007-10#1)(2008-7#1)
superior sagittal##6##2##(1997-3#3)(1997-6#1)(2007-10#1)(2008-7#1)
superior soft tissue contrast##2##4##(2008-1#1)(2008-8#1)
superior temporal and##2##3##(2008-10#1)(2008-9#1)
superior temporal gyral volume##2##4##(1996-7#2)
superior temporal gyrus##9##3##(1996-2#2)(1996-7#3)(2008-11#2)(2009-2#2)
superior temporal sulcus (STS)##2##4##(2008-11#1)(2009-2#1)
superior temporal sulcus##5##3##(2008-11#3)(2009-10#1)(2009-2#1)
superior temporal##21##2##(1996-2#2)(1996-7#5)(2008-10#1)(2008-11#6)(2008-9#1)(2009-10#2)(2009-2#3)(2012-12#1)
superior to a##3##3##(2008-3#1)(2010-3#1)(2012-2#1)
superior to aspirin##3##3##(2008-8#3)
superior to both##3##3##(1993-12#1)(2008-10#2)
superior to conventional##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
superior to other##7##3##(1992-9#1)(2008-10#1)(2008-5#3)(2010-6#1)(2012-3#1)
superior to that for##2##4##(1994-5#1)(2008-10#1)
superior to that of##8##4##(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-3#1)
superior to that##14##3##(1993-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2010-3#1)
superior to the conventional##3##4##(1997-8#1)(2008-2#1)(2011-2#1)
superior to the simple wire technique for closure of the##2##10##(2007-8#2)
superior to the simple wire technique for##3##7##(2007-8#3)
superior to the traditional##2##4##(1992-1#1)(2008-1#1)
superior to the##38##3##(1992-1#1)(1992-10#1)(1992-5#1)(1992-8#2)(1994-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#3)
superior to those of##5##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
superior to those##8##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)
superior to##137##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-1#4)(1992-10#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-3#1)(1997-8#2)(2006-7#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#2)(2008-10#24)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
superior vena cava (SVC) syndrome##2##5##(2007-8#1)(2008-1#1)
superior vena cava (SVC)##4##4##(2007-8#2)(2008-1#1)(2011-2#1)
superior vena cava syndrome##4##4##(1995-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
superior vena cava was##2##4##(2007-7#1)(2007-8#1)
superior vena cava##26##3##(1995-8#1)(2007-7#1)(2007-8#9)(2008-1#2)(2008-11#1)(2008-12#2)(2008-7#2)(2010-11#3)(2011-2#2)(2012-2#2)(2013-1#1)
superior vena##27##2##(1995-8#1)(2007-7#1)(2007-8#9)(2008-1#2)(2008-11#1)(2008-12#2)(2008-7#2)(2010-11#3)(2011-2#3)(2012-2#2)(2013-1#1)
superior##426##1##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#7)(1991-6#2)(1991-7#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#7)(1996-2#7)(1996-5#3)(1996-7#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#10)(1997-4#1)(1997-6#1)(1997-8#2)(2006-7#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#22)(2008-1#8)(2008-10#63)(2008-11#25)(2008-12#4)(2008-2#8)(2008-3#13)(2008-4#3)(2008-5#12)(2008-6#5)(2008-7#17)(2008-8#16)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#2)(2010-6#3)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#19)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#9)(2012-8#1)(2012-9#1)(2013-1#21)(2013-8#3)
superior-posterior radiograms in##2##3##(2007-8#2)
superior-posterior radiograms##3##2##(2007-8#3)
superiority in##2##2##(2008-10#1)(2008-2#1)
superiority of the##9##3##(1995-5#2)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-3#1)
superiority of##24##2##(1990-9#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#3)(2012-3#2)
superiority over##4##2##(1992-2#1)(1992-9#1)(2007-5#1)(2008-10#1)
superiority to##2##2##(1992-12#1)(2008-7#1)
superiority##38##1##(1990-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#1)
superiorly and##2##2##(2007-12#1)(2009-2#1)
superiorly##5##1##(2007-12#1)(2009-2#1)(2011-1#1)(2012-12#2)
superiors'##2##1##(2012-3#2)
superlattice##10##1##(2007-11#4)(2007-12#5)(2008-2#1)
superlattices##4##1##(1991-9#1)(1993-5#1)(1994-9#1)(2012-2#1)
superlinear##2##1##(2007-12#2)
superluminal excitation in microdroplets##2##4##(2007-12#2)
superluminal or##2##2##(2007-11#2)
superluminal##5##1##(2007-11#2)(2007-12#2)(2008-3#1)
superluminescent diode##7##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
superluminescent diodes##2##2##(2007-11#1)(2008-3#1)
superluminescent##10##1##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#3)
supermarkets##3##1##(2008-9#1)(2012-2#1)(2013-8#1)
supermirror##2##1##(2008-2#1)(2008-3#1)
supermode##4##1##(2007-11#3)(2007-12#1)
supermodes of##2##2##(2008-3#2)
supermodes##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
supernatant and pellet##2##3##(1997-4#1)(2008-11#1)
supernatant and##7##2##(1997-4#1)(2008-10#2)(2008-11#4)
supernatant containing##3##2##(2008-11#2)(2012-2#1)
supernatant fluid##2##2##(1991-2#1)(1992-12#1)
supernatant fraction of the##2##4##(1991-12#1)(1995-3#1)
supernatant fraction of##3##3##(1991-12#2)(1995-3#1)
supernatant fraction##7##2##(1991-12#2)(1992-12#2)(1995-3#1)(1996-12#1)(2008-10#1)
supernatant from##2##2##(2008-10#1)(2008-11#1)
supernatant is##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)
supernatant of human##2##3##(1992-12#1)(2008-11#1)
supernatant of the##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
supernatant of##14##2##(1992-12#1)(1993-11#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#2)(2012-2#1)(2013-1#3)
supernatant solutions##2##2##(2008-11#2)
supernatant was##9##2##(1990-2#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)
supernatant##85##1##(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#4)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#2)(2008-10#13)(2008-11#21)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#1)(2012-2#2)(2013-1#3)(2013-8#3)
supernatants and##2##2##(1992-8#1)(2008-4#1)
supernatants by##2##2##(1997-3#1)(2008-5#1)
supernatants for##2##2##(2007-2#1)(2008-9#1)
supernatants from the##2##3##(2008-10#1)(2011-3#1)
supernatants from##4##2##(1991-9#1)(1997-3#1)(2008-10#1)(2011-3#1)
supernatants of spleen##2##3##(1995-11#1)(2008-5#1)
supernatants of##11##2##(1991-12#1)(1992-3#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
supernatants were##3##2##(1992-9#1)(2008-11#1)(2011-3#1)
supernatants##36##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-3#3)(2007-2#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-3#2)(2012-2#1)(2013-1#2)
supernormal controls##2##2##(1997-5#2)
supernumeraries of the##2##3##(2008-2#2)
supernumerary chromosomes##4##2##(2008-5#2)(2010-3#2)
supernumerary eyes were##2##3##(2008-5#2)
supernumerary eyes##6##2##(2008-5#6)
supernumerary spleen##3##2##(1990-5#3)
supernumerary##32##1##(1990-5#3)(1996-2#1)(2008-10#1)(2008-3#5)(2008-5#12)(2010-3#3)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
supernutritional Se##2##2##(2012-2#2)
superolateral##2##1##(2008-8#1)(2012-3#1)
superoxide (O2##2##2##(1994-11#1)(2008-5#1)
superoxide and hydrogen peroxide##2##4##(2011-2#2)
superoxide and##3##2##(2007-10#1)(2011-2#2)
superoxide anion (##2##3##(1996-9#1)(2008-10#1)
superoxide anion (O2*-)##2##3##(2008-4#1)(2013-8#1)
superoxide anion (O2-)##2##3##(1994-8#1)(1996-2#1)
superoxide anion and hydrogen peroxide##3##5##(1994-8#1)(1997-4#1)(2008-10#1)
superoxide anion and##5##3##(1990-5#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)
superoxide anion by##2##3##(1993-6#1)(2008-9#1)
superoxide anion radical (O(2)(-))##2##4##(2008-10#2)
superoxide anion radical##10##3##(1990-5#1)(1993-3#1)(2008-10#6)(2010-5#1)(2011-1#1)
superoxide anion##47##2##(1990-5#3)(1991-9#1)(1992-11#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-6#1)(1994-8#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-4#2)(2008-10#13)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#3)(2013-8#2)
superoxide anions was##2##3##(1990-5#1)(2008-10#1)
superoxide anions##4##2##(1990-5#2)(1995-6#1)(2008-10#1)
superoxide dismutase (MnSOD)##2##3##(1994-6#1)(1995-6#1)
superoxide dismutase (SOD) activities##2##4##(2008-12#1)(2013-1#1)
superoxide dismutase (SOD) activity##4##4##(2008-10#2)(2008-11#1)(2008-5#1)
superoxide dismutase (SOD) and catalase (CAT)##2##6##(1994-6#1)(2009-5#1)
superoxide dismutase (SOD) and##6##4##(1994-6#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
superoxide dismutase (SOD)##29##3##(1990-11#1)(1991-9#2)(1992-9#1)(1994-6#1)(1997-4#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)
superoxide dismutase activities##3##3##(2008-10#2)(2013-1#1)
superoxide dismutase activity##2##3##(1990-5#1)(1992-12#1)
superoxide dismutase and catalase##4##4##(1992-11#1)(1994-6#2)(1995-6#1)
superoxide dismutase and glutathione peroxidase activities##2##6##(1991-12#2)
superoxide dismutase and##10##3##(1990-5#1)(1991-12#2)(1992-11#1)(1992-7#1)(1994-6#2)(1995-6#1)(2007-11#1)(2008-5#1)
superoxide dismutase gene##2##3##(1996-6#1)(1997-4#1)
superoxide dismutase in##2##3##(1994-6#1)(2008-10#1)
superoxide dismutase or##2##3##(1993-11#1)(1995-3#1)
superoxide dismutase##94##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1991-12#5)(1991-9#3)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#8)(1995-3#2)(1995-6#4)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-4#4)(2007-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#3)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#7)
superoxide generation by##2##3##(1993-6#1)(1994-11#1)
superoxide generation in response to##2##5##(1991-8#1)(1993-6#1)
superoxide generation in##4##3##(1991-8#1)(1993-6#1)(1994-11#2)
superoxide generation##12##2##(1990-2#1)(1991-2#1)(1991-8#1)(1993-6#5)(1994-11#4)
superoxide production##3##2##(1990-5#1)(2008-10#1)(2008-4#1)
superoxide radical anion##3##3##(2008-10#1)(2008-5#2)
superoxide radical##9##2##(1990-5#1)(1992-12#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-5#2)(2010-5#1)
superoxide radicals##5##2##(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-4#1)
superoxide##198##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#9)(1991-12#6)(1991-2#1)(1991-8#1)(1991-9#4)(1992-11#3)(1992-12#3)(1992-5#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#9)(1993-8#1)(1994-11#7)(1994-6#9)(1994-8#4)(1995-12#1)(1995-3#3)(1995-6#7)(1995-8#2)(1996-2#4)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#6)(2006-7#1)(2007-10#1)(2007-11#2)(2008-1#3)(2008-10#30)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#12)(2008-7#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-5#3)(2011-1#3)(2011-2#6)(2012-2#8)(2012-3#1)(2013-1#7)(2013-8#2)
superoxide-generating##4##1##(1993-8#1)(1994-8#3)
superparamagnetic iron oxide nanoparticles##6##4##(2009-8#2)(2012-12#2)(2012-2#1)(2013-1#1)
superparamagnetic iron oxide##8##3##(2009-8#2)(2012-12#2)(2012-2#2)(2013-1#2)
superparamagnetic##13##1##(2009-6#1)(2009-8#2)(2010-5#1)(2012-12#2)(2012-2#3)(2013-1#4)
superposed by##2##2##(1991-8#1)(2008-3#1)
superposed##5##1##(1991-8#1)(2008-10#1)(2008-3#2)(2008-7#1)
superposition of a##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
superposition of the##6##3##(1992-8#1)(2007-11#2)(2008-3#3)
superposition of two##3##3##(2007-12#3)
superposition of##24##2##(1992-8#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#10)(2008-7#1)(2011-2#1)
superposition principle##2##2##(1995-3#1)(2008-5#1)
superposition##33##1##(1992-8#1)(1995-3#2)(1996-3#1)(1997-6#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#11)(2008-5#3)(2008-7#2)(2011-2#1)
superprecipitation##3##1##(1992-9#3)
superprism##2##1##(2007-11#2)
superregenerative receiver##2##2##(2007-12#2)
superregenerative##5##1##(2007-12#5)
superresolution (SR)##2##2##(2008-3#2)
superresolution disks##3##2##(2008-2#3)
superresolution in##3##2##(2008-2#1)(2008-3#2)
superresolution optical##2##2##(2008-2#2)
superresolution##26##1##(2007-11#1)(2007-12#3)(2008-2#10)(2008-3#12)
superresolved##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
superresolving##6##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
supersaturated##2##1##(2008-3#1)(2013-1#1)
supersaturation of##2##2##(1992-9#1)(2008-10#1)
supersaturation##4##1##(1990-11#2)(1992-9#1)(2008-10#1)
superscript theta##2##2##(2008-3#2)
superseded by##5##2##(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
superseded##8##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)
supersedes##2##1##(2008-11#1)(2010-11#1)
superselective##2##1##(1997-3#1)(1997-6#1)
supersensitivity of the pupil##2##4##(2008-7#2)
supersensitivity to##2##2##(1995-12#1)(2008-7#1)
supersensitivity##11##1##(1990-11#1)(1991-1#1)(1992-11#1)(1992-12#1)(1993-12#3)(1995-12#1)(2008-7#3)
supersonic nozzle##2##2##(2007-12#2)
supersonic##11##1##(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)(2009-11#1)(2010-7#1)
superstition##2##1##(1993-11#1)(2009-6#1)
superstrate##7##1##(2007-11#3)(2008-2#2)(2008-3#2)
superstructure##7##1##(1995-6#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2013-1#1)
supertrees##2##1##(2010-6#1)(2011-2#1)
supervened##2##1##(1995-12#1)(2006-10#1)
supervenience##2##1##(2012-2#2)
supervise##3##1##(1991-3#1)(1992-3#1)(2013-8#1)
supervised by the##2##3##(1994-12#1)(2010-1#1)
supervised classification##2##2##(2008-3#1)(2013-8#1)
supervised learning##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
supervised time##4##2##(2009-7#4)
supervised##30##1##(1994-12#1)(1995-3#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-7#6)(2010-1#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
supervising a student##3##3##(1995-3#3)
supervising##4##1##(1995-2#1)(1995-3#3)
supervision and##7##2##(1992-9#1)(1995-3#1)(1996-1#1)(1997-7#1)(2008-7#1)(2010-10#1)(2010-12#1)
supervision as##2##2##(1992-11#1)(2013-1#1)
supervision by##3##2##(1991-6#1)(2008-6#1)(2012-3#1)
supervision during##2##2##(1992-6#1)(2012-2#1)
supervision from##2##2##(2008-11#1)(2012-2#1)
supervision in##7##2##(1995-6#1)(1996-7#1)(1997-2#1)(2008-4#1)(2012-12#1)(2013-1#2)
supervision is##5##2##(1992-11#2)(1997-7#1)(2012-3#2)
supervision of a##3##3##(2007-10#1)(2008-11#1)(2012-12#1)
supervision of##5##2##(1991-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
supervision time##4##2##(1995-3#3)(2009-4#1)
supervision##71##1##(1990-2#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#4)(1992-6#3)(1992-9#1)(1994-3#1)(1995-3#6)(1995-6#4)(1996-1#2)(1996-7#3)(1997-2#1)(1997-7#5)(2007-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#3)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#3)
supervisor must be##3##3##(1992-11#2)(2008-7#1)
supervisor##13##1##(1992-11#2)(1992-6#1)(1994-1#1)(1995-2#1)(1995-6#2)(1996-7#1)(2008-12#1)(2008-7#2)(2009-10#1)(2013-1#1)
supervisors at##2##2##(1996-2#1)(2013-1#1)
supervisors##11##1##(1992-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
supervisors'##3##1##(2012-3#2)(2013-1#1)
supervisors)##3##1##(1990-12#1)(2008-11#1)(2011-2#1)
supervisory approaches##2##2##(2013-1#2)
supervisory positions##2##2##(1993-1#1)(1996-1#1)
supervisory practices##2##2##(2013-1#2)
supervisory style##4##2##(2012-3#4)
supervisory##15##1##(1992-2#1)(1993-1#1)(1993-2#1)(1996-1#1)(2008-1#1)(2011-1#1)(2012-3#4)(2013-1#5)
supine BP##2##2##(2008-7#2)
supine position which##2##3##(2011-2#1)(2012-12#1)
supine position with##2##3##(2011-2#1)(2012-3#1)
supine position##13##2##(1995-12#1)(2008-1#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-3#4)
supine##29##1##(1992-11#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-12#1)(1994-3#1)(1995-12#1)(2008-1#1)(2008-7#4)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#6)(2013-1#1)
suplatast tosilate and high-dose inhaled corticosteroid##2##6##(2008-1#2)
suplatast tosilate##3##2##(2008-1#3)
supplant##3##1##(1996-2#1)(1997-1#1)(2013-1#1)
supplanted##2##1##(1995-5#1)(2011-2#1)
supplement and##3##2##(2008-12#1)(2009-11#1)(2013-8#1)
supplement at##3##2##(2013-8#3)
supplement before grazing##2##3##(2012-2#2)
supplement conventional##2##2##(1997-2#1)(1997-4#1)
supplement for animal##2##3##(2008-11#1)(2008-6#1)
supplement for the##2##3##(1994-2#2)
supplement for##7##2##(1994-2#3)(2008-11#2)(2008-6#1)(2012-6#1)
supplement in serum-free##2##3##(2008-11#2)
supplement in##5##2##(2008-11#2)(2008-5#1)(2010-7#1)(2013-1#1)
supplement of##4##2##(1991-6#1)(2007-11#1)(2008-10#1)(2009-7#1)
supplement on##4##2##(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)
supplement the##8##2##(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
supplement to the##2##3##(1991-6#1)(1997-3#1)
supplement to##14##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
supplement use and##2##3##(2008-10#2)
supplement use##5##2##(2007-12#1)(2008-10#4)
supplement##97##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#3)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#5)(1994-6#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#3)(2012-6#1)(2013-1#4)(2013-8#9)
supplemental insurance##2##2##(1994-1#2)
supplemental medium##2##2##(2008-7#2)
supplemental oxygen and##2##3##(1993-1#2)
supplemental oxygen##6##2##(1992-2#1)(1993-1#4)(2007-8#1)
supplemental water##2##2##(2008-10#2)
supplemental##22##1##(1992-2#1)(1992-9#2)(1993-1#4)(1994-1#2)(1995-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2012-12#1)(2013-1#1)(2013-7#1)
supplementary health insurance##2##3##(1996-3#1)(2008-7#1)
supplementary insurance##4##2##(1995-12#1)(1996-2#1)(1996-3#2)
supplementary motor##2##2##(2008-9#1)(2013-1#1)
supplementary treatment##2##2##(1993-2#1)(1996-8#1)
supplementary##53##1##(1991-12#1)(1991-2#1)(1992-4#1)(1993-2#2)(1994-11#1)(1995-12#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2010-1#2)(2010-10#4)(2010-2#1)(2011-1#4)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
supplementation and##7##2##(1994-6#1)(1996-12#1)(2007-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
supplementation at the##2##3##(2008-11#1)(2013-1#1)
supplementation at##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
supplementation can##2##2##(2008-5#2)
supplementation does not##2##3##(1990-3#1)(2008-5#1)
supplementation during pregnancy##2##3##(2007-11#1)(2011-2#1)
supplementation during##6##2##(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-3#1)
supplementation for##2##2##(1990-3#1)(2008-11#1)
supplementation groups##3##2##(1990-3#1)(2011-1#2)
supplementation has been##2##3##(2008-5#1)(2013-1#1)
supplementation has##3##2##(2008-5#2)(2013-1#1)
supplementation improves##2##2##(2010-2#1)(2012-12#1)
supplementation in hemodialysis patients##3##4##(2008-1#3)
supplementation in pregnancy and its##2##5##(2012-3#2)
supplementation in the##2##3##(2008-7#1)(2010-2#1)
supplementation in##22##2##(2007-11#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#2)(2010-2#2)(2010-6#1)(2011-2#1)(2012-3#2)
supplementation is##6##2##(1997-1#1)(2007-11#1)(2008-1#1)(2008-5#1)(2013-1#2)
supplementation of Euphorbia heterophylla on##2##5##(2013-1#2)
supplementation of zymosan with morphine##2##5##(2008-12#2)
supplementation of##19##2##(1995-6#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
supplementation on the growth performance and meat quality in finishing##2##10##(2010-2#2)
supplementation on the growth performance##4##5##(2010-2#4)
supplementation on the growth##5##4##(2008-8#1)(2010-2#4)
supplementation on##18##2##(1990-3#1)(1993-6#1)(1996-12#2)(1997-3#1)(2007-11#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#4)(2011-1#1)
supplementation or##2##2##(2009-2#1)(2011-2#1)
supplementation period##2##2##(2008-5#1)(2013-1#1)
supplementation to##3##2##(1992-11#1)(2008-1#1)(2008-10#1)
supplementation were##2##2##(1994-5#1)(2007-11#1)
supplementation with a##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
supplementation with##15##2##(1991-12#1)(1991-6#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-12#1)(2011-2#1)
supplementation##198##1##(1990-3#4)(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#4)(1993-1#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-12#3)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#9)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#4)(2008-11#21)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#34)(2008-6#1)(2008-7#6)(2008-8#6)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#4)(2010-12#1)(2010-2#8)(2010-5#2)(2010-6#1)(2011-1#8)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#1)
supplementation)##2##1##(2008-3#1)(2012-2#1)
supplementations##2##1##(2008-8#1)(2011-1#1)
supplemented by the##4##3##(1990-5#1)(2008-10#1)(2008-2#1)(2010-12#1)
supplemented by##16##2##(1990-5#1)(1994-3#1)(1996-11#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
supplemented in##2##2##(2008-11#2)
supplemented media##3##2##(1995-11#1)(2007-11#1)(2008-7#1)
supplemented medium##6##2##(1990-7#1)(1994-2#2)(2008-11#3)
supplemented the##2##2##(1996-6#1)(2013-1#1)
supplemented to##2##2##(2008-11#1)(2008-5#1)
supplemented with 1##5##3##(1995-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
supplemented with 1%##2##3##(2008-11#1)(2008-5#1)
supplemented with 10%##3##3##(2007-11#1)(2008-11#2)
supplemented with 100##3##3##(2008-7#1)(2013-1#2)
supplemented with 2##2##3##(2008-7#1)(2008-8#1)
supplemented with a##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
supplemented with additional##2##3##(1994-5#1)(1996-3#1)
supplemented with different##2##3##(2008-12#1)(2013-1#1)
supplemented with fetal bovine serum##2##5##(2008-11#1)(2010-3#1)
supplemented with glucose##5##3##(2008-10#1)(2008-11#4)
supplemented with more##2##3##(1992-12#1)(2008-11#1)
supplemented with other##2##3##(2008-10#1)(2010-8#1)
supplemented with sodium selenite##2##4##(2008-10#1)(2010-11#1)
supplemented with the##3##3##(2007-11#1)(2008-11#2)
supplemented with tryptophan##2##3##(2008-10#1)(2008-7#1)
supplemented with vitamin##2##3##(1993-12#1)(2013-1#1)
supplemented with##101##2##(1991-10#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(2007-11#4)(2007-5#1)(2008-10#14)(2008-11#27)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#8)
supplemented##150##1##(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-11#7)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#16)(2008-11#37)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-3#2)(2013-1#10)(2013-8#1)
supplementing the##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
supplementing##9##1##(1993-2#1)(1993-8#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
supplements and##15##2##(1992-9#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#7)(2009-5#1)(2010-3#1)
supplements as well##2##3##(2008-10#1)(2011-2#1)
supplements for##2##2##(2008-11#1)(2011-2#1)
supplements in##2##2##(2008-10#1)(2011-1#1)
supplements that##2##2##(2008-5#1)(2013-7#1)
supplements to##6##2##(1991-2#1)(1997-6#1)(2008-5#3)(2012-2#1)
supplements was##2##2##(2008-11#1)(2013-1#1)
supplements were##3##2##(1995-11#1)(2008-11#1)(2013-7#1)
supplements##84##1##(1991-2#2)(1992-9#3)(1993-11#2)(1995-11#2)(1995-2#2)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-3#2)(2008-5#21)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-3#3)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
supplied and##2##2##(2008-3#1)(2011-1#1)
supplied by##9##2##(1991-9#1)(1996-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#2)(2011-2#1)
supplied from the##2##3##(1992-1#1)(2011-2#1)
supplied in##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
supplied the##2##2##(2011-2#2)
supplied to a##2##3##(2008-10#2)
supplied to the##4##3##(1995-3#1)(2007-11#1)(2008-10#2)
supplied to##7##2##(1995-3#1)(2007-11#1)(2008-10#4)(2008-9#1)
supplied with adequate##2##3##(1992-9#1)(2008-11#1)
supplied with##10##2##(1990-11#1)(1992-9#1)(1997-3#1)(2008-11#2)(2008-2#1)(2011-1#2)(2011-2#2)
supplied##57##1##(1990-11#2)(1991-9#1)(1992-1#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-3#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#10)(2008-11#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2010-11#1)(2011-1#3)(2011-2#6)(2012-12#2)(2013-1#1)
supplier of##2##2##(2010-2#1)(2011-2#1)
supplier##12##1##(1991-12#1)(1992-1#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#2)(2008-10#1)(2010-2#1)(2011-2#2)
suppliers and##3##2##(1993-12#1)(1994-1#1)(2008-7#1)
suppliers to##2##2##(1994-1#1)(2011-2#1)
suppliers##14##1##(1992-3#1)(1993-12#1)(1994-1#3)(1994-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#2)
suppliers'##2##1##(2010-11#1)(2011-2#1)
supplies a##5##2##(1995-2#1)(1997-1#1)(2007-5#1)(2008-3#1)(2008-9#1)
supplies and##2##2##(1991-12#1)(1996-6#1)
supplies of##4##2##(1994-9#1)(1996-6#1)(2007-12#1)(2008-7#1)
supplies the##3##2##(1995-5#1)(2011-2#2)
supplies##34##1##(1991-12#2)(1993-1#1)(1993-3#1)(1994-1#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#3)(1997-1#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#3)(2012-1#1)(2012-2#1)
supply and the##2##3##(2011-2#2)
supply and##11##2##(1992-1#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
supply are##2##2##(1992-3#1)(1994-1#1)
supply as##3##2##(2007-5#1)(2009-12#1)(2012-1#1)
supply both##2##2##(2007-12#1)(2008-9#1)
supply by##3##2##(1995-6#1)(2008-7#1)(2008-8#1)
supply chain##2##2##(2007-12#1)(2011-2#1)
supply costs##3##2##(1994-3#1)(2010-9#1)(2012-2#1)
supply in the##2##3##(2009-3#1)(2012-1#1)
supply in##7##2##(2008-11#1)(2008-5#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
supply industry##2##2##(1994-2#1)(2011-2#1)
supply is##7##2##(1991-9#2)(1996-3#2)(2008-11#1)(2008-6#1)(2009-10#1)
supply of charity##2##3##(1992-3#2)
supply of cysteine##2##3##(1991-9#1)(2009-8#1)
supply of doctors##2##3##(1991-2#2)
supply of the##3##3##(2007-12#2)(2012-2#1)
supply of volunteer labor##2##4##(1994-3#2)
supply of##57##2##(1991-2#3)(1991-3#4)(1991-9#2)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-3#5)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-3#1)(1997-1#1)(2007-12#2)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)
supply or##3##2##(1996-2#1)(2007-12#1)(2008-10#1)
supply ratios##3##2##(2008-8#3)
supply services##2##2##(2012-12#2)
supply the##12##2##(1997-1#2)(2007-12#4)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-3#1)
supply to plants##2##3##(2013-8#2)
supply to the##15##3##(1993-1#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-1#1)
supply to##20##2##(1993-1#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
supply tubing##2##2##(2011-1#2)
supply was##8##2##(2006-12#2)(2008-11#4)(2008-5#2)
supply were##2##2##(2007-11#1)(2011-2#1)
supply with##3##2##(2008-1#1)(2011-2#1)(2012-1#1)
supply##267##1##(1990-6#1)(1991-2#4)(1991-3#4)(1991-9#4)(1992-1#1)(1992-3#5)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-8#1)(1996-9#3)(1997-1#3)(1997-4#1)(1997-8#1)(2006-12#3)(2007-11#7)(2007-12#14)(2007-2#2)(2007-4#1)(2007-5#3)(2007-8#3)(2008-1#4)(2008-10#19)(2008-11#21)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#5)
supplying the##5##2##(1993-11#1)(2008-2#1)(2008-7#2)(2011-2#1)
supplying##18##1##(1991-9#2)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
support a hypothesis that##3##4##(2009-11#1)(2011-2#1)(2012-3#1)
support a mechanism of##2##4##(1992-6#1)(1993-11#1)
support a model##2##3##(1994-2#1)(2008-10#1)
support a novel##3##3##(1991-12#1)(2012-2#2)
support a protective role##2##4##(1993-5#1)(2010-11#1)
support a role for##11##4##(1990-5#1)(1992-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-9#1)(2008-2#1)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
support a single##3##3##(1994-3#2)(2008-3#1)
support a##67##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1994-1#3)(1994-2#3)(1994-3#2)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-5#1)(1997-9#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)
support activities##2##2##(1994-3#1)(1996-1#1)
support after##4##2##(1995-6#1)(2009-5#3)
support an##12##2##(1992-3#1)(1995-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
support and a##3##3##(2007-8#1)(2008-11#1)(2008-7#1)
support and education##3##3##(1994-3#2)(2013-1#1)
support and guidance##2##3##(2008-12#2)
support and involvement##2##3##(1992-12#1)(2010-3#1)
support and its##3##3##(1992-3#1)(2008-10#1)(2010-3#1)
support and networks##2##3##(2010-10#2)
support and participation##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
support and perceived##2##3##(2009-7#1)(2010-2#1)
support and psychological##2##3##(2010-1#1)(2010-2#1)
support and the##7##3##(1995-1#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#2)(2009-7#1)
support and well-being##2##3##(1992-3#2)
support and##89##2##(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#4)(1994-1#2)(1994-12#1)(1994-3#3)(1995-1#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-2#1)(2007-8#2)(2008-10#10)(2008-11#6)(2008-12#5)(2008-4#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2010-1#2)(2010-10#2)(2010-2#2)(2010-3#4)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
support any##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
support are essential##2##3##(1992-1#1)(1992-3#1)
support are##4##2##(1992-1#1)(1992-3#1)(2008-12#1)(2008-5#1)
support as a##5##3##(1992-3#1)(1996-3#1)(2008-9#2)(2012-2#1)
support as well as##2##4##(2008-11#2)
support as##8##2##(1992-3#1)(1996-3#1)(2008-11#2)(2008-3#1)(2008-9#2)(2012-2#1)
support at the##3##3##(1993-9#1)(2010-5#1)(2012-2#1)
support at##5##2##(1992-1#1)(1993-9#1)(2010-5#2)(2012-2#1)
support available##3##2##(1992-2#1)(2007-6#1)(2008-12#1)
support both##3##2##(1995-1#1)(2008-1#1)(2010-3#1)
support breeding##2##2##(2008-10#2)
support by##4##2##(1992-2#1)(2007-8#1)(2008-10#2)
support can##3##2##(1994-3#1)(2007-11#1)(2008-10#1)
support cell growth in##2##4##(1996-2#1)(2008-11#1)
support cell growth##4##3##(1996-2#1)(2008-11#2)(2012-8#1)
support cell##5##2##(1996-2#1)(2008-11#2)(2009-7#1)(2012-8#1)
support cells##4##2##(2007-12#1)(2008-7#1)(2008-9#1)(2009-3#1)
support could be##2##3##(2008-10#1)(2011-2#1)
support current##2##2##(1994-8#1)(2012-3#1)
support device##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
support devices##2##2##(1991-3#1)(2008-11#1)
support during labour##2##3##(2010-3#1)(2013-1#1)
support during the##2##3##(1993-3#1)(2008-11#1)
support during##7##2##(1993-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
support earlier reports##2##3##(2008-10#1)(2008-8#1)
support early##3##2##(1997-1#1)(2008-9#2)
support for a role of##2##5##(1994-9#1)(2008-8#1)
support for a##11##3##(1994-3#1)(1994-9#2)(1997-5#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
support for all##2##3##(2008-11#1)(2011-2#1)
support for clinical##2##3##(1995-3#1)(2008-8#1)
support for our##2##3##(2008-8#1)(2013-1#1)
support for the concept##2##4##(1995-12#1)(1995-2#1)
support for the hypothesis of##2##5##(2008-10#1)(2008-5#1)
support for the hypothesis##5##4##(1994-8#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
support for the presence of##2##5##(2008-8#1)(2013-8#1)
support for the principle of##2##5##(2008-1#1)(2008-11#1)
support for the proposition that women##2##6##(2009-11#2)
support for the proposition that##3##5##(2009-11#3)
support for the reliability and validity of the##2##8##(2008-6#1)(2011-1#1)
support for the##61##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-2#3)(2007-12#3)(2008-1#5)(2008-10#5)(2008-11#7)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#3)(2009-11#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#4)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
support for their##3##3##(2008-9#1)(2010-3#2)
support for this##2##3##(2008-8#1)(2011-2#1)
support for your##2##3##(1991-1#1)(1993-2#1)
support for##160##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-11#1)(1993-2#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-7#1)(2007-12#6)(2008-1#6)(2008-10#11)(2008-11#13)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#4)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#4)
support from classmates and##2##4##(2009-7#2)
support from family##2##3##(2008-12#1)(2013-1#1)
support from friends and family##2##5##(1994-1#1)(2008-6#1)
support from medical##3##3##(1995-3#1)(1996-1#1)(2010-2#1)
support from the##4##3##(1991-12#1)(1996-3#1)(2009-11#1)(2010-10#1)
support from##28##2##(1991-12#1)(1992-12#1)(1992-3#2)(1994-1#1)(1995-3#1)(1996-1#2)(1996-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#6)(2010-10#1)(2010-2#1)(2011-1#2)(2013-1#1)
support future##3##2##(1995-12#1)(1996-2#1)(2013-1#1)
support group for adolescents with##2##5##(1993-3#2)
support group for##4##3##(1991-12#2)(1993-3#2)
support group##10##2##(1991-12#3)(1992-12#1)(1993-3#2)(2007-12#1)(2007-8#1)(2008-11#2)
support groups and##5##3##(1994-3#1)(1996-3#3)(2008-2#1)
support groups are##3##3##(1992-12#1)(1995-1#1)(2008-5#1)
support groups in##2##3##(2008-12#1)(2009-7#1)
support groups##25##2##(1991-12#1)(1992-12#3)(1994-3#1)(1995-1#3)(1996-1#1)(1996-3#6)(2007-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#2)(2009-7#2)(2011-1#1)(2012-2#1)
support growth of##2##3##(1993-6#1)(2011-2#1)
support growth##4##2##(1993-6#1)(1994-2#1)(2011-2#1)(2012-3#1)
support has been used##2##4##(2008-10#1)(2008-7#1)
support has been##5##3##(2008-10#2)(2008-7#1)(2010-10#1)(2010-3#1)
support have##2##2##(2008-10#1)(2010-6#1)
support in a##2##3##(2008-10#1)(2010-2#1)
support in an##2##3##(1992-3#1)(2008-10#1)
support in the##8##3##(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#2)
support in##28##2##(1992-3#4)(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
support interventions##3##2##(1996-3#2)(2013-1#1)
support is needed##2##3##(2008-7#1)(2013-1#1)
support is used##2##3##(2008-10#2)
support is##12##2##(1992-3#1)(1993-10#1)(1995-12#1)(2007-2#1)(2008-10#5)(2008-7#1)(2011-2#1)(2013-1#1)
support its use##2##3##(1997-5#1)(2013-8#1)
support its##7##2##(1994-3#1)(1995-5#1)(1997-5#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-8#1)
support material##6##2##(2008-10#5)(2008-6#1)
support may be##2##3##(2009-7#1)(2012-3#1)
support may##5##2##(2008-11#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-3#1)
support mechanism for##2##3##(2008-11#2)
support mechanism##3##2##(2008-11#2)(2008-4#1)
support media##2##2##(2008-4#1)(2008-5#1)
support membrane##2##2##(2008-4#2)
support models##3##2##(1992-6#1)(1997-5#1)(2009-10#1)
support network for##3##3##(2008-9#1)(2011-2#2)
support network##7##2##(1991-12#1)(1997-2#1)(2008-11#2)(2008-9#1)(2011-2#2)
support networks##9##2##(1992-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#2)(2009-6#1)(2011-2#1)
support normal##2##2##(1994-11#1)(1996-6#1)
support not only##3##3##(1994-1#1)(1994-3#1)(2012-12#1)
support nurses##2##2##(1992-2#1)(2008-11#1)
support of a##6##3##(1991-2#1)(2007-8#1)(2008-2#1)(2008-8#2)(2010-5#1)
support of early##2##3##(1992-2#1)(2011-2#1)
support of the hypothesis##3##4##(1995-2#1)(2008-11#1)(2009-2#1)
support of the##30##3##(1991-1#1)(1991-5#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#1)
support of this hypothesis##2##4##(1990-11#1)(2008-7#1)
support of this##11##3##(1990-11#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-6#1)
support of your##2##3##(1994-12#1)(2007-10#1)
support of##91##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#2)(2010-5#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
support offered##2##2##(2008-11#1)(2013-1#1)
support on##7##2##(1994-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)
support or##5##2##(1996-3#1)(2007-2#1)(2009-10#1)(2012-1#1)(2012-3#1)
support other##2##2##(1994-6#1)(2007-2#1)
support our hypothesis##2##3##(1996-12#1)(2012-5#1)
support our##7##2##(1996-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-5#1)(2013-1#1)
support previous studies##2##3##(1995-6#1)(2008-5#1)
support previous##6##2##(1995-6#1)(1996-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
support program##3##2##(1997-2#1)(2007-10#1)(2013-1#1)
support protocol describes a##4##4##(2008-2#1)(2008-4#3)
support protocol describes how to##4##5##(2008-2#1)(2008-4#3)
support protocol describes the##7##4##(2008-2#1)(2008-4#6)
support protocol describes##20##3##(2008-2#4)(2008-4#15)(2008-9#1)
support protocol for##4##3##(2008-1#1)(2008-4#3)
support protocol##35##2##(2008-1#1)(2008-2#5)(2008-4#28)(2008-9#1)
support protocols are provided##2##4##(2008-4#2)
support protocols describe##3##3##(2008-4#3)
support protocols for##2##3##(2008-1#1)(2008-4#1)
support protocols provide##2##3##(2008-4#1)(2008-9#1)
support protocols##17##2##(2008-1#1)(2008-2#1)(2008-4#13)(2008-9#2)
support provided by##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
support provided##5##2##(1991-5#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
support recent##3##2##(2009-11#1)(2009-8#1)(2010-7#1)
support resources and##2##3##(1995-1#2)
support roles for##2##3##(2008-1#1)(2008-8#1)
support roles##5##2##(2008-1#1)(2008-11#3)(2008-8#1)
support services##16##2##(1993-1#2)(1994-2#1)(1996-1#1)(2008-6#1)(2009-5#1)(2013-8#10)
support should be##2##3##(1992-2#1)(2013-1#1)
support some previous##2##3##(2008-11#1)(2008-6#1)
support staff and##2##3##(2008-12#1)(2010-2#1)
support staff##9##2##(1991-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-12#2)(2010-2#1)
support structures##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
support such a##2##3##(2008-10#1)(2008-4#1)
support such##9##2##(1992-1#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
support system##13##2##(1991-1#1)(1993-2#1)(1995-2#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2010-6#1)(2010-8#3)(2012-2#1)
support systems and##2##3##(2008-1#1)(2009-7#1)
support systems for##3##3##(2010-6#1)(2010-8#1)(2012-12#1)
support systems in##3##3##(1993-2#1)(1995-1#1)(1997-3#1)
support systems that##2##3##(2007-2#1)(2008-11#1)
support systems##25##2##(1993-2#2)(1993-3#1)(1995-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-11#5)(2009-11#1)(2009-7#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
support that the##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
support that##13##2##(1995-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
support the argument that females can gain paternal investment##2##9##(2008-8#2)
support the argument that##3##4##(1997-1#1)(2008-8#2)
support the argument##5##3##(1997-1#1)(2008-12#1)(2008-5#1)(2008-8#2)
support the assumption of##3##4##(1995-12#1)(2010-8#1)(2013-8#1)
support the assumption that##2##4##(1992-8#1)(2013-1#1)
support the assumption##5##3##(1992-8#1)(1995-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
support the claim that##2##4##(1997-6#1)(2013-8#1)
support the clinical##2##3##(1994-3#1)(2008-3#1)
support the concept of##2##4##(1991-9#1)(1997-8#1)
support the concept that the##2##5##(2008-5#1)(2008-7#1)
support the concept that##5##4##(1996-5#1)(2008-3#1)(2008-5#1)(2008-7#2)
support the concept##8##3##(1991-9#1)(1996-5#1)(1997-8#1)(2008-3#2)(2008-5#1)(2008-7#2)
support the conclusion that the##4##5##(1992-2#1)(1996-7#1)(2008-10#1)(2008-9#1)
support the conclusion that##10##4##(1991-12#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-8#1)
support the contention that the##2##5##(1994-3#1)(1997-6#1)
support the contention that##7##4##(1994-3#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
support the development of##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
support the development##5##3##(1994-2#1)(2008-7#1)(2012-3#1)(2013-1#2)
support the efficacy of##3##4##(1996-2#1)(1997-8#1)(2008-5#1)
support the evidence##2##3##(2008-10#1)(2008-4#1)
support the existence of a##3##5##(1994-12#1)(1996-4#1)(2008-5#1)
support the existence of##6##4##(1994-12#1)(1996-4#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
support the experimental##2##3##(1992-3#1)(2007-11#1)
support the feasibility##2##3##(2009-7#1)(2013-8#1)
support the formation of##2##4##(2008-10#1)(2008-11#1)
support the growth of##4##4##(2008-11#2)(2008-5#1)(2008-8#1)
support the growth##5##3##(2008-11#3)(2008-5#1)(2008-8#1)
support the hypotheses that##4##4##(1996-4#1)(2008-10#1)(2008-7#1)(2010-6#1)
support the hypothesis of a##3##5##(1991-12#1)(1993-5#1)(1994-11#1)
support the hypothesis of##6##4##(1991-12#1)(1992-5#1)(1993-5#1)(1994-11#1)(1994-6#1)(2008-10#1)
support the hypothesis that IAA-producing bacteria cause cranberry stem gall##2##10##(2008-10#2)
support the hypothesis that a##3##5##(1992-6#1)(2009-5#1)(2012-1#1)
support the hypothesis that the##9##5##(1991-2#1)(1992-7#1)(1993-3#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#3)
support the hypothesis that##50##4##(1990-12#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#3)(1992-7#2)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#3)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
support the hypothesis##60##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-5#2)(1992-6#3)(1992-7#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#3)(2008-10#14)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
support the idea of##2##4##(1994-12#1)(2008-1#1)
support the idea that the##2##5##(1993-12#1)(2008-9#1)
support the idea that##12##4##(1992-11#1)(1992-9#1)(1993-12#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)
support the idea##15##3##(1992-11#1)(1992-9#1)(1993-12#1)(1994-12#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)
support the involvement of##2##4##(1995-12#1)(2008-3#1)
support the model##3##3##(1992-12#1)(1994-2#1)(1995-2#1)
support the need for##2##4##(2011-2#1)(2013-1#1)
support the new##3##3##(1992-5#1)(2007-12#1)(2008-10#1)
support the notion that the##4##5##(1993-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
support the notion that##11##4##(1990-2#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
support the notion##12##3##(1990-2#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
support the potential##3##3##(1995-12#2)(2008-7#1)
support the premise that##2##4##(1992-6#1)(2008-8#1)
support the proposal that the##2##5##(1990-10#1)(1997-2#1)
support the proposal that##4##4##(1990-10#1)(1994-11#1)(1997-2#1)(2009-4#1)
support the role of##3##4##(2008-7#1)(2010-4#1)(2011-2#1)
support the role##4##3##(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)
support the systemic##2##3##(2008-10#2)
support the use of##14##4##(1995-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-1#2)
support the usefulness of##2##4##(2008-3#1)(2013-8#1)
support the value of##2##4##(1992-9#1)(2008-1#1)
support the view that##15##4##(1992-11#1)(1992-8#1)(1993-3#1)(1994-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-9#1)
support the view##16##3##(1992-11#1)(1992-8#1)(1993-3#1)(1994-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-9#1)
support the well-being of##2##4##(2010-11#1)(2010-5#1)
support the##346##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#9)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#5)(1996-7#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#4)(1997-7#3)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#42)(2008-11#15)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#15)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#9)(2013-1#9)(2013-7#2)(2013-8#8)
support their##7##2##(1993-12#2)(1993-3#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
support these##7##2##(1995-1#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)
support this assumption##2##3##(1996-6#1)(2008-10#1)
support this hypothesis##3##3##(1991-3#1)(2008-7#1)(2008-8#1)
support this##18##2##(1991-3#1)(1993-3#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-5#1)(2013-1#2)
support to a role for##3##5##(1992-7#1)(1995-8#1)(2008-7#1)
support to a##6##3##(1992-7#1)(1994-2#1)(1995-12#1)(1995-8#1)(2008-7#1)(2013-1#1)
support to facilitate the##2##4##(2008-11#2)
support to health##2##3##(2007-2#1)(2010-12#1)
support to improve##2##3##(2010-4#1)(2010-5#1)
support to the hypothesis that##5##5##(1991-6#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
support to the use of##2##5##(2008-2#1)(2008-7#1)
support to the##24##3##(1990-11#1)(1990-5#1)(1991-6#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
support to their##2##3##(1995-1#1)(2010-3#1)
support to this##2##3##(1990-3#1)(1991-8#1)
support to##74##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
support tool for##3##3##(2008-10#1)(2011-2#2)
support tool##5##2##(2008-10#1)(2009-6#1)(2010-8#1)(2011-2#2)
support two##2##2##(1993-12#1)(2007-11#1)
support uncompensated care##2##3##(1996-1#2)
support using##3##2##(1991-5#1)(2008-4#1)(2010-2#1)
support vector machine##5##3##(2010-7#2)(2010-8#2)(2012-2#1)
support vector machines##4##3##(2008-11#1)(2009-12#1)(2010-8#1)(2013-8#1)
support vector##9##2##(2008-11#1)(2009-12#1)(2010-7#2)(2010-8#3)(2012-2#1)(2013-8#1)
support was a robust unique predictor##2##6##(2010-1#2)
support was provided##2##3##(1997-2#1)(2008-11#1)
support was##21##2##(1990-10#1)(1993-8#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-7#3)(2009-5#1)(2010-1#2)(2010-3#1)(2010-8#1)(2011-2#1)
support were##5##2##(1994-3#1)(1995-1#1)(2007-9#1)(2008-10#1)(2013-1#1)
support which##3##2##(1993-8#1)(2008-7#1)(2013-8#1)
support will##3##2##(1993-2#1)(2008-12#1)(2012-3#1)
support with##10##2##(1990-8#1)(2007-8#1)(2008-10#3)(2009-7#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
support##1881##1##(1990-10#4)(1990-11#4)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#7)(1991-12#14)(1991-2#6)(1991-3#2)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#7)(1992-11#2)(1992-12#13)(1992-2#10)(1992-3#36)(1992-4#1)(1992-5#7)(1992-6#8)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#8)(1993-10#1)(1993-11#6)(1993-12#16)(1993-2#8)(1993-3#12)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-1#13)(1994-11#3)(1994-12#9)(1994-2#18)(1994-3#24)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#6)(1994-9#5)(1995-1#23)(1995-11#2)(1995-12#20)(1995-2#13)(1995-3#7)(1995-4#1)(1995-5#6)(1995-6#4)(1995-8#7)(1996-1#10)(1996-11#5)(1996-12#9)(1996-2#13)(1996-3#24)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#4)(1996-9#2)(1997-1#10)(1997-2#10)(1997-3#12)(1997-4#8)(1997-5#9)(1997-6#8)(1997-7#6)(1997-8#3)(1997-9#1)(2006-10#3)(2007-10#5)(2007-11#14)(2007-12#25)(2007-2#8)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#17)(2007-9#3)(2008-1#22)(2008-10#190)(2008-11#123)(2008-12#44)(2008-2#22)(2008-3#18)(2008-4#72)(2008-5#31)(2008-6#21)(2008-7#58)(2008-8#32)(2008-9#38)(2009-10#7)(2009-11#13)(2009-12#8)(2009-2#3)(2009-3#5)(2009-4#6)(2009-5#23)(2009-6#9)(2009-7#30)(2009-8#10)(2009-9#6)(2010-1#14)(2010-10#11)(2010-11#7)(2010-12#8)(2010-2#8)(2010-3#18)(2010-4#10)(2010-5#19)(2010-6#15)(2010-7#7)(2010-8#30)(2010-9#2)(2011-1#21)(2011-2#84)(2011-3#2)(2011-9#1)(2012-1#8)(2012-12#28)(2012-2#28)(2012-3#40)(2012-5#1)(2012-8#1)(2013-1#70)(2013-7#3)(2013-8#35)
support) and##3##2##(2008-2#1)(2009-7#2)
support)##6##1##(2008-10#1)(2008-2#1)(2009-5#1)(2009-7#3)
supported a##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)
supported an##3##2##(2008-11#1)(2009-10#1)(2009-8#1)
supported and##2##2##(1997-4#1)(2008-11#1)
supported as a##3##3##(2007-8#2)(2012-3#1)
supported bilayer##2##2##(2008-4#1)(2009-12#1)
supported both##2##2##(1995-2#1)(2009-4#1)
supported by a##14##3##(1992-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2013-1#1)
supported by an##3##3##(2008-10#1)(2008-3#2)
supported by clinical##2##3##(2008-1#1)(2008-7#1)
supported by data##2##3##(1997-3#1)(2008-11#1)
supported by experimental##2##3##(2008-2#1)(2008-3#1)
supported by field##2##3##(2008-1#1)(2008-3#1)
supported by findings##2##3##(1993-12#1)(2012-2#1)
supported by our##2##3##(1990-7#1)(1997-3#1)
supported by restriction analysis of##2##5##(1996-6#1)(2008-10#1)
supported by results##3##3##(1990-12#1)(1991-11#1)(1992-3#1)
supported by statistical##2##3##(2008-10#1)(2013-1#1)
supported by the absence of##2##5##(2007-12#1)(2008-10#1)
supported by the data##2##4##(2010-8#2)
supported by the fact that##2##5##(1990-2#1)(2008-8#1)
supported by the finding that##3##5##(2008-10#1)(2008-12#1)(2008-7#1)
supported by the identification##2##4##(1991-2#1)(2009-10#1)
supported by the results of##2##5##(2008-10#2)
supported by the##45##3##(1990-2#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-9#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
supported by##152##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#2)(1991-12#2)(1991-2#1)(1992-3#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#3)(1997-5#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#28)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-6#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#2)
supported capillary membrane sampling-gas chromatography##2##5##(2008-10#2)
supported for##2##2##(1997-5#1)(2008-9#1)
supported in the##6##3##(1991-11#1)(1994-3#1)(1996-4#1)(2008-1#1)(2008-12#1)(2012-2#1)
supported in##10##2##(1991-11#1)(1993-12#1)(1994-3#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-2#1)
supported lipid##3##2##(2008-10#1)(2008-7#2)
supported liquid membrane (SLM)##3##4##(2008-10#2)(2012-1#1)
supported liquid membrane containing##2##4##(2008-10#2)
supported liquid membrane##12##3##(2008-10#11)(2012-1#1)
supported liquid membranes (SLMs)##2##4##(2008-10#2)
supported liquid membranes##3##3##(2008-10#3)
supported liquid##15##2##(2008-10#14)(2012-1#1)
supported monophyletic group##2##3##(2008-10#1)(2008-5#1)
supported on a##3##3##(2007-11#1)(2008-10#2)
supported on poly(ethylene-co-vinyl-acetate)##2##3##(2008-10#2)
supported on##11##2##(2007-11#1)(2008-10#9)(2012-1#1)
supported only##3##2##(1990-3#1)(2008-10#1)(2010-6#1)
supported our##3##2##(1990-12#1)(2008-10#1)(2009-8#1)
supported that##2##2##(2007-12#1)(2008-10#1)
supported the development##2##3##(2008-10#1)(2008-11#1)
supported the growth and##2##4##(1995-5#1)(2012-8#1)
supported the hypotheses##2##3##(1996-3#1)(2012-12#1)
supported the hypothesis that##2##4##(2007-12#1)(2008-10#1)
supported the hypothesis##3##3##(2007-12#1)(2008-10#2)
supported the validity of##2##4##(2008-10#1)(2009-12#1)
supported the##54##2##(1990-10#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-12#4)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-8#1)(2013-1#1)
supported their learning##2##3##(2008-11#2)
supported these##2##2##(1990-11#1)(2007-8#1)
supported this##2##2##(2008-10#1)(2010-8#1)
supported to##3##2##(1997-1#1)(2008-4#1)(2012-12#1)
supported via##2##2##(2008-11#1)(2012-3#1)
supported with##4##2##(2006-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
supported##399##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#3)(1994-3#3)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#3)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#10)(2007-4#2)(2007-8#3)(2008-1#4)(2008-10#110)(2008-11#25)(2008-12#8)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#10)(2008-6#6)(2008-7#11)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#7)(2009-2#2)(2009-4#2)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#4)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#9)(2012-8#1)(2013-1#18)(2013-7#1)(2013-8#3)
supporters##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
supporting Sertoli cells##2##3##(2009-10#1)(2010-5#1)
supporting Sertoli##3##2##(2009-10#2)(2010-5#1)
supporting a##11##2##(1990-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
supporting cell##2##2##(1994-5#1)(2008-10#1)
supporting cells##2##2##(1993-9#1)(1994-6#1)
supporting data##2##2##(1991-5#1)(2011-2#1)
supporting electrolyte and oxygen removing agent##2##6##(2008-10#2)
supporting electrolyte and##5##3##(2008-10#5)
supporting electrolyte in the##2##4##(2008-10#2)
supporting electrolyte on the##2##4##(2008-10#2)
supporting electrolyte was##3##3##(2008-10#3)
supporting electrolyte##40##2##(2008-10#40)
supporting electrolytes##7##2##(2008-10#7)
supporting evidence##4##2##(1991-6#1)(1992-10#1)(2008-10#1)(2012-2#1)
supporting growth of##4##3##(1995-11#1)(2008-11#3)
supporting growth##6##2##(1995-11#1)(1995-2#1)(2008-11#4)
supporting health##2##2##(1996-12#1)(2008-12#1)
supporting information##2##2##(1997-3#1)(2008-9#1)
supporting its##4##2##(1994-12#1)(2008-10#1)(2010-10#1)(2010-5#1)
supporting our##5##2##(1996-5#1)(2008-11#2)(2008-3#1)(2012-12#1)
supporting structures##3##2##(1997-1#1)(2012-3#2)
supporting students##2##2##(2008-11#1)(2008-12#1)
supporting that##3##2##(1990-12#1)(2008-5#1)(2012-12#1)
supporting the concept that##2##4##(2008-5#1)(2008-7#1)
supporting the hypothesis of##2##4##(2008-10#2)
supporting the hypothesis that the##3##5##(1995-2#1)(1997-7#1)(2009-3#1)
supporting the hypothesis that##12##4##(1990-5#1)(1991-9#1)(1994-10#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)
supporting the hypothesis##15##3##(1990-5#1)(1991-9#1)(1994-10#1)(1995-2#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)
supporting the importance of##2##4##(2008-9#1)(2010-3#1)
supporting the involvement of##2##4##(2008-7#1)(2011-2#1)
supporting the monophyly of##2##4##(2008-10#1)(2010-3#1)
supporting the notion that##3##4##(2008-11#1)(2010-8#1)(2012-3#1)
supporting the reliability##2##3##(2008-12#1)(2011-2#1)
supporting the role of##4##4##(1995-2#1)(1997-3#1)(2011-2#2)
supporting the use of##5##4##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
supporting the validity of##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
supporting the view that the##4##5##(1990-5#1)(1994-11#1)(1995-5#1)(2008-1#1)
supporting the view that##7##4##(1990-5#1)(1994-11#1)(1995-5#1)(2008-1#1)(2008-4#2)(2012-3#1)
supporting the##93##2##(1990-5#2)(1990-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
supporting their##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
supporting these##4##2##(1994-1#1)(1996-2#1)(2008-5#1)(2013-8#1)
supporting this##4##2##(1991-6#1)(2008-12#1)(2008-2#1)(2011-2#1)
supporting##289##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#3)(1995-6#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-3#2)(1997-7#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#72)(2008-11#21)(2008-12#9)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-8#3)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#7)
supportive acts##2##2##(1992-2#2)
supportive and##2##2##(2008-7#1)(2011-1#1)
supportive cancer therapy##13##3##(2008-7#13)
supportive care and##2##3##(2008-11#1)(2010-9#1)
supportive care in##4##3##(2007-5#1)(2008-7#3)
supportive care##25##2##(1990-2#1)(1991-8#1)(1994-3#1)(2007-5#3)(2008-11#1)(2008-12#1)(2008-7#9)(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#2)
supportive environment##3##2##(2007-7#1)(2008-12#1)(2010-9#1)
supportive evidence for the##2##4##(2008-10#1)(2013-1#1)
supportive evidence for##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
supportive evidence##9##2##(2008-10#2)(2008-11#1)(2008-8#3)(2012-2#1)(2013-1#1)(2013-8#1)
supportive measures##2##2##(2011-2#1)(2013-1#1)
supportive network##2##2##(1997-2#1)(2008-11#1)
supportive of adoption of##2##4##(2010-11#2)
supportive of the##3##3##(2007-7#1)(2008-10#1)(2010-8#1)
supportive of##8##2##(1995-12#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-11#2)(2010-8#1)
supportive oral care##2##3##(2008-7#2)
supportive processes##2##2##(2008-11#1)(2009-4#1)
supportive role##5##2##(1992-3#1)(1996-1#1)(2010-8#1)(2013-1#2)
supportive services##2##2##(1993-12#1)(1996-3#1)
supportive supervision##2##2##(2011-1#1)(2012-12#1)
supportive therapies##2##2##(1995-1#1)(2007-7#1)
supportive therapy##6##2##(1992-10#1)(1994-6#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-3#1)
supportive treatment##3##2##(2009-1#1)(2012-12#1)(2013-8#1)
supportive treatments##2##2##(2010-5#1)(2013-1#1)
supportive##135##1##(1990-2#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#2)(2007-11#1)(2007-4#1)(2007-5#3)(2007-7#4)(2008-10#4)(2008-11#8)(2008-12#4)(2008-4#1)(2008-7#26)(2008-8#4)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#5)(2010-1#2)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#11)(2013-8#2)
supportiveness##2##1##(2008-10#1)(2010-9#1)
supports 48 independent##2##3##(2008-3#2)
supports a role for##3##4##(1991-2#1)(1996-2#1)(1997-1#1)
supports a##16##2##(1990-7#1)(1991-2#1)(1992-10#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-9#1)(2013-1#1)
supports an##3##2##(1991-5#1)(1994-2#1)(1997-6#1)
supports and extends##2##3##(2007-6#1)(2008-7#1)
supports and##8##2##(1996-1#1)(1997-3#1)(1997-4#1)(2007-6#1)(2008-10#2)(2008-7#1)(2010-8#1)
supports at##2##2##(1997-3#1)(2008-7#1)
supports both##3##2##(1995-1#1)(2009-9#1)(2012-1#1)
supports cell##2##2##(1996-12#1)(2008-11#1)
supports for##5##2##(2007-2#1)(2008-10#2)(2008-7#1)(2010-4#1)
supports normal##2##2##(2008-4#1)(2008-5#1)
supports previous##3##2##(1994-2#1)(1997-3#1)(2007-12#1)
supports regular##2##2##(2008-11#1)(2008-9#1)
supports that##5##2##(1993-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
supports the concept of##2##4##(1997-4#1)(2009-5#1)
supports the concept##3##3##(1995-12#1)(1997-4#1)(2009-5#1)
supports the conclusion that##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
supports the fact that##2##4##(1997-4#1)(2011-2#1)
supports the hypothesis of##3##4##(1994-3#1)(2008-10#1)(2012-3#1)
supports the hypothesis that a##2##5##(1993-6#1)(2008-10#1)
supports the hypothesis that the##3##5##(1993-9#1)(1997-1#1)(2008-8#1)
supports the hypothesis that##21##4##(1990-11#1)(1991-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1997-1#1)(1997-2#1)(1997-9#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#2)
supports the hypothesis##24##3##(1990-11#1)(1991-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-2#1)(1997-9#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
supports the idea that##9##4##(1990-11#1)(1990-5#1)(1997-7#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
supports the idea##10##3##(1990-11#1)(1990-5#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
supports the importance of##2##4##(2008-10#1)(2009-8#1)
supports the interpretation##2##3##(1997-9#1)(2009-11#1)
supports the possibility##2##3##(1993-1#1)(2008-10#1)
supports the presence of##2##4##(2008-10#1)(2010-4#1)
supports the recent##2##3##(2008-4#1)(2009-10#1)
supports the recommendation##2##3##(1991-8#1)(2008-3#1)
supports the role of##4##4##(1990-12#1)(2008-3#1)(2008-8#1)(2009-5#1)
supports the theory that##2##4##(1992-4#1)(2008-7#1)
supports the theory##3##3##(1992-4#1)(2008-7#1)(2008-9#1)
supports the use of these##2##5##(2008-3#1)(2008-9#1)
supports the use of##7##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#2)
supports the view that##4##4##(1994-2#1)(2007-11#1)(2008-7#1)(2013-7#1)
supports the view##5##3##(1994-2#1)(1996-5#1)(2007-11#1)(2008-7#1)(2013-7#1)
supports the##118##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-6#2)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-7#1)(1997-9#2)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#13)(2008-11#6)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
supports their##2##2##(1997-6#1)(2008-10#1)
supports these##2##2##(1996-3#1)(2008-2#1)
supports this##3##2##(1991-5#1)(1992-9#1)(2010-10#1)
supports to##2##2##(1996-1#1)(1997-2#1)
supports was##2##2##(2008-10#2)
supports##252##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#6)(1997-6#2)(1997-7#1)(1997-9#2)(2006-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#33)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#2)
suppose that##6##2##(1990-5#1)(1994-6#1)(2008-10#2)(2008-7#1)(2010-8#1)
suppose##7##1##(1990-5#1)(1993-6#1)(1994-6#1)(2008-10#2)(2008-7#1)(2010-8#1)
supposed that##4##2##(1990-11#1)(1997-7#1)(2008-10#2)
supposed to be responsible for##2##5##(1994-10#1)(2008-11#1)
supposed to be##9##3##(1994-10#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
supposed to##20##2##(1990-12#1)(1990-6#1)(1994-10#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
supposed##36##1##(1990-11#1)(1990-12#1)(1990-6#1)(1993-11#1)(1994-10#1)(1994-11#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
supposedly##4##1##(1993-11#1)(1996-3#1)(2008-3#1)(2012-3#1)
supposition##4##1##(1990-8#1)(2008-11#1)(2008-2#1)(2008-9#1)
suppository##3##1##(2012-12#2)(2012-3#1)
suppress PTGS##2##2##(2008-10#2)
suppress ascospore germination##2##3##(2008-10#2)
suppress colorectal##2##2##(2007-4#1)(2008-12#1)
suppress foliar##2##2##(2008-10#2)
suppress in##2##2##(1990-12#1)(1990-6#1)
suppress noise##2##2##(2008-2#1)(2010-2#1)
suppress or##7##2##(1991-9#1)(1993-6#1)(2006-10#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
suppress populations of##2##3##(2008-10#2)
suppress populations##3##2##(2008-10#3)
suppress proliferation##2##2##(1992-3#1)(2012-12#1)
suppress the growth of##4##4##(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
suppress the internalization of ADH-I##2##5##(2008-11#2)
suppress the severity of##2##4##(2008-10#2)
suppress the##44##2##(1990-11#1)(1990-2#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-4#1)(2007-11#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-7#1)(2012-3#1)
suppress this##2##2##(1993-8#1)(2011-1#1)
suppress##164##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#49)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#3)(2010-2#1)(2010-7#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
suppressant##4##1##(2008-10#1)(2008-6#2)(2012-2#1)
suppressants##7##1##(1996-12#3)(2008-2#2)(2012-2#1)(2012-3#1)
suppressed Fusarium wilt##2##3##(2008-10#2)
suppressed P##2##2##(2008-10#2)
suppressed Pythium##2##2##(2008-10#2)
suppressed and the##2##3##(1994-12#1)(2008-5#1)
suppressed and##6##2##(1994-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#2)
suppressed at##3##2##(2008-10#2)(2008-11#1)
suppressed below##2##2##(2007-11#1)(2009-5#1)
suppressed both the##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
suppressed both##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
suppressed by a##4##3##(1993-8#1)(1994-8#1)(1995-11#1)(2012-3#1)
suppressed by an##2##3##(2007-11#1)(2011-2#1)
suppressed by high##2##3##(1994-3#1)(2008-10#1)
suppressed by the addition of##3##5##(1997-2#1)(2008-10#2)
suppressed by the simultaneous##2##4##(1992-6#1)(2007-12#1)
suppressed by the##13##3##(1990-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
suppressed by use of##2##4##(2007-11#1)(2007-12#1)
suppressed by##56##2##(1990-11#1)(1990-2#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#4)(2007-12#3)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
suppressed conductivity##3##2##(1994-9#1)(2008-10#2)
suppressed damping-off##2##2##(2008-10#2)
suppressed disease##4##2##(2008-10#3)(2012-2#1)
suppressed due to##2##3##(1993-12#1)(2008-8#1)
suppressed during##3##2##(1993-12#1)(2009-10#1)(2013-8#1)
suppressed either by##2##3##(1993-3#1)(1997-2#1)
suppressed growth of##3##3##(2008-10#2)(2008-11#1)
suppressed in all##3##3##(2008-10#2)(2011-2#1)
suppressed in lactating mothers##2##4##(2011-2#2)
suppressed in the##5##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
suppressed in##22##2##(1993-12#1)(1993-9#1)(1994-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#3)(2013-8#1)
suppressed induction##2##2##(1992-8#1)(2007-11#1)
suppressed mycelial##2##2##(2008-10#2)
suppressed numbers of##2##3##(2008-10#1)(2008-5#1)
suppressed only##2##2##(1994-2#1)(2008-10#1)
suppressed protein synthesis##2##3##(1994-8#2)
suppressed protein##3##2##(1994-8#2)(2008-10#1)
suppressed secondary axis formation##2##4##(2008-6#2)
suppressed spontaneous##2##2##(1993-5#1)(2011-2#1)
suppressed the development of##2##4##(1994-2#1)(2008-10#1)
suppressed the disease##3##3##(2008-10#3)
suppressed the generation of androstenone##2##5##(2008-5#2)
suppressed the generation of##3##4##(2008-5#2)(2012-12#1)
suppressed the invasion of##2##4##(2008-11#2)
suppressed the uptake of Pb by##2##6##(2008-10#2)
suppressed the uptake of##3##4##(2008-10#3)
suppressed the##55##2##(1990-12#1)(1991-5#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(2008-10#15)(2008-11#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
suppressed weight loss associated with##2##5##(2008-5#2)
suppressed when a##2##3##(2007-12#1)(2008-10#1)
suppressed when##8##2##(1992-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
suppressed##333##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#4)(1993-11#2)(1993-12#6)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-6#2)(1994-8#8)(1994-9#1)(1995-11#6)(1995-12#7)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#4)(1996-5#4)(1996-6#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-6#3)(1997-7#1)(2007-11#10)(2007-12#10)(2007-7#1)(2008-1#1)(2008-10#87)(2008-11#34)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#3)
suppresses and delays the##2##4##(1994-8#2)
suppresses any##2##2##(2008-2#1)(2008-3#1)
suppresses both##2##2##(1991-9#1)(2007-12#1)
suppresses the growth of##2##4##(2008-7#1)(2012-3#1)
suppresses the##19##2##(1990-3#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
suppresses tumor##2##2##(2011-2#1)(2013-1#1)
suppresses##68##1##(1990-3#1)(1991-1#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#3)(1995-6#1)(1997-1#2)(1997-2#3)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
suppressing cell growth##2##3##(2008-11#2)
suppressing cell##3##2##(2008-11#2)(2013-1#1)
suppressing gastric##2##2##(1994-2#1)(2008-5#1)
suppressing the expression of##2##4##(2008-4#1)(2008-8#1)
suppressing the growth of##2##4##(2008-10#1)(2008-5#1)
suppressing the##25##2##(1990-2#1)(1994-2#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2013-1#1)(2013-8#1)
suppressing##73##1##(1990-2#1)(1991-1#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-8#2)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-6#1)(2007-7#1)(2008-10#18)(2008-11#8)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#3)(2010-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
suppression (&gt##2##2##(2007-12#1)(2008-10#1)
suppression and##18##2##(1993-12#1)(1994-8#1)(1995-2#2)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#2)(2009-5#1)(2011-2#1)(2012-3#1)
suppression at##7##2##(1995-6#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-8#1)
suppression by a##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
suppression by the##3##3##(2008-10#3)
suppression by##25##2##(1992-12#1)(1993-8#1)(1997-1#1)(1997-6#1)(2007-12#3)(2008-10#11)(2008-11#1)(2008-2#2)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
suppression can be##2##3##(2007-12#1)(2008-4#1)
suppression due to##2##3##(1995-8#1)(2007-12#1)
suppression effect of##2##3##(2008-10#2)
suppression have been##2##3##(2009-11#1)(2013-8#1)
suppression have##3##2##(2008-10#1)(2009-11#1)(2013-8#1)
suppression in a##3##3##(2007-12#2)(2008-10#1)
suppression in##26##2##(1993-5#1)(1994-8#1)(1995-3#2)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
suppression induced by##2##3##(1991-8#1)(2011-2#1)
suppression is##10##2##(1995-3#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-4#1)(2011-1#1)
suppression may be##2##3##(2007-11#1)(2008-8#1)
suppression occurred##2##2##(1995-2#1)(2008-10#1)
suppression occurs##2##2##(1995-3#1)(2008-10#1)
suppression of Botrytis cinerea##6##4##(2008-10#6)
suppression of Fusarium crown and root rot of asparagus##2##9##(2008-10#2)
suppression of Fusarium wilt of flax##2##6##(2008-10#2)
suppression of Fusarium wilt##4##4##(2008-10#4)
suppression of Fusarium##6##3##(2008-10#6)
suppression of I(gaba)##2##3##(2008-8#2)
suppression of LOH in##2##4##(2011-1#2)
suppression of a##2##3##(2008-10#1)(2008-11#1)
suppression of both##2##3##(2008-10#1)(2010-1#1)
suppression of cell##5##3##(2008-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
suppression of colony formation##2##4##(1990-12#1)(2012-12#1)
suppression of damping-off##3##3##(2008-10#3)
suppression of disease##4##3##(1997-8#1)(2008-10#3)
suppression of dollar spot by##2##5##(2008-10#2)
suppression of dollar spot##3##4##(2008-10#3)
suppression of fire blight##2##4##(2008-10#2)
suppression of growth##3##3##(1992-10#1)(2008-10#1)(2008-8#1)
suppression of hepatitis B virus##2##5##(2008-8#2)
suppression of maturation##2##3##(2008-5#2)
suppression of plant pathogens##4##4##(2008-10#4)
suppression of plant##5##3##(2008-10#5)
suppression of plasmin##2##3##(2011-2#2)
suppression of rbcS-m3 expression in MC##2##6##(1994-8#2)
suppression of soilborne##2##3##(2008-10#2)
suppression of stimulated##2##3##(2007-11#1)(2008-3#1)
suppression of the JNK pathway##2##5##(2008-1#2)
suppression of the antibody response##2##5##(2008-10#2)
suppression of the##35##3##(1993-11#1)(1993-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-2#3)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-11#1)(2013-1#1)
suppression of their##3##3##(1990-11#1)(2008-11#1)(2008-4#1)
suppression of this##2##3##(2008-10#1)(2008-11#1)
suppression of##251##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#6)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#5)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#7)(2008-1#5)(2008-10#83)(2008-11#15)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#4)(2009-2#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#4)(2013-7#1)
suppression on##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
suppression only##2##2##(2008-10#2)
suppression or enhancement##2##3##(2008-10#1)(2010-11#1)
suppression or##3##2##(2008-10#1)(2008-11#1)(2010-11#1)
suppression subtractive hybridization##3##3##(2008-11#1)(2008-7#1)(2010-4#1)
suppression to##2##2##(2008-11#1)(2012-12#1)
suppression using##3##2##(2008-10#3)
suppression was not##2##3##(2008-10#1)(2010-11#1)
suppression was##21##2##(1993-5#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-3#1)(2009-11#1)(2010-11#1)(2013-1#1)
suppression were##2##2##(2008-10#2)
suppression with##3##2##(1994-2#1)(2008-10#2)
suppression##521##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#11)(1993-2#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#5)(1994-6#4)(1994-8#6)(1994-9#4)(1995-11#3)(1995-12#4)(1995-2#11)(1995-3#8)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#3)(1997-1#3)(1997-2#5)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#15)(2007-12#22)(2007-2#1)(2008-1#5)(2008-10#178)(2008-11#26)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#9)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#13)(2008-9#8)(2009-10#1)(2009-11#9)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#4)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#9)(2011-2#20)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#1)
suppressive and##2##2##(2008-10#2)
suppressive effect of##6##3##(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2012-12#1)
suppressive effect on##5##3##(1992-5#1)(1994-2#1)(1996-5#1)(2008-11#1)(2009-8#1)
suppressive effect##13##2##(1992-5#1)(1994-2#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
suppressive effects of##5##3##(1994-10#1)(1996-5#1)(2008-10#2)(2008-5#1)
suppressive effects##8##2##(1994-10#1)(1996-5#2)(2008-10#3)(2008-5#1)(2013-8#1)
suppressive or conducive##2##3##(2008-10#2)
suppressive or##3##2##(2008-10#3)
suppressive soil and##2##3##(2008-10#2)
suppressive soil had##3##3##(2008-10#3)
suppressive soil##13##2##(2008-10#13)
suppressive soils##3##2##(2008-10#3)
suppressive to##9##2##(2008-10#9)
suppressive##78##1##(1992-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1996-5#3)(2008-10#49)(2008-11#3)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
suppressiveness against##3##2##(2008-10#3)
suppressiveness in the different##2##4##(2008-10#2)
suppressiveness in##3##2##(2008-10#3)
suppressiveness of soils to##2##4##(2008-10#2)
suppressiveness of soils##4##3##(2008-10#4)
suppressiveness of the##2##3##(2008-10#2)
suppressiveness of##10##2##(2008-10#10)
suppressiveness to##3##2##(2008-10#3)
suppressiveness##33##1##(2008-10#33)
suppressor activity of##2##3##(1995-2#1)(2008-10#1)
suppressor activity##6##2##(1993-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2009-5#1)
suppressor cells##5##2##(1991-6#2)(2008-9#1)(2011-2#1)(2013-1#1)
suppressor function of##2##3##(1991-5#1)(2009-4#1)
suppressor function##4##2##(1991-5#2)(2008-6#1)(2009-4#1)
suppressor gene in##3##3##(1992-3#1)(2007-5#1)(2008-10#1)
suppressor gene is##2##3##(1997-9#1)(2009-5#1)
suppressor gene of the##3##4##(1995-6#2)(1997-8#1)
suppressor gene##37##2##(1990-12#1)(1991-10#1)(1992-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-6#1)(1997-7#1)(1997-8#1)(1997-9#2)(2007-5#1)(2008-10#2)(2008-6#1)(2008-9#4)(2009-5#2)(2009-9#2)(2010-3#1)(2011-2#6)(2012-2#1)(2013-1#2)
suppressor genes in##3##3##(1990-12#1)(2008-7#2)
suppressor genes##24##2##(1990-12#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#1)(2011-2#6)(2013-1#2)(2013-8#2)
suppressor macrophages##2##2##(2008-8#2)
suppressor of##8##2##(1994-10#1)(1995-6#2)(1995-8#2)(2008-10#2)(2012-12#1)
suppressor p53##4##2##(1991-11#1)(2007-8#1)(2009-7#1)(2011-2#1)
suppressor proteins##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
suppressor##132##1##(1990-12#2)(1991-10#1)(1991-11#1)(1991-5#2)(1991-6#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-6#9)(1995-8#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#3)(1997-9#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#9)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#4)(2010-3#2)(2011-1#2)(2011-2#18)(2012-12#2)(2012-2#3)(2013-1#8)(2013-8#3)
suppressors of##5##2##(1993-6#1)(2008-8#1)(2011-2#1)(2012-3#2)
suppressors##12##1##(1990-5#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-3#3)(2011-2#1)(2012-3#2)
suppuration##3##1##(2008-7#1)(2011-2#1)(2013-1#1)
suppurations##2##1##(2011-2#2)
suppurative hidradenitis##2##2##(1992-6#1)(1993-8#1)
suppurative infection##2##2##(2007-12#1)(2010-12#1)
suppurative inflammation##4##2##(2008-9#4)
suppurative otitis media##4##3##(2008-9#4)
suppurative##22##1##(1991-8#2)(1992-6#1)(1993-8#1)(1994-12#4)(1996-3#1)(1997-1#1)(2007-12#1)(2008-12#1)(2008-9#8)(2010-12#1)(2013-8#1)
supra##4##1##(2007-7#1)(2007-8#1)(2011-1#2)
supra- and##4##2##(2008-7#3)(2013-1#1)
supra-annual##2##1##(2008-9#2)
supra-linear##2##1##(2008-7#2)
supracardinal##2##1##(2008-7#1)(2010-11#1)
supracervical (subtotal) hysterectomy (LASH)##2##4##(1994-2#2)
supracervical##3##1##(1994-2#3)
suprachiasmatic nuclei##2##2##(1993-12#1)(1994-2#1)
suprachiasmatic nucleus (SCN)##3##3##(1993-12#1)(1993-9#1)(1994-5#1)
suprachiasmatic nucleus##6##2##(1993-12#3)(1993-9#1)(1994-5#1)(1997-6#1)
suprachiasmatic##9##1##(1993-12#4)(1993-9#2)(1994-2#1)(1994-5#1)(1997-6#1)
supraclavicular lymph nodes##3##3##(1990-8#1)(1997-8#2)
supraclavicular##9##1##(1990-8#1)(1994-12#1)(1997-8#2)(2008-7#2)(2011-2#1)(2012-2#2)
supraconducive temperatures##2##2##(2008-10#2)
supraconducive##4##1##(2008-10#4)
supracondylar fracture##2##2##(2010-11#1)(2013-1#1)
supracondylar fractures##2##2##(2008-7#1)(2013-1#1)
supracondylar humerus fractures in children##3##5##(2009-3#2)(2013-1#1)
supracondylar humerus fractures in##4##4##(2009-3#2)(2013-1#2)
supracondylar humerus fractures##5##3##(2009-3#3)(2013-1#2)
supracondylar##10##1##(2008-7#1)(2009-3#4)(2010-11#1)(2013-1#4)
supraglottic##2##1##(2010-7#1)(2013-8#1)
supragranular##2##1##(1993-12#1)(1995-12#1)
supramaximal inhibition##3##2##(1992-8#3)
supramaximal##9##1##(1992-8#3)(1993-12#2)(2013-8#4)
suprameatal approach##3##2##(2008-9#2)(2011-2#1)
supramolecular catalytic kinetic##2##3##(2008-10#2)
supramolecular chemistry##2##2##(2006-12#1)(2008-8#1)
supramolecular complex##4##2##(2008-10#1)(2009-10#3)
supramolecular liquid crystals##2##3##(2008-7#2)
supramolecular metallacycles and metallacages##2##4##(2009-12#2)
supramolecular structures that##2##3##(1993-12#1)(2010-12#1)
supramolecular structures##3##2##(1993-12#1)(2008-8#1)(2010-12#1)
supramolecular system of##2##3##(2008-10#2)
supramolecular system##4##2##(2008-10#4)
supramolecular##37##1##(1993-12#1)(1993-8#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#16)(2008-7#3)(2008-8#3)(2009-10#3)(2009-12#3)(2010-12#2)(2012-1#1)(2012-2#1)
supranuclear palsy (PSP)##2##3##(1992-8#1)(2012-12#1)
supranuclear palsy##5##2##(1992-8#2)(2008-7#1)(2012-12#2)
supranuclear##6##1##(1992-8#2)(2007-10#1)(2008-7#1)(2012-12#2)
supraoptic and##2##2##(1993-12#2)
supraoptic nucleus (SON)##2##3##(1995-12#1)(2008-8#1)
supraoptic nucleus##6##2##(1990-5#1)(1993-12#2)(1994-8#1)(1995-12#1)(2008-8#1)
supraoptic##13##1##(1990-5#1)(1993-12#5)(1994-8#1)(1995-12#2)(1996-12#2)(2008-7#1)(2008-8#1)
supraorbital##2##1##(2006-12#1)(2011-2#1)
suprapubic pain##2##2##(2008-7#1)(2012-2#1)
suprapubic##8##1##(1994-9#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
suprarenal##5##1##(1991-6#1)(2007-7#2)(2008-7#1)(2010-12#1)
suprasellar extension##2##2##(1993-2#1)(2011-2#1)
suprasellar variant superior##2##3##(2012-3#2)
suprasellar##5##1##(1993-2#1)(2011-2#1)(2012-3#3)
supraspinal##3##1##(1991-1#1)(1997-2#2)
supratentorial infarction##4##2##(2006-7#1)(2012-3#3)
supratentorial primitive neuroectodermal tumor with glioblastomatous differentiation##2##7##(2009-1#2)
supratentorial primitive neuroectodermal tumor with##3##5##(2009-1#3)
supratentorial##17##1##(1996-6#1)(2006-7#2)(2007-9#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#3)(2012-12#2)(2012-3#3)
suprathreshold 0##2##2##(2011-2#2)
suprathreshold tests##3##2##(2008-9#3)
suprathreshold##5##1##(2008-9#3)(2011-2#2)
supraventricular extrasystoles##3##2##(1996-6#3)
supraventricular tachycardia##5##2##(1993-2#2)(2008-7#2)(2012-3#1)
supraventricular##15##1##(1991-11#1)(1993-2#2)(1995-2#1)(1996-6#5)(2008-7#2)(2010-11#1)(2010-5#1)(2012-1#1)(2012-3#1)
supravesical hernia##2##2##(2008-12#2)
supravesical##3##1##(2008-12#2)(2011-2#1)
supreme##2##1##(1996-1#1)(2008-4#1)
sur le##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
sur les données de##2##4##(2013-1#2)
sur les##5##2##(2008-5#1)(2009-4#1)(2013-1#3)
sur##14##1##(2008-11#1)(2008-5#1)(2009-4#2)(2011-2#4)(2013-1#6)
sural nerve##2##2##(1995-12#1)(2011-2#1)
sural##3##1##(1995-12#1)(2010-11#1)(2011-2#1)
suramin and##2##2##(1995-11#1)(2008-11#1)
suramin##5##1##(1991-2#1)(1993-8#1)(1995-11#1)(2008-11#1)(2008-4#1)
sure that the##6##3##(1993-1#2)(1995-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
sure that##11##2##(1993-1#3)(1993-3#2)(1995-9#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
sure to##2##2##(1994-2#1)(2006-10#1)
sure##25##1##(1990-8#1)(1993-1#3)(1993-3#2)(1994-2#1)(1994-6#1)(1995-6#1)(1995-9#1)(2006-10#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
surely##8##1##(1991-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-6#1)
surf clam##3##2##(1992-11#3)
surface (0##3##2##(2008-10#3)
surface EMG recording in##3##4##(2011-2#3)
surface EMG recording##4##3##(2011-2#4)
surface EMG##7##2##(1990-6#1)(2011-2#4)(2012-2#2)
surface FcepsilonRI expression was##3##4##(2008-11#3)
surface FcepsilonRI expression##4##3##(2008-11#4)
surface H and##2##3##(2008-10#2)
surface acoustic wave (SAW) devices##3##5##(2008-10#3)
surface acoustic wave (SAW)##6##4##(2007-12#1)(2008-10#4)(2008-3#1)
surface acoustic wave devices##2##4##(2007-12#1)(2008-10#1)
surface acoustic wave##12##3##(2007-11#1)(2007-12#3)(2008-10#6)(2008-3#1)(2009-5#1)
surface acoustic waves##6##3##(2007-11#2)(2008-10#1)(2008-3#3)
surface acoustic##18##2##(2007-11#3)(2007-12#3)(2008-10#7)(2008-3#4)(2009-5#1)
surface active##5##2##(2008-10#5)
surface activity reduction due to##2##5##(2008-10#2)
surface activity##9##2##(1994-5#2)(2008-10#6)(2008-5#1)
surface adsorption##2##2##(2008-10#2)
surface after##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
surface albedo on##2##3##(2008-2#2)
surface albedo##5##2##(2008-2#4)(2008-3#1)
surface allows the##2##3##(2008-10#2)
surface allows##4##2##(1992-5#1)(2008-10#3)
surface alloying at the##2##4##(2009-11#2)
surface alloying##4##2##(2009-11#4)
surface analysis##3##2##(1995-6#1)(2008-10#1)(2009-11#1)
surface and a##5##3##(1990-12#1)(1992-6#1)(1995-2#1)(2008-2#1)(2008-3#1)
surface and an##2##3##(2008-10#1)(2008-3#1)
surface and are##2##3##(2008-1#1)(2008-3#1)
surface and in the##2##4##(1992-11#1)(2008-10#1)
surface and in##4##3##(1992-11#1)(2008-10#2)(2008-3#1)
surface and intracellular antigens##3##4##(1990-12#2)(2008-9#1)
surface and intracellular##5##3##(1990-12#2)(2008-4#1)(2008-9#2)
surface and is##2##3##(1991-12#1)(2008-3#1)
surface and middle of##2##4##(2008-9#2)
surface and of##2##3##(1996-12#1)(2013-1#1)
surface and the##12##3##(2008-10#4)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2011-1#1)
surface and then##2##3##(2008-1#1)(2008-7#1)
surface and to##4##3##(2008-1#1)(2008-10#2)(2008-5#1)
surface and was##2##3##(2008-10#2)
surface and wastewaters##3##3##(2008-10#3)
surface and##116##2##(1990-12#3)(1990-5#1)(1991-12#2)(1992-11#2)(1992-5#1)(1992-6#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#33)(2008-11#2)(2008-2#5)(2008-3#20)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#8)(2009-3#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
surface antigen (HBsAg) and##2##4##(2008-8#1)(2012-3#1)
surface antigen (HBsAg)##11##3##(1994-11#1)(1995-2#1)(1997-4#2)(1997-6#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
surface antigen expression##2##3##(1996-9#1)(2008-10#1)
surface antigen##37##2##(1994-11#2)(1994-5#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-4#4)(1997-6#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
surface antigens that are##2##4##(1995-6#1)(2008-4#1)
surface antigens##12##2##(1995-6#1)(2008-10#2)(2008-4#4)(2008-8#1)(2008-9#4)
surface appearance##2##2##(2008-5#1)(2010-6#1)
surface are discussed##2##3##(2008-3#2)
surface are##12##2##(2007-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)
surface area and##10##3##(2008-10#2)(2008-6#1)(2008-7#3)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
surface area as##3##3##(1992-5#1)(2007-12#1)(2010-10#1)
surface area by##2##3##(2008-10#1)(2013-1#1)
surface area from##2##3##(2008-10#1)(2008-11#1)
surface area in##5##3##(2008-11#2)(2010-10#1)(2010-4#1)(2013-1#1)
surface area of 3##2##4##(2013-1#2)
surface area of the##7##4##(1994-5#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
surface area of##21##3##(1993-12#1)(1994-5#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-10#5)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#3)
surface area than##2##3##(2008-11#1)(2012-12#1)
surface area to the##2##4##(1992-5#1)(2008-10#1)
surface area to##3##3##(1992-5#1)(2008-10#1)(2008-11#1)
surface area was##3##3##(2008-10#2)(2009-11#1)
surface area##113##2##(1990-6#1)(1990-8#2)(1992-5#4)(1993-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#25)(2008-11#7)(2008-2#1)(2008-3#8)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)
surface areas of##4##3##(1995-5#1)(1996-12#1)(2008-3#1)(2013-1#1)
surface areas##15##2##(1990-8#1)(1995-5#1)(1996-12#1)(1997-2#2)(2008-10#5)(2008-3#2)(2010-10#1)(2010-4#1)(2013-1#1)
surface as a function of##2##5##(2008-11#1)(2008-3#1)
surface as a##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
surface as##10##2##(1994-11#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
surface associated with##2##3##(2008-2#1)(2008-5#1)
surface associated##3##2##(1996-12#1)(2008-2#1)(2008-5#1)
surface at a##2##3##(2008-7#1)(2012-3#1)
surface at the##3##3##(2008-3#2)(2008-7#1)
surface at##14##2##(1992-6#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-7#2)(2012-3#1)
surface attachment##3##2##(2008-10#2)(2008-11#1)
surface before##2##2##(2008-6#1)(2008-7#1)
surface between the##3##3##(2008-3#1)(2008-8#1)(2009-4#1)
surface between##4##2##(2008-3#1)(2008-8#1)(2009-4#1)(2013-1#1)
surface binding##4##2##(1990-12#1)(1997-1#1)(2008-10#1)(2008-12#1)
surface but##2##2##(1996-2#1)(2009-9#1)
surface by a##2##3##(1990-2#1)(2008-5#1)
surface by an##2##3##(2008-10#1)(2008-3#1)
surface by the##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
surface by using##2##3##(2008-10#1)(2008-3#1)
surface by##29##2##(1990-11#1)(1990-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#6)(2008-5#2)(2010-12#1)(2012-3#1)
surface can be##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
surface can##7##2##(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2011-1#1)
surface cells##2##2##(2008-5#1)(2008-7#1)
surface characteristics of the##5##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
surface characteristics of##8##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
surface characteristics##13##2##(1992-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-8#1)
surface charge and##2##3##(1994-5#1)(2008-10#1)
surface charge density and the##2##5##(2008-5#2)
surface charge density of##2##4##(2008-4#1)(2008-8#1)
surface charge density##9##3##(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-8#2)
surface charge development##2##3##(2008-10#2)
surface charge of##2##3##(1994-3#1)(2013-1#1)
surface charge##28##2##(1994-3#1)(1994-5#2)(1997-2#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-8#3)(2010-6#2)(2013-1#1)
surface chemistry##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
surface class I##2##3##(2008-4#2)
surface coating##4##2##(2008-10#1)(2008-3#2)(2010-6#1)
surface coatings##2##2##(2009-11#1)(2010-4#1)
surface coil##2##2##(1992-3#2)
surface coils##3##2##(1990-10#1)(1997-8#2)
surface complexes##3##2##(2008-10#1)(2013-1#2)
surface components##4##2##(1991-12#3)(2008-10#1)
surface concentration of##3##3##(1991-8#1)(2008-10#1)(2008-9#1)
surface concentration##6##2##(1991-8#1)(2008-10#3)(2008-9#1)(2009-12#1)
surface contact##2##2##(1997-6#1)(2008-6#1)
surface contamination##4##2##(2008-10#3)(2008-3#1)
surface contours##2##2##(2008-3#1)(2008-8#1)
surface cooling in##2##3##(1994-5#1)(2007-10#1)
surface could be##2##3##(2008-10#2)
surface coverage of##3##3##(1997-2#1)(2008-10#2)
surface coverage##10##2##(1997-2#1)(2008-10#9)
surface covered##2##2##(1995-2#1)(2008-10#1)
surface damage##4##2##(2008-3#4)
surface damages##2##2##(1990-10#1)(2008-3#1)
surface defects##4##2##(2008-3#4)
surface definition##2##2##(2008-3#2)
surface deformation##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
surface deformations##3##2##(2008-3#1)(2008-6#1)(2009-7#1)
surface densities##6##2##(1997-2#3)(2009-10#3)
surface density of##2##3##(1994-9#1)(2008-9#1)
surface details##2##2##(2008-3#2)
surface displacement##3##2##(2007-12#2)(2012-2#1)
surface does not##2##3##(2008-10#1)(2008-11#1)
surface doses##2##2##(2008-3#2)
surface drip system##2##3##(2008-10#2)
surface due to##2##3##(1996-4#1)(2008-10#1)
surface during the##2##3##(2008-10#1)(2008-5#1)
surface during##8##2##(1992-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-12#1)
surface ectoderm and##2##3##(1994-12#2)
surface effects##2##2##(2008-2#1)(2008-3#1)
surface elasticity##2##2##(1994-3#1)(2008-10#1)
surface electrodes##6##2##(2008-2#1)(2012-2#5)
surface electromyography and##2##3##(1990-6#1)(2008-6#1)
surface electromyography can be used as a tool to##2##9##(2010-6#2)
surface electromyography##7##2##(1990-6#1)(2008-6#1)(2009-6#1)(2010-6#4)
surface emission##2##2##(2008-3#2)
surface emissivity in##2##3##(2008-3#1)(2013-8#1)
surface emissivity##4##2##(2008-3#1)(2013-8#3)
surface energy##5##2##(1997-2#1)(2007-8#1)(2009-11#2)(2010-4#1)
surface enhanced Raman scattering of##2##5##(2013-8#2)
surface enhanced Raman scattering##3##4##(2013-8#3)
surface enhanced resonance Raman scattering (SERRS)##2##6##(2008-10#2)
surface enhanced resonance Raman scattering##3##5##(2008-10#3)
surface enhanced##8##2##(2008-10#4)(2011-2#1)(2013-8#3)
surface epithelium##5##2##(1994-9#1)(1995-12#1)(1997-1#1)(2011-2#2)
surface excess##2##2##(2008-10#2)
surface exhibited a##2##3##(2007-11#1)(2008-10#1)
surface exposed##2##2##(1990-11#1)(2013-1#1)
surface expression in##2##3##(1993-8#1)(2008-4#1)
surface expression of FcepsilonRI##4##4##(2008-11#4)
surface expression of HLA class I##2##6##(1994-5#1)(1997-9#1)
surface expression of the##2##4##(1992-9#1)(2008-11#1)
surface expression of##17##3##(1992-8#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-6#2)(1995-2#3)(1997-9#1)(2008-11#5)(2008-4#1)(2008-9#1)
surface expression##23##2##(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#2)(1995-2#4)(1997-9#1)(2008-10#1)(2008-11#5)(2008-4#4)(2008-9#1)
surface feature##2##2##(2009-11#2)
surface features of##2##3##(2008-3#1)(2009-11#1)
surface features##8##2##(2007-11#2)(2008-3#2)(2009-11#4)
surface figure is##2##3##(2008-3#2)
surface figure##3##2##(2008-3#3)
surface film##2##2##(2011-2#1)(2013-1#1)
surface flatness##2##2##(2008-2#1)(2008-3#1)
surface fluorescence##3##2##(2008-10#2)(2013-8#1)
surface followed by##3##3##(1997-8#1)(2008-10#2)
surface for the##7##3##(1995-2#1)(2008-10#3)(2008-3#1)(2009-5#1)(2012-3#1)
surface for##15##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-3#2)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
surface forces##2##2##(1997-2#1)(2008-10#1)
surface fouling##2##2##(2008-10#1)(2010-5#1)
surface free energy##2##3##(2008-5#1)(2009-11#1)
surface from##10##2##(1992-5#2)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)
surface functional groups##2##3##(2008-10#1)(2009-7#1)
surface functionalization##3##2##(2010-2#1)(2010-5#2)
surface glycoprotein##6##2##(1992-6#1)(1993-11#1)(1996-12#1)(2011-2#1)(2013-1#2)
surface glycoproteins##3##2##(1994-5#1)(1997-4#1)(2008-9#1)
surface grafted chromophores##2##3##(2008-5#2)
surface grafted##3##2##(2008-5#2)(2010-6#1)
surface gratings##2##2##(2008-3#2)
surface grown cultures of##2##4##(2008-7#2)
surface had##2##2##(1991-11#1)(2008-10#1)
surface has been##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
surface has##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#1)(2013-1#1)
surface have##2##2##(2008-10#1)(2008-3#1)
surface height##6##2##(1995-1#4)(2008-3#2)
surface hydrophobicity##4##2##(1996-12#2)(2008-10#1)(2010-4#1)
surface immunoglobulin##3##2##(1991-2#1)(1994-3#1)(2008-4#1)
surface in a##3##3##(2007-11#1)(2008-10#2)
surface in the##8##3##(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-4#1)
surface in##25##2##(1990-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
surface induces##2##2##(2007-11#1)(2008-10#1)
surface integrals is##2##3##(2008-3#2)
surface integration##3##2##(2008-3#3)
surface interactions##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
surface into##2##2##(2009-12#1)(2011-2#1)
surface irregularities##3##2##(2008-10#1)(2008-2#2)
surface is calculated##2##3##(2008-2#2)
surface is covered##2##3##(2007-12#1)(2008-10#1)
surface is described##4##3##(2008-3#2)(2008-4#1)(2008-5#1)
surface is presented##3##3##(2007-11#1)(2008-10#2)
surface is the##2##3##(2008-5#2)
surface is##50##2##(1990-6#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-5#1)(2007-11#2)(2007-12#4)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#5)(2009-11#1)(2009-6#1)(2010-10#1)(2010-4#1)
surface labeling##2##2##(1994-11#1)(1997-4#1)
surface layer of##2##3##(1994-3#1)(2008-10#1)
surface layer##9##2##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2013-8#1)
surface layers##7##2##(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-2#2)
surface lipids##2##2##(2008-5#2)
surface makes##2##2##(1992-5#1)(2008-10#1)
surface mapping##4##2##(2008-10#2)(2008-3#2)
surface marker##4##2##(2008-11#2)(2011-2#1)(2012-4#1)
surface markers has##2##3##(2008-9#1)(2013-1#1)
surface markers##10##2##(1992-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#3)(2010-12#1)(2011-2#1)(2013-1#1)
surface mastoidotomy##2##2##(2008-7#2)
surface materials on marble##2##4##(2008-10#2)
surface materials##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
surface may##3##2##(1996-4#1)(2008-2#1)(2008-3#1)
surface measured by##2##3##(2008-2#1)(2008-3#1)
surface measurement##2##2##(2008-2#1)(2008-3#1)
surface measurements of##2##3##(2008-2#2)
surface measurements with##2##3##(2008-3#2)
surface measurements##6##2##(2008-2#2)(2008-3#4)
surface methodology (RSM)##2##3##(2008-10#1)(2008-6#1)
surface methodology##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
surface metrology##4##2##(2008-3#4)
surface models##2##2##(1994-11#1)(2008-10#1)
surface modification##12##2##(2008-10#9)(2010-3#2)(2012-2#1)
surface modified##3##2##(2008-10#2)(2013-8#1)
surface molecules such as##2##4##(1995-2#1)(2008-4#1)
surface molecules##10##2##(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#1)(2011-1#1)
surface morphologies##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
surface morphology of##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
surface morphology##12##2##(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-4#1)(2010-5#1)(2013-8#1)
surface mucous cells##2##3##(1993-11#1)(1995-2#1)
surface normal##2##2##(2008-3#2)
surface not only##2##3##(2007-12#1)(2008-10#1)
surface occurs##2##2##(2008-10#1)(2008-7#1)
surface of CCPE##3##3##(2008-10#3)
surface of a glass plate##2##5##(2008-2#2)
surface of a glass##3##4##(1991-5#1)(2008-2#2)
surface of a lens##2##4##(2008-2#1)(2008-3#1)
surface of a metal##2##4##(2008-2#1)(2008-7#1)
surface of a quartz crystal##2##5##(2008-10#2)
surface of a thin##3##4##(2008-2#2)(2008-3#1)
surface of a##57##3##(1990-12#1)(1990-5#1)(1991-5#1)(2007-11#1)(2007-12#3)(2008-10#21)(2008-11#1)(2008-2#10)(2008-3#7)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
surface of an##10##3##(2007-12#2)(2008-10#4)(2008-3#3)(2010-5#1)
surface of cultured##2##3##(1990-7#1)(2008-11#1)
surface of each##2##3##(2007-12#1)(2008-10#1)
surface of inoculated##2##3##(2008-10#2)
surface of target cells##4##4##(2006-10#1)(2010-10#1)(2011-1#1)(2012-2#1)
surface of the chorion##2##4##(2008-12#2)
surface of the dish##2##4##(2011-2#2)
surface of the electrode##6##4##(2008-10#6)
surface of the gap##2##4##(2008-3#2)
surface of the glass##2##4##(2007-12#2)
surface of the plasma membrane##2##5##(1992-12#1)(2008-1#1)
surface of the sample##3##4##(2008-10#2)(2008-3#1)
surface of the tibial##2##4##(2008-8#1)(2008-9#1)
surface of the##181##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-9#1)(1994-11#3)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#62)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#13)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
surface of these two##2##4##(2008-11#1)(2008-5#1)
surface of these##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
surface of##407##2##(1990-12#4)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#14)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#147)(2008-11#19)(2008-12#3)(2008-2#15)(2008-3#28)(2008-4#11)(2008-5#19)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#5)(2009-11#3)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#3)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#3)
surface on a##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
surface on the##4##3##(1996-12#1)(2008-10#1)(2010-6#1)(2011-2#1)
surface on##7##2##(1996-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2010-6#1)(2011-2#1)
surface or buried##2##3##(2008-10#2)
surface or##12##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)
surface orientation##2##2##(2008-6#2)
surface oxidation##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
surface oxide##2##2##(2008-3#1)(2009-7#1)
surface pH and##3##3##(2008-5#3)
surface pH##17##2##(2008-5#17)
surface pK(a)##2##2##(2008-10#2)
surface passivation##2##2##(2010-2#1)(2010-4#1)
surface patches##3##2##(2008-6#1)(2008-7#1)(2010-4#1)
surface patterns##2##2##(2008-2#1)(2008-5#1)
surface plasmon resonance (SPR) biosensor##5##5##(2008-10#3)(2008-11#1)(2008-4#1)
surface plasmon resonance (SPR) sensor##5##5##(2008-10#4)(2008-2#1)
surface plasmon resonance (SPR)##19##4##(2008-10#15)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
surface plasmon resonance and##2##4##(2008-10#1)(2009-5#1)
surface plasmon resonance biosensor##7##4##(2008-10#7)
surface plasmon resonance sensor with##2##5##(2008-10#2)
surface plasmon resonance sensor##5##4##(2008-10#4)(2008-3#1)
surface plasmon resonance spectroscopy##3##4##(2008-10#1)(2008-3#2)
surface plasmon resonance##55##3##(1992-11#1)(1995-12#1)(2007-11#2)(2008-10#38)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-9#1)(2009-12#1)(2009-5#1)(2013-1#2)
surface plasmon resonances##3##3##(2008-6#2)(2010-2#1)
surface plasmon##66##2##(1992-11#1)(1995-12#1)(2007-11#4)(2007-12#3)(2008-10#38)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-6#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#2)
surface plasmons can##2##3##(2007-12#1)(2008-7#1)
surface plasmons##9##2##(2007-12#4)(2008-11#1)(2008-7#2)(2012-2#2)
surface possessed##2##2##(1990-12#1)(2008-10#1)
surface potential mapping##2##3##(2008-7#2)
surface potential##8##2##(1991-3#1)(1994-5#1)(2008-10#3)(2008-7#2)(2008-8#1)
surface pressure##13##2##(1992-6#1)(1994-3#4)(1994-6#1)(1995-5#1)(1997-2#2)(2008-10#3)(2008-2#1)
surface pressures##3##2##(1992-6#1)(2008-10#2)
surface pretreatment##2##2##(1997-2#1)(2008-10#1)
surface probability##3##2##(1990-4#3)
surface profile of a##2##4##(2007-12#1)(2008-3#1)
surface profile of the##2##4##(2008-2#1)(2008-3#1)
surface profile of##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
surface profile##13##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#8)
surface profiles##7##2##(2008-2#2)(2008-3#5)
surface profiling##3##2##(2008-3#3)
surface properties of##3##3##(1990-12#1)(2008-10#1)(2012-1#1)
surface properties##12##2##(1990-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-7#1)(2011-1#1)(2012-1#1)
surface protein##10##2##(1991-5#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)
surface protein-1 (MSP-1)##2##3##(1994-12#2)
surface protein-7##2##2##(2012-2#2)
surface proteins##8##2##(1992-3#1)(1994-11#1)(1995-8#1)(1997-4#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-2#1)
surface quality and##2##3##(2008-3#2)
surface quality##3##2##(2008-3#3)
surface rather than##4##3##(1993-8#1)(2008-10#3)
surface reactions##4##2##(2008-10#2)(2008-3#1)(2010-12#1)
surface receptor##10##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-2#1)(2008-7#1)(2010-8#1)
surface receptors##18##2##(1990-2#1)(1993-3#1)(1994-11#1)(1995-2#2)(1996-2#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
surface reconstruction##4##2##(2008-6#3)(2011-1#1)
surface reflectance##8##2##(2008-2#1)(2008-3#7)
surface reflection##3##2##(2008-2#1)(2008-3#2)
surface reflections##2##2##(2008-3#2)
surface reflectivity##2##2##(2008-3#1)(2011-1#1)
surface region of##2##3##(2008-10#1)(2008-5#1)
surface region##3##2##(2008-10#1)(2008-5#2)
surface relief##7##2##(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#3)
surface reliefs in##2##3##(2008-3#2)
surface reliefs##4##2##(2008-3#4)
surface residues##6##2##(2008-10#5)(2008-4#1)
surface response##2##2##(2008-3#1)(2008-5#1)
surface roughness and##5##3##(2008-2#1)(2008-3#2)(2009-7#1)(2012-7#1)
surface roughness for##2##3##(2008-3#1)(2012-2#1)
surface roughness from##2##3##(2007-12#1)(2008-3#1)
surface roughness is##3##3##(2008-3#3)
surface roughness of##8##3##(2008-10#1)(2008-2#1)(2008-3#4)(2009-11#1)(2012-2#1)
surface roughness on##2##3##(2008-3#2)
surface roughness parameters##3##3##(2008-3#1)(2009-7#2)
surface roughness was##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
surface roughness##54##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#7)(2008-3#31)(2008-7#1)(2009-11#1)(2009-7#4)(2012-2#4)(2012-7#1)(2013-8#1)
surface scattering##7##2##(2007-12#4)(2008-3#3)
surface science##3##2##(2008-10#2)(2012-1#1)
surface seawater##3##2##(2008-10#2)(2008-11#1)
surface sediments##3##2##(2008-10#2)(2011-2#1)
surface shape##5##2##(2008-3#5)
surface soil##3##2##(2008-10#2)(2008-11#1)
surface soils##2##2##(2008-10#1)(2013-8#1)
surface structure of##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
surface structure##11##2##(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#1)
surface structures##4##2##(1990-11#1)(1992-2#1)(2007-12#1)(2008-3#1)
surface studies##2##2##(2008-10#1)(2008-3#1)
surface technology##2##2##(2008-11#1)(2012-2#1)
surface temperature and##2##3##(2008-5#1)(2011-1#1)
surface temperature##13##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2011-1#2)
surface temperatures have##2##3##(2008-5#1)(2008-9#1)
surface temperatures##4##2##(1997-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
surface tension and viscosity of the##2##6##(2008-3#1)(2013-8#1)
surface tension and viscosity of##3##5##(2008-3#1)(2013-8#2)
surface tension and##4##3##(2008-3#1)(2010-4#1)(2013-8#2)
surface tension lowering##4##3##(2008-10#4)
surface tension measurements##2##3##(2008-10#2)
surface tension of the##2##4##(1995-3#1)(1996-3#1)
surface tension of##5##3##(1995-3#1)(1996-3#1)(2008-10#1)(2008-6#2)
surface tension##54##2##(1990-4#1)(1994-5#2)(1995-3#1)(1996-3#1)(2008-10#28)(2008-2#1)(2008-3#5)(2008-5#5)(2008-6#2)(2008-8#1)(2009-6#2)(2010-2#2)(2010-4#1)(2013-8#2)
surface tensions##2##2##(2008-10#1)(2010-4#1)
surface texture##4##2##(2008-10#1)(2008-5#2)(2010-4#1)
surface than##4##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-3#1)
surface that is##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2010-4#1)
surface that##9##2##(1992-2#1)(2007-12#1)(2008-3#3)(2008-5#1)(2009-7#1)(2010-4#1)(2011-1#1)
surface through a##2##3##(2007-12#1)(2008-10#1)
surface through##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
surface tissue##2##2##(2008-3#1)(2011-1#1)
surface to develop##2##3##(2008-10#2)
surface to the##12##3##(1990-12#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-6#1)(2009-12#1)(2009-7#1)
surface to##24##2##(1990-12#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#5)(2008-6#1)(2008-8#2)(2009-12#1)(2009-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
surface topography##6##2##(2008-2#1)(2008-3#3)(2008-5#1)(2012-2#1)
surface topology##3##2##(2008-10#1)(2008-2#2)
surface treatment by##2##3##(2008-11#1)(2012-2#1)
surface treatment##9##2##(2008-10#1)(2008-11#1)(2008-12#2)(2009-7#1)(2009-8#3)(2012-2#1)
surface treatments##5##2##(2008-11#1)(2008-12#2)(2009-11#1)(2009-8#1)
surface under the##2##3##(2008-10#1)(2008-3#1)
surface under##8##2##(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
surface upon##2##2##(1995-2#1)(2007-12#1)
surface upregulation##2##2##(1994-6#1)(2008-11#1)
surface using a##4##3##(2008-10#3)(2012-2#1)
surface using##7##2##(1995-2#1)(2008-10#4)(2012-2#1)(2013-8#1)
surface velocity of a natural debris flow##2##7##(2008-3#2)
surface velocity of##7##3##(2008-2#3)(2008-3#4)
surface viscosity##2##2##(2008-10#1)(2008-9#1)
surface was determined##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
surface was identified##2##3##(1990-2#1)(2010-10#1)
surface was measured by##2##4##(1991-5#2)
surface was monitored with##2##4##(2008-10#1)(2008-2#1)
surface was monitored##3##3##(2008-10#2)(2008-2#1)
surface was optimized##2##3##(2008-10#2)
surface was performed##2##3##(2008-10#1)(2008-11#1)
surface was used##2##3##(2008-10#2)
surface was##48##2##(1990-2#1)(1991-5#3)(1991-8#1)(1994-7#1)(1995-12#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#18)(2008-11#4)(2008-2#2)(2008-3#3)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
surface water and##2##3##(2008-10#2)
surface water in##2##3##(2008-11#1)(2012-2#1)
surface water is##2##3##(2008-10#2)
surface water samples##7##3##(2008-10#7)
surface water##33##2##(2007-5#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-8#3)(2011-2#1)(2012-2#1)
surface waters and sediments##2##4##(2008-10#2)
surface waters and##3##3##(2008-10#3)
surface waters##7##2##(2008-10#7)
surface waves in##5##3##(2007-11#2)(2007-12#2)(2012-2#1)
surface waves##13##2##(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#3)(2012-2#1)
surface were##11##2##(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
surface wetness##2##2##(2008-10#2)
surface where the##3##3##(2008-2#1)(2008-5#1)(2009-11#1)
surface where##4##2##(2008-2#1)(2008-5#1)(2009-11#1)(2009-9#1)
surface which is##3##3##(2008-10#2)(2013-8#1)
surface which##8##2##(2008-10#2)(2008-5#3)(2009-7#1)(2009-8#1)(2013-8#1)
surface with a##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
surface with##21##2##(1994-2#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)
surface without##3##2##(1994-6#1)(2007-11#1)(2008-10#1)
surface##3023##1##(1990-10#2)(1990-11#6)(1990-12#14)(1990-2#6)(1990-4#4)(1990-5#7)(1990-6#5)(1990-7#2)(1990-8#9)(1991-1#1)(1991-11#1)(1991-12#11)(1991-2#4)(1991-3#2)(1991-5#13)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#9)(1992-4#1)(1992-5#9)(1992-6#8)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#6)(1993-3#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-11#19)(1994-12#11)(1994-2#4)(1994-3#18)(1994-5#18)(1994-6#8)(1994-7#1)(1994-8#6)(1994-9#10)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#26)(1995-3#3)(1995-5#10)(1995-6#7)(1995-8#6)(1996-11#1)(1996-12#10)(1996-2#6)(1996-3#2)(1996-4#4)(1996-5#8)(1996-9#2)(1997-1#7)(1997-2#26)(1997-3#3)(1997-4#14)(1997-5#1)(1997-6#7)(1997-7#5)(1997-8#3)(1997-9#1)(2006-10#3)(2006-6#2)(2007-10#4)(2007-11#54)(2007-12#98)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#14)(2008-10#831)(2008-11#95)(2008-12#19)(2008-2#144)(2008-3#430)(2008-4#53)(2008-5#159)(2008-6#37)(2008-7#69)(2008-8#52)(2008-9#48)(2009-10#3)(2009-11#31)(2009-12#12)(2009-2#4)(2009-3#6)(2009-4#5)(2009-5#4)(2009-6#9)(2009-7#22)(2009-8#12)(2009-9#7)(2010-10#12)(2010-11#1)(2010-12#9)(2010-2#9)(2010-3#2)(2010-4#33)(2010-5#11)(2010-6#11)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#18)(2011-2#44)(2011-3#1)(2011-7#1)(2012-1#12)(2012-12#10)(2012-2#53)(2012-3#12)(2012-4#1)(2012-5#1)(2012-7#1)(2013-1#66)(2013-8#42)
surface)##4##1##(1995-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
surface-acoustic-wave##2##1##(2008-3#2)
surface-active compounds##3##2##(2008-10#2)(2008-6#1)
surface-active##8##1##(2008-10#6)(2008-5#1)(2008-6#1)
surface-area##5##1##(2008-3#5)
surface-associated##3##1##(1996-12#2)(2012-2#1)
surface-bound HPRG##2##2##(1997-2#2)
surface-bound TSP##2##2##(1991-2#1)(2013-8#1)
surface-bound##12##1##(1990-2#1)(1991-2#1)(1992-3#1)(1997-2#3)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
surface-breaking defects##2##2##(2007-11#2)
surface-breaking##3##1##(2007-11#3)
surface-confined Ru(bpy)(3)(2+)##2##2##(2008-10#2)
surface-disinfested##3##1##(2008-10#3)
surface-emitting laser (VCSEL)##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
surface-emitting laser arrays##4##3##(2007-11#1)(2008-3#3)
surface-emitting laser with##3##3##(2007-12#3)
surface-emitting laser##21##2##(2007-11#2)(2007-12#6)(2008-2#4)(2008-3#9)
surface-emitting lasers##27##2##(2007-11#8)(2007-12#3)(2008-2#5)(2008-3#11)
surface-emitting semiconductor laser##2##3##(2007-12#1)(2008-3#1)
surface-emitting semiconductor lasers##3##3##(2007-11#1)(2007-12#2)
surface-emitting semiconductor##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
surface-emitting##53##1##(2007-11#11)(2007-12#12)(2008-2#9)(2008-3#21)
surface-enhanced Raman scattering (SERS) activity##2##5##(2007-12#1)(2013-1#1)
surface-enhanced Raman scattering (SERS)##5##4##(2007-12#1)(2008-10#3)(2013-1#1)
surface-enhanced Raman scattering and##2##4##(2007-12#1)(2013-8#1)
surface-enhanced Raman scattering##17##3##(2007-12#4)(2008-10#8)(2012-2#1)(2013-1#1)(2013-8#3)
surface-enhanced Raman spectroscopy (SERS)##5##4##(2007-12#1)(2008-10#2)(2012-1#1)(2013-1#1)
surface-enhanced Raman spectroscopy##9##3##(2007-12#2)(2008-10#3)(2008-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
surface-enhanced Raman##27##2##(2007-12#6)(2008-10#11)(2008-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#5)
surface-enhanced effects##2##2##(2013-8#2)
surface-enhanced infrared absorption spectroscopy##2##4##(2013-8#2)
surface-enhanced infrared absorption##3##3##(2008-10#1)(2013-8#2)
surface-enhanced##33##1##(2007-12#6)(2008-10#13)(2008-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#9)
surface-fitting##2##1##(2008-3#1)(2008-9#1)
surface-induced##2##1##(1994-8#1)(2008-10#1)
surface-initiated##3##1##(2008-10#1)(2010-4#2)
surface-light-scattering instrumentation##2##2##(2008-3#2)
surface-light-scattering spectroscopy##2##2##(2008-3#2)
surface-light-scattering##4##1##(2008-3#4)
surface-located##3##1##(2008-4#3)
surface-mediated reactions##2##2##(2008-10#2)
surface-mediated##4##1##(2007-12#1)(2008-10#2)(2009-10#1)
surface-modified by grafting collagen via NH(3) plasma##2##7##(2008-5#2)
surface-modified##4##1##(2008-10#2)(2008-5#2)
surface-mulched plots amended with##2##4##(2008-10#2)
surface-plasmon microscopy##2##2##(2008-3#2)
surface-plasmon polariton##2##2##(2008-3#2)
surface-plasmon resonance (SPR)##4##3##(2008-3#4)
surface-plasmon resonance for the determination of##2##6##(2008-3#2)
surface-plasmon resonance##11##2##(2008-2#1)(2008-3#10)
surface-plasmon##21##1##(2008-2#3)(2008-3#18)
surface-plasmon-coupled waveguide modes##2##3##(2008-3#2)
surface-profile function zeta(x(1))##2##3##(2008-2#2)
surface-reflected##3##1##(2008-3#3)
surface-relief diffractive optical##2##3##(2008-3#2)
surface-relief##9##1##(2008-2#1)(2008-3#8)
surface-skimming##2##1##(2013-1#2)
surface-to-volume ratio##3##2##(2009-11#1)(2010-7#1)(2012-1#1)
surface-wave##2##1##(2007-11#1)(2008-3#1)
surfaced##5##1##(2007-12#2)(2008-7#1)(2011-2#2)
surfaces across##2##2##(2008-3#2)
surfaces after##2##2##(1996-12#1)(2008-10#1)
surfaces and is##2##3##(1994-8#1)(2008-3#1)
surfaces and matrices is##2##4##(1990-2#2)
surfaces and matrices##3##3##(1990-2#3)
surfaces and on the##2##4##(2007-12#1)(2008-7#1)
surfaces and the##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#2)
surfaces and##35##2##(1990-2#3)(1993-9#1)(1994-8#1)(2007-12#4)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-8#2)
surfaces are##12##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2010-10#1)(2011-2#1)
surfaces as##2##2##(1991-9#1)(2013-8#1)
surfaces at##2##2##(2008-10#1)(2012-2#1)
surfaces by##13##2##(2007-11#1)(2008-10#5)(2008-3#3)(2008-7#2)(2010-4#1)(2013-8#1)
surfaces can be##3##3##(1990-11#1)(2008-3#1)(2008-7#1)
surfaces during##2##2##(2008-10#1)(2008-3#1)
surfaces exposed to##2##3##(2008-2#1)(2009-4#1)
surfaces for##10##2##(1990-5#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)(2009-11#1)
surfaces from##3##2##(2008-3#3)
surfaces has##3##2##(2008-2#2)(2008-5#1)
surfaces have been##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
surfaces have##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-1#1)
surfaces in a##4##3##(2007-11#2)(2009-12#1)(2010-4#1)
surfaces in accelerated ageing##2##4##(2008-10#2)
surfaces in the##5##3##(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)
surfaces in##20##2##(2007-10#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2009-12#1)(2010-10#1)(2010-4#1)(2012-1#1)(2013-1#1)
surfaces is described##3##3##(2008-10#1)(2008-3#2)
surfaces is presented##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
surfaces is##21##2##(2008-10#5)(2008-2#4)(2008-3#10)(2008-5#1)(2013-1#1)
surfaces of arbitrary##2##3##(2008-6#2)
surfaces of the##27##3##(1990-8#1)(1994-8#2)(1996-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#1)(2011-2#1)(2013-1#1)
surfaces of##72##2##(1990-12#1)(1990-8#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-11#2)(1996-12#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#8)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
surfaces on the##2##3##(2008-10#1)(2008-7#1)
surfaces on##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
surfaces or##3##2##(2008-3#1)(2009-8#1)(2012-2#1)
surfaces over##3##2##(2008-3#2)(2010-7#1)
surfaces that##4##2##(1997-3#1)(2007-11#1)(2008-12#1)(2008-3#1)
surfaces through##2##2##(2008-10#1)(2010-4#1)
surfaces to form##2##3##(2008-10#1)(2008-7#1)
surfaces to##8##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-2#1)
surfaces under##2##2##(2007-11#1)(2008-3#1)
surfaces using##3##2##(2008-10#2)(2008-3#1)
surfaces was initially##2##3##(2010-10#2)
surfaces was observed##2##3##(2008-10#1)(2008-7#1)
surfaces was##10##2##(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#4)
surfaces were fabricated##3##3##(2008-12#1)(2008-2#1)(2009-12#1)
surfaces were modified by##2##4##(2008-10#1)(2008-6#1)
surfaces were##17##2##(1990-8#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-7#2)(2013-1#1)
surfaces with an##2##3##(2008-10#1)(2008-3#1)
surfaces with different##2##3##(2008-3#2)
surfaces with##18##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-12#1)(2012-5#1)
surfaces##576##1##(1990-11#1)(1990-12#1)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-12#1)(1991-2#1)(1991-9#4)(1992-12#2)(1993-9#1)(1994-11#1)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#19)(2007-12#24)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#117)(2008-11#8)(2008-12#11)(2008-2#41)(2008-3#129)(2008-4#4)(2008-5#11)(2008-6#10)(2008-7#24)(2008-8#7)(2008-9#2)(2009-11#10)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#8)(2010-1#1)(2010-10#10)(2010-12#1)(2010-4#6)(2010-6#6)(2010-7#5)(2010-8#1)(2011-2#7)(2012-1#5)(2012-12#2)(2012-2#7)(2012-3#2)(2012-5#2)(2013-1#16)(2013-8#11)
surfactant (Curosurf)##2##2##(1990-11#2)
surfactant Triton X-100##4##3##(1990-11#1)(2008-10#2)(2008-12#1)
surfactant Triton##5##2##(1990-11#1)(2008-10#3)(2008-12#1)
surfactant administration##2##2##(1996-6#1)(1997-1#1)
surfactant aggregates##3##2##(2008-10#3)
surfactant and a##2##3##(2008-10#1)(2008-5#1)
surfactant and its##2##3##(1997-1#1)(2008-5#1)
surfactant and##16##2##(1990-5#1)(1996-5#1)(1997-1#2)(2008-10#5)(2008-5#4)(2009-12#2)(2011-1#1)
surfactant as##2##2##(1994-9#1)(1997-1#1)
surfactant can##2##2##(1997-1#1)(2011-2#1)
surfactant concentration and##2##3##(2008-10#2)
surfactant concentration##13##2##(1992-5#1)(1994-9#1)(1996-5#1)(2008-10#8)(2008-5#2)
surfactant concentrations##2##2##(1996-5#1)(2008-10#1)
surfactant for##3##2##(1994-9#1)(2008-12#1)(2008-5#1)
surfactant in the##4##3##(1996-5#1)(2008-10#2)(2008-5#1)
surfactant in##9##2##(1996-5#2)(2008-10#4)(2008-5#1)(2008-8#1)(2011-1#1)
surfactant is##6##2##(1997-1#1)(2008-10#4)(2008-8#1)
surfactant may##2##2##(1994-5#1)(2010-3#1)
surfactant micelles##7##2##(2008-10#7)
surfactant mixtures##4##2##(2008-10#2)(2008-5#2)
surfactant on the##2##3##(2008-5#1)(2013-8#1)
surfactant or##3##2##(1994-5#1)(2008-10#1)(2008-5#1)
surfactant phase##2##2##(2008-10#2)
surfactant phospholipid##2##2##(1994-5#2)
surfactant preparations##4##2##(1994-5#1)(2007-11#3)
surfactant reduced##2##2##(1990-11#1)(1997-1#1)
surfactant sodium##4##2##(2008-10#3)(2010-11#1)
surfactant solution##5##2##(2008-10#3)(2008-5#2)
surfactant solutions##4##2##(2008-10#3)(2008-5#1)
surfactant solvent media##2##3##(2008-10#2)
surfactant system##2##2##(1997-1#1)(2008-10#1)
surfactant systems##2##2##(2008-10#1)(2008-5#1)
surfactant to##2##2##(2008-10#1)(2008-5#1)
surfactant treatment##2##2##(1990-11#1)(2008-8#1)
surfactant used##3##2##(2008-10#2)(2008-5#1)
surfactant was##4##2##(1994-5#1)(1994-9#1)(2008-10#2)
surfactant with##2##2##(1994-5#1)(2008-10#1)
surfactant##285##1##(1990-11#5)(1990-12#1)(1990-5#1)(1992-5#3)(1993-2#2)(1994-12#1)(1994-3#1)(1994-5#10)(1994-9#8)(1996-5#6)(1996-6#1)(1997-1#15)(1997-2#5)(2007-11#8)(2008-10#143)(2008-12#2)(2008-5#40)(2008-7#1)(2008-8#10)(2009-10#1)(2009-12#4)(2010-11#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#2)
surfactant)##3##1##(2008-10#3)
surfactant-based products##3##2##(2008-5#3)
surfactant-based##5##1##(2008-5#5)
surfactant-free##2##1##(2008-10#2)
surfactant-rich phase##9##2##(2008-10#7)(2008-7#2)
surfactant-rich##10##1##(2008-10#8)(2008-7#2)
surfactant-selective##2##1##(2008-10#2)
surfactants and the##3##3##(2008-10#2)(2012-2#1)
surfactants and##11##2##(1996-1#1)(2008-10#8)(2008-6#1)(2012-2#1)
surfactants are##4##2##(1996-1#1)(2008-10#3)
surfactants as##2##2##(2008-10#1)(2008-5#1)
surfactants at##3##2##(2008-10#2)(2012-1#1)
surfactants by##2##2##(2008-10#2)
surfactants in the##5##3##(2008-10#4)(2008-5#1)
surfactants in water##2##3##(2008-10#2)
surfactants in##18##2##(1996-5#1)(2008-10#14)(2008-5#2)(2011-1#1)
surfactants is##3##2##(2008-10#3)
surfactants of##4##2##(2008-10#4)
surfactants on the##4##3##(2008-10#2)(2008-5#2)
surfactants on##8##2##(1996-5#1)(2008-10#3)(2008-5#3)(2011-1#1)
surfactants was##2##2##(2008-5#2)
surfactants were used##2##3##(1994-12#1)(2008-10#1)
surfactants were##7##2##(1994-12#1)(2008-10#4)(2008-5#2)
surfactants with##2##2##(2008-10#1)(2008-5#1)
surfactants##145##1##(1990-8#1)(1994-12#1)(1996-1#3)(1996-2#1)(1996-5#4)(1997-1#1)(2008-10#91)(2008-5#30)(2008-6#2)(2008-7#2)(2011-1#7)(2012-1#1)(2012-2#1)
surficial##3##1##(1990-11#1)(1992-3#2)
surge capacity##2##2##(2008-1#1)(2009-3#1)
surge of##4##2##(1990-9#1)(2009-11#1)(2011-1#1)(2012-2#1)
surge##12##1##(1990-9#1)(1992-8#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-11#1)(2009-3#1)(2011-1#1)(2012-2#1)
surgeon and##10##2##(2007-11#1)(2007-12#3)(2007-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
surgeon can##2##2##(2007-8#1)(2012-2#1)
surgeon experience##2##2##(2008-8#1)(2013-1#1)
surgeon for##2##2##(2007-8#1)(2008-7#1)
surgeon in the##2##3##(1990-9#1)(1993-9#1)
surgeon in##6##2##(1990-9#1)(1993-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)
surgeon is##5##2##(1992-1#1)(1993-11#1)(1996-1#1)(2007-12#2)
surgeon must##2##2##(2010-8#1)(2011-2#1)
surgeon should be##2##3##(2008-9#1)(2013-1#1)
surgeon should##4##2##(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
surgeon to the##2##3##(2012-12#2)
surgeon to##16##2##(1992-12#2)(1993-12#1)(2009-4#2)(2009-5#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)
surgeon volume##3##2##(2008-7#3)
surgeon with##3##2##(2011-2#1)(2012-2#2)
surgeon##146##1##(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(2007-11#5)(2007-12#11)(2007-3#1)(2007-5#2)(2007-8#7)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#6)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#14)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#9)(2013-8#1)
surgeon's experience##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2010-8#1)
surgeon's perspective##2##2##(2008-4#1)(2008-9#1)
surgeon's##18##1##(1990-5#1)(1991-9#1)(1995-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
surgeonfish is##2##2##(2008-5#2)
surgeonfish##5##1##(2008-5#5)
surgeons and##15##2##(1993-12#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-8#2)(2011-2#2)
surgeons are##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
surgeons but##2##2##(1995-9#1)(2007-11#1)
surgeons for##2##2##(2009-3#1)(2010-8#1)
surgeons have##3##2##(1990-2#1)(1993-9#1)(2007-8#1)
surgeons in the##7##3##(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)
surgeons in##14##2##(1996-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
surgeons should be##3##3##(1991-3#1)(2008-6#1)(2008-8#1)
surgeons should##9##2##(1991-3#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-12#1)
surgeons that##2##2##(2010-8#1)(2013-8#1)
surgeons the##2##2##(2008-4#1)(2012-12#1)
surgeons to##9##2##(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#3)(2011-2#1)(2013-1#2)
surgeons using##3##2##(1995-1#1)(1996-9#1)(2007-8#1)
surgeons were##4##2##(1995-1#1)(1996-3#1)(2008-9#2)
surgeons will##2##2##(1996-9#1)(2010-8#1)
surgeons wishing to##2##3##(2009-3#1)(2009-7#1)
surgeons with##2##2##(2008-4#1)(2012-3#1)
surgeons##147##1##(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1995-1#2)(1995-9#1)(1996-3#1)(1996-9#3)(2007-11#3)(2007-12#7)(2007-3#2)(2007-4#1)(2007-5#2)(2007-8#9)(2008-1#2)(2008-10#5)(2008-4#15)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#9)(2009-1#1)(2009-10#1)(2009-3#5)(2009-5#1)(2009-7#4)(2010-11#1)(2010-12#1)(2010-8#16)(2011-2#10)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
surgeons'##3##1##(1991-9#1)(2007-11#1)(2008-9#1)
surgeons?##3##1##(1993-2#1)(2009-5#1)(2010-8#1)
surgeons]##2##1##(1990-5#1)(1991-6#1)
surgeries for##2##2##(1996-12#1)(2008-2#1)
surgeries in##2##2##(2008-7#1)(2011-1#1)
surgeries were##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
surgeries##33##1##(1990-9#1)(1992-11#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#4)
surgery (0##2##2##(2013-1#2)
surgery (VATS)##6##2##(2007-8#2)(2008-1#1)(2008-10#1)(2010-8#1)(2013-7#1)
surgery (p##2##2##(1991-6#1)(1995-3#1)
surgery a##3##2##(2007-5#1)(2008-7#1)(2008-9#1)
surgery after the##2##3##(1991-2#1)(2010-8#1)
surgery after##11##2##(1990-6#2)(1991-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
surgery alone in##2##3##(2008-6#1)(2013-8#1)
surgery alone##10##2##(1990-8#1)(1991-8#1)(1995-5#1)(2008-6#2)(2012-3#3)(2013-1#1)(2013-8#1)
surgery and 1##2##3##(1995-2#1)(2012-12#1)
surgery and adjuvant##3##3##(1992-10#1)(1992-12#1)(2008-11#1)
surgery and anesthesia##2##3##(1993-1#1)(2012-3#1)
surgery and chemotherapy for##2##4##(2012-12#1)(2013-1#1)
surgery and chemotherapy##7##3##(1990-8#1)(1992-2#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
surgery and followed##2##3##(2008-7#1)(2011-2#1)
surgery and immediate loading##2##4##(2008-11#1)(2013-1#1)
surgery and radiation therapy##4##4##(1994-8#1)(1995-8#1)(1995-9#1)(2012-1#1)
surgery and radiation##5##3##(1994-8#1)(1995-8#1)(1995-9#2)(2012-1#1)
surgery and radiotherapy##4##3##(1990-8#1)(1991-4#1)(2007-5#1)(2008-6#1)
surgery and the relationship##2##4##(2007-11#1)(2008-9#1)
surgery and the##14##3##(1993-3#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
surgery and to##2##3##(2008-3#1)(2012-3#1)
surgery and with##2##3##(1993-1#1)(2013-1#1)
surgery and##131##2##(1990-11#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-5#2)(2007-8#10)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#10)(2013-8#1)
surgery and/or##2##2##(1991-9#1)(2008-7#1)
surgery applications##3##2##(2008-8#1)(2009-12#2)
surgery are discussed##3##3##(2010-8#1)(2013-1#2)
surgery are##22##2##(1990-2#1)(1991-1#1)(1991-5#1)(2007-11#2)(2007-8#3)(2008-12#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
surgery as a##2##3##(2006-10#1)(2007-11#1)
surgery as compared with##2##4##(1990-9#1)(1996-3#1)
surgery as compared##3##3##(1990-9#1)(1996-3#1)(2008-6#1)
surgery as##8##2##(1990-9#1)(1996-3#1)(2006-10#1)(2007-11#2)(2008-6#1)(2008-9#1)(2011-2#1)
surgery at a##2##3##(2011-2#1)(2013-1#1)
surgery at the Department of##2##5##(2007-8#1)(2013-1#1)
surgery at the##6##3##(1991-4#1)(2007-12#1)(2007-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
surgery at##20##2##(1991-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
surgery backup##2##2##(2008-3#2)
surgery because of the##2##4##(2011-2#1)(2012-12#1)
surgery because of##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
surgery because##8##2##(1991-9#1)(1993-9#1)(2008-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
surgery between##2##2##(2011-2#1)(2013-8#1)
surgery both##2##2##(2007-8#1)(2013-1#1)
surgery but##4##2##(1997-2#1)(2012-3#2)(2013-8#1)
surgery by a##2##3##(2011-2#1)(2013-1#1)
surgery by##10##2##(1992-3#1)(1997-2#1)(2007-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
surgery can be performed##2##4##(1990-2#1)(1991-3#1)
surgery can be##8##3##(1990-2#1)(1991-3#1)(1992-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)
surgery can##12##2##(1990-2#1)(1991-3#1)(1992-5#1)(1992-9#1)(1994-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
surgery combined with##3##3##(1997-3#1)(2008-6#2)
surgery community##2##2##(2009-12#1)(2012-2#1)
surgery depends on##2##3##(2010-8#1)(2013-1#1)
surgery developed##2##2##(2008-6#1)(2009-7#1)
surgery does not##2##3##(1996-2#1)(2008-6#1)
surgery does##3##2##(1996-2#1)(2007-8#1)(2008-6#1)
surgery due to##6##3##(1993-6#1)(2007-11#2)(2010-6#1)(2012-12#1)(2013-1#1)
surgery during the##4##3##(1993-5#1)(1993-6#1)(2011-3#1)(2012-2#1)
surgery followed by chemotherapy##2##4##(2007-8#1)(2013-8#1)
surgery followed by##3##3##(2007-8#1)(2008-8#1)(2013-8#1)
surgery for a large##2##4##(2008-7#2)
surgery for a##8##3##(1992-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2010-8#1)
surgery for benign esophageal##3##4##(2012-1#1)(2013-1#2)
surgery for benign##4##3##(2011-2#1)(2012-1#1)(2013-1#2)
surgery for cerebral##3##3##(1996-6#1)(1996-9#1)(2008-7#1)
surgery for congenital##2##3##(2008-11#1)(2011-2#1)
surgery for craniopharyngioma##2##3##(1995-5#1)(2008-7#1)
surgery for liver##2##3##(1991-8#1)(2008-1#1)
surgery for obstructive sleep apnea syndrome##2##6##(2007-12#2)
surgery for patients with##3##4##(1994-9#1)(2010-12#1)(2013-1#1)
surgery for patients##4##3##(1994-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
surgery for primary##2##3##(1992-10#1)(2008-10#1)
surgery for the treatment of##3##5##(2010-8#1)(2012-3#1)(2013-8#1)
surgery for their##3##3##(1991-3#1)(2008-7#2)
surgery for treating##2##3##(2008-11#1)(2008-9#1)
surgery for tumors##2##3##(2010-7#1)(2013-1#1)
surgery for##109##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-3#2)(1991-8#1)(1992-10#1)(1992-2#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#6)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-7#1)(2010-8#5)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#1)
surgery from##3##2##(1990-8#1)(2008-3#1)(2011-2#1)
surgery has become the##2##4##(2010-8#1)(2013-1#1)
surgery has become##5##3##(1990-2#1)(1990-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
surgery has been##4##3##(1991-11#1)(1992-3#1)(2012-3#2)
surgery has##19##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#1)(1992-3#2)(2008-10#1)(2010-8#4)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)
surgery have been##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
surgery have##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-3#1)
surgery in 10 cases##2##4##(2008-6#1)(2011-2#1)
surgery in Poland##3##3##(2007-8#3)
surgery in Vietnam##2##3##(2008-9#1)(2010-10#1)
surgery in breast cancer##2##4##(1993-11#2)
surgery in breast##4##3##(1991-2#2)(1993-11#2)
surgery in children##2##3##(2006-10#2)
surgery in patients with##2##4##(2007-11#1)(2009-8#1)
surgery in patients##4##3##(1994-3#1)(2007-11#1)(2007-8#1)(2009-8#1)
surgery in relation to the##2##5##(1990-9#1)(2006-12#1)
surgery in selected patients##3##4##(2007-8#1)(2009-5#1)(2013-8#1)
surgery in the UK##2##4##(2012-12#2)
surgery in the treatment of##4##5##(2007-11#2)(2007-8#1)(2007-9#1)
surgery in the upper gastrointestinal tract##2##6##(2012-1#2)
surgery in the upper##3##4##(1991-6#1)(2012-1#2)
surgery in the##30##3##(1991-6#2)(1995-5#1)(2007-11#2)(2007-8#6)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-8#3)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2013-1#1)
surgery in this##4##3##(2007-8#1)(2008-6#1)(2008-7#1)(2012-3#1)
surgery in ulcerative##2##3##(1990-6#1)(1992-9#1)
surgery in which##2##3##(2007-11#1)(2009-3#1)
surgery in##111##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-2#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-11#5)(2007-8#18)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-9#6)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-3#1)(2010-8#5)(2010-9#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#1)
surgery is a significant##2##4##(2011-2#1)(2012-3#1)
surgery is a##8##3##(2006-10#1)(2007-12#3)(2010-8#1)(2011-2#1)(2012-3#2)
surgery is an##3##3##(1991-4#1)(2006-12#1)(2008-10#1)
surgery is associated with a##2##5##(2008-6#1)(2012-2#1)
surgery is based##2##3##(2007-8#1)(2010-8#1)
surgery is described##2##3##(1993-9#1)(2007-8#1)
surgery is indicated##2##3##(1996-11#1)(2013-1#1)
surgery is not##4##3##(2008-1#1)(2013-1#2)(2013-8#1)
surgery is often##3##3##(1992-9#1)(2009-8#1)(2012-2#1)
surgery is possible and##2##4##(1990-12#1)(1993-3#1)
surgery is possible##3##3##(1990-12#1)(1993-3#1)(2008-3#1)
surgery is rare##2##3##(2007-8#1)(2012-12#1)
surgery is still the##2##4##(1990-5#1)(2008-11#1)
surgery is still##3##3##(1990-5#1)(2008-11#1)(2011-2#1)
surgery is the treatment of choice##3##6##(1997-2#1)(2008-4#1)(2010-3#1)
surgery is the##6##3##(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)
surgery is to##2##3##(1997-2#1)(2007-11#1)
surgery is##81##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-4#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-9#1)(1996-11#1)(1996-12#1)(1997-2#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-8#7)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-8#5)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
surgery malpractice##2##2##(1991-12#1)(2008-7#1)
surgery may be##3##3##(2007-12#1)(2009-4#1)(2011-2#1)
surgery may##6##2##(2007-12#1)(2009-4#1)(2011-2#3)(2012-3#1)
surgery more##3##2##(1992-9#1)(2007-12#1)(2008-10#1)
surgery must##2##2##(1996-6#1)(2008-4#1)
surgery of the human cerebrum##2##5##(2008-9#2)
surgery of the shoulder##2##4##(2007-11#1)(2007-8#1)
surgery of the##7##3##(1992-9#1)(2007-11#1)(2007-8#1)(2008-9#3)(2013-1#1)
surgery of##33##2##(1990-12#1)(1990-6#2)(1990-9#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-8#1)(1996-8#1)(1997-8#1)(2007-11#6)(2007-8#2)(2008-7#2)(2008-9#5)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
surgery on the##4##3##(2007-8#2)(2010-8#1)(2011-2#1)
surgery on##14##2##(1990-5#1)(1993-12#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#4)
surgery only##2##2##(1990-3#1)(1991-2#1)
surgery or chemotherapy##2##3##(1993-9#1)(2008-8#1)
surgery or embolization##2##3##(2008-7#2)
surgery or endovascular##2##3##(1995-11#1)(2008-7#1)
surgery or radiotherapy##2##3##(2007-8#1)(2012-3#1)
surgery or##32##2##(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#2)(1992-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
surgery patient##2##2##(2010-8#1)(2012-2#1)
surgery patients##8##2##(1993-5#1)(2007-8#1)(2009-9#1)(2010-8#5)
surgery performed at##2##3##(1991-2#1)(2012-12#1)
surgery performed##3##2##(1991-2#1)(2008-11#1)(2012-12#1)
surgery practice##3##2##(2008-9#1)(2013-1#2)
surgery procedures##2##2##(2011-2#1)(2013-1#1)
surgery programs##2##2##(2008-3#1)(2012-3#1)
surgery provided that##2##3##(1990-11#1)(2008-7#1)
surgery remains the##2##3##(1997-3#1)(2010-3#1)
surgery requiring##3##2##(2010-7#1)(2011-2#1)(2012-3#1)
surgery residency##2##2##(2008-7#1)(2012-3#1)
surgery resulted in##2##3##(1994-12#1)(2008-8#1)
surgery revealed##2##2##(2008-7#1)(2012-1#1)
surgery seems to be##2##4##(2008-7#2)
surgery should be##4##3##(1991-12#1)(1997-3#1)(1997-8#1)(2007-7#1)
surgery simulation##2##2##(2008-6#1)(2009-12#1)
surgery since##2##2##(1990-9#1)(1996-3#1)
surgery still##2##2##(2010-8#1)(2013-1#1)
surgery than##2##2##(2012-3#1)(2013-1#1)
surgery that##4##2##(1990-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
surgery the##8##2##(1992-9#1)(1993-2#1)(2007-9#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#1)
surgery through##2##2##(2007-8#1)(2012-12#1)
surgery time##6##2##(1993-12#2)(1996-2#3)(2012-12#1)
surgery to remove##3##3##(2007-8#1)(2013-7#1)(2013-8#1)
surgery to##21##2##(1994-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
surgery today##2##2##(1991-3#1)(2010-8#1)
surgery under general anaesthesia##2##4##(2010-7#2)
surgery under##6##2##(1991-1#1)(1993-1#1)(2007-8#1)(2008-3#1)(2010-7#2)
surgery unless##2##2##(1991-5#1)(2008-1#1)
surgery using a##5##3##(1992-9#1)(2010-3#1)(2012-2#1)(2013-1#2)
surgery using the##2##3##(2008-7#1)(2010-8#1)
surgery using##12##2##(1990-9#1)(1992-9#1)(2007-8#1)(2008-7#1)(2010-3#2)(2010-8#2)(2012-2#2)(2013-1#2)
surgery vs##5##2##(1992-2#1)(2010-3#4)
surgery was done##4##3##(1993-6#1)(1997-3#1)(2007-8#2)
surgery was performed to##2##4##(2007-8#2)
surgery was performed##9##3##(1990-12#1)(1992-6#1)(2007-8#3)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
surgery was the##4##3##(1997-3#1)(2010-12#1)(2010-8#1)(2013-1#1)
surgery was written according to a structured protocol##12##8##(2007-8#12)
surgery was##68##2##(1990-12#2)(1990-8#2)(1991-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-4#1)(1996-6#1)(1997-3#2)(2006-12#1)(2007-11#4)(2007-8#20)(2008-10#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
surgery were analysed##2##3##(1991-11#1)(2013-8#1)
surgery were evaluated##2##3##(1997-3#1)(2011-2#1)
surgery were randomly##2##3##(2007-8#1)(2011-2#1)
surgery were##25##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-12#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#1)
surgery where##2##2##(1996-9#1)(2007-4#1)
surgery will be##2##3##(2009-5#1)(2010-8#1)
surgery will continue to##2##4##(1996-9#1)(2007-12#1)
surgery will##6##2##(1996-9#2)(2007-12#1)(2009-5#1)(2009-8#1)(2010-8#1)
surgery with a##6##3##(1992-12#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-8#1)
surgery with extracorporeal circulation##2##4##(2012-3#2)
surgery with extracorporeal##3##3##(2012-3#3)
surgery with or without##2##4##(1997-3#1)(2012-2#1)
surgery with##38##2##(1991-2#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#3)(1993-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#4)(2008-12#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
surgery without any##3##3##(2010-12#1)(2011-2#2)
surgery without##11##2##(1990-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-8#1)
surgery##2041##1##(1990-10#2)(1990-11#3)(1990-12#9)(1990-2#11)(1990-3#6)(1990-5#4)(1990-6#14)(1990-8#9)(1990-9#20)(1991-1#10)(1991-11#5)(1991-12#6)(1991-2#12)(1991-3#14)(1991-4#6)(1991-5#4)(1991-6#11)(1991-7#1)(1991-8#8)(1991-9#3)(1992-1#2)(1992-10#6)(1992-11#4)(1992-12#7)(1992-2#6)(1992-3#13)(1992-5#10)(1992-6#7)(1992-8#3)(1992-9#18)(1993-1#16)(1993-11#5)(1993-12#10)(1993-2#5)(1993-3#11)(1993-5#7)(1993-6#6)(1993-9#13)(1994-1#2)(1994-11#1)(1994-12#9)(1994-2#5)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#9)(1995-11#5)(1995-12#3)(1995-2#5)(1995-3#5)(1995-4#4)(1995-5#4)(1995-8#5)(1995-9#3)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#6)(1996-3#13)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#11)(1997-2#10)(1997-3#13)(1997-4#8)(1997-5#1)(1997-7#4)(1997-8#7)(2006-10#16)(2006-12#6)(2006-6#1)(2007-10#4)(2007-11#68)(2007-12#53)(2007-3#1)(2007-4#4)(2007-5#6)(2007-7#4)(2007-8#177)(2007-9#10)(2008-1#11)(2008-10#43)(2008-11#26)(2008-12#18)(2008-2#2)(2008-3#13)(2008-4#20)(2008-5#10)(2008-6#38)(2008-7#94)(2008-8#42)(2008-9#53)(2009-1#5)(2009-10#6)(2009-12#5)(2009-2#8)(2009-3#7)(2009-4#12)(2009-5#17)(2009-6#3)(2009-7#14)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#20)(2010-3#23)(2010-4#9)(2010-5#6)(2010-6#10)(2010-7#14)(2010-8#81)(2010-9#6)(2011-1#15)(2011-2#156)(2011-3#7)(2011-7#2)(2012-1#20)(2012-12#69)(2012-2#58)(2012-3#85)(2012-5#1)(2012-8#1)(2013-1#133)(2013-7#6)(2013-8#25)
surgery&quot##2##1##(1991-3#1)(2008-4#1)
surgery'##2##1##(2007-8#1)(2009-2#1)
surgery) were##2##2##(1990-11#1)(2012-3#1)
surgery)##10##1##(1990-11#1)(1990-6#1)(1991-3#1)(1993-3#1)(1995-4#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
surgery-related##2##1##(1994-12#1)(2010-12#1)
surgery?##5##1##(2007-8#4)(2012-2#1)
surgery]##53##1##(1990-2#1)(1990-5#2)(1990-6#3)(1990-9#1)(1991-3#2)(1991-6#1)(1992-3#3)(1992-6#3)(1992-9#2)(1993-3#1)(1993-5#1)(1993-9#2)(1994-3#1)(1994-8#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-8#4)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#5)(2013-1#2)(2013-8#4)
surges##2##1##(1992-12#1)(1995-1#1)
surgical ablation##3##2##(2010-3#2)(2010-8#1)
surgical access##2##2##(2009-4#1)(2013-1#1)
surgical alternative for##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
surgical anatomy##2##2##(2007-12#2)
surgical and medical complications##2##4##(2008-9#2)
surgical and medical##4##3##(2007-7#1)(2008-9#2)(2013-1#1)
surgical and non-surgical##2##3##(1994-3#1)(2007-11#1)
surgical and nonsurgical##2##3##(2008-3#2)
surgical and##34##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#2)(1993-5#1)(1994-3#1)(1995-12#1)(1995-6#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#3)(2011-3#1)(2013-1#3)(2013-8#2)
surgical approach and##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
surgical approach for the##2##4##(2011-2#2)
surgical approach for##3##3##(2007-8#1)(2011-2#2)
surgical approach in the##2##4##(1993-6#1)(2011-3#1)
surgical approach in##3##3##(1993-6#1)(2011-1#1)(2011-3#1)
surgical approach to##3##3##(1990-12#1)(2008-10#1)(2010-8#1)
surgical approach was##4##3##(1991-6#1)(1993-8#1)(2008-7#1)(2013-1#1)
surgical approach##46##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(2007-8#5)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#3)
surgical approaches in##2##3##(2008-8#1)(2011-2#1)
surgical approaches to##4##3##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
surgical approaches##22##2##(1991-3#1)(1993-3#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#4)(2013-1#4)
surgical aspects of##4##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
surgical aspects##7##2##(1990-9#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-8#1)(2012-2#1)
surgical biopsy of##2##3##(1990-6#1)(2012-3#1)
surgical biopsy##5##2##(1990-6#1)(1994-7#1)(2008-5#1)(2008-6#1)(2012-3#1)
surgical blood##2##2##(1996-9#2)
surgical care##13##2##(1992-6#1)(1993-12#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-8#3)(2013-1#1)
surgical cases##4##2##(1993-12#2)(2008-8#1)(2009-7#1)
surgical cement##2##2##(2007-11#2)
surgical center##2##2##(1997-1#2)
surgical challenges##2##2##(2008-9#1)(2012-3#1)
surgical clipping##2##2##(1997-6#1)(2013-8#1)
surgical closure of##2##3##(2008-3#1)(2012-12#1)
surgical closure##4##2##(2008-3#1)(2012-1#2)(2012-12#1)
surgical complication##5##2##(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
surgical complications were##2##3##(2010-7#1)(2013-1#1)
surgical complications##16##2##(1993-3#1)(1994-12#1)(2007-7#1)(2007-8#2)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#4)
surgical conditions##2##2##(2008-7#1)(2010-8#1)
surgical correction and##3##3##(2007-7#1)(2007-8#1)(2012-2#1)
surgical correction of the##2##4##(2007-12#1)(2010-10#1)
surgical correction##9##2##(2007-12#1)(2007-7#1)(2007-8#3)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
surgical debridement of##2##3##(2010-12#1)(2010-6#1)
surgical debridement##10##2##(1995-11#1)(1995-2#1)(2007-11#1)(2007-8#2)(2010-12#1)(2010-3#1)(2010-6#2)(2012-2#1)
surgical decompression is##3##3##(2011-2#2)(2012-12#1)
surgical decompression##6##2##(2008-6#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
surgical defects##2##2##(1994-6#1)(2013-1#1)
surgical delay##3##2##(2013-1#3)
surgical devices##3##2##(1993-6#1)(2010-8#1)(2011-2#1)
surgical diseases##3##2##(1990-5#1)(1991-3#1)(2008-3#1)
surgical drainage and##4##3##(2007-7#2)(2008-7#1)(2009-2#1)
surgical drainage of##2##3##(2011-2#1)(2012-2#1)
surgical drainage##9##2##(2007-7#2)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#3)(2012-2#1)
surgical education##2##2##(2012-3#1)(2013-1#1)
surgical emergency##2##2##(2009-4#1)(2011-2#1)
surgical excision and##2##3##(1993-6#1)(2007-12#1)
surgical excision is##4##3##(2007-8#1)(2008-6#1)(2008-9#1)(2010-3#1)
surgical excision of a##3##4##(2008-9#1)(2013-1#2)
surgical excision of the##2##4##(2008-6#2)
surgical excision of##9##3##(1991-6#1)(2007-12#1)(2008-6#2)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
surgical excision was done##2##4##(2011-1#1)(2012-3#1)
surgical excision was##4##3##(2007-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
surgical excision with##3##3##(2008-6#1)(2011-2#1)(2012-1#1)
surgical excision##40##2##(1990-6#1)(1991-6#1)(1993-1#1)(1993-6#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#4)(2008-9#3)(2009-4#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-3#3)(2013-1#3)
surgical exeresis##3##2##(1990-3#1)(1991-11#1)(2008-5#1)
surgical exploration and##2##3##(2008-7#1)(2010-7#1)
surgical exploration is##2##3##(2008-7#1)(2012-3#1)
surgical exploration of the neck##2##5##(2010-12#1)(2011-2#1)
surgical exploration##10##2##(1991-3#1)(1993-3#1)(2008-1#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
surgical exposure##5##2##(1990-5#1)(2007-8#1)(2008-4#1)(2010-8#1)(2013-1#1)
surgical field##8##2##(1996-1#1)(2007-8#1)(2008-9#2)(2010-8#1)(2012-12#2)(2012-3#1)
surgical findings##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
surgical glove##3##2##(1993-6#1)(1995-3#2)
surgical implications##2##2##(1990-2#1)(2011-2#1)
surgical in##2##2##(1993-9#1)(2008-1#1)
surgical incision##2##2##(2008-9#1)(2013-8#1)
surgical indication##2##2##(1997-8#1)(2013-1#1)
surgical injury##2##2##(1996-2#1)(2011-2#1)
surgical instruments##3##2##(2007-8#1)(2009-12#1)(2009-4#1)
surgical intervention and##5##3##(1990-8#1)(2007-12#1)(2008-7#1)(2010-3#1)(2013-1#1)
surgical intervention at##2##3##(1997-2#1)(2011-2#1)
surgical intervention can##2##3##(2008-7#1)(2013-8#1)
surgical intervention in##2##3##(1994-6#1)(2011-2#1)
surgical intervention is##8##3##(1991-3#1)(1995-5#1)(2007-11#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
surgical intervention to##2##3##(2007-12#1)(2008-7#1)
surgical intervention##65##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-3#1)(1992-9#1)(1993-5#1)(1994-6#1)(1995-5#2)(1997-2#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#2)(2009-12#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#4)
surgical interventions##8##2##(1991-3#1)(1993-5#1)(1994-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
surgical journey##2##2##(1992-2#1)(2013-8#1)
surgical light##2##2##(2010-9#1)(2011-2#1)
surgical literature##2##2##(1992-1#1)(2011-2#1)
surgical lung biopsy##3##3##(2013-1#3)
surgical lung##4##2##(2013-1#4)
surgical management is##5##3##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
surgical management of the##3##4##(2007-8#1)(2010-3#1)(2013-1#1)
surgical management of##32##3##(1994-12#2)(1994-3#1)(1997-5#1)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
surgical management with##2##3##(1993-3#1)(2008-12#1)
surgical management##51##2##(1991-3#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1997-5#1)(2007-12#4)(2007-2#1)(2007-8#7)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#2)(2010-12#1)(2010-3#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
surgical maneuvers##2##2##(2007-12#1)(2011-7#1)
surgical margin achieved##3##3##(2008-6#3)
surgical margin##5##2##(2008-6#4)(2011-2#1)
surgical margins may##2##3##(1997-7#2)
surgical margins were##3##3##(1990-12#1)(1995-4#2)
surgical margins##11##2##(1990-12#1)(1995-4#6)(1997-7#2)(2011-2#2)
surgical materials##2##2##(2010-8#2)
surgical measures##2##2##(1992-9#1)(2013-1#1)
surgical meshes##3##2##(2012-1#3)
surgical method##3##2##(1995-8#1)(2007-11#1)(2008-10#1)
surgical methods##7##2##(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-9#1)
surgical navigation system##2##3##(2007-8#1)(2008-9#1)
surgical navigation##3##2##(2007-8#1)(2008-9#2)
surgical nurses##4##2##(2010-10#3)(2010-7#1)
surgical nurses' experiences in caring for patients with postoperative pain##2##10##(2010-7#2)
surgical oncology##4##2##(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
surgical operation##4##2##(1993-5#1)(2008-7#1)(2010-8#1)(2011-1#1)
surgical operations##7##2##(1992-11#1)(2007-8#2)(2008-4#1)(2009-4#1)(2010-6#1)(2012-2#1)
surgical option##2##2##(2011-2#1)(2013-8#1)
surgical options##5##2##(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)
surgical or nonsurgical##2##3##(1997-3#1)(2007-12#1)
surgical or##7##2##(1997-3#1)(2007-12#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
surgical orientation##2##2##(2008-9#1)(2011-2#1)
surgical outcome##9##2##(1991-2#1)(2007-8#2)(2008-7#2)(2009-5#1)(2010-3#1)(2010-8#1)(2013-8#1)
surgical outcomes##6##2##(1993-12#1)(2007-12#1)(2008-10#1)(2010-3#1)(2010-8#1)(2013-1#1)
surgical outpatient##2##2##(2009-7#1)(2013-1#1)
surgical pathology in##2##3##(2007-5#1)(2013-1#1)
surgical pathology##4##2##(2006-10#1)(2007-4#1)(2007-5#1)(2013-1#1)
surgical patient##2##2##(2008-4#1)(2013-1#1)
surgical patients and##4##3##(1993-12#1)(2007-8#1)(2009-12#1)(2010-12#1)
surgical patients##25##2##(1991-6#1)(1993-12#2)(1996-9#1)(2006-10#1)(2007-10#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-12#3)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#2)(2010-8#2)(2011-2#1)(2012-1#1)(2013-8#1)
surgical planning##5##2##(2006-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
surgical practice##9##2##(2008-11#1)(2008-4#2)(2008-9#3)(2010-8#1)(2011-2#2)
surgical principles##2##2##(2007-12#1)(2009-5#1)
surgical problems##2##2##(1993-6#1)(1993-9#1)
surgical procedure and##3##3##(1996-9#1)(2008-8#1)(2009-5#1)
surgical procedure for##4##3##(1990-9#1)(2009-10#1)(2010-10#1)(2011-1#1)
surgical procedure in##2##3##(2009-3#1)(2013-1#1)
surgical procedure is##4##3##(1994-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
surgical procedure was##4##3##(2007-11#2)(2008-7#1)(2010-7#1)
surgical procedure with##3##3##(1991-3#1)(2008-9#1)(2012-3#1)
surgical procedure##61##2##(1990-9#2)(1991-3#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-9#1)(2007-11#5)(2007-7#2)(2007-8#5)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
surgical procedures and##7##3##(1992-2#1)(1994-3#1)(2007-8#2)(2010-8#1)(2011-1#1)(2013-8#1)
surgical procedures are##2##3##(1990-3#1)(2008-9#1)
surgical procedures for which##2##4##(1996-9#1)(2008-6#1)
surgical procedures for##4##3##(1996-9#1)(2007-12#1)(2008-12#1)(2008-6#1)
surgical procedures in##3##3##(1995-8#1)(2008-7#1)(2013-1#1)
surgical procedures of##2##3##(1992-3#1)(2007-11#1)
surgical procedures performed##2##3##(2006-10#1)(2009-3#1)
surgical procedures that##2##3##(1992-5#1)(1993-3#1)
surgical procedures used##2##3##(2007-11#1)(2012-2#1)
surgical procedures were performed##3##4##(1991-8#1)(1992-6#1)(2007-7#1)
surgical procedures were##7##3##(1991-8#1)(1992-6#2)(2007-11#1)(2007-7#1)(2012-12#1)(2012-3#1)
surgical procedures##94##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(1996-9#3)(2006-10#2)(2007-11#6)(2007-12#6)(2007-7#2)(2007-8#7)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#4)(2011-1#2)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
surgical reconstruction of##3##3##(2007-12#1)(2013-1#1)(2013-8#1)
surgical reconstruction##6##2##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#2)(2013-8#1)
surgical relief of##2##3##(2013-1#2)
surgical removal of the tumor##2##5##(2009-3#1)(2011-2#1)
surgical removal of the##9##4##(1992-12#1)(1995-12#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#2)
surgical removal of##12##3##(1992-10#1)(1992-12#1)(1995-12#1)(1996-9#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#3)
surgical removal##15##2##(1992-10#1)(1992-12#1)(1994-11#1)(1995-12#1)(1996-9#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-3#1)(2011-1#1)(2011-2#3)
surgical repair and##2##3##(2007-8#1)(2013-1#1)
surgical repair of##6##3##(1993-1#1)(1996-6#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
surgical repair##21##2##(1993-1#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-7#2)(2010-3#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
surgical reports##2##2##(1991-5#1)(1993-6#1)
surgical resection and adjuvant##2##4##(1990-9#1)(2011-3#1)
surgical resection and##7##3##(1990-9#1)(2008-11#1)(2010-3#1)(2011-2#2)(2011-3#1)(2013-8#1)
surgical resection followed by radiation##2##5##(2011-1#1)(2013-1#1)
surgical resection for##2##3##(2007-8#1)(2008-2#1)
surgical resection is indicated##2##4##(1997-3#1)(2009-12#1)
surgical resection is##4##3##(1997-3#1)(2008-1#1)(2008-7#1)(2009-12#1)
surgical resection of the##4##4##(2007-11#2)(2007-12#1)(2010-7#1)
surgical resection of##11##3##(2007-11#2)(2007-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#2)
surgical resection or##2##3##(1996-3#1)(2013-1#1)
surgical resection was##2##3##(2007-8#1)(2008-8#1)
surgical resection with##2##3##(1994-6#1)(2007-8#1)
surgical resection##57##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2009-12#1)(2009-4#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
surgical resections##2##2##(2006-12#1)(2010-3#1)
surgical residents##2##2##(2008-4#1)(2012-3#1)
surgical resources##2##2##(1995-3#2)
surgical results##5##2##(1990-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)
surgical revascularization##2##2##(2008-1#1)(2012-3#1)
surgical risk##8##2##(1991-3#1)(1993-9#1)(2007-8#2)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
surgical robot##2##2##(2007-8#2)
surgical salvage##3##2##(1991-8#1)(2011-1#1)(2012-3#1)
surgical services##3##2##(1995-12#2)(2011-2#1)
surgical setting##2##2##(2012-3#1)(2013-1#1)
surgical simulation##2##2##(2008-6#2)
surgical site complications##2##3##(2013-1#2)
surgical site infection (SSI)##2##4##(2008-8#1)(2010-12#1)
surgical site infection##5##3##(2008-8#2)(2010-12#2)(2012-3#1)
surgical site infections in##4##4##(2008-10#2)(2009-3#2)
surgical site infections##11##3##(2007-8#1)(2008-10#3)(2009-3#2)(2010-8#2)(2012-3#3)
surgical site##22##2##(2007-8#2)(2008-10#3)(2008-8#2)(2009-3#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#2)(2012-3#5)(2013-1#2)
surgical skill##2##2##(1996-12#1)(2008-7#1)
surgical skills##4##2##(1995-6#1)(1996-12#1)(2012-3#2)
surgical specialties##2##2##(1992-12#1)(2011-2#1)
surgical specialty##4##2##(2008-4#2)(2010-3#1)(2010-8#1)
surgical specimen##6##2##(2007-8#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
surgical specimens of##3##3##(1992-3#1)(1996-10#1)(2010-11#1)
surgical specimens##6##2##(1992-3#1)(1995-3#1)(1996-10#1)(2008-4#1)(2008-9#1)(2010-11#1)
surgical sponge with##2##3##(2012-3#2)
surgical stabilization consisting of##2##4##(2012-3#2)
surgical stabilization##3##2##(2012-3#3)
surgical strategies##2##2##(2008-7#1)(2008-9#1)
surgical strategy in patients with myasthenia gravis##2##7##(2007-8#2)
surgical strategy##6##2##(1992-9#1)(2007-8#3)(2010-8#1)(2011-2#1)
surgical stress##3##2##(1992-5#1)(2008-12#1)(2013-1#1)
surgical sutures##2##2##(2010-10#2)
surgical system##7##2##(2007-8#5)(2008-10#1)(2009-4#1)
surgical team##2##2##(2008-7#1)(2011-3#1)
surgical technique and##8##3##(1990-3#1)(1995-3#1)(1997-2#1)(2007-11#2)(2012-2#2)(2013-1#1)
surgical technique for##5##3##(2007-12#1)(2008-7#2)(2008-9#2)
surgical technique has##2##3##(2007-7#1)(2011-2#1)
surgical technique in##2##3##(2009-8#1)(2011-2#1)
surgical technique of##5##3##(1992-9#1)(1996-2#1)(2009-3#1)(2010-11#1)(2011-2#1)
surgical technique that##2##3##(2008-7#1)(2008-8#1)
surgical technique to##2##3##(1991-5#1)(2008-7#1)
surgical technique##57##2##(1990-3#1)(1990-9#3)(1991-3#1)(1991-5#1)(1992-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#4)(2008-7#6)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#1)
surgical techniques and##3##3##(1994-5#1)(2011-3#1)(2013-8#1)
surgical techniques are##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
surgical techniques for##3##3##(2007-8#1)(2011-2#2)
surgical techniques has##2##3##(1994-6#1)(2008-8#1)
surgical techniques have been##2##4##(2009-10#1)(2011-3#1)
surgical techniques have##3##3##(1994-3#1)(2009-10#1)(2011-3#1)
surgical techniques of##2##3##(1990-3#1)(2007-7#1)
surgical techniques##44##2##(1990-3#1)(1990-6#2)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#2)(2012-3#3)(2013-1#1)(2013-8#2)
surgical terminology##2##2##(1997-8#2)
surgical therapies##3##2##(2010-5#1)(2010-6#1)(2013-1#1)
surgical therapy and##4##3##(1990-5#2)(1992-5#1)(2011-2#1)
surgical therapy for##2##3##(2007-5#1)(2009-2#1)
surgical therapy of##6##3##(1990-6#1)(1990-9#1)(1992-3#1)(2008-7#1)(2011-3#2)
surgical therapy##22##2##(1990-5#2)(1990-6#2)(1990-9#2)(1991-6#1)(1992-3#1)(1992-5#1)(1993-9#1)(2007-5#1)(2007-8#2)(2008-7#2)(2009-2#1)(2010-12#1)(2011-2#1)(2011-3#3)(2013-1#1)
surgical therapy]##3##2##(1992-9#1)(1997-6#2)
surgical time##2##2##(1994-2#1)(2011-2#1)
surgical tools##2##2##(2008-3#1)(2009-4#1)
surgical training##4##2##(2008-4#2)(2008-6#1)(2012-3#1)
surgical trauma##6##2##(1993-1#1)(2008-12#1)(2012-12#2)(2013-1#2)
surgical treatment and##4##3##(1990-5#1)(2007-11#1)(2008-11#1)(2009-4#1)
surgical treatment are##4##3##(1993-6#1)(1993-9#1)(2007-8#2)
surgical treatment can##2##3##(2007-11#1)(2010-6#1)
surgical treatment for##8##3##(2007-8#2)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)
surgical treatment has been##2##4##(2007-8#1)(2010-11#1)
surgical treatment in##4##3##(1993-3#1)(2007-11#1)(2007-8#1)(2013-1#1)
surgical treatment is indicated##3##4##(2007-8#1)(2008-9#1)(2010-3#1)
surgical treatment is##15##3##(1992-9#1)(1993-3#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
surgical treatment may be indicated##2##5##(1991-11#1)(2013-1#1)
surgical treatment may##3##3##(1991-11#1)(2008-7#1)(2013-1#1)
surgical treatment of a##2##4##(2008-7#1)(2011-2#1)
surgical treatment of atrial fibrillation##2##5##(2007-8#2)
surgical treatment of bone metastases to##2##6##(2007-11#2)
surgical treatment of bone metastases##5##5##(2007-11#5)
surgical treatment of familial adenomatous polyposis coli##2##7##(2012-1#2)
surgical treatment of hepatic##2##4##(1993-9#1)(2013-1#1)
surgical treatment of idiopathic##2##4##(1990-9#1)(2007-11#1)
surgical treatment of rheumatoid##2##4##(1991-11#1)(2007-11#1)
surgical treatment of spinal##3##4##(2007-11#2)(2013-8#1)
surgical treatment of the urinary bladder##2##6##(2011-2#2)
surgical treatment of the##4##4##(1991-6#1)(1993-8#1)(2011-2#2)
surgical treatment of##73##3##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#17)(2007-12#2)(2007-8#5)(2008-10#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#4)
surgical treatment options##2##3##(2010-6#1)(2013-1#1)
surgical treatment results##2##3##(2007-11#1)(2013-1#1)
surgical treatment was performed##2##4##(1993-9#1)(2007-11#1)
surgical treatment was##10##3##(1990-3#1)(1990-8#1)(1993-9#1)(1994-12#1)(2007-11#3)(2007-8#1)(2009-3#1)(2012-3#1)
surgical treatment were##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
surgical treatment with##4##3##(1991-6#1)(2006-12#1)(2007-11#1)(2008-10#1)
surgical treatment within##2##3##(2007-11#1)(2011-3#1)
surgical treatment##209##2##(1990-12#1)(1990-3#3)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#6)(1991-11#2)(1991-2#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-9#4)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#36)(2007-12#2)(2007-8#21)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#7)(2009-1#1)(2009-3#3)(2009-4#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#3)(2012-3#3)(2013-1#10)(2013-8#5)
surgical treatment]##4##2##(1993-2#1)(1993-5#1)(2008-4#1)(2013-8#1)
surgical treatments in##2##3##(1990-6#1)(2012-3#1)
surgical treatments##6##2##(1990-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-3#1)
surgical wards##2##2##(2007-12#2)
surgical wound##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
surgical##1587##1##(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#10)(1990-5#13)(1990-6#17)(1990-8#5)(1990-9#17)(1991-1#5)(1991-11#4)(1991-12#3)(1991-2#5)(1991-3#18)(1991-5#4)(1991-6#11)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#6)(1992-6#12)(1992-9#11)(1993-1#5)(1993-12#7)(1993-2#2)(1993-3#13)(1993-5#7)(1993-6#10)(1993-8#2)(1993-9#9)(1994-11#1)(1994-12#9)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#6)(1995-4#7)(1995-5#3)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-6#2)(1996-9#9)(1997-1#2)(1997-2#4)(1997-3#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#7)(2006-10#7)(2006-12#5)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#72)(2007-12#42)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-7#16)(2007-8#113)(2007-9#3)(2008-1#12)(2008-10#35)(2008-11#17)(2008-12#18)(2008-2#6)(2008-3#10)(2008-4#25)(2008-5#10)(2008-6#38)(2008-7#79)(2008-8#34)(2008-9#52)(2009-1#1)(2009-10#3)(2009-12#7)(2009-2#4)(2009-3#13)(2009-4#16)(2009-5#10)(2009-6#1)(2009-7#6)(2009-8#6)(2010-10#10)(2010-11#7)(2010-12#14)(2010-3#20)(2010-4#1)(2010-5#7)(2010-6#10)(2010-7#11)(2010-8#36)(2010-9#1)(2011-1#22)(2011-2#134)(2011-3#12)(2011-7#2)(2012-1#15)(2012-12#33)(2012-2#28)(2012-3#62)(2013-1#115)(2013-7#2)(2013-8#30)
surgically and##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
surgically by##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
surgically challenging##2##2##(2008-10#1)(2011-2#1)
surgically correctable##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
surgically excised##5##2##(1997-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
surgically implanted##2##2##(2008-5#1)(2010-6#1)
surgically in##2##2##(2007-8#1)(2008-7#1)
surgically prepared##2##2##(1993-12#1)(2008-9#1)
surgically removed##6##2##(1991-2#1)(1997-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
surgically resected##7##2##(1993-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-12#1)(2012-1#1)
surgically treated by##2##3##(1994-6#1)(2008-7#1)
surgically treated cases##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
surgically treated in childhood##2##4##(1996-11#1)(2007-8#1)
surgically treated in the same center##2##6##(2008-6#2)
surgically treated in the##3##4##(2008-6#2)(2012-3#1)
surgically treated in##6##3##(1996-11#1)(2007-8#2)(2008-6#2)(2012-3#1)
surgically treated patients##2##3##(2008-7#2)
surgically treated##26##2##(1990-9#1)(1992-9#2)(1994-6#1)(1996-11#1)(2006-12#1)(2007-11#3)(2007-8#2)(2008-12#1)(2008-6#2)(2008-7#5)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
surgically##120##1##(1990-12#2)(1990-2#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-9#2)(1993-12#2)(1993-2#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#11)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#18)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#1)
surging##2##1##(2008-1#1)(2010-8#1)
surimi samples##2##2##(2011-2#2)
surimi seafood products##2##3##(2011-2#2)
surimi##4##1##(2011-2#4)
surmised##2##1##(2008-5#1)(2009-10#1)
surmounted##3##1##(2008-4#1)(2010-11#1)(2012-3#1)
surname##2##1##(1992-5#1)(1997-5#1)
surnames)##2##1##(2013-1#2)
surpass##3##1##(1995-12#1)(2011-2#1)(2013-8#1)
surpassed the##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
surpassed##8##1##(1991-5#1)(1994-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2012-2#1)
surplus##5##1##(1992-12#1)(1994-11#1)(1996-3#1)(2008-6#1)(2012-12#1)
surpluses##3##1##(1991-3#1)(1992-12#1)(2008-7#1)
surprise##10##1##(1990-11#2)(1990-3#1)(1992-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-5#1)(2011-1#1)
surprises##3##1##(1992-2#1)(2010-11#2)
surprising and##3##2##(1991-12#1)(2008-5#1)(2008-7#1)
surprising given the##2##3##(2008-10#1)(2010-3#1)
surprising number##3##2##(2007-2#1)(2008-11#1)(2013-1#1)
surprising result##2##2##(2008-6#1)(2008-7#1)
surprising that##7##2##(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-8#1)
surprising to##2##2##(2008-11#1)(2012-3#1)
surprising##43##1##(1990-8#1)(1991-12#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
surprisingly complex##2##2##(1991-5#1)(2008-8#1)
surprisingly high##6##2##(1991-8#1)(1994-8#1)(2007-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
surprisingly little##4##2##(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
surprisingly similar##2##2##(1995-11#1)(2008-8#1)
surprisingly##53##1##(1990-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-12#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-12#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#3)
surrender##2##1##(2010-12#1)(2011-2#1)
surrogate assays##2##2##(2008-9#1)(2011-1#1)
surrogate biomarkers##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
surrogate decision makers##2##3##(1995-12#1)(2010-4#1)
surrogate endpoint##3##2##(2011-2#1)(2012-3#2)
surrogate endpoints in##2##3##(1994-9#1)(2008-8#1)
surrogate endpoints##3##2##(1994-9#1)(2008-11#1)(2008-8#1)
surrogate marker for##4##3##(2007-10#2)(2009-4#1)(2009-6#1)
surrogate marker##6##2##(2007-10#2)(2008-8#1)(2009-4#1)(2009-6#1)(2011-7#1)
surrogate markers##7##2##(2006-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
surrogate measures##2##2##(2008-1#1)(2008-8#1)
surrogate serologic tests##3##3##(1995-5#3)
surrogate standard##2##2##(2008-10#2)
surrogate test##2##2##(1995-1#2)
surrogate##64##1##(1992-3#3)(1992-8#1)(1993-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#3)(1995-6#1)(1997-3#1)(2006-10#1)(2007-10#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
surrogates##8##1##(1995-5#1)(2008-10#3)(2008-8#1)(2009-2#1)(2010-4#1)(2013-1#1)
surround the##3##2##(1991-5#1)(1994-5#1)(2008-10#1)
surround##9##1##(1991-5#1)(1994-5#1)(1994-9#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
surrounded by a##11##3##(1991-11#1)(1991-8#1)(2007-10#1)(2007-12#3)(2008-10#2)(2008-7#1)(2012-2#1)(2013-8#1)
surrounded by an area of##3##5##(1991-11#1)(2008-10#1)(2011-2#1)
surrounded by an##7##3##(1991-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2011-2#1)
surrounded by regions##2##3##(2007-12#1)(2008-10#1)
surrounded by the##2##3##(2008-10#1)(2009-10#1)
surrounded by##45##2##(1991-11#2)(1991-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-4#1)(2007-10#1)(2007-12#7)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
surrounded the##2##2##(2007-10#1)(2008-10#1)
surrounded##53##1##(1991-11#2)(1991-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-12#8)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2009-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
surrounding OxyContin abuse##2##3##(2008-3#2)
surrounding a##9##2##(1991-5#1)(1992-3#1)(1994-11#1)(1997-4#2)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
surrounding area##4##2##(1995-11#3)(2007-11#1)
surrounding areas##4##2##(1993-6#1)(2008-11#1)(2009-10#1)(2013-1#1)
surrounding blood##2##2##(1995-12#1)(2011-2#1)
surrounding brain tissue##3##3##(2008-5#1)(2008-7#2)
surrounding cell##2##2##(2008-7#2)
surrounding each##2##2##(2008-10#1)(2008-8#1)
surrounding environment##7##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#2)
surrounding microenvironment##2##2##(2011-1#1)(2011-2#1)
surrounding municipalities##2##2##(1990-2#2)
surrounding muscles##2##2##(2008-12#1)(2013-8#1)
surrounding normal##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)
surrounding regions##2##2##(1995-3#1)(2008-4#1)
surrounding soft tissue##2##3##(2008-9#1)(2010-6#1)
surrounding soft tissues##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
surrounding soft##5##2##(2007-8#1)(2008-9#2)(2010-6#1)(2012-12#1)
surrounding soil##2##2##(2008-12#2)
surrounding solvent##3##2##(1993-8#1)(2008-10#2)
surrounding structures and##3##3##(2011-2#2)(2013-1#1)
surrounding structures##9##2##(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
surrounding support cells##2##3##(2008-9#1)(2009-3#1)
surrounding the hip##2##3##(2007-11#2)
surrounding the nucleus##2##3##(2008-10#1)(2009-10#1)
surrounding the potential##2##3##(2008-11#2)
surrounding the translation initiation sites on##2##6##(1996-8#1)(1997-2#1)
surrounding the translation initiation sites##6##5##(1996-8#3)(1997-2#2)(1997-6#1)
surrounding the use of##2##4##(2008-11#1)(2008-3#1)
surrounding the##77##2##(1991-10#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#2)(1993-2#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-8#4)(1997-2#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-9#1)(2006-10#1)(2007-11#5)(2007-12#4)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
surrounding this##2##2##(1992-3#1)(2008-11#1)
surrounding tissue##5##2##(1990-11#2)(1991-2#1)(1997-4#1)(2013-1#1)
surrounding tissues##10##2##(1990-6#1)(1993-11#1)(1993-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
surrounding##291##1##(1990-11#2)(1990-2#2)(1990-6#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-5#4)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#3)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#6)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#4)(1997-2#7)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-11#10)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#22)(2008-11#15)(2008-12#9)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#13)(2008-8#15)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#3)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#13)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#9)(2013-8#3)
surroundings of the##2##3##(2008-5#1)(2009-7#1)
surroundings of##3##2##(1995-2#1)(2008-5#1)(2009-7#1)
surroundings to##2##2##(1992-2#1)(2008-10#1)
surroundings##18##1##(1992-2#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2008-3#4)(2008-5#2)(2008-9#1)(2009-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
surrounds a##2##2##(2007-12#1)(2011-2#1)
surrounds the##6##2##(1996-5#1)(2007-12#2)(2008-7#2)(2008-8#1)
surrounds##10##1##(1996-11#1)(1996-5#1)(2007-12#3)(2008-7#3)(2008-8#1)(2011-2#1)
surtout##2##1##(2008-11#1)(2011-2#1)
surveillance and assessment activities##2##4##(1997-3#2)
surveillance and assessment##3##3##(1997-3#3)
surveillance and information systems##2##4##(1997-3#2)
surveillance and management##3##3##(2009-12#1)(2012-3#2)
surveillance and monitoring##2##3##(1997-1#1)(2007-12#1)
surveillance and public health information systems##3##6##(1997-3#3)
surveillance and public health##4##4##(1997-3#3)(2010-8#1)
surveillance and research##2##3##(2009-5#1)(2011-2#1)
surveillance and the##2##3##(2009-12#1)(2011-2#1)
surveillance and##44##2##(1990-12#1)(1990-3#2)(1992-2#1)(1993-1#1)(1997-1#1)(1997-2#2)(1997-3#8)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
surveillance are##2##2##(1997-3#1)(2008-8#1)
surveillance data are##2##3##(1997-3#1)(2008-8#1)
surveillance data for##2##3##(1995-3#1)(2013-8#1)
surveillance data##10##2##(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#3)(2008-8#2)(2013-8#2)
surveillance definition##3##2##(1992-9#3)
surveillance efforts##2##2##(2007-12#1)(2010-8#1)
surveillance for##15##2##(1994-12#1)(1997-3#5)(2008-1#1)(2008-10#2)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
surveillance form##2##2##(2007-12#2)
surveillance from##3##2##(1996-11#1)(2011-2#1)(2012-3#1)
surveillance in the##4##3##(1997-3#2)(2011-1#1)(2012-3#1)
surveillance in##14##2##(1996-6#1)(1997-3#3)(2007-12#2)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
surveillance is##5##2##(1995-3#1)(1997-3#2)(2012-3#2)
surveillance network##2##2##(2011-9#2)
surveillance of acute##2##3##(2007-10#1)(2007-12#1)
surveillance of health and safety in microbiology laboratories##2##8##(1995-3#2)
surveillance of the##7##3##(1990-12#1)(1991-11#1)(1992-11#1)(1992-5#1)(1997-5#1)(2008-1#1)(2009-12#1)
surveillance of these##2##3##(1991-11#1)(2009-12#1)
surveillance of##44##2##(1990-12#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-5#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#3)(2009-12#2)(2009-2#1)(2010-4#2)(2011-2#2)(2012-12#3)(2012-3#7)(2013-1#1)(2013-8#1)
surveillance on the##3##3##(1996-11#1)(2013-8#2)
surveillance on##4##2##(1996-11#1)(2011-2#1)(2013-8#2)
surveillance or##2##2##(2010-12#1)(2012-12#1)
surveillance program##4##2##(1993-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
surveillance programs have##2##3##(1991-12#1)(2012-1#1)
surveillance programs##6##2##(1991-12#2)(2008-10#1)(2012-1#1)(2012-12#2)
surveillance protocol##2##2##(2008-1#1)(2008-6#1)
surveillance results##2##2##(2011-2#2)
surveillance site of##2##3##(2012-3#2)
surveillance site##7##2##(2012-3#7)
surveillance strategies##3##2##(2008-1#1)(2009-5#1)(2011-2#1)
surveillance studies##2##2##(1993-2#1)(2007-11#1)
surveillance study conducted##2##3##(1991-11#1)(2008-3#1)
surveillance study in##2##3##(1991-11#1)(2008-7#1)
surveillance study##6##2##(1991-11#2)(1993-2#1)(2007-7#1)(2008-3#1)(2008-7#1)
surveillance system for##2##3##(1997-3#1)(2012-12#1)
surveillance system in##2##3##(2007-12#1)(2011-2#1)
surveillance system##17##2##(1991-12#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-3#4)(2007-12#1)(2011-2#1)(2012-12#5)
surveillance systems and##2##3##(1997-3#2)
surveillance systems for##2##3##(1997-3#1)(2008-12#1)
surveillance systems were##2##3##(1994-9#1)(1997-3#1)
surveillance systems will##2##3##(1997-3#2)
surveillance systems##23##2##(1994-9#1)(1997-3#12)(2008-12#1)(2008-7#5)(2011-2#1)(2012-12#1)(2013-1#2)
surveillance to##4##2##(2007-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
surveillance using a##3##3##(1997-3#1)(2013-1#2)
surveillance was##2##2##(2010-12#1)(2011-2#1)
surveillance will##2##2##(1997-3#1)(2008-12#1)
surveillance##334##1##(1990-12#2)(1990-3#2)(1991-11#4)(1991-12#6)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#3)(1992-5#1)(1992-6#2)(1992-9#4)(1993-1#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#2)(1996-1#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#55)(1997-5#2)(2007-10#1)(2007-11#2)(2007-12#24)(2007-7#4)(2008-1#13)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#2)(2009-12#9)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#3)(2010-8#3)(2011-1#2)(2011-2#27)(2011-3#2)(2011-9#5)(2012-1#1)(2012-12#20)(2012-2#4)(2012-3#21)(2013-1#11)(2013-7#2)(2013-8#8)
surveillance)##3##1##(2008-10#1)(2009-12#1)(2010-3#1)
survenue##4##1##(2011-2#1)(2013-1#3)
survey about##2##2##(1990-3#1)(2013-1#1)
survey also##3##2##(1994-12#1)(2008-6#1)(2010-5#1)
survey among##8##2##(1990-11#1)(1992-3#1)(2007-12#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
survey and a##3##3##(1992-5#1)(2007-11#1)(2010-3#1)
survey and administrative data##2##4##(1995-2#1)(1995-3#1)
survey and in##2##3##(2008-8#1)(2011-1#1)
survey and##19##2##(1991-11#1)(1992-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
survey are##3##2##(1994-1#1)(1996-3#2)
survey area##2##2##(2007-5#2)
survey as a##2##3##(2008-12#1)(2009-10#1)
survey as##4##2##(1994-2#1)(2008-12#1)(2009-10#1)(2013-1#1)
survey assessing##2##2##(2008-11#1)(2013-1#1)
survey at##3##2##(2006-12#1)(2009-5#1)(2013-1#1)
survey can##3##2##(1994-9#1)(1995-12#1)(2011-2#1)
survey cards##3##2##(1994-11#3)
survey conducted among the##3##4##(1991-12#1)(1996-1#1)(1997-3#1)
survey conducted by##2##3##(1996-3#1)(2013-1#1)
survey conducted in##4##3##(1991-3#1)(1996-9#1)(2008-1#1)(2008-10#1)
survey conducted##12##2##(1991-12#1)(1991-3#1)(1994-2#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
survey consisting of##2##3##(1996-1#1)(2008-7#1)
survey data and##2##3##(1997-3#1)(2008-10#1)
survey data from the##2##4##(1993-3#1)(1997-3#1)
survey data from##4##3##(1992-12#1)(1993-3#1)(1997-3#1)(2010-9#1)
survey data##24##2##(1991-6#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-3#3)(2007-11#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
survey during##2##2##(2008-11#1)(2011-1#1)
survey findings##3##2##(1994-1#1)(2013-1#2)
survey for the##2##3##(1994-3#1)(2013-8#1)
survey for##14##2##(1990-12#1)(1991-5#1)(1994-3#2)(1995-12#1)(1996-3#1)(2008-10#4)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
survey from##5##2##(1992-3#1)(1995-8#1)(1997-2#1)(2008-8#1)(2011-1#1)
survey has##3##2##(1991-11#1)(1996-1#1)(1997-8#1)
survey in a##4##3##(2007-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
survey in the##5##3##(1991-6#1)(1992-2#1)(1994-3#1)(1995-11#1)(2009-10#1)
survey in##32##2##(1990-3#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-8#1)(1995-11#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#2)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
survey included##2##2##(2008-1#1)(2008-11#1)
survey includes##2##2##(1991-12#1)(2008-10#1)
survey indicate that##2##3##(1990-3#1)(1992-11#1)
survey indicate##4##2##(1990-3#1)(1992-11#1)(1995-1#1)(2008-12#1)
survey indicated##2##2##(1995-1#1)(2008-10#1)
survey information##2##2##(1992-12#1)(1996-2#1)
survey instrument and##2##3##(1994-2#1)(1996-3#1)
survey instrument##3##2##(1994-2#1)(1996-1#1)(1996-3#1)
survey instruments##2##2##(1996-2#1)(2013-8#1)
survey is presented##2##3##(2008-11#1)(2012-1#1)
survey is##8##2##(1995-1#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-1#1)
survey measurements##2##2##(1990-11#1)(2007-12#1)
survey method##2##2##(1991-3#1)(2008-11#1)
survey methods##6##2##(1994-2#1)(1995-2#1)(1997-1#1)(2009-4#1)(2010-1#1)(2013-7#1)
survey of 200##3##3##(1997-2#1)(2008-12#1)(2009-4#1)
survey of Canadian##3##3##(1992-2#1)(1994-12#1)(2008-11#1)
survey of U##2##3##(1995-1#1)(2012-1#1)
survey of a##2##3##(2008-10#1)(2009-11#1)
survey of all##8##3##(1990-12#1)(1994-3#2)(1995-5#1)(1997-2#1)(2008-1#2)(2010-9#1)
survey of commercial##2##3##(2008-10#2)
survey of current##2##3##(2008-10#1)(2008-9#1)
survey of excipients used in approved injectable products##2##8##(2012-2#2)
survey of general practitioners##2##4##(1997-5#1)(2008-3#1)
survey of hospital##2##3##(1994-1#1)(1994-3#1)
survey of members##3##3##(1994-3#1)(1995-1#1)(1995-2#1)
survey of mental##2##3##(2010-5#1)(2011-1#1)
survey of pediatric##2##3##(1992-12#1)(1997-8#1)
survey of the literature##2##4##(2008-10#1)(2010-3#1)
survey of the##20##3##(1992-10#1)(1992-3#1)(1994-2#2)(1994-3#1)(1994-6#2)(1996-9#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
survey of trypanozoon infection in horses##2##6##(2011-2#2)
survey of users##2##3##(1991-1#2)
survey of##195##2##(1990-12#1)(1991-1#2)(1991-11#1)(1991-3#3)(1991-6#1)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#3)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#8)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-8#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-1#7)(2008-10#23)(2008-11#8)(2008-12#4)(2008-3#2)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
survey on indoor##2##3##(2008-10#2)
survey on knowledge##2##3##(1990-8#1)(1997-6#1)
survey on the##3##3##(2010-3#1)(2011-2#1)(2012-2#1)
survey on##18##2##(1990-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#3)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
survey points##2##2##(2008-9#1)(2013-8#1)
survey procedures##2##2##(1996-2#1)(2012-3#1)
survey provides##2##2##(1997-2#1)(2008-12#1)
survey questionnaire##3##2##(1991-8#1)(1993-12#1)(2012-2#1)
survey questionnaires##2##2##(2008-12#1)(2012-12#1)
survey questions##3##2##(1993-2#1)(2008-7#1)(2013-1#1)
survey reported##2##2##(2013-8#2)
survey respondents##2##2##(2013-1#2)
survey responses from##2##3##(1996-3#1)(2012-3#1)
survey responses##7##2##(1993-1#1)(1994-12#1)(1995-1#1)(1996-3#1)(2008-12#1)(2012-3#1)(2013-1#1)
survey results##15##2##(1991-3#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-12#1)(2011-10#1)(2013-1#3)(2013-8#1)
survey revealed a##2##3##(2008-10#1)(2008-8#1)
survey revealed that##3##3##(1994-3#1)(2008-10#2)
survey revealed##6##2##(1990-12#1)(1994-3#1)(2008-10#3)(2008-8#1)
survey reveals that##2##3##(2008-11#1)(2013-8#1)
survey sampling##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
survey showed that the##2##4##(2007-11#1)(2008-12#1)
survey showed that##6##3##(1993-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)
survey showed##10##2##(1993-6#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
survey showing##2##2##(2008-5#1)(2008-9#1)
survey study##4##2##(2008-8#1)(2009-11#1)(2010-10#1)(2012-2#1)
survey suggests that##2##3##(1994-12#1)(1996-1#1)
survey that##4##2##(1993-11#1)(1996-3#1)(2012-3#1)(2013-1#1)
survey the##5##2##(2007-11#2)(2008-10#1)(2009-12#1)(2013-1#1)
survey to assess##2##3##(1995-12#1)(2012-12#1)
survey to determine##2##3##(1996-12#1)(2009-11#1)
survey to##12##2##(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-11#1)(2012-12#1)(2013-1#2)
survey tool##2##2##(2012-12#1)(2013-1#1)
survey two##2##2##(1991-2#1)(2007-8#1)
survey undertaken##2##2##(1996-12#1)(2008-10#1)
survey using##3##2##(1997-1#1)(2008-10#1)(2011-1#1)
survey was administered to##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
survey was administered##4##3##(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
survey was applied to##2##4##(2012-2#1)(2013-1#1)
survey was carried out in##2##5##(2008-9#1)(2010-5#1)
survey was carried out##7##4##(1997-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)
survey was completed by##2##4##(1992-12#1)(2008-11#1)
survey was conducted in early##2##5##(1997-1#1)(2008-9#1)
survey was conducted in##9##4##(1991-3#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2012-12#1)
survey was conducted on##3##4##(1997-5#1)(2008-12#1)(2013-1#1)
survey was conducted to identify##2##5##(1997-1#1)(2012-3#1)
survey was conducted to##9##4##(1997-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
survey was conducted using a##2##5##(1991-12#1)(2010-8#1)
survey was conducted##33##3##(1991-12#1)(1991-3#1)(1992-6#1)(1993-2#1)(1994-2#1)(1996-1#2)(1997-1#2)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
survey was designed to##2##4##(1996-3#1)(2010-3#1)
survey was designed##3##3##(1996-3#1)(2008-8#1)(2010-3#1)
survey was sent to the##2##5##(2007-12#1)(2013-1#1)
survey was sent to##6##4##(1993-1#1)(2007-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
survey was sent##7##3##(1993-1#1)(2007-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
survey was to##5##3##(1991-12#1)(1993-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
survey was undertaken##3##3##(2008-3#1)(2010-1#1)(2013-1#1)
survey was used to##3##4##(1996-3#1)(2010-6#1)(2013-7#1)
survey was##86##2##(1990-12#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#2)(1996-3#2)(1997-1#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#2)(2008-10#7)(2008-11#3)(2008-12#6)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
survey were##8##2##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#1)(2011-2#1)
survey will##2##2##(1996-1#1)(2008-12#1)
survey with##4##2##(1992-12#1)(1997-5#1)(2008-7#1)(2010-10#1)
survey##849##1##(1990-11#2)(1990-12#4)(1990-3#7)(1990-6#2)(1990-8#2)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#3)(1991-3#10)(1991-5#3)(1991-6#3)(1991-8#4)(1992-1#7)(1992-10#1)(1992-11#3)(1992-12#7)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#4)(1992-7#1)(1993-1#8)(1993-10#2)(1993-11#3)(1993-12#9)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#3)(1994-1#12)(1994-11#6)(1994-12#13)(1994-2#22)(1994-3#20)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#10)(1995-11#1)(1995-12#12)(1995-2#11)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#19)(1996-11#1)(1996-12#9)(1996-2#7)(1996-3#20)(1996-4#1)(1996-8#3)(1996-9#2)(1997-1#9)(1997-2#7)(1997-3#11)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#1)(1997-8#5)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-5#3)(2007-7#3)(2007-8#2)(2008-1#18)(2008-10#71)(2008-11#32)(2008-12#32)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#6)(2008-7#12)(2008-8#12)(2008-9#15)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#16)(2011-10#2)(2011-2#34)(2012-1#7)(2012-12#13)(2012-2#22)(2012-3#11)(2013-1#50)(2013-7#4)(2013-8#21)
survey]##7##1##(1990-12#1)(1993-11#2)(1993-2#1)(1994-5#1)(1997-3#1)(2012-3#1)
surveyed 1##2##2##(1991-2#1)(2010-8#1)
surveyed areas##2##2##(2008-10#1)(2008-8#1)
surveyed by##5##2##(1990-12#1)(1995-1#1)(2007-12#1)(2008-5#1)(2010-2#1)
surveyed for##7##2##(1996-12#1)(1997-4#1)(2007-5#1)(2008-10#2)(2010-8#1)(2012-3#1)
surveyed in the##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
surveyed in##13##2##(1992-3#1)(1993-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)
surveyed its members##2##3##(1994-1#1)(1995-3#1)
surveyed its##4##2##(1994-1#1)(1995-3#1)(1996-1#1)(2008-1#1)
surveyed the##2##2##(2010-7#1)(2011-2#1)
surveyed were##3##2##(1992-5#1)(1995-6#1)(2008-7#1)
surveyed##122##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)
surveying##10##1##(1993-1#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#2)(2008-9#1)(2011-2#2)(2012-2#1)
surveys and##16##2##(1991-12#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-3#1)(2008-10#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
surveys are##6##2##(1993-6#1)(1994-3#2)(1996-3#1)(1997-3#1)(2008-8#1)
surveys as a##2##3##(1996-3#1)(2012-12#1)
surveys assessing##2##2##(2009-5#1)(2010-8#1)
surveys at##3##2##(1994-2#1)(2013-1#2)
surveys conducted by##3##3##(1996-2#1)(1997-1#1)(2008-9#1)
surveys conducted in##5##3##(1993-1#1)(2008-12#1)(2010-9#1)(2013-7#1)(2013-8#1)
surveys conducted##10##2##(1993-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-9#1)(2013-7#1)(2013-8#1)
surveys for##3##2##(1993-6#1)(1995-2#1)(2012-2#1)
surveys from##2##2##(1993-6#1)(1996-12#1)
surveys in the United States##2##5##(2008-12#1)(2013-8#1)
surveys in the##6##3##(1993-6#1)(1996-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
surveys in##13##2##(1993-6#2)(1995-3#1)(1996-3#2)(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
surveys indicate that##3##3##(1994-3#1)(2010-8#1)(2012-12#1)
surveys indicate##4##2##(1994-3#1)(2008-8#1)(2010-8#1)(2012-12#1)
surveys of parents##2##3##(2012-12#2)
surveys of the##2##3##(1996-11#1)(2008-1#1)
surveys of##13##2##(1993-6#1)(1993-9#1)(1996-11#1)(1996-12#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#2)(2012-2#1)
surveys on##5##2##(1992-2#1)(1994-2#1)(2008-10#2)(2008-2#1)
surveys show that##4##3##(1990-6#1)(2013-8#3)
surveys the##4##2##(1990-2#1)(1991-1#1)(1992-3#1)(2008-4#1)
surveys to##10##2##(1991-9#1)(1992-1#1)(1994-3#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-8#1)
surveys using##3##2##(2007-5#1)(2009-4#1)(2009-8#1)
surveys were conducted in##2##4##(1992-12#1)(1994-9#1)
surveys were conducted##4##3##(1992-12#1)(1994-9#1)(2007-5#2)
surveys were part of the##2##5##(1991-9#1)(2013-8#1)
surveys were received##2##3##(1994-2#1)(2008-12#1)
surveys were returned##3##3##(2007-10#1)(2007-11#1)(2010-11#1)
surveys were##19##2##(1991-9#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-10#2)(2008-12#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
surveys will##2##2##(1996-3#1)(2008-12#1)
surveys##206##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1993-1#2)(1993-12#1)(1993-2#2)(1993-6#7)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#5)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#18)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#4)(2007-5#5)(2007-7#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#7)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-2#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#10)
survivability of the##2##3##(1992-6#1)(2008-11#1)
survivability##9##1##(1992-6#1)(1994-5#1)(1996-12#5)(2007-6#1)(2008-11#1)
survival (DFS)##7##2##(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)
survival (OS)##12##2##(1991-8#1)(1992-10#1)(1993-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#4)
survival (P##2##2##(2012-3#1)(2013-1#1)
survival (RFS)##3##2##(2008-6#1)(2011-2#2)
survival ability##2##2##(2008-10#2)
survival advantage in GBM##2##4##(2009-4#2)
survival advantage in##5##3##(2008-1#1)(2009-4#4)
survival advantage was found with##2##5##(2008-7#2)
survival advantage##11##2##(1997-7#1)(2007-12#1)(2008-1#1)(2008-7#2)(2009-4#4)(2011-2#1)(2012-3#1)
survival after sleeve pneumonectomy combined with the superior vena cava##2##10##(2007-8#2)
survival after##15##2##(1992-5#1)(1993-8#1)(1997-3#1)(1997-5#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
survival age##3##2##(1996-2#3)
survival among##6##2##(1990-8#1)(1991-6#1)(2008-4#1)(2009-1#1)(2009-5#1)(2010-3#1)
survival analysis##9##2##(1997-4#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-7#1)(2013-1#1)
survival and a significant##2##4##(1994-6#1)(2013-7#1)
survival and a##3##3##(1994-6#1)(2008-6#1)(2013-7#1)
survival and breeding##2##3##(2008-8#2)
survival and chlamydospore production##2##4##(2008-10#2)
survival and development of##2##4##(2008-4#1)(2010-2#1)
survival and development##5##3##(2008-4#1)(2010-2#1)(2013-7#3)
survival and differentiation of##2##4##(1996-12#1)(2010-11#1)
survival and differentiation##8##3##(1996-12#1)(1996-5#1)(1997-6#2)(2008-5#1)(2009-8#1)(2010-11#1)(2010-8#1)
survival and disease-free survival##2##4##(1992-8#1)(2011-2#1)
survival and disease-free##3##3##(1992-8#1)(1994-2#1)(2011-2#1)
survival and formation of##2##4##(2008-11#1)(2012-1#1)
survival and function##3##3##(2009-3#1)(2010-11#2)
survival and growth of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
survival and growth##9##3##(1993-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-7#1)
survival and insufficient neuronal differentiation##2##5##(2009-10#2)
survival and progression##2##3##(2008-10#1)(2012-12#1)
survival and proliferation of##2##4##(2008-9#1)(2011-2#1)
survival and quality of life of the##2##7##(2007-11#1)(2011-3#1)
survival and quality of life of##3##6##(2007-11#1)(2008-7#1)(2011-3#1)
survival and the##7##3##(1991-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-3#2)(2013-1#1)
survival and time to##2##4##(2008-10#1)(2008-8#1)
survival and to reduce##2##4##(1994-6#1)(2007-8#1)
survival and to##3##3##(1994-6#1)(2007-8#1)(2010-5#1)
survival and##118##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-4#2)(1991-8#1)(1992-8#1)(1993-2#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#6)
survival and/or##2##2##(1994-12#1)(1996-12#1)
survival are##3##2##(2008-10#1)(2010-3#1)(2011-1#1)
survival as##2##2##(1990-6#1)(2008-1#1)
survival at 5 years of##2##5##(1991-2#1)(1994-6#1)
survival at 5 years was##2##5##(1990-2#1)(2008-6#1)
survival at 5 years##4##4##(1990-2#1)(1991-2#1)(1994-6#1)(2008-6#1)
survival at 5##5##3##(1990-2#1)(1991-2#1)(1994-6#1)(2006-10#1)(2008-6#1)
survival at three years##2##4##(1991-4#1)(2007-8#1)
survival at##16##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1994-6#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)
survival benefit in##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
survival benefit##9##2##(1993-1#1)(2008-10#2)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#3)
survival benefits##2##2##(2008-11#1)(2011-2#1)
survival between##6##2##(1993-9#1)(1996-9#1)(2008-6#3)(2010-3#1)
survival beyond##3##2##(1995-12#1)(1997-4#1)(2009-12#1)
survival but##2##2##(2008-10#1)(2011-2#1)
survival by##6##2##(1993-11#1)(1993-9#1)(1995-4#1)(2007-8#1)(2008-9#2)
survival can be##4##3##(1995-5#1)(1997-3#1)(2007-12#1)(2013-1#1)
survival compared with##2##3##(2008-7#1)(2010-3#1)
survival compared##3##2##(2008-7#2)(2010-3#1)
survival curve##6##2##(1995-3#4)(1997-4#1)(2008-8#1)
survival curves of##2##3##(1995-1#1)(2012-2#1)
survival curves were##5##3##(1992-5#1)(2007-7#1)(2007-8#1)(2008-6#1)(2013-1#1)
survival curves##20##2##(1991-4#2)(1992-5#1)(1995-1#2)(1995-3#3)(2007-7#1)(2007-8#2)(2008-6#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
survival data##7##2##(1990-2#1)(1992-2#1)(1995-12#1)(1997-3#2)(1997-7#1)(2012-2#1)
survival depends on##2##3##(2008-8#1)(2011-3#1)
survival depends##3##2##(1996-12#1)(2008-8#1)(2011-3#1)
survival distribution##4##2##(1995-12#1)(1995-9#3)
survival due to##2##3##(1991-12#1)(2012-3#1)
survival during the##3##3##(1994-2#1)(2008-6#1)(2010-11#1)
survival during##12##2##(1994-2#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-3#1)
survival dynamics##2##2##(2012-2#2)
survival expectancies##2##2##(2010-3#1)(2011-2#1)
survival factor##3##2##(2008-11#1)(2009-8#1)(2010-11#1)
survival following##3##2##(1995-4#1)(2008-10#1)(2011-2#1)
survival for patients with##3##4##(2008-3#2)(2011-2#1)
survival for patients##7##3##(1990-8#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-2#1)
survival for the##2##3##(2008-1#1)(2008-8#1)
survival for##19##2##(1990-6#1)(1990-8#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#2)(2011-2#3)(2012-2#1)
survival from##3##2##(1993-1#1)(2008-7#2)
survival function##6##2##(1995-12#1)(2008-10#2)(2012-2#2)(2013-1#1)
survival improvement##3##2##(2007-11#1)(2010-3#1)(2013-1#1)
survival in a##4##3##(1994-12#1)(1995-2#1)(2007-5#1)(2008-10#1)
survival in our##2##3##(1990-8#1)(2008-9#1)
survival in patients with##9##4##(1997-5#1)(1997-7#1)(2008-3#1)(2008-7#1)(2010-11#2)(2011-2#2)(2013-7#1)
survival in patients##13##3##(1994-7#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-11#2)(2011-1#1)(2011-2#3)(2013-7#1)
survival in rat##2##3##(1995-12#1)(2012-1#1)
survival in the##7##3##(2008-11#1)(2008-12#1)(2008-7#2)(2009-9#1)(2012-1#2)
survival in this##2##3##(1991-11#1)(2008-1#1)
survival in vitro##4##3##(2008-10#1)(2008-5#1)(2012-2#2)
survival in##68##2##(1990-3#1)(1990-8#1)(1991-11#1)(1994-12#2)(1994-7#1)(1995-12#1)(1995-2#1)(1996-12#3)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-9#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-2#2)(2013-1#3)(2013-7#1)
survival index##5##2##(2008-10#5)
survival is still##2##3##(2007-5#1)(2011-3#1)
survival is##22##2##(1990-6#1)(1990-9#1)(1992-8#1)(1993-1#1)(1994-12#2)(1994-2#2)(1995-9#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#3)
survival level at the end of irradiation##2##7##(2008-9#2)
survival mechanism##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
survival model##6##2##(1992-6#1)(1994-2#1)(1996-12#2)(1997-8#1)(2013-1#1)
survival models##6##2##(1992-9#1)(1997-4#1)(1997-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
survival of Fusarium##2##3##(2008-10#2)
survival of P##3##3##(2008-10#3)
survival of Verticillium dahliae##2##4##(2008-12#2)
survival of a##3##3##(2008-10#2)(2009-2#1)
survival of an##2##3##(2007-2#1)(2010-10#1)
survival of approximately##2##3##(2007-10#1)(2008-5#1)
survival of cells##2##3##(1993-8#1)(2008-9#1)
survival of cultured##3##3##(1995-5#1)(1996-5#1)(2013-7#1)
survival of exposed##5##3##(2008-9#5)
survival of microsclerotia##2##3##(2008-10#2)
survival of neurons and##2##4##(1996-2#2)
survival of neurons##5##3##(1993-3#1)(1996-2#2)(2008-4#1)(2013-8#1)
survival of patients with##11##4##(1994-6#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
survival of patients##16##3##(1993-8#1)(1994-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
survival of selected pathogenic bacteria in##3##6##(1997-4#3)
survival of the cells##3##4##(2008-11#3)
survival of the pathogen##3##4##(2008-10#1)(2011-2#1)(2013-7#1)
survival of the patients was##2##5##(1993-9#1)(2008-7#1)
survival of the patients##3##4##(1993-9#1)(2008-1#1)(2008-7#1)
survival of the##31##3##(1990-2#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-10#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
survival of these##2##3##(2007-10#1)(2008-10#1)
survival of this##2##3##(1994-12#1)(2011-1#1)
survival of those##2##3##(2008-5#1)(2010-5#1)
survival of two##2##3##(1991-5#1)(2008-10#1)
survival of##194##2##(1990-2#3)(1990-3#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-3#2)(1997-4#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#10)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#15)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-12#2)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#4)
survival on##2##2##(2010-8#1)(2012-2#1)
survival or the##2##3##(1990-11#1)(2008-8#1)
survival or##10##2##(1990-11#1)(1990-8#1)(1992-2#1)(1995-2#1)(2008-8#3)(2008-9#3)
survival outcomes##2##2##(2012-3#1)(2013-1#1)
survival over##2##2##(2008-10#1)(2008-6#1)
survival pathway##5##2##(2009-7#2)(2011-2#3)
survival period of##3##3##(2008-6#2)(2008-7#1)
survival period was##2##3##(2007-11#2)
survival period##6##2##(2007-11#2)(2008-6#2)(2008-7#1)(2012-3#1)
survival periods##2##2##(1995-4#1)(2011-2#1)
survival predictions##2##2##(1992-9#2)
survival probability in##2##3##(1994-10#1)(2011-2#1)
survival probability of##2##3##(2008-6#2)
survival probability##7##2##(1994-10#3)(1995-9#1)(2008-6#2)(2011-2#1)
survival rate after##3##3##(1990-12#1)(1993-8#1)(2010-3#1)
survival rate and##5##3##(1997-7#1)(2006-10#1)(2007-12#1)(2012-12#1)(2013-1#1)
survival rate for##4##3##(2008-6#2)(2010-3#1)(2012-1#1)
survival rate in##4##3##(1994-7#1)(1995-2#1)(2008-10#1)(2011-2#1)
survival rate nor##3##3##(1990-8#1)(1997-7#2)
survival rate of the##3##4##(2007-11#1)(2008-11#1)(2012-3#1)
survival rate of##11##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
survival rate was 88%##2##4##(1991-2#1)(1991-6#1)
survival rate was##24##3##(1990-6#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-10#1)(1993-11#1)(1993-5#1)(1997-7#4)(2007-8#3)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#3)(2013-1#2)
survival rate##84##2##(1990-12#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-10#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-7#2)(1995-2#1)(1995-3#1)(1997-7#9)(2006-10#3)(2007-11#1)(2007-12#2)(2007-8#5)(2008-1#1)(2008-10#5)(2008-11#6)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
survival rates are##2##3##(2008-9#1)(2012-2#1)
survival rates as##2##3##(1994-7#1)(2012-3#1)
survival rates for patients with##2##5##(2007-7#1)(2010-11#1)
survival rates for##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-11#1)
survival rates of##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
survival rates were##4##3##(1990-8#1)(1991-8#1)(2008-3#1)(2012-1#1)
survival rates##45##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-8#1)(1994-12#2)(1994-7#1)(1994-9#3)(1995-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
survival remain##2##2##(2008-8#1)(2010-11#1)
survival showed##2##2##(1994-7#1)(2007-8#1)
survival significantly##3##2##(2008-10#2)(2013-8#1)
survival strategies##5##2##(1990-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
survival studies##4##2##(1994-12#1)(1994-2#2)(1996-2#1)
survival study##2##2##(1993-1#1)(2013-1#1)
survival substantially##2##2##(2008-8#1)(2009-10#1)
survival than##5##2##(1990-2#1)(1991-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
survival that##2##2##(2008-7#1)(2011-2#1)
survival time after##4##3##(1990-9#1)(2007-11#1)(2012-3#2)
survival time for##2##3##(1997-4#2)
survival time is##3##3##(1992-9#1)(1994-2#1)(2007-11#1)
survival time of patients irradiated due to bone metastases##2##9##(2007-11#2)
survival time of patients##4##4##(2007-11#3)(2008-7#1)
survival time of two##2##4##(2013-1#2)
survival time of##12##3##(1990-9#1)(1992-3#1)(2007-11#4)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
survival time or##2##3##(1991-11#1)(2009-9#1)
survival time was 7##2##4##(1991-2#1)(1994-8#1)
survival time was##10##3##(1990-9#1)(1991-2#1)(1992-10#1)(1994-8#1)(2007-11#3)(2008-10#1)(2012-1#1)(2013-8#1)
survival time##47##2##(1990-12#1)(1990-9#3)(1991-11#1)(1991-2#2)(1992-10#1)(1992-3#1)(1992-9#1)(1994-2#2)(1994-8#1)(1995-12#4)(1997-4#2)(2007-11#12)(2007-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
survival times##9##2##(1995-4#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-8#2)
survival tips##2##2##(1997-1#1)(2010-3#1)
survival to##10##2##(1993-8#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#2)(2011-2#1)(2011-9#1)(2012-3#1)
survival under##5##2##(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-3#1)
survival was 36##2##3##(1990-10#1)(2011-2#1)
survival was 8##2##3##(1990-2#1)(2013-1#1)
survival was investigated##2##3##(1992-12#1)(2008-7#1)
survival was reduced##2##3##(2008-6#1)(2008-7#1)
survival was seen##2##3##(1992-12#1)(2012-3#1)
survival was significantly##3##3##(2007-8#1)(2008-6#1)(2008-7#1)
survival was##75##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-8#2)(1991-2#1)(1991-6#5)(1991-8#3)(1992-10#1)(1992-12#6)(1992-5#2)(1993-1#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#4)(2008-6#9)(2008-7#3)(2008-9#6)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
survival were also##2##3##(2012-2#1)(2013-1#1)
survival were##16##2##(1990-12#1)(1990-6#2)(1991-4#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-6#2)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
survival which##2##2##(2008-8#1)(2012-1#1)
survival with an##2##3##(1992-9#1)(2006-10#1)
survival with##8##2##(1992-9#1)(1993-2#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#2)
survival##1392##1##(1990-10#4)(1990-11#1)(1990-12#10)(1990-2#10)(1990-3#2)(1990-5#2)(1990-6#10)(1990-8#11)(1990-9#7)(1991-11#4)(1991-12#7)(1991-2#9)(1991-3#2)(1991-4#8)(1991-5#1)(1991-6#9)(1991-8#10)(1992-10#5)(1992-12#6)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#3)(1992-9#8)(1993-1#11)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#8)(1994-1#1)(1994-10#4)(1994-12#15)(1994-2#10)(1994-3#2)(1994-5#2)(1994-6#9)(1994-7#6)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#13)(1995-2#13)(1995-3#8)(1995-4#5)(1995-5#2)(1995-8#3)(1995-9#8)(1996-11#2)(1996-12#14)(1996-2#7)(1996-3#3)(1996-5#7)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#11)(1997-5#6)(1997-6#2)(1997-7#15)(1997-8#1)(1997-9#1)(2006-10#6)(2006-6#1)(2007-10#9)(2007-11#26)(2007-12#13)(2007-2#1)(2007-4#1)(2007-5#9)(2007-6#2)(2007-7#4)(2007-8#31)(2008-1#27)(2008-10#129)(2008-11#37)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#19)(2008-6#55)(2008-7#79)(2008-8#47)(2008-9#52)(2009-1#2)(2009-10#9)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#10)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#10)(2010-12#4)(2010-2#5)(2010-3#32)(2010-4#2)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#12)(2010-9#2)(2011-1#11)(2011-2#97)(2011-3#11)(2011-9#2)(2012-1#12)(2012-12#15)(2012-2#37)(2012-3#42)(2012-5#2)(2012-7#1)(2013-1#55)(2013-7#15)(2013-8#20)
survival)##4##1##(1992-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
survival-adjusted##2##1##(2008-7#2)
survival/proliferation##2##1##(2009-10#1)(2009-3#1)
survival?##4##1##(1995-3#1)(1995-9#1)(2007-8#1)(2008-7#1)
survival]##2##1##(1995-5#1)(2008-5#1)
survivals for IgAN RTX were##2##5##(2008-8#2)
survivals##3##1##(2008-8#3)
survive an##2##2##(2007-10#1)(2007-2#1)
survive and thrive##2##3##(1994-12#1)(1997-1#1)
survive and##9##2##(1992-3#1)(1994-12#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#2)
survive as##2##2##(2008-10#2)
survive beyond##2##2##(1991-11#1)(2008-7#1)
survive for##8##2##(1996-5#1)(2007-12#1)(2008-7#2)(2008-8#2)(2009-6#1)(2013-1#1)
survive in the##3##3##(2008-10#2)(2011-2#1)
survive in today's##2##3##(1992-12#1)(1993-2#1)
survive in##10##2##(1992-12#1)(1993-2#1)(1996-12#1)(2008-10#2)(2008-7#1)(2009-12#2)(2011-2#1)(2013-8#1)
survive longer##2##2##(2008-10#2)
survive the##3##2##(2011-2#2)(2012-3#1)
survive their##3##2##(2008-3#1)(2010-12#1)(2010-8#1)
survive to##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
survive under##2##2##(2011-1#1)(2013-1#1)
survive when##2##2##(2008-10#1)(2012-1#1)
survive##88##1##(1991-11#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-3#3)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-12#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
survived MIR604 in the field the previous##2##7##(2011-2#2)
survived a##3##2##(1990-5#1)(1996-12#1)(2008-10#1)
survived after##5##2##(1994-6#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
survived and##3##2##(2008-10#2)(2011-2#1)
survived at##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
survived for 5 years after##2##5##(2007-8#1)(2008-7#1)
survived for 5 years##3##4##(2007-8#1)(2008-6#1)(2008-7#1)
survived for at least 10##2##5##(2007-6#2)
survived for more than 1##2##5##(2008-10#1)(2011-2#1)
survived for more than three months##2##6##(1990-12#2)
survived for more than##5##4##(1990-12#2)(1991-8#1)(2008-10#1)(2011-2#1)
survived for##13##2##(1990-12#2)(1991-8#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
survived in the##3##3##(2008-10#2)(2012-12#1)
survived in##5##2##(2008-10#3)(2012-12#2)
survived more than 1 year##2##5##(2008-11#1)(2010-8#1)
survived more than 5 years##2##5##(1990-6#1)(2008-6#1)
survived more than##4##3##(1990-6#1)(2008-11#1)(2008-6#1)(2010-8#1)
survived the##6##2##(1990-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#1)
survived to the end of the study##8##7##(2008-9#8)
survived to##9##2##(2008-11#1)(2008-9#8)
survived well in##2##3##(1996-12#1)(2008-8#1)
survived with##5##2##(1990-12#1)(1990-9#2)(2008-4#1)(2013-1#1)
survived without##2##2##(1992-5#1)(1994-9#1)
survived##100##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-2#2)(1996-12#3)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#8)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-12#2)(2013-1#4)
survives in##2##2##(1991-12#1)(2008-3#1)
survives##7##1##(1991-12#1)(1992-6#1)(1995-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)
survivin and##2##2##(2011-2#2)
survivin in##5##2##(2010-1#1)(2011-2#4)
survivin protein##3##2##(2011-2#3)
survivin##19##1##(2010-1#3)(2011-2#16)
surviving and##3##2##(1994-12#1)(2008-7#1)(2009-6#1)
surviving at##2##2##(1997-3#1)(2007-10#1)
surviving birds of groups##2##4##(2010-4#2)
surviving cell##2##2##(2008-6#1)(2008-9#1)
surviving cells##2##2##(2008-11#1)(2008-5#1)
surviving children##2##2##(1994-3#2)
surviving in##3##2##(1996-8#1)(2008-10#1)(2008-7#1)
surviving neurons##2##2##(1994-5#1)(2008-7#1)
surviving patients##3##2##(1991-3#1)(1993-1#1)(2012-3#1)
surviving the##2##2##(1996-12#1)(2010-4#1)
surviving##66##1##(1991-3#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#10)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-8#1)(2011-2#3)(2012-3#2)(2013-8#1)
survivor##17##1##(1991-12#1)(1997-3#2)(2008-10#1)(2008-7#3)(2010-3#2)(2011-2#2)(2012-3#2)(2013-1#4)
survivors after##2##2##(2011-2#1)(2013-1#1)
survivors also##2##2##(2008-7#1)(2010-3#1)
survivors and##7##2##(1991-4#1)(1991-6#2)(2008-11#2)(2008-7#1)(2010-7#1)
survivors are##2##2##(2012-12#1)(2012-3#1)
survivors at##4##2##(2007-10#2)(2008-6#1)(2011-3#1)
survivors in##3##2##(2007-10#1)(2012-3#1)(2013-1#1)
survivors of a##4##3##(1990-5#1)(1991-6#1)(2008-6#2)
survivors of prostate cancer##2##4##(2008-7#2)
survivors of violence##4##3##(2008-11#4)
survivors of##25##2##(1990-5#3)(1991-6#1)(1995-11#1)(1995-6#1)(1996-1#1)(2008-11#7)(2008-12#1)(2008-6#3)(2008-7#5)(2010-3#1)(2012-12#1)
survivors was##3##2##(2008-6#2)(2008-7#1)
survivors##116##1##(1990-11#1)(1990-5#4)(1990-9#1)(1991-12#2)(1991-4#1)(1991-6#3)(1991-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-10#8)(2008-11#9)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#8)(2008-7#22)(2008-8#3)(2009-10#2)(2009-6#1)(2010-11#2)(2010-2#2)(2010-3#5)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-3#6)(2013-1#4)
survivors'##6##1##(2009-10#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
survivorship and##5##2##(2008-9#2)(2012-12#3)
survivorship at##2##2##(2009-4#1)(2013-1#1)
survivorship in##2##2##(2011-2#1)(2013-1#1)
survivorship of##9##2##(2007-5#1)(2008-9#4)(2011-2#1)(2013-1#3)
survivorship on MIR604 in the##2##5##(2011-2#2)
survivorship on MIR604 in##3##4##(2011-2#3)
survivorship on##4##2##(2011-2#4)
survivorship was##4##2##(2009-4#1)(2011-2#2)(2013-1#1)
survivorship##57##1##(2007-5#2)(2008-11#1)(2008-7#8)(2008-8#2)(2008-9#12)(2009-4#2)(2011-2#10)(2012-12#3)(2012-3#6)(2013-1#11)
susceptibilities of##4##2##(1991-8#1)(2007-12#1)(2008-7#2)
susceptibilities to##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
susceptibilities##19##1##(1991-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#8)(2008-10#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-8#1)
susceptibility and a##2##3##(2008-10#2)
susceptibility and##13##2##(1994-2#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
susceptibility and/or##2##2##(2007-10#1)(2008-7#1)
susceptibility between##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
susceptibility can be##2##3##(1993-6#1)(2007-11#1)
susceptibility data##2##2##(1997-7#1)(2008-5#1)
susceptibility effects##2##2##(2012-2#2)
susceptibility for##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
susceptibility from##4##2##(2007-12#2)(2008-10#2)
susceptibility gene for##2##3##(1994-6#1)(2010-2#1)
susceptibility gene##6##2##(1994-6#2)(1994-9#1)(1995-12#1)(1997-8#1)(2010-2#1)
susceptibility genes##8##2##(1994-9#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)
susceptibility has##2##2##(2007-12#1)(2008-4#1)
susceptibility in the##2##3##(1990-7#1)(2011-2#1)
susceptibility in vitro##2##3##(2008-5#1)(2012-2#1)
susceptibility in##14##2##(1990-7#1)(1991-9#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#2)
susceptibility is##2##2##(2011-2#2)
susceptibility loci##3##2##(1997-5#1)(2009-4#1)(2012-3#1)
susceptibility locus##9##2##(1994-12#1)(1994-9#1)(1996-2#1)(1997-5#5)(2011-2#1)
susceptibility may be##2##3##(2008-10#1)(2008-9#1)
susceptibility may##4##2##(2008-1#2)(2008-10#1)(2008-9#1)
susceptibility of 20##2##3##(2008-5#1)(2011-2#1)
susceptibility of LDL to##2##4##(1995-12#2)
susceptibility of diabetic##2##3##(2012-1#1)(2012-2#1)
susceptibility of peach to##2##4##(2008-10#2)
susceptibility of the chickpea cultivar##2##5##(2008-10#2)
susceptibility of the##15##3##(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)
susceptibility of these##4##3##(1994-5#1)(1994-6#1)(1996-12#2)
susceptibility of##80##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-3#1)(1996-12#3)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-6#2)(2008-10#20)(2008-12#2)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
susceptibility on##3##2##(2007-8#1)(2011-1#2)
susceptibility or resistance to##2##4##(2008-7#1)(2008-9#1)
susceptibility or resistance##3##3##(2008-7#1)(2008-9#1)(2012-12#1)
susceptibility or##4##2##(2007-12#1)(2008-7#1)(2008-9#1)(2012-12#1)
susceptibility pattern in Mulago Hospital##2##5##(2010-8#2)
susceptibility pattern in##3##3##(2010-8#2)(2012-3#1)
susceptibility pattern of##3##3##(2007-7#1)(2010-8#1)(2012-3#1)
susceptibility pattern##7##2##(1995-11#1)(2007-7#1)(2010-8#3)(2012-3#2)
susceptibility patterns of##3##3##(2008-12#1)(2008-5#1)(2010-11#1)
susceptibility patterns##6##2##(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
susceptibility period of##2##3##(2008-10#2)
susceptibility period##3##2##(2008-10#3)
susceptibility results##2##2##(2007-7#1)(2011-2#1)
susceptibility should##2##2##(1991-12#1)(2008-10#1)
susceptibility test##2##2##(2008-12#1)(2008-8#1)
susceptibility testing by flow cytometry##2##5##(2008-9#2)
susceptibility testing of##2##3##(2008-7#1)(2011-2#1)
susceptibility testing was##2##3##(2008-7#1)(2012-3#1)
susceptibility testing##23##2##(1996-10#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#4)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#3)
susceptibility tests##4##2##(2008-12#1)(2008-5#2)(2013-1#1)
susceptibility to H##2##3##(2008-10#1)(2011-10#1)
susceptibility to a##2##3##(2009-5#1)(2011-2#1)
susceptibility to alcoholism##2##3##(1997-5#2)
susceptibility to antibiotics##3##3##(1990-6#1)(1997-4#1)(2009-6#1)
susceptibility to bacterial canker##4##4##(2008-10#4)
susceptibility to colitis-associated##2##3##(2011-2#2)
susceptibility to disease##2##3##(2008-10#1)(2008-9#1)
susceptibility to distraction by##2##4##(2012-3#2)
susceptibility to essential hypertension in Han Chinese##2##7##(2008-9#2)
susceptibility to human##2##3##(2011-2#1)(2013-8#1)
susceptibility to infection by##3##4##(2008-10#1)(2009-5#2)
susceptibility to infection##7##3##(1995-5#1)(2008-10#3)(2009-12#1)(2009-5#2)
susceptibility to infections##5##3##(1991-9#1)(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
susceptibility to inhibition##2##3##(1992-6#1)(1997-2#1)
susceptibility to killing by##2##4##(1991-9#1)(1995-8#1)
susceptibility to lung cancer##2##4##(2010-12#1)(2011-1#1)
susceptibility to lung##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
susceptibility to lysis by##2##4##(1992-2#1)(2008-9#1)
susceptibility to proteolytic##2##3##(1993-8#1)(1997-4#1)
susceptibility to pulmonary tuberculosis##2##4##(2011-1#2)
susceptibility to the virus##3##4##(2008-9#3)
susceptibility to the##12##3##(1990-2#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-12#1)
susceptibility to this disease##2##4##(2008-5#1)(2013-1#1)
susceptibility to tuberculosis##4##3##(2011-1#2)(2013-1#2)
susceptibility to type 1##2##4##(2006-10#1)(2008-1#1)
susceptibility to type##3##3##(2006-10#1)(2008-1#1)(2011-1#1)
susceptibility to##172##2##(1990-2#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-9#3)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-8#7)(2006-10#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#46)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#10)(2008-7#5)(2008-8#3)(2008-9#7)(2009-12#1)(2009-5#5)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#7)(2011-10#1)(2011-2#11)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#2)
susceptibility was##5##2##(1992-2#1)(2008-10#2)(2012-12#2)
susceptibility were##2##2##(2008-10#2)
susceptibility with##4##2##(1994-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
susceptibility x((3))##2##2##(2007-12#2)
susceptibility##502##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#4)(1991-2#1)(1991-8#1)(1991-9#4)(1992-12#2)(1992-2#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#9)(1997-6#1)(1997-7#5)(1997-8#9)(2006-10#1)(2007-10#3)(2007-11#8)(2007-12#25)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#123)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#27)(2008-7#20)(2008-8#12)(2008-9#20)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#7)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#12)(2011-10#1)(2011-2#38)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#9)(2012-3#17)(2013-1#14)(2013-7#1)(2013-8#5)
susceptible B##2##2##(2008-10#2)
susceptible accessions##2##2##(2008-10#2)
susceptible and a resistant##2##4##(2008-10#2)
susceptible and partially resistant cultivars##2##5##(2008-10#2)
susceptible and resistant cultivars##5##4##(2008-10#5)
susceptible and resistant roots##2##4##(2008-10#2)
susceptible and resistant##16##3##(1996-12#1)(2008-10#14)(2011-10#1)
susceptible and three##2##3##(2008-10#2)
susceptible and##34##2##(1996-12#3)(2008-10#29)(2011-10#1)(2011-2#1)
susceptible at##4##2##(1990-11#1)(2008-10#3)
susceptible barley cultivars##2##3##(2008-10#2)
susceptible barley##3##2##(2008-10#3)
susceptible beetles##2##2##(2011-2#2)
susceptible berries than##2##3##(2008-10#2)
susceptible berries##6##2##(2008-10#6)
susceptible control##3##2##(2008-10#3)
susceptible controls##5##2##(2008-10#4)(2011-2#1)
susceptible crops##9##2##(2008-10#9)
susceptible cultivar was##4##3##(2008-10#4)
susceptible cultivar were##2##3##(2008-10#2)
susceptible cultivar##30##2##(2008-10#30)
susceptible cultivars and##4##3##(2008-10#4)
susceptible cultivars##27##2##(2008-10#25)(2011-10#2)
susceptible cv##19##2##(2008-10#19)
susceptible cvs##5##2##(2008-10#5)
susceptible ecotype N913##3##3##(2008-10#3)
susceptible families##3##2##(2008-10#2)(2011-10#1)
susceptible flag leaves##2##3##(2008-10#2)
susceptible genotypes##12##2##(2008-10#12)
susceptible host tissue##4##3##(2008-10#4)
susceptible host##12##2##(2008-10#10)(2008-8#1)(2013-8#1)
susceptible hosts as##2##3##(2008-10#2)
susceptible hosts##4##2##(2008-10#4)
susceptible in##4##2##(2008-10#1)(2008-5#1)(2011-2#2)
susceptible inbred##5##2##(2008-10#5)
susceptible individuals##5##2##(2008-10#3)(2008-3#1)(2013-8#1)
susceptible leaves##3##2##(2008-10#3)
susceptible line##6##2##(1997-6#1)(2008-10#5)
susceptible lines##4##2##(2008-10#4)
susceptible maize genotypes##2##3##(2008-10#1)(2011-2#1)
susceptible maize##3##2##(2008-10#2)(2011-2#1)
susceptible oat##2##2##(2008-10#2)
susceptible ones##6##2##(2008-10#5)(2008-12#1)
susceptible only##2##2##(2008-10#1)(2008-5#1)
susceptible or resistant##3##3##(1996-12#1)(2008-10#2)
susceptible or##5##2##(1996-12#1)(2008-10#3)(2011-2#1)
susceptible parent##10##2##(2008-10#10)
susceptible plant##2##2##(2008-10#1)(2008-12#1)
susceptible plants##13##2##(2008-10#11)(2009-8#2)
susceptible potato cv##4##3##(2008-10#4)
susceptible potato##6##2##(2008-10#6)
susceptible reactions##2##2##(2008-10#2)
susceptible roots##4##2##(2008-10#4)
susceptible sorghum cultivar##2##3##(2008-10#2)
susceptible sorghum##3##2##(2008-10#3)
susceptible soybean##2##2##(2008-10#2)
susceptible strain##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
susceptible strains##2##2##(1994-5#1)(1996-12#1)
susceptible subgroups##2##2##(1997-1#1)(2011-1#1)
susceptible than##3##2##(2008-10#2)(2012-2#1)
susceptible to A##3##3##(2008-10#3)
susceptible to S##4##3##(2008-10#4)
susceptible to all races##3##4##(2008-10#3)
susceptible to all##6##3##(2008-10#5)(2008-5#1)
susceptible to apoptosis##2##3##(1995-2#1)(2008-11#1)
susceptible to bacterial##2##3##(1991-3#1)(2008-10#1)
susceptible to both pathogens##3##4##(2008-10#3)
susceptible to both##10##3##(1993-6#1)(2008-10#5)(2008-11#2)(2011-2#2)
susceptible to damage##3##3##(1994-2#1)(2008-3#1)(2011-2#1)
susceptible to infection by##4##4##(2008-10#3)(2009-5#1)
susceptible to infection with##2##4##(2008-12#1)(2008-9#1)
susceptible to infection##20##3##(2007-12#1)(2008-10#15)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)
susceptible to inhibition##2##3##(1990-11#1)(1994-6#1)
susceptible to injury from##2##4##(1995-11#2)
susceptible to injury##3##3##(1995-11#2)(2008-9#1)
susceptible to isolates##2##3##(2008-10#2)
susceptible to leaf##3##3##(2008-10#3)
susceptible to powdery mildew##2##4##(2008-10#2)
susceptible to proteolysis##2##3##(1992-11#2)
susceptible to several##2##3##(2008-10#2)
susceptible to the pathogen##2##4##(2008-10#2)
susceptible to the##16##3##(1992-11#1)(1993-2#1)(1996-12#1)(2008-10#7)(2008-5#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)
susceptible to these##2##3##(1995-2#1)(2007-12#1)
susceptible to transformation by##2##4##(2008-10#1)(2008-6#1)
susceptible to##208##2##(1990-11#2)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-11#3)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-12#2)(1997-3#3)(2006-12#1)(2006-5#1)(2007-12#4)(2008-10#96)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#4)(2011-10#2)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
susceptible tomato##4##2##(2008-10#4)
susceptible wheat##4##2##(2008-10#4)
susceptible when##2##2##(2008-10#2)
susceptible winter wheat##2##3##(2008-10#2)
susceptible zucchini##2##2##(2008-10#2)
susceptible##660##1##(1990-11#3)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-11#3)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-12#10)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-6#1)(2008-10#472)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#3)(2008-5#14)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#3)(2009-2#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-10#8)(2011-2#25)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
suspect that##3##2##(1992-12#1)(2008-4#1)(2012-2#1)
suspect##26##1##(1991-4#1)(1992-12#1)(1993-1#1)(1993-3#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-5#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
suspected acute PE##2##3##(2011-2#2)
suspected acute##10##2##(1991-12#1)(1995-11#2)(2008-3#3)(2010-8#1)(2011-2#3)
suspected after##2##2##(2008-12#1)(2009-3#1)
suspected and##3##2##(1996-1#1)(2013-1#1)(2013-8#1)
suspected as##4##2##(1990-2#1)(1995-6#1)(2010-4#1)(2013-1#1)
suspected cases of##2##3##(2013-8#2)
suspected cases##9##2##(1990-12#1)(2007-2#1)(2008-12#1)(2009-7#1)(2010-10#1)(2011-1#1)(2013-8#3)
suspected clinically##2##2##(2007-12#1)(2008-5#1)
suspected from##3##2##(2008-7#2)(2011-1#1)
suspected in a##3##3##(1996-12#1)(2009-8#1)(2012-12#1)
suspected in##12##2##(1990-2#1)(1996-12#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
suspected lesions##2##2##(1990-6#1)(2008-9#1)
suspected malignancy##3##2##(1995-11#1)(2008-1#1)(2008-5#1)
suspected of an infectious##2##4##(1990-12#1)(2008-8#1)
suspected of being##5##3##(1996-1#1)(1996-9#1)(2007-6#2)(2008-10#1)
suspected of having a##2##4##(2009-3#1)(2010-12#1)
suspected of having##7##3##(1992-8#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
suspected of##23##2##(1990-12#1)(1992-8#1)(1993-12#1)(1995-11#1)(1996-1#1)(1996-9#1)(1997-8#2)(2007-6#2)(2007-7#1)(2008-10#4)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
suspected on the##3##3##(1990-3#1)(2008-7#1)(2009-9#1)
suspected on##7##2##(1990-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2012-2#2)
suspected patients##2##2##(2012-12#1)(2012-3#1)
suspected preoperatively##2##2##(2007-7#1)(2008-12#1)
suspected pulmonary##2##2##(1991-11#1)(1991-3#1)
suspected risk##2##2##(1992-12#1)(1996-6#1)
suspected scaphoid fractures##5##3##(2008-9#5)
suspected scaphoid##6##2##(2008-9#6)
suspected secondary hypertension##2##3##(2008-1#2)
suspected skeletal dysplasia##3##3##(2011-1#3)
suspected that##3##2##(1990-9#1)(1997-4#1)(2007-3#1)
suspected to be a##3##4##(1991-12#1)(2008-5#1)(2010-6#1)
suspected to be the cause##2##5##(2008-10#1)(2008-6#1)
suspected to be##9##3##(1991-12#1)(1992-9#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-8#1)
suspected to have##6##3##(1990-2#2)(1997-4#1)(2007-7#1)(2011-2#1)(2012-12#1)
suspected to##18##2##(1990-2#2)(1991-12#1)(1992-9#1)(1994-5#1)(1997-4#2)(2006-6#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
suspected when##2##2##(1997-8#1)(2013-1#1)
suspected##264##1##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#2)(1990-6#7)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-3#5)(1991-6#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-11#6)(1995-2#1)(1995-5#1)(1995-6#5)(1996-1#2)(1996-12#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#1)(1997-8#5)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#13)(2008-11#3)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-3#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#13)(2012-12#5)(2012-2#11)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#7)
suspecting##2##1##(2010-11#1)(2011-2#1)
suspended carriers in##2##3##(2008-7#2)
suspended carriers##4##2##(1994-5#1)(2008-7#3)
suspended cells##4##2##(1994-3#1)(2008-11#2)(2013-1#1)
suspended for##2##2##(2007-11#1)(2011-2#1)
suspended from the##2##3##(2008-10#1)(2011-2#1)
suspended from##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
suspended in a##2##3##(2008-10#1)(2008-3#1)
suspended in distilled water##2##4##(2007-12#1)(2008-5#1)
suspended in non-alcoholic beer##2##4##(2012-2#2)
suspended in solution##3##3##(1994-6#1)(2008-10#2)
suspended in the##2##3##(2008-10#1)(2008-11#1)
suspended in water##2##3##(2008-10#1)(2008-2#1)
suspended in##29##2##(1992-12#1)(1992-2#1)(1992-6#1)(1994-6#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2012-2#4)
suspended matter##6##2##(2008-10#3)(2008-2#1)(2008-5#2)
suspended mirrors##4##2##(2008-3#4)
suspended on##2##2##(2008-10#2)
suspended particles##6##2##(2008-10#3)(2008-2#3)
suspended particulate matter##3##3##(2008-10#2)(2008-3#1)
suspended particulate##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
suspended sediments##2##2##(2008-3#1)(2013-8#1)
suspended solids##9##2##(2007-5#1)(2008-10#4)(2008-5#1)(2010-5#2)(2013-1#1)
suspended##105##1##(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#2)(1994-3#1)(1994-5#1)(1994-6#1)(1996-1#1)(1997-4#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#26)(2008-11#6)(2008-2#9)(2008-3#14)(2008-5#7)(2008-7#8)(2009-11#1)(2009-7#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-4#1)(2013-1#4)(2013-8#1)
suspending agents##2##2##(1992-3#2)
suspending##7##1##(1992-3#2)(1993-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
suspensa##8##1##(2007-12#3)(2011-2#5)
suspension and monolayer##3##3##(2008-11#3)
suspension and##18##2##(1994-11#1)(1994-2#1)(2008-10#5)(2008-11#9)(2008-2#1)(2008-5#1)
suspension bioreactor##2##2##(2008-11#2)
suspension cell culture##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
suspension cell##6##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)
suspension cells and##2##3##(2008-8#2)
suspension cells using##2##3##(2008-11#1)(2008-8#1)
suspension cells##15##2##(1991-5#1)(2008-1#3)(2008-11#5)(2008-2#1)(2008-8#4)(2008-9#1)
suspension culture of##3##3##(2008-11#2)(2008-9#1)
suspension culture was##3##3##(2008-11#3)
suspension culture##35##2##(1992-9#1)(1997-1#1)(2008-11#28)(2008-2#1)(2008-9#3)(2009-6#1)
suspension cultured##2##2##(2008-11#1)(2008-8#1)
suspension cultures in##3##3##(2008-11#2)(2008-7#1)
suspension cultures of##5##3##(2008-11#5)
suspension cultures##22##2##(1994-5#1)(2008-11#14)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#1)
suspension galvanic cells##2##3##(2008-10#2)
suspension growth##3##2##(2008-11#3)
suspension in a##3##3##(2008-10#1)(2008-11#2)
suspension in the##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
suspension in##10##2##(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#5)
suspension into##2##2##(2008-10#2)
suspension of P##3##3##(2008-10#3)
suspension of an##3##3##(2008-10#2)(2008-4#1)
suspension of polystyrene microspheres##2##4##(2008-2#1)(2008-3#1)
suspension of##26##2##(1990-11#1)(1994-3#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)
suspension on the##2##3##(2008-10#1)(2008-11#1)
suspension or dry##2##3##(2008-6#2)
suspension or##8##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-9#1)
suspension to##2##2##(1990-12#1)(2008-10#1)
suspension was##6##2##(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)
suspension with##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
suspension##265##1##(1990-11#1)(1990-12#3)(1990-8#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1996-1#2)(1996-2#1)(1997-1#1)(2007-12#3)(2008-1#5)(2008-10#59)(2008-11#107)(2008-12#2)(2008-2#8)(2008-3#11)(2008-4#10)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#9)(2008-9#8)(2009-6#1)(2012-1#1)
suspensions and##6##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
suspensions are prepared by weighing##2##5##(2008-10#2)
suspensions are##7##2##(2008-10#2)(2008-3#3)(2008-8#1)(2008-9#1)
suspensions for##2##2##(2008-10#1)(2008-2#1)
suspensions in##5##2##(1993-3#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#1)
suspensions is also##2##3##(2008-4#2)
suspensions is##4##2##(2007-11#1)(2007-12#1)(2008-4#2)
suspensions of polystyrene latex spheres##2##5##(2008-3#2)
suspensions of polystyrene##3##3##(2007-12#1)(2008-3#2)
suspensions of##40##2##(1991-9#1)(1994-12#1)(1994-2#1)(2007-12#3)(2007-7#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#1)(2010-8#1)(2013-1#1)
suspensions prior to##3##3##(1992-6#2)(2008-4#1)
suspensions to##5##2##(1994-2#2)(2008-10#2)(2008-2#1)
suspensions was##2##2##(2008-10#1)(2008-3#1)
suspensions were##6##2##(1990-12#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
suspensions with##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
suspensions##130##1##(1990-12#2)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#3)(1995-2#1)(2007-11#3)(2007-12#10)(2007-7#2)(2008-1#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#23)(2008-4#8)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
suspensor cells##2##2##(2009-8#2)
suspensor##4##1##(2009-8#4)
suspensory fixation##2##2##(2013-1#2)
suspensory##3##1##(2011-2#1)(2013-1#2)
suspicion and the##2##3##(1991-6#1)(2010-7#1)
suspicion and##5##2##(1991-6#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
suspicion for##6##2##(2006-10#1)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
suspicion in##4##2##(2008-9#1)(2010-10#1)(2010-12#1)(2013-1#1)
suspicion is##9##2##(1993-6#1)(1995-10#1)(2007-7#3)(2008-1#1)(2010-1#1)(2011-2#1)(2012-12#1)
suspicion of an##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
suspicion of malignancy##2##3##(1991-2#1)(1994-12#1)
suspicion of##27##2##(1991-2#1)(1992-5#1)(1994-12#2)(1994-7#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#3)(2008-3#3)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
suspicion##72##1##(1990-12#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-7#1)(1995-10#1)(1995-5#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#8)(2013-8#2)
suspicions that##2##2##(1995-6#1)(2008-7#1)
suspicious breast##2##2##(2008-4#1)(2012-2#1)
suspicious cases##2##2##(1990-6#1)(2012-12#1)
suspicious in##2##2##(1995-4#1)(2011-1#1)
suspicious of##3##2##(1991-6#1)(1997-2#1)(2010-12#1)
suspicious##20##1##(1990-6#1)(1991-6#2)(1993-2#1)(1994-1#1)(1995-4#2)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
suspiciousness/feelings of persecution##2##3##(2008-6#2)
suspiciousof##2##1##(2009-8#2)
sustain a healthy##2##3##(2012-2#1)(2013-7#1)
sustain a##6##2##(1993-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)
sustain life##2##2##(1991-2#1)(2013-8#1)
sustain long-lasting in vitro hematopoiesis##2##5##(2009-12#2)
sustain that##2##2##(2012-12#1)(2013-1#1)
sustain the##9##2##(1990-2#1)(1992-8#1)(1995-12#1)(2007-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
sustain their##2##2##(2008-1#1)(2010-5#1)
sustain##50##1##(1990-2#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-6#1)(1995-12#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-5#1)(2009-8#1)(2010-10#3)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
sustainability and##3##2##(2008-12#1)(2009-5#1)(2010-7#1)
sustainability of the##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
sustainability of##12##2##(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#4)
sustainability will##2##2##(2011-1#1)(2012-2#1)
sustainability##29##1##(1997-3#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-5#4)(2009-8#2)(2010-7#1)(2011-1#3)(2012-2#5)(2013-1#2)
sustainable and##4##2##(1995-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
sustainable development##7##2##(1996-5#1)(2008-11#4)(2008-12#1)(2008-8#1)
sustainable environmental##2##2##(2008-10#1)(2008-11#1)
sustainable management##2##2##(2008-10#2)
sustainable##62##1##(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-7#4)(2007-11#1)(2007-5#1)(2008-10#8)(2008-11#7)(2008-12#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-7#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#3)
sustained a##15##2##(1991-5#1)(2007-10#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-1#1)(2012-12#2)(2012-3#2)(2013-1#3)
sustained activation of the##2##4##(1997-7#1)(2008-8#1)
sustained activation of##4##3##(1994-6#1)(1997-7#1)(2008-8#1)(2012-2#1)
sustained activation##7##2##(1994-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
sustained an##4##2##(2008-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
sustained and transient ON signals of##2##6##(2008-9#2)
sustained and transient##3##3##(2008-9#3)
sustained and##12##2##(1994-9#1)(1995-12#1)(1995-3#1)(2008-4#1)(2008-9#3)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
sustained at##3##2##(1993-8#1)(1996-5#1)(2013-1#1)
sustained attention and##2##3##(2008-10#1)(2008-2#1)
sustained attention##4##2##(2008-10#1)(2008-2#2)(2011-2#1)
sustained blockade of##2##3##(1995-2#2)
sustained by##4##2##(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#1)
sustained contraction induced by bombesin or##2##6##(1991-12#2)
sustained contractions##3##2##(1997-7#1)(2013-8#2)
sustained for up to##2##4##(1994-11#1)(2008-10#1)
sustained for##8##2##(1990-10#1)(1994-11#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
sustained growth##2##2##(1995-8#1)(2008-11#1)
sustained high##2##2##(2008-11#1)(2008-5#1)
sustained hyperglycemia##2##2##(2009-11#1)(2012-4#1)
sustained improvement in##2##3##(2011-2#1)(2012-3#1)
sustained improvement##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
sustained in##3##2##(2006-4#1)(2013-1#2)
sustained increase in inositol##2##4##(1994-9#2)
sustained increase in##9##3##(1991-6#1)(1991-9#1)(1992-6#1)(1994-9#2)(1997-1#1)(1997-2#1)(2012-12#1)(2013-8#1)
sustained increase##11##2##(1991-6#1)(1991-9#1)(1992-6#3)(1994-9#2)(1997-1#1)(1997-2#1)(2012-12#1)(2013-8#1)
sustained neural activity##2##3##(1996-5#2)
sustained oscillations##2##2##(1996-6#1)(2010-10#1)
sustained over a##2##3##(1994-3#1)(1997-8#1)
sustained over##5##2##(1994-3#1)(1997-8#1)(2007-10#1)(2008-3#1)(2013-1#1)
sustained phase##4##2##(1991-12#1)(1991-5#2)(1994-2#1)
sustained power##2##2##(2008-3#2)
sustained reduction in##3##3##(1990-12#1)(1995-12#1)(1995-5#1)
sustained release of##3##3##(1994-6#1)(2013-1#2)
sustained release##10##2##(1994-6#1)(1997-4#1)(2008-11#4)(2012-2#2)(2013-1#2)
sustained remission##2##2##(2008-1#1)(2011-2#1)
sustained the diagnosis of##2##4##(2013-7#2)
sustained the##6##2##(1995-12#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#2)
sustained this##2##2##(2008-7#2)
sustained through##2##2##(1991-12#1)(2008-1#1)
sustained until##3##2##(1992-3#1)(2008-3#1)(2008-9#1)
sustained ventricular tachycardia##4##3##(1990-3#4)
sustained virologic response (SVR)##2##4##(2013-1#2)
sustained virological response##2##3##(2012-1#2)
sustained##253##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#1)(1990-6#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-8#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#3)(1997-8#2)(2006-4#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#8)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#5)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#6)(2012-2#9)(2012-3#4)(2012-4#1)(2013-1#19)(2013-7#2)(2013-8#6)
sustained-release formulation of##2##3##(2009-11#1)(2011-2#1)
sustained-release formulation##3##2##(2009-11#2)(2011-2#1)
sustained-release##10##1##(1992-8#1)(1993-1#1)(2009-11#3)(2011-2#1)(2012-2#1)(2012-3#3)
sustaining a##2##2##(1993-1#1)(2008-4#1)
sustaining the##4##2##(1994-6#1)(1995-3#1)(2008-11#1)(2013-8#1)
sustaining##29##1##(1990-11#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-10#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
sustains an##2##2##(2008-12#1)(2008-2#1)
sustains##11##1##(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-9#1)
suture and##3##2##(1993-9#1)(2007-11#2)
suture closure##4##2##(1991-12#1)(2007-8#2)(2011-2#1)
suture fixation of the##2##4##(2008-10#1)(2010-3#1)
suture material##2##2##(1995-1#1)(2007-8#1)
suture materials##5##2##(1991-1#2)(2009-5#2)(2010-10#1)
suture needle##2##2##(2007-8#1)(2008-9#1)
suture of##2##2##(2007-8#1)(2011-3#1)
suture placement##2##2##(2007-7#1)(2008-9#1)
suture repair##3##2##(2008-7#1)(2011-2#2)
suture retention##2##2##(2008-5#2)
suture technique##4##2##(1991-2#2)(2007-8#2)
suture techniques##3##2##(1992-1#1)(1993-12#1)(2013-8#1)
suture##72##1##(1990-3#1)(1990-6#1)(1991-1#4)(1991-12#2)(1991-2#2)(1992-1#3)(1992-2#4)(1993-11#1)(1993-12#1)(1993-9#1)(1995-1#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#11)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#2)(2010-10#1)(2010-3#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
suture-anchor##2##1##(2012-12#2)
sutured and##2##2##(1992-3#1)(2013-1#1)
sutured##10##1##(1992-3#1)(1993-11#1)(1994-8#1)(2008-12#1)(2013-1#6)
sutureless##5##1##(2007-8#3)(2008-10#1)(2011-1#1)
sutures and##2##2##(2012-2#1)(2013-1#1)
sutures applied##2##2##(1994-2#1)(2010-10#1)
sutures are##4##2##(2007-12#1)(2010-10#2)(2013-1#1)
sutures in##2##2##(2008-7#1)(2008-9#1)
sutures##27##1##(1994-2#1)(1994-9#1)(1995-1#1)(2007-12#6)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#5)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)
suturing and##2##2##(2008-10#1)(2010-8#1)
suturing##17##1##(1990-6#1)(1992-3#1)(1995-1#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-6#2)(2010-11#1)(2010-8#3)(2011-2#1)(2012-3#1)(2013-8#1)
suxamethonium##6##1##(1996-8#1)(2012-2#5)
sw/B/98##2##1##(2011-2#2)
sw/IA/04##4##1##(2011-2#4)
swab eluates##2##2##(1996-12#2)
swab was##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
swab##18##1##(1996-12#4)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)
swabbed##3##1##(2010-4#2)(2012-2#1)
swabbing##2##1##(1997-4#1)(2008-12#1)
swabs and##3##2##(2008-5#1)(2011-2#2)
swabs from the##4##3##(2010-5#1)(2013-8#3)
swabs from##7##2##(2010-4#1)(2010-5#1)(2011-2#2)(2013-8#3)
swabs taken from the##2##4##(2008-12#1)(2009-6#1)
swabs taken##3##2##(2008-12#2)(2009-6#1)
swabs were collected from##4##4##(2010-8#1)(2011-2#1)(2013-8#2)
swabs were collected##5##3##(1997-6#1)(2010-8#1)(2011-2#1)(2013-8#2)
swabs were taken from##2##4##(2007-7#1)(2008-5#1)
swabs were##9##2##(1997-6#1)(2007-7#2)(2008-5#1)(2010-8#1)(2011-2#2)(2013-8#2)
swabs##37##1##(1997-6#1)(2007-6#1)(2007-7#5)(2008-10#2)(2008-12#2)(2008-5#5)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#9)(2013-8#6)
swainsoni##5##1##(2008-5#1)(2013-8#4)
swainsonine##4##1##(1995-2#1)(2008-11#3)
swallow##4##1##(1994-9#1)(2007-8#1)(2008-7#1)(2008-9#1)
swallowed##7##1##(1990-6#1)(1995-11#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-8#2)
swallowing problems##2##2##(2008-7#1)(2012-2#1)
swallowing##22##1##(1991-3#1)(1993-12#6)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
swallows##5##1##(2008-8#2)(2008-9#1)(2013-7#1)(2013-8#1)
swam in##2##2##(1995-6#1)(1996-8#1)
swam##4##1##(1995-6#1)(1996-8#1)(2008-5#1)(2013-1#1)
swamp##3##1##(2007-5#3)
swap##4##1##(1993-5#1)(2008-3#3)
swapped##2##1##(1995-11#1)(2008-3#1)
swapped-out pages##2##2##(2008-3#2)
swarm##4##1##(2007-12#1)(2007-9#3)
swarmer cells##2##2##(1994-8#2)
swarming motility##2##2##(1994-8#2)
swarming##8##1##(1994-8#2)(2009-5#1)(2009-6#5)
sway and##2##2##(1994-1#2)
sway##8##1##(1994-1#4)(1995-5#1)(2010-10#1)(2010-8#1)(2012-3#1)
sweat and sebum##2##3##(2008-5#2)
sweat and##6##2##(2008-5#6)
sweat components##2##2##(2008-10#2)
sweat gland##2##2##(1991-6#2)
sweat glands##5##2##(1991-6#1)(1996-6#1)(2008-5#3)
sweat pH of##3##3##(2008-5#3)
sweat pH##5##2##(2008-5#5)
sweat rate##4##2##(1992-3#1)(2008-5#3)
sweat the##2##2##(2013-8#2)
sweat##45##1##(1991-6#3)(1992-3#2)(1996-6#1)(2008-10#5)(2008-5#26)(2009-12#5)(2010-4#1)(2013-8#2)
sweating was##7##2##(2008-5#7)
sweating##23##1##(1992-3#1)(1994-3#1)(2006-10#1)(2008-5#15)(2008-7#1)(2009-12#3)(2009-5#1)
sweats##4##1##(1993-9#1)(1997-4#1)(2008-11#1)(2010-12#1)
sweep and##2##2##(2008-10#2)
sweep rate##4##2##(2008-10#4)
sweep voltammetric##3##2##(2008-10#3)
sweep voltammetry##14##2##(2008-10#14)
sweep##47##1##(2007-11#1)(2007-12#2)(2008-10#41)(2008-3#2)(2011-2#1)
sweeping legislation##2##2##(1991-12#1)(1992-1#1)
sweeping technique##2##2##(2008-10#1)(2008-3#1)
sweeping##12##1##(1991-12#1)(1992-1#2)(1993-5#1)(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-7#1)(2011-2#1)
sweeps were##2##2##(2008-5#2)
sweeps##5##1##(2008-10#1)(2008-5#2)(2008-9#1)(2009-5#1)
sweet Spanish onions we studied had##2##6##(1993-12#2)
sweet and##2##2##(2008-5#1)(2013-1#1)
sweet basil oil##2##3##(2008-5#2)
sweet basil##5##2##(2008-5#4)(2012-12#1)
sweet cherry fruit##2##3##(2008-10#2)
sweet cherry##4##2##(2008-10#4)
sweet corn##7##2##(2008-10#7)
sweet orange grafted on Rangpur lime##2##6##(2008-10#2)
sweet orange##13##2##(2008-10#13)
sweet pepper ferredoxin-I protein##2##4##(2008-10#2)
sweet pepper##3##2##(2008-10#3)
sweet potato (Ipomoea batatas)##2##4##(2008-10#2)
sweet potato (Ipomoea##3##3##(2008-10#3)
sweet potato feathery mottle##3##4##(2008-10#3)
sweet potato root##3##3##(2008-10#2)(2008-6#1)
sweet potato##18##2##(2008-10#12)(2008-6#2)(2011-2#4)
sweet substances and##2##3##(2008-10#1)(2008-9#1)
sweet taste##2##2##(2008-2#2)
sweet wine##2##2##(2008-10#2)
sweet wines##2##2##(2008-10#2)
sweet##75##1##(1993-12#2)(2007-9#1)(2008-10#51)(2008-2#3)(2008-5#6)(2008-6#3)(2008-9#3)(2011-2#4)(2012-12#1)(2013-1#1)
sweetened beverages##2##2##(2012-2#2)
sweetener with##2##2##(2008-5#1)(2008-6#1)
sweetener##11##1##(2008-2#3)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)
sweetener-preferring strain##2##2##(2008-2#2)
sweeteners##9##1##(1992-11#1)(2008-10#2)(2008-2#3)(2011-1#3)
sweetness##11##1##(2008-10#1)(2008-2#1)(2008-5#5)(2011-2#2)(2012-2#2)
sweetpotato weevil##3##2##(2011-2#3)
sweetpotato##9##1##(2008-10#6)(2011-2#3)
swell in##2##2##(2008-9#1)(2010-6#1)
swell##6##1##(1992-12#1)(2008-10#1)(2008-9#1)(2010-2#1)(2010-6#1)(2013-1#1)
swelled vallate papillae##2##3##(2011-2#2)
swelled##5##1##(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#2)
swelling after##2##2##(2010-12#1)(2013-1#1)
swelling and pain##3##3##(2008-5#1)(2012-12#2)
swelling and##20##2##(1990-2#1)(1991-3#1)(1993-2#1)(1996-5#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#2)(2012-12#2)(2013-1#1)
swelling and/or##2##2##(1997-3#1)(2013-1#1)
swelling are##2##2##(2007-11#1)(2011-2#1)
swelling around##3##2##(2009-3#2)(2012-12#1)
swelling in the##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)
swelling in##9##2##(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-11#1)(2012-12#1)
swelling of the left thigh##2##5##(2007-7#1)(2008-6#1)
swelling of the left##3##4##(1991-3#1)(2007-7#1)(2008-6#1)
swelling of the##17##3##(1990-11#1)(1991-3#1)(1991-5#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
swelling of##28##2##(1990-11#1)(1991-3#1)(1991-5#1)(1997-5#1)(2006-10#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
swelling on the##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
swelling over the##2##3##(2012-2#1)(2012-3#1)
swelling over##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
swelling ratio##2##2##(2008-10#1)(2009-7#1)
swelling was##3##2##(2008-12#1)(2010-11#1)(2011-1#1)
swelling with##2##2##(2011-1#1)(2013-1#1)
swelling##134##1##(1990-11#1)(1990-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-5#3)(1997-3#4)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#15)(2008-12#4)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#9)(2012-12#5)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#10)(2013-8#2)
swelling]##2##1##(1997-8#1)(2011-2#1)
swellings were##2##2##(1995-12#1)(2008-10#1)
swellings##11##1##(1995-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-5#1)(2009-7#1)(2013-1#1)(2013-7#1)
swells##3##1##(2008-10#1)(2008-5#2)
swept by##2##2##(2008-10#2)
swept into a##3##3##(2008-10#3)
swept##12##1##(1992-1#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)
swim speed##8##2##(1993-12#4)(2008-12#4)
swim stress##5##2##(1995-12#3)(1997-4#2)
swim training##3##2##(2012-3#3)
swim##26##1##(1990-8#1)(1993-12#4)(1995-12#3)(1997-4#2)(2008-11#4)(2008-12#4)(2008-5#1)(2008-7#1)(2010-5#2)(2012-3#3)(2013-8#1)
swim-to-platform##2##1##(1992-12#2)
swimmers##4##1##(1995-6#2)(1996-8#1)(2009-1#1)
swimming behavior of##2##3##(2008-5#2)
swimming behavior##4##2##(1992-6#1)(2008-4#1)(2008-5#2)
swimming exercise##2##2##(1995-6#1)(2013-1#1)
swimming in a##2##3##(2007-10#1)(2008-5#1)
swimming in the##2##3##(1990-11#1)(2012-3#1)
swimming in##5##2##(1990-11#1)(2007-10#1)(2008-5#2)(2012-3#1)
swimming motility##2##2##(1994-8#1)(2013-8#1)
swimming performance was##2##3##(1995-6#1)(2010-8#1)
swimming performance##3##2##(1995-6#1)(2010-8#2)
swimming pool##5##2##(1992-11#1)(1995-6#1)(2008-10#3)
swimming speed##2##2##(1992-6#2)
swimming##51##1##(1990-11#2)(1990-5#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-6#3)(1993-3#1)(1994-8#1)(1995-6#5)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#4)(2009-9#1)(2010-8#5)(2012-3#1)(2013-1#2)(2013-8#1)
swine and human##2##3##(2011-1#1)(2013-1#1)
swine and##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
swine farms##2##2##(1996-12#1)(2013-1#1)
swine fever##3##2##(2007-6#1)(2011-2#2)
swine influenza viruses##3##3##(2011-2#2)(2013-1#1)
swine influenza##6##2##(1997-6#1)(2011-2#3)(2013-1#1)(2013-8#1)
swine manure##8##2##(2008-10#8)
swine waste application sites in##2##5##(2008-10#2)
swine waste##3##2##(2008-10#3)
swine##52##1##(1992-1#1)(1996-12#1)(1996-5#3)(1997-6#2)(2007-12#1)(2007-6#1)(2008-10#12)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-1#3)(2011-2#11)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#3)
swing beds##4##2##(1991-1#2)(1994-2#2)
swing shift workers##2##3##(2011-2#2)
swing##17##1##(1991-1#2)(1993-3#2)(1994-2#2)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-3#1)(2011-2#6)
swing-bed program##2##2##(1991-1#1)(1994-2#1)
swing-bed##3##1##(1991-1#2)(1994-2#1)
swinging##2##1##(2007-11#1)(2008-3#1)
swiss needle cast##2##3##(2008-10#2)
swiss##5##1##(1992-6#1)(2008-10#2)(2008-12#1)(2010-1#1)
switch and##4##2##(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
switch are##2##2##(2008-3#2)
switch at##2##2##(2008-10#1)(2013-1#1)
switch based on##2##3##(2007-11#1)(2009-7#1)
switch between##8##2##(1990-11#1)(1995-11#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)
switch by##3##2##(1995-2#1)(2008-3#2)
switch core##4##2##(2008-3#4)
switch for##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2009-6#1)
switch from the##2##3##(1997-6#1)(2011-1#1)
switch from##10##2##(1992-3#1)(1992-9#1)(1997-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2013-8#1)
switch in the##2##3##(1992-11#1)(1992-12#1)
switch in##8##2##(1992-11#1)(1992-12#2)(1997-2#1)(2007-12#1)(2008-10#1)(2009-6#1)(2013-1#1)
switch is##8##2##(2008-10#2)(2008-3#6)
switch of##5##2##(1994-2#2)(2008-5#1)(2008-8#1)(2011-1#1)
switch on##3##2##(2008-9#1)(2009-11#1)(2011-2#1)
switch that##7##2##(2007-11#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-2#1)
switch the##2##2##(2008-3#1)(2008-8#1)
switch to a##3##3##(2007-9#1)(2008-11#1)(2011-1#1)
switch to##9##2##(2007-9#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
switch##155##1##(1990-11#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-8#1)(1995-11#1)(1995-2#2)(1996-7#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#5)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-2#15)(2008-3#40)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#3)(2010-6#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
switch-on##2##1##(2008-9#1)(2012-2#1)
switchable##4##1##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
switched between##3##2##(2007-11#1)(2008-3#1)(2010-12#1)
switched by##3##2##(2008-3#2)(2010-12#1)
switched from##4##2##(2008-2#1)(2008-5#1)(2009-10#1)(2011-2#1)
switched magnetic fields##2##3##(1992-3#2)
switched off##5##2##(1990-5#1)(1992-11#1)(1992-3#1)(2008-10#1)(2008-4#1)
switched on##5##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
switched to##5##2##(2008-1#1)(2008-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
switched with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
switched with##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
switched##46##1##(1990-5#1)(1992-11#1)(1992-3#4)(1996-5#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
switches and##4##2##(2008-3#2)(2008-7#1)(2010-12#1)
switches for##5##2##(2008-2#2)(2008-3#2)(2012-12#1)
switches from##2##2##(1990-8#1)(2008-10#1)
switches in the##2##3##(1997-7#1)(2009-10#1)
switches in##4##2##(1997-7#1)(2008-3#1)(2009-10#1)(2011-1#1)
switches target##2##2##(2011-1#2)
switches that##3##2##(2008-2#1)(2012-12#2)
switches to##2##2##(1996-8#1)(2009-4#1)
switches##53##1##(1990-8#2)(1996-8#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#8)(2012-12#3)(2012-2#1)(2013-8#3)
switchgrass##5##1##(2011-2#5)
switching and image storage##2##4##(1995-6#2)
switching and##10##2##(1995-6#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)
switching behaviors##2##2##(2007-12#1)(2008-3#1)
switching between a##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
switching between the##2##3##(2007-12#1)(2008-2#1)
switching between##12##2##(2007-11#3)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)
switching by##2##2##(2007-12#1)(2008-3#1)
switching efficiency of##2##3##(2007-12#1)(2008-3#1)
switching efficiency##3##2##(2007-12#2)(2008-3#1)
switching energy##2##2##(2007-12#2)
switching for##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
switching from##14##2##(1992-11#1)(2007-12#5)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#1)
switching in a bulk##2##4##(2007-11#1)(2007-12#1)
switching in a##8##3##(2007-11#1)(2007-12#1)(2008-3#6)
switching in##16##2##(2007-11#4)(2007-12#4)(2008-3#6)(2009-9#1)(2012-3#1)
switching is##9##2##(2007-12#3)(2008-3#4)(2008-7#1)(2010-4#1)
switching mechanism##2##2##(2007-12#1)(2008-8#1)
switching network##2##2##(2008-3#2)
switching of the##3##3##(2007-12#2)(2008-3#1)
switching of##17##2##(2007-11#2)(2007-12#3)(2008-11#1)(2008-3#11)
switching operations##2##2##(2008-3#2)
switching power##2##2##(2008-3#2)
switching powers of##2##3##(2007-12#2)
switching system##2##2##(2008-10#1)(2008-3#1)
switching systems##2##2##(2008-2#1)(2008-3#1)
switching the##8##2##(1995-11#2)(2007-8#1)(2008-10#2)(2008-3#2)(2009-6#1)
switching time##2##2##(2007-11#1)(2007-12#1)
switching to alternative food##2##4##(2008-8#2)
switching to##5##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#2)
switching valve##4##2##(2008-10#4)
switching voltage##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
switching with##5##2##(2007-12#2)(2008-3#2)(2008-7#1)
switching##206##1##(1990-8#1)(1992-11#2)(1995-11#2)(1995-6#2)(1996-5#1)(1997-4#1)(2007-11#21)(2007-12#48)(2007-8#1)(2008-10#12)(2008-11#5)(2008-2#13)(2008-3#62)(2008-4#3)(2008-7#10)(2008-8#6)(2008-9#2)(2009-11#1)(2009-6#2)(2009-9#2)(2010-4#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
swollen connective tissue##2##3##(2012-12#2)
swollen lamellar gel network phase##2##5##(2008-5#2)
swollen lamellar##3##2##(2008-5#3)
swollen##30##1##(1990-8#1)(1992-11#1)(1992-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
sword in##2##2##(2008-10#1)(2010-5#1)
sword of##2##2##(1994-2#1)(1997-5#1)
sword##7##1##(1994-2#1)(1997-5#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
swords##4##1##(1995-12#1)(2008-8#2)(2009-8#1)
swordtails##6##1##(2008-8#2)(2009-9#4)
sycamore##3##1##(2008-10#3)
syllabi##2##1##(2008-12#1)(2008-5#1)
syllable structure##2##2##(2008-8#1)(2008-9#1)
syllable##8##1##(2008-8#1)(2008-9#2)(2013-8#5)
syllables##8##1##(1993-9#4)(2008-9#3)(2013-8#1)
syllabus##5##1##(2008-11#1)(2008-5#4)
sylvatica##2##1##(2008-10#1)(2013-8#1)
sylvaticum##4##1##(2008-10#4)
sylvestrene##3##1##(2008-11#3)
sylvestris and##3##2##(2008-11#1)(2008-7#1)(2011-10#1)
sylvestris##4##1##(2008-11#1)(2008-7#1)(2011-10#2)
sylvian fissure##2##2##(2008-12#1)(2011-1#1)
symbiont population##2##2##(2007-12#2)
symbiont##8##1##(2007-12#2)(2008-10#1)(2008-8#1)(2011-2#3)(2013-8#1)
symbionts##6##1##(2007-12#1)(2008-10#1)(2008-7#1)(2010-6#2)(2013-1#1)
symbioses with##2##2##(2008-8#1)(2011-2#1)
symbioses##9##1##(2008-10#1)(2008-7#1)(2008-8#2)(2009-8#2)(2011-2#1)(2012-8#1)(2013-1#1)
symbiosis and##2##2##(2008-11#1)(2008-8#1)
symbiosis of##3##2##(1996-2#1)(2009-6#1)(2009-8#1)
symbiosis with##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
symbiosis##20##1##(1996-2#1)(2007-12#1)(2008-11#4)(2008-5#1)(2008-8#5)(2009-6#1)(2009-8#1)(2010-10#2)(2010-6#1)(2011-2#1)(2012-8#2)
symbiotic events##2##2##(2011-2#2)
symbiotic microbes##2##2##(2009-6#2)
symbiotic##27##1##(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-8#2)
symbiotrophic##2##1##(2010-6#2)
symbiotrophy##2##1##(2010-6#2)
symbol Rpc1##2##2##(2008-10#2)
symbol of WAIS##2##3##(1994-6#2)
symbol of##3##2##(1994-6#2)(2009-7#1)
symbol##10##1##(1994-6#2)(2008-10#2)(2008-4#1)(2008-7#2)(2009-7#1)(2010-5#1)(2011-2#1)
symbolic substitution##3##2##(2008-2#2)(2008-3#1)
symbolic##17##1##(1991-12#1)(1994-3#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-10#1)(2009-7#3)(2010-4#1)(2011-1#1)(2011-3#2)(2013-8#2)
symbolism of##3##2##(2007-10#1)(2009-10#2)
symbolism##4##1##(2007-10#1)(2009-10#3)
symbolizing##2##1##(2009-10#1)(2012-12#1)
symbols##2##1##(1992-2#1)(2008-4#1)
symmetric about the##2##3##(2008-10#1)(2008-7#1)
symmetric about##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
symmetric and asymmetric fusion##3##4##(2008-8#3)
symmetric and asymmetric##7##3##(2008-10#2)(2008-7#1)(2008-8#4)
symmetric and##11##2##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#6)
symmetric beam##2##2##(2007-11#1)(2007-12#1)
symmetric emission##2##2##(2008-3#1)(2008-5#1)
symmetric intervals##2##2##(2008-10#2)
symmetric mean filter##2##3##(2008-3#2)
symmetric modified Daubechie##2##3##(2010-4#2)
symmetric multiprocessors##2##2##(2008-3#2)
symmetric stretching band##2##3##(2008-10#2)
symmetric stretching mode of the##2##5##(1995-5#1)(2008-10#1)
symmetric stretching##6##2##(1994-11#1)(1995-5#1)(2008-10#4)
symmetric##113##1##(1990-11#1)(1991-3#1)(1992-6#1)(1993-12#3)(1993-8#4)(1994-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#3)(2007-10#1)(2007-11#8)(2007-12#11)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#27)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2009-4#1)(2009-7#1)(2010-4#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
symmetrical and unsymmetrical##2##3##(2008-10#2)
symmetrical and##3##2##(2008-10#2)(2010-3#1)
symmetrical arthritis##2##2##(1990-3#1)(2012-3#1)
symmetrical dual-coupling##2##2##(2007-12#2)
symmetrical peak and with##2##4##(2008-10#2)
symmetrical peak and##3##3##(2008-10#3)
symmetrical##67##1##(1990-3#1)(1990-8#2)(1991-11#1)(1991-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-5#3)(1997-8#1)(2006-10#1)(2007-12#6)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
symmetrically##7##1##(1995-3#1)(2008-10#1)(2008-3#3)(2009-2#1)(2012-3#1)
symmetries are##3##2##(2008-3#1)(2010-8#2)
symmetries in##4##2##(2008-3#1)(2010-8#2)(2013-1#1)
symmetries##19##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#6)(2008-6#1)(2009-8#1)(2010-8#5)(2012-2#1)(2013-1#1)
symmetry and##10##2##(1992-9#1)(1994-3#1)(1996-2#2)(2007-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
symmetry conservation##2##2##(1990-8#2)
symmetry differences in##2##3##(2008-8#2)
symmetry differences##3##2##(2008-8#3)
symmetry filtering##2##2##(2008-3#2)
symmetry from##2##2##(2008-10#1)(2008-8#1)
symmetry in the##4##3##(2007-10#1)(2007-11#2)(2008-3#1)
symmetry in##8##2##(1990-8#1)(1992-11#1)(2007-10#1)(2007-11#2)(2008-3#1)(2008-7#1)(2013-1#1)
symmetry is##5##2##(2007-11#2)(2008-3#2)(2008-6#1)
symmetry of the##12##3##(1990-8#1)(1993-11#1)(1997-7#2)(2007-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-12#1)
symmetry of##18##2##(1990-8#1)(1993-11#1)(1997-7#2)(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#1)
symmetry or##3##2##(1990-8#1)(2007-11#1)(2008-8#1)
symmetry with##2##2##(1992-9#1)(2007-11#1)
symmetry##131##1##(1990-11#1)(1990-12#1)(1990-8#6)(1992-11#1)(1992-8#2)(1992-9#3)(1993-11#1)(1994-3#1)(1995-11#1)(1996-2#6)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#3)(2006-4#1)(2007-10#1)(2007-11#16)(2007-12#9)(2008-10#7)(2008-2#5)(2008-3#19)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#14)(2008-9#4)(2009-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-1#2)(2012-12#3)(2013-1#2)(2013-8#4)
sympathectomy##2##1##(1990-7#1)(1993-7#1)
sympathetic activation##3##2##(1992-8#1)(2010-5#1)(2013-8#1)
sympathetic activity in##2##3##(2012-2#2)
sympathetic activity##3##2##(2008-7#1)(2012-2#2)
sympathetic and parasympathetic##4##3##(2008-10#1)(2010-5#1)(2012-2#2)
sympathetic and##5##2##(2007-8#1)(2008-10#1)(2010-5#1)(2012-2#2)
sympathetic denervation##2##2##(2013-1#1)(2013-8#1)
sympathetic drive to the bladder and related organs##2##8##(1995-12#2)
sympathetic drive##3##2##(1995-12#2)(2008-12#1)
sympathetic dystrophy##5##2##(1995-6#1)(2006-10#2)(2008-10#1)(2008-4#1)
sympathetic innervation##5##2##(1994-5#3)(1995-3#1)(2012-2#1)
sympathetic nerve activity##2##3##(1990-12#1)(2008-7#1)
sympathetic nerve function in##2##4##(2008-7#2)
sympathetic nerve function##4##3##(2008-7#4)
sympathetic nerve##16##2##(1990-12#1)(1991-2#1)(1993-1#1)(1994-5#1)(2008-7#5)(2008-9#4)(2009-12#1)(2009-3#1)(2012-2#1)
sympathetic nerves##2##2##(1990-12#1)(1997-1#1)
sympathetic nervous system activity##3##4##(2008-7#2)(2011-2#1)
sympathetic nervous system##6##3##(1991-2#1)(1997-2#1)(2008-7#2)(2011-2#1)(2012-2#1)
sympathetic nervous##7##2##(1991-2#1)(1997-2#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
sympathetic outflow##2##2##(1992-6#1)(2008-1#1)
sympathetic sprouting in the DRG and##2##6##(2008-9#2)
sympathetic sprouting in the##3##4##(2008-9#3)
sympathetic sprouting in##5##3##(2008-9#5)
sympathetic vasoconstriction in##2##3##(1995-12#2)
sympathetic##88##1##(1990-12#2)(1990-9#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-5#4)(1994-9#1)(1995-12#6)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#10)(2009-11#1)(2009-12#2)(2009-3#1)(2010-5#3)(2010-7#1)(2011-2#2)(2012-2#11)(2013-1#1)(2013-8#2)
sympathomimetic amines##2##2##(2008-10#2)
sympathomimetic##8##1##(1995-2#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-5#1)(2011-2#1)
sympathovagal balance##4##2##(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
sympathovagal imbalance in##2##3##(2012-2#2)
sympathovagal imbalance##3##2##(2012-2#3)
sympathovagal##9##1##(2009-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#1)
sympathy##5##1##(2007-11#1)(2012-2#4)
sympatric divergence of host races##2##5##(2008-10#2)
sympatric locations##3##2##(2008-8#3)
sympatric species##7##2##(2008-10#1)(2008-8#2)(2008-9#2)(2012-3#1)(2013-1#1)
sympatric##26##1##(2008-10#9)(2008-6#1)(2008-8#7)(2008-9#2)(2010-8#3)(2012-3#3)(2013-1#1)
sympatry and allopatry##2##3##(2008-10#2)
sympatry and##3##2##(2008-10#3)
sympatry##15##1##(2008-10#8)(2008-8#6)(2012-3#1)
symphyseal##2##1##(1995-6#1)(2013-1#1)
symphysis pubis diastasis##2##3##(2012-1#2)
symphysis pubis##5##2##(1994-3#1)(2012-1#2)(2012-12#2)
symphysis reconstruction##2##2##(2008-10#2)
symphysis##12##1##(1990-6#1)(1994-3#1)(2008-10#2)(2011-1#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#1)
symplastic##2##1##(1992-12#1)(2008-11#1)
symport##3##1##(2008-6#1)(2008-7#2)
symporter##2##1##(1997-7#1)(2008-6#1)
symposia and##3##2##(2008-5#2)(2008-7#1)
symposia##10##1##(2008-11#1)(2008-5#6)(2008-7#2)(2010-5#1)
symposium on##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
symposium to##2##2##(2008-5#1)(2012-1#1)
symposium was the##2##3##(2008-5#2)
symposium was##6##2##(2008-5#6)
symposium##38##1##(1991-12#1)(1992-2#1)(1992-3#2)(1994-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#20)(2008-8#2)(2010-7#1)(2012-1#1)(2013-1#3)
symptom and##5##2##(2008-10#1)(2011-1#1)(2011-2#3)
symptom area##2##2##(2008-10#2)
symptom assessment##2##2##(2008-10#1)(2008-3#1)
symptom at##2##2##(1990-3#1)(1997-3#1)
symptom burden and##5##3##(1994-3#1)(2008-7#4)
symptom burden in##3##3##(2008-7#3)
symptom burden##12##2##(1994-3#1)(2008-7#11)
symptom complex##4##2##(1991-11#1)(1996-1#1)(1997-2#1)(2008-7#1)
symptom control##3##2##(2010-12#2)(2011-2#1)
symptom criteria##2##2##(1991-1#1)(2011-2#1)
symptom descriptors##2##2##(2008-10#2)
symptom development by##2##3##(2008-10#2)
symptom development of##2##3##(2008-10#2)
symptom development on##2##3##(2008-10#2)
symptom development was##3##3##(2008-10#2)(2008-9#1)
symptom development##24##2##(2008-10#22)(2008-9#1)(2012-9#1)
symptom diagnoses##3##2##(1997-6#3)
symptom duration##2##2##(2007-10#1)(2008-7#1)
symptom expression and##5##3##(2008-10#5)
symptom expression of##2##3##(2008-10#2)
symptom expression was##2##3##(2008-10#2)
symptom expression##22##2##(2008-10#22)
symptom for##2##2##(1996-6#1)(2010-12#1)
symptom free##3##2##(2010-5#1)(2012-12#1)(2012-2#1)
symptom in##7##2##(1991-2#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
symptom intensity##2##2##(2008-6#1)(2008-9#1)
symptom is##3##2##(1996-9#1)(2008-7#1)(2009-4#1)
symptom levels##2##2##(1996-2#1)(2008-8#1)
symptom management##5##2##(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
symptom of the disease##2##4##(2008-10#1)(2012-1#1)
symptom of##21##2##(1991-8#1)(1994-2#1)(1994-7#1)(1995-11#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#2)
symptom onset##10##2##(1994-3#1)(2007-10#2)(2007-9#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
symptom or sign##3##3##(1991-8#2)(1993-5#1)
symptom or##5##2##(1991-8#2)(1993-5#1)(2008-10#1)(2008-7#1)
symptom phenotype##3##2##(2008-10#3)
symptom recurrence after##2##3##(2010-6#2)
symptom recurrence##3##2##(2010-6#3)
symptom reduction##3##2##(2009-1#2)(2009-11#1)
symptom score and##2##3##(2007-2#1)(2012-3#1)
symptom score##8##2##(2007-2#4)(2007-7#1)(2008-11#1)(2008-7#1)(2012-3#1)
symptom severity and##2##3##(2008-10#1)(2008-9#1)
symptom severity for##2##3##(2008-10#2)
symptom severity in##6##3##(2008-10#4)(2008-9#1)(2013-7#1)
symptom severity score##2##3##(2008-10#2)
symptom severity##33##2##(2008-10#18)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-8#2)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
symptom structures##3##2##(1996-5#3)
symptom that##2##2##(2007-11#1)(2007-7#1)
symptom type##2##2##(2008-10#2)
symptom was##9##2##(1990-9#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
symptom##283##1##(1990-12#3)(1990-3#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#3)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#2)(1996-1#1)(1996-2#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#5)(1997-8#1)(2007-10#4)(2007-11#6)(2007-2#6)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#90)(2008-11#4)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#24)(2008-8#2)(2008-9#8)(2009-1#2)(2009-11#2)(2009-4#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-5#3)(2010-6#3)(2011-1#4)(2011-10#1)(2011-2#16)(2011-8#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#5)(2013-7#3)(2013-8#4)
symptom)##2##1##(2008-7#1)(2010-12#1)
symptom-days##3##1##(2013-1#3)
symptom-free after##2##2##(1997-8#1)(2012-3#1)
symptom-free##8##1##(1996-11#1)(1997-8#1)(2008-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
symptomatic ASD##3##2##(1996-6#1)(2012-12#1)(2012-3#1)
symptomatic and asymptomatic##5##3##(2008-10#2)(2008-3#1)(2010-8#2)
symptomatic and##13##2##(1996-8#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#3)
symptomatic and/or##2##2##(2010-12#1)(2012-12#1)
symptomatic benefit##3##2##(1997-6#1)(2010-12#2)
symptomatic benign##2##2##(1994-5#1)(2013-1#1)
symptomatic berries##2##2##(2008-10#2)
symptomatic bone metastases##3##3##(2008-7#3)
symptomatic carotid stenosis##3##3##(1993-1#1)(2008-8#2)
symptomatic carotid##4##2##(1993-1#1)(2008-8#3)
symptomatic cholelithiasis##2##2##(1993-9#1)(2009-3#1)
symptomatic control##2##2##(2008-7#1)(2010-7#1)
symptomatic for##3##2##(1992-5#1)(2010-3#1)(2012-3#1)
symptomatic improvement##8##2##(1993-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-12#1)
symptomatic internal carotid artery##3##4##(2007-10#1)(2008-7#1)(2008-8#1)
symptomatic internal carotid##5##3##(2007-10#3)(2008-7#1)(2008-8#1)
symptomatic intracranial haemorrhage##2##3##(2007-10#2)
symptomatic intracranial##4##2##(2007-10#2)(2008-8#2)
symptomatic leaves##3##2##(2008-10#3)
symptomatic patient##3##2##(2008-10#1)(2011-2#2)
symptomatic patients##7##2##(1991-11#1)(1991-3#1)(1993-11#1)(2009-10#1)(2009-4#1)(2010-6#1)(2013-1#1)
symptomatic plants##9##2##(2008-10#9)
symptomatic relief##5##2##(1991-3#1)(1997-8#1)(2008-5#1)(2008-6#1)(2008-7#1)
symptomatic samples##4##2##(2008-10#4)
symptomatic sternal nonunion##2##3##(2012-2#2)
symptomatic therapy##2##2##(1990-6#1)(1996-3#1)
symptomatic treatment of##3##3##(1996-11#1)(2008-7#1)(2010-7#1)
symptomatic treatment##10##2##(1991-2#1)(1996-11#2)(1997-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
symptomatic trees were##2##3##(2008-10#2)
symptomatic trees##7##2##(2008-10#7)
symptomatic unilateral##2##2##(2007-10#1)(2008-10#1)
symptomatic uterine fibroids##2##3##(1993-12#2)
symptomatic vertebrobasilar artery stenosis##2##4##(2012-3#2)
symptomatic vines##2##2##(2008-10#2)
symptomatic##246##1##(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-6#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-11#2)(1996-3#1)(1996-6#3)(1996-8#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-8#1)(2007-10#7)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#60)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#16)(2008-8#10)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#5)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#19)(2011-3#2)(2012-12#10)(2012-2#8)(2012-3#10)(2013-1#10)(2013-7#2)(2013-8#1)
symptomatological##3##1##(1990-6#1)(1990-9#1)(2013-1#1)
symptomatology and##6##2##(1990-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
symptomatology by##2##2##(1993-3#1)(2008-7#1)
symptomatology in##3##2##(1996-5#1)(1996-9#1)(2008-10#1)
symptomatology is##2##2##(1990-6#1)(1992-9#1)
symptomatology of##6##2##(1994-3#1)(1997-8#1)(2008-10#2)(2009-10#1)(2013-1#1)
symptomatology was##5##2##(1991-6#1)(1996-9#2)(2008-7#1)(2013-8#1)
symptomatology were##3##2##(1990-9#1)(2008-10#1)(2013-1#1)
symptomatology##74##1##(1990-11#1)(1990-5#3)(1990-6#1)(1990-9#4)(1991-1#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-5#2)(1996-9#3)(1997-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-4#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-4#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#4)
symptomless Austrian##2##2##(2008-10#2)
symptomless infections##2##2##(2008-10#2)
symptomless pear fruit##2##3##(2008-10#2)
symptomless pine shoots##3##3##(2008-10#3)
symptomless plants from##2##3##(2008-10#2)
symptomless plants##6##2##(2008-10#6)
symptomless##33##1##(2008-10#33)
symptoms (P&lt##2##2##(2006-10#2)
symptoms (e##2##2##(1997-2#1)(2010-6#1)
symptoms 6##2##2##(1991-8#1)(2008-10#1)
symptoms according to##2##3##(2008-10#2)
symptoms after a##2##3##(1992-6#1)(2013-1#1)
symptoms after##17##2##(1992-6#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-6#2)(2011-2#2)(2012-12#2)(2013-1#1)
symptoms among##5##2##(1992-6#1)(1995-8#2)(2008-7#1)(2009-7#1)
symptoms and clinical##4##3##(1996-3#1)(2010-9#1)(2011-1#1)(2012-2#1)
symptoms and diagnosis##3##3##(1992-5#1)(2012-12#2)
symptoms and diagnostic##2##3##(2011-2#1)(2012-2#1)
symptoms and frequent##2##3##(1992-2#1)(2010-5#1)
symptoms and functional##2##3##(2008-7#1)(2011-8#1)
symptoms and functioning##2##3##(1992-9#1)(2009-8#1)
symptoms and has##2##3##(1997-1#1)(2008-7#1)
symptoms and histological##2##3##(2008-5#1)(2011-3#1)
symptoms and improving##2##3##(2006-10#1)(2008-7#1)
symptoms and internal##2##3##(2011-2#2)
symptoms and life##2##3##(1991-8#1)(2008-10#1)
symptoms and physical##3##3##(1992-9#1)(2008-6#1)(2008-8#1)
symptoms and quality of life in##2##6##(2008-4#1)(2010-6#1)
symptoms and quality of life##3##5##(2008-4#1)(2010-6#1)(2011-2#1)
symptoms and school##2##3##(2009-7#1)(2009-9#1)
symptoms and signs of##7##4##(1990-2#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2011-3#1)
symptoms and signs similar to##2##5##(1992-4#1)(2008-3#1)
symptoms and signs##21##3##(1990-2#1)(1990-6#1)(1992-4#1)(1994-2#1)(1995-2#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2010-12#1)(2011-2#1)(2011-3#1)
symptoms and sometimes##2##3##(2008-7#2)
symptoms and that##2##3##(2008-10#1)(2008-2#1)
symptoms and the need for##2##5##(2010-10#1)(2011-2#1)
symptoms and the##16##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-6#1)(1994-6#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
symptoms and their##3##3##(1993-5#1)(1996-3#1)(2008-3#1)
symptoms and treatment##5##3##(1996-9#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-12#1)
symptoms and wall motion abnormalities##2##5##(2007-8#2)
symptoms and##208##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-9#2)(1993-12#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-11#2)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#3)(2006-10#4)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#29)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#15)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#4)(2009-12#1)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#2)(2011-8#1)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
symptoms appear##3##2##(1993-3#1)(2009-9#1)(2013-8#1)
symptoms appeared##4##2##(1990-3#1)(2008-10#3)
symptoms appearing##2##2##(1997-8#1)(2008-10#1)
symptoms are a##2##3##(1993-6#1)(2008-4#1)
symptoms are frequently##2##3##(2013-1#2)
symptoms are often##2##3##(1996-11#1)(2012-2#1)
symptoms are reported##2##3##(1990-12#1)(1991-6#1)
symptoms are similar to##2##4##(2008-10#1)(2010-8#1)
symptoms are the##2##3##(1997-3#1)(2013-8#1)
symptoms are usually##2##3##(2008-11#1)(2012-3#1)
symptoms are##39##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
symptoms as well as the##2##5##(2011-1#1)(2012-1#1)
symptoms as##10##2##(1994-12#1)(1997-8#1)(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
symptoms associated with##9##3##(1992-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
symptoms associated##10##2##(1990-9#1)(1992-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
symptoms at all##2##3##(1997-6#1)(2008-12#1)
symptoms at discharge##3##3##(2011-2#3)
symptoms at the##3##3##(1997-8#1)(2008-10#1)(2008-4#1)
symptoms at##11##2##(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#3)(2013-8#1)
symptoms began##2##2##(2008-10#1)(2012-12#1)
symptoms being##2##2##(2008-1#1)(2013-8#1)
symptoms but##7##2##(1995-5#1)(2008-10#3)(2008-7#2)(2013-1#1)
symptoms by##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
symptoms can be##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
symptoms can##4##2##(2008-12#1)(2008-7#1)(2009-9#1)(2011-2#1)
symptoms caused by the##2##4##(2008-10#2)
symptoms caused by##10##3##(1990-6#1)(2008-10#7)(2009-6#1)(2011-2#1)
symptoms completely##2##2##(2011-2#1)(2013-8#1)
symptoms consistent with##2##3##(2008-12#1)(2013-8#1)
symptoms described##2##2##(1994-3#1)(2008-12#1)
symptoms despite##2##2##(1992-9#1)(2006-10#1)
symptoms develop##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
symptoms developed in##2##3##(2008-10#1)(2008-5#1)
symptoms developed##8##2##(2008-10#6)(2008-5#1)(2012-3#1)
symptoms did not##3##3##(1990-11#1)(2008-7#1)(2011-2#1)
symptoms disappeared##6##2##(1991-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
symptoms do not##4##3##(1991-3#1)(1995-11#1)(2007-11#1)(2008-10#1)
symptoms during the##3##3##(1995-11#1)(2011-1#1)(2012-12#1)
symptoms during##6##2##(1990-6#1)(1995-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
symptoms even though##2##3##(2008-10#1)(2012-2#1)
symptoms even##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
symptoms experienced by patients##2##4##(2008-10#1)(2008-6#1)
symptoms experienced##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
symptoms five years later##2##4##(2012-2#2)
symptoms following##6##2##(1990-12#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
symptoms for##2##2##(1992-5#1)(2008-7#1)
symptoms free##2##2##(2007-11#1)(2007-8#1)
symptoms from##7##2##(1990-2#1)(1991-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
symptoms had##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
symptoms has been##2##3##(1997-6#1)(2011-2#1)
symptoms has##3##2##(1997-6#1)(2008-11#1)(2011-2#1)
symptoms have been##2##3##(2010-10#1)(2012-1#1)
symptoms have##4##2##(1991-4#1)(2010-10#1)(2011-2#1)(2012-1#1)
symptoms improved significantly##2##3##(2008-1#1)(2009-3#1)
symptoms improved##7##2##(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#2)(2013-1#1)(2013-8#1)
symptoms in Parkinson's disease (PD)##2##5##(2010-12#1)(2013-8#1)
symptoms in a##7##3##(1995-8#1)(2008-10#3)(2008-8#1)(2012-12#1)(2012-2#1)
symptoms in bean##2##3##(2008-10#2)
symptoms in both##2##3##(2008-10#2)
symptoms in healthy##2##3##(2008-10#1)(2013-1#1)
symptoms in patients with schizophrenia##2##5##(2009-12#1)(2013-8#1)
symptoms in patients with##5##4##(1997-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-8#1)
symptoms in patients##7##3##(1997-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
symptoms in response to##3##4##(2008-10#3)
symptoms in susceptible##3##3##(1995-6#1)(2008-10#2)
symptoms in the##12##3##(2008-10#7)(2008-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
symptoms in tobacco##2##3##(2008-10#2)
symptoms in tomato##5##3##(2008-10#5)
symptoms in two cases##2##4##(1997-8#1)(2007-12#1)
symptoms in two##4##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
symptoms in women with##2##4##(2011-8#1)(2013-1#1)
symptoms in##124##2##(1990-2#2)(1991-1#1)(1991-6#1)(1991-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-7#1)(1997-1#1)(1997-6#2)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#50)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-8#2)(2011-2#9)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#7)
symptoms include##3##2##(1992-4#1)(2008-10#1)(2012-3#1)
symptoms included##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
symptoms including##5##2##(1991-4#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
symptoms induced by##4##3##(2008-10#3)(2008-3#1)
symptoms induced##6##2##(2008-10#5)(2008-3#1)
symptoms initially##2##2##(2008-10#2)
symptoms is##7##2##(2008-10#2)(2008-2#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
symptoms like##2##2##(2011-1#1)(2012-2#1)
symptoms may appear##2##3##(2008-11#1)(2010-8#1)
symptoms may be##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
symptoms may##14##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
symptoms must##2##2##(2008-10#1)(2008-8#1)
symptoms observed in##2##3##(2007-12#1)(2008-10#1)
symptoms observed##3##2##(2007-12#1)(2008-10#2)
symptoms occur##2##2##(2008-10#1)(2008-7#1)
symptoms occurred##3##2##(1991-2#1)(2006-10#1)(2008-10#1)
symptoms of ASPD##2##3##(1994-2#2)
symptoms of Eutypa dieback##2##4##(2008-10#2)
symptoms of KLS##2##3##(2012-2#2)
symptoms of Parkinson's disease##2##4##(1994-6#1)(2008-7#1)
symptoms of a##4##3##(1992-9#1)(1995-6#1)(2006-10#1)(2007-8#1)
symptoms of acute abdomen##2##4##(1993-5#1)(2011-1#1)
symptoms of acute##6##3##(1993-5#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
symptoms of allergic rhinitis##2##4##(2012-12#1)(2013-8#1)
symptoms of an##2##3##(1996-4#1)(2008-9#1)
symptoms of anthracnose##2##3##(2008-10#2)
symptoms of anxiety##3##3##(2008-6#1)(2008-7#1)(2009-12#1)
symptoms of autonomic##2##3##(2008-6#1)(2013-1#1)
symptoms of bacterial##2##3##(2008-10#1)(2009-3#1)
symptoms of chronic fatigue##2##4##(2008-10#2)
symptoms of citrus variegated chlorosis##2##5##(2008-10#2)
symptoms of citrus##3##3##(2008-10#3)
symptoms of dementia##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
symptoms of depression##6##3##(2008-4#1)(2010-12#1)(2010-7#2)(2011-2#1)(2013-1#1)
symptoms of diabetic neuropathy##2##4##(2008-1#1)(2013-1#1)
symptoms of disease##2##3##(2008-10#2)
symptoms of dysphagia##2##3##(2011-1#1)(2013-8#1)
symptoms of heart failure##2##4##(2013-1#1)(2013-8#1)
symptoms of hyperthyroidism##2##3##(2007-8#2)
symptoms of infection by##2##4##(2008-10#2)
symptoms of menopause##2##3##(2013-8#2)
symptoms of mental##2##3##(2012-12#1)(2013-7#1)
symptoms of neuroticism##4##3##(2008-6#4)
symptoms of schizophrenia##5##3##(1995-3#1)(1995-5#1)(2008-2#2)(2012-12#1)
symptoms of severe heart failure##2##5##(2007-8#1)(2008-4#1)
symptoms of severe##3##3##(2007-8#1)(2008-4#1)(2012-1#1)
symptoms of sleep##2##3##(2009-4#1)(2013-1#1)
symptoms of spinal cord compression##2##5##(1992-12#1)(2007-11#1)
symptoms of the common cold##2##5##(2008-10#2)
symptoms of the common##3##4##(2008-10#3)
symptoms of the disease and the##2##6##(2008-10#1)(2013-7#1)
symptoms of the disease##10##4##(1990-6#1)(1997-3#1)(2007-7#1)(2008-10#4)(2008-7#2)(2013-7#1)
symptoms of the##22##3##(1990-10#1)(1990-6#1)(1992-2#1)(1995-5#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-7#2)(2013-1#1)(2013-7#2)
symptoms of these##3##3##(2010-2#1)(2012-2#1)(2013-8#1)
symptoms of this##5##3##(1990-9#1)(1993-3#1)(1997-3#1)(2007-8#1)(2008-7#1)
symptoms of##269##2##(1990-10#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#3)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-6#3)(2007-7#6)(2007-8#9)(2008-1#8)(2008-10#45)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#7)(2008-5#6)(2008-6#8)(2008-7#12)(2008-9#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-7#2)(2010-8#4)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#15)(2013-7#3)(2013-8#11)
symptoms often##3##2##(1991-6#1)(2008-2#1)(2008-8#1)
symptoms on soybean##3##3##(2008-10#3)
symptoms on the##5##3##(2007-8#1)(2008-10#4)
symptoms on##32##2##(2007-8#1)(2008-10#26)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#2)
symptoms onset##3##2##(2007-10#1)(2008-3#1)(2008-7#1)
symptoms or signs##2##3##(1991-8#1)(1997-6#1)
symptoms or##17##2##(1991-8#1)(1991-9#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
symptoms over time##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
symptoms persisted##2##2##(2010-12#1)(2011-2#1)
symptoms potentially indicative of##2##4##(2008-12#2)
symptoms prior to##2##3##(1990-6#1)(2007-12#1)
symptoms produced by##2##3##(2008-10#2)
symptoms ranging from##2##3##(2008-7#1)(2011-2#1)
symptoms recurred##2##2##(1997-6#1)(2012-2#1)
symptoms related to the##2##4##(2007-11#1)(2008-5#1)
symptoms related to##6##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)
symptoms related##7##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
symptoms require##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
symptoms resolved##6##2##(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)
symptoms revealed##2##2##(2008-4#1)(2012-2#1)
symptoms should be##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
symptoms should##4##2##(2008-10#1)(2010-4#1)(2010-5#1)(2013-8#1)
symptoms showed##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
symptoms similar to those observed in##2##6##(2008-10#2)
symptoms similar to those##6##4##(2008-10#6)
symptoms similar to##9##3##(1991-3#1)(2008-10#8)
symptoms spontaneously resolved##2##3##(2007-8#1)(2008-10#1)
symptoms such as##14##3##(1993-9#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
symptoms suggestive of##5##3##(1991-11#1)(2007-8#1)(2008-10#1)(2009-9#1)(2011-2#1)
symptoms than##8##2##(1996-7#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)
symptoms that##14##2##(1991-6#1)(1993-10#1)(1995-8#1)(1996-6#1)(2008-10#2)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
symptoms they##2##2##(2008-10#1)(2008-6#1)
symptoms to##11##2##(1993-2#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
symptoms typical of##3##3##(2008-10#2)(2008-12#1)
symptoms under##2##2##(2008-10#1)(2012-3#1)
symptoms was noted##2##3##(2006-10#1)(2009-3#1)
symptoms was the##2##3##(2008-10#1)(2012-12#1)
symptoms was##26##2##(1990-10#1)(1994-2#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-10#6)(2008-5#1)(2008-7#4)(2009-3#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
symptoms were assessed##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
symptoms were completely relieved##2##4##(1995-11#1)(2008-7#1)
symptoms were found##2##3##(2008-10#1)(2013-1#1)
symptoms were measured##2##3##(2009-9#1)(2010-5#1)
symptoms were not##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
symptoms were observed on##2##4##(2008-10#2)
symptoms were observed##7##3##(1990-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
symptoms were present in##3##4##(2008-6#1)(2013-1#2)
symptoms were relieved##2##3##(2008-1#2)
symptoms were reported by##2##4##(2010-7#1)(2013-1#1)
symptoms were significantly##3##3##(2008-6#1)(2009-11#1)(2013-1#1)
symptoms were visible by 3 days after inoculation with the pathogen##2##11##(2008-10#2)
symptoms were##81##2##(1990-10#1)(1990-2#2)(1990-8#1)(1990-9#2)(1991-3#1)(1992-2#2)(1992-9#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#4)(2008-10#23)(2008-5#2)(2008-6#5)(2008-7#5)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#9)(2013-8#3)
symptoms when the##2##3##(1995-6#1)(2009-11#1)
symptoms when they##2##3##(1995-6#1)(1996-6#1)
symptoms when##13##2##(1991-8#1)(1995-6#2)(1996-6#1)(2008-10#5)(2009-11#1)(2011-10#1)(2013-1#2)
symptoms which##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
symptoms with##16##2##(1992-4#1)(2007-10#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
symptoms within##3##2##(1990-6#1)(1991-4#1)(2013-8#1)
symptoms##1788##1##(1990-10#6)(1990-11#4)(1990-12#3)(1990-2#7)(1990-3#5)(1990-4#1)(1990-6#16)(1990-8#1)(1990-9#8)(1991-1#4)(1991-11#6)(1991-12#2)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#3)(1991-6#10)(1991-7#1)(1991-8#9)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#7)(1992-3#2)(1992-4#5)(1992-5#9)(1992-6#2)(1992-9#8)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#9)(1994-3#1)(1994-6#5)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#9)(1995-8#10)(1996-11#3)(1996-12#1)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#5)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#6)(1997-2#4)(1997-3#10)(1997-4#3)(1997-6#11)(1997-7#2)(1997-8#13)(2006-10#20)(2007-1#1)(2007-10#14)(2007-11#30)(2007-12#12)(2007-2#7)(2007-4#1)(2007-5#2)(2007-6#7)(2007-7#17)(2007-8#32)(2008-1#31)(2008-10#389)(2008-11#19)(2008-12#26)(2008-2#16)(2008-3#26)(2008-4#19)(2008-5#22)(2008-6#44)(2008-7#90)(2008-8#20)(2008-9#15)(2009-1#3)(2009-10#8)(2009-11#12)(2009-12#5)(2009-2#1)(2009-3#9)(2009-4#4)(2009-5#11)(2009-6#7)(2009-7#13)(2009-8#7)(2009-9#22)(2010-1#7)(2010-10#14)(2010-11#4)(2010-12#29)(2010-2#7)(2010-3#2)(2010-4#11)(2010-5#9)(2010-6#6)(2010-7#5)(2010-8#12)(2010-9#1)(2011-1#25)(2011-10#3)(2011-2#106)(2011-3#4)(2011-8#2)(2012-1#19)(2012-12#39)(2012-2#42)(2012-3#22)(2012-7#1)(2013-1#96)(2013-7#10)(2013-8#61)
symptoms&quot##3##1##(1996-3#1)(2011-2#2)
symptoms)##6##1##(2008-10#3)(2010-11#1)(2012-12#1)(2013-1#1)
symptoms/diseases##2##1##(2008-11#2)
symptoms]##7##1##(1992-4#1)(1992-5#1)(1993-5#1)(1994-8#1)(1995-11#1)(2013-8#2)
syn##6##1##(1992-3#1)(1996-5#2)(2008-10#2)(2011-2#1)
synapomorphic##2##1##(2008-10#1)(2008-7#1)
synapomorphies of##2##2##(2007-12#1)(2011-2#1)
synapomorphies##4##1##(2007-12#1)(2008-7#1)(2011-2#2)
synapse formation and##3##3##(1992-12#1)(2009-11#1)(2009-9#1)
synapse formation##6##2##(1992-12#1)(1995-12#2)(1997-6#1)(2009-11#1)(2009-9#1)
synapse remodeling##2##2##(2009-11#2)
synapse##32##1##(1991-12#1)(1992-12#1)(1992-6#1)(1995-12#3)(1996-2#1)(1997-6#1)(1997-7#1)(2008-4#2)(2008-7#2)(2009-11#6)(2009-12#1)(2009-8#6)(2009-9#2)(2012-2#2)(2013-1#1)(2013-8#1)
synapses and##4##2##(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
synapses formed with##2##3##(1997-3#2)
synapses formed##3##2##(1997-3#2)(2009-8#1)
synapses in the##3##3##(2008-7#2)(2013-8#1)
synapses in##4##2##(1995-2#1)(2008-7#2)(2013-8#1)
synapses is##2##2##(1996-2#1)(1997-7#1)
synapses on##6##2##(1993-9#1)(1994-2#1)(1997-2#2)(1997-7#1)(2012-2#1)
synapses onto##2##2##(1992-12#1)(1997-2#1)
synapses that##2##2##(2008-4#1)(2008-7#1)
synapses to##2##2##(1995-2#1)(2008-1#1)
synapses were##2##2##(1997-2#1)(1997-3#1)
synapses with##6##2##(1997-3#1)(2008-7#1)(2011-2#4)
synapses within##2##2##(2008-7#2)
synapses##79##1##(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-12#3)(1995-2#2)(1996-2#3)(1997-2#6)(1997-3#7)(1997-7#5)(2008-1#3)(2008-11#2)(2008-4#2)(2008-7#14)(2008-8#1)(2009-3#1)(2009-8#6)(2009-9#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
synapsin##4##1##(1994-8#3)(1996-12#1)
synapsins##4##1##(1994-8#4)
synapsis##2##1##(2008-5#1)(2008-7#1)
synaptic activity##7##2##(1995-2#1)(1996-12#2)(2008-11#1)(2008-7#1)(2009-3#1)(2013-8#1)
synaptic and non-synaptic##5##3##(1990-3#3)(1992-3#1)(2008-7#1)
synaptic and##6##2##(1990-3#3)(1992-3#1)(2008-11#1)(2008-7#1)
synaptic connections##5##2##(1997-2#1)(2008-11#1)(2008-4#1)(2009-8#2)
synaptic contact with dendritic##3##4##(1995-12#1)(1997-2#2)
synaptic contact with##4##3##(1995-12#1)(1997-2#3)
synaptic currents##2##2##(1995-2#2)
synaptic depression##2##2##(1997-7#1)(2008-11#1)
synaptic drive##2##2##(1996-2#1)(2008-11#1)
synaptic efficacy##5##2##(1993-12#1)(1994-8#1)(1996-2#1)(2008-6#1)(2008-7#1)
synaptic efficiency##2##2##(1996-2#1)(1997-2#1)
synaptic events##3##2##(1990-9#1)(2008-7#1)(2012-2#1)
synaptic expression of##2##3##(2008-7#2)
synaptic function##5##2##(1996-5#1)(2008-4#1)(2008-7#1)(2009-8#2)
synaptic functions##2##2##(2009-9#2)
synaptic homeostasis##6##2##(2009-9#6)
synaptic impairment##2##2##(2012-3#1)(2013-8#1)
synaptic information##2##2##(2009-3#2)
synaptic inhibition##3##2##(1996-5#1)(2008-7#2)
synaptic input##3##2##(1994-2#1)(2008-4#2)
synaptic inputs##3##2##(1994-2#1)(1995-2#1)(2009-3#1)
synaptic localization of##2##3##(1997-2#1)(2009-8#1)
synaptic mitochondria##4##2##(1990-3#3)(1994-6#1)
synaptic modification and##2##3##(1994-8#1)(2009-8#1)
synaptic modification is##2##3##(1997-7#1)(2008-11#1)
synaptic modification##5##2##(1994-8#1)(1997-7#1)(2008-11#1)(2009-10#1)(2009-8#1)
synaptic physiology##2##2##(2008-7#1)(2008-9#1)
synaptic plasma##6##2##(1995-12#1)(1995-6#2)(1997-1#3)
synaptic plasticity and##8##3##(1996-2#1)(2008-11#2)(2008-7#1)(2009-8#3)(2013-8#1)
synaptic plasticity in the nervous system##2##6##(1996-12#1)(2008-7#1)
synaptic plasticity in the##5##4##(1993-12#1)(1996-12#1)(2008-7#3)
synaptic plasticity in##9##3##(1993-12#1)(1995-12#1)(1996-12#1)(2008-4#2)(2008-7#3)(2013-1#1)
synaptic plasticity might##3##3##(2008-7#2)(2012-2#1)
synaptic plasticity##50##2##(1993-12#4)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-11#2)(2008-4#3)(2008-7#12)(2008-9#1)(2009-8#10)(2009-9#1)(2011-2#2)(2012-2#5)(2013-1#1)(2013-8#2)
synaptic potentials##6##2##(1991-12#2)(2008-7#4)
synaptic proteins##3##2##(1996-12#2)(2007-12#1)
synaptic strength and learning rules##2##5##(2008-11#2)
synaptic strength and##3##3##(2008-1#1)(2008-11#2)
synaptic strength##8##2##(1995-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-9#1)
synaptic tagging##2##2##(2013-8#2)
synaptic terminals##6##2##(1994-8#1)(1996-2#1)(1997-2#1)(1997-3#3)
synaptic transmission and plasticity##6##4##(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#2)(2009-9#1)
synaptic transmission and##11##3##(1994-5#1)(2008-11#1)(2008-7#3)(2009-11#1)(2009-3#1)(2009-8#3)(2009-9#1)
synaptic transmission in the hippocampus##3##5##(1993-12#1)(1995-12#1)(1997-2#1)
synaptic transmission in the##8##4##(1993-12#1)(1995-11#1)(1995-12#2)(1997-2#2)(2008-5#1)(2013-8#1)
synaptic transmission in##12##3##(1993-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-5#1)(1997-2#2)(2008-4#2)(2008-5#1)(2013-8#1)
synaptic transmission mediated by##2##4##(1995-11#1)(1996-2#1)
synaptic transmission##54##2##(1990-7#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#6)(1995-2#1)(1995-6#1)(1996-2#3)(1996-5#5)(1997-2#3)(1997-7#2)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#4)(2009-9#2)(2013-8#1)
synaptic vesicle isolation procedures##2##4##(2008-1#2)
synaptic vesicle##9##2##(1996-12#1)(1997-1#1)(2008-1#3)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
synaptic vesicles and##4##3##(1993-12#1)(1995-12#2)(1997-2#1)
synaptic vesicles##11##2##(1993-12#2)(1995-12#2)(1997-2#2)(1997-7#2)(2008-1#2)(2008-8#1)
synaptic weights##3##2##(1996-2#1)(2008-1#1)(2008-11#1)
synaptic##292##1##(1990-12#1)(1990-3#7)(1990-7#2)(1990-9#1)(1991-12#3)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#10)(1993-3#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#5)(1995-11#4)(1995-12#14)(1995-2#8)(1995-5#1)(1995-6#3)(1996-12#8)(1996-2#10)(1996-5#9)(1997-1#4)(1997-2#12)(1997-3#5)(1997-7#9)(2007-12#1)(2008-1#8)(2008-11#18)(2008-2#1)(2008-3#1)(2008-4#14)(2008-5#3)(2008-6#1)(2008-7#41)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#5)(2009-6#1)(2009-8#24)(2009-9#13)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#2)(2013-8#10)
synaptically##2##1##(2008-11#1)(2009-3#1)
synaptogenesis of##2##2##(1996-2#2)
synaptogenesis##5##1##(1996-2#2)(2008-7#3)
synaptonemal complex##3##2##(2008-5#2)(2008-9#1)
synaptonemal##5##1##(2008-5#3)(2008-7#1)(2008-9#1)
synaptoneurosomes##3##1##(1996-5#3)
synaptophysin##12##1##(1991-6#1)(1991-8#1)(1992-2#1)(1996-5#2)(2011-2#2)(2012-3#2)(2013-1#3)
synaptosomal and##2##2##(1993-8#2)
synaptosomal membranes##2##2##(1990-7#1)(1992-3#1)
synaptosomal##9##1##(1990-7#1)(1991-1#1)(1992-3#2)(1993-8#2)(1994-12#2)(1995-11#1)
synaptosome##3##1##(1991-2#2)(1997-2#1)
synaptosomes with arachidonic acid##2##4##(1995-11#2)
synaptosomes with##3##2##(1995-11#2)(1995-3#1)
synaptosomes##14##1##(1994-12#2)(1995-11#7)(1995-3#1)(1996-2#4)
synbiotics##2##1##(2010-4#2)
synchronicity##2##1##(2008-8#1)(2013-7#1)
synchronisation of##2##2##(2007-12#2)
synchronised##2##1##(1994-7#1)(2008-11#1)
synchronism##3##1##(2008-3#3)
synchronization and##5##2##(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)
synchronization in coupled Nd##2##4##(2007-12#2)
synchronization in##11##2##(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#2)
synchronization is##2##2##(2007-11#1)(2009-8#1)
synchronization of the##3##3##(1996-2#1)(2007-11#1)(2008-7#1)
synchronization of two##2##3##(2007-11#1)(2007-12#1)
synchronization of##17##2##(1996-2#2)(2007-11#4)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
synchronization to##2##2##(2007-11#1)(2009-8#1)
synchronization with##2##2##(2008-9#1)(2010-5#1)
synchronization##65##1##(1993-2#1)(1995-9#1)(1996-2#3)(2007-11#11)(2007-12#5)(2007-9#5)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#5)(2010-5#1)(2012-2#5)(2013-1#1)
synchronization-1st derivative fluorescence##2##3##(2008-10#2)
synchronize##8##1##(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#2)(2010-8#1)
synchronized dual wavelength modulation##2##4##(2008-10#2)
synchronized femtosecond##2##2##(2007-11#1)(2008-3#1)
synchronized in##2##2##(2007-12#1)(2008-4#1)
synchronized picosecond##3##2##(2007-11#3)
synchronized states##2##2##(2008-11#1)(2012-2#1)
synchronized to the##2##3##(2008-3#1)(2010-8#1)
synchronized to##5##2##(2007-11#1)(2008-3#2)(2010-8#1)(2013-1#1)
synchronized with##3##2##(1993-2#2)(2013-8#1)
synchronized##48##1##(1993-12#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-5#1)(1997-2#1)(1997-7#2)(2007-11#10)(2007-12#1)(2008-10#2)(2008-11#4)(2008-3#5)(2008-4#2)(2008-5#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
synchronizers##3##1##(2008-5#2)(2008-8#1)
synchronizes##2##1##(2008-8#1)(2011-1#1)
synchronizing the##3##2##(2008-5#1)(2010-11#1)(2010-9#1)
synchronizing##4##1##(2008-5#1)(2009-8#1)(2010-11#1)(2010-9#1)
synchronous activity##2##2##(2013-8#2)
synchronous and metachronous##2##3##(1992-8#1)(2010-3#1)
synchronous and##4##2##(1992-8#1)(2008-10#1)(2008-3#1)(2010-3#1)
synchronous derivative fluorimetry##2##3##(2008-10#2)
synchronous detection##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
synchronous fluorescence spectra##2##3##(2008-10#2)
synchronous fluorescence spectrometry##5##3##(2008-10#5)
synchronous fluorescence spectroscopy##4##3##(2008-10#4)
synchronous fluorescence##18##2##(2008-10#18)
synchronous luminescence analysis##2##3##(2008-10#2)
synchronous luminescence##5##2##(2008-10#5)
synchronous metastases##5##2##(2008-6#5)
synchronous or metachronous##2##3##(1992-8#1)(2013-1#1)
synchronous oscillations##2##2##(1996-2#1)(2008-2#1)
synchronous polarimeter##2##2##(2008-3#2)
synchronous scan fluorescence spectroscopy##2##4##(2013-8#2)
synchronous scan##4##2##(2008-10#1)(2013-8#3)
synchronous scanning##2##2##(1993-8#2)
synchronous spectrofluorimetry##5##2##(2008-10#5)
synchronous##112##1##(1990-5#1)(1990-6#4)(1991-2#1)(1991-6#2)(1992-3#1)(1992-8#2)(1993-12#1)(1993-8#3)(1994-12#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#40)(2008-11#4)(2008-2#3)(2008-3#11)(2008-5#2)(2008-6#6)(2008-7#2)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-3#1)(2013-1#2)(2013-8#7)
synchronously pumped by##2##3##(2007-11#1)(2007-12#1)
synchronously pumped optical parametric oscillator##3##5##(2007-11#2)(2008-3#1)
synchronously pumped optical parametric##4##4##(2007-11#3)(2008-3#1)
synchronously pumped##11##2##(2007-11#7)(2007-12#3)(2008-3#1)
synchronously with the##3##3##(2007-12#2)(2008-3#1)
synchronously##31##1##(1992-5#1)(2007-11#9)(2007-12#8)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-9#1)(2009-12#1)(2010-5#2)(2011-2#1)
synchrony (0##2##2##(2008-5#2)
synchrony between the##3##3##(2013-8#3)
synchrony in the##2##3##(2008-11#1)(2013-8#1)
synchrony in##5##2##(2008-11#1)(2009-8#3)(2013-8#1)
synchrony##23##1##(2008-11#6)(2008-2#1)(2008-5#3)(2008-8#1)(2009-8#4)(2010-5#1)(2010-8#1)(2013-8#6)
synchrotron X-ray##4##2##(2006-4#2)(2008-4#1)(2012-2#1)
synchrotron beamline##2##2##(2008-3#1)(2008-4#1)
synchrotron radiation in##3##3##(2008-10#2)(2008-3#1)
synchrotron radiation sources##2##3##(2006-4#2)
synchrotron radiation##30##2##(1995-6#1)(2006-4#3)(2007-11#2)(2008-10#5)(2008-2#4)(2008-3#11)(2008-5#2)(2010-5#1)(2012-12#1)
synchrotron sources##2##2##(2008-10#1)(2008-11#1)
synchrotron##45##1##(1995-6#1)(2006-4#5)(2007-11#3)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#5)(2010-5#1)(2012-12#1)(2012-2#1)
synchrotron-based##2##1##(2006-4#1)(2008-3#1)
syncopal episodes##2##2##(1992-4#1)(2008-12#1)
syncopal##4##1##(1992-4#1)(2008-11#1)(2008-12#1)(2008-2#1)
syncope and##3##2##(2008-11#1)(2008-12#2)
syncope##10##1##(1992-9#1)(2008-11#1)(2008-12#2)(2008-7#3)(2011-2#1)(2012-12#1)(2013-1#1)
syncytia##3##1##(1990-8#1)(2008-10#1)(2008-12#1)
syncytial virus (RSV)##6##3##(1996-3#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#2)
syncytial virus##13##2##(1994-6#3)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-10#2)(2010-5#1)(2011-2#3)
syncytial##16##1##(1994-6#3)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#2)(2010-5#1)(2011-2#3)(2013-1#2)
syncytiotrophoblast##10##1##(1990-12#2)(2011-1#7)(2013-1#1)
syncytium##4##1##(1991-2#1)(1993-6#1)(2008-7#1)(2010-11#1)
syndecan-1 is expressed in##2##4##(2008-5#2)
syndesmosis##3##1##(2009-1#1)(2012-12#2)
syndesmotic##3##1##(2009-3#2)(2012-3#1)
syndet surfactants##2##2##(2008-5#2)
syndicate learning##4##2##(2012-1#4)
syndicate##6##1##(2012-1#6)
syndrom##2##1##(2007-11#1)(2011-2#1)
syndromal##2##1##(2007-12#1)(2008-6#1)
syndrome (8##2##2##(2008-7#1)(2008-8#1)
syndrome (AIDS)##22##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#3)(1992-12#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-8#1)(2011-2#1)(2011-3#1)
syndrome (CBS)##2##2##(2011-2#2)
syndrome (DS)##3##2##(1991-1#1)(1996-2#1)(2012-2#1)
syndrome (FMS) is##2##3##(1990-6#1)(2011-2#1)
syndrome (HS)##2##2##(2011-2#2)
syndrome (MDS)##4##2##(1997-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
syndrome (PCOS)##12##2##(2008-3#2)(2008-4#8)(2013-1#1)(2013-8#1)
syndrome (VCFS)##2##2##(2012-12#2)
syndrome (multiple##2##2##(2008-8#1)(2013-8#1)
syndrome (n = 3)##2##4##(1994-6#1)(2012-12#1)
syndrome (n =##6##3##(1994-6#1)(1997-8#1)(2008-11#1)(2008-3#1)(2012-12#2)
syndrome - a##3##3##(2008-11#1)(2012-2#1)(2013-7#1)
syndrome -##4##2##(2007-4#1)(2008-11#1)(2012-2#1)(2013-7#1)
syndrome X patients##2##3##(2008-12#2)
syndrome X##8##2##(2008-12#5)(2008-3#2)(2011-2#1)
syndrome affecting##3##2##(1994-11#1)(2008-10#1)(2011-1#1)
syndrome affects##2##2##(2011-2#1)(2013-1#1)
syndrome after a##2##3##(2008-7#1)(2012-3#1)
syndrome after##12##2##(1990-2#2)(1995-12#1)(2008-7#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#1)
syndrome also##4##2##(2006-10#1)(2007-10#1)(2009-3#1)(2013-1#1)
syndrome among##3##2##(2010-10#1)(2012-2#1)(2013-8#1)
syndrome and a##2##3##(1991-8#1)(2007-8#1)
syndrome and acute##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
syndrome and chronic##3##3##(1992-2#1)(2010-10#1)(2012-3#1)
syndrome and diabetes##3##3##(2008-1#1)(2008-3#1)(2011-2#1)
syndrome and discuss##2##3##(2007-11#1)(2008-1#1)
syndrome and idiopathic##2##3##(2008-11#1)(2012-2#1)
syndrome and in##4##3##(1990-2#1)(1994-7#1)(2008-1#1)(2013-1#1)
syndrome and is##2##3##(2009-11#1)(2012-2#1)
syndrome and its##6##3##(1990-2#2)(2008-3#2)(2008-7#1)(2013-1#1)
syndrome and most##2##3##(1996-5#1)(2007-11#1)
syndrome and multiple##2##3##(1997-1#1)(2008-12#1)
syndrome and other##6##3##(1990-3#3)(1997-8#1)(2010-12#1)(2010-4#1)
syndrome and quality of life##2##5##(2011-2#2)
syndrome and related disorders##2##4##(2008-3#1)(2009-7#1)
syndrome and the##7##3##(1994-5#1)(1995-2#1)(2007-7#1)(2008-3#1)(2012-12#2)(2012-2#1)
syndrome and##151##2##(1990-11#1)(1990-2#3)(1990-3#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-5#2)(1993-12#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#2)(1996-5#2)(1997-1#2)(1997-8#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#3)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#16)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#5)(2011-2#15)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#4)
syndrome are described##2##3##(1991-5#1)(2012-2#1)
syndrome are discussed##2##3##(2007-8#1)(2013-1#1)
syndrome are##21##2##(1991-12#1)(1991-5#1)(1995-2#1)(1996-6#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
syndrome as a##6##3##(1991-5#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-3#1)(2012-3#1)
syndrome as well as##3##4##(1990-3#1)(2008-7#1)(2011-2#1)
syndrome as well##4##3##(1990-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
syndrome as##16##2##(1990-3#1)(1991-2#1)(1991-5#1)(1995-2#1)(2007-10#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-3#1)
syndrome associated with##9##3##(1997-3#1)(2007-7#2)(2008-11#1)(2010-7#1)(2011-1#3)(2012-12#1)
syndrome at the##2##3##(2008-11#1)(2008-9#1)
syndrome at##4##2##(2006-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
syndrome based on##3##3##(2010-6#1)(2011-2#1)(2013-1#1)
syndrome because##2##2##(1991-12#1)(2006-10#1)
syndrome by proxy##4##3##(1995-5#2)(1996-2#1)(2010-12#1)
syndrome by##13##2##(1990-6#1)(1995-5#2)(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2013-8#3)
syndrome can##5##2##(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
syndrome caused by a##4##4##(2007-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
syndrome caused by mutations in the##2##6##(2007-7#1)(2008-1#1)
syndrome caused by##9##3##(1997-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
syndrome characterized by##14##3##(1990-10#1)(1997-4#2)(2008-11#1)(2008-4#2)(2009-11#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
syndrome complicated##2##2##(2007-10#1)(2013-8#1)
syndrome complicating##2##2##(1996-6#2)
syndrome confirmed by##2##3##(2011-2#1)(2012-12#1)
syndrome de glissement&quot##2##3##(2010-6#2)
syndrome de sevrage à la nicotine##2##6##(2013-1#2)
syndrome de sevrage##3##3##(2013-1#3)
syndrome de##5##2##(2010-6#2)(2013-1#3)
syndrome due to##4##3##(1992-10#1)(2008-12#1)(2011-2#2)
syndrome during##6##2##(2008-12#2)(2008-3#1)(2008-9#1)(2011-3#1)(2012-3#1)
syndrome fibroblasts##2##2##(1990-3#1)(2008-7#1)
syndrome following##5##2##(2008-7#1)(2009-1#2)(2010-11#1)(2011-2#1)
syndrome from##4##2##(1996-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
syndrome group##3##2##(2008-3#2)(2008-7#1)
syndrome had##3##2##(1990-9#1)(1994-3#1)(2008-11#1)
syndrome has been reported##2##4##(2011-2#1)(2013-1#1)
syndrome has been##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
syndrome has recently##2##3##(2008-11#1)(2011-2#1)
syndrome has to be##2##4##(1990-9#1)(2011-2#1)
syndrome has##13##2##(1990-9#1)(1991-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#3)(2013-1#2)
syndrome have a##3##3##(1997-3#1)(1997-6#1)(2010-5#1)
syndrome have##9##2##(1997-3#2)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)
syndrome in Jamaican##2##3##(2011-2#2)
syndrome in Parkinson's disease##2##4##(2009-11#2)
syndrome in a patient with##3##5##(1997-3#1)(2011-1#1)(2013-7#1)
syndrome in a young##2##4##(1993-3#1)(2011-2#1)
syndrome in a##14##3##(1993-3#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-3#3)(2011-1#2)(2011-2#3)(2013-7#1)
syndrome in adults##4##3##(1996-11#1)(2008-7#2)(2012-3#1)
syndrome in an##3##3##(2007-12#2)(2007-8#1)
syndrome in children with##2##4##(2011-2#2)
syndrome in children##8##3##(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#2)
syndrome in patients with##3##4##(2008-1#1)(2008-3#1)(2012-2#1)
syndrome in the first##2##4##(1990-12#1)(2008-1#1)
syndrome in the##11##3##(1990-12#1)(1990-2#2)(1995-8#1)(2008-1#1)(2008-3#4)(2008-7#1)(2013-1#1)
syndrome in two##3##3##(1994-8#1)(1997-5#1)(2008-1#1)
syndrome in which##3##3##(1996-11#1)(2008-10#1)(2009-10#1)
syndrome in##108##2##(1990-12#1)(1990-2#2)(1992-5#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#5)(2008-1#8)(2008-10#6)(2008-12#4)(2008-3#14)(2008-5#2)(2008-7#7)(2009-10#1)(2009-11#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#3)(2011-2#11)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#1)
syndrome including##2##2##(2008-3#2)
syndrome induced by##3##3##(2007-8#1)(2008-4#1)(2009-6#1)
syndrome involves##3##2##(2008-12#1)(2009-5#1)(2013-8#1)
syndrome is a potentially##2##4##(2008-10#1)(2009-11#1)
syndrome is a rare autosomal recessive##2##6##(1997-8#1)(2011-1#1)
syndrome is a rare complication##2##5##(2009-11#1)(2011-2#1)
syndrome is a rare##9##4##(1997-8#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
syndrome is a##30##3##(1995-8#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#2)(2011-1#3)(2011-2#2)(2012-2#3)(2013-1#4)(2013-8#2)
syndrome is also##2##3##(2008-1#1)(2012-2#1)
syndrome is an autosomal dominant disorder characterized by##2##8##(2008-8#1)(2010-3#1)
syndrome is an autosomal dominant##5##5##(2008-12#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-1#1)
syndrome is an autosomal##6##4##(2008-12#1)(2008-8#1)(2010-3#2)(2010-8#1)(2013-1#1)
syndrome is caused by a##3##5##(2008-10#1)(2008-3#1)(2010-4#1)
syndrome is characterized by a##2##5##(1995-8#1)(2008-7#1)
syndrome is characterized by##10##4##(1991-3#1)(1994-12#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
syndrome is not##2##3##(1990-2#1)(2008-4#1)
syndrome is reported##2##3##(1992-6#1)(2009-5#1)
syndrome is the most common##4##5##(1992-5#1)(2009-12#1)(2010-11#1)(2012-1#1)
syndrome is the##9##3##(1992-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#1)(2011-3#1)(2012-1#1)(2012-2#1)
syndrome is##98##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-5#1)(1994-12#2)(1995-8#2)(1996-6#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#3)
syndrome may be##4##3##(1992-10#1)(1996-3#1)(2008-1#2)
syndrome may##8##2##(1992-10#1)(1996-3#1)(2006-10#1)(2008-1#2)(2008-7#1)(2009-6#1)(2010-11#1)
syndrome mosaic##3##2##(2008-6#3)
syndrome mutation##2##2##(2011-2#1)(2012-3#1)
syndrome occurs##3##2##(1990-6#1)(2008-7#1)(2010-6#1)
syndrome of inappropriate##2##3##(2008-1#1)(2009-8#1)
syndrome of the battered##2##4##(1995-5#2)
syndrome of the##4##3##(1995-5#2)(2008-12#1)(2009-3#1)
syndrome of##41##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#4)(2013-8#1)
syndrome on the basis of##2##5##(1990-6#1)(2008-5#1)
syndrome on the##3##3##(1990-6#1)(1995-2#1)(2008-5#1)
syndrome on##4##2##(1990-6#1)(1995-2#1)(2008-5#1)(2013-1#1)
syndrome or##12##2##(1994-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
syndrome patient##2##2##(1997-5#1)(2009-5#1)
syndrome patients##6##2##(2008-11#3)(2008-7#1)(2009-12#2)
syndrome per se##2##3##(2007-7#1)(2008-6#1)
syndrome presents with##2##3##(2008-9#1)(2012-12#1)
syndrome presents##3##2##(1991-12#1)(2008-9#1)(2012-12#1)
syndrome reactions##2##2##(2008-8#2)
syndrome region##2##2##(1996-2#1)(1997-3#1)
syndrome reported##2##2##(1991-2#1)(2008-1#1)
syndrome screening##5##2##(1996-12#3)(1996-3#2)
syndrome secondary to##2##3##(2007-7#1)(2013-8#1)
syndrome should be considered##2##4##(2011-2#1)(2012-2#1)
syndrome should##5##2##(1996-3#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
syndrome than##2##2##(1991-12#1)(2009-6#1)
syndrome that have been##2##4##(2008-1#1)(2008-7#1)
syndrome that is##2##3##(2007-10#1)(2008-10#1)
syndrome that##11##2##(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)
syndrome to##2##2##(1995-6#1)(2008-11#1)
syndrome type##7##2##(1992-6#1)(1997-8#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
syndrome using##3##2##(2007-8#1)(2008-1#1)(2010-8#1)
syndrome usually##2##2##(1991-5#1)(2007-7#1)
syndrome was diagnosed in##3##4##(1992-5#1)(1997-8#1)(2011-2#1)
syndrome was diagnosed##5##3##(1992-5#1)(1997-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
syndrome was first described##2##4##(2008-3#1)(2011-1#1)
syndrome was the##4##3##(2008-1#4)
syndrome was##24##2##(1990-6#1)(1992-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#4)(2008-11#2)(2008-3#4)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
syndrome were treated##2##3##(2008-3#1)(2012-3#1)
syndrome were##9##2##(1990-12#1)(1990-3#1)(1992-5#1)(1993-1#1)(2008-3#2)(2008-7#1)(2012-12#1)(2012-3#1)
syndrome which is##2##3##(2007-7#1)(2008-10#1)
syndrome which##9##2##(1991-12#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
syndrome who had##2##3##(2010-8#1)(2013-1#1)
syndrome who##6##2##(2007-7#1)(2008-1#2)(2010-8#1)(2012-2#1)(2013-1#1)
syndrome with a##2##3##(2009-1#1)(2010-5#1)
syndrome with bilateral##2##3##(2008-10#1)(2011-1#1)
syndrome with lactic acidosis and cerebral##2##6##(1990-3#2)
syndrome with minimal##2##3##(1996-6#1)(2012-3#1)
syndrome with##42##2##(1990-3#3)(1992-2#1)(1992-9#1)(1994-7#1)(1996-6#3)(1996-8#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
syndrome without##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#2)
syndrome##1858##1##(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#19)(1990-3#19)(1990-5#3)(1990-6#13)(1990-8#1)(1990-9#14)(1991-1#2)(1991-10#1)(1991-11#11)(1991-12#18)(1991-2#4)(1991-3#6)(1991-5#4)(1991-6#2)(1991-8#5)(1991-9#9)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#8)(1992-3#1)(1992-4#1)(1992-5#11)(1992-6#3)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#11)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#6)(1995-2#7)(1995-5#8)(1995-6#1)(1995-8#7)(1996-1#1)(1996-11#4)(1996-12#18)(1996-2#9)(1996-3#11)(1996-5#4)(1996-6#17)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#8)(1997-3#33)(1997-4#3)(1997-5#8)(1997-6#8)(1997-7#4)(1997-8#13)(2006-10#26)(2007-10#16)(2007-11#16)(2007-12#19)(2007-2#7)(2007-4#2)(2007-5#1)(2007-7#41)(2007-8#33)(2007-9#2)(2008-1#68)(2008-10#59)(2008-11#46)(2008-12#45)(2008-2#4)(2008-3#136)(2008-4#36)(2008-5#18)(2008-6#16)(2008-7#93)(2008-8#40)(2008-9#33)(2009-1#8)(2009-10#12)(2009-11#10)(2009-12#8)(2009-2#4)(2009-3#9)(2009-4#1)(2009-5#10)(2009-6#6)(2009-7#8)(2009-8#7)(2009-9#5)(2010-1#6)(2010-10#4)(2010-11#6)(2010-12#9)(2010-2#3)(2010-3#9)(2010-4#12)(2010-5#13)(2010-6#12)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#56)(2011-2#126)(2011-3#5)(2011-8#1)(2011-9#1)(2012-1#5)(2012-12#38)(2012-2#49)(2012-3#51)(2012-5#1)(2012-8#1)(2013-1#121)(2013-7#6)(2013-8#41)
syndrome&quot##14##1##(1990-6#1)(1993-3#1)(1995-6#1)(1996-9#1)(1997-6#1)(2007-5#1)(2007-7#1)(2009-7#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
syndrome'##6##1##(1996-2#1)(2007-12#1)(2008-10#1)(2010-5#2)(2013-8#1)
syndrome) and##4##2##(1995-5#1)(1995-6#1)(2008-11#1)(2011-2#1)
syndrome) in##4##2##(1995-3#1)(1997-8#1)(2007-2#1)(2007-8#1)
syndrome)##29##1##(1990-11#1)(1990-3#1)(1992-6#1)(1994-3#1)(1995-3#2)(1995-5#2)(1995-6#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
syndrome)]##2##1##(1990-11#1)(2012-3#1)
syndrome-##2##1##(2012-2#1)(2012-3#1)
syndrome--a case report]##3##3##(2008-11#1)(2008-4#1)(2012-3#1)
syndrome--a case##4##2##(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
syndrome-associated##3##1##(2007-12#1)(2008-11#1)(2008-7#1)
syndrome?##9##1##(1997-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#2)(2011-1#1)(2012-3#1)
syndrome?]##2##1##(2008-4#1)(2009-5#1)
syndrome]##49##1##(1990-10#1)(1990-11#2)(1990-2#3)(1990-3#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-5#3)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
syndromes and##14##2##(1992-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-11#1)(2011-1#1)
syndromes are##12##2##(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#1)(2009-12#1)(2011-2#5)(2012-2#2)
syndromes associated with##3##3##(2009-12#1)(2009-3#1)(2012-2#1)
syndromes can##2##2##(2008-4#1)(2009-12#1)
syndromes caused by##2##3##(2006-10#1)(2008-10#1)
syndromes have been##2##3##(2007-12#1)(2008-7#1)
syndromes have##5##2##(1990-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
syndromes in a##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
syndromes in##7##2##(1990-3#1)(1996-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
syndromes include##3##2##(1996-6#1)(2007-10#1)(2008-3#1)
syndromes is##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
syndromes may be##2##3##(1997-5#1)(2008-11#1)
syndromes may##4##2##(1992-6#1)(1997-5#1)(2008-11#1)(2012-3#1)
syndromes of##4##2##(1990-3#1)(1995-6#1)(2008-2#1)(2010-12#1)
syndromes or##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
syndromes that##3##2##(2007-7#1)(2008-9#1)(2009-12#1)
syndromes were##4##2##(1990-8#1)(2007-10#1)(2007-11#1)(2008-3#1)
syndromes which##4##2##(2008-12#2)(2011-2#1)(2012-2#1)
syndromes with##4##2##(2007-7#1)(2008-10#1)(2009-10#1)(2009-8#1)
syndromes##249##1##(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#1)(1991-12#2)(1991-4#2)(1992-12#2)(1992-6#1)(1993-10#1)(1993-11#2)(1994-10#1)(1994-9#1)(1995-5#2)(1995-6#2)(1996-11#6)(1996-6#2)(1997-3#1)(1997-5#2)(2006-10#4)(2007-10#3)(2007-11#4)(2007-12#8)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#11)(2008-11#9)(2008-12#9)(2008-2#4)(2008-3#35)(2008-4#12)(2008-5#2)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#5)(2009-12#13)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#3)(2010-11#5)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#20)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#6)
syndromes)##2##1##(2008-10#1)(2008-5#1)
syndromes]##11##1##(1990-11#1)(1991-5#1)(1996-11#1)(2008-10#7)(2012-2#1)
syndromic retinal dystrophies##2##3##(2012-12#2)
syndromic##16##1##(1996-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2009-10#2)(2009-6#1)(2010-3#1)(2011-2#1)(2011-9#1)(2012-12#2)(2013-1#4)
synergetic effect of##2##3##(2008-10#1)(2008-12#1)
synergetic##5##1##(1994-6#1)(2008-1#1)(2008-10#2)(2008-12#1)
synergic effect##3##2##(2008-10#2)(2008-11#1)
synergic##6##1##(2008-10#3)(2008-11#1)(2011-3#1)(2012-1#1)
synergid##3##1##(2008-11#2)(2009-8#1)
synergies between##2##2##(2008-5#1)(2010-10#1)
synergies##4##1##(1992-9#1)(2008-5#1)(2010-10#2)
synergism between##2##2##(1993-11#1)(2008-2#1)
synergism of##4##2##(1994-6#1)(2008-8#1)(2009-3#1)(2010-4#1)
synergism was observed##2##3##(1995-12#1)(2008-10#1)
synergism was##3##2##(1995-12#1)(2008-10#2)
synergism with##5##2##(1990-2#1)(1994-11#1)(1994-9#1)(2008-4#2)
synergism##26##1##(1990-2#1)(1993-11#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-12#3)(2008-10#9)(2008-2#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
synergist##3##1##(2007-10#1)(2008-10#2)
synergistic activation of##2##3##(1991-9#1)(1995-2#1)
synergistic activity##3##2##(2008-10#1)(2008-8#1)(2011-3#1)
synergistic and##2##2##(2008-10#1)(2008-6#1)
synergistic effect of the##2##4##(2008-10#1)(2013-1#1)
synergistic effect of##8##3##(1993-6#1)(2008-10#3)(2008-11#2)(2012-6#1)(2013-1#1)
synergistic effect on the##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
synergistic effect on##9##3##(1992-2#2)(1993-6#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2010-10#1)
synergistic effect##28##2##(1992-2#2)(1993-3#1)(1993-6#2)(1997-4#1)(1997-8#1)(2007-2#1)(2008-10#9)(2008-11#5)(2008-5#2)(2008-8#1)(2010-10#1)(2012-6#1)(2013-1#1)
synergistic effects of##2##3##(1996-12#1)(2013-8#1)
synergistic effects##13##2##(1995-5#1)(1996-12#2)(2008-10#3)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#1)(2012-3#1)(2012-6#1)(2013-8#1)
synergistic extraction##3##2##(2008-10#3)
synergistic in##2##2##(2008-10#1)(2008-8#1)
synergistic interaction between##2##3##(1993-8#1)(2008-10#1)
synergistic interaction is not##2##4##(2008-10#1)(2008-4#1)
synergistic interaction##7##2##(1993-8#1)(2008-10#4)(2008-4#1)(2008-8#1)
synergistic interactions##4##2##(2008-10#1)(2008-9#1)(2009-3#1)(2012-2#1)
synergistic or antagonistic##2##3##(2008-10#2)
synergistic or##3##2##(2008-10#2)(2008-8#1)
synergistic relationships between##2##3##(2008-10#1)(2008-11#1)
synergistic with##4##2##(1993-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
synergistic##114##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#3)(2007-2#1)(2008-10#37)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#2)(2013-1#1)(2013-7#1)(2013-8#1)
synergistically increased by##3##3##(1995-6#1)(1997-1#2)
synergistically mediate the gene transfer into primary rat hepatocytes##2##9##(2008-9#2)
synergistically to enhance##3##3##(2008-5#1)(2009-4#1)(2009-7#1)
synergistically to increase##2##3##(1993-6#1)(2008-10#1)
synergistically to##8##2##(1991-12#1)(1991-9#1)(1993-6#1)(2008-10#2)(2008-5#1)(2009-4#1)(2009-7#1)
synergistically with##6##2##(1993-6#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-8#1)
synergistically##33##1##(1991-12#1)(1991-5#1)(1991-9#1)(1993-6#2)(1994-11#2)(1995-6#1)(1995-8#1)(1997-1#2)(2006-6#1)(2008-10#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#2)
synergize with##5##2##(1993-12#1)(1995-8#1)(2009-12#3)
synergizes with##3##2##(1991-9#1)(2012-12#2)
synergy between##7##2##(1991-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2011-3#1)
synergy with##7##2##(1992-8#1)(1994-3#1)(1995-12#1)(1997-4#1)(2008-12#1)(2008-5#1)(2009-6#1)
synergy##29##1##(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-3#2)(1995-12#1)(1996-8#1)(1997-4#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-3#1)(2011-3#2)(2012-1#1)(2012-3#1)
syngamosis##2##1##(2007-2#2)
syngeneic and allogeneic##2##3##(1992-9#1)(1994-6#1)
syngeneic lymphocytes##2##2##(1990-12#2)
syngeneic mice##3##2##(1990-8#1)(1997-4#1)(2008-4#1)
syngeneic mouse##2##2##(2010-11#1)(2013-1#1)
syngeneic##20##1##(1990-12#2)(1990-8#1)(1991-6#1)(1992-9#3)(1994-5#1)(1994-6#1)(1995-12#2)(1997-4#2)(2008-4#2)(2010-11#1)(2011-1#1)(2013-1#3)
synonymized##3##1##(2011-2#2)(2013-8#1)
synonymous and##2##2##(1994-8#1)(2012-5#1)
synonymous with##7##2##(1997-8#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)
synonymous##19##1##(1993-11#2)(1994-8#3)(1997-8#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-5#1)
synonyms##4##1##(2008-10#2)(2008-7#1)(2011-2#1)
synonymy##4##1##(2008-10#2)(2013-1#2)
synopsis of the##3##3##(1992-1#1)(2008-10#1)(2010-12#1)
synopsis of##7##2##(1992-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)
synopsis##9##1##(1991-3#1)(1992-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2012-12#1)
synoptic##5##1##(1994-2#1)(1996-12#2)(2008-10#1)(2008-2#1)
synostosis##3##1##(2007-12#1)(2013-1#2)
synovectomy##5##1##(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
synoviae##2##1##(1997-3#2)
synovial bursae##3##2##(2007-11#3)
synovial cells##3##2##(2007-11#1)(2008-5#1)(2011-2#1)
synovial chondromatosis##2##2##(1992-4#1)(2008-8#1)
synovial deposits##2##2##(2008-8#2)
synovial estradiol and##2##3##(1992-3#2)
synovial estradiol level was##2##4##(1992-3#2)
synovial estradiol##4##2##(1992-3#4)
synovial fluid##17##2##(1990-2#1)(1990-6#2)(1992-8#1)(1993-6#1)(1994-8#2)(2006-10#3)(2008-10#1)(2008-12#1)(2010-10#1)(2011-1#3)(2013-8#1)
synovial membrane of a knee joint##2##6##(2013-1#2)
synovial membrane##7##2##(1990-6#1)(1992-4#1)(1996-6#1)(2009-3#1)(2013-1#3)
synovial mononuclear cells and synovial tissue from patients affected by##2##10##(1991-5#2)
synovial osteochondromatosis##2##2##(2010-5#2)
synovial reaction##2##2##(2011-2#2)
synovial sarcoma of the##4##4##(2008-7#1)(2009-3#1)(2013-1#2)
synovial sarcoma##14##2##(1993-12#1)(2008-6#6)(2008-7#1)(2009-3#1)(2010-3#1)(2013-1#4)
synovial sarcomas##4##2##(2008-6#4)
synovial specimens##2##2##(1990-6#2)
synovial tissue from patients##3##4##(1991-5#2)(1994-8#1)
synovial tissue from##4##3##(1991-5#3)(1994-8#1)
synovial tissue##6##2##(1991-5#3)(1994-8#1)(2012-2#1)(2013-1#1)
synovial##88##1##(1990-2#1)(1990-6#5)(1991-5#5)(1992-3#6)(1992-4#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#5)(1996-6#1)(1996-9#1)(2006-10#3)(2007-11#6)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#10)(2008-7#2)(2008-8#4)(2009-3#4)(2010-10#1)(2010-3#2)(2010-5#2)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
synoviocytes##4##1##(2008-10#3)(2013-8#1)
synovitis##6##1##(1990-6#1)(2010-3#2)(2012-3#1)(2013-1#1)(2013-8#1)
synovium in 2 patients and##2##5##(2006-10#2)
synovium##4##1##(2006-10#2)(2007-11#1)(2008-5#1)
syntactic and##2##2##(2008-7#1)(2008-9#1)
syntactic categories in##2##3##(2008-2#2)
syntactic categories##5##2##(2008-2#5)
syntactic constructions##2##2##(2008-2#2)
syntactic##13##1##(2008-11#1)(2008-2#7)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
syntax##10##1##(1997-3#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-9#1)(2010-4#2)(2013-8#1)
syntax)##2##1##(2013-8#2)
syntenic region##2##2##(2008-10#1)(2012-3#1)
syntenic##5##1##(2008-10#3)(2008-7#1)(2012-3#1)
synteny with##2##2##(1993-2#1)(2008-7#1)
synthase (EC 1##2##3##(1992-3#1)(2008-8#1)
synthase (NOS)##14##2##(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#2)(1996-12#1)(1997-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-1#1)
synthase (iNOS) activity##2##3##(1993-3#1)(2008-8#1)
synthase (iNOS)##10##2##(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
synthase (nos)##2##2##(1997-2#2)
synthase A##2##2##(2008-9#2)
synthase II##2##2##(1992-4#1)(2008-9#1)
synthase activity##9##2##(1992-6#1)(1993-11#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-6#1)(2008-4#1)
synthase and a##2##3##(1992-12#1)(1995-2#1)
synthase and##10##2##(1992-10#1)(1992-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(2008-5#1)(2009-11#1)(2010-10#1)
synthase cDNA##4##2##(1991-5#1)(1994-8#2)(1995-2#1)
synthase catalyzes the##2##3##(1991-5#1)(1997-8#1)
synthase catalyzes##3##2##(1991-5#1)(1994-5#1)(1997-8#1)
synthase enzyme##4##2##(1992-12#3)(2008-6#1)
synthase from##6##2##(1994-8#2)(1995-3#1)(1996-6#1)(2008-8#1)(2008-9#1)
synthase gene and##2##3##(1995-12#1)(2008-9#1)
synthase gene in##2##3##(1993-8#1)(1995-2#1)
synthase gene##24##2##(1993-3#1)(1993-8#1)(1994-8#2)(1995-12#1)(1995-2#3)(1996-12#1)(1997-4#1)(1997-8#2)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)
synthase in the##3##3##(1992-8#1)(1995-11#1)(2008-10#1)
synthase in##13##2##(1992-8#1)(1993-2#1)(1995-11#3)(1995-12#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
synthase inhibitor##10##2##(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-5#3)(1997-2#1)(1997-4#1)
synthase inhibitors##4##2##(1992-3#1)(1995-11#1)(2008-5#1)(2009-4#1)
synthase is##4##2##(1992-3#1)(1995-12#1)(2008-10#1)(2008-8#1)
synthase kinase##2##2##(1995-12#1)(2008-7#1)
synthase of##3##2##(1997-4#2)(1997-8#1)
synthase revealed##2##2##(1992-8#1)(1997-8#1)
synthase that##2##2##(1996-6#1)(2008-10#1)
synthase was##4##2##(1990-5#1)(1993-11#1)(1995-11#1)(1995-2#1)
synthase were##3##2##(1990-5#1)(1994-5#1)(2008-10#1)
synthase with##6##2##(1991-8#1)(1994-5#1)(1995-2#2)(1997-1#1)(2009-9#1)
synthase##276##1##(1990-11#1)(1990-5#3)(1990-7#2)(1991-12#2)(1991-3#2)(1991-5#4)(1991-8#2)(1992-10#5)(1992-12#6)(1992-3#10)(1992-4#1)(1992-6#3)(1992-8#12)(1993-11#5)(1993-2#5)(1993-3#4)(1993-8#4)(1994-11#1)(1994-12#2)(1994-5#5)(1994-8#11)(1995-11#11)(1995-12#13)(1995-2#20)(1995-3#1)(1995-5#3)(1995-9#1)(1996-12#6)(1996-2#4)(1996-5#4)(1996-6#4)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#5)(1997-7#1)(1997-8#10)(2008-10#15)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#13)(2008-9#10)(2009-10#4)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#4)(2011-2#4)(2012-2#5)(2013-1#3)(2013-8#1)
synthase) in##2##2##(1997-8#1)(2008-6#1)
synthase)##8##1##(1992-8#1)(1994-8#1)(1995-12#2)(1997-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
synthase-1 in##2##2##(1992-3#1)(2012-2#1)
synthase-1##9##1##(1992-3#4)(1995-5#1)(2008-4#3)(2012-2#1)
synthase-2##10##1##(1992-8#1)(1993-3#5)(2008-4#3)(2008-7#1)
synthases in##2##2##(1990-8#1)(1995-6#1)
synthases##18##1##(1990-8#1)(1992-10#1)(1993-2#2)(1995-11#1)(1995-6#4)(1997-1#1)(2008-10#3)(2009-4#1)(2013-1#3)(2013-8#1)
syntheses are##3##2##(1992-12#2)(1992-2#1)
syntheses of the##3##3##(1997-4#1)(2008-10#1)(2009-5#1)
syntheses of##14##2##(1991-6#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-6#1)(2013-1#1)
syntheses##33##1##(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1996-2#2)(1997-4#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#3)(2009-5#1)(2009-9#1)(2010-5#2)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
synthesis and a##5##3##(1993-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(2009-7#1)
synthesis and accumulation of##2##4##(1995-11#1)(2008-8#1)
synthesis and action##2##3##(1992-9#1)(2008-7#1)
synthesis and antimicrobial evaluation of##2##5##(2012-3#2)
synthesis and antimicrobial##3##3##(2007-11#1)(2012-3#2)
synthesis and application##2##3##(2008-10#1)(2008-4#1)
synthesis and applications as##2##4##(2008-10#2)
synthesis and biological##2##3##(2011-2#1)(2013-1#1)
synthesis and breakdown of##2##4##(1993-8#1)(2011-2#1)
synthesis and breakdown##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
synthesis and cell##10##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-11#2)(1996-2#1)(2008-4#1)
synthesis and characterization of##10##4##(1990-8#1)(1994-8#1)(2008-10#2)(2008-4#3)(2009-11#1)(2010-4#1)(2010-6#1)
synthesis and degradation of##4##4##(1991-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
synthesis and deposition##2##3##(2009-8#2)
synthesis and detection##2##3##(1995-2#1)(2012-2#1)
synthesis and evaluation of##2##4##(2008-10#1)(2012-3#1)
synthesis and evaluation##3##3##(2008-10#2)(2012-3#1)
synthesis and phosphorylation##2##3##(1993-9#1)(1994-8#1)
synthesis and release of##6##4##(1994-9#1)(1995-11#1)(1996-2#1)(2008-5#1)(2008-9#1)(2013-7#1)
synthesis and release##9##3##(1994-9#1)(1995-11#1)(1996-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-7#2)
synthesis and secretion of##5##4##(1994-6#1)(1994-8#1)(1997-4#2)(2007-12#1)
synthesis and secretion##7##3##(1990-2#1)(1994-6#1)(1994-8#1)(1997-4#2)(2007-12#1)(2008-11#1)
synthesis and the##6##3##(1992-8#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
synthesis and##163##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#3)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#8)(1995-2#2)(1995-3#2)(1995-6#2)(1996-2#4)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#1)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#7)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
synthesis and/or##2##2##(1992-3#1)(1993-6#1)
synthesis andin vitro##2##3##(2008-11#1)(2008-7#1)
synthesis applications##2##2##(1997-4#1)(2008-4#1)
synthesis are described##2##3##(1997-4#1)(2008-4#1)
synthesis are##11##2##(1997-4#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-11#1)(2011-1#1)
synthesis as well as##3##4##(1990-7#1)(2008-5#2)
synthesis as##6##2##(1990-7#1)(1992-10#1)(1995-2#1)(2008-5#2)(2009-12#1)
synthesis at 37 degrees C##2##5##(1990-5#1)(1991-2#1)
synthesis at the##4##3##(1992-3#1)(1995-3#2)(2008-10#1)
synthesis at##10##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#1)(1995-2#2)(1995-3#2)(2008-10#1)
synthesis but##2##2##(1993-6#1)(1994-5#1)
synthesis by the##7##3##(1992-3#1)(1993-12#1)(1995-2#1)(2008-4#2)(2008-6#1)(2013-1#1)
synthesis by##39##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-1#4)(1997-3#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
synthesis can##2##2##(1990-5#1)(2008-4#1)
synthesis compared##2##2##(1990-11#1)(1992-9#1)
synthesis conditions and##3##3##(2008-1#1)(2008-10#1)(2010-4#1)
synthesis conditions##4##2##(2008-1#2)(2008-10#1)(2010-4#1)
synthesis during##2##2##(2008-9#1)(2009-12#1)
synthesis enzymes##3##2##(1991-4#1)(2011-2#2)
synthesis for##3##2##(2007-12#1)(2008-3#1)(2013-1#1)
synthesis from##6##2##(1995-5#1)(1995-8#1)(1996-5#1)(2007-11#1)(2011-1#1)(2013-1#1)
synthesis gene##2##2##(1992-10#1)(2008-4#1)
synthesis genes##3##2##(2011-2#2)(2012-3#1)
synthesis had been##2##3##(1993-6#1)(1997-3#1)
synthesis has been##2##3##(2008-4#1)(2008-9#1)
synthesis has##5##2##(2008-2#1)(2008-4#1)(2008-9#2)(2009-8#1)
synthesis have been##2##3##(1994-9#1)(2008-10#1)
synthesis have##3##2##(1994-9#1)(2008-10#1)(2008-7#1)
synthesis in a##3##3##(1995-11#1)(1995-12#1)(2008-10#1)
synthesis in hepatocytes##3##3##(1993-3#2)(1995-8#1)
synthesis in human##4##3##(1992-5#1)(1992-9#1)(1997-1#1)(2008-9#1)
synthesis in response to##4##4##(1990-2#2)(1996-12#1)(2008-1#1)
synthesis in the liver##2##4##(1995-3#1)(1997-3#1)
synthesis in the presence of##3##5##(1994-5#1)(1995-11#1)(2008-3#1)
synthesis in the retina##2##4##(2008-5#2)
synthesis in the##20##3##(1990-12#1)(1990-2#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-3#1)(1996-12#1)(1997-3#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#1)(2013-1#1)
synthesis in this##2##3##(1994-8#1)(2008-10#1)
synthesis in vitro and in vivo##2##6##(2008-5#2)
synthesis in vitro##3##3##(1996-2#1)(2008-5#2)
synthesis in vivo##3##3##(1992-10#1)(1992-11#1)(1995-3#1)
synthesis in yeast##2##3##(2011-1#1)(2011-2#1)
synthesis in##106##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#8)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-2#1)(1997-1#3)(1997-3#2)(1997-7#2)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
synthesis induced##2##2##(2008-4#2)
synthesis inhibitor##7##2##(1992-11#1)(1993-12#1)(1993-3#2)(1995-12#1)(1996-6#1)(2008-9#1)
synthesis inhibitor)##3##2##(1994-5#2)(2008-7#1)
synthesis inhibitors##8##2##(1991-2#1)(1991-5#3)(1994-11#1)(1994-9#1)(1997-7#1)(2008-11#1)
synthesis is dependent##2##3##(1995-11#1)(2009-8#1)
synthesis is##25##2##(1991-3#1)(1995-11#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
synthesis may##3##2##(1990-12#1)(1993-9#1)(1997-1#1)
synthesis method is##2##3##(2008-2#1)(2008-6#1)
synthesis method##5##2##(2008-11#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-4#1)
synthesis of 1##2##3##(1996-5#1)(2007-11#1)
synthesis of 9##2##3##(2007-11#2)
synthesis of DNA##5##3##(1990-2#1)(1995-8#1)(2008-4#3)
synthesis of LH beta##3##4##(1997-2#3)
synthesis of a series of##3##5##(2008-12#1)(2008-4#1)(2009-12#1)
synthesis of a variety of##2##5##(2008-4#1)(2012-2#1)
synthesis of a##21##3##(1991-3#1)(1991-8#1)(1992-6#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-12#1)(2012-2#2)
synthesis of activated##2##3##(1992-11#1)(2009-10#1)
synthesis of all##2##3##(1994-12#1)(2008-7#1)
synthesis of amino##2##3##(2008-11#1)(2008-7#1)
synthesis of an##3##3##(1996-5#1)(2008-10#1)(2009-5#1)
synthesis of both subunits##2##4##(1996-2#2)
synthesis of both##4##3##(1996-2#2)(2007-12#1)(2010-3#1)
synthesis of branched##2##3##(2008-4#2)
synthesis of chiral##2##3##(1992-11#1)(2009-10#1)
synthesis of cyclooxygenase##3##3##(1994-9#3)
synthesis of endomorphin-2##2##3##(2013-1#2)
synthesis of highly sulfated##2##4##(2008-9#2)
synthesis of highly##3##3##(2008-9#2)(2009-10#1)
synthesis of large##2##3##(1997-4#1)(2010-12#1)
synthesis of melatonin##2##3##(1995-11#1)(1995-3#1)
synthesis of nascent##2##3##(2008-10#1)(2008-9#1)
synthesis of new##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)
synthesis of oligodeoxyribonucleotides##3##3##(2008-4#3)
synthesis of oligonucleotides##2##3##(2008-4#2)
synthesis of phosphatidylinositol##3##3##(1992-6#1)(1997-1#1)(1997-8#1)
synthesis of prostaglandin E2 (PGE2)##2##5##(1990-2#1)(2007-11#1)
synthesis of prostanoids##3##3##(1992-8#3)
synthesis of proteins##2##3##(1991-9#1)(1997-2#1)
synthesis of salinosporamide A##2##4##(2010-7#2)
synthesis of several##7##3##(1991-9#1)(1992-8#1)(1993-8#1)(1995-11#1)(2007-11#2)(2008-11#1)
synthesis of sex##2##3##(2008-11#1)(2009-7#1)
synthesis of some##6##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)
synthesis of substituted##2##3##(2007-11#2)
synthesis of the cortistatin core##2##5##(2009-11#2)
synthesis of the##43##3##(1990-11#3)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)
synthesis of these##3##3##(1993-12#1)(2008-12#1)(2011-2#1)
synthesis of this##2##3##(1993-3#1)(2008-10#1)
synthesis of three-dimensional##2##3##(2007-12#2)
synthesis of tricycloillicinone##2##3##(2009-11#2)
synthesis of##467##2##(1990-11#5)(1990-2#6)(1990-5#7)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#3)(1991-9#7)(1992-1#1)(1992-11#5)(1992-12#7)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#8)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#15)(1997-1#4)(1997-2#5)(1997-3#5)(1997-4#8)(1997-7#1)(1997-8#1)(2007-11#28)(2007-12#5)(2007-5#1)(2007-6#1)(2008-10#38)(2008-11#13)(2008-12#5)(2008-2#5)(2008-3#6)(2008-4#43)(2008-5#18)(2008-6#8)(2008-7#14)(2008-8#7)(2008-9#10)(2009-10#9)(2009-11#8)(2009-12#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#7)(2011-3#2)(2012-1#3)(2012-2#8)(2012-3#7)(2012-7#2)(2013-1#5)(2013-7#1)(2013-8#1)
synthesis or a##2##3##(1993-8#1)(2008-7#1)
synthesis or##8##2##(1990-12#1)(1990-5#1)(1993-8#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
synthesis procedure##2##2##(2008-10#1)(2010-12#1)
synthesis process##5##2##(2008-10#4)(2011-2#1)
synthesis rate##4##2##(1992-8#1)(1994-5#1)(1995-12#1)(1997-4#1)
synthesis reaction##2##2##(1997-2#1)(2008-5#1)
synthesis reactions##2##2##(1995-3#1)(2008-6#1)
synthesis studies##2##2##(1994-8#1)(2008-9#1)
synthesis technique##2##2##(2007-11#1)(2008-3#1)
synthesis techniques##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
synthesis that##3##2##(1992-3#1)(1995-3#1)(1997-7#1)
synthesis through##2##2##(1994-11#1)(1994-8#1)
synthesis to##7##2##(1991-12#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-7#1)
synthesis using##7##2##(1994-3#1)(2007-12#1)(2008-4#4)(2008-6#1)
synthesis via##5##2##(1991-9#1)(1992-10#1)(1997-1#1)(2008-3#1)(2011-1#1)
synthesis was also##3##3##(1990-7#1)(2008-4#1)(2008-5#1)
synthesis was developed##2##3##(2008-4#1)(2012-3#1)
synthesis was induced##2##3##(1993-9#1)(2008-10#1)
synthesis was inhibited by##2##4##(1993-12#1)(1993-6#1)
synthesis was inhibited##4##3##(1993-12#1)(1993-6#1)(1994-11#1)(2008-2#1)
synthesis was initiated##2##3##(1990-5#1)(1994-12#1)
synthesis was investigated##2##3##(1997-1#1)(2008-7#1)
synthesis was##42##2##(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1992-11#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-8#1)(2012-3#1)
synthesis were##6##2##(1991-12#1)(1991-9#1)(1996-12#1)(2008-11#2)(2013-1#1)
synthesis when##2##2##(1995-11#1)(2009-11#1)
synthesis which##2##2##(1990-5#1)(2009-8#1)
synthesis while##2##2##(1990-12#1)(2008-5#1)
synthesis with##5##2##(1991-5#1)(1993-9#1)(1994-3#1)(2009-8#1)(2012-2#1)
synthesis without##5##2##(2008-4#4)(2008-9#1)
synthesis##1416##1##(1990-11#12)(1990-12#9)(1990-2#17)(1990-3#2)(1990-5#21)(1990-7#8)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#5)(1991-8#3)(1991-9#13)(1992-1#1)(1992-10#5)(1992-11#19)(1992-12#14)(1992-3#19)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#15)(1992-9#17)(1993-1#1)(1993-11#11)(1993-12#12)(1993-3#7)(1993-5#1)(1993-6#14)(1993-8#13)(1993-9#10)(1994-11#16)(1994-12#8)(1994-2#4)(1994-3#8)(1994-5#15)(1994-6#6)(1994-8#15)(1994-9#9)(1995-11#33)(1995-12#12)(1995-2#17)(1995-3#24)(1995-5#4)(1995-6#8)(1995-8#7)(1995-9#1)(1996-11#2)(1996-12#11)(1996-2#16)(1996-5#22)(1996-6#2)(1996-7#1)(1997-1#19)(1997-2#15)(1997-3#13)(1997-4#30)(1997-6#1)(1997-7#13)(1997-8#3)(2006-12#1)(2007-11#35)(2007-12#12)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#112)(2008-11#53)(2008-12#7)(2008-2#14)(2008-3#25)(2008-4#106)(2008-5#49)(2008-6#18)(2008-7#46)(2008-8#15)(2008-9#31)(2009-10#10)(2009-11#15)(2009-12#10)(2009-3#1)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#16)(2009-9#7)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#1)(2010-4#10)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#20)(2011-2#30)(2011-3#3)(2012-1#5)(2012-2#23)(2012-3#18)(2012-7#2)(2013-1#19)(2013-7#4)(2013-8#6)
synthesis) and##2##2##(1991-12#2)
synthesis)##6##1##(1990-12#1)(1991-12#2)(1994-8#1)(1997-4#1)(2012-4#1)
synthesise##3##1##(2008-10#1)(2010-12#1)(2012-12#1)
synthesised and tested##2##3##(2008-10#1)(2011-2#1)
synthesised and##7##2##(1990-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#2)(2011-2#1)
synthesised by the##2##3##(2008-10#1)(2008-5#1)
synthesised by##5##2##(2007-11#1)(2008-10#2)(2008-5#1)(2013-7#1)
synthesised in our##2##3##(2008-10#2)
synthesised in##4##2##(1991-3#1)(1992-8#1)(2008-10#2)
synthesised##26##1##(1990-11#1)(1990-2#1)(1991-3#1)(1992-8#1)(1997-3#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
synthesize IGF-I##2##2##(1994-2#1)(1996-2#1)
synthesize a##6##2##(1990-7#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-2#1)(2011-2#1)
synthesize and secrete reelin in##2##5##(2009-8#2)
synthesize and secrete##7##3##(1993-3#1)(1994-6#1)(1996-2#1)(2008-7#1)(2009-8#2)(2013-1#1)
synthesize and##10##2##(1993-3#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#2)(2013-1#1)(2013-8#1)
synthesize both##3##2##(1991-9#1)(1992-8#1)(2012-12#1)
synthesize cDNA##2##2##(2008-9#1)(2011-2#1)
synthesize the##7##2##(1996-6#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-1#1)
synthesize##79##1##(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-3#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
synthesized RNA hairpin##2##3##(1994-8#2)
synthesized a##6##2##(1993-3#1)(1995-11#1)(1995-2#1)(2008-4#1)(2010-6#1)(2012-2#1)
synthesized analogs##2##2##(1992-11#1)(2009-2#1)
synthesized and characterized by##6##4##(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#1)(2011-1#1)
synthesized and characterized with##2##4##(1995-3#1)(2008-10#1)
synthesized and characterized##16##3##(1993-8#1)(1994-8#1)(1995-3#2)(1996-2#2)(1997-7#1)(2007-11#1)(2008-10#6)(2008-5#1)(2011-1#1)
synthesized and evaluated as##3##4##(1993-1#1)(1995-3#1)(2008-10#1)
synthesized and evaluated in##2##4##(1995-3#1)(2007-11#1)
synthesized and evaluated##7##3##(1992-12#1)(1993-1#1)(1995-3#2)(2007-11#2)(2008-10#1)
synthesized and investigated##3##3##(2008-10#1)(2008-12#1)(2009-2#1)
synthesized and its##4##3##(1997-7#1)(2008-10#3)
synthesized and released##2##3##(1992-6#1)(2009-10#1)
synthesized and secreted by##2##4##(1996-2#1)(2008-1#1)
synthesized and secreted##4##3##(1993-12#1)(1996-2#1)(2008-1#1)(2009-3#1)
synthesized and shown to##2##4##(1991-12#1)(2010-6#1)
synthesized and studied##3##3##(1992-8#1)(1995-3#1)(2008-10#1)
synthesized and tested as##2##4##(1992-8#1)(2008-11#1)
synthesized and tested in##2##4##(2008-8#1)(2011-2#1)
synthesized and tested##6##3##(1992-8#1)(1993-3#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
synthesized and the##3##3##(1992-8#1)(2008-10#2)
synthesized and their##8##3##(1990-2#1)(1991-7#1)(1993-11#1)(1995-2#1)(2007-11#2)(2008-10#1)(2008-11#1)
synthesized and thoroughly characterized##2##4##(2013-1#2)
synthesized and used as##3##4##(2008-10#3)
synthesized and used for the##2##5##(1990-2#1)(2008-10#1)
synthesized and used##7##3##(1990-2#1)(2008-10#6)
synthesized and##91##2##(1990-12#1)(1990-2#2)(1991-12#1)(1991-7#1)(1992-12#1)(1992-6#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#5)(1996-2#4)(1997-7#2)(2007-11#5)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#4)
synthesized as a##7##3##(1990-12#1)(1990-8#1)(1991-11#2)(2008-10#2)(2012-12#1)
synthesized as##18##2##(1990-12#1)(1990-8#1)(1991-11#2)(1991-5#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)
synthesized at a##2##3##(1993-6#1)(2008-10#1)
synthesized at the##2##3##(2008-10#1)(2008-12#1)
synthesized at##7##2##(1991-11#1)(1993-6#1)(2008-10#3)(2008-12#1)(2008-3#1)
synthesized brood food proteins##2##4##(2008-6#2)
synthesized by a##5##3##(2008-10#4)(2013-8#1)
synthesized by coupling##2##3##(2008-10#1)(2009-11#1)
synthesized by osteoblasts##2##3##(1997-1#2)
synthesized by reacting##3##3##(1994-2#1)(1995-3#1)(2008-5#1)
synthesized by solid-phase##3##3##(1990-12#1)(1992-3#1)(2008-9#1)
synthesized by suspension polymerization##2##4##(2008-10#2)
synthesized by the##9##3##(1990-7#1)(1992-6#1)(1995-2#1)(1996-2#1)(2008-10#4)(2011-1#1)
synthesized by us##2##3##(1991-12#1)(1995-3#1)
synthesized by using##4##3##(1991-3#1)(2008-10#3)
synthesized by##77##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-2#1)(1997-1#2)(2007-10#1)(2007-11#1)(2008-10#24)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-8#1)(2011-1#2)(2013-1#2)(2013-8#2)
synthesized cell wall materials##2##4##(2008-10#2)
synthesized compounds have##2##3##(2012-2#1)(2012-3#1)
synthesized compounds were##9##3##(2007-11#3)(2008-11#1)(2008-4#1)(2008-5#2)(2010-3#1)(2010-5#1)
synthesized compounds##14##2##(2007-11#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)
synthesized directly##2##2##(2010-12#1)(2011-3#1)
synthesized for the##3##3##(1996-5#1)(2008-3#1)(2008-6#1)
synthesized for##9##2##(1995-2#1)(1996-5#1)(2008-10#3)(2008-3#2)(2008-6#1)(2012-12#1)
synthesized from a##3##3##(2007-12#1)(2008-4#1)(2008-9#1)
synthesized from an##2##3##(2008-10#2)
synthesized from the##2##3##(1996-5#1)(2008-5#1)
synthesized from##23##2##(1990-8#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-2#1)
synthesized in E##4##3##(1990-11#1)(1997-2#2)(2008-11#1)
synthesized in Escherichia coli##2##4##(1992-6#1)(1993-12#1)
synthesized in a##4##3##(1990-8#1)(1994-5#1)(1996-2#1)(2009-10#1)
synthesized in order to##2##4##(1992-12#1)(2009-2#1)
synthesized in our laboratory##3##4##(1993-1#1)(2008-10#2)
synthesized in the endoplasmic##2##4##(1994-11#1)(1996-9#1)
synthesized in the##10##3##(1992-10#1)(1993-12#1)(1994-11#2)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)
synthesized in vitro##2##3##(1994-6#1)(1994-8#1)
synthesized in##52##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-7#2)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
synthesized macrocyclic##2##2##(2008-10#2)
synthesized on the basis##2##4##(1997-2#1)(2012-1#1)
synthesized on##7##2##(1992-6#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2012-1#1)
synthesized peptides##2##2##(1994-8#1)(2008-4#1)
synthesized populations##2##2##(2010-5#2)
synthesized proteins##4##2##(1993-2#1)(2008-1#1)(2008-7#1)(2012-2#1)
synthesized the##2##2##(1992-5#1)(1992-6#1)
synthesized through##3##2##(1992-6#1)(2008-10#1)(2009-11#1)
synthesized to##2##2##(1995-3#1)(2008-10#1)
synthesized two##3##2##(1991-12#1)(1992-9#1)(1994-8#1)
synthesized under##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
synthesized using##17##2##(1995-3#1)(2008-1#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)
synthesized via##5##2##(1996-5#1)(2008-11#1)(2008-6#1)(2009-2#1)(2012-2#1)
synthesized were##3##2##(1994-12#1)(1995-9#1)(2007-11#1)
synthesized with a##4##3##(1990-5#1)(2008-5#1)(2013-1#2)
synthesized with##9##2##(1990-5#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2013-1#2)
synthesized##589##1##(1990-11#4)(1990-12#4)(1990-2#7)(1990-5#4)(1990-7#3)(1990-8#4)(1991-11#3)(1991-12#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#5)(1992-3#1)(1992-5#1)(1992-6#8)(1992-8#5)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#5)(1993-9#2)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#11)(1994-9#3)(1995-11#8)(1995-12#3)(1995-2#6)(1995-3#12)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#7)(1996-5#5)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#18)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#160)(2008-11#19)(2008-12#5)(2008-2#3)(2008-3#11)(2008-4#20)(2008-5#21)(2008-6#9)(2008-7#6)(2008-8#11)(2008-9#6)(2009-10#8)(2009-11#4)(2009-12#1)(2009-2#4)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#10)(2010-6#4)(2011-1#8)(2011-2#4)(2011-3#3)(2012-1#1)(2012-12#4)(2012-2#9)(2012-3#4)(2013-1#12)(2013-8#4)
synthesizer##7##1##(1990-5#1)(1997-3#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-10#1)
synthesizers##2##1##(2008-3#1)(2008-4#1)
synthesizes a##3##2##(1997-4#1)(2007-12#1)(2008-9#1)
synthesizes the##2##2##(1994-9#1)(2012-3#1)
synthesizes##11##1##(1993-12#1)(1994-9#1)(1996-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
synthesizing a##5##2##(2007-12#1)(2008-3#2)(2008-4#1)(2011-2#1)
synthesizing ability##2##2##(1997-4#2)
synthesizing enzyme##3##2##(1996-12#1)(1996-5#2)
synthesizing enzymes##2##2##(1996-12#2)
synthesizing research results##2##3##(2008-10#2)
synthesizing the##6##2##(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2013-8#1)
synthesizing##42##1##(1990-11#1)(1992-8#1)(1994-11#2)(1994-8#1)(1996-12#3)(1996-5#2)(1997-4#3)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
synthetase activity##2##2##(1995-6#1)(2008-11#1)
synthetase and##2##2##(2008-11#1)(2012-2#1)
synthetase in the##4##3##(1992-12#1)(1993-6#1)(1995-9#1)(1996-12#1)
synthetase in##11##2##(1990-9#1)(1992-11#1)(1992-12#2)(1993-6#2)(1994-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(2008-11#1)
synthetase##75##1##(1990-5#1)(1990-7#5)(1990-9#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-12#2)(1992-8#2)(1993-12#3)(1993-6#4)(1993-8#2)(1994-6#5)(1994-8#3)(1995-12#1)(1995-6#4)(1995-9#2)(1996-12#6)(1996-2#2)(1997-1#2)(1997-3#1)(1997-6#2)(2008-10#1)(2008-11#11)(2008-2#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-2#4)
synthetases##7##1##(1990-7#2)(1993-8#1)(1994-8#1)(2012-2#3)
synthetic DI RNA##2##3##(1997-3#2)
synthetic DNA##4##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-4#1)
synthetic HA##2##2##(2008-10#2)
synthetic RNA##2##2##(2008-10#1)(2008-4#1)
synthetic SIV protease##2##3##(1992-6#2)
synthetic activity of##4##3##(1993-12#1)(1994-11#1)(1994-8#1)(2012-1#1)
synthetic activity##6##2##(1993-12#1)(1994-11#1)(1994-8#2)(2011-2#1)(2012-1#1)
synthetic analog##3##2##(1990-2#1)(1993-6#1)(2009-9#1)
synthetic analogue##2##2##(1990-7#1)(1995-9#1)
synthetic analogues##2##2##(1994-11#2)
synthetic and biologic##2##3##(2011-2#2)
synthetic and natural photosensitising agents##2##5##(2008-11#2)
synthetic and natural##5##3##(2008-10#2)(2008-11#2)(2010-10#1)
synthetic and real data##2##4##(2008-10#1)(2013-1#1)
synthetic and real samples##5##4##(2008-10#5)
synthetic and real##9##3##(2008-10#8)(2013-1#1)
synthetic and water samples##2##4##(2008-10#2)
synthetic and##30##2##(1990-10#1)(1991-5#1)(1997-3#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
synthetic antioxidant##3##2##(2008-10#2)(2009-3#1)
synthetic aperture imaging##2##3##(2007-11#2)
synthetic aperture infrared laser radar##2##5##(2008-3#2)
synthetic aperture integral imaging##2##4##(2007-11#2)
synthetic aperture radar (SAR)##2##4##(2008-2#1)(2008-3#1)
synthetic aperture radar images##2##4##(2007-12#1)(2008-3#1)
synthetic aperture radar##9##3##(2007-12#1)(2008-2#1)(2008-3#6)(2008-6#1)
synthetic aperture##21##2##(2007-11#7)(2007-12#1)(2008-2#1)(2008-3#11)(2008-6#1)
synthetic approach##2##2##(2008-8#1)(2010-5#1)
synthetic arteriovenous grafts##2##3##(2007-7#2)
synthetic association##4##2##(2012-3#4)
synthetic biology##8##2##(2009-5#4)(2012-2#4)
synthetic bone graft substitutes##2##4##(2008-8#2)
synthetic bone graft##3##3##(2008-8#3)
synthetic bone##4##2##(2008-8#3)(2008-9#1)
synthetic cationic##2##2##(2007-11#1)(2008-5#1)
synthetic ceramides##2##2##(1995-12#2)
synthetic chemical##2##2##(2008-10#1)(2009-11#1)
synthetic chemicals##2##2##(2008-11#1)(2012-2#1)
synthetic chromone derivatives was##2##4##(2009-3#2)
synthetic compound##5##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-2#1)(2012-2#1)
synthetic compounds to##2##3##(2008-11#1)(2013-1#1)
synthetic compounds##5##2##(1993-11#1)(1993-8#1)(2008-11#2)(2013-1#1)
synthetic constructs##2##2##(1991-7#1)(2013-7#1)
synthetic data##5##2##(2008-2#1)(2008-3#3)(2012-12#1)
synthetic diamond##2##2##(2008-10#2)
synthetic discriminant function##3##3##(2008-2#1)(2008-3#2)
synthetic discriminant##4##2##(2008-2#1)(2008-3#3)
synthetic drugs##2##2##(2008-10#1)(2012-2#1)
synthetic emergence inhibitors##2##3##(2008-10#2)
synthetic enzyme##3##2##(1996-2#1)(2008-10#1)(2009-3#1)
synthetic enzymes##3##2##(1992-8#1)(1997-3#1)(2009-10#1)
synthetic estrogen##3##2##(2013-1#3)
synthetic extensions of##2##3##(1994-11#2)
synthetic fertilizers##4##2##(2008-10#4)
synthetic fiber##2##2##(2008-2#2)
synthetic gene##4##2##(1990-11#1)(1991-5#1)(2008-11#2)
synthetic grafts##5##2##(2007-7#5)
synthetic hexaploid wheat##2##3##(2008-10#2)
synthetic holograms##2##2##(2008-2#2)
synthetic human##3##2##(1993-3#1)(1993-6#1)(2012-3#1)
synthetic images##3##2##(2008-3#3)
synthetic insecticides##2##2##(2011-2#1)(2013-7#1)
synthetic intermediates for the preparation of##2##6##(1996-5#1)(2011-1#1)
synthetic iron hydroxide##2##3##(2008-10#2)
synthetic iron##3##2##(2008-10#2)(2009-10#1)
synthetic kitchen waste (KW)##2##4##(2013-1#2)
synthetic latex##2##2##(2008-10#1)(2011-2#1)
synthetic lidar signals##2##3##(2008-3#2)
synthetic ligands##2##2##(2008-10#1)(2008-9#1)
synthetic material##2##2##(1993-9#1)(2008-5#1)
synthetic materials##2##2##(1991-3#1)(2011-2#1)
synthetic media##2##2##(2008-10#1)(2008-8#1)
synthetic medium containing##3##3##(2008-10#2)(2008-6#1)
synthetic medium##6##2##(2008-10#3)(2008-5#1)(2008-6#2)
synthetic membranes##2##2##(2008-1#1)(2008-5#1)
synthetic mesh##2##2##(2010-4#1)(2012-2#1)
synthetic metal-doped##2##2##(2008-10#2)
synthetic method##2##2##(2008-10#1)(2008-12#1)
synthetic methods##2##2##(2008-4#1)(2010-10#1)
synthetic mixture##8##2##(2008-10#7)(2008-6#1)
synthetic mixtures and mineral sample##2##5##(2008-10#2)
synthetic mixtures and##10##3##(2008-10#10)
synthetic mixtures containing##4##3##(2008-10#4)
synthetic mixtures of the##2##4##(2008-10#2)
synthetic mixtures of##8##3##(2008-10#8)
synthetic mixtures##34##2##(2008-10#33)(2008-6#1)
synthetic molecular machines##2##3##(2008-7#2)
synthetic molecular##3##2##(2008-7#3)
synthetic near-field##2##2##(2008-3#2)
synthetic nectar##2##2##(2008-10#2)
synthetic oligodeoxyribonucleotide##2##2##(1990-11#1)(1997-7#1)
synthetic oligodeoxyribonucleotides##2##2##(1994-12#1)(2008-4#1)
synthetic oligonucleotides##7##2##(1992-3#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-4#2)
synthetic or natural##3##3##(2008-10#1)(2010-10#1)(2010-7#1)
synthetic or##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-7#1)
synthetic peptide combinatorial libraries##2##4##(1997-3#1)(2008-4#1)
synthetic peptide corresponding to##3##4##(1990-11#1)(1994-6#1)(1995-2#1)
synthetic peptide##31##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#2)(1991-9#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#2)(1994-6#1)(1995-11#2)(1995-2#3)(1995-6#3)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)
synthetic peptides are##3##3##(2008-2#1)(2008-4#2)
synthetic peptides corresponding to the##2##5##(1991-9#1)(1995-11#1)
synthetic peptides corresponding to##3##4##(1991-9#1)(1995-11#1)(2010-11#1)
synthetic peptides encompassing##2##3##(1993-6#1)(1994-12#1)
synthetic peptides representing##2##3##(1993-8#1)(2008-10#1)
synthetic peptides##38##2##(1990-12#1)(1990-4#2)(1990-7#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#2)(2008-10#2)(2008-2#4)(2008-4#11)(2010-11#1)(2012-1#1)
synthetic phase##2##2##(1993-8#1)(2007-12#1)
synthetic playing surfaces##3##3##(2013-1#3)
synthetic polymers##3##2##(2008-11#1)(2010-6#1)(2011-1#1)
synthetic polynucleotides##2##2##(1994-8#1)(2008-10#1)
synthetic procedure##2##2##(1993-11#1)(2008-10#1)
synthetic procedures##3##2##(2008-4#1)(2008-5#1)(2012-3#1)
synthetic process##2##2##(2008-10#1)(2008-11#1)
synthetic processes##2##2##(1991-6#1)(2010-12#1)
synthetic products##2##2##(1996-5#1)(2012-2#1)
synthetic protocols##2##2##(2008-10#1)(2008-4#1)
synthetic psoralen##2##2##(2008-11#2)
synthetic pterin##2##2##(2010-5#2)
synthetic pyrethroids##3##2##(2008-10#3)
synthetic rat##3##2##(1994-12#1)(1994-6#1)(1994-8#1)
synthetic replicators##2##2##(1992-6#2)
synthetic retinoid##3##2##(1991-12#1)(1992-9#2)
synthetic route also##2##3##(1996-5#1)(2009-11#1)
synthetic route##6##2##(1996-5#1)(2008-10#1)(2008-11#1)(2009-11#2)(2010-2#1)
synthetic saliva##3##2##(2008-10#3)
synthetic sample solutions by##2##4##(2008-10#2)
synthetic sample##6##2##(2008-10#6)
synthetic samples in##2##3##(2008-10#2)
synthetic samples prepared with##3##4##(2008-10#3)
synthetic samples prepared##5##3##(2008-10#5)
synthetic samples were##3##3##(2008-10#3)
synthetic samples with##4##3##(2008-10#4)
synthetic samples##38##2##(2008-10#38)
synthetic sea water##2##3##(2008-10#2)
synthetic seawater##3##2##(2008-10#2)(2008-2#1)
synthetic serum and pharmaceutical##2##4##(2008-10#2)
synthetic serum and##3##3##(2008-10#3)
synthetic serum samples##2##3##(2008-10#2)
synthetic serum##5##2##(2008-10#5)
synthetic slit##2##2##(2008-3#2)
synthetic solution##3##2##(2008-10#3)
synthetic solutions##4##2##(2008-10#3)(2013-1#1)
synthetic spectra##2##2##(2008-2#1)(2008-3#1)
synthetic strategies for##3##3##(2009-10#3)
synthetic strategies##4##2##(2009-10#3)(2012-3#1)
synthetic substrate##3##2##(1990-2#1)(1994-5#1)(1995-6#1)
synthetic substrates##5##2##(1990-11#1)(1990-5#1)(1991-12#2)(2008-4#1)
synthetic sunscreen##6##2##(2008-5#6)
synthetic sweeteners##3##2##(2011-1#3)
synthetic target##2##2##(2008-10#2)
synthetic tear##2##2##(2009-4#2)
synthetic telomeres##2##2##(1991-7#2)
synthetic tetradecapeptide##2##2##(1990-8#2)
synthetic vascular##2##2##(2009-11#1)(2011-3#1)
synthetic wastewater##2##2##(2008-10#1)(2011-2#1)
synthetic wavelength##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
synthetic##734##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#5)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-11#4)(1992-12#5)(1992-3#2)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#2)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#6)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#6)(1994-8#6)(1994-9#2)(1995-11#5)(1995-12#4)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#3)(1996-5#4)(1997-1#2)(1997-3#5)(1997-6#1)(1997-7#3)(1997-8#1)(2007-11#17)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#2)(2008-1#3)(2008-10#228)(2008-11#19)(2008-12#3)(2008-2#23)(2008-3#37)(2008-4#31)(2008-5#27)(2008-6#9)(2008-7#9)(2008-8#9)(2008-9#5)(2009-10#5)(2009-11#4)(2009-12#2)(2009-3#6)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#6)(2011-2#14)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#16)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#1)
synthetic)##2##1##(2008-10#2)
synthetics##2##1##(2008-11#2)
synthetized##3##1##(1992-3#1)(1995-6#1)(2008-7#1)
synthons in##2##2##(1995-6#1)(2012-3#1)
synthons##4##1##(1995-6#1)(1997-3#1)(2009-9#1)(2012-3#1)
syphilis and##4##2##(1991-6#1)(2011-2#2)(2013-8#1)
syphilis in##4##2##(1997-7#1)(2007-10#1)(2007-7#2)
syphilis infections##4##2##(1997-6#1)(2008-12#3)
syphilis with##2##2##(1997-5#1)(2013-1#1)
syphilis##34##1##(1991-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-5#3)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-7#3)(2008-10#4)(2008-12#3)(2011-2#6)(2013-1#4)(2013-8#1)
syphilitic##2##1##(1997-5#1)(2010-3#1)
syrB gene##5##2##(2008-10#5)
syrB##8##1##(2008-10#8)
syringae B728a##2##2##(2008-10#2)
syringae Cit7 was the most effective##2##6##(2008-10#2)
syringae Cit7##3##2##(2008-10#3)
syringae and C##2##3##(2008-10#2)
syringae and##7##2##(2008-10#7)
syringae in the##2##3##(2008-10#2)
syringae pathovars##5##2##(2008-10#5)
syringae pv##86##2##(2008-10#85)(2009-6#1)
syringae pvs##9##2##(2008-10#9)
syringae strain##3##2##(2008-10#2)(2009-8#1)
syringae strains##4##2##(2008-10#4)
syringae subsp##5##2##(2008-10#5)
syringae was##2##2##(2008-10#2)
syringae were##2##2##(2008-10#2)
syringae##182##1##(2008-10#178)(2009-6#1)(2009-8#3)
syringae)##2##1##(2008-10#2)
syringaldazine##5##1##(2008-10#5)
syringe and##3##2##(2008-10#3)
syringe filled with##2##3##(2008-10#2)
syringe needle##2##2##(2008-10#2)
syringe pump##10##2##(2008-10#8)(2011-2#1)(2013-1#1)
syringe pumps##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
syringe##40##1##(1995-5#1)(2007-7#1)(2008-10#27)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)(2013-1#4)
syringes and##2##2##(2008-10#1)(2012-2#1)
syringes##7##1##(1996-11#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
syringic acid##5##2##(2008-10#1)(2008-11#1)(2011-1#3)
syringic##6##1##(2008-10#1)(2008-11#1)(2011-1#3)(2011-2#1)
syringomatous features##2##2##(1990-6#2)
syringomycin##2##1##(2008-10#2)
syringyl lignin##2##2##(2009-8#2)
syrinx##2##1##(2008-7#1)(2008-8#1)
syrup##16##1##(1992-3#1)(1995-11#1)(1997-4#1)(2008-10#5)(2008-5#2)(2008-7#2)(2012-12#2)(2012-2#2)
syrups by##2##2##(2008-10#2)
syrups##7##1##(2008-10#7)
system (IL-1##2##2##(1996-12#2)
system (RAS)##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
system (e##2##2##(1997-2#1)(2011-2#1)
system (in##2##2##(1992-8#1)(2010-6#1)
system (the##3##2##(2008-10#2)(2013-1#1)
system BqsS-BqsR##2##2##(2009-6#2)
system XAG-##2##2##(1990-12#2)
system a##6##2##(1996-6#1)(2008-10#2)(2008-3#2)(2008-7#1)
system achieved##3##2##(2008-10#2)(2010-3#1)
system activity##8##2##(2008-3#2)(2008-4#1)(2008-7#3)(2009-10#1)(2011-2#1)
system acts as a##2##4##(2008-3#2)
system adapted to##2##3##(2008-10#2)
system after##7##2##(1993-3#1)(2007-11#1)(2008-10#3)(2008-9#1)(2011-1#1)
system all##2##2##(2008-3#1)(2012-2#1)
system allow##2##2##(2008-10#1)(2008-12#1)
system allowed determination of##2##4##(2008-10#2)
system allowed for##2##3##(2008-10#1)(2009-9#1)
system allowed the##3##3##(2008-10#3)
system allowed##8##2##(2008-10#7)(2009-9#1)
system allowing##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
system allows for the##2##4##(2008-2#2)
system allows for##4##3##(1992-3#1)(2008-2#2)(2011-1#1)
system allows us to##2##4##(2008-10#1)(2008-3#1)
system allows##17##2##(1990-5#1)(1992-3#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2011-1#1)
system alone##2##2##(2008-11#1)(2009-12#1)
system along##2##2##(2008-11#1)(2008-2#1)
system also##8##2##(1991-9#1)(1993-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
system analysis##5##2##(2008-3#3)(2011-1#2)
system and (3)##2##3##(1991-5#1)(2009-5#1)
system and 0##3##3##(2008-10#2)(2010-4#1)
system and a##15##3##(1990-5#1)(1991-3#1)(1992-5#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-12#3)(2008-10#3)(2008-3#1)(2009-10#1)(2012-2#1)
system and achieved##2##3##(2008-10#1)(2008-2#1)
system and an##2##3##(2006-10#1)(2009-12#1)
system and applied##2##3##(2007-11#1)(2008-10#1)
system and are##2##3##(2011-2#1)(2013-7#1)
system and data##2##3##(2008-12#1)(2008-2#1)
system and for##6##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
system and have##2##3##(1990-5#1)(2007-11#1)
system and in##5##3##(1992-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)
system and it##2##3##(1990-2#1)(2013-1#1)
system and its application to the##2##6##(2008-10#1)(2008-2#1)
system and its application to##4##5##(2008-10#3)(2008-2#1)
system and its##15##3##(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-7#1)(2012-3#1)
system and lead to##2##4##(1996-11#1)(2010-4#1)
system and may##2##3##(2008-10#2)
system and mixed##2##3##(2008-10#1)(2010-8#1)
system and obtained##2##3##(1997-7#1)(2008-8#1)
system and of##2##3##(1994-12#1)(2011-1#1)
system and others##2##3##(2008-2#1)(2011-2#1)
system and provides##2##3##(1990-12#1)(2012-12#1)
system and show##2##3##(2008-2#2)
system and suggest##2##3##(1994-8#1)(1995-12#1)
system and the amounts of##2##5##(2008-10#2)
system and the##49##3##(1990-6#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#3)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
system and then##3##3##(1992-1#1)(2007-12#1)(2008-10#1)
system and those obtained##2##4##(2008-10#2)
system and those##3##3##(2008-10#2)(2009-11#1)
system and thus##2##3##(1996-2#1)(2009-8#1)
system and to determine##2##4##(2008-10#1)(2008-2#1)
system and to##10##3##(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2009-6#1)(2010-8#1)
system and transported to##2##4##(1994-11#1)(1995-4#1)
system and was##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
system and were##2##3##(2008-10#1)(2012-2#1)
system and##310##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-4#1)(1992-5#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#3)(2006-4#1)(2007-11#3)(2007-12#7)(2007-8#4)(2008-1#4)(2008-10#82)(2008-11#12)(2008-12#4)(2008-2#11)(2008-3#14)(2008-4#4)(2008-5#3)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-4#4)(2010-7#1)(2010-8#7)(2011-1#4)(2011-2#13)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#4)
system appears to##2##3##(1991-8#1)(1993-6#1)
system applications##2##2##(2008-3#2)
system applied to##2##3##(2008-10#1)(2008-7#1)
system architecture##2##2##(2008-2#1)(2008-3#1)
system are also##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
system are considered##2##3##(1991-3#1)(2008-2#1)
system are described##4##3##(2008-10#2)(2008-3#1)(2010-2#1)
system are discussed in detail##2##5##(2008-10#1)(2008-3#1)
system are discussed##5##3##(2008-10#3)(2008-3#1)(2011-2#1)
system are presented##8##3##(2007-11#4)(2008-2#2)(2008-3#2)
system are shown##2##3##(2007-11#1)(2007-12#1)
system are##74##2##(1990-11#1)(1991-3#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#7)(2007-12#5)(2007-8#1)(2008-10#11)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
system around##2##2##(1997-2#1)(2008-5#1)
system as a##11##3##(1995-12#1)(2007-11#1)(2008-10#4)(2008-5#1)(2009-9#2)(2010-11#1)(2012-2#1)
system as an##2##3##(2008-9#1)(2010-7#1)
system as it##3##3##(1994-1#1)(2012-12#1)(2012-3#1)
system as the##3##3##(2008-2#1)(2012-3#1)(2013-1#1)
system as well as the##3##5##(2008-10#1)(2008-11#1)(2011-2#1)
system as well as##12##4##(1991-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
system as##40##2##(1991-12#1)(1991-2#1)(1994-1#1)(1995-12#2)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
system assembly##2##2##(2008-2#2)
system associated with##2##3##(2008-10#1)(2008-5#1)
system at a##3##3##(1995-2#1)(2007-11#1)(2008-10#1)
system at equilibrium##2##3##(1990-8#1)(2008-10#1)
system at the##8##3##(1993-12#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-6#1)
system at##26##2##(1990-8#1)(1993-12#1)(1995-2#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-4#1)(2010-4#1)(2010-6#1)(2013-1#2)
system atrophy (MSA)##2##3##(2008-7#2)
system atrophy##9##2##(2008-7#8)(2009-11#1)
system attractive##2##2##(2008-11#1)(2008-2#1)
system automatically##3##2##(1995-12#1)(2008-11#1)(2010-8#1)
system back##2##2##(2008-3#2)
system bandwidth is##2##3##(2008-3#2)
system bandwidth##3##2##(2008-3#3)
system based on a##11##4##(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-3#3)(2008-7#1)
system based on an array of##2##6##(2008-10#2)
system based on the##11##4##(1991-3#1)(1991-7#1)(1992-2#1)(2008-10#4)(2008-3#2)(2010-8#1)(2013-8#1)
system based on##62##3##(1991-3#1)(1991-7#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-6#1)(2007-11#6)(2007-12#4)(2007-5#2)(2008-10#20)(2008-11#1)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#2)(2011-2#1)(2013-8#1)
system based##65##2##(1991-3#1)(1991-7#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-6#1)(2007-11#6)(2007-12#4)(2007-5#2)(2007-9#1)(2008-10#20)(2008-11#1)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)(2011-3#1)(2013-8#1)
system because of the##2##4##(2007-10#1)(2007-12#1)
system because of##3##3##(1996-6#1)(2007-10#1)(2007-12#1)
system because##4##2##(1996-6#1)(2007-10#1)(2007-12#1)(2009-6#1)
system before##2##2##(1995-3#1)(2012-1#1)
system being##2##2##(2008-10#1)(2008-5#1)
system between##2##2##(1995-11#1)(2008-3#1)
system built##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
system but also##2##3##(1994-9#1)(2012-6#1)
system but##4##2##(1994-6#1)(1994-9#1)(2008-7#1)(2012-6#1)
system by the##4##3##(2008-10#2)(2008-7#2)
system by use of a##2##5##(2007-11#1)(2008-3#1)
system by use of##3##4##(2007-11#1)(2008-3#2)
system by using##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
system by##48##2##(1990-11#1)(1992-10#1)(1992-9#1)(1994-11#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#5)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)
system called##2##2##(2008-10#1)(2008-3#1)
system can also be used##2##5##(2010-8#1)(2011-1#1)
system can also be##3##4##(2008-10#1)(2010-8#1)(2011-1#1)
system can also##5##3##(1992-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)
system can be a##3##4##(1992-12#1)(2008-10#1)(2008-7#1)
system can be easily##2##4##(2008-10#1)(2008-3#1)
system can be enhanced by##2##5##(2008-10#2)
system can be readily applied to the##2##7##(1992-11#1)(2008-10#1)
system can be used for##4##5##(2007-12#1)(2008-3#2)(2010-1#1)
system can be used to##6##5##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
system can be used##11##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-1#1)(2011-2#1)
system can be##48##3##(1990-2#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#11)(2008-5#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#2)(2013-8#1)
system can contribute##2##3##(2008-3#1)(2010-6#1)
system can perform##3##3##(2008-10#1)(2008-3#2)
system can provide a##2##4##(2008-10#1)(2008-2#1)
system can provide##4##3##(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
system can recognize##2##3##(2008-3#1)(2008-4#1)
system can result in##2##4##(2008-2#1)(2010-9#1)
system can##91##2##(1990-2#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#19)(2008-11#2)(2008-2#9)(2008-3#19)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-9#1)(2010-1#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
system capabilities##2##2##(1991-12#1)(2011-1#1)
system capable of##4##3##(1993-9#1)(1996-12#1)(2008-10#1)(2009-8#1)
system capable##5##2##(1993-9#1)(1996-12#1)(2008-10#2)(2009-8#1)
system caused by##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
system caused##4##2##(1997-6#1)(2007-11#1)(2008-2#1)(2008-7#1)
system characteristics to mitigate##2##4##(2008-2#1)(2008-3#1)
system characteristics##3##2##(2008-2#1)(2008-3#2)
system combined with##6##3##(2007-10#1)(2008-10#3)(2008-3#1)(2009-4#1)
system combined##8##2##(2007-10#1)(2008-10#5)(2008-3#1)(2009-4#1)
system combines##4##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
system combining##2##2##(2007-12#1)(2008-10#1)
system compared to##2##3##(2008-9#1)(2010-8#1)
system compared with that of##2##5##(2008-3#1)(2012-2#1)
system compared with that##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
system compared with##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
system compared##6##2##(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
system complexity##2##2##(2008-2#1)(2008-3#1)
system components##9##2##(1994-6#1)(1996-12#1)(1997-3#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-1#1)
system composed of a##4##4##(2008-10#1)(2008-3#2)(2010-10#1)
system composed of the##2##4##(1990-5#1)(2008-5#1)
system composed of##13##3##(1990-5#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-10#1)(2011-1#3)(2012-1#2)(2012-2#1)
system composed##14##2##(1990-5#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#3)(2012-1#2)(2012-2#1)
system comprises a##2##3##(2007-11#1)(2007-12#1)
system comprises two##2##3##(1994-12#1)(2008-7#1)
system comprises##5##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
system comprising high performance liquid chromatography##2##6##(2008-10#1)(2012-1#1)
system comprising##4##2##(1992-8#1)(2008-10#1)(2009-8#1)(2012-1#1)
system configuration##2##2##(2008-2#2)
system conforms to##2##3##(2008-10#2)
system connected to a flow##2##5##(2008-10#2)
system connected to##3##3##(2008-10#2)(2009-10#1)
system consisted of a##2##4##(2008-10#1)(2010-2#1)
system consisted of##7##3##(1996-5#1)(2008-10#4)(2008-5#1)(2010-2#1)
system consisting of a##8##4##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#2)
system consisting of two##2##4##(2008-10#1)(2008-3#1)
system consisting of##20##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-8#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#4)(2009-4#1)(2009-8#1)
system consists of a##12##4##(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2009-5#1)
system consists of two##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
system consists of##24##3##(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2009-5#1)(2012-12#1)(2013-8#1)
system consists##25##2##(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2009-5#1)(2012-12#1)(2013-8#1)
system containing a##3##3##(1993-9#1)(2008-10#2)
system containing both##2##3##(1996-3#1)(2008-5#1)
system containing##19##2##(1993-9#1)(1995-6#2)(1996-3#1)(1996-5#1)(2008-10#11)(2008-5#3)
system contains a##2##3##(1994-8#1)(2008-10#1)
system contains##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
system control##2##2##(2008-10#1)(2012-3#1)
system correlates##2##2##(2008-11#1)(2013-8#1)
system could be##8##3##(2008-10#3)(2008-3#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#1)
system could##19##2##(1992-3#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
system coupled to a flame atomic absorption spectrometer##2##8##(2008-10#2)
system coupled to a##3##4##(2008-10#3)
system coupled to##9##3##(2008-10#9)
system coupled with a##3##4##(2008-10#3)
system coupled with##4##3##(2008-10#4)
system coupled##13##2##(2008-10#13)
system coupling##2##2##(2008-10#2)
system covering##2##2##(2008-10#1)(2012-12#1)
system damage##4##2##(1991-3#1)(1992-5#1)(1993-3#1)(2010-12#1)
system data##2##2##(1995-5#1)(2012-5#1)
system decreases with##2##3##(2008-10#1)(2008-3#1)
system demonstrated##3##2##(2008-10#1)(2008-6#1)(2010-8#1)
system depends on the##2##4##(2008-10#1)(2008-3#1)
system depends on##5##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)
system described in this unit##2##5##(2008-2#1)(2008-4#1)
system described in this##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
system described##8##2##(1990-12#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
system design and##3##3##(2008-2#2)(2008-9#1)
system design for a##2##4##(2008-3#2)
system design for##4##3##(2008-10#2)(2008-3#2)
system design is##2##3##(2008-2#1)(2008-3#1)
system design##22##2##(1992-4#1)(1994-1#1)(2007-11#2)(2008-10#3)(2008-2#8)(2008-3#6)(2008-9#1)
system designed to##4##3##(1993-2#1)(1995-2#1)(2008-3#1)(2010-8#1)
system designed##8##2##(1993-2#1)(1995-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#1)
system designs##3##2##(1993-2#1)(2008-3#2)
system detects##2##2##(2008-10#2)
system developed and implemented by##2##5##(1996-12#1)(2013-1#1)
system developed for##2##3##(1997-1#1)(2008-10#1)
system developed is##2##3##(2008-10#2)
system developed##14##2##(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2013-1#1)
system development##9##2##(1992-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)
system did not##4##3##(1997-2#1)(2008-8#1)(2009-5#1)(2009-6#1)
system differs from##2##3##(2008-2#1)(2008-5#1)
system differs##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
system diseases##6##2##(1990-11#1)(1993-5#1)(1994-9#1)(2009-5#1)(2013-1#2)
system disorders##4##2##(2008-4#1)(2008-9#1)(2012-1#1)(2013-1#1)
system disturbances##3##2##(2008-12#2)(2008-3#1)
system does not##7##3##(1994-3#1)(2008-3#3)(2008-8#2)(2011-2#1)
system due to##2##3##(2008-10#1)(2008-7#1)
system during the##2##3##(1994-12#1)(2008-5#1)
system during##4##2##(1994-12#1)(1995-5#1)(2008-5#1)(2009-10#1)
system dynamics##3##2##(1996-4#1)(2008-9#1)(2010-8#1)
system dysfunction##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
system effects##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-12#1)(2010-8#1)
system efficiency##3##2##(1991-5#1)(2008-11#1)(2008-3#1)
system employing a##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
system employing##8##2##(1991-9#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
system employs a##2##3##(2007-11#1)(2008-10#1)
system employs##8##2##(2007-11#2)(2008-10#4)(2008-3#1)(2008-9#1)
system enables the##3##3##(2008-10#2)(2008-11#1)
system enables##9##2##(1991-9#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2009-10#1)
system enhances##2##2##(2008-10#1)(2013-8#1)
system equipped with##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)
system errors##2##2##(2008-3#1)(2013-8#1)
system evolution##2##2##(1997-3#1)(2008-9#1)
system evolved from##2##3##(1994-12#1)(2008-11#1)
system evolved##3##2##(1994-12#1)(2008-11#1)(2008-7#1)
system exhibited##6##2##(1995-2#1)(2008-10#3)(2010-4#1)(2013-7#1)
system exhibits a##2##3##(1996-8#1)(2008-10#1)
system exhibits##6##2##(1991-3#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-2#1)
system exploiting multicommutation##2##3##(2008-10#2)
system expressing##2##2##(2008-11#1)(2008-8#1)
system facilitates##3##2##(1995-6#1)(2008-11#1)(2008-2#1)
system following##2##2##(2008-10#1)(2013-1#1)
system for a##12##3##(1992-11#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2010-7#1)(2010-8#1)
system for ambulatory care##3##4##(1993-12#1)(1994-3#2)
system for ambulatory##5##3##(1991-1#2)(1993-12#1)(1994-3#2)
system for an##2##3##(2008-3#2)
system for analysis of##3##4##(1990-8#2)(2009-8#1)
system for assessing##2##3##(2008-11#1)(2008-5#1)
system for automated dissolution testing##2##5##(2008-10#2)
system for automated##4##3##(2008-10#4)
system for automatic determination of chemical oxygen demand##2##8##(2008-10#2)
system for copper##3##3##(2008-10#3)
system for detecting##2##3##(2008-4#1)(2010-8#1)
system for detection of##2##4##(2008-10#1)(2010-8#1)
system for determination of ascorbic acid##2##6##(2008-10#2)
system for determination of##7##4##(2008-10#7)
system for determination##9##3##(2008-10#8)(2010-8#1)
system for determining##2##3##(2008-10#2)
system for digital##2##3##(2007-12#1)(2008-3#1)
system for efficient##3##3##(2008-11#2)(2011-1#1)
system for evaluating##2##3##(2007-8#1)(2008-10#1)
system for health care##2##4##(1993-2#1)(1993-3#1)
system for high##2##3##(2008-3#1)(2008-7#1)
system for imaging##2##3##(2007-12#1)(2008-3#1)
system for in##2##3##(2008-11#1)(2008-2#1)
system for lead##2##3##(2008-10#2)
system for measurement of the##2##5##(2008-2#1)(2008-3#1)
system for measurement of##3##4##(2008-2#1)(2008-3#2)
system for measuring the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
system for measuring##5##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
system for monitoring##2##3##(1997-2#1)(2008-10#1)
system for on-line preconcentration and determination of##2##7##(2008-10#2)
system for on-line##6##3##(2008-10#5)(2008-3#1)
system for physician##3##3##(1992-1#1)(1992-12#1)(2013-1#1)
system for protein##3##3##(1991-5#1)(2008-4#2)
system for rapid##2##3##(2008-10#2)
system for real-time##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
system for recombinant##2##3##(2008-11#1)(2008-9#1)
system for sampling##2##3##(2010-12#2)
system for separation of##2##4##(2008-10#1)(2008-7#1)
system for separation##3##3##(2008-10#2)(2008-7#1)
system for simultaneous##5##3##(2007-12#1)(2008-10#4)
system for spectrophotometric determination of##3##5##(2008-10#3)
system for studies##2##3##(2008-11#1)(2008-2#1)
system for study on adaptive mutations##2##6##(2008-9#2)
system for studying##6##3##(1995-3#1)(1996-2#1)(2008-10#1)(2009-12#1)(2009-2#1)(2009-8#1)
system for superresolution of temporally restricted objects##3##7##(2007-12#3)
system for surveillance##2##3##(2008-10#1)(2011-2#1)
system for synthesizing##2##3##(2007-12#1)(2008-3#1)
system for testing##2##3##(2008-3#1)(2008-9#1)
system for the analysis of##2##5##(1994-12#1)(2008-10#1)
system for the automated##2##4##(2008-10#1)(2008-9#1)
system for the detection of##4##5##(2008-10#1)(2008-3#2)(2013-8#1)
system for the detection##5##4##(2008-10#2)(2008-3#2)(2013-8#1)
system for the determination of copper##2##6##(2008-10#2)
system for the determination of fish freshness##2##7##(2008-10#2)
system for the determination of mercury by##2##7##(2008-10#2)
system for the determination of the##2##6##(2008-10#2)
system for the determination of total##2##6##(2008-10#2)
system for the determination of trace boron in iron and##2##10##(2008-10#2)
system for the determination of trace##4##6##(2008-10#4)
system for the determination of##33##5##(2008-10#31)(2008-3#1)(2010-4#1)
system for the determination##34##4##(2008-10#32)(2008-3#1)(2010-4#1)
system for the evaluation of##2##5##(2008-5#1)(2009-11#1)
system for the generation of##2##5##(2008-11#1)(2008-3#1)
system for the management of##3##5##(2007-8#1)(2008-12#1)(2011-2#1)
system for the on-line##3##4##(2008-10#3)
system for the production of##3##5##(1997-4#1)(2008-11#1)(2011-2#1)
system for the selective##2##4##(2008-10#2)
system for the simultaneous detection##2##5##(2008-10#1)(2008-2#1)
system for the simultaneous determination of##3##6##(2008-10#3)
system for the simultaneous##6##4##(2008-10#5)(2008-2#1)
system for the spectrophotometric determination of##7##6##(2008-10#7)
system for the study of##4##5##(2008-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
system for the##138##3##(1990-5#1)(1992-1#1)(1992-3#1)(1993-1#1)(1994-12#2)(1995-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#76)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#4)(2008-9#4)(2009-11#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
system for use in##2##4##(1994-5#1)(1996-2#1)
system for your##2##3##(1992-2#1)(2007-4#1)
system for zinc determination in##3##5##(2008-10#3)
system for##530##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#4)(1991-1#2)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#8)(1992-3#5)(1992-4#3)(1992-6#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#9)(2007-12#18)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#196)(2008-11#23)(2008-12#3)(2008-2#24)(2008-3#41)(2008-4#7)(2008-5#9)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#14)(2009-11#3)(2009-12#2)(2009-2#3)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#8)(2011-1#6)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#1)
system formation##2##2##(1992-12#1)(2010-1#1)
system from a##2##3##(1995-1#1)(2008-10#1)
system from the##5##3##(1990-5#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
system from which the##2##4##(2007-12#1)(2008-10#1)
system from which##4##3##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#1)
system from##21##2##(1990-5#1)(1990-6#1)(1991-9#1)(1993-12#1)(1995-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
system function in##2##3##(2008-10#1)(2009-8#1)
system function##6##2##(1996-5#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)
system functions##2##2##(1997-3#1)(2008-10#1)
system gave##4##2##(1992-11#1)(1997-7#1)(2008-10#1)(2008-11#1)
system generating##2##2##(2007-12#1)(2008-10#1)
system geometry##2##2##(2008-2#1)(2008-7#1)
system gives a##2##3##(2008-8#1)(2013-8#1)
system gives##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
system greatly##2##2##(2008-10#1)(2008-9#1)
system had a##5##3##(2008-10#3)(2008-11#1)(2009-10#1)
system had##9##2##(1990-9#1)(1992-12#1)(2008-10#5)(2008-11#1)(2009-10#1)
system handles about 65 samples per hour##2##7##(2008-10#2)
system handles about##4##3##(2008-10#4)
system handles##5##2##(2008-10#5)
system has a detection limit of 0##2##7##(2008-10#2)
system has a##11##3##(1992-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-8#1)
system has also been investigated##2##5##(2008-10#2)
system has also been##3##4##(1995-5#1)(2008-10#2)
system has been applied to the analysis of##2##8##(2008-10#2)
system has been applied to the##3##6##(1994-12#1)(2008-10#2)
system has been applied to##4##5##(1994-12#1)(2008-10#2)(2010-5#1)
system has been applied##6##4##(1994-12#1)(2008-10#4)(2010-5#1)
system has been demonstrated by##2##5##(2007-12#1)(2008-2#1)
system has been developed for the##3##6##(2008-10#3)
system has been developed for##7##5##(1992-6#1)(2008-10#5)(2008-2#1)
system has been developed using##2##5##(1996-2#1)(2008-10#1)
system has been developed##17##4##(1992-6#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#2)
system has been established##2##4##(2008-10#1)(2010-6#1)
system has been explored for##2##5##(2008-10#2)
system has been identified as an##2##6##(2008-2#1)(2012-2#1)
system has been implemented in##2##5##(2007-12#1)(2008-3#1)
system has been proposed##3##4##(2008-10#2)(2012-12#1)
system has been studied##3##4##(1992-9#1)(2008-10#1)(2012-7#1)
system has been successfully applied##2##5##(1991-12#1)(2008-10#1)
system has been successfully used##2##5##(2007-12#1)(2008-10#1)
system has been successfully##4##4##(1991-12#1)(2007-12#1)(2008-10#2)
system has been suggested##2##4##(1994-6#1)(2009-9#1)
system has been tested##5##4##(2008-10#4)(2008-3#1)
system has been used for##4##5##(2008-10#2)(2008-11#1)(2011-1#1)
system has been used to##2##5##(1993-6#1)(2008-8#1)
system has been used##8##4##(1992-4#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
system has been##86##3##(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#4)(2008-10#30)(2008-11#3)(2008-2#5)(2008-3#8)(2008-6#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)
system has failed to##2##4##(1994-2#1)(1995-3#1)
system has found##2##3##(1991-9#1)(2008-11#1)
system has made it possible##2##5##(2008-7#1)(2010-12#1)
system has not##3##3##(2008-11#1)(2011-2#1)(2012-1#1)
system has supported##2##3##(1997-3#1)(2008-10#1)
system has the##8##3##(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#1)
system has##151##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#2)(1995-5#2)(1996-1#1)(1996-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(2007-11#5)(2007-12#4)(2008-10#49)(2008-11#7)(2008-12#1)(2008-2#11)(2008-3#14)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
system have been##5##3##(2008-10#1)(2008-3#3)(2008-7#1)
system have##16##2##(1991-2#1)(1991-3#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#1)(2010-3#1)(2013-8#1)
system having a##2##3##(2008-3#2)
system identification##3##2##(1997-6#1)(2007-9#2)
system implementation##3##2##(1992-12#1)(1993-2#1)(1996-2#1)
system in Escherichia coli##2##4##(1990-11#1)(1990-5#1)
system in a##13##3##(1990-9#1)(1994-2#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
system in an##3##3##(1996-2#1)(2008-3#1)(2011-2#1)
system in both##4##3##(1997-8#1)(2008-10#2)(2008-7#1)
system in cancer cells##2##4##(1994-11#1)(2008-4#1)
system in cancer##3##3##(1994-11#1)(2008-4#1)(2013-1#1)
system in general##2##3##(1994-2#1)(2012-12#1)
system in heart failure##2##4##(2008-7#1)(2012-2#1)
system in human##2##3##(1991-8#1)(1997-1#1)
system in many diseases##2##4##(2008-10#1)(2008-5#1)
system in many##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
system in order to##3##4##(1995-3#1)(1997-4#1)(2011-1#1)
system in other##2##3##(2008-1#1)(2012-12#1)
system in patients with##3##4##(1997-1#1)(1997-7#1)(2013-1#1)
system in place##2##3##(1991-3#1)(2012-1#1)
system in regulating##2##3##(2008-11#1)(2011-2#1)
system in such a##2##4##(1991-9#1)(2008-10#1)
system in terms of##2##4##(2007-11#1)(2008-11#1)
system in the form of##2##5##(2012-2#1)(2013-8#1)
system in the management of##2##5##(2007-8#1)(2008-9#1)
system in the presence of##4##5##(2008-10#4)
system in the rat##3##4##(1991-2#1)(1993-1#1)(1995-12#1)
system in the regulation##2##4##(1993-12#1)(2010-11#1)
system in the##48##3##(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#4)(2008-9#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
system in this##2##3##(2008-7#1)(2008-8#1)
system in vivo##3##3##(1990-5#1)(1995-2#1)(1997-4#1)
system in which a##3##4##(1992-10#1)(2008-3#1)(2008-7#1)
system in which the##8##4##(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
system in which to study the##2##6##(1995-2#1)(1997-3#1)
system in which to##4##4##(1995-2#1)(1997-3#1)(2009-8#1)(2012-3#1)
system in which##30##3##(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#1)
system in##266##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-12#5)(1992-2#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#5)(2008-1#4)(2008-10#31)(2008-11#12)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#14)(2008-8#8)(2008-9#7)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#8)(2013-2#1)(2013-8#2)
system include##5##2##(1994-12#1)(1997-4#1)(2007-8#1)(2008-2#1)(2011-2#1)
system includes a##3##3##(2008-10#3)
system includes##5##2##(2008-10#4)(2008-3#1)
system including the##2##3##(1993-6#1)(1996-9#1)
system including##11##2##(1990-5#1)(1993-6#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
system incorporates##2##2##(2008-2#2)
system incorporating a##2##3##(2007-12#1)(2008-10#1)
system incorporating##7##2##(2007-12#1)(2008-1#1)(2008-10#4)(2011-2#1)
system increased the##2##3##(2007-11#1)(2008-7#1)
system injury##2##2##(2007-8#1)(2011-2#1)
system integration##3##2##(2008-7#1)(2010-8#2)
system interventions##2##2##(2009-4#1)(2009-9#1)
system into a##2##3##(2007-11#1)(2010-4#1)
system into the##2##3##(2007-11#1)(2010-8#1)
system into##5##2##(1992-6#1)(2007-11#2)(2010-4#1)(2010-8#1)
system involvement in##2##3##(1993-12#1)(2008-3#1)
system involvement##8##2##(1990-11#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
system involves##3##2##(2008-10#2)(2010-8#1)
system involving the##3##3##(2008-10#2)(2008-4#1)
system involving##8##2##(1990-2#1)(1991-12#1)(2008-10#5)(2008-4#1)
system is 0##3##3##(2008-10#2)(2008-3#1)
system is a good##2##4##(2008-11#1)(2009-2#1)
system is a new##2##4##(2008-3#1)(2012-2#1)
system is a##25##3##(1992-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
system is able to detect##2##5##(2008-11#1)(2008-3#1)
system is able to##12##4##(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
system is affected##2##3##(1996-6#1)(2013-1#1)
system is also##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#2)
system is an##6##3##(1990-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
system is applied to##2##4##(2008-2#2)
system is applied##3##3##(2008-2#2)(2008-3#1)
system is approximately##2##3##(2008-3#1)(2008-6#1)
system is based on a Nd##2##6##(2008-3#2)
system is based on a##12##5##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-8#1)
system is based on the##5##5##(1992-6#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
system is based on##24##4##(1992-4#1)(1992-6#1)(1995-5#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-9#1)(2009-8#1)
system is built##2##3##(2008-2#1)(2008-7#1)
system is called##2##3##(2010-8#2)
system is capable of##6##4##(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)
system is characterized##2##3##(2008-2#1)(2008-3#1)
system is composed of##2##4##(2008-10#2)
system is considered to originate from intramolecular and intermolecular energy transfers##2##11##(2008-10#2)
system is considered##4##3##(2008-10#3)(2008-3#1)
system is controlled by##2##4##(2008-10#1)(2008-2#1)
system is currently##2##3##(1992-3#1)(2008-3#1)
system is demonstrated with##2##4##(2007-12#1)(2008-10#1)
system is demonstrated##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
system is described for the determination of##2##7##(2008-10#2)
system is described in this paper##3##6##(2007-12#1)(2008-10#2)
system is described in##4##4##(1994-5#1)(2007-12#1)(2008-10#2)
system is described##19##3##(1991-12#1)(1994-5#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2009-11#1)
system is designed for##2##4##(1991-1#1)(2008-2#1)
system is designed to##4##4##(2007-12#1)(2008-3#2)(2011-2#1)
system is designed##7##3##(1991-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
system is determined by##2##4##(2008-3#1)(2008-8#1)
system is developed##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
system is discussed##5##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)
system is evaluated##2##3##(2008-3#2)
system is formed by##2##4##(1990-11#1)(2007-12#1)
system is found to be##2##5##(2008-10#1)(2008-2#1)
system is found to##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
system is found##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
system is fully##2##3##(2008-2#1)(2008-3#1)
system is highly##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
system is important in##2##4##(2008-2#1)(2011-2#1)
system is important##3##3##(1994-6#1)(2008-2#1)(2011-2#1)
system is in place##2##4##(2008-9#1)(2012-2#1)
system is in the##2##4##(1996-12#1)(2008-3#1)
system is in##6##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
system is involved in the##2##5##(1996-2#1)(2008-7#1)
system is involved in##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
system is likely to be##2##5##(2008-8#1)(2009-6#1)
system is likely##3##3##(2008-8#1)(2009-6#1)(2009-8#1)
system is modified##2##3##(2008-3#1)(2008-5#1)
system is more##4##3##(1993-5#1)(2007-12#1)(2008-10#1)(2013-1#1)
system is needed##2##3##(2010-5#1)(2012-12#1)
system is not##2##3##(1991-12#1)(1992-3#1)
system is one of##2##4##(1995-5#1)(2012-2#1)
system is one##3##3##(1995-5#1)(2008-2#1)(2012-2#1)
system is particularly##2##3##(2008-3#1)(2008-4#1)
system is prepared##2##3##(2008-10#2)
system is presented that##3##4##(2008-3#3)
system is presented##11##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-10#1)
system is proposed for the determination of##4##7##(2008-10#4)
system is proposed for the##7##5##(2008-10#7)
system is proposed for##10##4##(2008-10#10)
system is proposed##17##3##(1991-5#1)(1996-2#1)(2008-10#14)(2008-3#1)
system is quite##2##3##(1994-2#1)(2008-10#1)
system is reported##2##3##(2008-10#1)(2008-2#1)
system is robust##2##3##(2008-2#1)(2008-7#1)
system is shown to be##2##5##(2008-2#1)(2008-3#1)
system is shown to##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
system is stable##2##3##(2008-10#1)(2008-2#1)
system is suitable for##5##4##(2008-10#4)(2008-3#1)
system is tested##2##3##(2008-10#1)(2008-2#1)
system is the most##2##4##(2008-10#1)(2013-1#1)
system is the##9##3##(2008-10#6)(2008-2#1)(2008-9#1)(2013-1#1)
system is to##4##3##(1994-2#1)(2007-8#1)(2010-10#1)(2013-8#1)
system is unaffected by##2##4##(1993-11#1)(2008-10#1)
system is used to##9##4##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
system is used##16##3##(1991-2#1)(1996-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-8#1)(2010-6#1)
system is useful for##3##4##(2007-11#1)(2008-11#1)(2008-3#1)
system is useful##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
system is very##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)
system is##426##2##(1990-11#2)(1990-7#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#5)(1992-4#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#4)(1997-3#2)(1997-4#1)(2007-11#10)(2007-12#21)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#111)(2008-11#14)(2008-12#1)(2008-2#47)(2008-3#73)(2008-4#2)(2008-5#6)(2008-6#6)(2008-7#7)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#8)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
system it is##2##3##(2008-3#2)
system itself##2##2##(1991-12#1)(2008-3#1)
system leading to##3##3##(1992-3#1)(2008-10#1)(2008-5#1)
system lesions##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
system level##5##2##(1994-12#1)(2008-2#1)(2008-3#1)(2013-1#2)
system linearity##2##2##(2008-9#2)
system located in the##2##4##(1992-5#1)(2012-12#1)
system made up##3##3##(2008-10#3)
system made##4##2##(2008-10#4)
system maintained##2##2##(2008-10#1)(2008-11#1)
system makes it possible##2##4##(2007-12#1)(2008-4#1)
system makes##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
system making##2##2##(2008-5#1)(2010-6#1)
system may be used##2##4##(2008-10#1)(2008-7#1)
system may be##14##3##(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
system may##27##2##(1992-12#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
system mediated by##2##3##(1992-8#1)(2011-2#1)
system might be##2##3##(2008-11#1)(2008-4#1)
system might##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)
system model##2##2##(2008-2#1)(2009-5#1)
system modelling##2##2##(2008-11#1)(2010-10#1)
system models##3##2##(1997-2#1)(2007-11#1)(2012-1#1)
system modulation##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
system more than##2##3##(2008-11#1)(2013-1#1)
system more##4##2##(1991-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
system must be##2##3##(1996-3#1)(1997-1#1)
system must##4##2##(1993-12#1)(1996-3#1)(1997-1#1)(2008-12#1)
system near##2##2##(1992-6#1)(2008-3#1)
system needs##2##2##(2009-12#1)(2013-8#1)
system noise##2##2##(2008-2#2)
system nonuniformity that results from the system components##2##8##(2008-3#2)
system nonuniformity##5##2##(2008-3#5)
system not only##4##3##(2007-12#1)(2008-10#2)(2010-8#1)
system not##6##2##(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-8#1)
system obeys Beer's law in the range##3##7##(2008-10#3)
system obeys Beer's law##6##4##(2008-10#6)
system occur##2##2##(1992-5#1)(2008-1#1)
system of 0##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
system of 7##2##3##(2008-1#1)(2008-10#1)
system of Neisseria gonorrhoeae##2##4##(1993-9#2)
system of Tb-TMA-beta-CD##2##3##(2008-10#2)
system of a##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
system of care##3##3##(1997-1#1)(2009-10#1)(2010-12#1)
system of choice for the##2##5##(1996-2#1)(1997-4#1)
system of choice##4##3##(1996-1#1)(1996-2#1)(1997-4#1)(2008-11#1)
system of classification##2##3##(2007-7#1)(2008-10#1)
system of differential equations##2##4##(2010-11#1)(2013-8#1)
system of equations##2##3##(2007-12#2)
system of free##2##3##(2008-10#1)(2008-5#1)
system of local##2##3##(2008-3#1)(2008-8#1)
system of medical##2##3##(2008-6#1)(2012-3#1)
system of medicine in India##2##5##(2008-10#2)
system of medicine is##2##4##(2008-7#1)(2013-1#1)
system of medicine##8##3##(2008-10#3)(2008-7#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
system of partial differential equations##2##5##(2013-8#2)
system of performance intervention zones##2##5##(2008-12#2)
system of radiation protection##3##4##(2008-12#2)(2008-7#1)
system of service##11##3##(2013-8#11)
system of the fruit##2##4##(2007-12#1)(2008-10#1)
system of the lamprey##2##4##(1997-3#2)
system of the##42##3##(1990-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-3#2)(1997-6#1)(2007-12#8)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#4)(2008-6#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
system of this##2##3##(2008-2#1)(2008-9#1)
system of two##7##3##(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
system of##302##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#20)(2007-7#1)(2008-1#2)(2008-10#53)(2008-11#14)(2008-12#9)(2008-2#13)(2008-3#11)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#10)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#28)
system offered improved##2##3##(2008-10#2)
system offered##4##2##(2008-10#4)
system offers a##2##3##(1995-3#1)(2008-10#1)
system offers several##2##3##(1991-9#1)(2008-10#1)
system offers the##4##3##(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
system offers##12##2##(1991-9#1)(1993-3#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
system on a##3##3##(2008-10#2)(2012-2#1)
system on chip##3##3##(2009-10#1)(2010-8#2)
system on the##9##3##(1996-2#2)(2006-10#1)(2008-10#3)(2008-3#1)(2010-6#2)
system on##33##2##(1990-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-5#1)(2006-10#1)(2008-10#5)(2008-3#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-6#2)(2010-8#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
system operated##2##2##(2008-2#1)(2008-3#1)
system operates##2##2##(2007-12#1)(2008-2#1)
system operating at##2##3##(2008-2#2)
system operating in the##2##4##(1990-5#1)(2008-3#1)
system operating##6##2##(1990-5#1)(2007-12#1)(2008-2#2)(2008-3#2)
system or a##2##3##(1990-12#1)(2008-2#1)
system or the##2##3##(1993-12#1)(2008-9#1)
system or##16##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-5#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-12#1)(2013-7#1)
system output##3##2##(2008-2#1)(2008-9#1)(2009-8#1)
system over the##4##3##(1993-12#1)(2008-10#3)
system over##8##2##(1993-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)
system parameters are##2##3##(2008-3#2)
system parameters##15##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#9)(2008-7#1)
system performance for##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
system performance is##3##3##(2008-3#3)
system performance results##2##3##(2008-2#1)(2008-3#1)
system performance was evaluated##2##4##(2008-3#1)(2013-1#1)
system performance was##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
system performance with##2##3##(2008-3#2)
system performance##39##2##(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#18)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
system performs##2##2##(2008-10#1)(2008-3#1)
system permits the##2##3##(1994-3#1)(2007-12#1)
system permits##6##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)
system permitted##2##2##(2008-10#1)(2008-11#1)
system plays a##5##3##(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)
system plays an important role in##2##6##(1993-12#1)(2010-3#1)
system plays##9##2##(1993-12#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)
system presented an analytical##2##4##(2008-10#2)
system presented##6##2##(2008-10#4)(2008-11#1)(2008-4#1)
system presents##3##2##(1990-2#1)(1997-2#1)(2012-3#1)
system primarily##2##2##(2008-10#1)(2008-3#1)
system processes##2##2##(1990-11#1)(2008-10#1)
system produced##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
system produces an##2##3##(1996-2#1)(2008-10#1)
system produces##6##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
system proposed by##3##3##(1990-8#1)(2007-11#1)(2011-1#1)
system proposed##4##2##(1990-8#1)(2007-11#1)(2010-8#1)(2011-1#1)
system proved to be##3##4##(1995-11#1)(2008-10#2)
system provided a##2##3##(2008-10#1)(2008-9#1)
system provided excellent##2##3##(1995-12#1)(2008-3#1)
system provided##6##2##(1995-12#1)(2008-10#3)(2008-3#1)(2008-9#1)
system provides a##7##3##(1994-3#2)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
system provides high##2##3##(2007-11#1)(2008-3#1)
system provides the##2##3##(2007-12#1)(2008-3#1)
system provides##18##2##(1992-2#1)(1994-3#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)
system pumped by a##2##4##(2008-3#1)(2008-5#1)
system rather than the##2##4##(1990-8#1)(2008-7#1)
system reached##4##2##(1996-3#1)(1997-8#1)(2008-6#2)
system reconstituted with##2##3##(1991-9#1)(1995-2#1)
system reduced##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2010-3#1)
system reform##18##2##(1993-12#4)(1993-3#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#2)(2007-5#1)(2009-3#1)(2012-12#1)
system related##2##2##(2007-11#1)(2010-3#1)
system reliability##2##2##(2008-3#2)
system relies on##2##3##(2008-10#1)(2008-3#1)
system remains##2##2##(1992-12#1)(2008-7#1)
system represents an##2##3##(2008-10#2)
system represents the##2##3##(1996-9#1)(2008-1#1)
system represents##5##2##(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)
system required##2##2##(2008-10#1)(2008-11#1)
system requirements##5##2##(1991-1#1)(1996-3#1)(2010-12#1)(2010-8#2)
system requires only##2##3##(2008-11#1)(2010-6#1)
system requires##4##2##(1994-1#1)(2008-11#2)(2010-6#1)
system response##7##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-6#1)(2013-1#1)
system resulted in##4##3##(1992-8#1)(1995-6#1)(2008-10#1)(2008-7#1)
system results in##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
system revealed##4##2##(1995-6#1)(2007-11#1)(2008-11#1)(2013-1#1)
system review##4##2##(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
system safety##2##2##(1990-11#2)
system serves##2##2##(1995-12#1)(2010-2#1)
system settings##2##2##(2008-2#2)
system should be useful for##2##5##(1992-1#1)(2008-11#1)
system should be useful##3##4##(1992-1#1)(2008-11#1)(2008-5#1)
system should be##9##3##(1992-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#1)
system should not be##2##4##(2008-10#1)(2013-8#1)
system should##16##2##(1992-1#1)(1994-3#2)(1994-8#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
system showed good##4##3##(2008-10#4)
system showed that##6##3##(1993-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
system showed##12##2##(1993-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
system shows that the##2##4##(2007-11#1)(2008-10#1)
system shows that##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
system shows##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)
system simulation##2##2##(2008-2#2)
system since it##2##3##(2008-10#1)(2010-5#1)
system since##3##2##(1994-1#1)(2008-10#1)(2010-5#1)
system size##4##2##(2008-2#2)(2012-2#1)(2013-8#1)
system so that##3##3##(2008-10#1)(2008-3#2)
system specifically##2##2##(2007-11#1)(2009-11#1)
system states##2##2##(2008-11#1)(2009-10#1)
system successfully##2##2##(2008-2#1)(2008-3#1)
system such as##5##3##(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
system such that##2##3##(2008-3#2)
system such##7##2##(1995-2#1)(2008-10#1)(2008-3#3)(2008-7#1)(2011-2#1)
system suggests that##2##3##(1996-12#1)(2009-10#1)
system suitability##2##2##(2008-10#1)(2012-2#1)
system takes##2##2##(2007-11#1)(2008-10#1)
system technology##2##2##(2008-10#1)(2008-11#1)
system than the##2##3##(1997-4#1)(2008-10#1)
system than##5##2##(1997-3#1)(1997-4#1)(2008-10#2)(2008-4#1)
system that allows us to##2##5##(2010-5#2)
system that allows##4##3##(2010-5#2)(2011-2#1)(2013-8#1)
system that are##2##3##(2008-3#1)(2008-9#1)
system that can be used to##2##6##(1991-2#1)(1997-4#1)
system that can be used##3##5##(1991-2#1)(1997-4#1)(2008-10#1)
system that can##10##3##(1991-2#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)
system that combines the##2##4##(1993-3#1)(2008-12#1)
system that combines##4##3##(1993-3#1)(2007-12#1)(2008-10#1)(2008-12#1)
system that consists of##2##4##(2008-2#1)(2008-4#1)
system that could be used##2##5##(1995-2#1)(2009-10#1)
system that could be##3##4##(1995-2#1)(2008-7#1)(2009-10#1)
system that does not##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
system that employs##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
system that has been developed##2##5##(2008-10#1)(2008-2#1)
system that has been##7##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
system that has##9##3##(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
system that includes##3##3##(1993-6#1)(2008-1#1)(2008-3#1)
system that incorporates##2##3##(2008-3#2)
system that integrates##2##3##(2008-10#1)(2008-3#1)
system that is able to##5##5##(1995-11#1)(2008-5#1)(2011-1#1)(2013-8#2)
system that is##16##3##(1991-9#1)(1995-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
system that operates##2##3##(2007-11#1)(2008-3#1)
system that produces##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
system that provides##3##3##(1991-4#1)(1994-3#1)(2008-3#1)
system that regulates##2##3##(1995-8#1)(2009-6#1)
system that relies##2##3##(1996-1#1)(2007-12#1)
system that uses a##9##4##(2007-11#1)(2008-3#8)
system that uses the##2##4##(2008-2#1)(2008-3#1)
system that uses##17##3##(1994-12#1)(2007-11#2)(2008-2#2)(2008-3#12)
system that was developed##3##4##(1994-3#1)(1995-2#1)(2008-10#1)
system that we##2##3##(2008-11#1)(2008-5#1)
system that will##3##3##(1994-12#1)(2008-2#1)(2008-3#1)
system that would##4##3##(1995-2#1)(2008-10#1)(2013-1#2)
system that##160##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-4#1)(2007-11#9)(2007-12#6)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#43)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
system the##4##2##(1993-8#1)(2007-11#1)(2008-3#2)
system theory##2##2##(1990-12#1)(2008-9#1)
system there##2##2##(2008-10#1)(2008-5#1)
system through a##4##3##(1993-8#2)(2008-10#1)(2008-2#1)
system through the##5##3##(1997-7#1)(2008-5#1)(2008-9#2)(2013-8#1)
system through##10##2##(1993-8#2)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2011-1#1)(2013-8#1)
system throughput##2##2##(2008-3#1)(2008-5#1)
system thus##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
system to a##4##3##(1995-11#1)(1996-1#1)(2008-10#1)(2008-3#1)
system to analyze##2##3##(2008-10#1)(2011-2#1)
system to assess##4##3##(1994-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
system to avoid##2##3##(2008-10#2)
system to be used in##2##5##(2008-3#1)(2010-11#1)
system to be used to##2##5##(2008-2#1)(2009-12#1)
system to be used##4##4##(2008-2#1)(2008-3#1)(2009-12#1)(2010-11#1)
system to be##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-11#2)
system to characterize the##2##4##(1997-3#1)(2008-10#1)
system to characterize##3##3##(1991-5#1)(1997-3#1)(2008-10#1)
system to control##2##3##(2008-11#1)(2011-2#1)
system to demonstrate the##2##4##(2007-11#1)(2008-2#1)
system to detect##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
system to determine##2##3##(2008-10#2)
system to evaluate the##4##4##(2008-10#1)(2008-5#1)(2009-3#1)(2013-8#1)
system to evaluate##6##3##(1990-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-8#1)
system to examine the##2##4##(1997-6#1)(2007-11#1)
system to examine##3##3##(1997-6#1)(2007-11#1)(2008-9#1)
system to experimentally##2##3##(2009-2#1)(2010-2#1)
system to express##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
system to generate##2##3##(2008-9#1)(2012-3#1)
system to identify##6##3##(1994-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-8#2)
system to increase##2##3##(1997-8#1)(2008-10#1)
system to induce##2##3##(2007-10#1)(2008-9#1)
system to investigate the##3##4##(2008-9#2)(2009-2#1)
system to investigate##5##3##(1994-6#1)(2008-11#1)(2008-9#2)(2009-2#1)
system to measure the##2##4##(2007-12#1)(2008-3#1)
system to measure##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#1)(2012-12#1)
system to meet##3##3##(1990-5#1)(1992-1#1)(1994-1#1)
system to perform##4##3##(2008-10#3)(2008-2#1)
system to produce##2##3##(1996-3#1)(2008-10#1)
system to provide##2##3##(1996-2#1)(2013-8#1)
system to reduce##2##3##(2008-10#1)(2010-3#1)
system to study##11##3##(1990-3#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-9#1)
system to support##2##3##(1996-2#1)(1997-1#1)
system to test##2##3##(2008-10#1)(2008-11#1)
system to the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)
system to work##2##3##(1996-2#1)(2013-1#1)
system to##193##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-2#4)(1996-3#4)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#40)(2008-11#11)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#8)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#7)
system together##2##2##(1992-11#1)(2008-10#1)
system transfer function##2##3##(2007-12#1)(2008-3#1)
system transfer##3##2##(2007-12#1)(2008-3#2)
system transforms##2##2##(2008-10#1)(2008-9#1)
system under the##3##3##(2007-12#1)(2010-12#1)(2010-8#1)
system under##14##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2010-12#1)(2010-4#1)(2010-8#1)
system used in##3##3##(1996-12#1)(2008-10#1)(2010-6#1)
system used was##2##3##(2008-7#2)
system used##13##2##(1990-11#1)(1993-3#1)(1996-12#1)(2008-10#2)(2008-7#3)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)
system uses a##4##3##(1994-12#1)(2008-10#1)(2008-3#2)
system uses##14##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-6#1)(2008-9#1)
system using a flow cytometer to##2##6##(1994-2#2)
system using a##20##3##(1994-2#2)(2008-10#13)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#1)
system using an##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
system using human##2##3##(1993-3#1)(2008-11#1)
system using the##8##3##(1991-9#1)(1997-4#1)(2008-10#3)(2008-5#2)(2012-12#1)
system using##84##2##(1990-11#1)(1990-2#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-9#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#2)(2007-11#2)(2007-12#3)(2008-10#39)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
system utilized##2##2##(2008-10#1)(2008-2#1)
system utilizes the##2##3##(1997-4#1)(2008-10#1)
system utilizes##6##2##(1997-4#1)(2008-10#3)(2008-3#2)
system utilizing##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
system variables##3##2##(1990-7#1)(2008-10#1)(2008-2#1)
system velocity##2##2##(2008-2#2)
system via##4##2##(1992-8#1)(2008-10#1)(2009-9#1)(2012-12#1)
system volume##2##2##(2008-2#2)
system was able to##3##4##(2007-5#1)(2008-10#2)
system was achieved##2##3##(2008-10#2)
system was also##6##3##(2008-10#5)(2008-3#1)
system was applied for the determination of##2##7##(2008-10#2)
system was applied to the determination of##4##7##(2008-10#4)
system was applied to the##9##5##(2008-10#9)
system was applied to##14##4##(2008-10#12)(2008-3#1)(2011-3#1)
system was applied##17##3##(1997-4#1)(2008-10#14)(2008-3#1)(2011-3#1)
system was approximately##2##3##(2008-10#1)(2008-2#1)
system was ascertained by analyzing a set of##3##8##(2008-10#3)
system was assembled with a##2##5##(2008-10#2)
system was assembled##4##3##(2008-10#4)
system was built##2##3##(2008-10#1)(2008-3#1)
system was calculated##2##3##(2008-3#1)(2013-8#1)
system was calibrated in the range##2##6##(2008-10#2)
system was calibrated in##3##4##(2008-10#2)(2008-2#1)
system was calibrated##6##3##(2007-11#1)(2008-10#4)(2008-2#1)
system was capable of##2##4##(2008-10#1)(2008-11#1)
system was carried out by##2##5##(2008-10#2)
system was carried out##4##4##(2008-10#4)
system was constructed and##2##4##(2008-10#1)(2008-3#1)
system was constructed by using##2##5##(2008-11#1)(2011-3#1)
system was constructed##8##3##(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2011-3#1)
system was controlled by##2##4##(2008-10#2)
system was controlled##3##3##(2008-10#3)
system was demonstrated##5##3##(2008-10#5)
system was designed and##3##4##(2007-11#1)(2008-11#1)(2008-8#1)
system was designed to##2##4##(2007-12#1)(2008-10#1)
system was designed##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
system was detected##2##3##(1995-8#1)(2008-10#1)
system was developed for the determination of##3##7##(2008-10#3)
system was developed for the##6##5##(1992-11#1)(2008-10#5)
system was developed for##9##4##(1992-11#1)(2008-10#8)
system was developed to##5##4##(1995-3#1)(2008-10#2)(2008-11#1)(2011-1#1)
system was developed using##3##4##(2008-10#3)
system was developed##25##3##(1992-11#1)(1993-8#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-7#2)(2011-1#1)
system was employed to##4##4##(2008-10#3)(2008-3#1)
system was employed##6##3##(1997-4#1)(2008-10#4)(2008-3#1)
system was established##3##3##(1991-12#1)(2008-8#2)
system was evaluated by##3##4##(1993-1#1)(2008-10#2)
system was evaluated for the##2##5##(2008-10#2)
system was evaluated for##3##4##(2008-10#3)
system was evaluated in##2##4##(2008-2#1)(2008-6#1)
system was evaluated##9##3##(1993-1#1)(2008-10#6)(2008-2#1)(2008-6#1)
system was found to be##2##5##(2008-10#1)(2009-5#1)
system was found to##8##4##(1991-9#1)(2007-11#1)(2008-10#4)(2008-5#1)(2009-5#1)
system was found##9##3##(1991-9#1)(2007-11#1)(2008-10#5)(2008-5#1)(2009-5#1)
system was further##2##3##(2008-10#2)
system was higher than##2##4##(2008-11#1)(2008-9#1)
system was implemented to##2##4##(1997-1#1)(2008-10#1)
system was implemented##4##3##(1992-4#1)(1997-1#1)(2008-10#1)(2010-2#1)
system was introduced##2##3##(1995-6#1)(2008-11#1)
system was investigated by##2##4##(2008-10#1)(2008-11#1)
system was investigated in##3##4##(1997-4#1)(2008-10#1)(2011-2#1)
system was investigated##9##3##(1997-4#1)(2008-10#6)(2008-11#1)(2011-2#1)
system was linear##2##3##(2008-10#2)
system was more##2##3##(1993-12#1)(2008-10#1)
system was not##2##3##(1997-8#1)(2008-10#1)
system was obtained##2##3##(2008-10#2)
system was operated##2##3##(2008-10#1)(2008-2#1)
system was optimised##2##3##(2008-10#2)
system was optimized and##3##4##(2008-10#3)
system was optimized##5##3##(2008-10#4)(2008-11#1)
system was proposed##2##3##(2007-12#1)(2008-10#1)
system was reported##2##3##(2008-12#1)(2008-2#1)
system was studied##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2010-5#1)
system was successfully applied to##5##5##(1994-9#1)(2007-12#1)(2008-10#3)
system was successfully applied##6##4##(1994-9#1)(2007-12#1)(2008-10#4)
system was successfully##8##3##(1994-9#1)(2007-12#1)(2007-7#1)(2008-10#5)
system was tested by##2##4##(2008-10#1)(2013-8#1)
system was tested##5##3##(2008-10#3)(2008-3#1)(2013-8#1)
system was the##3##3##(2008-10#2)(2011-1#1)
system was used as a##3##5##(2007-11#1)(2008-10#2)
system was used as##6##4##(2007-11#1)(2008-10#4)(2008-8#1)
system was used for the##4##5##(1991-2#1)(2008-10#3)
system was used for##8##4##(1991-2#1)(2008-10#5)(2008-12#1)(2010-12#1)
system was used to determine the##2##6##(1993-8#1)(2008-10#1)
system was used to determine##3##5##(1990-11#1)(1993-8#1)(2008-10#1)
system was used to evaluate##2##5##(2007-8#1)(2008-10#1)
system was used to##19##4##(1990-11#1)(1993-8#2)(1994-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2013-8#1)
system was used##37##3##(1990-11#1)(1991-2#1)(1993-8#2)(1994-5#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2013-8#1)
system was validated##2##3##(2008-10#2)
system was##309##2##(1990-11#2)(1991-12#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#174)(2008-11#11)(2008-12#4)(2008-2#8)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
system we have##2##3##(2008-11#2)
system we used##3##3##(1990-12#1)(1994-10#1)(1996-2#1)
system we##10##2##(1990-12#1)(1994-10#1)(1994-2#1)(1996-2#1)(1997-8#1)(2008-11#2)(2008-3#2)(2011-1#1)
system were also evaluated##2##4##(2008-10#2)
system were also##4##3##(1991-2#1)(2008-10#3)
system were assessed##2##3##(1992-2#1)(2008-3#1)
system were compared##2##3##(2008-10#2)
system were determined##2##3##(2008-5#1)(2012-1#1)
system were discussed##2##3##(2008-10#1)(2008-6#1)
system were evaluated##4##3##(2008-10#4)
system were examined in##2##4##(1993-12#1)(2008-5#1)
system were examined##4##3##(1992-3#1)(1993-12#1)(1997-3#1)(2008-5#1)
system were found to be##2##5##(2008-10#2)
system were investigated##4##3##(2008-10#3)(2008-3#1)
system were not##2##3##(2008-10#2)
system were optimized and##2##4##(2008-10#2)
system were optimized##6##3##(2008-10#5)(2013-8#1)
system were studied##2##3##(2008-10#2)
system were the##2##3##(2008-10#1)(2008-7#1)
system were##63##2##(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#35)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#2)
system when##5##2##(1996-1#1)(2008-10#1)(2008-3#2)(2008-7#1)
system where the##2##3##(2008-3#1)(2008-8#1)
system where##11##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2013-8#1)
system which can##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
system which is##6##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
system which uses##3##3##(1996-12#1)(2008-10#1)(2010-8#1)
system which##26##2##(1990-12#2)(1991-5#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
system while the##2##3##(2008-10#1)(2008-2#1)
system while##6##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-2#1)
system will allow##2##3##(2012-12#1)(2013-8#1)
system will be discussed##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
system will be##13##3##(1991-6#1)(1992-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)
system will have a##3##4##(1994-12#1)(2008-2#1)(2008-3#1)
system will not be##2##4##(1992-11#1)(1992-3#1)
system will##33##2##(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1994-12#2)(1994-3#2)(1996-3#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2013-7#1)(2013-8#2)
system with a carbon##2##4##(2008-10#2)
system with a set of##2##5##(2007-11#1)(2012-2#1)
system with a##40##3##(1996-5#1)(2007-11#3)(2007-12#3)(2008-10#17)(2008-11#1)(2008-2#4)(2008-3#6)(2009-6#1)(2010-8#1)(2011-1#2)(2012-2#1)
system with an##8##3##(1993-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-3#1)
system with bead injection##3##4##(2008-10#3)
system with extracorporeal ultrafiltration by##2##5##(2007-12#2)
system with fluorimetric detection##2##4##(1990-8#1)(2008-10#1)
system with fluorimetric##3##3##(1990-8#1)(2008-10#2)
system with hydride##2##3##(2008-10#2)
system with microwave irradiation##2##4##(2008-10#2)
system with microwave-assisted sample digestion##3##5##(2008-10#3)
system with on-line##2##3##(2008-10#2)
system with spectrophotometric detection##2##4##(2008-10#2)
system with spectrophotometric##3##3##(2008-10#3)
system with the##18##3##(1992-3#1)(1995-5#1)(1996-12#1)(2008-10#6)(2008-2#2)(2008-4#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
system with three##3##3##(1991-9#1)(2008-3#2)
system with two##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
system with##201##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-11#6)(2007-12#11)(2008-10#86)(2008-11#1)(2008-2#17)(2008-3#30)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#3)(2013-8#3)
system within##3##2##(2008-10#3)
system without##10##2##(1990-8#1)(2008-10#7)(2008-3#1)(2011-2#1)
system works##4##2##(1994-1#1)(2008-3#2)(2010-12#1)
system would be##3##3##(1990-3#1)(2008-10#1)(2010-8#1)
system would##7##2##(1990-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)
system##7733##1##(1990-10#3)(1990-11#25)(1990-12#18)(1990-2#10)(1990-3#5)(1990-5#30)(1990-6#4)(1990-7#11)(1990-8#21)(1990-9#6)(1991-1#15)(1991-10#2)(1991-11#1)(1991-12#32)(1991-2#29)(1991-3#20)(1991-4#1)(1991-5#16)(1991-6#4)(1991-7#4)(1991-8#11)(1991-9#27)(1992-1#23)(1992-10#6)(1992-11#13)(1992-12#68)(1992-2#28)(1992-3#42)(1992-4#8)(1992-5#9)(1992-6#17)(1992-7#1)(1992-8#16)(1992-9#8)(1993-1#10)(1993-11#10)(1993-12#57)(1993-2#15)(1993-3#51)(1993-5#9)(1993-6#15)(1993-8#19)(1993-9#12)(1994-1#27)(1994-10#1)(1994-11#16)(1994-12#51)(1994-2#40)(1994-3#26)(1994-5#18)(1994-6#21)(1994-7#1)(1994-8#23)(1994-9#13)(1995-1#14)(1995-11#25)(1995-12#44)(1995-2#48)(1995-3#43)(1995-4#1)(1995-5#23)(1995-6#14)(1995-8#15)(1995-9#3)(1996-1#32)(1996-11#7)(1996-12#57)(1996-2#57)(1996-3#44)(1996-4#7)(1996-5#22)(1996-6#8)(1996-8#7)(1996-9#3)(1997-1#24)(1997-2#44)(1997-3#42)(1997-4#37)(1997-5#3)(1997-6#15)(1997-7#23)(1997-8#11)(1997-9#1)(2006-10#16)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#19)(2007-11#160)(2007-12#229)(2007-2#9)(2007-4#7)(2007-5#9)(2007-7#7)(2007-8#52)(2007-9#8)(2008-1#57)(2008-10#1884)(2008-11#300)(2008-12#64)(2008-2#403)(2008-3#729)(2008-4#114)(2008-5#133)(2008-6#66)(2008-7#237)(2008-8#133)(2008-9#168)(2009-1#3)(2009-10#29)(2009-11#19)(2009-12#25)(2009-2#16)(2009-3#10)(2009-4#12)(2009-5#21)(2009-6#24)(2009-7#11)(2009-8#43)(2009-9#22)(2010-1#10)(2010-10#12)(2010-11#15)(2010-12#38)(2010-2#18)(2010-3#21)(2010-4#18)(2010-5#23)(2010-6#13)(2010-7#18)(2010-8#92)(2010-9#9)(2011-1#90)(2011-2#166)(2011-3#11)(2011-7#2)(2012-1#25)(2012-12#59)(2012-2#67)(2012-3#69)(2012-4#1)(2012-5#2)(2012-6#3)(2012-7#1)(2012-8#2)(2013-1#127)(2013-2#2)(2013-7#11)(2013-8#123)
system&quot##3##1##(1996-3#1)(2008-10#1)(2008-12#1)
system'##3##1##(2007-8#1)(2008-11#1)(2008-12#1)
system's ability to##4##3##(2008-2#1)(2008-3#1)(2013-7#1)(2013-8#1)
system's performance##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
system's##37##1##(1990-12#1)(1991-1#1)(1991-12#1)(1994-1#2)(1995-1#1)(1995-2#2)(1996-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-9#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
system) and##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
system)##34##1##(1990-12#1)(1991-6#1)(1992-8#5)(1993-2#1)(1993-8#2)(1996-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-6#1)
system-based##5##1##(1996-12#1)(2012-2#1)(2012-3#3)
system-level parameters##2##2##(2008-3#2)
system-level##5##1##(2007-12#1)(2008-3#4)
system-mediated##2##1##(2007-7#1)(2008-10#1)
system-performance##3##1##(2008-2#1)(2008-3#2)
system-wide##2##1##(1994-1#1)(1996-1#1)
system? The##2##2##(1991-2#1)(2008-8#1)
system? This article##2##3##(1993-12#1)(1994-9#1)
system?##10##1##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(2008-8#1)(2012-3#1)
system]##15##1##(1990-3#1)(1992-11#1)(1993-6#1)(1993-9#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#2)
systematic adverse##2##2##(2009-5#1)(2013-1#1)
systematic analysis of the##2##4##(2008-10#1)(2008-4#1)
systematic analysis of##4##3##(1993-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
systematic analysis##6##2##(1993-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
systematic and random errors##2##4##(2008-3#1)(2011-2#1)
systematic and random##3##3##(2008-3#2)(2011-2#1)
systematic and##12##2##(1996-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
systematic approach for##2##3##(2008-10#1)(2008-2#1)
systematic approach to item reduction based on results of##2##9##(2012-2#2)
systematic approach to optimizing##2##4##(2008-1#1)(2012-1#1)
systematic approach to planning##2##4##(1994-2#2)
systematic approach to the##3##4##(2006-5#1)(2008-3#1)(2009-9#1)
systematic approach to##17##3##(1994-2#2)(1995-12#1)(1996-12#2)(2006-5#1)(2008-1#1)(2008-11#1)(2008-3#3)(2009-10#1)(2009-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
systematic approach##24##2##(1991-12#1)(1994-2#2)(1995-12#1)(1996-12#2)(1996-2#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
systematic approaches##2##2##(2008-2#1)(2008-7#1)
systematic bias##3##2##(2008-11#1)(2009-1#1)(2013-1#1)
systematic biases##2##2##(2008-3#1)(2008-7#1)
systematic collection##2##2##(2011-3#1)(2013-1#1)
systematic comparison of##2##3##(2008-10#1)(2008-9#1)
systematic decrease##2##2##(2010-4#1)(2011-2#1)
systematic diagnostic##2##2##(2008-3#2)
systematic difference##3##2##(2008-10#1)(2008-3#2)
systematic differences in##2##3##(1995-3#1)(2010-12#1)
systematic differences##4##2##(1994-2#1)(1995-3#1)(2008-11#1)(2010-12#1)
systematic discussion of##2##3##(2011-2#1)(2013-8#1)
systematic effect on##2##3##(1993-2#1)(2010-8#1)
systematic effect##3##2##(1993-2#1)(2008-10#1)(2010-8#1)
systematic effects##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
systematic effort to##2##3##(1991-1#1)(1995-12#1)
systematic error in##2##3##(1993-2#1)(2008-10#1)
systematic error of##2##3##(2008-2#1)(2008-3#1)
systematic error##11##2##(1993-2#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)
systematic errors and##2##3##(1992-11#1)(2008-2#1)
systematic errors can##2##3##(2008-2#1)(2008-3#1)
systematic errors in##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2008-6#1)
systematic errors is##2##3##(2008-3#2)
systematic errors##26##2##(1990-8#1)(1992-11#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#4)(2008-3#11)(2008-6#1)(2010-2#1)
systematic evaluation of##5##3##(2008-10#1)(2009-2#1)(2011-1#1)(2013-1#2)
systematic evolution of ligands by exponential enrichment (SELEX)##2##8##(2008-4#1)(2008-9#1)
systematic experimental##4##2##(2007-12#1)(2008-2#2)(2010-8#1)
systematic exploration of##2##3##(2011-1#1)(2013-1#1)
systematic functional analysis##2##3##(2008-7#1)(2012-12#1)
systematic investigation of the##5##4##(2010-2#2)(2010-5#1)(2012-2#1)(2013-1#1)
systematic investigation of##8##3##(2008-3#1)(2008-5#2)(2010-2#2)(2010-5#1)(2012-2#1)(2013-1#1)
systematic investigation##10##2##(2008-3#1)(2008-5#2)(2008-8#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
systematic literature review##6##3##(1996-11#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
systematic literature search##3##3##(2011-2#2)(2013-1#1)
systematic literature##10##2##(1996-11#1)(2008-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
systematic method for##3##3##(2008-3#1)(2008-6#1)(2008-7#1)
systematic method##4##2##(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
systematic methods##2##2##(1994-1#1)(2013-8#1)
systematic monitoring and feedback of##2##5##(2012-2#2)
systematic phase errors##2##3##(2008-3#2)
systematic process##2##2##(1992-3#1)(2012-3#1)
systematic review and##9##3##(2008-6#1)(2009-11#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
systematic review is##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
systematic review of published##2##4##(1995-9#1)(2012-3#1)
systematic review of the literature was undertaken##2##7##(2012-12#1)(2012-2#1)
systematic review of the literature##6##5##(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
systematic review of the##13##4##(2007-7#1)(2008-6#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
systematic review of##24##3##(1995-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
systematic review was conducted##3##4##(2007-11#1)(2009-11#1)(2011-2#1)
systematic review was##9##3##(2007-11#1)(2008-10#1)(2009-11#1)(2011-2#1)(2012-12#4)(2012-3#1)
systematic review##86##2##(1992-2#1)(1995-9#1)(2007-10#3)(2007-11#4)(2007-7#2)(2008-10#3)(2008-11#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2010-10#1)(2010-8#1)(2011-2#13)(2011-7#1)(2012-1#4)(2012-12#14)(2012-2#1)(2012-3#6)(2013-1#10)(2013-8#6)
systematic reviews of the##2##4##(1993-12#1)(2012-2#1)
systematic reviews of##6##3##(1993-12#2)(1996-11#1)(2011-2#2)(2012-2#1)
systematic reviews##15##2##(1993-12#2)(1996-11#1)(2007-5#3)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#3)
systematic sample##2##2##(1991-8#1)(2009-10#1)
systematic sampling##3##2##(2011-1#1)(2012-12#1)(2013-8#1)
systematic screening##4##2##(1991-3#1)(2008-4#2)(2013-1#1)
systematic search of##4##3##(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
systematic search##7##2##(1996-12#1)(2008-6#1)(2012-12#2)(2012-2#1)(2013-8#2)
systematic sequencing##2##2##(1996-3#1)(2008-7#1)
systematic studies##3##2##(1996-2#1)(2010-10#1)(2011-2#1)
systematic study of the##5##4##(1994-10#1)(2008-10#3)(2008-2#1)
systematic study of##7##3##(1994-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-6#1)
systematic study##11##2##(1994-10#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-6#1)
systematic use of##4##3##(1990-10#1)(1997-1#1)(2007-8#1)(2010-8#1)
systematic variation##3##2##(1993-1#1)(2008-10#1)(2012-2#1)
systematic way of##2##3##(1994-12#1)(2008-11#1)
systematic way##7##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)
systematic##435##1##(1990-10#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#3)(1993-12#4)(1993-2#3)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-8#1)(1997-9#1)(2006-5#1)(2007-10#4)(2007-11#6)(2007-12#6)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#30)(2008-11#14)(2008-12#4)(2008-2#17)(2008-3#42)(2008-4#6)(2008-5#7)(2008-6#8)(2008-7#13)(2008-8#5)(2008-9#2)(2009-1#3)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#19)(2012-2#16)(2012-3#7)(2013-1#30)(2013-7#1)(2013-8#15)
systematically analyze##3##2##(2008-6#1)(2009-5#1)(2010-10#1)
systematically and##2##2##(2008-11#2)
systematically assessed##2##2##(2013-1#1)(2013-8#1)
systematically collected in##2##3##(2008-10#2)
systematically collected##3##2##(1996-3#1)(2008-10#2)
systematically determined##2##2##(2008-3#1)(2009-5#1)
systematically evaluate the##2##3##(2008-4#1)(2011-2#1)
systematically evaluate##3##2##(2008-4#1)(2009-4#1)(2011-2#1)
systematically evaluated##3##2##(1991-2#1)(2007-8#1)(2008-3#1)
systematically examined##5##2##(1992-3#1)(1992-6#1)(2008-10#2)(2013-8#1)
systematically from##2##2##(2008-10#2)
systematically investigated##9##2##(2008-10#7)(2008-2#1)(2010-11#1)
systematically over##2##2##(1991-4#1)(1991-8#1)
systematically replaced##2##2##(1995-5#1)(1995-6#1)
systematically review the##2##3##(2011-2#1)(2013-1#1)
systematically studied and##2##3##(1991-12#1)(2008-10#1)
systematically studied with##2##3##(2008-10#1)(2012-12#1)
systematically studied##9##2##(1991-12#1)(2008-10#5)(2008-3#1)(2012-12#1)(2013-8#1)
systematically tested##2##2##(2008-5#1)(2010-12#1)
systematically the##3##2##(2008-11#1)(2008-3#1)(2012-1#1)
systematically to##3##2##(1993-12#1)(1994-9#1)(2013-8#1)
systematically varied##3##2##(1997-7#1)(2008-2#1)(2013-8#1)
systematically##136##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#28)(2008-11#6)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#4)(2013-8#7)
systematics and##2##2##(2008-8#1)(2011-2#1)
systematics of##2##2##(2008-8#1)(2010-4#1)
systematics##7##1##(2008-10#1)(2008-8#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#1)
systematization##3##1##(2012-3#2)(2013-1#1)
systemic (0##2##2##(1993-6#2)
systemic acquired resistance (SAR)##6##4##(2008-10#5)(2011-10#1)
systemic acquired resistance in##2##4##(2008-10#2)
systemic acquired resistance##14##3##(2008-10#12)(2011-10#1)(2011-2#1)
systemic acquired resistance-inducing##2##3##(2008-10#2)
systemic acquired##16##2##(2008-10#14)(2011-10#1)(2011-2#1)
systemic administration of##7##3##(1992-3#1)(1994-3#1)(1995-12#1)(2007-10#1)(2008-2#1)(2009-9#1)(2011-2#1)
systemic administration##9##2##(1992-3#1)(1994-3#1)(1995-12#2)(2007-10#1)(2008-2#1)(2008-4#1)(2009-9#1)(2011-2#1)
systemic adverse effects##3##3##(2007-11#1)(2009-11#1)(2013-1#1)
systemic adverse##5##2##(2007-11#2)(2008-1#1)(2009-11#1)(2013-1#1)
systemic agents##2##2##(2011-2#1)(2012-1#1)
systemic allergic reactions##2##3##(1990-8#2)
systemic amyloidosis associated with##2##4##(2008-7#1)(2011-2#1)
systemic amyloidosis##5##2##(2008-7#1)(2011-2#4)
systemic analysis of the##2##4##(2009-10#2)
systemic analysis##3##2##(2009-10#3)
systemic anaphylactic##2##2##(2008-10#1)(2009-6#1)
systemic and local##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
systemic and oropharyngeal##2##3##(2008-8#2)
systemic and##14##2##(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
systemic approaches to##2##3##(2010-12#2)
systemic arterial pressure##2##3##(1991-5#1)(1996-3#1)
systemic arterial##4##2##(1991-5#1)(1996-3#1)(2008-11#1)(2012-3#1)
systemic autoimmune disease##4##3##(2007-7#1)(2008-10#2)(2008-5#1)
systemic autoimmune diseases##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
systemic autoimmune##8##2##(2007-7#1)(2008-10#3)(2008-5#1)(2012-3#1)(2013-1#2)
systemic bacterial##2##2##(1991-8#1)(2008-5#1)
systemic blood##2##2##(1992-8#1)(1993-12#1)
systemic candidiasis##5##2##(1997-1#1)(2008-5#4)
systemic causes##2##2##(2010-2#1)(2010-8#1)
systemic chemotherapy##10##2##(1992-12#1)(1992-2#1)(1994-12#2)(1997-3#1)(2007-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-3#1)
systemic circulation and##2##3##(1994-8#1)(2010-6#1)
systemic circulation##5##2##(1994-8#1)(2008-10#1)(2008-3#1)(2010-6#2)
systemic complications##3##2##(2010-3#1)(2011-2#1)(2013-1#1)
systemic corticosteroids##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
systemic disease control##2##3##(2008-10#2)
systemic disease that##2##3##(1992-9#1)(2011-2#1)
systemic disease##26##2##(1990-8#1)(1991-12#1)(1992-9#1)(1995-1#1)(1995-10#1)(1997-6#1)(1997-8#2)(2006-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#3)
systemic diseases##10##2##(1993-2#2)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2013-1#1)
systemic disorder of the##2##4##(2011-2#1)(2013-1#1)
systemic disorder##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
systemic disorders##4##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)
systemic dissemination following##2##3##(2008-9#2)
systemic dissemination##4##2##(2008-5#1)(2008-9#2)(2009-4#1)
systemic drugs##2##2##(1997-1#1)(2011-2#1)
systemic effect##2##2##(1994-9#1)(2008-10#1)
systemic effects##8##2##(1997-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#3)(2013-1#1)
systemic embolization##4##2##(2009-10#1)(2012-3#3)
systemic exposure##3##2##(1992-3#1)(2010-11#2)
systemic florigen signalling##2##3##(2012-2#2)
systemic flow by prostaglandin E1 infusion or a main pulmonary artery to the descending aorta shunt##2##16##(2007-8#2)
systemic flow##3##2##(2007-8#2)(2010-6#1)
systemic fungal##2##2##(1997-1#1)(1997-2#1)
systemic glucose concentration##3##3##(1994-2#3)
systemic health##3##2##(2010-3#1)(2012-3#1)(2013-8#1)
systemic hosts##3##2##(2008-10#3)
systemic hypertension##4##2##(1997-3#1)(2008-2#1)(2011-2#2)
systemic hypotension##2##2##(2008-12#1)(2009-5#1)
systemic immune##2##2##(2008-10#2)
systemic immunosuppressive response##2##3##(2011-2#2)
systemic immunosuppressive##3##2##(2011-2#2)(2012-1#1)
systemic infection by the virus##2##5##(2008-10#1)(2011-1#1)
systemic infection of##4##3##(2008-10#4)
systemic infection##21##2##(1995-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
systemic infections in##3##3##(2008-10#3)
systemic infections##11##2##(1995-5#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-7#1)
systemic inflammation##5##2##(2008-1#1)(2011-2#2)(2013-1#2)
systemic inflammatory response syndrome##5##4##(2008-5#1)(2008-7#2)(2010-5#2)
systemic inflammatory response##10##3##(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-5#2)(2012-3#2)
systemic inflammatory##19##2##(1997-7#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#4)
systemic involvement##2##2##(2013-1#2)
systemic level work was##2##4##(2008-12#2)
systemic level work##7##3##(2008-12#7)
systemic level##8##2##(1996-12#1)(2008-12#7)
systemic lupus erythematosus (SLE) and##3##5##(1994-6#1)(2006-10#1)(2008-1#1)
systemic lupus erythematosus (SLE) patients##3##5##(2006-10#1)(2008-10#1)(2013-1#1)
systemic lupus erythematosus (SLE)##17##4##(1990-12#1)(1994-6#1)(2006-10#4)(2008-1#4)(2008-10#2)(2011-2#3)(2012-12#1)(2013-1#1)
systemic lupus erythematosus and##3##4##(2008-8#1)(2009-3#1)(2012-12#1)
systemic lupus erythematosus in remission##2##5##(1992-5#2)
systemic lupus erythematosus in##4##4##(1990-9#1)(1992-5#2)(2006-10#1)
systemic lupus erythematosus patients##2##4##(1991-5#1)(2006-10#1)
systemic lupus erythematosus with##2##4##(1997-8#1)(2012-2#1)
systemic lupus erythematosus##63##3##(1990-12#1)(1990-9#2)(1991-5#2)(1992-2#1)(1992-5#2)(1993-2#1)(1994-6#1)(1994-9#2)(1995-5#1)(1997-8#1)(2006-10#12)(2007-12#2)(2007-7#1)(2008-1#5)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)
systemic lupus##66##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-5#2)(1992-2#1)(1992-5#2)(1993-2#1)(1994-6#1)(1994-9#2)(1995-5#1)(1997-8#1)(2006-10#12)(2007-12#2)(2007-7#1)(2008-1#5)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#5)
systemic management##3##2##(1990-11#1)(2007-10#1)(2007-11#1)
systemic manifestations##2##2##(2011-2#1)(2012-3#1)
systemic mastocytosis and##2##3##(1991-11#1)(2010-1#1)
systemic mastocytosis##4##2##(1991-11#2)(2010-1#1)(2011-2#1)
systemic metastases##2##2##(2007-6#1)(2010-3#1)
systemic movement of##2##3##(2008-10#2)
systemic movement##4##2##(2008-10#4)
systemic or##5##2##(1990-9#1)(1994-2#1)(2008-10#1)(2008-7#2)
systemic oxygen saturation##2##3##(2010-10#1)(2010-5#1)
systemic perfusion##2##2##(2008-10#1)(2011-2#1)
systemic peripheral gangrene##2##3##(2013-1#2)
systemic peripheral##3##2##(2007-10#1)(2013-1#2)
systemic pneumococcal disease##3##3##(1994-9#3)
systemic protection against##2##3##(2008-10#2)
systemic protection##7##2##(2008-10#7)
systemic resistance against##3##3##(2008-10#3)
systemic resistance and##3##3##(2008-10#2)(2013-8#1)
systemic resistance in apple fruit##2##5##(2008-10#2)
systemic resistance in plants##4##4##(2008-10#4)
systemic resistance in##14##3##(2008-10#14)
systemic resistance to##5##3##(2008-10#4)(2013-8#1)
systemic resistance##46##2##(2008-10#43)(2009-8#1)(2013-8#2)
systemic response##2##2##(2007-11#1)(2008-9#1)
systemic responses to##2##3##(1994-2#1)(2008-10#1)
systemic responses##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
systemic sclerosis (SSc)##3##3##(2008-8#1)(2010-10#1)(2011-2#1)
systemic sclerosis and##3##3##(2009-8#3)
systemic sclerosis bind##2##3##(2009-8#2)
systemic sclerosis in a##2##4##(1995-11#1)(2008-8#1)
systemic sclerosis in##3##3##(1995-11#1)(2008-8#1)(2012-2#1)
systemic sclerosis##24##2##(1991-3#1)(1992-8#1)(1995-11#1)(2006-10#4)(2007-7#1)(2008-12#1)(2008-8#2)(2009-8#7)(2009-9#1)(2010-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
systemic side effects##3##3##(1992-3#1)(1995-5#1)(1997-1#1)
systemic spread of##2##3##(2008-10#2)
systemic spread##4##2##(2008-10#4)
systemic steroid therapy##2##3##(2011-2#2)
systemic symptoms##5##2##(1991-4#1)(2007-12#1)(2008-10#3)
systemic therapies##2##2##(1995-10#1)(2013-1#1)
systemic therapy and##2##3##(1995-4#1)(2012-1#1)
systemic therapy##19##2##(1990-6#1)(1991-8#2)(1994-8#1)(1995-4#2)(1996-11#1)(1997-8#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
systemic toxicity##4##2##(1992-2#1)(1997-1#1)(2008-10#1)(2013-1#1)
systemic treatment of##2##3##(2007-11#1)(2013-1#1)
systemic treatment##9##2##(1993-1#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-5#1)(2008-5#1)(2011-2#1)(2013-1#1)
systemic treatments##4##2##(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
systemic vascular resistance of##2##4##(2007-9#1)(2009-5#1)
systemic vascular resistance##6##3##(1991-3#1)(2007-9#2)(2008-7#1)(2009-5#1)(2010-8#1)
systemic vascular##8##2##(1991-3#1)(1995-12#1)(2007-9#2)(2008-7#1)(2009-5#2)(2010-8#1)
systemic vasculitis##8##2##(1995-5#1)(1996-8#1)(2006-10#1)(2008-1#2)(2008-3#1)(2012-3#2)
systemic veins##2##2##(1997-1#1)(2007-8#1)
systemic virus##2##2##(2008-10#2)
systemic##681##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-8#4)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#3)(1994-12#6)(1994-2#6)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#5)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#8)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#6)(2006-10#18)(2006-12#1)(2007-10#5)(2007-11#8)(2007-12#8)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#3)(2008-1#13)(2008-10#144)(2008-11#12)(2008-12#13)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#16)(2008-6#5)(2008-7#24)(2008-8#10)(2008-9#11)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#7)(2010-5#4)(2010-6#5)(2010-8#2)(2011-1#6)(2011-10#1)(2011-2#45)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#14)(2012-3#26)(2013-1#37)(2013-7#1)(2013-8#11)
systemically administered CDP##2##3##(1993-12#2)
systemically administered##6##2##(1993-11#1)(1993-12#5)
systemically infect##2##2##(2008-10#2)
systemically infected leaves##2##3##(2008-10#2)
systemically infected wheat##2##3##(2008-10#2)
systemically infected##11##2##(1995-2#1)(2008-10#10)
systemically##44##1##(1992-9#1)(1993-11#1)(1993-12#5)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#25)(2008-5#1)(2008-8#1)(2010-12#2)(2011-1#2)(2012-2#2)(2013-8#1)
systems (PACS)##3##2##(1996-2#2)(1997-8#1)
systems (eg##2##2##(2007-10#2)
systems (i##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
systems a##2##2##(2008-2#1)(2008-3#1)
systems affected by##2##3##(2009-10#1)(2011-2#1)
systems affected##3##2##(2009-10#1)(2011-2#1)(2013-1#1)
systems against##2##2##(2008-10#1)(2008-5#1)
systems allow for##2##3##(1994-3#1)(2008-7#1)
systems allow us to##2##4##(2008-2#1)(2008-3#1)
systems allow##11##2##(1992-8#1)(1994-2#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#2)
systems allows##2##2##(2007-12#1)(2009-12#1)
systems analysis of##2##3##(2012-2#2)
systems analysis##3##2##(2012-2#3)
systems and a##2##3##(2008-10#1)(2008-7#1)
systems and for##2##3##(1994-2#1)(2008-2#1)
systems and health##2##3##(1997-2#1)(2012-12#1)
systems and improving##2##3##(2009-7#1)(2010-8#1)
systems and in##4##3##(1991-9#1)(1994-5#1)(2008-2#1)(2008-7#1)
systems and is##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
systems and measurement##2##3##(1992-3#1)(2008-10#1)
systems and suggest##2##3##(1990-2#1)(2008-8#1)
systems and the##12##3##(1991-3#1)(1994-12#1)(1996-3#1)(1997-3#2)(2008-10#2)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)
systems and their applications##2##4##(2008-3#1)(2008-9#1)
systems and their##5##3##(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
systems and to##2##3##(2007-12#1)(2011-2#1)
systems and will##2##3##(2008-10#2)
systems and##135##2##(1990-2#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#3)(1997-3#3)(2007-11#1)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#18)(2008-11#6)(2008-2#5)(2008-3#10)(2008-4#3)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#5)(2011-7#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
systems applied to##2##3##(2008-12#1)(2008-2#1)
systems approach to asthma care##2##5##(1997-2#2)
systems approach to##8##3##(1992-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#2)(2008-2#1)(2008-3#1)
systems approach##12##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
systems are a##2##3##(1994-2#1)(2010-4#1)
systems are also##4##3##(2008-5#1)(2010-5#1)(2010-8#1)(2012-3#1)
systems are an##2##3##(2008-10#1)(2008-3#1)
systems are analyzed by use of##2##6##(2008-3#2)
systems are being##4##3##(1994-5#1)(1996-12#1)(1997-3#1)(2008-3#1)
systems are capable of##2##4##(2008-3#1)(2010-8#1)
systems are characterized by##2##4##(1997-1#1)(2008-10#1)
systems are compared##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
systems are described##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)
systems are discussed##6##3##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)
systems are examined##3##3##(1992-12#1)(1994-2#1)(2008-2#1)
systems are highly##2##3##(1994-12#1)(2008-4#1)
systems are not##2##3##(2008-3#1)(2008-7#1)
systems are presented##3##3##(2008-10#2)(2009-9#1)
systems are required##2##3##(1993-8#1)(1994-5#1)
systems are the##2##3##(2008-10#1)(2008-7#1)
systems are used in##2##4##(2008-9#1)(2010-8#1)
systems are used##3##3##(1995-2#1)(2008-9#1)(2010-8#1)
systems are usually##2##3##(2008-10#1)(2010-7#1)
systems are##110##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#3)(1994-5#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1997-1#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#4)(2008-3#16)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
systems as a##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
systems as well as##4##4##(2008-10#1)(2008-12#1)(2008-9#1)(2010-4#1)
systems as well##5##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-4#1)
systems as##15##2##(1993-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
systems at the##2##3##(2008-3#1)(2008-5#1)
systems at##10##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-4#1)
systems available##3##2##(1993-3#1)(2007-8#1)(2008-9#1)
systems based on the##6##4##(1991-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
systems based on these##2##4##(1994-12#1)(2008-1#1)
systems based on##24##3##(1991-9#1)(1994-12#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#4)(2008-7#1)(2012-2#1)
systems based##25##2##(1991-9#1)(1994-12#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#4)(2008-7#1)(2012-2#1)
systems because of##3##3##(2007-11#1)(2007-12#1)(2010-4#1)
systems between##2##2##(1992-8#1)(1997-2#1)
systems biology##29##2##(2008-11#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-5#2)(2010-9#5)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
systems but##3##2##(1997-1#2)(2008-11#1)
systems by use of##3##4##(2007-11#3)
systems by using##2##3##(2007-12#1)(2010-8#1)
systems by##15##2##(1991-2#1)(1992-3#1)(2007-11#4)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#1)(2013-8#1)
systems can be obtained##2##4##(2008-10#1)(2008-2#1)
systems can be readily##2##4##(1994-3#1)(2007-12#1)
systems can be##9##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-12#1)(2011-1#1)
systems can have##2##3##(1995-5#1)(2008-3#1)
systems can occur##2##3##(1995-2#1)(2012-12#1)
systems can##17##2##(1991-5#1)(1994-3#2)(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)
systems cannot be##3##3##(1995-5#1)(2008-10#1)(2012-2#1)
systems cannot##4##2##(1995-5#1)(2008-1#1)(2008-10#1)(2012-2#1)
systems capable of##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
systems change##2##2##(1996-3#1)(2012-2#1)
systems consisting of##2##3##(2008-2#1)(2008-3#1)
systems containing##8##2##(1990-7#3)(2007-12#2)(2008-3#1)(2008-5#1)(2009-3#1)
systems could be##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
systems could##9##2##(1991-5#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
systems derived from##2##3##(2008-1#1)(2008-11#1)
systems described##2##2##(2007-12#1)(2008-5#1)
systems designed##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
systems developed to date have##2##5##(1995-2#1)(2008-12#1)
systems developed##4##2##(1992-3#1)(1995-2#1)(2008-12#1)(2011-2#1)
systems development##3##2##(1993-2#2)(1995-12#1)
systems did##2##2##(2008-11#1)(2008-8#1)
systems differ##2##2##(2008-7#1)(2013-1#1)
systems do##2##2##(1993-11#1)(1995-2#1)
systems during the##2##3##(1996-12#1)(2008-7#1)
systems during##3##2##(1992-3#1)(1996-12#1)(2008-7#1)
systems employed##2##2##(1991-3#1)(2008-6#1)
systems employing##3##2##(1995-3#1)(2007-12#1)(2008-10#1)
systems engineering##2##2##(2007-12#2)
systems environment##2##2##(1993-2#1)(1996-3#1)
systems established##2##2##(2008-10#1)(2008-11#1)
systems exhibit##2##2##(2008-10#1)(2008-9#1)
systems experience##2##2##(2008-11#1)(2008-3#1)
systems exploiting##2##2##(2008-10#2)
systems for cancer##2##3##(2008-11#1)(2012-2#1)
systems for clinical##2##3##(1992-3#1)(2008-5#1)
systems for evaluating##2##3##(2008-10#1)(2008-4#1)
systems for gene##2##3##(2008-11#1)(2008-2#1)
systems for long-term##2##3##(1997-1#1)(2012-2#1)
systems for managed care##2##4##(1994-2#1)(1996-12#1)
systems for medical##2##3##(1992-5#1)(2010-6#1)
systems for new##2##3##(1994-3#1)(2008-9#1)
systems for nursing##2##3##(1991-2#2)
systems for public health##2##4##(1997-3#1)(2010-8#1)
systems for the analysis of##2##5##(2008-10#1)(2008-4#1)
systems for the detection##2##4##(2008-10#1)(2008-2#1)
systems for the determination of##2##5##(2008-10#2)
systems for the##24##3##(1990-5#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-5#1)(1995-6#1)(1997-1#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
systems for their##2##3##(1990-4#1)(2008-11#1)
systems for##133##2##(1990-4#1)(1990-5#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-1#4)(1997-3#3)(1997-4#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#4)(2008-10#21)(2008-11#9)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#5)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
systems from##12##2##(1994-8#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)
systems generally##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
systems give##2##2##(1994-5#1)(2008-11#1)
systems has been##8##3##(1991-1#1)(1992-8#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
systems has##15##2##(1991-1#1)(1991-3#1)(1992-8#1)(1993-6#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#1)
systems have become##2##3##(1992-12#1)(1996-3#1)
systems have been developed for##2##5##(2008-10#2)
systems have been developed to##2##5##(1994-6#1)(2010-7#1)
systems have been developed##7##4##(1992-3#1)(1994-6#1)(2008-10#2)(2009-11#1)(2010-7#1)(2013-8#1)
systems have been implicated in the##2##6##(1993-3#1)(1996-7#1)
systems have been implicated in##3##5##(1993-3#1)(1994-12#1)(1996-7#1)
systems have been implicated##4##4##(1993-3#1)(1994-12#1)(1996-7#1)(2009-7#1)
systems have been used to##2##5##(2008-5#1)(2008-7#1)
systems have been used##4##4##(1992-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
systems have been##29##3##(1990-3#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-7#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-7#1)(2013-8#1)
systems have begun to##2##4##(1996-1#1)(2010-10#1)
systems have evolved##2##3##(2008-8#1)(2010-9#1)
systems have the##3##3##(2008-4#1)(2009-11#1)(2012-2#1)
systems have##58##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-7#2)(2010-8#2)(2010-9#1)(2012-2#3)(2013-8#1)
systems improve##2##2##(1996-2#1)(2008-9#1)
systems in a##6##3##(2008-2#3)(2008-3#2)(2013-8#1)
systems in an##2##3##(1996-3#1)(2010-8#1)
systems in general##2##3##(2008-5#1)(2008-8#1)
systems in health care##2##4##(1992-1#2)
systems in health##5##3##(1992-1#2)(1997-3#1)(2008-7#1)(2008-8#1)
systems in many##2##3##(2008-9#1)(2012-12#1)
systems in order to##5##4##(2008-1#1)(2008-8#2)(2010-3#2)
systems in other##2##3##(1995-1#1)(2008-9#1)
systems in patients##2##3##(2007-12#1)(2012-3#1)
systems in place##2##3##(1995-12#1)(2008-5#1)
systems in the Pacific##3##4##(2012-12#3)
systems in the brain##3##4##(1991-5#1)(1993-5#1)(1994-8#1)
systems in the past##2##4##(1994-1#1)(1994-12#1)
systems in the presence of##3##5##(1997-2#1)(2008-1#1)(2009-8#1)
systems in the##31##3##(1991-5#1)(1991-8#1)(1993-2#2)(1993-5#2)(1994-1#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-12#3)(2012-2#1)
systems in which the##2##4##(2008-10#1)(2008-3#1)
systems in which##7##3##(1990-2#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
systems in##130##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-2#3)(1993-5#2)(1993-6#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#4)(2009-3#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-7#1)(2013-8#4)
systems include##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-11#1)
systems including the##3##3##(2008-10#1)(2010-4#1)(2011-1#1)
systems including their##2##3##(2008-10#1)(2013-8#1)
systems including##7##2##(2008-10#2)(2008-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
systems indicated that##2##3##(1992-6#1)(2008-5#1)
systems into##6##2##(1991-5#1)(1992-12#1)(1996-3#1)(1997-3#3)
systems involved##3##2##(1993-12#1)(1996-6#1)(2007-4#1)
systems involving##4##2##(1991-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
systems is a##2##3##(1994-11#1)(2008-7#1)
systems is also##4##3##(2007-11#1)(2008-10#1)(2008-12#1)(2010-8#1)
systems is described##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
systems is discussed##6##3##(1995-12#1)(1997-4#1)(2007-12#2)(2008-3#1)(2008-4#1)
systems is limited##2##3##(2007-12#1)(2008-3#1)
systems is not##4##3##(1994-1#1)(2008-10#1)(2010-2#2)
systems is of##2##3##(2008-10#1)(2008-11#1)
systems is presented in##2##4##(2008-10#1)(2008-4#1)
systems is presented##10##3##(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-11#1)
systems is shown##2##3##(2008-3#1)(2012-1#1)
systems is the##2##3##(2008-11#1)(2008-9#1)
systems is to ensure that##2##5##(2008-7#1)(2012-12#1)
systems is to##3##3##(2008-7#1)(2008-8#1)(2012-12#1)
systems is##66##2##(1990-8#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-12#1)(1997-4#1)(2007-11#2)(2007-12#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2010-2#2)(2010-8#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#3)
systems it is##2##3##(1997-1#1)(2008-2#1)
systems like##6##2##(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)
systems management under pressure##2##4##(1992-12#2)
systems management##6##2##(1992-12#4)(1993-1#2)
systems managers##2##2##(1993-2#1)(1994-3#1)
systems may be##7##3##(1993-1#1)(1995-11#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-11#1)(2008-6#1)
systems may have##3##3##(1994-6#1)(2008-11#1)(2008-3#1)
systems may##16##2##(1991-5#1)(1993-1#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-3#1)
systems mediate##2##2##(1990-8#1)(2009-7#1)
systems medicine##3##2##(2013-8#3)
systems might##2##2##(1990-3#1)(2007-12#1)
systems more##4##2##(1991-1#1)(1993-2#1)(2008-11#1)(2008-3#1)
systems must be##3##3##(1994-3#1)(1997-3#1)(2007-11#1)
systems must##4##2##(1994-3#1)(1996-3#1)(1997-3#1)(2007-11#1)
systems need to##2##3##(1997-1#1)(1997-3#1)
systems neuroscience##2##2##(2008-6#1)(2012-2#1)
systems not##2##2##(2008-3#1)(2008-5#1)
systems of a##3##3##(1990-11#1)(2008-10#1)(2008-9#1)
systems of care##9##3##(1992-4#2)(1994-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2010-12#3)
systems of four##2##3##(2007-12#1)(2008-3#1)
systems of interest##3##3##(2008-10#1)(2009-12#1)(2011-1#1)
systems of many##2##3##(2007-12#1)(2011-2#1)
systems of public health##2##4##(1996-1#1)(1997-3#1)
systems of social##2##3##(1996-1#1)(2008-11#1)
systems of the 1980s##2##4##(1993-3#1)(1997-3#1)
systems of the##12##3##(1993-2#1)(1993-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
systems of three##2##3##(2008-10#1)(2008-3#1)
systems of tumor-immune##2##3##(2013-8#2)
systems of##83##2##(1990-11#1)(1991-9#1)(1992-4#2)(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1996-1#4)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-6#2)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
systems offer##3##2##(1996-3#1)(2008-1#1)(2008-11#1)
systems often##4##2##(2007-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
systems on the##3##3##(2008-10#2)(2012-3#1)
systems on##11##2##(1993-12#1)(1993-2#1)(1994-2#1)(2008-10#3)(2008-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
systems or##5##2##(1991-12#1)(1992-3#1)(2008-2#1)(2008-5#1)(2009-8#1)
systems over a wide##2##4##(2007-12#1)(2008-10#1)
systems over##6##2##(2007-12#2)(2008-10#2)(2008-3#1)(2011-2#1)
systems perform##2##2##(2008-3#1)(2008-7#1)
systems permit##2##2##(2008-3#1)(2008-7#1)
systems permitting##2##2##(2008-10#1)(2008-2#1)
systems perspective##14##2##(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#10)
systems physiology##2##2##(2010-9#2)
systems profilometry##2##2##(2008-3#2)
systems provide##4##2##(1993-12#1)(1997-1#1)(2008-10#1)(2008-5#1)
systems providing##2##2##(1995-1#1)(2008-8#1)
systems pumped by##2##3##(2007-12#1)(2008-2#1)
systems pumped##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
systems rather than##2##3##(2008-10#1)(2009-12#1)
systems reform##2##2##(2012-12#2)
systems rely on the##2##4##(2008-10#1)(2013-8#1)
systems rely on##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
systems rely##4##2##(1997-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
systems reported##2##2##(2008-10#1)(2010-8#1)
systems represent##2##2##(1994-12#1)(1997-3#1)
systems require##4##2##(2008-3#1)(2008-9#1)(2009-11#1)(2012-12#1)
systems requires##2##2##(2008-7#1)(2009-8#1)
systems resulted in a##2##4##(2008-10#1)(2008-12#1)
systems resulted in##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
systems separately##2##2##(2008-10#2)
systems should be##5##3##(1991-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)
systems should##11##2##(1991-9#1)(1993-3#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-6#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
systems shows that##2##3##(1997-8#1)(2008-7#1)
systems since##2##2##(2008-1#1)(2008-10#1)
systems such as the##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-8#1)
systems such as##13##3##(1992-9#1)(1994-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-11#1)(2010-8#1)
systems such##15##2##(1992-9#1)(1994-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-11#1)(2010-8#1)
systems supporting##2##2##(1995-1#1)(2008-11#1)
systems than in the##2##4##(2008-10#1)(2008-6#1)
systems than in##3##3##(2008-10#2)(2008-6#1)
systems that are##14##3##(1992-3#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-3#3)(2008-7#2)(2009-5#1)(2009-9#1)(2010-5#1)(2013-8#2)
systems that can##2##3##(2008-11#1)(2008-9#1)
systems that employ##2##3##(2008-11#1)(2008-2#1)
systems that have been implemented##2##5##(1997-1#1)(2007-12#1)
systems that have been##4##4##(1992-12#1)(1997-1#1)(2007-12#1)(2008-11#1)
systems that have##5##3##(1992-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#1)
systems that incorporate##2##3##(2008-2#1)(2010-7#1)
systems that meet##2##3##(1993-12#1)(1996-3#1)
systems that rely on##2##4##(1995-12#1)(2008-10#1)
systems that use##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
systems that will##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
systems that##71##2##(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-5#1)(1996-12#2)(1996-3#3)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
systems the##8##2##(2007-11#1)(2008-10#1)(2008-3#4)(2009-9#1)(2010-10#1)
systems theory##6##2##(1993-12#2)(1996-2#1)(2009-8#1)(2012-12#2)
systems they##2##2##(1994-1#1)(2008-8#1)
systems thinking##2##2##(1994-2#1)(1997-3#1)
systems this##2##2##(1990-12#1)(2008-3#1)
systems through##5##2##(1995-12#1)(1996-1#1)(2008-10#2)(2009-5#1)
systems to address##2##3##(2008-8#1)(2013-8#1)
systems to assess##3##3##(2008-9#1)(2009-11#1)(2011-1#1)
systems to be##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
systems to detect##2##3##(2008-10#1)(2008-3#1)
systems to enhance##2##3##(1994-3#1)(1997-3#1)
systems to monitor##3##3##(1997-2#1)(2008-2#1)(2008-9#1)
systems to provide a##2##4##(1993-12#1)(2008-10#1)
systems to provide##4##3##(1992-12#1)(1993-12#1)(2008-10#2)
systems to reduce##2##3##(1990-4#1)(2008-11#1)
systems to study##2##3##(2008-10#2)
systems to support a##3##4##(1994-1#2)(2010-8#1)
systems to support##6##3##(1993-3#1)(1994-1#2)(1994-12#1)(1996-12#1)(2010-8#1)
systems to the##2##3##(1992-3#1)(1996-2#1)
systems to##66##2##(1990-4#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(2007-12#3)(2007-2#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
systems under##9##2##(1991-1#1)(1992-12#1)(1992-3#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)
systems upside down##2##3##(1994-12#2)
systems used in the##2##4##(2007-8#1)(2008-10#1)
systems used##4##2##(1996-2#1)(2007-8#2)(2008-10#1)
systems using a##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
systems using the##2##3##(1996-2#1)(2008-10#1)
systems using##16##2##(1993-9#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)
systems was investigated##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
systems was##15##2##(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2012-1#1)(2013-1#1)
systems were assessed##2##3##(2008-5#1)(2008-8#1)
systems were created##2##3##(1997-3#1)(2008-11#1)
systems were designed##2##3##(2008-10#2)
systems were developed##2##3##(1996-3#1)(2008-5#1)
systems were established##2##3##(1994-9#1)(2008-8#1)
systems were identified##3##3##(2013-8#3)
systems were investigated##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
systems were not##4##3##(1996-1#1)(2008-10#1)(2011-2#2)
systems were studied##3##3##(2008-10#3)
systems were tested##3##3##(2008-10#2)(2008-9#1)
systems were useful##2##3##(2011-2#2)
systems were##55##2##(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#21)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#1)(2013-8#3)
systems where high##2##3##(2007-5#1)(2013-1#1)
systems where##6##2##(1990-11#1)(2007-5#1)(2008-3#1)(2008-9#2)(2013-1#1)
systems which##4##2##(1990-11#1)(1995-6#1)(1997-2#1)(2008-3#1)
systems while##3##2##(1994-8#1)(1996-2#1)(2013-1#1)
systems will be##4##3##(1993-12#1)(1994-2#1)(1995-12#1)(2011-2#1)
systems will##16##2##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#4)(2008-10#1)(2008-11#1)(2010-10#1)(2010-3#1)(2011-2#1)
systems with a mean##2##4##(2008-10#1)(2008-8#1)
systems with a##8##3##(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#1)(2010-4#1)
systems with an##2##3##(1995-5#1)(2008-3#1)
systems with different##2##3##(2008-10#1)(2008-9#1)
systems with either##2##3##(2007-11#1)(2008-3#1)
systems with higher##2##3##(2008-10#1)(2008-2#1)
systems with optical amplifiers##2##4##(2008-2#1)(2008-3#1)
systems with the##3##3##(2008-3#2)(2008-6#1)
systems with##67##2##(1992-3#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-6#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#13)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-2#1)
systems within##3##2##(1990-8#1)(1994-2#1)(2011-2#1)
systems without##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
systems would##2##2##(2008-10#1)(2008-11#1)
systems##2939##1##(1990-11#12)(1990-12#5)(1990-2#6)(1990-3#3)(1990-4#2)(1990-5#11)(1990-6#1)(1990-7#4)(1990-8#7)(1991-1#8)(1991-12#5)(1991-2#8)(1991-3#7)(1991-5#9)(1991-6#1)(1991-8#1)(1991-9#10)(1992-1#8)(1992-10#1)(1992-11#3)(1992-12#26)(1992-2#2)(1992-3#29)(1992-4#2)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#1)(1993-1#7)(1993-11#1)(1993-12#29)(1993-2#22)(1993-3#17)(1993-5#2)(1993-6#5)(1993-8#6)(1993-9#1)(1994-1#11)(1994-10#1)(1994-11#2)(1994-12#22)(1994-2#24)(1994-3#27)(1994-5#8)(1994-6#3)(1994-8#8)(1994-9#3)(1995-1#16)(1995-11#5)(1995-12#27)(1995-2#15)(1995-3#7)(1995-5#9)(1995-6#3)(1995-8#2)(1996-1#27)(1996-12#34)(1996-2#26)(1996-3#26)(1996-4#2)(1996-5#9)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#35)(1997-2#25)(1997-3#53)(1997-4#5)(1997-6#14)(1997-7#5)(1997-8#3)(2006-10#6)(2006-12#1)(2006-5#1)(2007-10#7)(2007-11#62)(2007-12#84)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#2)(2007-8#26)(2007-9#1)(2008-1#42)(2008-10#445)(2008-11#121)(2008-12#28)(2008-2#131)(2008-3#235)(2008-4#44)(2008-5#61)(2008-6#21)(2008-7#107)(2008-8#70)(2008-9#69)(2009-10#16)(2009-11#16)(2009-12#16)(2009-2#2)(2009-3#10)(2009-4#2)(2009-5#14)(2009-6#4)(2009-7#7)(2009-8#19)(2009-9#10)(2010-1#1)(2010-10#16)(2010-11#14)(2010-12#14)(2010-2#6)(2010-3#9)(2010-4#29)(2010-5#14)(2010-6#3)(2010-7#10)(2010-8#34)(2010-9#13)(2011-1#27)(2011-2#54)(2011-3#1)(2011-7#3)(2011-9#2)(2012-1#6)(2012-12#51)(2012-2#79)(2012-3#21)(2012-5#1)(2013-1#53)(2013-7#2)(2013-8#53)
systems&quot##2##1##(1994-1#1)(2013-8#1)
systems'##4##1##(1997-1#2)(2008-11#2)
systems) and##2##2##(1996-5#1)(2008-10#1)
systems)##14##1##(1992-12#1)(1992-2#1)(1994-12#1)(1996-12#1)(1996-5#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#2)
systems?##4##1##(1992-12#1)(1996-1#2)(2012-1#1)
systemwide##5##1##(1993-3#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-3#1)
systole##2##1##(1992-9#2)
systolic BP##4##2##(1991-3#1)(1992-6#1)(2008-10#1)(2008-5#1)
systolic and diastolic BP##3##4##(1991-3#1)(2010-7#2)
systolic and diastolic blood pressure and##2##6##(1997-8#1)(2013-1#1)
systolic and diastolic blood pressure in##2##6##(1992-8#2)
systolic and diastolic blood pressure were##2##6##(1992-8#1)(2013-1#1)
systolic and diastolic blood pressure##15##5##(1992-8#4)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-7#1)(2012-3#1)(2013-1#2)
systolic and diastolic blood pressures were##2##6##(2008-10#1)(2008-3#1)
systolic and diastolic blood##17##4##(1992-8#4)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2010-7#1)(2012-3#1)(2013-1#2)
systolic and diastolic function##2##4##(1991-2#1)(2006-10#1)
systolic and diastolic##28##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-8#4)(1994-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2010-4#1)(2010-7#3)(2012-3#1)(2013-1#2)
systolic and##32##2##(1990-8#2)(1991-2#1)(1991-3#1)(1992-8#4)(1994-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#2)(2010-4#1)(2010-7#3)(2011-1#1)(2012-3#1)(2013-1#2)
systolic anterior motion##2##3##(2007-8#2)
systolic arterial blood pressure (SABP)##2##5##(1997-6#1)(2007-8#1)
systolic arterial blood pressure##3##4##(1997-6#1)(2007-8#1)(2008-5#1)
systolic blood pressure (SBP)##6##4##(1990-7#1)(1991-10#1)(1992-12#1)(2009-9#1)(2010-4#1)(2013-8#1)
systolic blood pressure was##2##4##(1993-10#1)(2007-10#1)
systolic blood pressure##32##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-6#2)(1992-12#1)(1992-6#1)(1993-10#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#4)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
systolic blood##35##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-6#2)(1992-12#1)(1992-6#1)(1993-10#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#4)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
systolic dysfunction##7##2##(2007-10#1)(2008-7#1)(2010-11#1)(2010-5#1)(2013-1#2)(2013-7#1)
systolic function following##3##3##(2008-11#1)(2010-6#2)
systolic function in##2##3##(2008-12#1)(2009-4#1)
systolic function##14##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2009-4#1)(2009-9#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#1)
systolic heart failure##3##3##(1990-9#1)(2008-3#1)(2008-8#1)
systolic hypertension##5##2##(1991-12#1)(1992-6#1)(1993-1#1)(2008-1#1)(2011-1#1)
systolic peak##2##2##(1991-12#1)(2008-1#1)
systolic pressure##3##2##(2008-1#2)(2009-12#1)
systolic velocity##6##2##(2007-10#2)(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
systolic##132##1##(1990-11#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#3)(1992-8#4)(1993-1#1)(1993-10#1)(1994-11#1)(1996-3#1)(1996-6#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#1)(2007-8#3)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2011-1#7)(2011-2#6)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
systolic/diastolic##2##1##(2008-7#1)(2011-2#1)
sévère et##2##2##(2013-1#2)
sévère##3##1##(2013-1#3)
t (max)##2##2##(2011-2#2)
t -test##2##2##(2008-11#2)
t =##3##2##(1996-12#1)(2008-10#2)
t gypsum ha(-1)##3##3##(2008-12#3)
t ha(-1)##2##2##(2008-12#2)
t ha(-1))##3##2##(2008-12#3)
t test##11##2##(1990-12#1)(1995-1#1)(2007-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
t tests##3##2##(1992-3#1)(2009-5#1)(2012-2#1)
t##67##1##(1990-12#2)(1991-2#1)(1992-3#4)(1993-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-2#5)(1997-4#1)(2007-5#2)(2007-8#1)(2008-10#9)(2008-11#5)(2008-12#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-8#4)(2011-2#6)(2012-2#2)(2013-1#2)
t(0)##3##1##(2008-10#3)
t(1)##5##1##(2008-10#4)(2012-2#1)
t(1/2) values##4##2##(2008-10#4)
t(1/2)##10##1##(2008-10#7)(2012-2#3)
t(11##2##1##(2009-8#1)(2011-3#1)
t(14##7##1##(1994-10#1)(2009-8#5)(2010-11#1)
t(15##3##1##(1991-9#2)(2007-4#1)
t(2##7##1##(1993-2#2)(2009-2#5)
t(2)##2##1##(2008-10#2)
t(8##2##1##(2010-1#2)
t(9##3##1##(2007-11#1)(2011-3#1)(2012-12#1)
t(a) =##2##2##(2007-12#2)
t(ip) and##2##2##(2008-10#2)
t(ip)##3##1##(2008-10#3)
t(m)##2##1##(2007-11#1)(2008-10#1)
t(max)##2##1##(2008-12#1)(2010-8#1)
t(o)##2##1##(1994-12#2)
t)##5##1##(1991-5#1)(1995-2#2)(2008-3#1)(2011-2#1)
t-ACPD##4##1##(1992-12#4)
t-BuOH and##2##2##(2008-11#1)(2008-9#1)
t-BuOH##3##1##(2008-11#1)(2008-9#1)(2012-3#1)
t-PA expression levels##2##3##(2008-7#2)
t-PA production##2##2##(2008-11#2)
t-PA was##2##2##(2008-11#2)
t-PA##15##1##(1994-3#2)(1995-8#1)(2008-11#10)(2008-7#2)
t-PA/PAI-1 complexes are##2##3##(1995-8#2)
t-PA/PAI-1 complexes##5##2##(1995-8#5)
t-PA/PAI-1##6##1##(1995-8#6)
t-butyl##3##1##(1992-5#1)(1996-2#1)(2008-10#1)
t-test and##4##2##(1990-12#1)(1991-2#1)(2008-10#1)(2008-11#1)
t-test at the 95% confidence level##2##6##(2008-10#2)
t-test at the 95%##3##4##(2008-10#3)
t-test shows##2##2##(2008-10#2)
t-test to##2##2##(2008-10#1)(2011-2#1)
t-test##43##1##(1990-12#1)(1990-2#1)(1991-2#1)(1994-2#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
t-test)##7##1##(1993-12#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
t-tests showed##2##2##(2009-4#1)(2010-6#1)
t-tests##11##1##(1992-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-6#2)(2011-2#1)(2012-1#1)
t-tests)##2##1##(1990-9#1)(2008-3#1)
t/ha##3##1##(2008-10#3)
t/km2/year)##3##1##(2008-5#3)
t1/2##6##1##(1992-5#2)(1995-5#2)(1995-6#1)(1995-8#1)
t11-CLA##3##1##(2012-2#3)
t=-5##2##1##(2010-6#1)(2013-7#1)
tBuBHQ caused O2- production##2##4##(1996-2#2)
tBuBHQ##6##1##(1996-2#6)
tDCS##6##1##(2010-7#1)(2012-2#5)
tMCAO##3##1##(2011-2#3)
tNOX activity##2##2##(2009-9#2)
tNOX expression##2##2##(2009-9#2)
tNOX##11##1##(2008-7#2)(2009-9#9)
tPA activity##2##2##(2008-8#2)
tPA in##3##2##(2008-11#1)(2008-8#1)(2010-3#1)
tPA production##2##2##(2008-11#1)(2008-8#1)
tPA##15##1##(2008-11#5)(2008-8#6)(2008-9#1)(2010-3#2)(2011-2#1)
tPMET##2##1##(2009-9#2)
tRAUDPC##2##1##(2008-10#2)
tRNA (1) (Leu)##2##3##(2008-4#2)
tRNA (2) (Leu)##2##3##(2008-4#2)
tRNA found in##2##3##(1992-6#2)
tRNA gene##6##2##(1995-12#1)(1996-6#1)(1997-7#3)(2008-9#1)
tRNA genes and##4##3##(1995-6#1)(2008-9#3)
tRNA genes is##2##3##(2008-9#2)
tRNA genes were##2##3##(1995-6#1)(1995-8#1)
tRNA genes##15##2##(1995-6#2)(1995-8#1)(1996-6#1)(1997-7#2)(2008-9#8)(2012-3#1)
tRNA ligase##3##2##(2008-8#3)
tRNA species##7##2##(1992-6#5)(1995-6#1)(1995-8#1)
tRNA synthetase##2##2##(1997-3#1)(1997-6#1)
tRNA##66##1##(1990-12#1)(1992-11#4)(1992-6#13)(1993-11#2)(1993-8#2)(1995-12#1)(1995-6#4)(1995-8#2)(1996-6#2)(1997-3#1)(1997-6#2)(1997-7#5)(2008-2#1)(2008-4#7)(2008-8#7)(2008-9#9)(2012-2#2)(2012-3#1)
tRNA(Gly)1##4##1##(1997-7#4)
tRNA(Leu)##6##1##(1990-12#1)(2008-4#2)(2008-8#3)
tRNA(Lys##8##1##(1992-6#8)
tRNA(Phe)##2##1##(2008-11#1)(2008-8#1)
tRNA(TGASer)##3##1##(1991-6#3)
tRNA(fMet)##8##1##(1991-12#1)(1995-6#7)
tRNA(phe)##3##1##(1993-3#2)(1995-9#1)
tRNA-specific##2##1##(1992-11#2)
tRNA2(fMet)##6##1##(1993-11#6)
tRNAThr##2##1##(1997-3#2)
tRNA[Ser]Sec TATA element##2##3##(1997-2#2)
tRNA[Ser]Sec gene##3##2##(1997-2#3)
tRNA[Ser]Sec##6##1##(1997-2#6)
tRNAa##3##1##(2008-8#3)
tRNAb##3##1##(2008-8#3)
tRNAs and##2##2##(1997-3#1)(2011-2#1)
tRNAs##18##1##(1990-12#1)(1991-6#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-8#1)(1997-3#3)(1997-7#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
tSAH##4##1##(2008-7#4)
tabaci and##2##2##(2008-10#2)
tabaci biotype##2##2##(2008-10#2)
tabaci in the New World##2##5##(2011-2#2)
tabaci in the##3##3##(2011-2#3)
tabaci in##5##2##(2008-10#2)(2011-2#3)
tabaci population##2##2##(2008-10#2)
tabaci##39##1##(2008-10#32)(2008-12#3)(2011-2#4)
tabacina DNA##2##2##(2008-10#2)
tabacina##29##1##(2008-10#29)
tabacum cv##6##2##(2008-10#4)(2008-9#2)
tabacum##19##1##(1997-2#1)(2008-10#14)(2008-7#1)(2008-9#2)(2012-2#1)
tabes dorsalis##2##2##(1991-11#2)
tabes##3##1##(1991-11#3)
tabira population##2##2##(2010-8#2)
tabira##6##1##(2010-8#6)
table analysis of##2##3##(1991-12#1)(2008-10#1)
table analysis##5##2##(1991-12#1)(1991-3#1)(1993-2#1)(2008-10#1)(2008-9#1)
table and##2##2##(2008-10#1)(2013-1#1)
table is##3##2##(1995-9#1)(2008-10#2)
table of the##2##3##(2008-3#1)(2013-8#1)
table of##12##2##(1992-6#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
table salt samples##5##3##(2008-10#5)
table salt##11##2##(2008-10#11)
table salts##3##2##(2008-10#3)
table to##3##2##(1993-1#1)(2009-12#1)(2011-2#1)
table##90##1##(1990-5#1)(1991-12#2)(1991-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#3)(1994-2#1)(1995-2#1)(1995-3#2)(1995-9#2)(1996-1#2)(1996-3#1)(1997-3#2)(1997-6#1)(2007-10#3)(2007-11#1)(2008-1#2)(2008-10#25)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#2)(2010-11#1)(2010-12#2)(2011-2#9)(2012-2#1)(2013-1#2)(2013-8#1)
tables and##6##2##(1993-2#2)(1995-9#1)(1996-2#1)(2008-4#1)(2012-3#1)
tables are provided##2##3##(1994-6#1)(1997-4#1)
tables are##3##2##(1994-6#1)(1995-2#1)(1997-4#1)
tables generated##2##2##(2008-2#1)(2008-3#1)
tables of##8##2##(1993-2#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
tables with little##2##3##(2012-12#2)
tables with##3##2##(2010-1#1)(2012-12#2)
tables##49##1##(1993-2#5)(1994-11#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2010-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)
tablet and##3##2##(2008-10#2)(2008-7#1)
tablet as##2##2##(2008-6#1)(2010-5#1)
tablet coatings##2##2##(2010-5#2)
tablet containing##2##2##(2008-10#2)
tablet dosage form and##2##4##(2008-10#1)(2010-5#1)
tablet dosage form##9##3##(2008-10#2)(2010-5#6)(2012-12#1)
tablet dosage##10##2##(2008-10#3)(2010-5#6)(2012-12#1)
tablet formulation##5##2##(2008-10#2)(2010-3#2)(2012-2#1)
tablet formulations##4##2##(2008-10#3)(2012-2#1)
tablet matrix##2##2##(2010-5#2)
tablet of##3##2##(1990-8#1)(1996-5#1)(2010-5#1)
tablet preparations##2##2##(2008-10#2)
tablet samples##3##2##(2008-10#3)
tablet was##5##2##(2008-10#1)(2008-5#1)(2010-5#3)
tablet##73##1##(1990-11#2)(1990-8#2)(1996-5#1)(2007-11#1)(2008-10#30)(2008-5#2)(2008-6#1)(2008-7#3)(2010-3#2)(2010-5#21)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
tablet) were##2##2##(2008-10#2)
tablet)##5##1##(2008-10#5)
tabletop laser##3##2##(2007-12#2)(2008-3#1)
tabletop soft-x-ray##2##2##(2007-12#1)(2008-3#1)
tabletop##10##1##(2007-12#5)(2008-2#1)(2008-3#3)(2011-7#1)
tablets and human serum##3##4##(2008-10#3)
tablets and##20##2##(2008-10#20)
tablets by##4##2##(2008-10#3)(2012-2#1)
tablets containing##2##2##(1991-3#1)(2008-10#1)
tablets for##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
tablets in##2##2##(2010-12#1)(2012-3#1)
tablets is##2##2##(2008-10#2)
tablets of miconazole##2##3##(2010-5#2)
tablets of##11##2##(1990-2#1)(2008-10#1)(2010-3#3)(2010-5#4)(2012-2#2)
tablets remained in the stomach for##2##6##(2012-2#2)
tablets remained##3##2##(2012-2#3)
tablets using##2##2##(2008-10#1)(2010-5#1)
tablets was##5##2##(2008-10#3)(2010-4#1)(2010-5#1)
tablets were also##2##3##(2010-5#1)(2011-2#1)
tablets were prepared by##2##4##(2010-5#1)(2012-2#1)
tablets were##16##2##(2008-10#5)(2010-3#2)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#4)
tablets with##5##2##(2008-10#5)
tablets##150##1##(1990-2#1)(1991-3#1)(2007-7#1)(2008-10#91)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-3#6)(2010-4#2)(2010-5#15)(2011-1#2)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#17)(2012-3#1)(2013-8#1)
tablets)##2##1##(2008-10#2)
taboo search##2##2##(2008-10#2)
taboo##4##1##(1993-6#1)(1996-6#1)(2008-10#2)
tabs##4##1##(1991-5#2)(2010-8#1)(2013-8#1)
tabular##2##1##(2007-7#1)(2008-12#1)
tabulare##2##1##(2013-7#2)
tabulated and##3##2##(1994-1#1)(2008-10#1)(2010-8#1)
tabulated##24##1##(1991-3#1)(1994-1#1)(2007-8#12)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#2)(2010-8#1)(2011-2#1)
tac promoter##3##2##(1990-5#1)(1994-8#1)(1997-4#1)
tac##4##1##(1990-5#2)(1994-8#1)(1997-4#1)
tachyarrhythmia##4##1##(1992-6#1)(2008-3#1)(2010-11#1)(2011-2#1)
tachyarrhythmias in##2##2##(2010-4#1)(2012-2#1)
tachyarrhythmias##5##1##(1993-2#1)(2010-4#3)(2012-2#1)
tachycardia and##11##2##(1993-2#1)(1995-12#4)(1996-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2013-1#1)
tachycardia of##3##2##(2008-7#2)(2009-7#1)
tachycardia was induced##2##3##(1990-3#2)
tachycardia was##7##2##(1990-3#2)(1991-12#1)(1993-2#1)(1995-12#2)(2007-8#1)
tachycardia with##2##2##(2007-8#1)(2012-3#1)
tachycardia##66##1##(1990-3#8)(1990-5#1)(1991-12#1)(1991-9#1)(1993-2#5)(1994-11#1)(1995-12#6)(1996-3#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#5)(2009-10#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#4)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
tachycardia)##2##1##(1995-12#1)(1996-3#1)
tachycardia]##3##1##(1995-11#1)(1995-2#1)(2013-1#1)
tachycardias##3##1##(1991-3#1)(2009-10#1)(2010-11#1)
tachycardic##2##1##(1995-2#1)(2012-2#1)
tachykinin NK1 and NK2 receptor antagonists##3##6##(1995-12#1)(1997-4#2)
tachykinin NK1 and NK2 receptor##4##5##(1995-12#2)(1997-4#2)
tachykinin NK1 and NK2##5##4##(1995-12#3)(1997-4#2)
tachykinin NK1##6##2##(1995-12#4)(1997-4#2)
tachykinin##14##1##(1990-12#1)(1991-5#2)(1993-8#1)(1995-12#5)(1997-4#2)(2008-8#3)
tachykinins##5##1##(1991-5#2)(1995-12#2)(1997-4#1)
tackle the##2##2##(2008-4#1)(2010-11#1)
tackle this issue##2##3##(2009-5#1)(2013-8#1)
tackle this##4##2##(1995-5#1)(2009-5#1)(2011-2#1)(2013-8#1)
tackle##19##1##(1991-11#1)(1994-3#1)(1995-5#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
tackled##5##1##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)
tackles##5##1##(1992-1#1)(1994-2#1)(1997-3#1)(2007-10#1)(2009-5#1)
tackling##8##1##(1990-4#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)
tacrine##6##1##(1996-9#4)(2011-3#1)(2012-3#1)
tacrolimus and##2##2##(2007-11#1)(2011-2#1)
tacrolimus##11##1##(2007-11#3)(2008-10#4)(2008-3#1)(2011-1#1)(2011-2#2)
tacrolimus)##2##1##(2008-1#1)(2008-3#1)
tactic for##2##2##(2008-10#1)(2008-8#1)
tactic##13##1##(1991-1#2)(1993-12#1)(2008-10#3)(2008-8#4)(2010-8#1)(2011-2#2)
tactical##4##1##(1997-1#1)(2008-12#1)(2008-3#2)
tactics and##3##2##(1996-3#1)(2008-10#1)(2010-8#1)
tactics are##2##2##(1991-5#1)(2008-10#1)
tactics for the##2##3##(1991-3#1)(1993-12#1)
tactics for##5##2##(1991-3#1)(1993-12#1)(2007-8#1)(2008-9#1)(2013-8#1)
tactics including##2##2##(2008-10#2)
tactics of##2##2##(2008-5#1)(2008-6#1)
tactics to##4##2##(1992-12#1)(1994-12#1)(2010-1#1)(2013-1#1)
tactics##33##1##(1990-3#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-3#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#6)(2010-8#2)(2013-1#1)(2013-8#1)
tactile allodynia##2##2##(1997-2#2)
tactile events##2##2##(2009-8#2)
tactile hypersensitivity##3##2##(1997-2#3)
tactile perception##3##2##(1995-8#1)(2008-5#2)
tactile placing##2##2##(1992-12#2)
tactile responses##2##2##(1993-12#2)
tactile stimulation##5##2##(1993-12#2)(1997-2#1)(2008-5#2)
tactile stimuli##2##2##(1993-12#1)(1996-12#1)
tactile##35##1##(1992-12#2)(1993-12#6)(1995-8#1)(1996-12#1)(1997-2#7)(2008-3#4)(2008-4#2)(2008-5#6)(2009-8#5)(2013-1#1)
tadalafil##6##1##(2008-10#5)(2008-11#1)
tadpole pupil##2##2##(2011-1#2)
tadpole##8##1##(1997-7#1)(2008-8#5)(2011-1#2)
tadpoles have##2##2##(2008-7#1)(2012-12#1)
tadpoles of##2##2##(2011-2#2)
tadpoles##15##1##(1995-12#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#9)
tag (EST)##5##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
tag at##2##2##(2008-11#2)
tag genes##2##2##(1997-8#1)(2008-10#1)
tag in##2##2##(1997-4#1)(2008-7#1)
tag line##3##2##(2008-3#3)
tag sequences are##2##3##(1997-3#2)
tag sequences##5##2##(1997-3#4)(2008-2#1)
tag was##2##2##(2008-10#1)(2008-11#1)
tag##55##1##(1994-12#1)(1994-8#1)(1995-2#1)(1995-9#1)(1997-3#4)(1997-4#2)(1997-6#1)(1997-8#1)(2008-10#9)(2008-11#9)(2008-2#2)(2008-3#5)(2008-4#3)(2008-7#3)(2008-9#3)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#2)(2013-8#2)
tag)##2##1##(1996-6#1)(2008-10#1)
tagged fish##2##2##(2008-8#1)(2010-8#1)
tagged proteins##5##2##(2008-1#1)(2008-4#2)(2008-7#1)(2010-7#1)
tagged site##3##2##(1994-12#1)(2008-10#2)
tagged with##4##2##(1993-6#1)(1996-6#1)(2008-10#2)
tagged##35##1##(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-8#3)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-9#1)(2010-7#1)(2010-8#3)(2011-2#1)
tagging and##3##2##(1997-8#1)(2008-2#1)(2013-8#1)
tagging method##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
tagging of##8##2##(1995-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2009-9#1)(2012-2#1)(2013-1#1)
tagging studies##2##2##(2013-1#2)
tagging the##3##2##(1995-6#1)(1997-2#1)(2007-11#1)
tagging velocimetry##2##2##(2008-3#2)
tagging with GFP##2##3##(2008-7#2)
tagging##43##1##(1991-5#3)(1995-2#1)(1995-6#1)(1995-9#1)(1997-2#2)(1997-8#2)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-9#1)(2010-8#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
tagitinin C##4##2##(2008-10#4)
tagmosis of the##2##3##(2007-12#2)
tags and##2##2##(2008-12#1)(2011-2#1)
tags for##2##2##(1996-6#1)(2008-7#1)
tags from##4##2##(2008-11#1)(2008-8#1)(2010-4#2)
tags##36##1##(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-7#5)(2008-8#1)(2009-10#2)(2010-10#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
tai chi group##2##3##(2008-10#2)
tai chi##9##2##(2007-12#1)(2008-10#7)(2010-12#1)
taiga##3##1##(2011-2#3)
taiji quan training on##2##4##(2009-3#2)
taiji quan##5##2##(2009-3#5)
taiji##6##1##(2009-3#6)
tail DNA##6##2##(1997-4#3)(2010-5#3)
tail and##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
tail at##3##2##(1993-8#1)(2008-10#1)(2008-2#1)
tail coverage##3##2##(1993-1#3)
tail currents evoked at potentials more##2##6##(1997-2#2)
tail domain of vinculin##2##4##(2009-7#2)
tail domain of##5##3##(1990-11#2)(2009-7#2)(2011-2#1)
tail domain##6##2##(1990-11#3)(2009-7#2)(2011-2#1)
tail in##4##2##(1995-12#1)(1997-5#2)(2008-3#1)
tail is##6##2##(1992-9#1)(1997-2#1)(2007-11#1)(2010-6#2)(2011-1#1)
tail length and##3##3##(2008-8#1)(2008-9#1)(2010-5#1)
tail length##7##2##(2008-8#3)(2008-9#1)(2010-5#3)
tail markings as##2##3##(2008-9#2)
tail markings##5##2##(2008-9#5)
tail moment##3##2##(1997-4#1)(2008-10#2)
tail of pancreas##2##3##(2008-7#2)
tail of the pancreas##2##4##(2010-12#1)(2013-1#1)
tail of the##7##3##(1992-8#1)(1993-9#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
tail of##16##2##(1991-2#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-12#1)(2011-1#1)(2013-1#1)
tail or##4##2##(1997-5#2)(2008-6#1)(2008-7#1)
tail part##2##2##(1997-2#1)(2011-2#1)
tail region##3##2##(1995-3#1)(2011-1#2)
tail that##2##2##(1990-5#1)(2011-2#1)
tail traits in##2##3##(2008-9#2)
tail traits##3##2##(2008-9#3)
tail vein##5##2##(1991-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
tail were##2##2##(1992-12#1)(2007-5#1)
tail##166##1##(1990-11#3)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#2)(1992-9#3)(1993-1#5)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#5)(1997-2#10)(1997-4#8)(1997-5#4)(1997-7#3)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#20)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#7)(2010-6#4)(2011-1#7)(2011-2#13)(2012-2#2)(2013-1#1)
tail&quot##2##1##(1991-3#1)(1993-1#1)
tail)##6##1##(1994-11#2)(2008-8#2)(2012-2#1)(2013-8#1)
tail-flick response##5##2##(1992-3#5)
tail-flick test##4##2##(1991-1#3)(1992-8#1)
tail-flick##11##1##(1991-1#3)(1992-3#6)(1992-8#1)(1993-1#1)
tail-withdrawal##2##1##(1996-2#2)
tailed##3##1##(1992-3#1)(2007-12#1)(2008-12#1)
tailflip##2##1##(2007-12#2)
tailflipping##3##1##(2007-12#3)
tailflips##2##1##(2007-12#2)
tailing in##2##2##(2010-4#1)(2012-2#1)
tailing##4##1##(1997-4#1)(2008-10#1)(2010-4#1)(2012-2#1)
tailor the##5##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
tailor##12##1##(1993-2#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-7#2)(2009-12#1)(2010-4#1)(2013-1#2)
tailor-made##6##1##(1996-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-3#1)
tailored approach##2##2##(2008-8#1)(2013-1#1)
tailored by##3##2##(2007-11#1)(2009-11#1)(2011-2#1)
tailored design##2##2##(2010-10#1)(2012-3#1)
tailored for##6##2##(2008-3#2)(2008-9#1)(2010-2#1)(2012-12#2)
tailored to each##2##3##(1992-6#1)(2008-10#1)
tailored to individual##2##3##(2008-11#1)(2008-5#1)
tailored to the individual##2##4##(2010-1#1)(2013-8#1)
tailored to the purposes of##2##5##(1996-9#1)(2008-9#1)
tailored to the##6##3##(1996-9#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-1#1)(2013-8#1)
tailored to##21##2##(1992-6#1)(1995-1#1)(1996-3#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
tailored treatment##3##2##(2009-2#1)(2010-12#1)(2013-8#1)
tailored use of##2##3##(2007-10#1)(2008-9#1)
tailored##70##1##(1990-12#1)(1990-3#1)(1992-6#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#3)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#3)
tailoring interventions##2##2##(2010-2#1)(2012-1#1)
tailoring of##2##2##(2008-3#1)(2008-4#1)
tailoring the##3##2##(2007-11#1)(2008-10#2)
tailoring##21##1##(1993-12#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
tails and##3##2##(2008-8#2)(2011-2#1)
tails are##2##2##(2008-1#1)(2011-2#1)
tails in##2##2##(1992-11#2)
tails of the##3##3##(1995-6#1)(2007-12#1)(2012-3#1)
tails of##4##2##(1995-6#1)(1997-4#1)(2007-12#1)(2012-3#1)
tails were##2##2##(1997-4#1)(2008-11#1)
tails##38##1##(1990-2#1)(1992-11#2)(1993-9#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-9#4)(1997-4#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#2)(2010-4#1)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#1)
tainted##3##1##(1995-6#1)(1996-8#1)(1997-5#1)
taiwanin C and##2##3##(1996-5#2)
taiwanin##3##1##(1996-5#3)
take a more##2##3##(1993-1#1)(2007-10#1)
take a##19##2##(1990-6#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-12#1)(1997-7#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)
take account of the##4##4##(1990-3#1)(2008-11#1)(2008-3#2)
take account of##6##3##(1990-3#1)(1996-11#1)(2008-11#1)(2008-3#2)(2010-10#1)
take account##7##2##(1990-3#1)(1996-11#1)(2008-11#1)(2008-3#2)(2010-10#1)(2013-8#1)
take action##5##2##(1995-3#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
take advantage of a##3##4##(2007-11#1)(2008-10#1)(2012-3#1)
take advantage of the##7##4##(1994-3#2)(1996-3#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-5#1)
take advantage of this##3##4##(1993-12#2)(2008-7#1)
take advantage of##23##3##(1990-11#1)(1991-5#1)(1993-12#2)(1994-3#2)(1995-5#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#1)(2012-3#1)(2013-1#1)
take advantage##25##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-12#2)(1994-3#2)(1995-5#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#1)(2012-3#1)(2013-1#1)
take an active role##3##4##(1994-1#1)(1995-3#1)(2010-12#1)
take an##6##2##(1994-1#1)(1995-3#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)
take care of their##2##4##(1992-12#1)(2008-6#1)
take care of##3##3##(1992-12#1)(1995-12#1)(2008-6#1)
take care##4##2##(1992-12#1)(1995-12#1)(2008-2#1)(2008-6#1)
take full advantage of the##3##5##(1996-4#1)(2008-7#2)
take full advantage of##5##4##(1994-2#1)(1996-4#1)(2008-2#1)(2008-7#2)
take in##4##2##(1994-1#1)(1996-2#1)(2009-10#1)(2009-9#1)
take into account the##26##4##(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-5#2)(1996-6#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#3)(2009-12#1)(2011-2#1)
take into account##42##3##(1990-7#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1995-12#1)(1995-5#2)(1996-6#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-6#1)(2011-2#3)(2012-12#1)(2013-8#1)
take into consideration the##6##4##(1996-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)
take into consideration##9##3##(1995-12#1)(1996-3#1)(1996-6#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)
take into##51##2##(1990-7#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1995-12#2)(1995-5#2)(1996-3#1)(1996-6#2)(1997-2#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-6#1)(2011-2#3)(2012-12#1)(2013-8#1)
take it##2##2##(1992-9#1)(2007-11#1)
take longer##2##2##(1994-9#1)(2012-2#1)
take many##6##2##(1992-1#1)(2008-1#2)(2008-10#1)(2008-5#1)(2012-12#1)
take on a##2##3##(1993-12#1)(2008-9#1)
take on these##2##3##(1992-3#1)(1996-2#1)
take on##8##2##(1990-4#1)(1992-3#1)(1993-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-9#1)
take part in research##4##4##(1992-3#2)(2009-6#2)
take part in the##3##4##(1993-3#1)(1997-6#1)(2008-10#1)
take part in##19##3##(1990-11#1)(1992-3#2)(1993-3#1)(1996-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#6)(2013-8#1)
take part##22##2##(1990-11#1)(1992-3#2)(1993-3#1)(1996-11#1)(1997-6#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-9#1)(2009-6#6)(2013-1#1)(2013-8#1)
take place as##2##3##(1991-9#1)(2008-9#1)
take place at the##3##4##(1991-2#1)(2008-10#1)(2008-8#1)
take place at##5##3##(1991-2#1)(1996-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
take place between##2##3##(2007-12#1)(2008-8#1)
take place in a##7##4##(1993-12#1)(1996-11#1)(2008-10#2)(2011-1#1)(2012-2#1)(2013-8#1)
take place in the##12##4##(1992-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-3#1)(2012-3#1)
take place in##27##3##(1992-3#1)(1993-12#1)(1995-2#1)(1996-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
take place via##3##3##(1996-2#1)(1996-8#1)(2010-4#1)
take place##74##2##(1990-10#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-12#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-8#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
take responsibility for##6##3##(1995-1#1)(1995-3#1)(2008-12#1)(2008-3#1)(2009-5#2)
take several##3##2##(1992-12#1)(1996-8#1)(1997-3#1)
take steps to prevent##2##4##(1993-1#1)(2007-12#1)
take steps to##5##3##(1993-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2012-2#1)
take that##2##2##(2008-12#1)(2013-8#1)
take the lead in##3##4##(1995-2#1)(1995-3#1)(1997-7#1)
take the lead##7##3##(1995-12#2)(1995-2#1)(1995-3#1)(1997-7#1)(2008-8#1)(2012-2#1)
take the place of##2##4##(1990-6#1)(2008-11#1)
take the##24##2##(1990-6#1)(1992-11#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-3#2)(1996-8#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
take their medication##2##3##(1993-11#1)(2011-1#1)
take their##5##2##(1993-11#1)(1995-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
take them##4##2##(1994-1#1)(1994-12#1)(2011-1#1)(2012-2#1)
take this into##2##3##(2011-2#1)(2012-2#1)
take this##5##2##(1992-1#1)(1992-6#1)(1996-3#1)(2011-2#1)(2012-2#1)
take to deal with##2##4##(1996-2#1)(2008-11#1)
take to##14##2##(1991-12#1)(1992-2#1)(1993-2#2)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
take two##2##2##(1991-9#1)(1994-12#1)
take up##13##2##(1990-2#1)(1991-3#1)(1995-12#1)(1995-2#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)
take##414##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#9)(1993-3#3)(1994-1#5)(1994-12#6)(1994-2#3)(1994-3#3)(1994-9#1)(1995-1#4)(1995-12#8)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#5)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#3)(1997-2#3)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#24)(2008-11#23)(2008-12#5)(2008-2#5)(2008-3#16)(2008-4#3)(2008-5#10)(2008-6#10)(2008-7#16)(2008-8#8)(2008-9#11)(2009-10#3)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#7)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#12)(2011-3#1)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#8)
take-all conducive soil##2##3##(2008-10#2)
take-all decline##3##2##(2008-10#3)
take-all disease##3##2##(2008-10#3)
take-all epidemics##4##2##(2008-10#4)
take-all incidence##2##2##(2008-10#2)
take-all of wheat##3##3##(2008-10#3)
take-all##30##1##(2008-10#30)
take-all-suppressive##2##1##(2008-10#2)
take-up##3##1##(1993-8#1)(2008-10#1)(2008-9#1)
take?##2##1##(2008-4#1)(2008-7#1)
taken 1##2##2##(2010-12#2)
taken 2##2##2##(1995-11#1)(2013-8#1)
taken 6 weeks##2##3##(2007-11#1)(2008-9#1)
taken a##4##2##(1991-1#1)(1994-3#1)(1997-3#1)(1997-6#1)
taken advantage of##2##3##(1997-3#1)(2010-8#1)
taken after##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
taken along the##2##3##(2008-3#2)
taken an##2##2##(2008-11#1)(2013-1#1)
taken and the##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
taken and##9##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
taken any##2##2##(2013-1#2)
taken as a##3##3##(1997-7#1)(2008-2#1)(2008-8#1)
taken as an##5##3##(1996-5#1)(2007-11#1)(2008-10#3)
taken as evidence that##2##4##(2007-12#1)(2008-11#1)
taken as evidence##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
taken as the##8##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-8#1)
taken as##34##2##(1990-12#1)(1990-8#1)(1992-11#1)(1993-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
taken at days##2##3##(2008-7#2)
taken at the end of round##3##6##(1997-4#3)
taken at the end of##5##5##(1997-4#5)
taken at the time of##2##5##(2009-1#1)(2011-2#1)
taken at the##9##3##(1991-12#1)(1997-4#5)(2008-10#1)(2009-1#1)(2011-2#1)
taken at##32##2##(1991-12#1)(1991-9#1)(1994-2#1)(1995-9#1)(1997-4#5)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2009-1#1)(2010-2#2)(2010-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
taken away##3##2##(1992-5#1)(1997-1#1)(2008-3#1)
taken based on##2##3##(1996-9#1)(2012-2#1)
taken before and##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
taken before the##2##3##(2008-5#1)(2010-12#1)
taken before##9##2##(1990-3#1)(1991-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
taken between##2##2##(2007-12#1)(2008-3#1)
taken by a##2##3##(2008-2#1)(2010-7#1)
taken by the nurse##2##4##(2010-7#2)
taken by the##11##3##(1991-3#1)(1995-12#1)(2007-12#1)(2007-8#2)(2008-3#1)(2010-7#3)(2011-2#1)(2012-3#1)
taken by##23##2##(1991-3#1)(1995-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-7#4)(2011-2#2)(2012-3#1)(2013-1#1)
taken care of##4##3##(1992-6#1)(1997-5#1)(2011-1#1)(2011-3#1)
taken during a##2##3##(2008-8#1)(2012-12#1)
taken during the##3##3##(1990-8#1)(2011-1#1)(2011-2#1)
taken during##8##2##(1990-8#1)(1991-3#1)(2007-8#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
taken for analysis##3##3##(2008-10#2)(2012-12#1)
taken for each##2##3##(2008-10#1)(2008-3#1)
taken for granted##2##3##(2008-11#1)(2008-6#1)
taken for the##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
taken for##29##2##(1990-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-7#1)(1995-3#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-6#1)(2008-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
taken four##3##2##(1997-3#1)(2008-3#1)(2010-4#1)
taken from 10##2##3##(1997-3#1)(2009-8#1)
taken from a##5##3##(2008-10#2)(2008-7#1)(2010-8#1)(2012-12#1)
taken from an##6##3##(2008-10#4)(2010-3#1)(2010-8#1)
taken from different##3##3##(1995-6#2)(2008-10#1)
taken from each##2##3##(2008-10#2)
taken from patients with##2##4##(2007-7#1)(2008-7#1)
taken from patients##3##3##(2007-7#2)(2008-7#1)
taken from the literature##3##4##(2008-10#2)(2008-2#1)
taken from the##38##3##(1991-2#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-9#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
taken from these##2##3##(2008-10#1)(2010-4#1)
taken from two##2##3##(2007-12#1)(2008-10#1)
taken from##111##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1994-1#1)(1995-12#1)(1995-6#4)(1996-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(2006-4#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#7)(2013-8#3)
taken in a##4##3##(1997-4#2)(2008-10#1)(2008-3#1)
taken in the##7##3##(1990-8#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-3#1)(2013-7#2)
taken in##26##2##(1990-8#1)(1993-1#1)(1994-11#1)(1995-11#1)(1997-3#1)(1997-4#2)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2012-1#1)(2013-1#1)(2013-7#3)
taken into account and##2##4##(2007-11#1)(2008-7#1)
taken into account by##8##4##(1993-12#1)(2008-10#3)(2008-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
taken into account for the##2##5##(2008-3#1)(2008-5#1)
taken into account for##4##4##(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
taken into account in a##2##5##(2008-2#1)(2013-1#1)
taken into account in order##2##5##(1992-3#1)(2008-10#1)
taken into account in the##10##5##(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)
taken into account in##23##4##(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#3)(2008-10#5)(2008-2#5)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#2)
taken into account the##2##4##(1994-11#1)(2008-10#1)
taken into account to##4##4##(1991-3#1)(2008-10#1)(2009-8#1)(2010-4#1)
taken into account##98##3##(1990-9#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-10#16)(2008-11#3)(2008-2#12)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
taken into consideration for##2##4##(2008-10#1)(2010-11#1)
taken into consideration in##6##4##(1991-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
taken into consideration##28##3##(1990-6#1)(1991-11#1)(1992-4#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#2)(2009-4#2)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
taken into##131##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-8#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#19)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#2)
taken not##2##2##(2008-7#1)(2008-8#1)
taken of##4##2##(1995-6#1)(2007-12#1)(2011-2#1)(2012-3#1)
taken on the##2##3##(2009-10#1)(2010-12#1)
taken on##13##2##(1993-1#1)(1993-2#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
taken out of the##2##4##(1990-9#1)(1997-6#1)
taken out##4##2##(1990-9#1)(1997-6#1)(2007-8#1)(2008-10#1)
taken over by##2##3##(2010-8#1)(2011-2#1)
taken over the##3##3##(1994-6#1)(2008-3#2)
taken over##7##2##(1992-10#1)(1994-6#1)(1995-12#1)(2008-3#2)(2010-8#1)(2011-2#1)
taken place in##5##3##(1991-2#1)(1991-3#1)(1995-3#1)(2008-2#1)(2011-1#1)
taken place##10##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-3#1)(1997-1#1)(2008-12#1)(2008-2#1)(2009-4#1)(2011-1#1)
taken sdNVP##2##2##(2011-1#2)
taken so far##3##3##(1993-8#1)(2008-11#2)
taken so##5##2##(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#2)
taken the##6##2##(1990-4#1)(1992-11#1)(1994-3#1)(2007-12#1)(2007-7#1)(2011-2#1)
taken to a##2##3##(2008-10#2)
taken to address##2##3##(2008-4#1)(2012-12#1)
taken to avoid##3##3##(2008-10#2)(2009-11#1)
taken to be the##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
taken to be##8##3##(1992-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)
taken to indicate##2##3##(1994-8#1)(2008-10#1)
taken to initiate##2##3##(1990-11#1)(2008-11#1)
taken to minimize the##2##4##(1995-12#1)(2008-8#1)
taken to overcome this##2##4##(2008-10#1)(2009-11#1)
taken to prevent the##2##4##(1997-6#1)(2008-10#1)
taken to prevent##3##3##(1997-6#1)(2008-10#2)
taken to protect##3##3##(1992-3#1)(1996-6#1)(2011-2#1)
taken to the management of##2##5##(1996-3#1)(1997-3#1)
taken to the##3##3##(1996-3#1)(1997-3#1)(2010-12#1)
taken to##69##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#3)(2009-11#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#1)
taken together indicate that##2##4##(1990-7#1)(1996-12#1)
taken together with previous##2##4##(1993-12#1)(1994-12#1)
taken together with##4##3##(1993-12#1)(1993-3#1)(1994-12#1)(1996-5#1)
taken together##10##2##(1990-12#1)(1990-7#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(2008-11#1)
taken under##4##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)
taken up and##5##3##(1993-6#1)(1995-6#1)(1996-2#1)(2008-12#1)(2008-9#1)
taken up by the cells##2##5##(1994-8#1)(2008-10#1)
taken up by the##7##4##(1994-12#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#1)
taken up by##20##3##(1990-2#1)(1991-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)
taken up in##2##3##(1992-8#1)(2012-2#1)
taken up into##2##3##(1992-3#1)(2007-10#1)
taken up##35##2##(1990-2#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#3)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#1)
taken using##2##2##(1993-11#1)(2010-7#1)
taken when##4##2##(1995-1#1)(2008-9#1)(2009-9#1)(2013-8#1)
taken with a##5##3##(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#1)
taken with the##2##3##(2007-12#1)(2012-3#1)
taken with##17##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
taken##758##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#7)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#5)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#7)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#9)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#4)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#8)(1997-4#8)(1997-5#3)(1997-6#3)(1997-7#1)(2006-4#1)(2007-10#4)(2007-11#11)(2007-12#19)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#1)(2008-10#109)(2008-11#34)(2008-12#15)(2008-2#24)(2008-3#56)(2008-4#5)(2008-5#25)(2008-6#3)(2008-7#21)(2008-8#14)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#8)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#15)(2010-9#1)(2011-1#11)(2011-2#31)(2011-3#2)(2012-1#1)(2012-12#14)(2012-2#11)(2012-3#7)(2013-1#27)(2013-7#9)(2013-8#11)
takeover##2##1##(1995-9#1)(1996-12#1)
takers##4##1##(2009-12#3)(2010-4#1)
takes a##18##2##(1991-1#1)(1992-1#1)(1993-1#1)(1994-1#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
takes about##3##2##(1995-2#1)(2008-10#2)
takes account of the##3##4##(1996-12#1)(1996-3#1)(2008-10#1)
takes account of##5##3##(1996-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)
takes advantage of the known##2##5##(2008-2#1)(2008-3#1)
takes advantage of the##12##4##(1993-8#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-8#1)(2011-1#1)
takes advantage of##17##3##(1993-8#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2011-1#1)
takes an average##2##3##(1994-12#1)(2008-3#1)
takes an##4##2##(1994-12#1)(2008-3#1)(2009-9#1)(2013-1#1)
takes care of##2##3##(1995-6#1)(2012-3#1)
takes into account the##12##4##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-2#1)
takes into account##26##3##(1996-5#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-3#1)(2012-2#1)
takes into consideration##2##3##(2008-10#1)(2008-4#1)
takes into##28##2##(1996-5#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-3#1)(2012-2#1)
takes its##2##2##(1995-1#1)(2008-4#1)
takes less than##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
takes longer##2##2##(1995-2#1)(2008-5#1)
takes many forms##2##3##(1996-8#1)(2008-11#1)
takes more##2##2##(1996-8#1)(2010-12#1)
takes on##3##2##(1997-6#1)(2008-11#1)(2008-4#1)
takes only##2##2##(2007-12#1)(2009-2#1)
takes part in##2##3##(1991-3#1)(1995-5#1)
takes place at the##2##4##(2007-8#1)(2008-10#1)
takes place at##6##3##(1990-11#1)(1993-12#1)(2007-8#1)(2008-10#3)
takes place during##2##3##(1995-12#1)(2008-10#1)
takes place from##3##3##(2008-10#2)(2012-12#1)
takes place in the##6##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
takes place in##10##3##(1992-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2009-10#1)(2012-12#1)(2012-8#1)
takes place is##2##3##(2008-9#1)(2009-10#1)
takes place##49##2##(1990-11#2)(1992-6#2)(1993-12#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#16)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#3)(2009-11#2)(2009-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-8#1)
takes the form of##5##4##(1992-6#1)(1993-2#1)(2008-2#1)(2008-3#2)
takes the##17##2##(1992-6#1)(1993-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-9#1)(2010-3#1)(2012-9#1)
takes time and##2##3##(2009-4#1)(2010-4#1)
takes to##6##2##(1993-12#1)(1993-3#1)(2008-1#1)(2008-7#1)(2010-5#1)(2012-3#1)
takes toll in##2##3##(1997-6#2)
takes toll##3##2##(1994-9#1)(1997-6#2)
takes up##2##2##(1992-3#1)(1995-2#1)
takes##215##1##(1990-11#2)(1990-8#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#3)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#2)(1997-3#2)(1997-5#1)(1997-6#3)(1997-8#1)(2006-12#1)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#8)(2008-12#2)(2008-2#12)(2008-3#20)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#4)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#7)(2012-8#1)(2012-9#1)(2013-1#1)(2013-8#3)
taking COX-2 selective##2##3##(2006-10#1)(2011-2#1)
taking a hard look at##2##5##(1990-4#1)(1993-3#1)
taking a##11##2##(1990-10#1)(1990-4#1)(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-12#2)(2013-1#1)
taking account of##3##3##(1997-1#1)(2008-11#1)(2008-3#1)
taking action##2##2##(1993-3#1)(2010-10#1)
taking advantage of the rapid##2##5##(2009-12#1)(2010-7#1)
taking advantage of the##12##4##(1995-3#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-7#1)
taking advantage of##21##3##(1991-9#1)(1995-3#1)(1996-1#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)
taking all##2##2##(2008-7#1)(2013-7#1)
taking an active##3##3##(1992-12#1)(1992-3#1)(2008-5#1)
taking an##9##2##(1992-12#1)(1992-3#1)(1995-6#2)(1997-7#1)(2008-11#2)(2008-12#1)(2008-5#1)
taking and##5##2##(1995-2#1)(1997-3#1)(2006-10#1)(2008-6#1)(2011-2#1)
taking antihypertensive##2##2##(2008-8#2)
taking as its##2##3##(1993-6#1)(2012-12#1)
taking as##3##2##(1993-6#1)(2008-11#1)(2012-12#1)
taking care of the##2##4##(1990-10#1)(2008-10#1)
taking care of##3##3##(1990-10#1)(1991-6#1)(2008-10#1)
taking drugs##3##2##(2008-7#3)
taking from##2##2##(1994-12#1)(2009-9#1)
taking full advantage of##2##4##(2008-3#1)(2012-2#1)
taking high##2##2##(2007-10#1)(2013-1#1)
taking in##3##2##(1993-11#1)(1995-5#1)(2008-10#1)
taking into account a##3##4##(1997-6#1)(2007-12#1)(2008-8#1)
taking into account all##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
taking into account both##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
taking into account data##2##4##(2008-2#2)
taking into account different##2##4##(2008-10#1)(2009-12#1)
taking into account the effects##2##5##(1990-8#1)(2008-10#1)
taking into account the##33##4##(1990-3#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-12#1)(1996-1#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
taking into account##63##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-12#1)(1996-1#1)(1997-6#1)(2007-12#4)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
taking into consideration the##6##4##(1995-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
taking into consideration##7##3##(1995-9#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
taking into##70##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
taking it##2##2##(2009-7#1)(2010-1#1)
taking medication##3##2##(2008-7#2)(2010-1#1)
taking medications and##2##3##(2008-9#2)
taking on the##2##3##(2008-8#1)(2013-8#1)
taking on##5##2##(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2013-8#1)
taking one##2##2##(2006-12#1)(2008-3#1)
taking part in##2##3##(2007-11#1)(2008-11#1)
taking place at##3##3##(2008-10#2)(2012-12#1)
taking place both in##2##4##(1994-2#1)(1995-3#1)
taking place in the##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
taking place in##8##3##(1996-2#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
taking place on the##2##4##(2008-10#1)(2008-8#1)
taking place##29##2##(1990-2#1)(1991-12#1)(1992-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
taking special##2##2##(1991-11#1)(2008-10#1)
taking steps##2##2##(1994-1#1)(1997-6#1)
taking stock##3##2##(1994-2#1)(1997-2#1)(2008-12#1)
taking the drugs##3##3##(2007-7#1)(2008-11#2)
taking the form of##2##4##(1992-11#1)(2007-12#1)
taking the sample##2##3##(2008-10#2)
taking the##23##2##(1992-1#1)(1992-11#1)(1992-6#1)(1993-3#1)(1997-3#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
taking their children to HIV care##2##6##(2012-12#2)
taking their##6##2##(1995-12#1)(1996-3#1)(2010-1#2)(2012-12#2)
taking these##2##2##(2006-12#1)(2008-7#1)
taking up the##2##3##(1994-9#1)(2008-11#1)
taking up##5##2##(1991-8#1)(1994-9#1)(2008-11#1)(2011-1#2)
taking##329##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-6#3)(1997-7#1)(2006-10#3)(2006-12#2)(2007-10#4)(2007-11#5)(2007-12#11)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#35)(2008-11#28)(2008-12#5)(2008-2#10)(2008-3#17)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#12)(2008-9#8)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#9)(2011-3#1)(2012-12#10)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#13)(2013-7#2)(2013-8#3)
talar osteitis##2##2##(2009-3#2)
talar##6##1##(2009-1#1)(2009-3#2)(2010-5#2)(2011-2#1)
talbot##3##1##(2008-3#3)
talc pleurodesis##2##2##(2006-10#1)(2007-8#1)
talc##9##1##(1993-9#3)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#2)
tale of##5##2##(1993-9#1)(1996-1#1)(2007-8#1)(2009-3#1)(2009-5#1)
tale##11##1##(1993-9#1)(1994-2#1)(1995-2#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-5#1)(2012-2#1)(2013-8#1)
talent##6##1##(1994-2#1)(1995-1#1)(2008-12#2)(2008-7#1)(2012-3#1)
talents to##2##2##(1991-12#1)(2008-10#1)
talents##3##1##(1991-12#1)(2008-1#1)(2008-10#1)
tales from##2##2##(1995-1#1)(1995-12#1)
tales##4##1##(1995-1#1)(1995-12#1)(2013-1#1)(2013-8#1)
talipes##2##1##(1990-9#1)(2009-7#1)
talk about emotions##2##3##(2012-12#2)
talk about##5##2##(1995-2#1)(2008-6#2)(2012-12#2)
talk and##6##2##(2008-2#2)(2008-3#3)(2012-12#1)
talk for##2##2##(2008-5#1)(2012-2#1)
talk in##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
talk of##9##2##(1995-12#1)(2008-2#2)(2008-3#5)(2008-8#1)
talk will##2##2##(2008-3#1)(2008-7#1)
talk with##2##2##(2009-11#1)(2009-12#1)
talk##78##1##(1993-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(2007-11#5)(2007-12#3)(2008-2#14)(2008-3#27)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)
talked about##4##2##(1996-11#1)(2007-7#1)(2013-1#2)
talked to##2##2##(1996-2#1)(1996-8#1)
talked##6##1##(1996-11#1)(1996-2#1)(1996-8#1)(2007-7#1)(2013-1#2)
talking about the##2##3##(1996-5#1)(2008-12#1)
talking about##5##2##(1992-3#1)(1996-5#1)(2008-12#1)(2009-5#1)(2011-2#1)
talking and##2##2##(2010-8#1)(2012-12#1)
talking to##2##2##(1992-3#2)
talking##10##1##(1992-3#3)(1996-5#1)(2008-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
talks and##2##2##(2008-7#1)(2010-12#1)
talks to##2##2##(2008-7#1)(2011-2#1)
talks with##3##2##(1990-6#1)(1991-2#1)(2008-7#1)
talks##16##1##(1990-6#1)(1991-2#1)(2007-5#1)(2008-7#8)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
tall fescue (Festuca arundinacea)##4##4##(2008-10#4)
tall fescue and##2##3##(2008-10#2)
tall fescue leaves##2##3##(2008-10#2)
tall fescue was##2##3##(2008-10#2)
tall fescue##23##2##(2008-10#22)(2008-8#1)
tall stature##4##2##(2008-10#2)(2013-1#2)
tall##30##1##(2008-10#25)(2008-8#1)(2009-2#1)(2013-1#3)
taller in##5##2##(2008-8#5)
taller##11##1##(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#5)(2013-8#1)
tallied##2##1##(2008-10#1)(2012-2#1)
talo-crural joint##4##2##(2007-11#3)(2007-8#1)
talocalcaneal coalition##3##2##(2010-5#3)
talocalcaneal##6##1##(2008-12#1)(2009-10#2)(2010-5#3)
talon cusp##6##2##(2012-2#6)
talonavicular##4##1##(2008-12#1)(2009-10#1)(2010-3#2)
talus is##2##2##(2010-5#2)
talus##8##1##(2008-12#1)(2009-1#1)(2009-5#1)(2010-5#4)(2012-2#1)
tamarillo isolates as C##2##4##(2008-10#2)
tamarillo isolates##4##2##(2008-10#4)
tamarillo##9##1##(2008-10#9)
tamarind fruit##3##2##(2008-5#3)
tamarind##5##1##(2008-5#5)
tamarind's fruit pulp##2##3##(2008-5#2)
tamarins##3##1##(1994-2#3)
tammar wallaby##4##2##(1992-8#2)(1996-5#2)
tamoxifen (TAM)##4##2##(1993-1#2)(1994-7#2)
tamoxifen and progestin##3##3##(1992-2#3)
tamoxifen and##6##2##(1992-2#3)(1994-7#1)(2008-10#2)
tamoxifen in##2##2##(1993-11#1)(2008-10#1)
tamoxifen therapy##2##2##(2008-10#2)
tamoxifen##49##1##(1990-2#1)(1991-4#1)(1991-8#3)(1992-2#4)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#6)(1993-6#1)(1994-7#3)(1995-2#1)(1995-9#1)(1997-7#1)(2008-10#14)(2008-11#3)(2008-4#1)(2008-7#1)(2011-2#2)
tamoxifen&gt##2##1##(2008-11#2)
tamoxifene##2##1##(2013-1#2)
tamponade as##2##2##(1991-6#1)(2007-8#1)
tamponade##13##1##(1991-6#1)(1996-6#1)(2007-10#1)(2007-8#4)(2008-1#2)(2008-11#1)(2010-5#2)(2013-1#1)
tan necrosis##2##2##(2008-10#2)
tan psi##2##2##(2008-3#2)
tan spot and leaf rust##3##5##(2008-10#3)
tan spot and##5##3##(2008-10#5)
tan spot##32##2##(2008-10#32)
tan theta(nu))##2##2##(2008-2#2)
tan##44##1##(2008-10#36)(2008-2#2)(2008-3#3)(2008-5#1)(2012-3#1)(2013-8#1)
tandem G x A##2##4##(1993-11#2)
tandem MS##4##2##(2008-9#2)(2012-12#2)
tandem arrays##2##2##(2008-11#1)(2008-9#1)
tandem conjugate##2##2##(1996-5#1)(2008-9#1)
tandem duplication##2##2##(2008-7#1)(2012-3#1)
tandem duplications##3##2##(2010-3#1)(2010-4#1)(2011-3#1)
tandem lesions##2##2##(1997-2#1)(2013-8#1)
tandem linked##2##2##(2008-8#2)
tandem mass spectra##2##3##(2008-4#1)(2011-2#1)
tandem mass spectrometer##2##3##(2011-1#1)(2011-3#1)
tandem mass spectrometric detection##2##4##(2008-10#1)(2012-1#1)
tandem mass spectrometric method##2##4##(2008-10#1)(2011-1#1)
tandem mass spectrometric##4##3##(2008-10#2)(2011-1#1)(2012-1#1)
tandem mass spectrometry (LC-MS/MS)##3##4##(2008-10#1)(2011-1#2)
tandem mass spectrometry (MS/MS)##3##4##(2008-4#1)(2008-7#1)(2008-8#1)
tandem mass spectrometry##31##3##(1990-7#2)(1994-12#1)(2008-10#11)(2008-4#3)(2008-7#2)(2008-8#1)(2009-11#1)(2010-2#1)(2011-1#6)(2011-2#2)(2012-1#1)
tandem mass##39##2##(1990-7#2)(1994-12#1)(2008-10#13)(2008-4#4)(2008-7#2)(2008-8#1)(2009-11#1)(2010-2#1)(2011-1#8)(2011-2#3)(2011-3#1)(2012-1#2)
tandem pairs##5##2##(2009-5#5)
tandem process##2##2##(2008-3#1)(2009-12#1)
tandem reactions with##2##3##(2012-3#2)
tandem repeat (VNTR)##3##3##(1997-5#1)(2008-10#2)
tandem repeat units and##2##4##(1997-7#2)
tandem repeat##26##2##(1990-12#1)(1991-6#1)(1992-11#1)(1994-9#1)(1995-11#1)(1996-10#1)(1997-5#1)(1997-7#6)(2008-10#2)(2008-11#2)(2008-12#7)(2008-7#1)(2008-9#1)
tandem repeats and##2##3##(1993-8#1)(1995-12#1)
tandem repeats in##2##3##(1990-12#1)(2013-1#1)
tandem repeats of the##2##4##(1991-7#1)(2008-10#1)
tandem repeats of##4##3##(1991-7#1)(1994-12#1)(2008-10#2)
tandem repeats##18##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
tandem running##3##2##(2009-5#3)
tandem technique for the##2##4##(2008-10#2)
tandem with##7##2##(1995-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-7#1)(2013-7#1)
tandem##181##1##(1990-12#4)(1990-7#2)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#3)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#2)(1996-4#1)(1996-5#3)(1997-2#1)(1997-5#1)(1997-7#6)(2007-11#1)(2008-10#32)(2008-11#7)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#2)(2008-7#8)(2008-8#8)(2008-9#7)(2009-11#1)(2009-12#2)(2009-5#9)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#3)(2011-3#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
tandem-flow##2##1##(2008-10#2)
tandemly arranged##2##2##(1991-8#1)(1993-12#1)
tandemly arrayed##3##2##(1990-5#2)(1993-2#1)
tandemly repeated##3##2##(1995-8#1)(1997-6#1)(2008-9#1)
tandemly##9##1##(1990-5#2)(1991-8#1)(1993-12#1)(1993-2#1)(1995-8#2)(1997-6#1)(2008-9#1)
tangelo##4##1##(2008-10#4)
tangent modulus##2##2##(2009-7#1)(2012-2#1)
tangent##8##1##(2008-10#1)(2008-2#2)(2008-3#3)(2009-7#1)(2012-2#1)
tangential cells##3##2##(2008-11#3)
tangential field##2##2##(2009-2#2)
tangential fields##2##2##(2007-10#1)(2009-2#1)
tangential flow filtration##5##3##(2008-10#2)(2008-7#3)
tangential plane##3##2##(2007-12#1)(2008-3#2)
tangential planes##3##2##(2008-3#3)
tangential to##2##2##(1995-5#1)(2010-2#1)
tangential ultrafiltration##3##2##(2008-10#2)(2008-6#1)
tangential##32##1##(1992-5#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#3)(2009-2#4)(2010-2#1)(2010-4#1)(2011-2#1)
tangential-flow##2##1##(2008-10#2)
tangentially##4##1##(1995-12#1)(2006-12#1)(2008-2#1)(2008-3#1)
tangerine pathotype of##2##3##(2008-10#2)
tangerine pathotype##3##2##(2008-10#3)
tangerine##8##1##(2008-10#7)(2012-12#1)
tangerines and##3##2##(2008-10#3)
tangerines##4##1##(1992-10#1)(2008-10#3)
tangible benefits##2##2##(1991-3#1)(2008-11#1)
tangible results##2##2##(1991-3#1)(1994-1#1)
tangible##14##1##(1991-3#2)(1992-12#1)(1994-1#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-10#1)(2013-1#2)
tangle##3##1##(1997-3#1)(2008-7#2)
tangles and abnormal##2##3##(1991-1#1)(1995-3#1)
tangles and##3##2##(1991-1#1)(1995-3#1)(2008-7#1)
tangles##14##1##(1991-1#5)(1992-12#1)(1992-8#2)(1995-3#1)(2008-5#1)(2008-7#3)(2009-11#1)
tangor##3##1##(2008-10#3)
tank in##2##2##(2009-9#2)
tank reactor where##2##3##(2008-10#1)(2008-11#1)
tank reactor##9##2##(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#4)
tank test##2##2##(2008-8#2)
tank##39##1##(1994-1#1)(1996-1#1)(1997-2#1)(2008-10#3)(2008-11#15)(2008-2#1)(2008-4#1)(2008-6#4)(2008-7#5)(2008-8#2)(2009-9#3)(2011-2#2)
tanker##2##1##(2008-10#1)(2008-11#1)
tanks and##3##2##(2008-7#1)(2009-6#1)(2011-2#1)
tanks of##2##2##(2008-7#1)(2013-7#1)
tanks##16##1##(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#4)(2013-7#1)
tankships have##2##2##(2008-11#2)
tankships##5##1##(2008-11#5)
tanned leather##2##2##(2008-10#2)
tanneries##4##1##(2008-10#1)(2009-12#3)
tannery effluents##2##2##(2008-10#2)
tannery wastewater##2##2##(2008-10#2)
tannery##10##1##(2008-10#10)
tannic acid##9##2##(2008-10#8)(2008-8#1)
tannin present in##2##3##(2008-10#2)
tannin##14##1##(2008-10#12)(2010-2#1)(2011-2#1)
tanning ability and##2##3##(1991-6#1)(2008-5#1)
tanning##13##1##(1991-6#1)(1993-5#1)(2008-10#5)(2008-5#4)(2008-9#2)
tannins and##2##2##(2008-12#1)(2009-8#1)
tannins##13##1##(1993-8#1)(2008-10#3)(2008-12#3)(2008-5#1)(2009-8#2)(2011-3#1)(2013-7#1)(2013-8#1)
tannophilus##2##1##(2008-6#2)
tanoak##2##1##(2008-10#2)
tanshinones##4##1##(2008-10#4)
tansy##3##1##(2008-10#3)
tantalum oxide##3##2##(2008-2#2)(2008-3#1)
tantalum##13##1##(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2009-7#1)
tanycytes##4##1##(2012-1#4)
tap and industrial wastewater)##2##4##(2008-10#2)
tap and river water samples##4##5##(2008-10#4)
tap and##16##2##(2008-10#16)
tap water and river water##2##5##(2008-10#2)
tap water and wastewater samples##2##5##(2008-10#2)
tap water and wastewater##3##4##(2008-10#3)
tap water and##21##3##(2008-10#20)(2008-8#1)
tap water sample##2##3##(2008-10#2)
tap water samples and##2##4##(2008-10#2)
tap water samples##13##3##(2008-10#13)
tap water##71##2##(2008-10#64)(2008-12#2)(2008-5#2)(2008-8#1)(2011-2#1)(2013-8#1)
tap waters##3##2##(2008-10#3)
tap##107##1##(1993-10#2)(1994-11#1)(2008-10#95)(2008-12#2)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
tap*&quot##2##1##(2013-1#2)
tape recorded##3##2##(1991-12#1)(2008-10#1)(2008-12#1)
tape stripping##4##2##(2008-5#4)
tape##21##1##(1991-12#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#7)(2013-7#1)
tape-recorded lung sounds##3##3##(1993-12#3)
taped interviews##2##2##(2008-11#2)
taped##3##1##(1996-3#1)(2008-11#2)
taper and##2##2##(2007-12#1)(2008-3#1)
taper is##3##2##(2007-11#2)(2008-3#1)
taper structure##2##2##(2007-11#2)
taper waist##2##2##(2008-3#2)
taper##30##1##(2007-11#7)(2007-12#5)(2008-2#7)(2008-3#9)(2011-1#1)(2013-1#1)
tapered PWG##3##2##(2008-2#1)(2008-3#2)
tapered PWG's##2##2##(2008-3#2)
tapered air-silica microstructure fiber##2##4##(2007-11#2)
tapered amplifier##5##2##(2007-12#1)(2008-2#4)
tapered directional coupler##2##3##(2008-3#2)
tapered fiber##5##2##(2007-11#4)(2007-12#1)
tapered hollow##2##2##(2008-2#2)
tapered optical##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
tapered thin-film planar waveguide##2##4##(2008-2#1)(2008-3#1)
tapered waveguide##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
tapered##59##1##(1996-2#1)(2007-11#14)(2007-12#8)(2007-7#1)(2008-10#2)(2008-2#11)(2008-3#19)(2008-7#1)(2011-2#2)
taperin##5##1##(2012-12#5)
tapering##5##1##(1997-8#1)(2008-2#1)(2008-3#1)(2008-7#2)
tapers##9##1##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)(2008-7#1)(2013-1#1)
tapes##4##1##(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
tapeworm##5##1##(1993-6#2)(1995-12#1)(2008-7#1)(2011-2#1)
taping on##2##2##(2007-11#1)(2010-9#1)
taping##8##1##(1995-12#1)(2007-11#2)(2008-10#1)(2008-9#1)(2010-9#1)(2013-1#2)
tapioca starch##3##2##(2008-5#3)
tapioca##4##1##(2008-5#4)
tapir##3##1##(2008-5#3)
tapped##3##1##(1994-12#1)(1994-2#1)(2010-11#1)
tapping mode##2##2##(2008-10#1)(2012-2#1)
tapping tasks##2##2##(1994-3#1)(2012-2#1)
tapping time##2##2##(2008-3#2)
tapping##21##1##(1991-12#2)(1994-12#3)(1994-2#1)(1994-3#5)(2008-10#2)(2008-3#2)(2008-7#1)(2009-5#1)(2012-2#3)(2012-3#1)
taproots##4##1##(2008-10#4)
taps##4##1##(1995-8#1)(1997-1#1)(2007-12#1)(2012-1#1)
tapwater and upland soil extracts##2##5##(2008-10#2)
tapwater and##4##2##(2008-10#4)
tapwater##6##1##(2008-10#6)
tar##5##1##(1995-5#1)(1997-4#1)(2008-10#1)(2009-7#2)
tarabine PFS and##5##3##(2008-10#5)
tarabine PFS##6##2##(2008-10#6)
tarantula (Brachypelma##2##2##(2009-4#2)
tarantula##4##1##(1990-8#1)(2009-4#3)
tardive dyskinesia##3##2##(1995-8#1)(1996-2#1)(1996-7#1)
tardive syndromes##2##2##(2008-7#2)
tardive##6##1##(1995-8#1)(1996-2#1)(1996-7#1)(2008-7#3)
tardy diagnosis##2##2##(1995-6#1)(2008-7#1)
target DNA fragment##2##3##(1995-8#1)(2008-10#1)
target DNA in##3##3##(2008-8#2)(2013-1#1)
target DNA sequence##3##3##(2008-10#2)(2008-4#1)
target DNA##26##2##(1992-3#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-3#1)(2008-10#14)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2013-1#1)
target DNAs##3##2##(1993-11#1)(1993-12#1)(2008-10#1)
target LDL-C##4##2##(2011-2#1)(2013-1#3)
target ODN##2##2##(2008-10#2)
target RPEs that##2##3##(2013-8#2)
target a##3##2##(2009-4#1)(2010-5#1)(2011-2#1)
target acquisition##4##2##(1991-6#1)(2008-3#2)(2008-7#1)
target against##2##2##(2011-1#1)(2012-2#1)
target amplification##2##2##(2008-7#2)
target analyte##7##2##(2008-10#6)(2009-11#1)
target analytes##11##2##(2008-10#8)(2008-8#1)(2012-2#1)(2013-1#1)
target and the##4##3##(1995-1#1)(2008-7#1)(2010-5#1)(2010-7#1)
target and##20##2##(1990-12#1)(1993-12#1)(1995-1#1)(1995-6#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
target antigen##5##2##(2008-10#1)(2008-11#1)(2008-9#3)
target antigens##2##2##(2008-7#1)(2008-9#1)
target are##3##2##(1994-3#1)(2007-11#1)(2008-3#1)
target area##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
target areas##4##2##(1991-5#1)(2007-11#1)(2008-7#2)
target as##2##2##(2008-11#1)(2008-5#1)
target attainment of AUC/MIC##2##4##(2011-2#2)
target attainment##3##2##(2011-2#3)
target audience##4##2##(1996-2#1)(2008-7#1)(2010-11#1)(2013-1#1)
target blood pressure##2##3##(2008-1#1)(2010-4#1)
target both##2##2##(2008-1#1)(2008-12#1)
target can be##2##3##(1991-2#1)(2009-11#1)
target cancer##2##2##(2010-12#1)(2010-5#1)
target cell##20##2##(1990-12#1)(1992-11#1)(1993-9#1)(1994-2#2)(2006-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-1#2)(2011-3#1)(2012-2#1)
target cells and##3##3##(1996-2#1)(2010-10#1)(2011-1#1)
target cells by##2##3##(1993-3#1)(2008-11#1)
target cells from##2##3##(2008-10#1)(2008-4#1)
target cells in the##3##4##(2008-4#1)(2008-5#1)(2008-7#1)
target cells in##5##3##(1991-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
target cells is##2##3##(1990-12#1)(2008-4#1)
target cells of##3##3##(1993-3#1)(2008-11#2)
target cells or##2##3##(1997-8#1)(2008-4#1)
target cells to##3##3##(2008-11#1)(2008-4#2)
target cells was##3##3##(1991-9#1)(1995-3#1)(2008-11#1)
target cells##77##2##(1990-12#5)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#5)(1993-3#3)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#4)(1995-3#1)(1996-2#1)(1997-4#1)(1997-8#3)(2006-10#1)(2008-10#1)(2008-11#11)(2008-12#1)(2008-4#12)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
target classification##2##2##(2008-11#1)(2013-1#1)
target compounds were##3##3##(2008-10#2)(2011-3#1)
target compounds##10##2##(2007-11#1)(2008-10#7)(2011-3#1)(2013-1#1)
target date##2##2##(1996-1#1)(2009-6#1)
target detection and##2##3##(2008-2#1)(2008-3#1)
target detection in##2##3##(2008-2#1)(2008-3#1)
target detection##7##2##(2008-11#1)(2008-2#3)(2008-3#3)
target different##3##2##(2009-7#1)(2012-3#2)
target during##3##2##(1992-9#1)(2009-8#1)(2011-2#1)
target elements composed of##2##4##(1995-8#2)
target enzyme##3##2##(1990-7#1)(1997-4#1)(2008-5#1)
target enzymes##2##2##(2007-11#1)(2009-9#1)
target factor analysis##4##3##(2008-10#4)
target factor##5##2##(2008-10#5)
target for a##2##3##(1992-9#1)(1995-2#1)
target for anti-cancer therapy##2##4##(1997-1#1)(2013-1#1)
target for anti-cancer##4##3##(1997-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
target for anticancer drug##3##4##(2008-5#1)(2010-7#1)(2012-2#1)
target for cancer immunotherapy##2##4##(2008-11#2)
target for cancer therapy##4##4##(2008-11#1)(2011-2#2)(2012-2#1)
target for cancer##9##3##(1995-2#1)(2007-4#1)(2008-11#3)(2011-2#3)(2012-2#1)
target for novel##3##3##(2008-5#2)(2010-2#1)
target for the development of##2##5##(2012-2#1)(2013-1#1)
target for the treatment of##5##5##(2008-1#1)(2012-2#3)(2013-1#1)
target for the##13##3##(1993-8#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#4)(2013-1#2)
target for therapeutic intervention##4##4##(2007-10#1)(2009-4#1)(2010-3#1)(2011-1#1)
target for therapeutic##5##3##(2007-10#1)(2007-8#1)(2009-4#1)(2010-3#1)(2011-1#1)
target for therapy of##2##4##(2010-3#1)(2011-3#1)
target for therapy##3##3##(2008-11#1)(2010-3#1)(2011-3#1)
target for these##2##3##(2008-1#1)(2011-2#1)
target for##116##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#4)(1995-5#1)(1995-9#2)(1996-1#1)(1997-1#2)(1997-4#2)(1997-7#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#11)(2011-3#2)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
target frequency##2##2##(2007-7#2)
target from a##2##3##(2008-2#1)(2008-4#1)
target gene expression##4##3##(1996-12#1)(2008-5#1)(2009-8#1)(2011-1#1)
target gene##18##2##(1991-9#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)
target gene(s)##3##2##(1994-12#1)(2008-2#2)
target generated##2##2##(2008-2#2)
target genes and##3##3##(1997-4#1)(2008-4#1)(2011-2#1)
target genes have##2##3##(1997-7#1)(2011-2#1)
target genes in##2##3##(1996-12#1)(2008-9#1)
target genes of##3##3##(2008-9#1)(2012-12#1)(2013-8#1)
target genes such as##2##4##(2009-3#1)(2010-7#1)
target genes##38##2##(1991-2#1)(1994-8#1)(1996-12#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#6)(2009-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
target group##3##2##(2010-12#1)(2012-1#1)(2012-2#1)
target groups##3##2##(1992-12#1)(2008-1#1)(2008-12#1)
target has been##2##3##(2007-11#1)(2008-3#1)
target have##2##2##(2007-11#1)(2008-11#1)
target hemoglobin##2##2##(2008-1#1)(2008-7#1)
target host factors required for##2##5##(2008-10#1)(2012-2#1)
target identification##3##2##(2008-5#3)
target images##2##2##(2008-2#2)
target in a scattering##2##4##(2008-3#2)
target in a##4##3##(2008-10#1)(2008-3#3)
target in the##6##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
target in##24##2##(1990-4#1)(1992-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#5)(2008-5#2)(2008-8#1)(2009-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
target is##9##2##(1991-2#1)(2007-11#1)(2008-11#1)(2008-3#3)(2009-11#1)(2009-4#1)(2011-2#1)
target lesion##2##2##(2008-11#1)(2010-8#1)
target lesions of##2##3##(1990-11#2)
target lesions##5##2##(1990-11#2)(2010-8#2)(2012-2#1)
target location in##2##3##(2007-12#1)(2008-3#1)
target location##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
target mRNA##7##2##(1996-12#2)(2008-10#1)(2008-4#3)(2013-1#1)
target molecule##4##2##(1992-3#1)(1994-2#1)(2008-6#1)(2009-10#1)
target molecules##9##2##(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2013-1#1)
target multiple##2##2##(2009-12#1)(2013-1#1)
target neuron##2##2##(2008-11#2)
target nucleic##2##2##(2008-10#1)(2008-9#1)
target nucleobases##2##2##(2008-10#2)
target number of##2##3##(2008-10#1)(2008-8#1)
target object##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
target of interest##2##3##(1994-8#1)(2008-1#1)
target of rapamycin (mTOR)##8##4##(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#3)
target of rapamycin##9##3##(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2013-1#3)
target of the protein##2##4##(1995-2#1)(2011-2#1)
target of the##3##3##(1995-2#1)(2008-8#1)(2011-2#1)
target of these##2##3##(1995-2#1)(2011-2#1)
target of this##3##3##(2008-10#1)(2009-6#1)(2010-12#1)
target of##48##2##(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-8#2)(1995-2#2)(1996-5#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#2)(2009-7#1)(2010-12#1)(2011-2#7)(2012-2#2)(2013-1#3)
target oligonucleotide##2##2##(2008-10#2)
target on##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
target or##2##2##(2008-4#1)(2008-8#1)
target organ damage##3##3##(2009-1#3)
target organ for##2##3##(1992-12#1)(2012-2#1)
target organ of##4##3##(1990-5#1)(1992-9#1)(2008-5#1)(2011-1#1)
target organ responses##2##3##(2008-7#2)
target organ##18##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-1#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
target organs##5##2##(1996-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)
target population##13##2##(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#3)
target position in relation to the body##2##7##(1995-5#2)
target prediction##2##2##(2008-11#1)(2013-8#1)
target protein in##2##3##(2008-4#1)(2008-7#1)
target protein##15##2##(1994-11#1)(1994-9#2)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-7#1)(2009-9#1)
target proteins of##2##3##(1990-11#1)(2012-3#1)
target proteins##12##2##(1990-11#1)(1997-4#2)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2012-3#1)
target range##2##2##(2008-2#1)(2008-3#1)
target recognition##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-8#1)
target selection##4##2##(2008-6#1)(2008-7#1)(2012-2#2)
target sequence in##2##3##(2008-10#1)(2008-9#1)
target sequence##18##2##(1993-11#1)(1994-12#2)(1994-9#1)(2008-10#5)(2008-12#4)(2008-2#2)(2008-4#2)(2008-9#1)
target sequences##10##2##(1995-5#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#3)(2013-8#1)
target signature##2##2##(2008-3#2)
target site duplication##2##3##(2012-3#2)
target site for##3##3##(1991-2#1)(1994-2#1)(2008-10#1)
target site of##2##3##(1994-11#1)(2007-8#1)
target site##15##2##(1990-11#2)(1991-2#4)(1993-11#1)(1994-11#1)(1994-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-3#2)
target sites##14##2##(1990-11#1)(1995-5#1)(1995-8#1)(1996-9#2)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
target size and##2##3##(2008-3#1)(2008-8#1)
target size##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
target species##6##2##(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
target specific##2##2##(2008-11#1)(2012-2#1)
target specificity##2##2##(2008-10#2)
target ssDNA##2##2##(2008-10#2)
target ssDNA(I)##2##2##(2008-10#2)
target stimuli##4##2##(1996-5#1)(2008-6#1)(2009-4#1)(2010-7#1)
target surface##4##2##(2008-3#2)(2013-1#2)
target that is##2##3##(2008-2#1)(2008-3#1)
target that##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
target the##21##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#1)
target therapy##3##2##(2010-8#1)(2011-2#1)(2012-3#1)
target this##2##2##(2009-7#1)(2011-2#1)
target tissue##6##2##(2008-1#1)(2008-10#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#1)
target tissues and##2##3##(1993-3#1)(1995-12#1)
target tissues##14##2##(1991-12#1)(1991-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-4#2)(1997-7#1)(2008-4#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
target to##9##2##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-5#1)(2009-6#1)(2013-8#1)
target tumor##2##2##(1990-11#1)(2008-11#1)
target using##2##2##(2008-10#1)(2008-11#1)
target validation##2##2##(2008-11#1)(2013-1#1)
target value of##2##3##(2008-10#2)
target value##3##2##(2008-10#2)(2011-2#1)
target vessel##2##2##(2007-8#1)(2008-11#1)
target volume##10##2##(1993-9#2)(2008-2#5)(2008-6#1)(2009-11#2)
target volumes defined##2##3##(2012-12#2)
target volumes for##3##3##(2008-2#2)(2012-12#1)
target volumes##7##2##(2008-2#2)(2012-12#5)
target was an##2##3##(2009-4#1)(2010-2#1)
target was##8##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-2#1)(2012-2#1)
target weight##6##2##(2013-1#6)
target were##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
target with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
target with##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
target words##2##2##(2009-8#1)(2012-1#1)
target##1275##1##(1990-11#7)(1990-12#7)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#3)(1991-6#5)(1991-9#10)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#2)(1993-9#5)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#9)(1994-9#3)(1995-1#5)(1995-12#4)(1995-2#15)(1995-3#3)(1995-5#9)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#2)(1996-12#8)(1996-2#5)(1996-5#3)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#10)(1997-5#1)(1997-7#4)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#19)(2007-12#18)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#26)(2008-10#164)(2008-11#72)(2008-12#12)(2008-2#61)(2008-3#77)(2008-4#46)(2008-5#25)(2008-6#16)(2008-7#37)(2008-8#31)(2008-9#29)(2009-1#3)(2009-10#1)(2009-11#10)(2009-12#6)(2009-2#3)(2009-3#1)(2009-4#10)(2009-5#6)(2009-6#10)(2009-7#8)(2009-8#13)(2009-9#5)(2010-1#2)(2010-10#8)(2010-11#6)(2010-12#6)(2010-2#6)(2010-3#5)(2010-4#5)(2010-5#11)(2010-6#1)(2010-7#8)(2010-8#14)(2010-9#1)(2011-1#21)(2011-2#63)(2011-3#5)(2012-1#7)(2012-12#24)(2012-2#36)(2012-3#18)(2013-1#56)(2013-7#2)(2013-8#19)
target(s)##2##1##(1997-3#1)(2012-2#1)
target-based screening##2##2##(1997-4#2)
target-based##4##1##(1997-4#3)(2009-6#1)
target-cell##2##1##(1993-9#1)(2008-4#1)
target-date funds##3##2##(2011-2#3)
target-derived##2##1##(1990-5#1)(1996-12#1)
target-object light levels##2##3##(2008-2#2)
target-oriented##2##1##(2008-10#2)
target-specific##4##1##(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
target?##2##1##(1995-3#1)(2011-2#1)
targeted ES cell##2##3##(2008-11#1)(2008-9#1)
targeted ES cells using##2##4##(2008-8#2)
targeted ES cells##3##3##(2008-11#1)(2008-8#2)
targeted ES##5##2##(2008-11#2)(2008-8#2)(2008-9#1)
targeted against##3##2##(2008-10#3)
targeted agents##4##2##(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
targeted and##8##2##(1997-1#1)(2008-11#2)(2008-7#2)(2009-3#1)(2010-10#1)(2012-2#1)
targeted antibiotic therapy and##2##4##(2007-8#1)(2011-2#1)
targeted approach##3##2##(1991-2#1)(2008-7#1)(2009-12#1)
targeted at the##3##3##(1997-4#1)(2008-10#1)(2009-10#1)
targeted at##10##2##(1993-11#1)(1995-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-3#2)(2009-10#1)(2010-3#1)(2012-2#1)
targeted by small molecules##2##4##(2010-12#1)(2011-2#1)
targeted by the##3##3##(2009-4#1)(2012-2#1)(2012-3#1)
targeted by##15##2##(2007-8#1)(2008-10#2)(2008-8#2)(2009-4#2)(2009-8#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
targeted cancer therapy##3##3##(2008-7#1)(2011-1#2)
targeted clones##2##2##(2008-11#2)
targeted communities##3##2##(1995-2#1)(2010-8#1)(2013-1#1)
targeted contrast##3##2##(2008-8#1)(2010-9#2)
targeted delivery of##3##3##(2008-7#1)(2010-5#2)
targeted disruption of##4##3##(1994-12#2)(2008-7#1)(2010-11#1)
targeted drug delivery##3##3##(2007-11#1)(2008-8#1)(2011-1#1)
targeted drugs##3##2##(2010-12#1)(2010-4#1)(2010-5#1)
targeted for##13##2##(1994-3#1)(1995-3#1)(1996-11#2)(1996-2#1)(2008-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)
targeted gene##2##2##(2011-1#1)(2013-1#1)
targeted genes##2##2##(2008-10#1)(2008-7#1)
targeted in##7##2##(1994-2#1)(1995-11#1)(1997-2#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
targeted interventions##3##2##(2008-10#1)(2009-7#1)(2012-3#1)
targeted magnetic##2##2##(2012-2#1)(2012-3#1)
targeted on the##2##3##(1994-2#1)(2008-5#1)
targeted quantitative##2##2##(2008-9#2)
targeted rotation##2##2##(2008-11#2)
targeted surveillance##2##2##(2011-2#1)(2012-3#1)
targeted the##2##2##(2008-10#1)(2008-6#1)
targeted therapeutic##2##2##(2008-6#1)(2010-4#1)
targeted therapies for##3##3##(2009-1#1)(2010-10#1)(2012-1#1)
targeted therapies##11##2##(2008-2#1)(2008-7#1)(2009-1#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
targeted therapy in##2##3##(2008-2#1)(2011-3#1)
targeted therapy##6##2##(2007-10#1)(2008-2#1)(2008-7#1)(2011-3#2)(2012-2#1)
targeted to the##6##3##(2008-10#1)(2008-9#1)(2009-7#1)(2010-5#2)(2011-2#1)
targeted to##24##2##(1994-5#1)(1995-11#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
targeted toward the##3##3##(1997-2#1)(1997-5#1)(2010-2#1)
targeted towards##2##2##(1991-9#1)(2007-7#1)
targeted toxins for##2##3##(2008-5#2)
targeted toxins##5##2##(2008-5#5)
targeted treatment##4##2##(1990-6#1)(2008-7#1)(2012-12#1)(2013-8#1)
targeted use of##2##3##(2008-10#1)(2008-7#1)
targeted with##2##2##(1993-9#1)(2013-1#1)
targeted##294##1##(1990-6#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-11#3)(1996-2#4)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#22)(2008-11#11)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#16)(2008-8#6)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-7#4)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#9)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#10)(2011-2#12)(2011-3#5)(2012-1#4)(2012-12#9)(2012-2#16)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#4)
targeting a specific##2##3##(2008-6#1)(2013-1#1)
targeting a##6##2##(1995-6#1)(1996-12#1)(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#1)
targeting and transcytosis##2##3##(2009-10#2)
targeting and##6##2##(1997-3#1)(2008-1#1)(2009-10#2)(2009-11#1)(2012-12#1)
targeting at##2##2##(2008-11#1)(2011-1#1)
targeting by##2##2##(2008-4#1)(2009-4#1)
targeting construct##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
targeting for##5##2##(1994-5#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
targeting fungal##2##2##(2008-10#1)(2011-2#1)
targeting gene delivery system##2##4##(2008-8#2)
targeting genes##2##2##(2012-12#1)(2012-2#1)
targeting in##7##2##(1993-11#1)(1995-2#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-6#1)
targeting is##4##2##(2008-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
targeting lesbian##2##2##(2008-12#2)
targeting methods##2##2##(2009-12#2)
targeting multiple##2##2##(2011-2#1)(2013-1#1)
targeting of its##2##3##(2008-11#1)(2012-3#1)
targeting of the##5##3##(1991-6#1)(1995-2#1)(2007-12#1)(2007-5#1)(2012-2#1)
targeting of these##2##3##(1990-12#1)(2009-8#1)
targeting of##32##2##(1990-12#1)(1991-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
targeting potential##2##2##(1993-11#2)
targeting sequence##2##2##(1990-11#1)(1994-8#1)
targeting sequences##2##2##(1994-8#1)(2008-1#1)
targeting signal of##2##3##(1994-9#1)(1997-4#1)
targeting signal##3##2##(1994-12#1)(1994-9#1)(1997-4#1)
targeting specific##3##2##(1995-5#1)(2010-8#1)(2012-3#1)
targeting strategies##4##2##(2010-2#1)(2011-2#2)(2012-2#1)
targeting subunits##2##2##(2012-12#2)
targeting the conserved##3##3##(1997-6#1)(2008-10#2)
targeting the##31##2##(1990-5#1)(1994-11#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
targeting these##4##2##(2008-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
targeting this##4##2##(2008-5#1)(2010-3#1)(2011-2#1)(2013-8#1)
targeting to the##2##3##(1994-8#1)(2009-8#1)
targeting to##3##2##(1994-8#1)(2009-10#1)(2009-8#1)
targeting vector##3##2##(2008-10#1)(2008-9#2)
targeting were##2##2##(2009-10#1)(2013-1#1)
targeting youth##2##2##(2011-1#1)(2012-12#1)
targeting##268##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#2)(1991-6#1)(1992-12#3)(1992-3#1)(1993-11#4)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#7)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#4)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#5)(2008-10#8)(2008-11#17)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#9)(2009-10#9)(2009-11#2)(2009-12#6)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#13)(2011-3#4)(2012-1#2)(2012-12#13)(2012-2#12)(2012-3#7)(2013-1#20)(2013-8#2)
targeting&quot##2##1##(1997-1#1)(2008-3#1)
targets and biomarkers##3##3##(2013-1#3)
targets and pathways##2##3##(2010-6#1)(2012-2#1)
targets and##33##2##(1992-1#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#4)(2009-12#3)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#5)
targets are present##2##3##(1992-12#1)(2008-3#1)
targets are##6##2##(1992-12#1)(2008-3#4)(2009-8#1)
targets as##4##2##(2008-11#1)(2008-7#1)(2009-12#1)(2012-3#1)
targets at the##2##3##(1995-1#1)(2007-7#1)
targets at##4##2##(1995-1#1)(2007-7#1)(2008-3#1)(2011-2#1)
targets by##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
targets can be##2##3##(2008-3#1)(2009-3#1)
targets during##2##2##(2008-10#1)(2008-2#1)
targets elicited##2##2##(2008-11#2)
targets embedded in a##2##4##(2007-11#1)(2008-11#1)
targets for action##2##3##(1991-2#1)(2008-11#1)
targets for chemoprevention##2##3##(2011-2#2)
targets for chemotherapy##2##3##(1991-5#1)(1997-7#1)
targets for future##2##3##(1995-6#1)(2012-3#1)
targets for immunotherapy##2##3##(2008-6#1)(2010-12#1)
targets for prevention##2##3##(1997-2#1)(2008-7#1)
targets for the development of##3##5##(2008-10#1)(2011-2#2)
targets for the treatment of##2##5##(2008-5#1)(2011-1#1)
targets for the year 2015##2##5##(2008-8#2)
targets for the##11##3##(1996-1#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#3)(2013-7#1)
targets for therapeutic intervention##3##4##(2008-11#1)(2008-8#1)(2010-3#1)
targets for therapeutic##5##3##(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#2)
targets for therapy##4##3##(2008-4#1)(2011-2#2)(2012-2#1)
targets for this##2##3##(2008-5#1)(2010-11#1)
targets for##79##2##(1991-2#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
targets have been##3##3##(2007-12#1)(2009-12#1)(2010-8#1)
targets have##4##2##(2007-12#1)(2009-12#1)(2009-9#1)(2010-8#1)
targets in the##11##3##(1990-5#1)(1996-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
targets in various##2##3##(1994-3#1)(2009-8#1)
targets in##30##2##(1990-5#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
targets involved##2##2##(2008-7#1)(2012-1#1)
targets is##2##2##(2009-12#1)(2012-3#1)
targets led to##2##3##(2010-8#1)(2012-2#1)
targets more##2##2##(2012-2#2)
targets of DNA##2##3##(1991-5#1)(2007-11#1)
targets of DNA-binding proteins##3##4##(2008-2#3)
targets of Hox protein Ultrabithorax##2##5##(2012-2#2)
targets of Notch signaling in##2##5##(2007-12#2)
targets of a##2##3##(1992-3#1)(2008-1#1)
targets of the##6##3##(1995-2#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
targets of this##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
targets of##49##2##(1991-5#2)(1992-12#1)(1992-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
targets on##2##2##(2008-3#1)(2012-2#1)
targets or##3##2##(2008-3#1)(2009-9#1)(2012-3#1)
targets such as##5##3##(2008-3#3)(2010-12#1)(2010-5#1)
targets than##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
targets that are##2##3##(2008-3#1)(2012-2#1)
targets that is##2##3##(2008-2#1)(2008-5#1)
targets that##11##2##(1995-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#1)
targets the##6##2##(1993-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
targets through##2##2##(1991-2#1)(1994-8#1)
targets to##7##2##(1994-8#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
targets were##9##2##(1996-5#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-7#1)
targets will##2##2##(2009-8#1)(2013-1#1)
targets with##5##2##(1994-12#1)(1994-8#1)(2007-12#1)(2008-3#1)(2013-8#1)
targets##471##1##(1990-5#2)(1991-2#2)(1991-5#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#4)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#25)(2008-11#25)(2008-12#4)(2008-2#18)(2008-3#32)(2008-4#17)(2008-5#9)(2008-6#4)(2008-7#30)(2008-8#5)(2008-9#15)(2009-1#1)(2009-10#1)(2009-12#13)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#12)(2010-3#4)(2010-5#7)(2010-6#2)(2010-7#7)(2010-8#4)(2011-1#5)(2011-2#23)(2011-3#5)(2012-1#4)(2012-12#10)(2012-2#27)(2012-3#10)(2013-1#15)(2013-7#5)(2013-8#14)
targets'##2##1##(2008-11#1)(2010-7#1)
targetting##3##1##(1991-2#2)(2008-8#1)
tarnished##4##1##(1997-7#1)(2007-12#2)(2008-3#1)
tarred##2##1##(1997-4#2)
tarsal coalition##3##2##(2009-10#3)
tarsal##7##1##(2007-11#1)(2007-12#2)(2009-10#4)
tarsus length##2##2##(2008-8#2)
tartarate##3##1##(1992-2#1)(2008-10#2)
tartaric acid in##2##3##(2008-10#2)
tartaric acid with##2##3##(2008-10#2)
tartaric acid##22##2##(2008-10#14)(2008-5#6)(2010-3#2)
tartaric##29##1##(2008-10#20)(2008-5#7)(2010-3#2)
tartrate and##2##2##(2008-10#2)
tartrate##18##1##(1990-8#1)(2008-10#13)(2008-6#2)(2012-2#2)
tartrazine and##3##2##(2008-10#3)
tartrazine##7##1##(2008-10#7)
task (i##2##2##(2008-11#1)(2013-8#1)
task analysis and##2##3##(2009-10#1)(2012-2#1)
task analysis##3##2##(2009-10#1)(2010-7#1)(2012-2#1)
task and the##4##3##(2007-7#1)(2008-4#1)(2009-11#1)(2013-8#1)
task and to##2##3##(1996-2#1)(2008-11#1)
task and##21##2##(1991-2#1)(1992-11#2)(1994-3#2)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-11#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
task as##2##2##(1995-3#1)(2008-4#1)
task at##5##2##(1994-8#3)(1997-2#1)(2013-1#1)
task but##2##2##(2007-8#1)(2013-8#1)
task by##3##2##(1994-8#1)(2008-7#1)(2012-2#1)
task can##2##2##(2007-12#1)(2008-4#1)
task decomposition##2##2##(2011-2#2)
task demands##2##2##(1991-1#1)(2012-1#1)
task depends on the##2##4##(2008-10#1)(2010-2#1)
task difficulty and response correctness##2##5##(2008-11#2)
task difficulty and##3##3##(2008-11#3)
task difficulty##7##2##(1995-12#1)(2008-11#5)(2013-8#1)
task during##2##2##(1991-2#1)(2009-8#1)
task faster than##2##3##(1994-8#1)(2012-2#1)
task for the##2##3##(1990-9#1)(2008-3#1)
task for which##2##3##(2007-8#1)(2009-5#1)
task for##16##2##(1990-9#1)(1991-6#1)(1994-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-12#1)
task force##9##2##(1994-1#2)(1994-12#2)(1994-3#1)(1995-2#1)(1997-3#1)(2008-6#1)(2013-1#1)
task forces##3##2##(1992-1#1)(1995-2#1)(2008-10#1)
task has##2##2##(2008-10#1)(2008-4#1)
task in a T-maze##2##4##(1993-3#2)
task in a##4##3##(1993-3#2)(2013-8#2)
task in mice##2##3##(1993-5#1)(2008-4#1)
task in the Morris water maze##2##6##(1993-12#1)(1993-3#1)
task in the##6##3##(1993-12#1)(1993-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
task in which##2##3##(1994-3#2)
task in##23##2##(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1994-3#2)(1995-12#1)(1995-5#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-2#1)(2013-8#3)
task is##14##2##(1992-11#1)(1993-12#1)(1995-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2013-1#1)(2013-8#1)
task measuring##2##2##(1992-11#1)(2008-1#1)
task more##2##2##(1994-8#2)
task of##25##2##(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-4#1)(2012-12#1)(2013-1#3)
task on##2##2##(1994-8#1)(1995-5#1)
task only##2##2##(1991-2#1)(2009-10#1)
task or##2##2##(1994-3#1)(2013-7#1)
task performance in##2##3##(1991-1#1)(1996-5#1)
task performance##14##2##(1991-1#2)(1992-11#1)(1994-8#1)(1995-12#1)(1996-5#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-8#2)(2013-1#3)
task than any other group##2##5##(1991-2#2)
task that involved##2##3##(2008-10#1)(2008-11#1)
task that requires##2##3##(2008-10#1)(2012-2#1)
task that##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
task to##6##2##(1995-11#1)(1995-5#1)(1996-1#1)(2008-11#1)(2008-9#1)(2012-3#1)
task training##2##2##(2012-2#2)
task using##4##2##(1993-3#1)(1994-3#1)(1996-2#1)(2010-7#1)
task variables##2##2##(1990-11#1)(2009-2#1)
task was to##2##3##(1994-8#1)(2008-6#1)
task was##14##2##(1993-3#1)(1994-3#1)(1994-8#1)(1996-5#1)(2008-11#3)(2008-6#2)(2008-8#1)(2009-10#1)(2010-5#1)(2012-1#1)(2013-1#1)
task were##5##2##(1994-3#1)(1996-2#1)(2008-8#1)(2010-5#1)(2013-8#1)
task where##2##2##(2008-11#1)(2011-2#1)
task which##2##2##(1992-11#1)(2008-12#1)
task with##6##2##(1993-12#1)(1994-3#1)(2009-10#1)(2010-3#1)(2012-3#1)(2013-8#1)
task##455##1##(1990-11#2)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#8)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#11)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#6)(1993-2#1)(1993-3#10)(1993-5#3)(1993-6#3)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#19)(1994-5#1)(1994-6#1)(1994-8#25)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#6)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#6)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#1)(2007-10#1)(2007-12#9)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#24)(2008-11#35)(2008-12#7)(2008-2#6)(2008-3#10)(2008-4#17)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#8)(2009-10#10)(2009-11#2)(2009-12#1)(2009-2#3)(2009-5#7)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#6)(2010-3#1)(2010-5#4)(2010-7#3)(2010-8#8)(2011-1#1)(2011-2#14)(2011-4#1)(2012-1#7)(2012-12#4)(2012-2#15)(2012-3#11)(2013-1#18)(2013-7#1)(2013-8#23)
task)##8##1##(1994-3#4)(1997-2#1)(2008-11#1)(2013-1#1)(2013-8#1)
task-irrelevant perceptual learning##2##3##(2010-5#2)
task-irrelevant##7##1##(2008-11#2)(2010-5#3)(2010-7#1)(2012-2#1)
task-related##3##1##(1991-6#1)(1995-2#1)(2009-6#1)
task-relevant and task-irrelevant##2##3##(2010-5#2)
task-relevant##5##1##(2008-11#2)(2010-5#2)(2010-7#1)
task-shifting##3##1##(2010-11#2)(2010-12#1)
tasked with##2##2##(2011-2#1)(2013-1#1)
tasks (passive##2##2##(1993-12#1)(2008-11#1)
tasks and##19##2##(1991-6#2)(1992-12#1)(1994-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#5)
tasks are##3##2##(2008-11#1)(2008-7#1)(2009-10#1)
tasks as well as the##2##5##(2009-5#1)(2012-3#1)
tasks as##4##2##(2008-11#1)(2008-7#1)(2009-5#1)(2012-3#1)
tasks assigned##2##2##(2008-9#1)(2011-2#1)
tasks associated with##3##3##(2008-10#2)(2010-7#1)
tasks can##2##2##(2013-1#1)(2013-8#1)
tasks for##4##2##(1992-1#1)(1996-12#1)(2008-2#1)(2013-7#1)
tasks have been##2##3##(2007-9#1)(2009-11#1)
tasks in a##2##3##(2009-11#1)(2010-12#1)
tasks in the##4##3##(2008-11#1)(2008-3#1)(2013-8#2)
tasks in##15##2##(2008-11#3)(2008-3#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#3)
tasks including##2##2##(2009-12#1)(2009-4#1)
tasks of##9##2##(1990-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
tasks on the##3##3##(1997-2#2)(2008-11#1)
tasks on##4##2##(1997-2#2)(2008-11#1)(2010-3#1)
tasks related to the##2##4##(2009-7#1)(2013-8#1)
tasks requiring##3##2##(2008-11#2)(2012-1#1)
tasks such as##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
tasks that##9##2##(1990-4#1)(1991-6#1)(1993-12#1)(1993-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-12#1)
tasks to##3##2##(2008-11#1)(2008-9#1)(2009-4#1)
tasks using##2##2##(2008-11#1)(2009-7#1)
tasks was##3##2##(1991-2#1)(1993-12#1)(2013-8#1)
tasks were compared to##2##4##(1991-6#1)(2013-1#1)
tasks were similar##2##3##(1994-8#1)(2012-2#1)
tasks were##13##2##(1991-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
tasks with##3##2##(2008-11#1)(2013-8#2)
tasks##254##1##(1990-3#1)(1990-4#1)(1991-2#2)(1991-3#1)(1991-6#5)(1992-1#1)(1992-11#1)(1992-12#2)(1993-12#6)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#5)(1994-8#7)(1995-12#2)(1995-2#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-7#1)(1997-2#4)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#6)(2008-11#32)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#6)(2009-10#6)(2009-11#6)(2009-12#1)(2009-2#5)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#6)(2010-1#1)(2010-12#2)(2010-3#2)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#6)(2012-12#5)(2012-2#5)(2012-3#11)(2013-1#10)(2013-7#1)(2013-8#20)
tasks) to##2##2##(2008-7#1)(2009-11#1)
tassels##3##1##(2008-8#3)
tastant delivery##4##2##(2008-11#4)
tastant##7##1##(2008-11#7)
tastants in a single lick##2##5##(2008-11#2)
tastants##8##1##(1993-12#1)(2008-11#6)(2009-10#1)
taste analyzing system##3##3##(2008-10#3)
taste analyzing##4##2##(2008-10#4)
taste and##3##2##(1993-12#1)(2008-10#1)(2010-5#1)
taste aversion##7##2##(1991-1#1)(1993-12#2)(1995-12#1)(2008-5#3)
taste buds##4##2##(2010-5#1)(2013-1#3)
taste center##2##2##(2008-9#2)
taste for sugar##2##3##(1993-9#2)
taste for##3##2##(1993-9#2)(2008-9#1)
taste function##2##2##(1993-12#2)
taste learning##2##2##(1996-5#2)
taste of##2##2##(2008-9#1)(2010-5#1)
taste panel##3##2##(2008-10#2)(2010-4#1)
taste receptor cells##2##3##(2013-1#2)
taste receptor##4##2##(2008-2#2)(2013-1#2)
taste receptors##2##2##(1993-12#1)(2008-2#1)
taste sensor##4##2##(2008-10#2)(2013-1#2)
taste stimuli in##2##3##(2008-7#2)
taste stimuli##14##2##(1993-12#2)(1996-5#1)(1996-8#1)(2008-7#3)(2012-12#5)(2013-1#2)
taste substances##4##2##(1996-8#1)(2008-10#3)
taste##92##1##(1991-1#1)(1991-3#3)(1993-12#10)(1993-9#2)(1995-12#1)(1996-5#6)(1996-8#2)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#4)(2008-7#6)(2008-9#9)(2009-10#2)(2010-4#1)(2010-5#4)(2012-12#5)(2012-3#1)(2013-1#12)
taste-elicited oral motor##2##3##(1993-12#2)
tastes and##4##2##(1993-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
tastes##10##1##(1993-12#2)(2008-10#4)(2008-7#1)(2012-2#1)(2013-1#2)
tasting##3##1##(2008-10#1)(2008-6#1)(2008-7#1)
tat##10##1##(1991-9#1)(1994-11#6)(1996-8#1)(2008-8#2)
tattoo##2##1##(2012-3#1)(2013-8#1)
tattooing##2##1##(2007-7#2)
tattoos##3##1##(1991-11#1)(2012-12#1)(2013-8#1)
tau (Walker)##2##2##(2011-2#1)(2013-8#1)
tau 1 core##5##3##(1995-2#5)
tau 1##6##2##(1995-2#6)
tau and##3##2##(1991-1#1)(1993-6#1)(1997-4#1)
tau b##3##2##(1995-2#3)
tau phosphatase##2##2##(1993-6#2)
tau protein##9##2##(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-12#2)(2008-9#1)(2011-2#2)
tau was##2##2##(1997-4#1)(2008-3#1)
tau##47##1##(1991-1#1)(1991-12#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-6#7)(1995-12#5)(1995-2#9)(1997-4#4)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2011-2#4)(2013-8#1)
tau(B)##2##1##(2008-7#2)
taught a##2##2##(2008-1#1)(2008-10#1)
taught by the##2##3##(2008-1#1)(2011-2#1)
taught by##5##2##(1991-12#1)(1994-12#1)(2007-5#1)(2008-1#1)(2011-2#1)
taught in##5##2##(1991-12#1)(1994-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
taught to##2##2##(2008-1#1)(2010-9#1)
taught##36##1##(1991-12#3)(1992-6#1)(1993-12#2)(1994-12#3)(1994-2#1)(1995-1#1)(1996-3#1)(2007-12#1)(2007-5#3)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
taurica##2##1##(2008-10#2)
taurine and##2##2##(2008-7#1)(2012-12#1)
taurine in##5##2##(1992-9#1)(2008-10#4)
taurine##27##1##(1990-8#2)(1992-9#1)(2008-10#14)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#2)(2013-1#1)
taurocholate##9##1##(1991-9#1)(1992-3#6)(1994-12#2)
taurocholate/phosphatidylcholine mixed micelles##2##3##(1993-11#2)
tautomer##3##1##(1994-8#1)(2007-12#2)
tautomeric##4##1##(1990-9#1)(1995-11#1)(2008-10#2)
taux de##2##2##(2008-11#1)(2013-1#1)
taux##4##1##(2008-11#2)(2013-1#2)
tax and##2##2##(1993-1#1)(1996-1#1)
tax dollars in##2##3##(2008-6#2)
tax exemption##11##2##(1991-3#1)(1992-8#1)(1993-2#1)(1995-12#1)(1995-2#2)(1996-2#1)(2008-11#4)
tax exemptions##2##2##(1993-2#1)(1996-2#1)
tax laws##2##2##(1992-12#1)(1994-3#1)
tax mRNA and protein##2##4##(2008-8#2)
tax planning##4##2##(1993-2#2)(2008-11#2)
tax##44##1##(1991-2#1)(1991-3#2)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#5)(1993-8#1)(1994-3#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#3)(1997-1#1)(2008-11#8)(2008-12#1)(2008-6#2)(2008-8#8)(2010-12#1)
tax-based##2##1##(1993-2#1)(2008-7#1)
tax-exempt bonds##2##2##(1992-8#2)
tax-exempt hospitals##3##2##(1994-1#1)(1994-3#1)(1996-2#1)
tax-exempt status##2##2##(1991-2#1)(1993-2#1)
tax-exempt##12##1##(1991-2#1)(1992-8#2)(1993-2#2)(1994-1#1)(1994-3#1)(1996-2#1)(1996-3#2)(2008-11#2)
tax-exemption##7##1##(1993-1#1)(1995-2#1)(1996-2#1)(2008-11#4)
tax-financed##2##1##(1995-2#1)(2008-7#1)
taxa and##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
taxa are##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
taxa at the##2##3##(2008-10#1)(2010-3#1)
taxa at##3##2##(2008-1#1)(2008-10#1)(2010-3#1)
taxa based on##2##3##(2008-10#1)(2011-2#1)
taxa by##2##2##(2011-2#2)
taxa have##3##2##(2008-10#1)(2008-11#2)
taxa in the##6##3##(2008-10#4)(2010-6#1)(2012-2#1)
taxa in##11##2##(2008-10#4)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
taxa may##3##2##(2008-1#1)(2008-9#1)(2013-7#1)
taxa of##2##2##(2008-10#2)
taxa than##2##2##(2008-11#1)(2008-9#1)
taxa that had##2##3##(2008-8#2)
taxa were##3##2##(2008-5#2)(2011-2#1)
taxa with##4##2##(2008-8#2)(2008-9#2)
taxa##111##1##(1996-4#1)(1997-5#1)(2007-12#4)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#2)(2008-5#8)(2008-7#3)(2008-8#14)(2008-9#9)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#14)(2010-6#2)(2010-8#1)(2011-2#9)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)
taxa)##2##1##(2007-5#1)(2008-8#1)
taxane##5##1##(2008-9#3)(2009-9#1)(2011-1#1)
taxanes##4##1##(1996-11#1)(2007-5#2)(2011-1#1)
taxation##4##1##(1990-12#1)(1993-2#1)(2008-1#1)(2012-1#1)
taxenes##2##1##(2008-8#2)
taxes and##2##2##(1995-3#1)(1996-3#1)
taxes##8##1##(1994-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-7#1)
taxing##5##1##(1992-3#1)(1994-1#1)(1994-2#1)(2009-9#1)(2010-8#1)
taxoid##3##1##(1994-5#3)
taxol##15##1##(1993-8#1)(1994-11#3)(1994-5#1)(1995-3#1)(1997-6#1)(2008-11#2)(2008-8#3)(2009-10#1)(2011-2#2)
taxometric procedures##2##2##(2007-12#2)
taxometric##4##1##(2007-12#3)(2009-2#1)
taxon groups##2##2##(2008-10#2)
taxon##17##1##(2007-12#2)(2008-10#8)(2008-5#1)(2010-6#1)(2011-2#3)(2013-7#1)(2013-8#1)
taxonomic and##2##2##(2008-12#1)(2008-8#1)
taxonomic characters##2##2##(2008-12#2)
taxonomic classification##3##2##(1997-4#1)(2008-10#1)(2011-2#1)
taxonomic group##3##2##(2008-10#2)(2008-9#1)
taxonomic groups##3##2##(2008-8#1)(2010-1#1)(2010-10#1)
taxonomic implications##2##2##(1994-3#1)(2008-6#1)
taxonomic issues##2##2##(2008-10#1)(2010-10#1)
taxonomic levels##2##2##(2008-12#1)(2008-8#1)
taxonomic orders##2##2##(2008-8#1)(2011-2#1)
taxonomic position##2##2##(1995-12#1)(2013-1#1)
taxonomic revision of the##2##4##(2007-7#1)(2013-8#1)
taxonomic revision##3##2##(2007-7#1)(2013-7#1)(2013-8#1)
taxonomic status##3##2##(2007-12#1)(2008-10#1)(2010-8#1)
taxonomic study##2##2##(2008-12#1)(2013-7#1)
taxonomic units##2##2##(2010-10#1)(2012-2#1)
taxonomic value##2##2##(2008-10#1)(2008-5#1)
taxonomic##83##1##(1994-3#2)(1995-12#1)(1997-4#2)(2007-12#2)(2007-7#1)(2008-10#17)(2008-12#6)(2008-5#4)(2008-6#2)(2008-8#11)(2008-9#4)(2009-8#1)(2010-1#1)(2010-10#4)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#9)(2012-2#2)(2013-1#2)(2013-7#6)(2013-8#3)
taxonomically##8##1##(1991-9#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
taxonomies##2##1##(2008-12#2)
taxonomy and##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-8#1)
taxonomy in##3##2##(1995-6#1)(2011-2#1)(2013-1#1)
taxonomy of the genus##2##4##(2008-10#1)(2008-5#1)
taxonomy of the##7##3##(1996-6#1)(2008-10#2)(2008-5#2)(2010-3#1)(2013-7#1)
taxonomy of##14##2##(1996-6#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2013-1#1)(2013-7#1)
taxonomy##40##1##(1995-6#2)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-8#4)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
taxpayer##3##1##(1995-1#1)(1996-1#1)(2009-11#1)
taxpayers funding holistic healthcare and the first amendment requirement for separation of church and state##2##15##(2009-11#2)
taxpayers##4##1##(1996-1#2)(2009-11#2)
tazarotene##4##1##(2007-11#3)(2010-3#1)
tbRAP1##2##1##(2011-2#2)
tbd1##5##1##(1996-2#3)(1997-7#2)
te##5##1##(2008-1#1)(2008-11#2)(2012-12#2)
tea (Camellia##2##2##(2008-10#1)(2008-11#1)
tea and drug##3##3##(2008-10#3)
tea and soil##5##3##(2011-1#5)
tea and##12##2##(2008-10#5)(2008-11#1)(2009-9#1)(2011-1#5)
tea components##2##2##(2008-11#2)
tea consumption##2##2##(1990-6#1)(2009-9#1)
tea extract was##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
tea extract##8##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#3)(2009-5#1)
tea extracts##2##2##(2008-10#1)(2008-11#1)
tea in the##2##3##(1993-6#1)(2009-8#1)
tea in##3##2##(1993-6#1)(2008-11#1)(2009-8#1)
tea leaves##3##2##(2008-10#3)
tea polyphenol##2##2##(1995-9#2)
tea products##3##2##(2008-10#1)(2012-2#2)
tea samples##8##2##(2008-10#8)
tea to##2##2##(2009-11#1)(2009-8#1)
tea varieties##2##2##(2008-10#2)
tea was##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
tea##114##1##(1990-6#1)(1993-6#1)(1994-2#3)(1995-9#2)(2008-10#52)(2008-11#17)(2008-5#1)(2008-7#2)(2009-11#5)(2009-3#1)(2009-5#4)(2009-8#8)(2009-9#3)(2010-1#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#3)(2012-8#1)(2013-8#2)
teach and##4##2##(2008-11#1)(2008-12#1)(2009-3#1)(2012-1#1)
teach students##3##2##(1990-2#1)(1995-12#1)(2010-3#1)
teach the##5##2##(1995-3#1)(1996-1#1)(2009-2#1)(2012-1#1)(2012-3#1)
teach this##2##2##(2008-1#1)(2008-10#1)
teach##40##1##(1990-2#1)(1992-4#1)(1993-12#2)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#2)(2008-7#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)
teacher and##2##2##(2008-12#1)(2009-7#1)
teacher expectations of##2##3##(2008-12#2)
teacher expectations##4##2##(2008-12#4)
teacher in##3##2##(1992-9#1)(2008-11#1)(2008-12#1)
teacher practices##4##2##(2008-12#4)
teacher ratings##2##2##(2008-2#2)
teacher support##2##2##(2009-7#2)
teacher training##2##2##(2008-12#1)(2012-1#1)
teacher##58##1##(1991-12#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(2008-10#3)(2008-11#2)(2008-12#18)(2008-2#2)(2008-4#7)(2008-7#2)(2009-11#1)(2009-12#1)(2009-7#4)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#7)(2012-2#2)(2013-1#1)
teacher's##5##1##(1991-12#1)(2008-11#2)(2008-12#1)(2011-2#1)
teacher-student relationships##2##2##(2008-12#1)(2011-2#1)
teacher-student##3##1##(2008-12#2)(2011-2#1)
teachers and##12##2##(1991-9#1)(2008-11#5)(2008-12#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#2)
teachers at##2##2##(1994-6#1)(2008-2#1)
teachers from##2##2##(1991-9#1)(2011-2#1)
teachers have##3##2##(1991-9#1)(2013-1#2)
teachers held##2##2##(2008-12#2)
teachers in##5##2##(1993-6#1)(2007-12#1)(2008-12#1)(2012-1#1)(2012-12#1)
teachers of physical exercise##2##4##(1993-6#2)
teachers of##5##2##(1991-9#1)(1993-6#2)(2007-4#1)(2012-3#1)
teachers to##3##2##(2008-12#1)(2011-2#2)
teachers was##2##2##(2008-12#1)(2009-7#1)
teachers were not##2##3##(2008-10#1)(2008-12#1)
teachers were##5##2##(1991-12#1)(1993-1#1)(2008-10#1)(2008-12#1)(2012-1#1)
teachers who##2##2##(2008-11#1)(2011-2#1)
teachers##97##1##(1990-8#1)(1991-12#6)(1991-9#4)(1993-1#1)(1993-6#5)(1994-6#1)(1995-3#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#11)(2008-12#21)(2008-2#1)(2008-4#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#10)(2012-1#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
teachers'##16##1##(1993-1#1)(2008-12#3)(2009-7#3)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#2)
teachers]##4##1##(1991-9#1)(2010-12#3)
teaches##2##1##(1995-2#1)(1997-3#1)
teaching and assessing##3##3##(2008-11#3)
teaching and evaluation##2##3##(2008-12#2)
teaching and feeding##2##3##(1990-12#2)
teaching and learning approaches##2##4##(2008-11#1)(2008-12#1)
teaching and learning strategies##4##4##(2008-11#3)(2008-12#1)
teaching and learning strategy##4##4##(2008-11#4)
teaching and learning##29##3##(1996-1#1)(2008-11#18)(2008-12#7)(2010-3#1)(2012-1#1)(2013-8#1)
teaching and research##4##3##(1993-3#1)(1994-3#2)(2008-11#1)
teaching and the##2##3##(2013-1#2)
teaching and training##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
teaching and##54##2##(1990-12#2)(1992-12#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#26)(2008-12#10)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
teaching are##3##2##(1994-2#1)(1997-5#1)(2012-1#1)
teaching at##3##2##(1990-3#1)(2008-12#1)(2010-1#1)
teaching breast##2##2##(2007-10#2)
teaching clinical##4##2##(1994-12#2)(2008-11#2)
teaching health##2##2##(1995-1#1)(2008-11#1)
teaching hospital and##3##3##(1993-2#1)(1995-1#1)(2012-3#1)
teaching hospital in##5##3##(2007-2#1)(2008-10#1)(2008-8#1)(2009-1#1)(2013-1#1)
teaching hospital of##4##3##(2008-7#1)(2009-10#2)(2012-3#1)
teaching hospital to##2##3##(1992-2#1)(1992-3#1)
teaching hospital were##2##3##(1993-12#1)(1997-2#1)
teaching hospital##37##2##(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-1#2)(1997-2#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#2)(2009-5#1)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#1)(2012-3#3)(2013-1#1)(2013-8#1)
teaching hospitals are##2##3##(1992-12#1)(1995-1#1)
teaching hospitals in##2##3##(2008-11#1)(2010-3#1)
teaching hospitals to##2##3##(1997-1#1)(2008-11#1)
teaching hospitals##23##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#3)(1996-3#1)(1997-1#1)(2007-8#1)(2008-11#8)(2008-7#1)(2010-3#2)(2012-12#1)
teaching in the##4##3##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
teaching in##15##2##(1997-2#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
teaching intensity##2##2##(1992-12#2)
teaching into##2##2##(2008-11#1)(2013-8#1)
teaching is##6##2##(1994-12#1)(2007-10#1)(2008-11#2)(2013-1#1)(2013-8#1)
teaching method##9##2##(2008-11#6)(2008-12#1)(2013-8#2)
teaching methodology##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
teaching methods##5##2##(1996-2#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)
teaching nursing home##2##3##(2008-12#2)
teaching nursing##4##2##(1996-2#2)(2008-12#2)
teaching of basic##2##3##(2013-1#2)
teaching of posterior composites##4##4##(2009-2#4)
teaching of##17##2##(1991-6#1)(1995-3#1)(2008-11#3)(2009-2#6)(2010-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
teaching program##3##2##(1995-1#3)
teaching programs##6##2##(1992-12#1)(1995-1#4)(2010-9#1)
teaching sessions##3##2##(2008-1#1)(2008-11#2)
teaching strategies##5##2##(2008-11#2)(2008-12#3)
teaching strategy for##2##3##(2008-11#1)(2008-12#1)
teaching strategy is##2##3##(2008-11#2)
teaching strategy that##2##3##(2008-12#2)
teaching strategy##13##2##(2008-11#5)(2008-12#5)(2010-3#1)(2012-3#2)
teaching students about##2##3##(1995-12#1)(2009-8#1)
teaching students##3##2##(1995-12#1)(1997-2#1)(2009-8#1)
teaching the##2##2##(1994-12#1)(2008-12#1)
teaching to##3##2##(1995-1#1)(1995-12#1)(2007-5#1)
teaching tools##2##2##(2008-11#1)(2010-9#1)
teaching##357##1##(1990-12#7)(1990-2#3)(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#7)(1992-2#4)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#3)(1994-12#7)(1994-2#6)(1994-3#6)(1994-6#1)(1995-1#17)(1995-12#3)(1995-2#3)(1995-3#3)(1996-1#8)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-7#1)(2007-10#6)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#92)(2008-12#35)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#1)(2009-1#2)(2009-10#2)(2009-2#8)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-3#7)(2010-8#2)(2010-9#3)(2011-2#9)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#15)(2013-8#14)
teaching-learning##3##1##(2012-3#1)(2013-8#2)
teaching/learning##2##1##(2008-11#2)
teachings##2##1##(1997-3#1)(2008-11#1)
teal##4##1##(2013-1#4)
team and the##2##3##(2009-6#1)(2010-1#1)
team and##8##2##(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-11#1)
team approach for##2##3##(2011-2#1)(2013-8#1)
team approach to##4##3##(1994-12#1)(1994-2#2)(1996-3#1)
team approach##15##2##(1994-12#2)(1994-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-8#1)
team at the##4##3##(1995-2#1)(2008-10#1)(2010-10#1)(2011-1#1)
team at##6##2##(1995-2#1)(1997-2#1)(2008-10#1)(2010-10#1)(2011-1#1)(2013-8#1)
team can##5##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(2008-7#1)
team concept##3##2##(1993-3#1)(2008-10#2)
team effectiveness##2##2##(1993-12#1)(2011-1#1)
team effort##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
team established##2##2##(1996-1#1)(2013-1#1)
team for##3##2##(1995-3#1)(2008-11#1)(2009-9#1)
team has the##2##3##(2008-11#2)
team has##7##2##(1990-3#1)(1994-12#1)(1995-3#1)(2008-11#2)(2008-9#1)(2013-8#1)
team identified##2##2##(1996-1#1)(2013-1#1)
team in##2##2##(1992-2#1)(2012-3#1)
team is to##2##3##(2008-1#1)(2008-10#1)
team is##5##2##(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
team leader##2##2##(1993-12#1)(2012-2#1)
team leadership##5##2##(1992-5#1)(2008-6#3)(2011-1#1)
team member##3##2##(1996-7#1)(2010-4#1)(2012-12#1)
team members who##3##3##(2007-11#1)(2008-8#1)(2011-1#1)
team members##16##2##(1993-12#2)(1994-12#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-1#1)(2013-1#1)
team must##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
team of health##4##3##(1990-3#1)(1994-12#1)(2007-12#1)(2008-1#1)
team of nurses##2##3##(2008-10#1)(2009-6#1)
team of specialists##2##3##(2007-8#2)
team of##23##2##(1990-3#1)(1990-6#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-1#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#1)
team performance##3##2##(1995-2#2)(2011-1#1)
team should##2##2##(1995-3#2)
team that##2##2##(1997-1#1)(2007-12#1)
team to determine##2##3##(1995-2#1)(2010-3#1)
team to make##2##3##(1995-9#1)(2012-2#1)
team to##16##2##(1993-12#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-3#1)(2012-2#1)
team was formed to##2##4##(1994-12#1)(2013-1#1)
team was formed##3##3##(1994-12#2)(2013-1#1)
team was##7##2##(1994-12#2)(1995-1#1)(1996-1#1)(2008-12#1)(2012-8#1)(2013-1#1)
team with##8##2##(1993-3#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-8#1)
team work##2##2##(1997-4#1)(2010-3#1)
team##307##1##(1990-3#2)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1993-1#4)(1993-12#10)(1993-2#1)(1993-3#5)(1993-5#1)(1994-1#2)(1994-12#10)(1994-2#10)(1994-3#6)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#8)(1995-5#2)(1995-9#2)(1996-1#13)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-7#3)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#2)(1997-6#1)(2007-10#4)(2007-11#2)(2007-12#8)(2007-5#3)(2007-8#3)(2008-1#8)(2008-10#16)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#2)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#7)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#10)(2011-2#10)(2011-3#2)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#4)(2012-8#1)(2013-1#12)(2013-7#1)(2013-8#4)
team's##10##1##(1990-4#1)(1993-12#2)(1994-1#1)(1995-12#1)(1997-2#2)(2009-6#1)(2009-9#1)(2013-8#1)
team-based structures##2##2##(1993-12#1)(1997-1#1)
team-based##10##1##(1993-12#2)(1997-1#1)(1997-2#1)(2007-8#1)(2008-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
teams and##8##2##(1993-10#1)(1993-2#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2011-3#1)
teams are##7##2##(1993-12#2)(1993-2#1)(1994-2#1)(2007-9#1)(2011-1#2)
teams can##3##2##(1993-12#1)(1994-2#1)(1997-1#1)
teams caring for clients with chronic conditions##2##7##(2011-1#2)
teams for##2##2##(1997-2#1)(2008-3#1)
teams have##2##2##(1994-2#1)(2008-8#1)
teams in the##4##3##(1993-11#1)(1994-1#1)(1994-2#1)(1996-3#1)
teams in##10##2##(1992-2#1)(1993-11#1)(1993-12#1)(1994-1#2)(1994-2#1)(1996-3#2)(2011-2#1)(2012-3#1)
teams involved in the##2##4##(2008-3#1)(2011-2#1)
teams involved in##3##3##(2008-3#2)(2011-2#1)
teams is##2##2##(1993-12#1)(2011-1#1)
teams of##8##2##(1993-1#1)(1994-2#1)(1996-2#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
teams that##3##2##(1995-2#1)(1996-1#1)(1997-3#1)
teams to##3##2##(1990-4#1)(1994-3#1)(2008-9#1)
teams##135##1##(1990-4#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#15)(1993-2#3)(1994-1#7)(1994-12#1)(1994-2#11)(1994-3#3)(1995-2#3)(1996-1#1)(1996-2#2)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#3)(2011-1#12)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#1)
teamwork and##3##2##(1993-3#1)(1994-1#1)(2010-5#1)
teamwork in##2##2##(1995-1#1)(2013-1#1)
teamwork##19##1##(1991-12#2)(1992-1#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-3#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
tear amount##4##2##(2013-8#4)
tear and##4##2##(2007-10#1)(2008-12#1)(2008-7#1)(2009-3#1)
tear film##5##2##(2009-4#4)(2011-2#1)
tear of##2##2##(2008-7#1)(2013-8#1)
tear##29##1##(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#7)(2009-9#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#1)(2013-8#6)
tearing of##2##2##(2008-5#1)(2012-2#1)
tearing##6##1##(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
tears are##2##2##(1994-2#1)(2007-11#1)
tears##16##1##(1992-6#1)(1993-11#2)(1994-2#3)(2007-11#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
teas and related components on the proliferation and invasion of##2##10##(2008-11#2)
teas and related components##3##4##(2008-11#3)
teas and##4##2##(2008-11#4)
teas were##2##2##(2008-10#2)
teas##21##1##(2008-10#10)(2008-11#6)(2009-8#1)(2012-2#4)
tease out##2##2##(1994-9#1)(2008-11#1)
teasing##3##1##(2007-12#1)(2008-2#1)(2009-4#1)
teat dip##4##2##(1990-6#4)
teat##8##1##(1990-6#6)(1992-2#2)
tebuconazole effect on##3##3##(2008-10#3)
tebuconazole##12##1##(2008-10#11)(2008-6#1)
tech VR helmet##2##3##(2010-4#2)
tech##8##1##(2008-12#3)(2008-7#1)(2009-9#1)(2010-4#2)(2013-8#1)
technetium##2##1##(1992-2#1)(1996-3#1)
technetium-99m##4##1##(1990-12#1)(1991-11#1)(1996-5#1)(2012-12#1)
technic##4##1##(1990-2#1)(1990-3#1)(1993-9#1)(2011-3#1)
technic]##3##1##(1990-2#1)(1990-3#2)
technical advances##5##2##(2008-12#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
technical and medical##4##3##(1990-11#1)(1997-6#1)(2008-3#1)(2013-1#1)
technical and##19##2##(1990-11#1)(1991-1#1)(1992-9#1)(1993-1#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-3#3)(2008-5#2)(2009-11#1)(2012-3#1)(2013-1#1)
technical approaches##2##2##(2008-11#1)(2011-2#1)
technical aspects and##2##3##(2007-7#1)(2009-5#1)
technical aspects of the##2##4##(2008-11#1)(2008-9#1)
technical aspects of##9##3##(1993-12#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
technical aspects##15##2##(1990-8#1)(1993-12#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-8#1)
technical assistance##6##2##(1994-3#1)(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
technical capabilities##2##2##(2007-11#1)(2008-7#1)
technical care and##2##3##(2008-12#1)(2011-1#1)
technical care##3##2##(2008-12#2)(2011-1#1)
technical challenges in##3##3##(2008-7#1)(2011-2#2)
technical challenges##6##2##(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)
technical change##3##2##(1992-1#3)
technical conditions##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
technical considerations##3##2##(2010-8#1)(2011-2#2)
technical details of##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
technical details##7##2##(1994-9#1)(2007-5#2)(2008-10#1)(2008-9#1)(2010-8#1)(2012-3#1)
technical developments of##2##3##(2008-1#1)(2012-2#1)
technical developments##3##2##(2008-1#1)(2010-2#1)(2012-2#1)
technical difficulties and##3##3##(2010-1#1)(2011-1#1)(2011-2#1)
technical difficulties##5##2##(2007-8#2)(2010-1#1)(2011-1#1)(2011-2#1)
technical ease##2##2##(2007-12#1)(2008-1#1)
technical efficiency##3##2##(2013-8#3)
technical error##2##2##(1991-12#1)(2008-9#1)
technical errors##2##2##(2010-8#1)(2012-2#1)
technical expertise##4##2##(1996-2#1)(2009-2#1)(2010-4#1)(2013-1#1)
technical experts and##2##3##(1996-1#1)(2010-10#1)
technical experts##3##2##(1994-12#1)(1996-1#1)(2010-10#1)
technical features##2##2##(2008-8#1)(2011-2#1)
technical grade##8##2##(2008-10#3)(2008-9#4)(2012-12#1)
technical hurdles##2##2##(2008-4#1)(2011-2#1)
technical improvements##2##2##(2008-11#1)(2008-7#1)
technical indicators and user##2##4##(2011-2#2)
technical issues##8##2##(2007-10#1)(2007-2#1)(2008-3#2)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
technical managerial/clinical##2##2##(2008-1#2)
technical note##9##2##(2007-7#1)(2008-10#1)(2011-2#5)(2012-2#1)(2013-1#1)
technical oil##2##2##(2008-10#2)
technical personnel##2##2##(2007-7#1)(2013-1#1)
technical possibilities##2##2##(1990-9#1)(2007-4#1)
technical principles##2##2##(2008-7#1)(2008-9#1)
technical problems involved##2##3##(1996-12#1)(2007-11#1)
technical problems##8##2##(1991-12#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)
technical quality and##2##3##(2009-3#1)(2012-12#1)
technical reasons##4##2##(1993-11#1)(2008-3#1)(2009-7#1)(2009-9#1)
technical report##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
technical requirements##3##2##(1996-1#1)(2008-12#1)(2010-7#1)
technical resources##3##2##(1991-3#1)(2007-11#1)(2009-10#1)
technical simplicity##4##2##(1995-5#1)(2006-12#1)(2009-5#2)
technical skills and##2##3##(1997-2#1)(2011-2#1)
technical skills of##2##3##(1994-2#1)(2008-11#1)
technical skills##8##2##(1992-2#1)(1993-12#2)(1994-2#1)(1997-2#1)(2008-11#2)(2011-2#1)
technical solutions##3##2##(1990-11#1)(1990-3#1)(2010-9#1)
technical specifications##2##2##(2008-3#2)
technical success##5##2##(2007-7#1)(2008-1#2)(2011-2#1)(2012-2#1)
technical variables##2##2##(2008-5#1)(2013-1#1)
technical waste plastics##2##3##(2008-10#2)
technical waste##3##2##(2008-10#3)
technical##301##1##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#7)(2007-8#7)(2008-1#9)(2008-10#24)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#27)(2012-12#5)(2012-2#11)(2012-3#6)(2013-1#9)(2013-8#4)
technically challenging and##2##3##(2008-4#1)(2011-2#1)
technically challenging##4##2##(2007-5#1)(2008-4#1)(2011-2#2)
technically demanding##4##2##(1996-9#1)(2008-12#1)(2009-2#1)(2013-1#1)
technically feasible##7##2##(2007-8#2)(2008-12#1)(2008-7#2)(2009-8#1)(2012-3#1)
technically simple##3##2##(1993-3#1)(2008-10#1)(2010-3#1)
technically##37##1##(1990-5#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-5#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
technician and##2##2##(2012-1#1)(2012-3#1)
technician to##2##2##(2008-10#1)(2009-8#1)
technician##11##1##(1990-12#1)(2007-11#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-3#1)
technicians##4##1##(1994-12#1)(2009-11#1)(2010-8#1)(2012-2#1)
technics##3##1##(1994-3#1)(2007-8#1)(2008-10#1)
technique (DGT)##2##2##(2008-10#2)
technique (a##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
technique after##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
technique allowed##7##2##(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
technique allows a##2##3##(2007-12#1)(2008-10#1)
technique allows one to##2##4##(2007-11#1)(2008-10#1)
technique allows the##2##3##(2008-10#1)(2008-3#1)
technique allows##20##2##(2007-11#3)(2007-12#2)(2008-10#8)(2008-3#4)(2008-7#1)(2008-9#1)(2012-12#1)
technique also provides a##2##4##(2008-10#1)(2008-3#1)
technique also##9##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)
technique and a##4##3##(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
technique and an##4##3##(1994-12#1)(2008-2#2)(2008-3#1)
technique and by##2##3##(2008-10#2)
technique and clinical##3##3##(1992-6#1)(2008-7#1)(2012-2#1)
technique and cyclic##2##3##(2008-10#2)
technique and early##2##3##(2007-8#1)(2012-2#1)
technique and its application##2##4##(2008-10#1)(2008-7#1)
technique and its applications in##2##5##(2008-3#1)(2008-7#1)
technique and its##9##3##(1992-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#2)(2013-1#1)
technique and outcomes##3##3##(2008-9#1)(2011-2#2)
technique and results##4##3##(1990-11#1)(1994-11#1)(1995-12#1)(2010-11#1)
technique and the results##2##4##(1997-2#1)(2008-10#1)
technique and the##11##3##(1990-10#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#2)
technique and to##2##3##(2010-7#1)(2011-2#1)
technique and##132##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#26)(2008-11#3)(2008-2#7)(2008-3#18)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#2)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
technique appears to be##3##4##(1992-2#1)(1993-11#1)(2007-7#1)
technique applied to##2##3##(1992-6#1)(2008-5#1)
technique applied##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
technique are discussed##6##3##(1993-10#1)(1994-9#1)(2007-11#2)(2008-10#1)(2008-3#1)
technique are investigated##2##3##(2008-3#2)
technique are its##2##3##(2008-1#1)(2008-11#1)
technique are##32##2##(1990-9#1)(1991-3#1)(1993-10#1)(1994-9#1)(1995-11#1)(1997-3#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#9)(2009-1#1)
technique as a tool##2##4##(2008-3#1)(2008-5#1)
technique as a##10##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)
technique as well##2##3##(2008-10#1)(2008-6#1)
technique as##14##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)
technique associated with##2##3##(2008-5#2)
technique at##8##2##(1994-3#1)(2008-10#5)(2011-2#1)(2012-3#1)
technique based on a regularized phase-tracking (RPT) system##2##8##(2008-3#2)
technique based on a##9##4##(2007-12#2)(2008-2#2)(2008-3#5)
technique based on the##12##4##(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)
technique based on##35##3##(1995-5#1)(1996-2#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#12)(2008-6#1)(2008-7#1)(2010-3#1)
technique based##36##2##(1995-5#1)(1996-2#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#12)(2008-6#1)(2008-7#1)(2010-3#1)
technique because of##3##3##(1991-12#1)(2008-10#1)(2013-8#1)
technique because##5##2##(1991-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
technique by measuring the##2##4##(2008-10#1)(2008-3#1)
technique by use of either molecular or aerosol atmospheric backscatter##2##10##(2008-2#2)
technique by##13##2##(2007-12#4)(2008-10#4)(2008-2#2)(2008-3#3)
technique called##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)
technique can also be used to##3##6##(2007-12#1)(2008-3#1)(2013-8#1)
technique can also be##5##4##(2007-12#1)(2008-3#2)(2008-4#1)(2013-8#1)
technique can also##7##3##(2007-12#1)(2008-3#3)(2008-4#1)(2009-2#1)(2013-8#1)
technique can be applied to##2##5##(2008-2#1)(2012-2#1)
technique can be implemented in##2##5##(2008-3#1)(2010-8#1)
technique can be used for##4##5##(2008-10#1)(2008-3#3)
technique can be used over a##2##6##(2007-11#1)(2008-3#1)
technique can be used to##4##5##(2008-10#2)(2008-3#1)(2008-5#1)
technique can be used##13##4##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#5)(2008-5#1)(2009-3#1)
technique can be##25##3##(1993-2#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#8)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
technique can give##2##3##(2008-10#1)(2008-5#1)
technique can provide##2##3##(2007-11#1)(2007-12#1)
technique can##49##2##(1993-2#1)(2007-11#4)(2007-12#7)(2007-9#1)(2008-10#10)(2008-2#3)(2008-3#13)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
technique combined with##4##3##(2007-7#1)(2008-2#1)(2008-3#2)
technique combines##3##2##(2007-11#1)(2008-7#1)(2009-12#1)
technique compared with##4##3##(2008-2#1)(2008-3#1)(2011-2#2)
technique consists of##4##3##(1990-9#1)(2008-10#1)(2008-3#1)(2010-6#1)
technique could be useful##2##4##(2008-10#1)(2008-3#1)
technique could be##9##3##(2008-10#3)(2008-11#1)(2008-3#4)(2013-8#1)
technique could##17##2##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
technique coupled with##3##3##(2008-10#2)(2008-5#1)
technique described by##2##3##(1996-12#1)(2008-10#1)
technique described here is##2##4##(2007-12#1)(2011-2#1)
technique described here##3##3##(2007-12#1)(2010-4#1)(2011-2#1)
technique described in this unit##2##5##(2008-9#2)
technique described in this##3##4##(2008-10#1)(2008-9#2)
technique described in##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
technique described##10##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)(2010-4#1)(2011-2#1)
technique developed for##2##3##(2007-12#1)(2008-10#1)
technique developed in this##2##4##(2008-10#1)(2008-7#1)
technique developed in##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
technique developed##9##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)
technique during the##2##3##(2007-8#1)(2008-10#1)
technique during##4##2##(2007-8#1)(2008-10#2)(2011-2#1)
technique employed##4##2##(2008-10#2)(2008-7#1)(2010-4#1)
technique employs##2##2##(2008-2#2)
technique enables the##2##3##(2008-10#1)(2008-3#1)
technique enables us to##4##4##(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
technique enables##8##2##(1997-8#1)(2007-11#1)(2008-10#3)(2008-3#2)(2011-1#1)
technique facilitates##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
technique failure##3##2##(2011-2#3)
technique for Doppler lidar wind##2##5##(2008-2#1)(2008-3#1)
technique for Doppler##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
technique for a##2##3##(2007-12#1)(2008-3#1)
technique for analysis of##2##4##(2008-10#2)
technique for assessing##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
technique for calculating the##2##4##(2007-12#1)(2008-2#1)
technique for closing##2##3##(2007-8#1)(2012-1#1)
technique for closure##3##3##(2007-8#2)(2011-2#1)
technique for detecting##4##3##(2007-11#1)(2008-2#1)(2008-9#1)(2010-8#1)
technique for detection of##4##4##(2008-10#4)
technique for determination of##2##4##(2008-10#1)(2008-2#1)
technique for determining the##5##4##(2008-2#2)(2008-3#3)
technique for determining##8##3##(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-3#1)
technique for diagnosis of##2##4##(2008-10#1)(2008-2#1)
technique for encoding##2##3##(2008-3#2)
technique for enhancing##2##3##(2008-3#1)(2012-2#1)
technique for environmental##2##3##(1994-9#1)(2008-3#1)
technique for evaluating##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
technique for fabricating##2##3##(2007-11#1)(2008-10#1)
technique for fascial closure##3##4##(1991-2#2)(1992-1#1)
technique for fiber##2##3##(2008-3#2)
technique for imaging##2##3##(1997-8#1)(2007-12#1)
technique for investigating##2##3##(2007-11#1)(2008-7#1)
technique for measurement of the##2##5##(2007-11#2)
technique for measurement of##3##4##(1996-2#1)(2007-11#2)
technique for measuring the##14##4##(1991-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#4)(2008-5#1)
technique for measuring##27##3##(1991-5#1)(2007-11#6)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#8)(2008-5#1)(2011-2#1)
technique for modeling##2##3##(2008-3#2)
technique for monitoring the##3##4##(2008-10#2)(2008-3#1)
technique for monitoring##5##3##(2008-10#3)(2008-3#2)
technique for myocardial##2##3##(1991-3#1)(2013-8#1)
technique for performing a##2##4##(2008-3#1)(2012-2#1)
technique for performing##5##3##(2007-11#1)(2007-12#2)(2008-3#1)(2012-2#1)
technique for producing a##2##4##(2007-11#1)(2008-3#1)
technique for rapid##2##3##(2008-10#1)(2012-3#1)
technique for reducing the##2##4##(2007-12#1)(2008-3#1)
technique for routine##4##3##(2008-10#3)(2008-9#1)
technique for sample##3##3##(2008-10#2)(2013-1#1)
technique for scatter##2##3##(2008-5#2)
technique for significantly##2##3##(2007-12#1)(2008-2#1)
technique for simultaneous##3##3##(2007-12#1)(2008-3#2)
technique for single##4##3##(2008-2#2)(2009-12#2)
technique for testing##2##3##(2008-3#1)(2010-1#1)
technique for the analysis of##6##5##(2008-10#5)(2008-3#1)
technique for the assay of##2##5##(1990-2#1)(2008-10#1)
technique for the assessment of##3##5##(1997-8#1)(2008-4#1)(2008-7#1)
technique for the automatic detection##2##5##(2008-3#2)
technique for the construction of##2##5##(1994-12#1)(2008-2#1)
technique for the design of##2##5##(2007-11#1)(2008-3#1)
technique for the detection of##3##5##(2007-11#1)(2008-10#2)
technique for the determination of##12##5##(2008-10#8)(2008-11#1)(2009-8#1)(2010-5#1)(2012-1#1)
technique for the direct##4##4##(2007-11#1)(2008-10#2)(2008-2#1)
technique for the evaluation of##2##5##(1990-11#1)(2010-11#1)
technique for the fabrication of##2##5##(2007-11#1)(2007-12#1)
technique for the management of##3##5##(2008-12#1)(2011-2#2)
technique for the measurement of##3##5##(2007-11#2)(2008-3#1)
technique for the quantitative##2##4##(2007-11#1)(2008-10#1)
technique for the simultaneous determination of##2##6##(2008-10#2)
technique for the simultaneous##3##4##(2008-10#3)
technique for the study of##5##5##(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
technique for the##97##3##(1990-11#1)(1990-2#1)(1990-5#1)(1994-12#1)(1994-2#1)(1997-8#1)(2007-11#8)(2007-12#5)(2007-8#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
technique for this##2##3##(2008-11#1)(2010-8#1)
technique for treatment of##2##4##(1991-9#2)
technique for visualizing##2##3##(2007-12#1)(2008-3#1)
technique for##425##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#2)(2007-11#32)(2007-12#35)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#91)(2008-11#9)(2008-12#1)(2008-2#33)(2008-3#88)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#7)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#3)
technique from a##2##3##(1995-12#1)(2008-11#1)
technique from##4##2##(1991-5#1)(1995-12#1)(2008-11#1)(2012-2#1)
technique gave a##2##3##(2008-10#1)(2008-7#1)
technique gave##5##2##(2008-10#4)(2008-7#1)
technique had a##3##3##(1993-9#1)(2007-8#1)(2012-12#1)
technique had##5##2##(1991-12#1)(1993-9#1)(2007-8#1)(2008-3#1)(2012-12#1)
technique has a number of##2##5##(2008-9#2)
technique has a##3##3##(2008-3#1)(2008-9#2)
technique has become##2##3##(2007-8#1)(2008-3#1)
technique has been applied to the##2##6##(2008-10#1)(2008-3#1)
technique has been applied to##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
technique has been applied##8##4##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
technique has been developed for##3##5##(2008-10#3)
technique has been developed##10##4##(2008-10#7)(2008-2#1)(2008-3#2)
technique has been implemented##2##4##(2007-12#1)(2008-2#1)
technique has been successfully applied##2##5##(2008-10#1)(2012-12#1)
technique has been used to assess the##2##7##(2008-5#2)
technique has been used to study the##2##7##(1994-5#1)(2008-10#1)
technique has been used to##6##5##(1994-5#1)(2008-10#3)(2008-5#2)
technique has been used##8##4##(1991-11#1)(1994-5#1)(2008-10#4)(2008-5#2)
technique has been##43##3##(1991-11#1)(1991-12#1)(1994-5#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-10#17)(2008-2#4)(2008-3#8)(2008-5#3)(2012-12#1)
technique has the potential to##2##5##(2008-2#1)(2008-3#1)
technique has the##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
technique has##72##2##(1991-11#1)(1991-12#1)(1994-5#1)(1996-8#1)(1997-4#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-2#6)(2008-3#14)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
technique have##3##2##(1995-2#1)(2007-12#1)(2008-8#1)
technique improved##2##2##(2008-10#1)(2013-1#1)
technique in a##6##3##(1992-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
technique in an##2##3##(2008-2#1)(2008-3#1)
technique in both##2##3##(2008-10#2)
technique in combination with a##2##5##(2008-3#1)(2010-5#1)
technique in order to##2##4##(1992-2#1)(2008-10#1)
technique in the clinical setting##2##5##(2008-8#1)(2009-9#1)
technique in the field of##2##5##(2008-3#1)(2013-8#1)
technique in the surgery of arteriovenous malformations of the brain##2##10##(2008-7#2)
technique in the treatment of##3##5##(2007-8#1)(2010-3#1)(2012-3#1)
technique in the##25##3##(1991-3#1)(1993-5#1)(1994-6#1)(1995-5#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
technique in which a##3##4##(2008-2#1)(2008-3#2)
technique in which the##2##4##(2008-3#1)(2011-2#1)
technique in which##10##3##(1992-9#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-7#1)(2011-2#1)
technique in##105##2##(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-5#2)(1996-1#1)(1996-5#1)(2007-11#5)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#6)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#6)(2011-7#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
technique include##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
technique includes##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
technique involved##2##2##(1996-3#1)(2012-2#1)
technique involves##10##2##(1990-12#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
technique is a powerful##2##4##(2008-3#1)(2008-4#1)
technique is a promising##2##4##(2008-10#2)
technique is a##10##3##(2008-10#3)(2008-3#3)(2008-4#2)(2008-8#1)(2009-7#1)
technique is able to##2##4##(2007-11#1)(2008-3#1)
technique is advantageous##2##3##(2008-4#1)(2009-10#1)
technique is also##6##3##(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)
technique is an##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
technique is analyzed##2##3##(2007-12#1)(2008-2#1)
technique is applicable to##2##4##(2008-10#1)(2008-9#1)
technique is applicable##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
technique is applied to##3##4##(2007-12#1)(2008-3#2)
technique is based on a##2##5##(2007-12#1)(2008-6#1)
technique is based on the##13##5##(2007-11#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2010-5#1)
technique is based on##29##4##(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
technique is based upon##2##4##(2008-5#1)(2008-9#1)
technique is based##32##3##(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#2)(2008-6#1)(2008-9#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
technique is being used##2##4##(2008-11#2)
technique is being##3##3##(2008-10#1)(2008-11#2)
technique is demonstrated in a##2##5##(2008-2#1)(2008-3#1)
technique is demonstrated to##2##4##(2007-11#1)(2007-12#1)
technique is demonstrated##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
technique is derived##2##3##(2008-3#1)(2012-3#1)
technique is described for##5##4##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
technique is described##10##3##(1990-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)
technique is developed to##3##4##(1997-4#1)(2008-2#1)(2008-3#1)
technique is developed##7##3##(1997-4#1)(2008-10#1)(2008-2#3)(2008-3#2)
technique is discussed##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
technique is easy to##2##4##(2008-4#1)(2011-2#1)
technique is effective##2##3##(2008-3#1)(2011-2#1)
technique is employed##2##3##(2008-10#1)(2008-3#1)
technique is essential##2##3##(1991-9#1)(2008-2#1)
technique is examined##2##3##(2008-3#2)
technique is fast and##2##4##(2008-10#1)(2010-4#1)
technique is found to be##2##5##(2007-11#1)(2008-10#1)
technique is highly##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
technique is illustrated##2##3##(2008-10#1)(2008-3#1)
technique is limited##2##3##(2008-3#1)(2008-7#1)
technique is not##5##3##(1992-6#1)(2007-8#2)(2008-10#1)(2008-2#1)
technique is now##2##3##(1994-5#1)(1997-8#1)
technique is of##2##3##(2007-12#1)(2008-11#1)
technique is one##2##3##(1994-12#1)(2008-3#1)
technique is particularly##2##3##(1992-6#1)(2008-4#1)
technique is presented for##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
technique is presented in##2##4##(2008-2#1)(2008-4#1)
technique is presented to##3##4##(2008-10#1)(2008-2#2)
technique is presented##16##3##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#3)(2008-4#2)
technique is proposed for##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
technique is proposed to##2##4##(2008-3#2)
technique is proposed##16##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#10)
technique is rapid##2##3##(1994-11#1)(1997-4#1)
technique is sensitive to small##2##5##(2007-11#1)(2008-2#1)
technique is sensitive to##3##4##(2007-11#1)(2008-2#1)(2011-1#1)
technique is shown##2##3##(2008-2#2)
technique is simple##2##3##(2008-10#1)(2010-5#1)
technique is still##2##3##(1997-7#1)(2008-12#1)
technique is suitable for the determination of##2##7##(2008-10#2)
technique is suitable for##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
technique is that##3##3##(2007-12#1)(2008-3#2)
technique is the##3##3##(2008-2#1)(2008-6#1)(2013-8#1)
technique is used in##3##4##(2008-2#1)(2008-3#2)
technique is used to measure the##2##6##(2008-3#2)
technique is used to##10##4##(2008-3#8)(2008-8#1)(2010-8#1)
technique is used##18##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#12)(2008-5#1)(2008-8#1)(2010-8#1)
technique is useful for##4##4##(2007-12#1)(2008-3#2)(2012-3#1)
technique is validated by##2##4##(2007-11#1)(2008-3#1)
technique is##284##2##(1990-9#2)(1991-12#2)(1991-9#1)(1992-12#1)(1992-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#18)(2007-12#21)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#35)(2008-3#83)(2008-4#9)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
technique it##4##2##(1990-8#1)(1992-11#1)(2007-12#1)(2008-3#1)
technique leads to##3##3##(2007-11#1)(2008-3#1)(2009-3#1)
technique like##2##2##(2008-10#1)(2010-5#1)
technique makes it possible to##3##5##(1996-5#1)(2008-11#1)(2008-2#1)
technique makes##7##2##(1991-5#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
technique may be useful##2##4##(2007-11#1)(2008-10#1)
technique may be##9##3##(1992-2#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
technique may##17##2##(1990-12#1)(1992-2#1)(1994-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-10#1)(2011-7#1)(2012-12#1)
technique measures##2##2##(2008-3#2)
technique not##2##2##(2008-10#1)(2008-11#1)
technique of a##2##3##(1992-9#1)(2010-11#1)
technique of choice in##3##4##(1995-11#1)(2007-11#2)
technique of choice##9##3##(1991-5#1)(1992-9#1)(1995-11#1)(2007-11#2)(2010-6#1)(2011-2#1)(2012-2#2)
technique of chromosome microdissection and microcloning##2##6##(2008-7#2)
technique of interspecific hybridization##2##4##(2008-9#2)
technique of laparoscopic##2##3##(1994-2#1)(2011-2#1)
technique of photoacoustic##2##3##(2008-2#1)(2008-3#1)
technique of superficially##2##3##(2007-8#2)
technique of the##8##3##(1990-3#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
technique of wound dressing##2##4##(2011-2#2)
technique of##128##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-8#7)(2008-10#17)(2008-11#3)(2008-2#10)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#5)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
technique offers a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
technique offers the##2##3##(2007-7#1)(2010-8#1)
technique offers##9##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)
technique on the##2##3##(2008-10#1)(2012-3#1)
technique on##14##2##(1991-4#1)(1995-1#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-5#1)(2012-3#1)
technique onto a##2##3##(2007-11#2)
technique or##7##2##(1990-3#1)(1996-2#1)(2008-10#2)(2008-3#2)(2010-9#1)
technique over the##2##3##(1990-6#1)(1991-12#1)
technique particularly##3##2##(1991-5#1)(2008-3#1)(2010-7#1)
technique permits the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
technique permits##12##2##(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)
technique presented here##2##3##(2008-11#1)(2008-3#1)
technique presented##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)
technique produces##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
technique proposed##4##2##(2008-10#3)(2008-3#1)
technique proved##2##2##(1991-12#1)(2008-3#1)
technique provides a##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
technique provides the##2##3##(2007-10#1)(2011-2#1)
technique provides##15##2##(1990-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
technique ranged from##2##3##(1992-11#1)(2008-10#1)
technique reduces##2##2##(2011-2#1)(2012-2#1)
technique relaxes the strict##2##4##(2007-12#1)(2008-3#1)
technique relies on the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
technique relies on##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
technique represents a##2##3##(1990-2#1)(1992-6#1)
technique represents##3##2##(1990-2#1)(1992-6#1)(2008-6#1)
technique requires no##2##3##(2007-11#1)(2008-3#1)
technique requires##8##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-3#3)(2009-5#1)(2011-2#1)
technique resulted in##3##3##(2011-2#2)(2013-8#1)
technique results##2##2##(2008-10#1)(2010-10#1)
technique reveals##2##2##(1994-9#1)(2012-12#1)
technique seems##2##2##(1997-3#1)(2008-9#1)
technique should##5##2##(1996-8#1)(2008-10#3)(2008-2#1)
technique showed that##2##3##(2008-8#1)(2008-9#1)
technique showed##4##2##(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)
technique shows##6##2##(1991-3#1)(2007-11#1)(2007-12#2)(2008-3#1)(2012-2#1)
technique simplifies##2##2##(2007-8#1)(2008-10#1)
technique such as##2##3##(2007-8#1)(2013-1#1)
technique suitable for##2##3##(1996-2#1)(2011-2#1)
technique survival in##2##3##(2011-2#2)
technique survival overall and in anuric patients##2##7##(2011-2#2)
technique survival##10##2##(2007-12#2)(2008-1#1)(2011-2#7)
technique takes advantage of the##2##5##(2008-2#1)(2008-4#1)
technique that allows the##2##4##(2010-6#1)(2012-2#1)
technique that allows##7##3##(1993-12#1)(2007-8#1)(2008-3#2)(2010-6#1)(2011-2#1)(2012-2#1)
technique that can be used to##2##6##(2007-12#1)(2008-4#1)
technique that can be used##4##5##(2007-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
technique that can##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
technique that combines the##2##4##(2008-10#1)(2008-9#1)
technique that combines##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
technique that does not require##2##5##(1995-12#1)(2008-10#1)
technique that has##6##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
technique that involves##2##3##(1993-8#1)(2012-2#1)
technique that is##10##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-2#1)(2012-3#1)
technique that permits the##2##4##(2008-3#2)
technique that permits##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
technique that provides##3##3##(2008-3#2)(2010-9#1)
technique that uses a##2##4##(2007-11#2)
technique that uses##13##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2009-10#1)(2011-2#1)
technique that we##2##3##(2008-2#1)(2008-3#1)
technique that##89##2##(1993-12#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-11#9)(2007-12#5)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#26)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)
technique the##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
technique to a##5##3##(1990-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
technique to analyze##2##3##(2008-10#2)
technique to assess the##2##4##(2008-5#1)(2012-3#1)
technique to assess##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
technique to characterize##4##3##(2007-12#2)(2008-10#1)(2010-4#1)
technique to control##2##3##(1997-4#1)(2009-9#1)
technique to detect##6##3##(1994-10#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
technique to determine the##2##4##(2008-2#1)(2008-3#1)
technique to determine##7##3##(1992-6#1)(1993-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
technique to examine the##2##4##(2008-3#2)
technique to examine##3##3##(2008-3#2)(2008-9#1)
technique to improve the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
technique to improve##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
technique to investigate the##3##4##(2008-2#1)(2010-9#1)(2011-3#1)
technique to investigate##4##3##(1994-8#1)(2008-2#1)(2010-9#1)(2011-3#1)
technique to isolate##2##3##(1990-12#1)(1991-5#1)
technique to measure the thermal##2##5##(2008-3#2)
technique to measure the##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
technique to measure##14##3##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#7)
technique to perform##2##3##(1991-2#1)(2008-10#1)
technique to reduce the##5##4##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)
technique to select##2##3##(1997-4#1)(2008-10#1)
technique to study##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
technique to the##9##3##(1990-3#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-1#1)
technique to understand##2##3##(2008-11#1)(2013-8#1)
technique to##144##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-8#2)(2007-11#6)(2007-12#8)(2007-8#3)(2008-10#22)(2008-11#3)(2008-2#15)(2008-3#33)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
technique used by##2##3##(1990-9#1)(2012-2#1)
technique used for##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
technique used in##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
technique used is##2##3##(2008-2#1)(2008-3#1)
technique used to##12##3##(1994-12#1)(2008-10#3)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)
technique used##30##2##(1990-9#1)(1991-2#1)(1994-12#1)(1997-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
technique uses a##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
technique uses##12##2##(2007-12#3)(2008-2#1)(2008-3#8)
technique using a##8##3##(1992-12#1)(1997-3#1)(2008-10#2)(2011-2#1)(2012-12#2)(2012-3#1)
technique using an##2##3##(1992-12#1)(1996-12#1)
technique using the##4##3##(1990-8#1)(1991-12#1)(1994-9#1)(2008-8#1)
technique using##29##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#2)(1994-9#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
technique utilized##2##2##(2008-10#1)(2008-12#1)
technique utilizes the##2##3##(2008-10#1)(2008-5#1)
technique utilizes##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
technique very##2##2##(2008-6#1)(2010-10#1)
technique was also used to##2##5##(2008-10#1)(2008-3#1)
technique was also##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
technique was applied for the##2##5##(2007-11#1)(2008-10#1)
technique was applied for##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
technique was applied in##2##4##(2008-10#1)(2008-3#1)
technique was applied to the##3##5##(2008-10#3)
technique was applied to##11##4##(1990-5#1)(2008-10#6)(2008-3#3)(2010-3#1)
technique was applied##17##3##(1990-5#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#4)(2010-3#1)(2013-1#1)
technique was confirmed##2##3##(2008-10#2)
technique was described##2##3##(2008-10#1)(2012-3#1)
technique was developed for##2##4##(2008-10#2)
technique was developed to localize##2##5##(2008-10#2)
technique was developed to produce##2##5##(2008-10#1)(2009-5#1)
technique was developed to##8##4##(1997-4#1)(2008-10#5)(2008-11#1)(2009-5#1)
technique was developed##13##3##(1997-4#1)(2008-10#9)(2008-11#1)(2008-2#1)(2009-5#1)
technique was employed to##2##4##(2008-10#1)(2008-3#1)
technique was employed##3##3##(1996-9#1)(2008-10#1)(2008-3#1)
technique was evaluated##2##3##(2008-10#2)
technique was examined##3##3##(2008-10#3)
technique was first##2##3##(2008-10#1)(2012-1#1)
technique was found to be##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
technique was found##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#1)
technique was investigated##2##3##(2008-10#1)(2013-8#1)
technique was performed in##3##4##(1991-5#1)(2007-11#2)
technique was performed on##2##4##(2008-10#1)(2008-7#1)
technique was performed##6##3##(1991-5#1)(2007-11#2)(2008-10#1)(2008-7#1)(2011-2#1)
technique was successfully applied##2##4##(2008-10#2)
technique was used and the##2##5##(2008-10#2)
technique was used for##5##4##(1994-11#1)(2008-10#3)(2013-1#1)
technique was used in##2##4##(2007-10#1)(2008-5#1)
technique was used to determine##3##5##(2007-5#1)(2008-10#1)(2008-2#1)
technique was used to measure##2##5##(1990-12#1)(2008-3#1)
technique was used to##21##4##(1990-12#2)(1995-12#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
technique was used##37##3##(1990-12#2)(1990-5#1)(1992-2#1)(1994-11#1)(1995-12#1)(1997-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
technique was utilized to reconstruct##2##5##(2007-12#1)(2012-1#1)
technique was utilized to##3##4##(1996-1#1)(2007-12#1)(2012-1#1)
technique was verified by##2##4##(1991-5#1)(2008-3#1)
technique was##147##2##(1990-12#2)(1990-5#2)(1991-2#1)(1991-5#3)(1992-11#1)(1992-2#1)(1994-1#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-5#1)(2008-10#60)(2008-11#3)(2008-2#7)(2008-3#14)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
technique we##4##2##(2007-11#1)(2008-11#1)(2008-2#1)(2012-3#1)
technique were compared##2##3##(2008-10#2)
technique were##17##2##(1994-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
technique which can be##2##4##(1993-9#1)(1996-3#1)
technique which can##3##3##(1993-9#1)(1996-3#1)(2008-10#1)
technique which is thought##2##4##(2008-5#1)(2010-8#1)
technique which utilizes the##2##4##(2008-10#1)(2008-6#1)
technique which##20##2##(1991-2#1)(1991-5#1)(1993-9#1)(1994-2#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
technique will be##5##3##(1992-12#1)(2007-11#1)(2007-12#1)(2009-2#1)(2011-1#1)
technique will##9##2##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#2)
technique with a##11##3##(1991-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)
technique with an##7##3##(1993-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-3#1)
technique with many##2##3##(1994-3#1)(2008-2#1)
technique with the##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#1)
technique with##64##2##(1991-12#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#2)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#6)(2008-10#18)(2008-11#1)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
technique without##4##2##(2007-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
technique would##2##2##(2008-10#1)(2008-3#1)
technique yields##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
technique##3252##1##(1990-10#3)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#5)(1990-5#7)(1990-6#2)(1990-7#2)(1990-8#7)(1990-9#10)(1991-1#1)(1991-11#4)(1991-12#15)(1991-2#10)(1991-3#10)(1991-4#1)(1991-5#12)(1991-6#4)(1991-9#5)(1992-1#2)(1992-11#5)(1992-12#7)(1992-2#5)(1992-3#3)(1992-5#4)(1992-6#10)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#10)(1993-2#1)(1993-3#8)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#5)(1994-1#3)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#12)(1995-1#3)(1995-11#4)(1995-12#10)(1995-2#7)(1995-3#1)(1995-5#7)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-12#11)(1996-2#9)(1996-3#6)(1996-5#7)(1996-6#2)(1996-8#4)(1996-9#4)(1997-1#3)(1997-2#5)(1997-3#10)(1997-4#16)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#9)(2006-12#2)(2006-4#2)(2006-6#2)(2007-10#8)(2007-11#167)(2007-12#192)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#58)(2007-9#1)(2008-1#14)(2008-10#687)(2008-11#58)(2008-12#22)(2008-2#226)(2008-3#575)(2008-4#47)(2008-5#56)(2008-6#19)(2008-7#76)(2008-8#52)(2008-9#54)(2009-1#3)(2009-10#5)(2009-11#7)(2009-12#8)(2009-2#7)(2009-3#8)(2009-4#5)(2009-5#15)(2009-6#2)(2009-7#4)(2009-8#14)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#6)(2010-12#7)(2010-2#1)(2010-3#10)(2010-4#6)(2010-5#13)(2010-6#7)(2010-7#10)(2010-8#15)(2010-9#6)(2011-1#21)(2011-2#115)(2011-3#4)(2011-7#5)(2012-1#18)(2012-12#30)(2012-2#62)(2012-3#28)(2012-4#1)(2012-5#1)(2013-1#73)(2013-7#2)(2013-8#25)
technique&quot##4##1##(1990-8#1)(1997-3#1)(2008-8#2)
technique's##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
technique)##5##1##(1990-5#1)(1991-12#1)(2008-10#2)(2008-2#1)
technique?]##2##1##(1991-2#1)(2007-6#1)
technique]##6##1##(1990-9#1)(1992-6#1)(1993-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
techniques (e##2##2##(1997-7#1)(2011-2#1)
techniques (i##2##2##(1996-7#1)(2008-10#1)
techniques -##2##2##(2008-10#2)
techniques a##2##2##(2008-10#2)
techniques allow##4##2##(2007-10#1)(2008-2#1)(2009-4#1)(2009-8#1)
techniques allows##2##2##(1991-9#1)(2007-8#1)
techniques and X-ray##2##3##(2007-11#1)(2008-10#1)
techniques and a##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)
techniques and an##2##3##(2008-10#2)
techniques and approaches##3##3##(1994-6#1)(2012-2#1)(2013-1#1)
techniques and in##2##3##(2008-10#1)(2011-2#1)
techniques and instrumentation##3##3##(2008-10#2)(2008-8#1)
techniques and is##3##3##(2008-1#1)(2008-3#1)(2010-7#1)
techniques and it##2##3##(2008-10#1)(2011-1#1)
techniques and mass spectrometry##2##4##(2008-7#1)(2013-1#1)
techniques and methodologies used##2##4##(2008-10#1)(2008-11#1)
techniques and other##2##3##(1991-3#1)(2008-7#1)
techniques and outcomes##2##3##(2008-9#1)(2013-8#1)
techniques and the development of##2##5##(1994-5#1)(2008-10#1)
techniques and the##9##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-11#1)(2010-3#1)(2010-5#1)
techniques and their##2##3##(1995-3#1)(2011-2#1)
techniques and##127##2##(1990-12#2)(1991-3#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#6)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
techniques applied to##2##3##(1993-12#1)(2013-1#1)
techniques applied##4##2##(1993-12#1)(2008-10#2)(2013-1#1)
techniques are adapted##2##3##(2008-10#1)(2008-9#1)
techniques are also##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
techniques are available for##2##4##(1991-9#1)(2008-7#1)
techniques are available##5##3##(1991-9#1)(2008-11#2)(2008-7#2)
techniques are based on##2##4##(1996-9#1)(2010-8#1)
techniques are being##3##3##(1994-12#1)(2009-3#1)(2010-8#1)
techniques are commonly used in the##2##6##(1997-8#1)(2008-4#1)
techniques are compared##2##3##(2008-10#1)(2008-2#1)
techniques are computationally##2##3##(2008-6#1)(2008-7#1)
techniques are currently##2##3##(2007-11#1)(2010-1#1)
techniques are described in##2##4##(2008-3#1)(2008-4#1)
techniques are described##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)
techniques are discussed##10##3##(1990-8#1)(2008-10#4)(2008-3#2)(2008-8#1)(2010-9#1)(2011-2#1)
techniques are employed to##2##4##(1994-2#1)(2008-10#1)
techniques are employed##3##3##(1994-2#1)(1994-9#1)(2008-10#1)
techniques are essential in##2##4##(2010-12#1)(2010-9#1)
techniques are feasible##2##3##(2008-3#1)(2009-2#1)
techniques are more##2##3##(2008-10#1)(2009-9#1)
techniques are not##3##3##(1994-12#1)(2008-7#1)(2010-11#1)
techniques are often##2##3##(2008-11#1)(2008-7#1)
techniques are presented##4##3##(2008-10#2)(2008-6#1)(2008-7#1)
techniques are the##2##3##(2008-10#1)(2008-3#1)
techniques are used to enhance the##2##6##(2008-3#1)(2009-10#1)
techniques are used to##5##4##(1990-8#1)(2007-12#1)(2008-3#2)(2009-10#1)
techniques are used##11##3##(1990-8#1)(2007-12#1)(2008-2#2)(2008-3#4)(2009-10#1)(2010-12#1)(2013-1#1)
techniques are useful in##2##4##(2008-10#1)(2008-2#1)
techniques are useful##3##3##(2008-10#1)(2008-2#2)
techniques are very##6##3##(1990-12#1)(1991-3#1)(2008-10#2)(2008-9#2)
techniques are##117##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-5#1)(1996-9#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-2#6)(2008-3#19)(2008-4#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
techniques as a##2##3##(2007-10#1)(2008-10#1)
techniques as well as##2##4##(2008-11#1)(2008-8#1)
techniques as##9##2##(1994-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
techniques associated with##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
techniques at##4##2##(1997-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
techniques available for##4##3##(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
techniques available is##2##3##(1990-6#1)(1993-11#1)
techniques available##12##2##(1990-6#1)(1993-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-12#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
techniques based on##10##3##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-5#1)
techniques based##11##2##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)
techniques because##2##2##(2008-10#1)(2008-2#1)
techniques but##4##2##(1997-7#1)(2008-10#1)(2008-11#1)(2010-12#1)
techniques by which this##2##4##(2007-8#1)(2008-11#1)
techniques by##5##2##(2007-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
techniques can also be##2##4##(2006-4#1)(2008-6#1)
techniques can be employed##2##4##(2008-2#1)(2010-8#1)
techniques can be used for##2##5##(2006-4#1)(2008-9#1)
techniques can be used in the##2##6##(2011-2#2)
techniques can be used in##4##5##(2008-10#1)(2009-2#1)(2011-2#2)
techniques can be used to##5##5##(1995-3#1)(2008-3#1)(2008-4#2)(2010-8#1)
techniques can be used##12##4##(1995-3#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#2)
techniques can be##21##3##(1994-12#1)(1995-3#2)(1997-7#1)(2006-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-8#2)(2011-2#2)
techniques can provide##2##3##(1994-3#1)(2007-5#1)
techniques can##33##2##(1994-12#1)(1994-3#1)(1995-3#2)(1997-3#1)(1997-7#1)(2006-4#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-8#2)(2011-2#2)(2012-2#1)
techniques cannot##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
techniques coupled##2##2##(1997-4#1)(2008-3#1)
techniques currently##2##2##(2008-5#1)(2013-1#1)
techniques described##6##2##(2008-10#4)(2008-11#1)(2008-2#1)
techniques detect##2##2##(2008-4#1)(2008-5#1)
techniques developed in##2##3##(2008-10#1)(2008-8#1)
techniques developed to##2##3##(2008-10#1)(2008-2#1)
techniques developed##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
techniques differ##2##2##(2008-9#1)(2009-1#1)
techniques do not##2##3##(2011-2#1)(2012-2#1)
techniques employed to##2##3##(2007-12#1)(2008-3#1)
techniques employed##7##2##(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#1)
techniques fail to##2##3##(2008-3#1)(2008-6#1)
techniques for a##2##3##(2008-10#1)(2008-2#1)
techniques for an##2##3##(2010-6#1)(2013-8#1)
techniques for ankle arthrodesis##2##4##(2008-12#2)
techniques for cancer##3##3##(2008-1#1)(2013-1#2)
techniques for detecting##2##3##(2008-10#2)
techniques for detection of##2##4##(2008-10#1)(2012-3#1)
techniques for determining##2##3##(2008-3#1)(2008-9#1)
techniques for diagnosis##2##3##(1996-12#1)(2013-1#1)
techniques for fluorescence##2##3##(2008-9#2)
techniques for handling##2##3##(2008-10#1)(2008-9#1)
techniques for measurements##2##3##(2008-10#1)(2008-3#1)
techniques for measuring##3##3##(2008-2#1)(2008-4#2)
techniques for screening##5##3##(2008-10#4)(2011-2#1)
techniques for the analysis of##2##5##(1996-3#1)(2008-10#1)
techniques for the analysis##3##4##(1996-3#1)(2008-10#2)
techniques for the detection of##2##5##(1995-12#1)(2008-10#1)
techniques for the detection##3##4##(1995-12#1)(2008-10#1)(2008-2#1)
techniques for the quantification of##2##5##(1994-12#1)(2008-10#1)
techniques for the treatment of##3##5##(1991-2#1)(2007-8#1)(2011-3#1)
techniques for the##36##3##(1991-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-4#3)(2008-7#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-3#1)
techniques for tissue##2##3##(2010-6#1)(2011-1#1)
techniques for##170##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-6#2)(2006-10#2)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#41)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#8)(2008-4#10)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#12)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#2)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#10)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
techniques from##2##2##(2008-10#1)(2008-9#1)
techniques gave##3##2##(2008-10#2)(2008-7#1)
techniques give##2##2##(2008-10#1)(2008-3#1)
techniques has been##5##3##(2008-2#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
techniques has led to the##3##5##(2008-10#1)(2008-8#1)(2010-3#1)
techniques has##19##2##(1992-5#1)(1994-6#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
techniques have also##3##3##(1994-3#1)(2008-11#1)(2008-9#1)
techniques have become##2##3##(2010-7#1)(2010-9#1)
techniques have been able to##2##5##(2008-7#1)(2011-2#1)
techniques have been applied to##4##5##(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)
techniques have been applied##5##4##(1996-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)
techniques have been described##3##4##(2009-10#1)(2010-3#1)(2012-2#1)
techniques have been developed to##2##5##(2008-1#1)(2011-2#1)
techniques have been developed##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
techniques have been employed##2##4##(2008-10#1)(2008-9#1)
techniques have been modified##2##4##(2010-8#1)(2011-3#1)
techniques have been used to##5##5##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
techniques have been used##7##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
techniques have been##37##3##(1996-3#1)(2007-11#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)
techniques have led to##2##4##(2011-1#1)(2013-8#1)
techniques have limited##2##3##(2008-4#1)(2010-5#1)
techniques have resulted in##2##4##(2008-10#1)(2012-1#1)
techniques have##66##2##(1990-12#1)(1994-3#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-7#6)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
techniques in a##2##3##(1994-11#1)(1994-12#1)
techniques in gene##2##3##(1995-8#1)(2008-8#1)
techniques in order to##2##4##(1993-2#1)(2009-4#1)
techniques in recent years##2##4##(2008-12#1)(2008-4#1)
techniques in the management of##3##5##(2007-7#1)(2007-9#1)(2008-3#1)
techniques in the##19##3##(1990-5#1)(1990-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
techniques in which##3##3##(2008-3#1)(2009-10#2)
techniques in##80##2##(1990-5#1)(1990-8#1)(1991-2#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
techniques include##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
techniques including##8##2##(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-8#1)(2010-9#1)(2011-2#1)
techniques involved in the##2##4##(2008-2#1)(2008-9#1)
techniques involving##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
techniques is described##4##3##(1996-2#1)(2008-10#2)(2010-11#1)
techniques is proposed##4##3##(2008-10#1)(2008-2#1)(2008-6#2)
techniques is reported##2##3##(2008-10#1)(2008-2#1)
techniques is required##2##3##(1994-2#1)(2008-4#1)
techniques is the##2##3##(2008-1#1)(2009-12#1)
techniques is##33##2##(1994-11#1)(1994-2#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#2)(2010-11#2)(2010-4#1)(2010-5#1)(2012-3#1)
techniques like##4##2##(2007-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
techniques may##8##2##(1991-12#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)
techniques might be##2##3##(2007-12#1)(2011-2#1)
techniques most commonly used##2##4##(2008-1#1)(2008-5#1)
techniques must be##2##3##(2007-11#1)(2010-11#1)
techniques needed to##2##3##(1993-12#1)(2011-1#1)
techniques of analysis##2##3##(2008-10#1)(2008-9#1)
techniques of molecular biology##2##4##(1997-7#1)(2011-2#1)
techniques of the##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
techniques of##55##2##(1990-3#1)(1991-11#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-9#1)(1997-4#2)(1997-7#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
techniques offer##3##2##(2009-12#1)(2012-2#1)(2013-1#1)
techniques on the##3##3##(1992-2#1)(2008-6#1)(2009-1#1)
techniques on##10##2##(1991-3#1)(1992-2#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-1#1)(2009-5#1)(2012-7#1)(2013-1#1)
techniques or##2##2##(2008-10#1)(2008-4#1)
techniques over the last##2##4##(2008-4#1)(2009-12#1)
techniques over##3##2##(2008-2#1)(2008-4#1)(2009-12#1)
techniques presented are##2##3##(2008-4#1)(2008-9#1)
techniques presented##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
techniques provide##4##2##(2008-2#1)(2008-3#3)
techniques provided##2##2##(2008-10#1)(2008-8#1)
techniques required for##2##3##(2008-5#1)(2010-9#1)
techniques result in##2##3##(2008-2#1)(2012-3#1)
techniques revealed##2##2##(1993-6#1)(2008-5#1)
techniques should be##2##3##(1991-6#1)(2008-9#1)
techniques should##4##2##(1991-6#1)(1994-2#1)(1996-9#1)(2008-9#1)
techniques showed that the##2##4##(1997-2#1)(2008-10#1)
techniques showed##3##2##(1994-12#1)(1997-2#1)(2008-10#1)
techniques such as flame atomic absorption spectrometry##2##7##(2008-10#2)
techniques such as the##3##4##(2008-2#2)(2008-4#1)
techniques such as##45##3##(1994-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#14)(2008-12#2)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#2)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
techniques such##46##2##(1994-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#14)(2008-12#2)(2008-2#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-12#2)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
techniques suitable for##2##3##(2008-1#1)(2008-3#1)
techniques that are currently##2##4##(2007-7#1)(2010-10#1)
techniques that are##7##3##(1992-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)
techniques that can be##2##4##(2008-4#1)(2008-9#1)
techniques that can##3##3##(1995-1#1)(2008-4#1)(2008-9#1)
techniques that have been developed for##3##6##(2008-11#1)(2008-4#1)(2010-12#1)
techniques that have been##7##4##(1991-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-12#1)
techniques that have##11##3##(1991-12#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-12#2)(2010-8#1)(2011-1#1)
techniques that show##2##3##(2008-2#1)(2008-8#1)
techniques that the##2##3##(1995-3#1)(2008-10#1)
techniques that use##2##3##(2008-3#1)(2012-2#1)
techniques that will be##2##4##(2008-10#2)
techniques that##45##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#6)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
techniques the##5##2##(1993-8#1)(2007-1#1)(2007-11#1)(2009-12#1)(2013-8#1)
techniques to be##4##3##(2008-3#2)(2008-8#1)(2012-12#1)
techniques to confirm##2##3##(2007-8#1)(2008-7#1)
techniques to determine the##3##4##(1997-4#1)(2008-10#2)
techniques to evaluate##2##3##(2008-8#1)(2008-9#1)
techniques to examine the##2##4##(1996-12#1)(2007-8#1)
techniques to examine##3##3##(1996-12#1)(2007-8#1)(2008-8#1)
techniques to generate##2##3##(2008-3#1)(2008-9#1)
techniques to improve the##2##4##(1996-3#1)(2010-8#1)
techniques to improve##3##3##(1996-3#1)(2008-10#1)(2010-8#1)
techniques to measure the##2##4##(2008-3#1)(2009-7#1)
techniques to measure##5##3##(1993-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)
techniques to perform##2##3##(2008-10#1)(2008-3#1)
techniques to provide a##2##4##(2008-11#1)(2013-8#1)
techniques to reduce##2##3##(2007-11#1)(2008-3#1)
techniques to the analysis of##2##5##(1995-5#1)(2008-10#1)
techniques to the##6##3##(1995-5#1)(2007-7#1)(2008-10#3)(2008-3#1)
techniques to water analysis Part##2##5##(2008-10#2)
techniques to water analysis##3##4##(2008-10#3)
techniques to yield a potentially low-cost##2##6##(2008-3#2)
techniques to##94##2##(1991-2#1)(1991-3#1)(1993-11#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#6)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
techniques used for##9##3##(1992-9#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
techniques used in the field of##2##6##(2008-10#1)(2012-3#1)
techniques used in the##3##4##(2007-10#1)(2008-10#1)(2012-3#1)
techniques used in##6##3##(1995-1#1)(2007-10#1)(2008-10#1)(2008-2#2)(2012-3#1)
techniques used to##9##3##(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2011-2#1)
techniques used were##2##3##(2008-10#2)
techniques used##33##2##(1992-9#1)(1994-1#1)(1995-1#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#4)(2009-10#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-3#1)
techniques using##10##2##(1991-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
techniques was applied##2##3##(2007-10#1)(2008-10#1)
techniques was##12##2##(1991-12#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
techniques we have##2##3##(2008-10#1)(2008-7#1)
techniques we##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
techniques were applied to the##2##5##(1997-3#1)(2008-11#1)
techniques were applied to##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
techniques were applied##7##3##(1997-3#1)(2008-10#2)(2008-11#1)(2011-2#2)(2013-1#1)
techniques were compared##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
techniques were employed to##2##4##(2008-3#1)(2008-7#1)
techniques were employed##3##3##(1992-3#1)(2008-3#1)(2008-7#1)
techniques were mainly##2##3##(1991-5#1)(2008-10#1)
techniques were reviewed##2##3##(2011-2#1)(2013-1#1)
techniques were used for##2##4##(2008-10#1)(2008-7#1)
techniques were used in##2##4##(1996-2#1)(2008-10#1)
techniques were used to study the##3##6##(1993-12#1)(2008-10#1)(2010-7#1)
techniques were used to##17##4##(1991-12#1)(1992-12#1)(1993-12#2)(1997-2#1)(1997-3#1)(2008-10#6)(2008-3#2)(2008-5#1)(2010-7#1)(2012-2#1)
techniques were used##24##3##(1991-12#1)(1992-12#1)(1993-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-3#2)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-2#1)
techniques were##59##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#2)(1994-11#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#2)(2007-2#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#4)
techniques when##2##2##(1990-9#1)(2012-3#1)
techniques which##5##2##(1992-12#1)(1995-3#1)(2007-6#1)(2009-5#1)(2010-11#1)
techniques will be##2##3##(2010-3#1)(2010-8#1)
techniques will##9##2##(1990-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)
techniques with more##2##3##(1991-3#1)(2008-10#1)
techniques with the##2##3##(2008-10#1)(2008-2#1)
techniques with##15##2##(1991-3#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-7#1)
techniques within the##2##3##(1992-6#1)(2008-9#1)
techniques without##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
techniques##2047##1##(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#10)(1991-2#7)(1991-3#8)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#8)(1993-2#5)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#8)(1994-5#3)(1994-6#6)(1994-8#1)(1994-9#4)(1995-1#9)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#10)(1995-5#10)(1995-6#2)(1995-8#4)(1996-1#3)(1996-12#6)(1996-2#4)(1996-3#6)(1996-5#2)(1996-6#1)(1996-7#4)(1996-9#5)(1997-2#6)(1997-3#8)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#6)(2006-10#5)(2006-4#6)(2007-1#2)(2007-10#8)(2007-11#33)(2007-12#50)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#27)(2007-9#4)(2008-1#32)(2008-10#449)(2008-11#59)(2008-12#15)(2008-2#89)(2008-3#149)(2008-4#81)(2008-5#33)(2008-6#21)(2008-7#82)(2008-8#43)(2008-9#72)(2009-1#3)(2009-10#8)(2009-11#6)(2009-12#12)(2009-2#7)(2009-3#10)(2009-4#8)(2009-5#14)(2009-7#4)(2009-8#6)(2009-9#6)(2010-1#3)(2010-10#1)(2010-11#14)(2010-12#12)(2010-2#2)(2010-3#11)(2010-4#6)(2010-5#9)(2010-6#6)(2010-7#24)(2010-8#25)(2010-9#18)(2011-1#32)(2011-2#87)(2011-3#3)(2012-1#5)(2012-12#13)(2012-2#42)(2012-3#30)(2012-7#1)(2013-1#39)(2013-7#2)(2013-8#14)
techniques)##3##1##(2008-2#1)(2011-2#2)
techniques]##2##1##(1991-3#1)(1996-9#1)
technologic advances##2##2##(2007-12#1)(2013-1#1)
technologic##7##1##(1992-3#1)(1993-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2013-1#1)
technological advance##2##2##(1992-2#1)(1992-3#1)
technological advancement##2##2##(1994-12#1)(2007-12#1)
technological advances and##2##3##(2008-11#1)(2008-12#1)
technological advances in##6##3##(2008-1#1)(2008-3#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-8#1)
technological advances##18##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
technological and scientific##2##3##(1992-2#1)(2010-12#1)
technological and##10##2##(1992-2#1)(1992-5#1)(1993-1#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#2)(2012-2#1)
technological application##2##2##(1997-6#1)(2008-7#1)
technological applications##2##2##(2008-3#1)(2008-7#1)
technological aspects##2##2##(2008-1#1)(2010-11#1)
technological competencies##2##2##(1994-2#2)
technological development##7##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)
technological developments in##2##3##(1997-8#1)(2008-1#1)
technological developments##5##2##(1995-1#1)(1997-8#1)(2008-1#1)(2008-7#1)(2010-7#1)
technological improvements##2##2##(1994-1#1)(2010-9#1)
technological progress##2##2##(1991-3#1)(1991-5#1)
technological properties##4##2##(2008-11#1)(2008-6#1)(2010-4#1)(2012-2#1)
technological support##2##2##(1992-1#1)(2008-9#1)
technological systems##2##2##(2011-1#2)
technological##105##1##(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-1#7)(2008-10#4)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#4)(2013-1#3)(2013-8#2)
technologically##6##1##(1993-12#1)(1996-3#1)(2008-3#1)(2009-12#1)(2011-1#1)(2012-2#1)
technologies allow##2##2##(2008-2#1)(2008-9#1)
technologies and the##4##3##(2008-10#1)(2010-4#1)(2010-8#1)(2011-1#1)
technologies and##23##2##(1993-12#2)(1993-2#1)(1996-1#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#1)
technologies are needed to##2##4##(2009-12#1)(2010-9#1)
technologies are##18##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#3)(2009-12#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-8#2)
technologies as##3##2##(1997-1#1)(2008-9#1)(2010-7#1)
technologies available##3##2##(2008-11#1)(2008-3#1)(2009-6#1)
technologies by##2##2##(2008-11#1)(2008-5#1)
technologies can##2##2##(2008-10#1)(2012-12#1)
technologies could be used##2##4##(2010-10#1)(2010-12#1)
technologies developed##2##2##(2010-7#1)(2012-3#1)
technologies for the##4##3##(1996-3#1)(2008-3#1)(2008-6#1)(2013-1#1)
technologies for##23##2##(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-6#2)(2008-7#1)(2009-12#3)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
technologies has##4##2##(2008-2#1)(2008-4#1)(2009-11#1)(2012-2#1)
technologies have been developed##2##4##(2010-7#1)(2013-1#1)
technologies have been##4##3##(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
technologies have##9##2##(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
technologies in a##2##3##(2008-10#1)(2013-8#1)
technologies in nurse education##2##4##(2008-11#2)
technologies in the##4##3##(1993-12#1)(2008-7#1)(2011-1#1)(2012-3#1)
technologies in##17##2##(1992-2#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
technologies is##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
technologies may##2##2##(2009-12#1)(2012-2#1)
technologies of##3##2##(2008-2#2)(2008-3#1)
technologies offer##2##2##(2008-2#1)(2011-1#1)
technologies requires##2##2##(2012-2#1)(2013-1#1)
technologies such as##10##3##(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
technologies that are##3##3##(2009-3#1)(2010-11#1)(2010-9#1)
technologies that##7##2##(2008-4#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-9#1)(2013-1#1)
technologies to support##2##3##(2008-12#1)(2008-3#1)
technologies to##17##2##(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)(2009-10#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
technologies using##2##2##(2012-2#2)
technologies were##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-2#1)
technologies with##3##2##(2008-3#1)(2008-7#1)(2009-2#1)
technologies##300##1##(1990-12#2)(1992-11#1)(1992-2#3)(1992-3#2)(1993-12#4)(1993-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#6)(1997-2#2)(1997-4#3)(2007-10#1)(2008-1#2)(2008-10#29)(2008-11#27)(2008-12#5)(2008-2#10)(2008-3#11)(2008-4#9)(2008-5#6)(2008-6#4)(2008-7#18)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#8)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#3)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#8)(2010-8#9)(2010-9#4)(2011-1#7)(2011-10#1)(2011-2#8)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#18)(2012-3#7)(2013-1#8)(2013-8#6)
technologies)##2##1##(2008-10#1)(2009-3#1)
technologies?##3##1##(1996-8#1)(2013-1#2)
technologist and##2##2##(1991-1#1)(1993-12#1)
technologist##10##1##(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#1)(1995-3#2)(2008-12#1)
technologist's##3##1##(1994-6#1)(1995-3#1)(1996-3#1)
technologists and##8##2##(1992-3#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(2008-12#1)
technologists in##3##2##(1992-1#1)(1995-3#1)(1996-3#1)
technologists##40##1##(1991-2#1)(1992-1#7)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#3)(1994-12#5)(1994-2#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#4)(1996-2#2)(1996-3#4)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)
technology acquisition in##3##3##(1991-1#1)(1994-12#1)(1996-2#1)
technology acquisition##4##2##(1991-1#1)(1994-12#1)(1996-2#1)(1997-1#1)
technology allows##4##2##(1992-5#1)(2008-12#1)(2008-2#1)(2008-7#1)
technology and a##2##3##(2008-10#1)(2008-3#1)
technology and clinical##2##3##(2008-4#1)(2008-7#1)
technology and its##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
technology and the##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
technology and##56##2##(1991-11#1)(1992-1#1)(1992-2#1)(1993-11#2)(1993-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
technology are##6##2##(1995-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)
technology as a##3##3##(1996-12#1)(1997-2#1)(2008-7#1)
technology as##7##2##(1992-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-7#2)
technology assessment and##2##3##(1993-3#1)(2008-2#1)
technology assessment##12##2##(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-2#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
technology assessments##2##2##(1994-12#1)(2009-3#1)
technology associated with the##2##4##(2008-11#1)(2008-9#1)
technology at##2##2##(2006-8#1)(2008-2#1)
technology by##3##2##(2008-3#1)(2008-7#1)(2009-12#1)
technology called##2##2##(2008-11#1)(2008-9#1)
technology can be##2##3##(2008-3#1)(2008-7#1)
technology can have a##2##4##(2008-11#2)
technology can provide##2##3##(2008-3#1)(2013-1#1)
technology can##8##2##(2008-11#2)(2008-3#2)(2008-7#2)(2012-3#1)(2013-1#1)
technology dependent##3##2##(1992-1#2)(2008-11#1)
technology development##2##2##(2009-11#1)(2012-3#1)
technology for the##7##3##(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)
technology for##39##2##(1994-9#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
technology has allowed##2##3##(2008-11#1)(2008-4#1)
technology has become##2##3##(2008-11#1)(2010-12#1)
technology has been a##2##4##(2007-12#1)(2008-7#1)
technology has been##6##3##(2007-12#1)(2008-11#3)(2008-3#1)(2008-7#1)
technology has had a significant impact on the##2##8##(2007-12#1)(2008-7#1)
technology has##26##2##(1994-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#2)(2010-12#1)(2012-2#1)
technology have led to##3##4##(2008-7#1)(2010-6#1)(2012-3#1)
technology have resulted in##2##4##(1996-2#1)(2008-9#1)
technology have##10##2##(1996-2#1)(2008-7#4)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
technology implications##2##2##(1995-12#1)(2007-9#1)
technology improves##2##2##(2010-12#1)(2012-2#1)
technology in a##4##3##(2008-10#2)(2008-7#1)(2010-4#1)
technology in clinical##3##3##(1994-12#1)(2008-8#1)(2011-7#1)
technology in health care and##2##5##(2008-1#1)(2008-10#1)
technology in health care##3##4##(2008-1#1)(2008-10#2)
technology in health##5##3##(2008-1#1)(2008-10#3)(2012-12#1)
technology in medicine##3##3##(1991-11#1)(2013-8#2)
technology in the##7##3##(1991-11#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-11#1)
technology in this##2##3##(2010-11#1)(2010-8#1)
technology in##51##2##(1991-11#2)(1993-2#1)(1994-12#2)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
technology into##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)
technology is a##5##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
technology is also##2##3##(2008-11#1)(2008-5#1)
technology is based on##3##4##(1996-12#1)(2008-6#1)(2008-7#1)
technology is described##2##3##(2008-3#1)(2013-1#1)
technology is growing##2##3##(1996-2#1)(2012-2#1)
technology is the##2##3##(2008-10#1)(2008-11#1)
technology is used to##2##4##(1994-12#1)(2008-3#1)
technology is used##3##3##(1994-12#1)(2008-3#2)
technology is##44##2##(1992-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-3#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
technology makes##2##2##(2012-3#1)(2013-8#1)
technology management##2##2##(2011-2#2)
technology may##3##2##(2008-11#1)(2008-3#1)(2009-3#1)
technology must##3##2##(1996-2#1)(2008-11#1)(2008-2#1)
technology not##2##2##(2008-7#1)(2011-2#1)
technology now##3##2##(2006-12#1)(2008-7#1)(2010-11#1)
technology of the##4##3##(1997-5#1)(2008-10#1)(2008-5#2)
technology of##18##2##(1990-8#1)(1991-3#1)(1994-1#1)(1997-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#2)
technology offers##2##2##(1991-11#1)(2012-12#1)
technology on##2##2##(1995-12#1)(2013-1#1)
technology platforms are##2##3##(2008-4#1)(2008-7#1)
technology provides a##2##3##(2008-7#1)(2012-2#1)
technology provides##5##2##(1992-5#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
technology refers to the##2##4##(1996-12#1)(2008-4#1)
technology related##2##2##(2010-8#1)(2011-1#1)
technology should be##2##3##(1996-2#1)(1996-3#1)
technology should##5##2##(1996-2#1)(1996-3#1)(2008-2#1)(2008-9#1)(2011-2#1)
technology specifically##2##2##(1995-2#1)(2008-10#1)
technology that allows##2##3##(1992-9#1)(2008-1#1)
technology that are##2##3##(1992-1#1)(2009-7#1)
technology that can##3##3##(2012-2#2)(2013-7#1)
technology that is##3##3##(1997-1#1)(2012-1#1)(2013-1#1)
technology that##21##2##(1992-1#1)(1992-11#1)(1992-9#1)(1994-3#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-7#1)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
technology to be##2##3##(2008-9#1)(2013-8#1)
technology to enhance##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
technology to facilitate##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
technology to manage##2##3##(1996-3#1)(2009-11#1)
technology to monitor##2##3##(2008-10#1)(2013-8#1)
technology to##50##2##(1990-4#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#4)(2008-9#5)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
technology together with##3##3##(2008-10#2)(2009-2#1)
technology under##2##2##(2008-10#1)(2008-5#1)
technology using##2##2##(2008-3#1)(2008-9#1)
technology was##8##2##(1994-3#1)(2008-1#1)(2008-10#4)(2008-5#2)
technology were##4##2##(2008-10#2)(2008-12#1)(2010-7#1)
technology which##5##2##(2008-10#2)(2008-11#2)(2008-7#1)
technology will allow##2##3##(1995-12#1)(1996-1#1)
technology will##8##2##(1994-12#1)(1995-12#1)(1996-1#1)(2007-6#1)(2008-10#3)(2008-3#1)
technology with##4##2##(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
technology##801##1##(1990-4#2)(1990-8#2)(1991-1#1)(1991-11#5)(1991-12#4)(1991-3#1)(1991-6#1)(1992-1#8)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#5)(1993-3#3)(1994-1#6)(1994-11#1)(1994-12#15)(1994-2#4)(1994-3#4)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#9)(1995-2#4)(1995-3#4)(1996-1#7)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#8)(1997-1#6)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#6)(2007-11#4)(2007-12#15)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#12)(2008-10#96)(2008-11#71)(2008-12#17)(2008-2#19)(2008-3#41)(2008-4#17)(2008-5#18)(2008-6#3)(2008-7#61)(2008-8#9)(2008-9#29)(2009-11#7)(2009-12#3)(2009-2#1)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#19)(2010-9#5)(2011-1#11)(2011-2#26)(2011-7#7)(2012-1#1)(2012-12#10)(2012-2#23)(2012-3#18)(2013-1#19)(2013-7#2)(2013-8#12)
technology's##2##1##(1994-12#1)(2010-8#1)
technology)##5##1##(1993-2#2)(2008-10#1)(2008-12#1)(2011-2#1)
technology]##5##1##(1990-9#1)(1994-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
tecnique##2##1##(2009-10#2)
tectal##4##1##(1993-9#1)(2008-7#3)
tectonic plate##2##2##(2008-9#2)
tectopontine##3##1##(1993-3#3)
tectorial membrane injury##2##3##(2012-12#2)
tectorial membrane##5##2##(1995-5#3)(2012-12#2)
tectum##9##1##(1990-5#1)(1993-12#4)(1993-9#1)(1997-3#1)(2008-6#2)
tedious and time consuming##3##4##(1990-2#1)(2008-10#1)(2008-9#1)
tedious and time-consuming##2##3##(2008-10#1)(2008-4#1)
tedious and##7##2##(1990-2#1)(1992-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)
tedious prior separation##2##3##(2008-10#2)
tedious##19##1##(1990-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(2008-10#9)(2008-4#1)(2008-9#2)(2010-8#2)(2012-2#1)
tedium##2##1##(1996-2#1)(2008-9#1)
teen pregnancy##2##2##(1997-2#1)(2013-1#1)
teen##10##1##(1994-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2008-7#2)(2013-1#4)
teenage pregnancy##2##2##(1996-12#1)(2013-1#1)
teenage##9##1##(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2013-1#2)
teenagehealthfreak##2##1##(2008-7#2)
teenagers than##2##2##(2008-11#1)(2008-9#1)
teenagers##25##1##(1996-6#1)(1996-9#1)(2008-11#7)(2008-12#1)(2008-9#7)(2009-7#1)(2012-12#1)(2013-1#5)(2013-8#1)
teens##15##1##(1996-3#1)(2008-7#1)(2009-7#1)(2009-8#2)(2012-2#1)(2013-1#8)(2013-8#1)
teeth after##3##2##(2008-9#2)(2013-1#1)
teeth and periodontium##2##3##(2010-3#1)(2013-1#1)
teeth and##19##2##(1995-9#2)(2007-12#2)(2008-1#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-1#5)(2013-8#1)
teeth are##4##2##(1993-2#1)(1997-4#1)(2010-3#2)
teeth extracted for orthodontic reasons##2##5##(2013-8#2)
teeth extracted##3##2##(2010-9#1)(2013-8#2)
teeth for##2##2##(2012-3#1)(2013-1#1)
teeth had##2##2##(2008-12#1)(2013-1#1)
teeth have##2##2##(2008-12#1)(2013-1#1)
teeth in children##4##3##(2007-12#3)(2013-1#1)
teeth in##12##2##(1991-6#2)(2007-12#3)(2008-12#1)(2008-7#2)(2012-3#1)(2013-1#3)
teeth is##2##2##(1997-4#1)(2013-1#1)
teeth marks##2##2##(1995-3#1)(1996-5#1)
teeth of the##2##3##(2008-7#1)(2011-2#1)
teeth of##6##2##(1996-3#1)(1997-4#2)(2008-7#1)(2011-2#1)(2013-8#1)
teeth show##2##2##(2008-12#1)(2008-7#1)
teeth to##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
teeth was##3##2##(1991-6#1)(2008-1#1)(2013-8#1)
teeth were bonded with##2##4##(2009-7#2)
teeth were restored using a##2##5##(2009-8#2)
teeth were##15##2##(1990-2#1)(1991-6#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-7#1)(2009-7#2)(2009-8#2)(2012-12#1)(2013-1#4)
teeth with##4##2##(1991-2#1)(1995-9#1)(2011-2#2)
teeth##185##1##(1990-10#2)(1990-2#3)(1990-5#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#5)(1993-2#1)(1995-3#1)(1995-9#5)(1996-3#4)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#5)(2007-12#10)(2008-1#10)(2008-11#2)(2008-12#11)(2008-3#3)(2008-5#5)(2008-7#11)(2008-9#7)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#6)(2010-3#6)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-12#6)(2012-3#4)(2012-8#1)(2013-1#31)(2013-7#1)(2013-8#11)
tef##4##1##(2008-5#4)
teflon membrane##6##2##(2008-10#6)
teflon##10##1##(2008-10#10)
tegafur (Futraful##2##2##(1994-7#1)(1997-7#1)
tegaserod##6##1##(2010-6#6)
tegmental area##18##2##(1993-12#4)(1995-12#1)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(2008-4#1)(2008-7#3)(2009-8#1)
tegmental nucleus##9##2##(1991-12#3)(1994-2#2)(1994-3#2)(1995-12#1)(2008-7#1)
tegmental##30##1##(1991-12#3)(1993-12#6)(1994-2#2)(1994-3#2)(1995-12#2)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-10#1)(2008-4#1)(2008-7#4)(2009-8#1)
tegmentum##4##1##(1995-12#2)(2008-6#1)(2008-7#1)
tehran##3##1##(2007-7#1)(2011-2#1)(2013-1#1)
teicoplanin modified with acetonitrile-based##2##4##(2008-10#2)
teicoplanin modified with##3##3##(2008-10#3)
teicoplanin phase##2##2##(2008-10#2)
teicoplanin stationary phase##2##3##(2008-10#2)
teicoplanin was##2##2##(2008-10#1)(2013-8#1)
teicoplanin##20##1##(2008-10#19)(2013-8#1)
teicoplanine##2##1##(2008-10#2)
telangiectasia in##2##2##(1994-12#1)(2008-8#1)
telangiectasia##19##1##(1994-12#1)(1995-6#3)(2007-10#1)(2008-1#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-6#4)(2012-1#1)
telangiectasias##2##1##(2010-6#2)
telbivudine##4##1##(2009-8#3)(2013-1#1)
telecentric##5##1##(2008-2#1)(2008-3#4)
telecom##4##1##(2007-11#4)
telecommunication fiber##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
telecommunication wavelength##2##2##(2008-3#2)
telecommunication##10##1##(1996-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
telecommunications system##3##2##(1995-2#1)(1997-2#1)(2007-9#1)
telecommunications##14##1##(1991-12#1)(1994-3#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#2)(1997-2#1)(2007-11#1)(2007-9#1)(2008-3#1)
telehealth nursing services##3##3##(2012-3#3)
telehealth nursing##4##2##(2012-3#4)
telehealth##5##1##(2012-3#4)(2013-8#1)
telemanipulation##2##1##(2007-8#2)
telemedicine has##2##2##(1996-11#1)(1996-3#1)
telemedicine in##2##2##(1996-2#1)(2013-1#1)
telemedicine##23##1##(1996-11#4)(1996-2#5)(1996-3#5)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
telemeter##3##1##(2008-2#2)(2008-3#1)
telemetric##3##1##(2007-8#1)(2008-4#1)(2009-3#1)
telemetry##10##1##(1992-4#1)(2008-2#1)(2008-9#6)(2010-6#1)(2010-8#1)
telemonitoring##3##1##(2009-3#2)(2010-8#1)
telencephali pars##2##2##(2008-6#2)
telencephali##3##1##(2008-6#3)
telencephalic regions##2##2##(1996-5#2)
telencephalic synaptoneurosomes##2##2##(1996-5#2)
telencephalic##5##1##(1996-5#4)(1997-3#1)
telencephalon in##2##2##(1995-12#2)
telencephalon or##2##2##(1996-5#2)
telencephalon##18##1##(1994-3#2)(1995-12#2)(1996-5#12)(2008-6#1)(2012-3#1)
teleologic processes##2##2##(2008-5#2)
teleological reasoning##2##2##(2012-2#2)
teleological##3##1##(2012-2#3)
teleology##3##1##(2012-2#3)
teleomorph has##2##2##(2008-10#2)
teleomorph stage and##2##3##(2008-10#2)
teleomorph##10##1##(2008-10#9)(2010-3#1)
teleomorphs##4##1##(2008-10#3)(2008-5#1)
teleost fish##5##2##(1995-12#1)(2008-7#2)(2009-2#1)(2012-3#1)
teleost fishes##2##2##(2008-1#2)
teleost##18##1##(1993-5#1)(1995-12#1)(1995-2#1)(1997-9#2)(2008-1#3)(2008-5#1)(2008-7#6)(2009-2#1)(2010-4#1)(2012-3#1)
teleostean##3##1##(1993-5#1)(2008-1#1)(2008-7#1)
teleosts##11##1##(1991-9#1)(1995-2#2)(1996-5#1)(1997-3#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-5#1)(2010-8#1)
telephone call was made##2##4##(2007-2#2)
telephone call##8##2##(2007-2#2)(2008-8#5)(2012-3#1)
telephone calls and##2##3##(1992-8#1)(2007-11#1)
telephone calls##5##2##(1992-11#1)(1992-8#1)(2007-11#1)(2011-2#1)(2012-3#1)
telephone counseling##2##2##(1996-5#1)(1997-2#1)
telephone interview##4##2##(2007-11#1)(2008-9#2)(2009-11#1)
telephone interviews##8##2##(1996-1#1)(2007-10#1)(2008-11#3)(2009-10#1)(2010-10#1)(2013-1#1)
telephone survey of##5##3##(1993-3#1)(1996-8#1)(1997-2#1)(2008-11#1)(2013-1#1)
telephone survey##10##2##(1993-3#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
telephone systems and##2##3##(1997-2#1)(2010-2#1)
telephone systems##3##2##(1997-2#1)(2008-10#1)(2010-2#1)
telephone##79##1##(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#4)(1996-2#1)(1996-3#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-5#1)(2007-10#1)(2007-11#2)(2007-2#2)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2010-10#1)(2010-2#5)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#1)
telephone-administered##3##1##(2007-10#3)
teleportation##3##1##(2007-11#1)(2007-12#2)
teleradiology and##2##2##(1996-2#1)(2007-11#1)
teleradiology may##2##2##(1997-4#1)(2007-11#1)
teleradiology##13##1##(1996-2#4)(1997-4#3)(1997-8#1)(2007-11#4)(2012-2#1)
telescope II##2##2##(2008-3#2)
telescope alignment##4##2##(2008-3#4)
telescope and a##2##3##(2007-12#1)(2008-3#1)
telescope and##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
telescope aperture##2##2##(2008-3#2)
telescope are##2##2##(2008-2#1)(2008-3#1)
telescope by##2##2##(2007-11#1)(2008-3#1)
telescope diameter##2##2##(2008-3#2)
telescope for##2##2##(2007-11#1)(2008-3#1)
telescope in##2##2##(2007-12#1)(2008-3#1)
telescope mirrors##4##2##(2008-3#4)
telescope system##2##2##(2008-3#2)
telescope was##2##2##(2008-2#1)(2008-3#1)
telescope with a##4##3##(2008-3#4)
telescope with##8##2##(2008-3#8)
telescope##98##1##(1991-2#1)(2007-11#6)(2007-12#5)(2008-2#14)(2008-3#72)
telescopes to##3##2##(2008-3#3)
telescopes with##2##2##(2008-2#1)(2008-3#1)
telescopes##29##1##(1990-8#1)(1995-6#1)(2008-2#6)(2008-3#20)(2012-12#1)
telescopic##3##1##(2007-12#1)(2008-3#1)(2012-1#1)
telescoping##2##1##(2007-12#1)(2008-5#1)
television advertising of prescription##2##4##(2008-12#2)
television advertising##3##2##(2008-12#2)(2012-2#1)
television and radio##3##3##(1995-2#1)(1997-1#1)(1997-6#1)
television and##5##2##(1995-2#1)(1997-1#1)(1997-6#1)(2011-1#1)(2012-12#1)
television commercials##2##2##(2007-12#2)
television holography##3##2##(2008-3#3)
television or radio##2##3##(1996-5#1)(2008-2#1)
television viewing##2##2##(2009-7#2)
television##31##1##(1995-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#2)(2007-2#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#5)(2009-4#1)(2009-7#4)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
televisions##4##1##(2008-11#1)(2008-2#3)
telia##6##1##(2008-10#6)
telial hosts##2##2##(2008-10#2)
telial##3##1##(2008-10#3)
teliospore germination##8##2##(2008-10#8)
teliospores of P##2##3##(2008-10#2)
teliospores of##6##2##(2008-10#6)
teliospores on##2##2##(2008-10#2)
teliospores produced##2##2##(2008-10#2)
teliospores##20##1##(2008-10#20)
tell us about##7##3##(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
tell us##9##2##(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
tell us?##3##2##(1997-4#1)(2009-10#1)(2009-5#1)
tell##26##1##(1990-6#1)(1990-8#1)(1991-2#1)(1992-3#1)(1996-5#1)(1997-4#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-8#2)
telling us about##2##3##(2011-1#1)(2011-2#1)
telling##13##1##(1990-6#1)(1992-3#1)(1992-6#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#3)
tells##7##1##(1994-1#1)(1994-6#2)(2008-11#1)(2008-7#1)(2009-7#1)(2013-8#1)
telluric##2##1##(1996-4#2)
tellurite glass##3##2##(2007-11#1)(2008-3#2)
tellurite##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
tellurium##11##1##(2007-12#1)(2008-10#9)(2008-3#1)
telmisartan##6##1##(2010-3#5)(2011-3#1)
teloRZ##6##1##(2008-9#6)
teloblastic##2##1##(2007-12#2)
telogen effluvium was##2##3##(2008-5#2)
telogen effluvium##7##2##(2008-5#5)(2008-8#1)(2012-3#1)
telogen##8##1##(2008-5#6)(2008-8#1)(2012-3#1)
telomerase RNA##2##2##(2008-9#2)
telomerase activation##2##2##(2008-11#2)
telomerase activity and##7##3##(2006-10#1)(2007-12#1)(2008-11#4)(2008-9#1)
telomerase activity in##8##3##(2008-1#1)(2008-11#2)(2008-6#3)(2008-9#2)
telomerase activity##26##2##(2006-10#1)(2007-12#1)(2008-1#2)(2008-11#10)(2008-6#7)(2008-9#4)(2010-2#1)
telomerase in##2##2##(2008-9#1)(2012-3#1)
telomerase may##2##2##(2006-10#1)(2008-6#1)
telomerase reverse##5##2##(2007-12#1)(2008-11#4)
telomerase##70##1##(1990-5#1)(2006-10#3)(2007-12#2)(2008-1#3)(2008-11#37)(2008-5#2)(2008-6#8)(2008-9#8)(2010-2#1)(2011-1#4)(2012-3#1)
telomere biology##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
telomere length and##2##3##(2006-10#1)(2013-8#1)
telomere length in##5##3##(2008-11#1)(2008-9#3)(2012-3#1)
telomere length##20##2##(2006-10#1)(2008-11#3)(2008-9#6)(2011-1#2)(2012-3#6)(2013-8#2)
telomere lengths from##2##3##(2008-9#1)(2012-3#1)
telomere lengths##3##2##(2008-9#2)(2012-3#1)
telomere maintenance##8##2##(2008-11#4)(2011-1#4)
telomere sequence##4##2##(1991-9#1)(2008-11#3)
telomere shortening##4##2##(2008-11#2)(2008-5#1)(2008-9#1)
telomere##64##1##(1990-5#1)(1991-7#1)(1991-9#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-11#18)(2008-5#1)(2008-8#1)(2008-9#10)(2010-2#1)(2011-1#8)(2011-2#4)(2012-3#11)(2013-1#1)(2013-8#2)
telomere-associated sequences##2##2##(2008-8#2)
telomere-associated##4##1##(2008-8#3)(2010-2#1)
telomere-controlled senescence##3##2##(2008-11#3)
telomere-independent##2##1##(2010-2#2)
telomere-like##2##1##(1993-12#2)
telomeres and telomerase##3##3##(2006-10#1)(2008-1#1)(2008-11#1)
telomeres and##7##2##(2006-10#1)(2008-1#1)(2008-11#3)(2011-2#1)(2012-3#1)
telomeres are##3##2##(2008-9#1)(2010-2#1)(2011-2#1)
telomeres containing##2##2##(1991-7#2)
telomeres in##2##2##(2008-1#1)(2011-2#1)
telomeres of##4##2##(1991-7#1)(1997-6#2)(2008-5#1)
telomeres to##2##2##(2010-2#1)(2011-2#1)
telomeres##39##1##(1990-5#1)(1991-7#7)(1997-6#2)(2006-10#2)(2008-1#2)(2008-11#9)(2008-12#2)(2008-5#1)(2008-9#2)(2010-2#4)(2011-1#1)(2011-2#5)(2012-3#1)
telomeric DNA sequences##2##3##(2008-8#2)
telomeric DNA##9##2##(1990-5#4)(2008-11#2)(2008-8#3)
telomeric damage##2##2##(2010-2#2)
telomeric regions##3##2##(2008-12#2)(2008-8#1)
telomeric repeat amplification##2##3##(2008-1#1)(2008-6#1)
telomeric repeat##3##2##(2008-1#1)(2008-6#1)(2008-8#1)
telomeric sequences##2##2##(2008-5#1)(2010-3#1)
telomeric##36##1##(1990-5#4)(1993-3#1)(1994-11#1)(1995-2#2)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#4)(2008-5#2)(2008-6#1)(2008-8#5)(2009-5#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-2#1)
teloptosis##2##1##(2008-5#2)
telotrophic##4##1##(2007-12#1)(2008-12#3)
temazepam and##2##2##(1995-2#1)(2008-11#1)
temazepam##7##1##(1991-11#1)(1995-2#5)(2008-11#1)
temozolomide##8##1##(2008-8#5)(2011-2#2)(2011-3#1)
temperament and##5##2##(2009-10#1)(2009-8#1)(2012-12#3)
temperament is##2##2##(1991-1#1)(2013-8#1)
temperament profiles##2##2##(2013-8#2)
temperament##26##1##(1991-1#2)(1994-2#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-10#5)(2009-8#1)(2009-9#1)(2012-12#3)(2012-5#1)(2013-8#4)
temperamental##3##1##(2008-2#1)(2013-8#2)
temperaments##2##1##(1991-1#1)(2010-6#1)
temperate and tropical isolates##8##4##(2008-10#8)
temperate and tropical##10##3##(2008-10#10)
temperate and##12##2##(2008-10#10)(2008-12#1)(2008-8#1)
temperate area##2##2##(2007-7#1)(2008-12#1)
temperate climates##3##2##(2008-10#3)
temperate forest##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
temperate isolates##5##2##(2008-10#5)
temperate regions of the##2##4##(1996-12#1)(2008-10#1)
temperate regions of##4##3##(1996-12#1)(2008-10#3)
temperate regions##7##2##(1996-12#1)(2007-2#1)(2008-10#4)(2008-8#1)
temperate##57##1##(1993-9#3)(1996-12#1)(2007-2#1)(2007-7#1)(2008-10#27)(2008-12#2)(2008-8#5)(2008-9#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#3)(2012-4#1)(2013-7#2)(2013-8#1)
temperature &lt##3##2##(2008-10#2)(2008-3#1)
temperature ( approximately##2##3##(2008-10#2)
temperature (##3##2##(2008-10#3)
temperature (20##2##2##(2010-4#1)(2011-2#1)
temperature (25 degrees C)##3##4##(2008-12#2)(2008-5#1)
temperature (25 degrees##4##3##(2008-12#2)(2008-5#1)(2010-4#1)
temperature (25##5##2##(2008-10#1)(2008-12#2)(2008-5#1)(2010-4#1)
temperature (4##2##2##(2008-10#1)(2009-8#1)
temperature (SST)##2##2##(1992-7#1)(2008-2#1)
temperature (T(m)) of##2##3##(2008-5#1)(2011-1#1)
temperature (T)##2##2##(2008-10#1)(2008-7#1)
temperature (Tb)##2##2##(2008-6#1)(2008-8#1)
temperature (Tc)##2##2##(1994-2#1)(2008-8#1)
temperature (Ts)##2##2##(1993-12#1)(2008-3#1)
temperature (r=0##2##2##(2013-7#2)
temperature 20##2##2##(2008-10#1)(2013-1#1)
temperature T(g)##2##2##(1995-3#1)(2008-2#1)
temperature above##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
temperature affected##2##2##(2008-10#1)(2008-9#1)
temperature after##2##2##(2008-10#1)(2013-7#1)
temperature along##2##2##(2008-3#1)(2012-6#1)
temperature and NaCl concentration##2##4##(1990-7#1)(1997-2#1)
temperature and OH concentration profiles##2##5##(2008-3#2)
temperature and OH##3##3##(2008-3#3)
temperature and RH##3##3##(2008-10#3)
temperature and a##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
temperature and applied##2##3##(2008-10#2)
temperature and build height##2##4##(2008-2#2)
temperature and concentration##2##3##(2008-10#1)(2008-3#1)
temperature and density##3##3##(2008-1#1)(2008-9#2)
temperature and dew period##3##4##(2008-10#3)
temperature and humidity on##3##4##(2008-10#1)(2011-2#2)
temperature and humidity##12##3##(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#6)(2013-1#1)(2013-7#2)
temperature and inoculum density of##2##5##(2008-10#2)
temperature and ionic strength##2##4##(1992-8#1)(2008-10#1)
temperature and leaf wetness duration##5##5##(2008-10#5)
temperature and leaf wetness##6##4##(2008-10#6)
temperature and modifier concentration on##2##5##(2008-10#2)
temperature and moisture##6##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-8#1)
temperature and pH for##2##4##(2008-10#2)
temperature and pH##11##3##(1993-12#1)(1994-5#1)(1997-4#1)(2008-10#6)(2008-5#1)(2009-9#1)
temperature and pain##3##3##(1992-5#1)(2008-7#2)
temperature and pressure and##2##4##(2007-12#1)(2010-12#1)
temperature and pressure are##2##4##(2008-3#2)
temperature and pressure from##2##4##(2008-3#2)
temperature and pressure##23##3##(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#9)(2008-6#1)(2010-12#1)(2012-1#1)(2012-2#1)
temperature and rainfall##3##3##(2008-10#2)(2008-8#1)
temperature and relative humidity (RH)##2##5##(1996-12#1)(2008-10#1)
temperature and relative humidity##9##4##(1995-3#1)(1996-12#1)(2008-10#5)(2008-8#1)(2010-10#1)
temperature and relative##12##3##(1995-3#1)(1996-12#1)(2008-10#5)(2008-3#3)(2008-8#1)(2010-10#1)
temperature and salinity##3##3##(1992-8#1)(2008-5#2)
temperature and soil moisture##2##4##(2008-10#2)
temperature and strain coefficients on##2##5##(2007-11#2)
temperature and strain##8##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)
temperature and subsequently##2##3##(2008-10#1)(2008-3#1)
temperature and that##3##3##(2007-2#1)(2008-10#1)(2013-8#1)
temperature and the##19##3##(1992-2#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-8#2)(2011-1#1)(2011-2#2)
temperature and time of##4##4##(2008-10#1)(2008-12#1)(2008-5#1)(2012-4#1)
temperature and time on the##2##5##(2008-3#1)(2011-1#1)
temperature and time on##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
temperature and time##9##3##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-4#1)(2013-1#1)
temperature and velocity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
temperature and voltage##2##3##(2008-10#2)
temperature and water##4##3##(2008-10#1)(2009-5#1)(2010-8#2)
temperature and wetness duration##2##4##(2008-10#2)
temperature and wetness##4##3##(2008-10#4)
temperature and##285##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-2#2)(1992-5#2)(1992-6#1)(1992-8#2)(1993-12#1)(1994-5#1)(1994-8#1)(1995-3#3)(1996-1#1)(1996-12#2)(1997-2#4)(1997-4#2)(2007-11#7)(2007-12#11)(2007-2#2)(2008-1#1)(2008-10#100)(2008-11#3)(2008-12#1)(2008-2#20)(2008-3#37)(2008-4#1)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#2)(2012-4#2)(2012-6#1)(2013-1#6)(2013-7#3)(2013-8#5)
temperature are##10##2##(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#1)(2013-7#1)
temperature as a##2##3##(2008-1#1)(2008-3#1)
temperature as the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
temperature as well as##4##4##(1992-3#1)(2008-10#1)(2008-3#2)
temperature as##15##2##(1992-3#1)(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2011-1#3)
temperature at the##2##3##(2008-12#1)(2008-3#1)
temperature at which the##2##4##(2008-10#1)(2008-3#1)
temperature at which##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
temperature at##12##2##(1995-2#1)(1996-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)
temperature below##2##2##(2008-11#1)(2009-7#1)
temperature between##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
temperature both##2##2##(2008-10#1)(2008-3#1)
temperature breaks##2##2##(2012-4#2)
temperature but not##2##3##(1996-2#1)(2007-8#1)
temperature by use of##3##4##(2008-3#3)
temperature by##9##2##(1991-5#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)
temperature can be##3##3##(2008-1#1)(2008-10#2)
temperature can##6##2##(1991-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
temperature change##5##2##(1991-2#1)(2008-10#1)(2008-3#2)(2012-6#1)
temperature changes on##2##3##(2008-3#1)(2008-8#1)
temperature changes##9##2##(1993-12#1)(1994-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
temperature close to##2##3##(2008-3#1)(2008-5#1)
temperature coefficient##2##2##(1991-5#1)(2008-10#1)
temperature coefficients##4##2##(1991-12#1)(1994-5#1)(2008-10#1)(2008-3#1)
temperature compensation of##2##3##(2008-2#1)(2008-3#1)
temperature compensation##6##2##(2008-2#3)(2008-3#2)(2013-8#1)
temperature condition##3##2##(2008-12#3)
temperature conditions##14##2##(1997-2#2)(2008-10#4)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-12#1)
temperature control of##2##3##(2008-2#2)
temperature control##8##2##(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)
temperature cultivation##2##2##(2008-11#2)
temperature curves##3##2##(2008-10#2)(2008-11#1)
temperature cycling##2##2##(2008-10#1)(2008-3#1)
temperature data##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
temperature decreased##2##2##(2008-10#2)
temperature dependence of the fluorescence##2##5##(2008-2#2)
temperature dependence of the##23##4##(1991-5#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#7)(2008-3#6)
temperature dependence of##37##3##(1990-7#1)(1991-5#1)(1992-7#1)(1994-12#1)(1995-2#2)(1996-12#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#9)(2008-3#10)(2009-12#1)
temperature dependence##52##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-2#11)(2008-3#15)(2008-5#1)(2009-12#1)
temperature dependent and##2##3##(1994-12#1)(1994-8#1)
temperature dependent##9##2##(1990-8#1)(1994-12#1)(1994-8#3)(2008-10#3)(2008-11#1)
temperature depression##2##2##(2008-10#2)
temperature derivative##2##2##(2008-2#1)(2008-3#1)
temperature did not##2##3##(2008-10#1)(2008-2#1)
temperature difference##7##2##(1990-7#1)(2008-10#1)(2008-3#4)(2008-5#1)
temperature differences##2##2##(2008-3#1)(2009-6#1)
temperature differential in rats##2##4##(2007-12#2)
temperature differential##4##2##(2007-12#3)(2008-2#1)
temperature distribution in##2##3##(2008-3#2)
temperature distribution on##2##3##(2008-2#1)(2008-3#1)
temperature distribution##12##2##(2008-10#2)(2008-2#3)(2008-3#6)(2008-7#1)
temperature distributions and thermal deformations##2##5##(2008-3#2)
temperature distributions##8##2##(2008-2#1)(2008-3#7)
temperature drift in##2##3##(2013-8#2)
temperature drift##4##2##(2008-2#1)(2013-8#3)
temperature dropped##2##2##(1995-3#1)(2008-10#1)
temperature during the##5##3##(2008-10#3)(2008-12#1)(2011-1#1)
temperature during##12##2##(2008-10#9)(2008-12#1)(2011-1#1)(2011-2#1)
temperature effect on##4##3##(2008-10#1)(2008-11#1)(2013-7#2)
temperature effect was##3##3##(2008-10#1)(2010-8#2)
temperature effect##12##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-8#2)(2012-5#1)(2013-7#2)
temperature effects##6##2##(2008-10#3)(2008-11#1)(2008-8#2)
temperature elevation##2##2##(1990-2#1)(2007-10#1)
temperature experienced##2##2##(2008-8#1)(2011-2#1)
temperature field database##2##3##(2008-3#2)
temperature field##6##2##(2008-2#1)(2008-3#5)
temperature fields##2##2##(2008-3#2)
temperature fluctuation##2##2##(2007-11#1)(2008-2#1)
temperature fluctuations##2##2##(1990-4#1)(2008-3#1)
temperature for a##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
temperature for growth of##2##4##(2008-10#1)(2010-3#1)
temperature for infection##2##3##(2008-10#2)
temperature for the reaction##2##4##(1994-11#1)(2008-10#1)
temperature for the##8##3##(1994-11#1)(2008-10#3)(2008-6#2)(2008-9#1)(2012-2#1)
temperature for##40##2##(1990-11#1)(1994-11#1)(1995-2#4)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
temperature from 37 degrees C to##2##6##(2008-11#2)
temperature from the##3##3##(2007-12#1)(2008-3#1)(2010-7#1)
temperature from##14##2##(1992-7#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-7#1)
temperature gradient##3##2##(2007-11#1)(2012-5#1)(2013-1#1)
temperature gradients##5##2##(2008-10#1)(2008-3#3)(2008-9#1)
temperature had##2##2##(2008-10#1)(2008-11#1)
temperature have been##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
temperature in a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
temperature in the range##5##4##(1995-6#1)(1997-2#1)(2008-10#3)
temperature in the sample chamber of a##2##7##(2008-11#1)(2008-9#1)
temperature in the##17##3##(1995-6#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-8#1)
temperature in this##2##3##(2007-12#1)(2008-11#1)
temperature in##36##2##(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-10#2)(2007-12#2)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#4)(2008-8#2)(2008-9#1)(2010-8#2)(2011-1#1)(2013-7#1)
temperature increase##2##2##(2008-2#1)(2008-7#1)
temperature increased##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)
temperature increases##5##2##(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
temperature independent##4##2##(1995-2#1)(2007-11#1)(2008-7#1)(2009-5#1)
temperature induced##2##2##(2007-12#1)(2008-10#1)
temperature inside the##2##3##(2008-10#1)(2008-2#1)
temperature inside##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
temperature inversion##2##2##(2008-3#2)
temperature is an important##2##4##(2008-10#1)(2008-9#1)
temperature is demonstrated##2##3##(2007-11#1)(2008-3#1)
temperature is determined##2##3##(2007-11#1)(2009-11#1)
temperature is raised from##2##4##(2008-11#1)(2008-6#1)
temperature is raised##3##3##(1995-2#1)(2008-11#1)(2008-6#1)
temperature is##33##2##(1993-11#1)(1995-2#4)(1996-12#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2013-8#1)
temperature leads to##2##3##(2008-10#1)(2010-3#1)
temperature lidar##2##2##(2008-2#2)
temperature management##3##2##(2006-10#1)(2007-10#2)
temperature may##2##2##(1996-2#1)(2011-1#1)
temperature measured##2##2##(2008-2#1)(2008-3#1)
temperature measurement##11##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)
temperature measurements and##2##3##(2007-11#1)(2008-2#1)
temperature measurements by##2##3##(2007-11#1)(2008-3#1)
temperature measurements in##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
temperature measurements of##2##3##(2008-2#1)(2008-3#1)
temperature measurements with##2##3##(2008-2#2)
temperature measurements##27##2##(2007-11#4)(2007-12#1)(2008-2#8)(2008-3#14)
temperature of 1000 degrees C##2##5##(2007-11#1)(2008-10#1)
temperature of 15 degrees C with an##2##7##(2008-2#2)
temperature of 1500 degrees C##2##5##(2008-10#1)(2008-2#1)
temperature of 1900 degrees C##2##5##(2008-10#2)
temperature of 24##2##3##(2008-10#1)(2013-7#1)
temperature of 25 +/-##2##4##(2008-10#1)(2008-6#1)
temperature of 25 degrees C##3##5##(2008-11#1)(2008-12#1)(2008-5#1)
temperature of 25##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)
temperature of 300##2##3##(1995-6#1)(2007-12#1)
temperature of 35 degrees C##3##5##(2007-10#1)(2008-10#1)(2008-5#1)
temperature of about##2##3##(1990-9#1)(2008-10#1)
temperature of the adhesive##2##4##(2008-3#2)
temperature of the incoming arterial blood##2##6##(2008-1#2)
temperature of the##34##3##(1992-2#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#11)(2008-3#9)(2008-7#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-2#2)
temperature of##127##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1994-12#1)(1995-2#1)(1995-6#3)(2007-10#2)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#49)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#14)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#4)(2013-7#1)
temperature on infection##2##3##(2008-10#2)
temperature on the##27##3##(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(1996-5#1)(1997-2#1)(2008-10#14)(2008-3#3)(2008-5#1)(2011-2#2)(2013-7#1)
temperature on their##2##3##(2008-10#1)(2008-7#1)
temperature on##65##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#30)(2008-11#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-7#2)
temperature optimum##4##2##(1990-5#1)(1991-5#1)(2008-10#2)
temperature or##11##2##(1990-5#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-5#2)(2010-4#1)(2012-7#1)
temperature over the##2##3##(1996-2#2)
temperature over##3##2##(1996-2#2)(2008-3#1)
temperature phosphorescence (RTP) emission##2##4##(2008-10#2)
temperature phosphorescence (RTP)##7##3##(2008-10#7)
temperature phosphorescence of##3##3##(2008-10#3)
temperature phosphorescence##24##2##(2008-10#24)
temperature phosphorimetry##3##2##(2008-10#3)
temperature preferences##2##2##(2008-10#1)(2010-8#1)
temperature profile##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
temperature profiles in the##2##4##(2008-3#2)
temperature profiles##11##2##(1996-12#1)(2008-2#4)(2008-3#4)(2011-2#2)
temperature profiling##4##2##(2008-2#2)(2008-3#2)
temperature program##8##2##(2008-10#6)(2012-1#2)
temperature range for##2##3##(2008-10#2)
temperature range from 10 to##2##5##(2008-10#1)(2008-3#1)
temperature range from##7##3##(2008-10#2)(2008-2#1)(2008-3#4)
temperature range of##11##3##(1993-8#1)(1994-12#1)(2007-11#1)(2008-10#3)(2008-3#4)(2009-9#1)
temperature range was##2##3##(2008-10#1)(2008-6#1)
temperature range##49##2##(1990-2#1)(1991-5#1)(1993-8#2)(1994-12#2)(1994-5#1)(1995-2#3)(1995-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-2#7)(2008-3#10)(2008-6#1)(2008-7#1)(2009-9#1)
temperature ranges##4##2##(1997-2#1)(2008-10#3)
temperature ranging from##2##3##(1996-12#1)(2008-10#1)
temperature regimes of##2##3##(2008-8#1)(2011-2#1)
temperature regimes##11##2##(2008-10#6)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
temperature regulation##3##2##(1996-2#1)(2008-1#2)
temperature relationships##2##2##(2008-10#2)
temperature resolution of##3##3##(2007-12#1)(2008-3#2)
temperature resolution##4##2##(2007-12#1)(2008-3#3)
temperature response##3##2##(2008-2#1)(2009-11#1)(2012-6#1)
temperature resulted##2##2##(2010-4#1)(2013-7#1)
temperature rise in the##2##4##(2008-2#1)(2008-3#1)
temperature rise in##3##3##(2008-2#1)(2008-3#2)
temperature rise##6##2##(2008-2#1)(2008-3#4)(2009-11#1)
temperature sensitive##4##2##(1997-6#1)(2008-10#2)(2011-2#1)
temperature sensitivities##3##2##(1995-5#1)(2007-11#2)
temperature sensitivity and##2##3##(2008-3#1)(2010-3#1)
temperature sensitivity in##2##3##(1997-6#1)(2008-3#1)
temperature sensitivity of##7##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#2)
temperature sensitivity##18##2##(1994-12#1)(1995-2#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)
temperature sensor based on##2##4##(2007-12#1)(2008-2#1)
temperature sensor with##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
temperature sensor##13##2##(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#2)
temperature shift##6##2##(1991-2#1)(1994-11#1)(1995-6#1)(2008-11#3)
temperature shifts##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
temperature simultaneously##2##2##(2007-12#1)(2008-8#1)
temperature stability of the##4##4##(1993-6#1)(2007-11#1)(2008-3#2)
temperature stability of##5##3##(1993-6#1)(2007-11#1)(2008-3#3)
temperature stability##9##2##(1993-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
temperature stabilization##2##2##(2008-2#2)
temperature than##6##2##(1990-12#1)(1992-3#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#1)
temperature that##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
temperature the##2##2##(1995-11#1)(2007-12#1)
temperature threshold##2##2##(2008-9#1)(2011-2#1)
temperature thresholds##2##2##(2008-10#2)
temperature to allow for##2##4##(2008-12#1)(2011-2#1)
temperature to##17##2##(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2010-10#1)(2011-2#1)
temperature treatment##2##2##(2008-10#1)(2008-9#1)
temperature tuned over##2##3##(2007-12#2)
temperature tuned##3##2##(2007-12#3)
temperature tuning of the##2##4##(2007-11#1)(2008-3#1)
temperature tuning##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
temperature under##2##2##(1997-2#1)(2007-12#1)
temperature up to##3##3##(2008-10#3)
temperature used##2##2##(2008-5#1)(2012-2#1)
temperature using##2##2##(2008-10#2)
temperature variation of##2##3##(1997-2#1)(2008-3#1)
temperature variation##5##2##(1997-2#1)(2007-11#1)(2008-3#1)(2011-1#1)(2012-6#1)
temperature variations##10##2##(1990-10#1)(1994-12#1)(2008-10#2)(2008-6#1)(2011-1#1)(2013-7#4)
temperature was 37##2##3##(2009-10#1)(2011-1#1)
temperature was also##3##3##(2008-10#1)(2008-6#1)(2010-4#1)
temperature was between##3##3##(2008-10#2)(2008-6#1)
temperature was kept##2##3##(2008-10#1)(2011-1#1)
temperature was observed##3##3##(2008-10#3)
temperature was recorded##2##3##(2008-10#1)(2008-3#1)
temperature was slightly##2##3##(2008-10#1)(2008-3#1)
temperature was##62##2##(1990-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#26)(2008-11#1)(2008-3#5)(2008-5#2)(2008-6#4)(2008-7#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#2)
temperature we##2##2##(2007-12#1)(2008-2#1)
temperature were developed##2##3##(2008-10#2)
temperature were investigated##2##3##(2008-10#2)
temperature were optimised##2##3##(2008-10#2)
temperature were optimized##3##3##(2008-10#3)
temperature were recorded##2##3##(1991-9#1)(2008-10#1)
temperature were##29##2##(1991-12#1)(1991-9#1)(1992-11#1)(1994-8#1)(2008-10#17)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
temperature with a##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
temperature with##12##2##(1992-3#1)(1996-7#1)(2008-10#3)(2008-2#1)(2008-3#5)(2010-12#1)
temperature zones##2##2##(2008-10#1)(2008-9#1)
temperature##2243##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#7)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#4)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#9)(1994-2#2)(1994-3#2)(1994-5#4)(1994-7#2)(1994-8#5)(1994-9#3)(1995-11#6)(1995-2#21)(1995-3#12)(1995-5#5)(1995-6#13)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#10)(1996-2#12)(1996-5#4)(1996-7#1)(1996-9#1)(1997-2#22)(1997-3#1)(1997-4#4)(1997-6#6)(1997-7#11)(2006-10#1)(2007-10#15)(2007-11#57)(2007-12#83)(2007-2#2)(2007-8#4)(2008-1#11)(2008-10#715)(2008-11#59)(2008-12#26)(2008-2#167)(2008-3#289)(2008-4#8)(2008-5#56)(2008-6#30)(2008-7#42)(2008-8#47)(2008-9#33)(2009-10#2)(2009-11#16)(2009-12#4)(2009-2#6)(2009-3#3)(2009-5#6)(2009-6#2)(2009-7#7)(2009-8#6)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#5)(2010-4#11)(2010-5#8)(2010-7#4)(2010-8#11)(2010-9#1)(2011-1#24)(2011-2#65)(2012-1#5)(2012-12#4)(2012-2#20)(2012-3#3)(2012-4#5)(2012-5#3)(2012-6#10)(2012-7#9)(2012-9#1)(2013-1#30)(2013-7#28)(2013-8#22)
temperature) and##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
temperature) was##2##2##(2008-10#1)(2008-11#1)
temperature) were##2##2##(2008-10#1)(2011-2#1)
temperature)##22##1##(1990-8#1)(1995-3#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2010-4#1)(2011-2#1)(2012-6#1)(2013-1#1)
temperature-##4##1##(1996-3#1)(2007-12#1)(2008-10#1)(2013-8#1)
temperature-controlled##3##1##(2007-11#1)(2007-8#1)(2013-1#1)
temperature-dependence##2##1##(1992-6#2)
temperature-dependent sex determination##3##3##(2008-8#2)(2010-3#1)
temperature-dependent##24##1##(1990-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-3#6)(2008-8#3)(2010-3#2)(2013-7#3)(2013-8#1)
temperature-imaging diagnostics##2##2##(2008-2#2)
temperature-induced##8##1##(1990-2#1)(1993-11#1)(2008-3#4)(2008-7#1)(2012-2#1)
temperature-insensitive##3##1##(2008-2#1)(2008-3#2)
temperature-programmed##2##1##(2010-7#2)
temperature-sensitive (ts)##3##2##(1994-12#1)(1995-9#1)(2008-10#1)
temperature-sensitive for##3##2##(1991-2#2)(1994-12#1)
temperature-sensitive mutant of##2##3##(1995-6#1)(2008-1#1)
temperature-sensitive mutant##4##2##(1994-12#1)(1995-2#1)(1995-6#1)(2008-1#1)
temperature-sensitive phenotype of##2##3##(1994-12#1)(1997-8#1)
temperature-sensitive phenotype##3##2##(1994-12#1)(1997-3#1)(1997-8#1)
temperature-sensitive##38##1##(1990-5#2)(1991-2#3)(1991-8#2)(1992-3#1)(1993-9#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1995-9#2)(1997-3#5)(1997-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#3)
temperatures &gt##6##2##(1995-6#3)(2008-10#3)
temperatures (20##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
temperatures (22##2##2##(2008-11#1)(2008-5#1)
temperatures (7 to##2##3##(2008-10#2)
temperatures (7##3##2##(2008-10#2)(2010-8#1)
temperatures above##6##2##(1990-2#1)(2008-10#3)(2010-4#1)(2013-1#1)
temperatures also##2##2##(2008-10#1)(2008-2#1)
temperatures and exposure##2##3##(2008-10#2)
temperatures and heating##2##3##(2008-10#2)
temperatures and high##3##3##(1995-5#1)(2008-10#1)(2010-4#1)
temperatures and its##2##3##(2008-10#1)(2008-5#1)
temperatures and leaf wetness##2##4##(2008-10#2)
temperatures and pH values##2##4##(2008-10#1)(2010-4#1)
temperatures and pressures##3##3##(2008-10#1)(2008-3#2)
temperatures and salinities##2##3##(2008-10#1)(2008-5#1)
temperatures and the##3##3##(2008-10#1)(2008-7#1)(2012-4#1)
temperatures and##45##2##(1992-6#1)(1993-5#1)(1993-8#1)(1995-5#2)(1996-12#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-4#1)(2013-1#1)(2013-7#1)
temperatures are##6##2##(1994-12#1)(2008-10#3)(2008-2#2)
temperatures as##4##2##(1992-6#1)(1994-9#1)(2008-10#1)(2008-2#1)
temperatures at##5##2##(2008-10#3)(2008-12#1)(2013-1#1)
temperatures below##3##2##(1993-11#1)(2007-12#1)(2008-10#1)
temperatures between 10##2##3##(2008-10#2)
temperatures between 22##2##3##(2008-10#1)(2008-11#1)
temperatures between##14##2##(1991-5#1)(1991-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
temperatures by##3##2##(2008-10#3)
temperatures close to##2##3##(1995-2#1)(2008-3#1)
temperatures during the##2##3##(2012-5#1)(2012-8#1)
temperatures during##6##2##(2008-10#3)(2012-4#1)(2012-5#1)(2012-8#1)
temperatures for pyrolysis and atomization##3##5##(2008-10#3)
temperatures for the##4##3##(2008-10#3)(2009-7#1)
temperatures for##21##2##(1990-2#1)(2008-10#15)(2008-12#1)(2008-4#1)(2009-7#1)(2012-12#1)(2013-1#1)
temperatures from 2##2##3##(2008-10#1)(2011-2#1)
temperatures from 20 to##3##4##(2008-10#3)
temperatures from 5 to##2##4##(2008-10#2)
temperatures from##27##2##(1990-3#1)(1991-8#1)(2008-10#15)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
temperatures has been##2##3##(1995-2#1)(2008-10#1)
temperatures have been##2##3##(2008-10#1)(2008-2#1)
temperatures have##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
temperatures higher than##2##3##(2008-3#1)(2008-9#1)
temperatures in the range##4##4##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
temperatures in the##6##3##(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
temperatures in##16##2##(1995-5#1)(1995-6#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
temperatures inferred from##2##3##(2008-2#2)
temperatures may##2##2##(2008-10#2)
temperatures near##2##2##(2008-2#1)(2008-3#1)
temperatures of &lt##3##3##(2008-10#2)(2008-3#1)
temperatures of 15##3##3##(2008-10#3)
temperatures of 20##2##3##(2008-10#2)
temperatures of##36##2##(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)
temperatures on the##2##3##(2008-9#1)(2010-8#1)
temperatures on##10##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-8#2)
temperatures or##6##2##(1995-8#1)(2008-10#3)(2008-3#1)(2008-8#1)
temperatures ranging from##13##3##(1995-5#1)(2008-10#9)(2008-2#1)(2008-7#1)(2011-2#1)
temperatures resulted in##2##3##(2008-10#1)(2008-8#1)
temperatures showed##2##2##(2008-10#1)(2009-5#1)
temperatures tested##3##2##(2008-10#2)(2008-5#1)
temperatures than##2##2##(1994-12#1)(2008-10#1)
temperatures that##6##2##(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
temperatures the development##2##3##(2008-10#2)
temperatures the##5##2##(1995-11#1)(2008-10#3)(2008-3#1)
temperatures to##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
temperatures under##3##2##(2008-10#3)
temperatures up to 50 degrees C##2##6##(2008-10#1)(2008-6#1)
temperatures up to##8##3##(2008-10#4)(2008-2#1)(2008-6#2)(2009-7#1)
temperatures was##5##2##(1994-6#1)(2007-12#1)(2008-10#2)(2012-12#1)
temperatures were maintained at##2##4##(1996-5#1)(2008-10#1)
temperatures were measured##4##3##(2007-10#1)(2008-10#2)(2013-1#1)
temperatures were##21##2##(1996-5#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-8#1)(2010-3#1)(2013-1#1)(2013-7#2)
temperatures with an##2##3##(2007-11#1)(2008-3#1)
temperatures with##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
temperatures##571##1##(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#3)(1992-6#2)(1993-11#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#5)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#5)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#8)(2008-10#253)(2008-11#7)(2008-12#9)(2008-2#30)(2008-3#49)(2008-4#4)(2008-5#16)(2008-6#11)(2008-7#11)(2008-8#22)(2008-9#9)(2009-5#1)(2009-7#5)(2009-8#1)(2010-3#2)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#7)(2012-4#2)(2012-5#5)(2012-6#2)(2012-7#2)(2012-8#5)(2013-1#9)(2013-7#4)(2013-8#1)
tempered by the fact that##2##5##(2008-11#1)(2008-9#1)
tempered by the##3##3##(1997-5#1)(2008-11#1)(2008-9#1)
tempered##5##1##(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
template DNA##5##2##(1993-3#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)
template and the##3##3##(1993-12#1)(1997-3#1)(2008-6#1)
template and##9##2##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#2)
template concentration and##2##3##(1994-12#1)(2008-12#1)
template for##10##2##(1995-12#1)(1996-1#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)
template fragments##2##2##(1996-12#1)(2008-2#1)
template guided##2##2##(2007-11#2)
template in##2##2##(2008-10#1)(2008-2#1)
template molecule##6##2##(2008-10#6)
template to##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
template update##2##2##(2008-6#2)
template was##2##2##(1994-8#1)(2008-10#1)
template##118##1##(1990-11#2)(1990-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#30)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#6)(2008-9#6)(2009-10#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-3#3)(2013-1#2)
templated##2##1##(2008-10#1)(2008-7#1)
templates and##4##2##(1992-12#2)(2010-3#1)(2013-8#1)
templates for PCR##2##3##(1994-8#1)(1996-8#1)
templates for the##2##3##(2008-4#1)(2010-12#1)
templates for##9##2##(1994-8#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)
templates from##3##2##(2008-10#3)
templates is##4##2##(1990-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
templates of##2##2##(2008-7#1)(2012-1#1)
templates to##2##2##(2008-10#1)(2010-6#1)
templates##55##1##(1990-11#3)(1990-12#1)(1990-7#1)(1992-12#4)(1992-6#1)(1994-8#2)(1995-6#2)(1996-8#1)(1997-4#1)(2007-12#1)(2008-10#10)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#6)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
templating##4##1##(2008-5#3)(2008-8#1)
tempo##2##1##(2013-8#2)
temporal Talbot effect##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
temporal Talbot##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
temporal and rate##2##3##(2008-11#2)
temporal and spatial dynamics of##3##5##(2008-10#3)
temporal and spatial expression##2##4##(1996-12#1)(2012-2#1)
temporal and spatial patterns of##2##5##(2007-12#1)(2008-10#1)
temporal and spatial patterns##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
temporal and spatial resolution that##2##5##(2008-10#2)
temporal and spatial resolution##10##4##(2007-8#1)(2008-10#3)(2008-3#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
temporal and spatial spread of SMV strain##2##7##(2008-10#2)
temporal and spatial##39##3##(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#14)(2008-2#1)(2008-3#5)(2008-8#1)(2009-11#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)
temporal and spectral##3##3##(2007-11#2)(2009-8#1)
temporal and##58##2##(1990-8#1)(1991-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#2)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
temporal areas##2##2##(2007-8#1)(2008-11#1)
temporal arteritis##10##2##(1990-8#1)(1994-9#3)(1997-8#6)
temporal artery##4##2##(1994-9#1)(1997-8#1)(2008-9#2)
temporal artery-superior cerebellar artery bypass##2##5##(2012-3#2)
temporal aspects##2##2##(1997-1#1)(2008-3#1)
temporal associations between##2##3##(2009-7#1)(2011-2#1)
temporal bone changes##2##3##(2008-9#2)
temporal bone computed tomography##2##4##(2008-9#1)(2011-2#1)
temporal bone erosion on##2##4##(2011-2#2)
temporal bone resection and parotidectomy##2##5##(2011-2#2)
temporal bone resection##3##3##(2011-2#3)
temporal bone##29##2##(1995-5#1)(2006-12#4)(2008-6#1)(2008-8#3)(2008-9#8)(2011-2#12)
temporal bones were##2##3##(2008-9#1)(2012-2#1)
temporal bones##3##2##(2008-9#2)(2012-2#1)
temporal broadening of a pulsed##2##5##(2008-3#2)
temporal broadening of##3##3##(2008-3#3)
temporal broadening##5##2##(2008-2#1)(2008-3#4)
temporal change##2##2##(1991-4#1)(2008-2#1)
temporal changes in the##5##4##(1993-1#1)(2007-12#1)(2008-10#2)(2008-3#1)
temporal changes in##12##3##(1993-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-4#1)(2013-1#1)(2013-7#1)
temporal changes##15##2##(1993-1#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)
temporal characteristics of##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
temporal characteristics##10##2##(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-8#3)(2013-1#1)
temporal coding##2##2##(1996-2#2)
temporal coherence of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
temporal coherence properties of##2##4##(2007-11#1)(2008-2#1)
temporal coherence##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
temporal compression##3##2##(2007-11#3)
temporal correlation between##2##3##(1996-4#1)(2008-3#1)
temporal correlation##8##2##(1992-3#1)(1996-4#1)(2008-3#3)(2008-8#1)(2009-8#1)(2013-8#1)
temporal cortex or amygdala##2##4##(1993-6#2)
temporal cortex##13##2##(1993-12#1)(1993-6#2)(1996-12#1)(1997-2#2)(2008-11#2)(2008-2#1)(2008-9#2)(2012-2#2)
temporal cortices##3##2##(1996-12#1)(1996-5#1)(2008-9#1)
temporal dependence##2##2##(1994-12#1)(2008-11#1)
temporal development of##4##3##(2007-12#1)(2008-10#3)
temporal differentiation##2##2##(2008-8#2)
temporal digital speckle photography##2##4##(2008-3#2)
temporal discrimination##4##2##(2011-2#4)
temporal distribution of##9##3##(2007-11#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)
temporal distribution##10##2##(2007-11#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)
temporal dynamics of the##2##4##(2008-10#1)(2009-8#1)
temporal dynamics of##9##3##(2008-10#4)(2008-2#1)(2008-8#1)(2009-8#2)(2010-11#1)
temporal dynamics##12##2##(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)
temporal evolution of the##8##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#5)
temporal evolution of##13##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#1)(2008-4#1)
temporal evolution##14##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#8)(2008-3#1)(2008-4#1)
temporal expression pattern##4##3##(1997-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
temporal expression patterns##2##3##(1992-9#1)(2008-10#1)
temporal expression##7##2##(1992-9#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
temporal features of##2##3##(2009-11#1)(2009-8#1)
temporal features##4##2##(2007-12#1)(2008-3#1)(2009-11#1)(2009-8#1)
temporal frequencies##3##2##(1996-2#2)(2008-2#1)
temporal gyrus##10##2##(1996-2#3)(1996-7#3)(2008-11#2)(2009-2#2)
temporal imaging##3##2##(2007-11#2)(2007-12#1)
temporal increase of##2##3##(2008-10#2)
temporal increase##5##2##(2008-10#5)
temporal information##5##2##(2008-3#2)(2008-9#3)
temporal integrated##2##2##(2008-3#2)
temporal jitter##2##2##(2007-11#2)
temporal lobe as##2##3##(1996-7#1)(2012-12#1)
temporal lobe damage##2##3##(1992-11#1)(2009-9#1)
temporal lobe epilepsy##2##3##(2008-4#2)
temporal lobe epileptic##2##3##(2010-8#2)
temporal lobe lesions##4##3##(1992-11#2)(1992-12#1)(1993-12#1)
temporal lobe structures##2##3##(2009-2#1)(2013-8#1)
temporal lobe##38##2##(1991-10#2)(1991-12#2)(1991-2#1)(1992-11#4)(1992-12#1)(1993-12#2)(1993-9#1)(1996-6#1)(1996-7#5)(2007-8#1)(2008-1#1)(2008-4#3)(2008-7#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-12#2)(2013-8#1)
temporal lobectomy subjects##2##3##(1992-12#2)
temporal lobectomy##5##2##(1990-5#1)(1992-12#3)(2008-11#1)
temporal lobes##4##2##(1996-7#1)(2007-8#1)(2008-6#1)(2010-7#1)
temporal macular##2##2##(2013-1#2)
temporal optical##3##2##(2008-2#2)(2008-3#1)
temporal or##2##2##(1997-6#1)(2009-10#1)
temporal order of##3##3##(1992-11#1)(1992-3#1)(1996-5#1)
temporal order##5##2##(1992-11#2)(1992-3#1)(1996-2#1)(1996-5#1)
temporal parameters##2##2##(1990-11#1)(2007-10#1)
temporal pattern of the##3##4##(1997-8#1)(2007-12#1)(2011-1#1)
temporal pattern of##8##3##(1992-3#1)(1994-12#1)(1995-5#1)(1997-8#1)(2007-12#2)(2010-11#1)(2011-1#1)
temporal patterns of the##4##4##(1997-8#1)(2008-11#1)(2008-7#2)
temporal patterns of##11##3##(1993-12#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)
temporal patterns##14##2##(1993-12#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#3)(2008-9#1)(2009-8#1)(2013-7#1)
temporal phase unwrapping##2##3##(2008-3#2)
temporal phase##10##2##(2007-12#3)(2008-2#2)(2008-3#5)
temporal phase-unwrapping algorithm##2##3##(2008-3#2)
temporal position of##2##3##(2007-11#1)(2008-10#1)
temporal position##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
temporal profile of the##3##4##(2008-3#2)(2008-7#1)
temporal profile of##4##3##(2008-3#2)(2008-7#1)(2013-8#1)
temporal profile##6##2##(2008-3#3)(2008-7#2)(2013-8#1)
temporal profiles of##3##3##(2007-11#1)(2008-1#1)(2009-8#1)
temporal profiles##5##2##(1994-3#1)(2007-11#2)(2008-1#1)(2009-8#1)
temporal properties of##2##3##(2007-11#1)(2008-1#1)
temporal properties##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
temporal pulse##3##2##(2007-11#1)(2008-10#2)
temporal region##5##2##(2007-12#1)(2008-9#2)(2009-1#1)(2010-7#1)
temporal regions##2##2##(1996-5#1)(2010-7#1)
temporal relationship between##7##3##(1994-10#1)(1994-2#1)(2006-6#2)(2008-4#1)(2008-7#1)(2013-8#1)
temporal relationship##8##2##(1994-10#1)(1994-2#1)(2006-6#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
temporal reshaping##2##2##(2007-12#2)
temporal resolution and##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2010-11#1)
temporal resolution images##2##3##(2012-1#2)
temporal resolution of##10##3##(1995-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#2)
temporal resolution to##2##3##(2008-3#1)(2008-6#1)
temporal resolution##35##2##(1995-2#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-11#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-8#1)
temporal response of##2##3##(2007-11#1)(2007-12#1)
temporal response##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
temporal separation##3##2##(1992-11#1)(2007-12#1)(2008-11#1)
temporal sequence of##3##3##(1995-3#1)(2008-10#1)(2012-12#1)
temporal sequence##4##2##(1995-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
temporal sequencing##2##2##(2008-1#1)(2009-3#1)
temporal shape of the##2##4##(2007-12#1)(2008-2#1)
temporal shape##3##2##(2007-12#1)(2008-2#2)
temporal signal##4##2##(2007-12#1)(2008-3#3)
temporal signals##3##2##(2008-2#1)(2008-3#2)
temporal soliton##2##2##(2008-2#1)(2008-3#1)
temporal solitons with##2##3##(2008-3#2)
temporal solitons##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
temporal spread of SMV##2##4##(2008-10#2)
temporal spread##3##2##(2008-10#3)
temporal stability##2##2##(2007-11#1)(2008-10#1)
temporal structures##5##2##(2008-11#3)(2008-6#1)(2012-2#1)
temporal trends##2##2##(2008-7#1)(2012-1#1)
temporal variability##7##2##(1992-9#3)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
temporal variables##2##2##(2008-5#1)(2013-7#1)
temporal variation in the opportunity for sexual selection##2##8##(2008-8#2)
temporal variation in##4##3##(2008-8#3)(2008-9#1)
temporal variation##9##2##(2008-10#1)(2008-3#1)(2008-8#3)(2008-9#2)(2010-12#1)(2013-1#1)
temporal variations in##2##3##(2008-6#1)(2008-9#1)
temporal variations of##2##3##(2008-5#1)(2013-8#1)
temporal variations##6##2##(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2013-8#1)
temporal water body of##2##4##(2008-5#2)
temporal water body##3##3##(2008-5#3)
temporal window##2##2##(2007-12#1)(2008-6#1)
temporal##696##1##(1990-11#1)(1990-5#2)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-11#7)(1992-12#4)(1992-3#3)(1992-8#1)(1992-9#4)(1993-1#1)(1993-12#4)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#4)(1995-2#3)(1995-3#1)(1995-5#3)(1996-12#3)(1996-2#9)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#15)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#10)(2006-12#4)(2006-6#2)(2007-10#3)(2007-11#41)(2007-12#45)(2007-5#1)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#63)(2008-11#30)(2008-12#3)(2008-2#48)(2008-3#72)(2008-4#11)(2008-5#10)(2008-6#6)(2008-7#16)(2008-8#25)(2008-9#38)(2009-1#1)(2009-10#5)(2009-11#4)(2009-2#8)(2009-3#1)(2009-5#3)(2009-7#3)(2009-8#13)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#29)(2012-1#4)(2012-12#5)(2012-2#16)(2012-3#7)(2013-1#10)(2013-7#8)(2013-8#8)
temporalis muscle flap in##2##4##(2007-12#2)
temporalis##4##1##(2007-12#2)(2008-5#2)
temporality##2##1##(2008-2#1)(2009-5#1)
temporally and spatially##4##3##(1994-3#1)(1994-9#1)(2008-8#1)(2012-3#1)
temporally and##6##2##(1994-3#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
temporally decorrelated##2##2##(2007-12#2)
temporally regulated during##2##3##(1997-4#1)(2009-3#1)
temporally regulated in the##2##4##(1991-11#1)(2009-3#1)
temporally regulated##8##2##(1991-11#1)(1994-2#1)(1996-5#1)(1997-4#1)(2009-3#2)(2009-8#1)(2011-2#1)
temporally restricted expression##2##3##(1994-8#1)(1997-4#1)
temporally restricted objects##4##3##(2007-12#3)(2008-2#1)
temporally restricted##6##2##(1994-8#1)(1997-4#1)(2007-12#3)(2008-2#1)
temporally separated##2##2##(2009-9#2)
temporally variable##2##2##(2008-8#1)(2008-9#1)
temporally varying##3##2##(2008-8#1)(2008-9#2)
temporally with##2##2##(1994-5#1)(2010-5#1)
temporally##71##1##(1991-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-7#1)(2007-11#5)(2007-12#10)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#3)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#2)(2009-3#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
temporaria##6##1##(2008-7#2)(2011-2#3)(2013-1#1)
temporarily for##2##2##(1990-11#1)(1996-1#1)
temporarily prior##2##2##(1990-12#1)(2008-8#1)
temporarily##32##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-12#1)(1995-9#3)(1996-1#1)(1996-4#1)(1996-5#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
temporary hemodialysis##2##2##(2008-1#1)(2011-2#1)
temporary increase of##2##3##(2008-11#1)(2008-8#1)
temporary increase##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
temporary or permanent##3##3##(2009-3#1)(2010-4#2)
temporary or##4##2##(1992-5#1)(2009-3#1)(2010-4#2)
temporary##77##1##(1990-5#1)(1990-6#1)(1990-8#1)(1992-5#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-8#1)(1994-9#1)(1996-2#2)(1996-3#1)(1997-3#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#2)(2012-5#1)(2013-1#6)(2013-7#1)
temporo-mandibular joint##5##2##(2011-2#5)
temporo-occipital##2##1##(2008-7#2)
temporo-parietal junction##2##2##(2008-11#2)
temporo-parietal##4##1##(2008-11#4)
temporo-suboccipital craniotomy##2##2##(2008-7#2)
temporolimbic##2##1##(1996-7#2)
temporomandibular disorder##3##2##(2013-1#3)
temporomandibular joint##10##2##(1990-10#1)(1993-1#1)(1995-10#1)(1996-2#1)(2007-12#2)(2009-4#2)(2012-3#2)
temporomandibular##13##1##(1990-10#1)(1993-1#1)(1995-10#1)(1996-2#1)(2007-12#2)(2009-4#2)(2012-3#2)(2013-1#3)
temporoparietal junction##3##2##(2008-11#2)(2010-2#1)
temporoparietal##6##1##(2007-12#2)(2008-11#2)(2008-12#1)(2010-2#1)
tempos##2##1##(2012-2#2)
temptation##2##1##(1993-3#1)(1995-5#1)
tempting##2##1##(2008-9#1)(2013-8#1)
ten and##2##2##(1994-11#1)(2008-9#1)
ten cases##3##2##(1997-3#1)(2007-8#1)(2009-8#1)
ten consecutive##2##2##(2008-10#2)
ten days##9##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-8#1)
ten determinations##5##2##(2008-10#5)
ten different##4##2##(1993-12#1)(2008-10#1)(2008-3#1)(2010-7#1)
ten exons##2##2##(1991-6#1)(1992-11#1)
ten gratings##3##2##(2013-8#3)
ten head and neck##2##4##(2008-2#2)
ten in##3##2##(2007-11#1)(2012-3#2)
ten laminin##2##2##(2008-11#2)
ten measurements##2##2##(2008-10#1)(2008-3#1)
ten minutes##3##2##(1990-5#1)(1991-6#1)(1996-2#1)
ten months##5##2##(1996-9#1)(2007-7#1)(2008-9#2)(2012-2#1)
ten normal##3##2##(2007-2#1)(2008-10#1)(2012-2#1)
ten of the##2##3##(1994-9#1)(2012-3#1)
ten of##4##2##(1994-9#1)(2008-12#1)(2008-5#1)(2012-3#1)
ten or 100 female##2##4##(1996-12#2)
ten or 100##3##3##(1996-12#3)
ten or##5##2##(1993-12#1)(1996-12#3)(2013-8#1)
ten patients who##2##3##(2007-7#1)(2008-7#1)
ten patients with##4##3##(1990-10#1)(1990-12#1)(1996-9#1)(2008-9#1)
ten patients##15##2##(1990-10#2)(1990-12#1)(1993-2#1)(1994-2#1)(1996-11#2)(1996-9#1)(2007-7#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)
ten percent of##2##3##(1992-5#1)(1993-12#1)
ten percent##4##2##(1992-5#1)(1993-12#1)(2008-10#1)(2010-8#1)
ten replicate##6##2##(2008-10#5)(2013-7#1)
ten subjects##2##2##(2008-5#2)
ten times higher than##3##4##(1990-12#1)(1991-5#1)(1992-2#1)
ten times higher##5##3##(1990-12#1)(1990-6#1)(1991-5#1)(1992-2#1)(2008-11#1)
ten times lower than##2##4##(1990-6#1)(1992-9#1)
ten times more##3##3##(1990-8#1)(1992-2#1)(2008-10#1)
ten times that of##2##4##(1994-9#1)(2008-10#1)
ten times the##4##3##(1990-6#1)(1993-12#1)(2008-10#2)
ten times##24##2##(1990-12#1)(1990-6#3)(1990-8#1)(1991-5#1)(1992-2#2)(1992-9#1)(1993-12#1)(1994-9#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)
ten to##2##2##(1992-1#1)(2008-4#1)
ten weeks##2##2##(2008-10#1)(2011-1#1)
ten were##7##2##(1990-12#1)(1990-2#1)(1992-1#1)(2007-7#1)(2008-9#2)(2013-8#1)
ten with##2##2##(2011-2#1)(2012-2#1)
ten year##7##2##(1994-2#1)(2008-5#1)(2008-8#3)(2010-5#1)(2011-1#1)
ten years ago##3##3##(1990-6#1)(2008-1#1)(2009-12#1)
ten years before##2##3##(1994-9#1)(2008-1#1)
ten years from##2##3##(2008-3#1)(2012-3#1)
ten years of##5##3##(1991-8#1)(1992-1#1)(1992-12#1)(2008-9#2)
ten years##46##2##(1990-11#1)(1990-6#3)(1991-12#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#2)(1996-7#1)(1996-9#1)(2007-11#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#1)(2011-2#1)(2012-3#3)
ten##342##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#6)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#4)(1991-6#3)(1991-8#4)(1991-9#1)(1992-1#5)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#6)(1993-2#3)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-9#5)(1995-12#2)(1995-2#3)(1995-6#1)(1996-11#3)(1996-12#8)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#2)(2006-11#2)(2007-11#6)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#7)(2008-10#46)(2008-11#9)(2008-12#7)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#12)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#8)(2011-9#1)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#9)
ten- to##2##2##(1990-5#1)(1991-9#1)
ten-channel##2##1##(2008-2#1)(2008-3#1)
ten-fold diluted##2##2##(1991-12#1)(1991-5#1)
ten-fold##8##1##(1991-12#1)(1991-5#1)(1992-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-7#1)
ten-year##9##1##(1990-2#1)(1991-9#1)(1993-1#3)(2006-12#1)(2008-4#1)(2008-9#1)(2012-2#1)
tenant##2##1##(1996-5#1)(2013-1#1)
tenants##3##1##(1993-1#2)(1996-5#1)
tend to be less##2##4##(2010-3#1)(2011-2#1)
tend to be more##4##4##(2007-12#1)(2008-1#1)(2008-2#1)(2012-2#1)
tend to be##37##3##(1991-12#1)(1991-5#1)(1992-5#1)(1994-3#2)(1994-9#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#2)
tend to decrease##4##3##(2008-8#1)(2009-5#1)(2009-6#1)(2013-1#1)
tend to develop##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
tend to fall into##2##4##(1997-1#1)(2011-2#1)
tend to have##6##3##(1994-2#1)(2006-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
tend to increase in the##2##5##(2008-9#1)(2013-1#1)
tend to increase##4##3##(1991-6#1)(2008-4#1)(2008-9#1)(2013-1#1)
tend to live in high density households compared to##2##9##(2011-2#2)
tend to lose##2##3##(2008-5#1)(2008-7#1)
tend to only##2##3##(1994-3#1)(2012-2#1)
tend to perform##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
tend to produce##3##3##(2007-11#1)(2008-7#1)(2010-3#1)
tend to remain##2##3##(2008-10#1)(2008-9#1)
tend to show##2##3##(1997-7#1)(2008-5#1)
tend to treat##2##3##(2008-5#1)(2010-12#1)
tend to##120##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-3#2)(2011-2#12)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#4)
tend##123##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-3#2)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#4)
tended to be greater##2##4##(2008-10#1)(2013-1#1)
tended to be higher in##3##5##(1994-5#1)(1995-3#1)(1996-9#1)
tended to be higher##4##4##(1994-5#1)(1995-3#1)(1996-9#1)(2008-3#1)
tended to be less##3##4##(1990-12#1)(2008-9#1)(2011-2#1)
tended to be lower than##2##5##(1993-12#1)(2007-8#1)
tended to be lower##5##4##(1993-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-8#1)
tended to be more##5##4##(1991-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-7#1)
tended to be older##2##4##(1994-12#1)(1995-3#1)
tended to be similar##2##4##(2008-10#1)(2008-9#1)
tended to be slightly##2##4##(1995-3#1)(1995-5#1)
tended to be younger##3##4##(1993-1#1)(1996-2#1)(2012-3#1)
tended to be##40##3##(1990-12#1)(1991-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-3#3)(1995-5#1)(1996-2#1)(1996-9#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#1)
tended to cluster##2##3##(2008-10#1)(2008-11#1)
tended to decline##2##3##(1995-12#1)(2011-2#1)
tended to decrease in##2##4##(1994-12#1)(2011-2#1)
tended to decrease##3##3##(1994-12#1)(2008-5#1)(2011-2#1)
tended to enhance the##2##4##(2008-10#1)(2009-12#1)
tended to follow##2##3##(2008-12#1)(2008-9#1)
tended to give a##2##4##(1991-2#1)(2008-5#1)
tended to give##3##3##(1991-2#1)(2008-5#2)
tended to have lower##3##4##(2008-10#1)(2008-9#1)(2010-10#1)
tended to have##11##3##(1990-5#1)(1991-11#1)(1994-3#1)(2007-2#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-8#2)(2011-2#1)
tended to improve##5##3##(2010-2#1)(2011-2#1)(2013-1#3)
tended to increase with time##2##5##(2008-10#2)
tended to increase##6##3##(1995-5#1)(2008-10#3)(2008-12#1)(2012-2#1)
tended to remain##2##3##(1991-1#1)(1993-1#1)
tended to report##2##3##(2008-5#1)(2013-8#1)
tended to yield##2##3##(1992-9#1)(2008-10#1)
tended to##122##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-3#4)(1995-5#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#7)(2009-12#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#3)
tended##126##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-3#4)(1995-5#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#18)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#7)(2009-12#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#6)(2013-8#3)
tendencies in##2##2##(1991-9#1)(2012-12#1)
tendencies of##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
tendencies to##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
tendencies##24##1##(1991-9#1)(1992-1#1)(1994-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-8#2)(2009-9#1)(2012-12#3)(2012-3#1)(2013-1#1)
tendency and##4##2##(1997-3#1)(2011-2#1)(2012-12#2)
tendency for the##3##3##(1994-3#1)(2008-1#1)(2008-5#1)
tendency for##21##2##(1991-2#1)(1994-3#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
tendency in the##2##3##(1995-3#1)(2008-7#1)
tendency in##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
tendency is##2##2##(1992-5#1)(1997-8#1)
tendency of a##2##3##(2008-7#1)(2008-8#1)
tendency of the##3##3##(1991-3#1)(2008-5#1)(2012-1#1)
tendency of##21##2##(1990-8#1)(1991-3#1)(1991-6#1)(1994-2#1)(1996-9#1)(1997-6#2)(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#3)(2011-2#1)(2012-1#1)(2012-12#1)
tendency to accumulate in the##2##5##(2008-10#1)(2010-2#1)
tendency to accumulate##3##3##(2008-10#2)(2010-2#1)
tendency to be##2##3##(2010-2#1)(2011-2#1)
tendency to decrease##2##3##(2008-10#1)(2013-1#1)
tendency to develop##2##3##(1990-12#1)(1997-8#1)
tendency to form##2##3##(2008-10#1)(2013-1#1)
tendency to spread##2##3##(1995-5#1)(2013-1#1)
tendency to##55##2##(1990-12#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#1)
tendency toward##3##2##(2011-2#2)(2012-12#1)
tendency towards higher##2##3##(1990-2#1)(2011-2#1)
tendency towards##7##2##(1990-2#1)(1991-2#1)(1992-6#1)(1993-3#1)(1995-11#1)(2008-4#1)(2011-2#1)
tendency was found for##2##4##(1996-7#1)(2011-2#1)
tendency was observed##2##3##(2008-11#1)(2013-7#1)
tendency was##10##2##(1993-3#1)(1995-11#1)(1996-2#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2011-2#1)(2013-7#1)
tendency##151##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#9)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#8)(2013-7#3)(2013-8#1)
tender points##2##2##(1990-6#1)(2008-12#1)
tender##14##1##(1990-2#1)(1990-6#1)(1993-8#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-8#3)
tenderness and##6##2##(2007-2#1)(2009-4#1)(2012-12#1)(2013-1#3)
tenderness of##2##2##(1990-6#1)(2007-11#1)
tenderness##24##1##(1990-6#1)(1992-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-2#1)(2010-4#3)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
tending to##4##2##(1991-12#1)(2008-9#1)(2011-1#1)(2012-4#1)
tending##5##1##(1991-12#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-4#1)
tendinitis of the shoulder##2##4##(1991-4#1)(1997-6#1)
tendinitis##3##1##(1991-4#2)(1997-6#1)
tendinopathy##4##1##(2008-12#1)(2011-2#1)(2013-1#2)
tendinosis##10##1##(1997-6#1)(2008-8#1)(2009-10#4)(2010-3#4)
tendinous xanthomas##3##2##(1997-8#3)
tendinous##5##1##(1997-8#3)(2008-9#1)(2012-12#1)
tendon and##4##2##(1990-11#1)(2008-9#1)(2009-10#2)
tendon disorders##2##2##(2009-10#1)(2010-3#1)
tendon in a##2##3##(2007-12#1)(2010-7#1)
tendon in##4##2##(1990-9#1)(2007-12#1)(2009-10#1)(2010-7#1)
tendon is##2##2##(2007-12#1)(2009-4#1)
tendon reflexes##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
tendon rupture following##3##3##(2009-4#1)(2010-3#2)
tendon rupture##9##2##(2009-4#4)(2010-3#3)(2012-12#2)
tendon sheath fistula formation##2##4##(2008-10#2)
tendon sheath##7##2##(2008-10#3)(2008-9#4)
tendon to the##2##3##(2009-10#2)
tendon to##3##2##(2008-9#1)(2009-10#2)
tendon transfer##2##2##(2009-10#2)
tendon was sectioned##2##3##(2008-9#1)(2009-4#1)
tendon was##5##2##(2008-9#2)(2009-10#2)(2009-4#1)
tendon##102##1##(1990-11#1)(1990-9#2)(1993-9#2)(1995-8#2)(1996-6#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#24)(2009-10#14)(2009-3#4)(2009-4#6)(2009-7#1)(2010-3#6)(2010-7#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#5)
tendonitis of the##2##3##(2012-12#2)
tendonitis##7##1##(2008-12#1)(2008-9#3)(2012-12#3)
tendons and the##3##3##(1997-8#1)(2008-9#2)
tendons and##7##2##(1990-11#1)(1997-8#1)(2008-6#1)(2008-9#2)(2009-7#1)(2013-1#1)
tendons of##3##2##(2008-7#3)
tendons showed##2##2##(1997-8#2)
tendons##41##1##(1990-11#1)(1990-6#1)(1995-8#1)(1997-8#3)(2007-11#1)(2007-12#2)(2007-8#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
tends to be greater##2##4##(1994-3#1)(1996-12#1)
tends to be more##2##4##(2008-4#1)(2013-1#1)
tends to be##18##3##(1992-6#1)(1994-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
tends to break down##2##4##(2008-3#1)(2008-5#1)
tends to break##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
tends to increase with##3##4##(1991-2#1)(2008-3#1)(2008-9#1)
tends to increase##5##3##(1991-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
tends to result in##2##4##(1994-9#1)(2009-10#1)
tends to##55##2##(1990-8#1)(1991-2#1)(1992-6#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
tenella##5##1##(2007-12#2)(2007-6#1)(2008-10#2)
tenellus##6##1##(2008-10#6)
tenet of##3##2##(1993-12#1)(2008-7#1)(2010-10#1)
tenets of##4##2##(1993-3#1)(1994-12#1)(2010-4#1)(2011-1#1)
tenets##7##1##(1991-12#1)(1993-3#1)(1994-12#1)(2008-11#1)(2010-4#1)(2011-1#1)(2011-2#1)
tenfold higher##2##2##(1993-6#1)(1997-3#1)
tenfold improvement##2##2##(2007-11#1)(2008-2#1)
tenfold increase in the##2##4##(2007-11#2)
tenfold increase in##3##3##(1990-12#1)(2007-11#2)
tenfold##12##1##(1990-11#1)(1990-12#1)(1991-1#1)(1993-6#1)(1997-3#1)(1997-7#1)(2007-11#3)(2008-10#1)(2008-2#1)(2010-8#1)
teniposide##3##1##(1992-2#1)(1994-5#1)(2008-11#1)
tennis elbow##3##2##(1997-6#1)(2008-12#1)(2011-2#1)
tennis serve##3##2##(2011-2#3)
tennis##8##1##(1997-6#1)(2008-12#1)(2009-1#1)(2011-2#5)
tenocyte##2##1##(2013-1#2)
tenocytes##6##1##(2013-1#6)
tenofovir resistance##4##2##(2013-1#4)
tenofovir##10##1##(2007-1#1)(2008-8#1)(2013-1#8)
tenosynovitis##4##1##(2008-9#4)
tens of megahertz##2##3##(2008-2#2)
tens of meters##2##3##(2008-3#2)
tens of micrometers##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
tens of milligrams of##2##4##(2008-10#2)
tens of millimeters##3##3##(2007-12#2)(2008-3#1)
tens of millions of##2##4##(1991-2#1)(1993-6#1)
tens of milliwatts##2##3##(2007-11#1)(2007-12#1)
tens of nanometers##3##3##(2007-12#1)(2008-3#1)(2012-1#1)
tens of thousands of##2##4##(2008-10#1)(2008-7#1)
tens of##41##2##(1991-2#1)(1993-6#1)(2007-11#4)(2007-12#8)(2008-10#7)(2008-2#5)(2008-3#10)(2008-7#3)(2008-9#1)(2012-1#1)
tens##44##1##(1991-2#1)(1993-6#1)(2007-11#4)(2007-12#8)(2008-10#9)(2008-2#5)(2008-3#10)(2008-7#3)(2008-9#1)(2011-2#1)(2012-1#1)
tense and agreement morphology##2##4##(2012-1#2)
tense and present tense/agreement##2##4##(2012-1#2)
tense and##6##2##(2008-5#2)(2012-1#4)
tense ascites##2##2##(2007-12#1)(2011-2#1)
tense##17##1##(2007-12#1)(2008-5#3)(2008-6#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-1#8)(2012-12#1)
tense/agreement morphology##3##2##(2009-8#1)(2012-1#2)
tense/agreement##8##1##(2009-8#4)(2012-1#4)
tensegrity principle##2##2##(2009-3#2)
tensegrity##3##1##(2008-10#1)(2009-3#2)
tensile and compressive##2##3##(2008-3#1)(2009-7#1)
tensile and##3##2##(2008-3#1)(2008-5#1)(2009-7#1)
tensile bond strength and##2##4##(2008-12#1)(2013-1#1)
tensile bond strength##3##3##(2008-12#1)(2013-1#2)
tensile forces##2##2##(2009-7#1)(2012-1#1)
tensile loading##4##2##(2009-7#1)(2012-7#3)
tensile properties of the hair##2##5##(2008-5#2)
tensile properties of the##3##4##(2008-5#2)(2009-7#1)
tensile properties of##5##3##(2008-5#3)(2009-7#2)
tensile properties##9##2##(2008-5#5)(2009-7#3)(2012-2#1)
tensile strain##3##2##(2009-7#1)(2011-2#2)
tensile strength values##2##3##(2008-5#2)
tensile strength when##2##3##(2008-12#1)(2009-3#1)
tensile strength with##2##3##(2008-12#1)(2012-1#1)
tensile strength##18##2##(1997-5#1)(2008-12#4)(2008-5#5)(2008-7#2)(2009-3#1)(2009-7#2)(2012-1#1)(2012-2#2)
tensile tests##3##2##(2008-5#1)(2012-2#2)
tensile##53##1##(1997-5#1)(2008-12#5)(2008-3#2)(2008-5#13)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#12)(2011-2#2)(2012-1#2)(2012-2#6)(2012-7#3)(2013-1#2)
tensio-actif##2##1##(2008-5#2)
tensioactifs##4##1##(2008-5#4)
tension and cell##2##3##(2008-7#1)(2009-5#1)
tension and pulmonary arterial##2##4##(2008-11#2)
tension and##22##2##(1990-11#1)(1991-12#1)(1994-2#2)(1995-5#1)(2008-11#4)(2008-3#1)(2008-7#2)(2009-4#2)(2009-5#2)(2010-4#1)(2011-1#2)(2013-1#1)(2013-8#2)
tension at##2##2##(2008-10#1)(2008-7#1)
tension between the##2##3##(2008-11#1)(2012-3#1)
tension between##9##2##(1991-3#1)(1995-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
tension during##2##2##(1991-12#1)(2006-10#1)
tension for##2##2##(2008-3#1)(2011-2#1)
tension forces##3##2##(1997-2#1)(2008-10#1)(2010-3#1)
tension in##3##2##(1990-12#1)(1996-9#1)(2007-8#1)
tension is##2##2##(1997-2#1)(2010-2#1)
tension of the##7##3##(1991-12#2)(1992-1#1)(1995-3#1)(1996-3#1)(2007-2#1)(2011-2#1)
tension of##15##2##(1991-12#3)(1992-1#1)(1995-3#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2011-1#1)(2011-2#1)
tension pneumothoraces##2##2##(2011-2#2)
tension to##3##2##(2007-12#1)(2007-8#1)(2009-7#1)
tension was recorded##2##3##(2007-10#1)(2007-8#1)
tension was##3##2##(2007-10#1)(2007-8#1)(2013-1#1)
tension with the##2##3##(2008-10#1)(2011-2#1)
tension##179##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#4)(1991-12#6)(1991-2#1)(1991-3#1)(1992-1#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#31)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-1#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-9#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
tension-band##2##1##(2009-3#2)
tension-free repair##2##2##(1996-9#1)(2010-8#1)
tension-free##4##1##(1996-9#1)(2010-8#1)(2011-2#2)
tension-type headache##3##2##(2008-4#1)(2012-3#2)
tensions between##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
tensions in##2##2##(2009-5#1)(2012-12#1)
tensions resulting from##2##3##(1991-9#1)(1995-12#1)
tensions that##2##2##(1995-3#1)(2008-8#1)
tensions##28##1##(1990-12#2)(1990-5#1)(1991-9#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
tensor ABCD law##2##3##(2007-11#2)
tensor elements##2##2##(2008-2#1)(2008-3#1)
tensor fasciae##3##2##(2009-3#3)
tensor of a##2##3##(2007-11#1)(2008-5#1)
tensor of##4##2##(2007-11#1)(2008-5#3)
tensor voting##5##2##(2008-6#5)
tensor##48##1##(1996-2#2)(1997-7#2)(2007-11#8)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#7)(2008-6#8)(2008-9#2)(2009-10#2)(2009-3#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
tensors for##2##2##(2008-5#1)(2010-7#1)
tensors of the two##2##4##(1996-2#1)(2008-3#1)
tensors of##4##2##(1996-2#1)(2008-3#1)(2013-1#2)
tensors##12##1##(1996-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2013-1#7)
tentacles##2##1##(2011-2#2)
tentative cpPKs and##2##3##(2009-5#2)
tentative cpPPs##2##2##(2009-5#2)
tentative group mean##2##3##(2011-2#2)
tentative mechanism which##2##3##(1996-5#2)
tentative##27##1##(1991-2#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-9#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2009-12#1)(2009-5#4)(2011-2#3)(2013-8#1)
tentatively classified as##2##3##(2008-10#2)
tentatively designated##2##2##(2008-10#1)(2008-7#1)
tentatively identified as##6##3##(1993-11#1)(1993-12#1)(1995-5#1)(1996-2#1)(2008-10#2)
tentatively identified##8##2##(1993-11#1)(1993-12#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-7#1)
tentatively named##2##2##(2008-10#2)
tentatively##25##1##(1990-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1995-5#1)(1996-2#1)(2008-10#12)(2008-7#3)(2008-9#1)(2009-10#1)(2012-2#1)
tenth of##5##2##(1994-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
tenth##19##1##(1994-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
tentorial##3##1##(2006-12#2)(2008-7#1)
tents##2##1##(1995-5#1)(2008-7#1)
tenuis in##2##2##(2008-8#1)(2010-8#1)
tenuis##6##1##(1993-11#1)(2008-8#2)(2010-8#3)
tenuissima##4##1##(2008-10#4)
tenure and##2##2##(2010-6#2)
tenure was##2##2##(2010-6#2)
tenure##14##1##(1994-1#1)(2008-12#2)(2010-6#10)(2011-2#1)
teosinte##6##1##(1995-8#1)(2008-5#4)(2012-3#1)
terabit##2##1##(2008-3#2)
terabits of##2##2##(2008-3#2)
terahertz (THz) imaging with##2##4##(2007-11#1)(2007-12#1)
terahertz (THz) pulses##3##3##(2007-11#1)(2007-12#2)
terahertz (THz) radiation##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
terahertz (THz)##17##2##(2007-11#8)(2007-12#8)(2008-3#1)
terahertz devices##2##2##(2012-2#2)
terahertz dipole antennas##2##3##(2007-12#2)
terahertz dipole##3##2##(2007-12#3)
terahertz electromagnetic##3##2##(2007-12#2)(2012-2#1)
terahertz imaging and spectroscopy for##2##5##(2012-12#2)
terahertz imaging and spectroscopy##3##4##(2012-12#3)
terahertz imaging with a dynamic##2##5##(2007-12#1)(2008-3#1)
terahertz imaging##9##2##(2007-11#1)(2007-12#2)(2008-3#1)(2012-12#5)
terahertz output##2##2##(2007-11#1)(2007-12#1)
terahertz pulses in##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
terahertz pulses##14##2##(2007-11#3)(2007-12#9)(2008-2#2)
terahertz radiation emitter##2##3##(2008-3#2)
terahertz radiation in##2##3##(2007-11#1)(2007-12#1)
terahertz radiation##12##2##(2007-11#5)(2007-12#4)(2008-3#3)
terahertz source##3##2##(2007-11#2)(2010-5#1)
terahertz spectroscopy##4##2##(2007-12#3)(2010-5#1)
terahertz time-domain spectroscopy##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
terahertz time-domain##5##2##(2007-12#1)(2008-3#2)(2010-5#1)(2013-8#1)
terahertz waves##3##2##(2007-12#1)(2013-8#2)
terahertz##99##1##(2007-11#24)(2007-12#40)(2008-2#3)(2008-3#8)(2010-5#6)(2011-1#1)(2012-12#9)(2012-2#5)(2013-8#3)
terahertz- (THz-) wave##2##3##(2007-12#1)(2008-3#1)
terahertz-band##3##1##(2013-8#3)
terahertz-wave generation##2##2##(2007-12#2)
terahertz-wave parametric##3##2##(2007-11#2)(2008-3#1)
terahertz-wave##11##1##(2007-11#3)(2007-12#5)(2008-3#1)(2013-8#2)
teratocarcinoma cells##5##2##(1992-9#2)(1994-11#3)
teratocarcinoma##7##1##(1992-9#2)(1994-11#3)(1995-5#1)(2008-10#1)
teratocarcinosarcoma##3##1##(2008-11#3)
teratogen##4##1##(1992-2#2)(1996-12#1)(2008-4#1)
teratogenesis##4##1##(1996-12#3)(2008-7#1)
teratogenic potential of##2##3##(2013-1#2)
teratogenic risk##3##2##(1994-6#1)(1995-8#1)(2008-7#1)
teratogenic##11##1##(1993-12#2)(1994-6#1)(1995-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#4)
teratogenicity of##5##2##(1990-5#1)(1993-12#1)(2013-1#3)
teratogenicity##9##1##(1990-5#1)(1993-12#2)(1995-8#1)(1996-12#1)(2010-12#1)(2013-1#3)
teratoid/rhabdoid tumor of the spine##2##5##(2011-2#2)
teratoid/rhabdoid tumor of the##3##4##(2011-2#3)
teratological##3##1##(1990-8#2)(2013-8#1)
teratoma and##2##2##(2008-7#1)(2013-1#1)
teratoma in a 2-month-old boy##2##5##(2007-5#2)
teratoma in an 11-month-old##2##4##(2008-12#2)
teratoma in##7##2##(2007-5#2)(2008-10#1)(2008-12#2)(2009-5#1)(2011-1#1)
teratoma is a##2##3##(2008-7#1)(2013-8#1)
teratoma is##4##2##(2007-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
teratoma of the##3##3##(2008-10#2)(2013-8#1)
teratoma of##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
teratoma was##4##2##(2007-5#1)(2008-10#1)(2011-1#2)
teratoma##40##1##(1990-9#1)(1992-8#1)(1994-9#1)(2007-5#4)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#3)(2008-7#3)(2008-8#2)(2009-4#1)(2009-5#2)(2009-7#1)(2011-1#4)(2013-1#2)(2013-8#5)
teratomas are##2##2##(2007-8#1)(2012-12#1)
teratomas##9##1##(1994-12#1)(2007-5#1)(2007-8#2)(2008-10#3)(2012-12#1)(2013-1#1)
terawatt##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
terazosin in bulk form##2##4##(2008-10#2)
terazosin in##3##2##(2008-10#3)
terazosin##11##1##(1995-12#5)(2008-10#6)
terbinafine##17##1##(2008-10#6)(2008-3#4)(2008-5#7)
terbium##12##1##(2008-10#9)(2008-2#2)(2012-2#1)
terbium(III)##9##1##(2008-10#4)(2008-4#5)
terbium-sensitised luminescence##3##2##(2008-10#3)
terbutaline in##3##2##(1997-2#1)(2008-10#2)
terbutaline##11##1##(1995-11#1)(1995-6#1)(1997-2#1)(2008-10#7)(2011-1#1)
terbuthylazine and##2##2##(2008-10#1)(2008-11#1)
terbuthylazine##6##1##(2008-10#2)(2008-11#3)(2008-7#1)
terbutryn##3##1##(2008-10#3)
terbutylazine##2##1##(2008-11#2)
terephthalate##5##1##(2008-10#1)(2013-1#4)
terephthalate)##8##1##(2007-12#1)(2008-10#6)(2010-5#1)
teres f##8##2##(2008-10#8)
teres##28##1##(2008-10#26)(2008-8#1)(2013-1#1)
teres)##2##1##(2008-10#2)
terfenadine##5##1##(1992-8#4)(2007-11#1)
tergal##4##1##(1994-2#1)(2007-12#2)(2008-9#1)
tergite##2##1##(2007-12#2)
tergites##8##1##(2007-12#8)
tergo-tergal mechanism##3##2##(2007-12#3)
tergo-tergal##4##1##(2007-12#4)
tergum and##2##2##(2007-12#2)
term &quot##24##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-5#1)(1994-1#1)(1995-6#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
term and preterm##3##3##(1994-3#2)(2012-3#1)
term and##13##2##(1992-4#1)(1993-10#1)(1994-3#3)(1995-3#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
term as##2##2##(1996-5#1)(2008-11#1)
term care##19##2##(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(2008-12#2)(2008-7#1)(2012-12#1)
term children##2##2##(2008-12#1)(2011-2#1)
term effects##7##2##(1990-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)
term ethanol##2##2##(2011-2#2)
term follow up##4##3##(1993-2#1)(2011-2#1)(2013-8#2)
term follow-up##2##2##(2011-2#2)
term for##2##2##(2008-1#1)(2008-11#1)
term has##2##2##(2008-10#1)(2011-1#1)
term impact##2##2##(1992-2#1)(2010-4#1)
term in the##5##3##(1995-1#1)(1996-12#1)(1997-8#1)(2008-2#1)(2008-3#1)
term in##12##2##(1993-2#2)(1995-1#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-7#1)
term infants##7##2##(1990-11#2)(1995-8#1)(2007-11#2)(2011-2#2)
term is##7##2##(1993-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
term labor##2##2##(2011-2#2)
term memory formation##2##3##(2009-8#1)(2013-1#1)
term memory##9##2##(1993-12#1)(2008-11#1)(2009-8#1)(2012-2#3)(2013-1#3)
term of the##5##3##(1994-1#1)(2008-10#2)(2008-12#1)(2008-3#1)
term of##13##2##(1994-1#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-9#1)
term optical##2##2##(2007-12#1)(2012-2#1)
term outcome##5##2##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
term placenta##2##2##(1995-11#1)(2008-10#1)
term pregnancy##4##2##(1990-12#2)(2011-1#1)(2012-12#1)
term registered##2##2##(2008-11#2)
term results obtained##2##3##(2007-11#1)(2007-8#1)
term results##7##2##(1991-6#1)(2007-11#3)(2007-8#1)(2011-2#1)(2013-1#1)
term stability##8##2##(2008-10#5)(2008-5#2)(2010-3#1)
term that is##2##3##(2008-3#1)(2008-9#1)
term that##6##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-9#1)(2012-2#1)
term this##3##2##(1991-2#1)(2007-12#1)(2013-1#1)
term to keep the##2##4##(2011-2#2)
term to##7##2##(2008-8#1)(2011-1#1)(2011-2#4)(2013-8#1)
term used to describe##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
term was##3##2##(1995-8#1)(2011-1#1)(2012-12#1)
term were##2##2##(1994-3#1)(2009-3#1)
term which##2##2##(1993-8#1)(2008-10#1)
term##454##1##(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#6)(1993-3#5)(1993-6#2)(1993-8#3)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#9)(1994-6#3)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#4)(1996-1#4)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#4)(2007-10#3)(2007-11#15)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-1#4)(2008-10#43)(2008-11#24)(2008-12#8)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#15)(2008-8#14)(2008-9#7)(2009-11#4)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#11)(2011-2#34)(2011-3#2)(2012-12#6)(2012-2#12)(2012-3#4)(2012-8#1)(2013-1#28)(2013-7#5)(2013-8#14)
term)##4##1##(1994-3#1)(1996-11#1)(2007-9#1)(2013-1#1)
termed &quot##4##2##(1995-2#1)(1996-12#1)(2008-10#1)(2012-2#1)
termed 6##2##2##(2008-11#2)
termed a##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
termed as##2##2##(2008-10#1)(2010-7#1)
termed beta##2##2##(1992-9#1)(1995-2#1)
termed the##7##2##(1996-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-8#1)
termed##112##1##(1990-11#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#3)(1995-12#4)(1995-2#7)(1995-6#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-7#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
terminal amino##2##2##(1990-12#1)(1992-9#1)
terminal and##3##2##(1994-3#1)(1995-3#1)(2008-8#1)
terminal branches of the##2##4##(1997-3#1)(2012-3#1)
terminal care##5##2##(1990-3#1)(1990-6#1)(1993-3#2)(1994-12#1)
terminal complement proteins##2##3##(1994-2#2)
terminal complement##3##2##(1993-11#1)(1994-2#2)
terminal cysteine##2##2##(2008-10#1)(2009-9#1)
terminal dendritic mass (TDM)##2##4##(2007-12#2)
terminal density##2##2##(1995-12#1)(1996-2#1)
terminal deoxynucleotidyl transferase (TdT)##2##4##(1992-6#1)(1997-9#1)
terminal deoxynucleotidyl transferase##4##3##(1992-6#1)(1997-9#2)(2008-9#1)
terminal deoxynucleotidyl##5##2##(1992-6#1)(1997-9#2)(2008-10#1)(2008-9#1)
terminal differentiated##3##2##(1990-11#1)(2008-8#1)(2008-9#1)
terminal differentiation of##7##3##(1990-11#2)(1990-5#1)(1992-9#1)(1993-6#1)(2008-7#1)(2008-9#1)
terminal differentiation##25##2##(1990-11#2)(1990-5#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#3)
terminal disease##2##2##(1992-5#1)(2013-1#1)
terminal domains##2##2##(1993-8#1)(1997-2#1)
terminal electron acceptor##3##3##(1990-7#2)(2009-8#1)
terminal field of the##2##4##(1997-3#2)
terminal field##3##2##(1997-3#3)
terminal fragments##2##2##(1995-3#1)(2008-8#1)
terminal galactose##2##2##(1993-11#2)
terminal groups##2##2##(2008-10#2)
terminal molars##2##2##(2012-12#2)
terminal of##3##2##(1996-8#1)(2007-11#1)(2008-9#1)
terminal oxidase##2##2##(1990-11#1)(2010-10#1)
terminal oxidases##2##2##(1994-8#1)(2009-9#1)
terminal part of the##2##4##(1992-6#1)(1993-11#1)
terminal part##3##2##(1992-6#1)(1993-11#1)(2008-8#1)
terminal phase of##2##3##(1997-5#1)(2010-11#1)
terminal pore##3##2##(2007-12#2)(2010-11#1)
terminal region of the##6##4##(1993-6#1)(1993-8#1)(1994-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
terminal region of##8##3##(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
terminal region##13##2##(1993-6#1)(1993-8#1)(1994-11#3)(1995-5#1)(1997-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
terminal regions of the##2##4##(1993-6#1)(2008-10#1)
terminal regions##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
terminal renal failure##2##3##(1990-8#1)(1992-5#1)
terminal repeat (LTR)##4##3##(1992-12#1)(1993-8#1)(1997-8#1)(2008-11#1)
terminal repeat##17##2##(1990-12#2)(1992-12#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#2)(1997-6#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
terminal repeats##5##2##(1994-8#1)(1995-8#2)(2008-10#1)(2008-8#1)
terminal sequence##2##2##(1991-5#1)(1992-8#1)
terminal sialic acid##2##3##(1991-9#1)(2008-11#1)
terminal stage##2##2##(2011-2#2)
terminal structure##2##2##(2008-8#2)
terminal sugar##3##2##(1992-12#3)
terminal sugars##2##2##(1994-3#1)(2011-2#1)
terminal ureter##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
terminal values##3##2##(2011-1#3)
terminal with##2##2##(1991-12#1)(2008-7#1)
terminal##305##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-12#1)(1991-5#4)(1991-7#1)(1991-9#3)(1992-12#7)(1992-3#1)(1992-5#7)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#4)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#7)(1994-6#1)(1994-8#6)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#10)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#3)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#21)(2008-9#10)(2009-3#3)(2009-5#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#2)
terminal-stream-limitation model##2##2##(2008-8#2)
terminalis and##2##2##(1994-2#1)(2008-4#1)
terminalis##6##1##(1993-12#1)(1994-2#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
terminally differentiated##3##2##(1995-2#1)(2008-5#1)(2009-10#1)
terminally ill patients##5##3##(1990-10#3)(1994-12#1)(2007-11#1)
terminally ill##10##2##(1990-10#4)(1992-2#1)(1993-12#1)(1994-12#2)(2007-11#1)(2013-8#1)
terminally##18##1##(1990-10#4)(1991-8#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#2)(1995-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
terminally-ill##2##1##(2012-12#2)
terminals and##4##2##(1991-12#1)(1997-3#2)(2012-3#1)
terminals are##4##2##(1993-8#1)(1994-8#1)(1995-12#1)(1997-3#1)
terminals from##2##2##(1993-8#1)(2007-12#1)
terminals in the striatum and##2##5##(1996-12#1)(2008-7#1)
terminals in the##10##3##(1990-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
terminals in##13##2##(1990-5#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
terminals is##2##2##(1995-11#1)(2008-4#1)
terminals made##2##2##(1992-3#1)(2013-8#1)
terminals of the##4##3##(1990-5#1)(1992-12#1)(1995-12#1)(2008-10#1)
terminals of##12##2##(1990-5#2)(1992-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-8#1)
terminals on##2##2##(1997-2#2)
terminals##93##1##(1990-5#5)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-12#3)(1993-8#2)(1993-9#1)(1994-8#3)(1995-11#3)(1995-12#9)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#4)(1996-5#4)(1997-2#12)(1997-3#9)(1997-7#3)(2007-12#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#3)
terminate in##3##2##(1996-2#1)(1996-7#1)(2007-12#1)
terminate the##8##2##(1991-3#1)(1992-6#1)(1994-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)
terminate with##2##2##(1992-10#2)
terminate##22##1##(1991-3#1)(1992-10#2)(1992-2#1)(1992-6#1)(1993-3#2)(1994-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-11#1)(2013-1#2)
terminated at the##2##3##(1997-2#1)(2008-7#1)
terminated at##3##2##(1992-3#1)(1997-2#1)(2008-7#1)
terminated by a##2##3##(2007-11#1)(2008-12#1)
terminated by##3##2##(1995-12#1)(2007-11#1)(2008-12#1)
terminated in##3##2##(2007-12#2)(2008-3#1)
terminated##29##1##(1990-5#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-11#1)(1995-12#2)(1996-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-4#1)
terminates in##2##2##(1992-12#1)(2008-7#1)
terminates##8##1##(1992-12#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-3#1)
terminating in the##2##3##(1994-8#1)(2008-11#1)
terminating in##3##2##(1994-8#1)(1994-9#1)(2008-11#1)
terminating outcome##3##2##(1997-4#3)
terminating##19##1##(1991-2#1)(1992-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-6#2)(1997-4#5)(2008-10#2)(2008-11#1)(2010-10#1)(2011-1#2)
termination are##2##2##(2008-10#1)(2008-11#1)
termination at##3##2##(1997-2#2)(1997-8#1)
termination by##2##2##(1991-2#1)(2008-2#1)
termination codon##3##2##(1990-7#1)(1992-6#1)(2008-10#1)
termination level##2##2##(2008-3#2)
termination of early pregnancy##2##4##(1995-8#2)
termination of pregnancy and##2##4##(2013-1#1)(2013-8#1)
termination of pregnancy##8##3##(1993-2#1)(1995-8#3)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
termination of the##4##3##(1992-12#1)(1992-6#1)(1997-2#1)(2008-4#1)
termination of translation##4##3##(2008-11#4)
termination of##34##2##(1991-3#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-6#1)(1995-12#1)(1995-2#1)(1995-8#5)(1996-12#2)(1997-2#1)(1997-8#1)(2008-1#2)(2008-11#5)(2008-3#1)(2008-4#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
termination or##3##2##(1997-5#1)(2007-4#1)(2009-2#1)
termination signal##2##2##(1990-5#1)(1990-8#1)
termination##93##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#4)(1991-3#2)(1992-12#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-6#1)(1995-12#2)(1995-2#4)(1995-8#5)(1996-12#3)(1996-6#2)(1997-2#10)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#5)(2008-4#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#2)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
terminations in##2##2##(1996-12#1)(2013-8#1)
terminations##4##1##(1996-12#1)(2008-9#2)(2013-8#1)
terminator in##2##2##(1997-6#1)(2008-9#1)
terminator of##3##2##(1994-12#1)(2008-8#2)
terminator##15##1##(1993-9#3)(1994-12#2)(1997-2#2)(1997-6#1)(2008-10#1)(2008-8#4)(2008-9#1)(2011-1#1)
terminators##6##1##(1990-5#2)(1994-12#1)(1994-5#1)(1997-2#1)(2008-7#1)
termini of the##5##3##(1992-6#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-9#1)
termini of##10##2##(1990-5#1)(1992-6#1)(1992-9#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)
termini##22##1##(1990-5#1)(1990-7#1)(1991-10#1)(1992-6#1)(1992-9#1)(1994-8#2)(1997-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#2)
terminological##2##1##(1991-9#1)(2008-7#1)
terminology and##7##2##(1995-1#1)(2007-11#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#2)
terminology for##5##2##(1992-3#1)(1996-2#1)(2008-10#1)(2013-1#2)
terminology in##4##2##(1997-8#1)(2008-10#1)(2013-1#2)
terminology is##4##2##(2008-10#1)(2010-9#1)(2013-1#2)
terminology of lean manufacturing and the Toyota Production System##3##9##(2012-2#3)
terminology of the##2##3##(1996-3#1)(2007-12#1)
terminology of##12##2##(1990-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#4)(2013-1#2)(2013-7#1)
terminology to##2##2##(2009-7#1)(2012-3#1)
terminology used##2##2##(2007-11#1)(2008-10#1)
terminology##62##1##(1990-11#1)(1990-3#1)(1991-12#1)(1992-1#2)(1992-3#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#2)(2007-11#4)(2007-12#3)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#17)(2013-7#1)
terminus and the##2##3##(1993-2#1)(1996-12#1)
terminus and##6##2##(1993-2#1)(1993-3#1)(1994-8#1)(1996-12#1)(2008-10#2)
terminus by##2##2##(1995-2#1)(1995-6#1)
terminus in##2##2##(1991-2#1)(1995-6#1)
terminus is##3##2##(1992-7#1)(1995-8#1)(1996-10#1)
terminus of a##2##3##(1990-5#1)(2012-2#1)
terminus of an##5##3##(2008-10#1)(2008-4#4)
terminus of the deduced##2##4##(1992-8#1)(1994-12#1)
terminus of the##20##3##(1990-5#1)(1991-6#1)(1992-11#1)(1992-8#2)(1992-9#1)(1994-12#3)(1994-8#2)(1995-12#1)(1995-2#3)(1995-6#1)(2008-11#1)(2008-4#3)
terminus of##39##2##(1990-5#2)(1991-10#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-12#4)(1994-8#3)(1995-12#1)(1995-2#4)(1995-6#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#8)(2012-2#1)
terminus region##4##2##(1995-2#3)(1996-12#1)
terminus were##2##2##(1992-9#1)(2008-10#1)
terminus##106##1##(1990-5#2)(1991-10#1)(1991-2#3)(1991-6#2)(1991-8#4)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#6)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-12#6)(1994-8#4)(1995-12#1)(1995-2#10)(1995-3#1)(1995-6#9)(1995-8#1)(1996-10#1)(1996-12#6)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#8)(2008-11#7)(2008-4#8)(2008-6#1)(2009-9#1)(2012-2#2)
termite Prorhinotermes simplex (Isoptera##2##4##(2007-12#2)
termite##11##1##(2007-12#2)(2009-5#1)(2010-1#1)(2011-2#7)
termites##14##1##(2009-5#3)(2011-2#7)(2013-8#4)
termiticides##3##1##(2011-2#3)
terms &quot##4##2##(2009-9#1)(2011-2#2)(2013-1#1)
terms and the##3##3##(1994-1#1)(1995-1#1)(2008-7#1)
terms and##13##2##(1994-1#2)(1995-1#1)(1996-2#2)(1996-9#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)
terms are used to##2##4##(2008-3#2)
terms are##13##2##(1990-11#1)(1990-8#1)(1991-6#1)(1993-2#2)(1994-12#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-2#2)
terms as##2##2##(2008-5#1)(2011-2#1)
terms between##2##2##(2007-12#1)(2008-3#1)
terms but##2##2##(2007-9#1)(2008-10#1)
terms for primary##2##3##(2008-10#2)
terms for##9##2##(2008-10#3)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)
terms in the##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
terms in##7##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-1#1)
terms is##3##2##(1996-9#1)(2011-2#2)
terms of a##30##3##(1990-11#1)(1990-8#1)(1991-8#1)(1993-11#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#7)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
terms of both##15##3##(1992-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
terms of clinical##3##3##(1993-12#1)(1997-1#1)(2007-12#1)
terms of disease##2##3##(2011-2#1)(2012-2#1)
terms of food##4##3##(2007-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
terms of her##2##3##(1991-6#1)(2012-3#1)
terms of length of stay##2##5##(1993-12#1)(2012-3#1)
terms of membrane##3##3##(2008-10#2)(2008-7#1)
terms of mortality##3##3##(1995-3#1)(1996-12#1)(2008-7#1)
terms of reference##3##3##(2008-1#1)(2008-12#1)(2010-12#1)
terms of reliability##2##3##(2008-1#1)(2013-1#1)
terms of specific##4##3##(1991-5#1)(1991-9#1)(2010-3#1)(2013-7#1)
terms of stability##2##3##(2008-10#2)
terms of survival##6##3##(1991-2#1)(1993-2#1)(2007-8#1)(2008-7#1)(2013-7#2)
terms of symptom expression##2##4##(2008-10#2)
terms of the range of##2##5##(2008-8#1)(2008-9#1)
terms of the settlement##2##4##(1995-12#1)(1997-5#1)
terms of the##156##3##(1990-11#1)(1990-7#2)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#4)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#5)(2008-2#12)(2008-3#15)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
terms of their##35##3##(1990-7#1)(1991-2#1)(1992-11#2)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-4#1)(2013-1#3)
terms of##826##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#9)(1990-9#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#7)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#5)(1995-6#2)(1996-1#2)(1996-12#4)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#16)(2007-12#14)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#10)(2008-10#151)(2008-11#30)(2008-12#16)(2008-2#41)(2008-3#68)(2008-4#6)(2008-5#22)(2008-6#9)(2008-7#23)(2008-8#19)(2008-9#17)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#9)(2011-2#27)(2011-3#1)(2012-1#7)(2012-12#6)(2012-2#20)(2012-3#12)(2012-4#2)(2012-8#1)(2013-1#25)(2013-7#7)(2013-8#8)
terms such as##4##3##(1994-9#1)(2008-7#1)(2010-4#1)(2012-12#1)
terms that are##3##3##(1993-2#1)(1995-1#1)(2007-12#1)
terms that##7##2##(1993-2#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-9#1)(2008-2#2)
terms the##2##2##(1991-12#1)(1992-3#1)
terms to##6##2##(1996-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)
terms used in##3##3##(2008-4#1)(2008-9#1)(2009-8#1)
terms used##5##2##(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
terms were##2##2##(1990-3#1)(2010-5#1)
terms with##7##2##(1994-1#1)(1995-1#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-11#1)(2012-3#1)
terms within the##2##3##(2008-7#2)
terms##1030##1##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#12)(1990-9#1)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#9)(1993-2#7)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-1#5)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#6)(1995-6#2)(1996-1#2)(1996-12#4)(1996-2#9)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#19)(2007-12#22)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#4)(2008-1#10)(2008-10#163)(2008-11#37)(2008-12#16)(2008-2#55)(2008-3#85)(2008-4#10)(2008-5#25)(2008-6#12)(2008-7#39)(2008-8#24)(2008-9#21)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#9)(2009-8#6)(2009-9#4)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#6)(2010-4#6)(2010-5#12)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#46)(2011-3#1)(2012-1#8)(2012-12#9)(2012-2#23)(2012-3#13)(2012-4#2)(2012-8#1)(2013-1#31)(2013-7#7)(2013-8#12)
terms)##2##1##(2007-12#1)(2009-7#1)
ternary SiO(2)##2##2##(2007-12#2)
ternary and##4##2##(2008-10#4)
ternary complex between##2##3##(1995-5#1)(2008-10#1)
ternary complex factors##2##3##(1994-11#1)(1994-6#1)
ternary complex formation##2##3##(1994-6#1)(2008-10#1)
ternary complex formed##2##3##(1994-5#1)(2008-10#1)
ternary complex model##2##3##(2008-3#2)
ternary complex on##3##3##(2008-10#2)(2012-12#1)
ternary complex with##4##3##(2008-10#4)
ternary complex##30##2##(1993-8#1)(1994-11#1)(1994-5#6)(1994-6#2)(1994-8#1)(1995-5#1)(2008-10#15)(2008-3#2)(2012-12#1)
ternary complexes have been##2##4##(2008-10#1)(2008-5#1)
ternary complexes of Cu(II)##2##4##(2008-10#2)
ternary complexes of##6##3##(2008-10#6)
ternary complexes with##3##3##(1990-7#1)(2008-10#2)
ternary complexes##22##2##(1990-7#1)(1994-6#1)(2008-10#18)(2008-5#1)(2010-6#1)
ternary composites##2##2##(2009-11#2)
ternary inclusion complex##2##3##(2008-10#2)
ternary ion associate##2##3##(2008-10#2)
ternary ion##3##2##(2008-10#3)
ternary mixture of##4##3##(2008-10#4)
ternary mixture##6##2##(2008-10#6)
ternary mixtures of purified##2##4##(2008-6#2)
ternary mixtures of##9##3##(2008-10#7)(2008-6#2)
ternary mixtures##22##2##(2008-10#19)(2008-6#2)(2013-8#1)
ternary solvent##3##2##(2008-10#3)
ternary system##5##2##(2008-10#3)(2008-3#1)(2008-6#1)
ternary systems##3##2##(2008-10#1)(2008-6#2)
ternary##126##1##(1990-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#3)(1994-8#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-12#2)(2008-10#83)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#5)(2009-11#2)(2009-8#1)(2010-6#2)(2012-12#1)(2012-2#1)(2013-8#2)
terotoma##3##1##(2012-12#3)
terpene concentration##2##2##(2011-10#2)
terpene content##2##2##(2011-10#2)
terpene emission rates##3##3##(2011-10#3)
terpene emission##4##2##(2011-10#4)
terpene trilactones##3##2##(2008-10#3)
terpene##16##1##(2008-10#3)(2008-11#1)(2008-6#1)(2011-10#11)
terpenes##7##1##(2008-10#5)(2008-11#1)(2011-2#1)
terpenoid compounds##2##2##(1994-8#1)(2008-10#1)
terpenoid synthesis##3##2##(2008-10#3)
terpenoid##13##1##(1990-11#1)(1994-8#4)(2008-10#7)(2012-2#1)
terpenoids in##2##2##(2008-10#1)(2013-8#1)
terpenoids##7##1##(1990-11#2)(2008-10#3)(2011-3#1)(2013-8#1)
terpolymers##4##1##(2008-5#1)(2008-9#1)(2013-1#2)
terra-cotta##2##1##(2008-10#2)
terracotta##5##1##(2007-5#1)(2008-10#4)
terrain##13##1##(1996-2#1)(2007-12#2)(2007-5#1)(2008-2#5)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)
terrestrial and##6##2##(1994-9#1)(1996-6#1)(2008-3#2)(2009-4#1)(2012-2#1)
terrestrial ecosystems##2##2##(2008-6#1)(2012-2#1)
terrestrial environment##2##2##(2008-5#1)(2010-8#1)
terrestrial impact structures##2##3##(1997-5#2)
terrestrial impact##4##2##(1997-5#4)
terrestrial invertebrates##2##2##(2008-11#1)(2009-4#1)
terrestrial mollusc##2##2##(1990-5#2)
terrestrial origin##2##2##(2008-10#1)(2011-2#1)
terrestrial planets##2##2##(1995-6#1)(1997-5#1)
terrestrial plant##2##2##(2008-10#1)(2008-12#1)
terrestrial plants##2##2##(2008-10#1)(2008-7#1)
terrestrial slug##2##2##(2008-6#1)(2008-7#1)
terrestrial species##2##2##(2008-7#1)(2013-7#1)
terrestrial##64##1##(1990-5#2)(1990-7#1)(1991-6#2)(1994-9#1)(1995-6#1)(1996-6#1)(1997-5#7)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-4#3)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-7#1)
terrestris##3##1##(2008-5#1)(2011-3#2)
terreus##5##1##(2008-5#4)(2012-2#1)
terrified##2##1##(2008-11#1)(2009-10#1)
territorial animals##2##2##(2008-8#2)
territorial inheritance##2##2##(2008-8#2)
territorial##12##1##(1997-7#1)(2007-6#1)(2008-5#1)(2008-8#8)(2008-9#1)
territoriality##2##1##(2008-8#1)(2008-9#1)
territories and##8##2##(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#2)(2011-1#2)
territories of the##3##3##(2008-3#1)(2012-2#2)
territories of##4##2##(2008-3#1)(2011-2#1)(2012-2#2)
territories##27##1##(1991-3#1)(1997-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#4)(2009-8#3)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#2)
territory and##4##2##(1991-12#1)(2008-12#1)(2008-8#1)(2009-2#1)
territory by##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
territory for##2##2##(1994-2#1)(2013-7#1)
territory in##2##2##(2009-10#1)(2012-3#1)
territory of a##2##3##(2007-10#1)(2008-4#1)
territory of the##4##3##(1992-2#1)(1993-2#1)(1995-12#1)(1996-3#1)
territory of##11##2##(1992-2#1)(1993-2#1)(1995-12#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#2)
territory owners##2##2##(2008-8#1)(2008-9#1)
territory##62##1##(1991-12#2)(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(2007-10#4)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#11)(2008-9#6)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
terror attacks##2##2##(2009-7#2)
terror##12##1##(1990-6#1)(1990-8#1)(2008-1#1)(2009-10#4)(2009-7#5)
terrorism preparedness##2##2##(2008-9#2)
terrorism##3##1##(2008-7#1)(2008-9#2)
terrorism-preparedness training##3##2##(2008-9#3)
terrorist event##2##2##(2008-12#1)(2008-9#1)
terrorist threat##2##2##(1996-12#2)
terrorist##4##1##(1996-12#2)(2008-12#1)(2008-9#1)
tert-butanol##2##1##(2008-10#1)(2013-1#1)
tert-butyl acrylate##3##2##(2008-12#2)(2010-2#1)
tert-butyl alcohol##2##2##(2007-11#1)(2008-10#1)
tert-butyl##16##1##(1995-11#1)(1996-5#1)(2007-11#3)(2008-10#1)(2008-12#4)(2009-8#2)(2010-2#1)(2011-1#2)(2011-2#1)
tert-butylhydroquinone (TBHQ)##2##2##(2008-10#2)
tert-butylhydroquinone##3##1##(2008-10#3)
tertiary alkyl halides##2##3##(2011-1#2)
tertiary alkyl##3##2##(2011-1#3)
tertiary amines##6##2##(1991-9#2)(2008-10#2)(2010-8#2)
tertiary and##3##2##(1992-8#1)(1997-2#2)
tertiary care center##4##3##(2007-7#1)(2010-4#1)(2010-5#1)(2012-12#1)
tertiary care centres##2##3##(1994-2#1)(2007-12#1)
tertiary care hospital##23##3##(1997-3#1)(2007-7#2)(2008-11#2)(2008-3#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
tertiary care paediatric##2##3##(2008-11#2)
tertiary care referral##2##3##(2012-2#2)
tertiary care##46##2##(1994-2#2)(1995-1#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#5)
tertiary center##4##2##(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
tertiary chloride##2##2##(1997-2#2)
tertiary conformational##2##2##(1990-8#1)(1992-8#1)
tertiary hospitals##4##2##(1993-2#1)(2007-11#1)(2008-3#1)(2011-2#1)
tertiary hyperparathyroidism##2##2##(2012-12#2)
tertiary interactions##2##2##(1993-11#1)(2008-7#1)
tertiary level##3##2##(2012-2#1)(2013-1#2)
tertiary or quaternary structure##2##4##(2008-4#2)
tertiary or##3##2##(2008-4#3)
tertiary rainbow of##2##3##(2008-2#2)
tertiary referral center##2##3##(2011-2#2)
tertiary referral centers##2##3##(2011-2#2)
tertiary referral##8##2##(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#4)(2013-1#1)
tertiary screening##2##2##(1993-11#1)(2008-10#1)
tertiary structural##4##2##(1990-7#1)(1994-5#2)(1995-5#1)
tertiary structure and##4##3##(1992-12#1)(1992-8#1)(2008-4#2)
tertiary structure as##2##3##(1995-5#1)(2008-9#1)
tertiary structure is##3##3##(1992-4#1)(2008-4#2)
tertiary structure of the proteins##2##5##(1997-4#1)(2008-10#1)
tertiary structure of the##5##4##(1990-12#1)(1990-5#1)(1997-4#1)(2008-10#1)(2008-9#1)
tertiary structure of##7##3##(1990-12#1)(1990-5#1)(1992-12#1)(1997-4#1)(2008-10#2)(2008-9#1)
tertiary structure##37##2##(1990-12#1)(1990-5#3)(1991-5#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#12)(2008-7#1)(2008-9#3)
tertiary##170##1##(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-2#3)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#1)(1996-2#1)(1997-2#4)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#3)(2007-7#3)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#18)(2008-6#2)(2008-7#5)(2008-9#4)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#5)(2011-2#11)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#12)(2013-8#5)
tertiles##6##1##(2008-3#3)(2008-7#1)(2011-2#2)
tessulatum##3##1##(1996-12#3)
test (BAT)##2##2##(2012-2#1)(2012-3#1)
test (DAT)##3##2##(1994-12#1)(1996-12#1)(2012-2#1)
test (LNT)##2##2##(2008-9#2)
test (P &lt##2##3##(2009-8#1)(2012-3#1)
test (p##2##2##(1991-2#1)(2011-1#1)
test (p&lt##2##2##(2008-12#2)
test (α=0##3##2##(2013-1#3)
test a hypothesis##2##3##(2008-10#2)
test a##14##2##(1993-12#1)(1996-6#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
test agents##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
test alone##2##2##(2007-2#1)(2008-7#1)
test also##4##2##(1995-1#1)(2008-3#1)(2008-5#1)(2011-2#1)
test among##2##2##(2009-5#1)(2013-1#1)
test an##6##2##(1997-3#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-4#1)(2011-2#1)
test analyte##4##2##(2008-10#4)
test and a##6##3##(1996-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
test and control sites##2##4##(2011-2#2)
test and the##14##3##(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-1#1)(2013-1#2)
test and##94##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-2#2)(1994-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#8)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-5#1)(2010-1#1)(2010-2#2)(2010-8#2)(2011-1#6)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#12)(2013-7#1)(2013-8#1)
test animals##3##2##(2007-8#1)(2010-2#2)
test anxiety may##2##3##(2012-1#2)
test anxiety##3##2##(2012-1#3)
test apparatus##2##2##(2008-12#1)(2008-4#1)
test are##6##2##(1992-6#1)(1995-11#1)(2008-1#1)(2008-2#1)(2008-6#1)(2013-1#1)
test as a##4##3##(1994-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
test as an##2##3##(1990-2#1)(2007-7#1)
test as well as the##2##5##(2007-11#1)(2012-2#1)
test as well as##3##4##(2007-11#1)(2008-11#1)(2012-2#1)
test as##12##2##(1990-2#1)(1994-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
test at##5##2##(1990-6#1)(2008-12#1)(2011-1#1)(2013-1#2)
test based on the##3##4##(2008-3#1)(2012-3#1)(2013-1#1)
test based on##11##3##(1990-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#1)
test battery##3##2##(2008-9#1)(2013-1#2)
test because##3##2##(1996-5#1)(1997-1#1)(2008-9#1)
test bed##2##2##(2007-11#1)(2008-10#1)
test between##4##2##(2008-11#2)(2013-1#1)(2013-8#1)
test but##3##2##(1990-12#1)(1994-9#1)(2007-7#1)
test by using##2##3##(2008-10#1)(2013-8#1)
test by##5##2##(1990-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
test can be##5##3##(2007-7#1)(2008-11#1)(2008-7#1)(2012-1#2)
test can##9##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-3#1)
test cannot be##2##3##(1991-12#1)(2008-5#1)
test carried out##3##3##(1990-2#1)(2008-6#1)(2009-6#1)
test case of a##2##4##(2008-3#2)
test case##8##2##(1991-1#1)(1992-3#1)(2008-11#1)(2008-3#3)(2009-5#1)(2010-2#1)
test cases##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
test changes##2##2##(2008-3#1)(2008-4#1)
test compounds##7##2##(1995-6#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)
test conditions##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)
test could be##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
test could##4##2##(1997-4#1)(2007-2#1)(2008-10#1)(2012-3#1)
test data set##3##3##(2008-10#2)(2008-3#1)
test data##7##2##(2008-10#4)(2008-3#2)(2009-10#1)
test detected##3##2##(2009-2#1)(2011-1#2)
test did not##3##3##(1994-8#1)(2010-6#1)(2013-1#1)
test emulsions##5##2##(2008-5#5)
test evaluations##2##2##(1996-8#1)(2008-1#1)
test for diagnosing##2##3##(2008-10#1)(2010-8#1)
test for evaluating##2##3##(1991-2#1)(2008-1#1)
test for paired##2##3##(1990-6#1)(1992-6#1)
test for significant##2##3##(1994-2#1)(2008-11#1)
test for spatial##2##3##(1994-3#1)(2012-3#1)
test for the detection of##4##5##(1994-6#1)(1997-6#1)(2007-7#1)(2008-5#1)
test for the presence of##2##5##(1994-6#1)(2008-4#1)
test for the##26##3##(1990-11#1)(1991-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
test for##119##2##(1990-11#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-8#1)(2009-9#2)(2010-2#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
test from##2##2##(1997-3#1)(2008-9#1)
test gas##3##2##(2008-10#1)(2008-2#2)
test grating##2##2##(2007-11#1)(2008-3#1)
test group##5##2##(1994-8#1)(2007-7#2)(2008-12#2)
test groups##6##2##(1995-8#2)(2008-10#1)(2008-12#1)(2010-5#1)(2010-7#1)
test had a##2##3##(1997-8#1)(2013-1#1)
test had##5##2##(1991-4#1)(1997-8#1)(2011-2#2)(2013-1#1)
test has been performed##2##4##(1997-4#1)(2008-2#1)
test has been##3##3##(1997-4#1)(2008-11#1)(2008-2#1)
test has##10##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#2)
test have##2##2##(1997-3#1)(2008-10#1)
test hypotheses about##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
test hypotheses##6##2##(2008-10#2)(2008-11#2)(2008-8#1)(2012-3#1)
test images##2##2##(2008-2#2)
test in a##4##3##(1997-2#1)(2007-12#1)(2008-9#1)(2009-5#1)
test in children##2##3##(2008-9#1)(2012-12#1)
test in end-stage renal disease patients is##2##7##(2008-7#2)
test in its##2##3##(1991-3#1)(2008-2#1)
test in mice##3##3##(1991-12#1)(2007-10#1)(2013-7#1)
test in patients with##2##4##(2011-2#1)(2013-1#1)
test in rats##2##3##(1992-11#1)(1995-12#1)
test in the assessment of##2##5##(2008-4#1)(2008-6#1)
test in the diagnosis of##2##5##(1996-12#1)(2007-7#1)
test in the diagnosis##3##4##(1996-12#1)(2007-7#1)(2008-12#1)
test in the##13##3##(1990-3#1)(1993-8#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-7#1)
test in##61##2##(1990-10#1)(1990-3#2)(1991-12#2)(1991-3#2)(1992-11#2)(1992-9#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-5#2)(2009-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-7#1)(2013-1#3)(2013-7#1)
test indicated##3##2##(2008-10#2)(2011-2#1)
test interferometer##2##2##(2008-2#1)(2008-3#1)
test is a useful##2##4##(1997-2#1)(2007-7#1)
test is a##7##3##(1997-2#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
test is an##2##3##(2008-10#1)(2008-5#1)
test is better than##2##4##(2011-2#1)(2012-3#1)
test is not##3##3##(1997-3#1)(2008-7#1)(2010-4#1)
test is presented##2##3##(2008-3#1)(2008-4#1)
test is proposed for##2##4##(2008-11#1)(2008-3#1)
test is the##2##3##(1996-3#1)(2008-1#1)
test is used to##3##4##(1996-8#1)(2008-10#1)(2012-12#1)
test is used##4##3##(1996-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
test is useful in##2##4##(1990-3#1)(1991-12#1)
test is widely##2##3##(1997-2#1)(2008-9#1)
test is##60##2##(1990-2#1)(1990-3#1)(1991-12#2)(1992-11#1)(1992-5#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#3)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)
test items##3##2##(2008-11#1)(2009-12#2)
test its effect on##2##4##(1990-11#1)(2008-12#1)
test its##5##2##(1990-11#1)(1997-1#1)(2008-12#1)(2008-8#2)
test kit##10##2##(1996-5#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
test kits##3##2##(1996-5#1)(2007-7#1)(2009-9#1)
test laboratory sediment##2##3##(2008-10#2)
test location##2##2##(2007-12#1)(2009-5#1)
test material for##2##3##(1990-12#1)(2008-9#1)
test material##4##2##(1990-12#1)(2008-11#1)(2008-9#2)
test may be##3##3##(1991-5#1)(1994-1#1)(2008-11#1)
test may##4##2##(1991-5#1)(1994-1#1)(2008-11#1)(2008-7#1)
test meals##3##2##(1997-4#1)(2008-3#2)
test measurements##2##2##(2008-3#2)
test method and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
test method##13##2##(1996-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#4)(2012-3#1)
test methodologies##4##2##(1996-12#1)(2008-10#1)(2008-5#2)
test methods are##3##3##(1996-12#1)(2008-10#2)
test methods for##5##3##(1996-12#1)(2008-10#3)(2011-1#1)
test methods##22##2##(1991-6#1)(1996-12#2)(2008-10#9)(2008-5#6)(2008-8#1)(2008-9#1)(2011-1#2)
test mixture##3##2##(2011-1#2)(2013-1#1)
test mixtures##2##2##(2008-10#2)
test must be##2##3##(1990-3#1)(1996-4#1)
test nationalities##2##2##(1995-6#2)
test nerve##3##2##(1997-3#3)
test object##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
test of a##3##3##(2007-10#1)(2008-12#1)(2008-3#1)
test of group differences##2##4##(1992-6#1)(1997-3#1)
test of spatial##2##3##(1992-11#1)(1993-5#1)
test of the##14##3##(1992-1#1)(1992-6#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
test of this##4##3##(1992-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
test of time##3##3##(2008-1#1)(2008-2#1)(2013-1#1)
test of##75##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-6#4)(1992-7#1)(1993-3#2)(1993-5#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#6)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
test on the##3##3##(1995-6#1)(2008-10#1)(2013-8#1)
test on##7##2##(1995-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
test or##4##2##(1990-6#1)(1992-9#1)(2008-10#1)(2008-7#1)
test organisms##4##2##(2008-11#1)(2008-5#2)(2008-8#1)
test our##3##2##(2008-7#1)(2008-8#1)(2012-7#1)
test p##2##2##(1990-12#1)(2011-2#1)
test patterns##3##2##(2008-3#2)(2008-6#1)
test performance##9##2##(1994-12#1)(1996-7#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2013-1#1)
test performed##4##2##(1990-12#1)(2008-10#1)(2008-5#1)(2009-3#1)
test period##4##2##(1991-5#1)(1996-4#1)(2008-10#1)(2011-1#1)
test piece##2##2##(2008-3#2)
test plant##2##2##(2008-10#1)(2008-12#1)
test plants##5##2##(2008-10#4)(2008-12#1)
test portion into##2##3##(2008-10#2)
test position##3##2##(2008-12#3)
test positive##2##2##(1996-5#1)(2008-10#1)
test problem##2##2##(2007-12#1)(2008-7#1)
test problems##3##2##(2007-9#2)(2008-10#1)
test procedure##6##2##(1995-9#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
test procedures##5##2##(2008-10#3)(2012-2#2)
test products or placebo for 8 weeks##2##7##(2008-10#2)
test products##4##2##(1995-2#1)(2008-10#2)(2009-6#1)
test proteins were##2##3##(1997-2#2)
test protocol##2##2##(2007-7#1)(2008-5#1)
test protocols##2##2##(2008-5#2)
test provides##2##2##(2008-10#1)(2013-1#1)
test questions##2##2##(2008-12#1)(2010-3#1)
test range##2##2##(2007-7#1)(2008-10#1)
test requirements##2##2##(1996-8#1)(2008-3#1)
test result##6##2##(1990-5#1)(1996-5#1)(1996-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
test results and##3##3##(1996-12#1)(2010-12#1)(2012-3#1)
test results are##2##3##(2008-3#2)
test results from##2##3##(2008-10#2)
test results##40##2##(1991-11#1)(1991-12#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-12#3)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#1)(2007-2#1)(2007-7#2)(2008-10#5)(2008-3#4)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#2)(2011-1#2)(2012-3#3)(2013-1#3)(2013-8#1)
test revealed a##2##3##(2011-1#1)(2012-3#1)
test revealed##4##2##(1990-8#1)(2010-6#1)(2011-1#1)(2012-3#1)
test sample##14##2##(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)
test samples and##2##3##(2007-11#1)(2008-10#1)
test samples of##2##3##(2008-10#2)
test samples##14##2##(1990-12#1)(2007-11#1)(2008-10#9)(2008-2#1)(2008-4#1)(2011-1#1)
test scores were##2##3##(2008-9#2)
test scores##6##2##(1991-12#1)(2008-12#1)(2008-9#2)(2009-7#2)
test section##5##2##(2008-2#1)(2008-3#3)(2009-11#1)
test sensitivity##4##2##(1992-11#1)(2011-2#3)
test sera##2##2##(1990-12#1)(2010-4#1)
test series##2##2##(2007-11#1)(2008-10#1)
test set were##2##3##(2008-10#1)(2008-6#1)
test set##15##2##(1996-12#1)(2007-11#1)(2008-10#8)(2008-6#2)(2009-3#1)(2010-2#1)(2013-8#1)
test sets##4##2##(1996-3#1)(2008-10#2)(2009-5#1)
test setup##2##2##(2008-2#1)(2008-3#1)
test should be##2##3##(1991-6#1)(2012-12#1)
test should##3##2##(1991-6#1)(1996-3#1)(2012-12#1)
test showed a##3##3##(2009-8#1)(2012-3#1)(2013-1#1)
test showed that the##2##4##(2008-10#1)(2011-1#1)
test showed that##11##3##(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)
test showed##16##2##(1997-6#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-8#2)(2009-8#2)(2009-9#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
test showing##2##2##(1992-9#1)(2010-10#1)
test shows##2##2##(1997-2#1)(2008-11#1)
test sites##4##2##(1996-3#1)(2008-11#1)(2008-3#1)(2012-3#1)
test size##2##2##(1994-9#1)(1997-3#1)
test solutes##2##2##(1994-9#1)(2013-1#1)
test solution##9##2##(2008-10#7)(2008-5#1)(2012-2#1)
test solutions##12##2##(2008-10#12)
test species##6##2##(2010-11#5)(2012-3#1)
test specimens were##2##3##(2008-10#1)(2013-1#1)
test specimens##4##2##(2008-10#2)(2013-1#2)
test statistic##5##2##(1992-9#1)(1995-9#1)(2008-10#2)(2012-1#1)
test statistics and##2##3##(1995-9#1)(2008-10#1)
test statistics for##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
test statistics to##2##3##(1997-3#1)(2009-10#1)
test statistics##18##2##(1995-2#2)(1995-9#1)(1997-3#5)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#2)(2012-3#2)
test strip##7##2##(2008-10#5)(2012-3#2)
test subjects##4##2##(1995-6#2)(1997-5#1)(2008-5#1)
test substrate##2##2##(2008-11#2)
test such##3##2##(1992-9#1)(2007-8#1)(2011-2#1)
test suggested that##2##3##(2009-7#1)(2013-1#1)
test surface##4##2##(2008-2#1)(2008-3#3)
test system and##2##3##(1995-3#1)(2008-11#1)
test system has##2##3##(1996-2#1)(2008-11#1)
test system is##3##3##(2008-11#2)(2008-5#1)
test system##13##2##(1990-11#1)(1992-9#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#4)(2008-5#1)(2011-1#1)(2012-3#2)
test systems for developmental toxicology##2##5##(1996-5#2)
test systems##11##2##(1990-12#1)(1991-12#1)(1994-3#1)(1996-5#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
test target##2##2##(2008-2#1)(2008-3#1)
test technique##2##2##(2008-3#1)(2008-5#1)
test than##2##2##(2008-3#1)(2010-2#1)
test that was##2##3##(1997-2#1)(2008-10#1)
test that##12##2##(1991-11#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
test the ability of##2##4##(1993-6#1)(1994-3#1)
test the accuracy of##2##4##(1990-12#1)(2008-2#1)
test the accuracy##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
test the effects of##10##4##(1992-1#1)(1994-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2010-11#1)(2012-2#1)(2013-7#1)
test the efficacy of##2##4##(2008-9#1)(2010-8#1)
test the feasibility of##5##4##(1996-2#1)(1997-8#1)(2008-10#1)(2009-7#1)(2011-2#1)
test the feasibility##6##3##(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)
test the function of##3##4##(1995-2#1)(2008-1#1)(2008-8#1)
test the hypothesis that the##5##5##(1994-6#1)(1995-2#1)(2008-11#1)(2008-7#1)(2009-7#1)
test the hypothesis that##32##4##(1990-11#1)(1990-8#2)(1993-12#2)(1994-6#1)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-5#1)
test the hypothesis##37##3##(1990-11#1)(1990-8#2)(1991-2#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-5#1)
test the method##4##3##(1990-11#1)(2008-10#1)(2008-2#1)(2010-12#1)
test the null hypothesis that##2##5##(2008-10#1)(2008-5#1)
test the null hypothesis##3##4##(1995-5#1)(2008-10#1)(2008-5#1)
test the performance of the##3##5##(2008-2#1)(2008-3#1)(2010-8#1)
test the performance of##4##4##(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
test the relationship between##2##4##(2013-1#1)(2013-8#1)
test the safety and efficacy of##2##6##(1997-3#1)(2008-8#1)
test the system##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
test the validity of the##3##5##(1997-2#1)(2007-12#1)(2008-10#1)
test the validity of##5##4##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
test the##175##2##(1990-11#3)(1990-12#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#3)(1995-5#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#18)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#4)(2009-11#2)(2009-2#1)(2009-3#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-5#2)(2013-1#2)(2013-7#2)(2013-8#2)
test theoretical##2##2##(1995-6#1)(2012-3#1)
test these hypotheses##2##3##(2008-8#2)
test these##11##2##(1991-5#1)(1992-12#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#3)(2009-5#1)(2012-2#1)
test this hypothesis by##3##4##(2008-2#1)(2008-8#1)(2009-7#1)
test this hypothesis##16##3##(1991-12#1)(1992-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
test this model##3##3##(1997-1#1)(2008-9#1)(2010-5#1)
test this theory##2##3##(2008-11#1)(2008-12#1)
test this##38##2##(1991-12#1)(1991-5#1)(1992-8#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
test time##2##2##(2008-10#2)
test to assess##2##3##(2008-10#1)(2008-9#1)
test to compare##2##3##(2008-10#1)(2013-8#1)
test to measure##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
test to predict the##2##4##(2008-10#1)(2008-9#1)
test to the##5##3##(2008-10#2)(2011-1#1)(2012-2#1)(2012-3#1)
test to##34##2##(1992-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-4#3)(2008-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
test tubes##2##2##(1991-1#1)(1997-6#1)
test under##5##2##(1996-3#2)(2008-7#1)(2013-1#2)
test used##2##2##(2011-2#1)(2013-1#1)
test using a##4##3##(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
test using neural##2##3##(2010-8#2)
test using pollen of##2##4##(2008-11#2)
test using the##2##3##(1990-2#1)(2008-12#1)
test using##21##2##(1990-2#1)(1991-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#3)(2010-8#2)(2011-1#1)(2011-2#1)
test values of##2##3##(1995-6#1)(2012-3#1)
test values##4##2##(1995-6#1)(2008-7#1)(2012-12#1)(2012-3#1)
test vessel##2##2##(2008-10#2)
test was also conducted##2##4##(2008-5#1)(2013-1#1)
test was also##3##3##(1991-3#1)(2008-5#1)(2013-1#1)
test was carried out##4##4##(2007-7#1)(2008-4#1)(2012-2#1)(2013-1#1)
test was developed##3##3##(2008-10#2)(2013-1#1)
test was done##2##3##(2012-12#1)(2013-1#1)
test was evaluated##2##3##(2010-4#1)(2011-2#1)
test was found to be##2##5##(1996-3#1)(2010-7#1)
test was found##3##3##(1996-3#1)(2006-10#1)(2010-7#1)
test was not##3##3##(1990-6#1)(2011-1#1)(2013-1#1)
test was performed by##2##4##(2008-5#1)(2012-3#1)
test was performed in##3##4##(1993-3#1)(2008-12#1)(2013-1#1)
test was performed with##5##4##(1990-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
test was performed##13##3##(1990-3#1)(1993-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
test was positive in##4##4##(2007-7#2)(2011-1#1)(2012-3#1)
test was positive##6##3##(1997-4#1)(2007-7#2)(2010-12#1)(2011-1#1)(2012-3#1)
test was reliable##2##3##(1991-3#1)(2007-7#1)
test was then##2##3##(2008-5#1)(2012-12#1)
test was used for##3##4##(1994-9#1)(2008-8#1)(2013-1#1)
test was used to##5##4##(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
test was used##10##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
test was##89##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-3#3)(1992-10#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-7#5)(2007-8#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#11)(2013-8#1)
test we##2##2##(1990-2#1)(1991-11#1)
test were found##2##3##(1996-3#1)(2008-7#1)
test were performed##2##3##(1994-3#1)(2007-11#1)
test were used to determine##3##5##(2008-10#2)(2008-8#1)
test were used##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
test were##22##2##(1990-3#1)(1991-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
test whether the##7##3##(1994-3#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
test whether##31##2##(1993-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
test with a loaded weight of 80 kg##2##7##(2013-1#2)
test with a##6##3##(2008-2#1)(2008-5#2)(2013-1#3)
test with the##4##3##(1990-3#1)(1994-3#1)(1996-3#1)(2006-4#1)
test with##29##2##(1990-3#1)(1990-5#1)(1991-12#1)(1992-6#2)(1992-9#1)(1994-3#1)(1996-3#2)(1997-4#1)(1997-8#1)(2006-4#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#4)
test within the##2##3##(2008-11#1)(2008-12#1)
test within##4##2##(1990-6#1)(2008-11#1)(2008-12#1)(2008-5#1)
test would##3##2##(1993-8#1)(2008-10#1)(2009-4#1)
test##2397##1##(1990-10#2)(1990-11#6)(1990-12#12)(1990-2#7)(1990-3#17)(1990-5#5)(1990-6#9)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#5)(1991-11#5)(1991-12#21)(1991-2#5)(1991-3#7)(1991-4#3)(1991-5#6)(1991-6#5)(1991-8#1)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#10)(1992-12#5)(1992-2#6)(1992-3#9)(1992-4#3)(1992-5#6)(1992-6#15)(1992-7#2)(1992-8#5)(1992-9#16)(1993-11#2)(1993-12#6)(1993-2#4)(1993-3#10)(1993-5#2)(1993-6#4)(1993-8#4)(1994-1#4)(1994-11#1)(1994-12#8)(1994-2#15)(1994-3#24)(1994-5#1)(1994-6#6)(1994-7#3)(1994-8#10)(1994-9#6)(1995-1#3)(1995-11#4)(1995-12#8)(1995-2#11)(1995-3#4)(1995-5#4)(1995-6#12)(1995-8#3)(1995-9#6)(1996-1#2)(1996-11#1)(1996-12#20)(1996-2#9)(1996-3#18)(1996-4#3)(1996-5#18)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#5)(1997-1#3)(1997-2#18)(1997-3#31)(1997-4#12)(1997-5#12)(1997-6#10)(1997-7#9)(1997-8#7)(2006-10#2)(2006-12#2)(2006-4#1)(2007-10#7)(2007-11#20)(2007-12#20)(2007-2#9)(2007-4#1)(2007-6#4)(2007-7#33)(2007-8#15)(2007-9#2)(2008-1#13)(2008-10#367)(2008-11#85)(2008-12#56)(2008-2#51)(2008-3#125)(2008-4#40)(2008-5#108)(2008-6#21)(2008-7#67)(2008-8#72)(2008-9#60)(2009-10#7)(2009-11#6)(2009-12#11)(2009-2#4)(2009-3#8)(2009-4#2)(2009-5#14)(2009-6#3)(2009-7#11)(2009-8#8)(2009-9#7)(2010-1#7)(2010-10#3)(2010-11#9)(2010-12#8)(2010-2#13)(2010-3#14)(2010-4#9)(2010-5#10)(2010-6#9)(2010-7#3)(2010-8#21)(2010-9#3)(2011-1#52)(2011-2#97)(2011-3#2)(2012-1#17)(2012-12#23)(2012-2#44)(2012-3#76)(2012-5#2)(2012-6#1)(2012-7#4)(2013-1#110)(2013-7#6)(2013-8#28)
test&quot##2##1##(1993-3#1)(2009-3#1)
test' in##2##2##(2007-7#1)(2008-7#1)
test) is##2##2##(2011-2#1)(2012-3#1)
test) were##3##2##(1994-7#1)(1995-3#1)(2007-10#1)
test)##40##1##(1990-6#1)(1991-11#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-9#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
test-retest reliability##6##2##(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-1#1)(2013-8#1)
test-retest##10##1##(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-6#2)(2009-9#1)(2011-1#1)(2013-8#1)
test-tube##2##1##(1991-5#2)
test]##2##1##(1990-11#1)(1996-11#1)
testable hypotheses about##2##3##(1996-11#1)(2008-5#1)
testable hypotheses##7##2##(1996-11#1)(1996-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)
testable hypothesis##2##2##(2008-10#1)(2008-9#1)
testable##15##1##(1996-11#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#1)
testaceipes and A##2##3##(2008-6#2)
testaceipes and##3##2##(2008-6#3)
testaceipes##9##1##(2008-6#7)(2013-8#2)
testament to##2##2##(1995-3#1)(2007-12#1)
testbed projector##2##2##(2008-3#2)
testbed##3##1##(2008-3#3)
tested (5 to##2##3##(2008-10#2)
tested (5##3##2##(2008-10#2)(2008-5#1)
tested 14##2##2##(1990-3#1)(1995-12#1)
tested 2##2##2##(1994-6#1)(1995-6#1)
tested 24##2##2##(1994-8#1)(1995-5#1)
tested a variety of##2##4##(1997-1#1)(2008-7#1)
tested a##16##2##(1994-3#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2013-1#1)
tested after##4##2##(1993-2#1)(2008-10#1)(2008-12#2)
tested against a panel of##2##5##(2008-10#1)(2008-8#1)
tested against a##6##3##(1992-3#1)(1994-6#1)(2008-10#3)(2008-8#1)
tested against experimental##2##3##(2008-3#1)(2013-1#1)
tested against##34##2##(1992-3#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-11#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2011-2#2)(2013-1#1)
tested an##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
tested and applied for the##2##5##(2008-10#2)
tested and compared##4##3##(2008-10#1)(2008-6#1)(2009-11#1)(2010-5#1)
tested and found to be##2##5##(1991-7#1)(2008-10#1)
tested and##36##2##(1990-5#1)(1991-3#1)(1991-7#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
tested are##2##2##(2008-10#1)(2012-12#1)
tested as a potential##2##4##(1993-12#1)(2008-7#1)
tested as a##9##3##(1992-3#1)(1993-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-2#1)(2008-7#1)
tested as an##3##3##(1994-11#1)(2008-10#2)
tested as inhibitors of##2##4##(1992-8#1)(1995-2#1)
tested as potential##2##3##(1995-3#1)(2009-2#1)
tested as solid##3##3##(2008-10#2)(2008-5#1)
tested as##42##2##(1990-11#3)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
tested at the##4##3##(1992-2#1)(1993-12#1)(2008-10#1)(2008-4#1)
tested at various##3##3##(2008-10#3)
tested at##21##2##(1992-2#1)(1993-12#1)(1993-3#1)(2007-10#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#2)(2010-3#1)(2011-2#2)(2013-1#1)
tested both##2##2##(2008-3#1)(2013-7#1)
tested but##3##2##(2008-10#2)(2011-2#1)
tested by ELISA##3##3##(1995-12#2)(2007-7#1)
tested by a##5##3##(1991-8#1)(1994-3#1)(2008-3#1)(2008-5#1)(2011-2#1)
tested by comparing##2##3##(2008-10#1)(2011-3#1)
tested by comparison with##2##4##(2008-10#1)(2008-2#1)
tested by cross-validation##2##3##(2008-10#1)(2010-4#1)
tested by determining##3##3##(2008-10#3)
tested by means of##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
tested by measurement of##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
tested by the##10##3##(1990-10#1)(1992-6#1)(1994-12#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-8#1)
tested by using##2##3##(2008-10#1)(2008-8#1)
tested by##98##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-7#1)(2013-1#3)(2013-8#2)
tested cells##2##2##(2009-9#1)(2011-2#1)
tested compounds##6##2##(1995-12#1)(2008-10#3)(2008-5#1)(2012-3#1)
tested concentrations##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
tested could##2##2##(1992-3#1)(1993-6#1)
tested did not##3##3##(1992-11#1)(2008-10#1)(2009-8#1)
tested different##2##2##(2008-10#1)(2008-11#1)
tested during a##2##3##(1991-2#1)(2008-5#1)
tested during##4##2##(1990-6#1)(1991-2#1)(2008-5#1)(2012-2#1)
tested empirically##2##2##(2008-8#2)
tested experimentally##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
tested first on synthetic##3##4##(2008-10#3)
tested first##5##2##(2008-10#4)(2008-2#1)
tested for 5##2##3##(2008-2#1)(2009-7#1)
tested for HCV RNA##2##4##(1994-8#1)(2007-7#1)
tested for HIV##3##3##(1995-12#1)(1996-5#1)(2009-5#1)
tested for a##3##3##(1995-2#1)(2008-10#2)
tested for anti##2##3##(1996-5#1)(2007-7#1)
tested for differences##4##3##(1997-5#1)(2008-10#2)(2008-9#1)
tested for inhibition of##2##4##(1996-5#1)(2012-2#1)
tested for its##6##3##(1992-2#1)(2008-10#5)
tested for pathogenicity on##4##4##(2008-10#4)
tested for potential##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
tested for specific##2##3##(1994-11#1)(2008-10#1)
tested for specificity##2##3##(2008-10#2)
tested for the determination of##5##5##(2008-10#5)
tested for the presence of##4##5##(1992-9#1)(2008-10#1)(2008-4#1)(2013-1#1)
tested for the separation##2##4##(2008-10#1)(2008-7#1)
tested for the##25##3##(1991-11#1)(1992-9#1)(1994-2#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
tested for their ability to inhibit##6##6##(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)
tested for their ability to##15##5##(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(2007-6#1)(2008-10#6)(2008-4#1)
tested for their##39##3##(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-11#1)(2007-11#1)(2007-6#1)(2008-10#13)(2008-4#3)(2008-5#2)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
tested for toxicity##2##3##(2008-8#1)(2011-1#1)
tested for use##2##3##(2007-9#1)(2008-10#1)
tested for viability##2##3##(1995-3#1)(2008-10#1)
tested for virulence##6##3##(2008-10#5)(2009-2#1)
tested for##227##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#5)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#4)(1997-4#2)(1997-5#1)(2007-11#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#93)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
tested from##3##2##(1996-12#1)(2008-10#2)
tested had an activity##2##4##(1991-6#2)
tested had##3##2##(1991-6#2)(2008-10#1)
tested here in##2##3##(1993-12#1)(2008-6#1)
tested here##4##2##(1993-12#1)(2008-10#1)(2008-6#1)(2012-5#1)
tested how##2##2##(1997-3#1)(2009-9#1)
tested if##2##2##(2008-11#1)(2008-3#1)
tested in 94##2##3##(2008-1#1)(2011-2#1)
tested in a clinical##2##4##(1994-6#1)(2013-1#1)
tested in a##27##3##(1990-8#1)(1991-6#1)(1994-6#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
tested in an##9##3##(1990-11#1)(1990-7#1)(1991-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)
tested in animal##2##3##(1995-8#1)(2008-7#1)
tested in clinical trials##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
tested in clinical##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
tested in conjunction with##2##4##(2008-10#1)(2008-3#1)
tested in female##2##3##(2008-10#1)(2008-5#1)
tested in order to##3##4##(2008-10#3)
tested in our##2##3##(1997-5#1)(2008-5#1)
tested in several##2##3##(1990-12#1)(2007-11#1)
tested in the Morris##2##4##(1992-11#1)(1993-3#1)
tested in the analysis of##3##5##(2008-10#3)
tested in the field##3##4##(1996-12#1)(2008-10#2)
tested in the greenhouse##4##4##(2008-10#4)
tested in the in vitro##2##5##(2011-1#2)
tested in the laboratory##3##4##(2008-10#2)(2011-1#1)
tested in the##32##3##(1990-4#1)(1990-5#1)(1990-6#1)(1992-11#1)(1993-3#2)(1993-6#1)(1994-8#1)(1996-12#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#3)(2013-1#1)(2013-8#1)
tested in this study was##2##5##(2007-7#1)(2013-1#1)
tested in this study##8##4##(1997-1#1)(2007-7#1)(2008-10#2)(2008-12#2)(2013-1#2)
tested in this##11##3##(1995-3#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2010-10#1)(2013-1#2)
tested in three##2##3##(1996-4#1)(2008-5#1)
tested in two##2##3##(2008-10#1)(2013-8#1)
tested in vitro and in##2##5##(2008-10#1)(2008-8#1)
tested in vitro##8##3##(1994-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)
tested in vivo for##2##4##(1997-3#1)(1997-7#1)
tested in##180##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#54)(2008-11#8)(2008-12#5)(2008-3#7)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-9#1)(2013-1#4)(2013-8#3)
tested include##2##2##(2008-10#1)(2008-3#1)
tested including##2##2##(2008-10#1)(2012-3#1)
tested individually##2##2##(1996-12#1)(1996-5#1)
tested inhibited##2##2##(1995-6#1)(2008-10#1)
tested isolates were##2##3##(2008-10#1)(2008-12#1)
tested isolates##6##2##(2008-10#5)(2008-12#1)
tested its##2##2##(2008-11#1)(2008-3#1)
tested materials##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
tested media##2##2##(2007-11#1)(2008-10#1)
tested negative for##2##3##(2008-10#1)(2011-2#1)
tested negative##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
tested on a##9##3##(1993-3#1)(1994-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)
tested on an##2##3##(1992-8#1)(2008-3#1)
tested on data from##2##4##(2008-10#2)
tested on data##3##3##(2008-10#2)(2008-9#1)
tested on several##4##3##(2008-10#2)(2008-3#2)
tested on synthetic##2##3##(2008-10#1)(2008-3#1)
tested on the##10##3##(1992-2#1)(1992-8#1)(2008-10#4)(2008-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
tested on their##2##3##(1992-11#1)(2012-1#1)
tested on three##2##3##(2008-12#1)(2008-3#1)
tested on two##2##3##(1992-3#1)(2008-7#1)
tested on##82##2##(1990-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-3#1)(1994-3#2)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#28)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
tested over##4##2##(2007-7#1)(2008-10#3)
tested per##2##2##(2010-4#1)(2011-2#1)
tested phenols##2##2##(2008-10#1)(2011-1#1)
tested positive for circulating AFP mRNA##4##6##(2008-10#4)
tested positive for##7##3##(2008-10#4)(2008-12#1)(2011-1#1)(2011-2#1)
tested positive##14##2##(2008-1#2)(2008-10#8)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
tested postsurgically for##2##3##(1993-3#2)
tested ranged from##2##3##(1995-3#1)(2008-10#1)
tested resulted in##2##3##(2008-10#1)(2011-1#1)
tested separately##4##2##(2008-10#3)(2010-8#1)
tested showed##3##2##(2008-10#2)(2008-8#1)
tested since##2##2##(1996-5#1)(2013-1#1)
tested so far##2##3##(1997-4#1)(2008-7#1)
tested standard##2##2##(2008-10#1)(2008-3#1)
tested strains##3##2##(2008-10#2)(2011-2#1)
tested substances##3##2##(1992-5#1)(2008-10#1)(2008-5#1)
tested such##2##2##(2008-10#1)(2008-3#1)
tested that##7##2##(1992-11#1)(1993-2#1)(1994-8#1)(1997-2#1)(2008-10#3)
tested the ability of##6##4##(1990-5#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-5#1)
tested the effect of flupirtine##2##5##(1995-12#2)
tested the effect of##8##4##(1992-3#1)(1995-12#3)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
tested the effectiveness of##3##4##(1993-3#1)(2008-11#2)
tested the effects of##4##4##(1995-2#1)(2008-5#1)(2008-9#1)(2009-12#1)
tested the feasibility of##3##4##(2007-9#1)(2008-3#1)(2008-8#1)
tested the feasibility##4##3##(2007-9#1)(2008-3#1)(2008-8#1)(2013-1#1)
tested the hypothesis that the##7##5##(1992-8#1)(1993-6#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2012-3#1)
tested the hypothesis that##23##4##(1990-5#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-9#1)(2012-3#1)(2013-7#1)
tested the impact of##2##4##(1996-12#1)(1997-3#1)
tested the performance of##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
tested the potential##3##3##(1992-12#1)(2009-6#1)(2010-10#1)
tested the##91##2##(1990-10#1)(1990-5#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-12#5)(1995-2#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#2)(2007-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#6)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-8#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
tested their##2##2##(2011-2#2)
tested them##2##2##(1993-12#1)(2008-5#1)
tested these##2##2##(2008-8#1)(2012-3#1)
tested this prediction by##3##4##(2008-8#2)(2009-2#1)
tested this##10##2##(1991-9#1)(1992-11#1)(1993-6#1)(1997-3#1)(2008-8#3)(2009-2#1)(2009-8#2)
tested three##3##2##(1991-3#1)(2008-8#1)(2009-11#1)
tested through##7##2##(2008-10#1)(2008-2#1)(2008-5#2)(2010-10#1)(2011-2#1)(2013-8#1)
tested thus far##2##3##(1997-5#1)(2008-10#1)
tested tissues##2##2##(1990-12#1)(1997-4#1)
tested to date##2##3##(2008-10#1)(2010-4#1)
tested to determine##3##3##(1990-5#1)(1992-2#1)(2009-7#1)
tested to failure##2##3##(2008-9#2)
tested to##27##2##(1990-5#1)(1992-2#2)(1995-2#1)(1996-1#1)(1997-5#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-2#1)
tested two##2##2##(2008-8#1)(2008-9#1)
tested under similar conditions##2##4##(2007-11#1)(2009-7#1)
tested under##17##2##(1992-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-3#2)(2009-7#1)(2012-3#1)
tested using a##7##3##(1997-3#1)(2008-10#4)(2008-12#1)(2011-2#1)
tested using data##2##3##(2008-10#2)
tested using the##11##3##(1990-5#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#2)
tested using two##4##3##(1995-2#1)(2006-4#1)(2008-10#2)
tested using##47##2##(1990-2#1)(1990-5#2)(1992-9#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-3#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)
tested vaccines##2##2##(1995-5#2)
tested via##2##2##(2008-10#1)(2012-12#1)
tested was found##2##3##(2008-6#1)(2010-5#1)
tested was observed##3##3##(2008-10#2)(2008-11#1)
tested was##15##2##(1992-8#1)(1994-12#1)(1997-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-6#1)(2010-5#1)(2013-1#1)
tested were highly##2##3##(2008-10#2)
tested were inhibited##2##3##(2008-10#2)
tested were sensitive##2##3##(2008-10#2)
tested were susceptible##3##3##(2008-10#2)(2008-5#1)
tested were##25##2##(1992-6#1)(1992-9#1)(1994-8#1)(2008-1#1)(2008-10#15)(2008-5#2)(2008-6#1)(2009-5#1)(2009-7#1)(2011-2#1)
tested when compared to##2##4##(1990-6#1)(2008-10#1)
tested when##3##2##(1990-6#1)(2008-10#2)
tested whether the##2##3##(1992-12#1)(2008-9#1)
tested whether##17##2##(1992-12#1)(1993-9#1)(1994-3#1)(1994-8#2)(1996-12#1)(2008-6#1)(2008-9#1)(2009-9#2)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
tested while##2##2##(1994-9#1)(2008-10#1)
tested with a##5##3##(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
tested with pure##2##3##(1997-6#1)(2013-1#1)
tested with the##7##3##(1992-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
tested with##68##2##(1990-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#3)(1996-2#2)(1996-8#1)(1997-6#1)(2007-10#1)(2007-7#2)(2007-9#2)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#5)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#3)
tested##1824##1##(1990-10#2)(1990-11#8)(1990-12#8)(1990-2#6)(1990-3#4)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#8)(1991-5#2)(1991-6#7)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#7)(1992-12#3)(1992-2#8)(1992-3#10)(1992-5#1)(1992-6#6)(1992-8#9)(1992-9#6)(1993-11#2)(1993-12#15)(1993-2#3)(1993-3#12)(1993-5#1)(1993-6#12)(1993-8#2)(1993-9#6)(1994-1#1)(1994-11#7)(1994-12#8)(1994-2#4)(1994-3#9)(1994-5#2)(1994-6#5)(1994-8#18)(1994-9#3)(1995-11#3)(1995-12#17)(1995-2#12)(1995-3#10)(1995-5#8)(1995-6#10)(1995-8#4)(1996-1#1)(1996-12#12)(1996-2#8)(1996-3#3)(1996-4#1)(1996-5#10)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#5)(1997-3#10)(1997-4#8)(1997-5#8)(1997-6#5)(1997-7#7)(2006-11#1)(2006-4#1)(2007-10#6)(2007-11#17)(2007-12#11)(2007-3#1)(2007-5#1)(2007-6#4)(2007-7#13)(2007-8#4)(2007-9#4)(2008-1#12)(2008-10#626)(2008-11#59)(2008-12#33)(2008-2#37)(2008-3#79)(2008-4#10)(2008-5#83)(2008-6#20)(2008-7#37)(2008-8#42)(2008-9#31)(2009-1#1)(2009-10#2)(2009-11#8)(2009-12#6)(2009-2#5)(2009-3#4)(2009-5#6)(2009-6#3)(2009-7#14)(2009-8#9)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#10)(2010-4#11)(2010-5#5)(2010-6#2)(2010-8#10)(2011-1#21)(2011-2#48)(2011-3#2)(2012-1#7)(2012-12#6)(2012-2#11)(2012-3#17)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#51)(2013-7#3)(2013-8#16)
tested)##3##1##(2008-10#3)
tester amplicons##2##2##(2008-2#2)
tester isolate##3##2##(2008-10#3)
tester isolates##6##2##(2008-10#6)
tester strain##2##2##(1992-2#1)(2008-10#1)
tester strains and##2##3##(2008-10#1)(2008-12#1)
tester strains of##3##3##(2008-10#3)
tester strains##8##2##(1991-12#1)(2008-10#5)(2008-12#1)(2011-1#1)
tester with##2##2##(2007-11#1)(2012-2#1)
tester##44##1##(1991-12#1)(1992-2#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#9)(2008-5#3)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
testers##6##1##(2008-10#3)(2008-3#2)(2008-5#1)
testes and##6##2##(1990-2#1)(1990-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
testes in##2##2##(2008-10#1)(2008-12#1)
testes of##5##2##(2008-12#1)(2008-5#2)(2008-7#1)(2013-1#1)
testes or##2##2##(1990-11#1)(1993-12#1)
testes weight and##2##3##(2008-5#2)
testes weight##3##2##(2008-5#2)(2013-7#1)
testes were##3##2##(1992-12#2)(2008-9#1)
testes##50##1##(1990-11#1)(1990-2#1)(1990-7#1)(1992-12#2)(1993-12#2)(1993-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#5)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#6)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#3)
testicle##3##1##(2008-10#3)
testicles##7##1##(2008-10#3)(2008-12#1)(2012-12#2)(2013-1#1)
testicular biopsy##2##2##(1990-9#1)(1997-3#1)
testicular cancer and##2##3##(1996-5#1)(2009-5#1)
testicular cancer##17##2##(1990-2#1)(1990-9#1)(1992-5#1)(1992-6#1)(1994-7#1)(1996-5#1)(2007-5#2)(2008-11#1)(2008-7#2)(2009-5#6)
testicular descent##2##2##(2008-10#2)
testicular function##5##2##(1992-12#1)(2009-10#1)(2011-2#2)(2013-8#1)
testicular germ##2##2##(2008-10#1)(2012-2#1)
testicular hyaluronidase##4##2##(1994-5#4)
testicular lipid peroxidation##2##3##(2008-10#1)(2011-2#1)
testicular shield##3##2##(2009-11#3)
testicular sperm##3##2##(2008-5#2)(2012-3#1)
testicular spermatogenesis##3##2##(2008-7#2)(2009-10#1)
testicular tissue##3##2##(2008-10#1)(2013-1#2)
testicular torsion##7##2##(2008-10#7)
testicular tumor##2##2##(1996-5#1)(2008-10#1)
testicular tumors##3##2##(1990-9#1)(1992-5#1)(2008-10#1)
testicular tumours##4##2##(1996-8#1)(2011-2#3)
testicular volumes##2##2##(1993-3#2)
testicular##111##1##(1990-2#1)(1990-5#1)(1990-9#6)(1991-2#1)(1992-12#2)(1992-5#2)(1992-6#1)(1993-12#2)(1993-3#3)(1994-11#1)(1994-5#4)(1994-7#2)(1995-5#1)(1995-6#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-5#6)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2009-10#5)(2009-11#3)(2009-5#8)(2010-5#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
testified##4##1##(2008-10#1)(2008-8#2)(2011-3#1)
testify the##3##2##(2008-10#2)(2013-1#1)
testify to the##4##3##(2007-12#1)(2008-10#3)
testify##8##1##(2007-12#1)(2008-10#5)(2008-11#1)(2013-1#1)
testifying##3##1##(2008-1#1)(2008-10#1)(2008-7#1)
testimonials##2##1##(2008-7#1)(2008-9#1)
testimony in the criminal proceedings##2##5##(2011-2#2)
testimony in##3##2##(1992-2#1)(2011-2#2)
testimony of##2##2##(1996-2#1)(2008-10#1)
testimony on##2##2##(1992-3#1)(2011-2#1)
testimony to the##2##3##(2008-9#1)(2009-10#1)
testimony##15##1##(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2011-2#6)
testing a##5##2##(1996-2#1)(1997-3#1)(2008-10#2)(2013-8#1)
testing accuracy##2##2##(2008-8#2)
testing algorithm##2##2##(1997-2#1)(2008-10#1)
testing and prevention##2##3##(2009-5#1)(2011-2#1)
testing and the##3##3##(2008-3#1)(2008-8#1)(2010-6#1)
testing and treatment##5##3##(1997-2#3)(2007-10#1)(2011-2#1)
testing and validation##2##3##(2008-10#2)
testing and##63##2##(1990-6#1)(1991-2#1)(1993-3#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#3)(1997-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-8#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
testing approaches##2##2##(1994-2#1)(2012-3#1)
testing are##4##2##(1994-2#1)(2008-11#1)(2008-4#1)(2013-1#1)
testing as the##2##3##(2008-12#1)(2008-5#1)
testing as well as##2##4##(2008-4#1)(2009-5#1)
testing as##7##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)
testing at the##2##3##(1994-12#1)(1997-4#1)
testing at##7##2##(1991-7#1)(1994-12#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-2#1)
testing based on##2##3##(2008-3#1)(2008-9#1)
testing by##14##2##(1994-1#1)(1994-6#1)(2007-9#1)(2008-10#1)(2008-12#4)(2008-9#3)(2013-1#2)(2013-8#1)
testing can be##5##3##(1992-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-8#1)
testing can##8##2##(1992-6#1)(1994-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#2)
testing conditions##2##2##(1992-11#2)
testing data##4##2##(2008-5#1)(2013-1#3)
testing device##2##2##(2008-3#1)(2010-4#1)
testing did not##2##3##(2008-9#1)(2011-2#1)
testing drugs##2##2##(2008-11#1)(2009-3#1)
testing during the##3##3##(1995-11#1)(2011-1#2)
testing during##4##2##(1995-11#1)(2008-5#1)(2011-1#2)
testing for HIV##3##3##(1996-5#1)(2007-12#1)(2013-1#1)
testing for SIP##2##3##(1993-6#2)
testing for a##3##3##(2008-3#1)(2008-8#1)(2012-3#1)
testing for the##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
testing for##41##2##(1990-6#1)(1993-6#2)(1994-1#1)(1994-2#1)(1996-10#1)(1996-5#1)(1996-6#3)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
testing has shown##2##3##(1996-2#1)(2007-8#1)
testing has##10##2##(1996-2#1)(2007-8#1)(2008-4#1)(2008-6#2)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
testing have##2##2##(2008-10#2)
testing in a##2##3##(1991-12#1)(2008-12#1)
testing in an##2##3##(2008-3#2)
testing in non-rodent species##2##4##(2008-10#2)
testing in patients with##2##4##(2007-5#1)(2009-6#1)
testing in patients##3##3##(2007-5#1)(2008-7#1)(2009-6#1)
testing in the clinical##3##4##(1994-1#2)(2009-7#1)
testing in the##10##3##(1994-1#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#1)(2011-2#1)
testing in##44##2##(1990-9#1)(1991-1#1)(1991-12#1)(1994-1#2)(1994-9#2)(1995-5#1)(1995-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)
testing is##20##2##(1994-2#1)(1995-9#1)(1996-11#1)(1996-6#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
testing its##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
testing machine##9##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#1)
testing may##6##2##(1994-1#1)(2007-7#2)(2008-10#2)(2009-4#1)
testing method##6##2##(1990-11#1)(2008-10#2)(2008-2#1)(2011-2#2)
testing methodologies##3##2##(2008-10#1)(2008-5#2)
testing methods and##2##3##(2009-5#1)(2010-7#1)
testing methods for##2##3##(2008-3#1)(2012-3#1)
testing methods##8##2##(1995-1#1)(2007-8#1)(2008-3#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
testing mice##2##2##(2008-10#1)(2008-4#1)
testing new##3##2##(1996-6#1)(2008-10#1)(2012-12#1)
testing of a##11##3##(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-2#1)
testing of bone##2##3##(2007-8#1)(2009-4#1)
testing of children##3##3##(2010-7#1)(2011-2#2)
testing of closed-loop##2##3##(2009-9#2)
testing of rotationally symmetric aspheres##2##5##(2008-3#2)
testing of sunscreens against##2##4##(2008-5#2)
testing of sunscreens##3##3##(2008-5#3)
testing of the##17##3##(1994-6#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#3)(2010-6#1)
testing of this##2##3##(2008-2#1)(2009-7#1)
testing of##139##2##(1990-3#1)(1990-8#1)(1991-1#1)(1992-2#1)(1992-3#2)(1993-3#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#23)(2008-4#5)(2008-5#10)(2008-7#1)(2008-8#1)(2008-9#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#3)(2009-9#2)(2010-10#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-2#2)(2013-1#1)
testing on##4##2##(1996-2#1)(2008-3#1)(2008-6#2)
testing or##3##2##(1994-6#1)(2008-9#1)(2009-5#1)
testing performed##3##2##(1994-8#1)(1994-9#1)(1995-1#1)
testing period##2##2##(1997-2#1)(2013-8#1)
testing procedure##4##2##(1990-11#1)(1995-9#1)(2008-4#1)(2008-5#1)
testing procedures have##2##3##(2008-12#1)(2011-2#1)
testing procedures##8##2##(1993-3#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-9#2)(2011-2#1)
testing program##4##2##(1997-1#1)(2009-5#3)
testing protocol##3##2##(1994-2#2)(2008-8#1)
testing protocols##2##2##(1994-2#1)(2008-5#1)
testing requirement##2##2##(1997-5#1)(2012-2#1)
testing requires##2##2##(1997-1#1)(1997-3#1)
testing results##4##2##(1995-9#1)(2008-2#1)(2010-5#1)(2011-1#1)
testing revealed that##3##3##(2008-10#2)(2008-12#1)
testing revealed##5##2##(1997-5#1)(2008-10#2)(2008-12#1)(2008-8#1)
testing sessions##2##2##(2008-5#2)
testing several##2##2##(2008-11#1)(2008-5#1)
testing should be##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
testing shows##2##2##(2009-11#1)(2011-2#1)
testing stage##2##2##(1997-6#1)(2008-10#1)
testing strategies##2##2##(2008-10#1)(2008-6#1)
testing system##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
testing the relationship between##2##4##(2008-10#1)(2008-9#1)
testing the##33##2##(1990-11#1)(1994-6#1)(1996-3#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
testing their##2##2##(2008-10#1)(2008-7#1)
testing time##2##2##(1992-3#1)(1994-3#1)
testing to be##2##3##(1992-9#1)(1997-1#1)
testing to identify##2##3##(2012-2#2)
testing to##11##2##(1992-9#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#2)(2012-3#1)
testing using##2##2##(1994-1#1)(2008-6#1)
testing was conducted##2##3##(2008-3#1)(2010-10#1)
testing was not##2##3##(1996-3#1)(2010-3#1)
testing was performed##5##3##(1995-3#1)(2007-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
testing was##17##2##(1993-11#1)(1994-6#2)(1994-8#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-3#1)(2012-2#1)(2012-3#1)
testing were##5##2##(1993-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)
testing when##2##2##(1992-4#1)(1997-2#1)
testing where##2##2##(2008-1#1)(2008-3#1)
testing whether##2##2##(2007-7#1)(2008-6#1)
testing which##2##2##(2008-12#1)(2008-5#1)
testing will##2##2##(1997-1#1)(2008-5#1)
testing with circular gratings##2##4##(2008-3#2)
testing with the##4##3##(2008-5#1)(2008-9#1)(2010-10#1)(2013-8#1)
testing with##14##2##(2007-7#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
testing##1000##1##(1990-11#3)(1990-12#2)(1990-3#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#7)(1993-8#2)(1993-9#1)(1994-1#6)(1994-11#3)(1994-12#6)(1994-2#12)(1994-3#4)(1994-6#9)(1994-8#2)(1994-9#5)(1995-1#5)(1995-11#2)(1995-12#4)(1995-3#1)(1995-5#4)(1995-6#4)(1995-9#7)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#9)(1996-3#10)(1996-4#3)(1996-5#17)(1996-6#9)(1996-8#2)(1997-1#4)(1997-2#11)(1997-3#4)(1997-4#2)(1997-5#6)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#7)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#10)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#125)(2008-11#27)(2008-12#32)(2008-2#15)(2008-3#66)(2008-4#32)(2008-5#55)(2008-6#12)(2008-7#18)(2008-8#20)(2008-9#30)(2009-10#3)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#5)(2009-4#7)(2009-5#18)(2009-6#1)(2009-7#9)(2009-8#4)(2009-9#6)(2010-1#2)(2010-10#9)(2010-11#3)(2010-12#2)(2010-2#11)(2010-3#5)(2010-4#8)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#10)(2011-1#21)(2011-2#46)(2011-8#1)(2012-12#9)(2012-2#32)(2012-3#16)(2013-1#32)(2013-8#16)
testing&quot##4##1##(1995-3#1)(2008-10#1)(2011-2#2)
testings##4##1##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
testis and ovary##4##3##(2008-7#3)(2009-7#1)
testis and##19##2##(1990-11#1)(1991-1#1)(1992-12#1)(1993-11#1)(1995-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2011-2#2)(2013-8#1)
testis are##3##2##(1990-2#1)(2008-10#1)(2008-4#1)
testis as##2##2##(2008-10#1)(2009-10#1)
testis by##2##2##(2008-9#1)(2010-5#1)
testis cDNA library##4##3##(1991-1#1)(1994-11#1)(1995-6#1)(2008-9#1)
testis has##2##2##(2008-7#1)(2009-10#1)
testis in##2##2##(2008-10#1)(2012-2#1)
testis of##3##2##(1992-12#1)(2008-7#2)
testis showed##2##2##(1997-3#1)(2008-8#1)
testis was##7##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
testis weights in##2##3##(2008-9#2)
testis weights##3##2##(2008-9#3)
testis were##2##2##(1992-12#1)(2008-9#1)
testis which##2##2##(1995-8#1)(2012-2#1)
testis##153##1##(1990-11#1)(1990-2#3)(1990-5#2)(1990-9#1)(1991-1#3)(1991-6#1)(1992-12#8)(1992-6#2)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#5)(1995-11#1)(1995-3#1)(1995-6#3)(1995-8#6)(1996-2#1)(1997-3#4)(1997-8#1)(2007-5#2)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#9)(2009-11#1)(2009-7#2)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#15)(2013-1#1)(2013-7#1)(2013-8#2)
testis-expressed##2##1##(2010-5#1)(2012-2#1)
testis-specific atypical##2##2##(2012-2#2)
testis-specific##5##1##(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#2)
testosterone (FT)##2##2##(2008-5#1)(2013-1#1)
testosterone (T) and##2##3##(1990-11#1)(1996-2#1)
testosterone (T)##8##2##(1990-11#2)(1991-5#1)(1994-11#1)(1996-2#1)(2008-1#1)(2008-3#1)(2009-7#1)
testosterone 5 alpha-reductase 2##2##4##(1994-11#2)
testosterone 5 alpha-reductase##3##3##(1990-11#1)(1994-11#2)
testosterone 6 beta-hydroxylase##2##3##(1991-5#2)
testosterone and##10##2##(1990-11#1)(1992-5#1)(1992-8#1)(1993-8#1)(1995-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-12#2)
testosterone by##2##2##(1990-11#1)(1990-2#1)
testosterone concentrations##2##2##(2008-9#1)(2013-8#1)
testosterone ester##2##2##(1995-2#2)
testosterone esters##4##2##(1995-2#4)
testosterone glucuronidation##2##2##(1990-12#1)(1992-8#1)
testosterone hormone##2##2##(2008-10#1)(2008-12#1)
testosterone in the##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
testosterone in##9##2##(1995-2#1)(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#2)
testosterone is##4##2##(1990-6#1)(2008-4#1)(2008-9#1)(2012-3#1)
testosterone level##2##2##(2008-12#1)(2008-5#1)
testosterone levels##8##2##(1990-5#1)(1990-6#2)(1995-2#1)(1995-3#1)(2008-5#1)(2011-2#2)
testosterone or##2##2##(2012-2#1)(2013-8#1)
testosterone propionate##2##2##(1990-11#1)(1991-12#1)
testosterone signals##2##2##(2012-2#2)
testosterone to##3##2##(1993-8#1)(2008-2#1)(2012-12#1)
testosterone treatment##3##2##(1994-2#1)(1996-5#1)(1996-8#1)
testosterone was##2##2##(1992-12#1)(2008-10#1)
testosterone with##2##2##(1990-11#1)(2008-10#1)
testosterone##159##1##(1990-11#14)(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#3)(1991-12#2)(1991-3#1)(1991-5#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#5)(1993-8#3)(1994-11#3)(1994-2#5)(1994-3#1)(1994-6#2)(1995-12#6)(1995-2#10)(1995-3#1)(1996-2#2)(1996-5#6)(1996-8#1)(2008-1#2)(2008-10#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#14)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-4#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#3)
testosterone's##2##1##(2008-8#2)
testosterone-induced##2##1##(2008-5#1)(2012-3#1)
testosterone-treated males##2##2##(2008-8#2)
tests a##2##2##(1993-1#1)(2010-10#1)
tests after##5##2##(1991-8#1)(2007-11#1)(2008-7#2)(2010-5#1)
tests allow##2##2##(2008-1#1)(2008-9#1)
tests also##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
tests and a##3##3##(1996-12#1)(1997-3#1)(2008-12#1)
tests and clinical##2##3##(2008-8#1)(2011-2#1)
tests and enzyme-linked##2##3##(1993-2#1)(1995-11#1)
tests and estimates##3##3##(1994-9#2)(2011-1#1)
tests and in##3##3##(2008-10#3)
tests and the##7##3##(1992-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
tests and their##3##3##(2008-10#2)(2011-3#1)
tests and to##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
tests and##86##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-8#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#4)(1994-9#2)(1995-11#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-2#3)(2007-7#1)(2008-10#19)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#1)
tests applied##2##2##(2008-10#1)(2008-5#1)
tests are available##3##3##(1990-6#1)(1993-2#1)(1997-2#1)
tests are conducted##2##3##(1994-7#1)(2009-7#1)
tests are not##4##3##(1993-12#2)(1995-1#1)(2010-3#1)
tests are only##2##3##(2007-2#1)(2012-2#1)
tests are used to##2##4##(2008-4#1)(2008-7#1)
tests are used##3##3##(2008-4#1)(2008-7#1)(2009-4#1)
tests are useful##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
tests are##50##2##(1990-2#1)(1990-6#1)(1991-11#1)(1993-12#2)(1993-2#1)(1994-7#1)(1995-1#1)(1996-4#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
tests as well as##2##4##(1993-12#1)(1995-6#1)
tests as##3##2##(1993-12#1)(1995-6#1)(2008-10#1)
tests at 12 months##2##4##(2008-9#1)(2013-1#1)
tests at the##2##3##(1991-6#1)(2013-1#1)
tests at##6##2##(1991-6#1)(2008-10#2)(2008-9#1)(2013-1#2)
tests available##2##2##(2008-2#1)(2008-5#1)
tests based on Vibrio fischeri##2##5##(2008-10#2)
tests based on the##7##4##(1996-3#1)(2008-10#5)(2012-3#1)
tests based on##14##3##(1996-3#1)(2008-10#7)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
tests can be considered##2##4##(1994-9#1)(2008-10#1)
tests can be used to##2##5##(2008-10#1)(2008-12#1)
tests can be used##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
tests can be##5##3##(1994-9#1)(2008-10#2)(2008-12#1)(2008-4#1)
tests can##11##2##(1993-3#1)(1994-9#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)
tests carried out in##2##4##(1993-3#1)(2008-3#1)
tests carried out##8##3##(1993-3#2)(1994-6#1)(2008-10#4)(2008-3#1)
tests conducted in the##2##4##(2008-3#1)(2008-9#1)
tests conducted##5##2##(1996-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
tests confirmed that the##2##4##(1991-2#1)(2008-10#1)
tests confirmed that##3##3##(1991-2#1)(2008-10#2)
tests confirmed the##3##3##(1992-6#1)(2007-12#1)(2008-10#1)
tests confirmed##9##2##(1991-2#1)(1992-6#1)(2007-12#1)(2008-10#5)(2011-2#1)
tests demonstrated that the##2##4##(2008-10#1)(2008-9#1)
tests demonstrated that##3##3##(2008-10#2)(2008-9#1)
tests demonstrated the##2##3##(2008-5#1)(2008-9#1)
tests demonstrated##8##2##(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#3)
tests did not##3##3##(1997-8#1)(2008-3#1)(2008-7#1)
tests do not##3##3##(1994-3#1)(1996-3#1)(2006-10#1)
tests done##2##2##(2008-10#1)(2012-2#1)
tests during##4##2##(1991-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
tests for a correct##2##4##(1991-5#1)(1991-6#1)
tests for comparing##2##3##(1992-9#1)(1997-4#1)
tests for malaria diagnosis##2##4##(2007-2#2)
tests for the detection of##5##5##(1991-3#2)(2008-10#2)(2008-11#1)
tests for the##17##3##(1990-9#1)(1991-3#2)(1994-9#1)(1995-2#2)(1995-5#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
tests for##65##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-2#3)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(2007-2#2)(2007-7#3)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
tests had##3##2##(1991-5#1)(1997-7#1)(2011-2#1)
tests has been##2##3##(2008-9#1)(2012-3#1)
tests has##3##2##(1991-11#1)(2008-9#1)(2012-3#1)
tests have been performed##2##4##(1994-6#1)(2012-2#1)
tests have been##8##3##(1993-8#1)(1994-6#1)(1997-1#1)(2007-2#1)(2008-10#2)(2010-12#1)(2012-2#1)
tests have limitations either in detecting pinholes and/or they are difficult to implement for routine testing##2##16##(2012-2#2)
tests have##19##2##(1991-9#1)(1993-8#1)(1994-6#1)(1996-11#1)(1997-1#1)(2007-2#2)(2008-10#5)(2008-12#1)(2008-5#1)(2010-12#1)(2012-2#3)(2013-8#1)
tests in a##2##3##(1996-12#1)(1997-2#1)
tests in order to##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
tests in the##8##3##(1991-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
tests in which##3##3##(2008-10#2)(2008-3#1)
tests in##46##2##(1991-1#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-7#2)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-8#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
tests include the##2##3##(1992-6#1)(2008-1#1)
tests include##3##2##(1992-6#1)(2008-1#1)(2010-10#1)
tests including##2##2##(2008-12#1)(2011-2#1)
tests indicate that##2##3##(2008-10#1)(2010-4#1)
tests indicate##4##2##(2007-2#1)(2008-10#1)(2009-7#1)(2010-4#1)
tests indicated a##2##3##(1996-12#1)(2008-6#1)
tests indicated that the##3##4##(2008-10#1)(2009-11#1)(2013-1#1)
tests indicated that##5##3##(1991-12#1)(2008-10#2)(2009-11#1)(2013-1#1)
tests indicated##8##2##(1991-12#1)(1996-12#1)(2008-10#2)(2008-6#1)(2009-11#1)(2013-1#1)(2013-8#1)
tests involving##2##2##(2008-3#1)(2008-7#1)
tests is##8##2##(1997-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2013-1#1)
tests may##4##2##(2007-11#1)(2011-2#1)(2013-1#2)
tests more##2##2##(2007-12#1)(2011-1#1)
tests must be performed##2##4##(1996-6#1)(2007-11#1)
tests of a##5##3##(1995-8#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
tests of association##3##3##(1995-12#1)(2012-3#2)
tests of cognitive function##2##4##(1993-5#1)(1995-11#1)
tests of executive function##2##4##(1995-11#2)
tests of liver function##3##4##(1992-12#2)(1992-5#1)
tests of memory and##2##4##(1991-5#1)(2012-1#1)
tests of the##9##3##(1996-9#1)(1997-5#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)(2011-2#1)
tests of their##2##3##(1993-3#1)(2008-9#1)
tests of##91##2##(1990-3#3)(1991-3#1)(1991-5#2)(1992-12#2)(1992-5#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1994-2#1)(1995-11#5)(1995-12#1)(1995-2#2)(1995-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
tests on the##5##3##(2006-12#1)(2008-3#1)(2008-5#2)(2010-12#1)
tests on two##2##3##(1992-3#1)(2008-12#1)
tests on##28##2##(1992-3#1)(1992-6#1)(1992-8#1)(1996-12#2)(2006-12#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-9#1)(2009-4#1)(2010-12#1)(2012-12#1)
tests or##2##2##(2010-11#1)(2012-3#1)
tests over##2##2##(1996-9#1)(2010-10#1)
tests per##2##2##(1990-9#1)(2008-5#1)
tests performed on##4##3##(2007-11#1)(2008-5#2)(2011-2#1)
tests performed##10##2##(1994-9#1)(1996-11#1)(2007-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
tests provide##3##2##(2008-2#1)(2013-1#2)
tests provided##2##2##(2008-10#2)
tests required to##2##3##(1996-1#1)(2008-8#1)
tests results##2##2##(2008-5#1)(2013-8#1)
tests reveal that##2##3##(1994-1#1)(2008-10#1)
tests revealed a##2##3##(1990-6#1)(2008-10#1)
tests revealed that##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
tests revealed##9##2##(1990-6#1)(2007-5#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#2)
tests run##2##2##(2008-10#1)(2008-3#1)
tests should be performed##2##4##(2008-7#1)(2009-8#1)
tests should##3##2##(1997-3#1)(2008-7#1)(2009-8#1)
tests show that the##2##4##(1992-3#1)(2013-1#1)
tests show that##7##3##(1992-3#1)(1995-6#1)(2007-11#1)(2008-3#2)(2009-12#1)(2013-1#1)
tests show##8##2##(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-12#1)(2013-1#1)
tests showed that##7##3##(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
tests showed##16##2##(1990-6#1)(1991-3#1)(1992-3#1)(1992-9#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
tests such as the##4##4##(1994-2#1)(2007-8#1)(2008-11#1)(2011-2#1)
tests that can##2##3##(2008-12#1)(2010-1#1)
tests that compared areas##2##4##(1997-3#2)
tests that##15##2##(1991-2#1)(1993-3#1)(1995-12#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2010-1#1)(2013-1#2)
tests the##7##2##(1990-3#1)(1990-6#1)(1991-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
tests to assess##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
tests to##23##2##(1990-3#1)(1991-12#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
tests used for##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
tests used in##2##3##(2008-12#1)(2011-2#1)
tests used to##3##3##(1996-11#1)(1997-3#1)(2010-7#1)
tests used##12##2##(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)
tests using##8##2##(1993-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
tests was varied by##2##4##(2009-11#2)
tests was##12##2##(1991-6#1)(1992-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
tests were administered##2##3##(2008-12#1)(2008-7#1)
tests were also##4##3##(1993-8#1)(2008-10#1)(2013-1#2)
tests were applied##2##3##(2008-10#1)(2013-1#1)
tests were carried out to##2##5##(2008-5#1)(2013-1#1)
tests were carried out##5##4##(2008-5#4)(2013-1#1)
tests were compared##2##3##(2007-2#1)(2008-7#1)
tests were conducted at##3##4##(2008-10#3)
tests were conducted on##2##4##(2008-10#2)
tests were conducted##9##3##(2008-10#7)(2008-6#1)(2008-8#1)
tests were done##3##3##(1996-3#1)(2008-5#1)(2008-6#1)
tests were normal##4##3##(2007-12#1)(2007-2#1)(2008-7#1)(2012-12#1)
tests were performed in##3##4##(1991-4#1)(2008-5#1)(2012-12#1)
tests were performed on##4##4##(2008-10#2)(2008-5#1)(2009-4#1)
tests were performed##14##3##(1991-4#1)(1996-2#1)(2007-8#1)(2008-10#3)(2008-12#3)(2008-5#2)(2009-4#1)(2011-1#1)(2012-12#1)
tests were significantly##3##3##(1991-6#1)(2008-5#1)(2013-1#1)
tests were used to assess the##2##6##(1994-11#1)(2008-5#1)
tests were used to##4##4##(1994-11#1)(1994-3#1)(2008-5#1)(2011-1#1)
tests were used##6##3##(1994-11#1)(1994-3#1)(1996-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
tests were##80##2##(1991-4#1)(1991-6#2)(1992-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-10#13)(2008-12#5)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
tests whether the##2##3##(1995-2#1)(2010-2#1)
tests which##4##2##(1992-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
tests with functional endpoints for the##2##6##(2008-11#2)
tests with##37##2##(1990-5#1)(1991-6#1)(1992-9#1)(1995-12#1)(1995-5#2)(2008-10#12)(2008-11#4)(2008-3#3)(2008-5#2)(2009-8#1)(2009-9#1)(2011-2#2)(2011-7#1)(2013-1#5)
tests##1226##1##(1990-2#2)(1990-3#10)(1990-5#1)(1990-6#7)(1990-8#2)(1990-9#8)(1991-1#2)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#7)(1991-4#2)(1991-5#4)(1991-6#14)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#6)(1992-2#3)(1992-3#5)(1992-5#3)(1992-6#11)(1992-8#1)(1992-9#7)(1993-1#2)(1993-12#6)(1993-2#5)(1993-3#14)(1993-5#3)(1993-6#4)(1993-8#4)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#10)(1994-6#6)(1994-7#1)(1994-8#5)(1994-9#8)(1995-1#1)(1995-11#6)(1995-12#5)(1995-2#9)(1995-3#2)(1995-5#6)(1995-6#4)(1995-8#1)(1996-1#3)(1996-11#7)(1996-12#13)(1996-2#7)(1996-3#7)(1996-4#2)(1996-6#4)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#12)(1997-4#7)(1997-5#6)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#10)(2007-12#9)(2007-2#18)(2007-5#1)(2007-6#1)(2007-7#22)(2007-8#7)(2008-1#8)(2008-10#271)(2008-11#24)(2008-12#34)(2008-2#15)(2008-3#36)(2008-4#11)(2008-5#60)(2008-6#12)(2008-7#30)(2008-8#16)(2008-9#38)(2009-10#1)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#3)(2009-7#5)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#11)(2011-2#44)(2011-3#2)(2011-7#2)(2011-8#1)(2012-1#4)(2012-12#9)(2012-2#29)(2012-3#27)(2012-4#1)(2012-7#1)(2013-1#55)(2013-7#3)(2013-8#15)
tests) and##2##2##(2008-8#1)(2012-3#1)
tests) in##2##2##(2008-10#1)(2008-11#1)
tests) that##2##2##(2011-1#1)(2011-2#1)
tests)##15##1##(1994-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
tests--are##2##1##(1990-3#1)(1991-3#1)
tests]##2##1##(1992-4#1)(1996-3#1)
testudinum in the##2##3##(2008-5#2)
testudinum##11##1##(2007-5#5)(2008-5#5)(2011-2#1)
tet##2##1##(1993-12#1)(1994-12#1)
tetanic stimulation##4##2##(1991-12#1)(1993-12#1)(2008-7#2)
tetanic tension##2##2##(2008-3#2)
tetanic##8##1##(1991-12#1)(1993-12#1)(2008-3#2)(2008-7#2)(2012-7#1)(2013-8#1)
tetanization##3##1##(1995-12#1)(1995-5#2)
tetanus and diphtheria##2##3##(1992-2#1)(1994-8#1)
tetanus and pertussis##2##3##(1992-2#1)(2007-11#1)
tetanus and##5##2##(1992-2#2)(1994-8#1)(2007-11#1)(2009-5#1)
tetanus toxin##7##2##(1995-2#2)(2008-10#3)(2008-5#2)
tetanus toxoid##5##2##(1992-2#1)(2009-5#1)(2011-2#3)
tetanus##41##1##(1990-8#1)(1992-2#7)(1992-5#1)(1993-12#1)(1994-8#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-6#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-5#2)(2009-5#3)(2009-9#2)(2011-2#3)(2012-3#2)(2013-1#1)
tetany##2##1##(2012-7#1)(2013-8#1)
tether##3##1##(1990-2#1)(1996-5#1)(2008-9#1)
tethered cord syndrome##4##3##(2008-7#3)(2009-3#1)
tethered vagina syndrome##2##3##(2012-3#2)
tethered##16##1##(1992-4#1)(2008-11#4)(2008-7#4)(2009-12#1)(2009-3#1)(2009-5#2)(2012-2#1)(2012-3#2)
tetherin##5##1##(2013-1#5)
tethering of##2##2##(2012-12#1)(2012-2#1)
tethering##9##1##(1992-6#1)(2008-3#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#2)
tethers to##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
tethers##5##1##(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)
tetra##6##1##(2008-10#4)(2008-8#1)(2009-12#1)
tetra-##2##1##(1996-5#1)(2008-10#1)
tetra-3##3##1##(2008-10#3)
tetra-N-hexadecylpyridiniumyl porphyrin##2##2##(2008-10#2)
tetra-coordinate nickel(II) complex##2##3##(2008-10#2)
tetra-n-butylammonium##2##1##(2008-10#2)
tetra-nucleotides are##2##2##(2012-3#2)
tetra-nucleotides##4##1##(2012-3#4)
tetra-substituted amino aluminum phthalocyanine##2##4##(2008-10#2)
tetra-substituted##4##1##(2008-10#4)
tetraacetal##2##1##(1996-5#2)
tetraacetic acid##4##2##(2008-10#4)
tetraacetic##5##1##(2008-10#4)(2008-9#1)
tetraalkylammonium##3##1##(2008-10#3)
tetraaminophthalocyanine##2##1##(2008-10#2)
tetraantennary complex-type sugar chains##2##4##(1993-11#2)
tetrabenzyl##2##1##(2008-10#2)
tetraborate##4##1##(1994-9#1)(1996-5#1)(2008-10#1)(2008-2#1)
tetrabromophenolphthalein##2##1##(2008-10#2)
tetrabutyl ammonium bromide##2##3##(2008-10#2)
tetrabutylammonium (TBA)##2##2##(2008-10#2)
tetrabutylammonium bromide (TBABr)##2##3##(2008-10#2)
tetrabutylammonium bromide##8##2##(2008-10#8)
tetrabutylammonium fluoride##2##2##(2008-4#1)(2009-5#1)
tetrabutylammonium hydroxide in##2##3##(1990-5#1)(2007-11#1)
tetrabutylammonium hydroxide##4##2##(1990-5#1)(2007-11#1)(2008-10#2)
tetrabutylammonium perchlorate##2##2##(2008-10#2)
tetrabutylammonium periodate##3##2##(2008-10#3)
tetrabutylammonium##28##1##(1990-5#1)(1992-9#1)(1995-5#2)(2007-11#1)(2008-10#21)(2008-4#1)(2009-5#1)
tetracaine hydrochloride##5##2##(2008-10#5)
tetracarboxy aluminum phthalocyanine##2##3##(2008-10#2)
tetrachloride##30##1##(1991-9#1)(1992-3#2)(1992-6#1)(1995-3#13)(2007-11#1)(2007-12#1)(2008-10#7)(2009-8#1)(2010-2#1)(2010-5#1)(2013-1#1)
tetrachlorinated quinone##2##2##(2008-10#2)
tetrachloro-p-benzoquinone##2##1##(2008-10#2)
tetrachlorobenzoquinone reductase##2##2##(2009-3#2)
tetrachlorobenzoquinone##5##1##(2008-10#1)(2009-3#4)
tetrachlorodibenzo-p-dioxin (TCDD)##2##2##(2008-10#2)
tetrachloroethylene##4##1##(2008-10#3)(2012-12#1)
tetrachlorohydroquinone and##2##2##(2008-10#1)(2009-3#1)
tetrachlorohydroquinone##7##1##(2008-10#1)(2009-3#6)
tetrachloromethane##2##1##(2008-10#2)
tetrachloromethane)##2##1##(2008-10#2)
tetrachlorothallate##4##1##(2008-10#4)
tetracyanoethylene##2##1##(2008-10#2)
tetracyclic##4##1##(2008-10#1)(2009-10#2)(2013-7#1)
tetracyclin##2##1##(1997-8#1)(2008-12#1)
tetracycline (TC)##3##2##(2008-10#3)
tetracycline and##7##2##(2007-10#1)(2008-10#4)(2008-12#1)(2008-2#1)
tetracycline antibiotics in##3##3##(2008-10#3)
tetracycline antibiotics##6##2##(2008-10#6)
tetracycline in the##2##3##(2008-10#2)
tetracycline in##6##2##(1993-2#1)(2008-10#5)
tetracycline##59##1##(1991-8#1)(1993-11#1)(1993-2#2)(1994-12#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#32)(2008-11#4)(2008-12#2)(2008-2#2)(2008-7#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
tetracycline-inducible##2##1##(2008-11#1)(2012-2#1)
tetracycline-regulated##2##1##(2008-11#1)(2008-2#1)
tetracyclines in surface water samples##2##5##(2008-10#2)
tetracyclines in##5##2##(2008-10#5)
tetracyclines##11##1##(1990-6#1)(1996-3#1)(2008-10#9)
tetradactylum on the##2##3##(2010-8#2)
tetradactylum##5##1##(2010-8#5)
tetradentate##3##1##(1997-7#1)(2008-10#2)
tetrads##3##1##(2008-10#2)(2012-3#1)
tetraether lipid##2##2##(1990-2#2)
tetraether##3##1##(1990-2#3)
tetraethoxysilane##2##1##(2008-3#1)(2008-5#1)
tetraethyl##3##1##(2008-10#2)(2010-11#1)
tetraethylammonium (TEA)##2##2##(1996-5#1)(2008-8#1)
tetraethylammonium##10##1##(1990-5#1)(1994-11#1)(1994-12#1)(1996-5#1)(2007-10#1)(2008-10#4)(2008-8#1)
tetraethylenepentamine##3##1##(2008-10#3)
tetraethylorthosilicate (TEOS)##3##2##(2008-10#3)
tetraethylorthosilicate##5##1##(2008-10#4)(2008-5#1)
tetrafluoroborate##2##1##(2008-10#2)
tetrafunctional##3##1##(2008-2#3)
tetragonal zirconia##3##2##(2008-10#3)
tetragonal##14##1##(1996-2#3)(1997-7#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)
tetragonus##2##1##(2008-10#2)
tetrahedra##4##1##(1997-7#1)(2011-2#3)
tetrahedral mesh##2##2##(2011-2#2)
tetrahedral##15##1##(1992-3#2)(1992-5#1)(1993-11#4)(1996-2#2)(1997-7#1)(2008-3#1)(2008-6#1)(2011-2#3)
tetrahedrally##2##1##(1995-3#1)(2008-3#1)
tetrahelical DNA##2##2##(1994-11#2)
tetrahelical##3##1##(1994-11#3)
tetrahelix##2##1##(1994-11#2)
tetraheme cytochrome subunit##3##3##(1993-8#3)
tetraheme cytochrome##4##2##(1993-8#3)(1994-5#1)
tetraheme##6##1##(1993-8#4)(1994-11#1)(1994-5#1)
tetrahydroaminoacridine##3##1##(1992-8#2)(1993-12#1)
tetrahydrobiopterin##5##1##(1992-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(2010-5#1)
tetrahydroborate##12##1##(2007-12#1)(2008-10#11)
tetrahydroborate(III)##4##1##(2008-10#4)
tetrahydrocannabinol##2##1##(1996-5#1)(2008-7#1)
tetrahydrocortisol and tetrahydro##2##3##(1997-1#2)
tetrahydrofuran (THF)##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
tetrahydrofuran and##3##2##(1990-8#1)(2008-10#2)
tetrahydrofuran##20##1##(1990-8#1)(1994-9#1)(1996-5#2)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-5#1)
tetrahydrofurane##3##1##(2008-10#3)
tetrahydrogestrinone##2##1##(2010-11#2)
tetrahydroisoquinoline alkaloids##2##2##(2007-11#2)
tetrahydroisoquinoline##5##1##(2007-11#3)(2011-3#2)
tetrahydropentalenolactone##2##1##(1994-5#2)
tetrahydropyridine##3##1##(1992-11#1)(1996-12#2)
tetraiodofluorescein##3##1##(2008-10#3)
tetrakis rare-earth compounds of##2##4##(2008-2#2)
tetrakis rare-earth##4##2##(2008-2#4)
tetrakis##10##1##(2008-10#6)(2008-2#4)
tetrakis(4-chlorophenyl)borate##6##1##(2008-10#6)
tetrakisphosphate##5##1##(1990-7#1)(1992-11#1)(1993-6#1)(1997-1#2)
tetralogy of Fallot##4##3##(1997-3#2)(2007-8#1)(2009-10#1)
tetralogy##5##1##(1996-11#1)(1997-3#2)(2007-8#1)(2009-10#1)
tetraloops##4##1##(1992-3#4)
tetramer and##4##2##(1992-6#1)(1993-8#1)(1995-2#1)(2008-8#1)
tetramer binding##2##2##(2008-8#1)(2008-9#1)
tetramer##23##1##(1990-10#1)(1990-8#1)(1992-6#1)(1993-8#2)(1994-11#2)(1994-6#1)(1995-2#1)(1997-2#6)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#3)
tetrameric enzyme##3##2##(2008-9#1)(2009-2#2)
tetrameric##21##1##(1990-8#3)(1992-2#1)(1992-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-2#2)
tetramerization##8##1##(1993-8#7)(1997-2#1)
tetramers and##3##2##(1990-8#1)(2008-9#1)(2010-8#1)
tetramers at##2##2##(1990-8#1)(1997-2#1)
tetramers in##2##2##(1990-8#1)(2008-4#1)
tetramers to##2##2##(1997-2#1)(2008-4#1)
tetramers##26##1##(1990-8#5)(1994-8#1)(1995-12#1)(1997-2#7)(2008-4#2)(2008-8#5)(2008-9#4)(2010-8#1)
tetramethyl##2##1##(1995-11#1)(2008-6#1)
tetramethylammonium hydroxide (TMAH)##5##3##(2008-10#3)(2013-1#2)
tetramethylammonium hydroxide##8##2##(2008-10#6)(2013-1#2)
tetramethylammonium##12##1##(1992-9#1)(2008-10#9)(2013-1#2)
tetramethylarsonium##3##1##(2008-10#3)
tetramethylpyrazine and##2##2##(1991-6#2)
tetramethylpyrazine##6##1##(1991-6#6)
tetramethylrhodamine##3##1##(2008-10#2)(2009-8#1)
tetranectin##4##1##(1992-8#4)
tetranitrate (PETN)##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
tetranitrate##6##1##(2008-10#4)(2008-3#1)(2009-5#1)
tetranuclear##2##1##(1997-7#1)(2007-11#1)
tetraoctylammonium bromide##2##2##(2008-10#2)
tetraoctylammonium##3##1##(2008-10#3)
tetraparesis##4##1##(2007-10#3)(2011-2#1)
tetrapeptide##21##1##(1990-11#3)(1990-2#1)(1991-5#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-5#3)(1997-3#5)(2008-10#3)(2013-1#1)
tetrapeptides##3##1##(1990-11#2)(1997-3#1)
tetrapetalum##2##1##(2008-10#2)
tetraphenyl borate##6##2##(2008-10#6)
tetraphenylborate as##2##2##(2008-10#2)
tetraphenylborate##19##1##(2008-10#19)
tetraplegia##2##1##(2012-2#2)
tetraplegics##2##1##(1991-6#2)
tetraploid Elymus species##2##3##(2008-5#2)
tetraploid and##2##2##(2008-10#1)(2008-5#1)
tetraploid wheat##5##2##(2008-10#3)(2012-3#2)
tetraploid##21##1##(2008-10#6)(2008-11#2)(2008-5#7)(2008-9#1)(2009-9#1)(2012-3#4)
tetraploids##9##1##(2008-5#7)(2008-9#2)
tetrapod##4##1##(1990-8#1)(2012-12#1)(2013-1#2)
tetrapods##4##1##(1990-8#1)(2009-6#2)(2013-1#1)
tetraruthenated porphyrin##2##2##(2008-10#2)
tetrasaccharide##4##1##(1990-9#1)(1992-12#1)(1995-11#2)
tetrasomic inheritance##3##2##(2008-5#3)
tetrasomic##4##1##(2008-10#1)(2008-5#3)
tetraspanin##3##1##(2009-8#3)
tetrasporic##2##1##(2007-5#1)(2009-12#1)
tetrasubstituted##2##1##(2008-10#1)(2010-3#1)
tetrasulfonate##3##1##(1990-11#2)(2008-10#1)
tetrasulfonated phthalocyanine (CoTSPc)##2##3##(2008-10#2)
tetrasulfonated phthalocyanine##3##2##(2008-10#3)
tetrasulfonated##6##1##(2008-10#5)(2008-3#1)
tetrathiafulvalene##4##1##(1996-5#1)(2008-10#1)(2010-12#2)
tetrathioethers##3##1##(2008-10#3)
tetratricopeptide repeat##2##2##(1996-2#2)
tetratricopeptide##3##1##(1996-2#2)(1997-7#1)
tetraurelia##5##1##(1990-7#2)(2008-12#3)
tetravalent##2##1##(2008-10#1)(2008-4#1)
tetrazole##2##1##(1992-9#1)(2013-1#1)
tetrazole-based##2##1##(2009-5#1)(2013-1#1)
tetrazolium salt##2##2##(1992-9#1)(2008-9#1)
tetrazolium##14##1##(1991-12#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
tetrodotoxin (TTX)##2##2##(1996-2#1)(2009-3#1)
tetrodotoxin or in##2##3##(1992-3#2)
tetrodotoxin##10##1##(1990-5#1)(1992-3#2)(1992-7#1)(1993-12#1)(1995-12#2)(1996-2#1)(2007-10#1)(2009-3#1)
tetrodotoxin-sensitive##2##1##(1990-5#1)(1996-5#1)
tetrol I-1##9##2##(2008-10#9)
tetrol##10##1##(2008-10#10)
text a##2##2##(2008-11#1)(2013-1#1)
text alexia##2##2##(2010-7#2)
text analysis##3##2##(1991-8#1)(1994-6#1)(2008-7#1)
text and image information##2##4##(2010-8#2)
text and##8##2##(1995-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-8#3)
text environments##2##2##(1991-8#2)
text field for##2##3##(2010-8#2)
text field##4##2##(2010-8#4)
text is##2##2##(1992-2#1)(2013-8#1)
text matching##2##2##(1991-8#2)
text mining##5##2##(2008-7#2)(2010-12#1)(2012-1#2)
text of##4##2##(1991-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
text paging##5##2##(2010-8#5)
text processing##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
text reading##3##2##(2008-11#1)(2010-7#2)
text##98##1##(1991-12#1)(1991-8#10)(1992-2#1)(1992-4#1)(1994-6#1)(1995-1#2)(1996-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-7#7)(2010-8#18)(2011-1#5)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
text)##2##1##(2009-6#1)(2013-8#1)
text-based searches##2##2##(2008-4#2)
textbook or##2##2##(1995-1#2)
textbook##6##1##(1995-1#2)(2008-2#1)(2009-5#1)(2009-8#1)(2012-2#1)
textbooks and##2##2##(2009-6#1)(2013-8#1)
textbooks##17##1##(1995-1#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-8#5)
textile##10##1##(2008-10#4)(2008-11#1)(2009-10#1)(2010-8#2)(2012-1#1)(2012-2#1)
textiles##7##1##(1991-6#1)(1995-5#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-8#1)
texting##2##1##(2013-1#2)
texts in##2##2##(1991-8#1)(2013-1#1)
texts##16##1##(1991-8#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
textual##5##1##(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
textural and##2##2##(2008-6#1)(2010-8#1)
textural properties##3##2##(2010-4#2)(2011-2#1)
textural##8##1##(2008-10#1)(2008-5#2)(2008-6#1)(2010-4#2)(2010-8#1)(2011-2#1)
texture analysis##3##2##(2008-2#1)(2009-12#1)(2010-8#1)
texture and##8##2##(2007-10#1)(2007-7#1)(2008-10#4)(2008-5#1)(2011-2#1)
texture at surface##2##3##(2013-8#2)
texture at##3##2##(2013-8#3)
texture discrimination##3##2##(1994-8#1)(2008-2#2)
texture features##7##2##(2008-10#1)(2008-6#1)(2010-4#2)(2010-8#3)
texture in##2##2##(2008-10#1)(2012-2#1)
texture information##3##2##(2008-6#3)
texture of##4##2##(2010-4#2)(2010-8#1)(2013-8#1)
texture pattern##2##2##(2008-6#2)
texture to##2##2##(2007-12#1)(2008-6#1)
texture type conditions##2##3##(2008-6#2)
texture##82##1##(1994-8#2)(1995-3#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#15)(2008-2#3)(2008-5#8)(2008-6#19)(2009-12#1)(2010-4#9)(2010-8#7)(2011-2#2)(2012-2#2)(2012-6#1)(2013-1#2)(2013-8#5)
texture-based##3##1##(2008-6#3)
textured##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
textures in##2##2##(1996-2#1)(2008-5#1)
textures##13##1##(1994-8#2)(1996-2#1)(2007-12#1)(2008-10#2)(2008-5#4)(2008-6#2)(2009-2#1)
tg##2##1##(2007-2#1)(2008-11#1)
tga1a##3##1##(2008-9#3)
tgr-1##3##1##(2008-10#3)
th##7##1##(1990-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2012-12#1)(2013-8#1)
thalami##5##1##(1995-8#1)(2008-6#2)(2012-3#2)
thalamic afferents##2##2##(1994-3#1)(1997-2#1)
thalamic and##2##2##(1990-5#1)(1996-12#1)
thalamic nuclei##4##2##(1990-5#1)(1991-12#1)(1997-2#1)(1997-3#1)
thalamic nucleus##4##2##(1996-5#1)(1997-2#2)(2013-8#1)
thalamic oscillations##3##2##(2008-1#1)(2008-2#2)
thalamic##37##1##(1990-5#2)(1991-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-5#2)(1997-2#7)(1997-3#1)(2007-10#1)(2008-1#2)(2008-2#6)(2008-7#6)(2008-8#1)(2010-1#1)(2013-8#1)
thalamocortical projection##2##2##(1994-2#2)
thalamocortical##6##1##(1994-2#2)(2008-1#3)(2008-2#1)
thalamus and##5##2##(1996-2#1)(2008-1#1)(2008-7#2)(2009-6#1)
thalamus##19##1##(1992-11#1)(1993-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-7#4)(2009-6#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#3)
thalassaemia and sickle cell anaemia patients##2##6##(2013-8#2)
thalassaemia##6##1##(2009-4#1)(2013-8#5)
thalassaemic##2##1##(2007-11#1)(2008-8#1)
thalassemia by##2##2##(1994-12#1)(2008-10#1)
thalassemia in##3##2##(2007-2#1)(2013-1#2)
thalassemia##22##1##(1993-8#1)(1994-12#1)(1995-12#2)(2007-2#1)(2008-10#7)(2008-8#1)(2011-2#3)(2013-1#6)
thalassemic patients##8##2##(2008-10#2)(2011-2#6)
thalassemic##10##1##(1990-8#1)(2008-10#2)(2011-2#7)
thaliana cytidylyltransferase cDNA##2##3##(1997-2#2)
thaliana ecotype##2##2##(2008-10#2)
thaliana ecotypes##3##2##(2008-10#1)(2012-3#2)
thaliana roots##3##2##(2008-10#2)(2012-1#1)
thaliana##105##1##(1991-6#2)(1992-3#1)(1993-2#2)(1994-12#1)(1996-10#4)(1997-2#6)(1997-6#2)(1997-8#3)(2008-1#1)(2008-10#35)(2008-12#1)(2008-4#1)(2008-7#5)(2008-9#10)(2009-10#5)(2009-3#1)(2009-5#2)(2009-8#5)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#3)(2012-1#2)(2012-3#6)(2013-8#2)
thalidomide and##3##2##(2011-1#2)(2011-2#1)
thalidomide or placebo##3##3##(2008-5#3)
thalidomide##26##1##(1991-11#1)(1991-6#1)(2006-10#1)(2008-3#1)(2008-5#14)(2008-7#1)(2010-4#3)(2011-1#2)(2011-2#2)
thalli##2##1##(2008-10#1)(2010-6#1)
thallium (I)##2##2##(2008-10#2)
thallium (III) and##2##3##(2008-10#2)
thallium (III)##5##2##(2008-10#5)
thallium and lead##3##3##(2008-10#3)
thallium atom##2##2##(1996-2#2)
thallium in the##2##3##(1994-5#2)
thallium in##10##2##(1991-12#1)(1993-9#1)(1994-5#3)(2008-10#5)
thallium is##2##2##(1996-2#2)
thallium scintigraphy##3##2##(1992-5#2)(2007-8#1)
thallium using##2##2##(2008-10#2)
thallium was##2##2##(2008-10#2)
thallium##58##1##(1991-12#4)(1992-12#2)(1992-5#3)(1993-7#1)(1993-9#1)(1994-5#5)(1996-2#4)(2007-11#4)(2007-8#1)(2008-10#32)(2013-1#1)
thallium(I)##11##1##(1996-2#1)(2008-10#10)
thallium(III)##3##1##(2007-11#2)(2008-10#1)
than &quot##4##2##(1991-2#1)(1994-3#1)(2008-10#1)(2012-12#1)
than 0##309##2##(1990-11#2)(1990-12#12)(1990-2#11)(1990-3#7)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#5)(1991-11#5)(1991-12#7)(1991-2#9)(1991-3#2)(1991-4#4)(1991-5#9)(1991-6#4)(1991-8#4)(1991-9#21)(1992-12#4)(1992-2#9)(1992-3#7)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#2)(1994-1#4)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-11#7)(2008-1#1)(2008-10#71)(2008-11#1)(2008-12#1)(2008-2#14)(2008-3#24)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2010-4#1)(2011-1#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#6)
than 1 and##3##3##(2008-10#2)(2008-3#1)
than 1 cm##2##3##(1997-1#1)(1997-4#1)
than 1 m##3##3##(2008-10#3)
than 1 mm##3##3##(2008-3#2)(2008-9#1)
than 1 month##4##3##(1990-2#1)(2008-10#2)(2008-11#1)
than 1 mum##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
than 1 year and##3##4##(1991-2#1)(2009-12#1)(2011-2#1)
than 1 year##12##3##(1991-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
than 1##164##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#4)(1992-9#3)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#3)(2007-11#1)(2007-12#13)(2008-1#1)(2008-10#43)(2008-11#5)(2008-2#9)(2008-3#24)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#3)(2009-5#1)(2010-1#1)(2010-11#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#1)
than 1% and##3##3##(2007-12#1)(2008-10#2)
than 1% of the##4##4##(1993-8#1)(1996-5#1)(2008-10#1)(2008-3#1)
than 1% of##15##3##(1991-12#1)(1993-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-4#1)(2010-3#1)(2013-7#2)
than 1%##50##2##(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-8#1)(1996-11#1)(1996-5#3)(1997-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#17)(2008-2#3)(2008-3#8)(2008-5#1)(2008-8#1)(2009-4#1)(2010-3#1)(2013-7#2)
than 10 and##2##3##(2008-10#1)(2008-2#1)
than 10 days##4##3##(2008-10#2)(2008-11#2)
than 10 h##2##3##(2008-10#2)
than 10 mg##2##3##(2008-10#1)(2009-8#1)
than 10 min##5##3##(2008-10#4)(2008-3#1)
than 10 mm##3##3##(2007-12#1)(2008-7#1)(2010-12#1)
than 10 mm/day)##2##3##(2008-10#2)
than 10 months##2##3##(2008-9#1)(2009-2#1)
than 10 nm##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
than 10 years##3##3##(1990-9#1)(2008-11#2)
than 10##71##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-5#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#4)
than 10% of the##4##4##(1992-3#1)(2007-2#1)(2008-10#2)
than 10% of##16##3##(1990-5#1)(1992-3#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
than 10% relative##2##3##(1995-12#1)(2011-1#1)
than 10%##46##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1995-12#1)(1996-12#1)(2007-2#1)(2007-7#2)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
than 10%)##3##2##(2008-10#2)(2008-9#1)
than 10(-5)##3##2##(1992-5#1)(2008-2#2)
than 10(-9) M##2##3##(1997-4#2)
than 10(-9)##4##2##(1997-4#2)(2008-3#1)(2010-1#1)
than 10(5)##2##2##(2008-7#1)(2010-4#1)
than 10(5)-fold##2##2##(1992-5#1)(1995-2#1)
than 10(9)##2##2##(2008-3#1)(2012-2#1)
than 10-fold##6##2##(1990-7#1)(1992-3#1)(1995-5#1)(1996-3#1)(2008-10#2)
than 100 amino acids##2##4##(1996-3#1)(1997-3#1)
than 100 amino##3##3##(1995-6#1)(1996-3#1)(1997-3#1)
than 100 kDa##2##3##(1991-9#1)(2008-10#1)
than 100 kHz##2##3##(2008-2#1)(2008-3#1)
than 100 mg##2##3##(1997-4#1)(2008-12#1)
than 100 microM##2##3##(1995-5#1)(1996-2#1)
than 100 mug##2##3##(2008-10#2)
than 100 nM##2##3##(1990-12#1)(2008-5#1)
than 100 nm##4##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
than 100 years##4##3##(1992-3#1)(2008-10#1)(2008-7#1)(2010-5#1)
than 100##70##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#3)(1997-3#2)(1997-4#1)(2007-11#3)(2007-5#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#4)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
than 100%##4##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
than 100-fold##3##2##(1992-6#1)(1992-8#1)(2008-10#1)
than 1000##9##2##(1991-12#1)(1991-9#1)(1994-12#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-11#2)(2013-1#1)
than 11##6##2##(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#3)
than 110##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
than 12 W of##2##4##(2007-11#2)
than 12 hours##3##3##(1990-12#1)(1993-12#1)(2010-7#1)
than 12 months##4##3##(1991-11#1)(1991-2#1)(1996-3#1)(1996-6#1)
than 12 years##3##3##(1993-2#1)(2008-7#1)(2008-8#1)
than 12##22##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1996-3#1)(1996-6#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-2#1)
than 12% of the##2##4##(2008-10#1)(2008-8#1)
than 12%##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
than 120##2##2##(1992-8#1)(1997-7#1)
than 120%##2##2##(1993-2#1)(2007-8#1)
than 13##4##2##(1995-2#1)(2007-12#1)(2007-6#1)(2008-10#1)
than 14##4##2##(1991-12#1)(1994-6#1)(2008-10#1)(2013-8#1)
than 15 s##2##3##(1991-10#1)(2008-10#1)
than 15 years##6##3##(2008-10#2)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
than 15##26##2##(1991-10#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-12#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
than 15% of##6##3##(1990-5#1)(1990-8#1)(1997-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
than 15%##11##2##(1990-5#1)(1990-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-3#1)(2013-1#1)
than 150##11##2##(1991-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2011-2#2)(2012-3#1)(2013-1#1)
than 1500##5##2##(1992-2#1)(2007-12#1)(2008-11#2)(2008-5#1)
than 16##6##2##(2008-10#1)(2008-2#2)(2012-3#1)(2013-1#2)
than 17##3##2##(1992-3#1)(1995-11#1)(2007-12#1)
than 18##7##2##(2007-11#1)(2008-1#1)(2009-10#1)(2009-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
than 180##3##2##(1996-12#1)(2007-8#1)(2008-3#1)
than 19##2##2##(2008-10#1)(2008-7#1)
than 2 cm in##2##4##(1991-4#2)
than 2 cm##7##3##(1990-9#1)(1991-4#2)(1995-4#2)(1997-4#1)(2008-10#1)
than 2 decades of##2##4##(2009-4#1)(2012-12#1)
than 2 months##5##3##(2006-5#2)(2008-10#2)(2008-11#1)
than 2 weeks##3##3##(1991-8#1)(2008-10#1)(2011-2#1)
than 2 years##2##3##(2008-6#1)(2011-2#1)
than 2##94##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-4#2)(1996-12#1)(1997-3#1)(1997-4#2)(2006-5#2)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#3)(2008-2#3)(2008-3#10)(2008-6#4)(2008-7#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
than 2% of the##3##4##(2009-11#1)(2011-2#1)(2012-12#1)
than 2% of##8##3##(1990-11#1)(1994-6#1)(2007-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
than 2%##26##2##(1990-11#1)(1994-6#1)(1996-8#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-3#3)(2009-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
than 2-fold##2##2##(1997-2#1)(2013-1#1)
than 20 min##3##3##(1994-3#1)(2008-10#2)
than 20 mm##2##3##(1990-2#1)(2008-2#1)
than 20 mmHg##2##3##(2008-7#1)(2010-5#1)
than 20 mum##2##3##(2008-10#1)(2008-3#1)
than 20 s##2##3##(2008-10#2)
than 20 to##2##3##(1992-6#1)(2010-8#1)
than 20 years ago##2##4##(1991-2#1)(2008-10#1)
than 20 years##13##3##(1991-2#1)(1993-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#2)
than 20##62##2##(1990-12#2)(1990-2#2)(1991-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1995-12#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
than 20% of the##3##4##(1992-5#1)(1997-4#1)(2007-11#1)
than 20% of##7##3##(1992-5#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
than 20%##17##2##(1992-5#1)(1992-9#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-3#1)
than 200 beds##2##3##(1993-2#1)(2007-12#1)
than 200 mW##2##3##(2007-11#1)(2008-3#1)
than 200##28##2##(1991-8#1)(1993-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)
than 2000##4##2##(1995-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
than 22##3##2##(1994-2#1)(2008-11#1)(2011-2#1)
than 23##2##2##(2008-10#1)(2008-8#1)
than 24 h##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
than 24 hours##2##3##(1995-5#1)(2012-12#1)
than 24##8##2##(1993-10#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
than 240##2##2##(1996-12#1)(2008-7#1)
than 245##2##2##(2008-10#2)
than 25 years##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
than 25##17##2##(1990-12#1)(1993-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#4)(2013-1#1)
than 25%##9##2##(1993-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)
than 250##3##2##(1993-9#1)(2008-10#1)(2008-3#1)
than 28##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
than 3 kDa)##2##3##(1990-5#1)(2008-10#1)
than 3 mm in diameter##3##5##(2007-8#2)(2011-2#1)
than 3 mm##4##3##(2007-8#2)(2011-2#1)(2012-3#1)
than 3 months##9##3##(1991-8#1)(2007-11#1)(2008-10#5)(2008-5#1)(2013-1#1)
than 3 x##2##3##(1991-6#1)(1994-2#1)
than 3##62##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1994-2#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#4)(2008-10#23)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#3)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
than 3% for##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
than 3% of the##2##4##(1994-6#1)(2008-2#1)
than 3% of##3##3##(1994-6#1)(2008-2#1)(2010-5#1)
than 3%##14##2##(1993-1#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-5#1)(2013-8#1)
than 30 min##2##3##(2008-10#1)(2008-6#1)
than 30 minutes##3##3##(1993-1#1)(1994-3#1)(1997-2#1)
than 30 years##9##3##(1994-12#1)(1996-11#1)(2007-6#1)(2008-6#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
than 30##47##2##(1990-11#1)(1990-12#1)(1990-5#2)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
than 30%##9##2##(1993-2#1)(1995-6#1)(2007-4#1)(2008-11#1)(2008-5#2)(2009-7#1)(2011-2#1)(2013-1#1)
than 300 bp##2##3##(1995-12#1)(1996-3#1)
than 300 mg##2##3##(1996-11#1)(2008-11#1)
than 300##18##2##(1995-12#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
than 3000##3##2##(1997-6#1)(2008-12#1)(2012-2#1)
than 31##2##2##(2007-12#1)(2008-10#1)
than 32##4##2##(1992-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
than 35 U/ml##2##3##(1991-4#2)
than 35 years##2##3##(1992-3#1)(2013-1#1)
than 35##5##2##(1991-4#2)(1992-3#1)(2008-6#1)(2013-1#1)
than 350##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-5#1)
than 37##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
than 3min##2##2##(2008-10#2)
than 3 × 10(7)##2##2##(2011-2#2)
than 4 mg/kg##2##3##(2008-1#2)
than 4 months##2##3##(2007-8#1)(2008-10#1)
than 4 weeks##2##3##(2007-7#1)(2008-10#1)
than 4 years##3##3##(2010-9#1)(2012-1#1)(2012-12#1)
than 4##50##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-7#1)(1995-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-2#7)(2008-3#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
than 4%##16##2##(1990-6#1)(1991-11#1)(2008-1#1)(2008-10#9)(2008-3#3)(2011-1#1)
than 4-h WD##2##3##(2008-10#2)
than 40 degrees C##2##4##(2007-12#1)(2008-7#1)
than 40 different##2##3##(2008-11#1)(2008-3#1)
than 40 mm##2##3##(1992-5#1)(1996-6#1)
than 40 years of age##3##5##(2010-12#1)(2012-12#1)(2013-1#1)
than 40 years of##5##4##(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
than 40 years were##2##4##(2010-12#1)(2013-1#1)
than 40 years##10##3##(1997-8#1)(2008-7#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
than 40##28##2##(1991-12#1)(1991-2#1)(1992-5#1)(1993-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#2)(2010-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
than 40% in##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
than 40%##12##2##(1991-12#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2013-1#1)
than 400 ng/ml)##4##3##(1992-3#4)
than 400##10##2##(1992-3#5)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
than 400%##2##2##(2008-10#1)(2008-7#1)
than 45 years##4##3##(1990-12#1)(2010-3#3)
than 45##7##2##(1990-12#1)(2008-7#1)(2010-3#3)(2011-2#1)(2013-1#1)
than 47##2##2##(2011-2#1)(2013-1#1)
than 48 h##2##3##(2008-10#1)(2008-6#1)
than 48 hours##3##3##(1990-12#1)(1993-12#1)(2007-8#1)
than 48##5##2##(1990-12#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-6#1)
than 5 and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
than 5 mm##3##3##(1994-9#1)(1997-3#1)(2008-10#1)
than 5 years##6##3##(1990-6#1)(1991-6#1)(1991-8#1)(1995-2#1)(2008-6#1)(2010-11#1)
than 5##57##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-4#2)(2007-12#3)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
than 5% and##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
than 5% blasts by the end of the second course of ADE##2##12##(2008-10#2)
than 5% error in the estimate of the 50% control mean##2##11##(2012-2#2)
than 5% error##3##3##(2008-2#1)(2012-2#2)
than 5% of C##2##4##(2008-5#1)(2011-2#1)
than 5% of patients##2##4##(2007-10#1)(2008-1#1)
than 5% of##12##3##(1991-12#1)(1995-2#1)(1995-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-8#1)(2011-2#2)(2012-2#1)
than 5%##49##2##(1991-12#1)(1992-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#21)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#4)(2013-1#2)
than 5-fold##2##2##(1993-9#1)(1994-12#1)
than 50 and##3##3##(2007-11#1)(2008-10#2)
than 50 m##2##3##(2008-10#1)(2008-3#1)
than 50 microM##2##3##(1990-2#1)(1990-7#1)
than 50 microm##2##3##(2008-10#2)
than 50 ml##2##3##(1991-2#1)(1993-2#1)
than 50 nm##2##3##(2007-11#1)(2008-3#1)
than 50 years##5##3##(1993-8#1)(2007-10#1)(2008-10#1)(2011-3#1)(2012-1#1)
than 50##46##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#2)(2008-10#14)(2008-3#4)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#2)
than 50% (&quot##2##3##(2011-2#2)
than 50% of patients##4##4##(2007-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
than 50% of the##11##4##(1994-11#1)(1995-11#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
than 50% of these##2##4##(1995-2#1)(2013-1#1)
than 50% of##28##3##(1990-12#1)(1990-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
than 50%##64##2##(1990-12#1)(1990-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-3#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
than 50%)##2##2##(1990-2#1)(2008-3#1)
than 500##7##2##(1993-2#1)(1993-3#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
than 5000##2##2##(2008-11#1)(2012-12#1)
than 57##2##2##(2008-10#2)
than 6 h##2##3##(1993-12#1)(2008-10#1)
than 6 months##9##3##(1991-2#1)(1996-12#1)(2008-10#4)(2008-11#1)(2012-12#1)(2013-1#1)
than 6##32##2##(1990-6#1)(1991-2#1)(1992-6#1)(1993-12#1)(1994-7#1)(1996-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
than 6%##4##2##(2008-10#3)(2010-1#1)
than 60 %##2##3##(2011-2#1)(2012-12#1)
than 60 mgCl(-1)##2##3##(2008-10#2)
than 60 nm##3##3##(2007-12#2)(2008-3#1)
than 60 years##5##3##(2007-12#1)(2008-2#1)(2011-2#2)(2012-3#1)
than 60##31##2##(1991-12#1)(1991-6#1)(1994-9#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
than 60% for##2##3##(1996-12#1)(2008-10#1)
than 60% of the##6##4##(1990-12#1)(1995-6#1)(1996-10#1)(1997-4#1)(2008-3#1)(2012-12#1)
than 60% of##9##3##(1990-12#1)(1995-6#1)(1996-10#1)(1997-4#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#1)
than 60%##18##2##(1990-12#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
than 600##5##2##(2007-12#2)(2010-7#1)(2010-8#1)(2011-3#1)
than 65 bpm##2##3##(2008-3#2)
than 65 years of age##5##5##(2010-3#1)(2011-2#4)
than 65 years##20##3##(1992-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#4)(2010-3#1)(2010-4#1)(2011-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
than 65##28##2##(1990-2#1)(1990-3#1)(1992-5#1)(2007-11#2)(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#4)(2010-3#1)(2010-4#2)(2011-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
than 65% of##2##3##(2008-10#1)(2008-5#1)
than 65%##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
than 7 months##2##3##(2008-6#1)(2013-1#1)
than 7##17##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1996-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
than 7% of the##2##4##(1997-6#1)(2008-2#1)
than 7%##9##2##(1997-6#1)(2008-10#5)(2008-2#3)
than 70 years##2##3##(2008-10#1)(2011-2#1)
than 70##12##2##(1991-12#1)(1993-11#1)(1997-3#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
than 70% of the##7##4##(1992-10#1)(2008-10#5)(2008-8#1)
than 70% of##11##3##(1992-10#1)(2007-8#1)(2008-10#5)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
than 70%##14##2##(1992-10#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
than 7300##2##2##(1991-11#1)(2008-1#1)
than 75 degrees##2##3##(2008-2#2)
than 75 years of age##3##5##(2008-3#1)(2011-2#2)
than 75 years##9##3##(1991-2#1)(1993-9#2)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)
than 75##17##2##(1991-2#1)(1992-6#1)(1993-9#2)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)
than 75% of the##3##4##(1995-8#1)(1997-3#1)(2011-3#1)
than 75%##5##2##(1995-8#1)(1997-3#1)(2011-1#1)(2011-3#1)(2012-1#1)
than 77%##2##2##(1991-6#1)(2008-10#1)
than 8##16##2##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
than 8% for##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
than 8%##9##2##(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)
than 80##8##2##(1990-12#1)(1995-11#1)(1996-3#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)
than 80% of the##5##4##(1993-6#1)(1995-2#1)(2008-6#1)(2008-8#1)(2010-8#1)
than 80% of##15##3##(1992-6#1)(1993-6#1)(1995-2#1)(1995-6#1)(2007-2#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)
than 80%##29##2##(1992-6#1)(1993-6#1)(1995-2#1)(1995-5#2)(1995-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
than 80%)##3##2##(1993-5#2)(2007-11#1)
than 800##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)
than 82##2##2##(1992-3#1)(2011-2#1)
than 84##2##2##(2008-10#1)(2008-3#1)
than 85##2##2##(2009-8#1)(2011-2#1)
than 85% of##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
than 85%##6##2##(1995-4#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-4#1)
than 86%##2##2##(2008-10#1)(2008-7#1)
than 88%##3##2##(1990-12#1)(2008-10#2)
than 9##6##2##(1990-11#1)(1993-3#1)(2007-12#1)(2008-10#1)(2011-1#1)(2013-1#1)
than 9%##3##2##(2008-10#2)(2008-3#1)
than 90 degrees##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
than 90 ng##2##3##(2008-10#2)
than 90##13##2##(1993-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
than 90% of the##10##4##(1991-12#1)(1993-11#1)(1994-9#1)(1995-3#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
than 90% of##20##3##(1991-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)
than 90%##47##2##(1991-11#1)(1991-12#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-4#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-7#1)
than 90%)##4##2##(1990-11#1)(1992-8#1)(1992-9#1)(2008-6#1)
than 9000##2##2##(1991-8#1)(2007-12#1)
than 91%##2##2##(2008-10#2)
than 93%##5##2##(1990-12#1)(1995-5#1)(2008-10#2)(2012-2#1)
than 94%##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
than 95% and##3##3##(2008-10#2)(2008-11#1)
than 95% of##10##3##(1990-12#1)(1990-8#1)(1992-3#1)(1992-8#1)(1994-8#1)(2008-10#2)(2008-6#2)(2012-2#1)
than 95% pure##2##3##(1991-5#1)(1997-4#1)
than 95%##27##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-8#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-6#3)(2012-2#1)
than 97% in##2##3##(2008-10#1)(2008-3#1)
than 97%##10##2##(2008-10#6)(2008-2#1)(2008-3#1)(2009-5#1)(2013-8#1)
than 98%##11##2##(1990-7#1)(1993-11#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#2)
than 99##9##2##(1992-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)
than 99%##14##2##(1990-11#1)(1996-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
than AAS-found metal##2##3##(2008-10#2)
than African##2##2##(2009-5#1)(2010-10#1)
than Ag and##2##3##(2007-12#1)(2008-10#1)
than Asians##3##2##(2012-2#3)
than B##3##2##(2008-5#2)(2013-8#1)
than Br-##2##2##(2008-10#2)
than C##2##2##(2008-5#1)(2012-3#1)
than Cantonese##2##2##(2013-8#2)
than Caucasian##2##2##(2008-4#1)(2009-5#1)
than Caucasians##2##2##(2008-12#1)(2008-4#1)
than E##2##2##(2008-10#1)(2011-1#1)
than English##3##2##(1996-3#1)(2008-2#1)(2009-8#1)
than F##2##2##(2008-10#2)
than FMRFamide##2##2##(1991-2#2)
than HA##2##2##(2009-7#1)(2013-8#1)
than L##2##2##(2008-10#1)(2010-8#1)
than LLE##2##2##(2008-10#2)
than ME##2##2##(1995-2#2)
than Manzanillo cv##2##3##(2008-12#2)
than Medicare##2##2##(1991-3#2)
than NP##4##2##(1997-4#2)(2007-11#2)
than Na##2##2##(2008-10#2)
than OB##5##2##(2008-2#5)
than OO##2##2##(2008-2#2)
than P##3##2##(2008-10#2)(2008-5#1)
than P1##2##2##(1992-9#2)
than PCR##2##2##(2012-2#1)(2013-8#1)
than Q##3##2##(2012-5#1)(2012-9#2)
than SA##2##2##(2008-10#1)(2011-1#1)
than SD##2##2##(1996-5#1)(2008-1#1)
than SDR##2##2##(1992-11#2)
than Shanyou63##2##2##(2008-9#2)
than T##2##2##(1991-8#1)(2008-10#1)
than T(382)##3##2##(2008-10#3)
than US-1##2##2##(2008-10#2)
than VCG##2##2##(2008-10#2)
than WC patients##2##3##(2011-2#2)
than WHO TEQ values)##2##4##(2008-10#2)
than WT##2##2##(2008-9#1)(2013-1#1)
than X##2##2##(2008-10#2)
than a century ago##3##4##(1997-3#1)(2008-3#1)(2011-2#1)
than a century##11##3##(1992-5#1)(1994-3#2)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#2)(2011-2#1)(2013-8#1)
than a comparable##2##3##(2008-10#1)(2008-11#1)
than a control##2##3##(2007-12#1)(2008-4#1)
than a decade##10##3##(1993-12#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
than a direct##2##3##(1994-8#1)(2007-11#1)
than a few##5##3##(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
than a simple##3##3##(1992-8#1)(2008-2#1)(2008-9#1)
than a single##8##3##(1993-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
than a standard##2##3##(2008-11#1)(2010-5#1)
than a traditional##2##3##(2008-10#1)(2008-9#1)
than a wavelength##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
than a year##3##3##(2010-10#1)(2012-3#2)
than a##169##2##(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#4)(2007-12#8)(2008-10#17)(2008-11#8)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#6)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#3)(2013-8#5)
than about##8##2##(1990-2#1)(1995-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-10#1)
than above##2##2##(2008-2#1)(2009-4#1)
than absolute##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
than acidic##2##2##(2008-10#1)(2008-11#1)
than acquisition##2##2##(2008-10#2)
than activation##3##2##(1991-2#1)(1997-6#1)(2009-10#1)
than active##2##2##(2008-7#1)(2012-1#1)
than actual##2##2##(1990-6#1)(1996-9#1)
than additive effects##3##3##(2008-10#3)
than additive inhibition of##2##4##(1990-2#1)(2008-10#1)
than additive##9##2##(1990-2#1)(1990-5#1)(2008-10#7)
than adult##4##2##(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
than adults and##2##3##(1993-12#1)(2011-2#1)
than adults##7##2##(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
than after##6##2##(1991-9#1)(1992-10#1)(1996-2#1)(2008-5#2)(2012-3#1)
than aged##2##2##(1994-12#1)(1997-2#1)
than air##3##2##(2008-1#1)(2008-6#1)(2011-1#1)
than all other##3##3##(1996-9#1)(2007-7#1)(2008-10#1)
than all##7##2##(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-2#1)
than alpha##2##2##(1995-11#1)(1995-5#1)
than among children##2##3##(1994-6#1)(2011-2#1)
than among other##2##3##(1996-3#1)(2008-5#1)
than among those##2##3##(2008-10#1)(2011-2#1)
than among##18##2##(1994-3#1)(1994-6#1)(1995-1#2)(1995-5#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)
than an existing##2##3##(2012-3#2)
than an order of magnitude##3##5##(2007-11#2)(2008-10#1)
than an##34##2##(1991-11#1)(1992-6#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#3)(2007-12#3)(2007-2#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-3#2)(2013-8#1)
than and##2##2##(2007-11#1)(2008-5#1)
than antibody##3##2##(1991-8#1)(2008-12#1)(2011-1#1)
than anticipated##4##2##(1992-1#1)(1994-2#1)(2008-11#1)(2011-2#1)
than any known##2##3##(2008-7#1)(2011-2#1)
than any of the##2##4##(2008-10#2)
than any of##4##3##(2008-10#2)(2008-8#1)(2012-1#1)
than any other technique##2##4##(2008-10#2)
than any other##18##3##(1991-2#2)(1991-6#1)(1994-3#2)(1994-8#1)(1996-5#1)(1997-8#1)(2006-10#1)(2008-10#4)(2008-4#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
than any previous##2##3##(2008-2#1)(2008-8#1)
than any previously##2##3##(1990-11#1)(2008-2#1)
than any##34##2##(1990-11#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-9#1)(1994-3#2)(1994-8#1)(1996-5#1)(1997-8#1)(2006-10#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
than approximately 10%##2##3##(1990-2#1)(2008-2#1)
than approximately 5 degrees##2##4##(2008-3#2)
than approximately 5##3##3##(2008-3#3)
than approximately 5%##2##3##(2008-3#2)
than approximately##20##2##(1990-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#13)(2008-5#1)
than are the##4##3##(1991-9#1)(1997-2#1)(2008-10#1)(2008-8#1)
than are their##2##3##(1996-3#1)(2008-3#1)
than are##17##2##(1991-9#1)(1993-2#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)(2013-8#1)
than as a##7##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)
than as an##5##3##(1996-3#1)(2008-7#1)(2009-12#1)(2013-1#2)
than as##17##2##(1990-11#1)(1990-5#1)(1996-3#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2013-1#2)
than aspirin##4##2##(2008-5#1)(2008-8#3)
than at ED##2##3##(1993-3#2)
than at any other time##2##5##(2008-5#1)(2013-1#1)
than at higher##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
than at low##2##3##(1992-8#1)(2008-10#1)
than at pH##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
than at the nearby non-AP site##2##6##(2008-10#2)
than at the##9##3##(1996-6#2)(2008-10#4)(2008-11#1)(2012-2#1)(2013-7#1)
than at##49##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#3)(1994-3#1)(1994-8#1)(1996-6#2)(1997-2#1)(2008-10#17)(2008-11#3)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
than available##2##2##(1991-1#1)(2013-1#1)
than average##4##2##(1994-11#1)(2007-12#2)(2008-9#1)
than basal##3##2##(2008-10#2)(2011-2#1)
than before##7##2##(1991-12#1)(1991-6#1)(1994-1#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-2#1)
than being##11##2##(1990-5#1)(1995-3#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
than between either##2##3##(2008-10#1)(2013-1#1)
than between the##3##3##(1997-6#1)(2008-10#1)(2010-10#1)
than between##11##2##(1993-11#1)(1997-6#2)(2008-10#4)(2008-11#2)(2010-10#1)(2013-1#1)
than bone##2##2##(2011-2#1)(2012-12#1)
than both the##2##3##(1994-3#1)(2007-6#1)
than both##4##2##(1994-3#1)(2007-6#1)(2008-10#1)(2013-1#1)
than boys##7##2##(1990-2#2)(1994-12#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
than by a##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
than by any##2##3##(1996-7#1)(2008-6#1)
than by the##5##3##(1996-6#1)(2008-10#2)(2008-7#1)(2012-3#1)
than by##36##2##(1990-11#2)(1990-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
than ca##2##2##(2007-8#1)(2008-10#1)
than calculating##2##2##(1996-12#1)(2008-2#1)
than can be achieved##2##4##(2008-3#1)(2008-4#1)
than can be obtained##3##4##(2008-2#1)(2008-4#1)(2008-5#1)
than can be##10##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2010-8#1)
than caregivers without##2##3##(2010-7#2)
than caregivers##3##2##(2010-7#3)
than cells##6##2##(1993-6#1)(1994-6#1)(2008-11#3)(2012-2#1)
than change##2##2##(1994-5#1)(1996-7#1)
than children of##2##3##(1994-6#1)(2008-1#1)
than children##7##2##(1994-6#2)(1995-1#1)(1996-2#1)(2008-1#1)(2008-11#1)(2010-3#1)
than cisplatin##2##2##(2012-2#1)(2013-1#1)
than classical##4##2##(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
than clinical##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
than commercially##2##2##(1994-12#2)
than common##2##2##(2008-8#1)(2013-1#1)
than commonly used##2##3##(2007-11#1)(2008-3#1)
than commonly##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2009-11#1)
than community##2##2##(1996-9#1)(1997-1#1)
than completely##2##2##(2007-11#1)(2008-9#1)
than concentration of##2##3##(2008-10#1)(2011-2#1)
than control and##2##3##(2008-10#1)(2008-12#1)
than control cells##3##3##(2008-11#1)(2008-8#1)(2009-12#1)
than control regions##2##3##(2009-8#1)(2009-9#1)
than control subjects##2##3##(2011-2#1)(2013-1#1)
than control values##2##3##(2009-11#1)(2013-1#1)
than control##20##2##(1995-6#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#3)
than controls in##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
than controls on the##2##4##(2010-8#1)(2012-3#1)
than controls on##3##3##(2008-3#1)(2010-8#1)(2012-3#1)
than controls##33##2##(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-3#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
than conventional methods##2##3##(2008-10#1)(2010-8#1)
than conventional##31##2##(1992-3#1)(1994-2#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
than copper##2##2##(2008-10#1)(2012-2#1)
than corresponding##3##2##(1992-3#1)(2008-2#1)(2008-9#1)
than could be##3##3##(1994-12#1)(2009-5#1)(2013-1#1)
than could##4##2##(1992-3#1)(1994-12#1)(2009-5#1)(2013-1#1)
than current models of##2##4##(1991-11#1)(2013-8#1)
than current##7##2##(1991-11#1)(1994-12#1)(1997-4#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
than data##2##2##(2008-4#1)(2012-1#1)
than demographic##2##2##(2010-6#1)(2010-8#1)
than detection##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
than devices##2##2##(2007-12#1)(2008-7#1)
than dialysis##2##2##(2007-8#1)(2008-10#1)
than did D##3##3##(2008-10#3)
than did adult##2##3##(1991-12#1)(1994-3#1)
than did parents of##2##4##(1993-3#1)(2009-7#1)
than did the adherent populations##2##5##(2008-10#2)
than did the untreated controls##2##5##(1997-4#2)
than did the untreated##3##4##(1997-4#2)(2008-11#1)
than did the##25##3##(1991-12#2)(1992-1#1)(1992-5#1)(1992-8#1)(1995-2#1)(1995-5#1)(1997-4#2)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
than did their##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
than did those##3##3##(1996-11#1)(2008-11#1)(2013-8#1)
than did##101##2##(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#3)(1991-2#1)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-9#1)(2008-10#30)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#6)(2009-11#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
than differences##3##2##(1993-2#1)(1997-6#1)(2008-11#1)
than digital##2##2##(2008-7#1)(2009-5#1)
than diploids##2##2##(2008-11#1)(2008-9#1)
than direct##7##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-1#1)
than directly##3##2##(2007-12#1)(2009-5#1)(2012-6#1)
than disease##3##2##(2012-1#2)(2013-8#1)
than do the##5##3##(1993-12#1)(1994-2#1)(1995-1#1)(2008-3#2)
than do##24##2##(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2013-8#1)
than does a##2##3##(2008-9#1)(2009-5#1)
than does the##5##3##(1995-3#1)(2008-3#4)
than does##14##2##(1991-12#1)(1993-8#1)(1995-3#1)(2008-1#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-8#1)
than dog##2##2##(2013-1#2)
than dominants##3##2##(1992-1#2)(2010-8#1)
than dried##2##2##(2008-7#1)(2011-2#1)
than drug##3##2##(1991-2#1)(2010-6#1)(2011-2#1)
than during the##2##3##(1995-11#1)(1996-3#1)
than during##10##2##(1994-8#1)(1995-11#1)(1996-3#1)(2008-11#1)(2009-12#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#2)
than each of the##2##4##(2008-10#2)
than each##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
than earlier##5##2##(1993-12#1)(1995-6#1)(2008-10#2)(2008-3#1)
than either of the##2##4##(1991-1#1)(2008-9#1)
than either treatment alone##4##4##(2008-10#2)(2009-8#1)(2013-1#1)
than either##20##2##(1990-7#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-11#1)(1995-2#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#1)
than elsewhere##2##2##(1992-9#1)(2011-2#1)
than environment##2##2##(1992-1#1)(2008-8#1)
than etidronate##2##2##(2008-11#2)
than ever before##7##3##(1991-12#1)(1991-2#1)(1994-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-4#1)
than ever to##2##3##(2008-1#1)(2008-4#1)
than ever##19##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-5#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
than expected based on##2##4##(1995-1#1)(2008-10#1)
than expected because##2##3##(2008-3#1)(2008-7#1)
than expected by chance##2##4##(2008-10#1)(2012-3#1)
than expected from##4##3##(1993-2#1)(1995-11#1)(2008-10#1)(2008-8#1)
than expected in the##2##4##(2008-7#1)(2008-8#1)
than expected in##7##3##(1990-12#1)(1992-2#2)(2008-7#3)(2008-8#1)
than expected levels##2##3##(1990-5#1)(2009-8#1)
than expected values##2##3##(2007-7#1)(2008-10#1)
than expected##49##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1995-1#1)(1995-11#2)(1996-3#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
than fat##2##2##(1997-8#1)(2007-12#1)
than female##3##2##(1995-12#1)(2013-1#1)(2013-8#1)
than females in##2##3##(2008-12#1)(2008-9#1)
than females##21##2##(1995-2#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
than fertile##2##2##(2008-12#1)(2013-7#1)
than five##6##2##(1990-7#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-5#1)
than for a##3##3##(1997-1#1)(2008-10#2)
than for men##2##3##(2008-11#1)(2011-2#1)
than for other##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
than for that of##2##4##(2008-10#2)
than for the case of##2##5##(1995-2#1)(2008-3#1)
than for the other species##2##5##(2008-10#1)(2012-5#1)
than for the other##4##4##(2008-10#2)(2011-2#1)(2012-5#1)
than for the##32##3##(1992-2#1)(1992-8#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(2007-11#2)(2007-12#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2012-5#1)
than for those that##2##4##(2008-10#2)
than for those##7##3##(1990-8#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
than for##136##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-2#3)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#9)(2009-11#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
than found in##3##3##(1991-2#1)(1993-8#1)(2008-11#1)
than four months##2##3##(2008-10#2)
than four years##2##3##(1992-4#1)(1993-6#1)
than four##20##2##(1990-12#2)(1992-4#1)(1993-6#1)(1997-4#1)(2008-10#7)(2008-4#1)(2008-8#1)(2011-2#2)(2012-12#3)(2012-3#1)
than frequency##2##2##(2008-3#1)(2010-8#1)
than from an##2##3##(1997-1#1)(2008-5#1)
than from the##2##3##(2008-10#1)(2008-7#1)
than from##18##2##(1992-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
than general##4##2##(1991-2#1)(1993-5#1)(2013-1#2)
than generally##2##2##(1994-3#1)(1995-11#1)
than genetic##2##2##(2008-7#1)(2008-8#1)
than girls##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
than glucagon##2##2##(1991-12#2)
than group 1##3##3##(2008-7#1)(2009-6#2)
than group A##2##3##(2008-1#2)
than group##9##2##(1993-3#1)(1994-11#1)(2008-1#2)(2008-7#1)(2009-6#2)(2011-2#1)(2012-3#1)
than growth##2##2##(1994-1#1)(2013-1#1)
than had previously been##2##4##(2008-11#1)(2008-2#1)
than had##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
than half a##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
than half of all##2##4##(2008-1#1)(2012-2#1)
than half of the patients##4##5##(1990-9#1)(1992-6#1)(2007-12#1)(2012-3#1)
than half of the population##2##5##(2008-3#1)(2011-1#1)
than half of the##25##4##(1990-9#1)(1991-5#1)(1992-6#1)(1995-6#3)(1996-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
than half of##37##3##(1990-9#1)(1991-5#1)(1992-6#1)(1994-2#1)(1995-6#3)(1996-10#1)(2007-10#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
than half the##10##3##(1990-11#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-5#1)(1997-4#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
than half##62##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)
than has been##4##3##(1992-2#1)(2008-8#3)
than has##5##2##(1992-2#1)(2008-8#3)(2012-3#1)
than have been##2##3##(2008-10#1)(2008-3#1)
than have##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
than having##3##2##(1995-1#1)(1997-5#1)(2013-1#1)
than healthy##6##2##(1991-6#2)(1993-2#1)(2008-10#1)(2009-5#1)(2010-9#1)
than high##5##2##(1990-12#2)(1990-5#1)(1992-3#1)(2008-4#1)
than hitherto##2##2##(1997-3#1)(2012-7#1)
than hospitals##2##2##(1992-12#1)(1993-3#1)
than human##4##2##(1992-2#1)(1993-2#1)(2008-6#1)(2012-2#1)
than if the##2##3##(2008-10#1)(2008-3#1)
than if##4##2##(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)
than in C##9##3##(2010-2#9)
than in CSW2-amended##2##3##(2008-10#2)
than in Europe##4##3##(2008-10#2)(2008-8#2)
than in G-1##2##3##(1996-9#2)
than in G-2##2##3##(1996-9#2)
than in Group S##2##4##(2010-7#2)
than in MRL(+/+) mice##3##4##(2008-10#3)
than in MSA-P##3##3##(2008-7#3)
than in NCH##2##3##(2012-3#2)
than in P##2##3##(1995-5#1)(2013-8#1)
than in S##2##3##(2008-10#1)(2012-3#1)
than in Wistar rats##2##4##(1993-12#1)(1994-11#1)
than in a control##3##4##(1992-12#1)(1992-6#1)(2010-4#1)
than in a##11##3##(1992-12#1)(1992-6#1)(1994-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)
than in adults##2##3##(1994-3#1)(2013-1#1)
than in age-matched##2##3##(1995-5#1)(2008-10#1)
than in all##2##3##(2008-12#1)(2011-2#1)
than in any##2##3##(1995-12#1)(2010-11#1)
than in autoclaved##2##3##(2008-10#2)
than in blood##2##3##(1991-11#1)(2009-11#1)
than in children##2##3##(1995-8#1)(2012-2#1)
than in control cells##4##4##(1992-3#1)(2008-4#2)(2010-1#1)
than in control mice##2##4##(1997-2#2)
than in control patients##2##4##(2008-7#2)
than in control rats##5##4##(1990-7#1)(1993-5#1)(1995-12#1)(1995-3#1)(2007-10#1)
than in control subjects##3##4##(1991-11#1)(1996-7#1)(2008-6#1)
than in control##25##3##(1990-7#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-12#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2010-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
than in controls (P##3##4##(2011-1#2)(2012-3#1)
than in controls (p = 0##2##6##(2008-10#1)(2008-12#1)
than in controls (p##3##4##(1991-5#1)(2008-10#1)(2008-12#1)
than in controls##25##3##(1991-5#1)(1992-11#1)(1992-12#1)(1994-11#1)(1995-12#2)(1996-5#2)(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-3#1)(2012-7#1)(2013-8#1)
than in conventional##6##3##(2007-11#1)(2007-12#1)(2008-10#4)
than in conventional-till fields##3##4##(2008-10#3)
than in cv##3##3##(2008-10#3)
than in developed countries##4##4##(2007-10#1)(2007-7#1)(2008-8#1)(2012-2#1)
than in developed##5##3##(1991-3#1)(2007-10#1)(2007-7#1)(2008-8#1)(2012-2#1)
than in either of the##2##5##(1990-11#1)(2008-10#1)
than in either##4##3##(1990-11#1)(2007-11#1)(2008-10#1)(2013-1#1)
than in female##3##3##(1994-11#1)(1994-2#1)(2008-10#1)
than in females##12##3##(1990-12#1)(1991-6#1)(1992-12#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)
than in fields with##2##4##(2008-10#2)
than in group of the patients without##2##7##(2008-7#2)
than in group##6##3##(1992-9#1)(1996-3#1)(2008-7#2)(2010-1#1)(2013-1#1)
than in healthy##3##3##(2008-10#2)(2008-7#1)
than in its absence##2##4##(1997-7#1)(2008-10#1)
than in leaves##3##3##(2008-10#3)
than in males##8##3##(1990-11#1)(1994-7#1)(2008-11#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)
than in men##6##3##(1992-3#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#1)
than in most##3##3##(2007-7#1)(2008-2#1)(2013-8#1)
than in mouse##2##3##(1994-11#1)(2008-3#1)
than in nontreated##4##3##(2008-10#3)(2008-11#1)
than in normal##7##3##(1990-5#1)(1995-12#1)(1996-12#2)(1996-5#1)(2008-1#1)(2011-1#1)
than in normotensive##2##3##(1990-2#1)(2008-11#1)
than in older##3##3##(1993-12#1)(2011-2#1)(2012-3#1)
than in organic##2##3##(2008-10#2)
than in other##15##3##(1990-11#1)(1993-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)
than in our##3##3##(1991-11#1)(1992-9#1)(2008-10#1)
than in patients with##6##4##(1993-2#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
than in patients without##3##4##(1994-7#1)(2007-8#1)(2008-7#1)
than in patients##11##3##(1993-2#1)(1994-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
than in permanent##2##3##(2007-10#2)
than in plants##2##3##(2008-10#2)
than in postmenopausal##2##3##(1992-3#1)(2007-5#1)
than in previous##4##3##(1990-3#1)(1994-9#1)(2008-8#1)(2011-2#1)
than in rat colon##2##4##(1997-4#2)
than in rat##3##3##(1997-4#2)(2008-2#1)
than in resistant##2##3##(2008-10#2)
than in similar##2##3##(1990-6#1)(2007-11#1)
than in soil from##2##4##(2008-10#2)
than in soil##4##3##(2008-10#4)
than in soils##2##3##(2008-10#2)
than in solution##2##3##(2008-10#1)(2008-3#1)
than in standard##2##3##(2008-10#1)(2008-3#1)
than in studies with mean##2##5##(2008-10#2)
than in studies##3##3##(2008-10#3)
than in summer##2##3##(2008-10#1)(2008-3#1)
than in susceptible cultivars##2##4##(2008-10#2)
than in susceptible##4##3##(2008-10#4)
than in the HB##2##4##(2011-2#2)
than in the case of##5##5##(1992-11#1)(2008-10#2)(2008-3#1)(2009-2#1)
than in the cerebral cortex##2##5##(1990-7#1)(2008-7#1)
than in the control group (p &lt##3##7##(2007-10#1)(2011-1#2)
than in the control group (p##4##6##(2007-10#1)(2011-1#3)
than in the control group##20##5##(1991-12#1)(1991-4#1)(1992-4#1)(1993-2#1)(1997-4#1)(2007-10#3)(2007-11#1)(2008-7#3)(2010-2#1)(2011-1#6)(2011-2#1)
than in the control##26##4##(1991-12#1)(1991-3#1)(1991-4#1)(1992-4#1)(1993-2#1)(1995-6#1)(1997-4#2)(2007-10#3)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#3)(2010-2#1)(2011-1#6)(2011-2#1)(2013-8#1)
than in the controls##13##4##(1990-3#3)(1991-4#1)(1992-2#1)(1995-8#1)(2008-10#1)(2008-7#3)(2011-1#2)(2011-2#1)
than in the corresponding##3##4##(1994-11#1)(1996-2#1)(2006-6#1)
than in the environment##2##4##(1994-3#1)(2008-10#1)
than in the free##2##4##(1997-2#1)(2008-10#1)
than in the general population##6##5##(1993-9#1)(2007-12#1)(2008-1#2)(2008-4#1)(2012-3#1)
than in the group##3##4##(1992-3#1)(1992-5#1)(2007-11#1)
than in the healthy##2##4##(2008-7#1)(2012-3#1)
than in the interior##2##4##(2013-7#2)
than in the male rats##2##5##(2013-1#2)
than in the male##3##4##(2013-1#3)
than in the native##2##4##(1990-8#1)(1995-5#1)
than in the non-MLC601 group##2##5##(2013-1#2)
than in the normal population##2##5##(1995-5#1)(1996-6#1)
than in the normal##8##4##(1995-11#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-8#1)(2008-10#1)
than in the other groups##3##5##(1993-12#1)(2008-7#1)(2011-2#1)
than in the other two##2##5##(2011-1#1)(2011-2#1)
than in the other##11##4##(1990-2#1)(1993-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#2)
than in the past##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
than in the patients##3##4##(1994-7#1)(2008-7#1)(2009-6#1)
than in the presence of##3##5##(1992-11#1)(1992-3#1)(2008-10#1)
than in the previous##2##4##(2008-10#1)(2008-11#1)
than in the primary##2##4##(2008-5#1)(2013-8#1)
than in the second##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
than in the susceptible genotype##2##5##(2008-10#2)
than in the susceptible##3##4##(2008-10#3)
than in the visible##2##4##(2008-3#2)
than in the wild-type Columbia##2##5##(2009-6#2)
than in the younger##2##4##(2008-6#1)(2008-7#1)
than in the##243##3##(1990-11#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-2#3)(1997-4#3)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#5)(2007-11#5)(2007-12#2)(2007-5#3)(2007-8#1)(2008-1#3)(2008-10#40)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#18)(2008-8#5)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-8#1)(2010-11#1)(2010-2#2)(2010-8#3)(2011-1#11)(2011-2#11)(2012-12#1)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#2)
than in their nontransgenic littermates##2##5##(1992-8#2)
than in their##5##3##(1992-8#2)(2008-10#1)(2008-11#1)(2008-8#1)
than in those of##4##4##(1994-6#1)(1997-4#1)(2008-5#1)(2013-1#1)
than in those receiving##2##4##(2007-11#1)(2011-2#1)
than in those with normal##2##5##(1990-2#1)(2008-7#1)
than in those with##7##4##(1990-2#1)(1992-12#1)(2007-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
than in those without##5##4##(1990-2#1)(1996-12#1)(2008-5#1)(2010-4#1)(2013-1#1)
than in those##28##3##(1990-2#2)(1991-6#1)(1992-12#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
than in treated##2##3##(2008-10#2)
than in uninfected##2##3##(2008-10#2)
than in untreated##4##3##(1995-12#1)(2008-10#2)(2008-2#1)
than in vitro##3##3##(2008-10#2)(2008-11#1)
than in wild-type##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
than in winter wheat##3##4##(2008-10#3)
than in women with##2##4##(1996-12#1)(2012-12#1)
than in women##8##3##(1990-12#1)(1994-5#1)(1996-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
than in young rats##2##4##(2008-7#2)
than in young##3##3##(2008-7#3)
than in younger patients##2##4##(1994-6#1)(2008-7#1)
than in younger##7##3##(1991-12#2)(1994-12#1)(1994-6#1)(2008-3#1)(2008-7#1)(2012-3#1)
than in##822##2##(1990-11#7)(1990-12#3)(1990-2#7)(1990-3#5)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1991-11#5)(1991-12#7)(1991-3#2)(1991-4#2)(1991-5#7)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#4)(1992-9#2)(1993-10#1)(1993-12#6)(1993-2#2)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#3)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#3)(1994-7#3)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#9)(1995-2#2)(1995-3#6)(1995-5#8)(1995-6#4)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#1)(1996-3#4)(1996-5#9)(1996-6#2)(1996-7#5)(1996-8#1)(1996-9#5)(1997-2#7)(1997-3#2)(1997-4#6)(1997-6#1)(1997-7#3)(1997-8#4)(2006-6#1)(2007-10#11)(2007-11#12)(2007-12#6)(2007-2#2)(2007-5#4)(2007-7#4)(2007-8#2)(2008-1#7)(2008-10#168)(2008-11#29)(2008-12#7)(2008-2#8)(2008-3#16)(2008-4#9)(2008-5#14)(2008-6#9)(2008-7#48)(2008-8#13)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#5)(2009-8#4)(2010-1#2)(2010-11#3)(2010-12#1)(2010-2#15)(2010-3#5)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#21)(2011-2#41)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#15)(2012-7#2)(2013-1#29)(2013-7#3)(2013-8#9)
than increasing##2##2##(2008-10#2)
than indicated##2##2##(1992-11#1)(2011-2#1)
than individual##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
than individuals with other##2##4##(2008-4#2)
than individuals##6##2##(2007-12#1)(2008-4#2)(2012-12#2)(2013-1#1)
than induced resistance##2##3##(2008-8#2)
than induced##3##2##(1992-6#1)(2008-8#2)
than initially expected##2##3##(1994-2#1)(2010-12#1)
than initially##4##2##(1994-2#1)(2007-8#1)(2008-10#1)(2010-12#1)
than intact##2##2##(1997-2#1)(2008-10#1)
than internal##2##2##(2010-12#1)(2013-1#1)
than into##2##2##(1990-11#1)(2008-11#1)
than invasive carcinomas##2##3##(1997-8#2)
than iodine or##2##3##(1990-8#1)(2013-1#1)
than iodine##4##2##(1990-8#1)(1997-8#2)(2013-1#1)
than iron##2##2##(2008-1#1)(2013-7#1)
than is currently##2##3##(2010-12#1)(2011-2#1)
than is possible##3##3##(1990-9#1)(2007-11#1)(2008-11#1)
than is the##8##3##(1990-11#1)(1992-5#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-8#1)(2013-8#1)
than is##30##2##(1990-11#1)(1990-8#1)(1990-9#1)(1992-5#1)(1994-1#1)(1994-3#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
than isolate##4##2##(2008-10#3)(2008-11#1)
than isolates from##2##3##(2008-10#2)
than isolates of the##2##4##(2008-10#2)
than isolates##5##2##(2008-10#5)
than it did##2##3##(2008-10#1)(2008-8#1)
than it does##2##3##(1991-2#1)(2008-8#1)
than it is##6##3##(1990-12#1)(1994-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
than it was for##2##4##(2008-10#1)(2012-1#1)
than it was##5##3##(2008-10#2)(2008-11#1)(2012-1#1)(2013-8#1)
than it##16##2##(1990-12#1)(1991-2#1)(1994-1#1)(1994-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2012-1#1)(2013-8#1)
than its counterpart##2##3##(1992-8#2)
than its parent##2##3##(2008-9#1)(2012-2#1)
than its##32##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-8#2)(1994-8#3)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
than just a##3##3##(1994-2#1)(2010-10#1)(2013-8#1)
than just the##4##3##(1993-12#1)(2008-11#1)(2009-8#1)(2011-2#1)
than just##14##2##(1990-9#1)(1993-12#1)(1994-2#2)(1994-3#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
than kidney##2##2##(1990-11#1)(1992-11#1)
than known##3##2##(1991-6#1)(1996-12#1)(2008-3#1)
than lack of##2##3##(2009-5#1)(2010-5#1)
than laparotomy##2##2##(1996-1#1)(2009-3#1)
than larger##4##2##(1990-2#1)(1995-2#1)(2007-11#1)(2008-2#1)
than late##4##2##(2008-10#3)(2008-9#1)
than later##2##2##(2012-3#1)(2013-1#1)
than leaf##2##2##(2008-10#2)
than leaves##2##2##(2008-10#1)(2008-9#1)
than less##2##2##(2008-10#1)(2008-8#1)
than light##2##2##(2008-10#1)(2008-9#1)
than linear regression##2##3##(2008-10#1)(2012-3#1)
than linear##4##2##(1990-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
than male subjects##2##3##(2008-5#2)
than male##7##2##(1994-6#1)(1995-6#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)
than males##22##2##(1990-12#1)(1992-9#1)(1993-2#1)(1994-7#1)(1995-3#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
than malignant##2##2##(2011-2#1)(2012-2#1)
than manual##2##2##(2008-10#1)(2008-8#1)
than mean##2##2##(2008-10#2)
than measured##2##2##(2008-11#1)(2008-3#1)
than measurement##2##2##(1996-12#1)(2013-7#1)
than medical##2##2##(2009-4#1)(2013-1#1)
than members of##2##3##(2008-10#1)(2009-8#1)
than members##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
than men and##2##3##(2008-5#1)(2010-5#1)
than men##33##2##(1992-2#1)(1992-5#1)(1995-2#1)(1996-6#1)(2007-10#1)(2007-7#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-11#2)(2009-5#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
than mere##2##2##(1995-12#1)(1995-8#1)
than merely##3##2##(2007-2#1)(2008-10#1)(2009-5#1)
than methanol##2##2##(2008-10#1)(2008-7#1)
than methods based on##2##4##(2008-1#1)(2008-10#1)
than methods##3##2##(2008-1#1)(2008-10#1)(2008-6#1)
than might have been expected on the basis of the demographic figures##2##12##(1992-5#2)
than might##3##2##(1992-5#2)(2013-1#1)
than mild##2##2##(2007-12#1)(2012-2#1)
than minimal##2##2##(1993-12#1)(1996-1#1)
than models##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
than monotherapy##2##2##(2008-8#1)(2013-1#1)
than monovalent##2##2##(1990-7#1)(2008-10#1)
than more##5##2##(2008-8#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
than most other##2##3##(2008-4#1)(2008-9#1)
than most##9##2##(1994-12#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
than mothers##2##2##(1995-1#1)(2007-2#1)
than native##4##2##(1991-9#1)(2008-10#1)(2009-2#1)(2012-12#1)
than natural##2##2##(1991-8#1)(2008-10#1)
than necessary##4##2##(1991-5#1)(1995-5#1)(2008-5#1)(2011-2#1)
than negative##4##2##(1994-1#1)(1997-1#1)(2008-11#1)(2008-4#1)
than no##2##2##(2008-8#1)(2012-12#1)
than non##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
than non-smokers##5##2##(1992-9#1)(2008-10#4)
than non-victims##3##2##(2008-2#3)
than nontransgender sisters and nontransgender brothers##2##6##(2008-12#2)
than nontransgender sisters##3##3##(2008-12#3)
than normal children##2##3##(1995-5#1)(2013-1#1)
than normal subjects##2##3##(1996-5#2)
than normal##30##2##(1990-11#1)(1991-12#1)(1992-11#1)(1993-3#1)(1993-8#1)(1995-5#1)(1996-4#2)(1996-5#2)(1996-7#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2010-12#1)(2013-1#3)
than normally##2##2##(1992-11#1)(1993-6#1)
than not##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
than nuclear##2##2##(1995-11#1)(2008-8#1)
than nurses##2##2##(1992-3#1)(2013-1#1)
than nursing and##2##3##(1990-12#1)(2008-11#1)
than observed for##2##3##(1995-2#1)(1995-6#1)
than observed in##2##3##(2007-11#1)(2008-3#1)
than observed##7##2##(1992-6#1)(1993-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-3#1)
than of the##2##3##(2008-10#1)(2008-11#1)
than of##9##2##(1990-8#1)(1991-11#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
than older men##2##3##(2008-7#1)(2009-5#1)
than older ones##2##3##(1991-2#1)(1995-5#1)
than older##7##2##(1991-2#1)(1995-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
than on Camelot##2##3##(2008-10#2)
than on isolines ECW##2##4##(2008-10#2)
than on leaves##2##3##(2008-10#2)
than on the##15##3##(1993-2#1)(1994-9#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#4)(2009-6#1)(2010-3#1)(2011-2#2)
than on##64##2##(1990-11#1)(1991-11#1)(1993-11#1)(1993-2#2)(1994-9#2)(1995-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#25)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#2)(2012-6#1)(2012-9#1)
than once##7##2##(1991-8#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
than one genotype##2##3##(2008-10#1)(2013-8#1)
than one month##2##3##(1993-3#1)(2012-2#1)
than one per##2##3##(1996-2#1)(2008-10#1)
than one season##2##3##(2008-8#1)(2011-2#1)
than one third##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
than one week##3##3##(1992-1#1)(1994-12#1)(2007-10#1)
than one year##6##3##(1992-5#1)(1996-8#1)(2008-1#1)(2009-12#1)(2010-8#1)(2013-8#1)
than one##129##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#4)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#4)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
than one-half##3##2##(1994-11#1)(1994-12#1)(2007-7#1)
than optically##2##2##(2007-12#2)
than or equal to 1##3##5##(1990-12#1)(1990-2#2)
than or equal to 3)##2##5##(1990-12#1)(1992-4#1)
than or equal to the##2##5##(2008-12#1)(2008-9#1)
than or equal to##48##4##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-6#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#9)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2012-2#1)(2013-8#1)
than or##51##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-6#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#9)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2012-2#1)(2013-8#1)
than originally##4##2##(1994-6#1)(1997-2#1)(2012-2#2)
than other Medicare##2##3##(1993-12#1)(1995-3#1)
than other groups##4##3##(2008-11#1)(2010-2#2)(2013-1#1)
than other hospital##2##3##(1990-2#1)(1990-9#1)
than other patients##2##3##(2008-7#1)(2013-1#1)
than other people##2##3##(2008-6#1)(2011-2#1)
than other reported##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
than other##77##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-11#2)(2007-7#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
than others by environmental##2##4##(2008-5#1)(2011-2#1)
than others in##2##3##(2008-1#1)(2012-1#1)
than others##27##2##(1990-3#1)(1992-9#1)(1993-3#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
than our##4##2##(1995-2#1)(2008-11#1)(2008-2#1)(2008-8#1)
than oxidized##2##2##(1994-5#1)(2013-1#1)
than parental##2##2##(1993-1#1)(2008-8#1)
than participants##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
than patients in group L##2##5##(1996-3#2)
than patients in group##3##4##(1996-3#3)
than patients in##6##3##(1991-5#1)(1996-3#3)(2007-10#1)(2008-7#1)
than patients treated with##2##4##(1996-9#1)(2008-2#1)
than patients who were##2##4##(2007-1#1)(2007-10#1)
than patients who##4##3##(1993-2#1)(2007-1#1)(2007-10#1)(2013-1#1)
than patients with##9##3##(1993-11#1)(1993-2#1)(1995-11#1)(1996-2#1)(1996-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
than patients##25##2##(1991-5#1)(1993-11#1)(1993-2#2)(1995-11#1)(1996-2#1)(1996-3#3)(1996-7#1)(1996-9#1)(2006-8#1)(2007-1#1)(2007-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
than people in##3##3##(2008-12#1)(2010-12#1)(2013-1#1)
than people##5##2##(1992-8#1)(2008-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
than peridinin##2##2##(2009-9#2)
than physical##4##2##(1992-3#1)(2008-5#1)(2008-8#2)
than placebo##4##2##(2008-5#1)(2009-7#1)(2013-8#2)
than plants##6##2##(2008-10#1)(2008-8#1)(2012-3#1)(2012-7#2)(2013-8#1)
than plasma##2##2##(1993-2#1)(2006-6#1)
than positive##3##2##(1993-12#1)(1997-3#1)(2013-1#1)
than postmating##2##2##(2008-9#2)
than potato##2##2##(2008-10#2)
than prairie##2##2##(2008-9#2)
than predicted by the##2##4##(2008-7#1)(2008-8#1)
than predicted by##11##3##(1990-5#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#2)(2013-8#1)
than predicted##16##2##(1990-5#1)(1995-11#1)(1996-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2010-3#1)(2013-8#1)
than present##2##2##(2010-11#1)(2012-2#1)
than preventive##2##2##(2008-10#1)(2009-9#1)
than previous##7##2##(1993-3#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-6#1)(2013-8#1)
than previously assumed##5##3##(1995-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
than previously described##2##3##(2008-10#1)(2008-11#1)
than previously published##2##3##(2008-10#1)(2008-11#1)
than previously recognized##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
than previously reported for##2##4##(1993-11#1)(1994-6#1)
than previously reported##11##3##(1991-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-6#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)
than previously shown##2##3##(1991-11#1)(2010-3#1)
than previously thought and##4##4##(1993-3#1)(1995-12#1)(2008-11#1)(2011-2#1)
than previously thought##11##3##(1990-5#1)(1993-3#1)(1993-8#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
than previously##51##2##(1990-5#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)
than primary##2##2##(1996-5#1)(2008-9#1)
than principal##2##2##(2008-10#2)
than protein##2##2##(2008-5#1)(2011-2#1)
than published##2##2##(2008-9#1)(2013-1#1)
than pure##5##2##(1990-8#1)(2008-2#1)(2009-8#1)(2009-9#1)(2010-5#1)
than purely##2##2##(2008-2#1)(2010-11#1)
than purified##2##2##(1992-6#1)(1996-12#1)
than qualitative##2##2##(2008-10#1)(2012-2#1)
than quantitative##2##2##(2009-6#1)(2012-2#1)
than race##2##2##(2008-10#2)
than random##2##2##(2008-10#1)(2010-10#1)
than rates reported by##2##4##(2013-8#2)
than recommended##4##2##(1991-6#1)(1997-8#1)(2007-7#1)(2008-5#1)
than reduction##2##2##(1992-1#1)(2010-8#1)
than regular##4##2##(2008-1#1)(2009-2#1)(2012-12#1)(2013-1#1)
than reported##5##2##(1994-11#1)(2008-10#1)(2009-7#1)(2011-1#1)(2013-8#1)
than representing a##2##3##(2008-7#1)(2010-11#1)
than required##2##2##(1996-5#1)(2007-11#1)
than requiring##2##2##(2007-12#1)(2008-10#1)
than rifampin##2##2##(2008-5#2)
than roots##2##2##(2008-10#2)
than rumination##2##2##(2008-8#1)(2009-11#1)
than satisfactory##2##2##(1993-12#1)(2008-2#1)
than seven##5##2##(1990-3#1)(1997-2#1)(2008-10#2)(2012-2#1)
than several##4##2##(1993-2#1)(1995-6#1)(1997-3#1)(2008-3#1)
than sexual##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
than similarly##2##2##(1997-6#1)(2009-7#1)
than simple##4##2##(1994-11#1)(1997-3#1)(2008-4#1)(2008-8#1)
than simply##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2012-2#2)
than single##9##2##(1990-8#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
than six##5##2##(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
than sodium##3##2##(1993-11#1)(2008-2#1)(2010-4#1)
than soil##2##2##(2008-5#1)(2010-5#1)
than somatostatin##2##2##(1994-11#2)
than some##4##2##(1990-6#1)(1993-3#1)(2008-5#1)(2012-3#1)
than specific##3##2##(1995-2#1)(1995-6#1)(2008-11#1)
than spontaneous##2##2##(1997-2#1)(2008-5#1)
than standard##10##2##(1990-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
than steady##2##2##(1996-12#1)(2011-2#1)
than students##4##2##(1995-3#2)(1997-2#1)(2012-3#1)
than subjects in##2##3##(2008-4#1)(2008-5#1)
than subjects with##2##3##(2008-7#1)(2008-9#1)
than subjects##8##2##(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
than survivors##2##2##(1993-1#1)(1995-3#1)
than susceptible##2##2##(2008-10#2)
than ten years##2##3##(1994-5#1)(1994-9#1)
than ten##10##2##(1990-2#1)(1990-6#2)(1991-11#1)(1994-5#1)(1994-9#1)(2008-3#2)(2008-8#1)(2008-9#1)
than tenfold##2##2##(1991-1#1)(2007-11#1)
than that achieved with##2##4##(2008-10#1)(2008-2#1)
than that achieved##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
than that associated##2##3##(2008-10#1)(2008-3#1)
than that at pH 7##2##5##(1995-5#1)(2011-3#1)
than that at##5##3##(1995-5#1)(2008-11#1)(2008-3#1)(2011-3#1)(2012-2#1)
than that between the##2##4##(2011-1#1)(2012-9#1)
than that between##6##3##(2008-10#1)(2008-5#1)(2008-8#2)(2011-1#1)(2012-9#1)
than that by##9##3##(1991-12#1)(1995-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-2#1)
than that caused by##2##4##(1990-7#1)(2008-10#1)
than that for a##3##4##(2008-2#1)(2008-3#2)
than that for the##5##4##(1990-8#1)(1997-7#1)(2008-2#2)(2008-8#1)
than that for##28##3##(1990-11#1)(1990-8#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#6)(2008-8#1)(2010-4#1)(2012-2#1)
than that found in the##3##5##(1991-9#1)(2008-10#1)(2008-11#1)
than that found in##5##4##(1990-6#1)(1991-9#1)(1994-11#1)(2008-10#1)(2008-11#1)
than that found##7##3##(1990-6#1)(1991-9#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
than that from##5##3##(1991-9#1)(1995-3#1)(1997-6#1)(2008-8#1)(2012-12#1)
than that in control (P &lt##2##6##(2008-10#2)
than that in control##3##4##(2008-10#3)
than that in other##2##4##(2008-9#1)(2010-5#1)
than that in the control group##5##6##(1996-12#1)(2007-8#1)(2008-9#1)(2012-2#2)
than that in the control##7##5##(1994-12#1)(1995-3#1)(1996-12#1)(2007-8#1)(2008-9#1)(2012-2#2)
than that in the general population##2##6##(2007-12#1)(2010-8#1)
than that in the##26##4##(1994-12#2)(1994-6#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#4)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
than that in##70##3##(1993-11#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#6)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#11)(2009-11#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
than that measured for##2##4##(2008-10#2)
than that measured##6##3##(1996-2#1)(2007-12#1)(2008-10#4)
than that observed for##3##4##(1993-8#1)(2008-10#1)(2008-11#1)
than that observed in western countries##2##6##(2009-2#2)
than that observed in##7##4##(1993-6#1)(1994-2#1)(1995-8#1)(2008-2#2)(2009-2#2)
than that observed##14##3##(1990-9#1)(1991-9#1)(1993-6#1)(1993-8#2)(1994-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-2#2)
than that obtained by##3##4##(1995-12#1)(2008-10#1)(2008-2#1)
than that obtained in the##3##5##(2008-10#1)(2008-11#1)(2008-6#1)
than that obtained using##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
than that obtained with the##4##5##(1990-12#1)(2008-10#2)(2008-2#1)
than that obtained with##7##4##(1990-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
than that obtained##19##3##(1990-12#1)(1992-9#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-10#1)
than that of a conventional##2##5##(2008-2#1)(2008-3#1)
than that of a##8##4##(1994-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)
than that of acetate ions##2##5##(2008-10#2)
than that of an##2##4##(2007-11#1)(2008-6#1)
than that of both##2##4##(2008-10#2)
than that of control##4##4##(1991-2#1)(2008-11#1)(2008-6#1)(2011-1#1)
than that of controls##3##4##(1997-4#1)(2008-10#1)(2008-8#1)
than that of conventional##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
than that of cotyledon##2##4##(2008-9#2)
than that of its##5##4##(1990-5#1)(2008-10#1)(2008-8#1)(2010-2#2)
than that of more##2##4##(2009-8#1)(2012-1#1)
than that of native##2##4##(1994-8#1)(1995-5#1)
than that of normal control##3##5##(2011-3#3)
than that of normal##7##4##(2008-5#1)(2008-8#1)(2011-2#2)(2011-3#3)
than that of other##2##4##(2008-1#1)(2008-10#1)
than that of powdered TCP##2##5##(2008-5#2)
than that of the CML hydrogel##2##6##(2009-7#2)
than that of the control group##2##6##(2011-2#1)(2013-1#1)
than that of the control##6##5##(1993-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
than that of the conventional##6##5##(2007-12#2)(2008-10#1)(2008-3#2)(2013-8#1)
than that of the integration method##2##6##(2008-3#2)
than that of the original system##2##6##(2008-3#2)
than that of the original##3##5##(2008-3#2)(2009-7#1)
than that of the other##2##5##(1995-3#1)(2008-5#1)
than that of the wild type##4##6##(1993-11#1)(2008-10#1)(2008-8#1)(2010-10#1)
than that of the wild-type##2##5##(1990-10#1)(2008-6#1)
than that of the##117##4##(1990-10#1)(1990-11#1)(1990-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#6)(2008-2#2)(2008-3#14)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#10)(2009-7#6)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#2)
than that of treatment##2##4##(1990-3#1)(2013-1#1)
than that of wild-type##2##4##(1993-12#1)(2009-9#1)
than that of##311##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2007-11#8)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#61)(2008-11#14)(2008-12#1)(2008-2#9)(2008-3#19)(2008-4#3)(2008-5#16)(2008-6#7)(2008-7#4)(2008-8#12)(2008-9#17)(2009-2#1)(2009-7#8)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#7)(2011-3#5)(2012-1#1)(2012-2#1)(2013-1#8)(2013-8#3)
than that on the LB##2##5##(2008-11#2)
than that on the##4##4##(2008-1#1)(2008-11#3)
than that on##8##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-6#1)
than that previously reported##2##4##(2008-8#1)(2012-12#1)
than that previously##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
than that produced by##4##4##(1990-8#1)(1994-6#1)(2008-11#1)(2008-12#1)
than that provided by the##2##5##(2008-10#1)(2012-3#1)
than that provided by##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
than that recorded in##2##4##(1994-8#1)(2008-10#1)
than that reported in##5##4##(1994-12#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-5#1)
than that reported##11##3##(1994-12#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-5#1)(2012-12#1)
than that required for##2##4##(2008-10#1)(2008-7#1)
than that required##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
than that seen##2##3##(1996-2#1)(2008-7#1)
than that to##5##3##(1991-12#1)(1993-8#1)(2008-10#2)(2008-8#1)
than that with symmetrical tetraalkylammonium cations##2##6##(2008-10#2)
than that with the##3##4##(2008-10#3)
than that with##11##3##(1993-6#1)(1994-5#1)(2008-10#7)(2008-3#1)(2011-1#1)
than that without##4##3##(2008-3#2)(2008-8#1)(2013-8#1)
than that##584##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#4)(1992-10#1)(1992-12#1)(1992-3#4)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#8)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#4)(1995-9#1)(1996-12#3)(1996-2#4)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#113)(2008-11#36)(2008-12#4)(2008-2#20)(2008-3#34)(2008-4#4)(2008-5#24)(2008-6#12)(2008-7#8)(2008-8#24)(2008-9#34)(2009-10#1)(2009-11#1)(2009-2#3)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#11)(2011-2#10)(2011-3#6)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2012-9#1)(2013-1#9)(2013-8#4)
than the &quot##2##3##(2010-11#1)(2010-4#1)
than the 0##2##3##(2008-2#2)
than the 1##2##3##(1993-11#1)(2012-2#1)
than the 6##2##3##(1991-5#1)(2008-1#1)
than the DWI volume (mismatch)##2##5##(2007-10#2)
than the MCS+##2##3##(2011-2#2)
than the MPM group##2##4##(1997-4#2)
than the actual##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
than the adjacent##2##3##(2008-8#1)(2013-1#1)
than the age##2##3##(2010-10#1)(2013-8#1)
than the amount of##2##4##(2008-11#1)(2010-5#1)
than the amount##3##3##(2008-11#1)(2008-12#1)(2010-5#1)
than the apparent##2##3##(1992-10#1)(2007-10#1)
than the average on a##2##5##(2008-10#2)
than the average##9##3##(1992-3#1)(1992-6#1)(1993-12#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-2#1)(2011-2#1)
than the background##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2012-2#1)
than the basal##2##3##(1992-7#1)(2008-8#1)
than the behavioural programme##2##4##(2008-9#2)
than the binomial##2##3##(2008-10#2)
than the cell##2##3##(2008-5#1)(2008-7#1)
than the cells##2##3##(2008-10#1)(2008-11#1)
than the changes##2##3##(2008-1#1)(2008-5#1)
than the coherence##2##3##(2007-11#1)(2008-3#1)
than the commonly used##2##4##(1995-11#1)(2008-12#1)
than the commonly##3##3##(1995-11#1)(2008-10#1)(2008-12#1)
than the contralateral##2##3##(1993-12#2)
than the control group in##2##5##(1997-2#1)(2008-8#1)
than the control group##12##4##(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-1#4)
than the control##27##3##(1993-6#1)(1995-12#1)(1995-6#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)(2013-1#6)
than the controls and##3##4##(1991-1#1)(2008-10#1)(2013-1#1)
than the controls##14##3##(1991-1#1)(1991-12#1)(1991-5#1)(1995-8#1)(1997-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
than the conventional univariate calibration method##2##6##(2008-10#2)
than the conventional##22##3##(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-2#1)
than the corresponding values##4##4##(2008-10#2)(2008-2#1)(2009-9#1)
than the corresponding wild-type##2##4##(2008-10#1)(2011-2#1)
than the corresponding##18##3##(1990-8#1)(1994-5#1)(1995-11#1)(1996-7#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
than the cost of providing##2##5##(1993-1#1)(1995-1#1)
than the cost of##4##4##(1993-1#1)(1995-1#1)(2008-8#1)(2011-1#1)
than the critical##5##3##(1996-5#1)(2008-11#1)(2008-3#2)(2008-7#1)
than the cumulative##2##3##(2008-7#1)(2012-2#1)
than the current##3##3##(1997-1#1)(2008-10#2)
than the currently##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
than the data##2##3##(2008-3#1)(2011-1#1)
than the development##2##3##(2008-10#1)(2008-4#1)
than the diffuse##2##3##(2008-2#1)(2008-3#1)
than the direct##5##3##(1992-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-2#1)
than the dose of 0##2##5##(2011-1#2)
than the effect of##2##4##(1994-11#1)(2012-2#1)
than the effects of##2##4##(2008-10#1)(2008-11#1)
than the electron##2##3##(2008-10#2)
than the equivalent##2##3##(2008-11#1)(2008-3#1)
than the ester-type##2##3##(2008-10#2)
than the expected##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
than the first##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#2)
than the first-order##2##3##(2008-3#2)
than the former##2##3##(2008-3#1)(2010-8#1)
than the frequency##3##3##(1995-8#2)(2008-10#1)
than the full##2##3##(2008-3#2)
than the gain##2##3##(2008-3#1)(2008-4#1)
than the general population##8##4##(1996-3#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2013-1#2)
than the general##9##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#2)
than the gross domestic product##2##5##(1993-3#1)(1996-2#1)
than the group##2##3##(2008-10#1)(2009-5#1)
than the hydrophilic##2##3##(1993-6#1)(2008-5#1)
than the incident##2##3##(2007-12#1)(2008-3#1)
than the individual##3##3##(1990-12#1)(2008-8#1)(2012-2#1)
than the initial##3##3##(1995-2#1)(1996-12#1)(2008-8#1)
than the isolates##2##3##(2008-10#1)(2008-5#1)
than the late##2##3##(2008-9#1)(2011-2#1)
than the lateral##3##3##(1993-6#1)(2008-3#1)(2009-11#1)
than the latter##2##3##(2008-10#1)(2008-8#1)
than the limit of detection##2##5##(2008-10#2)
than the limit of##3##4##(2008-10#2)(2011-2#1)
than the low##3##3##(1994-7#1)(1995-12#1)(2007-7#1)
than the maximum##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
than the mean CBF##2##4##(2008-7#2)
than the mean of the components##4##6##(2008-10#4)
than the mean of##8##4##(2008-10#7)(2011-1#1)
than the mean##16##3##(1991-12#1)(2008-10#9)(2008-11#1)(2008-7#2)(2009-11#1)(2011-1#1)(2011-2#1)
than the measured##2##3##(1993-2#1)(2008-3#1)
than the model group##2##4##(1990-12#2)
than the model##3##3##(1990-12#2)(1996-2#1)
than the models##2##3##(2007-12#1)(2013-8#1)
than the more##3##3##(1994-5#1)(2008-10#1)(2008-2#1)
than the most##2##3##(2008-10#1)(2012-2#1)
than the national average##5##4##(2008-10#3)(2008-11#1)(2008-6#1)
than the national##7##3##(2008-10#3)(2008-11#1)(2008-6#1)(2010-5#2)
than the nature of the##2##5##(1994-7#1)(2008-10#1)
than the nonamended##2##3##(2008-10#2)
than the normal##6##3##(1990-7#1)(1993-1#1)(1993-3#1)(2008-10#1)(2009-10#1)(2012-2#1)
than the number of##9##4##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
than the observed##3##3##(1996-2#1)(1997-2#1)(2008-8#1)
than the older##3##3##(1996-11#1)(2008-11#1)(2008-3#1)
than the one##7##3##(1995-8#1)(2008-10#4)(2008-8#1)(2008-9#1)
than the ones##2##3##(2008-10#1)(2008-8#1)
than the opposite##2##3##(2008-10#1)(2013-1#1)
than the optimal##2##3##(2008-7#1)(2008-8#1)
than the original##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
than the other four##2##4##(2008-10#2)
than the other methods##2##4##(1994-12#1)(2008-2#1)
than the other three##4##4##(1997-6#1)(2009-11#1)(2010-2#1)(2013-8#1)
than the other treatments##2##4##(2008-10#1)(2011-2#1)
than the other two methods##2##5##(1995-2#1)(2008-10#1)
than the other two##8##4##(1995-2#1)(2008-10#4)(2008-7#1)(2011-1#1)(2013-8#1)
than the other##47##3##(1991-2#1)(1994-12#1)(1994-6#1)(1995-2#2)(1996-5#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
than the others##7##3##(1991-11#1)(1993-3#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-7#1)
than the overall##3##3##(1995-3#1)(1997-1#1)(2011-2#1)
than the parent compound##3##4##(1990-12#2)(2008-5#1)
than the parent drug##2##4##(1995-3#1)(2008-8#1)
than the parent##10##3##(1990-12#2)(1992-4#1)(1992-9#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
than the parental##3##3##(1994-12#1)(2008-10#2)
than the phase##2##3##(2007-11#1)(2011-2#1)
than the present##3##3##(1990-5#1)(2008-10#1)(2013-7#1)
than the previous##6##3##(1992-6#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
than the previously##6##3##(1991-5#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2012-3#1)
than the protein##2##3##(2008-10#1)(2010-10#1)
than the rate of##5##4##(1993-11#1)(2008-10#2)(2008-7#1)(2013-1#1)
than the rate##7##3##(1993-11#1)(1994-2#1)(2008-10#3)(2008-7#1)(2013-1#1)
than the referred##2##3##(2010-8#1)(2010-9#1)
than the respective##2##3##(2008-10#1)(2008-11#1)
than the response of##2##4##(2008-10#1)(2008-9#1)
than the role##2##3##(2006-6#1)(2010-10#1)
than the same##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
than the second##2##3##(1995-12#1)(1995-2#1)
than the single##2##3##(2008-10#1)(2012-12#1)
than the skin##2##3##(1997-6#1)(2008-2#1)
than the slope##2##3##(2008-3#1)(2009-8#1)
than the standard##5##3##(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)
than the stirred tank bioreactor##2##5##(2008-11#2)
than the substrate##2##3##(1992-6#1)(1994-12#1)
than the sum of the##3##5##(1990-6#1)(2008-4#1)(2009-10#1)
than the sum of##4##4##(1990-6#1)(2008-11#1)(2008-4#1)(2009-10#1)
than the surrounding##2##3##(1996-4#1)(2008-2#1)
than the system##2##3##(2008-10#1)(2008-2#1)
than the target##2##3##(2007-12#1)(2008-10#1)
than the three##2##3##(1993-3#1)(2008-8#1)
than the threshold for##2##4##(2011-2#1)(2012-1#1)
than the threshold##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
than the total number of##2##5##(2007-12#1)(2008-4#1)
than the total population of long-term care patients##2##8##(1995-3#2)
than the total##6##3##(1995-3#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
than the traditional##10##3##(2008-10#5)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)
than the two##3##3##(1994-5#1)(1996-9#1)(2013-1#1)
than the type##2##3##(2009-7#1)(2009-9#1)
than the underlying##2##3##(1994-5#1)(2013-1#1)
than the use of##4##4##(1997-4#1)(2008-3#2)(2008-5#1)
than the usual##4##3##(1992-11#1)(1993-12#1)(1993-8#1)(2008-3#1)
than the value of##2##4##(2008-10#1)(2008-11#1)
than the variation##2##3##(2008-10#1)(2008-4#1)
than the wavelength##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
than the width##2##3##(2008-10#1)(2008-3#1)
than the wild type##5##4##(1997-2#1)(2008-10#3)(2008-11#1)
than the wild##6##3##(1997-2#1)(2008-10#4)(2008-11#1)
than the wild-type enzyme##2##4##(1993-8#1)(1995-2#1)
than the wild-type protein##2##4##(1994-5#1)(2011-1#1)
than the wild-type strain##3##4##(2008-10#3)
than the wild-type##9##3##(1993-8#1)(1994-5#1)(1995-2#1)(2008-10#4)(2011-1#1)(2012-2#1)
than the##1120##2##(1990-11#5)(1990-12#6)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#7)(1990-8#4)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#3)(1991-5#8)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#5)(1993-3#9)(1993-6#4)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#7)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#5)(1995-12#7)(1995-2#13)(1995-3#10)(1995-5#4)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#7)(1996-2#9)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#5)(1997-4#11)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#5)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#7)(2007-11#20)(2007-12#26)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#235)(2008-11#40)(2008-12#8)(2008-2#42)(2008-3#84)(2008-4#11)(2008-5#25)(2008-6#5)(2008-7#32)(2008-8#33)(2008-9#19)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#6)(2010-7#6)(2010-8#8)(2010-9#2)(2011-1#15)(2011-2#35)(2012-1#3)(2012-12#9)(2012-2#18)(2012-3#7)(2013-1#36)(2013-7#4)(2013-8#13)
than their counterparts##3##3##(1996-3#1)(2008-7#1)(2012-3#1)
than their female counterparts##3##4##(1996-3#1)(2013-1#2)
than their male colleagues##3##4##(1991-6#1)(1995-6#1)(1997-6#1)
than their male##4##3##(1991-6#1)(1995-6#1)(1997-6#1)(2009-1#1)
than their normal##2##3##(2008-10#1)(2008-6#1)
than their own##2##3##(2008-3#1)(2010-8#1)
than their parental##2##3##(2008-10#2)
than their younger##2##3##(2010-9#1)(2013-1#1)
than their##65##2##(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-3#3)(1997-6#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#3)
than these##2##2##(1994-9#1)(2008-7#1)
than they were in##2##4##(2009-12#1)(2010-3#1)
than they were##3##3##(2008-10#1)(2009-12#1)(2010-3#1)
than they would##2##3##(1993-12#1)(1997-1#1)
than they##17##2##(1992-11#1)(1992-4#1)(1993-12#2)(1995-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-3#1)(2013-1#1)
than thioredoxin m##2##3##(1990-12#2)
than this##4##2##(1992-9#1)(1997-4#1)(2008-8#1)(2012-2#1)
than those achievable with##2##4##(2007-12#1)(2008-10#1)
than those at##5##3##(1994-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2010-8#1)
than those based on##4##4##(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
than those before##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
than those by##2##3##(2008-10#1)(2012-1#1)
than those caused by##3##4##(2008-10#2)(2008-5#1)
than those collected from##2##4##(2008-10#1)(2012-3#1)
than those containing##2##3##(2008-10#1)(2008-5#1)
than those enrolled##2##3##(1991-12#1)(2010-3#1)
than those exposed to##2##4##(2008-10#1)(2008-9#1)
than those for the##6##4##(1995-5#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-3#1)
than those for##12##3##(1992-3#1)(1995-3#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
than those found in##2##4##(2012-2#1)(2013-1#1)
than those found##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
than those from BALB/c mice##2##5##(1996-12#2)
than those from conventional##2##4##(2007-11#1)(2008-11#1)
than those from the other##2##5##(2008-12#1)(2010-5#1)
than those from the##6##4##(2007-7#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-5#1)
than those from##18##3##(1991-12#1)(1991-5#1)(1993-8#1)(1996-12#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-8#1)(2010-5#1)
than those generated by##2##4##(1995-8#1)(2013-1#1)
than those grown##2##3##(1994-12#1)(1996-12#1)
than those having##3##3##(1997-4#1)(2008-10#1)(2008-7#1)
than those imposed by##2##4##(1994-3#1)(2011-2#1)
than those in Group##2##4##(2011-2#1)(2013-1#1)
than those in control rats##2##5##(1995-3#1)(2007-10#1)
than those in control##3##4##(1995-3#1)(2007-10#1)(2012-12#1)
than those in normal##2##4##(2008-4#1)(2013-8#1)
than those in other##3##4##(1993-3#1)(2008-10#2)
than those in the control group##3##6##(2008-12#1)(2008-9#1)(2011-2#1)
than those in the control##5##5##(2008-12#1)(2008-9#2)(2011-2#2)
than those in the group##2##5##(1994-12#1)(2013-1#1)
than those in the##33##4##(1990-5#1)(1991-11#1)(1994-12#1)(1994-3#1)(1996-7#2)(2007-10#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
than those in##67##3##(1990-5#1)(1991-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-7#2)(1997-3#1)(2007-10#3)(2007-6#1)(2007-8#2)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
than those induced by CPT##2##5##(1995-5#2)
than those induced by##5##4##(1991-12#1)(1995-5#2)(2008-8#1)(2011-2#1)
than those measured##2##3##(1990-8#1)(2008-10#1)
than those not##2##3##(2010-8#1)(2011-2#1)
than those observed after##2##4##(1995-5#1)(2008-5#1)
than those observed for##2##4##(2008-10#2)
than those observed in##2##4##(2006-10#1)(2010-4#1)
than those observed##7##3##(1995-5#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
than those obtained by the##4##5##(1990-8#1)(2008-10#2)(2008-11#1)
than those obtained by##11##4##(1990-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2012-3#1)
than those obtained from##4##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
than those obtained in a##2##5##(2008-11#2)
than those obtained in the##2##5##(1995-12#1)(2008-10#1)
than those obtained in##5##4##(1992-6#1)(1995-12#1)(2008-10#1)(2008-11#2)
than those obtained with the other##2##6##(2008-10#2)
than those obtained with the##4##5##(2008-10#3)(2009-3#1)
than those obtained with##7##4##(2008-10#5)(2009-3#1)(2011-2#1)
than those obtained##34##3##(1990-8#1)(1992-6#1)(1994-11#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#19)(2008-11#4)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
than those of a##2##4##(2008-3#1)(2012-2#1)
than those of group II##2##5##(2008-10#2)
than those of other##4##4##(2008-10#1)(2009-7#1)(2011-1#1)(2012-1#1)
than those of the control group##5##6##(1994-3#1)(2008-9#4)
than those of the control##12##5##(1994-11#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-9#8)
than those of the controls after weeks##2##7##(2008-8#1)(2008-9#1)
than those of the controls##8##5##(2008-8#2)(2008-9#6)
than those of the corresponding##2##5##(1993-8#1)(1995-11#1)
than those of the normal controls##2##6##(2008-10#2)
than those of the vehicle controls at##3##7##(2008-9#3)
than those of the vehicle controls##18##6##(2008-9#18)
than those of the vehicle##19##5##(2008-9#19)
than those of the wild-type strain##2##6##(2008-10#2)
than those of the##67##4##(1990-2#1)(1990-5#2)(1991-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#33)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#1)
than those of unoriented IPMCs##2##5##(2010-4#2)
than those of wild-type##2##4##(1995-5#1)(2008-8#1)
than those of##144##3##(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#3)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#34)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#3)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
than those on##4##3##(1996-5#1)(2008-10#2)(2008-5#1)
than those previously reported##3##4##(1995-5#1)(2008-10#1)(2008-9#1)
than those produced by##2##4##(2008-10#2)
than those produced##4##3##(2008-10#4)
than those reported previously##2##4##(2007-11#1)(2008-10#1)
than those reported##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
than those required for##2##4##(1994-3#1)(2007-11#1)
than those required to##2##4##(1990-7#1)(1992-11#1)
than those required##6##3##(1990-7#1)(1992-11#1)(1994-3#2)(2007-11#1)(2011-2#1)
than those seen##4##3##(1992-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
than those that did not##2##5##(2007-10#1)(2007-12#1)
than those that follow##2##4##(2008-2#2)
than those that##15##3##(1991-5#1)(1993-3#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-8#1)(2010-8#1)
than those used in##3##4##(2008-9#2)(2010-3#1)
than those using##2##3##(2008-10#1)(2009-7#1)
than those which##2##3##(1997-2#1)(2010-8#1)
than those who did not become ill abroad##2##8##(2007-2#2)
than those who did not##3##5##(1993-3#1)(2007-2#2)
than those who had##3##4##(2007-10#1)(2007-11#1)(2011-1#1)
than those who were##3##4##(2007-2#2)(2013-8#1)
than those who##14##3##(1993-1#1)(1993-3#1)(2007-10#1)(2007-11#1)(2007-2#4)(2008-1#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
than those with a##2##4##(1991-12#1)(2008-10#1)
than those with mild##2##4##(1995-3#1)(2008-11#1)
than those with no##3##4##(1994-2#1)(2007-12#1)(2008-9#1)
than those with only##2##4##(1993-2#1)(2008-7#1)
than those with##21##3##(1990-2#1)(1991-12#1)(1993-2#1)(1994-2#2)(1995-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-1#1)(2013-1#2)
than those without##9##3##(1994-12#1)(2007-10#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
than those##487##2##(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#4)(1991-11#2)(1991-12#5)(1991-3#2)(1991-5#2)(1992-1#2)(1992-11#1)(1992-3#2)(1992-6#3)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-3#3)(1995-4#1)(1995-5#6)(1995-8#5)(1996-12#3)(1996-2#1)(1996-5#3)(1996-7#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#8)(2007-11#6)(2007-12#7)(2007-2#4)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#103)(2008-11#22)(2008-12#13)(2008-2#7)(2008-3#9)(2008-4#4)(2008-5#17)(2008-6#4)(2008-7#14)(2008-8#15)(2008-9#49)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#7)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#4)
than three hours##2##3##(1996-11#1)(2008-10#1)
than three months##9##3##(1990-12#2)(1996-3#2)(2007-2#2)(2008-11#1)(2012-2#1)(2012-3#1)
than three##30##2##(1990-12#2)(1992-9#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-3#1)(2006-6#1)(2007-2#3)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
than through##9##2##(1994-1#2)(1994-10#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)
than to changes in the##2##5##(2008-10#1)(2008-8#1)
than to changes in##3##4##(2008-10#2)(2008-8#1)
than to differentials with Pc genes from##2##7##(2008-10#2)
than to the##13##3##(1992-12#1)(1993-12#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
than to those##2##3##(1997-3#1)(2008-7#1)
than to##69##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-8#2)
than total##4##2##(1993-12#2)(2008-12#1)(2008-4#1)
than traditional approaches##2##3##(2008-10#1)(2013-1#1)
than traditional##9##2##(1993-12#1)(1994-2#1)(2008-10#3)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
than transmission##2##2##(2007-12#1)(2011-3#1)
than treating##2##2##(2011-1#1)(2011-2#1)
than true##2##2##(2011-2#1)(2012-2#1)
than two weeks##6##3##(1991-9#1)(1994-6#1)(1995-11#1)(2007-12#1)(2008-5#1)(2009-2#1)
than two years##6##3##(1990-9#1)(1996-3#1)(2007-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
than two##30##2##(1990-6#1)(1990-9#1)(1991-9#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
than twofold##3##2##(2008-10#2)(2009-5#1)
than type 2##2##3##(1992-12#1)(1997-1#1)
than type##3##2##(1992-12#1)(1997-1#1)(2008-2#1)
than typically##2##2##(2007-7#1)(2008-8#1)
than undamaged plants##2##3##(2008-8#2)
than under furrow irrigation##3##4##(2008-10#3)
than under##9##2##(1993-12#1)(1995-6#1)(1996-12#1)(2008-10#5)(2012-6#1)
than uninfected females##2##3##(2012-3#2)
than uninfected##6##2##(1993-6#1)(1994-11#1)(2008-10#2)(2012-3#2)
than unity##6##2##(1990-8#1)(1993-3#1)(2008-3#4)
than urban##3##2##(1994-2#1)(1996-3#1)(2013-1#1)
than use of##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
than used##3##2##(1991-6#1)(1992-11#1)(2007-6#1)
than using a##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
than using##8##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)
than usual##5##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
than usually##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
than values for##2##3##(1994-8#1)(2009-8#1)
than virus##2##2##(2008-10#1)(2008-11#1)
than visual##2##2##(1992-11#1)(2008-5#1)
than vitamin E##2##3##(2008-5#1)(2013-1#1)
than was the##4##3##(1995-8#1)(1997-7#1)(2008-1#1)(2008-10#1)
than was##16##2##(1995-3#1)(1995-8#2)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)
than water##4##2##(2006-11#1)(2008-10#1)(2008-8#1)(2010-8#1)
than we##2##2##(1996-3#1)(2010-12#1)
than well-nourished##2##2##(2008-11#2)
than were the##3##3##(1992-2#1)(2008-10#1)(2008-3#1)
than were their##2##3##(2008-10#1)(2008-9#1)
than were those##2##3##(1993-3#1)(2008-10#1)
than were##22##2##(1992-2#1)(1993-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2013-8#2)
than what is##4##3##(2006-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
than what would be expected from the##2##7##(2008-6#1)(2008-7#1)
than what would be##3##4##(2008-6#1)(2008-7#1)(2009-7#1)
than what##9##2##(2006-10#1)(2008-3#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-7#1)
than when a##3##3##(1992-3#1)(2007-11#1)(2008-3#1)
than when it is##4##4##(1991-12#1)(2007-11#1)(2007-12#1)(2009-5#1)
than when it##8##3##(1991-12#1)(1993-12#1)(2007-11#1)(2007-12#2)(2008-8#1)(2009-5#1)(2012-2#1)
than when the##11##3##(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-3#3)(2010-5#1)(2012-2#1)
than when they were##2##4##(2008-10#1)(2008-6#1)
than when they##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
than when##45##2##(1991-12#1)(1991-3#1)(1992-11#1)(1992-3#2)(1993-1#2)(1993-12#3)(1994-5#1)(1995-12#1)(1995-5#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#13)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#1)(2012-2#2)(2012-3#1)
than white beneficiaries##2##3##(1995-2#2)
than white##6##2##(1995-12#2)(1995-2#2)(1995-8#1)(2012-3#1)
than whites##7##2##(1995-12#2)(2008-1#1)(2010-4#1)(2011-2#3)
than wild type##3##3##(1990-2#1)(1995-2#1)(2008-10#1)
than wild-type##7##2##(1995-9#1)(2008-10#4)(2009-10#1)(2012-3#1)
than with Group##2##3##(2010-7#2)
than with P##2##3##(2008-10#2)
than with a##11##3##(1993-6#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
than with conventional##2##3##(1990-8#1)(2008-10#1)
than with ethanol##2##3##(1997-8#1)(2008-10#1)
than with other##5##3##(1993-11#1)(1993-6#1)(2008-10#1)(2008-3#1)(2009-1#1)
than with the standard##2##4##(2007-12#1)(2009-3#1)
than with the##11##3##(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2009-3#1)(2009-4#1)(2010-8#1)(2012-3#1)
than with those##3##3##(1991-9#1)(2008-10#1)(2012-3#1)
than with##81##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-5#1)(1996-3#1)(1997-8#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
than within the##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
than within##5##2##(1990-6#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
than without such##2##3##(1990-10#1)(2008-3#1)
than without##8##2##(1990-10#1)(1990-5#1)(2008-10#1)(2008-11#1)(2008-3#4)
than women in##2##3##(1995-2#1)(2008-12#1)
than women with##3##3##(1996-12#1)(2007-2#1)(2008-12#1)
than women##15##2##(1991-6#1)(1992-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-12#4)(2008-7#1)(2013-1#1)
than would be##6##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
than would##8##2##(1992-3#2)(1994-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)
than you think##2##3##(1993-5#1)(1996-2#1)
than young##2##2##(1994-6#1)(2008-3#1)
than zero##4##2##(1994-2#2)(1996-6#1)(2008-9#1)
than##9947##1##(1990-10#4)(1990-11#45)(1990-12#71)(1990-2#59)(1990-3#28)(1990-4#1)(1990-5#50)(1990-6#32)(1990-7#34)(1990-8#46)(1990-9#31)(1991-1#7)(1991-10#2)(1991-11#33)(1991-12#67)(1991-2#50)(1991-3#23)(1991-4#14)(1991-5#53)(1991-6#34)(1991-8#41)(1991-9#44)(1992-1#15)(1992-10#6)(1992-11#20)(1992-12#29)(1992-2#33)(1992-3#81)(1992-4#8)(1992-5#26)(1992-6#48)(1992-7#4)(1992-8#41)(1992-9#44)(1993-1#19)(1993-10#2)(1993-11#28)(1993-12#62)(1993-2#47)(1993-3#47)(1993-5#11)(1993-6#25)(1993-8#45)(1993-9#17)(1994-1#21)(1994-10#2)(1994-11#35)(1994-12#45)(1994-2#49)(1994-3#48)(1994-5#29)(1994-6#37)(1994-7#14)(1994-8#42)(1994-9#14)(1995-1#20)(1995-11#42)(1995-12#57)(1995-2#63)(1995-3#47)(1995-4#10)(1995-5#55)(1995-6#36)(1995-8#34)(1995-9#6)(1996-1#11)(1996-10#3)(1996-11#16)(1996-12#61)(1996-2#43)(1996-3#53)(1996-4#8)(1996-5#48)(1996-6#16)(1996-7#20)(1996-8#12)(1996-9#16)(1997-1#25)(1997-2#54)(1997-3#49)(1997-4#66)(1997-5#10)(1997-6#36)(1997-7#23)(1997-8#33)(1997-9#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#5)(2006-8#1)(2007-1#1)(2007-10#44)(2007-11#164)(2007-12#215)(2007-2#21)(2007-4#5)(2007-5#9)(2007-6#11)(2007-7#36)(2007-8#47)(2007-9#4)(2008-1#94)(2008-10#1955)(2008-11#339)(2008-12#129)(2008-2#265)(2008-3#527)(2008-4#88)(2008-5#246)(2008-6#100)(2008-7#277)(2008-8#249)(2008-9#264)(2009-1#3)(2009-10#20)(2009-11#28)(2009-12#21)(2009-2#21)(2009-3#20)(2009-4#25)(2009-5#44)(2009-6#25)(2009-7#47)(2009-8#60)(2009-9#23)(2010-1#16)(2010-10#23)(2010-11#26)(2010-12#37)(2010-2#37)(2010-3#41)(2010-4#43)(2010-5#30)(2010-6#20)(2010-7#30)(2010-8#66)(2010-9#15)(2011-1#105)(2011-2#343)(2011-3#20)(2011-7#1)(2012-1#38)(2012-12#90)(2012-2#189)(2012-3#122)(2012-4#1)(2012-5#4)(2012-6#3)(2012-7#5)(2012-9#6)(2013-1#288)(2013-7#30)(2013-8#133)
thank the##2##2##(2008-4#1)(2011-2#1)
thank##5##1##(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
thanked##2##1##(2008-11#1)(2008-5#1)
thanks to its##5##3##(1990-5#1)(1990-9#1)(2008-10#1)(2012-2#2)
thanks to the##10##3##(1990-3#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#2)
thanks to##26##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)
thanthat##2##1##(2008-11#2)
thanthose##2##1##(2008-11#1)(2008-2#1)
thapsigargin and##2##2##(1994-3#1)(2006-6#1)
thapsigargin increased##2##2##(1992-5#2)
thapsigargin##18##1##(1991-6#2)(1991-8#1)(1992-11#1)(1992-5#4)(1994-11#1)(1994-3#1)(1996-5#1)(1997-7#2)(2006-6#2)(2008-11#1)(2008-4#1)(2013-1#1)
thapsigargin-induced##2##1##(1991-8#1)(1992-11#1)
thapsigargin-sensitive Ca2+##2##2##(1991-8#1)(1992-11#1)
thapsigargin-sensitive##5##1##(1991-8#2)(1992-11#1)(2008-4#2)
thapsinum##3##1##(2008-10#3)
that &gt##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
that &lt##2##2##(2008-10#1)(2008-3#1)
that &quot##24##2##(1991-3#1)(1992-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#3)
that (1) the##8##3##(1993-1#1)(1994-8#1)(2007-10#1)(2008-10#1)(2008-3#3)(2012-3#1)
that (1)##24##2##(1993-1#1)(1993-12#1)(1994-5#1)(1994-8#2)(1996-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#5)(2008-8#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
that (a) the##4##3##(1990-11#1)(1994-6#1)(2007-12#1)(2008-4#1)
that (a)##18##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-7#1)
that (i) in##2##3##(1994-8#1)(1995-2#1)
that (i) the##8##3##(1994-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#3)(2012-5#1)
that (i)##22##2##(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-2#1)(2008-10#7)(2008-3#1)(2008-8#4)(2008-9#3)(2012-5#1)
that 0##5##2##(1992-11#1)(2008-10#4)
that 1##10##2##(1990-3#1)(1992-12#1)(1995-12#2)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-1#1)
that 1)##2##2##(1992-3#1)(2011-1#1)
that 10##6##2##(1992-7#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-12#1)(2012-12#1)
that 100##4##2##(1993-11#1)(2007-12#1)(2012-12#1)(2012-2#1)
that 12##3##2##(1992-11#1)(1992-12#1)(2008-10#1)
that 13##2##2##(1994-6#1)(1995-8#1)
that 14##4##2##(1990-2#1)(1991-5#1)(2008-1#1)(2008-5#1)
that 14-3-3##2##2##(2008-11#2)
that 14Dea2##2##2##(2008-11#2)
that 16##2##2##(1992-12#1)(2008-8#1)
that 17##2##2##(1990-11#1)(1996-8#1)
that 2##10##2##(1995-2#2)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
that 2%##2##2##(1993-1#1)(2009-6#1)
that 2-azido-[32P]ATP is##2##3##(1995-6#2)
that 21##4##2##(2007-7#2)(2008-6#1)(2012-2#1)
that 24##3##2##(1990-11#1)(1990-5#1)(2008-7#1)
that 25%##2##2##(2008-7#1)(2011-2#1)
that 29##2##2##(1990-12#1)(1997-3#1)
that 2f detection##2##3##(2008-3#2)
that 2f##3##2##(2008-3#3)
that 3##4##2##(1991-5#1)(1992-6#1)(1996-2#1)(2010-1#1)
that 30%##2##2##(1997-8#1)(2008-10#1)
that 32##2##2##(2008-10#1)(2013-8#1)
that 37% of##2##3##(2007-10#1)(2010-3#1)
that 4##4##2##(2007-8#1)(2009-10#1)(2010-5#1)(2013-1#1)
that 40% of##2##3##(2008-1#1)(2011-2#1)
that 40%##3##2##(1990-7#1)(2008-1#1)(2011-2#1)
that 42##2##2##(1991-3#1)(2012-12#1)
that 4f##2##2##(2008-3#2)
that 5##7##2##(1991-11#1)(1994-8#1)(1997-8#1)(2008-10#2)(2009-12#1)(2012-2#1)
that 5-HT##8##2##(1990-5#1)(1992-1#1)(1992-8#1)(1993-12#1)(2008-2#1)(2008-7#2)(2011-3#1)
that 53% of##2##3##(1990-6#1)(1994-12#1)
that 59%##2##2##(2007-7#1)(2008-10#1)
that 6-year-old children##2##3##(2008-2#2)
that 63##2##2##(1992-11#1)(1994-8#1)
that 64% of the##2##4##(1992-9#1)(2008-10#1)
that 65% of##2##3##(1992-8#1)(2007-12#1)
that 7##4##2##(1992-8#1)(1994-5#2)(2008-7#1)
that 70##2##2##(2012-12#2)
that 8-BDB-TA-5'-TP reacts##2##3##(1990-7#2)
that 85% of##2##3##(1997-3#1)(2008-10#1)
that 89##2##2##(1993-3#1)(2008-12#1)
that 9##5##2##(1992-4#1)(1994-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
that 90% of the##2##4##(1992-12#1)(1995-5#1)
that 91% of##2##3##(1993-3#1)(2012-12#1)
that 92% of the##2##4##(1995-3#1)(2008-10#1)
that 92% of##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
that 93%##2##2##(2008-10#1)(2013-8#1)
that 95% of the##2##4##(2008-10#1)(2008-9#1)
that 95%##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
that 99##2##2##(1996-6#1)(2008-11#1)
that A beta 1-40##2##4##(1994-11#2)
that A beta##3##3##(1994-11#2)(1996-2#1)
that A##15##2##(1990-12#1)(1993-9#1)(1994-11#2)(1996-2#1)(2008-10#5)(2008-5#2)(2009-8#1)(2011-2#1)(2013-1#1)
that A4H##2##2##(2010-2#2)
that AA##2##2##(1993-3#1)(2008-11#1)
that ACh##2##2##(1995-12#1)(2008-8#1)
that ADAMTS13 is##2##3##(2009-7#2)
that ADAMTS13##3##2##(2009-7#3)
that ADH-I##2##2##(2008-11#2)
that ADT##2##2##(2008-2#1)(2008-7#1)
that AGP##2##2##(1991-12#1)(1997-3#1)
that AGR##2##2##(2008-10#2)
that AI##2##2##(2007-12#2)
that AIDS##2##2##(1993-1#1)(1996-9#1)
that AII##2##2##(1997-2#1)(2008-10#1)
that ALR##2##2##(2008-8#2)
that AM##2##2##(1994-11#2)
that AMP##2##2##(2008-10#1)(2008-9#1)
that ANN##2##2##(2008-10#1)(2010-8#1)
that ANP##3##2##(1993-8#1)(2008-5#2)
that APP##2##2##(1992-6#1)(1994-11#1)
that ASY##2##2##(2008-9#2)
that ATP levels##2##3##(1991-9#1)(1994-8#1)
that ATP##14##2##(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#1)(1994-8#1)(1995-12#1)(1997-7#3)(2008-4#4)(2008-5#1)
that ATRA##2##2##(2008-4#2)
that Affect##2##2##(2008-10#2)
that African Americans##2##3##(2010-7#1)(2013-1#1)
that African##5##2##(2009-5#1)(2010-1#1)(2010-5#1)(2010-7#1)(2013-1#1)
that Alport syndrome##2##3##(2011-2#2)
that Amberlite##2##2##(2008-10#2)
that AngCP##3##2##(2008-9#3)
that Ap(n)As##2##2##(1997-7#2)
that Argireline##2##2##(2008-5#2)
that As##2##2##(2008-10#2)
that As(2)O(3)##3##2##(2008-8#3)
that Asian##2##2##(2008-3#1)(2008-5#1)
that AtSNX2b is##2##3##(2009-10#2)
that AxRF1##2##2##(2008-9#2)
that B##10##2##(2008-10#5)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
that B/CYDVs##2##2##(2008-9#2)
that BAL##2##2##(1991-2#2)
that BCMoV##3##2##(2008-10#3)
that BDNF##6##2##(1995-5#1)(1997-2#1)(1997-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
that BGQ60##2##2##(1995-6#2)
that BMI is##2##3##(2007-12#1)(2013-8#1)
that BMI##3##2##(2007-12#2)(2013-8#1)
that BON cells##2##3##(1994-8#2)
that BR##2##2##(2008-9#2)
that BTX##2##2##(2008-8#2)
that Bifidobacterium##2##2##(2008-11#1)(2008-5#1)
that Black Deaf##2##3##(2011-2#2)
that Black##4##2##(2009-9#1)(2011-2#3)
that Bortezomib##2##2##(2012-12#2)
that Bp-1 protein##2##3##(1992-11#2)
that Buffon##2##2##(2008-12#2)
that C##18##2##(2007-7#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
that C-ADR##2##2##(2012-12#2)
that CA##2##2##(1995-11#1)(2008-11#1)
that CBF is a##2##4##(1995-2#1)(2012-2#1)
that CBF##3##2##(1995-2#1)(2012-2#2)
that CC-516##4##2##(2008-5#4)
that CCSV is a##2##4##(2008-10#2)
that CD39##2##2##(2008-4#2)
that CD4(+) T cells were##2##5##(2008-11#2)
that CD4(+) T cells##4##4##(2008-11#3)(2010-5#1)
that CD4(+)##5##2##(2008-11#3)(2010-1#1)(2010-5#1)
that CDS##2##2##(1990-6#1)(2008-3#1)
that CGRP##2##2##(1992-6#2)
that CI strains##2##3##(2008-8#2)
that CI##3##2##(2008-8#3)
that CL##4##2##(1995-2#2)(2008-8#2)
that CLCrV has a##2##4##(2008-10#2)
that CMV##5##2##(2007-7#1)(2008-10#4)
that CNP##2##2##(1993-11#1)(1994-11#1)
that CNTF##2##2##(1996-2#2)
that CR##2##2##(2008-10#1)(2009-10#1)
that CRF##2##2##(1997-4#2)
that CT##2##2##(2008-1#1)(2008-7#1)
that Ca2+ binding##2##3##(1990-7#1)(1994-5#1)
that Ca2+##8##2##(1990-7#3)(1992-11#1)(1993-5#1)(1994-11#1)(1994-5#1)(1997-7#1)
that CaM kinase II##2##4##(1990-5#2)
that CaM kinase##3##3##(1990-5#2)(1994-6#1)
that CaM##4##2##(1990-5#2)(1994-6#1)(2008-8#1)
that Catalyser-21(TM) has##2##3##(2008-11#2)
that Catalyser-21(TM)##4##2##(2008-11#4)
that Caucasian##3##2##(2008-5#1)(2009-7#1)(2010-8#1)
that Cause##2##2##(2008-10#2)
that Cd2+##2##2##(1991-12#2)
that ChMV##2##2##(2008-10#2)
that China##2##2##(2007-12#1)(2008-8#1)
that Congress##3##2##(1991-1#1)(1995-12#1)(1995-6#1)
that Crk##2##2##(2012-12#2)
that Cruzan's##2##2##(2008-2#2)
that CsA##6##2##(1990-12#1)(1994-3#1)(1994-8#3)(2007-7#1)
that Cu##2##2##(1995-3#1)(2008-10#1)
that Cuc E##2##3##(2008-11#2)
that D##6##2##(1995-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)
that DHEA##3##2##(1994-6#2)(2012-3#1)
that DM##2##2##(2007-7#1)(2008-3#1)
that DNA fragmentation##2##3##(1992-9#1)(1993-8#1)
that DNA##21##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
that DNA-A##2##2##(2008-10#2)
that DPPC##2##2##(2008-8#2)
that DYS19##2##2##(2008-12#2)
that Delta##2##2##(1997-5#2)
that DuP##2##2##(1991-5#1)(1991-9#1)
that E##6##2##(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-8#1)
that E-cadherin##2##2##(2012-2#1)(2013-1#1)
that E2##2##2##(1995-9#1)(2008-11#1)
that E5050##2##2##(1990-7#2)
that EA##2##2##(2008-10#2)
that EBV##2##2##(1993-8#1)(1994-8#1)
that EDRF1##3##2##(2008-8#1)(2008-9#2)
that EGF##6##2##(1991-7#1)(1993-3#1)(1993-9#1)(1994-6#1)(2008-6#1)(2008-8#1)
that EGF-R##2##2##(1994-9#1)(1995-6#1)
that ELISA##2##2##(2007-2#1)(2008-10#1)
that EPEC##2##2##(2011-2#2)
that ER##2##2##(1992-6#1)(2007-12#1)
that ERW supplemented with##2##4##(2008-11#2)
that ET-1##4##2##(1991-2#1)(1991-5#1)(1993-3#2)
that East Asians##2##3##(2008-5#2)
that F##9##2##(2008-10#8)(2008-5#1)
that FALSG93A mice##2##3##(1996-5#2)
that FGF##2##2##(1991-12#1)(2012-12#1)
that FGF-2##2##2##(1997-4#1)(2008-11#1)
that FHL3##3##2##(2012-3#3)
that FMRFamide or##2##3##(1991-1#2)
that FSH##2##2##(1993-11#1)(2012-12#1)
that Fas##3##2##(2008-8#1)(2010-3#2)
that Fe(II)##2##2##(1996-2#1)(2008-10#1)
that Fusarium##2##2##(2008-12#1)(2008-5#1)
that G beta##2##3##(1995-8#2)
that G protein##3##3##(1990-2#1)(2008-4#2)
that G##11##2##(1990-2#1)(1991-2#1)(1992-9#1)(1995-8#2)(1996-2#1)(2008-3#1)(2008-4#2)(2010-3#1)(2010-4#1)
that GABA##4##2##(1992-3#1)(1995-11#1)(2008-8#2)
that GABAB##2##2##(1990-5#1)(1992-3#1)
that GAP-43##2##2##(1995-12#1)(2008-9#1)
that GC7##3##2##(1997-1#3)
that GD12##2##2##(2013-8#2)
that GFP##3##2##(1996-6#1)(2008-11#1)(2008-7#1)
that GH##4##2##(1997-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
that GHR##2##2##(2012-1#2)
that GLA is##2##3##(2008-5#1)(2008-7#1)
that GLP-1##2##2##(1996-2#1)(2010-11#1)
that GPR80 is##2##3##(2008-4#2)
that GPR80/99 is an##2##4##(2008-4#2)
that GPR80/99 is##3##3##(2008-4#3)
that GSH##4##2##(1991-8#1)(1992-12#1)(2008-10#1)(2013-1#1)
that GTP##2##2##(2008-3#2)
that GUS##2##2##(2008-9#2)
that GhTub1##2##2##(2008-9#2)
that Glu-1##2##2##(2008-10#2)
that God##3##2##(2008-4#1)(2013-1#2)
that Golgi passage is##2##4##(2009-2#2)
that Golgi##3##2##(1995-2#1)(2009-2#2)
that H##7##2##(2008-1#1)(2008-12#1)(2008-2#1)(2008-8#2)(2010-12#1)(2011-2#1)
that HA##4##2##(2007-8#1)(2008-10#2)(2013-8#1)
that HAP##2##2##(2008-7#1)(2008-9#1)
that HBV##2##2##(2008-10#1)(2009-3#1)
that HCV##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
that HCWA may##2##3##(2008-10#2)
that HG##2##2##(2008-1#1)(2008-7#1)
that HGF##3##2##(1990-12#1)(1992-12#1)(1993-3#1)
that HIV##6##2##(1996-5#2)(1997-5#1)(1997-6#1)(2010-12#1)(2011-2#1)
that HIV-1##2##2##(2008-11#1)(2013-1#1)
that HMOs##2##2##(1993-1#1)(1994-3#1)
that HPRG##2##2##(1995-2#2)
that HPV infection in the##2##5##(2013-1#2)
that HPV##3##2##(1991-2#1)(2013-1#2)
that HcNPV attachment to Sf21 cells##2##6##(2008-11#2)
that HcNPV##3##2##(2008-11#3)
that HeLa##2##2##(1995-6#1)(2008-11#1)
that Hg##3##2##(1995-3#1)(2008-10#2)
that Hispanic##2##2##(2011-2#1)(2012-12#1)
that Hsp90##2##2##(1997-4#2)
that I will discuss##2##4##(2007-5#1)(2010-3#1)
that I##7##2##(1991-12#1)(1995-2#1)(2007-5#1)(2008-10#2)(2008-2#1)(2010-3#1)
that IBD slopes##2##3##(2008-9#2)
that IBD##3##2##(2008-9#3)
that IFN-gamma##4##2##(1992-12#1)(1996-12#1)(2008-8#1)(2010-12#1)
that IFN-β produced by MSC##2##5##(2011-1#2)
that IGF-I##3##2##(1991-5#1)(1996-2#1)(2008-8#1)
that IL-1 beta##2##3##(1994-9#1)(2007-2#1)
that IL-1##6##2##(1990-11#1)(1990-12#1)(1993-8#1)(1994-9#1)(1995-12#1)(2007-2#1)
that IL-17##4##2##(2007-11#4)
that IL-4##2##2##(1996-12#1)(2009-12#1)
that IL-6##3##2##(1990-5#1)(1996-2#1)(2008-9#1)
that IL-8##3##2##(1990-5#1)(1993-6#1)(2008-10#1)
that ILBS is##2##3##(2008-7#2)
that ILBS##3##2##(2008-7#3)
that IR##3##2##(2008-10#3)
that IRF-2##2##2##(1995-12#2)
that Id-1##3##2##(2008-8#3)
that IgG##2##2##(1996-12#1)(2009-8#1)
that InsP6##2##2##(1990-7#2)
that J##2##2##(2008-10#1)(2012-2#1)
that KT##2##2##(2013-1#2)
that Ki-energy may##2##3##(2008-10#2)
that Kv11##3##2##(2008-8#3)
that L##3##2##(2006-10#1)(2011-1#2)
that L-PHP##5##2##(2013-7#5)
that L1##2##2##(1995-2#1)(2008-7#1)
that LA##2##2##(2007-7#1)(2009-8#1)
that LAIV was more protective##2##5##(2011-2#2)
that LAIV##3##2##(2011-2#3)
that LAVH##2##2##(1995-1#1)(1995-3#1)
that LChV-3##2##2##(2008-10#2)
that LDH##3##2##(2008-11#1)(2011-2#2)
that LDL##2##2##(1995-12#1)(2008-1#1)
that LINC1##2##2##(2009-8#2)
that LIPUS##2##2##(2013-1#2)
that LMWH is##2##3##(2007-7#1)(2008-1#1)
that LP##2##2##(2008-10#1)(2008-12#1)
that LPS##6##2##(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#2)
that La##2##2##(1992-11#1)(2008-5#1)
that La(3+)##2##2##(2008-9#2)
that La/B(4)C##2##2##(2007-11#1)(2008-3#1)
that LapSVM##2##2##(2010-7#2)
that M##16##2##(1990-5#1)(2008-10#8)(2008-5#3)(2010-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
that M79##2##2##(2008-8#2)
that MAAE##2##2##(1996-12#2)
that MAP##2##2##(1992-8#1)(2008-4#1)
that MB##2##2##(2008-10#1)(2012-2#1)
that MC1R##3##2##(2008-9#3)
that MHC class I##2##4##(2008-1#2)
that MI is##2##3##(2013-1#1)(2013-8#1)
that MI##3##2##(2013-1#2)(2013-8#1)
that MMN##2##2##(2008-8#2)
that MP##2##2##(2008-9#2)
that MPP+##2##2##(1990-5#2)
that MRI is the##2##4##(1996-9#1)(2010-12#1)
that MRI##3##2##(1996-9#1)(2008-7#1)(2010-12#1)
that MS##2##2##(2008-3#2)
that MT##2##2##(1993-12#1)(2008-10#1)
that MTs##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
that MW##2##2##(2007-8#1)(2008-9#1)
that MaMPRV##2##2##(2008-10#2)
that Mb##2##2##(2008-10#2)
that Medicaid##3##2##(1995-2#1)(1996-1#1)(1997-1#1)
that Medicare##5##2##(1992-1#1)(1994-1#1)(1995-2#1)(1996-12#1)(1997-3#1)
that MhNPR1##2##2##(2011-10#2)
that N##2##2##(1991-8#1)(2010-8#1)
that N-terminal##2##2##(1997-6#1)(2008-7#1)
that NADPH##2##2##(2008-1#1)(2013-1#1)
that NF-kappa B##2##3##(1995-12#1)(1995-2#1)
that NF1##2##2##(1991-5#1)(2008-7#1)
that NGF##3##2##(1993-12#1)(1996-2#1)(1997-6#1)
that NIRS##2##2##(2008-10#2)
that NK cells##2##3##(1994-9#1)(2008-4#1)
that NK##3##2##(1994-9#1)(2006-10#1)(2008-4#1)
that NMDA receptor##2##3##(1996-12#1)(1997-2#1)
that NMDA receptors are##2##4##(1993-5#1)(1997-7#1)
that NMDA receptors##3##3##(1993-5#1)(1996-12#1)(1997-7#1)
that NMDA##6##2##(1992-8#1)(1993-5#1)(1996-12#2)(1997-2#1)(1997-7#1)
that NO is an##2##4##(2008-11#1)(2012-2#1)
that NO is##4##3##(1995-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
that NO##10##2##(1992-12#2)(1994-6#1)(1995-11#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
that NPIK##2##2##(1997-8#2)
that Na(+)##2##2##(2008-5#1)(2008-8#1)
that Nck##2##2##(1997-4#2)
that NodB##2##2##(1994-8#2)
that O##2##2##(2008-10#1)(2008-11#1)
that O2##2##2##(2008-10#1)(2008-3#1)
that OA##2##2##(1992-12#1)(1993-6#1)
that OH-Tam##2##2##(1990-12#2)
that P##26##2##(1992-12#1)(2008-10#16)(2008-12#1)(2008-5#2)(2009-9#1)(2010-3#1)(2010-8#1)(2011-10#1)(2012-12#1)(2013-7#1)
that P-450aldo##2##2##(1990-11#2)
that P-glycoprotein is##2##3##(2008-11#2)
that P-glycoprotein##4##2##(2008-11#3)(2008-7#1)
that P1##2##2##(1994-6#1)(1996-12#1)
that P2##3##2##(2008-11#2)(2008-4#1)
that P50##2##2##(2008-10#2)
that PAF##3##2##(1991-12#2)(2008-3#1)
that PAI-1##3##2##(2008-4#1)(2011-2#2)
that PAP##3##2##(2008-10#3)
that PC##3##2##(1991-5#1)(2008-10#1)(2012-3#1)
that PCFV is##2##3##(2008-10#2)
that PCFV##3##2##(2008-10#3)
that PCH will##2##3##(2013-8#2)
that PD patients have##2##4##(2008-7#2)
that PD patients##3##3##(2008-7#2)(2009-10#1)
that PD##4##2##(2008-7#3)(2009-10#1)
that PFE##2##2##(2008-9#2)
that PGD-S is##2##3##(1996-2#2)
that PI 3-kinase##2##3##(1995-8#1)(2008-11#1)
that PIP2-mediated inhibition of##2##4##(1993-6#2)
that PIP3##2##2##(1993-8#2)
that PKA##2##2##(2008-8#2)
that PKC epsilon##2##3##(1995-2#2)
that PKC##12##2##(1990-5#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1995-2#2)(2008-11#1)(2008-8#1)
that PL##2##2##(1990-12#1)(2008-7#1)
that PMA##2##2##(1994-6#1)(1996-2#1)
that PMM##2##2##(2007-12#2)
that PN-2/APP is##2##3##(1991-2#1)(1992-12#1)
that PN-2/APP##3##2##(1991-2#1)(1992-12#2)
that POMC##2##2##(1993-5#2)
that PP DCs##2##3##(2008-11#2)
that PRms##2##2##(2008-10#2)
that PSA##2##2##(2008-4#1)(2009-4#1)
that PSV strain BV-15##2##4##(2008-10#2)
that PSV##4##2##(2007-10#1)(2008-10#3)
that Pb##2##2##(2008-7#2)
that PcpD##2##2##(2009-3#2)
that Platycopia##2##2##(2008-5#2)
that PptT is##2##3##(2013-1#2)
that PptT##4##2##(2013-1#4)
that Pythium##2##2##(2008-10#2)
that QUAD##3##2##(1994-11#3)
that R##7##2##(2008-10#6)(2012-2#1)
that RA##3##2##(1990-6#1)(2008-11#2)
that RA538 could##2##3##(2008-8#2)
that RAM 7s encodes part of a##2##7##(1993-8#2)
that RAM 7s##3##3##(1993-8#3)
that RBM3##2##2##(1997-7#2)
that RBV##2##2##(2013-1#2)
that RNA polymerase II##2##4##(1994-3#1)(2010-11#1)
that RNA polymerase##3##3##(1994-3#1)(1994-8#1)(2010-11#1)
that RNA##5##2##(1991-9#1)(1994-3#1)(1994-8#1)(2008-10#1)(2010-11#1)
that RNAi##2##2##(2008-2#1)(2008-9#1)
that ROS##4##2##(2009-8#1)(2010-12#1)(2011-2#1)(2012-6#1)
that RW##2##2##(2008-11#2)
that Rab11 is##2##3##(1997-1#2)
that Rabphilin-3A##2##2##(1994-11#1)(1994-9#1)
that Ras can##2##3##(1996-2#1)(1997-6#1)
that Ras##4##2##(1994-8#1)(1996-2#1)(1997-6#2)
that RepK##2##2##(1997-6#2)
that S##11##2##(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
that S1 is##2##3##(1997-2#1)(2008-12#1)
that SC##2##2##(2008-5#1)(2011-2#1)
that SFE##2##2##(2008-10#2)
that SI##3##2##(1997-8#1)(2008-7#2)
that SNP##2##2##(2008-11#2)
that SO3##2##2##(1994-11#2)
that SR##2##2##(1995-6#2)
that SRT1720##2##2##(2012-2#2)
that SS767##2##2##(2008-10#2)
that STH2##2##2##(2009-8#2)
that SV-toxins##2##2##(2008-10#2)
that SVR##2##2##(2011-2#1)(2012-1#1)
that SYSV##2##2##(2008-10#2)
that Saccharomyces##2##2##(2011-1#1)(2012-3#1)
that SbPRP##2##2##(2008-8#2)
that Sec61##2##2##(1991-2#2)
that Si##3##2##(2008-10#2)(2008-9#1)
that Smad7##2##2##(2012-12#2)
that South##2##2##(2008-3#1)(2011-1#1)
that SqVYV##2##2##(2008-10#2)
that Src##3##2##(1995-11#1)(1995-6#1)(2011-2#1)
that T##18##2##(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-5#1)(2008-6#1)(2010-2#1)(2013-8#1)
that T-cells are##2##3##(2008-10#2)
that T-cells##3##2##(1997-6#1)(2008-10#2)
that TBARS##2##2##(1993-2#1)(2008-10#1)
that TCDD-induced##2##2##(1992-12#1)(1995-3#1)
that TGF##2##2##(1990-12#1)(1997-4#1)
that TGF-beta##2##2##(1993-8#1)(2008-11#1)
that TMV-p##2##2##(1997-6#2)
that TNF##4##2##(1990-12#1)(1990-5#2)(1990-7#1)
that TNF-alpha##2##2##(2013-1#2)
that TNT##2##2##(1995-6#1)(2008-10#1)
that TPA##4##2##(1990-8#1)(1992-8#1)(1992-9#2)
that TPN##2##2##(1994-6#2)
that TRBP##2##2##(1994-8#2)
that TRH##4##2##(1991-12#1)(1994-2#1)(1994-6#1)(2013-7#1)
that TSP##2##2##(1993-9#1)(2013-8#1)
that TSPO##3##2##(2012-2#3)
that TSWV##4##2##(2008-10#4)
that TTM##2##2##(2010-12#2)
that TUF##2##2##(1990-5#2)
that TYLCV-CHI is##2##3##(2008-8#2)
that TdT##2##2##(1997-9#2)
that Tf##2##2##(2013-7#2)
that Thal##2##2##(2008-3#2)
that Tid1##3##2##(2011-2#3)
that Title III##2##3##(1997-5#2)
that Trichoderma##2##2##(2008-10#2)
that U##3##2##(1996-2#1)(2008-10#2)
that UDCA##2##2##(2008-8#2)
that UFN##2##2##(1993-8#2)
that US##2##2##(2010-12#1)(2012-12#1)
that UTP##2##2##(1993-8#1)(2008-4#1)
that UV irradiation##2##3##(1995-2#1)(2008-5#1)
that UV##5##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
that UVA##2##2##(2008-5#1)(2011-2#1)
that UVR##2##2##(2011-2#2)
that V##5##2##(2008-10#3)(2008-9#1)(2009-8#1)
that VDR##2##2##(1992-12#1)(1995-2#1)
that VEGF##3##2##(2008-9#1)(2009-8#2)
that VIP##3##2##(1995-5#2)(2008-4#1)
that VPA##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
that WEP##2##2##(2008-11#2)
that WIPK##2##2##(2009-8#2)
that WM##2##2##(2010-7#1)(2012-2#1)
that WSMV##3##2##(2008-10#3)
that X##7##2##(1997-2#1)(2008-10#6)
that YY1##4##2##(2008-11#4)
that ZMA supplementation##2##3##(2008-5#2)
that Zn##5##2##(1993-12#1)(2008-10#3)(2008-12#1)
that Zn2+##2##2##(1995-6#2)
that [Ca(2+)](i)##2##2##(2008-9#2)
that a &quot##2##3##(1993-1#1)(1994-2#1)
that a 1##4##3##(1993-12#1)(2007-11#1)(2008-7#1)(2013-8#1)
that a 2##2##3##(1995-6#1)(2010-9#1)
that a broader##3##3##(1993-3#1)(2008-7#1)(2011-2#1)
that a careful##2##3##(1990-10#1)(2009-7#1)
that a causal relationship##2##4##(1992-2#1)(1997-4#1)
that a causal##4##3##(1992-2#1)(1997-4#1)(2008-11#1)(2013-7#1)
that a change in##3##4##(2008-8#1)(2008-9#1)(2013-7#1)
that a change##4##3##(1994-8#1)(2008-8#1)(2008-9#1)(2013-7#1)
that a close##2##3##(1990-2#1)(2009-2#1)
that a combination of##9##4##(1991-11#1)(1994-8#1)(1997-9#1)(2007-7#2)(2008-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
that a combination##10##3##(1991-11#1)(1994-8#1)(1997-9#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
that a common##2##3##(1990-5#1)(1997-2#1)
that a complex##2##3##(2008-2#1)(2010-4#1)
that a conserved##3##3##(1992-8#1)(2008-3#1)(2009-8#1)
that a critical##6##3##(1994-2#1)(1995-8#1)(1996-2#1)(2008-2#1)(2008-7#1)(2010-7#1)
that a decline##2##3##(2008-7#1)(2009-4#1)
that a decrease in##2##4##(2008-5#1)(2012-2#1)
that a decrease##3##3##(1994-5#1)(2008-5#1)(2012-2#1)
that a deeper understanding of##2##5##(2008-11#1)(2010-7#1)
that a defect in##2##4##(1995-2#1)(1996-9#1)
that a defined##2##3##(2008-10#1)(2009-5#1)
that a delayed##2##3##(2007-7#1)(2011-1#1)
that a difference in##2##4##(1990-2#1)(2013-8#1)
that a different##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
that a direct##2##3##(1994-8#1)(2007-11#1)
that a diverse range of##2##5##(2009-10#1)(2011-2#1)
that a double##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
that a factor##2##3##(1991-5#1)(2010-11#1)
that a few##3##3##(1991-6#1)(2008-10#1)(2011-2#1)
that a focal adhesion-like process##2##5##(2008-7#2)
that a fragment from##2##4##(1992-6#1)(1993-3#1)
that a fully##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
that a gene##3##3##(1997-3#2)(2008-4#1)
that a good##3##3##(1993-6#1)(1995-2#1)(2007-11#1)
that a greater##3##3##(1992-9#1)(2008-5#1)(2009-7#1)
that a high level of##5##5##(1992-9#1)(2008-10#1)(2008-11#2)(2008-9#1)
that a high level##6##4##(1992-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
that a high##16##3##(1991-12#1)(1992-9#1)(1993-9#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-6#1)(2013-1#1)
that a higher level##2##4##(2009-10#1)(2009-5#1)
that a higher##3##3##(2008-8#1)(2009-10#1)(2009-5#1)
that a highly##3##3##(1990-12#1)(1993-11#1)(2008-10#1)
that a hospital##3##3##(1991-3#1)(1993-2#1)(1996-2#1)
that a large number of##7##5##(1994-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
that a large##19##3##(1992-3#1)(1994-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
that a larger##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
that a limited##2##3##(2008-10#1)(2008-3#1)
that a linear##3##3##(1995-8#1)(2008-3#2)
that a low dose##2##4##(1991-11#1)(2008-3#1)
that a low##8##3##(1991-11#1)(1993-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
that a lower##2##3##(2008-3#1)(2011-2#1)
that a major##7##3##(1990-6#1)(1990-8#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-6#1)
that a majority of the people##2##6##(2010-12#2)
that a majority of the##4##5##(1994-2#1)(1996-3#1)(2010-12#2)
that a majority of##5##4##(1994-2#1)(1996-3#1)(1997-5#1)(2010-12#2)
that a majority##6##3##(1994-2#1)(1995-6#1)(1996-3#1)(1997-5#1)(2010-12#2)
that a mass transport##2##4##(1997-2#1)(2008-9#1)
that a maximum##2##3##(2008-3#2)
that a minimum of##2##4##(2008-10#1)(2010-4#1)
that a minimum##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
that a model##2##3##(2008-10#1)(2008-9#1)
that a moderate##2##3##(2008-10#1)(2008-8#1)
that a more##2##3##(2008-5#1)(2008-8#1)
that a multilayer##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
that a multimodal##2##3##(2008-12#1)(2012-3#1)
that a mutation##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
that a negative##2##3##(1996-5#1)(1997-6#1)
that a neural##3##3##(1992-8#1)(1993-6#1)(2008-2#1)
that a new##9##3##(1990-12#1)(1992-1#1)(1992-2#1)(1995-9#1)(1996-1#1)(2007-12#1)(2008-10#2)(2011-2#1)
that a nonlinear##2##3##(2007-12#1)(2011-1#1)
that a nuclear##4##3##(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)
that a number of##13##4##(1994-3#1)(1995-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-5#1)(2012-1#1)(2012-3#1)
that a parent##2##3##(2008-11#1)(2012-3#1)
that a part of##2##4##(1992-9#1)(2008-8#1)
that a particular##4##3##(1994-3#1)(2008-1#1)(2008-11#1)(2008-7#1)
that a patient##2##3##(1995-11#1)(2008-7#1)
that a physician##2##3##(1991-3#1)(1997-2#1)
that a policy##2##3##(1991-1#1)(1993-3#1)
that a portion of the##4##5##(1992-3#1)(2007-11#1)(2007-12#1)(2008-8#1)
that a positive##2##3##(1991-12#1)(2012-2#1)
that a practical##2##3##(2008-3#2)
that a previously##3##3##(1992-9#1)(1997-3#1)(2008-10#1)
that a proper##3##3##(1997-2#1)(2008-3#1)(2010-12#1)
that a protein##2##3##(1995-2#1)(2008-10#1)
that a radial##2##3##(1991-8#1)(2007-8#1)
that a reduced##2##3##(1994-11#1)(2007-11#1)
that a reduction in##4##4##(1990-5#1)(1993-9#1)(2008-9#1)(2013-1#1)
that a reduction of##2##4##(1997-7#1)(2011-2#1)
that a reduction##6##3##(1990-5#1)(1993-9#1)(1997-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
that a reference##2##3##(2008-10#1)(2009-9#1)
that a region##2##3##(1996-6#1)(1997-3#1)
that a resolution of##2##4##(2007-11#1)(2008-3#1)
that a sample##2##3##(1997-4#1)(2008-10#1)
that a second##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
that a selective##2##3##(1996-5#1)(2008-8#1)
that a set of##3##4##(2008-12#1)(2008-2#1)(2008-3#1)
that a shift in##2##4##(2008-5#1)(2008-9#1)
that a short##3##3##(1991-3#1)(2007-11#1)(2013-1#1)
that a significant improvement##3##4##(1995-4#1)(2007-12#1)(2008-3#1)
that a significant portion of the##2##6##(1990-5#1)(2008-10#1)
that a significant portion of##3##5##(1990-5#1)(2008-10#1)(2012-3#1)
that a significant proportion of##2##5##(2008-1#1)(2008-7#1)
that a significant##11##3##(1990-5#1)(1995-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
that a similar##2##3##(1993-6#1)(2009-8#1)
that a simple##9##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
that a single amino acid##2##5##(1990-11#1)(1997-2#1)
that a single dominant gene conferred##2##6##(2008-10#2)
that a single dominant gene##3##5##(2008-10#3)
that a single major gene##2##5##(2008-10#2)
that a single recessive gene##3##5##(2008-10#3)
that a single##42##3##(1990-11#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-8#1)(1994-12#2)(1995-5#1)(1996-2#1)(1997-2#2)(1997-3#1)(2006-6#1)(2007-12#2)(2008-10#15)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
that a small##4##3##(1992-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
that a specific##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
that a stable##2##3##(1995-5#1)(2008-9#1)
that a standard##2##3##(2007-11#1)(2008-7#1)
that a strong##2##3##(1992-12#1)(2008-3#1)
that a subset of##3##4##(1990-8#1)(1994-12#1)(2009-8#1)
that a substantial##2##3##(1993-12#1)(2008-8#1)
that a surprising number of##2##5##(2008-11#1)(2013-1#1)
that a systematic##2##3##(1996-3#1)(2008-3#1)
that a threshold##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
that a total##3##3##(2007-12#1)(2008-11#1)(2013-1#1)
that a trial judge##2##4##(1995-12#1)(1997-5#1)
that a uniform##2##3##(2007-11#1)(2008-3#1)
that a unique##2##3##(2008-10#1)(2008-3#1)
that a variable##2##3##(2008-5#1)(2010-6#1)
that a variety of##8##4##(1990-11#1)(1995-3#2)(1995-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
that a very##2##3##(1992-6#1)(2008-3#1)
that a wide range of##3##5##(2007-8#1)(2008-10#1)(2008-3#1)
that a wide##4##3##(2007-8#2)(2008-10#1)(2008-3#1)
that a##845##2##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#2)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#7)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#5)(1993-6#6)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#3)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#5)(1996-5#5)(1996-6#2)(1996-9#2)(1997-2#10)(1997-3#8)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#5)(1997-9#2)(2006-12#1)(2006-6#2)(2007-10#2)(2007-11#19)(2007-12#29)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#5)(2008-1#6)(2008-10#98)(2008-11#30)(2008-12#9)(2008-2#23)(2008-3#60)(2008-4#7)(2008-5#25)(2008-6#4)(2008-7#35)(2008-8#31)(2008-9#14)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#7)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#7)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#21)(2011-4#1)(2012-1#4)(2012-12#6)(2012-2#15)(2012-3#11)(2013-1#17)(2013-7#2)(2013-8#11)
that a)##2##2##(1992-3#1)(1993-11#1)
that aberrant##2##2##(2008-11#1)(2008-7#1)
that aberrations##2##2##(2008-3#2)
that abnormal##2##2##(2009-10#1)(2013-1#1)
that about 20% of##2##4##(1997-2#1)(2008-7#1)
that about half of the##2##5##(1990-11#1)(1990-2#1)
that about half of##3##4##(1990-11#1)(1990-2#1)(1991-5#1)
that about##13##2##(1990-11#1)(1990-2#3)(1991-5#1)(1995-4#1)(1996-2#1)(1997-2#2)(2007-4#1)(2008-7#1)(2008-8#1)(2009-8#1)
that above##2##2##(2007-11#1)(2008-9#1)
that absorbs##3##2##(2008-3#1)(2008-7#1)(2010-5#1)
that absorption##3##2##(2007-12#1)(2008-3#2)
that academic##2##2##(2008-11#1)(2008-12#1)
that acceptance of##2##3##(2007-12#1)(2008-10#1)
that access##3##2##(1993-12#1)(1995-12#1)(1995-2#1)
that accessions##2##2##(2008-10#1)(2008-5#1)
that accommodates the##2##3##(2008-3#1)(2013-1#1)
that accompanies the##2##3##(1993-6#1)(2008-10#1)
that accompanies##8##2##(1990-7#1)(1993-6#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#2)
that accompany the##2##3##(2008-3#1)(2011-1#1)
that accompany##7##2##(1990-3#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)
that according to##2##3##(2013-1#2)
that account for##10##3##(1993-11#1)(1993-3#2)(1994-12#1)(1996-3#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
that accounted for by##2##4##(2008-2#1)(2008-9#1)
that accounted for##5##3##(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
that accounts for the##8##4##(2008-2#2)(2008-3#3)(2008-6#1)(2012-3#1)(2013-8#1)
that accounts for##18##3##(1991-5#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
that accumulated##2##2##(1993-12#1)(2008-10#1)
that accumulates in the brain##2##5##(1992-12#2)
that accumulation of##2##3##(2008-10#1)(2009-10#1)
that accurate##3##2##(2008-3#2)(2008-7#1)
that accurately##3##2##(2008-1#2)(2008-3#1)
that acetyl-L-carnitine##2##2##(1990-7#1)(1992-7#1)
that achieved with##4##3##(1993-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
that achieved##11##2##(1993-2#1)(1995-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)
that achieves##4##2##(1990-9#1)(2007-12#2)(2008-2#1)
that acid##3##2##(1990-9#1)(2008-10#2)
that acidic##2##2##(1992-6#1)(2008-8#1)
that acknowledge##2##2##(2008-4#1)(2009-6#1)
that acoustic##4##2##(2007-5#1)(2008-3#2)(2013-7#1)
that acquire##2##2##(2008-10#1)(2008-7#1)
that acridones##2##2##(1996-4#2)
that act as##7##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
that act both##2##3##(2008-11#1)(2013-8#1)
that act by##2##3##(1993-11#1)(1995-2#1)
that act##19##2##(1993-11#1)(1995-2#1)(1997-1#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-8#1)
that actin##6##2##(1990-2#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
that activate the##3##3##(2008-8#1)(2009-3#1)(2010-10#1)
that activate##11##2##(1991-5#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)
that activated##5##2##(1992-11#1)(1996-12#1)(2008-1#2)(2008-7#1)
that activates##2##2##(1991-10#1)(1995-4#1)
that activation of the##8##4##(1992-12#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-8#1)(2013-1#1)
that activation of##25##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-7#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
that activation##27##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-7#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
that active##9##2##(1991-12#1)(1991-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
that activity in##2##3##(1990-7#1)(2008-6#1)
that activity##3##2##(1990-7#1)(2008-4#1)(2008-6#1)
that acts as a##4##4##(1992-8#1)(1995-2#1)(1997-4#1)(2008-2#1)
that acts as an##2##4##(1992-1#1)(2010-2#1)
that acts as##8##3##(1992-1#1)(1992-8#1)(1995-2#1)(1997-4#1)(2008-2#1)(2009-2#1)(2010-2#2)
that acts at the##2##4##(1995-3#1)(1997-6#1)
that acts on##2##3##(1994-12#1)(2007-12#1)
that acts##16##2##(1992-1#1)(1992-8#2)(1994-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-2#1)(2009-2#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-2#1)
that actual##3##2##(1992-3#1)(1997-8#1)(2008-5#1)
that acupuncture is##3##3##(1997-6#1)(2008-10#1)(2010-6#1)
that acupuncture##4##2##(1993-3#1)(1997-6#1)(2008-10#1)(2010-6#1)
that acute exposure to##2##4##(1992-3#1)(2008-10#1)
that acute exposure##3##3##(1992-3#1)(1993-12#1)(2008-10#1)
that acute##14##2##(1991-2#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)
that adaptation to##2##3##(2008-9#1)(2011-1#1)
that adaptations to##2##3##(1995-8#1)(2008-10#1)
that adaptations##4##2##(1995-8#1)(2008-10#1)(2008-2#1)(2009-8#1)
that adaptive##2##2##(2007-11#2)
that adapts##2##2##(2008-8#1)(2011-2#1)
that adding##2##2##(2008-6#1)(2008-8#1)
that addition of##7##3##(1993-6#1)(1994-8#1)(2007-7#1)(2008-12#1)(2009-3#1)(2010-3#1)(2010-4#1)
that additional##24##2##(1990-2#1)(1991-12#2)(1991-8#2)(1991-9#2)(1992-12#1)(1993-12#2)(1995-12#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-3#1)
that additive gene action##2##4##(2008-10#2)
that additive##4##2##(2008-10#4)
that address the##3##3##(1997-4#1)(2010-11#1)(2010-6#1)
that address these##2##3##(2008-10#1)(2010-8#1)
that address this##2##3##(1993-1#1)(2012-3#1)
that address##14##2##(1993-1#1)(1993-12#1)(1997-3#1)(1997-4#1)(2007-2#2)(2008-10#1)(2008-4#2)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-3#1)
that addressed the##2##3##(2009-9#1)(2011-2#1)
that addressed##3##2##(2009-9#1)(2011-2#1)(2013-1#1)
that addresses the##2##3##(2011-2#1)(2013-1#1)
that addresses these##2##3##(1992-9#1)(2012-3#1)
that addresses##10##2##(1991-12#1)(1992-9#1)(1995-12#1)(2008-1#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
that adenoregulin##2##2##(1993-3#1)(1994-5#1)
that adenosine##4##2##(1993-6#1)(1994-11#1)(1994-6#2)
that adequate##6##2##(1991-4#1)(1992-2#1)(1994-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
that adhered to the leaves##2##5##(2008-10#2)
that adherence to##3##3##(2008-10#1)(2008-11#1)(2009-4#1)
that adhesive AH109A cells##2##4##(2008-11#2)
that adipose tissue##2##3##(2008-5#1)(2009-2#1)
that adjunctive progestogen##3##3##(1994-9#3)
that adjunctive##7##2##(1994-9#3)(2008-6#4)
that adjusted##2##2##(1995-3#1)(2008-10#1)
that adjusts##2##2##(2008-10#1)(2008-3#1)
that adjuvant##3##2##(1991-8#1)(1992-12#1)(2007-5#1)
that administrative##2##2##(1993-2#1)(2008-4#1)
that adolescents##4##2##(2008-11#2)(2009-7#1)(2012-12#1)
that adopted a##2##3##(2010-3#1)(2012-2#1)
that adopted##3##2##(2009-8#1)(2010-3#1)(2012-2#1)
that adoption##2##2##(2008-9#1)(2009-8#1)
that adsorption##2##2##(2008-10#1)(2010-5#1)
that adult##10##2##(1991-11#1)(1992-1#1)(1994-2#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-2#1)
that adults##2##2##(2007-12#1)(2008-9#1)
that adversely##2##2##(2008-10#1)(2009-5#1)
that aerosol##2##2##(2008-3#1)(2010-3#1)
that affect synaptic##2##3##(2009-8#2)
that affect the heterogeneity of##2##5##(2008-11#1)(2008-4#1)
that affect the quality of the##2##6##(2008-2#1)(2008-3#1)
that affect the quality of##3##5##(2008-2#1)(2008-3#1)(2008-5#1)
that affect the world##2##4##(2010-9#1)(2013-1#1)
that affect the##38##3##(1991-9#1)(1993-1#1)(1994-9#2)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
that affect their##3##3##(1990-12#1)(1993-2#1)(1997-1#1)
that affect this##2##3##(2008-10#1)(2008-8#1)
that affect##70##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-9#2)(1995-12#1)(1997-1#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-7#1)
that affected the##2##3##(1995-3#1)(2008-8#1)
that affected##5##2##(1995-3#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
that affects the##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
that affects##20##2##(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
that afforded##2##2##(1992-9#1)(2008-5#1)
that after July was higher for PRE than for POST##2##10##(2012-2#2)
that after a##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
that after being##2##3##(1995-5#1)(2008-9#1)
that after the##3##3##(2009-8#1)(2012-1#1)(2013-8#1)
that after##27##2##(1992-2#1)(1995-5#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#2)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
that against##2##2##(2008-11#1)(2008-7#1)
that agarobiose##2##2##(2008-10#2)
that age at first##2##4##(1990-9#1)(2009-5#1)
that age##8##2##(1990-9#2)(1991-6#1)(1993-9#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#1)
that age-related differences in##2##4##(2008-11#1)(2009-9#1)
that age-related##5##2##(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
that aged##2##2##(1992-12#1)(1993-12#1)
that aggregate into##2##3##(2008-3#1)(2009-10#1)
that aggregation##3##2##(1992-8#1)(2008-10#2)
that aggressive##8##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-3#1)
that aging is associated with##2##5##(2008-3#1)(2008-7#1)
that aging is##3##3##(1994-5#1)(2008-3#1)(2008-7#1)
that aging##7##2##(1990-7#1)(1994-5#1)(2008-3#2)(2008-7#2)(2010-1#1)
that agree with##2##3##(2008-2#1)(2013-8#1)
that agree##3##2##(2008-2#2)(2013-8#1)
that agreed with##2##3##(1994-9#1)(2008-10#1)
that agreed##3##2##(1994-9#1)(2008-10#1)(2010-10#1)
that agreement between##2##3##(2008-8#1)(2008-9#1)
that aid##2##2##(1994-3#1)(2011-2#1)
that aids##3##2##(2008-2#1)(2011-2#1)(2012-2#1)
that aim at##2##3##(1996-3#1)(2008-7#1)
that aim to##4##3##(1996-1#1)(2009-5#1)(2011-1#1)(2011-2#1)
that aim##6##2##(1996-1#1)(1996-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
that aimed to##2##3##(2008-12#1)(2012-3#1)
that aimed##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
that aims to##4##3##(1997-4#1)(2008-7#1)(2009-5#1)(2013-8#1)
that albumin##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
that alkaline##2##2##(1992-12#1)(2008-6#1)
that all four##3##3##(1991-5#1)(1995-8#1)(2008-3#1)
that all individuals##2##3##(2008-11#2)
that all investigated##2##3##(2008-10#1)(2008-7#1)
that all isolates##2##3##(2008-10#2)
that all models##3##3##(1996-4#1)(2008-12#1)(2012-12#1)
that all of the##7##4##(1992-12#1)(1995-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)
that all of these##6##4##(1993-12#1)(1994-8#1)(2007-11#1)(2008-10#3)
that all of##13##3##(1992-12#1)(1993-12#1)(1994-8#1)(1995-9#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)
that all patients##4##3##(1990-3#1)(1997-8#1)(2008-12#1)(2012-3#1)
that all presented##2##3##(2007-10#1)(2010-5#1)
that all seven##2##3##(2008-10#1)(2009-5#1)
that all the compounds##2##4##(1992-11#1)(2008-5#1)
that all the##22##3##(1990-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#2)
that all these##3##3##(1993-8#1)(2009-4#1)(2010-3#1)
that all three isolates##2##4##(2007-12#1)(2008-10#1)
that all three##15##3##(1991-9#1)(1992-3#1)(1992-5#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
that all##149##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-8#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#1)
that alleles##2##2##(2008-10#2)
that allergic diseases##2##3##(1994-6#1)(2008-3#1)
that allergic##3##2##(1994-6#1)(2008-3#1)(2012-3#1)
that allopurinol##2##2##(1995-12#1)(2008-10#1)
that allow coexistence##2##3##(2008-8#2)
that allow for the##2##4##(2008-2#1)(2008-9#1)
that allow for##7##3##(1994-9#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
that allow one to##3##4##(2008-1#1)(2008-3#2)
that allow the##12##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#2)(2013-1#1)
that allow them to##2##4##(2008-10#1)(2010-9#1)
that allow us to##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)
that allow users to##2##4##(2008-4#2)
that allow##66##2##(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-5#2)(2008-1#3)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#2)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#3)
that allowed for the##2##4##(2008-12#1)(2013-1#1)
that allowed for##4##3##(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#1)
that allowed the##6##3##(1995-8#1)(2008-10#3)(2009-10#1)(2009-8#1)
that allowed us to##6##4##(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
that allowed##23##2##(1993-8#1)(1995-8#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#2)(2009-8#1)(2010-7#1)(2013-1#1)
that allows a##4##3##(1997-3#1)(2009-3#1)(2010-10#1)(2012-2#1)
that allows an##2##3##(2008-1#1)(2008-11#1)
that allows estimation of##2##4##(1992-12#1)(1992-6#1)
that allows for a##3##4##(2007-11#1)(2008-9#1)(2010-6#1)
that allows for the##2##4##(2008-3#1)(2013-8#1)
that allows for##10##3##(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-6#1)(2013-8#1)
that allows joint##2##3##(2008-9#1)(2009-11#1)
that allows one to##3##4##(2008-3#2)(2011-2#1)
that allows simultaneous##4##3##(2007-11#1)(2008-1#1)(2008-3#2)
that allows the use of##2##5##(2008-1#1)(2008-11#1)
that allows the##24##3##(2007-11#1)(2008-1#2)(2008-11#2)(2008-2#5)(2008-3#5)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
that allows them to##2##4##(2008-2#1)(2012-2#1)
that allows to##5##3##(2007-10#1)(2008-10#2)(2011-1#1)(2013-7#1)
that allows us to##8##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#2)(2013-1#1)
that allows us##9##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#2)(2013-1#1)
that allows##118##2##(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#19)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#8)(2009-11#2)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
that almost all of##2##4##(1997-3#1)(2012-2#1)
that almost all##4##3##(1993-6#1)(1997-3#1)(2012-2#2)
that almost half##2##3##(2007-10#1)(2008-12#1)
that almost##7##2##(1993-6#1)(1997-3#1)(2007-10#1)(2008-12#1)(2010-6#1)(2012-2#2)
that along with##3##3##(1995-1#1)(1996-2#1)(2008-10#1)
that alpha##6##2##(1990-12#1)(1991-12#1)(1993-9#1)(1995-11#1)(1996-12#1)(2009-12#1)
that alpha-CD##2##2##(2008-10#2)
that alpha-amylase##2##2##(2008-10#1)(2008-8#1)
that alpha-helices##2##2##(1995-2#1)(2008-10#1)
that also contained##2##3##(2008-10#1)(2013-1#1)
that also participate in the Caribbean Coastal Marine Productivity##2##9##(2007-5#2)
that also##34##2##(1990-11#1)(1992-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-11#3)(2007-5#2)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
that alter the##2##3##(2008-3#1)(2012-3#1)
that alter##5##2##(1992-8#1)(1994-9#1)(2006-10#1)(2008-3#1)(2012-3#1)
that alteration of the##2##4##(2008-11#1)(2011-2#1)
that alteration of##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
that alteration##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
that alterations in the##2##4##(1991-12#1)(2013-8#1)
that alterations in##4##3##(1991-12#1)(1996-5#1)(2011-1#1)(2013-8#1)
that alterations of the##2##4##(2008-8#1)(2008-9#1)
that alterations of##3##3##(2008-6#1)(2008-8#1)(2008-9#1)
that alterations##7##2##(1991-12#1)(1996-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
that altered##9##2##(1992-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(2011-2#2)(2012-3#1)
that alternative##13##2##(1990-12#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-2#2)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
that alters##2##2##(1997-3#1)(2008-10#1)
that although both##2##3##(1991-4#1)(1995-2#1)
that although some##2##3##(1992-2#1)(2008-12#1)
that although the peak##2##4##(2008-3#1)(2010-3#1)
that although the##9##3##(1993-12#2)(1995-3#1)(1997-8#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-7#1)
that although there##2##3##(1996-1#1)(2008-5#1)
that although##40##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
that altruism##2##2##(2008-10#1)(2008-9#1)
that always##3##2##(1997-8#1)(2007-12#1)(2008-10#1)
that amantadine may be##2##4##(1997-2#2)
that amantadine##4##2##(1992-3#1)(1997-2#2)(2011-2#1)
that ambient##2##2##(2008-10#2)
that amiloride##2##2##(1991-6#1)(2008-4#1)
that amino##2##2##(2008-10#1)(2008-9#1)
that aminophylline##2##2##(2007-8#2)
that ammonia##3##2##(1994-5#1)(2008-10#1)(2010-5#1)
that among the##3##3##(1993-9#1)(2008-10#1)(2008-5#1)
that among##8##2##(1990-2#1)(1992-5#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
that amplified##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
that amplify a##2##3##(2008-10#2)
that amplify##4##2##(2008-10#4)
that amygdala##2##2##(1994-8#1)(2008-11#1)
that amylin##2##2##(1991-12#1)(2008-9#1)
that an additional##3##3##(1992-12#1)(2008-10#1)(2012-3#1)
that an amino acid##2##4##(1991-9#1)(2008-10#1)
that an approach##2##3##(2008-1#1)(2013-1#1)
that an appropriate##2##3##(1990-8#1)(2010-4#1)
that an array of##3##4##(2007-11#1)(2008-3#2)
that an attempt##2##3##(2008-10#1)(2010-4#1)
that an early##4##3##(1992-3#1)(2008-11#1)(2009-6#1)(2009-7#1)
that an educational##2##3##(2011-2#1)(2012-2#1)
that an effective##2##3##(1996-9#1)(2008-3#1)
that an electrostatic##2##3##(2008-10#2)
that an experimental##2##3##(2008-11#1)(2008-3#1)
that an important##8##3##(1992-2#1)(1992-8#1)(1996-2#1)(2008-2#1)(2008-9#1)(2010-12#2)(2011-2#1)
that an increase in##8##4##(1990-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
that an increase of##3##4##(1993-6#1)(1994-3#1)(2008-5#1)
that an increase##11##3##(1990-5#1)(1993-6#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
that an individual##3##3##(1996-3#1)(2008-10#1)(2008-11#1)
that an individual's##2##3##(2008-5#1)(2012-3#1)
that an inflammatory##2##3##(2008-12#1)(2012-3#1)
that an intensive##2##3##(2008-7#1)(2012-2#1)
that an intrinsic##2##3##(2008-11#1)(2008-7#1)
that an optical##4##3##(1994-3#2)(2008-3#2)
that an##189##2##(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2007-11#5)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#21)(2008-11#13)(2008-12#3)(2008-2#8)(2008-3#19)(2008-4#2)(2008-5#5)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#2)
that analogs##2##2##(1994-8#1)(2008-8#1)
that analyses##2##2##(2008-10#1)(2013-1#1)
that analysis of##4##3##(1991-6#1)(1995-12#1)(2008-11#1)(2008-9#1)
that analysis##7##2##(1991-1#1)(1991-6#1)(1995-12#1)(2008-11#1)(2008-9#1)(2010-1#1)(2013-8#1)
that anatomically##2##2##(1994-3#1)(2008-9#1)
that animal##2##2##(2008-8#1)(2009-8#1)
that animals##4##2##(1993-12#1)(1995-12#1)(2008-8#1)(2012-3#1)
that another##8##2##(1991-9#1)(1992-12#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-2#1)
that antagonism##3##2##(2008-10#2)(2008-8#1)
that anterior##2##2##(1992-6#1)(2008-7#1)
that anti-metatype antibodies##2##3##(1992-6#2)
that anti-metatype##3##2##(1992-6#3)
that antibacterial lotions##2##3##(2008-5#2)
that antibiosis is##2##3##(2008-10#2)
that antibodies##4##2##(1991-12#1)(1996-2#1)(2008-4#1)(2009-3#1)
that antibody production##2##3##(1990-12#1)(2008-11#1)
that antibody##6##2##(1990-12#1)(1991-12#1)(1994-3#1)(2008-10#1)(2008-11#2)
that antidepressants##2##2##(2008-6#1)(2008-9#1)
that antigen##2##2##(1993-12#1)(2008-11#1)
that antimicrobial##2##2##(2008-9#1)(2011-2#1)
that antioxidant##2##2##(2009-8#1)(2011-1#1)
that antioxidants##2##2##(1992-12#1)(1993-2#1)
that antisense##2##2##(1992-8#1)(2008-8#1)
that antitrypsin Pittsburgh##2##3##(1993-2#2)
that anxiety##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
that any resultant##2##3##(1997-3#1)(2008-3#1)
that any##25##2##(1990-11#1)(1992-2#1)(1994-11#1)(1995-5#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#4)(2010-6#1)
that apart from the##2##4##(1990-9#1)(2008-10#1)
that apart from##4##3##(1990-9#1)(1994-8#1)(2007-7#1)(2008-10#1)
that aphid transmission##3##3##(2008-10#3)
that apoE##2##2##(1991-12#2)
that apoptosis##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
that apoptotic cell death##2##4##(1996-12#1)(2012-2#1)
that apparently##4##2##(1997-3#1)(2007-7#1)(2008-10#1)(2013-8#1)
that appear in##4##3##(2007-12#3)(2008-6#1)
that appear morphologically##2##3##(2011-2#2)
that appear to be##5##4##(1992-8#1)(1993-3#1)(2008-4#2)(2010-5#1)
that appear to##11##3##(1992-8#1)(1993-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#2)(2009-8#1)(2010-5#1)(2012-1#1)(2013-7#1)
that appear##21##2##(1992-8#1)(1993-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-7#1)
that appeared in##2##3##(2008-10#1)(2012-3#1)
that appeared to be##4##4##(1997-4#1)(2008-10#1)(2009-10#1)(2009-6#1)
that appeared to##6##3##(1992-3#1)(1997-4#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-6#1)
that appeared##10##2##(1992-3#1)(1996-10#1)(1997-4#1)(2007-11#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-6#1)(2012-3#1)
that appears in##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
that appears to be a##2##5##(1992-2#1)(2008-12#1)
that appears to be##6##4##(1992-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)
that appears to##13##3##(1992-2#1)(1993-6#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#1)
that appears##20##2##(1992-2#1)(1993-6#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)
that applicant##2##2##(1993-1#2)
that application of##11##3##(1994-12#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#1)(2013-8#1)
that application##12##2##(1994-12#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2011-1#1)(2013-8#1)
that applied##3##2##(2008-10#2)(2013-1#1)
that applies##3##2##(2008-3#2)(2008-8#1)
that apply to##3##3##(1997-1#1)(2008-3#1)(2008-5#1)
that apply##7##2##(1997-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-7#1)
that applying##2##2##(1994-3#1)(2008-10#1)
that appressoria##2##2##(2008-10#2)
that approach##6##2##(1993-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-2#1)
that approaches##3##2##(1997-1#1)(2007-11#1)(2008-7#1)
that appropriate combination of##2##4##(2008-11#1)(2011-1#1)
that appropriate##11##2##(1993-6#1)(1995-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-6#1)(2011-1#1)(2012-3#1)
that appropriately designed##2##3##(1996-12#1)(2007-12#1)
that appropriately##3##2##(1996-12#1)(2007-12#1)(2008-12#1)
that approved##2##2##(2008-11#1)(2012-2#1)
that approximate##2##2##(2008-9#2)
that approximately 30% of##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
that approximately##16##2##(1992-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#1)
that aprotinin##2##2##(1996-9#1)(2007-8#1)
that are 20 times##2##4##(2007-11#1)(2008-3#1)
that are 20##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
that are a##8##3##(1992-11#1)(1994-8#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#2)
that are able to##10##4##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#2)(2013-1#1)
that are accessible##2##3##(2008-3#1)(2009-10#1)
that are activated##3##3##(1996-2#1)(2008-10#1)(2008-12#1)
that are affected by the##2##5##(1991-8#1)(2008-10#1)
that are affected by##5##4##(1991-8#1)(1992-6#1)(1996-7#1)(2008-10#1)(2008-7#1)
that are already##3##3##(2007-7#1)(2008-3#1)(2012-3#1)
that are also##2##3##(1995-6#1)(2013-8#1)
that are altered##2##3##(2008-7#1)(2013-1#1)
that are applicable to##3##4##(2007-11#2)(2008-3#1)
that are applicable##4##3##(2007-11#2)(2008-3#1)(2008-4#1)
that are appropriate for##2##4##(1991-1#1)(2008-2#1)
that are appropriate##3##3##(1990-5#1)(1991-1#1)(2008-2#1)
that are as##2##3##(1997-7#1)(2008-7#1)
that are assigned##2##3##(2007-12#1)(2009-6#1)
that are associated with a##4##5##(1993-11#1)(2007-11#1)(2008-4#1)(2013-1#1)
that are associated with increased##2##5##(2008-10#1)(2008-8#1)
that are associated with the##6##5##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#1)
that are associated with these##2##5##(2010-9#1)(2011-2#1)
that are associated with##36##4##(1990-12#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#3)(2009-11#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
that are at##5##3##(1993-12#1)(1993-2#1)(1993-3#1)(2007-11#1)(2008-11#1)
that are attributable to##2##4##(2008-10#1)(2012-2#1)
that are available for##2##4##(2008-11#1)(2008-3#1)
that are available##12##3##(1992-6#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)
that are based on the##3##5##(2008-2#1)(2008-3#1)(2013-1#1)
that are based on##10##4##(1996-4#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2010-2#1)(2013-1#1)
that are becoming##3##3##(1995-1#1)(2008-10#2)
that are being##10##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)
that are believed to be##2##5##(1992-10#1)(2008-11#1)
that are believed to##3##4##(1992-10#1)(2008-11#1)(2008-4#1)
that are below##2##3##(2008-10#1)(2008-3#1)
that are beneficial##2##3##(2008-5#1)(2012-3#1)
that are better suited to##2##5##(1991-12#1)(2010-9#1)
that are better##3##3##(1991-12#1)(2007-11#1)(2010-9#1)
that are biologically##2##3##(2008-11#1)(2008-8#1)
that are both##4##3##(1993-3#1)(2007-12#1)(2008-1#1)(2010-11#1)
that are bound##2##3##(1990-6#1)(2008-4#1)
that are brought##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
that are calculated##2##3##(1993-1#1)(2009-11#1)
that are capable of##7##4##(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)
that are capable##8##3##(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-1#1)
that are caused by##3##4##(2007-11#1)(2008-10#1)(2013-8#1)
that are characteristic of##7##4##(1992-9#1)(1994-8#1)(2008-10#2)(2008-3#2)(2008-7#1)
that are characterized by##3##4##(1992-3#1)(2008-3#1)(2008-7#1)
that are closely##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
that are common to##3##4##(1991-5#1)(1995-3#1)(2008-4#1)
that are common##4##3##(1991-5#1)(1995-3#1)(2008-4#1)(2008-7#1)
that are commonly used in##2##5##(2008-4#1)(2009-3#1)
that are commonly used##4##4##(2008-4#2)(2009-3#1)(2012-5#1)
that are commonly##13##3##(1995-6#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-3#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-3#1)
that are comparable to##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-6#1)
that are comparable##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
that are compatible with##3##4##(1994-2#1)(2008-3#1)(2008-7#1)
that are complementary to the##2##5##(2008-10#1)(2008-7#1)
that are complex##2##3##(1996-3#1)(2008-8#1)
that are consistent with the##2##5##(2008-10#1)(2008-5#1)
that are consistent with##7##4##(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)
that are constitutively##2##3##(2008-5#1)(2012-12#1)
that are correlated with##2##4##(2008-4#1)(2008-8#1)
that are created##2##3##(1996-2#1)(2008-12#1)
that are critical for##5##4##(1994-5#1)(2007-12#2)(2008-10#1)(2009-10#1)
that are critical to##3##4##(1996-2#1)(2008-2#1)(2012-2#1)
that are critical##10##3##(1994-5#1)(1996-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2012-2#1)
that are crucial to the##2##5##(2008-3#1)(2008-9#1)
that are crucial##4##3##(2007-12#1)(2008-3#1)(2008-9#1)(2009-4#1)
that are currently available##2##4##(2007-7#1)(2013-1#1)
that are currently being used##2##5##(1990-2#1)(2008-3#1)
that are currently being##4##4##(1990-2#1)(2008-3#2)(2008-7#1)
that are currently in##2##4##(2008-2#1)(2008-5#1)
that are currently used##2##4##(2008-10#1)(2011-1#1)
that are currently##17##3##(1990-2#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
that are delivered##2##3##(2009-11#1)(2009-6#1)
that are deposited##2##3##(2007-12#1)(2011-2#1)
that are derived from##5##4##(2008-11#2)(2008-2#2)(2008-3#1)
that are described##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
that are designed to##3##4##(2007-11#1)(2007-2#1)(2009-7#1)
that are designed##4##3##(2007-11#1)(2007-12#1)(2007-2#1)(2009-7#1)
that are detected##2##3##(2007-12#1)(2008-10#1)
that are different from the##2##5##(2007-12#1)(2011-2#1)
that are differentially##2##3##(2008-9#1)(2011-2#1)
that are difficult to##6##4##(1994-9#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
that are difficult##7##3##(1994-9#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
that are discussed in##3##4##(1997-2#1)(2010-7#1)(2013-1#1)
that are discussed##4##3##(1993-8#1)(1997-2#1)(2010-7#1)(2013-1#1)
that are distinct##2##3##(2008-11#1)(2011-2#1)
that are due to aerosol##2##5##(2008-3#2)
that are due to the##15##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#8)
that are due to##43##4##(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#10)(2008-3#22)
that are easily##3##3##(1992-11#1)(2008-4#2)
that are effective against##2##4##(1991-11#1)(2008-10#1)
that are effective in##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
that are effective##6##3##(1991-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
that are either##5##3##(1992-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
that are embedded##2##3##(2008-11#1)(2010-8#1)
that are encoded in##2##4##(2008-4#1)(2008-7#1)
that are encoded##3##3##(2008-4#2)(2008-7#1)
that are essential for##7##4##(1992-11#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
that are essential to##2##4##(1994-5#1)(2008-1#1)
that are essential##9##3##(1992-11#1)(1994-5#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
that are evolving##2##3##(1994-2#1)(1996-12#1)
that are exceptionally diverse##2##4##(2008-8#2)
that are expected to##5##4##(2008-11#1)(2008-3#2)(2012-12#1)(2012-3#1)
that are expressed in##3##4##(1993-6#1)(1996-10#1)(2011-2#1)
that are expressed##6##3##(1993-6#2)(1993-9#1)(1996-10#1)(2008-2#1)(2011-2#1)
that are familiar to##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
that are favorable for##2##4##(1990-11#1)(2008-3#1)
that are favorable##3##3##(1990-11#1)(2008-3#1)(2008-8#1)
that are found in##4##4##(2007-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
that are found##7##3##(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-8#1)
that are frequently##3##3##(1993-11#1)(2008-6#1)(2011-2#1)
that are functionally##3##3##(1997-2#1)(2010-4#1)(2013-1#1)
that are fundamental##2##3##(1990-5#1)(2008-10#1)
that are generally##4##3##(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
that are genetically##3##3##(1997-7#1)(2008-2#1)(2008-8#1)
that are growing##2##3##(1994-3#1)(2008-9#1)
that are hard to##3##4##(1990-3#1)(1995-12#1)(2008-11#1)
that are highly conserved in##2##5##(1994-6#1)(1994-8#1)
that are highly conserved##4##4##(1990-8#1)(1994-6#1)(1994-8#1)(2012-2#1)
that are highly expressed in##2##5##(2009-10#1)(2011-2#1)
that are highly##19##3##(1990-5#1)(1990-8#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-4#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#2)(2009-10#2)(2011-2#1)(2012-2#1)
that are identical##2##3##(2007-5#1)(2008-10#1)
that are implemented##2##3##(1994-6#1)(2007-11#1)
that are important for the##3##5##(2008-10#1)(2008-8#1)(2012-12#1)
that are important for##13##4##(1991-6#1)(2007-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
that are important in the##3##5##(1994-8#1)(2008-4#1)(2008-7#1)
that are important in##4##4##(1994-8#1)(2008-4#2)(2008-7#1)
that are important to##2##4##(2008-7#1)(2010-2#1)
that are important##23##3##(1991-6#1)(1994-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
that are in agreement with##3##5##(2008-10#3)
that are in good agreement with##2##6##(2007-11#1)(2010-7#1)
that are in good agreement##3##5##(1994-5#1)(2007-11#1)(2010-7#1)
that are in the##3##4##(1992-12#1)(1994-3#2)
that are in##20##3##(1992-12#1)(1992-6#1)(1993-11#1)(1994-3#2)(1994-5#1)(1996-10#1)(2007-11#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2010-5#1)(2010-7#1)
that are included in the##2##5##(2008-2#1)(2008-3#1)
that are independent of##3##4##(2008-4#1)(2008-7#1)(2010-5#1)
that are indicative of##2##4##(2008-11#1)(2008-4#1)
that are induced by the##2##5##(2008-3#1)(2008-6#1)
that are induced##4##3##(1997-7#1)(2008-3#1)(2008-4#1)(2008-6#1)
that are inherent in##3##4##(2008-2#1)(2008-3#2)
that are involved in the##6##5##(1991-9#1)(1993-12#1)(2008-10#3)(2010-5#1)
that are involved in##17##4##(1991-9#1)(1993-12#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-5#1)
that are involved##18##3##(1991-9#1)(1993-12#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-5#1)(2013-8#1)
that are known to##9##4##(1993-11#1)(1993-6#1)(1995-9#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
that are known##10##3##(1993-11#1)(1993-6#1)(1995-9#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
that are largely##2##3##(1994-9#1)(2011-2#1)
that are less##4##3##(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)
that are likely to be##4##5##(1992-3#1)(1993-12#1)(2008-4#1)(2011-1#1)
that are likely to##9##4##(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)
that are likely##10##3##(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2013-8#1)
that are linked to##4##4##(2008-10#3)(2008-3#1)
that are linked##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
that are located##2##3##(2007-12#1)(2008-4#1)
that are lost##2##3##(2007-8#1)(2008-2#1)
that are made##2##3##(2007-12#1)(2008-3#1)
that are mediated by##2##4##(1996-7#1)(2008-10#1)
that are more likely to##2##5##(1993-11#1)(2008-10#1)
that are more than##3##4##(1993-12#1)(2011-2#1)(2012-2#1)
that are more vulnerable##2##4##(2008-11#1)(2008-4#1)
that are more##9##3##(1993-11#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#2)(2012-2#1)
that are most frequently##2##4##(1991-12#1)(2008-10#1)
that are most##10##3##(1991-12#1)(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-3#1)(2012-3#1)
that are much##2##3##(2010-4#1)(2013-7#1)
that are necessary for##5##4##(1992-3#1)(2008-2#1)(2008-3#2)(2009-2#1)
that are necessary to##3##4##(2007-11#1)(2008-10#1)(2008-4#1)
that are necessary##8##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)
that are needed to##2##4##(2008-3#1)(2012-2#1)
that are normally##2##3##(1990-5#1)(2008-3#1)
that are not affected by##2##5##(1996-4#1)(2008-2#1)
that are not necessarily##2##4##(1995-5#1)(2013-8#1)
that are not possible with##2##5##(1993-3#1)(2008-3#1)
that are not provided by BLAST##2##6##(2008-4#2)
that are not readily##2##4##(1991-5#1)(2008-10#1)
that are not##51##3##(1990-7#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-6#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2011-2#3)(2012-2#2)(2013-8#1)
that are now##5##3##(1997-2#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
that are observed##4##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
that are obtained##2##3##(2008-3#2)
that are of##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2010-8#1)(2011-3#1)
that are offered##2##3##(1993-12#1)(2008-11#1)
that are often##14##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
that are otherwise##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
that are part of the##2##5##(2008-10#1)(2013-7#1)
that are particularly##2##3##(2012-2#1)(2013-1#1)
that are pathogenic##2##3##(2008-10#2)
that are perceived##2##3##(1995-1#1)(2008-11#1)
that are possible##2##3##(2008-10#1)(2008-4#1)
that are potential##5##3##(1995-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)
that are predicted to have##2##5##(2008-9#1)(2010-3#1)
that are predicted to##3##4##(2008-9#1)(2010-3#1)(2011-2#1)
that are present in the##3##5##(2007-12#1)(2008-10#1)(2008-7#1)
that are present in##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)
that are present##8##3##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
that are presented##2##3##(2009-5#1)(2009-8#1)
that are probably##2##3##(1992-9#1)(1995-11#1)
that are produced##2##3##(1994-11#1)(2012-2#1)
that are recognized by##2##4##(1991-2#1)(1993-8#1)
that are reconstructed##2##3##(2008-3#2)
that are referred##2##3##(1997-6#1)(2011-2#1)
that are reflected##3##3##(2008-2#1)(2010-10#1)(2011-2#1)
that are regulated by##2##4##(1990-8#1)(2008-4#1)
that are regulated##3##3##(1990-8#1)(2008-4#1)(2008-9#1)
that are related to the##3##5##(1991-12#1)(1991-3#1)(2008-3#1)
that are related to##6##4##(1991-12#1)(1991-3#1)(2007-7#1)(2008-3#1)(2009-2#1)(2010-3#1)
that are released from##3##4##(2008-4#3)
that are relevant for##3##4##(2007-11#1)(2008-3#1)(2009-2#1)
that are relevant to##8##4##(1992-12#1)(1994-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-3#1)(2013-1#1)
that are relevant##12##3##(1992-12#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-2#1)(2009-3#1)(2012-1#1)(2013-1#1)
that are reliable and##2##4##(2008-11#1)(2012-12#1)
that are reported to##2##4##(1990-7#1)(2013-8#1)
that are required by##2##4##(1990-5#1)(2008-10#1)
that are required for##3##4##(1995-2#1)(2007-12#1)(2008-1#1)
that are required##9##3##(1990-5#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
that are resistant to##4##4##(1991-8#1)(2009-11#1)(2011-2#2)
that are responsible for the observed##2##6##(2008-10#1)(2008-4#1)
that are responsible for the##7##5##(1994-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)
that are responsible for##11##4##(1994-5#1)(1994-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)
that are restricted to##2##4##(2008-10#1)(2008-8#1)
that are selective for##2##4##(2008-11#1)(2008-5#1)
that are selective##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
that are sensitive to the##2##5##(1994-11#1)(2008-5#1)
that are sensitive to##9##4##(1990-8#1)(1994-11#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
that are shared##2##3##(2007-12#1)(2008-9#1)
that are significantly##4##3##(1991-8#1)(2007-12#1)(2008-8#1)(2010-4#1)
that are similar to the##2##5##(1993-12#1)(1995-2#1)
that are similar to those of##2##6##(1993-3#1)(2007-11#1)
that are similar to those##6##5##(1990-8#1)(1993-3#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-7#1)
that are similar to##15##4##(1990-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#1)
that are small##2##3##(1991-8#1)(2008-7#1)
that are smaller##2##3##(2008-10#1)(2010-6#1)
that are sometimes##2##3##(2011-2#1)(2013-1#1)
that are specific for either all##2##6##(2013-8#2)
that are specific for##6##4##(2008-10#3)(2008-4#1)(2013-8#2)
that are specific to##3##4##(2007-11#1)(2009-9#1)(2012-3#1)
that are specific##9##3##(2007-11#1)(2008-10#3)(2008-4#1)(2009-9#1)(2012-3#1)(2013-8#2)
that are specifically expressed in##2##5##(1996-10#1)(2010-7#1)
that are specifically##4##3##(1996-10#1)(1997-3#1)(2008-7#1)(2010-7#1)
that are still##4##3##(1995-12#1)(2007-12#1)(2009-5#1)(2013-8#1)
that are strongly##2##3##(1996-4#1)(2008-3#1)
that are structural##2##3##(2008-4#1)(2009-6#1)
that are sufficiently large##2##4##(2007-12#1)(2008-2#1)
that are suitable for##7##4##(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)
that are superimposed##2##3##(2008-2#1)(2008-3#1)
that are surrounded by##2##4##(1995-2#1)(2011-2#1)
that are taken##2##3##(1992-2#1)(1993-11#1)
that are the most##2##4##(1993-12#1)(1995-6#1)
that are the##8##3##(1990-8#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
that are thought to##3##4##(2008-6#1)(2009-10#1)(2010-11#1)
that are to be##2##4##(1997-4#1)(2007-11#1)
that are too##2##3##(2008-3#1)(2008-6#1)
that are toxic to##3##4##(1996-3#1)(2008-10#1)(2008-5#1)
that are transported##2##3##(1997-6#1)(2008-4#1)
that are triggered by##2##4##(2009-8#1)(2012-1#1)
that are typical of##3##4##(1993-2#1)(2008-12#1)(2008-7#1)
that are typical##5##3##(1993-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
that are typically##2##3##(1992-2#1)(2009-11#1)
that are unable to##3##4##(1991-11#1)(1993-9#1)(2008-10#1)
that are unique in##2##4##(2007-12#1)(2011-2#1)
that are unique to##2##4##(2008-3#1)(2008-7#1)
that are unique##7##3##(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
that are used as##2##4##(1992-9#1)(2011-1#1)
that are used by##3##4##(1990-12#1)(2008-1#1)(2013-8#1)
that are used for the##2##5##(2010-12#1)(2010-5#1)
that are used for##5##4##(2009-8#2)(2010-12#1)(2010-5#1)(2012-2#1)
that are used in the##3##5##(2008-1#1)(2008-2#1)(2008-4#1)
that are used in##8##4##(1997-2#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-3#1)
that are used to define the##2##6##(2008-3#1)(2008-7#1)
that are used to monitor##2##5##(2008-10#1)(2008-9#1)
that are used to##21##4##(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-11#1)
that are used##44##3##(1990-12#1)(1992-9#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
that are useful##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
that are usually##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
that are very##5##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
that are visible on##2##4##(2010-12#1)(2013-1#1)
that are vital for##2##4##(2008-2#1)(2011-1#1)
that are widely used##2##4##(2008-4#1)(2010-11#1)
that are widely##4##3##(1995-12#1)(2008-10#1)(2008-4#1)(2010-11#1)
that are within##2##3##(2011-2#1)(2013-1#1)
that are##1362##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#6)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#6)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#7)(1993-12#13)(1993-2#4)(1993-3#10)(1993-6#4)(1993-8#2)(1993-9#3)(1994-1#4)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#7)(1994-6#3)(1994-8#7)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#10)(1995-3#5)(1995-5#3)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-12#3)(1996-2#9)(1996-3#4)(1996-4#5)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#2)(1997-6#5)(1997-7#8)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#44)(2007-12#59)(2007-2#3)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#3)(2008-1#12)(2008-10#137)(2008-11#49)(2008-12#8)(2008-2#67)(2008-3#149)(2008-4#64)(2008-5#24)(2008-6#15)(2008-7#70)(2008-8#33)(2008-9#31)(2009-10#11)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#3)(2009-5#6)(2009-6#7)(2009-7#4)(2009-8#9)(2009-9#9)(2010-1#3)(2010-10#6)(2010-11#10)(2010-12#10)(2010-2#3)(2010-3#6)(2010-4#8)(2010-5#5)(2010-6#7)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#11)(2011-2#51)(2011-3#2)(2012-1#2)(2012-12#14)(2012-2#28)(2012-3#22)(2012-5#1)(2013-1#21)(2013-3#1)(2013-7#5)(2013-8#26)
that area##6##2##(1996-2#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
that areas in##2##3##(1993-12#1)(2008-11#1)
that areas of##2##3##(1992-1#1)(2007-5#1)
that areas##6##2##(1992-1#1)(1993-12#1)(1996-5#1)(1997-8#1)(2007-5#1)(2008-11#1)
that arise during##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
that arise from the##2##4##(2007-12#1)(2008-1#1)
that arise from##6##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#2)
that arise in the##3##4##(2007-8#1)(2008-3#1)(2011-2#1)
that arise in##6##3##(1994-2#1)(2007-8#1)(2008-3#2)(2008-6#1)(2011-2#1)
that arise when##2##3##(2008-3#1)(2012-2#1)
that arise##24##2##(1993-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
that arises from##4##3##(1995-6#1)(2008-4#1)(2008-9#1)(2012-2#1)
that arises in##2##3##(2007-12#1)(2010-4#1)
that arises##11##2##(1995-6#1)(1996-6#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
that arose from the##2##4##(1995-2#1)(2008-12#1)
that arose##5##2##(1995-2#1)(1997-1#1)(2008-12#1)(2009-9#1)(2012-3#1)
that around##3##2##(2007-4#1)(2008-11#1)(2013-8#1)
that arrestin##2##2##(1992-5#2)
that arsenate is the main##2##5##(2008-10#2)
that arsenic##2##2##(2008-10#1)(2008-8#1)
that arsenite##2##2##(1994-11#1)(2008-10#1)
that arterial##4##2##(1990-5#1)(1995-12#1)(2008-9#1)(2013-7#1)
that artificial##4##2##(2008-7#1)(2009-5#1)(2013-1#2)
that as a##2##3##(1993-6#1)(2010-9#1)
that as little as##2##4##(1994-11#1)(1994-2#1)
that as much as##2##4##(1993-12#1)(1995-2#1)
that as the##4##3##(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
that as##18##2##(1990-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
that asbestos-induced pleural##2##3##(1991-12#2)
that ascospores##3##2##(2008-10#3)
that asexual##2##2##(2008-5#1)(2013-1#1)
that asparagine##2##2##(1994-11#1)(1997-7#1)
that aspartate##2##2##(1995-6#2)
that aspects of##2##3##(2007-12#1)(2008-7#1)
that aspirin##2##2##(2008-3#1)(2008-8#1)
that assay of##2##3##(1991-3#1)(1993-12#1)
that assess##3##2##(1997-2#1)(2008-10#1)(2010-8#1)
that assessed##5##2##(2008-10#1)(2009-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
that assesses##2##2##(2011-2#1)(2013-1#1)
that assessing##2##2##(1997-4#1)(2008-1#1)
that assessment of##3##3##(1992-11#1)(2008-10#1)(2008-12#1)
that assessment##4##2##(1992-11#1)(2008-10#1)(2008-12#1)(2009-9#1)
that assigning##2##2##(2008-7#1)(2008-9#1)
that assist##2##2##(1994-2#1)(2013-1#1)
that associate##2##2##(1996-2#1)(2008-1#1)
that associated with the##3##4##(1993-12#2)(2008-2#1)
that associated with##8##3##(1993-12#3)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
that associated##10##2##(1993-12#3)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
that association of##2##3##(1994-12#1)(2008-10#1)
that association##4##2##(1991-12#1)(1994-12#1)(2008-10#1)(2010-1#1)
that assume##4##2##(2007-11#1)(2008-4#1)(2008-8#2)
that assumes a##3##3##(1992-12#1)(2008-2#1)(2008-3#1)
that assumes##5##2##(1992-12#1)(2008-2#1)(2008-3#3)
that astaxanthin##2##2##(2010-10#1)(2013-8#1)
that asthma##2##2##(2008-3#1)(2008-7#1)
that astrocytes##4##2##(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)
that at a##2##3##(2008-11#1)(2008-9#1)
that at age##2##3##(1995-8#1)(2011-1#1)
that at high##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
that at least one##5##4##(1990-9#1)(1994-6#1)(2008-1#1)(2008-6#1)(2013-1#1)
that at least part of the##2##6##(2008-10#2)
that at least part of##3##5##(1991-5#1)(2008-10#2)
that at least some of the##3##6##(1990-12#1)(2008-10#1)(2008-2#1)
that at least some of##4##5##(1990-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
that at least some##7##4##(1990-12#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-2#1)
that at least two major##2##5##(1991-8#1)(1994-11#1)
that at least two##12##4##(1990-12#1)(1990-2#1)(1990-5#1)(1991-8#1)(1992-10#1)(1994-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)
that at least##48##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
that at low concentrations##2##4##(1990-11#1)(2006-6#1)
that at low pH##2##4##(1990-8#1)(2008-10#1)
that at low##6##3##(1990-11#1)(1990-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-6#1)
that at pH##5##3##(1992-12#1)(1995-5#1)(2008-10#2)(2011-3#1)
that at physiological##2##3##(1994-5#1)(2013-8#1)
that at the same##2##4##(2008-1#1)(2009-5#1)
that at the##16##3##(1991-5#1)(1993-11#1)(1995-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2012-2#1)(2012-3#1)
that at##116##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#4)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
that atherosclerosis##3##2##(1997-8#2)(2008-6#1)
that atmospheric##4##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
that atomic##2##2##(1990-11#1)(2008-3#1)
that attachment##2##2##(2008-10#1)(2008-11#1)
that attacks##2##2##(1990-11#1)(2008-10#1)
that attempt to##2##3##(1997-1#1)(2008-11#1)
that attempts to provide##2##4##(1994-12#1)(1996-8#1)
that attempts to##7##3##(1991-1#1)(1994-12#1)(1996-8#1)(2008-3#2)(2008-9#1)(2012-1#1)
that attention to a stimulus##2##5##(2008-11#1)(2010-5#1)
that attention to##3##3##(2008-11#1)(2008-4#1)(2010-5#1)
that attention##5##2##(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)
that attentional##2##2##(1996-2#1)(2008-6#1)
that attenuate##2##2##(2008-10#1)(2008-2#1)
that attitudes##2##2##(1990-6#1)(2010-10#1)
that autism##2##2##(2007-8#1)(2012-3#1)
that autologous blood donation##2##4##(1996-9#2)
that autologous blood##3##3##(1996-9#3)
that autologous##5##2##(1996-9#4)(2007-9#1)
that autophagy##3##2##(2008-7#1)(2012-3#2)
that available##4##2##(2008-11#1)(2008-2#1)(2008-8#1)(2013-7#1)
that average##4##2##(1995-3#1)(2008-11#1)(2008-5#1)(2010-6#1)
that avian##2##2##(2008-9#1)(2013-1#1)
that avoids the##3##3##(2007-11#1)(2007-8#1)(2008-6#1)
that avoids##7##2##(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#1)
that await##2##2##(2008-10#1)(2011-2#1)
that awareness of##2##3##(2009-8#1)(2012-1#1)
that axillary##2##2##(2008-5#2)
that axons##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
that bFGF##2##2##(1992-3#1)(1995-12#1)
that baccalaureate##2##2##(1995-2#1)(2008-11#1)
that back##2##2##(2007-11#1)(2009-8#1)
that bacteria##6##2##(2008-10#3)(2008-5#3)
that bacterial##8##2##(1990-12#1)(1991-3#1)(1994-8#1)(2008-10#2)(2008-7#2)(2009-8#1)
that barrier##2##2##(2008-5#1)(2008-7#1)
that barriers##2##2##(2008-1#1)(2010-11#1)
that basal##5##2##(1992-5#1)(1995-11#1)(1995-12#1)(1996-5#1)(2013-1#1)
that based on##4##3##(1995-9#1)(2008-10#1)(2008-9#1)(2012-3#1)
that baseline##3##2##(1992-9#1)(2008-11#1)(2008-9#1)
that basic##2##2##(1995-12#1)(2007-12#1)
that bcl-2##2##2##(2008-11#1)(2008-7#1)
that bear a##2##3##(1993-8#1)(2009-12#1)
that bear##4##2##(1993-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
that bears##2##2##(2008-10#1)(2008-9#1)
that became more##2##3##(1990-12#1)(2008-7#1)
that became##9##2##(1990-12#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
that because of##4##3##(1995-6#1)(1996-5#1)(2007-10#1)(2010-1#1)
that because##9##2##(1995-12#1)(1995-6#2)(1996-5#1)(1997-5#2)(2007-10#1)(2009-8#1)(2010-1#1)
that become##5##2##(1992-3#1)(2008-11#1)(2008-3#2)(2008-7#1)
that becomes##3##2##(1991-5#1)(2008-2#1)(2008-5#1)
that before##4##2##(1995-5#1)(2008-7#1)(2009-6#1)(2010-3#1)
that began in##2##3##(2008-1#1)(2011-2#1)
that began##7##2##(1994-9#1)(2008-1#2)(2011-2#2)(2012-1#1)(2013-8#1)
that begin to##2##3##(1992-12#1)(1994-2#1)
that begin##3##2##(1992-12#1)(1994-2#1)(2010-9#1)
that begins at##2##3##(1994-3#1)(2008-6#1)
that begins with##3##3##(2008-11#1)(2012-12#2)
that begins##10##2##(1992-9#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2012-12#3)
that behavior##2##2##(2007-11#1)(2007-8#1)
that behavioral##6##2##(2007-10#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
that behaviors##2##2##(2008-5#1)(2009-7#1)
that belong to the##5##4##(1995-2#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-6#1)
that belong to##13##3##(1995-2#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)
that belong##14##2##(1995-2#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)
that belonged to##4##3##(2008-10#2)(2008-4#1)(2013-7#1)
that belongs to the##2##4##(1997-2#1)(2008-6#1)
that belongs to##3##3##(1997-2#1)(2008-6#1)(2010-10#1)
that benefit both##2##3##(2007-2#1)(2010-10#1)
that benefit the##2##3##(2008-11#1)(2011-2#1)
that benefit##5##2##(2007-2#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
that best fits##2##3##(1996-1#2)
that best##8##2##(1996-1#2)(1997-2#1)(1997-3#1)(2008-12#2)(2008-2#1)(2013-1#1)
that beta##5##2##(1990-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(1997-4#1)
that beta-CGRP##2##2##(1992-6#2)
that beta-amylase##3##2##(2008-9#3)
that beta-blockers##2##2##(1995-2#1)(1995-6#1)
that beta-galactosidase##3##2##(1990-5#2)(2011-2#1)
that better##8##2##(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-10#1)(2013-8#1)
that between##15##2##(1990-6#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-1#1)(2011-1#1)(2012-12#1)(2012-9#1)(2013-8#1)
that beyond a##2##3##(2007-12#1)(2008-10#1)
that bias##2##2##(2008-8#1)(2009-2#1)
that bind at##2##3##(2010-5#1)(2012-3#1)
that bind specifically to##2##4##(1995-11#1)(2008-10#1)
that bind to a##2##4##(2008-1#1)(2008-4#1)
that bind to the same##2##5##(1994-12#1)(1995-5#1)
that bind to the##4##4##(1992-8#1)(1994-12#1)(1995-5#1)(2013-8#1)
that bind to##15##3##(1992-8#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-4#2)(2009-11#1)(2013-8#1)
that bind##30##2##(1990-5#1)(1992-8#1)(1993-6#2)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-3#2)(2008-1#1)(2008-10#4)(2008-4#3)(2008-7#1)(2009-11#1)(2010-5#1)(2012-3#3)(2013-8#1)
that binding of the##2##4##(1993-1#1)(1997-6#1)
that binding of##7##3##(1992-12#1)(1993-1#1)(1993-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(2010-10#1)
that binding sites for##2##4##(1990-8#1)(1993-3#1)
that binding##12##2##(1990-8#1)(1992-12#2)(1993-1#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-8#1)(2010-10#1)
that binds both##2##3##(1995-3#1)(2007-12#1)
that binds specifically to##2##4##(1990-11#1)(1995-2#1)
that binds to the##4##4##(1990-2#1)(1991-10#1)(1992-6#1)(2008-5#1)
that binds to##8##3##(1990-2#1)(1991-10#1)(1992-10#1)(1992-6#1)(1995-2#1)(1995-8#1)(2008-5#1)(2011-2#1)
that binds##21##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-11#1)(1992-10#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
that biochemical##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)
that biocontrol##2##2##(2008-10#2)
that bioelectric or##2##3##(2008-7#2)
that biologically##2##2##(1994-8#1)(1996-2#1)
that bisphosphonates##2##2##(2008-8#1)(2012-1#1)
that black##4##2##(1995-12#2)(2008-10#1)(2013-1#1)
that blastocyst##2##2##(2008-9#2)
that block the##2##3##(1995-6#1)(1997-6#1)
that block##10##2##(1991-5#1)(1993-11#1)(1995-6#2)(1996-3#1)(1997-6#1)(2008-8#1)(2009-9#1)(2012-1#2)
that blockade of##3##3##(1995-12#1)(1996-2#1)(2008-2#1)
that blocked##2##2##(1995-12#1)(2007-8#1)
that blocking##2##2##(2009-2#1)(2010-11#1)
that blocks##4##2##(2008-5#1)(2009-8#1)(2010-7#1)(2012-3#1)
that blood banks##2##3##(1995-6#2)
that blood pressure##2##3##(2008-1#2)
that blood##6##2##(1995-6#2)(2008-1#2)(2010-3#1)(2011-2#1)
that boards##3##2##(1991-12#2)(1994-12#1)
that body##5##2##(2007-12#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-7#1)
that bone marrow##2##3##(1991-6#1)(2008-9#1)
that bone##7##2##(1990-6#1)(1991-6#1)(1993-11#1)(2007-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
that border the##2##3##(2008-7#1)(2011-2#1)
that border##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
that bore##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
that both antibodies##2##3##(1995-6#1)(2008-8#1)
that both are##2##3##(2008-5#1)(2008-7#1)
that both body##2##3##(2008-8#1)(2010-10#1)
that both cases##2##3##(2009-3#1)(2013-1#1)
that both drugs##2##3##(2008-5#2)
that both enzymes##2##3##(1990-11#1)(2008-11#1)
that both genes were##2##4##(2008-10#2)
that both genes##3##3##(2008-10#2)(2010-3#1)
that both genetic and##2##4##(2008-11#1)(2011-2#1)
that both groups of##2##4##(2009-11#1)(2009-9#1)
that both in##3##3##(1990-11#1)(1991-4#1)(1992-6#1)
that both internal##2##3##(1996-2#1)(2008-7#1)
that both methods##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
that both of the##3##4##(1991-8#1)(1993-3#1)(2008-11#1)
that both of them##2##4##(2008-10#1)(2008-9#1)
that both of these##4##4##(1997-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
that both of##11##3##(1991-8#1)(1993-12#1)(1993-3#2)(1997-3#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
that both parenting and children's##2##5##(2010-1#2)
that both patients##2##3##(2006-10#1)(2012-3#1)
that both species##2##3##(2008-8#1)(2013-7#1)
that both systems are##2##4##(1993-8#1)(2008-11#1)
that both techniques##2##3##(1991-12#1)(2010-7#1)
that both the##44##3##(1990-12#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-4#1)(2012-2#2)(2013-1#1)(2013-7#1)
that both types of##3##4##(2008-2#1)(2012-1#1)(2012-12#1)
that both##286##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#4)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#49)(2008-11#18)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#13)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#2)
that bound the##2##3##(1995-9#1)(2008-10#1)
that bound##7##2##(1990-11#1)(1993-8#1)(1995-9#1)(2006-6#1)(2008-10#2)(2012-2#1)
that boys##2##2##(1996-6#1)(2013-8#1)
that brain##7##2##(1995-11#1)(1996-5#1)(1997-4#1)(2007-8#1)(2008-5#1)(2008-7#2)
that brain-derived##3##2##(1990-7#1)(1997-2#1)(2008-7#1)
that branch##2##2##(1995-3#1)(2009-9#1)
that break##2##2##(2008-10#1)(2008-8#1)
that breast cancer is a##2##5##(1990-6#1)(1991-12#1)
that breast cancer##5##3##(1990-6#1)(1991-12#1)(1992-10#1)(1993-11#1)(2012-12#1)
that breast##7##2##(1990-10#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-11#1)(1994-7#1)(2012-12#1)
that breastfeeding##2##2##(1991-8#1)(2008-10#1)
that breeding##3##2##(2008-10#1)(2008-9#1)(2012-4#1)
that bright##2##2##(1997-6#1)(2008-9#1)
that broaden##2##2##(1996-6#1)(2010-3#1)
that brood amalgamation is##2##4##(2008-9#2)
that brood parasitism##2##3##(2010-8#2)
that brood##4##2##(2008-9#2)(2010-8#2)
that brought together the##2##4##(1997-3#1)(2008-12#1)
that brought##3##2##(1997-3#1)(2008-12#1)(2011-2#1)
that brown##2##2##(2008-10#2)
that bubbles##2##2##(2008-10#1)(2012-2#1)
that bud##2##2##(1997-3#1)(2009-8#1)
that builds##2##2##(2009-9#1)(2010-10#1)
that bullying##3##2##(2009-7#3)
that burst##2##2##(1991-5#1)(1996-2#1)
that butch women##2##3##(2008-12#2)
that by applying##2##3##(2008-10#1)(2009-3#1)
that by choosing##2##3##(2008-12#1)(2008-9#1)
that by control##3##3##(2008-9#2)(2010-2#1)
that by controls##3##3##(2008-9#3)
that by increasing the##2##4##(1993-11#1)(2008-12#1)
that by the control groups throughout##5##6##(2008-8#2)(2008-9#3)
that by the##7##3##(2008-10#1)(2008-8#2)(2008-9#4)
that by use of##2##4##(2008-3#2)
that by using##4##3##(1996-12#1)(2007-10#1)(2008-11#1)(2011-1#1)
that by utilizing##2##3##(2007-12#1)(2008-5#1)
that by##63##2##(1990-9#1)(1991-12#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#3)(2009-3#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2013-1#1)
that bystander effects##2##3##(2008-7#2)
that bystander##3##2##(2008-7#3)
that c-Abl##2##2##(2012-12#2)
that c-Jun##2##2##(1995-12#1)(1995-2#1)
that c-fos##2##2##(1994-8#1)(1996-12#1)
that cAMP##6##2##(1991-2#2)(1991-3#1)(1994-11#1)(1994-6#2)
that caffeine##2##2##(2008-5#2)
that calcitonin gene-related peptide##2##4##(1992-6#1)(2008-4#1)
that calcitonin##3##2##(1992-6#1)(1993-11#1)(2008-4#1)
that calcium##9##2##(1994-11#1)(1994-3#1)(1994-8#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
that calculated##4##2##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
that calculates the##2##3##(2007-11#1)(2008-3#1)
that call for##2##3##(2008-1#1)(2008-12#1)
that came##2##2##(2008-10#1)(2008-9#1)
that can accompany##2##3##(1990-9#1)(2013-1#1)
that can act as##2##4##(2008-11#1)(2008-2#1)
that can affect the##3##4##(1991-2#1)(1993-11#1)(2008-7#1)
that can affect##6##3##(1991-2#1)(1993-11#1)(2007-9#1)(2008-7#1)(2010-6#1)(2011-2#1)
that can arise##3##3##(1991-3#1)(2008-1#1)(2008-3#1)
that can assist##4##3##(1996-12#1)(1996-2#1)(2008-12#1)(2013-8#1)
that can associate with##2##4##(1991-5#1)(1995-6#1)
that can be achieved by##2##5##(2008-2#1)(2009-3#1)
that can be achieved using##2##5##(2008-1#1)(2009-8#1)
that can be achieved##5##4##(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-8#1)
that can be adapted to##2##5##(1996-1#1)(2008-11#1)
that can be adopted##2##4##(2008-10#1)(2008-12#1)
that can be analyzed##4##4##(2007-11#1)(2008-7#1)(2008-9#1)(2010-5#1)
that can be applied to the##2##6##(2008-12#1)(2008-3#1)
that can be applied to##10##5##(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)
that can be applied##16##4##(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
that can be attributed to##2##5##(2008-4#1)(2012-9#1)
that can be carried##2##4##(2008-10#1)(2009-12#1)
that can be characterized as a##2##6##(1993-3#1)(2009-10#1)
that can be clearly##2##4##(2008-10#1)(2012-2#1)
that can be considered##2##4##(2008-11#1)(2008-5#1)
that can be controlled##3##4##(1994-2#1)(2008-11#1)(2008-2#1)
that can be coupled##2##4##(2008-4#1)(2008-9#1)
that can be demonstrated##2##4##(1996-5#1)(2012-2#1)
that can be derived from##3##5##(1992-12#1)(2008-2#1)(2008-4#1)
that can be described by##3##5##(2008-10#1)(2008-2#1)(2013-1#1)
that can be described##4##4##(2007-10#1)(2008-10#1)(2008-2#1)(2013-1#1)
that can be detected##4##4##(2008-10#2)(2008-4#1)(2011-2#1)
that can be developed##3##4##(1995-1#1)(2008-10#1)(2011-1#1)
that can be done##2##4##(2008-9#1)(2011-1#1)
that can be drawn from##2##5##(2008-12#2)
that can be drawn##3##4##(2008-10#1)(2008-12#2)
that can be easily##8##4##(1994-3#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-3#1)
that can be employed##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
that can be enhanced##2##4##(1995-1#1)(2008-10#1)
that can be evaluated##2##4##(2008-3#1)(2012-3#1)
that can be explained by##2##5##(2008-10#2)
that can be exploited##2##4##(2008-10#1)(2008-4#1)
that can be formed##2##4##(2008-7#2)
that can be found in##6##5##(1995-8#1)(2008-10#3)(2009-5#1)(2011-2#1)
that can be imaged##2##4##(2008-1#1)(2008-3#1)
that can be implemented##3##4##(1991-12#1)(2008-4#1)(2009-3#1)
that can be important##2##4##(2010-8#1)(2012-2#1)
that can be integrated##2##4##(2008-3#1)(2008-7#1)
that can be isolated from##2##5##(2008-9#1)(2010-6#1)
that can be made##3##4##(1991-1#1)(2008-3#1)(2008-4#1)
that can be measured##2##4##(2008-3#1)(2010-6#1)
that can be monitored by##2##5##(2008-10#1)(2008-4#1)
that can be monitored##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
that can be observed##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)
that can be obtained##6##4##(1995-6#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
that can be of##6##4##(1990-8#1)(2008-11#1)(2008-4#3)(2008-9#1)
that can be performed to##2##5##(2008-11#1)(2008-4#1)
that can be performed##4##4##(2008-11#1)(2008-4#3)
that can be readily##4##4##(1994-2#1)(2008-1#1)(2008-7#1)(2008-8#1)
that can be realized##2##4##(1994-12#1)(2007-12#1)
that can be related to##2##5##(2008-10#1)(2013-1#1)
that can be separated by##2##5##(1993-12#1)(2008-10#1)
that can be successfully##2##4##(1997-8#1)(2008-9#1)
that can be tailored##2##4##(2008-10#1)(2008-7#1)
that can be tested##2##4##(2008-10#1)(2008-8#1)
that can be used as a##4##6##(1997-8#1)(2008-10#2)(2008-4#1)
that can be used as##6##5##(1992-12#1)(1997-8#1)(2008-10#2)(2008-4#1)(2012-2#1)
that can be used by##3##5##(1991-1#1)(1992-3#1)(2008-12#1)
that can be used during##2##5##(2007-8#1)(2008-10#1)
that can be used for the##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
that can be used for##20##5##(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)
that can be used freely suspended in solution to##2##9##(2008-10#2)
that can be used in the##3##6##(2008-4#1)(2010-10#1)(2012-12#1)
that can be used in##9##5##(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)(2010-10#1)(2010-8#1)(2012-12#1)
that can be used on a large##2##7##(1997-3#1)(2008-2#1)
that can be used to analyze##2##6##(1996-2#1)(2008-4#1)
that can be used to derive##2##6##(2008-2#1)(2008-9#1)
that can be used to distinguish##2##6##(2008-10#1)(2013-8#1)
that can be used to estimate the potential risk##2##9##(2008-10#2)
that can be used to generate##2##6##(1990-11#1)(2007-12#1)
that can be used to identify##2##6##(2008-4#1)(2011-2#1)
that can be used to improve the##3##7##(2007-12#1)(2008-3#2)
that can be used to improve##4##6##(1997-3#1)(2007-12#1)(2008-3#2)
that can be used to inform##2##6##(1996-1#1)(2012-12#1)
that can be used to measure##3##6##(2008-2#1)(2008-4#2)
that can be used to study##2##6##(2008-4#1)(2008-9#1)
that can be used to treat##2##6##(2007-11#1)(2011-2#1)
that can be used to##62##5##(1990-11#1)(1991-2#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#13)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
that can be used with##2##5##(2008-3#1)(2013-1#1)
that can be used##115##4##(1990-11#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#9)(2008-3#12)(2008-4#22)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
that can be useful in##2##5##(1996-12#1)(2008-10#1)
that can be useful##3##4##(1996-12#1)(2008-10#1)(2013-8#1)
that can be utilized##3##4##(1994-11#1)(2008-5#1)(2008-9#1)
that can be written as a sum of##2##8##(2008-2#1)(2013-1#1)
that can be##371##3##(1990-11#2)(1990-12#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#4)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#4)(1996-2#2)(1996-5#2)(1996-9#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#14)(2007-6#1)(2007-8#4)(2008-1#7)(2008-10#55)(2008-11#10)(2008-12#10)(2008-2#18)(2008-3#34)(2008-4#43)(2008-5#5)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#20)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#11)(2012-12#5)(2012-2#6)(2012-3#4)(2012-9#1)(2013-1#7)(2013-8#2)
that can become##2##3##(2008-11#1)(2013-7#1)
that can benefit from such##2##5##(1997-6#1)(2013-8#1)
that can benefit from##3##4##(1994-3#1)(1997-6#1)(2013-8#1)
that can bind to the##2##5##(2008-10#1)(2008-4#1)
that can bind to##3##4##(2008-10#2)(2008-4#1)
that can bind##4##3##(2008-10#2)(2008-4#1)(2009-12#1)
that can cause severe##2##4##(1996-11#1)(2007-8#1)
that can cause##9##3##(1996-11#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)
that can contribute to##3##4##(1995-1#1)(2007-6#1)(2012-2#1)
that can contribute##4##3##(1995-1#1)(2007-6#1)(2012-2#1)(2012-3#1)
that can create an##2##4##(1994-12#1)(2010-8#1)
that can degrade##2##3##(2008-10#1)(2011-2#1)
that can deliver##2##3##(2007-11#1)(2008-3#1)
that can distinguish##3##3##(2008-7#1)(2008-9#1)(2009-8#1)
that can easily be##2##4##(1996-2#1)(2010-1#1)
that can explain##2##3##(1991-9#1)(2013-1#1)
that can extract the##2##4##(1996-1#1)(2007-12#1)
that can facilitate the##2##4##(1997-2#1)(2008-12#1)
that can facilitate##3##3##(1997-2#1)(2008-12#1)(2008-4#1)
that can generate##2##3##(2008-10#1)(2008-3#1)
that can greatly##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
that can have##2##3##(2008-3#1)(2013-1#1)
that can help to##2##4##(2008-12#1)(2008-4#1)
that can help##12##3##(1993-2#1)(1994-1#1)(1995-1#1)(1996-12#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#1)
that can impact##3##3##(2010-10#1)(2011-2#1)(2012-12#1)
that can improve the##2##4##(2008-7#1)(2008-9#1)
that can improve##4##3##(1995-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
that can increase##2##3##(2008-5#1)(2008-7#1)
that can induce##2##3##(2008-10#2)
that can influence the##2##4##(2008-10#1)(2008-9#1)
that can influence##6##3##(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
that can interact with##2##4##(1992-12#1)(2008-9#1)
that can interfere with##2##4##(1993-3#1)(2010-11#1)
that can lead to the##3##5##(1996-5#1)(2008-5#1)(2012-1#1)
that can lead to##15##4##(1992-1#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-1#2)
that can measure the##2##4##(1991-9#1)(2008-2#1)
that can measure##5##3##(1991-9#1)(2008-2#1)(2008-6#1)(2012-12#1)(2013-7#1)
that can meet##2##3##(1996-3#1)(2008-10#1)
that can mimic##2##3##(2008-10#1)(2012-2#1)
that can monitor##2##3##(2008-10#1)(2008-2#1)
that can obscure the##2##4##(1995-12#1)(2008-2#1)
that can occur in##3##4##(1991-3#1)(2008-3#1)(2010-9#1)
that can occur##5##3##(1991-3#1)(2008-3#1)(2009-6#1)(2010-9#1)(2011-2#1)
that can only be##2##4##(2008-11#1)(2010-6#1)
that can only##3##3##(2008-11#2)(2010-6#1)
that can perform##2##3##(2008-10#1)(2008-7#1)
that can predict##2##3##(2008-3#1)(2008-7#1)
that can produce a##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
that can produce##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
that can protect the##2##4##(2008-11#1)(2008-7#1)
that can protect##4##3##(2008-11#1)(2008-3#1)(2008-7#2)
that can provide##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
that can readily be##2##4##(2008-10#1)(2011-1#1)
that can regulate##2##3##(2008-12#1)(2010-4#1)
that can replace##2##3##(1994-1#1)(2007-11#1)
that can result in##7##4##(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)
that can result##8##3##(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#1)
that can serve as##4##4##(1992-3#1)(2008-11#1)(2010-9#1)(2012-1#1)
that can serve##5##3##(1992-3#1)(1996-12#1)(2008-11#1)(2010-9#1)(2012-1#1)
that can significantly##2##3##(2008-3#1)(2013-7#1)
that can simultaneously##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
that can substantially##2##3##(2007-11#1)(2010-3#1)
that can support##2##3##(1996-6#1)(2008-11#1)
that can suppress##2##3##(2008-3#1)(2012-2#1)
that can then be##2##4##(2008-2#1)(2008-9#1)
that can then##3##3##(2008-2#1)(2008-9#1)(2012-2#1)
that can transport##2##3##(2008-7#1)(2011-2#1)
that can vary##3##3##(1992-8#1)(2009-7#1)(2010-11#1)
that can yield##2##3##(2012-12#1)(2012-2#1)
that can##707##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-9#2)(1992-1#3)(1992-12#5)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#2)(1995-1#6)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#2)(1996-5#3)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#2)(2006-10#2)(2007-10#3)(2007-11#15)(2007-12#20)(2007-2#2)(2007-6#2)(2007-8#5)(2007-9#1)(2008-1#9)(2008-10#89)(2008-11#22)(2008-12#19)(2008-2#27)(2008-3#53)(2008-4#52)(2008-5#11)(2008-6#5)(2008-7#38)(2008-8#15)(2008-9#28)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#6)(2011-2#26)(2012-1#3)(2012-12#14)(2012-2#20)(2012-3#9)(2012-9#1)(2013-1#16)(2013-7#3)(2013-8#10)
that cancer cells##2##3##(2008-8#1)(2009-9#1)
that cancer##7##2##(1992-8#1)(1995-2#1)(2008-8#1)(2009-4#1)(2009-9#2)(2012-2#1)
that cannot be achieved##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
that cannot be explained##2##4##(2008-8#1)(2013-1#1)
that cannot be##21##3##(1993-3#1)(1993-8#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-1#2)
that cannot##27##2##(1992-11#1)(1993-3#1)(1993-8#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-1#2)
that capitalize on##2##3##(1993-2#1)(2009-9#1)
that capitalizes on##2##3##(2008-1#1)(2008-10#1)
that capsaicin##3##2##(1993-11#1)(2008-11#1)(2009-9#1)
that capture the##3##3##(2008-4#1)(2009-5#1)(2009-7#1)
that capture##5##2##(1997-1#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-12#1)
that captures the##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
that captures##4##2##(2008-10#2)(2009-10#1)(2012-2#1)
that carbachol##2##2##(1996-12#2)
that carbon##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
that cardiac##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
that cardiovascular diseases##3##3##(1990-6#1)(2009-4#2)
that cardiovascular##7##2##(1990-5#1)(1990-6#1)(2008-1#1)(2008-7#2)(2009-4#2)
that care##9##2##(1991-3#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-9#1)(2010-10#2)
that careful##3##2##(2008-1#1)(2008-2#1)(2010-12#1)
that carefully##2##2##(1996-1#1)(2007-12#1)
that caregivers##3##2##(1991-12#2)(1997-8#1)
that carried##4##2##(1993-3#2)(2008-10#1)(2012-12#1)
that carries the##2##3##(1995-2#1)(2008-3#1)
that carries##6##2##(1995-2#1)(1997-6#1)(2008-3#2)(2011-2#1)(2013-8#1)
that carry out##2##3##(2010-12#1)(2011-1#1)
that carry the##3##3##(1991-12#1)(2007-12#1)(2008-12#1)
that carry##13##2##(1990-5#1)(1991-12#1)(1993-12#1)(1997-4#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
that case##8##2##(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#2)
that cases##2##2##(1997-8#1)(2007-11#1)
that catalyses the##2##3##(1993-8#1)(2008-10#1)
that catalyses##3##2##(1990-5#1)(1993-8#1)(2008-10#1)
that catalyze##2##2##(2011-2#1)(2012-2#1)
that catalyzes the##8##3##(1994-9#3)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#2)
that catalyzes##13##2##(1992-9#1)(1993-6#1)(1994-9#3)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-8#1)
that cataplexy##2##2##(1991-5#2)
that cathepsin D##3##3##(1990-12#1)(1990-5#1)(1994-5#1)
that cathepsin##4##2##(1990-12#1)(1990-5#1)(1992-12#1)(1994-5#1)
that cationic##2##2##(1996-12#1)(2008-5#1)
that cause a##5##3##(1997-2#1)(2008-10#2)(2009-8#1)(2012-3#1)
that cause disease##2##3##(2008-9#1)(2012-2#1)
that cause significant##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
that cause the##4##3##(1993-6#1)(1997-1#1)(2012-2#1)(2013-8#1)
that cause these##3##3##(1994-12#1)(2008-2#1)(2012-12#1)
that cause##58##2##(1990-12#1)(1991-11#1)(1991-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
that caused by##5##3##(1990-11#1)(1990-7#1)(1992-8#1)(2008-10#1)(2010-4#1)
that caused the##5##3##(1994-9#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-8#1)
that caused##16##2##(1990-11#1)(1990-7#1)(1992-8#1)(1994-9#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
that causes AIDS##2##3##(1996-5#1)(2010-10#1)
that causes a##4##3##(1991-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
that causes downy mildew##2##4##(2008-10#2)
that causes significant##2##3##(2008-10#2)
that causes the##5##3##(1994-8#1)(2008-10#2)(2008-3#1)(2009-10#1)
that causes##52##2##(1991-7#2)(1992-8#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-3#2)(1997-6#1)(2007-10#1)(2007-11#2)(2008-10#20)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that caution is##2##3##(2008-12#1)(2008-5#1)
that caution##4##2##(1995-1#1)(2008-12#1)(2008-5#1)(2013-8#1)
that caveolae##2##2##(1995-2#1)(1995-6#1)
that caveolin##2##2##(1995-6#2)
that cell death##2##3##(1992-9#1)(2008-9#1)
that cell division##2##3##(2008-11#1)(2008-2#1)
that cell surface##3##3##(1992-6#1)(1997-9#1)(2012-1#1)
that cell##23##2##(1991-8#1)(1992-6#1)(1992-9#1)(1996-11#1)(1997-1#1)(1997-9#1)(2008-11#9)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2012-1#1)
that cells from##2##3##(1994-8#1)(2011-2#1)
that cells##17##2##(1990-11#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#1)
that cellular##7##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-5#1)
that central##7##2##(1991-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(1996-7#1)(2007-7#1)(2008-12#1)
that cephalosporin##2##2##(2008-10#1)(2008-6#1)
that cerebellar##3##2##(1994-3#1)(1995-8#1)(2008-7#1)
that cerebral##7##2##(1995-6#1)(2007-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
that cerebroside##2##2##(2008-10#2)
that certain##33##2##(1990-11#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#4)(2008-8#1)(2009-9#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
that challenge##2##2##(2008-11#1)(2011-1#1)
that chance##2##2##(1994-3#1)(2008-11#1)
that change in##3##3##(2008-10#2)(2010-10#1)
that change##13##2##(1995-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#1)
that changed##7##2##(1993-9#1)(1996-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
that changes in the##8##4##(1995-12#1)(1996-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
that changes in##27##3##(1991-12#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-7#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#2)(2013-1#2)
that changes##37##2##(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-7#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#2)(2013-1#3)
that changing##2##2##(2008-11#1)(2008-8#1)
that channel##2##2##(2007-12#1)(2008-6#1)
that chaotic dynamics##2##3##(2008-11#2)
that characterize the##10##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-5#1)
that characterize these##2##3##(1993-1#1)(2008-10#1)
that characterize##17##2##(1993-1#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#2)(2009-5#1)(2009-9#1)(2010-5#1)(2011-2#1)
that characterizes the##5##3##(2007-12#1)(2008-3#2)(2010-5#1)(2012-3#1)
that characterizes##9##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2010-5#1)(2012-3#1)
that characters##2##2##(2008-8#1)(2010-6#1)
that chemerin regulates β-cell function##2##5##(2012-2#2)
that chemical##2##2##(2008-10#2)
that chemically##2##2##(2009-12#1)(2012-12#1)
that chest##2##2##(2008-3#1)(2009-4#1)
that child##2##2##(2008-12#1)(2012-12#1)
that childbirth educators##2##3##(2007-2#2)
that childbirth##3##2##(2007-2#2)(2013-1#1)
that childhood##2##2##(2011-2#1)(2012-2#1)
that children in this##2##4##(1995-12#1)(2013-7#1)
that children in##4##3##(1994-6#1)(1995-12#1)(1996-12#1)(2013-7#1)
that children who##3##3##(1995-1#1)(2011-1#1)(2012-12#1)
that children with ASD##2##4##(2012-2#1)(2013-1#1)
that children with##7##3##(2006-10#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
that children##22##2##(1990-2#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-2#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
that children's##5##2##(1995-3#1)(2007-12#1)(2009-11#1)(2010-11#1)(2013-8#1)
that chitinase##2##2##(2008-10#2)
that chitobiase##2##2##(1992-10#2)
that chlorambucil##2##2##(2008-11#2)
that choice##3##2##(2008-12#1)(2010-4#2)
that cholesterol##4##2##(1990-2#2)(2008-10#1)(2011-1#1)
that cholinergic##2##2##(1990-7#1)(1991-9#1)
that chromosomal##3##2##(2008-5#1)(2008-7#1)(2010-3#1)
that chromosome##5##2##(1996-6#1)(2008-10#3)(2010-3#1)
that chromosomes##2##2##(1996-6#1)(2008-11#1)
that chronic exposure##2##3##(2008-10#1)(2008-7#1)
that chronic treatment##2##3##(1992-3#1)(1996-12#1)
that chronic##20##2##(1992-3#1)(1992-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-12#3)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#2)(2013-1#1)
that cigarette smoke caused##2##4##(2008-5#2)
that cigarette smoke##4##3##(1991-9#1)(2008-5#3)
that cigarette smoking##2##3##(2008-12#2)
that cigarette##7##2##(1991-9#1)(1996-1#1)(2008-12#2)(2008-5#3)
that circadian##2##2##(1993-12#1)(2009-8#1)
that circulating##3##2##(2008-1#1)(2008-11#1)(2009-11#1)
that cis-acting##2##2##(1993-8#1)(2009-3#1)
that citA##2##2##(1997-4#2)
that claim##2##2##(2008-3#1)(2008-8#1)
that claimed##2##2##(2008-11#1)(2013-8#1)
that class##2##2##(2007-12#1)(2008-10#1)
that classical##3##2##(2007-6#1)(2008-5#1)(2008-9#1)
that clearly demonstrate##2##3##(1991-2#1)(2008-2#1)
that clearly distinguished##2##3##(1997-7#1)(2008-5#1)
that clearly##9##2##(1991-2#1)(1996-3#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
that cleavage##2##2##(1991-2#1)(1992-4#1)
that cleave##3##2##(2008-4#1)(2009-2#1)(2012-12#1)
that cleaves##4##2##(1990-2#1)(1993-3#1)(1994-11#1)(1996-12#1)
that clients##4##2##(1993-12#1)(2008-6#2)(2012-2#1)
that climate##2##2##(1990-8#1)(2012-12#1)
that clinical##8##2##(1997-7#1)(2006-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
that clinically##2##2##(2012-2#1)(2012-3#1)
that clinicians##8##2##(1992-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#2)(2011-2#1)
that clonal##2##2##(2008-10#1)(2008-5#1)
that clones##2##2##(2008-10#1)(2008-6#1)
that closely resemble##2##3##(1994-3#1)(2008-11#1)
that closely##9##2##(1990-8#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2012-3#1)
that closing##2##2##(1995-11#1)(1996-3#1)
that cloud##2##2##(2008-10#2)
that clustered with##2##3##(2008-10#2)
that clustered##3##2##(2008-10#3)
that clutch##3##2##(2008-9#3)
that co-occur in##2##3##(2008-10#1)(2010-3#1)
that co-occur##4##2##(2008-10#1)(2008-8#1)(2010-3#2)
that co-segregated with##2##3##(2008-10#2)
that co-suppression occurred##2##3##(2008-9#2)
that coalesce##2##2##(2009-10#1)(2011-2#1)
that coating##2##2##(2008-3#1)(2008-7#1)
that cocaine##2##2##(1990-7#1)(1993-12#1)
that cochlear implantation is##3##4##(2008-9#1)(2012-2#2)
that cochlear##4##2##(2008-9#2)(2012-2#2)
that code for##5##3##(1993-6#3)(2008-10#1)(2010-10#1)
that code##6##2##(1992-11#1)(1993-6#3)(2008-10#1)(2010-10#1)
that codes for##2##3##(1994-11#1)(1997-2#1)
that coding##4##2##(1993-12#1)(1994-6#1)(2007-12#1)(2012-12#1)
that coexistence##3##2##(2008-8#2)(2008-9#1)
that cognitive##2##2##(2008-4#1)(2010-4#1)
that coincide with##2##3##(2008-10#1)(2008-3#1)
that coincides with##2##3##(1996-5#1)(2011-2#1)
that coincides##3##2##(1996-5#1)(2009-5#1)(2011-2#1)
that coinfection##2##2##(2008-10#1)(2008-7#1)
that colchicine##3##2##(1995-5#1)(1997-6#2)
that collagen##2##2##(2008-5#1)(2013-1#1)
that collapsing##3##2##(2012-3#3)
that collect##2##2##(2008-12#1)(2010-8#1)
that collectively##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
that collects##3##2##(2008-10#1)(2008-2#2)
that colocalization of##2##3##(1994-2#1)(2008-4#1)
that colonize##2##2##(2008-10#2)
that combination##5##2##(1995-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
that combinations of##3##3##(2008-10#1)(2009-8#1)(2012-12#1)
that combine the##4##3##(1994-12#1)(2007-11#1)(2008-3#1)(2008-7#1)
that combine##19##2##(1992-2#1)(1993-11#1)(1994-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
that combined##10##2##(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2011-2#2)(2012-3#1)
that combines a##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
that combines an##2##3##(1997-2#1)(2008-3#1)
that combines the##20##3##(1993-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#1)
that combines##53##2##(1993-3#1)(1994-6#1)(1997-2#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
that combining##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
that come with##3##3##(1991-12#1)(1995-1#1)(2008-7#1)
that come##4##2##(1991-12#1)(1995-1#1)(2008-3#1)(2008-7#1)
that comes##3##2##(1995-6#1)(2008-10#2)
that common genetic##2##3##(2011-2#1)(2012-3#1)
that common spatial origin##2##4##(2009-9#2)
that common##7##2##(2008-3#1)(2009-6#1)(2009-9#2)(2011-2#1)(2012-3#2)
that commonly##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2012-2#1)
that communicate##3##2##(1996-2#1)(2008-12#1)(2009-5#1)
that communicating##2##2##(2013-1#1)(2013-8#1)
that communication##3##2##(2008-12#1)(2009-11#1)(2012-3#1)
that community##2##2##(2009-12#1)(2010-9#1)
that comparative studies##2##3##(1990-8#1)(2008-10#1)
that comparative##4##2##(1990-8#1)(1991-9#1)(2008-10#1)(2011-2#1)
that compare favorably with those obtained by the##2##8##(2008-10#2)
that compare favorably with those obtained by##3##7##(2008-10#3)
that compare favorably with##4##4##(2008-10#4)
that compare favorably##5##3##(1992-2#1)(2008-10#4)
that compare the##2##3##(1993-9#1)(2008-10#1)
that compare##13##2##(1991-3#1)(1992-2#1)(1993-9#1)(1994-1#1)(2008-10#5)(2008-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
that compared to##5##3##(1992-11#1)(1997-1#1)(2009-7#1)(2011-3#1)(2013-8#1)
that compared with the##2##4##(2008-2#1)(2009-5#1)
that compared with##3##3##(2008-2#1)(2009-5#1)(2011-2#1)
that compared##12##2##(1992-11#1)(1997-1#1)(1997-3#2)(1997-5#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-7#1)(2011-2#1)(2011-3#1)(2013-8#1)
that compares the##2##3##(2008-2#1)(2010-3#1)
that compares##3##2##(1997-3#1)(2008-2#1)(2010-3#1)
that compensates for##2##3##(2008-2#1)(2008-3#1)
that compensates##4##2##(2008-2#2)(2008-3#2)
that compete with##2##3##(2008-4#1)(2009-7#1)
that compete##4##2##(2008-4#1)(2008-8#2)(2009-7#1)
that competition##3##2##(1997-3#1)(2008-9#2)
that complement##5##2##(1991-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
that complements##2##2##(2008-7#1)(2008-8#1)
that complete loss of##2##4##(1995-6#1)(2008-10#1)
that complete##8##2##(1990-5#1)(1995-6#1)(2008-10#3)(2010-2#1)(2013-1#2)
that completely##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
that complex##8##2##(1990-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-8#1)
that compliance##2##2##(1997-1#1)(2011-2#1)
that complicate##4##2##(1996-11#1)(2008-8#2)(2011-1#1)
that compose the##2##3##(2008-10#1)(2008-2#1)
that composites of##2##3##(2009-7#1)(2010-4#1)
that compost-induced##2##2##(2008-10#2)
that compound##4##2##(1992-3#1)(2008-10#1)(2011-1#1)(2011-3#1)
that compounds##2##2##(2008-11#1)(2010-12#1)
that comprise the##6##3##(1995-6#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
that comprise##10##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
that comprised a##2##3##(2007-11#1)(2008-3#1)
that comprised##5##2##(1997-5#2)(2007-11#1)(2008-10#1)(2008-3#1)
that comprises##4##2##(2007-11#1)(2008-11#1)(2008-3#2)
that compromise##2##2##(2008-10#1)(2008-9#1)
that computed tomography##2##3##(2008-3#1)(2010-3#1)
that computed##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)
that computer##2##2##(2007-10#1)(2010-8#1)
that concentrate##2##2##(2008-10#1)(2008-5#1)
that concentrations of##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
that concern##5##2##(2008-10#2)(2008-2#1)(2008-7#1)(2013-8#1)
that conclusions##2##2##(2007-11#1)(2008-2#1)
that concurrent##2##2##(1993-5#1)(1994-7#1)
that condition##2##2##(2007-8#1)(2008-10#1)
that conditioned##2##2##(2008-10#2)
that conditions##2##2##(1995-5#1)(1995-6#1)
that condom use##2##3##(2012-2#1)(2013-1#1)
that confer resistance to##2##4##(2008-10#1)(2012-12#1)
that confer resistance##3##3##(2008-10#2)(2012-12#1)
that confer##9##2##(1992-11#1)(1996-3#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
that conferred##4##2##(2011-2#3)(2013-8#1)
that confers a##2##3##(2008-10#1)(2008-7#1)
that confers resistance to##2##4##(1995-2#1)(2008-10#1)
that confers resistance##3##3##(1995-2#1)(2008-10#2)
that confers##12##2##(1995-2#1)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
that confirm the##5##3##(2007-11#1)(2007-12#2)(2007-2#1)(2008-2#1)
that confirm##8##2##(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
that confirmed##2##2##(2008-10#1)(2012-12#1)
that confirms##2##2##(1996-5#1)(2008-3#1)
that conforms##2##2##(2008-3#1)(2011-2#1)
that conidia##3##2##(2008-10#3)
that connect the##3##3##(1997-3#1)(2007-11#1)(2008-3#1)
that connect##5##2##(1997-3#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-10#1)
that connects the##4##3##(1992-3#1)(2007-12#1)(2008-3#2)
that connects##8##2##(1992-3#1)(2007-12#2)(2008-10#1)(2008-3#4)
that consider the##2##3##(2008-2#1)(2008-7#1)
that consider##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
that considerable##3##2##(2008-10#2)(2008-8#1)
that consideration of##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
that consideration##4##2##(1996-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
that considered##2##2##(1993-9#1)(2008-6#1)
that considering the##2##3##(1993-5#1)(2008-3#1)
that considering##3##2##(1993-5#1)(2008-3#1)(2012-2#1)
that considers##5##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
that consist of##13##3##(1994-9#1)(2008-10#2)(2008-3#8)(2008-7#1)(2012-2#1)
that consist##14##2##(1994-9#1)(2008-10#2)(2008-3#9)(2008-7#1)(2012-2#1)
that consisted of a##3##4##(2008-10#2)(2008-3#1)
that consisted of##8##3##(1995-11#1)(2008-10#4)(2008-3#3)
that consistently##6##2##(1992-11#1)(2008-10#1)(2008-3#1)(2010-10#2)(2012-2#1)
that consists in##2##3##(2008-3#1)(2011-3#1)
that consists of a##5##4##(1994-9#1)(2007-11#1)(2008-2#1)(2008-3#2)
that consists of an##5##4##(2008-10#2)(2008-11#1)(2010-6#1)(2012-12#1)
that consists of##19##3##(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-8#1)(2010-6#1)(2012-12#1)
that consists##21##2##(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-8#1)(2010-6#1)(2011-3#1)(2012-12#1)
that constitute the##7##3##(1991-6#1)(1993-6#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-2#2)
that constitute##14##2##(1991-6#2)(1993-6#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#2)(2013-1#1)
that constitutes a##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
that constitutes this##2##3##(1995-2#1)(2008-6#1)
that constitutes##7##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-8#1)
that constitutively##3##2##(1993-6#1)(2010-11#1)(2012-12#1)
that constrain the##2##3##(2008-2#1)(2008-9#1)
that constrain##3##2##(2008-2#1)(2008-8#1)(2008-9#1)
that consumer satisfaction##2##3##(1993-12#1)(1996-3#1)
that consumer##4##2##(1993-12#1)(1995-1#1)(1996-3#1)(2008-8#1)
that consumers##5##2##(1993-3#1)(1997-3#2)(2010-1#2)
that consumption of##2##3##(2008-10#2)
that consumption##4##2##(2008-10#2)(2008-4#1)(2012-2#1)
that contain a##8##3##(1994-12#1)(1994-8#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
that contain an##2##3##(1995-3#1)(2007-11#1)
that contain multiple##2##3##(1995-2#1)(2008-3#1)
that contain the##4##3##(1991-2#1)(2007-10#1)(2008-2#1)(2008-4#1)
that contain##56##2##(1990-8#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
that contained a##7##3##(1992-8#1)(1994-5#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-12#1)
that contained an##2##3##(1991-5#1)(2008-10#1)
that contained both##2##3##(2008-7#2)
that contained less than##2##4##(2008-10#2)
that contained less##3##3##(2008-10#2)(2008-5#1)
that contained no detectable levels of estrogen receptors##2##8##(2008-11#2)
that contained no##3##3##(2008-10#1)(2008-11#2)
that contained one##2##3##(1990-5#1)(2008-10#1)
that contained the##6##3##(1990-11#1)(1992-8#1)(1994-8#1)(2008-10#2)(2008-11#1)
that contained##56##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-5#2)(1992-8#2)(1993-12#2)(1994-5#1)(1994-8#1)(1995-3#1)(1996-6#2)(1997-4#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2010-5#1)(2010-8#1)(2012-12#3)(2012-3#1)
that containing##6##2##(1992-8#1)(1992-9#1)(1993-11#1)(2008-10#2)(2012-12#1)
that contains a##11##3##(1991-2#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#3)(2009-2#1)(2009-3#1)
that contains all##2##3##(1995-3#1)(2008-10#1)
that contains an##2##3##(1997-4#1)(2007-11#1)
that contains only##2##3##(2008-3#2)
that contains the##13##3##(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-9#1)
that contains##51##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-3#1)(1997-4#2)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#13)(2008-4#4)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
that contaminated##2##2##(1995-11#1)(2008-12#1)
that contamination of##2##3##(2008-1#1)(2008-10#1)
that contamination##3##2##(2008-1#1)(2008-10#2)
that context##4##2##(1993-3#1)(2009-7#1)(2010-10#1)(2010-2#1)
that contextual##3##2##(2008-4#1)(2012-2#2)
that continued##3##2##(2008-12#1)(2011-7#1)(2012-3#1)
that continuous##5##2##(1991-2#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
that contraception would##2##3##(2012-12#2)
that contradict##2##2##(2006-10#1)(2008-7#1)
that contrary to##2##3##(2008-11#1)(2011-1#1)
that contrast##2##2##(2008-3#1)(2008-7#1)
that contribute to a##4##4##(1991-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
that contribute to adaptation##2##4##(2008-8#1)(2011-2#1)
that contribute to the##8##4##(1995-5#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
that contribute to this##2##4##(2008-7#1)(2012-3#1)
that contribute to variation##2##4##(2008-1#1)(2012-3#1)
that contribute to##42##3##(1991-12#1)(1994-8#1)(1995-5#2)(1996-2#1)(2007-10#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
that contribute##47##2##(1991-12#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#1)
that contributed to the##4##4##(1994-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
that contributed to##5##3##(1994-11#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
that contributed##6##2##(1994-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
that contributes to the##3##4##(2007-5#1)(2008-9#1)(2011-2#1)
that contributes to##7##3##(1997-1#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)
that contributes##9##2##(1997-1#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#2)(2011-2#1)
that control and##2##3##(2009-7#1)(2011-2#1)
that control of##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
that control plant##2##3##(2008-7#1)(2009-8#1)
that control the##12##3##(1990-7#1)(1992-5#1)(1995-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-4#1)(2010-5#1)(2011-2#1)
that control##40##2##(1990-7#1)(1991-11#1)(1992-5#1)(1993-6#2)(1995-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#4)(2012-3#2)(2013-1#1)
that controlled##2##2##(1994-6#1)(2008-3#1)
that controls the##6##3##(1992-3#1)(2008-10#3)(2012-12#1)(2013-7#1)
that controls##11##2##(1992-3#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
that conventional##6##2##(1992-9#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-7#1)(2010-10#1)
that converge to##2##3##(1997-1#1)(2007-12#1)
that converge##3##2##(1997-1#1)(2007-12#1)(2008-1#1)
that conversion of##2##3##(1994-8#1)(2008-7#1)
that conversion##4##2##(1992-5#1)(1994-8#1)(2007-12#1)(2008-7#1)
that convert##3##2##(1996-8#1)(2008-6#1)(2009-12#1)
that converted to##2##3##(2008-11#2)
that converted##3##2##(1995-2#1)(2008-11#2)
that converts the##2##3##(1990-8#1)(2008-4#1)
that converts##5##2##(1990-8#1)(1994-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
that convey##2##2##(1995-11#1)(2012-2#1)
that cooperation##3##2##(2008-8#3)
that cooperative##2##2##(1995-2#1)(2008-8#1)
that copper##6##2##(1995-11#2)(2008-10#4)
that cord blood##2##3##(2008-11#2)
that correct##2##2##(1990-5#1)(2008-3#1)
that correctly##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
that correlate with##2##3##(1993-3#1)(2008-9#1)
that correlate##4##2##(1993-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
that correlated with the##4##4##(1996-1#1)(2008-10#3)
that correlated with##10##3##(1992-12#1)(1996-1#2)(2008-10#6)(2009-8#1)
that correlated##11##2##(1992-12#1)(1996-1#2)(2008-10#7)(2009-8#1)
that correlates with##2##3##(2008-11#1)(2008-3#1)
that correspond to a##2##4##(2008-2#1)(2008-3#1)
that correspond to the##6##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
that correspond to two##2##4##(2008-3#2)
that correspond to##21##3##(1993-2#1)(1993-5#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-9#1)
that correspond##22##2##(1993-2#1)(1993-5#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-9#1)(2009-10#1)
that corresponded to 50%##3##4##(2013-8#3)
that corresponded to their##2##4##(2008-10#1)(2008-5#1)
that corresponded to##16##3##(1997-2#1)(2007-12#1)(2008-10#6)(2008-5#2)(2009-3#1)(2013-8#5)
that corresponded##17##2##(1997-2#1)(2007-12#1)(2008-10#7)(2008-5#2)(2009-3#1)(2013-8#5)
that corresponds to a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
that corresponds to the##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#1)
that corresponds to##14##3##(1993-6#1)(1994-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)(2013-1#1)
that corresponds##16##2##(1993-6#1)(1994-12#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)(2013-1#2)
that cosegregates##2##2##(1991-12#1)(2008-8#1)
that cost##7##2##(1990-4#1)(1992-3#1)(1994-1#1)(1994-3#2)(1994-9#1)(2009-5#1)
that costs##2##2##(1996-3#1)(2008-8#1)
that could act##3##3##(1994-8#1)(2008-5#2)
that could affect the##5##4##(2006-10#1)(2008-10#2)(2008-2#1)(2013-7#1)
that could affect##7##3##(2006-10#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-2#1)(2013-7#1)
that could aid in##2##4##(2008-10#1)(2008-6#1)
that could be easily##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
that could be explained by##2##5##(2008-10#2)
that could be used as##4##5##(1996-3#1)(1997-3#1)(2008-10#2)
that could be used for##6##5##(1992-1#1)(1995-2#1)(2008-10#1)(2008-6#1)(2009-3#1)(2012-2#1)
that could be used to discriminate between##2##7##(2008-10#1)(2008-7#1)
that could be used to improve##3##6##(2007-10#1)(2009-10#1)(2010-12#1)
that could be used to##15##5##(2007-10#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)
that could be used##28##4##(1992-1#1)(1992-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-3#2)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)
that could be##72##3##(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#3)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
that could cause##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
that could contribute to##5##4##(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
that could facilitate##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
that could guide##2##3##(1996-12#1)(2012-2#1)
that could have been##3##4##(1994-7#1)(1996-1#1)(2009-8#1)
that could have##7##3##(1990-3#1)(1994-7#1)(1996-1#1)(1997-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
that could help to##2##4##(2008-3#1)(2012-12#1)
that could help##6##3##(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
that could improve##2##3##(2008-10#1)(2008-9#1)
that could increase the##2##4##(2008-7#1)(2011-2#1)
that could influence##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
that could inhibit##3##3##(1991-12#1)(2008-7#1)(2008-8#1)
that could lead to##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)
that could modulate##2##3##(2008-11#1)(2008-5#1)
that could not be##10##4##(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
that could not##15##3##(1992-9#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#2)(2012-2#1)
that could prevent##2##3##(2008-11#1)(2009-8#1)
that could provide##3##3##(2008-10#1)(2009-2#1)(2010-12#1)
that could result in##5##4##(1992-1#1)(2008-9#1)(2009-9#1)(2011-2#2)
that could serve as##2##4##(1991-9#1)(2008-7#1)
that could support##2##3##(2008-10#1)(2013-1#1)
that could##212##2##(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#3)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-10#41)(2008-11#11)(2008-12#4)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#7)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#1)
that country##2##2##(1992-3#1)(1997-3#1)
that couple##3##2##(2008-3#1)(2010-12#1)(2013-1#1)
that couples##5##2##(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
that covalent##2##2##(1990-12#1)(1993-8#1)
that cover a##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
that cover the##2##3##(2008-3#1)(2008-5#1)
that cover##6##2##(2007-11#1)(2008-3#3)(2008-4#1)(2008-5#1)
that covers a##2##3##(2008-10#1)(2008-5#1)
that covers the##3##3##(2008-10#2)(2010-10#1)
that covers##7##2##(1997-7#1)(2007-12#1)(2008-10#3)(2008-5#1)(2010-10#1)
that create the##2##3##(2008-8#1)(2009-10#1)
that create##6##2##(1992-1#1)(1997-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)
that created##2##2##(2008-8#1)(2012-3#1)
that creates the##2##3##(2008-3#1)(2008-9#1)
that creates##7##2##(1991-9#1)(1994-9#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-9#1)
that creativity##3##2##(1995-1#3)
that critical##3##2##(1995-12#1)(1996-12#1)(2010-4#1)
that crosstalk##2##2##(2008-11#1)(2008-4#1)
that crystalline##2##2##(1995-11#1)(2008-3#1)
that cultivar##3##2##(2008-10#3)
that cultural##2##2##(2009-10#2)
that cultured normal##2##3##(2008-4#1)(2008-8#1)
that cultured##3##2##(1990-2#1)(2008-4#1)(2008-8#1)
that cumulatively##2##2##(2009-8#1)(2012-12#1)
that cupping##2##2##(2013-1#2)
that curcumin##3##2##(2011-2#1)(2012-3#2)
that current laws and practices##2##5##(1992-3#1)(1996-2#1)
that current##14##2##(1990-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
that currently exist in##2##4##(2008-1#1)(2012-12#1)
that currently exists##2##3##(1995-12#1)(2007-2#1)
that currently is##2##3##(2008-7#1)(2013-7#1)
that currently##13##2##(1994-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-7#1)
that cut##2##2##(2008-9#2)
that cutaneous##2##2##(2008-5#1)(2012-3#1)
that cyclic##4##2##(1993-6#1)(1994-11#1)(2008-10#1)(2012-7#1)
that cyclins##2##2##(1997-6#1)(2008-5#1)
that cysteine##2##2##(1991-9#1)(2008-10#1)
that cytokines##2##2##(1992-3#1)(2012-2#1)
that cytoplasmic##2##2##(1993-11#1)(2008-8#1)
that cytotoxic##3##2##(1994-8#1)(2008-1#1)(2012-12#1)
that daily##3##2##(1990-7#1)(1994-2#1)(2009-7#1)
that damage to the##2##4##(1994-11#1)(2008-5#1)
that damage to##3##3##(1994-11#1)(2008-5#1)(2009-1#1)
that damage##6##2##(1994-11#1)(1994-5#1)(2008-5#1)(2009-1#1)(2009-8#1)(2011-2#1)
that damaged##2##2##(2008-8#1)(2010-2#1)
that damages##2##2##(2010-12#1)(2011-2#1)
that dark##2##2##(2008-3#1)(2013-8#1)
that data are##2##3##(2008-9#1)(2009-12#1)
that data##5##2##(2008-11#1)(2008-12#1)(2008-9#2)(2009-12#1)
that de novo##2##3##(2008-11#1)(2008-5#1)
that deal with##3##3##(1996-2#1)(2007-8#1)(2012-1#1)
that dealt with##2##3##(1992-1#1)(1995-1#1)
that decision##2##2##(2008-11#1)(2008-7#1)
that declined##2##2##(1990-5#1)(2008-10#1)
that decompose##2##2##(2008-10#1)(2008-7#1)
that decrease##3##2##(1993-11#1)(2008-3#1)(2010-11#1)
that decreased as##2##3##(2008-10#1)(2010-4#1)
that decreased##9##2##(1990-2#1)(1995-6#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-7#1)(2010-4#1)
that decreases the##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
that decreases##5##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
that deep##3##2##(1994-9#1)(1996-2#1)(2012-2#1)
that defective##2##2##(1995-8#1)(2008-7#1)
that defects in##3##3##(1992-12#1)(1994-12#2)
that deficiencies in##2##3##(1991-8#1)(2011-1#1)
that define a##2##3##(1990-8#1)(2012-12#1)
that define the##5##3##(1991-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)
that define##12##2##(1990-8#1)(1991-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-12#2)(2012-2#1)
that defined##2##2##(2008-11#1)(2013-1#1)
that defines##4##2##(1995-3#1)(2007-6#1)(2008-9#1)(2011-1#1)
that degrade##2##2##(2012-3#1)(2013-1#1)
that degree of##2##3##(1991-12#1)(2008-10#1)
that delay malaria diagnosis and treatment##2##6##(2012-12#2)
that delay##3##2##(1991-11#1)(2012-12#2)
that deletion of##3##3##(1993-9#1)(1997-3#1)(2012-2#1)
that deletions##2##2##(2008-11#2)
that delivers the##2##3##(2008-2#1)(2012-3#1)
that delivers##6##2##(1992-3#1)(1996-11#1)(2007-11#1)(2008-2#1)(2010-6#1)(2012-3#1)
that deltamethrin##2##2##(2008-10#1)(2013-1#1)
that demographic variables##2##3##(2007-12#1)(2008-7#1)
that demographic##4##2##(1993-12#1)(1996-3#1)(2007-12#1)(2008-7#1)
that demonstrate a##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
that demonstrate that##2##3##(2008-3#1)(2008-7#1)
that demonstrate the advantages of the proposed##2##7##(2008-3#1)(2012-12#1)
that demonstrate the proposed##2##4##(2008-3#2)
that demonstrate the##24##3##(1991-1#1)(1992-12#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#10)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
that demonstrate##41##2##(1991-1#1)(1992-12#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#8)(2008-3#14)(2008-6#1)(2008-7#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
that demonstrated##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
that demonstrates the##4##3##(1993-1#1)(2008-12#1)(2009-8#1)(2012-12#1)
that demonstrates##8##2##(1993-1#1)(1996-12#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-8#1)(2012-12#1)
that dental##5##2##(1991-6#1)(1995-3#1)(2008-11#1)(2008-9#1)(2013-1#1)
that depend on the##7##4##(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#1)(2010-7#1)
that depend on##12##3##(1990-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-2#1)(2010-4#1)(2010-7#1)
that depend##13##2##(1990-7#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-2#1)(2010-4#1)(2010-7#1)
that depends on the##13##4##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#5)(2011-2#1)(2012-12#1)(2013-8#1)
that depends on##20##3##(1990-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#7)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
that depends##22##2##(1990-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
that depletes##2##2##(1997-1#1)(2008-12#1)
that depletion of##2##3##(1992-8#1)(2012-12#1)
that depolarization##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
that depression is associated with increased##2##6##(2008-11#1)(2012-12#1)
that depression##3##2##(2008-11#1)(2008-6#1)(2012-12#1)
that depressive##2##2##(2010-4#1)(2013-8#1)
that derive##2##2##(1993-12#1)(2008-3#1)
that derived from##3##3##(1994-5#1)(2008-3#1)(2008-9#1)
that derives##2##2##(2008-10#1)(2009-5#1)
that describe laser##2##3##(2008-3#2)
that describe the##16##3##(1990-8#1)(1993-12#1)(1993-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
that describe##28##2##(1990-8#1)(1993-12#1)(1993-8#1)(1996-4#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
that described##9##2##(1990-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-4#1)(2009-5#1)(2010-10#1)
that describes a##2##3##(2008-4#1)(2008-8#1)
that describes the##15##3##(1997-2#1)(2007-11#4)(2008-10#1)(2008-2#3)(2008-3#4)(2008-8#1)(2011-2#1)
that describes##30##2##(1996-12#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2011-2#1)(2013-8#1)
that deserve##2##2##(2009-10#1)(2012-2#1)
that design##2##2##(1990-4#1)(2008-2#1)
that despite the##6##3##(1997-5#1)(2008-11#2)(2008-3#1)(2008-7#1)(2011-1#1)
that despite##9##2##(1997-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)
that destroys the##2##3##(1991-12#1)(2012-3#1)
that detailed##2##2##(1993-12#1)(2008-9#1)
that detect##3##2##(1990-12#1)(2007-12#1)(2008-10#1)
that detected##6##2##(1990-2#1)(2008-10#3)(2008-3#1)(2011-1#1)
that detection##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
that determination of##3##3##(1991-12#1)(2008-10#2)
that determine the##18##3##(1994-5#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
that determine whether##2##3##(1993-6#1)(2008-9#1)
that determine##31##2##(1993-1#1)(1993-6#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
that determined##6##2##(1995-8#1)(1997-7#1)(2008-10#3)(2008-11#1)
that determines the##8##3##(1990-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2012-2#1)
that determines##15##2##(1990-6#1)(1992-12#1)(1994-1#1)(1995-2#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#1)(2012-2#1)(2012-3#1)
that develop in##2##3##(2007-11#1)(2010-12#1)
that develop##5##2##(1990-12#1)(1993-3#1)(2007-11#1)(2008-11#1)(2010-12#1)
that developed on##2##3##(2008-10#1)(2010-6#1)
that developed##18##2##(1991-6#1)(1993-6#1)(1996-12#1)(2006-10#2)(2008-10#6)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
that developing##2##2##(2008-11#1)(2009-4#1)
that development of##2##3##(1991-12#1)(2008-4#1)
that development##5##2##(1991-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-1#1)
that developmental##2##2##(2008-10#2)
that develops in##2##3##(2008-10#1)(2008-9#1)
that develops##9##2##(1996-8#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#1)
that devolution##2##2##(1997-2#2)
that diabetic##4##2##(2008-1#2)(2008-3#1)(2008-7#1)
that diagnosed##2##2##(2008-11#1)(2009-10#1)
that diagnosis of##2##3##(2011-2#1)(2012-2#1)
that diagnosis##3##2##(1993-2#1)(2011-2#1)(2012-2#1)
that diagnostic##2##2##(1990-12#1)(2010-5#1)
that dictate##3##2##(1993-2#1)(2008-10#1)(2012-12#1)
that did not alter##2##4##(2008-10#1)(2008-5#1)
that did not have a previous##2##6##(2013-1#2)
that did not increase##2##4##(1994-12#1)(1994-8#1)
that did not respond to##2##5##(2008-7#1)(2012-12#1)
that did not show##2##4##(2008-4#1)(2011-2#1)
that did not##46##3##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
that did##48##2##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2009-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
that died during##2##3##(2008-11#1)(2011-1#1)
that died##7##2##(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
that diet##2##2##(1990-8#1)(2008-5#1)
that dietary factors##2##3##(1992-10#1)(2008-7#1)
that dietary nucleotides##2##3##(2008-11#2)
that dietary##12##2##(1992-10#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-2#2)
that diets##2##2##(2008-7#1)(2013-1#1)
that differ by##6##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2013-8#1)
that differ considerably from##2##4##(2008-10#1)(2010-3#1)
that differ from those of##2##5##(2008-8#1)(2011-2#1)
that differ from##4##3##(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)
that differ in levels of##2##5##(1996-12#2)
that differ in their##5##4##(1994-2#1)(1994-8#1)(1997-8#1)(2008-10#1)(2013-8#1)
that differ in##10##3##(1994-2#1)(1994-8#1)(1996-12#2)(1997-8#1)(2007-7#1)(2008-10#2)(2013-8#2)
that differ##28##2##(1991-2#1)(1994-2#1)(1994-8#1)(1996-12#2)(1997-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#2)(2011-2#1)(2012-1#1)(2013-8#3)
that differed from##2##3##(2008-10#2)
that differed in their##3##4##(2008-11#2)(2009-10#1)
that differed in##10##3##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)
that differed##19##2##(1994-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)
that difference##5##2##(1994-1#1)(2008-11#1)(2011-2#3)
that differences between the##2##4##(1997-6#1)(2008-8#1)
that differences between##3##3##(1993-1#1)(1997-6#1)(2008-8#1)
that differences in the##4##4##(1995-11#1)(1997-3#1)(2008-10#1)(2008-9#1)
that differences in##10##3##(1991-12#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-9#2)(2009-11#1)(2009-5#1)(2012-12#1)
that differences##17##2##(1991-12#1)(1993-1#1)(1994-12#1)(1995-11#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2012-12#1)
that different analytes##2##3##(2008-10#2)
that different isoforms of PKC##2##5##(1995-11#2)
that different signaling cascades##2##4##(2008-11#2)
that different strains##2##3##(2007-6#1)(2012-3#1)
that different##55##2##(1990-7#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-12#1)(1996-9#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
that differential##5##2##(1995-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
that differentially##3##2##(1993-6#1)(2008-4#1)(2010-12#1)
that differentiate the##4##3##(2007-12#1)(2008-10#1)(2012-1#2)
that differentiate##8##2##(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-1#2)
that differentiated##2##2##(2009-4#1)(2010-5#1)
that differentiation of##5##3##(1991-12#1)(1992-9#1)(2008-11#1)(2008-4#1)(2008-6#1)
that differentiation##6##2##(1991-12#1)(1992-8#1)(1992-9#1)(2008-11#1)(2008-4#1)(2008-6#1)
that differs from the previously##2##5##(2008-10#2)
that differs from##3##3##(1991-8#1)(2008-10#2)
that differs##7##2##(1991-8#1)(2008-10#3)(2008-3#1)(2009-7#1)(2012-12#1)
that diffuse##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
that digital##2##2##(2007-11#1)(2008-3#1)
that diminished##3##2##(1995-1#1)(2008-4#1)(2008-7#1)
that direct the##2##3##(2007-11#1)(2008-10#1)
that direct##12##2##(1992-9#1)(1993-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
that directed##3##2##(1990-5#1)(1994-11#1)(2011-1#1)
that directly address##2##3##(2013-1#2)
that directly##19##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)
that directs the##2##3##(2008-2#1)(2008-7#1)
that directs##4##2##(1994-12#1)(1995-12#1)(2008-2#1)(2008-7#1)
that discriminates##2##2##(2009-3#1)(2010-3#1)
that discussion##2##2##(2010-11#1)(2012-3#1)
that disease control##3##3##(2008-10#3)
that disease incidence was##3##4##(2008-10#3)
that disease incidence##6##3##(2008-10#6)
that disease##17##2##(1991-2#1)(2008-10#14)(2008-7#1)(2012-3#1)
that diseases##2##2##(1997-3#1)(2010-1#1)
that dispersal##3##2##(2008-8#1)(2008-9#2)
that dispersion management##2##3##(2007-12#2)
that dispersion##3##2##(2007-12#2)(2008-3#1)
that dispersion-managed solitons##2##3##(2007-11#1)(2007-12#1)
that display similar traits##2##4##(2013-1#2)
that display the##4##3##(2007-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
that display##15##2##(1994-9#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#2)
that displayed##4##2##(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
that displays a##3##3##(1995-12#1)(1996-5#1)(2008-9#1)
that displays##8##2##(1992-10#1)(1993-3#1)(1995-12#1)(1996-5#1)(2008-3#2)(2008-6#1)(2008-9#1)
that disrupt##4##2##(1993-12#1)(1997-2#1)(2008-5#1)(2013-1#1)
that disrupted the##2##3##(2008-2#1)(2011-3#1)
that disruption of##2##3##(1997-3#1)(2012-2#1)
that disrupts the##2##3##(1991-7#1)(2013-1#1)
that disrupts##3##2##(1991-7#1)(2009-10#1)(2013-1#1)
that distal##2##2##(1995-6#1)(2010-11#1)
that distance learning is##2##4##(2008-11#1)(2010-10#1)
that distance learning##3##3##(2008-11#2)(2010-10#1)
that distance##5##2##(2007-12#1)(2008-10#1)(2008-11#2)(2010-10#1)
that distinct##4##2##(1992-3#1)(1993-8#1)(1997-7#1)(2008-5#1)
that distinguish between##2##3##(1990-2#1)(2008-4#1)
that distinguish it from##2##4##(2007-12#1)(2013-1#1)
that distinguish the##3##3##(1996-6#1)(2008-8#1)(2010-3#1)
that distinguish##20##2##(1990-2#1)(1991-12#1)(1991-6#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
that distinguished##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
that distinguishes the##2##3##(1995-2#1)(2008-10#1)
that distinguishes##5##2##(1995-2#1)(2008-10#2)(2008-12#1)(2008-9#1)
that distraction##2##2##(2007-12#1)(2012-3#1)
that distribution##2##2##(1995-12#1)(2008-8#1)
that disturbances of##2##3##(1991-2#1)(2007-11#1)
that divalent cations##2##3##(1990-7#1)(1994-5#1)
that diverged from the##2##4##(2009-10#1)(2009-8#1)
that diverged##3##2##(2009-10#1)(2009-8#1)(2013-1#1)
that diverse##3##2##(2008-8#1)(2010-10#1)(2013-1#1)
that divided##2##2##(2008-12#1)(2009-12#1)
that divorce##3##2##(2011-2#3)
that do not contain##4##4##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
that do not contribute to##2##5##(1994-12#1)(2009-8#1)
that do not follow##2##4##(1997-4#1)(2009-4#1)
that do not have a##2##5##(2012-1#1)(2012-12#1)
that do not have##3##4##(2008-1#1)(2012-1#1)(2012-12#1)
that do not interact##2##4##(1996-2#1)(2010-12#1)
that do not involve##3##4##(2008-11#1)(2008-4#1)(2012-12#1)
that do not require##5##4##(1993-12#1)(1995-2#1)(1997-3#1)(2008-11#1)(2011-2#1)
that do not respond to##3##5##(1992-3#1)(2008-7#1)(2010-12#1)
that do not##54##3##(1990-8#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-2#3)(1995-5#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#2)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
that do##62##2##(1990-8#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-2#3)(1995-5#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-10#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#2)(2010-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
that doctors##7##2##(1992-5#1)(1994-9#1)(1995-2#2)(1995-6#1)(2011-2#2)
that documented##2##2##(2008-10#1)(2008-7#1)
that does not depend on##3##5##(1995-3#1)(2008-11#1)(2008-3#1)
that does not have##2##4##(1993-1#1)(2008-10#1)
that does not involve##4##4##(1994-8#1)(1995-3#1)(1995-8#1)(2008-10#1)
that does not match the##2##5##(1997-7#1)(2012-2#1)
that does not need##2##4##(1996-3#1)(2008-10#1)
that does not require a##2##5##(2007-12#1)(2008-10#1)
that does not require any##2##5##(2008-10#1)(2013-8#1)
that does not require##10##4##(1995-12#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-9#1)(2013-8#1)
that does not##46##3##(1991-12#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-7#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
that dominate##2##2##(2008-10#1)(2008-2#1)
that dominated##2##2##(1995-2#1)(2008-10#1)
that dominates##2##2##(2008-5#1)(2012-12#1)
that dopamine##3##2##(1993-6#1)(1995-2#1)(1997-3#1)
that dopaminergic##2##2##(1993-6#1)(2013-1#1)
that dose##2##2##(1993-11#1)(2008-2#1)
that double##2##2##(2008-9#1)(2011-2#1)
that down-regulation of c-myc##2##4##(1991-9#1)(2008-11#1)
that down-regulation of##4##3##(1991-9#1)(2008-11#1)(2011-2#1)(2013-1#1)
that downregulation of##2##3##(1994-6#1)(2010-12#1)
that dramatically##3##2##(2008-8#1)(2008-9#2)
that drastically##2##2##(1997-4#1)(2008-2#1)
that draws on##3##3##(1993-12#1)(2008-8#1)(2012-3#1)
that draws##4##2##(1993-12#1)(1996-12#1)(2008-8#1)(2012-3#1)
that dreaming##2##2##(2013-8#2)
that drive the##4##3##(2008-3#1)(2010-8#1)(2012-3#2)
that drive##11##2##(1996-6#1)(2008-3#1)(2008-9#2)(2009-3#2)(2010-8#1)(2012-3#3)(2013-1#1)
that drives the##4##3##(2008-3#2)(2010-8#1)(2012-2#1)
that drives##7##2##(2008-10#1)(2008-3#2)(2010-8#1)(2012-2#1)(2013-1#2)
that drug##6##2##(1990-3#1)(1993-6#1)(2008-11#2)(2010-5#1)(2012-3#1)
that drugs are##2##3##(1990-2#1)(1996-3#1)
that drugs##6##2##(1990-2#1)(1993-3#1)(1994-8#1)(1996-3#1)(1997-1#1)(2012-2#1)
that dsRNA##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
that due to the##5##4##(1990-6#1)(1991-12#1)(1994-5#1)(2008-10#1)(2008-5#1)
that due to##6##3##(1990-6#1)(1991-12#1)(1994-5#1)(2008-10#2)(2008-5#1)
that due##7##2##(1990-6#1)(1991-12#1)(1993-12#1)(1994-5#1)(2008-10#2)(2008-5#1)
that during development##2##3##(1992-5#1)(1996-5#1)
that during the##4##3##(1990-11#1)(1996-9#1)(2008-2#1)(2008-5#1)
that during this##2##3##(2008-11#1)(2008-8#1)
that during##27##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#3)
that dye##3##2##(2008-2#1)(2008-4#1)(2011-1#1)
that dynamic##3##2##(2008-11#1)(2008-9#1)(2012-1#1)
that dynamics##2##2##(2008-10#1)(2008-8#1)
that each cell##2##3##(2008-6#1)(2012-3#1)
that each layer##3##3##(2008-11#1)(2008-3#2)
that each of the##6##4##(1991-7#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-12#1)(2009-2#1)
that each of these##4##4##(1991-1#1)(1991-9#1)(2008-11#1)(2008-7#1)
that each of##10##3##(1991-1#1)(1991-7#1)(1991-9#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)
that each##56##2##(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#2)(2007-12#1)(2007-9#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
that early diagnosis and##2##4##(2007-11#1)(2009-1#1)
that early intervention##2##3##(1996-7#1)(2008-1#1)
that early pharmacological and psychosocial treatment dramatically ameliorates poor prognosis and outcome for individuals with psychotic disorders##2##17##(2009-8#2)
that early##23##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-9#1)(1996-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-1#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
that economic##2##2##(1995-2#1)(2011-1#1)
that education and##2##3##(1997-8#1)(2008-11#1)
that education##5##2##(1994-8#1)(1995-1#1)(1997-8#1)(2008-11#1)(2012-3#1)
that educational##4##2##(1991-9#1)(2007-10#1)(2008-11#1)(2009-12#1)
that educators##2##2##(1995-12#1)(2007-11#1)
that effect##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
that effective##10##2##(1992-1#1)(1993-11#1)(1996-2#1)(2007-5#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)
that effectively treat##2##3##(2008-2#1)(2008-6#1)
that effectively##11##2##(1994-7#1)(1995-1#1)(1995-5#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-12#2)(2013-1#1)
that effects of##4##3##(1994-9#1)(1995-3#1)(2011-2#1)(2013-1#1)
that efficacy##2##2##(2008-6#1)(2012-12#1)
that efficient##4##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
that eight##2##2##(1997-3#1)(2009-4#1)
that either increase or decrease##2##5##(2008-7#1)(2010-12#1)
that either the##5##3##(1992-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2009-12#1)
that either##25##2##(1992-9#1)(1993-12#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
that elderly patients##2##3##(1993-9#1)(2008-7#1)
that elderly##4##2##(1993-9#1)(1994-6#1)(2008-7#2)
that electron##4##2##(1990-5#1)(1994-5#1)(2007-11#1)(2008-5#1)
that electronic nose##2##3##(2008-10#1)(2012-2#1)
that electrostatic interactions##2##3##(1994-5#1)(2008-4#1)
that electrostatic##3##2##(1990-8#1)(1994-5#1)(2008-4#1)
that elevate##2##2##(1995-8#1)(2008-5#1)
that elevated##12##2##(1991-12#3)(1992-8#1)(1993-12#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)
that elevates##2##2##(1991-9#1)(2010-12#1)
that elevation of##2##3##(2008-1#1)(2008-10#1)
that elevations in##2##3##(1995-2#1)(2008-7#1)
that elicit disgust##3##3##(2008-11#3)
that elicit##5##2##(2008-10#1)(2008-11#4)
that elicited by##2##3##(1996-5#1)(2008-5#1)
that eliminate##2##2##(1992-9#2)
that eliminated##2##2##(2008-10#2)
that eliminates the##3##3##(2008-3#3)
that eliminates##7##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)
that ellagic acid##2##3##(1994-6#1)(2011-2#1)
that eluted##2##2##(1990-12#1)(2008-10#1)
that embodies##2##2##(1997-3#1)(2008-8#1)
that embryos##2##2##(2008-6#1)(2009-5#1)
that emerge from the##3##4##(2008-11#1)(2008-2#1)(2010-11#1)
that emerge from##4##3##(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)
that emerge##6##2##(1996-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)(2010-12#1)
that emerged during##2##3##(1992-8#1)(2008-11#1)
that emerged from the##2##4##(2007-10#1)(2008-11#1)
that emerged from##6##3##(1991-12#1)(2007-10#1)(2008-11#2)(2013-1#2)
that emerged in##2##3##(2008-11#2)
that emerged##12##2##(1991-12#1)(1992-8#1)(2007-10#1)(2008-10#1)(2008-11#5)(2013-1#2)(2013-8#1)
that emerges is##2##3##(2009-6#1)(2009-7#1)
that emerges##3##2##(2008-3#1)(2009-6#1)(2009-7#1)
that emits##3##2##(1990-8#1)(2007-11#1)(2013-1#1)
that emphasize##5##2##(1994-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2012-2#1)
that emphasized##4##2##(2008-10#1)(2009-8#3)
that emphasizes the##2##3##(2008-10#1)(2012-3#1)
that emphasizes##4##2##(1995-2#1)(1997-1#1)(2008-10#1)(2012-3#1)
that empirical##3##2##(2008-11#1)(2008-8#1)(2009-4#1)
that employ a##2##3##(2008-8#1)(2010-2#1)
that employ holding beams##2##4##(2007-11#2)
that employ the##2##3##(2007-12#1)(2008-3#1)
that employ##14##2##(1993-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
that employed##3##2##(1991-5#1)(2008-11#1)(2008-2#1)
that employees##2##2##(1994-3#1)(2008-6#1)
that employers and##2##3##(1995-3#1)(2010-3#1)
that employers may##2##3##(1994-3#1)(1995-12#1)
that employers##5##2##(1994-1#1)(1994-3#1)(1995-12#1)(1995-3#1)(2010-3#1)
that employment##2##2##(2008-7#1)(2010-6#1)
that employs a##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
that employs the##2##3##(2008-3#2)
that employs##19##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#9)(2008-4#2)
that empower##2##2##(1993-1#1)(2008-11#1)
that empty##2##2##(2008-8#2)
that emulate ocean water##2##4##(2008-3#2)
that enable the##4##3##(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
that enable##21##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
that enabled a##2##3##(1994-2#1)(2007-10#1)
that enabled the##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
that enabled##6##2##(1994-2#1)(2007-10#1)(2008-10#2)(2009-6#1)(2011-1#1)
that enables a##2##3##(2008-10#1)(2008-11#1)
that enables one to##2##4##(1996-4#1)(2008-2#1)
that enables the determination##2##4##(2008-10#2)
that enables the##10##3##(1995-1#1)(2007-11#1)(2008-10#3)(2008-3#4)(2008-5#1)
that enables us to##4##4##(2008-3#2)(2012-12#1)(2012-2#1)
that enables##29##2##(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
that encapsulation##2##2##(2008-11#1)(2013-1#1)
that enclose the##2##3##(2008-6#2)
that enclose##3##2##(2007-12#1)(2008-6#2)
that encloses a##2##3##(1995-2#1)(2007-12#1)
that encode the##3##3##(1994-8#1)(1995-6#1)(2008-4#1)
that encode##18##2##(1992-11#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
that encoded a##2##3##(1991-12#1)(2008-9#1)
that encoded##5##2##(1991-12#1)(2008-11#1)(2008-8#2)(2008-9#1)
that encodes a##9##3##(1990-11#1)(1990-12#2)(1993-2#1)(1994-12#2)(2007-12#1)(2008-10#2)
that encodes the##8##3##(1991-9#1)(1993-2#1)(1995-2#1)(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#1)
that encodes##25##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-7#1)(1991-9#1)(1993-2#2)(1994-12#2)(1995-11#1)(1995-2#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
that encompass the##3##3##(2008-12#1)(2008-2#1)(2012-3#1)
that encompass##5##2##(2007-12#1)(2008-12#1)(2008-2#1)(2012-3#1)(2013-1#1)
that encompasses##5##2##(1993-3#1)(1995-6#1)(2007-12#1)(2008-8#1)(2012-2#1)
that encourage##5##2##(2009-10#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
that encouraged the##2##3##(1993-12#1)(2011-2#1)
that encouraged##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
that encourages##3##2##(1992-12#1)(1994-1#1)(2008-9#1)
that end##8##2##(1992-8#1)(1994-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
that endogenous##13##2##(1990-2#1)(1992-11#1)(1995-12#3)(1996-12#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-3#1)
that endos is required##2##4##(2012-3#2)
that endoscopic##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
that endothelial cells##3##3##(1993-3#1)(1994-11#1)(2008-11#1)
that endothelial##4##2##(1993-3#1)(1994-11#1)(2008-11#2)
that endothelin is##2##3##(1994-11#1)(1995-12#1)
that endothelin##3##2##(1993-3#1)(1994-11#1)(1995-12#1)
that energy##2##2##(2009-2#1)(2010-8#1)
that enhance the##3##3##(1993-11#1)(1995-8#1)(2013-1#1)
that enhance##10##2##(1993-11#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
that enhanced##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
that enhances the##3##3##(1997-3#1)(2008-2#1)(2008-9#1)
that enhances##9##2##(1993-6#1)(1994-5#1)(1995-1#1)(1997-3#1)(2008-12#1)(2008-2#2)(2008-9#1)(2012-12#1)
that ensure that##2##3##(2008-11#1)(2008-3#1)
that ensure##8##2##(1995-12#1)(2008-11#2)(2008-12#2)(2008-3#2)(2010-11#1)
that ensured the##2##3##(2008-10#2)
that ensures a##2##3##(2008-5#1)(2012-2#1)
that ensures the##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
that ensures##8##2##(1995-5#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-8#1)
that enter##3##2##(1995-12#1)(2007-11#1)(2008-11#1)
that enters the##2##3##(2008-2#1)(2008-3#1)
that environmental##6##2##(2008-10#2)(2008-8#1)(2009-6#1)(2009-8#1)(2013-1#1)
that enzymatic##2##2##(1991-9#1)(2008-12#1)
that epidemics of##3##3##(2008-10#2)(2008-8#1)
that epidemics##5##2##(2008-10#4)(2008-8#1)
that epidermal growth factor##2##4##(1991-7#1)(1994-11#1)
that epidermal##3##2##(1991-7#1)(1994-11#1)(2008-10#1)
that epidural##3##2##(2008-7#1)(2012-3#2)
that epigenetic##4##2##(2008-12#1)(2009-10#1)(2009-4#2)
that epilepsy##2##2##(1990-9#1)(2008-8#1)
that epimerization##2##2##(2008-11#1)(2008-5#1)
that epiphytic##2##2##(2008-10#2)
that eponemycin##2##2##(1991-12#2)
that equals##2##2##(2008-10#1)(2013-1#1)
that equilibrium##2##2##(2008-8#2)
that eradication of##2##3##(1993-12#1)(1997-1#1)
that errors##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
that escapes##2##2##(1994-11#1)(2008-3#1)
that essential##2##2##(2008-5#2)
that establish##2##2##(1997-6#1)(2012-2#1)
that establishes##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
that estimate##2##2##(2008-3#1)(2013-1#1)
that estimated##3##2##(1997-5#1)(2008-8#1)(2011-2#1)
that estimates of##2##3##(2008-3#1)(2008-9#1)
that estimates the##3##3##(2008-2#2)(2008-3#1)
that estimates##6##2##(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)
that estrogen##7##2##(1992-3#2)(1994-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)
that estrogens##2##2##(2009-7#1)(2013-1#1)
that ethanol exposure##2##3##(2009-12#2)
that ethanol##7##2##(1990-12#1)(1992-7#1)(2008-11#1)(2009-12#2)(2009-7#1)(2012-2#1)
that ethanolic extract of##2##4##(2008-12#1)(2011-1#1)
that ethnic##2##2##(2008-1#1)(2010-1#1)
that ethoxyresorufin##2##2##(1994-8#2)
that eugenol##2##2##(2009-12#2)
that eukaryotic##3##2##(1991-12#1)(2008-7#1)(2009-6#1)
that evaluate##4##2##(1991-2#1)(2007-4#1)(2008-10#1)(2008-2#1)
that evaluated##4##2##(2008-2#1)(2008-9#1)(2012-3#1)(2013-1#1)
that evaluation of##5##3##(1992-3#1)(1993-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
that evaluation##6##2##(1992-3#1)(1993-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-4#1)
that even a##2##3##(1997-6#1)(2008-3#1)
that even after##3##3##(1997-4#1)(2008-7#1)(2009-12#1)
that even at##2##3##(1991-5#1)(1995-12#1)
that even if the##2##4##(2007-2#1)(2013-8#1)
that even if##4##3##(2007-2#1)(2008-7#2)(2013-8#1)
that even in##5##3##(1992-6#1)(1994-12#1)(2007-7#1)(2008-9#1)(2011-2#1)
that even moderate##2##3##(1994-11#1)(1997-4#1)
that even partial##2##3##(2008-8#1)(2011-2#1)
that even small##3##3##(1991-12#1)(1993-2#1)(2010-4#1)
that even the##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
that even though##2##3##(1993-9#1)(2011-2#1)
that even##45##2##(1991-12#1)(1991-5#1)(1992-6#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-4#2)(1997-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
that eventually##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
that every##6##2##(1992-3#1)(1995-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-12#1)
that evidence of##2##3##(1995-6#1)(2010-9#1)
that evidence##5##2##(1992-3#1)(1995-6#1)(2008-9#1)(2010-9#1)(2011-2#1)
that evoke##2##2##(2008-7#1)(2009-8#1)
that evoked##3##2##(1995-12#2)(2007-8#1)
that evolution of##2##3##(2008-8#2)
that evolution##4##2##(2008-10#1)(2008-7#1)(2008-8#2)
that evolutionary##3##2##(2008-10#1)(2010-3#2)
that evolved in##2##3##(2007-12#1)(2008-10#1)
that evolved##5##2##(1993-12#1)(1994-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
that examine##8##2##(2008-11#1)(2008-7#3)(2009-5#1)(2009-7#1)(2009-9#1)(2012-2#1)
that examined the##2##3##(2007-8#2)
that examined##6##2##(1996-12#1)(2007-8#3)(2008-4#1)(2013-1#1)
that examines the##4##3##(2008-12#1)(2008-3#1)(2009-7#1)(2010-11#1)
that examines##6##2##(1996-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-11#1)
that exceed##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
that exceeded##5##2##(1994-12#1)(1997-4#1)(2008-10#1)(2009-7#1)(2011-2#1)
that exceeds the##2##3##(2008-2#1)(2008-3#1)
that exceeds##6##2##(2007-12#1)(2008-2#3)(2008-3#1)(2009-5#1)
that excellent##2##2##(2008-2#1)(2008-5#1)
that excess##3##2##(1995-2#1)(2012-2#1)(2013-1#1)
that excessive##6##2##(1992-3#1)(1994-2#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
that excitation of##2##3##(2007-11#1)(2007-12#1)
that exclusion of##3##3##(2008-10#3)
that executes##2##2##(2008-3#1)(2009-4#1)
that exenatide##2##2##(2012-3#2)
that exercise##2##2##(1993-11#2)
that exerts##2##2##(1993-9#1)(2009-11#1)
that exhibit a##2##3##(2008-3#1)(2008-8#1)
that exhibit different levels of##3##5##(2008-10#2)(2008-8#1)
that exhibit##26##2##(1991-5#1)(1992-3#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-5#2)(2009-6#1)(2012-3#2)
that exhibited the##2##3##(2008-10#1)(2010-2#1)
that exhibited##16##2##(1994-12#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-10#10)(2010-2#1)(2011-2#1)
that exhibits a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
that exhibits an##2##3##(2007-11#1)(2008-3#1)
that exhibits two##2##3##(2007-12#1)(2009-7#1)
that exhibits##18##2##(1993-9#1)(1996-12#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-3#5)(2009-7#1)(2010-3#1)(2011-1#1)(2012-2#1)
that exist between##4##3##(2008-10#1)(2008-8#1)(2009-11#1)(2009-5#1)
that exist for##2##3##(2007-10#1)(2007-11#1)
that exist in the##3##4##(2008-2#1)(2008-3#2)
that exist in##10##3##(1993-1#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)(2012-12#1)
that exist##23##2##(1993-1#1)(1996-1#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
that existed in##2##3##(1996-4#1)(2008-11#1)
that existing##4##2##(2008-3#1)(2009-11#1)(2009-4#1)(2010-10#1)
that exists among##2##3##(1997-8#1)(2008-10#1)
that exists between##2##3##(2007-12#1)(2013-1#1)
that exists in the##3##4##(2008-1#1)(2008-12#1)(2008-5#1)
that exists in##6##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
that exists within##3##3##(2007-5#1)(2008-12#1)(2012-12#1)
that exists##17##2##(1992-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that exit from##2##3##(2008-3#1)(2011-2#1)
that exit##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
that exogenous##9##2##(1990-2#1)(1991-12#1)(1996-2#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
that exogenously##2##2##(2008-11#1)(2011-10#1)
that exon##3##2##(1997-8#1)(2008-12#2)
that expansion##2##2##(1996-12#1)(2008-9#1)
that expected from the##2##4##(1992-8#1)(2008-10#1)
that expected from##6##3##(1992-8#1)(1994-12#1)(2007-11#1)(2008-10#2)(2008-3#1)
that expected##9##2##(1992-8#1)(1994-12#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-7#1)
that experience##8##2##(2007-11#1)(2008-8#3)(2008-9#2)(2012-12#1)(2013-8#1)
that experiences##2##2##(2008-10#1)(2008-8#1)
that experimental##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
that explain the##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2012-12#1)
that explain##7##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
that explained##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
that explains this##2##3##(2007-12#1)(2012-3#1)
that explains##5##2##(2007-12#2)(2010-10#1)(2012-2#1)(2012-3#1)
that explicitly consider the##2##4##(2008-3#1)(2008-8#1)
that explicitly includes##2##3##(1994-2#1)(2008-2#1)
that explicitly##5##2##(1994-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
that exploit the##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
that exploit##9##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#2)
that exploits the##3##3##(2008-3#2)(2012-2#1)
that exploits##8##2##(1995-6#1)(2007-12#1)(2008-3#4)(2008-7#1)(2012-2#1)
that explore the##2##3##(2008-6#1)(2011-2#1)
that explored the##4##3##(1996-3#1)(2007-10#1)(2008-12#1)(2011-1#1)
that explored##6##2##(1996-3#1)(2007-10#1)(2008-12#1)(2009-5#1)(2010-4#1)(2011-1#1)
that explores the##2##3##(1992-6#1)(2007-10#1)
that exposure of human##4##4##(1992-8#1)(1994-11#1)(1994-6#1)(2008-5#1)
that exposure of##8##3##(1992-8#1)(1994-11#1)(1994-6#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
that exposure to the##3##4##(1993-6#1)(2008-10#2)
that exposure to##21##3##(1991-12#1)(1991-4#1)(1993-6#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#2)
that exposure##31##2##(1991-12#1)(1991-4#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-6#2)(1997-1#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
that express high##2##3##(1995-5#1)(2008-11#1)
that express the##12##3##(1990-11#1)(1991-5#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2011-1#1)
that express##29##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#2)(2011-1#1)(2012-3#1)
that expressed##10##2##(1991-5#1)(1994-5#1)(1997-7#1)(2008-10#5)(2009-6#1)(2010-3#1)
that expresses the Bacillus thuringiensis (Bt)##2##6##(2011-2#2)
that expresses##7##2##(1994-12#1)(1995-2#1)(2008-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
that expression levels of##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
that expression of the##3##4##(1995-8#2)(2008-10#1)
that expression of these##2##4##(1997-8#1)(2009-10#1)
that expression of##19##3##(1990-12#1)(1992-9#1)(1993-3#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
that expression##25##2##(1990-12#1)(1992-9#1)(1993-3#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
that extend from the##3##4##(1995-11#1)(1997-8#1)(2010-12#1)
that extend##6##2##(1995-11#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2010-12#1)
that extended from the##2##4##(2011-2#1)(2012-3#1)
that extended to##2##3##(2007-8#1)(2008-10#1)
that extended##9##2##(1997-3#1)(2007-8#2)(2008-10#3)(2008-3#1)(2011-2#1)(2012-3#1)
that extends the##4##3##(1996-5#1)(2007-11#1)(2008-3#1)(2011-2#1)
that extends##12##2##(1996-5#1)(1997-3#1)(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-2#2)
that extensive##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
that external##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-10#1)(2011-2#1)
that extinction##2##2##(2008-2#1)(2008-9#1)
that extracellular ATP and other nucleotides##2##6##(2008-4#2)
that extracellular Ca2+ is##2##4##(1990-7#1)(1990-8#1)
that extracellular CaM##2##3##(2008-8#2)
that extracellular matrix##2##3##(2009-8#1)(2010-11#1)
that extracellular##15##2##(1990-7#1)(1990-8#1)(1994-11#1)(1995-2#1)(1997-2#1)(2008-4#4)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#1)
that extracts##3##2##(2008-3#1)(2010-2#2)
that eye##2##2##(2008-11#1)(2011-1#1)
that fabrication##2##2##(2008-10#1)(2008-3#1)
that face##4##2##(2008-1#1)(2009-10#1)(2010-3#1)(2012-1#1)
that faces##2##2##(2008-3#1)(2012-1#1)
that facilitate the##2##3##(2008-4#1)(2008-9#1)
that facilitate##12##2##(1993-9#1)(1995-3#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that facilitated##4##2##(1993-12#1)(2007-11#1)(2008-12#1)(2013-1#1)
that facilitates##8##2##(1991-2#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-9#1)(2010-6#1)(2011-2#1)
that factor##2##2##(1992-1#1)(1995-2#1)
that factors other than##2##4##(1990-5#1)(2011-2#1)
that factors##10##2##(1990-5#1)(1991-2#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#1)
that fail to##6##3##(1992-12#1)(1993-3#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)
that fail##7##2##(1992-12#1)(1993-3#1)(2008-11#1)(2008-9#2)(2009-10#1)(2011-2#1)
that failed to develop##2##4##(2008-10#2)
that failed to##5##3##(1994-8#1)(1996-12#1)(2008-10#2)(2010-6#1)
that failed##6##2##(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#2)(2010-6#1)
that failure to##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
that failure##4##2##(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
that faithfully##2##2##(1996-2#1)(2008-11#1)
that fall##2##2##(2008-2#1)(2008-4#1)
that false##2##2##(2008-8#1)(2012-3#1)
that families##3##2##(1991-12#1)(2008-8#1)(2010-9#1)
that family members##2##3##(1992-7#1)(2011-2#1)
that family planning was##2##4##(1992-4#2)
that family planning##4##3##(1992-4#3)(1994-7#1)
that family##12##2##(1992-4#3)(1992-7#1)(1994-7#1)(2007-4#1)(2008-5#1)(2009-12#1)(2010-1#1)(2011-2#2)(2013-1#1)
that far##2##2##(1992-2#1)(1993-3#1)
that farm-related##2##2##(2008-12#2)
that farmers##2##2##(2008-12#2)
that fast##2##2##(1992-11#1)(2008-3#1)
that fat##2##2##(1994-11#1)(2008-5#1)
that fatty acids are##2##4##(1995-6#1)(2008-8#1)
that fatty acids##3##3##(1995-6#2)(2008-8#1)
that favor the##2##3##(2008-9#1)(2011-1#1)
that favor##8##2##(1995-6#2)(1996-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#2)
that favors##4##2##(1990-8#1)(1995-2#1)(2008-10#1)(2013-8#1)
that favour hemi-fusion##2##3##(1991-5#2)
that favour##3##2##(1991-5#2)(1997-4#1)
that fear##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
that features##6##2##(1993-3#1)(2007-10#1)(2007-12#1)(2008-3#3)
that feed##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
that feedback##2##2##(1995-2#1)(1996-3#1)
that feeding##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
that female##5##2##(1990-12#1)(1995-3#1)(2008-12#1)(2008-8#1)(2012-3#1)
that females may##2##3##(2008-8#2)
that females were##2##3##(2008-4#1)(2009-9#1)
that females##14##2##(2007-7#1)(2008-4#2)(2008-5#1)(2008-8#6)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)
that ferritin##3##2##(1993-11#1)(2013-1#1)(2013-8#1)
that fetal cells##2##3##(1996-12#1)(2012-3#1)
that fetal##5##2##(1995-8#1)(1996-12#1)(2007-10#1)(2012-2#1)(2012-3#1)
that feverfew##2##2##(2008-10#2)
that few##2##2##(1993-12#1)(2008-7#1)
that field##7##2##(1997-1#1)(2007-10#2)(2008-10#3)(2013-8#1)
that fights##2##2##(2008-9#2)
that films##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
that financial##4##2##(1992-1#1)(1994-2#1)(1995-12#1)(2007-9#1)
that finding##2##2##(2008-8#1)(2009-12#1)
that finite##2##2##(2007-11#1)(2008-8#1)
that first##3##2##(1997-1#1)(2008-10#1)(2008-9#1)
that fish and##2##3##(2008-7#1)(2013-7#1)
that fish##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
that fit the data##2##4##(2008-3#2)
that fit##5##2##(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)
that fitness##2##2##(2008-10#1)(2008-8#1)
that fits with##3##3##(1993-1#1)(1994-3#1)(2010-8#1)
that five had##2##3##(2009-10#1)(2011-2#1)
that five##4##2##(1990-2#1)(2008-9#1)(2009-10#1)(2011-2#1)
that flavonoids##2##2##(2008-5#1)(2009-10#1)
that floral##2##2##(2008-9#1)(2009-6#1)
that flow##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
that flowering##2##2##(2008-9#1)(2009-8#1)
that flowers were##2##3##(2008-10#2)
that fluctuating##2##2##(1995-2#1)(2008-8#1)
that fluid##2##2##(2011-2#2)
that flumorph##2##2##(2008-10#2)
that fluorescence##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
that focus on the##3##4##(1994-12#1)(1994-3#1)(2008-12#1)
that focus on##12##3##(1992-12#1)(1994-12#1)(1994-3#1)(1997-2#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)
that focus##14##2##(1992-12#1)(1994-12#1)(1994-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)
that focused on the##3##4##(2007-12#1)(2008-11#1)(2012-1#1)
that focused on##6##3##(2007-12#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
that focuses on the##3##4##(2008-3#1)(2009-10#1)(2012-2#1)
that focuses on##7##3##(1996-12#1)(2008-3#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
that focuses##8##2##(1996-12#1)(2008-3#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that folate##3##2##(1992-3#1)(1992-9#1)(2008-7#1)
that foliar##2##2##(2008-10#1)(2008-8#1)
that follow the##3##3##(1994-11#1)(2008-2#1)(2011-2#1)
that follow##8##2##(1993-12#1)(1994-11#1)(1995-1#1)(1997-3#1)(2008-2#2)(2011-2#1)(2012-2#1)
that followed the##3##3##(1996-12#1)(1996-3#1)(2008-12#1)
that followed##8##2##(1992-11#1)(1993-12#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-6#1)
that following##4##2##(1992-8#1)(1995-11#1)(2008-6#1)(2008-7#1)
that follows the##2##3##(2008-11#2)
that follows##6##2##(1990-7#1)(1995-11#1)(2008-11#2)(2008-2#1)(2012-3#1)
that food##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
that for a##14##3##(1992-11#1)(2008-10#3)(2008-2#4)(2008-3#4)(2012-2#1)(2013-8#1)
that for an##6##3##(1994-2#1)(2008-3#4)(2012-2#1)
that for certain##5##3##(2008-11#1)(2008-3#2)(2011-1#1)(2013-8#1)
that for most##3##3##(1991-6#1)(2008-11#1)(2008-8#1)
that for other##2##3##(1994-7#1)(2011-2#1)
that for positive##2##3##(2007-12#1)(2008-2#1)
that for some##4##3##(1994-6#1)(2008-3#1)(2008-7#1)(2012-12#1)
that for the##26##3##(1990-3#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-2#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-8#2)
that for this##2##3##(2007-11#1)(2008-10#1)
that for##160##2##(1990-11#2)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#2)(2008-2#15)(2008-3#20)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-7#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#7)
that forage with##2##3##(2009-10#2)
that form a part of##2##5##(1992-6#1)(2008-1#1)
that form a##4##3##(1991-12#1)(1992-6#1)(1993-11#1)(2008-1#1)
that form the##7##3##(1993-12#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-4#1)(2009-8#1)(2012-2#1)
that form##22##2##(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-7#1)
that formation of##4##3##(1994-3#1)(1997-3#1)(2008-5#1)(2013-1#1)
that formed##3##2##(1996-5#1)(2008-10#1)(2013-1#1)
that forms a##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2011-2#1)
that forms the##2##3##(1990-12#1)(2009-7#1)
that forms##9##2##(1990-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-7#1)(2011-2#1)
that forskolin##2##2##(1994-11#1)(2009-12#1)
that foster##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2012-12#1)
that found for##2##3##(2007-11#1)(2008-5#1)
that found in the##8##4##(1991-9#1)(1995-6#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-11#2)(2012-12#1)
that found in##23##3##(1990-6#1)(1991-9#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#4)(2011-2#1)(2012-12#1)
that found that##2##3##(1997-5#1)(2011-2#1)
that found with##4##3##(1990-12#1)(1991-3#1)(1994-5#1)(2007-7#1)
that found##39##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#5)(2008-9#1)(2011-2#3)(2012-12#1)(2012-3#1)
that four##10##2##(1990-7#1)(1992-8#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-2#1)(2012-12#1)
that fracture##2##2##(2007-11#2)
that free##4##2##(1995-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
that frequency##2##2##(2007-12#1)(2012-1#1)
that frequently##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2010-7#1)
that from the##12##3##(1990-5#1)(1991-10#1)(1991-9#1)(1992-11#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
that from##35##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
that frozen sections##2##3##(1995-4#2)
that fructose and glucose##2##4##(2008-9#2)
that fructose##3##2##(1990-7#1)(2008-9#2)
that fruit##3##2##(1994-2#1)(2008-10#2)
that fucoidan extracts##3##3##(2008-11#3)
that fulfil##2##2##(2008-10#1)(2008-5#1)
that full##4##2##(1990-6#1)(2008-1#1)(2008-7#1)(2012-2#1)
that fully##6##2##(1993-11#1)(2006-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
that function as##4##3##(2008-1#1)(2009-5#1)(2010-10#1)(2012-2#1)
that function in vesicular trafficking and##2##6##(2009-10#1)(2009-7#1)
that function in##6##3##(2009-10#3)(2009-7#1)(2012-3#2)
that function##15##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#3)(2009-5#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#2)
that functional##8##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-12#1)
that functionally##2##2##(1992-12#1)(2008-8#1)
that functions as a##4##4##(1991-10#1)(2008-4#1)(2009-7#1)(2013-1#1)
that functions in##4##3##(1995-6#1)(1996-2#1)(1996-6#1)(2008-9#1)
that functions##10##2##(1991-10#1)(1995-6#2)(1996-2#1)(1996-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-1#1)
that fundamental##2##2##(2008-3#1)(2008-8#1)
that fungal##2##2##(2008-10#1)(2012-2#1)
that fungicide##2##2##(2008-10#2)
that further research is needed to##2##6##(2007-4#1)(2009-5#1)
that further research##4##3##(2007-4#1)(2009-5#2)(2013-1#1)
that further studies##3##3##(1990-12#1)(2008-9#1)(2009-8#1)
that further study of##2##4##(1996-8#1)(2008-7#1)
that further study##3##3##(1996-8#1)(2008-1#1)(2008-7#1)
that further##29##2##(1990-12#1)(1994-9#2)(1996-8#1)(1997-2#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
that fusicoccin##2##2##(1995-2#2)
that fusion##2##2##(2008-9#1)(2011-1#1)
that future research##3##3##(1992-8#1)(2008-5#1)(2008-8#1)
that future##15##2##(1992-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#3)(2012-12#1)
that galanin##3##2##(1993-3#3)
that gamma-tubulin##3##2##(1991-5#3)
that gap##2##2##(2008-12#1)(2013-1#1)
that gastroenterologists##2##2##(1990-2#1)(2013-1#1)
that gave a##2##3##(1991-2#1)(1995-6#1)
that gave rise to##3##4##(2010-7#1)(2010-9#1)(2011-2#1)
that gave##8##2##(1991-2#1)(1995-6#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#1)
that gel##2##2##(2008-10#1)(2008-9#1)
that gender##5##2##(2008-12#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
that gene flow##3##3##(2008-10#2)(2008-9#1)
that gene therapy##2##3##(2007-11#1)(2008-8#1)
that gene##12##2##(1991-7#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)
that general practitioners##2##3##(1993-2#1)(1997-8#1)
that general##5##2##(1993-1#1)(1993-2#1)(1997-8#1)(2008-7#1)(2009-8#1)
that generally##6##2##(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
that generate and##2##3##(1996-2#1)(2008-3#1)
that generate##11##2##(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-3#2)(2009-4#1)(2011-1#1)(2012-12#2)(2013-8#1)
that generated##3##2##(1992-3#1)(2008-3#1)(2011-2#1)
that generates a##6##3##(1990-5#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
that generates the##2##3##(2008-3#1)(2013-1#1)
that generates##17##2##(1990-5#1)(1994-5#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2013-1#1)
that genes for##3##3##(2008-10#3)
that genes##11##2##(1995-12#1)(1995-6#1)(1997-6#1)(2008-10#4)(2009-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
that genetic differences##2##3##(2007-3#1)(2008-10#1)
that genetic drift##2##3##(2008-10#2)
that genetic factors are important##2##5##(2008-1#1)(2008-7#1)
that genetic factors are##3##4##(2008-1#1)(2008-7#1)(2010-12#1)
that genetic variability##2##3##(2008-10#2)
that genetic##18##2##(1997-7#1)(2007-3#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)
that genetically##3##2##(2008-10#1)(2009-5#1)(2010-8#1)
that genistein##2##2##(1997-7#1)(2008-11#1)
that genome size##2##3##(2008-8#1)(2010-3#1)
that genome##5##2##(1992-3#1)(1992-5#1)(2008-8#1)(2010-3#1)(2011-1#1)
that genomic##4##2##(1994-8#1)(1995-8#1)(2009-2#1)(2011-2#1)
that genotype##2##2##(2008-10#2)
that genotypic##2##2##(1993-6#1)(2009-2#1)
that geographic##2##2##(2008-10#2)
that germ##2##2##(2008-10#2)
that germinated##3##2##(2008-10#2)(2008-5#1)
that ghrelin##4##2##(2008-3#1)(2011-1#1)(2011-2#2)
that gicerin expression##2##3##(1997-6#2)
that girls##2##2##(1990-2#1)(2012-2#1)
that give rise to##7##4##(1992-4#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
that give##10##2##(1992-4#1)(1994-11#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)
that given by##2##3##(2007-12#1)(2008-10#1)
that given##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
that gives a##2##3##(2008-11#2)
that gives rise to##2##4##(1990-11#1)(2007-12#1)
that gives the##2##3##(2008-2#1)(2010-4#1)
that gives##18##2##(1990-11#1)(1990-3#1)(1993-9#1)(1994-9#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-12#1)
that giving##2##2##(1996-5#1)(2010-2#1)
that glial cells##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
that glial##5##2##(1995-5#1)(2008-4#1)(2008-5#1)(2008-7#2)
that glove##2##2##(1995-3#2)
that glucocorticoid##2##2##(1994-9#1)(1997-4#1)
that glucocorticoids##4##2##(1994-6#1)(1994-9#1)(1996-12#1)(2008-7#1)
that glucose##5##2##(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
that glutamate##3##2##(1993-12#1)(2008-6#1)(2009-3#1)
that glutamatergic##2##2##(2008-7#1)(2012-2#1)
that glutathione##5##2##(1990-12#1)(1994-6#1)(1996-12#1)(2012-2#2)
that glycosylation##4##2##(1993-8#1)(1994-8#2)(1995-2#1)
that go##2##2##(1991-6#1)(2012-3#1)
that good##11##2##(1993-12#1)(1993-6#1)(1994-12#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-12#1)
that govern##10##2##(1990-9#1)(1993-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#1)
that governs the##5##3##(1996-5#1)(2007-12#1)(2009-11#1)(2010-8#1)(2011-2#1)
that governs##8##2##(1996-4#1)(1996-5#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#1)(2011-2#1)
that granules##2##2##(1997-7#1)(2013-1#1)
that gratings##2##2##(2008-2#1)(2008-3#1)
that great##2##2##(1991-6#1)(1995-5#1)
that greater than##4##3##(1992-10#1)(1997-1#1)(2007-12#1)(2008-10#1)
that greater##9##2##(1992-10#1)(1995-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-7#1)
that greatly##5##2##(1990-8#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
that green##2##2##(2008-10#2)
that grew##3##2##(2008-10#3)
that group##9##2##(1991-11#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)
that grouper##2##2##(2010-5#2)
that grouping##2##2##(2008-9#2)
that groups##3##2##(1995-2#1)(1996-1#1)(2008-2#1)
that grow and##2##3##(2007-12#1)(2008-10#1)
that grow##7##2##(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)
that grows##2##2##(2008-10#1)(2008-5#1)
that growth##10##2##(1990-12#1)(1991-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2007-5#1)(2008-7#2)(2012-3#1)(2013-7#1)
that guide##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
that guided##3##2##(2008-11#1)(2013-1#2)
that habitat##5##2##(2008-10#1)(2008-8#3)(2013-7#1)
that had a detection##2##4##(2008-10#1)(2008-3#1)
that had a higher##2##4##(2010-10#1)(2013-7#1)
that had a##14##3##(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2010-10#1)(2011-1#2)(2013-1#1)(2013-7#1)
that had already been##2##4##(1995-8#1)(2008-12#1)
that had an##3##3##(1991-1#1)(2008-10#2)
that had appeared##2##3##(1992-11#1)(2008-7#1)
that had been coated with##2##5##(1990-12#1)(2008-10#1)
that had been cultured##2##4##(1991-9#1)(2008-11#1)
that had been inoculated##3##4##(2008-10#3)
that had been intentionally##2##4##(2007-12#1)(2008-10#1)
that had been previously##3##4##(2008-10#3)
that had been selected for##2##5##(1997-7#1)(2008-8#1)
that had been treated##3##4##(2008-10#2)(2008-9#1)
that had been##63##3##(1990-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-6#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#3)(1997-3#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
that had fed on##3##4##(2008-10#3)
that had never been##3##4##(1990-2#1)(2008-10#2)
that had no##2##3##(1992-9#1)(1995-2#1)
that had not yet been##2##5##(2008-10#1)(2011-2#1)
that had not##8##3##(1994-2#2)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)
that had previously been##2##4##(2008-5#1)(2013-1#1)
that had previously learned the task at##2##7##(1994-8#2)
that had previously##4##3##(1994-8#2)(2008-5#1)(2013-1#1)
that had received##2##3##(1997-6#1)(2008-10#1)
that had shown##2##3##(1994-2#1)(2013-1#1)
that had significantly##2##3##(2008-10#1)(2008-3#1)
that had the##2##3##(2008-10#1)(2010-4#1)
that had to##2##3##(2008-11#1)(2013-1#1)
that had used the##2##4##(2008-10#2)
that had##171##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#3)(1994-8#3)(1994-9#1)(1995-2#2)(1995-8#3)(1996-12#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#49)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#3)(2009-2#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#6)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
that hair##4##2##(2007-7#1)(2008-5#3)
that half of the##2##4##(1996-9#1)(1997-7#1)
that half##4##2##(1993-11#1)(1996-2#1)(1996-9#1)(1997-7#1)
that halocyanin##2##2##(1993-11#2)
that handles##2##2##(2007-12#1)(2009-12#1)
that haploinsufficiency##2##2##(2009-5#1)(2012-12#1)
that happen##2##2##(2008-11#1)(2008-2#1)
that happened##2##2##(2008-1#2)
that harbours##3##2##(1995-5#1)(1997-3#1)(2008-1#1)
that has a pattern##2##4##(2007-11#1)(2008-3#1)
that has a##26##3##(1992-11#1)(1992-12#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#9)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
that has already been described##2##5##(1994-8#1)(2012-2#1)
that has already been##10##4##(1994-8#1)(2008-11#6)(2008-7#1)(2012-2#1)(2012-3#1)
that has an##6##3##(1993-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-1#1)
that has become##2##3##(1995-1#1)(2008-10#1)
that has been applied##2##4##(2007-11#1)(2009-10#1)
that has been associated with##2##5##(1991-8#1)(2008-10#1)
that has been described##2##4##(2008-1#1)(2008-7#1)
that has been designed##2##4##(2008-3#2)
that has been developed for the##3##6##(2008-10#2)(2008-11#1)
that has been developed for##6##5##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
that has been developed##8##4##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
that has been employed##2##4##(1996-1#1)(2008-12#1)
that has been identified##2##4##(1992-8#1)(2013-1#1)
that has been implicated in the##2##6##(1996-12#1)(2012-2#1)
that has been previously##5##4##(1991-9#1)(2008-10#1)(2009-8#1)(2012-12#1)(2012-3#1)
that has been recently##2##4##(2008-10#1)(2008-5#1)
that has been reported##2##4##(2008-10#1)(2010-7#1)
that has been shown to##2##5##(2008-3#1)(2008-5#1)
that has been shown##5##4##(1990-12#1)(1992-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
that has been suggested as##2##5##(1995-3#1)(2009-8#1)
that has been suggested##3##4##(1994-12#1)(1995-3#1)(2009-8#1)
that has been used in the##2##6##(1994-5#1)(2008-9#1)
that has been used to##2##5##(1996-1#1)(2012-2#1)
that has been used##5##4##(1994-5#1)(1996-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
that has been##94##3##(1990-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#3)(1994-5#1)(1994-6#1)(1995-3#1)(1996-1#3)(1996-12#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#3)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
that has caused##2##3##(2008-5#1)(2012-12#1)
that has emerged as##2##4##(2008-6#1)(2013-8#1)
that has emerged##3##3##(1994-12#1)(2008-6#1)(2013-8#1)
that has evolved##2##3##(1996-9#1)(2008-10#1)
that has failed##2##3##(2007-10#1)(2010-8#1)
that has generated much##2##4##(1997-2#1)(2013-1#1)
that has helped to##2##4##(1996-12#1)(2011-2#1)
that has its roots##2##4##(2008-9#1)(2013-8#1)
that has its##5##3##(1995-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-8#1)
that has led to##2##4##(2008-1#1)(2008-7#1)
that has not been described##2##5##(2008-10#1)(2008-11#1)
that has not been##6##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#1)
that has not yet been##2##5##(2008-10#1)(2008-2#1)
that has not##10##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
that has only rarely been##2##5##(2006-10#1)(2011-2#1)
that has only##3##3##(1990-11#1)(2006-10#1)(2011-2#1)
that has previously been##2##4##(1993-12#1)(2008-7#1)
that has produced##2##3##(1996-3#1)(2012-1#1)
that has proved##2##3##(2008-6#1)(2013-1#1)
that has received##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
that has recently been##4##4##(1993-1#1)(1994-12#2)(2008-10#1)
that has recently##5##3##(1993-1#1)(1994-12#2)(2008-10#1)(2008-11#1)
that has remained##2##3##(1994-11#1)(2008-10#1)
that has significant##2##3##(1992-4#1)(1993-9#1)
that has the potential to##2##5##(2008-5#1)(2011-7#1)
that has the##7##3##(1993-12#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2011-7#1)
that has to be##4##4##(1993-11#1)(1994-3#1)(2008-10#1)(2008-11#1)
that has two##2##3##(2007-12#1)(2008-3#1)
that has undergone##2##3##(2008-3#1)(2009-11#1)
that has until now been##2##5##(1992-12#1)(2008-2#1)
that has##289##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#6)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#28)(2008-11#20)(2008-12#3)(2008-2#12)(2008-3#28)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#5)
that have a relatively##2##4##(2008-6#1)(2008-8#1)
that have a##18##3##(1993-12#1)(1993-3#1)(1995-8#1)(2007-11#2)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
that have an effect on##2##5##(1990-2#1)(1992-3#1)
that have an##7##3##(1990-2#1)(1992-3#1)(1997-2#1)(2008-11#1)(2008-4#2)(2009-7#1)
that have arisen from##2##4##(1995-3#1)(2010-11#1)
that have arisen##3##3##(1995-3#1)(1997-7#1)(2010-11#1)
that have become##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)
that have been applied to##2##5##(1992-3#1)(2008-4#1)
that have been associated with##2##5##(2008-3#1)(2009-9#1)
that have been attributed to##2##5##(1995-3#1)(1996-5#1)
that have been characterized##2##4##(1992-3#2)
that have been conducted##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
that have been described##3##4##(2008-5#1)(2008-7#1)(2009-10#1)
that have been developed for##6##5##(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-7#1)(2011-1#1)
that have been developed##9##4##(2008-10#2)(2008-11#1)(2008-4#2)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)
that have been encountered##2##4##(2008-8#1)(2008-9#1)
that have been genetically##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
that have been hypothesized to##2##5##(1993-12#1)(2011-2#1)
that have been identified in##2##5##(2012-3#1)(2013-1#1)
that have been identified##4##4##(1992-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
that have been implicated in the##2##6##(1993-12#1)(2008-1#1)
that have been implicated in##5##5##(1993-12#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-1#1)
that have been introduced##3##4##(1997-6#1)(2008-10#1)(2009-5#1)
that have been investigated##3##4##(1995-11#1)(2008-1#1)(2008-7#1)
that have been learned from##2##5##(2009-6#1)(2010-1#1)
that have been made to##2##5##(1991-1#1)(2008-11#1)
that have been made##7##4##(1991-1#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-12#1)(2009-3#1)
that have been observed##2##4##(1994-6#1)(2008-10#1)
that have been obtained by##2##5##(1990-9#1)(2008-2#1)
that have been proposed for##2##5##(2008-10#1)(2008-3#1)
that have been recently##4##4##(2008-2#1)(2008-4#1)(2010-11#1)(2013-8#1)
that have been reported##5##4##(1997-6#1)(2008-10#2)(2010-10#1)(2012-3#1)
that have been shown to##3##5##(1997-1#1)(2008-4#1)(2010-12#1)
that have been specifically##2##4##(1996-1#1)(2008-3#1)
that have been studied##4##4##(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
that have been subjected to##2##5##(2010-7#1)(2012-12#1)
that have been successful in##2##5##(2008-10#1)(2008-3#1)
that have been taken##4##4##(1996-1#1)(2008-11#1)(2009-11#1)(2012-3#1)
that have been the##2##4##(2008-7#1)(2010-10#1)
that have been used for##3##5##(2008-4#1)(2008-8#1)(2012-2#1)
that have been used to##2##5##(2008-4#1)(2008-5#1)
that have been used##10##4##(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
that have been##169##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#3)(1995-3#2)(1996-1#3)(1996-4#1)(1996-5#2)(1997-1#2)(1997-5#1)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#22)(2008-11#7)(2008-2#6)(2008-3#7)(2008-4#13)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
that have both##2##3##(2007-11#1)(2011-2#1)
that have broad##2##3##(2008-2#1)(2012-3#1)
that have come##2##3##(2008-6#1)(2012-1#1)
that have contributed to the##3##5##(1996-2#1)(2008-6#1)(2010-8#1)
that have demonstrated##2##3##(2010-5#1)(2012-3#1)
that have developed##2##3##(1993-12#1)(2010-5#1)
that have different##3##3##(2008-3#3)
that have dominated##2##3##(2008-4#1)(2012-3#1)
that have emerged from##2##4##(1996-12#1)(2008-11#1)
that have emerged##3##3##(1996-12#1)(2008-11#2)
that have evaluated##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
that have formed##2##3##(1992-2#1)(1994-12#1)
that have good##2##3##(1997-1#1)(2008-5#1)
that have had##4##3##(2008-10#1)(2011-2#2)(2011-3#1)
that have high##3##3##(2007-6#1)(2008-3#1)(2010-8#1)
that have influenced##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
that have led to the##3##5##(2008-11#1)(2009-9#1)(2010-10#1)
that have led to##5##4##(1997-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)
that have limited##2##3##(1996-2#1)(2007-11#1)
that have low##3##3##(1995-2#1)(2008-3#2)
that have never##2##3##(2008-7#1)(2010-12#1)
that have no##3##3##(1990-2#1)(2007-11#1)(2009-2#1)
that have not been##4##4##(2008-10#1)(2008-7#1)(2009-6#1)(2010-1#1)
that have not yet been##2##5##(2008-10#1)(2008-6#1)
that have not yet##3##4##(1997-3#1)(2008-10#1)(2008-6#1)
that have not##9##3##(1993-12#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)
that have occurred during the##2##5##(2008-10#2)
that have occurred in the##3##5##(2008-11#1)(2010-12#1)(2011-2#1)
that have occurred in##4##4##(2008-11#2)(2010-12#1)(2011-2#1)
that have occurred##7##3##(2008-10#2)(2008-11#2)(2010-12#1)(2011-2#2)
that have potential##3##3##(1996-3#1)(2007-11#1)(2008-4#1)
that have previously##2##3##(2007-12#1)(2009-6#1)
that have proved to be##2##5##(2007-12#1)(2008-1#1)
that have proved##4##3##(2007-12#1)(2008-1#1)(2008-6#1)(2010-12#1)
that have recently been##3##4##(2009-5#1)(2009-7#1)(2013-8#1)
that have shaped the##2##4##(1994-1#1)(2012-12#1)
that have shaped##3##3##(1994-1#1)(2012-12#1)(2013-1#1)
that have shown a##2##4##(1992-4#1)(2008-12#1)
that have shown promise##3##4##(2008-10#1)(2008-8#1)(2010-10#1)
that have shown##6##3##(1992-4#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)
that have similar##2##3##(2008-10#1)(2008-8#1)
that have specific##2##3##(2009-12#1)(2009-6#1)
that have taken place in##3##5##(1991-3#1)(2008-2#1)(2011-1#1)
that have the capacity to##2##5##(2008-10#1)(2008-5#1)
that have the capacity##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
that have the highest##2##4##(1996-2#1)(2008-10#1)
that have the potential to##4##5##(2008-12#1)(2009-10#1)(2012-12#1)(2012-2#1)
that have the same##3##4##(2007-12#1)(2008-3#2)
that have the##15##3##(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#1)(2012-12#1)(2012-2#2)
that have to be considered##2##5##(2008-3#1)(2008-7#1)
that have to be##8##4##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)
that have used##3##3##(1991-3#1)(2012-2#1)(2012-3#1)
that have##456##2##(1990-2#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#1)(1992-8#1)(1993-12#9)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#6)(1995-3#4)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#7)(2008-10#51)(2008-11#16)(2008-12#3)(2008-2#15)(2008-3#33)(2008-4#21)(2008-5#10)(2008-6#9)(2008-7#19)(2008-8#9)(2008-9#16)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-5#2)(2009-6#6)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#8)(2010-11#3)(2010-12#10)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#12)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#5)
that having a##3##3##(2008-11#1)(2010-2#1)(2011-2#1)
that having##5##2##(1991-12#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
that he could not##2##4##(1996-5#1)(2013-1#1)
that he had##3##3##(1995-6#2)(2013-1#1)
that he would like##2##4##(2008-4#1)(2008-5#1)
that he would##5##3##(1995-12#1)(1995-6#2)(2008-4#1)(2008-5#1)
that he##22##2##(1990-11#1)(1991-6#1)(1993-5#1)(1995-12#2)(1995-6#4)(1996-5#3)(2007-5#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-8#1)(2013-1#2)
that health care is##4##4##(1993-3#1)(1996-1#1)(1997-5#1)(2008-7#1)
that health care organizations##3##4##(1994-1#1)(1996-2#1)(2010-7#1)
that health care providers should##2##5##(1994-3#1)(2007-10#1)
that health care providers##3##4##(1994-3#1)(1996-3#1)(2007-10#1)
that health care##17##3##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2007-10#1)(2008-7#1)(2010-7#1)(2010-8#1)
that health plans##2##3##(1997-1#1)(1997-2#1)
that health##26##2##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-12#1)
that healthcare##3##2##(1994-3#1)(1996-1#1)(2008-12#1)
that healthy##2##2##(1991-11#1)(2008-11#1)
that heat shock##2##3##(1994-11#2)
that heat stress##2##3##(2008-12#1)(2012-2#1)
that heat##5##2##(1994-11#2)(2008-12#1)(2012-2#1)(2013-8#1)
that heavy metals##2##3##(1995-3#1)(2010-11#1)
that help to##2##3##(2008-10#1)(2008-9#1)
that help##9##2##(1992-2#1)(2006-12#1)(2008-10#2)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#2)
that helped##2##2##(1995-1#1)(2011-2#1)
that helps##8##2##(1993-12#1)(1993-3#1)(1997-3#1)(2007-7#1)(2010-6#1)(2011-2#2)(2012-12#1)
that hemi-fusion##2##2##(1991-5#2)
that hemin##2##2##(2008-10#2)
that hepatitis C##2##3##(2006-10#2)
that hepatitis##3##2##(1995-2#1)(2006-10#2)
that hepatocytes##2##2##(1993-3#1)(1994-8#1)
that her##7##2##(1991-12#1)(1994-12#1)(1997-5#1)(2007-2#1)(2011-2#1)(2013-1#2)
that herbivore##2##2##(2008-9#2)
that herbivores##3##2##(2008-8#1)(2008-9#1)(2009-2#1)
that heterogeneity##3##2##(2008-10#1)(2008-9#2)
that high levels of##8##4##(1990-12#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-1#1)(2013-8#1)
that high selective vagotomy##2##4##(1990-6#2)
that high##36##2##(1990-12#1)(1990-6#2)(1991-12#1)(1992-6#1)(1997-6#1)(2007-12#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-9#2)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
that high-quality##2##2##(2008-2#1)(2008-8#1)
that high-sensitivity##2##2##(2008-3#1)(2013-1#1)
that higher doses of##2##4##(2009-7#1)(2012-1#1)
that higher doses##5##3##(1992-5#1)(1993-11#1)(2008-8#1)(2009-7#1)(2012-1#1)
that higher levels of##4##4##(2007-12#1)(2008-10#1)(2009-5#1)(2012-3#1)
that higher##35##2##(1992-3#1)(1992-5#1)(1993-11#1)(1994-8#1)(1995-3#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)
that highlight the##4##3##(2007-11#1)(2008-11#1)(2010-5#1)(2012-12#1)
that highlight##5##2##(2007-11#1)(2008-11#1)(2009-11#1)(2010-5#1)(2012-12#1)
that highlights##2##2##(2008-3#1)(2013-1#1)
that highly##5##2##(2008-10#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-2#1)
that hippocampal##7##2##(1992-11#1)(1992-3#1)(1993-12#3)(2008-11#1)(2008-7#1)
that his##9##2##(1991-6#1)(1992-3#1)(1995-12#2)(1995-6#1)(1996-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
that histamine##2##2##(1995-12#1)(2008-12#1)
that hold##2##2##(2008-5#1)(2008-8#1)
that holds##2##2##(1997-3#1)(2009-3#1)
that homocysteine##2##2##(1992-9#2)
that homogeneous##2##2##(2007-12#1)(2008-2#1)
that homologous recombination##2##3##(1995-6#1)(2008-8#1)
that homologous##4##2##(1994-8#1)(1995-6#1)(1997-3#1)(2008-8#1)
that hope##2##2##(2008-11#1)(2010-10#1)
that horizontal##4##2##(2008-10#3)(2009-6#1)
that hormesis##2##2##(2008-7#2)
that hospital##6##2##(1992-1#1)(1992-12#1)(1995-3#1)(1997-3#1)(2008-11#2)
that hospitals can##2##3##(1993-3#1)(1995-2#1)
that hospitals##10##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-11#3)
that host##6##2##(2008-10#6)
that how##3##2##(2012-2#1)(2013-1#2)
that human salivary alpha-amylase##2##4##(1990-12#2)
that human##36##2##(1990-12#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that humans are##2##3##(2008-10#1)(2012-2#1)
that humans have##3##3##(2007-12#1)(2008-5#1)(2009-5#1)
that humans##8##2##(1992-9#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
that hundreds of##2##3##(2008-10#1)(2008-7#1)
that hybrid##2##2##(1995-5#1)(2008-3#1)
that hybridization##3##2##(1990-7#1)(2008-3#1)(2008-8#1)
that hybridized to##2##3##(1990-12#1)(2008-10#1)
that hybridized##3##2##(1990-12#1)(2008-10#2)
that hybridoma cells##2##3##(1994-2#1)(2008-11#1)
that hydraulic and mechanical##2##4##(2009-8#2)
that hydraulic##3##2##(2009-8#2)(2010-6#1)
that hydrogen##4##2##(1992-3#1)(1995-5#1)(2011-2#2)
that hydrolysis of the##2##4##(1992-8#1)(1993-8#1)
that hydrolyze##3##2##(1991-3#1)(1992-3#1)(2008-4#1)
that hydrophobic##2##2##(1990-2#1)(2008-10#1)
that hypertension is highly prevalent in the##2##7##(2008-1#2)
that hypertension##4##2##(2007-7#1)(2008-1#2)(2011-1#1)
that hyperthermia##2##2##(2007-10#1)(2011-2#1)
that hypertrophic##2##2##(2010-11#1)(2012-12#1)
that hypothermia##2##2##(1995-12#1)(2010-1#1)
that hypothesis##2##2##(1995-5#1)(2008-10#1)
that i##3##2##(1992-3#1)(2008-1#2)
that ibotenic acid lesions of##2##5##(1993-12#1)(1993-6#1)
that ibotenic acid lesions##3##4##(1993-12#2)(1993-6#1)
that identification of##2##3##(2007-11#1)(2013-1#1)
that identification##3##2##(1991-3#1)(2007-11#1)(2013-1#1)
that identified##4##2##(1992-3#1)(2008-8#1)(2011-2#2)
that identifies the##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
that identifies##9##2##(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-2#1)(2010-3#1)(2012-2#1)
that identify##9##2##(1994-5#1)(1995-2#1)(1997-1#1)(2006-10#1)(2008-10#2)(2010-11#1)(2013-1#2)
that if a##2##3##(2008-7#1)(2009-12#1)
that if an##2##3##(1997-2#1)(2013-8#1)
that if the spatial##2##4##(2008-10#1)(2008-8#1)
that if the##15##3##(1990-9#1)(1994-2#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
that if there##2##3##(1997-5#1)(2008-4#1)
that if##34##2##(1990-9#1)(1991-4#1)(1994-2#2)(1994-9#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
that ignore##3##2##(1994-1#2)(2008-8#1)
that illuminates##3##2##(2007-11#1)(2008-3#2)
that illustrate the##6##3##(1994-3#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
that illustrate##10##2##(1994-2#1)(1994-3#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
that illustrates##2##2##(2012-12#1)(2012-2#1)
that image##2##2##(1991-12#1)(2009-5#1)
that images##2##2##(2007-12#1)(2008-3#1)
that immature CEs##2##3##(2008-5#2)
that immediate##4##2##(1996-2#1)(2007-7#1)(2012-1#1)(2013-8#1)
that immune response##2##3##(2008-8#1)(2008-9#1)
that immune##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-1#1)
that immunity##2##2##(2007-2#1)(2011-2#1)
that immunization##2##2##(1995-2#1)(1996-12#1)
that immunotoxicity testing##2##3##(2008-10#2)
that impact on##3##3##(2008-11#1)(2009-12#1)(2011-1#1)
that impact the morbidity and mortality of the population##2##9##(2013-8#2)
that impact the##5##3##(2008-10#2)(2008-7#1)(2013-8#2)
that impact upon##2##3##(2008-12#2)
that impact##17##2##(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
that impacted on##2##3##(2007-10#1)(2008-4#1)
that impacted##4##2##(2007-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
that impair##2##2##(2008-10#1)(2008-9#1)
that impairs##2##2##(2008-11#1)(2008-6#1)
that impede##2##2##(1996-2#1)(2008-6#1)
that impinge on##3##3##(2008-3#1)(2008-9#1)(2013-8#1)
that implementation is##2##3##(1995-2#1)(1996-1#1)
that implementation##4##2##(1994-1#1)(1995-2#1)(1996-1#1)(2008-9#1)
that implementing a##2##3##(2008-7#1)(2013-1#1)
that implements the##3##3##(1996-2#1)(2008-2#1)(2008-3#1)
that implements##6##2##(1996-2#1)(2008-2#1)(2008-3#4)
that implicit##2##2##(2009-9#1)(2010-10#1)
that important##4##2##(1992-5#1)(1994-11#1)(2008-11#1)(2008-9#1)
that impose##2##2##(2008-2#1)(2010-5#1)
that improve the##2##3##(1996-3#1)(2008-7#1)
that improve##7##2##(1996-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2013-1#1)
that improved##10##2##(1994-3#1)(1995-6#2)(1996-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-8#1)
that improvements in##2##3##(2007-12#1)(2012-2#1)
that improves the##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
that improves##6##2##(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2013-1#1)
that impulse activity##2##3##(2008-5#2)
that impulsivity in##2##3##(2013-1#2)
that in 150##2##3##(1991-11#1)(1991-5#1)
that in a##16##3##(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)
that in addition to its##2##5##(2008-4#1)(2008-5#1)
that in addition to the##5##5##(1992-9#1)(2008-10#1)(2008-8#1)(2009-11#1)(2012-12#1)
that in addition to their##2##5##(2011-1#1)(2012-12#1)
that in addition to##18##4##(1992-11#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#2)(2012-12#2)(2012-2#2)
that in all cases##2##4##(1992-3#1)(1997-6#1)
that in all##5##3##(1992-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
that in an##4##3##(1996-1#1)(2008-2#1)(2008-9#1)(2009-11#1)
that in animals##2##3##(1992-5#1)(1993-12#1)
that in aqueous##2##3##(2008-10#2)
that in both##3##3##(1997-2#1)(2008-11#1)(2008-7#1)
that in cases##2##3##(2008-10#1)(2010-6#1)
that in contrast to##3##4##(1995-2#1)(2008-3#1)(2008-7#1)
that in control##7##3##(2008-10#4)(2008-4#1)(2008-7#1)(2013-8#1)
that in controls##2##3##(1994-2#1)(2009-6#1)
that in general##2##3##(1994-9#1)(2008-3#1)
that in healthy##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
that in hepatocytes##4##3##(1990-12#1)(1990-5#1)(1992-5#1)(1993-8#1)
that in human##2##3##(1992-8#1)(1993-1#1)
that in infected##3##3##(2008-10#3)
that in its##2##3##(1990-11#1)(1993-8#1)
that in many cases##2##4##(2009-10#1)(2011-2#1)
that in many##4##3##(2008-8#2)(2009-10#1)(2011-2#1)
that in men##2##3##(2008-3#2)
that in most##5##3##(1990-12#1)(1993-2#1)(2008-9#1)(2009-8#1)(2012-3#1)
that in mouse##2##3##(1990-7#1)(2008-11#1)
that in nontransgenic##2##3##(1994-8#1)(2008-10#1)
that in normal##4##3##(1995-8#1)(1996-5#1)(2008-7#1)(2012-1#1)
that in normothermic##2##3##(1994-2#1)(1995-12#1)
that in order to##8##4##(2008-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2011-2#2)(2012-3#1)
that in order##9##3##(2008-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)
that in other##5##3##(1991-10#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-2#1)
that in particular cases##2##4##(2008-10#1)(2008-2#1)
that in patients with##7##4##(1990-8#1)(1994-12#1)(2008-9#3)(2012-1#1)(2013-8#1)
that in patients##9##3##(1990-8#1)(1994-12#1)(2008-9#3)(2012-1#2)(2013-1#1)(2013-8#1)
that in plants##3##3##(1994-11#1)(2008-12#1)(2009-3#1)
that in practice##2##3##(1991-6#1)(2008-2#1)
that in primary##3##3##(2008-11#2)(2009-9#1)
that in recent years##2##4##(1991-12#1)(1993-6#1)
that in some cases##2##4##(2008-10#2)
that in some##6##3##(2007-10#1)(2008-10#4)(2010-3#1)
that in spite of the##3##5##(1992-9#1)(2008-10#1)(2012-12#1)
that in such##2##3##(2007-11#1)(2008-12#1)
that in susceptible##2##3##(2008-10#2)
that in the Netherlands##2##4##(1991-11#1)(1997-5#1)
that in the PD##2##4##(2007-10#1)(2008-7#1)
that in the absence of##10##5##(1990-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-3#1)
that in the case of##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
that in the case##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
that in the control group##6##5##(1996-12#1)(2007-8#2)(2008-9#1)(2012-2#2)
that in the control group(p&lt##2##5##(1994-12#2)
that in the control##12##4##(1994-12#2)(1995-3#1)(1996-12#1)(2007-8#2)(2008-5#1)(2008-9#3)(2012-2#2)
that in the developing##2##4##(1994-8#1)(2008-9#1)
that in the first##2##4##(1990-5#1)(2008-1#1)
that in the future##3##4##(2007-7#1)(2011-2#2)
that in the general population##3##5##(2007-12#1)(2010-2#1)(2010-8#1)
that in the liver##2##4##(1990-11#1)(2008-12#1)
that in the most##2##4##(1994-9#1)(2008-10#1)
that in the near future##2##5##(2008-1#1)(2009-8#1)
that in the near##3##4##(2008-1#1)(2009-8#1)(2013-1#1)
that in the other##2##4##(2008-3#1)(2008-5#1)
that in the presence of##8##5##(1993-8#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2013-1#1)
that in the present##3##4##(1992-5#1)(2008-10#1)(2011-2#1)
that in the process of##2##5##(1990-5#1)(2013-1#1)
that in the vehicle controls##2##5##(2008-9#2)
that in the vehicle##4##4##(2008-9#4)
that in the wild-type and the mock-transduced cells##2##8##(2008-8#2)
that in the##157##3##(1990-11#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#3)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-5#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#18)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#9)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
that in these solvents##2##4##(2008-10#2)
that in this##10##3##(1993-6#1)(1996-3#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-6#1)(2013-1#2)
that in turn##8##3##(1991-9#1)(1994-11#1)(1994-12#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-8#1)
that in vitro##10##3##(1990-5#1)(1993-1#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2012-12#1)
that in vivo##3##3##(1994-6#1)(1996-12#1)(2009-3#1)
that in water##5##3##(2008-10#3)(2008-12#1)(2008-7#1)
that in which##2##3##(1995-11#1)(2008-7#1)
that in wild type##2##4##(2008-8#1)(2008-9#1)
that in wild##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
that in young animals##2##4##(2008-7#2)
that in young##4##3##(2007-10#1)(2008-7#2)(2013-7#1)
that in##553##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#4)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#7)(1994-11#8)(1994-12#6)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#5)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-10#4)(2007-11#10)(2007-12#12)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#83)(2008-11#36)(2008-12#8)(2008-2#10)(2008-3#13)(2008-4#6)(2008-5#16)(2008-6#3)(2008-7#17)(2008-8#18)(2008-9#28)(2009-10#3)(2009-11#4)(2009-2#2)(2009-3#3)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#5)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#10)(2011-2#13)(2011-3#1)(2012-1#6)(2012-12#7)(2012-2#7)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#5)
that inactivates##2##2##(1990-5#1)(2010-4#1)
that inactivation of the##2##4##(1994-11#1)(2010-11#1)
that inactivation##3##2##(1994-11#1)(2008-8#1)(2010-11#1)
that inbreeding depression##2##3##(2008-8#1)(2008-9#1)
that inbreeding##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
that incidence of##2##3##(2008-10#1)(2012-12#1)
that incidence##3##2##(1994-9#1)(2008-10#1)(2012-12#1)
that include all##2##3##(2010-3#1)(2011-2#1)
that include the##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
that include those##2##3##(2008-10#1)(2010-6#1)
that include##49##2##(1990-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-8#1)(1997-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-11#1)(2009-12#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
that included a##6##3##(1992-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-3#1)
that included the##3##3##(1991-2#1)(2008-10#1)(2012-3#1)
that included##47##2##(1990-9#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1997-1#2)(2007-10#3)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)
that includes a##8##3##(1990-8#1)(1991-9#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)(2011-3#1)
that includes an##2##3##(2008-1#1)(2008-11#1)
that includes both##3##3##(1994-12#1)(2008-3#1)(2009-9#1)
that includes local##2##3##(2008-11#1)(2008-8#1)
that includes other##2##3##(2008-1#1)(2008-3#1)
that includes the effects of the##2##6##(2007-12#1)(2010-10#1)
that includes the effects of##3##5##(2007-12#1)(2008-2#1)(2010-10#1)
that includes the##16##3##(1992-9#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2012-3#1)(2013-1#1)
that includes two##3##3##(2008-3#2)(2008-9#1)
that includes##68##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#2)(2013-7#1)
that including##2##2##(2008-2#1)(2012-3#1)
that inclusion of##7##3##(1990-11#1)(1992-2#1)(1992-5#1)(1993-3#1)(1995-12#1)(2008-3#1)(2008-9#1)
that income##2##2##(1992-2#1)(2013-1#1)
that incorporate a##2##3##(2008-10#1)(2010-3#1)
that incorporate the##2##3##(2011-1#1)(2013-7#1)
that incorporate##22##2##(1996-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
that incorporated##4##2##(2008-10#1)(2008-9#1)(2009-12#1)(2010-9#1)
that incorporates a##5##3##(1994-2#1)(1995-2#1)(2007-12#1)(2008-3#2)
that incorporates an##3##3##(1992-2#1)(2007-12#1)(2008-10#1)
that incorporates the##6##3##(2007-12#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)
that incorporates##28##2##(1992-2#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
that incorporating##3##2##(2008-10#1)(2009-2#1)(2012-3#1)
that increase risk##2##3##(2009-12#2)
that increase the risk of##2##5##(2010-6#1)(2011-1#1)
that increase the##8##3##(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)
that increase##22##2##(1990-5#2)(1993-11#1)(1993-3#2)(1994-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
that increased food intake may##2##5##(2009-12#2)
that increased funding is##2##4##(2008-7#2)
that increased skin##2##3##(1997-3#1)(2008-5#1)
that increased the##2##3##(1993-6#1)(2010-4#1)
that increased##40##2##(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-4#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-2#3)(2012-6#1)(2013-1#1)(2013-8#1)
that increases in##6##3##(1993-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
that increases the##5##3##(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
that increases with##3##3##(1992-4#1)(2008-3#1)(2008-5#1)
that increases##21##2##(1992-4#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2011-2#1)
that increasing salinity##2##3##(2008-12#1)(2009-8#1)
that increasing the##7##3##(1995-3#1)(1995-6#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-3#1)
that increasing##23##2##(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#4)(2008-9#3)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
that incubation##2##2##(1992-12#1)(2008-8#1)
that independently##2##2##(2007-7#1)(2008-10#1)
that indicate that##4##3##(1991-12#1)(2008-7#1)(2008-8#2)
that indicate##8##2##(1991-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)
that indicated that##2##3##(2008-11#1)(2008-7#1)
that indicated##6##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
that indicates that##2##3##(2008-8#1)(2009-3#1)
that indicates##4##2##(2008-2#1)(2008-8#1)(2009-3#1)(2010-5#1)
that indirect##2##2##(2008-8#1)(2008-9#1)
that individual differences in##2##4##(2008-11#1)(2009-8#1)
that individual differences##3##3##(2008-11#1)(2009-8#1)(2013-8#1)
that individual##19##2##(1994-6#1)(1995-8#1)(1996-3#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-8#1)
that individuals are##4##3##(1995-2#1)(1996-2#1)(2008-8#1)(2011-2#1)
that individuals who##3##3##(2008-4#1)(2009-7#1)(2011-2#1)
that individuals with##3##3##(2010-2#1)(2012-2#1)(2012-3#1)
that individuals##23##2##(1991-12#2)(1994-2#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#7)(2009-6#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)
that induce a##3##3##(1994-9#1)(2008-10#2)
that induce the##6##3##(1990-2#1)(1995-5#1)(2008-4#2)(2009-7#1)(2010-12#1)
that induce##26##2##(1990-2#1)(1990-8#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1997-1#1)(2008-10#5)(2008-3#3)(2008-4#4)(2008-7#2)(2009-7#1)(2010-12#1)(2012-12#2)
that induced and constitutive##2##4##(2008-8#2)
that induced by##13##3##(1990-2#1)(1990-7#1)(1992-6#1)(1993-3#2)(1993-9#1)(1994-11#1)(1995-3#1)(1995-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)
that induced resistance is##3##4##(2008-10#3)
that induced resistance##4##3##(2008-10#4)
that induced##25##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-3#2)(1993-9#1)(1994-11#1)(1995-3#1)(1995-9#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-8#2)(2009-10#1)(2012-2#1)
that induces a##3##3##(1994-9#1)(2008-10#2)
that induces##16##2##(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-8#1)(2008-10#5)(2008-4#1)(2009-8#1)(2010-3#1)(2013-1#2)(2013-8#1)
that induction of the##3##4##(1995-6#1)(2008-10#2)
that induction of##10##3##(1992-8#1)(1992-9#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(2008-10#4)
that infect##11##2##(2008-10#8)(2012-2#1)(2013-1#2)
that infected##2##2##(2008-10#1)(2010-10#1)
that infection of tobacco##2##4##(2008-10#1)(2012-2#1)
that infection of##4##3##(2008-10#3)(2012-2#1)
that infection with##2##3##(2008-10#1)(2011-2#1)
that infection##10##2##(1990-3#1)(2008-10#7)(2011-2#1)(2012-2#1)
that infections##2##2##(2008-10#2)
that infects##3##2##(2008-10#3)
that infiltration of##2##3##(2008-7#1)(2009-3#1)
that inflammation##3##2##(1991-4#1)(2008-3#1)(2012-8#1)
that inflammatory##2##2##(2009-10#1)(2010-1#1)
that influence quality of##2##4##(2008-11#1)(2011-2#1)
that influence the##33##3##(1991-11#1)(1992-10#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-2#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#2)
that influence their##4##3##(2008-11#1)(2008-8#1)(2012-1#2)
that influence this##2##3##(2008-3#1)(2008-8#1)
that influence##73##2##(1991-11#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-3#2)(2013-1#3)(2013-8#2)
that influenced the##8##3##(1990-10#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-8#1)
that influenced##13##2##(1990-10#1)(1991-2#1)(1991-6#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
that influences##2##2##(2008-10#1)(2009-9#1)
that influenza##2##2##(2013-1#1)(2013-8#1)
that inform the##2##3##(2008-11#1)(2012-3#1)
that inform##3##2##(2008-11#1)(2009-8#1)(2012-3#1)
that information is##3##3##(1992-12#1)(1993-2#1)(1996-11#1)
that information on##2##3##(1997-3#1)(2008-10#1)
that information to##2##3##(2008-11#1)(2008-7#1)
that information##14##2##(1992-12#1)(1993-2#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2012-3#1)
that infrared##2##2##(2008-10#1)(2013-8#1)
that ingested##2##2##(2008-10#1)(2008-5#1)
that inhabit##2##2##(2011-2#1)(2013-1#1)
that inhaled##3##2##(1990-5#2)(2008-8#1)
that inhibit the##6##3##(1990-7#1)(1993-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-12#1)
that inhibit##21##2##(1990-11#1)(1990-7#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)
that inhibited##4##2##(1990-5#1)(1994-3#1)(2008-10#1)(2008-9#1)
that inhibition by##2##3##(1990-5#1)(1994-8#1)
that inhibition of the##2##4##(1993-11#1)(2008-10#1)
that inhibition of##14##3##(1991-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-3#1)(2012-2#2)
that inhibition##18##2##(1990-5#1)(1991-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-3#1)(2012-2#2)
that inhibitory##2##2##(2008-11#1)(2011-2#1)
that inhibits the##6##3##(1991-2#1)(1992-9#1)(2008-10#2)(2008-11#1)(2011-3#1)
that inhibits##13##2##(1990-7#1)(1991-2#1)(1992-9#1)(1993-8#1)(1997-6#1)(2008-10#3)(2008-11#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-7#1)
that initial##3##2##(2008-10#2)(2008-12#1)
that initially presented##2##3##(2008-2#1)(2008-7#1)
that initially##10##2##(1994-12#1)(2008-10#3)(2008-2#2)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
that initiate##4##2##(1994-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
that initiates##4##2##(1991-9#1)(2008-10#1)(2008-9#1)(2012-3#1)
that initiation##2##2##(2011-2#1)(2013-8#1)
that innovative##2##2##(2008-12#1)(2012-3#1)
that inoculated##3##2##(2008-10#2)(2008-8#1)
that inoculum##4##2##(2008-10#4)
that insulin exerts##2##3##(2008-3#2)
that insulin is##2##3##(2008-3#2)
that insulin##16##2##(1990-7#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-3#7)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
that intact##3##2##(1997-3#1)(2008-12#1)(2009-6#1)
that intake of##2##3##(1994-2#1)(2008-7#1)
that integrate##4##2##(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
that integrated##2##2##(2008-10#1)(2008-4#1)
that integrates##10##2##(1993-3#1)(1995-12#1)(2008-10#1)(2008-3#2)(2009-10#2)(2009-12#1)(2010-9#1)(2012-12#1)
that integration of HPV-16 DNA##2##5##(1995-2#2)
that integration of##3##3##(1995-2#2)(2008-3#1)
that integration##4##2##(1995-2#2)(2008-11#1)(2008-3#1)
that integrins##4##2##(1995-2#2)(2008-7#1)(2013-1#1)
that intensities##2##2##(2007-12#1)(2008-4#1)
that intensity##2##2##(2008-3#1)(2008-9#1)
that interact with the##3##4##(1992-12#1)(1995-2#1)(2009-9#1)
that interact with##12##3##(1991-12#1)(1992-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2013-8#1)
that interact##15##2##(1991-12#1)(1992-12#1)(1992-8#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2013-8#1)
that interaction of##2##3##(1994-12#1)(2008-10#1)
that interaction##4##2##(1994-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
that interactions are##2##3##(1991-8#1)(2012-3#1)
that interactions between##3##3##(1995-8#1)(2008-10#2)
that interactions of the##2##4##(1994-8#1)(2008-10#1)
that interactions##11##2##(1991-8#1)(1994-8#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
that interacts with##9##3##(1992-8#2)(1994-9#1)(1995-2#1)(1995-5#2)(2008-10#1)(2009-10#1)(2010-2#1)
that interacts##11##2##(1992-8#2)(1994-9#1)(1995-2#1)(1995-5#2)(2008-10#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-2#1)
that interconnection##2##2##(2008-2#1)(2008-3#1)
that interfacial##4##2##(1991-5#1)(1995-5#1)(2009-11#1)(2009-3#1)
that interfere with##7##3##(1996-5#1)(2008-1#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
that interfere##9##2##(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
that interfered with##2##3##(1993-6#1)(2008-10#1)
that interference##5##2##(1993-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
that interferes with##4##3##(1997-6#1)(2006-6#1)(2008-10#1)(2010-2#1)
that internal##6##2##(1991-10#1)(1992-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2009-4#1)
that interpartner conflict##2##3##(2009-9#2)
that interventions to##2##3##(1996-12#1)(2012-12#1)
that interventions##3##2##(1996-12#1)(2009-6#1)(2012-12#1)
that intestinal##2##2##(1994-8#1)(2008-8#1)
that intraarterial##2##2##(1994-11#1)(1994-3#1)
that intracellular##10##2##(1992-3#1)(1993-6#1)(1994-6#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-7#1)
that intracerebral##2##2##(2007-10#1)(2012-1#1)
that intramuscular##3##2##(2008-7#1)(2010-4#1)(2012-1#1)
that intraoperative##2##2##(2008-7#1)(2010-7#1)
that intravenous##2##2##(2008-1#1)(2008-4#1)
that intrinsic##2##2##(1992-8#1)(2008-5#1)
that intrinsically##2##2##(1992-1#1)(2008-11#1)
that introduce##2##2##(1993-2#1)(2010-3#1)
that introduced##3##2##(2008-10#2)(2008-11#1)
that introduction of##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
that invasive##2##2##(1996-9#1)(2008-8#1)
that investigated the##4##3##(1995-2#1)(2007-10#1)(2008-2#1)(2010-3#1)
that investigated##7##2##(1995-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-1#1)
that investigates the##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
that investigates##6##2##(2008-2#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
that investigators##5##2##(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)
that involve the##8##3##(1991-5#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
that involve##35##2##(1991-5#1)(1992-5#1)(1993-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#5)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
that involved##12##2##(1994-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#2)(2013-1#1)
that involves a##10##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
that involves the##5##3##(1994-3#1)(1994-8#1)(1997-3#1)(2008-2#1)(2013-1#1)
that involves##35##2##(1992-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-9#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
that ion##2##2##(1993-12#1)(2008-10#1)
that ionic##5##2##(1995-3#1)(2008-10#3)(2012-12#1)
that ionizing radiation##2##3##(1995-8#1)(2008-7#1)
that ionizing##3##2##(1995-12#1)(1995-8#1)(2008-7#1)
that ions##2##2##(2008-10#1)(2009-10#1)
that iron and##2##3##(2008-10#1)(2011-2#1)
that iron could##2##3##(1996-2#2)
that iron##8##2##(1992-8#1)(1996-2#2)(1996-5#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
that irradiation##4##2##(1995-6#1)(2008-10#1)(2010-12#1)(2012-1#1)
that is 15##2##3##(1994-2#1)(2011-2#1)
that is 90%##2##3##(1997-4#1)(2010-11#1)
that is a direct##2##4##(2008-2#1)(2013-1#1)
that is a member of the##2##6##(1996-12#1)(2009-5#1)
that is a much##2##4##(2008-10#1)(2008-3#1)
that is a##17##3##(1990-3#1)(1993-1#1)(1994-11#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
that is able to detect##2##5##(2008-3#1)(2010-11#1)
that is able to##12##4##(1995-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#2)
that is absent in##3##4##(1993-2#1)(2008-3#1)(2012-2#1)
that is absent##4##3##(1993-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
that is absorbed##2##3##(2008-3#1)(2012-2#1)
that is acceptable##2##3##(1997-3#1)(2008-2#1)
that is accessible##3##3##(2008-12#1)(2008-3#1)(2010-8#1)
that is achieved##2##3##(2008-10#1)(2011-1#1)
that is activated##2##3##(2008-4#1)(2008-6#1)
that is also##8##3##(1994-6#1)(1994-8#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-2#1)
that is an##4##3##(1995-6#1)(2007-2#2)(2008-3#1)
that is applicable to##2##4##(2008-2#1)(2008-3#1)
that is applicable##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
that is applied to##2##4##(2008-3#1)(2009-6#1)
that is appropriate for##2##4##(2008-2#1)(2008-6#1)
that is approximately##3##3##(1995-6#1)(2007-11#1)(2008-10#1)
that is as##2##3##(2008-10#1)(2008-9#1)
that is associated with significant morbidity##2##6##(2008-1#1)(2008-7#1)
that is associated with##12##4##(1991-12#1)(1993-6#1)(1994-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-7#1)
that is associated##13##3##(1991-12#1)(1993-6#1)(1994-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-7#1)
that is at##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
that is available##6##3##(1992-9#1)(2008-2#2)(2008-9#1)(2010-8#1)(2013-8#1)
that is backscattered##2##3##(2008-3#2)
that is based on a##5##5##(2008-10#1)(2008-2#2)(2008-3#2)
that is based on the use of##3##7##(2008-2#1)(2008-3#2)
that is based on the##11##5##(1992-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)
that is based on##29##4##(1992-8#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#14)
that is based##30##3##(1992-8#1)(1997-1#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#14)
that is being increasingly##2##4##(2006-10#1)(2008-3#1)
that is being##9##3##(1996-2#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2013-1#1)
that is believed to##2##4##(2008-10#1)(2008-7#1)
that is best##3##3##(1997-6#1)(2011-2#2)
that is both safe and##2##5##(1992-2#1)(2012-3#1)
that is both##6##3##(1992-1#1)(1992-2#1)(2007-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
that is capable of measuring##2##5##(2008-2#1)(2008-3#1)
that is capable of##25##4##(1991-9#1)(1992-3#1)(1993-12#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#10)(2010-1#1)(2012-2#2)(2013-1#1)
that is caused by##2##4##(2008-10#1)(2008-2#1)
that is central to the##2##5##(2008-12#1)(2012-12#1)
that is central to##3##4##(2008-11#1)(2008-12#1)(2012-12#1)
that is challenging to##2##4##(2009-12#1)(2010-6#1)
that is characteristic of##7##4##(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)
that is characterized by##8##4##(1994-5#1)(1995-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)
that is characterized##10##3##(1994-5#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)
that is clinically##2##3##(2008-7#1)(2008-9#1)
that is closely##2##3##(2008-10#1)(2009-5#1)
that is closer to the##2##5##(1990-2#2)
that is common in##2##4##(2007-11#1)(2008-5#1)
that is common to##2##4##(1995-6#1)(2007-12#1)
that is common##5##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
that is commonly used##2##4##(2008-8#1)(2011-2#1)
that is commonly##4##3##(1996-2#1)(2008-8#1)(2009-10#1)(2011-2#1)
that is comparable to##2##4##(2007-12#2)
that is comparable with that##2##5##(2008-10#2)
that is comparable with##4##4##(2007-11#1)(2007-12#1)(2008-10#2)
that is comparable##7##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)
that is compatible with##2##4##(1997-1#1)(2010-8#1)
that is competitive with##2##4##(1994-5#1)(2008-3#1)
that is composed of##2##4##(2008-5#1)(2008-6#1)
that is composed##3##3##(2008-5#1)(2008-6#1)(2010-2#1)
that is conserved in##5##4##(1993-11#1)(1993-9#1)(1995-6#1)(2008-8#1)(2010-10#1)
that is conserved##7##3##(1992-11#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-8#1)(2010-10#1)
that is consistent with the##2##5##(2008-10#1)(2008-5#1)
that is consistent with##8##4##(1995-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)
that is critical for##3##4##(2008-5#1)(2008-9#1)(2009-8#1)
that is cross polarized to the##2##6##(2007-11#2)
that is currently being##2##4##(2008-10#1)(2008-11#1)
that is currently##8##3##(1993-12#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
that is delivered##2##3##(1997-2#1)(2009-8#1)
that is dependent on the##4##5##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
that is dependent##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
that is derived from##2##4##(2008-2#1)(2013-1#1)
that is derived##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
that is designed to##5##4##(1996-2#1)(2008-2#1)(2008-3#3)
that is determined##2##3##(2008-10#1)(2008-3#1)
that is different from all##2##5##(1993-12#1)(2008-10#1)
that is different from##4##4##(1993-12#1)(2008-10#2)(2008-2#1)
that is difficult to##4##4##(2008-9#3)(2013-1#1)
that is directly##7##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
that is distinct from the##2##5##(1995-11#1)(2007-12#1)
that is distinct from##4##4##(1995-11#1)(2007-12#1)(2008-10#1)(2010-12#1)
that is due to depolarization##2##5##(2007-12#1)(2008-2#1)
that is due to the difference in##2##7##(2007-11#1)(2008-3#1)
that is due to the##28##5##(1996-5#1)(2007-11#5)(2007-12#5)(2008-2#6)(2008-3#11)
that is due to##66##4##(1993-3#1)(1996-5#1)(2007-11#11)(2007-12#7)(2008-2#17)(2008-3#29)
that is easily##4##3##(2007-11#1)(2007-8#1)(2008-10#2)
that is easy to##2##4##(2008-2#1)(2012-2#1)
that is effective##2##3##(1993-12#1)(2008-10#1)
that is encoded##2##3##(1993-2#1)(2008-3#1)
that is especially suitable for##2##5##(2008-3#2)
that is especially##3##3##(2008-3#2)(2009-6#1)
that is essential for##2##4##(2008-10#1)(2010-10#1)
that is essential##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
that is excited##2##3##(2008-2#1)(2008-3#1)
that is expected##2##3##(2007-7#1)(2008-10#1)
that is expressed in##4##4##(1994-9#1)(1997-7#2)(2008-4#1)
that is expressed##8##3##(1991-9#1)(1993-12#1)(1994-9#1)(1997-7#2)(2008-1#1)(2008-11#1)(2008-4#1)
that is extremely sensitive to##2##5##(1990-3#1)(2009-5#1)
that is extremely##3##3##(1990-3#1)(2008-10#1)(2009-5#1)
that is far##2##3##(1991-3#1)(1995-5#1)
that is formed##3##3##(1994-5#1)(2008-10#2)
that is found in##3##4##(1995-12#1)(2008-2#1)(2008-7#1)
that is free from##2##4##(1991-12#1)(2007-12#1)
that is free##3##3##(1991-12#1)(2007-12#1)(2008-3#1)
that is functionally##2##3##(2008-11#1)(2009-8#1)
that is further##2##3##(2008-10#1)(2008-4#1)
that is generally##2##3##(2008-11#1)(2008-7#1)
that is given by the##2##5##(2008-3#1)(2010-10#1)
that is given##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
that is going to##2##4##(2008-7#1)(2011-2#1)
that is greater##2##3##(1993-11#1)(2008-2#1)
that is highly conserved##2##4##(2008-4#1)(2012-2#1)
that is highly expressed in##3##5##(1994-12#1)(1994-6#1)(2011-2#1)
that is highly selective to##2##5##(2008-10#2)
that is highly selective##3##4##(2008-10#3)
that is highly##12##3##(1992-11#1)(1992-12#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
that is homologous to##2##4##(1995-6#1)(1997-7#1)
that is identical to##2##4##(2008-10#1)(2008-4#1)
that is implemented##4##3##(1993-2#1)(2008-2#1)(2008-3#2)
that is important to##2##4##(1994-2#1)(2009-11#1)
that is important##5##3##(1994-2#1)(1995-2#1)(2009-11#1)(2013-1#2)
that is in##4##3##(1994-5#1)(2008-2#1)(2008-5#1)(2012-2#1)
that is incident upon##2##4##(2007-12#2)
that is incident##3##3##(2007-12#2)(2008-3#1)
that is increased##2##3##(1995-12#1)(2008-12#1)
that is increasingly##3##3##(1996-2#1)(1997-1#1)(2013-1#1)
that is independent of the##4##5##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
that is independent of##6##4##(1995-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
that is indistinguishable from##2##4##(1993-12#1)(2008-7#1)
that is induced by##4##4##(1990-11#2)(2008-2#1)(2010-3#1)
that is influenced##2##3##(2008-10#1)(2008-5#1)
that is inherent in the##3##5##(2007-12#1)(2008-3#2)
that is inherent in##6##4##(2007-11#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-3#1)
that is insensitive to the##2##5##(2008-2#1)(2008-8#1)
that is insensitive to##5##4##(2008-2#3)(2008-8#2)
that is intended to##2##4##(2008-3#1)(2008-7#1)
that is invariant##2##3##(2008-3#2)
that is involved in the##2##5##(1992-6#1)(2013-8#1)
that is involved in##6##4##(1992-6#1)(1995-11#1)(1995-6#1)(2008-5#1)(2010-11#1)(2013-8#1)
that is involved##7##3##(1992-6#1)(1995-11#1)(1995-6#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
that is known to be##3##5##(1996-2#1)(1997-8#1)(2008-4#1)
that is known to##6##4##(1996-2#2)(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
that is largely##2##3##(1994-5#1)(1997-3#1)
that is less than the##2##5##(2007-11#1)(2007-12#1)
that is less##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
that is likely to be involved in##3##7##(1991-7#1)(2008-7#1)(2010-10#1)
that is likely to be##5##5##(1991-7#1)(1995-5#1)(2007-12#1)(2008-7#1)(2010-10#1)
that is likely to##8##4##(1990-11#1)(1991-7#1)(1995-5#1)(2007-12#1)(2008-7#2)(2009-5#1)(2010-10#1)
that is linearly proportional to##2##5##(2007-11#1)(2008-2#1)
that is linked to##3##4##(1994-12#1)(2008-5#1)(2010-10#1)
that is localized##2##3##(1995-8#1)(2012-2#1)
that is located##6##3##(1997-2#2)(2007-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
that is made##2##3##(2008-3#2)
that is maintained##4##3##(1990-7#1)(1995-2#1)(2007-12#1)(2008-1#1)
that is measured at##2##4##(2008-10#1)(2008-3#1)
that is mediated by##3##4##(1990-5#1)(1992-3#1)(2012-2#1)
that is modulated##2##3##(1995-12#1)(2007-12#1)
that is more than##3##4##(1996-9#1)(2007-8#1)(2008-2#1)
that is more##11##3##(1996-9#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#2)
that is most##4##3##(1994-3#1)(2007-11#1)(2008-10#1)(2013-8#1)
that is much##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
that is necessary for##5##4##(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-3#1)
that is necessary to##3##4##(2008-2#1)(2011-2#1)(2012-2#1)
that is necessary##9##3##(1997-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)(2012-3#1)
that is needed to##2##4##(2008-10#1)(2008-3#1)
that is needed##4##3##(1993-6#1)(1994-1#1)(2008-10#1)(2008-3#1)
that is normally##5##3##(1993-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
that is not absorbed##2##4##(2008-3#2)
that is not observed in##2##5##(1996-2#1)(2007-11#1)
that is not predicted by##2##5##(1996-12#1)(2012-2#1)
that is not##34##3##(1991-1#2)(1994-11#1)(1994-12#2)(1996-12#2)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
that is observed##2##3##(1993-8#1)(2010-5#1)
that is obtained with##2##4##(2008-2#1)(2008-4#1)
that is obtained##4##3##(2007-11#1)(2008-2#2)(2008-4#1)
that is offered##2##3##(2007-11#1)(2010-1#1)
that is often associated with##3##5##(2007-12#1)(2008-4#1)(2009-9#1)
that is often##16##3##(1994-3#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
that is only##3##3##(1995-3#1)(1997-9#1)(2007-12#1)
that is open to##2##4##(1995-5#1)(2008-3#1)
that is optically##2##3##(2007-12#1)(2008-3#1)
that is passively mode locked by##2##6##(2007-12#2)
that is passively##3##3##(2007-12#3)
that is performed##2##3##(2007-12#1)(2008-4#1)
that is phase##3##3##(2007-12#3)
that is positive##2##3##(2008-10#1)(2009-6#1)
that is possible with##2##4##(2008-2#1)(2008-3#1)
that is possible##4##3##(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
that is potentially##2##3##(2008-4#1)(2012-2#1)
that is predicted##2##3##(1993-12#1)(2008-3#1)
that is predictive##2##3##(2012-3#1)(2013-8#1)
that is present both##2##4##(1994-12#1)(1995-6#1)
that is present in the##2##5##(1994-5#1)(2008-3#1)
that is present in##3##4##(1994-5#1)(2008-3#1)(2011-2#1)
that is present##6##3##(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
that is presumably##2##3##(1997-7#1)(2009-11#1)
that is primarily##2##3##(1990-12#1)(2009-10#1)
that is produced by##2##4##(2008-3#2)
that is produced##6##3##(1990-8#1)(2008-3#3)(2008-4#1)(2008-7#1)
that is proportional to the##2##5##(2008-3#2)
that is proportional to##3##4##(2007-12#1)(2008-3#2)
that is quite common in##2##5##(1995-3#1)(2008-3#1)
that is quite##3##3##(1995-3#1)(2007-12#1)(2008-3#1)
that is rarely##2##3##(2008-5#1)(2011-2#1)
that is recognized by##3##4##(1992-11#1)(1993-11#1)(2008-11#1)
that is recommended##2##3##(2008-3#1)(2008-4#1)
that is reflected##3##3##(2007-11#1)(2008-3#1)(2010-8#1)
that is related to the##3##5##(2007-12#1)(2008-3#1)(2008-4#1)
that is related to##7##4##(1990-8#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-4#2)
that is relatively##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
that is relevant##2##3##(2008-3#2)
that is required for the##2##5##(1995-12#1)(2008-9#1)
that is required for##15##4##(1991-12#1)(1993-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(2008-3#2)(2008-9#2)(2009-10#2)(2009-8#1)(2012-2#1)(2013-7#1)
that is required##19##3##(1991-12#1)(1993-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-10#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
that is responsible for information##2##5##(2008-3#1)(2011-1#1)
that is responsible for the##3##5##(1992-12#1)(2008-3#1)(2008-5#1)
that is responsible for##9##4##(1991-12#1)(1991-5#1)(1992-12#1)(2007-12#1)(2008-3#3)(2008-5#1)(2011-1#1)
that is seen##4##3##(1992-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
that is selectively##2##3##(1997-7#1)(2008-2#1)
that is shared by all##2##5##(1997-3#1)(2008-10#1)
that is similar in##2##4##(1990-5#1)(2008-11#1)
that is similar to that##2##5##(1997-2#1)(2012-3#1)
that is similar to##6##4##(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
that is similar##9##3##(1990-5#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
that is slightly##2##3##(2008-3#1)(2012-3#1)
that is smaller than##2##4##(1996-6#1)(2013-1#1)
that is sometimes##2##3##(1997-4#1)(2008-10#1)
that is spatially##2##3##(2007-12#1)(2009-5#1)
that is specific for the##2##5##(2008-10#1)(2011-1#1)
that is specific to##2##4##(2007-11#1)(2008-10#1)
that is specific##4##3##(2007-11#1)(2008-10#2)(2011-1#1)
that is stable##3##3##(2008-2#1)(2011-2#1)(2013-8#1)
that is still##5##3##(1994-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-3#1)
that is stimulated by##2##4##(1990-11#1)(2008-10#1)
that is strongly##2##3##(2007-11#1)(2009-5#1)
that is suitable for##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-1#1)
that is surrounded##2##3##(1994-12#1)(2007-12#1)
that is synthesized by##2##4##(2008-4#1)(2008-9#1)
that is the question##2##4##(1994-3#1)(1996-1#1)
that is the##17##3##(1991-12#1)(1991-6#2)(1994-3#2)(1996-1#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)
that is then##4##3##(2007-11#2)(2008-10#1)(2008-8#1)
that is thought to be##2##5##(2008-11#1)(2012-2#1)
that is thought to##4##4##(1992-8#1)(2008-11#1)(2008-9#1)(2012-2#1)
that is to##3##3##(1993-5#1)(2008-7#1)(2010-8#1)
that is transferred##2##3##(2007-12#1)(2008-9#1)
that is typical##2##3##(2007-11#1)(2008-2#1)
that is uncommon##2##3##(1994-11#1)(2010-10#1)
that is used by##3##4##(1990-12#1)(2007-12#1)(2012-3#1)
that is used to##5##4##(2007-11#1)(2008-3#3)(2008-4#1)
that is used widely##2##4##(1994-11#1)(2008-10#1)
that is used with##2##4##(2008-2#1)(2008-3#1)
that is used##15##3##(1990-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2012-3#1)
that is useful##3##3##(2008-2#2)(2011-2#1)
that is usually##7##3##(1991-6#1)(2008-2#1)(2008-3#3)(2011-2#1)(2013-1#1)
that is well suited##2##4##(2011-1#1)(2012-1#1)
that is well##6##3##(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
that is widely##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#1)
that is##1274##2##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#6)(1990-7#2)(1990-8#2)(1991-1#4)(1991-12#9)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#3)(1993-12#8)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#9)(1994-2#5)(1994-3#4)(1994-5#7)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#7)(1995-2#8)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#8)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#9)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#11)(1997-3#5)(1997-4#3)(1997-6#4)(1997-7#7)(1997-8#2)(1997-9#1)(2006-10#2)(2007-10#5)(2007-11#63)(2007-12#77)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#10)(2008-10#116)(2008-11#21)(2008-12#13)(2008-2#112)(2008-3#217)(2008-4#27)(2008-5#27)(2008-6#7)(2008-7#32)(2008-8#20)(2008-9#30)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#8)(2009-6#7)(2009-7#6)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#9)(2010-12#3)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#7)(2011-1#7)(2011-2#24)(2012-1#1)(2012-12#7)(2012-2#25)(2012-3#19)(2013-1#25)(2013-7#4)(2013-8#16)
that ischemia##4##2##(1991-9#2)(1993-6#2)
that isocratic##2##2##(2008-10#2)
that isolated##2##2##(2008-10#1)(2012-2#1)
that isolates from##2##3##(2008-10#2)
that isolates of##6##3##(2008-10#5)(2008-6#1)
that isolates##13##2##(2008-10#10)(2008-6#1)(2011-2#1)(2012-2#1)
that it acts##2##3##(2008-4#1)(2010-3#1)
that it affects##3##3##(1991-8#1)(2007-11#1)(2008-11#1)
that it allows##2##3##(2007-12#1)(2008-9#1)
that it also##5##3##(1990-7#1)(1994-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
that it be##2##3##(2008-10#1)(2008-2#1)
that it becomes a##2##4##(2008-11#1)(2008-8#1)
that it becomes##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
that it binds##2##3##(1994-12#1)(1994-2#1)
that it can also be##2##5##(2008-2#2)
that it can be used as##3##6##(2008-11#1)(2008-3#1)(2013-1#1)
that it can be used to measure the##2##8##(2008-3#2)
that it can be used to##3##6##(1994-5#1)(2008-3#2)
that it can be used##8##5##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2013-1#1)
that it can be##21##4##(1990-12#1)(1990-9#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
that it can only be##2##5##(2008-4#1)(2008-8#1)
that it can promote##2##4##(2010-6#1)(2013-8#1)
that it can##38##3##(1990-12#1)(1990-9#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#2)
that it contained##3##3##(1991-9#1)(1995-12#1)(2008-10#1)
that it contains##4##3##(1990-3#1)(1994-9#1)(1997-3#1)(2008-3#1)
that it could be##4##4##(1992-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
that it could##11##3##(1990-5#1)(1990-6#1)(1992-12#1)(1992-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-2#1)(2013-8#1)
that it delivers##2##3##(2008-6#1)(2011-2#1)
that it did##2##3##(1990-5#1)(2007-10#1)
that it does not##6##4##(1993-11#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#1)
that it does##7##3##(1993-11#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#1)
that it encodes a##3##4##(1990-11#1)(1990-12#1)(2008-9#1)
that it encodes##4##3##(1990-11#1)(1990-12#1)(1994-8#1)(2008-9#1)
that it exists##2##3##(1991-12#1)(1993-3#1)
that it forms a##2##4##(1992-3#1)(1997-2#1)
that it forms##3##3##(1992-3#1)(1997-2#1)(2008-1#1)
that it had a##2##4##(1994-9#1)(2008-7#1)
that it had##5##3##(1994-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
that it has a##3##4##(1992-8#1)(2008-1#1)(2008-2#1)
that it has an important##2##5##(1990-12#1)(1993-12#1)
that it has been##2##4##(1993-11#1)(2008-8#1)
that it has no##2##4##(2008-7#1)(2010-6#1)
that it has the potential to##2##6##(2008-10#1)(2008-11#1)
that it has##22##3##(1990-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)
that it increases##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
that it is a##14##4##(1992-8#1)(1993-12#1)(1993-3#2)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2013-1#1)
that it is able to##2##5##(1990-2#1)(2008-11#1)
that it is active##2##4##(1992-12#1)(2008-8#1)
that it is also##2##4##(1990-3#1)(2010-5#1)
that it is an integral##2##5##(1991-2#1)(2008-7#1)
that it is an##5##4##(1991-2#1)(2008-10#1)(2008-12#2)(2008-7#1)
that it is closely related to##2##6##(1996-12#1)(2008-10#1)
that it is closely related##3##5##(1996-12#1)(2008-10#2)
that it is composed of##2##5##(1994-12#1)(1995-2#1)
that it is difficult to##2##5##(1995-12#1)(1997-2#1)
that it is difficult##4##4##(1991-3#1)(1995-12#1)(1997-2#1)(2008-8#1)
that it is due to##2##5##(2008-5#2)
that it is essential to##2##5##(2008-8#1)(2008-9#1)
that it is essential##3##4##(2008-8#1)(2008-9#1)(2013-8#1)
that it is feasible to use##2##6##(2008-10#1)(2013-1#1)
that it is feasible to##5##5##(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
that it is generally##2##4##(2008-3#1)(2008-8#1)
that it is important to##4##5##(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
that it is more##2##4##(2008-7#1)(2008-8#1)
that it is necessary to##5##5##(1991-9#1)(1996-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
that it is necessary##6##4##(1991-9#1)(1996-12#1)(2008-11#2)(2011-2#1)(2012-3#1)
that it is not a##2##5##(1995-6#1)(2008-3#1)
that it is not necessary to##2##6##(1997-6#1)(2008-11#1)
that it is not##16##4##(1991-9#1)(1992-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-2#1)
that it is of##3##4##(1991-5#1)(1992-12#1)(1992-3#1)
that it is only##2##4##(1994-12#1)(2008-10#1)
that it is possible for##2##5##(2007-12#2)
that it is possible to avoid##2##6##(2007-11#1)(2008-2#1)
that it is possible to construct##2##6##(2008-2#1)(2008-3#1)
that it is possible to detect##2##6##(2008-10#1)(2008-3#1)
that it is possible to estimate##2##6##(2008-10#1)(2008-3#1)
that it is possible to obtain##3##6##(2007-12#1)(2008-10#2)
that it is possible to transfer##2##6##(1996-5#1)(2007-12#1)
that it is possible to##38##5##(1990-5#1)(1992-8#1)(1994-9#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#8)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
that it is possible##42##4##(1990-5#1)(1992-8#1)(1994-9#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#6)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#8)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
that it is predominantly##2##4##(1990-12#1)(1994-12#1)
that it is primarily##2##4##(1992-12#1)(2009-9#1)
that it is quite##2##4##(1994-3#1)(2008-8#1)
that it is reasonable to##3##5##(2008-5#1)(2011-2#1)(2012-3#1)
that it is relatively##2##4##(2007-11#1)(2009-6#1)
that it is simple##2##4##(2009-10#1)(2012-2#1)
that it is sufficient to##2##5##(2008-2#1)(2008-3#1)
that it is the most##2##5##(2008-1#1)(2008-7#1)
that it is the##13##4##(1990-2#1)(1991-10#1)(1993-9#1)(1997-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
that it is useful##2##4##(1991-1#1)(2008-10#1)
that it is very##2##4##(1993-2#1)(2008-11#1)
that it is##233##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#8)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#34)(2008-11#14)(2008-12#6)(2008-2#9)(2008-3#14)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#4)
that it makes##2##3##(1995-12#1)(2008-3#1)
that it may act as a##3##6##(1994-10#1)(2008-7#1)(2008-8#1)
that it may be a##5##5##(1990-2#1)(1993-2#1)(2008-10#3)
that it may be an effective##2##6##(2008-11#1)(2008-9#1)
that it may be associated##2##5##(2009-10#1)(2009-9#1)
that it may be possible to##4##6##(2008-11#1)(2008-3#2)(2009-4#1)
that it may be##19##4##(1990-2#1)(1992-8#1)(1993-2#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-10#1)
that it may not##2##4##(1992-10#1)(1997-3#1)
that it may play a##3##5##(1991-5#1)(1993-3#1)(2008-10#1)
that it may play##4##4##(1991-5#1)(1993-3#1)(2008-10#2)
that it may##37##3##(1990-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
that it mediates##2##3##(1993-12#1)(2008-5#1)
that it might##5##3##(1990-3#1)(2008-2#1)(2012-2#2)(2013-8#1)
that it played##2##3##(2008-10#1)(2008-3#1)
that it plays a##2##4##(1993-8#1)(1997-1#1)
that it provides##3##3##(2008-1#1)(2008-10#1)(2009-8#1)
that it remains##3##3##(1991-12#1)(2007-8#1)(2008-6#1)
that it requires##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
that it should be possible to##3##6##(2008-3#1)(2008-7#1)(2008-9#1)
that it should be##8##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)
that it was a##4##4##(1990-5#1)(1995-12#1)(2008-10#1)(2013-7#1)
that it was not##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
that it was the##3##4##(1990-6#1)(1991-8#1)(1994-11#1)
that it was##37##3##(1990-2#2)(1990-5#1)(1990-6#1)(1991-3#1)(1991-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1995-12#3)(1995-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#4)(2013-7#1)
that it will be a##2##5##(2008-5#1)(2009-5#1)
that it will be##8##4##(1996-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
that it will##12##3##(1990-2#1)(1993-3#1)(1995-8#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
that it would be##5##4##(1994-1#2)(2008-7#1)(2011-2#1)(2013-7#1)
that it would##7##3##(1994-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
that it##557##2##(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#4)(1991-9#4)(1992-10#1)(1992-12#5)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#4)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#7)(1993-6#6)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#5)(1997-6#1)(1997-7#3)(2007-10#3)(2007-11#7)(2007-12#11)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#8)(2008-10#80)(2008-11#28)(2008-12#11)(2008-2#23)(2008-3#38)(2008-4#7)(2008-5#16)(2008-6#4)(2008-7#19)(2008-8#17)(2008-9#9)(2009-10#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#4)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#15)(2013-7#2)(2013-8#10)
that it's##2##2##(1995-3#1)(2010-4#1)
that its amino##2##3##(1991-8#1)(2008-10#1)
that its association with##2##4##(1992-10#1)(1992-3#1)
that its gene##2##3##(1995-8#1)(2008-5#1)
that its resistance may##2##4##(2008-10#1)(2008-12#1)
that its use will##2##4##(2010-12#1)(2011-7#1)
that its use##4##3##(2010-12#1)(2010-5#1)(2011-7#1)(2013-8#1)
that its##51##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
that joint##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
that juvenile##4##2##(2008-10#1)(2008-9#1)(2010-8#2)
that kainate##2##2##(1995-11#1)(2012-2#1)
that keeps##2##2##(2008-10#1)(2008-8#1)
that key##3##2##(2008-7#1)(2009-12#1)(2011-1#1)
that kill##2##2##(1992-6#1)(2009-8#1)
that kills the##2##3##(1994-11#1)(2008-9#1)
that kills##4##2##(1994-11#1)(1996-9#1)(1997-2#1)(2008-9#1)
that knowledge of the##2##4##(2008-3#2)
that knowledge of##3##3##(2007-10#1)(2008-3#2)
that knowledge##6##2##(1995-11#1)(2007-10#1)(2008-11#1)(2008-3#2)(2012-12#1)
that kringle 1##2##3##(1990-5#1)(2008-8#1)
that labeled##3##2##(1996-5#1)(2008-10#2)
that lack a##3##3##(1997-7#1)(2008-8#1)(2012-2#1)
that lack of##2##3##(1995-2#1)(2008-10#1)
that lack##17##2##(1992-3#1)(1992-8#1)(1994-12#1)(1995-2#2)(1997-7#2)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
that lacked the##2##3##(1991-8#1)(2008-10#1)
that lacked##7##2##(1991-8#1)(1992-3#1)(1993-9#1)(2008-10#2)(2010-3#1)(2013-1#1)
that lacks the##5##3##(1993-12#1)(1997-3#1)(2008-8#2)(2009-9#1)
that lacks##8##2##(1993-12#1)(1993-3#1)(1997-3#1)(2008-4#1)(2008-8#2)(2009-9#1)(2012-12#1)
that lactate and##2##3##(1995-8#1)(2008-7#1)
that lambda##2##2##(1992-6#2)
that language##4##2##(2011-1#1)(2012-3#1)(2013-8#2)
that languages##2##2##(2012-3#1)(2013-8#1)
that laparoscopic##4##2##(1993-3#3)(2011-1#1)
that large amounts of##2##4##(2008-11#2)
that large##12##2##(1990-7#1)(1991-11#1)(1994-5#1)(1996-4#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
that larger##6##2##(1997-1#1)(2007-5#1)(2008-9#1)(2010-8#1)(2011-2#2)
that laser##5##2##(1991-1#1)(1992-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
that last##2##2##(2007-3#1)(2013-1#1)
that lasted for##2##3##(2008-3#1)(2013-1#1)
that lasts##2##2##(2008-7#2)
that late##2##2##(2008-7#1)(2008-8#1)
that latent##3##2##(2008-10#2)(2009-12#1)
that later##2##2##(2007-12#1)(2008-5#1)
that lateral##4##2##(1990-2#1)(1994-5#1)(2008-3#2)
that lead latent infection to fruit rot##2##7##(2008-10#2)
that lead to the##9##4##(2008-10#2)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#2)(2012-3#2)
that lead to##46##3##(1991-6#1)(1994-11#1)(1994-2#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
that lead##56##2##(1991-6#1)(1991-9#1)(1994-11#2)(1994-2#2)(1997-4#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
that leadership##2##2##(1996-1#1)(2009-5#1)
that leads to generation of a##2##6##(1997-8#1)(2007-11#1)
that leads to increased##2##4##(2008-8#1)(2008-9#1)
that leads to the##6##4##(1990-5#1)(1994-9#1)(2008-3#2)(2009-6#1)(2012-2#1)
that leads to##31##3##(1990-5#1)(1993-12#2)(1994-9#1)(1995-2#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2011-2#2)(2011-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
that leads##36##2##(1990-5#1)(1993-12#2)(1994-9#1)(1995-11#1)(1995-2#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2011-2#3)(2011-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
that leaf##2##2##(2008-10#1)(2012-5#1)
that learning##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)
that leaves##2##2##(1994-2#1)(1994-8#1)
that lecturers##2##2##(2008-11#2)
that led them to##2##4##(2012-1#2)
that led to a##2##4##(2008-8#2)
that led to an##2##4##(2007-12#1)(2012-12#1)
that led to the development of##2##6##(1995-12#1)(2008-3#1)
that led to the##16##4##(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
that led to##25##3##(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
that led##31##2##(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
that left##3##2##(1997-8#1)(2008-1#1)(2012-2#1)
that lemon##2##2##(2008-10#1)(2011-2#1)
that leptin##2##2##(2008-4#1)(2013-8#1)
that less than##2##3##(1990-12#1)(1993-12#1)
that less##8##2##(1990-12#1)(1993-12#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-2#1)(2009-11#1)(2012-12#1)
that lettuce##3##2##(2008-10#1)(2008-11#2)
that leukotrienes##2##2##(1994-8#1)(2010-1#1)
that level##3##2##(1996-5#1)(2008-10#1)(2009-8#1)
that levels of##4##3##(1991-12#1)(1992-8#1)(2009-7#1)(2013-1#1)
that levels##5##2##(1991-12#1)(1992-8#1)(2008-11#1)(2009-7#1)(2013-1#1)
that lexical##2##2##(2008-2#1)(2009-2#1)
that lie##6##2##(1993-12#1)(1994-8#2)(2008-3#1)(2008-8#1)(2010-8#1)
that lies##2##2##(1993-3#1)(2013-8#1)
that life##6##2##(1990-11#1)(1997-6#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#1)
that lifestyle##3##2##(2008-3#1)(2008-7#1)(2009-8#1)
that ligand##4##2##(1993-8#1)(2008-10#2)(2008-4#1)
that light##6##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
that like##4##2##(1992-6#1)(1993-8#1)(2007-7#1)(2009-10#1)
that likely##10##2##(1996-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
that limit the##8##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
that limit##14##2##(1992-3#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-7#1)
that limitations in##2##3##(2008-7#1)(2012-3#1)
that limitations##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
that limited data sets##2##4##(2008-3#2)
that limited##8##2##(1991-7#1)(1994-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)
that limits##4##2##(1994-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
that line##3##2##(1991-9#1)(2008-10#1)(2008-4#1)
that linear##2##2##(1993-6#1)(1995-6#1)
that link the##2##3##(2008-1#1)(2008-3#1)
that link##4##2##(2007-12#1)(2008-1#1)(2008-3#1)(2012-3#1)
that linkage##2##2##(1993-11#1)(2008-8#1)
that linked##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
that links##9##2##(1994-8#1)(2007-8#2)(2008-3#2)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
that lipid##6##2##(1993-11#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
that lipoprotein##2##2##(1990-12#1)(1995-5#1)
that liposomal##2##2##(1995-2#1)(1995-5#1)
that liposomes##2##2##(1990-12#1)(1995-5#1)
that liquid##3##2##(1995-11#1)(2008-11#1)(2008-7#1)
that little##9##2##(1991-3#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-5#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-1#1)
that live in##2##3##(2008-8#1)(2011-2#1)
that live##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
that lived##2##2##(2008-10#1)(2012-12#1)
that liver##6##2##(1990-2#1)(1992-6#1)(1992-9#1)(2008-8#1)(2010-8#1)(2013-8#1)
that lives in##2##3##(1996-12#1)(2008-10#1)
that lives##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
that livestock##2##2##(2011-1#1)(2011-2#1)
that living##4##2##(1995-11#1)(2007-7#1)(2008-9#1)(2012-3#1)
that local administration of##2##4##(2008-12#1)(2011-2#1)
that local application of##2##4##(1990-5#1)(1997-2#1)
that local processes##2##3##(2008-9#2)
that local##17##2##(1990-5#1)(1993-2#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2011-2#3)
that localization##2##2##(2008-1#1)(2008-8#1)
that long##5##2##(1991-2#1)(2008-12#1)(2011-2#3)
that long-term treatment with##3##4##(1992-11#1)(1994-6#1)(1996-3#1)
that long-term##14##2##(1992-11#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-2#1)(1996-3#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
that longer##3##2##(1991-6#1)(1992-2#1)(2011-2#1)
that loss of##13##3##(1990-11#1)(1992-11#1)(1993-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
that lost##2##2##(2013-1#2)
that low dose radiation##2##4##(2007-10#1)(2008-7#1)
that low dose##3##3##(1994-5#1)(2007-10#1)(2008-7#1)
that low doses of##3##4##(2008-7#3)
that low doses##6##3##(2008-7#6)
that low levels of##3##4##(2008-7#1)(2008-9#1)(2011-2#1)
that low##31##2##(1991-2#1)(1994-2#1)(1994-5#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-2#3)(2013-1#2)
that low-dose##3##2##(2006-7#1)(2008-7#1)(2010-4#1)
that lower##7##2##(1993-6#1)(1996-3#1)(2008-10#2)(2009-12#1)(2010-6#1)(2013-1#1)
that lung##4##2##(1994-12#1)(1994-3#1)(1997-1#1)(2008-7#1)
that luteal##2##2##(1992-9#1)(2008-9#1)
that lymphocytes##3##2##(1996-12#2)(2011-2#1)
that lysine##2##2##(1995-6#1)(2010-4#1)
that lysosomal hydrolases##2##3##(2012-12#2)
that mRNA levels##2##3##(1993-8#1)(1994-5#1)
that mRNA of##2##3##(1993-3#1)(2008-6#1)
that mRNA##5##2##(1993-3#1)(1993-8#1)(1994-5#1)(2008-6#2)
that macrophages##4##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-9#1)
that made##3##2##(1994-12#1)(2007-10#1)(2010-7#1)
that magnetic field##2##3##(2008-9#2)
that magnetic resonance imaging##2##4##(1990-12#1)(2008-7#1)
that magnetic##4##2##(1990-12#1)(2008-7#1)(2008-9#2)
that magnolol##3##2##(2011-2#3)
that mainly##3##2##(2007-12#1)(2008-7#1)(2012-1#1)
that maintain homeostasis##2##3##(2009-12#1)(2013-1#1)
that maintain the##2##3##(1995-2#1)(2007-11#1)
that maintain##11##2##(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-12#2)(2010-10#1)(2013-1#1)(2013-7#1)
that maintained##2##2##(1995-12#1)(2012-1#1)
that maintaining##2##2##(2009-8#1)(2010-9#1)
that maintains##4##2##(1996-8#1)(2006-10#1)(2008-6#1)(2008-7#1)
that major##7##2##(1995-11#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-10#2)
that make it possible to##3##5##(1992-5#1)(2008-3#1)(2010-3#1)
that make it##11##3##(1992-5#1)(1993-12#1)(1997-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
that make the##2##3##(1996-12#1)(2008-11#1)
that make them suitable##2##4##(2008-4#1)(2008-9#1)
that make them##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
that make up the##6##4##(2008-10#2)(2008-4#2)(2008-8#1)(2011-2#1)
that make up##8##3##(2007-12#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)
that make use of##2##4##(1992-9#1)(2008-2#1)
that make##38##2##(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-2#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-7#1)
that makes it possible to compute the##2##7##(2008-3#2)
that makes it##3##3##(2008-3#3)
that makes up the##2##4##(2007-12#1)(2010-8#1)
that makes use of##6##4##(1992-6#1)(2007-12#2)(2008-2#2)(2008-3#1)
that makes##25##2##(1990-3#1)(1992-6#1)(1996-8#1)(1997-3#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-8#3)(2009-3#1)(2010-8#1)(2013-8#1)
that male##12##2##(1990-12#1)(1993-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
that males##9##2##(2008-12#1)(2008-5#2)(2008-8#3)(2009-6#1)(2012-12#1)(2013-8#1)
that mammalian##3##2##(1990-12#1)(1991-1#1)(1991-6#1)
that mammary##2##2##(2007-8#1)(2012-12#1)
that manage##3##2##(1995-12#1)(1997-3#1)(2008-10#1)
that managed care##3##3##(1993-12#1)(1994-3#1)(2008-7#1)
that managed##6##2##(1993-12#1)(1994-3#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
that management of##3##3##(2007-12#1)(2008-10#2)
that management##7##2##(1993-12#1)(1994-12#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)
that managers##7##2##(1992-1#1)(1993-2#1)(1994-2#2)(1995-12#1)(2006-5#1)(2013-8#1)
that managing##2##2##(1997-2#1)(2008-1#1)
that manifest in##2##3##(2011-2#1)(2013-7#1)
that manifest##5##2##(2007-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
that manifests##3##2##(2008-2#1)(2009-12#1)(2011-2#1)
that manipulating the##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
that manipulation of##2##3##(1995-12#1)(2010-11#1)
that manual##3##2##(2008-10#2)(2012-2#1)
that manufacturers##3##2##(2008-10#2)(2008-11#1)
that many PD patients##2##4##(2008-7#1)(2009-10#1)
that many children##3##3##(1995-12#1)(1997-1#1)(1997-4#1)
that many genes##2##3##(1995-6#1)(2013-8#1)
that many more##3##3##(1990-2#1)(1992-3#1)(2008-10#1)
that many new##2##3##(1994-3#1)(2008-10#1)
that many of the same##2##5##(1992-10#1)(2008-3#1)
that many of the##14##4##(1992-10#1)(1993-12#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)
that many of these##5##4##(1994-6#1)(2008-10#1)(2010-3#2)(2011-2#1)
that many of##22##3##(1990-6#1)(1992-10#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#2)(2011-2#1)
that many patients##2##3##(2010-12#1)(2011-1#1)
that many people##3##3##(2008-5#1)(2009-10#1)(2011-2#1)
that many##89##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-4#1)(1997-5#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
that mapped on chromosome##2##4##(1996-10#1)(2008-10#1)
that mapped##4##2##(1996-10#1)(2008-10#2)(2008-5#1)
that mapping in##2##3##(2008-3#1)(2008-8#1)
that maps##2##2##(2008-10#1)(2010-5#1)
that marginal##2##2##(2008-10#1)(2011-2#1)
that marriage##2##2##(2009-11#1)(2011-2#1)
that maspin is##2##3##(1995-6#2)
that maspin##3##2##(1995-6#3)
that mass##2##2##(2008-5#1)(2008-9#1)
that mast cells are##2##4##(1995-12#1)(2008-7#1)
that mast cells##3##3##(1995-12#1)(2008-7#2)
that match the##2##3##(2007-11#1)(2007-12#1)
that matched##3##2##(1996-10#1)(2008-10#1)(2012-12#1)
that matches the##2##3##(1994-12#1)(2008-3#1)
that matches##3##2##(1994-12#1)(2008-3#1)(2011-2#1)
that mate##2##2##(2008-8#2)
that material##3##2##(1990-8#1)(1995-12#1)(1996-12#1)
that maternal##5##2##(1996-11#1)(2008-8#2)(2010-8#1)(2012-3#1)
that matrix effects were##2##4##(1997-2#1)(2008-10#1)
that matrix##4##2##(1997-2#1)(2008-10#2)(2008-8#1)
that matters##2##2##(1997-2#1)(2012-12#1)
that maturation of CEs was##2##5##(2008-5#2)
that maturation of##3##3##(1995-8#1)(2008-5#2)
that maximal##2##2##(1996-5#1)(2008-10#1)
that maximize the##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
that maximize##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
that maximizes the##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
that maximizes##12##2##(1997-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)
that maximum##4##2##(1995-6#1)(2008-10#2)(2008-8#1)
that may account for the##3##5##(2008-10#1)(2010-1#1)(2012-3#1)
that may account for##4##4##(2008-10#1)(2008-6#1)(2010-1#1)(2012-3#1)
that may act as a##2##5##(1990-5#1)(2008-10#1)
that may act as##3##4##(1990-5#1)(2008-10#1)(2009-2#1)
that may activate##2##3##(1991-4#1)(2011-1#1)
that may affect the##5##4##(2008-10#3)(2008-11#1)(2008-2#1)
that may affect##10##3##(1997-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2010-11#1)(2012-3#1)
that may aid##2##3##(2007-5#1)(2011-7#1)
that may also##2##3##(1997-3#1)(2008-7#1)
that may alter the##2##4##(2009-9#1)(2011-1#1)
that may alter##3##3##(2008-8#1)(2009-9#1)(2011-1#1)
that may arise in##4##4##(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)
that may arise##8##3##(1997-3#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
that may be associated with##6##5##(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-8#1)(2012-2#1)
that may be employed to##2##5##(2008-2#1)(2008-4#1)
that may be encountered when##2##5##(1993-2#1)(1996-9#1)
that may be encountered##5##4##(1993-2#1)(1995-8#1)(1996-9#1)(2011-1#1)(2012-2#1)
that may be important for##3##5##(1996-12#1)(1997-4#1)(2012-2#1)
that may be important##4##4##(1996-12#1)(1997-4#1)(2008-10#1)(2012-2#1)
that may be involved in the##3##6##(1991-1#1)(2008-1#1)(2008-5#1)
that may be involved in##7##5##(1991-1#1)(1992-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
that may be more##2##4##(2008-7#1)(2010-6#1)
that may be of##2##4##(2008-2#1)(2011-1#1)
that may be responsible for##2##5##(2008-7#1)(2011-2#1)
that may be used to##2##5##(2008-10#1)(2008-3#1)
that may be used##6##4##(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-8#1)
that may be useful in##3##5##(1994-8#1)(2008-4#1)(2013-8#1)
that may be useful to##2##5##(1993-12#1)(2007-2#1)
that may be useful##7##4##(1993-12#1)(1994-8#1)(2007-2#1)(2008-4#2)(2008-7#1)(2013-8#1)
that may be##112##3##(1991-1#2)(1991-12#2)(1991-2#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
that may become##2##3##(2008-10#1)(2008-3#1)
that may bind##2##3##(1994-5#1)(2010-10#1)
that may cause mutations##2##4##(1993-8#1)(1994-5#1)
that may cause##6##3##(1992-2#1)(1993-8#1)(1994-5#1)(2006-10#1)(2008-11#1)(2012-2#1)
that may contain##2##3##(2008-1#1)(2008-7#1)
that may contribute to suicidal behaviors##2##6##(2012-12#2)
that may contribute to the##2##5##(2009-9#1)(2013-7#1)
that may contribute to##10##4##(1992-9#1)(1996-12#1)(2007-8#1)(2008-11#1)(2009-7#1)(2009-9#1)(2012-12#2)(2013-7#1)(2013-8#1)
that may control##3##3##(1994-8#1)(2008-1#1)(2009-11#1)
that may enhance##3##3##(1992-12#1)(1994-2#1)(2013-1#1)
that may exert##2##3##(2008-11#1)(2012-2#1)
that may explain##3##3##(1995-2#1)(2009-8#1)(2012-2#1)
that may facilitate the##2##4##(2008-8#1)(2009-3#1)
that may facilitate##3##3##(2008-8#1)(2009-3#1)(2010-12#1)
that may guide##2##3##(2010-8#1)(2012-1#1)
that may have been##3##4##(1994-3#1)(2008-10#1)(2008-9#1)
that may have##11##3##(1992-9#1)(1993-6#1)(1994-3#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-9#1)(2010-8#1)(2012-1#1)
that may help##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
that may impact the##2##4##(2007-7#1)(2008-10#1)
that may impact##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
that may improve##2##3##(1993-12#1)(2010-4#1)
that may in##2##3##(2006-5#1)(2011-2#1)
that may increase##2##3##(2008-5#1)(2011-2#1)
that may indicate##2##3##(1993-1#1)(2008-4#1)
that may influence##6##3##(1995-6#1)(2007-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-1#1)
that may interfere with##2##4##(2013-1#1)(2013-8#1)
that may lead to a##2##5##(2006-10#1)(2010-7#1)
that may lead to##9##4##(2006-10#1)(2008-11#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
that may mediate##3##3##(1991-5#1)(1995-6#1)(2012-12#1)
that may mimic a##2##4##(1991-6#1)(2011-2#1)
that may mimic##3##3##(1991-6#1)(2008-3#1)(2011-2#1)
that may not be##2##4##(2008-10#1)(2013-1#1)
that may not##5##3##(2008-10#1)(2012-2#1)(2013-1#3)
that may occur during##3##4##(2010-8#1)(2011-2#1)(2013-1#1)
that may occur##9##3##(1994-3#1)(2007-11#1)(2008-5#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
that may often##2##3##(1992-3#1)(2013-8#1)
that may or may not be##2##6##(2010-1#1)(2013-1#1)
that may play a role in the##2##7##(2012-2#2)
that may play a##5##4##(1994-12#1)(1995-3#1)(2010-12#1)(2012-2#2)
that may play##7##3##(1994-12#1)(1995-11#1)(1995-3#1)(1997-1#1)(2010-12#1)(2012-2#2)
that may possibly##3##3##(1990-12#1)(2008-6#1)(2013-1#1)
that may predispose##3##3##(1990-9#1)(2008-1#1)(2008-12#1)
that may present##3##3##(2006-10#1)(2007-12#1)(2008-7#1)
that may prevent##2##3##(2008-5#1)(2010-2#1)
that may prove##2##3##(2010-12#1)(2010-8#1)
that may reduce##2##3##(2008-10#1)(2011-2#1)
that may replace##2##3##(1994-9#1)(2012-3#1)
that may represent##3##3##(1991-2#1)(1995-11#1)(2012-2#1)
that may require##3##3##(1995-11#1)(2012-1#1)(2012-2#1)
that may result from##5##4##(1995-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-2#1)
that may result in##6##4##(1993-3#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
that may result##11##3##(1993-3#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
that may serve as##2##4##(2010-11#1)(2013-1#1)
that may shape##2##3##(2011-2#1)(2012-3#1)
that may significantly##2##3##(2008-2#1)(2008-9#1)
that may underlie the##2##4##(1994-8#1)(2012-12#1)
that may underlie##4##3##(1990-8#1)(1994-8#1)(2010-10#1)(2012-12#1)
that may##374##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#4)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#4)(2006-5#2)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#33)(2008-11#12)(2008-12#8)(2008-2#6)(2008-3#9)(2008-4#14)(2008-5#7)(2008-6#8)(2008-7#12)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#6)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#6)(2012-2#20)(2012-3#6)(2013-1#17)(2013-7#2)(2013-8#10)
that mean antibody values##2##4##(2011-2#2)
that mean##8##2##(1990-11#1)(1992-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
that meaningful##2##2##(1994-2#1)(2010-12#1)
that means##4##2##(1995-1#1)(2008-10#1)(2008-12#1)(2010-1#1)
that measure the##2##3##(2008-3#1)(2008-7#1)
that measure##6##2##(1994-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
that measured for##3##3##(2008-10#2)(2008-3#1)
that measured in the##2##4##(1990-5#1)(1996-2#1)
that measured in##5##3##(1990-5#1)(1996-2#1)(2008-2#1)(2012-3#1)(2013-1#1)
that measured the##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
that measured with##2##3##(1992-9#1)(2007-12#1)
that measured##20##2##(1990-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
that measurement of##7##3##(1990-2#1)(1990-8#1)(1993-11#1)(1994-12#1)(1996-6#1)(2008-12#1)(2013-1#1)
that measurement##9##2##(1990-2#1)(1990-8#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
that measurements of##2##3##(1994-7#1)(2013-1#1)
that measurements##3##2##(1994-7#1)(2008-3#1)(2013-1#1)
that measures the##10##3##(1991-11#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
that measures##18##2##(1991-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#5)(2010-2#1)(2013-1#1)
that mechanical properties of the##2##5##(2007-8#1)(2010-4#1)
that mechanical##5##2##(1990-12#1)(2007-8#1)(2008-4#1)(2010-4#1)(2012-2#1)
that mechanisms other than##2##4##(2008-10#1)(2008-8#1)
that mechanisms##5##2##(1992-9#1)(2008-10#2)(2008-8#1)(2009-2#1)
that medial##3##2##(1992-11#1)(1992-8#1)(2008-6#1)
that mediate the##5##3##(1995-2#1)(1996-2#1)(2008-1#1)(2009-8#1)(2011-2#1)
that mediate##18##2##(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
that mediates a##2##3##(1995-2#1)(2013-1#1)
that mediates the##3##3##(1990-11#1)(1991-2#1)(2012-2#1)
that mediates##12##2##(1990-11#1)(1991-2#1)(1992-9#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#3)
that medical##7##2##(1993-3#1)(1996-2#1)(1997-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)
that meet the criteria##2##4##(1997-2#1)(2012-1#1)
that meet the needs of##2##5##(1996-3#1)(1997-2#1)
that meet the##6##3##(1996-3#1)(1997-2#3)(2008-9#1)(2012-1#1)
that meet##9##2##(1991-1#1)(1993-12#1)(1996-3#1)(1997-2#3)(2008-2#1)(2008-9#1)(2012-1#1)
that meets the##4##3##(1994-2#2)(1997-3#1)(2008-10#1)
that meets##8##2##(1993-2#1)(1994-2#2)(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#2)
that melatonin##3##2##(1990-2#1)(1994-5#2)
that members of##3##3##(1994-11#1)(1995-1#1)(2012-12#1)
that membrane##5##2##(1994-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
that memory##6##2##(1994-8#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)
that men and women##2##4##(2008-1#1)(2010-5#1)
that men##8##2##(2008-1#2)(2008-11#1)(2009-5#2)(2010-10#1)(2010-5#1)(2011-2#1)
that mental health##2##3##(2008-12#1)(2013-1#1)
that mental##4##2##(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
that menthol##2##2##(1994-6#1)(2011-1#1)
that merges the##2##3##(1993-2#1)(2008-5#1)
that merit##2##2##(1991-1#1)(2012-2#1)
that mesenchymal##2##2##(2008-9#1)(2011-1#1)
that met the##3##3##(1997-5#1)(2007-10#1)(2011-2#1)
that met##7##2##(1997-5#1)(2007-10#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
that metabolic##3##2##(2008-8#1)(2010-2#1)(2011-2#1)
that metabolism of##3##3##(1991-12#1)(1992-6#1)(1994-5#1)
that metabolism##4##2##(1991-12#1)(1992-6#1)(1994-5#1)(2008-8#1)
that metastasis##3##2##(2009-3#1)(2010-8#1)(2011-2#1)
that metastatic##3##2##(1990-2#1)(2008-6#1)(2009-3#1)
that metformin##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
that method##2##2##(2008-3#1)(2008-6#1)
that methods of##2##3##(1995-3#1)(2008-7#1)
that methods##4##2##(1995-3#1)(2008-12#1)(2008-3#1)(2008-7#1)
that miRNA##2##2##(2009-5#1)(2013-8#1)
that miRNAs may##2##3##(2011-2#2)
that miRNAs##5##2##(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#2)
that mice##5##2##(1996-2#1)(2010-11#1)(2012-2#3)
that microglial activation##2##3##(2008-7#1)(2012-2#1)
that microtubules##2##2##(1994-8#1)(2010-7#1)
that might arise##2##3##(2008-11#1)(2013-8#1)
that might be either a##3##5##(2008-2#3)
that might be employed##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
that might be useful in##2##5##(2008-3#1)(2011-1#1)
that might be##32##3##(1990-12#1)(1991-1#1)(1992-12#1)(1993-12#1)(1994-2#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-2#5)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that might benefit from##2##4##(2008-10#1)(2012-7#1)
that might explain this##2##4##(1995-2#1)(2007-7#1)
that might explain##3##3##(1995-2#1)(2007-7#1)(2010-4#1)
that might have been##2##4##(1991-4#1)(2008-3#1)
that might have##5##3##(1991-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
that might help##3##3##(2007-7#1)(2009-1#1)(2009-12#1)
that might induce##2##3##(2009-9#1)(2012-12#1)
that might influence##3##3##(1993-1#1)(2010-2#1)(2012-3#1)
that might otherwise##2##3##(2008-10#1)(2008-2#1)
that might##86##2##(1990-12#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-2#2)(1997-1#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#2)
that migraine##2##2##(2008-9#2)
that migrate##2##2##(1995-5#1)(1995-8#1)
that migrated##2##2##(1994-8#1)(2010-8#1)
that migration can##2##3##(2008-8#1)(2013-1#1)
that migration##7##2##(2008-10#2)(2008-8#2)(2013-1#2)(2013-8#1)
that mild##4##2##(1993-12#1)(2006-10#1)(2008-5#1)(2008-7#1)
that mimic the##5##3##(1997-4#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-7#1)
that mimic##14##2##(1997-4#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-3#1)(2013-8#1)
that mimics##3##2##(2009-10#1)(2009-3#1)(2009-7#1)
that minimize the##4##3##(2008-10#1)(2008-3#2)(2008-6#1)
that minimize##7##2##(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)
that minimizes the##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
that minimizes##9##2##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2011-2#1)
that minimizing##2##2##(1996-7#1)(2008-9#1)
that minor##3##2##(2008-10#2)(2013-8#1)
that missing##2##2##(1997-8#1)(2012-12#1)
that mitochondria##3##2##(2008-2#1)(2008-7#1)(2010-11#1)
that mitochondrial##2##2##(2009-8#1)(2012-2#1)
that mitral##2##2##(2012-2#1)(2013-1#1)
that model##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
that modeling##2##2##(1990-2#1)(2008-7#1)
that models of##2##3##(1996-4#1)(2009-12#1)
that models such as##2##4##(2008-12#1)(2008-5#1)
that models the##2##3##(2008-3#1)(2008-9#1)
that models##8##2##(1996-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-8#1)
that moderate##6##2##(1990-3#1)(1994-2#1)(1994-9#1)(2008-3#1)(2011-1#1)(2013-1#1)
that modern##2##2##(2008-11#1)(2013-8#1)
that modification of##2##3##(1993-11#1)(2010-3#1)
that modifies the##3##3##(2008-2#2)(2012-2#1)
that modify the##3##3##(1991-8#1)(2007-11#1)(2008-3#1)
that modify##5##2##(1991-8#1)(1994-5#1)(2007-11#1)(2008-3#1)(2008-8#1)
that modulate cellular##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
that modulate the##3##3##(1994-5#1)(2008-9#1)(2009-5#1)
that modulate##12##2##(1994-5#1)(1995-8#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
that modulates##5##2##(1990-5#1)(1993-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
that modulation of##3##3##(1990-12#1)(1995-3#1)(1996-2#1)
that modulation##4##2##(1990-12#1)(1995-3#1)(1996-2#1)(2008-10#1)
that molar##2##2##(1990-5#1)(2008-10#1)
that molecular##11##2##(1990-11#1)(1994-6#1)(1995-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
that monitor the##2##3##(2007-7#1)(2008-12#1)
that monitor##3##2##(2007-7#1)(2008-12#1)(2008-9#1)
that monitors##2##2##(1993-12#1)(2010-12#1)
that monoclonal antibodies##3##3##(1994-2#1)(1995-12#1)(2012-2#1)
that monoclonal##5##2##(1994-2#1)(1995-12#1)(2008-5#1)(2008-8#1)(2012-2#1)
that moral##2##2##(2008-11#1)(2013-8#1)
that more accurately##2##3##(1991-12#1)(2013-1#1)
that more effective##2##3##(1990-12#1)(2012-2#1)
that more frequent##2##3##(2008-5#1)(2009-11#1)
that more patients##2##3##(2008-7#1)(2013-8#1)
that more than##10##3##(1996-9#1)(1997-6#2)(2008-10#3)(2008-2#1)(2012-12#1)(2012-3#2)
that more##53##2##(1990-12#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-9#2)(1993-1#1)(1994-6#1)(1995-1#1)(1996-9#1)(1997-5#1)(1997-6#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
that mortality##4##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
that most affect##2##3##(1994-2#1)(2008-9#1)
that most closely##3##3##(1994-5#1)(1994-9#1)(2008-10#1)
that most frequently##2##3##(2008-10#1)(2012-2#1)
that most of the##24##4##(1990-8#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)
that most of these##5##4##(1997-2#1)(1997-3#1)(2008-5#1)(2011-3#1)(2012-3#1)
that most of##32##3##(1990-8#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#3)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)
that most patients##5##3##(1990-11#1)(1990-2#1)(1990-3#1)(1997-4#1)(2013-1#1)
that most##101##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
that mothers##6##2##(1991-8#1)(1994-9#1)(2008-2#1)(2009-9#1)(2011-1#1)(2012-3#1)
that motivational##2##2##(1994-3#1)(2008-6#1)
that motor##3##2##(2008-7#1)(2010-7#1)(2013-8#1)
that mouse##2##2##(1997-4#1)(2010-6#1)
that move##5##2##(1993-12#1)(1994-12#1)(2007-11#1)(2008-7#1)(2010-12#1)
that movement##3##2##(1990-11#1)(2007-12#1)(2008-7#1)
that much of the##5##4##(1991-12#1)(1993-11#1)(2007-11#1)(2012-12#1)(2013-1#1)
that much of##6##3##(1991-12#1)(1993-11#1)(1996-3#1)(2007-11#1)(2012-12#1)(2013-1#1)
that much##12##2##(1991-12#1)(1993-11#1)(1993-12#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-2#1)(2012-12#1)(2013-1#1)
that multimode##2##2##(2007-12#1)(2008-3#1)
that multiple infections##3##3##(2008-10#2)(2008-9#1)
that multiple##35##2##(1991-6#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-8#1)
that muscarinic##2##2##(1990-7#1)(1996-5#1)
that muscles##2##2##(2008-6#1)(2012-2#1)
that music##7##2##(1993-2#1)(2007-6#3)(2008-11#1)(2008-5#1)(2008-9#1)
that must be addressed##4##4##(1995-2#1)(2007-12#1)(2009-12#1)(2011-2#1)
that must be considered when##3##5##(2008-4#2)(2013-1#1)
that must be considered##7##4##(1992-2#1)(1997-2#1)(2007-12#1)(2008-4#3)(2013-1#1)
that must be met##3##4##(1995-2#1)(2008-7#2)
that must be removed##2##4##(1996-2#1)(2008-5#1)
that must be##34##3##(1992-2#1)(1993-1#1)(1995-2#3)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#2)
that must##38##2##(1992-2#1)(1993-1#1)(1995-2#3)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
that mutant##4##2##(1991-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
that mutants##2##2##(2008-10#2)
that mutation##3##2##(1997-7#1)(2008-11#1)(2008-8#1)
that mutations in##3##3##(1992-8#1)(1995-8#1)(2008-10#1)
that mutations##5##2##(1991-12#1)(1992-8#1)(1993-8#1)(1995-8#1)(2008-10#1)
that mycoparasitism##2##2##(2008-10#2)
that nanoparticle##2##2##(2008-3#1)(2008-7#1)
that national##3##2##(1992-9#1)(1994-2#1)(1996-9#1)
that natural disasters##2##3##(2013-1#2)
that natural selection in##2##4##(2008-9#2)
that natural selection##4##3##(2008-9#2)(2009-8#1)(2013-1#1)
that natural##15##2##(1993-6#1)(2008-11#1)(2008-8#4)(2008-9#2)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#4)
that naturally##3##2##(2008-10#2)(2008-11#1)
that nearly all##3##3##(1993-9#1)(2008-5#1)(2010-10#1)
that nearly##5##2##(1993-9#1)(2008-11#2)(2008-5#1)(2010-10#1)
that necrosis was##2##3##(2008-10#2)
that need further investigation##3##4##(1997-7#1)(2013-1#2)
that need to be addressed are##2##6##(2008-11#1)(2009-3#1)
that need to be addressed to##3##6##(2008-7#1)(2011-2#1)(2013-8#1)
that need to be addressed##20##5##(1993-11#1)(1994-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#11)
that need to be considered##4##5##(2008-3#1)(2008-4#1)(2009-1#1)(2011-2#1)
that need to be##35##4##(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#1)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-8#11)
that need to##36##3##(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-8#11)
that need##43##2##(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#11)
that needed to be##2##4##(2010-3#1)(2011-1#1)
that needed to##3##3##(1993-6#1)(2010-3#1)(2011-1#1)
that needed##6##2##(1990-9#1)(1993-6#1)(1997-7#1)(2010-3#2)(2011-1#1)
that needle##2##2##(2007-7#1)(2008-11#1)
that needs to be##2##4##(1992-9#1)(1997-2#1)
that needs##6##2##(1992-9#1)(1997-2#1)(2008-10#1)(2008-7#2)(2012-12#1)
that negative##3##2##(1997-3#1)(2008-11#1)(2010-10#1)
that negatively regulate gene expression post-transcriptionally##2##6##(2010-7#1)(2011-2#1)
that negatively regulate gene expression##3##5##(2008-7#1)(2010-7#1)(2011-2#1)
that negatively##8##2##(2008-10#2)(2008-11#1)(2008-7#2)(2010-7#2)(2011-2#1)
that neglects##2##2##(2007-12#1)(2008-2#1)
that neighborhood##2##2##(2008-5#1)(2009-7#1)
that neither the##6##3##(1991-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(2008-6#1)
that neither##22##2##(1991-3#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#2)(2008-8#1)(2009-3#1)(2013-8#1)
that nematodes##2##2##(2008-10#2)
that neonatal##3##2##(1994-8#1)(2007-11#1)(2008-10#1)
that neoplastic MC##2##3##(2011-2#2)
that nerve growth factor##2##4##(1994-8#1)(2008-10#1)
that nerve##3##2##(1992-6#1)(1994-8#1)(2008-10#1)
that nest in##2##3##(2008-6#2)
that neural##3##2##(1996-5#1)(2009-8#1)(2011-2#1)
that neurasthenia##2##2##(2008-7#2)
that neurofibromin##2##2##(1994-12#2)
that neurological##2##2##(1991-6#1)(2008-4#1)
that neuronal##3##2##(1997-2#1)(2008-11#1)(2009-6#1)
that neurons near PWCs##2##4##(2012-2#2)
that neurons##5##2##(1995-12#1)(1996-5#1)(2009-8#1)(2012-2#2)
that neurotoxic effects of##2##4##(1993-12#1)(2008-7#1)
that never##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
that new##17##2##(1991-5#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-8#1)(2009-12#1)(2009-7#1)(2012-1#1)(2012-2#1)
that nicotinic acetylcholine receptor##2##4##(2008-8#2)
that nine##2##2##(1996-8#1)(2008-11#1)
that nitrate##2##2##(2008-10#2)
that nitric oxide##6##3##(1993-3#1)(1995-12#1)(1996-5#1)(2008-11#1)(2009-8#1)(2013-7#1)
that nitrite production##2##3##(1993-11#2)
that no matter how##2##4##(2008-10#1)(2008-7#1)
that no matter##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
that no significant changes##2##4##(2008-11#1)(2011-1#1)
that no significant difference##2##4##(2009-9#1)(2011-2#1)
that no significant##8##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
that no single##6##3##(1997-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
that no specific##2##3##(1993-8#1)(1994-11#1)
that no##54##2##(1990-7#1)(1991-12#1)(1992-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#3)(2008-9#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2013-7#1)(2013-8#1)
that non-proven therapies##2##3##(1997-6#2)
that none of the##4##4##(1990-12#1)(1994-2#1)(2007-12#1)(2008-12#1)
that none of##5##3##(1990-12#1)(1994-2#1)(2007-12#1)(2008-12#1)(2008-5#1)
that nonlinear##7##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-8#1)(2009-8#2)
that nonprofit decisionmakers##2##3##(1992-12#2)
that nonprofit##5##2##(1992-12#2)(1992-3#1)(1995-2#2)
that normal##7##2##(1991-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1994-2#1)(2006-6#1)(2008-6#1)
that normally occurs##3##3##(1994-11#1)(1995-6#1)(2009-10#1)
that normally##15##2##(1991-9#2)(1994-11#1)(1994-8#1)(1995-6#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-10#1)
that nosocomial##2##2##(2007-7#1)(2010-4#1)
that not all of the##2##5##(1994-5#1)(2010-3#1)
that not all##10##3##(1992-1#1)(1994-5#1)(1995-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-2#1)
that not only the##6##4##(1992-2#1)(2008-10#2)(2008-11#2)(2008-3#1)
that not only##20##3##(1991-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2011-2#1)(2013-1#1)
that not##33##2##(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-11#1)(1994-5#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
that novel##3##2##(1997-7#1)(2008-8#1)(2011-2#1)
that now##5##2##(1991-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2009-9#1)
that nuclear##9##2##(1993-8#1)(1994-8#1)(2008-7#1)(2008-8#3)(2010-9#1)(2012-12#1)(2012-2#1)
that nucleotides##3##2##(2008-11#1)(2008-4#2)
that numerous##3##2##(1991-7#1)(1993-6#1)(2011-2#1)
that nurse##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
that nurses and##2##3##(2007-10#1)(2012-3#1)
that nurses are drawing##2##4##(2010-8#2)
that nurses are##3##3##(2008-11#1)(2010-8#2)
that nurses must##2##3##(2008-12#1)(2013-8#1)
that nurses##20##2##(1992-3#1)(2007-10#3)(2008-11#5)(2008-12#1)(2008-4#2)(2010-7#1)(2010-8#2)(2012-3#3)(2013-1#1)(2013-8#1)
that nursing##9##2##(1990-12#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#2)
that nutrient enrichment##2##3##(2011-1#2)
that nutrient##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#2)
that nutrition##2##2##(1994-3#1)(1995-2#1)
that obese##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
that obesity is##2##3##(2007-8#1)(2008-10#1)
that obesity##4##2##(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
that obey a##2##3##(2007-11#1)(2007-12#1)
that obey##4##2##(1990-8#1)(2007-11#2)(2007-12#1)
that object##4##2##(1993-12#1)(1996-2#1)(2008-11#1)(2011-1#1)
that observed at the##3##4##(1990-9#1)(1991-9#1)(2008-8#1)
that observed at##5##3##(1990-9#1)(1991-9#1)(2008-10#2)(2008-8#1)
that observed by##2##3##(1992-6#1)(1993-8#1)
that observed differences##3##3##(1992-2#1)(2009-11#1)(2012-2#1)
that observed during##3##3##(1990-9#1)(1993-11#1)(2009-5#1)
that observed for the##3##4##(1993-6#1)(1993-8#1)(1995-3#1)
that observed for##13##3##(1993-6#1)(1993-8#1)(1995-3#1)(1997-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2011-2#1)
that observed in the##7##4##(1991-2#1)(1991-6#1)(1995-12#1)(2008-10#3)(2009-12#1)
that observed in##41##3##(1990-3#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#3)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#2)(2011-1#1)(2012-2#1)(2013-1#2)
that observed on##3##3##(1994-10#1)(2007-12#1)(2012-2#1)
that observed when##2##3##(1996-5#1)(2008-10#1)
that observed with##7##3##(1994-8#1)(1996-5#1)(2008-10#4)(2008-7#1)
that observed##84##2##(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-6#2)(1993-8#3)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-12#3)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
that observers##2##2##(2008-11#2)
that obtain##2##2##(2008-11#1)(2008-8#1)
that obtained at##3##3##(2008-10#2)(2008-11#1)
that obtained by the##3##4##(2008-10#3)
that obtained by##8##3##(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2012-2#1)
that obtained for the enzyme##2##5##(1992-12#1)(1993-8#1)
that obtained for##5##3##(1992-12#1)(1993-8#1)(2008-10#2)(2008-5#1)
that obtained from##6##3##(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
that obtained in##11##3##(1990-12#1)(1992-12#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-11#4)(2008-6#1)
that obtained using##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
that obtained when##2##3##(2007-11#1)(2008-10#1)
that obtained with the red light##2##6##(2008-2#2)
that obtained with the##5##4##(1990-12#1)(2008-10#2)(2008-2#2)
that obtained with##16##3##(1990-12#1)(1990-8#1)(1995-12#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)
that obtained##60##2##(1990-12#2)(1990-8#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
that occupational##5##2##(1991-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
that occupied the##2##3##(2008-10#1)(2009-3#1)
that occur after##2##3##(1991-3#1)(2007-12#1)
that occur as##3##3##(2007-8#1)(2008-3#1)(2009-3#1)
that occur at the##2##4##(1996-3#1)(2008-3#1)
that occur at##5##3##(1995-12#1)(1996-3#1)(2008-11#1)(2008-3#1)(2009-7#1)
that occur between##2##3##(2007-11#1)(2007-12#1)
that occur during the##5##4##(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
that occur during##16##3##(1993-9#1)(1994-11#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
that occur in affected##2##4##(1990-12#1)(2012-12#1)
that occur in dry skin##2##5##(2008-5#2)
that occur in the##6##4##(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
that occur in##24##3##(1990-12#1)(1991-12#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
that occur on##2##3##(1997-5#1)(2008-10#1)
that occur with##3##3##(2010-4#2)(2012-3#1)
that occur within##3##3##(1993-12#1)(2008-7#1)(2009-7#1)
that occur##75##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-4#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
that occurred after##2##3##(2009-3#1)(2011-2#1)
that occurred as##2##3##(2008-10#1)(2012-3#1)
that occurred at##2##3##(1996-5#1)(2007-10#1)
that occurred in a patient##2##5##(2008-1#1)(2012-3#1)
that occurred in the##7##4##(1993-12#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
that occurred in##15##3##(1993-12#1)(1994-3#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
that occurred on the##3##4##(1995-11#1)(2008-10#1)(2010-5#1)
that occurred on##4##3##(1995-11#1)(2008-10#1)(2009-3#1)(2010-5#1)
that occurred prior to##2##4##(1996-4#1)(2009-2#1)
that occurred with##2##3##(1994-12#1)(2007-12#1)
that occurred##36##2##(1990-12#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-6#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#2)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#2)
that occurring in##2##3##(2008-10#1)(2008-3#1)
that occurring##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
that occurs after##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
that occurs at the##2##4##(1990-10#1)(2008-11#1)
that occurs at##6##3##(1990-10#1)(1991-9#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-5#1)
that occurs between##2##3##(2008-10#1)(2011-1#1)
that occurs during##5##3##(1994-9#1)(1997-7#1)(2007-11#1)(2008-10#1)(2012-2#1)
that occurs in patients with##2##5##(1997-7#1)(2008-6#1)
that occurs in the same##2##5##(1995-6#1)(2007-11#1)
that occurs in the##6##4##(1993-12#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
that occurs in this##2##4##(2006-10#1)(2008-5#1)
that occurs in##22##3##(1993-12#1)(1995-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2013-1#2)
that occurs when##2##3##(2008-3#1)(2008-4#1)
that occurs with##6##3##(1994-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-8#1)
that occurs##63##2##(1990-10#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#2)(2006-10#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
that oestrogen##3##2##(1992-8#2)(2007-10#1)
that of &quot##2##3##(1997-3#1)(2008-8#1)
that of 1##2##3##(2010-8#1)(2012-3#1)
that of 17E8##2##3##(1995-2#2)
that of 18C6##2##3##(2008-10#2)
that of 2##3##3##(2008-10#3)
that of 4##3##3##(1992-3#1)(1994-6#1)(1997-2#1)
that of A##2##3##(1997-6#1)(2008-10#1)
that of ATP##2##3##(1991-9#1)(2008-4#1)
that of C##2##3##(2008-10#2)
that of Ca2+ release##2##4##(1995-6#2)
that of CaMV 35S promoter##2##5##(2008-9#2)
that of CaMV 35S##3##4##(2008-9#3)
that of Cu(II)##2##3##(2008-10#2)
that of DNA##2##3##(1991-8#1)(1993-6#1)
that of HMG##2##3##(1990-3#2)
that of HRP##2##3##(2008-10#2)
that of Lowry##2##3##(2008-10#2)
that of S##3##3##(1990-5#1)(2008-8#1)(2012-3#1)
that of Xmsx-1##2##3##(2008-6#2)
that of a classic##2##4##(2007-12#1)(2008-3#1)
that of a conventional##7##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
that of a previous##2##4##(2008-3#1)(2011-2#1)
that of a reference##2##4##(2008-3#1)(2008-4#1)
that of a single##3##4##(2008-3#2)(2013-1#1)
that of a standard##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
that of a##83##3##(1990-6#1)(1991-3#1)(1992-8#1)(1994-6#1)(1994-7#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(2007-11#7)(2007-12#5)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that of age##2##3##(1996-5#1)(2008-10#1)
that of all##4##3##(2007-12#2)(2008-5#1)(2011-3#1)
that of an##12##3##(1991-12#1)(1991-9#1)(1994-2#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-12#1)
that of ara-C##3##3##(1992-5#3)
that of asymptomatic##2##3##(2008-10#1)(2013-8#1)
that of authentic##3##3##(1990-12#1)(1990-8#1)(1994-9#1)
that of bare##2##3##(2008-10#1)(2008-3#1)
that of being##2##3##(2010-10#1)(2012-1#1)
that of both##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
that of cells##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
that of chicken##3##3##(1991-3#1)(1993-2#1)(2008-5#1)
that of children##2##3##(1997-4#1)(2009-10#1)
that of classical##2##3##(2008-5#1)(2008-7#1)
that of commercially##2##3##(2007-11#1)(2008-10#1)
that of control cells##2##4##(2008-11#2)
that of control##20##3##(1991-2#1)(1992-10#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-6#1)(2008-10#2)(2008-11#7)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#1)
that of controls##7##3##(1990-11#1)(1992-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
that of conventional##17##3##(1994-5#1)(1997-1#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#3)(2010-12#1)(2012-2#1)
that of cotyledon##3##3##(2008-9#3)
that of each##2##3##(2008-2#1)(2008-3#1)
that of humans##2##3##(2012-2#1)(2013-7#1)
that of insulin##4##3##(1992-10#1)(2008-8#1)(2008-9#2)
that of its##11##3##(1990-5#2)(1993-1#1)(1997-7#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#2)(2012-3#1)
that of ketoconazole##2##3##(2008-11#2)
that of known##2##3##(1990-11#1)(1993-6#1)
that of low##2##3##(1993-8#1)(2008-8#1)
that of males##2##3##(1995-6#1)(2011-1#1)
that of mtRNA(Leu(UUR))##2##3##(2008-8#2)
that of native protein##2##4##(1992-8#1)(1993-11#1)
that of native##9##3##(1992-6#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-8#1)
that of natural##2##3##(1994-12#1)(2008-10#1)
that of naturally##2##3##(1994-8#1)(2009-10#1)
that of normal##12##3##(1990-12#1)(1990-8#1)(1994-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2011-3#3)
that of older##2##3##(1996-2#1)(2009-6#1)
that of other##33##3##(1990-11#1)(1990-12#1)(1993-2#2)(1993-6#1)(1994-5#1)(1997-3#2)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
that of patients##3##3##(2008-7#1)(2010-3#1)(2011-2#1)
that of plasminogen##2##3##(1991-6#1)(2010-3#1)
that of previously##3##3##(2007-11#1)(2008-7#1)(2009-10#1)
that of pure##3##3##(1990-5#1)(2008-3#2)
that of strain##2##3##(2008-10#2)
that of substrate/product##2##3##(1995-5#2)
that of synthetic grafts##2##4##(2007-7#2)
that of synthetic##5##3##(1990-12#1)(1994-6#1)(1994-8#1)(2007-7#2)
that of the Antarctic##2##4##(1991-5#1)(2013-8#1)
that of the EB-PVD##2##4##(2009-7#2)
that of the NC##2##4##(1996-7#2)
that of the adults##2##4##(2012-12#1)(2013-8#1)
that of the batch##2##4##(2008-6#1)(2008-7#1)
that of the bottom##2##4##(2008-10#1)(2008-2#1)
that of the cell##2##4##(2008-11#1)(2008-8#1)
that of the cells##2##4##(2008-11#1)(2009-7#1)
that of the control group was##2##6##(2007-10#1)(2008-8#1)
that of the control group##6##5##(1994-5#1)(2007-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
that of the control groups##7##5##(2008-5#1)(2008-8#1)(2008-9#5)
that of the control##23##4##(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-2#2)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#7)(2010-3#1)(2011-2#2)(2013-1#1)
that of the conventional##9##4##(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#3)(2013-8#1)
that of the corresponding##4##4##(1992-6#1)(1995-3#1)(2008-3#1)(2008-4#1)
that of the culture##3##4##(2008-11#3)
that of the first##2##4##(2008-2#1)(2013-1#1)
that of the fundamental##2##4##(2007-11#1)(2008-2#1)
that of the general population##4##5##(1991-2#1)(1993-1#1)(1997-3#1)(2008-12#1)
that of the human##8##4##(1990-12#1)(1991-12#1)(1993-11#1)(1994-12#1)(1996-5#1)(2007-7#1)(2008-4#1)(2011-1#1)
that of the increase in##2##5##(1990-7#1)(1993-8#1)
that of the input##2##4##(1992-6#1)(2008-3#1)
that of the intact##3##4##(1992-3#1)(1993-6#1)(1995-5#1)
that of the linear##2##4##(2008-3#2)
that of the most##2##4##(1994-11#1)(2008-10#1)
that of the native enzyme##2##5##(1990-11#2)
that of the native##8##4##(1990-11#4)(1995-11#1)(2007-11#1)(2008-11#1)(2008-8#1)
that of the normal##2##4##(1994-12#1)(2008-9#1)
that of the object##2##4##(2007-12#1)(2008-3#1)
that of the original##6##4##(2008-10#2)(2008-11#1)(2008-3#2)(2009-7#1)
that of the other##6##4##(1993-11#1)(1994-6#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
that of the parental##3##4##(1990-8#1)(1994-2#1)(2008-10#1)
that of the precursor##2##4##(1990-8#1)(2008-6#1)
that of the present-day##2##4##(2008-3#2)
that of the previously##2##4##(1991-2#1)(2007-11#1)
that of the product##2##4##(1997-2#1)(2008-5#1)
that of the rat##5##4##(1991-7#1)(1994-11#1)(1996-5#1)(2008-8#1)(2011-2#1)
that of the reference##3##4##(1995-3#1)(2008-3#2)
that of the traditional##4##4##(1994-2#1)(1996-5#1)(2008-2#1)(2012-3#1)
that of the untreated##2##4##(2008-10#1)(2008-4#1)
that of the vehicle controls##2##5##(2008-9#2)
that of the vehicle##6##4##(2008-9#6)
that of the well-known##2##4##(1997-7#1)(2008-6#1)
that of the wild type##9##5##(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(2008-10#1)(2008-8#1)(2010-10#1)
that of the wild-type enzyme##4##5##(1990-10#1)(1992-6#2)(1994-5#1)
that of the wild-type enzyme)##3##5##(1994-5#3)
that of the wild-type##11##4##(1990-10#1)(1992-6#2)(1994-5#4)(1994-6#1)(1995-5#1)(2008-10#1)(2008-6#1)
that of the##472##3##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#1)(1990-5#6)(1990-7#2)(1990-8#6)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#10)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#5)(1994-5#6)(1994-6#3)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#5)(1996-12#1)(1996-2#2)(1996-5#4)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#6)(2007-12#11)(2007-2#1)(2007-7#1)(2008-10#61)(2008-11#14)(2008-12#2)(2008-2#17)(2008-3#34)(2008-4#5)(2008-5#17)(2008-6#9)(2008-7#11)(2008-8#21)(2008-9#26)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#8)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#8)
that of their##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
that of those##2##3##(2010-11#1)(2012-2#1)
that of tissue from##2##4##(2008-10#2)
that of type STMV##3##4##(2008-10#3)
that of type##4##3##(2008-1#1)(2008-10#3)
that of typical##2##3##(1992-6#1)(1995-12#1)
that of water##2##3##(2008-10#1)(2008-2#1)
that of wild type##2##4##(1993-11#1)(2009-8#1)
that of wild##3##3##(1993-11#1)(2008-11#1)(2009-8#1)
that of wild-type##6##3##(1992-9#1)(1993-12#1)(1997-6#1)(2008-10#1)(2009-9#1)(2010-10#1)
that of yeast##2##3##(1990-11#1)(1994-6#1)
that of young##2##3##(1993-1#1)(2009-12#1)
that of##1440##2##(1990-10#1)(1990-11#14)(1990-12#11)(1990-2#3)(1990-3#3)(1990-5#12)(1990-6#3)(1990-7#8)(1990-8#14)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#5)(1991-5#9)(1991-6#4)(1991-7#3)(1991-8#6)(1991-9#8)(1992-10#4)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#4)(1992-6#15)(1992-8#8)(1992-9#6)(1993-1#4)(1993-11#12)(1993-12#5)(1993-2#4)(1993-3#7)(1993-6#9)(1993-8#11)(1993-9#6)(1994-11#8)(1994-12#11)(1994-2#7)(1994-3#1)(1994-5#10)(1994-6#11)(1994-7#2)(1994-8#10)(1994-9#6)(1995-1#1)(1995-11#6)(1995-12#10)(1995-2#18)(1995-3#9)(1995-4#1)(1995-5#10)(1995-6#12)(1995-8#6)(1996-10#2)(1996-12#7)(1996-2#9)(1996-3#2)(1996-4#1)(1996-5#8)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#15)(1997-3#13)(1997-4#18)(1997-5#2)(1997-6#5)(1997-7#13)(1997-8#3)(2006-10#1)(2006-6#1)(2007-10#9)(2007-11#31)(2007-12#32)(2007-2#3)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#10)(2008-10#239)(2008-11#58)(2008-12#17)(2008-2#40)(2008-3#78)(2008-4#12)(2008-5#52)(2008-6#18)(2008-7#34)(2008-8#57)(2008-9#51)(2009-10#7)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#4)(2009-6#4)(2009-7#11)(2009-8#3)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#6)(2010-2#9)(2010-3#5)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#14)(2011-10#2)(2011-2#31)(2011-3#7)(2012-1#3)(2012-12#6)(2012-2#16)(2012-3#8)(2013-1#18)(2013-7#2)(2013-8#13)
that offer##7##2##(1991-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2010-3#1)
that offered##3##2##(1991-2#1)(1995-11#1)(2008-12#1)
that offers the##2##3##(1996-12#1)(2011-7#1)
that offers##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-7#1)
that often have##2##3##(2008-4#2)
that often presents##2##3##(1992-6#1)(2008-1#1)
that often##23##2##(1992-6#1)(1994-12#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
that older people##4##3##(1991-1#1)(2008-3#1)(2008-7#2)
that older##11##2##(1991-1#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#2)(2009-7#1)(2011-2#2)(2012-12#1)
that olfactory##2##2##(1994-8#1)(2012-2#1)
that omeprazole##2##2##(1993-11#1)(2012-2#1)
that on the cast##2##4##(2008-11#2)
that on the##6##3##(1996-2#1)(2008-1#1)(2008-11#4)
that on##26##2##(1991-12#1)(1992-12#1)(1992-6#1)(1995-11#1)(1996-2#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
that once##8##2##(1994-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-8#1)(2013-8#1)
that one can control##2##4##(2007-11#1)(2008-3#1)
that one can use##3##4##(1994-11#1)(2008-2#1)(2008-3#1)
that one can##15##3##(1994-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#4)(2008-5#1)
that one must##3##3##(1994-9#1)(2008-2#1)(2009-5#1)
that one of the##22##4##(1990-5#2)(1993-8#1)(1994-2#2)(1994-8#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
that one of these##3##4##(2008-10#1)(2008-2#1)(2009-8#1)
that one of##26##3##(1990-5#2)(1993-8#1)(1994-2#2)(1994-8#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
that one or more##3##4##(1994-6#1)(1994-9#1)(1995-2#1)
that one or##5##3##(1991-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-9#1)
that one##97##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
that one-third of the##2##4##(1995-6#1)(2008-11#1)
that only 4##2##3##(1992-6#1)(2008-10#1)
that only a single##2##4##(2008-2#1)(2009-12#1)
that only a small##4##4##(1996-1#1)(2008-3#1)(2008-6#1)(2008-7#1)
that only a##12##3##(1991-12#1)(1991-6#1)(1993-6#1)(1996-1#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)
that only certain##2##3##(1993-6#1)(2008-8#1)
that only one##5##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
that only the##18##3##(1990-9#1)(1994-8#1)(1995-11#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)
that only##84##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2007-12#3)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
that oogenesis##3##2##(2007-12#1)(2008-12#1)(2008-5#1)
that oospores##3##2##(2008-10#3)
that opens##2##2##(2008-3#1)(2011-2#1)
that operate in##2##3##(2008-10#1)(2012-2#1)
that operate##11##2##(1990-9#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2012-2#1)
that operates at a##2##4##(2007-11#1)(2008-2#1)
that operates at##5##3##(1997-2#1)(2007-11#1)(2008-2#2)(2008-3#1)
that operates in a##3##4##(1995-6#2)(2008-2#1)
that operates in the##2##4##(1993-12#1)(2008-3#1)
that operates in##7##3##(1993-12#1)(1995-6#2)(2008-10#1)(2008-2#1)(2008-3#2)
that operates##17##2##(1993-12#1)(1995-6#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#2)
that opioid##2##2##(1992-12#1)(2008-2#1)
that optical##4##2##(1992-4#1)(2008-11#1)(2008-3#2)
that optimal##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
that optimally##3##2##(1994-2#1)(2008-4#1)(2008-6#1)
that optimize the##2##3##(2008-3#2)
that optimize##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#1)
that optimized##4##2##(2008-3#1)(2010-10#1)(2011-1#1)(2013-1#1)
that optimizes##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
that optimum##2##2##(2008-2#1)(2010-5#1)
that oral administration of##3##4##(2008-11#2)(2009-8#1)
that oral##10##2##(1991-3#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
that orally administered##2##3##(1990-2#1)(2008-11#1)
that orally fed##2##3##(2008-11#2)
that orally##4##2##(1990-2#1)(2008-11#3)
that orchestrate##2##2##(2009-5#1)(2012-3#1)
that organic matter##2##3##(2008-10#1)(2008-11#1)
that organic##4##2##(2008-10#3)(2008-11#1)
that organisms##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
that orient##2##2##(2008-10#1)(2008-3#1)
that originate from the##2##4##(2007-11#1)(2008-2#1)
that originate from##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
that originated from##6##3##(1993-3#1)(2008-10#3)(2008-2#1)(2010-6#1)
that originated in the##2##4##(2008-1#1)(2011-2#1)
that originated in##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
that originated##12##2##(1993-3#1)(2008-1#1)(2008-10#6)(2008-2#1)(2009-12#1)(2010-6#1)(2011-2#1)
that originates##2##2##(2008-3#1)(2008-7#1)
that osteoporosis##2##2##(1996-6#1)(2010-3#1)
that other factors are##2##4##(2008-1#1)(2013-1#1)
that other factors##7##3##(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#2)(2013-1#2)
that other mechanisms##4##3##(2008-10#2)(2008-4#1)(2010-12#1)
that other##38##2##(1990-2#2)(1991-9#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
that others##2##2##(2007-11#1)(2013-1#1)
that otherwise##7##2##(1997-2#1)(2007-11#1)(2008-10#2)(2009-3#1)(2010-3#1)(2013-8#1)
that our approach is##2##4##(2007-11#1)(2008-10#1)
that our approach##4##3##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
that our findings##4##3##(1992-1#1)(2007-7#1)(2008-8#1)(2012-2#1)
that our method##2##3##(2008-3#2)
that our model##2##3##(2008-10#2)
that our optical ring##4##4##(2008-3#4)
that our results are##2##4##(1995-6#1)(2008-8#1)
that our system is##2##4##(2008-10#1)(2008-11#1)
that our##64##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
that out of the##2##4##(1997-7#1)(2010-5#1)
that out of##6##3##(1997-7#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-7#1)(2010-5#1)
that outperforms##2##2##(2011-1#1)(2012-2#1)
that outward##2##2##(2008-10#1)(2008-8#1)
that over the##2##3##(2008-10#1)(2008-3#1)
that over##10##2##(1990-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
that over-expression of##3##3##(1996-12#1)(2008-11#2)
that overall##2##2##(2008-11#1)(2010-3#1)
that overcomes##2##2##(2007-11#1)(2008-3#1)
that overexpress the##2##3##(2008-11#1)(2008-6#1)
that overexpressed##2##2##(2008-10#2)
that overexpression of##4##3##(1995-6#1)(2008-10#2)(2008-11#1)
that overheating##2##2##(1992-4#2)
that overlap##3##2##(1997-3#1)(2008-4#1)(2009-11#1)
that overlaps the##3##3##(1994-8#2)(2008-10#1)
that overlaps##4##2##(1994-8#2)(1996-10#1)(2008-10#1)
that overwintered in##2##3##(2008-10#2)
that oxidation##2##2##(2008-5#1)(2013-7#1)
that oxidative damage is##2##4##(2008-3#1)(2010-12#1)
that oxidative metabolism##2##3##(1994-2#2)
that oxidative stress is an##2##5##(1992-9#1)(2013-8#1)
that oxidative stress is##3##4##(1992-9#1)(1995-6#1)(2013-8#1)
that oxidative stress##5##3##(1992-11#1)(1992-12#1)(1992-9#1)(1995-6#1)(2013-8#1)
that oxidative##10##2##(1992-11#1)(1992-12#1)(1992-9#1)(1994-2#2)(1994-6#1)(1995-6#1)(2008-3#1)(2010-12#1)(2013-8#1)
that oxygen free radicals##3##4##(1991-9#1)(1995-12#1)(1996-2#1)
that oxygen##8##2##(1990-7#1)(1991-9#1)(1995-12#1)(1996-2#1)(1996-9#2)(2008-11#1)(2013-8#1)
that ozone##2##2##(2008-10#1)(2008-3#1)
that p16(INK4A)##3##2##(2013-1#3)
that p21##3##2##(1995-6#3)
that p53##6##2##(1992-3#1)(1994-9#1)(2008-9#2)(2011-2#1)(2012-2#1)
that p59##2##2##(1993-8#2)
that p72syk is##4##3##(1992-6#2)(1993-11#2)
that p72syk##5##2##(1992-6#2)(1993-11#3)
that p73##2##2##(2010-3#2)
that pH##3##2##(2008-10#2)(2008-11#1)
that pacifier use##2##3##(2007-10#2)
that pain##6##2##(1992-5#1)(1997-5#1)(2010-4#1)(2012-2#1)(2013-1#2)
that parallel##4##2##(1992-3#1)(1996-5#2)(2008-3#1)
that parasites##6##2##(2008-8#2)(2008-9#1)(2009-2#1)(2010-2#1)(2010-3#1)
that parasitizes Pseudaletia separata##2##4##(2007-12#2)
that parasitizes##3##2##(2007-12#3)
that parental##5##2##(1990-10#1)(1996-2#1)(2007-12#1)(2008-11#1)(2010-1#1)
that parents##9##2##(1992-2#1)(1992-4#1)(1995-12#1)(1995-5#1)(2007-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)
that parents'##2##2##(2009-7#2)
that part of the##4##4##(1995-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
that part of##7##3##(1990-12#1)(1993-9#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-4#1)
that part##8##2##(1990-12#1)(1992-12#1)(1993-9#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-4#1)
that partial##6##2##(1991-12#1)(1994-11#1)(2008-10#3)(2011-2#1)
that partially##3##2##(1997-2#1)(2008-1#1)(2010-12#1)
that participants had##2##3##(2009-10#1)(2010-9#1)
that participants who##2##3##(2010-12#1)(2013-8#1)
that participants##12##2##(1995-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that participate in the##3##4##(2010-12#1)(2012-2#1)(2013-1#1)
that participate in##4##3##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
that participate##5##2##(1990-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
that participated in##3##3##(1994-12#1)(2010-8#1)(2011-2#1)
that participated##4##2##(1994-12#1)(2008-12#1)(2010-8#1)(2011-2#1)
that particles of##2##3##(2008-10#1)(2008-5#1)
that particles##5##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)
that particular##8##2##(1994-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)
that partly##2##2##(2009-4#1)(2012-2#1)
that pass##2##2##(1995-3#1)(2013-1#1)
that passed##3##2##(2008-10#1)(2008-3#2)
that passes through the##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
that passes##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2010-8#1)
that passive##4##2##(1996-3#1)(2007-12#1)(2008-3#1)(2009-7#1)
that pathogen##3##2##(2008-10#3)
that pathogens##2##2##(2008-10#2)
that pathway##2##2##(2008-10#1)(2012-3#1)
that patient was##2##3##(1995-9#1)(2012-2#1)
that patient##5##2##(1995-9#1)(2008-2#1)(2011-10#1)(2012-2#1)(2013-1#1)
that patients are##3##3##(1994-12#1)(1996-7#1)(2008-7#1)
that patients can##2##3##(2008-11#1)(2008-7#1)
that patients receiving##4##3##(1997-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
that patients treated with##2##4##(1997-8#1)(2008-7#1)
that patients who##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
that patients with schizophrenia##2##4##(1996-7#2)
that patients with##24##3##(1991-5#1)(1993-11#2)(1996-7#3)(2007-10#2)(2008-1#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
that patients##56##2##(1991-3#1)(1991-5#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#1)(1996-7#4)(1997-1#1)(1997-3#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#4)(2009-10#1)(2009-8#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
that patterns of##6##3##(1994-3#1)(1996-1#1)(2008-12#1)(2008-8#1)(2009-8#1)(2009-9#1)
that patterns##8##2##(1994-3#1)(1996-1#1)(2008-12#1)(2008-8#1)(2009-8#2)(2009-9#1)(2013-1#1)
that payers##2##2##(1997-3#1)(2007-10#1)
that payment##2##2##(1993-12#1)(1994-12#1)
that peak##2##2##(1997-3#1)(2010-3#1)
that penetrated the##2##3##(2008-10#2)
that penetrated##4##2##(2008-10#3)(2013-1#1)
that penetration##3##2##(2008-10#2)(2012-2#1)
that people in##2##3##(2008-8#1)(2011-2#1)
that people who##4##3##(1993-12#1)(2008-2#1)(2010-3#1)(2011-1#1)
that people with dementia##2##4##(2013-8#2)
that people with disabilities##2##4##(1995-6#1)(1996-1#1)
that people with##10##3##(1995-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
that people##26##2##(1993-12#1)(1995-6#1)(1996-1#2)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#2)
that peptides##2##2##(1991-2#1)(2008-1#1)
that perceived##5##2##(1994-3#1)(2008-4#1)(2009-7#2)(2010-1#1)
that perceivers##3##2##(2008-11#2)(2013-8#1)
that perception##2##2##(2012-12#1)(2012-2#1)
that perform##5##2##(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
that performance in the##3##4##(1992-11#1)(1992-12#1)(1996-7#1)
that performance of##2##3##(1992-8#1)(1993-12#1)
that performance##9##2##(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1996-7#1)(2007-2#1)(2008-7#1)(2009-4#1)(2012-2#1)
that performed##3##2##(1994-3#1)(1995-12#1)(2011-2#1)
that performs a##2##3##(2008-3#1)(2008-9#1)
that performs the##2##3##(2008-10#1)(2008-3#1)
that performs##8##2##(2008-10#1)(2008-2#2)(2008-3#4)(2008-9#1)
that perhaps##3##2##(1990-8#1)(1994-11#1)(2008-3#1)
that period##7##2##(1991-6#1)(1996-3#1)(2008-12#2)(2008-5#1)(2010-1#1)(2011-2#1)
that peripheral##8##2##(1990-7#1)(1997-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#2)
that permit the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
that permit##18##2##(1991-5#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-11#1)(2013-1#2)
that permits a##2##3##(2007-11#1)(2008-4#1)
that permits one to retrieve physical parameters of tropospheric particle size distributions##2##12##(2008-3#2)
that permits one to##3##4##(2008-2#1)(2008-3#2)
that permits reliable##2##3##(2008-3#1)(2012-2#1)
that permits the measurement##2##4##(2007-11#1)(2008-3#1)
that permits the##11##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
that permits us to##2##4##(2008-2#1)(2012-2#1)
that permits##37##2##(1992-3#1)(1993-3#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#9)(2008-4#2)(2010-10#1)(2012-2#2)
that permitted##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
that persisted##7##2##(1990-5#1)(1993-10#1)(1996-5#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
that persistent##5##2##(2007-10#1)(2008-8#2)(2009-8#1)(2012-12#1)
that persists in##3##3##(2008-4#2)(2009-8#1)
that persists##4##2##(2008-4#2)(2008-5#1)(2009-8#1)
that personal##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
that personality##2##2##(2008-11#2)
that persons with##3##3##(1997-2#1)(2008-1#1)(2008-7#1)
that persons##5##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
that pertain to##2##3##(1991-3#1)(1997-3#1)
that perturbation##2##2##(1994-8#1)(2008-6#1)
that pertussis toxin##2##3##(1991-12#2)
that pertussis##3##2##(1991-12#2)(1994-9#1)
that phage##3##2##(2007-7#1)(2008-8#1)(2013-1#1)
that pharmacological##3##2##(1993-12#1)(2008-4#1)(2008-8#1)
that phase##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
that phenanthrene##2##2##(1994-5#1)(2008-10#1)
that phenolic##2##2##(2008-10#1)(2013-1#1)
that phenolics##2##2##(2008-10#2)
that phenotypic##2##2##(2008-8#1)(2012-2#1)
that phenytoin##2##2##(2008-11#2)
that phonological##2##2##(2011-1#1)(2013-8#1)
that phosphatase##2##2##(1995-3#1)(1997-2#1)
that phosphate##4##2##(1992-3#2)(1992-6#2)
that phosphorylate##3##2##(1993-2#1)(2008-9#1)(2010-9#1)
that phosphorylates##2##2##(1991-2#1)(1997-1#1)
that phosphorylation at##2##3##(1994-11#1)(2010-11#1)
that phosphorylation of##4##3##(1990-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
that phosphorylation##7##2##(1990-11#1)(1993-11#1)(1994-11#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
that photoactivated##2##2##(1993-8#1)(2009-6#1)
that photographs##2##2##(2008-2#2)
that physical activity##4##3##(2013-1#4)
that physical therapy##2##3##(1994-3#1)(1995-3#1)
that physical##8##2##(1992-6#1)(1994-3#1)(1995-3#1)(2011-1#1)(2013-1#4)
that physically##2##2##(2008-5#1)(2013-1#1)
that physician##2##2##(1995-12#1)(2008-12#1)
that physicians and##2##3##(1991-2#1)(1997-6#1)
that physicians must##2##3##(2008-8#2)
that physicians should##2##3##(1991-1#1)(2010-1#1)
that physicians##15##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-1#2)(1995-6#1)(1997-1#1)(1997-6#1)(2008-8#3)(2010-1#1)
that physiological##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
that physiotherapists##2##2##(1992-12#1)(2008-3#1)
that phytoplasma##2##2##(2008-10#2)
that pigs##4##2##(1995-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
that pituitary##2##2##(1991-1#1)(2011-2#1)
that place##4##2##(1993-3#1)(1997-3#1)(2012-12#1)(2012-2#1)
that placebo##2##2##(1993-3#1)(2012-2#1)
that placental##2##2##(1995-11#1)(2013-1#1)
that places##5##2##(1992-4#1)(1992-8#1)(1993-1#1)(2008-11#1)(2008-3#1)
that planning and##2##3##(2008-2#1)(2010-11#1)
that planning##3##2##(1994-2#1)(2008-2#1)(2010-11#1)
that plans##2##2##(1991-2#1)(1991-3#1)
that plant resistance##2##3##(2008-8#1)(2008-9#1)
that plant##7##2##(2008-10#2)(2008-8#3)(2008-9#2)
that plants##7##2##(2008-10#3)(2008-11#1)(2009-8#1)(2012-7#1)(2013-8#1)
that plasma##13##2##(1991-9#1)(1992-12#1)(1992-9#1)(1994-6#1)(1997-7#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
that platelet##3##2##(1992-8#1)(1993-8#1)(1997-7#1)
that platelets##4##2##(2006-6#4)
that play a role in##4##5##(2008-10#2)(2011-2#1)(2012-12#1)
that play a##10##3##(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
that play an important role in the##2##7##(2008-1#1)(2013-7#1)
that play important roles in##3##5##(2008-10#1)(2008-9#1)(2013-1#1)
that play important##4##3##(1995-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
that play key roles in##3##5##(1996-10#1)(2007-12#1)(2013-1#1)
that play##23##2##(1995-8#1)(1996-10#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
that plays a critical role in##3##6##(2008-10#1)(2012-2#2)
that plays a crucial##2##4##(2008-10#1)(2008-3#1)
that plays a##8##3##(1995-6#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-2#2)
that plays an important role in##3##6##(1993-11#1)(2008-4#1)(2008-7#1)
that plays an##4##3##(1993-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
that plays##15##2##(1993-11#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
that plots##2##2##(1995-3#1)(2008-10#1)
that podoplanin##2##2##(2013-1#2)
that point##5##2##(2007-12#1)(2012-12#2)(2012-2#2)
that points##2##2##(2007-12#1)(2008-7#1)
that polar##3##2##(1994-3#1)(2008-10#1)(2009-8#1)
that polarization##3##2##(2007-11#1)(2008-3#2)
that polarized light##2##3##(2007-12#1)(2008-3#1)
that polymorphic##2##2##(1994-3#1)(2008-10#1)
that polymorphisms in##2##3##(2008-7#1)(2012-12#1)
that polyphenols##3##2##(2009-3#1)(2009-8#1)(2012-12#1)
that poor##7##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-6#1)(2013-1#1)
that population##9##2##(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-5#1)(2010-8#1)
that populations of##3##3##(2008-10#3)
that populations##7##2##(2008-10#5)(2008-8#1)(2009-6#1)
that porcine##2##2##(1991-12#1)(1994-11#1)
that portion of##2##3##(2007-12#1)(2012-2#1)
that pose##2##2##(1993-1#1)(1993-3#1)
that position##5##2##(1992-6#1)(1993-12#1)(1996-3#1)(2008-9#1)(2010-6#1)
that positive selection##2##3##(1994-8#1)(2012-3#1)
that positive##6##2##(1990-8#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-9#1)(2012-3#1)
that positively##2##2##(1992-5#1)(2008-11#1)
that possess the##2##3##(2007-11#1)(2008-9#1)
that possess##12##2##(1992-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-1#1)
that possesses a##2##3##(2007-11#1)(2009-5#1)
that possesses the##2##3##(2008-8#1)(2012-1#1)
that possesses##9##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-5#1)(2012-1#1)
that possible##4##2##(1990-9#1)(1992-11#1)(2008-10#1)(2011-2#1)
that possibly##3##2##(2008-10#1)(2011-2#2)
that post-transcriptional##2##2##(1993-6#1)(1996-12#1)
that post-translational##3##2##(1991-7#1)(1995-8#1)(2011-2#1)
that posterior##2##2##(1997-3#1)(2008-9#1)
that postmenopausal##2##2##(1993-12#1)(2008-3#1)
that postoperative##4##2##(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
that potential patients##2##3##(1996-2#1)(2010-8#1)
that potential##5##2##(1996-2#1)(2008-1#1)(2010-4#1)(2010-8#1)(2012-12#1)
that potentially##8##2##(1991-9#1)(1994-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
that power is##2##3##(1997-3#1)(2012-3#1)
that power##3##2##(1997-3#1)(2012-3#1)(2013-1#1)
that practical##4##2##(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
that practice##4##2##(1994-3#1)(2008-11#2)(2010-9#1)
that practices##2##2##(2008-10#1)(2013-7#1)
that practitioners##4##2##(1991-12#1)(2008-11#1)(2012-12#1)(2012-3#1)
that prayer##2##2##(2008-1#1)(2008-12#1)
that pre-registration##2##2##(2008-11#2)
that precede##4##2##(2008-2#2)(2008-8#1)(2012-12#1)
that preceded the##2##3##(1991-2#1)(2008-1#1)
that precedes the##3##3##(1992-11#1)(2008-2#1)(2011-2#1)
that precedes##5##2##(1992-11#1)(1993-12#1)(1995-11#1)(2008-2#1)(2011-2#1)
that precisely##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
that predators##2##2##(2008-8#2)
that predict the##2##3##(2008-3#1)(2012-12#1)
that predict##11##2##(1992-9#2)(1995-3#1)(1995-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
that predicted by the##5##4##(2008-3#3)(2008-8#1)(2009-6#1)
that predicted by##7##3##(2008-3#4)(2008-8#2)(2009-6#1)
that predicted from##2##3##(1991-2#1)(1996-2#1)
that predicted##12##2##(1991-2#1)(1993-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-3#4)(2008-8#2)(2009-6#1)
that predictions##2##2##(2008-3#1)(2008-9#1)
that predicts the##9##3##(2007-10#1)(2008-2#2)(2008-3#5)(2008-7#1)
that predicts##20##2##(1993-11#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#3)
that predispose to##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
that predispose##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
that predominantly##3##2##(1993-11#1)(2008-10#1)(2008-9#1)
that preferentially##3##2##(1992-8#1)(2012-12#1)(2013-8#1)
that pregnant women##2##3##(1995-6#1)(2009-4#1)
that premating barriers##2##3##(2008-8#1)(2012-3#1)
that premating##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
that premature##2##2##(1990-11#1)(2012-12#1)
that prenatal##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
that presence of##3##3##(2008-10#2)(2012-2#1)
that present in##2##3##(1996-12#1)(2008-10#1)
that present##7##2##(1994-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-9#1)
that presented as##3##3##(2008-10#1)(2010-6#1)(2013-1#1)
that presented in##2##3##(2009-2#1)(2012-12#1)
that presented with##6##3##(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2013-1#1)
that presented##15##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
that presents##7##2##(1991-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)
that preservation##2##2##(1996-12#1)(2008-10#1)
that preserves##6##2##(1994-5#1)(2008-10#2)(2009-8#1)(2009-9#1)(2012-3#1)
that pretreatment of cells with##2##5##(2008-4#1)(2011-2#1)
that pretreatment of##3##3##(1994-11#1)(2008-4#1)(2011-2#1)
that pretreatment##4##2##(1994-11#1)(2008-4#1)(2011-2#2)
that prevalence of##2##3##(2008-1#1)(2008-11#1)
that prevent##9##2##(1993-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
that prevented##4##2##(1996-9#1)(2008-10#1)(2008-7#1)(2012-12#1)
that preventive##2##2##(2009-5#1)(2010-8#1)
that prevents##8##2##(1994-8#2)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#2)(2013-7#1)
that previous exposure##2##3##(1996-12#1)(1997-3#1)
that previous studies have##2##4##(1992-9#1)(2010-5#1)
that previous studies##3##3##(1992-9#1)(2008-10#1)(2010-5#1)
that previous##12##2##(1992-9#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-5#1)(2013-8#1)
that previously observed##2##3##(1997-7#1)(2010-8#1)
that previously reported##5##3##(1991-8#1)(1993-1#1)(1995-12#1)(2008-8#1)(2012-12#1)
that previously##18##2##(1990-2#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-11#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
that primarily affects the##2##4##(2007-7#1)(2008-1#1)
that primarily##4##2##(2007-7#1)(2008-1#1)(2008-7#1)(2011-1#1)
that primary care practitioners##2##4##(2011-1#2)
that primary##6##2##(1995-11#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-7#1)
that prior##2##2##(1993-12#1)(2012-2#1)
that probably##8##2##(1990-8#1)(1993-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#1)
that probe##2##2##(2008-10#1)(2008-4#1)
that probiotics##4##2##(2008-10#1)(2011-2#1)(2012-1#1)(2013-7#1)
that problems##2##2##(1992-1#1)(2008-7#1)
that procedures##3##2##(2007-8#1)(2008-2#1)(2011-2#1)
that process##10##2##(1994-12#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-4#1)
that processes##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-9#1)
that processing of##4##3##(1993-6#1)(2008-11#1)(2010-7#1)(2011-1#1)
that processing##6##2##(1993-6#1)(1997-1#1)(2008-11#1)(2010-10#1)(2010-7#1)(2011-1#1)
that produce 2##2##3##(2008-10#2)
that produce a##2##3##(2008-2#2)
that produce the antibiotic 2##2##5##(2008-10#2)
that produce the##3##3##(2008-10#2)(2011-1#1)
that produce##33##2##(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-4#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#2)(2011-1#1)(2011-2#1)
that produced SLS##2##3##(2008-10#2)
that produced a##2##3##(2008-12#1)(2008-5#1)
that produced by##9##3##(1990-8#1)(1992-10#1)(1992-8#1)(1994-6#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-3#1)
that produced high amounts of IAA##2##6##(2008-10#2)
that produced the##2##3##(2008-12#1)(2009-8#1)
that produced##34##2##(1990-8#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#1)(2009-8#1)
that produces a##2##3##(2008-10#2)
that produces an##4##3##(2008-3#2)(2012-3#1)(2013-1#1)
that produces the##5##3##(2007-12#1)(2008-3#1)(2008-4#3)
that produces##38##2##(1993-12#1)(1995-8#1)(1996-3#1)(2007-10#1)(2007-11#6)(2007-12#8)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-6#1)(2009-10#2)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
that production of##2##3##(1992-10#1)(1993-8#1)
that productive binding##2##3##(1990-7#1)(1993-8#1)
that products##2##2##(1991-9#1)(2009-9#1)
that professional##2##2##(1994-12#1)(2013-8#1)
that professionals##2##2##(1991-12#1)(2013-1#1)
that profoundly##2##2##(1995-2#1)(2008-11#1)
that progress##5##2##(1997-3#1)(2008-8#1)(2008-9#2)(2010-9#1)
that progressed to##2##3##(2009-3#1)(2011-1#1)
that progressed##4##2##(1992-5#1)(2009-3#1)(2011-1#1)(2012-1#1)
that progressive##2##2##(2008-11#1)(2008-4#1)
that project to##2##3##(1995-2#1)(2013-8#1)
that project##4##2##(1995-2#1)(2007-12#1)(2008-4#1)(2013-8#1)
that proliferation of##2##3##(2008-10#1)(2010-11#1)
that proline##2##2##(1991-12#2)
that prolong##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
that prolonged##3##2##(2007-11#1)(2008-8#1)(2013-1#1)
that prolongs the##2##3##(2008-8#1)(2010-5#1)
that promote a##2##3##(1992-12#1)(2008-7#1)
that promote health##2##3##(2008-3#1)(2009-6#1)
that promote the##5##3##(2007-7#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-8#1)
that promote tumor##3##3##(2009-3#2)(2011-2#1)
that promote##29##2##(1992-12#1)(1992-5#1)(1993-1#1)(1994-1#1)(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#2)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
that promotes##7##2##(1992-11#1)(1992-3#1)(1994-12#1)(1997-2#1)(2008-12#1)(2010-6#1)(2012-3#1)
that prompt##2##2##(1993-8#1)(2013-1#1)
that prompted the##2##3##(2008-3#1)(2009-10#1)
that propagate along##2##3##(2007-12#1)(2008-3#1)
that propagate in##2##3##(2007-11#2)
that propagate##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
that propagates##4##2##(2007-11#1)(2008-3#3)
that propagules##2##2##(2008-10#1)(2008-8#1)
that proper##2##2##(2008-8#1)(2013-1#1)
that properly##2##2##(1991-12#1)(2008-2#1)
that prophylactic##2##2##(2008-7#1)(2013-1#1)
that proposed##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
that proposes that##2##3##(2009-9#1)(2012-3#1)
that prostaglandin##4##2##(1991-3#1)(1994-5#1)(1996-12#1)(2008-7#1)
that prostate cancer is##2##4##(2010-10#1)(2011-2#1)
that protect against##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
that protect the##3##3##(2008-7#2)(2011-2#1)
that protect##8##2##(1991-9#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-11#1)(2011-2#1)
that protection##3##2##(1991-5#1)(1997-6#1)(2012-7#1)
that protects##3##2##(1994-11#1)(1995-2#1)(2009-12#1)
that protein G-liposomal nanovesicles##2##4##(2008-10#2)
that protein kinase A##4##4##(1992-12#1)(1993-8#1)(2008-1#1)(2008-11#1)
that protein kinase C##2##4##(1995-6#1)(2008-11#1)
that protein kinase##6##3##(1992-12#1)(1993-8#1)(1995-6#1)(2008-1#1)(2008-11#2)
that protein phosphorylation##2##3##(1992-9#1)(1995-12#1)
that protein##29##2##(1990-7#2)(1991-5#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#2)(2009-6#1)(2009-8#2)(2011-3#1)
that proteinases##2##2##(1990-5#1)(2012-12#1)
that proteins from##3##3##(1996-5#1)(2008-10#1)(2010-4#1)
that proteins##7##2##(1991-5#1)(1996-5#1)(2008-10#2)(2010-4#2)(2012-2#1)
that proton##2##2##(1996-5#1)(2008-10#1)
that proved to be##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
that proved to##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
that proved##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
that provide a##7##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-3#1)(2011-1#1)
that provide an##4##3##(2008-11#1)(2008-3#1)(2009-6#1)(2012-2#1)
that provide information##4##3##(1992-12#1)(2007-2#1)(2008-2#1)(2009-9#1)
that provide the##6##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
that provide##53##2##(1991-1#1)(1992-12#2)(1992-8#1)(1993-12#2)(1994-1#2)(1994-12#1)(1995-1#2)(1996-3#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
that provided by the##3##4##(2008-10#2)(2012-3#1)
that provided by##8##3##(1992-5#1)(2007-10#1)(2008-10#3)(2008-9#1)(2012-12#1)(2012-3#1)
that provided##16##2##(1992-5#1)(1996-3#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
that provider##3##2##(1994-1#2)(2009-3#1)
that providers##2##2##(1992-3#1)(1997-1#1)
that provides a##10##3##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)
that provides an##4##3##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
that provides simultaneous##2##3##(2007-11#1)(2008-3#1)
that provides structural##2##3##(2009-8#1)(2012-2#1)
that provides the##7##3##(1994-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
that provides##55##2##(1991-12#1)(1991-4#1)(1992-8#1)(1994-3#1)(1996-12#2)(1996-2#1)(1997-7#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-8#1)
that providing##2##2##(1995-1#1)(2007-11#1)
that provokes##2##2##(1994-2#1)(2009-8#1)
that proximal##2##2##(2012-3#1)(2013-1#1)
that psilocybin##2##2##(2013-8#2)
that psychiatric##2##2##(1996-5#1)(2013-1#1)
that psychological##2##2##(2008-12#1)(2008-6#1)
that psychosocial factors##3##3##(1996-12#1)(2008-2#1)(2008-9#1)
that psychosocial##4##2##(1996-12#1)(2008-2#1)(2008-9#2)
that public health##4##3##(1995-12#1)(1996-2#1)(2008-10#1)(2010-9#1)
that public relations activities##2##4##(2008-12#2)
that public relations##3##3##(2008-12#3)
that public##9##2##(1991-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-12#3)(2008-7#1)(2010-9#1)
that published##3##2##(2008-1#1)(2008-7#1)(2012-3#1)
that pulmonary##3##2##(1997-1#1)(2008-1#2)
that pump##2##2##(2007-11#1)(2008-3#1)
that purified##7##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1991-8#1)(1995-2#1)(2012-2#1)
that purport to##2##3##(2009-5#1)(2010-12#1)
that purpose##8##2##(1993-1#1)(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
that qualitatively##3##2##(2007-11#1)(2008-11#1)(2008-8#1)
that quality of##3##3##(1996-3#1)(2007-11#1)(2013-8#1)
that quality##4##2##(1996-3#2)(2007-11#1)(2013-8#1)
that quantifies##2##2##(2007-11#1)(2010-8#1)
that quantify the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that quantify##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
that quantitative##6##2##(1993-12#1)(2008-10#4)(2008-9#1)
that quercetin##2##2##(2008-10#1)(2008-4#1)
that question##2##2##(2010-10#1)(2011-2#1)
that quickly##3##2##(1991-12#1)(1996-12#1)(2008-10#1)
that rabbit##4##2##(1990-8#1)(1992-6#1)(1993-8#1)(2008-4#1)
that race##3##2##(2008-10#3)
that radial##2##2##(2007-8#1)(2008-10#1)
that radiation##3##2##(1990-12#1)(2007-12#1)(2008-3#1)
that radiation-induced##3##2##(2008-2#1)(2008-7#2)
that radiative##2##2##(2007-11#1)(2008-2#1)
that radical surgery##2##3##(1990-9#1)(2009-4#1)
that radiotherapy is##2##3##(1990-12#1)(2007-11#1)
that radiotherapy##4##2##(1990-12#1)(2007-11#2)(2007-8#1)
that raised##2##2##(2010-5#1)(2011-2#1)
that raises##2##2##(2008-4#1)(2010-8#1)
that random##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
that range from##6##3##(1993-8#1)(1996-2#1)(2008-2#2)(2011-2#2)
that range##12##2##(1993-8#1)(1996-2#1)(2008-2#2)(2008-3#3)(2008-5#1)(2011-2#2)(2012-12#2)
that ranged from 0##2##4##(2008-10#1)(2010-5#1)
that ranged from mild##2##4##(1995-8#1)(2008-10#1)
that ranged from##8##3##(1995-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2010-5#1)
that rapid##8##2##(1990-8#1)(1992-6#1)(1995-2#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)
that rapidly##5##2##(1990-11#1)(1991-12#1)(2008-10#2)(2013-1#1)
that rare##4##2##(2008-9#1)(2012-3#3)
that rarely##2##2##(2010-6#1)(2012-12#1)
that rat##8##2##(1990-2#2)(1993-3#2)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)
that rate of aging##2##4##(2008-9#2)
that rate of##3##3##(2008-9#3)
that rate##4##2##(2008-3#1)(2008-9#3)
that rates of##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)
that rather than##3##3##(2008-10#2)(2009-9#1)
that rats##2##2##(1996-12#1)(2011-1#1)
that reached##2##2##(1994-11#1)(2011-2#1)
that reaches the##3##3##(2008-1#1)(2008-5#2)
that reaches##5##2##(1994-5#1)(2007-11#1)(2008-1#1)(2008-5#2)
that react with the##2##4##(1995-2#1)(2006-6#1)
that react with##5##3##(1995-2#1)(2006-6#1)(2008-4#1)(2008-7#1)(2012-12#1)
that react##6##2##(1995-2#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
that reacted with##4##3##(1993-6#1)(1994-6#1)(2008-10#2)
that reacted##5##2##(1992-12#1)(1993-6#1)(1994-6#1)(2008-10#2)
that reaction##2##2##(2008-10#1)(2008-9#1)
that reactivate##2##2##(2009-4#1)(2009-9#1)
that reactive##4##2##(1994-6#1)(2008-10#1)(2008-8#1)(2013-7#1)
that reacts##2##2##(1995-12#1)(2008-10#1)
that real##4##2##(1994-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
that real-time##3##2##(2008-1#1)(2008-7#1)(2010-6#1)
that realized##2##2##(2008-3#1)(2009-12#1)
that rearrangement of##2##3##(1995-6#1)(1996-6#1)
that receive##5##2##(1991-5#1)(1997-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
that received cytochrome c##2##4##(1995-5#2)
that received more than##2##4##(2008-10#1)(2011-2#1)
that received one##2##3##(2008-10#1)(2011-2#1)
that received##33##2##(1990-5#1)(1993-1#1)(1993-12#3)(1995-2#1)(1995-5#4)(1997-2#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
that receivers##2##2##(1995-5#2)
that recent##6##2##(1994-2#1)(1995-3#1)(2007-11#1)(2007-6#1)(2010-2#1)(2011-2#1)
that recently##5##2##(1993-3#1)(1994-3#2)(2008-8#1)(2013-8#1)
that recognition of the##2##4##(2008-10#2)
that recognition of##4##3##(1993-3#1)(2007-12#1)(2008-10#2)
that recognition##5##2##(1993-3#1)(2007-12#2)(2008-10#2)
that recognize intact proteins##6##4##(2008-2#2)(2008-4#4)
that recognize the##3##3##(1996-2#1)(2008-4#1)(2008-9#1)
that recognize##20##2##(1990-11#1)(1993-6#1)(1994-9#1)(1996-12#3)(1996-2#1)(1997-4#1)(2008-1#1)(2008-2#2)(2008-4#8)(2008-9#1)
that recognized the##2##3##(2008-7#1)(2012-3#1)
that recognized##4##2##(1993-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
that recognizes the##2##3##(1992-10#1)(1992-9#1)
that recognizes##6##2##(1992-10#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-2#1)(1997-7#1)
that recombinant##6##2##(1992-11#1)(1995-2#1)(1997-4#1)(2008-11#3)
that recombination##5##2##(2008-10#4)(2013-8#1)
that recommendations##2##2##(2007-11#1)(2011-1#1)
that recommended by##2##3##(1995-1#1)(2010-11#1)
that recommended##4##2##(1991-8#1)(1995-1#1)(2010-11#2)
that reconstruction##2##2##(2008-2#1)(2012-2#1)
that reconstructs the##2##3##(2007-12#1)(2008-3#1)
that recorded in the##2##4##(1994-8#1)(2008-3#1)
that recorded in##4##3##(1994-8#1)(2008-10#1)(2008-3#1)(2012-3#1)
that recorded##5##2##(1994-8#1)(2008-10#2)(2008-3#1)(2012-3#1)
that recovered##3##2##(1991-2#1)(2008-10#2)
that red##2##2##(1990-5#1)(1992-12#1)
that reduce the##5##3##(2007-8#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)
that reduce##14##2##(2007-8#1)(2008-10#4)(2008-12#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#1)
that reduced##13##2##(1990-2#1)(1992-12#1)(1993-8#1)(1994-5#1)(1994-6#2)(1994-9#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)
that reduces the##12##3##(2007-12#3)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)
that reduces##25##2##(1995-2#1)(1996-2#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-1#1)(2013-8#1)
that reducing the##3##3##(1992-4#1)(2008-9#1)(2010-11#1)
that reducing##6##2##(1992-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)
that reduction##2##2##(1992-1#1)(2013-8#1)
that refer##2##2##(1991-1#1)(1992-5#1)
that reflect a##2##3##(2008-10#2)
that reflect the##8##3##(1991-3#1)(1995-12#1)(1997-8#1)(2008-9#3)(2009-12#1)(2012-12#1)
that reflect their##2##3##(1994-3#1)(2011-1#1)
that reflect##19##2##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#3)(2009-12#1)(2011-1#1)(2012-12#1)
that reflection##4##2##(2007-11#1)(2008-11#3)
that reflects only##2##3##(2007-11#1)(2008-3#1)
that reflects the##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
that reflects##8##2##(1994-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-6#1)
that regenerated host axons##2##4##(2011-2#2)
that regenerated##3##2##(2011-2#3)
that region was##2##3##(2008-5#1)(2008-7#1)
that region##9##2##(1990-5#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)
that regional##4##2##(1991-6#1)(1996-12#1)(2007-10#1)(2008-7#1)
that regions##4##2##(1990-5#1)(1993-3#1)(2008-12#2)
that regular##3##2##(1991-8#1)(2009-5#1)(2012-3#1)
that regulate gene expression##4##4##(2008-11#2)(2008-3#1)(2012-12#1)
that regulate neurotransmitter##2##3##(1995-12#1)(1996-12#1)
that regulate the growth of##2##5##(1993-5#1)(1995-8#1)
that regulate the##11##3##(1992-2#1)(1992-5#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-12#1)(2008-9#1)(2009-12#1)(2012-2#1)
that regulate##55##2##(1990-2#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
that regulates biofilm decay in P##2##6##(2009-6#2)
that regulates cell##2##3##(2008-1#1)(2008-11#1)
that regulates the expression of##2##5##(1991-9#1)(2010-7#1)
that regulates the##5##3##(1991-9#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)
that regulates##24##2##(1991-9#1)(1993-8#1)(1995-8#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#4)
that regulation of##7##3##(1995-11#1)(1995-12#1)(1997-1#1)(2008-7#2)(2008-8#2)
that regulation##8##2##(1995-11#1)(1995-12#1)(1997-1#1)(2008-7#2)(2008-8#2)(2009-10#1)
that rehabilitation##2##2##(2009-8#1)(2013-1#1)
that reinforces the##2##3##(2008-12#1)(2013-8#1)
that reinforces##3##2##(2008-12#1)(2009-10#1)(2013-8#1)
that relapsed##2##2##(2007-5#1)(2008-1#1)
that relate the##2##3##(2008-3#2)
that relate to##3##3##(1995-3#1)(2008-3#1)(2009-9#1)
that relate##9##2##(1995-12#1)(1995-3#1)(2008-10#1)(2008-3#5)(2009-9#1)
that relates the##5##3##(1994-9#1)(2007-11#1)(2008-3#3)
that relates to##2##3##(2008-3#1)(2008-7#1)
that relates##11##2##(1990-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#5)(2008-7#1)
that relationship##2##2##(1992-3#1)(2008-10#1)
that relative##6##2##(2007-12#1)(2008-10#1)(2008-3#2)(2011-1#1)(2013-8#1)
that relatively large##2##3##(2008-3#2)
that relatively simple##2##3##(1995-2#1)(2007-12#1)
that relatively##8##2##(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
that release of##2##3##(1992-3#1)(1994-11#1)
that release##10##2##(1990-2#1)(1992-3#1)(1994-11#1)(1997-1#3)(2008-4#1)(2008-7#1)(2008-8#1)(2013-7#1)
that released##3##2##(1993-6#1)(1995-5#1)(2009-12#1)
that reliable results can be obtained##2##6##(2008-10#2)
that reliable##4##2##(2007-11#1)(2008-10#3)
that relies on##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)
that relies##7##2##(1996-1#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)
that religious##4##2##(1993-12#1)(2008-12#1)(2009-11#1)(2009-8#1)
that rely on the##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
that rely on##13##3##(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)
that rely##14##2##(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)
that remain in##2##3##(1997-1#1)(2012-2#1)
that remain to be##5##4##(1994-5#1)(1995-4#1)(2008-8#1)(2009-6#1)(2012-12#1)
that remain##11##2##(1994-5#1)(1995-4#1)(1997-1#1)(2007-12#2)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that remained##5##2##(1995-2#1)(2008-10#2)(2009-5#1)(2013-1#1)
that remains in##2##3##(2007-12#1)(2008-5#1)
that remains to be##3##4##(2008-10#2)(2008-11#1)
that remains##11##2##(1994-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
that remote##2##2##(2008-10#1)(2008-11#1)
that removal of the##6##4##(1992-3#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
that removal of##12##3##(1992-3#1)(1993-9#1)(1994-2#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
that remove##2##2##(2007-12#1)(2008-10#1)
that removes the COOH-terminal tripeptide from##2##6##(1990-2#2)
that removes the##4##3##(1990-2#2)(1995-5#1)(2008-3#1)
that removes##5##2##(1990-2#2)(1991-9#1)(1995-5#1)(2008-3#1)
that renal function##2##3##(1992-8#1)(2012-1#1)
that renal##6##2##(1992-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-1#1)
that render them##2##3##(2008-9#1)(2010-7#1)
that render##3##2##(1997-3#1)(2008-9#1)(2010-7#1)
that repair##3##2##(1994-5#2)(2008-7#1)
that repeated##7##2##(1993-12#2)(1993-2#1)(2008-10#2)(2008-7#1)(2010-12#1)
that repeatedly##3##2##(2008-10#2)(2008-8#1)
that repetitive##2##2##(1997-4#1)(2008-7#1)
that replacement of the##3##4##(1994-12#1)(2007-8#1)(2008-4#1)
that replacement of##4##3##(1994-12#1)(1994-9#1)(2007-8#1)(2008-4#1)
that replaces##3##2##(1993-12#1)(1997-7#1)(2012-2#1)
that replicate the##2##3##(1995-1#1)(2008-3#1)
that replicate##5##2##(1990-5#1)(1994-8#2)(1995-1#1)(2008-3#1)
that replicates##2##2##(2008-3#1)(2008-9#1)
that report##3##2##(1997-8#1)(2008-12#1)(2009-1#1)
that reported by##2##3##(2008-6#1)(2012-12#1)
that reported for##6##3##(1991-7#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
that reported in the literature##3##5##(1991-2#1)(1991-3#1)(2008-1#1)
that reported in the##4##4##(1991-2#1)(1991-3#1)(2006-10#1)(2008-1#1)
that reported in##9##3##(1991-2#1)(1991-3#1)(1994-12#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-12#1)
that reported previously for##2##4##(2008-10#1)(2008-2#1)
that reported previously##4##3##(1990-2#1)(1991-2#1)(2008-10#1)(2008-2#1)
that reported##37##2##(1990-2#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-12#1)(1993-3#2)(1994-12#1)(1994-3#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#3)(2009-5#1)(2010-8#1)(2012-12#5)
that represent the##7##3##(1995-9#2)(1996-2#1)(2008-10#2)(2008-8#1)(2010-8#1)
that represent##19##2##(1995-9#2)(1996-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
that represented##2##2##(2007-12#1)(2008-10#1)
that represents the##8##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-6#1)(2010-5#1)
that represents##11##2##(1994-3#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-1#1)(2009-6#1)(2010-5#1)
that represses##2##2##(2008-11#1)(2009-8#1)
that reproduce sexually##2##3##(2008-8#2)
that reproduce##4##2##(2008-3#1)(2008-8#3)
that reproduces##2##2##(1995-3#1)(2008-10#1)
that reproduction occurs##2##3##(2008-9#1)(2011-2#1)
that reproductive success##2##3##(2008-8#1)(2008-9#1)
that reproductive##4##2##(1994-3#1)(2008-8#2)(2008-9#1)
that require a##2##3##(1991-6#1)(2008-2#1)
that require the##2##3##(2008-12#1)(2008-9#1)
that require##39##2##(1991-2#1)(1991-6#1)(1991-9#1)(1994-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
that required a##2##3##(1994-3#1)(1994-9#1)
that required for##4##3##(2007-12#2)(2008-10#1)(2008-7#1)
that required the##2##3##(2011-1#1)(2013-8#1)
that required to##3##3##(1994-6#1)(2008-5#1)(2008-7#1)
that required##31##2##(1990-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2009-12#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
that requires a##3##3##(2008-10#1)(2011-2#2)
that requires multiple##2##3##(2008-1#1)(2008-3#1)
that requires no##3##3##(2007-12#1)(2008-2#2)
that requires##23##2##(1990-2#1)(1993-2#1)(1994-2#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#1)(2011-2#5)(2012-2#1)
that research should be##2##4##(1996-12#1)(2007-2#1)
that research##8##2##(1993-2#1)(1996-11#1)(1996-12#1)(2006-5#1)(2007-2#1)(2008-11#1)(2009-6#1)(2011-1#1)
that researchers should##2##3##(1997-5#1)(2010-6#1)
that researchers##8##2##(1992-3#1)(1997-5#1)(2008-4#2)(2010-6#1)(2012-12#1)(2013-1#2)
that resemble the##2##3##(1991-5#1)(1994-8#1)
that resemble##8##2##(1991-5#1)(1991-9#1)(1994-8#1)(2008-2#1)(2008-4#2)(2008-8#1)(2012-3#1)
that resembled##2##2##(2008-10#1)(2011-2#1)
that resembles the##2##3##(1997-6#1)(2007-12#1)
that resembles##4##2##(1991-5#1)(1997-6#1)(2007-12#2)
that reside##2##2##(1994-9#1)(2011-2#1)
that residents##2##2##(1995-3#2)
that residual##4##2##(2008-10#2)(2008-9#1)(2009-9#1)
that residue##2##2##(1995-11#1)(1995-5#1)
that residues##3##2##(1994-8#1)(2008-8#1)(2008-9#1)
that resistance in##4##3##(2008-10#4)
that resistance to these##2##4##(2008-10#2)
that resistance to##7##3##(1991-2#1)(2008-10#6)
that resistance##18##2##(1991-2#1)(2008-10#17)
that resisted##3##2##(1995-1#1)(2008-10#1)(2010-7#1)
that resolution##2##2##(2008-10#1)(2008-3#1)
that resolved##4##2##(1996-9#1)(2007-10#1)(2008-9#1)(2012-12#1)
that resolves##2##2##(2007-11#1)(2008-2#1)
that respects##2##2##(1997-5#1)(2008-12#1)
that respond to##9##3##(1992-8#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
that respond##11##2##(1992-8#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
that responded to##6##3##(1992-6#2)(1992-9#1)(1995-1#1)(2008-10#1)(2008-9#1)
that responded##7##2##(1992-6#2)(1992-9#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-9#1)
that respondents##2##2##(2007-12#1)(2009-7#1)
that responds to the##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
that responds to##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-9#1)
that responds##6##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
that response##4##2##(1995-8#1)(2008-4#1)(2012-1#1)(2013-8#1)
that responses to##2##3##(2008-8#1)(2011-2#1)
that responses##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
that resting##2##2##(2008-7#1)(2012-2#1)
that restored##2##2##(2008-6#1)(2011-1#1)
that restores##2##2##(2008-3#1)(2008-6#1)
that restrict##5##2##(1991-5#1)(1992-5#1)(2008-5#2)(2008-7#1)
that restriction of##3##3##(2007-11#1)(2008-10#2)
that result from the##4##4##(2007-11#1)(2008-3#2)(2012-2#1)
that result from##20##3##(1990-8#1)(1994-3#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#7)(2008-8#2)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
that result in a##2##4##(2008-11#1)(2009-2#1)
that result in improved##2##4##(1992-3#1)(2008-3#1)
that result in increased##2##4##(1995-2#1)(2008-1#1)
that result in more##2##4##(1994-3#1)(2012-12#1)
that result in##19##3##(1992-3#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
that result##42##2##(1990-8#1)(1992-3#1)(1994-3#2)(1995-2#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#9)(2008-5#1)(2008-8#4)(2008-9#3)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
that resulted from the##3##4##(1992-2#1)(2008-2#1)(2008-3#1)
that resulted from##6##3##(1992-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
that resulted in a##4##4##(1991-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
that resulted in the##2##4##(1995-6#1)(2013-1#1)
that resulted in##19##3##(1991-9#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
that resulted##26##2##(1991-9#1)(1992-2#2)(1993-2#1)(1994-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
that resulting from##2##3##(1991-3#1)(1995-12#1)
that results from a##3##4##(2007-12#1)(2008-3#2)
that results from the use of a##2##7##(2008-10#2)
that results from the##10##4##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
that results from##22##3##(1990-5#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-8#2)(2009-11#1)
that results in a##5##4##(1992-8#1)(1994-5#1)(2008-4#1)(2008-7#1)(2008-8#1)
that results in an##2##4##(1991-7#1)(1997-7#1)
that results in the delivery of a drug injection##2##9##(2008-4#1)(2012-3#1)
that results in the##5##4##(1994-12#1)(2007-8#1)(2008-4#1)(2009-12#1)(2012-3#1)
that results in##26##3##(1991-7#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2012-12#1)(2012-3#1)
that results##53##2##(1990-5#1)(1991-7#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2012-12#1)(2012-3#1)
that resveratrol is##2##3##(2008-5#1)(2009-12#1)
that resveratrol##3##2##(2008-5#2)(2009-12#1)
that retain##4##2##(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)
that retained##2##2##(2008-10#1)(2012-2#1)
that retains the##2##3##(1992-11#1)(2008-5#1)
that retinoic acid##2##3##(1992-8#1)(1993-3#1)
that retinol##2##2##(2008-5#2)
that retinol-binding protein##2##3##(1995-6#2)
that retrieved##2##2##(2008-2#1)(2008-3#1)
that retroviral##2##2##(1994-12#1)(2012-12#1)
that reveal##6##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
that revealed##4##2##(1990-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
that reveals##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
that reversible##2##2##(1990-2#1)(2008-3#1)
that rhabdomyolysis##2##2##(2011-2#1)(2013-8#1)
that rhizosphere priming may##2##4##(2013-8#2)
that rice##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
that risk factors##2##3##(2009-4#1)(2013-1#1)
that risk##8##2##(1993-1#1)(1997-1#1)(2008-7#2)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
that role models##2##3##(2009-7#2)
that role##8##2##(1993-2#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-3#1)(2009-4#1)(2009-7#2)
that root colonization##2##3##(2008-10#2)
that root##5##2##(2008-10#5)
that roots##2##2##(2009-8#2)
that rotates##2##2##(2008-2#1)(2008-3#1)
that rotation##2##2##(2007-11#1)(2007-8#1)
that round and##3##3##(1997-4#2)(2011-2#1)
that routine##5##2##(1990-2#1)(1990-8#1)(1997-8#1)(2007-7#1)(2008-10#1)
that routinely##2##2##(2008-9#1)(2013-1#1)
that rpGH##2##2##(2008-9#2)
that rps14 is##2##3##(1996-6#2)
that rumination is##2##3##(2008-8#1)(2009-11#1)
that run##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
that runs##4##2##(2007-12#1)(2008-11#1)(2008-5#1)(2012-2#1)
that rupintrivir##2##2##(2008-10#2)
that salivary##2##2##(1994-7#1)(2013-1#1)
that same##2##2##(2008-5#1)(2008-9#1)
that sample##8##2##(2008-10#4)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
that samples##2##2##(2008-10#1)(2008-6#1)
that sampling##2##2##(2008-10#1)(2013-1#1)
that sanguinarine##2##2##(2011-2#2)
that satisfaction with##2##3##(2007-6#1)(2008-9#1)
that satisfaction##4##2##(1994-2#1)(1995-1#1)(2007-6#1)(2008-9#1)
that satisfactory##2##2##(1996-12#1)(2008-10#1)
that satisfies the##3##3##(2008-2#1)(2008-3#2)
that satisfies##7##2##(2008-2#1)(2008-3#3)(2008-7#2)(2009-12#1)
that satisfy the##3##3##(1994-12#1)(1996-4#1)(2008-3#1)
that satisfy##5##2##(1994-12#1)(1996-4#1)(2008-3#2)(2008-6#1)
that scale##2##2##(2008-10#1)(2009-2#1)
that scaling relations##2##3##(2008-8#2)
that scattered##2##2##(2008-10#1)(2008-3#1)
that scattering##3##2##(2008-2#1)(2008-3#2)
that scatters##2##2##(2008-2#1)(2008-3#1)
that school##3##2##(2008-12#1)(2009-9#1)(2012-2#1)
that schools of##3##3##(1996-1#1)(2008-11#1)(2010-8#1)
that scientific##2##2##(2012-2#2)
that screening##5##2##(1991-6#1)(1992-2#1)(1992-5#1)(1994-6#1)(2011-1#1)
that seafarers##2##2##(2011-2#2)
that searches##2##2##(2008-3#1)(2008-8#1)
that season##2##2##(2008-5#1)(2012-2#1)
that seasonal##3##2##(1992-7#1)(1993-6#1)(2013-7#1)
that secondary spread##2##3##(2008-10#2)
that secondary##4##2##(1991-9#1)(2008-10#2)(2008-3#1)
that secrete##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
that section##2##2##(1993-9#1)(1995-2#1)
that seeds##2##2##(2008-10#1)(2012-9#1)
that seek to##2##3##(2008-3#1)(2008-7#1)
that seem to be##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
that seem to##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
that seem##7##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
that seemed to##2##3##(2008-9#1)(2010-8#1)
that seemed##3##2##(2008-9#1)(2009-7#1)(2010-8#1)
that seems to be##2##4##(1992-3#1)(2008-11#1)
that seems to##3##3##(1992-3#1)(2008-11#1)(2013-1#1)
that seems##5##2##(1992-3#1)(1994-8#1)(2007-8#1)(2008-11#1)(2013-1#1)
that seen in the##3##4##(1992-8#1)(1994-8#1)(2008-11#1)
that seen in##10##3##(1992-10#1)(1992-12#1)(1992-8#1)(1994-5#2)(1994-8#1)(2008-10#1)(2008-11#2)(2012-3#1)
that seen##19##2##(1990-5#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#1)
that segregated for##3##3##(2008-10#2)(2012-3#1)
that segregated##5##2##(2008-10#4)(2012-3#1)
that selected##2##2##(1991-12#1)(1992-2#1)
that selecting an##2##3##(2008-10#1)(2008-9#1)
that selecting##5##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
that selection for##4##3##(2008-10#3)(2008-9#1)
that selection##13##2##(2008-10#6)(2008-8#3)(2008-9#2)(2013-1#2)
that selective##5##2##(1991-5#1)(2008-10#2)(2008-9#1)(2010-1#1)
that selectively##7##2##(2006-10#1)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
that selects##2##2##(2008-3#1)(2009-8#1)
that selenium##4##2##(1992-11#1)(2008-6#3)
that senses##2##2##(2007-11#1)(2010-10#1)
that sensitively##2##2##(2008-2#1)(2009-7#1)
that sensitivity to Ptr##2##4##(2008-10#2)
that sensitivity to##3##3##(2008-10#2)(2008-11#1)
that sensory neurons##3##3##(2007-12#2)(2008-4#1)
that sensory##7##2##(1992-6#1)(2007-12#2)(2008-11#1)(2008-4#1)(2013-8#2)
that separate the##2##3##(2008-3#1)(2008-4#1)
that separate##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)
that separated the##2##3##(2008-9#1)(2011-2#1)
that separated##5##2##(2008-10#1)(2008-9#2)(2011-2#1)(2012-1#1)
that separates##2##2##(2008-3#1)(2011-2#1)
that separation##2##2##(2008-10#2)
that sequence##2##2##(1995-2#1)(1996-6#1)
that sequences##5##2##(1992-12#2)(1995-12#1)(1995-2#1)(2008-10#1)
that sequential##3##2##(1996-2#1)(2007-5#1)(2008-7#1)
that sequesters##2##2##(1991-9#1)(2008-11#1)
that serotonin plays##2##3##(1993-3#1)(2008-5#1)
that serotonin##3##2##(1993-3#1)(1995-12#1)(2008-5#1)
that serum starvation of##2##4##(2008-9#2)
that serum##11##2##(1990-3#1)(1997-1#1)(2008-10#1)(2008-7#2)(2008-9#3)(2011-2#1)(2012-5#1)(2013-1#1)
that serve as##5##3##(1992-6#1)(1997-6#1)(2008-2#1)(2010-10#1)(2012-2#1)
that serve##6##2##(1992-6#1)(1997-3#1)(1997-6#1)(2008-2#1)(2010-10#1)(2012-2#1)
that served as##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
that serves as a##2##4##(2008-7#1)(2012-2#1)
that serves as the##2##4##(2008-3#2)
that serves as##5##3##(1991-5#1)(2008-3#2)(2008-7#1)(2012-2#1)
that serves the##2##3##(1991-3#1)(2010-5#1)
that serves##9##2##(1991-3#1)(1991-5#1)(2008-1#1)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
that service industries are##2##4##(1995-1#1)(2009-8#1)
that service##3##2##(1994-2#1)(1995-1#1)(2009-8#1)
that services##2##2##(1991-12#1)(1996-3#1)
that setting##2##2##(1992-11#1)(1993-12#1)
that settlers win space by winning fights##2##7##(2008-9#2)
that seven##2##2##(1995-5#1)(2010-12#1)
that several different##2##3##(1997-7#1)(2008-10#1)
that several of##2##3##(1991-9#1)(2008-10#1)
that several##39##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-7#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#1)
that severe##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
that severity of##2##3##(1993-3#1)(2011-2#1)
that severity##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
that sex ratio##2##3##(2008-8#2)
that sex##8##2##(1991-12#1)(1997-7#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)
that sexual recombination is##2##4##(2008-10#2)
that sexual recombination may##2##4##(2008-10#2)
that sexual recombination##6##3##(2008-10#6)
that sexual reproduction##3##3##(2008-10#3)
that sexual selection##2##3##(1995-2#1)(2008-8#1)
that sexual##14##2##(1993-9#1)(1995-2#1)(2008-10#9)(2008-8#2)(2012-3#1)
that sexually active##2##3##(2009-7#1)(2012-2#1)
that sexually##3##2##(1990-3#1)(2009-7#1)(2012-2#1)
that sgcD##2##2##(2008-9#2)
that shape the##7##3##(2007-12#1)(2007-2#1)(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
that shape##13##2##(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
that shaped##2##2##(2008-12#1)(2009-10#1)
that share a##3##3##(2007-12#1)(2008-8#1)(2009-10#1)
that share common##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
that share##13##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
that shares##4##2##(1993-12#1)(2008-10#2)(2010-3#1)
that shaving##2##2##(2008-5#2)
that she had##2##3##(1992-6#1)(2011-2#1)
that she was##2##3##(1995-12#1)(1996-5#1)
that she##11##2##(1992-6#1)(1992-9#1)(1995-12#2)(1995-6#1)(1996-5#1)(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#2)
that shed light on the##2##5##(2008-4#1)(2010-12#1)
that short DNA##3##3##(2008-11#2)(2009-6#1)
that short##7##2##(2008-11#2)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#2)
that short-chain##2##2##(1992-6#1)(2008-5#1)
that short-term##4##2##(1995-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
that shorter##2##2##(2008-11#1)(2008-8#1)
that should be addressed##3##4##(2012-2#2)(2013-1#1)
that should be considered by##2##5##(1994-1#1)(2007-12#1)
that should be considered for##2##5##(1992-5#1)(2008-10#1)
that should be considered in the##3##6##(2007-10#1)(2011-2#1)(2013-1#1)
that should be considered in##5##5##(1991-8#1)(1992-12#1)(2007-10#1)(2011-2#1)(2013-1#1)
that should be considered when##2##5##(1995-1#1)(2008-10#1)
that should be considered##15##4##(1991-8#1)(1992-12#1)(1992-5#1)(1994-1#1)(1995-1#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
that should be followed##2##4##(1997-6#1)(2008-9#1)
that should be readily##2##4##(2008-3#1)(2010-11#1)
that should be taken into account##2##6##(1992-3#1)(2009-8#1)
that should be taken into consideration##2##6##(2008-7#1)(2010-8#1)
that should be taken into##4##5##(1992-3#1)(2008-7#1)(2009-8#1)(2010-8#1)
that should be useful##2##4##(2008-10#1)(2008-8#1)
that should be##44##3##(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1994-1#1)(1995-1#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)
that should##57##2##(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1994-1#1)(1995-1#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
that show a##7##3##(1994-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
that show different##2##3##(2008-12#1)(2008-9#1)
that show how##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
that show no##2##3##(1993-11#1)(2013-1#1)
that show promise##2##3##(2008-2#1)(2010-10#1)
that show that the##2##4##(1994-5#1)(2007-12#1)
that show that##5##3##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
that show the##6##3##(1993-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)
that show##50##2##(1991-10#1)(1991-6#1)(1991-9#1)(1993-11#2)(1994-12#1)(1994-5#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#7)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#3)(2012-3#2)(2013-1#2)
that showed a##4##3##(1994-11#1)(2007-12#1)(2008-5#1)(2013-8#1)
that showed no##2##3##(2008-10#1)(2008-3#1)
that showed that##2##3##(2008-10#1)(2008-3#1)
that showed the##5##3##(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#1)
that showed##27##2##(1992-3#1)(1994-11#1)(1995-11#1)(1996-7#1)(1997-4#1)(2007-12#2)(2008-10#8)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that shown##2##2##(1995-5#1)(2008-10#1)
that shows a##4##3##(1992-6#1)(1994-5#1)(1997-3#1)(2010-6#1)
that shows high##2##3##(2008-2#1)(2008-3#1)
that shows that##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
that shows the##2##3##(2007-12#1)(2008-3#1)
that shows##21##2##(1992-6#1)(1994-5#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-12#1)
that side##3##2##(2008-10#1)(2008-2#1)(2009-6#1)
that sigma##2##2##(1993-12#1)(1996-3#1)
that sigma1 receptors##2##3##(1995-12#2)
that signal peptide##2##3##(1991-9#1)(1997-8#1)
that signal##7##2##(1991-9#1)(1997-8#1)(2008-10#2)(2008-3#3)
that signaling##2##2##(2008-10#1)(2008-4#1)
that signals##2##2##(2008-10#1)(2008-9#1)
that significant improvements in##2##4##(1996-2#1)(2007-11#1)
that significant##19##2##(1990-3#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#2)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-5#1)(2011-2#1)(2013-8#1)
that significantly##12##2##(1992-2#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
that signs of##2##3##(1997-7#1)(2008-5#1)
that silicon##2##2##(2008-10#1)(2012-2#1)
that similar to##2##3##(1996-9#1)(2009-4#1)
that similar##7##2##(1994-12#1)(1995-11#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)
that simple##7##2##(1993-9#1)(1995-5#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
that simulate##5##2##(1991-11#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
that simulated##2##2##(2008-2#1)(2008-3#1)
that simulates a##2##3##(2008-10#1)(2011-2#1)
that simulates the##6##3##(1994-6#1)(2008-10#4)(2009-10#1)
that simulates##9##2##(1994-6#1)(2008-10#5)(2008-3#1)(2009-10#1)(2011-2#1)
that simultaneous determination##2##3##(2008-10#2)
that simultaneous##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
that simultaneously##7##2##(2008-3#2)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
that since##2##2##(2008-10#2)
that single##10##2##(1993-1#1)(1994-8#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-1#1)
that site##4##2##(1995-2#1)(1995-5#1)(2007-5#1)(2008-8#1)
that sites##2##2##(2008-10#1)(2012-3#1)
that six##5##2##(1993-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
that size##4##2##(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)
that skin##10##2##(1994-9#1)(2007-7#1)(2008-5#8)
that slow##3##2##(2008-1#1)(2008-10#1)(2009-5#1)
that small RNAs##2##3##(2008-1#1)(2009-3#1)
that small##14##2##(1990-7#1)(1990-8#1)(1994-11#1)(1995-11#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#3)(2009-3#1)(2009-7#1)(2013-1#1)
that smoking cessation##3##3##(2010-4#2)(2012-3#1)
that smoking is##2##3##(2011-2#1)(2013-1#1)
that smoking##6##2##(1997-7#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#1)
that smooth muscle##2##3##(1995-2#1)(1997-7#1)
that snow##2##2##(2008-10#2)
that so-called##2##2##(1994-5#1)(2010-12#1)
that social##14##2##(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
that sodium fluoride##2##3##(1993-11#1)(1995-12#1)
that sodium##8##2##(1992-9#1)(1993-11#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
that soft##2##2##(2010-8#1)(2013-1#1)
that soil##5##2##(2008-10#3)(2008-5#1)(2012-2#1)
that soils are a substantial source of##2##7##(2008-11#2)
that soils##3##2##(2008-11#3)
that solid##5##2##(1995-4#1)(1996-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
that soluble##4##2##(1990-2#1)(1994-8#1)(2008-10#2)
that solution##2##2##(2008-10#1)(2008-3#1)
that solutions##3##2##(1994-6#1)(2008-2#1)(2008-6#1)
that solvent##2##2##(1990-8#1)(2008-4#1)
that somatostatin##2##2##(1997-4#2)
that some bacterial##2##3##(2008-12#1)(2009-5#1)
that some components##2##3##(2008-10#2)
that some individuals##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
that some kind of##2##4##(1997-3#1)(2008-12#1)
that some of the##14##4##(1991-9#1)(1995-8#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
that some of these##6##4##(1996-3#1)(2008-3#1)(2008-7#2)(2010-4#1)(2012-2#1)
that some of##21##3##(1991-9#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-4#1)(2012-2#1)(2013-1#1)
that some##133##2##(1990-12#2)(1990-8#1)(1991-3#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-2#3)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-9#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#6)(2008-5#5)(2008-7#8)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
that sought to##4##3##(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
that span the##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
that span##10##2##(1994-11#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
that spans the##3##3##(1991-5#1)(2008-12#1)(2008-5#1)
that spatial redistribution##2##3##(2008-8#2)
that spatial variation in##2##4##(2008-8#2)
that spatial##15##2##(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#9)(2009-5#1)(2009-8#1)(2009-9#1)
that spatiotemporal##2##2##(2007-11#1)(2008-8#1)
that special##2##2##(1995-2#1)(2012-2#1)
that specially##2##2##(1993-2#1)(1995-3#1)
that species richness##3##3##(2008-8#3)
that species were##2##3##(2008-12#2)
that species##17##2##(1990-6#1)(2008-10#2)(2008-12#3)(2008-8#6)(2009-4#1)(2009-8#1)(2012-3#2)(2012-6#1)
that specific and##2##3##(1995-12#1)(2008-8#1)
that specific##24##2##(1991-12#1)(1992-3#2)(1994-11#2)(1994-12#1)(1995-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#2)(2010-12#1)(2012-12#1)(2012-2#1)
that specifically bind to##2##4##(1992-8#1)(2008-7#1)
that specifically binds##3##3##(1995-5#1)(1995-6#1)(2008-11#1)
that specifically recognize##2##3##(1992-8#1)(1996-5#1)
that specifically target##2##3##(2010-4#1)(2010-6#1)
that specifically##25##2##(1990-11#1)(1992-8#3)(1993-12#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-6#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)
that specify the##2##3##(1997-1#1)(2007-12#1)
that specify##3##2##(1997-1#1)(2007-12#1)(2008-2#1)
that spectral##6##2##(2007-12#1)(2008-10#2)(2008-2#2)(2009-9#1)
that speech##2##2##(2008-9#1)(2013-8#1)
that sperm are##2##3##(2007-12#1)(2008-8#1)
that sperm##6##2##(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
that spermine##2##2##(1994-11#1)(2008-8#1)
that spin##2##2##(2010-7#1)(2012-2#1)
that spirituality is##3##3##(2008-12#1)(2013-1#2)
that spirituality##7##2##(2008-12#1)(2008-4#4)(2013-1#2)
that splenectomized patients run increased risk of##2##7##(1990-9#1)(1994-9#1)
that splenic##2##2##(2008-11#2)
that spontaneous##6##2##(1990-5#1)(1996-11#1)(1997-2#1)(2008-11#2)(2009-3#1)
that spore##2##2##(2008-10#2)
that spores of##3##3##(2008-10#2)(2008-8#1)
that spores##4##2##(2008-10#3)(2008-8#1)
that spurious##2##2##(1996-11#1)(2008-3#1)
that stabilization of##3##3##(1990-8#1)(1991-5#1)(2008-8#1)
that stabilization##4##2##(1990-8#1)(1991-5#1)(2008-3#1)(2008-8#1)
that stabilize##3##2##(1991-6#1)(1991-8#1)(2007-8#1)
that stable##3##2##(2008-10#2)(2011-2#1)
that staff##4##2##(2007-11#1)(2010-10#1)(2011-2#1)(2012-12#1)
that stage##2##2##(2007-12#1)(2010-2#1)
that stained##2##2##(2008-10#2)
that standard##6##2##(2008-1#1)(2008-10#2)(2009-4#1)(2011-1#1)(2011-2#1)
that standards##2##2##(2008-12#1)(2008-5#1)
that starch##2##2##(2008-6#1)(2009-8#1)
that started##2##2##(2008-2#1)(2011-2#1)
that starts with##2##3##(2007-11#1)(2010-10#1)
that state##6##2##(1992-2#1)(1995-3#1)(1995-6#1)(2008-11#2)(2008-3#1)
that states##2##2##(1994-2#1)(2011-2#1)
that static##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
that statistical##2##2##(1996-4#1)(2008-9#1)
that staurosporine##2##2##(1993-6#1)(1995-12#1)
that stem cells##2##3##(2008-10#1)(2011-2#1)
that stem from##2##3##(2008-3#1)(2010-2#1)
that stem##4##2##(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)
that stereotypies##2##2##(2008-11#2)
that steroid##2##2##(1995-2#1)(2008-1#1)
that still need to be addressed##2##6##(1993-3#1)(2007-12#1)
that still need to be##3##5##(1993-3#1)(2007-12#1)(2008-7#1)
that still##7##2##(1993-3#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
that stimulate the##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
that stimulate##10##2##(1990-11#1)(1992-2#1)(1994-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)
that stimulated##4##2##(1991-3#1)(2007-11#1)(2008-11#1)(2008-2#1)
that stimulates the##2##3##(1991-12#1)(1994-8#1)
that stimulates##6##2##(1990-7#1)(1991-12#1)(1992-3#1)(1994-8#1)(1994-9#1)(2010-10#1)
that stimulation of the##2##4##(1996-2#1)(1997-7#1)
that stimulation of##10##3##(1994-2#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2012-1#1)(2013-1#1)
that stimulation##11##2##(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2012-1#1)(2013-1#1)
that stored##2##2##(1995-11#1)(2008-9#1)
that storytelling##2##2##(2008-11#1)(2008-12#1)
that strain##4##2##(2008-10#3)(2008-7#1)
that strains of X##2##4##(2008-10#2)
that strategies##3##2##(2008-11#1)(2009-7#1)(2012-2#1)
that stress##9##2##(1994-11#2)(1994-2#1)(1996-6#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-1#1)
that stressful##2##2##(2008-2#1)(2011-2#1)
that strictly##2##2##(2008-10#1)(2012-12#1)
that stromal##2##2##(1993-9#1)(2013-1#1)
that strong##9##2##(1996-12#1)(1996-4#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-8#1)(2012-2#1)
that strongly##6##2##(1994-6#1)(1995-11#1)(2008-10#2)(2008-9#1)(2012-12#1)
that structural differences##2##3##(2008-5#1)(2008-7#1)
that structural##6##2##(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
that structurally different##2##3##(2009-12#2)
that structurally##3##2##(2009-12#3)
that structured##2##2##(2008-11#1)(2012-2#1)
that student nurses##2##3##(2008-11#2)
that students are##3##3##(2008-11#2)(2008-12#1)
that students can##2##3##(1996-12#1)(2012-1#1)
that students have##3##3##(2008-11#1)(2010-3#1)(2012-12#1)
that students##20##2##(1996-1#1)(1996-12#1)(2008-11#6)(2008-12#4)(2009-7#1)(2010-3#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
that students'##4##2##(2008-11#1)(2008-12#2)(2013-1#1)
that studies of##2##3##(2008-11#2)
that studies##6##2##(2008-10#2)(2008-11#2)(2008-5#1)(2011-1#1)
that study##4##2##(2008-11#1)(2008-2#1)(2010-12#1)(2013-1#1)
that studying##2##2##(2008-1#1)(2010-12#1)
that subcultured isolates##2##3##(2008-10#2)
that subjects##4##2##(1991-2#1)(1995-5#1)(2008-10#2)
that subpopulations of##2##3##(1997-3#1)(1997-4#1)
that subpopulations##4##2##(1997-3#1)(1997-4#1)(2008-10#2)
that subsequent##3##2##(1990-5#1)(2008-11#1)(2008-4#1)
that subsequently##4##2##(2007-6#1)(2008-11#1)(2008-12#1)(2008-8#1)
that substantial##4##2##(1994-12#1)(1996-9#1)(2008-1#1)(2008-2#1)
that substantially##2##2##(2007-11#1)(2008-2#1)
that substitutes##2##2##(1994-12#1)(2012-2#1)
that substrate##2##2##(1991-9#1)(1997-2#1)
that subtelomeres##2##2##(2009-10#2)
that subtle changes##2##3##(1995-6#1)(2012-1#1)
that subtle##4##2##(1993-3#1)(1995-6#1)(2008-10#1)(2012-1#1)
that successful##8##2##(1993-1#1)(1995-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)
that successfully##2##2##(2008-11#1)(2008-2#1)
that such a correlation##2##4##(2008-12#1)(2012-2#1)
that such a##19##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
that such an##4##3##(1995-2#1)(1997-5#1)(2008-3#1)(2009-10#1)
that such experience##2##3##(1992-12#1)(2008-11#1)
that such##86##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-4#1)(1992-12#2)(1992-3#2)(1993-3#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-7#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
that suffered##2##2##(2007-8#1)(2008-5#1)
that sufficient##5##2##(1994-2#1)(1996-2#1)(2008-10#1)(2008-9#1)(2009-5#1)
that suggest a##2##3##(2008-11#1)(2009-10#1)
that suggest that##6##3##(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
that suggest the##4##3##(1995-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
that suggest##15##2##(1995-12#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
that suggested by##2##3##(1992-6#1)(1997-3#1)
that suggested##5##2##(1992-6#1)(1997-3#1)(2008-10#1)(2009-9#1)(2013-1#1)
that suggests that##3##3##(1995-4#1)(1995-6#1)(2013-1#1)
that suggests##4##2##(1993-12#1)(1995-4#1)(1995-6#1)(2013-1#1)
that summarizes##2##2##(1996-3#1)(2008-10#1)
that superoxide##2##2##(1995-8#1)(2008-5#1)
that supervised##2##2##(1995-3#1)(2009-7#1)
that supplementary##2##2##(2007-11#1)(2010-2#1)
that supplementation##2##2##(1995-6#1)(2008-12#1)
that supplies##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
that supply the##2##3##(2007-12#1)(2008-7#1)
that supply##6##2##(2007-12#2)(2008-7#1)(2008-9#1)(2012-12#2)
that support the##7##3##(1991-6#1)(1992-1#1)(1996-2#1)(2006-10#1)(2008-12#1)(2008-5#1)(2013-7#1)
that support##24##2##(1991-6#1)(1992-1#1)(1992-2#1)(1994-3#1)(1994-9#1)(1996-2#2)(1996-3#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
that supported##2##2##(1996-3#1)(2010-12#1)
that supports the use of##2##5##(2008-10#1)(2008-3#1)
that supports the##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
that supports##10##2##(1992-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-1#1)
that suppress fire blight##2##4##(2008-10#2)
that suppress the##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
that suppress##9##2##(1992-12#1)(1994-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2012-12#1)(2013-8#1)
that suppresses##3##2##(1997-8#1)(2008-10#2)
that suppression of##5##3##(2008-10#3)(2008-11#2)
that suppression##7##2##(2008-10#5)(2008-11#2)
that suprathreshold##2##2##(2008-9#1)(2011-2#1)
that surface##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-2#1)(2013-8#1)
that surfaces##2##2##(2008-10#1)(2008-3#1)
that surfactant##4##2##(1994-5#1)(1997-2#1)(2008-10#2)
that surgeons##2##2##(2008-4#1)(2009-1#1)
that surgery can##2##3##(1992-5#1)(2011-2#1)
that surgery##4##2##(1992-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
that surgical treatment##2##3##(1992-9#1)(2010-12#1)
that surgical##6##2##(1992-9#1)(1993-9#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
that surround##3##2##(1991-5#1)(1994-9#1)(2008-12#1)
that surrounds the##3##3##(2007-12#2)(2008-7#1)
that surrounds##4##2##(2007-12#3)(2008-7#1)
that survey##2##2##(1994-1#1)(1997-1#1)
that surveys##2##2##(1993-9#1)(1996-3#1)
that survival##5##2##(1990-9#1)(1995-9#1)(1996-12#1)(2008-7#1)(2009-4#1)
that survive##2##2##(2008-10#1)(2013-7#1)
that survived##2##2##(1995-2#1)(2008-10#1)
that susceptibility##2##2##(2007-6#1)(2011-2#1)
that sustain##2##2##(2008-4#1)(2010-5#1)
that sustained##4##2##(1995-11#1)(1996-5#1)(2008-11#1)(2009-8#1)
that sustains##2##2##(2008-11#1)(2008-12#1)
that symptom##2##2##(1996-5#1)(2008-10#1)
that symptomless##2##2##(2008-10#2)
that symptoms of##2##3##(2008-10#1)(2008-2#1)
that symptoms##5##2##(2008-10#3)(2008-2#1)(2010-11#1)
that synaptic##2##2##(1993-12#1)(2008-11#1)
that synchronization##2##2##(2007-9#1)(2009-8#1)
that synthesis of##2##3##(1991-2#1)(1993-12#1)
that synthesized##2##2##(2008-10#1)(2008-6#1)
that synthesizes a##2##3##(1997-4#1)(2007-12#1)
that synthesizes##4##2##(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)
that system##5##2##(1992-3#1)(1995-2#1)(1997-3#1)(2007-4#1)(2008-10#1)
that systematic##3##2##(2008-2#1)(2010-1#1)(2011-1#1)
that systematically##2##2##(1996-3#1)(2008-10#1)
that systemic##6##2##(1995-2#1)(1997-2#1)(2008-10#3)(2012-2#1)
that systemically administered##3##3##(1993-12#3)
that systems##3##2##(1995-2#1)(2008-3#1)(2012-2#1)
that systolic##2##2##(2008-7#1)(2010-7#1)
that tacrine##2##2##(1996-9#2)
that take into account##4##4##(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
that take into consideration##2##4##(2008-1#1)(2008-9#1)
that take into##6##3##(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)
that take place during##2##4##(2008-10#1)(2012-12#1)
that take place in the##3##5##(2008-3#1)(2009-12#1)(2009-3#1)
that take place##5##3##(2008-10#1)(2008-3#1)(2009-12#1)(2009-3#1)(2012-12#1)
that take##11##2##(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
that takes advantage of the##2##5##(2008-3#1)(2008-4#1)
that takes into account the##3##5##(2008-3#2)(2009-2#1)
that takes into account##8##4##(2008-2#2)(2008-3#3)(2008-8#1)(2009-2#1)(2010-3#1)
that takes##17##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-8#1)(2009-2#1)(2010-3#1)(2012-3#1)(2013-8#1)
that target the##2##3##(2013-1#1)(2013-8#1)
that target##16##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
that targeted##8##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
that targeting##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
that targets of##2##3##(2008-11#2)
that targets the##4##3##(1993-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
that targets these##2##3##(1993-1#1)(2011-1#1)
that targets##12##2##(1993-1#1)(1993-11#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
that task##2##2##(1991-2#1)(2008-4#1)
that taste##3##2##(1993-9#1)(2008-7#1)(2013-1#1)
that tat##2##2##(1994-11#2)
that teachers##2##2##(2008-12#1)(2013-1#1)
that technique##2##2##(2008-10#1)(2011-2#1)
that technology##2##2##(1997-1#1)(2008-7#1)
that teliospores##2##2##(2008-10#2)
that telomeres##2##2##(2008-11#1)(2011-2#1)
that temperature##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2013-7#1)
that temporal##2##2##(2008-8#1)(2011-2#1)
that temporally##2##2##(1995-2#1)(2008-3#1)
that tends to##2##3##(1994-6#1)(2011-2#1)
that terminate in##2##3##(1996-7#1)(2007-12#1)
that terminates the##2##3##(1997-4#1)(2012-3#1)
that territorial##2##2##(2008-8#2)
that test##2##2##(2008-7#1)(2012-1#1)
that tested##5##2##(1994-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-9#1)
that testing##2##2##(1993-6#1)(2009-2#1)
that testosterone##5##2##(1995-12#1)(1996-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
that that the##4##3##(2007-11#1)(2008-8#1)(2010-10#1)(2013-8#1)
that that##8##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-8#1)
that the &quot##11##3##(1990-12#1)(1991-1#1)(1992-11#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-7#1)(2013-8#1)
that the 1##3##3##(1990-12#1)(1997-4#1)(2008-2#1)
that the 12##2##3##(2008-10#1)(2013-8#1)
that the 14-kDa##2##3##(1991-12#1)(1995-6#1)
that the 175R##2##3##(1993-2#2)
that the 2##4##3##(1990-8#1)(2008-10#2)(2008-8#1)
that the 5##2##3##(2008-10#1)(2008-8#1)
that the 75 kDa protein is##2##6##(1990-8#1)(2008-7#1)
that the ASC-DHA pair##2##4##(2008-11#2)
that the ATP##2##3##(1990-5#1)(1994-6#1)
that the ATPase and histone kinase##2##6##(1992-6#2)
that the ATPase##4##3##(1991-2#1)(1992-6#3)
that the American##3##3##(1995-6#1)(2008-3#1)(2011-1#1)
that the B##4##3##(1992-12#1)(1997-2#1)(2007-12#1)(2008-10#1)
that the BBB##2##3##(2008-7#1)(2008-8#1)
that the Black Death##2##4##(1990-6#2)
that the C##4##3##(2008-10#2)(2008-11#1)(2010-11#1)
that the C-terminal portion of the##2##6##(1994-8#1)(1996-5#1)
that the C-terminal portion of##3##5##(1990-12#1)(1994-8#1)(1996-5#1)
that the C-terminal##9##3##(1990-12#1)(1990-7#1)(1991-5#1)(1993-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-8#1)(2008-9#1)
that the COOH-terminal##2##3##(1991-12#1)(1992-8#1)
that the CUL3-KLHL18 ligase##2##4##(2012-12#2)
that the Chief Medical Officer##2##5##(1993-3#2)
that the Chinese##2##3##(2007-12#1)(2011-3#1)
that the DNA##7##3##(1993-3#1)(1993-8#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#2)
that the DNA-binding##2##3##(1991-12#1)(2008-9#1)
that the DPH2 gene##2##4##(1993-9#2)
that the E##2##3##(2008-7#1)(2009-8#1)
that the EAP##2##3##(1992-10#1)(1995-6#1)
that the ELISA##2##3##(2008-10#2)
that the European##2##3##(2008-10#1)(2009-2#1)
that the G##2##3##(1993-9#1)(2008-10#1)
that the Glu-50--&gt##2##3##(1995-6#2)
that the H(2)O(2) system containing Cu(2+)##2##6##(2008-10#2)
that the H-Wave(R) device##3##4##(2010-1#3)
that the HC-Pro##2##3##(2008-10#2)
that the HIV##2##3##(1996-5#1)(2009-4#1)
that the ILS##2##3##(2008-10#2)
that the IR##2##3##(2007-12#1)(2013-8#1)
that the Internet##4##3##(1996-5#1)(2007-12#1)(2008-12#1)(2009-5#1)
that the Kd values##2##4##(1994-8#1)(2008-8#1)
that the Kobs##2##3##(1995-2#2)
that the LDH##2##3##(2008-11#1)(2010-4#1)
that the LRNB##2##3##(2008-3#2)
that the MAF##3##3##(2010-11#1)(2011-1#2)
that the MNS is##2##4##(2008-11#2)
that the N##2##3##(1993-2#1)(2008-10#1)
that the N-terminal domain of##2##5##(1992-3#1)(2008-9#1)
that the N-terminal##10##3##(1991-5#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-9#1)(2010-10#1)
that the NADH##2##3##(2008-10#1)(2008-11#1)
that the NFL theorems##3##4##(2010-3#3)
that the NH2-terminal##2##3##(1991-2#1)(1997-1#1)
that the NR##2##3##(1993-6#1)(2010-9#1)
that the Na##2##3##(1994-8#2)
that the P##4##3##(1993-11#1)(2008-10#2)(2008-5#1)
that the PANI##2##3##(2008-10#2)
that the PMD##2##3##(2007-11#2)
that the P[1##2##3##(1991-3#2)
that the Pdx-1##2##3##(2010-11#2)
that the QTL##2##3##(2008-10#2)
that the R##4##3##(1993-6#1)(2008-10#3)
that the RGD##2##3##(1995-6#1)(2008-7#1)
that the RNA integrity##2##4##(2008-7#1)(2009-12#1)
that the RNA##4##3##(1997-7#2)(2008-7#1)(2009-12#1)
that the RR##2##3##(2008-10#2)
that the RT-PCR##2##3##(2008-10#1)(2008-5#1)
that the RpoN sigma factor##2##5##(1993-12#2)
that the S##4##3##(2007-12#1)(2007-6#1)(2008-10#2)
that the S-dsRNA was##2##4##(2008-10#2)
that the SERS##2##3##(2013-1#1)(2013-8#1)
that the SLN##2##3##(2008-10#1)(2008-5#1)
that the Ser##2##3##(1992-3#2)
that the Span80-CPL##2##3##(2008-11#2)
that the T##3##3##(1990-11#1)(1997-8#1)(2008-10#1)
that the TPA-induced##2##3##(1990-2#1)(2012-3#1)
that the U##2##3##(2008-10#2)
that the VLO is##2##4##(1994-3#2)
that the VLO##3##3##(1994-3#3)
that the ZFPOU1 transcripts##2##4##(1992-9#2)
that the ability of the##3##5##(2008-10#1)(2008-9#1)(2009-12#1)
that the ability of##13##4##(1992-12#1)(1995-2#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)
that the ability to##8##4##(1990-11#1)(1990-12#1)(1991-2#1)(1992-10#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-12#1)
that the ability##21##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
that the abnormal##3##3##(1991-12#1)(2008-11#1)(2008-8#1)
that the abomasum##2##3##(2011-2#2)
that the above##5##3##(1991-1#1)(1991-6#1)(1994-9#1)(2008-10#1)(2009-11#1)
that the absence of##7##4##(1995-12#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
that the absolute##2##3##(1995-3#1)(2008-3#1)
that the absorbance##2##3##(2008-10#1)(2011-1#1)
that the absorption and scattering##3##5##(2008-3#2)(2009-12#1)
that the absorption##9##3##(2008-2#3)(2008-3#3)(2008-8#1)(2009-12#1)(2011-3#1)
that the abundance of##2##4##(1994-11#1)(2010-8#1)
that the accumulation of##2##4##(2008-10#1)(2008-7#1)
that the accumulation##3##3##(2008-10#2)(2008-7#1)
that the accuracy of the##4##5##(2008-3#3)(2010-5#1)
that the accuracy of##7##4##(2008-10#1)(2008-3#4)(2010-5#1)(2013-8#1)
that the accuracy##8##3##(2007-11#1)(2008-10#1)(2008-3#4)(2010-5#1)(2013-8#1)
that the acetylation of tyrosine 252##2##6##(2008-4#2)
that the actin cytoskeleton##2##4##(2008-11#1)(2008-9#1)
that the actin##4##3##(1990-12#1)(1992-3#1)(2008-11#1)(2008-9#1)
that the actin-based##2##3##(2008-10#2)
that the action of##4##4##(1991-9#1)(1994-6#1)(2008-2#1)(2008-9#1)
that the activation barrier for hydrogen desorption##2##7##(2008-10#2)
that the activation of the##3##5##(1995-2#1)(1997-2#2)
that the activation of##8##4##(1993-6#1)(1995-2#1)(1997-2#3)(2006-6#1)(2008-8#1)(2012-2#1)
that the activation##11##3##(1993-6#1)(1995-2#1)(1997-2#3)(2006-6#1)(2008-10#3)(2008-8#1)(2012-2#1)
that the active site is in the##2##7##(1992-5#2)
that the active site##3##4##(1992-5#2)(2008-4#1)
that the active##10##3##(1990-5#1)(1991-11#1)(1992-5#2)(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
that the activity is a##2##5##(1990-8#1)(2009-2#1)
that the activity is##3##4##(1990-8#1)(1994-2#1)(2009-2#1)
that the activity of the##3##5##(1997-6#1)(2007-7#1)(2008-9#1)
that the activity of##8##4##(1992-2#1)(1997-2#2)(1997-6#1)(2007-7#1)(2008-9#2)(2012-3#1)
that the activity##14##3##(1990-8#1)(1992-2#1)(1993-2#1)(1994-2#1)(1997-2#2)(1997-6#1)(2007-7#1)(2008-11#1)(2008-9#2)(2009-2#1)(2012-3#1)(2013-1#1)
that the actual##5##3##(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-1#1)
that the acute##3##3##(1994-8#1)(1996-5#1)(2008-10#1)
that the addition of a##2##5##(1996-7#1)(2008-5#1)
that the addition of##13##4##(1996-7#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
that the addition##14##3##(1996-7#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
that the additional##4##3##(1994-5#1)(1997-4#1)(2007-11#1)(2007-8#1)
that the adipose eyelid##2##4##(2010-8#2)
that the adipose##3##3##(2010-8#3)
that the administration of##6##4##(1994-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
that the adsorption of##2##4##(2008-10#2)
that the adsorption##5##3##(2008-10#5)
that the adult##2##3##(1993-12#1)(2007-12#1)
that the adults##2##3##(1996-1#1)(2007-12#1)
that the advantages##2##3##(1997-6#1)(2008-1#1)
that the affinity of##3##4##(1990-7#1)(1990-8#1)(1993-6#1)
that the affinity##6##3##(1990-7#1)(1990-8#3)(1993-6#1)(1994-6#1)
that the age##2##3##(1996-3#1)(2008-10#1)
that the age-related##2##3##(2008-7#1)(2011-2#1)
that the agents##2##3##(1992-8#1)(2008-10#1)
that the algorithm is##2##4##(2008-10#1)(2008-2#1)
that the algorithm##5##3##(2008-10#2)(2008-2#3)
that the alkyl##2##3##(2008-11#1)(2008-5#1)
that the alpha##2##3##(1990-8#1)(1996-12#1)
that the alteration in##2##4##(1993-3#1)(2008-8#1)
that the alteration of##3##4##(1991-12#1)(2008-8#1)(2008-9#1)
that the alteration##5##3##(1991-12#1)(1993-3#1)(2008-8#2)(2008-9#1)
that the alternative##3##3##(2008-8#1)(2009-8#1)(2013-1#1)
that the amide-(15)N CSA tensor##3##5##(2008-5#3)
that the amino acid##2##4##(1997-2#1)(2008-10#1)
that the amino##5##3##(1991-2#1)(1991-8#2)(1997-2#1)(2008-10#1)
that the amount of##13##4##(1993-9#1)(2008-10#4)(2008-11#2)(2008-6#3)(2008-8#1)(2009-7#1)(2012-2#1)
that the amount##15##3##(1990-5#1)(1993-9#1)(2008-10#4)(2008-11#2)(2008-6#3)(2008-8#2)(2009-7#1)(2012-2#1)
that the amounts of##4##4##(1994-11#1)(2008-10#1)(2008-12#2)
that the amygdala##4##3##(1993-12#1)(1993-6#2)(2013-8#1)
that the analysis of##3##4##(2008-10#3)
that the analysis##7##3##(1990-7#1)(2008-10#5)(2008-3#1)
that the angiogenic##2##3##(1990-4#1)(1992-3#1)
that the animal##2##3##(2008-11#1)(2008-4#1)
that the anisotropic##2##3##(2008-3#2)
that the annual##2##3##(1995-3#1)(1996-11#1)
that the antagonist##2##3##(2008-10#2)
that the antagonistic##2##3##(2008-10#2)
that the antibody##6##3##(1995-2#1)(2008-10#1)(2008-8#1)(2013-1#3)
that the antifungal##4##3##(1992-11#1)(2008-10#2)(2009-2#1)
that the antigenic##2##3##(1990-8#1)(2011-1#1)
that the antinociceptive##2##3##(1996-2#1)(2008-11#1)
that the antioxidant##5##3##(1992-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
that the antioxidative property of##2##5##(2008-11#2)
that the apparent##3##3##(1995-6#1)(2008-10#1)(2009-8#1)
that the appearance of##2##4##(1997-8#1)(2008-6#1)
that the applicability of##2##4##(2008-10#2)
that the application of the##2##5##(2008-10#1)(2008-3#1)
that the application of##9##4##(1991-5#1)(2008-10#5)(2008-11#1)(2008-3#2)
that the applied##3##3##(2008-10#2)(2008-5#1)
that the approach to##2##4##(2008-7#1)(2008-8#1)
that the approach##7##3##(1992-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#2)
that the approximation##3##3##(1997-4#1)(2007-12#1)(2008-3#1)
that the area##4##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
that the assay is##2##4##(2010-2#1)(2011-3#1)
that the assay##5##3##(1990-12#1)(1992-9#1)(2008-10#1)(2010-2#1)(2011-3#1)
that the assessment of##2##4##(1990-8#1)(1994-6#1)
that the association between##3##4##(2009-7#1)(2009-8#1)(2013-1#1)
that the association of##6##4##(1992-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
that the association##11##3##(1992-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2013-1#1)(2013-7#1)
that the assumption of a linear increase in risk with increasing dose in##2##13##(2008-7#2)
that the assumption of##3##4##(2008-6#1)(2008-7#2)
that the asymptotic##3##3##(1994-2#1)(2008-3#1)(2010-1#1)
that the atomic##2##3##(2007-12#1)(2008-7#1)
that the attenuation##2##3##(2008-3#2)
that the augmentation of##2##4##(1992-8#1)(1995-12#1)
that the authors##3##3##(1996-12#1)(2008-4#1)(2008-7#1)
that the availability of##2##4##(2008-10#1)(2008-3#1)
that the available##2##3##(2008-5#1)(2013-7#1)
that the average##16##3##(1994-6#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
that the avian##2##3##(1993-6#1)(1995-12#1)
that the axillary##2##3##(2008-5#2)
that the aziridine##2##3##(1991-5#2)
that the background##4##3##(1991-12#1)(2008-3#2)(2008-5#1)
that the backscattering##2##3##(2008-3#2)
that the bacterial##4##3##(1994-6#1)(1995-2#1)(2008-10#1)(2008-12#1)
that the bacterium##2##3##(1990-11#1)(1996-11#1)
that the balance of##2##4##(1992-3#1)(2008-8#1)
that the balance##4##3##(1992-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
that the barrier function##2##4##(2008-5#1)(2008-7#1)
that the barrier##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
that the basal ganglia##3##4##(1994-3#1)(1997-3#1)(2009-10#1)
that the basal##7##3##(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)
that the basic##6##3##(1990-2#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
that the bcl-2##2##3##(1993-3#1)(1994-10#1)
that the behavior of the##2##5##(2008-10#1)(2008-2#1)
that the behavior of##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
that the behavior##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
that the behavioral##2##3##(1997-2#1)(2008-10#1)
that the behaviour of##2##4##(2008-10#1)(2011-2#1)
that the beneficial##2##3##(1992-7#1)(2008-10#1)
that the benefit##2##3##(1995-12#1)(2011-2#1)
that the benefits of the##2##5##(1992-12#1)(1996-8#1)
that the benefits##3##3##(1992-12#1)(1996-8#1)(2012-2#1)
that the best results are obtained##2##6##(2008-10#1)(2008-3#1)
that the best##20##3##(1991-3#1)(1992-2#1)(1995-12#1)(1995-5#1)(1996-3#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
that the bilaterally##2##3##(2007-12#1)(2008-5#1)
that the binding of##9##4##(1990-8#1)(1991-9#1)(1993-9#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
that the binding site##2##4##(2008-11#1)(2008-8#1)
that the binding##20##3##(1990-11#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-9#1)(1995-2#3)(1995-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#4)
that the biocontrol##2##3##(2008-10#2)
that the biological##6##3##(1990-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
that the blockade of##3##4##(1990-5#1)(1992-12#1)(2013-1#1)
that the blood##3##3##(1991-7#1)(1992-4#1)(2008-8#1)
that the boron atom is##2##5##(1993-11#2)
that the botanical##2##3##(2008-10#2)
that the bound##2##3##(1990-2#1)(1993-11#1)
that the brain is##2##4##(1994-5#1)(2008-11#1)
that the brain##3##3##(1994-5#1)(2008-11#2)
that the bulk of##2##4##(1990-12#1)(2008-12#1)
that the burden of##2##4##(1996-11#1)(2012-3#1)
that the burden##3##3##(1993-3#1)(1996-11#1)(2012-3#1)
that the cAMP##2##3##(1993-3#1)(2008-11#1)
that the cDNA##6##3##(1990-12#1)(1993-6#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-8#1)
that the calculated##3##3##(1991-3#1)(2008-10#2)
that the campaign##2##3##(1995-1#2)
that the capacity of the##3##5##(1995-11#1)(1995-2#1)(2008-3#1)
that the capacity to##2##4##(1991-5#1)(2008-1#1)
that the capacity##6##3##(1991-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-3#1)
that the carbonyl##2##3##(1992-6#1)(2008-10#1)
that the carboxyl groups##2##4##(2008-10#2)
that the carboxyl##3##3##(1992-7#1)(2008-10#2)
that the cardiac##6##3##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(2008-10#1)(2012-3#1)
that the catalytic##4##3##(1992-12#1)(1997-3#1)(2008-10#1)(2009-9#1)
that the cationic##2##3##(1994-12#1)(2008-5#1)
that the cause of the##2##5##(2008-10#1)(2011-2#1)
that the cause of##8##4##(2008-1#1)(2008-10#2)(2011-2#3)(2013-1#2)
that the cell density##2##4##(2008-11#1)(2012-1#1)
that the cell##12##3##(1990-2#1)(1992-9#1)(1997-1#1)(1997-3#1)(2008-11#4)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)
that the cells##5##3##(1990-7#1)(1992-6#1)(1996-2#1)(2008-11#1)(2008-9#1)
that the central##2##3##(1997-5#1)(2008-5#1)
that the cerebellum participates in##2##5##(2007-8#2)
that the cerebellum##5##3##(1991-1#1)(2007-8#4)
that the change in##3##4##(1990-8#1)(1991-5#1)(2009-5#1)
that the change##5##3##(1990-8#2)(1991-5#1)(2009-5#1)(2012-12#1)
that the changes in##5##4##(1992-1#1)(1993-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
that the characteristic##2##3##(2008-10#2)
that the charge##3##3##(2008-10#2)(2008-8#1)
that the child##2##3##(1990-12#1)(2010-8#1)
that the children##3##3##(2007-8#1)(2008-4#1)(2008-9#1)
that the chromosome##2##3##(2008-8#1)(2012-3#1)
that the classical##2##3##(2008-4#1)(2008-6#1)
that the clinical##6##3##(1992-3#1)(1997-8#1)(2008-3#1)(2012-12#1)(2013-1#2)
that the clone##2##3##(2008-8#2)
that the cloned##2##3##(1992-3#1)(1993-8#1)
that the close##2##3##(2008-10#2)
that the closest##2##3##(2008-10#1)(2010-11#1)
that the coding##2##3##(1993-2#1)(2008-12#1)
that the coherence##2##3##(2007-11#1)(2007-12#1)
that the cold##2##3##(1994-12#1)(2009-8#1)
that the collagen##2##3##(1991-9#1)(2008-10#1)
that the collection##2##3##(1996-10#1)(2008-10#1)
that the colonization##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
that the color##2##3##(2008-3#2)
that the combination of##20##4##(1990-8#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-1#3)(2013-8#1)
that the combination##22##3##(1990-8#1)(1995-5#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-1#3)(2013-8#1)
that the combined##5##3##(1991-7#1)(1993-9#1)(2007-12#1)(2008-3#1)(2009-12#1)
that the common##7##3##(1990-11#1)(1991-8#1)(1995-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)
that the commonly used##3##4##(1992-6#1)(2008-3#1)(2013-1#1)
that the community can##2##4##(2008-11#1)(2011-2#1)
that the community##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
that the complete resistance to subgroup##2##6##(2008-10#2)
that the complete##7##3##(1990-5#1)(1992-12#1)(1995-5#1)(2008-10#3)(2008-3#1)
that the complex##9##3##(1992-11#2)(1993-8#1)(1994-5#1)(1996-2#2)(2008-10#3)
that the complexation##3##3##(2008-10#3)
that the complexes are##2##4##(1995-5#1)(2009-8#1)
that the complexes##3##3##(1991-9#1)(1995-5#1)(2009-8#1)
that the complication##2##3##(2010-8#1)(2011-2#1)
that the component##3##3##(1995-2#2)(2012-1#1)
that the components of the##3##5##(2007-12#2)(2008-3#1)
that the components of##4##4##(2007-12#2)(2008-12#1)(2008-3#1)
that the composite nanofiber mat##2##5##(2009-11#2)
that the composite##4##3##(2007-12#2)(2009-11#2)
that the composition of the##2##5##(2008-10#1)(2008-8#1)
that the composition of##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
that the compounds##4##3##(1991-12#1)(1992-12#1)(2008-10#1)(2012-3#1)
that the computed##2##3##(2008-2#1)(2010-2#1)
that the concentration of##5##4##(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
that the concentration##7##3##(1997-2#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
that the concentrations of##5##4##(1996-4#1)(2008-10#2)(2011-2#1)(2012-1#1)
that the concept of##4##4##(1992-12#1)(2007-8#1)(2011-2#1)(2012-2#1)
that the concept##5##3##(1992-12#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
that the condition##3##3##(2007-11#1)(2008-1#1)(2008-8#1)
that the conditions for##2##4##(2008-11#1)(2008-8#1)
that the conditions##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that the conformation of the##2##5##(1997-4#1)(2008-8#1)
that the conformation of##6##4##(1994-6#1)(1997-4#1)(2008-10#3)(2008-8#1)
that the conformation##7##3##(1992-6#1)(1994-6#1)(1997-4#1)(2008-10#3)(2008-8#1)
that the conformational##2##3##(1990-7#1)(1992-8#1)
that the constitutive##2##3##(2012-12#1)(2013-1#1)
that the consumption##2##3##(2008-1#1)(2008-10#1)
that the content of##2##4##(2008-10#2)
that the continuous##3##3##(2007-6#1)(2008-10#1)(2009-8#1)
that the contribution of the##2##5##(1990-8#1)(1991-5#1)
that the contribution of##6##4##(1990-8#1)(1991-5#1)(2008-10#1)(2008-3#2)(2008-6#1)
that the control group##2##4##(2007-10#1)(2010-6#1)
that the control of the##2##5##(1997-3#1)(2009-8#1)
that the control of##4##4##(1997-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
that the control##8##3##(1997-3#1)(2007-10#1)(2008-8#2)(2009-8#1)(2010-4#1)(2010-6#1)(2012-2#1)
that the conversion##3##3##(2007-12#1)(2008-2#1)(2009-12#1)
that the core protein##2##4##(1990-12#1)(2008-8#1)
that the core##5##3##(1990-12#1)(1992-8#1)(1994-5#1)(2007-10#1)(2008-8#1)
that the correct diagnosis was##2##5##(1990-12#1)(1997-5#1)
that the correct##3##3##(1990-12#1)(1997-5#1)(2010-8#1)
that the correlation between##2##4##(1996-5#1)(2008-5#1)
that the correlation##6##3##(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)
that the corresponding##5##3##(1991-2#1)(1997-7#1)(2007-11#1)(2008-3#2)
that the cost of##2##4##(2008-8#1)(2010-8#1)
that the coupler has##2##4##(2008-2#2)
that the coupler##3##3##(2007-11#1)(2008-2#2)
that the coupling##2##3##(2008-3#2)
that the course##3##3##(1990-11#1)(2010-7#1)(2012-12#1)
that the court##2##3##(1990-11#2)
that the criteria##2##3##(2010-2#2)
that the critical##2##3##(1993-11#1)(2012-3#1)
that the crystal##4##3##(1996-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
that the current##15##3##(1993-3#2)(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
that the cyst##2##3##(2007-8#1)(2008-5#1)
that the cysteines##2##3##(1991-2#1)(1994-11#1)
that the cytoplasm of teosinte##3##5##(2008-5#3)
that the cytoplasm##4##3##(1991-11#1)(2008-5#3)
that the cytoplasmic##2##3##(1997-7#1)(2008-9#1)
that the data are##3##4##(1990-8#1)(1992-2#1)(1994-2#1)
that the data from##4##4##(1992-11#1)(2008-10#1)(2008-6#1)(2010-6#1)
that the data##16##3##(1990-8#1)(1992-11#2)(1992-2#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
that the decision##2##3##(2010-2#1)(2010-8#1)
that the decrease in##5##4##(1993-12#2)(1993-9#1)(1997-2#1)(2013-1#1)
that the decrease##6##3##(1993-12#2)(1993-9#1)(1997-2#1)(2008-8#1)(2013-1#1)
that the decreased##5##3##(1992-6#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-3#1)
that the deduced##3##3##(1994-12#1)(2008-2#1)(2008-9#1)
that the deer##2##3##(2013-7#2)
that the defects##2##3##(2008-10#1)(2008-4#1)
that the degeneracy##2##3##(1995-5#1)(2008-8#1)
that the degradation##3##3##(1991-5#1)(2008-3#1)(2009-11#1)
that the degree and##2##4##(2008-11#1)(2008-9#1)
that the degree of##6##4##(1990-12#1)(1992-9#1)(1993-3#1)(1994-8#1)(2011-1#1)(2013-1#1)
that the degree##8##3##(1990-12#1)(1992-9#1)(1993-3#1)(1994-8#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-1#1)
that the delay##3##3##(1996-2#1)(1997-2#2)
that the delivered dose##2##4##(1996-2#2)
that the delivered##3##3##(1996-2#2)(2008-11#1)
that the demographic##2##3##(1995-2#1)(2008-7#1)
that the density effect on spore production##2##7##(2008-10#2)
that the density of##2##4##(1994-5#1)(1996-5#1)
that the density##5##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-6#1)
that the dependence of##3##4##(2007-11#1)(2008-2#2)
that the deposit##2##3##(1995-12#1)(2008-10#1)
that the described##2##3##(1997-2#1)(2008-11#1)
that the design##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
that the designed##2##3##(1991-9#1)(2008-3#1)
that the desired##4##3##(1997-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
that the details of the##2##5##(2008-7#1)(2008-8#1)
that the detected##3##3##(2008-2#3)
that the detection limit##2##4##(2008-10#1)(2008-11#1)
that the detection of##2##4##(2008-10#1)(2008-7#1)
that the detection##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
that the detector##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
that the developed method##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
that the developed##7##3##(2008-10#3)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
that the development of##3##4##(1990-8#1)(1994-9#1)(2010-7#1)
that the development##4##3##(1990-8#1)(1994-9#1)(2008-5#1)(2010-7#1)
that the developmental##2##3##(1996-5#1)(2007-12#1)
that the device was##2##4##(2008-11#1)(2012-3#1)
that the device##5##3##(2008-11#2)(2008-2#1)(2009-5#1)(2012-3#1)
that the diagnosis##2##3##(1997-8#1)(2008-7#1)
that the difference in the##3##5##(1994-12#1)(2008-2#2)
that the difference in##6##4##(1993-12#1)(1994-12#1)(1995-3#1)(2008-2#2)(2008-5#1)
that the difference of##2##4##(2008-11#1)(2010-7#1)
that the difference##10##3##(1993-12#1)(1994-12#1)(1995-3#1)(2008-11#2)(2008-2#3)(2008-5#1)(2010-7#1)
that the differences between the##2##5##(2008-10#1)(2013-8#1)
that the differences in##6##4##(1995-8#1)(2008-11#1)(2008-2#1)(2009-8#1)(2012-2#1)(2012-3#1)
that the differences##10##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-1#1)(2009-11#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
that the different##15##3##(1993-8#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2010-2#1)
that the differential##5##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
that the differentiation##2##3##(1993-6#1)(2008-9#1)
that the diffusion##2##3##(2008-10#1)(2008-3#1)
that the digestion##3##3##(2008-10#3)
that the direct##3##3##(2008-10#2)(2009-11#1)
that the direction##2##3##(2007-11#1)(2008-8#1)
that the disease is##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
that the disease was##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
that the disease##9##3##(1996-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
that the disorder##2##3##(2008-12#1)(2008-7#1)
that the displacement##2##3##(2008-3#2)
that the distal##2##3##(1991-6#1)(2007-12#1)
that the distribution of the##4##5##(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
that the distribution of##12##4##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
that the distribution##13##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
that the district##2##3##(1997-6#1)(2010-8#1)
that the disulfide##2##3##(1993-11#1)(1994-9#1)
that the domain##2##3##(1994-12#1)(2008-10#1)
that the dominant contribution to##2##5##(2007-12#1)(2008-3#1)
that the dominant##10##3##(1994-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-12#1)
that the dopaminergic##2##3##(2007-10#1)(2009-6#1)
that the dose##2##3##(2008-10#1)(2008-7#1)
that the dosing time##2##4##(2008-8#2)
that the double##2##3##(1996-5#1)(2008-5#1)
that the downstream##2##3##(1994-11#1)(2008-9#1)
that the drug is##2##4##(1991-5#1)(2008-10#1)
that the drug was##2##4##(2008-5#1)(2010-5#1)
that the drug##9##3##(1991-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#3)(2010-5#1)
that the duration of the##5##5##(1991-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
that the duration of##6##4##(1991-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
that the dynamic##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
that the dynamics of the##2##5##(2007-12#1)(2008-8#1)
that the dynamics of##5##4##(1997-1#1)(2007-12#1)(2008-8#2)(2008-9#1)
that the dynamics##7##3##(1997-1#1)(2007-12#1)(2008-8#4)(2008-9#1)
that the earlier##2##3##(1992-8#1)(2008-11#1)
that the early##9##3##(1990-11#1)(1992-3#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
that the eel##2##3##(2008-5#2)
that the efe gene##4##4##(2008-10#4)
that the effect of aging on the##2##7##(2008-7#2)
that the effect of the##5##5##(1992-6#1)(1995-12#1)(2008-10#2)(2008-2#1)
that the effect of##31##4##(1990-11#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#5)(2009-12#1)(2010-8#1)(2012-2#1)
that the effect was##2##4##(1992-8#1)(2008-11#1)
that the effect##36##3##(1990-11#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#5)(2009-12#1)(2010-8#1)(2012-2#1)
that the effective##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
that the effectiveness of##3##4##(1992-5#1)(1992-9#1)(2013-8#1)
that the effects of OP-1##2##5##(1994-6#2)
that the effects of these##2##5##(1990-7#1)(2008-4#1)
that the effects of##29##4##(1990-7#1)(1992-2#1)(1992-3#1)(1994-6#2)(1994-9#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
that the effects were not##2##5##(1991-1#1)(1994-2#1)
that the effects##36##3##(1990-7#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-6#2)(1994-9#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
that the efficacy of the##2##5##(2008-1#1)(2008-6#1)
that the efficacy of##5##4##(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-5#1)
that the efficiency of the##2##5##(2007-11#1)(2009-10#1)
that the efficiency of##3##4##(1993-3#1)(2007-11#1)(2009-10#1)
that the efficiency##5##3##(1993-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-10#1)
that the electric##2##3##(2009-12#1)(2013-8#1)
that the electrical##2##3##(1990-5#1)(2009-8#1)
that the electrode potential##2##4##(2008-10#2)
that the electrode##8##3##(2008-10#8)
that the electrodes##2##3##(2008-10#1)(2008-3#1)
that the electron transfer##2##4##(1991-8#1)(2008-10#1)
that the element##2##3##(1995-2#1)(2008-2#1)
that the elevated##3##3##(1990-8#1)(1995-12#1)(2008-5#1)
that the embryo##2##3##(1994-9#1)(2008-10#1)
that the embryonic##2##3##(2008-8#2)
that the emergence of##3##4##(2008-6#1)(2009-2#1)(2010-3#1)
that the endogenous##4##3##(1990-5#1)(1995-6#1)(2008-5#1)(2008-7#1)
that the endometrium##2##3##(1991-3#1)(2012-3#1)
that the energy##3##3##(2008-2#1)(2008-8#1)(2009-5#1)
that the enhanced##6##3##(1990-5#1)(2008-10#4)(2008-5#1)
that the enhancement in##2##4##(2008-3#1)(2008-7#1)
that the enhancement of##3##4##(1992-8#1)(2008-10#2)
that the enhancement##5##3##(1992-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
that the entire##5##3##(2008-10#2)(2008-11#1)(2009-9#1)(2010-3#1)
that the environmental##4##3##(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#1)
that the enzymatic##3##3##(1990-7#1)(1996-2#1)(2008-10#1)
that the enzyme is##2##4##(1992-9#1)(2008-9#1)
that the enzyme was##3##4##(1990-7#1)(1991-5#1)(1991-8#1)
that the enzyme##13##3##(1990-7#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
that the equilibrium##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
that the error in##2##4##(2008-2#2)
that the error##9##3##(1997-2#1)(2008-2#4)(2008-3#2)(2009-4#1)(2012-3#1)
that the event will##2##4##(2008-10#2)
that the evolution of##3##4##(2008-8#2)(2012-3#1)
that the evolution##4##3##(2008-8#2)(2008-9#1)(2012-3#1)
that the evolutionarily stable##2##4##(2008-8#1)(2008-9#1)
that the evolutionarily##3##3##(1994-8#1)(2008-8#1)(2008-9#1)
that the evolutionary##3##3##(2008-10#2)(2010-4#1)
that the exact##2##3##(2008-10#1)(2008-3#1)
that the excellent##2##3##(2008-10#2)
that the exchange##2##3##(1995-2#1)(2008-10#1)
that the existence of##5##4##(1997-2#1)(2008-7#2)(2008-8#1)(2010-3#1)
that the existing##4##3##(1995-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
that the expected runtime##2##4##(2010-2#2)
that the expected##3##3##(2008-9#1)(2010-2#2)
that the experience##2##3##(1996-3#1)(2010-3#1)
that the experimental##11##3##(1990-11#1)(1990-8#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)
that the exposure of##3##4##(2008-11#1)(2009-7#1)(2012-2#1)
that the exposure##4##3##(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)
that the expressed##2##3##(2008-8#1)(2010-6#1)
that the expression level##2##4##(2008-10#1)(2008-8#1)
that the expression levels##2##4##(2008-10#1)(2008-9#1)
that the expression of the##6##5##(1990-5#1)(1991-5#1)(1997-2#1)(1997-7#1)(2008-9#1)(2013-1#1)
that the expression of these##2##5##(1991-9#1)(1997-3#1)
that the expression of##29##4##(1990-11#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-3#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-8#3)(2008-9#4)(2012-12#1)(2013-1#2)(2013-8#1)
that the expression product##2##4##(2008-8#1)(2008-9#1)
that the expression##38##3##(1990-11#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-3#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-11#1)(2008-10#3)(2008-6#1)(2008-8#5)(2008-9#6)(2012-12#1)(2013-1#2)(2013-8#1)
that the extent of##5##4##(1994-8#1)(2008-10#1)(2008-5#2)(2008-6#1)
that the extra allele is##2##5##(2008-12#2)
that the extract of A##2##5##(2013-7#2)
that the extract##4##3##(2009-6#1)(2013-7#3)
that the extractability##2##3##(1994-8#1)(2008-10#1)
that the extraction of##2##4##(2008-10#2)
that the extraction##4##3##(2008-10#3)(2012-1#1)
that the factor##2##3##(1992-11#1)(1996-2#1)
that the factors##4##3##(2007-11#1)(2008-10#3)
that the familiar##2##3##(1994-1#1)(2008-2#1)
that the family##2##3##(2008-5#1)(2011-2#1)
that the fat##2##3##(2007-10#1)(2011-2#1)
that the features of##2##4##(1992-4#1)(2007-12#1)
that the features##3##3##(1992-4#1)(2007-12#1)(2008-3#1)
that the federal government##2##4##(1997-2#1)(1997-3#1)
that the federal##3##3##(1995-2#1)(1997-2#1)(1997-3#1)
that the feedback##2##3##(2008-8#1)(2009-8#1)
that the field of##2##4##(1994-1#1)(2008-3#1)
that the field##3##3##(1994-1#1)(2008-12#1)(2008-3#1)
that the film##2##3##(2008-10#2)
that the filter##2##3##(2008-2#1)(2008-3#1)
that the final##5##3##(1992-12#1)(2008-3#2)(2008-5#1)(2010-3#1)
that the finding of##2##4##(1991-12#1)(2008-7#1)
that the findings##3##3##(1993-12#1)(2008-11#1)(2008-7#1)
that the fine##2##3##(2007-11#2)
that the first intron##2##4##(2008-9#2)
that the first##20##3##(1990-12#1)(1990-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)
that the five##4##3##(1993-11#1)(1996-8#1)(2008-10#1)(2008-5#1)
that the flexural##2##3##(2009-5#1)(2009-7#1)
that the flow##2##3##(1996-12#1)(2008-2#1)
that the fluctuations##2##3##(1996-4#1)(2008-5#1)
that the fluorescence intensity of##3##5##(2008-10#2)(2008-5#1)
that the fluorescence##10##3##(1995-5#1)(2008-10#5)(2008-3#2)(2008-5#1)(2010-12#1)
that the fly##3##3##(2008-10#3)
that the focus##2##3##(1993-12#1)(2008-2#1)
that the form of the##2##5##(2008-10#1)(2008-8#1)
that the form of##4##4##(2008-10#2)(2008-8#2)
that the form##5##3##(1990-2#1)(2008-10#2)(2008-8#2)
that the formation of the##3##5##(1990-2#1)(1993-11#1)(2008-5#1)
that the formation of##11##4##(1990-2#1)(1993-11#1)(1994-2#1)(1994-8#2)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-7#1)(2013-1#1)
that the former##4##3##(1990-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
that the formulations##2##3##(2008-5#2)
that the four##6##3##(1990-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
that the fraction of##2##4##(2008-10#1)(2008-7#1)
that the fractions##2##3##(2008-10#2)
that the fragment is##2##4##(1992-6#2)
that the fragment##3##3##(1992-6#2)(2008-8#1)
that the fragmentation of Cu##2##5##(1997-8#2)
that the frequency of the##2##5##(2008-3#1)(2013-1#1)
that the frequency of##5##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
that the frequency##7##3##(1994-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
that the frequent##2##3##(1992-5#1)(2008-2#1)
that the full##2##3##(2008-1#1)(2008-8#1)
that the fully##3##3##(1990-8#1)(2008-3#2)
that the function of##3##4##(2008-11#1)(2008-6#1)(2008-9#1)
that the functional##7##3##(1992-6#1)(1995-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
that the functions##3##3##(1990-3#1)(1995-2#1)(2012-3#1)
that the fundamental##5##3##(1992-2#1)(1993-6#1)(2008-2#1)(2008-3#1)(2008-6#1)
that the fungal##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
that the fungus produced##2##4##(2008-10#2)
that the fungus##8##3##(2008-10#8)
that the fusion of##2##4##(1991-5#1)(2008-8#1)
that the fusion##6##3##(1991-5#1)(1994-11#1)(1994-12#1)(1997-3#1)(2008-8#2)
that the future##3##3##(1990-2#1)(1996-2#2)
that the gain##2##3##(2008-2#1)(2008-3#1)
that the gamma##2##3##(2008-10#1)(2008-8#1)
that the gene encoding the##2##5##(2008-10#1)(2008-9#1)
that the gene encoding##3##4##(1995-6#1)(2008-10#1)(2008-9#1)
that the gene is##3##4##(1990-5#1)(1993-2#1)(1995-8#1)
that the gene was##2##4##(1997-2#1)(2008-10#1)
that the gene##18##3##(1990-5#2)(1990-7#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
that the general##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
that the genes##7##3##(1991-9#1)(1993-3#1)(1994-8#1)(1995-12#1)(2007-11#1)(2012-3#2)
that the genetic##11##3##(1991-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-8#1)
that the genome##3##3##(2009-5#1)(2011-2#2)
that the genomic##2##3##(1993-6#1)(2010-3#1)
that the genus##3##3##(2008-6#1)(2010-3#2)
that the geographical##2##3##(2008-8#2)
that the global##2##3##(1996-5#1)(2008-8#1)
that the glucose##4##3##(1994-2#1)(2007-8#1)(2008-10#2)
that the glutamatergic system##2##4##(2008-7#2)
that the gold##3##3##(2007-12#1)(2008-10#2)
that the granule##2##3##(1994-8#1)(1995-8#1)
that the grating##3##3##(2007-11#1)(2008-3#2)
that the greater##2##3##(1997-1#1)(2009-8#1)
that the greatest##3##3##(2008-6#1)(2008-7#1)(2008-8#1)
that the ground##2##3##(2007-1#1)(2008-3#1)
that the group##4##3##(1993-3#2)(2008-10#1)(2012-3#1)
that the groups##2##3##(2007-11#1)(2008-11#1)
that the growth of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
that the growth##5##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)
that the guards were concerned about##2##6##(1995-6#2)
that the health##2##3##(1995-6#1)(2008-7#1)
that the heat##2##3##(1994-8#1)(1997-2#1)
that the heavy##2##3##(1997-9#1)(2008-10#1)
that the hepatic##3##3##(1992-3#1)(1993-9#1)(1995-6#1)
that the hexamer##2##3##(1994-6#1)(1997-2#1)
that the high affinity##2##4##(1990-5#1)(1991-1#1)
that the high##12##3##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-4#1)(2010-6#1)
that the higher the##2##4##(2007-10#1)(2008-11#1)
that the higher##13##3##(1990-12#1)(1990-9#1)(1996-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2013-1#1)
that the highest##9##3##(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)
that the highly##2##3##(1991-2#1)(1995-11#1)
that the hippocampus##3##3##(1993-5#1)(1993-6#1)(2013-8#1)
that the hormone##2##3##(1995-12#1)(2008-10#1)
that the hospital##2##3##(1996-2#1)(2011-2#1)
that the host##9##3##(1992-10#1)(2007-12#1)(2008-10#4)(2008-8#2)(2008-9#1)
that the human##23##3##(1990-7#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-2#1)
that the hybrid##4##3##(2008-10#1)(2008-3#2)(2008-8#1)
that the hydrocarbon production from##2##5##(2008-6#2)
that the hydrogel##2##3##(2008-5#2)
that the hydrolase##2##3##(1991-7#1)(1992-8#1)
that the hydrophobic and##2##4##(2008-10#2)
that the hydrophobic##3##3##(1994-8#1)(2008-10#2)
that the hydrophobicity of the##2##5##(1993-11#1)(2008-10#1)
that the hydrophobicity##3##3##(1993-11#1)(2008-10#2)
that the hydroxyl##2##3##(1992-6#1)(1995-6#1)
that the idea of##3##4##(2010-10#1)(2010-11#1)(2011-2#1)
that the identification of##3##4##(1997-7#1)(2007-3#1)(2008-10#1)
that the identity##2##3##(1991-2#1)(2010-3#1)
that the image quality##2##4##(1997-8#1)(2008-3#1)
that the image##5##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
that the immobilization##2##3##(2008-10#2)
that the immobilized##3##3##(2008-10#2)(2008-7#1)
that the immune system##2##4##(2013-1#1)(2013-7#1)
that the immune##3##3##(2008-11#1)(2013-1#1)(2013-7#1)
that the immunosuppressive##2##3##(1990-5#2)
that the impact of##5##4##(1992-8#1)(2008-10#2)(2008-2#1)(2008-8#1)
that the impacts##2##3##(2008-1#1)(2008-5#1)
that the impairment of##2##4##(1996-7#1)(2008-5#1)
that the implant##2##3##(2008-7#1)(2008-9#1)
that the importance of##3##4##(2008-1#1)(2008-5#1)(2009-2#1)
that the improved##6##3##(1996-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
that the improvement##3##3##(2008-10#2)(2012-1#1)
that the improvements##2##3##(2010-7#1)(2013-8#1)
that the in vitro##2##4##(1990-11#1)(1997-4#1)
that the in-flight##2##3##(1990-11#1)(2008-3#1)
that the incidence of##10##4##(1991-11#1)(1994-3#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
that the incidence##13##3##(1991-11#1)(1994-3#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
that the incident light##2##4##(2007-11#1)(2008-10#1)
that the incident##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
that the inclusion##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
that the incorporation of##2##4##(1990-2#1)(1994-6#1)
that the increase in the##3##5##(1992-12#1)(2008-11#1)(2008-3#1)
that the increase in##18##4##(1990-8#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)
that the increase of##3##4##(1990-2#1)(2008-10#1)(2008-12#1)
that the increase##22##3##(1990-2#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)
that the increased expression of##2##5##(1992-8#1)(1995-2#1)
that the increased susceptibility##2##4##(2008-10#2)
that the increased##16##3##(1990-11#1)(1990-12#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#2)(2010-10#1)(2013-1#1)
that the independent##2##3##(1992-1#1)(2008-3#1)
that the individual##5##3##(1990-12#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-3#1)
that the individuals##3##3##(1990-7#1)(2009-5#1)(2009-6#1)
that the induced##4##3##(1990-12#1)(2007-11#1)(2008-11#1)(2008-2#1)
that the induction of metallothionein by##2##6##(1991-5#2)
that the induction of##9##4##(1991-5#2)(1994-11#2)(1996-7#1)(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
that the infection##5##3##(1991-3#1)(1997-1#1)(2011-2#1)(2012-3#2)
that the influence of##4##4##(1992-3#1)(1996-12#1)(2010-2#1)(2011-2#1)
that the influence##6##3##(1992-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2010-2#1)(2011-2#1)
that the information##5##3##(1993-2#1)(2007-12#1)(2008-3#1)(2008-9#2)
that the inherent##2##3##(2007-11#1)(2010-8#1)
that the inheritance of##2##4##(2008-10#1)(2008-4#1)
that the inhibition of##9##4##(1993-12#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-9#1)
that the inhibition##10##3##(1990-2#1)(1993-12#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-9#1)
that the inhibitor was##3##4##(1990-5#1)(1991-3#1)(1993-3#1)
that the inhibitor##4##3##(1990-5#1)(1991-3#1)(1993-3#1)(1994-11#1)
that the inhibitory effect of##5##5##(1991-12#1)(1991-6#1)(1994-8#1)(1995-6#1)(2008-6#1)
that the inhibitory effect##7##4##(1991-12#1)(1991-6#1)(1991-9#2)(1994-8#1)(1995-6#1)(2008-6#1)
that the inhibitory effects of##4##5##(1991-12#1)(1995-11#1)(2008-10#1)(2008-11#1)
that the inhibitory effects##5##4##(1991-12#1)(1995-11#1)(2008-10#2)(2008-11#1)
that the inhibitory##13##3##(1990-5#1)(1991-12#2)(1991-6#1)(1991-9#2)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-6#1)
that the initial##19##3##(1990-10#1)(1990-11#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-6#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-11#1)(2013-1#1)
that the initiation of##2##4##(2008-10#1)(2008-6#1)
that the initiation##3##3##(2008-10#1)(2008-6#2)
that the injection of##2##4##(2008-8#1)(2012-3#1)
that the injection##3##3##(2007-4#1)(2008-8#1)(2012-3#1)
that the inner##2##3##(1995-3#1)(2008-8#1)
that the insertion##2##3##(2008-8#1)(2009-7#1)
that the instrument##4##3##(2008-10#1)(2008-3#2)(2010-12#1)
that the intact##2##3##(1996-2#1)(2008-8#1)
that the integrated##2##3##(1997-8#1)(2008-10#1)
that the integrity of the##2##5##(2008-10#1)(2008-7#1)
that the integrity of##3##4##(1995-5#1)(2008-10#1)(2008-7#1)
that the intensity of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
that the intensity of##5##4##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#2)
that the intensity##8##3##(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#4)
that the interaction between##2##4##(2008-8#2)
that the interaction is##2##4##(1997-7#1)(2008-10#1)
that the interaction of##7##4##(1991-5#1)(1994-6#2)(2008-10#3)(2008-9#1)
that the interaction##14##3##(1991-2#1)(1991-5#1)(1994-6#2)(1995-2#1)(1997-7#1)(2008-10#5)(2008-8#2)(2008-9#1)
that the interactions between##2##4##(2008-10#1)(2009-8#1)
that the intercalated##2##3##(1997-7#1)(2008-10#1)
that the interference from##2##4##(2008-10#1)(2008-3#1)
that the interference##6##3##(2007-12#2)(2008-10#1)(2008-3#2)(2013-8#1)
that the interferences##2##3##(2008-10#2)
that the interferogram##2##3##(2007-11#1)(2008-3#1)
that the intermediary##2##3##(2008-10#2)
that the intermediate##2##3##(1994-6#1)(1995-5#1)
that the intervention##2##3##(2008-12#1)(2008-9#1)
that the intracavity dispersion of##2##5##(2007-12#2)
that the intracellular##2##3##(1990-5#1)(1992-9#1)
that the intrinsic##3##3##(1992-6#1)(1994-9#1)(2008-8#1)
that the introduction and##2##4##(1991-4#1)(2008-10#1)
that the introduction of##7##4##(1990-5#1)(1992-6#1)(1996-2#1)(2008-11#2)(2008-3#1)(2013-1#1)
that the introduction##9##3##(1990-5#1)(1991-4#1)(1992-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2013-1#1)
that the iron chalcogenide membrane comprises##2##6##(2008-10#2)
that the iron##3##3##(2008-10#3)
that the isolated##2##3##(2008-10#1)(2008-8#1)
that the isolates were##2##4##(1996-12#1)(2008-10#1)
that the isolates##5##3##(1996-12#1)(2008-10#3)(2012-2#1)
that the jitter##2##3##(2008-3#2)
that the jump##2##3##(2007-12#1)(2008-9#1)
that the keto##2##3##(1993-11#1)(2008-11#1)
that the key to##3##4##(2008-7#1)(2011-2#2)
that the key##5##3##(1992-8#1)(1996-4#1)(2008-7#1)(2011-2#2)
that the laboratory##2##3##(2008-10#1)(2012-3#1)
that the lack of##11##4##(1991-2#1)(1994-7#1)(1994-8#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-12#1)(2013-8#1)
that the large##6##3##(1995-5#1)(1995-8#1)(2007-11#1)(2007-12#1)(2010-3#1)(2010-6#1)
that the larger the##2##4##(1995-11#1)(2008-3#1)
that the larger##3##3##(1995-11#1)(1995-5#1)(2008-3#1)
that the lateral##4##3##(1993-6#1)(2008-3#2)(2009-10#1)
that the latter method##2##4##(2008-10#1)(2011-2#1)
that the latter##11##3##(1991-12#1)(1993-11#1)(1995-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#3)
that the law##2##3##(1991-9#1)(1997-8#1)
that the leader##2##3##(1992-8#1)(2008-1#1)
that the lectin##2##3##(1991-12#1)(1992-6#1)
that the left##2##3##(1993-9#1)(2008-11#1)
that the legal##2##3##(2008-11#1)(2008-8#1)
that the length##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
that the lesion##3##3##(1992-2#1)(2010-6#1)(2013-1#1)
that the lesions##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
that the let-60##2##3##(1990-11#2)
that the level of##22##4##(1991-9#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#3)(2011-2#1)(2013-8#2)
that the levels of##4##4##(1991-12#1)(1994-12#1)(2008-7#1)(2009-12#1)
that the lidar##4##3##(2008-2#1)(2008-3#3)
that the lifetime of the##3##5##(2010-2#2)(2013-8#1)
that the light##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
that the limited##2##3##(2008-10#1)(2008-5#1)
that the line##2##3##(2008-2#1)(2008-3#1)
that the linear##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-1#1)
that the liver##3##3##(2008-12#1)(2008-8#1)(2013-7#1)
that the local##5##3##(1992-6#1)(1995-2#1)(1996-9#1)(2008-7#1)(2013-1#1)
that the local-field##2##3##(2007-11#1)(2008-3#1)
that the localization of##2##4##(1993-12#1)(1997-2#1)
that the location##2##3##(2008-10#1)(2009-5#1)
that the locus##2##3##(1995-12#1)(2008-10#1)
that the longer##4##3##(1990-2#1)(1995-8#2)(2008-5#1)
that the loop##2##3##(1995-2#2)
that the loss of##6##4##(1995-5#1)(1995-6#1)(1997-7#1)(2008-7#1)(2012-2#1)(2013-1#1)
that the loss##7##3##(1995-5#1)(1995-6#1)(1997-7#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
that the low##8##3##(1991-2#1)(1991-9#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
that the lower the##2##4##(2008-2#1)(2013-8#1)
that the lower##9##3##(1991-12#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
that the lung##2##3##(2010-5#1)(2011-3#1)
that the mRNA##2##3##(1995-8#1)(1996-12#1)
that the macroscopic##2##3##(2008-3#1)(2012-12#1)
that the magnetic field increased##2##5##(2008-8#2)
that the magnetic field##4##4##(2008-8#4)
that the magnetic##6##3##(2007-12#1)(2008-12#1)(2008-8#4)
that the magnitude of the##3##5##(2008-10#2)(2008-9#1)
that the magnitude of##7##4##(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
that the magnitude##8##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
that the main##17##3##(1990-6#1)(1995-12#1)(1995-5#1)(1996-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
that the maintenance of##3##4##(1991-2#1)(2008-10#1)(2013-1#1)
that the major##26##3##(1990-5#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-5#1)(1997-8#1)(1997-9#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-3#1)
that the majority of cases##2##5##(1990-8#1)(2007-7#1)
that the majority of the##9##5##(1991-11#1)(1994-11#1)(1996-12#1)(1996-6#1)(1997-3#2)(2008-6#1)(2008-7#1)(2011-2#1)
that the majority of##24##4##(1990-8#1)(1991-11#1)(1993-2#1)(1994-11#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-8#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
that the majority were##2##4##(2008-12#1)(2011-2#1)
that the majority##30##3##(1990-8#1)(1991-11#1)(1993-2#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
that the male##4##3##(2008-8#2)(2010-5#1)(2011-1#1)
that the males##2##3##(1991-2#1)(1996-12#1)
that the management of##2##4##(1991-3#1)(2010-3#1)
that the management##6##3##(1991-3#1)(1994-3#1)(1996-3#1)(2008-5#1)(2010-3#1)(2012-3#1)
that the mass was a##2##5##(2008-7#1)(2013-8#1)
that the mass##5##3##(2007-8#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-8#1)
that the material##2##3##(2008-3#1)(2008-7#1)
that the maximal##2##3##(2008-10#1)(2008-7#1)
that the maximum##13##3##(1990-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
that the mean value##2##4##(2008-10#1)(2008-2#1)
that the mean##14##3##(1991-9#1)(1992-11#1)(1994-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-2#1)(2010-7#1)(2012-3#1)
that the measure##3##3##(1995-6#2)(2008-10#1)
that the measured##6##3##(2008-2#2)(2008-3#3)(2012-2#1)
that the measurement of##2##4##(2006-6#1)(2008-10#1)
that the measurement##5##3##(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
that the measurements##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
that the mechanical##4##3##(1995-2#1)(2008-7#1)(2009-7#2)
that the mechanism by which##2##5##(1993-3#1)(2008-8#1)
that the mechanism of##9##4##(1990-2#1)(1991-5#2)(1993-11#1)(1995-8#1)(1997-2#1)(2008-10#1)(2010-11#1)(2013-8#1)
that the mechanism##12##3##(1990-2#1)(1991-5#2)(1993-11#1)(1993-3#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
that the mechanisms of##4##4##(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)
that the mechanisms##9##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#1)
that the medial##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
that the medical##4##3##(1992-3#1)(2008-11#1)(2008-7#1)(2010-8#1)
that the medium##2##3##(2008-11#1)(2008-7#1)
that the members of a##2##5##(2008-9#1)(2011-2#1)
that the membrane##5##3##(1991-9#1)(1992-12#1)(1992-9#1)(1993-9#1)(1997-7#1)
that the memory##3##3##(2008-1#1)(2008-12#1)(2008-2#1)
that the mentor##2##3##(2008-12#1)(2008-7#1)
that the message##2##3##(1994-11#1)(1995-12#1)
that the metapopulation##2##3##(2008-10#1)(2008-8#1)
that the method can be used to##2##7##(1996-5#1)(2008-2#1)
that the method can be##3##5##(1996-5#1)(2008-10#1)(2008-2#1)
that the method can##4##4##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
that the method could##2##4##(2008-10#1)(2013-8#1)
that the method is suitable for the##3##7##(1991-5#1)(2008-10#2)
that the method is suitable for##5##6##(1991-5#1)(1996-12#1)(2008-10#3)
that the method is##14##4##(1991-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-9#1)(2009-5#1)
that the method of##2##4##(1992-12#1)(2013-8#1)
that the method presented##2##4##(2008-10#1)(2013-8#1)
that the method provides##2##4##(2007-11#1)(2008-3#1)
that the method was##5##4##(2008-10#3)(2008-8#1)(2013-8#1)
that the method##40##3##(1991-5#1)(1992-12#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#19)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#2)(2013-8#4)
that the methodology##4##3##(2007-11#1)(2008-10#2)(2008-8#1)
that the methods##4##3##(1993-12#1)(1995-9#1)(2008-3#1)(2008-5#1)
that the methylation of##2##4##(2007-11#1)(2010-11#1)
that the methylation##3##3##(1994-9#1)(2007-11#1)(2010-11#1)
that the microenvironment of##2##4##(2008-10#2)
that the minimal##4##3##(1993-12#1)(1997-6#1)(2012-2#2)
that the minimum##3##3##(2008-2#1)(2008-5#1)(2009-9#1)
that the mitochondrial##2##3##(1994-8#1)(2008-2#1)
that the mixed##2##3##(2008-10#1)(2009-5#1)
that the mixture##2##3##(1990-12#1)(2012-3#1)
that the mode field##2##4##(2007-11#1)(2008-2#1)
that the mode of##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
that the mode##5##3##(2007-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
that the model can##3##4##(2008-3#1)(2008-7#1)(2009-9#1)
that the model has##2##4##(2008-10#1)(2013-8#1)
that the model is##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
that the model##17##3##(1991-12#1)(1996-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
that the modification of##2##4##(2008-10#1)(2008-7#1)
that the modification##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
that the modified electrode##2##4##(2008-10#2)
that the modified nucleotides##2##4##(2008-8#2)
that the modified##8##3##(1992-5#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-8#2)
that the modulation of##2##4##(2008-3#1)(2012-2#1)
that the modulation##6##3##(1994-6#1)(2007-11#1)(2008-3#2)(2012-2#2)
that the modulatory##2##3##(1994-8#1)(2011-2#1)
that the molecular structure of##2##5##(2008-7#1)(2012-2#1)
that the molecular##9##3##(1991-2#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-2#1)
that the molecule##2##3##(1993-11#1)(2008-6#1)
that the more##6##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-7#1)
that the morphological##2##3##(1997-8#1)(2008-8#1)
that the morphology of the##2##5##(2008-7#1)(2008-8#1)
that the morphology of##5##4##(1991-12#1)(2008-7#2)(2008-8#1)(2011-2#1)
that the most common##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
that the most cost-effective##2##4##(1994-3#1)(2008-11#1)
that the most important##6##4##(1995-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)
that the most likely##4##4##(1993-8#1)(1996-4#1)(2008-10#1)(2012-3#1)
that the most stable##2##4##(1996-7#1)(2012-3#1)
that the most##32##3##(1993-8#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-4#1)(1996-7#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#4)(2009-8#1)(2010-8#3)(2011-2#1)(2012-3#2)
that the mouse##2##3##(2008-8#1)(2008-9#1)
that the mutant##6##3##(1991-2#1)(1994-6#1)(1995-2#1)(2008-10#2)(2008-8#1)
that the mutants##2##3##(1997-3#1)(2008-10#1)
that the mutation##6##3##(1990-12#1)(1990-8#1)(2007-6#1)(2008-12#1)(2008-9#1)(2011-2#1)
that the mutations specifically##2##4##(1992-12#1)(1995-6#1)
that the mutations##6##3##(1992-12#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-8#1)
that the native##5##3##(1990-2#1)(1990-5#1)(1993-8#2)(2008-10#1)
that the natural history of##2##5##(2008-6#1)(2010-10#1)
that the natural##7##3##(1990-5#1)(1994-12#1)(1997-1#1)(2008-6#1)(2010-1#1)(2010-10#1)(2011-1#1)
that the nature of##4##4##(1994-5#1)(2008-10#2)(2008-11#1)
that the necessary##3##3##(2008-2#1)(2008-3#1)(2010-2#1)
that the needs of##4##4##(1996-2#1)(2008-1#1)(2008-10#1)(2013-1#1)
that the negative##5##3##(1995-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
that the network##2##3##(1994-3#1)(2008-10#1)
that the neural mechanisms##2##4##(2012-2#1)(2013-8#1)
that the neural network##2##4##(2008-10#1)(2010-8#1)
that the neural##11##3##(1991-2#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#3)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
that the new design##2##4##(2009-6#1)(2012-2#1)
that the new method##4##4##(2007-8#1)(2008-2#2)(2008-3#1)
that the new##24##3##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(1996-1#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#2)(2009-6#2)(2012-1#1)(2012-2#1)
that the next generation of##2##5##(2008-11#1)(2008-7#1)
that the nitric oxide##2##4##(1996-11#1)(1997-4#1)
that the nonlinear##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
that the nonlinearity##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
that the noradrenergic##2##3##(1995-5#1)(1996-5#1)
that the normal##4##3##(1991-5#1)(2008-12#1)(2008-5#1)(2008-9#1)
that the novel##2##3##(2008-10#1)(2010-10#1)
that the nucleotide##3##3##(1993-12#1)(1995-2#1)(2011-1#1)
that the nucleus accumbens##2##4##(1994-2#1)(2008-7#1)
that the null##2##3##(2008-10#1)(2008-12#1)
that the number of##33##4##(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
that the number##34##3##(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
that the nursing##3##3##(1994-3#1)(2007-10#1)(2011-1#1)
that the object##5##3##(2008-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
that the objective##2##3##(2009-6#1)(2013-1#1)
that the observed##19##3##(1991-9#1)(1992-12#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-3#3)(2008-7#2)(2008-9#1)(2013-7#1)
that the obtained##2##3##(2008-10#1)(2013-8#1)
that the occurrence of##5##4##(2008-10#1)(2008-8#2)(2010-5#1)(2011-1#1)
that the occurrence##6##3##(1990-11#1)(2008-10#1)(2008-8#2)(2010-5#1)(2011-1#1)
that the odds for##2##4##(2010-7#1)(2011-2#1)
that the off-axis##2##3##(2008-3#2)
that the oil##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
that the oligosaccharides##2##3##(1993-11#2)
that the only##4##3##(1991-7#1)(2007-11#1)(2008-5#1)(2010-12#1)
that the open##3##3##(1997-8#1)(2008-10#2)
that the opening##2##3##(2008-9#2)
that the optical##11##3##(1990-8#1)(2007-12#1)(2008-2#4)(2008-3#3)(2013-8#2)
that the optimal##12##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)
that the optimum##5##3##(2008-10#3)(2008-3#2)
that the order of##3##4##(1995-11#1)(2008-3#1)(2012-2#1)
that the order##4##3##(1995-11#1)(2008-3#2)(2012-2#1)
that the orientation##2##3##(1991-6#1)(2008-6#1)
that the origin of##3##4##(1991-3#1)(2008-10#1)(2013-8#1)
that the original##4##3##(1995-9#1)(1997-7#1)(2008-11#1)(2008-2#1)
that the oscillation##2##3##(2008-10#1)(2010-10#1)
that the other##5##3##(1991-1#1)(1993-5#1)(1997-3#1)(2008-7#1)(2008-8#1)
that the outcome##2##3##(2008-10#1)(2012-3#1)
that the outer##3##3##(1997-8#1)(2008-11#1)(2008-7#1)
that the outpatient##2##3##(1994-2#1)(2008-11#1)
that the output##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
that the overall##13##3##(1993-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-2#2)(2013-8#1)
that the overexpression of##4##4##(1992-12#1)(1995-6#2)(2008-10#1)
that the oxidative burst##2##4##(1995-6#1)(2008-10#1)
that the oxidative##3##3##(1991-5#1)(1995-6#1)(2008-10#1)
that the oxygen##2##3##(2008-7#1)(2012-2#1)
that the panel##2##3##(2008-2#1)(2010-12#1)
that the paradigm##2##3##(1994-12#1)(2013-8#1)
that the parallel##2##3##(1991-5#1)(1997-7#1)
that the parameter##2##3##(2008-10#1)(2008-8#1)
that the parameters##2##3##(1990-12#1)(1991-2#1)
that the parasite is able to##2##6##(1990-2#1)(2007-6#1)
that the parasite##3##3##(1990-2#1)(2007-6#1)(2008-8#1)
that the parents##2##3##(1995-12#1)(2008-10#1)
that the partial##4##3##(1991-9#1)(1997-2#1)(2008-11#2)
that the particles were##2##4##(1997-1#1)(2010-4#1)
that the particles##3##3##(1996-12#1)(1997-1#1)(2010-4#1)
that the pathogen##7##3##(2008-10#6)(2008-8#1)
that the pathological changes in##2##5##(1990-5#1)(2008-7#1)
that the pathological##3##3##(1990-5#1)(2008-7#2)
that the pathway##2##3##(2008-10#1)(2011-3#1)
that the patient had a##2##5##(1994-12#1)(1996-6#1)
that the patient had##4##4##(1991-3#1)(1994-12#1)(1996-6#1)(2011-2#1)
that the patient has##2##4##(1996-5#1)(2008-11#1)
that the patient is##4##4##(1990-11#1)(1992-1#1)(2011-2#1)(2013-1#1)
that the patient was##2##4##(1990-3#1)(1996-5#1)
that the patient##14##3##(1990-11#1)(1990-3#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-12#1)(1996-5#2)(1996-6#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
that the patients with##2##4##(1994-12#1)(2011-2#1)
that the patients##8##3##(1994-12#1)(1995-4#1)(1996-2#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
that the pattern of##3##4##(1993-9#1)(1994-5#1)(2008-10#1)
that the patterns of##2##4##(2007-7#1)(2008-1#1)
that the peak current##2##4##(2008-10#2)
that the peak##7##3##(1996-5#1)(2008-10#6)
that the peptide##9##3##(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#2)(2008-10#1)
that the peptides##2##3##(1997-2#1)(2008-9#1)
that the percentage of##2##4##(2008-10#1)(2008-8#1)
that the perception of##2##4##(2008-5#1)(2013-1#1)
that the performance of the##5##5##(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#1)
that the performance of##10##4##(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)
that the performance##12##3##(1992-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)
that the perinatal mortality rate##2##5##(1990-3#1)(1995-6#1)
that the period of##3##4##(1996-6#1)(2008-10#2)
that the period##4##3##(1996-6#1)(2008-10#2)(2008-5#1)
that the periodic##2##3##(2007-11#1)(2008-7#1)
that the permeability##2##3##(2008-11#1)(2008-7#1)
that the phase##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
that the phenomenon of##4##4##(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
that the phenomenon##5##3##(2007-11#1)(2008-10#2)(2008-9#1)(2011-2#1)
that the phosphorylation of##2##4##(1995-6#1)(1997-2#1)
that the phosphorylation##3##3##(1993-8#1)(1995-6#1)(1997-2#1)
that the photostability of##2##4##(2008-10#1)(2008-5#1)
that the physical##3##3##(1996-12#1)(2008-2#1)(2011-1#1)
that the physiological##3##3##(2008-4#1)(2008-8#1)(2013-1#1)
that the phytoplasmas##2##3##(2008-10#2)
that the plant##5##3##(1992-3#1)(1994-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
that the plasma##3##3##(1992-8#1)(2011-2#1)(2013-8#1)
that the plasmids##2##3##(1994-3#1)(1997-3#1)
that the point##2##3##(2008-11#1)(2008-3#1)
that the polarizing##2##3##(1991-5#1)(2007-11#1)
that the policy##2##3##(1992-12#1)(1996-5#1)
that the polymer##6##3##(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2011-3#1)
that the poor##3##3##(1991-2#1)(1992-2#1)(2011-3#1)
that the population is##2##4##(2008-10#1)(2008-12#1)
that the population of##3##4##(1993-5#1)(2008-10#2)
that the population##10##3##(1992-9#1)(1993-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)
that the population-based##2##3##(2009-8#1)(2013-1#1)
that the populations are##2##4##(2008-10#1)(2008-6#1)
that the porcine##2##3##(2008-11#1)(2012-2#1)
that the position of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
that the positive##4##3##(1994-2#1)(1997-7#1)(2008-6#1)(2008-8#1)
that the posterior##2##3##(1997-7#1)(2008-11#1)
that the potency##2##3##(1992-3#1)(1994-8#1)
that the potential##6##3##(1991-3#1)(1991-8#1)(1996-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
that the practice##2##3##(1993-6#1)(2008-11#1)
that the precision##2##3##(2008-2#1)(2008-3#1)
that the precursor##2##3##(1997-2#1)(2008-3#1)
that the predicted##4##3##(1993-12#1)(2008-6#1)(2008-8#1)(2009-9#1)
that the predictions##2##3##(2007-11#1)(2008-10#1)
that the predominant##3##3##(1992-12#1)(1993-6#1)(2008-12#1)
that the preference##2##3##(2008-5#1)(2008-9#1)
that the prepared##3##3##(2008-10#2)(2010-5#1)
that the presence of a##7##5##(1992-3#1)(1992-6#1)(1996-7#1)(2008-10#2)(2008-4#1)(2012-12#1)
that the presence of an##3##5##(1995-2#1)(1995-8#1)(2011-2#1)
that the presence of the##3##5##(2008-10#2)(2011-2#1)
that the presence of##55##4##(1990-5#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-7#1)
that the present##8##3##(1991-6#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-6#1)
that the presented##2##3##(2008-10#1)(2008-11#1)
that the presently##2##3##(1991-2#1)(1995-12#1)
that the pressure on##2##4##(2008-2#1)(2010-4#1)
that the prevalence of body dissatisfaction##2##6##(2007-12#2)
that the prevalence of##14##4##(1990-6#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-1#2)(2012-12#1)(2013-8#1)
that the prevalence##15##3##(1990-6#1)(1997-3#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-1#2)(2012-12#1)(2013-8#2)
that the previously reported##2##4##(1990-5#1)(1995-12#1)
that the previously##5##3##(1990-5#1)(1992-4#1)(1993-12#1)(1995-12#1)(1995-9#1)
that the prg##2##3##(2008-10#2)
that the primary##14##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
that the principal##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
that the prior##2##3##(2008-10#1)(2008-11#1)
that the probability of##4##4##(1990-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
that the probability##6##3##(1990-8#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
that the problem of##2##4##(1993-6#1)(1997-4#1)
that the problem##4##3##(1993-6#1)(1997-4#1)(2008-2#1)(2009-9#1)
that the procedure could be##2##5##(1996-9#1)(2009-8#1)
that the procedure is##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
that the procedure##12##3##(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
that the process of##4##4##(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
that the process##11##3##(1990-11#1)(1992-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
that the processes##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
that the product##8##3##(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-2#1)
that the production of##5##4##(1994-8#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-7#1)
that the products of##2##4##(1994-8#1)(1995-6#1)
that the products##3##3##(1994-8#1)(1995-6#1)(2011-2#1)
that the prognosis of##2##4##(2008-4#1)(2008-6#1)
that the prognostic##3##3##(1993-9#1)(2009-4#1)(2012-3#1)
that the program has##3##4##(1991-1#1)(1992-2#1)(1995-12#1)
that the program##4##3##(1991-1#1)(1992-12#1)(1992-2#1)(1995-12#1)
that the promoter##4##3##(1993-3#1)(1996-12#1)(2008-2#1)(2011-1#1)
that the prone position##2##4##(1992-11#1)(1992-4#1)
that the properties of the##2##5##(1991-4#1)(1993-8#1)
that the properties of##3##4##(1991-4#1)(1993-8#1)(2007-12#1)
that the proportion of##6##4##(1991-3#1)(1992-12#1)(1996-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
that the proposed algorithm##2##4##(2008-2#1)(2008-3#1)
that the proposed method is##5##5##(2008-10#3)(2008-3#1)(2012-3#1)
that the proposed method##10##4##(2008-10#5)(2008-3#1)(2008-5#1)(2012-1#1)(2012-3#1)(2013-8#1)
that the proposed model##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
that the proposed optical##2##4##(2008-2#1)(2008-3#1)
that the proposed procedure##5##4##(2008-10#5)
that the proposed##51##3##(1993-12#1)(1994-5#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#2)(2008-8#1)(2009-9#1)(2010-8#4)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#2)
that the protective effect##2##4##(1993-6#1)(1995-12#1)
that the protective##3##3##(1993-6#1)(1995-12#1)(2010-7#1)
that the protein encoded##2##4##(1993-11#1)(1993-12#1)
that the protein is##3##4##(1996-12#1)(2008-5#1)(2012-12#1)
that the protein may##2##4##(1991-2#1)(2008-9#1)
that the protein was##2##4##(1990-5#1)(1991-9#1)
that the protein##21##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-9#2)(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)(2012-12#2)
that the proteins were##2##4##(1995-8#1)(1996-2#1)
that the proteins##6##3##(1994-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-4#1)
that the public##3##3##(1996-11#1)(1996-3#1)(1997-8#1)
that the purified##6##3##(1990-10#1)(1990-12#1)(1995-8#1)(1997-4#1)(2008-9#1)(2012-2#1)
that the purity of##2##4##(2008-11#1)(2008-8#1)
that the purpose of##2##4##(2008-11#1)(2012-2#1)
that the putative##7##3##(1992-12#1)(1992-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)
that the quality of the##6##5##(1991-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
that the quality of##13##4##(1991-6#1)(1992-2#1)(1994-5#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
that the quality##14##3##(1991-6#1)(1992-2#1)(1994-5#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
that the quantitative##3##3##(1994-8#1)(2008-10#2)
that the radar##2##3##(2008-3#2)
that the radiation##2##3##(2007-12#1)(2008-2#1)
that the radiative transfer from a heated metal to a lossless dielectric##2##12##(2007-12#2)
that the radiative transfer##3##4##(2007-12#2)(2008-3#1)
that the range of validity of##2##6##(2008-2#2)
that the range of##4##4##(2008-2#2)(2008-3#2)
that the rapid##5##3##(1992-2#1)(1993-11#1)(1993-3#1)(2011-1#1)(2013-8#1)
that the rat##8##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1997-6#1)
that the rate of increase##2##5##(1990-7#1)(1993-3#1)
that the rate of##15##4##(1990-5#1)(1990-7#1)(1991-2#1)(1992-1#2)(1992-11#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-1#1)
that the rate##19##3##(1990-5#1)(1990-7#1)(1991-2#1)(1992-1#2)(1992-11#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-1#1)(2013-1#1)
that the ratio of##5##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
that the ratio##6##3##(1991-12#1)(2008-10#2)(2008-11#2)(2008-4#1)
that the rats treated with##2##5##(2011-2#1)(2013-1#1)
that the reaction of##3##4##(1996-5#1)(2008-10#2)
that the reaction rate##3##4##(2008-10#2)(2011-2#1)
that the reaction##10##3##(1991-12#1)(1996-5#1)(2008-10#6)(2008-7#1)(2011-2#1)
that the reactions##2##3##(2008-10#2)
that the reactive intermediate##2##4##(1995-6#2)
that the reactive##3##3##(1995-6#3)
that the reader will##2##4##(2008-4#1)(2012-3#1)
that the real##2##3##(1994-1#1)(2010-12#1)
that the recent##2##3##(2008-2#1)(2012-3#1)
that the recently##4##3##(1993-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
that the receptor is##3##4##(1990-11#1)(1993-3#1)(1994-8#1)
that the receptor##7##3##(1990-11#1)(1991-5#1)(1993-3#1)(1993-9#1)(1994-8#1)(2008-4#1)(2008-7#1)
that the recombinant##6##3##(1990-11#1)(2008-11#1)(2008-8#2)(2009-3#1)(2011-2#1)
that the recombination##3##3##(1995-8#1)(2008-10#1)(2013-8#1)
that the reconstituted##2##3##(1993-8#1)(2008-11#1)
that the reconstruction accuracy of the##2##6##(2007-11#1)(2007-12#1)
that the reconstruction##3##3##(2007-11#1)(2007-12#1)(2012-1#1)
that the recovery of##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
that the recovery##7##3##(1995-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-8#1)
that the reduced##8##3##(1995-12#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
that the reduction in the##2##5##(1995-3#1)(2008-10#1)
that the reduction in##5##4##(1995-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-7#1)
that the reduction of##3##4##(2007-11#1)(2009-4#1)(2011-2#1)
that the reduction##9##3##(1990-8#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)
that the reference##2##3##(2010-3#1)(2011-2#1)
that the refractive index##2##4##(2008-3#2)
that the region##6##3##(1990-10#1)(1992-12#1)(1995-6#1)(1997-8#1)(2008-8#2)
that the regions##2##3##(1995-8#1)(1997-7#1)
that the regular##3##3##(2008-5#2)(2008-7#1)
that the regulation of##5##4##(1990-11#1)(1991-2#1)(1992-8#1)(1994-9#1)(2008-11#1)
that the regulator##2##3##(1990-7#2)
that the regulatory##5##3##(1990-7#1)(1992-6#1)(1995-12#1)(1996-1#1)(2011-10#1)
that the related##3##3##(1993-8#1)(2009-8#1)(2012-12#1)
that the relationship between##11##4##(1994-2#2)(1994-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2013-8#1)
that the relationship##12##3##(1994-2#2)(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2013-8#1)
that the relationships between##2##4##(2009-7#2)
that the relative standard deviation##2##5##(2008-10#1)(2013-8#1)
that the relative standard##3##4##(2008-10#2)(2013-8#1)
that the relative##14##3##(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
that the relaxation##2##3##(2008-12#1)(2008-3#1)
that the release of##9##4##(1990-11#1)(1992-6#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#1)
that the release##10##3##(1990-11#1)(1990-2#1)(1992-6#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#1)
that the remaining##2##3##(2008-2#1)(2009-4#1)
that the removal of##3##4##(1997-4#1)(2008-10#1)(2009-9#1)
that the renal##2##3##(1990-11#1)(2008-10#1)
that the replacement of##3##4##(1992-8#1)(1994-5#1)(2012-12#1)
that the reported##2##3##(1991-2#1)(1997-5#1)
that the reproductive success##2##4##(2008-9#1)(2009-12#1)
that the reproductive##3##3##(1991-12#1)(2008-9#1)(2009-12#1)
that the required##2##3##(2008-3#2)
that the requirements##2##3##(1992-11#1)(2008-11#1)
that the research##3##3##(1995-1#1)(2008-11#1)(2008-2#1)
that the residual##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
that the residues##2##3##(1995-5#1)(1997-6#1)
that the resistance is##3##4##(2008-10#3)
that the resistance of the##2##5##(1991-5#1)(2008-10#1)
that the resistance of##5##4##(1991-5#1)(2008-10#4)
that the resistance was##2##4##(2008-10#2)
that the resistance##16##3##(1991-5#1)(2008-10#14)(2011-2#1)
that the resolution of##2##4##(2008-1#1)(2010-3#1)
that the resonant##3##3##(2007-12#1)(2008-3#2)
that the respective##3##3##(1995-11#1)(2008-1#1)(2008-3#1)
that the response is##2##4##(2008-10#1)(2008-3#1)
that the response of##7##4##(1990-7#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
that the response##17##3##(1990-7#1)(1993-9#1)(1997-3#1)(2006-10#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-7#1)(2009-8#1)
that the responses##2##3##(2008-9#1)(2009-8#1)
that the resulting##10##3##(1991-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
that the results are##2##4##(2008-2#1)(2010-8#1)
that the results of##4##4##(1996-11#1)(2008-8#2)(2011-2#1)
that the results##12##3##(1991-6#1)(1995-3#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-5#1)(2013-8#1)
that the retention##5##3##(1992-6#1)(1996-5#1)(2008-10#3)
that the retrieved##3##3##(2008-2#1)(2008-3#2)
that the risk is##2##4##(2008-9#1)(2013-1#1)
that the risk of##7##4##(1992-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#1)
that the risk##19##3##(1992-2#1)(1992-9#1)(1994-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-8#8)
that the rms##2##3##(2008-3#2)
that the rod's##2##3##(2008-2#2)
that the rodent##2##3##(1997-6#1)(2010-2#1)
that the role of##8##4##(1991-5#1)(1993-11#1)(1995-3#1)(1996-12#1)(2007-10#1)(2010-1#1)(2011-2#1)(2013-1#1)
that the role##11##3##(1991-5#1)(1993-11#1)(1995-3#1)(1996-12#1)(2007-10#1)(2008-11#1)(2010-1#1)(2011-2#2)(2013-1#2)
that the rules##2##3##(2007-11#1)(2009-9#1)
that the rust##2##3##(2008-10#2)
that the salivary gland##2##4##(1994-7#1)(2007-12#1)
that the same gene##2##4##(2008-10#2)
that the same##21##3##(1994-12#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-8#1)(2012-1#1)(2012-2#1)
that the sample size##2##4##(1995-9#1)(2009-11#1)
that the sample##5##3##(1995-9#1)(2008-10#2)(2009-11#1)(2012-12#1)
that the samples##3##3##(2008-10#2)(2012-2#1)
that the sampling##2##3##(2008-10#2)
that the scanner##2##3##(2008-3#1)(2011-1#1)
that the scattering##3##3##(2008-2#1)(2008-3#2)
that the schistosomiasis##2##3##(2012-3#2)
that the scientific##3##3##(2010-12#1)(2012-3#1)(2013-1#1)
that the second##10##3##(1992-9#1)(1995-6#1)(1997-2#1)(2007-11#2)(2008-2#1)(2008-3#2)(2009-6#1)(2009-8#1)
that the secondary structure of##4##5##(1992-8#1)(1993-8#1)(2008-10#2)
that the secondary structure##5##4##(1991-5#1)(1992-8#1)(1993-8#1)(2008-10#2)
that the secondary##6##3##(1991-5#1)(1992-8#1)(1993-8#1)(2007-12#1)(2008-10#2)
that the selected##2##3##(2008-10#1)(2010-3#1)
that the selection of##3##4##(1993-12#1)(2008-8#1)(2011-2#1)
that the selection##4##3##(1993-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
that the selectivity of the##3##5##(1996-5#1)(2008-10#2)
that the selectivity##5##3##(1996-5#1)(2008-10#4)
that the sensitivity of the##7##5##(1997-2#1)(2007-11#1)(2008-10#3)(2008-8#1)(2013-8#1)
that the sensitivity of##13##4##(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#2)(2013-8#1)
that the sensitivity##16##3##(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-8#2)(2011-1#1)(2013-8#1)
that the sensor can be used##2##6##(2008-10#1)(2008-3#1)
that the sensor can detect##2##5##(2007-11#1)(2008-10#1)
that the sensor can##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
that the sensor##9##3##(2007-11#3)(2008-10#4)(2008-2#1)(2008-3#1)
that the sensory##4##3##(1990-7#1)(2007-12#2)(2008-8#1)
that the separation##2##3##(1996-5#1)(2011-1#1)
that the sequence of the##2##5##(1996-2#1)(2008-10#1)
that the sequence of##4##4##(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
that the sequence##7##3##(1993-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
that the sequences##7##3##(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
that the serotonin##2##3##(2008-5#2)
that the seven##2##3##(1994-11#1)(2012-3#1)
that the severity of the effects##2##6##(1991-12#1)(2009-7#1)
that the severity of the##3##5##(1991-12#1)(2008-5#1)(2009-7#1)
that the severity of##4##4##(1991-12#1)(1991-9#1)(2008-5#1)(2009-7#1)
that the sex difference in##2##5##(1994-2#1)(2008-4#1)
that the sex##6##3##(1994-2#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#1)(2013-8#1)
that the shape of##3##4##(1994-8#1)(2007-12#1)(2008-7#1)
that the shift in##3##4##(1992-9#1)(2008-10#1)(2008-6#1)
that the shift##4##3##(1990-7#1)(1992-9#1)(2008-10#1)(2008-6#1)
that the shifting##2##3##(2008-3#2)
that the shortest##2##3##(1990-12#1)(2007-12#1)
that the signal and##2##4##(2007-11#1)(2008-2#1)
that the signal##8##3##(1993-8#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-8#1)
that the signal-to-noise ratio##2##4##(2007-12#1)(2008-10#1)
that the signaling##3##3##(1992-12#1)(2008-8#1)(2010-4#1)
that the simple##3##3##(1993-12#1)(2007-11#1)(2008-3#1)
that the simultaneous##2##3##(1996-12#1)(2008-10#1)
that the single##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
that the site##2##3##(1994-6#1)(2008-10#1)
that the sites##3##3##(1993-8#1)(1994-5#2)
that the six##2##3##(1994-6#1)(2008-8#1)
that the size of the##4##5##(1993-11#1)(1995-2#1)(1997-2#1)(2008-8#1)
that the size of##8##4##(1993-11#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
that the size##11##3##(1992-8#1)(1993-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#1)
that the skill set##2##4##(2007-12#2)
that the skills##2##3##(2008-11#1)(2012-2#1)
that the skin##5##3##(1995-11#1)(2008-10#1)(2008-5#3)
that the slope##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
that the small inclination##2##4##(2008-3#2)
that the small##5##3##(2008-10#1)(2008-3#3)(2012-3#1)
that the social##2##3##(1996-12#1)(2010-1#1)
that the soil##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
that the solubility of##2##4##(2008-10#2)
that the soluble##3##3##(1992-12#1)(1992-6#2)
that the solution##2##3##(2008-12#1)(2008-2#1)
that the spatial coherence of##2##5##(2008-2#1)(2008-3#1)
that the spatial##7##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
that the species##10##3##(2008-10#3)(2008-5#1)(2008-8#3)(2008-9#1)(2012-2#1)(2012-3#1)
that the specific##6##3##(1992-5#1)(1996-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
that the specificity##3##3##(1992-3#1)(1993-6#1)(1994-3#1)
that the spectra##2##3##(2008-3#2)
that the spectral properties of##2##5##(1994-11#1)(2013-1#1)
that the spectral properties##3##4##(1992-1#1)(1994-11#1)(2013-1#1)
that the spectral##9##3##(1992-1#1)(1994-11#1)(2007-12#4)(2013-1#1)(2013-8#2)
that the speech##2##3##(2008-2#1)(2008-9#1)
that the speed of##2##4##(2008-10#1)(2008-6#1)
that the spinach curtovirus##2##4##(2008-10#2)
that the spots##2##3##(2007-12#1)(2008-3#1)
that the stability of the##2##5##(1993-11#1)(2007-12#1)
that the stability of##5##4##(1990-2#1)(1992-6#1)(1993-11#1)(2007-12#1)(2008-10#1)
that the stability##7##3##(1990-2#1)(1992-6#1)(1993-11#1)(2007-12#1)(2008-10#3)
that the standard##6##3##(1990-6#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
that the state##4##3##(1995-2#2)(2008-11#1)(2008-2#1)
that the steady-state levels of##2##5##(1994-5#1)(2008-8#1)
that the stereochemistry of##2##4##(1996-5#1)(2011-2#1)
that the steric##2##3##(1996-2#1)(2012-2#1)
that the stimulation of##5##4##(1990-12#1)(1994-8#1)(1995-12#1)(2008-11#2)
that the stimulatory##2##3##(1997-8#1)(2013-1#1)
that the stoichiometry of##2##4##(1991-5#1)(2008-10#1)
that the stoichiometry##3##3##(1991-5#1)(1996-2#1)(2008-10#1)
that the strains##5##3##(1992-2#1)(1996-12#1)(2008-10#3)
that the stratum corneum##3##4##(2008-5#2)(2012-2#1)
that the strength of selection##2##5##(2008-8#1)(2013-1#1)
that the strength of the##2##5##(2008-11#1)(2008-2#1)
that the strength of##4##4##(2008-11#1)(2008-2#1)(2008-8#1)(2013-1#1)
that the strength##5##3##(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)(2013-1#1)
that the stress-induced##2##3##(1995-12#1)(2007-11#1)
that the strong##4##3##(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
that the structural##8##3##(1991-3#1)(1994-8#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#2)
that the structure and##2##4##(1994-3#1)(2008-4#1)
that the structure of the##2##5##(1992-6#1)(1995-3#1)
that the structure of##4##4##(1992-3#1)(1992-6#1)(1993-6#1)(1995-3#1)
that the structure##8##3##(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-3#1)(2008-3#1)(2008-4#1)
that the structures##3##3##(1992-4#1)(2008-7#1)(2008-8#1)
that the student##2##3##(2008-11#2)
that the students##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
that the studies##2##3##(1996-9#1)(2007-11#1)
that the study of ethics offers no right or wrong responses##2##11##(1994-1#2)
that the study of##3##4##(1994-1#2)(2011-2#1)
that the study was##3##4##(1993-3#1)(2008-11#1)(2008-3#1)
that the study##9##3##(1993-3#1)(1994-1#2)(2007-7#2)(2008-11#1)(2008-3#1)(2011-2#2)
that the subject##3##3##(1990-2#1)(2008-11#1)(2008-12#1)
that the substitution of##3##4##(1990-7#1)(1991-9#1)(2008-10#1)
that the substrate##2##3##(2008-7#2)
that the sudden##2##3##(1991-9#1)(2010-5#1)
that the superior##2##3##(2008-7#1)(2008-8#1)
that the supply of##2##4##(1993-2#1)(2008-10#1)
that the suppression of the##2##5##(1993-12#1)(2008-5#1)
that the suppression of##3##4##(1993-12#1)(2008-11#1)(2008-5#1)
that the suppressive##2##3##(2008-10#1)(2009-8#1)
that the surface##12##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-7#1)(2013-1#1)(2013-8#2)
that the survival of##2##4##(1991-3#1)(1993-8#1)
that the swarming##2##3##(2009-6#2)
that the synthesis of##4##4##(1990-11#1)(1991-8#1)(1996-11#1)(1997-1#1)
that the synthesis##5##3##(1990-11#1)(1991-8#1)(1995-11#1)(1996-11#1)(1997-1#1)
that the synthetic##4##3##(1990-8#1)(1992-9#1)(2008-5#2)
that the system can##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
that the system is##2##4##(1994-1#1)(2011-2#1)
that the system##11##3##(1994-1#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2011-2#1)(2012-3#1)
that the tablets remained##2##4##(2012-2#2)
that the tandemly##2##3##(1993-12#1)(1995-8#1)
that the technique can##2##4##(2008-2#1)(2010-8#1)
that the technique could##2##4##(2008-10#1)(2008-7#1)
that the technique is##3##4##(2007-11#1)(2008-2#1)(2011-1#1)
that the technique may be##2##5##(1992-2#1)(2006-6#1)
that the technique##15##3##(1992-2#1)(1996-3#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2010-8#1)(2011-1#1)
that the temperature dependence of##2##5##(1994-12#1)(2008-3#1)
that the temperature##4##3##(1994-12#1)(2008-10#1)(2008-3#2)
that the temporal##7##3##(1993-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
that the tensile strength of##2##5##(2008-5#1)(2008-7#1)
that the tensile##3##3##(2008-5#1)(2008-7#1)(2009-7#1)
that the term &quot##2##4##(2008-8#1)(2009-11#1)
that the term##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)
that the terminal##2##3##(2008-12#1)(2008-8#1)
that the tertiary structure of the##2##6##(1990-12#1)(1990-5#1)
that the tertiary structure of##3##5##(1990-12#1)(1990-5#1)(1992-12#1)
that the test##2##3##(1995-6#1)(2008-10#1)
that the testing of##2##4##(1993-3#1)(2012-2#1)
that the theoretical##5##3##(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-3#1)
that the theory##2##3##(2008-11#1)(2008-3#1)
that the thermal##3##3##(2007-12#1)(2008-10#2)
that the thermodynamic##2##3##(1990-7#1)(1991-11#1)
that the thickness##3##3##(2008-3#1)(2008-5#1)(2010-2#1)
that the third##2##3##(1990-8#1)(1991-2#1)
that the threat of##2##4##(1994-2#1)(2011-2#1)
that the three groups##2##4##(2008-10#1)(2009-9#1)
that the three strains##2##4##(2008-10#1)(2008-7#1)
that the three##25##3##(1991-9#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-1#1)
that the three-dimensional##3##3##(1993-6#1)(1995-2#1)(2008-3#1)
that the threshold##3##3##(1993-12#1)(2007-12#1)(2008-10#1)
that the thymic##2##3##(1993-12#1)(2013-7#1)
that the thyroid##2##3##(1996-3#1)(1997-7#1)
that the time##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
that the tissue##3##3##(1992-9#2)(2008-6#1)
that the total amount of##2##5##(1991-6#1)(2008-10#1)
that the total number of##3##5##(1995-12#1)(2008-4#1)(2012-2#1)
that the total##17##3##(1991-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2012-2#1)
that the toxicity of the##2##5##(2007-2#1)(2008-12#1)
that the toxicity of##3##4##(2007-2#1)(2008-12#1)(2013-8#1)
that the toxicity##4##3##(2007-2#1)(2008-12#1)(2012-3#1)(2013-8#1)
that the toxin##3##3##(2008-10#3)
that the traditional##4##3##(1996-1#1)(2008-1#1)(2008-10#1)(2012-3#1)
that the trait##2##3##(1997-7#1)(2008-8#1)
that the transcription of##3##4##(1990-5#1)(1994-12#1)(1995-6#1)
that the transcription start##2##4##(1993-12#1)(2008-9#1)
that the transcription##6##3##(1990-5#1)(1993-12#1)(1994-12#1)(1995-6#1)(2008-9#1)(2010-11#1)
that the transcriptional##3##3##(1994-8#1)(1994-9#1)(2011-2#1)
that the transfer of##3##4##(1992-3#1)(2008-11#1)(2008-3#1)
that the transfer##6##3##(1992-3#1)(2007-12#2)(2008-11#1)(2008-3#1)(2009-11#1)
that the transformation##2##3##(2008-6#1)(2013-1#1)
that the transgenic##2##3##(2008-9#2)
that the transit##2##3##(1997-7#1)(2007-11#1)
that the transition##2##3##(1992-6#1)(1995-2#1)
that the translation##2##3##(2008-9#1)(2010-6#1)
that the transmission##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
that the transmittance of##2##4##(2008-3#2)
that the transport##2##3##(1994-6#1)(2008-10#1)
that the treatment of##2##4##(1990-5#1)(1991-8#1)
that the treatment with furosemide impairs##2##6##(1992-8#2)
that the treatment##9##3##(1990-5#1)(1991-8#1)(1992-8#2)(1994-11#1)(1997-6#1)(2008-10#1)(2009-4#1)(2013-8#1)
that the trial##3##3##(1996-5#1)(1997-5#1)(2009-6#1)
that the true##2##3##(2008-7#1)(2008-8#1)
that the tumor cells##3##4##(1997-1#2)(2009-8#1)
that the tumor was composed##2##5##(2008-12#1)(2013-8#1)
that the tumor was##5##4##(1994-7#2)(2008-12#1)(2013-1#1)(2013-8#1)
that the tumor##10##3##(1991-5#1)(1994-7#2)(1997-1#2)(2008-12#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
that the tumour was##2##4##(2008-7#1)(2012-2#1)
that the turnover of##2##4##(1997-2#1)(2008-10#1)
that the turnover##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
that the two genes##2##4##(1990-11#1)(2008-10#1)
that the two methods are##2##5##(2008-2#1)(2008-3#1)
that the two methods##3##4##(2008-2#1)(2008-3#1)(2013-7#1)
that the two species##3##4##(2008-10#2)(2008-9#1)
that the two##70##3##(1990-11#2)(1990-2#4)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-1#1)(1993-11#2)(1994-3#1)(1994-8#1)(1995-3#2)(1995-6#3)(1996-2#3)(1996-5#2)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
that the type I error##2##5##(2012-3#1)(2013-1#1)
that the type I##3##4##(1995-3#1)(2012-3#1)(2013-1#1)
that the type and##2##4##(1995-12#1)(2008-11#1)
that the type of##4##4##(1995-11#1)(1997-2#1)(2008-10#1)(2011-2#1)
that the type##11##3##(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
that the unique##2##3##(2007-11#1)(2008-6#1)
that the university##4##3##(2008-10#3)(2008-12#1)
that the unusual##2##3##(1993-3#1)(2008-10#1)
that the use of a##3##5##(1992-2#1)(2007-9#1)(2008-10#1)
that the use of an##2##5##(2008-3#1)(2008-5#1)
that the use of prophylactic##2##5##(2008-3#1)(2008-7#1)
that the use of the##5##5##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
that the use of this##3##5##(2008-11#1)(2008-3#1)(2013-1#1)
that the use of##58##4##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-2#1)(1993-2#1)(1994-3#2)(1996-2#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#1)
that the validity of##2##4##(2008-3#1)(2008-9#1)
that the value of##4##4##(1990-7#1)(1995-12#1)(2008-3#1)(2008-8#1)
that the values of##3##4##(2007-11#1)(2008-10#1)(2010-6#1)
that the values##5##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-6#1)
that the variability in the##2##5##(1991-12#1)(2008-10#1)
that the variant##2##3##(1992-12#1)(2008-12#1)
that the variation##2##3##(2009-5#1)(2010-10#1)
that the various##8##3##(1992-12#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-12#2)(2011-2#1)
that the vascular##4##3##(1991-9#1)(1997-6#1)(2008-10#1)(2008-5#1)
that the vast majority of##2##5##(2008-11#2)
that the vast##3##3##(2008-10#1)(2008-11#2)
that the vehicle in which a chemical is##2##8##(2008-5#2)
that the vehicle##4##3##(2008-5#4)
that the vesicular ER##2##4##(2009-8#2)
that the viral load##2##4##(2008-5#1)(2012-3#1)
that the viral##3##3##(2008-5#1)(2008-8#1)(2012-3#1)
that the virulence##2##3##(2008-10#2)
that the virus was##2##4##(1997-6#1)(2008-10#1)
that the virus##9##3##(1997-6#1)(2007-6#1)(2008-10#6)(2008-11#1)
that the viscosity of the##2##5##(2008-10#2)
that the viscosity##3##3##(2008-10#3)
that the visual input is both necessary and sufficient for the##2##11##(1991-2#2)
that the visual##5##3##(1991-2#2)(1995-12#1)(1995-5#1)(2008-8#1)
that the vulnerability of##2##4##(2012-2#1)(2013-1#1)
that the waiver program is##2##5##(1991-1#1)(1993-1#1)
that the waiver##3##3##(1991-1#1)(1992-2#1)(1993-1#1)
that the water molecules##2##4##(1992-9#1)(1995-5#1)
that the water-soluble fraction of Kefram-Kefir##2##6##(2008-11#2)
that the water-soluble fraction of##3##5##(2008-11#3)
that the wavelength##3##3##(2007-12#1)(2008-10#2)
that the weak CL of##2##5##(2008-10#2)
that the weak##3##3##(2008-10#3)
that the weight##2##3##(1993-2#1)(2008-10#1)
that the whole##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
that the width##2##3##(2008-3#2)
that the wild-type##2##3##(1990-5#1)(2008-10#1)
that the wireless ECG##2##4##(2010-8#2)
that the working##2##3##(1995-8#1)(2010-9#1)
that the yeast##2##3##(2008-2#1)(2008-8#1)
that the##7295##2##(1990-10#4)(1990-11#57)(1990-12#39)(1990-2#38)(1990-3#7)(1990-4#1)(1990-5#50)(1990-6#11)(1990-7#33)(1990-8#40)(1990-9#1)(1991-1#9)(1991-11#11)(1991-12#40)(1991-2#45)(1991-3#16)(1991-4#3)(1991-5#40)(1991-6#22)(1991-7#6)(1991-8#12)(1991-9#35)(1992-1#10)(1992-10#6)(1992-11#21)(1992-12#51)(1992-2#27)(1992-3#45)(1992-4#7)(1992-5#12)(1992-6#39)(1992-7#3)(1992-8#37)(1992-9#39)(1993-1#9)(1993-11#44)(1993-12#46)(1993-2#18)(1993-3#47)(1993-5#3)(1993-6#46)(1993-8#44)(1993-9#23)(1994-1#11)(1994-10#1)(1994-11#39)(1994-12#37)(1994-2#34)(1994-3#36)(1994-5#27)(1994-6#33)(1994-7#6)(1994-8#67)(1994-9#19)(1995-1#6)(1995-11#27)(1995-12#61)(1995-2#75)(1995-3#26)(1995-4#2)(1995-5#37)(1995-6#88)(1995-8#33)(1995-9#15)(1996-1#7)(1996-10#2)(1996-11#10)(1996-12#41)(1996-2#54)(1996-3#17)(1996-4#11)(1996-5#55)(1996-6#9)(1996-7#7)(1996-8#5)(1996-9#9)(1997-1#24)(1997-2#73)(1997-3#31)(1997-4#24)(1997-5#11)(1997-6#23)(1997-7#44)(1997-8#30)(1997-9#3)(2006-10#5)(2006-6#6)(2007-1#1)(2007-10#19)(2007-11#123)(2007-12#171)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#11)(2007-7#12)(2007-8#18)(2007-9#2)(2008-1#49)(2008-10#1153)(2008-11#324)(2008-12#93)(2008-2#242)(2008-3#459)(2008-4#70)(2008-5#214)(2008-6#85)(2008-7#194)(2008-8#303)(2008-9#170)(2009-1#4)(2009-10#17)(2009-11#26)(2009-12#13)(2009-2#12)(2009-3#10)(2009-4#10)(2009-5#17)(2009-6#29)(2009-7#29)(2009-8#48)(2009-9#20)(2010-1#14)(2010-10#14)(2010-11#22)(2010-12#17)(2010-2#30)(2010-3#31)(2010-4#21)(2010-5#22)(2010-6#22)(2010-7#14)(2010-8#39)(2010-9#5)(2011-1#60)(2011-10#2)(2011-2#170)(2011-3#20)(2012-1#25)(2012-12#56)(2012-2#97)(2012-3#85)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#150)(2013-7#19)(2013-8#123)
that their 5'##2##3##(1997-6#1)(2008-8#1)
that their development##2##3##(1994-3#1)(2010-3#1)
that their epitopes##2##3##(2008-8#2)
that their expression##3##3##(2008-12#1)(2008-6#1)(2010-4#1)
that their mechanisms##2##3##(2008-10#1)(2008-4#1)
that their##82##2##(1990-11#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
that then##4##2##(2008-3#1)(2009-9#1)(2010-7#1)(2013-1#1)
that therapeutic##3##2##(2007-11#1)(2008-6#1)(2009-6#1)
that therapy##2##2##(1990-11#1)(2008-7#1)
that there are a##2##4##(2008-4#1)(2008-8#1)
that there are at least three##2##6##(1992-8#1)(1993-2#1)
that there are at least##6##5##(1992-8#2)(1993-2#1)(2007-6#1)(2008-10#1)(2008-11#1)
that there are barriers##2##4##(1995-2#1)(1996-2#1)
that there are differences in##2##5##(1993-2#1)(1997-2#1)
that there are functional differences between##2##6##(1994-2#1)(1994-3#1)
that there are important##2##4##(1995-3#1)(2011-10#1)
that there are many##5##4##(1994-2#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-1#1)
that there are multiple##2##4##(1991-2#1)(2008-5#1)
that there are no significant differences between##2##7##(2008-10#2)
that there are no significant##4##5##(2008-10#2)(2008-11#1)(2010-3#1)
that there are no##9##4##(1994-9#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2010-3#1)
that there are only##3##4##(2008-10#1)(2008-3#2)
that there are several##2##4##(2008-2#1)(2008-3#1)
that there are significant##4##4##(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
that there are six##2##4##(1994-2#1)(2010-1#1)
that there are some##4##4##(1992-3#1)(2008-11#1)(2008-3#1)(2012-3#1)
that there are two##14##4##(1992-3#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2011-3#1)
that there are various##2##4##(2007-7#1)(2008-2#1)
that there are##114##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-3#2)(1992-8#3)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
that there can be##3##4##(2008-12#1)(2008-8#2)
that there could be##2##4##(1997-6#1)(2009-3#1)
that there exist##4##3##(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
that there exists a##3##4##(1990-12#1)(2008-3#1)(2008-5#1)
that there exists an##2##4##(1990-12#1)(2011-2#1)
that there exists##7##3##(1990-12#2)(1997-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
that there has been a##2##5##(1995-2#1)(2008-10#1)
that there has been##3##4##(1995-2#1)(1996-6#1)(2008-10#1)
that there have been##3##4##(2008-11#1)(2008-9#1)(2010-3#1)
that there is a complex##2##5##(2010-8#1)(2011-2#1)
that there is a connection between##2##6##(2007-10#1)(2008-8#1)
that there is a conserved##2##5##(1994-11#1)(1994-12#1)
that there is a finite##2##5##(1990-8#1)(2008-9#1)
that there is a good##3##5##(1993-1#1)(2008-10#1)(2008-6#1)
that there is a high##4##5##(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
that there is a need for##6##6##(2008-11#1)(2008-4#1)(2009-12#1)(2013-1#3)
that there is a need##7##5##(2008-11#1)(2008-4#1)(2009-12#1)(2010-5#1)(2013-1#3)
that there is a significant##4##5##(1995-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
that there is a strong##3##5##(1991-2#1)(1997-1#1)(2007-10#1)
that there is a##69##4##(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#4)
that there is an inverse relationship between##2##7##(2008-10#1)(2008-12#1)
that there is an optimum##2##5##(2008-2#2)
that there is an##16##4##(1990-7#1)(1991-1#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
that there is considerable##2##4##(1991-11#1)(2008-10#1)
that there is direct##2##4##(2008-7#1)(2011-2#1)
that there is little##5##4##(1996-3#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
that there is no direct relationship between##2##7##(1996-2#1)(2008-5#1)
that there is no direct##3##5##(1996-2#1)(2008-5#1)(2009-2#1)
that there is no evidence for##2##6##(2007-6#1)(2012-3#1)
that there is no evidence##4##5##(2007-6#1)(2007-8#1)(2008-6#1)(2012-3#1)
that there is no relationship between the##2##7##(2008-12#1)(2008-8#1)
that there is no relationship between##3##6##(2008-11#1)(2008-12#1)(2008-8#1)
that there is no significant##2##5##(1990-6#1)(2008-10#1)
that there is no##31##4##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-2#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
that there is not##3##4##(2008-3#1)(2008-5#1)(2010-8#1)
that there is room for improvement in the##2##8##(1996-2#1)(2008-3#1)
that there is significant##2##4##(2008-10#1)(2011-2#1)
that there is still a##3##5##(2008-4#1)(2009-5#1)(2011-2#1)
that there is still##4##4##(1994-9#1)(2008-4#1)(2009-5#1)(2011-2#1)
that there is substantial##3##4##(1994-3#2)(2008-3#1)
that there is widespread##2##4##(1992-3#1)(2008-7#1)
that there is##169##3##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-11#2)(1995-12#1)(1996-1#1)(1996-2#3)(1996-3#3)(1997-1#2)(1997-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#8)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#13)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
that there may be a##5##5##(1991-2#1)(1996-12#1)(2008-9#1)(2013-7#1)(2013-8#1)
that there may be##17##4##(1991-2#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#2)(2013-7#1)(2013-8#1)
that there may exist##2##4##(1995-5#1)(2008-8#1)
that there may##21##3##(1991-2#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#3)(2008-9#1)(2009-11#1)(2011-2#2)(2013-7#1)(2013-8#1)
that there might be##3##4##(2009-10#1)(2010-10#1)(2012-2#1)
that there must be##2##4##(2008-11#1)(2009-9#1)
that there was a good##2##5##(2008-10#1)(2008-5#1)
that there was a lack of##2##6##(2008-10#1)(2012-2#1)
that there was a significant decrease in##2##7##(2008-10#1)(2013-8#1)
that there was a significant##6##5##(1995-12#1)(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
that there was a strong##2##5##(1994-8#1)(2008-10#1)
that there was a wide variation in##2##7##(1997-3#1)(2012-3#1)
that there was a##30##4##(1991-12#1)(1991-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
that there was an improvement##3##5##(2008-5#3)
that there was an##9##4##(1997-8#1)(2008-10#1)(2008-5#3)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
that there was no evidence of##2##6##(2008-10#1)(2013-1#1)
that there was no significant difference between##2##7##(1997-8#1)(2008-10#1)
that there was no significant difference##3##6##(1997-8#1)(2008-10#1)(2011-1#1)
that there was no significant##4##5##(1995-12#1)(1997-8#1)(2008-10#1)(2011-1#1)
that there was no##20##4##(1991-2#1)(1992-12#1)(1995-12#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
that there was##78##3##(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#2)(2007-10#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#2)(2009-7#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
that there were many##3##4##(2008-10#2)(2008-8#1)
that there were no##6##4##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2012-3#1)
that there were significant differences among##2##6##(1993-2#1)(2012-3#1)
that there were significant differences in##2##6##(2007-12#1)(2008-10#1)
that there were significant differences##6##5##(1993-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2012-3#1)
that there were some##3##4##(2012-1#1)(2012-12#1)(2012-2#1)
that there were three##2##4##(2008-9#1)(2010-8#1)
that there were##36##3##(1990-5#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
that there##455##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-3#3)(1992-8#5)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#4)(1996-12#4)(1996-2#6)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#2)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#52)(2008-11#20)(2008-12#13)(2008-2#8)(2008-3#19)(2008-4#12)(2008-5#20)(2008-6#4)(2008-7#8)(2008-8#28)(2008-9#24)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#3)(2010-8#6)(2011-1#4)(2011-10#1)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#10)(2013-1#10)(2013-7#1)(2013-8#6)
that therefore##2##2##(1991-12#1)(2011-2#1)
that thermal lens spectrometry##2##4##(2008-10#2)
that thermal##5##2##(2007-12#1)(2008-10#3)(2008-9#1)
that thermally induced##2##3##(2008-3#2)
that thermally##3##2##(2008-2#1)(2008-3#2)
that these X##2##3##(1993-6#1)(2008-10#1)
that these actions##3##3##(1997-2#1)(2008-11#1)(2012-2#1)
that these agents##4##3##(1995-6#1)(2008-7#1)(2010-11#1)(2010-5#1)
that these antibodies are##2##4##(1991-2#1)(1995-12#1)
that these antibodies##4##3##(1991-2#1)(1994-9#1)(1995-12#1)(2008-11#1)
that these are##6##3##(1996-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-3#1)
that these aspects of##2##4##(2007-12#1)(2008-11#1)
that these can be used##2##5##(1995-3#1)(2008-3#1)
that these can be##3##4##(1995-3#1)(2008-3#1)(2008-5#1)
that these can##4##3##(1995-3#1)(2008-2#1)(2008-3#1)(2008-5#1)
that these cells##4##3##(1990-8#1)(1996-12#1)(2006-10#1)(2008-11#1)
that these changes##3##3##(1992-6#1)(1992-9#1)(2011-2#1)
that these characteristics##2##3##(1991-3#1)(2008-5#1)
that these clusters are##2##4##(1993-11#1)(1997-8#1)
that these compounds are##5##4##(1991-9#1)(2006-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
that these compounds possess##2##4##(2008-10#1)(2008-5#1)
that these compounds##10##3##(1991-5#1)(1991-9#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
that these conditions##2##3##(2008-10#1)(2008-3#1)
that these conserved##2##3##(2012-2#1)(2012-3#1)
that these cytokines are##2##4##(1992-8#1)(2008-3#1)
that these data##2##3##(1990-2#1)(2008-3#1)
that these differences are##2##4##(1994-1#1)(2008-3#1)
that these differences##5##3##(1992-3#1)(1993-3#1)(1994-1#1)(1997-7#1)(2008-3#1)
that these disorders##2##3##(2011-2#1)(2012-3#1)
that these drugs may##3##4##(1993-2#1)(1993-8#1)(1995-2#1)
that these drugs##4##3##(1993-2#1)(1993-8#1)(1995-2#1)(2012-1#1)
that these effects are##2##4##(1992-11#1)(2009-6#1)
that these effects##4##3##(1992-11#1)(2007-12#1)(2009-6#1)(2012-3#1)
that these elements are##2##4##(1995-8#1)(2008-10#1)
that these factors##6##3##(1993-12#1)(1993-2#1)(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
that these findings were##2##4##(2007-12#1)(2008-11#1)
that these findings##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
that these four##2##3##(1990-7#1)(2008-10#1)
that these fragments##2##3##(1992-9#1)(2008-8#1)
that these genes are##2##4##(1990-8#1)(2009-8#1)
that these genes may play##2##5##(2008-7#2)
that these genes may##3##4##(2008-10#1)(2008-7#2)
that these genes were##2##4##(1996-8#1)(2010-4#1)
that these genes##11##3##(1990-8#1)(1991-9#1)(1992-3#1)(1995-12#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-4#1)
that these individuals##3##3##(1991-12#2)(2008-10#1)
that these induced##2##3##(2008-7#1)(2009-10#1)
that these metal ions##3##4##(2008-10#3)
that these methods are##2##4##(2008-1#1)(2008-5#1)
that these methods##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
that these mutations##3##3##(1993-11#1)(1994-9#1)(1995-2#1)
that these neurons##2##3##(2009-10#1)(2013-8#1)
that these novel##4##3##(1995-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
that these nuclear##2##3##(1992-12#1)(2007-12#1)
that these nurses##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
that these parameters##3##3##(1992-3#1)(1996-5#1)(2008-7#1)
that these patients##2##3##(2009-5#1)(2012-3#1)
that these patterns##3##3##(2008-11#1)(2008-8#2)
that these peptides##2##3##(1996-12#1)(2008-1#1)
that these phenomena##2##3##(2008-7#1)(2010-3#1)
that these populations are##2##4##(2008-10#2)
that these populations##4##3##(2008-10#3)(2011-2#1)
that these processes##2##3##(2008-10#1)(2008-7#1)
that these proteins are##4##4##(1994-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
that these proteins##8##3##(1993-8#1)(1994-11#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
that these receptors##2##3##(2008-4#1)(2008-5#1)
that these regions##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
that these relationships##3##3##(1990-11#1)(2009-4#1)(2009-5#1)
that these results##4##3##(1997-2#1)(2008-2#1)(2008-8#1)(2013-8#1)
that these species are##2##4##(2008-10#1)(2008-11#1)
that these species##4##3##(1997-7#1)(2008-10#2)(2008-11#1)
that these steroids##2##3##(1990-2#1)(1995-12#1)
that these strains##3##3##(2008-10#1)(2013-8#2)
that these structures##2##3##(1993-5#1)(2008-7#1)
that these students had##2##4##(2008-11#2)
that these students##3##3##(2008-11#3)
that these studies##3##3##(2008-7#1)(2009-2#1)(2009-3#1)
that these tissues##2##3##(2008-1#1)(2012-2#1)
that these treatments##2##3##(2008-10#1)(2009-7#1)
that these two proteins are##2##5##(1990-8#1)(1993-11#1)
that these two proteins##3##4##(1990-8#1)(1993-11#1)(1997-7#1)
that these two##35##3##(1990-12#2)(1990-8#1)(1992-12#2)(1992-2#2)(1992-5#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
that these vectors##2##3##(1997-4#2)
that these will##2##3##(2008-11#1)(2009-5#1)
that these##438##2##(1990-11#1)(1990-12#4)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#6)(1990-8#4)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#11)(1995-3#3)(1995-5#5)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#4)(2006-10#2)(2006-6#2)(2007-11#5)(2007-12#13)(2007-6#1)(2008-1#7)(2008-10#52)(2008-11#25)(2008-12#3)(2008-2#5)(2008-3#13)(2008-4#5)(2008-5#14)(2008-6#2)(2008-7#18)(2008-8#9)(2008-9#6)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#14)(2012-1#3)(2012-12#1)(2012-2#14)(2012-3#10)(2012-6#1)(2013-1#4)(2013-8#7)
that they &quot##2##3##(1990-6#1)(1993-3#1)
that they act as##2##4##(1992-2#1)(1992-9#1)
that they act##3##3##(1992-2#1)(1992-9#1)(2009-8#1)
that they all##3##3##(1992-11#1)(2008-12#1)(2011-2#1)
that they allow##2##3##(1992-3#1)(2008-10#1)
that they are all##2##4##(1994-6#1)(1996-10#1)
that they are effective##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
that they are in##4##4##(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)
that they are not##5##4##(1991-12#1)(2007-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
that they are separated by##2##5##(2008-10#1)(2008-8#1)
that they are the##2##4##(1991-2#1)(2008-11#1)
that they are transcribed##2##4##(1996-6#1)(2012-3#1)
that they are two##2##4##(1990-12#1)(2008-10#1)
that they are##78##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
that they belong to##2##4##(2008-11#1)(2008-8#1)
that they can be##8##4##(1994-3#1)(2008-10#1)(2008-2#1)(2008-9#3)(2011-2#1)(2013-8#1)
that they can##22##3##(1991-3#1)(1994-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
that they could be##2##4##(1996-9#1)(2008-10#1)
that they could##9##3##(1994-3#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#2)(2013-8#1)
that they did not##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
that they differ##2##3##(1996-5#1)(2008-7#1)
that they do not##7##4##(1992-12#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
that they do##9##3##(1991-2#1)(1991-9#1)(1992-12#1)(1993-8#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
that they experienced##2##3##(2010-3#1)(2012-2#1)
that they felt##2##3##(1994-3#1)(2008-11#1)
that they function##2##3##(1993-12#1)(2008-6#1)
that they gained##2##3##(2011-1#1)(2012-12#1)
that they had received##3##4##(1994-2#1)(1995-6#1)(2007-7#1)
that they had##16##3##(1992-2#1)(1992-6#1)(1994-2#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-12#1)
that they have a##3##4##(1991-12#1)(2008-1#1)(2008-5#1)
that they have to##2##4##(1993-9#1)(2012-2#1)
that they have##25##3##(1990-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-1#1)(1997-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2010-12#1)(2012-2#2)(2013-1#1)
that they include##2##3##(1997-3#1)(2008-11#1)
that they interact##2##3##(1994-2#1)(2008-4#1)
that they lacked##2##3##(2008-10#1)(2011-1#1)
that they may be involved in##2##6##(1994-5#1)(2010-4#1)
that they may be##6##4##(1993-8#1)(1994-5#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)
that they may have##3##4##(1991-2#1)(1992-2#1)(2008-5#1)
that they may##21##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
that they might##2##3##(1996-2#1)(2008-3#1)
that they must##2##3##(1996-2#1)(2008-12#1)
that they never##2##3##(1993-1#1)(2008-8#1)
that they offer a##2##4##(2008-10#1)(2008-7#1)
that they offer##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
that they often##2##3##(2008-10#1)(2011-2#1)
that they originate from##2##4##(1992-3#1)(1997-1#1)
that they perceived##2##3##(2008-11#1)(2012-3#1)
that they play a##2##4##(2008-10#1)(2008-7#1)
that they play##3##3##(1991-3#1)(2008-10#1)(2008-7#1)
that they provide##2##3##(2008-3#1)(2008-9#1)
that they remain##2##3##(1997-4#1)(2008-1#1)
that they represent##4##3##(1993-12#1)(2008-10#2)(2011-2#1)
that they share##5##3##(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#2)
that they support the##2##4##(2010-5#1)(2012-2#1)
that they use##3##3##(1993-12#1)(2008-11#1)(2012-12#1)
that they used##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
that they were derived from##3##5##(2008-10#3)
that they were either##2##4##(2007-12#1)(2013-8#1)
that they were not##2##4##(2007-11#1)(2008-7#1)
that they were##46##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#2)
that they will be##3##4##(1992-2#1)(1997-3#1)(1997-7#1)
that they will##8##3##(1992-12#1)(1992-2#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
that they would##12##3##(1990-6#2)(1993-2#1)(1995-12#1)(2007-2#1)(2008-12#1)(2010-4#4)(2011-2#1)(2012-12#1)
that they##424##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-6#3)(1990-8#1)(1991-12#4)(1991-2#5)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#6)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#3)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#12)(2007-2#5)(2007-5#1)(2007-7#1)(2008-1#8)(2008-10#47)(2008-11#20)(2008-12#10)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#18)(2008-8#16)(2008-9#13)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#4)(2010-4#7)(2010-5#4)(2010-8#5)(2011-1#3)(2011-2#20)(2012-12#10)(2012-2#8)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#6)
that thiamine##2##2##(1994-11#1)(2008-1#1)
that third variables##3##3##(1997-4#3)
that this &quot##4##3##(1993-1#1)(1995-5#1)(1996-9#1)(2009-3#1)
that this DNA fragment##2##4##(2008-8#2)
that this activation##3##3##(1993-12#1)(1994-2#1)(2012-12#1)
that this activity is##3##4##(1992-10#1)(1994-9#1)(2008-4#1)
that this activity##4##3##(1992-10#1)(1992-3#1)(1994-9#1)(2008-4#1)
that this agent is##2##4##(1995-8#1)(2008-7#1)
that this agent##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
that this antibody##3##3##(2008-6#1)(2013-1#2)
that this approach can##4##4##(1995-6#1)(2008-11#1)(2008-2#1)(2008-6#1)
that this approach##11##3##(1992-9#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)
that this approximation##2##3##(2008-3#1)(2013-1#1)
that this area may##2##4##(2007-12#1)(2008-10#1)
that this area##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
that this cDNA##3##3##(1990-12#1)(1993-11#1)(2008-8#1)
that this change##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
that this class##2##3##(1991-11#1)(2008-5#1)
that this clone##2##3##(1993-6#1)(2008-8#1)
that this combination##3##3##(1997-7#1)(2013-1#1)(2013-7#1)
that this component##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
that this compound##6##3##(1991-8#1)(1993-9#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
that this condition is##2##4##(2008-3#1)(2009-4#1)
that this condition##4##3##(2008-10#2)(2008-3#1)(2009-4#1)
that this cycle##2##3##(2008-9#2)
that this cysteine is##2##4##(1992-3#1)(1992-8#1)
that this device##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
that this difference##2##3##(1994-3#1)(2012-3#1)
that this discussion will##2##4##(1992-2#1)(2008-11#1)
that this disease##3##3##(1994-8#1)(1994-9#1)(1997-8#1)
that this distinction##2##3##(2008-11#1)(2008-3#1)
that this drug##2##3##(1990-10#1)(2011-2#1)
that this effect can be##2##5##(2008-3#2)
that this effect is mediated##2##5##(1993-3#1)(1993-6#1)
that this effect is##4##4##(1993-3#1)(1993-6#1)(2007-10#1)(2009-4#1)
that this effect may be##4##5##(1994-8#1)(2008-3#1)(2008-4#1)(2013-1#1)
that this effect##13##3##(1993-3#1)(1993-6#1)(1994-8#1)(2007-10#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
that this enzyme##4##3##(1992-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
that this event##3##3##(1994-10#1)(2008-10#1)(2009-10#1)
that this factor##3##3##(1992-3#1)(1992-6#1)(1994-12#1)
that this family of##3##4##(1996-9#1)(2008-6#1)(2010-3#1)
that this form##2##3##(1990-5#1)(1993-6#1)
that this fragment##3##3##(1990-5#1)(1991-9#1)(1996-8#1)
that this gene and##2##4##(1992-3#1)(1994-12#1)
that this gene is##4##4##(1990-12#1)(1991-6#1)(1993-9#1)(1994-12#1)
that this gene##11##3##(1990-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#2)(2008-2#1)(2008-8#2)(2008-9#1)
that this group of##2##4##(2008-11#1)(2012-2#1)
that this group##4##3##(1994-9#1)(2008-11#1)(2008-2#1)(2012-2#1)
that this growth##2##3##(2008-10#1)(2008-11#1)
that this has##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
that this in vitro##4##4##(2008-11#2)(2008-5#2)
that this in##6##3##(1990-12#1)(2008-11#2)(2008-5#2)(2010-4#1)
that this increase is##2##4##(1993-8#1)(2011-1#1)
that this increase##5##3##(1993-8#1)(1995-5#1)(2007-12#1)(2008-11#1)(2011-1#1)
that this increased##4##3##(1994-5#1)(2008-10#1)(2008-7#2)
that this information will be useful##2##6##(2008-12#1)(2012-2#1)
that this inhibitory##2##3##(2008-10#1)(2008-7#1)
that this interaction##2##3##(2008-10#1)(2013-8#1)
that this is a##12##4##(1990-8#1)(1991-3#1)(1993-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#1)(2013-7#1)
that this is an important##2##5##(1993-1#1)(2008-10#1)
that this is an##3##4##(1993-1#1)(2008-1#1)(2008-10#1)
that this is due to the##3##6##(2006-10#1)(2008-10#1)(2008-3#1)
that this is due to##4##5##(2006-10#1)(2008-10#1)(2008-3#1)(2012-3#1)
that this is due##5##4##(2006-10#1)(2008-10#1)(2008-3#1)(2012-3#2)
that this is not a##2##5##(1994-2#1)(2008-3#1)
that this is not##5##4##(1994-2#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-12#1)
that this is the##5##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-3#1)
that this is##40##3##(1990-8#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-8#1)(2009-1#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
that this kind of##2##4##(1990-10#1)(2008-3#1)
that this laser##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-5#1)
that this may be##4##4##(1990-5#1)(1991-2#1)(2008-8#1)(2009-4#1)
that this may##7##3##(1990-5#1)(1991-2#1)(1991-5#1)(2008-7#2)(2008-8#1)(2009-4#1)
that this metabolic##2##3##(1995-9#1)(2012-2#1)
that this method can be applied to##2##7##(1994-9#1)(2008-3#1)
that this method can be##5##5##(1992-5#1)(1994-9#1)(2008-11#1)(2008-3#2)
that this method can##8##4##(1992-5#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#2)
that this method has a##2##5##(2008-10#1)(2013-8#1)
that this method has##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
that this method is useful for##2##6##(2007-11#1)(2008-2#1)
that this method is##3##4##(2007-11#1)(2008-2#1)(2013-8#1)
that this method might##2##4##(2007-10#1)(2008-10#1)
that this method of##2##4##(2008-11#1)(2010-8#1)
that this method will##2##4##(2008-4#1)(2011-2#1)
that this method##25##3##(1992-5#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-8#2)
that this model##5##3##(2008-10#2)(2008-2#1)(2012-2#1)(2013-8#1)
that this molecule##3##3##(1993-6#1)(2008-10#2)
that this new##17##3##(1991-2#1)(1992-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2011-7#1)(2012-2#2)
that this novel##2##3##(1997-4#1)(2008-3#1)
that this operation##2##3##(2008-3#2)
that this organism##2##3##(1997-1#1)(1997-7#1)
that this particular##3##3##(1995-5#1)(2008-10#1)(2009-1#1)
that this pathogen##3##3##(2008-10#2)(2012-3#1)
that this peptide##2##3##(2008-10#1)(2008-3#1)
that this pest##2##3##(2011-2#1)(2013-8#1)
that this phenomenon is##2##4##(1992-8#1)(1997-7#1)
that this phenomenon was##2##4##(1990-5#1)(2008-9#1)
that this phenomenon##5##3##(1990-5#1)(1992-8#1)(1997-7#1)(2007-11#1)(2008-9#1)
that this population##3##3##(2008-10#2)(2013-1#1)
that this problem##2##3##(1997-8#1)(2007-11#1)
that this procedure##4##3##(2008-10#2)(2009-8#1)(2012-2#1)
that this process is##5##4##(1990-6#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
that this process##9##3##(1990-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)
that this property##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
that this protein##8##3##(1990-5#1)(1991-5#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2009-4#1)
that this receptor is##3##4##(1995-11#1)(1996-5#1)(2008-5#1)
that this receptor##5##3##(1993-3#1)(1994-8#1)(1995-11#1)(1996-5#1)(2008-5#1)
that this region is##4##4##(1990-12#1)(1990-6#1)(1990-8#1)(2008-5#1)
that this region##9##3##(1990-12#1)(1990-6#1)(1990-8#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-5#2)
that this regulation is##2##4##(1993-5#1)(2008-8#1)
that this relationship##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
that this residue is##2##4##(1992-8#1)(1993-8#1)
that this residue##4##3##(1990-8#2)(1992-8#1)(1993-8#1)
that this resistance##3##3##(2008-10#2)(2009-9#1)
that this response##2##3##(1991-5#1)(1992-3#1)
that this results in##2##4##(2008-10#1)(2008-6#1)
that this review##2##3##(2008-5#1)(2009-9#1)
that this role is##3##4##(1992-9#1)(1997-7#1)(2012-2#1)
that this role##4##3##(1992-9#1)(1997-7#1)(2008-10#1)(2012-2#1)
that this sensor can##2##4##(2008-10#1)(2008-2#1)
that this sequence is##2##4##(1991-11#1)(1995-6#1)
that this simple##2##3##(2008-3#1)(2010-3#1)
that this site may##2##4##(1991-12#1)(1997-3#1)
that this site##3##3##(1991-12#1)(1997-3#1)(2008-9#1)
that this species is##2##4##(2008-10#1)(2012-6#1)
that this species may##2##4##(1992-8#1)(2008-6#1)
that this species##5##3##(1992-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-6#1)
that this specific##2##3##(1996-5#1)(2011-2#1)
that this strain##2##3##(2008-10#1)(2012-2#1)
that this strategy##3##3##(1997-2#1)(2008-3#1)(2010-11#1)
that this structure##2##3##(2007-11#1)(2008-10#1)
that this study##3##3##(2007-8#1)(2008-6#1)(2010-8#1)
that this system##4##3##(1997-8#1)(2008-11#1)(2009-11#1)(2010-2#1)
that this technique can also be used to##2##8##(2008-3#1)(2013-8#1)
that this technique can also##3##5##(2008-3#1)(2009-2#1)(2013-8#1)
that this technique can##7##4##(2007-11#1)(2008-10#2)(2008-3#2)(2009-2#1)(2013-8#1)
that this technique is##5##4##(1997-7#1)(2007-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
that this technique will##2##4##(2007-12#1)(2012-2#1)
that this technique##18##3##(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-3#4)(2009-2#1)(2009-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
that this technology##2##3##(2008-10#1)(2011-2#1)
that this therapy##2##3##(1990-9#1)(2012-2#1)
that this treatment##2##3##(2008-8#1)(2010-5#1)
that this type of##5##4##(1991-11#1)(1994-11#1)(1997-5#1)(2008-5#1)(2013-1#1)
that this virus##5##3##(2008-10#4)(2008-12#1)
that this was a##2##4##(2007-2#1)(2011-2#1)
that this was##7##3##(1993-12#1)(1995-5#1)(2006-4#1)(2007-2#1)(2008-10#1)(2011-2#2)
that this will be##2##4##(2008-11#1)(2008-5#1)
that this will##7##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
that this would be##2##4##(1994-5#1)(2008-10#1)
that this would##4##3##(1994-5#1)(1997-1#1)(2008-10#2)
that this yeast##2##3##(2008-7#1)(2009-12#1)
that this##737##2##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#1)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#6)(1992-5#2)(1992-6#4)(1992-8#9)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#8)(1993-8#6)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1994-7#1)(1994-8#4)(1994-9#4)(1995-11#7)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#8)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#3)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#3)(2006-10#3)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#15)(2007-12#19)(2007-2#4)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#94)(2008-11#38)(2008-12#9)(2008-2#21)(2008-3#45)(2008-4#7)(2008-5#29)(2008-6#10)(2008-7#19)(2008-8#26)(2008-9#9)(2009-1#4)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#16)(2011-7#1)(2012-12#6)(2012-2#17)(2012-3#9)(2012-6#1)(2013-1#16)(2013-7#4)(2013-8#10)
that those of##2##3##(2007-10#1)(2008-10#1)
that those who##2##3##(2009-7#1)(2010-2#1)
that those##12##2##(1991-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
that though##2##2##(2010-4#1)(2011-2#1)
that threaten##2##2##(1994-12#1)(2008-12#1)
that three different##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
that three of the##3##4##(1992-9#1)(1994-9#1)(1997-1#1)
that three of##5##3##(1992-9#1)(1994-9#1)(1997-1#1)(2008-10#1)(2008-3#1)
that three##27##2##(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)
that three-dimensional##2##2##(2008-2#2)
that thrips##2##2##(2008-10#2)
that thrombin##2##2##(1997-7#2)
that through the##2##3##(2008-12#1)(2013-8#1)
that through##6##2##(2007-6#1)(2008-12#1)(2008-5#1)(2013-1#2)(2013-8#1)
that thymocytes##2##2##(2008-10#1)(2008-8#1)
that thyroid hormones##2##3##(1990-8#1)(2013-8#1)
that thyroid##4##2##(1990-8#1)(1993-3#1)(2011-1#1)(2013-8#1)
that time##32##2##(1990-10#1)(1990-8#1)(1991-4#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
that timing##3##2##(2008-1#1)(2008-10#1)(2010-7#1)
that tissue##5##2##(1995-11#1)(2007-11#1)(2008-10#1)(2011-1#2)
that to achieve##2##3##(1995-1#1)(2008-7#1)
that to the##4##3##(1996-5#1)(2008-10#3)
that to##26##2##(1991-12#2)(1992-1#1)(1992-6#1)(1993-8#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-3#1)(2013-1#2)
that tobacco##3##2##(1996-1#1)(2007-12#1)(2008-12#1)
that together##6##2##(1995-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
that tolerance##5##2##(1992-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
that too many##2##3##(2007-11#1)(2010-12#1)
that too##4##2##(2007-11#1)(2008-11#1)(2010-12#1)(2012-12#1)
that took into account##3##4##(1992-9#1)(1997-5#1)(2008-10#1)
that took place in##3##4##(1997-5#1)(2012-2#1)(2013-1#1)
that took place##7##3##(1994-3#1)(1997-5#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
that took##10##2##(1992-9#1)(1994-3#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
that topical application##2##3##(1990-11#1)(2011-2#1)
that topical##3##2##(1990-11#1)(2008-8#1)(2011-2#1)
that topological distance indices##2##4##(2007-11#2)
that total##5##2##(1993-3#1)(1994-3#1)(2008-12#2)(2012-2#1)
that toxicity##2##2##(2008-10#1)(2008-9#1)
that trace##6##2##(2008-1#1)(2008-10#4)(2013-1#1)
that traditional##11##2##(1995-3#1)(1996-1#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#2)
that traditionally have##2##3##(1993-12#1)(2008-3#1)
that trafficking##2##2##(2009-2#1)(2012-2#1)
that training##4##2##(1992-1#1)(1995-12#1)(2007-11#1)(2008-12#1)
that trait##4##2##(2008-11#2)(2008-8#1)(2012-3#1)
that traits that##2##3##(2008-8#1)(2012-3#1)
that transcription of the##3##4##(1990-11#1)(1994-8#1)(1995-8#1)
that transcription of##4##3##(1990-11#1)(1994-8#1)(1995-6#1)(1995-8#1)
that transcription##6##2##(1990-11#1)(1992-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-2#1)
that transcriptional control##2##3##(1993-8#1)(1994-12#1)
that transcriptional##6##2##(1993-8#1)(1994-11#1)(1994-12#1)(2008-8#1)(2012-3#2)
that transfer of##2##3##(1992-12#1)(2008-2#1)
that transfer##6##2##(1992-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-1#1)
that transfers##2##2##(2008-1#1)(2013-1#1)
that transformation##2##2##(1991-8#1)(2011-2#1)
that transforms##2##2##(2008-3#2)
that transgenic##5##2##(1996-6#1)(2008-10#3)(2008-8#1)
that transient expression##2##3##(1997-7#1)(2008-9#1)
that transient##4##2##(1991-3#1)(1997-7#1)(2008-11#1)(2008-9#1)
that translation of##2##3##(1991-1#1)(2008-10#1)
that translocation of##3##3##(1991-12#1)(1994-8#1)(2008-9#1)
that translocation##5##2##(1991-12#1)(1994-12#1)(1994-8#1)(2008-9#1)(2009-2#1)
that transmission of##3##3##(2007-11#1)(2008-10#2)
that transmission##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
that transmit##3##2##(2008-10#2)(2012-2#1)
that transmits##2##2##(2008-10#1)(2008-3#1)
that transplantation of##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
that transport##2##2##(1991-2#1)(2011-2#1)
that travel##3##2##(2007-2#1)(2008-1#1)(2008-3#1)
that treat##4##2##(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)
that treated##5##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
that treating##2##2##(2008-8#1)(2012-12#1)
that treatment aimed at the##2##5##(2010-1#1)(2010-9#1)
that treatment of##9##3##(1990-5#1)(1992-6#1)(1994-11#1)(1997-5#1)(2008-10#2)(2008-4#2)(2011-2#1)
that treatment with VPA##2##4##(2011-2#2)
that treatment with##23##3##(1990-12#1)(1990-6#1)(1991-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-3#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#3)(2012-12#1)
that treatment##40##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)
that treatments for##2##3##(2012-12#1)(2012-2#1)
that treatments##4##2##(2008-3#1)(2011-10#1)(2012-12#1)(2012-2#1)
that treats##3##2##(2007-12#1)(2008-2#1)(2012-3#1)
that trigger##2##2##(2011-2#1)(2012-3#1)
that triggered##2##2##(2008-9#1)(2012-2#1)
that triggers##3##2##(2009-5#1)(2010-3#1)(2013-8#1)
that true##6##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)
that try to##2##3##(2009-8#1)(2011-2#1)
that try##3##2##(1995-1#1)(2009-8#1)(2011-2#1)
that trypsin cleaved the##2##4##(1993-11#2)
that trypsin##3##2##(1992-3#1)(1993-11#2)
that tumor##8##2##(1994-11#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
that tumors##2##2##(1997-4#1)(2008-12#1)
that tumour##3##2##(2008-1#2)(2011-2#1)
that two different##4##3##(1994-5#1)(1995-5#1)(2008-8#1)(2009-2#1)
that two of the four##2##5##(1992-11#1)(1992-3#1)
that two of the##6##4##(1992-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#1)
that two of them##2##4##(2008-9#1)(2012-3#1)
that two of##8##3##(1992-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
that two regions##2##3##(1991-2#1)(1992-9#1)
that two types of##2##4##(2008-2#1)(2008-6#1)
that two##64##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(2007-8#1)(2008-10#11)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
that two-photon##3##2##(2008-3#3)
that type IV##2##3##(2008-8#2)
that type##5##2##(1990-12#1)(1996-4#1)(2007-12#1)(2008-8#2)
that typically##8##2##(1991-12#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)
that typify##2##2##(1992-3#1)(2008-6#1)
that tyrosine phosphorylation##2##3##(1996-12#1)(1996-5#1)
that tyrosine##4##2##(1993-3#1)(1994-11#1)(1996-12#1)(1996-5#1)
that ultimately leads to##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
that ultimately##11##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
that ultrasound##5##2##(1991-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
that under certain circumstances##2##4##(1995-8#1)(2007-8#1)
that under certain##3##3##(1995-8#1)(2007-11#1)(2007-8#1)
that under the##5##3##(1990-6#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
that under##24##2##(1990-6#1)(1991-12#1)(1992-3#1)(1994-12#1)(1995-8#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
that undergo##6##2##(1994-8#1)(1997-2#1)(2008-8#1)(2009-5#1)(2010-4#2)
that undergoes##2##2##(2008-12#1)(2008-3#1)
that underlie the##4##3##(2008-10#1)(2008-9#1)(2009-8#1)(2010-4#1)
that underlie these##2##3##(2008-11#1)(2009-3#1)
that underlie this##2##3##(2008-11#1)(2012-12#1)
that underlie##17##2##(1995-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#3)(2012-12#2)(2013-1#1)
that underlies##5##2##(1992-11#1)(2007-8#1)(2008-10#1)(2010-11#1)(2012-3#1)
that understanding##3##2##(1994-11#1)(2008-11#1)(2011-1#1)
that underwent##12##2##(1990-6#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
that undifferentiated##2##2##(1992-12#1)(1992-3#1)
that unilateral##2##2##(1993-12#1)(2013-8#1)
that unique##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
that uniquely##2##2##(1997-4#1)(2008-7#1)
that universal##2##2##(1995-2#1)(2010-4#1)
that unlike##2##2##(1990-5#1)(1995-11#1)
that until##3##2##(1992-11#1)(1995-5#1)(2008-8#1)
that up to##4##3##(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
that up-regulation of##2##3##(1996-12#1)(2008-4#1)
that up-regulation##3##2##(1996-12#1)(2008-4#2)
that upregulation##2##2##(2008-4#2)
that urgent##2##2##(2008-3#1)(2008-8#1)
that urinary##5##2##(1991-12#1)(1992-3#1)(2008-10#2)(2008-7#1)
that urine##4##2##(1990-12#1)(1990-2#1)(1995-3#1)(2011-2#1)
that use a single##2##4##(2008-3#2)
that use a##6##3##(2008-2#2)(2008-3#4)
that use of a##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
that use of this##3##4##(1994-2#1)(2008-10#1)(2010-7#1)
that use of##15##3##(1993-12#1)(1994-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
that use the##7##3##(2007-11#2)(2008-2#1)(2008-3#3)(2008-4#1)
that use various##2##3##(2008-3#1)(2008-7#1)
that use##75##2##(1990-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#2)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#23)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#5)
that used a##4##3##(2008-2#1)(2008-3#2)(2013-1#1)
that used by##2##3##(1993-6#1)(2008-10#1)
that used in##2##3##(2008-3#1)(2010-10#1)
that used the##2##3##(2009-2#1)(2012-2#1)
that used##29##2##(1993-6#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-4#1)(2009-2#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#6)
that users##2##2##(2008-9#1)(2011-2#1)
that uses a novel##2##4##(2007-11#1)(2007-12#1)
that uses a simple##2##4##(2007-12#2)
that uses a single##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
that uses a##55##3##(1993-1#1)(2007-11#7)(2007-12#6)(2008-2#4)(2008-3#29)(2008-6#2)(2008-7#3)(2009-12#1)(2012-2#1)(2012-3#1)
that uses an inclined##2##4##(2008-3#2)
that uses an##13##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)(2012-3#1)(2013-1#1)
that uses fully phase encryption##2##5##(2008-3#2)
that uses human##2##3##(1994-12#1)(2013-1#1)
that uses local##2##3##(2007-12#1)(2012-3#1)
that uses only##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
that uses phase##2##3##(2007-11#1)(2008-2#1)
that uses the##15##3##(2008-2#6)(2008-3#8)(2008-6#1)
that uses two##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
that uses##182##2##(1991-5#1)(1992-6#1)(1993-1#1)(1994-12#1)(1995-12#1)(1997-2#1)(2007-11#20)(2007-12#15)(2008-10#5)(2008-2#23)(2008-3#83)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
that using a##4##3##(1995-1#1)(2008-10#1)(2008-11#2)
that using the##3##3##(2008-3#1)(2008-8#1)(2010-5#1)
that using##23##2##(1991-5#1)(1993-2#1)(1994-2#1)(1995-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
that usually appears##2##3##(2008-3#1)(2013-1#1)
that usually occurs in##3##4##(2008-11#1)(2013-1#2)
that usually##15##2##(1997-3#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#3)
that utilization##2##2##(1993-3#1)(1996-3#1)
that utilize both##2##3##(2008-4#1)(2008-9#1)
that utilize the##4##3##(1997-4#1)(2007-12#1)(2008-2#1)(2010-5#1)
that utilize##14##2##(1990-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)
that utilized##3##2##(2008-10#2)(2012-2#1)
that utilizes the##7##3##(1994-5#1)(2007-11#1)(2007-12#1)(2008-3#2)(2011-1#1)(2012-2#1)
that utilizes##17##2##(1994-5#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#4)(2008-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
that vaccination##4##2##(1996-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
that vaccines##2##2##(2008-5#1)(2011-2#1)
that value##6##2##(1995-5#1)(1997-2#1)(2008-10#3)(2008-12#1)
that values##2##2##(2008-3#1)(2012-2#1)
that variability in##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
that variable##2##2##(1990-11#1)(2008-8#1)
that variation in##6##3##(2007-5#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
that variation##7##2##(2007-5#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
that variations in##5##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
that varied from##2##3##(1995-3#1)(2008-11#1)
that varied in##2##3##(2008-10#1)(2009-5#1)
that varied with##2##3##(2013-1#2)
that varied##10##2##(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-5#1)(2013-1#2)
that varies with##2##3##(2010-2#1)(2011-2#1)
that varies##5##2##(2008-10#1)(2008-3#2)(2010-2#1)(2011-2#1)
that various##13##2##(1991-2#1)(1994-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
that vary according to##2##4##(1995-1#1)(2010-6#1)
that vary by##3##3##(1996-1#1)(2007-11#1)(2011-2#1)
that vary in their##2##4##(1993-9#1)(2008-8#1)
that vary in##6##3##(1991-8#1)(1993-9#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
that vary with##2##3##(2007-9#1)(2008-2#1)
that vary##23##2##(1991-8#1)(1993-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
that varying the##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
that varying##4##2##(2008-10#2)(2008-3#1)(2012-1#1)
that vasectomy##2##2##(1990-9#2)
that ventral striatal##2##3##(2011-1#2)
that venular resistance##2##3##(2008-3#2)
that verbal##2##2##(2008-2#1)(2012-2#1)
that vertebral##2##2##(2011-2#2)
that vertebrate##2##2##(2011-2#1)(2012-3#1)
that vertical transmission##3##3##(2008-8#1)(2008-9#1)(2011-3#1)
that vertical##4##2##(2008-8#1)(2008-9#1)(2011-3#2)
that very little##2##3##(1992-12#1)(2010-8#1)
that very low##2##3##(1991-12#1)(2008-10#1)
that very##9##2##(1990-9#1)(1991-12#1)(1992-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
that vestibulo-ocular reflex##2##3##(2008-4#2)
that viability##2##2##(2008-11#1)(2009-7#1)
that victims##2##2##(2008-2#1)(2009-7#1)
that victims' reciprocal##2##3##(2009-7#2)
that vinyl carbamate##2##3##(1994-2#2)
that virions##2##2##(2008-10#2)
that virtually all##2##3##(1997-2#1)(2008-10#1)
that virulence##3##2##(2008-10#3)
that virus replication##3##3##(1997-3#1)(2008-10#2)
that virus##9##2##(1997-3#2)(2008-10#5)(2008-9#1)(2011-2#1)
that visual information##2##3##(2008-1#1)(2011-1#1)
that visual##5##2##(1994-8#1)(1995-11#1)(1996-2#1)(2008-1#1)(2011-1#1)
that vitamin B12 deficiency##2##4##(1993-12#1)(1995-11#1)
that vitamin B12##4##3##(1993-12#1)(1995-11#2)(2008-8#1)
that vitamin E##3##3##(1993-6#1)(1996-3#1)(2013-1#1)
that vitamin##16##2##(1992-12#2)(1993-12#1)(1993-6#1)(1994-3#1)(1995-11#2)(1996-3#1)(2008-11#2)(2008-5#1)(2008-8#2)(2012-1#1)(2012-3#1)(2013-1#1)
that volatile##2##2##(2008-11#2)
that volunteers##2##2##(1994-3#2)
that warrant##3##2##(1996-2#1)(2008-11#1)(2011-2#1)
that was also##3##3##(1995-12#1)(1995-2#1)(2008-5#1)
that was amplified by##2##4##(2007-12#1)(2008-10#1)
that was attributed to##2##4##(1990-5#1)(2008-3#1)
that was better than that##2##5##(2008-10#1)(2008-3#1)
that was blocked by##2##4##(1995-12#1)(2010-4#1)
that was caused by##2##4##(2008-5#1)(2008-9#1)
that was conducted##3##3##(1996-2#1)(2008-2#1)(2010-3#1)
that was consistently##2##3##(2008-10#1)(2008-9#1)
that was dependent on##2##4##(2008-4#1)(2008-5#1)
that was designed and##2##4##(2008-2#1)(2009-12#1)
that was designed to##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
that was designed##6##3##(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)
that was developed and##2##4##(2008-10#2)
that was developed by##2##4##(1995-2#1)(2008-10#1)
that was developed for##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)
that was developed##14##3##(1992-2#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-3#1)(2011-2#1)
that was diagnosed##3##3##(2007-7#1)(2007-8#1)(2011-3#1)
that was due to##5##4##(1995-5#1)(2007-12#1)(2008-3#3)
that was either##2##3##(2008-10#1)(2008-11#1)
that was established##2##3##(2008-10#1)(2008-5#1)
that was excited by##2##4##(2008-3#2)
that was first##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
that was followed by##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
that was found in##2##4##(2008-5#1)(2013-1#1)
that was found##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
that was heated##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
that was implemented##2##3##(1992-3#1)(2011-2#1)
that was in##2##3##(2008-10#2)
that was increased##2##3##(1993-6#1)(2008-10#1)
that was independent of##3##4##(1992-6#1)(1993-3#1)(1995-6#1)
that was induced by##3##4##(2007-11#1)(2008-10#2)
that was isolated from##2##4##(2011-2#2)
that was located near##2##4##(2012-3#2)
that was maintained##2##3##(2009-12#1)(2011-2#1)
that was managed##2##3##(2010-11#1)(2012-12#1)
that was missed##2##3##(1991-11#1)(2012-12#1)
that was more##3##3##(1990-5#1)(2008-11#1)(2008-12#1)
that was no longer##2##4##(1995-2#1)(2008-11#1)
that was not observed in##2##5##(2008-10#1)(2008-11#1)
that was not used##2##4##(1992-11#1)(1996-12#1)
that was not##15##3##(1992-11#1)(1993-6#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2009-3#1)(2013-1#2)
that was observed in##2##4##(2008-10#1)(2008-2#1)
that was observed##4##3##(1993-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
that was obtained##3##3##(1992-2#1)(2007-12#1)(2008-3#1)
that was originally##2##3##(2008-10#1)(2008-4#1)
that was part of##2##4##(2010-10#1)(2010-8#1)
that was perpendicular to##2##4##(2007-11#1)(2008-3#1)
that was predicted##3##3##(1990-12#1)(1992-2#1)(2008-2#1)
that was previously shown to##2##5##(1993-9#1)(1997-4#1)
that was previously##4##3##(1993-9#1)(1997-4#1)(2007-11#1)(2008-10#1)
that was recently##3##3##(2007-11#1)(2012-12#1)(2013-1#1)
that was reduced in##3##4##(1990-5#1)(2010-5#1)(2012-2#1)
that was refractory to##2##4##(2012-12#1)(2012-3#1)
that was related to##2##4##(2007-12#1)(2008-10#1)
that was segregating##2##3##(2008-10#2)
that was significantly##3##3##(1990-7#1)(1992-3#1)(2012-12#1)
that was statistically##2##3##(2008-10#1)(2010-3#1)
that was strongly##2##3##(2008-10#1)(2009-2#1)
that was supported by##2##4##(2008-3#1)(2009-4#1)
that was the##2##3##(2008-10#1)(2013-1#1)
that was then##2##3##(2008-10#1)(2008-2#1)
that was thought to be##2##5##(2007-8#1)(2013-1#1)
that was treated with##2##4##(2009-8#1)(2011-2#1)
that was used to##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
that was used##10##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-12#1)(2011-2#1)
that was within##2##3##(1996-5#1)(2008-3#1)
that was##353##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#2)(1993-12#3)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-11#8)(2007-12#11)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#64)(2008-11#13)(2008-12#6)(2008-2#16)(2008-3#32)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#5)(2012-7#1)(2013-1#10)(2013-8#3)
that water immersion##3##3##(2008-3#1)(2008-5#2)
that water##11##2##(1994-8#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-2#1)(2011-2#1)(2013-7#1)
that wave##2##2##(2008-3#1)(2009-8#1)
that way##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2010-8#1)
that we are only##2##4##(2007-8#1)(2013-8#1)
that we are##10##3##(1994-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
that we believe##4##3##(2008-10#1)(2008-7#2)(2012-2#1)
that we call##4##3##(1990-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
that we called##2##3##(1992-3#1)(2010-8#1)
that we can transfer##2##4##(2008-11#1)(2008-3#1)
that we can##17##3##(1993-1#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-8#1)(2010-11#2)(2012-12#1)(2013-7#2)(2013-8#1)
that we could##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
that we currently##2##3##(2008-9#1)(2010-7#1)
that we developed##2##3##(1995-5#1)(2007-12#1)
that we have previously##2##4##(2008-10#1)(2012-2#1)
that we have produced##3##4##(1994-12#1)(1995-12#1)(2010-11#1)
that we have##12##3##(1993-12#1)(1994-12#1)(1995-12#1)(1995-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
that we hypothesize##2##3##(2008-10#1)(2010-1#1)
that we identified##2##3##(2007-8#1)(2008-10#1)
that we know##2##3##(1994-3#1)(2008-10#1)
that we may##2##3##(1994-1#1)(2013-1#1)
that we must##2##3##(2008-2#1)(2011-2#1)
that we named##3##3##(2008-11#1)(2008-5#1)(2010-10#1)
that we observed##3##3##(2008-3#2)(2012-2#1)
that we obtained##2##3##(2008-3#1)(2008-8#1)
that we present##2##3##(2007-12#1)(2008-2#1)
that we previously##3##3##(1995-5#1)(2008-2#1)(2008-9#1)
that we propose##2##3##(2008-3#2)
that we recently##2##3##(2008-5#1)(2011-2#1)
that we screened##2##3##(2008-10#1)(2009-8#1)
that we see##2##3##(2008-11#1)(2008-12#1)
that we used##2##3##(2008-3#1)(2008-8#1)
that we will##3##3##(2008-9#1)(2009-11#1)(2009-3#1)
that we would##2##3##(1991-9#1)(2008-8#1)
that we##142##2##(1990-5#1)(1991-1#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-5#2)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#6)(2008-2#8)(2008-3#14)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
that wear##2##2##(2008-8#2)
that weight##4##2##(2008-12#1)(2008-3#1)(2010-12#1)(2010-8#1)
that went##2##2##(1992-12#1)(1997-5#1)
that were able to##3##4##(1996-9#1)(2008-10#1)(2008-5#1)
that were active in##2##4##(2009-10#1)(2010-3#1)
that were also##2##3##(2008-10#2)
that were associated with##2##4##(2008-10#1)(2009-5#1)
that were associated##4##3##(2008-10#2)(2009-5#1)(2012-2#1)
that were audio-taped##2##3##(2011-1#2)
that were being##2##3##(2008-12#1)(2009-6#1)
that were characteristic of##2##4##(1992-8#1)(2008-10#1)
that were characterized by##2##4##(1993-12#1)(2011-3#1)
that were collected and##2##4##(1992-1#1)(2008-5#1)
that were collected in the##3##5##(2008-10#3)
that were collected in##5##4##(2007-10#1)(2008-10#4)
that were collected##9##3##(1992-1#1)(2007-10#1)(2008-10#5)(2008-5#1)(2012-3#1)
that were common##2##3##(2008-2#1)(2008-5#1)
that were comparable to##3##4##(1990-5#1)(1993-12#1)(2013-1#1)
that were comparable##4##3##(1990-5#1)(1993-12#1)(1995-6#1)(2013-1#1)
that were compared##2##3##(2008-10#1)(2010-9#1)
that were composed of##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
that were considered##2##3##(2008-5#1)(2010-7#1)
that were consistent with the##2##5##(2008-11#2)
that were consistent with##3##4##(2008-10#1)(2008-11#2)
that were consistent##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
that were designed to##6##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
that were designed##7##3##(1994-1#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
that were detected##5##3##(2008-10#4)(2013-1#1)
that were developed for##2##4##(1990-8#1)(2008-3#1)
that were developed##6##3##(1990-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-1#1)
that were due to##2##4##(2008-2#1)(2008-3#1)
that were either##4##3##(2008-10#1)(2008-4#1)(2009-2#1)(2009-8#1)
that were evaluated##2##3##(2008-10#2)
that were examined##2##3##(2008-10#1)(2008-3#1)
that were experimentally##2##3##(2007-11#1)(2008-4#1)
that were exposed to##3##4##(2008-10#1)(2010-11#1)(2010-4#1)
that were expressed##2##3##(2008-9#1)(2012-2#1)
that were fabricated##2##3##(2007-12#1)(2008-2#1)
that were fed##2##3##(2008-8#1)(2009-9#1)
that were found in##2##4##(2008-10#1)(2008-5#1)
that were found to be significantly##2##6##(2007-12#1)(2008-12#1)
that were found to be##3##5##(2007-12#1)(2008-11#1)(2008-12#1)
that were found to##4##4##(1992-3#1)(2007-12#1)(2008-11#1)(2008-12#1)
that were found##10##3##(1992-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)
that were greater than##2##4##(2008-10#2)
that were grouped##2##3##(2008-10#1)(2008-11#1)
that were highly##2##3##(2008-10#2)
that were identified as##5##4##(1996-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
that were identified by##2##4##(1995-6#1)(1997-6#1)
that were identified##9##3##(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#3)(2010-2#1)(2012-3#1)(2013-8#1)
that were in the##3##4##(2008-10#3)
that were in##5##3##(2008-10#4)(2013-1#1)
that were indistinguishable from##2##4##(1992-8#1)(1994-8#1)
that were indistinguishable##3##3##(1992-8#1)(1994-8#1)(2008-11#1)
that were infected with R##2##5##(2008-10#2)
that were infected with##3##4##(2008-10#3)
that were inoculated with##2##4##(2008-10#2)
that were inoculated##5##3##(2008-10#5)
that were intermediate##2##3##(2008-12#1)(2008-5#1)
that were isolated from##2##4##(1990-12#1)(2008-6#1)
that were isolated##5##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#1)
that were labeled##2##3##(1992-12#1)(2008-10#1)
that were later##2##3##(2009-8#1)(2010-12#1)
that were less##2##3##(2008-10#1)(2008-5#1)
that were made##2##3##(1990-11#1)(2008-3#1)
that were maintained##2##3##(1992-11#1)(2008-10#1)
that were measured##3##3##(1997-2#1)(2008-3#1)(2012-3#1)
that were more##5##3##(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-2#1)
that were not apparent##2##4##(2007-12#1)(2013-1#1)
that were not exposed to the##2##6##(2008-12#1)(2008-7#1)
that were not##28##3##(1993-6#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2013-1#2)
that were observed in##2##4##(2007-12#1)(2011-1#1)
that were observed##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
that were obtained##4##3##(1995-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
that were open##2##3##(1992-9#1)(2008-10#1)
that were originally##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
that were partially##2##3##(1994-8#1)(2008-10#1)
that were performed##2##3##(2008-10#1)(2008-3#1)
that were polymorphic##2##3##(2008-10#1)(2008-4#1)
that were prepared##2##3##(2008-10#1)(2008-5#1)
that were present in##4##4##(2008-3#2)(2008-4#1)(2010-4#1)
that were present##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2010-4#1)
that were presented##2##3##(1993-12#1)(2013-8#1)
that were previously##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-6#1)
that were published##2##3##(2008-5#1)(2010-2#1)
that were randomly allocated into one of three groups completed the study##2##12##(2008-10#2)
that were recently##2##3##(2007-11#1)(2008-2#1)
that were recorded##2##3##(2008-3#2)
that were recovered from##3##4##(2008-10#3)
that were reported##3##3##(1994-9#1)(2008-2#1)(2012-2#1)
that were resistant to all three##2##6##(2008-10#1)(2008-5#1)
that were resistant to##3##4##(2008-10#2)(2008-5#1)
that were resistant##4##3##(2008-10#3)(2008-5#1)
that were seen##2##3##(1997-3#1)(2013-8#1)
that were sensitive##3##3##(2008-10#3)
that were significantly lower##2##4##(2008-10#1)(2013-8#1)
that were significantly##5##3##(1991-12#1)(1997-4#1)(2008-10#1)(2009-4#1)(2013-8#1)
that were slaughtered##2##3##(1994-7#1)(2011-1#1)
that were slightly##2##3##(1992-1#1)(1993-12#1)
that were specific for each##2##5##(2008-10#2)
that were specific for##3##4##(2008-10#3)
that were specific##4##3##(2008-10#4)
that were studied##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
that were successfully enriched##2##4##(2008-10#2)
that were successfully##3##3##(2006-10#1)(2008-10#2)
that were synthesized##2##3##(2008-10#2)
that were taken##2##3##(1990-11#1)(2007-12#1)
that were tested##5##3##(2008-10#4)(2008-7#1)
that were treated with np-BNR##2##5##(2008-10#2)
that were treated with##5##4##(2008-10#4)(2011-2#1)
that were treated##6##3##(2008-10#4)(2009-1#1)(2011-2#1)
that were unaffected by##2##4##(1994-8#1)(1996-12#1)
that were unique to##2##4##(1991-12#1)(1997-4#1)
that were used for##2##4##(2008-6#1)(2009-4#1)
that were used to##2##4##(2009-8#1)(2012-2#1)
that were used##4##3##(2008-6#1)(2009-4#1)(2009-8#1)(2012-2#1)
that were utilized##2##3##(1995-3#1)(2008-10#1)
that were virulent on##2##4##(2008-10#2)
that were well##3##3##(2008-5#1)(2008-8#2)
that were##530##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#2)(1997-3#5)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#10)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#171)(2008-11#22)(2008-12#12)(2008-2#9)(2008-3#22)(2008-4#6)(2008-5#20)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#8)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#16)(2011-3#2)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#7)(2012-7#1)(2013-1#16)(2013-7#2)(2013-8#7)
that what##2##2##(1994-1#1)(1996-2#1)
that when a##5##3##(1993-12#1)(2008-3#2)(2008-5#1)(2009-10#1)
that when the##10##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)(2013-8#2)
that when##60##2##(1990-6#1)(1991-3#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-9#2)(2010-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
that where##2##2##(2008-3#1)(2011-2#1)
that whereas##2##2##(2007-8#1)(2008-4#1)
that which is##3##3##(1993-8#1)(2007-12#1)(2008-11#1)
that which occurs##2##3##(2007-11#1)(2008-10#1)
that which##13##2##(1993-8#1)(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)
that while activation of##2##4##(1992-8#1)(2013-1#1)
that while both##2##3##(1994-8#1)(2009-7#1)
that while the##5##3##(1990-5#1)(1996-3#1)(2008-11#1)(2009-8#1)(2010-2#1)
that while##37##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
that whilst##3##2##(2007-8#1)(2008-1#1)(2010-11#1)
that wide##2##2##(2007-8#1)(2008-6#1)
that widespread##2##2##(1995-1#1)(2008-4#1)
that wild type##2##3##(1991-8#1)(2008-8#1)
that wild##4##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
that will affect##3##3##(1993-1#1)(1993-2#2)
that will allow##4##3##(1991-12#1)(1991-2#1)(1997-3#1)(2008-10#1)
that will be discussed##2##4##(2008-10#1)(2012-2#1)
that will be needed##2##4##(2008-1#1)(2008-10#1)
that will be required to##2##5##(2008-10#1)(2008-11#1)
that will be required##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
that will be used to##2##5##(1992-2#1)(1995-2#1)
that will be used##4##4##(1992-2#1)(1995-2#1)(2008-10#1)(2008-3#1)
that will be##31##3##(1992-1#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-2#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
that will become##2##3##(2008-10#1)(2013-1#1)
that will continue to##2##4##(1990-11#1)(1997-2#1)
that will enable the##2##4##(2007-8#1)(2010-9#1)
that will enable##6##3##(1996-2#1)(2007-8#1)(2010-3#2)(2010-9#1)(2013-1#1)
that will enhance##2##3##(1995-12#1)(2011-2#1)
that will give##2##3##(1996-12#1)(2008-2#1)
that will help##5##3##(1996-2#1)(2007-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
that will hopefully##2##3##(2007-7#1)(2008-11#1)
that will lead to##2##4##(2008-11#1)(2012-3#1)
that will likely##2##3##(2009-11#1)(2012-12#1)
that will make##2##3##(1997-1#1)(2011-2#1)
that will measure the##2##4##(1995-2#1)(2008-3#1)
that will meet the##3##4##(1993-2#1)(1994-12#1)(2008-3#1)
that will meet##4##3##(1993-2#2)(1994-12#1)(2008-3#1)
that will reduce##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
that will require##2##3##(1994-12#1)(2012-12#1)
that will result in a##2##5##(1991-2#1)(1994-12#1)
that will result in##3##4##(1991-2#1)(1994-12#1)(2008-6#1)
that will##143##2##(1990-11#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#5)(1994-1#1)(1994-12#3)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#6)(2008-2#7)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#5)
that winter##2##2##(2010-8#2)
that with a limited##2##4##(1990-12#1)(2008-5#1)
that with a##5##3##(1990-12#1)(1990-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
that with an##3##3##(1992-2#1)(2008-2#1)(2008-5#1)
that with the use of##2##5##(2008-10#1)(2008-11#1)
that with the##17##3##(1990-9#1)(1994-9#1)(1995-12#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-7#1)(2013-1#2)
that with this##5##3##(1991-5#1)(2007-11#1)(2007-12#2)(2008-3#1)
that with##68##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(2007-11#5)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#3)
that within##7##2##(1992-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-1#1)(2012-3#1)
that without##9##2##(1995-4#1)(2008-10#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
that wives##2##2##(2008-9#2)
that women are##4##3##(1995-12#1)(2007-4#1)(2008-1#1)(2012-12#1)
that women should##2##3##(2007-2#1)(2013-1#1)
that women with##3##3##(2008-12#1)(2008-4#1)(2011-1#1)
that women##21##2##(1990-2#2)(1995-12#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-4#2)(2008-7#1)(2009-11#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
that work##11##2##(1991-2#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-10#1)(2013-1#2)
that worked in##3##3##(1996-3#1)(1997-1#1)(2011-1#1)
that works on##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
that works##9##2##(1992-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)
that worst-case##2##2##(2008-3#2)
that wortmannin##2##2##(1995-6#2)
that would allow##5##3##(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)
that would also##2##3##(1992-12#1)(2008-10#1)
that would be consistent with an inflammatory response related to the dermatitis observed histopathologically##3##14##(2008-9#3)
that would be consistent with##5##5##(2008-9#5)
that would be difficult##2##4##(2007-12#1)(2008-7#1)
that would be expected##2##4##(2007-12#1)(2013-1#1)
that would be required##2##4##(1996-1#1)(2008-3#1)
that would be##28##3##(1990-11#1)(1990-8#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-9#2)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
that would benefit from##2##4##(2007-12#1)(2008-3#1)
that would enable##4##3##(1992-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
that would favor##2##3##(2008-9#1)(2009-10#1)
that would have been##3##4##(2008-10#1)(2008-7#2)
that would have##10##3##(1992-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-7#2)(2008-9#1)
that would otherwise##10##3##(1996-3#1)(2008-10#3)(2008-2#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
that would provide##2##3##(1997-3#1)(2009-7#1)
that would remain##2##3##(1996-12#1)(2013-1#1)
that would represent##2##3##(2008-11#1)(2011-2#1)
that would require##2##3##(1993-3#1)(2009-7#1)
that would##122##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-12#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#7)(2008-9#10)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)
that wrap around##2##3##(1994-5#1)(2008-9#1)
that year##7##2##(1990-2#1)(1991-1#1)(1993-12#1)(1993-6#1)(1997-3#2)(2008-10#1)
that yeast##7##2##(1993-6#1)(1996-3#1)(1997-3#2)(2008-10#2)(2011-2#1)
that yield a##2##3##(2008-2#1)(2008-3#1)
that yield##12##2##(1996-12#2)(1996-3#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
that yielded##6##2##(2008-10#4)(2008-3#2)
that yields a##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
that yields the maximum##3##4##(2007-12#1)(2008-3#2)
that yields the##7##3##(2007-12#1)(2008-10#1)(2008-3#4)(2009-10#1)
that yields##18##2##(1990-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#7)(2008-5#1)(2009-10#1)
that you##6##2##(1991-3#2)(1994-2#1)(1995-3#1)(1996-3#1)(2012-2#1)
that young people##4##3##(2012-12#2)(2012-3#2)
that young##16##2##(1994-12#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-2#1)(2009-12#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-1#1)
that younger##2##2##(2009-12#1)(2011-2#1)
that your organization##2##3##(1992-12#1)(1994-1#1)
that your##3##2##(1992-12#1)(1994-1#1)(1996-3#1)
that youth who##2##3##(2008-7#1)(2009-7#1)
that youth##3##2##(2008-7#2)(2009-7#1)
that zinc##9##2##(1991-12#1)(1991-2#1)(1992-9#1)(1994-6#2)(2008-10#2)(2008-4#1)(2013-7#1)
that α7 nAChRs##2##3##(2011-1#2)
that α7##4##2##(2011-1#4)
that##44673##1##(1990-10#18)(1990-11#204)(1990-12#207)(1990-2#175)(1990-3#49)(1990-4#9)(1990-5#216)(1990-6#63)(1990-7#130)(1990-8#155)(1990-9#47)(1991-1#62)(1991-10#11)(1991-11#51)(1991-12#272)(1991-2#165)(1991-3#97)(1991-4#16)(1991-5#174)(1991-6#91)(1991-7#30)(1991-8#76)(1991-9#164)(1992-1#62)(1992-10#38)(1992-11#113)(1992-12#255)(1992-2#112)(1992-3#280)(1992-4#38)(1992-5#60)(1992-6#187)(1992-7#15)(1992-8#195)(1992-9#173)(1993-1#100)(1993-10#1)(1993-11#194)(1993-12#340)(1993-2#130)(1993-3#248)(1993-5#21)(1993-6#213)(1993-8#202)(1993-9#116)(1994-1#70)(1994-10#9)(1994-11#226)(1994-12#259)(1994-2#219)(1994-3#198)(1994-5#172)(1994-6#166)(1994-7#26)(1994-8#320)(1994-9#149)(1995-1#88)(1995-10#1)(1995-11#161)(1995-12#372)(1995-2#430)(1995-3#192)(1995-4#17)(1995-5#202)(1995-6#321)(1995-8#167)(1995-9#48)(1996-1#98)(1996-10#18)(1996-11#36)(1996-12#290)(1996-2#284)(1996-3#157)(1996-4#64)(1996-5#211)(1996-6#57)(1996-7#31)(1996-8#25)(1996-9#64)(1997-1#171)(1997-2#292)(1997-3#267)(1997-4#184)(1997-5#87)(1997-6#153)(1997-7#209)(1997-8#125)(1997-9#16)(2006-10#59)(2006-11#1)(2006-12#11)(2006-4#3)(2006-5#5)(2006-6#33)(2006-7#1)(2006-8#2)(2007-1#4)(2007-10#169)(2007-11#799)(2007-12#1084)(2007-2#61)(2007-3#3)(2007-4#23)(2007-5#47)(2007-6#44)(2007-7#134)(2007-8#152)(2007-9#16)(2008-1#458)(2008-10#6038)(2008-11#1900)(2008-12#669)(2008-2#1316)(2008-3#2763)(2008-4#785)(2008-5#1127)(2008-6#455)(2008-7#1433)(2008-8#1626)(2008-9#1218)(2009-1#32)(2009-10#260)(2009-11#130)(2009-12#157)(2009-2#111)(2009-3#143)(2009-4#110)(2009-5#184)(2009-6#160)(2009-7#218)(2009-8#360)(2009-9#162)(2010-1#105)(2010-10#178)(2010-11#182)(2010-12#207)(2010-2#143)(2010-3#211)(2010-4#186)(2010-5#184)(2010-6#127)(2010-7#112)(2010-8#244)(2010-9#68)(2011-1#442)(2011-10#14)(2011-2#1355)(2011-3#66)(2011-4#1)(2011-7#8)(2011-9#2)(2012-1#169)(2012-12#528)(2012-2#884)(2012-3#656)(2012-4#2)(2012-5#8)(2012-6#5)(2012-7#9)(2012-8#3)(2012-9#4)(2013-1#1106)(2013-3#1)(2013-7#140)(2013-8#630)
that's##2##1##(2008-11#1)(2010-6#1)
thatthe##7##1##(2008-11#6)(2008-2#1)
thaumatin-like protein##3##2##(2008-10#3)
thaw##5##1##(1996-8#1)(2008-11#1)(2008-9#1)(2011-2#2)
thawed DS##3##2##(2011-2#3)
thawed##7##1##(2008-11#1)(2008-9#2)(2011-2#4)
thawing##19##1##(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-3#1)
thaxtomin A in##2##3##(2008-10#2)
thaxtomin A##5##2##(2008-10#5)
thaxtomin##8##1##(2008-10#8)
thdF##2##1##(1996-12#2)
the %##3##2##(1991-5#1)(1992-11#1)(1997-4#1)
the &gt##2##2##(1996-2#1)(2008-10#1)
the &lt##6##2##(1994-12#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-7#1)
the &quot##346##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#5)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#7)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-5#3)(1995-6#4)(1996-1#7)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(2006-10#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#8)(2008-10#26)(2008-11#10)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#12)(2008-6#7)(2008-7#3)(2008-8#16)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#14)(2013-7#3)(2013-8#4)
the '90s##6##2##(1990-4#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-3#2)
the 'B'##2##2##(1997-6#2)
the 'König' reaction and##2##4##(1993-8#2)
the 'König' reaction##9##3##(1993-8#9)
the 'Oketsu'##3##2##(2008-10#3)
the 'all on##2##3##(2010-5#2)
the 'epidemic##2##2##(2008-10#2)
the 'gold standard'##2##3##(2007-7#1)(2008-7#1)
the 'stop' cue##3##3##(2008-11#3)
the 'urgent' cases##2##3##(1994-3#2)
the (0##2##2##(2008-3#2)
the (1##5##2##(1991-8#3)(2008-3#2)
the (1)H NMR##2##3##(2008-10#1)(2012-12#1)
the (1)H##6##2##(1997-7#1)(2008-10#2)(2009-7#2)(2012-12#1)
the (1--&gt##4##2##(1995-11#4)
the (13)C NMR##2##3##(1996-5#1)(2008-10#1)
the (13)C##3##2##(1996-5#1)(2008-10#1)(2009-7#1)
the (23)Na##3##2##(1997-7#3)
the (27)Al NMR##2##3##(2008-10#2)
the (2S##2##2##(1995-3#1)(2009-12#1)
the (3)A(2g) --&gt##2##3##(1997-7#2)
the (44)Ca/(42)Ca isotope##2##3##(2008-10#2)
the (45)Ca(2+) uptake##2##3##(2008-11#2)
the (4p)(2) (5s)(1) (4)P(1/2)##2##4##(2008-2#2)
the (SSB)35 mode in##2##4##(1997-2#2)
the (SSB)35 mode##4##3##(1997-2#4)
the (dA)n##2##2##(1995-5#2)
the (n##2##2##(2008-10#1)(2008-3#1)
the +/-1##2##2##(2008-3#2)
the +1##9##2##(1990-5#1)(2007-12#1)(2008-2#2)(2008-3#5)
the +2##2##2##(1997-4#1)(2008-2#1)
the +49(∗)G allele##2##3##(2010-12#2)
the -1 order##7##3##(2008-2#4)(2008-3#3)
the -1##12##2##(2008-2#5)(2008-3#5)(2008-8#1)(2013-1#1)
the -c face of##2##4##(2008-2#2)
the 0##68##2##(1990-5#1)(1991-3#1)(1994-11#1)(1994-5#3)(1995-12#1)(1996-8#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#35)(2008-11#2)(2008-2#5)(2008-3#6)(2008-5#1)(2008-9#1)(2012-1#2)(2012-2#1)(2013-1#1)
the 0%##3##2##(2010-2#1)(2012-2#2)
the 0-50##2##2##(2008-10#2)
the 1 to##2##3##(2007-12#1)(2008-10#1)
the 1##140##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-11#7)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-2#6)(1996-5#6)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#40)(2008-11#2)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#2)
the 1%##2##2##(2008-10#1)(2008-2#1)
the 1'##2##2##(1993-11#2)
the 1- to##2##3##(2008-10#1)(2012-12#1)
the 1-##3##2##(1995-3#1)(2008-10#1)(2012-12#1)
the 1-Mb##2##2##(1996-8#2)
the 1-m##2##2##(2008-3#1)(2008-6#1)
the 1-month##2##2##(2008-10#2)
the 1-position##2##2##(2008-10#1)(2010-6#1)
the 1-year PRWE score##2##4##(2008-9#2)
the 1-year follow-up##4##3##(2008-10#1)(2012-2#2)(2012-3#1)
the 1-year survival rate was##2##5##(1991-2#2)
the 1-year##12##2##(1991-2#2)(1991-8#1)(2008-10#1)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
the 1/e(2)##2##2##(2008-3#2)
the 10 Commandments##2##3##(2008-12#2)
the 10 inoculated isolates##2##4##(2008-10#2)
the 10 mg##2##3##(2008-10#2)
the 10 months##2##3##(1996-2#2)
the 10 nm##2##3##(2008-8#1)(2009-5#1)
the 10 years##2##3##(1991-7#1)(2010-11#1)
the 10##54##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-11#2)(1993-12#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
the 10%##2##2##(2008-10#1)(2008-9#1)
the 10(-4)##2##2##(1994-9#1)(2008-10#1)
the 10-year##5##2##(1993-2#1)(1997-2#1)(2009-10#1)(2011-1#1)(2013-1#1)
the 100##8##2##(1993-6#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-8#1)
the 100%##2##2##(2008-10#1)(2009-11#1)
the 1000##2##2##(1990-3#1)(2012-3#1)
the 1000-W##2##2##(2008-3#2)
the 101-point scale##2##3##(2012-2#2)
the 1047-nm##2##2##(2008-3#2)
the 105##2##2##(2008-10#1)(2010-12#1)
the 106##2##2##(2008-10#1)(2011-2#1)
the 1064-nm##2##2##(2007-12#1)(2008-3#1)
the 10th##6##2##(1996-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)
the 11##33##2##(1993-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#2)
the 110##2##2##(1990-11#1)(1994-9#1)
the 114##2##2##(2008-10#1)(2008-4#1)
the 11th##3##2##(2008-11#2)(2013-1#1)
the 12 amino##2##3##(1991-9#1)(2013-1#1)
the 12 genes##2##3##(2009-10#2)
the 12 mg/kg group##3##4##(2008-9#3)
the 12 patients##3##3##(1991-11#1)(1997-7#1)(1997-8#1)
the 12##39##2##(1990-7#1)(1991-11#1)(1991-9#1)(1993-12#1)(1996-12#1)(1996-6#2)(1997-3#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#3)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the 12-week##2##2##(2008-10#1)(2008-7#1)
the 120##2##2##(2008-10#2)
the 121##2##2##(2008-10#1)(2008-3#1)
the 125##2##2##(2008-1#1)(2008-9#1)
the 126##2##2##(1990-12#1)(2008-10#1)
the 127 kDa##2##3##(1990-11#2)
the 12S ATPase##2##3##(1991-2#2)
the 12h immersion##2##3##(2013-7#2)
the 12th##10##2##(1990-5#1)(1992-8#2)(1993-9#1)(1994-6#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
the 13 patients##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
the 13##25##2##(1991-12#1)(1992-6#1)(1992-9#2)(1994-2#1)(1994-5#1)(1994-7#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#3)(2012-5#1)
the 130##2##2##(2012-2#2)
the 130K replication protein##2##4##(2008-10#2)
the 131##2##2##(2008-10#1)(2008-4#1)
the 133 RILs##2##3##(2008-10#2)
the 133##3##2##(2008-1#1)(2008-10#2)
the 135 patients##2##3##(2012-12#2)
the 135##3##2##(2008-10#1)(2012-12#2)
the 13th##4##2##(1993-3#1)(1996-5#1)(2008-11#1)(2008-8#1)
the 14 and##2##3##(1996-12#1)(2010-2#1)
the 14##26##2##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-4#2)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
the 14-kDa##4##2##(1991-12#1)(1995-6#2)(2008-10#1)
the 140-kDa##2##2##(1990-12#1)(1994-12#1)
the 144##4##2##(2007-7#1)(2008-10#2)(2008-12#1)
the 14th##4##2##(1990-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
the 15 min##2##3##(1994-6#1)(2008-5#1)
the 15##22##2##(1992-1#1)(1993-1#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-9#2)(1997-8#1)(2008-10#2)(2008-5#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
the 15- and##2##3##(1994-3#2)
the 15-##3##2##(1994-3#3)
the 15-ketosterol##3##2##(1993-6#3)
the 15-month##3##2##(1994-3#1)(2008-3#2)
the 150##6##2##(1990-5#1)(1992-8#1)(1997-2#1)(2008-10#1)(2008-5#2)
the 1550-nm##3##2##(2007-11#2)(2008-2#1)
the 15RKR17/AAA mutation##3##3##(2008-8#3)
the 15th##5##2##(1990-2#1)(1995-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
the 16 days##2##3##(1996-3#1)(2012-2#1)
the 16##30##2##(1991-2#1)(1991-7#1)(1992-2#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#4)(2009-6#2)(2010-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
the 1629-bp##2##2##(1993-12#2)
the 16S rDNA##4##3##(1997-3#1)(2008-10#1)(2008-12#2)
the 16S rRNA gene##5##4##(2008-10#3)(2009-6#1)(2013-8#1)
the 16S rRNA##9##3##(1995-8#1)(2008-10#6)(2009-6#1)(2013-8#1)
the 16S ribosomal RNA gene##2##5##(2011-2#1)(2013-1#1)
the 16S##18##2##(1995-8#1)(1997-3#1)(2008-10#8)(2008-12#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the 16S-23S rDNA spacer region##2##5##(2008-10#2)
the 16S-23S rDNA##3##3##(2008-10#3)
the 16S-23S##5##2##(2008-10#5)
the 16SrI-B subgroup##2##3##(2008-10#2)
the 16s rRNA gene##2##4##(2008-10#1)(2008-12#1)
the 16th##5##2##(1990-2#1)(1997-4#1)(2008-11#2)(2008-7#1)
the 17 patients##2##3##(1991-11#1)(1991-4#1)
the 17##17##2##(1990-2#1)(1991-11#1)(1991-4#1)(1992-11#1)(1996-5#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)
the 17-kDa protein were##2##4##(2008-10#2)
the 17-kDa protein##4##3##(2008-10#4)
the 171##4##2##(1993-2#3)(2008-10#1)
the 175-kDa protein##2##3##(1992-3#2)
the 175R protein##3##3##(1993-2#3)
the 175R##4##2##(1993-2#4)
the 178##2##2##(1995-8#1)(2008-12#1)
the 17th century]##2##3##(2008-10#2)
the 17th##10##2##(1997-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
the 18 patients##2##3##(1996-11#1)(2013-1#1)
the 18##18##2##(1990-3#1)(1992-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
the 18(V/KPEP)##2##2##(1995-2#2)
the 18-month##2##2##(2008-4#1)(2008-5#1)
the 180##2##2##(2007-10#1)(2009-9#1)
the 1800s##2##2##(2008-8#1)(2010-3#1)
the 181-bp PRE##2##3##(2012-3#2)
the 1870s##2##2##(1996-3#1)(2010-3#1)
the 1880s##2##2##(2008-12#1)(2010-3#1)
the 18S rDNA##2##3##(2008-10#1)(2013-1#1)
the 18S region##2##3##(2008-5#1)(2008-9#1)
the 18S##8##2##(2008-10#5)(2008-5#1)(2008-9#1)(2013-1#1)
the 18q- syndrome##3##3##(1997-3#3)
the 18th and##2##3##(1993-11#1)(2008-6#1)
the 18th century##5##3##(1993-11#2)(2008-12#1)(2010-1#1)(2012-2#1)
the 18th##12##2##(1993-11#3)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)
the 19##18##2##(1990-2#1)(1991-1#2)(1992-2#1)(1992-6#1)(1994-9#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-2#1)(2013-8#1)
the 19(th) century##3##3##(2008-12#2)(2009-8#1)
the 1906##2##2##(1990-11#2)
the 1918-1919 influenza pandemic in##3##5##(2009-7#1)(2011-2#2)
the 1918-1919 influenza pandemic##4##4##(2009-7#1)(2011-2#3)
the 1920s##4##2##(1997-3#1)(2008-1#1)(2008-10#1)(2010-1#1)
the 1930's##2##2##(1994-12#1)(2007-5#1)
the 1930s to##2##3##(2007-12#1)(2013-8#1)
the 1930s##8##2##(1991-12#1)(1993-12#1)(2007-12#1)(2007-5#2)(2008-8#1)(2010-1#1)(2013-8#1)
the 1940s##7##2##(1992-12#1)(1993-6#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
the 1950s##13##2##(1991-4#1)(1993-6#1)(1994-9#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#1)
the 1960s and 1970s##2##4##(1992-3#1)(2012-2#1)
the 1960s and##5##3##(1992-3#1)(2008-10#2)(2012-2#1)(2013-1#1)
the 1960s##22##2##(1992-1#1)(1992-3#1)(1996-3#2)(1997-2#2)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
the 1970s and 1980s##3##4##(1996-9#1)(2008-1#1)(2008-10#1)
the 1970s to##2##3##(1997-4#1)(2011-2#1)
the 1970s##31##2##(1991-2#2)(1991-3#3)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
the 1978##2##2##(1996-4#1)(2011-2#1)
the 1980's and early 1990's##2##5##(2008-10#1)(2008-11#1)
the 1980's##3##2##(2008-10#1)(2008-11#2)
the 1980s and##3##3##(1991-3#1)(1997-1#1)(2008-10#1)
the 1980s by the##2##4##(1994-9#1)(2008-7#1)
the 1980s by##3##3##(1994-9#1)(2008-4#1)(2008-7#1)
the 1980s there was##2##4##(1992-2#2)
the 1980s to##2##3##(1990-4#1)(1997-3#1)
the 1980s##36##2##(1990-4#1)(1991-11#1)(1991-3#2)(1992-2#3)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2013-1#1)
the 1982##3##2##(1991-1#1)(1995-2#1)(2006-10#1)
the 1983##2##2##(1991-2#1)(2008-7#1)
the 1984##3##2##(1991-8#1)(1993-3#1)(2008-5#1)
the 1985##7##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1996-2#1)(2011-2#1)
the 1987##5##2##(1991-1#1)(1991-12#2)(1997-6#1)(2008-6#1)
the 1988 1990 data##2##4##(1995-9#2)
the 1988 guidelines##2##3##(1995-6#2)
the 1988##7##2##(1992-1#1)(1992-2#1)(1994-3#1)(1995-6#2)(1995-9#2)
the 1989 Loma Prieta earthquake##2##5##(1990-11#2)
the 1989##8##2##(1990-11#2)(1991-1#1)(1992-1#1)(1992-2#1)(1993-3#1)(1995-12#1)(1995-2#1)
the 1989-90 influenza##2##3##(1992-6#2)
the 1989-90##3##2##(1992-6#2)(1994-3#1)
the 1989/90 season##2##3##(1996-6#2)
the 1990 census##2##3##(1991-5#1)(2008-8#1)
the 1990 samples##2##3##(1997-4#2)
the 1990##11##2##(1990-3#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-1#1)(1995-2#1)(1997-4#2)(2008-8#1)(2010-7#1)
the 1990-91 influenza##2##3##(1992-6#2)
the 1990s##62##2##(1990-11#1)(1990-6#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-6#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the 1991 Gulf War##3##4##(1997-4#1)(2011-2#2)
the 1991##8##2##(1996-1#1)(1996-12#1)(1997-1#1)(1997-4#2)(2009-3#1)(2011-2#2)
the 1992 Medicare Current Beneficiary Survey (MCBS)##2##7##(1995-3#1)(1996-3#1)
the 1992##10##2##(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
the 1993##6##2##(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-3#1)(2008-10#1)
the 1994 meeting in##2##4##(2008-5#2)
the 1994 samples##2##3##(1997-4#2)
the 1994##7##2##(1996-12#1)(1996-2#1)(1997-4#3)(2008-5#2)
the 1994/95 season##2##3##(1996-6#2)
the 1995##8##2##(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#1)(2008-10#3)
the 1996 to 1997##2##4##(2008-10#2)
the 1996##5##2##(1997-6#1)(2008-10#3)(2008-11#1)
the 1997 and 1999##2##4##(2008-10#1)(2013-8#1)
the 1997 and##3##3##(2008-10#2)(2013-8#1)
the 1997##8##2##(1997-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
the 1998##7##2##(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)
the 1999##15##2##(2006-9#1)(2008-10#7)(2008-11#7)
the 19th Century##3##3##(2009-10#1)(2012-2#1)(2013-1#1)
the 19th century and##3##4##(2008-10#1)(2009-7#1)(2011-2#1)
the 19th century##10##3##(1991-6#1)(1994-5#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#2)(2011-2#1)(2012-2#1)
the 19th century]##2##3##(1993-11#1)(2009-10#1)
the 19th##18##2##(1991-6#1)(1993-11#1)(1994-5#1)(1995-11#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-10#2)(2009-7#2)(2011-2#1)(2012-2#2)(2013-1#1)
the 1B chromosome of##2##4##(2008-10#2)
the 1BL##2##2##(2008-10#2)
the 1D x-ray transform##2##4##(2012-1#2)
the 1D##3##2##(2009-11#1)(2012-1#2)
the 1H##4##2##(1994-2#1)(1994-3#1)(1994-5#1)(2009-7#1)
the 1H-NMR##2##2##(1990-5#1)(1991-12#1)
the 1PS paper##3##3##(2008-10#3)
the 1st European##2##3##(2008-4#1)(2008-7#1)
the 1st and 2nd##2##4##(1990-10#1)(1992-12#1)
the 1st and##4##3##(1990-10#2)(1992-12#1)(2008-7#1)
the 1st antibody##3##3##(2008-10#3)
the 1st day of life##2##5##(1993-12#1)(2008-10#1)
the 1st##30##2##(1990-10#3)(1990-12#2)(1990-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-8#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-8#2)(2011-1#1)
the 2 and##4##3##(1994-12#1)(1994-9#1)(2008-4#2)
the 2 groups##10##3##(1991-11#4)(1997-3#1)(2007-7#1)(2009-10#1)(2009-3#1)(2012-3#1)(2013-1#1)
the 2 major##2##3##(1993-9#1)(2009-8#1)
the 2 microns plasmid##2##4##(1993-9#2)
the 2 week##2##3##(1995-12#1)(2007-10#1)
the 2 years##4##3##(2008-10#4)
the 2##115##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#4)(1992-3#1)(1992-9#3)(1993-11#1)(1993-9#6)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-5#1)(1997-3#2)(2007-10#3)(2007-11#5)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#33)(2008-11#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#5)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the 2%##2##2##(2008-10#1)(2010-8#1)
the 2'##2##2##(1993-11#1)(1994-8#1)
the 2(n)##2##2##(2008-2#1)(2008-7#1)
the 2- and##3##3##(1995-3#2)(2008-4#1)
the 2-D##9##2##(1997-7#1)(2008-3#4)(2008-4#1)(2010-12#1)(2010-8#1)(2012-1#1)
the 2-DE maps##2##3##(2011-3#2)
the 2-DE##3##2##(2008-12#1)(2011-3#2)
the 2-amino group##2##3##(1995-2#2)
the 2-methyl-2-phenylpropyl radical##2##3##(1996-5#2)
the 2-position##5##2##(1994-5#1)(1995-5#1)(1997-1#1)(2008-12#1)(2009-9#1)
the 2-pyrrolidone compound##3##3##(1990-5#3)
the 2-week##4##2##(1993-5#1)(2007-12#1)(2008-10#1)(2012-1#1)
the 2-year##5##2##(1996-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
the 20 patients##5##3##(1997-5#1)(2008-6#3)(2013-1#1)
the 20 reported##2##3##(2008-10#2)
the 20##35##2##(1990-11#1)(1990-2#1)(1993-1#1)(1993-11#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-5#1)(2007-8#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#1)(2011-2#3)(2012-1#1)(2013-1#1)
the 20% of##2##3##(1993-5#1)(2012-2#1)
the 20-carbon##2##2##(1994-11#1)(1995-11#1)
the 20-kDa##2##2##(1993-11#1)(1994-11#1)
the 200##3##2##(1990-3#1)(1991-5#1)(2012-3#1)
the 2000 census##2##3##(2010-11#1)(2011-2#1)
the 2000##17##2##(2008-10#4)(2008-11#8)(2008-8#1)(2010-11#1)(2011-2#3)
the 2000s##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
the 2001##19##2##(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#10)(2009-5#1)(2012-12#1)
the 2002##14##2##(2008-10#5)(2008-11#6)(2008-3#1)(2008-7#1)(2011-2#1)
the 2003##19##2##(2007-4#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#1)
the 2003-2009##2##2##(2011-2#2)
the 2004##14##2##(2007-12#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
the 2005 southern##2##3##(2008-11#1)(2009-5#1)
the 2005##15##2##(2008-11#8)(2008-12#1)(2008-4#2)(2009-5#2)(2012-12#1)(2012-2#1)
the 2006##15##2##(2008-10#1)(2008-11#9)(2008-12#1)(2008-6#2)(2008-8#1)(2011-2#1)
the 2007##9##2##(2008-11#4)(2008-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-5#1)
the 2008##5##2##(2010-8#1)(2012-1#2)(2012-2#1)(2013-7#1)
the 2009 H1N1 pandemic##3##4##(2011-2#3)
the 2009 influenza##2##3##(2011-2#1)(2012-12#1)
the 2009##7##2##(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#1)
the 2010##7##2##(2011-2#3)(2012-2#2)(2013-1#2)
the 20th century##23##3##(1994-12#1)(2006-10#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#4)(2010-1#1)(2010-10#1)(2011-1#1)(2011-7#1)
the 20th postnatal##2##3##(1993-12#2)
the 20th##35##2##(1990-9#1)(1992-6#1)(1993-12#2)(1994-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#4)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-7#1)
the 21 day##2##3##(1996-12#1)(2012-2#1)
the 21 kDa pea protein##2##5##(1993-6#2)
the 21##17##2##(1991-12#1)(1991-2#1)(1993-6#2)(1993-9#1)(1996-12#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
the 21(st) century##2##3##(2008-11#1)(2008-7#1)
the 21-##2##2##(1995-5#1)(2008-10#1)
the 210##2##2##(1993-2#1)(1994-9#1)
the 21q22##2##2##(1997-2#1)(1997-8#1)
the 21st Century##4##3##(1995-12#1)(2007-10#1)(2011-1#1)(2011-2#1)
the 21st amino##2##3##(2012-2#2)
the 21st century and##2##4##(2008-11#1)(2012-12#1)
the 21st century are##2##4##(1991-12#1)(2006-10#1)
the 21st century##52##3##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-12#1)(2008-1#5)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#3)
the 21st##63##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#6)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
the 22##11##2##(1991-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
the 22-month-old##2##2##(1994-3#2)
the 224-nm##3##2##(2008-2#3)
the 22nd##2##2##(1990-12#1)(2011-2#1)
the 22q11##4##2##(1997-3#3)(2012-12#1)
the 23 mothers prepared##2##4##(1991-9#2)
the 23##12##2##(1991-2#1)(1991-9#2)(1994-12#1)(1996-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-8#1)
the 23-kDa protein##2##3##(1993-6#1)(2009-11#1)
the 23-kDa##3##2##(1990-5#1)(1993-6#1)(2009-11#1)
the 23-valent pneumococcal##2##3##(1994-9#1)(2012-12#1)
the 23S##4##2##(1992-3#1)(1995-8#3)
the 23rd##2##2##(2007-6#1)(2012-2#1)
the 24 h##6##3##(1996-12#2)(1996-2#1)(1996-5#1)(2008-10#2)
the 24##20##2##(1990-2#1)(1991-8#1)(1993-2#1)(1995-12#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-6#1)(2008-1#2)(2008-10#4)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the 24-h mean##2##3##(1990-3#2)
the 24-h##6##2##(1990-3#2)(1994-8#1)(1995-11#1)(2008-10#1)(2008-9#1)
the 24-hour period##2##3##(2008-3#1)(2013-1#1)
the 24-hour##5##2##(1992-8#2)(2008-3#1)(2011-1#1)(2013-1#1)
the 24th##5##2##(1994-3#1)(1995-8#2)(1996-11#1)(2008-4#1)
the 25 degrees##4##3##(2008-5#4)
the 25 years##2##3##(1996-4#1)(1997-8#1)
the 25##17##2##(1992-12#1)(1996-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)
the 25-hydroxysterol and the 15-ketosterol##2##5##(1993-6#2)
the 25-item##2##2##(2011-1#2)
the 25-kDa##2##2##(1993-11#1)(2008-10#1)
the 257 patients##2##3##(1996-11#1)(2011-2#1)
the 26 cases##2##3##(1996-11#1)(2012-3#1)
the 26##8##2##(1993-12#1)(1995-2#1)(1996-11#3)(2009-9#1)(2011-2#1)(2012-3#1)
the 260##2##2##(2010-8#1)(2011-1#1)
the 265##2##2##(2008-10#1)(2013-1#1)
the 26S proteasome##2##3##(2008-4#2)
the 27 kD##2##3##(1990-7#1)(2008-5#1)
the 27##6##2##(1990-12#1)(1990-7#1)(1991-1#1)(2008-10#1)(2008-5#2)
the 27th International##2##3##(2008-7#1)(2010-3#1)
the 27th##3##2##(2008-10#1)(2008-7#1)(2010-3#1)
the 28##13##2##(1991-3#1)(1992-6#1)(1993-8#1)(1996-12#3)(1996-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
the 28S rRNA##3##3##(1994-12#1)(2008-5#1)(2010-4#1)
the 28S##6##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-4#1)
the 28th##3##2##(1995-6#1)(1996-12#1)(2008-10#1)
the 29##10##2##(1991-12#1)(1991-4#1)(1995-11#1)(1996-8#1)(2008-10#2)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#1)
the 29-kb plasmid##2##3##(2008-10#2)
the 2D and 3D##2##4##(2010-8#1)(2013-1#1)
the 2D separation##2##3##(2008-10#2)
the 2D##11##2##(1992-3#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-1#2)(2013-1#1)
the 2H##2##2##(1994-5#1)(2008-10#1)
the 2a##2##2##(2008-10#2)
the 2b protein##2##3##(2012-2#2)
the 2f##2##2##(2008-3#2)
the 2nd Helsingborg Declaration##3##4##(2008-8#3)
the 2nd and 3rd##6##4##(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)
the 2nd antibody##3##3##(2008-10#3)
the 2nd##19##2##(1990-8#1)(1991-3#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#3)(2010-12#2)(2010-3#2)(2010-8#2)(2011-1#1)
the 3 days##2##3##(2008-3#1)(2013-1#1)
the 3 groups##2##3##(1997-4#1)(2013-7#1)
the 3 mg/kg group##3##4##(2008-9#3)
the 3 months##2##3##(1990-3#1)(2007-7#1)
the 3 x 1 S##2##5##(1997-8#2)
the 3 year period##2##4##(2008-7#2)
the 3 years##7##3##(1995-12#1)(2008-10#6)
the 3##64##2##(1990-11#2)(1990-3#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-8#1)(1995-12#1)(1995-4#1)(1996-2#2)(1996-5#1)(1997-4#3)(1997-6#1)(1997-8#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the 3%##3##2##(2008-10#1)(2008-3#2)
the 3' UTR of the##2##5##(1996-12#1)(2011-2#1)
the 3' UTR of##4##4##(1996-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
the 3' UTR##5##3##(1996-12#2)(2010-11#1)(2011-2#1)(2012-3#1)
the 3' end of the genome##2##6##(2008-10#1)(2008-11#1)
the 3' end of the open reading frame##2##8##(1992-6#1)(1992-8#1)
the 3' end of the##18##5##(1991-7#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-4#2)(2008-10#3)(2008-11#1)(2008-4#1)(2013-1#1)
the 3' end of viral genomic##2##6##(2008-10#2)
the 3' end of##27##4##(1991-7#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
the 3' end##35##3##(1990-2#1)(1991-7#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
the 3' ends of the##2##5##(1994-12#1)(1995-2#1)
the 3' ends of##3##4##(1994-12#1)(1995-2#1)(2008-9#1)
the 3' non-coding##3##3##(1990-7#1)(1993-12#1)(1997-7#1)
the 3' nontranslated##2##3##(1993-3#1)(2008-10#1)
the 3' part of the##2##5##(1997-3#1)(2008-10#1)
the 3' part##3##3##(1997-3#1)(2008-10#2)
the 3' region of the##2##5##(1991-6#1)(1997-3#1)
the 3' region of##3##4##(1991-6#1)(1997-3#2)
the 3' region##5##3##(1991-6#1)(1995-8#1)(1997-3#2)(2008-10#1)
the 3' side##3##3##(1993-12#1)(1993-6#1)(2008-8#1)
the 3' terminal##5##3##(1991-7#1)(1997-3#2)(2008-10#2)
the 3' termini of##2##4##(2008-10#1)(2008-8#1)
the 3' termini##3##3##(2008-10#2)(2008-8#1)
the 3' terminus##2##3##(1994-8#1)(2008-10#1)
the 3' untranslated region (3'UTR)##2##5##(2008-10#1)(2009-5#1)
the 3' untranslated region of the##2##6##(1995-2#1)(1997-6#1)
the 3' untranslated region of##4##5##(1995-2#1)(1997-6#2)(2008-7#1)
the 3' untranslated region##10##4##(1991-9#1)(1994-11#1)(1995-2#1)(1997-4#1)(1997-6#3)(2008-10#1)(2008-7#1)(2009-5#1)
the 3' untranslated##12##3##(1991-2#1)(1991-9#1)(1994-11#1)(1995-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2008-10#1)(2008-7#1)(2009-5#1)
the 3'##107##2##(1990-2#1)(1990-7#3)(1991-2#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-8#3)(1994-9#2)(1995-2#2)(1995-8#2)(1996-12#2)(1996-6#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-6#4)(1997-7#2)(1997-8#1)(2007-12#2)(2008-10#23)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-5#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
the 3'- and##2##3##(2008-4#2)
the 3'-##4##2##(1990-5#1)(1997-6#1)(2008-4#2)
the 3'-5' exonuclease activity##3##4##(1997-6#3)
the 3'-5' exonuclease##5##3##(1997-6#5)
the 3'-UTR##3##2##(1995-12#1)(2008-1#1)(2013-1#1)
the 3'-end of##5##3##(1993-8#1)(1993-9#1)(1994-8#1)(2013-1#2)
the 3'-tRNA-like structure of##2##4##(1997-3#2)
the 3'-terminal##4##2##(1993-8#1)(1997-2#1)(2008-10#2)
the 3'-untranslated region##4##3##(1993-2#1)(1995-12#1)(2008-10#1)(2011-2#1)
the 3'-untranslated##5##2##(1993-2#2)(1995-12#1)(2008-10#1)(2011-2#1)
the 3'UTR of##3##3##(1994-12#1)(2008-9#1)(2011-2#1)
the 3'UTR##4##2##(1994-12#2)(2008-9#1)(2011-2#1)
the 3-(N-tert-butylcarboxamido)-1-propyl##2##2##(2008-4#2)
the 3-4##3##2##(1992-6#2)(2010-6#1)
the 3-5##2##2##(2011-1#1)(2013-8#1)
the 3-5-microm##2##2##(2007-11#1)(2008-3#1)
the 3-D culture##2##3##(2008-11#1)(2009-3#1)
the 3-D images##2##3##(2007-11#1)(2008-5#1)
the 3-D model of hIL-6R##2##5##(2008-8#2)
the 3-D model##3##3##(2008-3#1)(2008-8#2)
the 3-D structure##2##3##(2008-4#1)(2011-1#1)
the 3-D##24##2##(2007-11#1)(2008-11#2)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
the 3-amidoethane side chain##2##4##(1995-3#2)
the 3-h##2##2##(2008-10#2)
the 3-month##6##2##(1994-3#2)(2011-2#3)(2012-3#1)
the 3-week##2##2##(1996-1#1)(2008-12#1)
the 3-year##2##2##(1995-1#1)(2011-2#1)
the 30 patients##3##3##(1991-2#1)(1997-6#1)(2009-8#1)
the 30##22##2##(1990-8#1)(1991-2#1)(1992-12#1)(1995-4#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#4)(2012-3#1)
the 30-day##4##2##(2008-10#1)(2008-5#2)(2010-6#1)
the 30-kDa enzyme##2##3##(1994-11#2)
the 30-kDa##4##2##(1992-9#1)(1994-11#2)(1995-2#1)
the 30-minute##2##2##(2008-6#1)(2011-2#1)
the 305/311##2##2##(2008-3#2)
the 30S ribosomal##2##3##(1992-6#1)(2009-9#1)
the 30S small ribosomal subunit##2##5##(2009-9#2)
the 30S##5##2##(1992-6#1)(1993-11#1)(2009-9#3)
the 30th day##2##3##(2008-7#1)(2012-3#1)
the 30th##6##2##(1995-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)
the 31##7##2##(1990-2#3)(1990-9#1)(2007-8#1)(2008-10#1)(2008-9#1)
the 32##10##2##(1993-9#1)(1994-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the 32-kDa##2##2##(1994-11#1)(2008-10#1)
the 32nd##2##2##(1996-11#1)(2008-8#1)
the 33##8##2##(1994-2#1)(1995-11#2)(1996-12#1)(1997-5#1)(2008-9#1)(2011-2#2)
the 33-kD AX3##2##3##(1992-12#2)
the 34 kDa##6##3##(1991-12#1)(1995-5#1)(2009-7#4)
the 34##14##2##(1991-12#1)(1993-3#1)(1994-12#1)(1995-5#2)(1996-3#2)(2008-3#1)(2008-7#1)(2009-7#4)(2010-5#1)
the 34-kDa##2##2##(1990-5#1)(1993-6#1)
the 34th##2##2##(1997-8#1)(2007-8#1)
the 35##9##2##(1991-3#1)(1994-3#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-9#2)
the 36 patients##3##3##(1990-11#1)(1991-3#1)(1997-5#1)
the 36##11##2##(1990-11#1)(1990-2#1)(1991-3#1)(1993-1#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#2)
the 37 degrees##3##3##(1995-11#1)(2008-5#2)
the 37##11##2##(1990-8#1)(1993-3#1)(1995-11#2)(1997-7#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-8#1)
the 37th Annual##2##3##(2007-7#1)(2008-5#1)
the 38##5##2##(1996-3#1)(2008-12#1)(2010-8#1)(2011-2#2)
the 38th##2##2##(2011-1#1)(2012-12#1)
the 39 patients##2##3##(1990-6#1)(2008-5#1)
the 39##4##2##(1990-6#1)(1997-7#1)(2008-10#1)(2008-5#1)
the 3Bs rule (biocompatibility##2##4##(2008-11#2)
the 3Bs rule##3##3##(2008-11#3)
the 3CaO##2##2##(2008-10#2)
the 3D reconstruction of the sellar region##2##7##(2012-3#2)
the 3D reference##3##3##(2008-3#3)
the 3D scene##2##3##(2008-3#2)
the 3D##27##2##(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#8)(2008-6#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#2)(2012-2#2)(2012-3#3)
the 3d##2##2##(1990-9#1)(2007-12#1)
the 3rd and 6th##2##4##(2012-2#2)
the 3rd and##4##3##(1995-8#1)(2008-5#1)(2012-2#2)
the 3rd month and##2##4##(1990-8#1)(2007-7#1)
the 3rd month##4##3##(1990-8#1)(1994-6#1)(2007-11#1)(2007-7#1)
the 3rd year of life##2##5##(1991-8#2)
the 3rd year of##3##4##(1991-8#2)(2011-1#1)
the 3rd##22##2##(1990-8#1)(1991-8#2)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#2)
the 3sigma##3##2##(2008-10#3)
the 4 beta-methyl group of##2##5##(1992-3#2)
the 4 degrees C##2##4##(2008-10#1)(2012-2#1)
the 4 groups##2##3##(1990-7#1)(2008-3#1)
the 4 localities##3##3##(2011-1#3)
the 4 months of##2##4##(2010-10#1)(2011-1#1)
the 4 patients in##2##4##(1996-6#1)(2008-7#1)
the 4 patients##5##3##(1991-2#1)(1996-6#1)(2007-8#1)(2008-7#1)(2011-1#1)
the 4 study years##2##4##(1993-3#2)
the 4 years##2##3##(2008-10#2)
the 4##49##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#2)(1996-2#2)(1996-6#1)(1997-2#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#7)(2012-2#1)(2013-1#2)
the 4- and##2##3##(1991-5#1)(2008-2#1)
the 4-##3##2##(1991-5#1)(2008-2#1)(2008-3#1)
the 4-amine##2##2##(1995-3#2)
the 4-fold##2##2##(1997-7#1)(2013-1#1)
the 4-nitro group##2##3##(1995-3#2)
the 4-position##3##2##(1991-3#1)(1995-5#1)(2008-10#1)
the 4-week##3##2##(1994-8#1)(1996-12#1)(2008-7#1)
the 4-year period##3##3##(2008-10#3)
the 4-year##7##2##(2008-10#6)(2013-1#1)
the 40##8##2##(1990-5#1)(1995-8#1)(1996-12#3)(1997-3#1)(2008-4#1)(2008-9#1)
the 40-kDa complex##3##3##(1997-1#3)
the 40-kDa outer membrane protein##2##5##(1993-9#2)
the 40-kDa##7##2##(1993-9#3)(1995-5#1)(1997-1#3)
the 400##5##2##(1990-3#1)(1996-2#1)(1997-3#1)(2008-2#1)(2011-2#1)
the 41-week study##3##3##(2008-9#3)
the 42 patients with##2##4##(1990-3#1)(1994-7#1)
the 42##9##2##(1990-2#1)(1990-3#1)(1990-6#2)(1992-5#1)(1994-7#1)(1996-9#1)(2013-1#1)(2013-8#1)
the 43##8##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-9#1)(1996-3#1)(2008-11#1)(2009-7#1)
the 44##2##2##(2008-11#1)(2013-1#1)
the 45 patients##2##3##(1996-11#1)(2008-1#1)
the 45##14##2##(1993-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)
the 45-kDa##4##2##(1991-8#1)(1993-1#1)(1994-11#1)(1995-11#1)
the 45th##2##2##(2008-10#1)(2008-7#1)
the 46##7##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#2)(1997-2#1)(1997-3#1)
the 47th##2##2##(1990-2#2)
the 48##5##2##(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
the 4f##3##2##(2008-3#3)
the 4th and##3##3##(2007-7#1)(2008-5#1)(2013-1#1)
the 4th larval instar##2##4##(2008-12#1)(2008-5#1)
the 4th##21##2##(1990-12#1)(1992-9#1)(1993-11#1)(1994-3#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
the 5 A Day##2##4##(1997-1#1)(2012-2#1)
the 5 days##3##3##(1993-6#1)(1996-5#1)(2010-2#1)
the 5 patients who##2##4##(1991-5#1)(2013-1#1)
the 5 patients##5##3##(1991-5#1)(2007-10#1)(2007-11#1)(2011-2#1)(2013-1#1)
the 5 years##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
the 5##67##2##(1991-12#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-11#2)(1995-12#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-12#2)(2008-4#2)(2008-5#3)(2008-8#4)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
the 5%##2##2##(2008-10#1)(2008-6#1)
the 5' UTR##3##3##(2008-10#2)(2012-3#1)
the 5' and 3' regions of##2##6##(1992-8#1)(2008-10#1)
the 5' and 3'##9##4##(1992-3#1)(1992-8#1)(1993-2#1)(1997-8#1)(2008-10#4)(2008-8#1)
the 5' and the##2##4##(2008-10#2)
the 5' and##12##3##(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1997-8#1)(2008-10#6)(2008-8#1)
the 5' end of the gene##2##6##(1991-11#1)(2008-7#1)
the 5' end of the viral##2##6##(1992-12#2)
the 5' end of the##15##5##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#2)(1994-8#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)
the 5' end of##18##4##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#2)(1994-12#1)(1994-8#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
the 5' end##21##3##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#2)(1992-6#1)(1994-12#1)(1994-8#1)(1997-7#2)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
the 5' ends of##2##4##(1994-12#1)(2007-12#1)
the 5' ends##3##3##(1994-12#1)(2007-12#1)(2008-11#1)
the 5' exon##2##3##(1991-5#1)(1991-9#1)
the 5' exonuclease##3##3##(1997-8#3)
the 5' flanking region of the##2##6##(1993-12#1)(1993-3#1)
the 5' flanking region##7##4##(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1996-10#1)(2008-7#1)
the 5' flanking sequences##2##4##(1994-12#2)
the 5' flanking##12##3##(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#2)(1996-10#1)(2008-7#1)
the 5' non-coding region##2##4##(1991-9#1)(1995-6#1)
the 5' noncoding##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
the 5' portion of the##3##5##(1990-11#1)(1994-12#1)(1997-3#1)
the 5' promoter region##2##4##(1991-6#1)(1996-8#1)
the 5' region of the human##2##6##(1991-6#1)(1991-7#1)
the 5' region of the##7##5##(1991-6#3)(1991-7#1)(1995-2#1)(1995-8#1)(2008-8#1)
the 5' region of##8##4##(1991-6#3)(1991-7#1)(1992-3#1)(1995-2#1)(1995-8#1)(2008-8#1)
the 5' region##9##3##(1991-6#4)(1991-7#1)(1992-3#1)(1995-2#1)(1995-8#1)(2008-8#1)
the 5' regions##2##3##(1994-12#1)(1995-8#1)
the 5' side##4##3##(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)
the 5' splice site##2##4##(1991-5#2)
the 5' terminus of an oligonucleotide##3##6##(2008-4#3)
the 5' terminus of the oligonucleotide##3##6##(2008-4#3)
the 5' terminus of##7##4##(2008-4#7)
the 5' terminus##8##3##(1991-2#1)(2008-4#7)
the 5' untranslated region of##4##5##(1991-9#1)(1997-8#1)(2008-11#1)(2012-2#1)
the 5' untranslated region##8##4##(1991-9#1)(1992-11#1)(1992-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)
the 5' untranslated##10##3##(1991-9#1)(1992-11#2)(1992-3#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)
the 5' upstream##2##3##(1992-12#1)(1997-2#1)
the 5'##117##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#4)(1991-6#6)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#3)(1992-3#4)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#3)(1994-11#1)(1994-12#7)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#5)(2007-12#2)(2008-10#22)(2008-11#2)(2008-4#8)(2008-7#2)(2008-8#7)(2008-9#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-8#1)
the 5'- and 3'-untranslated regions##2##5##(1993-12#1)(2008-9#1)
the 5'- and##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
the 5'-UTR##6##2##(1996-5#5)(2012-3#1)
the 5'-end of the##2##4##(1993-8#1)(2008-10#1)
the 5'-end of##3##3##(1993-8#1)(1995-8#1)(2008-10#1)
the 5'-end##4##2##(1993-8#1)(1995-8#1)(2008-10#2)
the 5'-flanking DNA##2##3##(1991-11#1)(1994-2#1)
the 5'-flanking region and##2##4##(1991-7#1)(2010-5#1)
the 5'-flanking region of the gene##2##6##(1993-8#1)(1997-6#1)
the 5'-flanking region of the human##2##6##(1995-2#1)(1997-7#1)
the 5'-flanking region of the##9##5##(1991-2#1)(1993-8#3)(1994-9#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-9#1)
the 5'-flanking region of##11##4##(1991-2#2)(1993-8#3)(1994-9#1)(1995-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-9#1)
the 5'-flanking region##20##3##(1991-11#2)(1991-2#2)(1991-6#1)(1991-7#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-9#1)(1995-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-9#1)(2010-5#2)
the 5'-flanking sequence of##2##4##(1990-8#1)(2008-8#1)
the 5'-flanking sequence##4##3##(1990-8#1)(1995-6#1)(1997-7#1)(2008-8#1)
the 5'-flanking##27##2##(1990-8#1)(1991-11#3)(1991-2#2)(1991-6#1)(1991-7#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#2)(1997-6#1)(1997-7#3)(1997-8#1)(2008-8#1)(2008-9#1)(2010-5#2)
the 5'-nucleotidase##2##2##(1994-2#2)
the 5'-terminal sequence##2##3##(1993-11#2)
the 5'-terminal##5##2##(1993-11#2)(1993-3#1)(1994-8#1)(2008-10#1)
the 5'-terminus of##4##3##(1991-1#1)(2008-4#3)
the 5'-terminus##5##2##(1991-1#2)(2008-4#3)
the 5'-untranslated region (UTR) of the##2##6##(1996-5#1)(2008-10#1)
the 5'-untranslated region (UTR)##3##4##(1990-12#1)(1996-5#1)(2008-10#1)
the 5'-untranslated region##6##3##(1990-12#1)(1991-6#1)(1991-7#1)(1994-12#1)(1996-5#1)(2008-10#1)
the 5'-untranslated##7##2##(1990-12#1)(1991-6#1)(1991-7#1)(1993-2#1)(1994-12#1)(1996-5#1)(2008-10#1)
the 5'-upstream region of##4##4##(1993-12#1)(1996-3#2)(1997-7#1)
the 5'-upstream region##5##3##(1993-12#1)(1996-3#2)(1997-7#2)
the 5'-upstream##6##2##(1993-12#1)(1996-3#2)(1997-7#2)(2008-11#1)
the 5-##2##2##(2010-3#1)(2012-12#1)
the 5-2-1-AN message##2##3##(2010-8#2)
the 5-HT##3##2##(1995-12#1)(1996-12#1)(1996-5#1)
the 5-HT1A receptor##7##3##(1993-3#2)(1994-2#3)(1995-12#2)
the 5-HT1A##9##2##(1993-3#2)(1993-9#1)(1994-2#3)(1995-12#3)
the 5-HT1B##2##2##(1994-2#1)(1995-12#1)
the 5-HT2 receptor##3##3##(1991-12#1)(1993-9#1)(1995-3#1)
the 5-HT2C receptor mRNA##2##4##(1996-12#2)
the 5-HT2C receptor##5##3##(1996-12#5)
the 5-HT7 receptor##2##3##(2008-5#2)
the 5-choice serial reaction time task##3##6##(1992-11#1)(2008-4#2)
the 5-day##4##2##(1991-8#1)(1992-12#1)(2008-10#2)
the 5-methoxyl group##3##3##(1995-3#3)
the 5-month-old##2##2##(1995-8#1)(1996-1#1)
the 5-year EFS of##2##4##(2010-3#1)(2011-2#1)
the 5-year EFS##3##3##(2010-3#2)(2011-2#1)
the 5-year disease-free survival rate##3##5##(1994-7#1)(1997-7#2)
the 5-year disease-free##4##3##(1994-7#1)(1997-7#3)
the 5-year non-recurrence rate##3##4##(1997-7#3)
the 5-year period##2##3##(1995-9#1)(2007-8#1)
the 5-year survival rate was##2##5##(1990-9#1)(2007-8#1)
the 5-year survival rate##3##4##(1990-9#1)(1997-7#1)(2007-8#1)
the 5-year survival##4##3##(1990-9#1)(1997-7#1)(2007-8#1)(2008-3#1)
the 5-year##21##2##(1990-9#1)(1992-8#1)(1994-7#2)(1995-9#1)(1997-7#7)(2007-8#2)(2008-3#1)(2008-7#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
the 50 mg/kg/dose regimen##2##4##(2008-10#2)
the 50 patients##2##3##(1993-2#1)(2007-7#1)
the 50##18##2##(1993-11#2)(1993-2#1)(1997-4#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#2)(2010-5#1)(2013-1#1)
the 50% control##3##3##(2012-2#3)
the 50% of##3##3##(1997-8#1)(2013-1#2)
the 50% survival age##2##4##(1996-2#2)
the 50%##12##2##(1996-2#2)(1997-8#2)(2008-10#1)(2009-8#1)(2012-2#3)(2013-1#3)
the 50-kDa##3##2##(1995-6#1)(2008-10#2)
the 500 mg/kg##3##3##(2008-9#3)
the 500##7##2##(1996-12#1)(2008-9#3)(2010-5#2)(2011-2#1)
the 50S##2##2##(1993-11#2)
the 51##3##2##(1996-12#1)(2008-12#1)(2008-7#1)
the 514##2##2##(1997-7#1)(2008-2#1)
the 52##4##2##(2008-10#2)(2008-3#1)(2012-12#1)
the 53##2##2##(1994-1#1)(2011-2#1)
the 53-day##2##2##(2008-7#2)
the 54 patients##2##3##(1991-2#1)(2008-1#1)
the 54##9##2##(1990-2#1)(1991-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#4)
the 54-kDa##2##2##(1994-11#1)(1995-8#1)
the 55##5##2##(1993-6#1)(1994-2#2)(1996-12#1)(2008-8#1)
the 56##4##2##(1990-3#1)(1995-5#1)(2010-9#1)(2013-8#1)
the 57 amino acids##2##4##(1995-12#2)
the 57##6##2##(1990-8#1)(1995-12#2)(2008-10#1)(2009-10#1)(2012-12#1)
the 57-kDa form was##2##4##(1995-8#2)
the 58K-like protein##2##3##(2008-8#2)
the 59-kDa protein##3##3##(1990-5#3)
the 5HT1D pseudogene##2##3##(1993-12#2)
the 5HT1D##4##2##(1993-12#3)(2008-6#1)
the 5HT2A receptor##3##3##(1996-7#3)
the 5P(3/2)##2##2##(2008-3#2)
the 5S##3##2##(2008-10#3)
the 5S(1/2) ?##3##3##(2007-12#2)(2008-3#1)
the 5Z-syn##2##2##(1990-8#1)(1992-3#1)
the 5th##11##2##(1991-2#1)(1991-9#2)(1995-8#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
the 6 and 12 mg/kg##2##5##(2008-9#2)
the 6 months before##2##4##(2008-1#1)(2013-1#1)
the 6 months##4##3##(2008-1#2)(2008-3#1)(2013-1#1)
the 6 patients with##4##4##(1994-7#1)(1995-12#1)(1997-4#1)(2010-8#1)
the 6 patients##5##3##(1994-7#1)(1995-12#1)(1997-4#1)(2008-1#1)(2010-8#1)
the 6 years##2##3##(2008-10#1)(2009-4#1)
the 6##35##2##(1990-5#1)(1990-9#1)(1991-5#1)(1994-7#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
the 6(2)P(3/2)( degrees )##2##4##(2007-12#2)
the 6-kb##2##2##(1996-5#1)(1997-7#1)
the 6-methylquinolinium##2##2##(2008-10#2)
the 6-month follow-up##2##3##(1997-2#1)(2007-8#1)
the 6-month period##2##3##(1991-1#1)(2008-6#1)
the 6-month##5##2##(1991-1#1)(1997-2#1)(2007-8#1)(2008-6#1)(2008-8#1)
the 6-week##2##2##(2008-4#1)(2010-2#1)
the 6-year##2##2##(2008-10#1)(2013-1#1)
the 60 kDa IGBP##2##4##(1996-12#2)
the 60##6##2##(1993-12#1)(1996-12#2)(1996-5#1)(2009-10#1)(2013-8#1)
the 600##3##2##(1990-8#1)(1992-11#1)(2013-1#1)
the 600-nm##2##2##(1994-5#1)(1994-8#1)
the 60s##2##2##(2009-4#1)(2011-2#1)
the 61 patients##3##3##(2008-8#1)(2011-2#2)
the 61##7##2##(1990-11#1)(1992-6#1)(1993-9#1)(2008-10#1)(2008-8#1)(2011-2#2)
the 64##4##2##(1996-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
the 65##8##2##(1996-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
the 650-bp##2##2##(2008-10#2)
the 66 and##2##3##(1990-12#1)(2008-8#1)
the 66##3##2##(1990-12#1)(2008-8#1)(2013-1#1)
the 67 K protein##6##4##(1995-12#6)
the 67 K##7##3##(1995-12#7)
the 67##9##2##(1995-12#7)(1996-12#1)(2013-8#1)
the 68 isolates##2##3##(2008-10#1)(2013-8#1)
the 68 kDa##2##3##(1991-5#1)(1997-2#1)
the 68##7##2##(1991-11#1)(1991-4#1)(1991-5#1)(1997-2#1)(2008-10#2)(2013-8#1)
the 69##3##2##(1990-8#1)(1991-12#1)(2008-10#1)
the 695##3##2##(1991-9#1)(1992-12#1)(1992-9#1)
the 6th to##2##3##(1997-6#1)(2007-5#1)
the 6th##12##2##(1993-6#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2011-4#1)
the 7 cases##2##3##(1995-4#1)(2011-2#1)
the 7 patients with##2##4##(1991-5#1)(1995-12#1)
the 7 patients##3##3##(1990-3#1)(1991-5#1)(1995-12#1)
the 7##30##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1993-6#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-2#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
the 7-ku##3##2##(2008-9#3)
the 70##6##2##(1992-12#1)(1993-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
the 72##2##2##(1996-7#1)(1997-2#1)
the 7436 bp deletion##2##4##(1995-12#2)
the 75 kDa protein##3##4##(1990-8#1)(2008-7#2)
the 75 kDa##4##3##(1990-8#1)(2008-7#3)
the 75##7##2##(1990-8#1)(1992-12#1)(2007-8#1)(2008-7#4)
the 75th##3##2##(1997-3#1)(2007-11#1)(2013-1#1)
the 79 degrees-81 degrees region of the Bacillus subtilis genome##2##10##(1996-8#2)
the 79##3##2##(1996-8#2)(1997-2#1)
the 793/B##5##2##(2008-5#5)
the 7DL suppressor##4##3##(2008-10#4)
the 7q31-q32 region##2##3##(1996-6#2)
the 7th month##2##3##(1992-12#1)(2007-11#1)
the 7th##9##2##(1992-12#1)(1992-5#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2009-9#1)(2013-1#1)(2013-8#1)
the 8##11##2##(1990-2#2)(1990-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-5#1)
the 8-alkynyl derivatives##2##3##(2008-4#2)
the 8-bp sequence##4##3##(1995-6#4)
the 8-week##2##2##(1994-12#1)(2012-2#1)
the 80 kDa##2##3##(1992-6#1)(1996-2#1)
the 80##4##2##(1992-6#1)(1996-2#1)(2008-5#1)(2008-7#1)
the 800-nm##2##2##(2007-12#1)(2008-3#1)
the 802##3##2##(2008-10#1)(2008-7#2)
the 803##2##2##(2011-2#1)(2013-8#1)
the 83 kDa peptide is##2##5##(1990-11#2)
the 83 kDa peptide##3##4##(1990-11#3)
the 85##3##2##(2007-7#1)(2008-2#1)(2011-2#1)
the 87##2##2##(2008-10#1)(2008-7#1)
the 8th##10##2##(1992-3#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-5#1)(2011-2#1)(2011-4#1)(2013-1#1)(2013-7#1)
the 9 cases##2##3##(1993-9#1)(1994-7#1)
the 9 patients with##2##4##(1991-5#1)(1992-8#1)
the 9##18##2##(1991-5#2)(1992-8#1)(1993-9#1)(1994-7#1)(2008-10#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-2#2)
the 90 degrees##3##3##(1993-8#1)(2007-11#1)(2009-5#1)
the 90 kDa protein##2##4##(2008-7#2)
the 90##12##2##(1990-6#1)(1993-8#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-5#1)(2010-10#1)(2011-2#1)
the 90% of##2##3##(1993-9#1)(2013-7#1)
the 90%##3##2##(1993-9#1)(2008-7#1)(2013-7#1)
the 90's##3##2##(1993-3#1)(1993-9#1)(2008-1#1)
the 900-bp intron##2##3##(2008-10#2)
the 90s##5##2##(1991-12#1)(1991-3#1)(1994-1#1)(1994-2#1)(1995-12#1)
the 92 patients##2##3##(1996-3#1)(1997-3#1)
the 94##4##2##(1991-9#2)(2010-3#1)(2013-7#1)
the 95% confidence interval for##2##5##(1991-5#1)(1994-2#1)
the 95% confidence interval of##2##5##(2008-10#1)(2010-3#1)
the 95% confidence interval##5##4##(1991-5#1)(1994-2#1)(2008-10#2)(2010-3#1)
the 95% confidence intervals##2##4##(2008-10#1)(2008-9#1)
the 95% confidence##31##3##(1991-5#1)(1992-5#1)(1994-2#1)(1995-5#1)(2008-10#25)(2008-9#1)(2010-3#1)
the 95%##36##2##(1991-5#1)(1992-5#1)(1994-2#1)(1995-5#1)(2008-10#29)(2008-9#1)(2010-3#1)(2012-2#1)
the 96##2##2##(1990-2#1)(2007-7#1)
the 97##2##2##(1993-11#1)(1997-6#1)
the 98 kDa##2##3##(1994-6#2)
the 98##3##2##(1994-6#2)(2008-10#1)
the 98- to 120-aa##2##4##(2008-10#2)
the 99##4##2##(1991-9#1)(1997-2#1)(2007-8#1)(2008-10#1)
the 9alpha-hydroxylase system##2##3##(2008-11#2)
the 9th International##2##3##(2008-12#1)(2008-8#1)
the 9th and 10th##4##4##(1992-3#1)(2007-12#1)(2010-4#1)(2013-1#1)
the 9th day##3##3##(1994-7#1)(2008-10#1)(2008-11#1)
the 9th grade##3##3##(1991-9#3)
the 9th##18##2##(1991-9#3)(1992-3#1)(1993-3#1)(1994-7#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2013-1#2)
the ?(3/2) (v?##2##3##(2008-3#2)
the A and B##5##4##(1990-11#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-12#1)
the A and##6##3##(1990-11#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-12#1)
the A beta##3##3##(1994-11#1)(1994-8#1)(1995-12#1)
the A chain##3##3##(1993-11#2)(1997-4#1)
the A genotype##4##3##(2008-10#4)
the A or##3##3##(1994-5#1)(2008-10#2)
the A subunit##3##3##(1995-2#1)(1995-6#2)
the A##52##2##(1990-11#1)(1990-12#1)(1992-8#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-7#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
the A(section)E((R)) discrimination test##2##4##(2008-9#2)
the A(section)E((R))##3##2##(2008-9#3)
the A*##3##2##(2009-6#3)
the A-chain##2##2##(1990-11#1)(1992-3#1)
the A-complex##2##2##(1995-6#2)
the A-type##2##2##(1991-9#1)(2008-10#1)
the A1 adenosine receptor##3##4##(1993-3#1)(1993-6#1)(1994-5#1)
the A1 and A2##2##4##(2008-10#1)(2008-9#1)
the A1 cell group##2##4##(1990-5#2)
the A1 pulley in##2##4##(2008-9#2)
the A1 pulley##3##3##(2008-9#3)
the A1##17##2##(1990-5#3)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(2008-10#3)(2008-9#4)
the A10##2##2##(1991-1#1)(1995-3#1)
the A2 mating type##4##4##(2008-10#4)
the A2##13##2##(1993-6#1)(1996-3#3)(2008-10#5)(2008-12#1)(2008-9#3)
the A2-receptor-induced##2##2##(1994-6#2)
the A4##3##2##(1990-7#1)(1991-1#1)(1994-5#1)
the A6-cut and##2##3##(2008-6#2)
the A6-cut##4##2##(2008-6#4)
the A7 monoclonal antibody##2##4##(2008-11#2)
the AA##7##2##(1990-12#1)(2008-3#2)(2008-8#1)(2011-2#3)
the AAA##4##2##(2008-7#1)(2012-12#3)
the AABB##5##2##(1995-6#5)
the AAC##3##2##(2008-10#3)
the AAPCC##6##2##(1993-3#5)(1997-1#1)
the AAS##5##2##(2008-10#5)
the AB##2##2##(2009-4#2)
the ABA##2##2##(1994-11#1)(2008-8#1)
the ABBP##3##2##(2008-8#3)
the ABC ring##2##3##(2008-7#1)(2009-10#1)
the ABC transporter##2##3##(2008-11#1)(2011-2#1)
the ABC##7##2##(1993-12#1)(1994-3#2)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
the ABCD matrix##2##3##(2008-2#1)(2008-3#1)
the ABCD##5##2##(2008-2#3)(2008-3#1)(2009-10#1)
the ABI##3##2##(2007-7#1)(2008-9#1)(2013-1#1)
the ABL##4##2##(2008-2#4)
the ABM approach##2##3##(2008-5#2)
the ABQ##2##2##(2010-11#2)
the AC##7##2##(1990-5#2)(1994-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2013-1#1)
the ACC##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
the ACDF group##2##3##(2012-12#2)
the ACE##8##2##(1990-2#1)(2008-6#1)(2008-7#2)(2008-9#4)
the ACEHSA##2##2##(1996-12#2)
the ACIS##2##2##(2008-10#2)
the ACL##5##2##(1997-8#2)(2013-1#3)
the ACP##2##2##(1995-6#1)(2013-1#1)
the ACP1 gene product##3##4##(1992-12#3)
the ACS##5##2##(2008-4#2)(2008-5#2)(2008-6#1)
the ACTH##3##2##(1992-8#1)(1994-2#1)(2011-1#1)
the AChE layer##2##3##(2008-10#2)
the AChE##4##2##(1995-12#1)(1995-3#1)(2008-10#2)
the AD cases##4##3##(1991-1#4)
the AD duration##3##3##(1992-12#1)(1994-2#2)
the AD group##2##3##(2008-7#2)
the AD##11##2##(1991-1#4)(1992-12#1)(1994-2#2)(2008-7#3)(2011-2#1)
the AD3 subtype##2##3##(1995-8#2)
the ADA##14##2##(1994-1#2)(1995-12#3)(1995-6#2)(1996-1#2)(1996-5#2)(1997-5#2)(2008-3#1)
the ADH promoter##2##3##(1993-3#2)
the ADH##3##2##(1993-3#2)(1997-8#1)
the ADH1 gene##2##3##(1990-5#2)
the ADH1 promoter##3##3##(1990-5#2)(1997-3#1)
the ADH1##5##2##(1990-5#4)(1997-3#1)
the ADHD##3##2##(2006-10#2)(2012-1#1)
the ADL##2##2##(2008-7#1)(2012-1#1)
the ADP##3##2##(1990-11#1)(1990-7#1)(2006-6#1)
the ADP-ribosylation of HMG##2##4##(1990-3#2)
the ADP-ribosylation of##9##3##(1990-3#3)(1993-3#5)(1993-6#1)
the ADP-ribosylation##10##2##(1990-3#3)(1993-3#5)(1993-6#1)(1997-4#1)
the ADR of##2##3##(2008-10#2)
the ADR##3##2##(2008-10#2)(2011-2#1)
the ADR/AE##3##2##(2011-2#3)
the ADS##2##2##(2008-10#1)(2009-10#1)
the ADT##2##2##(2008-2#2)
the AF4Q initiative has##3##4##(2013-1#3)
the AF4Q initiative##8##3##(2013-1#8)
the AF4Q##11##2##(2013-1#11)
the AFC assay##5##3##(2008-10#5)
the AFC##11##2##(2008-10#5)(2011-2#6)
the AFLP data##2##3##(2008-10#2)
the AFLP groups##2##3##(2008-10#2)
the AFLP##12##2##(2008-10#12)
the AFM tip is##2##4##(2007-12#1)(2008-7#1)
the AFM tip##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
the AFM##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
the AG##3##2##(2007-8#1)(2008-10#2)
the AGL2 gene family from##2##5##(1997-2#2)
the AGL2 gene family##4##4##(1997-2#3)(1997-8#1)
the AGL2##6##2##(1997-2#4)(1997-8#2)
the AGT activity##3##3##(1993-11#1)(1995-12#1)(1995-5#1)
the AGT##6##2##(1993-11#1)(1995-12#1)(1995-5#3)(2008-5#1)
the AGabaA##3##2##(2012-12#3)
the AH109A invasion##2##3##(2008-11#2)
the AH109A##3##2##(2008-11#3)
the AHA##3##2##(1991-12#2)(1997-3#1)
the AHA's##3##2##(1991-1#1)(1991-3#1)(1992-12#1)
the AHP##4##2##(1994-1#1)(1995-1#1)(1995-3#1)(2008-10#1)
the AHRA Statistical Resource Committee##3##5##(1991-12#1)(1991-3#1)(1993-1#1)
the AHRA surveyed its##2##4##(1995-3#1)(1996-1#1)
the AHRA##9##2##(1991-12#3)(1991-3#1)(1993-1#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)
the AHRA's &quot##2##3##(1992-12#1)(1993-2#1)
the AHRA's##5##2##(1992-12#1)(1993-2#4)
the AI##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
the AIDS crisis##3##3##(1992-12#2)(1993-1#1)
the AIDS epidemic in##2##4##(1990-3#1)(2008-4#1)
the AIDS epidemic##11##3##(1990-12#2)(1990-3#3)(1994-9#1)(1995-1#1)(1996-5#1)(1996-6#1)(2008-4#1)(2008-5#1)
the AIDS virus##4##3##(1990-6#1)(1991-5#1)(1992-12#1)(1993-1#1)
the AIDS##31##2##(1990-12#2)(1990-3#4)(1990-6#1)(1991-5#2)(1992-12#3)(1992-9#2)(1993-1#2)(1994-1#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-5#1)(2008-4#1)(2008-5#3)(2010-10#1)(2010-3#1)
the AIF-PI method##2##3##(2009-9#2)
the AII-induced##2##2##(1991-5#2)
the AIS##3##2##(2008-10#2)(2010-7#1)
the ALD##3##2##(1993-12#1)(1993-3#1)(1995-2#1)
the AM##5##2##(1994-2#2)(1995-12#1)(2008-11#1)(2008-7#1)
the AMARTIS model##2##3##(2008-3#2)
the AMARTIS##3##2##(2008-3#3)
the AML##6##2##(2008-10#3)(2008-6#3)
the AMP##2##2##(1993-3#1)(2008-10#1)
the AMPA##2##2##(1993-12#1)(1995-5#1)
the AN##2##2##(1991-11#2)
the ANCOVA with equal slopes and##2##6##(2012-1#2)
the ANCOVA with equal slopes##4##5##(2012-1#4)
the ANCOVA with equal##5##4##(2012-1#5)
the ANCOVA with##6##3##(2012-1#6)
the ANCOVA##7##2##(2012-1#7)
the ANF##2##2##(1990-12#1)(2008-6#1)
the ANN method proved to be##2##6##(2008-10#2)
the ANN##9##2##(2008-10#7)(2009-3#1)(2010-8#1)
the ANN/FTNIR##2##2##(2008-10#2)
the AO##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
the AOAC##2##2##(2008-10#2)
the AP site##3##3##(1995-2#1)(2008-10#2)
the AP##7##2##(1995-2#1)(2008-10#2)(2009-11#1)(2010-2#2)(2010-4#1)
the AP-1##2##2##(1994-11#2)
the APC##3##2##(1994-11#1)(2008-4#2)
the API##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
the APP##5##2##(1992-12#2)(1992-9#1)(1993-3#1)(1996-12#1)
the APS##4##2##(2006-10#2)(2008-10#1)(2008-11#1)
the APT##2##2##(2012-12#2)
the AR cDNA##2##3##(1995-12#2)
the AR in##3##3##(1990-11#1)(1992-8#1)(2010-1#1)
the AR of##2##3##(1990-11#1)(2008-8#1)
the AR##10##2##(1990-11#2)(1992-8#1)(1995-12#2)(2008-8#3)(2010-1#1)(2011-2#1)
the ARC##3##2##(1994-8#2)(2008-10#1)
the ARE##2##2##(2008-9#1)(2009-8#1)
the ARF18-C##2##2##(2008-10#2)
the ARIA##3##2##(2012-12#3)
the ARS##4##2##(2008-10#1)(2008-3#1)(2008-6#2)
the AS##6##2##(2012-12#6)
the ASA##6##2##(1997-6#5)(2009-5#1)
the ASAD##2##2##(2012-2#2)
the ASC mice##2##3##(2013-1#2)
the ASC##4##2##(2012-4#1)(2013-1#3)
the ASE cartridge##2##3##(2008-10#2)
the ASE##5##2##(2007-11#1)(2008-10#3)(2008-2#1)
the ASI##2##2##(1991-1#1)(2011-1#1)
the ASMF##3##2##(2008-3#3)
the ASR##2##2##(1992-2#1)(1996-5#1)
the ASRC given##2##3##(1996-12#2)
the ASRC##4##2##(1996-12#4)
the ASTM##2##2##(2008-10#2)
the ASV peaks##2##3##(2008-10#2)
the ASV##4##2##(2008-10#4)
the AT region##3##3##(1995-6#3)
the AT##5##2##(1992-3#1)(1995-6#3)(2008-5#1)
the AT1 receptor subtype##3##4##(1992-3#1)(1994-8#1)(1994-9#1)
the AT1 receptor##4##3##(1992-3#1)(1994-8#2)(1994-9#1)
the AT1##5##2##(1992-3#1)(1994-8#2)(1994-9#1)(2008-8#1)
the AT2 receptor##4##3##(1994-8#2)(1994-9#1)(1996-5#1)
the AT2##6##2##(1991-9#1)(1994-8#2)(1994-9#2)(1996-5#1)
the ATG12##2##2##(2013-1#2)
the ATP binding##2##3##(1993-6#1)(2011-2#1)
the ATP##20##2##(1990-5#1)(1990-7#1)(1991-9#1)(1993-6#3)(1993-8#4)(1994-11#1)(1994-6#2)(2007-10#2)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
the ATP-binding##2##2##(1991-2#1)(2008-11#1)
the ATP-cytochrome c adducts##2##4##(1995-2#2)
the ATP-dependent##4##2##(1995-8#2)(1997-4#1)(2008-8#1)
the ATPase activity of##3##4##(1992-6#1)(1994-12#1)(1997-2#1)
the ATPase activity##4##3##(1992-6#1)(1993-9#1)(1994-12#1)(1997-2#1)
the ATPase reaction##2##3##(1992-6#2)
the ATPase##15##2##(1991-2#1)(1992-6#6)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-9#1)(1997-2#1)(2006-6#1)(2012-3#1)
the ATR##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
the AUC of##2##3##(2008-11#1)(2011-1#1)
the AUC##4##2##(2008-11#3)(2011-1#1)
the AUD severity factor##2##4##(2013-8#2)
the AUDPC##3##2##(2008-10#3)
the AV##3##2##(1992-5#1)(2011-3#2)
the AVF##4##2##(1996-9#1)(2007-7#3)
the AVM without##2##3##(2008-7#2)
the AVM##11##2##(1997-6#1)(2008-7#10)
the Ab production efficiency##3##4##(2008-11#3)
the Abbe##2##2##(2008-3#1)(2012-1#1)
the Abl##2##2##(1994-10#1)(2012-12#1)
the Ac elements are##2##4##(2012-3#2)
the Ac elements##3##3##(2012-3#3)
the Ac##5##2##(2012-3#5)
the AcNPV##2##2##(1997-4#2)
the Academy of##4##3##(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
the Acb##3##2##(2007-8#3)
the Achilles tendon##4##3##(2007-12#1)(2009-10#2)(2012-1#1)
the Achilles##7##2##(1997-8#1)(2007-12#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-1#1)
the Acomys##2##2##(2010-11#2)
the Act##4##2##(1991-1#1)(1993-3#2)(1997-8#1)
the Active##2##2##(1991-6#1)(2008-12#1)
the Activity of##2##3##(2008-10#2)
the Acute##4##2##(1993-3#1)(1997-1#1)(2008-10#1)(2013-1#1)
the Ad9 E4 region##3##4##(1992-9#3)
the Adair##4##2##(1990-8#4)
the Addiction##3##2##(1992-12#1)(2011-1#2)
the Adjusted##2##2##(1997-1#1)(2008-7#1)
the Advanced Earth Observing Satellite II##2##6##(2008-2#2)
the Advanced Photon Source at Argonne National Laboratory##2##8##(2008-11#1)(2008-3#1)
the Advanced##9##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)
the Adventist##2##2##(1996-1#1)(2011-2#1)
the Aerobics Center Longitudinal Study (ACLS)##2##6##(2009-3#2)
the Affymetrix##5##2##(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)
the Afmadow to Garissa routes##2##5##(2011-2#2)
the African American##4##3##(2010-8#3)(2012-12#1)
the African##13##2##(1992-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#4)(2011-2#1)(2012-12#1)(2013-8#1)
the Afro-Andean##3##2##(2008-10#3)
the Ag electrode##3##3##(2008-10#1)(2013-1#2)
the Ag##8##2##(1996-2#1)(2007-12#1)(2008-10#2)(2013-1#4)
the Ag(2)S##3##2##(2008-10#1)(2008-3#2)
the Aga Khan University Hospital##2##5##(2007-7#1)(2013-8#1)
the Age of##5##3##(1996-5#1)(2008-12#3)(2012-1#1)
the Age##6##2##(1996-5#1)(2008-12#3)(2009-7#1)(2012-1#1)
the Agency for Health Care Policy and Research##2##8##(1992-8#1)(1993-12#1)
the Agency for##3##3##(1992-8#1)(1993-12#1)(2011-2#1)
the Agency##4##2##(1992-8#1)(1993-12#1)(1997-3#1)(2011-2#1)
the Agricultural Production-Crops industry##2##4##(2008-12#2)
the Agricultural Production-Crops##4##3##(2008-12#4)
the Agricultural##6##2##(2008-12#6)
the Agrobacterium##2##2##(1991-7#1)(2008-9#1)
the Ah receptor##3##3##(1992-12#1)(1993-12#1)(1995-11#1)
the Ah##4##2##(1992-12#1)(1993-12#2)(1995-11#1)
the AhR complex##2##3##(1993-11#2)
the AhR##7##2##(1993-11#3)(2008-10#4)
the Aid##2##2##(1992-2#1)(2008-1#1)
the Air##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
the Airy caustics##3##3##(2008-2#3)
the Airy##8##2##(2007-11#4)(2008-2#4)
the Akaike##2##2##(2008-6#1)(2011-1#1)
the Al concentration##2##3##(2008-10#2)
the Al electrode##2##3##(2008-10#1)(2009-11#1)
the Al powder industry##2##4##(2013-8#2)
the Al##10##2##(2008-10#7)(2009-11#1)(2013-8#2)
the Ala##2##2##(1992-6#1)(1995-2#1)
the Albanian##2##2##(2008-10#1)(2011-2#1)
the Alberta Catholic Hospitals Foundation##2##5##(1993-12#1)(1994-1#1)
the Alberta##6##2##(1993-12#3)(1994-1#1)(1996-1#1)(2012-12#1)
the Aligning Forces for Quality (AF4Q)##2##6##(2013-1#2)
the Aligning Forces for Quality##4##5##(2013-1#4)
the All##2##2##(1996-12#1)(2011-2#1)
the Allan##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the Allee effect##6##3##(2008-10#1)(2008-8#5)
the Allen's test##3##3##(2007-8#3)
the AlloMap test##2##3##(2008-10#2)
the AlloMap##3##2##(2008-10#3)
the Alps##3##2##(2008-11#3)
the Alu consensus sequence##2##4##(1991-5#1)(1993-12#1)
the Alu##4##2##(1991-5#2)(1993-12#1)(1997-2#1)
the Alzheimer amyloid precursor protein gene##2##6##(1993-8#1)(1994-8#1)
the Alzheimer amyloid##5##3##(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)
the Alzheimer##14##2##(1990-3#3)(1992-12#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-8#1)(1996-11#1)(2008-7#1)
the Alzheimer's Disease Cooperative Study##2##5##(2008-5#1)(2011-2#1)
the Alzheimer's Disease##3##3##(1995-11#1)(2008-5#1)(2011-2#1)
the Alzheimer's disease##3##3##(1992-12#1)(1995-8#1)(2008-7#1)
the Alzheimer's##8##2##(1991-11#1)(1992-12#1)(1995-11#1)(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
the Amazon rainforest##2##3##(2010-7#2)
the Amazon##6##2##(2008-7#1)(2009-2#1)(2010-7#3)(2013-7#1)
the Amberlite##2##2##(2008-10#2)
the Amendment's##2##2##(1993-12#2)
the American Academy of Pediatrics##4##5##(1996-6#1)(2008-11#1)(2010-8#1)(2013-1#1)
the American Academy of##6##4##(1995-2#1)(1996-6#1)(2007-11#1)(2008-11#1)(2010-8#1)(2013-1#1)
the American Association for Partial Hospitalization##2##6##(1991-1#2)
the American Association for##3##4##(1991-1#2)(2008-9#1)
the American Association of##4##4##(1995-6#1)(2008-1#1)(2012-2#1)(2012-3#1)
the American Association##7##3##(1991-1#2)(1995-6#1)(2008-1#1)(2008-9#1)(2012-2#1)(2012-3#1)
the American Civil War##2##4##(2009-7#2)
the American College of Cardiology##2##5##(2008-3#1)(2009-6#1)
the American College of Cardiology/American Heart Association guidelines##2##8##(2008-3#2)
the American College of Cardiology/American Heart Association##3##7##(2008-3#3)
the American College of Surgeons##2##5##(2008-4#1)(2008-6#1)
the American College of##16##4##(1993-12#2)(1993-3#1)(1994-12#1)(2007-8#1)(2008-3#4)(2008-4#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)
the American Dietetic Association##2##4##(1994-2#1)(1995-2#1)
the American Heart Association (AHA)##2##5##(2008-3#1)(2012-3#1)
the American Heart Association and##3##5##(1996-6#2)(2010-9#1)
the American Heart Association##9##4##(1996-6#2)(2008-3#2)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#1)(2012-3#1)
the American Hospital Association Annual Survey##2##6##(1992-2#1)(2008-11#1)
the American Hospital Association##4##4##(1992-2#2)(1992-3#1)(2008-11#1)
the American Medical Association##4##4##(1991-8#2)(1993-3#1)(1996-12#1)
the American National##3##3##(1997-5#1)(1997-8#1)(2008-3#1)
the American Psychiatric##2##3##(2009-6#1)(2013-8#1)
the American Psychological Association##3##4##(1994-12#3)
the American Society for##3##4##(1997-7#1)(2011-1#1)(2011-2#1)
the American Society of Clinical Oncology##4##6##(2008-7#3)(2010-11#1)
the American Society of Gene Therapy##2##6##(2008-5#2)
the American Society of Naturalists##2##5##(2008-8#1)(2013-1#1)
the American Society of##9##4##(2008-5#2)(2008-7#4)(2008-8#1)(2010-11#1)(2013-1#1)
the American Society##12##3##(1997-7#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
the American Thoracic Society##2##4##(2008-7#1)(2013-1#1)
the American health care system##3##5##(1992-3#1)(1993-12#1)(1995-3#1)
the American population##3##3##(1993-12#1)(2008-10#1)(2012-3#1)
the American##119##2##(1990-6#1)(1991-1#2)(1991-12#1)(1991-8#2)(1992-2#2)(1992-3#2)(1993-12#4)(1993-2#1)(1993-3#2)(1994-12#4)(1994-2#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#3)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
the Americans With Disabilities Act (ADA)##2##6##(1994-1#2)
the Americans With Disabilities Act##4##5##(1991-12#1)(1994-1#2)(1995-1#1)
the Americans with Disabilities Act (ADA) and the##2##8##(1995-12#1)(1997-5#1)
the Americans with Disabilities Act (ADA) by##2##7##(1995-6#1)(1996-5#1)
the Americans with Disabilities Act (ADA)##11##6##(1995-12#4)(1995-6#2)(1996-1#1)(1996-5#1)(1997-5#3)
the Americans with Disabilities Act##17##5##(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)
the Americans with Disabilities##18##4##(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)
the Americans##23##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)
the Americas and was##2##4##(1994-9#1)(2008-10#1)
the Americas and##3##3##(1993-8#1)(1994-9#1)(2008-10#1)
the Americas##13##2##(1993-8#1)(1994-9#2)(2006-10#2)(2007-2#1)(2008-10#5)(2008-5#1)(2011-2#1)
the Ames test##2##3##(2008-4#1)(2011-1#1)
the Ames##4##2##(1996-12#1)(2008-2#1)(2008-4#1)(2011-1#1)
the AmpFISTR Identifiler##2##3##(2008-12#2)
the Amplatzer##2##2##(1997-8#1)(2013-1#1)
the An1##2##2##(1993-6#2)
the Anabaptist##3##2##(2008-12#3)
the Analysis of##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
the Anarrhichomenum complex##6##3##(2008-10#6)
the Andalusian##2##2##(2008-11#1)(2009-10#1)
the Andean highlands##2##3##(2008-10#2)
the Andean##10##2##(1997-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
the Andes##10##2##(2008-10#4)(2008-5#2)(2008-8#3)(2013-1#1)
the Annual Meeting of the##2##5##(2011-2#1)(2012-1#1)
the Annual##38##2##(2008-11#1)(2011-1#15)(2011-2#11)(2012-1#11)
the Antagonist##2##2##(2008-10#2)
the Antagonistic##2##2##(2008-10#2)
the Antarctic##4##2##(1991-5#1)(1996-1#1)(2013-8#2)
the Anterior##4##2##(1997-6#1)(2008-12#1)(2013-1#2)
the Apennine side##2##3##(2008-8#2)
the Apennine##3##2##(2008-8#3)
the Apgar score##2##3##(1995-6#1)(2008-4#1)
the Aphid Schizaphis graminum##2##4##(2008-10#2)
the Aplysia##3##2##(1990-7#1)(2008-6#2)
the Apple##4##2##(1991-12#1)(2008-10#3)
the Approved Lists of Bacterial Names##2##6##(2008-10#2)
the Arab World##2##3##(2007-7#1)(2008-10#1)
the Arab dominated groups##2##4##(2008-1#2)
the Arab##12##2##(2007-7#1)(2008-1#4)(2008-10#1)(2008-4#5)(2012-2#1)
the Arabian##2##2##(2008-1#1)(2008-3#1)
the Arabidopsis CAB2##2##3##(1995-2#2)
the Arabidopsis genome##5##3##(2007-12#1)(2008-7#1)(2009-10#3)
the Arabidopsis thaliana##4##3##(1994-12#1)(1997-6#1)(1997-8#1)(2008-10#1)
the Arabidopsis##17##2##(1994-12#2)(1995-2#3)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#3)(2012-3#1)
the Arc##2##2##(2007-11#2)
the Arctic Sun##2##3##(2007-10#2)
the Arctic polar##2##3##(1991-5#2)
the Arctic##6##2##(1991-5#2)(2007-10#2)(2008-11#1)(2010-8#1)
the Area Resource File##2##4##(2008-11#2)
the Area##3##2##(2008-11#2)(2008-5#1)
the Arg and##2##3##(1992-4#1)(1995-6#1)
the Arg##3##2##(1992-4#1)(1994-12#1)(1995-6#1)
the Arina##3##2##(2008-10#3)
the Arizona##3##2##(1995-12#1)(1997-8#1)(2008-5#1)
the Army##2##2##(1992-12#1)(2009-7#1)
the Arp2/3 complex##3##3##(2008-1#1)(2012-2#2)
the ArsA protein##3##3##(1994-5#3)
the As matrix##2##3##(2008-10#2)
the As##3##2##(2008-10#3)
the As(3+)-DDTP##2##2##(2008-10#2)
the As(III)##2##2##(2008-10#2)
the Asian patient##3##3##(2010-8#3)
the Asian##13##2##(2008-10#1)(2010-6#1)(2010-8#7)(2011-2#1)(2013-1#1)(2013-8#2)
the Asian-African##3##2##(2013-1#3)
the Aspergillus nidulans trpC##2##4##(2008-10#1)(2011-1#1)
the Aspergillus##3##2##(2008-10#2)(2011-1#1)
the Assessment##3##2##(1996-7#2)(1997-2#1)
the Association for Volunteer Administration##2##5##(1994-3#1)(1995-12#1)
the Association for##4##3##(1992-3#1)(1994-3#2)(1995-12#1)
the Association of Official##2##4##(2008-10#2)
the Association of##11##3##(1991-3#1)(1994-3#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-11#1)(2010-3#1)(2012-12#1)(2012-3#1)
the Association##21##2##(1990-6#1)(1991-3#1)(1992-3#1)(1994-3#3)(1995-12#3)(2007-12#1)(2007-8#1)(2008-10#3)(2009-11#1)(2010-3#1)(2011-4#1)(2012-12#2)(2012-3#2)
the Astro-E##2##2##(2008-3#2)
the Ataxia Telangiectasia##2##3##(2008-7#1)(2009-5#1)
the Ataxia##3##2##(1995-6#1)(2008-7#1)(2009-5#1)
the Atkins diet##2##3##(2008-3#2)
the Atkins##4##2##(2008-3#4)
the Atlantic##8##2##(1991-8#1)(1995-11#1)(1996-4#2)(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#1)
the Atmospheric##2##2##(2008-3#2)
the Atp7a gene##4##3##(2008-12#4)
the Au##6##2##(2008-10#4)(2009-11#1)(2011-1#1)
the AuAE##2##2##(2008-10#2)
the Aurora##3##2##(2013-1#3)
the Australian 'fire-beetle' Merimna atrata##2##5##(2007-12#2)
the Australian NH&amp##2##3##(1994-2#2)
the Australian Quality Awards##2##4##(1995-3#2)
the Australian and##2##3##(2011-2#1)(2013-1#1)
the Australian##30##2##(1990-2#3)(1991-2#1)(1994-12#1)(1994-2#2)(1995-3#3)(2007-12#4)(2007-2#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2009-2#1)(2011-2#2)(2012-12#1)(2013-1#3)
the Author##2##2##(1990-5#1)(1991-9#1)
the Authors describe a##2##4##(1990-3#1)(1992-9#1)
the Authors describe##3##3##(1990-3#1)(1990-9#1)(1992-9#1)
the Authors discuss##2##3##(1990-10#1)(1990-2#1)
the Authors report a##2##4##(1990-10#1)(1992-9#1)
the Authors to##2##3##(1990-10#1)(1991-5#1)
the Authors##23##2##(1990-10#4)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#1)(1990-9#3)(1991-3#2)(1991-5#2)(1992-6#1)(1992-9#4)
the Authors'##2##2##(1991-5#1)(1992-6#1)
the Autographa californica nuclear polyhedrosis virus (AcNPV)##2##7##(1997-4#1)(2008-7#1)
the Autographa californica nuclear polyhedrosis virus##3##6##(1997-4#2)(2008-7#1)
the Autographa californica##5##3##(1993-12#1)(1997-3#1)(1997-4#2)(2008-7#1)
the Award##2##2##(1996-2#2)
the Azores##3##2##(1997-5#3)
the B and##3##3##(1990-7#1)(2008-4#2)
the B biotype of##2##4##(2008-10#1)(2011-2#1)
the B biotype##3##3##(2008-10#2)(2011-2#1)
the B cell##4##3##(1991-3#1)(1994-12#1)(1997-6#1)(2008-4#1)
the B domain##2##3##(1994-12#1)(1997-8#1)
the B site##3##3##(1994-5#2)(1996-2#1)
the B subunit of##2##4##(1995-3#2)
the B subunit##3##3##(1995-3#2)(1995-6#1)
the B##67##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#4)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-12#4)(2008-4#5)(2008-5#1)(2008-7#1)(2011-2#4)(2012-3#1)
the B(rd)##2##2##(2008-12#2)
the B- and##2##3##(1995-2#2)
the B-Twin system##2##3##(2008-11#2)
the B-Twin##4##2##(2008-11#4)
the B-lymphocytes##2##2##(2008-10#2)
the B1##4##2##(1994-5#1)(1994-9#2)(2008-10#1)
the B2##3##2##(1991-12#1)(1991-5#2)
the B37##3##2##(1997-5#3)
the B73 genome##3##3##(2012-3#3)
the B73 x Tex6 cross##2##5##(2008-10#2)
the B73##5##2##(2008-10#2)(2012-3#3)
the BAA showed##2##3##(2011-2#2)
the BAC##4##2##(2008-10#1)(2008-4#2)(2008-8#1)
the BAC2##2##2##(2008-8#2)
the BAL##3##2##(2007-8#1)(2010-12#2)
the BAL-induced activation##3##3##(1991-2#3)
the BAS##2##2##(2007-12#2)
the BB84##2##2##(2007-12#1)(2008-2#1)
the BBA##6##2##(2008-11#6)
the BBB##8##2##(1996-5#2)(2008-7#4)(2008-8#2)
the BBO crystal##2##3##(2007-12#1)(2008-3#1)
the BBS##2##2##(2010-3#2)
the BC##2##2##(1993-3#1)(2008-9#1)
the BCA##2##2##(2008-10#2)
the BCR##4##2##(2008-10#4)
the BD##2##2##(2009-6#1)(2013-8#1)
the BET##2##2##(2009-11#1)(2012-12#1)
the BG rate of change##4##5##(2009-9#4)
the BGE##4##2##(1996-5#2)(2008-10#2)
the BHLF1 promoter##2##3##(1997-3#2)
the BHLF1##3##2##(1997-3#3)
the BHS##3##2##(2009-7#1)(2010-7#2)
the BHT-task##2##2##(2013-8#2)
the BHU##2##2##(2011-2#2)
the BI channel##2##3##(1994-9#2)
the BI##3##2##(1994-9#3)
the BIS scale##2##3##(2009-9#2)
the BIS##3##2##(2009-9#3)
the BLAST##5##2##(2008-4#3)(2008-9#1)(2009-5#1)
the BMI and the##2##4##(2007-8#1)(2008-1#1)
the BMI##10##2##(2007-8#4)(2008-1#2)(2008-12#1)(2008-3#1)(2009-2#1)(2012-12#1)
the BN whiskers##2##3##(2008-10#2)
the BNR##2##2##(2008-10#2)
the BOD##4##2##(2008-10#4)
the BP titer##3##3##(2008-11#3)
the BP##7##2##(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#1)
the BPE##2##2##(2013-7#2)
the BPI##3##2##(2008-7#3)
the BPMV-pCP##2##2##(2008-10#2)
the BPP calibration set##3##4##(2007-12#3)
the BPP spectra set##2##4##(2007-12#2)
the BPP spectra##3##3##(2007-12#3)
the BPP##7##2##(2007-12#7)
the BPs##5##2##(2008-7#5)
the BR display##3##3##(2007-12#3)
the BR##5##2##(2007-11#1)(2007-12#4)
the BRA-3 mRNA##2##3##(1993-6#2)
the BRDF##4##2##(2008-3#4)
the BRP##2##2##(2013-1#2)
the BSA##2##2##(1997-2#1)(2008-10#1)
the BSE##2##2##(2011-2#2)
the BTB must##2##3##(2009-10#2)
the BTB##23##2##(2009-10#10)(2012-12#1)(2012-2#12)
the BVS##2##2##(1997-7#2)
the BYDV##2##2##(2008-10#1)(2008-8#1)
the BYSV CP##3##3##(2008-10#3)
the BZ oscillating chemical system##3##5##(2008-10#3)
the BZD##3##2##(1991-12#3)
the Bacillus cereus group collected in##2##6##(2011-2#2)
the Bacillus cereus group##3##4##(2011-2#3)
the Bacillus subtilis##8##3##(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-7#2)
the Bacillus thuringiensis##3##3##(2008-10#1)(2011-2#2)
the Bacillus##19##2##(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-7#2)(2008-10#3)(2008-3#1)(2010-10#1)(2011-2#6)
the Bacterial##2##2##(2008-10#1)(2008-7#1)
the Bahamas##4##2##(2008-12#1)(2008-5#2)(2009-7#1)
the Bahia##4##2##(2008-5#2)(2008-8#1)(2009-10#1)
the Bahian##5##2##(2009-10#5)
the Baja California##2##3##(2008-5#1)(2010-8#1)
the Balance##2##2##(2008-11#1)(2010-12#1)
the Balanced Budget Act of 1997##3##6##(2008-1#1)(2008-7#2)
the Balanced Budget Act##5##4##(2008-1#1)(2008-11#2)(2008-7#2)
the Balanced Budget##6##3##(2008-1#1)(2008-11#3)(2008-7#2)
the Baldrige criteria##2##3##(1995-12#1)(1995-3#1)
the Baldrige##3##2##(1995-12#1)(1995-2#1)(1995-3#1)
the Balkan countries##2##3##(2011-1#2)
the Balkan##3##2##(2011-1#3)
the Baltic Sea and##3##4##(2007-12#2)(2008-5#1)
the Baltic Sea##8##3##(2007-12#2)(2008-11#2)(2008-5#2)(2010-8#2)
the Baltic##10##2##(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-5#2)(2010-8#2)
the BamHI##2##2##(1997-6#1)(2008-5#1)
the Bantu##3##2##(1991-11#1)(2008-12#1)(2012-12#1)
the Barley Scald##2##3##(2008-10#2)
the Barley##4##2##(2008-10#4)
the Baroque and Rococo lacquer films##2##6##(2008-10#2)
the Basic Protocol##3##3##(2008-4#3)
the Basic##8##2##(1993-6#1)(2008-11#1)(2008-4#4)(2008-9#1)(2012-1#1)
the Bavarian##2##2##(2008-4#1)(2012-6#1)
the Bayer DCA 2000 in##2##5##(2008-6#2)
the Bayesian##6##2##(1994-9#3)(1997-8#1)(2011-1#1)(2011-2#1)
the BazookaSPECT detector##2##3##(2009-6#2)
the Bb 23S##2##3##(1995-8#2)
the Bcl-2 expression was##2##4##(2008-9#2)
the Bcl-2 family##7##3##(2008-11#2)(2009-12#2)(2011-2#3)
the Bcl-2##10##2##(2008-11#3)(2008-9#2)(2009-12#2)(2011-2#3)
the Bcl-2/Bax ratio##2##3##(2013-1#1)(2013-8#1)
the Bcl-2/Bax##3##2##(2013-1#2)(2013-8#1)
the Bean##3##2##(2008-10#3)
the Beck Depression Inventory##4##4##(1991-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
the Beck##5##2##(1991-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the Becton Dickinson FACS Calibur##2##5##(2008-4#2)
the Beer-Lambert law##4##3##(2008-10#1)(2008-3#1)(2008-4#2)
the Beet##2##2##(2008-10#2)
the Behavioral##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
the Behring Nephelometer##2##3##(2008-10#2)
the Belgian##4##2##(2008-10#3)(2011-2#1)
the Belousov-Zhabotinsky##2##2##(2008-10#2)
the Benes##3##2##(2008-2#3)
the Berlin Aging Study (BASE)##2##5##(1994-6#2)
the Berlin Heart##2##3##(2011-2#2)
the Berlin##7##2##(1994-6#2)(1995-1#1)(2007-1#2)(2011-2#2)
the Bessel function##3##3##(2008-3#3)
the Bessel##4##2##(2008-2#1)(2008-3#3)
the Better Beginnings##5##3##(1995-3#5)
the Bhutanese##2##2##(2008-7#1)(2010-5#1)
the Bi films##2##3##(2007-11#2)
the Bi2WO6##2##2##(2013-8#2)
the BiP##2##2##(2008-11#1)(2008-7#1)
the Biceps femoris##4##3##(2010-4#4)
the Bielschowsky##2##2##(1991-1#1)(2013-1#1)
the Big Bend##2##3##(1996-4#1)(2008-10#1)
the Big##3##2##(1996-4#1)(2008-10#2)
the Binding##2##2##(2008-10#1)(2009-2#1)
the Biocontrol Agent##5##3##(2008-10#5)
the Biocontrol Fungus##2##3##(2008-10#2)
the Biocontrol##10##2##(2008-10#10)
the Bioinformatics##2##2##(2008-7#2)
the Biological Control of##2##4##(2008-10#2)
the Biological Control##3##3##(2008-10#3)
the Biological##7##2##(1992-12#1)(2008-10#3)(2008-6#1)(2010-4#1)(2012-12#1)
the Biomolecular Screening##2##3##(2008-10#2)
the Bipolar##2##2##(2013-8#2)
the Black##4##2##(1990-6#2)(2009-9#1)(2010-8#1)
the Bligh-Dyer##2##2##(2008-10#1)(2008-11#1)
the Bloch##2##2##(2008-3#2)
the Blue##4##2##(1990-12#1)(1994-12#1)(1997-6#1)(2008-4#1)
the Bm86##2##2##(1994-3#2)
the BmNPV##4##2##(1997-3#3)(1997-4#1)
the Bmax values##2##3##(1994-8#1)(1997-2#1)
the Bmax##4##2##(1994-8#1)(1996-2#1)(1997-2#2)
the Board of##5##3##(1991-12#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-8#1)
the Board##8##2##(1991-12#1)(1993-3#4)(1994-12#1)(2008-10#1)(2008-8#1)
the Body##4##2##(2007-12#1)(2007-8#1)(2008-6#1)(2008-9#1)
the Bohr effect##5##3##(1990-8#5)
the Boltzmann##3##2##(2007-12#3)
the Bombyx mori##3##3##(1995-6#1)(1997-4#1)(2008-11#1)
the Bon Accord Lagoon##2##4##(2007-5#2)
the Bon##3##2##(2007-5#2)(2012-3#1)
the Boolean##2##2##(1995-12#1)(2008-9#1)
the Boomers##2##2##(1997-3#1)(2011-1#1)
the Born##2##2##(1997-2#1)(2008-2#1)
the Boston EMS##3##3##(2008-3#3)
the Boston##6##2##(2007-12#1)(2008-3#4)(2008-9#1)
the Boswellia serrata at##2##4##(2013-1#2)
the Boswellia serrata##3##3##(2013-1#3)
the Bournemouth Collaborative Model##2##4##(2008-11#2)
the Bowman##2##2##(1992-1#1)(2008-10#1)
the Boyacá##2##2##(2013-1#2)
the BqsS-BqsR two-component system##2##4##(2009-6#2)
the BrAAP component##2##3##(1994-5#2)
the Bradford Hill criteria##3##4##(2013-8#3)
the Bradford##5##2##(2008-1#1)(2008-10#1)(2013-8#3)
the Bragg angle##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
the Bragg grating##4##3##(2007-11#3)(2008-2#1)
the Bragg reflection##2##3##(2007-11#1)(2007-12#1)
the Bragg scattering##2##3##(2007-12#1)(2008-3#1)
the Bragg wavelength was##2##4##(2007-11#2)
the Bragg wavelength##8##3##(2007-11#4)(2007-12#4)
the Bragg##25##2##(2007-11#9)(2007-12#6)(2008-2#5)(2008-3#4)(2008-7#1)
the Brain##3##2##(2007-9#1)(2008-2#1)(2008-6#1)
the Branch &amp##2##3##(2008-6#2)
the Brassica##3##2##(2008-10#1)(2011-10#1)(2012-3#1)
the Bratton-Marshall##3##2##(2008-10#3)
the Brazilian Research Network in Bipolar Disorder##2##7##(2013-8#2)
the Brazilian population##2##3##(1991-9#1)(2013-8#1)
the Brazilian##28##2##(1991-12#2)(1991-9#2)(1993-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#2)(2009-10#2)(2009-7#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#6)
the Breast##8##2##(1994-12#1)(1994-7#2)(1995-4#2)(1995-9#1)(1997-1#1)(1997-7#1)
the Brewer##2##2##(2008-2#2)
the Brewster angle##3##3##(2008-3#3)
the Brewster dip on reflection from##2##6##(2007-11#2)
the Brewster##7##2##(2007-11#2)(2008-3#5)
the Brief COPE Scale##2##4##(2011-1#2)
the Brief##5##2##(2008-7#2)(2010-2#1)(2011-1#2)
the Brillouin backscattered##3##3##(2007-12#1)(2008-3#2)
the Brillouin backscattered-light power spectrum##2##5##(2008-3#2)
the Brillouin gain##2##3##(2007-11#2)
the Brillouin signal is##2##4##(2007-11#1)(2007-12#1)
the Brillouin##11##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#4)
the British Pharmacopoeia##3##3##(2008-10#3)
the British##19##2##(1990-9#1)(1991-1#1)(1992-1#1)(1992-2#1)(1995-8#1)(1996-8#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
the Brn-3##3##2##(1996-12#3)
the Brown Norway rat##3##4##(2008-10#3)
the Brown##4##2##(2008-10#4)
the Brownian motion##2##3##(2008-3#1)(2008-8#1)
the Brownian##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
the Brugada syndrome##5##3##(2008-12#3)(2011-2#1)(2013-1#1)
the Bruggeman##2##2##(2008-2#1)(2008-3#1)
the Bruhat##2##2##(1991-12#2)
the Buccoo Reef##2##3##(2007-5#2)
the Buccoo##3##2##(2007-5#3)
the Bureau of##3##3##(1993-1#1)(2008-1#1)(2008-10#1)
the Bureau##4##2##(1993-1#1)(2008-1#1)(2008-10#2)
the Button Sampler##5##3##(2008-5#5)
the Button##6##2##(2008-5#6)
the C = O and CH2 stretching frequencies##2##8##(1994-3#2)
the C = O and##3##5##(1992-6#1)(1994-3#2)
the C = O##4##4##(1992-6#1)(1994-3#3)
the C balance##2##3##(2008-11#2)
the C derived from##2##4##(2010-3#2)
the C protein##2##3##(1997-4#2)
the C terminal##3##3##(2008-8#1)(2008-9#2)
the C terminus of the##6##5##(1991-6#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-6#1)
the C terminus of##8##4##(1991-6#1)(1994-12#2)(1994-8#2)(1995-2#2)(1995-6#1)
the C terminus##12##3##(1991-6#1)(1993-6#1)(1994-12#4)(1994-8#2)(1995-2#3)(1995-6#1)
the C##86##2##(1990-5#2)(1990-6#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#6)(1994-3#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#2)(2007-11#1)(2007-12#6)(2008-10#17)(2008-11#4)(2008-5#2)(2008-6#4)(2008-8#2)(2008-9#3)(2010-11#1)(2010-3#2)(2010-6#2)(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#2)
the C(18) phase##2##3##(2008-10#2)
the C(18)##6##2##(2008-10#6)
the C(4)##3##2##(1992-11#2)(2008-9#1)
the C-##2##2##(1991-5#1)(2008-7#1)
the C-2##2##2##(1995-3#1)(2007-11#1)
the C-4##3##2##(1994-11#1)(1996-5#1)(2007-12#1)
the C-C mode##2##3##(2007-1#2)
the C-C##3##2##(1996-5#1)(2007-1#2)
the C-H activated##2##3##(2010-5#2)
the C-Leg##3##2##(2013-1#3)
the C-domain of IGF-1##2##4##(2008-9#2)
the C-domain of##3##3##(2008-9#3)
the C-terminal 18##2##3##(1991-6#1)(1995-2#1)
the C-terminal 4 amino acids##2##5##(1992-8#2)
the C-terminal actin-binding domain##2##4##(2009-7#2)
the C-terminal domain of##2##4##(2008-9#1)(2009-7#1)
the C-terminal domain##5##3##(1992-9#1)(1994-5#1)(2008-9#1)(2009-7#1)(2012-2#1)
the C-terminal domains##3##3##(1993-8#1)(2008-10#2)
the C-terminal end of the##2##5##(1995-5#1)(1997-4#1)
the C-terminal end##3##3##(1995-5#1)(1996-12#1)(1997-4#1)
the C-terminal half of the##4##5##(1990-11#1)(1993-11#1)(1994-5#1)(2008-10#1)
the C-terminal half of##6##4##(1990-11#1)(1993-11#1)(1994-5#1)(1995-8#1)(2008-10#1)(2010-5#1)
the C-terminal half##7##3##(1990-11#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2008-10#1)(2010-5#1)
the C-terminal hydrophobic##2##3##(1995-5#1)(2008-8#1)
the C-terminal part of the##2##5##(1997-7#1)(2008-10#1)
the C-terminal part of##3##4##(1990-5#1)(1997-7#1)(2008-10#1)
the C-terminal part##4##3##(1990-5#1)(1996-12#1)(1997-7#1)(2008-10#1)
the C-terminal region of##7##4##(1992-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1997-7#1)(2008-4#1)(2012-2#1)
the C-terminal region##15##3##(1990-7#1)(1992-6#1)(1993-8#1)(1994-12#2)(1994-5#2)(1995-2#1)(1997-2#3)(1997-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
the C-terminal sequence of##3##4##(1991-2#1)(1994-11#1)(2008-4#1)
the C-terminal sequence##4##3##(1991-2#1)(1993-11#1)(1994-11#1)(2008-4#1)
the C-terminal##95##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#4)(1994-11#2)(1994-12#3)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#4)(1997-4#2)(1997-7#2)(2008-10#7)(2008-11#3)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-7#3)(2010-5#1)(2011-2#2)(2012-2#2)(2013-8#1)
the C-terminus is##2##3##(1994-2#1)(1997-3#1)
the C-terminus of the##8##4##(1992-3#1)(1992-9#1)(1994-12#1)(1995-5#1)(2007-6#2)(2008-10#1)(2012-2#1)
the C-terminus of##15##3##(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-12#2)(1995-5#1)(2007-6#2)(2008-10#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
the C-terminus##29##2##(1990-7#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-2#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-3#2)(1997-8#1)(2007-6#2)(2008-10#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
the C-truncated variant##2##3##(1994-12#2)
the C/EBP##2##2##(1993-3#2)
the C/N##2##2##(2008-10#1)(2008-12#1)
the C1 and##2##3##(1994-5#1)(2013-1#1)
the C1##8##2##(1990-8#2)(1994-5#1)(2008-10#1)(2012-12#3)(2013-1#1)
the C1-C2##2##2##(1993-8#1)(2011-2#1)
the C10##3##2##(1990-8#1)(1993-11#2)
the C11-C12##2##2##(1994-3#1)(2009-8#1)
the C19-GAs##2##2##(1994-8#2)
the C1q-deficient SLE patient group##2##5##(2011-2#2)
the C1q-deficient SLE##4##3##(2011-2#4)
the C2 content##3##3##(2007-12#3)
the C2##9##2##(1993-11#1)(1995-5#1)(2007-12#4)(2008-6#1)(2009-10#1)(2012-3#1)
the C26-CBS/diC14-PC mixture##2##3##(1993-8#2)
the C3##2##2##(1990-8#1)(2008-10#1)
the C4##3##2##(1992-3#1)(1994-8#1)(1995-2#1)
the C40/C40+##2##2##(2008-9#2)
the C57BL/6##2##2##(1997-3#1)(2008-4#1)
the C7##2##2##(1994-5#1)(2009-3#1)
the C8##2##2##(2008-4#2)
the C?N stretching##3##3##(2008-2#3)
the CA and OR##2##4##(2008-10#2)
the CA and##3##3##(1995-11#1)(2008-10#2)
the CA##8##2##(1991-4#1)(1994-2#1)(1995-11#2)(1995-3#1)(2008-10#2)(2011-1#1)
the CA-PVD##2##2##(2009-7#2)
the CA-clonal##3##2##(2008-10#3)
the CA1 region of the##2##5##(1995-12#1)(1996-12#1)
the CA1 region of##3##4##(1995-12#2)(1996-12#1)
the CA1 region##8##3##(1990-7#1)(1995-12#5)(1996-12#1)(1997-2#1)
the CA1##14##2##(1990-5#3)(1990-7#1)(1994-6#1)(1995-12#5)(1995-5#1)(1996-12#2)(1997-2#1)
the CA3##6##2##(1990-5#1)(1996-12#1)(1996-7#1)(2008-11#2)(2009-8#1)
the CAA##2##2##(2008-10#2)
the CAF##2##2##(1994-7#2)
the CAF+FT group##5##3##(1997-7#5)
the CAF+FT##6##2##(1997-7#6)
the CAF+FT+ADR group##2##3##(1997-7#2)
the CAF+FT+TAM group##4##3##(1997-7#4)
the CAK activity##2##3##(1997-1#2)
the CALUX bioassay for##3##4##(2008-10#3)
the CALUX bioassay##8##3##(2008-10#8)
the CALUX response##3##3##(2008-10#3)
the CALUX technique##2##3##(2008-10#2)
the CALUX##17##2##(2008-10#17)
the CAPD##2##2##(2007-12#2)
the CARICOMP##2##2##(2008-5#1)(2011-2#1)
the CARS signal##2##3##(2007-11#1)(2008-2#1)
the CARS##3##2##(2007-11#1)(2008-2#2)
the CART models##2##3##(2008-10#2)
the CART##3##2##(2008-10#3)
the CAS##2##2##(2006-12#1)(2011-2#1)
the CASA assay##2##3##(1993-2#2)
the CAT reporter##2##3##(1992-12#1)(2008-4#1)
the CAT##5##2##(1992-12#1)(1993-8#1)(1997-8#1)(2008-4#1)(2009-5#1)
the CATT/T##2##2##(2011-2#2)
the CAdSV##4##2##(2008-10#4)
the CArG##4##2##(1993-8#3)(2009-8#1)
the CB CO##2##3##(1993-12#2)
the CB subtype##2##3##(2008-2#2)
the CB##9##2##(1993-12#2)(2008-11#3)(2008-2#2)(2009-12#1)(2010-6#1)
the CB(2)##2##2##(2009-8#2)
the CB3##2##2##(1994-5#2)
the CBA strain##2##3##(2008-12#1)(2013-1#1)
the CBA##3##2##(1995-12#1)(2008-12#1)(2013-1#1)
the CBS##5##2##(1993-8#4)(2008-10#1)
the CC genotype##2##3##(2011-1#1)(2013-1#1)
the CC group##2##3##(2008-10#2)
the CC##6##2##(2008-10#3)(2008-7#1)(2011-1#1)(2013-1#1)
the CCA##4##2##(2007-12#1)(2009-12#1)(2011-2#2)
the CCAAT/enhancer binding protein (C/EBP)##2##5##(1990-5#1)(1993-3#1)
the CCD array##2##3##(2008-2#1)(2008-3#1)
the CCD camera##4##3##(2008-2#2)(2008-3#2)
the CCD sensor##2##3##(2008-3#2)
the CCD##20##2##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#9)(2011-2#1)
the CCKA receptor##2##3##(1993-6#1)(1996-2#1)
the CCOP and its##2##4##(1992-12#2)
the CCOP and##3##3##(1992-12#3)
the CCOP##5##2##(1992-12#5)
the CD Plus##3##3##(1991-12#2)(1992-2#1)
the CD _ 2 bending and CH _ 2 rocking modes##2##11##(2008-5#2)
the CD _ 2##3##4##(2008-5#3)
the CD and##2##3##(1995-5#1)(2008-10#1)
the CD spectra##2##3##(1990-5#1)(1992-8#1)
the CD##21##2##(1990-5#1)(1990-8#1)(1991-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1994-5#2)(1995-5#3)(1996-5#1)(2008-10#3)(2008-12#1)(2008-5#3)(2012-1#1)
the CD-ROM##2##2##(1991-3#1)(2008-11#1)
the CD4 cell count##2##4##(2009-8#1)(2012-2#1)
the CD4##12##2##(1992-5#1)(1992-6#1)(1993-3#3)(1997-4#1)(2006-10#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
the CD4(+)##2##2##(2008-11#1)(2008-9#1)
the CD4+##2##2##(1990-12#1)(1990-2#1)
the CD4+/CD8+##3##2##(2010-8#2)(2013-8#1)
the CD4/CD8 ratio##2##3##(1991-6#2)
the CD40##2##2##(2008-1#1)(2008-11#1)
the CD4000##5##2##(2008-10#5)
the CDC##7##2##(1992-6#1)(1996-1#1)(1996-5#2)(2008-2#1)(2011-2#1)(2012-12#1)
the CDDP sensitivity##2##3##(1993-9#2)
the CDDP/DOX##2##2##(2010-3#2)
the CDEI##2##2##(1992-12#2)
the CDER##2##2##(2010-11#2)
the CDI process##2##3##(2010-8#2)
the CDOM##2##2##(2008-2#2)
the CDP-choline pathway of phosphatidylcholine synthesis at the CTP##2##9##(1995-3#2)
the CDP-treated##2##2##(1994-3#2)
the CDS##6##2##(2008-3#6)
the CE method##3##3##(1997-2#1)(2008-10#2)
the CE procedure developed##2##4##(2008-10#2)
the CE separation of##2##4##(1996-5#2)
the CE##13##2##(1996-5#2)(1997-2#1)(2008-10#7)(2008-5#3)
the CEA##7##2##(1990-5#2)(1991-4#1)(1992-11#1)(1994-2#1)(1994-5#1)(2009-11#1)
the CEF##3##2##(2007-12#1)(2008-10#2)
the CER3 and##4##3##(2008-10#4)
the CER3##6##2##(2008-10#6)
the CER3/PA-d(31) dispersion at pH 5##2##6##(2008-10#2)
the CEs##2##2##(2008-10#1)(2008-5#1)
the CF##4##2##(1990-3#1)(1990-8#1)(2008-5#2)
the CFH and Worland##3##4##(2008-10#3)
the CFH##6##2##(2008-10#6)
the CFTR gene##3##3##(1997-1#2)(1997-3#1)
the CFTR protein##3##3##(1990-8#3)
the CFTR##6##2##(1990-8#3)(1997-1#2)(1997-3#1)
the CGH##2##2##(2008-3#2)
the CGRP##2##2##(1992-6#1)(1997-3#1)
the CH _ 2##2##4##(2008-5#2)
the CH cartridge##2##3##(2008-10#2)
the CH##9##2##(2008-10#6)(2008-2#1)(2008-5#2)
the CH(2) antisymmetric##2##3##(2008-10#2)
the CH(2)##8##2##(1997-2#1)(2008-10#6)(2008-5#1)
the CH(3) scissoring##2##3##(2008-10#2)
the CH(3) symmetric and asymmetric stretching##2##6##(2008-10#2)
the CH(3)##5##2##(2008-10#5)
the CH1##2##2##(1993-6#1)(1997-2#1)
the CHAC##2##2##(1991-3#2)
the CHAP domain##2##3##(2009-6#2)
the CHAP-SH3b fusion##2##3##(2009-6#2)
the CHIN (community health information network)##3##6##(1996-1#3)
the CHIN##4##2##(1996-1#4)
the CHO##7##2##(1993-8#1)(1994-1#1)(2008-11#5)
the CHO-K1 cell##2##3##(1997-1#1)(2008-11#1)
the CHUM##2##2##(2012-12#2)
the CI##3##2##(1993-10#1)(2007-10#1)(2008-10#1)
the CI-1 proteins##2##3##(1994-6#2)
the CIC##2##2##(2007-11#1)(2008-10#1)
the CIE##2##2##(2008-2#1)(2008-3#1)
the CIP##3##2##(2008-10#3)
the CIPIC-conjugated CCL##2##3##(2008-10#2)
the CIS strategy##2##3##(2008-9#2)
the CIS##3##2##(1994-9#1)(2008-9#2)
the CKD##2##2##(2012-2#1)(2013-1#1)
the CL detection##5##3##(2008-10#5)
the CL emission##3##3##(2008-10#3)
the CL intensity of##3##4##(2008-10#2)(2010-4#1)
the CL intensity was linear to the##2##7##(2008-10#2)
the CL intensity was linear##3##5##(2008-10#3)
the CL intensity##12##3##(2008-10#11)(2010-4#1)
the CL reaction between##3##4##(2008-10#3)
the CL reaction of##8##4##(2008-10#8)
the CL reaction was##2##4##(2008-10#2)
the CL reaction##14##3##(2008-10#14)
the CL response##2##3##(1991-9#1)(2008-10#1)
the CL striatum##2##3##(2008-11#2)
the CL##54##2##(1991-9#2)(2008-10#43)(2008-11#2)(2008-8#2)(2008-9#3)(2010-4#2)
the CL-1000##5##2##(2008-11#5)
the CLA group##2##3##(2008-5#2)
the CLB dose was##2##4##(2007-10#2)
the CLB dose##3##3##(2007-10#3)
the CLB skin received##2##4##(2007-10#2)
the CLB skin##3##3##(2007-10#3)
the CLB##6##2##(2007-10#6)
the CLCrV DNA-A##2##3##(2008-10#2)
the CLMMG mucosa##2##3##(2009-3#2)
the CLMMG##3##2##(2009-3#3)
the CLN-proteins into##2##3##(2009-5#2)
the CLN-proteins##3##2##(2009-5#3)
the CLP##4##2##(2012-3#4)
the CLPT##3##2##(2012-3#3)
the CM group##2##3##(2012-3#2)
the CM##7##2##(2008-10#3)(2011-2#2)(2012-3#2)
the CMC##3##2##(2008-10#3)
the CME##3##2##(2008-10#3)
the CML stem cell##2##4##(2010-4#2)
the CML##4##2##(2009-7#2)(2010-4#2)
the CMM group##3##3##(2008-7#3)
the CMS##4##2##(1996-7#3)(2008-9#1)
the CMV promoter##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
the CMV##7##2##(1992-6#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#2)
the CMV-based##2##2##(2008-8#2)
the CNC##5##2##(2013-8#5)
the CNPHI has##2##3##(2008-11#2)
the CNR##2##2##(2008-2#1)(2008-3#1)
the CNS and##7##3##(1990-11#1)(1995-2#1)(1996-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
the CNS from the##2##4##(2008-5#1)(2008-8#1)
the CNS##75##2##(1990-11#1)(1990-3#1)(1991-12#3)(1991-2#1)(1992-10#3)(1992-8#1)(1993-5#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#4)(1997-5#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#6)(2008-7#17)(2008-8#7)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
the CNSS##2##2##(2008-7#2)
the CNT##4##2##(2008-10#1)(2008-7#1)(2013-8#2)
the CNTF gene##3##3##(1996-5#3)
the CNTF##4##2##(1996-5#4)
the CNTO 328/dex##2##3##(2009-4#2)
the CNVM##2##2##(2010-10#2)
the CO 2 laser via laparoscopy##2##6##(1991-3#2)
the CO 2 laser##8##4##(1991-3#2)(1992-1#3)(1992-3#3)
the CO 2##9##3##(1991-3#2)(1992-1#3)(1992-3#4)
the CO isolate##2##3##(2008-10#2)
the CO stretching##2##3##(2008-10#1)(2008-8#1)
the CO##25##2##(1991-3#2)(1992-1#3)(1992-3#4)(1992-6#1)(1994-11#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-8#2)
the CO(2) and##2##3##(2008-10#1)(2008-2#1)
the CO(2) concentration##2##3##(2008-10#1)(2008-11#1)
the CO(2)##12##2##(2008-10#5)(2008-11#1)(2008-2#4)(2009-6#1)(2012-3#1)
the CO-sensing##2##2##(2008-10#2)
the CO2 activation##2##3##(1993-6#2)
the CO2##4##2##(1993-6#2)(1994-12#2)
the CO3 PDF##2##3##(2008-6#2)
the COLIPA##2##2##(2008-5#2)
the COMFORT Behavior##2##3##(2012-2#2)
the COMFORT-B##2##2##(2012-2#2)
the CONTINUUM project##2##3##(1995-3#2)
the COOH-terminal domain of the##3##5##(1992-3#1)(1995-6#2)
the COOH-terminal domain of##4##4##(1992-3#1)(1995-6#3)
the COOH-terminal domain##6##3##(1991-12#2)(1992-3#1)(1995-6#3)
the COOH-terminal region of##3##4##(1990-2#1)(1995-6#2)
the COOH-terminal tripeptide from 125I-hANF##2##5##(1990-2#2)
the COOH-terminal tripeptide from##3##4##(1990-2#3)
the COOH-terminal tripeptide##4##3##(1990-2#4)
the COOH-terminal##17##2##(1990-2#5)(1990-8#1)(1991-12#2)(1992-3#1)(1992-8#1)(1992-9#2)(1995-6#5)
the COOH-terminus of the##2##4##(1991-12#1)(1992-9#1)
the COOH-terminus##4##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-9#1)
the COP layer##2##3##(2008-2#2)
the COP##7##2##(1994-1#2)(2008-2#2)(2009-7#1)(2012-12#2)
the COPII##2##2##(2011-2#1)(2012-2#1)
the COS cell##2##3##(1991-9#2)
the COVER survey##2##3##(2012-2#2)
the CP and the##2##4##(2008-10#2)
the CP and##3##3##(1995-6#1)(2008-10#2)
the CP gene of##2##4##(2008-10#2)
the CP gene##11##3##(1997-6#1)(2008-10#10)
the CP of##2##3##(2008-10#2)
the CP sequences of##2##4##(2008-10#2)
the CP transgene##2##3##(2008-8#2)
the CP##36##2##(1995-6#1)(1997-6#3)(2008-10#28)(2008-8#2)(2008-9#1)(2010-2#1)
the CP7 mutant##2##3##(2008-10#2)
the CPAx score##2##3##(2012-12#2)
the CPAx##4##2##(2012-12#4)
the CPM##2##2##(2008-11#2)
the CPMG sequence##2##3##(2011-2#2)
the CPMG##3##2##(2011-1#1)(2011-2#2)
the CPOE##2##2##(2010-8#2)
the CPP##4##2##(1993-6#3)(2009-8#1)
the CPPSU##2##2##(2008-11#2)
the CPR##2##2##(1993-12#1)(2013-1#1)
the CPTQ##4##2##(2008-12#4)
the CPU is##2##3##(2008-3#2)
the CPU##4##2##(2008-3#3)(2009-6#1)
the CPy(+) cation##2##3##(2008-10#2)
the CQI##2##2##(1993-2#1)(1994-3#1)
the CR lever##3##3##(1993-6#3)
the CR##6##2##(1993-6#4)(2008-10#1)(2010-8#1)
the CR011-vcMMAE antibody-drug conjugate##2##4##(2009-4#2)
the CRB##2##2##(2008-10#2)
the CRE##4##2##(1994-11#1)(1997-2#1)(2013-1#2)
the CRF receptor##2##3##(1997-4#1)(2008-4#1)
the CRF test##3##3##(1990-3#3)
the CRF##7##2##(1990-3#3)(1997-4#1)(2008-1#1)(2008-4#2)
the CRL##2##2##(2008-3#2)
the CRM##2##2##(2008-10#1)(2012-3#1)
the CRMs##2##2##(2008-10#2)
the CRP##2##2##(1990-12#1)(1997-6#1)
the CRS##2##2##(1994-6#1)(2007-11#1)
the CS##7##2##(1995-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-3#2)
the CSF##14##2##(1993-12#1)(1995-12#2)(1996-12#1)(1996-2#1)(2006-12#1)(2008-12#1)(2008-3#4)(2011-2#1)(2012-3#2)
the CSF-1##5##2##(1991-6#2)(1997-7#3)
the CT activity of##2##4##(2008-7#2)
the CT scan##2##3##(1992-5#1)(2013-1#1)
the CT scans##2##3##(2008-7#2)
the CT##20##2##(1990-6#1)(1991-12#1)(1992-5#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-2#1)(2008-7#4)(2009-5#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
the CT60(∗)G allele##2##3##(2010-12#2)
the CTN##2##2##(1997-2#2)
the CTV status of##2##4##(2008-10#2)
the CTV##9##2##(2008-10#7)(2008-2#2)
the CUDS##2##2##(2008-10#2)
the CV and FOL##2##4##(1993-12#2)
the CV and##3##3##(1993-12#2)(2008-10#1)
the CV##5##2##(1993-12#2)(2008-10#2)(2008-8#1)
the CVB1##3##2##(2013-8#3)
the CYBA gene##4##3##(2013-8#4)
the CYP##2##2##(2007-11#2)
the CYP19a gene##3##3##(2009-7#3)
the CYP1A##2##2##(1994-8#2)
the CYP21 gene##2##3##(2008-1#2)
the CYP21##3##2##(2008-1#3)
the CYP2A6##4##2##(2008-8#4)
the CYP2E1 gene is##2##4##(1990-11#2)
the CYP2E1##3##2##(1990-11#2)(2008-8#1)
the CYP3A subfamily##2##3##(1994-5#1)(1994-8#1)
the CYP3A##5##2##(1994-5#2)(1994-8#1)(2011-2#2)
the CYVD strains##2##3##(2008-10#2)
the Ca##6##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
the Ca(2+) messenger##2##3##(2008-4#2)
the Ca(2+)##6##2##(2008-11#1)(2008-4#4)(2012-2#1)
the Ca(2+)-ATPase##2##2##(1992-5#1)(1993-8#1)
the Ca(2+)-activated K+##2##3##(1992-6#1)(1996-5#1)
the Ca(2+)-activated##4##2##(1992-6#2)(1996-5#1)(1997-2#1)
the Ca(2+)-dependent##4##2##(1992-12#1)(1994-6#1)(1995-11#1)(2008-8#1)
the Ca(2+)-triggered##2##2##(1992-6#1)(2012-2#1)
the Ca2+ channel##3##3##(1993-3#1)(1995-12#1)(1995-6#1)
the Ca2+ ionophore##3##3##(1994-3#1)(1994-6#1)(2008-8#1)
the Ca2+ pump of##2##4##(1994-11#1)(1995-11#1)
the Ca2+ pump##4##3##(1991-8#2)(1994-11#1)(1995-11#1)
the Ca2+ release##2##3##(1995-12#1)(1995-3#1)
the Ca2+##22##2##(1990-12#1)(1990-2#1)(1991-6#1)(1991-8#2)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-8#1)(2009-3#1)
the Ca2+/CaM/CaN signal pathway in 5-HT-induced proliferation of rat##2##9##(2011-3#2)
the CaM-BP68##3##2##(1994-5#3)
the CaMV 35S promoter##4##4##(1997-2#1)(1997-6#1)(1997-8#1)(2011-10#1)
the CaSR mRNA##2##3##(2008-11#2)
the Caco-2 cell##3##3##(2008-11#3)
the Caco-2##4##2##(2008-11#4)
the Caenorhabditis elegans homologue##2##4##(1995-6#2)
the Caenorhabditis elegans##5##3##(1993-12#1)(1995-6#2)(2012-3#2)
the California Critical Thinking##2##4##(2008-11#2)
the California isolates##2##3##(2008-10#2)
the California##19##2##(1995-12#3)(1995-8#1)(1996-2#1)(1996-3#1)(2008-10#8)(2008-11#2)(2010-8#2)(2011-2#1)
the Calu-6##2##2##(1992-9#2)
the Cambridge##5##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)
the Canadian Criminal Code##2##4##(1993-9#1)(1996-1#1)
the Canadian Dietetic Association##2##4##(1994-2#2)
the Canadian Health##2##3##(2008-12#1)(2009-3#1)
the Canadian Institute for Health Information##2##6##(2008-6#1)(2012-12#1)
the Canadian Institute##3##3##(1991-3#1)(2008-6#1)(2012-12#1)
the Canadian Nosocomial Infection Surveillance Program##2##6##(2007-12#2)
the Canadian guideline values for##2##5##(2008-10#2)
the Canadian health care system##3##5##(1993-3#1)(1994-1#1)(1996-12#1)
the Canadian health system##2##4##(1994-2#1)(1995-1#1)
the Canadian health##6##3##(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(2011-2#1)
the Canadian healthcare system##2##4##(1997-3#2)
the Canadian##62##2##(1991-3#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(2007-12#10)(2007-5#1)(2008-10#8)(2008-11#5)(2008-12#4)(2008-4#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
the Canary Island##2##3##(2008-10#2)
the Canary Islands##3##3##(1996-4#1)(2008-10#2)
the Canary##5##2##(1996-4#1)(2008-10#4)
the Cancer Atlas Viewer##2##4##(2008-5#2)
the Cancer Care Monitor##2##4##(2008-7#2)
the Cancer##8##2##(1991-3#1)(1995-2#1)(2008-5#2)(2008-7#3)(2011-1#1)
the Candida##6##2##(1990-5#1)(1991-9#1)(2010-5#2)(2011-2#1)(2013-1#1)
the Canton of##4##3##(1990-6#1)(1996-11#3)
the Capacity##2##2##(1997-1#1)(2011-2#1)
the Cape##3##2##(1992-8#1)(2007-9#1)(2011-2#1)
the Captopril-Test##2##2##(1990-2#2)
the Carboseal composite valve graft##2##5##(2007-8#2)
the Carboseal##3##2##(2007-8#3)
the Cardiology##2##2##(2008-10#1)(2009-3#1)
the Cardiovascular Hospitalization Atherosclerosis Management Program##2##6##(2008-3#2)
the Care of##4##3##(1992-3#1)(1994-3#1)(2010-7#1)(2012-12#1)
the Care##5##2##(1992-3#1)(1994-3#1)(1995-3#1)(2010-7#1)(2012-12#1)
the Caribbean Basin##5##3##(2008-10#5)
the Caribbean and##7##3##(1991-11#1)(2008-10#1)(2008-5#2)(2009-7#1)(2011-2#2)
the Caribbean are##2##3##(1996-6#1)(2007-5#1)
the Caribbean region and##2##4##(2008-10#2)
the Caribbean region##5##3##(2008-10#3)(2008-11#1)(2012-12#1)
the Caribbean##53##2##(1991-11#1)(1991-3#1)(1996-6#2)(2007-12#2)(2007-2#2)(2007-5#5)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#5)(2009-7#4)(2010-4#1)(2011-2#10)(2012-1#1)(2012-12#1)
the Carolinas##5##2##(2008-8#5)
the Carr-Purcell-Meiboom-Gill (CPMG)##2##3##(2011-1#1)(2011-2#1)
the Cartesian coordinate system##2##4##(2008-3#2)
the Casa do Indio##2##4##(1991-12#2)
the Caspian##2##2##(2008-12#1)(2010-8#1)
the Catholic University of##3##4##(1990-8#1)(2013-1#2)
the Catholic##8##2##(1990-6#1)(1990-8#1)(1991-3#1)(1994-1#1)(1995-2#1)(2011-2#1)(2013-1#2)
the Caucasian population##2##3##(2008-7#1)(2010-8#1)
the Caucasian##5##2##(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#2)
the Caucasus##8##2##(2008-10#7)(2008-11#1)
the Causal Agent of Bacterial##2##5##(2008-10#2)
the Causal Agent of Green Mold##2##6##(2008-10#2)
the Causal Agent of##13##4##(2008-10#13)
the Cause of Citrus Greasy Spot##2##6##(2008-10#2)
the Cause of##5##3##(2008-10#5)
the Cd##6##2##(1995-3#1)(2008-10#4)(2008-9#1)
the Ce-PbO(2) modified electrode was##2##5##(2008-10#2)
the CeAX rat##2##3##(1993-12#2)
the Cell SELEX##2##3##(2010-5#2)
the Cell##3##2##(2009-7#1)(2010-5#2)
the Cellscreen system##2##3##(2008-11#2)
the Cellular##2##2##(2008-10#1)(2008-11#1)
the Center for Devices and Radiological Health##2##7##(1993-3#1)(2010-6#1)
the Center for##15##3##(1990-11#2)(1993-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
the Center of Origin##2##4##(2008-10#2)
the Center of##5##3##(1994-1#1)(2007-8#1)(2008-10#2)(2008-12#1)
the Center##24##2##(1990-11#2)(1992-2#3)(1993-3#1)(1994-1#1)(1994-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
the Centers for Disease Control and Prevention (CDC)##7##8##(1995-12#2)(1995-6#3)(1996-5#1)(1997-1#1)
the Centers for Disease Control and Prevention##10##7##(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-8#1)
the Centers for Disease Control and##14##6##(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
the Centers for Disease Control##17##5##(1992-2#1)(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
the Centers for##18##3##(1992-2#1)(1995-12#2)(1995-6#3)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
the Central American Gap##2##4##(2013-7#2)
the Central American##3##3##(2008-5#1)(2013-7#2)
the Central##16##2##(1991-9#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#4)(2013-7#2)
the Centre for##4##3##(1990-3#1)(2008-11#1)(2008-6#1)(2011-2#1)
the Centre hospitalier Robert-Giffard##3##4##(1993-12#1)(2008-2#2)
the Centre hospitalier##4##3##(1993-12#1)(2008-2#3)
the Centre##9##2##(1990-3#1)(1993-12#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-6#1)(2011-2#1)
the Centre's##2##2##(1995-12#2)
the Centro##2##2##(1993-3#1)(2008-10#1)
the Cercospora##2##2##(2008-10#2)
the Cerrado##3##2##(2008-6#1)(2008-8#1)(2010-3#1)
the ChL##3##2##(2008-10#3)
the Chair##2##2##(2007-11#1)(2008-5#1)
the Chairman##2##2##(1993-2#1)(2008-5#1)
the Changbai Mountain##2##3##(2008-9#2)
the Characterization of##2##3##(1997-7#1)(2008-10#1)
the Chernobyl nuclear##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
the Chernobyl##8##2##(2008-10#2)(2008-4#2)(2008-7#1)(2010-4#2)(2011-1#1)
the Chernoff criterion##2##3##(2008-6#2)
the Chernoff##3##2##(2008-6#3)
the Chetumal Bay##2##3##(2008-5#2)
the Chicago##2##2##(1996-3#2)
the Chicxulub##2##2##(1997-5#2)
the Chief##3##2##(1993-3#2)(2008-12#1)
the Chikungunya IgM antibody##2##4##(2013-8#2)
the Chikungunya##6##2##(2013-8#6)
the Child and Adolescent Social Support Scale##2##7##(2010-1#2)
the Child and Adolescent##3##4##(2008-11#1)(2010-1#2)
the Child##12##2##(1992-12#1)(1993-1#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-9#3)(2009-11#1)(2010-1#2)
the Children##3##2##(2008-9#3)
the Children's Oncology Group##2##4##(2008-6#1)(2010-5#1)
the Children's##8##2##(1994-3#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#1)
the Chilean##2##2##(2011-2#1)(2013-1#1)
the China##3##2##(2008-7#1)(2011-2#2)
the Chinese femur##2##3##(1995-6#2)
the Chinese hamster ovary##2##4##(1995-11#1)(2008-11#1)
the Chinese hamster##4##3##(1994-12#1)(1995-11#1)(1997-7#1)(2008-11#1)
the Chinese herbal##4##3##(2008-10#3)(2013-1#1)
the Chinese isolate##3##3##(2008-10#3)
the Chinese population##3##3##(2008-7#1)(2011-1#2)
the Chinese##41##2##(1994-12#1)(1995-11#1)(1995-6#2)(1997-7#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#6)(2008-8#3)(2011-1#5)(2011-2#3)(2011-3#1)(2013-1#3)
the Chlamydia trachomatis##2##3##(1991-9#1)(1993-9#1)
the Chlamydia##4##2##(1991-9#1)(1993-9#1)(2008-5#1)(2008-9#1)
the Cibacron Blue##2##3##(1990-12#1)(1997-2#1)
the Cincinnati##5##2##(1994-12#2)(1995-3#1)(2008-5#1)(2011-2#1)
the City of##3##3##(1991-12#1)(2011-2#2)
the City##4##2##(1991-12#2)(2011-2#2)
the Civil##3##2##(1994-1#1)(2007-2#1)(2008-8#1)
the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)##2##11##(1994-12#1)(1996-12#1)
the Cl- channels##2##3##(1990-2#2)
the Cl-##4##2##(1990-2#3)(1995-12#1)
the Clarion##5##2##(2008-9#5)
the Classification##2##2##(1991-12#2)
the Clauss##2##2##(2008-10#2)
the Cleveland Clinic Foundation##2##4##(1995-12#1)(2008-7#1)
the Cleveland Clinic##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
the Cleveland##4##2##(1995-12#1)(1996-1#1)(2008-7#1)(2011-2#1)
the Clinic of Orthopedics##2##4##(2007-8#1)(2012-3#1)
the Clinic of##8##3##(1996-11#1)(2007-11#1)(2007-8#1)(2008-9#4)(2012-3#1)
the Clinic##13##2##(1993-12#1)(1994-12#1)(1995-9#1)(1996-11#1)(2007-11#1)(2007-8#2)(2008-9#4)(2011-2#1)(2012-3#1)
the Clinical Efficacy##2##3##(1993-12#1)(2010-8#1)
the Clinical Test of Executive Functions##2##6##(2007-11#2)
the Clinical##15##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
the Clinton##6##2##(1994-12#1)(1995-1#2)(1995-2#2)(1995-6#1)
the Cluster##3##2##(1996-2#1)(1997-5#1)(2008-10#1)
the Co##2##2##(1997-7#1)(2008-10#1)
the Co(2+)##4##2##(2007-11#1)(2008-3#3)
the Co-4##3##2##(2008-10#3)
the CoHCF##2##2##(2008-10#2)
the Coastal##2##2##(2008-2#1)(2008-3#1)
the Coat Protein Gene##2##4##(2008-10#2)
the Coat Protein##3##3##(2008-10#3)
the Cobb angle##2##3##(2007-8#2)
the Cobb##3##2##(2007-8#3)
the Cochrane Database of Systematic Reviews##2##6##(1993-12#1)(2011-2#1)
the Cochrane##7##2##(1993-12#1)(2007-8#1)(2008-6#1)(2009-9#1)(2011-2#1)(2013-1#2)
the Cohesion to Therapist Scale##2##5##(2013-1#2)
the College of##2##3##(1993-12#1)(2008-12#1)
the College##3##2##(1993-12#1)(2008-12#1)(2008-6#1)
the Collins##4##2##(1994-8#4)
the Colombian##11##2##(2008-10#1)(2008-12#1)(2008-5#2)(2012-12#4)(2013-1#1)(2013-7#2)
the Colorado potato beetle##3##4##(2008-10#3)
the Colorado##4##2##(2008-10#4)
the Columbia Basin of Washington and Oregon##2##7##(2008-10#2)
the Columbia Basin of Washington##3##5##(2008-10#3)
the Columbia Basin##7##3##(2008-10#7)
the Columbia##9##2##(2008-10#7)(2008-7#1)(2010-8#1)
the Commission for Health##2##4##(2008-7#2)
the Commission on##2##3##(2012-12#1)(2012-2#1)
the Commission##9##2##(1996-12#1)(2008-10#2)(2008-2#2)(2008-7#2)(2012-12#1)(2012-2#1)
the Committee for##2##3##(2008-11#1)(2008-7#1)
the Committee on##5##3##(1991-1#1)(2007-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
the Committee##9##2##(1991-1#1)(1993-1#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#2)(2013-1#1)
the Common Bean##2##3##(2008-10#2)
the Common##7##2##(1996-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-11#1)(2013-1#1)
the Community##7##2##(1991-5#1)(1992-12#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
the Complaints score##2##3##(1991-6#2)
the Complex##4##2##(1994-11#1)(1997-7#1)(2008-11#1)(2008-12#1)
the Concentric##2##2##(1994-3#1)(2012-1#1)
the Confusion Assessment Method (CAM)##2##5##(2008-7#1)(2013-1#1)
the Congo##2##2##(2007-7#1)(2008-10#1)
the Congress##3##2##(1994-3#1)(1995-3#1)(2010-11#1)
the Consejo Superior de Investigaciones##2##5##(2008-10#2)
the Constitution##3##2##(2011-2#2)(2012-12#1)
the Consumer Price Index for prescription drugs##2##7##(1993-1#2)
the Consumer Price Index##3##4##(1993-1#2)(1993-3#1)
the Control condition##2##3##(2008-4#2)
the Control##5##2##(2008-4#3)(2011-2#2)
the Convention##4##2##(1990-2#1)(1992-12#3)
the Cookie Theft##2##3##(2013-1#2)
the Coomassie brilliant blue##2##4##(2008-10#2)
the Copenhagen##6##2##(1996-9#1)(2007-10#1)(2007-8#1)(2008-3#2)(2011-1#1)
the Coping##2##2##(2008-11#1)(2008-12#1)
the Core##2##2##(1995-12#1)(2008-10#1)
the Corneometer##2##2##(2008-5#2)
the Coronary##3##2##(1991-8#2)(2011-2#1)
the Coroner's##3##2##(1996-1#2)(2011-2#1)
the Correlation of##2##3##(2008-10#1)(2011-1#1)
the Cortés##2##2##(2008-5#2)
the Corynebacterium##2##2##(1990-11#1)(2008-5#1)
the Coulomb##3##2##(1996-2#1)(1996-7#1)(2012-2#1)
the Council on##2##3##(1991-8#1)(1997-3#1)
the Council##7##2##(1991-8#1)(1995-6#5)(1997-3#1)
the County of##2##3##(1991-9#1)(1997-3#1)
the Course of##2##3##(2010-1#1)(2012-3#1)
the Court of Appeal##3##4##(1997-5#3)
the Court of##4##3##(1995-12#1)(1997-5#3)
the Cox##3##2##(1994-7#1)(1997-3#1)(2008-3#1)
the CpG islands##2##3##(1996-6#1)(2012-2#1)
the CpG##6##2##(1994-5#1)(1995-2#1)(1996-6#1)(1997-4#2)(2012-2#1)
the Cr##9##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
the Cr(3+)##2##2##(2008-10#1)(2008-2#1)
the Cr(4+)##3##2##(2007-12#1)(2008-3#2)
the Cr(III)##2##2##(2008-10#1)(2011-2#1)
the Cr(VI) concentrations##2##3##(2008-10#2)
the Cr(VI)##8##2##(2008-10#8)
the Cr2 gene##3##3##(2008-10#3)
the Cr2 phenotype##2##3##(2008-10#2)
the Cr2##6##2##(2008-10#6)
the CrCL##2##2##(2012-3#2)
the Crack##2##2##(2008-10#2)
the Cracow##2##2##(2007-8#1)(2008-10#1)
the Cre-loxP##3##2##(1995-2#1)(2008-2#1)(2008-4#1)
the Cricket##3##2##(2008-5#2)(2008-6#1)
the Crisis Center for##2##4##(1995-5#2)
the Critical Indicator Project in##2##5##(1992-2#2)
the Critical##5##2##(1992-2#2)(1995-12#1)(2013-1#2)
the Croatian##7##2##(2008-10#2)(2011-2#3)(2013-1#2)
the Cross##2##2##(2008-10#1)(2013-1#1)
the Cryptosporidium DNA##2##3##(2008-10#2)
the CsA##2##2##(1997-2#2)
the Csfm gene##2##3##(1990-5#2)
the Csfm##4##2##(1990-5#4)
the Cu##8##2##(1993-11#1)(1995-3#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-12#1)
the Cu(2+)##2##2##(1997-7#1)(2008-10#1)
the Cu(II)##3##2##(2008-10#3)
the Cu(II)-DDTC complex##3##3##(2008-10#3)
the CuN(6) units on site##2##5##(1996-2#2)
the CuN(6)##3##2##(1996-2#3)
the CuO2##2##2##(1992-8#1)(1996-9#1)
the Cuban##2##2##(1996-11#1)(2008-5#1)
the Curie##2##2##(2008-3#2)
the Cushing##2##2##(1991-11#1)(2009-3#1)
the CyA##2##2##(2008-10#2)
the Cys##3##2##(1990-12#1)(1994-12#1)(2008-10#1)
the Czech Republic##7##3##(1990-11#1)(1996-7#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
the Czech##11##2##(1990-11#3)(1996-7#3)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
the D and##3##3##(1992-12#1)(2008-10#2)
the D genotype##2##3##(2008-10#2)
the D loop of##2##4##(1993-11#2)
the D##25##2##(1992-12#1)(1993-11#2)(1993-2#3)(1993-8#1)(1995-2#2)(2007-12#2)(2008-10#12)(2008-9#1)(2013-1#1)
the D(1) line##2##3##(2007-11#2)
the D(1)##3##2##(2007-11#3)
the D(2) line##2##3##(2007-11#2)
the D(2)##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
the D-alanyl##2##2##(1995-6#2)
the D-glucose##2##2##(1991-5#1)(2007-11#1)
the D-lactate##2##2##(1991-12#1)(2008-7#1)
the D-loop##4##2##(1996-9#1)(2008-5#1)(2008-8#1)(2011-2#1)
the D-wave##2##2##(2008-7#2)
the D2 receptor##2##3##(1995-2#1)(1995-3#1)
the D2##7##2##(1993-3#1)(1993-5#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-7#1)
the D222A or D222N enzyme##2##5##(1992-6#2)
the D222A##3##2##(1992-6#3)
the D3 receptor##4##3##(1995-2#4)
the D6-2 transgenic##2##3##(2008-4#2)
the DA##4##2##(1993-6#1)(1996-12#1)(1997-2#1)(2008-10#1)
the DAG##3##2##(1991-12#3)
the DAT was##2##3##(1992-6#1)(1996-12#1)
the DAT##4##2##(1992-6#2)(1994-12#1)(1996-12#1)
the DAV##2##2##(2008-8#2)
the DAX-8 and XAD-8 resins##2##5##(2008-10#2)
the DAX-8##3##2##(2008-10#3)
the DBSQ ligand##2##3##(1996-2#2)
the DCC##3##2##(1992-10#2)(2007-12#1)
the DD##3##2##(2008-10#3)
the DD-FD-OCT##2##2##(2011-1#2)
the DDR##5##2##(2011-2#3)(2013-1#2)
the DDX13 gene##2##3##(1997-6#2)
the DEA##2##2##(1996-12#2)
the DEB test to##2##4##(2008-4#2)
the DEB test##3##3##(2008-4#3)
the DEB##4##2##(2008-4#3)(2010-4#1)
the DEF##2##2##(2007-10#1)(2008-11#1)
the DEJ##3##2##(2008-5#1)(2010-10#2)
the DFG##2##2##(2012-12#1)(2012-2#1)
the DFHT##2##2##(2008-3#2)
the DG##7##2##(1996-12#2)(2007-7#2)(2009-8#1)(2012-12#2)
the DGC##2##2##(2012-2#2)
the DGN##6##2##(2012-2#6)
the DH gene##2##3##(2008-8#2)
the DH##4##2##(2008-10#2)(2008-8#2)
the DHFR##3##2##(1994-12#1)(1995-2#1)(2008-2#1)
the DHP##2##2##(1991-2#1)(1995-3#1)
the DI##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
the DIAL system##2##3##(2008-2#1)(2008-3#1)
the DIAL##7##2##(2008-2#5)(2008-3#2)
the DII progress##2##3##(2008-10#2)
the DII##3##2##(2008-10#3)
the DIN 6800-2 protocol and##2##5##(2012-1#2)
the DIPD##2##2##(2008-10#2)
the DL##3##2##(2008-10#1)(2008-3#2)
the DLQI##2##2##(2012-1#2)
the DM group##2##3##(2011-2#2)
the DM-Allo group##2##3##(2011-2#2)
the DME##2##2##(2008-10#1)(2012-12#1)
the DMFT##2##2##(2008-9#2)
the DMI##2##2##(2008-10#2)
the DMN##2##2##(2013-8#2)
the DNA IQ System##2##4##(2008-12#2)
the DNA and##2##3##(1991-2#1)(1995-8#1)
the DNA backbone##3##3##(1994-5#1)(2008-10#2)
the DNA binding domain of##2##5##(1990-11#1)(1995-6#1)
the DNA binding properties of the##2##6##(1991-3#1)(1995-5#1)
the DNA binding properties of##3##5##(1991-3#1)(1995-5#1)(1996-3#1)
the DNA binding site for the##2##6##(1991-5#1)(1992-8#1)
the DNA binding site for##3##5##(1991-5#2)(1992-8#1)
the DNA binding site##4##4##(1990-11#1)(1991-5#2)(1992-8#1)
the DNA binding specificity of##2##5##(1995-5#2)
the DNA binding##16##3##(1990-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-8#1)(1993-3#1)(1995-5#3)(1995-6#1)(1996-3#1)(2008-2#2)(2008-7#1)
the DNA concentration##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
the DNA content##2##3##(1991-6#1)(2008-11#1)
the DNA damage checkpoint##2##4##(2008-11#1)(2013-1#1)
the DNA damage response (DDR)##2##5##(2011-2#1)(2013-1#1)
the DNA damage response##4##4##(2011-2#1)(2012-12#1)(2013-1#2)
the DNA damage##12##3##(1995-6#2)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#2)(2013-1#4)
the DNA damaging##2##3##(2008-7#1)(2010-2#1)
the DNA data##2##3##(1997-6#2)
the DNA double helix##2##4##(2008-10#1)(2008-11#1)
the DNA double##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
the DNA extraction##3##3##(2008-12#1)(2012-3#2)
the DNA fingerprint probe pSTL70##2##5##(2008-10#2)
the DNA fragment##2##3##(1995-2#1)(1997-6#1)
the DNA fragmentation##2##3##(1991-12#1)(1993-8#1)
the DNA fragments##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
the DNA helix##2##3##(1994-5#1)(1996-2#1)
the DNA hybridization##3##3##(2008-10#3)
the DNA in##3##3##(1993-8#1)(1995-3#1)(1997-4#1)
the DNA is##4##3##(1993-11#1)(1994-6#1)(2008-2#1)(2008-4#1)
the DNA microarray##5##3##(2008-10#1)(2008-7#1)(2012-3#3)
the DNA molecule##2##3##(2008-11#2)
the DNA molecules##3##3##(1995-8#1)(2008-2#1)(2008-7#1)
the DNA of##7##3##(1991-5#1)(1993-11#1)(1993-8#1)(1994-7#1)(2008-10#1)(2013-1#2)
the DNA polymerase alpha##2##4##(1995-4#1)(1995-6#1)
the DNA polymerase##5##3##(1992-3#1)(1995-4#1)(1995-6#1)(1997-6#1)(2009-8#1)
the DNA sequence of the##2##5##(1993-8#1)(2008-10#1)
the DNA sequence of##3##4##(1993-8#1)(1997-7#1)(2008-10#1)
the DNA sequence##8##3##(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)
the DNA sequences of the##2##5##(2008-10#1)(2008-8#1)
the DNA sequences of##3##4##(1997-7#1)(2008-10#1)(2008-8#1)
the DNA sequences##7##3##(1993-6#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
the DNA substrate##2##3##(1991-9#1)(1997-3#1)
the DNA surface##2##3##(1994-6#1)(1997-2#1)
the DNA synthesis##2##3##(1992-3#1)(1993-8#1)
the DNA target##2##3##(1994-3#1)(2008-10#1)
the DNA template##5##3##(1994-8#2)(1995-2#1)(2008-4#1)(2008-7#1)
the DNA was##3##3##(1993-8#2)(2008-10#1)
the DNA##188##2##(1990-11#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#5)(1991-6#2)(1991-9#2)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-11#5)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#8)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#3)(1995-11#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#4)(1995-8#2)(1996-10#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#3)(2007-11#2)(2008-10#30)(2008-11#11)(2008-12#5)(2008-2#6)(2008-3#1)(2008-4#7)(2008-7#6)(2008-8#3)(2008-9#3)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#6)
the DNA-A and DNA-B##2##4##(2008-10#2)
the DNA-A##3##2##(2008-10#3)
the DNA-B##2##2##(2008-10#2)
the DNA-binding activity of##2##4##(1991-7#1)(2008-9#1)
the DNA-binding domain of##2##4##(1991-12#1)(1995-8#1)
the DNA-binding domain##4##3##(1991-12#1)(1991-6#1)(1993-12#1)(1995-8#1)
the DNA-binding protein##2##3##(2008-2#2)
the DNA-binding##11##2##(1990-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-8#1)(2008-2#2)(2008-9#1)
the DNA/protein complex containing##2##4##(1994-9#2)
the DNAbeta molecules##2##3##(2008-10#2)
the DNAbeta##3##2##(2008-10#3)
the DNAzyme##2##2##(2008-10#2)
the DNB and NBM##2##4##(1993-3#2)
the DNB and##3##3##(1993-3#3)
the DNB##4##2##(1993-3#4)
the DNC diet##3##3##(2010-2#3)
the DNC##5##2##(2010-2#5)
the DNP initiative##2##3##(2012-2#2)
the DNP probe##2##3##(2007-9#2)
the DNP##6##2##(2007-9#2)(2012-2#4)
the DNPH-method and##2##3##(2010-4#2)
the DNPH-method##3##2##(2010-4#3)
the DNR##2##2##(1992-12#2)
the DNS##5##2##(2008-6#2)(2013-8#3)
the DO##2##2##(1994-3#1)(2008-11#1)
the DOF##5##2##(2008-3#1)(2010-8#4)
the DP method##2##3##(2008-2#2)
the DP##3##2##(2008-2#2)(2010-1#1)
the DPE's we designed##2##4##(2008-3#2)
the DPH2 gene##3##3##(1993-9#3)
the DPH2##6##2##(1993-9#6)
the DPM##3##2##(2008-5#3)
the DPP##2##2##(2008-10#2)
the DPPH assay##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
the DPPH##8##2##(2008-10#2)(2008-11#2)(2008-5#3)(2012-1#1)
the DQB1(*)0602##2##2##(1997-9#2)
the DR##2##2##(1996-12#1)(2010-8#1)
the DR-CALUX((R)) measured##2##3##(2008-10#2)
the DR-CALUX((R))##3##2##(2008-10#3)
the DRA##2##2##(2007-12#2)
the DRE##2##2##(1993-11#2)
the DRG##9##2##(1991-12#1)(1992-2#1)(1993-1#1)(1994-12#2)(1997-2#2)(2008-9#2)
the DRN##3##2##(1995-5#3)
the DRR206 promoter##3##3##(2008-10#3)
the DRUJ##3##2##(2008-9#3)
the DS##6##2##(1996-2#3)(2008-10#1)(2008-3#1)(2011-2#1)
the DSES##3##2##(2009-11#3)
the DSM##4##2##(1992-5#1)(1996-9#1)(2009-10#2)
the DSM-IV criteria for##2##4##(2007-7#1)(2010-2#1)
the DSM-IV criteria##5##3##(2007-10#1)(2007-7#1)(2010-2#1)(2011-2#2)
the DSM-IV##9##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#3)(2013-1#1)
the DSRU##2##2##(2008-11#2)
the DSTD##3##2##(2008-10#3)
the DT##2##2##(2011-1#2)
the DUF683 family##2##3##(2009-7#2)
the DWI abnormalities##2##3##(2007-10#2)
the DWI##4##2##(2007-10#4)
the DXR PKS##2##3##(1994-12#2)
the Dagua river estuary##2##4##(2008-5#2)
the Dagua##3##2##(2008-5#3)
the Dana-Farber Cancer Institute##2##4##(2008-5#1)(2013-1#1)
the Dane County Drug Treatment Court##2##6##(2010-6#2)
the Danish SPF##2##3##(1992-5#2)
the Danish##8##2##(1990-12#3)(1992-5#2)(1997-3#1)(2011-2#1)(2012-2#1)
the Danube##2##2##(2008-10#1)(2010-8#1)
the Data##4##2##(1995-3#1)(1996-6#1)(1997-5#1)(2013-8#1)
the DeFord and Hume formalism##2##5##(2008-10#2)
the Deaf##3##2##(2011-2#3)
the Debye approximation##3##3##(2007-12#3)
the Debye length##2##3##(1997-6#2)
the Debye##5##2##(1997-6#2)(2007-12#3)
the Debye-Hückel equation##2##3##(2008-10#2)
the December##2##2##(1995-12#1)(2009-8#1)
the Delirium##2##2##(2008-7#1)(2011-2#1)
the Democratic##2##2##(2007-7#1)(2012-2#1)
the Demographic##2##2##(2010-5#1)(2012-12#1)
the Department and##2##3##(2008-9#2)
the Department for##2##3##(2007-2#1)(2008-10#1)
the Department of Child##2##4##(1997-8#1)(2006-10#1)
the Department of Correction's##2##4##(1997-5#2)
the Department of Defense (DOD)##2##5##(1995-6#1)(1996-5#1)
the Department of Defense##3##4##(1995-6#1)(1996-12#1)(1996-5#1)
the Department of Energy (DOE)##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
the Department of Energy##4##4##(2008-10#1)(2008-5#1)(2011-2#2)
the Department of Health and Human Services##2##7##(1994-2#1)(1996-5#1)
the Department of Health and Human##3##6##(1994-2#1)(1996-5#1)(1997-3#1)
the Department of Health##9##4##(1991-2#1)(1992-1#1)(1994-2#1)(1996-5#1)(1997-3#1)(2007-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
the Department of Infection Control and Prevention##2##7##(2010-6#2)
the Department of Nursing##2##4##(1992-2#1)(2008-11#1)
the Department of Obstetrics and Gynaecology##2##6##(1996-1#1)(2008-3#1)
the Department of Obstetrics and##3##5##(1996-1#1)(1996-9#1)(2008-3#1)
the Department of Oncology##3##4##(1993-3#2)(1995-5#1)
the Department of Orthopaedics and Traumatology##2##6##(2013-1#2)
the Department of Paediatrics##2##4##(2008-11#1)(2009-5#1)
the Department of Pathology##3##4##(1991-9#1)(2008-5#1)(2013-8#1)
the Department of Pediatrics##2##4##(1991-6#1)(2009-5#1)
the Department of Surgery##2##4##(1991-9#1)(1992-3#1)
the Department of Veterans Affairs##3##5##(1992-12#1)(1992-2#1)(1996-3#1)
the Department of the##3##4##(1992-12#1)(2007-8#1)(2008-9#1)
the Department of##98##3##(1990-10#2)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#2)(2010-6#2)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
the Department##107##2##(1990-10#2)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#1)(1993-3#2)(1994-1#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#2)(2006-10#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-5#2)(2010-6#2)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
the Departments of##2##3##(1991-9#1)(1996-12#1)
the Depression##3##2##(1991-2#1)(2007-12#1)(2007-7#1)
the Dermatology Life Quality Index (DLQI)##2##6##(2012-1#1)(2013-1#1)
the Descartes##2##2##(2008-2#1)(2008-3#1)
the Development of##7##3##(1994-7#1)(1997-6#1)(2008-10#3)(2010-11#1)(2011-1#1)
the Development##9##2##(1994-7#1)(1997-6#1)(2007-12#1)(2008-10#4)(2010-11#1)(2011-1#1)
the Developmental##2##2##(2008-4#1)(2012-12#1)
the Diagnosis of##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
the Diagnosis##5##2##(2008-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
the Diagnostic and Statistical Manual of Mental Disorders##5##8##(2010-11#1)(2011-1#1)(2011-2#3)
the Diagnostic and Statistical Manual##6##5##(2010-11#1)(2011-1#1)(2011-2#4)
the Diagnostic##7##2##(2008-11#1)(2010-11#1)(2011-1#1)(2011-2#4)
the Diels-Alder##5##2##(1996-5#5)
the Dif phenotype##2##3##(1995-2#2)
the Dimension##5##2##(2008-10#5)
the Diskus##5##2##(1996-2#5)
the District of Columbia##9##4##(1991-5#1)(1992-3#1)(1996-12#4)(1997-1#1)(1997-5#1)(2010-5#1)
the District of##10##3##(1991-5#1)(1992-2#1)(1992-3#1)(1996-12#4)(1997-1#1)(1997-5#1)(2010-5#1)
the District##11##2##(1991-5#1)(1992-2#1)(1992-3#1)(1996-12#5)(1997-1#1)(1997-5#1)(2010-5#1)
the Division of##6##3##(1991-12#2)(1995-6#1)(1996-3#1)(2008-8#2)
the DnaB helicase##2##3##(1991-12#2)
the DnaK##2##2##(1995-6#2)
the Dobson##2##2##(2008-3#2)
the Dominican Republic and##2##4##(2008-10#1)(2008-5#1)
the Dominican Republic in the##2##5##(2008-10#2)
the Dominican Republic##14##3##(2008-10#10)(2008-11#1)(2008-5#2)(2011-2#1)
the Donnan effect##4##3##(2011-2#4)
the Doppler bandwidth in##2##4##(2007-11#1)(2008-3#1)
the Doppler bandwidth##3##3##(2007-11#2)(2008-3#1)
the Doppler frequency##2##3##(2008-3#2)
the Doppler shift in the frequency##2##6##(2008-3#2)
the Doppler shift in the##3##5##(2008-2#1)(2008-3#2)
the Doppler shift##8##3##(2007-12#1)(2008-2#4)(2008-3#3)
the Doppler##23##2##(2007-11#4)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#11)(2011-1#1)
the Doppler-shifted##2##2##(2008-2#2)
the Doto area##2##3##(2010-8#2)
the Doto##3##2##(2010-8#3)
the Down syndrome##4##3##(1996-2#2)(1997-2#1)(2008-11#1)
the Down's syndrome##2##3##(1996-5#1)(2008-7#1)
the Drosophila eye##2##3##(2008-9#2)
the Drosophila male germ line##2##5##(2009-3#2)
the Drosophila melanogaster##6##3##(1993-2#2)(1993-6#2)(1994-12#1)(1997-6#1)
the Drosophila segment polarity gene hedgehog##2##6##(1993-12#1)(1994-12#1)
the Drosophila segment polarity gene##3##5##(1993-12#2)(1994-12#1)
the Drosophila system##2##3##(1994-8#1)(2008-10#1)
the Drosophila##40##2##(1991-5#1)(1993-12#2)(1993-2#2)(1993-6#2)(1994-12#3)(1994-8#1)(1995-2#1)(1995-6#3)(1995-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#9)(2009-3#4)(2012-12#1)(2012-3#1)
the Drude model##2##3##(2008-3#2)
the Drug##2##2##(1991-3#1)(2008-11#1)
the Ds##2##2##(2008-10#1)(2012-3#1)
the Dutch TAD soils##2##4##(2008-10#2)
the Dutch##15##2##(1992-6#1)(1994-12#1)(1994-5#1)(1996-8#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
the Dynabeads##2##2##(1990-12#2)
the E degrees' values##2##4##(1995-5#2)
the E##41##2##(1990-11#5)(1990-12#1)(1991-5#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-6#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
the E(pa)##2##2##(2008-10#2)
the E-box##3##2##(1997-7#2)(2012-12#1)
the E1 region##2##3##(1994-5#1)(1997-4#1)
the E1##4##2##(1994-5#1)(1997-4#1)(2008-9#2)
the E1A##2##2##(1993-2#1)(2008-11#1)
the E1A/E1B sequence##2##3##(2008-11#2)
the E2 protein##2##3##(1990-5#1)(2008-10#1)
the E2##9##2##(1990-5#2)(1994-8#1)(1995-3#1)(2008-10#4)(2010-12#1)
the E2F##5##2##(1995-2#2)(2012-12#1)(2012-2#2)
the E5-1 gene##2##3##(1995-8#2)
the E5-1##3##2##(1995-8#3)
the EA##2##2##(1995-2#1)(2008-10#1)
the EAP##5##2##(1992-10#2)(1995-6#2)(2012-12#1)
the EASE##4##2##(2008-11#4)
the EAT##2##2##(2007-7#1)(2013-8#1)
the EB##2##2##(2008-10#1)(2008-3#1)
the EB-PVD##3##2##(2009-7#3)
the EBCM##2##2##(2008-2#1)(2008-3#1)
the EBID##2##2##(2009-11#2)
the EBL##4##2##(2008-11#1)(2008-12#1)(2008-3#2)
the EBV##5##2##(1994-8#1)(1997-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
the EBs##2##2##(2008-11#2)
the EC Standards##2##3##(2008-10#2)
the EC and##2##3##(2009-10#1)(2012-2#1)
the EC##7##2##(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)
the EC(50) values##2##3##(2008-10#1)(2008-11#1)
the EC3##3##2##(2008-10#3)
the EC50##2##2##(1995-11#1)(1995-2#1)
the ECA to##2##3##(2008-7#2)
the ECD##2##2##(1995-12#1)(2008-10#1)
the ECG##9##2##(1991-3#1)(1992-6#1)(1994-6#1)(1995-8#2)(1996-3#1)(2008-10#1)(2010-8#1)(2011-1#1)
the ECL intensity of##2##4##(2008-10#2)
the ECL intensity##3##3##(2008-10#3)
the ECL of##5##3##(2008-10#5)
the ECL##10##2##(2008-10#10)
the ECM##8##2##(1993-3#1)(2008-11#4)(2008-3#1)(2009-12#1)(2009-8#1)
the ECR##2##2##(2008-10#2)
the ED and##2##3##(2009-6#1)(2010-8#1)
the ED for##2##3##(2008-11#1)(2009-8#1)
the ED or##2##3##(1997-2#1)(2008-11#1)
the ED with##2##3##(2007-5#1)(2008-11#1)
the ED##30##2##(1997-2#3)(1997-8#1)(2007-11#1)(2007-5#3)(2008-11#5)(2009-6#3)(2009-8#4)(2010-8#2)(2012-2#2)(2013-1#6)
the ED(50)##4##2##(2008-10#2)(2008-11#2)
the ED50##2##2##(1990-12#1)(1995-12#1)
the EDP was##2##3##(2008-7#2)
the EDP##7##2##(1994-6#2)(2008-7#5)
the EDTA##6##2##(1993-3#1)(2008-10#4)(2008-11#1)
the EDXRF##2##2##(2008-10#2)
the EEG##6##2##(1990-9#1)(1991-9#1)(1993-9#1)(2009-8#2)(2010-8#1)
the EF##3##2##(1993-9#1)(2008-10#2)
the EFS-evoked##5##2##(1997-4#2)(2008-2#3)
the EGF +61##2##3##(2011-2#2)
the EGF receptor##5##3##(1993-8#3)(1994-11#1)(1995-2#1)
the EGF##9##2##(1993-8#3)(1994-11#1)(1995-2#1)(2007-12#1)(2008-4#1)(2011-2#2)
the EGF-R##3##2##(1992-9#1)(1994-8#1)(1995-6#1)
the EGFP expression##2##3##(2008-11#2)
the EGFP##5##2##(2008-11#5)
the EGFR gene##5##3##(1993-3#1)(2008-4#1)(2008-5#1)(2012-1#2)
the EGFR kinase domain##3##4##(2008-4#3)
the EGFR##12##2##(1993-3#1)(1993-8#1)(2008-4#4)(2008-5#2)(2010-5#1)(2011-2#1)(2012-1#2)
the EHR value##2##3##(2010-8#2)
the EHV and##2##3##(2008-7#2)
the EI##2##2##(2011-1#1)(2013-1#1)
the EIA##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
the EKF approach##2##3##(2008-2#1)(2008-3#1)
the ELISA and##4##3##(1992-5#3)(2008-10#1)
the ELISA method##4##3##(2008-10#4)
the ELISA##29##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#5)(1995-2#2)(1995-6#1)(1997-3#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
the ELISA-based assays are##2##4##(2008-10#2)
the ELISE##3##2##(2008-3#3)
the ELISPOT assay##3##3##(2008-4#3)
the ELISPOT##4##2##(2008-4#4)
the EM algorithm##2##3##(2008-2#1)(2008-8#1)
the EM sputum##2##3##(2013-1#2)
the EM##6##2##(2008-2#3)(2008-8#1)(2013-1#2)
the EMC test system of##2##5##(2012-3#2)
the EMC##3##2##(2012-3#3)
the EMEP##2##2##(2008-10#2)
the EMG pattern##2##3##(1993-12#2)
the EMG##4##2##(1993-12#2)(2008-9#1)(2013-1#1)
the EMS-induced##2##2##(2008-4#2)
the EN 12341 standard##3##4##(2008-10#3)
the EN##5##2##(2008-10#3)(2008-11#2)
the ENTO##3##2##(1994-3#3)
the ENs in this study determined their own scope of practice##2##11##(2007-10#2)
the ENs##3##2##(2007-10#3)
the EO##6##2##(2007-11#1)(2008-2#2)(2013-1#3)
the EOF modifier##2##3##(1996-5#2)
the EOF##3##2##(1996-5#2)(2008-10#1)
the EOPO##2##2##(2007-12#2)
the EORTC##4##2##(1992-10#1)(1994-3#1)(2008-6#2)
the EPA##2##2##(2008-10#1)(2008-2#1)
the EPCS substrate##2##3##(2011-2#2)
the EPO##5##2##(2007-7#1)(2008-11#2)(2008-5#2)
the EPR##4##2##(1993-11#2)(1997-7#1)(2008-10#1)
the EPSP##2##2##(1993-12#1)(2008-9#1)
the EPSR##2##2##(2008-2#2)
the EQ-5D health##2##3##(2009-11#1)(2011-2#1)
the EQ-5D##5##2##(2008-7#1)(2009-11#2)(2011-2#1)(2012-12#1)
the ER and##2##3##(2009-2#1)(2011-2#1)
the ER gene##2##3##(1997-7#2)
the ER in##2##3##(1994-12#1)(2008-11#1)
the ER##38##2##(1991-2#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#2)(1995-2#2)(1997-7#2)(2008-11#7)(2008-8#4)(2009-2#3)(2009-8#3)(2010-11#1)(2011-2#2)(2012-2#3)(2013-1#1)
the ER-positive##2##2##(1990-5#1)(1993-9#1)
the ES##5##2##(1995-2#1)(2008-8#2)(2012-2#2)
the ESA##2##2##(2008-3#1)(2010-11#1)
the ESI##2##2##(1997-8#1)(2011-2#1)
the ESLI appliqué##2##3##(2008-3#2)
the ESLI##3##2##(2008-3#3)
the ESR spectra##2##3##(1990-5#1)(2008-10#1)
the ESR##8##2##(1990-5#3)(1997-6#1)(2008-10#3)(2012-2#1)
the ESRD patients##2##3##(2007-7#2)
the ESRD population is##2##4##(1991-3#2)
the ESRD##6##2##(1991-3#2)(1996-2#2)(2007-7#2)
the ESS level of selfishness is##2##6##(2008-9#2)
the ESS##7##2##(2008-8#3)(2008-9#3)(2012-3#1)
the ET##4##2##(1990-12#1)(1996-2#1)(2008-10#1)(2013-1#1)
the ET-1##3##2##(1992-3#1)(1992-9#1)(1995-11#1)
the ETA##7##2##(1991-11#1)(1992-9#3)(1993-3#1)(1994-8#1)(2012-2#1)
the ETAAS##6##2##(2008-10#6)
the ETS##2##2##(2008-6#2)
the ETV##2##2##(2008-10#2)
the EU race##2##3##(2008-10#2)
the EU##17##2##(2008-10#10)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
the EURACHEM Guide##2##3##(2008-10#2)
the EURACHEM##3##2##(2008-10#3)
the EURAMOS##2##2##(2010-3#2)
the EUV reflectance##2##3##(2008-3#2)
the EUV spectral region##2##4##(2008-3#2)
the EUV##12##2##(2007-11#1)(2008-3#11)
the EV71 strains##2##3##(2008-12#2)
the EV71##4##2##(2008-12#2)(2008-8#1)(2011-1#1)
the EVAR-1 trial criteria##2##4##(2012-2#2)
the EWS##2##2##(2008-6#2)
the Early##9##2##(1993-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
the Earth Observing System##2##4##(2008-3#2)
the Earth and##2##3##(1997-5#1)(2008-10#1)
the Earth##18##2##(1996-4#1)(1997-5#4)(2008-10#1)(2008-12#1)(2008-3#10)(2011-2#1)
the Earth's atmosphere##6##3##(2008-11#1)(2008-2#1)(2008-3#4)
the Earth's surface##4##3##(2008-2#2)(2008-3#1)(2009-7#1)
the Earth's##15##2##(2008-11#1)(2008-2#4)(2008-3#9)(2009-7#1)
the Earth-atmosphere system##2##3##(2008-3#2)
the East Asian region##3##4##(2008-8#3)
the East Asian##6##3##(2008-8#3)(2010-3#2)(2011-2#1)
the East China Sea##3##4##(2008-10#1)(2010-8#2)
the East##17##2##(2008-10#3)(2008-11#1)(2008-8#3)(2009-7#1)(2010-1#1)(2010-3#2)(2010-8#3)(2011-2#3)
the Eastern##9##2##(1996-9#1)(1997-5#2)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-7#2)
the Eating##3##2##(2012-5#2)(2013-8#1)
the Ebro river basin##3##4##(2008-10#3)
the Ec##3##2##(1995-8#3)
the Economic Stabilization Program##2##4##(1994-12#2)
the Ecuadorian##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
the Edinburgh##2##2##(1995-11#1)(2013-1#1)
the Edinger-Westphal nucleus##2##3##(1992-8#1)(1993-12#1)
the Editor##7##2##(2008-10#2)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
the Editors-in-Chief are retracting this article##2##6##(2008-10#2)
the Editors-in-Chief##5##2##(2008-10#5)
the Effect of##4##3##(2008-10#3)(2008-4#1)
the Effects of##5##3##(2008-10#4)(2008-11#1)
the Egyptian##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
the Ehrlich ascites tumour##2##4##(1990-5#2)
the Ehrlich##3##2##(1990-5#2)(2012-3#1)
the El Niño##3##3##(2008-5#1)(2008-9#1)(2010-8#1)
the El##7##2##(1992-5#1)(1994-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)
the Elderly (PACE)##4##3##(1992-1#1)(1994-2#1)(1995-1#1)(2008-7#1)
the Elderly##11##2##(1992-1#1)(1994-2#1)(1995-1#1)(1997-3#2)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
the Electronic##2##2##(1997-7#1)(2008-11#1)
the Eleventh##2##2##(1994-1#1)(1995-6#1)
the Emergency Department##7##3##(1991-12#1)(1997-2#1)(2008-11#1)(2008-3#3)(2012-12#1)
the Emergency##9##2##(1991-12#1)(1992-6#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-3#3)(2012-12#1)
the Endophytic##2##2##(2008-10#2)
the English National Board##2##4##(2008-11#2)
the English literature##12##3##(2006-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#3)(2013-1#1)
the English##25##2##(1995-2#1)(1995-3#1)(1996-6#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
the Enneking##3##2##(2007-11#1)(2008-6#2)
the Entrez system##2##3##(2008-4#2)
the Environment##6##2##(1995-6#1)(2008-10#1)(2008-11#2)(2010-4#1)(2013-1#1)
the Environmental Satellite##2##3##(2008-3#2)
the Environmental##6##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)
the Epstein-Barr virus (EBV)##2##4##(1993-8#1)(1994-2#1)
the Epstein-Barr virus##5##3##(1993-8#1)(1994-2#1)(1995-2#1)(2007-12#1)(2011-2#1)
the Er##5##2##(1991-9#2)(2008-2#1)(2008-7#2)
the Er(3+)##2##2##(2007-12#1)(2008-3#1)
the Er-doped##2##2##(2007-12#2)
the Eremothecium##2##2##(2012-3#2)
the Erwinia##2##2##(2008-10#1)(2010-11#1)
the EryA strains##2##3##(1990-5#2)
the Escherichia coli DNA##2##4##(1992-3#2)
the Escherichia coli ribosome##2##4##(1992-6#1)(1993-11#1)
the Escherichia coli##36##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-7#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-3#1)(1996-6#3)(1997-2#3)(1997-8#1)(2013-1#1)
the Estrogen Receptor##2##3##(1997-7#1)(2013-1#1)
the Ethical##2##2##(1991-3#2)
the Ethics in Patient Referrals Act##2##6##(1991-1#1)(1996-3#1)
the Ethics##3##2##(1991-1#1)(1996-3#1)(2012-2#1)
the Etude##3##2##(2008-2#3)
the Eu(3+)##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
the Eu(III)##7##2##(2008-10#7)
the Euclidean distance##2##3##(2008-3#1)(2010-7#1)
the Euclidean perimeter of the##2##5##(2008-6#2)
the Euclidean##6##2##(2007-12#1)(2008-3#1)(2008-6#2)(2010-7#1)(2011-2#1)
the Eurasian badger##2##3##(2008-12#2)
the Eurasian group and##2##4##(2010-8#2)
the Eurasian##6##2##(2008-12#2)(2008-9#1)(2010-8#3)
the European (EU) race of Gremmeniella abietina##2##7##(2008-10#2)
the European Commission##7##3##(1996-1#1)(2008-10#6)
the European Community##4##3##(1993-2#1)(1994-5#1)(2008-10#2)
the European Economic##2##3##(1990-2#1)(2008-3#1)
the European Medicines Agency##4##4##(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
the European Pharmacopoeia##2##3##(2008-10#2)
the European Race of Gremmeniella abietina##2##6##(2008-10#2)
the European Science Foundation##3##4##(2008-7#2)(2010-3#1)
the European Society for##2##4##(2008-10#1)(2013-1#1)
the European Society of Cardiology##2##5##(2012-3#1)(2013-1#1)
the European Society of Radiology (ESR)##2##6##(2012-2#2)
the European Society of Radiology##6##5##(2012-2#6)
the European Society of##12##4##(1993-12#1)(2008-7#3)(2012-2#6)(2012-3#1)(2013-1#1)
the European Society##14##3##(1993-12#1)(2008-10#1)(2008-7#3)(2012-2#6)(2012-3#1)(2013-1#2)
the European Space Agency##3##4##(2008-3#3)
the European Standard##2##3##(2007-7#1)(2008-10#1)
the European Union and##4##4##(2007-5#1)(2008-10#3)
the European Union##16##3##(1996-3#1)(1997-6#1)(2007-5#1)(2007-6#1)(2008-10#9)(2008-5#1)(2011-2#1)(2013-8#1)
the European market##2##3##(2008-11#1)(2008-5#1)
the European response##2##3##(2007-2#2)
the European##119##2##(1990-11#1)(1990-12#1)(1990-2#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-6#2)(1996-1#1)(1996-3#1)(1997-6#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-2#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#3)
the Evaluation and Management of##2##5##(2008-4#1)(2010-9#1)
the Evaluation and##3##3##(2008-4#1)(2010-9#1)(2011-2#1)
the Evaluation of##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
the Evaluation##6##2##(2008-11#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
the Evolutionary##2##2##(2009-8#1)(2011-2#1)
the Ewald##3##2##(1992-6#2)(2012-2#1)
the Excimer-laser##2##2##(1991-9#2)
the Executive Office Building##2##4##(1995-6#2)
the Executive##5##2##(1992-2#1)(1995-6#2)(1996-9#1)(2008-6#1)
the Experimental Lidar##2##3##(2008-3#2)
the Experimental##3##2##(2008-12#1)(2008-3#2)
the Expression of##4##3##(2010-8#3)(2013-1#1)
the F sex factor TraD protein##2##6##(1992-7#2)
the F##27##2##(1990-11#2)(1991-7#1)(1992-7#2)(2007-6#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
the F(1) generation##4##3##(2008-10#4)
the F(1) hybrid of##2##4##(2008-10#2)
the F(1) hybrid##3##3##(2008-10#2)(2008-9#1)
the F(1) hybrids##2##3##(2008-10#2)
the F(1)##17##2##(2008-10#15)(2008-9#1)(2009-9#1)
the F(2) and##3##3##(2008-10#3)
the F(2) generation and##2##4##(2008-10#2)
the F(2) generation##3##3##(2008-10#3)
the F(2) population##5##3##(2008-10#4)(2008-8#1)
the F(2)##13##2##(2008-10#12)(2008-8#1)
the F(3) and##3##3##(2008-10#3)
the F(3)##7##2##(2008-10#7)
the F-actin content##2##3##(1994-6#2)
the F-actin##5##2##(1993-8#1)(1994-6#2)(2007-12#1)(2008-10#1)
the F-test##2##2##(2008-10#2)
the F1 and F2 populations##2##5##(2008-10#2)
the F1##8##2##(2008-10#3)(2008-12#1)(2008-5#3)(2011-2#1)
the F1021##2##2##(1997-7#2)
the F1Fo-ATPsynthase in##2##3##(2012-2#2)
the F2##2##2##(1996-12#1)(2007-6#1)
the F3 generation##2##3##(2008-12#2)
the F3##3##2##(2008-12#3)
the FA##6##2##(2008-10#6)
the FAAS##2##2##(2008-10#2)
the FAD cofactor##2##3##(1990-12#1)(1992-1#1)
the FAD##3##2##(1990-12#1)(1990-7#1)(1992-1#1)
the FAM##2##2##(1990-2#1)(2008-10#1)
the FAME##2##2##(2008-10#1)(2009-8#1)
the FAS and CTLA-4 genes##2##5##(2009-8#2)
the FAS##3##2##(2009-8#2)(2009-9#1)
the FB##3##2##(2007-8#1)(2012-2#2)
the FBR##3##2##(2008-6#1)(2009-11#2)
the FC##2##2##(2008-3#1)(2013-1#1)
the FCO##3##2##(2008-7#3)
the FCU##3##2##(2013-7#3)
the FD data are##2##4##(2008-3#2)
the FD##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
the FDA for##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
the FDA issued##2##3##(2008-9#1)(2013-8#1)
the FDA##20##2##(1994-2#1)(1997-4#1)(2007-10#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-9#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
the FDA's warning##2##3##(2013-8#2)
the FDA's##4##2##(1997-5#1)(2008-5#1)(2013-8#2)
the FDPM##3##2##(2008-3#3)
the FDTD method is##2##4##(2008-3#2)
the FDTD method##3##3##(2008-3#3)
the FDTD##8##2##(2007-11#1)(2008-3#7)
the FED##2##2##(1996-12#2)
the FFA##3##2##(2007-8#1)(2008-12#1)(2013-8#1)
the FFT##2##2##(2008-10#1)(2008-3#1)
the FGF-2##2##2##(1996-12#1)(1997-4#1)
the FHB##2##2##(2008-10#2)
the FI system##5##3##(2008-10#5)
the FI##10##2##(2008-10#10)
the FIA method##2##3##(2008-10#2)
the FIA system and##3##4##(2008-10#3)
the FIA system##8##3##(2008-10#8)
the FIA##18##2##(1995-3#1)(2008-10#17)
the FIE##2##2##(2007-8#2)
the FISH technique##2##3##(2008-11#1)(2010-12#1)
the FISH##4##2##(1996-8#1)(2008-11#1)(2008-9#1)(2010-12#1)
the FKNMS by##2##3##(2007-5#2)
the FKNMS##4##2##(2007-5#4)
the FKRP gene##2##3##(2008-7#2)
the FLACC##3##2##(2012-2#3)
the FLAIR model##2##3##(2008-10#2)
the FLC##2##2##(2008-2#2)
the FLIPR##3##2##(2008-10#3)
the FLO5 gene##2##3##(1995-6#2)
the FMN##2##2##(1992-12#1)(1994-8#1)
the FMS##2##2##(2011-2#2)
the FOAD-hypothesis##3##2##(2013-1#3)
the FOCS##2##2##(2008-3#2)
the FOITS##3##2##(2008-5#3)
the FOV##2##2##(2008-3#2)
the FP##2##2##(2008-3#1)(2009-2#1)
the FPI transmission comb##2##4##(2008-3#2)
the FPI##4##2##(2008-2#1)(2008-3#3)
the FPI's free spectral range##2##5##(2008-3#2)
the FRET efficiency##2##3##(2009-8#2)
the FRET##5##2##(2008-4#1)(2008-9#1)(2009-8#2)(2009-9#1)
the FROG##2##2##(2008-3#2)
the FRS##3##2##(2011-1#3)
the FRT##3##2##(2007-11#1)(2008-2#2)
the FS##5##2##(1991-12#2)(2011-2#3)
the FSH receptor##2##3##(1995-11#1)(2010-8#1)
the FSMD##3##2##(2008-10#3)
the FT##4##2##(1991-11#2)(2008-7#1)(2012-2#1)
the FT-IR spectra of##2##4##(2007-12#1)(2008-10#1)
the FT-IR spectra##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
the FT-IR##6##2##(2007-12#1)(2008-10#4)(2008-5#1)
the FT-Raman##2##2##(1996-2#1)(2008-10#1)
the FTIR spectra##4##3##(2008-10#3)(2013-8#1)
the FTIR##9##2##(2008-10#7)(2008-3#1)(2013-8#1)
the FY##2##2##(1992-12#1)(1994-1#1)
the Fab and exhibited a rotational correlation time (theta##2##9##(1995-5#2)
the Fab with##2##3##(1995-5#2)
the Fab##7##2##(1993-6#1)(1995-5#6)
the Fabry-Perot interferometer##3##3##(2008-2#1)(2008-3#2)
the Fabry-Perot##12##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#5)(2013-8#2)
the Face##2##2##(2010-1#2)
the Factor##2##2##(2008-5#1)(2012-12#1)
the Facts##2##2##(2007-2#1)(2010-10#1)
the Faculty of Medicine##4##4##(1994-2#1)(2009-7#1)(2010-1#1)(2010-8#1)
the Faculty of##8##3##(1994-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)
the Fair##2##2##(1995-12#1)(1997-5#1)
the False##2##2##(2007-7#1)(2008-11#1)
the Family Health##3##3##(2008-9#2)(2011-2#1)
the Family##13##2##(1994-3#1)(1997-6#1)(2008-10#4)(2008-9#3)(2009-12#1)(2011-2#2)(2013-8#1)
the Fanconi Syndrome##2##3##(2008-1#2)
the Fano factor can##2##4##(2010-10#2)
the Fano factor##3##3##(2010-10#3)
the Far East##2##3##(2008-5#1)(2010-8#1)
the Far##3##2##(2008-3#1)(2008-5#1)(2010-8#1)
the Faraday##5##2##(1993-5#1)(2007-12#2)(2008-3#2)
the Faroe##2##2##(1996-6#1)(2011-4#1)
the Fast##2##2##(2007-9#1)(2009-12#1)
the Fc portion of##3##4##(1990-12#1)(2008-4#2)
the Fc##8##2##(1990-12#3)(2008-11#2)(2008-4#2)(2009-2#1)
the Fc-binding##2##2##(1997-4#1)(2008-10#1)
the FcepsilonRI##2##2##(2008-11#2)
the Fd##3##2##(1992-12#1)(1993-6#2)
the Fe##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)
the Fe(II)##3##2##(1991-8#1)(2008-10#2)
the Fe(III)##3##2##(1997-7#1)(2008-10#2)
the Feature##2##2##(2008-2#1)(2010-8#1)
the Federal Government through##2##4##(1995-3#1)(1996-1#1)
the Federal Government##7##3##(1995-3#1)(1996-1#2)(1997-2#1)(2008-11#1)(2008-6#2)
the Federal Republic of Germany##6##5##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#2)(1995-1#1)
the Federal Republic of##7##4##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#2)(1995-1#1)
the Federal Republic##8##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#3)(1995-1#1)
the Federal Trade Commission##2##4##(1993-1#2)
the Federal University of##3##4##(1993-6#1)(2011-2#1)(2013-8#1)
the Federal government##2##3##(1995-12#1)(1997-5#1)
the Federal##34##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#4)(1993-1#2)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#2)(1997-2#2)(1997-5#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Feiring##2##2##(1994-11#2)
the Feldenkrais method##2##3##(2010-6#2)
the Fellowship##2##2##(1996-1#1)(1996-12#1)
the Fenton reaction##2##3##(2008-10#1)(2008-5#1)
the Fermi level##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the Fermi##7##2##(2008-10#3)(2008-3#1)(2008-7#2)(2011-1#1)
the Fertile Crescent##3##3##(2008-10#3)
the Field##4##2##(2008-10#2)(2009-11#1)(2011-2#1)
the Fifth##2##2##(2008-2#1)(2010-12#1)
the Fiji Islands##2##3##(2008-1#2)
the Fiji School of##2##4##(2008-1#2)
the Fiji##8##2##(2008-1#7)(2012-12#1)
the Final Rule##2##3##(2009-4#2)
the Finnish##3##2##(1991-8#1)(1996-3#1)(2007-7#1)
the Fire##2##2##(1993-12#1)(2008-10#1)
the First Dental Home##2##4##(2011-2#2)
the First Department of##2##4##(2007-8#1)(2008-7#1)
the First World War##4##4##(2008-10#2)(2009-7#1)(2011-4#1)
the First##21##2##(1994-11#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-2#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#2)(2011-4#1)(2013-1#1)
the Firth of Vistula##2##4##(2008-11#2)
the Fisher##4##2##(2008-3#1)(2008-6#1)(2009-8#1)(2013-7#1)
the Flo##2##2##(2011-2#2)
the Florence District##2##3##(1992-10#1)(1992-2#1)
the Florence##3##2##(1992-10#2)(1992-2#1)
the Florida Keys National Marine Sanctuary##2##6##(2007-5#2)
the Florida Keys##6##3##(2007-5#6)
the Florida##12##2##(1996-2#1)(2007-5#6)(2008-10#3)(2008-12#1)(2008-2#1)
the Flu-6plx PCR##2##3##(2011-2#2)
the Flu-6plx##3##2##(2011-2#3)
the Fny-CMV##2##2##(2008-10#2)
the Food and Drug Administration (FDA)##6##6##(1996-5#2)(1997-5#1)(2008-12#1)(2008-5#1)(2008-8#1)
the Food and Drug Administration and the##2##7##(2008-7#1)(2010-6#1)
the Food and Drug Administration and##3##6##(1994-1#1)(2008-7#1)(2010-6#1)
the Food and Drug Administration to##2##6##(2008-7#1)(2008-8#1)
the Food and Drug Administration##15##5##(1994-1#1)(1996-5#2)(1997-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
the Food and##16##3##(1994-1#1)(1996-5#2)(1997-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
the Food##22##2##(1991-2#1)(1994-1#1)(1996-5#2)(1997-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-4#2)(2010-6#1)(2010-9#1)(2012-2#2)(2013-1#1)
the Formation of##2##3##(2008-10#2)
the Formosan subterranean termite##2##4##(2009-5#1)(2011-2#1)
the Forum##2##2##(2010-11#2)
the Foster/CIho 4780##3##3##(2008-10#3)
the Foster/CIho##4##2##(2008-10#4)
the Foundation##3##2##(1994-3#1)(2008-10#1)(2009-3#1)
the Fourier plane##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
the Fourier spectrum of##2##4##(2007-12#1)(2008-3#1)
the Fourier spectrum##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the Fourier transform of##2##4##(2008-3#2)
the Fourier transform##8##3##(1991-5#1)(2008-2#2)(2008-3#5)
the Fourier##43##2##(1991-5#1)(2007-11#7)(2007-12#2)(2008-1#1)(2008-2#8)(2008-3#24)
the Fourier-transform method##2##3##(2008-3#2)
the Fourier-transform##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
the Fourth Paradigm##2##3##(1994-11#2)
the Fourth Scope of Work##2##5##(1993-2#2)
the Fourth##9##2##(1993-2#2)(1994-11#2)(1995-6#2)(1997-6#1)(2008-11#1)(2008-5#1)
the Framingham##6##2##(1993-3#1)(2007-10#1)(2008-1#2)(2009-12#1)(2011-1#1)
the Franz-Keldysh effect##2##3##(2008-2#2)
the Fraunhofer##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the Free State province##2##4##(2012-12#2)
the Free State##3##3##(2012-12#3)
the Free##4##2##(2008-3#1)(2012-12#3)
the FreeStyle Navigator##2##3##(2009-9#2)
the Freedom##2##2##(1995-6#1)(2009-11#1)
the Frejka pillow is##2##4##(2007-8#2)
the Frejka pillow##4##3##(2007-8#4)
the French##24##2##(1990-8#3)(1991-9#1)(1994-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-9#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the Fresnel approximation is no longer valid##2##7##(2008-2#1)(2008-3#1)
the Fresnel approximation##5##3##(2008-2#1)(2008-3#4)
the Fresnel diffraction##7##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
the Fresnel number is##2##4##(2008-3#2)
the Fresnel##25##2##(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#13)
the Fresnel-Kirchhoff diffraction theory##2##4##(2008-3#2)
the Fresnel-Kirchhoff integral##3##3##(2008-2#2)(2008-3#1)
the Fresnel-Kirchhoff##6##2##(2008-2#3)(2008-3#3)
the Freundlich##3##2##(2008-10#2)(2013-1#1)
the FsphDNase##2##2##(2008-10#2)
the Fukushima##4##2##(2012-2#3)(2013-1#1)
the Functional Assessment of Cancer##3##5##(2008-7#2)(2009-11#1)
the Functional##7##2##(1993-1#1)(2008-7#3)(2009-11#1)(2011-2#2)
the Fund for##2##3##(1997-3#1)(2008-11#1)
the Fungus##4##2##(2008-10#4)
the Fusarium oxysporum##3##3##(2008-10#3)
the Fusarium redolens-F##2##3##(2008-10#2)
the Fusarium##10##2##(1995-2#1)(2008-10#9)
the Future Search##3##3##(1996-3#3)
the Future of##2##3##(1996-2#1)(2008-10#1)
the Future##10##2##(1994-12#2)(1996-2#1)(1996-3#3)(2008-10#2)(2010-7#1)(2013-1#1)
the G bead##2##3##(2008-6#2)
the G beta gamma dimer##2##5##(1993-9#2)
the G beta##3##3##(1993-9#2)(1995-8#1)
the G line of the HiPco composite (1% mass fraction)##2##10##(2008-10#2)
the G protein##2##3##(1993-8#1)(1997-3#1)
the G protein-coupled##2##3##(1994-12#1)(2009-7#1)
the G##25##2##(1990-6#1)(1993-1#1)(1993-11#2)(1993-8#1)(1993-9#4)(1994-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-6#2)(2009-7#1)
the G(1)##2##2##(2008-11#2)
the G+C##2##2##(1997-4#1)(2008-8#1)
the G-R##2##2##(1996-4#2)
the G-protein##6##2##(1991-5#1)(1993-6#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-7#1)
the G1 phase of##2##4##(1993-3#1)(1994-3#1)
the G1 phase##7##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(2008-11#2)(2009-8#1)
the G1##13##2##(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1997-7#1)(2008-11#5)(2009-8#1)(2012-3#1)
the G1-phase##4##2##(1997-1#1)(2008-11#1)(2008-7#1)(2012-3#1)
the G1-to-S transition##2##3##(1994-3#2)
the G1-to-S##3##2##(1991-5#1)(1994-3#2)
the G1/S boundary##2##3##(1997-1#2)
the G2##2##2##(2008-10#1)(2013-1#1)
the G212V##2##2##(1995-2#2)
the GA##7##2##(1993-12#4)(2008-10#2)(2009-8#1)
the GAB mutant##2##3##(2008-10#2)
the GAB##5##2##(2008-10#3)(2010-4#2)
the GABA##4##2##(1992-3#1)(1995-11#1)(1996-12#1)(1997-2#1)
the GABAA##4##2##(1990-5#1)(1992-3#1)(1995-11#2)
the GABAB antagonist##2##3##(1992-3#1)(1993-12#1)
the GABAB##3##2##(1992-3#1)(1993-12#2)
the GAC mutant##2##3##(2008-10#2)
the GAL##3##2##(1990-5#1)(1995-2#1)(1997-3#1)
the GAP1 gene##2##3##(1990-5#2)
the GAP1##4##2##(1990-5#4)
the GARP model##2##3##(2008-8#2)
the GARP##3##2##(2008-8#3)
the GATA-a motif##2##3##(2012-2#2)
the GAW17 data##2##3##(2012-3#2)
the GB##4##2##(2008-10#3)(2009-12#1)
the GC electrode##2##3##(2008-10#2)
the GC rich region##2##4##(1993-3#2)
the GC##13##2##(1993-3#2)(1997-2#1)(2008-10#9)(2008-7#1)
the GC-HRMS##6##2##(2008-10#6)
the GC-MS##2##2##(2008-10#2)
the GC/MS##3##2##(2008-10#3)
the GCAP##2##2##(1992-3#2)
the GCS##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
the GDC##2##2##(1997-6#2)
the GDI##2##2##(2013-1#2)
the GDS##2##2##(2006-10#2)
the GEPR##2##2##(1996-12#2)
the GEPR-3##2##2##(1996-12#2)
the GFAP gene and##2##4##(2011-2#2)
the GFAP##3##2##(1997-2#1)(2011-2#2)
the GFD##2##2##(2011-2#2)
the GFP##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
the GG##2##2##(2008-10#1)(2011-1#1)
the GGP1##2##2##(1996-3#2)
the GH receptor##4##3##(1995-8#1)(1996-2#1)(2008-1#2)
the GH secretagogue##2##3##(2007-7#1)(2010-5#1)
the GH##11##2##(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(2007-7#1)(2008-1#2)(2008-7#2)(2010-5#1)(2011-1#1)
the GHR1##4##2##(1995-8#4)
the GI tract##4##3##(2009-8#1)(2012-1#3)
the GI##7##2##(2008-1#2)(2008-10#1)(2009-8#1)(2012-1#3)
the GINA##2##2##(2010-5#2)
the GIT is##2##3##(2012-2#1)(2013-1#1)
the GK##2##2##(2008-1#1)(2008-8#1)
the GLF##2##2##(1996-7#2)
the GLM##2##2##(2008-10#2)
the GLU and PWB##2##4##(2010-8#2)
the GLUT1 isoform##2##3##(1993-6#2)
the GLUT1##3##2##(1993-6#3)
the GM varieties##2##3##(2011-2#2)
the GM variety in##2##4##(2011-2#2)
the GM##9##2##(2008-8#1)(2009-7#2)(2011-2#6)
the GMM##3##2##(2012-3#3)
the GNRs##2##2##(2012-12#2)
the GO##5##2##(2008-7#1)(2008-9#2)(2010-1#1)(2012-2#1)
the GP sensilla##3##3##(2007-12#3)
the GP##10##2##(1990-6#1)(1990-9#1)(1993-12#1)(1997-4#1)(2007-12#3)(2008-11#1)(2008-7#1)(2008-8#1)
the GP's##3##2##(1997-4#2)(2011-1#1)
the GPDCM##2##2##(2008-2#2)
the GPIIIa##4##2##(2006-6#4)
the GPO##2##2##(2007-9#1)(2008-10#1)
the GPRD##2##2##(2008-11#2)
the GPU##3##2##(2011-1#2)(2013-8#1)
the GRAV CP sequence##2##4##(2008-10#2)
the GRAV CP##3##3##(2008-10#3)
the GRAV##4##2##(2008-10#4)
the GRNN##2##2##(2008-10#2)
the GROC and had a##2##5##(2008-12#2)
the GROC and##3##3##(2008-12#3)
the GS gene amplification system##2##5##(2008-11#2)
the GS##4##2##(1993-12#1)(2008-11#2)(2008-2#1)
the GSC and its##2##4##(2011-2#2)
the GSC##3##2##(2011-2#3)
the GSEM##2##2##(2008-10#2)
the GSH levels##2##3##(1990-2#1)(2013-1#1)
the GSH##4##2##(1990-2#2)(2011-1#1)(2013-1#1)
the GST##8##2##(1990-2#1)(1994-2#1)(1995-6#1)(1997-7#2)(2007-10#1)(2009-11#2)
the GTH-II##3##2##(2008-5#3)
the GTP-binding##2##2##(1991-12#1)(1993-9#1)
the GTPase activity of the##5##5##(1992-11#5)
the GTPase activity of##6##4##(1992-11#6)
the GTPase##8##2##(1992-11#6)(1992-8#1)(1995-2#1)
the GTV##3##2##(2008-2#3)
the GUM##2##2##(2008-10#2)
the GUS gene##3##3##(1997-2#3)
the GUS##4##2##(1997-2#3)(2008-10#1)
the GVD of##2##3##(2008-3#2)
the GaAs surface##2##3##(2009-11#1)(2009-6#1)
the GaAs##8##2##(2008-2#3)(2008-3#1)(2009-11#2)(2009-6#2)
the Gait Deviation Index##2##4##(2013-1#2)
the Gait##3##2##(2013-1#2)(2013-7#1)
the Galician##2##2##(2008-10#2)
the Gamma Knife##2##3##(1997-4#2)
the Gamma nail##2##3##(2007-8#2)
the Gamma##5##2##(1996-3#1)(1997-4#2)(2007-8#2)
the Garden##2##2##(2007-11#1)(2008-1#1)
the Gaussian beam TL##2##4##(2008-3#2)
the Gaussian beam##5##3##(2008-2#1)(2008-3#4)
the Gaussian##20##2##(2008-10#1)(2008-2#8)(2008-3#11)
the Gazeta Medica da##2##4##(2009-10#2)
the Gazeta##4##2##(2009-10#4)
the Gcm pathway##2##3##(2008-7#2)
the Gd-BOPTA##2##2##(2008-7#2)
the Gel'fand-Graev##2##2##(2012-1#2)
the GenBank##5##2##(1994-12#1)(1994-8#1)(2008-7#1)(2009-2#1)(2011-1#1)
the GenMark##2##2##(1995-12#2)
the Gene Ontology Consortium##2##4##(2008-7#2)
the Gene Ontology##10##3##(2008-7#6)(2008-9#2)(2011-2#1)(2013-1#1)
the Gene##12##2##(2008-4#1)(2008-7#6)(2008-9#3)(2011-2#1)(2013-1#1)
the GeneMark##2##2##(1996-6#1)(2008-4#1)
the General Health Questionnaire##4##4##(2008-1#2)(2008-11#1)(2008-3#1)
the General Health##5##3##(1994-3#1)(2008-1#2)(2008-11#1)(2008-3#1)
the General Life Functioning##2##4##(1996-7#2)
the General Practice##2##3##(2008-11#1)(2008-3#1)
the General##15##2##(1991-1#1)(1992-5#1)(1994-3#1)(1996-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#2)(2012-2#2)
the Generation##3##2##(2008-10#2)(2010-10#1)
the Genetic Analysis Workshop 17 data##3##6##(2012-3#3)
the Genetic Analysis Workshop 17##8##5##(2012-3#8)
the Genetic Diversity of##2##4##(2008-10#2)
the Genetic##12##2##(2008-10#3)(2009-5#1)(2012-3#8)
the Genome##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
the Genomic Standards Consortium##2##4##(2011-2#2)
the Genomic##43##2##(2008-10#1)(2011-2#42)
the Genus##5##2##(2008-10#4)(2010-2#1)
the Georgia system##3##3##(1996-12#3)
the Georgia##4##2##(1996-12#3)(2010-12#1)
the Gerbich##2##2##(1992-6#2)
the Geriatric Depression Scale (GDS)##2##5##(2006-10#2)
the Geriatric Depression Scale##5##4##(2006-10#2)(2007-10#2)(2008-7#1)
the Geriatric##6##2##(2006-10#2)(2007-10#2)(2008-7#2)
the German Health##3##3##(1994-6#1)(2009-7#1)(2012-2#1)
the German Institute##2##3##(2011-2#1)(2012-2#1)
the German cockroach##2##3##(2011-2#2)
the German##26##2##(1990-11#1)(1990-6#1)(1994-6#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#4)(2011-2#5)(2012-2#5)(2013-1#1)
the Gi##2##2##(2008-4#2)
the Gibberella##2##2##(1995-2#1)(2008-10#1)
the Gibbs sampler##2##3##(1994-9#1)(1997-7#1)
the Gibbs##8##2##(1994-9#1)(1997-2#2)(1997-7#1)(2008-10#2)(2008-4#1)(2011-2#1)
the Gibbs-Donnan model##2##3##(2008-10#2)
the Gla##2##2##(1995-2#1)(1995-6#1)
the Glasgow Coma Scale##2##4##(2007-10#1)(2011-2#1)
the Glasgow##3##2##(2007-10#1)(2011-2#1)(2012-3#1)
the Global Ozone Monitoring by Occultation of Stars (GOMOS)##2##9##(2008-3#2)
the Global Ozone Monitoring##3##4##(2008-3#3)
the Global##18##2##(1991-2#1)(1994-6#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)
the Glu and##2##3##(1991-5#1)(1992-3#1)
the Glu##5##2##(1991-5#1)(1992-11#1)(1992-3#2)(1993-12#1)
the Glu-50--&gt##7##2##(1995-6#7)
the Gly##2##2##(1992-6#1)(2008-5#1)
the GnRH##2##2##(1995-11#1)(1996-2#1)
the Golden##3##2##(1992-10#1)(2009-6#1)(2012-2#1)
the Golgi apparatus is##2##4##(2009-2#1)(2012-2#1)
the Golgi apparatus##16##3##(1990-5#1)(1990-7#4)(1992-12#1)(1993-12#1)(1995-5#1)(1997-7#2)(2008-11#3)(2009-2#1)(2011-1#1)(2012-2#1)
the Golgi is##3##3##(2009-2#3)
the Golgi##44##2##(1990-5#1)(1990-7#4)(1992-12#4)(1993-12#2)(1993-6#1)(1994-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(1997-7#2)(2008-11#6)(2008-7#4)(2008-8#1)(2009-2#6)(2009-8#2)(2010-12#1)(2011-1#1)(2012-2#3)
the Gompertz model##6##3##(2008-10#5)(2008-9#1)
the Gompertz##10##2##(1993-12#1)(2008-1#2)(2008-10#6)(2008-9#1)
the Goos-Hänchen##3##2##(2007-11#3)
the Gouy phase shift##2##4##(2007-11#2)
the Gouy##3##2##(2007-11#2)(2007-12#1)
the Government##7##2##(1992-9#1)(1995-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
the Graham##2##2##(1997-3#1)(2008-9#1)
the Grain##2##2##(2008-12#2)
the Gram stain##2##3##(2008-9#2)
the Gram##4##2##(2008-9#2)(2010-12#1)(2012-2#1)
the Gram-negative##2##2##(1997-8#1)(2007-7#1)
the Gray##2##2##(2008-10#1)(2008-7#1)
the Great East Japan Earthquake##2##5##(2012-2#1)(2013-8#1)
the Great Plains##6##3##(2008-10#6)
the Great##16##2##(2008-10#7)(2008-5#1)(2009-7#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
the Greater##7##2##(1993-9#1)(1995-2#2)(2007-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
the Greek##3##2##(2009-1#1)(2010-2#1)(2011-2#1)
the Green##4##2##(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#1)
the Green's function##5##3##(2008-3#4)(2011-1#1)
the Green's##6##2##(2008-10#1)(2008-3#4)(2011-1#1)
the Greenhouse##2##2##(1992-3#1)(2008-10#1)
the Greenwood frequency##2##3##(2008-2#2)
the Gross##2##2##(2010-6#1)(2011-2#1)
the Group##6##2##(1997-7#1)(2008-10#1)(2008-11#2)(2013-1#2)
the Groups##3##2##(1993-6#3)
the Grubbs reagent##2##3##(2007-11#2)
the Guglielmi##2##2##(1996-9#1)(2008-7#1)
the Guidelines##2##2##(2008-7#1)(2011-2#1)
the Gulf of California##3##4##(2008-5#2)(2009-2#1)
the Gulf of Gdańsk##2##4##(2008-11#2)
the Gulf of Paria##3##4##(2007-5#3)
the Gulf of##17##3##(2007-5#3)(2008-11#2)(2008-5#5)(2009-2#1)(2011-2#2)(2013-7#4)
the Gulf##22##2##(1997-4#2)(2007-5#3)(2008-11#2)(2008-5#5)(2009-2#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-7#4)
the Gus##3##2##(1993-8#3)
the Gushov-Solodkin algorithm##2##3##(2008-3#2)
the Gutenberg-Richter##2##2##(1996-4#2)
the Guttmacher Institute##2##3##(2013-1#2)
the Guyon's canal and##2##4##(1992-6#1)(2008-9#1)
the Guyon's canal##4##3##(1992-6#1)(2008-9#3)
the H and##2##3##(2008-11#1)(2011-2#1)
the H group##4##3##(2011-2#4)
the H##23##2##(1994-8#2)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#3)(2008-5#1)(2011-2#7)
the H(+)##2##2##(2008-10#1)(2008-8#1)
the H(+)-ATPase from##2##3##(1995-2#2)
the H(+)-ATPase##3##2##(1992-6#1)(1995-2#2)
the H(2)##2##2##(1996-2#1)(2011-2#1)
the H(2)O##3##2##(2008-2#1)(2008-3#2)
the H(2)O(2) generated##2##3##(2008-10#2)
the H(2)O(2)##7##2##(2008-10#7)
the H+ gradient##2##3##(1990-11#1)(1994-6#1)
the H+##5##2##(1990-11#1)(1994-11#1)(1994-6#2)(1997-8#1)
the H+L*##2##2##(2013-8#2)
the H-2##2##2##(1992-8#1)(2008-5#1)
the H-Wave(R) device is##2##4##(2010-1#2)
the H-Wave(R) device##7##3##(2010-1#7)
the H-bond##2##2##(1992-10#1)(2008-10#1)
the H-bonding##2##2##(1993-11#2)
the H-phosphonate##2##2##(2008-4#2)
the H-point and generalised H-point standard##2##6##(2008-10#2)
the H-point standard addition method##6##5##(2008-10#6)
the H-point standard##7##3##(2008-10#7)
the H-point##9##2##(2008-10#9)
the H-reflex##5##2##(1993-12#3)(2013-1#2)
the H-type##2##2##(2008-10#2)
the H1 receptor and##2##4##(1992-11#2)
the H1 receptor##3##3##(1992-11#3)
the H1##7##2##(1992-11#3)(1992-9#2)(1993-6#2)
the H1-H2 domain##2##3##(2013-1#2)
the H2 receptor##2##3##(1991-9#1)(1994-2#1)
the H2##4##2##(1990-12#1)(1991-9#1)(1992-9#1)(1994-2#1)
the HA and##3##3##(1993-12#1)(2007-8#1)(2008-5#1)
the HA molecular weights##2##4##(2008-5#2)
the HA samples##2##3##(2008-10#1)(2013-8#1)
the HA##18##2##(1992-9#1)(1993-12#2)(1996-12#1)(2007-8#1)(2008-10#3)(2008-5#4)(2010-8#1)(2011-2#4)(2013-8#1)
the HA1##5##2##(1994-8#3)(1997-6#2)
the HAART era##2##3##(2007-12#1)(2008-3#1)
the HAART##3##2##(2007-12#1)(2008-3#2)
the HAD##2##2##(2009-10#1)(2011-1#1)
the HAP##2##2##(2008-7#2)
the HB group##2##3##(2011-2#2)
the HB##3##2##(2011-2#3)
the HB-EGF##2##2##(2013-8#2)
the HBV core##2##3##(1997-4#1)(2008-8#1)
the HBV##9##2##(1997-4#3)(2008-10#1)(2008-8#2)(2008-9#1)(2009-3#1)(2013-1#1)
the HBX protein##4##3##(2008-8#4)
the HC##5##2##(1991-12#1)(2008-10#4)
the HC-Pro##4##2##(2008-10#3)(2008-9#1)
the HCP##3##2##(2008-10#3)
the HCV core##2##3##(1994-8#2)
the HCV##9##2##(1994-8#2)(2007-7#1)(2008-1#1)(2008-8#3)(2012-2#1)(2013-1#1)
the HCl##3##2##(2008-10#3)
the HD region##2##3##(1996-8#2)
the HD sessions##4##3##(2008-1#4)
the HD##12##2##(1996-8#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-3#2)
the HDL-C##2##2##(2013-1#2)
the HERG gene##2##3##(1996-2#1)(2010-8#1)
the HERG##4##2##(1996-2#2)(2008-8#1)(2010-8#1)
the HEV71 strains##3##3##(2013-8#3)
the HF + HClO(4) digestion##2##5##(2008-10#2)
the HF##3##2##(2007-11#1)(2008-10#2)
the HFD test##3##3##(2008-7#3)
the HG##2##2##(2008-10#2)
the HGDP-CEPH##2##2##(2012-3#2)
the HI group##5##3##(1996-5#5)
the HI##7##2##(1992-9#1)(1996-12#1)(1996-5#5)
the HIC1##2##2##(2009-8#2)
the HII phase##3##3##(1990-12#3)
the HII##4##2##(1990-12#4)
the HIP##2##2##(1995-12#1)(1997-3#1)
the HIS Knowledge Hub##2##4##(2012-12#2)
the HIS##5##2##(1993-12#1)(2007-10#1)(2012-12#3)
the HITRAN database##2##3##(2008-2#1)(2008-3#1)
the HITRAN##4##2##(2008-2#3)(2008-3#1)
the HIV epidemic##14##3##(1990-12#1)(1990-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-3#1)(2009-7#1)(2010-5#3)(2011-2#1)
the HIV virus##3##3##(2007-2#1)(2012-2#2)
the HIV##40##2##(1990-12#1)(1990-6#1)(1991-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-5#2)(1997-3#2)(1997-5#1)(1997-6#1)(2007-2#1)(2008-4#3)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#3)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
the HIV-1 antigen test##2##4##(1994-2#2)
the HIV-1##21##2##(1990-8#2)(1992-12#1)(1994-2#3)(1994-8#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2011-2#1)(2011-3#3)(2013-1#4)
the HIV-positive##2##2##(1992-12#1)(1996-5#1)
the HIV/AIDS##4##2##(1994-2#1)(1996-2#1)(2007-7#1)(2011-2#1)
the HL##2##2##(1992-12#1)(2012-2#1)
the HLA##5##2##(1991-11#1)(1997-5#1)(2008-1#1)(2008-10#1)(2011-2#1)
the HLA-DR##2##2##(1991-2#1)(1997-9#1)
the HLH##2##2##(2008-8#1)(2011-2#1)
the HMG##4##2##(1993-2#1)(1995-8#1)(2008-8#2)
the HMG-CoA reductase inhibitor Pravastatin##2##5##(1991-12#2)
the HMG2 gene##4##3##(1995-2#4)
the HMGCoA reductase##2##3##(1991-6#2)
the HMO industry##2##3##(1991-3#2)
the HMO##13##2##(1991-1#2)(1991-3#3)(1993-3#2)(1994-12#1)(1996-2#3)(1997-1#1)(1997-3#1)
the HMOs##2##2##(1991-3#1)(1993-12#1)
the HMPS pathway##2##3##(1993-3#2)
the HN##3##2##(2007-6#1)(2008-11#1)(2008-9#1)
the HNDB and##2##3##(1994-3#2)
the HNDB##3##2##(1994-3#3)
the HOE's##3##2##(2008-2#3)
the HOOK domain##2##3##(2008-8#2)
the HOOK##3##2##(2008-8#3)
the HOOK-domain##4##2##(2008-8#4)
the HOS##2##2##(2008-3#2)
the HOX##2##2##(1993-9#1)(2007-12#1)
the HP##3##2##(1990-5#1)(1996-5#1)(2008-10#1)
the HPA axis and##2##4##(1990-3#1)(2008-4#1)
the HPA axis##6##3##(1990-3#1)(1994-2#2)(1995-12#1)(2008-4#2)
the HPAEC-PAD##2##2##(1995-2#2)
the HPLC and##2##3##(1997-4#1)(2008-8#1)
the HPLC determination of##3##4##(2008-10#3)
the HPLC method was##2##4##(1990-8#1)(2008-10#1)
the HPLC method with##2##4##(2008-10#2)
the HPLC method##12##3##(1990-8#2)(2008-10#7)(2008-5#1)(2009-8#2)
the HPLC procedure##2##3##(1995-2#1)(2008-10#1)
the HPLC profiles of##2##4##(1990-8#1)(1992-3#1)
the HPLC separation##2##3##(2008-10#1)(2011-1#1)
the HPLC##36##2##(1990-8#7)(1992-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#19)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#2)(2011-1#1)
the HPLC-UV##2##2##(2008-10#2)
the HPSAM and GHPSAM##2##4##(2008-10#2)
the HPSAM##3##2##(2008-10#3)
the HPV##5##2##(1991-2#2)(2008-11#1)(2011-1#2)
the HR deceleration##2##3##(2013-8#2)
the HR in##2##3##(2008-10#2)
the HR##12##2##(1996-3#1)(2008-10#5)(2008-11#1)(2013-1#1)(2013-8#4)
the HRCT##2##2##(2011-2#1)(2012-2#1)
the HS concentration##2##3##(2008-10#2)
the HS##6##2##(2008-10#5)(2013-8#1)
the HS2core DNA sequence which##2##5##(2008-8#2)
the HS2core DNA sequence##3##4##(2008-8#3)
the HSA##2##2##(2008-10#1)(2008-4#1)
the HSA-hormone binding and##2##4##(2008-10#2)
the HSAD system is##2##4##(2008-6#2)
the HSAD system##4##3##(2008-6#4)
the HSCCC##2##2##(2008-10#1)(2011-1#1)
the HSE##3##2##(1991-9#1)(1994-8#1)(1995-5#1)
the HSGC##2##2##(2008-10#2)
the HSP##4##2##(1994-11#3)(2008-10#1)
the HSP70 gene##3##3##(1994-8#2)(2010-2#1)
the HSP70##5##2##(1994-8#2)(2008-10#2)(2010-2#1)
the HT plan##2##3##(2008-11#2)
the HTH##2##2##(1992-4#1)(2008-7#1)
the HTLV-1##2##2##(2012-12#2)
the HTLV-I protein p27rex##2##4##(1991-2#2)
the HTLV-I##3##2##(1991-12#1)(1991-2#2)
the HTS group##2##3##(2008-10#2)
the HUT11##2##2##(1995-6#2)
the HVTN##2##2##(2012-12#2)
the HYP and AMB##2##4##(1993-12#2)
the HaCaT##2##2##(1997-1#1)(2008-11#1)
the Hach##2##2##(2008-10#2)
the Hacinas monster##2##3##(2009-10#2)
the Hacinas##4##2##(2009-10#4)
the Hadamard##2##2##(2008-10#1)(2008-3#1)
the Haemophilus influenzae##3##3##(1995-5#1)(2008-11#1)(2008-7#1)
the Hagen's glands##2##3##(2007-12#2)
the Hagen's##3##2##(2007-12#3)
the Hall##5##2##(2008-10#2)(2013-1#3)
the Hamilton-Zuk hypothesis or the immunocompetence##2##6##(2008-8#2)
the Han##2##2##(2008-8#1)(2011-1#1)
the Hardy-Weinberg##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
the Harran##5##2##(2008-12#5)
the Hartmann test##3##3##(2008-3#3)
the Hartmann##4##2##(2008-10#1)(2008-3#3)
the Harvard Medical##2##3##(1992-1#1)(1993-3#1)
the Harvard##5##2##(1990-11#1)(1992-1#1)(1993-3#1)(2008-1#1)(2010-5#1)
the Haversian canals##3##3##(1995-6#2)(2013-1#1)
the Haversian##5##2##(1995-6#2)(2013-1#3)
the Hawaii##2##2##(1995-1#1)(2007-10#1)
the Hawaiian##3##2##(1996-6#1)(2008-3#1)(2008-8#1)
the Hazard##2##2##(1993-3#1)(1996-12#1)
the Hb##2##2##(1991-2#1)(2011-2#1)
the HbO-HA ELISA##2##3##(1990-12#2)
the Hct was##2##3##(1994-12#1)(1997-6#1)
the HeLa##3##2##(1992-3#1)(2008-11#2)
the Health Belief Model (HBM)##2##5##(2008-4#1)(2011-1#1)
the Health Care Financing Administration (HCFA) to##3##7##(1994-1#1)(1995-12#1)(1997-3#1)
the Health Care Financing Administration (HCFA)##11##6##(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)
the Health Care Financing Administration is##2##6##(1994-2#1)(1997-3#1)
the Health Care Financing Administration##19##5##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#2)
the Health Care Financing Administration's##2##5##(1993-2#1)(1996-2#1)
the Health Care Financing##27##4##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#4)(1996-3#2)(1997-2#3)(1997-3#3)
the Health Care Quality Improvement Act##5##6##(1991-1#2)(1991-3#1)(1992-2#1)(1994-1#1)
the Health Care Quality Improvement##7##5##(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#1)
the Health Care Quality##8##4##(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#2)
the Health Care##40##3##(1991-1#3)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#2)(1993-2#2)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-2#6)(1996-3#3)(1997-2#3)(1997-3#3)(2008-11#1)(2013-8#1)
the Health Council##2##3##(1996-8#2)
the Health Insurance##2##3##(1994-2#1)(2007-12#1)
the Health Services##3##3##(1996-1#1)(1997-2#1)(2010-3#1)
the Health Utilities##2##3##(2007-10#2)
the Health and##6##3##(1993-11#1)(1994-1#1)(1995-6#2)(2008-10#1)(2011-2#1)
the Health##75##2##(1990-2#1)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#2)(1994-1#5)(1994-12#2)(1994-2#3)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#2)(1996-1#2)(1996-2#7)(1996-3#4)(1996-8#2)(1997-2#6)(1997-3#3)(2007-10#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the Healthcare##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
the Healthy##2##2##(1994-3#1)(1995-1#1)
the Heaney method##2##3##(1995-12#2)
the Heaney##3##2##(1995-12#3)
the Hebrew##2##2##(2008-4#1)(2009-11#1)
the Hebrides##2##2##(1996-6#2)
the Helsinki area##3##3##(1992-3#3)
the Helsinki##4##2##(1992-3#3)(2008-7#1)
the Henderson##2##2##(1994-3#1)(2008-10#1)
the HepG2 cell line##4##4##(1992-3#3)(2007-10#1)
the HepG2##6##2##(1992-3#3)(2007-10#3)
the Hepatitis B##2##3##(2008-10#1)(2008-11#1)
the Hermite##2##2##(2009-12#2)
the Hermite-Gaussian modes##2##3##(2007-12#2)
the Hertfordshire##2##2##(2008-11#1)(2012-12#1)
the Hessian##2##2##(2008-3#2)
the Hg electrode##4##3##(2008-10#4)
the Hg##8##2##(2007-11#1)(2008-10#7)
the Hg(2+)##2##2##(2008-10#2)
the Hg(II)##4##2##(2008-10#4)
the Hg(II)/HS ratio##2##3##(2008-10#2)
the HgI(2)##2##2##(2008-3#2)
the HiPco composite##3##3##(2008-10#3)
the HiPco##5##2##(2008-10#5)
the HiRIS##4##2##(2008-10#4)
the High Court##2##3##(1995-6#2)
the High Resolution##3##3##(2007-8#1)(2008-3#1)(2011-1#1)
the High Throughput Screening##2##4##(2009-6#2)
the High##12##2##(1992-12#1)(1995-6#2)(2007-8#1)(2008-11#1)(2008-3#2)(2009-6#2)(2009-8#1)(2011-1#1)(2012-7#1)
the High-Resolution##2##2##(2008-3#1)(2013-8#1)
the Higher##2##2##(1995-3#1)(2008-11#1)
the Hilbert transform##2##3##(2008-2#1)(2012-1#1)
the Hilbert##3##2##(2007-11#1)(2008-2#1)(2012-1#1)
the Hill coefficient##3##3##(1990-11#1)(1991-5#1)(1993-8#1)
the Hill##4##2##(1990-11#1)(1991-5#1)(1993-5#1)(1993-8#1)
the Himalayan##4##2##(2008-7#1)(2008-8#1)(2011-2#2)
the Hira##2##2##(2008-7#2)
the Hispanic##3##2##(2010-8#2)(2012-2#1)
the History of##3##3##(1994-2#1)(1995-12#1)(2013-1#1)
the Hitachi##2##2##(1990-8#1)(2008-10#1)
the Hoehn##2##2##(2008-7#1)(2013-8#1)
the Hofmeister##4##2##(2009-10#2)(2009-2#1)(2012-2#1)
the Home Health##2##3##(1994-2#1)(1995-3#1)
the Home##4##2##(1991-2#1)(1994-2#1)(1995-3#1)(2006-10#1)
the Hong Kong##4##3##(2008-8#1)(2010-2#1)(2011-1#1)(2012-6#1)
the Honiara##2##2##(2012-12#2)
the Hopfield##2##2##(2008-2#1)(2008-3#1)
the Hospital Anxiety and Depression Scale (HADS)##2##7##(2007-11#1)(2008-10#1)
the Hospital Medical Records Institute (HMRI)##2##6##(1993-12#1)(1994-3#1)
the Hospital for Special Surgery##3##5##(2008-8#2)(2009-3#1)
the Hospital for the Ruptured and Crippled##3##7##(2008-8#3)
the Hospital for##7##3##(2008-8#5)(2009-3#1)(2013-8#1)
the Hospital of##2##3##(1993-5#1)(2013-8#1)
the Hospital##20##2##(1990-9#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-8#6)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#2)
the Hospital's##2##2##(2008-11#1)(2008-12#1)
the Host##3##2##(2008-10#3)
the House version##3##3##(1995-6#3)
the House##9##2##(1995-12#1)(1995-6#5)(1996-5#1)(1997-2#1)(2008-11#1)
the Howard##2##2##(2008-9#1)(2013-1#1)
the Hox gene##3##3##(2007-12#1)(2008-1#2)
the Hox##5##2##(2007-12#2)(2008-1#3)
the HrcC protein##2##3##(2008-10#2)
the Hsp70##3##2##(1991-9#2)(2009-5#1)
the Hsp90##2##2##(2008-4#1)(2010-4#1)
the Hubble Space Telescope##4##4##(1990-11#1)(2008-2#2)(2008-3#1)
the Human Genome Project##3##4##(1994-9#1)(2007-3#1)(2008-7#1)
the Human Genome##5##3##(1994-9#2)(2007-3#1)(2008-4#1)(2008-7#1)
the Human Rights##2##3##(1996-5#1)(1997-5#1)
the Human##15##2##(1994-9#2)(1996-5#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
the Hunger##2##2##(2012-12#2)
the Hunter Region##4##3##(2007-10#4)
the Huntington's disease##4##3##(1996-8#2)(2011-2#1)(2012-2#1)
the Huntington's##5##2##(1995-9#1)(1996-8#2)(2011-2#1)(2012-2#1)
the HupBF3##2##2##(1990-11#2)
the Huygens-Fresnel principle##3##3##(2008-2#1)(2008-3#2)
the Hv-p68 gene##2##3##(2008-10#2)
the Hv-p68##3##2##(2008-10#3)
the Hydrogen Bond##2##3##(2008-10#1)(2009-10#1)
the Hydrogen##3##2##(1991-8#1)(2008-10#1)(2009-10#1)
the Hydrolight radiative transfer model##2##5##(2008-3#2)
the Hydrolight radiative transfer##3##4##(2008-3#3)
the Hydrolight##6##2##(2008-2#1)(2008-3#5)
the Hypersensitive Response##2##3##(2008-10#2)
the Hückel##2##2##(2008-10#2)
the I allele##2##3##(2008-10#2)
the I##12##2##(1992-2#1)(1995-8#1)(2008-10#5)(2010-4#1)(2011-1#1)(2011-2#3)
the I2##3##2##(2008-12#3)
the IA##2##2##(1992-8#1)(2010-3#1)
the IAHSS##4##2##(1992-12#2)(1993-2#1)(1997-2#1)
the IAI##3##2##(2008-12#3)
the IAR translates in the##2##5##(2012-2#2)
the IAR##4##2##(2012-2#4)
the IAT##4##2##(1994-9#4)
the IBG System##2##3##(1994-6#2)
the IBGE##2##2##(1991-9#2)
the IBM##4##2##(1996-12#1)(2008-8#1)(2012-3#2)
the IBV##4##2##(1997-6#4)
the IBZM##2##2##(1996-12#2)
the IC columns##2##3##(2008-10#2)
the IC##8##2##(2008-10#7)(2008-5#1)
the IC(50) values##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
the IC(50)##4##2##(2008-11#1)(2008-7#2)(2013-1#1)
the IC50##3##2##(1995-12#1)(1995-8#1)(1996-2#1)
the ICA##5##2##(1997-3#2)(2012-3#1)(2013-1#2)
the ICBI##2##2##(2007-11#2)
the ICEUs##3##2##(2008-7#3)
the ICF##4##2##(2011-2#3)(2012-12#1)
the ICH##4##2##(2008-10#3)(2010-11#1)
the ICP level##2##3##(2008-7#2)
the ICP##4##2##(2008-10#2)(2008-7#2)
the ICP-AES method##3##3##(2008-10#3)
the ICP-AES##4##2##(2008-10#4)
the ICP-MS determination##2##3##(2008-10#2)
the ICP-MS##9##2##(2008-10#9)
the ICPD##5##2##(1994-9#5)
the ICR##2##2##(2008-10#1)(2011-2#1)
the ICRP##3##2##(1996-6#1)(1997-8#1)(2013-1#1)
the ICU experience##2##3##(1992-2#1)(1995-12#1)
the ICU##23##2##(1991-2#3)(1992-2#5)(1995-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#3)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#3)(2013-8#1)
the ICs##4##2##(2008-8#4)
the ID50##3##2##(1991-12#1)(1992-2#1)(1995-3#1)
the IDA##2##2##(2008-10#1)(2008-2#1)
the IDH##4##2##(2008-9#4)
the IDO##2##2##(1992-11#2)
the IDP##2##2##(2008-7#2)
the IE1##2##2##(1993-8#2)
the IFCC##2##2##(1994-12#1)(2008-10#1)
the IFN-gamma inducible IDO##2##4##(2008-11#2)
the IFN-gamma secretion##2##3##(2008-10#1)(2008-11#1)
the IFN-gamma##7##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#4)
the IFSP process##2##3##(1991-12#2)
the IGF##2##2##(2008-5#1)(2010-3#1)
the IGF-1 receptor##2##3##(1994-11#1)(2010-11#1)
the IGF-1##3##2##(1994-11#2)(2010-11#1)
the IGF-I gene##2##3##(1992-9#1)(2008-11#1)
the IGF-I receptor and##2##4##(1993-9#1)(1996-2#1)
the IGF-I receptor##5##3##(1991-5#1)(1993-9#2)(1996-2#1)(2008-5#1)
the IGF-I##9##2##(1991-5#1)(1992-9#2)(1993-9#2)(1996-2#2)(2008-11#1)(2008-5#1)
the IGF-II##4##2##(1992-9#3)(2008-6#1)
the IGF-II/Man6P receptor##3##3##(1990-5#3)
the IGKC##2##2##(1997-8#2)
the IGS##2##2##(2008-10#2)
the IHA##6##2##(1992-5#6)
the IIB promoter##2##3##(1995-6#2)
the III##2##2##(2008-4#1)(2012-3#1)
the IL-1 beta##5##3##(1995-2#2)(1996-12#2)(2008-4#1)
the IL-1##7##2##(1995-2#3)(1996-12#2)(2007-11#1)(2008-4#1)
the IL-10##2##2##(1994-8#1)(2008-11#1)
the IL-12##2##2##(2008-8#2)
the IL-2##4##2##(1992-5#1)(1994-11#2)(2008-8#1)
the IL-3 receptor##2##3##(1990-12#1)(1993-12#1)
the IL-6##9##2##(1990-5#2)(1994-2#1)(1995-2#1)(1996-2#2)(2009-6#2)(2012-3#1)
the ILL algorithm##2##3##(2008-3#2)
the ILS in##3##3##(2008-10#2)(2008-3#1)
the ILS##6##2##(2008-10#4)(2008-3#2)
the IMA##2##2##(2007-8#1)(2009-10#1)
the IMC technique##2##3##(2008-3#2)
the IMC##3##2##(2008-3#3)
the IMI##2##2##(2013-1#2)
the IMMP##4##2##(2008-11#1)(2008-8#3)
the IMS##6##2##(2008-10#6)
the IMx##2##2##(1992-6#2)
the IN isolate##2##3##(2008-10#2)
the IN subtype##5##3##(2008-2#5)
the IN##9##2##(1995-12#1)(2008-10#3)(2008-2#5)
the INM##3##2##(2009-9#1)(2011-2#2)
the IOM##2##2##(2007-12#1)(2010-3#1)
the IOP##3##2##(2008-3#1)(2011-2#2)
the IOR effect##2##3##(2008-2#2)
the IP(L) condition##2##3##(2008-10#2)
the IPA##2##2##(1997-3#2)
the IPD##2##2##(2008-10#1)(2008-7#1)
the IPSF##2##2##(2008-11#2)
the IPTpd research##2##3##(2009-6#2)
the IR absorption##2##3##(2007-11#1)(2008-3#1)
the IR region##2##3##(2008-2#2)
the IR spectra##3##3##(2007-11#2)(2013-8#1)
the IR spectral##2##3##(2007-11#1)(2008-3#1)
the IR##26##2##(1992-6#1)(1994-11#1)(1996-2#1)(2007-11#4)(2007-12#3)(2008-10#4)(2008-2#4)(2008-3#4)(2008-7#3)(2013-8#1)
the IRB-RAT##3##2##(2009-4#3)
the IRMA##4##2##(1993-2#4)
the IRS##3##2##(1991-2#1)(1995-2#1)(2008-12#1)
the IS##3##2##(1993-3#1)(2008-10#2)
the IS1112 probe##2##3##(2008-10#2)
the ISE##3##2##(2008-10#3)
the ISO gene##3##3##(1990-11#3)
the ISO##8##2##(1990-11#3)(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)
the ISR assessment##2##3##(2010-11#2)
the ISSN##2##2##(2008-5#2)
the IT15##2##2##(1995-5#1)(1996-8#1)
the ITA##5##2##(2007-8#5)
the ITFDE##3##2##(1993-12#3)
the ITO##2##2##(2009-11#1)(2010-6#1)
the ITS 1##2##3##(2008-10#2)
the ITS region##10##3##(2008-10#8)(2009-2#1)(2010-3#1)
the ITS##21##2##(2008-10#18)(2009-2#1)(2010-3#2)
the ITS-1##2##2##(2008-10#1)(2008-9#1)
the ITS1 region of##2##4##(2008-10#2)
the IV##3##2##(1994-11#1)(1995-5#1)(2006-10#1)
the IVB and IVB/IVT groups##2##5##(2011-2#2)
the IVB and##4##3##(2011-2#4)
the IVB##5##2##(2011-2#5)
the IVB/IVT##4##2##(2011-2#4)
the IVC##10##2##(2008-7#1)(2011-2#7)(2013-1#2)
the IVD##2##2##(2012-2#2)
the IVF##3##2##(1990-2#3)
the IVIG solution##2##3##(1996-3#2)
the Ia##2##2##(2008-10#2)
the Iberian Peninsula##3##3##(2008-10#2)(2013-8#1)
the Iberian##4##2##(2008-10#3)(2013-8#1)
the Icelandic##2##2##(1993-3#1)(2006-8#1)
the Ig-fold##2##2##(2011-2#2)
the IgA##5##2##(1991-12#1)(1994-2#2)(1994-8#1)(2008-10#1)
the IgG anti-Toxoplasma##2##3##(2007-10#2)
the IgG##19##2##(1990-12#2)(1991-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(2007-10#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)
the IgG-binding##3##2##(1990-8#1)(1995-5#1)(1996-12#1)
the IgM##3##2##(1990-12#1)(2007-10#1)(2008-10#1)
the Ilizarov apparatus##4##3##(2007-11#2)(2007-8#1)(2009-4#1)
the Ilizarov method##3##3##(2008-8#2)(2013-1#1)
the Ilizarov technique##2##3##(2009-3#2)
the Ilizarov##10##2##(2007-11#2)(2007-8#1)(2008-8#2)(2009-3#2)(2009-4#1)(2013-1#2)
the Illinois##3##2##(1992-9#1)(1996-12#1)(2008-9#1)
the Immunization Programme##4##3##(2009-5#4)
the Impact of Events##2##4##(2008-1#1)(2010-2#1)
the Impact of##6##3##(2008-1#2)(2008-10#1)(2010-2#1)(2010-8#1)(2012-2#1)
the Imperial##2##2##(2008-10#1)(2008-5#1)
the Implementation Teams##2##3##(1996-1#2)
the Implementation##4##2##(1996-1#2)(2008-10#1)(2008-12#1)
the Index of Well-being##2##4##(1991-6#2)
the Index of##3##3##(1991-6#2)(2008-2#1)
the Indian population##2##3##(1997-8#1)(2010-5#1)
the Indian subcontinent##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
the Indian##26##2##(1992-12#1)(1994-8#1)(1997-8#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-5#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
the Indiana and##2##3##(2008-10#2)
the Indiana##5##2##(2008-10#4)(2008-6#1)
the Indians##3##2##(1991-12#2)(1997-8#1)
the Indigenous##2##2##(2008-1#1)(2008-10#1)
the Infection of##2##3##(2008-10#2)
the Information##9##2##(1991-3#1)(1991-9#2)(1995-12#1)(1996-3#1)(2008-1#2)(2009-8#1)(2011-2#1)
the Infrared Atmospheric Sounding Interferometer##3##5##(2008-2#2)(2008-3#1)
the Infrared##4##2##(1996-2#1)(2008-2#2)(2008-3#1)
the Inhibition of##2##3##(2010-8#1)(2012-3#1)
the Initiative##3##2##(1995-3#1)(1996-12#1)(2010-5#1)
the Ins(1##2##2##(1990-7#2)
the InsP(3) binding activity##2##4##(2008-8#2)
the Institut Pasteur##3##3##(2010-1#3)
the Institut für##3##3##(2008-10#2)(2008-11#1)
the Institut##9##2##(1990-10#1)(1992-9#1)(2008-10#3)(2008-11#1)(2010-1#3)
the Institute for##5##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2011-2#1)
the Institute of Forensic Medicine##3##5##(1995-3#1)(1997-8#2)
the Institute of Medicine (IOM)##2##5##(2007-12#1)(2010-3#1)
the Institute of Medicine##7##4##(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2010-3#1)(2010-4#1)(2012-2#1)
the Institute of##20##3##(1990-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-12#1)(2007-5#1)(2008-3#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
the Institute##29##2##(1990-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
the Institutes for##2##3##(1994-12#1)(2012-2#1)
the Institution##2##2##(2008-11#2)
the Instituto##5##2##(1993-6#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-7#1)
the Insulin##2##2##(2008-6#1)(2008-9#1)
the Intensive Care Unit##3##4##(2008-5#1)(2012-3#1)(2013-1#1)
the Intensive Care##4##3##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
the Interaction Between##3##3##(2008-10#3)
the Interaction##4##2##(2008-10#4)
the Interdisciplinary Home Care Program##2##5##(2008-9#2)
the Internal Medicine##3##3##(1992-5#1)(1996-11#1)(2008-11#1)
the Internal Revenue Code##2##4##(1991-2#1)(1996-3#1)
the Internal Revenue##3##3##(1991-2#1)(1992-12#1)(1996-3#1)
the Internal##9##2##(1991-2#1)(1992-12#1)(1992-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(2008-10#2)(2008-11#1)
the International AIDS##3##3##(1990-11#2)(2013-1#1)
the International Agency for Research on Cancer##2##7##(2009-4#1)(2013-1#1)
the International Blackleg of Crucifers Network##2##6##(2008-10#2)
the International Classification of##2##4##(1991-9#1)(1994-6#1)
the International Code of##3##4##(2008-10#2)(2010-5#1)
the International Conference on##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
the International Federation##2##3##(1994-3#1)(2008-10#1)
the International Headache Society##2##4##(2008-4#1)(2012-3#1)
the International Labour Office (ILO)##2##5##(1991-12#2)
the International Liaison Committee on Resuscitation##2##6##(2008-11#2)
the International Maritime Organization##2##4##(2008-11#2)
the International Organization for Standardization##4##5##(2008-10#1)(2008-3#2)(2011-2#1)
the International Prognostic Scoring System##2##5##(2009-2#1)(2010-11#1)
the International Prognostic##3##3##(2007-5#1)(2009-2#1)(2010-11#1)
the International Society for##5##4##(2007-12#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-9#1)
the International Society of##6##4##(1994-9#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
the International Society##11##3##(1994-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2011-2#1)(2011-9#1)(2012-2#1)
the International Triticeae Mapping Initiative##3##5##(2008-10#3)
the International##82##2##(1990-11#2)(1991-12#2)(1991-5#1)(1991-9#1)(1993-12#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#2)(1997-2#1)(1997-6#1)(2007-12#2)(2007-5#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#6)(2011-3#1)(2011-9#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
the Internet and information technology to##2##6##(2008-11#2)
the Internet and##7##3##(1994-3#1)(2008-11#2)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)
the Internet are##2##3##(1994-12#1)(2008-11#1)
the Internet can##2##3##(2007-8#1)(2009-5#1)
the Internet for##4##3##(1994-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
the Internet has##4##3##(2007-2#1)(2008-12#1)(2009-5#1)(2011-1#1)
the Internet in##3##3##(2007-12#1)(2008-1#1)(2010-8#1)
the Internet to##5##3##(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)
the Internet using a##2##4##(2008-10#1)(2008-7#1)
the Internet##68##2##(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#3)(1996-2#5)(1996-5#1)(1996-8#1)(1997-1#2)(2007-12#5)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#2)(2008-4#5)(2008-7#2)(2008-9#1)(2009-5#6)(2010-12#1)(2010-8#2)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the Intervention condition##2##3##(2008-4#2)
the Intervention##4##2##(2008-4#4)
the Iowa##5##2##(1994-2#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
the Iranian##6##2##(2008-12#4)(2008-7#2)
the Irish##2##2##(2008-11#1)(2013-8#1)
the Iron##2##2##(2013-8#2)
the Isc##3##2##(2008-1#1)(2008-5#2)
the Island of Rab##2##4##(2011-2#2)
the Israeli Medical Association##3##4##(1997-8#3)
the Israeli##13##2##(1997-8#3)(2008-1#3)(2008-10#6)(2013-1#1)
the Istituto Nazionale Tumori of Milan##2##6##(1991-12#1)(2011-2#1)
the Istituto Nazionale Tumori of##3##5##(1990-12#1)(1991-12#1)(2011-2#1)
the Istituto Nazionale Tumori##5##4##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2011-2#1)
the Istituto##7##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2008-10#1)(2010-4#1)(2011-2#1)
the Italian Group on Rare Tumors##2##6##(2008-6#2)
the Italian National##2##3##(1990-6#1)(2010-11#1)
the Italian Society for##2##4##(2011-2#2)
the Italian Society##4##3##(1991-6#1)(2011-2#3)
the Italian version of the##2##5##(2008-10#1)(2011-2#1)
the Italian##37##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(2008-10#4)(2008-11#2)(2008-6#2)(2008-7#4)(2008-8#2)(2010-1#1)(2010-11#2)(2010-3#1)(2011-2#5)(2011-3#1)
the IxxLxQ motif##2##3##(1997-8#2)
the J##4##2##(1992-10#1)(2008-10#2)(2008-7#1)
the JAK##2##2##(1996-2#1)(2008-1#1)
the JCAHO##7##2##(1993-2#4)(1995-1#3)
the JCAHO's##3##2##(1993-2#1)(1995-1#1)(1996-2#1)
the JDBM##2##2##(2012-2#2)
the JFP##2##2##(1995-6#2)
the JNDs measured##2##3##(1990-11#2)
the JNK pathway in##2##4##(2008-1#2)
the JNK pathway##7##3##(2008-1#7)
the JNK##8##2##(2008-1#7)(2011-2#1)
the JSTP##2##2##(2012-1#2)
the JTC##4##2##(2008-2#1)(2008-3#2)(2012-1#1)
the JTPS##2##2##(2008-3#2)
the JUPITER##2##2##(2010-12#2)
the Jaccard index##2##3##(2008-10#2)
the Jackson Heart Study##3##4##(2011-2#2)(2013-8#1)
the Jackson##6##2##(1993-12#1)(1994-1#2)(2011-2#2)(2013-8#1)
the Jalowiec Coping Scale##2##4##(2010-10#1)(2010-5#1)
the Jamaican##2##2##(2010-1#1)(2011-2#1)
the January##2##2##(2008-2#1)(2011-2#1)
the Janus##2##2##(1996-2#1)(2008-4#1)
the Japan##5##2##(2008-11#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
the Japanese Erwinia##2##3##(2008-10#2)
the Japanese Society of Clinical Chemistry##2##6##(1994-12#2)
the Japanese Society of Clinical##3##5##(1994-12#3)
the Japanese Society of##5##4##(1994-12#3)(2010-1#1)(2012-1#1)
the Japanese pear##2##3##(2008-10#2)
the Japanese puffer fish##2##4##(1995-2#1)(2008-7#1)
the Japanese##45##2##(1991-5#1)(1993-3#2)(1994-12#3)(1995-2#1)(1997-8#3)(2007-10#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#4)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#1)
the Jeddah Kidney Center##3##4##(2007-7#1)(2008-1#2)
the Jeddah##4##2##(2007-7#2)(2008-1#2)
the Jennings Disaster Nursing Management Model##2##6##(2008-11#2)
the Jet Propulsion##2##3##(2008-2#1)(2008-3#1)
the Jichi cohort##2##3##(2012-7#2)
the Job##2##2##(2008-10#2)
the Johns Hopkins Ambulatory Care Group##2##6##(1995-2#2)
the Johns Hopkins##6##3##(1992-3#1)(1993-1#1)(1995-2#2)(1996-9#1)(2011-2#1)
the Joint Commission on Accreditation of Healthcare Organizations##2##8##(1993-2#1)(1995-3#1)
the Joint Commission##3##3##(1993-2#2)(1995-3#1)
the Joint Commission's##2##3##(1993-2#1)(1995-2#1)
the Joint Council of Governmental Public Health Agencies##3##8##(1996-3#3)
the Joint##11##2##(1993-2#3)(1995-2#1)(1995-3#1)(1996-3#3)(2008-8#1)(2009-9#1)(2011-2#1)
the Jones##2##2##(2008-3#2)
the Jones-matrix formalism##2##3##(2008-2#1)(2008-3#1)
the Jordan##3##2##(2008-1#2)(2009-2#1)
the Journal of the Optical Society of America A##2##9##(2008-3#2)
the Journal of the##3##4##(1990-6#1)(2008-3#2)
the Journal of##14##3##(1990-6#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)
the Journal##20##2##(1990-6#1)(1993-9#1)(1994-3#1)(1997-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-4#1)
the Justice Department##2##3##(1995-12#1)(1995-6#1)
the K##10##2##(1990-2#1)(1992-6#2)(1994-9#1)(1995-6#1)(1997-2#1)(1997-7#4)
the K&amp##2##2##(2008-10#2)
the K(+)##2##2##(2008-4#1)(2008-8#1)
the K(+)-evoked##3##2##(1993-3#1)(1997-2#2)
the K(ex##3##2##(2008-10#3)
the K(m) for the##3##4##(2008-7#3)
the K(m) for##4##3##(2008-7#3)(2009-2#1)
the K+##8##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-2#1)(1996-2#1)
the K+-evoked release of##2##4##(1995-12#2)
the K+-evoked##3##2##(1995-12#3)
the K/T boundary##2##3##(1997-5#2)
the K/T##4##2##(1997-5#4)
the K1 antigen and##2##4##(1991-8#2)
the K1 capsular antigen##2##4##(1991-8#2)
the K1##4##2##(1991-8#4)
the K22DAP complexes of##2##4##(2008-10#2)
the KBr##2##2##(2008-2#2)
the KCl##2##2##(1990-5#1)(1995-12#1)
the KCl-induced##2##2##(1995-12#1)(1996-5#1)
the KD##2##2##(2011-2#2)
the KDN-containing##2##2##(1994-5#2)
the KF##3##2##(1993-9#1)(1996-5#1)(2008-10#1)
the KP theory is##2##4##(2009-9#2)
the KP theory##5##3##(2009-9#5)
the KP##7##2##(2009-6#1)(2009-9#5)(2010-8#1)
the KPI##2##2##(1992-12#1)(1996-12#1)
the KR##3##2##(2008-10#3)
the KTP##4##2##(2007-11#1)(2008-3#3)
the Kaiwá##2##2##(1991-12#2)
the Kalman filter##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the Kaplan-Meier method##2##3##(2007-8#1)(2008-6#1)
the Kaplan-Meier##4##2##(1991-8#1)(2007-8#1)(2008-6#1)(2008-7#1)
the Kappa value##2##3##(2008-5#2)
the Kappa##4##2##(2008-5#2)(2008-9#1)(2009-8#1)
the Karnofski scale##3##3##(2008-1#3)
the Kathmandu##2##2##(2008-7#1)(2012-3#1)
the Kd for##2##3##(1995-6#2)
the Kd value##2##3##(1992-12#1)(1996-2#1)
the Kd##9##2##(1992-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-6#2)(1996-2#1)(1997-2#1)(2008-8#1)
the Keck##4##2##(2008-2#1)(2008-3#3)
the Kefir extract##5##3##(2008-11#5)
the Kentucky##2##2##(1994-3#1)(2008-10#1)
the Kerr##2##2##(2007-12#1)(2008-3#1)
the Keystone action plan criteria##3##5##(2011-1#3)
the Ki##3##2##(1992-8#1)(1993-8#1)(1995-2#1)
the Kidd##2##2##(1995-6#2)
the Kidney##2##2##(2008-7#1)(2012-12#1)
the Kii Channel##2##3##(2010-8#2)
the King Khalid University Hospital##2##5##(2008-1#2)
the King##5##2##(2007-7#3)(2008-1#2)
the Kingdom of Saudi Arabia (KSA)##3##6##(2008-1#1)(2008-4#1)(2013-1#1)
the Kingdom of Saudi Arabia##5##5##(2008-1#2)(2008-4#2)(2013-1#1)
the Kingdom of##6##3##(2008-1#2)(2008-10#1)(2008-4#2)(2013-1#1)
the Kingdom##13##2##(2007-2#1)(2008-1#6)(2008-10#1)(2008-4#3)(2009-6#1)(2013-1#1)
the Kinkazan deer##3##3##(2008-5#3)
the Kinkazan population##2##3##(2008-5#2)
the Kinkazan##5##2##(2008-5#5)
the Kirchhoff approximation##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
the Kirchhoff##9##2##(2007-11#2)(2008-2#3)(2008-3#4)
the Kitchener-Waterloo Hospital was##2##4##(1993-1#2)
the Kiyosawa and Shiyomi model##3##5##(2008-10#3)
the Kjeldahl method##4##3##(2008-10#3)(2008-5#1)
the Kjeldahl##6##2##(2008-10#5)(2008-5#1)
the Km and##2##3##(1991-12#1)(1994-5#1)
the Km for##4##3##(1990-11#2)(1994-8#1)(1995-2#1)
the Km of##4##3##(1990-5#1)(1990-8#1)(1991-5#1)(1995-8#1)
the Km values for##3##4##(1995-6#3)
the Km values##4##3##(1990-5#1)(1995-6#3)
the Km##18##2##(1990-11#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-6#3)(1995-8#1)(2008-5#1)
the Knoevenagel condensation##2##3##(2007-11#2)
the Knoevenagel##3##2##(2007-11#2)(2010-5#1)
the Kobs for##2##3##(1995-2#2)
the Kobs##3##2##(1995-2#3)
the Korean##6##2##(1992-12#1)(1997-6#2)(2008-10#2)(2009-3#1)
the KpnI##2##2##(1993-3#1)(2008-10#1)
the Kramers-Kronig##2##2##(2008-3#2)
the Krebs TCA cycle##2##4##(1993-11#2)
the Krebs##3##2##(1993-11#2)(2009-11#1)
the Kretschmann configuration##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the Kruskal-Wallis test##3##3##(2010-3#1)(2013-1#2)
the Kubelka-Munk##4##2##(2008-10#3)(2008-3#1)
the Kuna##2##2##(2010-4#2)
the Kunitz##3##2##(1991-2#1)(1992-12#1)(1992-8#1)
the Kunitz-type##4##2##(1991-11#1)(1994-11#1)(1996-12#2)
the Kupffer cell##2##3##(1992-11#1)(1995-3#1)
the Kuruma Prawn##2##3##(2008-5#1)(2008-6#1)
the Kyoto Encyclopedia of Genes and Genomes (KEGG)##2##8##(2008-4#1)(2009-11#1)
the L alpha -I##3##4##(1994-3#3)
the L alpha##4##3##(1993-11#1)(1994-3#3)
the L intermediate of##2##4##(1995-5#2)
the L intermediate##4##3##(1995-5#4)
the L##21##2##(1992-8#2)(1993-11#1)(1993-2#1)(1994-3#3)(1994-5#1)(1995-5#4)(1997-4#1)(2008-10#4)(2008-7#1)(2010-4#1)(2011-2#2)
the L(4) resistance gene##2##4##(2008-10#2)
the L(4)##4##2##(2008-10#4)
the L-L diastereomer##2##3##(1993-8#2)
the L-L##4##2##(1993-8#3)(1994-3#1)
the L-dsRNA##3##2##(2008-10#3)
the L-lactate##2##2##(1991-5#1)(1993-11#1)
the L-type calcium channel##3##4##(1994-11#1)(1995-3#2)
the L-type calcium##4##3##(1994-11#1)(1995-3#3)
the L-type##7##2##(1990-8#1)(1994-11#1)(1994-9#1)(1995-3#3)(1997-2#1)
the L/K/B alkaline phosphatase##2##4##(1993-6#2)
the L1##6##2##(1991-11#1)(1993-11#1)(1997-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
the L3##4##2##(1991-11#1)(1992-8#1)(1993-12#1)(2008-8#1)
the L4##3##2##(2008-7#1)(2011-2#2)
the L4-5##3##2##(2008-3#1)(2012-3#2)
the L5 vertebra##2##3##(2007-11#2)
the L5##5##2##(1993-12#1)(2007-11#3)(2012-2#1)
the L929##2##2##(2008-5#2)
the LA##5##2##(2008-10#1)(2011-2#4)
the LAB diet##3##3##(2011-1#3)
the LAD group and##2##4##(2013-1#2)
the LAD group##4##3##(2013-1#4)
the LAD##8##2##(2007-8#1)(2013-1#4)(2013-7#3)
the LAMP##2##2##(2009-6#2)
the LAN##2##2##(2007-12#2)
the LAP score##2##3##(1991-4#2)
the LAS##2##2##(2008-10#2)
the LASSO method##2##3##(2012-3#2)
the LAVH group##3##3##(1994-2#1)(2010-3#2)
the LAVH##5##2##(1994-2#1)(1996-2#1)(2010-3#3)
the LB films##4##3##(2007-12#1)(2008-11#3)
the LB##10##2##(2007-12#1)(2008-10#1)(2008-11#7)(2013-1#1)
the LBL##2##2##(2008-10#2)
the LBO crystal##2##3##(2007-12#1)(2008-3#1)
the LC group##2##3##(2008-4#2)
the LC##6##2##(2008-10#3)(2008-4#2)(2011-2#1)
the LC/MS##2##2##(2008-10#1)(2009-8#1)
the LCD##5##2##(2008-2#2)(2008-3#2)(2010-9#1)
the LCWS##2##2##(2008-3#2)
the LD and##2##3##(2007-10#1)(2007-11#1)
the LD##5##2##(2007-10#1)(2007-11#1)(2008-3#2)(2011-2#1)
the LDH activity##2##3##(1993-12#1)(2008-11#1)
the LDH##4##2##(1993-12#1)(2008-11#1)(2010-4#2)
the LDL receptor##7##3##(1990-7#4)(1995-6#1)(2008-6#2)
the LDL##18##2##(1990-7#4)(1991-12#2)(1992-5#1)(1993-12#1)(1993-6#1)(1994-3#4)(1995-5#1)(1995-6#1)(2008-6#2)(2011-1#1)
the LDLR##2##2##(1995-2#2)
the LE model##5##3##(2008-10#5)
the LEAP##3##2##(1996-3#3)
the LED##4##2##(2008-12#1)(2008-3#2)(2011-2#1)
the LEF-1##2##2##(1995-8#2)
the LEH##2##2##(1994-12#2)
the LEOPARD syndrome##3##3##(2013-8#3)
the LES##4##2##(2011-2#1)(2013-8#3)
the LFD##2##2##(2008-10#2)
the LG##6##2##(2008-10#3)(2008-7#2)(2012-2#1)
the LGB##3##2##(2010-8#3)
the LGC/VAM protocol##2##3##(2008-10#2)
the LGN##2##2##(2008-1#2)
the LH beta##2##3##(1995-2#1)(1997-2#1)
the LH##8##2##(1994-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2009-10#4)
the LH/hCG receptor##2##3##(1995-8#2)
the LHR promoter##3##3##(1996-5#3)
the LHR##5##2##(1996-5#4)(2008-8#1)
the LHRH##3##2##(1992-12#2)(2008-4#1)
the LIBS##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
the LIDT of##3##3##(2007-11#1)(2008-3#2)
the LIDT##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
the LIF##4##2##(2008-2#3)(2008-3#1)
the LILACS##2##2##(2012-3#2)
the LIM protein##2##3##(1994-8#1)(2008-9#1)
the LIM##4##2##(1994-8#2)(2007-12#1)(2008-9#1)
the LIP##2##2##(1990-12#2)
the LITA##5##2##(2007-8#4)(2008-3#1)
the LLNA##4##2##(2008-10#2)(2008-5#2)
the LLPS##2##2##(2008-10#2)
the LMP2##2##2##(1997-9#1)(2012-2#1)
the LMWH##2##2##(2007-7#1)(2008-10#1)
the LNN##3##2##(2008-2#2)(2008-3#1)
the LNT model##2##3##(2008-7#1)(2013-1#1)
the LNT theory##2##3##(2008-7#2)
the LNT##4##2##(2008-7#3)(2013-1#1)
the LOD was##2##3##(2008-10#2)
the LOD##7##2##(2008-10#6)(2012-1#1)
the LODs##3##2##(2008-10#3)
the LOQ##2##2##(1992-8#1)(2011-3#1)
the LOV##2##2##(2008-10#2)
the LP(01) mode of##2##4##(2007-11#1)(2008-3#1)
the LP(01) mode##3##3##(2007-11#2)(2008-3#1)
the LP(01)##4##2##(2007-11#2)(2008-3#2)
the LPIA##5##2##(2008-3#5)
the LPL##5##2##(1993-3#3)(1994-11#2)
the LPP##3##2##(1994-8#2)(2008-5#1)
the LPS-induced IL-12##2##3##(2008-8#2)
the LPS-induced##7##2##(1997-1#1)(2008-10#1)(2008-8#4)(2011-2#1)
the LR parsing##3##3##(2011-3#3)
the LR##4##2##(2008-10#1)(2011-3#3)
the LS method##2##3##(2008-10#2)
the LSPV##2##2##(2011-2#2)
the LSU##2##2##(1993-11#1)(1995-8#1)
the LTR##2##2##(1991-2#1)(1994-12#1)
the LV##5##2##(1991-3#2)(2008-10#2)(2012-2#1)
the La##3##2##(1995-3#1)(2008-5#2)
the Laboratory for##2##3##(2008-3#1)(2010-5#1)
the Laboratory of##4##3##(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
the Laboratory##12##2##(1990-11#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the Labour Inspection##2##3##(1992-5#1)(1995-2#1)
the Lagoa do Peixe##2##4##(2013-7#2)
the Lagoa do##3##3##(2013-7#3)
the Lagrangian approach##3##3##(2008-7#3)
the Laitinen questionnaire##3##3##(2007-8#3)
the Lake Maggiore##2##3##(2008-10#2)
the Lake##4##2##(2008-10#3)(2010-8#1)
the Lambert##2##2##(2008-10#2)
the Lambertian##3##2##(2008-2#2)(2008-3#1)
the Lamellar Gel##3##3##(2008-5#3)
the Landers earthquake##2##3##(1996-4#1)(2008-3#1)
the Landolt paradigm##3##3##(2013-8#3)
the Landolt##4##2##(2013-8#4)
the Langmuir isotherm approach##2##4##(2008-10#2)
the Langmuir isotherm##3##3##(2008-10#3)
the Langmuir##9##2##(1994-5#1)(2008-10#7)(2008-6#1)
the Laplace##2##2##(2008-7#1)(2012-1#1)
the Laser Interferometer Gravitational Wave Observatory##3##6##(2007-11#1)(2008-3#2)
the Laser Interferometer Gravitational-Wave Observatory (LIGO)##3##6##(2008-3#3)
the Laser Interferometer##6##3##(2007-11#1)(2008-3#5)
the Laser##7##2##(2007-11#1)(2008-3#6)
the Lateral##2##2##(1994-8#1)(2008-3#1)
the Latin American clade##2##4##(2008-10#2)
the Latin American##6##3##(1992-5#1)(2008-10#3)(2010-10#1)(2011-2#1)
the Latium##2##2##(1992-9#2)
the Leaves##3##2##(2008-8#1)(2013-1#2)
the Lebanon##2##2##(2009-2#1)(2010-4#1)
the Lee##2##2##(2008-2#1)(2008-9#1)
the Leeward Islands of the Netherlands Antilles##2##7##(1992-2#2)
the Leishmania##5##2##(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
the Lena##2##2##(2010-8#2)
the Leptosphaeria##3##2##(2008-10#3)
the Let-7##2##2##(2010-7#2)
the Leuven Intensive Insulin Therapy Trial##2##6##(2010-12#2)
the Levenberg-Marquardt algorithm##2##3##(2008-10#1)(2010-8#1)
the Lewis##3##2##(1996-5#1)(2009-2#1)(2013-8#1)
the LiF##3##2##(2008-2#1)(2008-3#2)
the Lidar In-Space Technology Experiment##2##5##(2008-3#2)
the Life Course##2##3##(2009-10#1)(2012-12#1)
the Ligasure##4##2##(2009-2#2)(2011-2#2)
the Lindenberg Aerosol Characterization Experiment##2##5##(2008-3#2)
the Lipid Study Leipzig (LSL)##2##5##(2008-7#2)
the Literature##14##2##(1997-3#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
the Lithuanian health system##2##4##(2013-8#2)
the Lithuanian##3##2##(2007-10#1)(2013-8#2)
the Living Sky Health District##2##5##(1996-1#2)
the Lixiscope##2##2##(1997-3#2)
the Ln##2##2##(1997-7#2)
the Local##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
the Log TG/HDL-C ratio##3##4##(2008-3#3)
the Logan Rep protein##2##4##(2008-10#2)
the Loma##2##2##(1992-12#1)(1993-2#1)
the London Health Sciences Centre##2##5##(2008-11#2)
the London##5##2##(1997-1#1)(2008-1#1)(2008-11#2)(2012-2#1)
the Long Ashton splashmeter##2##4##(2008-10#2)
the Long##3##2##(2008-10#2)(2011-2#1)
the Lorentz-Lorenz formula##2##3##(2008-2#2)
the Lorentzian##2##2##(2008-10#1)(2008-3#1)
the Los##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
the Lotka-Volterra##2##2##(2008-8#2)
the Louisiana State University Medical Center##2##6##(1996-1#2)
the Louisiana##3##2##(1996-1#2)(2008-10#1)
the Lovelace##2##2##(1996-1#1)(1996-12#1)
the Low##4##2##(1992-12#1)(1997-3#1)(2008-3#1)(2012-7#1)
the Lowenstein-Jensen##2##2##(2013-1#1)(2013-8#1)
the Lower##2##2##(2008-10#1)(2013-8#1)
the Lowry method##2##3##(2008-1#1)(2008-9#1)
the Lp(a)##5##2##(1991-12#1)(1993-2#3)(1995-2#1)
the Lr26##2##2##(2008-10#2)
the Lung##4##2##(1995-3#1)(2010-8#2)(2013-1#1)
the Ly-49+##2##2##(1995-2#2)
the Lyme disease spirochetes in Japan##2##6##(1997-4#2)
the Lyme disease spirochetes##3##4##(1997-4#3)
the Lyme disease##4##3##(1997-4#3)(2010-6#1)
the Lys##2##2##(1990-8#1)(1995-6#1)
the Lysholm##2##2##(2011-2#1)(2013-1#1)
the M =##2##3##(1996-2#1)(2008-3#1)
the M genotypes##2##3##(2008-10#2)
the M##30##2##(1992-3#2)(1993-12#1)(1995-5#1)(1996-2#1)(1997-3#5)(1997-4#1)(2008-10#6)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-10#1)(2011-2#2)
the M(2) factor and##3##4##(2007-12#1)(2008-3#2)
the M(2)##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
the M(r)##3##2##(1992-8#1)(1994-5#2)
the M-cell monolayer##2##3##(2008-11#2)
the M/# is##2##3##(2008-3#2)
the M1 and M2##2##4##(1990-2#1)(1992-10#1)
the M1##4##2##(1990-2#1)(1992-10#1)(1993-9#1)(2013-8#1)
the M2##2##2##(1990-2#1)(1992-8#1)
the M2(D)##3##2##(2008-8#3)
the M3##3##2##(1997-7#1)(2007-10#1)(2011-2#1)
the M4 segment of the##2##5##(2008-12#2)
the M4##3##2##(1991-2#1)(2008-12#2)
the MA Advanced##2##3##(2008-11#2)
the MA values##2##3##(1990-8#2)
the MA##7##2##(1990-8#2)(2008-10#2)(2008-11#2)(2008-3#1)
the MAC genome##2##3##(2012-3#2)
the MADS##3##2##(1997-2#1)(1997-8#2)
the MAF or##2##3##(2011-1#2)
the MAF##5##2##(2010-11#1)(2011-1#4)
the MAGE index##2##3##(2009-11#2)
the MAO-B##2##2##(1994-6#1)(1994-8#1)
the MAP kinase##5##3##(1995-2#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-4#1)
the MAP##7##2##(1995-2#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-6#1)(2008-4#2)
the MAPK module is localized to##2##6##(2009-8#2)
the MAPK module is##3##4##(2009-8#3)
the MAPK module##4##3##(2009-8#4)
the MAPK signal##2##3##(2008-11#2)
the MAPK##9##2##(1995-2#1)(2008-11#2)(2009-8#6)
the MAS##4##2##(2008-1#1)(2008-3#3)
the MAT-1 pheromone##2##3##(2008-10#2)
the MAT-1##3##2##(2008-10#3)
the MAX##2##2##(1995-6#2)
the MAb##2##2##(2008-10#1)(2008-11#1)
the MAbs##3##2##(1994-3#1)(2008-10#2)
the MB signal##2##3##(2008-10#2)
the MB##5##2##(1993-8#1)(2008-10#4)
the MBAS total##2##3##(2007-12#2)
the MBDCG plate##2##3##(2008-2#2)
the MBDCG##3##2##(2008-2#3)
the MBI##2##2##(2008-10#1)(2008-9#1)
the MC##9##2##(1996-5#1)(2007-11#4)(2008-10#2)(2008-11#1)(2011-1#1)
the MCA##10##2##(1996-5#1)(2007-10#5)(2008-12#4)
the MCBS##3##2##(1995-2#1)(1996-2#1)(1997-1#1)
the MCCB##3##2##(2012-12#3)
the MCF-7 human breast cancer cell line##2##7##(2008-11#1)(2012-3#1)
the MCF-7##5##2##(1992-9#1)(1994-12#1)(2008-11#1)(2012-3#2)
the MCMC##3##2##(2009-12#1)(2009-4#1)(2012-7#1)
the MCS##3##2##(1994-12#1)(2007-8#1)(2011-2#1)
the MCS+##4##2##(2011-2#4)
the MD##2##2##(2008-10#1)(2011-2#1)
the MDA levels##2##3##(2013-8#2)
the MDA##3##2##(2011-1#1)(2013-8#2)
the MDB##5##2##(2010-8#5)
the MDCK##4##2##(1995-11#3)(2008-11#1)
the MDG##2##2##(2011-1#2)
the MDI##11##2##(1992-3#5)(1996-1#3)(1996-2#2)(1997-2#1)
the MDM##2##2##(2008-3#2)
the MDR phenotype##2##3##(2008-11#2)
the MDR##3##2##(1993-3#1)(2008-11#2)
the MDR1 gene##3##3##(2008-11#2)(2011-2#1)
the MDR1##9##2##(1994-5#1)(2007-10#3)(2008-11#3)(2011-2#2)
the ME##4##2##(2011-2#2)(2013-1#1)(2013-8#1)
the MECC##2##2##(1994-9#2)
the MED-EL COMBI 40+##2##4##(2008-9#2)
the MED-EL##4##2##(2008-9#4)
the MEDLINE##2##2##(2013-1#1)(2013-8#1)
the MEK-8118 haematology analyser##2##4##(2008-10#2)
the MEK-ERK pathway##2##3##(2011-2#2)
the MEP##2##2##(2008-11#1)(2008-7#1)
the MF##2##2##(1993-9#1)(2008-10#1)
the MFN was##2##3##(2008-11#2)
the MFN##3##2##(2008-11#3)
the MFS##8##2##(1994-1#6)(1996-1#1)(2011-1#1)
the MG content##2##3##(2008-6#2)
the MG##3##2##(1996-2#1)(2008-6#2)
the MGED ontology##2##3##(2008-7#2)
the MGMT gene##2##3##(1992-3#2)
the MGMT##3##2##(1992-3#3)
the MHC class##3##3##(1993-6#1)(2008-4#2)
the MHC molecules##2##3##(1995-5#2)
the MHC region##2##3##(1997-9#1)(2008-4#1)
the MHC##15##2##(1990-5#1)(1993-6#1)(1995-5#2)(1997-6#1)(1997-9#1)(2008-4#6)(2008-5#1)(2008-9#1)(2010-5#1)
the MHO phenotype##3##3##(2013-1#3)
the MHSIP##2##2##(1992-12#2)
the MI##2##2##(1993-8#1)(2008-5#1)
the MIC##4##2##(2007-1#1)(2008-5#3)
the MICs of##3##3##(2008-12#1)(2008-5#1)(2010-6#1)
the MIH##4##2##(2008-6#1)(2013-1#3)
the MIMS response of##3##4##(2008-10#3)
the MIMS response##4##3##(2008-10#4)
the MINT##2##2##(2008-4#2)
the MIP##2##2##(2008-10#2)
the MIS##2##2##(1993-12#1)(2008-8#1)
the ML##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
the MLPNN##2##2##(2010-8#2)
the MM##2##2##(1991-8#1)(1997-7#1)
the MM3##4##2##(1991-2#1)(1995-11#1)(1996-5#2)
the MMA##3##2##(2007-9#1)(2008-12#2)
the MMBI##2##2##(2008-3#2)
the MMP-1 and MMP-9 expressions##2##5##(2012-3#2)
the MMP-1 and MMP-9 mRNA##2##5##(2012-3#2)
the MMP-1 and MMP-9##4##4##(2012-3#4)
the MMP-1##5##2##(2008-5#1)(2012-3#4)
the MMV##2##2##(2007-2#2)
the MNS##6##2##(2008-11#6)
the MOF is##2##3##(2008-10#2)
the MOPITT##2##2##(2008-3#2)
the MOSFET##3##2##(2009-5#3)
the MP##5##2##(1997-3#1)(2008-10#1)(2008-9#3)
the MPC##4##2##(1994-5#1)(1996-2#1)(2007-12#1)(2008-11#1)
the MPG##2##2##(1992-8#2)
the MPI##3##2##(1995-6#2)(2008-2#1)
the MPOA##3##2##(1992-5#1)(1994-2#2)
the MPQ as##2##3##(2012-2#2)
the MPQ in##2##3##(2012-2#2)
the MPQ##7##2##(2012-2#7)
the MPs of##2##3##(2007-11#1)(2008-10#1)
the MR findings##2##3##(1995-4#1)(2011-2#1)
the MR##12##2##(1993-12#2)(1995-4#2)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the MRI##10##2##(1992-3#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the MS is##4##3##(2008-3#4)
the MS##29##2##(1994-3#1)(1995-12#1)(1996-12#2)(2008-10#5)(2008-3#16)(2008-7#1)(2010-4#1)(2012-3#2)
the MS-ATP##2##2##(2008-3#2)
the MS-WHO##2##2##(2008-3#2)
the MSDchem##2##2##(2008-4#2)
the MSE##2##2##(2008-3#2)
the MSH 'core'##2##3##(1995-12#2)
the MSH##3##2##(1993-5#1)(1995-12#2)
the MSH27Ep##2##2##(2008-8#2)
the MSKCC grading##2##3##(2011-2#2)
the MSP procedure##2##3##(2008-10#2)
the MSV resistance of##2##4##(2008-10#2)
the MT##11##2##(1996-4#1)(2008-10#9)(2013-1#1)
the MT-1 peak##2##3##(2008-10#2)
the MT-1##3##2##(2008-10#3)
the MT-2 isoform was##2##4##(2008-10#2)
the MT-like##2##2##(1990-5#2)
the MT1 receptor##3##3##(2013-7#3)
the MT1##4##2##(2013-7#4)
the MTC test##4##3##(2008-7#4)
the MTD##4##2##(2008-6#3)(2012-3#1)
the MTF##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
the MTT assay##5##3##(1992-2#1)(2011-2#1)(2012-3#2)(2013-1#1)
the MTT##8##2##(1992-2#1)(2007-10#2)(2008-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
the MTX concentration##2##3##(2008-11#2)
the MTX##4##2##(1992-8#1)(1994-2#1)(2008-11#2)
the MTs##2##2##(2008-10#1)(2009-10#1)
the MVB group were##2##4##(2007-7#2)
the MVB group##7##3##(2007-7#7)
the MVB##8##2##(2007-7#8)
the MWC model##2##3##(1990-8#1)(2012-1#1)
the MWNT-film##2##2##(2008-10#2)
the MWNTs##2##2##(2008-10#2)
the MX line##7##3##(2008-10#7)
the Mabs##2##2##(2008-5#2)
the Madison##2##2##(1994-12#1)(2010-11#1)
the Magic 1##2##3##(1997-3#2)
the Major##2##2##(2008-10#1)(2008-11#1)
the Majority##2##2##(2010-9#2)
the Malassezia spp##2##3##(2008-5#2)
the Management of##8##3##(2008-1#1)(2008-3#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#2)
the Management##10##2##(1993-12#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#2)
the Mancozeb##2##2##(2008-10#2)
the Mann-Whitney##7##2##(1992-6#1)(1997-3#1)(2007-8#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
the Manus Basin##4##3##(2008-6#4)
the March##2##2##(2009-8#1)(2012-12#1)
the Marfan syndrome##2##3##(2013-1#2)
the Marfan##3##2##(2008-8#1)(2013-1#2)
the Markov chain##2##3##(2008-7#1)(2012-7#1)
the Markov##4##2##(2008-6#1)(2008-7#1)(2008-8#1)(2012-7#1)
the Marshall Islands##12##3##(1994-9#3)(2008-1#5)(2008-10#1)(2013-8#3)
the Masaoka##2##2##(2007-8#2)
the Mashona heifers##2##3##(1996-12#2)
the Mashona##3##2##(1996-12#3)
the Maslach Burnout Inventory (MBI)##2##5##(2008-11#1)(2011-2#1)
the Maslach Burnout Inventory##6##4##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
the Massachusetts Behavioral Risk Factor Surveillance System##2##7##(2008-12#2)
the Massachusetts General Hospital##12##4##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-10#1)
the Massachusetts strain##2##3##(1997-6#1)(2008-5#1)
the Massachusetts##20##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-12#2)(2008-5#1)
the Maternal##2##2##(1995-3#1)(2010-5#1)
the Maturation##2##2##(2008-10#1)(2009-9#1)
the Maximizer##4##2##(2008-11#4)
the Maxwell-Garnett##2##2##(2008-2#1)(2008-3#1)
the Mayo Clinic##3##3##(2008-5#1)(2009-11#1)(2009-5#1)
the Mayo##5##2##(2008-1#1)(2008-5#1)(2009-11#1)(2009-5#1)(2009-7#1)
the McGill Pain Questionnaire##3##4##(2009-12#1)(2010-6#1)(2012-2#1)
the McGill##5##2##(1996-2#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
the MeOH##2##2##(2008-11#2)
the MeSH##3##2##(1995-1#1)(2008-1#1)(2013-1#1)
the Mean##2##2##(2008-10#1)(2008-12#1)
the Meaningful##2##2##(2011-1#2)
the Mechanisms##2##2##(2008-10#2)
the Mecklenburg Medical Group##2##4##(1991-1#2)
the Mecklenburg Medical##3##3##(1991-1#3)
the Medicaid and Medicare##2##4##(1995-12#1)(1995-3#1)
the Medicaid program##5##3##(1996-1#4)(1997-2#1)
the Medicaid##15##2##(1991-2#1)(1991-3#1)(1993-1#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#4)(1997-2#3)(2008-11#1)
the Medicaid-eligible elderly##2##3##(1993-3#1)(1997-2#1)
the Medical Birth Registry of Norway##2##6##(1995-6#1)(1996-11#1)
the Medical Department##3##3##(1992-9#1)(1996-3#2)
the Medical Education##2##3##(1991-8#1)(2013-8#1)
the Medical Faculty##2##3##(1993-6#1)(2007-8#1)
the Medical University in Warsaw##2##5##(2007-11#2)
the Medical University in##3##4##(2007-11#2)(2007-8#1)
the Medical University of##2##4##(2007-8#1)(2008-7#1)
the Medical University##7##3##(2007-11#2)(2007-8#2)(2008-7#1)(2008-9#2)
the Medical##33##2##(1991-8#2)(1992-12#2)(1992-9#1)(1993-2#1)(1993-6#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-7#1)(2008-9#3)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the Medicare Current Beneficiary Survey (MCBS)##6##6##(1994-1#1)(1995-12#3)(1995-2#1)(1997-2#1)
the Medicare Current Beneficiary Survey##7##5##(1994-1#1)(1995-12#3)(1995-2#2)(1997-2#1)
the Medicare Part A##2##4##(1991-1#1)(1993-3#1)
the Medicare and Medicaid programs##2##5##(1991-2#1)(1996-3#1)
the Medicare and Medicaid##5##4##(1991-12#2)(1991-2#1)(1992-12#1)(1996-3#1)
the Medicare and##6##3##(1991-12#3)(1991-2#1)(1992-12#1)(1996-3#1)
the Medicare diagnosis-related groups##2##4##(1994-12#2)
the Medicare fee schedule (MFS)##4##5##(1994-1#2)(1994-12#1)(1996-1#1)
the Medicare fee schedule##9##4##(1991-12#1)(1993-3#1)(1994-1#4)(1994-12#1)(1996-1#1)(1996-3#1)
the Medicare home health##2##4##(1992-3#1)(1995-3#1)
the Medicare hospice benefit##3##4##(1991-3#1)(1994-12#1)(1995-2#1)
the Medicare population##6##3##(1993-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)
the Medicare program##12##3##(1991-1#2)(1991-3#2)(1992-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1997-3#2)(2008-10#1)
the Medicare prospective payment system (PPS)##3##6##(1992-12#1)(1993-12#1)(1993-3#1)
the Medicare prospective payment system##6##5##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)
the Medicare prospective payment##7##4##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)
the Medicare##82##2##(1991-1#3)(1991-12#4)(1991-2#3)(1991-3#4)(1992-1#2)(1992-12#5)(1992-2#4)(1992-3#1)(1993-1#1)(1993-12#4)(1993-3#5)(1994-1#6)(1994-12#6)(1994-3#2)(1995-1#1)(1995-12#7)(1995-2#6)(1995-3#2)(1996-1#1)(1996-12#2)(1996-3#3)(1997-1#2)(1997-2#2)(1997-3#3)(2008-10#1)(2008-11#1)(2008-6#1)
the Medicinal##2##2##(2008-10#1)(2008-5#1)
the Mediterranean Basin##5##3##(2008-10#3)(2011-2#2)
the Mediterranean region##2##3##(2008-8#1)(2013-1#1)
the Mediterranean##23##2##(1990-8#2)(1996-4#1)(2008-1#1)(2008-10#7)(2008-8#2)(2010-1#1)(2011-2#5)(2012-2#1)(2013-1#3)
the Medline##2##2##(2008-10#1)(2011-1#1)
the Melbourne perspective##2##3##(2008-10#2)
the Melbourne##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
the Menkes##2##2##(1993-11#2)
the Mental Health Act##3##4##(2008-7#1)(2010-1#1)(2013-1#1)
the Mental Health##4##3##(1992-12#1)(2008-7#1)(2010-1#1)(2013-1#1)
the Mental##5##2##(1992-12#1)(2008-7#1)(2009-7#1)(2010-1#1)(2013-1#1)
the Mersey##2##2##(2008-6#2)
the Mesay##2##2##(2008-5#2)
the Met##2##2##(1991-9#1)(1993-11#1)
the Metrohm##2##2##(2008-10#2)
the Metropolitan Area of Costa##2##5##(2008-5#2)
the Metropolitan Region of Santiago##2##5##(2012-2#1)(2013-1#1)
the Metropolitan Region##4##3##(2012-2#2)(2013-1#2)
the Metropolitan##10##2##(1994-1#1)(1997-6#1)(2007-8#1)(2008-5#3)(2012-2#2)(2013-1#2)
the Mexican##15##2##(1993-6#1)(2008-10#4)(2008-12#1)(2008-5#3)(2009-7#1)(2011-2#2)(2012-12#2)(2013-7#1)
the Mg(2+)##2##2##(2008-10#2)
the Mg2+##2##2##(1990-7#1)(1992-3#1)
the Mi##3##2##(1995-11#2)(2008-10#1)
the Michaelis constant##3##3##(1990-5#1)(1991-5#1)(1993-3#1)
the Michaelis##5##2##(1990-5#1)(1991-5#2)(1993-3#1)(1995-2#1)
the Michelson Interferometer for Passive Atmospheric Sounding (MIPAS)##2##8##(2008-3#2)
the Michelson Interferometer for Passive Atmospheric Sounding##4##7##(2008-3#4)
the Michigan##4##2##(1994-9#1)(1995-12#1)(1996-2#1)(2012-2#1)
the Microbial##4##2##(2007-3#1)(2008-10#3)
the Microbiology##2##2##(2007-10#1)(2010-8#1)
the Mid##3##2##(2008-10#1)(2013-8#2)
the Middle Ages##3##3##(2009-10#1)(2013-8#2)
the Middle Atlantic Bight##3##4##(2008-3#3)
the Middle East and##4##4##(1997-8#1)(2008-10#1)(2009-2#1)(2011-2#1)
the Middle East##18##3##(1995-3#1)(1997-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-2#3)(2011-2#3)
the Middle Eastern##2##3##(2008-10#2)
the Middle Volga region##3##4##(2013-1#3)
the Middle##30##2##(1995-3#1)(1997-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#3)(2009-7#1)(2011-2#3)(2013-1#3)(2013-8#2)
the Midwestern##2##2##(2008-10#1)(2009-7#1)
the Mie theory##6##3##(2008-2#2)(2008-3#3)(2009-6#1)
the Mie##9##2##(2008-2#2)(2008-3#6)(2009-6#1)
the Millennium Development Goals##4##4##(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)
the Mini Mental State Examination##2##5##(2008-7#1)(2013-1#1)
the Mini Mental State##4##4##(1994-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
the Mini##5##2##(1994-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
the Mini-Mental State Examination (MMSE)##2##5##(2008-6#1)(2008-7#1)
the Mini-Mental State Examination##4##4##(2008-6#2)(2008-7#2)
the Ministry of Agriculture##2##4##(2008-8#1)(2010-4#1)
the Ministry of Health and Social Affairs has##2##8##(1993-6#1)(1994-2#1)
the Ministry of Health and Social Affairs##3##7##(1993-6#2)(1994-2#1)
the Ministry of Health and Social##4##6##(1993-6#2)(1994-2#1)(2013-1#1)
the Ministry of Health and the##3##6##(1993-1#1)(2007-5#1)(2013-1#1)
the Ministry of Health and##8##5##(1993-1#1)(1993-6#2)(1994-2#1)(2007-5#1)(2008-5#1)(2013-1#2)
the Ministry of Health of##2##5##(2008-1#1)(2008-8#1)
the Ministry of Health##22##4##(1991-2#1)(1993-1#1)(1993-6#2)(1994-12#1)(1994-2#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)
the Ministry of Health's##2##4##(2010-10#1)(2012-12#1)
the Ministry of the##2##4##(2010-4#1)(2012-12#1)
the Ministry of##32##3##(1991-2#1)(1991-3#1)(1993-1#1)(1993-6#2)(1994-12#1)(1994-2#1)(1996-8#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)
the Ministry##33##2##(1991-2#2)(1991-3#1)(1993-1#1)(1993-6#2)(1994-12#1)(1994-2#1)(1996-8#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)
the Minnesota Department of Health's##2##5##(2012-12#2)
the Minnesota##8##2##(1990-2#2)(1991-2#1)(2008-10#1)(2010-1#1)(2012-12#2)(2012-2#1)
the Miocene##2##2##(2008-10#1)(2008-6#1)
the Mississippi##3##2##(2008-10#2)(2008-8#1)
the Missouri##2##2##(1995-12#1)(1996-2#1)
the Mitsunobu reaction##3##3##(2007-11#1)(2008-4#1)(2008-6#1)
the Mixed##2##2##(2008-10#1)(2009-10#1)
the Mmd1 gene##2##3##(2008-10#2)
the Mmd1##3##2##(2008-10#3)
the Mo##3##2##(2008-10#1)(2009-11#2)
the Mode of##2##3##(1997-7#1)(2008-10#1)
the Modified Bromley's Methodology (MBM)##2##5##(2008-10#2)
the Modified##6##2##(2007-10#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-2#1)
the Molecular##2##2##(2008-10#1)(2013-1#1)
the Mono Q##2##3##(1991-12#1)(2008-10#1)
the Monte Carlo method##8##4##(1992-6#1)(1994-3#1)(2008-10#1)(2008-2#3)(2008-3#2)
the Monte Carlo simulation##2##4##(2008-2#2)
the Monte Carlo technique##4##4##(2008-2#1)(2008-3#3)
the Monte Carlo##19##3##(1992-6#1)(1994-3#2)(2008-10#1)(2008-2#8)(2008-3#7)
the Monte##20##2##(1992-6#1)(1994-3#2)(2008-10#1)(2008-2#8)(2008-3#8)
the Montreal Biodome##3##3##(2009-4#3)
the Montreal Protocol##4##3##(1992-3#2)(1996-1#1)(1996-2#1)
the Montreal##8##2##(1992-3#3)(1996-1#1)(1996-2#1)(2009-4#3)
the Moon##4##2##(1997-5#1)(2008-2#2)(2012-3#1)
the More Individuals Hypothesis##3##4##(2008-9#3)
the Morphology and##2##3##(2008-2#1)(2010-6#1)
the Morris water maze test##2##5##(2011-2#1)(2012-3#1)
the Morris water maze##17##4##(1992-8#1)(1993-12#8)(1993-3#1)(1994-6#2)(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
the Morris water task and##2##5##(1992-11#2)
the Morris water task##3##4##(1992-11#3)
the Morris water##21##3##(1992-11#3)(1992-8#1)(1993-12#9)(1993-3#1)(1994-6#2)(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
the Morris water-maze##2##3##(1993-3#1)(1994-8#1)
the Morris##24##2##(1992-11#3)(1992-8#1)(1993-12#9)(1993-3#2)(1994-6#2)(1994-8#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
the Morse##2##2##(2009-9#1)(2010-7#1)
the Mos##3##2##(1994-8#3)
the Mount Sinai##3##3##(1991-12#1)(1995-8#1)(1996-3#1)
the Mount##5##2##(1991-12#1)(1995-8#1)(1996-3#1)(2008-8#1)(2010-6#1)
the Mouse##2##2##(2008-5#1)(2009-12#1)
the Mt##5##2##(2008-2#3)(2008-3#1)(2008-8#1)
the Mueller matrix elements##2##4##(2008-2#1)(2008-3#1)
the Mueller matrix##13##3##(2007-11#3)(2008-2#3)(2008-3#7)
the Mueller scattering##2##3##(2008-2#1)(2008-3#1)
the Mueller##16##2##(2007-11#3)(2008-2#4)(2008-3#9)
the Multidimensional##4##2##(2007-12#1)(2008-12#2)(2012-2#1)
the Multinational##2##2##(2008-7#1)(2011-2#1)
the Multiple Risk Factor Intervention Trial##2##6##(1991-8#1)(1992-9#1)
the Municipal Forest##4##3##(2008-5#4)
the Municipal##7##2##(1997-5#1)(2008-5#4)(2008-9#2)
the Museum##3##2##(2010-1#2)(2011-2#1)
the MycER##2##2##(2008-11#2)
the Mycoparasite Pythium oligandrum##2##4##(2008-10#2)
the Mycoparasite##3##2##(2008-10#3)
the N and C domains##2##5##(1995-5#2)
the N and C##3##4##(1995-5#2)(1997-8#1)
the N and##5##3##(1995-5#2)(1997-8#1)(2008-5#1)(2012-5#1)
the N epsilon##2##3##(1991-3#1)(1994-5#1)
the N gene of##2##4##(2008-10#2)
the N gene##4##3##(2008-10#4)
the N protein of##2##4##(2008-10#2)
the N protein##4##3##(2008-10#4)
the N terminus and##3##4##(1993-2#1)(1994-8#1)(2008-10#1)
the N terminus##6##3##(1990-5#1)(1993-2#1)(1994-8#1)(2008-10#2)(2008-6#1)
the N##38##2##(1990-5#1)(1991-3#1)(1992-11#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#4)(1996-2#1)(1997-8#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-3#1)(2012-5#1)
the N(2)##3##2##(2008-3#3)
the N(6)- and 4'-position##2##4##(2008-4#2)
the N- and C-terminal##5##4##(1990-7#1)(1991-5#1)(1992-6#1)(1995-2#1)(2013-1#1)
the N- and##7##3##(1990-7#1)(1991-5#1)(1992-6#2)(1995-2#1)(1997-4#1)(2013-1#1)
the N-##8##2##(1990-7#1)(1991-5#1)(1992-6#2)(1995-2#1)(1996-12#1)(1997-4#1)(2013-1#1)
the N-H bond##2##3##(1995-11#1)(2008-5#1)
the N-N##2##2##(1996-5#1)(2008-10#1)
the N-S##2##2##(1992-10#1)(2008-10#1)
the N-acetyl##2##2##(1991-5#1)(2010-2#1)
the N-acetyl-beta-D-hexosaminidase##3##2##(1990-5#2)(1997-6#1)
the N-acetylation of##2##3##(1992-6#1)(1993-5#1)
the N-fatty##2##2##(1995-6#2)
the N-heterocyclic##2##2##(2010-5#1)(2012-12#1)
the N-linked oligosaccharide##2##3##(1992-12#1)(2008-7#1)
the N-linked##8##2##(1990-5#1)(1992-12#1)(1993-11#1)(1993-8#1)(2008-11#1)(2008-7#3)
the N-methyl-D-aspartate (NMDA) glutamate receptor##2##5##(1994-8#1)(1997-6#1)
the N-methyl-D-aspartate (NMDA) receptor##2##4##(1995-12#1)(1997-2#1)
the N-methyl-D-aspartate (NMDA)##6##3##(1994-8#2)(1995-12#1)(1997-2#2)(1997-6#1)
the N-methyl-D-aspartate receptor##4##3##(1990-7#2)(1994-8#1)(1997-2#1)
the N-methyl-D-aspartate##11##2##(1990-7#2)(1994-8#3)(1995-12#2)(1997-2#3)(1997-6#1)
the N-ras##2##2##(1995-2#2)
the N-terminal amino acid##4##4##(1993-9#1)(1994-8#1)(2008-6#1)(2009-2#1)
the N-terminal amphiphilic leader##2##4##(1991-10#2)
the N-terminal and##2##3##(1992-11#1)(1995-2#1)
the N-terminal arm##4##3##(1995-5#2)(2008-9#2)
the N-terminal domain of GPIIIa##2##5##(1997-7#1)(2006-6#1)
the N-terminal domain of the GPIIIa subunit##2##7##(2006-6#2)
the N-terminal domain of the##4##5##(1992-8#1)(2006-6#2)(2012-2#1)
the N-terminal domain of##15##4##(1990-2#1)(1992-3#1)(1992-8#1)(1997-7#1)(2006-6#3)(2008-9#2)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
the N-terminal domain##18##3##(1990-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1997-7#1)(2006-6#3)(2008-4#1)(2008-9#2)(2009-7#3)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
the N-terminal extracellular domain##3##4##(1991-12#2)(1992-9#1)
the N-terminal extracellular##4##3##(1991-12#2)(1992-9#2)
the N-terminal half of the RTD##2##6##(2008-10#2)
the N-terminal half of the##5##5##(1994-2#1)(2008-10#3)(2011-1#1)
the N-terminal half##6##3##(1994-2#1)(1997-2#1)(2008-10#3)(2011-1#1)
the N-terminal of the##3##4##(1990-2#1)(2006-6#1)(2008-11#1)
the N-terminal part of##2##4##(1991-5#1)(1992-6#1)
the N-terminal portion of the##2##5##(1994-12#1)(1994-6#1)
the N-terminal region of human La##2##6##(2009-7#2)
the N-terminal region of the##2##5##(1996-3#1)(2008-10#1)
the N-terminal region of##5##4##(1991-5#1)(1996-3#1)(2008-10#1)(2009-7#2)
the N-terminal region##7##3##(1991-5#1)(1994-5#1)(1996-3#2)(2008-10#1)(2009-7#2)
the N-terminal sequence of the##2##5##(1991-11#1)(1994-11#1)
the N-terminal sequence of##4##4##(1990-12#1)(1991-11#1)(1994-11#1)(1994-12#1)
the N-terminal sequence##8##3##(1990-12#1)(1991-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-6#2)
the N-terminal tail##2##3##(1992-8#1)(1997-2#1)
the N-terminal truncated enzyme##2##4##(1995-2#2)
the N-terminal##111##2##(1990-12#1)(1990-2#3)(1990-7#5)(1991-10#4)(1991-11#2)(1991-12#2)(1991-5#2)(1992-11#2)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#4)(1995-8#1)(1996-3#2)(1997-2#4)(1997-6#3)(1997-7#1)(2006-6#4)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#1)(2009-7#7)(2009-8#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-2#1)
the N-termini of##2##3##(1990-2#1)(1991-6#1)
the N-terminus of the##5##4##(1990-2#2)(1992-6#1)(1997-3#1)(2008-10#1)
the N-terminus of##11##3##(1990-2#3)(1990-7#1)(1991-9#1)(1992-6#1)(1995-12#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-8#1)
the N-terminus##23##2##(1990-2#3)(1990-5#2)(1990-7#3)(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-8#1)(2008-9#3)(2010-11#1)
the N-type##2##2##(1993-11#1)(2008-8#1)
the N1##3##2##(2008-4#1)(2008-8#2)
the N2##2##2##(2008-11#2)
the N7##2##2##(1992-6#1)(2008-4#1)
the NA and##2##3##(1994-3#2)
the NA is##2##3##(2007-11#1)(2008-3#1)
the NA##5##2##(1994-3#2)(2007-11#1)(2008-3#1)(2008-7#1)
the NAC##4##2##(1996-5#2)(2008-6#2)
the NAD(+)##3##2##(2008-10#3)
the NAD(P)H##2##2##(1996-2#1)(2008-10#1)
the NAD+##2##2##(1990-10#1)(1990-11#1)
the NAD+/NADH ratio##2##3##(1990-11#2)
the NADH concentration##2##3##(2008-10#2)
the NADH reductase component of the steroid 9alpha-hydroxylase##2##8##(2008-11#2)
the NADH##13##2##(1990-11#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-3#2)(1997-8#1)(2008-10#3)(2008-11#2)(2010-5#1)
the NADPH oxidase##3##3##(1990-2#1)(1990-5#1)(1994-6#1)
the NADPH##5##2##(1990-2#1)(1990-5#1)(1992-3#2)(1994-6#1)
the NADPH-binding##2##2##(1994-8#2)
the NAS##3##2##(1993-12#2)(1993-6#1)
the NASA##4##2##(2008-2#2)(2008-3#2)
the NAc##7##2##(2008-7#7)
the NB##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
the NB1-RGB cells##2##3##(2008-11#2)
the NBICU##2##2##(1991-12#2)
the NBM and COMB groups##2##5##(1993-3#2)
the NBM##3##2##(1993-3#3)
the NBME USMLE steps 1 and 2 examinations##2##8##(2012-3#2)
the NBMPR-sensitive transporter##2##3##(1995-8#2)
the NBS domain were##2##4##(2008-10#2)
the NBS##3##2##(2008-10#3)
the NC and##2##3##(2010-2#2)
the NC diet##2##3##(2010-2#2)
the NC subjects##2##3##(1996-7#2)
the NC##14##2##(1996-7#3)(2007-10#1)(2008-10#4)(2010-2#5)(2012-12#1)
the NCBI##5##2##(2008-4#3)(2012-3#1)(2013-1#1)
the NCI##6##2##(1992-1#1)(2008-7#3)(2009-4#1)(2012-3#1)
the NCLEX##2##2##(2010-3#2)
the ND##3##2##(1995-2#3)
the ND4##2##2##(2008-2#1)(2008-5#1)
the NDELA content of##2##4##(2008-5#2)
the NDFWM signal##2##3##(2007-12#2)
the NDNAD##2##2##(2008-12#2)
the NE##2##2##(1996-7#1)(2011-2#1)
the NF-kappa##2##2##(1995-12#1)(1995-2#1)
the NF-κB##2##2##(2011-2#2)
the NF1##2##2##(1997-3#1)(2013-1#1)
the NFL theorems are not##2##5##(2010-3#2)
the NFL theorems##5##3##(2010-3#5)
the NFL##7##2##(1991-10#1)(1991-5#1)(2010-3#5)
the NFP hospital tax exemption##2##5##(2008-11#2)
the NH##4##2##(1991-5#1)(2008-10#2)(2008-2#1)
the NH2 terminus of##2##4##(1992-12#1)(1995-6#1)
the NH2 terminus##5##3##(1992-12#1)(1992-9#1)(1993-3#1)(1995-6#2)
the NH2##7##2##(1992-12#1)(1992-9#2)(1993-3#1)(1994-9#1)(1995-6#2)
the NH2-terminal domain##2##3##(1990-11#1)(1991-12#1)
the NH2-terminal##13##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#2)(1992-9#2)(1995-12#1)(1995-6#2)(1997-1#2)
the NH2-terminus of thyroglobulin##2##4##(1992-12#2)
the NH2-terminus of##3##3##(1992-12#2)(1997-1#1)
the NH2-terminus##7##2##(1992-12#2)(1992-4#1)(1992-8#2)(1997-1#1)(2008-8#1)
the NHC samples##2##3##(2013-8#2)
the NHC##3##2##(2013-8#3)
the NHS was##2##3##(2008-7#1)(2013-8#1)
the NHS##30##2##(1991-6#1)(1991-8#1)(1996-11#1)(1997-5#5)(2008-11#5)(2008-12#1)(2008-7#4)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#8)
the NICE guidance##2##3##(2010-2#2)
the NICE guidelines##2##3##(2008-7#1)(2013-8#1)
the NICE##5##2##(2008-7#1)(2010-2#3)(2013-8#1)
the NICU##12##2##(1991-1#2)(1991-12#3)(1994-2#3)(1995-1#2)(2009-6#1)(2010-10#1)
the NIH##5##2##(1997-3#1)(2008-11#2)(2008-5#1)(2012-3#1)
the NIL sets##2##3##(2008-10#2)
the NIL##4##2##(1992-12#1)(2008-10#3)
the NILs##11##2##(2008-10#11)
the NIMH Genetics Initiative##3##4##(1997-5#3)
the NIMH genetics initiative##5##4##(1997-5#5)
the NIMH##9##2##(1997-5#9)
the NIOSH##2##2##(2008-10#1)(2008-8#1)
the NIR spectra of##2##4##(2008-10#2)
the NIR spectra##4##3##(2008-10#3)(2011-1#1)
the NIR spectral##2##3##(2008-10#1)(2012-12#1)
the NIR##10##2##(2008-10#6)(2008-3#2)(2011-1#1)(2012-12#1)
the NIRS technique##3##3##(2008-10#3)
the NIRS##4##2##(2008-10#3)(2008-3#1)
the NIS##2##2##(1995-3#1)(1997-1#1)
the NIST##8##2##(2008-1#1)(2008-10#4)(2008-3#3)
the NJ##2##2##(2008-9#1)(2010-7#1)
the NK1 receptor##2##3##(1997-4#1)(2008-5#1)
the NK1##3##2##(1997-4#1)(2008-5#2)
the NL-3 K strain##2##4##(2008-10#2)
the NL-3 K##3##3##(2008-10#3)
the NL-3##4##2##(2008-10#4)
the NLM##2##2##(1996-3#1)(2010-5#1)
the NMDA receptor##18##3##(1993-12#2)(1994-6#2)(1994-8#5)(1995-5#1)(1996-2#4)(1996-5#1)(2008-11#1)(2008-7#1)(2010-4#1)
the NMDA receptors##3##3##(1997-2#1)(2011-1#1)(2012-12#1)
the NMDA##23##2##(1992-3#1)(1993-12#2)(1994-6#2)(1994-8#5)(1995-5#1)(1996-2#5)(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-12#1)
the NMDA-evoked##2##2##(1995-12#1)(2008-8#1)
the NMDA-receptor##2##2##(1995-12#1)(1997-7#1)
the NMJ has##2##3##(2009-11#2)
the NMJ##4##2##(1990-5#1)(2009-11#2)(2009-8#1)
the NMR data##2##3##(1990-5#1)(1995-3#1)
the NMR##18##2##(1990-5#1)(1991-11#3)(1991-8#1)(1994-5#2)(1995-3#2)(2007-9#1)(2008-10#2)(2009-7#4)(2009-9#2)
the NO acceptor##2##3##(1995-5#2)
the NO message##2##3##(2011-2#2)
the NO synthase##2##3##(1995-5#1)(1996-2#1)
the NO##12##2##(1993-6#1)(1994-6#1)(1995-5#5)(1996-2#1)(2008-2#1)(2011-2#2)(2013-1#1)
the NO(2)(-)##2##2##(2008-10#2)
the NOD##2##2##(1995-12#1)(2010-11#1)
the NOM##3##2##(1992-5#2)(2008-3#1)
the NOS##5##2##(2008-10#4)(2009-9#1)
the NP##4##2##(2008-10#1)(2009-12#1)(2012-12#2)
the NPC##10##2##(2011-2#10)
the NPD##2##2##(2008-9#2)
the NPPV group##2##3##(2008-1#2)
the NPPV##3##2##(2008-1#3)
the NPS##2##2##(2008-9#2)
the NR##3##2##(1993-6#1)(2008-10#1)(2010-9#1)
the NRC vision##2##3##(2011-1#2)
the NRC##3##2##(2011-1#3)
the NSAIDs##2##2##(1990-11#1)(1993-2#1)
the NSCs cultured in##2##4##(2008-11#2)
the NSE concentrations##2##3##(1992-11#2)
the NSE##3##2##(1992-11#2)(2011-2#1)
the NSF##2##2##(2008-7#1)(2010-12#1)
the NSI##2##2##(2013-1#2)
the NSP##3##2##(2012-12#3)
the NSSF##3##2##(2008-6#3)
the NSm##3##2##(2008-10#3)
the NSs##3##2##(2008-10#3)
the NT(+)##2##2##(2008-11#2)
the NTP-binding##2##2##(2008-10#2)
the NTPDase isoforms##2##3##(2008-4#2)
the NTPDase##3##2##(2008-4#3)
the NTS##6##2##(1992-3#2)(1995-12#1)(1997-2#3)
the NW##4##2##(2008-11#1)(2008-7#3)
the NXSM##2##2##(1994-8#2)
the NYAPs##3##2##(2008-10#3)
the NZ##3##2##(2008-11#2)(2008-8#1)
the Na##7##2##(1994-8#6)(1997-7#1)
the Na(+)-dependent##2##2##(1990-12#1)(1991-12#1)
the Na(2)CO(3) fusion##2##3##(2008-10#2)
the Na(V)1##2##2##(2008-8#2)
the Na+ binding##2##3##(1997-2#2)
the Na+ current##2##3##(1992-3#1)(1995-12#1)
the Na+##15##2##(1991-8#4)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-11#2)(1995-12#2)(1997-2#2)(1997-8#1)
the Na+-ATPase##2##2##(2008-11#2)
the Na+/H+ exchanger and##2##4##(1993-3#2)
the Na+/H+##4##2##(1990-2#1)(1993-3#2)(1994-3#1)
the Na+/K(+)-ATPase activity##2##3##(1990-12#2)
the Na+/K(+)-ATPase##6##2##(1990-12#2)(1990-2#1)(1990-5#2)(1994-12#1)
the Na+/K+ ATPase##2##3##(1990-12#1)(2007-10#1)
the Na-K-2Cl cotransporter##2##3##(2007-7#1)(2008-8#1)
the NaCl##4##2##(1997-2#1)(2008-10#2)(2013-1#1)
the Nafion##2##2##(2008-10#2)
the Nafion/MV modified GDME##2##4##(2008-10#2)
the Nafion/MV modified##4##3##(2008-10#4)
the Nafion/MV##5##2##(2008-10#5)
the Naples##2##2##(1993-5#1)(2008-2#1)
the Nation##6##2##(1992-3#2)(1993-3#1)(1996-1#1)(2008-11#1)(2011-2#1)
the Nation's first##2##3##(1996-1#1)(2008-6#1)
the Nation's##8##2##(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-6#1)
the National Association of##3##4##(1992-3#1)(1994-12#1)(1996-5#1)
the National Board of##2##4##(1996-9#1)(2012-3#1)
the National Cancer Center##2##4##(2007-8#1)(2008-7#1)
the National Cancer Institute (NCI)##2##5##(1997-1#1)(1997-3#1)
the National Cancer Institute##16##4##(1991-3#1)(1991-5#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#1)(2012-3#1)
the National Cancer##21##3##(1991-3#1)(1991-5#1)(1993-6#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
the National Center for Prevention Services##2##6##(1997-3#2)
the National Center for##3##4##(1997-3#2)(2007-7#1)
the National Center##4##3##(1997-3#2)(2007-10#1)(2007-7#1)
the National Cholesterol Education Program (NCEP)##2##6##(1991-8#1)(2008-3#1)
the National Cholesterol Education Program Expert Panel##2##7##(2008-1#1)(2008-3#1)
the National Cholesterol Education Program##4##5##(1991-8#1)(2008-1#1)(2008-3#2)
the National Committee for Clinical Laboratory Standards##2##7##(2008-5#1)(2010-8#1)
the National Committee for##3##4##(1996-3#1)(2008-5#1)(2010-8#1)
the National Council##2##3##(1990-6#1)(1995-2#1)
the National Health Accounts##2##4##(1991-2#1)(1997-1#1)
the National Health Insurance Fund##2##5##(2007-5#1)(2013-8#1)
the National Health Interview Survey##3##5##(1995-12#1)(1996-5#1)(1997-3#1)
the National Health Screening Service conducted cardiovascular risk factor screening of##2##11##(1991-6#1)(1994-11#1)
the National Health Screening Service##4##5##(1991-6#1)(1994-11#3)
the National Health Service (NHS)##5##5##(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
the National Health Service##11##4##(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
the National Health and Nutrition Examination Survey##2##7##(2008-1#1)(2010-12#1)
the National Health##26##3##(1991-2#1)(1991-6#1)(1994-11#3)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the National Heart##5##3##(2008-3#2)(2009-12#2)(2011-2#1)
the National Ignition Facility##5##4##(2008-3#5)
the National Institute for Occupational Safety and Health##2##8##(2008-10#1)(2012-12#1)
the National Institute for##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
the National Institute of Allergy and Infectious Diseases##2##8##(2008-5#1)(2011-2#1)
the National Institute of Cardiology##4##5##(2008-10#4)
the National Institute of Environmental Health Sciences##2##7##(2008-9#2)
the National Institute of Standards and Technology (NIST)##2##8##(2008-10#1)(2008-3#1)
the National Institute of Standards and Technology##6##7##(2008-10#1)(2008-2#1)(2008-3#4)
the National Institute of Standards##7##5##(2008-10#1)(2008-2#1)(2008-3#4)(2013-8#1)
the National Institute of##24##4##(1991-3#3)(1992-12#1)(1994-7#1)(1996-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
the National Institute on Aging##2##5##(2009-5#1)(2010-5#1)
the National Institute on##4##4##(1992-3#1)(1996-4#1)(2009-5#1)(2010-5#1)
the National Institute##31##3##(1991-3#3)(1992-12#1)(1992-3#1)(1994-7#1)(1996-4#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#2)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
the National Institutes of Health (NIH)##2##6##(1997-8#1)(2008-5#1)
the National Institutes of Health##19##5##(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#10)
the National Institutes of##21##4##(1994-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#10)
the National Insurance##4##3##(1991-8#2)(1995-2#1)(1997-6#1)
the National Library of Medicine (NLM)##4##6##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)
the National Library of Medicine##11##5##(1991-2#2)(1992-1#2)(1992-2#1)(1994-12#1)(1995-1#1)(1996-3#1)(2010-4#1)(2010-5#1)(2012-3#1)
the National Library of Medicine's##2##5##(1993-3#1)(1995-11#1)
the National Library of##13##4##(1991-2#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-3#1)(2010-4#1)(2010-5#1)(2012-3#1)
the National Longitudinal Study of Adolescent Health##5##7##(2009-7#1)(2010-7#2)(2012-12#1)(2013-8#1)
the National Longitudinal##6##3##(2009-7#1)(2009-8#1)(2010-7#2)(2012-12#1)(2013-8#1)
the National Oceanic and Atmospheric Administration##2##6##(2008-2#1)(2008-3#1)
the National Practitioner Data Bank##4##5##(1992-1#1)(1992-3#2)(1994-2#1)
the National Reference##2##3##(2008-10#1)(2010-4#1)
the National Research##2##3##(2008-10#1)(2013-8#1)
the National Science Foundation##2##4##(2008-10#1)(2013-8#1)
the National Science Foundation's##2##4##(1997-6#1)(2010-12#1)
the National Science##4##3##(1997-6#1)(2008-10#1)(2010-12#1)(2013-8#1)
the National Service Framework##2##4##(2008-11#1)(2008-3#1)
the National Statistics##2##3##(2012-12#1)(2013-1#1)
the National Survey of##3##4##(2008-2#1)(2009-5#1)(2010-10#1)
the National University Hospital##2##4##(2006-10#1)(2012-12#1)
the National University of##2##4##(2011-2#1)(2013-7#1)
the National University##4##3##(2006-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
the National##229##2##(1990-6#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#4)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#4)(1996-11#1)(1996-3#2)(1996-4#3)(1996-5#4)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#5)(1997-5#1)(1997-6#3)(1997-8#1)(2006-10#2)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#19)(2008-5#6)(2008-7#9)(2008-8#1)(2008-9#4)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#5)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#17)
the Natural##2##2##(1990-3#1)(2010-2#1)
the Nature##2##2##(2008-10#1)(2008-7#1)
the Nautilus##2##2##(1997-4#2)
the Naval Medical##2##3##(1996-12#1)(2013-1#1)
the Navarre##3##2##(2011-2#1)(2013-1#2)
the Navon task##2##3##(2008-11#2)
the Nd##15##2##(1991-3#2)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#4)
the Nd(3+)##4##2##(2007-11#3)(2008-3#1)
the Neck Disability Index##2##4##(2008-12#2)
the Nederlands Tijdschrift voor Geneeskunde##2##5##(1991-6#1)(1995-12#1)
the Nederlands Tijdschrift voor##3##4##(1991-6#1)(1995-12#2)
the Need for##2##3##(2007-12#1)(2011-2#1)
the Neonatal##3##2##(1991-6#1)(2009-9#1)(2012-2#1)
the Neotropical##2##2##(2007-12#1)(2008-5#1)
the Neotropics and##2##3##(2012-2#1)(2013-7#1)
the Nepalese##3##2##(2008-8#2)(2012-3#1)
the Nestin gene##2##3##(2011-2#2)
the Netherlands Antilles##3##3##(1992-2#2)(1994-12#1)
the Netherlands were##3##3##(1992-12#1)(2008-10#2)
the Netherlands##69##2##(1990-3#2)(1991-11#2)(1991-4#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#5)(1992-5#1)(1994-12#3)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-5#2)(1997-8#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-12#5)(2008-2#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-8#2)
the Network##3##2##(1991-3#2)(2008-3#1)
the Neumann##2##2##(2008-3#2)
the Neurobehavioral Symptom Inventory##2##4##(2013-1#2)
the New Brunswick##2##3##(1994-1#1)(1996-1#1)
the New Mexico##2##3##(1997-3#2)
the New World Sciurus and the##2##6##(2008-5#2)
the New World Sciurus##4##4##(2008-5#4)
the New World##9##3##(2008-10#2)(2008-5#4)(2011-2#3)
the New York Academy of Sciences##2##6##(1990-3#1)(1994-12#1)
the New York City Board of Education##2##7##(1991-12#2)
the New York City##3##4##(1991-12#2)(1996-3#1)
the New York State Department of Health##3##7##(1994-12#1)(1996-3#1)(1997-1#1)
the New York State##7##4##(1992-3#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)
the New York experience##2##4##(1996-1#1)(1997-1#1)
the New York statutory model--Part##2##5##(1992-12#1)(1992-3#1)
the New York##22##3##(1990-3#1)(1991-12#2)(1992-12#2)(1992-3#2)(1992-8#1)(1994-12#3)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(2008-3#2)(2008-8#1)(2011-2#1)
the New Zealand##7##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2011-1#1)
the New##51##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1992-12#2)(1992-3#2)(1992-8#1)(1994-1#1)(1994-12#3)(1996-1#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-3#3)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#4)(2008-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)
the Newtonian##2##2##(2013-8#2)
the NgoII##2##2##(1993-9#2)
the Ni##2##2##(2008-10#2)
the Ni-Ti alloy electrode##2##4##(2008-10#2)
the Ni-Ti##3##2##(2008-10#3)
the NifA##2##2##(1993-12#1)(2008-9#1)
the Nigerian##2##2##(1990-3#1)(2011-1#1)
the Nikolskii-Eisenman equation##2##3##(2008-10#2)
the Nikolskii-Eisenman##3##2##(2008-10#3)
the Nile River Delta and##2##5##(2008-10#2)
the Nile River Delta##3##4##(2008-10#3)
the Nile##4##2##(2008-10#4)
the Nipah virus##2##3##(2008-12#2)
the No##2##2##(2008-8#1)(2013-1#1)
the Nobel Prize##2##3##(2010-7#1)(2013-1#1)
the Nobel##3##2##(2010-1#1)(2010-7#1)(2013-1#1)
the Nordic Psychiatric##2##3##(2011-4#2)
the Nordic countries##9##3##(1990-11#2)(1990-6#1)(1992-11#1)(1997-6#1)(2008-10#3)(2011-4#1)
the Nordic##16##2##(1990-11#2)(1990-6#1)(1991-2#2)(1992-11#1)(1997-6#1)(2008-10#3)(2008-2#1)(2011-4#5)
the Norse##2##2##(2008-3#2)
the North American Great Lakes##4##5##(2008-11#4)
the North American opossum##2##4##(1996-5#2)
the North American##15##3##(1996-5#2)(2008-10#4)(2008-11#4)(2008-7#1)(2009-2#1)(2010-10#1)(2010-3#1)(2011-2#1)
the North Carolina sample##3##4##(2008-10#3)
the North Central##2##3##(1991-1#1)(1992-8#1)
the North Fiji Basin##5##4##(2008-6#5)
the North Sea##4##3##(2008-10#1)(2009-10#3)
the North and Nicaraguan dialect##2##5##(2009-9#2)
the North and South##2##4##(1992-2#1)(2009-9#1)
the North and##6##3##(1992-2#1)(2009-9#3)(2011-2#1)(2013-7#1)
the North of##4##3##(1990-8#1)(2007-8#1)(2008-12#1)(2008-3#1)
the North##52##2##(1990-8#1)(1991-1#1)(1992-2#4)(1992-5#2)(1992-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1996-5#2)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#5)(2008-7#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-9#3)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-7#2)
the North-West##2##2##(1995-5#1)(2011-2#1)
the Northern Cape Province of South Africa and in Namibia##2##10##(2011-1#2)
the Northern Cape Province##4##4##(2011-1#4)
the Northern Chinese Han population##2##5##(2013-1#2)
the Northern blot data##2##4##(2008-7#2)
the Northern blot##3##3##(2008-7#2)(2008-8#1)
the Northern parts of China##3##5##(2011-1#3)
the Northern parts of##4##4##(2011-1#4)
the Northern##36##2##(1992-2#1)(1994-9#1)(1996-12#1)(1996-9#1)(2007-10#1)(2008-1#5)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#3)(2011-1#8)(2013-1#2)(2013-8#4)
the Northwest##5##2##(2008-11#1)(2008-12#2)(2008-8#1)(2012-12#1)
the Northwestern##3##2##(1996-12#1)(2007-12#1)(2011-2#1)
the Norwegian Board of Health##2##5##(1996-6#1)(1997-8#1)
the Norwegian Institute of Public Health##2##6##(2008-10#1)(2010-6#1)
the Norwegian Institute of##3##4##(1996-6#1)(2008-10#1)(2010-6#1)
the Norwegian Medical Association##4##4##(1990-6#2)(1994-2#1)(1997-6#1)
the Norwegian Medical##5##3##(1990-6#2)(1991-11#1)(1994-2#1)(1997-6#1)
the Norwegian Mother and Child Cohort Study##2##7##(2010-6#2)
the Norwegian population##4##3##(1990-6#2)(1992-11#1)(1996-3#1)
the Norwegian##43##2##(1990-6#6)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-5#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#3)(1996-8#2)(1996-9#2)(1997-6#4)(1997-8#2)(2008-10#1)(2010-6#3)(2011-2#2)(2012-3#1)
the Notch##3##2##(2007-12#1)(2010-3#2)
the Nottingham##2##2##(1994-5#1)(2008-9#1)
the Nova##2##2##(1996-1#1)(2008-5#1)
the Nuclear##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
the Nucleus 24 cochlear implant system##4##6##(2008-9#4)
the Nucleus 24 cochlear implant##5##5##(2008-9#5)
the Nucleus##13##2##(2008-9#9)(2012-2#4)
the Nugent test##2##3##(2013-1#2)
the Number of##2##3##(2008-10#1)(2010-3#1)
the Number##4##2##(1996-9#1)(2008-10#1)(2009-5#1)(2010-3#1)
the Nur77 family##3##3##(1994-12#3)
the Nurses'##2##2##(2007-10#1)(2009-7#1)
the Nursing Care Comfort Scale##2##5##(2008-11#2)
the Nursing Outcomes Classification##2##4##(2013-1#2)
the Nursing##13##2##(2008-11#6)(2008-12#1)(2010-10#2)(2013-1#4)
the Nyquist plot##2##3##(2008-10#2)
the Nyquist sampling##2##3##(2007-11#1)(2008-3#1)
the Nyquist##9##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#4)
the O antigen of##2##4##(1996-12#2)
the O##10##2##(1996-12#2)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2013-1#1)
the O'Brien##2##2##(1996-3#1)(1997-3#1)
the O(2) A-band absorption##2##4##(2008-2#2)
the O(2)##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the O(3)##4##2##(2008-3#4)
the O-atom energy##2##3##(2010-4#2)
the O-buffer##2##2##(2008-6#2)
the O-sulfo derivative of MK-447##2##5##(1991-8#2)
the O111 and O145##2##4##(2012-2#2)
the O2##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
the O45 antigen##2##3##(1995-11#2)
the O66##2##2##(1995-11#2)
the OAP system##3##3##(2008-11#3)
the OB##2##2##(1996-5#1)(2012-2#1)
the OC spectrum##2##3##(2008-1#2)
the OCI##2##2##(2008-2#2)
the OCLC Online Union Catalog##2##5##(1991-12#2)
the OCN##3##2##(2010-2#3)
the OCT##5##2##(2007-12#1)(2008-3#2)(2011-7#2)
the ODNs##2##2##(1994-12#2)
the OECD##4##2##(1994-1#1)(2008-5#1)(2011-1#2)
the OEIS complex##2##3##(2008-10#2)
the OH group of##2##4##(1993-11#1)(2008-8#1)
the OH group##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
the OH stretching##3##3##(2007-12#2)(2008-2#1)
the OH tag##2##3##(2008-3#2)
the OH##10##2##(1993-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
the OH(-) group in##2##4##(2008-10#2)
the OHS##2##2##(2012-12#2)
the OIE##9##2##(2011-2#9)
the OLUC##2##2##(1991-12#2)
the OMIM database##3##3##(2008-4#2)(2008-9#1)
the ONL##2##2##(2010-1#2)
the OPA##2##2##(2008-2#2)
the OPC instrument##3##3##(2010-10#3)
the OPD##2##2##(2008-3#2)
the OPG##2##2##(2013-8#2)
the OPO cavity mirrors##2##4##(2008-2#1)(2008-3#1)
the OPO cavity##3##3##(2008-2#1)(2008-3#2)
the OPO##15##2##(2007-11#1)(2007-12#6)(2008-2#4)(2008-3#4)
the OR##5##2##(1994-3#1)(1997-1#1)(2008-4#1)(2008-6#1)(2011-2#1)
the ORA##5##2##(2008-2#3)(2008-3#2)
the ORF I##2##3##(2008-10#2)
the ORF##6##2##(1994-12#1)(2008-10#2)(2008-7#1)(2008-8#2)
the ORF-36##2##2##(1990-11#2)
the ORF3 protein##2##3##(1997-4#2)
the ORFs##5##2##(1994-12#2)(1996-3#1)(1997-3#2)
the ORL-1 receptor##4##3##(2008-11#4)
the OS##2##2##(1991-8#1)(2008-10#1)
the OSC amplitude in##3##4##(2008-6#3)
the OSC amplitude##7##3##(2008-6#7)
the OSC##9##2##(2008-5#1)(2008-6#8)
the OSCE##4##2##(1994-2#1)(2008-11#3)
the OUR##2##2##(2008-11#2)
the OVA##2##2##(1991-2#1)(2008-11#1)
the OVA/IL12##3##2##(2008-11#3)
the OY phytoplasmas##2##3##(2008-10#2)
the Obligate Biotroph##2##3##(2008-10#2)
the Occupational Safety and Health Administration##2##6##(1993-3#1)(1994-3#1)
the Occupational Safety and Health##3##5##(1993-12#1)(1993-3#1)(1994-3#1)
the Occupational##4##2##(1993-12#1)(1993-3#2)(1994-3#1)
the Odin##2##2##(2008-3#2)
the Office of Inspector General##2##5##(1991-12#1)(1993-12#1)
the Office of##4##3##(1991-1#1)(1991-12#1)(1993-12#1)(2008-1#1)
the Office##6##2##(1991-1#1)(1991-12#1)(1993-12#1)(2007-6#1)(2008-1#1)(2008-7#1)
the Offord##2##2##(1996-5#2)
the Ohio##2##2##(1997-5#1)(2008-10#1)
the Okavango Delta##3##3##(2008-10#3)
the Oklahoma##3##2##(1994-3#1)(1995-12#1)(2008-10#1)
the Old World Sciurus##3##4##(2008-5#3)
the Old World##5##3##(1995-11#1)(2008-5#4)
the Old##9##2##(1995-11#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#1)(2011-2#1)
the Olympus##4##2##(1992-6#4)
the Omnibus Budget Reconciliation Act (OBRA) of 1990##2##8##(1991-12#1)(1997-3#1)
the Omnibus Budget Reconciliation Act (OBRA) of##3##7##(1991-12#1)(1994-3#1)(1997-3#1)
the Omnibus Budget Reconciliation Act of##2##6##(1994-1#1)(1996-3#1)
the Omnibus Budget Reconciliation Act##5##5##(1991-12#1)(1994-1#1)(1994-3#1)(1996-3#1)(1997-3#1)
the Omnibus Budget Reconciliation##6##4##(1991-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#1)
the Omnibus##7##2##(1991-1#1)(1991-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#1)
the Ontario Hospital Association##2##4##(1991-2#1)(1994-3#1)
the Ontario Ministry of Health and##2##6##(1991-2#1)(2011-2#1)
the Ontario Ministry of Health##4##5##(1991-2#2)(1994-1#1)(2011-2#1)
the Ontario Ministry of##5##4##(1991-2#2)(1994-1#1)(1995-3#1)(2011-2#1)
the Ontario##15##2##(1991-2#6)(1993-3#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(2007-5#1)(2008-6#1)(2011-2#1)
the Optical Properties of##2##4##(2008-2#1)(2008-3#1)
the Optical Properties##3##3##(2008-2#1)(2008-3#2)
the Optical Society of America##5##5##(2008-2#2)(2008-3#3)
the Optical##11##2##(2008-2#5)(2008-3#6)
the Oral##2##2##(2011-2#1)(2013-1#1)
the Oregon Coast Range##3##4##(2008-10#3)
the Oregon coast##2##3##(2008-10#2)
the Oregon##11##2##(1992-2#1)(1993-1#1)(1995-1#1)(1996-1#1)(2008-10#5)(2008-12#2)
the Organization for Economic Cooperation and Development (OECD)##2##8##(1993-2#1)(1993-3#1)
the Organization for Economic Cooperation and Development countries##2##8##(1993-3#1)(1994-1#1)
the Organization for Economic Cooperation and Development##4##7##(1993-2#1)(1993-3#2)(1994-1#1)
the Organization##5##2##(1993-2#1)(1993-3#2)(1994-1#1)(1996-11#1)
the Origin of##3##3##(1996-5#1)(2008-10#1)(2010-5#1)
the Oromia##2##2##(2008-8#1)(2011-2#1)
the OrthoPilot##2##2##(2007-8#2)
the Orthopedic Clinic##2##3##(2007-11#1)(2007-8#1)
the Orthopedic and Traumatology##2##4##(2007-11#2)
the Orthopedic##5##2##(1997-6#1)(2007-11#3)(2007-8#1)
the Orthopedics##3##2##(2007-11#1)(2007-8#2)
the Ortigas river##2##3##(2008-10#2)
the Oryza##2##2##(2008-10#2)
the OsMADS genes##2##3##(1997-8#2)
the Oslo area##2##3##(1990-2#1)(1992-6#1)
the Oswestry scale##2##3##(2007-11#2)
the Oswestry##3##2##(2007-11#2)(2012-12#1)
the Ottoman##2##2##(2008-11#1)(2011-2#1)
the Overton Prize winner##2##4##(2008-7#2)
the Oxford Colposcopy Clinic##2##4##(1994-2#2)
the Oxford##4##2##(1994-2#2)(2007-10#1)(2008-2#1)
the P = O##2##4##(1990-2#2)
the P absorption band##2##4##(1993-11#2)
the P site of##2##4##(1993-11#2)
the P##56##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-5#1)(1992-3#1)(1993-11#4)(1993-9#2)(1995-2#1)(1997-5#1)(2008-10#27)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-1#4)(2013-1#1)
the P(1)(2)##2##2##(2008-3#2)
the P(33) 6-3 transition##2##4##(2008-3#2)
the P(33) 6-3##3##3##(2008-3#3)
the P-R interval##4##3##(1994-5#2)(1994-6#2)
the P-T-Q index##2##3##(1994-6#2)
the P-glycoprotein of A2-1 cells##2##5##(1995-11#2)
the P-glycoprotein##7##2##(1992-12#1)(1995-11#2)(2008-11#4)
the P1 helix##2##3##(1995-6#2)
the P1##15##2##(1993-12#2)(1994-5#2)(1994-6#1)(1995-6#2)(1996-2#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)
the P11##3##2##(2008-2#2)(2008-3#1)
the P2 Tin protein##2##4##(1997-3#2)
the P2##10##2##(1990-11#1)(1990-8#1)(1995-12#1)(1995-8#3)(1997-3#2)(2008-2#1)(2008-4#1)
the P2'##2##2##(1992-11#2)
the P2000##2##2##(2008-3#2)
the P2X(7)R##3##2##(2008-4#3)
the P2Y##3##2##(1995-11#1)(2008-4#2)
the P2Y(1) receptor##8##3##(2008-4#7)(2008-7#1)
the P2Y(12)##3##2##(2008-4#3)
the P2Y(2) receptor##2##3##(2008-4#2)
the P3##4##2##(1994-5#2)(2008-10#2)
the P450##4##2##(1993-8#1)(1994-9#1)(2009-9#2)
the PA method##3##3##(2012-2#3)
the PA##7##2##(2007-11#1)(2009-11#1)(2009-6#1)(2012-2#4)
the PAA##2##2##(2008-10#2)
the PACE##4##2##(1992-1#1)(2008-7#3)
the PAD and##2##3##(2008-10#2)
the PAD##3##2##(2008-10#3)
the PAH##4##2##(2008-10#2)(2010-10#1)(2010-5#1)
the PAHs##3##2##(2008-10#3)
the PAI##3##2##(1995-2#1)(2008-10#2)
the PAM process##4##3##(2008-7#4)
the PAM##5##2##(2008-7#4)(2008-9#1)
the PANAS##4##2##(2013-8#4)
the PANI film##3##3##(2008-10#3)
the PANI##4##2##(2008-10#4)
the PANSS##2##2##(2008-12#1)(2008-6#1)
the PAP system##3##3##(2008-11#3)
the PAP##7##2##(2008-11#6)(2008-2#1)
the PAR##2##2##(2008-10#1)(2012-12#1)
the PAR1 region##2##3##(2008-7#2)
the PARI IS-2##2##3##(1995-3#2)
the PARP##2##2##(1993-12#1)(2010-6#1)
the PAS##3##2##(2007-12#3)
the PAV##2##2##(2008-10#2)
the PB film##2##3##(2008-10#2)
the PB layer##4##3##(2008-10#4)
the PB modified##2##3##(2008-10#2)
the PB##11##2##(1997-2#1)(2008-10#10)
the PB/HC-OES method and##2##4##(2010-11#2)
the PBL##5##2##(2008-10#1)(2008-12#1)(2013-8#3)
the PBMC##2##2##(2008-7#1)(2010-12#1)
the PBN##2##2##(2009-10#2)
the PBS##3##2##(2008-11#1)(2008-2#1)(2010-1#1)
the PC diet compared with##2##5##(2010-2#2)
the PC diet##4##3##(2010-2#4)
the PC##9##2##(1993-8#2)(2007-12#1)(2008-10#1)(2010-2#5)
the PC/TD system##3##3##(2008-10#3)
the PC12 cells##3##3##(1992-12#2)(2008-11#1)
the PC12##6##2##(1992-12#2)(1997-6#3)(2008-11#1)
the PCA##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
the PCA-BP neural network##2##4##(2013-8#2)
the PCB##2##2##(2008-10#2)
the PCDD/Fs##2##2##(2008-10#2)
the PCF##2##2##(2007-11#2)
the PCNA gene##2##3##(1995-6#2)
the PCNA##3##2##(1994-7#1)(1995-6#2)
the PCR and##3##3##(2008-10#1)(2008-4#2)
the PCR assay##2##3##(2008-10#2)
the PCR product##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
the PCR products##5##3##(1992-8#1)(1992-9#1)(2008-10#3)
the PCR reaction##2##3##(1994-11#1)(2008-8#1)
the PCR##31##2##(1990-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-1#1)
the PCR-amplified##2##2##(2008-10#2)
the PCR-based##2##2##(2008-10#2)
the PD and##2##3##(2012-3#1)(2013-1#1)
the PD patients##4##3##(2008-7#4)
the PD##18##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#6)(2011-2#4)(2012-3#1)(2013-1#3)
the PD-score##2##2##(2010-8#2)
the PDA##7##2##(2008-10#3)(2008-12#2)(2012-12#1)(2012-2#1)
the PDB##6##2##(2008-4#1)(2008-7#3)(2011-3#2)
the PDFE##3##2##(2008-2#3)
the PDGF##3##2##(1992-9#1)(1994-6#2)
the PDL##4##2##(2008-11#3)(2008-3#1)
the PDLC##3##2##(2008-2#1)(2008-3#2)
the PDLLA##2##2##(2008-5#2)
the PDMS##3##2##(2007-5#1)(2008-10#1)(2010-8#1)
the PDS##4##2##(2008-2#1)(2011-1#2)(2012-12#1)
the PDSI##2##2##(2008-7#2)
the PDT##2##2##(1994-1#1)(2008-3#1)
the PDZ-binding domain##2##3##(2011-2#2)
the PE##4##2##(1991-1#1)(1994-3#1)(2008-3#2)
the PEEK##2##2##(2008-10#1)(2010-4#1)
the PEG hydrogel group##3##4##(2012-3#3)
the PEG hydrogel##4##3##(2012-3#4)
the PEG##7##2##(2008-3#1)(2012-1#2)(2012-3#4)
the PEI##2##2##(1992-11#1)(2008-11#1)
the PEMS##2##2##(2009-5#2)
the PENTAX##2##2##(2008-5#2)
the PEP##4##2##(1997-3#1)(2009-12#3)
the PEPCK promoter##2##3##(1995-6#2)
the PEPCK##4##2##(1995-6#3)(1996-2#1)
the PET##5##2##(2011-2#2)(2012-12#3)
the PF-LIF signal##2##3##(2008-2#2)
the PFC of##3##3##(1997-2#3)
the PFC##16##2##(1996-5#2)(1997-2#7)(2008-4#1)(2008-7#1)(2013-8#5)
the PFH model##2##3##(1992-12#2)
the PFH##3##2##(1992-12#3)
the PFO##2##2##(1996-6#1)(2011-2#1)
the PG##7##2##(1990-2#3)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
the PGC column##2##3##(1996-5#1)(2008-10#1)
the PGE(2)##2##2##(2010-9#2)
the PGF2alpha##3##2##(1997-7#3)
the PGHS##3##2##(1997-1#3)
the PH##2##2##(2008-3#1)(2013-8#1)
the PHC##2##2##(2008-1#1)(2011-2#1)
the PHCs##2##2##(1994-3#2)
the PI pathway##2##3##(2008-8#2)
the PI##9##2##(1992-6#1)(1994-11#1)(1994-9#2)(1996-2#1)(2008-8#2)(2009-3#2)
the PI3K pathway##3##3##(2010-9#2)(2012-1#1)
the PI3K##5##2##(2010-9#2)(2012-1#1)(2012-3#1)(2013-7#1)
the PI3K/Akt pathway##2##3##(2009-9#1)(2013-7#1)
the PI3K/Akt##3##2##(2009-9#1)(2013-7#2)
the PICC##2##2##(2009-4#2)
the PIG1 locus##2##3##(2008-10#2)
the PIHCP##3##2##(2008-1#3)
the PILP approach##2##3##(2009-11#2)
the PILP models learned from##2##5##(2009-11#2)
the PILP##4##2##(2009-11#4)
the PIR##4##2##(1997-2#1)(2008-3#2)(2008-5#1)
the PISHG##3##2##(2008-3#3)
the PK##5##2##(2010-11#1)(2011-2#1)(2013-1#3)
the PKC inhibitor##2##3##(1993-3#1)(2008-4#1)
the PKC##9##2##(1992-9#1)(1993-3#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-4#1)
the PKC- and/or cAMP-dependent##2##4##(1997-2#2)
the PL##5##2##(1993-8#1)(1994-3#3)(2008-7#1)
the PL-free diet group##3##4##(2008-7#3)
the PLC##4##2##(1992-12#1)(2008-4#1)(2009-3#2)
the PLL is##2##3##(2008-10#2)
the PLLA##2##2##(2009-7#2)
the PLNA##3##2##(2008-10#3)
the PLP##2##2##(1992-6#2)
the PLS method##2##3##(2008-10#1)(2013-8#1)
the PLS model##2##3##(2008-10#2)
the PLS models##2##3##(2008-10#2)
the PLS##10##2##(2007-11#1)(2008-10#7)(2008-5#1)(2013-8#1)
the PLTP##2##2##(1997-4#2)
the PM and##2##3##(2008-10#1)(2008-7#1)
the PM##11##2##(2008-10#3)(2008-7#7)(2009-10#1)
the PM(2##3##2##(2008-5#3)
the PMD parameter##2##3##(2007-11#2)
the PMD##7##2##(2007-11#5)(2007-12#1)(2008-3#1)
the PMDF##2##2##(2008-3#2)
the PMG##4##2##(2008-1#4)
the PML##2##2##(2008-3#2)
the PMMA##2##2##(2008-2#1)(2009-11#1)
the PMMV-k##2##2##(1997-6#2)
the PMP22##2##2##(1997-3#2)
the PMT##5##2##(2008-10#2)(2008-3#2)(2008-5#1)
the PNDC##3##2##(2008-11#3)
the PNN##3##2##(2010-8#3)
the PNS##2##2##(2008-7#2)
the PNW were##2##3##(2008-10#2)
the PNW##3##2##(2008-10#3)
the PO2##3##2##(2013-8#3)
the POA neurons in##2##4##(2008-8#2)
the POA neurons##3##3##(2008-8#3)
the POM##3##2##(1995-2#1)(2010-6#2)
the POR##2##2##(1993-1#1)(1995-5#1)
the POU domain##2##3##(1992-6#2)
the POX##2##2##(1997-4#2)
the PP RTA##2##3##(2007-12#2)
the PP##3##2##(2007-12#2)(2008-10#1)
the PPA/HP-beta-CD##2##2##(2008-10#2)
the PPI##2##2##(1996-5#1)(2012-2#1)
the PPLN##2##2##(2007-12#2)
the PPP##2##2##(2008-7#2)
the PPS##4##2##(1992-12#1)(2008-2#3)
the PPSDHM##2##2##(2011-1#2)
the PPT##2##2##(2009-5#2)
the PPTg##4##2##(1994-2#3)(1995-12#1)
the PPy##2##2##(2008-10#2)
the PR##5##2##(1994-9#1)(1996-5#1)(2008-10#2)(2010-1#1)
the PRL profile##2##3##(2008-7#2)
the PRL##5##2##(2008-10#1)(2008-7#4)
the PROT protein##2##3##(1995-6#2)
the PRRS##2##2##(2008-3#2)
the PS##3##2##(2008-10#3)
the PSA##3##2##(2008-3#1)(2008-4#1)(2009-5#1)
the PSC##4##2##(2010-10#4)
the PSD##8##2##(1996-12#4)(1997-2#1)(2008-3#3)
the PSG##2##2##(1990-5#1)(2008-3#1)
the PSI##2##2##(2008-7#1)(2008-8#1)
the PSII extrinsic polypeptides##2##4##(2008-4#2)
the PSII##4##2##(2008-4#3)(2008-8#1)
the PSP temperatures##2##3##(2008-3#2)
the PSP##6##2##(2008-3#6)
the PT##2##2##(2012-12#1)(2013-1#1)
the PTFE##5##2##(2007-7#1)(2008-10#3)(2008-3#1)
the PTH##4##2##(1997-7#2)(2008-10#1)(2008-8#1)
the PTH2 receptor##2##3##(1995-6#2)
the PTSD##2##2##(1996-7#1)(2012-1#1)
the PVA##6##2##(2008-10#2)(2008-12#1)(2008-5#2)(2009-12#1)
the PVN##2##2##(1994-8#2)
the PVP layer##2##3##(2010-4#2)
the PVP##4##2##(2008-10#2)(2010-4#2)
the PVV isolates##2##3##(2008-10#2)
the Pacific Island Health Care Project (PIHCP)##2##7##(2008-1#2)
the Pacific Island##4##3##(2008-1#4)
the Pacific Northwest##11##3##(2008-10#10)(2008-5#1)
the Pacific Ocean##5##3##(1996-4#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)
the Pacific coast of##3##4##(2008-10#1)(2009-2#1)(2012-12#1)
the Pacific coast##5##3##(2008-10#1)(2008-5#1)(2009-2#1)(2012-12#2)
the Pacific##66##2##(1990-12#1)(1994-9#1)(1995-11#2)(1996-4#1)(2008-1#20)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#7)(2008-9#1)(2009-2#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#11)(2013-7#4)(2013-8#1)
the Pacificans'##2##2##(2008-1#2)
the Paediatric##2##2##(2009-5#1)(2013-1#1)
the Page serovar C##2##4##(2008-5#2)
the Painlevé##2##2##(1991-9#2)
the Palau AHEC##3##3##(2008-1#3)
the Palau##8##2##(2008-1#8)
the Pan American Health Organization##3##5##(1992-5#1)(1994-9#1)(2013-1#1)
the Panhandle##2##2##(2008-10#2)
the Pantanal##4##2##(2013-7#4)
the Pap smear##5##3##(1991-6#2)(1992-3#3)
the Pap test##2##3##(1991-6#1)(2008-11#1)
the Pap##7##2##(1991-6#3)(1992-3#3)(2008-11#1)
the Parasitic##2##2##(2008-10#2)
the Parent##3##2##(1992-2#1)(1994-3#1)(2011-2#1)
the Parental##2##2##(1992-2#1)(2009-11#1)
the Paridae##2##2##(2008-9#2)
the Paris##3##2##(2008-2#1)(2010-1#1)(2012-3#1)
the Parkinson's##4##2##(2008-7#3)(2013-1#1)
the Parliament##2##2##(2007-5#1)(2009-7#1)
the Parque Nacional Cahuita##3##4##(2011-2#3)
the Parque Nacional##5##3##(2008-5#2)(2011-2#3)
the Parry##2##2##(2008-3#2)
the Part##2##2##(1993-12#1)(1995-12#1)
the Parties##2##2##(1996-1#2)
the Partnered Research Center for Quality Care##2##7##(2012-2#2)
the Pathogen##3##2##(2008-10#3)
the Patient Self-Determination Act##2##4##(1992-12#1)(1993-3#1)
the Patient##9##2##(1992-12#1)(1993-3#2)(1994-1#1)(1994-3#1)(1996-1#1)(2010-2#1)(2011-1#1)(2012-1#1)
the Pavlik harness in##2##4##(2007-8#2)
the Pavlik harness##5##3##(2007-8#5)
the Pavlik##6##2##(2007-8#6)
the Pb concentration in##2##4##(1992-3#2)
the Pb isotopic##4##3##(2013-8#4)
the Pb##6##2##(1992-3#2)(2013-8#4)
the Pb2+ concentration##2##3##(2013-8#2)
the Pb2+##4##2##(2013-8#4)
the Ped gene (Qa-2(a))##2##4##(2008-5#2)
the Ped gene##3##3##(2008-5#3)
the Pediatric Clinic##2##3##(2008-9#1)(2011-1#1)
the Pediatric Emergency##2##3##(2011-2#1)(2013-8#1)
the Pediatric##9##2##(1990-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
the Peltier##2##2##(2008-10#1)(2008-9#1)
the Peninsula Maternal and Neonatal##2##5##(2010-3#2)
the Pennsylvania##3##2##(1995-1#1)(2008-1#1)(2010-1#1)
the Pentagon##2##2##(1996-5#2)
the People's Republic of China##4##5##(1997-3#1)(2007-12#1)(2007-7#1)(2008-7#1)
the Performance of##2##3##(2007-12#1)(2010-8#1)
the Performance##3##2##(2007-12#2)(2010-8#1)
the Perl's Prussian blue reaction##2##5##(2013-8#2)
the Persian Gulf##3##3##(2008-12#3)
the Peruvian##9##2##(2008-10#3)(2008-8#1)(2011-2#1)(2013-8#4)
the Pfam database##2##3##(2008-4#2)
the Pfam##3##2##(2008-4#2)(2010-10#1)
the Pharmaceutical##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
the Pharmacy##3##2##(2011-1#1)(2012-3#2)
the Phase##4##2##(1996-9#1)(2008-3#2)(2009-4#1)
the Phe M197--&gt##2##3##(1993-11#2)
the Phe##4##2##(1992-4#1)(1992-8#1)(1993-11#2)
the Philadelphia chromosome##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
the Philadelphia##4##2##(2008-6#1)(2010-1#1)(2011-2#1)(2012-12#1)
the Philippine##2##2##(2008-10#2)
the Philippines##7##2##(2007-5#2)(2008-5#1)(2008-8#2)(2010-8#1)(2012-12#1)
the Phreatoicidea##2##2##(2007-12#2)
the Physical##3##2##(1994-3#1)(1997-3#1)(2008-4#1)
the Physician##2##2##(1994-1#1)(2012-1#1)
the Physikalisch-Meteorologisches Observatorium##2##3##(2008-2#1)(2008-3#1)
the Phytophthora alpha1 mating hormone##2##5##(2008-11#2)
the Phytophthora genus-specific amplicon##2##4##(2008-10#2)
the Phytophthora genus-specific primer pair##2##5##(2008-10#2)
the Phytophthora genus-specific##5##3##(2008-10#5)
the Phytophthora sp-h isolates##4##4##(2008-10#4)
the Phytophthora##14##2##(2008-10#12)(2008-11#2)
the Pi-ta##4##2##(2008-10#4)
the Picture Description Task##2##4##(2008-7#2)
the Pierre##3##2##(1990-5#1)(2008-3#2)
the Pik##3##2##(2008-10#3)
the Pista River##2##3##(2013-1#2)
the Plan##2##2##(2008-7#1)(2013-1#1)
the Planck function##2##3##(2008-2#1)(2008-3#1)
the Planetary##2##2##(2008-2#2)
the Plant Ontology##5##3##(2008-7#5)
the Plant##8##2##(2008-10#3)(2008-7#5)
the Plant-Parasitic##3##2##(2008-10#3)
the Plaque Assay and##2##4##(2008-10#2)
the Plaque Assay##5##3##(2008-10#5)
the Plasmodium yoelii yoelii##2##4##(1994-12#2)
the Plasmodium yoelii##3##3##(1994-12#2)(2008-3#1)
the Plasmodium##5##2##(1994-12#2)(2008-3#1)(2008-8#1)(2012-12#1)
the Pleistocene##6##2##(1996-6#1)(2008-8#1)(2008-9#2)(2010-8#2)
the Plum pox virus##2##4##(2008-10#2)
the Plum##3##2##(2008-10#2)(2011-2#1)
the Pm-AMP1##4##2##(2008-10#4)
the Pm3##2##2##(2008-10#2)
the Pockels readout optical modulator##2##5##(2008-2#2)
the Poisson distribution##2##3##(1995-6#1)(2008-10#1)
the Poisson##5##2##(1995-6#1)(2008-10#3)(2008-3#1)
the Polish Pediatric Leukemia/Lymphoma Study Group##2##6##(2011-2#2)
the Polish intelligentsia##2##3##(2008-12#2)
the Polish##24##2##(2007-8#3)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#3)(2009-5#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
the Polymerase Chain Reaction##3##4##(2008-10#2)(2013-8#1)
the Population##7##2##(1996-3#1)(1996-8#1)(2008-10#3)(2008-3#1)(2010-12#1)
the Portuguese##4##2##(2009-10#2)(2009-7#2)
the Positive and Negative Syndrome Scale##3##6##(1996-5#1)(2008-6#1)(2011-1#1)
the Positive and Negative##4##4##(1996-5#1)(2008-6#1)(2011-1#1)(2013-8#1)
the Postharvest##3##2##(2008-10#3)
the Potato##2##2##(2008-10#2)
the Potential##3##2##(2008-10#2)(2013-8#1)
the Pourbaix##2##2##(2008-10#2)
the Power##2##2##(2009-11#1)(2013-1#1)
the Presence of##7##3##(1994-7#1)(1996-5#1)(2008-10#4)(2011-1#1)
the President of##3##3##(1992-3#1)(2008-7#2)
the President signed into law House Resolution##3##7##(1991-12#1)(1991-3#1)(1993-1#1)
the President signed into law##4##5##(1991-12#1)(1991-3#1)(1993-1#1)(1994-3#1)
the President##9##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-12#1)(2008-7#2)
the President's##2##2##(1993-5#1)(2010-1#1)
the Prestige's##2##2##(2008-10#2)
the Prevention of##5##3##(2008-11#1)(2010-12#1)(2011-1#2)(2013-8#1)
the Primary Care##2##3##(1996-1#1)(1996-2#1)
the Primary Health Care##2##4##(1990-6#1)(2009-10#1)
the Primary Health##3##3##(1990-6#1)(2009-10#1)(2013-8#1)
the Primary##8##2##(1990-6#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-5#1)(2009-10#1)(2013-8#1)
the Principles##2##2##(2008-8#2)
the Pro##2##2##(1990-5#1)(2011-2#1)
the Process##2##2##(1997-7#1)(2008-11#1)
the Production of##3##3##(2008-10#1)(2008-11#2)
the Production##4##2##(2008-10#2)(2008-11#2)
the Profile of##2##3##(2009-10#1)(2013-8#1)
the Profile##3##2##(2008-4#1)(2009-10#1)(2013-8#1)
the Program of##2##3##(1991-2#1)(1994-2#1)
the Program##7##2##(1991-2#1)(1991-8#1)(1993-6#1)(1994-2#1)(1995-12#1)(2008-7#1)(2013-1#1)
the Programme of Action##3##4##(2008-11#3)
the Project 2000 curriculum##2##4##(2008-11#2)
the Project 2000##3##3##(2008-11#3)
the Protein Data Bank##3##4##(2008-4#2)(2011-3#1)
the Province of##4##3##(1991-2#1)(1991-6#1)(1992-12#1)(1995-12#1)
the Prunus##2##2##(2011-2#2)
the Prussian blue##2##3##(2008-10#2)
the Prussian##5##2##(2008-10#5)
the Pseudomonas##5##2##(1995-2#1)(2008-10#3)(2009-6#1)
the Pt##3##2##(2008-10#2)(2008-11#1)
the PubMed##6##2##(2008-11#1)(2011-1#1)(2012-2#1)(2013-8#3)
the Public Health Service##2##4##(1991-1#1)(2012-2#1)
the Public Health##7##3##(1991-1#1)(1996-2#1)(1997-2#1)(2008-11#1)(2012-12#2)(2012-2#1)
the Public##10##2##(1991-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#2)(2012-2#1)
the Pulse##2##2##(2013-7#2)
the PurR function##2##3##(2008-8#2)
the PurR##3##2##(2008-8#3)
the Purkinje cell##4##3##(1992-12#2)(1992-9#1)(2013-8#1)
the Purkinje##6##2##(1992-12#2)(1992-9#1)(1994-2#1)(2008-10#1)(2013-8#1)
the Pygmy##2##2##(1993-6#1)(2011-2#1)
the Pythium##3##2##(2008-10#3)
the Q factor of the##2##5##(2007-12#1)(2008-3#1)
the Q factor of##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
the Q factor##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
the Q##9##2##(2007-11#2)(2007-12#1)(2008-3#4)(2011-2#2)
the Q-switched mode##4##3##(2008-3#4)
the Q-switched pulse##3##3##(2008-3#3)
the Q-switched##8##2##(2007-12#1)(2008-3#7)
the Q-switching##2##2##(2008-3#2)
the Q/R site##3##3##(1993-12#1)(1995-5#2)
the QA-810 V##4##3##(2008-10#4)
the QCM##5##2##(2008-10#5)
the QDA##2##2##(2008-10#2)
the QDs##2##2##(2013-8#2)
the QI##2##2##(1993-2#1)(1994-12#1)
the QIs##3##2##(1996-2#2)(2013-1#1)
the QOL score##2##3##(1994-12#2)
the QOL##6##2##(1994-12#3)(1995-4#1)(2008-4#1)(2012-2#1)
the QRS complex##2##3##(2010-8#2)
the QRS##5##2##(2008-10#1)(2010-1#1)(2010-8#2)(2013-8#1)
the QS-L1##2##2##(1997-4#2)
the QT interval##2##3##(2008-8#2)
the QT##3##2##(2008-12#1)(2008-8#2)
the QTL for##3##3##(2008-10#3)
the QTL on##3##3##(2008-10#3)
the QTL##15##2##(2008-10#12)(2009-10#1)(2009-5#2)
the QTLs##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
the QWB##2##2##(1996-7#2)
the Qinghai-Tibet Plateau##3##3##(2008-9#2)(2009-5#1)
the Quality Assurance##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
the Quality of Life##4##4##(1994-3#2)(1995-4#1)(2010-3#1)
the Quality of##5##3##(1994-3#2)(1995-4#1)(1996-7#1)(2010-3#1)
the Quality##9##2##(1993-12#1)(1994-3#2)(1995-4#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2010-3#1)
the Quebec experience##2##3##(2012-2#2)
the Quebec##7##2##(1991-12#1)(1993-12#1)(1997-7#1)(2008-11#1)(2008-3#1)(2012-2#2)
the Quercus species##2##3##(2012-6#1)(2012-9#1)
the QuickVue##3##2##(2011-2#3)
the R state##2##3##(1990-8#2)
the R##53##2##(1990-8#5)(1993-6#6)(1995-3#2)(1995-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#28)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-7#1)
the R&amp##3##2##(2008-5#1)(2008-8#2)
the R(50) transition##2##3##(2008-3#2)
the R-D-LSI##3##2##(2012-2#3)
the R-state##2##2##(1995-2#1)(1995-6#1)
the R1##2##2##(1993-11#1)(2008-10#1)
the R2 protein##2##3##(1993-11#2)
the R304K mutant##2##3##(1995-2#2)
the RA##3##2##(2007-8#1)(2008-11#2)
the RA5 antibody##2##3##(2008-6#2)
the RAD3##2##2##(1993-12#1)(1995-9#1)
the RAM##2##2##(2008-10#1)(2012-2#1)
the RAND##3##2##(2008-10#2)(2010-12#1)
the RAPD##6##2##(2008-10#3)(2008-5#3)
the RAS##3##2##(2008-6#1)(2011-3#1)(2012-3#1)
the RB##5##2##(1992-8#1)(1993-8#1)(1996-2#1)(2008-10#1)(2013-1#1)
the RBC##4##2##(1995-2#1)(2008-10#1)(2013-1#2)
the RBCM##3##2##(1994-12#3)
the RBCs##2##2##(1994-12#2)
the RCA cells##2##3##(1992-3#2)
the RCA##4##2##(1992-3#3)(2008-10#1)
the RCCS bioreactor##2##3##(2009-7#2)
the RE##2##2##(2008-10#2)
the REE concentrations##2##3##(2008-10#2)
the REE##5##2##(2008-10#5)
the RESEARCH and T-SEARCH##2##4##(2008-11#2)
the RF##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
the RFLP and RAPD##2##4##(2008-5#2)
the RFLP markers##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
the RFLP##6##2##(2008-10#2)(2008-5#3)(2008-9#1)
the RFN##2##2##(1993-12#2)
the RGD sequence##6##3##(1994-11#2)(1995-6#4)
the RGD##8##2##(1994-11#2)(1995-6#4)(2008-7#2)
the RGDS##2##2##(1990-5#2)
the RH##2##2##(1994-12#1)(2008-10#1)
the RHD##2##2##(2012-2#1)(2012-3#1)
the RI of##2##3##(2007-11#2)
the RI##5##2##(1994-5#1)(2007-11#2)(2008-10#2)
the RIG##2##2##(2008-10#2)
the RIL population##4##3##(2008-10#4)
the RILs##2##2##(2008-10#2)
the RIP##2##2##(2008-10#1)(2008-2#1)
the RIPs##2##2##(1990-12#2)
the RIS##3##2##(1994-2#1)(1996-3#2)
the RK motif##3##3##(1995-6#3)
the RK##6##2##(1995-6#5)(2009-8#1)
the RLS of##2##3##(2008-10#2)
the RLS signals of##2##4##(2008-10#2)
the RLS signals##4##3##(2008-10#4)
the RLS##8##2##(2008-10#8)
the RLV-2100 &quot##2##3##(1991-3#2)
the RM##4##2##(1991-4#1)(1996-2#1)(2008-10#2)
the RMI show that 62##2##5##(2013-8#2)
the RMI##3##2##(2008-1#1)(2013-8#2)
the RMSE##2##2##(2008-2#1)(2013-8#1)
the RN buddy role##2##4##(2008-12#2)
the RN##8##2##(1992-12#1)(2008-1#1)(2008-12#4)(2010-2#1)(2010-4#1)
the RN's##2##2##(2010-11#2)
the RNA component of##2##4##(2008-11#1)(2008-9#1)
the RNA from##2##3##(1993-8#1)(2008-10#1)
the RNA is##3##3##(1997-7#2)(2008-2#1)
the RNA polymerase II##2##4##(1997-7#1)(2008-10#1)
the RNA polymerase##6##3##(1995-6#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)
the RNA product##3##3##(1994-8#1)(2008-4#2)
the RNA secondary structure##3##4##(1991-9#2)(2011-3#1)
the RNA secondary##4##3##(1991-9#2)(2008-4#1)(2011-3#1)
the RNA structure##2##3##(1994-11#1)(2008-10#1)
the RNA##47##2##(1990-5#1)(1991-9#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#3)(1997-2#1)(1997-3#1)(1997-7#3)(2008-10#10)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-6#1)(2011-3#1)
the RNA-dependent RNA polymerase gene##2##5##(2008-10#2)
the RNA-dependent RNA polymerase##4##4##(2008-10#4)
the RNAs##2##2##(2008-10#1)(2008-9#1)
the RNase##5##2##(1990-11#1)(1992-11#3)(2008-4#1)
the RO children at##2##4##(2008-11#2)
the RO children were##2##4##(2008-11#2)
the RO children##5##3##(2008-11#5)
the RO##6##2##(2008-11#6)
the ROC##8##2##(2007-8#2)(2008-10#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-12#1)
the ROI##2##2##(2010-2#1)(2010-8#1)
the ROS##2##2##(1995-5#1)(2010-12#1)
the RP##4##2##(2010-1#1)(2010-10#1)(2012-2#2)
the RP-HPLC official method##2##4##(2008-10#2)
the RP-HPLC##3##2##(1990-2#1)(2008-10#2)
the RPP and##2##3##(2007-12#2)
the RPP calibration set##3##4##(2007-12#3)
the RPP sample set##2##4##(2007-12#2)
the RPP##9##2##(2007-12#9)
the RPT technique##4##3##(2008-3#4)
the RPT##5##2##(2008-3#5)
the RR values##2##3##(2008-10#2)
the RR##3##2##(2008-10#3)
the RRE and##2##3##(1994-8#2)
the RRE with##3##3##(1993-8#3)
the RRE##10##2##(1993-8#8)(1994-8#2)
the RRS intensity##2##3##(2008-10#2)
the RRS technology##2##3##(2008-10#2)
the RRS##6##2##(2008-10#6)
the RRs##2##2##(1993-9#1)(2013-1#1)
the RS and IRS##2##4##(2008-12#2)
the RS##5##2##(1995-3#1)(2008-10#1)(2008-12#2)(2009-2#1)
the RS+##3##2##(1997-8#3)
the RSC##2##2##(2008-10#1)(2012-12#1)
the RSD of the##4##4##(2008-10#4)
the RSD was##3##3##(2008-10#3)
the RSD##10##2##(2008-10#10)
the RT##5##2##(1995-5#1)(1997-3#3)(2011-2#1)
the RT-PCR##10##2##(2008-10#3)(2008-5#3)(2008-8#1)(2009-12#1)(2010-5#1)(2012-2#1)
the RTD##4##2##(2008-10#4)
the RTP quenching##2##3##(2008-10#2)
the RTP##11##2##(2008-10#11)
the RTS endpoints##2##3##(2008-10#2)
the RTS##3##2##(2008-10#3)
the RUC##2##2##(2009-7#2)
the RV##2##2##(2008-10#2)
the RVC##4##2##(2008-10#4)
the RWJF##2##2##(2013-1#2)
the RYSV##2##2##(2008-8#2)
the Rab##2##2##(1994-9#1)(1995-6#1)
the Radionics##2##2##(2008-7#2)
the Rainbow Trout##2##3##(2008-5#1)(2008-6#1)
the Ram1##2##2##(1993-9#2)
the Raman contribution##2##3##(2008-3#2)
the Raman differential absorption lidar##2##5##(2008-3#2)
the Raman effect##3##3##(2007-12#2)(2008-10#1)
the Raman gain coefficient was##2##5##(2007-11#1)(2008-3#1)
the Raman gain coefficients##2##4##(2007-12#1)(2008-3#1)
the Raman gain##6##3##(2007-11#3)(2007-12#1)(2008-3#2)
the Raman peaks##2##3##(1996-2#1)(2007-11#1)
the Raman scattering coefficient##3##4##(2008-2#2)(2008-3#1)
the Raman scattering cross section of##2##6##(2008-3#2)
the Raman scattering cross section##3##5##(2007-12#1)(2008-3#2)
the Raman scattering##8##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2011-1#1)
the Raman signal##2##3##(2008-10#1)(2009-4#1)
the Raman source function##2##4##(2008-3#2)
the Raman spectra of##2##4##(2008-2#1)(2013-8#1)
the Raman spectra##4##3##(2008-10#1)(2008-2#1)(2013-8#2)
the Raman spectroscopy##2##3##(2013-8#2)
the Raman spectrum of##2##4##(2008-2#1)(2008-3#1)
the Raman spectrum##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
the Raman##63##2##(1991-5#1)(1996-2#2)(2007-11#8)(2007-12#4)(2008-10#8)(2008-2#5)(2008-3#18)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#3)(2011-2#1)(2013-8#8)
the Raman-Nath##3##2##(2007-12#1)(2008-2#2)
the Ras signaling pathway##2##4##(1994-8#2)
the Ras##6##2##(1994-8#3)(1995-2#2)(1995-8#1)
the Ras-binding##3##2##(1995-5#2)(2013-8#1)
the Rasch model##4##3##(2008-11#1)(2009-11#1)(2012-2#2)
the Rasch##6##2##(2008-11#1)(2009-11#1)(2011-2#1)(2012-2#3)
the Rayleigh limit of resolution##2##5##(2008-3#2)
the Rayleigh limit##4##3##(2008-2#1)(2008-3#3)
the Rayleigh scattering##3##3##(2008-2#1)(2008-3#2)
the Rayleigh##15##2##(2007-11#1)(2008-10#1)(2008-2#6)(2008-3#7)
the Rayleigh-Gans approximation##2##3##(2008-2#2)
the Rayleigh-Sommerfeld##3##2##(2008-2#1)(2008-3#2)
the Rb##2##2##(1992-6#1)(1997-7#1)
the ReView##2##2##(2008-11#2)
the Reactome database##3##3##(2008-4#3)
the Reagan administration##5##3##(1991-1#5)
the Reagan##7##2##(1991-1#5)(1993-2#2)
the Real Economic Stabilization##2##4##(2008-9#2)
the Real##3##2##(2008-5#1)(2008-9#2)
the Red Queen hypothesis##3##4##(2009-2#3)
the Red##5##2##(1991-11#1)(2008-10#1)(2009-2#3)
the Reduced##2##2##(1990-11#1)(2008-10#1)
the Reference##2##2##(1995-1#1)(2013-1#1)
the Regional##10##2##(1990-2#2)(1991-12#1)(1997-8#1)(2008-10#3)(2012-12#2)(2013-8#1)
the Registrar General of##2##4##(2008-10#1)(2009-4#1)
the Rehabilitation Act##2##3##(1995-12#2)
the Rehabilitation Clinic##2##3##(2007-11#1)(2007-8#1)
the Rehabilitation##6##2##(1995-12#2)(2007-11#2)(2007-8#1)(2008-10#1)
the Relational Completion Procedure##4##4##(2011-2#4)
the Relationship between##3##3##(1996-9#1)(2008-3#1)(2013-1#1)
the Relationship##4##2##(1996-9#1)(2008-3#1)(2010-8#1)(2013-1#1)
the Release of##3##3##(2008-10#2)(2009-11#1)
the Release##4##2##(2008-10#3)(2009-11#1)
the Religious Society of Friends##2##5##(2012-2#2)
the Renaissance##2##2##(2008-11#1)(2011-2#1)
the Rep gene##3##3##(2008-10#3)
the Rep##7##2##(2008-10#7)
the Republic of Belarus##2##4##(2008-10#1)(2011-2#1)
the Republic of Croatia##4##4##(2011-2#2)(2013-1#2)
the Republic of Ireland##2##4##(1997-8#1)(2008-10#1)
the Republic of Palau and##3##5##(2008-1#2)(2013-8#1)
the Republic of Palau##9##4##(2008-1#7)(2013-8#2)
the Republic of the Marshall Islands##4##6##(2008-1#2)(2013-8#2)
the Republic of the##5##4##(2008-1#3)(2013-8#2)
the Republic of##28##3##(1995-3#1)(1997-8#1)(2008-1#10)(2008-10#2)(2010-11#1)(2010-3#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#4)
the Republic##29##2##(1995-3#1)(1997-8#1)(2008-1#10)(2008-10#2)(2010-11#1)(2010-3#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
the Republicans##2##2##(1995-6#1)(1997-2#1)
the Research##4##2##(1997-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
the Resource Utilization Groups##2##4##(1993-2#1)(1997-1#1)
the Resource##3##2##(1993-2#1)(1994-3#1)(1997-1#1)
the Response##3##2##(2008-10#2)(2009-4#1)
the Restin##2##2##(2008-9#2)
the Rev virus##2##3##(2007-6#2)
the Rev##3##2##(1993-8#1)(2007-6#2)
the Rev-mediated RNA nuclear export##2##5##(2011-3#2)
the Rev-responsive element##2##3##(1994-8#2)
the Rex-1 promoter##2##3##(1994-9#2)
the Rex-1##6##2##(1994-9#6)
the Rh##4##2##(1992-12#1)(1994-12#2)(2008-2#1)
the RhB##2##2##(2008-10#2)
the Rhizobium-legume symbiosis##2##3##(2008-11#2)
the Rhodamine##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
the Rhône##2##2##(2008-10#1)(2010-8#1)
the Rice##4##2##(2008-10#2)(2009-10#1)(2013-8#1)
the Richards function##2##3##(2008-10#2)
the Richards model##2##3##(2008-10#2)
the Richards##5##2##(2008-10#5)
the Right##2##2##(2012-3#1)(2013-1#1)
the Rio Grande Valley##2##4##(2008-10#2)
the Rio##4##2##(2008-10#3)(2008-5#1)
the Rippey and the Rodel appliqués##2##6##(2008-3#2)
the Rippey and##3##3##(2008-3#3)
the Rippey##4##2##(2008-3#4)
the Risk of##3##3##(2008-10#2)(2009-6#1)
the Risk##4##2##(1997-3#1)(2008-10#2)(2009-6#1)
the Ritz-Carlton's approach to strategic planning##2##6##(1994-2#1)(1994-3#1)
the Riyadh##3##2##(2008-1#2)(2013-1#1)
the Road Map##3##3##(2011-1#3)
the Robert Wood Johnson Foundation's##2##5##(1996-12#1)(2013-1#1)
the Robert Wood Johnson##3##4##(1993-2#1)(1996-12#1)(2013-1#1)
the Robert##5##2##(1993-2#1)(1996-1#1)(1996-12#1)(2011-2#1)(2013-1#1)
the Roberts wavelet filter##2##4##(2008-2#2)
the Roberts##3##2##(2008-2#3)
the Robo1##2##2##(2011-2#2)
the Rochester##2##2##(1992-12#1)(1996-2#1)
the Rodel##3##2##(2008-3#3)
the Role of##11##3##(2008-10#3)(2008-6#1)(2009-10#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
the Role##12##2##(2008-10#3)(2008-6#1)(2009-10#2)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
the Roles##2##2##(1997-2#1)(2013-1#1)
the Roman##4##2##(2008-10#2)(2010-1#2)
the Romanian##3##2##(1990-5#1)(2008-1#1)(2010-4#1)
the Ronchi test##4##3##(2008-2#1)(2008-3#3)
the Ronchi##6##2##(2008-2#1)(2008-3#5)
the Root##2##2##(2008-10#2)
the Root-Knot Nematode##2##3##(2008-10#2)
the Rosascos##3##2##(1996-5#3)
the Royal College of Physicians##4##5##(1990-9#1)(1994-12#1)(1996-8#2)
the Royal College of##8##4##(1990-3#1)(1990-9#1)(1994-12#2)(1996-8#2)(2012-12#1)(2012-3#1)
the Royal College##9##3##(1990-3#1)(1990-9#1)(1994-12#2)(1996-8#2)(2008-11#1)(2012-12#1)(2012-3#1)
the Royal Marsden Hospital##2##4##(2008-6#2)
the Royal##24##2##(1990-2#1)(1990-3#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#2)(1996-8#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
the Rp isomer of##2##4##(1990-12#1)(2009-2#1)
the Rp##4##2##(1990-12#1)(1994-12#2)(2009-2#1)
the RpII LS##3##3##(1997-7#3)
the Rpc1 locus##2##3##(2008-10#2)
the Rph3##2##2##(2008-10#2)
the Rural Health##3##3##(1996-2#1)(1996-3#1)(2008-12#1)
the Russian##9##2##(1995-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
the Rust Fungus##2##3##(2008-10#2)
the Rust##3##2##(2008-10#3)
the Rx1##2##2##(2008-10#2)
the RyR1s##5##2##(2008-9#5)
the Ryan White CARE Act and##2##6##(1995-12#1)(1996-5#1)
the Ryan White##3##3##(1995-12#1)(1995-6#1)(1996-5#1)
the Ría##2##2##(2010-5#2)
the S RNA##3##3##(2008-10#3)
the S and##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
the S column##3##3##(1995-3#3)
the S function##2##3##(2008-3#2)
the S phase of the cell cycle##2##7##(1994-8#1)(2008-9#1)
the S phase##11##3##(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-8#1)(2008-11#2)(2008-9#2)
the S strain##3##3##(2008-10#3)
the S##60##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-2#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#4)(1995-5#1)(1996-6#3)(1997-5#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#16)(2008-11#6)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-8#2)
the S(1)##2##2##(2007-1#1)(2009-9#1)
the S-100 family##2##3##(1991-6#2)
the S-dsRNA##5##2##(2008-10#5)
the S-nitroso adduct of##3##4##(1995-5#3)
the S-phase fraction##3##3##(1993-1#1)(1993-11#1)(1994-12#1)
the S-phase##6##2##(1993-1#1)(1993-11#1)(1994-12#1)(1997-1#2)(2008-4#1)
the S-shaped##2##2##(2008-10#1)(2010-2#1)
the S1 protein##2##3##(1997-3#1)(2008-5#1)
the S1##11##2##(1997-3#4)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#3)
the S100 family##2##3##(1992-6#2)
the S182 gene on chromosome 14q24##2##6##(1995-8#2)
the S182 gene##3##3##(1995-8#3)
the S182##4##2##(1995-8#4)
the S1NPV polh promoter##2##4##(1997-4#2)
the S4##2##2##(1995-8#1)(2008-8#1)
the S6##2##2##(1997-6#1)(2008-8#1)
the SA concentration range##2##4##(2008-10#2)
the SA##7##2##(1995-11#1)(2008-10#3)(2008-2#1)(2009-8#1)(2011-10#1)
the SAB1##2##2##(1997-8#2)
the SAGE II##2##3##(2008-2#2)
the SAGE##3##2##(2008-2#3)
the SAM##13##2##(2008-10#11)(2010-4#1)(2012-2#1)
the SAMs##3##2##(2008-10#3)
the SAR##4##2##(1992-3#1)(2008-3#1)(2008-8#2)
the SAR-inducing##3##2##(2008-10#3)
the SARS##2##2##(2007-5#1)(2009-7#1)
the SAS##2##2##(2008-7#1)(2009-8#1)
the SBCH##3##2##(2008-2#3)
the SC and HDC##2##4##(2008-10#2)
the SC and##3##3##(2008-10#2)(2008-5#1)
the SC barrier function##2##4##(2008-5#2)
the SC##30##2##(2008-10#4)(2008-5#25)(2009-11#1)
the SCA 4 l/min group##2##5##(2011-2#2)
the SCA1##2##2##(1997-5#2)
the SCAR locus##2##3##(2008-10#2)
the SCAR##6##2##(2008-10#4)(2009-10#2)
the SCAVM##2##2##(1995-11#1)(1997-6#1)
the SCC-DFTB##3##2##(2008-10#1)(2012-12#2)
the SCG##2##2##(1991-12#1)(1994-8#1)
the SCGE assay##2##3##(1997-4#2)
the SCMV##3##2##(2008-10#3)
the SCN##11##2##(1993-12#5)(1993-9#2)(1994-2#3)(1994-5#1)
the SCR##2##2##(2008-10#1)(2011-2#1)
the SD of HbA1c levels (r = 0##2##6##(2012-5#2)
the SD of HbA1c levels##3##5##(2012-5#3)
the SD##6##2##(2008-6#1)(2009-11#1)(2012-5#3)(2013-1#1)
the SDC##2##2##(1991-9#2)
the SDLA##2##2##(2008-3#2)
the SDS gel##2##3##(2008-10#2)
the SDS##6##2##(1994-9#1)(2008-10#4)(2008-5#1)
the SDS-PAGE##3##2##(1990-8#1)(1992-12#1)(2012-3#1)
the SE United States##2##4##(2008-10#2)
the SE##7##2##(2008-10#5)(2008-11#1)(2008-3#1)
the SEA##4##2##(1993-6#4)
the SEC##2##2##(1991-2#1)(1997-2#1)
the SERS measurement##2##3##(2007-12#1)(2008-2#1)
the SERS spectra of HA##2##5##(2013-8#2)
the SERS spectrum##2##3##(2008-10#2)
the SERS##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2013-1#2)(2013-8#2)
the SERS-active##2##2##(2008-10#2)
the SERVQUAL scale##2##3##(1993-12#2)
the SF##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
the SF-36##7##2##(1994-3#2)(1996-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
the SF-CO(2) extraction##2##3##(2008-10#2)
the SF-CO(2)##3##2##(2008-10#3)
the SFC##2##2##(2008-10#1)(2008-6#1)
the SFE and##2##3##(2008-10#2)
the SFE##5##2##(2008-10#5)
the SFG nonresonant signal##2##4##(2008-10#2)
the SFG##4##2##(2008-10#4)
the SFLLR##2##2##(1992-4#2)
the SFO##3##2##(1992-5#1)(1994-2#2)
the SFV expression##2##3##(2008-11#2)
the SFV##3##2##(2008-1#1)(2008-11#2)
the SG##4##2##(1993-12#2)(2012-2#2)
the SGC##4##2##(1995-2#1)(2008-3#3)
the SGD##3##2##(2013-8#3)
the SGP##2##2##(1994-11#2)
the SH group##3##3##(1996-5#2)(2006-6#1)
the SH##10##2##(1996-5#4)(2006-6#1)(2007-12#4)(2008-5#1)
the SH2 domain of##2##4##(1995-6#1)(1997-7#1)
the SH2 domains of Src##2##5##(1995-6#2)
the SH2 domains of##3##4##(1995-6#3)
the SH2##6##2##(1991-12#1)(1995-6#4)(1997-7#1)
the SH3##2##2##(1997-4#1)(2008-8#1)
the SH3-domain##2##2##(2008-8#2)
the SHG##4##2##(2007-11#1)(2007-12#3)
the SHIP2-SH2 domain##2##3##(2012-2#2)
the SHIP2-SH2##3##2##(2012-2#3)
the SHM##3##2##(2008-8#2)(2011-2#1)
the SHR##2##2##(1994-2#1)(1994-8#1)
the SI system##2##3##(2008-10#2)
the SI##8##2##(1996-2#1)(2007-12#1)(2008-10#3)(2012-2#3)
the SIA system##5##3##(2008-10#5)
the SIA##6##2##(2008-10#6)
the SIL##2##2##(2008-3#2)
the SIP##5##2##(2008-3#5)
the SIV##2##2##(1992-6#1)(1994-12#1)
the SK-N-MC cells##2##3##(2008-7#2)
the SLM##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
the SLN and##3##3##(1993-12#2)(2013-1#1)
the SLN##7##2##(1993-12#3)(2008-10#1)(2008-5#1)(2013-1#2)
the SM group were significantly lower than##2##7##(2012-3#2)
the SM group were significantly##3##5##(2012-3#3)
the SM##6##2##(1996-2#1)(2008-5#2)(2012-3#3)
the SMART##2##2##(2011-2#2)
the SMBG##2##2##(2009-11#2)
the SMI##2##2##(2009-6#2)
the SMR##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
the SN##3##2##(1994-2#2)(2010-8#1)
the SNAP-25 gene##2##3##(1996-12#1)(1997-7#1)
the SNAP-25 promoter##3##3##(1996-12#3)
the SNAP-25##5##2##(1996-12#4)(1997-7#1)
the SNF##2##2##(1994-12#1)(1994-2#1)
the SNOM##4##2##(2008-3#4)
the SNP##6##2##(2008-10#2)(2008-4#1)(2011-1#1)(2012-12#1)(2012-5#1)
the SNP-PCR##2##2##(2011-2#2)
the SNPs##2##2##(2011-1#1)(2012-2#1)
the SNR##6##2##(2007-12#1)(2008-3#5)
the SNS##6##2##(2011-1#6)
the SO(2)##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
the SOA##3##2##(2007-12#2)(2008-3#1)
the SOC(4) -conjugates##2##3##(2011-2#2)
the SOD##2##2##(1990-11#1)(2008-7#1)
the SOHO spacecraft##2##3##(2008-3#2)
the SOHO##4##2##(2008-2#2)(2008-3#2)
the SOI##3##2##(2007-12#3)
the SOM##4##2##(1992-1#2)(2012-3#2)
the SOP cell##3##3##(2009-5#3)
the SOWG##4##2##(2008-10#4)
the SOX3-positive primordial germ cells develop toward##2##7##(2010-5#2)
the SP##4##2##(2008-10#1)(2008-12#1)(2010-4#1)(2010-6#1)
the SP1##2##2##(1991-2#2)
the SPA-intermediate group##3##3##(1990-5#3)
the SPA-negative group##3##3##(1990-5#3)
the SPA-positive group##3##3##(1990-5#3)
the SPD##2##2##(2008-5#2)
the SPE cartridge##3##3##(1997-2#2)(2008-10#1)
the SPE column##3##3##(2008-10#3)
the SPE step##2##3##(2008-10#2)
the SPE##19##2##(1997-2#3)(2007-11#1)(2008-10#13)(2011-2#1)(2013-1#1)
the SPF##6##2##(1993-1#1)(2008-5#5)
the SPH&amp##2##2##(2008-1#2)
the SPM##4##2##(2008-2#2)(2012-2#2)
the SPME fiber##3##3##(2008-10#3)
the SPME fibre##3##3##(2008-10#3)
the SPME##8##2##(2008-10#8)
the SPR angle and##2##4##(2008-3#2)
the SPR biosensor##2##3##(2008-10#2)
the SPR intensity##3##3##(2008-10#3)
the SPR sensor system##2##4##(2008-10#2)
the SPR sensor##6##3##(2008-10#5)(2008-4#1)
the SPR##21##2##(2008-10#16)(2008-2#1)(2008-3#3)(2008-4#1)
the SPSS##4##2##(2008-11#1)(2010-6#1)(2012-3#1)(2013-8#1)
the SQUID##2##2##(2008-7#2)
the SR##4##2##(1994-8#1)(1995-6#1)(2008-10#2)
the SRA##2##2##(2012-2#2)
the SRBC##2##2##(2008-10#1)(2008-4#1)
the SS inlet##2##3##(2008-10#2)
the SS##10##2##(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)(2010-4#2)(2011-2#1)
the SSCP analysis##2##3##(2008-10#2)
the SSCT##5##2##(2008-9#5)
the SSE##2##2##(2013-1#1)(2013-8#1)
the SSF##4##2##(2008-6#4)
the SSG##4##2##(1995-11#4)
the SSLB resistance##2##3##(2008-10#2)
the SSO genes##2##3##(1997-3#2)
the SSTR2##2##2##(1993-3#2)
the ST##6##2##(1996-6#1)(2008-10#4)(2008-7#1)
the STA##2##2##(1995-6#1)(2008-10#1)
the STAR##2##2##(2008-10#2)
the STARD and QUADAS##2##4##(2008-12#2)
the STARD##3##2##(2008-12#3)
the STIKO##2##2##(2008-4#2)
the STR##5##2##(1994-12#1)(2008-12#3)(2008-7#1)
the SV40 early promoter##2##4##(1995-6#1)(2008-11#1)
the SV40##5##2##(1995-6#1)(2008-11#2)(2008-2#2)
the SVC##3##2##(2007-8#2)(2008-1#1)
the SVP##2##2##(1993-6#2)
the SVZ##4##2##(2008-7#4)
the SW and##2##3##(1991-8#1)(2008-10#1)
the SW##3##2##(1991-8#1)(2008-10#1)(2008-5#1)
the SW613-S human colon carcinoma cell line##2##7##(1992-9#2)
the SW613-S##3##2##(1992-9#3)
the SWI/SNF complex##2##3##(1996-2#2)
the SWNTs##3##2##(2008-10#1)(2008-7#2)
the SYBR Green real-time PCR##2##5##(2012-3#2)
the SZ##4##2##(2009-7#4)
the Sac locus##2##3##(2008-2#2)
the Sac##3##2##(1990-5#1)(2008-2#2)
the Saccharomyces cerevisiae##19##3##(1990-5#2)(1990-7#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-3#1)
the Saccharomyces complex##2##3##(2012-3#2)
the Saccharomyces##21##2##(1990-5#2)(1990-7#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-3#3)
the Safe Motherhood##2##3##(1994-3#1)(2010-12#1)
the Safe##3##2##(1993-12#1)(1994-3#1)(2010-12#1)
the Safety of##3##3##(2008-10#2)(2012-3#1)
the Safety##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
the Sagnac frequency##2##3##(2008-2#2)
the Sagnac##7##2##(2007-11#3)(2007-12#1)(2008-2#3)
the Saint Gaudens specimen##2##4##(2011-2#2)
the Saint##5##2##(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#2)
the SalI##4##2##(1991-9#1)(1994-12#3)
the Salinas valley##2##3##(2008-10#2)
the Salinas##6##2##(2008-10#6)
the Salmonella assay##2##3##(1995-11#1)(1996-2#1)
the Salmonella##6##2##(1991-12#1)(1995-11#1)(1996-2#1)(1996-6#1)(2010-8#1)(2011-1#1)
the Same##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
the San Andreas fault##2##4##(1990-11#1)(1996-4#1)
the San Andreas##3##3##(1990-11#1)(1996-4#2)
the San Joaquin Valley##3##4##(2008-10#3)
the San##10##2##(1990-11#1)(1991-2#1)(1996-4#2)(2008-1#1)(2008-10#3)(2008-3#1)(2012-12#1)
the Sanjabi##2##2##(2008-12#2)
the Santa##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
the Santiago de Cuba Techo strain##2##6##(2007-10#2)
the Santiago de Cuba##3##4##(2007-10#3)
the Santiago##4##2##(2007-10#3)(2012-2#1)
the Sarason##2##2##(1992-1#2)
the Sargasso Sea##2##3##(2008-2#1)(2008-3#1)
the Saskatchewan##5##2##(1995-12#1)(2007-12#1)(2008-7#2)(2008-8#1)
the Sauerbrey shift##2##3##(2009-5#2)
the Sc##2##2##(1995-8#2)
the Scale for the Assessment of Negative Symptoms##2##8##(1996-7#2)
the Scandinavian##6##2##(1991-4#1)(2008-3#1)(2010-3#1)(2011-4#3)
the Scatchard##2##2##(2008-10#2)
the Schaffer collateral-CA1 region##2##4##(2008-7#2)
the Schaffer##4##2##(1995-12#1)(2008-7#3)
the Scheimpflug PIV##2##3##(2008-2#2)
the Scheimpflug##4##2##(2008-2#4)
the Schiff base##9##3##(1994-5#2)(1995-5#3)(2008-10#4)
the Schiff##10##2##(1994-5#2)(1995-5#3)(2008-10#5)
the Schlieren effect##3##3##(2008-10#3)
the Schlieren##4##2##(2008-10#4)
the School of Medical Sciences##3##5##(2008-10#2)(2013-8#1)
the School of Medicine of##3##5##(2008-10#1)(2012-3#2)
the School of Medicine##4##4##(1992-1#1)(2008-10#1)(2012-3#2)
the School of Nursing and Midwifery##2##6##(2008-11#2)
the School of Nursing##4##4##(2008-11#2)(2008-12#1)(2010-3#1)
the School of##16##3##(1992-1#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2010-3#2)(2012-12#1)(2012-3#2)(2013-8#1)
the School##19##2##(1992-1#1)(1996-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2009-9#1)(2010-3#2)(2010-9#1)(2012-12#1)(2012-3#2)(2013-8#1)
the Scientific##3##2##(1991-3#1)(2008-10#1)(2008-12#1)
the Scope##2##2##(2012-12#1)(2012-2#1)
the Scottish##6##2##(2008-11#4)(2008-12#1)(2008-9#1)
the Sea-Viewing Wide##2##3##(2008-3#2)
the SeaWiFS 765-nm band##2##4##(2008-2#2)
the SeaWiFS 765-nm##3##3##(2008-2#3)
the SeaWiFS##16##2##(2008-2#6)(2008-3#10)
the Seattle##2##2##(2007-9#1)(2008-5#1)
the SecA##3##2##(2008-10#2)(2012-1#1)
the Second World War##3##4##(2008-11#1)(2008-7#1)(2011-4#1)
the Second##11##2##(1995-4#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-4#1)
the Secret##2##2##(1995-6#2)
the Secretary of##2##3##(1991-12#1)(1996-5#1)
the Self##2##2##(2008-11#2)
the Self-Help Clearinghouse of Metropolitan Toronto##2##6##(1994-1#1)(1996-3#1)
the Self-Help Clearinghouse##3##3##(1994-1#2)(1996-3#1)
the Semliki Forest##3##3##(2008-11#3)
the Senate##8##2##(1995-6#6)(1997-2#1)(2008-8#1)
the Septoria tritici##2##3##(2008-10#2)
the Septoria##3##2##(2008-10#3)
the Sequoia District##2##3##(1996-3#2)
the Ser residue##3##3##(1992-3#2)(1992-4#1)
the Ser##4##2##(1992-3#3)(1992-4#1)
the Serengeti##2##2##(2012-2#2)
the Sertoli cell##2##3##(2012-2#2)
the Sertoli##6##2##(2009-10#1)(2012-2#4)(2013-1#1)
the Serum Response##2##3##(1994-6#2)
the Serum##4##2##(1992-6#1)(1994-6#2)(2012-3#1)
the Service##3##2##(2008-3#1)(2010-9#1)(2013-1#1)
the Sexual Stage of##2##4##(2008-10#2)
the Sexual##5##2##(2008-10#2)(2012-3#3)
the Shack-Hartmann sensor##2##3##(2008-3#2)
the Shack-Hartmann##3##2##(2008-3#3)
the Shanghai##2##2##(2009-9#1)(2013-8#1)
the Shannon index##2##3##(2008-10#2)
the Shannon##3##2##(2008-10#2)(2008-8#1)
the Shc##3##2##(1997-7#3)
the Shiga-like##2##2##(1992-3#1)(2011-1#1)
the Shine-Dalgarno sequence were##2##4##(1992-6#1)(1996-8#1)
the Shine-Dalgarno sequence##4##3##(1992-6#2)(1996-8#1)(1997-2#1)
the Short Form 36##2##4##(1996-3#1)(2008-10#1)
the Short Form##3##3##(1996-3#1)(2008-10#2)
the Short##6##2##(1996-3#1)(2008-10#3)(2009-10#1)(2010-8#1)
the Si##5##2##(2007-11#4)(2008-10#1)
the SiO(2)##2##2##(2007-11#1)(2008-2#1)
the Siberian##3##2##(1994-2#1)(2008-6#1)(2010-8#1)
the Simple##2##2##(2011-1#2)
the Simultaneous##5##2##(2008-10#1)(2010-5#1)(2011-1#2)(2012-2#1)
the Singapore Chinese Health Study##3##5##(2010-6#3)
the Sixth International##2##3##(2008-5#1)(2012-3#1)
the Sixth##4##2##(1996-1#1)(2008-5#2)(2012-3#1)
the Slave River##5##3##(1997-4#5)
the Slump Test in##2##4##(2008-12#2)
the Slump Test##5##3##(2008-12#5)
the Sm##3##2##(1993-2#1)(1997-9#1)(2008-10#1)
the Smad2 conditional##2##3##(2008-9#2)
the Snail density##3##3##(2011-1#3)
the Sobel wavelet filter##2##4##(2008-2#2)
the Sobel wavelet##3##3##(2008-2#3)
the Social Action##2##3##(2008-11#2)
the Social Security##3##3##(1992-2#1)(1993-1#1)(2012-12#1)
the Social##11##2##(1992-2#1)(1993-1#1)(1995-5#1)(2007-10#1)(2008-11#2)(2010-12#2)(2011-1#1)(2012-12#2)
the Society for the##3##4##(2011-1#2)(2013-1#1)
the Society for##8##3##(1996-8#1)(2008-7#1)(2011-1#3)(2012-1#1)(2013-1#1)(2013-8#1)
the Society of##6##3##(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
the Society##16##2##(1994-12#1)(1994-6#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#3)(2012-1#1)(2013-1#2)(2013-8#1)
the Sokoto##2##2##(2010-4#2)
the Solanaceae##2##2##(1993-12#1)(2008-7#1)
the Solar and Heliospheric Observatory (SOHO) are##2##7##(2008-3#2)
the Solar##4##2##(2008-2#1)(2008-3#3)
the SoloSTAR and FlexPen##2##4##(2009-11#2)
the Solomon Islands##2##3##(2012-12#2)
the Somogyi-Nelson batch procedure##2##4##(2008-10#2)
the Sonoran Desert##5##3##(2008-10#4)(2009-8#1)
the Soret band##5##3##(1990-8#3)(1992-12#1)(1995-2#1)
the Soret peak##2##3##(2008-6#1)(2009-2#1)
the Soret##8##2##(1990-8#3)(1992-12#1)(1995-2#1)(2008-10#1)(2008-6#1)(2009-2#1)
the South African##4##3##(2008-8#1)(2010-1#1)(2010-3#1)(2011-2#1)
the South American##5##3##(1997-4#1)(2008-10#2)(2010-3#1)(2011-2#1)
the South Carolina##2##3##(2008-10#1)(2011-2#1)
the South China Sea##3##4##(2010-8#2)(2013-8#1)
the South Pacific##7##3##(2008-1#6)(2008-5#1)
the South West##3##3##(2008-11#2)(2008-5#1)
the South to##2##3##(1992-5#1)(2008-10#1)
the South##48##2##(1990-11#1)(1992-2#3)(1992-3#1)(1992-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2008-1#6)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-2#6)(2013-1#3)(2013-7#2)(2013-8#1)
the Southeast##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
the Southern##15##2##(1990-8#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#4)
the Southwest##4##2##(1995-6#1)(2008-3#1)(2008-8#2)
the Soviet Union and##2##4##(2008-12#1)(2011-2#1)
the Soviet Union##4##3##(1990-3#1)(2008-12#2)(2011-2#1)
the Soviet##5##2##(1990-3#2)(2008-12#2)(2011-2#1)
the Soybean##4##2##(2008-10#4)
the SpA##2##2##(1994-6#2)
the Span80-CPL##3##2##(2008-11#3)
the Spanish isolates##2##3##(2008-10#2)
the Spanish population##3##3##(1990-9#2)(2008-10#1)
the Spanish##25##2##(1990-8#1)(1990-9#2)(1993-5#2)(1995-2#1)(1996-5#1)(1997-6#1)(2008-10#10)(2008-6#1)(2009-10#3)(2009-5#1)(2011-1#2)
the Spatial##2##2##(2008-10#2)
the Spatiotemporal##2##2##(2008-10#1)(2008-11#1)
the Spearman##2##2##(2008-4#1)(2013-7#1)
the Special Supplemental##2##3##(1996-12#2)
the Spectra Optia##5##3##(2011-2#5)
the Spectromètre à Diodes Laser Accordables##2##6##(2008-3#2)
the Spo0A##2##2##(1995-6#1)(2011-2#1)
the Spodoptera frugiperda##3##3##(2008-11#2)(2008-7#1)
the Spr3 locus##3##3##(2009-10#3)
the Spread of##2##3##(2008-10#2)
the Spread##3##2##(2008-10#3)
the Squash leaf curl virus##2##5##(2008-10#2)
the Sri Lankan strains##3##4##(2008-10#3)
the Sso##2##2##(1997-3#2)
the St##4##2##(1993-12#1)(1993-2#1)(1996-3#1)(2007-9#1)
the Standard##2##2##(2008-10#1)(2008-9#1)
the Stanford##4##2##(1995-9#2)(2008-11#1)(2013-1#1)
the Star-PAP##2##2##(2013-1#2)
the Stark tuning rate##3##4##(2008-10#3)
the Stark##5##2##(1996-3#1)(2007-12#1)(2008-10#3)
the State Food and Drug Administration##2##6##(2011-2#1)(2012-3#1)
the State of Minas Gerais##2##5##(2008-6#1)(2010-10#1)
the State of##20##3##(1990-11#1)(1991-1#1)(1991-8#2)(1993-6#1)(1994-9#1)(1997-3#1)(2008-10#2)(2008-6#3)(2008-8#2)(2009-11#1)(2010-10#2)(2011-2#1)(2013-7#2)
the State##37##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#2)(1992-1#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#3)(2008-8#2)(2009-10#2)(2009-11#1)(2010-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
the State-Trait Anxiety Inventory##5##4##(1995-12#2)(2007-7#1)(2010-6#1)(2013-8#1)
the Statement##2##2##(1993-11#2)
the States##8##2##(1992-3#1)(1994-1#1)(1994-3#2)(1995-1#1)(1997-2#1)(2008-7#1)(2009-5#1)
the Stb4 locus in##2##4##(2008-10#2)
the Stb4 locus##3##3##(2008-10#3)
the Stb4##4##2##(2008-10#4)
the Stem##2##2##(2008-10#2)
the Steris System##2##3##(2011-2#2)
the Stern-Volmer plot##2##3##(2008-10#2)
the Stern-Volmer##4##2##(2008-10#4)
the Stoffel fragment##2##3##(2008-5#2)
the Stokes and anti-Stokes##2##4##(2007-11#2)
the Stokes parameters##2##3##(2007-12#2)
the Stokes shift##2##3##(2008-10#1)(2008-2#1)
the Stokes vectors##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the Stokes##18##2##(1993-8#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#2)
the Stone maze##3##3##(1994-6#3)
the Stone##4##2##(1994-6#3)(2008-1#1)
the Strategic##2##2##(1995-2#1)(2008-4#1)
the Stratospheric Aerosol and Gas Experiment II##2##7##(2008-2#1)(2008-3#1)
the Stratospheric Aerosol and Gas Experiment##4##6##(2008-2#3)(2008-3#1)
the Strehl intensity ratio##2##4##(2008-3#2)
the Strehl ratio and the##2##5##(2008-2#1)(2008-3#1)
the Strehl ratio##7##3##(2008-2#4)(2008-3#3)
the Strehl##10##2##(2008-2#4)(2008-3#6)
the Streptococcus##5##2##(1992-5#1)(2009-6#2)(2011-1#1)(2011-2#1)
the Strong##3##2##(1996-9#1)(2012-3#1)(2013-1#1)
the Structure and##2##3##(1996-2#1)(2010-2#1)
the Structure of##2##3##(1996-2#1)(2008-10#1)
the Structure##4##2##(1996-2#2)(2008-10#1)(2010-2#1)
the Structured Clinical Interview for##2##5##(2012-12#2)
the Student##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
the Student's##4##2##(2007-8#1)(2008-10#2)(2012-12#1)
the Study of##10##3##(1992-2#1)(1995-11#2)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
the Study##12##2##(1992-2#1)(1995-11#2)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
the Suffern##2##2##(2008-10#2)
the Sugarcane Leaf Scald Pathogen##2##5##(2008-10#2)
the Sun is##2##3##(2008-3#2)
the Sun##13##2##(1991-9#1)(2007-12#1)(2008-2#7)(2008-3#4)
the Sunnybrook Health Science Centre##3##5##(1995-12#1)(1995-2#1)(1997-3#1)
the Sunnybrook##5##2##(1995-12#1)(1995-2#1)(1997-3#1)(2007-9#1)(2008-7#1)
the Superior##2##2##(2008-9#1)(2013-1#1)
the Supplemental Security Income Program##2##5##(1995-12#2)
the Supplemental Security Income##3##4##(1992-1#1)(1995-12#2)
the Suppression of##3##3##(2008-10#3)
the Supreme Court's##2##3##(1991-12#1)(1992-2#1)
the Surgical Department of##3##4##(1990-9#1)(1993-3#1)(2008-10#1)
the Surgical Department##4##3##(1990-9#1)(1992-4#1)(1993-3#1)(2008-10#1)
the Surgical##9##2##(1990-9#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-3#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-9#1)
the Suruí##3##2##(1991-12#3)
the Survey of Respirator Use and Practices##2##7##(2008-12#2)
the Survey of##3##3##(1992-2#1)(2008-12#2)
the Survival of##3##3##(2008-10#2)(2010-7#1)
the Swedish##7##2##(1991-11#1)(1996-5#1)(2008-2#1)(2008-7#1)(2010-3#2)(2013-1#1)
the Swiss Federal##3##3##(1991-11#2)(2008-3#1)
the Swiss##12##2##(1991-11#3)(1991-2#1)(1991-6#1)(1993-9#2)(1996-8#1)(2008-10#1)(2008-3#2)(2011-2#1)
the SyF##2##2##(2008-10#2)
the SyFS##3##2##(2008-10#3)
the Sydney##2##2##(2008-9#1)(2010-8#1)
the Symposium##3##2##(2009-3#2)(2010-5#1)
the Symptom##2##2##(2011-2#1)(2012-5#1)
the Synechocystis##2##2##(1995-12#1)(1996-6#1)
the Synthesis of##4##3##(1996-2#1)(1996-5#1)(2009-11#1)(2009-5#1)
the Syrian hamster##6##3##(1990-7#4)(1992-2#1)(1996-8#1)
the Syrian##7##2##(1990-6#1)(1990-7#4)(1992-2#1)(1996-8#1)
the System of##2##3##(2008-2#1)(2013-8#1)
the Systolic Hypertension in the Elderly Program (SHEP)##2##8##(1997-3#2)
the Szeged and PI indices of##2##6##(2009-3#2)
the Szeged and##3##3##(2009-3#3)
the São Paulo##3##3##(1990-12#1)(2012-3#1)(2013-7#1)
the São##6##2##(1990-12#1)(2009-10#2)(2009-7#1)(2012-3#1)(2013-7#1)
the T and R##2##4##(1990-8#2)
the T and##3##3##(1990-8#2)(1995-6#1)
the T cell clones##2##4##(1990-6#1)(2008-11#1)
the T cell receptor##3##4##(1995-8#1)(2007-12#1)(2011-1#1)
the T cell##9##3##(1990-6#1)(1993-11#1)(1995-8#1)(2007-12#1)(2008-11#3)(2008-4#1)(2011-1#1)
the T current##2##3##(1992-8#2)
the T growth##2##3##(2013-8#2)
the T loop##2##3##(1995-2#2)
the T matrix##5##3##(2008-2#3)(2008-3#2)
the T state##3##3##(1990-8#3)
the T##58##2##(1990-11#1)(1990-6#1)(1990-7#3)(1990-8#8)(1991-3#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-12#2)(2008-10#10)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#2)
the T(1)##2##2##(2008-10#1)(2010-8#1)
the T(2) progeny of line##2##5##(2008-10#2)
the T(2) progeny of##3##4##(2008-10#3)
the T(in)##7##2##(1995-2#1)(2008-4#6)
the T--&gt##2##2##(1994-8#1)(1995-6#1)
the T-DNA in a##2##4##(2008-10#2)
the T-DNA##8##2##(1990-11#2)(2008-10#6)
the T-cell##7##2##(1990-5#1)(1994-12#1)(1995-2#1)(1997-6#1)(2008-10#2)(2012-2#1)
the T-cell-dependent antigen##2##3##(1993-12#1)(2008-10#1)
the T-cell-dependent##3##2##(1993-12#1)(2008-10#2)
the T-lymphocyte##2##2##(1993-6#1)(2008-10#1)
the T-matrix and the finite-difference time-domain methods##2##7##(2008-3#2)
the T-matrix method to##2##4##(2008-3#2)
the T-matrix##5##2##(2008-3#5)
the T-tubule##2##2##(1991-2#2)
the T1 and T2##3##4##(1992-12#1)(2006-12#1)(2009-7#1)
the T1##5##2##(1990-2#1)(1992-12#1)(1995-11#1)(2006-12#1)(2009-7#1)
the T2DM group##2##3##(2011-1#2)
the T3 isolate##2##3##(2008-10#2)
the T3##6##2##(1995-8#1)(2008-10#5)
the T3-resistant##2##2##(2008-10#2)
the T36##3##2##(2008-10#3)
the T4##6##2##(1990-5#1)(1995-6#1)(1997-3#2)(2008-10#1)(2008-6#1)
the T7 RNA polymerase##3##4##(1990-11#1)(1991-9#1)(2008-8#1)
the T7 RNA##4##3##(1990-11#1)(1991-12#1)(1991-9#1)(2008-8#1)
the T7##6##2##(1990-11#1)(1991-12#1)(1991-9#1)(2008-11#1)(2008-8#1)(2009-3#1)
the TA2 domain was##2##4##(1995-6#2)
the TAD soils##2##3##(2008-10#2)
the TAD##3##2##(2008-10#3)
the TAG72##2##2##(1993-2#1)(1997-2#1)
the TAR loop##3##3##(1994-8#3)
the TAR##4##2##(1992-12#1)(1994-8#3)
the TAT peptide##2##3##(2009-6#2)
the TAT##4##2##(1997-4#1)(2008-1#1)(2009-6#2)
the TATA box##4##3##(1993-6#1)(1993-8#1)(1995-8#1)(1997-2#1)
the TATA element##3##3##(1995-2#1)(1995-8#2)
the TATA##8##2##(1993-6#1)(1993-8#1)(1995-2#1)(1995-8#3)(1997-2#2)
the TATA-binding protein (TBP)##2##4##(1993-9#1)(1997-2#1)
the TATA-binding protein##3##3##(1993-8#1)(1993-9#1)(1997-2#1)
the TB##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
the TB/C3-bcl2##2##2##(2008-11#2)
the TB/C3-pEF##2##2##(2008-11#2)
the TBI##2##2##(2007-11#1)(2008-9#1)
the TBP extraction method##2##4##(2008-10#2)
the TCA cycle and##2##4##(2008-10#1)(2012-1#1)
the TCA cycle##8##3##(1993-11#1)(1993-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)
the TCA##9##2##(1993-11#1)(1993-6#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)
the TCD##2##2##(2008-7#1)(2012-1#1)
the TCDD##2##2##(1992-8#1)(2008-11#1)
the TCR##7##2##(1994-3#1)(2008-11#3)(2008-4#1)(2011-1#2)
the TCRAC gene##3##3##(1997-9#3)
the TCRAC##4##2##(1997-9#4)
the TD##2##2##(2007-7#1)(2008-10#1)
the TDAR to##2##3##(2008-10#2)
the TDT##3##2##(2008-4#1)(2008-9#2)
the TDX system##4##3##(1993-8#4)
the TE##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
the TEM00##2##2##(2008-3#2)
the TEMPO+##8##2##(2008-9#8)
the TES##3##2##(2008-2#3)
the TEWL##3##2##(2008-5#3)
the TFIIB gene##2##3##(1997-6#2)
the TFO##3##2##(1995-5#3)
the TGF beta##3##3##(1992-8#2)(2013-8#1)
the TGF##4##2##(1992-8#2)(1997-1#1)(2013-8#1)
the TGF-beta element##2##3##(2008-9#2)
the TGF-beta##9##2##(1994-12#1)(1995-2#3)(2008-6#1)(2008-9#3)(2011-2#1)
the TGF-beta1/SMAD signaling pathway##5##4##(2011-2#5)
the TGF-beta1/SMAD##6##2##(2011-2#6)
the TH##4##2##(1993-8#1)(1997-5#2)(2011-2#1)
the THA##2##2##(2009-3#1)(2012-2#1)
the THz wave##3##3##(2008-3#3)
the THz##7##2##(2007-12#2)(2008-3#3)(2011-1#1)(2012-2#1)
the TIR##2##2##(2008-8#2)
the TIR-60 UP leads##2##4##(2008-3#2)
the TIRF-based biosensor##2##3##(2008-10#2)
the TIS11 family of immediate early genes##2##7##(1994-12#2)
the TL##2##2##(2008-3#2)
the TLC##2##2##(1996-5#1)(2008-10#1)
the TLC-LSD method##2##3##(2008-10#2)
the TLR4##3##2##(2008-10#1)(2013-8#2)
the TM##12##2##(1991-8#1)(1994-3#2)(2007-11#2)(2008-3#1)(2009-7#6)
the TMG##2##2##(2008-10#2)
the TMS coil##2##3##(2010-7#2)
the TMS##3##2##(2008-10#1)(2010-7#2)
the TNF alpha-308 polymorphism##2##4##(1995-12#2)
the TNF##7##2##(1994-2#1)(1995-12#2)(1997-2#1)(2007-8#1)(2008-8#1)(2009-3#1)
the TNF-alpha##7##2##(1991-6#1)(1992-12#1)(1995-12#2)(2011-1#2)(2013-1#1)
the TNF-beta gene##3##3##(1991-6#1)(1997-7#2)
the TNF-beta locus##2##3##(1997-7#2)
the TNF-beta##5##2##(1991-6#1)(1997-7#4)
the TNM##2##2##(1993-11#1)(2012-3#1)
the TNT##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the TOA##2##2##(2008-2#1)(2008-3#1)
the TP##2##2##(2008-10#1)(2008-3#1)
the TP53 gene##2##3##(2008-7#1)(2009-8#1)
the TP53 locus##2##3##(2009-8#2)
the TP53##4##2##(2008-7#1)(2009-8#3)
the TP82-induced intracellular Ca2+##2##4##(1990-8#2)
the TPA-induced MMP-1 and MMP-9##2##5##(2012-3#2)
the TPA-induced##4##2##(1990-2#1)(1992-9#1)(2012-3#2)
the TPDE##2##2##(2008-10#2)
the TPF##6##2##(2008-10#2)(2008-3#4)
the TQM##3##2##(1993-3#1)(1994-1#1)(1994-12#1)
the TR##3##2##(1990-11#1)(1996-2#1)(2008-3#1)
the TRA##4##2##(2011-2#4)
the TRAMP##2##2##(2008-4#1)(2013-1#1)
the TRF spectra##2##3##(2008-10#2)
the TRLFS##2##2##(2008-10#2)
the TRP1##3##2##(1997-3#2)(1997-8#1)
the TS##3##2##(2008-11#3)
the TSA##2##2##(1990-6#1)(2008-9#1)
the TSC##2##2##(1992-1#2)
the TSH receptor##10##3##(1990-12#2)(1991-9#1)(1992-12#2)(1993-3#1)(1996-5#4)
the TSH##17##2##(1990-12#3)(1991-9#1)(1992-12#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-5#2)(1996-5#4)
the TSHr##3##2##(1994-11#1)(2008-4#2)
the TSI##5##2##(2012-3#5)
the TSK##3##2##(1997-8#2)(2008-10#1)
the TSPO##9##2##(2012-2#9)
the TSPO-labeled##2##2##(2012-2#2)
the TSS concentration##4##3##(2013-8#4)
the TSST-1##3##2##(1993-3#2)(1997-2#1)
the TST##3##2##(2010-5#3)
the TSWV N##2##3##(2008-10#2)
the TSWV##5##2##(2008-10#5)
the TTM scheme##2##3##(2012-2#2)
the TTM##5##2##(2010-12#1)(2010-2#2)(2012-2#2)
the TUG##3##2##(2010-3#3)
the TUNEL##3##2##(2008-11#1)(2008-7#1)(2010-1#1)
the TYS1 gene##2##3##(1995-6#1)(1997-3#1)
the Taiwan##2##2##(2008-8#1)(2010-8#1)
the Talbot interferometry##2##3##(2008-3#2)
the Talbot##5##2##(2007-11#1)(2008-3#3)(2012-12#1)
the Talipexole##2##2##(2007-10#2)
the Tapajós National Forest##2##4##(2013-7#2)
the Tapajós##3##2##(2013-7#3)
the TaqMan probes##2##3##(2008-10#1)(2012-2#1)
the TaqMan##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
the Tar-16##2##2##(1994-8#2)
the Tarasca is##2##3##(2009-10#2)
the Tarasca##8##2##(2009-10#8)
the Tarasca's##2##2##(2009-10#2)
the Tasmanian##2##2##(2008-9#2)
the Tawanchai Cleft##2##3##(2011-2#2)
the Taxus##2##2##(2009-5#1)(2012-7#1)
the Taylor's##2##2##(2008-10#1)(2008-2#1)
the Tb-Gd-Trp-SDBS system##2##3##(2008-10#2)
the Tca DNA polymerase##2##4##(1997-4#2)
the Teacher##2##2##(2006-10#1)(2011-2#1)
the Teaching##2##2##(1996-2#1)(2009-10#1)
the Teakettle##2##2##(2008-10#2)
the Teflon AF##2##3##(2010-8#2)
the Teflon##5##2##(2008-10#3)(2010-8#2)
the Telephone##2##2##(2008-8#2)
the Temperament##2##2##(2011-1#1)(2013-8#1)
the Tenth##2##2##(2010-11#1)(2013-8#1)
the Texas##8##2##(1996-2#1)(2008-10#5)(2010-8#1)(2011-2#1)
the Tg##3##2##(2008-8#1)(2008-9#2)
the Th2 immune##2##3##(2009-5#1)(2012-12#1)
the Theory of Reasoned Action##2##5##(2008-4#1)(2011-1#1)
the Third International##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
the Third##9##2##(1993-6#1)(2008-11#1)(2008-7#2)(2011-2#4)(2013-1#1)
the Thirteenth Amendment##5##3##(2011-2#5)
the Thr147##2##2##(2012-2#2)
the Ti film##2##3##(2009-7#2)
the Ti##15##2##(1990-11#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#2)(2009-7#3)
the TiNi foam samples##2##4##(2009-7#2)
the TiNi##3##2##(2009-7#3)
the TiO(2)##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2012-2#1)
the TiO2##4##2##(2007-12#4)
the Time##2##2##(1991-8#1)(2010-11#1)
the Tm by 2##2##4##(1997-7#2)
the Tm##6##2##(1990-7#1)(1990-8#1)(1995-5#1)(1997-7#2)(2008-3#1)
the Tn antigen##4##3##(1992-8#4)
the Tn3##2##2##(1996-12#2)
the Tn5 insertion##2##3##(1993-9#1)(2008-10#1)
the Toll##3##2##(1991-5#2)(2010-11#1)
the Toluca Valley of##2##4##(2008-10#2)
the Toluca Valley##5##3##(2008-10#5)
the Toluca valley##2##3##(2008-10#2)
the Toluca##7##2##(2008-10#7)
the Toronto Clearinghouse##3##3##(1996-3#3)
the Toronto##9##2##(1991-11#1)(1992-3#1)(1996-3#4)(2007-12#1)(2008-6#1)(2008-7#1)
the Torpedo nicotinic acetylcholine receptor##2##5##(1994-5#2)
the Torpedo##3##2##(1993-3#1)(1994-5#2)
the Toyota Production System##4##4##(2012-2#4)
the Toyota##5##2##(2012-2#4)(2013-8#1)
the Traditional##2##2##(1995-12#1)(2009-5#1)
the Translocator Protein (TSPO)##3##4##(2012-2#3)
the Translocator Protein##4##3##(2012-2#4)
the Transtheoretical Model##2##3##(2008-4#1)(2013-1#1)
the Transverse Ranges##2##3##(1995-6#2)
the Transverse##3##2##(1995-6#2)(2011-2#1)
the Treatment of##22##3##(1994-7#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)
the Trichoderma##4##2##(2008-10#4)
the Trp##2##2##(1991-12#1)(1992-12#1)
the Ts65Dn mouse model of##2##5##(2012-2#2)
the Tsukuba and Chiba populations##2##5##(2008-10#2)
the Tumor##2##2##(2010-8#1)(2013-1#1)
the Tunisian##3##2##(2007-8#1)(2008-10#1)(2009-10#1)
the Turkana of Lodwar township##2##5##(2009-4#2)
the Turkana##3##2##(2009-4#3)
the Turkish##8##2##(1997-5#1)(2008-12#1)(2008-2#3)(2008-9#1)(2010-11#1)(2011-1#1)
the Tutotest in a hybrid##2##5##(2008-10#2)
the Tutotest##4##2##(2008-10#4)
the Twyman-Green interferometer##2##3##(2008-3#2)
the Twyman-Green##3##2##(2008-3#3)
the Type I error rate##3##5##(2012-2#3)
the Type##4##2##(2012-2#3)(2013-1#1)
the U##129##2##(1990-11#2)(1990-4#1)(1990-6#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-3#3)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1994-1#4)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#5)(1997-6#1)(2007-12#1)(2007-5#2)(2008-1#4)(2008-10#23)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#5)
the U-G units##3##3##(1997-3#3)
the U1##2##2##(1991-6#1)(1995-6#1)
the U2 snRNP##2##3##(1993-6#1)(1995-6#1)
the U2##4##2##(1991-6#1)(1993-6#1)(1993-8#1)(1995-6#1)
the U6 chimeric ribozyme##2##4##(2008-9#2)
the UCLA Natural History Interview##2##5##(2011-1#2)
the UDP##2##2##(1992-8#2)
the UG reflex##4##3##(1994-2#4)
the UGT2B17 deletion##2##3##(2013-8#2)
the UGT2B17 genotype##3##3##(2013-8#3)
the UGT2B17##6##2##(2013-8#6)
the UICC##2##2##(1991-8#1)(1994-12#1)
the UK and Ireland##3##4##(2008-10#2)(2008-12#1)
the UK and##14##3##(1991-4#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2013-8#1)
the UK is##3##3##(2009-4#1)(2012-12#1)(2013-8#1)
the UK was##2##3##(2007-2#1)(2008-11#1)
the UK##90##2##(1991-4#2)(1992-2#1)(1992-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-4#3)(2007-2#3)(2008-10#8)(2008-11#21)(2008-12#8)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#3)(2013-8#7)
the UL9 gene of##2##4##(1994-11#2)
the UL9 promoter##3##3##(1994-11#3)
the UL9##5##2##(1994-11#5)
the UMLS##7##2##(2008-7#7)
the UNICEF##4##2##(2008-11#2)(2010-3#1)(2010-5#1)
the UP layers##3##3##(1997-7#3)
the UP##4##2##(1997-7#4)
the UPDRS##4##2##(2008-7#4)
the UR cell line##2##4##(2008-11#2)
the UR##3##2##(2008-11#2)(2008-2#1)
the URA3 gene##2##3##(1991-7#1)(2008-10#1)
the URA3##5##2##(1991-7#3)(2008-10#2)
the US Congress passed##2##4##(1994-8#1)(2008-8#1)
the US Congress##4##3##(1994-8#1)(2008-1#1)(2008-5#1)(2008-8#1)
the US Court of Appeals for the##2##7##(1995-6#2)
the US FDA for the##2##5##(2008-5#2)
the US FDA for##3##4##(2008-5#2)(2011-2#1)
the US FDA##7##3##(2008-5#5)(2010-5#1)(2011-2#1)
the US Food and Drug Administration (FDA)##6##7##(1997-4#1)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
the US Food and Drug Administration##10##6##(1995-8#1)(1997-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2012-12#2)(2013-1#1)
the US Food and Drug##11##5##(1995-8#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2012-12#2)(2013-1#1)
the US National Institute##2##4##(1996-12#1)(2008-5#1)
the US National##6##3##(1996-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)
the US ONCHIT##2##3##(2010-8#2)
the US Pharmacopoeia##2##3##(2008-10#2)
the US and Japan##2##4##(2008-5#1)(2010-12#1)
the US and##10##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2010-12#2)(2011-2#1)(2012-12#1)
the US government##3##3##(2008-11#1)(2008-8#1)(2009-3#1)
the US health care system##4##5##(2008-11#3)(2008-7#1)
the US image##2##3##(1990-9#2)
the US population##3##3##(2008-9#1)(2010-5#1)(2010-8#1)
the US##126##2##(1990-2#1)(1990-9#2)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#5)(1995-8#1)(1996-11#2)(1996-12#1)(1996-8#1)(1996-9#4)(1997-2#3)(1997-4#2)(2007-11#1)(2008-1#3)(2008-10#9)(2008-11#8)(2008-3#1)(2008-5#22)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-3#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-8#5)(2011-2#2)(2012-12#5)(2012-2#1)(2013-1#6)(2013-8#4)
the US-1 genotype##3##3##(2008-10#3)
the US-1##9##2##(2008-10#9)
the US-7##4##2##(2008-10#4)
the US-8 genotype##4##3##(2008-10#4)
the US-8##10##2##(2008-10#10)
the USA and Canada##2##4##(1992-2#1)(2008-9#1)
the USA and##7##3##(1992-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)
the USA for##2##3##(2008-4#1)(2010-11#1)
the USA in##2##3##(1996-11#1)(2009-4#1)
the USA##34##2##(1992-2#2)(1994-3#1)(1996-11#3)(1996-6#1)(1997-8#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#5)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#3)(2013-8#1)
the USAPIs##2##2##(2008-1#2)
the USDA##4##2##(2008-7#4)
the USDA's Food Guide Pyramid diet##2##6##(2008-3#2)
the USEPA##2##2##(2008-10#2)
the USP and##2##3##(2008-5#1)(2012-2#1)
the USP##6##2##(2008-10#3)(2008-5#1)(2012-2#2)
the USSR##3##2##(1990-2#1)(1990-3#2)
the UTP##2##2##(1993-8#1)(1994-8#1)
the UV absorption##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
the UV and##2##3##(2008-10#1)(2009-12#1)
the UV detection##2##3##(2008-10#2)
the UV light##2##3##(2008-10#1)(2009-12#1)
the UV protection##2##3##(2008-5#2)
the UV radiation##2##3##(2011-2#2)
the UV range##2##3##(2008-10#1)(2009-11#1)
the UV spectra##2##3##(1996-5#1)(2008-10#1)
the UV##48##2##(1991-12#1)(1996-5#1)(2007-12#4)(2008-10#16)(2008-2#6)(2008-3#6)(2008-5#7)(2009-11#1)(2009-12#2)(2011-2#2)(2013-7#2)
the UV-A##2##2##(2008-11#1)(2008-2#1)
the UV-MFRSR divided by##2##4##(2008-2#2)
the UV-MFRSR##3##2##(2008-2#3)
the UV-VIS##2##2##(2008-10#1)(2010-11#1)
the UV-blocking capacity##2##3##(2008-5#2)
the UV-spectrophotometric##2##2##(2008-10#2)
the UV-vis spectra of##2##4##(2008-10#2)
the UV-vis##4##2##(1995-2#1)(2008-10#3)
the UV-visible##3##2##(1996-5#1)(1997-7#1)(2008-3#1)
the UVA protection##2##3##(2008-5#2)
the UVA##7##2##(2008-5#7)
the UVA-induced sebum##2##3##(2008-5#2)
the UVA/UVB ratio##3##3##(2008-5#3)
the UVA/UVB##4##2##(2008-5#4)
the UVS112 gene##2##3##(1995-9#2)
the Ugandan success story##2##4##(2009-4#2)
the Unified Parkinson's Disease Rating Scale (UPDRS)##2##7##(2008-7#2)
the Unified Parkinson's##3##3##(2008-7#3)
the Unified##7##2##(2008-7#5)(2012-3#1)(2013-8#1)
the Uniform Clinical Data Set##3##5##(1993-2#3)
the Uniform##5##2##(1991-3#1)(1993-2#3)(1996-12#1)
the UniformMu##3##2##(2012-3#3)
the Unit##3##2##(2007-11#1)(2008-9#1)(2012-3#1)
the United Arab Emirates##3##4##(2008-1#1)(2013-1#1)(2013-8#1)
the United Kingdom and##3##4##(2007-12#1)(2008-10#1)(2008-9#1)
the United Kingdom##55##3##(1991-2#1)(1991-3#2)(1991-8#2)(1992-1#1)(1993-2#1)(1994-12#2)(1994-7#2)(1995-1#2)(1995-2#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-12#2)(2007-2#3)(2008-10#10)(2008-11#7)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
the United Kingdom's National Health Service##2##6##(1995-3#1)(1996-2#1)
the United Kingdom's National##3##4##(1995-3#1)(1996-2#1)(2012-3#1)
the United Kingdom's##5##3##(1995-3#1)(1996-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
the United Nations Children's Fund##3##5##(2010-12#3)
the United Nations##8##3##(1992-6#1)(1996-1#1)(2008-11#1)(2008-9#1)(2010-12#3)(2012-12#1)
the United States (U##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
the United States Court of Appeals for the District of Columbia Circuit##3##12##(1996-12#3)
the United States Department of Health and Human Services##2##9##(1994-3#1)(2008-7#1)
the United States Department of##6##5##(1994-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)
the United States Pharmacopeia##4##4##(2008-10#4)
the United States and Brazil##2##5##(2008-10#2)
the United States and Canada##15##5##(1991-12#1)(2007-12#1)(2008-10#10)(2008-8#1)(2012-2#2)
the United States and Europe##4##5##(2008-7#1)(2008-8#1)(2009-11#1)(2013-1#1)
the United States and the##2##5##(1991-12#1)(2008-10#1)
the United States and##62##4##(1990-10#1)(1991-12#2)(1991-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(2007-12#3)(2007-2#2)(2008-1#1)(2008-10#26)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#3)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
the United States are##5##4##(1991-2#1)(1993-1#1)(2009-6#1)(2010-6#1)(2011-2#1)
the United States as##3##4##(2008-10#1)(2009-5#1)(2011-1#1)
the United States by##3##4##(1995-3#1)(2008-2#1)(2012-12#1)
the United States faces##2##4##(1996-12#1)(2008-12#1)
the United States has##3##4##(1997-2#1)(2008-10#1)(2010-3#1)
the United States have##6##4##(1993-3#2)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
the United States in##11##4##(1993-2#1)(1994-1#1)(1994-2#2)(1995-8#1)(2008-10#5)(2011-2#1)
the United States is##5##4##(1991-5#1)(1992-3#1)(2008-1#1)(2008-9#1)(2013-1#1)
the United States of America##2##5##(2010-3#1)(2012-12#1)
the United States on##2##4##(2007-12#1)(2008-10#1)
the United States since##5##4##(1992-8#1)(1995-3#1)(2008-1#1)(2008-10#1)(2012-3#1)
the United States than##2##4##(2007-2#1)(2008-10#1)
the United States that##2##4##(1997-1#1)(2011-2#1)
the United States to##4##4##(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
the United States was##3##4##(2008-10#2)(2011-2#1)
the United States were characterized##2##5##(2008-10#2)
the United States were tested##2##5##(2008-10#1)(2008-5#1)
the United States were##13##4##(2007-12#1)(2008-10#11)(2008-5#1)
the United States will##4##4##(1993-3#1)(1995-12#1)(1995-2#1)(2012-12#1)
the United States with##4##4##(1991-12#1)(1993-2#1)(2008-8#1)(2010-10#1)
the United States##494##3##(1990-10#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#4)(1993-2#6)(1993-3#7)(1993-6#1)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#2)(1995-1#7)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#1)(1997-1#7)(1997-2#4)(1997-3#9)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#11)(2007-2#6)(2007-7#1)(2008-1#7)(2008-10#148)(2008-11#13)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#6)(2009-11#9)(2009-12#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#6)(2011-2#30)(2012-1#1)(2012-12#12)(2012-2#9)(2012-3#10)(2013-1#14)(2013-7#1)(2013-8#9)
the United States-Mexico border##2##4##(2006-10#2)
the United##582##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#1)(1991-8#5)(1992-1#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#4)(1993-2#8)(1993-3#7)(1993-6#1)(1994-1#1)(1994-12#7)(1994-2#4)(1994-3#3)(1994-7#2)(1995-1#9)(1995-12#2)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#1)(1997-1#7)(1997-2#5)(1997-3#9)(1997-5#2)(1997-8#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#13)(2007-2#10)(2007-7#1)(2008-1#9)(2008-10#161)(2008-11#22)(2008-12#12)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#9)(2009-11#9)(2009-12#1)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#6)(2011-2#32)(2012-1#2)(2012-12#13)(2012-2#11)(2012-3#11)(2013-1#16)(2013-7#1)(2013-8#12)
the Units##2##2##(2008-9#1)(2012-3#1)
the Universal##2##2##(2008-6#1)(2008-9#1)
the Universitary##2##2##(2008-5#1)(2012-3#1)
the University Clinic##4##3##(1991-11#1)(1995-5#1)(2013-1#2)
the University Hospital of the West Indies##5##7##(2011-2#5)
the University Hospital of##11##4##(1991-3#1)(1993-3#1)(1996-11#1)(1996-6#1)(2008-10#1)(2009-5#1)(2011-2#5)
the University Hospital##14##3##(1991-3#1)(1993-3#1)(1996-11#1)(1996-6#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#7)
the University of Alabama##2##4##(2008-12#1)(2009-8#1)
the University of Alberta Hospitals##3##5##(1992-12#1)(1995-3#1)(1996-3#1)
the University of Alberta##5##4##(1992-12#1)(1995-12#1)(1995-3#2)(1996-3#1)
the University of Auckland##2##4##(2008-1#1)(2008-12#1)
the University of Bologna##2##4##(2007-8#1)(2008-7#1)
the University of California##5##4##(1997-5#1)(2008-10#2)(2008-3#1)(2010-10#1)
the University of Dundee##3##4##(2008-11#2)(2008-12#1)
the University of KwaZulu-Natal##2##4##(2010-3#1)(2013-8#1)
the University of Massachusetts##3##4##(1995-1#1)(1997-2#1)(2008-11#1)
the University of Michigan##6##4##(1991-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-11#1)
the University of Pennsylvania##4##4##(1993-2#1)(1996-12#1)(2008-2#1)(2012-12#1)
the University of Surrey##2##4##(2010-11#2)
the University of Toronto##5##4##(1991-1#1)(1991-2#1)(1996-12#1)(2007-5#1)(2008-11#1)
the University of Tromsø##3##4##(1993-6#2)(1996-9#1)
the University of Vienna##2##4##(1990-10#1)(1996-3#1)
the University of the West Indies##2##6##(2011-2#2)
the University of the##3##4##(2011-2#3)
the University of##126##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#4)(1993-1#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#4)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
the University##153##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#4)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#11)(2008-12#9)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
the Upper Atmosphere Research Satellite##2##5##(2008-2#2)
the Upper Galilee##4##3##(2011-2#4)
the Upper Madeira##2##3##(1993-6#2)
the Upper##12##2##(1991-12#1)(1993-6#2)(2007-12#1)(2008-10#1)(2008-2#2)(2011-2#5)
the Use of##4##3##(2008-3#1)(2009-3#1)(2012-3#1)(2013-1#1)
the Use##5##2##(2008-3#1)(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
the Ushuaia##2##2##(2008-3#2)
the V##6##2##(1993-9#1)(2008-10#3)(2008-2#1)(2011-2#1)
the V(D)J##3##2##(1997-7#1)(2008-7#2)
the V-ATPase##8##2##(1993-11#2)(1995-6#5)(2008-9#1)
the V-PPase##2##2##(2008-11#2)
the V281L mutation##3##3##(2008-1#3)
the V2R##2##2##(1994-8#2)
the VA##2##2##(2012-1#1)(2012-3#1)
the VAT##2##2##(2008-12#1)(2008-5#1)
the VCSEL wavelength##2##3##(2008-3#2)
the VCSEL's##2##2##(2008-2#1)(2008-3#1)
the VDCC##3##2##(1997-4#3)
the VDR gene##3##3##(1997-7#1)(2008-4#1)(2013-1#1)
the VDR##5##2##(1992-12#2)(1997-7#1)(2008-4#1)(2013-1#1)
the VEGF##2##2##(1992-3#1)(2013-8#1)
the VEP latency##2##3##(1995-12#2)
the VH##2##2##(1997-2#1)(1997-9#1)
the VHA has been##2##4##(2008-7#2)
the VI##2##2##(2008-10#1)(2012-3#1)
the VIP-receptor##2##2##(1994-3#1)(1995-11#1)
the VL##2##2##(1994-12#1)(2008-3#1)
the VLDL receptor##4##3##(1995-6#4)
the VLO##7##2##(1994-3#7)
the VM##3##2##(2012-3#3)
the VNTR##2##2##(1992-3#1)(2008-10#1)
the VO(2)##3##2##(2007-11#3)
the VP group##2##3##(2007-10#2)
the VP##3##2##(1996-5#1)(2007-10#2)
the VP1 coding regions of##2##5##(2013-8#2)
the VP1##3##2##(2008-12#1)(2013-8#2)
the VP6##2##2##(2008-5#2)
the VSF##3##2##(2008-3#3)
the VT group##2##3##(2008-10#2)
the VT##3##2##(2008-10#3)
the VTA##6##2##(1993-12#5)(1996-12#1)
the VWA STR##2##3##(2008-12#2)
the VWA##3##2##(2008-12#3)
the VZ##3##2##(1996-5#3)
the Valsalva maneuver##3##3##(2008-7#1)(2012-3#2)
the Valsalva##4##2##(1994-3#1)(2008-7#1)(2012-3#2)
the VanderLugt##2##2##(2007-12#1)(2008-3#1)
the Vatican##2##2##(1990-6#1)(1994-9#1)
the Vector##3##2##(2008-10#3)
the Vectra Graft##2##3##(2007-7#2)
the Venezuelan Andes##2##3##(2008-5#2)
the Venezuelan##8##2##(2008-10#1)(2008-5#6)(2008-9#1)
the Venus flytrap##2##3##(2009-8#2)
the Venus##4##2##(1991-5#1)(1992-7#1)(2009-8#2)
the Vermont Academic Medical Center##2##5##(1994-2#2)
the Very##2##2##(2008-3#1)(2009-12#1)
the Veterans Administration##2##3##(2009-11#1)(2012-12#1)
the Veterans Health Administration##2##4##(2008-7#2)
the Veterans##6##2##(1990-11#1)(2008-7#2)(2009-11#1)(2012-12#1)(2013-1#1)
the Veterinary##2##2##(1992-2#1)(1996-12#1)
the Vf gene##5##3##(2008-10#5)
the Vf##8##2##(2008-10#8)
the Vg##2##2##(2008-10#2)
the Victorian##2##2##(1995-6#1)(2011-2#1)
the Vienna RNA package##2##4##(2008-4#2)
the Vienna##3##2##(1990-10#1)(2008-4#2)
the Vistula River##2##3##(2008-11#2)
the Visual##2##2##(2007-8#1)(2008-12#1)
the Vitamin##3##2##(2008-1#1)(2008-10#2)
the Vmax of the##2##4##(1990-5#1)(1993-6#1)
the Vmax of##5##3##(1990-5#1)(1991-5#1)(1993-6#1)(1994-5#2)
the Vmax##16##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-6#2)(1993-6#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(2011-2#1)
the Volume##2##2##(1993-12#1)(2012-2#1)
the Voluntary##2##2##(1994-2#1)(1995-2#1)
the W (VI)##2##3##(2008-10#2)
the W##6##2##(2008-10#4)(2008-3#1)(2010-3#1)
the W/O/W multiple emulsion##2##4##(2008-5#2)
the W/O/W multiple##3##3##(2008-5#3)
the W54S##3##2##(1997-2#3)
the W60dS mutant##2##3##(1997-2#2)
the WAN##4##2##(2010-3#4)
the WB##3##2##(2008-10#2)(2008-5#1)
the WCST##2##2##(1995-11#2)
the WD-40 family##2##3##(1994-12#2)
the WDM##2##2##(2008-2#1)(2008-3#1)
the WGA diet##2##3##(2008-7#2)
the WGA-fed larvae##2##3##(2008-7#2)
the WHO World Mental Health (WMH)##2##6##(2013-8#2)
the WHO criteria##2##3##(2008-9#1)(2011-1#1)
the WHO##29##2##(1990-12#2)(1991-2#1)(1992-12#1)(1994-9#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
the WHOQOL-OLD##2##2##(2011-2#2)
the WLC##3##2##(2007-11#1)(2008-7#2)
the WRAP##3##2##(2008-11#3)
the WT##6##2##(1995-5#1)(1995-6#1)(2008-10#2)(2008-8#1)(2012-12#1)
the WT-voltammetric analyzer##2##3##(2008-10#2)
the WT1##2##2##(1991-10#2)
the WWTP##4##2##(2008-10#3)(2013-1#1)
the Walter##2##2##(1990-2#1)(2013-8#1)
the Warburg effect##4##3##(2010-12#4)
the Washington State##2##3##(1996-1#1)(1997-2#1)
the Washington##3##2##(1996-1#1)(1997-2#1)(2013-1#1)
the Water##4##2##(2008-10#3)(2012-12#1)
the Wave Bioreactor##3##3##(2008-11#3)
the Wave##4##2##(2008-11#4)
the Ways##2##2##(1994-12#1)(2010-8#1)
the Web or##3##3##(2008-4#2)(2008-9#1)
the Web##13##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
the Wechsler##2##2##(1995-11#1)(2008-7#1)
the Wei-Lachin##2##2##(1992-6#1)(1997-3#1)
the Weibull function##2##3##(2008-10#2)
the Weibull model##4##3##(2008-9#1)(2010-4#2)(2011-2#1)
the Weibull##9##2##(2008-10#4)(2008-9#2)(2010-4#2)(2011-2#1)
the Wellcome##2##2##(2008-7#2)
the Welsh##2##2##(1996-7#1)(2008-10#1)
the West African##2##3##(2007-7#1)(2008-10#1)
the West in##2##3##(2008-10#1)(2009-4#1)
the West##27##2##(1993-9#1)(1995-1#3)(1995-2#1)(1996-8#1)(2007-5#3)(2007-7#1)(2008-10#5)(2009-4#3)(2010-8#1)(2011-2#8)
the Western Atlantic##2##3##(2008-5#1)(2013-7#1)
the Western Cape##3##3##(2010-3#2)(2011-2#1)
the Western Hemisphere##4##3##(2008-10#3)(2013-7#1)
the Western United States##2##4##(2008-10#2)
the Western blot##2##3##(1990-7#1)(2008-11#1)
the Western countries##4##3##(1993-11#1)(2009-4#1)(2010-2#2)
the Western##44##2##(1990-7#1)(1992-11#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-2#2)(2010-3#2)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#1)
the Wheat##3##2##(1997-8#1)(2008-10#2)
the WhiA##2##2##(2012-2#2)
the White House##2##3##(1994-12#1)(1995-6#1)
the White##3##2##(1994-12#1)(1995-6#1)(2008-3#1)
the Wigner distribution function of##2##5##(2007-12#1)(2008-3#1)
the Wigner distribution function##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the Wigner transform of##2##4##(2007-12#2)
the Wigner##8##2##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)
the Wilcoxon rank-sum##2##3##(1996-3#1)(2012-1#1)
the Wilcoxon test##2##3##(1996-3#1)(2013-1#1)
the Wilcoxon##7##2##(1996-3#3)(1997-8#1)(2010-6#1)(2012-1#1)(2013-1#1)
the Wilson##2##2##(1993-11#1)(2008-10#1)
the Winter##2##2##(2008-10#1)(2008-7#1)
the Wisconsin Card Sorting Test##2##5##(1995-11#1)(2008-7#1)
the Wisconsin Card Sorting##4##4##(1995-11#1)(1995-5#1)(2007-8#1)(2008-7#1)
the Wisconsin biotype##3##3##(2008-10#3)
the Wisconsin##8##2##(1995-11#1)(1995-5#1)(1995-9#1)(2007-8#1)(2008-10#3)(2008-7#1)
the Wld(S) mutation##4##3##(1997-3#4)
the Wld(S)##5##2##(1997-3#5)
the Wnt##3##2##(2008-10#1)(2013-1#2)
the Working Group##2##3##(1996-6#1)(2007-9#1)
the Working##3##2##(1996-6#1)(2007-9#1)(2008-4#1)
the Worland##2##2##(2008-10#2)
the World AIDS Day##2##4##(1990-11#2)
the World Bank and##2##4##(1990-3#1)(1997-8#1)
the World Bank##3##3##(1990-3#1)(1997-8#2)
the World Health Organisation##6##4##(2008-1#1)(2008-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
the World Health Organization (WHO)##14##5##(1994-9#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-3#3)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
the World Health Organization and##3##5##(2007-12#1)(2007-2#1)(2011-2#1)
the World Health Organization##43##4##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-9#3)(1996-9#1)(1997-6#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#4)
the World Health##49##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-9#3)(1996-9#1)(1997-6#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#5)
the World Organisation for Animal Health (OIE)##2##7##(2011-2#2)
the World Organisation for Animal Health##5##6##(2011-2#5)
the World Wide Web##7##4##(1996-11#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#1)
the World-Wide Web##4##3##(1996-12#2)(2007-11#1)(2008-3#1)
the Wright##2##2##(2008-9#1)(2012-2#1)
the X and Y coordinates##2##5##(1994-1#2)
the X and Y##5##4##(1994-1#2)(2008-7#1)(2008-8#1)(2010-5#1)
the X and##7##3##(1994-1#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#2)
the X axis##2##3##(2008-10#1)(2008-3#1)
the X chromosome##15##3##(1994-8#1)(1994-9#2)(1995-5#1)(1996-12#2)(1996-6#1)(1997-5#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-1#1)
the X##41##2##(1992-11#1)(1993-6#1)(1994-1#2)(1994-8#1)(1994-9#2)(1995-5#1)(1996-12#2)(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-5#2)(2012-1#1)
the X-POL potential##3##3##(2008-11#3)
the X-chromosome##6##2##(1990-8#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-12#2)
the X-linked PGK-1##2##3##(1992-8#2)
the X-linked##3##2##(1992-8#2)(2008-9#1)
the X-ray crystal##2##3##(1996-5#1)(2013-7#1)
the X-ray structure##2##3##(1993-8#2)
the X-ray##17##2##(1992-12#1)(1992-5#1)(1993-11#1)(1993-8#2)(1995-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-7#1)(2013-8#3)
the XAD-8 resin##2##3##(2008-10#2)
the XE-2100##6##2##(2008-10#6)
the XRT group##2##3##(1991-4#2)
the XVII##2##2##(1991-6#1)(1996-3#1)
the Xa22(t) locus##2##3##(2008-10#2)
the Xenopus laevis##5##3##(1993-12#1)(1993-6#2)(1994-12#1)(1995-2#1)
the Xenopus melanophore assay##2##4##(1995-3#2)
the Xenopus oocyte expression system##2##5##(1995-2#1)(1997-2#1)
the Xenopus##16##2##(1992-6#2)(1993-12#1)(1993-6#3)(1994-12#1)(1995-2#2)(1995-3#2)(1997-2#1)(1997-7#2)(2008-5#1)(2012-3#1)
the Xist gene##2##3##(1994-11#2)
the Xoo##2##2##(1993-9#2)
the Y chromosome and##2##4##(1996-12#1)(2008-8#1)
the Y chromosome##8##3##(1993-9#2)(1996-12#1)(1996-5#2)(2008-4#1)(2008-8#1)(2012-3#1)
the Y transfer set##2##4##(2007-12#2)
the Y##17##2##(1993-9#4)(1996-12#1)(1996-5#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#2)(2012-3#1)(2013-8#1)
the Y-branch DWG##3##3##(2007-11#3)
the Y12##2##2##(1993-2#2)
the YAC contigs##2##3##(1995-6#1)(1996-10#1)
the YAC##5##2##(1991-9#1)(1995-6#1)(1996-10#2)(1996-12#1)
the YAG##2##2##(2008-2#1)(2013-8#1)
the YG bead caused##2##4##(2008-6#2)
the Yanomámi territory##2##3##(1991-12#2)
the Yanomámi##4##2##(1991-12#4)
the Yeast##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
the Yellow##2##2##(2008-2#1)(2013-8#1)
the Yerkes##2##2##(2007-12#2)
the Yorkshire Cochlear Implant##2##4##(2008-9#1)(2012-2#1)
the Young's modulus of##2##4##(2007-12#1)(2009-7#1)
the Young's modulus##4##3##(2007-11#1)(2007-12#1)(2009-7#1)(2010-8#1)
the Young's##5##2##(2007-11#1)(2007-12#1)(2009-7#2)(2010-8#1)
the Yucatan##2##2##(2008-10#1)(2008-5#1)
the Z axis##2##3##(2007-12#1)(2008-3#1)
the Z##8##2##(1992-3#1)(2007-12#1)(2008-3#2)(2008-6#3)(2010-5#1)
the Z- and C-forms##2##4##(2009-9#2)
the Z-scan technique##4##3##(2007-11#2)(2007-12#2)
the ZFPOU1 transcripts were##2##4##(1992-9#2)
the ZFPOU1 transcripts##3##3##(1992-9#3)
the ZP3##2##2##(2008-4#2)
the ZPA##3##2##(1993-12#3)
the Zea genus##2##3##(1995-12#2)
the Zea##3##2##(1995-12#2)(2009-8#1)
the Zeeman modulation##3##3##(2008-2#1)(2008-3#2)
the Zeeman shift##2##3##(2008-2#2)
the Zeeman##7##2##(2008-2#3)(2008-3#4)
the Zernike##6##2##(2007-12#1)(2008-3#5)
the Zeus##4##2##(2007-8#3)(2011-2#1)
the Zmspds2##2##2##(2009-8#2)
the Zn (-) treatment##2##4##(2013-8#2)
the Zn##7##2##(1993-12#1)(2008-10#3)(2010-11#1)(2013-8#2)
the Zn(2+)##2##2##(2008-10#2)
the ZnO##3##2##(2009-5#1)(2009-8#1)(2010-4#1)
the Zone Diet##2##3##(2008-3#2)
the Zone of Maximal Protection##2##5##(2008-7#2)
the Zone##4##2##(2008-3#2)(2008-7#2)
the [Ca2+]i##4##2##(1990-7#1)(1993-3#2)(1996-2#1)
the [Cl-/HCO3-] exchanger##2##3##(1991-8#2)
the [K+##2##2##(1991-8#2)
the [K5HPg]##2##2##(1993-8#2)
the [Na+##2##2##(1991-8#2)
the a priori##7##3##(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)
the a##13##2##(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-9#2)
the a3##2##2##(2008-10#1)(2008-8#1)
the aa sequence of##2##4##(1990-11#1)(1990-5#1)
the aa sequence##5##3##(1990-11#1)(1990-5#1)(1991-6#1)(1993-2#1)(1993-6#1)
the aa sequences of##3##4##(1990-11#1)(1993-12#1)(1995-8#1)
the aa##11##2##(1990-11#2)(1990-5#1)(1991-6#2)(1993-12#2)(1993-2#1)(1993-6#1)(1995-8#1)(2011-1#1)
the ab initio##3##3##(1996-5#2)(1997-7#1)
the abattoir##3##2##(2010-4#2)(2011-1#1)
the abattoirs##2##2##(2011-1#2)
the abaxial##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
the abdomen and pelvis and##2##5##(2012-2#2)
the abdomen and##4##3##(1997-5#1)(2012-2#2)(2013-8#1)
the abdomen in##2##3##(1991-5#1)(2008-11#1)
the abdomen was##2##3##(1993-6#1)(2011-2#1)
the abdomen with##2##3##(1995-11#1)(2012-3#1)
the abdomen##34##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-6#1)(1995-11#1)(1995-3#2)(1997-3#1)(1997-4#1)(1997-5#2)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#4)
the abdominal aorta##4##3##(1997-8#3)(2010-11#1)
the abdominal cavity##6##3##(1991-2#1)(1993-6#1)(1993-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
the abdominal gland##2##3##(2008-6#2)
the abdominal region##2##3##(2009-6#1)(2012-2#1)
the abdominal wall##19##3##(1990-5#1)(1991-12#1)(1991-9#1)(1995-3#2)(1996-3#1)(1996-8#1)(1996-9#1)(2008-10#2)(2011-2#7)(2012-12#1)(2012-2#1)
the abdominal##55##2##(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-6#2)(1993-9#1)(1995-3#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-8#3)(2007-12#4)(2008-1#1)(2008-10#4)(2008-5#2)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the aberrant##8##2##(1991-12#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
the aberration of##2##3##(2008-3#2)
the aberration##6##2##(2008-2#1)(2008-3#5)
the aberrations of an##2##4##(2007-12#1)(2008-3#1)
the aberrations that are##2##4##(2008-3#2)
the aberrations##10##2##(2007-12#1)(2008-3#9)
the abilities of##4##3##(1992-8#1)(1995-5#1)(1995-8#1)(2008-3#1)
the abilities to##2##3##(1995-1#1)(2008-9#1)
the abilities##10##2##(1992-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#2)(2011-1#1)
the ability and##3##3##(1994-9#1)(1995-12#1)(2008-11#1)
the ability of 1##2##4##(1992-10#1)(1992-12#1)
the ability of C##4##4##(2008-10#3)(2011-1#1)
the ability of FGF2 to stimulate##2##6##(2008-4#2)
the ability of Trichoderma spp##2##5##(2008-10#2)
the ability of a##16##4##(1991-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)(2013-8#1)
the ability of an##2##4##(1997-3#1)(2009-1#1)
the ability of cells to##3##5##(1994-11#1)(2008-10#1)(2008-11#1)
the ability of cells##4##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
the ability of health##2##4##(1994-3#1)(2008-11#1)
the ability of human##4##4##(1995-5#1)(2008-5#2)(2010-2#1)
the ability of in vitro##2##5##(2008-8#1)(2008-9#1)
the ability of patients to##2##5##(2008-7#1)(2010-9#1)
the ability of rats##2##4##(2007-10#1)(2008-7#1)
the ability of some##2##4##(2008-10#2)
the ability of specific##2##4##(1996-3#1)(2008-11#1)
the ability of the enzyme##2##5##(1990-2#1)(1992-3#1)
the ability of the##49##4##(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#2)(2009-12#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)
the ability of these##13##4##(1990-5#1)(1992-12#2)(1992-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#2)(2009-2#1)(2010-11#1)
the ability of this##7##4##(1990-2#1)(1993-5#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
the ability of tumour cells to##2##6##(1992-9#2)
the ability of##271##3##(1990-11#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-5#4)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#50)(2008-11#16)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#16)(2008-7#9)(2008-8#9)(2008-9#10)(2009-1#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
the ability to achieve##2##4##(2007-12#1)(2011-1#1)
the ability to activate##3##4##(1991-11#1)(1993-8#1)(2009-8#1)
the ability to analyze##3##4##(1992-11#1)(2008-9#1)(2009-2#1)
the ability to be##9##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
the ability to bind##3##4##(1990-5#1)(1994-12#1)(2010-10#1)
the ability to cause##2##4##(2008-10#2)
the ability to change##2##4##(2008-11#1)(2011-2#1)
the ability to communicate##3##4##(2008-11#1)(2013-1#2)
the ability to conduct##2##4##(2008-11#1)(2009-6#1)
the ability to control the##3##5##(2007-11#1)(2008-11#1)(2008-7#1)
the ability to control##4##4##(2007-11#1)(2008-11#1)(2008-7#2)
the ability to convert##2##4##(1995-5#1)(1996-2#1)
the ability to deliver##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
the ability to detect##5##4##(1992-2#1)(1997-5#1)(2007-12#1)(2008-11#1)(2010-4#1)
the ability to determine##3##4##(2011-1#1)(2013-1#2)
the ability to diagnose it during life##2##7##(2008-7#2)
the ability to diagnose##3##4##(1995-3#1)(2008-7#2)
the ability to differentiate##6##4##(1990-5#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-9#2)
the ability to discriminate##3##4##(1993-8#1)(2008-10#1)(2010-2#1)
the ability to elevate##2##4##(1992-8#1)(2007-11#1)
the ability to enforce##2##4##(2008-10#1)(2013-1#1)
the ability to form H-bonds##2##5##(1992-10#2)
the ability to form a##2##5##(1990-11#1)(2008-7#1)
the ability to form##5##4##(1990-11#1)(1992-10#2)(2008-10#1)(2008-7#1)
the ability to generate##3##4##(1990-2#1)(2008-7#1)(2008-9#1)
the ability to grow on##3##5##(1990-5#1)(2008-10#1)(2008-8#1)
the ability to grow##4##4##(1990-5#1)(2008-10#1)(2008-8#1)(2009-11#1)
the ability to handle##4##4##(2008-10#1)(2008-4#2)(2009-12#1)
the ability to induce the##2##5##(2008-10#2)
the ability to induce##9##4##(2006-6#1)(2008-10#6)(2008-8#1)(2011-2#1)
the ability to infect##2##4##(2008-10#2)
the ability to kill##2##4##(1995-2#1)(2008-4#1)
the ability to maintain normal blood glucose homeostasis##2##8##(2008-3#2)
the ability to maintain##4##4##(2008-3#2)(2008-8#1)(2012-3#1)
the ability to make##5##4##(1992-12#1)(2011-2#3)(2012-2#1)
the ability to measure##4##4##(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
the ability to modulate##2##4##(2008-4#1)(2010-1#1)
the ability to multiply##2##4##(1995-2#1)(2008-10#1)
the ability to obtain##3##4##(2008-2#1)(2010-12#1)(2010-8#1)
the ability to organize##3##4##(1994-3#1)(1997-6#1)(2008-7#1)
the ability to penetrate##2##4##(2008-10#1)(2008-8#1)
the ability to perform##4##4##(1996-12#1)(2007-11#1)(2008-12#1)(2012-12#1)
the ability to predict##2##4##(1995-12#1)(2008-3#1)
the ability to produce##8##4##(2008-10#7)(2012-2#1)
the ability to proliferate##3##4##(2008-11#2)(2012-12#1)
the ability to recognize##2##4##(1991-2#1)(2008-5#1)
the ability to release##2##4##(2008-5#1)(2012-12#1)
the ability to resolve##2##4##(2008-3#1)(2008-9#1)
the ability to segment language##3##5##(2012-3#3)
the ability to segment##4##4##(2012-3#4)
the ability to synthesize##2##4##(2007-11#1)(2008-9#1)
the ability to tune##3##4##(2007-11#1)(2008-10#1)(2012-12#1)
the ability to understand and##2##5##(2010-11#1)(2013-1#1)
the ability to understand##3##4##(1993-1#1)(2010-11#1)(2013-1#1)
the ability to use##2##4##(2008-10#1)(2008-7#1)
the ability to walk##4##4##(1996-9#2)(2007-11#1)(2012-2#1)
the ability to##271##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-9#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-11#8)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#47)(2008-11#14)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#14)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#7)
the ability##548##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#6)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#7)(1995-3#1)(1995-5#7)(1995-6#1)(1995-8#4)(1996-12#6)(1996-2#3)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#10)(2007-12#9)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#98)(2008-11#31)(2008-12#8)(2008-2#6)(2008-3#14)(2008-4#16)(2008-5#20)(2008-6#1)(2008-7#22)(2008-8#16)(2008-9#24)(2009-1#1)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#17)(2012-1#3)(2012-12#9)(2012-2#9)(2012-3#9)(2012-5#1)(2013-1#9)(2013-8#4)
the abiotic##5##2##(2008-10#2)(2008-8#1)(2013-7#1)(2013-8#1)
the ablated material##2##3##(2008-1#1)(2008-3#1)
the ablated##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
the ablation of##2##3##(1995-2#1)(2009-10#1)
the ablation##13##2##(1995-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#3)(2009-10#1)(2011-1#3)(2011-2#1)
the abnormal EF group##2##4##(2011-2#2)
the abnormal development of##2##4##(2008-4#1)(2012-2#1)
the abnormal or##2##3##(2007-7#1)(2008-8#1)
the abnormal##20##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-9#1)(1996-11#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#2)(2012-2#1)
the abnormalities##3##2##(1990-6#1)(1991-6#1)(1997-8#1)
the abnormally##2##2##(1994-8#1)(1995-3#1)
the abolition of##2##3##(1994-11#1)(1995-12#1)
the abolition##3##2##(1994-11#1)(1995-12#1)(2008-10#1)
the abomasum##6##2##(1991-8#1)(2010-2#1)(2011-2#4)
the abortion##2##2##(1996-5#1)(2008-8#1)
the above conditions##2##3##(2008-10#1)(2011-3#1)
the above effects##3##3##(1994-1#1)(2011-1#1)(2013-7#1)
the above findings##4##3##(1997-8#1)(2008-10#3)
the above loci are##2##4##(1994-9#1)(2008-4#1)
the above mentioned##23##3##(1990-9#1)(1993-5#1)(1996-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#12)(2010-6#1)(2011-2#2)(2012-3#2)
the above parameters in##2##4##(1995-9#1)(1996-5#1)
the above parameters##8##3##(1994-5#1)(1995-9#1)(1996-5#1)(2007-11#1)(2008-8#1)(2013-1#3)
the above procedure has been successfully employed for the analysis of##2##11##(2008-10#2)
the above procedure has been successfully employed for##3##8##(2008-10#3)
the above procedure##4##3##(2008-10#4)
the above questions##2##3##(1991-1#1)(1992-2#1)
the above results##5##3##(1994-3#1)(1994-8#1)(2008-10#2)(2012-2#1)
the above said##2##3##(1992-6#1)(2008-12#1)
the above system##2##3##(2008-10#2)
the above theory##2##3##(2008-1#1)(2008-2#1)
the above two##5##3##(1991-5#1)(1995-11#1)(1995-4#1)(2008-4#1)(2012-2#1)
the above##150##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#4)(1991-1#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#44)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
the above-mentioned##20##2##(1997-7#2)(1997-8#2)(2007-12#2)(2007-9#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2011-2#1)(2011-3#1)
the abovementioned##3##2##(2008-10#2)(2011-2#1)
the abrasives##2##2##(2008-5#2)
the abrupt##2##2##(1995-6#1)(2008-11#1)
the abscess and##2##3##(2013-8#2)
the abscess##5##2##(2007-7#1)(2013-8#4)
the abscissa##3##2##(2008-10#3)
the absence and presence of##16##5##(1990-8#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#2)(2011-2#1)(2012-5#1)
the absence and the presence of##3##6##(1991-12#1)(1993-9#1)(1995-5#1)
the absence and##24##3##(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#1)(2011-2#1)(2012-5#1)
the absence of ATP##3##4##(1993-6#1)(1993-8#1)(1995-2#1)
the absence of CYP1A induction##3##5##(2008-10#3)
the absence of Ca2+##3##4##(1994-12#1)(1995-6#1)(1996-2#1)
the absence of a##35##4##(1990-12#1)(1990-5#1)(1990-8#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#2)
the absence of aminoacylation##3##4##(1997-3#3)
the absence of an##11##4##(1990-3#1)(1991-2#1)(1994-9#1)(1996-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)
the absence of any other##3##5##(1992-9#1)(2007-12#1)(2008-8#1)
the absence of any##24##4##(1990-12#1)(1991-3#1)(1992-9#1)(1993-8#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
the absence of apoptosis##2##4##(2008-11#1)(2012-1#1)
the absence of competitive##2##4##(1992-2#1)(2008-8#1)
the absence of controlled##2##4##(2006-10#1)(2012-1#1)
the absence of data##3##4##(2008-10#1)(2008-9#2)
the absence of detectable##5##4##(1990-12#1)(1992-6#1)(1995-6#1)(2008-10#1)(2012-3#1)
the absence of direct##3##4##(1992-6#1)(2008-7#1)(2010-12#1)
the absence of divalent##3##4##(1990-2#1)(1995-2#1)(1995-5#1)
the absence of estrogen##2##4##(1997-7#1)(2008-6#1)
the absence of exogenous##2##4##(2008-11#1)(2012-3#1)
the absence of external Ca2+##3##5##(1990-7#1)(1993-12#2)
the absence of external##6##4##(1990-5#1)(1990-7#1)(1993-12#2)(1993-3#1)(2008-10#1)
the absence of extracellular calcium##2##5##(1990-5#1)(1995-11#1)
the absence of extracellular##3##4##(1990-5#1)(1992-3#1)(1995-11#1)
the absence of glucose##2##4##(1995-8#2)
the absence of glutamine##2##4##(2008-11#2)
the absence of hemin##2##4##(1994-5#2)
the absence of iron##2##4##(1995-6#1)(2008-8#1)
the absence of ligand##3##4##(1990-8#1)(1993-8#1)(1994-12#1)
the absence of light##4##4##(1993-8#1)(1994-5#1)(1994-8#1)(2009-8#1)
the absence of nerve growth factor##2##6##(1993-5#1)(2008-11#1)
the absence of scattering##2##4##(2008-3#1)(2008-7#1)
the absence of serum##5##4##(1990-11#1)(2008-11#4)
the absence of sex##2##4##(1996-5#1)(2010-3#1)
the absence of significant##3##4##(2007-11#1)(2008-10#2)
the absence of such##6##4##(1991-12#1)(1991-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
the absence of the##40##4##(1990-8#1)(1991-9#1)(1992-3#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#3)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the absence of these##5##4##(1993-8#1)(1995-2#1)(2008-11#1)(2009-10#1)(2011-1#1)
the absence of this##2##4##(1993-5#1)(1995-12#1)
the absence of visible##2##4##(2008-10#1)(2013-1#1)
the absence of##552##3##(1990-10#2)(1990-11#8)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#8)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#6)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#6)(1993-8#8)(1993-9#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#9)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#8)(1995-3#4)(1995-5#5)(1995-6#9)(1995-8#4)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#8)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#76)(2008-11#36)(2008-12#3)(2008-2#4)(2008-3#14)(2008-4#6)(2008-5#4)(2008-6#7)(2008-7#14)(2008-8#26)(2008-9#20)(2009-1#1)(2009-10#5)(2009-11#4)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#5)(2010-5#3)(2010-8#2)(2011-1#4)(2011-2#19)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#7)(2012-7#1)(2013-1#15)(2013-7#2)(2013-8#4)
the absence or##11##3##(1990-2#1)(1992-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
the absence##597##2##(1990-10#2)(1990-11#8)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#9)(1991-1#1)(1991-10#1)(1991-12#7)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#7)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#6)(1993-8#8)(1993-9#7)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#9)(1994-6#4)(1994-8#5)(1994-9#1)(1995-11#5)(1995-12#5)(1995-2#9)(1995-3#4)(1995-5#6)(1995-6#11)(1995-8#6)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#8)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#3)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#81)(2008-11#39)(2008-12#4)(2008-2#4)(2008-3#14)(2008-4#9)(2008-5#4)(2008-6#7)(2008-7#16)(2008-8#27)(2008-9#21)(2009-1#1)(2009-10#5)(2009-11#4)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#5)(2010-5#3)(2010-8#2)(2011-1#4)(2011-2#22)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#7)(2012-5#1)(2012-7#1)(2013-1#15)(2013-7#2)(2013-8#4)
the absolute EC50/IC50##2##3##(2012-2#2)
the absolute absorptance of##2##4##(2008-2#2)
the absolute and relative##3##4##(2008-10#2)(2008-7#1)
the absolute and##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
the absolute calibration##2##3##(2008-2#1)(2008-3#1)
the absolute concentration of##2##4##(2008-10#2)
the absolute configuration of the##2##5##(1992-12#1)(2008-10#1)
the absolute configuration of##3##4##(1992-12#1)(2008-10#1)(2009-10#1)
the absolute number of##4##4##(1991-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
the absolute number##5##3##(1991-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)
the absolute phase shift##2##4##(2008-2#1)(2008-8#1)
the absolute phase##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
the absolute requirement##2##3##(1991-9#1)(1995-8#1)
the absolute value of the##4##5##(2007-12#1)(2008-3#3)
the absolute values of the##2##5##(2008-3#1)(2008-6#1)
the absolute wavelength##2##3##(2008-3#2)
the absolute##76##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#22)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the absorbance and fluorescence spectra were##2##6##(2008-10#2)
the absorbance and fluorescence##3##4##(2008-10#3)
the absorbance and##5##3##(1992-8#1)(2008-10#4)
the absorbance as##2##3##(2007-12#1)(2008-10#1)
the absorbance at##6##3##(2008-10#6)
the absorbance change##2##3##(1990-12#1)(2008-10#1)
the absorbance data##2##3##(2008-10#2)
the absorbance of MB##2##4##(2008-10#2)
the absorbance of the dye##2##5##(2008-10#2)
the absorbance of the formed##2##5##(2008-10#2)
the absorbance of the##19##4##(2008-10#19)
the absorbance of##31##3##(2008-10#30)(2011-1#1)
the absorbance values and##2##4##(2008-10#2)
the absorbance values##3##3##(2008-10#3)
the absorbance versus the##2##4##(2008-10#2)
the absorbance versus##4##3##(2008-10#4)
the absorbance##77##2##(1990-12#1)(1991-12#1)(1992-8#1)(2007-12#1)(2008-10#68)(2008-2#1)(2008-8#1)(2011-1#2)(2013-1#1)
the absorbances##2##2##(2008-10#2)
the absorbed pump##4##3##(2007-11#2)(2008-3#2)
the absorbed##8##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
the absorbent##3##2##(2008-10#3)
the absorber##5##2##(2007-12#2)(2008-3#2)(2012-2#1)
the absorbing medium##2##3##(2008-3#2)
the absorbing solution##3##3##(2008-10#3)
the absorbing structures in the##2##5##(2007-12#1)(2008-3#1)
the absorbing##10##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#3)
the absorption and backscattering coefficients##4##5##(2008-2#2)(2008-3#2)
the absorption and reduced scattering coefficients of##2##7##(2008-3#2)
the absorption and reduced scattering coefficients##3##6##(2008-3#3)
the absorption and scattering coefficients of##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
the absorption and scattering coefficients##7##5##(2007-11#1)(2008-2#2)(2008-3#4)
the absorption and scattering##10##4##(2007-11#1)(2008-2#3)(2008-3#5)(2009-12#1)
the absorption and the reduced-scattering coefficients of##2##7##(2008-2#2)
the absorption and the transport scattering##2##6##(2008-2#1)(2008-3#1)
the absorption and the##7##4##(2008-2#3)(2008-3#3)(2013-8#1)
the absorption and##30##3##(2007-11#2)(2008-10#1)(2008-2#8)(2008-3#15)(2008-5#1)(2008-7#1)(2009-12#1)(2013-8#1)
the absorption band##3##3##(2008-10#2)(2008-2#1)
the absorption bands at##2##4##(2008-10#1)(2008-3#1)
the absorption bands##3##3##(2008-10#1)(2008-3#2)
the absorption coefficient a##2##4##(2008-2#1)(2008-3#1)
the absorption coefficient and##5##4##(2008-2#3)(2008-3#2)
the absorption coefficient has##2##4##(2008-3#2)
the absorption coefficient is##4##4##(2008-2#1)(2008-3#3)
the absorption coefficient of pulsed##3##5##(2008-2#3)
the absorption coefficient of the##3##5##(2007-12#1)(2008-3#2)
the absorption coefficient of##12##4##(2007-12#1)(2008-2#6)(2008-3#5)
the absorption coefficient##42##3##(2007-11#1)(2007-12#3)(2008-2#15)(2008-3#23)
the absorption coefficients of##4##4##(2007-12#1)(2008-3#3)
the absorption coefficients##5##3##(2007-12#1)(2008-3#4)
the absorption cross section of##2##5##(2008-2#2)
the absorption cross section##7##4##(2007-11#1)(2008-2#3)(2008-3#3)
the absorption cross##8##3##(2007-11#1)(2008-2#4)(2008-3#3)
the absorption distribution##3##3##(2008-3#3)
the absorption effect##2##3##(2008-2#2)
the absorption efficiency and single-scattering albedo of##3##7##(2008-3#3)
the absorption in the##2##4##(2008-2#1)(2009-11#1)
the absorption in##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
the absorption index##2##3##(2008-10#1)(2008-3#1)
the absorption lines##2##3##(2008-2#1)(2008-3#1)
the absorption loss of##2##4##(2008-3#2)
the absorption maximum of##3##4##(2008-10#1)(2008-8#2)
the absorption maximum##6##3##(1994-5#2)(2008-10#2)(2008-8#2)
the absorption minimum is##2##4##(2008-2#2)
the absorption of Hct##2##4##(2011-3#2)
the absorption of the defect##2##5##(2007-11#2)
the absorption of the##7##4##(1993-11#1)(2007-11#3)(2008-2#1)(2008-3#2)
the absorption of##27##3##(1992-4#1)(1993-11#1)(1994-9#1)(1997-1#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#6)(2008-5#1)(2008-8#1)(2011-3#5)
the absorption peak##3##3##(2007-11#1)(2008-8#1)(2013-8#1)
the absorption peaks of##2##4##(2008-10#1)(2008-8#1)
the absorption properties##2##3##(2008-2#1)(2008-3#1)
the absorption signal##3##3##(2008-10#2)(2008-3#1)
the absorption spectra of the##5##5##(2007-12#1)(2008-10#4)
the absorption spectra of##10##4##(2007-12#1)(2008-10#8)(2008-9#1)
the absorption spectra##17##3##(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)
the absorption spectrum of pure water##3##6##(2008-2#2)(2008-3#1)
the absorption spectrum of##7##4##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
the absorption spectrum##12##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)
the absorption wavelengths in the ultraviolet##2##6##(2008-2#1)(2008-3#1)
the absorption##221##2##(1992-4#1)(1993-11#1)(1994-5#2)(1994-9#1)(1997-1#1)(2006-4#1)(2007-11#12)(2007-12#9)(2008-10#32)(2008-11#4)(2008-2#49)(2008-3#82)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2011-3#6)(2012-2#1)(2013-8#2)
the absorptive##3##2##(2007-11#2)(2008-10#1)
the abstract##4##2##(2008-11#1)(2009-4#3)
the abstractness of children's##2##4##(2008-2#2)
the abstracts##3##2##(2008-5#1)(2010-12#1)(2013-8#1)
the abundance and diversity##2##4##(2008-10#1)(2013-7#1)
the abundance and##4##3##(2008-10#1)(2008-7#1)(2010-12#1)(2013-7#1)
the abundance of the##3##4##(1994-6#1)(2008-9#1)(2013-7#1)
the abundance of##30##3##(1994-11#1)(1994-2#3)(1994-6#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#2)
the abundance of C##2##3##(2012-3#2)
the abundance##43##2##(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-3#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#4)
the abundances of##3##3##(1994-2#1)(2008-9#1)(2011-2#1)
the abundances##4##2##(1994-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
the abundant##8##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-8#1)(2012-2#1)
the abuse of prescription##2##4##(2008-3#1)(2012-1#1)
the abuse of##7##3##(1993-12#1)(2008-3#2)(2010-11#1)(2010-4#1)(2010-7#1)(2012-1#1)
the abuse##11##2##(1993-12#1)(2008-3#3)(2008-4#2)(2010-11#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-3#1)
the abusers##4##2##(1990-2#1)(1993-12#1)(1996-5#1)(2010-3#1)
the abyss##2##2##(1993-2#1)(1995-1#1)
the ac##2##2##(2007-12#1)(2008-3#1)
the academic and research##2##4##(1996-12#1)(2013-1#1)
the academic community##3##3##(1990-2#1)(1996-1#1)(2008-10#1)
the academic engagement##2##3##(2008-12#2)
the academic performance and##2##4##(2013-8#2)
the academic performance##8##3##(2013-8#8)
the academic world##2##3##(2009-10#1)(2009-11#1)
the academic##33##2##(1990-2#2)(1991-8#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-12#4)(2009-10#1)(2009-11#1)(2010-1#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#8)
the accelerated failure time model##2##5##(2008-10#2)
the accelerated##9##2##(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
the accelerating effect of##3##4##(2008-10#2)(2008-11#1)
the accelerating##5##2##(1996-4#1)(2008-10#2)(2008-11#1)(2008-3#1)
the acceleration of##4##3##(1996-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
the acceleration##8##2##(1994-9#1)(1996-2#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)(2013-8#1)
the accelerometer##2##2##(2008-2#2)
the acceptability and##2##3##(2009-11#1)(2010-10#1)
the acceptability of##4##3##(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
the acceptability##7##2##(2008-7#1)(2009-11#2)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
the acceptable##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
the acceptance of a##2##4##(1994-7#1)(1995-2#1)
the acceptance of the##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
the acceptance of##12##3##(1994-7#1)(1995-2#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
the acceptance or##2##3##(2007-10#1)(2008-10#1)
the acceptance##15##2##(1994-7#1)(1995-2#2)(2007-10#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
the accepted##9##2##(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)
the acceptor solution##2##3##(2008-10#1)(2012-1#1)
the acceptor stream##4##3##(2008-10#4)
the acceptor##20##2##(1990-12#1)(1995-6#1)(1996-4#1)(1996-5#1)(2007-11#1)(2008-10#13)(2009-2#1)(2012-1#1)
the access and##2##3##(1994-12#1)(1994-2#1)
the access of the##2##4##(2008-10#1)(2009-8#1)
the access of##7##3##(1993-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#1)
the access to##5##3##(1991-9#1)(1994-2#1)(1995-11#1)(2008-7#1)(2012-2#1)
the access##17##2##(1991-9#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
the accessibility of##6##3##(1991-12#1)(1992-12#1)(1993-12#1)(1995-2#1)(2008-4#1)(2008-8#1)
the accessible##7##2##(1993-11#1)(1995-2#1)(1997-6#1)(2008-11#2)(2008-3#1)(2010-5#1)
the accessory nerve##2##3##(2008-7#2)
the accessory nuclei##2##3##(2007-12#1)(2008-7#1)
the accessory olfactory bulb##2##4##(1992-8#2)
the accessory##13##2##(1992-8#2)(1994-8#1)(2007-12#2)(2008-10#1)(2008-7#5)(2012-2#1)(2013-1#1)
the accident##12##2##(1990-9#2)(1992-4#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-4#2)(2009-10#2)(2013-1#2)
the accidental##2##2##(1993-5#1)(2009-10#1)
the acclimation phase##2##3##(2008-7#2)
the acclimation##3##2##(2008-7#3)
the accompanying##17##2##(1990-11#1)(1991-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#2)
the accomplishment of##3##3##(2008-9#1)(2009-5#1)(2013-1#1)
the account##3##2##(2011-2#2)(2012-2#1)
the accumbens##2##2##(1991-5#1)(1993-6#1)
the accumulated evidence##2##3##(1994-6#1)(2013-8#1)
the accumulated##11##2##(1990-8#1)(1992-3#1)(1994-6#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
the accumulating##3##2##(2008-7#1)(2012-3#2)
the accumulation and##2##3##(2008-10#2)
the accumulation of a##5##4##(1994-11#1)(1995-12#1)(2007-8#1)(2010-2#1)(2011-2#1)
the accumulation of deleterious mutations##2##5##(2008-8#1)(2010-3#1)
the accumulation of malonyl-CoA##2##4##(1995-6#2)
the accumulation of sequence##2##4##(1995-8#1)(1997-2#1)
the accumulation of superoxide##2##4##(1994-11#1)(2008-10#1)
the accumulation of the##8##4##(1990-2#1)(1992-11#1)(2008-10#5)(2008-7#1)
the accumulation of these##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
the accumulation of##98##3##(1990-2#2)(1990-5#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#32)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-1#2)
the accumulation time##5##3##(1992-3#1)(2008-10#4)
the accumulation##113##2##(1990-2#2)(1990-5#2)(1991-12#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#42)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-1#3)
the accuracy and precision of the##3##6##(2008-10#2)(2008-3#1)
the accuracy and precision of##7##5##(1991-3#1)(2008-10#5)(2008-3#1)
the accuracy and precision##9##4##(1991-3#1)(2008-10#7)(2008-3#1)
the accuracy and reliability of##2##5##(2008-3#1)(2012-3#1)
the accuracy and reproducibility of##3##5##(2008-10#2)(2008-9#1)
the accuracy and the sensitivity##2##5##(2008-1#1)(2008-10#1)
the accuracy and the##10##4##(1993-12#1)(2008-1#1)(2008-10#3)(2008-3#4)(2010-8#1)
the accuracy and##35##3##(1991-3#1)(1993-12#3)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#7)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-8#1)(2012-3#1)
the accuracy for the##2##4##(2008-10#2)
the accuracy for##3##3##(1994-12#1)(2008-10#2)
the accuracy in the determination of the##2##7##(2008-2#1)(2008-3#1)
the accuracy in the determination of##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
the accuracy in##6##3##(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)
the accuracy is##2##3##(2008-10#1)(2008-3#1)
the accuracy levels##2##3##(2008-2#2)
the accuracy of DNA##2##4##(2008-3#1)(2008-9#1)
the accuracy of a##2##4##(1992-3#1)(2007-10#1)
the accuracy of an##2##4##(2007-12#1)(2012-1#1)
the accuracy of predictions##2##4##(1994-3#1)(2008-10#1)
the accuracy of the analysis##2##5##(2008-10#1)(2012-2#1)
the accuracy of the derived##2##5##(2008-3#1)(2008-7#1)
the accuracy of the determined##2##5##(2008-3#2)
the accuracy of the developed method##4##6##(2008-10#4)
the accuracy of the interferometer##2##5##(2008-3#2)
the accuracy of the measurement##2##5##(2008-10#1)(2008-2#1)
the accuracy of the method##3##5##(2008-10#3)
the accuracy of the procedure##3##5##(2008-10#1)(2008-3#1)(2010-5#1)
the accuracy of the proposed method##3##6##(2008-10#3)
the accuracy of the proposed##6##5##(2008-10#6)
the accuracy of the results##2##5##(2008-10#1)(2008-3#1)
the accuracy of the retrieved##2##5##(2008-2#1)(2008-3#1)
the accuracy of the technique##5##5##(2008-10#1)(2008-2#1)(2008-3#3)
the accuracy of the##82##4##(1991-12#1)(1992-2#1)(1993-1#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#26)(2008-2#12)(2008-3#25)(2008-6#2)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#4)
the accuracy of this##5##4##(1990-12#1)(2008-3#3)(2013-8#1)
the accuracy of##153##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-3#3)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#2)(2007-8#1)(2008-10#31)(2008-11#1)(2008-2#18)(2008-3#40)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#4)
the accuracy was##2##3##(2008-10#2)
the accuracy with which the##2##5##(2008-2#1)(2009-11#1)
the accuracy with which##3##4##(2008-2#1)(2008-3#1)(2009-11#1)
the accuracy##226##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1997-2#1)(1997-3#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#61)(2008-11#2)(2008-2#23)(2008-3#57)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#4)
the accurate analysis of##2##4##(2008-10#1)(2008-2#1)
the accurate analysis##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
the accurate determination of##3##4##(2008-10#3)
the accurate diagnosis of##2##4##(2008-1#1)(2011-2#1)
the accurate diagnosis##3##3##(2008-1#2)(2011-2#1)
the accurate measurement of##3##4##(1991-11#1)(2008-3#2)
the accurate molecular##2##3##(1997-2#1)(2008-4#1)
the accurate##31##2##(1991-11#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2009-2#1)(2010-8#1)(2011-2#2)
the accused##2##2##(1996-3#1)(2011-1#1)
the acetabular component##3##3##(2008-11#1)(2008-8#2)
the acetabular roof in##2##4##(2007-8#2)
the acetabular roof##4##3##(2007-8#4)
the acetabular##11##2##(2007-8#5)(2008-11#2)(2008-5#1)(2008-8#3)
the acetabulum##8##2##(2007-8#1)(2008-5#2)(2008-8#2)(2009-4#2)(2013-1#1)
the acetate##7##2##(1997-2#2)(2008-10#2)(2008-7#2)(2011-1#1)
the acetic acid##2##3##(2012-12#1)(2013-7#1)
the acetic acid-induced writhing##2##4##(2011-1#1)(2013-7#1)
the acetic##4##2##(2011-1#1)(2012-12#1)(2013-7#2)
the acetone##4##2##(2008-10#2)(2008-11#2)
the acetoxy##2##2##(1996-5#2)
the acetoxymethyl ester##3##3##(1992-5#2)(2010-11#1)
the acetylation##3##2##(2008-10#1)(2008-4#2)
the acetylcholine##3##2##(1992-3#1)(1997-2#1)(2008-10#1)
the acetylcholinesterase inhibitor##2##3##(1996-9#1)(2012-2#1)
the acetylcholinesterase##6##2##(1996-9#1)(2008-10#1)(2008-11#3)(2012-2#1)
the achievable##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
the achieved##2##2##(1995-5#1)(2008-10#1)
the achievement of a##3##4##(1994-3#1)(1996-2#1)(2007-5#1)
the achievement of##16##3##(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-3#2)(2011-2#1)(2012-2#1)
the achievement##18##2##(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-7#1)(2010-3#2)(2011-2#1)(2012-2#1)
the achievements and##2##3##(2008-5#1)(2010-8#1)
the achievements of the##2##4##(2008-12#2)
the achievements of##5##3##(1995-1#1)(2007-8#1)(2008-12#2)(2012-3#1)
the achievements##9##2##(1995-1#1)(2007-8#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
the achromatic device AD-1##2##4##(2008-2#2)
the achromatic##6##2##(2008-2#4)(2008-3#2)
the acid and the##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
the acid and##5##3##(1990-7#1)(2008-10#2)(2008-5#1)(2008-9#1)
the acid phosphatase##3##3##(1992-12#2)(2008-7#1)
the acid##37##2##(1990-5#1)(1990-7#1)(1992-12#2)(1995-12#1)(2008-10#23)(2008-5#6)(2008-7#2)(2008-9#1)
the acid-base behaviour of##2##4##(2008-10#2)
the acid-base properties of the##2##5##(1995-6#1)(2008-10#1)
the acid-base properties of##3##4##(1995-6#1)(2008-10#2)
the acid-base properties##4##3##(1995-6#1)(2008-10#3)
the acid-base##11##2##(1994-5#1)(1995-6#1)(2008-10#9)
the acid-extractable##2##2##(2008-10#2)
the acid-washed PM 1648 instilled##2##5##(2008-10#2)
the acid-washed PM 1648##3##4##(2008-10#3)
the acidic and##4##3##(1993-11#1)(2008-10#3)
the acidic hydrolysis of lorazepam##2##5##(2008-10#2)
the acidic##28##2##(1990-7#1)(1993-11#2)(1994-3#1)(1994-5#2)(2006-6#1)(2008-10#16)(2008-5#3)(2008-7#1)(2010-12#1)
the acidification of##2##3##(1990-11#1)(1994-8#1)
the acidification##5##2##(1990-11#1)(1990-7#1)(1994-8#1)(2008-10#1)(2012-3#1)
the acidity and##2##3##(2008-10#2)
the acidity of the##4##4##(2008-10#4)
the acidity of##6##3##(2008-10#6)
the acidity##13##2##(2008-10#13)
the acids##5##2##(2008-10#3)(2008-5#1)(2012-1#1)
the acinar##3##2##(1992-8#1)(1995-11#1)(2008-7#1)
the acinus##5##2##(1995-11#1)(2007-12#4)
the acitric allele##2##3##(2008-5#2)
the acorn barnacle##5##3##(1990-5#4)(1993-6#1)
the acoustic field##3##3##(2008-2#2)(2008-3#1)
the acoustic measures##2##3##(2011-1#2)
the acoustic velocity##2##3##(2008-3#2)
the acoustic##24##2##(1996-2#1)(2007-12#2)(2007-5#1)(2008-2#3)(2008-3#8)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#3)(2011-1#2)
the acquired images##2##3##(2008-10#1)(2012-1#1)
the acquired immunodeficiency syndrome (AIDS)##4##5##(1990-6#1)(1990-9#1)(1993-12#1)(1996-12#1)
the acquired immunodeficiency syndrome##9##4##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-9#1)(1996-12#1)
the acquired information##2##3##(2008-3#1)(2013-1#1)
the acquired##29##2##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-9#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2009-8#1)(2010-3#1)(2010-6#1)(2012-1#2)(2012-3#1)(2013-1#2)
the acquisition and##4##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
the acquisition of a##4##4##(1992-10#1)(1993-6#2)(2008-10#1)
the acquisition of data##2##4##(2008-10#1)(2008-7#1)
the acquisition of the##3##4##(1991-2#1)(2009-3#2)
the acquisition of##35##3##(1991-2#1)(1992-10#3)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#2)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the acquisition##46##2##(1991-2#1)(1992-1#1)(1992-10#3)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
the acronym of##2##3##(2008-3#1)(2011-2#1)
the acronym##4##2##(1996-12#1)(2008-3#2)(2011-2#1)
the acrosomal complex##2##3##(2007-12#2)
the acrosomal membrane##2##3##(1994-8#2)
the acrosomal region##2##3##(2008-7#2)
the acrosomal##8##2##(1994-8#3)(2007-12#2)(2008-7#3)
the acrosome reaction##9##3##(1992-8#2)(2008-8#7)
the acrosome##16##2##(1992-8#2)(2008-4#1)(2008-7#6)(2008-8#7)
the act of##4##3##(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
the act##5##2##(1994-1#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
the actin and##2##3##(1990-12#1)(2009-10#1)
the actin binding##2##3##(1994-8#1)(2009-7#1)
the actin cytoskeleton in##4##4##(2008-10#1)(2008-11#2)(2009-10#1)
the actin cytoskeleton is##2##4##(2011-2#1)(2012-12#1)
the actin cytoskeleton##22##3##(1996-12#2)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-9#2)(2009-10#1)(2009-7#2)(2011-1#2)(2011-2#1)(2012-12#2)
the actin gene##2##3##(2008-10#2)
the actin##38##2##(1990-12#2)(1992-3#3)(1994-6#1)(1994-8#1)(1996-12#2)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-9#3)(2009-10#2)(2009-7#3)(2011-1#2)(2011-2#1)(2012-12#2)
the actin-binding site##2##3##(1993-8#2)
the actin-binding##6##2##(1993-8#3)(1994-8#2)(2011-1#1)
the actin-related protein centractin (Arp-1)##2##5##(1995-2#2)
the actinobacterial family Cellulomonadaceae##2##4##(2011-2#2)
the actinobacterial family##4##3##(2011-2#4)
the actinobacterial##5##2##(2011-2#5)
the action of TSH##2##4##(1991-5#1)(1996-5#1)
the action of a##7##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-3#1)
the action of glutamate##2##4##(1995-12#1)(2008-7#1)
the action of insulin##3##4##(1995-6#1)(1996-2#1)(2008-11#1)
the action of the##12##4##(1990-11#1)(1990-5#1)(1992-3#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
the action of these##5##4##(1990-2#1)(1991-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
the action of this##3##4##(1992-3#1)(1994-3#1)(1997-2#1)
the action of##112##3##(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#2)(1992-3#3)(1992-6#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#2)(1997-2#4)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#1)
the action plan##2##3##(1991-3#1)(1995-3#1)
the action potential##6##3##(1991-5#2)(1996-2#2)(2008-11#1)(2009-5#1)
the action##137##2##(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#2)(1991-3#1)(1991-5#3)(1991-9#2)(1992-1#1)(1992-3#3)(1992-6#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#5)(1996-4#1)(1996-5#3)(1997-2#4)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#10)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)
the action-perception cycle##2##3##(2008-11#2)
the actions of the##2##4##(1990-5#1)(1990-8#1)
the actions of##28##3##(1990-5#4)(1990-8#1)(1991-12#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-2#1)(1997-1#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2012-2#1)
the actions##31##2##(1990-5#4)(1990-8#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-9#1)(1993-11#1)(1993-2#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2012-2#1)
the activated macrophages##3##3##(2008-11#2)(2009-12#1)
the activated membranes##2##3##(1994-8#2)
the activated partial thromboplastin time##2##5##(1991-2#1)(1994-9#1)
the activated partial thromboplastin##3##4##(1991-2#1)(1994-9#1)(2008-9#1)
the activated partial##4##3##(1991-2#1)(1994-9#1)(1996-6#1)(2008-9#1)
the activated polycarbonate##3##3##(2008-10#3)
the activated##39##2##(1991-2#1)(1991-9#2)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-7#2)(2008-10#13)(2008-11#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)
the activating effect of ET-1##2##5##(1994-8#2)
the activating##5##2##(1993-12#1)(1994-11#1)(1994-8#2)(2008-3#1)
the activation and##2##3##(1993-8#1)(2008-8#1)
the activation energy for the##3##5##(2008-10#3)
the activation energy for##6##4##(2008-10#5)(2012-2#1)
the activation energy of##3##4##(1990-2#1)(1996-7#1)(2007-12#1)
the activation energy##12##3##(1990-2#1)(1996-7#2)(2007-12#1)(2008-10#7)(2012-2#1)
the activation in##2##3##(2008-1#1)(2008-5#1)
the activation loop##3##3##(1995-2#1)(2012-12#2)
the activation of N-methyl-D-aspartate (NMDA) receptors##2##6##(2009-8#1)(2012-2#1)
the activation of NADPH oxidase##2##5##(1993-6#1)(1994-6#1)
the activation of NMDA receptors##2##5##(1990-7#1)(2009-8#1)
the activation of PKC##2##4##(1997-2#1)(2008-8#1)
the activation of T##2##4##(1994-3#1)(2008-4#1)
the activation of a##8##4##(1992-8#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
the activation of cell##2##4##(1993-3#1)(2012-12#1)
the activation of complement##2##4##(1993-3#2)
the activation of either##2##4##(1996-2#2)
the activation of heat shock factor##3##6##(1994-8#2)(2010-2#1)
the activation of p72syk##3##4##(1992-6#1)(1993-11#2)
the activation of phospholipase##2##4##(1992-9#1)(1996-2#1)
the activation of protein kinase C##4##6##(1990-12#1)(1990-8#1)(1992-6#1)(1993-6#1)
the activation of protein##6##4##(1990-12#1)(1990-8#1)(1992-6#1)(1993-6#1)(1995-11#1)(2008-7#1)
the activation of proto-oncogenes##2##4##(2008-7#1)(2011-2#1)
the activation of quiescent##2##4##(2008-10#2)
the activation of the##14##4##(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#2)(1997-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-3#1)(2012-2#1)
the activation of these##3##4##(1993-11#1)(2008-6#1)(2008-8#1)
the activation of various##3##4##(2008-11#1)(2010-7#1)(2013-1#1)
the activation of##142##3##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#5)(1993-6#3)(1993-8#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#4)(1995-11#3)(1995-12#2)(1995-2#4)(1995-6#3)(1996-12#1)(1996-2#6)(1996-5#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-4#11)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#6)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#4)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
the activation parameters for the interconversion between the alpha- and beta-conformations of fac-Re(CO)(3)(dpknph)Cl##2##13##(2008-10#2)
the activation parameters##3##3##(1996-2#1)(2008-10#2)
the activation process##2##3##(1993-6#1)(2008-4#1)
the activation spreads##2##3##(2008-7#2)
the activation state of##3##4##(1995-6#1)(2008-1#1)(2008-9#1)
the activation status of##2##4##(2008-11#1)(2008-7#1)
the activation##197##2##(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#5)(1993-6#4)(1993-8#4)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#4)(1995-11#3)(1995-12#2)(1995-2#5)(1995-6#5)(1996-12#1)(1996-2#7)(1996-5#1)(1996-7#2)(1997-2#5)(1997-3#3)(1997-4#2)(1997-7#1)(2006-6#1)(2007-12#1)(2008-1#6)(2008-10#18)(2008-11#3)(2008-4#14)(2008-5#4)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#2)(2009-6#2)(2009-8#3)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#4)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
the activator protein##2##3##(1994-3#1)(2008-9#1)
the activator##6##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
the activators##4##2##(1993-12#1)(1993-3#1)(1997-2#1)(2008-9#1)
the active and##2##3##(1990-3#1)(2007-11#1)
the active area##2##3##(2008-2#1)(2008-3#1)
the active avoidance test##2##4##(2013-1#2)
the active center##2##3##(1990-7#1)(2008-8#1)
the active channel##2##3##(1997-8#2)
the active chemical##2##3##(2008-10#1)(2008-8#1)
the active components of##2##4##(2008-10#2)
the active components##4##3##(1996-2#1)(2008-10#3)
the active compound##3##3##(2008-10#2)(2008-12#1)
the active compounds##3##3##(2008-10#2)(2010-7#1)
the active form of##3##4##(1991-6#1)(2008-6#1)(2012-2#1)
the active form##5##3##(1990-2#1)(1991-6#1)(1995-2#1)(2008-6#1)(2012-2#1)
the active formation##2##3##(1997-2#1)(2013-7#1)
the active immunoglobulin heavy chain gene##2##6##(2008-11#2)
the active ingredient##8##3##(2008-10#1)(2008-5#5)(2011-2#2)
the active ingredients##4##3##(2008-5#3)(2010-9#1)
the active material##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
the active medium##3##3##(2007-12#2)(2008-3#1)
the active metabolite##2##3##(1991-8#1)(1995-2#1)
the active oxygen##2##3##(1994-5#1)(2008-8#1)
the active participation of##3##4##(1993-3#1)(2008-10#2)
the active principle of##2##4##(1991-2#1)(1991-8#1)
the active principle##7##3##(1991-2#1)(1991-8#1)(1992-3#2)(2008-10#3)
the active region##3##3##(2007-11#1)(2008-8#2)
the active ret##2##3##(1993-8#2)
the active site by##2##4##(1995-3#1)(1997-6#1)
the active site cysteine residue##2##5##(1995-2#2)
the active site cysteine##3##4##(1995-2#2)(1995-5#1)
the active site in the##2##5##(1992-5#1)(1992-6#1)
the active site is##3##4##(1990-5#1)(1992-5#2)
the active site nucleophile##3##4##(1995-2#1)(1995-6#2)
the active site of PKC##2##5##(1992-6#2)
the active site of the enzyme##7##6##(1990-9#1)(1992-11#1)(1992-6#1)(1994-5#1)(1994-8#1)(2008-4#1)(2009-9#1)
the active site of the##10##5##(1990-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-4#1)(2009-9#1)
the active site of##34##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#2)(1992-11#3)(1992-3#2)(1992-6#4)(1992-8#1)(1993-11#1)(1994-5#7)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(2008-4#1)(2008-8#1)(2009-9#1)
the active site or##2##4##(1997-2#1)(1997-6#1)
the active site were##2##4##(1991-6#1)(1993-11#1)
the active site##98##3##(1990-2#1)(1990-5#5)(1990-7#1)(1990-8#3)(1990-9#1)(1991-3#2)(1991-5#3)(1991-6#1)(1992-11#4)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#11)(1992-8#2)(1993-11#4)(1993-8#1)(1994-5#11)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#6)(1995-3#1)(1995-5#5)(1995-6#4)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2008-4#2)(2008-8#2)(2009-11#1)(2009-9#1)(2010-11#1)(2013-1#1)
the active sites of##5##4##(1992-8#2)(1994-12#1)(1995-5#1)(2012-12#1)
the active sites##10##3##(1991-11#1)(1992-8#3)(1994-12#1)(1995-5#2)(2008-10#1)(2011-2#1)(2012-12#1)
the active species##2##3##(1990-5#1)(1993-6#1)
the active substance##4##3##(1990-5#1)(2008-10#3)
the active transport of##2##4##(1990-9#1)(2011-2#1)
the active treatment##2##3##(2008-5#1)(2012-3#1)
the active zone##2##3##(1994-8#1)(2007-11#1)
the active##276##2##(1990-2#2)(1990-3#1)(1990-5#7)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#2)(1992-11#4)(1992-12#2)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#14)(1992-8#5)(1992-9#1)(1993-11#4)(1993-3#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#12)(1994-6#1)(1994-8#6)(1995-11#2)(1995-2#8)(1995-3#2)(1995-5#8)(1995-6#5)(1995-8#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#3)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#37)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#11)(2009-11#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
the active-site cysteine##2##3##(1993-11#1)(1995-2#1)
the active-site##7##2##(1993-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-6#1)(2009-9#1)
the actively##2##2##(2010-3#1)(2012-3#1)
the activities and##4##3##(1994-5#1)(2008-1#2)(2008-4#1)
the activities of both##2##4##(2008-10#1)(2011-2#1)
the activities of key##2##4##(2008-11#1)(2011-2#1)
the activities of lipoprotein lipase##2##5##(2008-7#1)(2013-1#1)
the activities of plasma##2##4##(1993-9#1)(2008-7#1)
the activities of respiratory enzymes##2##5##(2008-10#2)
the activities of superoxide dismutase##2##5##(1990-3#1)(1994-6#1)
the activities of the##9##4##(1991-12#1)(1992-2#1)(1993-3#1)(1994-8#1)(1995-5#1)(2007-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
the activities of these enzymes##2##5##(1994-8#1)(1995-11#1)
the activities of these##3##4##(1994-8#1)(1995-11#1)(2008-9#1)
the activities of##58##3##(1990-3#2)(1990-8#2)(1991-1#1)(1991-12#2)(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-8#2)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
the activities##74##2##(1990-11#1)(1990-3#2)(1990-8#2)(1991-1#1)(1991-12#2)(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-7#1)(2010-4#1)(2010-8#3)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
the activity and expression of##2##5##(1996-12#1)(2008-11#1)
the activity and##10##3##(1994-8#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
the activity at##3##3##(1990-7#1)(1994-12#1)(2008-4#1)
the activity in##2##3##(1993-3#1)(2008-11#1)
the activity is##5##3##(1990-8#1)(1994-2#1)(1995-6#1)(2008-7#1)(2009-2#1)
the activity level the##2##4##(2007-11#1)(2008-8#1)
the activity of NK cells##2##5##(2008-10#2)
the activity of a##9##4##(1995-2#2)(2007-11#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
the activity of an##4##4##(1991-5#1)(2007-8#1)(2008-10#1)(2010-11#1)
the activity of both##2##4##(2008-10#1)(2008-11#1)
the activity of cytochrome c with##2##6##(1995-2#2)
the activity of cytochrome##3##4##(1995-2#2)(1997-2#1)
the activity of cytosolic##2##4##(1990-5#1)(1991-5#1)
the activity of different##2##4##(1992-5#1)(2009-3#1)
the activity of enzymes##3##4##(1991-5#1)(2008-10#1)(2008-2#1)
the activity of growth factor##2##5##(2008-12#1)(2012-1#1)
the activity of heterotrophic microorganism in membrane bioreactor##2##8##(2013-1#2)
the activity of its##2##4##(2009-3#1)(2010-5#1)
the activity of phospholipase A2##2##5##(1994-5#2)
the activity of phospholipase##3##4##(1994-5#2)(2011-2#1)
the activity of recombinant##2##4##(2008-10#1)(2011-2#1)
the activity of superoxide dismutase (SOD)##2##6##(2011-1#1)(2012-2#1)
the activity of the enzyme##5##5##(1994-6#1)(1996-2#1)(2008-9#1)(2009-6#1)(2013-1#1)
the activity of the immobilized##2##5##(2008-10#2)
the activity of the respiratory##2##5##(1992-8#1)(1994-6#1)
the activity of the##66##4##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#4)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#1)
the activity of these##4##4##(1991-1#1)(2007-11#1)(2008-10#1)(2008-8#1)
the activity of this drug##2##5##(1997-2#1)(2008-6#1)
the activity of this enzyme##2##5##(1990-12#1)(1991-9#1)
the activity of this##7##4##(1990-12#1)(1990-5#1)(1991-9#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-6#1)
the activity of three##2##4##(2008-10#1)(2008-11#1)
the activity of various##2##4##(1994-12#1)(1994-8#1)
the activity of##269##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-5#4)(1990-7#5)(1990-8#3)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#7)(1994-7#1)(1994-8#9)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#7)(1995-5#3)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#5)(1996-4#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#27)(2008-11#10)(2008-12#4)(2008-2#1)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#5)(2008-8#10)(2008-9#10)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-11#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#3)
the activity profile during the host infection process and the effect of lipase activity inhibitor ebelactone B on infection##2##19##(2010-10#2)
the activity recovery##2##3##(2011-2#2)
the activity therapies##2##3##(1993-2#2)
the activity was##6##3##(1990-2#1)(1991-5#1)(1994-11#1)(2008-10#1)(2009-2#1)(2013-1#1)
the activity##348##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#5)(1990-5#4)(1990-7#7)(1990-8#5)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#3)(1994-5#3)(1994-6#8)(1994-7#1)(1994-8#11)(1994-9#2)(1995-11#2)(1995-12#6)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#2)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-6#4)(1997-7#2)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#35)(2008-11#15)(2008-12#4)(2008-2#1)(2008-4#8)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#12)(2008-9#10)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#4)
the actor effect##2##3##(2013-8#2)
the actor##5##2##(2008-11#2)(2013-8#3)
the actual capacity (equipment##3##4##(2008-10#3)
the actual concentrations##2##3##(2008-10#2)
the actual distribution of##2##4##(2007-5#1)(2008-10#1)
the actual impact of##2##4##(1994-1#1)(1997-3#1)
the actual level of##2##4##(1993-2#1)(2012-3#1)
the actual location of the##2##5##(2006-6#1)(2010-8#1)
the actual mechanism##3##3##(1991-1#1)(1993-6#1)(2008-11#1)
the actual phase##3##3##(2008-3#3)
the actual use of medicines##2##5##(2008-11#2)
the actual use of##3##4##(1995-3#1)(2008-11#2)
the actual values of the##2##5##(2007-11#1)(2008-3#1)
the actual##114##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#16)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-3#2)
the actuarial##3##2##(1990-6#1)(1990-9#1)(2011-2#1)
the actuation##3##2##(2009-11#1)(2010-4#2)
the actuator##2##2##(2008-3#2)
the actuators##2##2##(2009-9#1)(2011-1#1)
the aculeus apex##2##3##(2008-6#2)
the aculeus##3##2##(2008-6#3)
the acupoints of left HM##3##5##(2008-9#3)
the acupoints of##4##3##(2008-9#4)
the acute and chronic##4##4##(1991-9#1)(1997-1#1)(2008-5#1)(2013-1#1)
the acute and the chronic##2##5##(1994-2#1)(1995-12#1)
the acute and##12##3##(1991-9#1)(1994-2#1)(1995-12#1)(1997-1#1)(2007-8#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
the acute care setting##2##4##(2008-3#1)(2011-1#1)
the acute care##9##3##(1996-2#2)(1996-3#1)(1997-1#1)(2008-3#1)(2010-4#1)(2011-1#1)(2013-1#2)
the acute coronary ischemic syndromes##3##5##(2008-10#3)
the acute coronary syndromes##2##4##(2008-3#1)(2010-12#1)
the acute coronary##6##3##(2008-10#3)(2008-3#2)(2010-12#1)
the acute effect of##3##4##(2008-3#1)(2008-6#1)(2009-12#1)
the acute effects of##4##4##(1992-3#1)(1993-8#1)(1997-2#1)(2011-2#1)
the acute medical##2##3##(2010-12#1)(2010-5#1)
the acute phase of the##3##5##(1997-3#1)(1997-5#1)(2013-1#1)
the acute phase of##14##4##(1991-11#1)(1997-3#1)(1997-5#6)(2008-12#1)(2008-7#2)(2013-1#3)
the acute phase response##3##4##(1992-9#1)(1993-12#1)(1994-6#1)
the acute phase##24##3##(1991-11#2)(1992-12#1)(1992-9#1)(1993-12#2)(1994-6#1)(1997-3#1)(1997-5#6)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#3)
the acute stage of##5##4##(1990-9#1)(1995-5#2)(1997-6#1)(2008-12#1)
the acute stage##10##3##(1990-12#1)(1990-9#1)(1995-5#3)(1997-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)
the acute toxicity##2##3##(2008-10#1)(2008-7#1)
the acute##116##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#6)(1997-6#1)(2006-10#1)(2007-10#4)(2007-11#1)(2007-8#2)(2008-10#6)(2008-12#2)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#8)
the acutely##8##2##(1991-2#2)(1994-6#1)(1995-2#2)(1996-9#1)(1997-3#2)
the acyclic##4##2##(1990-9#2)(1996-5#1)(2008-10#1)
the acyl chain length of##2##5##(1990-7#1)(1994-5#1)
the acyl chain##5##3##(1990-7#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)
the acyl##11##2##(1990-7#1)(1990-8#1)(1991-3#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-5#1)(2008-10#2)(2009-2#1)
the acyl-CoA##2##2##(1990-5#1)(1995-5#1)
the acyl-coenzyme A binding protein##2##5##(1995-5#2)
the acylation process##2##3##(1990-11#1)(1990-8#1)
the acylation##6##2##(1990-11#1)(1990-5#2)(1990-8#2)(1997-4#1)
the acyltransferase##2##2##(1991-2#2)
the ad##2##2##(2008-7#2)
the adaptation of the##4##4##(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)
the adaptation of##11##3##(1990-12#1)(1991-11#1)(1992-2#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-3#1)
the adaptation##18##2##(1990-12#1)(1991-11#1)(1992-2#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2010-1#1)(2011-1#1)(2012-3#2)
the adapted##2##2##(2008-7#1)(2013-8#1)
the adaptive immune response##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
the adaptive immune##5##3##(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-8#1)
the adaptive response##3##3##(2008-7#2)(2013-1#1)
the adaptive significance of##2##4##(1993-12#1)(2008-9#1)
the adaptive value of##2##4##(2008-8#1)(2009-8#1)
the adaptive##36##2##(1993-12#1)(1994-12#1)(1994-2#1)(1997-2#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#2)
the adaptor protein##2##3##(2013-1#2)
the addAB##2##2##(1995-8#2)
the added amount##2##3##(2008-10#2)
the added benefit of##2##4##(2008-8#1)(2010-4#1)
the added copper##2##3##(1990-8#1)(1997-8#1)
the added##27##2##(1990-5#1)(1990-8#2)(1991-12#1)(1992-3#1)(1993-12#1)(1994-5#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)
the adding##2##2##(2008-10#1)(2008-3#1)
the addition of 0##2##4##(2008-10#2)
the addition of Cremophor EL##2##5##(2008-3#2)
the addition of Cu##2##4##(2008-11#2)
the addition of HSA##2##4##(1994-9#2)
the addition of a known##2##5##(2008-10#1)(2008-9#1)
the addition of a small amount of##2##7##(2008-3#1)(2008-5#1)
the addition of a##21##4##(1990-7#1)(1996-7#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2013-1#1)
the addition of actinomycin D##3##5##(1992-8#1)(1997-2#1)(2008-11#1)
the addition of ammonium##3##4##(1991-5#1)(2008-10#1)(2011-1#1)
the addition of an##5##4##(1992-9#1)(2008-10#2)(2008-2#1)(2011-2#1)
the addition of apyrase##2##4##(2008-4#2)
the addition of chemotherapy##2##4##(2011-1#1)(2012-3#1)
the addition of cytochrome b(5)##2##5##(2011-2#2)
the addition of different##2##4##(2008-6#1)(2011-2#1)
the addition of excess##2##4##(1992-2#1)(2008-10#1)
the addition of exogenous genes##2##5##(2012-3#2)
the addition of exogenous##3##4##(2008-11#1)(2012-3#2)
the addition of gentamycin##2##4##(2007-12#1)(2013-8#1)
the addition of more##2##4##(2008-10#1)(2008-6#1)
the addition of multiple##2##4##(2008-3#1)(2010-11#1)
the addition of muramyl##2##4##(2008-11#2)
the addition of one##2##4##(1993-12#1)(2008-3#1)
the addition of salt##3##4##(2008-10#3)
the addition of small##3##4##(2008-10#3)
the addition of sodium##3##4##(2008-10#3)
the addition of the##15##4##(1990-7#1)(1990-8#2)(1992-12#1)(1995-1#2)(1995-2#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-8#1)
the addition of vitamin##2##4##(1993-6#1)(2008-10#1)
the addition of water##2##4##(2008-10#1)(2009-8#1)
the addition of##273##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#76)(2008-11#29)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#8)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
the addition or##2##3##(2009-8#2)
the addition to##2##3##(2007-11#1)(2008-11#1)
the addition##280##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#77)(2008-11#30)(2008-2#5)(2008-3#11)(2008-4#5)(2008-5#8)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
the additional advantage##2##3##(2008-10#2)
the additional advantages of##2##4##(1996-3#1)(2012-1#1)
the additional requirement of##2##4##(2007-12#1)(2009-12#1)
the additional##45##2##(1991-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-3#2)(1997-4#1)(2006-12#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
the additive and##2##3##(2007-8#2)
the additive effects of##3##4##(1996-12#1)(2008-11#1)(2013-7#1)
the additive genetic##2##3##(2008-8#1)(2013-1#1)
the additive##18##2##(1996-12#2)(2007-8#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-6#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
the additivity##2##2##(1992-3#1)(2008-10#1)
the adduct formation##2##3##(2008-10#2)
the adduct was##3##3##(1992-3#1)(2008-10#2)
the adduct##10##2##(1991-5#1)(1992-3#2)(1994-5#1)(2008-10#6)
the adductor##4##2##(2008-9#1)(2009-10#3)
the adducts##3##2##(1993-11#1)(2008-10#2)
the adenine nucleotide##2##3##(1994-6#1)(1995-8#1)
the adenine##14##2##(1990-8#1)(1992-6#3)(1993-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-9#2)
the adenocarcinoma##2##2##(2008-4#1)(2013-8#1)
the adenoma##3##2##(1990-11#1)(1996-11#1)(2013-8#1)
the adenomas##3##2##(1990-11#1)(2013-8#2)
the adenosine receptor##5##3##(1993-3#1)(1994-5#1)(1995-8#2)(2008-4#1)
the adenosine##16##2##(1990-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-7#1)(2008-10#1)(2008-4#4)
the adenovirus major late promoter##2##5##(1997-2#1)(2008-11#1)
the adenovirus##7##2##(1992-8#1)(1992-9#1)(1993-2#1)(1997-2#1)(1997-7#1)(2008-11#2)
the adenylate cyclase##4##3##(1990-5#1)(1990-7#1)(1996-2#1)(1997-2#1)
the adenylate##7##2##(1990-5#1)(1990-7#1)(1992-3#1)(1994-5#1)(1996-2#1)(1996-6#1)(1997-2#1)
the adequacy of a##2##4##(1990-11#1)(2008-11#1)
the adequacy of the##3##4##(1990-3#1)(2007-9#1)(2008-11#1)
the adequacy of##19##3##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#2)(2007-9#1)(2008-11#2)(2008-5#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-8#1)
the adequacy##20##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-3#2)(2007-9#1)(2008-11#2)(2008-5#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-8#1)
the adequate##9##2##(1993-6#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-8#1)
the adherence of##5##3##(1993-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2012-2#1)
the adherence to##2##3##(2011-2#1)(2012-3#1)
the adherence##12##2##(1993-9#1)(1997-4#1)(2008-10#2)(2008-3#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)
the adherent##8##2##(1990-8#1)(2008-10#3)(2008-11#3)(2009-7#1)
the adhesion and##2##3##(2008-11#1)(2013-1#1)
the adhesion of platelets to##2##5##(1997-7#2)
the adhesion of the##2##4##(2008-10#1)(2012-2#1)
the adhesion of##12##3##(1993-8#1)(1997-7#4)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
the adhesion to the##2##4##(2008-11#1)(2012-3#1)
the adhesion##27##2##(1992-1#1)(1993-8#1)(1997-7#4)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
the adhesive and invasive##2##4##(2008-8#2)
the adhesive and##3##3##(1994-9#1)(2008-8#2)
the adhesive function##2##3##(1990-11#2)
the adhesive joint##2##3##(2010-4#2)
the adhesive##17##2##(1990-11#2)(1994-9#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#4)(2012-2#1)
the adhesiveness of##2##3##(1992-9#1)(1995-12#1)
the adiabatic##2##2##(1992-7#1)(2007-11#1)
the adipocyte differentiation##2##3##(2008-11#1)(2008-3#1)
the adipocyte lipid binding protein##2##5##(1992-12#1)(1992-9#1)
the adipocyte##7##2##(1992-12#1)(1992-9#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-5#2)
the adipogenic program##2##3##(2012-2#2)
the adipogenic##3##2##(2012-2#3)
the adiponectin concentration##2##3##(2011-1#2)
the adiponectin##4##2##(2011-1#4)
the adipose eyelid##4##3##(2010-8#4)
the adipose tissue##8##3##(2008-10#1)(2008-3#2)(2008-5#2)(2010-8#1)(2012-2#1)(2013-8#1)
the adipose##16##2##(1992-9#1)(1994-12#1)(2008-10#2)(2008-3#2)(2008-5#3)(2010-8#5)(2012-2#1)(2013-8#1)
the adjacent muscle##2##3##(1992-9#1)(2008-10#1)
the adjacent teeth##2##3##(2007-12#1)(2013-1#1)
the adjacent##40##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-5#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-1#1)(2013-1#3)
the adjunct##2##2##(2008-3#1)(2013-1#1)
the adjunctive##2##2##(2006-12#1)(2013-1#1)
the adjustable##2##2##(2007-11#1)(2008-10#1)
the adjusted##3##2##(1993-3#1)(1993-9#1)(2008-10#1)
the adjustment of initially random configural stimuli##2##7##(1993-12#2)
the adjustment of the##3##4##(2008-2#2)(2008-7#1)
the adjustment of##7##3##(1993-12#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
the adjustment##12##2##(1991-1#1)(1992-12#2)(1993-12#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2013-8#1)
the adjustments##2##2##(1991-1#1)(1992-12#1)
the adjuvant##4##2##(1997-5#1)(2008-6#1)(2010-7#1)(2013-8#1)
the administered##3##2##(1991-12#1)(2008-1#1)(2008-8#1)
the administration and##2##3##(1991-12#1)(1991-3#1)
the administration of RS extract##2##5##(2008-11#2)
the administration of a##7##4##(1993-10#1)(1994-3#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
the administration of contrast material##2##5##(2007-10#1)(2008-7#1)
the administration of oxygen##2##4##(1994-3#1)(2008-10#1)
the administration of the##7##4##(1993-1#1)(1993-5#1)(1995-12#1)(1996-6#1)(2007-11#1)(2008-12#1)(2013-1#1)
the administration of##75##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-5#1)(1994-10#1)(1994-3#2)(1994-6#2)(1994-8#5)(1995-12#3)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(2007-10#3)(2007-11#1)(2007-5#2)(2008-1#4)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
the administration##81##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#3)(1991-3#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-5#1)(1994-10#1)(1994-3#2)(1994-6#2)(1994-8#5)(1995-12#3)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(2007-10#3)(2007-11#1)(2007-5#2)(2008-1#4)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
the administrative##17##2##(1991-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2012-3#3)(2013-8#7)
the administrator##2##2##(1992-2#1)(1994-2#1)
the administrators##2##2##(1993-1#1)(2009-6#1)
the admission##8##2##(1990-9#1)(1991-2#2)(1992-1#1)(1997-2#1)(2007-8#1)(2008-3#1)(2008-7#1)
the admissions##2##2##(1991-1#1)(2012-12#1)
the adolescent girls##2##3##(2008-1#1)(2011-1#1)
the adolescent years##3##3##(1994-2#1)(2009-7#2)
the adolescent##19##2##(1990-12#3)(1990-6#1)(1993-3#1)(1994-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#4)(2010-3#1)(2011-1#1)(2013-1#1)
the adolescents reported##2##3##(1993-3#1)(2010-11#1)
the adolescents##9##2##(1990-2#1)(1993-3#1)(1994-2#1)(2008-9#3)(2010-11#1)(2011-1#1)(2012-12#1)
the adolescents'##2##2##(2009-7#1)(2010-7#1)
the adopted##2##2##(2008-10#1)(2008-2#1)
the adoption of a##4##4##(1995-1#1)(1995-9#1)(2008-10#1)(2008-12#1)
the adoption of the##6##4##(1993-3#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-8#1)(2012-3#1)
the adoption of##30##3##(1991-12#2)(1993-3#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
the adoption##32##2##(1991-12#2)(1993-3#1)(1995-1#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
the adoptive##2##2##(2009-11#1)(2011-2#1)
the adrenal cortex##10##3##(1990-11#1)(1990-5#2)(1991-8#2)(2008-4#2)(2011-1#2)(2011-2#1)
the adrenal gland##13##3##(1990-5#3)(1991-6#1)(1993-3#2)(2008-12#1)(2008-4#2)(2011-2#3)(2013-1#1)
the adrenal medulla##4##3##(1990-5#2)(1991-8#1)(1996-12#1)
the adrenal##35##2##(1990-11#1)(1990-5#7)(1991-5#3)(1991-6#1)(1991-8#3)(1992-8#1)(1993-3#2)(1994-2#1)(1996-12#1)(1996-5#1)(2008-12#1)(2008-4#4)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#1)
the adrenals and##2##3##(1994-2#1)(2008-4#1)
the adrenals##5##2##(1994-2#1)(1994-5#1)(1995-3#1)(2008-4#1)(2012-2#1)
the adrenergic##3##2##(1993-5#1)(1994-2#1)(1997-7#1)
the adrenoceptor##2##2##(1996-2#1)(2008-3#1)
the adrenocorticotropic hormone##2##3##(1992-8#1)(1993-5#1)
the adrenocorticotropic hormone-releasing##2##3##(1990-2#2)
the adrenocorticotropic##4##2##(1990-2#2)(1992-8#1)(1993-5#1)
the adriamycin-perfused##2##2##(1990-5#2)
the adsorbate and##2##3##(2007-12#1)(2008-10#1)
the adsorbate##3##2##(2007-12#1)(2008-10#2)
the adsorbed elements##2##3##(2008-10#2)
the adsorbed##20##2##(1990-12#1)(2008-10#15)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)
the adsorbent surface##2##3##(2008-10#2)
the adsorbent##13##2##(2008-10#10)(2008-4#2)(2008-7#1)
the adsorbents##4##2##(1997-2#1)(2008-10#3)
the adsorbing##2##2##(1994-12#1)(2008-10#1)
the adsorption and desorption of decanethiol##2##6##(2008-10#2)
the adsorption and##4##3##(2008-10#3)(2008-7#1)
the adsorption capacities##2##3##(2008-10#2)
the adsorption chamber##3##3##(2008-7#3)
the adsorption constant##2##3##(2008-10#2)
the adsorption equilibrium##2##3##(2008-10#2)
the adsorption layer##2##3##(2008-2#2)
the adsorption of atrazine onto a##2##6##(2008-10#2)
the adsorption of the##3##4##(2008-10#3)
the adsorption of##23##3##(2008-10#21)(2008-6#1)(2008-7#1)
the adsorption process##2##3##(2008-10#2)
the adsorption##62##2##(1997-2#2)(2008-10#48)(2008-2#2)(2008-6#1)(2008-7#6)(2011-2#1)(2013-1#1)(2013-8#1)
the adsorptive##5##2##(2008-10#4)(2008-11#1)
the adult and##3##3##(1991-12#1)(2007-12#1)(2013-7#1)
the adult animal##2##3##(1997-2#1)(2008-9#1)
the adult brain##4##3##(1993-12#1)(1996-12#1)(2008-7#2)
the adult mammalian##2##3##(2008-11#1)(2008-7#1)
the adult mice##2##3##(2008-9#1)(2012-3#1)
the adult mouse##5##3##(1995-2#1)(2008-11#2)(2010-11#1)(2012-12#1)
the adult organism##2##3##(2008-8#1)(2009-3#1)
the adult patients##2##3##(2011-1#1)(2013-1#1)
the adult phase##2##3##(2008-6#1)(2011-1#1)
the adult plant##5##3##(2008-10#5)
the adult population##15##3##(1992-5#1)(1996-6#1)(1997-2#1)(2008-11#1)(2008-8#3)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#5)
the adult rat testis##2##4##(2009-10#1)(2012-2#1)
the adult rat##14##3##(1991-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-12#3)(1997-3#2)(2008-11#1)(2009-10#1)(2012-2#1)
the adult stage##6##3##(1990-3#2)(2008-10#4)
the adult##154##2##(1990-11#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-12#3)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-12#7)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#2)(1996-10#1)(1996-12#9)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-7#1)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#6)
the adults##20##2##(1996-1#1)(2007-12#3)(2008-12#1)(2008-6#1)(2008-9#3)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#4)
the advance##2##2##(2008-5#1)(2010-8#1)
the advanced management##3##3##(2008-1#1)(2010-12#2)
the advanced stages of##2##4##(2007-12#1)(2008-10#1)
the advanced##12##2##(1992-12#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2010-12#2)(2012-2#1)
the advancement of##12##3##(1993-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)
the advancement##13##2##(1993-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
the advances in##6##3##(1996-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2012-2#1)(2013-1#1)
the advances of the##2##4##(2008-5#1)(2010-8#1)
the advances of##3##3##(2008-1#1)(2008-5#1)(2010-8#1)
the advances##16##2##(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#1)
the advantage of a##5##4##(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
the advantage of being##9##4##(1990-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
the advantage of reduced##3##4##(2011-2#2)(2012-3#1)
the advantage of specificity##2##4##(2008-10#2)
the advantage of the##3##4##(2007-12#1)(2008-4#1)(2008-9#1)
the advantage of total body##2##5##(2007-11#1)(2010-3#1)
the advantage of using##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
the advantage of##75##3##(1990-11#1)(1990-6#2)(1991-1#1)(1991-3#1)(1994-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#5)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-3#1)(2012-5#1)(2013-1#3)
the advantage that the##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
the advantage that##13##3##(1992-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)
the advantage##94##2##(1990-11#1)(1990-6#2)(1991-1#1)(1991-3#1)(1992-3#1)(1994-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#5)(2008-3#11)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#6)(2009-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2012-5#1)(2013-1#3)
the advantages and disadvantages of each##3##6##(1992-2#1)(2011-2#1)(2013-8#1)
the advantages and disadvantages of flow##2##6##(2008-10#1)(2008-9#1)
the advantages and disadvantages of the##4##6##(2007-5#1)(2008-10#2)(2009-5#1)
the advantages and disadvantages of using##2##6##(2007-5#1)(2007-6#1)
the advantages and disadvantages of various##2##6##(2008-4#1)(2008-9#1)
the advantages and disadvantages of##17##5##(1991-1#1)(1992-2#1)(1996-3#1)(2007-10#1)(2007-5#2)(2007-6#1)(2008-10#3)(2008-4#1)(2008-9#2)(2009-5#2)(2011-2#1)(2013-8#1)
the advantages and disadvantages##18##4##(1991-1#1)(1992-2#1)(1996-3#1)(2007-10#1)(2007-5#2)(2007-6#1)(2008-10#4)(2008-4#1)(2008-9#2)(2009-5#2)(2011-2#1)(2013-8#1)
the advantages and limitations of each##2##6##(2008-9#1)(2010-8#1)
the advantages and limitations of the##4##6##(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)
the advantages and limitations of##9##5##(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-8#1)(2012-3#1)(2013-7#1)
the advantages and limitations##11##4##(1994-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
the advantages and##36##3##(1991-1#1)(1992-2#1)(1994-1#1)(1996-3#1)(2007-10#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#4)(2009-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
the advantages of a##2##4##(1994-3#1)(1997-1#1)
the advantages of being##2##4##(2008-3#1)(2008-7#1)
the advantages of each##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
the advantages of low resistance##2##5##(2008-10#2)
the advantages of simplicity##2##4##(2008-10#2)
the advantages of the##14##4##(1990-5#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#4)(2011-2#1)(2012-12#1)
the advantages of this##4##4##(1993-1#1)(1997-6#1)(2008-10#1)(2008-11#1)
the advantages of using##3##4##(2008-3#2)(2012-12#1)
the advantages of##85##3##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the advantages offered by##2##4##(1990-9#1)(2012-2#1)
the advantages##137##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-3#4)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#15)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-5#4)(2010-12#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
the advent of managed care##2##5##(1996-12#1)(1997-2#1)
the advent of new##3##4##(2008-5#1)(2009-10#1)(2010-7#1)
the advent of the##4##4##(1993-2#1)(1996-11#1)(2008-4#1)(2008-5#1)
the advent of##33##3##(1993-2#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
the advent##34##2##(1993-2#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
the adventitia##5##2##(1991-8#1)(1997-3#1)(1997-8#3)
the adventitial##3##2##(1992-12#1)(1997-1#1)(2010-4#1)
the adventitious root##4##3##(2008-12#4)
the adverse consequences of##2##4##(1993-3#1)(2008-11#1)
the adverse consequences##3##3##(1992-2#1)(1993-3#1)(2008-11#1)
the adverse drug##2##3##(2010-5#1)(2011-2#1)
the adverse effect of##4##4##(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#1)
the adverse effect##5##3##(2008-7#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
the adverse effects of##8##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#1)
the adverse effects##11##3##(1992-3#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
the adverse impact##2##3##(2008-7#1)(2008-8#1)
the adverse outcomes##2##3##(2008-11#1)(2009-9#1)
the adverse reactions of##2##4##(1991-9#1)(2008-8#1)
the adverse reactions##3##3##(1991-9#1)(2008-8#1)(2011-1#1)
the adverse##37##2##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1996-6#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
the advertisement call of##2##4##(2013-7#2)
the advertisement##3##2##(2013-7#3)
the advisability of##4##3##(1992-2#1)(1995-1#1)(1996-2#1)(2008-6#1)
the advocacy##2##2##(2008-11#1)(2012-12#1)
the aeciospores##2##2##(2008-10#2)
the aedeagus##2##2##(2007-12#1)(2008-8#1)
the aerial parts##4##3##(2007-11#1)(2008-11#2)(2013-1#1)
the aerial##7##2##(2007-11#1)(2008-11#3)(2008-3#1)(2010-2#1)(2013-1#1)
the aero-optic linking equation##2##4##(2008-3#2)
the aerobic and##2##3##(2009-12#1)(2013-8#1)
the aerobic##7##2##(1994-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
the aerodynamic size##2##3##(1992-3#2)
the aerodynamic##4##2##(1992-3#2)(2008-11#1)(2008-3#1)
the aerosol and##2##3##(1991-1#1)(1992-3#1)
the aerosol backscattering##4##3##(2008-3#4)
the aerosol bolus##2##3##(1997-1#2)
the aerosol complex index of refraction and size distribution from scattering measurements of polarized light##2##15##(2008-2#2)
the aerosol concentration##2##3##(2008-3#2)
the aerosol extinction coefficient##3##4##(2008-2#1)(2008-3#2)
the aerosol extinction profile##3##4##(2008-3#3)
the aerosol extinction##6##3##(2008-2#1)(2008-3#5)
the aerosol optical properties##2##4##(2008-2#2)
the aerosol optical thickness##3##4##(2008-2#1)(2008-3#2)
the aerosol optical##6##3##(2008-2#4)(2008-3#2)
the aerosol phase function##2##4##(2008-2#2)
the aerosol properties##2##3##(2008-3#2)
the aerosol refractive index##4##4##(2008-2#1)(2008-3#3)
the aerosol single-scattering albedo##2##4##(2008-2#2)
the aerosol size distribution##2##4##(2008-3#2)
the aerosol size##3##3##(2008-3#3)
the aerosol volume##2##3##(2008-2#1)(2008-3#1)
the aerosol was##2##3##(1992-2#1)(1994-12#1)
the aerosol##70##2##(1991-1#2)(1992-2#1)(1992-3#4)(1994-12#3)(1995-3#2)(1996-2#2)(1996-3#1)(1997-1#2)(2008-10#3)(2008-2#20)(2008-3#30)
the aerosols##6##2##(1992-2#1)(2008-10#2)(2008-2#1)(2008-3#2)
the aesthetic##7##2##(1990-9#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#2)
the aetiological##4##2##(1990-3#1)(2008-5#1)(2008-7#1)(2010-1#1)
the aetiologies##2##2##(1995-10#1)(2008-12#1)
the aetiology and##5##3##(1997-1#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
the aetiology of this##2##4##(2009-4#1)(2009-7#1)
the aetiology of##24##3##(1992-5#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-8#1)
the aetiology##32##2##(1992-5#1)(1996-11#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-8#1)
the aetiopathogenesis of schizophrenia##2##4##(1996-5#2)
the aetiopathogenesis##3##2##(1990-9#1)(1996-5#2)
the affect##3##2##(1993-6#1)(1994-2#1)(2008-11#1)
the affected area##4##3##(1996-6#1)(2008-10#1)(2013-8#2)
the affected families##2##3##(1997-5#1)(2008-8#1)
the affected individuals##3##3##(1997-3#1)(1997-4#1)(2010-8#1)
the affected knee##3##3##(2007-8#1)(2008-12#1)(2013-1#1)
the affected limb##3##3##(2006-10#1)(2008-7#1)(2009-3#1)
the affected members##2##3##(1997-8#1)(2010-3#1)
the affected patients##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2009-4#1)
the affected people in##2##4##(2011-1#2)
the affected region##3##3##(1990-6#1)(1994-12#1)(2007-8#1)
the affected side##2##3##(2007-7#1)(2013-1#1)
the affected teeth##2##3##(2008-12#1)(2013-1#1)
the affected tissue##2##3##(1993-3#1)(2007-7#1)
the affected zone##2##3##(2008-10#1)(2008-2#1)
the affected##78##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#4)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
the afferent##5##2##(1990-5#1)(1997-3#1)(2008-10#1)(2008-7#2)
the affinities of##4##3##(1991-9#1)(1993-8#1)(1995-12#1)(2008-10#1)
the affinity between##2##3##(2008-10#2)
the affinity constant of the##2##5##(2008-10#2)
the affinity constant##6##3##(1991-5#1)(2008-10#5)
the affinity for heme##2##4##(1990-8#1)(1994-8#1)
the affinity for##3##3##(1990-8#2)(1994-8#1)
the affinity of P1 for DNA##2##6##(1992-6#2)
the affinity of agonists for##3##5##(1990-5#2)(1996-2#1)
the affinity of protein kinase C for##2##7##(1994-5#2)
the affinity of sIL-1R for##2##5##(1995-2#2)
the affinity of the receptor for##2##6##(1992-12#1)(1994-5#1)
the affinity of the##15##4##(1990-7#1)(1992-12#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-5#1)(1994-6#2)(1995-2#1)(1997-4#1)(2008-4#2)(2008-8#2)
the affinity of this##2##4##(1990-8#1)(1995-8#1)
the affinity of##35##3##(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#2)(1991-2#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-6#3)(1993-8#1)(1994-5#3)(1994-6#2)(1995-2#4)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-8#2)
the affinity to##2##3##(1992-9#1)(1994-2#1)
the affinity##67##2##(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#6)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#3)(1992-9#2)(1993-1#1)(1993-6#4)(1993-8#1)(1994-2#1)(1994-5#4)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#1)(2012-2#1)
the afflicted##2##2##(1991-6#1)(2011-2#1)
the affluent##3##2##(1997-7#1)(2007-9#1)(2008-3#1)
the aflatoxin##2##2##(1992-9#2)
the afore##2##2##(2007-12#1)(2008-8#1)
the aforementioned##20##2##(1993-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the african american##3##3##(2010-8#3)
the after##2##2##(1991-12#1)(2012-2#1)
the aftermath of##6##3##(1993-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-1#1)(2013-8#1)
the aftermath##7##2##(1993-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-8#1)
the afternoon##5##2##(1993-12#1)(2008-3#1)(2008-5#2)(2010-5#1)
the agar dilution method##2##4##(2008-10#1)(2012-12#1)
the agar dilution##3##3##(1994-11#1)(2008-10#1)(2012-12#1)
the agar surface##5##3##(2008-10#4)(2008-8#1)
the agar##16##2##(1994-11#1)(1994-8#1)(2008-10#7)(2008-12#1)(2008-8#3)(2011-1#1)(2012-12#1)(2012-2#1)
the agarose gel##3##3##(1990-11#1)(2008-10#2)
the agarose##5##2##(1990-11#1)(1997-4#1)(2008-10#2)(2008-8#1)
the agate industry##2##3##(2009-12#2)
the age and sex##2##4##(1990-8#1)(2012-3#1)
the age and##11##3##(1990-8#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-3#2)
the age at the time of##2##6##(2011-2#1)(2012-2#1)
the age at which##5##4##(2008-10#2)(2008-8#1)(2009-5#1)(2012-12#1)
the age at##10##3##(2007-7#1)(2008-10#2)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the age distribution of##3##4##(1996-1#1)(1997-8#1)(2009-7#1)
the age group of##8##4##(2007-7#1)(2008-11#1)(2008-7#1)(2010-5#2)(2013-8#3)
the age group##20##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1993-11#1)(1995-9#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-5#2)(2011-1#2)(2012-3#2)(2013-8#4)
the age groups of##2##4##(1991-12#1)(2008-7#1)
the age groups##8##3##(1991-12#1)(1991-6#1)(1996-5#1)(2007-10#1)(2008-7#2)(2008-9#1)(2013-8#1)
the age of 10##4##4##(2008-5#1)(2008-9#2)(2010-3#1)
the age of 15##2##4##(2008-1#1)(2008-9#1)
the age of 16##3##4##(1991-8#1)(1995-6#1)(2008-7#1)
the age of 17##3##4##(1992-4#1)(1997-3#1)(2012-2#1)
the age of 18 months##2##5##(1991-11#1)(1994-6#1)
the age of 18##5##4##(1991-11#1)(1994-6#1)(2008-12#1)(2011-2#2)
the age of 20##2##4##(1997-3#1)(2013-8#1)
the age of 3##4##4##(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
the age of 30 years##2##5##(2008-6#1)(2013-7#1)
the age of 30##5##4##(1991-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-7#1)
the age of 4 months##2##5##(1995-12#1)(2007-11#1)
the age of 4##3##4##(1995-12#1)(1996-11#1)(2007-11#1)
the age of 40 years##2##5##(2008-5#2)
the age of 40##7##4##(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#3)
the age of 5 years##4##5##(1997-3#1)(2007-8#1)(2008-8#1)(2013-8#1)
the age of 5##6##4##(1997-3#1)(2007-8#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
the age of 50 years##3##5##(1994-12#1)(2007-2#1)(2007-7#1)
the age of 50##7##4##(1994-12#2)(2007-2#1)(2007-7#1)(2008-5#2)(2011-2#1)
the age of 6##4##4##(1994-6#1)(1997-3#1)(2008-7#1)(2013-1#1)
the age of 75##3##4##(1997-8#1)(2011-2#1)(2013-7#1)
the age of 85##2##4##(1994-5#1)(1996-3#1)
the age of a##5##4##(1996-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
the age of one year##2##5##(1990-12#1)(1994-6#1)
the age of one##5##4##(1990-12#1)(1992-11#2)(1994-6#1)(1997-3#1)
the age of the girl##2##5##(1995-6#2)
the age of the patient##4##5##(1990-10#1)(1990-11#1)(1990-9#1)(2008-7#1)
the age of the patients##2##5##(2007-10#1)(2008-7#1)
the age of the population##2##5##(2011-2#2)
the age of the##23##4##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#1)(1992-10#1)(1994-11#1)(1994-5#1)(1995-6#3)(1997-6#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#2)
the age of three months and##2##6##(1991-11#1)(1993-6#1)
the age of three##3##4##(1991-11#1)(1993-6#1)(2010-10#1)
the age of two##2##4##(1993-11#1)(1995-8#1)
the age of##145##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-4#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-5#2)(1994-6#3)(1995-1#1)(1995-12#3)(1995-3#1)(1995-6#4)(1995-8#2)(1996-11#1)(1996-3#3)(1997-3#7)(1997-6#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#8)(2009-10#1)(2009-5#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#11)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
the age range##7##3##(2008-7#4)(2013-1#1)(2013-8#2)
the age related changes##2##4##(2008-12#1)(2011-2#1)
the age##224##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#4)(1991-3#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-4#1)(1992-5#1)(1993-11#2)(1993-6#1)(1994-11#3)(1994-12#3)(1994-5#3)(1994-6#3)(1995-1#1)(1995-12#3)(1995-3#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#4)(1996-5#1)(1997-3#7)(1997-6#2)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#17)(2008-8#3)(2008-9#9)(2009-10#1)(2009-5#3)(2009-7#2)(2010-10#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#16)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#10)
the age-1##2##2##(2008-3#2)
the age-adjusted death##2##3##(1997-7#1)(2008-10#1)
the age-adjusted##5##2##(1997-7#1)(2008-10#1)(2008-8#1)(2012-3#2)
the age-associated##2##2##(1996-12#1)(2010-2#1)
the age-dependent##3##2##(1995-8#1)(2008-3#1)(2008-7#1)
the age-matched controls##2##3##(1990-3#1)(1996-5#1)
the age-matched##3##2##(1990-3#1)(1993-1#1)(1996-5#1)
the age-related changes in##3##4##(1990-3#1)(1994-6#1)(2013-8#1)
the age-related changes##4##3##(1990-3#1)(1994-6#1)(2008-7#1)(2013-8#1)
the age-related decline##3##3##(1992-8#1)(2008-7#2)
the age-related decrease##2##3##(1994-5#2)
the age-related##15##2##(1990-3#1)(1992-8#1)(1994-5#3)(1994-6#1)(1995-6#1)(1996-2#1)(2008-5#1)(2008-7#3)(2011-2#2)(2013-8#1)
the age-specific##5##2##(1992-5#1)(1994-11#2)(2008-7#2)
the aged group##3##3##(1997-2#3)
the aged rat##2##3##(1992-12#1)(1994-2#1)
the aged##32##2##(1990-11#1)(1990-3#2)(1991-1#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-2#3)(1997-2#4)(2007-8#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#1)
the aged-care##2##2##(2010-10#2)
the aged]##2##2##(1991-11#1)(1996-2#1)
the ageing process##4##3##(1992-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
the ageing##9##2##(1992-11#1)(1995-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-12#1)(2011-1#1)
the agency that had##2##4##(1994-2#2)
the agency##5##2##(1992-1#1)(1993-1#1)(1994-2#2)(1995-3#1)
the agency's##2##2##(1992-8#1)(1995-6#1)
the agent##11##2##(1991-12#1)(1991-3#2)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)
the agents of##2##3##(2008-5#1)(2012-3#1)
the agents that##2##3##(1992-8#1)(2012-12#1)
the agents##18##2##(1990-6#1)(1991-12#1)(1992-8#1)(1993-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the ages of 10 and##2##5##(1995-8#1)(2012-12#1)
the ages of the##2##4##(2008-7#1)(2009-2#1)
the ages of##19##3##(1990-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-5#1)(2007-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
the ages##20##2##(1990-2#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-5#1)(2007-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
the aggravation of##2##3##(2008-10#1)(2008-6#1)
the aggrecan mRNA##2##3##(1992-1#1)(2008-11#1)
the aggrecan##6##2##(1992-1#5)(2008-11#1)
the aggregate##11##2##(1994-5#1)(1996-3#1)(2008-1#1)(2008-10#2)(2009-3#1)(2010-3#1)(2012-2#3)(2013-1#1)
the aggregated##8##2##(1991-11#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#2)
the aggregates##4##2##(1990-12#1)(2008-10#2)(2010-8#1)
the aggregation of##10##3##(1996-2#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-6#1)(2013-1#1)
the aggregation##16##2##(1994-12#1)(1996-2#1)(1997-3#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-6#1)(2013-1#2)
the aggressive##10##2##(1991-6#1)(2008-10#6)(2009-3#1)(2010-6#1)(2011-2#1)
the aggressiveness of treatment##2##4##(2007-11#1)(2012-3#1)
the aggressiveness of##4##3##(2007-11#1)(2008-10#2)(2012-3#1)
the aggressiveness##5##2##(2007-11#1)(2008-10#3)(2012-3#1)
the aging brain##4##3##(1994-5#1)(1996-11#1)(2008-7#2)
the aging of the population and##2##6##(1996-3#1)(2013-1#1)
the aging of the population##3##5##(1992-1#1)(1996-3#1)(2013-1#1)
the aging of the##4##4##(1992-1#1)(1996-3#1)(2008-12#1)(2013-1#1)
the aging of##7##3##(1992-1#2)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
the aging population##5##3##(1991-12#1)(1996-8#1)(2008-12#1)(2011-2#2)
the aging process and##2##4##(2009-12#1)(2009-5#1)
the aging process is##2##4##(1995-6#1)(2008-9#1)
the aging process##20##3##(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-6#1)(1997-2#4)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-8#1)
the aging processes##2##3##(2008-7#1)(2013-7#1)
the aging##47##2##(1990-6#1)(1991-12#2)(1992-1#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#4)(1995-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#2)(2009-5#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the agitation##2##2##(2008-10#1)(2013-1#1)
the agonist concentration##3##3##(1994-6#3)
the agonist##11##2##(1990-7#2)(1992-5#1)(1992-9#1)(1994-6#3)(2008-7#1)(2008-8#1)(2012-2#2)
the agonists for##2##3##(1995-12#2)
the agonists##7##2##(1995-11#2)(1995-12#3)(1997-7#1)(2008-9#1)
the agranular##3##2##(1994-2#1)(2008-5#2)
the agreement between the##2##4##(2007-11#1)(2008-3#1)
the agreement between##6##3##(2007-11#1)(2008-10#3)(2008-3#1)(2012-1#1)
the agreement with##2##3##(2008-10#2)
the agreement##11##2##(1995-6#1)(2007-11#1)(2008-10#5)(2008-3#2)(2012-1#2)
the agricultural industry##2##3##(2008-11#1)(2013-1#1)
the agricultural##9##2##(1991-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-12#3)(2013-1#1)
the agrochemical##2##2##(1997-7#1)(2008-10#1)
the agroecological##2##2##(2008-10#1)(2013-8#1)
the aid of a##9##4##(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)
the aid of an##6##4##(1990-5#1)(2008-10#1)(2008-3#2)(2009-3#1)(2010-5#1)
the aid of crutches##2##4##(2007-11#2)
the aid of the##8##4##(1991-6#1)(1991-8#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#2)
the aid of##56##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-9#1)(1994-11#1)(1996-6#1)(1997-6#1)(2007-11#3)(2007-12#3)(2008-10#22)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
the aim is to##4##4##(1991-12#1)(2008-1#1)(2008-10#1)(2011-3#1)
the aim of reducing##5##4##(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
the aim of studying the##2##5##(1995-12#1)(2007-6#1)
the aim of studying##3##4##(1995-12#1)(2007-6#1)(2010-3#1)
the aim of testing##2##4##(2008-10#1)(2008-5#1)
the aim of the present study was to##4##8##(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
the aim of the present study##5##6##(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)
the aim of the present##6##5##(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
the aim of the##8##4##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
the aim of this review##2##5##(2009-11#1)(2012-12#1)
the aim of this study to##2##6##(1990-11#1)(2008-11#1)
the aim of this study was to compare##2##8##(2008-12#1)(2013-7#1)
the aim of this study was to##5##7##(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
the aim of this study##7##5##(1990-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
the aim of this##11##4##(1990-11#1)(1994-5#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the aim of##85##3##(1990-11#1)(1990-6#2)(1990-8#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#14)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
the aim to##21##3##(1990-9#1)(1992-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#3)
the aim##112##2##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#5)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#4)(2013-8#1)
the aims of this##3##4##(2009-5#1)(2010-4#1)(2011-2#1)
the aims of##8##3##(1997-7#1)(2007-4#1)(2008-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
the aims##9##2##(1997-7#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
the air in the##2##4##(1995-6#1)(1997-4#1)
the air of##3##3##(2008-10#1)(2010-4#2)
the air passage##2##3##(1991-11#1)(2010-4#1)
the air sample##3##3##(2008-10#3)
the air samples##5##3##(2008-10#5)
the air superficial##2##3##(2008-6#2)
the air temperature was##2##4##(2008-6#2)
the air temperature##4##3##(2008-10#1)(2008-6#3)
the air##69##2##(1990-3#1)(1991-11#1)(1992-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#5)(2009-7#1)(2010-2#1)(2010-4#4)(2011-2#1)(2013-1#1)(2013-8#1)
the air-acetylene flame##2##3##(2008-10#2)
the air-acetylene##3##2##(2008-10#3)
the airborne##5##2##(2008-10#2)(2008-3#3)
the aircraft##10##2##(1996-12#3)(2008-3#3)(2009-9#4)
the airspaces##2##2##(1991-9#1)(2008-10#1)
the airway and##3##3##(1992-2#1)(1997-1#1)(2008-8#1)
the airway circulation##4##3##(1996-1#1)(1997-1#3)
the airway epithelium##2##3##(1997-2#2)
the airway is##4##3##(1996-1#1)(2007-12#2)(2010-7#1)
the airway sealing pressure##3##4##(2010-7#3)
the airway##38##2##(1992-2#5)(1994-2#1)(1994-6#1)(1995-12#1)(1996-1#3)(1996-12#1)(1997-1#6)(1997-2#2)(2007-12#5)(2008-10#1)(2008-12#3)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#4)(2013-8#1)
the airways and the##2##4##(1996-12#1)(2009-1#1)
the airways of the##3##4##(1997-1#2)(2008-3#1)
the airways of##6##3##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#2)(2008-3#1)
the airways##30##2##(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-7#2)(1997-1#10)(1997-2#2)(2007-6#2)(2008-3#1)(2009-1#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
the alane decomposition and##2##4##(2010-4#2)
the alane##3##2##(1996-2#1)(2010-4#2)
the alanine##2##2##(2008-11#2)
the alarming##3##2##(1996-1#1)(2008-8#1)(2013-1#1)
the albino##3##2##(1992-8#1)(1994-8#2)
the albumin concentration##2##3##(1993-8#1)(2008-10#1)
the albumin secretion##3##3##(2008-11#3)
the albumin##7##2##(1990-8#1)(1993-8#1)(2008-10#1)(2008-11#4)
the albumin-fixed membrane was##3##4##(2008-5#3)
the alcohol in the##2##4##(2008-10#1)(2008-7#1)
the alcohol was##2##3##(2008-10#1)(2008-5#1)
the alcohol##22##2##(1992-7#1)(1993-12#1)(1994-11#1)(1994-6#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-5#1)(2008-7#2)(2009-8#1)(2010-7#2)(2011-1#1)(2012-12#1)(2013-8#1)
the alcohol-induced##2##2##(1992-6#1)(2012-2#1)
the alcoholic patients##3##3##(1991-12#3)
the alcoholic##7##2##(1991-1#1)(1991-12#3)(1995-2#1)(2008-10#2)
the alcohols##5##2##(1990-11#2)(1992-6#1)(1996-5#1)(2008-10#1)
the aldehyde##6##2##(1991-5#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-4#1)
the aldehydes by##2##3##(2010-12#2)
the aldehydes##3##2##(2008-10#1)(2010-12#2)
the alert##3##2##(1991-12#1)(1991-5#1)(1995-12#1)
the alfalfa##5##2##(2008-10#4)(2008-5#1)
the alga##3##2##(2008-10#1)(2008-6#2)
the algae##5##2##(2008-10#4)(2008-5#1)
the algal##3##2##(2008-10#1)(2008-6#1)(2012-1#1)
the algebraic##2##2##(2008-3#2)
the alginate##3##2##(2008-11#2)(2008-7#1)
the algorithm and##6##3##(2008-12#1)(2008-3#3)(2010-8#1)(2011-1#1)
the algorithm are##3##3##(2008-2#2)(2008-3#1)
the algorithm can be##2##4##(1997-2#1)(2008-3#1)
the algorithm can##3##3##(1997-2#1)(2008-3#1)(2008-6#1)
the algorithm for##2##3##(2008-2#1)(2008-3#1)
the algorithm includes##2##3##(2008-3#1)(2011-1#1)
the algorithm is##12##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-6#1)(2011-1#1)
the algorithm solves##2##3##(2009-12#1)(2012-1#1)
the algorithm that##2##3##(2008-3#2)
the algorithm to##4##3##(2008-2#2)(2010-9#1)(2013-1#1)
the algorithm was##2##3##(2008-3#1)(2010-8#1)
the algorithm##69##2##(1997-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#16)(2008-3#24)(2008-6#5)(2008-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-8#2)(2010-9#1)(2011-1#4)(2012-1#1)(2012-2#1)(2013-1#2)
the algorithm's performance##3##3##(2008-2#2)(2008-3#1)
the algorithm's##4##2##(2008-2#3)(2008-3#1)
the algorithms are##2##3##(2008-3#1)(2013-1#1)
the algorithms of##2##3##(2008-3#1)(2013-8#1)
the algorithms##12##2##(2007-11#1)(2008-3#6)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
the alien chromosome in##2##4##(2008-5#2)
the alien fragment##2##3##(2008-10#2)
the alien##8##2##(2008-10#2)(2008-5#5)(2013-1#1)
the aligning forces for quality initiative##3##6##(2013-1#3)
the alignment of the##5##4##(1994-8#1)(2007-11#1)(2007-12#2)(2008-4#1)
the alignment of##6##3##(1994-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)
the alignment tolerance##2##3##(2008-2#2)
the alignment##18##2##(1994-8#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#2)(2013-1#1)
the alimentary canal##2##3##(2008-10#1)(2008-7#1)
the alimentary tract##2##3##(2008-5#2)
the alimentary##6##2##(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)
the alkali metal##5##3##(2008-10#5)
the alkali##8##2##(1992-8#1)(2008-10#7)
the alkaline comet assay##2##4##(1997-4#2)
the alkaline elution##3##3##(1992-3#1)(1993-12#2)
the alkaline hydrothermal conversion of##2##5##(2008-10#2)
the alkaline phosphatase##2##3##(1990-12#1)(1992-3#1)
the alkaline treatment##2##3##(2008-10#1)(2013-1#1)
the alkaline##19##2##(1990-12#1)(1992-3#3)(1993-12#2)(1997-4#3)(2008-10#7)(2008-11#1)(2008-9#1)(2013-1#1)
the alkaloid##2##2##(2007-1#1)(2007-11#1)
the alkaloids##2##2##(2007-11#2)
the alkene##2##2##(1996-5#2)
the alkyl chain##5##3##(1990-11#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
the alkyl groups##2##3##(1994-12#1)(2008-11#1)
the alkyl##11##2##(1990-11#1)(1994-12#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#3)(2010-4#1)
the alkylation##2##2##(1993-11#1)(2008-10#1)
the alkylphenols##4##2##(2008-10#2)(2008-11#2)
the all##6##2##(1990-12#1)(1991-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
the all-optical##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
the all-trans##4##2##(1991-5#1)(1992-9#1)(2010-2#2)
the alleged##4##2##(1996-5#1)(2008-10#3)
the allele##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
the alleles##2##2##(1997-8#1)(2008-8#1)
the allelic diversity##2##3##(2008-10#1)(2008-5#1)
the allelic##6##2##(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
the allelism##2##2##(2007-7#1)(2008-10#1)
the allergen##3##2##(2008-10#2)(2010-5#1)
the allergenic##2##2##(2007-2#1)(2008-11#1)
the allergic##4##2##(1992-3#1)(2007-11#1)(2010-4#1)(2012-12#1)
the alleviation of##3##3##(1993-2#1)(2010-4#1)(2011-1#1)
the alliances'##2##2##(2013-1#2)
the alligator gar##3##3##(2008-7#3)
the alligator##4##2##(2008-7#3)(2010-3#1)
the allocation of##10##3##(1991-6#1)(1995-12#1)(2008-11#2)(2008-7#1)(2008-8#4)(2012-2#1)
the allocation##11##2##(1991-6#1)(1992-3#1)(1995-12#1)(2008-11#2)(2008-7#1)(2008-8#4)(2012-2#1)
the allograft group##2##3##(2009-3#1)(2012-3#1)
the allograft##8##2##(1992-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2012-3#2)
the allometric##3##2##(2008-5#1)(2008-8#1)(2010-8#1)
the alloscutum##3##2##(2007-12#3)
the allosteric interaction##4##3##(1995-11#4)
the allosteric properties of##2##4##(1990-8#2)
the allosteric transition##3##3##(1990-8#2)(1995-5#1)
the allosteric transitions##2##3##(1995-5#1)(2012-1#1)
the allosteric##19##2##(1990-8#5)(1995-11#4)(1995-2#4)(1995-5#3)(2008-4#1)(2012-1#2)
the allowable##3##2##(2008-2#3)
the alloy##3##2##(2008-10#1)(2009-7#2)
the alloys##2##2##(2009-7#1)(2013-1#1)
the allozyme##2##2##(2008-10#1)(2008-9#1)
the almond##3##2##(2008-10#2)(2008-11#1)
the almost##5##2##(1992-12#1)(1995-2#1)(2008-1#1)(2009-8#1)(2013-1#1)
the alpha 1 (I) promoter##2##5##(1991-5#2)
the alpha 1 (I)##3##4##(1991-5#3)
the alpha 1 beta 1 dimer##3##6##(1993-8#3)
the alpha 1##8##3##(1991-5#3)(1993-8#3)(1994-6#1)(1996-2#1)
the alpha 2##2##3##(1992-8#1)(1993-8#1)
the alpha 2(I) promoter##2##4##(1991-5#2)
the alpha 2(I)##3##3##(1991-5#3)
the alpha 5##3##3##(1992-2#1)(1993-9#1)(1995-11#1)
the alpha 5/beta 1 FnR##2##5##(1993-9#2)
the alpha 5/beta 1##3##4##(1993-9#3)
the alpha 7##4##3##(1996-12#3)(2010-8#1)
the alpha and beta subunits of##6##6##(1990-7#1)(1991-10#1)(1993-2#2)(1993-6#1)(1995-11#1)
the alpha and beta subunits##9##5##(1990-7#1)(1990-8#1)(1991-10#1)(1992-6#1)(1993-2#2)(1993-6#1)(1994-6#1)(1995-11#1)
the alpha and beta##14##4##(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-10#1)
the alpha chain of the##3##5##(1991-2#1)(1994-6#2)
the alpha chain of##5##4##(1991-2#1)(1992-12#1)(1994-6#3)
the alpha chain##9##3##(1990-12#1)(1991-2#1)(1992-12#4)(1994-6#3)
the alpha donor##2##3##(1991-5#2)
the alpha subunit of calcium/calmodulin-dependent protein kinase II##2##8##(1995-2#2)
the alpha subunit of calcium/calmodulin-dependent##3##5##(1995-2#2)(1996-12#1)
the alpha subunit of the##3##5##(1991-5#1)(1994-2#1)(2008-8#1)
the alpha subunit of##11##4##(1991-5#1)(1991-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
the alpha subunit##16##3##(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#2)(1995-8#1)(1996-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
the alpha subunits##2##3##(1990-7#1)(1992-2#1)
the alpha##106##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#10)(1991-8#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#5)(1993-9#4)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#5)(1994-8#5)(1995-11#6)(1995-2#4)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-12#1)(2012-2#1)
the alpha- and beta-globin genes##2##5##(1990-8#1)(1994-8#1)
the alpha- and##11##3##(1990-8#1)(1991-6#1)(1992-3#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-10#4)(2008-5#1)
the alpha-##12##2##(1990-8#1)(1991-6#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-10#4)(2008-5#1)
the alpha-1##2##2##(1995-5#2)
the alpha-3##2##2##(1993-11#2)
the alpha-MHC##2##2##(1991-9#2)
the alpha-[PMo(12)O(40)](3-) complex##2##3##(2008-10#2)
the alpha-[PMo(12)O(40)](3-)##3##2##(2008-10#3)
the alpha-amino##3##2##(1992-6#1)(1992-8#2)
the alpha-amylase from##2##3##(1992-8#1)(2008-10#1)
the alpha-amylase##3##2##(1992-8#1)(1997-3#1)(2008-10#1)
the alpha-chain of H+##3##4##(1995-6#3)
the alpha-chain of##5##3##(1990-5#1)(1995-6#4)
the alpha-chain##8##2##(1990-5#1)(1991-6#1)(1995-6#6)
the alpha-cycloadduct##2##2##(1996-5#2)
the alpha-globin genes##4##3##(1990-8#4)
the alpha-helices##3##2##(1994-6#1)(2008-10#2)
the alpha-helix##5##2##(1990-5#1)(1992-6#1)(1995-5#1)(2008-7#2)
the alpha-hydroxy##2##2##(2008-5#2)
the alpha-meso##2##2##(1994-5#2)
the alpha-myosin heavy chain##3##4##(1991-9#3)
the alpha-phosphate##2##2##(1993-8#2)
the alpha-subunit of##4##3##(1990-11#1)(1991-3#2)(2008-5#1)
the alpha-subunit##11##2##(1990-11#3)(1991-3#4)(1993-11#1)(1994-8#1)(1995-6#1)(2008-5#1)
the alpha-toxin gene##2##3##(2010-6#2)
the alpha-toxin##4##2##(2010-6#4)
the alpha/alpha'##2##2##(1992-6#2)
the alpha1##2##2##(2008-4#1)(2008-7#1)
the alpha1-adrenoceptor##3##2##(1995-12#3)
the alpha2##3##2##(2008-11#3)
the already known##2##3##(2008-12#1)(2011-2#1)
the already##11##2##(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the als##2##2##(2008-6#2)
the alteration in##4##3##(1993-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
the alteration of the##2##4##(1993-8#1)(2008-10#1)
the alteration of##9##3##(1991-12#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-2#2)
the alteration##15##2##(1991-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-8#4)(2008-9#2)(2011-2#2)(2013-1#1)
the alterations and##2##3##(1992-12#1)(2013-1#1)
the alterations in the##2##4##(2008-2#1)(2008-7#1)
the alterations in##4##3##(2008-2#1)(2008-7#3)
the alterations of##6##3##(1991-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-8#2)
the alterations##16##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-5#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-7#4)(2010-4#1)(2013-1#1)(2013-8#2)
the altered enzyme##3##3##(1992-1#2)(1995-2#1)
the altered mineral metabolism of CKD##2##6##(2009-1#2)
the altered mineral metabolism of##3##5##(2009-1#3)
the altered mineral metabolism##4##4##(2009-1#4)
the altered##30##2##(1990-5#1)(1992-1#2)(1992-10#1)(1992-6#1)(1993-6#1)(1995-2#2)(1996-3#1)(1997-1#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-7#2)(2009-1#4)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the alternata##2##2##(2008-10#2)
the alternate protocol##2##3##(2008-2#1)(2008-4#1)
the alternate protocols##2##3##(2008-4#2)
the alternate##13##2##(1993-12#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-4#3)
the alternating least squares##2##4##(2007-12#1)(2008-10#1)
the alternating##6##2##(1997-3#1)(2007-12#2)(2008-10#2)(2009-6#1)
the alternative food source##2##4##(2008-8#2)
the alternative food##3##3##(2008-8#3)
the alternative methods##2##3##(1993-3#1)(2010-5#1)
the alternative oxidase (AOX)##2##4##(2008-9#1)(2009-8#1)
the alternative oxidase##3##3##(1991-5#1)(2008-9#1)(2009-8#1)
the alternative pathway##4##3##(1994-11#2)(1994-8#1)(2009-8#1)
the alternative procedure##4##3##(2008-10#2)(2008-11#2)
the alternative splicing##3##3##(1993-8#1)(1994-9#1)(1995-12#1)
the alternative##39##2##(1990-6#1)(1990-9#1)(1991-5#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-8#3)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the alternatives to##2##3##(2008-6#1)(2008-9#1)
the alternatives##6##2##(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#1)
the altitude range##3##3##(2008-2#1)(2008-3#2)
the altitude##5##2##(2008-2#2)(2008-3#3)
the altitudes covered by the##2##5##(2008-3#2)
the altitudes##3##2##(2008-2#1)(2008-3#2)
the aluminium matrix##2##3##(2008-10#2)
the aluminium##6##2##(2008-10#6)
the aluminum##5##2##(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
the alveolar cleft##2##3##(2007-12#1)(2012-12#1)
the alveolar ridge##2##3##(2007-12#2)
the alveolar##16##2##(1992-12#2)(1992-5#1)(1994-12#1)(1995-12#1)(1995-8#2)(1997-1#1)(2007-12#3)(2008-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
the alveoli##3##2##(2007-8#2)(2012-12#1)
the amalgamation of##2##3##(1996-2#1)(2008-11#1)
the amaranth method for##2##4##(2008-10#2)
the amaranth method##3##3##(2008-10#3)
the amaranth##4##2##(2008-10#3)(2008-11#1)
the amaranthin##2##2##(2008-4#2)
the ambient air##2##3##(1995-3#1)(2008-10#1)
the ambient atmosphere##2##3##(2008-11#2)
the ambient medium and the##2##5##(2008-3#2)
the ambient medium##3##3##(2008-3#2)(2008-7#1)
the ambient temperature##3##3##(2007-12#1)(2008-10#2)
the ambient thermal conditions##2##4##(2008-6#2)
the ambient##25##2##(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-3#5)(2008-6#2)(2008-7#1)(2010-7#1)(2012-12#1)(2013-8#1)
the ambiguity function##3##3##(2007-11#2)(2008-3#1)
the ambiguity in##2##3##(1992-4#1)(2008-2#1)
the ambiguity##7##2##(1992-4#1)(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-11#1)
the ambiguous##2##2##(2008-11#1)(2008-5#1)
the ambulance and##2##3##(2007-9#1)(2013-1#1)
the ambulance##3##2##(2007-9#1)(2013-1#2)
the ambulatory setting##2##3##(1996-3#1)(2008-9#1)
the ambulatory##8##2##(1991-1#1)(1991-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
the amelioration##2##2##(2008-10#1)(2010-4#1)
the amendment##2##2##(1995-6#1)(1996-5#1)
the amide bond##2##3##(2007-7#1)(2008-12#1)
the amide##12##2##(1991-3#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
the amide-(15)N##4##2##(2008-5#4)
the amine and##2##3##(2008-10#2)
the amine group##3##3##(2008-10#3)
the amine##16##2##(1990-5#1)(1993-12#1)(1995-6#1)(1996-5#1)(1997-7#2)(2008-10#9)(2010-4#1)
the amines##3##2##(1994-9#1)(1996-5#1)(2010-8#1)
the amino acid at position##3##5##(1995-5#1)(2008-10#2)
the amino acid composition of the##3##6##(1990-8#1)(1993-8#1)(2008-9#1)
the amino acid composition of##5##5##(1990-8#1)(1993-8#1)(1994-9#1)(2008-9#1)(2012-1#1)
the amino acid composition##8##4##(1990-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-9#1)(2008-10#1)(2008-9#1)(2012-1#1)
the amino acid content##2##4##(1994-8#1)(2008-11#1)
the amino acid level##4##4##(1991-9#1)(1992-12#1)(2008-7#1)(2008-8#1)
the amino acid residue##2##4##(1992-6#1)(2009-3#1)
the amino acid residues##4##4##(1995-5#1)(1997-2#1)(2008-10#1)(2009-8#1)
the amino acid sequence of the N-terminal##2##7##(1990-7#2)
the amino acid sequence of the protein##2##7##(1991-2#1)(1993-8#1)
the amino acid sequence of the rat##2##7##(1990-12#1)(1996-12#1)
the amino acid sequence of the##10##6##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1993-8#1)(1996-12#1)(1997-6#1)(2008-10#1)
the amino acid sequence of this peptide##2##7##(1994-12#1)(1997-8#1)
the amino acid sequence of##24##5##(1990-12#1)(1990-5#1)(1990-7#4)(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-12#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
the amino acid sequence with##2##5##(1990-12#1)(2009-2#1)
the amino acid sequence##42##4##(1990-12#2)(1990-5#1)(1990-7#4)(1991-12#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-2#1)(1996-12#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#2)(2013-8#1)
the amino acid sequences of the##4##6##(1991-12#1)(1993-3#1)(2007-6#1)(2008-10#1)
the amino acid sequences of##11##5##(1990-7#1)(1991-12#2)(1991-2#1)(1993-3#1)(1993-6#1)(2007-6#1)(2008-10#3)(2008-12#1)
the amino acid sequences##17##4##(1990-7#1)(1991-12#2)(1991-2#2)(1993-3#1)(1993-6#1)(1997-4#1)(2007-6#2)(2008-10#3)(2008-12#1)(2008-5#1)(2009-9#1)(2010-5#1)
the amino acid substitutions##3##4##(1990-8#1)(1997-9#1)(2008-10#1)
the amino acid##114##3##(1990-12#2)(1990-5#1)(1990-7#5)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-9#4)(1992-10#1)(1992-12#2)(1992-3#3)(1992-6#3)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-12#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-6#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#2)
the amino acids in##2##4##(1992-8#1)(1995-2#1)
the amino acids of##2##4##(1993-6#1)(1994-12#1)
the amino acids##19##3##(1990-7#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2011-1#1)
the amino and##2##3##(1992-6#1)(2008-10#1)
the amino group of the##2##5##(1992-3#1)(2008-10#1)
the amino group of##5##4##(1992-3#2)(2008-10#2)(2009-9#1)
the amino group##7##3##(1991-3#1)(1992-3#2)(2008-10#3)(2009-9#1)
the amino terminal##4##3##(1992-6#1)(1994-11#3)
the amino terminus of the##2##5##(1992-8#1)(1995-2#1)
the amino terminus of##4##4##(1991-10#1)(1992-5#1)(1992-8#1)(1995-2#1)
the amino terminus##14##3##(1991-10#1)(1991-8#2)(1992-5#1)(1992-8#3)(1995-2#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-11#2)
the amino##164##2##(1990-12#2)(1990-5#1)(1990-7#6)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-12#2)(1992-3#5)(1992-5#1)(1992-6#6)(1992-8#7)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-11#3)(1994-12#2)(1994-6#3)(1994-8#4)(1994-9#2)(1995-12#2)(1995-2#4)(1995-5#3)(1995-8#1)(1996-12#4)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(1997-9#1)(2007-11#1)(2007-6#2)(2008-10#27)(2008-11#9)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#2)
the amino-acid sequence of##2##4##(1990-5#1)(1997-3#1)
the amino-acid sequence##3##3##(1990-5#1)(1993-6#1)(1997-3#1)
the amino-acid##4##2##(1990-5#1)(1993-6#1)(1994-12#1)(1997-3#1)
the amino-terminal domain##3##3##(1990-11#1)(1990-5#1)(1991-9#1)
the amino-terminal sequences##3##3##(1992-8#1)(1995-11#1)(1996-8#1)
the amino-terminal##15##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1995-11#1)(1995-6#3)(1996-8#1)(1997-6#1)(2008-7#1)
the amino-terminus##2##2##(1990-12#1)(1993-11#1)
the aminoacid##2##2##(1992-9#2)
the aminopeptidase##3##2##(1990-2#1)(1991-5#1)(1992-5#1)
the ammine-complexes##2##2##(2008-10#2)
the ammonia##6##2##(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#2)
the ammonium##4##2##(2008-10#3)(2008-12#1)
the amnioserosa and##2##3##(2012-12#2)
the amnioserosa##4##2##(2012-12#4)
the amniotic fluid##5##3##(1990-12#1)(1990-9#1)(2008-5#1)(2008-9#1)(2012-12#1)
the amniotic##7##2##(1990-12#1)(1990-9#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-12#1)
the amoeba##2##2##(1994-8#1)(2010-9#1)
the amorphous content of a##2##5##(2008-10#2)
the amorphous content of##4##4##(2008-10#4)
the amorphous content##5##3##(2008-10#5)
the amorphous##9##2##(2008-10#7)(2008-3#1)(2010-8#1)
the amount and distribution of##2##5##(1995-5#1)(2011-2#1)
the amount and##10##3##(1990-5#1)(1995-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
the amount of B-GOx##2##4##(2008-10#2)
the amount of DNA isolated##2##5##(1996-12#2)
the amount of DNA##5##4##(1996-12#2)(1996-5#1)(2008-10#1)(2010-2#1)
the amount of active ingredient delivered to the scalp##2##9##(2008-5#2)
the amount of added##2##4##(1991-8#1)(2008-10#1)
the amount of albicidin produced in vitro##3##7##(2008-10#3)
the amount of anesthetic medicine to be applied##2##8##(2010-8#2)
the amount of antibody per sample##2##6##(2008-10#2)
the amount of antibody##4##4##(1994-5#1)(1996-5#1)(2008-10#2)
the amount of aromatase##2##4##(1993-8#2)
the amount of arsenic##2##4##(2008-10#2)
the amount of black carbon##2##5##(2008-3#2)
the amount of blood##2##4##(1994-3#2)
the amount of chemical##3##4##(2008-10#2)(2013-8#1)
the amount of community##2##4##(1997-1#1)(2008-11#1)
the amount of data##2##4##(2007-11#1)(2008-2#1)
the amount of disease##3##4##(2008-10#3)
the amount of drug##2##4##(1997-2#1)(2010-4#1)
the amount of dust##2##4##(1992-12#1)(2008-11#1)
the amount of energy delivered##3##5##(2008-9#1)(2013-1#2)
the amount of energy##5##4##(2008-9#2)(2010-3#1)(2013-1#2)
the amount of extra-metabolic energy##2##5##(2012-2#2)
the amount of extractable##2##4##(2008-11#1)(2008-12#1)
the amount of food##3##4##(2008-5#1)(2008-9#2)
the amount of fresh water##2##5##(2008-6#2)
the amount of incorporated##2##4##(1994-12#1)(2008-10#1)
the amount of information##4##4##(1994-2#1)(1996-3#1)(1997-3#1)(2008-7#1)
the amount of intracellular##2##4##(2008-11#2)
the amount of lead##2##4##(1995-11#1)(2008-10#1)
the amount of misalignment##2##4##(2008-3#2)
the amount of ozone##2##4##(2008-10#1)(2008-2#1)
the amount of pain##2##4##(1996-2#1)(2008-11#1)
the amount of pathogen DNA present in the##2##8##(2008-10#2)
the amount of pathogen DNA##3##5##(2008-10#3)
the amount of pathogen##4##4##(2008-10#4)
the amount of phospholipids##2##4##(1993-6#1)(2008-11#1)
the amount of protein##2##4##(1994-11#1)(2008-9#1)
the amount of reagent##2##4##(2008-10#2)
the amount of released##2##4##(2009-8#2)
the amount of residual##2##4##(2008-10#1)(2009-7#1)
the amount of resources##2##4##(2008-10#1)(2008-8#1)
the amount of sample available##2##5##(2008-10#1)(2010-4#1)
the amount of sample##5##4##(2007-12#1)(2008-10#3)(2010-4#1)
the amount of secreted##2##4##(1997-3#1)(2008-10#1)
the amount of spread##2##4##(2008-10#2)
the amount of the##19##4##(1990-12#1)(1990-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-6#1)(1997-2#1)(2008-10#7)(2008-8#1)(2009-2#1)(2009-8#1)
the amount of time elapsed between##2##6##(1996-3#1)(2008-11#1)
the amount of time##5##4##(1996-3#1)(2008-11#2)(2008-12#1)(2011-2#1)
the amount of total##5##4##(1990-2#1)(1996-12#1)(2008-12#1)(2008-5#1)(2010-2#1)
the amount of water##3##4##(1995-3#1)(2008-10#1)(2008-3#1)
the amount of##349##3##(1990-10#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#6)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#110)(2008-11#20)(2008-12#6)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#8)(2008-7#4)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#2)(2009-2#3)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#6)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#4)
the amount or##2##3##(1991-12#1)(1992-3#1)
the amount##377##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#6)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#113)(2008-11#20)(2008-12#8)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#8)(2008-7#4)(2008-8#8)(2008-9#12)(2009-10#1)(2009-11#2)(2009-2#3)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#6)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#4)
the amounts of iron transferred to the palm##2##8##(2008-10#2)
the amounts of the##3##4##(1992-9#1)(2008-10#1)(2008-6#1)
the amounts of##32##3##(1991-11#1)(1992-9#1)(1994-11#2)(1995-2#2)(1997-2#2)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-5#3)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the amounts##38##2##(1991-11#1)(1992-9#1)(1994-11#2)(1995-1#1)(1995-2#2)(1997-2#2)(2007-11#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-5#3)(2008-6#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the amperometric detection of##7##4##(2008-10#7)
the amperometric response of##2##4##(2008-10#2)
the amperometric response##4##3##(2008-10#4)
the amperometric##26##2##(1992-11#1)(2008-10#25)
the amphibian Xenopus laevis##2##4##(1990-12#1)(2008-9#1)
the amphibian##5##2##(1990-12#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-9#1)
the amphipathic##7##2##(1990-2#1)(1990-5#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#1)
the amphiphilic character##2##3##(1994-5#1)(1994-8#1)
the amphiphilic##7##2##(1991-10#1)(1994-11#1)(1994-5#2)(1994-8#1)(2008-10#1)(2008-5#1)
the ampholytic nature of##2##4##(2010-8#2)
the ampicillin##2##2##(2008-10#1)(2011-1#1)
the amplification of a##3##4##(1993-9#1)(2008-10#2)
the amplification of the##2##4##(2008-10#1)(2010-4#1)
the amplification of##17##3##(1991-6#1)(1993-2#1)(1993-9#1)(1994-3#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#2)(2010-4#1)
the amplification process##2##3##(2007-12#2)
the amplification##29##2##(1990-12#1)(1991-6#2)(1993-2#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-7#2)(2007-11#3)(2007-12#2)(2008-10#10)(2008-11#2)(2009-5#1)(2010-4#1)(2010-5#1)
the amplified DNA##4##3##(1990-12#1)(1993-12#1)(2008-5#1)(2011-2#1)
the amplified fragment length polymorphism##3##5##(2008-10#3)
the amplified fragment##5##3##(1996-8#1)(2008-10#3)(2008-12#1)
the amplified fragments##4##3##(1992-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
the amplified products##4##3##(1990-3#1)(2008-10#2)(2012-2#1)
the amplified signal and##3##4##(2007-11#3)
the amplified spontaneous emission##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
the amplified##35##2##(1990-12#1)(1990-3#1)(1992-8#1)(1993-12#1)(1996-8#1)(1997-2#1)(2007-11#4)(2007-12#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#2)
the amplifier chain##2##3##(2008-2#2)
the amplifier output##2##3##(2007-12#1)(2008-2#1)
the amplifier##16##2##(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#3)
the amplitude and duration of the##3##6##(1990-12#1)(1992-3#1)(2008-9#1)
the amplitude and frequency of##2##5##(2009-12#1)(2010-3#1)
the amplitude and phase##2##4##(2007-12#1)(2008-3#1)
the amplitude and the phase of##2##6##(2007-11#1)(2007-12#1)
the amplitude and the phase##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
the amplitude and the##8##4##(1996-2#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
the amplitude and##17##3##(1990-12#1)(1992-3#1)(1996-2#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
the amplitude matrix for a nonspherical particle in##2##8##(2008-3#2)
the amplitude of a##2##4##(1996-5#1)(2007-12#1)
the amplitude of the NANC##2##5##(1997-4#2)
the amplitude of the refractive-index modulation##2##6##(2008-3#2)
the amplitude of the##22##4##(1990-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1997-4#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#1)
the amplitude of##30##3##(1990-7#3)(1993-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-4#3)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)
the amplitude ratio and phase difference##2##6##(2007-12#2)
the amplitude ratio and##3##4##(2007-12#2)(2008-2#1)
the amplitude ratio##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the amplitude##66##2##(1990-12#1)(1990-7#3)(1992-3#3)(1993-12#2)(1993-3#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#3)(2007-11#6)(2007-12#10)(2008-10#1)(2008-2#5)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-9#1)(2010-3#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
the amplitudes of the##4##4##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
the amplitudes of##10##3##(1992-8#1)(1997-2#3)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
the amplitudes##11##2##(1992-8#1)(1997-2#3)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
the ampulla of##2##3##(1990-9#1)(2008-11#1)
the amputee##2##2##(2010-3#1)(2013-1#1)
the amygdala and hippocampus##2##4##(1993-6#1)(2008-6#1)
the amygdala and the##2##4##(1994-2#1)(2008-7#1)
the amygdala and##6##3##(1993-6#2)(1994-2#1)(2008-11#1)(2008-6#1)(2008-7#1)
the amygdala does##2##3##(1993-6#1)(2008-11#1)
the amygdala in the##2##4##(2008-11#1)(2008-7#1)
the amygdala in##6##3##(1991-1#1)(1992-6#1)(1993-12#1)(2008-11#1)(2008-6#1)(2008-7#1)
the amygdala is##4##3##(1992-6#1)(1994-8#1)(2008-11#2)
the amygdala or##2##3##(1996-12#1)(2007-10#1)
the amygdala##59##2##(1991-1#2)(1991-10#2)(1992-6#3)(1992-8#3)(1993-12#9)(1993-6#8)(1994-2#3)(1994-8#3)(1995-12#1)(1996-12#2)(1996-5#2)(2007-10#2)(2008-11#9)(2008-6#3)(2008-7#4)(2009-10#1)(2013-8#2)
the amylase from##2##3##(2008-10#2)
the amyloid beta A4 protein##2##5##(1992-8#1)(1992-9#1)
the amyloid beta##3##3##(1992-8#1)(1992-9#1)(1996-5#1)
the amyloid beta-protein##3##3##(1991-11#1)(1991-2#1)(1992-12#1)
the amyloid deposits##2##3##(1991-11#1)(2008-5#1)
the amyloid precursor protein##5##4##(1992-12#2)(1992-3#1)(1993-11#2)
the amyloid protein##2##3##(1993-3#1)(2011-2#1)
the amyloid##22##2##(1991-11#4)(1991-2#1)(1992-12#4)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1996-5#1)(2008-5#2)(2010-11#1)(2011-2#1)
the amyloid-β##2##2##(2010-8#1)(2011-1#1)
the amylose##2##2##(2008-10#2)
the anabolic##2##2##(1992-6#1)(2008-11#1)
the anaerobic##8##2##(1990-12#1)(1991-12#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#2)
the anaesthetic management of##3##4##(2010-7#1)(2011-1#1)(2011-2#1)
the anaesthetic vapours##2##3##(1991-6#1)(1997-3#1)
the anaesthetic##8##2##(1991-6#1)(1992-11#1)(1997-3#1)(2010-7#2)(2011-1#2)(2011-2#1)
the anaesthetist##3##2##(2009-3#1)(2012-12#2)
the anagen hair percentage##2##4##(2008-5#2)
the anagen##3##2##(2008-5#3)
the anal canal##2##3##(2013-1#2)
the anal fin##3##3##(2013-7#3)
the anal##12##2##(1997-8#1)(2008-5#1)(2011-2#3)(2013-1#4)(2013-7#3)
the analgesic effect of morphine##2##5##(1996-2#2)
the analgesic effect##3##3##(1991-2#1)(1996-2#2)
the analgesic effectiveness of##2##4##(2010-4#2)
the analgesic##14##2##(1991-2#1)(1993-1#1)(1995-12#1)(1996-2#2)(1997-2#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-4#2)(2011-2#1)(2013-1#1)
the analog is##2##3##(1991-5#1)(1997-6#1)
the analog##6##2##(1991-5#1)(1992-5#1)(1992-6#1)(1997-6#2)(2008-2#1)
the analogous zinc##2##3##(1991-2#1)(1996-2#1)
the analogous##12##2##(1990-5#1)(1991-2#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-7#2)
the analogs##4##2##(1990-2#1)(1994-5#1)(1994-8#1)(1995-3#1)
the analogue##4##2##(1992-6#1)(1994-11#1)(1994-8#2)
the analogues of##2##3##(2008-10#1)(2011-2#1)
the analogues##6##2##(1990-2#1)(1992-6#1)(1994-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
the analysed samples in the##2##5##(2008-10#2)
the analysed samples##4##3##(2008-10#4)
the analysed##9##2##(1993-9#1)(2008-10#7)(2011-2#1)
the analyser##3##2##(1990-8#1)(2008-10#2)
the analyses of##17##3##(1995-5#1)(2008-10#13)(2008-7#1)(2013-1#1)(2013-7#1)
the analyses##35##2##(1994-12#1)(1995-5#1)(1997-7#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the analysis accuracy of the##2##5##(2008-3#2)
the analysis accuracy##3##3##(2008-3#3)
the analysis and##13##3##(1992-3#1)(1993-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2010-4#1)(2013-1#1)
the analysis by##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
the analysis can be##2##4##(2008-10#1)(2008-3#1)
the analysis for##2##3##(2008-10#2)
the analysis is##8##3##(1992-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)
the analysis of DNA##2##4##(2008-12#1)(2008-4#1)
the analysis of a##14##4##(1994-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-4#2)(2009-4#1)(2012-2#1)
the analysis of aroma##2##4##(2008-10#2)
the analysis of biological##3##4##(2008-10#2)(2008-7#1)
the analysis of both##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
the analysis of cancer##2##4##(1994-2#1)(2009-12#1)
the analysis of certified reference material##2##6##(2008-10#2)
the analysis of certified reference materials and##3##7##(2008-10#3)
the analysis of certified reference materials##8##6##(2008-10#8)
the analysis of certified reference##11##5##(2008-10#11)
the analysis of certified##12##4##(2008-10#12)
the analysis of complex matrices##2##5##(2008-10#2)
the analysis of complex##5##4##(1997-2#1)(2008-10#3)(2008-2#1)
the analysis of data from##2##5##(1994-11#1)(2011-8#1)
the analysis of data##5##4##(1994-11#1)(1997-2#1)(2008-10#1)(2011-8#1)(2012-12#1)
the analysis of different##3##4##(2007-8#1)(2008-10#2)
the analysis of drugs##2##4##(2008-10#1)(2010-11#1)
the analysis of dynamic##3##4##(2008-1#1)(2008-3#2)
the analysis of each of##2##5##(1992-3#1)(2007-8#1)
the analysis of each sample##2##5##(2008-10#2)
the analysis of each##4##4##(1992-3#1)(2007-8#1)(2008-10#2)
the analysis of environmental##2##4##(2008-10#2)
the analysis of four certified reference##2##6##(2008-10#2)
the analysis of fringe##2##4##(2008-3#2)
the analysis of life##2##4##(1994-11#1)(2011-1#1)
the analysis of longitudinal##2##4##(1997-8#1)(2011-1#1)
the analysis of major##3##4##(2008-10#2)(2012-2#1)
the analysis of mixed##2##4##(2008-10#1)(2008-12#1)
the analysis of multiple##2##4##(1997-4#1)(2008-4#1)
the analysis of one##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
the analysis of organic##3##4##(2008-10#2)(2008-11#1)
the analysis of other##2##4##(2008-10#1)(2008-2#1)
the analysis of patients##2##4##(2011-2#1)(2013-1#1)
the analysis of pharmaceutical##4##4##(2008-10#4)
the analysis of phosphorus##2##4##(2008-10#1)(2008-12#1)
the analysis of potable##2##4##(2008-10#2)
the analysis of proteins and##2##5##(2008-10#1)(2008-9#1)
the analysis of rare variants##2##5##(2012-3#2)
the analysis of real samples##3##5##(2008-10#3)
the analysis of real##7##4##(2008-10#6)(2008-2#1)
the analysis of relatively##2##4##(2008-10#1)(2008-4#1)
the analysis of selected##3##4##(1993-9#1)(2008-10#2)
the analysis of serum##2##4##(2008-10#2)
the analysis of several##3##4##(2008-10#2)(2009-10#1)
the analysis of small##2##4##(2008-10#2)
the analysis of some##10##4##(2008-10#10)
the analysis of spiked##4##4##(2008-10#4)
the analysis of standard reference materials##2##6##(2008-10#2)
the analysis of such##5##4##(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
the analysis of survival data##2##5##(1990-2#1)(1997-3#1)
the analysis of synthetic##8##4##(2008-10#6)(2008-2#1)(2008-4#1)
the analysis of the bulk##2##5##(2008-10#2)
the analysis of the changes##2##5##(2008-11#1)(2013-8#1)
the analysis of the data##2##5##(1995-8#1)(2010-10#1)
the analysis of the genetic##2##5##(2008-10#1)(2011-2#1)
the analysis of the##81##4##(1990-11#1)(1990-5#2)(1990-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#2)(1994-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the analysis of these compounds##2##5##(2008-10#2)
the analysis of these herbicides in spiked##2##7##(2008-10#2)
the analysis of these herbicides in##3##6##(2008-10#3)
the analysis of these##7##4##(2008-10#7)
the analysis of this##6##4##(2008-10#6)
the analysis of three##2##4##(2008-10#2)
the analysis of total##3##4##(2008-10#2)(2012-2#1)
the analysis of toxic metal##2##5##(2008-10#2)
the analysis of trace##5##4##(2008-10#5)
the analysis of two##6##4##(2007-12#1)(2008-10#4)(2008-3#1)
the analysis of urine samples##2##5##(2008-10#2)
the analysis of urine##3##4##(2008-10#3)
the analysis of variance (ANOVA)##2##5##(2008-10#1)(2013-1#1)
the analysis of variance##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
the analysis of water samples##2##5##(2008-10#2)
the analysis of##593##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#351)(2008-11#12)(2008-12#5)(2008-2#14)(2008-3#19)(2008-4#22)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#8)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#8)(2011-8#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#1)
the analysis showed##2##3##(2008-12#1)(2008-5#1)
the analysis time and##2##4##(2008-10#2)
the analysis time is##2##4##(2008-10#2)
the analysis time##5##3##(2008-10#5)
the analysis to##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
the analysis was##11##3##(1992-12#1)(1993-12#1)(2008-10#6)(2008-8#1)(2010-10#1)(2013-8#1)
the analysis were##3##3##(2008-11#2)(2010-5#1)
the analysis with##2##3##(2008-10#1)(2008-7#1)
the analysis##743##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#3)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#4)(1995-8#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#3)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#7)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#397)(2008-11#14)(2008-12#8)(2008-2#21)(2008-3#38)(2008-4#25)(2008-5#5)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#14)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#11)(2011-8#1)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#7)(2012-6#1)(2013-1#10)(2013-8#4)
the analyst##2##2##(2008-10#1)(2012-12#1)
the analyte and the##4##4##(2008-10#3)(2010-7#1)
the analyte and##9##3##(2008-10#8)(2010-7#1)
the analyte at##2##3##(2008-10#2)
the analyte by##4##3##(2008-10#3)(2009-8#1)
the analyte concentration##6##3##(2008-10#5)(2008-7#1)
the analyte concentrations##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
the analyte elements were##4##4##(2008-10#4)
the analyte elements##6##3##(2008-10#6)
the analyte from the##4##4##(2008-10#4)
the analyte from##5##3##(1996-5#1)(2008-10#4)
the analyte in the##9##4##(2008-10#7)(2009-8#1)(2010-5#1)
the analyte in##13##3##(2008-10#11)(2009-8#1)(2010-5#1)
the analyte is##5##3##(2008-10#5)
the analyte pulse perturbation##3##4##(2008-10#3)
the analyte pulse##4##3##(2008-10#4)
the analyte signal from the##2##5##(2008-10#2)
the analyte solution##8##3##(2008-10#8)
the analyte to##5##3##(2008-10#5)
the analyte was retained##2##4##(2008-10#2)
the analyte was##8##3##(2008-10#8)
the analyte##142##2##(1996-5#1)(2007-12#1)(2008-10#129)(2008-3#1)(2008-7#2)(2009-8#2)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
the analyte's##2##2##(2008-10#2)
the analytes and##4##3##(2008-10#4)
the analytes are##7##3##(2008-10#6)(2013-1#1)
the analytes from the##2##4##(2008-10#2)
the analytes from##5##3##(1997-2#1)(2008-10#4)
the analytes in##6##3##(2008-10#6)
the analytes of interest##2##4##(2008-10#2)
the analytes was##3##3##(2008-10#3)
the analytes were detected by##2##5##(2011-1#1)(2013-1#1)
the analytes were##17##3##(2008-10#14)(2011-1#1)(2012-1#1)(2013-1#1)
the analytes with##3##3##(2008-10#3)
the analytes##98##2##(1997-2#3)(2008-1#1)(2008-10#86)(2008-3#1)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#3)
the analytic hierarchy process##3##4##(2008-10#1)(2011-2#2)
the analytic##9##2##(1995-2#2)(2007-10#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-12#1)
the analytical capabilities of##2##4##(2008-10#1)(2010-11#1)
the analytical characteristics of the procedure##2##6##(2008-10#2)
the analytical characteristics of the##3##5##(2008-10#3)
the analytical characteristics of##6##4##(2008-10#6)
the analytical characteristics##11##3##(2008-10#11)
the analytical chemical##2##3##(2008-10#2)
the analytical chemistry##2##3##(2008-10#2)
the analytical column##5##3##(1990-8#1)(2008-10#4)
the analytical community##2##3##(2008-10#2)
the analytical conditions##3##3##(2008-10#2)(2011-1#1)
the analytical curve was##2##4##(2008-10#2)
the analytical curve##4##3##(2008-10#4)
the analytical curves##3##3##(2008-10#3)
the analytical data##4##3##(1995-5#1)(2008-10#3)
the analytical design##2##3##(2008-2#1)(2008-3#1)
the analytical determination of##2##4##(2008-10#2)
the analytical determination##3##3##(2008-10#3)
the analytical figures of merit##3##5##(2008-10#3)
the analytical method##5##3##(2008-10#3)(2010-11#1)(2012-2#1)
the analytical methods##3##3##(1996-12#1)(2008-4#1)(2010-7#1)
the analytical minimalism concept##2##4##(2008-10#2)
the analytical performance of the method##2##6##(2008-10#2)
the analytical performance of the##6##5##(2008-10#6)
the analytical performance of##7##4##(2008-10#7)
the analytical performance##9##3##(2008-10#9)
the analytical performances of the##2##5##(2008-10#2)
the analytical performances of##3##4##(2008-10#3)
the analytical performances##4##3##(2008-10#4)
the analytical procedure##8##3##(2008-10#8)
the analytical response##2##3##(2008-10#2)
the analytical results were in good agreement with##2##8##(2008-10#2)
the analytical results were##5##4##(2008-10#5)
the analytical results##10##3##(2007-11#1)(2008-10#7)(2008-3#2)
the analytical sensitivity and##2##4##(2008-10#2)
the analytical sensitivity##5##3##(2008-10#4)(2011-2#1)
the analytical signal from##2##4##(2008-10#2)
the analytical signal is##2##4##(2008-10#2)
the analytical signal of##3##4##(2008-10#3)
the analytical signal showed a very good linearity in the range##2##11##(2008-10#2)
the analytical signal to##2##4##(2008-10#2)
the analytical signal versus concentration dependence was linear##2##8##(2008-10#2)
the analytical signal##25##3##(2008-10#25)
the analytical signals##6##3##(2008-10#5)(2008-3#1)
the analytical solution##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2011-2#1)
the analytical system##3##3##(2008-10#3)
the analytical time was##2##4##(2008-10#2)
the analytical##194##2##(1990-8#1)(1992-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-9#1)(2008-10#156)(2008-2#1)(2008-3#9)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the analytically##2##2##(2007-11#1)(2008-2#1)
the analyzed##22##2##(2007-8#1)(2008-10#9)(2008-12#1)(2008-7#2)(2009-10#1)(2009-5#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
the analyzer with##2##3##(2007-11#1)(2008-3#1)
the analyzer##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
the analyzing##2##2##(2008-10#1)(2008-3#1)
the anamorphic##2##2##(2008-3#2)
the anastomosis##10##2##(1990-6#1)(1991-3#1)(1993-6#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)
the anastomotic##2##2##(2006-6#1)(2013-7#1)
the anatomic basis##2##3##(2012-2#1)(2012-3#1)
the anatomic##13##2##(1990-9#1)(1992-4#1)(1994-3#1)(1994-6#1)(2006-12#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the anatomical and##3##3##(2008-2#1)(2009-7#1)(2013-1#1)
the anatomical features##2##3##(1996-9#1)(2013-1#1)
the anatomical location##2##3##(1996-12#1)(2013-8#1)
the anatomical##37##2##(1990-6#2)(1992-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the anatomy and physiology of the##2##6##(2007-8#1)(2010-9#1)
the anatomy and##6##3##(1993-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-9#1)
the anatomy of the##3##4##(1990-11#1)(2008-10#1)(2010-8#1)
the anatomy of this region##2##5##(1994-3#1)(1996-9#1)
the anatomy of##6##3##(1990-11#1)(1994-3#1)(1996-9#1)(2007-11#1)(2008-10#1)(2010-8#1)
the anatomy##18##2##(1990-11#1)(1990-8#1)(1993-6#1)(1994-3#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2013-1#3)
the ancestor of##5##3##(2008-1#1)(2008-9#2)(2009-10#1)(2010-6#1)
the ancestor##6##2##(2008-1#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-6#1)
the ancestors of##2##3##(2009-2#1)(2009-8#1)
the ancestral gene##2##3##(1991-6#1)(1992-12#1)
the ancestral##12##2##(1991-6#1)(1992-12#1)(1995-8#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2013-1#3)
the anchor cell##4##3##(1994-12#1)(2007-12#3)
the anchor##8##2##(1994-12#1)(1997-6#1)(1997-7#1)(2007-12#3)(2008-10#1)(2010-10#1)
the anchored##2##2##(2008-10#1)(2011-2#1)
the ancient##5##2##(1991-2#1)(2008-10#3)(2009-10#1)
the ancillary##3##2##(1994-6#1)(2008-4#1)(2011-7#1)
the androgen receptor (AR)##3##4##(1990-11#2)(2011-2#1)
the androgen receptor##11##3##(1990-11#2)(1995-3#2)(2008-4#3)(2009-4#2)(2011-2#1)(2012-2#1)
the androgen##14##2##(1990-11#2)(1995-3#2)(2008-4#3)(2008-9#2)(2009-10#1)(2009-4#2)(2011-2#1)(2012-2#1)
the androgenic steroid##3##3##(1990-11#2)(1993-1#1)
the androgenic##6##2##(1990-11#2)(1991-9#1)(1993-1#1)(1996-5#1)(2010-1#1)
the android and##2##3##(2008-11#1)(2009-7#1)
the anemia of##2##3##(2010-12#1)(2012-2#1)
the anemia##3##2##(2010-12#1)(2011-2#1)(2012-2#1)
the anesthesia##6##2##(1994-3#1)(2010-8#4)(2011-2#1)
the anesthesiologist##4##2##(2007-11#2)(2009-4#1)(2012-12#1)
the anesthetic management##3##3##(2009-4#1)(2011-1#1)(2011-2#1)
the anesthetic##11##2##(1990-12#1)(1990-2#1)(1991-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
the anesthetized##2##2##(2008-4#1)(2008-8#1)
the aneurysm##21##2##(1997-3#1)(1997-6#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#3)
the aneurysmal sac##3##3##(1997-3#2)(2008-11#1)
the aneurysmal##8##2##(1997-3#3)(1997-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
the aneurysms were##2##3##(1995-11#1)(1997-3#1)
the aneurysms##4##2##(1995-11#1)(1997-3#1)(2009-8#1)(2013-8#1)
the angiogenesis##2##2##(1991-12#1)(2011-2#1)
the angiogenic##9##2##(1990-4#1)(1992-3#1)(2008-1#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
the angiographic findings##3##3##(1997-8#3)
the angiographic##8##2##(1990-6#1)(1992-9#1)(1994-11#1)(1996-6#1)(1997-8#3)(2008-7#1)
the angiotensin II receptor##2##4##(1994-8#1)(1995-11#1)
the angiotensin II##4##3##(1994-8#1)(1995-11#1)(2008-1#1)(2008-8#1)
the angiotensin converting enzyme##2##4##(1990-12#1)(1990-5#1)
the angiotensin##12##2##(1990-12#1)(1990-5#1)(1991-9#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#2)(2008-1#1)(2008-8#1)
the angle between the##3##4##(2007-12#1)(2008-3#2)
the angle between##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the angle formed by the##2##5##(1995-6#1)(2008-1#1)
the angle of incidence of light##3##6##(2008-2#2)(2008-3#1)
the angle of incidence of the##2##6##(2008-1#1)(2008-3#1)
the angle of incidence of##5##5##(2008-1#1)(2008-2#2)(2008-3#2)
the angle of incidence with##2##5##(2008-3#2)
the angle of incidence##14##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#7)
the angle of polarization##2##4##(2008-3#2)
the angle of the##4##4##(2007-11#2)(2007-8#1)(2008-3#1)
the angle of total##3##4##(2008-2#1)(2008-3#2)
the angle of##29##3##(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#14)
the angle range##2##3##(2008-3#2)
the angle##49##2##(1995-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#9)(2008-3#26)(2012-2#1)(2013-1#1)(2013-8#1)
the angles between##2##3##(2008-10#1)(2008-3#1)
the angles##3##2##(2008-10#1)(2008-3#2)
the angular and the spectral selectivities##2##6##(2008-2#2)
the angular deflection##2##3##(2008-3#2)
the angular distribution of##6##4##(2007-11#2)(2008-2#3)(2008-3#1)
the angular distribution##8##3##(2007-11#3)(2008-2#3)(2008-3#2)
the angular frequency##2##3##(2008-2#1)(2008-3#1)
the angular range##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the angular sensitivity of the##2##5##(2007-11#1)(2008-2#1)
the angular size of the##2##5##(2008-3#2)
the angular##52##2##(1995-5#1)(2007-11#6)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#12)(2008-3#25)(2008-7#1)(2009-4#1)
the anhydride##2##2##(1995-11#1)(2008-10#1)
the anhydrous##2##2##(2008-10#2)
the aniline##2##2##(2008-10#2)
the animal hemisphere of##2##4##(1993-6#2)
the animal kingdom##4##3##(1996-12#1)(2007-12#2)(2009-8#1)
the animal model##2##3##(2008-9#2)
the animal models of##3##4##(2008-3#1)(2008-7#1)(2009-12#1)
the animal models##5##3##(2008-3#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)
the animal showed##2##3##(2008-5#1)(2012-1#1)
the animal species##2##3##(2010-11#1)(2012-2#1)
the animal test species##2##4##(2010-11#2)
the animal to##3##3##(1992-12#1)(2008-4#1)(2012-12#1)
the animal##69##2##(1990-2#1)(1991-5#1)(1992-12#2)(1992-6#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-6#3)(1997-7#1)(2007-12#6)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#3)(2010-1#1)(2010-11#3)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the animal's behavior##2##3##(2008-11#2)
the animal's##4##2##(1992-11#1)(1993-12#1)(2008-11#2)
the animal-sourced proteins##2##3##(2008-11#2)
the animals at##2##3##(1997-4#1)(2010-1#1)
the animals from##2##3##(1993-5#1)(2008-5#1)
the animals had been##2##4##(1990-11#1)(2008-12#1)
the animals had##5##3##(1990-11#1)(1990-5#1)(1993-12#1)(1997-8#1)(2008-12#1)
the animals in the##3##4##(1992-3#1)(1993-12#1)(1993-9#1)
the animals involved should be procured in good health##2##9##(2008-4#2)
the animals kept##2##3##(2008-7#2)
the animals received##3##3##(1993-12#1)(1993-3#1)(1995-12#1)
the animals that received##2##4##(1995-5#2)
the animals that##5##3##(1995-5#2)(2008-11#1)(2008-7#1)(2010-7#1)
the animals were allowed##2##4##(2009-3#2)
the animals were anesthetized##2##4##(2011-2#2)
the animals were sacrificed##2##4##(2008-7#1)(2011-2#1)
the animals were##19##3##(1992-12#1)(1992-3#1)(1994-3#1)(1996-12#1)(2008-12#1)(2008-7#4)(2009-3#2)(2009-4#1)(2010-2#2)(2010-8#1)(2011-2#3)(2013-1#1)
the animals##85##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#1)(1992-12#1)(1992-3#3)(1992-7#1)(1993-12#5)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-5#2)(1995-8#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-8#2)(2008-10#3)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#9)(2008-8#1)(2009-3#3)(2009-4#1)(2010-1#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-2#6)(2013-1#3)(2013-8#2)
the anion and cation##2##4##(2007-12#1)(2012-1#1)
the anion and##3##3##(1994-5#1)(2007-12#1)(2012-1#1)
the anion of##2##3##(1996-5#1)(2008-10#1)
the anion##18##2##(1994-5#1)(1994-6#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#10)(2008-11#1)(2011-1#1)(2012-1#1)
the anion-exchange##6##2##(2008-10#6)
the anionic additive##3##3##(2008-10#3)
the anionic exchanger##2##3##(2008-10#2)
the anionic form of the##2##5##(2008-10#2)
the anionic form of##3##4##(1995-6#1)(2008-10#2)
the anionic form##4##3##(1995-6#1)(2008-10#2)(2009-6#1)
the anionic surfactant sodium##3##4##(2008-10#3)
the anionic surfactant##5##3##(2008-10#5)
the anionic##24##2##(1990-5#1)(1995-6#1)(2008-10#19)(2008-11#1)(2008-5#1)(2009-6#1)
the anions##8##2##(1995-5#1)(2008-10#6)(2010-4#1)
the anisotropic molecule dope method##2##5##(2008-3#2)
the anisotropic##11##2##(2008-2#2)(2008-3#8)(2010-4#1)
the anisotropy factor##2##3##(2007-11#1)(2008-3#1)
the anisotropy of the##2##4##(2008-3#1)(2008-6#1)
the anisotropy of##5##3##(2008-10#1)(2008-3#2)(2008-6#1)(2009-11#1)
the anisotropy##13##2##(1991-5#1)(2007-11#2)(2008-10#2)(2008-3#6)(2008-6#1)(2009-11#1)
the ankle and##4##3##(2009-11#1)(2011-2#3)
the ankle joint##9##3##(2007-11#1)(2009-7#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#2)
the ankle##27##2##(1995-12#2)(2007-11#2)(2008-12#1)(2008-8#2)(2009-11#1)(2009-7#2)(2010-3#1)(2010-5#1)(2011-2#6)(2012-2#7)(2012-3#1)(2013-1#1)
the ankyrin##2##2##(1991-7#1)(2008-8#1)
the annealing step##3##3##(1994-12#2)(2007-11#1)
the annealing##7##2##(1994-12#3)(2007-11#1)(2007-12#1)(2008-5#1)(2009-5#1)
the annotation of the##3##4##(2007-11#1)(2008-7#1)(2008-9#1)
the annotation of##5##3##(2007-11#1)(2008-7#1)(2008-9#2)(2010-11#1)
the annual frequency##2##3##(1996-3#1)(1997-8#1)
the annual incidence##3##3##(1996-11#2)(2011-2#1)
the annual mortality rate##2##4##(1995-3#2)
the annual##35##2##(1991-6#1)(1992-2#4)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-3#1)(1996-6#2)(1997-8#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-5#1)
the annulus##7##2##(1996-6#3)(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
the anode##4##2##(2007-11#1)(2008-10#2)(2012-12#1)
the anodic oxidation##2##3##(2008-10#2)
the anodic peak##4##3##(2008-10#4)
the anodic stripping voltammetric##2##4##(2008-10#2)
the anodic stripping##4##3##(2008-10#4)
the anodic##17##2##(1995-6#1)(2008-10#16)
the anodized##2##2##(2009-7#2)
the anogenital##2##2##(1994-1#1)(2011-1#1)
the anomalous diffraction approximation##2##4##(2008-2#1)(2008-3#1)
the anomalous diffraction##4##3##(2008-2#3)(2008-3#1)
the anomalous vein##2##3##(2007-8#2)
the anomalous##15##2##(1996-4#1)(2006-4#1)(2007-11#1)(2007-8#3)(2008-2#5)(2008-3#1)(2008-7#2)(2012-3#1)
the answer##11##2##(1992-11#1)(1994-11#1)(1994-12#2)(1995-1#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2012-2#2)
the answers##6##2##(1994-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-9#1)(2012-2#1)
the ant sex ratio##2##4##(2008-8#2)
the ant##7##2##(2007-12#2)(2008-5#1)(2008-6#1)(2008-8#3)
the ant's##2##2##(2007-12#1)(2012-3#1)
the antagonism of##2##3##(1990-2#1)(2008-10#1)
the antagonism##5##2##(1990-2#1)(1991-9#1)(2008-10#2)(2008-8#1)
the antagonist and the pathogen##2##5##(2008-10#2)
the antagonist and##5##3##(2008-10#4)(2008-7#1)
the antagonist effects of naloxonazine were##2##6##(1996-2#2)
the antagonist effects of naloxonazine##3##5##(1996-2#3)
the antagonist on##2##3##(2008-10#2)
the antagonist##35##2##(1992-6#1)(1995-11#1)(1995-12#1)(1996-2#3)(1997-6#1)(1997-7#1)(2008-10#26)(2008-7#1)
the antagonist's##2##2##(1995-11#1)(2008-10#1)
the antagonistic activity of##2##4##(2008-10#1)(2008-12#1)
the antagonistic effects of##2##4##(1996-12#1)(2008-12#1)
the antagonistic process##2##3##(2008-10#2)
the antagonistic##17##2##(1996-12#1)(2007-12#1)(2008-10#10)(2008-12#2)(2008-8#1)(2008-9#1)(2012-12#1)
the antagonists##5##2##(1994-6#1)(1995-11#1)(2008-10#1)(2008-8#2)
the antecedents and consequences of binge eating##2##7##(2007-7#2)
the antecedents and consequences of##3##5##(2007-7#2)(2008-11#1)
the antecedents and consequences##4##4##(2007-7#3)(2008-11#1)
the antecedents##5##2##(1996-3#1)(2007-7#3)(2008-11#1)
the antenatal##5##2##(2008-1#3)(2008-11#1)(2013-1#1)
the antenna base##2##3##(2007-12#2)
the antenna elements##2##3##(2007-12#1)(2008-3#1)
the antenna is##4##3##(2007-12#3)(2008-3#1)
the antenna of the##3##4##(2007-12#2)(2008-10#1)
the antenna of##4##3##(2007-12#3)(2008-10#1)
the antenna##23##2##(1993-11#1)(2007-12#16)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)
the antennal lobe##2##3##(2007-12#2)
the antennal##7##2##(2007-12#6)(2008-7#1)
the antennular##2##2##(2007-12#2)
the anterior abdominal wall##4##4##(1991-1#2)(2011-2#1)(2012-12#1)
the anterior abdominal##5##3##(1991-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
the anterior and lateral walls##2##5##(2008-7#2)
the anterior and lateral##4##4##(2007-11#1)(2008-7#3)
the anterior and posterior##9##4##(1993-12#1)(1995-2#1)(1997-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
the anterior and##14##3##(1992-12#1)(1993-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-7#4)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
the anterior border of the Fl1-Fl6 flagellomeres##2##7##(2007-12#2)
the anterior cerebral artery##4##4##(1997-3#1)(1997-6#1)(2007-10#1)(2008-7#1)
the anterior cerebral##6##3##(1997-3#1)(1997-6#1)(2007-10#1)(2008-7#2)(2008-9#1)
the anterior chamber##3##3##(2011-2#3)
the anterior cingulate##4##3##(1994-3#3)(2012-12#1)
the anterior clinoid##2##3##(2006-12#1)(2011-2#1)
the anterior communicating artery##2##4##(2008-7#2)
the anterior cranial base##2##4##(2011-2#2)
the anterior cruciate ligament (ACL)##2##5##(2013-1#2)
the anterior cruciate ligament##10##4##(2007-8#6)(2009-1#1)(2013-1#3)
the anterior horns##2##3##(2008-7#1)(2009-3#1)
the anterior hypothalamic-preoptic area##2##4##(1994-8#2)
the anterior lobe##4##3##(1992-9#3)(1996-5#1)
the anterior maxilla##5##3##(2007-12#2)(2009-8#2)(2013-1#1)
the anterior mesenteron##2##3##(2008-7#2)
the anterior of##2##3##(1993-12#1)(2007-12#1)
the anterior part of the##6##5##(1996-2#1)(1996-6#2)(2008-5#1)(2010-5#1)(2012-2#1)
the anterior part##7##3##(1996-2#1)(1996-6#2)(2008-5#1)(2009-4#1)(2010-5#1)(2012-2#1)
the anterior pituitary gland##2##4##(1997-2#1)(2008-1#1)
the anterior pituitary##6##3##(1992-10#1)(1993-5#2)(1994-6#1)(1997-2#1)(2008-1#1)
the anterior pole of the##3##5##(1994-12#1)(2007-12#1)(2008-12#1)
the anterior pole##5##3##(1994-12#1)(2007-12#3)(2008-12#1)
the anterior portion of the##3##5##(1991-8#1)(2006-12#1)(2009-1#1)
the anterior region of the##4##5##(2008-7#1)(2009-1#2)(2013-1#1)
the anterior region of##5##4##(2007-12#1)(2008-7#1)(2009-1#2)(2013-1#1)
the anterior segment of the eye##3##6##(2010-1#1)(2011-7#2)
the anterior segment of the##4##5##(2010-1#1)(2011-7#3)
the anterior segment##5##3##(2010-1#1)(2010-9#1)(2011-7#3)
the anterior side##2##3##(1997-8#1)(2013-2#1)
the anterior surface of##2##4##(1996-9#1)(2012-2#1)
the anterior vagina##2##3##(2007-12#2)
the anterior wall of the##6##5##(2006-12#2)(2007-8#1)(2011-2#1)(2011-7#1)(2012-12#1)
the anterior wall of##7##4##(2006-12#2)(2007-8#1)(2011-2#2)(2011-7#1)(2012-12#1)
the anterior##167##2##(1990-9#2)(1991-1#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#3)(1993-12#4)(1993-5#2)(1994-12#2)(1994-3#3)(1994-6#1)(1994-8#2)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-8#1)(2006-12#6)(2007-10#1)(2007-11#1)(2007-12#15)(2007-8#11)(2008-1#1)(2008-10#7)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#15)(2008-8#3)(2008-9#2)(2009-1#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#3)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#12)(2011-7#4)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#9)(2013-2#1)(2013-7#1)(2013-8#1)
the anterior-posterior##2##2##(1993-2#1)(2008-5#1)
the anterograde##2##2##(1995-2#1)(1996-2#1)
the anterolateral approach##4##3##(2011-2#2)(2012-3#2)
the anterolateral##5##2##(2011-2#2)(2012-3#2)(2013-8#1)
the anteromedial##2##2##(2013-1#1)(2013-8#1)
the anteroposterior##2##2##(2008-10#2)
the anther##2##2##(2008-8#2)
the anthracnose pathogen Colletotrichum##2##4##(2008-10#2)
the anthropogenic##3##2##(2008-10#1)(2008-11#2)
the anti##2##2##(1993-11#1)(2010-2#1)
the anti-FLAG##3##2##(1997-3#3)
the anti-IL-6##2##2##(2008-10#2)
the anti-Stokes##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the anti-TNP antibody##3##3##(2008-10#3)
the anti-aging##2##2##(1990-3#1)(2008-5#1)
the anti-apoptotic gene##2##3##(2008-11#1)(2010-1#1)
the anti-apoptotic##8##2##(2008-11#4)(2010-1#1)(2012-12#2)(2013-1#1)
the anti-atherogenic potential of losartan##2##5##(2011-2#2)
the anti-estrogens##2##2##(2008-2#1)(2008-5#1)
the anti-gluconeogenic##2##2##(1994-8#2)
the anti-hypertensive##2##2##(2008-10#1)(2008-7#1)
the anti-inflammatory drug##4##3##(2008-10#3)(2009-11#1)
the anti-inflammatory##11##2##(1990-5#1)(1990-6#1)(2008-10#5)(2009-1#1)(2009-11#1)(2011-2#1)(2012-2#1)
the anti-proliferative##2##2##(2009-9#1)(2013-1#1)
the anti-subunit antibodies##2##3##(1997-7#2)
the anti-synthetase syndrome##2##3##(2006-10#2)
the anti-tumor effect of##2##4##(1992-9#1)(2010-11#1)
the anti-tumor##5##2##(1992-9#1)(1993-9#1)(2008-10#1)(2008-11#1)(2010-11#1)
the antiadipogenic effect of retinol##2##5##(2008-5#2)
the antiaggregating drug picotamide##2##4##(2008-7#2)
the antibacterial##7##2##(1990-6#1)(2008-12#2)(2008-5#3)(2010-5#1)
the antibiogram##3##2##(2013-1#3)
the antibiotic 2##6##3##(2008-10#6)
the antibiotic chloramphenicol##2##3##(2008-10#2)
the antibiotic treatment##2##3##(1990-2#1)(2008-10#1)
the antibiotic##37##2##(1990-2#2)(1991-12#2)(1991-2#1)(1992-12#2)(1993-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-3#1)(1997-2#3)(2007-7#3)(2008-10#12)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
the antibiotics produced by the##2##5##(2008-10#2)
the antibiotics##8##2##(1991-1#1)(2008-10#5)(2010-8#1)(2012-3#1)
the antibodies and##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
the antibodies##31##2##(1990-12#1)(1991-12#1)(1992-11#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-3#2)(1997-7#2)(2008-10#8)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-6#1)(2011-2#1)
the antibody against##2##3##(1992-3#2)
the antibody and##3##3##(1993-9#1)(2008-10#1)(2009-3#1)
the antibody concentration##2##3##(2008-10#1)(2008-11#1)
the antibody for##2##3##(1995-8#1)(2008-10#1)
the antibody in##4##3##(2008-7#3)(2010-4#1)
the antibody is##5##3##(1994-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
the antibody on the sensor##3##5##(1997-2#1)(2008-10#2)
the antibody production##2##3##(1992-12#2)
the antibody response to##2##4##(1994-5#1)(2008-10#1)
the antibody response##6##3##(1994-5#1)(2008-10#4)(2008-4#1)
the antibody responses##2##3##(2008-4#1)(2012-12#1)
the antibody were##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
the antibody with##2##3##(2008-10#2)
the antibody##73##2##(1991-5#4)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1997-2#3)(1997-6#1)(2007-7#1)(2008-10#17)(2008-11#6)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#4)(2009-3#1)(2010-4#1)(2012-12#1)(2013-1#4)(2013-8#1)
the antibody-antigen##4##2##(2008-4#4)
the anticancer PG##2##3##(2008-11#2)
the anticancer activity##2##3##(2009-12#1)(2009-4#1)
the anticancer benefits##2##3##(2009-12#2)
the anticancer drug##3##3##(2008-10#1)(2008-7#2)
the anticancer##10##2##(2008-10#1)(2008-11#2)(2008-7#2)(2009-12#3)(2009-4#1)(2009-9#1)
the anticholinergic##2##2##(2008-11#1)(2008-3#1)
the anticipated##10##2##(1993-12#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)
the anticipation of##2##3##(2009-7#1)(2011-2#1)
the anticoagulant activity of warfarin##3##5##(1990-12#3)
the anticoagulant##12##2##(1990-12#3)(1990-5#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#4)(2009-11#1)
the anticonvulsant activity of##2##4##(1992-3#1)(1995-12#1)
the anticonvulsant effect of##2##4##(1992-3#1)(2010-3#1)
the anticonvulsant effects of##2##4##(1994-2#1)(1995-12#1)
the anticonvulsant effects##3##3##(1990-5#1)(1994-2#1)(1995-12#1)
the anticonvulsant##12##2##(1990-5#1)(1992-3#2)(1994-2#2)(1994-8#3)(1995-12#3)(2010-3#1)
the antidandruff climbazole##2##3##(2008-5#2)
the antidandruff##3##2##(2008-10#1)(2008-5#2)
the antidepressant drug##4##3##(2008-10#2)(2008-6#2)
the antidepressant##7##2##(2008-10#4)(2008-6#3)
the antidepressants##4##2##(2008-11#1)(2008-9#1)(2010-5#2)
the antiestrogen##3##2##(1993-1#1)(2008-11#2)
the antifouling agent##2##3##(2008-10#2)
the antifouling##4##2##(2008-10#2)(2008-11#2)
the antifreeze##2##2##(1994-9#2)
the antifungal activities##2##3##(2008-10#1)(2013-1#1)
the antifungal activity##3##3##(2008-10#2)(2009-2#1)
the antifungal compounds##2##3##(2008-10#2)
the antifungal effect of##2##4##(2008-5#1)(2009-2#1)
the antifungal properties of##2##4##(2008-10#1)(2012-2#1)
the antifungal properties##3##3##(2008-10#2)(2012-2#1)
the antifungal##19##2##(1992-11#1)(2008-10#11)(2008-5#3)(2009-2#2)(2012-2#1)(2013-1#1)
the antigen and##3##3##(1993-12#1)(1994-11#1)(2008-10#1)
the antigen by##4##3##(1990-12#2)(1994-2#1)(2008-4#1)
the antigen from##3##3##(1995-11#2)(2008-4#1)
the antigen is##3##3##(1990-12#1)(1994-11#1)(2008-8#1)
the antigen receptor##3##3##(1995-6#2)(2008-4#1)
the antigen specificity of##2##4##(1991-2#1)(2008-4#1)
the antigen##44##2##(1990-12#6)(1991-2#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-11#4)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-2#1)(1997-7#1)(2008-10#7)(2008-11#3)(2008-4#5)(2008-5#1)(2008-8#2)(2012-2#1)
the antigen-antibody reaction##2##3##(2008-10#2)
the antigen-antibody##6##2##(2008-10#4)(2008-4#1)(2009-11#1)
the antigen-binding##2##2##(1995-5#1)(2008-10#1)
the antigen-coated##2##2##(1990-12#1)(1995-12#1)
the antigen-combining site##5##3##(1995-5#5)
the antigen-presenting##2##2##(2008-4#1)(2008-8#1)
the antigen-specific##2##2##(2008-10#1)(2008-11#1)
the antigenic target##2##3##(1993-1#1)(2008-4#1)
the antigenic##20##2##(1990-8#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(2008-2#1)(2008-4#2)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#2)
the antigenicity##3##2##(1994-9#1)(2008-10#1)(2013-8#1)
the antigens of##3##3##(1997-1#1)(2008-5#1)(2009-5#1)
the antigens##11##2##(1990-12#2)(1994-3#1)(1995-5#2)(1997-1#2)(2008-4#1)(2008-5#2)(2009-5#1)
the antiherpetic##2##2##(1995-6#1)(2010-3#1)
the antihyperglycemic##2##2##(1995-11#1)(2012-2#1)
the antihypertensive##7##2##(1990-8#1)(1992-8#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-3#1)
the antiinflammatory##2##2##(1993-11#1)(2008-11#1)
the antiischemic action of##2##4##(1994-6#2)
the antimalarial##4##2##(1994-12#1)(1994-8#1)(2008-10#1)(2010-1#1)
the antimetamorphic action of JH##2##5##(2012-2#2)
the antimicrobial activity of##4##4##(2008-11#1)(2008-5#1)(2010-5#2)
the antimicrobial activity##5##3##(2008-11#1)(2008-5#1)(2010-5#2)(2012-3#1)
the antimicrobial resistance patterns of the##2##6##(1991-8#1)(2007-7#1)
the antimicrobial resistance patterns##3##4##(1991-8#1)(2007-7#1)(2012-2#1)
the antimicrobial resistance##4##3##(1991-8#1)(2007-7#1)(2012-12#1)(2012-2#1)
the antimicrobial##15##2##(1991-8#1)(1994-11#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the antimutagenic system##2##3##(2008-7#2)
the antimutagenic##3##2##(2008-4#1)(2008-7#2)
the antinociception##2##2##(1996-2#2)
the antinociceptive and ventilatory effects of##2##6##(1996-2#2)
the antinociceptive and##4##3##(1996-2#2)(2008-11#1)(2008-7#1)
the antinociceptive effect of buprenorphine##2##5##(2008-11#2)
the antinociceptive effect of morphine##2##5##(1996-2#2)
the antinociceptive effect of##4##4##(1996-2#2)(2008-11#2)
the antinociceptive effect##5##3##(1996-2#2)(2008-11#2)(2010-5#1)
the antinociceptive##9##2##(1996-2#4)(2008-11#3)(2008-7#1)(2010-5#1)
the antioxidant activity of##8##4##(1992-9#1)(2008-10#5)(2009-6#1)(2013-1#1)
the antioxidant activity##10##3##(1992-9#1)(2008-10#6)(2009-6#1)(2013-1#1)(2013-8#1)
the antioxidant capacity of##4##4##(2008-10#3)(2012-1#1)
the antioxidant effect##2##3##(1995-12#1)(2008-10#1)
the antioxidant network##2##3##(2008-2#2)
the antioxidant potential##2##3##(2008-10#1)(2012-2#1)
the antioxidant properties of##3##4##(2008-10#2)(2011-2#1)
the antioxidant system##3##3##(2008-7#1)(2010-5#1)(2012-6#1)
the antioxidant##57##2##(1991-9#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#17)(2008-11#2)(2008-2#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#2)(2009-8#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#4)
the antioxidants##8##2##(1992-9#1)(1993-2#1)(2008-10#4)(2008-5#2)
the antioxidative##6##2##(1991-12#1)(2008-11#4)(2008-5#1)
the antiphase##2##2##(1990-11#1)(2008-3#1)
the antiproliferative activity##2##3##(1990-12#1)(1991-4#1)
the antiproliferative effect of GC7##2##5##(1997-1#2)
the antiproliferative effect of##5##4##(1990-11#1)(1990-12#1)(1995-2#1)(1997-1#2)
the antiproliferative##8##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-4#1)(1995-2#1)(1997-1#2)
the antipsychotic##4##2##(1996-7#1)(1997-7#1)(2008-11#1)(2008-6#1)
the antiretroviral##2##2##(1992-6#1)(2012-12#1)
the antisense transcript##2##3##(1992-8#1)(1994-11#1)
the antisense##11##2##(1991-9#1)(1992-8#4)(1994-10#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
the antisera only##2##3##(2008-10#1)(2008-5#1)
the antisera##5##2##(1994-6#1)(1995-8#1)(2008-10#1)(2008-5#1)(2010-6#1)
the antiserum##5##2##(1992-9#1)(1994-8#1)(2007-12#1)(2008-4#2)
the antithetic##2##2##(2009-6#1)(2011-2#1)
the antithrombotic activity##3##3##(1997-7#1)(2006-6#2)
the antithrombotic##4##2##(1997-7#1)(2006-6#2)(2007-11#1)
the antitrust laws##4##3##(1992-12#1)(1993-1#2)(1994-2#1)
the antitumor drug##2##3##(1991-6#1)(1993-8#1)
the antitumor effects##2##3##(1991-12#1)(2013-7#1)
the antitumor##8##2##(1991-12#1)(1991-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-4#1)(2013-1#1)(2013-7#1)
the antitumoral##2##2##(1991-8#1)(1992-5#1)
the antivenoms##3##2##(2008-5#3)
the antiviral activity of##3##4##(1990-2#2)(1994-11#1)
the antiviral drug##2##3##(1994-6#1)(1995-6#1)
the antiviral##13##2##(1990-10#1)(1990-2#2)(1994-11#4)(1994-6#1)(1995-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the antral##2##2##(2007-12#1)(2013-1#1)
the ants##3##2##(2008-6#3)
the anurans##2##2##(1997-3#2)
the anxiety##8##2##(1991-2#1)(1994-2#1)(2007-6#1)(2008-11#2)(2009-7#1)(2010-5#1)(2013-1#1)
the anxiolytic effects of##2##4##(1992-7#1)(1994-2#1)
the anxiolytic##5##2##(1992-7#1)(1994-2#1)(2008-10#1)(2008-11#2)
the aorta and its branches##2##5##(1997-8#2)
the aorta and its##3##4##(1997-8#3)
the aorta and##5##3##(1997-8#3)(2008-3#1)(2012-1#1)
the aorta of##3##3##(1991-9#2)(2009-11#1)
the aorta to supply##2##4##(2007-12#2)
the aorta##37##2##(1990-2#1)(1991-9#4)(1993-6#2)(1996-11#1)(1997-1#1)(1997-8#5)(2007-11#2)(2007-12#3)(2007-8#5)(2008-3#2)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-3#1)
the aortic arch and##2##4##(1997-8#1)(2008-8#1)
the aortic arch was##2##4##(2007-8#2)
the aortic arch##12##3##(1997-8#1)(2007-8#5)(2008-8#4)(2010-7#1)(2010-8#1)
the aortic pre-ejection time##2##4##(2008-10#2)
the aortic valve##4##3##(1990-11#1)(1997-5#1)(2007-8#1)(2012-2#1)
the aortic wall##3##3##(1997-8#1)(2009-7#1)(2010-8#1)
the aortic##32##2##(1990-11#1)(1991-5#1)(1991-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-7#1)(2007-8#9)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#4)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)
the aortomitral angle##2##3##(2008-10#2)
the ape chromosomes##2##3##(1997-6#2)
the aperture field##2##3##(2011-2#2)
the aperture size of the##2##5##(2008-2#2)
the aperture size##3##3##(2007-12#1)(2008-2#2)
the aperture##22##2##(2007-11#2)(2007-12#3)(2008-2#7)(2008-3#8)(2011-2#2)
the aperture-focus distance##2##3##(2008-3#2)
the aperture-interface distance##2##3##(2008-3#2)
the apertured##2##2##(2008-3#2)
the apertures##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the apex of the##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
the apex of##7##3##(2007-11#1)(2007-12#1)(2007-8#2)(2008-5#1)(2008-7#1)(2012-2#1)
the apex##19##2##(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
the apheresis##2##2##(1994-12#2)
the aphid Acyrthosiphon pisum##2##4##(1996-12#1)(2007-12#1)
the aphid Rhopalosiphum##2##3##(2008-10#2)
the aphid that inoculated the##2##5##(2008-10#2)
the aphid vector##2##3##(2008-10#2)
the aphid##19##2##(1996-12#4)(2007-12#3)(2008-10#10)(2008-5#1)(2011-2#1)
the aphid-transmitted isolates##2##3##(2008-10#2)
the apical ES##7##3##(2012-2#7)
the apical and basal##2##4##(2007-12#1)(2012-2#1)
the apical and##4##3##(2007-12#1)(2008-9#1)(2012-2#2)
the apical cell membrane##2##4##(2007-12#2)
the apical cell##4##3##(2007-12#2)(2008-9#1)(2009-8#1)
the apical ectoplasmic specialization##2##4##(2012-2#2)
the apical membrane of the##3##5##(1992-5#1)(2008-4#1)(2008-6#1)
the apical membrane of##4##4##(1992-5#1)(2008-4#2)(2008-6#1)
the apical membrane##5##3##(1992-5#1)(2008-4#3)(2008-6#1)
the apical portion of the##2##5##(2007-12#1)(2013-1#1)
the apical position##2##3##(1997-7#1)(2007-12#1)
the apical region of##3##4##(1995-11#2)(2013-1#1)
the apical surface##4##3##(1991-12#1)(1995-8#1)(2007-12#1)(2008-1#1)
the apical##63##2##(1991-12#1)(1992-5#1)(1995-11#2)(1995-8#1)(1997-1#1)(1997-7#1)(2007-12#7)(2008-1#2)(2008-10#3)(2008-11#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-7#2)(2009-8#1)(2010-3#1)(2012-1#1)(2012-2#14)(2013-1#6)(2013-8#1)
the apo and##2##3##(1991-12#1)(2009-7#1)
the apo structure##3##3##(1991-12#1)(2010-10#2)
the apo##10##2##(1991-12#2)(1993-6#1)(1993-8#1)(1994-3#1)(1997-8#2)(2009-7#1)(2010-10#2)
the apo(a)##2##2##(1992-3#1)(1993-3#1)
the apo(a)-EIA##2##2##(1993-2#2)
the apo-E gene##2##3##(2008-10#2)
the apo-E##3##2##(2008-10#3)
the apoA-IV-1##2##2##(1990-8#1)(1991-8#1)
the apoA-IV-3 allele##2##3##(1990-8#1)(1991-8#1)
the apoB##2##2##(1990-7#1)(1994-8#1)
the apoE##3##2##(1995-6#3)
the apodization##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
the apoenzyme##2##2##(1990-11#1)(1993-6#1)
the apolipoprotein B gene##3##4##(1990-7#1)(1995-2#1)(1997-8#1)
the apolipoprotein E##3##3##(1995-5#1)(2008-4#1)(2008-7#1)
the apolipoprotein##7##2##(1990-7#1)(1993-6#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-4#1)(2008-7#1)
the apomictic parent##2##3##(2008-5#2)
the aponeurosis##2##2##(2008-10#1)(2009-3#1)
the apoprotein##5##2##(1990-8#2)(1991-12#1)(1992-10#1)(1993-8#1)
the apoptosis and##2##3##(2008-11#1)(2013-7#1)
the apoptosis of##3##3##(2008-11#2)(2009-4#1)
the apoptosis##12##2##(1995-6#1)(2008-10#1)(2008-11#5)(2008-9#1)(2009-4#1)(2011-2#2)(2013-7#1)
the apoptotic cell##2##3##(2010-10#1)(2011-2#1)
the apoptotic effects of##2##4##(1995-2#1)(2008-11#1)
the apoptotic machinery##2##3##(2008-8#1)(2009-12#1)
the apoptotic process##2##3##(2008-9#1)(2009-3#1)
the apoptotic program in##2##4##(2008-1#1)(2012-1#1)
the apoptotic##23##2##(1995-12#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#2)(2011-2#1)(2012-1#1)(2013-1#1)
the apparatus##11##2##(1990-8#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-3#7)
the apparent K(m) for exogenous ADP##2##6##(2008-7#2)
the apparent K(m) for##3##4##(2008-7#3)
the apparent K(m)##5##3##(2008-7#5)
the apparent Km##6##3##(1990-11#1)(1992-3#1)(1992-6#2)(1995-5#1)(1997-2#1)
the apparent activation##2##3##(1991-2#1)(1992-3#1)
the apparent affinity of##3##4##(1990-7#1)(1995-11#1)(1995-12#1)
the apparent affinity##4##3##(1990-7#1)(1995-11#1)(1995-12#2)
the apparent binding##6##3##(1991-5#1)(1994-3#1)(1997-2#1)(1997-7#1)(2008-10#2)
the apparent diffusion coefficient (ADC)##2##5##(1996-5#1)(2008-11#1)
the apparent diffusion coefficient##5##4##(1996-5#1)(2008-10#2)(2008-11#1)(2010-12#1)
the apparent infection rate##3##4##(2008-10#3)
the apparent molar##5##3##(2008-10#5)
the apparent molecular mass of the##3##6##(1990-7#1)(1995-6#2)
the apparent molecular mass of##6##5##(1990-5#1)(1990-7#1)(1992-10#1)(1995-6#2)(1997-2#1)
the apparent optical properties of##2##5##(2008-2#1)(2008-3#1)
the apparent optical properties##3##4##(2008-2#2)(2008-3#1)
the apparent permeability##2##3##(1990-11#2)
the apparent specific##2##3##(2008-10#2)
the apparent viscosity and##2##4##(2008-5#1)(2011-2#1)
the apparent viscosity##4##3##(2008-5#3)(2011-2#1)
the apparent##119##2##(1990-11#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-5#2)(1992-6#3)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-2#6)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#35)(2008-11#4)(2008-2#4)(2008-3#4)(2008-5#4)(2008-7#5)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)
the apparently##6##2##(1991-9#1)(2008-10#1)(2009-8#2)(2010-6#1)(2012-3#1)
the appeals court##2##3##(1996-5#2)
the appeals##3##2##(1995-6#1)(1996-5#2)
the appearance and##2##3##(1995-2#1)(1997-8#1)
the appearance of a &quot##2##5##(1994-5#1)(2009-2#1)
the appearance of a new##3##5##(1992-8#1)(2008-10#1)(2008-9#1)
the appearance of a second##2##5##(1992-10#1)(2008-3#1)
the appearance of a##15##4##(1991-6#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-5#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)
the appearance of degenerative changes##2##5##(1997-3#1)(2007-8#1)
the appearance of new##2##4##(2008-10#1)(2011-2#1)
the appearance of skin##2##4##(2008-5#1)(2008-7#1)
the appearance of the first##3##5##(2008-10#2)(2012-2#1)
the appearance of the##16##4##(1991-6#1)(1994-11#2)(1996-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#3)(2009-12#1)(2009-5#1)(2012-2#2)
the appearance of two##2##4##(1993-8#1)(2008-10#1)
the appearance of##115##3##(1990-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
the appearance ofa##2##3##(2008-11#1)(2013-8#1)
the appearance##121##2##(1990-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the appearence of##2##3##(1997-9#1)(2008-2#1)
the appendage##2##2##(2007-12#1)(2007-8#1)
the appendiceal wall##2##3##(2009-7#1)(2011-2#1)
the appendicular skeleton##2##3##(2010-3#1)(2011-2#1)
the appendicular##6##2##(1991-11#1)(2007-12#2)(2010-3#1)(2011-2#2)
the appendix##18##2##(1990-8#1)(1992-2#1)(1993-12#2)(1993-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2009-7#4)(2011-2#4)(2013-1#1)
the applanation##3##2##(2008-3#3)
the apple pectin##2##3##(2008-10#2)
the apple proliferation##3##3##(2008-10#3)
the apple sooty blotch##2##4##(2008-10#2)
the apple##13##2##(1996-2#1)(2008-10#10)(2008-11#2)
the applicability of such##2##4##(1993-6#1)(2007-8#1)
the applicability of the method to##2##6##(2008-10#2)
the applicability of the method##4##5##(2008-10#3)(2008-3#1)
the applicability of the proposed method##3##6##(2008-10#3)
the applicability of the proposed##4##5##(1997-8#1)(2008-10#3)
the applicability of the##19##4##(1993-1#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)
the applicability of this method##2##5##(2008-10#1)(2009-12#1)
the applicability of this##5##4##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
the applicability of##45##3##(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#14)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2009-12#2)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
the applicability to##2##3##(2008-10#1)(2008-3#1)
the applicability##49##2##(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#15)(2008-2#4)(2008-3#6)(2008-5#1)(2008-8#1)(2009-12#2)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
the applicable##7##2##(1991-1#1)(1991-2#1)(1992-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
the applicant##2##2##(1992-5#1)(1995-5#1)
the applicants##4##2##(1992-5#1)(1995-5#1)(1997-3#2)
the application and##2##3##(2008-10#1)(2008-5#1)
the application for##3##3##(1992-5#1)(2008-10#1)(2008-3#1)
the application in##3##3##(2007-11#1)(2009-10#1)(2013-8#1)
the application of SPA technology to##2##6##(2008-4#2)
the application of a##27##4##(1992-2#1)(1993-2#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#2)
the application of acetone##2##4##(2008-2#1)(2009-12#1)
the application of an external##3##5##(2008-2#1)(2008-7#2)
the application of an##11##4##(1993-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2012-1#1)
the application of both##2##4##(1996-12#1)(2008-10#1)
the application of cancer control science##2##6##(1997-1#2)
the application of data##2##4##(2008-10#1)(2008-9#1)
the application of different##2##4##(2008-10#2)
the application of genetic##2##4##(1994-9#1)(2007-7#1)
the application of immunohistochemistry##2##4##(1997-3#1)(2010-8#1)
the application of molecular##2##4##(2008-10#1)(2011-1#1)
the application of new##3##4##(2008-11#1)(2009-8#1)(2010-11#1)
the application of standard##2##4##(2008-2#1)(2008-4#1)
the application of such##3##4##(2008-2#1)(2009-12#1)(2010-10#1)
the application of the hybrid method##2##6##(2008-3#2)
the application of the method##2##5##(1997-7#1)(2007-10#1)
the application of the new##2##5##(1992-9#1)(2008-7#1)
the application of the proposed##2##5##(2008-10#2)
the application of the##51##4##(1990-9#1)(1991-11#1)(1992-9#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#4)(2013-1#4)(2013-8#1)
the application of these methods##2##5##(2008-8#1)(2008-9#1)
the application of these techniques to##2##6##(2008-8#1)(2010-9#1)
the application of these techniques##3##5##(2008-7#1)(2008-8#1)(2010-9#1)
the application of these##11##4##(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-9#1)(2012-2#1)
the application of this technique in##2##6##(1993-10#1)(2013-1#1)
the application of this##10##4##(1990-3#1)(1993-10#1)(1994-3#1)(1994-5#1)(1996-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
the application of total##2##4##(2007-8#1)(2008-12#1)
the application of##312##3##(1990-3#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#3)(1992-2#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-1#3)(1997-3#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#72)(2008-11#22)(2008-12#6)(2008-2#15)(2008-3#22)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#8)(2009-10#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#12)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#10)(2013-8#3)
the application scope of##2##4##(2008-10#1)(2011-1#1)
the application to##3##3##(2008-10#3)
the application##352##2##(1990-3#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-12#3)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-1#3)(1997-3#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#85)(2008-11#22)(2008-12#6)(2008-2#15)(2008-3#26)(2008-4#8)(2008-5#12)(2008-6#2)(2008-7#14)(2008-8#7)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#6)(2013-1#13)(2013-8#4)
the applications in##2##3##(2008-3#1)(2008-5#1)
the applications of these##2##4##(2008-7#1)(2011-2#1)
the applications of##11##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2011-7#1)
the applications##21##2##(1990-8#1)(1992-5#1)(1994-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-7#1)(2011-2#1)(2011-7#1)
the applied electric##2##3##(2009-12#1)(2013-1#1)
the applied potential##6##3##(2008-10#6)
the applied pressure##2##3##(2010-12#1)(2010-4#1)
the applied treatment##3##3##(2007-8#1)(2008-10#2)
the applied voltage##7##3##(2008-10#2)(2008-2#3)(2013-8#2)
the applied##56##2##(1994-9#1)(1995-3#2)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#26)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#2)
the appliqués##2##2##(2008-3#2)
the appointment of##2##3##(1992-12#1)(1997-8#1)
the appointment##5##2##(1992-12#1)(1993-6#1)(1997-8#1)(2013-1#1)(2013-8#1)
the appraisals of daily##2##4##(2012-1#2)
the appreciation of##4##3##(1993-12#1)(2008-1#1)(2008-8#1)(2008-9#1)
the apprentice's##2##2##(2008-7#2)
the approach allows##2##3##(2008-9#1)(2009-10#1)
the approach and##6##3##(1993-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-3#1)(2013-1#1)
the approach gives##2##3##(2008-3#1)(2012-2#1)
the approach is##8##3##(1996-5#1)(2008-10#3)(2008-12#1)(2008-3#2)(2012-2#1)
the approach of the##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
the approach of##8##3##(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
the approach presented##2##3##(2008-3#1)(2008-7#1)
the approach taken##2##3##(1991-12#1)(2008-11#1)
the approach to a##2##4##(1993-6#1)(2008-11#1)
the approach to the##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
the approach to##18##3##(1991-2#1)(1993-6#1)(1995-1#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
the approach used in##2##4##(1996-8#1)(2008-3#1)
the approach with##3##3##(1995-2#1)(2008-10#1)(2009-9#1)
the approach##81##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-9#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#2)
the approaches of##3##3##(2008-6#1)(2008-8#1)(2012-3#1)
the approaches that##4##3##(1994-1#1)(2008-11#1)(2009-11#1)(2011-2#1)
the approaches used##2##3##(2008-12#1)(2013-1#1)
the approaches##17##2##(1994-1#1)(1994-11#1)(1997-2#2)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the appropriate administrative##2##3##(1994-3#1)(1997-3#1)
the appropriate antibiotic##2##3##(1994-12#1)(1996-6#1)
the appropriate clinical##2##3##(2008-6#1)(2012-3#1)
the appropriate combination of##2##4##(1993-11#1)(2008-10#1)
the appropriate fusion##2##3##(1990-5#1)(1995-12#1)
the appropriate imaging##2##3##(2008-8#1)(2012-1#1)
the appropriate management##2##3##(2008-1#1)(2008-9#1)
the appropriate number of##2##4##(1992-9#1)(2013-8#1)
the appropriate patient##2##3##(2008-5#1)(2009-12#1)
the appropriate sample size##2##4##(1995-3#1)(2008-10#1)
the appropriate sample##3##3##(1995-3#1)(2008-10#2)
the appropriate setting##2##3##(1994-12#1)(2010-12#1)
the appropriate steps to##2##4##(2007-11#1)(2008-9#1)
the appropriate stimulation##2##3##(2008-9#1)(2012-12#1)
the appropriate treatment##2##3##(2011-2#1)(2012-2#1)
the appropriate type of##2##4##(2007-11#1)(2008-4#1)
the appropriate use of preventive##2##5##(1994-2#2)
the appropriate use of##4##4##(1994-2#2)(2007-2#1)(2011-2#1)
the appropriate utilization of##2##4##(1994-12#1)(2008-3#1)
the appropriate##148##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#3)(1994-3#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#3)(1997-7#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#5)
the appropriateness of a##2##4##(2008-12#1)(2010-11#1)
the appropriateness of the##3##4##(1991-12#1)(1992-1#1)(2007-2#1)
the appropriateness of using##2##4##(1995-5#1)(2008-11#1)
the appropriateness of##14##3##(1991-12#1)(1992-1#1)(1995-5#1)(1996-2#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-8#1)
the appropriateness##15##2##(1991-12#1)(1992-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-8#1)
the appropriation##2##2##(1995-6#2)
the approval of##5##3##(1993-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-4#1)
the approval##8##2##(1991-3#1)(1993-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#1)(2010-4#1)
the approximate##16##2##(1992-4#1)(1992-6#1)(1997-4#1)(1997-7#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#1)
the approximately##13##2##(1990-5#1)(1990-8#1)(1993-8#1)(1995-2#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-5#1)
the approximation is##2##3##(2007-12#1)(2008-3#1)
the approximation##14##2##(1990-8#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-9#1)(2012-1#1)(2013-1#1)
the approximations##2##2##(2008-2#1)(2008-3#1)
the aprX mutant##2##3##(2008-10#2)
the aprX##3##2##(2008-10#3)
the apricot##2##2##(2008-10#1)(2012-8#1)
the aqua regia extraction##3##4##(2008-10#3)
the aqua regia##4##3##(2008-10#4)
the aquatic environment##6##3##(2008-10#4)(2008-11#1)(2010-8#1)
the aquatic habitat##3##3##(2008-9#2)(2011-2#1)
the aquatic macrophyte Stratiotes aloides##2##5##(2010-6#2)
the aquatic macrophyte##3##3##(2010-6#2)(2013-7#1)
the aquatic##23##2##(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#4)(2010-6#2)(2010-8#1)(2011-2#1)(2013-7#2)
the aquation process##2##3##(2008-10#2)
the aquation##3##2##(2008-10#3)
the aqueous and ethanol##2##4##(2010-3#2)
the aqueous and##6##3##(1994-5#1)(2008-10#1)(2010-3#2)(2010-4#2)
the aqueous environment##2##3##(1995-12#1)(2008-10#1)
the aqueous extract of##4##4##(2008-5#1)(2010-3#1)(2011-1#2)
the aqueous extract##5##3##(2008-11#1)(2008-5#1)(2010-3#1)(2011-1#2)
the aqueous glucose##3##3##(2008-2#3)
the aqueous ion-pair formation (K(MLA))##2##5##(2008-10#2)
the aqueous layer##3##3##(2008-10#2)(2009-4#1)
the aqueous phase and##5##4##(2008-10#4)(2010-4#1)
the aqueous phase as a##2##5##(2008-10#1)(2008-7#1)
the aqueous phase##31##3##(1990-5#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-2#1)(2008-10#21)(2008-5#2)(2008-7#2)(2010-4#1)
the aqueous sample##2##3##(2008-10#2)
the aqueous samples##2##3##(2008-10#2)
the aqueous solution was##2##4##(2008-10#2)
the aqueous solution##10##3##(1997-2#1)(2008-10#8)(2008-5#1)
the aqueous solutions##3##3##(2008-10#3)
the aqueous to##2##3##(2008-10#2)
the aqueous##108##2##(1990-5#1)(1991-5#3)(1992-3#1)(1992-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#64)(2008-11#2)(2008-12#3)(2008-2#3)(2008-5#4)(2008-6#2)(2008-7#2)(2009-4#1)(2010-3#3)(2010-4#3)(2011-1#2)(2012-2#1)(2013-7#2)
the aquo-met##3##2##(1995-3#3)
the arabinose strain##2##3##(2008-6#2)
the arbitrarily##2##2##(1993-12#1)(2007-12#1)
the arbuscular##2##2##(2008-10#1)(2010-10#1)
the arc discharge composite##3##4##(2008-10#3)
the arc discharge##4##3##(2008-10#4)
the arc##5##2##(2008-10#4)(2008-5#1)
the archaeological##2##2##(2008-10#2)
the archetypal##3##2##(1990-8#1)(1993-2#1)(2008-7#1)
the archetype##2##2##(1996-2#1)(2007-12#1)
the architectural##3##2##(1995-8#1)(1996-2#1)(2008-3#1)
the architecture of the##5##4##(1993-5#1)(1994-2#1)(1997-4#1)(2009-6#1)(2011-1#1)
the architecture of##8##3##(1993-5#1)(1994-2#1)(1997-4#1)(2008-2#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#1)
the architecture##14##2##(1991-11#1)(1993-5#1)(1994-2#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#1)
the archival##2##2##(1992-1#1)(1996-3#1)
the arcjet plume##4##3##(2008-3#4)
the arcjet##6##2##(2008-2#2)(2008-3#4)
the arcjet's##2##2##(2008-3#2)
the arctic##3##2##(1991-5#1)(2010-6#1)(2012-3#1)
the arcuate nucleus of the hypothalamus##2##6##(1993-5#1)(1996-12#1)
the arcuate nucleus##7##3##(1993-5#5)(1994-2#1)(1996-12#1)
the arcuate##9##2##(1993-5#5)(1994-2#1)(1996-12#1)(2008-4#1)(2008-7#1)
the area and##3##3##(1995-6#1)(2008-10#1)(2009-4#1)
the area are##2##3##(2007-5#1)(2008-12#1)
the area around the##2##4##(1992-1#1)(2008-5#1)
the area around##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
the area irradiated##2##3##(1997-3#1)(2008-10#1)
the area is##2##3##(2008-10#1)(2008-11#1)
the area of artificial##2##4##(2009-11#1)(2012-1#1)
the area of interest##2##4##(2007-11#1)(2008-10#1)
the area of sexual##2##4##(1996-12#1)(2010-3#1)
the area of the##20##4##(1991-2#1)(1991-3#1)(1992-6#1)(1993-3#1)(1997-3#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#1)
the area of##96##3##(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#3)(2009-3#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
the area the##2##3##(2008-10#2)
the area to##3##3##(1992-2#1)(1995-3#1)(2008-10#1)
the area under the curve (AUC)##3##6##(2008-11#1)(2012-12#1)(2012-3#1)
the area under the curve##6##5##(1992-9#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
the area under the disease progress curve (AUDPC)##3##8##(2008-10#3)
the area under the disease progress curve##6##7##(2008-10#6)
the area under the receiver operating curve##2##7##(2012-3#1)(2013-1#1)
the area under the##21##4##(1990-7#1)(1992-9#1)(2008-10#10)(2008-11#1)(2008-3#1)(2009-12#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
the area under##24##3##(1990-7#1)(1992-9#1)(1997-3#1)(2008-10#12)(2008-11#1)(2008-3#1)(2009-12#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
the area where##4##3##(1993-6#1)(1995-1#1)(2008-10#2)
the area##189##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-1#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#4)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#35)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#8)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#4)(2012-12#5)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#5)(2013-7#3)(2013-8#1)
the areas for##2##3##(1992-2#1)(1995-5#1)
the areas of potential##2##4##(1991-1#1)(1991-2#1)
the areas of##31##3##(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-2#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-7#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the areas where##3##3##(1997-8#1)(2008-7#2)
the areas##50##2##(1991-1#1)(1991-2#1)(1992-2#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-8#1)(2007-2#2)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#3)(2009-4#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the arena of##3##3##(2007-5#1)(2009-3#1)(2012-3#1)
the arena##4##2##(2007-5#1)(2008-11#1)(2009-3#1)(2012-3#1)
the arginine##3##2##(1995-2#1)(2008-5#1)(2008-7#1)
the argon beam coagulator##3##4##(1993-12#2)(1994-3#1)
the argon##4##2##(1993-12#2)(1994-3#1)(2008-10#1)
the argon/water interface##4##3##(1994-3#4)
the argument for##2##3##(1996-1#2)
the argument that##5##3##(1995-6#1)(1997-1#1)(2008-8#2)(2010-3#1)
the argument##12##2##(1995-6#1)(1996-1#2)(1997-1#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#3)(2010-3#1)(2012-12#1)
the arguments##3##2##(1996-2#1)(2008-9#1)(2011-2#1)
the arithmetic##2##2##(2007-12#1)(2009-11#1)
the arm as##2##3##(2008-7#1)(2011-2#1)
the arm cavity##2##3##(2008-2#2)
the arm was##2##3##(1993-6#1)(2007-11#1)
the arm##22##2##(1990-11#1)(1993-6#2)(1994-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
the armamentarium of the reconstructive surgeon##2##6##(2007-12#2)
the armamentarium of the##3##4##(2007-12#2)(2011-2#1)
the armamentarium of##4##3##(2007-12#2)(2011-2#1)(2012-3#1)
the arms of##3##3##(1996-2#1)(2007-7#1)(2012-2#1)
the arms##8##2##(1996-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-3#1)(2010-6#1)(2012-2#1)
the aroma##3##2##(2008-10#3)
the aromatase##5##2##(1991-5#1)(1993-8#3)(2008-5#1)
the aromatic ring##5##3##(1993-12#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
the aromatic##15##2##(1992-6#1)(1993-12#1)(1993-8#1)(1996-5#1)(2008-10#7)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
the arotinoid##3##2##(1993-9#3)
the arrangement of the##2##4##(2008-7#2)
the arrangement of##5##3##(1994-5#1)(2008-7#3)(2009-8#1)
the arrangement##9##2##(1993-12#1)(1994-5#1)(1996-3#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-8#1)
the array and##3##3##(2008-10#2)(2012-3#1)
the array is##2##3##(2008-2#1)(2008-3#1)
the array of##5##3##(1991-3#1)(2008-10#1)(2009-5#1)(2009-6#1)(2011-2#1)
the array to##2##3##(2008-10#1)(2012-3#1)
the array was##2##3##(2008-10#1)(2011-2#1)
the array##30##2##(1991-3#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-3#3)
the arrays##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
the arrest of##2##3##(1992-6#1)(2007-7#1)
the arrested polymerase##2##3##(1994-8#2)
the arrested##10##2##(1991-2#1)(1992-3#1)(1994-8#2)(2007-12#1)(2007-8#4)(2008-11#1)
the arrival of##2##3##(2008-9#1)(2009-8#1)
the arrival##3##2##(2008-1#1)(2008-9#1)(2009-8#1)
the arsenic and selenium##2##4##(2008-10#2)
the arsenic and##3##3##(2008-10#3)
the arsenic species##6##3##(2008-10#6)
the arsenic##21##2##(2008-10#17)(2009-7#1)(2011-2#2)(2013-1#1)
the arsine##2##2##(2008-10#2)
the art of##10##3##(1997-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
the art##39##2##(1991-9#1)(1993-3#2)(1994-8#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
the arterial and##3##3##(1990-2#1)(2007-7#1)(2008-7#1)
the arterial blood##2##3##(1991-6#1)(1993-12#1)
the arterial lumen##3##3##(1990-5#1)(1997-4#1)(2008-7#1)
the arterial perfusion##2##3##(2008-7#1)(2012-2#1)
the arterial system##3##3##(2008-3#1)(2008-9#2)
the arterial vasodilatation##2##3##(1997-7#2)
the arterial wall and##2##4##(2008-6#1)(2008-9#1)
the arterial wall##11##3##(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2011-2#1)(2013-1#1)
the arterial##40##2##(1990-2#1)(1990-5#1)(1991-6#1)(1993-1#1)(1993-12#1)(1995-8#1)(1997-4#1)(1997-7#2)(1997-8#2)(2006-6#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#8)(2008-9#4)(2009-1#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
the arteries of##2##3##(1991-3#1)(2008-2#1)
the arteries##4##2##(1991-3#1)(2007-8#1)(2008-2#1)(2008-7#1)
the arterioarterial graft##2##3##(2008-1#2)
the arteriovenous malformation##2##3##(2008-7#2)
the arteriovenous##4##2##(1993-6#1)(2008-7#2)(2011-3#1)
the artery and##2##3##(2008-4#1)(2008-7#1)
the artery##13##2##(1995-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#2)(2012-3#1)
the arthrodesis##2##2##(2008-6#1)(2012-3#1)
the arthroplasty##4##2##(2007-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
the arthropod##10##2##(2007-12#5)(2008-6#3)(2008-9#1)(2011-2#1)
the article &quot##2##3##(1995-2#1)(2008-7#1)
the article also##2##3##(1993-1#1)(2011-2#1)
the article are##2##3##(2010-11#1)(2012-3#1)
the article by##2##3##(1990-8#1)(1995-2#1)
the article describes##3##3##(1993-3#1)(1994-1#1)(2012-12#1)
the article discusses the##3##4##(1990-12#1)(1994-1#2)
the article includes##2##3##(1994-1#1)(2008-12#1)
the article provides##2##3##(1995-12#1)(2008-12#1)
the article##74##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-1#1)(1993-3#3)(1993-6#1)(1994-1#5)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-6#1)(2008-7#6)(2009-10#1)(2009-4#2)(2009-5#3)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
the articles published in this issue of the Review##2##9##(1997-2#1)(1997-3#1)
the articles##12##2##(1992-6#2)(1994-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
the articular cavity##2##3##(2007-11#2)
the articular##8##2##(1997-6#1)(2007-11#4)(2008-8#2)(2012-3#1)
the articulation##2##2##(2008-12#1)(2013-1#1)
the artifact##3##2##(2008-3#3)
the artificial electron##2##3##(1995-2#1)(2008-11#1)
the artificial neural##2##3##(2008-10#2)
the artificial sandbar opening##2##4##(2013-7#2)
the artificial sandbar##3##3##(2013-7#3)
the artificial##29##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-9#1)(1992-12#1)(1995-2#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#4)(2011-2#1)(2012-1#2)(2013-7#3)
the artificially##2##2##(1992-8#1)(2008-5#1)
the artisanal##4##2##(2008-5#1)(2013-7#3)
the aryl hydrocarbon receptor##5##4##(2008-10#2)(2008-7#2)(2013-1#1)
the aryl hydrocarbon##6##3##(1995-11#1)(2008-10#2)(2008-7#2)(2013-1#1)
the aryl##7##2##(1992-6#1)(1995-11#1)(2008-10#2)(2008-7#2)(2013-1#1)
the as-prepared##2##2##(2008-10#1)(2013-1#1)
the asbestos##2##2##(1991-12#2)
the ascending aorta undergoing coronary surgery##2##6##(2007-8#2)
the ascending aorta was##4##4##(1997-5#1)(2007-8#3)
the ascending aorta##29##3##(1997-5#4)(1997-8#2)(2007-8#18)(2008-11#1)(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#1)
the ascending colon##2##3##(1993-9#1)(2006-8#1)
the ascending##36##2##(1993-9#1)(1996-9#1)(1997-5#4)(1997-8#2)(2006-8#1)(2007-8#18)(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-3#2)
the ascidian##3##2##(1993-6#1)(2008-6#1)(2008-7#1)
the ascites##6##2##(1991-4#2)(1997-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
the ascitic fluid##3##3##(2007-12#2)(2008-1#1)
the ascomycete fungus##2##3##(2008-10#1)(2011-1#1)
the ascomycete##5##2##(2008-10#4)(2011-1#1)
the ascorbate##3##2##(1990-2#1)(1990-9#2)
the ascorbic acid##4##3##(1992-11#1)(2008-10#3)
the asexual##4##2##(2008-10#4)
the ash content##2##3##(2008-10#2)
the ash##4##2##(2008-10#4)
the ashing##2##2##(2008-10#2)
the asialoglycoprotein receptor##3##3##(1993-11#1)(1995-2#1)(2008-8#1)
the aspartate receptor and the trp repressor##2##7##(1992-8#2)
the aspartate receptor##7##3##(1992-8#6)(1992-9#1)
the aspartate##9##2##(1991-12#1)(1992-8#7)(1992-9#1)
the aspartic##2##2##(1990-8#1)(2008-4#1)
the aspect of the##3##4##(1990-11#1)(1996-9#1)(2008-10#1)
the aspect of##9##3##(1990-11#1)(1993-11#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-7#1)
the aspect ratio##2##3##(2007-12#1)(2008-2#1)
the aspect##13##2##(1990-11#1)(1993-11#1)(1995-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2013-7#1)
the aspects of the##2##4##(2011-2#1)(2012-3#1)
the aspects of##13##3##(1993-1#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
the aspects##14##2##(1993-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
the aspiration##3##2##(2008-10#3)
the assay are##3##3##(1992-9#1)(2008-10#1)(2008-9#1)
the assay at##2##3##(1990-12#1)(2011-2#1)
the assay can be used to##2##6##(2008-10#1)(2008-4#1)
the assay can be##3##4##(2008-10#1)(2008-4#1)(2010-5#1)
the assay can##4##3##(1992-9#1)(2008-10#1)(2008-4#1)(2010-5#1)
the assay conditions##5##3##(1990-2#1)(1993-11#1)(1993-8#1)(2008-4#1)(2008-9#1)
the assay for##2##3##(2008-4#1)(2013-1#1)
the assay in the##2##4##(2008-10#1)(2011-1#1)
the assay in this##2##4##(2008-11#1)(2013-8#1)
the assay in##5##3##(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
the assay is carried out##2##5##(2008-10#2)
the assay is##8##3##(1992-9#1)(2008-10#3)(2008-9#2)(2010-2#1)(2011-3#1)
the assay medium##3##3##(1990-12#1)(1996-5#1)(2008-10#1)
the assay of S-perindopril##2##4##(2008-10#2)
the assay of creatinine##2##4##(1992-11#1)(2008-10#1)
the assay of this##2##4##(1990-2#1)(2008-11#1)
the assay of##76##3##(1990-2#1)(1991-11#1)(1991-5#3)(1992-11#1)(1992-6#2)(1994-7#1)(1995-2#1)(1996-12#1)(2008-10#60)(2008-11#1)(2008-4#3)(2008-6#1)
the assay results##3##3##(2008-10#3)
the assay system##2##3##(1993-12#1)(2008-10#1)
the assay was##9##3##(1990-12#1)(1991-12#1)(1992-6#1)(1996-12#1)(2008-10#3)(2008-11#1)(2010-4#1)
the assay##177##2##(1990-12#6)(1990-2#2)(1990-3#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#5)(1992-11#1)(1992-6#5)(1992-9#4)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-7#1)(1995-2#4)(1996-12#4)(1996-5#3)(1997-2#1)(1997-4#2)(2008-1#1)(2008-10#86)(2008-11#6)(2008-12#1)(2008-4#9)(2008-6#1)(2008-9#7)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
the assayed##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
the assays were##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
the assays##21##2##(1992-5#1)(1993-12#1)(1993-2#1)(1995-5#1)(1997-3#1)(2007-7#1)(2008-10#9)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
the assemblage##5##2##(2007-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
the assembled sequence##2##3##(1996-6#2)
the assembled##5##2##(1996-6#2)(2008-10#2)(2008-8#1)
the assembly and function of##2##5##(1995-8#1)(2011-1#1)
the assembly and##3##3##(1990-5#1)(1995-8#1)(2011-1#1)
the assembly of the enzyme##2##5##(1994-8#1)(2008-9#1)
the assembly of the##5##4##(1993-12#1)(1994-8#1)(2008-9#2)(2013-1#1)
the assembly of##25##3##(1990-11#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
the assembly process of##2##4##(1997-4#2)
the assembly process##5##3##(1994-2#2)(1997-4#2)(2011-2#1)
the assembly##41##2##(1990-11#1)(1990-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-8#2)(1997-2#3)(1997-4#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#4)(2008-9#3)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
the assertion that##2##3##(1993-12#1)(2007-12#1)
the assessment and management of##4##5##(2007-10#1)(2010-10#2)(2010-12#1)
the assessment and treatment of##3##5##(2008-10#1)(2008-6#1)(2010-9#1)
the assessment and treatment##4##4##(2008-10#1)(2008-11#1)(2008-6#1)(2010-9#1)
the assessment and##13##3##(1992-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-9#1)(2012-2#1)
the assessment of brain##2##4##(2007-7#1)(2008-7#1)
the assessment of cardiac##3##4##(2008-7#1)(2009-1#1)(2012-2#1)
the assessment of learning##2##4##(2008-11#2)
the assessment of left ventricular##2##5##(2008-12#1)(2009-1#1)
the assessment of left##3##4##(2008-12#1)(2009-1#1)(2011-2#1)
the assessment of long-term##2##4##(2008-11#1)(2008-3#1)
the assessment of new##2##4##(2008-10#1)(2008-9#1)
the assessment of the potential##2##5##(2008-11#1)(2008-8#1)
the assessment of the##28##4##(1990-8#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the assessment of treatment##2##4##(1996-6#1)(2010-12#1)
the assessment of##152##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#4)(1996-6#1)(1997-7#1)(1997-8#3)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#13)(2008-12#3)(2008-3#4)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#1)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
the assessment period##3##3##(2012-12#3)
the assessment##187##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#4)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#19)(2008-12#3)(2008-3#4)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#1)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#6)
the assessments##3##2##(2007-6#1)(2012-1#1)(2012-12#1)
the assigned##7##2##(1992-3#1)(2008-10#2)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
the assignment of a##2##4##(2008-10#1)(2009-7#1)
the assignment of the##3##4##(1991-12#1)(1995-9#1)(2008-10#1)
the assignment of##13##3##(1991-12#1)(1995-9#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#2)(2010-11#1)(2012-3#1)
the assignment##18##2##(1991-12#1)(1992-2#1)(1995-12#1)(1995-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2009-7#2)(2010-11#1)(2012-3#1)
the assignments##2##2##(2008-11#2)
the assimilation##2##2##(2008-3#1)(2009-8#1)
the assistance of##6##3##(1993-1#1)(1993-3#1)(2008-12#1)(2009-5#1)(2011-1#2)
the assistance##8##2##(1991-1#1)(1993-1#1)(1993-3#1)(2007-7#1)(2008-12#1)(2009-5#1)(2011-1#2)
the assistant's##2##2##(1992-1#1)(2009-4#1)
the associated benefits##2##3##(1997-3#1)(2013-8#1)
the associated factors##2##3##(2007-7#1)(2008-10#1)
the associated patent##2##3##(2008-5#2)
the associated risk of##2##4##(2008-10#1)(2013-1#1)
the associated risk##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
the associated##82##2##(1990-11#1)(1991-12#2)(1991-3#1)(1993-3#2)(1995-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-7#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#3)
the association and##3##3##(1991-8#1)(1996-2#1)(2008-8#1)
the association between DNA double-strand break repair gene NBS1##2##9##(2011-1#2)
the association between higher##2##4##(2008-7#1)(2013-1#1)
the association between interparental conflict and##2##6##(2010-1#2)
the association between polymorphisms##2##4##(2008-10#1)(2011-1#1)
the association between socioeconomic##2##4##(2008-12#1)(2011-1#1)
the association between the##8##4##(1990-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the association between these two##2##5##(1993-12#1)(2011-1#1)
the association between these##3##4##(1993-12#1)(2011-1#1)(2012-12#1)
the association between##89##3##(1990-9#1)(1991-12#1)(1991-8#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#3)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#7)(2011-2#5)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#13)(2013-8#1)
the association complex##2##3##(2008-10#2)
the association constant##3##3##(2008-10#3)
the association constants were##2##4##(2008-10#2)
the association constants##4##3##(2008-10#4)
the association is##3##3##(1991-8#1)(2011-2#2)
the association of adiposity with cardiovascular reactivity in##2##8##(2012-2#2)
the association of adiposity with cardiovascular reactivity##4##7##(2012-2#4)
the association of adiposity with##5##5##(2012-2#5)
the association of chronic##2##4##(2011-2#1)(2013-1#1)
the association of individual proteins with specific##2##7##(2008-2#2)
the association of nutritional##2##4##(2008-1#1)(2008-10#1)
the association of partial##2##4##(2008-1#1)(2008-8#1)
the association of the##3##4##(2008-3#1)(2008-5#1)(2010-12#1)
the association of this##3##4##(2008-10#1)(2009-8#1)(2012-12#1)
the association of two##4##4##(1995-2#1)(2007-7#1)(2008-10#2)
the association of##74##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-12#2)(1994-6#1)(1995-2#3)(1996-5#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#12)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#1)
the association rate##3##3##(1993-8#2)(2008-10#1)
the association with cigarette smoking##2##5##(2008-10#2)
the association with the##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
the association with##8##3##(2007-5#1)(2008-10#3)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
the association##202##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-8#4)(1992-12#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-2#1)(1994-6#2)(1995-2#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#33)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#4)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#10)(2011-2#10)(2012-12#11)(2012-2#12)(2012-3#8)(2013-1#18)(2013-7#2)(2013-8#1)
the associations among##2##3##(2008-5#1)(2012-12#1)
the associations between sexual##2##4##(2009-5#2)
the associations between##11##3##(2008-11#1)(2009-10#1)(2009-5#2)(2009-7#2)(2011-1#2)(2011-2#1)(2013-8#2)
the associations of##5##3##(1994-7#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
the associations##23##2##(1994-7#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-7#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
the associative##4##2##(2012-2#2)(2013-1#2)
the assumed##14##2##(1993-8#1)(2007-10#1)(2008-10#5)(2008-2#3)(2008-3#2)(2009-11#1)(2011-2#1)
the assumption of a##6##4##(1997-2#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)
the assumption of horizontal homogeneity##2##5##(2008-3#2)
the assumption of the##2##4##(1995-12#1)(2013-8#1)
the assumption of##24##3##(1994-2#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#3)
the assumption that a##2##4##(1995-9#1)(2008-10#1)
the assumption that each##3##4##(1996-7#1)(2008-3#2)
the assumption that the##14##4##(1992-6#1)(1992-8#1)(1995-3#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
the assumption that##42##3##(1990-5#1)(1990-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the assumption##70##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
the assumptions and##3##3##(1992-2#1)(1993-3#1)(2008-7#1)
the assumptions made in##3##4##(1991-2#1)(1993-9#1)(2008-3#1)
the assumptions of a##2##4##(2008-2#1)(2008-3#1)
the assumptions of the##5##4##(1995-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-7#1)
the assumptions of##15##3##(1994-11#1)(1995-8#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-9#2)(2010-3#1)(2013-7#1)
the assumptions underlying##2##3##(2007-11#1)(2008-9#1)
the assumptions##32##2##(1991-2#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#8)(2008-7#1)(2008-9#4)(2009-12#1)(2010-3#1)(2012-2#1)(2013-7#1)
the aster yellows##5##3##(2008-10#5)
the aster##6##2##(2008-10#5)(2008-6#1)
the asthma##6##2##(1990-9#1)(1995-6#1)(2008-12#2)(2009-6#2)
the asthmatic patient]##2##3##(2007-6#2)
the asthmatic##5##2##(2007-6#3)(2007-8#1)(2008-10#1)
the astigmatism of the##2##4##(2008-3#2)
the astigmatism of##3##3##(2008-3#3)
the astigmatism##5##2##(2008-3#5)
the astrocyte##7##2##(1990-7#3)(1996-2#2)(1997-6#1)(2008-11#1)
the asylums##2##2##(1990-6#1)(2010-6#1)
the asymmetric synthesis of##4##4##(2007-11#2)(2008-11#2)
the asymmetric unit##11##3##(1992-4#3)(1992-9#1)(1993-8#1)(1995-2#1)(2008-8#3)(2008-9#2)
the asymmetric##27##2##(1992-3#1)(1992-4#3)(1992-9#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-4#1)(2007-11#4)(2008-11#2)(2008-3#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-3#1)
the asymmetry factor##3##3##(2008-10#1)(2008-3#2)
the asymmetry in the##2##4##(2007-11#1)(2012-12#1)
the asymmetry of##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
the asymmetry parameter##6##3##(2008-2#4)(2008-3#2)
the asymmetry##20##2##(2007-11#1)(2008-10#1)(2008-2#6)(2008-3#5)(2008-5#4)(2008-8#1)(2010-9#1)(2012-12#1)
the asymptomatic##9##2##(1990-8#2)(1996-9#1)(1997-3#3)(2008-10#2)(2013-1#1)
the asymptotic properties of the ANCOVA with equal slopes##2##9##(2012-1#2)
the asymptotic properties of the##3##5##(2012-1#3)
the asymptotic properties of##4##4##(2008-2#1)(2012-1#3)
the asymptotic results##2##3##(2007-12#1)(2008-3#1)
the asymptotic values of##2##4##(2008-2#2)
the asymptotic##24##2##(1994-2#2)(1994-3#1)(1996-3#1)(2007-12#1)(2008-2#3)(2008-3#7)(2008-8#1)(2009-10#2)(2010-1#1)(2012-1#4)(2013-8#1)
the at-risk##2##2##(1994-2#1)(2013-1#1)
the atherogenic##4##2##(1994-9#1)(2008-12#1)(2008-3#1)(2013-7#1)
the atherosclerosis##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
the atherosclerotic plaque##4##3##(1993-6#1)(2008-7#1)(2010-9#1)(2011-2#1)
the atherosclerotic process##4##3##(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#1)
the atherosclerotic##11##2##(1991-6#1)(1993-6#1)(1997-3#2)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-9#1)(2011-2#1)
the atherothrombotic##2##2##(2008-3#1)(2011-1#1)
the athlete to##2##3##(2011-1#1)(2011-2#1)
the athlete##3##2##(2008-8#1)(2011-1#1)(2011-2#1)
the athletes##2##2##(1995-6#1)(2012-1#1)
the atlas is##2##3##(2008-2#1)(2013-1#1)
the atlas##7##2##(1997-4#1)(2008-2#3)(2012-3#1)(2013-1#2)
the atmosphere and the##2##4##(1997-1#1)(2008-3#1)
the atmosphere and##11##3##(1992-3#1)(1997-1#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#3)
the atmosphere are##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
the atmosphere below an observer##2##5##(2008-2#2)
the atmosphere by##2##3##(2008-10#1)(2008-2#1)
the atmosphere is##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the atmosphere of the##3##4##(2008-5#2)(2012-3#1)
the atmosphere of##8##3##(2008-10#3)(2008-3#2)(2008-5#2)(2012-3#1)
the atmosphere on##2##3##(2008-10#1)(2008-2#1)
the atmosphere that##3##3##(2007-11#1)(2008-3#2)
the atmosphere was##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
the atmosphere with a##3##4##(2008-3#3)
the atmosphere with##7##3##(2008-2#2)(2008-3#5)
the atmosphere##107##2##(1991-3#1)(1991-6#1)(1992-3#1)(1995-3#2)(1996-1#1)(1997-1#1)(2007-11#6)(2007-12#2)(2008-10#13)(2008-11#7)(2008-2#26)(2008-3#40)(2008-4#1)(2008-5#3)(2011-2#1)(2012-3#1)
the atmosphere-ocean system##2##3##(2008-2#2)
the atmospheric aerosol##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
the atmospheric and##2##3##(1996-12#1)(2008-3#1)
the atmospheric boundary layer##3##4##(2008-3#3)
the atmospheric column##2##3##(2008-3#2)
the atmospheric correction and##2##4##(2008-2#1)(2008-3#1)
the atmospheric correction##7##3##(2008-2#2)(2008-3#2)(2013-8#3)
the atmospheric model##2##3##(2008-3#2)
the atmospheric optical##2##3##(2008-2#1)(2008-3#1)
the atmospheric physical parameters##2##4##(2013-8#2)
the atmospheric profile##2##3##(2008-2#2)
the atmospheric propagation of##2##4##(2008-3#2)
the atmospheric spectra##2##3##(2008-3#2)
the atmospheric transmittance##2##3##(2008-2#1)(2008-3#1)
the atmospheric##53##2##(1996-1#1)(1996-12#1)(2008-10#3)(2008-2#15)(2008-3#27)(2012-2#1)(2013-8#5)
the atom##5##2##(1996-3#1)(2007-11#2)(2007-12#1)(2008-12#1)
the atomic absorption spectrometric determination of##2##6##(2008-10#2)
the atomic absorption spectrometric##3##4##(2008-10#3)
the atomic absorption##9##3##(2008-10#9)
the atomic and##2##3##(2008-10#1)(2010-7#1)
the atomic bomb survivor##2##4##(2013-1#2)
the atomic number##4##3##(2008-10#2)(2008-3#2)
the atomic##34##2##(1997-2#1)(2007-12#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-7#4)(2010-7#2)(2013-1#2)(2013-8#1)
the atomization of##2##3##(2008-10#2)
the atomization##5##2##(2008-10#5)
the atomizer##4##2##(2008-10#4)
the atoms##3##2##(1991-5#1)(2007-12#1)(2008-3#1)
the atria##4##2##(1994-3#1)(2009-5#1)(2012-1#1)(2013-1#1)
the atrial septal defect##2##4##(2008-11#2)
the atrial septal defects##2##4##(2008-11#1)(2012-3#1)
the atrial septal##4##3##(2008-11#3)(2012-3#1)
the atrial##9##2##(1990-9#1)(2007-8#1)(2008-11#3)(2008-5#3)(2012-3#1)
the atrium##2##2##(1992-5#1)(2008-5#1)
the atrophic##4##2##(2008-4#1)(2008-5#1)(2010-5#1)(2011-7#1)
the atrophy of##2##3##(2008-7#1)(2011-2#1)
the atrophy##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
the atropine-resistant##2##2##(1990-5#1)(1997-4#1)
the atropine-sensitive##2##2##(1997-4#2)
the attached##4##2##(1994-5#1)(1995-2#1)(2008-11#1)(2011-2#1)
the attachment of the##7##4##(1991-12#1)(1991-6#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-4#1)
the attachment of##14##3##(1990-12#1)(1991-12#1)(1991-6#1)(1993-5#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-12#1)
the attachment##22##2##(1990-12#1)(1991-12#1)(1991-6#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-4#2)(2010-12#1)(2012-2#1)
the attack of##2##3##(1993-6#1)(2008-7#1)
the attack rates##2##3##(1997-3#2)
the attack##8##2##(1993-6#1)(1994-6#1)(1997-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
the attacked##2##2##(2010-3#1)(2012-3#1)
the attacks##2##2##(1990-3#1)(2007-2#1)
the attainable precision##2##3##(2008-10#2)
the attainable##3##2##(2008-10#3)
the attainment of high##3##4##(1994-3#1)(2007-12#1)(2008-2#1)
the attainment of##8##3##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-5#1)(2013-8#1)
the attempt to##7##3##(1992-1#1)(1997-6#2)(2008-2#1)(2009-11#1)(2012-2#1)(2013-1#1)
the attempt##9##2##(1992-1#1)(1997-6#2)(2007-8#1)(2008-2#1)(2009-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
the attempts to##2##3##(2008-11#1)(2011-1#1)
the attempts##5##2##(1991-1#1)(1994-2#1)(2008-11#2)(2011-1#1)
the attendant##2##2##(2008-6#1)(2011-2#1)
the attendees##2##2##(1991-12#1)(2013-1#1)
the attending##5##2##(1992-3#1)(1996-9#1)(2007-8#2)(2011-1#1)
the attention and##2##3##(1994-2#1)(1997-3#1)
the attention of an##2##4##(2007-4#1)(2008-6#1)
the attention of the##3##4##(1991-6#1)(2008-10#2)
the attention of##11##3##(1991-6#1)(1994-2#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2013-1#1)
the attention to##2##3##(1997-3#1)(2012-12#1)
the attention##25##2##(1991-6#1)(1992-1#1)(1992-12#1)(1994-2#2)(1997-3#2)(1997-4#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
the attentional blink##3##3##(2008-11#1)(2009-4#2)
the attentional##4##2##(2008-11#1)(2009-4#2)(2013-8#1)
the attenuated##5##2##(2008-7#2)(2008-9#2)(2012-2#1)
the attenuation coefficient##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the attenuation of the##3##4##(1993-9#1)(2008-3#2)
the attenuation of##5##3##(1992-3#1)(1993-9#1)(2008-2#1)(2008-3#2)
the attenuation##17##2##(1992-3#1)(1993-9#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#7)(2008-7#1)(2012-3#1)
the attine##3##2##(2008-8#3)
the attitude of the##3##4##(2008-1#1)(2010-8#2)
the attitude of##5##3##(1990-6#1)(2008-1#1)(2009-10#1)(2010-8#2)
the attitude towards##2##3##(1992-5#1)(2012-2#1)
the attitude##11##2##(1990-6#1)(1992-5#1)(2008-1#2)(2009-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
the attitudes and behaviors of##2##5##(2010-5#1)(2011-1#1)
the attitudes and beliefs of##2##5##(1995-1#1)(1996-1#1)
the attitudes and##7##3##(1990-11#1)(1995-1#1)(1996-1#1)(1997-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
the attitudes of the physicians##2##5##(1995-5#1)(2007-7#1)
the attitudes of##10##3##(1994-3#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-7#2)(2008-10#1)(2008-12#1)(2010-10#1)(2010-12#1)
the attitudes##18##2##(1990-11#1)(1994-3#1)(1995-1#2)(1995-5#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-7#2)(2008-10#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
the attitudinal##2##2##(1996-2#1)(2007-12#1)
the attraction##3##2##(2007-5#1)(2008-11#1)(2008-5#1)
the attractive##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
the attractiveness of##5##3##(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
the attractiveness##6##2##(2008-10#2)(2008-5#2)(2009-8#1)(2011-2#1)
the attributable##3##2##(1994-11#2)(2011-1#1)
the attributes##5##2##(1995-1#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-6#1)
the attribution of##2##3##(2008-10#1)(2010-8#1)
the attribution##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
the atypical clinical##2##3##(1990-5#1)(2008-7#1)
the atypical presentation##2##3##(2009-8#1)(2012-12#1)
the atypical##9##2##(1990-5#1)(2007-11#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#1)
the audience##2##2##(2008-7#1)(2010-2#1)
the audit##6##2##(1993-1#2)(2007-11#1)(2008-11#3)
the auditory and visual##2##4##(2008-8#2)
the auditory brainstem response##2##4##(2008-4#2)
the auditory cortex##5##3##(1993-9#1)(2010-7#3)(2012-2#1)
the auditory nerve##3##3##(2008-8#1)(2008-9#2)
the auditory system##4##3##(1996-6#1)(2007-7#1)(2008-9#1)(2013-1#1)
the auditory##31##2##(1991-1#1)(1993-9#1)(1995-5#1)(1996-5#2)(1996-6#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-8#3)(2008-9#10)(2009-9#1)(2010-5#1)(2010-7#3)(2012-2#1)(2013-1#1)(2013-8#1)
the augmentation of glucose uptake##2##5##(2008-10#1)(2008-11#1)
the augmentation of the##2##4##(1992-11#1)(1992-8#1)
the augmentation of##6##3##(1992-11#1)(1992-8#1)(1995-12#2)(2008-10#1)(2008-11#1)
the augmentation##7##2##(1991-8#1)(1992-11#1)(1992-8#1)(1995-12#2)(2008-10#1)(2008-11#1)
the augmented##3##2##(1995-12#1)(2008-8#1)(2013-1#1)
the auricular##2##2##(2008-4#1)(2010-6#1)
the authentic 5'##2##3##(1994-8#1)(2008-11#1)
the authentic##11##2##(1990-12#1)(1990-2#2)(1991-2#2)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
the authenticity of the cDNA##2##5##(1990-12#1)(1991-5#1)
the authenticity of the##3##4##(1990-12#1)(1991-5#1)(1992-8#1)
the authenticity of##9##3##(1990-12#1)(1991-5#1)(1992-8#1)(2008-10#3)(2008-11#1)(2009-9#1)(2010-11#1)
the author addresses##2##3##(1992-3#1)(2010-3#1)
the author analyzes##2##3##(1993-12#1)(1995-5#1)
the author and##3##3##(1991-11#1)(1996-12#1)(2008-2#1)
the author describes how##2##4##(1992-1#1)(1992-2#1)
the author describes the##9##4##(1991-1#2)(1991-2#1)(1991-3#2)(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
the author describes##14##3##(1991-1#3)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#2)(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
the author discusses the##5##4##(1991-2#1)(1992-2#1)(1993-2#2)(1994-6#1)
the author discusses##6##3##(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#2)(1994-6#1)
the author examines how##2##4##(2007-2#1)(2010-3#1)
the author examines the##5##4##(1991-12#1)(1992-1#1)(1994-3#1)(2007-2#2)
the author examines##13##3##(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#1)(2007-2#3)(2010-3#1)(2012-2#1)
the author explores##2##3##(1995-2#1)(1996-2#1)
the author found##2##3##(1996-12#1)(2007-2#1)
the author has##4##3##(2008-8#2)(2009-9#1)(2011-3#1)
the author in##3##3##(1997-6#1)(2008-12#1)(2010-8#1)
the author investigates##2##3##(1992-3#1)(1994-3#1)
the author of this case study##2##6##(1991-1#1)(1992-3#1)
the author of##4##3##(1991-1#1)(1992-3#1)(2008-12#1)(2010-10#1)
the author offers##2##3##(1992-12#1)(1992-3#1)
the author points##2##3##(1996-6#1)(2008-12#1)
the author presents a##2##4##(1992-12#1)(2008-1#1)
the author presents the##2##4##(1991-2#1)(2008-12#1)
the author presents##7##3##(1991-2#1)(1992-12#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-12#2)
the author proposes##2##3##(1991-1#1)(2008-1#1)
the author provides##2##3##(1993-12#1)(2007-2#1)
the author reviews##2##3##(1991-3#1)(2007-2#1)
the author suggests that##2##4##(1992-3#1)(1997-3#1)
the author suggests##4##3##(1991-12#1)(1992-3#1)(1997-3#1)(2009-5#1)
the author summarizes the##2##4##(2010-5#1)(2010-8#1)
the author summarizes##3##3##(1991-2#1)(2010-5#1)(2010-8#1)
the author##134##2##(1990-8#1)(1991-1#6)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#7)(1992-1#6)(1992-12#2)(1992-2#7)(1992-3#7)(1993-1#1)(1993-12#2)(1993-2#6)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-2#9)(2007-8#1)(2008-1#3)(2008-11#3)(2008-12#5)(2008-2#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)
the author's knowledge##6##3##(2007-12#1)(2008-10#1)(2008-2#4)
the author's own experience##3##4##(1994-3#1)(2007-8#1)(2008-12#1)
the author's own##4##3##(1994-3#1)(2007-8#1)(2008-10#1)(2008-12#1)
the author's##29##2##(1991-1#1)(1991-3#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
the authorities##3##2##(1991-6#1)(2008-9#1)(2009-7#1)
the authority to##2##3##(1991-12#1)(1994-12#1)
the authority##5##2##(1991-12#1)(1994-1#1)(1994-12#1)(2007-7#1)(2010-3#1)
the authors address##2##3##(2010-10#1)(2012-12#1)
the authors also##2##3##(1994-7#1)(2012-3#1)
the authors analyzed##2##3##(1990-6#1)(2012-3#1)
the authors are aware of##2##5##(2008-7#1)(2010-1#1)
the authors are aware##5##4##(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#2)
the authors are##6##3##(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#2)
the authors argue that##3##4##(1993-3#1)(1997-3#1)(2008-12#1)
the authors assessed##2##3##(1992-2#1)(2008-3#1)
the authors believe that##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
the authors believe##7##3##(1991-4#1)(1994-1#1)(1994-6#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
the authors call##2##3##(1991-4#1)(2008-6#1)
the authors conclude that##3##4##(1994-2#1)(1995-1#1)(2008-11#1)
the authors describe a##5##4##(2008-1#1)(2008-11#1)(2009-9#1)(2010-3#1)(2011-1#1)
the authors describe the##2##4##(1993-2#1)(2012-1#1)
the authors describe##12##3##(1993-2#2)(1995-1#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)
the authors developed a##2##4##(1994-3#1)(1996-3#1)
the authors developed##3##3##(1993-12#1)(1994-3#1)(1996-3#1)
the authors discuss##4##3##(1993-3#1)(2007-12#1)(2008-7#1)(2011-2#1)
the authors emphasise##2##3##(1991-5#1)(1991-6#1)
the authors examine the##6##4##(1991-12#2)(1994-3#1)(1995-3#1)(2007-2#1)(2008-2#1)
the authors examine##9##3##(1991-12#2)(1993-12#1)(1994-3#2)(1995-3#1)(2007-2#1)(2007-8#1)(2008-2#1)
the authors examined the##2##4##(1992-12#1)(2012-3#1)
the authors examined##4##3##(1992-12#1)(1993-12#1)(2011-1#1)(2012-3#1)
the authors explain##2##3##(1990-3#1)(2012-3#1)
the authors explore##4##3##(1991-12#1)(1993-1#1)(1994-3#1)(2010-10#1)
the authors found that##3##4##(1995-3#1)(1996-1#2)
the authors found##5##3##(1994-12#1)(1995-3#1)(1996-1#2)(2007-11#1)
the authors give a##2##4##(1990-8#1)(1992-2#1)
the authors give##4##3##(1990-8#1)(1992-2#1)(2007-8#1)(2008-4#1)
the authors have developed a##2##5##(1993-2#1)(2007-11#1)
the authors have##9##3##(1992-2#1)(1993-2#1)(1993-3#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-9#1)(2010-10#1)
the authors hypothesize that##3##4##(1993-9#1)(2008-11#1)(2010-1#1)
the authors identified##2##3##(2007-11#1)(2010-10#1)
the authors measured##2##3##(1996-6#1)(2012-3#1)
the authors of this##2##4##(2010-3#1)(2011-1#1)
the authors of##5##3##(1996-12#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-3#1)
the authors present a##2##4##(1992-3#1)(2008-11#1)
the authors present the##3##4##(1993-2#1)(2007-8#1)(2012-1#1)
the authors present##9##3##(1990-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(2007-8#2)(2008-11#1)(2008-9#1)(2012-1#1)
the authors propose##2##3##(2010-12#1)(2010-6#1)
the authors provide##3##3##(2006-7#1)(2008-11#1)(2008-9#1)
the authors recommend##3##3##(1991-2#1)(2008-9#1)(2011-2#1)
the authors report the results of##2##6##(1990-9#1)(1997-6#1)
the authors report the##3##4##(1990-9#1)(1997-6#1)(2008-7#1)
the authors report##6##3##(1990-9#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2013-7#1)
the authors review the##5##4##(1990-2#1)(1996-7#1)(2007-8#1)(2010-8#1)(2011-2#1)
the authors review##7##3##(1990-2#1)(1993-12#1)(1996-7#1)(2007-8#2)(2010-8#1)(2011-2#1)
the authors show that##3##4##(1993-1#1)(1993-2#1)(2010-5#1)
the authors show the##2##4##(1990-3#1)(2010-10#1)
the authors show##5##3##(1990-3#1)(1993-1#1)(1993-2#1)(2010-10#1)(2010-5#1)
the authors suggest that the##3##5##(1994-1#1)(1996-1#1)(2007-8#1)
the authors suggest##5##3##(1990-9#1)(1993-12#1)(1994-1#1)(1996-1#1)(2007-8#1)
the authors to##8##3##(1991-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1997-3#1)(2008-5#1)(2009-4#1)(2009-5#1)
the authors treated##3##3##(2007-11#1)(2007-8#1)(2010-12#1)
the authors use##2##3##(2008-11#1)(2010-10#1)
the authors will##2##3##(1993-2#1)(2008-7#1)
the authors##249##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#5)(1992-2#4)(1992-3#1)(1992-5#1)(1993-1#2)(1993-12#6)(1993-2#7)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#5)(1994-6#1)(1994-7#1)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#6)(1997-6#1)(2006-7#1)(2007-10#1)(2007-11#10)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#9)(2008-1#3)(2008-10#8)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#6)(2008-7#7)(2008-8#4)(2008-9#6)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#9)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#1)(2013-7#2)(2013-8#2)
the authors' experience of##2##4##(2008-12#1)(2009-11#1)
the authors' experience##5##3##(1990-10#1)(2008-12#1)(2009-11#1)(2010-11#1)(2011-3#1)
the authors' knowledge##24##3##(2007-11#3)(2007-12#8)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#2)(2012-3#1)
the authors' laboratories##2##3##(2008-6#1)(2008-7#1)
the authors' laboratory##2##3##(2008-10#1)(2008-4#1)
the authors' own experience##2##4##(2007-11#1)(2013-1#1)
the authors' own##4##3##(2007-11#2)(2007-8#1)(2013-1#1)
the authors' personal experience##2##4##(1993-3#1)(1993-9#1)
the authors' personal##3##3##(1993-3#1)(1993-9#1)(2012-3#1)
the authors'##53##2##(1990-10#1)(1990-11#1)(1990-9#1)(1992-1#1)(1993-3#2)(1993-9#1)(1995-2#1)(2007-11#7)(2007-12#9)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-5#2)(2010-11#1)(2010-9#1)(2011-1#2)(2011-3#1)(2012-3#2)(2013-1#1)
the autistic##2##2##(2008-11#2)
the autoclaved rockwool##2##3##(2008-10#2)
the autoclaved##3##2##(2008-10#3)
the autocorrelation function of##2##4##(2008-3#1)(2010-8#1)
the autocorrelation function##5##3##(2008-3#3)(2008-8#1)(2010-8#1)
the autocorrelation of##2##3##(2007-12#1)(2008-8#1)
the autocorrelation##13##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2010-8#1)(2013-1#2)
the autocrine growth factor##2##4##(1993-9#1)(2008-4#1)
the autocrine growth##3##3##(1993-9#1)(2008-11#1)(2008-4#1)
the autocrine##6##2##(1993-3#1)(1993-9#1)(2008-11#1)(2008-4#2)(2013-1#1)
the autofluorescence##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
the autograft root##2##3##(2007-8#2)
the autograft##5##2##(2007-8#3)(2009-3#1)(2012-3#1)
the autoimmune##8##2##(1991-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#2)(2011-1#1)(2013-8#1)
the autologous##8##2##(1995-12#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
the automated assay##2##3##(1993-12#1)(1995-12#1)
the automated devices##2##3##(2007-7#2)
the automated marine pH sensor (AMpS)##2##6##(2008-10#2)
the automated method##2##3##(2008-10#2)
the automated operation##2##3##(2008-10#1)(2008-7#1)
the automated##33##2##(1991-5#1)(1992-2#1)(1993-12#1)(1995-12#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-10#17)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-7#1)
the automatic##15##2##(1990-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)
the automation of the##2##4##(2008-10#2)
the automation of##5##3##(2008-10#5)
the automation##9##2##(2008-10#9)
the automobile and##2##3##(1996-10#1)(2008-10#1)
the automotive industry##3##3##(2008-3#1)(2011-2#2)
the automotive##4##2##(2008-3#1)(2008-7#1)(2011-2#2)
the autonomic nervous system##10##4##(1997-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the autonomic nervous##11##3##(1997-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the autonomic##16##2##(1997-2#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
the autonomous nerve system##2##4##(2008-5#2)
the autonomous##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
the autonomy##2##2##(2008-10#1)(2012-1#1)
the autophagy interactome##2##3##(2013-1#2)
the autophagy pathway##2##3##(2013-1#2)
the autophagy##5##2##(2013-1#5)
the autophosphorylation site##2##3##(1991-12#1)(1993-11#1)
the autophosphorylation##6##2##(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-2#2)
the autopsy##4##2##(1991-9#1)(1992-2#1)(2009-4#1)(2012-12#1)
the autoregressive##2##2##(2008-8#1)(2009-4#1)
the autosampler cup##3##3##(2008-10#3)
the autosampler##9##2##(2008-10#9)
the autosomal recessive##3##3##(2008-6#1)(2008-7#1)(2012-12#1)
the autosomal##4##2##(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
the autosomes##2##2##(2008-12#2)
the autumn of 1992##2##4##(2008-2#2)
the autumn of##4##3##(1991-11#1)(2008-2#2)(2010-8#1)
the autumn##9##2##(1991-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-8#2)
the autumnal cooling rate##3##4##(2008-8#3)
the autumnal##6##2##(2008-10#1)(2008-11#1)(2008-8#3)(2010-8#1)
the auxiliary telescope##2##3##(2008-3#2)
the auxiliary##7##2##(1991-2#1)(1995-1#1)(1995-3#1)(2008-3#2)(2008-7#1)(2008-8#1)
the auxin##2##2##(2009-8#1)(2011-1#1)
the auxins##2##2##(2008-10#1)(2008-12#1)
the auxotroph##2##2##(1994-8#2)
the availability and use of##3##5##(1991-12#1)(1992-12#1)(2008-9#1)
the availability and##6##3##(1991-12#1)(1992-12#1)(1993-8#1)(1995-2#1)(2008-9#1)(2013-7#1)
the availability of a large##2##5##(2008-5#1)(2011-1#1)
the availability of a##8##4##(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)
the availability of an##2##4##(2008-10#1)(2012-2#1)
the availability of commercial##2##4##(2008-10#1)(2011-2#1)
the availability of donor##2##4##(2008-9#1)(2011-2#1)
the availability of free##2##4##(2008-10#1)(2008-5#1)
the availability of hand-washing materials##3##5##(2013-8#3)
the availability of partial##2##4##(1991-1#1)(2013-1#1)
the availability of simple##3##4##(1997-7#1)(2008-10#1)(2009-10#1)
the availability of sufficient##2##4##(2007-9#1)(2008-1#1)
the availability of the##9##4##(1991-9#1)(1992-12#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
the availability of these##2##4##(2008-3#1)(2008-7#1)
the availability of##104##3##(1990-11#1)(1990-12#1)(1991-1#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#2)(1996-12#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#3)
the availability##113##2##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#1)(1991-9#2)(1992-12#3)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#2)(1995-2#1)(1996-12#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#3)
the available data on##3##4##(1991-12#1)(1994-6#1)(2010-8#1)
the available data##18##3##(1991-12#3)(1994-6#1)(1996-1#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-8#2)(2013-1#2)
the available evidence is##2##4##(1992-2#1)(2008-3#1)
the available evidence on the##2##5##(2011-2#1)(2012-3#1)
the available evidence##9##3##(1992-2#1)(1993-12#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
the available information on the##4##5##(1993-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
the available information##11##3##(1991-9#1)(1993-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-8#1)
the available literature on the##2##5##(2008-11#1)(2008-4#1)
the available literature on##5##4##(2007-10#1)(2007-11#1)(2008-11#2)(2008-4#1)
the available literature##17##3##(1992-2#1)(1996-12#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
the available resources##2##3##(1994-3#1)(2008-11#1)
the available results##2##3##(1993-12#1)(2008-10#1)
the available tests##2##3##(1991-11#1)(2013-8#1)
the available therapeutic##2##3##(2011-2#1)(2012-2#1)
the available treatments##4##3##(2008-7#2)(2011-2#1)(2012-12#1)
the available##133##2##(1990-9#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#5)
the avascular##4##2##(2011-2#3)(2013-1#1)
the avenue##2##2##(2008-10#2)
the average SABP##2##3##(1997-6#2)
the average accuracy##2##3##(2008-2#1)(2008-4#1)
the average age at##2##4##(2008-6#1)(2008-7#1)
the average age of##3##4##(2007-12#1)(2008-7#1)(2011-2#1)
the average age##5##3##(2007-12#1)(2008-6#1)(2008-7#2)(2011-2#1)
the average and median ratios##2##5##(1996-12#2)
the average and##3##3##(1990-9#1)(1996-12#2)
the average annual##2##3##(1993-3#1)(2010-12#1)
the average cosine##4##3##(2008-3#4)
the average cost of##2##4##(1993-1#1)(1995-12#1)
the average daily##3##3##(1992-12#1)(2008-12#1)(2008-9#1)
the average degree of substitution of methyl-β-cyclodextrin##2##7##(2011-2#2)
the average degree of##3##4##(1990-5#1)(2011-2#2)
the average detection##2##3##(2008-10#2)
the average diameters of the encapsulated and decapsulated cysts were 230##2##11##(2008-5#2)
the average dispersion##2##3##(2007-11#1)(2007-12#1)
the average duration of##3##4##(2008-1#1)(2011-2#2)
the average efficiency##2##3##(2008-2#1)(2008-3#1)
the average error##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the average female##2##3##(2008-3#1)(2008-9#1)
the average flow velocity of##2##5##(2011-2#2)
the average flow##3##3##(2008-3#1)(2011-2#2)
the average for##2##3##(1992-6#1)(1995-11#1)
the average genetic distance##2##4##(2008-10#1)(2011-2#1)
the average genetic##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
the average group##2##3##(1992-6#1)(2012-3#1)
the average improvement in##2##4##(2008-9#2)
the average in##2##3##(1996-11#1)(2008-6#1)
the average minimum temperature##2##4##(2008-8#2)
the average minimum##3##3##(2008-10#1)(2008-8#2)
the average molecular##2##3##(2008-2#1)(2008-5#1)
the average mortality rate##2##4##(1995-12#1)(2008-7#1)
the average number of visits##2##5##(1991-12#1)(1995-3#1)
the average number of##16##4##(1991-12#1)(1991-7#1)(1992-2#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-3#2)
the average number##18##3##(1991-12#1)(1991-7#1)(1992-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-3#2)
the average of the##5##4##(2008-2#2)(2008-3#2)(2012-2#1)
the average of##12##3##(1997-3#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2011-1#2)(2012-2#1)
the average percentages of erythroblasts##2##5##(2008-10#2)
the average power##2##3##(2007-11#1)(2010-8#1)
the average prediction##2##3##(2008-10#2)
the average quadratic##2##3##(2007-12#2)
the average recoveries of##2##4##(2008-10#1)(2011-1#1)
the average recoveries varied from##2##5##(2008-10#2)
the average recoveries##4##3##(2008-10#3)(2011-1#1)
the average recovery##4##3##(2008-10#3)(2011-1#1)
the average reduction of crestal bone height around the implants placed##2##11##(2013-1#2)
the average relative standard##2##4##(2008-10#2)
the average size of the##2##5##(1996-1#1)(2008-3#1)
the average size of##8##4##(1994-12#1)(1995-8#1)(1996-1#1)(1997-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
the average temperature##3##3##(2008-10#1)(2008-8#2)
the average time between##2##4##(2008-3#1)(2012-12#1)
the average time required was##3##5##(2010-6#3)
the average time##5##3##(2008-3#1)(2010-6#3)(2012-12#1)
the average to##2##3##(1993-12#1)(2013-1#1)
the average value of the##2##5##(2007-11#1)(2011-2#1)
the average value of##4##4##(2007-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
the average value##8##3##(1993-3#1)(2007-11#2)(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
the average values of the reaction##2##6##(2013-8#2)
the average values of##3##4##(2008-7#1)(2013-8#2)
the average values##5##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#2)
the average##313##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-3#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-6#4)(1997-8#4)(2007-10#1)(2007-11#8)(2007-12#7)(2007-8#5)(2008-1#4)(2008-10#53)(2008-11#4)(2008-12#5)(2008-2#17)(2008-3#29)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#13)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#4)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#3)(2010-8#1)(2011-1#6)(2011-2#16)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#6)
the averaged CARS temperature##2##4##(2008-2#2)
the averaged growth##2##3##(2010-8#2)
the averaged##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2010-8#3)
the averaging##3##2##(2008-3#1)(2008-6#1)(2008-9#1)
the aversive##3##2##(1993-12#1)(2008-11#1)(2008-2#1)
the avian embryo##2##3##(2008-5#1)(2012-12#1)
the avian vocal system##2##4##(2009-2#2)
the avian##13##2##(1993-6#3)(1995-12#1)(1995-2#2)(1996-5#2)(1997-2#1)(2008-5#1)(2009-2#2)(2012-12#1)
the avidin-biotin##2##2##(1995-5#1)(2008-10#1)
the avirulence gene##5##3##(2008-10#5)
the avirulence##6##2##(2008-10#6)
the avocado##2##2##(2008-10#2)
the avoidance of##5##3##(1993-10#1)(1993-3#1)(2008-10#1)(2009-6#1)(2012-1#1)
the avoidance##7##2##(1993-10#1)(1993-3#2)(2008-10#1)(2008-8#1)(2009-6#1)(2012-1#1)
the avrBs1##3##2##(2008-10#3)
the awareness and##2##3##(2010-12#1)(2013-1#1)
the awareness in##2##3##(2008-11#1)(2012-3#1)
the awareness of##9##3##(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
the awareness on UI in the elderly and##2##8##(2011-1#2)
the awareness##17##2##(1994-1#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
the axial and##2##3##(1997-7#1)(2007-11#1)
the axial direction##3##3##(2008-3#2)(2009-7#1)
the axial force##3##3##(2008-2#3)
the axial intensity distribution##2##4##(2008-3#2)
the axial position##2##3##(2008-3#2)
the axial skeleton##5##3##(1995-11#1)(2009-10#1)(2011-2#2)(2012-12#1)
the axial##41##2##(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-7#4)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#9)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#2)(2011-2#3)(2012-12#2)(2012-2#1)
the axilla in##2##3##(1994-12#1)(2008-5#1)
the axilla is##2##3##(2008-5#2)
the axilla##22##2##(1994-12#1)(1995-9#1)(2008-12#1)(2008-5#18)(2008-8#1)
the axillary artery##3##3##(2008-7#3)
the axillary lymph nodes##2##4##(1994-12#1)(2010-6#1)
the axillary microflora was##2##4##(2008-5#2)
the axillary microflora##4##3##(2008-5#4)
the axillary nerve##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
the axillary region##2##3##(2007-8#1)(2008-7#1)
the axillary skin##2##3##(2008-5#2)
the axillary vault##3##3##(2008-5#3)
the axillary##25##2##(1994-12#1)(2007-8#1)(2008-10#2)(2008-5#11)(2008-7#4)(2008-8#1)(2008-9#1)(2010-6#2)(2012-12#1)(2013-1#1)
the axis of the##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the axis of##10##3##(2007-12#1)(2008-2#3)(2008-3#3)(2008-8#1)(2009-8#1)(2013-8#1)
the axis on##2##3##(2008-11#1)(2008-3#1)
the axis perpendicular to the##2##5##(2008-10#1)(2008-3#1)
the axis##21##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#11)(2008-8#1)(2009-8#1)(2013-8#1)
the axon terminals##2##3##(1996-2#1)(2008-4#1)
the axon##9##2##(1995-2#1)(1996-2#1)(2008-4#1)(2009-12#3)(2009-7#1)(2012-2#2)
the axonal##9##2##(1995-2#1)(1996-6#1)(2007-12#1)(2008-6#1)(2008-7#3)(2009-7#1)(2012-2#1)
the axoneme and##2##3##(2007-12#1)(2008-4#1)
the axoneme##7##2##(1991-2#2)(2007-12#2)(2008-4#1)(2008-7#2)
the axons of##2##3##(1990-5#1)(1993-9#1)
the axons##5##2##(1990-5#1)(1993-9#1)(2008-5#1)(2009-7#2)
the aza-BODIPY dyes##2##3##(2009-5#2)
the azetidine##2##2##(1995-3#2)
the azide moiety##2##3##(1993-11#2)
the azide##4##2##(1993-11#2)(1997-4#2)
the azimuth##4##2##(2008-2#1)(2008-3#3)
the azimuthal##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
the azo dye##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
the azo##6##2##(1995-6#1)(2007-12#1)(2008-10#3)(2011-1#1)
the azobenzene##4##2##(2008-10#4)
the azoxymethane rat carcinogenesis model##2##5##(2011-1#2)
the azygos vein##6##3##(2008-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
the b##5##2##(1995-3#1)(2007-11#1)(2008-10#2)(2008-7#1)
the b(1)(psi) orbital##2##3##(1996-2#2)
the b(1)(psi)##3##2##(1996-2#3)
the bR##2##2##(1993-11#2)
the bZIP##2##2##(2008-9#1)(2013-8#1)
the babies'##2##2##(1991-2#1)(1992-4#1)
the baboon and rabbit##2##4##(2008-9#2)
the baboon and##3##3##(1993-6#1)(2008-9#2)
the baboon##5##2##(1993-6#1)(1994-12#2)(2008-9#2)
the baby and##2##3##(2007-10#1)(2008-2#1)
the baby boom generation##2##4##(2008-10#1)(2009-5#1)
the baby boom##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
the baby##16##2##(1993-12#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-11#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
the baby's##3##2##(2008-11#1)(2008-2#2)
the baccalaureate graduate##2##3##(1995-2#2)
the baccalaureate##4##2##(1994-12#1)(1994-2#1)(1995-2#2)
the back and##2##3##(1997-3#1)(2008-5#1)
the back of a##3##4##(2008-11#2)(2008-3#1)
the back of the hand##2##5##(2008-2#1)(2008-6#1)
the back of the##6##4##(1990-6#1)(1991-6#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
the back of##11##3##(1990-6#1)(1991-6#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
the back or##2##3##(1997-4#1)(2008-12#1)
the back plate##2##3##(2007-12#2)
the back skin and##2##4##(1997-7#2)
the back skin##3##3##(1997-7#2)(2013-1#1)
the back surface##2##3##(2008-3#1)(2008-8#1)
the back##46##2##(1990-6#1)(1991-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#3)(2007-11#1)(2007-12#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#1)
the back-up device##2##3##(2008-9#2)
the back-up##3##2##(2008-11#1)(2008-9#2)
the backbone and side##2##4##(2009-7#2)
the backbone and side-chain##2##4##(1995-5#1)(2009-7#1)
the backbone and##5##3##(1995-5#1)(2008-4#1)(2009-7#3)
the backbone of##4##3##(1993-12#1)(1995-8#1)(2008-9#1)(2013-1#1)
the backbone##18##2##(1993-12#1)(1994-5#1)(1995-2#2)(1995-5#1)(1995-8#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-7#7)(2010-3#1)(2013-1#1)
the backbones##2##2##(2006-12#2)
the backdrop of##3##3##(2012-2#1)(2013-1#2)
the background and##8##3##(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-4#1)(2013-8#1)
the background current##2##3##(2008-10#2)
the background electrolyte##2##3##(2008-10#2)
the background noise##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
the background of the##5##4##(1995-2#1)(1995-8#1)(2008-12#1)(2008-5#1)(2009-7#1)
the background of##16##3##(1994-2#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
the background rate##2##3##(1994-8#1)(2010-3#1)
the background signal##2##3##(2008-10#2)
the background signals##6##3##(2008-10#1)(2008-3#5)
the background to the##2##4##(2008-11#1)(2011-1#1)
the background were##2##3##(2008-2#1)(2008-3#1)
the background##85##2##(1991-12#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#4)(2007-5#2)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#12)(2008-5#3)(2008-7#1)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
the backing##3##2##(2008-10#1)(2009-5#1)(2009-7#1)
the backpropagation algorithm##2##3##(2008-10#1)(2010-8#1)
the backreflected##2##2##(2007-11#1)(2008-3#1)
the backscatter and##2##3##(2008-3#2)
the backscatter##7##2##(2008-2#2)(2008-3#5)
the backscatter-to-extinction ratio##2##3##(2008-2#2)
the backscattered beam##3##3##(2008-2#3)
the backscattered laser pulse##3##4##(2008-3#3)
the backscattered light##7##3##(2008-2#4)(2008-3#3)
the backscattered signal##2##3##(2007-12#1)(2008-3#1)
the backscattered speckle pattern##2##4##(2008-2#2)
the backscattered##25##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#9)(2008-3#13)
the backscattering coefficient b(b)##2##4##(2008-2#1)(2008-3#1)
the backscattering coefficient##9##3##(2008-2#3)(2008-3#6)
the backscattering cross section for##2##5##(2008-3#2)
the backscattering fraction##3##3##(2008-3#3)
the backscattering is##2##3##(2008-3#2)
the backscattering##31##2##(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#21)
the backup##2##2##(1997-2#1)(2008-9#1)
the backward inversion algorithm##2##4##(2008-3#2)
the backward second-harmonic##2##3##(2007-12#2)
the backward##9##2##(2007-12#2)(2008-2#1)(2008-3#4)(2009-3#1)(2010-10#1)
the bacteria on##2##3##(2008-10#2)
the bacteria or##3##3##(2006-6#1)(2008-11#1)(2008-5#1)
the bacteria was##2##3##(1996-12#1)(2008-6#1)
the bacteria were##4##3##(1994-11#1)(1996-12#1)(2008-10#2)
the bacteria##52##2##(1990-12#1)(1991-11#1)(1993-2#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-12#4)(1997-4#3)(1997-8#1)(2006-6#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the bacterial cell##3##3##(2008-10#3)
the bacterial chloramphenicol acetyltransferase gene##2##5##(1990-12#1)(1993-3#1)
the bacterial chloramphenicol acetyltransferase##3##4##(1990-12#1)(1993-3#1)(1993-8#1)
the bacterial community##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
the bacterial count##2##3##(2008-5#2)
the bacterial cytoplasmic membrane##3##4##(1990-11#3)
the bacterial number##3##3##(2008-7#3)
the bacterial pathogen##2##3##(2008-10#2)
the bacterial populations##3##3##(2008-10#3)
the bacterial spot pathogen##3##4##(2008-10#3)
the bacterial strain##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
the bacterial strains##2##3##(2008-10#1)(2010-2#1)
the bacterial surface##2##3##(1990-12#1)(2008-1#1)
the bacterial##88##2##(1990-11#4)(1990-12#2)(1991-12#2)(1991-3#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-8#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-8#1)
the bacterially expressed##3##3##(1994-11#2)(1994-5#1)
the bactericidal##3##2##(1991-2#1)(1991-8#1)(2010-4#1)
the bacteriophage T4##2##3##(1990-5#1)(1995-6#1)
the bacteriophage##8##2##(1990-5#1)(1991-5#1)(1992-12#2)(1995-6#1)(1996-2#1)(2008-2#1)(2008-8#1)
the bacterium Erwinia##3##3##(2008-10#3)
the bacterium Pseudomonas##2##3##(2008-10#1)(2008-8#1)
the bacterium and##2##3##(2008-5#1)(2008-7#1)
the bacterium into the host##2##5##(1996-12#1)(2013-1#1)
the bacterium to##3##3##(2008-10#2)(2011-1#1)
the bacterium##36##2##(1990-11#1)(1992-11#1)(1993-6#1)(1993-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#19)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)
the baculovirus expression system##5##4##(1992-8#1)(1995-6#1)(1997-4#1)(2008-2#2)
the baculovirus expression vector system##2##5##(1997-4#1)(2008-7#1)
the baculovirus expression##7##3##(1992-8#1)(1995-6#1)(1997-4#2)(2008-2#2)(2008-7#1)
the baculovirus very late##2##4##(1997-3#1)(1997-4#1)
the baculovirus##16##2##(1992-8#1)(1995-6#1)(1997-3#3)(1997-4#3)(2008-11#1)(2008-2#5)(2008-7#2)
the baculovirus-insect cell system##4##4##(1997-4#1)(2008-11#2)(2008-7#1)
the bad##7##2##(1993-11#1)(2008-10#1)(2008-7#3)(2011-2#1)(2013-8#1)
the baffle system##3##3##(1995-3#3)
the bait-lamina test##2##3##(2008-11#2)
the baker's transformation##2##3##(2007-10#2)
the baking industry##2##3##(2010-7#2)
the baking##3##2##(1990-3#1)(2010-7#2)
the balance between##18##3##(1992-12#1)(1993-1#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#2)(2012-1#1)(2013-7#1)(2013-8#1)
the balance in the##2##4##(2008-11#1)(2008-3#1)
the balance in##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
the balance of the##2##4##(2008-5#1)(2008-9#1)
the balance of##14##3##(1992-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
the balance##35##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-8#2)(1995-5#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#2)
the balanced##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the ball##11##2##(2008-11#1)(2008-3#1)(2008-6#3)(2009-7#2)(2011-1#3)(2011-2#1)
the ballistic##3##2##(2008-3#2)(2008-7#1)
the balloon and##2##3##(2008-10#1)(2008-7#1)
the balloon##8##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-8#1)
the ban on##2##3##(1996-5#1)(2011-3#1)
the ban##6##2##(1995-6#3)(1996-1#1)(1996-5#1)(2011-3#1)
the band gap##4##3##(2008-10#2)(2008-2#1)(2013-8#1)
the band positions##2##3##(2008-10#1)(2008-9#1)
the band##19##2##(1993-11#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#2)
the bandage##2##2##(2008-10#2)
the bandgap of##3##3##(2007-12#2)(2008-3#1)
the bandgap##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
the bandpass##2##2##(2007-11#1)(2008-2#1)
the bands in##3##3##(2008-10#2)(2008-9#1)
the bands of##2##3##(2008-10#1)(2008-4#1)
the bands##9##2##(1994-6#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
the bandwidth from##2##3##(2007-11#2)
the bandwidth of the##7##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)
the bandwidth of##11##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)
the bandwidth##29##2##(1994-8#1)(2007-11#6)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#13)
the barbed##2##2##(2008-1#1)(2012-2#1)
the bare electrode##4##3##(2008-10#4)
the bare##14##2##(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#1)(2013-1#1)
the barium hydroxide##2##3##(2008-10#2)
the barium##3##2##(2008-10#3)
the bark##2##2##(2008-10#1)(2008-7#1)
the barley stripe##2##3##(1997-3#1)(2008-10#1)
the barley##14##2##(1997-3#1)(2008-10#9)(2008-5#3)(2008-9#1)
the barn owl##2##3##(1990-5#2)
the barn##3##2##(1990-5#2)(2008-9#1)
the barrier for##4##3##(1996-2#1)(2007-7#1)(2012-1#1)(2013-1#1)
the barrier function of the##3##5##(2008-5#3)
the barrier function of##4##4##(2008-5#4)
the barrier function##8##3##(2008-5#7)(2008-7#1)
the barrier in##2##3##(2007-7#1)(2008-3#1)
the barrier##25##2##(1992-9#1)(1996-2#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#9)(2008-7#2)(2008-8#1)(2012-1#1)(2013-1#1)
the barriers perceived by##2##4##(1994-1#1)(2012-2#1)
the barriers that##5##3##(1994-12#1)(1996-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
the barriers to the##2##4##(1996-5#1)(2008-8#1)
the barriers to##8##3##(1991-1#1)(1993-12#1)(1994-1#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-8#1)(2013-1#1)
the barriers##25##2##(1990-11#1)(1991-1#1)(1993-12#1)(1994-1#4)(1994-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#3)(2008-8#2)(2009-5#1)(2011-1#2)(2012-2#2)(2013-1#2)
the basal ES at the##2##5##(2012-2#2)
the basal ES##5##3##(2012-2#5)
the basal activity of##2##4##(1995-6#1)(2009-11#1)
the basal activity##3##3##(1992-7#1)(1995-6#1)(2009-11#1)
the basal and##4##3##(1993-3#1)(1996-2#2)(2009-10#1)
the basal body of the flagellum##2##6##(2008-7#2)
the basal body##3##3##(1991-11#1)(2008-7#2)
the basal diet##2##3##(1992-9#1)(2008-10#1)
the basal expression##2##3##(1993-12#1)(2008-6#1)
the basal forebrain cholinergic neurons##2##5##(1991-12#2)
the basal forebrain cholinergic##3##4##(1991-12#2)(1996-5#1)
the basal forebrain##7##3##(1991-12#2)(1992-10#2)(1993-12#1)(1996-5#2)
the basal ganglia and##2##4##(1995-5#1)(2008-7#1)
the basal ganglia of amphibians##2##5##(1997-3#2)
the basal ganglia##23##3##(1994-3#1)(1995-3#2)(1995-5#1)(1996-12#2)(1997-3#2)(2008-1#1)(2008-7#8)(2009-10#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
the basal lamina##6##3##(1992-9#1)(2007-12#1)(2008-12#2)(2008-5#1)(2009-10#1)
the basal level of##3##4##(1992-9#1)(1993-8#1)(1996-5#1)
the basal level##5##3##(1992-9#1)(1993-8#1)(1995-12#1)(1996-5#1)(1997-7#1)
the basal medium##4##3##(2008-10#1)(2008-11#3)
the basal nuclei of Meynert##2##5##(1995-5#1)(1997-2#1)
the basal or##2##3##(1995-2#1)(2008-6#1)
the basal part of the##2##5##(1991-9#2)
the basal promoter##2##3##(1991-6#1)(1997-7#1)
the basal secretion##2##3##(1995-5#1)(2008-7#1)
the basal transcriptional machinery##2##4##(2010-11#2)
the basal##133##2##(1991-11#1)(1991-12#2)(1991-6#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-7#1)(1992-9#4)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#3)(1996-12#4)(1996-2#4)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#8)(2008-6#2)(2008-7#16)(2008-8#2)(2008-9#4)(2009-10#4)(2009-11#1)(2009-6#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#7)(2012-3#3)(2013-1#1)(2013-8#2)
the basalis##2##2##(1994-9#2)
the base and##5##3##(2008-10#2)(2008-5#3)
the base of support##2##4##(1994-1#2)
the base of the food web is##2##7##(2008-9#2)
the base of the food web##3##6##(2008-9#3)
the base of the pole##2##5##(2011-2#2)
the base of the skull##3##5##(1991-3#1)(2008-7#1)(2013-1#1)
the base of the##24##4##(1991-2#1)(1991-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#1)
the base of tongue##5##4##(2013-1#5)
the base of##42##3##(1991-2#1)(1991-3#1)(1992-9#1)(1994-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-11#1)(2011-2#4)(2012-3#1)(2013-1#6)
the base sequence##2##3##(1991-9#1)(1993-11#1)
the base to##3##3##(1991-12#1)(1993-11#1)(2008-10#1)
the base##78##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-1#2)(1995-5#1)(1995-6#1)(1997-2#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2010-11#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#6)
the baseline and##6##3##(1992-9#1)(2007-10#1)(2008-10#2)(2008-3#1)(2012-4#1)
the baseline colonoscopy##2##3##(1997-8#2)
the baseline condition##3##3##(1992-7#1)(1995-11#1)(2013-1#1)
the baseline drift##2##3##(2008-10#2)
the baseline levels##2##3##(1994-6#1)(1997-4#1)
the baseline separation of##2##4##(2008-10#2)
the baseline startle##2##3##(2008-11#2)
the baseline week##2##3##(2008-7#2)
the baseline##65##2##(1990-11#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-11#1)(1997-4#2)(1997-8#2)(2007-10#2)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#7)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-4#1)(2013-1#5)
the baselines##2##2##(1992-1#1)(2008-2#1)
the basement membrane and the##2##5##(2009-10#1)(2013-8#1)
the basement membrane and##4##4##(1992-9#2)(2009-10#1)(2013-8#1)
the basement membrane of##2##4##(2011-2#1)(2012-2#1)
the basement membrane##14##3##(1992-9#3)(1995-12#1)(2009-10#5)(2011-2#1)(2012-2#2)(2013-8#2)
the basement##15##2##(1992-9#3)(1995-12#1)(2007-12#1)(2009-10#5)(2011-2#1)(2012-2#2)(2013-8#2)
the bases of##8##3##(1991-5#1)(1994-3#1)(1995-2#1)(2008-10#4)(2008-7#1)
the bases##16##2##(1991-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-7#2)
the basic amphipathic##2##3##(1990-2#2)
the basic and##2##3##(1994-12#1)(2008-2#1)
the basic aspects##2##3##(2008-1#1)(2010-6#1)
the basic assumptions of the##2##5##(2007-12#1)(2010-9#1)
the basic biology of##3##4##(1991-12#1)(2008-4#1)(2010-3#1)
the basic cell##2##3##(1994-9#1)(2008-3#1)
the basic concepts of##4##4##(1993-3#1)(1994-3#1)(2008-9#1)(2011-2#1)
the basic concepts##7##3##(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
the basic features of the##3##5##(1994-8#1)(2008-3#1)(2012-1#1)
the basic features of##6##4##(1994-8#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-1#1)
the basic information needed to##2##5##(1994-2#1)(2008-7#1)
the basic information##3##3##(1990-12#1)(1994-2#1)(2008-7#1)
the basic knowledge##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
the basic mechanisms of##4##4##(2006-10#1)(2006-12#1)(2010-9#1)(2012-1#1)
the basic mechanisms underlying the##2##5##(1994-11#1)(2010-10#1)
the basic mechanisms##9##3##(1994-11#1)(2006-10#1)(2006-12#1)(2010-10#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-7#1)
the basic methodology for##2##4##(2008-10#1)(2008-4#1)
the basic methods of recycling steel cans##2##7##(1996-12#1)(1996-3#1)
the basic methods##3##3##(1996-12#1)(1996-3#1)(2007-11#1)
the basic operation of the##2##5##(2007-12#1)(2008-4#1)
the basic performance of##2##4##(2008-10#2)
the basic principles and##2##4##(2011-1#1)(2012-1#1)
the basic principles of the##3##5##(2008-9#2)(2011-7#1)
the basic principles of##10##4##(1997-3#1)(2007-12#1)(2008-2#1)(2008-9#3)(2009-5#1)(2010-3#1)(2010-7#1)(2011-7#1)
the basic principles##13##3##(1997-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-9#3)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-7#1)(2012-1#1)
the basic procedures##2##3##(2008-4#1)(2008-7#1)
the basic protocol that##2##4##(2008-4#2)
the basic protocol##9##3##(2008-1#1)(2008-4#8)
the basic question##2##3##(2010-8#1)(2013-1#1)
the basic reproductive number##4##4##(2008-10#4)
the basic requirements for##2##4##(2008-10#1)(2008-2#1)
the basic requirements of##2##4##(2008-5#1)(2012-12#1)
the basic requirements##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
the basic side chain##2##4##(1995-11#2)
the basic theory##2##3##(1997-2#1)(2012-3#1)
the basic##184##2##(1990-12#1)(1990-2#2)(1991-12#2)(1992-1#1)(1992-11#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-7#1)(2008-1#4)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#19)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#5)(2011-7#1)(2012-1#3)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)
the basicities##2##2##(1996-2#2)
the basicity of##2##3##(2008-10#2)
the basicity##3##2##(2008-10#3)
the basics of image##2##4##(2008-4#1)(2008-9#1)
the basics of##7##3##(1995-8#1)(2007-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2013-1#1)
the basidiomata of Thelephora sp##2##5##(2013-7#2)
the basidiomycete##5##2##(1991-11#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-6#1)
the basil##3##2##(2008-10#2)(2008-5#1)
the basilar artery##9##3##(1996-6#1)(1997-6#2)(2007-10#1)(2008-4#2)(2011-2#1)(2013-8#2)
the basilar##15##2##(1996-6#1)(1997-6#3)(2007-10#2)(2008-4#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
the basin##3##2##(1997-5#1)(2008-11#2)
the basis and##2##3##(2008-12#1)(2011-2#1)
the basis for a##10##4##(1990-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
the basis for an##4##4##(1992-6#1)(2008-11#1)(2008-3#1)(2012-2#1)
the basis for developing##2##4##(2007-12#1)(2008-7#1)
the basis for further##2##4##(2007-11#1)(2009-7#1)
the basis for subsequent##2##4##(2008-7#1)(2008-9#1)
the basis for the development of##2##6##(1996-1#1)(2012-1#1)
the basis for the##24##4##(1990-5#1)(1990-8#1)(1991-9#1)(1992-11#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2009-7#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
the basis for this effect is not##2##7##(2008-10#1)(2012-3#1)
the basis for this##5##4##(1995-6#1)(1997-2#1)(2008-10#1)(2010-3#1)(2012-3#1)
the basis for##100##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-12#1)(1994-11#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-7#1)(2013-8#4)
the basis of a recent##2##5##(1990-9#1)(2007-12#1)
the basis of a##42##4##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#2)
the basis of all##2##4##(2008-2#1)(2008-5#1)
the basis of an##11##4##(1994-11#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-6#1)
the basis of analysis of the##2##6##(2013-1#1)(2013-8#1)
the basis of biological##2##4##(1997-6#1)(2008-10#1)
the basis of clinical##5##4##(1990-6#1)(1993-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
the basis of comparison##2##4##(2008-10#1)(2008-9#1)
the basis of current##2##4##(2007-8#1)(2010-1#1)
the basis of data##4##4##(1990-9#1)(1994-5#1)(2007-8#1)(2008-2#1)
the basis of differences in##2##5##(2008-10#2)
the basis of differences##3##4##(2008-10#2)(2013-1#1)
the basis of disease##2##4##(2008-2#1)(2013-1#1)
the basis of experimental results##4##5##(1995-11#2)(2008-2#2)
the basis of genetic##2##4##(2008-10#1)(2008-6#1)
the basis of infrared##2##4##(1997-7#1)(2008-10#1)
the basis of its##8##4##(1992-12#1)(1992-9#1)(1993-11#1)(2008-10#3)(2008-3#1)(2008-6#1)
the basis of molecular##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
the basis of personal experience##2##5##(1990-3#2)
the basis of present##2##4##(1991-6#1)(2008-12#1)
the basis of previous##2##4##(1990-12#1)(1996-12#1)
the basis of results##2##4##(1990-6#1)(2011-2#1)
the basis of the available##3##5##(1991-12#1)(2007-11#1)(2009-4#1)
the basis of the data obtained##3##6##(1991-2#1)(1993-6#1)(2008-10#1)
the basis of the data##4##5##(1991-2#1)(1993-6#1)(2008-10#2)
the basis of the differences in##3##6##(1992-12#1)(1996-5#1)(2008-10#1)
the basis of the literature and##2##6##(2007-8#2)
the basis of the mechanism##3##5##(1992-3#1)(2008-10#2)
the basis of the results of##5##6##(1991-9#1)(1995-12#1)(2007-11#1)(2008-10#2)
the basis of the results##10##5##(1990-5#1)(1990-6#1)(1991-3#1)(1991-9#1)(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-6#1)
the basis of the##129##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#3)(1992-6#1)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#7)(2007-12#1)(2007-8#3)(2008-10#30)(2008-11#5)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
the basis of their##30##4##(1990-5#1)(1990-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
the basis of theoretical##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
the basis of these methods##2##5##(2008-10#1)(2008-3#1)
the basis of these results##13##5##(1993-1#1)(1993-11#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2013-1#1)
the basis of these studies##2##5##(1994-5#1)(2008-10#1)
the basis of these##34##4##(1991-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2012-1#3)(2013-1#1)
the basis of this##21##4##(1990-6#1)(1991-2#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2011-2#1)(2012-3#2)
the basis of traditional##2##4##(1996-7#1)(1997-1#1)
the basis of##573##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#4)(1990-5#7)(1990-6#7)(1990-7#4)(1990-8#3)(1990-9#6)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#6)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#3)(1992-5#5)(1992-6#4)(1992-7#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#9)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#2)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#3)(2007-11#13)(2007-12#8)(2007-4#1)(2007-7#3)(2007-8#12)(2008-1#6)(2008-10#103)(2008-11#15)(2008-12#3)(2008-2#23)(2008-3#45)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#14)(2008-8#10)(2008-9#11)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-6#1)(2009-8#1)(2010-1#3)(2010-11#3)(2010-12#1)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#11)(2011-3#2)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#19)(2013-7#1)(2013-8#4)
the basis to##2##3##(2007-12#1)(2008-9#1)
the basis##688##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#4)(1990-5#8)(1990-6#7)(1990-7#4)(1990-8#4)(1990-9#6)(1991-1#2)(1991-12#3)(1991-2#5)(1991-3#6)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#4)(1992-5#5)(1992-6#6)(1992-7#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#10)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#2)(1995-1#2)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(2006-10#3)(2007-11#14)(2007-12#11)(2007-4#1)(2007-7#3)(2007-8#12)(2008-1#7)(2008-10#115)(2008-11#20)(2008-12#6)(2008-2#30)(2008-3#50)(2008-4#9)(2008-5#15)(2008-6#9)(2008-7#20)(2008-8#11)(2008-9#14)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#2)(2010-3#8)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#13)(2011-3#2)(2012-1#6)(2012-12#4)(2012-2#7)(2012-3#9)(2013-1#19)(2013-7#2)(2013-8#8)
the basitarsus##2##2##(2007-12#2)
the basolateral amygdala##9##3##(1990-5#1)(1993-12#1)(1993-6#3)(1995-12#2)(1997-7#1)(2008-7#1)
the basolateral cell surface##2##4##(1991-12#2)
the basolateral membrane of##2##4##(1992-5#1)(1994-3#1)
the basolateral membrane##4##3##(1992-5#1)(1993-3#1)(1994-3#1)(2008-11#1)
the basolateral membranes##2##3##(1990-5#1)(1993-6#1)
the basolateral##24##2##(1990-5#3)(1991-12#2)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-3#1)(1995-12#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-7#1)(2008-8#1)
the basophilic cells##2##3##(2008-7#2)
the bat##2##2##(2008-5#2)
the batch components##2##3##(2011-2#2)
the batch culture##4##3##(1994-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
the batch injection analysis##3##4##(2008-10#3)
the batch method##3##3##(2008-10#3)
the batch mode##2##3##(2008-10#2)
the batch##29##2##(1994-8#1)(2008-10#16)(2008-11#3)(2008-6#1)(2008-7#3)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
the batchculture with medium exchange##2##5##(2008-11#2)
the batchwise method##2##3##(2008-10#2)
the batchwise##3##2##(2008-10#3)
the bath##4##2##(1992-11#1)(1995-3#1)(2008-12#1)(2008-4#1)
the bathtub##7##2##(1995-3#7)
the battery##4##2##(1996-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
the battle against##3##3##(2008-3#1)(2009-5#1)(2012-2#1)
the battle##7##2##(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-2#1)
the bc-1(2)##2##2##(2008-10#2)
the bcl-2 and bag-1##2##4##(2008-11#2)
the bcl-2 gene##2##3##(1993-3#1)(1994-3#1)
the bcl-2 product##3##3##(1994-10#3)
the bcl-2 transfected cells##2##4##(2008-11#2)
the bcl-2 transfected##4##3##(2008-11#4)
the bcl-2##16##2##(1993-3#3)(1994-10#4)(1994-3#1)(2008-11#8)
the beach##4##2##(2007-5#2)(2008-2#1)(2010-8#1)
the beacon##2##2##(2008-2#1)(2008-3#1)
the bead injection##2##3##(2008-10#2)
the bead##7##2##(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)
the beads task##3##3##(2012-1#3)
the beads##18##2##(1995-6#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-1#3)
the beam and##2##3##(2008-2#2)
the beam at##2##3##(1997-8#1)(2008-3#1)
the beam axis##3##3##(2007-11#1)(2008-2#2)
the beam collimation of a lens##2##6##(2008-3#2)
the beam divergence and##2##4##(2007-12#1)(2008-3#1)
the beam divergence##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the beam fanning##2##3##(2008-3#2)
the beam in##2##3##(2008-3#2)
the beam intensity##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the beam is spatially##2##4##(2007-11#1)(2008-3#1)
the beam is##7##3##(2007-11#2)(2008-2#1)(2008-3#4)
the beam propagation method##4##4##(2007-11#2)(2008-3#2)
the beam quality produced by the##2##6##(2008-3#2)
the beam quality##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
the beam ratio##2##3##(2008-3#2)
the beam shape##2##3##(2008-2#1)(2008-3#1)
the beam size##2##3##(2008-3#2)
the beam splitter##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
the beam that is##2##4##(2007-12#1)(2008-3#1)
the beam that##3##3##(2007-12#2)(2008-3#1)
the beam through##2##3##(2008-2#1)(2012-3#1)
the beam waist##2##3##(2007-11#1)(2008-10#1)
the beam width##2##3##(2008-3#2)
the beam##122##2##(1997-8#2)(2007-11#17)(2007-12#12)(2008-10#3)(2008-11#1)(2008-2#23)(2008-3#58)(2009-11#1)(2009-7#1)(2011-1#1)(2012-1#2)(2012-3#1)
the beam's transverse##2##3##(2007-11#1)(2008-3#1)
the beam's##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
the beam-fanning novelty filter##2##4##(2008-3#2)
the beam-fanning phenomenon##2##3##(2008-3#2)
the beam-fanning##4##2##(2008-3#4)
the beam-pointing jitter error##2##4##(2008-3#2)
the beam-propagation##2##2##(2007-12#1)(2008-3#1)
the beam-quality parameter##2##3##(2008-3#2)
the beam-shape coefficients##2##3##(2008-2#1)(2008-3#1)
the beam-splitter##5##2##(2008-3#5)
the beamline##2##2##(2008-11#2)
the beams##10##2##(2006-4#1)(2007-12#1)(2008-2#5)(2008-3#3)
the bean crop##2##3##(2008-10#2)
the bean population##2##3##(2008-8#2)
the bean##9##2##(2008-10#4)(2008-8#2)(2010-11#2)(2011-10#1)
the beans##4##2##(2008-10#1)(2008-3#3)
the beat frequency##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
the beat length##2##3##(2007-12#1)(2008-3#1)
the beat##16##2##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#6)(2013-7#1)
the beating heart##6##3##(2007-8#5)(2009-12#1)
the beating##9##2##(1996-3#1)(2007-8#5)(2008-11#2)(2009-12#1)
the beauty##2##2##(2008-9#2)
the bed is##2##3##(2008-6#1)(2009-4#1)
the bed of##2##3##(2008-7#1)(2008-9#1)
the bed##15##2##(1994-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#1)
the bedside and##2##3##(1993-3#1)(2007-3#1)
the bedside##7##2##(1993-3#1)(1996-1#1)(1996-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2011-2#1)
the bee##3##2##(1996-5#1)(2008-5#1)(2008-7#1)
the beet cyst nematode##3##4##(2008-10#1)(2008-12#2)
the beet##6##2##(2008-10#4)(2008-12#2)
the beetle##2##2##(2008-5#1)(2008-6#1)
the beginning of a##6##4##(1991-12#1)(1997-2#1)(2007-11#1)(2008-10#2)(2012-2#1)
the beginning of each##7##4##(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
the beginning of the 1990s##2##5##(1997-6#1)(2008-8#1)
the beginning of the 20th century##3##6##(2009-7#2)(2010-10#1)
the beginning of the study##2##5##(2008-9#1)(2011-1#1)
the beginning of the third##2##5##(1997-8#1)(2008-10#1)
the beginning of the##51##4##(1990-12#1)(1990-2#1)(1991-7#1)(1992-2#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-3#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#3)(2010-10#1)(2010-2#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
the beginning of treatment##2##4##(2011-2#1)(2013-1#1)
the beginning of##105##3##(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-2#2)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)
the beginning to##3##3##(2007-8#1)(2010-1#1)(2010-3#1)
the beginning##137##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#3)(1991-12#2)(1991-7#1)(1992-2#2)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#3)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#5)(2013-7#1)
the beginnings of##3##3##(2008-10#3)
the behaving##2##2##(1993-6#1)(2007-12#1)
the behavior and##5##3##(1991-12#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
the behavior observed##4##3##(2008-10#2)(2008-7#1)(2009-11#1)
the behavior of a##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
the behavior of an##2##4##(2008-10#1)(2008-8#1)
the behavior of cells##2##4##(2008-11#1)(2009-12#1)
the behavior of dispersion-managed solitons##2##5##(2007-12#2)
the behavior of dispersion-managed##3##4##(2007-12#3)
the behavior of individual##2##4##(1994-9#1)(2008-3#1)
the behavior of its##2##4##(2008-8#1)(2009-5#1)
the behavior of some##2##4##(1991-4#1)(2008-3#1)
the behavior of the wild-type##2##5##(1995-6#1)(2008-10#1)
the behavior of the##24##4##(1990-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
the behavior of these pumps##2##5##(2011-2#2)
the behavior of these##4##4##(1996-5#1)(2008-3#1)(2011-2#2)
the behavior of##88##3##(1990-8#1)(1991-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#3)(2007-10#1)(2007-12#8)(2008-10#10)(2008-11#5)(2008-2#2)(2008-3#14)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#3)(2009-12#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
the behavior##104##2##(1990-8#1)(1991-12#1)(1991-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#3)(2007-10#1)(2007-12#8)(2008-10#13)(2008-11#7)(2008-2#2)(2008-3#15)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
the behavioral activation##2##3##(1993-12#1)(2011-2#1)
the behavioral and biochemical##2##4##(1993-12#1)(1995-12#1)
the behavioral and neurochemical##2##4##(2008-4#1)(2011-2#1)
the behavioral and##9##3##(1991-1#1)(1993-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
the behavioral effects of cocaine by##2##6##(1991-1#1)(2008-10#1)
the behavioral inhibition system##2##4##(2009-9#2)
the behavioral tasks##2##3##(1997-2#2)
the behavioral##38##2##(1991-1#2)(1992-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-12#3)(1996-2#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-8#5)(2008-9#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
the behaviors of##2##3##(2008-5#1)(2008-8#1)
the behaviors##5##2##(1995-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
the behaviour of a##3##4##(2008-10#2)(2008-12#1)
the behaviour of the##8##4##(1992-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)
the behaviour of##35##3##(1990-2#1)(1990-9#2)(1991-5#1)(1992-3#1)(1993-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#3)(2012-2#1)(2012-7#1)
the behaviour##39##2##(1990-2#1)(1990-9#2)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2011-2#3)(2012-2#1)(2012-7#1)
the behavioural##12##2##(1992-11#1)(1992-7#2)(1994-3#1)(1994-8#1)(1995-12#2)(1996-2#1)(2008-9#3)(2012-2#1)
the belief that the##2##4##(1994-2#1)(1996-2#1)
the belief that##10##3##(1990-5#1)(1991-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)
the beliefs##2##2##(1994-12#1)(2008-11#1)
the belly and groin##2##4##(1996-12#2)
the bench##4##2##(1996-2#1)(2007-3#1)(2008-3#1)(2008-5#1)
the benchmark##7##2##(1991-2#1)(2008-5#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
the benchmarking##4##2##(1995-12#3)(2008-11#1)
the bend##3##2##(1992-5#1)(1996-2#1)(2008-3#1)
the bending##5##2##(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
the beneficial effect of##8##4##(1990-2#1)(1994-11#1)(1996-1#1)(1997-5#1)(2008-10#2)(2012-3#1)(2013-7#1)
the beneficial effects of##12##4##(1992-7#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#3)(2011-2#2)(2012-12#1)(2012-2#2)
the beneficial effects##14##3##(1992-7#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#4)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#2)
the beneficial role##2##3##(2008-1#1)(2010-1#1)
the beneficial##35##2##(1990-2#1)(1991-12#1)(1992-7#1)(1994-11#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
the beneficiaries in##2##3##(1991-3#1)(2008-7#1)
the beneficiaries##3##2##(1991-3#1)(1994-3#1)(2008-7#1)
the benefit and##3##3##(1994-2#1)(1995-3#1)(2012-3#1)
the benefit may##2##3##(1991-8#1)(1993-11#1)
the benefit of a##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
the benefit of the##6##4##(1992-2#1)(1997-2#1)(1997-8#1)(2008-11#1)(2013-1#2)
the benefit of##46##3##(1992-11#1)(1992-2#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
the benefit to##3##3##(1991-1#1)(1992-3#1)(2008-8#1)
the benefit##61##2##(1991-1#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
the benefits and challenges of##2##5##(1997-2#1)(2011-2#1)
the benefits and costs of##2##5##(1993-1#1)(2009-4#1)
the benefits and costs##3##4##(1993-1#1)(1995-3#1)(2009-4#1)
the benefits and drawbacks of##2##5##(2013-1#2)
the benefits and limitations of##5##5##(1996-12#1)(1997-3#1)(2008-10#1)(2008-6#1)(2010-8#1)
the benefits and problems##2##4##(1990-2#1)(2008-3#1)
the benefits and risks of##5##5##(1993-1#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
the benefits and risks##8##4##(1992-3#1)(1993-1#1)(2008-6#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
the benefits and##24##3##(1990-2#1)(1992-3#1)(1993-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-12#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
the benefits are##2##3##(1992-3#1)(2009-1#1)
the benefits for##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
the benefits from##3##3##(1997-7#1)(2009-6#1)(2013-8#1)
the benefits of a comprehensive##2##5##(1993-1#1)(2008-3#1)
the benefits of a##6##4##(1991-2#1)(1993-1#1)(1994-2#1)(1996-3#1)(2008-12#1)(2008-3#1)
the benefits of early##2##4##(1992-2#1)(2012-2#1)
the benefits of implementing##2##4##(2008-3#2)
the benefits of philopatry##2##4##(2008-8#2)
the benefits of recycling##2##4##(1996-12#1)(1996-3#1)
the benefits of such##2##4##(1992-3#1)(2011-1#1)
the benefits of the##10##4##(1992-12#1)(1993-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
the benefits of using##2##4##(2009-5#1)(2010-8#1)
the benefits of##82##3##(1990-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-5#1)(2009-9#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
the benefits to be gained##2##5##(1994-2#1)(1994-3#1)
the benefits to##6##3##(1994-2#1)(1994-3#1)(2010-12#3)(2011-2#1)
the benefits##136##2##(1990-11#1)(1990-2#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#3)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#5)(2009-1#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#3)
the benign nature of the##2##5##(2010-12#1)(2011-1#1)
the benign nature of##3##4##(2010-12#1)(2011-1#1)(2011-2#1)
the benign##9##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
the benomyl-resistant##3##2##(1997-2#1)(2008-10#2)
the bent##9##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
the benthic##4##2##(2007-5#2)(2008-9#1)(2011-2#1)
the benzene molecules##2##3##(1993-11#2)
the benzene ring##2##3##(2008-10#2)
the benzene sulfonic acid monolayer film##2##6##(2008-10#2)
the benzene##8##2##(1993-11#2)(2008-10#6)
the benzodiazepine receptor##3##3##(1992-3#1)(1994-2#1)(1995-11#1)
the benzodiazepine##9##2##(1992-3#2)(1994-2#1)(1995-11#5)(2008-10#1)
the benzodiazepine-Gaba receptor complex##2##4##(1991-1#2)
the benzoyl peroxide foaming cloth##3##5##(2010-8#3)
the benzoyl peroxide##4##3##(2008-10#1)(2010-8#3)
the benzoyl##9##2##(1990-9#1)(1991-3#1)(2007-11#2)(2008-10#1)(2010-8#4)
the benzylic##5##2##(1995-3#3)(2012-12#1)(2013-1#1)
the bereaved##2##2##(1991-2#1)(2008-12#1)
the berry surface##2##3##(2008-10#2)
the best accuracy##2##3##(2008-10#1)(2011-2#1)
the best alternative##3##3##(2008-10#2)(2008-4#1)
the best analytical performance##2##4##(2008-10#2)
the best analytical##4##3##(2008-10#4)
the best and##3##3##(2007-11#1)(2008-4#1)(2008-6#1)
the best approach for##2##4##(1996-1#1)(2008-10#1)
the best approach##7##3##(1992-2#1)(1995-12#1)(1996-1#1)(2008-10#3)(2009-12#1)
the best at##2##3##(1992-8#1)(2008-6#1)
the best available data##2##4##(2008-3#1)(2012-1#1)
the best available evidence##2##4##(2007-11#1)(2008-9#1)
the best available##8##3##(2007-11#1)(2008-3#2)(2008-9#1)(2011-2#3)(2012-1#1)
the best basis for##2##4##(2008-10#1)(2012-3#1)
the best basis##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
the best candidate##2##3##(2006-6#1)(2008-10#1)
the best care##2##3##(1992-11#1)(2010-11#1)
the best chance of##4##4##(1994-6#1)(1994-7#1)(1997-3#1)(2013-1#1)
the best chance##5##3##(1994-6#1)(1994-7#1)(1997-3#1)(2008-4#1)(2013-1#1)
the best characterized##7##3##(1991-12#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#1)
the best choice for##6##4##(2008-10#4)(2008-3#1)(2012-3#1)
the best choice##10##3##(2008-10#5)(2008-3#4)(2012-3#1)
the best clinical##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
the best combination of##4##4##(1993-1#1)(2008-12#1)(2008-3#1)(2008-7#1)
the best combination##6##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)
the best compromise of##3##4##(1997-7#1)(2008-10#1)(2009-7#1)
the best compromise##4##3##(1997-7#1)(2008-10#2)(2009-7#1)
the best conditions for the##3##5##(2008-10#2)(2011-2#1)
the best conditions for##7##4##(1992-9#1)(2008-10#5)(2011-2#1)
the best conditions##11##3##(1992-9#1)(2008-10#7)(2008-11#1)(2011-2#1)(2013-1#1)
the best diagnostic##3##3##(1990-9#1)(1991-2#1)(2013-8#1)
the best enantioselectivity and time-stability##2##5##(2008-10#2)
the best evidence to answer the clinical question##9##8##(2007-8#9)
the best evidence to answer the##10##6##(2007-8#10)
the best evidence to##11##4##(2007-8#10)(2009-8#1)
the best evidence##14##3##(2007-8#12)(2008-7#1)(2009-8#1)
the best experiment##2##3##(2008-5#1)(2013-8#1)
the best experimental conditions##2##4##(2007-12#1)(2008-10#1)
the best extraction efficiency##2##4##(2008-10#2)
the best extraction##3##3##(2008-10#3)
the best fit for##2##4##(2008-10#2)
the best fit##7##3##(1995-5#1)(1996-12#1)(2008-10#4)(2008-2#1)
the best for##6##3##(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#2)
the best formulation##2##3##(2012-2#2)
the best functional##2##3##(2008-6#1)(2012-12#1)
the best in##3##3##(1995-3#1)(2007-4#1)(2008-8#1)
the best information##2##3##(2008-9#1)(2011-1#1)
the best interests of the##3##5##(1992-3#1)(2010-9#2)
the best interests of##4##4##(1992-3#1)(1995-2#1)(2010-9#2)
the best jump height##2##4##(2009-1#2)
the best known and##2##4##(1991-4#1)(1995-5#1)
the best known##8##3##(1991-4#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)
the best long-term##3##3##(2008-10#1)(2009-5#1)(2009-8#1)
the best management of##2##4##(2007-12#1)(2013-1#1)
the best management##3##3##(2007-12#1)(2010-3#1)(2013-1#1)
the best means of##2##4##(1996-3#1)(2008-5#1)
the best method of##3##4##(2007-8#1)(2008-3#1)(2013-1#1)
the best method##6##3##(1990-12#1)(1994-5#1)(2007-8#1)(2008-3#1)(2008-6#1)(2013-1#1)
the best model for##3##4##(2008-3#1)(2010-4#1)(2011-2#1)
the best model of##2##4##(2008-10#1)(2010-4#1)
the best model##7##3##(2008-10#2)(2008-3#1)(2010-4#2)(2010-8#1)(2011-2#1)
the best modifier##2##3##(2008-10#2)
the best of our knowledge##44##5##(1991-9#1)(1994-12#1)(1995-5#1)(2007-11#4)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-6#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the best of our##46##4##(1991-9#1)(1994-12#1)(1995-5#1)(2007-11#4)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-6#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the best of the##5##4##(1996-7#1)(1996-8#1)(1997-4#1)(2008-2#1)(2011-1#1)
the best of##57##3##(1991-9#1)(1994-1#1)(1994-12#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-11#4)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#5)(2008-6#1)(2008-8#1)(2009-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the best one##3##3##(1991-3#1)(2007-12#1)(2011-2#1)
the best option##4##3##(1996-3#1)(2007-7#1)(2008-9#1)(2011-2#1)
the best outcome##2##3##(2007-8#1)(2011-1#1)
the best overall##2##3##(2010-4#1)(2012-2#1)
the best peak##2##3##(2008-10#2)
the best performance in##2##4##(2008-10#2)
the best performance of##3##4##(2008-10#2)(2008-11#1)
the best performance was##2##4##(2008-10#2)
the best performance##9##3##(1995-3#1)(2008-10#7)(2008-11#1)
the best possible care##2##4##(1995-1#1)(2013-1#1)
the best possible##13##3##(1993-12#1)(1994-1#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
the best practices##2##3##(1996-3#1)(2008-11#1)
the best prediction results##2##4##(2008-10#2)
the best prediction##3##3##(1992-12#1)(2008-10#2)
the best predictor of##8##4##(1993-1#1)(1996-3#1)(1996-7#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
the best predictors of##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
the best predictors##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
the best protection against##2##4##(2008-10#1)(2008-5#1)
the best recoveries##2##3##(2008-10#2)
the best recovery##2##3##(2008-10#2)
the best response##2##3##(2008-10#1)(2008-12#1)
the best result##6##3##(2007-11#1)(2008-10#5)
the best results are obtained##3##5##(1990-6#1)(2008-10#1)(2008-3#1)
the best results are##4##4##(1990-6#1)(1994-11#1)(2008-10#1)(2008-3#1)
the best results in##2##4##(2008-4#1)(2011-2#1)
the best results were obtained using##2##6##(2008-10#1)(2013-1#1)
the best results were obtained##5##5##(2008-10#3)(2008-5#1)(2013-1#1)
the best results were##6##4##(2007-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
the best results##26##3##(1990-10#1)(1990-11#1)(1990-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
the best root##2##3##(2008-10#1)(2011-2#1)
the best selectivity for the##2##5##(2008-10#2)
the best selectivity in##2##4##(2008-10#2)
the best selectivity##6##3##(2008-10#6)
the best sensitivity##2##3##(2007-2#1)(2008-10#1)
the best separation##3##3##(2008-10#3)
the best signal##2##3##(2008-10#1)(2008-3#1)
the best single##2##3##(1991-12#1)(2008-3#1)
the best solution is##2##4##(2007-8#1)(2011-2#1)
the best solution##4##3##(1990-3#1)(2007-8#1)(2008-8#1)(2011-2#1)
the best storage##2##3##(1996-12#2)
the best strategy##2##3##(2011-2#1)(2011-3#1)
the best studied##2##3##(2008-12#1)(2008-3#1)
the best surgical approach##2##4##(2007-8#1)(2008-12#1)
the best surgical##3##3##(2007-8#1)(2008-12#1)(2010-8#1)
the best system##2##3##(1991-2#1)(2012-2#1)
the best temperatures for pyrolysis and atomization were##2##8##(2008-10#2)
the best temperatures for##3##4##(2008-10#3)
the best therapeutic##3##3##(1991-3#1)(1994-6#1)(2009-7#1)
the best therapy##3##3##(1993-12#1)(2011-2#1)(2013-1#1)
the best timing of application##2##5##(2008-10#2)
the best treatment for##5##4##(2008-12#1)(2008-7#2)(2010-3#1)(2013-1#1)
the best treatment##10##3##(1997-8#1)(2008-1#1)(2008-12#1)(2008-7#4)(2010-3#1)(2012-3#1)(2013-1#1)
the best understood##2##3##(2007-12#1)(2008-1#1)
the best value##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the best way of##2##4##(1993-11#1)(2010-12#1)
the best way to integrate##2##5##(1997-2#1)(2008-9#1)
the best way to##10##4##(1994-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-9#2)(2011-2#1)
the best way##13##3##(1990-12#1)(1993-11#1)(1994-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-9#2)(2010-12#1)(2011-2#1)
the best ways to##2##4##(2007-10#1)(2008-11#1)
the best ways##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
the best##603##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#5)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#6)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#2)(2007-11#14)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#20)(2008-1#6)(2008-10#148)(2008-11#15)(2008-12#13)(2008-2#16)(2008-3#29)(2008-4#10)(2008-5#17)(2008-6#9)(2008-7#15)(2008-8#11)(2008-9#12)(2009-1#2)(2009-11#2)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#28)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#8)(2013-1#22)(2013-7#2)(2013-8#9)
the best-fit##2##2##(2008-4#1)(2012-2#1)
the best-fitting##2##2##(2008-10#1)(2008-3#1)
the best-focus frame##2##3##(2008-3#2)
the best-known##2##2##(2008-8#1)(2008-9#1)
the best-performing##2##2##(2007-11#1)(2011-1#1)
the best-studied##2##2##(2007-7#1)(2008-7#1)
the beta 1##5##3##(1991-2#1)(1992-2#2)(1992-3#1)(1995-6#1)
the beta 2 strand of WW##2##6##(2008-11#2)
the beta 2 strand of##3##5##(2008-11#3)
the beta 2 strand##4##4##(2008-11#4)
the beta 2##6##3##(1993-6#1)(2008-11#4)(2010-6#1)
the beta 3-adrenoceptor##3##3##(1995-11#3)
the beta A4##2##3##(1992-8#1)(1992-9#1)
the beta adrenergic##2##3##(1994-9#1)(1997-1#1)
the beta gamma##2##3##(1992-9#1)(1993-6#1)
the beta subunit of human chorionic gonadotropin##2##7##(1993-6#1)(1994-8#1)
the beta subunit of##5##4##(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)
the beta subunit##17##3##(1990-7#2)(1992-3#1)(1992-9#3)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#2)(2008-8#1)
the beta##75##2##(1990-11#2)(1990-12#1)(1990-7#9)(1990-8#1)(1991-2#1)(1991-5#3)(1991-6#1)(1992-2#2)(1992-3#5)(1992-8#1)(1992-9#7)(1993-12#1)(1993-6#4)(1993-8#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-6#1)(2012-3#1)
the beta- and##5##3##(1990-8#2)(1993-8#1)(2006-12#1)(2008-10#1)
the beta-1##5##2##(1991-12#2)(2008-10#3)
the beta-CD cavity##3##3##(1994-3#1)(2008-10#2)
the beta-CD##5##2##(1994-3#1)(2008-10#3)(2008-11#1)
the beta-CGRP gene##2##3##(1992-6#2)
the beta-MyHC gene##2##3##(1995-2#2)
the beta-actin##2##2##(1996-2#1)(2008-11#1)
the beta-adrenergic receptor##2##3##(1995-3#2)
the beta-adrenergic##4##2##(1995-3#2)(2008-2#1)(2008-9#1)
the beta-amyloid precursor protein##2##4##(1992-12#2)
the beta-amyloid##3##2##(1992-12#2)(1992-8#1)
the beta-binomial distribution and##2##4##(2008-10#2)
the beta-binomial distribution to##2##4##(2008-10#2)
the beta-binomial distribution##12##3##(2008-10#11)(2010-3#1)
the beta-binomial##21##2##(2008-10#19)(2010-3#2)
the beta-binomial-based function##2##3##(2008-10#2)
the beta-blockers tested##5##3##(1995-6#5)
the beta-carboline##2##2##(2008-10#2)
the beta-cell##2##2##(1992-6#1)(2008-1#1)
the beta-chain of##3##3##(1995-3#2)(1995-6#1)
the beta-chain##5##2##(1991-6#1)(1993-8#1)(1995-3#2)(1995-6#1)
the beta-cyclodextrin##2##2##(2008-10#2)
the beta-elimination##2##2##(1995-2#1)(2009-8#1)
the beta-gal##2##2##(1997-8#1)(2008-7#1)
the beta-galactosidase from Lactobacillus delbrückii subsp##2##6##(1994-6#2)
the beta-galactosidase##7##2##(1992-12#1)(1994-11#1)(1994-6#2)(1997-8#2)(2008-11#1)
the beta-galactosidase-binding interface on cathepsin A##2##6##(1995-2#2)
the beta-globin gene##2##3##(1993-3#1)(2008-11#1)
the beta-glucuronidase##3##2##(2008-10#2)(2008-9#1)
the beta-lactamase##3##2##(1992-6#1)(1997-4#1)(2010-2#1)
the beta-lactams##2##2##(1993-8#1)(1996-3#1)
the beta-oxidation##3##2##(1990-5#1)(2008-6#1)(2012-2#1)
the beta-peptide##3##2##(2008-5#3)
the beta-secretase##2##2##(2008-11#2)
the beta-sheet##5##2##(1991-11#1)(1992-6#2)(1995-5#2)
the beta-subunit of##8##3##(1993-11#2)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-4#1)
the beta-subunit##10##2##(1992-9#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-6#2)(1994-9#1)(1996-12#1)(1997-4#1)
the beta-tubulin gene##5##3##(2008-10#5)
the beta-tubulin##9##2##(1995-5#1)(2008-10#7)(2010-3#1)
the beta-type complex of Y-CPApK##2##5##(2008-10#2)
the better control of##2##4##(2008-10#1)(2008-9#1)
the better efficacy of##2##4##(1994-6#1)(2011-2#1)
the better the##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
the better understanding of##2##4##(2010-8#1)(2013-8#1)
the better##36##2##(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the between-class scatter is generalized##2##5##(2008-6#2)
the bi-directional##2##2##(2008-10#1)(2009-3#1)
the bias and the##2##4##(1995-12#1)(2008-3#1)
the bias and##4##3##(1995-12#1)(1996-3#1)(2008-2#1)(2008-3#1)
the bias error##2##3##(2008-10#2)
the bias is##2##3##(2009-9#1)(2013-8#1)
the bias of##2##3##(2008-7#1)(2012-2#1)
the bias voltage is##2##4##(2008-10#2)
the bias##21##2##(1995-12#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#6)(2008-2#4)(2008-3#3)(2008-7#1)(2009-9#1)(2012-2#1)(2013-8#1)
the bibliography##3##2##(2008-10#2)(2013-1#1)
the biceps brachii##2##3##(2007-12#1)(2008-12#1)
the biceps##4##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-12#1)
the bicyclic##4##2##(1991-8#2)(1996-5#1)(2007-11#1)
the bidirectional communication##2##3##(2009-3#1)(2009-5#1)
the bidirectional reflectance distribution function##3##5##(2008-2#2)(2008-3#1)
the bidirectional reflectance##4##3##(2008-2#3)(2008-3#1)
the bidirectional##10##2##(2007-8#1)(2008-2#3)(2008-3#2)(2008-6#1)(2009-3#1)(2009-5#1)(2011-2#1)
the bifunctional fusion protein RM4/TNF##2##5##(1997-2#2)
the bifurcation##6##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
the big picture##2##3##(1995-6#1)(2013-8#1)
the big##4##2##(1995-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
the biggest impact##2##3##(2010-7#1)(2012-12#1)
the biggest##15##2##(1990-2#1)(1991-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
the bilateral##20##2##(1990-9#1)(1996-2#1)(1996-5#2)(1997-6#1)(2007-10#3)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#2)(2011-3#1)(2012-12#1)(2013-1#1)
the bilaterally##3##2##(1992-3#1)(2007-12#1)(2008-5#1)
the bilayer and##4##3##(1990-12#1)(1991-5#1)(1993-11#1)(2008-10#1)
the bilayer is##2##3##(1992-5#2)
the bilayer structure of##2##4##(1990-7#1)(2008-8#1)
the bilayer##31##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1991-5#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(2008-10#5)(2008-4#1)(2008-8#1)
the bilayers##4##2##(1992-5#1)(2008-10#2)(2008-8#1)
the bile duct##2##3##(1991-8#1)(2013-1#1)
the bile##12##2##(1990-8#1)(1991-3#2)(1991-8#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)
the biliary flow##2##3##(2012-2#1)(2013-1#1)
the biliary tree##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
the biliary##26##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#5)(2008-11#1)(2008-4#4)(2008-9#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the bilinear##2##2##(2008-10#1)(2008-6#1)
the biliverdin##2##2##(1992-3#1)(2008-10#1)
the bill##6##2##(1992-1#2)(1995-6#3)(1996-5#1)
the bimodal response##2##3##(2008-10#2)
the bimodal##6##2##(1991-2#1)(2008-10#2)(2008-12#1)(2009-7#1)(2013-8#1)
the bimolecular##2##2##(1992-2#1)(2008-8#1)
the binary complex of##3##4##(1995-5#3)
the binary complexes of##2##4##(2008-10#2)
the binary form of Taylor's power law##2##7##(2008-10#2)
the binary form of the##2##5##(2008-10#2)
the binary form of##4##4##(2008-10#4)
the binary mixture of##2##4##(2008-10#2)
the binary power law##4##4##(2008-10#4)
the binary power##5##3##(2008-10#5)
the binary##28##2##(1995-5#3)(2007-12#1)(2008-10#21)(2008-2#2)(2008-3#1)
the binder##2##2##(2008-10#2)
the binding ability of##2##4##(2008-10#2)
the binding activity##4##3##(1992-9#1)(1997-3#1)(1997-4#1)(1997-7#1)
the binding affinities of##2##4##(1993-11#1)(2008-11#1)
the binding affinities##3##3##(1993-11#1)(1996-5#1)(2008-11#1)
the binding affinity for##3##4##(1990-5#1)(1993-11#1)(2008-10#1)
the binding affinity of the##4##5##(1990-5#2)(1995-2#2)
the binding affinity of##5##4##(1990-5#2)(1995-11#1)(1995-2#2)
the binding affinity to the##2##5##(1990-2#1)(1997-3#1)
the binding affinity##15##3##(1990-2#1)(1990-5#3)(1991-12#1)(1993-11#1)(1995-11#2)(1995-2#3)(1995-3#1)(1997-3#1)(2008-10#1)(2013-7#1)
the binding and##7##3##(1991-9#1)(1993-11#2)(1994-5#1)(1995-2#1)(2008-10#1)(2008-5#1)
the binding between##2##3##(2009-10#1)(2011-2#1)
the binding capacity of##4##4##(1990-12#1)(1991-5#1)(1992-4#1)(2008-8#1)
the binding cavity of##2##4##(1992-6#1)(2013-8#1)
the binding cavity##3##3##(1992-6#1)(2010-12#1)(2013-8#1)
the binding characteristics of##8##4##(1990-2#1)(1991-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)
the binding constant for##2##4##(1992-3#1)(2008-10#1)
the binding constant of the##2##5##(2008-10#2)
the binding constant##8##3##(1992-3#1)(1994-5#1)(1995-2#1)(2008-10#5)
the binding constants##2##3##(1992-4#1)(2008-10#1)
the binding domain##2##3##(2008-8#2)
the binding energies of##2##4##(2008-3#1)(2010-7#1)
the binding energies##3##3##(2008-3#1)(2010-7#2)
the binding energy of##2##4##(1992-5#1)(1993-8#1)
the binding interactions##2##3##(2008-9#1)(2010-11#1)
the binding is##2##3##(1990-12#1)(1990-6#1)
the binding kinetics##2##3##(2008-10#1)(2009-10#1)
the binding number##3##3##(2008-10#3)
the binding of 125I-IGF-II to the IGF-II/Man6P receptor##2##8##(1990-5#2)
the binding of 125I-IGF-II to the receptor##3##7##(1990-5#3)
the binding of 125I-IGF-II to the##5##6##(1990-5#5)
the binding of ATP to##2##5##(1991-9#1)(1992-12#1)
the binding of ATP##4##4##(1991-9#1)(1992-12#1)(1993-6#1)(1995-2#1)
the binding of FSH##2##4##(1995-11#2)
the binding of [3H]MK-801 was increased in pons and medulla and##2##11##(1997-2#2)
the binding of [3H]MK-801##3##4##(1997-2#3)
the binding of [3H]flunitrazepam to##2##5##(1996-2#2)
the binding of [3H]prazosin to##2##5##(1991-6#2)
the binding of a##5##4##(1991-11#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
the binding of an##2##4##(2008-4#1)(2012-12#1)
the binding of casein kinase I##2##6##(1994-11#2)
the binding of plasmid DNA to##2##6##(2008-8#2)
the binding of the##22##4##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-2#1)(2013-1#2)
the binding of these##3##4##(1994-12#1)(1994-5#1)(1995-2#1)
the binding of transcription factors##2##5##(1994-9#1)(2008-7#1)
the binding of##152##3##(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#8)(1990-6#1)(1990-7#2)(1990-8#4)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#4)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1993-3#1)(1993-6#5)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#10)(1995-12#1)(1995-2#8)(1995-5#3)(1995-6#3)(1996-12#1)(1996-2#3)(1997-2#4)(1997-4#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-2#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
the binding process##4##3##(1991-12#1)(1997-2#1)(2008-10#2)
the binding protein for dipeptides and beta-lactam antibiotics of##2##9##(1990-11#2)
the binding protein for dipeptides and beta-lactam antibiotics##3##8##(1990-11#3)
the binding protein##5##3##(1990-11#3)(1994-2#1)(2008-11#1)
the binding reaction##3##3##(1992-9#1)(2008-10#2)
the binding site for##4##4##(1990-7#1)(1994-6#1)(2008-10#1)(2010-10#1)
the binding site in##2##4##(1990-8#1)(2008-10#1)
the binding site of##6##4##(1992-9#1)(1993-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
the binding site##16##3##(1990-7#1)(1990-8#1)(1992-6#1)(1992-9#2)(1993-2#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
the binding sites for##2##4##(1992-2#1)(1993-11#1)
the binding sites of the##2##5##(1990-12#1)(2008-10#1)
the binding sites of##3##4##(1990-12#1)(1993-3#1)(2008-10#1)
the binding sites on##2##4##(1993-8#1)(2010-5#1)
the binding sites##16##3##(1990-12#1)(1990-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-3#2)
the binding to DREF##2##4##(1995-6#2)
the binding to the##3##4##(1990-7#1)(2009-7#1)(2009-8#1)
the binding to##9##3##(1990-7#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-6#2)(2009-7#1)(2009-8#1)
the binding was##5##3##(1993-6#1)(1994-2#1)(1994-6#1)(1996-5#1)(2010-5#1)
the binding##338##2##(1990-11#6)(1990-12#7)(1990-2#3)(1990-5#12)(1990-6#2)(1990-7#4)(1990-8#7)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#5)(1991-9#5)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#7)(1993-8#5)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#10)(1994-6#4)(1994-8#3)(1994-9#1)(1995-11#13)(1995-12#5)(1995-2#16)(1995-3#2)(1995-5#4)(1995-6#5)(1995-8#1)(1996-12#1)(1996-2#5)(1996-5#3)(1997-2#9)(1997-3#2)(1997-4#2)(1997-7#2)(1997-9#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#52)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#5)(2009-10#2)(2009-2#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#1)
the bindings of##2##3##(1992-6#1)(2008-3#1)
the binomial distribution##6##3##(2008-10#6)
the binomial##8##2##(2008-10#8)
the binormal assumption##3##3##(1997-3#3)
the binormal##5##2##(1997-3#5)
the binuclear centre##2##3##(1997-7#2)
the binuclear##3##2##(1995-2#1)(1997-7#2)
the bioaccumulation of##2##3##(2008-12#2)
the bioaccumulation##3##2##(2008-11#1)(2008-12#2)
the bioactive##11##2##(1992-12#1)(1994-8#1)(2008-12#1)(2008-4#1)(2009-7#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
the bioactivity of##2##3##(2008-4#1)(2011-3#1)
the bioactivity##3##2##(2008-4#1)(2011-1#1)(2011-3#1)
the bioanalytical##3##2##(2008-10#3)
the bioassay and##2##3##(2008-10#2)
the bioassay##7##2##(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2013-7#1)
the bioavailability of##9##3##(2008-10#4)(2008-11#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
the bioavailability##11##2##(2008-10#4)(2008-11#2)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
the biocatalytic##4##2##(2008-10#3)(2010-4#1)
the biochemical and##6##3##(1993-8#1)(1994-8#1)(1997-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
the biochemical basis##2##3##(1990-8#1)(2009-8#1)
the biochemical characteristics of##2##4##(1992-8#1)(1997-6#1)
the biochemical diagnosis of##2##4##(1994-9#1)(2007-5#1)
the biochemical effects of##3##4##(1993-8#1)(2008-5#1)(2010-1#1)
the biochemical function##2##3##(2008-9#1)(2011-2#1)
the biochemical mechanism##2##3##(2010-7#2)
the biochemical mechanisms##3##3##(1997-2#1)(1997-6#1)(2011-1#1)
the biochemical nature of the##2##5##(1997-2#1)(2008-6#1)
the biochemical pathways and##2##4##(2011-1#2)
the biochemical processes##2##3##(2008-7#1)(2009-8#1)
the biochemical properties and##2##4##(1995-6#1)(1997-7#1)
the biochemical properties##3##3##(1995-6#1)(1997-7#1)(2009-3#1)
the biochemical##54##2##(1990-11#1)(1990-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-8#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#3)(1997-6#2)(1997-7#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-4#2)(2010-7#2)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)
the biochemistry and##2##3##(2008-11#1)(2012-2#1)
the biochemistry##4##2##(1992-3#1)(1997-8#1)(2008-11#1)(2012-2#1)
the biocide##2##2##(2008-7#1)(2013-7#1)
the biocompatibility of implantable devices##2##5##(2009-11#2)
the biocompatibility of##5##3##(2008-7#1)(2009-11#3)(2012-2#1)
the biocompatibility##7##2##(2008-5#2)(2008-7#1)(2009-11#3)(2012-2#1)
the biocontrol activity of CHA0##2##5##(2008-10#2)
the biocontrol activity of##5##4##(2008-10#5)
the biocontrol agent Trichoderma##2##4##(2008-10#2)
the biocontrol agent was##2##4##(2008-10#2)
the biocontrol agent##8##3##(2008-10#8)
the biocontrol agents##6##3##(2008-10#6)
the biocontrol fungus Trichoderma##3##4##(2008-10#3)
the biocontrol isolates were##3##4##(2008-10#3)
the biocontrol isolates##5##3##(2008-10#5)
the biocontrol strain##2##3##(2008-10#2)
the biocontrol##36##2##(2008-10#36)
the bioconversion##2##2##(2008-6#1)(2011-1#1)
the biodegradability and##2##3##(1992-5#1)(2008-5#1)
the biodegradable##3##2##(2008-12#1)(2009-12#2)
the biodegradation of##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#2)
the biodiversity##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
the bioenergetics of the##2##4##(2008-1#2)
the biofilm formation##3##3##(2009-6#1)(2013-1#1)(2013-8#1)
the biofilm were##2##3##(2008-7#2)
the biofilm##15##2##(2008-7#7)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#3)(2013-8#2)
the biogenesis of##4##3##(1994-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
the biogenic##2##2##(1992-3#1)(2008-7#1)
the biogeochemical cycling of##2##4##(2008-10#2)
the biogeochemical##3##2##(2008-10#3)
the bioinformatics community##2##3##(2008-4#1)(2008-7#1)
the biologic activity of##2##4##(1995-3#1)(1995-5#1)
the biologic##9##2##(1992-10#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-3#1)(2008-9#1)(2013-1#3)
the biological action of##6##4##(1992-6#1)(2008-10#2)(2008-11#1)(2010-10#1)(2013-7#1)
the biological activities of the##3##5##(2010-5#1)(2013-8#2)
the biological activities of##4##4##(2008-9#1)(2010-5#1)(2013-8#2)
the biological activities##5##3##(2008-9#1)(2010-5#1)(2011-3#1)(2013-8#2)
the biological activity of the##4##5##(1997-2#1)(1997-7#1)(2008-8#1)(2009-3#1)
the biological activity of##18##4##(1990-12#2)(1990-5#1)(1992-6#1)(1992-8#2)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2009-3#1)(2012-2#1)
the biological activity##27##3##(1990-12#2)(1990-5#1)(1990-7#1)(1992-5#1)(1992-6#1)(1992-8#3)(1994-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-3#2)(2010-12#1)(2010-6#1)(2012-2#1)
the biological and genetic##2##4##(2008-7#1)(2008-9#1)
the biological and social##2##4##(1991-6#1)(2008-2#1)
the biological and##10##3##(1991-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)
the biological aspects##2##3##(2012-12#1)(2012-3#1)
the biological basis of##3##4##(1993-9#1)(2008-4#1)(2013-1#1)
the biological basis##4##3##(1993-9#1)(2007-12#1)(2008-4#1)(2013-1#1)
the biological behavior of##3##4##(2007-10#1)(2009-11#1)(2013-1#1)
the biological behaviour of##2##4##(1993-6#1)(2008-7#1)
the biological behaviour##3##3##(1993-6#1)(2008-7#1)(2009-4#1)
the biological characteristics of##3##4##(1992-8#1)(2007-8#1)(2008-4#1)
the biological characteristics##4##3##(1992-8#1)(2007-8#1)(2008-4#1)(2013-8#1)
the biological consequences of##5##4##(1997-7#1)(2008-4#2)(2008-7#2)
the biological control activity##2##4##(2008-10#2)
the biological control agent##3##4##(2008-10#2)(2008-5#1)
the biological control of##10##4##(2008-10#9)(2008-8#1)
the biological control##19##3##(2008-10#15)(2008-5#1)(2008-8#2)(2011-2#1)
the biological effect of##4##4##(1991-12#1)(1996-12#1)(2008-10#1)(2008-8#1)
the biological effects of##6##4##(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
the biological effects##7##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
the biological function of##5##4##(1991-2#1)(1994-11#2)(2008-7#1)(2012-3#1)
the biological function##6##3##(1991-2#1)(1994-11#2)(2008-4#1)(2008-7#1)(2012-3#1)
the biological functions of##4##4##(1991-5#1)(1992-12#1)(1993-11#1)(2009-11#1)
the biological importance of##3##4##(2008-10#2)(2012-3#1)
the biological markers##2##3##(1991-11#1)(1993-2#1)
the biological pathways##2##3##(2008-11#1)(2008-4#1)
the biological processes##2##3##(2008-10#1)(2009-5#1)
the biological properties of##2##4##(2009-7#1)(2010-3#1)
the biological properties##3##3##(2007-11#1)(2009-7#1)(2010-3#1)
the biological relevance of##3##4##(1997-1#1)(2008-7#1)(2009-8#1)
the biological role of##3##4##(1993-6#1)(2008-4#1)(2008-5#1)
the biological sample##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
the biological significance of the##2##5##(1996-3#1)(2010-12#1)
the biological significance of##6##4##(1990-9#1)(1996-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
the biological##201##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#46)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#6)(2008-7#9)(2008-8#8)(2008-9#4)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#4)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#5)
the biologically active##8##3##(1990-12#1)(1992-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-4#1)(2008-8#1)(2010-5#1)
the biologically##14##2##(1990-12#1)(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-5#1)(2012-3#1)
the biologist##2##2##(2008-10#1)(2008-7#1)
the biology and ecology##2##4##(2008-10#1)(2008-8#1)
the biology and##14##3##(1992-8#1)(1993-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
the biology of the##12##4##(1991-6#1)(1994-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2010-3#1)(2013-7#1)
the biology of this##2##4##(2008-6#1)(2008-7#1)
the biology of##31##3##(1991-6#1)(1993-12#1)(1994-8#1)(1995-6#1)(1996-1#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-7#1)
the biology##49##2##(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-1#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
the bioluminescence inhibition of##3##4##(2008-10#3)
the bioluminescence inhibition##4##3##(2008-10#4)
the bioluminescence##5##2##(2008-10#4)(2011-1#1)
the biomarker##2##2##(2008-11#1)(2010-9#1)
the biomass of##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
the biomass##23##2##(2008-10#7)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#1)(2013-1#2)(2013-8#1)
the biomaterial##2##2##(2008-10#1)(2009-12#1)
the biomechanical properties of the##2##5##(2008-9#1)(2009-8#1)
the biomechanical properties of##4##4##(2008-9#2)(2009-3#1)(2009-8#1)
the biomechanical properties##5##3##(2008-5#1)(2008-9#2)(2009-3#1)(2009-8#1)
the biomechanical##14##2##(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-9#1)(2013-1#3)
the biomechanics of##3##3##(2013-1#3)
the biomechanics##4##2##(2010-3#1)(2013-1#3)
the biomedical domain##3##3##(2008-7#3)
the biomedical field##3##3##(2009-12#1)(2011-1#2)
the biomedical##12##2##(2008-10#2)(2008-7#3)(2009-12#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-8#1)(2013-1#1)
the biomes##2##2##(2008-9#1)(2010-3#1)
the biomolecule##3##2##(2007-10#1)(2007-11#1)(2008-2#1)
the biomolecules##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
the bioparticle##2##2##(2008-6#1)(2008-7#1)
the biopharmaceutical##2##2##(2008-11#1)(2012-2#1)
the biophysical consequences of the##2##5##(2008-8#2)
the biophysical properties of##2##4##(1997-1#1)(1997-6#1)
the biophysical##10##2##(1996-12#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-5#3)(2008-8#2)(2009-9#1)
the biopolymer##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
the biopreparation treatments and the older control treatment##2##8##(2008-10#2)
the biopsies##12##2##(1990-11#1)(1991-11#1)(1992-10#1)(1994-1#1)(1994-6#1)(1996-12#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-9#1)
the biopsy specimen##2##3##(2007-10#1)(2009-3#1)
the biopsy##9##2##(1991-2#1)(2007-10#1)(2007-5#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
the biopsychosocial model##2##3##(2008-10#1)(2013-8#1)
the bioreactor was##2##3##(2008-11#1)(2008-6#1)
the bioreactor##23##2##(1994-5#1)(2008-11#16)(2008-6#1)(2008-7#3)(2010-5#1)(2012-2#1)
the biosafety##2##2##(2008-11#1)(2008-8#1)
the biosensor for##3##3##(2008-10#3)
the biosensor performance##2##3##(1994-8#1)(2008-10#1)
the biosensor was##4##3##(2008-10#4)
the biosensor##50##2##(1994-8#1)(2008-10#49)
the biosensors were##2##3##(2008-10#2)
the biosensors##9##2##(2008-10#9)
the biosorption##2##2##(2011-2#2)
the biosynthesis of a##2##4##(1990-5#1)(2008-8#1)
the biosynthesis of active##2##4##(1994-5#1)(2012-3#1)
the biosynthesis of the##8##4##(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
the biosynthesis of these##2##4##(1990-3#1)(1994-11#1)
the biosynthesis of this##2##4##(1992-12#2)
the biosynthesis of##40##3##(1990-3#1)(1990-5#3)(1991-5#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the biosynthesis##44##2##(1990-3#1)(1990-5#3)(1991-5#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the biosynthetic and##2##3##(1994-3#1)(2012-2#1)
the biosynthetic pathway##3##3##(1994-8#1)(1997-6#1)(2008-1#1)
the biosynthetic##10##2##(1990-12#1)(1993-5#3)(1994-3#1)(1994-8#1)(1997-6#1)(2007-8#1)(2008-1#1)(2012-2#1)
the biotech industry##2##3##(2008-11#2)
the biotechnology industry##4##3##(2008-10#2)(2008-7#2)
the biotechnology##6##2##(2008-10#2)(2008-7#2)(2009-3#1)(2010-2#1)
the biotic##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
the biotin is##2##3##(2008-10#1)(2008-4#1)
the biotin##9##2##(1990-12#1)(1990-2#1)(1992-6#3)(2008-10#3)(2008-4#1)
the biotin/avidin interaction##2##3##(2008-10#2)
the biotinylated polypyrrole/avidin assembly##2##4##(2008-10#2)
the biotinylated##6##2##(1992-6#1)(1995-6#1)(1995-8#1)(2008-10#3)
the biotinylation of the cap structure##2##6##(1997-2#2)
the biotinylation of##3##3##(1997-2#2)(2008-4#1)
the biotransformation of xenobiotics##2##4##(1990-6#1)(2008-11#1)
the biotransformation of##7##3##(1990-6#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#2)
the biotransformation##9##2##(1990-6#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)
the biotrophic fungus##2##3##(2008-10#2)
the biovolume##3##2##(2008-11#3)
the bipartite##5##2##(1992-3#1)(2008-10#4)
the biphasic##2##2##(1995-3#1)(2008-5#1)
the biphosphonate##2##2##(1991-11#1)(2013-1#1)
the bipolar##3##2##(1995-11#1)(1996-7#1)(2008-3#1)
the bird##6##2##(2008-5#3)(2008-8#2)(2012-2#1)
the birds with##2##3##(2008-8#2)
the birds##15##2##(1991-11#2)(1992-2#1)(1997-3#3)(2007-6#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-2#1)(2013-1#1)
the birefringence of the##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
the birefringence of##11##3##(2007-12#1)(2008-2#1)(2008-3#8)(2009-11#1)
the birefringence vector distribution in a##2##6##(2008-3#2)
the birefringence vector##3##3##(2008-3#3)
the birefringence##25##2##(1990-7#1)(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#14)(2009-11#1)(2010-4#1)
the birefringent blur filter##2##4##(2008-3#2)
the birefringent properties of lens materials##2##6##(2008-3#2)
the birefringent##5##2##(2008-2#1)(2008-3#4)
the birth of##8##3##(1991-6#1)(1993-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2008-12#1)(2008-9#1)(2012-2#1)
the birth##16##2##(1991-6#1)(1992-6#1)(1993-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-11#1)(2012-2#1)
the births##2##2##(2008-1#1)(2012-12#1)
the bis(phenylsulfonyl)diene##2##2##(1996-5#2)
the bis-phosphorylated##2##2##(2010-12#2)
the bis[[(dimethylamino)methyl]furans] in##2##3##(1992-8#2)
the bismuth film electrode##2##4##(2008-10#2)
the bismuth##4##2##(2008-10#3)(2010-11#1)
the bismuth(III)##2##2##(2008-10#2)
the bisphenol S derivative compounds##2##5##(2013-1#2)
the bisphenol##4##2##(2008-10#1)(2013-1#3)
the bisphosphonate##2##2##(2008-11#1)(2010-3#1)
the bit error##3##3##(2008-3#3)
the bit##4##2##(1996-2#1)(2008-3#3)
the bit-error rate is##2##4##(2008-3#2)
the bit-error rate of##2##4##(2008-2#2)
the bit-error rate##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
the bit-error##7##2##(2007-12#2)(2008-2#3)(2008-3#2)
the bitch##2##2##(1996-11#2)
the bite of the##2##4##(2008-7#1)(2010-1#1)
the bite of##3##3##(2008-7#1)(2010-1#2)
the bite##5##2##(2007-12#1)(2008-7#1)(2010-1#2)(2010-9#1)
the bits##3##2##(2007-11#1)(2008-3#1)(2008-4#1)
the bitter taste##2##3##(2008-9#1)(2010-5#1)
the biuret method##4##3##(2008-10#2)(2008-9#1)(2009-8#1)
the biuret##7##2##(1990-8#1)(2008-10#4)(2008-9#1)(2009-8#1)
the bivariate##7##2##(1994-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-8#1)(2012-3#1)
the bizarre##2##2##(1992-4#1)(2011-1#1)
the black carbon mass##2##4##(2008-3#2)
the black carbon##3##3##(2008-3#3)
the black pixel assumption##4##4##(2008-3#4)
the black porgy##2##3##(2008-7#2)
the black##20##2##(1995-6#1)(2007-11#1)(2008-3#7)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
the bladder and##9##3##(1995-12#2)(1996-12#1)(1997-7#2)(2007-9#1)(2008-10#1)(2011-2#2)
the bladder cases##2##3##(2008-10#2)
the bladder is a rare##3##5##(1992-12#1)(2010-12#1)(2013-1#1)
the bladder is a##4##4##(1992-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
the bladder neck##2##3##(2008-10#2)
the bladder of##2##3##(2008-10#2)
the bladder or##2##3##(1996-12#1)(2011-2#1)
the bladder wall##4##3##(1992-12#3)(1993-11#1)
the bladder was expanded##2##4##(1992-3#1)(1997-7#1)
the bladder was##4##3##(1992-3#1)(1997-7#3)
the bladder##73##2##(1990-5#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#2)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#2)(1996-12#3)(1997-4#1)(1997-7#6)(2007-10#3)(2007-9#1)(2008-10#22)(2008-12#1)(2008-4#1)(2010-12#2)(2011-2#5)(2012-12#2)(2013-1#6)
the blades##2##2##(1992-1#1)(2008-3#1)
the blank values##2##3##(2008-10#2)
the blank##24##2##(2008-10#22)(2008-9#1)(2010-5#1)
the blast##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
the blastocyst stage##3##3##(1995-2#1)(2008-11#1)(2013-1#1)
the blastocyst##7##2##(1992-2#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
the blaze angle##2##3##(2008-2#1)(2008-3#1)
the bleaching of##2##3##(2008-10#1)(2008-3#1)
the bleaching##4##2##(2008-10#1)(2008-3#2)(2012-2#1)
the bleeding##5##2##(1995-11#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
the blend##3##2##(2007-11#1)(2009-8#2)
the blended##2##2##(2008-5#2)
the blind##8##2##(1991-9#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)
the blinded##2##2##(2007-10#1)(2008-7#1)
the blindness##2##2##(2010-8#1)(2011-2#1)
the blister rust##2##3##(2008-10#2)
the blister##3##2##(2006-10#1)(2008-10#2)
the block of##2##3##(2008-8#1)(2012-3#1)
the block##12##2##(1995-11#3)(1996-5#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-3#1)
the blockade of##6##3##(1990-5#1)(1992-12#1)(2008-11#2)(2013-1#2)
the blockage of##3##3##(1994-8#1)(2011-3#1)(2013-1#1)
the blocked##2##2##(1990-3#1)(2008-7#1)
the blocking##2##2##(1993-3#1)(2007-8#1)
the blocks##2##2##(2008-11#1)(2008-9#1)
the blood and##6##3##(1996-5#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-9#1)(2013-1#1)
the blood bank##3##3##(1991-7#3)
the blood coagulation pathway##2##4##(1993-3#1)(2008-10#1)
the blood coagulation##3##3##(1993-11#1)(1993-3#1)(2008-10#1)
the blood compatibility of##2##4##(2008-8#2)
the blood culture##2##3##(2008-5#1)(2010-12#1)
the blood flow of##4##4##(2008-10#3)(2008-12#1)
the blood flow##8##3##(2008-10#4)(2008-12#2)(2011-2#1)(2012-3#1)
the blood glucose level##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
the blood glucose levels##2##4##(2008-10#1)(2008-3#1)
the blood glucose##8##3##(1992-9#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-3#1)(2012-2#1)
the blood is##5##3##(1991-11#1)(1992-4#1)(1992-5#1)(2007-9#1)(2008-10#1)
the blood of the##2##4##(1993-12#1)(2007-7#1)
the blood of##17##3##(1990-12#1)(1993-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2011-1#3)(2012-2#1)(2013-1#1)
the blood or##2##3##(1994-5#1)(2008-5#1)
the blood outflow##2##3##(2008-3#2)
the blood picture of the brown rats##2##7##(2008-12#2)
the blood picture of##3##4##(2008-12#3)
the blood pressure and##2##4##(1990-5#1)(2008-7#1)
the blood pressure is##2##4##(1997-5#1)(2008-5#1)
the blood pressure response to##2##5##(2008-1#1)(2008-7#1)
the blood pressure response##3##4##(2008-1#2)(2008-7#1)
the blood pressure##16##3##(1990-5#1)(1992-2#1)(1994-11#1)(1997-5#1)(2008-1#2)(2008-5#2)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
the blood sample##2##3##(1994-12#1)(2008-4#1)
the blood samples were##2##4##(2008-12#1)(2011-1#1)
the blood samples##6##3##(1990-12#1)(1990-7#1)(2008-12#1)(2008-5#1)(2011-1#2)
the blood serum and##2##4##(2008-5#1)(2008-7#1)
the blood serum##5##3##(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)
the blood stains##2##3##(1990-7#1)(2008-12#1)
the blood sugar##2##3##(1994-8#1)(1996-11#1)
the blood supply##7##3##(1995-6#1)(1996-2#1)(1996-9#3)(2006-12#1)(2007-11#1)
the blood to##2##3##(1990-2#1)(2008-10#1)
the blood urea nitrogen##2##4##(1994-5#1)(2008-5#1)
the blood vessel##4##3##(1995-3#1)(1996-3#1)(2008-3#2)
the blood vessels of recipient##2##5##(2008-11#2)
the blood vessels of##3##4##(2008-11#3)
the blood vessels##4##3##(1996-3#1)(2008-11#3)
the blood which##2##3##(1990-12#1)(2013-8#1)
the blood##178##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#4)(1997-1#2)(1997-5#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#6)(2008-12#7)(2008-3#7)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#1)(2009-2#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#7)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#5)
the blood-brain barrier (BBB)##4##4##(1990-5#1)(1996-5#1)(2008-7#1)(2012-2#1)
the blood-brain barrier and##6##4##(1993-12#1)(1997-2#1)(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
the blood-brain barrier##26##3##(1990-5#2)(1990-7#1)(1992-3#2)(1993-12#1)(1994-5#1)(1995-12#3)(1995-2#1)(1996-5#1)(1997-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
the blood-labyrinth barrier##5##3##(2009-8#4)(2012-2#1)
the blood-testis barrier (BTB)##2##4##(2009-10#1)(2012-2#1)
the blood-testis barrier##3##3##(2009-10#2)(2012-2#1)
the bloodstream##6##2##(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
the bloom##3##2##(2008-8#3)
the blots##2##2##(2008-10#1)(2008-4#1)
the blubber##4##2##(2008-10#4)
the blue crab Callinectes sapidus##2##5##(1994-11#2)
the blue crab##4##3##(1994-11#2)(2007-12#2)
the blue region of the spectrum##3##6##(2007-12#1)(2008-2#2)
the blue spectral region##2##4##(2007-11#1)(2008-3#1)
the blue##39##2##(1990-9#1)(1992-11#1)(1994-11#3)(1994-5#1)(1997-4#1)(2007-11#2)(2007-12#6)(2007-7#1)(2008-10#9)(2008-2#5)(2008-3#7)(2008-5#1)(2013-8#1)
the blue-green##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
the blunt##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
the blur function##2##3##(2008-3#2)
the board of directors##2##4##(1993-1#1)(1995-6#1)
the board##11##2##(1991-1#1)(1992-11#1)(1993-1#1)(1993-3#1)(1995-12#3)(1995-6#1)(1997-1#1)(2007-9#1)(2010-3#1)
the board's role in##2##4##(1991-12#1)(2008-11#1)
the board's role##3##3##(1991-12#1)(1995-12#1)(2008-11#1)
the board's##4##2##(1991-1#1)(1991-12#1)(1995-12#1)(2008-11#1)
the boards##2##2##(1994-1#1)(2008-2#1)
the body and a##2##4##(1992-3#1)(2008-9#1)
the body and is##2##4##(2008-10#1)(2011-2#1)
the body and the##2##4##(2008-11#1)(2008-5#1)
the body and##17##3##(1991-6#1)(1992-3#1)(1992-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#3)
the body are##2##3##(2008-10#1)(2009-7#1)
the body axis##3##3##(1995-8#1)(2007-12#2)
the body cavity##4##3##(1996-12#1)(1997-3#1)(2008-8#1)(2008-9#1)
the body composition##2##3##(1990-5#1)(2008-7#1)
the body fat##2##3##(1990-9#1)(2008-1#1)
the body image##3##3##(2007-12#3)
the body in##2##3##(2008-11#1)(2010-6#1)
the body mass index (BMI)##3##5##(2008-12#1)(2008-9#1)(2013-1#1)
the body mass index##5##4##(1991-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
the body of the##7##4##(1996-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)
the body of##19##3##(1995-12#1)(1996-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-5#3)(2011-2#1)(2012-1#1)
the body or the##2##4##(1995-5#1)(2011-2#1)
the body surface##3##3##(2007-12#2)(2008-7#1)
the body temperature##2##3##(2008-6#1)(2008-8#1)
the body to##3##3##(2007-7#1)(2008-5#1)(2008-8#1)
the body using##2##3##(2008-10#2)
the body weight of##2##4##(2010-5#1)(2013-1#1)
the body without##2##3##(1994-5#1)(2013-1#1)
the body##189##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-5#1)(1993-3#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-3#2)(1995-5#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#13)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#14)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#9)(2009-11#4)(2009-12#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#2)
the body's natural##3##3##(2008-5#2)(2013-1#1)
the body's##13##2##(1992-11#1)(1997-6#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-6#1)(2012-3#1)(2013-1#1)
the boiling##2##2##(2008-10#1)(2011-2#1)
the bolus##4##2##(1995-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
the bond length##2##3##(1996-2#1)(2008-9#1)
the bond strength of##4##4##(2009-8#2)(2013-1#2)
the bond valence##2##3##(1997-7#2)
the bond##13##2##(1991-9#1)(1995-2#1)(1996-2#1)(1997-7#2)(2008-9#2)(2009-8#2)(2009-9#1)(2012-2#1)(2013-1#2)
the bonded##3##2##(1992-6#1)(1997-2#1)(2008-10#1)
the bonding force between the##2##5##(2008-10#2)
the bonding##7##2##(1995-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-12#1)
the bone and soft##2##4##(2010-6#1)(2011-2#1)
the bone and##6##3##(2008-10#1)(2010-6#2)(2011-2#1)(2013-1#1)(2013-8#1)
the bone defect in the mastoid area##2##7##(2008-7#2)
the bone grafts##3##3##(2007-11#3)
the bone in the##2##4##(2007-8#1)(2009-7#1)
the bone in##5##3##(2007-8#1)(2009-7#1)(2010-3#1)(2010-6#1)(2012-2#1)
the bone loss##2##3##(2008-12#1)(2012-2#1)
the bone marrow aspirate##2##4##(2008-11#2)
the bone marrow cells##2##4##(1994-12#1)(2009-2#1)
the bone marrow microenvironment##2##4##(2011-1#1)(2011-2#1)
the bone marrow of##2##4##(1994-5#1)(2010-6#1)
the bone marrow stem cell##2##5##(2010-11#1)(2010-8#1)
the bone marrow##30##3##(1990-6#1)(1993-8#2)(1994-12#1)(1994-5#2)(1996-3#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#4)(2008-9#1)(2009-2#1)(2010-11#2)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the bone mineral##2##3##(1995-6#2)
the bone remodeling##3##3##(1991-11#1)(2007-8#1)(2010-9#1)
the bone tissue##4##3##(1995-6#3)(2009-3#1)
the bone union##4##3##(2007-8#4)
the bone##104##2##(1990-6#1)(1991-11#5)(1991-12#1)(1991-8#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-5#2)(1995-6#7)(1996-3#1)(2007-11#8)(2007-12#1)(2007-8#6)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#11)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#2)(2010-11#2)(2010-3#2)(2010-6#6)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
the bone-resorbing activity of mature osteoclasts through##2##7##(2008-11#2)
the bone-resorbing activity of##3##4##(2008-11#3)
the bone-resorbing##4##2##(2008-11#4)
the bones##12##2##(1995-3#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2012-1#1)(2013-8#1)
the bony##7##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2012-2#1)
the book##2##2##(2008-11#1)(2008-7#1)
the books##3##2##(1994-3#1)(2008-4#1)(2012-12#1)
the bootstrap analysis##2##3##(2008-10#2)
the bootstrap##3##2##(2008-10#3)
the border between the##2##4##(2007-12#2)
the border of##7##3##(1996-10#1)(2008-10#1)(2008-9#1)(2012-2#4)
the border##15##2##(1990-11#1)(1996-10#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#5)
the border-crossing adjustment##2##3##(1995-12#2)
the borderline value##2##3##(1990-9#1)(1992-6#1)
the borderline##9##2##(1990-2#2)(1990-9#1)(1992-1#1)(1992-6#1)(1995-4#1)(2007-9#1)(2009-8#1)(2012-1#1)
the borders of the##2##4##(1990-7#1)(2008-10#1)
the borders of##5##3##(1990-7#1)(2008-1#1)(2008-10#3)
the borders##6##2##(1990-7#1)(1993-11#1)(2008-1#1)(2008-10#3)
the boron##4##2##(1990-3#1)(1993-11#2)(1996-2#1)
the boronic acid group##3##4##(2008-10#3)
the botanical origin of the##2##5##(2008-10#2)
the botanical##3##2##(2008-10#3)
the both the##2##3##(2007-6#1)(2013-1#1)
the both##10##2##(1992-9#1)(1994-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
the bottleneck##3##2##(2008-10#1)(2008-2#1)(2010-7#1)
the bottom layer##4##3##(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
the bottom line##4##3##(1994-1#1)(1995-1#1)(1997-6#1)(2007-9#1)
the bottom of the atmosphere##3##5##(2008-2#2)(2008-3#1)
the bottom of the##16##4##(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-12#2)(2009-9#1)(2012-4#1)
the bottom of##20##3##(1992-4#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-9#1)(2009-12#2)(2009-9#1)(2011-2#1)(2012-4#1)
the bottom phase##2##3##(2008-10#2)
the bottom surface of##2##4##(2008-11#1)(2011-2#1)
the bottom surface##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
the bottom##55##2##(1992-4#1)(1994-1#1)(1995-1#1)(1995-8#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#2)(2009-9#1)(2011-2#5)(2012-3#1)(2012-4#1)
the botulinum##2##2##(1990-5#1)(2011-2#1)
the bound CaD*##2##3##(1994-5#2)
the bound antigen##2##3##(1990-12#1)(2008-4#1)
the bound inhibitor##2##3##(1993-11#2)
the bound thymocytes on##2##4##(2008-8#2)
the bound##36##2##(1990-10#1)(1990-12#3)(1990-2#1)(1991-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#2)
the boundaries of the##2##4##(1997-1#1)(2008-9#1)
the boundaries of##3##3##(1997-1#1)(2008-7#1)(2008-9#1)
the boundaries##8##2##(1996-4#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
the boundary between the##4##4##(2008-2#2)(2009-9#1)(2013-1#1)
the boundary between##10##3##(1994-12#1)(1995-6#1)(2008-2#2)(2009-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
the boundary conditions##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
the boundary layer##5##3##(2008-11#2)(2008-3#3)
the boundary of the##4##4##(1996-12#1)(2008-10#1)(2008-2#2)
the boundary of##7##3##(1996-12#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-8#1)
the boundary value and##2##4##(2008-3#2)
the boundary value##4##3##(2008-2#1)(2008-3#3)
the boundary##42##2##(1994-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#10)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the boundary-element method (BEM)##2##4##(2008-11#1)(2008-3#1)
the boundary-element method##3##3##(2008-11#1)(2008-3#2)
the bounds##2##2##(2008-10#1)(2008-3#1)
the bovine NPR-B##2##3##(1994-8#2)
the bovine brain##2##3##(1991-5#1)(1997-2#1)
the bovine natriuretic peptide receptor-B##2##5##(1994-8#2)
the bovine serum albumin##3##4##(2008-10#1)(2008-5#2)
the bovine β-actin gene##2##4##(2012-3#2)
the bovine##37##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-2#2)(1993-3#2)(1994-8#4)(1995-11#1)(1996-12#2)(1996-3#1)(1997-2#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-11#1)(2012-3#2)
the bowel and##2##3##(1996-3#1)(1996-6#1)
the bowel wall##5##3##(1992-5#1)(2009-12#2)(2012-2#2)
the bowel##12##2##(1991-3#1)(1992-5#2)(1993-9#1)(1994-9#1)(1996-3#1)(1996-6#1)(2007-5#1)(2009-12#2)(2012-2#2)
the bowels##3##2##(1996-6#2)(2009-10#1)
the box##4##2##(1993-9#1)(1997-3#1)(2009-12#1)(2010-11#1)
the boy and##2##3##(1996-5#1)(2012-2#1)
the boy##7##2##(1995-5#2)(1996-5#3)(2008-10#1)(2012-2#1)
the boys##6##2##(1991-9#3)(1996-6#1)(2007-11#1)(2009-8#1)
the boys'##2##2##(2009-10#1)(2011-1#1)
the brachial plexus##5##3##(2008-9#2)(2009-3#3)
the brachial##9##2##(2007-8#1)(2008-9#2)(2009-1#3)(2009-3#3)
the bradycardic##2##2##(1997-2#2)
the brain activity##2##3##(2008-10#1)(2008-11#1)
the brain and lungs##2##4##(2008-7#1)(2009-9#1)
the brain and reproductive##2##4##(1990-11#1)(2010-1#1)
the brain and spinal cord##7##5##(1995-3#1)(1996-12#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)
the brain and the##3##4##(1993-5#1)(2008-2#1)(2010-8#1)
the brain and##45##3##(1990-11#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
the brain are##7##3##(1995-5#1)(1997-6#1)(2007-12#1)(2008-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
the brain area##2##3##(2007-8#1)(2011-2#1)
the brain areas##2##3##(2008-7#1)(2008-9#1)
the brain as well as##3##5##(2008-11#1)(2008-6#1)(2009-12#1)
the brain as##5##3##(1994-5#1)(2008-11#1)(2008-6#1)(2009-12#1)(2009-6#1)
the brain at##2##3##(1995-5#1)(2007-12#1)
the brain but##3##3##(1990-11#1)(1992-6#1)(2008-7#1)
the brain by##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
the brain damage##2##3##(1994-2#1)(2011-2#1)
the brain death##3##3##(1995-6#1)(1996-2#1)(2007-11#1)
the brain determine##2##3##(2007-8#1)(2010-5#1)
the brain during##2##3##(1995-2#1)(2013-1#1)
the brain has a unique##2##5##(2008-11#2)
the brain has been##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
the brain has##7##3##(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)
the brain in a##2##4##(1997-7#1)(2009-8#1)
the brain in##12##3##(1990-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2013-1#3)
the brain is##9##3##(1994-5#2)(1995-11#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#2)(2009-5#1)
the brain l-CaD##2##3##(1993-11#2)
the brain lesions##2##3##(1997-3#1)(2011-2#1)
the brain must##2##3##(1990-5#1)(2009-8#1)
the brain networks##2##3##(2009-8#1)(2013-8#1)
the brain of the leech Theromyzon tessulatum##2##7##(1996-12#2)
the brain of the##8##4##(1993-5#2)(1994-2#1)(1996-12#2)(1997-3#1)(2008-6#2)
the brain of##28##3##(1990-7#1)(1992-12#1)(1993-3#1)(1993-5#3)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#2)(2007-12#1)(2008-4#1)(2008-6#4)(2008-7#3)(2009-2#1)(2012-1#1)
the brain parenchyma##4##3##(1992-12#1)(1993-12#1)(2008-8#1)(2009-8#1)
the brain reward system##2##4##(2007-8#1)(2011-2#1)
the brain reward##4##3##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
the brain stem and spinal cord##2##6##(2008-7#2)
the brain stem##14##3##(1990-5#1)(1993-3#1)(1994-2#1)(1995-12#3)(2008-7#5)(2009-3#1)(2011-1#1)(2012-3#1)
the brain structure##2##3##(2007-12#1)(2013-8#1)
the brain structures##2##3##(1996-12#2)
the brain that##4##3##(1996-12#1)(1996-5#1)(2008-4#1)(2009-5#1)
the brain through##2##3##(2010-5#1)(2013-1#1)
the brain tissue##4##3##(1995-12#1)(1996-5#1)(2008-3#1)(2008-5#1)
the brain to##6##3##(1991-1#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
the brain was##5##3##(1992-11#1)(1993-12#2)(1997-2#1)(2010-1#1)
the brain were##3##3##(1992-8#1)(1995-11#1)(2008-8#1)
the brain##449##2##(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#3)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#7)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#6)(1993-3#6)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#7)(1994-5#8)(1994-6#3)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#16)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1996-12#13)(1996-2#3)(1996-3#1)(1996-5#10)(1996-7#1)(1997-2#5)(1997-3#5)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#14)(2007-8#8)(2008-1#8)(2008-10#4)(2008-11#22)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#14)(2008-5#10)(2008-6#10)(2008-7#34)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#10)(2009-9#2)(2010-1#4)(2010-11#1)(2010-12#3)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#6)(2012-12#1)(2012-2#12)(2012-3#1)(2013-1#20)(2013-7#3)(2013-8#4)
the brain's##7##2##(1994-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-8#2)(2012-12#1)
the brain-gut axis##4##3##(2009-10#4)
the brain-gut##5##2##(2009-10#4)(2013-1#1)
the brains and##3##3##(1997-3#1)(2008-6#2)
the brains of##19##3##(1991-5#1)(1992-8#2)(1995-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#4)(2008-11#2)(2008-7#2)(2011-1#1)(2011-2#1)
the brains##24##2##(1991-5#1)(1992-8#2)(1995-12#1)(1996-5#2)(1997-2#1)(1997-3#2)(2007-10#2)(2007-12#4)(2008-11#2)(2008-6#2)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
the brainstem##12##2##(1991-5#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(2007-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
the branch cuts##3##3##(2008-3#3)
the branch##9##2##(1992-12#1)(1993-11#1)(1995-3#1)(2008-3#3)(2008-9#1)(2011-1#1)(2012-2#1)
the branches of the external carotid artery##2##7##(1997-3#2)
the branches of the##5##4##(1997-3#2)(2008-11#1)(2009-3#1)(2012-3#1)
the branches##6##2##(1997-3#2)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
the branchial heart##5##3##(2008-7#5)
the branchial##9##2##(1996-5#1)(2008-7#8)
the branching##6##2##(1997-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
the breadth of the##2##4##(2008-1#1)(2008-10#1)
the breadth of##5##3##(2008-1#1)(2008-10#3)(2011-2#1)
the breadth##6##2##(1995-2#1)(2008-1#1)(2008-10#3)(2011-2#1)
the break##2##2##(2008-10#1)(2012-2#1)
the breakage of##2##3##(1995-5#1)(2008-8#1)
the breakdown of##6##3##(2008-10#2)(2008-12#1)(2008-4#1)(2010-3#1)(2011-2#1)
the breakdown products of the chemical warfare agent##2##8##(2008-11#2)
the breakdown products of the##3##5##(1994-2#1)(2008-11#2)
the breakdown pulses##2##3##(1991-5#2)
the breakdown threshold##2##3##(2008-1#1)(2008-3#1)
the breakdown zone##2##3##(1996-4#2)
the breakdown##16##2##(1991-5#2)(1994-2#1)(1996-4#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2010-3#1)(2011-2#1)
the breaking activity was##2##4##(1996-2#2)
the breaking##5##2##(1996-2#3)(2008-3#1)(2012-2#1)
the breakpoint junction of the##2##5##(1996-12#2)
the breakpoints##3##2##(2008-5#2)(2013-1#1)
the breakthrough##3##2##(1997-4#1)(1997-6#1)(2008-10#1)
the breakup of##3##3##(2008-2#1)(2008-7#1)(2009-8#1)
the breakup##4##2##(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)
the breast and prostate##2##4##(2007-11#1)(2008-11#1)
the breast and##7##3##(1994-12#1)(1994-2#1)(2007-11#1)(2008-11#1)(2010-7#1)(2012-1#1)(2013-8#1)
the breast are##2##3##(1991-8#1)(1993-12#1)
the breast cancer##8##3##(1993-11#1)(1993-8#1)(1994-12#1)(2008-4#3)(2012-3#1)(2013-8#1)
the breast epithelial mucin##4##4##(1993-1#4)
the breast is##4##3##(1992-2#1)(1995-4#1)(2007-5#1)(2008-1#1)
the breast which##2##3##(1990-10#1)(2007-5#1)
the breast##85##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-2#3)(1992-5#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-6#1)(1993-8#3)(1994-12#4)(1994-2#1)(1994-6#2)(1994-7#6)(1994-8#1)(1995-4#5)(1995-9#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-5#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2009-1#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-8#5)
the breasts##2##2##(1995-4#1)(2007-8#1)
the breath holding task##2##4##(2013-8#2)
the breath##3##2##(2008-10#1)(2013-8#2)
the breathing cassette##3##3##(1991-3#3)
the breathing##5##2##(1991-3#3)(1996-2#1)(2011-2#1)
the breeding migration##3##3##(2008-5#1)(2008-6#2)
the breeding period of##2##4##(2013-7#2)
the breeding period##3##3##(2013-7#3)
the breeding season##12##3##(2008-5#1)(2008-6#3)(2008-8#4)(2008-9#1)(2010-8#2)(2013-7#1)
the breeding##29##2##(1995-6#1)(2008-10#3)(2008-5#4)(2008-6#6)(2008-8#5)(2008-9#3)(2009-10#1)(2010-8#2)(2013-7#4)
the breeds##2##2##(1996-12#1)(2011-2#1)
the brewing##3##2##(2008-10#1)(2013-1#2)
the bridge##8##2##(2008-2#4)(2012-2#1)(2013-1#3)
the bridging ligand##3##3##(1997-7#3)
the bridging##9##2##(1995-2#2)(1997-7#5)(2008-10#1)(2012-2#1)
the brief period##2##3##(1990-11#1)(1996-3#1)
the brief##8##2##(1990-11#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)(2013-1#1)
the bright lesions##2##3##(2010-8#2)
the bright spot##2##3##(2008-3#1)(2010-12#1)
the bright##8##2##(2008-3#3)(2008-8#1)(2010-12#1)(2010-8#2)(2013-1#1)
the brightness of##2##3##(2008-3#2)
the brightness##4##2##(1995-6#1)(2007-10#1)(2008-3#2)
the brine shrimp Artemia##4##4##(1994-8#1)(2007-12#2)(2008-9#1)
the brittle##2##2##(1991-12#1)(1996-4#1)
the broad field of##2##4##(1994-12#1)(2007-7#1)
the broad host range of##2##5##(2008-10#1)(2008-5#1)
the broad host range##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
the broad host##4##3##(2008-10#1)(2008-5#1)(2012-2#2)
the broad range of##4##4##(2007-10#1)(2008-10#1)(2008-5#1)(2013-7#1)
the broad spectrum of##2##4##(2008-10#1)(2008-12#1)
the broad spectrum##3##3##(1992-3#1)(2008-10#1)(2008-12#1)
the broad##37##2##(1992-3#1)(1994-12#1)(1995-12#1)(1997-3#2)(1997-5#2)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-7#1)
the broadband algorithm##2##3##(2008-3#2)
the broadband##7##2##(2007-11#1)(2008-3#6)
the broadening of the##2##4##(1991-12#1)(2008-3#1)
the broadening of##3##3##(1991-12#1)(2008-3#1)(2012-12#1)
the broadening##9##2##(1991-12#1)(2007-11#2)(2008-2#3)(2008-3#2)(2012-12#1)
the broader context of##3##4##(2008-8#1)(2009-5#1)(2009-8#1)
the broader context##7##3##(1996-8#4)(2008-8#1)(2009-5#1)(2009-8#1)
the broader public##2##3##(1993-1#1)(2010-12#1)
the broader social##2##3##(2009-10#1)(2011-2#1)
the broader##23##2##(1993-1#2)(1994-12#2)(1996-8#4)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
the broadest##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
the broiler##5##2##(1997-3#3)(2008-10#1)(2012-1#1)
the broken##3##2##(2008-4#1)(2012-2#1)(2013-8#1)
the bromate oxidation of N##2##5##(2008-10#2)
the bromate##3##2##(2008-10#2)(2010-5#1)
the bromide ion##2##3##(2008-10#2)
the bromide##3##2##(2008-10#3)
the bromination##3##2##(2008-10#1)(2010-2#1)(2010-5#1)
the bromine atom##2##3##(1991-3#1)(2010-2#1)
the bromine##3##2##(1991-3#1)(1996-5#1)(2010-2#1)
the bronchi##2##2##(2008-3#1)(2010-8#1)
the bronchial circulation##2##3##(1997-1#2)
the bronchial resection margin##2##4##(2007-8#2)
the bronchial tree##4##3##(1994-9#1)(1995-12#2)(1996-1#1)
the bronchial vasculature##3##3##(1997-1#3)
the bronchial##22##2##(1990-9#2)(1991-12#1)(1991-9#1)(1992-2#1)(1994-9#1)(1995-12#3)(1996-1#1)(1997-1#6)(2007-8#2)(2008-1#1)(2010-8#2)(2011-2#1)
the bronchiolar##3##2##(2008-1#1)(2013-1#2)
the bronchiolitis obliterans syndrome##3##4##(2011-3#3)
the bronchoalveolar lavage fluid##2##4##(1992-11#1)(1995-12#1)
the bronchoalveolar lavage##3##3##(1992-11#1)(1995-12#1)(2013-8#1)
the bronchoscopy##2##2##(2010-10#1)(2010-8#1)
the bronchus##3##2##(1995-11#1)(2011-2#1)(2013-1#1)
the brood##5##2##(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
the broth##2##2##(2008-12#1)(2008-7#1)
the brother##2##2##(1990-9#1)(1997-3#1)
the brown citrus aphid##2##4##(2008-10#2)
the brown##7##2##(2008-10#4)(2008-12#2)(2013-1#1)
the brown-headed cowbird##2##3##(2008-9#2)
the brush border membrane of##2##5##(1990-11#1)(1991-12#1)
the brush border membrane##3##4##(1990-11#2)(1991-12#1)
the brush border##8##3##(1990-11#3)(1990-12#1)(1991-12#1)(1993-6#1)(2008-7#2)
the brush phase##2##3##(2008-10#2)
the brush##13##2##(1990-11#3)(1990-12#1)(1991-12#2)(1993-6#1)(2008-10#2)(2008-7#2)(2009-5#2)
the bubble is##2##3##(2008-11#2)
the bubble##12##2##(1994-3#1)(2008-11#7)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
the bubbles##3##2##(2008-2#1)(2009-11#2)
the buccal mucosa##6##3##(1991-2#1)(1992-9#1)(1995-9#1)(2013-1#2)(2013-8#1)
the buccal##11##2##(1991-2#1)(1992-9#1)(1995-9#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the bud##7##2##(1995-6#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#2)
the budding yeast Saccharomyces cerevisiae##6##5##(1990-5#1)(1992-8#1)(1993-8#2)(1996-3#1)(1997-7#1)
the budding yeast##10##3##(1990-5#1)(1992-8#1)(1993-8#3)(1996-3#1)(1996-6#1)(1997-7#1)(2008-9#2)
the budding##14##2##(1990-5#1)(1992-8#1)(1993-8#3)(1996-3#1)(1996-6#3)(1997-7#1)(2008-10#1)(2008-9#2)(2011-2#1)
the budget of##3##3##(2008-11#2)(2012-2#1)
the budget##9##2##(1991-3#1)(1992-3#2)(1993-1#1)(1994-3#1)(2008-11#2)(2012-12#1)(2012-2#1)
the buffer capacity##2##3##(2008-10#2)
the buffer in##2##3##(2008-10#1)(2008-4#1)
the buffer solution at##2##4##(1994-3#1)(2008-10#1)
the buffer solution##8##3##(1990-5#1)(1994-3#1)(2008-10#4)(2008-3#1)(2008-8#1)
the buffer to##2##3##(1992-10#1)(1994-3#1)
the buffer##47##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#2)(1992-10#1)(1994-3#2)(1996-5#1)(1996-9#1)(2007-12#2)(2008-10#30)(2008-3#2)(2008-4#2)(2008-8#1)
the buffered##2##2##(1991-5#1)(2008-10#1)
the buffering##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
the build-up##3##2##(1994-8#1)(2008-10#2)
the building block of##2##4##(1992-6#1)(2010-7#1)
the building blocks of##4##4##(1992-11#1)(1996-2#1)(2008-11#1)(2009-5#1)
the building blocks##5##3##(1992-11#1)(1996-2#1)(2008-11#2)(2009-5#1)
the building of##2##3##(1995-1#1)(2009-7#1)
the building##14##2##(1992-11#1)(1992-2#2)(1992-6#1)(1995-1#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-7#1)
the buildup##3##2##(1996-12#1)(2007-12#1)(2008-2#1)
the bulge##2##2##(2008-5#2)
the bulgy morph##2##3##(2012-12#2)
the bulk and surface##2##4##(1991-8#1)(2010-4#1)
the bulk and##3##3##(1991-8#1)(2008-12#1)(2010-4#1)
the bulk density##3##3##(2008-12#1)(2011-1#2)
the bulk mating experiment##2##4##(2008-10#2)
the bulk of the##12##4##(1994-9#2)(2007-12#2)(2008-10#4)(2008-3#2)(2010-8#1)(2012-2#1)
the bulk of variance in academic buoyancy##2##7##(2008-12#2)
the bulk of##27##3##(1990-12#1)(1990-5#1)(1994-9#2)(2007-12#5)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
the bulk optical properties##2##4##(2008-3#2)
the bulk phase##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
the bulk solution##7##3##(2008-10#5)(2008-6#2)
the bulk##88##2##(1990-12#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-9#2)(2007-12#7)(2008-10#32)(2008-12#4)(2008-2#2)(2008-3#11)(2008-5#1)(2008-6#4)(2008-7#5)(2008-9#1)(2009-3#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-2#2)
the bulky##2##2##(1996-2#1)(1996-5#1)
the bullfrog##3##2##(1990-5#1)(1992-3#1)(1993-5#1)
the bundle##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the bundles##2##2##(1992-2#1)(2007-12#1)
the buoyant##2##2##(1990-5#1)(1996-12#1)
the burden of disease##6##4##(2011-2#2)(2012-12#3)(2013-8#1)
the burden of human influenza in##2##6##(2009-5#2)
the burden of stroke##6##4##(2008-8#6)
the burden of the##2##4##(1996-1#1)(2011-1#1)
the burden of##34##3##(1994-1#1)(1996-1#1)(1996-11#1)(2007-12#2)(2008-11#3)(2008-8#6)(2009-5#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-8#3)
the burden##43##2##(1993-3#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-11#1)(2007-12#2)(2008-11#4)(2008-7#1)(2008-8#7)(2009-3#1)(2009-5#3)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#2)(2013-8#5)
the burden-of-illness##2##2##(1994-9#2)
the burdens due to selected NCD (diabetes##2##7##(2013-8#2)
the burdens due to selected##3##5##(2013-8#3)
the burdens due to##7##4##(2013-8#7)
the burdens##8##2##(2013-8#8)
the bureaucracy##2##2##(1994-5#1)(1995-3#1)
the bureaucratic##3##2##(1995-1#1)(2008-11#1)(2008-6#1)
the burgeoning field of##2##4##(2006-10#1)(2008-5#1)
the burgeoning##4##2##(1992-2#1)(1994-1#1)(2006-10#1)(2008-5#1)
the buried residues##2##3##(2008-10#2)
the buried##7##2##(1992-3#2)(1997-2#1)(1997-5#1)(2008-10#2)(2008-2#1)
the burning##5##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
the burnout##7##2##(1996-2#1)(2010-9#1)(2011-2#4)(2013-1#1)
the bursae##2##2##(2007-11#1)(2008-5#1)
the bus##2##2##(2008-3#1)(2012-12#1)
the business and##3##3##(1994-3#1)(1996-3#2)
the business community##2##3##(1993-3#1)(1995-2#1)
the business of##2##3##(1992-3#1)(1995-2#1)
the business sector##2##3##(1994-1#1)(1995-12#1)
the business##16##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#2)(1996-3#3)(2008-10#1)(2008-4#1)(2013-8#1)
the butt-coupling##2##2##(2008-2#2)
the butterfly##2##2##(2008-3#1)(2008-9#1)
the buttocks##2##2##(2008-5#1)(2013-8#1)
the button##2##2##(1991-2#1)(2013-8#1)
the butyltin chloride##2##3##(2008-10#2)
the butyrate##2##2##(1990-6#1)(1993-6#1)
the bypass##2##2##(2008-7#1)(2013-7#1)
the bystander effect##3##3##(2008-7#3)
the bystander##4##2##(2008-7#4)
the bzip region##2##3##(1992-3#2)
the c axis and the incident angle##3##7##(2008-3#3)
the c axis##6##3##(1990-4#1)(1996-2#1)(2008-3#4)
the c##8##2##(1990-4#1)(1996-2#1)(2008-10#1)(2008-3#4)(2010-8#1)
the c-Jun##4##2##(1995-2#2)(2010-3#2)
the c-Ki-ras gene##3##3##(1992-8#2)(1992-9#1)
the c-Ki-ras##4##2##(1992-8#3)(1992-9#1)
the c-Myc##2##2##(1996-12#2)
the c-erbB-2 gene product##3##4##(1994-11#3)
the c-fos promoter##3##3##(1994-11#2)(1994-6#1)
the c-fos##5##2##(1992-9#1)(1994-11#2)(1994-6#1)(1994-8#1)
the c-met##2##2##(1995-8#2)
the c-myc allele on the translocated chromosome##2##7##(1993-2#2)
the c-myc gene##9##3##(1992-8#3)(1992-9#1)(1993-2#2)(1993-3#2)(2008-11#1)
the c-myc##14##2##(1992-2#1)(1992-8#3)(1992-9#1)(1993-2#4)(1993-3#2)(1995-9#1)(2008-11#2)
the c1/c1 genotype##3##3##(2008-8#3)
the cAMP level of brain##2##5##(2008-8#2)
the cAMP pathway##2##3##(1994-12#1)(1996-5#1)
the cAMP signaling pathway##2##4##(1994-8#1)(2008-11#1)
the cAMP##15##2##(1993-3#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-5#2)(1997-2#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-8#2)
the cAMP-dependent protein kinase (PKA)##2##5##(1995-5#1)(2008-8#1)
the cAMP-dependent protein kinase##3##4##(1995-2#1)(1995-5#1)(2008-8#1)
the cAMP-dependent##4##2##(1994-11#1)(1995-2#1)(1995-5#1)(2008-8#1)
the cAMP-induced##2##2##(1991-2#2)
the cDNA and genomic##3##4##(1991-9#1)(1993-6#1)(1994-8#1)
the cDNA and##5##3##(1991-9#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-4#1)
the cDNA as##2##3##(1995-6#1)(2008-9#1)
the cDNA clone##6##3##(1991-5#1)(1994-11#1)(1995-8#1)(1997-2#2)(2008-5#1)
the cDNA clones were##2##4##(1996-10#1)(1997-8#1)
the cDNA clones##4##3##(1993-6#1)(1996-10#1)(1996-2#1)(1997-8#1)
the cDNA cloning of##2##4##(1993-3#1)(1994-11#1)
the cDNA encoding the##2##4##(1990-12#1)(1991-6#1)
the cDNA encoding##7##3##(1990-12#1)(1991-6#1)(1993-2#1)(1993-6#1)(1995-8#1)(2008-11#1)(2008-8#1)
the cDNA for##6##3##(1990-12#1)(1990-5#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-7#1)
the cDNA in##3##3##(1990-12#1)(1993-6#1)(1994-8#1)
the cDNA is##2##3##(1993-11#1)(2008-8#1)
the cDNA library##2##3##(1995-6#1)(2008-2#1)
the cDNA nucleotide##3##3##(1993-2#1)(1996-12#2)
the cDNA of##6##3##(1990-12#1)(1992-3#1)(2008-10#1)(2008-12#2)(2008-8#1)
the cDNA sequence##11##3##(1990-8#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-4#1)
the cDNA sequences##2##3##(1990-12#1)(1992-6#1)
the cDNA was##3##3##(1991-1#1)(1994-11#1)(2008-10#1)
the cDNA##89##2##(1990-12#6)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#4)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#5)(1993-8#2)(1994-11#4)(1994-12#1)(1994-8#4)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#4)(1996-2#1)(1996-8#1)(1997-2#3)(1997-7#2)(1997-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-5#1)
the cDNAs of##3##3##(1994-11#1)(1994-12#1)(2008-7#1)
the cDNAs##10##2##(1991-5#1)(1993-2#1)(1994-11#2)(1994-12#1)(1995-8#2)(2008-7#1)(2008-8#1)(2010-5#1)
the cGMP-PDE##2##2##(1994-12#2)
the cI repressor##2##3##(1995-8#2)
the cPCR##2##2##(2012-3#2)
the cPLA2##4##2##(1993-11#4)
the cabbage looper##3##3##(1990-8#2)(2008-7#1)
the cabbage##4##2##(1990-8#2)(2008-7#1)(2008-8#1)
the cabin environment##2##3##(1996-12#1)(2007-2#1)
the cabin##7##2##(1996-12#6)(2007-2#1)
the cable##4##2##(2008-10#1)(2008-9#3)
the cadaveric##2##2##(2011-2#1)(2012-1#1)
the cadence##3##2##(2013-1#3)
the cadmium speciation##2##3##(2008-10#2)
the cadmium##7##2##(1992-12#1)(2008-10#5)(2012-2#1)
the caecal tonsil##2##3##(1997-6#1)(2008-5#1)
the caecum##2##2##(1993-9#1)(2012-2#1)
the caffeine##2##2##(2008-10#1)(2008-5#1)
the cage##2##2##(2008-10#1)(2008-6#1)
the caged##2##2##(1991-12#1)(1994-6#1)
the cages were recovered##2##4##(2008-10#2)
the cages were##3##3##(2008-10#3)
the calcaneal##2##2##(2007-11#1)(2012-2#1)
the calcaneus##4##2##(2007-11#2)(2009-10#1)(2010-11#1)
the calcar##2##2##(2007-11#1)(2008-7#1)
the calcified cusps##2##3##(2011-2#2)
the calcified##4##2##(2009-7#1)(2011-2#2)(2013-8#1)
the calcitonin##5##2##(1990-12#2)(1990-2#1)(2008-7#1)(2013-8#1)
the calcitonin/alpha-CGRP and beta-CGRP genes##2##5##(1992-6#2)
the calcitonin/alpha-CGRP gene##3##3##(1992-6#3)
the calcitonin/alpha-CGRP##5##2##(1992-6#5)
the calcium and##2##3##(2008-10#1)(2013-8#1)
the calcium channel##4##3##(1993-12#1)(1996-5#1)(2008-8#1)(2012-12#1)
the calcium concentration in the##2##5##(1994-6#1)(2008-10#1)
the calcium ion##2##3##(1997-7#1)(2010-8#1)
the calcium ionophore##4##3##(1993-3#1)(1995-11#1)(1995-12#1)(2012-12#1)
the calcium response##2##3##(2008-4#2)
the calcium##31##2##(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-5#1)(1997-7#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-8#1)
the calcium-dependent##2##2##(1995-3#1)(1995-8#1)
the calculated activation barriers of##3##5##(2008-10#3)
the calculated and##2##3##(2008-3#2)
the calculated detection##2##3##(2008-10#2)
the calculated spectrum##2##3##(2008-2#1)(2008-3#1)
the calculated times##2##3##(2012-12#2)
the calculated value##2##3##(2008-10#1)(2008-3#1)
the calculated values##3##3##(2008-10#1)(2008-3#2)
the calculated##59##2##(1991-3#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#4)(2008-10#18)(2008-2#2)(2008-3#22)(2008-4#1)(2008-8#1)(2009-1#1)(2009-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
the calculation of a##6##4##(1992-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
the calculation of net charge from##2##6##(2008-4#2)
the calculation of the effective##3##5##(2008-2#1)(2008-3#1)(2008-8#1)
the calculation of the##17##4##(1993-3#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-8#1)(2010-12#1)(2013-8#1)
the calculation of##55##3##(1992-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-3#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-10#12)(2008-2#11)(2008-3#12)(2008-4#3)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-8#1)(2013-8#1)
the calculation results##2##3##(2013-1#1)(2013-8#1)
the calculation time##2##3##(2008-3#2)
the calculation##65##2##(1992-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-3#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-10#15)(2008-2#12)(2008-3#16)(2008-4#3)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-8#1)(2013-1#1)(2013-8#2)
the calculations for a##2##4##(2008-3#1)(2010-8#1)
the calculations of the##2##4##(1991-11#1)(2008-10#1)
the calculations of##5##3##(1990-12#1)(1991-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
the calculations##20##2##(1990-12#1)(1991-11#1)(2007-11#1)(2008-10#7)(2008-2#3)(2008-3#5)(2010-8#1)(2011-1#1)
the calendar##3##2##(1993-9#2)(2008-10#1)
the calf thymus##2##3##(1995-3#1)(2008-10#1)
the calf##12##2##(1990-11#2)(1991-6#1)(1995-3#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-5#2)(2009-3#1)(2011-2#1)
the caliber##2##2##(1992-1#1)(2010-8#1)
the calibrated##2##2##(1997-2#1)(2013-8#1)
the calibration accuracy##2##3##(2008-3#2)
the calibration and the##2##4##(2008-10#1)(2008-11#1)
the calibration by##3##3##(2008-10#3)
the calibration curve is linear##6##5##(2008-10#6)
the calibration curve is##8##4##(2008-10#8)
the calibration curve of##2##4##(2008-10#2)
the calibration curve was##6##4##(2008-10#6)
the calibration curve##24##3##(2008-10#23)(2008-5#1)
the calibration curves are linear##2##5##(2008-10#2)
the calibration curves are##3##4##(2008-10#2)(2008-3#1)
the calibration curves##13##3##(2008-10#10)(2008-2#1)(2008-3#1)(2009-8#1)
the calibration for the##3##4##(2008-10#1)(2008-2#2)
the calibration from##2##3##(2008-3#2)
the calibration function##2##3##(2008-10#2)
the calibration graph is linear##3##5##(2008-10#3)
the calibration graph is##8##4##(2008-10#8)
the calibration graph was linear from 0##3##7##(2008-10#3)
the calibration graph was linear in the##2##7##(2008-10#2)
the calibration graph was linear##7##5##(2008-10#7)
the calibration graph was##8##4##(2008-10#8)
the calibration graph##19##3##(2008-10#19)
the calibration graphs were linear##2##5##(2008-10#2)
the calibration graphs were##3##4##(2008-10#3)
the calibration graphs##9##3##(2008-10#9)
the calibration line##2##3##(2008-10#2)
the calibration matrix was##2##4##(2008-10#2)
the calibration matrix##7##3##(2008-10#7)
the calibration model is based on absorption spectra in the##2##10##(2008-10#2)
the calibration model is##3##4##(2008-10#3)
the calibration model##7##3##(2007-12#1)(2008-10#6)
the calibration models##4##3##(2008-10#4)
the calibration of a##2##4##(1997-8#1)(2008-10#1)
the calibration of the instrument##2##5##(2008-3#2)
the calibration of the##7##4##(2008-3#7)
the calibration of##16##3##(1997-8#1)(2008-10#5)(2008-2#1)(2008-3#9)
the calibration parameters##3##3##(1995-9#3)
the calibration plot##2##3##(2008-10#2)
the calibration plots##3##3##(2008-10#3)
the calibration procedure##2##3##(2008-10#1)(2008-3#1)
the calibration range##8##3##(2008-10#8)
the calibration recovery##2##3##(2008-10#2)
the calibration set##4##3##(2008-10#4)
the calibration standards##2##3##(2008-10#2)
the calibration was##2##3##(2008-10#2)
the calibration##177##2##(1995-9#3)(1997-8#1)(2007-12#2)(2008-10#138)(2008-11#1)(2008-2#8)(2008-3#21)(2008-5#1)(2008-6#1)(2009-8#1)
the calibrator##6##2##(1995-2#1)(2008-10#5)
the call##5##2##(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#1)
the calling##2##2##(2010-2#1)(2013-8#1)
the calls##2##2##(1996-9#1)(2009-9#1)
the callus##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
the calmodulin##2##2##(1990-12#1)(1992-9#1)
the calmodulin-binding##2##2##(1990-11#2)
the calorimeter##2##2##(2008-10#2)
the calorimetric studies##2##3##(1997-2#2)
the calorimetric##5##2##(1990-2#1)(1997-2#3)(1997-7#1)
the calvaria##2##2##(2008-10#1)(2008-11#1)
the calvarium##2##2##(2008-7#1)(2012-2#1)
the calves##6##2##(1991-3#1)(1996-3#1)(1997-5#2)(2010-2#1)(2012-2#1)
the calyptra##3##2##(2008-10#3)
the calyx##2##2##(2008-10#2)
the cambium##5##2##(2008-10#5)
the camera##16##2##(2007-11#1)(2007-8#1)(2008-2#5)(2008-3#3)(2008-6#2)(2008-9#2)(2010-11#2)
the camera's##2##2##(2007-12#1)(2008-3#1)
the cameras'##2##2##(2008-6#2)
the campaign against##2##3##(1992-12#1)(2011-1#1)
the campaign is##2##3##(1995-1#1)(2007-10#1)
the campaign was##3##3##(1993-6#1)(2008-12#2)
the campaign##23##2##(1992-12#1)(1992-2#2)(1993-6#1)(1995-1#3)(1996-8#6)(1997-6#1)(2007-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
the campaigns##2##2##(1997-6#1)(2011-3#1)
the camptothecin##2##2##(1993-8#1)(1995-5#1)
the canal##4##2##(2006-10#1)(2007-12#1)(2007-5#1)(2008-11#1)
the canalicular ATP-dependent##2##3##(1994-12#2)
the canalicular##7##2##(1990-12#1)(1994-12#3)(1995-2#1)(2008-11#2)
the canals##2##2##(2007-5#1)(2008-11#1)
the cancer cell##2##3##(1994-2#1)(1994-3#1)
the cancer cells##5##3##(1990-5#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
the cancer incidence##2##3##(1995-2#1)(2008-7#1)
the cancer patients##2##3##(2011-1#1)(2013-8#1)
the cancer risk##3##3##(2012-12#1)(2013-1#2)
the cancer stem##2##3##(2009-5#1)(2010-4#1)
the cancer##36##2##(1990-5#1)(1990-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#6)(2013-8#1)
the cancer-relevant##2##2##(2008-7#1)(2012-3#1)
the cancer-specific##2##2##(2008-7#1)(2009-9#1)
the cancerous and##2##3##(1992-9#1)(2009-10#1)
the cancerous##4##2##(1992-9#1)(1994-7#1)(2009-10#2)
the candidacy of##2##3##(2006-10#1)(2010-2#1)
the candidate genes for##2##4##(2008-8#1)(2009-10#1)
the candidate genes##4##3##(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
the candidate##16##2##(1993-9#1)(1994-1#2)(1997-4#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the candidates for##2##3##(1991-12#1)(2008-9#1)
the candidates##3##2##(1991-12#1)(2008-4#1)(2008-9#1)
the canine##13##2##(1990-11#1)(1991-9#1)(1993-6#1)(1995-2#1)(1996-5#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2013-1#1)
the canker##2##2##(2008-10#2)
the cannabinoid binding site##2##4##(1991-1#1)(1996-2#1)
the cannabinoid receptor##3##3##(1991-1#2)(2008-7#1)
the cannabinoid receptors in the##2##5##(1991-4#2)
the cannabinoid##9##2##(1991-1#4)(1991-4#2)(1996-2#1)(2008-7#2)
the cannulation##2##2##(2007-7#1)(2007-8#1)
the canonical##10##2##(1990-8#1)(1992-6#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-7#1)
the canopy and##2##3##(2008-10#2)
the canopy of##2##3##(2008-10#1)(2008-5#1)
the canopy##13##2##(2008-10#10)(2008-12#1)(2008-5#1)(2008-9#1)
the cantaloupe##3##2##(1996-2#1)(2008-10#2)
the cantilever##5##2##(2008-10#1)(2008-3#2)(2010-4#1)(2012-2#1)
the cantilevers##2##2##(2008-3#2)
the cap site##3##3##(1990-12#1)(1991-6#1)(1995-6#1)
the cap structure is##2##4##(1997-2#1)(2008-10#1)
the cap structure##7##3##(1997-2#2)(2008-10#4)(2008-9#1)
the cap##11##2##(1990-12#1)(1991-6#1)(1995-6#1)(1997-2#2)(2008-10#4)(2008-7#1)(2008-9#1)
the capabilities of the##8##4##(2007-12#1)(2008-10#1)(2008-2#5)(2011-7#1)
the capabilities of this##4##4##(1992-2#1)(2008-3#2)(2008-6#1)
the capabilities of##23##3##(1992-2#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-2#6)(2008-3#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-7#1)(2012-12#1)
the capability for##3##3##(1995-12#1)(2008-7#2)
the capability of the method##2##5##(2008-3#1)(2009-7#1)
the capability of the proposed##2##5##(2008-3#1)(2013-1#1)
the capability of the##14##4##(2008-10#4)(2008-2#1)(2008-3#4)(2009-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
the capability of##33##3##(1990-7#1)(1993-2#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#10)(2009-5#1)(2009-7#1)(2010-8#1)(2011-7#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
the capability to##13##3##(1993-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
the capability##50##2##(1990-7#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-12#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#12)(2008-5#1)(2008-7#3)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
the capacitance##4##2##(2008-10#2)(2008-11#1)(2012-2#1)
the capacities##2##2##(1997-2#1)(2012-7#1)
the capacity for recognizing a noun in a##2##8##(2007-12#2)
the capacity for##11##3##(1994-12#1)(1995-1#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-4#1)
the capacity of MT synthesis##2##5##(1995-3#2)
the capacity of a##2##4##(2008-7#1)(2010-10#1)
the capacity of some##2##4##(2010-7#1)(2013-1#1)
the capacity of the health##2##5##(2012-12#1)(2013-8#1)
the capacity of the mammary glands to##2##7##(2012-12#2)
the capacity of the melanotrope cells to produce inositol phosphates##2##10##(1993-5#2)
the capacity of the##24##4##(1992-6#1)(1993-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-8#1)(2009-8#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#2)
the capacity of this##2##4##(2008-5#1)(2009-10#1)
the capacity of##65##3##(1991-12#1)(1992-6#1)(1993-12#1)(1993-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#3)(2013-7#1)(2013-8#2)
the capacity to generate##2##4##(2008-11#1)(2008-8#1)
the capacity to##41##3##(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#4)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
the capacity##127##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#3)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#6)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
the capillaries##2##2##(1997-2#1)(2007-12#1)
the capillary column##2##3##(2008-10#2)
the capillary electrophoresis method##2##4##(2008-10#2)
the capillary electrophoretic##2##3##(1994-12#1)(1996-5#1)
the capillary is##2##3##(2008-10#1)(2008-3#1)
the capillary of a##2##4##(2008-10#2)
the capillary##44##2##(1994-12#1)(1994-9#5)(1996-5#3)(2007-5#1)(2008-1#1)(2008-10#21)(2008-3#5)(2008-4#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
the capital city of##3##4##(2007-10#1)(2008-1#1)(2013-1#1)
the capital city##4##3##(1994-9#1)(2007-10#1)(2008-1#1)(2013-1#1)
the capital of##4##3##(1994-3#1)(2008-1#1)(2008-12#1)(2008-3#1)
the capital##15##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-9#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#1)
the capitation##2##2##(1992-12#1)(1994-3#1)
the capped##2##2##(2008-10#2)
the capping##2##2##(1991-6#1)(2009-5#1)
the capsaicin##2##2##(2008-10#1)(2008-11#1)
the capsid polyprotein##2##3##(2008-10#2)
the capsid protein##3##3##(2007-6#1)(2008-10#2)
the capsid##15##2##(1991-5#2)(1992-8#1)(1994-8#2)(2007-6#1)(2008-10#7)(2008-8#2)
the capstone course##2##3##(1993-1#2)
the capsular polysaccharide of##2##4##(1990-12#1)(2007-10#1)
the capsular polyssacharide##2##3##(2007-10#2)
the capsular##5##2##(1990-12#1)(1994-9#1)(2007-10#3)
the capsule##7##2##(1990-10#1)(1990-11#1)(1991-8#1)(2007-12#1)(2008-10#1)(2008-5#2)
the capsules##3##2##(2007-12#1)(2008-10#2)
the captopril group##2##3##(1992-5#2)
the capture of##6##3##(1990-12#2)(2008-10#1)(2008-4#2)(2013-7#1)
the capture##11##2##(1990-12#2)(1994-11#1)(2008-10#2)(2008-4#3)(2012-2#2)(2013-7#1)
the captured##3##2##(1992-2#1)(1994-12#1)(2008-3#1)
the caput##4##2##(1992-3#3)(2011-1#1)
the carbamates##2##2##(2008-10#2)
the carbaryl##2##2##(2008-10#2)
the carbohydrate moieties##2##3##(1995-8#1)(1997-4#1)
the carbohydrate moiety of##2##4##(1994-8#1)(2008-11#1)
the carbohydrate moiety##6##3##(1990-11#2)(1990-7#1)(1992-5#1)(1994-8#1)(2008-11#1)
the carbohydrate##22##2##(1990-11#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-5#1)(1992-5#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2013-8#1)
the carbohydrate-binding##2##2##(1990-7#1)(1994-8#1)
the carbohydrate-restricted##2##2##(2008-3#2)
the carbon and##3##3##(1996-3#1)(2008-10#1)(2010-11#1)
the carbon content##3##3##(2008-10#1)(2008-3#2)
the carbon dioxide laser##3##4##(1991-12#2)(1993-8#1)
the carbon fiber##2##3##(1992-11#1)(2008-10#1)
the carbon flux to##2##4##(2008-7#1)(2012-3#1)
the carbon flux##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
the carbon paste electrode##5##4##(2008-10#5)
the carbon paste##9##3##(2008-10#9)
the carbon source##9##3##(1990-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(2008-10#2)(2008-6#2)(2008-7#1)
the carbon surface##2##3##(2008-10#2)
the carbon tetrachloride dose##3##4##(1995-3#3)
the carbon##59##2##(1990-5#1)(1991-12#2)(1991-3#1)(1992-11#1)(1993-8#1)(1995-3#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#25)(2008-11#2)(2008-3#2)(2008-6#5)(2008-7#2)(2010-11#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
the carbonate##4##2##(2008-10#4)
the carbons of##3##3##(1995-11#3)
the carbonyl and##2##3##(1995-5#1)(2008-10#1)
the carbonyl group of##3##4##(1992-3#1)(1995-6#1)(2008-5#1)
the carbonyl group##5##3##(1992-3#1)(1995-6#1)(1996-2#1)(2008-5#2)
the carbonyl oxygen of##3##4##(1991-3#1)(1992-6#1)(1996-5#1)
the carbonyl oxygen##4##3##(1991-3#1)(1992-6#1)(1996-5#2)
the carbonyl stretching##3##3##(1995-5#2)(2008-8#1)
the carbonyl##20##2##(1990-7#1)(1991-3#1)(1992-3#1)(1992-6#2)(1993-11#1)(1995-5#5)(1995-6#1)(1996-2#1)(1996-5#2)(2008-10#2)(2008-5#2)(2008-8#1)
the carboxy terminals##2##3##(1993-8#2)
the carboxy terminus##2##3##(1992-9#1)(1993-8#1)
the carboxy##5##2##(1992-9#1)(1993-6#1)(1993-8#3)
the carboxy-terminal##7##2##(1991-9#2)(1992-6#1)(1993-11#1)(1994-6#1)(2008-11#1)(2008-4#1)
the carboxy-terminus##2##2##(1992-6#1)(1995-6#1)
the carboxyl group##6##3##(1991-8#1)(1993-11#1)(1993-3#2)(2008-10#1)(2009-9#1)
the carboxyl groups##4##3##(1993-6#1)(2008-10#3)
the carboxyl side##3##3##(1991-5#1)(1994-5#2)
the carboxyl terminal##4##3##(1992-8#2)(1993-8#1)(1995-5#1)
the carboxyl terminus of##2##4##(1992-8#1)(2012-2#1)
the carboxyl terminus##9##3##(1991-8#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#3)(1995-2#1)(2012-2#1)
the carboxyl##27##2##(1991-5#1)(1991-8#2)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-5#2)(1995-2#1)(1995-5#1)(2008-10#5)(2009-9#1)(2012-2#1)
the carboxyl-terminal##5##2##(1992-5#1)(1992-9#1)(1994-8#1)(1995-2#1)(1997-8#1)
the carboxylate groups##2##3##(2008-10#2)
the carboxylate##6##2##(1992-3#1)(1995-5#1)(1997-7#1)(2008-10#2)(2011-1#1)
the carboxylic acid and##2##4##(1991-9#1)(1995-5#1)
the carboxylic acid##5##3##(1991-9#1)(1995-5#2)(1996-7#1)(2008-10#1)
the carboxylic group is##2##4##(2008-10#2)
the carboxylic##10##2##(1991-9#2)(1995-5#2)(1996-7#1)(2008-10#5)
the carboxyltransferase component##2##3##(1992-9#2)
the carboxymethyl##2##2##(2008-10#2)
the carcases##3##2##(1997-5#3)
the carcass and##2##3##(2013-1#2)
the carcass##6##2##(2008-12#1)(2008-6#2)(2013-1#3)
the carcinoembryonic antigen (CEA)##2##4##(1990-5#1)(1993-8#1)
the carcinogen##6##2##(1990-11#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(2009-9#1)
the carcinogenesis##2##2##(2012-3#1)(2013-7#1)
the carcinogenic##7##2##(1990-5#2)(1992-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
the carcinogenicity of##8##3##(1990-8#1)(1991-12#4)(1991-6#1)(1992-9#1)(1993-8#1)
the carcinomas##2##2##(1990-11#1)(1990-12#1)
the cardia##2##2##(2009-3#2)
the cardiac QT(c) interval##3##4##(2007-11#3)
the cardiac alpha1-adrenoceptor##2##3##(1995-12#2)
the cardiac and##3##3##(1995-2#1)(2007-12#1)(2010-12#1)
the cardiac arrest##2##3##(1990-12#1)(2010-8#1)
the cardiac cell cycle##2##4##(1997-6#2)
the cardiac function in##2##4##(2008-10#1)(2012-3#1)
the cardiac muscle##6##3##(1991-12#1)(1992-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
the cardiac myocytes##2##3##(1993-3#1)(1994-11#1)
the cardiac output##2##3##(2008-12#1)(2012-3#1)
the cardiac surgical##2##3##(1997-8#1)(2008-10#1)
the cardiac tissue##2##3##(2008-10#1)(2008-8#1)
the cardiac##61##2##(1990-12#2)(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#3)(1994-12#1)(1994-6#2)(1995-12#3)(1995-2#1)(1996-6#1)(1997-6#2)(1997-8#1)(2007-11#3)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#6)(2012-3#2)
the cardinal##4##2##(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
the cardiomyocyte##2##2##(1997-6#1)(2009-5#1)
the cardiomyocytes##3##2##(1992-9#1)(1994-11#1)(1994-8#1)
the cardiomyopathy locus##2##3##(1996-8#2)
the cardiomyopathy##4##2##(1990-9#1)(1996-8#2)(2008-10#1)
the cardioplegia##2##2##(2007-8#2)
the cardioprotective effect##2##3##(2008-7#1)(2012-3#1)
the cardioprotective effects of##4##4##(1994-9#1)(2008-5#1)(2008-7#1)(2013-7#1)
the cardioprotective##8##2##(1991-9#1)(1992-5#1)(1994-9#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-7#1)
the cardiorespiratory##2##2##(2007-9#1)(2013-1#1)
the cardiovascular and##4##3##(1990-5#1)(1991-1#1)(2008-1#1)(2010-6#1)
the cardiovascular disease##2##3##(2009-4#1)(2011-1#1)
the cardiovascular effects##2##3##(1990-5#1)(2008-5#1)
the cardiovascular risk##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
the cardiovascular system in the##2##5##(1991-2#1)(2013-8#1)
the cardiovascular system of the##2##5##(1990-10#1)(2008-4#1)
the cardiovascular system##25##3##(1990-10#1)(1991-2#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
the cardiovascular##57##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#2)(1992-8#1)(1994-3#1)(1995-12#2)(1995-6#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2009-10#2)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
the care and##3##3##(1992-1#1)(2008-11#1)(2008-7#1)
the care of children##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
the care of elderly##3##4##(1992-3#1)(2008-11#1)(2012-3#1)
the care of individuals##3##4##(2010-8#1)(2011-2#2)
the care of older people##5##5##(2010-10#5)
the care of patients with##4##5##(1997-4#1)(2008-1#1)(2008-3#1)(2012-3#1)
the care of patients##5##4##(1992-1#1)(1997-4#1)(2008-1#1)(2008-3#1)(2012-3#1)
the care of persons with##2##5##(1995-3#1)(1997-1#1)
the care of persons##4##4##(1995-3#1)(1997-1#1)(2008-6#2)
the care of the chronically##2##5##(1992-1#1)(1997-1#1)
the care of the##10##4##(1991-11#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-12#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-7#1)
the care of these patients##2##5##(2006-12#1)(2008-11#1)
the care of##60##3##(1991-11#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-4#2)(2006-12#1)(2008-1#3)(2008-10#1)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#1)(2010-10#5)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
the care plan##5##3##(1993-3#1)(2013-1#4)
the care provided to##3##4##(1991-3#1)(2007-12#1)(2010-8#1)
the care provided##5##3##(1991-3#1)(1993-3#1)(2007-10#1)(2007-12#1)(2010-8#1)
the care reform##2##3##(1997-8#2)
the care rendered##2##3##(1994-2#1)(1996-3#1)
the care requirements of##2##4##(1994-12#1)(1996-1#1)
the care team##2##3##(2008-3#1)(2011-2#1)
the care that##2##3##(1995-2#1)(2008-7#1)
the care they provided##2##4##(2007-10#1)(2008-11#1)
the care they##3##3##(1997-1#1)(2007-10#1)(2008-11#1)
the care##108##2##(1990-10#1)(1991-11#2)(1991-3#1)(1992-1#3)(1992-11#1)(1992-2#3)(1992-3#2)(1992-5#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-4#2)(1997-6#1)(1997-8#3)(2006-12#1)(2007-10#3)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#9)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-5#3)(2009-7#1)(2010-10#5)(2010-12#1)(2010-8#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#8)
the career status of##2##4##(1993-3#1)(2012-3#1)
the career##5##2##(1993-3#1)(1995-12#1)(1997-2#1)(2008-5#1)(2012-3#1)
the careers##2##2##(1993-6#1)(2010-1#1)
the careful##3##2##(1992-9#1)(2008-10#1)(2013-1#1)
the caregiver##4##2##(1992-2#1)(1997-3#1)(2008-6#1)(2009-5#1)
the caregivers##6##2##(1992-3#3)(1994-3#1)(2008-10#1)(2008-6#1)
the caregiving##4##2##(1992-3#2)(1995-3#1)(2008-7#1)
the cargo##2##2##(2008-11#1)(2010-10#1)
the carina##6##2##(2007-8#1)(2010-7#2)(2012-1#2)(2012-3#1)
the caring##4##2##(1992-1#1)(1992-3#1)(2008-11#1)(2011-1#1)
the carotenogenic##2##2##(1992-8#1)(2010-10#1)
the carotenoid##2##2##(2008-8#1)(2009-10#1)
the carotenoids##4##2##(1992-9#2)(2010-2#2)
the carotid arteries##10##3##(2006-12#1)(2008-7#6)(2008-8#2)(2011-2#1)
the carotid artery is##2##4##(1993-3#2)
the carotid artery##12##3##(1993-3#2)(1996-5#1)(1997-2#1)(2006-6#1)(2007-10#1)(2008-7#2)(2009-7#2)(2011-2#2)
the carotid canal and jugular foramen##2##6##(2012-3#2)
the carotid##35##2##(1991-3#1)(1991-5#1)(1992-6#1)(1993-3#2)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-7#9)(2008-8#4)(2009-7#2)(2010-6#1)(2011-2#4)(2012-3#2)
the carp##5##2##(2008-5#3)(2008-7#1)(2008-9#1)
the carpal tunnel##3##3##(2008-12#1)(2008-9#2)
the carpal##6##2##(2008-12#1)(2008-9#3)(2012-1#1)(2013-1#1)
the carpenter bee##2##3##(2008-7#2)
the carriage of##2##3##(2008-11#1)(2008-5#1)
the carrier buffer##4##3##(1996-5#1)(2008-10#3)
the carrier concentration##4##3##(1992-6#1)(2008-10#2)(2008-3#1)
the carrier density##2##3##(2007-11#1)(2008-7#1)
the carrier envelope phase of##2##5##(2007-12#2)
the carrier flow##2##3##(2008-10#2)
the carrier frequency##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the carrier fringes##2##3##(2008-2#1)(2008-3#1)
the carrier gas flow rate##2##5##(2008-10#2)
the carrier gas##6##3##(2008-10#5)(2008-6#1)
the carrier lifetime##2##3##(2007-12#2)
the carrier solution was##2##4##(2008-10#2)
the carrier solution##12##3##(2008-10#12)
the carrier stream##10##3##(2008-10#10)
the carrier##84##2##(1990-11#3)(1991-5#2)(1992-3#3)(1992-6#2)(1994-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-11#6)(2007-12#5)(2008-1#1)(2008-10#41)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2010-11#1)(2011-1#1)(2013-1#1)
the carrier-envelope offset frequency##2##4##(2007-11#2)
the carrier-envelope offset phase##3##4##(2007-11#3)
the carrier-envelope offset##5##3##(2007-11#5)
the carrier-envelope phase of##4##4##(2007-11#3)(2007-12#1)
the carrier-envelope phase##7##3##(2007-11#4)(2007-12#3)
the carrier-envelope##14##2##(2007-11#11)(2007-12#3)
the carriers and##2##3##(2008-10#1)(2008-11#1)
the carriers##8##2##(1992-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)
the carrot##3##2##(2008-10#2)(2008-9#1)
the carryover##2##2##(2008-10#1)(2013-8#1)
the cartilage and bone##2##4##(2007-11#1)(2008-7#1)
the cartilage tissue##2##3##(2008-3#1)(2008-7#1)
the cartilage##9##2##(1990-3#1)(1993-2#1)(2007-11#1)(2008-3#1)(2008-7#3)(2009-1#1)(2012-3#1)
the cartilaginous region##2##3##(2008-9#2)
the cartilaginous##4##2##(2007-11#1)(2008-9#2)(2010-8#1)
the cartridge is##4##3##(2008-10#4)
the cartridge##9##2##(2008-10#9)
the cascade of##4##3##(1994-6#1)(2008-3#1)(2012-2#1)(2012-3#1)
the cascade##9##2##(1992-2#1)(1994-6#1)(2007-12#2)(2008-3#2)(2009-10#1)(2012-2#1)(2012-3#1)
the cascaded phase shift##3##4##(2007-12#3)
the cascaded##8##2##(2007-12#6)(2008-2#1)(2008-3#1)
the cascading##2##2##(2007-12#1)(2008-3#1)
the case and review##2##4##(2010-5#1)(2013-1#1)
the case and##4##3##(1994-5#1)(2010-5#1)(2013-1#2)
the case described here##2##4##(1994-3#1)(2008-11#1)
the case described##3##3##(1990-3#1)(1994-3#1)(2008-11#1)
the case for a##3##4##(1992-1#1)(1995-2#1)(2010-5#1)
the case for its##2##4##(2013-1#2)
the case for the##5##4##(1991-6#1)(1993-1#1)(1995-2#1)(2008-11#2)
the case for##31##3##(1990-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-1#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
the case group##4##3##(2011-2#4)
the case history of a##2##5##(1991-8#1)(2008-6#1)
the case history of##3##4##(1991-8#1)(1994-2#1)(2008-6#1)
the case history##4##3##(1991-8#1)(1994-2#1)(1995-5#1)(2008-6#1)
the case if##2##3##(1992-2#1)(1992-3#1)
the case in a##3##4##(1994-9#1)(2009-2#1)(2013-1#1)
the case in the##5##4##(1995-6#1)(2008-10#2)(2008-3#1)(2008-7#1)
the case in which a##2##5##(2007-8#1)(2008-3#1)
the case in which the##3##5##(2008-2#1)(2008-3#2)
the case in which##8##4##(2007-8#1)(2008-2#1)(2008-3#6)
the case in##28##3##(1991-9#1)(1993-11#1)(1994-9#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-11#1)(2011-2#2)(2013-1#1)
the case mix##2##3##(1995-2#2)
the case notes##2##3##(1996-9#1)(2008-6#1)
the case of B##2##4##(2008-10#2)
the case of DNA##2##4##(1993-3#1)(1997-6#1)
the case of a 35-year-old woman##2##6##(2011-2#1)(2013-1#1)
the case of a 35-year-old##3##5##(2011-2#2)(2013-1#1)
the case of a 38-year-old woman with##2##7##(1992-5#1)(2008-6#1)
the case of a 45-year-old##3##5##(2010-5#1)(2013-1#1)(2013-8#1)
the case of a 46-year-old##2##5##(2008-7#1)(2008-9#1)
the case of a 49-year-old##2##5##(2008-7#1)(2013-8#1)
the case of a 51-year-old##2##5##(2011-2#1)(2013-1#1)
the case of a 52-year-old##3##5##(2011-2#2)(2013-7#1)
the case of a 60-year-old man##2##6##(2007-8#1)(2008-7#1)
the case of a 60-year-old##4##5##(1997-2#1)(2007-8#1)(2008-4#1)(2008-7#1)
the case of a 63 years old##2##7##(1991-11#1)(2013-7#1)
the case of a 66-year-old##3##5##(2007-8#1)(2008-6#1)(2013-1#1)
the case of a 70-year-old woman##2##6##(2012-3#1)(2013-7#1)
the case of a 70-year-old##3##5##(2012-3#1)(2013-1#1)(2013-7#1)
the case of a female patient with##2##7##(1992-12#1)(2008-1#1)
the case of a girl##2##5##(1991-6#1)(2011-1#1)
the case of a male##2##5##(2010-3#1)(2011-2#1)
the case of a man##3##5##(2008-11#1)(2008-8#1)(2011-2#1)
the case of a patient affected##2##6##(1993-6#2)
the case of a patient who developed##2##7##(1993-8#1)(2008-10#1)
the case of a patient who##6##6##(1993-8#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
the case of a patient with##8##6##(2006-10#1)(2006-12#1)(2007-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#2)
the case of a patient##18##5##(1993-6#2)(1993-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2011-2#3)(2012-3#1)(2013-1#3)
the case of a single##2##5##(2008-3#2)
the case of a young##4##5##(2006-10#1)(2008-7#2)(2012-2#1)
the case of a##160##4##(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-6#3)(1993-8#2)(1994-1#1)(1995-5#1)(1997-2#1)(1997-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#3)(2011-1#1)(2011-2#19)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#6)(2013-1#12)(2013-7#4)(2013-8#6)
the case of an##15##4##(1990-6#1)(1991-2#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
the case of cancer of##2##5##(1991-12#1)(2013-1#1)
the case of cell##2##4##(1994-6#1)(2008-11#1)
the case of diffuse##2##4##(2008-10#1)(2008-3#1)
the case of natural##2##4##(1990-8#1)(2008-10#1)
the case of other##3##4##(1993-5#1)(1997-2#1)(1997-3#1)
the case of such##2##4##(1994-11#1)(2008-7#1)
the case of the biosensor##2##5##(2008-10#2)
the case of the small##2##5##(1990-11#1)(2009-11#1)
the case of the##60##4##(1990-11#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#3)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the case of total##2##4##(2007-11#1)(2008-3#1)
the case of two##2##4##(2008-2#1)(2008-9#1)
the case of very##4##4##(2008-10#4)
the case of##567##3##(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#4)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#7)(1993-8#5)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#4)(1997-7#5)(2006-10#3)(2006-12#2)(2006-4#2)(2006-6#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#112)(2008-11#18)(2008-12#5)(2008-2#20)(2008-3#44)(2008-4#4)(2008-5#13)(2008-6#8)(2008-7#22)(2008-8#7)(2008-9#7)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#30)(2012-1#3)(2012-12#7)(2012-2#8)(2012-3#8)(2013-1#27)(2013-7#6)(2013-8#10)
the case report of a##2##5##(2008-11#1)(2013-1#1)
the case report of##3##4##(2008-11#1)(2012-2#1)(2013-1#1)
the case studies##2##3##(1990-12#1)(1996-1#1)
the case study method##2##4##(1993-3#1)(1994-2#1)
the case study##5##3##(1993-3#1)(1994-2#1)(2008-11#1)(2012-12#2)
the case that##4##3##(1990-11#1)(1993-2#1)(2008-12#1)(2008-4#1)
the case was considered##2##4##(2007-10#1)(2008-10#1)
the case was##4##3##(1995-11#1)(2007-10#1)(2007-7#1)(2008-10#1)
the case when the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the case when##6##3##(1991-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
the case where##5##3##(1995-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)
the case with##14##3##(1990-5#1)(1992-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#3)(2013-1#1)(2013-7#1)
the case without##2##3##(2012-3#1)(2013-8#1)
the case##759##2##(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#6)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#4)(1992-6#3)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#9)(1993-8#6)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#7)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#1)(2006-10#5)(2006-12#2)(2006-4#2)(2006-6#1)(2007-10#3)(2007-11#10)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#126)(2008-11#28)(2008-12#7)(2008-2#26)(2008-3#54)(2008-4#7)(2008-5#15)(2008-6#12)(2008-7#26)(2008-8#12)(2008-9#10)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#3)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#45)(2012-1#3)(2012-12#10)(2012-2#10)(2012-3#9)(2013-1#38)(2013-7#7)(2013-8#13)
the case-control##2##2##(1992-9#1)(2012-3#1)
the cases and##7##3##(1990-6#1)(1992-2#1)(1993-2#1)(2007-7#2)(2008-11#1)(2008-5#1)
the cases are##3##3##(1992-2#1)(1995-12#1)(2008-1#1)
the cases in##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
the cases of##21##3##(1991-11#1)(1992-10#1)(1993-8#1)(1995-8#1)(2007-12#1)(2007-7#3)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
the cases reported##2##3##(1990-2#1)(2006-10#1)
the cases studied##4##3##(1993-2#1)(2007-11#1)(2008-3#1)(2012-3#1)
the cases that##4##3##(1997-3#1)(1997-6#1)(2008-6#1)(2012-1#1)
the cases with a##2##4##(1993-8#1)(2008-10#1)
the cases with##6##3##(1991-8#1)(1993-8#2)(2008-10#1)(2011-1#1)(2013-1#1)
the cases##189##2##(1990-10#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#4)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#3)(1993-3#1)(1993-8#3)(1994-1#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-3#2)(1996-6#2)(1996-9#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#2)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-7#12)(2007-8#7)(2008-1#5)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#4)
the casino##2##2##(2012-2#2)
the caspase##2##2##(2008-11#1)(2012-2#1)
the caspases##2##2##(2008-4#1)(2008-7#1)
the cassette##3##2##(1991-3#2)(1993-9#1)
the casual##3##2##(2008-10#3)
the cat adrenal medulla##2##4##(1992-3#2)
the cat##11##2##(1991-2#1)(1992-3#2)(1993-6#1)(1993-9#2)(1997-6#1)(2008-7#1)(2008-8#3)
the cat-86##2##2##(1991-9#2)
the catabolic##4##2##(1994-12#1)(2008-10#1)(2012-1#1)(2013-1#1)
the catabolism of##6##3##(1990-2#1)(1991-9#1)(1994-8#1)(2008-11#1)(2008-6#1)(2011-1#1)
the catalase activity##2##3##(1991-12#2)
the catalase##6##2##(1990-12#3)(1991-12#2)(2008-10#1)
the catalog of##2##3##(2008-9#2)
the catalysis of##7##3##(1990-12#1)(1993-8#1)(2008-10#4)(2008-4#1)
the catalysis##13##2##(1990-12#1)(1990-5#1)(1991-5#2)(1992-3#1)(1993-11#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-4#1)
the catalyst and##4##3##(2008-10#3)(2008-12#1)
the catalyst for##3##3##(2008-10#2)(2008-7#1)
the catalyst is##2##3##(2008-10#2)
the catalyst##17##2##(1995-2#1)(1997-2#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)
the catalysts##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
the catalytic Zn(II)##2##3##(1992-3#2)
the catalytic active##2##3##(2010-12#1)(2013-1#1)
the catalytic activity of the enzyme##2##6##(2008-10#1)(2008-7#1)
the catalytic activity of the##4##5##(2008-10#3)(2008-7#1)
the catalytic activity of##10##4##(2008-10#8)(2008-7#1)(2012-2#1)
the catalytic activity##11##3##(1992-3#1)(2008-10#8)(2008-7#1)(2012-2#1)
the catalytic and regulatory##2##4##(1990-8#1)(1993-11#1)
the catalytic and the##2##4##(1995-11#1)(1997-1#1)
the catalytic and##4##3##(1990-8#1)(1993-11#1)(1995-11#1)(1997-1#1)
the catalytic chains of Escherichia coli aspartate transcarbamoylase##2##8##(1995-6#2)
the catalytic chains##3##3##(1990-8#1)(1995-6#2)
the catalytic core##4##3##(2008-4#2)(2011-1#2)
the catalytic cycle##3##3##(1996-2#1)(2009-9#1)(2013-1#1)
the catalytic domain of##6##4##(1990-5#1)(1991-10#1)(1992-11#2)(1994-8#1)(2008-4#1)
the catalytic domain##11##3##(1990-5#1)(1991-10#1)(1992-11#2)(1993-12#1)(1994-8#1)(1995-8#1)(1997-2#2)(1997-3#1)(2008-4#1)
the catalytic domains of##5##4##(1991-6#1)(1993-2#1)(1994-8#2)(1997-8#1)
the catalytic efficiency##2##3##(1992-6#2)
the catalytic fragment of##2##4##(1992-12#1)(1995-11#1)
the catalytic function##4##3##(1990-7#1)(1992-6#2)(2008-9#1)
the catalytic hydrogen##4##3##(2008-10#4)
the catalytic mechanism of##4##4##(1992-6#1)(1993-11#1)(1995-2#1)(1995-6#1)
the catalytic mechanism##6##3##(1992-11#1)(1992-6#1)(1993-11#2)(1995-2#1)(1995-6#1)
the catalytic oxidation of##3##4##(2008-10#2)(2010-12#1)
the catalytic process##2##3##(1994-5#1)(2010-12#1)
the catalytic reaction##4##3##(2008-10#4)
the catalytic site of##5##4##(1990-11#1)(1992-3#1)(1994-5#2)(1995-2#1)
the catalytic site##12##3##(1990-11#2)(1992-3#1)(1994-5#2)(1995-2#1)(1995-5#3)(2009-7#3)
the catalytic subunit of the##2##5##(1994-5#1)(1995-11#1)
the catalytic subunit of##13##4##(1992-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
the catalytic subunit##19##3##(1990-8#1)(1992-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)
the catalytic triad of##2##4##(1992-3#1)(1995-5#1)
the catalytic triad##6##3##(1992-3#2)(1995-3#1)(1995-5#2)(1997-6#1)
the catalytic turnover of##2##4##(2009-11#1)(2012-2#1)
the catalytic##167##2##(1990-11#2)(1990-5#1)(1990-7#2)(1990-8#5)(1991-10#1)(1991-6#1)(1992-11#3)(1992-12#3)(1992-3#10)(1992-4#1)(1992-6#7)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-5#4)(1994-8#4)(1994-9#1)(1995-11#5)(1995-2#6)(1995-3#2)(1995-5#7)(1995-6#5)(1995-8#2)(1996-2#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#43)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#3)(2009-9#1)(2010-12#3)(2010-4#1)(2011-1#2)(2012-2#2)(2013-1#2)
the catalytically##2##2##(1991-12#1)(1995-5#1)
the catalyzed reaction##3##3##(1990-7#1)(2008-10#2)
the catalyzed##5##2##(1990-7#1)(2008-10#3)(2013-1#1)
the catastrophic##2##2##(2006-10#1)(2012-1#1)
the catch##3##2##(2008-5#1)(2008-6#1)(2009-5#1)
the catch-up##2##2##(2013-1#2)
the catechol##5##2##(2008-10#4)(2009-9#1)
the categorical##2##2##(2008-10#1)(2013-8#1)
the categories of##4##3##(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
the categories##6##2##(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
the categorization of##4##3##(1993-2#1)(2008-11#2)(2010-11#1)
the category membership for##2##4##(2008-9#2)
the category of##8##3##(1990-11#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)
the category##14##2##(1990-11#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#2)(2011-2#1)
the catenation##2##2##(1992-11#1)(2008-10#1)
the catfish genome##2##3##(2008-7#2)
the catfish##5##2##(2008-5#2)(2008-7#3)
the catheter exit site##3##4##(2007-12#1)(2007-7#1)(2008-5#1)
the catheter had to be removed##2##6##(1990-8#2)
the catheter has##2##3##(2008-11#1)(2010-8#1)
the catheter material##2##3##(2011-2#2)
the catheter was##2##3##(2008-7#1)(2011-2#1)
the catheter##26##2##(1990-3#1)(1990-8#2)(1993-5#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#4)(2011-2#7)
the catheterization laboratory##2##3##(1996-6#1)(2008-3#1)
the catheterization##3##2##(1996-6#1)(2008-3#1)(2011-3#1)
the catheters##4##2##(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
the cathode##6##2##(2007-12#1)(2008-10#5)
the cathodic adsorptive stripping##3##4##(2008-10#3)
the cathodic stripping##2##3##(2008-10#2)
the cathodic##12##2##(2008-10#11)(2010-6#1)
the cation exchange##2##3##(2008-10#2)
the cation of the##2##4##(2008-10#2)
the cation of##3##3##(2008-10#3)
the cation##17##2##(1992-3#1)(1996-2#1)(2008-10#10)(2008-8#3)(2012-12#1)(2012-7#1)
the cation-exchange##2##2##(2008-10#2)
the cationic polymer##4##3##(1996-5#1)(2008-11#1)(2008-5#2)
the cationic surfactant##4##3##(2008-10#2)(2008-5#1)(2008-8#1)
the cationic##29##2##(1990-8#1)(1991-7#1)(1992-6#4)(1994-12#1)(1996-5#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#4)(2008-8#1)(2009-8#1)(2011-1#1)
the cations and anions##2##4##(2008-10#2)
the cations were##2##3##(2008-10#2)
the cations##11##2##(2008-10#11)
the cattle population##2##3##(1990-3#1)(2011-2#1)
the cattle tick Boophilus microplus##2##5##(1994-3#1)(1997-7#1)
the cattle tick##3##3##(1994-3#1)(1997-7#1)(2010-10#1)
the cattle##10##2##(1990-3#1)(1991-8#1)(1994-11#1)(1994-3#1)(1997-7#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-3#1)
the cauda equina##4##3##(2008-12#1)(2008-3#3)
the caudal KF##2##3##(1996-5#2)
the caudal neurosecretory system (CNSS)##2##5##(2008-7#2)
the caudal##24##2##(1990-3#1)(1990-5#1)(1990-9#1)(1992-8#1)(1993-12#2)(1993-3#1)(1996-5#4)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#2)(2013-8#1)
the caudate nucleus in##2##4##(2007-8#1)(2008-7#1)
the caudate nucleus##5##3##(1995-5#1)(2007-8#1)(2008-10#1)(2008-7#2)
the caudate##12##2##(1991-4#1)(1992-8#1)(1995-5#1)(1995-6#1)(1996-12#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#2)
the caudate-putamen##6##2##(1993-6#3)(1995-12#2)(2008-7#1)
the cauliflower##4##2##(1997-4#1)(2008-10#3)
the causal agent has not been##2##6##(2008-10#2)
the causal agent has##3##4##(2008-10#3)
the causal agent of Alternaria##2##5##(2008-10#2)
the causal agent of Dutch elm disease##2##7##(2008-10#2)
the causal agent of Fusarium##2##5##(2008-10#2)
the causal agent of bacterial##3##5##(2008-10#3)
the causal agent of dollar spot of##2##7##(2008-10#2)
the causal agent of gray mold##2##6##(1997-4#1)(2008-10#1)
the causal agent of late##2##5##(2008-10#2)
the causal agent of maize##2##5##(2008-10#2)
the causal agent of potato and tomato late blight##2##9##(2008-10#2)
the causal agent of potato##5##5##(2008-10#5)
the causal agent of stem canker of oilseed rape##2##9##(2008-10#2)
the causal agent of this##2##5##(2008-10#2)
the causal agent of##71##4##(1997-4#1)(2008-10#68)(2008-12#1)(2011-10#1)
the causal agent##79##3##(1997-4#1)(2008-10#76)(2008-12#1)(2011-10#1)
the causal agents of##3##4##(2008-10#3)
the causal effect of##2##4##(2013-1#1)(2013-8#1)
the causal mechanisms##2##3##(2009-8#2)
the causal organism of##2##4##(2008-10#2)
the causal organism##4##3##(2008-10#4)
the causal relationship##2##3##(1990-3#1)(1990-6#1)
the causal role##2##3##(2008-6#1)(2011-2#1)
the causal##105##2##(1990-3#1)(1990-6#1)(1995-3#1)(1997-4#1)(2008-10#89)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#2)(2010-5#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the causative agent in##2##4##(2007-7#1)(2008-5#1)
the causative agent of##15##4##(1992-8#3)(2007-6#1)(2008-10#2)(2008-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
the causative agent##21##3##(1990-7#1)(1992-8#3)(1994-5#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
the causative factors##2##3##(2008-7#1)(2010-12#1)
the causative##33##2##(1990-7#1)(1991-8#1)(1992-5#1)(1992-8#3)(1994-5#2)(1997-3#1)(2007-6#1)(2007-7#2)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
the cause and##5##3##(1991-11#1)(1992-3#1)(2007-10#2)(2011-2#1)
the cause for##8##3##(1991-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-1#2)(2011-2#1)(2013-1#1)
the cause of Cushing's##2##4##(2011-2#2)
the cause of a##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
the cause of citrus##2##4##(2008-10#2)
the cause of death of the##2##6##(2011-2#1)(2012-2#1)
the cause of death was##3##5##(1994-11#1)(1995-11#1)(2011-2#1)
the cause of death##9##4##(1990-11#1)(1994-11#1)(1995-11#1)(1995-3#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
the cause of pain##2##4##(2007-11#1)(2013-1#1)
the cause of renal##2##4##(2008-1#1)(2008-10#1)
the cause of the disease##2##5##(2008-10#1)(2011-2#1)
the cause of the##14##4##(1992-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#2)(2011-2#3)
the cause of these##2##4##(2008-1#1)(2011-2#1)
the cause of this##7##4##(1990-11#1)(1991-12#1)(1992-12#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
the cause of##104##3##(1990-11#2)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#6)(2008-9#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)
the cause##132##2##(1990-11#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#16)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
the causes and consequences of##3##5##(2007-4#1)(2008-8#1)(2010-3#1)
the causes and##9##3##(1990-9#1)(1994-11#1)(1995-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-3#1)
the causes for##4##3##(1990-2#1)(1996-11#1)(2009-3#1)(2012-3#1)
the causes of the##3##4##(1996-8#1)(2008-8#1)(2012-12#1)
the causes of##35##3##(1990-8#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#1)(1996-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
the causes underlying##2##3##(1996-2#1)(2008-10#1)
the causes##59##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-6#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#2)
the caustic##6##2##(2008-2#5)(2008-6#1)
the cavernous sinus and##3##4##(1990-12#1)(2009-6#1)(2011-2#1)
the cavernous sinus##12##3##(1990-12#3)(1993-9#1)(2008-7#2)(2009-6#2)(2011-2#3)(2012-3#1)
the cavernous##15##2##(1990-12#3)(1993-9#1)(1996-9#1)(2008-7#2)(2009-10#1)(2009-6#2)(2011-2#3)(2012-3#2)
the cavities##6##2##(2007-11#1)(2008-10#1)(2008-3#3)(2012-2#1)
the cavity Fresnel number##2##4##(2007-12#1)(2008-3#1)
the cavity and the##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
the cavity and##6##3##(2008-10#1)(2008-2#2)(2008-3#3)
the cavity by##2##3##(2007-12#1)(2008-3#1)
the cavity center##2##3##(2008-3#2)
the cavity is##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the cavity length##7##3##(2007-11#4)(2007-12#3)
the cavity loss##2##3##(2008-3#2)
the cavity mode##2##3##(2007-12#1)(2008-2#1)
the cavity of a##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the cavity of##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the cavity optics##2##3##(2008-2#1)(2008-3#1)
the cavity output##2##3##(2007-11#2)
the cavity to##2##3##(2007-12#1)(2008-3#1)
the cavity were##2##3##(1995-2#1)(2007-12#1)
the cavity##96##2##(1995-2#3)(1996-5#2)(1997-6#1)(1997-8#1)(2007-11#11)(2007-12#24)(2007-8#1)(2008-10#4)(2008-2#11)(2008-3#36)(2008-7#1)(2009-9#1)
the cavity's##2##2##(2007-12#1)(2008-3#1)
the cavo-tricuspid isthmus##2##3##(2007-8#2)
the cecum##5##2##(2007-12#1)(2008-12#4)
the ceiling##2##2##(1996-12#1)(2008-11#1)
the celiac artery##2##3##(1995-12#1)(2008-12#1)
the celiac##6##2##(1995-12#1)(2008-12#3)(2008-7#1)(2012-2#1)
the cell adhesion and##2##4##(1994-11#1)(2008-9#1)
the cell adhesion molecule##2##4##(1990-11#1)(2009-9#1)
the cell adhesion##4##3##(1990-11#1)(1994-11#1)(2008-9#1)(2009-9#1)
the cell affinity of##2##4##(2008-5#2)
the cell alone##2##3##(2008-11#2)
the cell and##17##3##(1990-11#1)(1990-8#1)(1991-9#1)(1994-6#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2013-1#1)(2013-8#1)
the cell as##3##3##(1991-6#1)(1994-8#1)(2008-1#1)
the cell attachment##2##3##(1992-3#1)(2010-2#1)
the cell bodies##3##3##(1991-5#1)(1993-12#1)(1994-2#1)
the cell body##9##3##(1994-6#2)(2008-11#1)(2008-7#5)(2013-1#1)
the cell boundaries##4##3##(2008-5#2)(2008-7#1)(2011-1#1)
the cell concentration##2##3##(2008-11#1)(2008-7#1)
the cell culture medium##2##4##(2008-11#1)(2013-1#1)
the cell culture method##2##4##(2012-2#2)
the cell culture##16##3##(1991-6#1)(1996-2#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)(2012-2#2)(2013-1#1)
the cell cycle and##4##4##(2008-11#2)(2011-1#1)(2012-1#1)
the cell cycle arrest##2##4##(1997-3#1)(2008-11#1)
the cell cycle during##2##4##(2009-8#1)(2012-3#1)
the cell cycle in##5##4##(1996-3#1)(2008-11#1)(2008-4#2)(2008-9#1)
the cell cycle of##2##4##(2008-5#1)(2008-7#1)
the cell cycle progression##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
the cell cycle regulation##2##4##(2008-11#1)(2008-5#1)
the cell cycle##72##3##(1990-2#1)(1992-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#3)(1994-8#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#1)(2008-11#19)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-2#1)(2009-3#1)(2009-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
the cell cytoplasm##4##3##(1997-6#1)(2007-12#1)(2008-10#2)
the cell death machinery##2##4##(2008-11#2)
the cell death##9##3##(1993-8#1)(2008-11#4)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
the cell density and##2##4##(2010-10#1)(2012-1#1)
the cell density on the##2##5##(2008-11#2)
the cell density##12##3##(2008-11#8)(2008-7#1)(2010-10#2)(2012-1#1)
the cell division cycle##2##4##(1995-2#1)(1997-6#1)
the cell division##4##3##(1990-7#1)(1995-2#1)(1997-6#1)(2009-10#1)
the cell entered##2##3##(2008-8#2)
the cell extract##2##3##(1990-11#1)(1990-2#1)
the cell fraction##2##3##(2008-11#1)(2009-3#1)
the cell growth and##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
the cell growth in##2##4##(2008-11#2)
the cell growth inhibitory factor##2##5##(1992-9#2)
the cell growth##15##3##(1992-9#2)(2008-11#9)(2008-7#2)(2008-8#1)(2009-8#1)
the cell into##2##3##(2007-12#1)(2008-11#1)
the cell is##7##3##(1993-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
the cell killing##2##3##(1993-8#1)(2008-8#1)
the cell line##20##3##(1990-5#1)(1991-6#2)(1992-10#1)(1992-2#1)(1994-5#1)(1997-1#1)(2008-11#11)(2008-4#1)(2010-11#1)
the cell lineage of##2##4##(2007-12#1)(2012-3#1)
the cell lineage##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
the cell lines to##2##4##(2008-11#2)
the cell lines used##2##4##(2008-11#1)(2013-1#1)
the cell lines##16##3##(1992-8#1)(1994-12#1)(1995-12#1)(2008-11#7)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2013-1#1)
the cell lysate was##2##4##(1992-8#1)(2010-11#1)
the cell lysate##4##3##(1992-8#1)(1997-4#1)(2008-10#1)(2010-11#1)
the cell lysates##2##3##(2008-7#2)
the cell membrane and##4##4##(1991-9#2)(2008-1#1)(2009-2#1)
the cell membrane is##2##4##(1990-11#1)(2009-11#1)
the cell membrane may##2##4##(1991-12#1)(2013-8#1)
the cell membrane of##3##4##(1990-5#1)(2008-8#1)(2009-2#1)
the cell membrane##46##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-2#3)(2013-8#1)
the cell membranes of##2##4##(1991-12#1)(2013-1#1)
the cell membranes##3##3##(1991-12#1)(2009-2#1)(2013-1#1)
the cell nucleus##3##3##(1991-2#1)(2008-4#1)(2011-2#1)
the cell number##5##3##(1992-3#1)(1994-5#1)(2008-10#1)(2008-11#2)
the cell of origin##3##4##(2010-3#2)(2013-1#1)
the cell of##4##3##(2008-10#1)(2010-3#2)(2013-1#1)
the cell or##2##3##(1991-10#1)(2008-7#1)
the cell path length##2##4##(2008-2#1)(2008-4#1)
the cell periphery##8##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)(2012-2#2)
the cell population##8##3##(1992-9#1)(2008-11#3)(2008-7#3)(2013-1#1)
the cell proliferation##7##3##(1990-12#2)(1997-2#3)(2008-9#2)
the cell protein content##2##4##(1995-9#2)
the cell size##6##3##(1995-9#3)(2008-10#1)(2008-7#2)
the cell surface FcepsilonRI expression##2##5##(2008-11#2)
the cell surface and a##2##5##(1990-12#1)(1995-2#1)
the cell surface and##6##4##(1990-12#1)(1992-11#1)(1995-2#1)(1996-5#1)(2008-8#1)(2010-11#1)
the cell surface is##2##4##(2008-11#1)(2008-4#1)
the cell surface of##9##4##(1990-12#1)(1990-7#1)(1991-12#1)(1991-9#1)(2008-10#1)(2008-11#3)(2008-5#1)
the cell surface with##2##4##(1995-2#1)(2008-4#1)
the cell surface##68##3##(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#3)(1996-5#1)(1997-1#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#4)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
the cell suspension##4##3##(2008-11#4)
the cell to potentials more##2##5##(1993-3#2)
the cell to##6##3##(1992-9#1)(1993-3#2)(1995-2#1)(2008-11#1)(2011-2#1)
the cell type used##2##4##(1997-3#1)(2008-2#1)
the cell type##7##3##(1992-6#1)(1993-8#2)(1997-3#1)(2008-2#2)(2008-7#1)
the cell via##2##3##(2008-4#1)(2008-8#1)
the cell viability##3##3##(2008-11#2)(2013-7#1)
the cell volume##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the cell wall##30##3##(1990-5#1)(1994-2#1)(1995-6#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)
the cell walls of##3##4##(2008-10#2)(2008-11#1)
the cell walls##5##3##(2008-10#4)(2008-11#1)
the cell was##2##3##(2007-11#1)(2008-10#1)
the cell were##2##3##(1996-8#1)(2008-11#1)
the cell##665##2##(1990-11#5)(1990-12#8)(1990-2#4)(1990-5#5)(1990-7#2)(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#3)(1991-6#5)(1991-9#8)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#6)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#3)(1993-8#9)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#1)(1995-6#2)(1995-8#3)(1995-9#8)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#9)(2008-1#11)(2008-10#53)(2008-11#126)(2008-12#3)(2008-2#11)(2008-3#7)(2008-4#27)(2008-5#13)(2008-6#6)(2008-7#41)(2008-8#22)(2008-9#28)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#6)(2009-3#2)(2009-5#2)(2009-7#3)(2009-8#9)(2009-9#7)(2010-10#3)(2010-11#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#13)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#4)
the cell's##4##2##(2008-1#1)(2008-3#1)(2009-3#1)(2009-8#1)
the cell)##2##2##(1990-5#1)(2008-10#1)
the cell-based##3##2##(2008-5#1)(2010-2#2)
the cell-cell##4##2##(1996-8#1)(2008-9#2)(2009-8#1)
the cell-free system##2##3##(2008-5#1)(2008-8#1)
the cell-free##7##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#3)
the cell-specific##3##2##(1993-5#1)(1997-7#1)(2008-11#1)
the cell-surface##3##2##(1990-12#1)(2009-6#1)(2013-1#1)
the cell-to-cell movement of##2##4##(2008-10#2)
the cell-to-cell##3##2##(2008-10#3)
the cells and the##2##4##(1995-2#1)(2008-7#1)
the cells and was##5##4##(1991-12#1)(1994-11#1)(2008-10#1)(2008-11#2)
the cells and##20##3##(1990-8#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-10#4)(2008-11#6)(2008-6#1)(2008-7#1)(2008-9#1)
the cells are##8##3##(1991-5#1)(1992-6#2)(1993-12#1)(1997-3#1)(2008-4#1)(2009-8#1)(2012-2#1)
the cells at a##2##4##(2008-11#1)(2012-7#1)
the cells at##7##3##(1993-8#1)(2008-11#4)(2008-9#1)(2012-7#1)
the cells by##4##3##(1992-5#1)(1994-2#1)(1994-8#1)(2008-11#1)
the cells can be##2##4##(1990-12#1)(1990-2#1)
the cells could##2##3##(2008-11#2)
the cells examined##2##3##(1992-8#1)(2008-11#1)
the cells for##2##3##(1991-5#1)(2008-8#1)
the cells from the##2##4##(1992-6#1)(1994-11#1)
the cells from##9##3##(1990-8#1)(1992-11#1)(1992-6#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-8#1)
the cells grown##3##3##(2008-11#2)(2008-5#1)
the cells had##2##3##(1994-8#1)(2008-9#1)
the cells in the##6##4##(1993-11#1)(1993-6#1)(1994-11#1)(2008-11#2)(2010-2#1)
the cells in##16##3##(1990-11#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-11#1)(1995-9#1)(2008-11#8)(2008-4#1)(2010-2#1)
the cells incubated##2##3##(1994-3#1)(2008-11#1)
the cells into the##3##4##(1994-8#1)(2008-1#1)(2008-4#1)
the cells into##5##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
the cells is##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
the cells of origin##2##4##(2013-1#2)
the cells of the female germ unit and##2##8##(2008-11#2)
the cells of the##10##4##(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2012-3#1)
the cells of##23##3##(1996-9#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#2)
the cells on##3##3##(1991-12#1)(1992-6#1)(2008-11#1)
the cells rather than##3##4##(1990-5#1)(1994-8#1)(2008-10#1)
the cells that##5##3##(1992-6#1)(2007-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
the cells to a##3##4##(1990-5#1)(1993-6#1)(2008-11#1)
the cells to##13##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1995-12#1)(2008-11#5)(2008-4#1)(2008-9#1)
the cells transfected with##2##4##(1994-9#1)(2008-8#1)
the cells treated with##2##4##(2008-11#1)(2010-12#1)
the cells treated##3##3##(2008-11#2)(2010-12#1)
the cells was##10##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#5)(2013-1#1)(2013-7#1)
the cells were cultivated##2##4##(1990-12#1)(2008-11#1)
the cells were cultured##4##4##(1995-3#1)(1996-12#1)(1997-2#1)(2008-6#1)
the cells were resuspended##2##4##(2008-11#2)
the cells were strongly##2##4##(2007-5#1)(2008-11#1)
the cells were subjected to##2##5##(2008-11#2)
the cells were##33##3##(1990-12#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-5#1)(2008-11#13)(2008-6#2)(2008-7#1)(2011-2#1)
the cells with a##3##4##(1994-8#1)(2008-11#1)(2008-7#1)
the cells with the##2##4##(1992-6#1)(2008-11#1)
the cells with##26##3##(1992-6#2)(1993-9#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#4)(2008-1#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#2)(2012-3#1)(2013-1#1)
the cells##373##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-5#4)(1990-7#1)(1990-8#3)(1991-12#3)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#9)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#4)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#9)(1994-9#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#1)(2007-12#5)(2007-5#1)(2008-1#7)(2008-10#17)(2008-11#99)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#17)(2008-8#12)(2008-9#8)(2009-12#1)(2009-5#1)(2009-7#3)(2009-8#4)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#3)
the cells'##6##2##(1992-3#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
the cells)##2##2##(1990-12#1)(1993-3#1)
the cellular accumulation of##2##4##(1993-8#1)(2013-1#1)
the cellular and molecular levels##2##5##(2008-7#1)(2009-5#1)
the cellular and molecular mechanisms of##2##6##(2009-10#1)(2009-8#1)
the cellular and molecular mechanisms that regulate##2##7##(2008-4#1)(2013-1#1)
the cellular and molecular mechanisms underlying the##2##7##(2008-7#1)(2008-8#1)
the cellular and molecular mechanisms##6##5##(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)
the cellular and molecular##11##4##(1994-6#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
the cellular and tissue##2##4##(2008-7#1)(2013-1#1)
the cellular and##15##3##(1994-6#1)(2008-4#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#2)
the cellular basis of##2##4##(2007-8#1)(2008-7#1)
the cellular basis##3##3##(1996-5#1)(2007-8#1)(2008-7#1)
the cellular changes##2##3##(2008-10#1)(2009-12#1)
the cellular components##2##3##(1990-2#1)(2008-10#1)
the cellular composition##3##3##(2008-7#1)(2009-12#2)
the cellular content##2##3##(1995-3#1)(2008-9#1)
the cellular distribution of iron##2##5##(1996-5#2)
the cellular distribution of##5##4##(1995-11#1)(1996-5#2)(2008-11#1)(2012-2#1)
the cellular environment##4##3##(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
the cellular enzyme##2##3##(1996-5#1)(2008-5#1)
the cellular expression##2##3##(1996-12#1)(2010-1#1)
the cellular growth##3##3##(1993-11#1)(2008-7#1)(2011-2#1)
the cellular level of the##2##5##(1991-12#1)(2013-1#1)
the cellular level##25##3##(1991-12#1)(1993-11#1)(1994-2#1)(1995-11#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
the cellular levels of##2##4##(1991-12#1)(1992-8#1)
the cellular lipid##2##3##(1991-4#1)(1991-9#1)
the cellular localization of##3##4##(1994-10#1)(1995-5#1)(1996-6#1)
the cellular machinery##2##3##(2008-1#1)(2008-7#1)
the cellular mechanism##3##3##(2007-2#1)(2008-11#1)(2008-7#1)
the cellular mechanisms##3##3##(1994-8#1)(1997-2#1)(2007-8#1)
the cellular membrane##4##3##(2008-9#2)(2009-8#1)(2010-11#1)
the cellular metabolism##2##3##(2008-11#2)
the cellular morphology##2##3##(2008-11#2)
the cellular origin of##2##4##(1996-2#2)
the cellular proliferation##2##3##(2008-11#2)
the cellular protein##2##3##(1994-12#1)(2012-12#1)
the cellular response to##3##4##(2008-2#1)(2008-4#1)(2011-2#1)
the cellular response##6##3##(2008-2#1)(2008-4#1)(2011-2#3)(2013-1#1)
the cellular transport##2##3##(2008-11#2)
the cellular uptake of##2##4##(2008-11#2)
the cellular uptake##3##3##(1997-2#1)(2008-11#2)
the cellular##186##2##(1990-2#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#4)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#1)(2007-12#2)(2007-2#1)(2007-8#3)(2008-1#4)(2008-10#6)(2008-11#20)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#7)(2008-6#1)(2008-7#15)(2008-8#2)(2008-9#7)(2009-10#2)(2009-12#7)(2009-3#1)(2009-5#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)
the cellulase##2##2##(2008-10#1)(2008-6#1)
the cellulose##7##2##(2008-10#2)(2008-6#1)(2008-7#2)(2013-1#1)(2013-8#1)
the cement##3##2##(2009-7#1)(2010-2#1)(2013-1#1)
the cementoenamel junction##2##3##(2008-12#1)(2009-8#1)
the censoring##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
the centenarians##4##2##(2008-7#3)(2010-12#1)
the center and##3##3##(2007-11#1)(2008-2#2)
the center line##2##3##(2008-3#2)
the center of a##5##4##(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)
the center of origin of##2##5##(2008-10#2)
the center of origin##3##4##(2008-10#3)
the center of pressure##2##4##(2010-9#1)(2012-2#1)
the center of the city##2##5##(2008-10#1)(2008-5#1)
the center of the##30##4##(1993-11#1)(1993-8#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#3)
the center of##57##3##(1991-2#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-12#4)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the center position and##2##4##(2007-12#1)(2008-3#1)
the center wavelength of the rectified THz radiation##2##8##(2007-11#2)
the center wavelength of##4##4##(2007-11#3)(2007-12#1)
the center##96##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#2)(2007-11#8)(2007-12#6)(2008-10#12)(2008-11#2)(2008-2#9)(2008-3#19)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the centering of the femoral neck##2##6##(2007-8#2)
the centerpiece of##2##3##(1996-3#1)(2011-2#1)
the centers of the##2##4##(2008-11#1)(2009-7#1)
the centers of##6##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)
the centers that##2##3##(2011-2#2)
the centers##11##2##(1991-10#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)
the central Chilean##2##3##(2008-8#1)(2009-2#1)
the central United States##2##4##(2008-10#1)(2008-11#1)
the central airways##3##3##(1990-6#1)(1994-12#1)(1996-3#1)
the central and northern##3##4##(2007-1#1)(2008-10#1)(2010-3#1)
the central and peripheral nervous system##7##6##(1996-12#1)(1996-5#1)(2008-3#1)(2008-7#3)(2013-8#1)
the central and peripheral nervous systems##2##6##(1997-6#1)(2008-4#1)
the central and peripheral nervous##9##5##(1996-12#1)(1996-5#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-7#3)(2013-8#1)
the central and peripheral##12##4##(1992-8#1)(1996-12#2)(1996-5#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-6#1)(2013-8#1)
the central and##19##3##(1992-11#1)(1992-8#1)(1996-12#2)(1996-5#1)(1997-6#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-3#1)(2010-6#1)(2013-8#1)
the central anterior skull base##2##5##(2006-12#2)
the central axis of the##2##5##(2009-2#1)(2013-1#1)
the central axis of##3##4##(2008-10#1)(2009-2#1)(2013-1#1)
the central axis##5##3##(2007-10#1)(2008-10#2)(2009-2#1)(2013-1#1)
the central canal##3##3##(1995-5#1)(1996-12#1)(1996-5#1)
the central cavity##3##3##(1990-8#1)(2008-8#2)
the central cell and primary endosperm##2##6##(2008-9#2)
the central cell and##3##4##(2008-9#3)
the central cell##9##3##(2007-12#1)(2008-11#2)(2008-9#6)
the central cells of the##2##5##(2008-5#2)
the central cholinergic system##3##4##(1991-12#1)(2008-10#2)
the central complex##3##3##(2007-12#3)
the central component of the##2##5##(2008-7#1)(2012-2#1)
the central core of the##2##5##(1995-3#1)(2012-3#1)
the central core##4##3##(1995-3#1)(1997-3#1)(2008-7#1)(2012-3#1)
the central cylinder##2##3##(2012-2#2)
the central dopaminergic##4##3##(2008-10#4)
the central elements of##2##4##(1994-11#1)(2008-5#1)
the central fold of##2##4##(1993-11#2)
the central hospital##2##3##(2010-6#1)(2010-8#1)
the central lumen##3##3##(2008-6#2)(2008-7#1)
the central metabolism of##2##4##(2008-7#2)
the central metabolism##4##3##(2008-7#4)
the central metal##2##3##(2008-10#1)(2008-5#1)
the central nervous depressive##2##4##(1995-12#2)
the central nervous system (CNS) is##2##6##(2008-7#1)(2013-8#1)
the central nervous system (CNS)##32##5##(1991-12#1)(1991-2#1)(1991-5#1)(1994-2#1)(1995-5#1)(1996-12#3)(1997-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#5)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
the central nervous system and##13##5##(1992-4#1)(1995-12#1)(1996-12#2)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#2)(2012-3#1)
the central nervous system are##3##5##(1995-2#1)(2007-8#1)(2012-2#1)
the central nervous system can##2##5##(1995-8#1)(2008-9#1)
the central nervous system in##2##5##(2007-10#1)(2013-1#1)
the central nervous system including##2##5##(1990-5#1)(2007-8#1)
the central nervous system may##2##5##(1996-2#1)(2013-1#1)
the central nervous system of##6##5##(1992-6#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#1)
the central nervous system##148##4##(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#8)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#18)(2008-9#6)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
the central nervous##150##3##(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#8)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#18)(2008-9#6)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
the central nicotinic##2##3##(1996-12#1)(1996-2#1)
the central nucleus of the amygdala (CeAX)##2##7##(1993-12#2)
the central nucleus of the amygdala##5##6##(1993-12#5)
the central nucleus of the##6##5##(1993-12#5)(2012-3#1)
the central nucleus##7##3##(1992-6#1)(1993-12#5)(2012-3#1)
the central part of the##6##5##(1994-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
the central part##9##3##(1994-3#4)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
the central pathophysiological##2##3##(2008-3#1)(2011-2#1)
the central posterior/prepacemaker nucleus (CP/PPn)##2##5##(1995-12#1)(1996-5#1)
the central posterior/prepacemaker nucleus##4##4##(1995-12#2)(1996-5#2)
the central processing##2##3##(1994-8#1)(2008-3#1)
the central region of the perikaryon##2##6##(2008-7#2)
the central region of the##4##5##(2008-10#1)(2008-7#2)(2008-9#1)
the central region##6##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)
the central role of the##2##5##(1994-5#1)(2008-11#1)
the central role of##10##4##(1994-5#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#2)(2011-2#1)
the central spot##2##3##(2008-2#1)(2008-3#1)
the central themes##2##3##(1997-2#1)(2008-7#1)
the central venous##2##3##(1990-3#1)(2007-7#1)
the central wavelength of##2##4##(2007-12#1)(2008-3#1)
the central wavelength##3##3##(2007-12#1)(2008-3#2)
the central##385##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#7)(1993-12#9)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#13)(1996-2#4)(1996-3#1)(1996-5#4)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2006-12#2)(2006-4#1)(2007-1#2)(2007-10#3)(2007-12#17)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#39)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#36)(2008-8#9)(2008-9#18)(2009-2#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#9)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#10)(2013-7#3)(2013-8#9)
the centrality of##3##3##(1995-1#1)(2013-1#2)
the centralized##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
the centre of the##4##4##(2008-7#1)(2010-11#1)(2010-8#1)(2012-2#1)
the centre of##13##3##(1996-11#2)(1997-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-7#1)
the centre##20##2##(1991-11#1)(1992-12#1)(1995-3#1)(1995-5#2)(1996-11#2)(1996-6#2)(1997-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-7#1)
the centres##3##2##(1990-3#1)(2008-10#1)(2009-5#1)
the centrioles##2##2##(2008-7#2)
the centroid of the##2##4##(2007-11#1)(2008-3#1)
the centroid of##4##3##(2007-11#1)(2008-3#3)
the centroid potential##2##3##(2009-9#2)
the centroid##7##2##(2007-11#1)(2008-3#4)(2009-9#2)
the centromere of##3##3##(2008-5#2)(2012-3#1)
the centromere on the##2##4##(1996-3#1)(2008-10#1)
the centromere on##3##3##(1996-3#1)(2008-10#2)
the centromere##8##2##(1996-3#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2012-3#1)
the centromeric region of##3##4##(1996-8#1)(2008-10#1)(2008-5#1)
the centromeric region##4##3##(1996-8#1)(2008-10#1)(2008-5#1)(2010-8#1)
the centromeric##6##2##(1996-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-8#1)
the centrosome##4##2##(1991-5#1)(2008-9#2)(2009-7#1)
the century of##2##3##(1991-11#1)(2008-8#1)
the century##13##2##(1991-11#1)(1992-2#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)
the cephalosporin##3##2##(1990-8#1)(2011-1#2)
the ceramic surface##2##3##(2008-5#1)(2008-8#1)
the ceramic##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
the ceramide dispersions##2##3##(1994-5#2)
the ceramide##8##2##(1990-7#1)(1992-8#1)(1993-11#1)(1994-5#2)(2008-5#3)
the cereal##4##2##(2008-10#1)(2008-7#1)(2012-2#2)
the cerebellar##18##2##(1992-11#1)(1992-3#1)(1992-6#1)(1995-8#1)(1996-5#4)(1997-3#1)(2008-4#2)(2008-7#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the cerebellopontine angle and##2##4##(2006-12#1)(2008-7#1)
the cerebellopontine angle##6##3##(2006-12#1)(2008-7#3)(2011-2#1)(2012-3#1)
the cerebellum in the##2##4##(1992-6#1)(2013-1#1)
the cerebellum in##3##3##(1992-6#1)(2008-4#1)(2013-1#1)
the cerebellum to##2##3##(1991-1#1)(1992-11#1)
the cerebellum##44##2##(1991-1#3)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#5)(1996-5#3)(1997-8#1)(2007-8#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
the cerebral arteries##2##3##(2008-7#1)(2009-4#1)
the cerebral cortex of nucleus basalis magnocellularis lesioned rats##2##9##(1993-12#2)
the cerebral cortex of##5##4##(1993-12#2)(1994-2#1)(1997-2#1)(2008-7#1)
the cerebral cortex##42##3##(1990-7#3)(1991-2#1)(1993-12#4)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#2)(1997-2#6)(1997-4#1)(2007-8#1)(2007-9#1)(2008-11#6)(2008-7#9)(2008-9#1)(2011-2#2)(2012-1#1)
the cerebral hemisphere##3##3##(2008-7#2)(2013-8#1)
the cerebral neocortex##2##3##(2008-11#2)
the cerebral white matter##3##4##(2008-7#1)(2010-12#2)
the cerebral##78##2##(1990-5#1)(1990-7#3)(1991-2#1)(1992-12#1)(1993-12#4)(1994-2#4)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#2)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-8#1)(2007-9#2)(2008-11#8)(2008-5#2)(2008-7#20)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the cerebro-spinal fluid##2##3##(1992-11#2)
the cerebrospinal fluid (CSF) and##2##5##(1995-12#1)(2008-7#1)
the cerebrospinal fluid (CSF) of##3##5##(2008-3#1)(2011-2#2)
the cerebrospinal fluid (CSF)##6##4##(1995-12#1)(1996-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
the cerebrospinal fluid of##2##4##(1995-12#1)(2008-12#1)
the cerebrospinal fluid##17##3##(1995-12#2)(1995-5#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#3)
the cerebrovascular##5##2##(1991-6#1)(1992-2#1)(2012-3#3)
the cerebrum and##2##3##(2008-9#2)
the cerebrum##6##2##(1993-12#1)(1995-8#1)(2008-9#4)
the certain##3##2##(1994-12#1)(2008-6#1)(2011-2#1)
the certified and##2##3##(2008-10#2)
the certified range##2##3##(2008-10#2)
the certified reference material##4##4##(2008-10#4)
the certified reference materials##4##4##(2008-10#4)
the certified reference##9##3##(2008-10#9)
the certified value and##2##4##(2008-10#2)
the certified value##16##3##(2008-10#16)
the certified values and##6##4##(2008-10#6)
the certified values##23##3##(2008-10#23)
the certified##68##2##(2008-10#66)(2008-12#2)
the cervical and thoracic##2##4##(2008-12#2)
the cervical and##5##3##(2007-11#1)(2008-12#2)(2013-1#1)(2013-8#1)
the cervical canal##2##3##(1993-12#1)(1994-9#1)
the cervical cancer##6##3##(1992-10#1)(2007-8#2)(2011-3#1)(2012-3#1)(2013-7#1)
the cervical cord##2##3##(1997-6#1)(2008-7#1)
the cervical esophagus##3##3##(2011-2#1)(2013-1#2)
the cervical line##2##3##(2011-2#2)
the cervical lymph nodes##4##4##(1991-9#1)(2008-2#1)(2013-8#2)
the cervical region##2##3##(2013-1#2)
the cervical spine in a##2##5##(2008-12#1)(2011-2#1)
the cervical spine##29##3##(1995-11#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#4)(2008-12#3)(2009-3#3)(2010-12#3)(2011-2#4)(2012-12#5)(2013-1#2)
the cervical##78##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-11#3)(2007-8#9)(2008-12#7)(2008-2#1)(2008-7#3)(2008-8#1)(2009-3#3)(2010-12#4)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
the cervix##21##2##(1990-8#3)(1991-3#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#2)(1996-12#3)(1996-2#1)(1996-6#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-7#1)
the cesarean section##2##3##(1991-6#1)(2011-2#1)
the cesium D(2) line##2##4##(2008-3#2)
the cesium##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
the cessation of##4##3##(1995-6#1)(2008-11#1)(2009-12#1)(2010-3#1)
the cessation##5##2##(1995-6#1)(2008-11#1)(2009-12#1)(2010-2#1)(2010-3#1)
the chain and##2##3##(2008-12#1)(2009-9#1)
the chain length of the##2##5##(1993-11#1)(1993-3#1)
the chain length of##3##4##(1993-11#1)(1993-3#1)(2009-3#1)
the chain length##6##3##(1992-11#1)(1993-11#1)(1993-3#1)(1995-11#1)(2008-12#1)(2009-3#1)
the chain of##6##3##(1994-2#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
the chain##28##2##(1990-2#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#3)(1995-11#2)(2006-12#1)(2008-1#1)(2008-10#3)(2008-12#6)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
the chain-length inequivalence##2##3##(1990-7#2)
the chain-length##3##2##(1990-11#1)(1990-7#2)
the chair and##2##3##(2008-4#1)(2008-5#1)
the chair##3##2##(2007-5#1)(2008-4#1)(2008-5#1)
the chalcogenide##4##2##(2007-11#1)(2008-10#3)
the challenge for the##2##4##(1996-3#1)(2008-1#1)
the challenge for##5##3##(1992-12#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-11#1)
the challenge is##3##3##(1996-2#1)(2009-12#1)(2010-12#1)
the challenge of##27##3##(1991-12#2)(1992-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#1)
the challenge##53##2##(1991-12#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
the challenges and opportunities##2##4##(2008-1#1)(2013-1#1)
the challenges and##8##3##(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
the challenges associated with##3##4##(2008-12#1)(2008-4#1)(2012-3#1)
the challenges faced by##3##4##(1994-3#1)(2008-3#1)(2012-12#1)
the challenges faced##4##3##(1994-3#1)(2008-3#1)(2009-11#1)(2012-12#1)
the challenges facing##5##3##(1996-1#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-7#1)
the challenges for##2##3##(2008-11#1)(2012-2#1)
the challenges in##2##3##(2008-10#1)(2008-8#1)
the challenges inherent in##2##4##(1995-2#1)(1995-3#1)
the challenges of the##4##4##(1990-4#1)(1991-3#1)(1992-12#1)(1994-2#1)
the challenges of##26##3##(1990-4#1)(1991-3#1)(1992-1#2)(1992-12#1)(1994-2#1)(1996-1#1)(2007-7#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)(2012-8#1)(2013-7#1)
the challenges posed by##2##4##(2008-12#1)(2012-12#1)
the challenges related to##2##4##(1995-1#1)(2008-2#1)
the challenges that##4##3##(2007-4#1)(2009-8#1)(2011-2#2)
the challenges to##2##3##(2009-11#1)(2009-12#1)
the challenges##80##2##(1990-4#1)(1991-3#1)(1992-1#3)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#3)(1997-2#1)(1997-3#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#5)(2008-10#1)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#4)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
the challenging##7##2##(1997-2#1)(2008-7#1)(2008-9#1)(2009-9#2)(2010-12#1)(2013-1#1)
the chamber and##2##3##(2008-10#1)(2008-11#1)
the chamber##9##2##(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)
the chambers##2##2##(2008-10#1)(2012-12#1)
the chance of##15##3##(1990-2#2)(1995-12#1)(1995-6#1)(1995-8#1)(2007-8#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)
the chance that##3##3##(1995-1#1)(2007-2#1)(2008-7#1)
the chance to##7##3##(1993-2#1)(1993-5#1)(1997-7#1)(2010-6#1)(2012-3#1)(2013-1#2)
the chance##28##2##(1990-2#2)(1993-2#1)(1993-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)
the chances of##8##3##(1993-10#1)(1993-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
the chances##12##2##(1993-10#1)(1993-8#1)(1996-3#1)(1996-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
the change for##2##3##(1990-8#1)(2008-3#1)
the change from the##2##4##(1990-8#1)(2009-8#1)
the change from##5##3##(1990-8#1)(1992-3#1)(1995-11#1)(2008-5#1)(2009-8#1)
the change in absorbance##5##4##(2008-10#5)
the change in average##2##4##(2008-11#2)
the change in effective##2##4##(2008-2#2)
the change in fluorescence intensity##2##5##(1995-11#1)(2008-10#1)
the change in loss##2##4##(2008-3#2)
the change in the absorption coefficient##2##6##(2008-2#2)
the change in the##25##4##(1990-2#1)(1990-5#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#5)(2008-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
the change in transfer##2##4##(1997-2#1)(2008-3#1)
the change in##79##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#17)(2008-11#4)(2008-2#8)(2008-3#14)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
the change is##3##3##(1994-1#1)(2008-11#1)(2008-3#1)
the change of the##3##4##(2007-12#1)(2008-10#1)(2013-8#1)
the change of##25##3##(1990-2#1)(1992-6#1)(1994-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#3)
the change process##4##3##(1995-3#2)(1996-12#1)(2008-11#1)
the change to##6##3##(1990-10#1)(1992-1#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-7#1)
the change was##2##3##(2008-11#1)(2008-5#1)
the change would##2##3##(2008-12#1)(2012-12#1)
the change##144##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#3)(1991-5#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#3)(1995-3#5)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-5#1)(1997-2#4)(1997-4#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#24)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#18)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#5)
the changed##4##2##(1996-2#1)(1997-4#1)(2007-11#1)(2010-6#1)
the changes are##2##3##(1990-2#1)(1993-2#1)
the changes in [Ca2+]i##2##4##(1993-3#2)
the changes in absorption##2##4##(2008-10#1)(2008-2#1)
the changes in gene expression##3##5##(2008-10#1)(2008-7#1)(2010-4#1)
the changes in mechanical properties##2##5##(2008-6#1)(2009-4#1)
the changes in sialylation pattern of##2##6##(2008-11#2)
the changes in the fluorescence##2##5##(2008-10#2)
the changes in the radiometric##2##5##(2008-3#2)
the changes in the##35##4##(1990-2#1)(1990-8#1)(1991-12#1)(1995-12#1)(1995-2#1)(1996-6#1)(2008-10#7)(2008-12#2)(2008-3#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
the changes in##110##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-3#1)(1993-11#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-4#2)(1996-5#2)(1996-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#9)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#7)
the changes induced in the##2##5##(1994-3#1)(2008-2#1)
the changes induced in##3##4##(1991-5#1)(1994-3#1)(2008-2#1)
the changes made##2##3##(1994-1#1)(1997-3#1)
the changes observed##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
the changes occurring##2##3##(2008-4#1)(2012-2#1)
the changes of the##4##4##(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
the changes of##18##3##(1994-6#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
the changes that are##2##4##(1996-2#1)(2008-7#1)
the changes that occur in##2##5##(1991-12#1)(2008-7#1)
the changes that occur##3##4##(1991-12#1)(2008-7#1)(2009-3#1)
the changes that the##2##4##(2007-11#1)(2008-12#1)
the changes that##13##3##(1991-12#1)(1995-1#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-3#1)
the changes was##2##3##(1992-8#1)(2007-11#1)
the changes were##5##3##(1992-6#1)(1994-3#1)(1997-2#1)(1997-7#1)(2008-10#1)
the changes##190##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-3#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-9#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#20)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#9)
the changing health care##2##4##(1996-12#1)(1996-2#1)
the changing healthcare##2##3##(1996-2#1)(1997-6#1)
the changing nature of the##2##5##(2008-1#1)(2008-12#1)
the changing nature of##3##4##(2007-11#1)(2008-1#1)(2008-12#1)
the changing##27##2##(1992-3#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#3)
the channel is##3##3##(1990-11#1)(2008-2#1)(2009-11#1)
the channel models##4##3##(2008-3#4)
the channel molecule by the agonist##2##6##(2012-2#2)
the channel to##2##3##(1990-11#1)(2008-8#1)
the channel wall##2##3##(2009-11#1)(2010-8#1)
the channel##56##2##(1990-11#4)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-5#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#1)(2008-7#1)(2008-8#9)(2009-11#3)(2010-8#1)(2012-1#2)(2012-2#2)
the channels and##2##3##(2008-10#1)(2008-8#1)
the channels of##3##3##(2008-3#2)(2010-4#1)
the channels were##2##3##(1994-11#1)(2008-7#1)
the channels##17##2##(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#5)(2008-7#1)(2008-8#2)(2010-4#1)(2010-8#1)
the chaos of##2##3##(2007-11#1)(2012-2#1)
the chaotic oscillation##2##3##(2007-11#1)(2007-12#1)
the chaotic##11##2##(2007-11#7)(2007-12#2)(2008-8#1)(2010-1#1)
the chaperone##2##2##(2008-7#2)
the chaperonin##4##2##(1993-9#1)(1994-5#3)
the character and##2##3##(2007-10#1)(2012-3#1)
the character of the##4##4##(1996-5#1)(2007-8#1)(2008-3#2)
the character of##6##3##(1996-5#1)(2007-8#1)(2008-3#2)(2008-8#1)(2012-2#1)
the character##12##2##(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the characterisation and##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
the characterisation of##12##3##(1993-11#1)(1995-3#1)(2008-10#8)(2008-11#1)(2012-2#1)
the characterisation##16##2##(1993-11#1)(1995-3#1)(2008-10#10)(2008-11#1)(2008-5#1)(2012-2#2)
the characteristic CT##2##3##(2008-1#1)(2012-2#1)
the characteristic clinical##3##3##(2008-6#1)(2011-2#2)
the characteristic dimensions of##2##4##(2008-2#1)(2011-2#1)
the characteristic dyslipidemia in the metabolic syndrome X##2##8##(2008-3#2)
the characteristic features of the##4##5##(1990-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
the characteristic features of##10##4##(1990-11#1)(1990-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-7#1)(2011-1#1)
the characteristic features##12##3##(1990-11#1)(1990-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2010-7#1)(2011-1#1)
the characteristic mass (m(o)) was of##2##6##(2008-10#2)
the characteristic mass of##2##4##(2008-10#2)
the characteristic mass##5##3##(2008-10#5)
the characteristic of negative phototropism when##2##6##(2008-9#2)
the characteristic of##7##3##(1990-6#1)(2008-9#4)(2011-2#1)(2013-8#1)
the characteristic##92##2##(1990-11#2)(1990-12#3)(1990-6#2)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-4#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#5)(2009-11#1)(2009-12#1)(2010-10#2)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
the characteristics and management of postmenopausal women##2##7##(2011-1#2)
the characteristics and##6##3##(2007-12#1)(2007-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
the characteristics of a##8##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
the characteristics of an##2##4##(2008-3#1)(2008-5#1)
the characteristics of each##4##4##(1991-12#1)(2008-3#2)(2010-8#1)
the characteristics of human##2##4##(2008-9#1)(2011-1#1)
the characteristics of male##2##4##(1997-7#1)(2009-5#1)
the characteristics of several##2##4##(2008-3#1)(2008-9#1)
the characteristics of the##49##4##(1992-12#1)(1992-5#1)(1993-12#1)(1995-5#1)(1996-9#2)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-8#1)
the characteristics of this##5##4##(1990-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
the characteristics of which##2##4##(1991-6#1)(1994-2#1)
the characteristics of##115##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-7#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-9#2)(1997-3#1)(1997-7#2)(2007-10#2)(2007-11#7)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#13)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
the characteristics that##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
the characteristics##129##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-7#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-7#2)(2007-10#2)(2007-11#7)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
the characterization and the##2##4##(2008-3#2)
the characterization and##8##3##(1993-5#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#1)
the characterization of a##4##4##(1990-12#1)(2008-10#1)(2009-7#1)(2012-3#1)
the characterization of materials##2##4##(2008-10#2)
the characterization of optical##3##4##(2008-2#2)(2008-3#1)
the characterization of recombinant##2##4##(1995-6#1)(2008-4#1)
the characterization of the##13##4##(1991-5#1)(1992-2#1)(1994-5#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-1#1)(2013-7#1)
the characterization of##68##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-12#4)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#1)
the characterization##80##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-12#4)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#1)
the characters##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
the charge density##3##3##(1991-5#1)(2008-10#2)
the charge distribution##3##3##(1997-6#1)(2007-11#1)(2007-12#1)
the charge of the##3##4##(1994-9#1)(2008-10#1)(2008-7#1)
the charge of##5##3##(1994-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
the charge on##2##3##(1992-3#1)(1992-8#1)
the charge separation##2##3##(2008-8#2)
the charge transfer##3##3##(2008-10#3)
the charge##33##2##(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-5#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-10#14)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2013-1#1)
the charge-transfer##2##2##(2008-10#2)
the charged##6##2##(1990-8#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#1)(2010-4#1)
the charges of##3##3##(1990-7#1)(2007-11#1)(2008-10#1)
the charges##6##2##(1990-7#1)(1991-3#1)(1992-12#1)(1992-8#1)(2007-11#1)(2008-10#1)
the charging##4##2##(2007-11#2)(2008-10#1)(2008-8#1)
the charts##2##2##(1997-3#1)(2007-10#1)
the cheapest##2##2##(1993-11#1)(2008-10#1)
the check##2##2##(1994-3#1)(2008-12#1)
the cheek##11##2##(1995-9#1)(2008-4#2)(2008-5#8)
the chelate##7##2##(2008-10#7)
the chelate-modified Fenton reaction##2##4##(2010-4#2)
the chelating agent-metal##2##3##(2008-10#2)
the chelating fiber##3##3##(2008-10#3)
the chelating sites##3##3##(2008-10#3)
the chelating##19##2##(1994-5#1)(1996-2#2)(2008-10#16)
the chelation of##2##3##(2008-10#2)
the chelator##2##2##(2008-10#2)
the chemical analysis##4##3##(2008-10#3)(2013-1#1)
the chemical and biological diversity of##2##6##(2008-8#2)
the chemical and biological##3##4##(1994-12#1)(2008-8#2)
the chemical and pharmaceutical industries##2##5##(2008-10#1)(2008-9#1)
the chemical and physical##4##4##(1997-5#1)(2008-10#1)(2008-2#1)(2010-7#1)
the chemical and##16##3##(1994-11#1)(1994-12#1)(1997-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)
the chemical availability##2##3##(2008-10#2)
the chemical characteristics of##2##4##(2008-10#2)
the chemical composition and##2##4##(2008-7#1)(2012-2#1)
the chemical composition of the##5##5##(1991-5#1)(1994-12#1)(2008-11#1)(2008-3#1)(2013-8#1)
the chemical composition of##12##4##(1991-5#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
the chemical composition##15##3##(1991-5#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the chemical constituents of##2##4##(2008-11#1)(2012-2#1)
the chemical constituents##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
the chemical context (pH)##2##4##(2008-10#2)
the chemical effect of direct current arc plasma##2##8##(2013-8#2)
the chemical energy##2##3##(2009-12#1)(2010-8#1)
the chemical environment and##2##4##(2010-11#1)(2012-2#1)
the chemical environment##4##3##(2008-10#2)(2010-11#1)(2012-2#1)
the chemical inducer##2##3##(2008-10#2)
the chemical industry##2##3##(2008-11#1)(2008-6#1)
the chemical information##2##3##(2013-8#2)
the chemical markers##2##3##(2012-3#2)
the chemical model##2##3##(2008-10#2)
the chemical modification##2##3##(2008-10#1)(2008-3#1)
the chemical modifier##4##3##(2008-10#4)
the chemical nature of the lesions##2##6##(2008-11#2)
the chemical nature of##3##4##(2008-11#2)(2008-6#1)
the chemical potential of##2##4##(2008-10#1)(2011-1#1)
the chemical potential##3##3##(2008-10#1)(2009-2#1)(2011-1#1)
the chemical properties of the##2##5##(1992-6#1)(1997-2#1)
the chemical properties of##6##4##(1990-7#1)(1992-6#2)(1997-2#1)(2008-10#2)
the chemical reaction##5##3##(2008-10#5)
the chemical reduction##2##3##(2008-6#1)(2012-2#1)
the chemical shift of some##2##5##(1993-11#1)(2008-10#1)
the chemical shift of##3##4##(1993-11#1)(2008-10#2)
the chemical shift##6##3##(1993-11#2)(1994-5#1)(2008-10#3)
the chemical shifts##2##3##(1991-5#1)(1991-8#1)
the chemical speciation##2##3##(2008-10#2)
the chemical species##4##3##(2008-10#3)(2008-3#1)
the chemical stability##2##3##(2008-10#2)
the chemical structure of the##5##5##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
the chemical structure of##6##4##(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)
the chemical structure##10##3##(1991-6#1)(1995-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#1)(2012-3#1)
the chemical structures of##2##4##(1996-12#1)(2008-10#1)
the chemical synthesis of##2##4##(1993-11#1)(2008-4#1)
the chemical variables##3##3##(2008-10#3)
the chemical##194##2##(1990-7#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#3)(1993-11#3)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-11#2)(1995-6#1)(1996-12#2)(1997-2#2)(1997-4#1)(1997-5#1)(2007-12#3)(2008-10#84)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#9)
the chemical-physical##2##2##(2008-2#1)(2013-7#1)
the chemically##4##2##(1994-5#1)(2008-10#2)(2008-2#1)
the chemicals as##2##3##(1995-6#1)(2013-1#1)
the chemicals##9##2##(1995-6#2)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
the chemiluminescence (CL) intensity##2##4##(2008-10#2)
the chemiluminescence (CL)##8##3##(2008-10#7)(2010-4#1)
the chemiluminescence determination of##2##4##(2008-10#2)
the chemiluminescence emission##3##3##(2008-10#3)
the chemiluminescence intensity##3##3##(2008-10#3)
the chemiluminescence produced##2##3##(2008-10#2)
the chemiluminescence reaction##5##3##(2008-10#5)
the chemiluminescence##37##2##(1991-5#1)(2008-10#35)(2010-4#1)
the chemiluminescent behaviour of phenols and polyphenols##2##7##(2008-10#2)
the chemiluminescent behaviour of##3##4##(2008-10#3)
the chemiluminescent##9##2##(2008-10#9)
the chemiluminometric##3##2##(2008-10#3)
the chemistry of##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
the chemistry##9##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
the chemokine##10##2##(1994-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#2)(2013-1#1)
the chemometric approach##3##3##(2008-10#3)
the chemometric##9##2##(2008-10#7)(2008-3#2)
the chemoprevention##3##2##(1995-9#1)(1996-12#1)(2007-4#1)
the chemoresistance##2##2##(2010-3#1)(2011-2#1)
the chemostat##4##2##(2008-6#1)(2008-7#3)
the chemotactic##4##2##(1992-3#1)(1993-11#1)(1995-8#1)(1997-3#1)
the chemotaxis of##2##3##(1993-6#2)
the chemotaxis##3##2##(1993-6#2)(1994-8#1)
the chemotherapeutic##4##2##(1991-6#1)(2010-3#1)(2010-8#1)(2013-1#1)
the chemotherapy group##3##3##(1991-8#1)(2008-6#2)
the chemotherapy##15##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#2)(2008-11#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2010-3#1)
the chest X-ray##2##3##(2007-10#1)(2013-1#1)
the chest and##5##3##(2007-11#1)(2007-8#1)(2012-2#3)
the chest pain center##4##4##(2008-3#4)
the chest pain##5##3##(1996-3#1)(2008-3#4)
the chest wall and##2##4##(2010-6#1)(2012-2#1)
the chest wall is a rare##2##6##(2007-8#2)
the chest wall##24##3##(1991-12#1)(2007-8#5)(2008-6#5)(2009-1#1)(2009-3#1)(2010-6#1)(2010-8#1)(2012-2#8)(2013-1#1)
the chest##53##2##(1990-5#1)(1990-6#1)(1991-12#2)(1991-9#1)(1994-2#1)(1995-8#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#9)(2008-1#1)(2008-11#1)(2008-3#4)(2008-6#6)(2008-7#1)(2009-1#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#11)(2013-1#3)
the chestnut blight fungus##4##4##(2008-10#3)(2008-9#1)
the chestnut blight##5##3##(2008-10#4)(2008-9#1)
the chewing##2##2##(2008-1#1)(2011-2#1)
the chi((3))##2##2##(2007-12#1)(2008-3#1)
the chi(3)##2##2##(2008-3#2)
the chi-square test##3##3##(2007-8#1)(2008-12#1)(2013-8#1)
the chick embryo##4##3##(1994-5#1)(1996-12#1)(1996-5#1)(2008-1#1)
the chick##15##2##(1990-4#1)(1990-5#2)(1991-9#1)(1992-12#1)(1994-5#1)(1995-5#1)(1996-12#2)(1996-5#2)(2008-1#2)(2012-12#2)
the chicken H3 histone-encoding gene family##2##6##(1991-6#2)
the chicken T-cell receptor alpha chain constant region##2##8##(1997-9#2)
the chicken Z##3##3##(2008-5#2)(2010-3#1)
the chicken anaemia##2##3##(1991-3#1)(2008-5#1)
the chicken and##2##3##(1994-8#1)(1996-5#1)
the chicken brain##3##3##(1995-3#3)
the chicken embryo model##2##4##(2008-12#2)
the chicken embryo related##2##4##(2007-6#2)
the chicken embryo##6##3##(1992-11#1)(1992-3#1)(2007-6#2)(2008-12#2)
the chicken transferrin receptor##2##4##(1991-6#2)
the chicken##58##2##(1990-8#1)(1991-3#1)(1991-5#3)(1991-6#5)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#3)(1996-5#2)(1997-1#1)(1997-3#3)(1997-6#2)(1997-7#1)(1997-9#6)(2007-6#2)(2008-11#2)(2008-12#2)(2008-5#11)(2010-12#1)(2010-3#1)(2013-1#1)
the chickens##2##2##(1997-6#2)
the chickpea##5##2##(2008-10#5)
the chicks##4##2##(2008-12#2)(2008-5#1)(2008-6#1)
the chief##13##2##(1991-3#1)(1993-11#1)(1994-1#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#4)
the child and family##3##4##(2008-11#2)(2012-12#1)
the child and##11##3##(1995-5#1)(1996-7#1)(2008-11#2)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the child from##4##3##(1991-6#1)(1995-5#2)(2010-7#1)
the child in##2##3##(1995-5#1)(2010-6#1)
the child is##4##3##(2008-11#1)(2010-8#1)(2012-1#1)(2013-1#1)
the child poverty rate##2##4##(2008-11#2)
the child to##2##3##(1995-5#1)(2011-2#1)
the child was##3##3##(1993-12#1)(2008-9#1)(2010-6#1)
the child with##7##3##(1990-10#1)(1993-1#1)(2008-10#1)(2008-11#2)(2010-9#1)(2013-8#1)
the child##101##2##(1990-10#1)(1990-12#3)(1991-6#3)(1992-12#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-6#1)(1995-5#10)(1996-2#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-5#5)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#11)(2008-12#1)(2008-2#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
the child's age##2##3##(2008-10#1)(2013-8#1)
the child's testimony##4##3##(2011-2#4)
the child's##28##2##(1990-10#1)(1991-12#1)(1992-1#2)(1992-2#2)(1993-2#4)(1995-1#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-6#1)(2010-9#2)(2011-2#4)(2013-8#1)
the childbearing##4##2##(1993-6#1)(2008-4#1)(2013-1#2)
the childbirth experience##2##3##(2007-2#1)(2013-1#1)
the childhood obesity epidemic##2##4##(2012-2#2)
the childhood obesity##3##3##(2008-12#1)(2012-2#2)
the childhood##9##2##(1993-11#1)(1994-11#1)(1995-5#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-2#2)
the children and their parents##2##5##(1991-2#1)(1995-6#1)
the children and their##3##4##(1991-2#1)(1995-6#1)(2007-12#1)
the children and##5##3##(1991-2#1)(1995-6#1)(2007-12#1)(2008-11#1)(2012-12#1)
the children at##3##3##(1994-1#1)(2008-2#1)(2012-2#1)
the children from##2##3##(2007-11#1)(2012-12#1)
the children had been##2##4##(2006-10#1)(2008-9#1)
the children had##5##3##(1997-4#1)(2006-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
the children in the##2##4##(2008-3#1)(2008-4#1)
the children in##3##3##(1992-2#1)(2008-3#1)(2008-4#1)
the children included in the study##2##6##(2012-12#1)(2013-1#1)
the children were##10##3##(1990-12#2)(1993-6#1)(1995-6#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
the children who received##2##4##(2010-4#1)(2011-1#1)
the children who##3##3##(1994-6#1)(2010-4#1)(2011-1#1)
the children with##16##3##(1996-1#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#2)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
the children##92##2##(1990-11#1)(1990-12#5)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-6#2)(1995-5#1)(1995-6#2)(1996-1#4)(1996-9#1)(1997-4#2)(2006-10#3)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-9#11)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
the children's speech##2##3##(2008-9#1)(2011-1#1)
the children's usual prehospital##2##4##(1991-2#2)
the children's##20##2##(1990-2#1)(1991-2#3)(1991-6#1)(1993-1#1)(1993-6#2)(1994-6#1)(1995-12#1)(1995-6#2)(1996-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#2)
the chimaera##2##2##(1994-6#2)
the chimeric##10##2##(1991-5#1)(1994-3#1)(1997-2#3)(1997-3#1)(2008-1#1)(2008-6#1)(2008-8#1)(2011-2#1)
the chin##3##2##(2007-5#1)(2011-2#1)(2012-2#1)
the chin]##2##2##(1993-9#1)(2008-4#1)
the chip##7##2##(2008-10#4)(2008-3#2)(2012-3#1)
the chips##3##2##(1994-1#1)(2008-3#2)
the chiral recognition##3##3##(2008-10#3)
the chiral selector##4##3##(1996-5#1)(2008-10#2)(2013-1#1)
the chiral separation##2##3##(1996-5#1)(2008-10#1)
the chiral##22##2##(1995-2#1)(1995-6#2)(1996-5#2)(1997-2#1)(2008-10#13)(2008-9#1)(2010-4#1)(2013-1#1)
the chirality of##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
the chirp amplitude##2##3##(2008-2#2)
the chirp of##3##3##(2007-11#1)(2007-12#2)
the chirp##9##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#1)
the chit33 gene##2##3##(2008-10#2)
the chitin##3##2##(2008-10#2)(2008-7#1)
the chitinase##2##2##(2008-10#2)
the chitobiase gene##2##3##(1992-10#2)
the chitosan##3##2##(2008-10#3)
the chloramphenicol acetyl transferase (CAT)##2##5##(1992-12#2)
the chloramphenicol acetyltransferase (CAT)##5##4##(1990-8#1)(1991-2#1)(1992-6#1)(1997-8#1)(2008-4#1)
the chloramphenicol acetyltransferase##7##3##(1990-8#1)(1991-2#2)(1992-6#1)(1995-2#1)(1997-8#1)(2008-4#1)
the chloramphenicol##10##2##(1990-8#1)(1991-2#2)(1992-12#2)(1992-6#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-4#1)
the chloride channel##3##3##(1990-5#1)(1997-3#1)(2007-7#1)
the chloride conductance in##3##4##(1995-11#3)
the chloride##18##2##(1990-5#1)(1994-5#1)(1995-11#3)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#8)(2011-1#1)(2011-3#1)
the chlorinated##2##2##(2008-10#2)
the chlorination##3##2##(2008-10#2)(2008-9#1)
the chlorine concentration##3##3##(1992-11#2)(2008-10#1)
the chlorine##6##2##(1992-11#2)(2008-10#3)(2010-4#1)
the chloroform extraction##2##3##(2008-10#2)
the chloroform##4##2##(2008-10#3)(2012-2#1)
the chlorophyll##5##2##(2008-2#1)(2008-3#3)(2010-6#1)
the chloroplast envelope##2##3##(1994-11#1)(1995-2#1)
the chloroplast genome##3##3##(1997-2#1)(2008-12#1)(2010-6#1)
the chloroplast##20##2##(1990-12#1)(1990-5#1)(1990-7#2)(1994-11#2)(1995-2#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-6#1)(2012-3#3)
the choice and duration of##2##5##(1990-6#1)(2013-1#1)
the choice and##5##3##(1990-6#1)(1997-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
the choice between##4##3##(1990-3#1)(1993-2#1)(1995-12#1)(1995-5#1)
the choice is##2##3##(1992-12#1)(2009-8#1)
the choice of a##3##4##(1995-5#1)(2008-9#1)(2010-3#1)
the choice of appropriate##2##4##(2008-10#1)(2008-6#1)
the choice of both##2##4##(2009-2#1)(2011-1#1)
the choice of operating##2##4##(2008-2#1)(2008-7#1)
the choice of the best##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
the choice of the##19##4##(1990-2#1)(1990-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
the choice of treatment##3##4##(1991-3#1)(2010-12#1)(2011-2#1)
the choice of which##2##4##(2007-11#1)(2008-4#1)
the choice of##92##3##(1990-2#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#3)(1996-1#1)(1996-11#2)(1996-3#1)(1997-3#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
the choice##114##2##(1990-2#1)(1990-3#3)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#2)(1995-5#4)(1996-1#1)(1996-11#2)(1996-3#1)(1997-3#2)(1997-4#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#1)
the choices of##2##3##(2008-8#1)(2009-8#1)
the choices##6##2##(1991-2#1)(1991-3#1)(1994-3#1)(2008-8#1)(2009-8#1)(2010-11#1)
the cholera to##2##3##(1992-6#2)
the cholera##5##2##(1992-6#2)(1993-3#2)(2009-2#1)
the cholesterol##11##2##(1992-6#2)(1993-3#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-6#1)
the choline and serine headgroups##2##5##(1990-7#2)
the choline##3##2##(1990-7#2)(1995-3#1)
the cholinergic system##3##3##(1993-12#1)(1994-8#1)(2008-10#1)
the cholinergic##13##2##(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
the chondrocyte##2##2##(1991-11#1)(2008-11#1)
the chondrogenic##3##2##(1994-11#1)(2008-11#2)
the chopstick##2##2##(2011-2#2)
the chorion s15 promoter##2##4##(1993-6#2)
the chorion##9##2##(1993-1#1)(1993-6#2)(2007-12#2)(2008-12#4)
the choroid plexus and##2##4##(1993-12#1)(1996-12#1)
the choroid plexus##12##3##(1993-12#2)(1996-12#4)(1996-5#4)(2008-10#1)(2008-7#1)
the choroid with##2##3##(2011-7#2)
the choroid##21##2##(1993-12#2)(1996-12#4)(1996-5#4)(1997-3#1)(2008-10#1)(2008-7#1)(2011-7#3)(2012-12#2)(2013-1#3)
the chosen level of confidence##2##5##(2008-10#2)
the chosen##13##2##(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-1#1)
the chromate anion##2##3##(2008-10#2)
the chromatic aberration##2##3##(2007-12#1)(2008-3#1)
the chromatic dispersion of##3##4##(2007-11#1)(2007-12#2)
the chromatic##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
the chromaticity coordinates##2##3##(2008-3#2)
the chromatin##13##2##(1992-3#1)(1994-5#1)(1997-3#1)(2007-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
the chromatogram##4##2##(1991-5#1)(2008-10#3)
the chromatographic behavior of##5##4##(2008-10#4)(2012-1#1)
the chromatographic column##4##3##(1991-5#1)(2008-10#3)
the chromatographic conditions##3##3##(1990-8#1)(2008-10#2)
the chromatographic determination##3##3##(2008-10#3)
the chromatographic methods##3##3##(2008-10#2)(2010-4#1)
the chromatographic response##2##3##(2008-10#2)
the chromatographic separation##2##3##(2008-10#2)
the chromatographic##46##2##(1990-8#1)(1991-5#1)(1994-11#1)(1996-5#1)(2008-10#36)(2008-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-1#1)
the chromatography##4##2##(1991-12#1)(2008-10#2)(2010-7#1)
the chromatomembrane cell##3##3##(2008-10#3)
the chromatomembrane##5##2##(2008-10#5)
the chromium isotope ratios was##2##5##(2008-10#2)
the chromium##7##2##(2008-10#6)(2008-2#1)
the chromium(VI) concentration##2##3##(2008-10#2)
the chromium(VI)##3##2##(2008-10#3)
the chromogenic reaction of##2##4##(2008-10#2)
the chromogenic reaction##4##3##(2008-10#4)
the chromogenic reagent##5##3##(2008-10#5)
the chromogenic##10##2##(1990-2#1)(2008-10#9)
the chromophore and##3##3##(1991-3#1)(1992-8#1)(2008-10#1)
the chromophore##13##2##(1991-3#1)(1992-8#1)(1994-5#1)(1996-5#1)(1997-2#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-9#1)
the chromophores##3##2##(1996-5#1)(2008-3#1)(2009-9#1)
the chromosomal DNA##2##3##(2009-6#1)(2011-2#1)
the chromosomal gene##2##3##(2008-10#2)
the chromosomal instability##2##3##(2008-7#2)
the chromosomal location of the##4##5##(1997-2#1)(2008-10#2)(2008-11#1)
the chromosomal location of##6##4##(1997-2#1)(2008-10#4)(2008-11#1)
the chromosomal region##2##3##(1997-5#1)(2008-4#1)
the chromosomal replication origin##2##4##(1994-12#1)(1995-8#1)
the chromosomal##33##2##(1993-12#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-8#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)
the chromosomally##2##2##(1994-12#1)(2012-12#1)
the chromosome of S##2##4##(2008-8#2)
the chromosome of##6##3##(1993-9#1)(1997-2#1)(2008-10#2)(2008-8#2)
the chromosome##40##2##(1990-5#1)(1990-8#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-8#1)
the chromosomes of the##3##4##(1997-6#1)(1997-8#1)(2008-7#1)
the chromosomes of##5##3##(1997-6#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-8#1)
the chromosomes##17##2##(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
the chronic inflammation##2##3##(1991-3#1)(2009-1#1)
the chronic phase of##2##4##(1997-3#1)(2008-12#1)
the chronic phase##3##3##(1994-2#1)(1997-3#1)(2008-12#1)
the chronic stage##3##3##(2009-11#1)(2012-3#1)(2013-8#1)
the chronic use of##2##4##(1996-5#1)(2012-12#1)
the chronic##38##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
the chronically ethanol fed rats was##2##6##(1993-11#2)
the chronically ethanol fed rats##3##5##(1993-11#3)
the chronically ill##3##3##(1995-2#1)(1997-1#1)(2008-1#1)
the chronically mentally ill##3##4##(1992-1#1)(1997-2#2)
the chronically##10##2##(1992-1#1)(1993-11#3)(1995-2#1)(1997-1#1)(1997-2#2)(2008-1#1)(2008-3#1)
the chronoamperometric##2##2##(2008-10#2)
the chronological##3##2##(1997-4#1)(2008-7#1)(2012-3#1)
the chronology of##3##3##(1993-12#1)(1996-11#1)(2008-10#1)
the church##4##2##(1990-8#4)
the chyluria##2##2##(2008-1#2)
the cibarial armature and##2##4##(2008-5#2)
the cibarial armature##3##3##(2008-5#3)
the cibarial##4##2##(2008-5#4)
the cicatricial##4##2##(2012-1#4)
the cichlid Hemichromis bimaculatus##2##4##(2008-7#2)
the cichlid Pelvicachromis taeniatus##2##4##(2010-8#2)
the cichlid##4##2##(2008-7#2)(2010-8#2)
the cigarette##2##2##(2008-1#1)(2008-5#1)
the ciliary##5##2##(1992-8#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-12#1)
the cilium##4##2##(2008-7#1)(2013-1#3)
the cine loop##2##3##(2013-1#2)
the cingulate cortex##2##3##(1996-5#1)(2013-8#1)
the cingulate gyrus##2##3##(1996-5#1)(2012-1#1)
the cingulate##4##2##(1996-5#2)(2012-1#1)(2013-8#1)
the cinnamyl moiety of both##2##5##(1993-6#2)
the circadian amplitude##2##3##(2008-11#2)
the circadian clock and##3##4##(1995-2#1)(2009-8#2)
the circadian clock##5##3##(1995-2#2)(2009-8#3)
the circadian pacemaker##3##3##(1994-2#1)(2008-5#2)
the circadian rhythm##3##3##(1993-6#1)(1997-6#1)(2008-5#1)
the circadian##24##2##(1992-10#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-2#1)(1995-2#3)(1997-6#1)(2008-11#5)(2008-5#4)(2008-8#1)(2009-8#3)(2012-1#1)
the circle of Willis##3##4##(1993-12#1)(1995-11#1)(2008-7#1)
the circle of##4##3##(1993-12#1)(1995-11#1)(2008-3#1)(2008-7#1)
the circle##7##2##(1993-1#1)(1993-12#1)(1995-11#1)(2008-3#2)(2008-7#1)(2008-8#1)
the circuit##7##2##(2008-11#3)(2008-3#1)(2009-9#1)(2010-11#1)(2010-9#1)
the circuitry##3##2##(2008-11#1)(2008-4#1)(2010-2#1)
the circuits##3##2##(1992-1#1)(1995-3#1)(2013-8#1)
the circular dichroism##3##3##(1991-9#1)(1992-5#1)(2008-2#1)
the circular muscle##4##3##(1997-3#1)(1997-4#3)
the circular##19##2##(1991-9#1)(1992-5#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-4#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-6#2)(2010-2#1)
the circulating IR light##2##4##(2007-12#2)
the circulating reagent solution##3##4##(2008-10#3)
the circulating##13##2##(1991-12#1)(1993-11#1)(1994-8#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
the circulation and##5##3##(1994-8#1)(2008-4#2)(2009-2#1)(2009-6#1)
the circulation of the virus vaccine##2##6##(2007-10#2)
the circulation of the##7##4##(1992-7#1)(2007-10#3)(2008-10#1)(2008-3#1)(2009-10#1)
the circulation of##12##3##(1992-3#1)(1992-7#1)(2007-10#3)(2008-1#3)(2008-10#1)(2008-3#1)(2009-10#1)(2009-11#1)
the circulation##37##2##(1991-8#2)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-7#1)(2006-6#1)(2007-10#3)(2008-1#3)(2008-10#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#1)(2011-1#1)(2013-8#1)
the circulatory system##6##3##(1991-2#1)(2007-12#2)(2008-7#2)(2013-8#1)
the circulatory##9##2##(1991-2#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-7#2)(2013-8#1)
the circumference of the knee and hip##2##7##(2007-8#2)
the circumference of the##5##4##(2007-11#2)(2007-8#2)(2013-1#1)
the circumference##6##2##(2007-11#2)(2007-8#2)(2008-7#1)(2013-1#1)
the circumferential##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
the circumflex##3##2##(2007-8#2)(2013-1#1)
the circumstance is##2##3##(2008-6#2)
the circumstances of##2##3##(2008-10#1)(2010-8#1)
the circumstances under which##3##4##(1994-3#1)(1997-2#1)(2008-11#1)
the circumstances##11##2##(1992-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-8#1)
the cis isomer##4##3##(1996-5#1)(2007-12#1)(2010-2#2)
the cis regulatory element##2##4##(1995-2#2)
the cis state##2##3##(2007-12#2)
the cis##12##2##(1990-9#1)(1995-2#2)(1996-5#1)(2007-12#3)(2008-9#1)(2010-2#4)
the cis- and trans-acting##2##4##(1996-5#1)(2008-10#1)
the cis- and##3##3##(1996-5#1)(2008-10#1)(2012-3#1)
the cis-isomer##2##2##(1994-8#1)(2008-10#1)
the cisplatin##2##2##(1990-12#1)(1991-2#1)
the cited##3##2##(2008-10#3)
the cities##10##2##(1990-6#1)(1995-9#1)(2008-11#2)(2008-9#1)(2012-12#2)(2013-1#1)(2013-8#2)
the citizens of##2##3##(2008-12#1)(2009-3#1)
the citizens##3##2##(2008-12#1)(2009-3#1)(2012-3#1)
the citrate##5##2##(1992-9#2)(2008-7#1)(2012-5#1)(2013-1#1)
the citric##2##2##(2008-10#1)(2008-4#1)
the citrus industry##2##3##(2008-10#1)(2013-8#1)
the citrus strains from all##2##5##(2008-10#2)
the citrus tristeza virus##2##4##(2008-10#1)(2008-5#1)
the citrus##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
the citrus-leafminer##2##2##(2008-6#2)
the city as well as##2##5##(1997-4#1)(2008-10#1)
the city center##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
the city of Rio de Janeiro##2##6##(2009-7#1)(2012-3#1)
the city of##55##3##(1991-6#1)(1991-9#1)(1992-8#1)(1993-3#2)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1997-1#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#4)(2009-7#4)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#6)(2013-8#1)
the city##79##2##(1990-11#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-2#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-4#1)(2007-5#1)(2007-7#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#4)(2009-7#5)(2011-1#2)(2011-2#5)(2012-12#5)(2012-3#2)(2013-1#7)(2013-8#2)
the city's##7##2##(1995-12#2)(1996-5#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
the civil war##2##3##(1994-9#1)(1997-6#1)
the civil##5##2##(1994-9#1)(1996-12#1)(1996-5#1)(1997-6#1)(2011-2#1)
the cladding and##3##3##(2007-11#2)(2007-12#1)
the cladding layer##2##3##(2008-10#1)(2010-8#1)
the cladding of a##3##4##(2007-12#2)(2008-3#1)
the cladding of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the cladding##18##2##(2007-11#7)(2007-12#5)(2008-10#1)(2008-3#4)(2010-8#1)
the clade##2##2##(2008-8#1)(2009-5#1)
the claim that##8##3##(1992-2#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
the claim##9##2##(1992-2#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
the claimed##4##2##(1997-4#1)(2008-10#3)
the claims of##3##3##(1996-3#1)(2008-4#1)(2008-6#1)
the claims##6##2##(1993-3#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-3#1)
the clamp##5##2##(1994-12#3)(2008-10#1)(2011-2#1)
the clarification of the##2##4##(2008-10#1)(2010-5#1)
the clarified##3##2##(2008-10#2)(2008-7#1)
the clarity and##2##3##(1996-1#1)(2013-8#1)
the clarity##3##2##(1990-12#1)(1996-1#1)(2013-8#1)
the class Actinomycetes##2##3##(2008-10#2)
the class I##5##3##(1991-2#1)(1995-12#1)(2008-4#2)(2010-7#1)
the class III##5##3##(1997-6#2)(2008-4#2)(2008-8#1)
the class identity of##2##4##(2008-10#2)
the class in##2##3##(2008-11#1)(2008-2#1)
the class of compounds##2##4##(2008-10#1)(2008-5#1)
the class of##15##3##(1991-6#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#3)(2009-9#1)(2011-1#1)(2011-2#1)
the class##52##2##(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-12#2)(1997-6#2)(1997-7#1)(2007-10#3)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#3)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#6)
the classes of##4##3##(2008-10#1)(2008-11#1)(2010-3#1)(2010-7#1)
the classes##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-7#1)
the classic model##2##3##(2008-10#1)(2010-4#1)
the classic nuclear##2##3##(1992-12#1)(2008-4#1)
the classic##41##2##(1990-8#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-3#1)(1994-5#1)(2006-8#1)(2007-12#4)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-8#2)(2009-1#1)(2009-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#4)
the classical SLN##2##3##(2008-5#2)
the classical biuret##2##3##(1990-8#1)(2008-10#1)
the classical gene-for-gene##2##3##(2008-10#1)(2008-8#1)
the classical mixed effects##2##4##(2012-3#2)
the classical pathway##2##3##(1994-11#1)(2008-4#1)
the classical##91##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-3#1)(1996-6#1)(1997-8#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#2)
the classically##2##2##(1992-9#1)(2008-2#1)
the classification and##5##3##(1990-2#1)(2007-11#1)(2008-10#2)(2008-8#1)
the classification of the##8##4##(1990-6#2)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)
the classification of##39##3##(1990-2#1)(1990-3#1)(1990-6#2)(1993-5#1)(1994-2#2)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#3)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
the classification systems##2##3##(2007-8#1)(2010-9#1)
the classification was##2##3##(1991-9#1)(2007-5#1)
the classification##71##2##(1990-2#2)(1990-3#1)(1990-6#3)(1991-12#2)(1991-9#1)(1993-5#1)(1994-2#2)(1996-3#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#3)
the classifications##2##2##(2011-2#2)
the classroom and##4##3##(2008-11#1)(2008-12#2)(2009-7#1)
the classroom environment##3##3##(2008-12#3)
the classroom setting##2##3##(2008-11#2)
the classroom##17##2##(2008-11#5)(2008-12#11)(2009-7#1)
the classwide##2##2##(2013-1#2)
the claw##4##2##(2011-1#1)(2011-2#3)
the claws##3##2##(2007-12#1)(2011-2#2)
the clay##3##2##(1993-8#1)(2008-10#1)(2012-12#1)
the clean-up##3##2##(2008-10#2)(2008-11#1)
the cleaning##2##2##(2008-10#2)
the clear relationship between##2##4##(2008-10#1)(2011-2#1)
the clear##11##2##(1995-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-10#1)(2011-2#3)
the clearance of##4##3##(1995-2#1)(1996-1#1)(2007-11#1)(2008-6#1)
the clearance##6##2##(1992-3#1)(1995-2#1)(1996-1#1)(2007-11#1)(2008-5#1)(2008-6#1)
the clearest##2##2##(2008-5#1)(2008-9#1)
the cleavable##3##2##(1990-2#1)(1995-3#1)(1995-5#1)
the cleavage of the##8##4##(1990-7#1)(1990-8#1)(1992-11#1)(2008-10#3)(2008-4#1)(2008-8#1)
the cleavage of##17##3##(1990-7#1)(1990-8#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#1)(2010-6#1)
the cleavage site of the##2##5##(2007-6#1)(2008-5#1)
the cleavage site of##3##4##(1991-12#1)(2007-6#1)(2008-5#1)
the cleavage site##5##3##(1991-10#1)(1991-12#1)(1993-6#1)(2007-6#1)(2008-5#1)
the cleavage##35##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#3)(1997-2#1)(1997-4#1)(2007-6#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-6#1)(2013-1#1)
the cleft patient##2##3##(2007-12#2)
the cleft##9##2##(1992-3#1)(1993-11#1)(2007-12#4)(2009-7#1)(2012-12#2)
the click##3##2##(2009-11#3)
the client with##3##3##(2008-11#1)(2012-3#2)
the client##10##2##(1994-2#1)(2007-10#1)(2007-6#1)(2008-11#2)(2009-6#1)(2010-8#1)(2012-3#2)(2013-8#1)
the client's##2##2##(1996-3#1)(2010-8#1)
the clients##2##2##(1993-1#1)(2013-8#1)
the climate of##2##3##(2012-3#1)(2012-5#1)
the climate##5##2##(2012-1#1)(2012-3#1)(2012-5#2)(2012-9#1)
the climatic conditions##2##3##(2008-10#1)(2013-1#1)
the climatic##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
the climbazole##3##2##(2008-5#3)
the climbing##3##2##(1992-6#1)(1994-2#1)(2010-8#1)
the clinic or##2##3##(1995-5#1)(2007-8#1)
the clinic setting##2##3##(2008-1#1)(2011-7#1)
the clinic##40##2##(1990-3#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-3#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#6)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
the clinical and economic##2##4##(1997-2#1)(2007-11#1)
the clinical and epidemiological characteristics##2##5##(2008-7#1)(2013-1#1)
the clinical and epidemiological##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
the clinical and histopathologic##2##4##(2006-10#1)(2013-1#1)
the clinical and histopathological##2##4##(2008-1#1)(2010-6#1)
the clinical and laboratory##5##4##(1990-2#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-12#1)
the clinical and morphological##2##4##(1997-6#1)(2009-8#1)
the clinical and pathologic##2##4##(1991-8#1)(2008-1#1)
the clinical and pathological features of##2##6##(1991-12#1)(1991-6#1)
the clinical and pathological##4##4##(1991-12#1)(1991-6#1)(1991-8#1)(2011-2#1)
the clinical and radiologic##2##4##(2007-12#1)(2011-2#1)
the clinical and radiological manifestations##2##5##(1991-11#1)(2012-12#1)
the clinical and radiological##5##4##(1991-11#1)(1997-3#1)(2006-7#1)(2008-6#1)(2012-12#1)
the clinical and##55##3##(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-5#1)(1993-12#1)(1994-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#2)(2010-6#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-3#3)(2013-1#4)
the clinical applicability of this##2##5##(2011-1#1)(2011-2#1)
the clinical applicability of##3##4##(1994-1#1)(2011-1#1)(2011-2#1)
the clinical application of the##2##5##(2008-1#1)(2008-10#1)
the clinical application of##5##4##(1990-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
the clinical application##7##3##(1990-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-12#1)
the clinical applications of##5##4##(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-2#1)
the clinical area##6##3##(2008-11#5)(2008-12#1)
the clinical arena##2##3##(2009-5#1)(2012-12#1)
the clinical assessment of##2##4##(2008-5#1)(2010-6#1)
the clinical behaviour of##2##4##(2008-4#1)(2013-1#1)
the clinical benefit##3##3##(1997-7#2)(2008-10#1)
the clinical benefits of##2##4##(2009-6#1)(2011-2#1)
the clinical benefits##3##3##(2009-6#1)(2010-6#1)(2011-2#1)
the clinical care##2##3##(1997-2#1)(2012-12#1)
the clinical case of a##3##5##(2011-2#1)(2013-1#2)
the clinical cases##2##3##(1990-3#1)(2008-5#1)
the clinical characteristics of##6##4##(1992-2#1)(1993-12#1)(1994-12#1)(2007-7#1)(2008-4#1)(2011-2#1)
the clinical characteristics##8##3##(1992-2#1)(1993-12#1)(1994-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
the clinical condition of the##2##5##(1991-3#1)(2008-11#1)
the clinical condition##3##3##(1991-3#1)(2008-11#1)(2012-2#1)
the clinical course and prognosis##2##5##(2009-5#1)(2010-6#1)
the clinical course and##5##4##(2008-3#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-12#1)
the clinical course of the disease##3##6##(1990-11#1)(2008-7#1)(2011-2#1)
the clinical course of the##4##5##(1990-11#1)(1993-6#1)(2008-7#1)(2011-2#1)
the clinical course of##10##4##(1990-11#1)(1993-6#1)(1994-7#2)(1996-11#1)(1997-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)
the clinical course##18##3##(1990-11#1)(1993-5#1)(1993-6#1)(1994-7#2)(1996-11#1)(1997-3#1)(1997-5#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
the clinical data of##3##4##(1991-3#1)(1997-7#1)(2011-2#1)
the clinical data##9##3##(1991-3#1)(1993-11#1)(1997-7#1)(2007-12#3)(2008-7#2)(2011-2#1)
the clinical decision##2##3##(2010-12#1)(2012-12#1)
the clinical development of##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#1)
the clinical diagnosis of##5##4##(1992-12#1)(1996-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
the clinical diagnosis was##2##4##(2008-5#1)(2012-12#1)
the clinical diagnosis##9##3##(1992-12#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
the clinical diagnostic##2##3##(2008-5#1)(2010-12#1)
the clinical effect of##3##4##(1997-5#1)(2011-1#1)(2013-8#1)
the clinical effectiveness##2##3##(2008-11#1)(2008-7#1)
the clinical efficacy of##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
the clinical efficacy##4##3##(1990-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
the clinical environment##5##3##(2008-11#2)(2008-12#2)(2008-7#1)
the clinical evaluation of##3##4##(2007-8#1)(2008-7#1)(2012-2#1)
the clinical evaluation##4##3##(1997-2#1)(2007-8#1)(2008-7#1)(2012-2#1)
the clinical evidence for##2##4##(2008-10#1)(2011-2#1)
the clinical evidence##5##3##(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
the clinical evolution##2##3##(2008-7#1)(2008-8#1)
the clinical experience##2##3##(2008-11#1)(2012-12#1)
the clinical features and##2##4##(2008-9#1)(2010-5#1)
the clinical features of the##3##5##(1993-5#1)(2007-11#1)(2008-5#1)
the clinical features of##8##4##(1993-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
the clinical features##19##3##(1992-4#1)(1993-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
the clinical findings##4##3##(1995-5#1)(1997-4#1)(2006-10#1)(2013-1#1)
the clinical forms of##2##4##(2008-5#1)(2008-6#1)
the clinical hematology##2##3##(2008-9#2)
the clinical history##4##3##(1992-5#1)(1995-11#1)(1996-9#1)(2012-12#1)
the clinical impact of the##2##5##(2008-7#1)(2013-1#1)
the clinical impact of##3##4##(2008-7#1)(2013-1#2)
the clinical implication of##2##4##(2008-1#1)(2008-5#1)
the clinical implications##3##3##(2008-3#1)(2008-4#1)(2011-2#1)
the clinical improvement##2##3##(2011-1#1)(2013-1#1)
the clinical interview]##2##3##(1993-11#1)(1993-3#1)
the clinical isolates##2##3##(2008-5#1)(2012-2#1)
the clinical laboratory##7##3##(1993-12#1)(1994-1#2)(1994-12#1)(2008-12#1)(2008-7#1)(2008-9#1)
the clinical learning environment and##2##5##(2008-11#1)(2008-12#1)
the clinical learning environment##7##4##(2007-10#1)(2008-11#1)(2008-12#4)(2009-12#1)
the clinical learning##9##3##(2007-10#1)(2008-11#2)(2008-12#5)(2009-12#1)
the clinical literature##3##3##(1992-12#1)(1993-12#2)
the clinical management of##5##4##(2008-11#1)(2008-2#1)(2009-12#1)(2009-5#1)(2009-7#1)
the clinical management##7##3##(2008-11#2)(2008-2#1)(2009-12#1)(2009-5#1)(2009-7#1)(2011-2#1)
the clinical manifestations##5##3##(1991-3#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-7#1)
the clinical outcome of##3##4##(1990-6#1)(2008-6#1)(2013-1#1)
the clinical outcome##7##3##(1990-6#1)(1991-2#1)(1997-3#1)(2008-6#1)(2011-2#1)(2013-1#2)
the clinical outcomes##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
the clinical parameters##2##3##(2011-1#1)(2012-12#1)
the clinical pathology##2##3##(1994-12#1)(2007-2#1)
the clinical pharmacokinetics##2##3##(2007-11#1)(2010-11#1)
the clinical phase of##2##4##(1992-6#1)(2008-10#1)
the clinical phenotype and##3##4##(2007-7#1)(2011-2#1)(2012-3#1)
the clinical phenotype##4##3##(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
the clinical phenotypes##2##3##(2008-11#1)(2010-1#1)
the clinical picture and##2##4##(1997-7#1)(2007-10#1)
the clinical picture may##2##4##(2007-7#1)(2008-8#1)
the clinical picture was##2##4##(1990-2#1)(2009-5#1)
the clinical picture##15##3##(1990-2#1)(1990-3#1)(1990-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
the clinical placement##2##3##(2008-11#1)(2008-12#1)
the clinical practice of##4##4##(1993-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
the clinical practice##10##3##(1993-11#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
the clinical presentation and##5##4##(2007-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
the clinical presentation of##3##4##(1990-6#1)(2009-12#1)(2013-7#1)
the clinical presentation##16##3##(1990-6#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
the clinical problems##2##3##(2007-12#1)(2010-10#1)
the clinical profile##2##3##(2009-11#1)(2012-3#1)
the clinical question##10##3##(2007-8#9)(2012-2#1)
the clinical records of##2##4##(1993-11#1)(2006-10#1)
the clinical records##3##3##(1992-9#1)(1993-11#1)(2006-10#1)
the clinical relevance of##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
the clinical response of##4##4##(1991-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
the clinical response##5##3##(1991-3#1)(1991-6#1)(2008-5#1)(2008-8#1)(2013-1#1)
the clinical setting##26##3##(1991-11#1)(1992-3#1)(1993-3#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
the clinical severity of##3##4##(1997-6#1)(2007-6#1)(2011-1#1)
the clinical severity##5##3##(1997-6#1)(2007-6#1)(2009-6#2)(2011-1#1)
the clinical significance of##8##4##(1994-9#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-6#1)(2012-3#1)
the clinical significance##9##3##(1994-9#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-6#1)(2012-3#1)(2013-2#1)
the clinical signs and symptoms##2##5##(1992-1#1)(2013-1#1)
the clinical signs of##2##4##(1994-7#1)(2012-3#1)
the clinical signs##5##3##(1992-1#1)(1994-7#1)(2012-3#1)(2013-1#2)
the clinical situation and##2##4##(1996-9#1)(2008-10#1)
the clinical situation##5##3##(1990-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
the clinical spectrum##2##3##(2008-10#1)(2008-7#1)
the clinical stage IV##2##4##(2008-1#2)
the clinical stage of##2##4##(1990-9#1)(2008-10#1)
the clinical stage##5##3##(1990-9#1)(2008-1#2)(2008-10#1)(2008-5#1)
the clinical status of patients##2##5##(2006-10#1)(2009-5#1)
the clinical status of the##2##5##(1995-11#1)(2008-7#1)
the clinical status of##4##4##(1995-11#1)(2006-10#1)(2008-7#1)(2009-5#1)
the clinical status##6##3##(1995-11#1)(2006-10#1)(2008-7#1)(2009-5#1)(2013-1#2)
the clinical studies##6##3##(2007-11#2)(2008-11#2)(2010-5#2)
the clinical symptoms##8##3##(1990-11#1)(1994-6#1)(2007-11#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
the clinical syndrome##2##3##(1997-8#1)(2008-1#1)
the clinical trial##5##3##(1992-9#1)(2008-7#1)(2010-6#1)(2010-8#1)(2013-8#1)
the clinical trials##8##3##(1994-2#1)(1996-8#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
the clinical use of##13##4##(1990-3#1)(1991-12#1)(1992-3#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-7#1)
the clinical use##14##3##(1990-3#1)(1991-12#1)(1992-3#1)(1995-12#1)(2007-11#2)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-7#1)
the clinical usefulness of the##2##5##(1991-1#1)(1992-10#1)
the clinical usefulness of##4##4##(1991-1#1)(1992-10#1)(2011-2#1)(2013-1#1)
the clinical utility of##4##4##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
the clinical value of##4##4##(2007-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
the clinical work-up##2##3##(2013-8#2)
the clinical##616##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#4)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#5)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#8)(1992-9#2)(1993-11#5)(1993-12#6)(1993-3#2)(1993-5#4)(1993-6#1)(1994-1#3)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#3)(1994-9#2)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#3)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#4)(1997-3#8)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#5)(2006-10#6)(2006-7#1)(2007-10#5)(2007-11#13)(2007-12#9)(2007-2#1)(2007-5#4)(2007-6#1)(2007-7#8)(2007-8#16)(2007-9#1)(2008-1#13)(2008-10#17)(2008-11#31)(2008-12#18)(2008-2#7)(2008-3#7)(2008-4#9)(2008-5#21)(2008-6#7)(2008-7#26)(2008-8#9)(2008-9#14)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#4)(2010-3#3)(2010-5#3)(2010-6#7)(2010-8#4)(2011-1#11)(2011-2#30)(2011-7#1)(2012-12#23)(2012-2#16)(2012-3#14)(2013-1#44)(2013-2#1)(2013-7#4)(2013-8#9)
the clinically important##4##3##(1993-12#1)(2008-5#1)(2009-10#1)(2012-3#1)
the clinically relevant##2##3##(2008-3#1)(2012-2#1)
the clinically useful##2##3##(2007-11#1)(2008-7#1)
the clinically##15##2##(1990-5#1)(1993-12#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
the clinician and the##2##4##(2009-8#1)(2013-1#1)
the clinician and##4##3##(1992-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
the clinician in the##2##4##(2011-2#1)(2012-3#1)
the clinician in##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
the clinician must be##2##4##(2008-8#1)(2013-8#1)
the clinician must##5##3##(1993-2#1)(2008-4#1)(2008-8#1)(2013-8#2)
the clinician to##8##3##(1991-2#1)(1994-12#1)(2006-10#1)(2007-9#1)(2008-12#2)(2008-7#1)(2013-1#1)
the clinician##42##2##(1990-9#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1997-3#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
the clinician's##7##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-1#1)
the clinicians##7##2##(1994-12#1)(1995-1#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-8#1)
the clinicopathologic features##2##3##(2008-11#1)(2010-1#1)
the clinicopathologic##3##2##(1991-6#1)(2008-11#1)(2010-1#1)
the clinicopathological##8##2##(1997-3#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-2#1)
the clinics##7##2##(1991-1#1)(1994-1#2)(1996-1#1)(2008-1#1)(2008-5#1)(2011-1#1)
the cloaca##2##2##(2007-12#1)(2008-6#1)
the clock##3##2##(1991-12#1)(1997-1#1)(2008-9#1)
the clonal lineage##2##3##(2008-10#2)
the clonal##16##2##(1992-9#1)(1994-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-2#1)(2011-2#1)
the clone was inserted into the pSVL vector (pUDPGTh2) and expressed in COS 1 cells##2##15##(2008-11#2)
the clone was##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
the clone##17##2##(1990-11#4)(1990-5#1)(1993-3#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#2)
the cloned DNA##4##3##(1991-9#1)(1997-4#2)(2008-10#1)
the cloned cDNA##2##3##(1992-12#1)(1994-11#1)
the cloned embryos##2##3##(2008-9#2)
the cloned fragment##4##3##(1991-6#2)(1994-12#1)(1996-12#1)
the cloned fragments##3##3##(2008-10#3)
the cloned gene product##5##4##(1994-3#5)
the cloned gene##8##3##(1991-9#2)(1994-3#5)(1995-6#1)
the cloned human##4##3##(1991-12#1)(1993-11#1)(1993-8#1)(1995-11#1)
the cloned receptor##3##3##(1990-8#1)(1992-3#2)
the cloned##53##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#3)(1992-12#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#5)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#4)(1997-6#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)
the clones##18##2##(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-10#2)(1997-2#3)(1997-4#1)(1997-8#1)(2008-11#2)(2008-9#2)
the cloning and characterization of##2##5##(1993-12#1)(1995-8#1)
the cloning and expression of##2##5##(1993-6#1)(1997-4#1)
the cloning and sequencing of##2##5##(1994-12#1)(2008-4#1)
the cloning and##11##3##(1991-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(2008-4#3)
the cloning of a full-length cDNA encoding##2##7##(1991-2#1)(1994-12#1)
the cloning of a##4##4##(1990-5#1)(1991-2#1)(1994-12#1)(1995-8#1)
the cloning of the##8##4##(1990-11#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-8#1)
the cloning of##19##3##(1990-11#1)(1990-5#1)(1991-2#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#3)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
the cloning##36##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2013-1#1)
the close collaboration##2##3##(2008-10#1)(2012-2#1)
the close of the 20th century##2##6##(2006-10#1)(2008-1#1)
the close phylogenetic relationship of##2##5##(1994-11#1)(1996-12#1)
the close relationship##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
the close##27##2##(1990-11#1)(1991-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
the closed##10##2##(1992-3#1)(1997-8#1)(2006-7#1)(2007-8#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#1)
the closed-mouth##2##2##(2010-2#2)
the closely related##12##3##(1991-5#1)(1992-8#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-5#1)
the closely##15##2##(1991-5#1)(1992-8#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)(2012-5#1)
the closeness##2##2##(1996-5#1)(2007-1#1)
the closer the##2##3##(2008-2#1)(2011-2#1)
the closer##4##2##(2008-2#1)(2011-2#3)
the closest relative for the##2##5##(2008-10#2)
the closest relative##3##3##(2008-10#3)
the closest relatives to the##2##5##(2010-11#2)
the closest relatives to##3##4##(2010-11#3)
the closest to the##2##4##(2006-6#1)(2008-6#1)
the closest##19##2##(2006-6#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#3)(2011-1#1)(2012-12#1)
the closing of##2##3##(1991-8#1)(1993-3#1)
the closing##3##2##(1991-8#1)(1993-3#1)(1996-12#1)
the closure of the##2##4##(1994-9#1)(1997-3#1)
the closure of##5##3##(1994-9#1)(1996-3#1)(1997-3#1)(2010-5#1)(2012-1#1)
the closure##9##2##(1993-3#1)(1994-9#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-1#1)
the clot##2##2##(1997-3#1)(1997-4#1)
the clothing##2##2##(1990-2#1)(2008-10#1)
the clotting time##3##3##(1997-2#1)(2007-7#2)
the clotting##6##2##(1993-11#1)(1997-2#1)(2007-7#2)(2008-9#1)(2011-2#1)
the cloud base##2##3##(2008-2#1)(2008-3#1)
the cloud is##3##3##(2008-3#3)
the cloud optical depth##2##4##(2008-2#1)(2008-3#1)
the cloud particles##2##3##(2008-2#1)(2008-3#1)
the cloud point extraction##2##4##(2008-10#2)
the cloud point##4##3##(2008-10#4)
the cloud top##2##3##(2008-2#2)
the cloud##33##2##(1991-5#1)(1992-3#2)(1992-7#1)(2008-10#4)(2008-2#10)(2008-3#14)(2013-7#1)
the clouds##3##2##(1992-7#1)(2008-2#2)
the cluster analysis##2##3##(2008-10#2)
the cluster of##2##3##(2007-12#1)(2009-12#1)
the cluster##21##2##(1990-5#1)(1993-11#1)(1996-6#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-6#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2013-1#1)
the clustering of##4##3##(2008-10#1)(2008-3#1)(2010-6#1)(2012-1#1)
the clustering##11##2##(1990-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-1#1)
the clusters of##2##3##(1995-6#1)(2008-10#1)
the clusters##8##2##(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-2#1)(2011-1#1)
the clutch##2##2##(2008-8#1)(2008-9#1)
the cly5 and cly7##2##4##(1997-3#2)
the co- polymer trimethylamine microcarriers##2##5##(2008-11#2)
the co-evolution of##3##3##(2011-10#2)(2013-8#1)
the co-existence of##5##3##(1995-12#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#1)
the co-existence##6##2##(1995-12#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#2)
the co-expression of##2##3##(1990-12#1)(2008-7#1)
the co-infection##2##2##(2007-7#1)(2011-1#1)
the co-ligands##2##2##(1996-2#2)
the co-localization of##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
the co-migration##2##2##(2008-10#2)
the co-occurrence of##2##3##(1994-6#1)(2008-8#1)
the co-occurrence##4##2##(1994-6#1)(2008-2#2)(2008-8#1)
the co-ordination##2##2##(2008-4#1)(2013-8#1)
the co-polymer trimethylamine microcarriers##2##4##(2008-11#2)
the co-researchers##2##2##(2008-11#2)
the co-solvent##2##2##(2008-10#1)(2013-1#1)
the coaches'##2##2##(1995-3#2)
the coaggregation of##2##3##(2008-5#2)
the coaggregation##3##2##(1997-5#1)(2008-5#2)
the coagulation assay##2##3##(1994-9#2)
the coagulation##6##2##(1994-9#2)(2007-10#1)(2008-10#1)(2008-7#1)(2012-12#1)
the coalition##3##2##(1996-1#1)(2009-10#1)(2009-11#1)
the coarse-grained##2##2##(2007-9#1)(2008-8#1)
the coarsening##2##2##(2008-3#1)(2008-7#1)
the coast and##3##3##(1990-6#1)(1996-4#1)(2010-8#1)
the coast of##2##3##(2008-5#2)
the coast##5##2##(1990-6#1)(1996-4#1)(2008-5#2)(2010-8#1)
the coastal and##2##3##(2008-8#2)
the coastal plain of##3##4##(2008-5#1)(2011-2#2)
the coastal saline##2##3##(2010-4#2)
the coastal##19##2##(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#5)(2010-4#2)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
the coat protein (CP) and##3##5##(2008-10#3)
the coat protein (CP) gene of##4##6##(2008-10#4)
the coat protein (CP) gene##7##5##(2008-10#6)(2008-8#1)
the coat protein (CP)##14##4##(2008-10#13)(2008-8#1)
the coat protein gene of##4##5##(1997-2#1)(1997-6#1)(2008-10#2)
the coat protein gene##7##4##(1997-2#1)(1997-6#1)(2008-10#5)
the coat protein of##2##4##(1997-2#1)(2008-10#1)
the coat protein##34##3##(1991-5#3)(1997-2#4)(1997-6#1)(2008-10#25)(2008-8#1)
the coat##40##2##(1991-5#3)(1997-2#4)(1997-6#1)(2008-10#31)(2008-8#1)
the coated##15##2##(1995-2#1)(1995-6#2)(2007-12#1)(2008-10#7)(2008-2#1)(2008-4#1)(2009-11#1)(2010-5#1)
the coating and##2##3##(2008-10#1)(2008-3#1)
the coating of the##2##4##(1993-3#1)(2008-2#1)
the coating of##3##3##(1993-3#1)(2008-2#1)(2013-1#1)
the coating or film##2##4##(2008-10#2)
the coating surface##2##3##(2008-3#2)
the coating thickness##3##3##(2008-3#3)
the coating##28##2##(1993-3#1)(1995-12#1)(2008-10#8)(2008-2#3)(2008-3#10)(2008-5#1)(2009-11#1)(2009-7#1)(2013-1#2)
the coatings##5##2##(2008-3#2)(2008-7#1)(2010-4#2)
the cochlea##11##2##(2008-9#4)(2009-5#2)(2009-9#1)(2012-2#4)
the cochlear implant##11##3##(2008-9#8)(2012-2#3)
the cochlear##17##2##(1993-12#1)(2008-9#9)(2009-5#1)(2009-8#1)(2012-2#5)
the cochleostomy site##2##3##(2008-9#2)
the cockatoo##2##2##(1997-3#2)
the cockroach##4##2##(1995-11#1)(2007-12#2)(2008-8#1)
the coculture##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
the code##3##2##(2008-10#1)(2008-3#2)
the coded##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
the coding and classification systems##2##5##(1994-2#2)
the coding and##4##3##(1992-9#1)(1994-2#2)(2008-7#1)
the coding capacity of a##2##5##(1995-8#1)(2008-1#1)
the coding domain##3##3##(1991-6#1)(1994-5#2)
the coding region and##3##4##(1990-6#1)(1993-6#1)(2008-12#1)
the coding region of lambdaN gene##3##6##(2008-8#3)
the coding region of the##7##5##(1990-5#2)(1993-6#2)(1994-8#1)(1997-7#1)(2008-4#1)
the coding region of##20##4##(1990-12#1)(1990-5#2)(1990-8#1)(1992-8#2)(1993-2#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-6#1)(2008-8#3)
the coding region##40##3##(1990-12#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-8#2)(1993-2#3)(1993-6#4)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2010-5#1)(2013-8#1)
the coding regions##3##3##(1991-9#1)(1997-4#1)(2008-10#1)
the coding sequence for the##2##5##(1995-8#1)(1997-3#1)
the coding sequence of the##2##5##(1992-8#1)(1997-8#1)
the coding sequence of##6##4##(1992-10#1)(1992-8#1)(1993-2#1)(1995-8#1)(1997-8#1)(2008-1#1)
the coding sequence was##2##4##(1997-4#1)(2008-8#1)
the coding sequence##12##3##(1992-10#1)(1992-8#2)(1993-12#1)(1993-2#1)(1995-8#2)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-8#1)
the coding sequences of##7##4##(1995-8#2)(1996-10#2)(1996-2#3)
the coding sequences##8##3##(1992-3#1)(1995-8#2)(1996-10#2)(1996-2#3)
the coding##83##2##(1990-12#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-2#5)(1993-6#4)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#5)(1996-10#2)(1996-2#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#3)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
the codon for##3##3##(1993-8#1)(2008-10#2)
the codon##11##2##(1991-11#1)(1992-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1997-6#1)(1997-8#1)(2008-10#2)(2013-8#1)
the coefficient of determination##2##4##(2008-10#1)(2011-2#1)
the coefficient of variation (CV) of##2##6##(2008-10#1)(2008-8#1)
the coefficient of variation for##2##5##(1990-2#1)(2008-10#1)
the coefficient of variation was##2##5##(2008-10#1)(2008-3#1)
the coefficient of variation##15##4##(1990-2#1)(1992-3#1)(1996-5#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#1)
the coefficient of##23##3##(1990-2#1)(1992-3#1)(1996-5#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
the coefficient##25##2##(1990-2#1)(1992-3#1)(1996-5#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
the coefficients of the##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)
the coefficients of variation##4##4##(1996-3#2)(2008-10#2)
the coefficients of##12##3##(1996-3#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-6#2)
the coefficients##17##2##(1996-3#2)(2008-10#4)(2008-2#5)(2008-3#3)(2008-6#2)(2008-8#1)
the coelomic##4##2##(1990-5#1)(2007-6#1)(2008-5#1)(2011-2#1)
the coenzyme in##2##3##(1992-6#1)(2013-8#1)
the coenzyme specificity##2##3##(1990-7#2)
the coenzyme##9##2##(1990-7#2)(1992-6#4)(1994-8#1)(2008-10#1)(2013-8#1)
the coercive##2##2##(1996-11#1)(2007-12#1)
the coevolution between##2##3##(2008-8#2)
the coevolution of##2##3##(2008-1#1)(2008-8#1)
the coevolution##5##2##(2008-1#1)(2008-10#1)(2008-8#3)
the coevolutionary dynamics##2##3##(2008-10#2)
the coevolutionary##3##2##(1995-5#1)(2008-10#2)
the coexistence of both##2##4##(2008-9#1)(2013-8#1)
the coexistence of competitors##2##4##(2008-8#1)(2008-9#1)
the coexistence of two##2##4##(1994-9#1)(2010-6#1)
the coexistence of##22##3##(1992-10#1)(1992-6#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-8#4)(2008-9#4)(2010-6#1)(2013-1#1)(2013-8#1)
the coexistence##23##2##(1992-10#1)(1992-6#1)(1992-8#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-8#4)(2008-9#4)(2010-6#1)(2013-1#1)(2013-8#1)
the coexisting##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
the cofactor##13##2##(1990-5#1)(1990-7#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-5#4)(1995-5#1)(1995-6#1)(2008-11#1)(2009-3#1)
the cognate mRNA##2##3##(2008-9#2)
the cognate##13##2##(1990-3#1)(1991-2#1)(1995-8#1)(1996-5#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-9#3)
the cognition##2##2##(2009-10#2)
the cognitive and##9##3##(1993-1#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-7#1)
the cognitive decline##4##3##(1991-6#1)(2008-7#2)(2013-8#1)
the cognitive function##2##3##(2009-10#1)(2010-10#1)
the cognitive functions##2##3##(2008-4#1)(2008-7#1)
the cognitive##38##2##(1990-3#1)(1991-6#1)(1993-1#1)(1993-12#1)(1994-6#2)(1995-11#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#5)(2008-4#1)(2008-7#4)(2008-9#2)(2009-10#4)(2009-7#1)(2010-10#1)(2012-1#2)(2012-12#1)(2013-8#1)
the cohered structures##2##3##(1991-7#2)
the cohered##4##2##(1991-7#4)
the coherence function##4##3##(2008-3#4)
the coherence length of the##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the coherence length of##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
the coherence length##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
the coherence of the##2##4##(2006-4#1)(2007-11#1)
the coherence of##4##3##(2006-4#1)(2007-11#1)(2008-3#2)
the coherence##17##2##(2006-4#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#10)
the coherent and the incoherent combinations##2##6##(2008-3#2)
the coherent and the incoherent##4##5##(2008-3#4)
the coherent and##5##3##(2008-10#1)(2008-3#4)
the coherent noise##2##3##(2008-3#2)
the coherent speckle##2##3##(2007-11#2)
the coherent sum##2##3##(2008-2#2)
the coherent##26##2##(2007-11#6)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#10)(2009-5#1)
the cohesive ends of##2##4##(1993-11#2)
the cohesive##3##2##(1993-11#2)(2010-4#1)
the cohort of##2##3##(2006-10#1)(2008-6#1)
the cohort was##4##3##(1995-9#1)(2007-12#1)(2008-8#1)(2013-1#1)
the cohort with##2##3##(1994-2#1)(2008-7#1)
the cohort##16##2##(1993-12#1)(1994-12#1)(1994-2#1)(1995-8#1)(1995-9#2)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#2)(2013-1#1)
the coil and##2##3##(2008-10#2)
the coil to##2##3##(2010-7#1)(2012-2#1)
the coil##9##2##(1996-9#1)(2008-10#3)(2008-9#1)(2010-7#3)(2012-2#1)
the coiled coil##2##3##(1992-9#1)(1993-11#1)
the coiled##4##2##(1992-9#1)(1993-11#1)(2008-2#1)(2011-2#1)
the coiled-coil pitch##2##3##(1992-9#2)
the coiled-coil##4##2##(1992-6#1)(1992-9#3)
the coils##2##2##(1995-11#1)(1996-9#1)
the coincidence of##5##3##(1996-6#1)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
the coincidence##6##2##(1996-6#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
the col-36##2##2##(1993-12#2)
the col-6##2##2##(1993-12#2)
the cold vapor mercury##2##4##(2008-10#2)
the cold##17##2##(1994-12#1)(1994-9#2)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#1)
the cold-exposed##2##2##(1995-3#1)(2008-7#1)
the cold-hardiness strategies##2##3##(2008-8#2)
the cold-shock response in mammalian##2##5##(2008-11#2)
the cold-shock##3##2##(1997-7#1)(2008-11#2)
the collaborative efforts of##4##4##(1994-9#1)(1996-1#1)(2010-10#1)(2013-1#1)
the collaborative encoding deficit##4##4##(2013-1#4)
the collaborative##19##2##(1994-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
the collagen network##2##3##(2008-5#1)(2008-7#1)
the collagen##25##2##(1991-11#1)(1991-9#1)(1992-6#6)(1993-3#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-7#1)(2012-12#1)(2013-1#3)
the collagenous##3##2##(2008-11#1)(2008-7#2)
the collapse of the##2##4##(2008-10#1)(2008-12#1)
the collapse of##6##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
the collapse##8##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
the collapsed##2##2##(2006-10#1)(2012-12#1)
the collar##3##2##(1995-12#2)(2008-10#1)
the collateral##8##2##(1991-2#1)(1994-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2012-2#1)
the collected data##8##3##(1992-1#1)(1992-3#1)(1994-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)
the collected power##2##3##(2008-2#2)
the collected##22##2##(1991-2#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#2)(2008-6#2)(2010-8#1)(2011-2#1)
the collecting lens aperture##3##4##(2008-2#3)
the collecting##5##2##(2008-2#3)(2008-5#1)(2011-2#1)
the collection and analysis of##2##5##(1994-2#1)(2008-1#1)
the collection and##5##3##(1994-2#1)(2008-1#1)(2008-10#2)(2010-1#1)
the collection efficiency##2##3##(2007-11#1)(2011-1#1)
the collection of data##6##4##(1990-12#1)(1991-3#1)(1995-12#1)(1997-3#2)(1997-4#1)
the collection of##34##3##(1990-12#1)(1991-3#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-3#3)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
the collection##58##2##(1990-12#1)(1991-3#1)(1992-1#1)(1994-2#2)(1995-12#1)(1996-10#1)(1996-3#1)(1997-3#3)(1997-4#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-7#1)
the collective knowledge##2##3##(2008-10#1)(2010-10#1)
the collective##12##2##(1991-11#1)(1994-1#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-10#1)
the collector##4##2##(2008-10#4)
the college##3##2##(1992-1#1)(1996-1#1)(2013-8#1)
the collembola-biotest##2##2##(2008-11#2)
the collision##3##2##(1993-3#2)(2008-10#1)
the collisional##3##2##(1997-2#1)(2008-2#2)
the colloid##7##2##(2008-10#3)(2008-2#4)
the colloidal##7##2##(2008-10#5)(2008-3#1)(2008-5#1)
the colon and rectum##4##4##(1992-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the colon and##7##3##(1990-2#1)(1992-8#1)(2008-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
the colon during##2##3##(1992-6#1)(2011-2#1)
the colon in##3##3##(1991-6#2)(2006-8#1)
the colon of##5##3##(2008-12#4)(2011-3#1)
the colon was##2##3##(2008-11#1)(2009-1#1)
the colon##57##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#4)(1992-2#1)(1992-6#1)(1992-8#1)(1993-8#2)(1993-9#2)(1994-2#2)(1997-8#1)(2006-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#8)(2009-1#2)(2009-12#4)(2010-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
the colonial##2##2##(1995-9#1)(2008-8#1)
the colonic##10##2##(1990-7#1)(1991-12#2)(1992-8#2)(2009-1#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
the colonies##9##2##(1991-9#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2010-1#1)
the colonization effect##2##3##(2008-8#2)
the colonization of##6##3##(2008-10#6)
the colonization##15##2##(2008-10#8)(2008-8#4)(2013-1#1)(2013-8#2)
the colony and##2##3##(2008-10#1)(2009-5#1)
the colony counting method##2##4##(2008-10#2)
the colony##22##2##(1991-12#1)(1996-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2009-5#2)
the colony-forming units##2##3##(2007-10#1)(2013-1#1)
the color and##3##3##(2008-3#2)(2008-5#1)
the color of a##2##4##(2007-12#1)(2012-2#1)
the color of the##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
the color of##11##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#3)(2011-2#1)(2012-2#1)
the color pigment genes##2##4##(1993-3#1)(1993-6#1)
the color pigment##3##3##(1993-3#2)(1993-6#1)
the color reaction##3##3##(2008-10#3)
the color stability of##3##4##(2010-3#1)(2012-7#1)(2013-1#1)
the color##51##2##(1993-3#2)(1993-6#3)(2007-10#1)(2007-12#4)(2008-10#13)(2008-2#1)(2008-3#14)(2008-5#1)(2008-6#1)(2009-8#4)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#1)
the colorants##4##2##(2008-10#4)
the colorectal##2##2##(1992-8#1)(2008-10#1)
the colorectum##2##2##(1990-11#1)(2008-4#1)
the colored##4##2##(2008-10#4)
the colorimetric method##5##3##(1994-3#2)(2008-10#3)
the colorimetric reaction between##2##4##(2008-10#2)
the colorimetric##13##2##(1994-3#2)(2008-10#10)(2008-5#1)
the colors##2##2##(2007-12#1)(2008-3#1)
the colour induced##2##3##(2008-5#2)
the colour of the##2##4##(2008-10#2)
the colour of##3##3##(2008-10#3)
the colour##17##2##(1990-12#1)(1992-11#4)(2008-10#7)(2008-5#3)(2010-4#2)
the coloured##8##2##(2008-10#7)(2008-5#1)
the colposcopy directed biopsy##3##4##(2008-11#3)
the colposcopy directed cytology##2##4##(2008-11#2)
the colposcopy directed##6##3##(2008-11#6)
the column and##3##3##(2008-10#2)(2008-9#1)
the column could tolerate##2##4##(2008-10#2)
the column could##3##3##(2008-10#3)
the column eluate##2##3##(2008-10#2)
the column method##3##3##(2008-10#3)
the column temperature##4##3##(2008-10#3)(2011-1#1)
the column was##5##3##(1992-6#1)(2008-10#4)
the column with##6##3##(1990-12#1)(2008-10#5)
the column##72##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-6#1)(2008-10#55)(2008-2#2)(2008-3#1)(2008-6#4)(2008-9#2)(2011-1#1)
the columnar aerosol##2##3##(2008-2#2)
the columnar##4##2##(2008-2#2)(2008-3#1)(2009-10#1)
the columnar-lined mucosa##2##3##(2009-3#2)
the columns were##3##3##(1990-8#1)(2008-10#1)(2011-1#1)
the columns##10##2##(1990-8#1)(2008-10#6)(2008-8#1)(2009-5#1)(2011-1#1)
the coma aberration##2##3##(2008-3#2)
the coma##5##2##(1991-8#1)(2008-3#4)
the comb##7##2##(2007-12#6)(2008-3#1)
the combination group##3##3##(2008-12#2)(2008-7#1)
the combination of DTPA and BHT##2##6##(2008-5#2)
the combination of Nep1 and P##2##6##(2008-10#2)
the combination of a##8##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
the combination of band depth analysis and PLSR##3##8##(2013-8#3)
the combination of both##2##4##(2011-2#1)(2013-1#1)
the combination of clozapine##2##4##(2008-12#2)
the combination of different##2##4##(2008-10#2)
the combination of high##2##4##(2008-10#1)(2012-3#1)
the combination of insulin##2##4##(2008-3#1)(2009-9#1)
the combination of radiation##2##4##(1991-2#1)(2010-3#1)
the combination of the two##3##5##(2008-7#1)(2010-5#1)(2012-5#1)
the combination of the##11##4##(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-5#1)
the combination of these drugs with##2##6##(1995-5#1)(2013-8#1)
the combination of these drugs##3##5##(1995-5#1)(2008-7#1)(2013-8#1)
the combination of these##5##4##(1995-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2013-8#1)
the combination of##151##3##(1990-10#2)(1990-2#2)(1990-8#2)(1990-9#1)(1991-2#2)(1991-4#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#2)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#8)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#8)
the combination therapy##3##3##(2008-10#1)(2008-6#2)
the combination treatment##3##3##(2008-6#1)(2012-12#1)(2013-7#1)
the combination was##2##3##(2009-4#1)(2010-3#1)
the combination with##2##3##(2011-2#1)(2013-8#1)
the combination##191##2##(1990-10#2)(1990-2#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#7)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#2)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#6)(2008-8#7)(2008-9#8)(2009-1#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#9)
the combinations of##7##3##(1991-12#1)(2008-10#3)(2008-9#2)(2013-1#1)
the combinations##10##2##(1991-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
the combinatorial##3##2##(1996-3#1)(1997-9#1)(2010-4#1)
the combined action of##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
the combined addition of##2##4##(1990-7#1)(2008-11#1)
the combined data set##4##4##(2008-10#3)(2008-11#1)
the combined data##6##3##(2008-10#4)(2008-11#1)(2010-4#1)
the combined density of##2##4##(1993-9#1)(2008-9#1)
the combined effect of##10##4##(1990-2#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-4#1)
the combined effects of energy diffusion##2##6##(2009-2#2)
the combined effects of temperature##2##5##(2008-10#2)
the combined effects of##12##4##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-2#2)(2011-2#1)
the combined effects##13##3##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#2)(2009-2#2)(2011-2#1)
the combined endpoint##2##3##(1992-9#1)(2007-8#1)
the combined lipid profile of a high fasting triglyceride level and a low HDL cholesterol level##2##16##(2008-3#2)
the combined method of##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
the combined method##4##3##(2008-10#1)(2008-2#1)(2010-3#1)(2013-1#1)
the combined power of##2##4##(2012-2#1)(2012-3#1)
the combined therapy##4##3##(2008-1#1)(2012-3#1)(2013-1#2)
the combined treatment##4##3##(1991-9#1)(2012-6#3)
the combined use of##8##4##(1997-7#1)(2006-6#1)(2008-10#2)(2008-7#3)(2013-1#1)
the combined use##9##3##(1997-7#1)(2006-6#1)(2008-10#3)(2008-7#3)(2013-1#1)
the combined##122##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#4)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#3)(2013-1#7)(2013-8#2)
the combs##2##2##(2007-11#1)(2008-6#1)
the combustion of##2##3##(2008-10#1)(2008-11#1)
the combustion phase of##2##4##(2008-2#2)
the combustion##13##2##(1996-12#4)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)
the comet assay and##2##4##(1997-4#2)
the comet assay as a##2##5##(1997-4#2)
the comet assay may##2##4##(1997-4#2)
the comet assay to##2##4##(1997-4#2)
the comet assay##17##3##(1997-4#12)(2008-10#2)(2010-5#2)(2013-1#1)
the comet##19##2##(1997-4#12)(1997-5#1)(2008-10#3)(2010-5#2)(2013-1#1)
the comfort of the##2##4##(1994-1#1)(2011-2#1)
the comfort of##3##3##(1994-1#1)(2007-11#1)(2011-2#1)
the comfort##5##2##(1994-1#1)(2007-11#1)(2008-11#1)(2011-2#1)(2013-7#1)
the coming of the##2##4##(1993-2#1)(2010-1#1)
the coming years##4##3##(1993-12#1)(1996-1#1)(2006-10#1)(2008-7#1)
the coming##10##2##(1991-11#1)(1993-12#1)(1993-2#1)(1996-1#1)(2006-10#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)
the commencement of the experiment##2##5##(1992-2#1)(1992-9#1)
the commencement of the##3##4##(1992-2#1)(1992-9#1)(2007-5#1)
the commencement of##6##3##(1992-2#1)(1992-9#1)(2007-5#1)(2007-8#1)(2008-6#1)(2009-6#1)
the commercial catches##2##3##(2013-7#2)
the commercial enzyme##2##3##(1994-8#1)(1996-12#1)
the commercial##35##2##(1990-7#1)(1994-8#1)(1996-12#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#4)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)
the commercially available##9##3##(1991-12#1)(1997-3#1)(2008-10#4)(2008-5#2)(2010-4#1)
the commercially##10##2##(1991-12#1)(1997-3#1)(2008-10#4)(2008-5#2)(2010-4#1)(2011-1#1)
the commitment of##2##3##(2007-11#1)(2008-11#1)
the commitment##6##2##(1992-12#1)(1996-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2009-10#1)
the committee##3##2##(1994-2#1)(2011-2#1)(2012-2#1)
the common alphabeta##3##3##(2009-8#3)
the common ancestor of##3##4##(1997-6#1)(2009-8#1)(2010-4#1)
the common and comet##2##4##(2010-8#2)
the common and##4##3##(2010-8#2)(2012-2#1)(2013-1#1)
the common approach##2##3##(2008-11#1)(2013-1#1)
the common bean##5##3##(2008-10#5)
the common bile duct##9##4##(1990-5#2)(1990-6#1)(1990-9#2)(1991-3#1)(1993-9#1)(1996-11#1)(2009-9#1)
the common causes of##3##4##(2007-7#1)(2007-8#1)(2012-3#1)
the common characteristics##2##3##(2008-10#1)(2009-12#1)
the common cold##6##3##(1992-3#1)(2008-10#4)(2012-3#1)
the common diagnostic##3##3##(1991-8#1)(2010-5#1)(2011-1#1)
the common disease/common variant##2##4##(2012-3#2)
the common goal of##2##4##(1991-2#1)(2008-6#1)
the common good##2##3##(1993-2#1)(2009-4#1)
the common hepatic artery##2##4##(2012-12#1)(2012-2#1)
the common morning glory Ipomoea purpurea##4##6##(2008-9#4)
the common obstacles##2##3##(1994-2#1)(2008-4#1)
the common pathways##2##3##(1993-12#1)(2011-2#1)
the common pitfalls##2##3##(1993-1#1)(2010-5#1)
the common practice of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
the common precursor##2##3##(1994-2#1)(2012-3#1)
the common region##5##3##(1990-11#1)(2008-10#3)(2008-8#1)
the common sense##3##3##(1996-3#1)(2008-1#1)(2010-4#1)
the common vole##2##3##(1991-8#2)
the common##192##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#39)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#7)(2009-1#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#6)(2013-8#1)
the commonest benign##2##3##(1993-9#1)(2008-12#1)
the commonest cause of##6##4##(1992-4#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)
the commonest cause##8##3##(1992-4#1)(2007-7#2)(2008-1#3)(2008-4#1)(2008-7#1)
the commonest offending drug##2##4##(2008-8#2)
the commonest primary##4##3##(2007-7#1)(2008-1#1)(2010-11#1)(2013-1#1)
the commonest secondary##2##3##(2007-7#1)(2008-1#1)
the commonest species##4##3##(2007-7#1)(2008-5#3)
the commonest##51##2##(1990-6#1)(1991-8#1)(1992-4#1)(1993-9#1)(1997-8#1)(2007-7#11)(2008-1#12)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2010-11#1)(2011-1#1)(2012-3#2)(2013-1#3)(2013-8#2)
the commonly used##13##3##(1992-6#1)(1995-11#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2013-1#1)
the commonly##21##2##(1992-11#1)(1992-2#1)(1992-6#1)(1995-11#1)(1996-2#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#1)
the communication and##2##3##(2008-11#1)(2008-12#1)
the communication between##4##3##(2008-10#1)(2008-4#1)(2009-10#1)(2009-8#1)
the communication of##2##3##(1990-12#1)(2010-4#1)
the communication system##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
the communication##26##2##(1990-12#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
the communications##5##2##(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#2)
the communities in which they##2##5##(1995-3#1)(1996-3#1)
the communities in which##4##4##(1995-3#1)(1996-3#2)(2008-1#1)
the communities of##2##3##(2008-1#1)(2008-10#1)
the communities that##2##3##(1991-12#1)(2009-2#1)
the communities##10##2##(1991-12#1)(1995-3#1)(1996-3#2)(2008-1#2)(2008-10#1)(2008-11#1)(2009-2#1)(2012-12#1)
the community about##2##3##(1992-12#1)(2011-2#1)
the community and the##3##4##(1994-1#1)(1995-3#1)(1996-2#1)
the community and##11##3##(1990-9#1)(1991-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-7#1)(2013-1#2)(2013-8#1)
the community approach##2##3##(1992-1#2)
the community as a##2##4##(1995-2#1)(2008-8#1)
the community as##4##3##(1995-2#1)(2008-8#1)(2012-12#2)
the community burden of##2##4##(2008-10#1)(2008-11#1)
the community care##2##3##(1997-8#1)(2010-10#1)
the community health##6##3##(1991-3#1)(1996-2#1)(1997-2#2)(2008-1#1)(2013-8#1)
the community in##4##3##(1997-1#1)(2009-6#1)(2013-1#2)
the community of##3##3##(1995-3#1)(2008-1#1)(2011-2#1)
the community served##2##3##(1993-1#1)(1993-2#1)
the community structure of##2##4##(2008-6#1)(2008-8#1)
the community to##3##3##(1992-1#1)(1995-11#1)(2009-10#1)
the community##165##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-1#6)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#7)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-7#2)(2008-1#4)(2008-10#2)(2008-11#13)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#6)(2011-2#7)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#11)(2013-8#3)
the compact myelin##2##3##(2008-7#2)
the compact##5##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#2)
the compactibility##2##2##(2010-5#2)
the compaction##2##2##(2011-1#1)(2011-2#1)
the companies##3##2##(1997-5#2)(2012-12#1)
the company##13##2##(1992-12#1)(1992-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2010-4#1)(2012-3#1)
the company's##9##2##(1990-2#1)(1992-3#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-5#2)(2011-2#2)
the comparability of##6##3##(1990-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
the comparability##7##2##(1990-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
the comparable##4##2##(1994-11#1)(2008-11#1)(2008-8#1)(2010-8#1)
the comparative analysis of##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
the comparative group##2##3##(2011-2#2)
the comparative##20##2##(1990-6#1)(1994-5#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the comparator##2##2##(2008-11#1)(2013-1#1)
the comparison among##2##3##(2008-10#1)(2011-2#1)
the comparison as##2##3##(1991-9#2)
the comparison between experimental##2##4##(2008-11#1)(2008-2#1)
the comparison between##6##3##(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
the comparison group##3##3##(1995-1#1)(1995-3#1)(2008-11#1)
the comparison groups##2##3##(1996-1#1)(2011-1#1)
the comparison is##3##3##(1994-9#1)(1996-3#1)(2013-1#1)
the comparison of the##8##4##(1990-8#1)(2008-10#4)(2011-1#1)(2011-2#1)(2013-8#1)
the comparison of two##3##4##(1994-9#1)(1995-2#1)(2008-10#1)
the comparison of##25##3##(1990-8#1)(1994-9#2)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
the comparison##52##2##(1990-5#1)(1990-8#1)(1991-9#2)(1992-6#1)(1994-2#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#4)(2008-3#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-8#1)
the compartment##2##2##(1991-5#1)(2007-11#1)
the compartmental##2##2##(2008-10#1)(2013-8#1)
the compartmentalization of##3##3##(1994-8#1)(2010-5#1)(2012-2#1)
the compartmentalization##4##2##(1994-11#1)(1994-8#1)(2010-5#1)(2012-2#1)
the compatibility of SHLI with##2##5##(2011-2#2)
the compatibility of##8##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#3)
the compatibility##10##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#3)
the compatible##2##2##(2008-10#2)
the compensated##2##2##(1991-2#1)(2009-7#1)
the compensation of##4##3##(1991-2#2)(1993-5#1)(2009-6#1)
the compensation##12##2##(1991-2#2)(1991-3#1)(1993-5#1)(1996-2#1)(2008-10#2)(2008-3#3)(2009-6#1)(2011-1#1)
the compensator##2##2##(2008-3#2)
the compensatory##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
the competence of nurses##2##4##(2008-12#2)
the competence of##4##3##(1996-2#1)(1997-4#1)(2008-12#2)
the competence##6##2##(1996-2#1)(1997-4#1)(2008-12#2)(2009-6#1)(2010-9#1)
the competencies##2##2##(2007-11#1)(2012-12#1)
the competency##3##2##(2007-11#1)(2008-1#1)(2008-11#1)
the competing risks problem##2##4##(1995-9#1)(1997-4#1)
the competing##8##2##(1995-9#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)
the competition between##6##3##(1993-12#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-7#1)
the competition of two##2##4##(2008-10#1)(2012-2#1)
the competition of##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
the competition with##2##3##(2008-10#1)(2008-11#1)
the competition##25##2##(1992-2#1)(1993-12#1)(1993-6#1)(1994-8#1)(1996-1#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#7)(2008-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
the competition-colonization##3##2##(2008-8#1)(2008-9#2)
the competitive adsorption of##2##4##(2008-10#2)
the competitive reaction##3##3##(2008-10#3)
the competitive##40##2##(1992-8#2)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
the compilation of the##2##4##(2008-10#1)(2008-3#1)
the compilation##3##2##(2008-10#2)(2008-3#1)
the complaint of##3##3##(2008-1#1)(2008-5#1)(2012-3#1)
the complaint##4##2##(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
the complaints of##2##3##(2011-2#1)(2013-1#1)
the complaints##5##2##(1990-11#1)(1996-3#1)(2011-2#2)(2013-1#1)
the complement of##2##3##(2008-5#1)(2010-12#1)
the complement##15##2##(1991-2#1)(1991-3#2)(1993-11#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
the complementarity of##2##3##(1991-2#1)(1996-5#1)
the complementarity-determining region##2##3##(1995-2#2)
the complementarity-determining##3##2##(1992-8#1)(1995-2#2)
the complementary and alternative##2##4##(1991-3#1)(2008-10#1)
the complementary and##3##3##(1991-3#1)(2008-10#1)(2013-1#1)
the complementary strand##3##3##(1994-12#1)(1997-3#1)(2008-4#1)
the complementary target##3##3##(2008-10#3)
the complementary##25##2##(1990-12#2)(1991-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-1#3)(2008-10#10)(2008-4#2)(2008-9#1)(2013-1#1)
the complementation##2##2##(1996-3#1)(2008-6#1)
the complete ITS##3##3##(2008-10#3)
the complete automation of##2##4##(1991-5#1)(2008-10#1)
the complete coding sequence##2##4##(1993-2#1)(1994-12#1)
the complete coding##3##3##(1993-2#1)(1994-12#1)(1997-7#1)
the complete distribution of##2##4##(2008-10#1)(2012-3#1)
the complete gene##2##3##(1993-2#1)(1993-8#1)
the complete genome of##3##4##(2007-6#1)(2008-10#1)(2012-3#1)
the complete genome sequence of##2##5##(2008-9#1)(2013-8#1)
the complete genome sequence##25##4##(2008-9#1)(2011-2#23)(2013-8#1)
the complete genome sequences##2##4##(2008-10#2)
the complete genome##31##3##(2007-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#23)(2012-3#1)(2013-8#1)
the complete genomic##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
the complete loss of##2##4##(2008-11#1)(2012-2#1)
the complete nucleotide sequence of a##4##6##(1993-3#1)(1995-9#1)(1997-4#1)(2008-10#1)
the complete nucleotide sequence of the gene##2##7##(1994-12#2)
the complete nucleotide sequence of the##3##6##(1994-12#2)(1997-7#1)
the complete nucleotide sequence of##8##5##(1993-3#1)(1994-12#2)(1995-9#1)(1996-10#1)(1997-4#1)(1997-7#1)(2008-10#1)
the complete nucleotide sequence##10##4##(1993-3#1)(1994-12#2)(1995-8#1)(1995-9#1)(1996-10#1)(1997-4#1)(1997-7#1)(2008-10#2)
the complete nucleotide sequences of##2##5##(2008-10#1)(2013-8#1)
the complete nucleotide##13##3##(1993-12#1)(1993-3#1)(1994-12#2)(1995-8#1)(1995-9#1)(1996-10#1)(1997-4#1)(1997-7#1)(2008-10#3)(2013-8#1)
the complete polarization##2##3##(2008-2#1)(2008-3#1)
the complete removal of##2##4##(1994-11#1)(2011-1#1)
the complete resistance##3##3##(2008-10#3)
the complete separation of the##2##5##(1990-12#2)
the complete separation of##3##4##(1990-12#2)(2008-10#1)
the complete sequence and##2##4##(2008-7#1)(2011-2#1)
the complete sequence of##4##4##(1993-2#2)(2007-12#1)(2010-5#1)
the complete sequence##6##3##(1993-2#2)(2007-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
the complete set of##4##4##(1997-7#1)(2008-4#1)(2008-6#1)(2012-3#1)
the complete system##3##3##(2008-10#1)(2008-3#2)
the complete##161##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#5)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#4)(1994-6#2)(1995-2#1)(1995-5#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#6)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#34)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#26)(2012-12#1)(2012-2#1)(2012-3#4)(2013-8#5)
the completed##4##2##(1992-3#2)(2010-6#1)(2012-12#1)
the completely sequenced##2##3##(1990-5#1)(2008-7#1)
the completely##6##2##(1990-5#1)(1992-11#1)(1997-6#1)(2008-12#1)(2008-5#1)(2008-7#1)
the completeness of##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
the completeness##5##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2013-7#1)
the completion of a##2##4##(1991-6#1)(2008-10#1)
the completion of the##11##4##(1992-3#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the completion of##29##3##(1990-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the completion##30##2##(1990-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the complex ML(2)##2##3##(2008-10#2)
the complex amplitude of the##3##5##(2007-11#1)(2007-12#2)
the complex amplitude##6##3##(2007-11#2)(2007-12#3)(2008-3#1)
the complex amplitudes of the##2##5##(2008-2#1)(2008-3#1)
the complex anatomy##2##3##(2008-1#1)(2012-2#1)
the complex and##7##3##(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-2#1)
the complex are##6##3##(1990-7#1)(1995-2#1)(2008-10#3)(2009-10#1)
the complex at##2##3##(2008-10#2)
the complex biological##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
the complex coupling##2##3##(2008-3#2)
the complex formation between##4##4##(1997-6#1)(2008-10#2)(2008-7#1)
the complex formation##15##3##(1992-11#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-7#1)
the complex formed between##2##4##(1994-5#1)(2008-10#1)
the complex formed##4##3##(1994-5#1)(2008-10#2)(2009-8#1)
the complex genetic##2##3##(2009-10#1)(2009-3#1)
the complex impedance##3##3##(2008-10#2)(2008-7#1)
the complex in##4##3##(2008-10#3)(2013-1#1)
the complex index of refraction and size distribution of aerosols##2##10##(2008-3#2)
the complex index of refraction and the size distribution##2##9##(2008-2#2)
the complex index of refraction and##5##6##(2008-2#3)(2008-3#2)
the complex index of refraction##8##5##(2008-2#6)(2008-3#2)
the complex interactions between##2##4##(2008-5#1)(2008-7#1)
the complex interactions##4##3##(1993-8#1)(2008-5#1)(2008-7#1)(2009-3#1)
the complex interplay between##2##4##(2007-12#1)(2008-8#1)
the complex interplay##3##3##(2007-12#2)(2008-8#1)
the complex is##14##3##(1995-12#1)(1995-2#1)(1996-2#1)(2007-12#2)(2008-10#9)
the complex mechanism of##2##4##(1995-12#1)(2010-3#1)
the complex mechanisms regulating##2##4##(2008-10#1)(2008-4#1)
the complex mechanisms##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
the complex nature of##4##4##(2007-5#1)(2008-10#2)(2008-11#1)
the complex of the##3##4##(1991-2#1)(2008-10#2)
the complex of##14##3##(1991-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-8#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
the complex process of##2##4##(1995-12#1)(2009-6#1)
the complex process##5##3##(1995-12#1)(2009-6#2)(2011-2#1)(2013-1#1)
the complex reflection spectrum##2##4##(2008-3#2)
the complex refractive index of##4##5##(2008-2#1)(2008-3#3)
the complex refractive index##15##4##(2008-10#1)(2008-2#4)(2008-3#10)
the complex refractive indices##3##4##(2007-11#2)(2008-3#1)
the complex refractive##18##3##(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#11)
the complex relationship between##4##4##(2008-11#1)(2009-5#1)(2011-2#2)
the complex relationship##5##3##(2008-11#1)(2009-5#1)(2011-2#3)
the complex role##2##3##(2008-10#1)(2008-4#1)
the complex spectral##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
the complex structure of##2##4##(1994-9#1)(1995-9#1)
the complex structure##4##3##(1994-9#1)(1995-9#1)(2008-10#2)
the complex to##3##3##(1990-2#1)(1993-11#1)(2007-12#1)
the complex was##13##3##(1990-5#2)(1994-11#2)(2007-12#1)(2008-10#6)(2009-10#2)
the complex with##6##3##(1992-2#1)(1995-2#1)(2008-10#3)(2011-1#1)
the complex##335##2##(1990-12#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-8#7)(1993-9#2)(1994-1#1)(1994-11#5)(1994-2#3)(1994-3#1)(1994-5#4)(1994-8#3)(1994-9#1)(1995-12#3)(1995-2#7)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#5)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#7)(2007-12#13)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#106)(2008-11#8)(2008-2#13)(2008-3#26)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#7)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#5)
the complex-formation##2##2##(2008-10#2)
the complex-valued##2##2##(2008-3#2)
the complexation and##2##3##(2008-10#1)(2013-1#1)
the complexation between##2##3##(2008-10#2)
the complexation constants of##2##4##(2008-10#2)
the complexation equilibria##2##3##(2008-10#2)
the complexation in water##2##4##(2008-10#2)
the complexation in##3##3##(2008-10#3)
the complexation of the##3##4##(1994-3#1)(2008-10#2)
the complexation of##10##3##(1994-3#1)(2008-10#8)(2008-7#1)
the complexation reaction is##2##4##(2008-10#2)
the complexation reaction of##2##4##(2008-10#2)
the complexation reaction##8##3##(2008-10#8)
the complexation with##3##3##(2008-10#3)
the complexation##39##2##(1994-3#1)(2008-10#36)(2008-7#1)(2013-1#1)
the complexed##3##2##(2008-10#3)
the complexes are##3##3##(1995-5#1)(2008-10#1)(2009-8#1)
the complexes formed##3##3##(2008-10#3)
the complexes of##8##3##(1993-11#1)(1997-3#1)(2007-11#1)(2008-10#5)
the complexes were##3##3##(1994-5#1)(2008-10#2)
the complexes with##2##3##(1997-7#1)(2008-10#1)
the complexes##48##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-9#1)(1993-11#2)(1994-11#1)(1994-5#1)(1995-5#1)(1996-2#4)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#25)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-7#2)
the complexing agent##8##3##(2008-10#8)
the complexing properties of##2##4##(2008-10#2)
the complexing##14##2##(2008-10#14)
the complexities of##6##3##(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#2)(2013-8#1)
the complexities##11##2##(1994-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#1)(2009-5#1)(2013-1#2)(2013-8#1)
the complexity of maintaining##2##4##(1993-3#1)(2011-2#1)
the complexity of the apparatus##2##5##(2008-3#2)
the complexity of the feeding apparatus##2##6##(2010-8#2)
the complexity of the##35##4##(1993-2#1)(1993-3#1)(1993-9#1)(1995-5#1)(1996-3#1)(1997-3#3)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the complexity of these##2##4##(2008-5#1)(2008-9#1)
the complexity of##71##3##(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-5#1)(1996-3#2)(1996-4#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the complexity##77##2##(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-5#1)(1996-3#2)(1996-4#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the complexometric##2##2##(2008-10#2)
the compliance of##3##3##(1996-3#1)(2008-10#1)(2008-5#1)
the compliance with##3##3##(1996-2#1)(2008-10#1)(2012-3#1)
the compliance##9##2##(1996-2#1)(1996-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-2#1)(2012-3#1)
the complicated##8##2##(2008-11#1)(2008-3#2)(2009-6#1)(2010-5#1)(2012-3#2)(2013-8#1)
the complication of##2##3##(2009-3#1)(2012-2#1)
the complication rate##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
the complication rates of##2##4##(2008-8#1)(2011-2#1)
the complication##19##2##(1992-5#1)(1993-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the complications and mortality##2##4##(1997-3#1)(2013-8#1)
the complications and##3##3##(1997-3#1)(2008-6#1)(2013-8#1)
the complications of##15##3##(1991-8#1)(1992-2#1)(1994-2#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#3)(2012-3#1)
the complications rate##2##3##(2007-8#1)(2009-3#1)
the complications that##3##3##(1994-6#1)(2008-10#1)(2012-2#1)
the complications##37##2##(1990-6#2)(1991-8#1)(1992-2#1)(1992-5#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the component of##3##3##(1990-4#1)(2008-10#1)(2008-11#1)
the component##33##2##(1990-4#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-5#1)(1995-2#2)(1996-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2012-1#2)(2013-8#2)
the components are##2##3##(2008-10#1)(2008-3#1)
the components involved##2##3##(1991-12#1)(2008-9#1)
the components of a##6##4##(1993-1#1)(1993-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
the components of the##20##4##(1991-12#1)(1991-2#1)(1993-11#1)(1996-12#2)(2007-12#2)(2008-1#1)(2008-10#8)(2008-3#2)(2009-10#1)(2010-1#1)
the components of##41##3##(1991-12#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#3)(1996-2#2)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#1)
the components##71##2##(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#3)(1996-2#3)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
the composite OWG##2##3##(2008-10#2)
the composite interval mapping##2##4##(2008-10#2)
the composite nanofiber mat electrospun from##2##6##(2009-11#2)
the composite nanofiber mat##3##4##(2009-11#3)
the composite##31##2##(1994-3#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#3)(2008-5#1)(2009-11#3)(2009-6#1)(2009-7#4)(2010-8#1)(2012-12#1)
the composites##6##2##(2008-3#1)(2008-5#1)(2009-11#2)(2010-4#2)
the composition and##11##3##(1996-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
the composition change of##2##4##(2008-10#2)
the composition in##3##3##(1990-5#1)(2008-2#1)(2008-3#1)
the composition of a##4##4##(1990-9#1)(2008-10#2)(2008-7#1)
the composition of evacuees who##2##5##(2011-2#2)
the composition of the natural enemy community##2##7##(2008-8#2)
the composition of the##24##4##(1992-1#1)(1994-12#1)(2008-10#18)(2008-8#2)(2011-2#2)
the composition of##69##3##(1990-9#1)(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#36)(2008-11#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
the composition range##2##3##(2007-12#1)(2008-10#1)
the composition##100##2##(1990-12#1)(1990-5#1)(1990-9#1)(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-3#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#45)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the compositional##5##2##(1992-6#1)(1994-12#2)(2010-4#1)(2012-12#1)
the compositions of##4##3##(1995-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
the compositions##7##2##(1993-8#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-1#1)
the compost mix##7##3##(2008-10#7)
the compost##16##2##(2008-10#14)(2008-12#2)
the compound action potential##2##4##(1990-7#1)(1992-3#1)
the compound eye##3##3##(2007-12#3)
the compound fertilizer##2##3##(2008-10#2)
the compound in##3##3##(2008-10#2)(2011-1#1)
the compound that##4##3##(1990-5#1)(2008-2#1)(2008-8#2)
the compound to##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
the compound was removed and replaced with water##2##8##(2008-10#2)
the compound was##5##3##(2008-10#3)(2009-6#1)(2011-1#1)
the compound with##2##3##(1993-6#1)(1996-2#1)
the compound##54##2##(1990-5#2)(1990-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-6#3)(1996-2#2)(1996-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#17)(2008-2#2)(2008-5#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-3#2)(2013-1#2)
the compounds acylated on nitrogen by an##2##7##(1995-3#2)
the compounds are##5##3##(1992-11#2)(2008-10#2)(2009-8#1)
the compounds at##3##3##(2008-10#2)(2011-3#1)
the compounds bind##2##3##(1991-12#1)(1992-11#1)
the compounds examined##2##3##(1990-5#1)(1995-5#1)
the compounds except##2##3##(1994-8#1)(2008-10#1)
the compounds having##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
the compounds in##2##3##(1995-6#1)(2008-10#1)
the compounds studied##3##3##(1994-8#1)(2008-10#2)
the compounds tested##8##3##(1990-12#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(2009-8#1)
the compounds to##2##3##(1992-8#1)(1997-7#1)
the compounds used##2##3##(2008-10#1)(2008-5#1)
the compounds were##8##3##(1993-1#1)(1995-3#1)(2008-10#5)(2008-5#1)
the compounds with##2##3##(1997-7#1)(2008-10#1)
the compounds##94##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-11#4)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2008-10#42)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
the comprehension of##5##3##(1994-11#1)(1997-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
the comprehension##6##2##(1994-11#1)(1997-3#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
the comprehensive##13##2##(1992-2#1)(1993-8#1)(1994-1#1)(1995-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-3#2)
the compressed##7##2##(2007-12#3)(2008-2#3)(2010-3#1)
the compression effect##2##3##(2013-8#2)
the compression of##5##3##(2007-11#1)(2008-10#1)(2008-2#3)
the compression##13##2##(1992-6#1)(1993-3#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2013-8#3)
the compressive##5##2##(2008-11#1)(2009-7#4)
the compressor##3##2##(2008-2#3)
the compromise##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
the compulsory##3##2##(1991-6#1)(1994-1#1)(2008-11#1)
the computation of the##3##4##(2008-10#1)(2008-3#2)
the computation of##16##3##(1997-8#1)(2008-10#3)(2008-3#10)(2008-4#1)(2008-8#1)
the computation time##5##3##(2008-2#1)(2008-3#4)
the computation##27##2##(1997-8#1)(2008-10#3)(2008-2#4)(2008-3#15)(2008-4#1)(2008-6#1)(2008-8#1)(2013-8#1)
the computational burden##2##3##(2008-2#1)(2009-9#1)
the computational domain##2##3##(2008-3#1)(2008-7#1)
the computational effort##2##3##(2008-8#1)(2011-2#1)
the computational methodology for##2##4##(2008-10#1)(2008-3#1)
the computational time##2##3##(2008-2#1)(2008-3#1)
the computational##29##2##(1990-11#1)(1992-9#1)(2008-10#2)(2008-2#4)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
the computationally##2##2##(2008-11#1)(2008-8#1)
the computations##5##2##(1997-7#1)(2008-2#1)(2008-3#2)(2012-2#1)
the computed result##2##3##(1996-12#1)(2008-3#1)
the computed##13##2##(1991-12#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-8#1)(2009-9#2)(2010-2#1)
the computer and##3##3##(1995-12#1)(2012-12#1)(2013-8#1)
the computer program##9##3##(1995-12#3)(1997-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
the computer system##2##3##(1992-4#1)(1997-3#1)
the computer##44##2##(1991-9#1)(1992-12#2)(1992-4#3)(1993-2#1)(1993-3#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
the computer-aided##2##2##(2008-11#1)(2010-8#1)
the computer-based##3##2##(1993-12#1)(1994-2#1)(1994-6#1)
the computing time##2##3##(2008-3#2)
the computing##3##2##(2008-3#2)(2009-11#1)
the concatenated##2##2##(2012-1#1)(2012-3#1)
the concatenation can##2##3##(2007-12#2)
the concave side of the##2##5##(1996-5#1)(2012-2#1)
the concave side of##3##4##(1996-5#1)(2012-2#2)
the concentrated##9##2##(2008-10#6)(2008-5#1)(2008-6#1)(2012-2#1)
the concentrating##2##2##(2008-10#1)(2013-1#1)
the concentration and the##2##4##(2008-10#1)(2008-3#1)
the concentration and##19##3##(1990-2#1)(1991-5#1)(1993-12#1)(1994-8#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)
the concentration corresponding to##2##4##(2008-10#1)(2012-2#1)
the concentration in##3##3##(2008-10#2)(2011-1#1)
the concentration is##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
the concentration level of##4##4##(2008-10#3)(2012-1#1)
the concentration level##6##3##(2008-10#5)(2012-1#1)
the concentration levels of##3##4##(2008-10#2)(2008-11#1)
the concentration levels##6##3##(2008-10#5)(2008-11#1)
the concentration of 0##2##4##(2008-10#2)
the concentration of AA in the range##2##7##(2008-10#2)
the concentration of CV and##2##5##(2008-10#2)
the concentration of Cr(VI)##2##4##(2008-10#2)
the concentration of FP-IX##2##4##(1994-8#2)
the concentration of Mn##2##4##(2008-10#2)
the concentration of NO##2##4##(1993-8#1)(2008-10#1)
the concentration of STA ion##2##5##(2008-10#2)
the concentration of TCE in the##2##6##(2008-10#1)(2010-4#1)
the concentration of Zn(2+)##2##4##(2008-10#2)
the concentration of a##6##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)
the concentration of analyte##2##4##(2008-10#2)
the concentration of ascorbic acid##3##5##(2008-10#3)
the concentration of both##2##4##(1991-2#1)(2008-10#1)
the concentration of each##5##4##(2008-10#4)(2008-2#1)
the concentration of free DAPI##2##5##(2008-2#2)
the concentration of free##6##4##(1994-12#1)(2008-10#2)(2008-2#2)(2011-2#1)
the concentration of glucose##2##4##(2008-10#1)(2008-11#1)
the concentration of hormones##2##4##(1997-4#1)(2008-8#1)
the concentration of hydrogen##2##4##(2008-10#2)
the concentration of iron##2##4##(2008-10#2)
the concentration of ligand##2##4##(2008-10#2)
the concentration of metal##2##4##(2008-10#2)
the concentration of methanol in##2##5##(1996-5#2)
the concentration of nitrite##2##4##(2008-10#2)
the concentration of nucleic acids##4##5##(2008-10#4)
the concentration of orthophosphate##2##4##(2008-10#2)
the concentration of oxygen##2##4##(2008-10#2)
the concentration of poverty##2##4##(1992-1#1)(2008-1#1)
the concentration of proteins##3##4##(2008-10#2)(2008-4#1)
the concentration of surface##2##4##(2008-10#1)(2008-5#1)
the concentration of the free##2##5##(2008-10#2)
the concentration of the sulfate ion##2##6##(2008-10#2)
the concentration of the surfactant##2##5##(2008-10#1)(2008-7#1)
the concentration of the##50##4##(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#28)(2008-12#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
the concentration of these molecules##2##5##(1994-8#1)(2008-5#1)
the concentration of these##4##4##(1994-8#1)(2007-12#1)(2008-5#1)(2009-4#1)
the concentration of urea##3##4##(2008-10#2)(2008-4#1)
the concentration of vanadium##4##4##(1990-5#1)(2008-10#3)
the concentration of which##2##4##(2008-10#2)
the concentration of##388##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#5)(1997-2#1)(1997-4#3)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#213)(2008-11#8)(2008-12#6)(2008-2#9)(2008-3#10)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#8)(2009-11#3)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-3#4)(2010-4#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#5)
the concentration range 0##24##4##(1996-5#1)(2008-10#23)
the concentration range 1##7##4##(2008-10#7)
the concentration range 10(-6)-10(-3)##2##4##(2008-10#2)
the concentration range 2##3##4##(2008-10#3)
the concentration range 5##4##4##(2008-10#4)
the concentration range between##5##4##(1992-3#1)(2008-10#4)
the concentration range from 0##2##5##(2008-10#2)
the concentration range from 5##6##5##(2008-10#6)
the concentration range from 50 to##3##6##(2008-10#3)
the concentration range from##24##4##(2008-10#24)
the concentration range of 0##29##5##(1990-12#1)(2008-10#26)(2011-1#1)(2011-3#1)
the concentration range of 1##6##5##(1995-11#1)(2008-10#5)
the concentration range of 1x10(-6) to 1x10(-5)M##2##7##(2008-10#2)
the concentration range of 3##2##5##(2008-10#1)(2008-12#1)
the concentration range of 5##3##5##(2008-10#3)
the concentration range of##73##4##(1990-12#1)(1995-11#1)(2008-10#67)(2008-12#1)(2010-5#1)(2011-1#1)(2011-3#1)
the concentration range studied##3##4##(1991-5#1)(2008-10#2)
the concentration range##193##3##(1990-12#1)(1991-5#1)(1992-3#1)(1995-11#1)(1996-5#3)(2008-10#182)(2008-12#1)(2010-5#1)(2011-1#1)(2011-3#1)
the concentration ranges of##7##4##(2008-10#7)
the concentration ranges##13##3##(2008-10#13)
the concentration ratio of##3##4##(2008-10#2)(2011-1#1)
the concentration ratio##4##3##(2008-10#3)(2011-1#1)
the concentration required##2##3##(1990-5#1)(1997-5#1)
the concentration sensitivity##2##3##(2008-10#1)(2010-7#1)
the concentration was##5##3##(1996-12#1)(2008-10#3)(2011-2#1)
the concentration##691##2##(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-2#1)(1991-5#3)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#6)(1996-2#1)(1996-5#8)(1997-2#2)(1997-4#3)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#4)(2008-10#467)(2008-11#9)(2008-12#8)(2008-2#11)(2008-3#16)(2008-4#7)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#8)(2009-11#3)(2009-12#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#5)
the concentration-dependent##2##2##(1993-8#1)(2008-2#1)
the concentration-response curve##2##3##(1990-12#1)(1992-8#1)
the concentration-response##3##2##(1990-12#1)(1992-8#1)(2008-10#1)
the concentration-time##4##2##(2008-10#2)(2008-7#1)(2011-1#1)
the concentrations and##2##3##(1996-12#1)(2010-3#1)
the concentrations found##2##3##(2008-10#2)
the concentrations in##2##3##(1992-11#1)(2008-10#1)
the concentrations of all chemokines##2##5##(2012-1#2)
the concentrations of all##3##4##(2008-10#1)(2012-1#2)
the concentrations of extracellular##2##4##(2008-11#1)(2013-8#1)
the concentrations of the analytes##2##5##(2008-10#2)
the concentrations of the##13##4##(1990-6#1)(1990-8#1)(1996-5#1)(2008-1#1)(2008-10#9)
the concentrations of these##2##4##(2008-10#2)
the concentrations of##82##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-9#1)(1993-1#1)(1993-12#3)(1994-11#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-10#42)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#6)(2012-2#1)(2013-1#1)(2013-8#1)
the concentrations ranged##2##3##(2008-10#2)
the concentrations tested##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
the concentrations used##2##3##(2008-10#1)(2008-11#1)
the concentrations##111##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-10#60)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#6)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the concentrator##3##2##(2008-3#3)
the concept and##4##3##(1993-2#1)(1994-2#1)(2009-12#1)(2009-5#1)
the concept is##2##3##(2008-3#1)(2008-9#1)
the concept of &quot##7##4##(1991-12#1)(1997-1#1)(2007-12#1)(2009-10#1)(2012-12#2)(2012-3#1)
the concept of HC-transcomplementation##2##4##(2008-10#2)
the concept of a##12##4##(1990-3#1)(1991-1#1)(1992-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-5#1)(2012-2#1)
the concept of acute##2##4##(1996-9#2)
the concept of an##3##4##(1994-11#1)(1997-8#1)(2008-3#1)
the concept of differential optical##2##5##(2008-2#2)
the concept of disease##3##4##(1993-12#1)(1997-6#1)(1997-7#1)
the concept of impulsivity##2##4##(2013-7#2)
the concept of nursing##2##4##(2009-12#1)(2010-3#1)
the concept of stewardship in health##2##6##(2012-2#2)
the concept of the##10##4##(1990-6#1)(1991-9#1)(1992-12#1)(1997-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-12#1)(2012-12#1)
the concept of##150##3##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#5)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#5)(2009-10#3)(2009-12#1)(2009-5#3)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#3)
the concept that some##2##4##(2008-10#1)(2012-2#1)
the concept that the##6##4##(1992-3#1)(1994-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
the concept that##28##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#5)(2009-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
the concept##207##2##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#3)(1997-1#3)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#6)(2008-2#9)(2008-3#21)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#7)(2009-1#1)(2009-10#4)(2009-12#2)(2009-5#4)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#6)(2013-1#9)(2013-7#3)(2013-8#1)
the conception rate##2##3##(2013-1#2)
the concepts of wave propagation through##2##6##(2007-12#2)
the concepts of##16##3##(1993-6#1)(1994-12#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
the concepts##24##2##(1992-1#1)(1993-6#1)(1994-12#1)(1995-1#2)(1996-1#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
the conceptual framework##7##3##(1994-12#1)(1997-2#2)(1997-3#1)(2008-7#1)(2010-3#1)(2013-1#1)
the conceptual##22##2##(1991-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-4#1)(1997-2#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-3#1)(2010-8#2)(2013-1#1)(2013-8#2)
the conceptualization##2##2##(1995-1#1)(2009-9#1)
the concern##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)
the concerned##2##2##(2008-11#1)(2008-7#1)
the concerns of##3##3##(1993-12#1)(1996-5#1)(2008-1#1)
the concerns##8##2##(1993-12#1)(1994-1#1)(1994-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#2)
the concerted action of##3##4##(1991-5#1)(1995-6#1)(2009-5#1)
the concerted##5##2##(1991-5#1)(1991-9#1)(1995-6#1)(2009-5#1)(2013-8#1)
the conclusion drawn##2##3##(2008-10#1)(2008-3#1)
the conclusion of a##3##4##(1992-3#1)(1994-1#1)(1994-11#1)
the conclusion of the study##2##5##(2008-11#1)(2013-8#1)
the conclusion of the##6##4##(1997-4#2)(2008-11#2)(2008-3#1)(2013-8#1)
the conclusion of##14##3##(1990-3#1)(1991-3#1)(1992-3#2)(1994-1#1)(1994-11#1)(1997-4#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2013-8#1)
the conclusion that the##16##4##(1990-7#1)(1992-2#1)(1992-6#1)(1992-9#1)(1996-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)
the conclusion that these##2##4##(1990-12#1)(2008-3#1)
the conclusion that##47##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-7#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#4)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the conclusion##65##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-4#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#4)(2009-4#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the conclusions drawn from##3##4##(2008-2#1)(2010-7#1)(2011-2#1)
the conclusions of the##3##4##(1993-12#1)(2008-3#1)(2013-1#1)
the conclusions of##5##3##(1993-12#2)(2008-3#1)(2012-3#1)(2013-1#1)
the conclusions were##2##3##(1993-6#1)(2012-3#1)
the conclusions##18##2##(1991-12#1)(1993-12#2)(1993-6#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
the conclusive identification of##2##4##(1993-2#1)(2010-6#1)
the conclusive##3##2##(1993-2#1)(2007-11#1)(2010-6#1)
the concomitant use of##3##4##(2008-10#1)(2011-2#2)
the concomitant##19##2##(1990-8#1)(1992-3#1)(1994-6#1)(1995-6#1)(1996-2#2)(1997-2#1)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
the concordance between##4##3##(1991-2#1)(1992-3#1)(2007-8#1)(2008-8#1)
the concordance##9##2##(1991-2#1)(1992-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-8#1)
the concurrent processing##2##3##(2007-11#1)(2013-8#1)
the concurrent##14##2##(1990-8#1)(1992-5#1)(1993-5#2)(1994-11#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
the condensation of the amino##2##5##(1992-3#1)(2011-1#1)
the condensation of##5##3##(1992-3#1)(2008-10#2)(2011-1#2)
the condensation product##2##3##(2008-10#2)
the condensation reaction between##2##4##(2008-10#1)(2008-8#1)
the condensation reaction##3##3##(2008-10#2)(2008-8#1)
the condensation##11##2##(1992-3#1)(2008-10#6)(2008-8#1)(2010-12#1)(2011-1#2)
the condensed##4##2##(2008-10#4)
the condition and##3##3##(1992-5#1)(1996-6#1)(2013-1#1)
the condition can##2##3##(1996-11#1)(2007-8#1)
the condition in##2##3##(2007-10#1)(2009-5#1)
the condition is##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
the condition of the##7##4##(1990-6#2)(1991-3#1)(2007-12#2)(2008-6#1)(2010-8#1)
the condition of##22##3##(1990-6#2)(1991-3#1)(1992-8#1)(1994-7#1)(1996-6#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-6#1)(2008-9#1)(2010-8#1)(2013-8#1)
the condition that##2##3##(2008-1#1)(2008-10#1)
the condition##76##2##(1990-3#2)(1990-6#2)(1990-9#1)(1991-3#1)(1992-5#1)(1992-8#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-11#4)(1996-6#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-3#5)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
the conditional formation##2##3##(2008-10#2)
the conditional##12##2##(1992-6#1)(1993-8#1)(1995-9#1)(1996-4#1)(2008-10#6)(2008-5#1)(2010-7#1)
the conditioned emotional response##2##4##(1993-5#1)(2008-4#1)
the conditioned medium##5##3##(1990-2#1)(1993-12#1)(1997-1#1)(2008-11#2)
the conditioned stimulus##2##3##(1995-12#1)(1997-7#1)
the conditioned suppression##2##3##(1993-5#2)
the conditioned##14##2##(1990-2#1)(1993-12#1)(1993-5#3)(1993-9#1)(1995-12#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#1)
the conditioning effects of##3##4##(2008-5#3)
the conditioning##8##2##(2008-10#3)(2008-11#1)(2008-5#4)
the conditions and##2##3##(2008-10#1)(2008-11#1)
the conditions are##3##3##(1997-4#1)(2010-3#1)(2011-2#1)
the conditions employed##5##3##(1994-9#1)(2008-10#4)
the conditions for the##8##4##(2008-10#6)(2008-3#1)(2008-9#1)
the conditions for##36##3##(1990-11#1)(1994-12#1)(1995-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-8#5)(2008-9#4)(2012-2#1)
the conditions in##4##3##(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
the conditions of the present##2##5##(1992-8#1)(2008-10#1)
the conditions of the##6##4##(1990-8#1)(1992-8#2)(2008-10#1)(2008-5#1)(2009-7#1)
the conditions of this##7##4##(1990-6#1)(2008-10#1)(2008-8#1)(2008-9#3)(2013-1#1)
the conditions of##45##3##(1990-6#1)(1990-8#1)(1992-8#2)(1995-3#1)(1996-2#1)(1997-4#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-7#1)(2010-7#2)(2011-1#1)(2012-3#1)(2013-1#4)
the conditions studied##2##3##(1994-9#1)(2008-7#1)
the conditions that##3##3##(1991-5#1)(1996-8#1)(2013-1#1)
the conditions under which the##2##5##(2008-2#1)(2012-2#1)
the conditions under which##12##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#2)(2012-2#1)
the conditions used##4##3##(1991-2#1)(1996-2#1)(1997-1#1)(2008-10#1)
the conditions when##2##3##(2008-11#1)(2008-2#1)
the conditions which##2##3##(2008-11#1)(2010-3#1)
the conditions##130##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-8#2)(1993-6#1)(1994-12#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-4#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#35)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#12)(2009-12#1)(2009-7#1)(2010-3#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)
the condom is##2##3##(1990-6#2)
the condom##5##2##(1990-6#3)(2008-10#2)
the conduciveness of the environment##2##5##(2008-10#2)
the conduciveness of##3##3##(2008-10#3)
the conduct and##2##3##(2008-10#1)(2010-5#1)
the conduct of human##2##4##(2008-9#1)(2009-4#1)
the conduct of##8##3##(1992-2#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-10#1)
the conduct##12##2##(1992-1#1)(1992-2#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-5#1)
the conductance of##5##3##(2008-7#2)(2009-11#1)(2009-8#1)(2013-1#1)
the conductance##8##2##(1995-11#1)(1995-5#1)(2008-7#3)(2009-11#1)(2009-8#1)(2013-1#1)
the conducting airways##4##3##(1991-12#2)(2013-1#2)
the conducting##8##2##(1991-12#2)(2008-10#2)(2008-11#1)(2013-1#3)
the conduction mechanism##2##3##(1991-3#1)(2009-11#1)
the conduction##4##2##(1991-3#1)(2007-11#1)(2008-7#1)(2009-11#1)
the conductive##2##2##(2008-2#1)(2013-8#1)
the conductivity of the##3##4##(2008-10#2)(2013-1#1)
the conductivity##11##2##(1996-4#1)(2008-10#6)(2009-11#1)(2009-8#1)(2010-4#1)(2013-1#1)
the conductor##2##2##(2008-10#2)
the conduit##2##2##(2007-7#1)(2007-8#1)
the conduits of##3##3##(2008-10#3)
the cone##4##2##(1991-1#1)(2008-3#1)(2011-1#1)(2013-1#1)
the cones##2##2##(2007-5#1)(2008-12#1)
the conference##14##2##(1993-12#1)(1994-3#2)(1996-6#1)(2007-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)
the confidence interval##4##3##(1994-2#1)(2008-10#3)
the confidence of the##2##4##(1994-3#1)(2008-11#1)
the confidence of##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
the confidence that##2##3##(2008-10#1)(2008-5#1)
the confidence##14##2##(1994-2#1)(1994-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
the confidentiality of##4##3##(1991-12#1)(1991-3#1)(1997-5#1)(2008-7#1)
the configural##2##2##(2008-11#1)(2012-12#1)
the configuration of the##3##4##(1992-8#1)(1995-3#1)(2008-11#1)
the configuration of##10##3##(1992-8#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-6#1)(2012-2#1)
the configuration##21##2##(1992-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#1)(2009-6#1)(2009-9#1)(2012-2#1)
the configurations##2##2##(1996-1#1)(2008-5#1)
the confined water##2##3##(2008-10#2)
the confined##3##2##(2007-11#1)(2008-10#2)
the confines of the##3##4##(2008-10#2)(2011-2#1)
the confines of##5##3##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
the confirmation##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
the conflict##9##2##(1992-9#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)
the conflicting##5##2##(1995-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
the conflicts##5##2##(1995-12#1)(1996-7#2)(2008-8#1)(2012-2#1)
the confluence of##2##3##(1996-1#1)(2008-7#1)
the confluence##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
the confocal##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
the conformation and##4##3##(2008-3#1)(2008-8#1)(2009-3#2)
the conformation of the peptide##2##5##(1995-6#1)(2008-8#1)
the conformation of the protein##2##5##(1993-3#1)(2008-7#1)
the conformation of the##17##4##(1992-4#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2012-12#1)(2012-2#1)
the conformation of these##2##4##(1991-12#1)(1993-11#1)
the conformation of##32##3##(1990-7#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-9#1)(2012-12#1)(2012-2#2)
the conformation##40##2##(1990-7#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#2)(2009-9#1)(2012-12#1)(2012-2#2)
the conformational change of##4##4##(1997-7#1)(2008-11#1)(2009-3#2)
the conformational change##8##3##(1995-6#2)(1997-7#1)(2008-11#1)(2008-8#1)(2009-3#2)(2009-5#1)
the conformational changes of immobilized##2##5##(2008-10#2)
the conformational changes of the##2##5##(2008-9#1)(2009-3#1)
the conformational changes of##5##4##(1993-8#1)(2008-10#2)(2008-9#1)(2009-3#1)
the conformational changes##7##3##(1992-6#1)(1992-8#1)(1993-8#1)(2008-10#2)(2008-9#1)(2009-3#1)
the conformational properties of the##2##5##(1992-6#1)(1993-8#1)
the conformational##27##2##(1990-7#1)(1991-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-8#2)(1995-6#2)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#3)(2009-5#1)
the conformationally##3##2##(1994-11#1)(1997-4#1)(2008-5#1)
the conformations of##3##3##(1993-3#2)(2008-8#1)
the confounding factors that##2##4##(2008-7#1)(2013-1#1)
the confounding factors##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
the confounding##6##2##(1995-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#1)
the confusion##2##2##(1991-12#1)(2008-1#1)
the congenital##4##2##(2007-11#1)(2009-3#3)
the congress##2##2##(2008-5#1)(2008-8#1)
the congruence angle##3##3##(2007-8#3)
the congruence##6##2##(1996-1#1)(2007-8#3)(2010-12#1)(2010-6#1)
the congruity of the joint##2##5##(2007-8#2)
the conical##3##2##(1993-5#1)(2007-10#1)(2008-2#1)
the conically sculpted##3##3##(1995-2#3)
the conidia germinated##2##3##(2008-10#2)
the conidia germination##2##3##(2008-10#2)
the conidia were##3##3##(2008-10#3)
the conidia##10##2##(2008-10#10)
the conidial##4##2##(2008-10#4)
the conjugate beam##3##3##(2007-12#2)(2008-2#1)
the conjugate image and the zero-order image##2##7##(2008-3#2)
the conjugate image##3##3##(2008-3#3)
the conjugate was##2##3##(2008-10#1)(2008-11#1)
the conjugate##19##2##(1994-11#1)(2007-10#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-11#1)(2010-6#1)(2013-8#1)
the conjugate-gradient method##2##3##(2008-2#1)(2008-3#1)
the conjugated##5##2##(1991-5#2)(1992-3#1)(1995-3#1)(2008-10#1)
the conjugation of##3##3##(2008-4#1)(2009-9#2)
the conjugation##4##2##(2008-11#1)(2008-4#1)(2009-9#2)
the conjugative##2##2##(1991-7#1)(2008-10#1)
the conjunction of##2##3##(1990-10#1)(2008-10#1)
the conjunctiva##4##2##(2008-2#1)(2011-1#3)
the conjunctival##3##2##(2008-11#2)(2012-3#1)
the connecting peptide##4##3##(2008-9#4)
the connecting##5##2##(2008-3#1)(2008-9#4)
the connection between the##2##4##(2007-12#1)(2008-3#1)
the connection between these##2##4##(2007-12#1)(2008-4#1)
the connection between##8##3##(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#2)(2013-1#1)
the connection of##4##3##(2008-11#1)(2008-3#3)
the connection strengths##2##3##(2008-3#2)
the connection##17##2##(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2012-2#2)(2013-1#2)
the connections between##2##3##(2008-11#1)(2012-5#1)
the connections##4##2##(1991-6#1)(2008-11#2)(2012-5#1)
the connective tissue##10##3##(1990-2#1)(2007-8#1)(2008-5#3)(2012-12#1)(2012-2#1)(2013-1#3)
the connective tissues##2##3##(1990-2#2)
the connective##12##2##(1990-2#3)(2007-8#1)(2008-5#3)(2012-12#1)(2012-2#1)(2013-1#3)
the connectivity##6##2##(2007-11#3)(2008-11#1)(2008-3#1)(2008-7#1)
the conscious rat##3##3##(1991-1#1)(1995-12#1)(2008-11#1)
the conscious##6##2##(1991-1#1)(1995-1#1)(1995-12#1)(2008-11#1)(2010-4#2)
the consecutive##5##2##(2008-10#2)(2008-4#1)(2009-5#1)(2009-9#1)
the consensus sequence of##3##4##(1992-8#1)(1996-6#1)(1997-4#1)
the consensus sequence##8##3##(1992-8#1)(1993-6#1)(1993-8#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2009-6#1)
the consensus statements##2##3##(2011-2#2)
the consensus##29##2##(1990-5#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-6#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-3#1)
the consent for donation##2##4##(2011-2#2)
the consent process##5##3##(2008-8#5)
the consent##12##2##(1991-3#1)(1992-12#1)(2008-8#5)(2009-4#2)(2010-11#1)(2011-2#2)
the consequence of a weak##2##5##(1992-8#1)(2008-10#1)
the consequence of a##3##4##(1992-8#1)(2008-10#2)
the consequence of the presence of##2##6##(1990-8#1)(1994-2#1)
the consequence of the##5##4##(1990-8#1)(1994-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
the consequence of##25##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-8#1)(1994-2#1)(1995-12#2)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
the consequence##29##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-8#1)(1994-2#1)(1995-12#2)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#3)
the consequences and##2##3##(2007-11#1)(2011-2#1)
the consequences for##4##3##(2008-6#1)(2008-8#2)(2012-2#1)
the consequences of stroke##2##4##(2008-2#1)(2013-1#1)
the consequences of the##6##4##(1993-3#1)(2008-10#1)(2008-2#1)(2010-10#1)(2011-1#1)(2012-12#1)
the consequences of their##3##4##(2008-11#1)(2010-1#1)(2011-2#1)
the consequences of these##2##4##(1992-3#1)(1994-2#1)
the consequences of this##3##4##(2008-8#1)(2008-9#1)(2013-8#1)
the consequences of##67##3##(1990-2#1)(1992-1#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
the consequences##82##2##(1990-2#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the consequent loss##2##3##(1992-9#1)(2008-3#1)
the consequent##10##2##(1992-12#1)(1992-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-12#1)(2013-1#1)
the consequential##2##2##(2008-3#1)(2013-1#1)
the conservation of the##3##4##(1991-6#1)(2008-3#1)(2008-8#1)
the conservation of##12##3##(1991-6#1)(1993-8#1)(1994-2#1)(1996-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2013-1#1)(2013-7#1)
the conservation state of##3##4##(2008-10#3)
the conservation##18##2##(1991-6#1)(1993-8#1)(1994-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2013-1#2)(2013-7#2)
the conservative treatment##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
the conservative##15##2##(1993-8#2)(1993-9#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-7#1)(2013-1#2)
the conserved C-terminal##3##3##(1993-8#2)(1997-2#1)
the conserved amino acid##2##4##(1992-3#1)(1997-7#1)
the conserved breast##3##3##(1990-12#3)
the conserved motifs##2##3##(2008-10#2)
the conserved region##4##3##(1992-11#1)(1992-6#1)(1996-12#1)(2008-8#1)
the conserved regions##3##3##(1991-9#1)(1995-5#1)(1997-4#1)
the conserved sequence##3##3##(1993-3#1)(1995-6#1)(2008-10#1)
the conserved sequences of##2##4##(1997-4#1)(2013-8#1)
the conserved sequences##3##3##(1995-8#1)(1997-4#1)(2013-8#1)
the conserved##48##2##(1990-12#3)(1990-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-9#1)(2007-12#2)(2008-10#8)(2008-6#1)(2008-8#2)(2009-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
the considerable difference##2##3##(2008-10#2)
the considerable##10##2##(1990-11#1)(1995-1#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)
the consideration of##6##3##(1993-2#1)(1995-6#1)(1996-1#1)(2008-7#1)(2009-9#1)(2011-2#1)
the consideration##8##2##(1993-2#1)(1995-1#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
the considerations##2##2##(2008-11#1)(2008-12#1)
the considered##13##2##(1992-2#2)(1994-3#1)(2007-10#1)(2008-10#6)(2008-3#2)(2013-8#1)
the consistency and##2##3##(2008-10#2)
the consistency of##3##3##(1997-6#1)(2008-11#2)
the consistency##8##2##(1997-6#1)(2008-10#2)(2008-11#3)(2008-3#1)(2011-2#1)
the consolidation of##2##3##(2009-7#1)(2013-8#1)
the consolidation##3##2##(1994-3#1)(2009-7#1)(2013-8#1)
the consonant##2##2##(2007-7#1)(2009-12#1)
the consortium##4##2##(1996-1#1)(2008-7#1)(2010-5#2)
the conspecific##3##2##(2009-5#1)(2009-9#1)(2013-8#1)
the conspicuous##2##2##(1997-4#1)(2008-7#1)
the constant comparative method##2##4##(2008-11#1)(2008-12#1)
the constant component of the##2##5##(2008-3#2)
the constant current##2##3##(2008-10#2)
the constant ratio method##3##4##(2008-10#3)
the constant##25##2##(1990-11#1)(1990-5#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-4#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#2)
the constants for##2##3##(2008-10#2)
the constants##8##2##(2008-10#5)(2008-3#1)(2008-7#1)(2011-2#1)
the constituent equilibrium constants##3##4##(2008-10#3)
the constituent##11##2##(1991-11#1)(1994-8#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-7#1)(2012-2#1)
the constituents of the##4##4##(2008-10#1)(2009-4#1)(2009-8#1)(2012-2#1)
the constituents##11##2##(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#5)(2009-8#1)(2011-3#1)(2012-2#1)
the constitution of##3##3##(2008-11#1)(2009-5#2)
the constitution##4##2##(2008-11#1)(2009-5#2)(2009-7#1)
the constitutional##7##2##(1995-10#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-5#1)(1997-6#1)(2011-2#1)
the constitutive activation of the##2##5##(2012-12#1)(2013-1#1)
the constitutive activation of##3##4##(2012-12#2)(2013-1#1)
the constitutive expression and##2##4##(1994-6#1)(2009-3#1)
the constitutive expression##3##3##(1994-6#1)(1997-8#1)(2009-3#1)
the constitutive form of##2##4##(1992-12#1)(2008-4#1)
the constitutive law##3##3##(1996-4#3)
the constitutive pathway##2##3##(1992-12#1)(1994-11#1)
the constitutive##26##2##(1991-9#1)(1992-12#3)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-4#4)(1996-5#1)(1997-8#1)(2008-11#1)(2008-4#2)(2009-3#1)(2012-1#1)(2012-12#2)(2013-1#3)
the constrained##3##2##(1994-12#1)(2008-10#1)(2009-8#1)
the constraint of##4##3##(1993-1#1)(1994-9#1)(2008-1#1)(2008-8#1)
the constraint##7##2##(1993-1#1)(1994-9#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-5#1)(2012-3#1)
the constraints and##2##3##(2008-3#1)(2008-7#1)
the constraints imposed by##3##4##(2008-3#2)(2008-9#1)
the constraints of##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
the constraints##15##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-1#1)(2012-2#1)
the construct is##2##3##(2008-12#1)(2008-5#1)
the construct validity of eye-tracking assessments of RJA##2##8##(2013-1#2)
the construct validity of the##2##5##(2007-12#2)
the construct validity of##5##4##(2007-12#2)(2013-1#3)
the construct##12##2##(1997-6#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#4)
the constructed##6##2##(1990-11#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-3#1)
the construction and application of##2##5##(2008-10#1)(2008-2#1)
the construction and performance##2##4##(2008-10#1)(2008-2#1)
the construction and testing of##2##5##(2011-1#1)(2011-2#1)
the construction and##15##3##(1990-8#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-1#1)(2008-10#3)(2008-2#2)(2008-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
the construction of a critical##2##5##(1990-12#1)(2008-11#1)
the construction of a##24##4##(1990-12#1)(1990-8#1)(1991-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
the construction of an##2##4##(1997-4#1)(2013-8#1)
the construction of calibration##2##4##(2008-10#2)
the construction of expression##2##4##(1993-2#1)(2008-8#1)
the construction of large##2##4##(1991-12#1)(1994-12#1)
the construction of the##11##4##(1992-6#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
the construction of##95##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#4)(1995-2#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
the construction##112##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-5#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#4)(1995-2#3)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#6)(2008-5#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
the constructor##2##2##(2007-11#1)(2008-9#1)
the constructs##5##2##(1996-5#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
the consultant##3##2##(1990-2#1)(1996-2#1)(2012-3#1)
the consultation##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
the consulting##2##2##(1993-12#2)
the consumed##3##2##(2008-10#2)(2011-2#1)
the consumer or##2##3##(2008-5#1)(2011-2#1)
the consumer##19##2##(1992-1#1)(1992-12#1)(1994-2#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-8#4)(2008-9#2)(2011-2#1)
the consumer's##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
the consumers##3##2##(2008-8#1)(2010-4#1)(2010-8#1)
the consummatory##2##2##(1990-7#1)(1993-12#1)
the consumption of an##2##4##(1990-6#1)(1996-2#1)
the consumption of food##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
the consumption of vegetables##2##4##(2008-10#1)(2012-2#1)
the consumption of##35##3##(1990-6#1)(1990-8#1)(1992-8#2)(1993-2#1)(1994-2#1)(1994-5#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#2)
the consumption##39##2##(1990-6#1)(1990-8#1)(1992-8#2)(1993-2#1)(1994-2#1)(1994-5#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#2)(2010-8#3)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#2)(2013-7#2)
the contact angle##2##3##(2009-11#1)(2009-7#1)
the contact area##2##3##(2013-1#2)
the contact of the##2##4##(2008-10#1)(2008-7#1)
the contact of##4##3##(1991-5#1)(2008-10#2)(2008-7#1)
the contact time##2##3##(2008-10#2)
the contact with the##2##4##(2007-8#1)(2008-5#1)
the contact with##3##3##(1991-2#1)(2007-8#1)(2008-5#1)
the contact##31##2##(1991-2#1)(1991-5#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#2)(2009-7#1)(2011-2#1)(2012-4#1)(2013-1#2)
the contacts between##2##3##(1994-5#1)(2008-7#1)
the contacts##3##2##(1994-5#1)(2008-7#1)(2010-5#1)
the contaminant##2##2##(2008-3#2)
the contaminants##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
the contaminated##3##2##(2008-10#2)(2012-3#1)
the contamination of##9##3##(1991-11#1)(1994-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
the contamination risk##2##3##(2008-10#1)(2012-2#1)
the contamination source##2##3##(2008-10#2)
the contamination##16##2##(1991-11#1)(1992-3#1)(1994-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2012-2#1)
the contemporary literature##3##3##(2007-12#1)(2011-2#2)
the contemporary##16##2##(1990-11#1)(1994-12#1)(1996-1#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
the content and structure of##2##5##(2009-12#1)(2012-12#1)
the content and##7##3##(1990-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#2)(2012-12#1)
the content of both##2##4##(1993-12#1)(1995-5#1)
the content of free##2##4##(2012-2#1)(2013-7#1)
the content of phosphorus##2##4##(2008-10#2)
the content of the##10##4##(1994-12#1)(1994-7#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-6#1)(2011-3#1)(2012-1#1)
the content of these##2##4##(2008-7#1)(2013-8#1)
the content of##64##3##(1991-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-1#1)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
the content validity of##2##4##(2007-8#1)(2010-9#1)
the content validity##3##3##(2007-8#1)(2010-9#1)(2011-1#1)
the content word##2##3##(2008-2#2)
the content##83##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(2007-8#1)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#4)
the contention that the##3##4##(1994-3#1)(1996-12#1)(1997-6#1)
the contention that##10##3##(1994-3#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)
the contents of the##3##4##(1992-11#1)(1995-5#1)(2011-2#1)
the contents of##14##3##(1990-2#1)(1991-2#1)(1992-11#1)(1993-6#1)(1995-5#1)(2008-10#5)(2008-12#1)(2011-1#1)(2011-2#2)
the contents##19##2##(1990-2#1)(1991-2#1)(1992-11#1)(1993-6#1)(1994-12#1)(1995-5#1)(2008-10#6)(2008-12#2)(2008-8#1)(2011-1#1)(2011-2#2)(2011-3#1)
the contest##4##2##(1995-12#1)(2009-10#1)(2012-3#2)
the context in which##2##4##(2008-1#1)(2009-6#1)
the context of a##30##4##(1993-12#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#2)(1997-4#1)(2007-12#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
the context of an##7##4##(1992-1#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
the context of current##3##4##(2008-11#1)(2008-7#1)(2011-1#1)
the context of family and##2##5##(2007-2#1)(2010-8#1)
the context of family##4##4##(2007-2#1)(2008-9#1)(2010-8#1)(2012-3#1)
the context of health##2##4##(2008-7#1)(2009-6#1)
the context of its##2##4##(2008-7#1)(2013-8#1)
the context of the current##2##5##(1994-1#1)(2008-3#1)
the context of the##50##4##(1991-3#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
the context of their##3##4##(2007-11#1)(2010-10#1)(2012-2#1)
the context of##262##3##(1990-11#1)(1990-7#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#3)(1996-3#4)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#17)(2008-12#4)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#9)(2008-7#12)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#6)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#13)(2011-7#1)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#7)(2012-8#1)(2013-1#3)(2013-8#6)
the context##274##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#3)(1996-3#4)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#3)(2007-11#5)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#18)(2008-12#6)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#9)(2008-7#12)(2008-8#11)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#6)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#13)(2011-7#1)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#7)(2012-8#1)(2013-1#3)(2013-8#6)
the contexts in which##2##4##(2009-5#1)(2013-1#1)
the contexts##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
the contextual##4##2##(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
the continent##8##2##(1990-6#1)(1996-4#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-8#1)
the continental##5##2##(1995-6#1)(2008-10#2)(2010-8#2)
the continual reassessment method##2##4##(1994-9#2)
the continual##4##2##(1994-9#2)(2009-6#1)(2010-11#1)
the continuation of##6##3##(1996-2#1)(1997-7#1)(2008-4#1)(2011-1#1)(2011-2#2)
the continuation##8##2##(1996-2#1)(1997-7#1)(2008-4#1)(2010-8#2)(2011-1#1)(2011-2#2)
the continued##16##2##(1991-12#1)(1991-8#1)(1993-12#3)(1995-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
the continuing education of##2##4##(1994-12#1)(1997-8#1)
the continuing education##3##3##(1992-3#1)(1994-12#1)(1997-8#1)
the continuing##9##2##(1992-3#1)(1993-3#1)(1994-12#2)(1994-2#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
the continuity and##2##3##(2008-11#1)(2008-7#1)
the continuity of care##2##4##(1993-1#1)(1994-3#1)
the continuity of##8##3##(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-9#1)(2012-12#1)(2012-2#1)
the continuity##10##2##(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
the continuous ER morphology##2##4##(2009-8#2)
the continuous culture of##2##4##(2008-11#1)(2008-7#1)
the continuous culture##3##3##(2008-11#2)(2008-7#1)
the continuous extraction##3##3##(2008-10#3)
the continuous spectrum##2##3##(2008-3#1)(2013-8#1)
the continuous wave##2##3##(2008-2#1)(2011-1#1)
the continuous wavelet transform##2##4##(2008-2#1)(2008-3#1)
the continuous##82##2##(1991-3#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#25)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#3)(2009-11#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
the continuous-time##2##2##(2008-2#1)(2008-8#1)
the continuous-wave##2##2##(2007-11#1)(2008-2#1)
the continuum of care##11##4##(1991-1#1)(1992-12#1)(1994-12#3)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#3)
the continuum of##13##3##(1991-1#1)(1992-12#1)(1994-12#3)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#4)(2008-11#1)
the continuum##23##2##(1991-1#1)(1992-12#1)(1994-12#3)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#4)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2012-2#1)
the contour group##2##3##(1991-2#2)
the contour##7##2##(1991-2#3)(2007-11#1)(2008-10#1)(2008-3#2)
the contraceptive##4##2##(1994-8#1)(1996-11#1)(2008-10#1)(2008-11#1)
the contract##7##2##(1992-2#1)(1993-12#2)(1994-2#1)(1996-12#1)(2007-4#1)(2008-11#1)
the contractile action of##2##4##(1990-8#1)(1997-4#1)
the contractile effect of##4##4##(1990-12#1)(1994-11#2)(1995-12#1)
the contractile properties of##2##4##(2008-3#1)(2013-7#1)
the contractile response##3##3##(1990-5#1)(2008-2#2)
the contractile##17##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#1)(1994-11#2)(1995-12#1)(1997-4#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-6#1)(2013-7#1)
the contracting##3##2##(1994-1#1)(1994-12#1)(2007-4#1)
the contraction of##2##3##(1994-11#1)(2008-12#1)
the contraction##10##2##(1990-8#1)(1994-11#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2013-8#1)
the contractions##4##2##(1995-12#1)(1997-7#1)(2008-3#2)
the contractive##2##2##(2008-2#1)(2011-1#1)
the contradictory##2##2##(1996-6#1)(2008-9#1)
the contralateral SI##2##3##(1995-12#2)
the contralateral auditory##2##3##(1996-5#1)(2008-2#1)
the contralateral breast##3##3##(1990-12#1)(1994-12#1)(2007-10#1)
the contralateral hemisphere##4##3##(1993-12#1)(2007-10#1)(2009-11#1)(2012-1#1)
the contralateral paw##2##3##(1992-10#1)(2008-9#1)
the contralateral side##10##3##(1991-2#1)(1993-12#1)(1995-12#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#2)
the contralateral stimulation was##2##4##(1993-3#2)
the contralateral stimulation##3##3##(1993-3#3)
the contralateral##65##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-12#11)(1993-3#3)(1994-12#1)(1994-2#1)(1995-12#6)(1996-12#1)(1996-5#4)(1996-9#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
the contrary the##2##3##(1991-12#1)(2011-2#1)
the contrary##77##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-2#2)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-8#2)
the contrast agent##3##3##(1993-9#1)(2008-7#2)
the contrast and the##2##4##(2007-11#1)(2008-3#1)
the contrast and##3##3##(2007-11#1)(2008-3#2)
the contrast between##2##3##(2008-6#1)(2008-8#1)
the contrast deterioration##2##3##(2008-3#2)
the contrast in images##2##4##(2007-11#1)(2008-1#1)
the contrast in the##3##4##(2008-3#3)
the contrast in##5##3##(2007-11#1)(2008-1#1)(2008-3#3)
the contrast medium##4##3##(2008-7#4)
the contrast of a##2##4##(2007-11#1)(2008-3#1)
the contrast of the##4##4##(2007-12#1)(2008-3#3)
the contrast of##9##3##(1996-2#1)(2007-11#2)(2007-12#1)(2008-3#4)(2008-5#1)
the contrast parameter##2##3##(2008-6#1)(2011-1#1)
the contrast ratio##2##3##(2008-2#1)(2008-3#1)
the contrast##48##2##(1991-1#1)(1993-9#1)(1996-2#1)(1997-4#2)(2007-11#7)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
the contribution from the##4##4##(2008-2#1)(2008-3#3)
the contribution from##7##3##(1992-5#1)(2008-2#2)(2008-3#4)
the contribution of DNA repair to##2##6##(2008-11#2)
the contribution of DNA##3##4##(1994-3#1)(2008-11#2)
the contribution of Raman scattering to the water-leaving radiance in##2##10##(2008-3#2)
the contribution of Sir Henry Thompson##2##6##(2007-10#2)
the contribution of a##3##4##(2008-10#2)(2008-11#1)
the contribution of astrocytes##2##4##(2008-7#1)(2013-7#1)
the contribution of different##2##4##(2008-10#1)(2008-5#1)
the contribution of disease-induced root##2##5##(2008-10#2)
the contribution of each##4##4##(1992-1#1)(2008-10#1)(2008-5#1)(2010-11#1)
the contribution of genetic##2##4##(1994-2#1)(2008-10#1)
the contribution of teacher##2##4##(2008-12#2)
the contribution of the Responsive Classroom##2##6##(2008-12#2)
the contribution of the different##2##5##(1992-3#1)(2008-8#1)
the contribution of the##20##4##(1990-7#1)(1990-8#1)(1991-5#1)(1992-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)
the contribution of these##2##4##(2008-6#1)(2013-1#1)
the contribution of##109##3##(1990-7#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-10#15)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
the contribution to the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the contribution##126##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-1#2)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#15)(2008-11#10)(2008-12#8)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
the contributions from##2##3##(1992-5#1)(2008-2#1)
the contributions of the##6##4##(1992-6#1)(2008-12#1)(2008-3#3)(2013-1#1)
the contributions of##27##3##(1992-11#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the contributions to##2##3##(1997-2#2)
the contributions##37##2##(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-2#1)(1997-2#2)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#4)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the control and the##5##4##(2007-12#1)(2008-10#1)(2011-3#1)(2012-3#1)(2013-8#1)
the control and##23##3##(1990-3#1)(1991-8#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#1)
the control animals##2##3##(1992-11#1)(1993-12#1)
the control at##2##3##(2008-5#1)(2008-9#1)
the control cell##3##3##(1990-8#1)(2008-11#2)
the control cells##4##3##(2008-1#1)(2008-11#2)(2008-9#1)
the control condition##4##3##(1992-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
the control culture##3##3##(1994-11#1)(2008-11#2)
the control diet containing##2##4##(1993-12#1)(2010-2#1)
the control diet##3##3##(1993-12#1)(2010-2#1)(2012-2#1)
the control dose-response##2##3##(1993-12#2)
the control flies##2##3##(1995-6#2)
the control group (18##2##4##(2008-1#1)(2008-7#1)
the control group (P##3##4##(1994-3#1)(2009-8#1)(2012-3#1)
the control group (P&lt##2##4##(2007-8#1)(2008-3#1)
the control group (n =##2##5##(2010-4#1)(2012-3#1)
the control group (p&lt##6##4##(1994-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
the control group and##7##4##(1991-12#1)(2007-6#1)(2007-9#1)(2008-12#1)(2009-5#2)(2013-1#1)
the control group did not##3##5##(2007-10#1)(2008-3#1)(2013-1#1)
the control group in all##2##5##(2007-11#1)(2008-8#1)
the control group in##5##4##(1997-2#1)(2007-10#1)(2007-11#1)(2008-8#1)(2010-6#1)
the control group of##2##4##(2007-11#1)(2012-3#1)
the control group received##6##4##(2007-11#1)(2008-11#1)(2008-12#2)(2009-12#1)(2009-4#1)
the control group was##4##4##(2007-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
the control group were##2##4##(2009-8#1)(2011-1#1)
the control group with##2##4##(2008-9#1)(2011-1#1)
the control group##215##3##(1990-11#1)(1991-12#2)(1991-4#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-5#2)(1994-8#4)(1995-12#1)(1995-8#1)(1996-12#1)(1996-7#2)(1997-2#2)(1997-4#1)(1997-6#3)(2007-10#11)(2007-11#8)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#13)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#3)(2009-12#5)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-12#2)(2010-2#2)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#15)(2011-2#15)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#5)
the control groups throughout##6##4##(2008-8#2)(2008-9#4)
the control groups##28##3##(1992-8#1)(1993-3#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#15)(2011-2#2)(2012-12#1)
the control level##9##3##(1993-12#1)(1994-12#2)(1996-5#1)(2008-11#1)(2008-6#2)(2012-1#2)
the control light##3##3##(2007-11#1)(2008-3#2)
the control mean##5##3##(1996-7#4)(2012-2#1)
the control method was##2##4##(2013-8#2)
the control of a##7##4##(1991-9#1)(1992-10#1)(1995-12#1)(1995-6#1)(2008-10#2)(2013-8#1)
the control of apoptosis##2##4##(2008-7#1)(2012-2#1)
the control of arterial##2##4##(2009-5#1)(2011-1#1)
the control of cell growth##2##5##(2008-7#1)(2011-2#1)
the control of cell##9##4##(1990-5#1)(1992-12#1)(1993-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#1)
the control of insulin secretion##2##5##(2008-4#1)(2009-12#1)
the control of several##3##4##(1994-10#1)(2008-7#1)(2010-10#1)
the control of soilborne##2##4##(2008-10#2)
the control of spermatogenesis##2##4##(2009-10#1)(2012-2#1)
the control of such##2##4##(1995-8#1)(2010-5#1)
the control of the##46##4##(1991-12#1)(1992-3#1)(1992-8#2)(1993-6#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#3)(2010-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
the control of this disease##2##5##(2008-10#1)(2008-5#1)
the control of this##4##4##(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)
the control of various##3##4##(1994-2#1)(1996-5#1)(2011-1#1)
the control of##231##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#4)(1992-3#4)(1992-8#2)(1993-12#1)(1993-3#2)(1993-6#4)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#4)(1995-8#2)(1996-12#2)(1996-3#1)(1996-5#3)(1997-1#1)(1997-3#2)(1997-4#8)(1997-6#2)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#3)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#34)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-2#6)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#4)
the control one##2##3##(2008-10#1)(2009-6#1)
the control over behaviour by##3##5##(1993-6#3)
the control population##3##3##(1996-12#1)(1997-4#1)(2007-10#1)
the control rats##8##3##(1991-5#1)(1993-11#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-8#1)(2011-1#2)
the control site##6##3##(2007-5#1)(2008-5#1)(2008-7#4)
the control subjects##3##3##(1996-12#1)(2007-10#1)(2011-2#1)
the control system##2##3##(2008-10#1)(2008-3#1)
the control treatment##4##3##(2008-10#3)(2010-9#1)
the control value##3##3##(1992-6#1)(1992-8#1)(1993-1#1)
the control values obtained from##2##5##(1996-5#1)(2013-1#1)
the control values##4##3##(1996-2#1)(1996-5#1)(2011-2#1)(2013-1#1)
the control waveguide##5##3##(2008-3#5)
the control week##2##3##(2008-5#2)
the control with##3##3##(2008-10#1)(2010-4#2)
the control##744##2##(1990-11#5)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#6)(1993-6#8)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#6)(1994-12#10)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#9)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#3)(1996-1#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#6)(1996-7#6)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#10)(1997-5#1)(1997-6#9)(1997-7#3)(2007-10#14)(2007-11#10)(2007-12#5)(2007-2#1)(2007-5#4)(2007-6#4)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#79)(2008-11#33)(2008-12#19)(2008-2#2)(2008-3#18)(2008-4#10)(2008-5#23)(2008-6#7)(2008-7#32)(2008-8#22)(2008-9#33)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#7)(2009-2#1)(2009-4#2)(2009-5#7)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#11)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#22)(2011-2#30)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#23)(2012-3#9)(2012-6#2)(2013-1#17)(2013-7#4)(2013-8#19)
the controlateral untreated uterine tissues##2##5##(1997-6#2)
the controllable##3##2##(1992-2#1)(2007-11#1)(2008-2#1)
the controlled release of##3##4##(1995-11#1)(2008-10#1)(2012-6#1)
the controlled##27##2##(1990-11#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-6#1)
the controller output##3##3##(2008-10#3)
the controller voltage##2##3##(2008-10#2)
the controller##7##2##(2008-10#7)
the controlling##6##2##(1994-3#1)(2007-11#1)(2008-10#3)(2009-5#1)
the controls after##4##3##(2008-7#2)(2008-8#1)(2008-9#1)
the controls and##5##3##(1991-1#1)(1996-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
the controls throughout##3##3##(2008-8#1)(2008-9#2)
the controls were##2##3##(2012-3#1)(2013-8#1)
the controls##90##2##(1990-2#2)(1990-3#3)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#3)(1992-9#1)(1993-12#2)(1994-5#1)(1995-12#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-7#1)(1997-8#1)(2007-7#3)(2007-8#1)(2008-10#15)(2008-11#2)(2008-5#2)(2008-7#8)(2008-8#5)(2008-9#8)(2009-12#1)(2009-3#1)(2009-6#1)(2010-4#2)(2011-1#4)(2011-2#4)(2012-3#3)(2013-1#1)(2013-8#3)
the controversial##4##2##(2008-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
the controversies over##2##3##(2008-11#1)(2008-9#1)
the controversies surrounding the##2##4##(2008-11#1)(2008-3#1)
the controversies surrounding##3##3##(2008-11#2)(2008-3#1)
the controversies##8##2##(2008-11#4)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
the controversy regarding##2##3##(1990-12#1)(1995-11#1)
the controversy surrounding the##2##4##(2006-10#1)(2010-8#1)
the controversy##6##2##(1990-12#1)(1991-11#1)(1995-11#1)(2006-10#1)(2008-3#1)(2010-8#1)
the controversy's##2##2##(2008-11#2)
the conus medullaris##3##3##(2008-7#3)
the conus##4##2##(2008-7#3)(2012-2#1)
the convective##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
the convenience and##2##3##(2008-3#2)
the convenience of##3##3##(1994-12#1)(1996-12#1)(2008-3#1)
the convenience##6##2##(1994-12#1)(1996-12#1)(2008-12#1)(2008-3#3)
the convenient##3##2##(2008-10#2)(2008-9#1)
the conventional &quot##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
the conventional 12-lead##2##3##(2008-3#2)
the conventional Fourier transform##2##4##(2008-2#1)(2008-3#1)
the conventional PDA##2##3##(2008-3#2)
the conventional analysis##2##3##(2008-10#1)(2008-6#1)
the conventional approach##3##3##(2008-2#1)(2009-5#1)(2012-12#1)
the conventional confocal##2##3##(2008-2#2)
the conventional culture dish##3##4##(2008-11#3)
the conventional group##4##3##(2009-2#1)(2013-1#3)
the conventional method##14##3##(1990-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-8#1)(2010-6#1)
the conventional methods##7##3##(2007-12#1)(2008-10#2)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
the conventional optical##2##3##(2008-3#2)
the conventional pellet culture##2##4##(2008-11#2)
the conventional planar##2##3##(1994-1#1)(2008-3#1)
the conventional polyol synthesis##2##4##(2008-5#1)(2013-1#1)
the conventional procedure##5##3##(2008-10#3)(2011-2#1)(2011-3#1)
the conventional procedures##2##3##(2008-10#1)(2008-5#1)
the conventional process##2##3##(2008-6#2)
the conventional sample##2##3##(1995-2#1)(2008-10#1)
the conventional surgical##2##3##(1992-6#1)(2009-2#1)
the conventional technique##4##3##(2008-3#1)(2008-5#1)(2011-2#1)(2011-7#1)
the conventional treatment##2##3##(2011-1#1)(2012-12#1)
the conventional variety##2##3##(2011-2#2)
the conventional##235##2##(1990-8#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-2#2)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#8)(2007-12#10)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#63)(2008-11#12)(2008-12#2)(2008-2#11)(2008-3#30)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#5)(2011-1#2)(2011-2#7)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#7)
the convergence of##3##3##(1992-6#1)(2008-7#1)(2009-3#1)
the convergence rate##2##3##(2007-12#2)
the convergence##8##2##(1992-6#1)(2007-12#3)(2008-3#1)(2008-7#2)(2009-3#1)
the converging##3##2##(2008-2#1)(2008-3#1)(2009-9#1)
the conversation##7##2##(2007-11#2)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#2)
the converse is true##2##4##(2008-8#1)(2010-11#1)
the converse##3##2##(2008-3#1)(2008-8#1)(2010-11#1)
the conversion efficiency can be##2##5##(2007-11#1)(2008-2#1)
the conversion efficiency of the##2##5##(2008-2#1)(2008-3#1)
the conversion efficiency of##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
the conversion efficiency was##2##4##(2008-6#2)
the conversion efficiency##12##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)(2008-6#3)(2013-1#1)
the conversion from##2##3##(1994-3#1)(2011-2#1)
the conversion of 11-deoxycorticosterone##2##4##(1990-11#1)(2008-4#1)
the conversion of 5-monosubstituted hydantoins to enantiomerically pure L-amino acids##2##10##(1995-3#2)
the conversion of L-arginine##2##4##(1992-3#1)(1995-11#1)
the conversion of glucose to glycogen in##2##7##(1995-8#2)
the conversion of glucose to glycogen##3##6##(1995-8#3)
the conversion of the##4##4##(1991-5#1)(1992-12#1)(2008-10#1)(2008-11#1)
the conversion of##50##3##(1990-11#1)(1990-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#4)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-9#1)
the conversion##75##2##(1990-11#1)(1990-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#4)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#1)(2013-1#2)
the converter##3##2##(2008-10#3)
the convex side of##2##4##(1996-5#1)(2012-2#1)
the convex##6##2##(1996-5#2)(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)
the convexity##2##2##(1990-5#1)(2008-6#1)
the conviction##2##2##(1997-5#1)(2013-8#1)
the convolution of the##2##4##(2008-2#1)(2008-3#1)
the convolution##7##2##(2008-11#1)(2008-2#1)(2008-3#4)(2013-8#1)
the cooking##3##2##(2008-9#1)(2010-2#1)(2010-4#1)
the cooling##2##2##(2008-10#1)(2008-3#1)
the cooperation of##5##3##(1991-3#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-1#1)
the cooperation##7##2##(1991-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#2)(2012-1#1)
the cooperative binding of##2##4##(1990-11#1)(2008-10#1)
the cooperative nature of##2##4##(1990-8#1)(1995-6#1)
the cooperative##14##2##(1990-11#1)(1990-8#2)(1993-11#1)(1994-7#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#2)(2013-1#1)
the cooperatively breeding##3##3##(2008-9#2)(2010-8#1)
the coordinate##5##2##(1991-5#2)(1994-12#1)(2008-10#1)(2010-7#1)
the coordinated##7##2##(1993-6#1)(1994-5#1)(1996-2#1)(2007-12#1)(2008-4#2)(2008-7#1)
the coordinates of the##2##4##(1992-4#1)(2007-12#1)
the coordinates of##3##3##(1991-6#1)(1992-4#1)(2007-12#1)
the coordinates##5##2##(1991-6#1)(1992-4#2)(1995-5#1)(2007-12#1)
the coordination of the##2##4##(1991-5#1)(2013-7#1)
the coordination of##11##3##(1990-6#1)(1991-5#1)(2006-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
the coordination sites##2##3##(1997-7#1)(2008-10#1)
the coordination##22##2##(1990-6#1)(1991-5#1)(1997-7#2)(2006-4#2)(2008-10#6)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
the copepod##2##2##(2008-5#1)(2010-8#1)
the coping##4##2##(1990-10#2)(1991-1#1)(2009-7#1)
the copolymer##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)
the copolymerization between EO and##2##5##(2012-12#2)
the copolymerization of##2##3##(2010-2#1)(2012-12#1)
the copolymerization##5##2##(2010-2#1)(2012-12#4)
the copper ions##2##3##(2008-10#1)(2008-9#1)
the copper oxide##3##3##(1993-5#1)(2008-10#2)
the copper##23##2##(1993-2#1)(1993-5#1)(1996-2#2)(1997-2#1)(2008-10#13)(2008-5#1)(2008-9#2)(2010-5#1)(2012-2#1)
the copper(II)##3##2##(1997-7#1)(2008-10#2)
the copper-modified gold electrode##2##4##(2008-10#2)
the copper-protein complexes##2##3##(2008-10#2)
the copper-protein##3##2##(2008-10#3)
the coprecipitation##3##2##(2008-10#3)
the copy number of MDR1 DNA##2##6##(1995-11#2)
the copy number of the##2##5##(1997-3#1)(2008-10#1)
the copy number of##6##4##(1995-11#2)(1997-3#1)(2008-10#1)(2008-11#1)(2010-5#1)
the copy number##8##3##(1995-11#3)(1997-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-5#1)
the copy of##2##3##(1990-5#1)(1995-8#1)
the copy##10##2##(1990-5#1)(1995-11#3)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-5#1)
the coracoid##3##2##(2013-1#3)
the cord##8##2##(2008-10#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
the core and the##2##4##(1994-8#1)(2008-3#1)
the core and##3##3##(1994-8#1)(2008-3#1)(2010-5#1)
the core functions of public health##2##6##(1995-12#2)
the core functions##3##3##(1995-12#2)(1996-2#1)
the core material##3##3##(2009-8#3)
the core of a##2##4##(1991-2#1)(2012-2#1)
the core of any##2##4##(1993-3#1)(1996-12#1)
the core of the##15##4##(1992-8#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)
the core of##32##3##(1991-2#2)(1992-8#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
the core part##3##3##(1994-8#3)
the core protein##3##3##(1990-12#1)(1995-5#1)(2008-8#1)
the core public health functions and##2##6##(1996-2#2)
the core public health##3##4##(1996-2#2)(1997-1#1)
the core region##3##3##(1991-2#1)(2008-5#1)(2008-7#1)
the core sequences##2##3##(1996-2#1)(1996-8#1)
the core temperature##3##3##(2007-10#1)(2008-2#1)(2010-7#1)
the core##113##2##(1990-12#1)(1991-2#4)(1991-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#6)(1995-12#3)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#6)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
the core-histone genes##3##3##(1990-5#3)
the core-histone##4##2##(1990-5#4)
the cores##2##2##(2007-11#1)(2008-10#1)
the corn oil and lard##2##5##(1990-7#2)
the corn oil##4##3##(1990-7#3)(2008-10#1)
the corn##11##2##(1990-7#3)(2008-10#3)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)
the cornea and##2##3##(2008-11#1)(2011-2#1)
the cornea in##2##3##(2011-1#1)(2013-1#1)
the cornea retention time##2##4##(2011-3#2)
the cornea##23##2##(1997-3#1)(2007-12#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#2)(2011-7#1)(2012-2#2)(2013-1#1)
the corneal epithelium##2##3##(2008-11#1)(2008-4#1)
the corneal surface##4##3##(2009-7#2)(2010-10#1)(2011-7#1)
the corneal##13##2##(2008-11#2)(2008-3#1)(2008-4#1)(2009-7#2)(2010-10#1)(2011-2#5)(2011-7#1)
the corneocyte##4##2##(2008-5#4)
the cornerstone of the##2##4##(1994-12#1)(2010-6#1)
the cornerstone of treatment##2##4##(2011-2#1)(2012-12#1)
the cornerstone of##13##3##(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-12#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
the cornerstones of##4##3##(1994-7#1)(1997-3#2)(2008-3#1)
the cornerstones##5##2##(1994-7#1)(1997-3#2)(2008-3#1)(2011-1#1)
the corona radiata##2##3##(2007-10#2)
the corona##5##2##(2007-10#2)(2008-2#3)
the coronal##2##2##(2008-9#1)(2013-1#1)
the coronary angiography##2##3##(2008-3#1)(2008-7#1)
the coronary arterial##2##3##(2011-2#1)(2013-2#1)
the coronary arteries and##2##4##(2008-10#1)(2008-3#1)
the coronary arteries##11##3##(1994-11#2)(2008-10#2)(2008-3#1)(2009-5#1)(2011-2#1)(2012-3#4)
the coronary artery##9##3##(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2012-2#1)(2013-2#1)
the coronary bypass##2##3##(2008-10#1)(2008-8#1)
the coronary care unit##2##4##(2008-3#1)(2012-2#1)
the coronary circulation##2##3##(1990-8#1)(1994-11#1)
the coronary sinus##2##3##(2007-8#1)(2012-2#1)
the coronary syndromes]##3##3##(2008-10#3)
the coronary##55##2##(1990-8#1)(1992-9#1)(1993-2#1)(1994-11#3)(1995-3#2)(2007-8#4)(2008-10#13)(2008-12#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#4)(2012-2#3)(2012-3#7)(2013-2#3)(2013-8#1)
the coronoid process##4##3##(1991-2#1)(2008-7#2)(2012-3#1)
the corpora##7##2##(1991-12#1)(1995-11#1)(2008-10#3)(2008-9#2)
the corporate##4##2##(1990-4#1)(1991-2#1)(1994-3#1)(2013-1#1)
the corpus callosum (CC)##2##4##(2008-7#1)(2013-1#1)
the corpus callosum##14##3##(1996-2#1)(1996-5#5)(2008-6#1)(2008-7#3)(2011-1#2)(2011-2#1)(2013-1#1)
the corpus cerebelli##2##3##(1993-12#2)
the corpus luteum##2##3##(1994-6#1)(1995-12#1)
the corpus vertebrae##3##3##(2007-11#3)
the corpus##28##2##(1992-12#1)(1992-3#1)(1993-12#3)(1994-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#5)(2007-11#3)(2008-6#1)(2008-7#3)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#2)
the correct behavior of##2##4##(2007-12#1)(2008-3#1)
the correct diagnosis of the##2##5##(1991-2#1)(2013-1#1)
the correct diagnosis of##5##4##(1991-2#1)(2007-7#1)(2008-6#1)(2011-2#1)(2013-1#1)
the correct diagnosis##16##3##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1997-5#1)(2007-7#2)(2008-11#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the correct dosage##2##3##(2008-12#1)(2008-8#1)
the correct identification of##2##4##(2008-10#1)(2010-12#1)
the correct name##2##3##(2008-3#1)(2013-7#1)
the correct phase key##2##4##(2008-3#2)
the correct phase##3##3##(2008-3#3)
the correct placement of##2##4##(2007-8#1)(2008-7#1)
the correct structure is found by repeating the GMDS for several close##2##12##(2008-4#2)
the correct structure must (by definition) accept all of the silent amino acid substitutions##2##14##(2008-4#2)
the correct structure##5##3##(2008-4#4)(2008-9#1)
the correct use of##4##4##(1993-8#1)(1994-9#1)(2008-11#1)(2008-9#1)
the correct value##3##3##(2008-10#1)(2008-2#2)
the correct##101##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
the corrected##9##2##(1993-12#1)(1994-6#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
the correction of the##5##4##(2008-1#1)(2008-3#2)(2009-10#1)(2013-1#1)
the correction of##23##3##(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#10)(2009-10#3)(2010-11#1)(2013-1#1)(2013-8#1)
the correction##36##2##(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#13)(2009-10#3)(2010-11#1)(2013-1#1)(2013-8#3)
the corrective##2##2##(1993-1#1)(1994-8#1)
the correctness of the##3##4##(2007-8#1)(2008-2#2)
the correctness##4##2##(2007-8#1)(2008-2#2)(2009-5#1)
the correlated##4##2##(1993-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
the correlates of##4##3##(1992-11#1)(1993-1#1)(1995-3#1)(2012-3#1)
the correlation between laminin 332##3##5##(2013-8#3)
the correlation between the in vitro##2##6##(1997-7#1)(2008-5#1)
the correlation between the##18##4##(1992-9#1)(1993-11#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2012-3#2)(2013-1#1)(2013-8#2)
the correlation between##60##3##(1991-9#1)(1992-9#2)(1993-11#1)(1994-2#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-5#1)(2010-8#2)(2012-3#3)(2013-1#1)(2013-8#6)
the correlation coefficient of 0##2##5##(2008-10#2)
the correlation coefficient of##5##4##(2008-10#4)(2011-1#1)
the correlation coefficient was 0##2##5##(1990-12#1)(2013-8#1)
the correlation coefficient was##3##4##(1990-12#1)(2008-10#1)(2013-8#1)
the correlation coefficient##11##3##(1990-12#1)(2008-10#6)(2008-3#1)(2011-1#1)(2011-3#1)(2013-8#1)
the correlation coefficients of##3##4##(2008-10#1)(2011-1#2)
the correlation coefficients were##2##4##(2008-10#1)(2011-1#1)
the correlation coefficients##11##3##(1992-3#1)(2008-10#6)(2011-1#4)
the correlation function##6##3##(2008-3#6)
the correlation length of the##3##5##(2007-12#1)(2008-3#2)
the correlation of disease status of plants##2##7##(2008-10#2)
the correlation of the##5##4##(1995-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
the correlation of##22##3##(1990-2#1)(1992-3#1)(1995-2#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
the correlation peak##3##3##(2008-2#2)(2008-3#1)
the correlation time function##3##4##(2008-3#3)
the correlation time##6##3##(2008-10#2)(2008-3#4)
the correlation was##2##3##(2008-10#1)(2009-8#1)
the correlation with the##2##4##(2007-7#1)(2008-10#1)
the correlation##143##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-3#2)(1992-9#2)(1993-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#24)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#8)
the correlation-peak##2##2##(2008-2#1)(2008-3#1)
the correlations between NaCl and other##2##6##(2009-10#2)
the correlations between##12##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2009-10#2)(2010-3#1)(2012-3#1)(2012-4#1)(2013-7#1)(2013-8#2)
the correlations##20##2##(1993-12#1)(1995-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#3)(2009-10#2)(2009-11#1)(2010-3#1)(2010-4#1)(2012-3#1)(2012-4#1)(2013-7#2)(2013-8#2)
the correlative##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
the correlator##6##2##(2007-12#1)(2008-3#5)
the corresponded##4##2##(2008-11#4)
the correspondence##4##2##(2008-5#1)(2008-6#2)(2012-1#1)
the corresponding 1##2##3##(2008-10#1)(2008-5#1)
the corresponding FTIR spectrum##2##4##(2008-10#2)
the corresponding FTIR##3##3##(2008-10#3)
the corresponding N##2##3##(1995-2#1)(2007-11#1)
the corresponding RNAs##2##3##(1995-6#1)(2008-10#1)
the corresponding avirulence gene##2##4##(2008-10#2)
the corresponding binary complexes##2##4##(2008-10#1)(2008-5#1)
the corresponding bulk##3##3##(2008-3#2)(2008-7#1)
the corresponding cDNA##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
the corresponding cell##2##3##(1990-5#1)(2008-10#1)
the corresponding complex##2##3##(2008-10#2)
the corresponding controls##2##3##(1995-8#1)(2006-6#1)
the corresponding enzymes##2##3##(1990-5#1)(1997-3#1)
the corresponding gene##10##3##(1990-11#1)(1992-8#1)(1993-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
the corresponding genes##7##3##(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
the corresponding hydrides##2##3##(2008-10#2)
the corresponding mean##2##3##(2007-12#1)(2010-7#1)
the corresponding monoclonal##2##3##(1997-4#1)(2008-10#1)
the corresponding output##2##3##(2008-2#1)(2008-3#1)
the corresponding parent##3##3##(1991-9#1)(1994-5#1)(2008-4#1)
the corresponding proteins##5##3##(1996-2#1)(1997-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
the corresponding quenching##2##3##(2008-10#2)
the corresponding rat sequence##2##4##(1996-10#1)(2008-7#1)
the corresponding rates##3##3##(1995-9#1)(2008-11#1)(2008-7#1)
the corresponding region##3##3##(1990-12#1)(1991-6#1)(2007-11#1)
the corresponding regions of##2##4##(1997-2#1)(2008-10#1)
the corresponding resistance gene##2##4##(2008-10#2)
the corresponding sense##2##3##(1994-10#1)(2008-7#1)
the corresponding solution##2##3##(2008-10#1)(2008-9#1)
the corresponding steps for##2##4##(2008-2#2)
the corresponding tumor##2##3##(1994-7#1)(2007-8#1)
the corresponding value##4##3##(1990-8#1)(2007-11#1)(2008-3#1)(2011-1#1)
the corresponding values for##5##4##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
the corresponding values in the bulk sediments##2##7##(2008-10#2)
the corresponding values in the##4##5##(2008-10#2)(2008-2#1)(2008-5#1)
the corresponding values of##2##4##(1990-7#1)(2009-9#1)
the corresponding values predicted by##2##5##(2008-2#2)
the corresponding values##15##3##(1990-7#1)(1991-2#1)(1992-12#1)(1994-11#1)(2008-10#3)(2008-2#4)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)
the corresponding##382##2##(1990-11#5)(1990-12#3)(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#3)(1991-6#4)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#3)(1995-2#3)(1995-3#7)(1995-5#1)(1995-6#3)(1995-8#5)(1995-9#2)(1996-10#2)(1996-2#5)(1996-3#1)(1996-5#13)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#5)(2006-12#1)(2006-6#1)(2007-11#24)(2007-12#3)(2007-8#1)(2008-10#89)(2008-11#3)(2008-12#1)(2008-2#19)(2008-3#23)(2008-4#7)(2008-5#10)(2008-7#8)(2008-8#8)(2008-9#3)(2009-10#3)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
the corrosion inhibition##2##3##(2013-1#2)
the corrosion##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#2)
the corrugated structure##2##3##(2008-3#2)
the corrugated##4##2##(2007-12#1)(2008-3#3)
the cortex and##6##3##(1991-9#1)(1994-2#1)(1995-6#1)(2008-1#1)(2008-9#1)(2013-1#1)
the cortex in the##3##4##(2008-5#1)(2008-9#1)(2009-10#1)
the cortex of sour orange##2##5##(2008-10#2)
the cortex of the##5##4##(1992-9#1)(1995-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
the cortex of trifoliate orange##2##5##(2008-10#2)
the cortex of##11##3##(1992-9#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
the cortex##51##2##(1990-12#1)(1990-9#1)(1991-9#1)(1992-7#1)(1992-9#1)(1994-2#2)(1995-6#3)(1996-12#3)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#3)(2011-2#1)(2013-1#1)
the cortical and basal##2##4##(1991-10#2)
the cortical cells of##3##4##(2008-10#3)
the cortical region##2##3##(2008-11#1)(2010-7#1)
the cortical tissue##2##3##(1996-12#1)(2008-10#1)
the cortical##39##2##(1990-9#2)(1991-10#2)(1994-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#3)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2010-7#3)(2011-1#1)(2012-2#1)(2013-1#1)
the corticoid##2##2##(1997-2#1)(2010-12#1)
the cortisol awakening##2##3##(2008-11#1)(2013-1#1)
the cortisol concentrations##2##3##(2008-5#1)(2013-1#1)
the cortisol##5##2##(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#2)
the cos site##2##3##(1996-2#2)
the cos##3##2##(1990-11#1)(1996-2#2)
the cosine of the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
the cosine##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the cosmetic field##2##3##(2008-5#2)
the cosmetic industry##6##3##(2008-5#6)
the cosmetic needs##2##3##(2008-5#2)
the cosmetic##21##2##(1991-2#1)(1993-9#1)(1994-12#1)(2008-5#16)(2010-8#2)
the cosmetics##4##2##(2007-7#1)(2008-5#3)
the cosmid##4##2##(1995-9#1)(1997-2#1)(1997-3#1)(2008-6#1)
the cosmogonic hypothesis##2##3##(2008-12#2)
the cosmopolitan##2##2##(2008-10#1)(2008-12#1)
the cost and size of##2##5##(2008-3#1)(2010-11#1)
the cost and the##2##4##(1992-5#1)(2008-2#1)
the cost and##10##3##(1991-3#1)(1992-5#1)(1996-1#1)(1996-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-8#1)
the cost effectiveness of the##2##5##(2008-4#1)(2012-12#1)
the cost effectiveness of##6##4##(1992-2#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2012-12#1)
the cost for##2##3##(1991-3#1)(2008-7#1)
the cost is##3##3##(2008-8#1)(2010-9#1)(2012-2#1)
the cost of a drug##2##5##(1995-1#1)(1996-2#1)
the cost of a##9##4##(1995-1#2)(1996-2#1)(2008-3#1)(2008-8#2)(2012-12#2)(2012-2#1)
the cost of an additional##2##5##(2008-10#2)
the cost of caring for##2##5##(1993-3#1)(1997-6#1)
the cost of each##2##4##(1990-2#1)(1991-9#1)
the cost of health care##2##5##(1995-3#1)(2013-8#1)
the cost of hospitalization##2##4##(2013-1#2)
the cost of outpatient##2##4##(1995-12#1)(1995-2#1)
the cost of parasitism##2##4##(2008-8#2)
the cost of prescription drugs##2##5##(2008-11#2)
the cost of providing##3##4##(1993-1#1)(1995-1#1)(2008-2#1)
the cost of the##8##4##(1993-1#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
the cost of treating##2##4##(1994-3#1)(1995-6#1)
the cost of##87##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-9#1)(1992-12#2)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#4)(2009-9#1)(2010-8#1)(2011-1#2)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
the cost per##3##3##(1992-2#1)(1992-5#1)(1997-2#1)
the cost##126##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-3#2)(1991-9#1)(1992-12#4)(1992-2#2)(1992-5#2)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#4)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#12)(2008-9#6)(2009-9#1)(2010-11#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-7#1)(2012-12#5)(2012-2#2)(2013-1#4)(2013-8#1)
the cost-effective##2##2##(1993-3#1)(1996-11#1)
the cost-effectiveness of advanced cancer imaging##2##6##(2008-2#2)
the cost-effectiveness of##11##3##(1990-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
the cost-effectiveness##13##2##(1990-12#1)(1993-2#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#2)
the cost/benefit##2##2##(1991-3#2)
the costing##2##2##(1993-3#1)(1996-9#1)
the costly##2##2##(1991-6#1)(2008-11#1)
the costs and benefits##3##4##(1994-12#1)(2008-6#1)(2013-1#1)
the costs and rewards of diabetes and its##2##8##(2010-9#2)
the costs and the##2##4##(2008-10#1)(2008-9#1)
the costs and##10##3##(1993-12#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-8#1)(2010-9#2)(2013-1#1)
the costs associated with##5##4##(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-5#1)
the costs of care##3##4##(1995-12#1)(1996-12#1)(2013-8#1)
the costs of control##2##4##(2008-10#2)
the costs of providing##2##4##(1994-2#1)(1995-2#1)
the costs of the##4##4##(1990-8#1)(2008-1#1)(2008-10#1)(2008-6#1)
the costs of##47##3##(1990-8#1)(1990-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2010-4#1)(2013-8#1)
the costs##72##2##(1990-8#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#5)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
the cotransfection of##3##3##(1993-8#1)(2008-4#2)
the cotransfection##4##2##(1993-8#1)(2008-11#1)(2008-4#2)
the cotton leafworm##2##3##(2010-10#1)(2013-8#1)
the cotton##6##2##(2008-10#3)(2010-10#1)(2011-2#1)(2013-8#1)
the cotton-top tamarin (Saguinus oedipus)##2##5##(1994-2#2)
the cotyledon##2##2##(2008-10#2)
the cotyledonary##3##2##(1991-12#1)(2008-10#1)(2013-8#1)
the cotyledons##4##2##(1994-8#1)(2008-10#2)(2013-8#1)
the couch##4##2##(2011-2#4)
the coulombic interactions##2##3##(2008-10#2)
the counseling##2##2##(1995-9#1)(2012-12#1)
the counselors'##2##2##(2008-6#2)
the counter electrode##2##3##(2008-10#2)
the counter##10##2##(1996-5#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-7#3)
the counterparts##2##2##(2008-10#1)(2008-8#1)
the counterpropagating##3##2##(2007-11#2)(2008-3#1)
the counting##2##2##(2008-10#1)(2013-8#1)
the countries with##2##3##(1990-12#1)(1995-5#1)
the countries##9##2##(1990-12#1)(1995-5#1)(1996-9#1)(2007-11#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#2)
the country and##4##3##(1991-6#1)(1996-1#1)(2011-2#1)(2013-1#1)
the country are##4##3##(1991-12#1)(1992-2#1)(1995-2#1)(2009-12#1)
the country as##2##3##(1994-1#1)(2008-1#1)
the country by the##2##4##(1997-6#1)(2013-1#1)
the country has##2##3##(1994-3#1)(2008-4#1)
the country in##4##3##(1997-6#1)(2008-1#1)(2008-8#1)(2009-10#1)
the country##84##2##(1991-12#1)(1991-6#3)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-6#5)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)
the country's##3##2##(1995-12#1)(1997-6#1)(2008-11#1)
the counts of CFU##2##4##(2013-7#2)
the counts of##5##3##(1996-3#1)(2008-10#1)(2008-12#1)(2013-7#2)
the counts##9##2##(1990-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
the county to##2##3##(1992-2#1)(1997-3#1)
the county##13##2##(1991-1#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-6#2)(1994-11#1)(1996-9#2)(1997-3#1)(2008-8#1)(2011-1#1)
the coupled reactions of##2##4##(1997-2#1)(2008-10#1)
the coupled system##4##3##(1996-8#1)(2008-10#2)(2008-2#1)
the coupled##20##2##(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(2007-11#3)(2008-10#6)(2008-2#3)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)
the coupled-dipole method##2##3##(2008-3#2)
the coupled-dipole##3##2##(2008-3#3)
the coupled-local-mode##2##2##(2008-3#2)
the coupled-mode theory##2##3##(2007-11#1)(2008-3#1)
the coupled-mode##5##2##(2007-11#1)(2008-3#4)
the coupled-resonator optical##2##3##(2007-11#1)(2007-12#1)
the coupled-wave##2##2##(2008-2#1)(2008-3#1)
the coupler in##2##3##(2007-11#1)(2008-3#1)
the coupler##17##2##(2007-11#3)(2007-12#3)(2008-2#7)(2008-3#4)
the coupler's##3##2##(2007-12#3)
the couples##4##2##(1994-7#1)(1996-9#2)(2012-2#1)
the coupling among##3##3##(1990-8#1)(1995-11#1)(2008-3#1)
the coupling between##2##3##(2008-10#1)(2008-3#1)
the coupling coefficient##4##3##(2007-11#1)(2008-3#2)(2013-8#1)
the coupling efficiency of a##3##5##(2008-2#2)(2008-3#1)
the coupling efficiency##6##3##(2008-2#4)(2008-3#2)
the coupling length##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the coupling loss##2##3##(2008-3#2)
the coupling of a##3##4##(2007-12#1)(2008-10#2)
the coupling of an##3##4##(2008-10#2)(2008-3#1)
the coupling of light##2##4##(2008-3#2)
the coupling of the##2##4##(1991-5#1)(2008-3#1)
the coupling of##23##3##(1991-12#1)(1991-5#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#2)
the coupling procedure has been performed##3##6##(2008-2#1)(2008-4#2)
the coupling reaction##3##3##(2008-4#3)
the coupling strength##2##3##(2007-12#1)(2008-3#1)
the coupling##73##2##(1990-8#1)(1991-12#1)(1991-5#1)(1995-11#1)(1997-7#1)(2007-11#5)(2007-12#5)(2008-10#16)(2008-2#10)(2008-3#16)(2008-4#7)(2008-7#2)(2009-11#2)(2009-5#1)(2009-7#1)(2009-9#1)(2013-8#2)
the course and##6##3##(2008-11#5)(2008-4#1)
the course in##2##3##(2008-11#1)(2012-12#1)
the course is##2##3##(2010-12#1)(2010-7#1)
the course of a##16##4##(1990-6#1)(1991-3#1)(1991-9#1)(1994-2#1)(1995-3#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
the course of acute##2##4##(2008-7#1)(2013-1#1)
the course of an##3##4##(1990-9#1)(2008-10#1)(2008-11#1)
the course of clinical care##2##5##(2008-12#1)(2008-7#1)
the course of disease##2##4##(2011-2#2)
the course of distraction osteogenesis##2##5##(2007-8#2)
the course of multiple##2##4##(1994-9#1)(2012-2#1)
the course of our##2##4##(2008-11#1)(2008-2#1)
the course of pregnancy##5##4##(1995-12#1)(2012-3#4)
the course of rheumatoid arthritis##2##5##(2013-1#2)
the course of the disease##14##5##(1990-6#1)(1991-4#1)(1991-6#1)(1993-12#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-7#3)(2011-1#1)(2012-12#1)
the course of the epidemic##2##5##(1996-5#1)(2008-10#1)
the course of the experiment##3##5##(2008-10#2)(2008-7#1)
the course of the illness##2##5##(1992-11#1)(2012-2#1)
the course of the outbreak and##2##6##(2011-3#1)(2013-1#1)
the course of the study##2##5##(2008-10#2)
the course of the titration##2##5##(2008-10#2)
the course of the##61##4##(1990-11#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)
the course of their##6##4##(1991-12#1)(2008-12#2)(2008-8#1)(2008-9#1)(2013-1#1)
the course of therapy##4##4##(2007-12#1)(2008-8#1)(2012-2#2)
the course of these studies##2##5##(2008-10#1)(2008-8#1)
the course of these##5##4##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)
the course of this study##3##5##(1991-8#1)(2008-10#2)
the course of this##4##4##(1991-8#1)(2008-10#2)(2011-2#1)
the course of treatment and##2##5##(1996-9#1)(2008-12#1)
the course of treatment in##2##5##(1996-7#1)(2010-11#1)
the course of treatment##9##4##(1991-12#1)(1991-6#1)(1996-2#1)(1996-7#1)(1996-9#1)(2008-12#1)(2010-11#1)(2012-2#1)(2013-8#1)
the course of two years##2##5##(1995-5#1)(2012-2#1)
the course of two##4##4##(1995-11#1)(1995-5#1)(2007-12#1)(2012-2#1)
the course of##256##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#9)(2008-10#29)(2008-11#12)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#2)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#3)(2011-1#3)(2011-2#16)(2011-3#1)(2012-12#3)(2012-2#13)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#3)
the course was##2##3##(1995-5#1)(2008-11#1)
the course##308##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-5#4)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#8)(2007-2#1)(2007-7#2)(2007-8#9)(2008-10#30)(2008-11#34)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#2)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#19)(2011-3#1)(2012-12#8)(2012-2#14)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#6)
the course's##2##2##(1996-12#1)(2007-11#1)
the courses##4##2##(1991-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
the court##12##2##(1990-11#2)(1990-2#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-4#1)(2008-11#1)(2010-10#1)
the courts and##2##3##(1996-1#1)(2008-9#1)
the courts##9##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#1)(1996-1#1)(1996-2#1)(2007-3#1)(2008-9#1)(2011-2#1)
the courtship##3##2##(1990-11#1)(2008-6#2)
the covalency##2##2##(1997-7#2)
the covalent attachment of##2##4##(2008-5#1)(2013-1#1)
the covalent binding of##2##4##(1994-5#1)(2008-10#1)
the covalent linkage of##2##4##(1992-6#1)(2008-11#1)
the covalent linkage##3##3##(1992-6#1)(1995-6#1)(2008-11#1)
the covalent##14##2##(1992-6#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
the covalently bound##2##3##(2008-5#2)
the covalently##3##2##(2008-5#2)(2010-4#1)
the covariance matrix of the##2##5##(1992-6#1)(2009-4#1)
the covariance matrix##5##3##(1992-6#1)(1997-3#1)(2008-9#1)(2009-4#2)
the covariance##8##2##(1992-6#1)(1992-9#1)(1997-3#2)(2008-3#1)(2008-9#1)(2009-4#2)
the covariates##10##2##(1994-2#1)(1997-4#1)(2008-8#3)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
the cover##4##2##(2008-10#1)(2008-2#2)(2011-2#1)
the coverage of the##4##4##(1993-9#1)(1996-1#1)(2008-10#1)(2011-2#1)
the coverage probability of##2##4##(2008-10#2)
the coverage probability##4##3##(1995-9#1)(2008-10#3)
the coverage reduction##2##3##(2008-10#2)
the coverage##18##2##(1993-3#1)(1993-9#1)(1995-9#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
the covered##2##2##(1991-1#1)(1996-12#1)
the cows##5##2##(1990-6#2)(1991-3#2)(1991-8#1)
the coxa and##2##3##(2007-12#1)(2008-5#1)
the coxa##3##2##(2007-12#2)(2008-5#1)
the crab##2##2##(2008-10#1)(2013-7#1)
the crack phenomena at a##2##5##(2009-7#2)
the crack propagation##2##3##(1991-8#1)(2009-7#1)
the crack tip##2##3##(2008-8#1)(2009-7#1)
the crack##14##2##(1991-8#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#5)(2010-4#2)(2012-2#1)
the cranial and##2##3##(2007-10#1)(2008-7#1)
the cranial base##2##3##(2007-12#2)
the cranial nerves##4##3##(2008-1#3)(2012-3#1)
the cranial vault##3##3##(2007-12#3)
the cranial##17##2##(1996-6#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-12#6)(2008-1#3)(2008-7#1)(2012-3#1)(2013-8#1)
the craniocervical##5##2##(2011-2#4)(2012-12#1)
the craniofacial region of##2##4##(1996-6#1)(2008-9#1)
the craniofacial region##5##3##(1996-6#1)(2007-12#1)(2008-9#3)
the craniofacial team##2##3##(2007-12#2)
the craniofacial##15##2##(1996-6#1)(2007-12#5)(2008-4#1)(2008-6#1)(2008-9#3)(2010-6#4)
the craniotomy##2##2##(2008-7#2)
the cranium and face##2##4##(2007-12#1)(2010-6#1)
the cranium##12##2##(1996-9#2)(2007-12#2)(2008-7#3)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
the crater lakes##2##3##(2013-1#2)
the cream##4##2##(2008-5#4)
the creams##3##2##(2008-5#3)
the creatinine##3##2##(1995-3#1)(2008-10#2)
the creation and##2##3##(1997-3#1)(2013-1#1)
the creation of a new##3##5##(2008-10#2)(2010-1#1)
the creation of a##23##4##(1991-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1997-2#3)(1997-3#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-7#2)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the creation of health##2##4##(1994-12#1)(2008-1#1)
the creation of new##5##4##(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
the creation of the##7##4##(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-1#1)(2010-3#1)(2012-3#1)
the creation of truly portable##2##5##(2008-10#2)
the creation of##78##3##(1990-5#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-12#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-7#6)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the creation##81##2##(1990-5#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-12#3)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the creative arts therapies##2##4##(1994-12#1)(1995-1#1)
the creative##7##2##(1994-12#1)(1995-1#3)(1996-1#1)(1997-1#1)(2008-12#1)
the credentialing##4##2##(1991-12#2)(1991-3#1)(1992-1#1)
the credit##2##2##(1993-1#1)(2013-8#1)
the creep##2##2##(2009-4#1)(2009-7#1)
the crevice##2##2##(2008-10#1)(2008-2#1)
the crew##2##2##(1992-6#1)(2011-2#1)
the cribriform plate##2##3##(2008-11#1)(2011-2#1)
the cricket##2##2##(2007-12#1)(2008-5#1)
the crime##3##2##(1993-3#1)(1996-11#1)(2008-10#1)
the criminal justice system##7##4##(1996-1#2)(2008-11#3)(2009-11#1)(2012-2#1)
the criminal justice##8##3##(1996-1#3)(2008-11#3)(2009-11#1)(2012-2#1)
the criminal##10##2##(1996-1#3)(2008-11#3)(2009-11#1)(2011-2#2)(2012-2#1)
the crisis of##2##3##(1995-8#1)(2013-1#1)
the crisis##13##2##(1993-12#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-5#1)(2008-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
the crista galli##2##3##(2006-12#2)
the crista##3##2##(2006-12#2)(2007-8#1)
the criteria and##2##3##(1992-3#1)(2013-1#1)
the criteria are##2##3##(1997-8#1)(2007-8#1)
the criteria for a##2##4##(2008-12#1)(2008-9#1)
the criteria for obtaining a disability##2##6##(1995-5#1)(1997-6#1)
the criteria for##26##3##(1992-11#1)(1992-2#1)(1993-6#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-6#1)(1997-8#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#3)
the criteria of##10##3##(1991-3#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
the criteria that##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
the criteria used for##2##4##(2008-1#1)(2010-5#1)
the criteria used to##4##4##(1993-12#1)(1996-3#1)(1997-2#1)(2008-4#1)
the criteria used##6##3##(1993-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-4#1)(2010-5#1)
the criteria with##2##3##(1991-3#1)(1992-2#1)
the criteria##69##2##(1990-6#1)(1991-11#1)(1991-3#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-6#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-6#1)(1997-8#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#8)
the criterion for##4##3##(2007-8#1)(2008-10#1)(2010-2#1)(2012-9#1)
the criterion of##4##3##(1991-2#1)(1993-1#1)(2010-2#2)
the criterion##10##2##(1991-2#1)(1993-1#1)(2007-8#1)(2008-10#2)(2010-2#3)(2012-9#1)(2013-1#1)
the critical angle##12##3##(2008-2#2)(2008-3#10)
the critical appraisal##2##3##(2007-5#1)(2008-11#1)
the critical areas of##2##4##(1997-3#1)(2008-6#1)
the critical care##5##3##(1991-1#3)(2011-2#1)(2012-12#1)
the critical concentration of##2##4##(1994-5#1)(2008-6#1)
the critical concentration##5##3##(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-6#1)
the critical depth of##3##4##(2008-10#3)
the critical depth##4##3##(2008-10#4)
the critical dilution rate##2##4##(1997-2#1)(2008-7#1)
the critical evaluation of##2##4##(2008-10#1)(2009-8#1)
the critical examination of the##2##5##(2008-10#1)(2008-11#1)
the critical factors##2##3##(2008-9#1)(2012-12#1)
the critical importance of##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
the critical level##2##3##(2008-11#1)(2008-7#1)
the critical micellar concentration (CMC)##2##5##(1996-5#1)(2008-10#1)
the critical micelle concentration for##2##5##(2008-10#2)
the critical micelle concentration##7##4##(1994-9#1)(2008-10#6)
the critical need for##5##4##(1992-1#1)(1995-1#1)(2009-8#1)(2012-2#1)(2013-1#1)
the critical need##6##3##(1992-1#1)(1995-1#1)(1995-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
the critical parameters##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
the critical period##4##3##(1993-12#1)(2012-2#3)
the critical role of the##2##5##(2011-1#1)(2012-3#1)
the critical role of##8##4##(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
the critical role##9##3##(1992-3#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
the critical stages of##2##4##(2008-7#1)(2010-4#1)
the critical success factors##3##4##(1993-3#1)(2008-12#1)(2008-9#1)
the critical thinking and##2##4##(2008-12#1)(2012-2#1)
the critical thinking##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
the critical threshold##3##3##(2008-4#1)(2010-10#2)
the critical value##2##3##(2008-7#1)(2012-2#1)
the critical wavelength##3##3##(2008-5#3)
the critical##156##2##(1990-3#1)(1990-5#1)(1991-1#3)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#3)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#23)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#15)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#7)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#5)
the critically endangered Arakan forest turtle (Heosemys depressa)##2##8##(2013-1#2)
the critically ill patient##5##4##(2007-8#2)(2008-11#1)(2008-3#1)(2010-11#1)
the critically ill##7##3##(2007-8#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)
the critically##10##2##(2007-8#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
the criticism##2##2##(2011-2#1)(2013-7#1)
the cromoglycate##2##2##(2008-10#2)
the crop is##2##3##(2008-10#2)
the crop production system##2##4##(2008-10#2)
the crop##14##2##(1991-11#1)(2008-10#11)(2008-11#1)(2008-8#1)
the cropping season##2##3##(2008-10#2)
the cropping##5##2##(2008-10#5)
the cross between##7##3##(2008-10#6)(2012-3#1)
the cross clamp##2##3##(1996-9#2)
the cross correlation##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the cross of##7##3##(2008-10#7)
the cross section of##2##4##(2008-3#2)
the cross section##3##3##(2008-3#2)(2010-4#1)
the cross talk between##4##4##(2007-12#1)(2008-2#1)(2013-1#2)
the cross talk of##2##4##(2008-2#1)(2008-3#1)
the cross talk##10##3##(2007-12#1)(2008-2#4)(2008-3#2)(2009-12#1)(2013-1#2)
the cross##61##2##(1996-9#2)(2007-12#3)(2008-10#32)(2008-2#6)(2008-3#7)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
the cross-ambiguity##2##2##(2008-2#2)
the cross-bridge##2##2##(1992-3#1)(2009-6#1)
the cross-correlation##2##2##(2008-3#2)
the cross-linked##5##2##(1990-8#1)(1992-3#1)(1995-6#2)(2010-4#1)
the cross-linker##2##2##(2008-10#1)(2010-4#1)
the cross-linking process##2##3##(1993-11#1)(2007-12#1)
the cross-linking##13##2##(1992-3#1)(1993-11#2)(1993-8#1)(1994-5#1)(1995-6#1)(2007-12#2)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#2)
the cross-polarization##2##2##(2008-3#2)
the cross-reactivity of##2##3##(1990-12#1)(2008-11#1)
the cross-reactivity##5##2##(1990-12#1)(1991-9#1)(2008-10#2)(2008-11#1)
the cross-sectional area of##2##4##(2008-2#1)(2008-7#1)
the cross-sectional area##3##3##(2008-2#1)(2008-7#1)(2013-3#1)
the cross-sectional design##2##3##(2010-2#1)(2012-5#1)
the cross-sectional##10##2##(1996-8#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-5#1)(2013-3#1)(2013-8#1)
the cross-spectral density##3##3##(2007-11#3)
the cross-talk between##2##3##(2008-7#1)(2009-10#1)
the cross-talk##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
the cross-validation##3##2##(2008-10#1)(2010-3#1)(2011-3#1)
the crosses were##2##3##(2008-10#2)
the crosses##4##2##(2008-10#4)
the crossing of##2##3##(1996-2#1)(2007-11#1)
the crossing##4##2##(1993-8#1)(1996-2#1)(2007-11#1)(2011-1#1)
the crosslinking##2##2##(1991-2#1)(2008-10#1)
the crossover##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
the crossroads##2##2##(1996-1#1)(2013-1#1)
the crosstalk##2##2##(2008-11#1)(2013-7#1)
the crown and##2##3##(2008-10#1)(2011-2#1)
the crown ether##5##3##(2008-10#5)
the crown of the##2##4##(2008-5#1)(2013-1#1)
the crown of##5##3##(2008-5#1)(2008-6#2)(2013-1#2)
the crown rust resistance gene##2##5##(2008-10#2)
the crown##19##2##(2007-12#1)(2008-10#10)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#2)(2013-1#2)
the crowns##3##2##(1995-9#1)(2008-10#1)(2013-1#1)
the crucial role of##8##4##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
the crucial role##9##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
the crucial##22##2##(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the crude drug was##2##4##(2008-11#2)
the crude extract and##2##4##(2008-11#2)
the crude extract of##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
the crude extract##7##3##(2008-10#1)(2008-11#4)(2008-12#1)(2011-1#1)
the crude extracts of##2##4##(2008-10#1)(2008-11#1)
the crude extracts##5##3##(2008-10#2)(2008-11#2)(2008-8#1)
the crude##36##2##(1990-2#2)(1990-6#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-7#1)(2007-10#1)(2008-10#10)(2008-11#8)(2008-12#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2013-1#1)
the crustacean##5##2##(1990-2#2)(1995-11#1)(2007-12#1)(2008-10#1)
the crux of##2##3##(2008-4#1)(2009-7#1)
the crux##3##2##(2007-8#1)(2008-4#1)(2009-7#1)
the cry1Ab gene##2##3##(2008-9#2)
the cryogenic##2##2##(2007-12#1)(2008-10#1)
the cryopreservation##3##2##(1996-8#2)(2008-9#1)
the crypt-villus##5##2##(1990-12#3)(1991-12#2)
the crypts##4##2##(1991-12#1)(2009-12#1)(2011-2#1)(2013-1#1)
the crystal and##2##3##(2008-2#1)(2012-2#1)
the crystal are##3##3##(1992-4#1)(2008-3#2)
the crystal becomes##2##3##(2007-11#1)(2008-3#1)
the crystal has##2##3##(1996-5#1)(2013-1#1)
the crystal is##3##3##(2008-3#2)(2013-1#1)
the crystal lattice##3##3##(2006-4#1)(2007-12#1)(2008-10#1)
the crystal length##2##3##(2008-2#2)
the crystal structure and##2##4##(2008-10#1)(2008-4#1)
the crystal structure of allophycocyanin from##2##6##(2008-8#2)
the crystal structure of the##3##5##(1990-7#1)(1994-3#1)(2008-8#1)
the crystal structure of##14##4##(1990-7#1)(1991-11#2)(1992-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(2008-8#3)(2008-9#1)(2012-2#2)(2013-7#1)
the crystal structure##23##3##(1990-7#1)(1991-11#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
the crystal structures of##5##4##(1994-5#2)(1995-5#1)(2009-8#1)(2011-1#1)
the crystal structures##6##3##(1994-5#2)(1995-5#1)(2009-11#1)(2009-8#1)(2011-1#1)
the crystal surface##2##3##(2007-11#1)(2007-12#1)
the crystal temperature##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the crystal to##3##3##(1992-8#1)(2007-12#1)(2008-3#1)
the crystal violet##2##3##(2008-10#1)(2008-9#1)
the crystal##113##2##(1990-7#1)(1991-11#2)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#3)(1995-5#1)(1995-6#1)(1996-5#2)(1997-7#4)(2006-4#2)(2007-11#10)(2007-12#11)(2008-10#4)(2008-11#1)(2008-2#13)(2008-3#25)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
the crystalline##11##2##(1990-9#1)(1993-8#1)(1996-2#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
the crystallinity##2##2##(2013-1#1)(2013-8#1)
the crystallite##2##2##(2008-10#1)(2010-4#1)
the crystallization##5##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-10#1)
the crystallographic##4##2##(1992-9#1)(1995-2#1)(1997-7#1)(2008-3#1)
the crystals of##2##3##(2007-11#1)(2008-10#1)
the crystals##9##2##(1990-7#1)(1992-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)
the cube##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
the cubic##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-3#1)
the cue##4##2##(2008-1#1)(2008-2#1)(2009-8#1)(2013-8#1)
the cue-based retrieval##2##3##(2007-12#2)
the cued side##2##3##(2010-5#2)
the cued##3##2##(1994-8#1)(2010-5#2)
the cues##3##2##(2008-11#1)(2013-8#2)
the cuff##7##2##(1991-12#3)(2007-11#1)(2008-2#2)(2013-8#1)
the culmination of##2##3##(2008-6#1)(2009-4#1)
the cultivar##10##2##(2008-10#10)
the cultivars were##3##3##(2008-10#3)
the cultivars##14##2##(2008-10#13)(2008-8#1)
the cultivated##8##2##(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#2)
the cultivation of##17##3##(2006-11#1)(2008-11#9)(2008-6#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
the cultivation##27##2##(2006-11#1)(2008-10#1)(2008-11#13)(2008-12#1)(2008-6#7)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
the culturable##3##2##(2008-10#3)
the cultural and##6##3##(1997-1#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)(2012-12#1)
the cultural##33##2##(1994-1#1)(1996-1#1)(1996-8#1)(1997-1#2)(2007-2#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)
the culture and the##2##4##(2008-7#1)(2008-9#1)
the culture and##6##3##(2008-11#3)(2008-7#1)(2008-9#2)
the culture broth##3##3##(2008-11#1)(2008-12#1)(2008-6#1)
the culture conditions##5##3##(2008-11#4)(2008-7#1)
the culture confirmed the##2##4##(2008-1#1)(2008-11#1)
the culture dish##2##3##(1995-12#1)(2008-11#1)
the culture filtrate of##3##4##(1991-5#1)(2008-10#2)
the culture filtrate##5##3##(1991-5#1)(2008-10#3)(2008-8#1)
the culture in the##2##4##(2008-6#1)(2008-7#1)
the culture in##3##3##(2007-10#1)(2008-6#1)(2008-7#1)
the culture incubated##2##3##(2008-11#2)
the culture media was##2##4##(2008-11#1)(2013-1#1)
the culture media##8##3##(1992-5#1)(1992-8#1)(1994-2#1)(1994-9#1)(2008-11#3)(2013-1#1)
the culture medium and##5##4##(1995-3#1)(1997-4#1)(2008-11#1)(2008-7#1)(2012-6#1)
the culture medium by##2##4##(1993-3#1)(1993-6#1)
the culture medium of##6##4##(1993-9#1)(1994-6#1)(1997-1#1)(1997-4#1)(2009-3#2)
the culture medium resulted in##3##5##(1993-12#1)(1994-6#1)(2008-11#1)
the culture medium was##2##4##(1994-6#1)(1996-2#1)
the culture medium were##2##4##(1993-9#1)(2008-11#1)
the culture medium##76##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-9#6)(1994-11#1)(1994-12#2)(1994-6#3)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#3)(2008-1#2)(2008-10#1)(2008-11#20)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-6#1)
the culture of the##2##4##(1994-2#1)(2008-8#1)
the culture of##15##3##(1994-1#1)(1994-2#2)(2008-11#7)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)
the culture or##2##3##(2008-11#1)(2012-2#1)
the culture period##5##3##(1993-3#1)(2008-11#4)
the culture plate method##2##4##(2008-10#2)
the culture pond water##3##4##(2008-5#3)
the culture pond##4##3##(2008-5#4)
the culture process##4##3##(1997-2#1)(2008-11#2)(2008-7#1)
the culture solution was##2##4##(2010-3#2)
the culture supernatant##5##3##(1990-8#1)(1993-11#1)(2008-11#2)(2008-6#1)
the culture supernatants##2##3##(1990-2#1)(2011-3#1)
the culture system##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
the culture temperature##3##3##(2008-11#2)(2008-7#1)
the culture was##2##3##(2008-11#1)(2008-7#1)
the culture with##3##3##(2008-11#2)(2013-1#1)
the culture##214##2##(1990-11#1)(1990-2#2)(1990-8#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#4)(1993-9#6)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(2007-10#1)(2007-7#2)(2008-1#3)(2008-10#6)(2008-11#84)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#20)(2008-8#4)(2008-9#8)(2009-10#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)
the cultured cardiac myocytes##2##4##(1993-3#2)
the cultured cells##8##3##(1995-12#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-12#1)(2012-2#1)
the cultured human##2##3##(1993-6#1)(2008-5#1)
the cultured##18##2##(1993-3#3)(1993-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2012-2#1)
the cultures by##2##3##(2008-10#1)(2008-11#1)
the cultures had##2##3##(1992-3#1)(2008-11#1)
the cultures was##3##3##(1994-5#1)(2008-10#2)
the cultures were##3##3##(1993-8#1)(1996-5#1)(1997-4#1)
the cultures with##2##3##(2008-11#2)
the cultures##33##2##(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#6)(2008-11#14)(2008-4#1)(2008-5#1)(2010-8#1)
the culturing##2##2##(2008-11#1)(2008-9#1)
the cumbersome##2##2##(1995-2#1)(2008-9#1)
the cumulative action of multiple##2##5##(1995-5#1)(2012-3#1)
the cumulative amount of##3##4##(2008-5#1)(2008-7#1)(2011-3#1)
the cumulative effect of##2##4##(2008-10#1)(2012-12#1)
the cumulative effects of##2##4##(2008-6#1)(2008-7#1)
the cumulative effects##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
the cumulative incidence of##4##4##(2008-7#3)(2013-1#1)
the cumulative incidence##7##3##(1997-4#2)(2008-11#1)(2008-7#3)(2013-1#1)
the cumulative number of##3##4##(2008-10#3)
the cumulative probability of##4##4##(2008-2#1)(2011-3#2)(2013-8#1)
the cumulative time required for sequential implantation##2##7##(2012-2#2)
the cumulative##48##2##(1991-6#1)(1993-9#1)(1994-9#1)(1995-5#1)(1997-4#2)(2007-10#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#8)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the cupping##2##2##(2008-5#1)(2012-1#1)
the cups##3##2##(1996-3#1)(2008-10#2)
the curative##4##2##(1995-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
the curd forming ability##2##4##(2010-2#2)
the curd##5##2##(2010-2#5)
the cure and##2##3##(2008-3#1)(2012-3#1)
the cure of##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
the cure rate##2##3##(2008-1#1)(2010-3#1)
the cure##10##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
the curing##4##2##(2007-12#1)(2008-12#1)(2008-8#2)
the current &quot##2##3##(1994-3#1)(2012-2#1)
the current U##2##3##(1994-1#1)(2008-6#1)
the current and potential future##2##5##(2008-11#1)(2009-4#1)
the current and##5##3##(1996-2#1)(2008-10#1)(2008-11#2)(2009-4#1)
the current approach to##2##4##(2007-4#1)(2010-12#1)
the current approach##3##3##(2007-4#1)(2008-3#1)(2010-12#1)
the current article##3##3##(2008-5#1)(2013-8#2)
the current case##2##3##(2010-10#1)(2013-1#1)
the current classification##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
the current clinical##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
the current configuration##2##3##(2008-10#1)(2008-3#1)
the current data##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2010-6#1)
the current debate##3##3##(1993-12#1)(1994-12#1)(2008-11#1)
the current during SD was##2##5##(1993-12#2)
the current epidemiological##3##3##(2007-2#1)(2008-10#1)(2008-8#1)
the current estimate##2##3##(2010-2#2)
the current evidence##7##3##(2007-8#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
the current experimental##2##3##(2011-2#1)(2012-2#1)
the current findings##2##3##(2008-10#1)(2013-8#1)
the current health care system##2##5##(1996-12#1)(1997-3#1)
the current health care##5##4##(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#2)
the current health##9##3##(1993-12#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(2010-8#1)(2013-1#1)
the current in the##2##4##(1991-9#1)(2009-11#1)
the current indications for##2##4##(2007-12#1)(2011-2#1)
the current indications##3##3##(2007-12#1)(2009-4#1)(2011-2#1)
the current interest in##2##4##(1995-8#1)(2008-10#1)
the current international##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
the current knowledge about the##2##5##(2008-11#1)(2008-4#1)
the current knowledge about##3##4##(1996-5#1)(2008-11#1)(2008-4#1)
the current knowledge of the##4##5##(2007-7#1)(2008-5#1)(2013-1#1)(2013-7#1)
the current knowledge of##9##4##(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
the current knowledge on the##3##5##(2008-4#1)(2009-4#1)(2011-7#1)
the current knowledge on##7##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-7#1)
the current knowledge##21##3##(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#4)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#1)(2013-7#1)
the current level of##6##4##(1994-2#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
the current literature and##2##4##(2011-2#1)(2012-2#1)
the current literature on the##3##5##(1995-12#1)(2008-5#1)(2011-2#1)
the current literature on##4##4##(1995-12#1)(2008-5#1)(2011-2#2)
the current literature##20##3##(1992-12#1)(1995-12#1)(1997-8#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)
the current management strategies##2##4##(2012-2#1)(2013-8#1)
the current management##3##3##(2008-1#1)(2012-2#1)(2013-8#1)
the current method##2##3##(2008-5#2)
the current methods used for##2##5##(2008-11#1)(2013-1#1)
the current methods##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
the current nature##2##3##(1995-12#1)(2007-10#1)
the current opinions##2##3##(2007-2#1)(2012-3#1)
the current paper##6##3##(1993-6#1)(1997-3#1)(1997-4#1)(2008-8#1)(2010-10#1)(2010-3#1)
the current policy##3##3##(1995-6#1)(1996-2#1)(2008-11#1)
the current practice of##4##4##(1991-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
the current practice##5##3##(1991-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
the current problem##2##3##(2008-3#1)(2010-5#1)
the current problems##2##3##(1991-2#1)(1997-8#1)
the current provision of##2##4##(2008-11#1)(2010-4#1)
the current response##4##3##(2008-10#4)
the current results##3##3##(1996-5#1)(2007-12#1)(2010-12#1)
the current shortage of##3##4##(1994-1#1)(2008-11#1)(2008-12#1)
the current situation in##2##4##(2007-5#1)(2009-5#1)
the current situation##5##3##(1991-3#1)(2007-5#1)(2007-7#1)(2009-5#1)(2012-12#1)
the current standard##5##3##(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#2)
the current state of knowledge on##2##6##(1995-11#1)(2012-2#1)
the current state of knowledge##9##5##(1995-11#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2012-2#1)(2012-3#1)
the current state of research##2##5##(2010-11#1)(2012-2#1)
the current state of the art##2##6##(2008-10#1)(2008-8#1)
the current state of the##7##5##(1994-9#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#1)
the current state of##29##4##(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)
the current state##31##3##(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)
the current state-of-the-art##2##3##(2008-4#1)(2011-7#1)
the current status of knowledge##2##5##(2008-11#1)(2013-1#1)
the current status of renal transplantation in the##2##8##(2008-4#2)
the current status of research##2##5##(2008-11#1)(2010-11#1)
the current status of the##3##5##(1996-8#1)(1997-3#1)(2013-1#1)
the current status of these##2##5##(1994-12#1)(1997-1#1)
the current status of##26##4##(1994-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-7#1)(2012-12#1)(2013-1#3)(2013-8#1)
the current status##29##3##(1992-10#1)(1994-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#3)(2013-8#1)
the current study used##2##4##(2007-12#1)(2012-3#1)
the current study##60##3##(1994-6#1)(1995-2#3)(1996-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-10#10)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-6#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#2)
the current system##6##3##(1991-3#2)(1997-2#1)(2008-12#1)(2008-8#1)(2009-5#1)
the current understanding of the##4##5##(2008-7#3)(2009-12#1)
the current understanding of##9##4##(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-5#1)(2012-3#1)
the current understanding##10##3##(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#2)(2010-5#1)(2012-3#1)
the current use of##5##4##(2007-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
the current was##3##3##(1993-3#1)(1994-3#1)(1995-12#1)
the current##571##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-6#2)(1991-9#3)(1992-10#1)(1992-12#4)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#8)(1993-2#1)(1993-3#3)(1993-6#2)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#6)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#5)(2007-12#11)(2007-2#4)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#61)(2008-11#41)(2008-12#8)(2008-2#9)(2008-3#21)(2008-4#10)(2008-5#14)(2008-6#7)(2008-7#14)(2008-8#14)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#4)(2010-11#6)(2010-12#10)(2010-2#5)(2010-3#8)(2010-4#4)(2010-5#5)(2010-6#3)(2010-8#7)(2010-9#2)(2011-1#5)(2011-2#30)(2011-7#3)(2012-1#2)(2012-12#10)(2012-2#19)(2012-3#18)(2013-1#26)(2013-7#3)(2013-8#11)
the currently accepted##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
the currently available data##3##4##(2008-1#1)(2008-7#1)(2013-7#1)
the currently available##14##3##(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the currently known##2##3##(2007-12#1)(2012-2#1)
the currently used##5##3##(1992-11#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-8#1)
the currently##35##2##(1992-11#1)(1992-3#1)(1995-3#1)(1996-2#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
the currents##3##2##(1995-5#1)(2008-8#1)(2009-8#1)
the curricula##2##2##(1996-1#1)(2008-12#1)
the curricular##2##2##(1996-2#1)(2008-11#1)
the curriculum of##3##3##(1996-8#1)(2007-11#1)(2011-2#1)
the curriculum##20##2##(1993-2#1)(1994-1#2)(1994-12#1)(1995-2#1)(1996-8#1)(2007-11#1)(2007-5#1)(2008-11#5)(2008-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)
the curvature and##3##3##(2007-12#1)(2008-3#1)(2012-1#1)
the curvature of##3##3##(2007-11#1)(2008-9#1)(2009-11#1)
the curvature was##2##3##(2008-2#1)(2008-3#1)
the curvature##17##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)(2008-9#2)(2009-11#1)(2009-2#3)(2009-6#1)(2010-2#1)(2012-1#1)
the curve and##2##3##(2008-10#1)(2008-7#1)
the curve of the##2##4##(2007-8#1)(2008-10#1)
the curve of##7##3##(1993-1#1)(2007-8#1)(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
the curve values##3##3##(2007-10#1)(2008-7#1)(2013-7#1)
the curve was##2##3##(2008-10#1)(2013-1#1)
the curve##37##2##(1992-9#1)(1993-1#1)(1994-12#2)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#2)(2009-6#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
the curved surface##2##3##(1994-9#1)(2008-2#1)
the curved##6##2##(1994-9#1)(2008-2#2)(2008-3#2)(2009-11#1)
the curves obtained##2##3##(1990-6#1)(2008-10#1)
the curves##14##2##(1990-6#1)(1994-3#1)(1995-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)
the custom##5##2##(2008-1#1)(2008-10#2)(2008-9#1)(2010-4#1)
the customer##5##2##(1992-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-3#1)
the customer's##3##2##(1991-12#1)(1994-12#2)
the customers##4##2##(1994-12#1)(1995-2#1)(1996-1#1)(2008-12#1)
the cut##7##2##(1993-12#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-12#1)
the cut-off value##3##3##(1997-3#2)(2010-4#1)
the cut-off values##2##3##(1994-12#1)(2011-1#1)
the cut-off##9##2##(1993-1#1)(1994-12#1)(1997-3#2)(2008-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#1)
the cutaneous lesions##3##3##(2008-5#2)(2013-8#1)
the cutaneous mass##2##3##(2013-8#2)
the cutaneous##15##2##(1990-9#1)(1992-6#1)(2008-5#6)(2009-1#1)(2010-6#2)(2013-8#4)
the cuticle and##5##3##(2008-10#5)
the cuticle layer##2##3##(2008-10#2)
the cuticle of##3##3##(2007-12#1)(2008-10#2)
the cuticle##34##2##(1993-12#2)(2007-12#7)(2008-10#17)(2008-5#3)(2008-7#1)(2008-8#4)
the cuticular apparatus##2##3##(2007-12#2)
the cuticular##12##2##(1993-9#1)(2007-12#7)(2008-10#1)(2008-5#1)(2008-9#2)
the cutoff frequency##2##3##(2007-11#1)(2008-2#1)
the cutoff##12##2##(1992-6#3)(1995-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#1)
the cutting edge##4##3##(1994-1#1)(2008-1#1)(2008-6#1)(2008-8#1)
the cutting##5##2##(1994-1#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)
the cuvette##2##2##(1992-11#1)(2008-3#1)
the cv##2##2##(2008-10#1)(2008-6#1)
the cw laser##2##3##(2008-2#1)(2008-3#1)
the cw regime##2##3##(2007-11#1)(2007-12#1)
the cw##15##2##(2007-11#3)(2007-12#3)(2008-2#5)(2008-3#4)
the cyanelle##2##2##(1997-6#2)
the cyanide complex of##2##4##(1993-8#2)
the cyanide##5##2##(1990-12#1)(1993-8#2)(2008-10#2)
the cyano propyl stationary phase##2##5##(2008-10#2)
the cyano propyl stationary##3##4##(2008-10#3)
the cyano##4##2##(2007-11#1)(2008-10#3)
the cyanobacterial##2##2##(1990-11#1)(2012-2#1)
the cyanobacterium Synechococcus sp##2##4##(1992-3#1)(1996-6#1)
the cyanobacterium##6##2##(1992-12#1)(1992-3#1)(1995-12#1)(1996-12#2)(1996-6#1)
the cycad Lepidozamia peroffskyana##2##4##(1994-11#2)
the cycle of the seminiferous epithelium##2##6##(2009-10#2)
the cycle of##5##3##(2008-10#1)(2009-10#2)(2010-1#1)(2013-1#1)
the cycle##11##2##(1990-12#1)(1991-11#1)(1994-9#2)(2008-10#1)(2008-5#1)(2009-10#3)(2010-1#1)(2013-1#1)
the cycles##4##2##(1994-7#2)(1997-3#1)(2008-3#1)
the cyclic AMP##4##3##(1990-12#1)(1993-6#1)(1994-11#1)(1997-2#1)
the cyclic lipopeptide massetolide A##2##5##(2008-10#2)
the cyclic lipopeptide##3##3##(2008-10#3)
the cyclic##23##2##(1990-11#1)(1990-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#4)(2009-10#1)(2009-8#3)(2013-1#1)(2013-7#1)
the cyclin D3 pseudogene##2##4##(1997-4#2)
the cyclin##4##2##(1997-4#2)(1997-8#1)(2012-3#1)
the cyclin-dependent kinase inhibitor##3##4##(2008-11#2)(2012-12#1)
the cycling##2##2##(1990-8#1)(2010-5#1)
the cyclo-oxygenase inhibitor##2##3##(1995-11#1)(2006-6#1)
the cyclo-oxygenase##3##2##(1995-11#1)(1995-6#1)(2006-6#1)
the cycloadditions##2##2##(1996-5#2)
the cyclodextrin (CD)##2##3##(2008-10#2)
the cyclodextrin##5##2##(2008-10#5)
the cyclooxygenase##6##2##(1992-3#1)(1994-5#2)(1995-12#1)(2008-4#1)(2011-2#1)
the cyclosporine A-induced##2##3##(1995-12#2)
the cyfluthrin##2##2##(2011-2#2)
the cylinder diameters##2##3##(2009-2#2)
the cylinder##17##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#8)(2009-2#5)
the cylinder's##4##2##(2008-2#1)(2008-3#3)
the cylinders##2##2##(2008-3#1)(2012-2#1)
the cylindrical inclusion##2##3##(2008-10#2)
the cylindrical##8##2##(2008-10#3)(2008-2#1)(2008-3#4)
the cynomolgus monkey##4##3##(2008-10#4)
the cynomolgus##5##2##(1997-8#1)(2008-10#4)
the cyoE gene in##2##4##(1992-12#2)
the cyoE gene##3##3##(1992-12#3)
the cyst and##4##3##(1991-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
the cyst wall##2##3##(2008-5#1)(2008-7#1)
the cyst was##5##3##(1997-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)
the cyst##32##2##(1990-6#1)(1991-8#3)(1995-12#1)(1997-8#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#4)(2008-7#4)(2009-9#1)(2011-1#1)(2012-2#4)(2013-1#2)
the cystathionine##2##2##(1995-2#1)(2008-10#1)
the cysteine residues##3##3##(1992-5#1)(1993-8#1)(1993-9#1)
the cysteine##13##2##(1990-5#1)(1991-2#2)(1991-9#1)(1992-5#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#1)(1997-6#2)
the cysteine-rich##3##2##(1995-2#1)(1995-6#1)(2008-10#1)
the cysteines##3##2##(1991-2#1)(1994-11#2)
the cysteinyl##2##2##(1991-5#2)
the cystic duct##8##3##(1992-9#3)(2008-12#3)(2010-12#2)
the cystic fibrosis##3##3##(1990-8#1)(1994-5#1)(2007-6#1)
the cystic lesion##3##3##(2006-10#1)(2008-1#1)(2008-5#1)
the cystic lumen##2##3##(2009-3#2)
the cystic##19##2##(1990-8#1)(1992-9#3)(1993-9#1)(1994-5#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#2)(2009-3#2)(2010-12#2)
the cystine##2##2##(1990-5#1)(2007-7#1)
the cysts and##2##3##(1993-1#1)(2008-5#1)
the cysts are##2##3##(1993-1#1)(2008-7#1)
the cysts were##3##3##(2008-7#1)(2011-1#1)(2012-3#1)
the cysts##17##2##(1993-1#3)(1995-12#1)(2008-10#2)(2008-5#2)(2008-7#4)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
the cyt b gene##2##4##(2010-4#2)
the cyt##3##2##(2010-4#2)(2011-2#1)
the cytidylyltransferase##2##2##(1991-11#1)(1997-2#1)
the cytobrush##3##2##(1992-1#3)
the cytochrome P-450 monooxygenase##2##4##(1990-7#1)(1992-3#1)
the cytochrome P-450##4##3##(1990-7#1)(1992-11#1)(1992-3#1)(2008-3#1)
the cytochrome P450##6##3##(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-4#1)(2012-12#1)
the cytochrome b gene##3##4##(2008-10#3)
the cytochrome b##5##3##(1995-11#1)(2008-10#3)(2009-9#1)
the cytochrome##33##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#2)(2012-12#1)
the cytogenetic##6##2##(1990-8#1)(1992-8#1)(2008-5#2)(2012-3#2)
the cytokine secretion##3##3##(2008-10#1)(2008-11#2)
the cytokine##15##2##(1991-2#1)(1992-3#1)(1994-9#1)(1996-12#1)(1996-2#3)(2007-8#1)(2008-10#2)(2008-11#2)(2011-1#1)(2013-8#2)
the cytokines##8##2##(1990-2#1)(1992-3#1)(1992-8#1)(1994-6#1)(1995-12#1)(1995-5#1)(2006-10#1)(2008-11#1)
the cytologic##3##2##(1991-2#2)(2008-6#1)
the cytological grading and typing##2##5##(2013-8#2)
the cytological##10##2##(1991-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-8#2)
the cytologists in##2##3##(2008-6#2)
the cytology##2##2##(2012-12#1)(2013-8#1)
the cytolytic activity##2##3##(1991-12#1)(2008-10#1)
the cytolytic##3##2##(1991-12#1)(1993-6#1)(2008-10#1)
the cytomegalic cells##2##3##(2012-3#2)
the cytomegalovirus (CMV) promoter##2##4##(1995-12#1)(2008-11#1)
the cytomegalovirus##5##2##(1995-12#1)(2007-12#1)(2008-11#3)
the cytopathic##2##2##(1992-8#1)(2007-6#1)
the cytoplasm and##8##3##(1994-12#1)(1997-4#1)(2008-11#1)(2009-8#1)(2011-2#3)(2012-2#1)
the cytoplasm at##2##3##(1991-2#1)(1992-3#1)
the cytoplasm of oocytes##2##4##(1995-12#1)(2013-1#1)
the cytoplasm of the##8##4##(1991-2#1)(1992-2#1)(1995-5#1)(2008-11#2)(2008-9#1)(2009-2#1)(2012-2#1)
the cytoplasm of##38##3##(1990-11#1)(1991-11#2)(1991-2#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#2)(1997-2#1)(1997-4#1)(2006-6#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
the cytoplasm transfer##2##3##(2007-12#2)
the cytoplasm was##3##3##(1994-6#1)(2008-8#1)(2008-9#1)
the cytoplasm with##2##3##(2008-5#1)(2008-7#1)
the cytoplasm##107##2##(1990-11#1)(1991-11#5)(1991-2#2)(1992-11#1)(1992-2#1)(1992-3#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#2)(1997-2#1)(1997-4#2)(1997-8#1)(2006-6#2)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#10)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#1)(2009-2#2)(2009-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#3)(2012-7#2)(2013-1#2)(2013-8#1)
the cytoplasmic domain of the##2##5##(1994-9#1)(2008-5#1)
the cytoplasmic domain of##3##4##(1994-9#1)(1995-2#1)(2008-5#1)
the cytoplasmic domain##4##3##(1994-9#1)(1995-2#1)(2008-5#1)(2013-1#1)
the cytoplasmic face of##2##4##(2009-7#1)(2013-1#1)
the cytoplasmic membrane and##3##4##(1991-10#2)(2011-2#1)
the cytoplasmic membrane of Escherichia coli##2##6##(1990-11#1)(1991-5#1)
the cytoplasmic membrane of##3##4##(1990-11#1)(1991-5#1)(1994-2#1)
the cytoplasmic membrane##12##3##(1990-11#1)(1990-8#2)(1991-10#2)(1991-5#1)(1994-12#1)(1994-2#2)(2008-5#1)(2008-9#1)(2011-2#1)
the cytoplasmic receptor domain##2##4##(1997-7#2)
the cytoplasmic side of the platelet membranes##2##7##(1992-6#2)
the cytoplasmic side of the##3##5##(1990-8#1)(1992-6#2)
the cytoplasmic side##4##3##(1990-8#1)(1992-6#3)
the cytoplasmic tail##2##3##(2008-9#2)
the cytoplasmic##46##2##(1990-11#1)(1990-8#3)(1991-10#2)(1991-5#2)(1992-10#1)(1992-6#3)(1993-11#1)(1993-3#3)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#6)(2009-11#1)(2009-7#1)(2009-9#1)(2011-2#1)(2013-1#2)
the cytosine##2##2##(2008-10#1)(2008-9#1)
the cytoskeletal fraction##3##3##(1997-2#3)
the cytoskeletal##6##2##(1993-8#1)(1997-2#3)(2007-12#1)(2008-11#1)
the cytoskeleton and##4##3##(1992-11#1)(1997-3#1)(2008-11#1)(2011-2#1)
the cytoskeleton##15##2##(1990-12#1)(1992-11#1)(1992-6#1)(1993-11#1)(1997-3#1)(2008-10#2)(2008-11#3)(2009-10#1)(2011-2#2)(2012-12#2)
the cytosol and the##2##4##(1991-2#1)(2008-11#1)
the cytosol and##8##3##(1990-2#1)(1990-5#2)(1991-2#1)(1992-3#1)(1993-9#1)(2008-11#1)(2009-8#1)
the cytosol fraction##4##3##(1990-11#2)(1992-6#1)(2008-10#1)
the cytosol from##2##3##(1990-5#1)(1994-5#1)
the cytosol of##11##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-6#1)(1995-11#1)(1996-5#1)(1997-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
the cytosol to##6##3##(1992-12#1)(1992-6#1)(1995-11#2)(1997-1#1)(2011-2#1)
the cytosol##61##2##(1990-11#2)(1990-2#3)(1990-5#4)(1991-12#2)(1991-2#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#3)(2013-1#1)
the cytosolic and##4##3##(1993-11#1)(1993-12#2)(1996-5#1)
the cytosolic enzyme was##2##4##(1990-5#1)(1996-5#1)
the cytosolic fraction##3##3##(1991-2#1)(1992-11#1)(1992-6#1)
the cytosolic fractions##2##3##(1990-7#1)(1996-2#1)
the cytosolic free##2##3##(1990-2#1)(1992-6#1)
the cytosolic space##2##3##(2007-12#2)
the cytosolic transport##2##3##(1994-6#2)
the cytosolic##38##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1992-11#3)(1992-6#3)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-6#2)(2007-12#2)(2008-8#1)(2009-11#1)(2009-12#1)(2012-12#1)
the cytostatic##4##2##(2008-7#3)(2012-12#1)
the cytotoxic T##2##3##(1993-9#1)(2010-12#1)
the cytotoxic activity of human natural killer cells##3##8##(1990-12#3)
the cytotoxic activity of##5##4##(1990-12#3)(1992-9#1)(2008-10#1)
the cytotoxic activity##7##3##(1990-12#3)(1992-5#1)(1992-9#1)(2008-10#1)(2011-2#1)
the cytotoxic and##3##3##(1993-8#1)(2008-4#1)(2011-2#1)
the cytotoxic effect of##3##4##(2008-12#1)(2010-12#1)(2012-12#1)
the cytotoxic effect##5##3##(1995-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-12#1)
the cytotoxic effects of##4##4##(1990-2#1)(2008-11#1)(2012-3#1)(2013-1#1)
the cytotoxic effects##5##3##(1990-2#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
the cytotoxic response##2##3##(1992-10#1)(1995-8#1)
the cytotoxic##32##2##(1990-12#4)(1990-2#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-8#1)(1993-9#1)(1994-2#1)(1995-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the cytotoxicity of some##2##4##(2013-1#1)(2013-7#1)
the cytotoxicity of the##6##4##(2008-11#1)(2008-5#1)(2008-8#3)(2009-4#1)
the cytotoxicity of##18##3##(1991-5#1)(1992-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#5)(2009-4#2)(2013-1#2)(2013-7#1)
the cytotoxicity##23##2##(1990-2#1)(1991-5#1)(1992-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#6)(2009-4#2)(2011-1#1)(2011-3#1)(2013-1#2)(2013-7#1)
the d##2##2##(2008-10#1)(2008-11#1)
the dA-dT##2##2##(1992-6#2)
the dLGN##2##2##(1992-10#2)
the dRTA was##2##3##(2008-1#2)
the dRTA##3##2##(2008-1#3)
the daily activities##2##3##(2008-9#1)(2010-5#1)
the daily dose of##2##4##(1994-6#1)(2013-1#1)
the daily dose##4##3##(1992-10#1)(1994-6#1)(2011-2#1)(2013-1#1)
the daily intake of##2##4##(1992-9#1)(2013-1#1)
the daily life of##2##4##(2008-11#1)(2010-10#1)
the daily life##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
the daily pattern of##2##4##(2008-10#1)(2009-9#1)
the daily routine##2##3##(1993-12#1)(2008-11#1)
the daily##41##2##(1991-12#2)(1992-10#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#2)(2013-1#2)
the damage caused by##5##4##(1992-3#1)(2008-5#2)(2008-6#1)(2013-1#1)
the damage caused##6##3##(1992-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2013-1#1)
the damage threshold of##3##4##(2008-3#3)
the damage threshold##7##3##(2007-11#1)(2008-10#2)(2008-3#3)(2013-8#1)
the damage to##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
the damage##40##2##(1990-4#1)(1991-9#1)(1992-3#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#2)(2013-8#2)
the damaged area##2##3##(2012-1#2)
the damaged tissues##2##3##(2007-11#1)(2010-8#1)
the damaged##14##2##(1990-11#1)(1991-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#1)
the damages##3##2##(1990-11#1)(1995-6#1)(2009-8#1)
the damaging effects of##3##4##(1994-6#1)(1996-5#1)(2013-8#1)
the damped linear oscillator##2##4##(2009-10#2)
the damped linear##3##3##(2009-10#3)
the damped##4##2##(2008-10#1)(2009-10#3)
the damselfish##2##2##(2008-5#2)
the dance##2##2##(2009-3#2)
the dandruff density##2##3##(2008-5#2)
the dandruff##3##2##(2008-5#3)
the danger of##9##3##(1990-11#1)(1992-9#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
the danger##15##2##(1990-11#1)(1992-9#1)(1996-11#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-12#1)(2013-1#1)
the dangerous##2##2##(2009-10#1)(2010-12#1)
the dangers of AIDS##2##4##(1992-2#1)(1997-6#1)
the dangers of##7##3##(1992-2#1)(1995-6#1)(1997-6#1)(2008-10#1)(2009-2#1)(2010-12#1)(2010-5#1)
the dangers##10##2##(1992-2#1)(1992-3#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-2#1)(2008-10#1)(2009-2#1)(2010-12#1)(2010-5#1)
the dansyl group##2##3##(1994-5#2)
the dansyl##12##2##(1990-8#1)(1992-3#1)(1994-5#5)(1996-5#2)(2008-10#3)
the dansylation##2##2##(2008-10#2)
the dark period##5##3##(1990-7#1)(1995-11#1)(1997-2#2)(2008-11#1)
the dark phase##3##3##(1993-12#1)(1994-2#1)(2008-5#1)
the dark##51##2##(1990-7#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-2#2)(2006-11#2)(2007-11#4)(2007-12#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#8)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-3#1)
the data about##2##3##(2008-10#1)(2009-5#1)
the data acquired##2##3##(2008-10#1)(2008-3#1)
the data analysis of##2##4##(1990-3#1)(2008-10#1)
the data analysis was##2##4##(2010-12#1)(2013-8#1)
the data analysis##11##3##(1990-3#1)(1990-8#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
the data and the##2##4##(2008-8#1)(2013-8#1)
the data and##13##3##(1992-3#1)(1995-11#1)(1996-3#1)(1997-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-8#1)
the data are analyzed##2##4##(1992-11#1)(1994-2#1)
the data are consistent with##3##5##(1992-2#1)(2008-8#1)(2011-2#1)
the data are##19##3##(1990-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-2#2)(1994-9#1)(1995-12#2)(1996-3#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
the data as well as##3##5##(2008-3#1)(2009-8#1)(2013-8#1)
the data as##4##3##(1994-9#1)(2008-3#1)(2009-8#1)(2013-8#1)
the data at##2##3##(1990-8#1)(2008-2#1)
the data available##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
the data base##3##3##(1991-2#1)(1993-12#1)(1994-3#1)
the data better than the##2##5##(1997-7#1)(2008-10#1)
the data by using##2##4##(2008-3#1)(2008-6#1)
the data by##5##3##(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)
the data can be##3##4##(2008-9#1)(2010-11#1)(2010-12#1)
the data can##4##3##(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)
the data collected##4##3##(1990-8#1)(1991-12#1)(1992-2#1)(1997-4#1)
the data collection##4##3##(1993-12#1)(1997-2#1)(2007-4#1)(2008-11#1)
the data concerning##2##3##(2008-12#1)(2013-1#1)
the data demonstrated##2##3##(1996-6#1)(2010-10#1)
the data derived from##2##4##(2008-11#1)(2008-3#1)
the data do not##2##4##(1992-11#1)(2008-8#1)
the data elements##2##3##(1997-3#1)(2008-6#1)
the data file##2##3##(2008-9#2)
the data for both##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
the data for the##2##4##(2008-11#1)(2008-3#1)
the data for##15##3##(1990-11#1)(1992-9#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)
the data from the##9##4##(1990-7#1)(1992-11#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-5#1)(2010-6#1)
the data from this##2##4##(2008-1#1)(2010-6#1)
the data from##23##3##(1990-7#1)(1992-11#2)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)
the data generated by##3##4##(2008-3#1)(2010-12#1)(2011-2#1)
the data generated##6##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
the data have been##3##4##(1994-6#1)(2008-10#2)
the data in the##3##4##(1995-8#1)(2007-12#1)(2008-10#1)
the data in##14##3##(1990-8#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
the data indicate that the##2##5##(1990-8#1)(2008-10#1)
the data indicate that##6##4##(1990-8#1)(1992-8#1)(2008-10#2)(2009-8#1)(2011-2#1)
the data indicate##8##3##(1990-8#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
the data indicated that##2##4##(2008-10#2)
the data indicated##3##3##(2008-10#3)
the data is##10##3##(1990-3#1)(1991-12#1)(1994-5#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-9#1)
the data matrix##2##3##(1992-11#1)(2008-10#1)
the data may##2##3##(2013-8#2)
the data model##2##3##(1997-3#1)(2008-7#1)
the data obtained at the##2##5##(2011-1#1)(2013-1#1)
the data obtained by##3##4##(2008-10#3)
the data obtained from##2##4##(2008-10#1)(2010-8#1)
the data obtained in##2##4##(1992-3#1)(2008-5#1)
the data obtained using the##2##5##(2008-10#2)
the data obtained##20##3##(1991-2#1)(1992-3#1)(1993-6#1)(1993-8#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
the data of a##2##4##(2008-10#1)(2008-2#1)
the data of the##8##4##(1997-8#1)(2008-10#4)(2008-3#1)(2009-7#1)(2013-1#1)
the data of##21##3##(1990-8#1)(1994-7#1)(1997-8#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-8#1)(2009-7#1)(2012-3#1)(2013-1#1)
the data on the##2##4##(1990-11#1)(2008-11#1)
the data on##12##3##(1990-11#1)(1990-6#1)(1991-4#1)(1996-4#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
the data or##4##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
the data page##2##3##(2007-12#1)(2008-3#1)
the data points##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
the data presented##4##3##(2008-10#1)(2008-5#1)(2008-7#2)
the data provide a##2##4##(1994-6#1)(2008-11#1)
the data provide##3##3##(1994-6#1)(2008-11#1)(2009-8#1)
the data quality##2##3##(2007-12#1)(2008-10#1)
the data recorded in##2##4##(2008-10#1)(2012-3#1)
the data regarding the##2##4##(2010-8#1)(2011-2#1)
the data reported##3##3##(2007-12#1)(2008-2#1)(2009-4#1)
the data set##12##3##(1997-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2012-3#1)
the data sets##12##3##(2008-10#9)(2008-8#1)(2008-9#1)(2009-5#1)
the data show##3##3##(1990-5#1)(1991-9#1)(1994-6#1)
the data shows that##2##4##(1997-2#1)(2008-11#1)
the data sources##2##3##(1991-2#1)(2009-11#1)
the data structure##2##3##(2008-10#2)
the data suggest a##2##4##(1995-6#1)(2008-5#1)
the data suggest that##6##4##(1990-2#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-8#1)(2012-2#1)
the data suggest##9##3##(1990-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1997-8#1)(2008-5#1)(2008-8#2)(2012-2#1)
the data suggested##2##3##(1990-6#1)(1997-2#1)
the data supporting##2##3##(2008-10#1)(2008-11#1)
the data system##2##3##(1994-2#1)(1994-3#1)
the data that##4##3##(1995-6#1)(2008-11#1)(2008-9#1)(2012-2#1)
the data to inform##2##4##(2008-11#1)(2008-12#1)
the data to the##2##4##(2008-10#1)(2010-4#1)
the data to##13##3##(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2010-4#1)(2010-8#1)
the data used and##2##4##(1994-12#1)(1995-6#1)
the data used##4##3##(1994-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
the data via an##2##4##(2008-10#1)(2012-12#1)
the data was##8##3##(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
the data were analyzed##4##4##(1993-9#1)(2008-10#1)(2008-12#1)(2009-8#1)
the data were used to##2##5##(2008-10#1)(2008-8#1)
the data were##13##3##(1993-12#1)(1993-9#1)(1994-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
the data with a##2##4##(2008-7#1)(2009-6#1)
the data with the##2##4##(1994-3#1)(2008-2#1)
the data with those##2##4##(2008-10#2)
the data with##8##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)
the data##533##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#9)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-9#1)(1992-11#6)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#4)(1994-7#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#4)(1995-3#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-3#4)(1996-4#2)(1996-6#1)(1997-1#2)(1997-2#7)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2007-10#2)(2007-11#4)(2007-12#7)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#106)(2008-11#30)(2008-12#4)(2008-2#23)(2008-3#43)(2008-4#7)(2008-5#11)(2008-6#9)(2008-7#26)(2008-8#17)(2008-9#17)(2009-11#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#8)(2011-1#5)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#11)(2013-8#10)
the data-reduction process##2##3##(2008-3#2)
the data?##2##2##(1994-2#1)(1997-1#1)
the database and##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
the database as a##2##4##(1997-3#1)(2008-7#1)
the database for##2##3##(2008-4#1)(2010-5#1)
the database in##2##3##(2008-11#1)(2010-5#1)
the database is##3##3##(1991-3#1)(1993-1#1)(2008-7#1)
the database of##5##3##(1993-8#1)(1997-8#1)(2008-7#2)(2012-2#1)
the database##39##2##(1991-12#1)(1991-3#2)(1992-12#1)(1993-1#2)(1993-8#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#8)(2009-10#1)(2010-5#4)(2011-1#1)(2011-2#1)(2012-2#1)
the databases##12##2##(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2013-8#1)
the dataset##7##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-3#1)
the date of##13##3##(1990-8#1)(1991-12#1)(1997-5#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#1)
the date##19##2##(1990-8#1)(1991-11#1)(1991-12#1)(1997-5#1)(2008-10#8)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2013-1#2)
the daughter cells##2##3##(2009-2#1)(2009-5#1)
the daughter##7##2##(1995-9#2)(2008-3#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)
the dawn of a new era##2##6##(2008-7#1)(2011-2#1)
the dawn of the##4##4##(1991-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
the dawn of##7##3##(1991-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
the day after the##2##4##(2007-10#1)(2007-12#1)
the day after##4##3##(1993-11#1)(2007-10#1)(2007-12#1)(2011-2#1)
the day and##2##3##(1995-1#1)(2011-2#1)
the day before surgery##4##4##(1996-3#1)(2008-8#3)
the day before the##2##4##(1992-6#1)(2007-8#1)
the day before##10##3##(1992-6#1)(1994-7#2)(1996-3#1)(2007-8#2)(2008-8#3)(2012-2#1)
the day following##2##3##(1995-3#1)(2010-6#1)
the day hospital##2##3##(2008-7#2)
the day of emergence##2##4##(2007-12#2)
the day of surgery##6##4##(1997-7#1)(2008-8#3)(2012-2#2)
the day of the##4##4##(1996-1#1)(1996-3#1)(2007-10#1)(2008-10#1)
the day of##26##3##(1990-2#1)(1992-6#1)(1996-1#2)(1996-3#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#5)(2008-5#1)(2008-8#3)(2010-6#1)(2012-2#2)(2013-1#1)
the day##72##2##(1990-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-6#2)(1994-7#2)(1995-1#2)(1995-3#1)(1996-1#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-7#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#8)(2008-5#4)(2008-7#3)(2008-8#6)(2009-9#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#4)(2013-1#1)
the day-night rhythm of##2##4##(1990-7#2)
the day-to-day##2##2##(1995-1#1)(2007-10#1)
the days##7##2##(1993-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
the daytime##4##2##(1995-12#1)(2008-3#2)(2013-1#1)
the db/db##3##2##(2008-3#1)(2012-3#2)
the dc##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
the de facto standard##2##4##(2008-10#1)(2008-7#1)
the de novo synthesis of##2##5##(1995-12#1)(2012-1#1)
the de novo##5##3##(1994-6#1)(1995-12#1)(1997-3#1)(2008-4#1)(2012-1#1)
the de##11##2##(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2012-1#1)
the deacetylase##2##2##(1991-5#1)(2012-12#1)
the deactivation of##2##3##(1996-4#1)(2008-5#1)
the deactivation##4##2##(1993-11#1)(1996-4#1)(2008-5#1)(2008-8#1)
the dead space##2##3##(2008-10#1)(2008-9#1)
the dead##15##2##(1991-11#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
the deadline##2##2##(1991-11#1)(2008-11#1)
the deadly##3##2##(2008-10#1)(2010-1#1)(2010-12#1)
the deafferented##3##2##(1991-2#1)(1992-10#1)(1997-3#1)
the deal##2##2##(1990-4#1)(1997-5#1)
the death and##4##3##(2008-3#2)(2011-2#2)
the death certificate##2##3##(1991-12#1)(1991-2#1)
the death of a grandchild##2##5##(2010-9#2)
the death of a##9##4##(1991-6#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-7#1)(2010-9#2)(2011-2#1)
the death of the##2##4##(1994-11#1)(2007-12#1)
the death of##24##3##(1991-6#1)(1991-8#1)(1994-11#1)(1995-11#1)(1996-6#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
the death programme##2##3##(2008-11#2)
the death rate##4##3##(2008-11#1)(2008-7#1)(2010-9#1)(2012-3#1)
the death##47##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#4)(2008-3#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-9#3)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)
the deaths in##2##3##(2009-4#1)(2010-8#1)
the deaths##8##2##(1995-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
the debate about##4##3##(1992-2#1)(1995-2#1)(1997-6#1)(2012-3#1)
the debate on##5##3##(1994-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
the debate over##4##3##(1994-3#1)(1996-5#1)(2008-8#2)
the debate surrounding##3##3##(1990-6#1)(1992-1#1)(2008-12#1)
the debate##24##2##(1990-6#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#2)(2010-7#1)(2012-3#2)
the debridement##2##2##(2007-8#1)(2012-2#1)
the debriefing##2##2##(2008-11#2)
the debt##3##2##(1990-2#1)(1992-5#2)
the decade##8##2##(1992-6#1)(1994-2#2)(1994-9#1)(2008-11#1)(2008-4#1)(2009-7#1)(2013-1#1)
the decapeptide##5##2##(1992-11#1)(1992-12#1)(1995-3#1)(2008-4#2)
the decarboxylation##3##2##(1990-7#1)(1993-8#2)
the decay constant##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
the decay in##2##3##(2008-2#1)(2008-3#1)
the decay of the##4##4##(1992-12#1)(1996-4#1)(2006-6#1)(2008-3#1)
the decay of##6##3##(1992-12#1)(1995-2#1)(1996-4#1)(2006-6#1)(2008-3#1)(2009-8#1)
the decay rate of the##2##5##(1992-3#1)(2008-2#1)
the decay rate of##4##4##(1992-3#1)(2007-11#1)(2008-2#1)(2009-5#1)
the decay time constant##3##4##(2008-2#1)(2008-3#2)
the decay time##4##3##(2008-2#1)(2008-3#2)(2009-8#1)
the decay##25##2##(1992-12#1)(1992-3#1)(1995-2#1)(1996-4#1)(2006-6#1)(2007-11#2)(2008-10#2)(2008-2#5)(2008-3#6)(2008-8#1)(2009-5#1)(2009-8#2)(2011-1#1)
the decaying##3##2##(2008-10#3)
the deceased##10##2##(1992-3#1)(1995-3#2)(1995-6#3)(1997-3#1)(2007-11#1)(2007-7#1)(2011-2#1)
the decentralization##2##2##(2008-7#1)(2012-12#1)
the decidua##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
the decidualized uterine tissue##2##4##(1997-6#2)
the decision for##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
the decision making process##3##4##(1992-3#1)(1996-6#2)
the decision making##4##3##(1992-3#1)(1996-6#2)(2007-11#1)
the decision of nurses to receive influenza vaccinations##2##8##(2012-3#2)
the decision of women to##2##5##(2013-1#2)
the decision of##10##3##(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
the decision process##3##3##(1996-1#1)(2008-10#2)
the decision to##17##3##(1991-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-4#1)(2008-11#1)(2008-12#1)(2008-9#3)(2009-5#1)(2010-5#1)(2011-2#2)
the decision tree##2##3##(2008-10#1)(2012-3#1)
the decision##65##2##(1991-3#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-3#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-6#3)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#6)(2013-1#4)
the decision-making process for##2##4##(2008-12#2)
the decision-making process of##3##4##(1993-1#1)(2009-1#1)(2009-6#1)
the decision-making process##13##3##(1993-1#1)(1997-1#1)(2008-1#1)(2008-12#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#2)(2011-2#1)(2012-2#1)
the decision-making##16##2##(1993-1#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-12#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#2)(2011-2#2)(2012-2#1)
the decisions##4##2##(1993-3#1)(1995-1#1)(2009-6#1)(2010-9#1)
the decisive##3##2##(2008-5#1)(2008-9#1)(2012-2#1)
the declared##2##2##(2007-5#1)(2008-10#1)
the decline in the##2##4##(1990-6#1)(1991-3#1)
the decline in##7##3##(1990-3#1)(1990-6#1)(1991-3#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)
the decline of##8##3##(1995-3#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-7#2)
the decline was##2##3##(2008-11#1)(2013-1#1)
the decline##22##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1995-3#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-7#2)(2013-1#1)
the declining##5##2##(1993-3#1)(1996-1#1)(2009-4#2)(2012-2#1)
the decoding##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
the decoloration of##2##3##(2008-10#1)(2008-11#1)
the decomposition of the##4##4##(1992-12#1)(1994-8#1)(2008-10#1)(2008-3#1)
the decomposition of##13##3##(1990-5#2)(1992-12#1)(1994-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-11#1)
the decomposition plateau##2##3##(2008-10#2)
the decomposition##18##2##(1990-5#2)(1992-12#1)(1994-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2009-11#1)
the deconvolution##2##2##(2008-3#1)(2010-3#1)
the deconvolved##2##2##(2008-10#1)(2008-3#1)
the decoration of##3##3##(1995-2#1)(2008-10#1)(2009-7#1)
the decoration##4##2##(1995-2#1)(2008-10#2)(2009-7#1)
the decorrelation##2##2##(2008-2#1)(2008-3#1)
the decrease in absorbance of##6##5##(2008-10#6)
the decrease in absorbance##8##4##(2008-10#8)
the decrease in colour##2##4##(1993-12#1)(2008-10#1)
the decrease in fluorescence##2##4##(1990-5#1)(1994-5#1)
the decrease in the absorbance of the##2##7##(2008-10#2)
the decrease in the absorbance of##4##6##(2008-10#4)
the decrease in the##17##4##(1992-6#1)(1993-12#1)(1994-3#1)(1995-9#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-7#1)
the decrease in##63##3##(1990-11#1)(1990-5#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-6#1)(1993-12#3)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-2#2)(2011-1#1)(2013-1#1)(2013-7#1)
the decrease of the##8##4##(1994-11#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-4#1)(2011-2#1)
the decrease of##31##3##(1990-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#4)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
the decrease was not##3##4##(1995-2#1)(2008-10#2)
the decrease was##4##3##(1995-2#1)(2008-10#2)(2011-1#1)
the decrease##102##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#4)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#36)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-7#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the decreased CL intensity##2##4##(2008-10#2)
the decreased risk of##2##4##(1992-9#1)(2013-1#1)
the decreased##22##2##(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
the decreasing of##2##3##(2008-10#1)(2008-9#1)
the decreasing##7##2##(1992-12#1)(2007-11#1)(2008-10#3)(2008-9#1)(2012-3#1)
the decrement of CL intensity##2##5##(2008-10#2)
the decrement of##3##3##(2008-10#3)
the decrypted##3##2##(2008-3#3)
the decryption##2##2##(2008-3#2)
the dedifferentiation##2##2##(2008-11#2)
the deduced aa sequence##2##4##(1991-6#1)(1993-12#1)
the deduced aa sequences##2##4##(1993-2#1)(1993-6#1)
the deduced aa##4##3##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)
the deduced amino acid (aa) sequence##3##6##(1991-7#1)(1993-6#1)(1994-12#1)
the deduced amino acid (aa)##4##5##(1991-6#1)(1991-7#1)(1993-6#1)(1994-12#1)
the deduced amino acid sequence##9##5##(1991-12#1)(1992-12#1)(1993-9#1)(1997-2#2)(2008-10#2)(2008-8#1)(2008-9#1)
the deduced amino acid sequences##6##5##(1990-12#1)(1993-2#1)(2008-10#3)(2008-9#1)
the deduced amino acid##20##4##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1997-2#2)(2008-10#5)(2008-8#1)(2008-9#2)
the deduced amino##21##3##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1997-2#2)(2008-10#5)(2008-8#1)(2008-9#3)
the deduced amino-acid sequence##3##4##(1994-12#2)(1996-12#1)
the deduced amino-acid##4##3##(1994-12#3)(1996-12#1)
the deduced protein##3##3##(1991-9#1)(1994-12#1)(2008-8#1)
the deduced sequence##4##3##(1992-8#1)(1992-9#1)(1993-2#1)(1995-6#1)
the deduced##47##2##(1990-12#1)(1991-12#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#4)(1993-6#3)(1993-9#1)(1994-12#6)(1994-8#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#3)
the deep breathing##2##3##(1994-3#1)(2012-2#1)
the deep squat##2##3##(2011-2#2)
the deep##31##2##(1993-12#3)(1994-3#1)(1995-3#2)(1996-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
the deep-sea fish##2##3##(2008-11#2)
the deep-sea##4##2##(2008-11#3)(2012-2#1)
the deeper furrows##2##3##(2008-5#2)
the deeper layers##2##3##(1990-5#1)(2008-5#1)
the deeper##6##2##(1990-5#1)(2008-3#1)(2008-5#4)
the deepest##6##2##(1996-2#1)(2008-5#4)(2011-2#1)
the deer##4##2##(2008-5#1)(2013-7#3)
the default##2##2##(2008-9#1)(2013-8#1)
the defect and##2##3##(2008-5#1)(2009-5#1)
the defect by##2##3##(1997-1#1)(2012-1#1)
the defect is##4##3##(2008-1#1)(2008-7#1)(2012-12#1)(2013-8#1)
the defect mode##2##3##(2007-11#2)
the defect of##3##3##(1993-9#1)(1997-3#1)(2009-8#1)
the defect was##4##3##(1996-6#1)(2007-8#1)(2008-12#1)(2011-2#1)
the defect with##2##3##(2008-6#1)(2011-2#1)
the defect##43##2##(1991-2#1)(1993-9#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#8)(2007-12#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the defect-tolerance##2##2##(2012-2#2)
the defective retrovirus##2##3##(2008-11#2)
the defective##6##2##(1990-12#1)(1993-9#1)(1995-9#1)(2008-10#1)(2008-11#2)
the defects and##2##3##(2007-11#2)
the defects in##3##3##(1990-5#1)(2007-11#1)(2008-10#1)
the defects##9##2##(1990-5#2)(2007-11#4)(2008-10#1)(2008-3#1)(2008-4#1)
the defendant##3##2##(1991-7#2)(1995-12#1)
the defendants'##2##2##(1995-6#2)
the defense bill##2##3##(1995-6#1)(1996-5#1)
the defense gene##2##3##(2008-10#2)
the defense in##2##3##(1993-2#1)(1996-12#1)
the defense mechanisms of##2##4##(2008-10#2)
the defense mechanisms##4##3##(1991-9#1)(2008-10#3)
the defense response of##3##4##(1992-8#1)(2008-10#2)
the defense response##6##3##(1992-8#1)(2008-10#4)(2008-9#1)
the defense system of the human lungs##2##7##(1992-12#2)
the defense system of##3##4##(1992-12#2)(2008-10#1)
the defense system##4##3##(1992-12#2)(1994-6#1)(2008-10#1)
the defense##30##2##(1991-9#1)(1992-12#3)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#11)(2008-9#5)(2010-7#1)
the defensive behavior##2##3##(2007-12#2)
the defensive##4##2##(1993-12#1)(2007-12#3)
the deficiencies##2##2##(2008-9#1)(2011-1#1)
the deficiency of##8##3##(1993-2#1)(2006-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the deficiency##13##2##(1993-2#1)(2006-6#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the deficient##4##2##(1992-11#1)(1995-11#1)(2008-2#1)(2012-12#1)
the deficit in##2##3##(1992-10#1)(1992-11#1)
the deficit irrigation regime##2##4##(2008-10#2)
the deficit was##2##3##(1997-2#2)
the deficit##9##2##(1990-3#1)(1992-10#1)(1992-11#1)(1997-2#2)(2007-10#1)(2008-10#2)(2008-8#1)
the deficits in##2##3##(1993-12#1)(2009-9#1)
the deficits of##2##3##(2011-1#1)(2013-1#1)
the deficits##5##2##(1993-12#1)(2007-10#1)(2009-9#1)(2011-1#1)(2013-1#1)
the defined##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)
the defining features##2##3##(2009-5#1)(2010-8#1)
the defining##5##2##(1996-1#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
the definition and##6##3##(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#2)
the definition of a##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
the definition of the GTV##2##5##(2008-2#2)
the definition of the##11##4##(1991-12#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-7#1)(2012-2#2)
the definition of##35##3##(1991-12#2)(1993-1#1)(1993-2#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
the definition##44##2##(1991-12#2)(1992-11#1)(1993-1#1)(1993-2#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-5#4)(2008-7#3)(2008-8#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-8#1)
the definitions and##2##3##(1992-12#1)(2008-11#1)
the definitions of the##2##4##(2008-1#1)(2011-2#1)
the definitions of##4##3##(1996-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
the definitions##8##2##(1991-2#1)(1992-12#1)(1993-2#1)(1996-9#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
the definitive diagnosis of##2##4##(2008-1#1)(2012-2#1)
the definitive diagnostic##2##3##(2008-6#1)(2011-2#1)
the definitive treatment##2##3##(2007-8#1)(2010-3#1)
the definitive##16##2##(1993-2#1)(1995-8#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
the deflection signal##3##3##(2008-2#3)
the deflection##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
the deformable##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
the deformation of##5##3##(1993-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)
the deformation##15##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2013-1#1)
the deformations##2##2##(2008-3#1)(2009-10#1)
the deforming##2##2##(2008-3#2)
the deformities##2##2##(2007-11#1)(2007-12#1)
the deformity##7##2##(2007-12#1)(2007-8#1)(2008-8#2)(2009-10#1)(2009-3#1)(2012-2#1)
the degUh##2##2##(1997-4#2)
the degeneracy##3##2##(1995-5#1)(2008-2#1)(2008-8#1)
the degenerate primers##4##3##(1994-12#2)(1996-8#1)(2008-10#1)
the degenerate##7##2##(1994-12#2)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the degeneration of the intervertebral disc##2##6##(2007-11#2)
the degeneration of the##5##4##(1990-5#1)(2007-11#2)(2010-5#1)(2011-2#1)
the degeneration of##11##3##(1990-5#3)(1992-12#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)
the degeneration##12##2##(1990-5#3)(1992-12#1)(1994-8#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)
the degenerative changes##4##3##(1990-3#1)(2007-11#1)(2013-1#2)
the degenerative##9##2##(1990-3#1)(1997-6#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#2)
the degradation of IkappaBalpha##2##4##(2008-8#2)
the degradation of the old##2##5##(2008-7#2)
the degradation of the##13##4##(1991-5#1)(1992-12#1)(1994-2#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)
the degradation of these##2##4##(1995-8#1)(2008-5#1)
the degradation of##49##3##(1990-7#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#3)(1996-8#1)(1997-1#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2012-2#1)(2013-8#1)
the degradation pathway##2##3##(2008-10#1)(2010-4#1)
the degradation product##2##3##(1991-5#1)(2008-10#1)
the degradation products of##3##4##(2008-10#2)(2010-11#1)
the degradation products##8##3##(2008-10#7)(2010-11#1)
the degradation rate##4##3##(2008-10#1)(2008-11#2)(2008-6#1)
the degradation##83##2##(1990-2#1)(1990-7#1)(1991-5#2)(1992-10#1)(1992-12#2)(1992-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#3)(1996-8#1)(1997-1#1)(2007-11#1)(2007-5#1)(2008-10#23)(2008-11#6)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#2)
the degradations##2##2##(2008-3#2)
the degradative##2##2##(1995-8#1)(2008-5#1)
the degree and##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
the degree of aggregation##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
the degree of association##2##4##(1996-2#1)(2008-10#1)
the degree of carotid artery##2##5##(2011-2#2)
the degree of clustering of##2##5##(1990-11#1)(2008-12#1)
the degree of competition##2##4##(1997-1#2)
the degree of contracture##2##4##(2008-9#2)
the degree of correlation##2##4##(1996-3#1)(2008-3#1)
the degree of coupling between##2##5##(1994-12#1)(2011-1#1)
the degree of coupling##3##4##(1994-12#1)(2008-9#1)(2011-1#1)
the degree of disease control##2##5##(2008-10#2)
the degree of disease##3##4##(2008-10#3)
the degree of ellipticity##2##4##(2007-11#1)(2007-12#1)
the degree of fasting hyperglycemia##2##5##(1991-7#2)
the degree of fluorescence##2##4##(1991-3#1)(1995-8#1)
the degree of fungal##2##4##(2008-10#2)
the degree of heterogeneity##3##4##(2008-10#3)
the degree of host specificity##2##5##(2008-10#1)(2013-1#1)
the degree of hydrophobicity##2##4##(1991-5#1)(2008-7#1)
the degree of impairment##2##4##(1991-1#1)(1991-2#1)
the degree of inbreeding##3##4##(2008-12#1)(2009-5#2)
the degree of increase##2##4##(1993-6#1)(2008-11#1)
the degree of inhibition of##2##5##(1995-2#1)(2008-10#1)
the degree of inhibition##4##4##(1995-11#1)(1995-2#1)(2008-10#1)(2008-7#1)
the degree of initial##2##4##(2007-8#1)(2008-9#1)
the degree of liver fibrosis##2##5##(2013-1#2)
the degree of obesity##2##4##(2011-1#1)(2013-8#1)
the degree of omnivory##2##4##(2008-9#2)
the degree of order of the##2##6##(2008-5#2)
the degree of order of##3##5##(2008-5#3)
the degree of polarization of##2##5##(2008-2#1)(2008-3#1)
the degree of polarization##9##4##(2007-12#2)(2008-2#4)(2008-3#3)
the degree of purification##2##4##(1990-5#1)(2008-11#1)
the degree of resistance##2##4##(2008-10#2)
the degree of response##2##4##(1990-12#1)(2008-5#1)
the degree of role conflict##2##5##(1990-2#2)
the degree of salinity of water##2##6##(2008-3#2)
the degree of saturation of##2##5##(2011-1#1)(2013-1#1)
the degree of saturation##3##4##(2011-1#1)(2013-1#2)
the degree of sedation##2##4##(2008-8#2)
the degree of similarity##2##4##(2008-4#1)(2013-8#1)
the degree of size##2##4##(2008-8#2)
the degree of spatial coherence##2##5##(2007-11#1)(2007-12#1)
the degree of specialization of##2##5##(2008-8#2)
the degree of stenosis##3##4##(1993-8#1)(2008-7#2)
the degree of stress##2##4##(2008-12#1)(2008-5#1)
the degree of susceptibility to##2##5##(1992-2#1)(2012-3#1)
the degree of the##9##4##(1993-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
the degree of this##2##4##(2008-10#1)(2008-3#1)
the degree of tolerance##2##4##(2008-10#2)
the degree of variability in##2##5##(2009-11#1)(2009-6#1)
the degree of variability##3##4##(2008-10#1)(2009-11#1)(2009-6#1)
the degree of vascular##2##4##(2007-10#1)(2008-10#1)
the degree of##327##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#6)(1997-6#2)(2007-10#2)(2007-11#8)(2007-12#9)(2007-8#1)(2008-1#4)(2008-10#56)(2008-11#9)(2008-12#5)(2008-2#10)(2008-3#20)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#19)(2008-8#15)(2008-9#13)(2009-11#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#11)(2013-8#5)
the degree to which the##6##5##(1992-6#1)(1993-5#1)(1996-3#1)(2008-2#1)(2010-6#1)(2011-2#1)
the degree to which they##3##5##(1996-1#1)(2008-3#1)(2008-9#1)
the degree to which##24##4##(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
the degree##356##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-6#2)(2007-10#2)(2007-11#8)(2007-12#9)(2007-8#1)(2008-1#4)(2008-10#56)(2008-11#11)(2008-12#7)(2008-2#11)(2008-3#21)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#21)(2008-8#18)(2008-9#15)(2009-11#2)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#11)(2013-8#5)
the degrees of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
the dehydrated##2##2##(2008-10#2)
the dehydration##3##2##(2008-10#2)(2012-2#1)
the dehydrogenase##2##2##(1990-11#1)(2008-11#1)
the delay and diffusion##2##4##(2013-8#2)
the delay and##4##3##(1990-11#1)(2011-2#1)(2013-8#2)
the delay between##5##3##(1991-2#1)(1991-3#1)(2008-12#1)(2008-3#1)(2011-2#1)
the delay in##7##3##(1991-2#1)(1991-9#1)(1992-3#1)(2007-2#1)(2008-10#2)(2008-12#1)
the delay of ascospore##2##4##(2008-10#2)
the delay of##5##3##(2008-10#2)(2008-12#1)(2012-12#2)
the delay time##4##3##(2007-12#1)(2010-9#1)(2013-8#2)
the delay##38##2##(1990-11#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-3#1)(1996-2#1)(1997-2#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-12#3)(2008-3#2)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-8#7)
the delay-time dependence##2##3##(2008-3#2)
the delayed##10##2##(1992-11#1)(1992-6#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#2)(2013-8#1)
the deleted receptor##2##3##(1997-7#2)
the deleted##5##2##(1993-6#1)(1997-3#1)(1997-7#2)(2008-10#1)
the deleterious effect of##3##4##(1996-11#1)(2008-2#1)(2008-3#1)
the deleterious effects of##8##4##(1991-6#1)(1994-11#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)
the deleterious effects##10##3##(1991-6#1)(1994-11#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
the deleterious##15##2##(1991-6#1)(1992-3#1)(1994-11#2)(1996-11#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)
the deletion mutant##2##3##(1997-3#1)(2012-3#1)
the deletion of the##4##4##(1991-9#1)(1994-5#1)(1997-2#1)(1997-3#1)
the deletion of##11##3##(1990-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-8#1)
the deletion##27##2##(1990-12#2)(1990-5#1)(1990-7#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#4)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
the deletions##3##2##(1992-8#1)(1993-11#1)(1994-11#1)
the deliberations##2##2##(1994-12#1)(2007-12#1)
the delineation of##5##3##(1994-11#1)(2008-7#1)(2009-11#2)(2010-5#1)
the delinquent adolescent##3##3##(1990-12#3)
the delinquent group##2##3##(1990-12#2)
the delinquent##6##2##(1990-10#1)(1990-12#5)
the delirium protocol##2##3##(2010-10#2)
the delivered protein##2##3##(2008-11#2)
the delivered##8##2##(1991-12#1)(1996-2#2)(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#1)
the delivery and financing of health care##2##7##(1992-3#1)(1995-1#1)
the delivery and##5##3##(1992-3#1)(1995-1#2)(1996-3#1)(2008-12#1)
the delivery of a##5##4##(2008-11#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
the delivery of aerosolized##2##4##(1995-3#2)
the delivery of an##3##4##(2008-5#2)(2010-8#1)
the delivery of care to##2##5##(2007-12#1)(2011-1#1)
the delivery of care##4##4##(1992-2#1)(2007-12#1)(2008-11#1)(2011-1#1)
the delivery of concurrent chemotherapy and radiotherapy##2##7##(2008-6#2)
the delivery of health care services##5##6##(1994-12#1)(1994-3#1)(1995-3#2)(2010-3#1)
the delivery of health care##10##5##(1992-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1997-1#1)(2010-3#1)(2010-8#1)
the delivery of health services##4##5##(1993-2#1)(1993-6#1)(2008-1#1)(2009-3#1)
the delivery of health##15##4##(1992-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1997-1#1)(2008-1#1)(2009-3#1)(2010-3#1)(2010-8#1)
the delivery of mental health services to##2##7##(1994-1#1)(1996-3#1)
the delivery of mental health services##3##6##(1994-1#2)(1996-3#1)
the delivery of services##4##4##(1991-3#1)(1994-12#1)(1997-2#2)
the delivery of the##2##4##(1990-6#1)(2009-11#1)
the delivery of therapeutic##3##4##(2008-5#2)(2008-6#1)
the delivery of##87##3##(1990-6#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#4)(1994-3#3)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#5)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#3)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#4)(2009-11#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-8#5)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#1)
the delivery system of choice##2##5##(1996-1#1)(1996-2#1)
the delivery system##9##3##(1993-3#1)(1995-1#1)(1996-1#2)(1996-2#1)(1997-2#1)(2008-3#1)(2008-7#1)(2012-6#1)
the delivery##110##2##(1990-6#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#1)(1995-1#4)(1995-12#1)(1995-3#5)(1995-6#1)(1996-1#2)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#5)(2009-11#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-8#5)(2011-1#3)(2011-2#2)(2012-3#2)(2012-6#1)(2013-1#1)
the delta 12-16##2##3##(1994-12#2)
the delta G degrees value of##2##6##(1993-8#2)
the delta G degrees##3##4##(1993-8#3)
the delta receptor##2##3##(1995-3#1)(1995-6#1)
the delta##19##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-8#3)(1994-11#1)(1994-12#3)(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2013-8#1)
the delta-9##2##2##(1996-6#2)
the delta-selective##2##2##(1995-12#1)(1995-3#1)
the deltoid muscle##4##3##(2009-9#2)(2010-4#1)(2013-8#1)
the deltoid##6##2##(2009-9#2)(2010-4#2)(2013-8#2)
the demand for health care##2##5##(1996-3#1)(1997-8#1)
the demand for##21##3##(1990-2#2)(1990-6#2)(1994-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)
the demand of grain filling##2##5##(2008-9#2)
the demand##25##2##(1990-2#2)(1990-6#2)(1994-1#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#3)(2011-2#1)
the demands for##2##3##(2008-4#1)(2008-9#1)
the demands of the##4##4##(1993-12#1)(1994-2#1)(2008-7#1)(2012-3#1)
the demands of##13##3##(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)
the demands on##2##3##(2006-4#1)(2008-3#1)
the demands##22##2##(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#3)(1995-2#1)(2006-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)
the demetalization##2##2##(2008-10#2)
the demethylated##2##2##(1991-5#2)
the demethylating##2##2##(2007-11#1)(2013-1#1)
the demise of##4##3##(1993-2#1)(2008-11#1)(2008-12#1)(2013-7#1)
the demodulated##4##2##(2007-12#1)(2008-3#3)
the demodulation process##3##3##(2008-3#3)
the demodulation##5##2##(2008-3#5)
the demographic basis of##3##4##(2008-8#3)
the demographic figures##3##3##(1992-5#3)
the demographic survey##2##3##(2008-8#2)
the demographic##25##2##(1992-1#1)(1992-5#3)(1995-12#1)(1995-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#4)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
the demographics of##3##3##(1992-2#1)(2008-4#1)(2013-1#1)
the demographics##4##2##(1992-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
the demography##3##2##(2008-8#3)
the demonstrated##8##2##(1992-6#1)(1995-2#1)(2007-11#3)(2008-2#1)(2008-7#1)(2013-1#1)
the demonstration of a##3##4##(1992-6#1)(2007-12#1)(2008-2#1)
the demonstration of the##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
the demonstration of two##2##4##(1997-6#1)(2011-2#1)
the demonstration of##20##3##(1992-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
the demonstration##23##2##(1992-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
the denaturant##2##2##(1992-8#1)(1997-2#1)
the denaturation of##2##3##(1990-12#1)(1997-7#1)
the denaturation##5##2##(1990-12#1)(1995-2#1)(1997-7#1)(2008-10#2)
the denatured state##3##3##(1992-6#3)
the denatured##10##2##(1990-5#2)(1992-6#3)(1993-11#1)(2008-10#2)(2009-9#1)(2011-1#1)
the denaturing agent##2##3##(1997-4#1)(2008-10#1)
the dendrites##2##2##(1992-11#1)(2007-12#1)
the dendritic arbors of##2##4##(1994-2#2)
the dendritic morphology##2##3##(2008-8#1)(2013-1#1)
the dendritic trees##2##3##(1996-2#1)(2012-2#1)
the dendritic##18##2##(1990-11#1)(1990-5#1)(1991-5#1)(1994-2#4)(1996-2#2)(2006-10#1)(2007-12#3)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
the denominator##6##2##(1992-12#1)(1995-3#1)(1996-2#2)(2008-9#1)(2013-1#1)
the dense##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
the densely##2##2##(1991-12#1)(2007-7#1)
the densities and##2##3##(1995-11#1)(2008-10#1)
the densities of##6##3##(1994-2#1)(2008-10#3)(2008-3#1)(2008-9#1)
the densities##9##2##(1994-2#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)
the density and##4##3##(1995-12#1)(2008-10#2)(2008-11#1)
the density in##2##3##(2008-2#1)(2008-5#1)
the density matrix##2##3##(2007-12#1)(2008-3#1)
the density of both##2##4##(1990-5#1)(1993-12#1)
the density of its partner##2##5##(2008-8#2)
the density of opioid receptors##2##5##(2008-11#2)
the density of states##5##4##(2008-2#1)(2009-11#4)
the density of the##8##4##(1994-2#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-8#1)
the density of type II pneumocytes is reduced in##2##9##(1994-5#2)
the density of##51##3##(1990-11#1)(1990-5#3)(1990-7#1)(1993-12#1)(1993-9#2)(1994-2#2)(1994-5#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#4)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#1)
the density##73##2##(1990-11#1)(1990-5#3)(1990-7#1)(1993-12#1)(1993-9#2)(1994-2#2)(1994-5#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-11#4)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#4)(2013-8#2)
the density-based EL ratio test##2##5##(2013-1#2)
the dental biofilms of patients with##2##6##(2013-1#2)
the dental clinic##2##3##(2008-7#1)(2012-3#1)
the dental##27##2##(1990-2#1)(1990-9#1)(1991-3#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
the dentate gyrus and##5##4##(1994-8#1)(1996-12#2)(2008-11#1)(2009-8#1)
the dentate gyrus as##2##4##(1995-12#1)(1997-6#1)
the dentate gyrus##28##3##(1990-5#1)(1990-7#3)(1993-12#1)(1994-8#3)(1995-12#9)(1996-12#4)(1996-2#2)(1997-6#1)(2008-11#1)(2009-8#2)(2013-8#1)
the dentate##33##2##(1990-5#1)(1990-7#4)(1991-7#1)(1993-12#1)(1994-8#4)(1995-12#10)(1996-12#4)(1996-2#2)(1997-6#1)(2008-1#1)(2008-11#1)(2009-8#2)(2013-8#1)
the dentist##9##2##(1990-10#1)(1992-5#1)(1996-3#1)(2008-7#1)(2011-1#3)(2012-12#1)(2013-8#1)
the dentists##3##2##(1990-5#1)(2008-1#1)(2011-1#1)
the denture##4##2##(2009-4#2)(2013-1#2)
the denuder-based##2##2##(2008-10#2)
the department and##3##3##(1996-1#1)(1996-3#1)(2011-2#1)
the department in##2##3##(1997-4#1)(2008-12#1)
the department of##11##3##(1990-10#1)(1991-3#2)(1993-3#1)(2008-1#1)(2008-10#3)(2010-4#1)(2013-1#1)(2013-8#1)
the department##30##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-3#2)(1993-12#2)(1993-2#2)(1993-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
the departments of##3##3##(1995-12#1)(1997-3#1)(2012-12#1)
the departments##10##2##(1990-9#1)(1993-10#2)(1995-12#1)(1997-3#1)(2008-10#1)(2012-12#3)(2013-1#1)
the dependence between##2##3##(2008-10#2)
the dependence of absorption##2##4##(2008-1#1)(2008-10#1)
the dependence of the efficiency on the##2##7##(2007-12#1)(2008-3#1)
the dependence of the intensity##2##5##(2007-12#1)(2008-2#1)
the dependence of the mixing##2##5##(2007-10#1)(2008-2#1)
the dependence of the output power##2##6##(2008-3#2)
the dependence of the peak##2##5##(2008-10#1)(2008-3#1)
the dependence of the##37##4##(1990-12#1)(1990-5#1)(1995-11#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-10#7)(2008-2#5)(2008-3#11)(2009-7#1)(2009-8#1)
the dependence of##63##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1995-11#1)(1996-5#1)(2007-10#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#10)(2008-2#7)(2008-3#17)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)
the dependence on##4##3##(2007-11#1)(2008-3#2)(2009-7#1)
the dependence##70##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#9)(2008-1#1)(2008-10#12)(2008-2#7)(2008-3#19)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#2)(2009-8#1)(2009-9#1)(2011-2#1)
the dependency of the##2##4##(1997-2#1)(2007-12#1)
the dependency of##5##3##(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
the dependency##6##2##(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
the dependent measures##2##3##(2007-12#1)(2008-12#1)
the dependent variable##3##3##(1992-1#1)(2007-8#1)(2008-10#1)
the dependent virus##2##3##(2008-10#2)
the dependent##8##2##(1992-1#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)
the dephosphorylation of##4##3##(1993-6#1)(1994-11#1)(2008-7#1)(2013-8#1)
the dephosphorylation##5##2##(1993-6#2)(1994-11#1)(2008-7#1)(2013-8#1)
the depigmenting##2##2##(2008-5#2)
the depletion of the##3##4##(1993-2#1)(2008-7#1)(2009-8#1)
the depletion of##11##3##(1991-9#1)(1992-11#2)(1993-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
the deployment of resistant##2##4##(2008-10#2)
the deployment of##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
the depolarization loss##2##3##(2007-12#1)(2008-2#1)
the depolarization of air##2##4##(2008-3#2)
the depolarization of##4##3##(1992-6#1)(2007-11#1)(2008-3#2)
the depolarization ratio##2##3##(2008-3#2)
the depolarization spectrum##2##3##(2008-3#2)
the depolarization##16##2##(1990-8#1)(1992-6#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#7)(2008-7#1)
the depolarizing##3##2##(1991-9#1)(1992-3#1)(2008-5#1)
the depopulation of##2##3##(1990-9#1)(2007-6#1)
the deposit##5##2##(1995-12#1)(2008-10#3)(2008-5#1)
the deposited layers##2##3##(2008-10#1)(2008-3#1)
the deposited##5##2##(2008-10#3)(2008-3#2)
the deposition of Cd in the##2##6##(1995-3#2)
the deposition of ECM##2##4##(1994-5#1)(2013-8#1)
the deposition of amyloid##3##4##(1991-9#1)(1996-5#1)(2008-11#1)
the deposition of the##4##4##(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
the deposition of##30##3##(1990-8#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-3#2)(1996-5#2)(1997-8#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-7#1)(2010-5#3)(2012-3#1)(2013-8#1)
the deposition on the##2##4##(2008-10#2)
the deposition step##3##3##(2008-10#3)
the deposition##46##2##(1990-8#1)(1991-12#1)(1991-9#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-3#2)(1996-5#2)(1997-8#1)(2007-12#2)(2008-10#22)(2008-11#1)(2008-2#1)(2008-7#2)(2010-5#3)(2012-3#1)(2013-8#1)
the deposits##3##2##(1994-5#3)
the depressant effects of##4##4##(1995-12#1)(1997-2#2)(2008-8#1)
the depressed patients##3##3##(1996-5#2)(1996-7#1)
the depressed##4##2##(1996-5#2)(1996-7#1)(2008-7#1)
the depression induced by##2##4##(1995-12#2)
the depression of synaptic transmission##2##5##(1995-12#2)
the depression of##3##3##(1995-12#2)(2008-9#1)
the depression##6##2##(1995-12#4)(2008-9#1)(2010-5#1)
the depressive##2##2##(1991-11#1)(2011-2#1)
the depressor##3##2##(1991-5#2)(1996-5#1)
the deprived eye##2##3##(1994-8#1)(2012-2#1)
the deprotonated##2##2##(1994-12#1)(1995-5#1)
the deprotonation##2##2##(1995-5#1)(2008-10#1)
the depside##2##2##(2008-5#2)
the depth and##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
the depth localization##2##3##(2011-1#2)
the depth of field##3##4##(2007-11#1)(2008-3#1)(2012-2#1)
the depth of focus##2##4##(2008-3#2)
the depth of the avascular plane and##2##7##(2011-2#2)
the depth of the avascular plane##3##6##(2011-2#3)
the depth of the focal point##2##6##(2008-3#2)
the depth of the##10##4##(2007-12#2)(2008-3#5)(2011-2#3)
the depth of##32##3##(1990-9#1)(1992-9#1)(1994-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#13)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#4)(2012-2#1)(2013-8#1)
the depth profile##2##3##(2008-3#2)
the depth resolution##2##3##(2008-3#2)
the depth##57##2##(1990-9#1)(1992-9#1)(1994-9#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#26)(2008-5#3)(2008-7#1)(2008-8#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#1)(2013-8#1)
the deregulated##2##2##(1993-2#1)(1994-10#1)
the deregulation of##3##3##(2009-5#1)(2011-2#2)
the derivation and##2##3##(2008-8#1)(2008-9#1)
the derivation of the##5##4##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
the derivation of##16##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2012-4#1)
the derivation##19##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2012-4#1)
the derivatisation reaction##2##3##(2008-10#2)
the derivative method##2##3##(2008-10#2)
the derivative##16##2##(2007-11#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-9#1)
the derivatives in##2##3##(2008-10#2)
the derivatives##12##2##(1990-5#1)(2008-10#4)(2008-11#3)(2008-6#2)(2008-7#1)(2011-2#1)
the derivatization of##3##3##(2008-10#2)(2008-4#1)
the derivatization reaction##5##3##(2008-10#5)
the derivatization##15##2##(2008-10#14)(2008-4#1)
the derivatized##4##2##(2008-10#3)(2008-7#1)
the derived FPDF##2##3##(2008-2#2)
the derived total ozone##2##4##(2008-2#2)
the derived##29##2##(1992-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-2#7)(2008-3#10)(2008-7#1)(2010-1#1)(2010-8#1)
the dermal and##4##3##(2008-5#2)(2008-9#1)(2013-8#1)
the dermal layer##2##3##(2008-9#1)(2012-3#1)
the dermal##17##2##(1992-12#1)(2008-5#7)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-8#4)
the dermal-epidermal junction##3##3##(1992-6#1)(1996-6#1)(2008-5#1)
the dermatitis##5##2##(1990-3#1)(2008-9#4)
the dermatologic##4##2##(2006-10#2)(2010-6#1)(2013-7#1)
the dermatologists##2##2##(2007-7#1)(2008-5#1)
the dermis and epidermis##2##4##(1996-12#1)(2008-5#1)
the dermis and##7##3##(1996-12#1)(2008-5#4)(2008-9#1)(2010-6#1)
the dermis##32##2##(1996-12#6)(2008-1#1)(2008-3#1)(2008-5#11)(2008-9#6)(2010-6#3)(2011-1#1)(2012-12#1)(2012-3#2)
the descendents of##2##3##(1994-1#1)(2008-10#1)
the descending aorta##6##3##(2007-7#1)(2007-8#4)(2008-11#1)
the descending colon##3##3##(1993-9#2)(2011-2#1)
the descending thoracic aorta##3##4##(2010-8#2)(2013-3#1)
the descending thoracic##4##3##(2008-10#1)(2010-8#2)(2013-3#1)
the descending##16##2##(1993-9#2)(2007-10#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#2)(2011-2#1)(2013-3#1)
the described method##2##3##(1990-9#1)(2008-10#1)
the described model##2##3##(1996-1#1)(1997-2#1)
the described technique##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
the described##25##2##(1990-9#2)(1991-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
the description of a##2##4##(1991-2#1)(2008-9#1)
the description of the##10##4##(1993-9#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-6#1)(2013-8#1)
the description of##27##3##(1990-8#1)(1991-2#1)(1993-9#1)(1996-3#1)(2007-11#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#4)(2009-6#2)(2010-7#1)(2011-7#1)(2012-3#1)(2013-8#1)
the description##31##2##(1990-8#1)(1991-2#1)(1993-9#1)(1996-3#1)(2007-11#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#4)(2009-6#2)(2010-1#1)(2010-7#2)(2011-7#1)(2012-3#1)(2013-8#1)
the descriptive data##2##3##(2008-11#1)(2008-7#1)
the descriptive##7##2##(1991-12#1)(1991-6#2)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
the descriptors##3##2##(1997-2#1)(2008-10#2)
the desensitization##4##2##(1995-12#1)(2008-3#1)(2008-4#1)(2009-7#1)
the desert##6##2##(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2013-1#1)
the desiccation##2##2##(1992-12#1)(2013-7#1)
the design and analysis of##4##5##(1992-6#1)(1996-6#1)(2008-2#1)(2008-3#1)
the design and analysis##5##4##(1992-6#1)(1994-2#1)(1996-6#1)(2008-2#1)(2008-3#1)
the design and characterization of##2##5##(2007-12#1)(2008-3#1)
the design and construction of##2##5##(2008-2#1)(2008-3#1)
the design and fabrication of##4##5##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
the design and implementation of##7##5##(1991-1#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2010-11#2)
the design and management of##2##5##(1995-12#1)(2010-4#1)
the design and performance of##2##5##(2008-2#1)(2008-3#1)
the design and performance##3##4##(2008-2#1)(2008-3#2)
the design and synthesis of##3##5##(1994-12#1)(1994-3#1)(2010-12#1)
the design and the fabrication##2##5##(2008-2#1)(2008-3#1)
the design and the##6##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
the design and##56##3##(1991-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#3)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#10)(2008-7#2)(2008-9#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
the design can##2##3##(2007-11#1)(2008-3#1)
the design is##2##3##(1995-9#1)(2008-2#1)
the design of Expresso##2##4##(2008-7#2)
the design of a new##2##5##(1996-6#1)(2008-3#1)
the design of a##18##4##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#8)(2008-7#1)(2008-8#1)
the design of an##8##4##(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
the design of clinical trials##2##5##(2008-8#1)(2010-11#1)
the design of diffractive elements##2##5##(2007-11#1)(2007-12#1)
the design of diffractive optical elements##2##6##(2007-12#1)(2008-3#1)
the design of diffractive optical##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
the design of diffractive##6##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
the design of effective##2##4##(2011-2#2)
the design of efficient##2##4##(2008-10#1)(2009-4#1)
the design of future##4##4##(2008-7#1)(2009-5#1)(2010-3#1)(2012-1#1)
the design of more effective##2##5##(1993-11#1)(2008-12#1)
the design of more##3##4##(1993-11#1)(2008-12#1)(2012-2#1)
the design of new##9##4##(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
the design of novel##4##4##(2008-1#1)(2008-3#1)(2008-5#1)(2009-3#1)
the design of such a##2##5##(2008-2#1)(2008-3#1)
the design of such##5##4##(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
the design of the system##2##5##(2008-2#1)(2012-3#1)
the design of the##18##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-3#1)
the design of this##3##4##(2007-12#1)(2008-12#1)(2008-3#1)
the design of##169##3##(1992-12#1)(1992-9#2)(1993-11#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#12)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#4)(2008-2#14)(2008-3#32)(2008-4#2)(2008-5#4)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#1)
the design optimization##2##3##(2008-2#1)(2008-3#1)
the design parameters of##3##4##(2008-3#3)
the design parameters##4##3##(2008-2#1)(2008-3#3)
the design procedure##3##3##(2008-3#3)
the design process##3##3##(2008-2#1)(2008-3#1)(2010-10#1)
the design requirements##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
the design##310##2##(1990-11#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#4)(1997-6#1)(2007-11#15)(2007-12#12)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#25)(2008-11#6)(2008-12#9)(2008-2#31)(2008-3#70)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#3)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#8)(2012-3#6)(2013-1#8)(2013-8#5)
the designated movement##2##3##(2007-6#2)
the designated##6##2##(2007-6#2)(2008-1#1)(2008-10#1)(2009-2#1)(2010-8#1)
the designation of##2##3##(2007-7#1)(2008-6#1)
the designation##3##2##(1992-5#1)(2007-7#1)(2008-6#1)
the designed##12##2##(1991-9#2)(2008-10#3)(2008-2#1)(2008-3#5)(2011-2#1)
the designing of##2##3##(2008-3#1)(2011-3#1)
the designs##4##2##(1994-9#1)(2008-2#1)(2008-3#1)(2009-7#1)
the desirability function##4##3##(2008-10#4)
the desirability of health technology##2##5##(2009-3#2)
the desirability of##4##3##(2008-3#1)(2008-9#1)(2009-3#2)
the desirability##9##2##(1994-1#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-3#2)
the desirable##4##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
the desire for##2##3##(1993-1#1)(2008-7#1)
the desire of##3##3##(1992-9#1)(2008-10#2)
the desire to##8##3##(1996-8#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
the desire##13##2##(1992-9#1)(1993-1#1)(1996-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
the desired characteristics##2##3##(1990-8#1)(1993-2#1)
the desired effect##2##3##(1994-11#1)(2009-8#1)
the desired image##6##3##(2008-2#3)(2008-3#3)
the desired outcome##2##3##(2010-8#1)(2013-7#1)
the desired product##3##3##(2008-10#2)(2010-4#1)
the desired##97##2##(1990-8#1)(1992-1#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#1)(1995-3#3)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#8)(2008-3#16)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-7#1)
the desmosome and gap junction##2##5##(2012-2#2)
the desorption of##2##3##(2008-10#1)(2009-12#1)
the desorption##4##2##(1994-3#1)(2008-10#2)(2009-12#1)
the desquamation process##3##3##(2008-5#3)
the desquamation##6##2##(2008-5#5)(2012-3#1)
the desquamatory enzymes##2##3##(2008-5#2)
the destabilizing##2##2##(1993-8#1)(1995-5#1)
the destination##2##2##(2008-5#1)(2011-2#1)
the destroyed##2##2##(2007-8#2)
the destruction of the##3##4##(1992-9#1)(1994-5#1)(2013-8#1)
the destruction of##11##3##(1992-9#2)(1994-5#1)(2007-11#2)(2008-7#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
the destruction##13##2##(1992-9#2)(1993-9#1)(1994-5#1)(2007-11#2)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
the destructive##7##2##(1990-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
the detached##2##2##(2008-10#2)
the detachment of##2##3##(1991-3#1)(1991-9#1)
the detachment##3##2##(1991-3#1)(1991-9#1)(2008-11#1)
the detail##2##2##(2007-12#1)(2008-3#1)
the detailed composition of##3##4##(1995-8#1)(2008-3#2)
the detailed description of the##2##5##(2008-9#1)(2010-12#1)
the detailed mechanism##2##3##(2008-10#1)(2008-9#1)
the detailed molecular##2##3##(2010-12#2)
the detailed study of##2##4##(2008-10#1)(2008-11#1)
the detailed##36##2##(1993-8#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#3)(2011-3#1)(2012-12#1)(2013-8#1)
the details of the##8##4##(1992-2#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#2)
the details of##22##3##(1992-2#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#2)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#1)(2013-8#2)
the details##24##2##(1992-2#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#2)(2007-11#2)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#1)(2013-8#2)
the detectability of a lung nodule##2##6##(2010-9#2)
the detectability of##5##3##(2008-10#3)(2010-9#2)
the detectability##7##2##(1996-4#1)(2008-10#3)(2008-3#1)(2010-9#2)
the detectable##4##2##(1997-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
the detected fluorescence##4##3##(2008-10#2)(2008-3#2)
the detected light##3##3##(2008-2#1)(2008-3#2)
the detected phase##2##3##(2008-3#2)
the detected pulse##2##3##(2007-11#1)(2007-12#1)
the detected radiation##2##3##(2008-2#1)(2008-3#1)
the detected signal is##2##4##(2008-2#1)(2008-3#1)
the detected signal##4##3##(2008-2#2)(2008-3#2)
the detected##37##2##(1990-7#1)(1994-1#1)(1995-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#6)(2008-3#14)(2008-6#1)(2012-3#1)(2013-1#1)
the detecting##4##2##(2007-11#1)(2008-10#2)(2009-8#1)
the detection and characterization of##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
the detection and quantification limits##3##5##(2008-10#3)
the detection and quantification##4##4##(2008-10#4)
the detection and treatment of##4##5##(2007-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
the detection and##37##3##(1990-12#1)(1990-6#1)(1991-5#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
the detection area##3##3##(2008-10#2)(2009-6#1)
the detection being##2##3##(2008-10#1)(2012-2#1)
the detection cell##3##3##(2008-10#3)
the detection efficiency##2##3##(2008-9#1)(2013-8#1)
the detection electrode##2##3##(2008-10#2)
the detection frequency##2##3##(2008-10#2)
the detection limit (3sigma) of##2##5##(2008-10#2)
the detection limit (3sigma)##5##4##(2008-10#5)
the detection limit (S/N=3)##2##4##(2008-10#2)
the detection limit and the##2##5##(2008-10#2)
the detection limit and##3##4##(2008-10#3)
the detection limit by##2##4##(2008-10#1)(2008-3#1)
the detection limit for##8##4##(2008-10#8)
the detection limit in##2##4##(2008-10#1)(2008-3#1)
the detection limit is 0##6##5##(2008-10#6)
the detection limit is 1##4##5##(2008-10#4)
the detection limit is 2##2##5##(2008-10#2)
the detection limit is##19##4##(2008-10#18)(2013-1#1)
the detection limit obtained##2##4##(2008-10#1)(2008-3#1)
the detection limit of 0##7##5##(2008-10#7)
the detection limit of 1##6##5##(2008-10#5)(2008-11#1)
the detection limit of 2##2##5##(2008-10#2)
the detection limit of the##6##5##(1997-2#1)(2008-10#3)(2008-2#2)
the detection limit of##38##4##(1997-2#1)(2008-10#31)(2008-11#2)(2008-2#2)(2011-1#1)(2013-8#1)
the detection limit was 0##13##5##(2008-10#13)
the detection limit was 1##4##5##(2008-10#4)
the detection limit was 3##2##5##(2008-10#2)
the detection limit was estimated as 0##2##7##(2008-10#2)
the detection limit was lower than##2##6##(2008-10#2)
the detection limit was##48##4##(2008-10#48)
the detection limit##158##3##(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#142)(2008-11#2)(2008-2#4)(2008-3#3)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
the detection limits (DL)##2##4##(2008-10#2)
the detection limits and##2##4##(2008-10#2)
the detection limits are##2##4##(2008-10#2)
the detection limits for##6##4##(2008-10#6)
the detection limits of the##4##5##(2008-10#3)(2013-8#1)
the detection limits of##19##4##(2008-10#18)(2013-8#1)
the detection limits were##10##4##(2008-10#9)(2011-1#1)
the detection limits##63##3##(2008-10#60)(2008-2#1)(2011-1#1)(2013-8#1)
the detection of 0##2##4##(2008-10#2)
the detection of DNA##6##4##(1995-12#1)(2008-10#5)
the detection of Escherichia##3##4##(2008-10#3)
the detection of F(-)##2##4##(2008-10#2)
the detection of FZ##2##4##(2008-10#2)
the detection of NO##5##4##(2008-10#2)(2008-3#2)(2010-7#1)
the detection of P##3##4##(2008-10#3)
the detection of TNT##2##4##(2008-10#1)(2009-3#1)
the detection of a variety of##2##6##(2008-10#1)(2010-11#1)
the detection of a##7##4##(1991-9#1)(2008-10#3)(2008-3#1)(2009-3#1)(2010-11#1)
the detection of an##4##4##(2007-11#1)(2008-10#2)(2011-2#1)
the detection of antigens##3##4##(1993-2#1)(2007-2#1)(2008-10#1)
the detection of cattle##2##4##(2010-4#1)(2012-3#1)
the detection of cholera antitoxin##2##5##(2008-10#2)
the detection of differences##2##4##(2008-10#1)(2008-2#1)
the detection of early##2##4##(2008-3#2)
the detection of human##3##4##(1992-6#1)(2008-10#1)(2008-2#1)
the detection of lipids##2##4##(2008-10#1)(2012-12#1)
the detection of low levels of##2##6##(2008-10#1)(2008-5#1)
the detection of low##4##4##(2008-10#3)(2008-5#1)
the detection of membrane##2##4##(1992-11#2)
the detection of nitric oxide (NO)##2##6##(2008-10#2)
the detection of nitric oxide##3##5##(2008-10#3)
the detection of nitrite##2##4##(2008-10#2)
the detection of outlier data in chemical analysis##2##8##(2008-10#2)
the detection of phenolic##2##4##(2008-10#2)
the detection of plasma##2##4##(1994-2#1)(2008-10#1)
the detection of several##3##4##(2008-10#1)(2008-2#1)(2009-3#1)
the detection of short##3##4##(1996-12#2)(2008-10#1)
the detection of sulfur##2##4##(2008-10#2)
the detection of the mecA gene##2##6##(2008-10#2)
the detection of the##30##4##(1990-12#1)(1991-5#1)(1992-6#1)(1993-9#1)(2007-11#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#4)(2013-8#1)
the detection of this##2##4##(1997-6#1)(2008-11#1)
the detection of trace##7##4##(2008-10#7)
the detection of##399##3##(1990-12#11)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#2)(1996-12#7)(1996-3#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-6#4)(1997-8#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#168)(2008-11#9)(2008-12#1)(2008-2#16)(2008-3#21)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#3)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#7)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
the detection point##3##3##(2008-10#3)
the detection process##2##3##(2008-2#1)(2008-3#1)
the detection rate of CIN##2##5##(1992-10#1)(1994-1#1)
the detection rate of##5##4##(1991-12#1)(1992-10#1)(1994-1#1)(2007-8#1)(2012-2#1)
the detection scheme##3##3##(1995-6#1)(2007-11#1)(2008-3#1)
the detection step##2##3##(1995-6#1)(2008-10#1)
the detection system##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
the detection technique##2##3##(2008-10#2)
the detection wavelength was##2##4##(2011-1#1)(2012-3#1)
the detection wavelength##4##3##(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
the detection zone##2##3##(2008-10#2)
the detection##748##2##(1990-12#12)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#2)(1991-12#3)(1991-3#4)(1991-5#2)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#3)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#5)(1996-11#1)(1996-12#7)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#5)(1997-8#2)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#427)(2008-11#15)(2008-12#1)(2008-2#30)(2008-3#33)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#7)(2009-1#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#4)(2010-12#5)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#1)(2011-1#10)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#8)
the detector and a##2##4##(2008-10#1)(2008-3#1)
the detector and##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the detector array##4##3##(2008-2#1)(2008-3#3)
the detector as well as##2##5##(2008-2#1)(2008-3#1)
the detector as##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the detector at a##2##4##(2008-10#2)
the detector at##3##3##(2008-10#3)
the detector for the##2##4##(2008-10#2)
the detector is##3##3##(2008-2#1)(2008-3#2)
the detector plane##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the detector port##2##3##(2008-3#2)
the detector readings##2##3##(2008-2#2)
the detector response is linear##2##5##(2008-10#2)
the detector response##5##3##(2008-10#5)
the detector signals##2##3##(2008-10#1)(2008-3#1)
the detector surface##2##3##(2008-3#2)
the detector that##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
the detector##90##2##(1995-6#1)(1996-5#1)(2007-11#2)(2007-12#6)(2008-10#39)(2008-11#1)(2008-2#14)(2008-3#26)
the detector)##2##2##(1996-5#1)(2008-3#1)
the detectors##5##2##(2008-2#2)(2008-3#2)(2008-9#1)
the detectors' field of view##2##5##(2008-3#2)
the detectors'##3##2##(2007-12#1)(2008-3#2)
the detergent and##2##3##(1994-9#1)(2011-2#1)
the detergent##8##2##(1990-2#1)(1990-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-4#1)(2011-2#1)
the detergents used##2##3##(1991-12#1)(1994-12#1)
the detergents##5##2##(1990-7#1)(1991-12#1)(1992-11#1)(1994-12#2)
the deterioration index##2##3##(1994-6#2)
the deterioration of##4##3##(1991-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
the deterioration##6##2##(1991-8#1)(1994-6#2)(2008-1#1)(2008-7#1)(2013-1#1)
the determinant##2##2##(1991-6#1)(2009-7#1)
the determinants of##11##3##(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
the determinants##14##2##(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#2)(1995-12#1)(1996-1#1)(1996-3#2)(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
the determination and##8##3##(2008-10#7)(2010-11#1)
the determination is based on##2##5##(2008-10#1)(2010-6#1)
the determination is##8##3##(2008-10#6)(2008-5#1)(2010-6#1)
the determination limit##2##3##(2008-10#2)
the determination method for##2##4##(2008-10#2)
the determination method##3##3##(2008-10#3)
the determination of 0##8##4##(2008-10#8)
the determination of 1##3##4##(2008-10#3)
the determination of 2-acetyl-1-pyrroline##3##4##(2011-1#3)
the determination of Ag##4##4##(2008-10#4)
the determination of Al##3##4##(2008-10#3)
the determination of As and##3##5##(2008-10#3)
the determination of As##6##4##(2008-10#6)
the determination of As(III) and As(V)##2##6##(2008-10#2)
the determination of As(III) in water samples##2##7##(2008-10#2)
the determination of As(III) in##3##5##(2008-10#3)
the determination of As(III)##8##4##(2008-10#8)
the determination of Au##2##4##(2008-10#2)
the determination of BPA in##2##5##(2008-10#1)(2009-8#1)
the determination of Bi in##2##5##(2008-10#2)
the determination of Bi##4##4##(2008-10#4)
the determination of Ca##3##4##(2008-10#3)
the determination of Captopril by differential pulse polarography##2##8##(2008-10#2)
the determination of Captopril##4##4##(2008-10#4)
the determination of Cd and Pb##3##6##(2008-10#3)
the determination of Cd##9##4##(2008-10#9)
the determination of Co(II)##2##4##(2008-10#2)
the determination of Cr(III)##4##4##(2008-10#4)
the determination of Cr(VI)##3##4##(2008-10#3)
the determination of Cu(II)##6##4##(2008-10#6)
the determination of DMA in##3##5##(2008-10#3)
the determination of DMA##4##4##(2008-10#4)
the determination of DNA##2##4##(2008-10#1)(2008-9#1)
the determination of Fe##5##4##(2008-10#4)(2013-8#1)
the determination of Fe(II)##2##4##(2008-10#2)
the determination of H(2)O(2)##4##4##(2008-10#4)
the determination of Hg in##2##5##(2008-10#2)
the determination of Hg(II) in##2##5##(2008-10#2)
the determination of Hg(II) is##2##5##(2008-10#2)
the determination of Hg(II)##5##4##(2008-10#5)
the determination of Mg in##2##5##(2008-10#2)
the determination of Mo##3##4##(2008-10#3)
the determination of NAA##2##4##(2008-10#2)
the determination of NAL in##2##5##(2008-10#2)
the determination of NH(4)(+)##2##4##(2008-10#2)
the determination of Ni##4##4##(2008-10#4)
the determination of PA##3##4##(2008-10#3)
the determination of PBDEs##3##4##(2008-10#3)
the determination of Pb##3##4##(2008-1#1)(2008-10#2)
the determination of Pb(2+)##3##4##(2008-10#3)
the determination of Pu##3##4##(2008-10#3)
the determination of Sb(III) in##2##5##(2008-10#2)
the determination of Se in##3##5##(2008-10#3)
the determination of Se##8##4##(2008-10#8)
the determination of Se(IV)##3##4##(2008-10#3)
the determination of Si-tot##2##4##(2008-10#2)
the determination of V(V)##2##4##(2008-10#2)
the determination of W(VI)##2##4##(2008-10#2)
the determination of a##7##4##(1994-11#1)(2008-10#5)(2008-2#1)
the determination of absorbed dose to water##2##7##(2012-1#2)
the determination of acetaminophen in##2##5##(2008-10#2)
the determination of acetylcholine##4##4##(2008-10#4)
the determination of acid volatile##3##5##(2008-10#3)
the determination of acid##4##4##(2008-10#4)
the determination of aliphatic amines in##2##6##(2008-10#2)
the determination of aliphatic##3##4##(2008-10#3)
the determination of ammonia in##3##5##(2008-10#3)
the determination of ammonium ion##2##5##(2008-10#2)
the determination of ammonium##5##4##(2008-10#5)
the determination of an##3##4##(2008-10#3)
the determination of analytes in##2##5##(2008-10#2)
the determination of anionic surfactants in river water##2##8##(2008-10#2)
the determination of anionic surfactants in##3##6##(2008-10#3)
the determination of anionic##5##4##(2008-10#5)
the determination of antimony by hydride generation##2##7##(2008-10#2)
the determination of antimony by##4##5##(2008-10#4)
the determination of antimony in##3##5##(2008-10#3)
the determination of antimony##8##4##(2008-10#8)
the determination of arsenic in##7##5##(2008-10#7)
the determination of arsenic##11##4##(2008-10#11)
the determination of ascorbic acid in##3##6##(2008-10#3)
the determination of ascorbic acid##9##5##(2008-10#9)
the determination of benzo[a]pyrene##4##4##(2008-10#4)
the determination of bismuth in##2##5##(2008-10#2)
the determination of bismuth##4##4##(2008-10#4)
the determination of boron in##3##5##(2008-10#3)
the determination of boron##6##4##(2008-10#6)
the determination of both##6##4##(2008-10#6)
the determination of bromide in seawater samples##2##7##(2008-10#2)
the determination of bromide in seawater##4##6##(2008-10#4)
the determination of bromide in##5##5##(2008-10#5)
the determination of bromide##8##4##(2008-10#8)
the determination of cadmium and##3##5##(2008-10#3)
the determination of cadmium in##8##5##(2008-10#8)
the determination of cadmium##16##4##(2008-10#16)
the determination of calcium and magnesium##2##6##(2008-10#2)
the determination of calcium##4##4##(2008-10#4)
the determination of carbaryl##2##4##(2008-10#2)
the determination of cationic polyelectrolytes such as poly (diallyldimethylammonium chloride) (Cat-floc) by##2##12##(2008-10#2)
the determination of cationic##3##4##(2008-10#3)
the determination of cefadroxil##3##4##(2008-10#3)
the determination of cefixime##2##4##(2008-10#2)
the determination of chlorate##2##4##(2008-10#2)
the determination of chloride in##4##5##(2008-10#4)
the determination of chloride##7##4##(2008-10#7)
the determination of chromium in##5##5##(2008-10#5)
the determination of chromium##12##4##(2008-10#12)
the determination of chromium(VI) in##3##5##(2008-10#3)
the determination of chromium(VI)##4##4##(2008-10#4)
the determination of ciprofloxacin in##3##5##(2008-10#3)
the determination of ciprofloxacin##4##4##(2008-10#4)
the determination of cobalt and##2##5##(2008-10#2)
the determination of cobalt in##5##5##(2008-10#5)
the determination of cobalt##12##4##(2008-10#12)
the determination of copper in the##3##6##(2008-10#3)
the determination of copper in##11##5##(2008-10#11)
the determination of copper##22##4##(2008-10#22)
the determination of creatinine##2##4##(2008-10#2)
the determination of cyanide in##2##5##(2008-10#2)
the determination of cyanide##4##4##(2008-10#4)
the determination of dimethyltin chloride##2##5##(2008-10#2)
the determination of dissolved silver##3##5##(2008-10#3)
the determination of dissolved##8##4##(2008-10#8)
the determination of dopamine in injection##2##6##(2008-10#2)
the determination of dopamine in##3##5##(2008-10#3)
the determination of dopamine##7##4##(2008-10#7)
the determination of doxycycline hydrochloride##3##5##(2008-10#3)
the determination of electroosmotic mobility##2##5##(2008-10#2)
the determination of epinephrine##3##4##(2008-10#3)
the determination of fluoride in##3##5##(2008-10#3)
the determination of fluoride##6##4##(2008-10#6)
the determination of fluoxetine##2##4##(2008-10#2)
the determination of formaldehyde in##2##5##(2008-10#2)
the determination of formaldehyde##3##4##(2008-10#3)
the determination of free ammonium and##2##6##(2008-10#2)
the determination of free##4##4##(1990-8#1)(2008-10#3)
the determination of gallium##3##4##(2008-10#3)
the determination of gentamycin##2##4##(2008-10#2)
the determination of glucose in the##2##6##(2008-10#2)
the determination of glucose in##9##5##(2008-10#8)(2010-5#1)
the determination of glucose##12##4##(2008-10#11)(2010-5#1)
the determination of hydrazine##6##4##(2008-10#6)
the determination of hydrochlorothiazide##2##4##(2008-10#2)
the determination of hydrogen peroxide in rainwater##3##7##(2008-10#3)
the determination of hydrogen peroxide in##5##6##(2008-10#5)
the determination of hydrogen peroxide##11##5##(2008-10#11)
the determination of hydrogen##12##4##(2008-10#12)
the determination of hydroquinone in photographic developers##2##7##(2008-10#2)
the determination of hydroquinone in##3##5##(2008-10#3)
the determination of indium##2##4##(2008-10#2)
the determination of iodate and iodide##2##6##(2008-10#2)
the determination of iodate and sulphate in##2##7##(2008-10#2)
the determination of iodate and##4##5##(2008-10#4)
the determination of iodate##5##4##(2008-10#5)
the determination of iodide in##2##5##(2008-10#2)
the determination of iodide##3##4##(2008-10#3)
the determination of iridium in##2##5##(2008-10#2)
the determination of iron and##2##5##(2008-10#2)
the determination of iron in##9##5##(2008-10#9)
the determination of iron##17##4##(2008-10#17)
the determination of iron(III) in##2##5##(2008-10#2)
the determination of isoproturon##2##4##(2008-10#2)
the determination of lactic acid in##2##6##(2008-10#2)
the determination of lead in##16##5##(2008-10#16)
the determination of lead isotope ratios in wine##2##8##(2008-10#2)
the determination of lead##26##4##(2008-1#1)(2008-10#25)
the determination of lead(II)##5##4##(2008-10#5)
the determination of lithium ion in aqueous solution##2##8##(2008-10#2)
the determination of lithium##5##4##(2008-10#5)
the determination of low levels##4##5##(2008-10#4)
the determination of low##7##4##(2008-10#7)
the determination of magnesium##3##4##(2008-10#3)
the determination of manganese in##4##5##(2008-10#4)
the determination of manganese##6##4##(2008-10#6)
the determination of manganese(II)##5##4##(2008-10#5)
the determination of mercury in##3##5##(2008-10#3)
the determination of mercury##9##4##(2008-10#9)
the determination of mercury(II)##2##4##(2008-10#2)
the determination of methionine##2##4##(2008-10#2)
the determination of metoclopramide##2##4##(2008-10#2)
the determination of metrifonate##2##4##(2008-10#2)
the determination of minoxidil##2##4##(2008-10#2)
the determination of molybdenum in##4##5##(2008-10#4)
the determination of molybdenum##10##4##(2008-10#10)
the determination of naproxen##3##4##(2008-10#3)
the determination of nickel in##7##5##(2008-10#7)
the determination of nickel##11##4##(2008-10#11)
the determination of nitrate and##2##5##(2008-10#2)
the determination of nitrate in##4##5##(2008-10#4)
the determination of nitrate##7##4##(2008-10#7)
the determination of nitrite in the##2##6##(2008-10#2)
the determination of nitrite in##8##5##(2008-10#8)
the determination of nitrite##17##4##(2008-10#16)(2008-11#1)
the determination of nitrogen oxides##2##5##(2008-10#2)
the determination of nitrogen##3##4##(2008-10#3)
the determination of nucleic acids##4##5##(2008-10#4)
the determination of ochratoxin A in##2##6##(2008-10#2)
the determination of ofloxacin in##2##5##(2008-10#2)
the determination of optical##3##4##(2008-2#2)(2008-3#1)
the determination of organic##2##4##(1994-9#1)(2008-10#1)
the determination of orthophosphate in##2##5##(2008-10#2)
the determination of orthophosphate##3##4##(2008-10#3)
the determination of oxalate##2##4##(2008-10#2)
the determination of oxidizable##2##4##(2008-10#2)
the determination of paracetamol in pharmaceuticals##2##6##(2008-10#2)
the determination of paracetamol in##5##5##(2008-10#5)
the determination of paracetamol##6##4##(2008-10#6)
the determination of paraquat in##2##5##(2008-10#2)
the determination of paraquat##5##4##(2008-10#5)
the determination of partition coefficients of drugs##2##7##(2008-10#2)
the determination of partition coefficients##3##5##(2008-10#3)
the determination of perchlorate in##3##5##(2008-10#3)
the determination of periodate and iodate##2##6##(2008-10#2)
the determination of perphenazine in##2##5##(2008-10#2)
the determination of perphenazine##3##4##(2008-10#3)
the determination of phenols##2##4##(2008-10#2)
the determination of phosphate##3##4##(2008-10#3)
the determination of phosphatidylcholine in sediment##2##6##(2008-10#2)
the determination of phosphatidylcholine##3##4##(2008-10#3)
the determination of phosphorus by##2##5##(2008-10#2)
the determination of phosphorus species##3##5##(2008-10#3)
the determination of phosphorus##9##4##(2008-10#9)
the determination of piroxicam##3##4##(2008-10#3)
the determination of plasma##2##4##(1991-3#1)(1994-8#1)
the determination of platinum##4##4##(2008-10#4)
the determination of polychlorinated##2##4##(2008-10#2)
the determination of potassium##2##4##(2008-10#2)
the determination of procaine hydrochloride##2##5##(2008-10#2)
the determination of protein in##2##5##(2008-10#2)
the determination of protein##8##4##(1990-12#1)(1991-11#1)(2008-10#3)(2008-4#2)(2009-12#1)
the determination of proteins in##2##5##(2008-10#2)
the determination of proteins with##3##5##(2008-10#3)
the determination of proteins##8##4##(2008-10#8)
the determination of psilocin and psilocybin##2##6##(2008-10#2)
the determination of pyridoxine hydrochloride##2##5##(2008-10#2)
the determination of relative##2##4##(2008-3#1)(2008-5#1)
the determination of rhodium in##2##5##(2008-10#2)
the determination of rhodium##5##4##(2008-10#5)
the determination of rubidate in##2##5##(2008-10#2)
the determination of rutin in##2##5##(2008-10#2)
the determination of rutin##3##4##(2008-10#3)
the determination of salbutamol##2##4##(2008-10#2)
the determination of salsalate in##2##5##(2008-10#2)
the determination of salsalate##3##4##(2008-10#3)
the determination of scandium##2##4##(2008-10#2)
the determination of selenium in##2##5##(2008-10#2)
the determination of selenium##5##4##(2008-10#5)
the determination of several##3##4##(2008-10#3)
the determination of silicate##2##4##(2008-10#2)
the determination of silicon##2##4##(2008-10#2)
the determination of silver in##4##5##(2008-10#4)
the determination of silver##5##4##(2008-10#5)
the determination of silver(I)##3##4##(2008-10#3)
the determination of sodium##5##4##(2008-10#5)
the determination of soluble##3##4##(1994-2#1)(2008-10#2)
the determination of studied##2##4##(2008-10#2)
the determination of substances in##2##5##(2008-10#1)(2010-11#1)
the determination of sucrose##2##4##(2008-10#2)
the determination of sulfide in##4##5##(2008-10#4)
the determination of sulfide##5##4##(2008-10#5)
the determination of sulfite in##3##5##(2008-10#3)
the determination of sulfite##5##4##(2008-10#5)
the determination of terbium##3##4##(2008-10#3)
the determination of thallium##6##4##(1991-12#2)(2008-10#4)
the determination of the above mentioned##2##6##(2008-10#2)
the determination of the above##4##5##(2008-10#4)
the determination of the analyte in a##2##7##(2008-10#2)
the determination of the analyte in##3##6##(2008-10#2)(2010-5#1)
the determination of the analyte##5##5##(2008-10#4)(2010-5#1)
the determination of the complex index of refraction##2##8##(2008-2#2)
the determination of the drug in capsules and##2##8##(2008-10#2)
the determination of the drug in##6##6##(2008-10#6)
the determination of the drug##7##5##(2008-10#7)
the determination of the drugs in plasma##2##7##(1990-8#1)(2008-10#1)
the determination of the drugs in##5##6##(1990-8#1)(2008-10#4)
the determination of the four##3##5##(2008-10#3)
the determination of the inclusion constant##2##6##(2008-10#2)
the determination of the investigated##3##5##(2008-10#3)
the determination of the levels of##2##6##(2008-10#1)(2011-2#1)
the determination of the metal##2##5##(2008-10#2)
the determination of the optical constants##2##6##(2008-2#2)
the determination of the optical##3##5##(2008-2#3)
the determination of the refractive##3##5##(2008-3#3)
the determination of the studied##3##5##(2008-10#3)
the determination of the surfactant##2##5##(2008-10#2)
the determination of the trace##2##5##(2008-10#2)
the determination of the two##2##5##(2008-10#2)
the determination of the##160##4##(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-7#1)(1993-1#1)(1993-11#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#107)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
the determination of their##4##4##(1995-6#1)(2008-10#1)(2009-5#1)(2013-1#1)
the determination of these antioxidants##2##5##(2008-10#2)
the determination of these catecholamines##2##5##(2008-10#2)
the determination of these compounds##6##5##(2008-10#6)
the determination of these ions##3##5##(2008-10#3)
the determination of these parameters##2##5##(2008-10#2)
the determination of these##29##4##(2008-10#29)
the determination of thiamine in pharmaceutical##2##6##(2008-10#2)
the determination of thiamine##4##4##(2008-10#4)
the determination of thiram##2##4##(2008-10#2)
the determination of this element##3##5##(2008-10#3)
the determination of this##7##4##(2008-10#7)
the determination of thorium##2##4##(2008-10#2)
the determination of three##5##4##(2008-10#5)
the determination of tin##3##4##(2008-10#3)
the determination of total arsenic##3##5##(2008-10#3)
the determination of total iron##2##5##(2008-10#2)
the determination of total sulfur##3##5##(2008-10#3)
the determination of total##33##4##(2008-10#33)
the determination of trace Cd and Pb##2##7##(2008-10#2)
the determination of trace amount of##12##6##(2008-10#12)
the determination of trace amounts of lead##2##7##(2008-10#2)
the determination of trace amounts of##33##6##(2008-10#33)
the determination of trace cobalt##3##5##(2008-10#3)
the determination of trace elements in##5##6##(2008-10#3)(2011-2#1)(2013-8#1)
the determination of trace elements##7##5##(2008-10#5)(2011-2#1)(2013-8#1)
the determination of trace lead##3##5##(2008-10#1)(2013-8#2)
the determination of trace levels of##9##6##(1990-8#1)(2008-10#8)
the determination of trace manganese##3##5##(2008-10#3)
the determination of trace mercury in water##2##7##(2008-10#2)
the determination of trace mercury in##5##6##(2008-10#5)
the determination of trace mercury##7##5##(2008-10#7)
the determination of trace metals in##3##6##(2008-10#3)
the determination of trace metals##6##5##(2008-10#6)
the determination of trace nitrite in##2##6##(2008-10#2)
the determination of trace##116##4##(1990-8#1)(2008-10#111)(2011-2#1)(2013-8#3)
the determination of trihalomethanes##2##4##(2008-10#2)
the determination of trimethylamine##2##4##(2008-10#2)
the determination of tungsten in##4##5##(2008-10#4)
the determination of tungsten##5##4##(2008-10#5)
the determination of uptake rates##2##5##(2008-10#2)
the determination of uranium in##4##5##(2008-10#4)
the determination of uranium##6##4##(2008-10#6)
the determination of urea##2##4##(2008-10#2)
the determination of uric acid##4##5##(2008-10#4)
the determination of vanadium in##10##5##(2008-10#10)
the determination of vanadium##16##4##(2008-10#16)
the determination of vitamin##3##4##(2008-10#3)
the determination of yperites##2##4##(2008-10#2)
the determination of zinc and nickel##2##6##(2008-10#2)
the determination of zinc in##2##5##(2008-10#2)
the determination of zinc##7##4##(2008-10#7)
the determination of zinc(II)##2##4##(2008-10#2)
the determination of##1930##3##(1990-12#8)(1990-2#5)(1990-3#1)(1990-7#1)(1990-8#11)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#6)(1991-7#1)(1992-11#3)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#8)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1717)(2008-11#10)(2008-12#2)(2008-2#15)(2008-3#28)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#2)(2010-5#5)(2011-1#12)(2011-2#4)(2011-3#1)(2012-1#4)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#5)
the determination range##2##3##(2008-10#2)
the determination was performed##2##4##(2008-10#2)
the determination was##13##3##(2008-10#13)
the determination were investigated##2##4##(2008-10#2)
the determination were##3##3##(2008-10#3)
the determination##2002##2##(1990-12#8)(1990-2#5)(1990-3#1)(1990-7#1)(1990-8#11)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#6)(1991-7#1)(1992-11#3)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#8)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1784)(2008-11#10)(2008-12#2)(2008-2#15)(2008-3#28)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#4)(2010-2#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2011-1#12)(2011-2#4)(2011-3#1)(2012-1#4)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#5)
the determinations of##8##3##(2008-10#8)
the determinations##16##2##(2008-10#16)
the determined and foreign ions##2##5##(2008-10#2)
the determined values##5##3##(2008-10#5)
the determined##22##2##(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#15)(2008-3#2)(2008-8#1)(2010-12#1)
the determining##2##2##(2008-7#1)(2008-9#1)
the deterministic##4##2##(1996-6#1)(2007-11#1)(2008-8#1)(2008-9#1)
the detoxification of##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
the detoxification##8##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
the detrimental effect of##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
the detrimental effects of##4##4##(1993-12#1)(1994-3#1)(1996-12#1)(2008-5#1)
the detrimental effects##5##3##(1993-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(2008-5#1)
the detrimental##10##2##(1993-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-8#1)
the detuning##3##2##(2007-11#1)(2007-12#2)
the deuterated##2##2##(1996-5#1)(2008-4#1)
the deuterium##3##2##(1990-7#1)(1996-5#1)(2008-10#1)
the deutocerebrum##3##2##(2007-12#3)
the devastating##3##2##(2007-12#1)(2010-5#1)(2010-8#1)
the developed PCR assay##2##4##(2008-10#1)(2013-1#1)
the developed and developing##2##4##(1997-7#1)(2008-10#1)
the developed immunoassay##2##3##(2008-10#1)(2010-5#1)
the developed method are##3##4##(2008-10#3)
the developed method is##4##4##(2008-10#3)(2011-1#1)
the developed method was##7##4##(2008-10#7)
the developed method##40##3##(2008-10#37)(2008-3#1)(2011-1#1)(2012-12#1)
the developed methodology was##2##4##(2008-10#2)
the developed methodology##3##3##(2008-10#2)(2011-2#1)
the developed methods##2##3##(2008-10#2)
the developed model##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)
the developed procedure##10##3##(2008-10#10)
the developed system##5##3##(2008-10#2)(2008-3#1)(2010-10#1)(2010-8#1)
the developed world##8##3##(1994-9#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-12#1)
the developed##127##2##(1993-8#1)(1994-9#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#87)(2008-2#1)(2008-3#6)(2008-5#1)(2008-8#3)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-6#1)(2013-1#2)
the developer##2##2##(2008-10#1)(2008-2#1)
the developers of the##2##4##(1997-2#1)(2008-7#1)
the developers of##3##3##(1994-1#1)(1997-2#1)(2008-7#1)
the developers##4##2##(1994-1#1)(1995-2#1)(1997-2#1)(2008-7#1)
the developing and##6##3##(1995-5#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-4#1)
the developing brain##5##3##(1994-2#1)(1995-12#2)(2007-12#1)(2008-7#1)
the developing cerebellum##3##3##(1995-12#1)(1996-5#2)
the developing countries##6##3##(2007-12#1)(2007-7#3)(2008-11#1)(2011-2#1)
the developing fruit##3##3##(2008-10#3)
the developing human##3##3##(1990-7#1)(1991-7#1)(2008-7#1)
the developing limb##5##3##(2008-11#3)(2009-3#1)(2010-3#1)
the developing lung##2##3##(1991-12#1)(2009-9#1)
the developing nervous system##2##4##(1992-3#1)(2012-3#1)
the developing or##2##3##(1997-3#1)(2013-1#1)
the developing rodent brain##2##4##(1994-2#1)(2008-7#1)
the developing world##20##3##(1997-7#3)(2007-2#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#2)
the developing##116##2##(1990-7#1)(1991-12#1)(1991-7#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#2)(1994-2#3)(1994-8#2)(1995-12#4)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#2)(1996-5#7)(1997-3#1)(1997-7#3)(1997-9#2)(2007-12#8)(2007-2#1)(2007-7#3)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
the development and application of a##3##6##(2008-10#2)(2012-2#1)
the development and application of##7##5##(1994-3#1)(1996-3#1)(2008-10#3)(2008-8#1)(2012-2#1)
the development and assessment of##2##5##(2008-11#1)(2011-8#1)
the development and characterization of a##2##6##(2008-3#1)(2013-1#1)
the development and characterization of##3##5##(2008-3#2)(2013-1#1)
the development and design of the##2##6##(2012-12#1)(2012-2#1)
the development and evaluation of a##3##6##(2008-11#1)(2008-12#2)
the development and evaluation of##4##5##(2008-11#1)(2008-12#2)(2008-9#1)
the development and function of##2##5##(2007-5#1)(2008-4#1)
the development and implementation of a##2##6##(1993-3#2)
the development and implementation of##9##5##(1993-3#2)(1994-2#2)(2008-11#3)(2009-12#1)(2010-6#1)
the development and maintenance of persistent pain##2##7##(2008-7#2)
the development and maintenance of##7##5##(1996-5#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-2#1)
the development and maintenance##8##4##(1996-5#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-2#2)
the development and perpetuation of##3##5##(2008-12#3)
the development and progression of##14##5##(1993-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
the development and testing of##3##5##(1992-2#1)(1996-2#1)(2007-11#1)
the development and the##2##4##(2008-6#1)(2008-8#1)
the development and use of##6##5##(1992-1#1)(1993-12#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
the development and validation of a##2##6##(2008-10#1)(2008-5#1)
the development and##103##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-3#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#1)(2007-11#3)(2007-5#1)(2008-1#3)(2008-10#12)(2008-11#7)(2008-12#7)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#2)(2010-3#2)(2010-6#1)(2011-2#7)(2011-8#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#1)
the development and/or##2##3##(1995-6#1)(2008-6#1)
the development in##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
the development is##2##3##(2008-10#2)
the development of Burnout Syndrome##2##5##(2013-1#2)
the development of DME and retinal NV##2##7##(2008-1#2)
the development of FHB##2##4##(2011-10#2)
the development of IPA in##2##5##(2011-2#2)
the development of a capillary electrophoresis method for the##2##9##(2008-10#2)
the development of a capillary##3##5##(2008-10#3)
the development of a complex##2##5##(2007-12#1)(2009-8#1)
the development of a comprehensive##2##5##(1995-3#1)(1997-3#1)
the development of a highly##2##5##(2008-10#1)(2008-3#1)
the development of a laboratory##2##5##(2008-10#2)
the development of a marketing plan will provide a strategy that will keep the medical group competitive among older consumers##2##20##(1994-3#2)
the development of a method##2##5##(2008-10#1)(2008-4#1)
the development of a methodology##2##5##(2007-6#1)(2008-10#1)
the development of a more##4##5##(1994-11#1)(1997-2#1)(2008-11#1)(2010-8#1)
the development of a new##14##5##(1995-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#6)(2008-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
the development of a shared##2##5##(1993-12#1)(2008-11#1)
the development of a simple##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
the development of a single##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
the development of a successful##3##5##(1991-3#1)(2008-10#1)(2010-10#1)
the development of a vaccine##2##5##(1997-7#1)(2011-2#1)
the development of a##149##4##(1990-10#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#37)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)
the development of alternative##6##4##(1994-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2010-12#1)(2012-12#1)
the development of an in##2##5##(1990-12#1)(2008-3#1)
the development of an integrated##4##5##(2006-9#1)(2008-10#2)(2008-6#1)
the development of an##38##4##(1990-12#1)(1991-1#2)(1993-12#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(2006-9#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-3#5)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
the development of analytical methods for the determination of rhodium has increased##2##12##(2008-10#2)
the development of analytical##4##4##(2008-10#3)(2011-2#1)
the development of animal##3##4##(1992-9#1)(2008-11#1)(2011-2#1)
the development of appropriate##3##4##(2007-10#1)(2008-1#1)(2011-2#1)
the development of arterial hypertension in##2##6##(2011-2#2)
the development of artificial##2##4##(2011-1#1)(2013-1#1)
the development of atherosclerotic lesions##2##5##(1996-3#1)(2010-8#1)
the development of atrial##2##4##(2012-12#2)
the development of autism##2##4##(2012-3#2)
the development of autoimmune##2##4##(2008-10#2)
the development of autoimmunity##3##4##(2008-10#2)(2010-5#1)
the development of bacterial##2##4##(2008-10#1)(2009-5#1)
the development of better##2##4##(2008-7#1)(2011-1#1)
the development of both##3##4##(1991-8#1)(1992-12#1)(2008-1#1)
the development of breast cancer##3##5##(1994-12#1)(2008-12#1)(2013-8#1)
the development of cardiovascular disease##4##5##(1997-8#1)(2008-1#2)(2011-1#1)
the development of cardiovascular##6##4##(1997-8#1)(2008-1#2)(2008-7#1)(2011-1#1)(2013-7#1)
the development of case##2##4##(1995-2#1)(2008-11#1)
the development of cellular##2##4##(1990-5#1)(2010-12#1)
the development of central##2##4##(2008-7#1)(2008-9#1)
the development of cerebral##2##4##(1995-6#1)(2008-9#1)
the development of chronic kidney disease##2##6##(2008-8#1)(2010-10#1)
the development of chronic##5##4##(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
the development of clinical##12##4##(1993-12#1)(1996-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
the development of colon##2##4##(1993-11#1)(2013-8#1)
the development of colorectal##2##4##(1993-8#1)(2011-2#1)
the development of competencies##2##4##(2008-12#1)(2012-3#1)
the development of competent practitioners##2##5##(2008-11#1)(2008-12#1)
the development of coronary##2##4##(2008-10#1)(2008-3#1)
the development of diabetes##2##4##(2008-1#1)(2011-2#1)
the development of diabetic complications##2##5##(2008-1#1)(2009-11#1)
the development of diabetic##3##4##(2008-1#1)(2009-11#1)(2012-2#1)
the development of different##2##4##(2010-8#2)
the development of disease##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
the development of diseases##2##4##(2008-7#1)(2013-1#1)
the development of drug resistance##2##5##(1997-6#1)(2007-11#1)
the development of drug##3##4##(1997-6#1)(2007-11#1)(2012-2#1)
the development of early##5##4##(1990-2#1)(1992-12#1)(1994-2#1)(2008-10#1)(2012-2#1)
the development of educational##2##4##(2008-1#1)(2008-12#1)
the development of effective##5##4##(1993-12#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-12#1)
the development of efficient##2##4##(2008-10#1)(2012-2#1)
the development of emphysema##2##4##(1991-12#2)
the development of experimental##2##4##(1996-12#1)(2007-11#1)
the development of further##3##4##(2008-11#1)(2008-5#1)(2012-2#1)
the development of future##4##4##(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
the development of gastric##2##4##(1995-2#1)(2008-12#1)
the development of gene##2##4##(2008-11#1)(2008-9#1)
the development of guidelines##2##4##(2009-4#1)(2013-1#1)
the development of highly sensitive##2##5##(2008-10#1)(2010-7#1)
the development of human resource management skills##2##7##(1995-3#2)
the development of human##8##4##(1994-12#1)(1994-5#1)(1995-3#2)(2007-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
the development of hyperalgesia in##2##5##(1993-12#1)(1996-5#1)
the development of hypertension##6##4##(1997-6#3)(2008-1#1)(2010-2#1)(2011-2#1)
the development of implantable##2##4##(2008-7#1)(2009-11#1)
the development of improved##2##4##(2008-11#1)(2011-2#1)
the development of increasingly##2##4##(1992-11#1)(2008-7#1)
the development of insulin resistance##5##5##(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-5#1)
the development of insulin##6##4##(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-5#1)
the development of interventions##2##4##(2008-7#1)(2012-1#1)
the development of latent##2##4##(2008-5#1)(2012-2#1)
the development of lesions##3##4##(2008-10#2)(2010-12#1)
the development of long-term potentiation##2##5##(1990-5#2)
the development of long-term##3##4##(1990-5#2)(2008-7#1)
the development of lupus##2##4##(2007-7#1)(2008-10#1)
the development of malignant##2##4##(2007-8#1)(2011-2#1)
the development of many##3##4##(2008-6#2)(2013-8#1)
the development of medical##4##4##(1993-2#1)(2010-1#1)(2010-8#1)(2012-3#1)
the development of medicine##2##4##(1993-11#1)(2011-2#1)
the development of metastases##2##4##(1991-8#1)(2008-7#1)
the development of methods##2##4##(2008-10#1)(2008-7#1)
the development of minimally invasive##3##5##(2007-8#1)(2009-4#1)(2011-2#1)
the development of modern##2##4##(1991-11#1)(2007-8#1)
the development of molecular##4##4##(2008-10#2)(2008-2#1)(2011-1#1)
the development of more accurate##2##5##(2008-3#1)(2008-5#1)
the development of more effective##2##5##(2007-7#1)(2009-12#1)
the development of more potent##2##5##(1994-5#1)(2008-4#1)
the development of more##16##4##(1994-5#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
the development of motor complications##2##5##(2010-12#2)
the development of multiple##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
the development of nanosensors##2##4##(2008-10#2)
the development of neural##2##4##(1994-12#1)(2008-8#1)
the development of new and##2##5##(1994-9#1)(1997-4#1)
the development of new methods##3##5##(1997-1#1)(2008-10#1)(2011-1#1)
the development of new neurological deficits##2##6##(2007-10#2)
the development of new programs##2##5##(1992-1#1)(1994-1#1)
the development of new strategies and##2##6##(2008-11#1)(2011-10#1)
the development of new strategies##5##5##(1997-8#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-10#1)
the development of new surgical techniques##2##6##(1994-6#1)(2007-8#1)
the development of new therapeutic strategies to##2##7##(2008-4#1)(2008-6#1)
the development of new therapies##3##5##(2008-6#1)(2008-8#1)(2011-2#1)
the development of new##61##4##(1991-12#1)(1991-8#2)(1991-9#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-10#1)(2011-2#1)(2013-1#1)
the development of non-invasive##2##4##(2010-6#1)(2012-3#1)
the development of novel cancer##2##5##(2010-5#1)(2011-2#1)
the development of novel treatment##2##5##(2011-2#1)(2013-1#1)
the development of novel##22##4##(1994-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
the development of nursing##3##4##(1997-7#1)(2008-12#2)
the development of one of##2##5##(2008-10#2)
the development of ontogenic resistance##2##5##(2008-10#2)
the development of optical##3##4##(2007-12#1)(2008-10#1)(2010-12#1)
the development of optimal##2##4##(2008-7#1)(2010-5#1)
the development of oral##2##4##(2008-8#1)(2012-2#1)
the development of our##2##4##(1997-8#1)(2012-2#1)
the development of patient-based measurement systems##2##6##(1994-3#2)
the development of periodic##2##4##(2008-10#2)
the development of physical##2##4##(1991-3#1)(2008-7#1)
the development of policies##2##4##(1996-1#1)(2010-7#1)
the development of preeclampsia##3##4##(2008-11#2)(2011-2#1)
the development of preventive##3##4##(2009-4#1)(2009-6#1)(2010-12#1)
the development of primary##3##4##(1993-10#1)(1996-1#1)(2009-9#1)
the development of programs##2##4##(1995-3#1)(2008-1#1)
the development of pulmonary##2##4##(1994-8#1)(2009-5#1)
the development of rapid##3##4##(2008-10#2)(2008-7#1)
the development of reflective##2##4##(2008-12#2)
the development of resistance##5##4##(1994-8#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-3#1)
the development of resistant##2##4##(2008-1#1)(2010-11#1)
the development of robust##5##4##(2007-11#1)(2008-10#2)(2008-7#1)(2012-12#1)
the development of several##5##4##(2008-12#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
the development of sexual##2##4##(2008-7#1)(2012-3#1)
the development of significant##2##4##(2008-10#1)(2008-7#1)
the development of simple##2##4##(1997-3#1)(2009-2#1)
the development of skills##2##4##(1990-12#1)(2011-2#1)
the development of specific##4##4##(1994-1#1)(2008-10#2)(2010-11#1)
the development of spontaneous##2##4##(1993-12#1)(2008-6#1)
the development of stable##2##4##(2008-11#1)(2008-5#1)
the development of strategies##2##4##(1994-3#1)(2010-11#1)
the development of subsequent##2##4##(1997-8#1)(2008-7#1)
the development of such##4##4##(1995-3#1)(1996-11#1)(2008-2#1)(2009-5#1)
the development of supra ventricular disorders of##2##7##(2011-1#2)
the development of sustainable##2##4##(2008-10#1)(2012-1#1)
the development of techniques##3##4##(2007-11#1)(2007-8#1)(2008-11#1)
the development of technology##2##4##(1997-3#1)(2008-10#1)
the development of testicular##2##4##(1992-5#1)(2010-5#1)
the development of the Georgia system##2##6##(1996-12#2)
the development of the disease##2##5##(1990-6#1)(2013-1#1)
the development of the guidelines##2##5##(2010-5#1)(2012-2#1)
the development of the immune##2##5##(1993-12#1)(1995-12#1)
the development of the medical##2##5##(2008-11#1)(2011-2#1)
the development of the reaction between##3##6##(2008-10#3)
the development of the##98##4##(1990-11#1)(1990-6#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#14)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#2)
the development of their##3##4##(1990-12#1)(2008-11#1)(2008-12#1)
the development of therapeutic##5##4##(1990-6#1)(2007-8#1)(2009-6#1)(2012-12#1)(2012-2#1)
the development of thermal##2##4##(2008-7#1)(2009-7#1)
the development of these disorders##2##5##(2008-2#1)(2011-2#1)
the development of these##10##4##(1995-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2011-7#1)(2013-8#1)
the development of this disease##2##5##(2008-10#1)(2012-3#1)
the development of this##18##4##(1992-2#1)(1994-6#1)(1994-9#1)(1995-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-3#1)
the development of tissue##2##4##(1995-2#1)(2011-1#1)
the development of tolerance to these##2##6##(1995-11#1)(2009-7#1)
the development of tolerance##4##4##(1991-1#1)(1991-5#1)(1995-11#1)(2009-7#1)
the development of tumors##3##4##(1991-9#1)(2011-1#1)(2013-1#1)
the development of type 2 diabetes##2##6##(2008-1#1)(2008-11#1)
the development of vaccines##3##4##(1994-11#1)(2011-1#1)(2013-8#1)
the development of various##4##4##(2009-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
the development of vascular##4##4##(1996-12#1)(2008-1#1)(2008-9#1)(2009-1#1)
the development of vectors##2##4##(1994-5#1)(2008-11#1)
the development of what we##2##5##(2007-11#1)(2008-9#1)
the development of##1275##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#2)(1991-1#5)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#13)(1993-2#2)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#4)(1994-12#13)(1994-2#6)(1994-3#12)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#4)(1996-12#7)(1996-2#6)(1996-3#11)(1996-5#5)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#11)(1997-3#10)(1997-4#4)(1997-6#9)(1997-7#5)(1997-8#9)(2006-10#3)(2006-6#2)(2006-9#1)(2007-10#6)(2007-11#17)(2007-12#10)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#11)(2008-1#25)(2008-10#179)(2008-11#77)(2008-12#31)(2008-2#15)(2008-3#30)(2008-4#25)(2008-5#26)(2008-6#11)(2008-7#55)(2008-8#19)(2008-9#24)(2009-1#3)(2009-10#4)(2009-11#8)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#7)(2009-6#7)(2009-7#11)(2009-8#4)(2009-9#5)(2010-1#7)(2010-10#6)(2010-11#10)(2010-12#17)(2010-2#1)(2010-3#6)(2010-4#7)(2010-5#10)(2010-6#4)(2010-7#6)(2010-8#12)(2010-9#3)(2011-1#23)(2011-10#3)(2011-2#63)(2011-3#6)(2011-7#3)(2012-1#5)(2012-12#23)(2012-2#34)(2012-3#27)(2012-4#1)(2012-5#2)(2013-1#34)(2013-7#5)(2013-8#22)
the development##1416##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#2)(1991-1#5)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#14)(1993-2#2)(1993-3#7)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#4)(1994-11#4)(1994-12#13)(1994-2#8)(1994-3#13)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#3)(1995-9#2)(1996-1#4)(1996-11#4)(1996-12#8)(1996-2#8)(1996-3#12)(1996-5#6)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#11)(1997-3#10)(1997-4#4)(1997-6#9)(1997-7#5)(1997-8#9)(2006-10#3)(2006-6#2)(2006-9#1)(2007-10#6)(2007-11#20)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#12)(2008-1#28)(2008-10#202)(2008-11#88)(2008-12#39)(2008-2#15)(2008-3#33)(2008-4#29)(2008-5#31)(2008-6#14)(2008-7#60)(2008-8#23)(2008-9#28)(2009-1#3)(2009-10#4)(2009-11#8)(2009-12#8)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#7)(2009-7#12)(2009-8#4)(2009-9#5)(2010-1#7)(2010-10#6)(2010-11#10)(2010-12#17)(2010-2#1)(2010-3#8)(2010-4#7)(2010-5#10)(2010-6#5)(2010-7#6)(2010-8#13)(2010-9#3)(2011-1#23)(2011-10#3)(2011-2#70)(2011-3#6)(2011-7#3)(2011-8#1)(2012-1#5)(2012-12#29)(2012-2#37)(2012-3#30)(2012-4#1)(2012-5#2)(2013-1#43)(2013-7#5)(2013-8#25)
the developmental barrier between##2##4##(2012-12#2)
the developmental dynamics of##2##4##(2007-12#1)(2011-2#1)
the developmental expression##2##3##(1997-2#1)(2008-8#1)
the developmental pattern##2##3##(2008-11#1)(2008-7#1)
the developmental periods##2##3##(2009-11#1)(2011-2#1)
the developmental processes of##2##4##(2008-8#1)(2011-2#1)
the developmental program of##2##4##(1991-9#1)(2007-12#1)
the developmental stage##3##3##(1991-9#1)(2008-6#1)(2008-9#1)
the developmental stages##3##3##(1994-9#1)(2008-10#1)(2008-8#1)
the developmental state of the plant##2##6##(1990-5#1)(2008-11#1)
the developmental toxicity##2##3##(1993-12#1)(2010-1#1)
the developmental##58##2##(1990-2#1)(1990-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-12#3)(1994-9#1)(1995-2#2)(1996-12#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)
the developmentally disabled##2##3##(1997-6#1)(2008-12#1)
the developmentally regulated##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
the developmentally##6##2##(1992-12#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
the developments in##7##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
the developments##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-8#1)
the deviance##3##2##(1994-9#2)(1996-3#1)
the deviant##2##2##(2008-8#2)
the deviation from##2##3##(2008-3#2)
the deviation of the##3##4##(2008-2#2)(2009-11#1)
the deviation of##5##3##(2008-10#1)(2008-2#3)(2009-11#1)
the deviation##11##2##(2008-10#3)(2008-2#3)(2008-3#4)(2009-11#1)
the deviations from the##2##4##(2008-7#1)(2010-2#1)
the deviations from##3##3##(2008-3#1)(2008-7#1)(2010-2#1)
the deviations##9##2##(2008-10#3)(2008-3#2)(2008-7#2)(2009-3#1)(2010-2#1)
the device and##6##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#2)
the device as##3##3##(2008-2#2)(2008-3#1)
the device can be##2##4##(2007-12#1)(2008-2#1)
the device for##2##3##(2008-10#1)(2008-3#1)
the device has##2##3##(2008-10#1)(2008-3#1)
the device is##13##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#3)(2010-2#1)
the device sensitivity##2##3##(2009-5#2)
the device to be##2##4##(2007-11#1)(2008-3#1)
the device to the##2##4##(2007-8#1)(2008-11#1)
the device to##6##3##(1994-3#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-3#1)
the device was##8##3##(1994-9#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-9#1)(2012-3#1)
the device##122##2##(1991-12#1)(1994-3#1)(1994-9#2)(1996-2#1)(1996-6#1)(1997-2#1)(2007-11#11)(2007-12#10)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#10)(2008-11#11)(2008-12#1)(2008-2#15)(2008-3#23)(2008-7#1)(2008-9#6)(2009-10#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-6#4)(2010-7#2)(2010-8#1)(2012-2#2)(2012-3#5)(2013-1#1)
the device's##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-7#1)
the devices and##2##3##(1993-12#1)(2012-3#1)
the devices are##2##3##(2008-2#2)
the devices used##2##3##(2008-4#1)(2013-7#1)
the devices were##2##3##(1993-12#1)(2008-9#1)
the devices##17##2##(1991-3#1)(1993-12#2)(1996-2#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
the dexamethasone suppression test##3##4##(1990-3#1)(1995-11#2)
the dextran##2##2##(2008-10#2)
the dextrose##2##2##(2008-9#1)(2011-2#1)
the diabetes##11##2##(1993-11#1)(1993-12#1)(1996-11#3)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
the diabetic foot##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
the diabetic men##3##3##(2008-7#2)(2011-2#1)
the diabetic patient##5##3##(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
the diabetic patients##3##3##(1991-12#1)(1993-11#1)(2013-1#1)
the diabetic population##3##3##(2008-1#1)(2008-8#1)(2012-2#1)
the diabetic rats##2##3##(1994-11#1)(1994-8#1)
the diabetic retinal microvascular environment##2##5##(2012-4#2)
the diabetic##32##2##(1990-3#1)(1991-12#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#5)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-4#2)(2013-1#1)
the diabetics##2##2##(1990-9#1)(2008-3#1)
the diacylglycerol##2##2##(1991-9#1)(1993-8#1)
the diafiltration buffer pH for##2##5##(2011-2#2)
the diafiltration buffer##3##3##(2011-2#3)
the diafiltration##4##2##(2011-2#4)
the diagnoses##13##2##(1990-12#1)(1994-6#1)(1995-11#2)(1997-8#2)(2007-12#2)(2007-8#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-12#1)
the diagnosis and differential diagnosis##2##5##(1996-11#1)(2007-5#1)
the diagnosis and evaluation of##2##5##(1992-5#1)(2007-8#1)
the diagnosis and follow-up of patients with##2##7##(2012-2#2)
the diagnosis and follow-up of##6##5##(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)
the diagnosis and management of a##2##6##(2008-12#2)
the diagnosis and management of neovascular age-related macular degeneration##2##9##(2011-7#2)
the diagnosis and management of patients with##2##7##(2007-11#1)(2011-2#1)
the diagnosis and management of small##2##6##(2012-2#2)
the diagnosis and management of##29##5##(1992-5#1)(1993-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#3)(2011-2#3)(2011-7#5)(2012-2#2)(2013-1#1)
the diagnosis and monitoring of##2##5##(2008-5#1)(2013-1#1)
the diagnosis and prognosis of##5##5##(1995-9#1)(2007-7#1)(2008-11#1)(2008-4#2)
the diagnosis and the therapy of##2##6##(1993-6#1)(2013-8#1)
the diagnosis and the##6##4##(1991-3#1)(1993-6#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
the diagnosis and therapeutic##2##4##(2008-1#1)(2011-2#1)
the diagnosis and therapy of##3##5##(1990-2#1)(2008-7#1)(2012-3#1)
the diagnosis and treatment of bronchiolitis obliterans in##2##8##(2013-1#2)
the diagnosis and treatment of patients with##2##7##(2008-12#1)(2011-7#1)
the diagnosis and treatment of the##2##6##(1996-3#1)(2008-4#1)
the diagnosis and treatment of this##4##6##(1992-5#1)(2010-12#1)(2011-7#1)(2013-1#1)
the diagnosis and treatment of##29##5##(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1996-3#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-7#2)(2012-2#1)(2013-1#5)
the diagnosis and treatment##31##4##(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1995-8#1)(1996-3#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#2)(2011-7#2)(2012-2#1)(2013-1#5)
the diagnosis and##111##3##(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#3)(1993-11#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#2)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#2)(2009-10#2)(2009-4#2)(2009-5#1)(2010-12#7)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-7#7)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#1)
the diagnosis are##3##3##(1997-8#1)(2013-1#2)
the diagnosis as##5##3##(1991-12#1)(2007-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
the diagnosis but##2##3##(1990-5#1)(1997-3#1)
the diagnosis can##2##3##(2010-8#1)(2012-12#1)
the diagnosis for##2##3##(2008-1#1)(2012-12#1)
the diagnosis in##4##3##(2007-10#1)(2007-8#1)(2008-5#1)(2011-2#1)
the diagnosis is made##6##4##(1992-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-1#1)
the diagnosis is not##2##4##(1991-2#1)(2013-8#1)
the diagnosis is##14##3##(1990-12#1)(1991-2#1)(1992-11#2)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
the diagnosis of &quot##2##4##(1991-12#1)(2013-7#1)
the diagnosis of CTEPH##2##4##(2010-6#2)
the diagnosis of M##2##4##(2008-5#1)(2011-2#1)
the diagnosis of a##7##4##(2007-7#1)(2007-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
the diagnosis of acute##10##4##(1994-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-3#3)(2008-9#1)(2013-1#2)
the diagnosis of an##5##4##(2007-7#1)(2007-8#1)(2008-11#1)(2012-3#2)
the diagnosis of autoimmune hepatitis##2##5##(1996-11#1)(2011-1#1)
the diagnosis of breast##4##4##(1991-12#3)(2008-3#1)
the diagnosis of cancer##2##4##(1996-11#1)(2012-3#1)
the diagnosis of chronic##4##4##(1992-5#2)(1994-11#1)(2010-6#1)
the diagnosis of coronary artery##3##5##(2008-11#1)(2012-1#1)(2012-2#1)
the diagnosis of disseminated##2##4##(2007-7#1)(2008-5#1)
the diagnosis of early##2##4##(1991-12#1)(2008-5#1)
the diagnosis of gout##2##4##(2006-10#2)
the diagnosis of hepatitis##2##4##(1997-4#1)(2008-10#1)
the diagnosis of invasive##2##4##(2011-2#1)(2013-1#1)
the diagnosis of malaria##2##4##(2007-2#1)(2007-7#1)
the diagnosis of mild##2##4##(2012-2#1)(2013-8#1)
the diagnosis of multiple##3##4##(1990-3#1)(2008-7#1)(2012-3#1)
the diagnosis of oral lesions##2##5##(2013-1#2)
the diagnosis of primary##3##4##(1995-12#1)(2013-1#2)
the diagnosis of pulmonary##2##4##(1991-11#1)(2008-10#1)
the diagnosis of renal##3##4##(1990-9#1)(2008-1#1)(2011-2#1)
the diagnosis of sarcoidosis##2##4##(2008-1#1)(2013-7#1)
the diagnosis of the acute##2##5##(1997-3#1)(2007-10#1)
the diagnosis of the##13##4##(1990-3#1)(1990-6#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
the diagnosis of these##4##4##(1990-5#1)(2009-3#1)(2010-2#1)(2012-2#1)
the diagnosis of this##5##4##(1997-8#1)(2006-10#1)(2008-8#1)(2009-3#1)(2010-8#1)
the diagnosis of tuberculosis##2##4##(2008-12#1)(2013-1#1)
the diagnosis of##291##3##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#4)(1991-11#3)(1991-12#7)(1991-2#1)(1991-3#5)(1991-6#1)(1992-10#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-11#3)(1996-12#2)(1996-3#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-8#4)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#8)(2007-11#4)(2007-12#3)(2007-2#5)(2007-5#1)(2007-7#8)(2007-8#4)(2008-1#9)(2008-10#9)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#27)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#10)(2013-1#32)(2013-7#4)(2013-8#7)
the diagnosis was confirmed by##4##5##(1990-2#1)(1990-6#1)(1997-8#1)(2008-7#1)
the diagnosis was confirmed with##2##5##(2010-5#1)(2012-12#1)
the diagnosis was confirmed##7##4##(1990-2#1)(1990-6#1)(1997-8#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)
the diagnosis was established##2##4##(2007-12#1)(2011-2#1)
the diagnosis was not##3##4##(1992-5#1)(2007-8#1)(2008-7#1)
the diagnosis was##23##3##(1990-2#1)(1990-3#2)(1990-6#1)(1992-5#1)(1993-3#1)(1993-5#1)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)
the diagnosis##548##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#5)(1990-5#2)(1990-6#5)(1990-8#4)(1990-9#6)(1991-1#2)(1991-11#4)(1991-12#10)(1991-2#3)(1991-3#6)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#8)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-11#4)(1996-12#2)(1996-3#4)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#9)(1997-4#2)(1997-8#8)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#11)(2007-11#9)(2007-12#8)(2007-2#6)(2007-5#4)(2007-7#13)(2007-8#11)(2008-1#17)(2008-10#13)(2008-11#8)(2008-12#12)(2008-2#4)(2008-3#11)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#14)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#11)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#5)(2010-6#8)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#7)(2011-2#45)(2011-3#1)(2011-7#7)(2012-1#1)(2012-12#12)(2012-2#18)(2012-3#13)(2013-1#49)(2013-7#5)(2013-8#12)
the diagnostic accuracy of##7##4##(2008-12#1)(2009-11#1)(2009-4#1)(2010-8#1)(2012-2#2)(2013-1#1)
the diagnostic accuracy##8##3##(2008-12#2)(2009-11#1)(2009-4#1)(2010-8#1)(2012-2#2)(2013-1#1)
the diagnostic and prognostic##2##4##(1995-5#1)(2011-3#1)
the diagnostic and therapeutic##6##4##(1997-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2013-7#1)
the diagnostic and##8##3##(1995-5#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-3#1)(2013-7#1)
the diagnostic approach##4##3##(1992-9#1)(2008-1#1)(2009-8#1)(2010-8#1)
the diagnostic armamentarium##2##3##(1996-1#1)(2011-2#1)
the diagnostic criteria for##6##4##(1991-3#1)(1995-6#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
the diagnostic criteria##11##3##(1991-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(2008-1#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
the diagnostic difficulties##2##3##(1992-5#1)(2008-6#1)
the diagnostic evaluation of##2##4##(1992-12#1)(2012-1#1)
the diagnostic evaluation##3##3##(1992-12#1)(2012-1#1)(2013-1#1)
the diagnostic imaging##2##3##(1994-1#1)(1994-2#1)
the diagnostic possibilities##2##3##(2007-11#1)(2011-2#1)
the diagnostic procedures##5##3##(1993-11#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)
the diagnostic process##7##3##(1990-9#1)(1996-11#1)(2007-4#1)(2008-10#2)(2013-1#1)(2013-7#1)
the diagnostic recognition of chronic SPs##2##6##(2013-1#2)
the diagnostic test##2##3##(2012-12#1)(2013-1#1)
the diagnostic tools##2##3##(2007-2#1)(2008-1#1)
the diagnostic utility of##5##4##(2008-12#2)(2009-8#1)(2011-2#1)(2012-2#1)
the diagnostic value of##5##4##(1991-6#1)(1992-3#1)(1996-3#1)(2013-1#2)
the diagnostic workup##2##3##(1992-1#1)(2012-2#1)
the diagnostic yield from##2##4##(1997-8#1)(2013-1#1)
the diagnostic yield of##3##4##(2010-12#1)(2011-2#2)
the diagnostic yield##7##3##(1990-3#1)(1997-8#1)(2010-12#1)(2011-2#3)(2013-1#1)
the diagnostic##132##2##(1990-2#1)(1990-3#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#4)(2008-10#10)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2009-11#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-8#3)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2013-1#15)(2013-7#2)(2013-8#2)
the diagnostics of##3##3##(1990-5#1)(2007-11#1)(2013-8#1)
the diagnostics##4##2##(1990-5#1)(2007-11#2)(2013-8#1)
the diagonal##9##2##(1994-3#2)(1997-7#1)(2007-12#1)(2008-3#2)(2008-4#2)(2008-8#1)
the diagrams##2##2##(1993-2#1)(2008-10#1)
the dialysate from the##2##4##(2008-10#2)
the dialysate##11##2##(1995-12#2)(2008-1#2)(2008-10#5)(2011-2#2)
the dialysis centers##2##3##(2008-1#2)
the dialysis membrane##2##3##(1992-3#1)(1993-12#1)
the dialysis population##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
the dialysis probe##2##3##(1992-3#1)(1997-2#1)
the dialysis unit##2##3##(1996-12#1)(2007-7#1)
the dialysis was##2##3##(1990-12#1)(2008-10#1)
the dialysis##22##2##(1990-12#1)(1992-3#2)(1993-12#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#3)(2008-1#5)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#2)
the diamagnetic##3##2##(1994-5#1)(1997-7#1)(2008-9#1)
the diameter of the ball lens##2##6##(2011-1#2)
the diameter of the##12##4##(2007-8#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2011-1#2)(2013-1#1)
the diameter of##20##3##(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the diameter##25##2##(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
the diameters of the##3##4##(2008-2#3)
the diameters of##4##3##(2008-10#1)(2008-2#3)
the diameters##5##2##(1990-6#1)(2008-10#1)(2008-2#3)
the diamine##2##2##(1996-2#1)(2013-8#1)
the diamond##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
the diapause##2##2##(2008-8#2)
the diaphorase##2##2##(1992-3#1)(1992-6#1)
the diaphragm and##3##3##(1990-2#1)(2010-9#1)(2012-2#1)
the diaphragm into the pleural cavity##2##6##(1991-8#1)(2007-12#1)
the diaphragm of##2##3##(2009-6#1)(2010-2#1)
the diaphragm##18##2##(1990-2#2)(1990-5#1)(1991-3#1)(1991-8#1)(1993-6#1)(2007-12#1)(2007-8#2)(2008-11#1)(2009-6#1)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
the diastereomeric##3##2##(1990-8#1)(1995-3#1)(2008-11#1)
the diastolic##5##2##(1992-9#1)(1996-6#2)(2008-10#1)(2008-8#1)
the diatom Thalassiosira weissflogii##2##4##(1994-8#1)(2011-2#1)
the diatom##3##2##(1994-8#1)(2010-11#1)(2011-2#1)
the diauxic growth pattern##2##4##(2008-7#2)
the diauxic##3##2##(2008-6#1)(2008-7#2)
the diazepam-insensitive site##2##3##(1995-11#2)
the diazepam-insensitive##5##2##(1992-3#3)(1995-11#2)
the diazonium salt##2##3##(1992-9#1)(2008-10#1)
the diazonium##3##2##(1992-9#1)(2008-10#2)
the dicarboxylic##2##2##(2008-10#1)(2013-1#1)
the dichloromethane fraction##3##3##(2008-11#3)
the dichotomous trait##2##3##(2012-3#2)
the dichotomous##4##2##(1996-2#1)(2009-12#1)(2012-3#2)
the dichotomy##2##2##(2008-4#1)(2008-6#1)
the dichromate##2##2##(2008-10#1)(2008-3#1)
the dictionary##3##2##(2008-4#2)(2012-12#1)
the dideoxy##2##2##(2008-2#2)
the dielectric constant##4##3##(2008-10#1)(2008-3#1)(2008-7#2)
the dielectric##22##2##(1993-5#1)(1997-2#2)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#8)(2008-7#2)(2009-5#1)(2013-1#1)
the diene##2##2##(1991-5#1)(1994-9#1)
the diet for##2##3##(1991-2#1)(1992-3#1)
the diet in##2##3##(1991-6#1)(2008-10#1)
the diet is##2##3##(2008-10#1)(2008-9#1)
the diet of white-lipped peccary##2##5##(2008-5#2)
the diet of##7##3##(1994-8#1)(1997-3#1)(2008-5#2)(2010-8#1)(2012-12#1)(2012-2#1)
the diet##39##2##(1990-6#1)(1990-8#2)(1991-2#2)(1991-6#1)(1992-3#3)(1992-8#2)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#3)(1997-3#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
the dietary fiber##2##3##(1993-11#1)(2010-8#1)
the dietary##19##2##(1990-6#1)(1990-8#1)(1991-12#3)(1993-11#1)(1994-12#1)(1994-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
the dietetic##2##2##(1994-2#1)(1995-2#1)
the diethyl##2##2##(2008-10#1)(2010-5#1)
the dietitian in the##2##4##(1993-3#2)
the dietitian in##3##3##(1993-12#1)(1993-3#2)
the dietitian##6##2##(1993-12#3)(1993-3#2)(1994-2#1)
the diets##6##2##(1991-12#1)(1993-11#1)(2008-6#2)(2010-8#1)(2011-2#1)
the difference and##2##3##(2008-10#1)(2008-9#1)
the difference being##2##3##(1994-2#1)(2008-10#1)
the difference between a##2##4##(1997-6#1)(2008-3#1)
the difference between the effect of##2##6##(2008-1#1)(2008-10#1)
the difference between the groups##2##5##(1991-2#1)(2008-7#1)
the difference between the measured##2##5##(2008-2#1)(2012-1#1)
the difference between the superficial dimension of the sagging surface of the lower eyelid and the dimension of its##2##19##(2008-5#2)
the difference between the two##5##5##(1996-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
the difference between the##38##4##(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1993-2#1)(1994-9#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
the difference between total inorganic##2##5##(2008-10#2)
the difference between total##3##4##(2008-10#3)
the difference between##69##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#5)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2013-8#2)
the difference did not##2##4##(2008-1#1)(2008-7#1)
the difference in log K(ex)##2##5##(2008-10#2)
the difference in reactivity of##2##5##(1996-2#1)(2008-10#1)
the difference in the##19##4##(1990-8#1)(1991-8#1)(1994-12#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-9#1)(2011-2#1)
the difference in##70##3##(1990-11#2)(1990-8#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-12#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)
the difference of one##2##4##(2008-11#1)(2008-3#1)
the difference of the two##3##5##(2008-10#1)(2008-3#2)
the difference of the##6##4##(2007-12#1)(2008-10#2)(2008-3#2)(2012-3#1)
the difference of##17##3##(1990-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-9#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the difference was not significant##5##5##(1992-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
the difference was not##7##4##(1992-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
the difference was##10##3##(1992-11#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
the difference##195##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#4)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#2)(1997-6#2)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#41)(2008-11#8)(2008-12#5)(2008-2#14)(2008-3#16)(2008-5#7)(2008-7#7)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
the differences among the##2##4##(2008-10#1)(2008-3#1)
the differences among##3##3##(2008-10#1)(2008-3#1)(2009-1#1)
the differences and##2##3##(2009-12#1)(2010-8#1)
the differences are##2##3##(2008-10#1)(2012-12#1)
the differences between the two##3##5##(2007-11#1)(2008-8#1)(2013-8#1)
the differences between the##8##4##(1995-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
the differences between these##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
the differences between##41##3##(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1993-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-5#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
the differences in facial##3##4##(2008-5#1)(2010-8#2)
the differences in the##19##4##(1991-9#1)(1992-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2010-9#1)(2013-1#2)
the differences in their##4##4##(1996-5#1)(2007-7#1)(2008-10#1)(2013-8#1)
the differences in##61##3##(1991-9#1)(1992-12#1)(1992-3#2)(1994-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-8#1)(2010-12#1)(2010-8#3)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
the differences observed between##2##4##(2008-10#1)(2008-5#1)
the differences observed in##2##4##(1997-9#1)(2013-8#1)
the differences observed##4##3##(1997-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
the differences of##6##3##(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
the differences that##2##3##(2008-3#1)(2008-8#1)
the differences were##6##3##(1992-2#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-5#2)
the differences##139##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#2)(1993-2#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-1#1)(2009-11#3)(2009-12#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#5)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
the different P##2##3##(1996-2#1)(2008-8#1)
the different SSB binding modes##2##5##(1997-2#2)
the different age##2##3##(1996-3#1)(2013-7#1)
the different approaches##3##3##(2008-10#2)(2008-7#1)
the different areas of##2##4##(2008-10#1)(2009-10#1)
the different aspects of##6##4##(1992-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#2)
the different aspects##7##3##(1992-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)
the different categories of##2##4##(1990-9#1)(1991-6#1)
the different categories##4##3##(1990-9#1)(1991-6#1)(2012-12#2)
the different cell cycle##2##4##(1995-9#1)(2008-11#1)
the different cell##5##3##(1995-9#1)(2008-11#2)(2008-2#1)(2011-1#1)
the different classes of##6##4##(1997-6#1)(2008-10#1)(2008-3#1)(2012-12#3)
the different classes##8##3##(1997-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-12#3)
the different clinical##2##3##(2008-8#1)(2012-12#1)
the different components of##2##4##(2008-10#1)(2008-8#1)
the different components##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
the different concentration##2##3##(2008-10#2)
the different conditions##2##3##(1995-6#1)(2008-10#1)
the different countries##2##3##(1990-11#1)(2008-10#1)
the different detection##2##3##(2008-10#2)
the different ethnic groups##2##4##(2008-1#1)(2008-9#1)
the different evolution of##2##4##(2009-10#1)(2013-7#1)
the different experimental##3##3##(1995-3#1)(2008-10#2)
the different factors##4##3##(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)
the different forms##4##3##(1990-12#3)(1990-5#1)
the different functional##3##3##(2007-12#2)(2008-4#1)
the different groups##6##3##(1993-8#1)(1996-12#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
the different host##2##3##(2008-10#1)(2008-3#1)
the different in##2##3##(2008-5#1)(2013-8#1)
the different kinds of##2##4##(1992-3#1)(2013-1#1)
the different layers of the##2##5##(1990-9#1)(2008-3#1)
the different mechanisms##4##3##(1991-9#1)(1993-3#1)(2008-8#1)(2012-3#1)
the different methods for##2##4##(2008-10#1)(2011-1#1)
the different methods##8##3##(1991-3#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-1#1)
the different mobility species##2##4##(1991-7#2)
the different molecular weight##2##4##(1990-12#2)
the different molecular##3##3##(1990-12#2)(2010-9#1)
the different organs##2##3##(2007-10#1)(2008-10#1)
the different parameters##2##3##(1990-9#1)(2008-10#1)
the different phases of##2##4##(2008-7#1)(2013-1#1)
the different phases##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
the different plant##3##3##(2008-10#2)(2013-7#1)
the different populations##2##3##(1993-6#1)(2009-9#1)
the different portions of the##2##5##(1994-6#1)(2008-5#1)
the different problems##2##3##(2007-5#1)(2009-10#1)
the different protocols##2##3##(1990-10#1)(2012-1#1)
the different set##2##3##(2008-2#2)
the different spatial##2##3##(2007-11#1)(2008-3#1)
the different species##10##3##(1993-11#1)(1994-6#1)(2008-10#7)(2008-8#1)
the different stages of the##2##5##(1990-12#1)(2008-11#1)
the different stages of##3##4##(1990-12#1)(2008-11#1)(2011-2#1)
the different strains##2##3##(2012-2#1)(2012-3#1)
the different structural##2##3##(2007-11#1)(2008-10#1)
the different structures##2##3##(1993-12#1)(1995-3#1)
the different subcellular fractions##2##4##(1990-5#1)(1996-2#1)
the different subunits##2##3##(2008-7#1)(2008-9#1)
the different systems##2##3##(1993-2#1)(2007-4#1)
the different techniques available##3##4##(2008-10#2)(2009-12#1)
the different techniques##6##3##(1995-5#1)(2008-10#3)(2009-12#1)(2012-1#1)
the different treatment##3##3##(1996-9#1)(2009-6#1)(2011-2#1)
the different treatments##2##3##(2008-10#2)
the different types of##14##4##(1993-8#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
the different types##17##3##(1993-8#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
the different units##2##3##(2008-1#1)(2008-12#1)
the different##469##2##(1990-10#1)(1990-11#2)(1990-12#8)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#5)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#3)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#2)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-6#1)(1997-7#3)(2006-6#1)(2007-10#5)(2007-11#4)(2007-12#9)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#136)(2008-11#18)(2008-12#2)(2008-2#8)(2008-3#16)(2008-4#5)(2008-5#16)(2008-6#2)(2008-7#20)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#8)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#5)(2012-8#1)(2012-9#1)(2013-1#16)(2013-7#6)(2013-8#8)
the differential absorption##4##3##(2006-4#1)(2008-2#1)(2008-3#2)
the differential cultivars##2##3##(2008-10#2)
the differential detection scheme##2##4##(2008-2#1)(2008-3#1)
the differential determination of##2##4##(2008-10#2)
the differential diagnosis and##4##4##(1993-8#1)(2007-10#1)(2008-9#1)(2012-1#1)
the differential diagnosis are##2##4##(1992-11#1)(2008-11#1)
the differential diagnosis of a##5##5##(1992-2#1)(2007-12#1)(2007-8#1)(2009-1#1)(2010-12#1)
the differential diagnosis of dementia##2##5##(1996-11#1)(2008-7#1)
the differential diagnosis of mass##2##5##(2007-8#1)(2008-1#1)
the differential diagnosis of##58##4##(1990-11#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-2#2)(1996-11#2)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#3)(2009-1#1)(2009-3#4)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
the differential diagnosis with##2##4##(1990-8#1)(2008-9#1)
the differential diagnosis##82##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#2)(1993-2#2)(1993-8#1)(1996-11#2)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-3#5)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
the differential effect of##4##4##(2008-10#2)(2010-1#1)(2013-1#1)
the differential effective group index##2##5##(2008-3#2)
the differential effective##3##3##(2008-3#3)
the differential expression of the##2##5##(1993-12#1)(1997-7#1)
the differential expression of##4##4##(1992-10#1)(1992-9#1)(1993-12#1)(1997-7#1)
the differential expression##5##3##(1992-10#1)(1992-9#1)(1993-12#1)(1997-7#1)(2008-7#1)
the differential group delay##4##4##(2007-11#1)(2007-12#3)
the differential hosts##3##3##(2008-10#3)
the differential impact of##3##4##(1996-3#1)(2009-8#1)(2011-2#1)
the differential piston##2##3##(2007-11#2)
the differential pressure##3##3##(2008-10#3)
the differential pulse voltammetry (DPV)##3##5##(2008-10#3)
the differential pulse##10##3##(2008-10#10)
the differential regulation of##2##4##(1992-3#1)(2008-11#1)
the differential##186##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#14)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
the differentially expressed##4##3##(2008-8#1)(2011-3#3)
the differentially##5##2##(2008-7#1)(2008-8#1)(2011-3#3)
the differentials##2##2##(2008-10#2)
the differentiated phenotype##2##3##(1994-11#1)(1994-6#1)
the differentiated status##2##3##(2008-11#2)
the differentiated##11##2##(1994-11#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-11#4)(2008-9#2)(2011-2#1)
the differentiating##4##2##(1990-5#2)(2008-3#1)(2013-1#1)
the differentiation and activation##2##4##(1990-9#1)(1995-6#1)
the differentiation and maturation##2##4##(2010-12#2)
the differentiation and##7##3##(1990-9#1)(1995-6#1)(1996-2#1)(2008-10#1)(2009-10#1)(2010-12#2)
the differentiation between##7##3##(1991-3#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-2#1)
the differentiation capacity of##2##4##(2008-11#1)(2010-6#1)
the differentiation of cells##2##4##(2008-5#1)(2008-8#1)
the differentiation of embryonic##2##4##(1997-2#1)(2008-9#1)
the differentiation of human##2##4##(2008-11#2)
the differentiation of the##10##4##(1991-9#1)(1992-8#1)(1994-12#1)(2008-1#2)(2008-10#5)
the differentiation of##47##3##(1990-11#2)(1991-11#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#3)(1996-5#1)(1997-2#1)(1997-4#1)(2007-4#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the differentiation ofHL-60##2##3##(2008-11#2)
the differentiation procedure##2##3##(2008-9#1)(2010-8#1)
the differentiation process##9##3##(1992-12#1)(1992-3#1)(1997-6#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-8#1)
the differentiation programs##2##3##(1995-6#1)(2008-8#1)
the differentiation##96##2##(1990-11#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#3)(1995-6#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#13)(2008-11#13)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-9#2)(2010-12#3)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
the differing##8##2##(1991-3#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
the difficult diagnosis##2##3##(1992-5#1)(2008-10#1)
the difficult##9##2##(1992-12#1)(1992-5#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
the difficulties and##2##3##(2011-2#1)(2012-3#1)
the difficulties caused by##2##4##(1995-6#1)(2008-12#1)
the difficulties encountered in##3##4##(1997-3#1)(2008-11#1)(2012-2#1)
the difficulties encountered##5##3##(1996-12#1)(1997-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
the difficulties faced by##2##4##(1992-3#1)(2011-2#1)
the difficulties in applying adequate##2##5##(2007-6#1)(2008-1#1)
the difficulties in developing##2##4##(2009-12#1)(2009-8#1)
the difficulties in the##3##4##(2008-2#1)(2008-5#1)(2013-8#1)
the difficulties in##11##3##(1993-8#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
the difficulties of applying##2##4##(2009-8#1)(2011-2#1)
the difficulties of##8##3##(1990-6#1)(1991-6#1)(1997-3#1)(2007-12#1)(2007-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
the difficulties##46##2##(1990-6#1)(1991-6#1)(1992-3#2)(1992-5#1)(1993-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-3#2)(2007-12#3)(2007-6#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the difficulty in##31##3##(1990-12#1)(1990-3#1)(1992-8#1)(1993-11#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#3)
the difficulty of the##3##4##(1997-2#1)(2011-3#1)(2012-2#1)
the difficulty of##21##3##(1990-3#1)(1992-12#1)(1994-11#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
the difficulty to##5##3##(1993-6#1)(1997-7#1)(2008-12#1)(2008-5#1)(2011-2#1)
the difficulty##64##2##(1990-12#1)(1990-3#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#3)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
the diffracted field##2##3##(2007-11#1)(2008-3#1)
the diffracted light##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
the diffracted##13##2##(2007-11#2)(2008-2#3)(2008-3#8)
the diffracting structure##2##3##(2008-2#2)
the diffracting##4##2##(2007-12#1)(2008-2#3)
the diffraction angle##3##3##(2007-12#2)(2008-3#1)
the diffraction data##2##3##(1992-9#1)(2008-4#1)
the diffraction efficiency and the##3##5##(2008-3#3)
the diffraction efficiency of a##2##5##(2007-11#1)(2008-3#1)
the diffraction efficiency of the##3##5##(2007-11#1)(2008-3#2)
the diffraction efficiency of##10##4##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)
the diffraction efficiency##27##3##(2007-11#3)(2007-12#5)(2008-2#5)(2008-3#14)
the diffraction limit in##2##4##(2008-3#1)(2009-5#1)
the diffraction limit of##2##4##(2008-3#2)
the diffraction limit##13##3##(2007-11#2)(2007-12#1)(2008-3#6)(2009-5#3)(2012-2#1)
the diffraction of a##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
the diffraction of light##2##4##(2008-2#1)(2008-3#1)
the diffraction of##7##3##(2007-11#1)(2008-2#3)(2008-3#2)(2009-5#1)
the diffraction pattern of a##2##5##(2008-2#1)(2008-3#1)
the diffraction pattern##9##3##(2007-11#1)(2008-2#2)(2008-3#6)
the diffraction patterns##3##3##(2008-2#1)(2008-3#2)
the diffraction spot##2##3##(2008-3#2)
the diffraction theory##2##3##(2008-3#2)
the diffraction##93##2##(1992-4#1)(1992-9#1)(2007-11#8)(2007-12#14)(2008-2#16)(2008-3#47)(2008-4#1)(2009-5#4)(2012-2#1)
the diffraction-limited spot size##2##4##(2007-11#1)(2008-3#1)
the diffraction-limited spot##3##3##(2007-11#1)(2008-3#2)
the diffraction-limited##6##2##(2007-11#2)(2008-3#4)
the diffraction-order##2##2##(2008-3#2)
the diffractional divergence of the scattered wave##2##7##(2008-3#2)
the diffractional##3##2##(2008-2#1)(2008-3#2)
the diffractive EPE##2##3##(2008-3#2)
the diffractive##12##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#6)
the diffuse and the total##2##5##(2008-3#2)
the diffuse attenuation coefficient##4##4##(2008-2#1)(2008-3#3)
the diffuse attenuation##5##3##(2008-2#2)(2008-3#3)
the diffuse form##2##3##(1995-11#1)(2013-1#1)
the diffuse reflectance spectrum of##2##5##(2008-10#1)(2008-3#1)
the diffuse reflectance##3##3##(2008-10#2)(2008-3#1)
the diffuse reflection coefficient of##2##5##(2008-2#2)
the diffuse transmittance##2##3##(2008-2#1)(2008-3#1)
the diffuse##30##2##(1995-11#1)(2007-12#1)(2008-10#4)(2008-2#7)(2008-3#15)(2012-12#1)(2013-1#1)
the diffusely##2##2##(2008-3#2)
the diffuser##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
the diffusing##3##2##(2007-12#1)(2008-3#2)
the diffusion and##4##3##(2008-10#1)(2008-5#1)(2010-5#1)(2011-1#1)
the diffusion approximation of the##2##5##(2008-2#1)(2008-3#1)
the diffusion approximation##14##3##(2008-2#6)(2008-3#8)
the diffusion coefficient of the##2##5##(2007-10#1)(2008-3#1)
the diffusion coefficient of##5##4##(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#1)
the diffusion coefficient##9##3##(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
the diffusion coefficients##5##3##(1990-2#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
the diffusion equation and##2##4##(2008-2#2)
the diffusion equation for##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
the diffusion equation##12##3##(2007-11#2)(2008-2#5)(2008-3#4)(2008-7#1)
the diffusion layer##3##3##(1990-12#1)(2008-10#2)
the diffusion model##2##3##(2008-10#1)(2008-3#1)
the diffusion of the complex##2##5##(2008-10#2)
the diffusion of the##3##4##(2008-10#3)
the diffusion of two##2##4##(2007-12#1)(2008-5#1)
the diffusion of##22##3##(1990-12#1)(1991-9#1)(1993-11#2)(1993-8#1)(1994-12#1)(2007-12#2)(2008-10#6)(2008-5#2)(2008-7#3)(2009-11#1)(2010-10#1)(2012-2#1)
the diffusion process##2##3##(2008-2#1)(2008-5#1)
the diffusion rate##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
the diffusion##100##2##(1990-12#2)(1990-2#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-12#1)(1996-5#1)(1997-6#2)(2007-10#4)(2007-11#4)(2007-12#6)(2008-10#19)(2008-11#5)(2008-2#12)(2008-3#19)(2008-5#5)(2008-7#5)(2008-8#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#3)
the diffusive##4##2##(1992-9#1)(2008-10#2)(2008-3#1)
the digest##3##2##(1994-12#1)(1997-2#1)(2008-10#1)
the digested sample##2##3##(2008-10#2)
the digested##6##2##(2008-10#6)
the digester##4##2##(2008-6#2)(2008-7#1)(2013-1#1)
the digestion method##2##3##(2008-10#2)
the digestion of##8##3##(1994-12#1)(2008-10#5)(2008-4#1)(2010-8#1)
the digestion##21##2##(1993-8#1)(1994-12#1)(2008-10#15)(2008-4#2)(2008-5#1)(2010-8#1)
the digestive cells##2##3##(2007-12#2)
the digestive system##7##3##(1992-3#1)(2008-10#1)(2008-5#1)(2009-10#2)(2009-6#1)(2010-5#1)
the digestive tract are##2##4##(2007-12#1)(2011-2#1)
the digestive tract of##4##4##(2008-11#1)(2008-5#2)(2012-2#1)
the digestive tract##18##3##(1990-6#1)(1990-8#2)(1990-9#1)(1991-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
the digestive##34##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-6#1)(1992-3#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#2)
the digital image##2##3##(2008-10#1)(2008-3#1)
the digital speckle##2##3##(2008-3#2)
the digital##14##2##(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-9#2)(2009-11#1)(2012-2#1)
the digitization##2##2##(2007-12#1)(2008-10#1)
the digitized##3##2##(1995-6#1)(2008-10#1)(2008-3#1)
the digits##3##2##(1996-2#1)(2008-6#2)
the dihedral angle of C4-C1-C2-S3##2##5##(1993-8#2)
the dihedral angle##4##3##(1993-8#3)(1997-7#1)
the dihydrofolate reductase (DHFR)##3##4##(1994-9#1)(2008-11#1)(2008-2#1)
the dihydrofolate reductase##4##3##(1994-9#1)(2008-11#2)(2008-2#1)
the dihydropyridine##3##2##(1990-7#1)(1996-5#1)(2012-12#1)
the diiron##3##2##(1991-12#2)(1991-8#1)
the dilatation##2##2##(2008-10#1)(2011-1#1)
the dilated ureter##2##3##(2008-10#2)
the dilemma of##7##3##(1991-8#1)(1992-1#1)(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
the dilemma##8##2##(1991-8#1)(1992-1#1)(1992-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
the dilemmas##3##2##(1997-3#1)(2008-3#1)(2008-8#1)
the diluent##3##2##(2008-10#3)
the diluents##2##2##(2008-10#2)
the dilute##4##2##(2008-10#3)(2008-6#1)
the diluted##4##2##(1994-9#1)(2008-10#3)
the dilution of##2##3##(1995-3#1)(2008-10#1)
the dilution##7##2##(1995-3#1)(2008-10#4)(2008-6#1)(2013-8#1)
the dimension of the##2##4##(2009-9#1)(2012-1#1)
the dimension of##11##3##(1996-2#1)(1996-3#1)(2008-10#1)(2008-5#2)(2009-1#1)(2009-11#2)(2009-9#1)(2011-2#1)(2012-1#1)
the dimension##14##2##(1993-5#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-5#2)(2009-1#1)(2009-11#2)(2009-9#1)(2011-2#2)(2012-1#1)
the dimensional##2##2##(2007-12#1)(2012-2#1)
the dimensionality of the TSI##2##5##(2012-3#2)
the dimensionality of the##5##4##(2008-11#1)(2008-7#1)(2009-11#1)(2012-3#2)
the dimensionality of##7##3##(1994-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-2#1)(2012-3#2)
the dimensionality##8##2##(1994-9#1)(2008-11#1)(2008-7#2)(2009-11#1)(2012-2#1)(2012-3#2)
the dimensionless##4##2##(2007-10#1)(2008-2#2)(2008-7#1)
the dimensions and##2##3##(1991-12#1)(2008-11#1)
the dimensions of a##2##4##(1996-2#1)(2008-7#1)
the dimensions of the##5##4##(1991-9#1)(2008-10#1)(2008-3#2)(2012-2#1)
the dimensions of##14##3##(1991-9#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2012-2#1)
the dimensions##20##2##(1991-12#1)(1991-9#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-3#1)(2012-2#1)
the dimer interface##2##3##(1995-5#1)(2008-8#1)
the dimer is##2##3##(1994-11#1)(2008-10#1)
the dimer##19##2##(1990-8#1)(1991-7#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-5#3)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#3)(2013-1#1)
the dimeric protein##2##3##(1995-5#1)(2008-8#1)
the dimeric structure##2##3##(1990-5#1)(1990-7#1)
the dimeric##15##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1994-12#1)(1995-5#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-2#2)
the dimerization of##2##3##(1996-2#1)(2008-9#1)
the dimerization##6##2##(1996-2#1)(2008-10#4)(2008-9#1)
the dimethyl##4##2##(1994-8#2)(2008-10#1)(2010-5#1)
the diminished##2##2##(1990-3#1)(1993-8#1)
the dimmer##2##2##(2008-10#1)(2013-1#1)
the dimorphic fungus##2##3##(1991-9#1)(2008-5#1)
the dimorphic##4##2##(1991-9#1)(1996-6#1)(2008-5#1)(2013-7#1)
the dinuclear##2##2##(1991-8#1)(1996-2#1)
the dinucleotide##4##2##(1991-5#1)(1997-6#2)(2008-4#1)
the diode laser##8##3##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2013-1#1)
the diode##16##2##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#6)(2012-1#1)(2013-1#1)
the diode-laser##3##2##(2008-2#1)(2008-3#2)
the diol substrate##2##3##(2008-7#2)
the diol to the##2##4##(1991-5#1)(2008-10#1)
the diol##6##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#3)
the dioptric##2##2##(2007-12#1)(2008-2#1)
the dioxin##11##2##(1993-11#1)(2008-10#10)
the dioxin-responsive##2##2##(1992-8#1)(2008-11#1)
the dioxygen concentration in##2##4##(2008-10#2)
the dioxygen##4##2##(1997-7#1)(2008-10#3)
the dipeptide##3##2##(1990-8#1)(2008-4#2)
the dipeptides are##2##3##(1990-8#2)
the dipeptides##3##2##(1990-8#2)(2008-10#1)
the diploid##6##2##(2008-11#1)(2008-5#3)(2010-3#1)(2013-1#1)
the dipole antenna##3##3##(2007-12#3)
the dipole emits from##2##4##(2008-2#2)
the dipole moment##3##3##(2007-11#2)(2008-10#1)
the dipole moments of##2##4##(1997-6#1)(2007-11#1)
the dipole moments##3##3##(1997-6#1)(2007-11#2)
the dipole##21##2##(1990-5#1)(1992-12#2)(1992-6#1)(1997-6#2)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-8#1)
the dipping##2##2##(2008-10#1)(2008-12#1)
the direct UV detection of non-absorbing inorganic cations##2##8##(2008-10#2)
the direct UV detection of##3##5##(2008-10#3)
the direct analysis of the##2##5##(2008-10#2)
the direct analysis of trace metals in estuarine waters by square-wave anodic stripping voltammetry##2##14##(2008-10#2)
the direct analysis of##8##4##(1997-2#1)(2008-10#7)
the direct analysis##9##3##(1997-2#1)(2008-10#8)
the direct and indirect effects of##2##6##(1997-1#1)(2010-8#1)
the direct and indirect##6##4##(1997-1#1)(2008-10#3)(2008-11#1)(2010-8#1)
the direct and##11##3##(1990-9#1)(1992-3#1)(1997-1#1)(2008-10#6)(2008-11#1)(2010-8#1)
the direct assay##2##3##(2008-10#2)
the direct binding of##2##4##(1994-8#1)(2008-9#1)
the direct coupling##2##3##(2008-2#1)(2008-3#1)
the direct detection and##2##4##(2008-10#2)
the direct detection of##5##4##(1990-5#1)(2008-10#2)(2008-3#1)(2008-4#1)
the direct detection##7##3##(1990-5#1)(2008-10#4)(2008-3#1)(2008-4#1)
the direct determination of antimony##2##5##(2008-10#2)
the direct determination of the##8##5##(2008-10#7)(2008-2#1)
the direct determination of this compound in##2##7##(2008-10#2)
the direct determination of trace##2##5##(2008-10#2)
the direct determination of##49##4##(1991-12#1)(2008-10#46)(2008-2#1)(2008-3#1)
the direct determination##51##3##(1991-12#1)(2008-10#48)(2008-2#1)(2008-3#1)
the direct effect of##6##4##(1991-12#1)(2008-10#2)(2008-8#1)(2009-9#1)(2012-2#1)
the direct effects of##5##4##(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)
the direct electrochemistry of##2##4##(2008-10#2)
the direct examination##2##3##(2007-10#1)(2008-5#1)
the direct identification of##2##4##(2008-10#1)(2011-2#1)
the direct injection of##2##4##(1990-8#1)(2008-10#1)
the direct injection##3##3##(1990-8#1)(2008-10#2)
the direct interaction of##2##4##(1992-3#1)(1994-8#1)
the direct interaction##3##3##(1992-3#1)(1994-8#1)(2008-11#1)
the direct involvement of##3##4##(1990-11#1)(1992-11#1)(2013-1#1)
the direct irradiance##2##3##(2008-2#2)
the direct measurement of##4##4##(1992-3#1)(2007-11#1)(2008-3#1)(2012-3#1)
the direct measurement##5##3##(1992-3#1)(2007-11#1)(2008-3#2)(2012-3#1)
the direct observation of##3##4##(2007-12#1)(2008-2#1)(2011-1#1)
the direct potentiometric method##2##4##(2008-10#2)
the direct quantification of##2##4##(2008-10#1)(2013-1#1)
the direct##229##2##(1990-11#4)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#4)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-12#2)(1993-6#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-7#2)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#122)(2008-11#7)(2008-2#9)(2008-3#13)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)
the direct-binary-search##3##2##(2008-3#3)
the directed##2##2##(1990-12#1)(2008-3#1)
the direction and magnitude of##2##5##(1990-8#1)(1992-2#1)
the direction and##5##3##(1990-8#1)(1992-2#1)(2007-12#1)(2008-7#1)(2012-3#1)
the direction cosines of##2##4##(2008-2#1)(2008-3#1)
the direction in which the##2##5##(2007-4#1)(2008-3#1)
the direction in which##3##4##(2007-4#1)(2008-3#1)(2013-8#1)
the direction of evolution##2##4##(2008-8#1)(2008-9#1)
the direction of motion##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the direction of propagation##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the direction of rotation##2##4##(2008-2#1)(2009-6#1)
the direction of the##26##4##(1992-11#1)(1993-12#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#8)(2008-6#3)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
the direction of##76##3##(1990-11#2)(1990-9#1)(1991-3#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-12#1)(1995-11#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-8#2)(2008-10#5)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the direction selectivity##2##3##(2008-8#2)
the direction##106##2##(1990-11#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#2)(1995-11#1)(1997-1#1)(1997-3#1)(2007-11#3)(2007-12#9)(2007-4#2)(2007-8#2)(2008-10#9)(2008-11#2)(2008-2#9)(2008-3#20)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
the directional form of Kirchhoff's##2##5##(2008-2#2)
the directional##7##2##(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)
the directions of##3##3##(1990-12#1)(2008-2#1)(2008-9#1)
the directly##5##2##(2007-8#1)(2008-10#2)(2008-3#1)(2009-12#1)
the director of mission services##2##5##(1993-12#1)(1994-1#1)
the director of the##2##4##(1990-11#1)(2007-5#1)
the director of##6##3##(1990-11#1)(1993-12#1)(1994-1#1)(2007-5#1)(2008-3#1)(2013-8#1)
the director##7##2##(1990-11#1)(1993-12#1)(1994-1#1)(2007-5#1)(2008-3#2)(2013-8#1)
the director's##2##2##(1994-3#2)
the directors of##2##3##(1991-5#1)(1994-1#1)
the directors##3##2##(1991-5#1)(1994-1#1)(2008-4#1)
the disability##8##2##(1991-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
the disabled##11##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-2#1)(2008-8#1)(2009-6#2)
the disabling##3##2##(2008-12#1)(2008-8#1)(2013-1#1)
the disaccharide##4##2##(1990-2#1)(1992-12#1)(1992-6#1)(1995-11#1)
the disadvantage of being##3##4##(1995-5#1)(2008-11#1)(2009-8#1)
the disadvantage that##2##3##(1990-2#1)(2013-1#1)
the disadvantage##5##2##(1990-2#1)(1995-5#1)(2008-11#1)(2009-8#1)(2013-1#1)
the disadvantaged##2##2##(1992-1#1)(2010-3#1)
the disadvantages of##3##3##(1990-11#1)(2012-3#1)(2013-1#1)
the disadvantages##6##2##(1990-11#1)(1994-3#1)(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the disagreement##2##2##(1991-6#1)(2008-8#1)
the disappearance of the##7##4##(1990-5#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-9#1)
the disappearance of##16##3##(1990-5#2)(1992-6#1)(1993-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-9#1)(2011-2#2)
the disaster##5##2##(1991-2#1)(2008-12#1)(2008-2#1)(2013-1#2)
the disc and##2##3##(1996-6#1)(2007-8#1)
the disc diffusion##2##3##(2008-12#1)(2008-5#1)
the disc harrow##2##3##(2008-10#2)
the disc##18##2##(1994-11#1)(1995-12#1)(1996-6#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#4)(2011-2#2)(2012-2#1)
the discharge of##2##3##(2008-10#1)(2008-6#1)
the discharge##13##2##(1993-12#1)(1997-7#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#2)
the discharged##2##2##(1993-1#1)(2008-7#1)
the discipline##8##2##(1994-2#1)(2007-4#2)(2008-12#5)
the disciplines##3##2##(1991-2#1)(1996-3#1)(2008-10#1)
the disclosure of##3##3##(1992-3#2)(2008-2#1)
the disclosure##4##2##(1992-3#2)(1997-3#1)(2008-2#1)
the discomfort##4##2##(1995-6#1)(1996-9#1)(2007-7#1)(2008-4#1)
the discontinued##2##2##(2008-11#2)
the discontinuous##2##2##(1996-12#1)(2008-3#1)
the discourse##2##2##(2007-12#1)(2010-10#1)
the discoveries of##2##3##(2010-1#1)(2011-2#1)
the discovery and characterization of##2##5##(1997-1#1)(2008-10#1)
the discovery and development of##2##5##(2007-2#1)(2010-8#1)
the discovery and##9##3##(1997-1#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-3#1)
the discovery of a##7##4##(1992-6#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
the discovery of multiple##3##4##(2008-10#1)(2009-5#1)(2012-3#1)
the discovery of new##3##4##(2008-10#1)(2009-12#1)(2011-3#1)
the discovery of novel##6##4##(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
the discovery of potential therapeutic##2##5##(2009-12#1)(2010-12#1)
the discovery of potential##4##4##(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)
the discovery of several##2##4##(2010-3#1)(2012-3#1)
the discovery of the##18##4##(1991-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-8#1)
the discovery of##92##3##(1990-9#1)(1991-8#1)(1992-6#1)(1994-11#2)(1994-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#3)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
the discovery phase##2##3##(2008-9#1)(2010-5#1)
the discovery that##5##3##(1994-5#1)(1997-2#1)(1997-3#1)(2010-3#1)(2012-12#1)
the discovery##111##2##(1990-9#1)(1991-8#1)(1992-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#4)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
the discrepancies##4##2##(1994-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
the discrepancy between the##4##4##(1990-8#1)(1991-1#1)(2008-11#1)(2008-3#1)
the discrepancy between##6##3##(1990-8#1)(1991-1#1)(1993-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
the discrepancy in##4##3##(1993-9#1)(2008-1#1)(2008-3#1)(2008-6#1)
the discrepancy##13##2##(1990-8#1)(1991-1#1)(1993-11#1)(1993-9#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)
the discrete Fourier transform##2##4##(2008-2#1)(2008-6#1)
the discrete dipole approximation##2##4##(2008-3#2)
the discrete ordinates method##2##4##(2008-2#1)(2008-3#1)
the discrete##15##2##(1995-3#1)(1996-4#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-8#1)(2011-2#1)
the discrete-time##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
the discretion of##2##3##(1996-9#1)(2011-2#1)
the discretion##3##2##(1996-9#1)(1997-6#1)(2011-2#1)
the discriminant##2##2##(2008-10#2)
the discrimination between different##2##4##(2008-10#2)
the discrimination between##6##3##(1991-5#1)(2007-11#1)(2008-10#4)
the discrimination of##9##3##(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
the discrimination power of##3##4##(1995-11#1)(2008-12#1)(2011-2#1)
the discrimination##25##2##(1991-5#1)(1992-11#1)(1995-11#1)(2007-11#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
the discriminative accuracy##3##3##(1992-11#3)
the discriminative##5##2##(1992-11#3)(1997-7#1)(2010-8#1)
the discussed##3##2##(1992-6#1)(1995-2#1)(2007-11#1)
the discussion and##2##3##(2008-12#1)(2011-2#1)
the discussion of the##5##4##(1996-3#1)(2008-10#1)(2010-9#1)(2013-1#2)
the discussion of their##2##4##(2008-10#1)(2010-6#1)
the discussion of##13##3##(1991-6#1)(1992-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)
the discussion on##2##3##(2008-10#1)(2008-11#1)
the discussion will##2##3##(2008-10#1)(2008-11#1)
the discussion##28##2##(1990-8#1)(1991-6#1)(1992-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#2)
the discussions##4##2##(1994-12#1)(1995-5#1)(2008-12#1)(2011-2#1)
the disease among##2##3##(1993-2#1)(1996-8#1)
the disease and its treatment##2##5##(1991-2#1)(1996-3#1)
the disease and its##5##4##(1991-2#1)(1996-3#1)(2008-1#1)(2008-5#1)(2012-12#1)
the disease and the##10##4##(1991-6#1)(1992-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-2#1)(2013-7#1)
the disease and##38##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
the disease appears to be##2##5##(2008-10#1)(2008-5#1)
the disease are recognized##2##4##(2008-11#1)(2011-1#1)
the disease are##9##3##(1991-9#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
the disease as##6##3##(1993-11#1)(2008-10#1)(2008-11#3)(2008-8#1)
the disease at##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
the disease burden##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
the disease by the##2##4##(1993-11#1)(1994-9#1)
the disease can be##3##4##(2008-9#1)(2011-2#1)(2013-8#1)
the disease caused##2##3##(2008-10#1)(2011-2#1)
the disease control##2##3##(2008-10#2)
the disease could##2##3##(2007-6#1)(2012-2#1)
the disease cycle of##2##4##(2008-10#2)
the disease cycle##5##3##(2008-10#5)
the disease development##3##3##(2008-10#3)
the disease during##2##3##(1992-9#1)(2011-2#1)
the disease for##2##3##(2007-7#1)(2010-11#1)
the disease gene##6##3##(1992-3#1)(1993-1#1)(1995-5#1)(1997-8#1)(2008-4#1)(2008-7#1)
the disease had been##2##4##(1994-9#1)(2007-7#1)
the disease has been##5##4##(1997-8#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
the disease has##9##3##(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#1)
the disease have##2##3##(2007-8#1)(2008-1#1)
the disease in a##4##4##(2007-7#1)(2008-10#1)(2010-2#1)(2013-8#1)
the disease in the field##2##5##(2008-10#2)
the disease in the##10##4##(1990-9#1)(1992-9#2)(1994-9#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-12#1)
the disease in##39##3##(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-5#1)(1994-9#2)(1995-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#13)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
the disease incidence was##2##4##(1997-6#1)(2008-10#1)
the disease incidence##5##3##(1990-3#1)(1997-6#1)(2008-10#3)
the disease intensity##2##3##(2008-10#2)
the disease is of##2##4##(2008-10#2)
the disease is spread##2##4##(1993-6#1)(2008-10#1)
the disease is usually##2##4##(2008-1#1)(2011-2#1)
the disease is##40##3##(1991-11#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-6#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the disease itself##3##3##(1990-6#1)(2008-10#1)(2011-1#1)
the disease level##2##3##(2008-10#2)
the disease may##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
the disease of##3##3##(1997-8#1)(2007-10#1)(2008-10#1)
the disease on##4##3##(1990-3#1)(2008-10#2)(2008-8#1)
the disease phenotype##3##3##(2007-7#1)(2008-10#2)
the disease process and##3##4##(2010-8#1)(2013-1#1)(2013-8#1)
the disease process##10##3##(1991-9#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
the disease processes##2##3##(2008-5#1)(2010-12#1)
the disease progress curve was##2##5##(2008-10#2)
the disease progress curve##24##4##(2008-10#24)
the disease progress##27##3##(2008-10#27)
the disease progressed##2##3##(2008-10#1)(2008-12#1)
the disease progresses##3##3##(2008-2#1)(2008-8#1)(2013-1#1)
the disease progression##2##3##(2008-10#1)(2010-5#1)
the disease ratings of the##2##5##(2008-10#2)
the disease resistance##2##3##(2008-10#1)(2008-9#1)
the disease severity##6##3##(1994-11#1)(2008-10#5)
the disease should be##2##4##(2008-10#2)
the disease should##3##3##(2008-10#2)(2013-1#1)
the disease spread##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
the disease states##2##3##(2008-3#2)
the disease status of patients##2##5##(1992-3#2)
the disease status of##5##4##(1992-3#2)(2008-10#2)(2008-9#1)
the disease than##2##3##(2008-10#1)(2009-5#1)
the disease through##4##3##(1993-8#1)(2006-6#1)(2007-12#1)(2008-10#1)
the disease to##5##3##(1990-9#1)(2008-10#1)(2008-2#1)(2010-1#1)(2011-2#1)
the disease under##4##3##(2008-10#3)(2008-4#1)
the disease was observed##2##4##(2008-10#2)
the disease was##21##3##(1991-8#1)(1992-8#1)(1993-1#1)(1994-9#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#9)(2011-2#1)(2012-3#1)(2013-1#1)
the disease will##2##3##(2008-7#1)(2013-8#1)
the disease with##6##3##(1990-2#1)(1990-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
the disease##675##2##(1990-10#2)(1990-11#3)(1990-2#1)(1990-3#4)(1990-5#2)(1990-6#8)(1990-9#3)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#6)(1991-8#4)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#12)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#4)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#3)(1996-6#4)(1996-8#1)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#10)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#9)(2008-1#11)(2008-10#181)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#11)(2008-6#7)(2008-7#35)(2008-8#10)(2008-9#10)(2009-10#8)(2009-12#2)(2009-5#3)(2009-7#2)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#5)(2010-6#5)(2010-8#5)(2011-1#9)(2011-2#38)(2011-3#1)(2012-1#3)(2012-12#10)(2012-2#10)(2012-3#14)(2013-1#26)(2013-7#2)(2013-8#9)
the disease's##2##2##(2007-10#1)(2009-1#1)
the disease-free survival rate##3##4##(1997-7#2)(2011-2#1)
the diseased seedlings##2##3##(2008-10#2)
the diseased##13##2##(1992-3#2)(1992-6#1)(1994-11#1)(2008-10#5)(2011-2#1)(2012-2#2)(2012-3#1)
the diseases caused by these##2##5##(2008-10#1)(2008-9#1)
the diseases caused by##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
the diseases of##3##3##(1997-1#1)(2008-1#1)(2010-3#1)
the diseases##24##2##(1991-6#1)(1993-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)
the diseases?##2##2##(2008-7#2)
the disector##3##2##(1995-8#1)(2008-4#2)
the disgust induction##2##3##(2012-2#2)
the dish##9##2##(2008-11#5)(2011-2#4)
the dishes##3##2##(1995-8#1)(1997-4#1)(2008-11#1)
the dishing##2##2##(2008-3#2)
the disinfection rates##2##3##(2013-1#2)
the disinfection##4##2##(2008-3#1)(2013-1#2)(2013-8#1)
the disintegration of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
the disk is##3##3##(2008-2#1)(2008-3#2)
the disk##28##2##(1995-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#9)(2008-5#1)(2009-3#1)(2013-8#1)
the disk's##2##2##(2008-2#2)
the disks##3##2##(2008-10#2)(2008-3#1)
the dislocated femoral##2##3##(2009-4#2)
the dislocation##3##2##(2008-10#1)(2009-3#1)(2009-4#1)
the dismutation##2##2##(1997-2#2)
the disorder are##2##3##(2012-3#1)(2013-7#1)
the disorder in##3##3##(1997-8#1)(2008-1#1)(2013-1#1)
the disorder is##2##3##(2007-11#1)(2008-4#1)
the disorder##46##2##(1991-12#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
the disorders of##2##3##(1991-12#1)(2012-3#1)
the disorders##9##2##(1991-12#1)(1996-3#1)(1997-5#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-7#1)
the disparities in##2##3##(2008-1#1)(2008-10#1)
the disparities##3##2##(2008-1#1)(2008-10#2)
the disparity##3##2##(1990-8#1)(1997-1#1)(2012-7#1)
the dispersal of##9##3##(2008-10#7)(2010-3#1)(2012-3#1)
the dispersal rate of the##2##5##(2008-8#2)
the dispersal##17##2##(2008-10#10)(2008-5#1)(2008-8#4)(2010-3#1)(2012-3#1)
the dispersed##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
the disperser##4##2##(2007-11#2)(2008-5#2)
the dispersion characteristics of##2##4##(2007-11#1)(2008-3#1)
the dispersion coefficient##2##3##(2008-2#1)(2008-3#1)
the dispersion in##2##3##(2008-10#2)
the dispersion of the group velocity of light in##2##9##(2008-2#2)
the dispersion of the##8##4##(2008-10#1)(2008-2#4)(2008-3#2)(2010-4#1)
the dispersion of##14##3##(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#2)(2010-4#1)(2010-8#1)
the dispersion relation for##2##4##(2008-2#1)(2008-3#1)
the dispersion relation##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the dispersion turning points##3##4##(2007-12#3)
the dispersion##40##2##(2007-11#7)(2007-12#8)(2008-10#4)(2008-11#1)(2008-2#11)(2008-3#5)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
the dispersions##2##2##(2007-12#1)(2013-1#1)
the dispersive##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
the displaced##4##2##(1991-9#1)(2008-3#1)(2012-12#1)(2013-1#1)
the displacement field##2##3##(2008-2#1)(2008-3#1)
the displacement of a##3##4##(2008-2#1)(2008-3#1)(2010-12#1)
the displacement of the##2##4##(2009-10#1)(2010-7#1)
the displacement of##14##3##(1992-9#1)(1997-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
the displacement##24##2##(1992-9#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-2#4)(2008-3#6)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
the displacements##3##2##(2008-2#2)(2008-3#1)
the displacer##2##2##(2008-7#2)
the display exit pupil##2##4##(2008-3#2)
the display of a##2##4##(1991-2#1)(1994-12#1)
the display of##3##3##(1991-2#1)(1994-12#1)(2008-11#1)
the display##19##2##(1991-2#1)(1994-12#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
the displayed##2##2##(2008-4#1)(2008-6#1)
the disposable screen-printed electrode##2##4##(2008-10#2)
the disposable##3##2##(2008-10#2)(2011-1#1)
the disposition of##2##3##(2008-10#1)(2013-1#1)
the disposition##4##2##(2008-10#1)(2012-3#1)(2013-1#2)
the dispute mediation system##2##4##(1992-12#1)(1992-3#1)
the dispute##4##2##(1992-12#1)(1992-2#1)(1992-3#1)(2009-7#1)
the disrupted##3##2##(1995-2#1)(2008-10#2)
the disruption of the##5##4##(1991-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)
the disruption of##14##3##(1991-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2010-3#1)(2010-7#1)
the disruption##16##2##(1991-12#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2010-3#1)(2010-7#1)
the dissection of the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
the dissection of##4##3##(2008-11#2)(2011-2#1)(2013-1#1)
the dissection##8##2##(2008-10#1)(2008-11#2)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
the disseminating structures are##2##4##(2007-12#2)
the dissemination and##2##3##(1992-2#1)(2013-1#1)
the dissemination of##3##3##(1993-6#1)(2008-10#1)(2010-2#1)
the dissemination##7##2##(1992-2#1)(1993-12#1)(1993-6#1)(2008-10#1)(2010-2#1)(2012-1#1)(2013-1#1)
the dissociated##2##2##(2008-10#1)(2008-8#1)
the dissociation and somatization##2##4##(2012-12#2)
the dissociation and##3##3##(2008-10#1)(2012-12#2)
the dissociation constant for the##2##5##(1992-5#2)
the dissociation constant of##3##4##(1993-8#1)(1995-2#1)(2008-10#1)
the dissociation constant##11##3##(1991-8#1)(1992-5#2)(1993-8#3)(1995-2#1)(2008-10#3)(2008-6#1)
the dissociation constants of the##2##5##(1993-8#1)(2008-10#1)
the dissociation constants of##4##4##(1993-8#1)(1995-11#1)(2008-10#2)
the dissociation constants##9##3##(1992-3#1)(1993-8#2)(1995-11#1)(2008-10#5)
the dissociation equilibrium##2##3##(2007-11#1)(2008-10#1)
the dissociation limit##3##3##(2007-11#3)
the dissociation of##9##3##(1991-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-9#1)
the dissociation rate##2##3##(1993-8#1)(2008-10#1)
the dissociation##46##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-5#2)(1993-6#1)(1993-8#6)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-7#2)(2007-11#4)(2008-10#15)(2008-2#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-12#2)
the dissociative disorders and##2##4##(2009-10#2)
the dissolution of the##4##4##(2008-10#2)(2008-12#1)(2009-7#1)
the dissolution of##12##3##(2008-10#9)(2008-12#1)(2008-3#1)(2009-7#1)
the dissolution rate of mefenamic acid##3##6##(2012-2#3)
the dissolution rate##5##3##(2008-10#1)(2008-5#1)(2012-2#3)
the dissolution##31##2##(2008-10#19)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#2)(2010-3#1)(2010-5#1)(2012-2#3)(2013-1#2)
the dissolved hydrogen##2##3##(2008-7#2)
the dissolved organic##3##3##(2008-10#2)(2008-3#1)
the dissolved oxygen##5##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
the dissolved##23##2##(1994-3#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-7#4)(2009-8#1)(2011-2#1)
the distal end of a##2##5##(1992-12#1)(2008-8#1)
the distal end of the external carotid artery##2##8##(1997-6#2)
the distal end of the##8##5##(1991-7#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
the distal end of##12##4##(1991-7#1)(1992-12#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)
the distal end##13##3##(1991-7#1)(1992-12#1)(1997-6#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)
the distal ends of the##2##5##(2008-2#1)(2008-5#1)
the distal ends of##3##4##(1995-6#1)(2008-2#1)(2008-5#1)
the distal ends##4##3##(1995-6#1)(2008-2#1)(2008-5#1)(2008-8#1)
the distal esophageal##2##3##(2009-3#1)(2013-8#1)
the distal esophagus##3##3##(2009-3#2)(2013-1#1)
the distal extremities##2##3##(2008-7#2)
the distal femur##2##3##(2012-12#1)(2013-1#1)
the distal half of##2##4##(2007-12#1)(2007-8#1)
the distal maxillary##2##3##(1991-2#1)(2007-12#1)
the distal part of the femur##2##6##(2008-7#1)(2013-1#1)
the distal part of the##9##5##(1997-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-1#1)(2013-1#2)
the distal part##10##3##(1997-8#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2012-1#1)(2013-1#2)
the distal portion of the##2##5##(1991-5#1)(2007-12#1)
the distal portion of##4##4##(1991-5#1)(1996-8#1)(1997-4#1)(2007-12#1)
the distal portion##6##3##(1991-5#1)(1996-8#1)(1997-4#1)(2007-12#1)(2011-2#2)
the distal portions##2##3##(2007-12#1)(2008-5#1)
the distal radius##11##3##(2008-9#7)(2009-3#3)(2013-1#1)
the distal region##2##3##(1991-9#1)(1997-8#1)
the distal segment##2##3##(2013-8#2)
the distal third##2##3##(2008-5#1)(2013-8#1)
the distal urethra##2##3##(2008-10#2)
the distal##134##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#3)(2007-12#9)(2007-7#2)(2007-8#11)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#14)(2009-3#7)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#4)
the distance between the two##2##5##(2008-2#1)(2008-3#1)
the distance between the##23##4##(1993-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2010-2#1)
the distance between them##2##4##(2008-10#1)(2008-3#1)
the distance between##34##3##(1993-12#1)(1993-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#7)(2010-2#1)(2013-1#1)
the distance from the##7##4##(2008-2#2)(2008-3#3)(2008-9#1)(2013-7#1)
the distance from##10##3##(1994-9#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2013-7#1)
the distance of the##2##4##(2007-11#1)(2008-12#1)
the distance of##6##3##(1993-6#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
the distance that##2##3##(2008-10#2)
the distance to##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
the distance##73##2##(1993-12#1)(1993-6#1)(1993-8#2)(1994-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-7#1)
the distances and##2##3##(2008-3#1)(2010-8#1)
the distances between the##2##4##(2008-6#1)(2008-9#1)
the distances between##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
the distances of##3##3##(2008-2#1)(2010-10#1)(2012-2#1)
the distances##13##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#1)(2012-2#1)
the distant##4##2##(1993-1#1)(1993-3#1)(1996-5#1)(2013-1#1)
the distinct biological##2##3##(1995-2#1)(2011-1#1)
the distinct imaging##2##3##(2010-9#2)
the distinct##23##2##(1991-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-2#1)(2010-10#1)(2010-9#3)(2011-1#1)(2011-2#1)
the distinction between short-term and long-term##2##6##(1992-11#1)(1996-4#1)
the distinction between the##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
the distinction between##16##3##(1992-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-6#1)(2012-12#1)
the distinction of##3##3##(1997-5#1)(2008-10#1)(2013-7#1)
the distinction##20##2##(1992-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-6#1)(2012-12#1)(2013-7#1)
the distinctions##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
the distinctive features##2##3##(1996-12#1)(2008-6#1)
the distinctive##10##2##(1991-7#1)(1992-6#1)(1995-2#1)(1996-1#1)(1996-12#2)(2008-10#1)(2008-6#1)(2010-3#1)(2011-2#1)
the distinguishing##2##2##(1996-1#1)(2013-1#1)
the distorted##3##2##(2007-11#1)(2008-10#1)(2009-7#1)
the distortion amplitude##2##3##(2008-2#2)
the distortion##5##2##(2008-2#4)(2008-3#1)
the distortions##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
the distraction##2##2##(2011-2#1)(2013-8#1)
the distributed##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2012-2#1)
the distribution and##15##3##(1991-12#1)(1994-2#1)(1994-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#3)(2009-11#1)(2009-12#1)(2012-2#1)(2013-1#1)
the distribution between##2##3##(1992-9#1)(2008-5#1)
the distribution coefficient##2##3##(2008-10#2)
the distribution coefficients##2##3##(2008-10#2)
the distribution constants of 16C5##2##5##(2008-10#2)
the distribution constants of##3##4##(2008-10#3)
the distribution constants##4##3##(2008-10#4)
the distribution function##4##3##(2008-2#2)(2008-3#2)
the distribution is##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
the distribution of RAPD##2##4##(2008-5#2)
the distribution of Snails##2##4##(2011-1#2)
the distribution of both##2##4##(2008-10#1)(2010-8#1)
the distribution of brain##2##4##(1997-2#1)(2008-1#1)
the distribution of iron##2##4##(2008-10#1)(2013-8#1)
the distribution of paternity##2##4##(2008-8#2)
the distribution of resistance##2##4##(2008-10#2)
the distribution of the##46##4##(1990-5#2)(1991-1#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-8#1)(1996-5#1)(1997-8#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)
the distribution of these##4##4##(1990-12#1)(1992-6#1)(2008-10#1)(2008-6#1)
the distribution of this##3##4##(1994-2#1)(1997-4#1)(2008-3#1)
the distribution of##216##3##(1990-12#2)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-3#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#18)(2008-9#7)(2009-10#1)(2009-12#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#9)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
the distribution pattern of the##2##5##(2008-5#1)(2012-3#1)
the distribution pattern of##6##4##(1997-4#1)(2007-10#1)(2008-10#2)(2008-5#1)(2012-3#1)
the distribution pattern##7##3##(1997-4#1)(2007-10#1)(2008-10#2)(2008-5#1)(2012-3#2)
the distribution##283##2##(1990-12#2)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#4)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#3)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#6)(1993-3#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#4)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#51)(2008-11#7)(2008-12#1)(2008-2#9)(2008-3#14)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#21)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#10)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#3)
the distributions of##4##3##(2008-10#1)(2008-11#2)(2013-8#1)
the distributions##8##2##(1992-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-2#1)(2013-8#1)
the district court##3##3##(1996-12#2)(1997-6#1)
the district##11##2##(1993-3#1)(1996-1#1)(1996-12#2)(1997-6#2)(2008-1#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
the districts##2##2##(1997-5#1)(2012-12#1)
the disturbance of##4##3##(1994-5#1)(2007-11#1)(2008-10#1)(2009-12#1)
the disturbance##9##2##(1994-5#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-12#1)
the disturbances in##2##3##(2008-3#2)
the disturbances of##4##3##(2008-12#1)(2008-7#2)(2009-6#1)
the disturbances##6##2##(2008-12#1)(2008-3#2)(2008-7#2)(2009-6#1)
the disturbed environments##2##3##(2008-5#2)
the disturbed##5##2##(1997-4#1)(2008-5#2)(2012-1#1)(2013-7#1)
the disturbing effect of##2##4##(2008-10#1)(2008-2#1)
the disturbing##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
the disulfide bonds##3##3##(1990-5#1)(1993-8#1)(1994-9#1)
the disulfide exchange reaction##2##4##(1993-11#2)
the disulfide exchange##3##3##(1993-11#3)
the disulfide##14##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-9#1)(1997-4#1)(2008-4#1)
the dither##3##2##(2007-12#2)(2008-3#1)
the dithiol##2##2##(2008-11#1)(2010-4#1)
the diuretic##4##2##(1992-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
the diuretics##2##2##(1994-8#1)(2008-10#1)
the diurnal pattern of##2##4##(1997-8#1)(2013-1#1)
the diurnal schedule of male female-search##2##6##(2008-6#2)
the diurnal schedule of##3##4##(2008-6#3)
the diurnal##7##2##(1990-3#1)(1997-8#1)(2008-6#3)(2013-1#2)
the divalent cations##2##3##(1990-7#1)(1994-5#1)
the divalent##5##2##(1990-7#1)(1994-5#1)(2008-10#3)
the divergence in##3##3##(2007-12#1)(2009-12#1)(2012-2#1)
the divergence of the##6##4##(1993-6#1)(2008-2#1)(2008-3#2)(2010-3#1)(2011-1#1)
the divergence of##9##3##(1991-6#1)(1993-6#1)(1994-11#1)(2008-2#1)(2008-3#3)(2010-3#1)(2011-1#1)
the divergence##13##2##(1991-6#1)(1993-6#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)(2010-3#1)(2011-1#1)(2012-2#1)
the divergent results##2##3##(1990-6#1)(1993-12#1)
the divergent##7##2##(1990-6#1)(1990-8#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
the diverse group of##2##4##(2008-3#1)(2012-12#1)
the diverse range of##3##4##(2009-12#1)(2010-5#1)(2011-3#1)
the diverse##30##2##(1991-3#1)(1993-5#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#2)(2009-7#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)
the diversification of##2##3##(2010-3#1)(2010-6#1)
the diversification##4##2##(1991-1#1)(2008-9#1)(2010-3#1)(2010-6#1)
the diversion##2##2##(1996-12#1)(2008-9#1)
the diversity among##2##3##(2008-10#1)(2008-6#1)
the diversity and##4##3##(2008-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
the diversity in##5##3##(1992-8#1)(1994-11#1)(1997-8#1)(2008-10#1)(2012-3#1)
the diversity of the##5##4##(1997-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
the diversity of these##2##4##(2013-7#2)
the diversity of##41##3##(1990-12#1)(1992-3#1)(1997-5#1)(1997-6#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
the diversity##66##2##(1990-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-3#4)(2013-1#2)(2013-7#5)(2013-8#1)
the diverticulum##3##2##(1991-6#1)(1992-1#1)(2008-10#1)
the dividing cells##2##3##(2008-9#1)(2012-12#1)
the dividing##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
the division of labor in##2##5##(2008-8#1)(2008-9#1)
the division of the##3##4##(2007-8#1)(2008-2#1)(2008-5#1)
the division of##11##3##(1991-2#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2012-2#1)
the division##17##2##(1991-2#1)(1994-3#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-6#1)(2012-2#1)
the dlt operon##2##3##(1995-6#2)
the dnaA region of##3##4##(1994-12#1)(1996-12#2)
the dnaA##4##2##(1994-12#1)(1996-12#3)
the docked##2##2##(1992-9#1)(1997-7#1)
the docking##3##2##(1995-2#2)(1997-7#1)
the doctor and##2##3##(2011-1#2)
the doctor##16##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-3#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-4#1)(2010-12#1)(2011-1#2)
the doctor's office##2##3##(1996-11#1)(2009-5#1)
the doctor's role##4##3##(1992-6#4)
the doctor's##7##2##(1992-6#4)(1996-1#1)(1996-11#1)(2009-5#1)
the doctor-patient relationship##3##3##(1992-12#1)(2011-2#2)
the doctor-patient##5##2##(1992-12#1)(1997-6#2)(2011-2#2)
the doctors and##2##3##(1997-4#1)(2010-8#1)
the doctors##20##2##(1990-9#2)(1991-6#1)(1992-6#1)(1993-11#1)(1994-6#1)(1994-7#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-2#3)(2009-10#1)(2010-8#1)(2013-7#2)
the doctors'##5##2##(1993-11#1)(1994-6#1)(1997-6#1)(2011-2#2)
the doctrine of double effect##2##5##(2012-2#2)
the doctrine of##4##3##(1991-3#1)(1994-3#1)(2012-2#2)
the doctrine##5##2##(1991-3#1)(1994-3#2)(2012-2#2)
the document##4##2##(1994-3#1)(2007-12#1)(2007-9#1)(2011-1#1)
the documentation of##6##3##(1991-12#1)(1993-12#1)(2007-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
the documentation##10##2##(1991-12#1)(1993-12#1)(1995-6#1)(1997-6#1)(2007-10#1)(2008-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
the documented##5##2##(1992-11#1)(1997-6#1)(2008-11#1)(2011-3#1)(2012-1#1)
the dog is##2##3##(1995-2#1)(1996-11#1)
the dog liver##2##3##(1995-11#2)
the dog##20##2##(1991-1#1)(1991-3#1)(1993-2#1)(1995-11#4)(1995-2#1)(1996-11#1)(1996-5#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-1#3)(2012-2#1)(2013-1#1)
the dogma##2##2##(2008-11#1)(2008-12#1)
the dogs were##2##3##(1991-6#1)(1992-3#1)
the dogs##10##2##(1991-6#1)(1992-3#1)(1992-5#3)(1996-12#1)(1996-6#1)(2008-6#1)(2012-3#2)
the dollar##2##2##(1991-1#1)(1993-3#1)
the dolls##2##2##(1992-3#2)
the domain of the##2##4##(1991-3#1)(1997-4#1)
the domain of##11##3##(1991-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-2#1)(2009-5#1)(2009-9#2)
the domain wall##3##3##(2008-2#1)(2009-6#2)
the domain##32##2##(1991-1#1)(1991-11#1)(1991-3#1)(1994-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-9#3)(2013-1#1)
the domains and##2##3##(1994-8#1)(2012-12#1)
the domains##12##2##(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#2)(2007-12#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
the dome and the##2##4##(1991-6#1)(2008-3#1)
the dome of the acetabulum##2##5##(2008-5#2)
the dome of the bladder##2##5##(2008-10#2)
the dome of the##4##4##(2008-10#2)(2008-5#2)
the dome of##5##3##(2008-10#2)(2008-5#2)(2010-5#1)
the dome##9##2##(1991-6#1)(2008-10#2)(2008-3#1)(2008-5#3)(2009-7#1)(2010-5#1)
the domestic hen (Gallus domesticus)##2##5##(2008-12#2)
the domestic hen##3##3##(2008-12#3)
the domestic##7##2##(1997-2#1)(2007-12#1)(2008-12#3)(2008-6#1)(2011-2#1)
the dominance of the##2##4##(2008-3#1)(2010-5#1)
the dominance of##6##3##(1991-6#1)(2008-10#2)(2008-3#2)(2010-5#1)
the dominance##9##2##(1991-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-9#1)(2010-5#1)
the dominant and##2##3##(2010-8#1)(2012-3#1)
the dominant contribution to the##3##5##(1992-5#1)(1995-12#1)(2008-3#1)
the dominant contribution to##4##4##(1992-5#1)(1995-12#1)(2007-12#1)(2008-3#1)
the dominant factor determining##2##4##(2008-10#2)
the dominant factor##3##3##(1993-1#1)(2008-10#2)
the dominant gene was##2##4##(2008-10#2)
the dominant gene##3##3##(2008-10#3)
the dominant haplotype##2##3##(2008-10#2)
the dominant noise##2##3##(2007-12#1)(2008-2#1)
the dominant or##2##3##(1996-6#1)(2008-10#1)
the dominant organisms in##2##4##(2008-5#2)
the dominant role in##2##4##(2010-11#1)(2011-3#1)
the dominant species##5##3##(2008-10#2)(2008-5#1)(2011-2#2)
the dominant##90##2##(1990-11#1)(1992-3#1)(1992-5#2)(1993-1#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#2)
the dominant-negative##2##2##(1994-12#1)(1994-8#1)
the dominating##5##2##(1992-3#1)(1996-6#1)(1996-8#1)(2007-11#1)(2008-8#1)
the donation##5##2##(2011-2#4)(2012-12#1)
the donor and##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
the donor phase##2##3##(2008-10#2)
the donor site##4##3##(2011-2#4)
the donor strains##2##3##(1993-12#2)
the donor vesicles##2##3##(1992-3#1)(1994-5#1)
the donor was##2##3##(1991-7#2)
the donor##55##2##(1991-1#1)(1991-7#4)(1992-3#1)(1992-6#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-2#19)(2011-3#1)(2012-12#1)
the donor's##3##2##(1990-3#1)(1994-9#1)(2011-2#1)
the donors##9##2##(1994-9#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-7#2)(2011-2#3)
the donut hole##2##3##(2008-11#2)
the donut##3##2##(2008-11#3)
the door to##2##3##(2007-11#1)(2008-4#1)
the door##4##2##(1994-12#1)(2007-11#1)(2008-4#1)(2008-9#1)
the doors##2##2##(2008-7#1)(2009-5#1)
the dopamine D1 receptor##2##4##(1993-3#1)(1996-2#1)
the dopamine D1##3##3##(1993-3#1)(1996-2#1)(1996-5#1)
the dopamine D3 receptor##3##4##(1995-2#2)(2008-9#1)
the dopamine agonist##2##3##(1993-3#1)(2008-7#1)
the dopamine level##2##3##(1995-5#1)(2008-10#1)
the dopamine uptake system##3##4##(1995-11#3)
the dopamine##28##2##(1991-1#1)(1991-12#1)(1993-1#1)(1993-3#2)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#1)(2008-10#3)(2008-7#2)(2008-9#2)(2012-1#1)
the dopaminergic function in##2##4##(2008-7#2)
the dopaminergic function##3##3##(2008-7#2)(2012-2#1)
the dopaminergic neurons of the##2##5##(1996-12#1)(2008-7#1)
the dopaminergic neurons##4##3##(1990-7#1)(1996-12#1)(2008-7#2)
the dopaminergic neurotoxicant##2##3##(1990-7#2)
the dopaminergic system##4##3##(1994-5#1)(2008-7#1)(2009-6#1)(2012-1#1)
the dopaminergic##23##2##(1990-7#3)(1991-12#1)(1992-10#1)(1993-5#1)(1994-5#1)(1995-5#2)(1996-12#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-7#6)(2009-6#2)(2012-1#1)(2012-2#1)
the dopant##2##2##(2008-3#1)(2010-11#1)
the doped##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-2#1)
the doping##6##2##(1993-3#1)(2008-10#3)(2009-11#1)(2009-2#1)
the dorsal and medial raphe##2##5##(1991-12#1)(2008-7#1)
the dorsal and ventral##4##4##(1996-12#2)(2007-12#1)(2011-2#1)
the dorsal and##8##3##(1991-12#1)(1991-2#1)(1996-12#3)(2007-12#1)(2008-7#1)(2011-2#1)
the dorsal anterior cingulate##2##4##(2008-11#1)(2010-2#1)
the dorsal anterior##3##3##(2007-12#1)(2008-11#1)(2010-2#1)
the dorsal caudate-putamen##2##3##(1993-6#2)
the dorsal fin and##2##4##(2010-8#1)(2013-7#1)
the dorsal fin##6##3##(2010-8#1)(2013-7#5)
the dorsal hippocampus of##2##4##(1992-3#1)(1995-12#1)
the dorsal hippocampus##5##3##(1991-2#1)(1992-3#1)(1995-12#1)(2008-11#1)(2013-8#1)
the dorsal horn and##2##4##(1995-5#1)(1996-12#1)
the dorsal horn of the rat##2##6##(1994-2#1)(1995-12#1)
the dorsal horn of the##3##5##(1994-2#1)(1995-12#1)(2008-7#1)
the dorsal horn of##4##4##(1994-2#1)(1995-12#1)(2008-7#1)(2011-2#1)
the dorsal horn##18##3##(1990-7#4)(1993-12#1)(1994-2#1)(1995-12#3)(1995-5#1)(1996-12#1)(1997-3#4)(2008-4#1)(2008-7#1)(2011-2#1)
the dorsal lateral geniculate nucleus##2##5##(1992-10#1)(1997-7#1)
the dorsal motor nucleus of the vagus##2##7##(1993-12#2)
the dorsal nucleus of the lateral lemniscus##6##7##(1993-12#1)(1997-3#5)
the dorsal nucleus of##7##4##(1991-7#1)(1993-12#1)(1997-3#5)
the dorsal olfactory mucosae##2##4##(1993-3#2)
the dorsal papillae##2##3##(2008-5#2)
the dorsal raphe nucleus##4##4##(1992-3#2)(1993-12#1)(1995-5#1)
the dorsal raphe##9##3##(1991-2#1)(1992-3#2)(1993-12#1)(1994-2#2)(1995-5#1)(1996-12#1)(1997-6#1)
the dorsal root ganglia##2##4##(1997-3#1)(2008-9#1)
the dorsal root ganglion##5##4##(1995-12#1)(1997-2#2)(2008-8#1)(2011-2#1)
the dorsal root##8##3##(1995-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
the dorsal side##5##3##(2008-5#3)(2008-7#1)(2011-2#1)
the dorsal striatum##4##3##(1993-6#1)(1996-2#1)(2010-2#1)(2013-8#1)
the dorsal surface of the foot##2##6##(2012-3#2)
the dorsal surface of the##5##5##(2007-11#1)(2008-4#1)(2011-2#1)(2012-3#2)
the dorsal surface##6##3##(2007-11#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-3#2)
the dorsal##122##2##(1990-7#5)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#3)(1993-12#8)(1993-3#3)(1993-5#1)(1993-6#3)(1994-2#3)(1994-8#2)(1995-12#5)(1995-5#3)(1996-12#5)(1996-2#2)(1996-5#2)(1997-2#3)(1997-3#10)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#12)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2010-2#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#5)(2013-8#4)
the dorsogluteal##2##2##(2013-8#2)
the dorsolateral region##2##3##(1993-9#1)(2008-7#1)
the dorsolateral##10##2##(1991-2#1)(1993-9#1)(1994-8#1)(2007-12#2)(2008-12#1)(2008-7#2)(2010-7#1)(2012-12#1)
the dorsomedial posterior tubercle##2##4##(1997-3#2)
the dorsomedial##5##2##(1993-12#1)(1994-8#1)(1996-5#1)(1997-3#2)
the dorsoventral plane##3##3##(1990-3#1)(1997-3#2)
the dorsoventral##5##2##(1990-3#1)(1991-5#1)(1997-3#2)(2010-4#1)
the dorsum of the##4##4##(1997-4#1)(2007-7#1)(2008-6#1)(2012-3#1)
the dorsum of##5##3##(1997-4#1)(2007-7#1)(2008-6#1)(2010-3#1)(2012-3#1)
the dorsum##6##2##(1997-4#1)(2007-7#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-3#1)
the dosage and##2##3##(2007-11#1)(2013-1#1)
the dosage compensation complex##2##4##(2007-12#2)
the dosage forms##2##3##(2008-10#1)(2012-2#1)
the dosage of dietary##2##4##(2012-2#2)
the dosage of##7##3##(1991-2#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#2)
the dosage##20##2##(1990-9#1)(1991-2#2)(1994-6#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#1)
the dose administered##2##3##(1991-11#1)(2008-7#1)
the dose and##2##3##(1995-12#1)(2008-2#1)
the dose delivered from the##2##5##(1995-3#1)(1997-2#1)
the dose in##3##3##(1992-10#1)(1993-6#1)(1994-8#1)
the dose is##2##3##(1995-3#1)(2008-10#1)
the dose of 0##3##4##(1990-9#1)(2011-1#2)
the dose of 2##2##4##(1992-3#1)(1996-2#1)
the dose of 200 and 400 mg/kg significantly##2##8##(2010-3#2)
the dose of 500 mg/kg##2##5##(2013-1#2)
the dose of##43##3##(1990-11#1)(1990-9#2)(1991-2#1)(1992-12#2)(1992-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-3#3)(2013-1#6)
the dose range of##2##4##(1994-8#2)
the dose range##5##3##(1993-6#1)(1994-8#2)(2008-7#2)
the dose received##2##3##(2009-10#1)(2009-11#1)
the dose was##2##3##(1991-2#1)(2006-10#1)
the dose##98##2##(1990-11#1)(1990-9#2)(1991-11#1)(1991-2#2)(1992-10#2)(1992-12#2)(1992-3#1)(1993-6#2)(1993-9#1)(1994-6#1)(1994-8#4)(1995-12#3)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#3)(2010-3#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#4)(2013-1#9)
the dose-dependent##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
the dose-effect##2##2##(1993-6#1)(2008-7#1)
the dose-related##3##2##(1994-8#1)(2008-3#1)(2011-2#1)
the dose-response curve##4##3##(1994-11#2)(1996-2#1)(1997-1#1)
the dose-response curves##2##3##(1995-12#1)(2008-7#1)
the dose-response for##3##3##(1995-3#2)(2008-7#1)
the dose-response relationship##4##3##(1992-9#1)(1996-6#1)(2008-10#1)(2008-4#1)
the dose-response##17##2##(1992-9#1)(1994-11#2)(1995-12#1)(1995-3#2)(1996-2#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-5#1)(2012-2#1)
the doses of##7##3##(2008-7#3)(2010-3#1)(2013-1#3)
the doses tested##2##3##(1994-11#1)(2010-1#1)
the doses##18##2##(1991-9#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-3#2)(2013-1#4)
the dosing##7##2##(1996-3#1)(1997-2#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)
the dot##3##2##(1994-1#1)(2008-3#1)(2009-11#1)
the dots##2##2##(2007-11#1)(2008-7#1)
the double bond##2##3##(1992-6#1)(2007-11#1)
the double frequency##2##3##(2007-12#2)
the double helix##2##3##(1995-8#1)(2008-7#1)
the double mutant receptor##2##4##(1995-6#2)
the double mutant##4##3##(1995-6#3)(1997-1#1)
the double stranded##2##3##(2008-10#2)
the double##39##2##(1991-5#1)(1992-6#1)(1995-6#5)(1995-8#3)(1996-5#2)(1997-1#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-5#1)(2012-2#1)
the double-edge technique##7##3##(2008-2#4)(2008-3#3)
the double-edge##11##2##(2008-2#5)(2008-3#6)
the double-layer interferometer##2##3##(2008-3#2)
the double-stranded DNA##4##3##(1992-3#1)(2008-10#1)(2010-5#2)
the double-stranded##8##2##(1992-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#2)
the doubled haploid##2##3##(2008-10#2)
the doubled##3##2##(2007-11#1)(2008-10#2)
the doublet##2##2##(2008-3#2)
the doubling crystal##2##3##(2008-3#2)
the doubly resonant##2##3##(2008-2#1)(2008-3#1)
the doubly##9##2##(1990-8#2)(1991-3#1)(1992-3#1)(1997-2#1)(2008-2#1)(2008-3#3)
the down-regulation of##8##3##(1993-8#1)(1995-6#1)(1996-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
the downgrading##2##2##(1990-9#2)
the downsizing process##2##3##(1994-3#1)(1996-12#1)
the downsizing##5##2##(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2012-3#1)
the downstream component of oriLyt##2##5##(1997-3#2)
the downstream component##4##3##(1997-3#4)
the downstream##32##2##(1991-9#2)(1992-9#1)(1994-11#2)(1994-2#1)(1995-2#1)(1997-1#1)(1997-2#2)(1997-3#4)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
the downward##6##2##(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
the downy mildew##3##3##(2008-10#2)(2012-3#1)
the downy##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
the dowsers##2##2##(1997-6#2)
the draft##4##2##(2008-3#1)(2008-9#2)(2010-3#1)
the drain of precursors##2##4##(2008-7#2)
the drain##7##2##(2008-7#2)(2008-8#1)(2011-2#4)
the drainage##3##2##(1991-3#1)(2007-10#1)(2007-8#1)
the draining lymph nodes##2##4##(2008-10#2)
the draining veins##4##3##(1997-3#1)(2008-7#2)(2012-3#1)
the draining##7##2##(1997-3#1)(2008-10#2)(2008-7#3)(2012-3#1)
the dramatic increase in##2##4##(1997-3#1)(2013-1#1)
the dramatic increase##3##3##(1997-3#1)(1997-4#1)(2013-1#1)
the dramatic##9##2##(1992-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
the drastic##2##2##(2008-5#1)(2010-8#1)
the drawback of##3##3##(2007-12#1)(2008-12#1)(2008-3#1)
the drawbacks of the##2##4##(2008-10#2)
the drawbacks of##6##3##(1995-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-1#1)
the drawbacks##7##2##(1990-2#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-1#1)
the drawing##2##2##(2007-12#1)(2008-3#1)
the drawn##4##2##(2008-3#2)(2009-10#2)
the dreaded##2##2##(1990-11#1)(1993-2#1)
the dream of##2##3##(1993-6#1)(2010-8#1)
the dream##3##2##(1993-6#1)(2008-12#1)(2010-8#1)
the dried##5##2##(2008-10#1)(2008-12#1)(2009-5#1)(2010-4#1)(2012-2#1)
the driest##3##2##(2008-10#1)(2008-5#2)
the drift of the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the drift of##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2010-4#1)
the drift##9##2##(2007-11#1)(2008-10#4)(2008-3#2)(2010-4#1)(2012-2#1)
the drinking water for##3##4##(2008-10#1)(2008-9#2)
the drinking water##15##3##(1990-6#1)(1995-12#1)(1995-3#1)(2008-10#4)(2008-9#7)(2013-7#1)
the drinking##17##2##(1990-6#1)(1995-12#2)(1995-3#1)(2008-10#4)(2008-11#1)(2008-9#7)(2013-7#1)
the drip##2##2##(2008-10#1)(2011-2#1)
the drive to##2##3##(2008-1#1)(2010-12#1)
the drive##4##2##(1996-5#1)(2008-1#1)(2008-11#1)(2010-12#1)
the drivers##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)
the driving force for##2##4##(2008-5#1)(2013-8#1)
the driving force of##2##4##(1991-12#1)(2010-2#1)
the driving force##5##3##(1991-12#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-8#1)
the driving##13##2##(1991-12#1)(1993-1#1)(1994-8#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-8#1)
the drop volume##2##3##(2008-10#2)
the drop##13##2##(1991-5#3)(2007-11#1)(2008-10#9)
the drop-out mechanism for the##2##5##(1997-7#2)
the droplet and##2##3##(1995-3#1)(2008-10#1)
the droplet diameter##2##3##(2008-10#2)
the droplet is##2##3##(1994-9#1)(2008-10#1)
the droplet##15##2##(1994-9#2)(1995-3#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#1)(2012-2#1)
the droplets##7##2##(1995-3#2)(1996-3#1)(2008-10#2)(2008-3#1)(2008-7#1)
the dropout rate##2##3##(2008-12#1)(2011-1#1)
the dropout##3##2##(2008-12#1)(2011-1#2)
the dropping mercury electrode##5##4##(2008-10#5)
the dropping##6##2##(1991-12#1)(2008-10#5)
the drops##2##2##(1994-2#1)(2008-10#1)
the drug administration##2##3##(1992-6#1)(2007-10#1)
the drug and the##2##4##(1994-5#1)(2008-10#1)
the drug and##7##3##(1990-3#1)(1993-6#1)(1994-5#1)(2008-10#2)(2010-9#1)(2011-2#1)
the drug at##4##3##(1991-10#1)(1995-2#1)(2008-10#2)
the drug benefit##2##3##(1995-1#1)(2007-9#1)
the drug binding##2##3##(1995-5#1)(2008-10#1)
the drug by##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
the drug concentration time curve##2##5##(1996-3#1)(2008-11#1)
the drug concentration##4##3##(1990-2#1)(1996-3#1)(2008-11#1)(2008-7#1)
the drug content##3##3##(2010-3#2)(2012-2#1)
the drug delivery##2##3##(2012-2#2)
the drug discovery process##2##4##(2008-10#1)(2008-7#1)
the drug discovery##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2011-3#1)
the drug disorder diagnosed population##2##5##(1993-12#2)
the drug for##4##3##(1992-5#1)(2008-11#1)(2008-8#1)(2012-3#1)
the drug from its##3##4##(2008-10#2)(2010-5#1)
the drug from##5##3##(2008-10#3)(2009-11#1)(2010-5#1)
the drug in the##4##4##(1990-11#1)(2008-10#3)
the drug in urine and##2##5##(2008-10#2)
the drug in##18##3##(1990-11#1)(2008-10#16)(2008-8#1)
the drug is##8##3##(1990-3#1)(1991-5#1)(1992-3#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
the drug of choice in##2##5##(2010-8#1)(2011-2#1)
the drug of choice##3##4##(1991-10#1)(2010-8#1)(2011-2#1)
the drug release##4##3##(2012-2#4)
the drug significantly##2##3##(2008-5#2)
the drug solution##2##3##(2008-10#2)
the drug substance##4##3##(1997-2#1)(2008-10#2)(2011-2#1)
the drug to be##3##4##(1990-3#1)(1996-1#1)(2008-8#1)
the drug to##6##3##(1990-3#1)(1990-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
the drug treatment##4##3##(1990-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
the drug was##14##3##(1990-6#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1996-7#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#2)
the drug were##5##3##(1990-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
the drug within##2##3##(1992-2#1)(2007-11#1)
the drug##247##2##(1990-11#3)(1990-2#5)(1990-3#4)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#4)(1991-5#1)(1991-6#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#3)(1995-6#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#62)(2008-11#12)(2008-3#2)(2008-5#17)(2008-6#3)(2008-7#9)(2008-8#10)(2009-11#2)(2009-12#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#6)(2010-8#2)(2010-9#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#2)
the drug's##8##2##(1991-2#1)(1994-8#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
the drug-adsorption mechanism##2##3##(1994-6#2)
the drugs and##4##3##(1996-5#1)(2008-10#1)(2009-10#1)(2013-8#1)
the drugs used to##2##4##(1996-3#1)(2011-1#1)
the drugs used##4##3##(1994-11#1)(1996-1#1)(1996-3#1)(2011-1#1)
the drugs##71##2##(1990-2#2)(1990-8#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-5#3)(1997-1#1)(1997-4#3)(2007-7#1)(2008-10#25)(2008-11#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-6#1)(2010-11#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the drum##2##2##(2008-4#1)(2008-9#1)
the dry forest##2##3##(2008-5#2)
the dry season of 1997##2##5##(2007-5#2)
the dry season of##3##4##(2007-5#2)(2008-5#1)
the dry season##17##3##(2007-2#1)(2007-5#4)(2008-5#8)(2008-6#1)(2008-8#1)(2013-7#2)
the dry season)##2##3##(2008-5#1)(2013-7#1)
the dry##37##2##(1990-7#1)(2007-2#1)(2007-5#4)(2008-10#3)(2008-11#2)(2008-5#13)(2008-6#2)(2008-7#1)(2008-8#1)(2013-7#8)(2013-8#1)
the drying process of##2##4##(2008-7#1)(2011-1#1)
the drying process##6##3##(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
the drying##15##2##(2008-10#7)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
the dsDNA##4##2##(1995-2#2)(2008-10#2)
the dsRNA##8##2##(2008-10#7)(2008-9#1)
the dual blood supply to the hand##2##7##(2011-2#2)
the dual grid##4##3##(2013-1#4)
the dual##24##2##(1990-2#1)(1991-6#1)(1991-8#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#4)
the dual-axis joint##2##3##(2008-2#2)
the dually entitled##3##3##(1995-3#3)
the dually##5##2##(1995-3#3)(2008-10#1)(2008-5#1)
the duct cells##2##3##(2007-12#2)
the duct##6##2##(1991-9#1)(1994-7#1)(2007-12#3)(2011-2#1)
the ductal epithelia##2##3##(2013-8#2)
the ductal##5##2##(2008-5#1)(2009-4#1)(2011-2#1)(2013-8#2)
the ductile part of the##2##5##(1996-4#2)
the ducts##3##2##(2007-12#1)(2008-5#1)(2008-6#1)
the ductus##2##2##(1994-9#1)(1996-3#1)
the duodenal ulcer##2##3##(1992-6#1)(2008-12#1)
the duodenal##5##2##(1991-6#1)(1992-6#1)(1997-3#1)(2008-12#1)(2011-2#1)
the duodenum and##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
the duodenum##19##2##(1990-10#3)(1994-12#1)(1995-11#1)(1996-8#1)(1997-3#1)(2008-12#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
the duplex##8##2##(1995-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2012-3#1)(2013-8#1)
the duplicate##2##2##(2008-1#1)(2008-10#1)
the duplicated##2##2##(1997-3#1)(2009-10#1)
the duplication event##2##3##(1997-8#1)(2009-8#1)
the duplication##4##2##(1997-8#1)(2009-8#1)(2012-3#2)
the dura and##2##3##(2008-7#1)(2009-8#1)
the dura mater##3##3##(2006-12#1)(2009-8#1)(2013-1#1)
the dura propria of the temporal lobe##2##7##(2011-2#2)
the dura##12##2##(1993-10#1)(1996-9#1)(2006-12#2)(2008-7#2)(2009-8#3)(2011-2#2)(2013-1#1)
the durability of resistance to##2##5##(2008-10#2)
the durability of resistance##5##4##(2008-10#5)
the durability of##11##3##(2008-10#9)(2010-8#1)(2012-12#1)
the durability##12##2##(2008-10#9)(2010-8#1)(2012-12#1)(2012-2#1)
the dural defect##2##3##(2011-2#1)(2013-8#1)
the dural sinuses##2##3##(2008-7#2)
the dural##10##2##(2007-8#1)(2008-7#6)(2011-2#1)(2012-3#1)(2013-8#1)
the duration (h)##2##3##(2008-10#2)
the duration and the##2##4##(1993-1#1)(2011-2#1)
the duration and##3##3##(1993-1#1)(2011-2#1)(2012-3#1)
the duration of dialysis##2##4##(2007-7#2)
the duration of each##2##4##(2007-6#1)(2010-2#1)
the duration of exposure##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
the duration of leaf wetness##2##5##(2008-10#2)
the duration of life##2##4##(1990-3#1)(2008-11#1)
the duration of motility##3##4##(2008-7#3)
the duration of symptoms##3##4##(2008-3#1)(2008-5#1)(2013-1#1)
the duration of the asymptomatic period##2##6##(1997-3#2)
the duration of the disease##2##5##(1994-12#1)(2013-1#1)
the duration of the follow-up##2##5##(2008-7#1)(2011-2#1)
the duration of the following##2##5##(1997-2#1)(2008-7#1)
the duration of the inhibition##2##5##(1991-12#1)(1996-2#1)
the duration of the spike##2##5##(1992-3#2)
the duration of the study##2##5##(2008-10#1)(2008-7#1)
the duration of the surgical procedure##2##6##(2008-8#2)
the duration of the treatment##2##5##(2007-7#1)(2008-8#1)
the duration of the##58##4##(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-12#1)(1996-2#2)(1997-2#3)(1997-3#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
the duration of treatment##4##4##(1993-11#1)(2007-8#2)(2011-1#1)
the duration of##125##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#2)(1994-12#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#4)(2008-10#15)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#3)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
the duration on dialysis##2##4##(2008-1#2)
the duration##138##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#2)(1994-12#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#17)(2008-8#8)(2008-9#3)(2009-6#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
the durum##3##2##(2008-10#2)(2012-3#1)
the dust##7##2##(2008-10#3)(2010-5#2)(2013-8#2)
the duties of##2##3##(1991-12#1)(1993-3#1)
the duties##3##2##(1991-12#1)(1992-2#1)(1993-3#1)
the duty cycle ratio##2##4##(2008-3#2)
the duty cycle##4##3##(2008-2#2)(2008-3#2)
the duty##6##2##(2008-2#2)(2008-3#3)(2013-8#1)
the dwell time##3##3##(1990-11#1)(2008-10#1)(2009-7#1)
the dwell##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
the dwellings##3##2##(1995-6#2)(2011-1#1)
the dye and##2##3##(2008-10#1)(2008-2#1)
the dye in##2##3##(2008-10#1)(2008-9#1)
the dye is##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
the dye methylene blue##2##4##(2008-10#1)(2012-2#1)
the dye molecules##5##3##(1991-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-4#1)
the dye stability##2##3##(2008-2#2)
the dye to##2##3##(1994-12#1)(2008-8#1)
the dye with##2##3##(1992-6#1)(2008-4#1)
the dye##57##2##(1990-12#2)(1991-5#4)(1992-6#1)(1993-11#1)(1994-12#3)(1994-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-2#5)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#3)(2010-4#5)(2012-2#1)
the dyeing of##2##3##(2008-5#2)
the dyeing##3##2##(2008-5#2)(2011-1#1)
the dyes and nitrite##3##4##(1990-6#3)
the dyes##13##2##(1990-6#3)(2007-11#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)
the dying process##4##3##(1990-10#4)
the dying##11##2##(1990-10#4)(1991-12#1)(1991-2#1)(1993-12#1)(1993-6#1)(1997-6#1)(2010-10#1)(2010-8#1)
the dynamic and##4##3##(2008-3#1)(2008-8#1)(2011-2#2)
the dynamic baroreflex gain##2##4##(2009-9#1)(2010-5#1)
the dynamic behavior of##2##4##(2007-12#1)(2008-2#1)
the dynamic behavior##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
the dynamic changes##2##3##(2008-12#1)(2008-8#1)
the dynamic coating##2##3##(2008-10#2)
the dynamic interactions##2##3##(2008-4#1)(2012-2#1)
the dynamic nature of##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
the dynamic performance##2##3##(2008-7#1)(2012-2#1)
the dynamic progression##2##3##(2010-6#1)(2013-8#1)
the dynamic properties of##6##4##(1995-6#1)(2008-3#2)(2008-5#1)(2012-2#2)
the dynamic properties##7##3##(1993-8#1)(1995-6#1)(2008-3#2)(2008-5#1)(2012-2#2)
the dynamic range and##2##4##(2008-10#1)(2008-3#1)
the dynamic range of Cu(II)##2##5##(2008-10#2)
the dynamic range of##9##4##(2007-11#2)(2007-12#1)(2008-10#5)(2013-8#1)
the dynamic range##22##3##(2007-11#2)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#6)(2008-9#1)(2013-8#1)
the dynamic surface tension detector (DSTD)##2##6##(2008-10#2)
the dynamic surface tension##4##4##(2008-10#4)
the dynamic##105##2##(1993-8#1)(1995-5#1)(1995-6#1)(1996-4#1)(2007-11#5)(2007-12#7)(2007-8#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-3#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#2)
the dynamical structure of##2##4##(1990-2#1)(1990-5#1)
the dynamical##4##2##(1990-2#1)(1990-5#1)(1994-8#1)(2010-10#1)
the dynamically##2##2##(1992-5#1)(2007-11#1)
the dynamics and##12##3##(1997-4#1)(2008-10#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-8#1)
the dynamics of a##8##4##(1993-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)
the dynamics of actin##2##4##(2008-9#1)(2012-2#1)
the dynamics of ecological##2##4##(2008-8#1)(2008-9#1)
the dynamics of gene##2##4##(2008-7#1)(2010-9#1)
the dynamics of host-pathogen interactions##2##5##(2008-9#2)
the dynamics of live##2##4##(2008-3#2)
the dynamics of surface##2##4##(2007-11#1)(2007-12#1)
the dynamics of the##25##4##(1993-2#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-3#2)(2008-8#3)(2008-9#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-3#1)
the dynamics of##113##3##(1990-8#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-6#1)(1997-1#2)(1997-3#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#16)(2008-11#7)(2008-2#1)(2008-3#7)(2008-7#1)(2008-8#15)(2008-9#10)(2009-2#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
the dynamics##137##2##(1990-8#2)(1993-1#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-4#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-8#1)(2008-1#4)(2008-10#18)(2008-11#7)(2008-2#1)(2008-3#7)(2008-7#1)(2008-8#19)(2008-9#12)(2009-10#1)(2009-2#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#7)
the dysfunction of##4##3##(2008-11#1)(2008-4#1)(2009-8#1)(2011-1#1)
the dyslipidaemia##3##2##(2008-4#1)(2008-6#2)
the dyslipidemia of the metabolic syndrome##2##6##(2008-3#2)
the dyslipidemia##3##2##(2008-1#1)(2008-3#2)
the dysthymic group and major depression group##3##7##(2011-2#3)
the e##5##2##(1995-12#3)(1995-2#1)(1997-4#1)
the e-mails were##2##3##(2012-3#2)
the eFDR##2##2##(2010-3#2)
the ePTFE group##6##3##(2007-7#6)
the ePTFE##8##2##(2007-7#8)
the eSRT programme##3##3##(2008-9#3)
the each##2##2##(1997-4#1)(2008-10#1)
the ear canal##2##3##(1995-9#1)(2008-4#1)
the ear leaf##2##3##(2008-10#2)
the ear##19##2##(1995-9#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#3)(2010-8#4)(2011-2#1)
the earlier study##3##3##(1994-3#1)(1995-3#1)(2009-2#1)
the earlier years##2##3##(1990-3#1)(2008-8#1)
the earlier##33##2##(1990-3#1)(1991-12#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-2#2)(2013-1#1)
the earliest events##2##3##(1995-2#1)(1997-8#1)
the earliest possible##2##3##(1997-3#1)(2008-4#1)
the earliest stage##3##3##(1994-8#1)(1995-1#1)(2012-2#1)
the earliest stages of##7##4##(1995-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-7#1)
the earliest times##2##3##(1990-2#1)(1995-12#1)
the earliest visual areas##2##4##(1995-11#2)
the earliest##42##2##(1990-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
the early 1900s##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
the early 1950s##3##3##(2008-12#1)(2008-9#1)(2010-1#1)
the early 1960s##4##3##(1996-12#1)(2009-7#2)(2010-7#1)
the early 1970s##8##3##(1992-4#1)(1994-12#1)(1994-3#2)(1996-3#1)(2008-11#1)(2008-12#1)(2012-12#1)
the early 1980s and##2##4##(1997-6#1)(2008-5#1)
the early 1980s##9##3##(1994-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
the early 1990s##14##3##(1993-3#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)
the early 19th##2##3##(1993-6#1)(2009-10#1)
the early 20th##2##3##(1997-8#1)(2013-1#1)
the early and 1 year postoperative##2##6##(2007-8#2)
the early and late##2##4##(1996-5#1)(2010-8#1)
the early and long-term##2##4##(2008-8#1)(2009-8#1)
the early and##9##3##(1996-5#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-8#1)
the early appearance##2##3##(2008-4#1)(2009-4#1)
the early beta ERD##2##4##(2013-8#2)
the early childhood##2##3##(2007-8#1)(2010-12#1)
the early control##3##3##(2013-1#3)
the early days of##2##4##(2008-11#1)(2009-10#1)
the early detection of##14##4##(1990-10#1)(1991-4#1)(1994-12#1)(1994-7#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
the early detection##15##3##(1990-10#1)(1991-4#1)(1994-12#1)(1994-7#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
the early development of the##2##5##(1992-12#1)(2008-8#1)
the early development of##6##4##(1992-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#1)
the early development##7##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#1)
the early diagnosis and##3##4##(2008-3#1)(2013-1#2)
the early diagnosis of prostatic##2##5##(1991-2#1)(2009-5#1)
the early diagnosis of##7##4##(1990-9#1)(1991-2#1)(1993-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)
the early diagnosis##11##3##(1990-9#1)(1991-2#1)(1993-3#1)(1994-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#2)
the early embryo##6##3##(2007-12#2)(2008-10#1)(2009-3#1)(2009-8#1)(2012-3#1)
the early embryonic brain of the grasshopper Schistocerca gregaria##2##9##(2007-12#2)
the early embryonic##3##3##(2007-12#2)(2008-11#1)
the early event of cytotoxicity of##2##6##(2009-12#2)
the early events##4##3##(2008-10#1)(2008-7#1)(2012-2#2)
the early identification and##2##4##(2010-12#1)(2011-1#1)
the early identification of##2##4##(2008-9#1)(2010-12#1)
the early identification##4##3##(2008-9#1)(2010-12#2)(2011-1#1)
the early induction##3##3##(1990-6#1)(1996-12#1)(2008-10#1)
the early life##3##3##(2010-7#1)(2010-8#1)(2012-1#1)
the early modern##5##3##(2008-10#4)(2008-11#1)
the early morning hours##2##4##(2008-10#1)(2013-1#1)
the early morning##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
the early part of the##4##5##(1991-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
the early part of##5##4##(1991-8#1)(2008-1#1)(2008-10#1)(2008-9#2)
the early period after##2##4##(2010-11#1)(2012-3#1)
the early period of##2##4##(1993-3#1)(2008-11#1)
the early period##4##3##(1993-3#1)(2008-11#1)(2010-11#1)(2012-3#1)
the early phase of rehabilitation##2##5##(2007-8#2)
the early phase of the##2##5##(1992-3#1)(2008-10#1)
the early phase of##12##4##(1992-12#1)(1992-3#1)(1993-9#1)(1994-11#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
the early phase##16##3##(1992-12#1)(1992-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#2)
the early phases of##3##4##(1995-3#1)(2008-11#1)(2012-12#1)
the early phases##4##3##(1991-8#1)(1995-3#1)(2008-11#1)(2012-12#1)
the early postnatal##5##3##(1990-5#1)(1991-1#1)(1997-2#1)(2008-11#1)(2010-1#1)
the early postoperative period##9##4##(1991-2#1)(1991-5#1)(1994-3#1)(1995-4#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-3#1)
the early postoperative##12##3##(1990-6#1)(1991-2#1)(1991-5#1)(1994-3#1)(1995-4#1)(2007-7#1)(2007-8#2)(2011-2#2)(2012-1#1)(2012-3#1)
the early psychosis##2##3##(2008-1#2)
the early recognition of##2##4##(2008-4#1)(2012-12#1)
the early response genes##2##4##(1992-12#1)(1994-8#1)
the early response##3##3##(1992-12#1)(1994-8#1)(1996-5#1)
the early risk of stroke##2##5##(2008-8#1)(2012-3#1)
the early stage of infection##3##5##(2008-10#2)(2008-5#1)
the early stage of the disease##2##6##(1990-6#1)(2012-3#1)
the early stage of the##5##5##(1990-6#1)(1991-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
the early stage of##26##4##(1990-6#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#2)(1994-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-9#4)(2009-12#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
the early stage##28##3##(1990-6#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#2)(1994-3#1)(1994-7#1)(1995-12#1)(1995-4#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-9#4)(2009-12#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
the early stages of development##4##5##(1993-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
the early stages of disasters##2##5##(2010-8#2)
the early stages of peritonitis##2##5##(2008-12#2)
the early stages of the##5##5##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
the early stages of##43##4##(1993-2#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2010-6#1)(2010-8#4)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
the early stages##53##3##(1993-2#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#3)(2009-6#1)(2010-6#1)(2010-8#4)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
the early steps in##2##4##(2007-12#1)(2009-8#1)
the early steps of##2##4##(1992-2#1)(2008-2#1)
the early steps##4##3##(1992-2#1)(2007-12#1)(2008-2#1)(2009-8#1)
the early subjective##2##3##(2008-5#2)
the early to##5##3##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)
the early twentieth century##4##4##(2008-12#1)(2009-10#1)(2010-1#1)(2012-12#1)
the early twentieth##5##3##(2008-12#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
the early years of##3##4##(1992-2#1)(1992-3#1)(1993-12#1)
the early years##7##3##(1992-2#1)(1992-3#1)(1993-12#1)(2008-11#1)(2010-12#2)(2010-8#1)
the early##415##2##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#4)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#7)(1994-7#2)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#3)(1996-9#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#11)(2007-7#2)(2007-8#10)(2008-1#4)(2008-10#42)(2008-11#22)(2008-12#12)(2008-2#3)(2008-3#4)(2008-4#9)(2008-5#9)(2008-6#8)(2008-7#13)(2008-8#9)(2008-9#15)(2009-10#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#9)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#18)(2012-1#5)(2012-12#4)(2012-2#10)(2012-3#7)(2013-1#18)(2013-7#2)(2013-8#5)
the early-morning##2##2##(1992-8#1)(2013-1#1)
the earth surface##2##3##(2008-10#2)
the earth##3##2##(2008-10#2)(2008-5#1)
the earth's crust##3##3##(1996-4#1)(2008-10#1)(2013-8#1)
the earth's surface##3##3##(1996-4#1)(2008-10#1)(2010-5#1)
the earth's##7##2##(1996-4#2)(2008-10#2)(2008-3#1)(2010-5#1)(2013-8#1)
the earthquake in##2##3##(1996-4#1)(2008-9#1)
the earthquake##17##2##(1996-4#6)(2008-2#1)(2008-9#1)(2011-1#1)(2012-1#2)(2013-1#4)(2013-8#2)
the earthworm##5##2##(2008-5#3)(2008-9#1)(2011-1#1)
the ease of scientific##2##4##(2012-2#2)
the ease of use of the##2##6##(1994-3#1)(2012-3#1)
the ease of use of##3##5##(1994-3#1)(2012-3#1)(2013-1#1)
the ease of##19##3##(1992-11#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
the ease##21##2##(1992-11#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
the easier##2##2##(2008-9#1)(2013-8#1)
the easiest##3##2##(1990-3#1)(2007-8#1)(2011-2#1)
the easiness##2##2##(2008-5#1)(2008-7#1)
the east and west coasts of##2##6##(2008-10#2)
the east and##3##3##(2008-10#3)
the east coast of##2##4##(2009-12#1)(2010-8#1)
the east##13##2##(1992-2#1)(2007-5#1)(2008-10#6)(2008-5#1)(2009-12#1)(2009-7#1)(2010-8#2)
the eastern United States##6##4##(2008-10#6)
the eastern section##3##3##(2007-5#3)
the eastern subpopulation##2##3##(2012-12#2)
the eastern##27##2##(2007-5#3)(2008-1#1)(2008-10#13)(2008-5#2)(2008-9#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#1)
the easy##9##2##(1990-5#1)(1990-9#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-4#1)(2008-9#1)(2013-8#2)
the eating##2##2##(2008-11#1)(2012-3#1)
the ecdysial##2##2##(2008-7#2)
the echinocandin##2##2##(2011-2#2)
the echo##2##2##(2011-2#1)(2012-3#1)
the echocardiographic##2##2##(1990-8#1)(2008-10#1)
the ecological and evolutionary##2##4##(1996-6#1)(2008-8#1)
the ecological and##3##3##(1996-6#1)(2007-5#1)(2008-8#1)
the ecological characteristics of##2##4##(2008-5#1)(2008-8#1)
the ecological factors##2##3##(2007-10#1)(2010-10#1)
the ecological literature##2##3##(2008-8#1)(2008-9#1)
the ecological significance of##2##4##(2009-8#2)
the ecological significance##3##3##(2008-10#1)(2009-8#2)
the ecological##38##2##(1994-3#1)(1996-6#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-8#6)(2008-9#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#4)(2012-5#1)(2013-7#2)
the ecologically##2##2##(2008-10#1)(2008-9#1)
the ecology and epidemiology of##2##5##(2007-10#1)(2008-9#1)
the ecology and evolution of##3##5##(2008-8#1)(2009-8#1)(2012-3#1)
the ecology and##6##3##(2007-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
the ecology of this##3##4##(2008-9#1)(2009-4#1)(2012-2#1)
the ecology of##14##3##(2007-5#1)(2008-10#6)(2008-8#1)(2008-9#2)(2009-4#2)(2012-2#1)(2013-1#1)
the ecology##20##2##(2007-10#1)(2007-5#1)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#3)(2009-4#2)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the economic and##4##3##(1990-12#1)(1993-2#1)(1995-5#1)(2011-2#1)
the economic aspects of##2##4##(1993-12#2)
the economic burden of##3##4##(1995-11#1)(2008-6#1)(2010-3#1)
the economic cost##2##3##(2008-11#1)(2013-8#1)
the economic downturn on##2##4##(2012-3#2)
the economic downturn##3##3##(2012-3#3)
the economic impact of##2##4##(2008-10#1)(2008-8#1)
the economic impact##4##3##(2007-11#1)(2008-10#2)(2008-8#1)
the economic##48##2##(1990-12#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#3)(2013-8#2)
the economical##2##2##(2008-11#1)(2008-5#1)
the economically inactive##2##3##(2013-8#2)
the economically##5##2##(2008-10#2)(2010-3#1)(2013-8#2)
the economy of##2##3##(2008-10#1)(2013-8#1)
the economy##13##2##(1991-1#1)(1992-4#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
the ecosystem##8##2##(1997-7#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
the ecotoxicological effect of##2##4##(2008-10#1)(2008-11#1)
the ectatic area##3##3##(1997-3#3)
the ectomycorrhizal##2##2##(2012-6#2)
the ectoparasitic##2##2##(2008-10#1)(2009-5#1)
the ectopic expression of##3##4##(1996-5#1)(2008-11#1)(2008-7#1)
the ectopic meatus##2##3##(2009-5#2)
the ectopic##8##2##(1990-9#1)(1996-5#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-8#1)(2011-1#1)
the edema##2##2##(2008-5#1)(2010-2#1)
the edentulous##2##2##(1996-3#1)(2007-12#1)
the edge enhancement of##3##4##(2008-3#3)
the edge enhancement##4##3##(2008-2#1)(2008-3#3)
the edge image waviness##3##4##(2008-3#3)
the edge image##5##3##(2008-3#5)
the edge of a##4##4##(2008-3#2)(2008-9#1)(2013-7#1)
the edge of the orchard##2##5##(2008-10#2)
the edge of the##15##4##(1992-3#1)(1994-5#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)
the edge of##31##3##(1992-3#1)(1994-5#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the edge##59##2##(1992-3#1)(1994-5#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#10)(2008-3#19)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#4)(2013-8#1)
the edges are##2##3##(2008-3#2)
the edges of the##4##4##(2008-2#2)(2010-7#1)(2011-2#1)
the edges of##6##3##(1997-3#1)(2008-2#3)(2010-7#1)(2011-2#1)
the edges##10##2##(1997-3#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-7#1)(2011-2#1)
the edible##5##2##(2008-10#3)(2008-11#1)(2013-7#1)
the editing protein##4##3##(1994-8#4)
the editing status##2##3##(1995-5#2)
the editing##9##2##(1992-11#1)(1994-8#4)(1995-5#2)(1997-2#1)(2011-1#1)
the editor##24##2##(1995-8#1)(1996-9#1)(1997-3#1)(2008-11#4)(2008-12#8)(2008-6#1)(2008-9#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
the editor]##2##2##(1993-10#1)(2008-8#1)
the editorial##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
the editors##2##2##(1996-12#1)(2007-12#1)
the educated##2##2##(2007-12#1)(2008-11#1)
the education and training##4##4##(1991-1#1)(2008-11#1)(2008-12#2)
the education and##5##3##(1991-1#1)(2006-10#1)(2008-11#1)(2008-12#2)
the education level of the##2##5##(2008-7#2)
the education level##3##3##(1991-2#1)(2008-7#2)
the education of health care##2##5##(1992-2#1)(2008-12#1)
the education of health##5##4##(1992-2#1)(1993-2#1)(2008-11#2)(2008-12#1)
the education of##13##3##(1992-2#1)(1992-4#1)(1993-2#1)(1994-12#1)(2007-7#1)(2008-11#5)(2008-12#2)(2012-1#1)
the education##28##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-12#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-11#7)(2008-12#5)(2008-7#2)(2008-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
the educational and##3##3##(1996-2#1)(2008-12#1)(2011-2#1)
the educational experience of##2##4##(2008-12#1)(2013-7#1)
the educational needs of##3##4##(1992-12#2)(2008-11#1)
the educational process##2##3##(1993-3#1)(2008-12#1)
the educational value##2##3##(2008-11#1)(2008-12#1)
the educational##35##2##(1990-3#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-11#8)(2008-12#7)(2009-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
the educator##2##2##(1996-3#1)(2008-12#1)
the eel##5##2##(2008-5#5)
the efe gene##9##3##(2008-10#9)
the efe##12##2##(2008-10#12)
the effect and##4##3##(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#1)
the effect being##2##3##(2007-11#1)(2008-11#1)
the effect in##2##3##(2008-3#1)(2012-2#1)
the effect is more##2##4##(2008-5#2)
the effect is##10##3##(1990-2#1)(1992-1#1)(1992-3#1)(1997-6#1)(2008-2#1)(2008-5#3)(2008-9#1)(2011-2#1)
the effect of Cisplatin-liposome on Hela cells##2##7##(2008-10#2)
the effect of EGF on##2##5##(1994-6#2)
the effect of Gaussian apodization on##2##6##(2008-2#1)(2008-3#1)
the effect of Gaussian##3##4##(2008-2#2)(2008-3#1)
the effect of Ge alloying on##2##6##(2008-10#2)
the effect of LPL-mediated##2##4##(1992-12#1)(1995-6#1)
the effect of MOEE##2##4##(2008-10#2)
the effect of PTH##2##4##(2008-8#2)
the effect of a 5-min residence time##2##7##(2008-5#2)
the effect of a finite##2##5##(2008-3#2)
the effect of a single##2##5##(1991-8#1)(1997-7#1)
the effect of a small##2##5##(2008-7#2)
the effect of a##45##4##(1991-2#2)(1991-6#2)(1991-8#1)(1992-3#2)(1992-6#1)(1993-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1997-4#1)(1997-7#2)(1997-8#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
the effect of acupuncture##2##4##(1993-3#1)(2012-3#1)
the effect of acute##4##4##(1991-10#1)(1994-11#1)(1996-2#1)(2008-10#1)
the effect of adding##3##4##(1997-3#1)(2008-10#1)(2010-4#1)
the effect of age and##2##5##(2008-7#2)
the effect of age on##3##5##(2008-1#1)(2008-7#2)
the effect of age##6##4##(2008-1#1)(2008-7#4)(2009-5#1)
the effect of aging on##5##5##(1994-6#1)(2008-7#4)
the effect of aging##6##4##(1994-6#1)(2008-7#5)
the effect of alcohol##2##4##(1992-9#1)(1994-11#1)
the effect of an##9##4##(1994-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-6#1)(2010-2#1)(2013-1#1)
the effect of background##2##4##(2008-2#1)(2008-3#1)
the effect of both##3##4##(1997-1#1)(2008-1#1)(2008-10#1)
the effect of carbachol##2##4##(1996-12#2)
the effect of cell##4##4##(2008-11#3)(2008-7#1)
the effect of changes in##2##5##(1997-2#1)(2008-2#1)
the effect of changes##3##4##(1997-2#1)(2008-2#1)(2012-2#1)
the effect of chloroquine##2##4##(1993-8#1)(1994-3#1)
the effect of chronic##3##4##(1994-2#1)(2008-10#1)(2013-1#1)
the effect of cigarette smoking on##3##6##(1996-3#1)(2008-10#1)(2008-12#1)
the effect of cigarette##4##4##(1991-9#1)(1996-3#1)(2008-10#1)(2008-12#1)
the effect of cocaine##4##4##(1993-12#1)(2013-8#3)
the effect of common##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
the effect of continuous##2##4##(2008-11#1)(2008-12#1)
the effect of copper##2##4##(1990-8#1)(2008-10#1)
the effect of dementia##2##4##(2008-7#2)
the effect of diabetes on##2##5##(2008-10#2)
the effect of dietary##2##4##(2010-2#1)(2013-1#1)
the effect of different##18##4##(1992-9#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-12#6)(2010-4#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
the effect of drugs##2##4##(2008-4#1)(2012-2#1)
the effect of duration of##2##5##(2008-10#1)(2010-8#1)
the effect of ethanolic extract of##2##6##(2008-10#1)(2012-2#1)
the effect of exercise##3##4##(2008-8#1)(2012-3#1)(2013-1#1)
the effect of exhaustive treadmill running##2##6##(2012-1#2)
the effect of exogenous##2##4##(2008-11#1)(2008-12#1)
the effect of experimental##2##4##(1990-7#1)(2008-10#1)
the effect of exposure to##2##5##(2007-12#1)(2009-12#1)
the effect of family##3##4##(2010-9#1)(2011-2#1)(2013-1#1)
the effect of feeding##3##4##(2008-12#1)(2012-2#2)
the effect of fiber tilt##2##5##(2008-2#2)
the effect of finite##2##4##(2008-3#2)
the effect of flow rate##2##5##(2008-10#2)
the effect of folic acid##2##5##(2010-5#2)
the effect of foreign ions##3##5##(2008-10#3)
the effect of four##2##4##(1995-5#1)(2008-12#1)
the effect of gene##2##4##(2008-8#2)
the effect of growth##2##4##(1994-9#1)(2008-10#1)
the effect of heat stress on##2##6##(2008-12#2)
the effect of heat##4##4##(1993-6#1)(2008-12#2)(2013-1#1)
the effect of image##2##4##(2008-2#1)(2009-4#1)
the effect of increasing the##3##5##(1991-2#1)(2008-2#1)(2008-8#1)
the effect of increasing##5##4##(1991-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
the effect of interferences##2##4##(2008-10#2)
the effect of light initiation##2##5##(2008-10#2)
the effect of light##4##4##(1993-12#1)(1997-6#1)(2008-10#2)
the effect of lithium##2##4##(1996-12#1)(2009-8#1)
the effect of low##5##4##(1993-1#1)(1996-12#1)(2008-7#1)(2010-9#1)(2011-2#1)
the effect of lowering##2##4##(2007-10#1)(2008-5#1)
the effect of massage##2##4##(2008-12#2)
the effect of morphine##5##4##(1991-1#1)(1996-2#4)
the effect of mother##2##4##(1996-2#2)
the effect of neuropeptides##2##4##(2007-2#1)(2008-4#1)
the effect of nicotine on naloxone-induced jumping##2##7##(1996-2#2)
the effect of nicotine on##3##5##(1991-1#1)(1996-2#2)
the effect of nicotine##4##4##(1991-1#1)(1996-2#3)
the effect of noise##2##4##(2008-3#2)
the effect of nutrient availability##2##5##(2008-10#2)
the effect of other##2##4##(1991-12#1)(2009-12#1)
the effect of pH and##2##5##(2008-10#1)(2008-7#1)
the effect of pH on the peak##2##7##(2008-10#2)
the effect of pH on the##3##6##(2008-10#2)(2008-8#1)
the effect of pH on##5##5##(2008-10#3)(2008-6#1)(2008-8#1)
the effect of pH##16##4##(2008-10#12)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
the effect of parameters##2##4##(2008-10#1)(2008-7#1)
the effect of parathyroid hormone##2##5##(1994-11#1)(1994-6#1)
the effect of parental##2##4##(1994-2#1)(2013-8#1)
the effect of physical##2##4##(2011-2#1)(2013-1#1)
the effect of potential##2##4##(2008-10#1)(2011-1#1)
the effect of pressure##2##4##(2008-10#1)(2008-6#1)
the effect of protein##2##4##(1993-3#1)(1994-11#1)
the effect of quadrat##2##4##(2008-10#2)
the effect of radiation##2##4##(2008-5#1)(2013-1#1)
the effect of recombinant hFGF-10 adenovirus on##2##7##(2011-3#2)
the effect of recombinant##4##4##(1992-3#1)(1994-8#1)(2011-3#2)
the effect of relative##2##4##(2008-10#1)(2011-2#1)
the effect of relevant##2##4##(2008-10#1)(2008-7#1)
the effect of resource##2##4##(2007-12#1)(2008-8#1)
the effect of retention##3##4##(2008-10#2)(2008-12#1)
the effect of salt##2##4##(1991-9#1)(2009-8#1)
the effect of scattering##3##4##(2008-3#3)
the effect of selected##2##4##(1997-6#1)(2008-7#1)
the effect of several##2##4##(1995-3#1)(1995-6#1)
the effect of sex##2##4##(1991-3#1)(1997-7#1)
the effect of soil##5##4##(2008-10#3)(2008-5#2)
the effect of some##5##4##(1996-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
the effect of spatial hole burning##3##6##(2007-11#2)(2008-3#1)
the effect of specific##2##4##(2008-10#1)(2008-4#1)
the effect of such##7##4##(1993-1#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2012-1#1)(2013-8#1)
the effect of surgical##2##4##(2008-10#1)(2008-7#1)
the effect of temperature on##5##5##(1992-5#1)(2008-10#3)(2009-8#1)
the effect of temperature##11##4##(1992-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-7#1)
the effect of the addition of##2##6##(1997-1#1)(2008-6#1)
the effect of the different##2##5##(1996-2#1)(2008-7#1)
the effect of the following##2##5##(2008-10#1)(2008-7#1)
the effect of the inhibitor on##2##6##(1990-11#1)(2008-4#1)
the effect of the mutations##2##5##(1992-9#1)(1997-2#1)
the effect of the number of##2##6##(2007-8#1)(2011-2#1)
the effect of the time##2##5##(2008-10#1)(2013-1#1)
the effect of the##105##4##(1990-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
the effect of their##2##4##(1994-5#1)(2009-6#1)
the effect of thermal injury on##2##6##(2008-9#2)
the effect of these##11##4##(1991-12#1)(1991-2#1)(1995-6#1)(1996-2#2)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-9#1)(2013-8#1)
the effect of this##2##4##(1990-12#1)(2008-3#1)
the effect of three##2##4##(1995-12#1)(2011-2#1)
the effect of tissue##2##4##(2008-2#1)(2010-8#1)
the effect of treatment##3##4##(1990-5#1)(1992-8#1)(1997-3#1)
the effect of variation in##2##5##(2007-5#1)(2008-4#1)
the effect of various##8##4##(1990-11#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)
the effect of varying##2##4##(2008-9#1)(2012-2#1)
the effect of vitamin##4##4##(1990-3#1)(2007-7#1)(2008-1#1)(2011-1#1)
the effect of water##3##4##(2008-10#3)
the effect of##1089##3##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#10)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#3)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#12)(1992-5#1)(1992-6#7)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#6)(1993-6#5)(1993-8#5)(1993-9#1)(1994-11#12)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#7)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#7)(1995-12#15)(1995-2#3)(1995-3#8)(1995-5#3)(1995-6#4)(1995-8#5)(1995-9#1)(1996-12#8)(1996-2#20)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#10)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#9)(1997-8#1)(2006-10#1)(2007-10#8)(2007-11#12)(2007-12#12)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#10)(2008-10#183)(2008-11#43)(2008-12#41)(2008-2#32)(2008-3#60)(2008-4#11)(2008-5#33)(2008-6#17)(2008-7#43)(2008-8#35)(2008-9#19)(2009-10#1)(2009-11#1)(2009-12#8)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#11)(2011-2#32)(2011-3#5)(2012-1#7)(2012-12#3)(2012-2#30)(2012-3#15)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#34)(2013-7#6)(2013-8#20)
the effect on temperature##2##4##(1996-2#2)
the effect on the##6##4##(1993-3#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#2)
the effect on##32##3##(1991-12#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-5#2)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
the effect that the##2##4##(2008-8#1)(2013-1#1)
the effect that##13##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#2)
the effect was not##2##4##(1995-6#1)(2008-11#1)
the effect was##16##3##(1992-8#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
the effect##1204##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#11)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#13)(1992-5#1)(1992-6#7)(1992-8#5)(1992-9#5)(1993-1#3)(1993-11#3)(1993-12#12)(1993-2#1)(1993-3#8)(1993-6#6)(1993-8#5)(1993-9#1)(1994-11#12)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#4)(1994-6#7)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#7)(1995-12#15)(1995-2#4)(1995-3#8)(1995-5#4)(1995-6#5)(1995-8#5)(1995-9#1)(1996-12#10)(1996-2#23)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#10)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#2)(2006-10#1)(2007-10#8)(2007-11#14)(2007-12#15)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#12)(2008-10#194)(2008-11#52)(2008-12#43)(2008-2#34)(2008-3#70)(2008-4#12)(2008-5#42)(2008-6#17)(2008-7#45)(2008-8#38)(2008-9#28)(2009-10#1)(2009-11#1)(2009-12#8)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#3)(2010-4#8)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#11)(2011-2#35)(2011-3#5)(2012-1#7)(2012-12#3)(2012-2#32)(2012-3#15)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#37)(2013-7#7)(2013-8#20)
the effective area##2##3##(2008-3#2)
the effective concentration##3##3##(2008-10#3)
the effective delivery of##3##4##(2010-12#1)(2010-6#1)(2013-1#1)
the effective dose##5##3##(1995-12#1)(1997-8#2)(2008-12#1)(2013-8#1)
the effective immobilization of##2##4##(2008-10#2)
the effective medium theory##2##4##(2008-3#2)
the effective medium##3##3##(2007-11#1)(2008-3#2)
the effective migration rate##2##4##(2008-10#1)(2008-8#1)
the effective optical##2##3##(2008-2#1)(2008-3#1)
the effective population size##2##4##(2008-10#1)(2013-1#1)
the effective radius##3##3##(2008-3#3)
the effective refractive index##4##4##(2007-11#2)(2008-3#2)
the effective size of a##3##5##(2007-12#2)(2008-8#1)
the effective size of the##2##5##(1990-11#1)(2008-10#1)
the effective size of##5##4##(1990-11#1)(2007-12#2)(2008-10#1)(2008-8#1)
the effective sizes of##2##4##(2008-10#2)
the effective use of##2##4##(1992-9#1)(2008-6#1)
the effective use##3##3##(1992-2#1)(1992-9#1)(2008-6#1)
the effective utilization of##2##4##(2008-10#1)(2010-10#1)
the effective wavelength of the##2##5##(2008-2#1)(2008-3#1)
the effective wavelength##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the effective##121##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2006-6#1)(2007-11#7)(2007-12#9)(2007-5#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#23)(2008-6#1)(2008-7#2)(2008-8#4)(2009-4#2)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#4)(2012-6#1)(2013-1#3)(2013-8#2)
the effective-index##2##2##(2007-12#1)(2008-2#1)
the effectiveness and safety of##3##5##(1993-2#1)(2013-1#2)
the effectiveness and tolerance of##2##5##(1990-6#1)(2008-5#1)
the effectiveness and##12##3##(1990-6#1)(1993-2#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-1#3)
the effectiveness of ASPs##2##4##(2013-1#2)
the effectiveness of a given##2##5##(2008-3#1)(2012-3#1)
the effectiveness of a##22##4##(1990-6#1)(1992-1#2)(1994-12#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-11#1)(2007-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2012-3#2)
the effectiveness of an##5##4##(1995-2#1)(1997-1#1)(2008-8#1)(2010-10#1)(2012-2#1)
the effectiveness of antimicrobially impregnated catheters##2##6##(2007-7#2)
the effectiveness of different##5##4##(1994-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
the effectiveness of exercise for##2##5##(2013-1#2)
the effectiveness of five##2##4##(2008-11#1)(2008-4#1)
the effectiveness of interventions##2##4##(1997-2#1)(2011-2#1)
the effectiveness of our##4##4##(2008-3#1)(2008-6#1)(2008-7#1)(2010-9#1)
the effectiveness of routine##2##4##(2011-2#1)(2012-12#1)
the effectiveness of the proposed method##2##6##(2007-12#1)(2008-3#1)
the effectiveness of the proposed##6##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the effectiveness of the##48##4##(1991-2#1)(1992-9#1)(1993-1#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
the effectiveness of their##6##4##(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
the effectiveness of these##6##4##(1991-1#1)(1996-1#1)(2007-11#1)(2008-9#1)(2010-6#1)(2012-2#1)
the effectiveness of this method##4##5##(1996-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
the effectiveness of this technique##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
the effectiveness of this type of##3##6##(2007-12#1)(2012-2#2)
the effectiveness of this##17##4##(1990-8#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2010-4#1)(2012-12#1)(2012-2#2)
the effectiveness of treatment##4##4##(1996-3#1)(2008-3#1)(2008-7#1)(2012-1#1)
the effectiveness of using##2##4##(2007-5#1)(2012-12#1)
the effectiveness of##255##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#3)(1995-4#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#10)(2007-12#5)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#6)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#7)(2008-7#13)(2008-8#3)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#2)(2012-1#3)(2012-12#6)(2012-2#12)(2012-3#4)(2013-1#24)(2013-7#2)(2013-8#2)
the effectiveness##273##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#3)(1995-4#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#10)(2007-12#5)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#9)(2008-12#6)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#5)(2008-6#7)(2008-7#14)(2008-8#3)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#15)(2011-3#2)(2012-1#3)(2012-12#7)(2012-2#12)(2012-3#4)(2013-1#27)(2013-7#2)(2013-8#2)
the effector cells##3##3##(1990-12#1)(1993-6#1)(1995-2#1)
the effector phase##3##3##(2008-10#3)
the effector site##2##3##(1995-2#2)
the effector##15##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-2#3)(1995-6#1)(2008-10#3)(2008-3#1)(2009-2#1)(2011-2#1)
the effectors of##2##3##(1996-2#1)(2008-9#1)
the effects and##7##3##(1995-2#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2011-3#1)(2012-3#1)
the effects are##4##3##(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
the effects can be##2##4##(1991-8#1)(2012-1#1)
the effects caused by##2##4##(2008-10#1)(2008-2#1)
the effects in##2##3##(1995-2#1)(2011-2#1)
the effects mediated##2##3##(1996-5#1)(2010-1#1)
the effects of CR##4##4##(1994-5#2)(2008-10#1)(2008-11#1)
the effects of ET##2##4##(2012-3#2)
the effects of LDL##2##4##(1994-9#2)
the effects of a DNR order##2##6##(1992-12#1)(1992-3#1)
the effects of a##34##4##(1990-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-7#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
the effects of acute##4##4##(1991-9#1)(2008-12#1)(2011-2#1)(2013-1#1)
the effects of age and##3##5##(1994-9#1)(1996-5#1)(2008-8#1)
the effects of age at##2##5##(2008-9#1)(2011-1#1)
the effects of age##6##4##(1991-12#1)(1994-9#1)(1996-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
the effects of agents##2##4##(1996-2#1)(2008-5#1)
the effects of agricultural practices##2##5##(2008-10#2)
the effects of agricultural##3##4##(2008-10#2)(2008-11#1)
the effects of an##6##4##(2007-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
the effects of angiotensins in##2##5##(1997-7#2)
the effects of aqueous##2##4##(1992-2#1)(2011-1#1)
the effects of atmospheric##2##4##(2008-3#2)
the effects of base time on the diagnosticity of##2##9##(2008-8#2)
the effects of bilateral##2##4##(1994-3#1)(1997-6#1)
the effects of bortezomib##2##4##(2011-2#2)
the effects of both##2##4##(2008-11#1)(2009-6#1)
the effects of cadmium##2##4##(1994-6#1)(2013-1#1)
the effects of caloric restriction##2##5##(1994-5#1)(2008-10#1)
the effects of cations##2##4##(2008-6#2)
the effects of cell##2##4##(1995-3#1)(2008-7#1)
the effects of cetyltriethylammonium bromide (CTAB) on the##2##8##(2008-11#2)
the effects of changes in##3##5##(1993-11#1)(2007-12#1)(2012-12#1)
the effects of chronic##5##4##(1995-12#1)(1996-12#1)(2008-12#1)(2010-6#1)(2013-1#1)
the effects of cisapride and BRL 24924##2##7##(1990-5#2)
the effects of climate change##2##5##(2012-12#2)
the effects of continuous##2##4##(1995-12#1)(2010-6#1)
the effects of cultivating##2##4##(2011-2#2)
the effects of cultural##2##4##(1991-12#1)(2008-10#1)
the effects of dexamethasone##3##4##(1994-10#1)(1994-3#1)(2010-12#1)
the effects of diet##2##4##(2008-10#1)(2009-4#1)
the effects of dietary##3##4##(2008-5#1)(2008-7#1)(2009-8#1)
the effects of different types of##2##6##(2008-8#1)(2011-1#1)
the effects of different##15##4##(1992-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
the effects of disease and##2##5##(2009-10#1)(2013-7#1)
the effects of donor knowledge and perceived risk on##2##9##(1994-3#2)
the effects of donor##3##4##(1994-3#2)(2008-9#1)
the effects of drug treatment##2##5##(2008-10#1)(2009-9#1)
the effects of drugs##2##4##(2006-6#1)(2010-9#1)
the effects of each##3##4##(1992-1#1)(2008-12#1)(2008-8#1)
the effects of either##2##4##(2008-10#1)(2009-12#1)
the effects of electrical##2##4##(1994-5#1)(2009-10#1)
the effects of elevated##2##4##(1994-2#1)(2008-5#1)
the effects of emotions on##2##5##(2007-2#1)(2008-5#1)
the effects of estrogen on##3##5##(2008-11#2)(2008-7#1)
the effects of estrogen##4##4##(2008-11#2)(2008-7#2)
the effects of exogenous##4##4##(1992-8#1)(1994-11#1)(2011-1#1)(2011-10#1)
the effects of explanatory##2##4##(1997-8#1)(2008-4#1)
the effects of external##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
the effects of extracellular ATP##2##5##(2008-4#2)
the effects of extracellular##3##4##(2008-4#2)(2008-8#1)
the effects of frequent##2##4##(2009-7#1)(2009-8#1)
the effects of gamma-aminobutyric acid (GABA)##2##6##(2008-8#1)(2008-9#1)
the effects of gender and##2##5##(2007-4#1)(2009-7#1)
the effects of genes##3##4##(1997-7#2)(2012-3#1)
the effects of genetic##2##4##(2010-4#1)(2013-1#1)
the effects of glucocorticoids##2##4##(1994-9#1)(2008-9#1)
the effects of glutamate##2##4##(1996-12#1)(2008-7#1)
the effects of grazing##2##4##(2008-12#1)(2010-2#1)
the effects of growth hormone##2##5##(1997-8#1)(2010-5#1)
the effects of health care##2##5##(1993-12#2)
the effects of heat##2##4##(2008-7#1)(2013-8#1)
the effects of heavy##2##4##(2008-10#2)
the effects of herbivory on##2##5##(2008-8#1)(2008-9#1)
the effects of increasing##2##4##(1990-7#1)(2008-8#1)
the effects of indirubin-3-monoxime##2##4##(2008-10#2)
the effects of initial##3##4##(2008-10#3)
the effects of inoculum density##3##5##(2008-10#3)
the effects of inoculum##4##4##(2008-10#4)
the effects of intrastriatal##2##4##(1995-5#1)(1997-2#1)
the effects of lead##3##4##(1995-11#1)(1997-4#1)(2011-1#1)
the effects of light##2##4##(2008-10#1)(2008-3#1)
the effects of long-term##4##4##(1995-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
the effects of low doses of##2##6##(2008-7#1)(2013-1#1)
the effects of low##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
the effects of maternal##2##4##(1992-12#1)(2009-7#1)
the effects of music on##3##5##(1991-12#1)(2007-6#1)(2008-5#1)
the effects of mutations in##2##5##(2007-12#1)(2010-4#1)
the effects of natural perturbations##2##5##(2008-10#2)
the effects of natural##3##4##(2008-10#2)(2013-1#1)
the effects of noise##2##4##(2008-3#2)
the effects of noncompliance##2##4##(2007-11#2)
the effects of nonlinear polarization##2##5##(2007-12#2)
the effects of optical##2##4##(2008-2#1)(2008-3#1)
the effects of other##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the effects of pH##5##4##(1991-5#1)(2008-10#4)
the effects of perceived##2##4##(2009-7#1)(2010-2#1)
the effects of pharmacological##2##4##(1994-10#1)(2008-7#1)
the effects of physical activity##3##5##(2012-12#1)(2013-1#2)
the effects of physical##4##4##(2008-9#1)(2012-12#1)(2013-1#2)
the effects of pollution in Elazig##2##6##(2013-8#2)
the effects of prenatal WIC participation and the use of prenatal care##2##12##(1993-3#2)
the effects of prenatal##5##4##(1993-3#2)(2008-2#1)(2011-2#1)(2012-2#1)
the effects of pretreatment of##2##5##(1990-11#1)(1992-6#1)
the effects of prior##2##4##(2008-10#1)(2008-11#1)
the effects of repeated##2##4##(2011-2#1)(2013-1#1)
the effects of salt##2##4##(2009-12#1)(2012-2#1)
the effects of sample##3##4##(1995-1#1)(2008-10#1)(2009-10#1)
the effects of scattering##2##4##(2008-2#1)(2008-3#1)
the effects of selective##2##4##(2008-10#1)(2010-1#1)
the effects of several##5##4##(1992-3#1)(1995-2#1)(2008-10#1)(2011-2#1)(2012-5#1)
the effects of single and##2##5##(1993-3#1)(2012-1#1)
the effects of social##2##4##(2008-1#1)(2010-1#1)
the effects of solvent and##2##5##(2008-10#2)
the effects of spatial##2##4##(2008-10#1)(2008-8#1)
the effects of specific##4##4##(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
the effects of stress##3##4##(2008-5#1)(2008-6#1)(2008-7#1)
the effects of such##2##4##(2008-3#1)(2010-11#1)
the effects of temperature and##3##5##(1997-2#1)(2008-9#1)(2010-8#1)
the effects of temperature on the##2##6##(1991-11#1)(1991-5#1)
the effects of temperature on##3##5##(1991-11#1)(1991-5#1)(2008-10#1)
the effects of temperature##8##4##(1991-11#1)(1991-5#1)(1997-2#1)(2008-10#2)(2008-9#1)(2010-4#1)(2010-8#1)
the effects of the absence of##2##6##(1992-1#1)(2008-11#1)
the effects of the atmosphere##2##5##(2008-3#2)
the effects of the drug##2##5##(1990-3#1)(2008-11#1)
the effects of the finite##2##5##(2008-2#2)
the effects of the interaction of##2##6##(2008-2#1)(2013-7#1)
the effects of the mutations##2##5##(1991-10#1)(1997-2#1)
the effects of the treatment##2##5##(1995-12#1)(2012-2#1)
the effects of the##85##4##(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-2#5)(2008-3#12)(2008-5#4)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
the effects of therapy##2##4##(1996-2#1)(2012-2#1)
the effects of these agents on##2##6##(2008-8#1)(2012-2#1)
the effects of these changes##2##5##(2008-6#1)(2010-2#1)
the effects of these mutations##2##5##(1993-3#1)(2008-11#1)
the effects of these substitutions on the##2##7##(1994-8#1)(1995-2#1)
the effects of these two##3##5##(1990-7#1)(1992-2#1)(2008-3#1)
the effects of these variables##2##5##(2008-4#2)
the effects of these##26##4##(1990-7#1)(1992-2#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#2)(2010-2#1)(2011-2#1)(2012-2#1)
the effects of this##9##4##(1991-2#2)(1997-6#1)(2007-11#1)(2008-3#2)(2008-8#1)(2012-12#1)(2013-7#1)
the effects of three##2##4##(2008-11#1)(2011-1#1)
the effects of tillage practices on##2##6##(2008-10#2)
the effects of timing and##2##5##(2008-10#1)(2008-12#1)
the effects of two factors##2##5##(2008-10#2)
the effects of two novel##2##5##(2007-11#2)
the effects of two##11##4##(1993-1#1)(1994-12#1)(1994-5#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
the effects of unilateral##2##4##(1997-2#1)(2008-7#1)
the effects of various cationic##2##5##(2008-10#2)
the effects of various factors on##2##6##(2008-5#1)(2013-8#1)
the effects of various##11##4##(1991-2#1)(1992-1#1)(1992-6#1)(1994-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-8#1)
the effects of varying##4##4##(2008-10#2)(2008-5#1)(2011-2#1)
the effects of vitamin##2##4##(2008-1#1)(2011-1#1)
the effects of##1065##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#5)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#2)(1991-5#7)(1991-6#1)(1991-9#5)(1992-1#6)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#7)(1992-8#7)(1992-9#2)(1993-1#5)(1993-11#6)(1993-12#9)(1993-3#11)(1993-5#2)(1993-6#3)(1993-8#5)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#7)(1994-6#5)(1994-8#7)(1994-9#5)(1995-1#2)(1995-11#9)(1995-12#16)(1995-2#9)(1995-3#6)(1995-5#8)(1995-8#2)(1995-9#1)(1996-12#8)(1996-2#11)(1996-3#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#8)(1997-8#4)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#18)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#2)(2008-1#7)(2008-10#128)(2008-11#50)(2008-12#18)(2008-2#32)(2008-3#71)(2008-4#17)(2008-5#39)(2008-6#13)(2008-7#28)(2008-8#28)(2008-9#24)(2009-10#5)(2009-11#5)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#10)(2009-8#4)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#5)(2010-4#10)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#6)(2011-1#12)(2011-10#2)(2011-2#29)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#12)(2012-2#22)(2012-3#21)(2012-5#2)(2012-7#1)(2013-1#37)(2013-7#9)(2013-8#14)
the effects on the##6##4##(1992-6#1)(2008-5#2)(2010-4#1)(2011-3#2)
the effects on##37##3##(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-4#1)(2013-1#1)
the effects that##3##3##(1991-2#1)(2008-10#2)
the effects were more##2##4##(2008-10#1)(2010-2#1)
the effects were##6##3##(1991-1#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-4#1)(2010-2#1)
the effects##1159##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#5)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#6)(1991-3#2)(1991-5#8)(1991-6#2)(1991-8#1)(1991-9#5)(1992-1#6)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#8)(1992-8#7)(1992-9#2)(1993-1#5)(1993-11#6)(1993-12#12)(1993-3#11)(1993-5#2)(1993-6#4)(1993-8#5)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#7)(1994-12#3)(1994-2#6)(1994-3#6)(1994-5#8)(1994-6#5)(1994-8#9)(1994-9#5)(1995-1#2)(1995-11#9)(1995-12#17)(1995-2#12)(1995-3#6)(1995-5#8)(1995-8#2)(1995-9#1)(1996-12#9)(1996-2#12)(1996-3#4)(1996-5#8)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#8)(1997-8#4)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#21)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#2)(2008-1#7)(2008-10#141)(2008-11#53)(2008-12#20)(2008-2#34)(2008-3#76)(2008-4#19)(2008-5#42)(2008-6#14)(2008-7#30)(2008-8#28)(2008-9#25)(2009-10#6)(2009-11#6)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#10)(2009-8#4)(2009-9#6)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#7)(2010-4#11)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#6)(2011-1#13)(2011-10#2)(2011-2#32)(2011-3#4)(2011-7#1)(2012-1#4)(2012-12#12)(2012-2#23)(2012-3#22)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#39)(2013-7#9)(2013-8#14)
the efferent vessel##2##3##(2008-7#2)
the efferent##7##2##(1992-3#1)(1994-2#1)(1997-3#1)(2008-4#1)(2008-7#3)
the efficacy and safety of##9##5##(1993-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
the efficacy and safety##11##4##(1993-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-1#1)
the efficacy and tolerability of##2##5##(2008-3#1)(2011-2#1)
the efficacy and tolerance of##3##5##(2008-10#1)(2008-5#1)(2010-3#1)
the efficacy and tolerance##4##4##(1996-6#1)(2008-10#1)(2008-5#1)(2010-3#1)
the efficacy and toxicity of a##2##6##(1990-2#1)(2007-10#1)
the efficacy and toxicity of##3##5##(1990-2#1)(2007-10#1)(2008-6#1)
the efficacy and##29##3##(1990-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-8#1)(1996-6#1)(2007-10#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2011-2#2)(2013-1#3)
the efficacy and/or##2##3##(1990-2#1)(2008-3#1)
the efficacy of ASRC##2##4##(1996-12#2)
the efficacy of a new##3##5##(1997-8#1)(2008-10#1)(2012-3#1)
the efficacy of a##20##4##(1995-2#1)(1996-5#1)(1997-2#1)(1997-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2012-3#3)(2013-1#2)
the efficacy of acute##2##4##(1992-9#1)(2007-9#1)
the efficacy of an alternative##2##5##(1993-5#1)(2012-12#1)
the efficacy of an##3##4##(1993-5#1)(2008-5#1)(2012-12#1)
the efficacy of cosmetics##2##4##(2008-5#2)
the efficacy of drug##2##4##(2009-12#1)(2012-2#1)
the efficacy of four##2##4##(1995-3#1)(2008-10#1)
the efficacy of intra##2##4##(2007-11#1)(2012-2#1)
the efficacy of preservatives##2##4##(2008-5#2)
the efficacy of prophylactic##2##4##(1994-2#1)(2010-7#1)
the efficacy of resistance elicitors##2##5##(2008-10#2)
the efficacy of resistance##3##4##(2008-10#2)(2011-2#1)
the efficacy of self-tanning##2##4##(2008-5#2)
the efficacy of soil##2##4##(2008-10#2)
the efficacy of surgical##2##4##(2012-1#1)(2013-1#1)
the efficacy of the treatment##2##5##(2012-3#1)(2013-8#1)
the efficacy of the##33##4##(1991-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
the efficacy of therapeutic##2##4##(2007-12#1)(2010-2#1)
the efficacy of these##3##4##(2008-10#1)(2008-11#1)(2010-5#1)
the efficacy of this##5##4##(1997-4#1)(2007-8#1)(2008-3#1)(2009-12#2)
the efficacy of treatment##5##4##(1994-5#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
the efficacy of various##2##4##(2006-10#1)(2008-2#1)
the efficacy of##239##3##(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#28)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#22)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#10)(2013-1#16)(2013-7#2)(2013-8#4)
the efficacy or##2##3##(2008-5#1)(2012-3#1)
the efficacy profile of sunscreens##2##5##(2008-5#2)
the efficacy##290##2##(1990-2#3)(1990-3#2)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#34)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#28)(2008-6#7)(2008-7#12)(2008-8#11)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#16)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#11)(2013-1#20)(2013-7#2)(2013-8#4)
the efficiencies of##3##3##(1996-3#1)(2008-3#1)(2008-8#1)
the efficiency and stability of##2##5##(2008-3#1)(2012-12#1)
the efficiency and##16##3##(1997-1#1)(1997-2#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
the efficiency of a##5##4##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
the efficiency of different##2##4##(2008-10#1)(2008-3#1)
the efficiency of extraction##2##4##(2008-10#2)
the efficiency of the health##2##5##(1992-2#1)(1996-12#1)
the efficiency of the method##3##5##(2008-2#2)(2008-3#1)
the efficiency of the##34##4##(1992-2#1)(1992-9#1)(1994-9#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#3)(2011-1#1)(2012-8#1)
the efficiency of this##4##4##(1994-5#1)(2007-12#1)(2008-10#1)(2009-10#1)
the efficiency of transmission##3##4##(2007-11#1)(2008-10#2)
the efficiency of##127##3##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-5#2)(1994-9#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#4)(2008-10#29)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#3)(2013-7#1)
the efficiency##167##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#2)(1994-12#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#6)(2007-12#10)(2007-9#1)(2008-10#34)(2008-11#7)(2008-12#6)(2008-2#8)(2008-3#15)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#4)(2013-7#1)
the efficient and##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
the efficient delivery of##2##4##(2008-11#1)(2010-10#1)
the efficient operation of a##2##5##(2008-2#2)
the efficient use of##4##4##(1992-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
the efficient##27##2##(1992-12#1)(1992-2#1)(2008-10#7)(2008-11#3)(2008-2#5)(2008-3#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
the effluent at##2##3##(2008-10#1)(2008-7#1)
the effluent of##3##3##(2008-10#2)(2013-1#1)
the effluent##17##2##(1994-6#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-7#2)(2013-1#1)
the efflux of##4##3##(1990-11#1)(1992-7#1)(1993-12#1)(1994-8#1)
the efflux##5##2##(1990-11#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-8#1)
the effort of##2##3##(1991-3#1)(2008-10#1)
the effort to##8##3##(1993-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
the effort##17##2##(1991-3#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-9#3)(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
the efforts by the##2##4##(1991-6#1)(1993-12#1)
the efforts of the##3##4##(1992-1#1)(1994-9#1)(1996-1#1)
the efforts of##6##3##(1992-1#2)(1994-9#1)(1995-3#1)(1996-1#1)(2012-2#1)
the efforts to##7##3##(1991-1#1)(1993-3#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-12#1)(2012-3#1)
the efforts##18##2##(1991-1#1)(1991-6#1)(1992-1#2)(1993-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-2#1)(2012-3#1)
the egg capsule##2##3##(2008-12#2)
the egg cell and##2##4##(2008-11#1)(2008-9#1)
the egg cell##4##3##(1991-5#1)(2008-11#1)(2008-8#1)(2008-9#1)
the egg jelly##3##3##(1992-8#2)(1994-11#1)
the egg maturation rate##2##4##(2008-9#2)
the egg shell/lipid layer##2##4##(2008-10#2)
the egg stage##2##3##(1990-3#1)(2008-8#1)
the egg##38##2##(1990-3#1)(1991-5#2)(1992-8#2)(1993-6#1)(1994-11#1)(1997-6#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#4)(2008-12#5)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#6)(2010-2#1)(2011-2#1)
the eggs of##2##3##(2008-10#1)(2009-2#1)
the eggs##15##2##(1993-6#1)(1995-2#1)(1995-3#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-10#3)(2010-8#1)(2012-12#1)
the egl1 gene##3##3##(2008-10#3)
the eigenmodes##3##2##(2007-11#2)(2008-3#1)
the eigenvalue##4##2##(2008-3#4)
the eigenvalues##2##2##(2008-2#1)(2008-3#1)
the eigenvectors##5##2##(2007-12#2)(2008-2#2)(2009-9#1)
the eight Ac##2##3##(2012-3#2)
the eight key issues in##2##5##(1992-3#2)
the eight races##3##3##(2008-10#3)
the eight##36##2##(1991-12#1)(1992-3#2)(1993-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#2)(2007-11#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)
the eight-channel condition##2##3##(2008-9#2)
the eighteen##2##2##(2012-3#2)
the eighteenth century##2##3##(2008-10#1)(2010-5#1)
the eighteenth##3##2##(2008-10#1)(2010-1#1)(2010-5#1)
the eighth day##4##3##(1994-3#1)(2007-12#1)(2008-5#1)(2011-2#1)
the eighth in a series on##2##6##(1992-2#1)(2008-3#1)
the eighth##13##2##(1992-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#3)(2013-1#1)
the ejaculatory duct lumen##2##4##(2008-7#2)
the ejaculatory duct##5##3##(2008-7#5)
the ejaculatory##8##2##(1997-8#3)(2008-7#5)
the ejection fraction and the cardiac index##2##7##(1993-2#2)
the ejection fraction and##3##4##(1993-2#2)(2009-5#1)
the ejection fraction##6##3##(1990-9#1)(1993-2#2)(2008-7#2)(2009-5#1)
the ejection##10##2##(1990-9#2)(1993-2#2)(1994-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-5#1)
the elaboration and##2##3##(2008-5#1)(2008-9#1)
the elaboration of##10##3##(1996-2#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)
the elaboration##13##2##(1996-2#1)(2008-10#3)(2008-2#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)
the elastic and viscous##2##4##(2008-5#2)
the elastic modulus of##2##4##(1996-12#1)(2010-8#1)
the elastic modulus##5##3##(1996-12#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-2#1)
the elastic properties of##3##4##(2008-10#1)(2009-7#1)(2010-4#1)
the elastic properties##4##3##(2008-10#1)(2009-7#2)(2010-4#1)
the elastic##19##2##(1992-7#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-5#1)(2009-7#3)(2010-4#3)(2010-8#1)(2012-2#1)
the elastically scattered irradiances##2##4##(2008-3#2)
the elasticity of the##2##4##(2007-7#1)(2008-5#1)
the elasticity of##3##3##(2007-7#1)(2008-5#1)(2009-4#1)
the elasticity##6##2##(2007-7#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-8#1)
the elastin##2##2##(1990-8#1)(2008-5#1)
the elbow##15##2##(1992-5#1)(1995-6#1)(2008-1#3)(2008-12#1)(2008-8#1)(2008-9#6)(2010-11#1)(2013-1#1)
the elderly and their##2##4##(1992-3#1)(2011-1#1)
the elderly and##19##3##(1991-3#1)(1992-3#1)(1994-6#4)(1995-1#1)(1996-1#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-7#2)(2011-1#2)(2012-3#1)(2013-1#1)
the elderly are discussed##3##4##(1994-12#1)(1995-2#1)(2008-2#1)
the elderly are##9##3##(1990-11#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
the elderly in the##2##4##(2007-11#1)(2013-8#1)
the elderly in##13##3##(1991-2#1)(1993-3#1)(1995-5#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the elderly is##2##3##(2008-2#1)(2009-1#1)
the elderly living##2##3##(2008-7#2)
the elderly patient##6##3##(1990-11#1)(1992-3#1)(1993-11#1)(1996-3#1)(2008-4#1)(2008-8#1)
the elderly people##3##3##(2010-8#1)(2011-1#2)
the elderly population##20##3##(1991-3#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
the elderly were##3##3##(1994-1#1)(1995-8#1)(2009-7#1)
the elderly with##4##3##(1991-2#1)(1991-6#1)(2008-7#2)
the elderly##238##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-6#3)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#6)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#4)(1993-9#1)(1994-1#7)(1994-12#5)(1994-5#2)(1994-6#9)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#2)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#2)(2006-10#4)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#35)(2008-8#11)(2008-9#2)(2009-1#3)(2009-10#1)(2009-12#3)(2009-5#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#8)(2011-7#1)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#2)
the elderly]##10##2##(1990-10#1)(1990-3#1)(1990-6#1)(1992-6#2)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(2008-4#1)
the elected##2##2##(1991-1#1)(2008-6#1)
the elective##2##2##(1991-6#1)(1997-2#1)
the electorate##2##2##(1991-1#1)(1997-3#1)
the electric current##3##3##(2008-10#1)(2013-1#2)
the electric field by##2##4##(2008-3#2)
the electric field in the##2##5##(2008-3#2)
the electric field inside##2##4##(2007-11#1)(2008-3#1)
the electric field of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
the electric field of##6##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)
the electric field##31##3##(1990-12#1)(1990-7#1)(1996-12#1)(2007-11#4)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#11)(2013-8#1)
the electric fields##2##3##(2007-11#1)(2009-12#1)
the electric##42##2##(1990-12#1)(1990-7#1)(1996-12#1)(2007-11#5)(2007-12#6)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#11)(2008-7#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
the electric-field##2##2##(2007-12#1)(2008-2#1)
the electric-field-induced reorientation of##2##4##(2007-12#2)
the electrical activity of##3##4##(1994-2#1)(1996-2#1)(2010-8#1)
the electrical activity signals of the heart##3##7##(2010-8#3)
the electrical activity##6##3##(1994-2#1)(1996-2#1)(2010-8#4)
the electrical and##2##3##(2008-2#1)(2010-8#1)
the electrical current and##2##4##(2008-3#1)(2009-10#1)
the electrical or##2##3##(1995-2#1)(2008-7#1)
the electrical stimulus##2##3##(2009-8#1)(2012-12#1)
the electrical##35##2##(1990-11#1)(1990-5#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#3)(2010-8#6)(2012-12#1)(2012-3#1)(2013-1#1)
the electrically##8##2##(1990-5#2)(1995-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
the electro##2##2##(2008-10#1)(2012-2#1)
the electro-optic crystal##3##3##(2007-11#1)(2008-3#2)
the electro-optic effect##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
the electro-optic##13##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#4)
the electro-optical##2##2##(2008-2#1)(2008-3#1)
the electro-reduction of the product of the enzyme-catalyzed reaction have been##2##11##(2008-10#2)
the electro-reduction##3##2##(2008-10#3)
the electroactive##7##2##(2008-10#6)(2008-5#1)
the electroanalytical##4##2##(2008-10#4)
the electrocardiogram##9##2##(1994-6#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
the electrocatalytic effect of##2##4##(2008-10#1)(2010-5#1)
the electrocatalytic oxidation of##2##4##(2008-10#2)
the electrocatalytic process##2##3##(2008-10#2)
the electrocatalytic reduction of##2##4##(2008-10#2)
the electrocatalytic##9##2##(2008-10#8)(2010-5#1)
the electrocautery##2##2##(1994-12#2)
the electrochemical behavior of the##2##5##(2008-10#2)
the electrochemical behavior of##6##4##(2008-10#5)(2010-6#1)
the electrochemical detection of##3##4##(2008-10#1)(2008-12#2)
the electrochemical detection##6##3##(1993-1#1)(2008-10#3)(2008-12#2)
the electrochemical determination of##5##4##(2008-10#5)
the electrochemical hydride generation##4##4##(2008-10#4)
the electrochemical oxidation of##4##4##(2008-10#4)
the electrochemical reaction##2##3##(1990-12#1)(2008-10#1)
the electrochemical reduction of##3##4##(2008-10#3)
the electrochemical response of##2##4##(2008-10#2)
the electrochemical response##6##3##(2008-10#6)
the electrochemical##59##2##(1990-12#1)(1991-8#1)(1993-1#1)(1996-2#1)(2008-10#49)(2008-12#2)(2008-8#2)(2010-2#1)(2010-6#1)
the electrochemically##6##2##(2008-10#5)(2009-12#1)
the electrochemiluminescence##2##2##(2008-10#2)
the electrochemistry of##2##3##(2008-10#2)
the electrode and##9##3##(1990-5#1)(2008-10#6)(2008-12#1)(2008-9#1)
the electrode as##2##3##(2007-11#1)(2008-9#1)
the electrode based on##3##4##(2008-10#3)
the electrode by##5##3##(1995-6#1)(2008-10#4)
the electrode can be used##2##5##(2008-10#2)
the electrode can be##4##4##(2008-10#4)
the electrode can##5##3##(2008-10#5)
the electrode exhibited good selectivity##2##5##(2008-10#2)
the electrode exhibited##4##3##(2008-10#4)
the electrode has##2##3##(2008-10#2)
the electrode in a##2##4##(2008-10#2)
the electrode in the##2##4##(2008-10#2)
the electrode in##7##3##(2008-10#7)
the electrode is##6##3##(2008-10#6)
the electrode materials##2##3##(2008-10#2)
the electrode membrane##3##3##(2008-10#3)
the electrode performance##2##3##(2008-10#2)
the electrode potential and##2##4##(2008-10#2)
the electrode potential is##2##4##(2008-10#2)
the electrode potential##7##3##(2008-10#7)
the electrode prepared##3##3##(2008-10#3)
the electrode process was##2##4##(2008-10#2)
the electrode process##3##3##(2008-10#3)
the electrode reaction was##2##4##(2008-10#2)
the electrode response##8##3##(2008-10#8)
the electrode responses##2##3##(2008-10#2)
the electrode selectivity##2##3##(2008-10#2)
the electrode shows##2##3##(2008-10#2)
the electrode surface and##5##4##(2008-10#5)
the electrode surface by##3##4##(2008-10#3)
the electrode surface such that##2##5##(2008-10#2)
the electrode surface was##2##4##(2008-10#2)
the electrode surface##50##3##(2008-10#49)(2009-12#1)
the electrode system##2##3##(2008-3#2)
the electrode to##2##3##(2008-10#1)(2008-3#1)
the electrode was##19##3##(2008-10#18)(2008-9#1)
the electrode were##3##3##(2008-10#3)
the electrode with##3##3##(2008-10#3)
the electrode wrapping angle##2##4##(2008-2#2)
the electrode##234##2##(1990-5#1)(1995-6#1)(2007-11#1)(2008-10#209)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#2)(2008-9#11)(2009-12#1)(2010-2#1)
the electrode's position##2##3##(2008-9#1)(2010-8#1)
the electrodeposited##3##2##(2008-10#3)
the electrodeposition of##2##3##(2008-10#2)
the electrodeposition##4##2##(2008-10#4)
the electrodes are##8##3##(2008-10#7)(2013-1#1)
the electrodes based on##2##4##(2008-10#2)
the electrodes on the##2##4##(2008-3#2)
the electrodes were##5##3##(2008-10#4)(2008-9#1)
the electrodes##46##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#32)(2008-3#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#1)(2013-1#1)
the electroencephalogram##2##2##(2009-8#1)(2011-2#1)
the electrogenerated##2##2##(2008-10#2)
the electrolyte##7##2##(2008-10#6)(2010-7#1)
the electrolytes##2##2##(2008-10#1)(2013-1#1)
the electrolytic chamber##2##3##(2008-10#2)
the electrolytic##6##2##(2007-12#1)(2008-10#5)
the electromagnetic fields##4##3##(2008-2#2)(2008-3#2)
the electromagnetic power##2##3##(2008-3#2)
the electromagnetic spectrum##4##3##(2008-2#2)(2010-5#1)(2012-12#1)
the electromagnetic wave theory##2##4##(2008-3#2)
the electromagnetic wave##3##3##(2007-11#1)(2008-3#2)
the electromagnetic wavelets##2##3##(2008-2#2)
the electromagnetic##26##2##(2007-11#2)(2007-12#2)(2008-2#9)(2008-3#9)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
the electromyographic activity of the##3##5##(2010-6#1)(2010-9#2)
the electromyographic signal##2##3##(2010-6#1)(2010-9#1)
the electromyographic##7##2##(2008-10#1)(2008-9#1)(2010-6#2)(2010-9#3)
the electron density##2##3##(2007-12#1)(2008-9#1)
the electron impact##2##3##(2008-10#2)
the electron injection##3##3##(2008-10#3)
the electron microscope##6##3##(1997-3#1)(2008-10#3)(2008-7#2)
the electron microscopic level##3##4##(1991-9#1)(1995-3#1)(2008-7#1)
the electron paramagnetic resonance (EPR)##2##5##(1990-2#1)(2008-8#1)
the electron phase space beam model##2##6##(2009-11#2)
the electron spin resonance technique##2##5##(2008-10#1)(2008-8#1)
the electron spin resonance##3##4##(2008-10#2)(2008-8#1)
the electron transfer between##2##4##(2008-10#2)
the electron transfer was##2##4##(2008-10#2)
the electron transfer##12##3##(1991-12#1)(1991-8#1)(2008-10#8)(2008-8#1)(2009-9#1)
the electron##55##2##(1990-2#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-4#1)(2007-12#2)(2007-6#1)(2008-10#25)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#2)(2009-7#1)(2009-9#1)(2011-1#1)
the electron-phonon coupling factor##3##4##(2008-3#3)
the electron-phonon coupling##4##3##(1990-4#1)(2008-3#3)
the electron-phonon##5##2##(1990-4#1)(2008-3#3)(2012-2#1)
the electron-transfer##5##2##(1990-5#1)(1995-2#1)(2008-10#3)
the electron-withdrawing##2##2##(1992-6#1)(1996-5#1)
the electronic absorption##2##3##(2008-10#2)
the electronic coupling between##2##4##(1995-2#1)(2008-10#1)
the electronic coupling##6##3##(1995-2#2)(2008-10#1)(2010-2#2)(2012-2#1)
the electronic health##2##3##(1994-2#1)(1996-12#1)
the electronic medical record##2##4##(1993-12#1)(1994-3#1)
the electronic medical##3##3##(1993-12#1)(1994-3#1)(2012-3#1)
the electronic patient record##2##4##(1997-1#2)
the electronic structure of##2##4##(1993-11#1)(2010-7#1)
the electronic structure##3##3##(1993-11#1)(2007-11#1)(2010-7#1)
the electronic tongue##2##3##(2008-10#2)
the electronic##50##2##(1990-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1996-12#2)(1996-2#1)(1997-1#2)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#4)(2008-9#1)(2009-11#2)(2009-6#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)
the electronics##5##2##(2008-10#2)(2008-3#2)(2008-5#1)
the electrons##5##2##(2008-3#2)(2008-7#2)(2012-2#1)
the electroosmotic flow (EOF)##3##4##(1997-2#1)(2008-10#2)
the electroosmotic flow##5##3##(1994-9#1)(1996-5#1)(1997-2#1)(2008-10#2)
the electrophoresis##2##2##(2008-10#1)(2009-8#1)
the electrophoretic mobilities of the##2##5##(1990-7#1)(2008-10#1)
the electrophoretic mobility of the##2##5##(1994-11#1)(2008-10#1)
the electrophoretic mobility of##3##4##(1992-6#1)(1994-11#1)(2008-10#1)
the electrophoretic mobility##4##3##(1992-6#1)(1994-11#1)(1994-9#1)(2008-10#1)
the electrophoretic##12##2##(1990-7#1)(1992-6#1)(1994-11#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)
the electrophysiological and##2##3##(2008-11#1)(2008-9#1)
the electrophysiological##5##2##(1990-9#1)(1993-8#1)(2008-11#1)(2008-9#1)(2013-1#1)
the electropolymerization of pyrrole##2##4##(2008-10#2)
the electropolymerization of##4##3##(2008-10#4)
the electropolymerization##8##2##(2008-10#8)
the electroporation of##3##3##(2008-1#1)(2008-11#1)(2008-2#1)
the electrospray##2##2##(1997-2#1)(2008-10#1)
the electrospun##2##2##(2008-5#1)(2009-7#1)
the electrostatic contribution##2##3##(2008-4#1)(2008-7#1)
the electrostatic field##2##3##(2008-10#1)(2008-2#1)
the electrostatic force##2##3##(2008-10#2)
the electrostatic interaction between##3##4##(2008-5#1)(2012-6#1)(2013-1#1)
the electrostatic potential##2##3##(1992-3#1)(2009-5#1)
the electrostatic##24##2##(1990-12#1)(1992-3#1)(1994-5#2)(2007-11#1)(2008-10#7)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-5#2)(2012-6#1)(2013-1#2)
the electrostrictive response##2##3##(2007-12#2)
the electrostrictive##4##2##(2007-12#4)
the electrothermal atomic absorption spectrometric##2##5##(2008-10#2)
the electrothermal atomic absorption##3##4##(2008-10#3)
the electrothermal atomizer##3##3##(2008-10#3)
the electrothermal##6##2##(2008-10#6)
the element##16##2##(1990-3#1)(1995-2#1)(1995-8#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2009-6#1)
the elemental analysis of##2##4##(2008-10#2)
the elemental analysis##3##3##(2008-10#3)
the elemental composition of##4##4##(2008-10#3)(2012-2#1)
the elemental##18##2##(1993-6#1)(2007-11#1)(2008-10#14)(2012-2#1)(2013-7#1)
the elementary events underlying force generation##2##6##(2012-2#2)
the elementary##3##2##(2007-12#1)(2012-2#2)
the elements and##4##3##(1997-1#1)(2008-10#2)(2013-1#1)
the elements in the##3##4##(2008-10#2)(2008-2#1)
the elements in##5##3##(2008-10#4)(2008-2#1)
the elements investigated##2##3##(2008-10#2)
the elements involved in##2##4##(1993-12#1)(1993-2#1)
the elements of a successful##2##5##(1993-2#1)(1997-2#1)
the elements of a##3##4##(1993-2#1)(1997-2#1)(2007-12#1)
the elements of the##7##4##(2007-8#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#2)
the elements of##21##3##(1993-2#1)(1994-12#1)(1994-3#2)(1996-12#1)(1996-9#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#2)(2013-7#1)
the elements studied##2##3##(2008-10#2)
the elements that##2##3##(2008-10#1)(2013-1#1)
the elements##74##2##(1993-12#2)(1993-2#2)(1994-12#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#39)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
the elevated blood pressure##2##4##(1997-5#2)
the elevated blood##3##3##(1992-5#1)(1997-5#2)
the elevated levels of##2##4##(1990-8#1)(2011-2#1)
the elevated plus-maze and the shock-probe burying tests##2##8##(1993-3#2)
the elevated plus-maze test##5##4##(1993-3#2)(2008-11#1)(2013-1#2)
the elevated plus-maze##10##3##(1992-7#1)(1993-3#4)(2008-11#3)(2013-1#2)
the elevated##31##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-5#1)(1992-7#1)(1993-3#4)(1995-12#1)(1995-5#1)(1997-5#2)(2007-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#4)(2013-1#4)(2013-8#1)
the elevation angle##2##3##(2008-3#2)
the elevation of blood##2##4##(2009-7#1)(2010-11#1)
the elevation of the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
the elevation of##13##3##(1995-6#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
the elevation##16##2##(1995-6#1)(1997-2#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2009-1#1)(2009-7#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
the eleven##4##2##(1992-11#1)(1992-3#1)(1996-2#1)(2008-10#1)
the elicitation of dilemmas##2##4##(2008-8#2)
the elicitation of##3##3##(2008-4#1)(2008-8#2)
the elicitation##5##2##(2008-10#2)(2008-4#1)(2008-8#2)
the elicitin family##2##3##(2008-10#2)
the eligibility##2##2##(1997-2#1)(2013-1#1)
the elimination of the##5##4##(1991-3#1)(1993-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
the elimination of##29##3##(1990-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-1#1)
the elimination##33##2##(1990-11#2)(1991-3#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#6)(2013-1#2)
the elite level##3##3##(2007-11#3)
the elite##5##2##(2007-11#4)(2011-2#1)
the ellipsoids##2##2##(1997-3#1)(2008-3#1)
the ellipsometer##2##2##(2008-3#2)
the ellipsometric parameters##3##3##(2008-2#2)(2008-3#1)
the ellipsometric##7##2##(2008-2#2)(2008-3#5)
the elliptic##2##2##(2007-11#1)(2008-5#1)
the elliptical##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
the ellipticity##6##2##(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#3)
the elongate##2##2##(2007-12#1)(2008-6#1)
the elongated##8##2##(1994-5#1)(1994-8#2)(1995-2#1)(1997-6#1)(2007-12#1)(2009-8#1)(2011-2#1)
the elongating##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
the elongation of the##3##4##(2007-11#1)(2011-2#1)(2012-2#1)
the elongation of##4##3##(2007-11#1)(2011-2#1)(2012-2#2)
the elongation##7##2##(1990-5#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
the eluant##3##2##(2008-10#3)
the eluate was evaporated##2##4##(2008-10#2)
the eluate was##5##3##(1990-8#1)(2008-10#4)
the eluate##12##2##(1990-8#2)(1991-5#1)(1992-9#1)(1994-12#1)(2008-10#7)
the elucidation of the##5##4##(1994-10#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-8#1)
the elucidation of##11##3##(1994-10#1)(1997-8#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-1#1)(2011-2#2)(2013-8#1)
the eluent##17##2##(1995-6#1)(2008-10#15)(2008-7#1)
the elusive##3##2##(1991-12#1)(1997-2#1)(2008-10#1)
the eluted##3##2##(2008-10#3)
the eluting##3##2##(2008-10#3)
the elution of the##2##4##(1990-8#1)(2008-7#1)
the elution of##9##3##(1990-8#1)(1991-12#1)(2008-10#5)(2008-4#1)(2008-7#1)
the elution order of##2##4##(2008-10#2)
the elution##23##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1996-5#1)(2008-10#14)(2008-4#1)(2008-7#1)
the embargo##3##2##(1996-11#3)
the embedded##4##2##(2008-10#2)(2008-11#1)(2009-8#1)
the embolization##6##2##(1991-2#1)(2007-8#1)(2008-7#3)(2012-12#1)
the embryo implantation##2##3##(2008-9#1)(2013-1#1)
the embryo sac##6##3##(2008-11#2)(2008-4#1)(2009-8#3)
the embryo to##3##3##(1995-3#1)(2007-12#1)(2008-11#1)
the embryo##40##2##(1991-5#1)(1993-12#1)(1994-12#1)(1994-9#2)(1995-3#1)(2007-12#8)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#4)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
the embryo-larval stages of##2##4##(1996-2#2)
the embryo-larval stages##3##3##(1996-2#3)
the embryology##2##2##(2008-11#1)(2008-12#1)
the embryonal##4##2##(1993-6#1)(1994-11#1)(2008-11#1)(2009-8#1)
the embryonic and##2##3##(2008-10#1)(2012-12#1)
the embryonic brain of the grasshopper Schistocerca gregaria##2##8##(2007-12#2)
the embryonic brain##7##3##(1997-6#1)(2007-12#6)
the embryonic development of##2##4##(2008-6#1)(2010-5#1)
the embryonic development##3##3##(2008-6#1)(2010-5#1)(2012-12#1)
the embryonic stage##3##3##(1990-5#1)(2008-5#1)(2008-8#1)
the embryonic zebrafish model##2##4##(2008-8#2)
the embryonic##33##2##(1990-5#1)(1993-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-12#9)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#2)(2010-5#1)(2012-12#4)
the embryos##6##2##(1991-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2010-8#1)
the emergence and##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
the emergence of a new##4##5##(1994-1#1)(1994-12#1)(2008-10#1)(2013-1#1)
the emergence of a##7##4##(1994-1#1)(1994-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2013-1#1)
the emergence of drug-resistant##3##4##(1991-4#1)(2011-3#1)(2013-1#1)
the emergence of new##2##4##(2008-10#1)(2008-11#1)
the emergence of novel##2##4##(2009-6#1)(2011-9#1)
the emergence of the##3##4##(2008-6#1)(2013-8#2)
the emergence of women's health centers has been a nationally growing trend##2##12##(1994-3#2)
the emergence of##64##3##(1991-3#1)(1991-4#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#9)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
the emergence##73##2##(1991-3#1)(1991-4#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#9)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#5)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#3)
the emergency department (ED)##6##4##(2007-5#1)(2008-3#1)(2009-6#2)(2010-8#1)(2012-2#1)
the emergency department of##2##4##(2008-10#1)(2013-1#1)
the emergency department with cardiac magnetic resonance imaging##2##8##(2008-3#2)
the emergency department with cardiac magnetic resonance##3##7##(2008-3#3)
the emergency department with##14##4##(2007-10#1)(2007-5#2)(2008-3#7)(2009-9#2)(2011-2#1)(2013-1#1)
the emergency department##63##3##(1991-12#1)(2006-5#2)(2007-10#4)(2007-5#8)(2008-10#2)(2008-11#3)(2008-3#16)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
the emergency physician##2##3##(1994-3#2)
the emergency room for##3##4##(1995-11#1)(2011-2#1)(2013-1#1)
the emergency room##17##3##(1992-1#1)(1994-2#1)(1995-11#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
the emergency service of a##2##5##(1994-5#1)(1996-9#1)
the emergency service##3##3##(1994-5#1)(1996-9#1)(2007-8#1)
the emergency##112##2##(1991-12#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1996-2#1)(1996-9#1)(2006-5#4)(2007-10#5)(2007-12#4)(2007-5#11)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#4)(2008-3#18)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)
the emergent##7##2##(2008-10#1)(2008-2#1)(2010-1#2)(2011-2#1)(2012-12#2)
the emerging concept##2##3##(2008-7#1)(2010-1#1)
the emerging field of##5##4##(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2013-8#1)
the emerging field##6##3##(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-8#1)
the emerging health##2##3##(1995-12#1)(1997-3#1)
the emerging##40##2##(1991-2#1)(1992-2#1)(1995-12#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
the emission from##2##3##(2008-2#1)(2008-3#1)
the emission intensity##2##3##(2008-10#2)
the emission of a##2##4##(2007-11#1)(2008-10#1)
the emission of the##3##4##(2007-12#1)(2008-10#2)
the emission of##21##3##(1990-5#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
the emission spectra of##4##4##(1990-5#1)(2008-10#1)(2009-8#1)(2013-8#1)
the emission spectra##7##3##(1990-5#1)(2007-12#1)(2008-10#3)(2009-8#1)(2013-8#1)
the emission spectrum of##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
the emission spectrum##10##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2013-8#1)
the emission wavelength is##2##4##(2008-10#1)(2008-2#1)
the emission wavelength##6##3##(2008-10#5)(2008-2#1)
the emission##69##2##(1990-5#3)(1991-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#3)(2007-12#6)(2008-10#33)(2008-11#2)(2008-2#5)(2008-3#6)(2008-7#2)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#2)
the emissions##2##2##(2007-12#1)(2008-1#1)
the emissivities of vegetation##2##4##(2013-8#2)
the emissivities##3##2##(2013-8#3)
the emissivity is##2##3##(2008-3#2)
the emissivity of the##2##4##(2007-12#1)(2008-3#1)
the emissivity of##3##3##(2007-12#2)(2008-3#1)
the emissivity##8##2##(2007-12#2)(2008-2#1)(2008-3#5)
the emitted and##2##3##(2008-3#2)
the emitted light##2##3##(2008-10#1)(2012-12#1)
the emitted##13##2##(2007-11#2)(2008-10#4)(2008-2#2)(2008-3#4)(2012-12#1)
the emitter##2##2##(2007-12#1)(2008-3#1)
the emitting##4##2##(1995-6#1)(2007-11#1)(2008-2#1)(2012-2#1)
the emollient##2##2##(2008-5#2)
the emotion##2##2##(2007-8#1)(2012-12#1)
the emotional distress##2##3##(1991-12#1)(1995-9#1)
the emotional reactions of##2##4##(1993-11#1)(2008-2#1)
the emotional##15##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-9#1)(1997-1#1)(1997-4#1)(2008-11#2)(2008-2#1)(2011-1#1)(2012-12#2)(2013-1#1)
the emotionality of##2##3##(1993-3#1)(2010-10#1)
the emotionality##3##2##(1993-3#1)(2010-10#2)
the emotionally##2##2##(1997-1#1)(2013-1#1)
the emotions##7##2##(2008-11#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
the emphasis is on##2##4##(2007-5#1)(2012-2#1)
the emphasis is##3##3##(2007-5#1)(2010-5#1)(2012-2#1)
the emphasis##8##2##(1996-6#1)(1996-7#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)
the empirical data##2##3##(2008-2#2)
the empirical evidence for##2##4##(2008-10#1)(2010-4#1)
the empirical evidence##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
the empirical literature on the##2##5##(2007-12#1)(2013-1#1)
the empirical literature##3##3##(2007-12#2)(2013-1#1)
the empirical results##2##3##(2008-8#1)(2013-1#1)
the empirical##31##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-2#1)(2007-12#4)(2008-10#4)(2008-12#1)(2008-2#4)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-4#2)(2013-1#2)
the empirically##4##2##(1994-8#1)(2008-8#1)(2008-9#1)(2013-1#1)
the employee##4##2##(1991-2#1)(1994-2#1)(1995-6#1)(1996-5#1)
the employees##7##2##(1992-5#1)(1996-3#1)(1996-9#1)(2008-12#1)(2011-2#3)
the employer##4##2##(1991-8#1)(1994-12#1)(1995-6#1)(1997-2#1)
the employer's##5##2##(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-6#1)
the employment of an##2##4##(2007-11#1)(2008-3#1)
the employment of##10##3##(1995-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
the employment##11##2##(1994-1#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
the empty##3##2##(1990-7#1)(1992-8#1)(2010-12#1)
the emptying##2##2##(1997-4#2)
the emulsion formulations##3##3##(2008-5#3)
the emulsion##14##2##(1994-12#1)(2008-10#4)(2008-11#1)(2008-5#7)(2009-11#1)
the emulsions##5##2##(2008-10#1)(2008-5#3)(2008-8#1)
the enactment of##2##3##(2011-1#1)(2012-12#1)
the enamel##4##2##(1993-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
the enantiomer##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
the enantiomeric composition of##3##4##(2008-10#3)
the enantiomeric composition##5##3##(1991-12#1)(2008-10#4)
the enantiomeric separation##2##3##(2008-10#2)
the enantiomeric##10##2##(1991-12#1)(1995-6#1)(1997-7#1)(2008-10#7)
the enantiomers of##6##3##(2008-10#4)(2008-11#1)(2008-8#1)
the enantiomers##13##2##(1995-2#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-8#1)
the enantiopurity of##4##3##(2008-10#4)
the enantioselective##6##2##(2008-10#5)(2009-10#1)
the enantioselectivity##2##2##(1994-9#1)(2008-10#1)
the enantioseparation of##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
the enantioseparation##5##2##(2008-10#3)(2010-4#1)(2013-1#1)
the encapsulation of##4##3##(2008-10#2)(2008-7#1)(2010-6#1)
the encapsulation##6##2##(1990-11#1)(2008-10#3)(2008-7#1)(2010-6#1)
the enchytraeid-biotest##2##2##(2008-11#2)
the enclosure##4##2##(1996-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
the encoder##3##2##(2008-2#2)(2008-3#1)
the encoding of##2##3##(2008-11#1)(2013-8#1)
the encoding process##2##3##(2008-2#1)(2008-3#1)
the encoding task##2##3##(2013-1#2)
the encoding##15##2##(1990-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2009-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
the encounter##3##2##(2008-3#1)(2009-2#1)(2010-8#1)
the encrypted image##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the encrypted##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the encryption##3##2##(2008-2#1)(2008-3#2)
the encystment##2##2##(2008-10#2)
the end effect##2##3##(2008-3#2)
the end goal##2##3##(2008-3#1)(2012-3#1)
the end of 1##2##4##(1995-2#1)(2008-7#1)
the end of 1993##2##4##(1996-6#1)(2008-2#1)
the end of 1994##3##4##(1996-3#1)(1997-6#2)
the end of 1998##5##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#2)
the end of 2006##2##4##(2008-10#1)(2011-2#1)
the end of August##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
the end of January##2##4##(2008-5#1)(2008-7#1)
the end of World War II##3##6##(2007-8#1)(2008-12#1)(2011-2#1)
the end of a##14##4##(1994-2#1)(1996-6#1)(1997-1#1)(2008-10#7)(2008-3#2)(2008-8#1)(2013-1#1)
the end of each##14##4##(1994-3#1)(1997-4#3)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
the end of follow up##2##5##(2013-1#2)
the end of induction##2##4##(2013-8#2)
the end of its##2##4##(2008-12#1)(2009-7#1)
the end of life##3##4##(2008-7#1)(2011-2#2)
the end of one##2##4##(1995-8#1)(2008-6#1)
the end of our##3##4##(1992-5#1)(2008-8#1)(2011-1#1)
the end of study##2##4##(2011-1#1)(2013-1#1)
the end of surgery##3##4##(1990-2#1)(2007-8#1)(2010-3#1)
the end of that##2##4##(1997-3#1)(2008-12#1)
the end of the 1980s##3##5##(1993-2#1)(2011-2#2)
the end of the 19th century##3##6##(1991-6#1)(2009-7#2)
the end of the century##4##5##(1994-5#1)(1994-9#1)(1996-3#1)(1997-6#1)
the end of the common##2##5##(2007-12#1)(2008-11#1)
the end of the course##5##5##(2008-11#3)(2012-12#1)(2013-8#1)
the end of the decade##2##5##(1994-2#1)(1994-9#1)
the end of the experiment##9##5##(1992-9#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-1#2)(2013-1#1)
the end of the experimental##2##5##(2011-2#1)(2012-2#1)
the end of the first year##3##6##(1996-12#1)(2011-1#1)(2013-1#1)
the end of the first##5##5##(1996-12#1)(1996-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
the end of the follow-up period##3##6##(2008-3#1)(2008-7#2)
the end of the follow-up##5##5##(1992-6#1)(2008-3#1)(2008-7#2)(2008-8#1)
the end of the fourth year##2##6##(1992-12#2)
the end of the fourth##4##5##(1992-12#2)(1995-6#1)(2012-9#1)
the end of the growing season##3##6##(2008-10#3)
the end of the growth period##3##6##(2007-8#2)(2008-11#1)
the end of the growth##5##5##(2007-8#2)(2008-11#3)
the end of the nineteenth century##3##6##(2008-2#1)(2009-7#1)(2012-2#1)
the end of the observation period##4##6##(2007-7#1)(2008-1#1)(2008-2#1)(2008-6#1)
the end of the season##4##5##(2007-5#1)(2008-10#1)(2008-8#2)
the end of the second week##2##6##(1997-2#1)(2008-8#1)
the end of the second year##2##6##(1996-11#1)(1996-12#1)
the end of the second##7##5##(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
the end of the signal##2##5##(1991-6#1)(2008-3#1)
the end of the study period##2##6##(2008-4#1)(2010-3#1)
the end of the study##35##5##(1990-9#2)(1997-4#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#18)(2010-3#1)(2011-2#1)
the end of the third year##2##6##(1992-12#2)
the end of the treatment period##3##6##(1990-11#1)(2007-7#1)(2008-5#1)
the end of the treatment##7##5##(1990-11#1)(1990-9#1)(1991-8#1)(1997-3#1)(2007-7#1)(2008-5#1)(2013-1#1)
the end of the trial##5##5##(1991-3#1)(1994-6#2)(1994-9#1)(2008-8#1)
the end of the##207##4##(1990-11#1)(1990-2#1)(1990-9#3)(1991-12#2)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#5)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#2)(1994-2#3)(1994-5#1)(1994-6#3)(1994-9#4)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#3)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#25)(2008-11#12)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#23)(2009-10#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#6)(2012-7#1)(2012-9#1)(2013-1#4)(2013-7#2)(2013-8#4)
the end of their lives##2##5##(2012-12#1)(2013-1#1)
the end of their##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
the end of therapy##8##4##(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#1)
the end of this##9##4##(1996-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-2#1)(2010-5#1)(2011-3#1)(2012-12#1)
the end of treatment##7##4##(1991-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
the end of##394##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#5)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-2#2)(1993-5#1)(1993-9#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#5)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#3)(1996-6#3)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#14)(1997-5#1)(1997-6#5)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#8)(2007-8#7)(2008-1#6)(2008-10#50)(2008-11#13)(2008-12#13)(2008-2#5)(2008-3#14)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#9)(2008-8#10)(2008-9#28)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#16)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#20)(2013-7#3)(2013-8#8)
the end point##5##3##(2008-10#4)(2012-12#1)
the end product##2##3##(2008-10#2)
the end result##5##3##(1996-3#1)(1997-3#1)(2007-12#1)(2009-3#1)(2013-1#1)
the end stage##2##3##(1996-2#1)(2009-10#1)
the end##434##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#6)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#5)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-6#3)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#14)(1997-5#1)(1997-6#6)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#8)(2007-8#8)(2008-1#6)(2008-10#57)(2008-11#14)(2008-12#14)(2008-2#6)(2008-3#21)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#10)(2008-8#10)(2008-9#28)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#16)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#2)(2012-7#1)(2012-9#1)(2013-1#21)(2013-7#3)(2013-8#8)
the end-point of##2##3##(2008-10#1)(2011-2#1)
the end-point##9##2##(2008-10#8)(2011-2#1)
the end-stage##2##2##(2006-10#1)(2011-3#1)
the endemic##11##2##(1996-11#1)(2007-12#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)
the endo##4##2##(1996-5#4)
the endobronchial route##2##3##(1994-9#2)
the endobronchial##4##2##(1994-9#4)
the endocervical##2##2##(1991-2#2)
the endocervix##2##2##(1992-3#1)(1994-12#1)
the endocrine action of##2##4##(2008-7#2)
the endocrine effects of subcutaneous##2##5##(1991-6#2)
the endocrine pancreas##3##3##(1991-7#1)(1994-8#1)(2008-1#1)
the endocrine system##4##3##(2008-11#2)(2008-4#1)(2008-9#1)
the endocrine systems##2##3##(2008-5#1)(2010-5#1)
the endocrine##25##2##(1990-11#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-5#1)(1994-8#1)(1994-9#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2010-11#2)(2010-5#1)(2011-2#1)
the endocrinological and the immune system##2##6##(2008-5#2)
the endocrinological##3##2##(2008-5#3)
the endocrinology##2##2##(2011-2#2)
the endocytic##3##2##(1990-11#1)(1996-2#1)(2009-10#1)
the endocytosis##2##2##(1990-11#1)(2008-1#1)
the endoderm##4##2##(2008-11#1)(2008-6#2)(2008-7#1)
the endodontic management of a##2##5##(2013-1#2)
the endodontic##7##2##(2008-7#1)(2009-8#1)(2012-3#2)(2013-1#3)
the endogenous circadian##2##3##(1990-5#1)(1997-6#1)
the endogenous gene##2##3##(1991-9#1)(2008-9#1)
the endogenous levels of##2##4##(1990-7#1)(1995-2#1)
the endogenous ligands##2##3##(2008-5#1)(2009-9#1)
the endogenous opioid system##2##4##(2008-7#1)(2009-7#1)
the endogenous##63##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-5#2)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2008-10#3)(2008-11#7)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
the endogenously##2##2##(1993-1#1)(1995-12#1)
the endoglucanase##2##2##(2008-10#1)(2008-6#1)
the endolymphatic sac##3##3##(2006-12#3)
the endometrial cancer##2##3##(1994-9#1)(2008-10#1)
the endometrial cavity and##2##4##(1994-9#1)(2009-8#1)
the endometrial##11##2##(1994-9#4)(1995-3#1)(1996-2#1)(2008-10#1)(2008-9#2)(2009-8#1)(2013-8#1)
the endometrium and##2##3##(1991-3#1)(2012-3#1)
the endometrium in##2##3##(1994-9#1)(2008-9#1)
the endometrium is##3##3##(2011-2#1)(2012-3#2)
the endometrium##33##2##(1991-12#1)(1991-3#1)(1993-11#1)(1993-9#1)(1994-9#8)(1995-3#1)(1996-2#2)(2008-4#1)(2008-9#2)(2011-1#2)(2011-2#9)(2012-3#4)
the endonuclease##6##2##(1990-3#1)(1990-7#1)(1992-12#1)(1995-12#1)(1995-2#1)(2008-8#1)
the endophyte##3##2##(2008-10#3)
the endoplasmic reticulum (ER) of##3##5##(1994-11#1)(2009-2#1)(2009-8#1)
the endoplasmic reticulum (ER) stress##2##5##(2008-7#1)(2012-2#1)
the endoplasmic reticulum (ER)##11##4##(1991-2#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the endoplasmic reticulum and##7##4##(1990-7#1)(1995-5#1)(1996-9#1)(2008-11#1)(2009-7#1)(2009-8#1)(2013-1#1)
the endoplasmic reticulum membrane##5##4##(1991-10#1)(1995-6#3)(1997-7#1)
the endoplasmic reticulum##53##3##(1990-7#1)(1991-10#1)(1991-2#2)(1993-11#1)(1993-8#2)(1994-11#2)(1994-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1996-3#3)(1996-9#1)(1997-1#1)(1997-7#2)(2008-1#2)(2008-10#3)(2008-11#6)(2008-7#3)(2009-2#2)(2009-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
the endoplasmic##57##2##(1990-7#1)(1991-10#1)(1991-2#2)(1993-11#1)(1993-8#3)(1994-11#3)(1994-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1996-3#3)(1996-9#1)(1997-1#1)(1997-7#2)(2008-1#2)(2008-10#3)(2008-11#6)(2008-7#3)(2008-9#1)(2009-2#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
the endoreduplication##2##2##(2008-5#2)
the endoscope##5##2##(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
the endoscopic##15##2##(1990-3#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-3#1)(1994-9#1)(2007-11#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#1)
the endoscopy##3##2##(1992-11#1)(1992-5#1)(2008-5#1)
the endosomal compartment##2##3##(2009-2#1)(2012-2#1)
the endosome##3##2##(1992-6#1)(1994-5#1)(2008-11#1)
the endosomes##4##2##(1990-11#1)(1992-6#1)(1995-11#1)(2009-2#1)
the endosperm##6##2##(1994-8#2)(2008-10#3)(2009-12#1)
the endosymbiont##4##2##(1996-12#3)(2012-3#1)
the endothelial P2Y(1) receptor##2##4##(2008-4#2)
the endothelial cell loss and clinical outcome##2##7##(2011-2#2)
the endothelial cell##11##3##(1990-4#1)(1991-2#1)(1993-6#2)(1993-8#1)(1995-2#2)(2008-1#1)(2011-2#3)
the endothelial cells##5##3##(1992-9#1)(1995-11#1)(1995-12#2)(2007-12#1)
the endothelial dysfunction##3##3##(2008-1#1)(2008-11#1)(2010-10#1)
the endothelial##26##2##(1990-4#1)(1991-2#1)(1992-9#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-10#2)(2011-2#3)
the endothelin##6##2##(1990-2#1)(1993-6#1)(1995-12#4)
the endothelin-B receptor gene##2##4##(1994-12#2)
the endothelin-B receptor##4##3##(1994-12#4)
the endothelium and perivascular infiltrating inflammatory cells##2##7##(2012-3#2)
the endothelium and##4##3##(1995-2#1)(2008-10#1)(2012-3#2)
the endothelium of##4##3##(1994-5#1)(2012-1#1)(2012-3#2)
the endothelium##22##2##(1990-12#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-5#2)(1994-9#1)(1995-2#2)(1996-2#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-1#1)(2012-12#2)(2012-3#4)
the endothelium-dependent relaxation##3##3##(1995-12#1)(2007-8#2)
the endothelium-dependent##4##2##(1994-11#1)(1995-12#1)(2007-8#2)
the endotoxin##2##2##(1990-12#1)(2012-12#1)
the endotracheal tube (ETT) is##2##5##(2007-11#1)(2008-8#1)
the endotracheal tube##4##3##(1996-3#1)(2007-11#1)(2008-8#1)(2010-7#1)
the endovascular procedure##3##3##(1996-6#1)(2008-7#1)(2013-8#1)
the endovascular##8##2##(1995-11#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-7#2)(2008-8#1)(2013-8#1)
the endpoint##3##2##(1992-9#1)(2008-7#2)
the ends of chromosomes##2##4##(2006-10#1)(2008-11#1)
the ends of the##3##4##(1997-4#1)(2007-11#1)(2008-8#1)
the ends of##11##3##(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)
the ends##17##2##(1993-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2013-1#1)
the endurance##2##2##(2007-8#1)(2011-1#1)
the energetic cost of##2##4##(2008-8#2)
the energetic costs##2##3##(2008-9#2)
the energetic equivalence rule##2##4##(2008-9#2)
the energetic invariant##2##3##(2008-3#2)
the energetic state##2##3##(2008-7#1)(2012-12#1)
the energetic##17##2##(1994-11#1)(1994-3#2)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#4)(2012-12#1)
the energetics of##3##3##(1997-2#2)(2010-12#1)
the energy budget##2##3##(2008-9#1)(2012-2#1)
the energy change##2##3##(2007-11#2)
the energy density##3##3##(2007-12#1)(2008-3#2)
the energy distribution##2##3##(2008-3#2)
the energy gap##3##3##(1993-5#1)(2008-3#1)(2012-12#1)
the energy in the##2##4##(2007-11#1)(2013-1#1)
the energy in##3##3##(2007-11#1)(2012-3#1)(2013-1#1)
the energy levels of##2##4##(2008-2#1)(2008-8#1)
the energy levels##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
the energy of the##7##4##(1997-7#1)(2007-11#2)(2008-3#3)(2008-4#1)
the energy of##14##3##(1992-5#1)(1997-7#1)(2007-11#3)(2008-10#1)(2008-3#6)(2008-4#1)(2013-1#1)
the energy production from##2##4##(2012-3#2)
the energy production##3##3##(2008-5#1)(2012-3#2)
the energy supply##2##3##(1994-2#1)(2009-8#1)
the energy transfer##8##3##(2008-10#4)(2008-8#3)(2009-5#1)
the energy##106##2##(1992-5#1)(1993-5#1)(1994-2#2)(1995-11#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#8)(2007-12#5)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#23)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-5#2)(2009-8#3)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
the energy-density distribution##2##3##(2008-2#2)
the enforcement of a##2##4##(2007-6#2)
the enforcement of##3##3##(2007-6#2)(2009-7#1)
the engine##2##2##(2008-2#1)(2008-3#1)
the engineered##2##2##(2008-1#1)(2008-10#1)
the engineering of##3##3##(1995-3#1)(2008-11#1)(2009-5#1)
the engineering##7##2##(1995-3#1)(2008-11#2)(2008-3#1)(2009-12#1)(2009-5#1)(2012-3#1)
the engineerized enzyme##2##3##(2008-10#2)
the engrailed protein##2##3##(2007-12#2)
the enhanced ECL##5##3##(2008-10#5)
the enhanced RLS intensity##4##4##(2008-10#4)
the enhanced growth##2##3##(1992-8#1)(2008-11#1)
the enhanced intensity of fluorescence is in proportion to the concentration of##2##12##(2008-10#2)
the enhanced ray-optics##2##3##(2008-3#2)
the enhanced resonance light scattering (RLS)##2##6##(2008-10#2)
the enhanced stability of##2##4##(2012-12#2)
the enhanced##58##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-8#2)(1992-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#24)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
the enhancement effect of##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
the enhancement effect##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
the enhancement factor was##4##4##(2008-10#4)
the enhancement in##4##3##(1997-8#1)(2007-11#1)(2008-3#1)(2008-7#1)
the enhancement of the##7##4##(1993-3#1)(2008-10#4)(2008-11#1)(2008-8#1)
the enhancement of##41##3##(1990-6#1)(1992-10#1)(1992-8#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-2#3)(1997-8#1)(2007-11#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-6#1)
the enhancement or##2##3##(1995-5#1)(2009-11#1)
the enhancement##63##2##(1990-6#2)(1992-10#1)(1992-8#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-2#3)(1997-8#3)(2007-11#3)(2008-10#22)(2008-11#3)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-8#1)
the enhancer activity##2##3##(1991-11#1)(1994-11#1)
the enhancer##9##2##(1990-11#1)(1991-11#2)(1991-5#1)(1992-10#1)(1994-11#1)(1995-8#1)(2008-9#1)(2012-3#1)
the enhancing effect of arginine-vasopressin on##2##6##(1995-12#2)
the enhancing effect of##6##4##(1995-12#3)(2008-10#2)(2008-11#1)
the enhancing effect##10##3##(1995-12#3)(1997-2#1)(2008-10#3)(2008-11#2)(2009-8#1)
the enhancing##11##2##(1995-12#3)(1997-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-8#1)
the enlarged##7##2##(1990-8#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
the enlargement of##4##3##(2008-10#1)(2008-3#2)(2009-4#1)
the enlargement##5##2##(2008-10#1)(2008-3#3)(2009-4#1)
the enormous amount of##2##4##(2008-4#1)(2008-7#1)
the enormous##14##2##(1995-12#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
the enriched environment##4##3##(1991-2#1)(1992-11#3)
the enriched##8##2##(1991-2#1)(1992-11#3)(2008-10#2)(2008-11#1)(2010-2#1)
the enrichment and##2##3##(2008-10#1)(2013-7#1)
the enrichment column##2##3##(2008-10#2)
the enrichment factor##4##3##(2008-10#4)
the enrichment factors##2##3##(2008-10#2)
the enrichment of the##2##4##(1992-9#1)(1997-3#1)
the enrichment of##11##3##(1992-9#1)(1997-3#1)(2008-10#6)(2008-11#1)(2011-2#1)(2013-7#1)
the enrichment##27##2##(1991-12#1)(1992-9#1)(1997-3#1)(2008-10#18)(2008-11#1)(2011-2#3)(2013-7#2)
the enrolled##2##2##(1996-2#1)(2013-1#1)
the enrollment##3##2##(1991-1#1)(1991-2#1)(2009-6#1)
the ensemble##2##2##(2008-10#1)(2008-7#1)
the ensuing##12##2##(1996-2#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)
the entA mutant##3##3##(2008-10#3)
the enteric nervous system##4##4##(1992-6#2)(2008-7#2)
the enteric neural##2##3##(2008-7#2)
the enteric##7##2##(1992-6#2)(2008-7#4)(2013-1#1)
the enterocyte##2##2##(1990-11#1)(1996-5#1)
the enterocytes##5##2##(1993-6#1)(1994-6#1)(1997-3#1)(2008-10#2)
the enterovirus##3##2##(2011-1#3)
the enterprise##4##2##(1994-12#1)(1995-2#1)(1996-3#1)(1997-3#1)
the enthalpy and entropy##2##4##(1996-2#1)(2008-10#1)
the enthalpy and##3##3##(1990-8#1)(1996-2#1)(2008-10#1)
the enthalpy change##3##3##(1993-8#1)(2008-10#2)
the enthalpy of##4##3##(1990-8#1)(1992-5#2)(1994-5#1)
the enthalpy##14##2##(1990-8#2)(1992-10#1)(1992-5#2)(1993-8#1)(1994-5#1)(1996-2#1)(1997-2#3)(2008-10#3)
the entire ITS##3##3##(2008-10#3)
the entire abdomen##2##3##(1997-8#1)(2008-7#1)
the entire body##2##3##(2007-12#1)(2012-2#1)
the entire brain##2##3##(2008-7#1)(2009-3#1)
the entire chromosome complement of##2##5##(2008-5#2)
the entire chromosome##4##3##(1997-5#1)(2008-10#1)(2008-5#2)
the entire clinical##2##3##(1996-3#1)(2008-7#1)
the entire coding region of the##2##6##(1993-6#1)(1994-12#1)
the entire coding region of##3##5##(1990-8#1)(1993-6#1)(1994-12#1)
the entire coding region##5##4##(1990-8#1)(1992-3#1)(1993-6#1)(1994-12#1)(1996-2#1)
the entire coding##6##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1996-2#1)
the entire colon##2##3##(2008-1#1)(2009-10#1)
the entire complex of##2##4##(1990-6#1)(1997-6#1)
the entire control##2##3##(2008-12#2)
the entire course of##2##4##(2008-10#1)(2008-7#1)
the entire experiment##3##3##(2008-10#2)(2012-9#1)
the entire extracellular##2##3##(1991-9#1)(1992-9#1)
the entire genome of Drosophila melanogaster using fusion analysis##2##9##(2008-7#2)
the entire genome of##5##4##(1996-6#1)(2008-10#1)(2008-7#2)(2008-8#1)
the entire genome##14##3##(1996-12#1)(1996-6#4)(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#1)
the entire group##7##3##(1991-12#1)(1992-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-7#1)
the entire health care##2##4##(1991-12#1)(1996-3#1)
the entire length of##5##4##(1990-5#1)(1996-10#1)(1997-4#1)(2007-8#1)(2009-7#1)
the entire length##6##3##(1990-5#1)(1996-10#1)(1996-6#1)(1997-4#1)(2007-8#1)(2009-7#1)
the entire lifetime##3##3##(2009-2#2)(2011-2#1)
the entire open reading frame##2##5##(1990-12#1)(1993-6#1)
the entire pH range##2##4##(2008-10#2)
the entire polypeptide##2##3##(1994-6#1)(1995-3#1)
the entire population##6##3##(1993-11#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#2)
the entire procedure was##3##4##(1993-3#1)(2008-10#2)
the entire procedure##7##3##(1993-1#1)(1993-3#1)(1994-8#1)(2008-10#3)(2010-6#1)
the entire range of##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
the entire range##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
the entire region of##2##4##(1995-6#1)(2009-7#1)
the entire section##2##3##(2011-2#2)
the entire sequence of the##2##5##(1991-3#1)(1993-6#1)
the entire sequence of##4##4##(1991-3#1)(1993-6#1)(2008-5#1)(2013-8#1)
the entire sequence##8##3##(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-9#1)(1997-6#1)(2008-5#1)(2013-8#1)
the entire set of##3##4##(2008-10#2)(2008-7#1)
the entire small##2##3##(1993-6#1)(2010-12#1)
the entire spatial##2##3##(2007-12#1)(2008-10#1)
the entire spectrum of##3##4##(2008-8#1)(2008-9#1)(2010-3#1)
the entire spectrum##5##3##(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-3#1)
the entire system##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
the entire thin##2##3##(2007-12#1)(2008-6#1)
the entire time##3##3##(1990-8#1)(1997-4#1)(2009-7#1)
the entire tuning range##3##4##(2007-12#1)(2008-2#2)
the entire visible region##3##4##(2007-11#1)(2008-3#1)(2013-1#1)
the entire##310##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#6)(1996-8#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#1)(2007-11#5)(2007-12#11)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#7)(2008-12#5)(2008-2#11)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#19)(2008-8#9)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#5)(2012-7#1)(2012-9#1)(2013-1#5)(2013-3#1)(2013-7#1)(2013-8#1)
the entirety of##2##3##(1997-3#1)(1997-5#1)
the entity##5##2##(1993-12#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-12#1)
the entomological##2##2##(2008-6#1)(2012-12#1)
the entorhinal cortex##12##3##(1994-3#5)(1994-8#1)(1995-5#1)(1997-3#1)(2008-11#4)
the entorhinal##13##2##(1992-11#1)(1994-3#5)(1994-8#1)(1995-5#1)(1997-3#1)(2008-11#4)
the entorhinal-hippocampal loop circuits##2##4##(2008-11#2)
the entrainment##2##2##(1994-2#1)(2008-5#1)
the entrance of the##3##4##(1992-12#1)(1994-9#1)(2008-3#1)
the entrance of##4##3##(1992-12#1)(1994-9#1)(2008-10#1)(2008-3#1)
the entrance to the##2##4##(2008-11#1)(2011-2#1)
the entrance##13##2##(1992-12#1)(1992-2#1)(1994-9#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-2#1)
the entrapment##3##2##(2008-10#2)(2008-8#1)
the entrapped##7##2##(1990-2#2)(2008-10#1)(2008-11#2)(2011-2#1)(2012-6#1)
the entry into##2##3##(1994-5#1)(2010-5#1)
the entry of##5##3##(1990-11#1)(1993-3#1)(1997-2#1)(1997-6#1)(2011-3#1)
the entry point##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
the entry##15##2##(1990-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
the enucleated##3##2##(1992-10#1)(2008-9#2)
the envelope glycoprotein##2##3##(1993-3#1)(1995-5#1)
the envelope is##2##3##(2007-12#1)(2008-8#1)
the envelope of##2##3##(2007-12#1)(2008-3#1)
the envelope##11##2##(1993-12#1)(1993-3#1)(1995-5#1)(1997-6#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
the environment and the##2##4##(1995-11#1)(2008-10#1)
the environment and##17##3##(1990-9#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
the environment can##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
the environment has##2##3##(2008-10#2)
the environment in the##3##4##(1990-3#1)(1992-3#1)(1996-7#1)
the environment in which##4##4##(1991-12#1)(1994-12#1)(2008-6#1)(2008-8#1)
the environment in##10##3##(1990-3#1)(1991-12#1)(1992-3#2)(1994-12#1)(1996-7#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)
the environment is##6##3##(2008-10#4)(2008-8#1)(2010-12#1)
the environment of a##2##4##(1994-11#1)(1995-1#1)
the environment of the##6##4##(1991-6#1)(1992-12#1)(1994-5#1)(1997-2#1)(2008-10#1)(2013-1#1)
the environment of##10##3##(1990-7#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-5#1)(1997-2#1)(2008-10#1)(2013-1#1)
the environment or##2##3##(2008-1#1)(2008-5#1)
the environment where##2##3##(1997-2#1)(2008-10#1)
the environment##189##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-12#2)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#3)(1997-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#48)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#12)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#2)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#3)
the environmental and biological##2##4##(2008-10#2)
the environmental and##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
the environmental compatibility##2##3##(2008-5#2)
the environmental conditions##5##3##(2008-10#1)(2008-3#1)(2008-8#2)(2010-10#1)
the environmental factors that##2##4##(2008-10#1)(2012-12#1)
the environmental factors##5##3##(1993-3#1)(2008-10#2)(2011-3#1)(2012-12#1)
the environmental impact of##2##4##(2008-10#1)(2008-11#1)
the environmental impacts of##2##4##(2008-11#2)
the environmental index##2##3##(2008-10#2)
the environmental monitoring of##3##4##(2008-10#2)(2013-8#1)
the environmental problems caused by##2##5##(1992-3#1)(2009-3#1)
the environmental risk##2##3##(2008-10#1)(2008-11#1)
the environmental variance##2##3##(2008-8#1)(2008-9#1)
the environmental##80##2##(1991-12#1)(1992-3#1)(1993-3#1)(1996-1#1)(2008-1#1)(2008-10#34)(2008-11#7)(2008-3#3)(2008-5#8)(2008-7#1)(2008-8#8)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the environmentally##2##2##(2008-8#1)(2012-2#1)
the environments##4##2##(2008-10#2)(2008-9#1)(2010-12#1)
the enzymatic activities of##2##4##(1993-12#1)(2008-10#1)
the enzymatic activities##3##3##(1990-3#1)(1993-12#1)(2008-10#1)
the enzymatic activity of the##3##5##(2008-10#2)(2008-6#1)
the enzymatic activity of##11##4##(1990-5#1)(1991-12#1)(1994-6#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-6#1)
the enzymatic activity was##3##4##(1992-6#1)(2008-10#2)
the enzymatic activity##20##3##(1990-5#1)(1991-12#1)(1992-6#1)(1994-6#1)(1995-2#1)(2008-10#8)(2008-11#2)(2008-6#2)(2008-7#2)(2009-2#1)
the enzymatic cleavage##2##3##(1996-12#1)(2008-7#1)
the enzymatic degradation##3##3##(2008-10#2)(2011-1#1)
the enzymatic hydrolysis of##8##4##(2008-10#4)(2008-6#1)(2008-7#1)(2013-1#2)
the enzymatic hydrolysis process##3##4##(2008-10#2)(2013-1#1)
the enzymatic hydrolysis##13##3##(2008-10#8)(2008-6#1)(2008-7#1)(2013-1#3)
the enzymatic probe sonication##2##4##(2008-10#2)
the enzymatic reaction and##2##4##(2008-10#1)(2011-2#1)
the enzymatic reaction is##2##4##(2008-10#2)
the enzymatic reaction of##4##4##(1991-5#1)(2008-10#3)
the enzymatic reaction##21##3##(1990-8#1)(1991-5#1)(2008-10#15)(2008-4#1)(2008-6#2)(2011-2#1)
the enzymatic reactor##2##3##(2008-10#2)
the enzymatic##95##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#5)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#5)
the enzymatically active##3##3##(1994-6#1)(2011-1#2)
the enzymatically##5##2##(1994-12#1)(1994-6#1)(2008-10#1)(2011-1#2)
the enzyme active site##3##4##(1995-6#3)
the enzyme activities##3##3##(1994-11#1)(1996-5#1)(2008-10#1)
the enzyme activity and##3##4##(1991-12#1)(1994-6#1)(1997-6#1)
the enzyme activity by 22##2##5##(1994-8#2)
the enzyme activity by##5##4##(1990-5#1)(1992-11#1)(1994-8#2)(2013-1#1)
the enzyme activity in##2##4##(1994-8#1)(2008-7#1)
the enzyme activity inNocardia andRhodococcus##2##5##(2008-11#2)
the enzyme activity was##4##4##(1993-9#1)(2008-10#3)
the enzyme activity##39##3##(1990-12#1)(1990-5#2)(1991-12#2)(1991-2#1)(1992-11#2)(1992-6#2)(1993-3#2)(1993-9#2)(1994-6#2)(1994-8#3)(1995-11#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
the enzyme after##2##3##(1992-6#2)
the enzyme against##2##3##(1990-11#1)(1992-5#1)
the enzyme also##2##3##(1992-8#1)(1997-4#1)
the enzyme and the##4##4##(1993-8#1)(2008-10#3)
the enzyme and##14##3##(1990-9#1)(1992-6#1)(1993-11#2)(1993-8#1)(1995-2#2)(2008-10#6)(2008-6#1)
the enzyme appears to be##3##5##(1993-6#1)(1997-4#1)(2008-8#1)
the enzyme at the##2##4##(1992-3#1)(1994-6#1)
the enzyme at##6##3##(1992-3#1)(1993-8#1)(1994-6#1)(2008-10#2)(2008-9#1)
the enzyme by##10##3##(1990-8#1)(1993-11#2)(1993-9#1)(1994-11#2)(1995-6#1)(1997-8#1)(2008-7#1)(2009-7#1)
the enzyme complex##2##3##(2012-2#1)(2012-3#1)
the enzyme conjugate##2##3##(2008-7#2)
the enzyme dilution##2##3##(2008-10#2)
the enzyme exhibited##2##3##(1994-11#1)(2012-2#1)
the enzyme from E##2##4##(1992-3#1)(1993-6#1)
the enzyme from the##2##4##(2008-10#1)(2008-11#1)
the enzyme from##17##3##(1992-12#1)(1992-3#4)(1993-2#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-2#3)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
the enzyme has been##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
the enzyme has##5##3##(1990-5#2)(2008-10#1)(2008-7#1)(2011-1#1)
the enzyme in an##2##4##(2008-10#1)(2008-5#1)
the enzyme in the##6##4##(1990-5#1)(1992-9#1)(2008-10#3)(2008-4#1)
the enzyme in##14##3##(1990-11#1)(1990-5#1)(1992-9#1)(1996-2#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)
the enzyme is##12##3##(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1996-2#1)(2008-4#1)(2008-9#1)
the enzyme layer##2##3##(2008-10#2)
the enzyme loading and time of##2##6##(2008-10#2)
the enzyme loading and##3##4##(2008-10#3)
the enzyme loading##4##3##(2008-10#3)(2008-6#1)
the enzyme microenvironment##2##3##(2008-10#2)
the enzyme molecule##3##3##(1992-11#1)(1993-8#1)(1994-11#1)
the enzyme molecules##2##3##(2008-10#2)
the enzyme nor##3##3##(1991-12#1)(1993-3#1)(2008-9#1)
the enzyme on the##2##4##(1993-11#1)(2008-10#1)
the enzyme on##4##3##(1990-7#1)(1993-11#1)(1995-6#1)(2008-10#1)
the enzyme product 13-HPODE##2##4##(1995-5#2)
the enzyme purified from##3##4##(1993-8#2)(1995-2#1)
the enzyme pyranose##2##3##(1995-2#1)(2008-6#1)
the enzyme reaction##9##3##(1990-5#1)(1997-2#1)(1997-6#1)(2008-10#5)(2011-2#1)
the enzyme responsible for the##2##5##(1990-8#1)(2008-11#1)
the enzyme solution##3##3##(2008-10#3)
the enzyme that is##2##4##(2008-7#1)(2009-8#1)
the enzyme that##9##3##(1990-5#1)(1991-9#1)(1992-6#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-8#1)(2013-1#1)
the enzyme to##7##3##(1990-2#1)(1992-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#1)(2009-8#1)
the enzyme toward##2##3##(1993-6#1)(1995-6#1)
the enzyme upon##2##3##(1990-5#1)(1990-8#1)
the enzyme was purified##2##4##(1994-6#1)(1994-8#1)
the enzyme was shown##2##4##(1990-10#1)(2008-9#1)
the enzyme was##22##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(2008-10#3)(2008-6#2)(2008-9#1)(2013-1#1)
the enzyme were##3##3##(1990-8#1)(1992-12#1)(1996-5#1)
the enzyme which##4##3##(1992-9#1)(1993-8#1)(2008-11#1)(2008-5#1)
the enzyme with a##2##4##(1993-6#1)(1994-5#1)
the enzyme with##10##3##(1990-7#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-6#1)(2008-10#2)(2009-11#1)
the enzyme##489##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#4)(1990-5#20)(1990-7#12)(1990-8#7)(1990-9#2)(1991-12#9)(1991-2#2)(1991-3#1)(1991-5#9)(1991-6#2)(1991-8#4)(1991-9#7)(1992-11#8)(1992-12#9)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#12)(1992-8#9)(1992-9#4)(1993-11#10)(1993-2#1)(1993-3#6)(1993-6#7)(1993-8#12)(1993-9#3)(1994-11#10)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#7)(1994-8#12)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#12)(1995-3#1)(1995-5#5)(1995-6#10)(1995-8#5)(1996-12#1)(1996-2#6)(1996-5#2)(1997-1#3)(1997-2#11)(1997-4#10)(1997-6#6)(1997-7#3)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#86)(2008-11#11)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#12)(2008-7#14)(2008-8#3)(2008-9#7)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#1)
the enzyme's active site##2##4##(1993-8#1)(1995-5#1)
the enzyme's activity##2##3##(1991-12#1)(2011-1#1)
the enzyme's##9##2##(1991-12#1)(1993-11#2)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(2008-10#1)(2011-1#1)
the enzyme-based##2##2##(2008-10#1)(2010-2#1)
the enzyme-bound##4##2##(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)
the enzyme-catalyzed##8##2##(1993-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-4#1)
the enzyme-linked immunosorbent assay (ELISA)##4##5##(1996-9#1)(2008-10#2)(2008-4#1)
the enzyme-linked immunosorbent assay##5##4##(1996-9#1)(2008-10#3)(2008-4#1)
the enzyme-linked immunosorbent##6##3##(1996-9#1)(2008-10#4)(2008-4#1)
the enzyme-linked##7##2##(1991-8#1)(1996-9#1)(2008-10#4)(2008-4#1)
the enzyme-substrate complex##3##3##(1990-8#1)(1994-5#1)(2008-5#1)
the enzyme-substrate##7##2##(1990-8#1)(1990-9#1)(1994-5#2)(2008-10#2)(2008-5#1)
the enzymes and##2##3##(1993-9#1)(1997-6#1)
the enzymes from##2##3##(1991-12#1)(1995-6#1)
the enzymes in##2##3##(2009-2#1)(2012-2#1)
the enzymes involved in##4##4##(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
the enzymes of the##2##4##(1991-4#1)(1997-1#1)
the enzymes of##4##3##(1991-4#1)(1997-1#1)(2008-3#1)(2010-7#1)
the enzymes responsible for##2##4##(1991-7#1)(2008-4#1)
the enzymes##45##2##(1990-5#2)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
the enzymic##2##2##(1991-5#2)
the eosinophil##2##2##(1992-3#1)(1992-6#1)
the eosinophilia##2##2##(1990-11#1)(2008-7#1)
the eosinophilic matrix##2##3##(2012-1#2)
the eosinophilic##4##2##(2008-11#1)(2008-5#1)(2012-1#2)
the epicenter##2##2##(2011-1#1)(2013-1#1)
the epicondylar area##2##3##(2007-11#2)
the epidemic and##3##3##(1993-3#1)(2007-12#1)(2009-10#1)
the epidemic in##6##3##(1990-12#1)(1992-5#1)(1995-6#1)(1996-11#1)(2008-1#1)(2011-2#1)
the epidemic of##2##3##(1996-11#1)(2012-3#1)
the epidemic onset##2##3##(2008-10#2)
the epidemic strains##2##3##(2011-1#2)
the epidemic was##2##3##(2008-10#2)
the epidemic##65##2##(1990-12#3)(1990-6#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-3#2)(1995-12#1)(1995-6#1)(1996-11#3)(1996-3#1)(1996-5#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#33)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
the epidemic's##3##2##(1997-3#1)(1997-6#1)(2008-8#1)
the epidemics in each##2##4##(2008-10#2)
the epidemics of##2##3##(2007-10#1)(2008-10#1)
the epidemics##10##2##(2007-10#1)(2008-10#7)(2012-3#2)
the epidemiologic data##2##3##(2009-9#1)(2013-8#1)
the epidemiologic##6##2##(1990-12#1)(1990-9#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
the epidemiological characteristics of##3##4##(2011-1#1)(2011-2#2)
the epidemiological characteristics##4##3##(2007-7#1)(2011-1#1)(2011-2#2)
the epidemiological evidence and the##2##5##(1992-4#1)(2008-5#1)
the epidemiological evidence##4##3##(1992-4#1)(2008-5#1)(2010-6#1)(2013-1#1)
the epidemiological literature##2##3##(2008-8#1)(2013-1#1)
the epidemiological situation in Norway##2##5##(1994-6#1)(1996-6#1)
the epidemiological##23##2##(1991-9#1)(1992-4#1)(1993-10#1)(1994-6#1)(1996-6#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#3)(2013-1#3)
the epidemiologist##4##2##(1994-3#4)
the epidemiology and management of soilborne##2##6##(2008-10#2)
the epidemiology and management of##5##5##(2007-12#1)(2008-10#4)
the epidemiology and##11##3##(2007-12#1)(2007-2#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-9#1)
the epidemiology of the##4##4##(2008-10#3)(2008-9#1)
the epidemiology of##33##3##(1991-8#1)(1992-6#1)(1995-12#1)(1995-9#1)(2007-10#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2011-2#4)(2011-3#1)(2013-1#1)
the epidemiology##58##2##(1991-8#1)(1992-6#1)(1995-12#1)(1995-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#1)(2013-1#1)
the epidermal cell##2##3##(2008-10#1)(2008-7#1)
the epidermal growth factor (EGF)##2##5##(1992-12#1)(2011-2#1)
the epidermal growth factor receptor (EGFR)##3##6##(2008-7#1)(2012-1#2)
the epidermal growth factor receptor##7##5##(1991-11#1)(1993-8#1)(1995-6#2)(2008-7#1)(2012-1#2)
the epidermal growth factor##10##4##(1991-11#1)(1992-12#1)(1993-3#1)(1993-8#1)(1995-6#2)(2008-7#1)(2011-2#1)(2012-1#2)
the epidermal layers of the eschar##2##6##(2013-8#2)
the epidermal##26##2##(1991-11#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#2)(2007-12#1)(2008-10#5)(2008-5#3)(2008-7#2)(2008-9#2)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#2)
the epidermis and dermis##5##4##(1996-12#1)(2008-5#3)(2008-9#1)
the epidermis and outer cortex tissues##4##6##(2008-10#4)
the epidermis and the dermis##2##5##(2008-1#1)(2008-5#1)
the epidermis and the##5##4##(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)
the epidermis and##20##3##(1996-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#7)(2008-7#1)(2008-9#2)
the epidermis in##2##3##(2008-1#1)(2012-12#1)
the epidermis of##6##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-5#2)
the epidermis##73##2##(1992-8#1)(1994-5#1)(1995-11#1)(1996-12#4)(1996-2#1)(1996-6#2)(2007-12#3)(2008-1#3)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#18)(2008-7#2)(2008-9#6)(2010-6#4)(2010-7#1)(2011-3#1)(2012-12#6)
the epididymis##6##2##(1992-3#1)(2008-9#2)(2011-1#2)(2012-12#1)
the epidural space##7##3##(1993-10#5)(2009-3#1)(2010-7#1)
the epidural##11##2##(1993-10#6)(2006-12#1)(2009-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
the epigenetic influence of##2##4##(2009-3#2)
the epigenetic influence##3##3##(2009-3#3)
the epigenetic##9##2##(2008-8#2)(2009-3#4)(2011-2#1)(2013-1#1)(2013-8#1)
the epilepsy patients was##2##4##(2008-8#1)(2010-8#1)
the epilepsy patients##4##3##(2008-8#3)(2010-8#1)
the epilepsy service##2##3##(1997-8#2)
the epilepsy##7##2##(1997-8#2)(2008-8#4)(2010-8#1)
the epileptic##4##2##(1996-9#1)(2008-11#1)(2008-7#1)(2009-8#1)
the epileptogenic##2##2##(2008-1#1)(2009-8#1)
the epinephrine##2##2##(2008-10#2)
the epiphyseal##4##2##(1992-8#1)(1996-11#1)(2007-11#1)(2011-2#1)
the epiphysis##4##2##(1995-6#1)(2007-11#1)(2008-8#2)
the epiphytic##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
the episode##2##2##(1996-6#1)(2011-1#1)
the episodes of##2##3##(2008-1#1)(2008-10#1)
the epistemological crisis in genomics##2##5##(2009-5#2)
the epistemological##3##2##(2008-11#1)(2009-5#2)
the epitaxial growth of##2##4##(1992-11#1)(2008-7#1)
the epithelial cell##5##3##(1991-5#1)(1992-5#1)(1993-8#1)(1997-6#1)(2008-7#1)
the epithelial cells of##4##4##(1996-5#1)(1997-6#1)(2008-10#1)(2008-8#1)
the epithelial cells##12##3##(1991-2#1)(1991-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
the epithelial cycle##6##3##(2009-10#3)(2012-2#3)
the epithelial lining##2##3##(2007-12#1)(2010-5#1)
the epithelial##39##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-5#1)(1993-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#5)(2007-12#4)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2010-5#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)
the epithelium and##3##3##(2007-12#1)(2013-1#2)
the epithelium of the##5##4##(2006-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-11#1)
the epithelium of##6##3##(2006-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-1#1)
the epithelium##28##2##(1991-5#1)(1995-8#1)(1997-1#2)(2006-12#1)(2007-12#4)(2008-12#1)(2008-5#1)(2008-7#4)(2009-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#3)
the epitope regions##2##3##(2008-11#2)
the epitope##9##2##(1990-11#1)(1991-12#1)(1993-12#1)(1997-7#1)(2008-11#3)(2008-8#2)
the epitope-tagged##2##2##(1992-9#1)(2008-2#1)
the epitopes##4##2##(2006-6#1)(2008-10#2)(2008-8#1)
the epoxy##6##2##(1996-5#1)(2008-10#2)(2008-3#1)(2010-4#2)
the epsilon##4##2##(1995-12#2)(2009-7#2)
the equal##2##2##(2008-10#1)(2011-2#1)
the equality of##2##3##(1996-3#1)(2013-1#1)
the equality##3##2##(1996-3#1)(2008-3#1)(2013-1#1)
the equation is##2##3##(2008-3#2)
the equation##16##2##(1995-6#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
the equations for the##2##4##(1996-12#1)(2008-10#1)
the equations for##5##3##(1996-12#1)(2008-10#2)(2008-3#1)(2012-3#1)
the equations of##3##3##(2008-11#1)(2008-3#1)(2009-11#1)
the equations##20##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)
the equator##2##2##(1992-7#1)(2010-6#1)
the equatorial plane##2##3##(1996-2#1)(1997-7#1)
the equatorial##6##2##(1996-2#1)(1996-5#1)(1997-7#3)(2008-3#1)
the equilibration time##2##3##(2008-10#2)
the equilibration##4##2##(1992-6#1)(2008-10#3)
the equilibria##2##2##(2008-10#2)
the equilibrium between the##2##4##(2008-10#2)
the equilibrium between##4##3##(1997-2#1)(2008-10#2)(2008-3#1)
the equilibrium concentration of##2##4##(2008-10#2)
the equilibrium constant for##2##4##(1997-2#2)
the equilibrium constant of the##2##5##(1994-8#1)(1995-6#1)
the equilibrium constant##9##3##(1994-8#2)(1995-6#1)(1997-2#2)(2007-12#1)(2008-10#3)
the equilibrium constants for##2##4##(2008-10#1)(2008-2#1)
the equilibrium constants of##2##4##(2008-10#1)(2008-2#1)
the equilibrium constants##6##3##(2008-10#4)(2008-2#2)
the equilibrium dissociation constant##4##4##(1993-3#1)(1993-6#1)(1995-5#1)(1997-2#1)
the equilibrium distribution of##4##4##(1990-7#1)(1995-2#1)(2008-10#2)
the equilibrium frequency of##2##4##(2008-9#2)
the equilibrium of##2##3##(2008-10#2)
the equilibrium population size##3##4##(2008-8#2)(2008-9#1)
the equilibrium population##4##3##(2008-8#2)(2008-9#2)
the equilibrium state##2##3##(1992-6#1)(2008-10#1)
the equilibrium temperature##4##3##(2008-2#4)
the equilibrium unfolding##2##3##(1990-7#1)(1995-5#1)
the equilibrium##70##2##(1990-7#2)(1992-6#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#4)(2007-12#1)(2008-10#29)(2008-12#1)(2008-2#6)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-5#2)(2010-2#1)
the equimolar##2##2##(1990-2#1)(2008-10#1)
the equipment and##4##3##(1990-5#1)(2008-1#1)(2008-4#1)(2013-1#1)
the equipment of##2##3##(2007-11#1)(2008-9#1)
the equipment##17##2##(1990-5#1)(1992-12#1)(1992-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the equity##2##2##(1992-12#1)(2011-2#1)
the equivalence of##3##3##(1995-9#1)(2009-7#1)(2012-3#1)
the equivalence point (EP)##2##4##(2008-10#2)
the equivalence point##8##3##(2008-10#8)
the equivalence##13##2##(1995-9#1)(2008-10#9)(2008-3#1)(2009-7#1)(2012-3#1)
the equivalent of##4##3##(2007-11#1)(2008-10#1)(2009-12#1)(2010-2#1)
the equivalent##29##2##(1991-9#1)(1992-12#1)(1992-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1997-6#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#8)(2009-12#1)(2010-2#1)(2012-3#1)
the era of the##2##4##(1993-1#1)(2009-7#1)
the era of##19##3##(1993-1#3)(1996-1#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-1#3)
the eradication of the##2##4##(2008-4#1)(2008-5#1)
the eradication of##10##3##(1995-5#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
the eradication##14##2##(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
the eriophyid mite-transmitted##2##3##(2008-10#2)
the eriophyid##3##2##(2008-10#3)
the erosion of##4##3##(2008-10#2)(2008-11#1)(2008-12#1)
the erosion yield caused by##2##5##(2010-4#2)
the erosion##8##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-4#3)
the error associated with##2##4##(2008-3#1)(2008-6#1)
the error caused by the##2##5##(2008-3#2)
the error in the##7##4##(1995-8#1)(2008-2#4)(2008-3#2)
the error in##10##3##(1995-8#1)(2008-10#1)(2008-2#6)(2008-3#2)
the error introduced##2##3##(2008-2#1)(2009-4#1)
the error is##3##3##(1995-3#1)(2008-3#2)
the error metric##2##3##(2008-2#2)
the error of the retrieved##2##5##(2008-3#2)
the error of the##3##4##(2008-3#3)
the error of##5##3##(2008-2#1)(2008-3#4)
the error propagation theory##2##4##(2008-10#2)
the error rate##4##3##(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#1)
the error that is due to##2##6##(2008-2#1)(2008-3#1)
the error that is##3##4##(2008-2#2)(2008-3#1)
the error that results##2##4##(2008-2#1)(2008-3#1)
the error that##5##3##(2008-2#3)(2008-3#2)
the error##71##2##(1995-3#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#19)(2008-3#25)(2008-6#4)(2009-10#1)(2009-4#2)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the errors are##3##3##(1992-9#1)(2008-3#2)
the errors caused by the##2##5##(2008-3#2)
the errors in the##2##4##(2007-12#1)(2013-8#1)
the errors in##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
the errors into account##2##4##(1992-6#1)(2008-3#1)
the errors of##3##3##(2008-10#1)(2008-3#2)
the errors were##2##3##(2008-12#1)(2008-3#1)
the errors##27##2##(1992-6#2)(1992-9#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#15)(2013-8#1)
the errors-in-variables context##2##3##(2010-3#2)
the eruption of Mt##2##4##(2008-2#1)(2008-3#1)
the eruption of##4##3##(2008-2#3)(2008-3#1)
the erythrocyte membrane lipid##2##4##(1990-2#1)(2008-11#1)
the erythrocyte membrane##4##3##(1990-2#1)(1993-11#1)(1995-8#1)(2008-11#1)
the erythrocyte membranes##3##3##(1990-2#1)(1991-5#1)(1994-8#1)
the erythrocyte sedimentation rate##3##4##(1990-11#1)(1997-6#1)(2007-7#1)
the erythrocyte##16##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1991-5#1)(1993-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-8#1)(2012-2#1)
the erythrocytes##4##2##(1990-2#1)(1994-9#1)(1997-6#1)(2008-8#1)
the erythrocytic##2##2##(2010-2#1)(2012-12#1)
the erythroid##4##2##(1990-5#1)(1991-5#1)(1992-12#1)(1994-8#1)
the erythropoietin##2##2##(1991-9#1)(2007-7#1)
the escalation##3##2##(2009-10#2)(2013-1#1)
the escape of MeBr##2##4##(1995-3#2)
the escape of##3##3##(1995-3#2)(1996-12#1)
the escape##4##2##(1995-3#2)(1996-12#1)(2008-9#1)
the escape-from-enemy hypothesis##2##3##(2008-8#2)
the eschar (tache noire)##2##4##(2013-8#2)
the eschar##5##2##(2013-8#5)
the esophageal##7##2##(2008-5#1)(2011-2#1)(2013-8#5)
the esophagus and stomach##2##4##(2011-2#1)(2012-3#1)
the esophagus and##7##3##(2007-7#1)(2007-8#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
the esophagus##32##2##(1992-6#1)(1992-9#1)(1993-8#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-5#6)(2009-3#2)(2010-12#1)(2010-8#1)(2011-2#6)(2012-3#1)(2013-8#6)
the essay##2##2##(2008-12#2)
the essence of the##2##4##(2008-8#1)(2009-7#1)
the essence of##9##3##(1992-2#1)(1994-2#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-7#1)
the essence##10##2##(1992-2#1)(1994-2#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)
the essential components##2##3##(1994-8#1)(1995-1#1)
the essential downstream component of##2##5##(1997-3#2)
the essential elements##3##3##(1991-12#1)(2007-11#1)(2008-4#1)
the essential features of the##2##5##(1994-12#1)(2008-10#1)
the essential features##3##3##(1994-12#1)(2008-10#1)(2011-1#1)
the essential oil of the fruits##5##6##(2008-11#4)(2008-12#1)
the essential oil of the##6##5##(2008-11#5)(2008-12#1)
the essential oil of##10##4##(2008-11#7)(2008-12#1)(2008-5#2)
the essential oil##16##3##(2007-1#1)(2008-11#7)(2008-12#2)(2008-5#2)(2012-3#2)(2013-1#2)
the essential oils and their##2##5##(2008-10#2)
the essential oils of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
the essential oils##7##3##(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)
the essential role of the##2##5##(1995-12#1)(2010-5#1)
the essential role of##8##4##(1995-12#1)(1995-2#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the essential role##9##3##(1995-12#1)(1995-2#1)(2008-1#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the essential##76##2##(1990-5#1)(1991-12#1)(1994-12#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#4)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#9)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
the essentials of##2##3##(1992-12#1)(1994-1#1)
the essentials##3##2##(1992-12#1)(1994-1#1)(2008-1#1)
the established experimental conditions##2##4##(2008-10#2)
the established method##2##3##(2008-10#1)(2011-1#1)
the established##29##2##(1991-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the establishment and maintenance of##4##5##(1996-11#1)(1997-2#1)(2008-9#1)(2013-1#1)
the establishment and##5##3##(1996-11#1)(1997-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
the establishment of a##16##4##(1991-12#1)(1996-2#2)(2006-6#1)(2008-10#4)(2008-2#1)(2009-10#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
the establishment of an##6##4##(1991-9#1)(1997-3#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)
the establishment of such##2##4##(2007-11#1)(2012-12#1)
the establishment of the##13##4##(1991-6#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)
the establishment of this##2##4##(2008-10#1)(2008-11#1)
the establishment of##81##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
the establishment or##2##3##(2011-2#2)
the establishment##89##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
the ester##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
the ester-type polyurethane membrane##2##4##(2008-10#2)
the ester-type##3##2##(2008-10#3)
the esterase##2##2##(2008-11#1)(2008-5#1)
the esterification of##3##3##(1992-6#1)(1994-9#1)(2008-7#1)
the esterification reaction##2##3##(2008-10#1)(2008-7#1)
the esterification##5##2##(1992-6#1)(1994-9#1)(2008-10#1)(2008-7#2)
the esterified##2##2##(1994-11#2)
the esthetic##4##2##(1993-8#1)(2008-5#1)(2009-8#1)(2012-3#1)
the estimate of the##5##4##(2007-12#1)(2008-10#1)(2010-7#1)(2012-2#2)
the estimate of##10##3##(1994-2#3)(2007-12#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-7#1)(2012-2#2)
the estimate##15##2##(1994-2#4)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#2)
the estimated average##2##3##(1997-2#1)(2008-10#1)
the estimated convexity is##2##4##(2008-6#2)
the estimated mean##3##3##(1991-6#1)(2008-10#1)(2008-2#1)
the estimated prevalence of##2##4##(2011-2#2)
the estimated prevalence##3##3##(2011-2#2)(2012-1#1)
the estimated regression##2##3##(1995-2#1)(2008-6#1)
the estimated##70##2##(1991-6#1)(1992-3#2)(1993-3#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#8)(2008-6#4)(2008-7#1)(2008-8#4)(2009-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the estimates of the##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
the estimates of##5##3##(2008-10#1)(2008-3#1)(2009-5#1)(2012-2#1)(2012-7#1)
the estimates##15##2##(1991-3#1)(1992-3#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-8#3)(2009-5#1)(2010-3#2)(2012-12#1)(2012-2#1)(2012-7#1)
the estimation method##2##3##(1997-3#2)
the estimation of a##2##4##(2008-3#1)(2012-2#1)
the estimation of growth##2##4##(1997-4#1)(2013-7#1)
the estimation of the activity coefficients##2##6##(2008-10#2)
the estimation of the##19##4##(1993-2#1)(2007-11#2)(2008-10#7)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#2)(2013-1#1)
the estimation of##64##3##(1990-8#1)(1992-9#1)(1993-2#1)(1997-4#1)(2007-11#2)(2007-6#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
the estimation##81##2##(1990-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1997-3#3)(1997-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#14)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
the estimations of##2##3##(2008-10#1)(2013-8#1)
the estimations##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
the estimator##3##2##(1997-3#1)(2010-3#1)(2012-1#1)
the estimators of the##3##4##(1995-9#1)(2009-5#2)
the estrogen receptor and##2##4##(1994-12#1)(2008-11#1)
the estrogen receptor in##2##4##(1994-12#2)
the estrogen receptor##20##3##(1990-5#1)(1994-12#6)(2007-10#1)(2008-11#10)(2010-5#1)(2011-1#1)
the estrogen response element (ERE)##2##5##(1991-2#1)(1992-6#1)
the estrogen response element##3##4##(1991-2#1)(1992-6#2)
the estrogen responsiveness of##2##4##(1991-2#2)
the estrogen##32##2##(1990-5#1)(1991-2#3)(1991-5#1)(1992-6#2)(1994-12#6)(1996-5#1)(2007-10#1)(2008-10#2)(2008-11#12)(2010-5#1)(2011-1#1)(2013-1#1)
the estrogenic##3##2##(2010-5#2)(2013-1#1)
the estrogens##3##2##(1996-5#1)(2008-11#1)(2012-2#1)
the estrous response##2##3##(2008-12#2)
the estrous##6##2##(1992-9#2)(1993-11#2)(2008-12#2)
the estuary##4##2##(2010-5#1)(2013-1#3)
the etalon##13##2##(2007-11#1)(2008-2#4)(2008-3#8)
the etched##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
the etching depth##2##3##(2008-3#2)
the etching process##2##3##(1997-2#1)(2008-10#1)
the etching rate##2##3##(2008-2#1)(2008-3#1)
the etching solution##3##3##(2008-10#3)
the etching##12##2##(1997-2#1)(2008-10#5)(2008-2#2)(2008-3#4)
the ethanol extract of##6##4##(2008-10#2)(2008-11#1)(2010-5#1)(2011-3#1)(2013-7#1)
the ethanol yield##2##3##(2008-6#1)(2013-1#1)
the ethanol##18##2##(1993-11#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#2)(2010-5#1)(2011-3#1)(2013-1#1)(2013-7#1)
the ethanol-induced##3##2##(1994-5#1)(1994-6#1)(2009-7#1)
the ethanolic extract of##2##4##(2008-10#2)
the ethanolic extract##3##3##(2008-10#3)
the ether extract##2##3##(1992-5#1)(2010-2#1)
the ether##3##2##(1992-5#1)(1995-2#1)(2010-2#1)
the ethical issues##5##3##(1994-12#2)(2008-9#2)(2012-1#1)
the ethical principles##3##3##(1994-1#1)(2009-6#1)(2013-1#1)
the ethical##33##2##(1991-2#2)(1994-1#1)(1994-12#2)(1995-6#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#2)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
the ethics committee##3##3##(1993-1#2)(2008-11#1)
the ethics of##3##3##(1991-3#1)(1995-5#1)(2010-11#1)
the ethics##7##2##(1991-3#1)(1993-1#2)(1995-5#1)(2007-3#1)(2008-11#1)(2010-11#1)
the ethidium-SRD##2##2##(1997-4#2)
the ethmoidal##2##2##(1996-5#1)(2006-12#1)
the ethnic composition of school##2##5##(2010-1#2)
the ethnic composition of##3##4##(2010-1#3)
the ethnic specific##2##3##(2008-1#2)
the ethnic##20##2##(1991-11#1)(1994-12#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-1#5)(2010-8#5)(2011-2#1)
the ethyl acetate##3##3##(2008-10#2)(2010-2#1)
the ethyl ester##2##3##(2008-5#1)(2008-7#1)
the ethyl##8##2##(1995-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
the ethylene##5##2##(1993-12#1)(1995-2#1)(2007-12#2)(2008-10#1)
the ethylene-forming enzyme##2##3##(2008-10#2)
the etiologic agent of##5##4##(1997-5#1)(2007-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
the etiologic agent##7##3##(1997-5#1)(2007-2#1)(2008-4#1)(2008-9#1)(2012-3#3)
the etiologic##10##2##(1990-3#1)(1997-5#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#3)
the etiological agent of##4##4##(1992-3#1)(1997-4#1)(2007-12#1)(2008-9#1)
the etiological factors##4##3##(1997-4#3)(2007-8#1)
the etiological##11##2##(1992-3#1)(1997-4#4)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
the etiology and the##2##4##(1997-3#1)(2011-1#1)
the etiology and treatment of##2##5##(2008-6#1)(2013-8#1)
the etiology and##14##3##(1990-11#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-9#1)(2011-1#1)(2013-8#1)
the etiology is##2##3##(2007-5#1)(2009-3#1)
the etiology of Parkinson's disease##2##5##(1995-3#1)(2008-7#1)
the etiology of anxiety##2##4##(1991-2#1)(1995-12#1)
the etiology of obesity in Mäori children##2##7##(2008-1#2)
the etiology of obesity##3##4##(2008-1#2)(2008-5#1)
the etiology of the disease##4##5##(1991-9#2)(2007-12#1)(2008-10#1)
the etiology of the diseases##2##5##(2008-10#1)(2008-3#1)
the etiology of the shortening##2##5##(2007-11#2)
the etiology of the##14##4##(1991-9#2)(1996-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
the etiology of this##3##4##(1993-11#1)(2007-11#1)(2011-2#1)
the etiology of##77##3##(1990-8#2)(1991-2#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the etiology##105##2##(1990-11#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
the etiopathogenesis of reactive##2##4##(1990-6#2)
the etiopathogenesis of##9##3##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1993-9#1)(2010-1#1)(2013-7#1)(2013-8#1)
the etiopathogenesis##11##2##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1993-5#1)(1993-9#1)(2009-5#1)(2010-1#1)(2013-7#1)(2013-8#1)
the etiopathogenetic##2##2##(1990-9#1)(1991-6#1)
the etiopathogenic##2##2##(2012-12#2)
the euarthropod##2##2##(2007-12#2)
the eukaryote##2##2##(2008-7#1)(2008-9#1)
the eukaryotic##20##2##(1990-11#2)(1991-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2011-1#1)(2012-1#1)
the evacuation of a##2##4##(1994-2#1)(2008-7#1)
the evacuation of##5##3##(1994-2#1)(1996-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
the evacuation##7##2##(1991-2#1)(1994-2#1)(1996-12#2)(2008-7#1)(2012-3#1)(2013-1#1)
the evaluated particle##2##3##(2008-3#2)
the evaluated##11##2##(1990-12#1)(2008-3#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
the evaluation and management of##4##5##(2006-5#1)(2007-12#1)(2007-8#1)(2013-8#1)
the evaluation and management##5##4##(2006-5#1)(2007-12#2)(2007-8#1)(2013-8#1)
the evaluation and monitoring of##2##5##(1995-5#1)(2011-3#1)
the evaluation and treatment of##2##5##(2009-1#1)(2009-3#1)
the evaluation and treatment##3##4##(2008-9#1)(2009-1#1)(2009-3#1)
the evaluation and##24##3##(1995-5#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
the evaluation of a##3##4##(1997-2#1)(2008-9#1)(2011-2#1)
the evaluation of acute##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
the evaluation of antimicrobial agents##2##5##(2008-7#2)
the evaluation of coronary artery disease##2##6##(2008-12#1)(2010-11#1)
the evaluation of coronary artery##3##5##(2008-12#1)(2010-11#1)(2011-2#1)
the evaluation of health##2##4##(1997-3#1)(2010-10#1)
the evaluation of models##2##4##(2008-8#1)(2011-2#1)
the evaluation of new##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
the evaluation of other##2##4##(2008-10#1)(2013-7#1)
the evaluation of patients with##6##5##(2007-4#1)(2008-3#2)(2008-9#2)(2012-2#1)
the evaluation of patients##8##4##(2007-11#1)(2007-4#1)(2008-3#2)(2008-9#2)(2009-8#1)(2012-2#1)
the evaluation of possible##2##4##(2009-6#1)(2011-2#1)
the evaluation of potential##2##4##(2008-10#2)
the evaluation of rectal polypoid lesions in##3##7##(2013-1#3)
the evaluation of small##2##4##(2009-11#1)(2012-2#1)
the evaluation of some##2##4##(2008-10#2)
the evaluation of the clinical##2##5##(1990-3#1)(2011-2#1)
the evaluation of the effects of##3##6##(2008-10#1)(2011-1#1)(2013-1#1)
the evaluation of the impact of##2##6##(2007-11#1)(2013-7#1)
the evaluation of the patient##2##5##(2008-9#1)(2013-8#1)
the evaluation of the results##2##5##(1990-9#1)(2011-2#1)
the evaluation of the##48##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-3#1)(1991-6#1)(1994-5#1)(1996-12#1)(1997-3#1)(2007-11#2)(2008-10#11)(2008-2#3)(2008-5#2)(2008-7#5)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
the evaluation of this##3##4##(1991-5#1)(2008-5#1)(2013-1#1)
the evaluation of various##2##4##(2008-11#1)(2012-2#1)
the evaluation of##190##3##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#3)(1996-5#3)(1997-2#2)(1997-3#3)(1997-8#1)(2007-10#2)(2007-11#5)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#33)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#4)(2008-5#14)(2008-7#17)(2008-8#4)(2008-9#7)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#13)(2012-1#1)(2012-2#8)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#3)
the evaluation process##2##3##(2008-10#1)(2008-12#1)
the evaluation proved##2##3##(1995-3#1)(2008-5#1)
the evaluation was##2##3##(2007-11#1)(2008-1#1)
the evaluation##234##2##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#3)(1996-2#1)(1996-5#3)(1997-2#2)(1997-3#3)(1997-8#1)(2006-5#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#38)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#16)(2008-7#17)(2008-8#4)(2008-9#9)(2009-1#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#16)(2013-7#3)(2013-8#4)
the evaluations of##2##3##(2009-6#1)(2011-2#1)
the evaluations##3##2##(2008-11#1)(2009-6#1)(2011-2#1)
the evaluative##2##2##(1995-3#1)(2011-1#1)
the evanescent field produced##2##4##(2008-3#2)
the evanescent field##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the evanescent##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the evaporation of##4##3##(2008-10#1)(2008-3#1)(2008-5#2)
the evaporation rate and##2##4##(2008-10#2)
the evaporation rate##3##3##(2008-10#3)
the evaporation##8##2##(1995-3#1)(2008-10#4)(2008-3#1)(2008-5#2)
the even##3##2##(1991-1#1)(1994-5#1)(1994-9#1)
the evening##9##2##(1992-3#1)(1996-5#1)(1997-6#1)(2008-5#3)(2011-2#1)(2012-5#2)
the event and##3##3##(2007-10#1)(2008-11#1)(2013-8#1)
the event of a##3##4##(1990-9#1)(2008-7#1)(2008-9#1)
the event of an emergency##3##5##(1992-1#1)(1997-2#1)(2010-1#1)
the event of an##4##4##(1992-1#1)(1997-2#1)(2010-1#1)(2013-1#1)
the event of##14##3##(1990-3#1)(1990-9#1)(1991-6#1)(1992-1#1)(1997-2#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2013-1#1)
the event that the##2##4##(2008-10#1)(2008-2#1)
the event that##4##3##(1997-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
the event##46##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#3)
the event-related brain potential##2##4##(1996-5#1)(2008-11#1)
the event-related potential##2##3##(1995-5#1)(2013-8#1)
the event-related##5##2##(1995-5#1)(1996-5#1)(2008-11#2)(2013-8#1)
the events and##2##3##(1996-2#1)(2009-10#1)
the events leading to##2##4##(1995-2#1)(2008-11#1)
the events of##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2009-11#1)
the events that##4##3##(2008-11#2)(2008-4#1)(2008-9#1)
the events##16##2##(1991-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)
the eventual##14##2##(1993-3#1)(1994-12#1)(1995-2#1)(1996-4#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
the ever##2##2##(1992-2#1)(2011-2#1)
the ever-increasing##2##2##(2008-11#1)(2008-7#1)
the everyday life of##2##4##(1995-6#1)(2011-2#1)
the everyday##10##2##(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
the evidence and##3##3##(1993-12#1)(2008-8#1)(2009-4#1)
the evidence base for##4##4##(2008-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
the evidence base##11##3##(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2010-5#3)(2012-12#1)(2012-2#1)(2013-1#2)
the evidence for a##2##4##(1995-12#1)(2008-7#1)
the evidence for and against##2##5##(2008-6#1)(2010-5#1)
the evidence for##21##3##(1991-12#1)(1992-9#1)(1995-12#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-2#3)(2012-3#2)(2013-1#1)
the evidence from clinical trials is##3##6##(1997-6#1)(2008-5#1)(2010-6#1)
the evidence from##6##3##(1992-4#1)(1993-12#1)(1997-6#1)(2008-5#1)(2009-7#1)(2010-6#1)
the evidence in the##3##4##(2008-6#2)(2010-1#1)
the evidence in##6##3##(1995-5#1)(2008-6#2)(2010-1#1)(2010-5#1)(2013-1#1)
the evidence is##12##3##(1992-5#1)(1994-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
the evidence of a##2##4##(1990-10#1)(2011-2#1)
the evidence of the##2##4##(2008-10#1)(2013-1#1)
the evidence of##9##3##(1990-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#2)
the evidence on the##4##4##(1995-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
the evidence on##7##3##(1995-5#1)(1996-6#1)(2008-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
the evidence regarding##2##3##(2013-1#1)(2013-8#1)
the evidence suggests that##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
the evidence supporting the hypothesis that##2##6##(2008-7#1)(2009-10#1)
the evidence supporting the##3##4##(2008-7#1)(2009-10#1)(2011-2#1)
the evidence supporting##8##3##(2007-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)
the evidence that##8##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#1)
the evidence to##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-1#1)
the evidence which suggests that##2##5##(1994-11#1)(2010-11#1)
the evidence##131##2##(1990-10#1)(1990-8#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#6)(1994-11#2)(1994-12#1)(1995-12#1)(1995-5#2)(1996-12#2)(1996-6#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-2#2)(2010-5#5)(2010-6#1)(2011-2#12)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#7)
the evidence-based##6##2##(2008-12#1)(2008-8#2)(2012-1#1)(2013-1#1)(2013-8#1)
the evidences##2##2##(2008-7#1)(2009-6#1)
the evoked##2##2##(1990-9#1)(2008-9#1)
the evolution and function of##2##5##(1993-2#1)(1996-2#1)
the evolution and##9##3##(1993-2#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)
the evolution in##2##3##(2008-10#1)(2011-2#1)
the evolution of a##4##4##(1995-2#1)(2008-10#1)(2009-10#1)(2013-1#1)
the evolution of altruism##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
the evolution of an##2##4##(1997-6#1)(2008-7#1)
the evolution of clinical practice##2##5##(1997-2#1)(2012-2#1)
the evolution of clutch size##2##5##(2008-9#2)
the evolution of cooperation through reciprocal altruism##2##7##(2008-8#2)
the evolution of cooperation##3##4##(2008-8#2)(2010-4#1)
the evolution of dispersal##3##4##(2008-8#2)(2008-9#1)
the evolution of emotional communication##2##5##(2008-11#2)
the evolution of endophytism##2##4##(2010-6#2)
the evolution of genome##2##4##(2008-4#1)(2010-3#1)
the evolution of guppy##2##4##(2008-8#2)
the evolution of host##2##4##(2008-8#1)(2008-9#1)
the evolution of human language##2##5##(1997-8#1)(2012-12#1)
the evolution of human##3##4##(1997-8#1)(2009-8#1)(2012-12#1)
the evolution of life##2##4##(2008-4#1)(2008-9#1)
the evolution of mating##2##4##(2008-8#1)(2008-9#1)
the evolution of migration rate##3##5##(2008-8#3)
the evolution of migration##4##4##(2008-8#3)(2008-9#1)
the evolution of natural##2##4##(2008-10#1)(2008-8#1)
the evolution of new traits##3##5##(2010-4#3)
the evolution of new##5##4##(2008-10#1)(2010-4#3)(2012-1#1)
the evolution of optimal phenotypes##2##5##(2008-8#2)
the evolution of parasite virulence##3##5##(2008-8#3)
the evolution of parasite##4##4##(2008-8#4)
the evolution of plant##2##4##(2008-10#1)(2008-8#1)
the evolution of premating##2##4##(2008-9#2)
the evolution of reproductive##2##4##(2008-8#2)
the evolution of resistance##3##4##(1995-6#1)(2008-9#1)(2010-4#1)
the evolution of sex##3##4##(2008-8#1)(2009-2#1)(2010-3#1)
the evolution of sexual dimorphism##3##5##(2008-8#3)
the evolution of sexual##4##4##(2008-8#3)(2013-1#1)
the evolution of sibling pathogens in##3##6##(2008-10#3)
the evolution of sociality##3##4##(2008-8#1)(2013-1#2)
the evolution of specialization and##2##5##(2008-8#2)
the evolution of specialization##3##4##(2008-8#3)
the evolution of strong##2##4##(1996-6#1)(2008-9#1)
the evolution of the disease##2##5##(2008-11#1)(2012-2#1)
the evolution of the##57##4##(1990-3#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-9#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-9#1)(2010-11#1)(2010-7#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the evolution of their##2##4##(2008-10#1)(2013-1#1)
the evolution of this##4##4##(2008-1#1)(2009-10#1)(2010-6#1)(2011-2#1)
the evolution of virulence##3##4##(2008-10#1)(2008-8#2)
the evolution of viviparity##2##4##(2008-8#2)
the evolution of worker policing##2##5##(2008-8#2)
the evolution of##312##3##(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-7#1)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#3)(2008-6#4)(2008-7#7)(2008-8#75)(2008-9#29)(2009-10#5)(2009-11#1)(2009-2#3)(2009-3#1)(2009-6#3)(2009-8#5)(2009-9#1)(2010-11#1)(2010-3#7)(2010-4#5)(2010-5#5)(2010-6#5)(2010-7#6)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#11)(2013-1#12)(2013-7#1)(2013-8#4)
the evolution##328##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-6#1)(1993-2#4)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-7#1)(2008-1#2)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#3)(2008-6#5)(2008-7#8)(2008-8#76)(2008-9#30)(2009-10#5)(2009-11#1)(2009-2#3)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-11#1)(2010-3#8)(2010-4#5)(2010-5#5)(2010-6#5)(2010-7#6)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#12)(2013-1#12)(2013-7#1)(2013-8#4)
the evolutionarily stable (ES)##2##4##(2008-8#2)
the evolutionarily stable strategy (ESS)##3##5##(2008-8#1)(2008-9#2)
the evolutionarily stable##9##3##(2008-8#5)(2008-9#4)
the evolutionarily##14##2##(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#5)(2008-9#4)(2011-2#2)
the evolutionary consequences of##2##4##(2008-8#2)
the evolutionary dynamics of##4##4##(2008-7#1)(2008-8#2)(2012-3#1)
the evolutionary dynamics##6##3##(2008-7#1)(2008-8#3)(2012-3#1)(2013-1#1)
the evolutionary forces##3##3##(2008-9#1)(2009-6#1)(2012-3#1)
the evolutionary history of the##2##5##(2008-10#1)(2008-8#1)
the evolutionary history of##3##4##(2008-10#1)(2008-8#1)(2009-2#1)
the evolutionary imperative##2##3##(2008-7#2)
the evolutionary interests##2##3##(2008-8#2)
the evolutionary origin of##3##4##(2007-12#1)(2010-1#1)(2013-1#1)
the evolutionary origin##4##3##(2007-12#1)(2008-8#1)(2010-1#1)(2013-1#1)
the evolutionary origins of##2##4##(2008-11#1)(2010-6#1)
the evolutionary outcome##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
the evolutionary process##4##3##(1994-3#1)(2010-4#1)(2010-5#1)(2012-3#1)
the evolutionary processes##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
the evolutionary relationships##2##3##(1994-11#1)(2008-10#1)
the evolutionary significance of##2##4##(2012-2#1)(2012-3#1)
the evolutionary stability of##3##4##(1993-2#1)(2008-8#1)(2012-3#1)
the evolutionary trajectories##2##3##(2008-8#1)(2012-3#1)
the evolutionary transition##2##3##(2008-9#1)(2009-6#1)
the evolutionary##78##2##(1992-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-5#1)(1997-7#1)(1997-9#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-7#5)(2008-8#20)(2008-9#5)(2009-2#1)(2009-5#1)(2009-6#3)(2010-1#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#2)
the evolved##9##2##(1995-2#1)(2008-10#2)(2008-8#1)(2011-1#4)(2012-12#1)
the evolving role of##4##4##(1993-12#1)(1994-2#1)(1996-9#1)(2009-5#1)
the evolving##10##2##(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-2#1)(2009-5#1)(2010-7#1)
the ex vivo##4##3##(2008-11#2)(2008-5#1)(2008-9#1)
the ex##6##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
the ex-type strain##2##3##(2008-10#2)
the exacerbation##2##2##(1996-8#1)(2008-2#1)
the exact conditional test under inverse sampling##2##7##(1996-3#2)
the exact conditional##3##3##(1995-9#1)(1996-3#2)
the exact date of##2##4##(1994-7#1)(2008-10#1)
the exact diagnosis##2##3##(1990-12#1)(2010-3#1)
the exact formulation##2##3##(2007-11#1)(2008-3#1)
the exact location of the##2##5##(1995-2#1)(2012-12#1)
the exact location##3##3##(1995-2#1)(1996-6#1)(2012-12#1)
the exact mechanism##2##3##(2008-7#2)
the exact nature of the##2##5##(2008-7#1)(2008-9#1)
the exact nature of##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
the exact same##2##3##(2008-11#2)
the exact size of##2##4##(2008-7#1)(2013-1#1)
the exact solution##2##3##(2008-3#2)
the exact value of##2##4##(2008-3#1)(2009-9#1)
the exact values##2##3##(2008-2#1)(2008-3#1)
the exact##86##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-1#1)(1994-7#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-2#6)(2008-3#22)(2008-7#4)(2008-9#3)(2009-12#1)(2009-8#2)(2009-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
the exaggerated##2##2##(1993-3#1)(2008-7#1)
the examination and##3##3##(1990-3#1)(1995-11#1)(1996-11#1)
the examination of##13##3##(1995-11#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-8#1)
the examination was##2##3##(1991-6#1)(2007-12#1)
the examination##30##2##(1990-3#2)(1991-6#2)(1995-11#2)(1995-6#1)(1996-11#1)(1996-12#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#2)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
the examinations were##2##3##(1996-9#1)(1997-3#1)
the examinations##4##2##(1992-5#1)(1995-5#1)(1996-9#1)(1997-3#1)
the examined##16##2##(1991-2#1)(1991-6#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#2)
the examiner##2##2##(2007-11#1)(2011-2#1)
the example of oxidation of##2##5##(1990-5#1)(2008-10#1)
the example of the##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
the example of##18##3##(1990-5#1)(1990-6#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
the example##26##2##(1990-5#1)(1990-6#1)(1992-6#1)(1994-2#2)(1995-1#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
the examples of##4##3##(2007-11#1)(2008-10#1)(2009-12#1)(2009-5#1)
the examples##8##2##(1991-12#1)(2007-11#2)(2008-10#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-7#1)
the excellent performance of##3##4##(2007-11#1)(2007-7#1)(2008-10#1)
the excellent##21##2##(1990-9#1)(1991-6#1)(1993-6#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#1)
the exception of a single##2##5##(2008-10#1)(2008-9#1)
the exception of a##4##4##(1991-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
the exception of the##18##4##(1990-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1996-11#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#2)(2011-2#2)
the exception of two##2##4##(2008-10#1)(2008-12#1)
the exception of##95##3##(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-10#26)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
the exception to##2##3##(1992-1#1)(2008-10#1)
the exception##106##2##(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-10#32)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
the exceptional##2##2##(1995-2#1)(2008-10#1)
the exceptionally##2##2##(2007-12#1)(2008-5#1)
the exceptions to this##2##4##(1996-5#1)(2007-11#1)
the exceptions##8##2##(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-5#1)
the excess demand argument##2##4##(1995-2#2)
the excess of##4##3##(2008-10#4)
the excess##22##2##(1990-8#1)(1991-12#2)(1995-2#2)(1995-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
the excessive use of##2##4##(2008-10#1)(2013-8#1)
the excessive##10##2##(1992-11#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2013-8#1)
the exchange and##4##3##(1996-12#1)(2008-11#1)(2008-3#1)(2010-8#1)
the exchange of information##2##4##(1992-12#1)(2011-2#1)
the exchange of knowledge and##2##5##(2008-9#1)(2012-2#1)
the exchange of##16##3##(1990-2#1)(1992-12#1)(1995-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
the exchange process##3##3##(1995-2#1)(2008-12#1)(2010-3#1)
the exchange##33##2##(1990-2#1)(1992-12#1)(1992-4#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-7#2)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
the exchanger##3##2##(2008-10#3)
the excimer##2##2##(1991-3#1)(1992-6#1)
the excipients##6##2##(2008-10#5)(2010-5#1)
the excised##14##2##(1990-12#1)(1991-5#1)(1995-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
the excision of##4##3##(2007-8#1)(2008-10#1)(2009-1#1)(2011-1#1)
the excision##8##2##(1995-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2011-1#1)
the excitability of##3##3##(1992-3#1)(1994-3#1)(2010-7#1)
the excitation and emission##3##4##(2007-11#1)(2008-10#2)
the excitation and##6##3##(2007-11#1)(2008-10#4)(2008-2#1)
the excitation beam##4##3##(2008-10#1)(2008-3#3)
the excitation energy density##2##4##(2008-3#2)
the excitation energy##3##3##(2007-12#1)(2008-3#2)
the excitation laser##3##3##(2008-3#3)
the excitation light of##2##4##(2007-11#1)(2013-8#1)
the excitation light##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-8#1)
the excitation of surface waves##2##5##(2008-2#2)
the excitation of##8##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
the excitation power##2##3##(2008-2#1)(2012-2#1)
the excitation spectra##2##3##(2008-2#1)(2012-2#1)
the excitation wavelength##2##3##(1994-5#1)(2008-3#1)
the excitation##59##2##(1994-5#1)(1995-3#1)(1996-2#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#7)(2008-3#19)(2008-5#1)(2008-7#2)(2012-2#2)(2013-8#1)
the excitatory neurotransmitter glutamate##2##4##(1990-8#1)(2008-4#1)
the excitatory##10##2##(1990-11#1)(1990-8#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#2)
the excited state energy##3##4##(2009-12#1)(2010-2#2)
the excited state of##2##4##(2008-10#2)
the excited state##11##3##(1995-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-12#1)(2009-6#2)(2010-2#2)
the excited states of##3##4##(2007-12#1)(2008-10#1)(2010-7#1)
the excited states##4##3##(2007-12#1)(2008-10#2)(2010-7#1)
the excited##23##2##(1992-12#1)(1995-11#1)(1995-6#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#4)(2009-12#1)(2009-6#2)(2010-2#2)(2010-7#1)(2012-12#1)
the excited-state absorption##5##3##(2008-10#2)(2008-3#3)
the excited-state##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
the excitement##2##2##(1995-12#1)(2008-7#1)
the exciting radiation##2##3##(2008-3#2)
the exciting##8##2##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#4)(2010-5#1)
the excitotoxic process##2##3##(2008-7#1)(2011-2#1)
the excluded##2##2##(1990-8#1)(1995-6#1)
the exclusion of an##2##4##(1991-6#1)(2010-12#1)
the exclusion of##12##3##(1991-6#1)(1993-2#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-10#1)(2010-12#1)(2012-3#1)
the exclusion##14##2##(1991-6#1)(1993-2#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
the exclusive involvement of##2##4##(1995-12#1)(2008-8#1)
the exclusive##9##2##(1991-1#1)(1993-6#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
the excretion action##2##3##(2011-3#2)
the excretion of##5##3##(1991-12#1)(1993-12#1)(1997-8#1)(2008-10#1)(2012-2#1)
the excretion##9##2##(1990-5#1)(1991-12#1)(1993-12#1)(1994-5#1)(1997-8#1)(2008-10#1)(2011-3#2)(2012-2#1)
the excretory duct##2##3##(2007-12#2)
the excretory##3##2##(2007-12#2)(2008-5#1)
the excursion of the##2##4##(2008-10#1)(2012-2#1)
the execution of##6##3##(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-8#2)
the execution time##3##3##(2008-3#1)(2009-5#1)(2012-2#1)
the execution##10##2##(1993-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
the executioner##2##2##(2008-3#1)(2011-2#1)
the executive function##2##3##(2008-2#1)(2013-8#1)
the executive##14##2##(1993-1#1)(1993-2#2)(1995-3#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-6#1)(2012-1#1)(2013-8#1)
the exemption##2##2##(1996-2#2)
the exercise instructor##2##3##(2007-6#2)
the exercise of power##2##4##(2008-11#2)
the exercise of##4##3##(1995-1#1)(2008-11#2)(2012-3#1)
the exercise was##3##3##(2008-10#2)(2008-12#1)
the exercise##29##2##(1991-12#1)(1991-8#1)(1992-3#4)(1995-1#1)(2007-11#1)(2007-6#3)(2008-10#7)(2008-11#4)(2008-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the exercises##4##2##(2007-11#4)
the exhaust##10##2##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)
the exine##2##2##(2011-2#2)
the existance of##2##3##(1992-3#1)(2009-5#1)
the existence and importance of##2##5##(1990-5#1)(2012-12#1)
the existence and stability of##2##5##(2007-12#1)(2009-8#1)
the existence and##11##3##(1990-5#1)(1991-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2012-12#1)(2013-8#1)
the existence of God##4##4##(2013-1#4)
the existence of a large##3##5##(1991-2#1)(1994-8#1)(2007-11#1)
the existence of a new type of##2##7##(1992-6#1)(2008-8#1)
the existence of a new##4##5##(1992-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
the existence of a##58##4##(1990-5#2)(1990-8#3)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-8#1)(1996-4#1)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#1)(2012-2#2)(2013-1#2)(2013-8#1)
the existence of agonist-specific activated states of##2##7##(1997-7#2)
the existence of an endogenous##2##5##(1994-5#1)(2010-8#1)
the existence of an inverse##2##5##(1994-8#1)(2008-8#1)
the existence of an##14##4##(1990-5#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-8#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)
the existence of at least three##2##6##(1990-8#1)(2008-10#1)
the existence of at least##4##5##(1990-8#1)(1992-12#1)(2008-10#1)(2013-1#1)
the existence of both##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
the existence of diffuse##2##4##(1991-12#1)(2008-2#1)
the existence of distinct##2##4##(1995-8#1)(2008-10#1)
the existence of four major##2##5##(1997-7#1)(2008-5#1)
the existence of many##2##4##(2008-5#1)(2010-8#1)
the existence of more##2##4##(2008-10#2)
the existence of multiple##3##4##(1991-5#1)(2008-10#1)(2008-7#1)
the existence of positive##2##4##(2008-3#1)(2008-9#1)
the existence of stable and##2##5##(1994-8#1)(2008-2#1)
the existence of the##13##4##(1990-7#1)(1990-8#1)(1991-3#1)(1993-11#1)(1994-11#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-5#1)
the existence of three##2##4##(1992-8#1)(2008-10#1)
the existence of two##10##4##(1990-11#1)(1990-7#1)(1991-1#1)(1993-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)
the existence of##251##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#2)(1990-8#5)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#3)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#3)(1997-3#2)(1997-6#4)(1997-7#5)(1997-9#1)(2007-11#4)(2007-12#10)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#35)(2008-11#11)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#3)(2009-2#3)(2009-3#1)(2009-5#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#7)(2013-8#4)
the existence##265##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#4)(1990-7#2)(1990-8#5)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-3#3)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#3)(1997-3#2)(1997-6#4)(1997-7#5)(1997-9#1)(2007-11#4)(2007-12#11)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#35)(2008-11#12)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#4)(2009-2#3)(2009-3#1)(2009-5#3)(2009-7#2)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#7)(2013-8#6)
the existing channels##2##3##(2008-2#2)
the existing conventional procedure##2##4##(2008-10#2)
the existing data##2##3##(1994-1#1)(2008-8#1)
the existing evidence##4##3##(2011-1#1)(2011-2#1)(2013-1#2)
the existing health##2##3##(1995-1#1)(2010-8#1)
the existing literature on the##2##5##(1996-11#1)(2008-5#1)
the existing literature on##4##4##(1993-12#1)(1996-11#1)(2008-5#1)(2012-12#1)
the existing literature##11##3##(1993-12#1)(1996-11#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
the existing methods##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)
the existing problems##2##3##(2010-12#1)(2012-3#1)
the existing process##2##3##(1993-12#1)(2012-3#1)
the existing recommendations##2##3##(2008-11#1)(2008-8#1)
the existing system##4##3##(1997-4#2)(2008-11#1)(2008-7#1)
the existing systems##2##3##(2008-7#1)(2010-8#1)
the existing theory##2##3##(2007-11#1)(2008-8#1)
the existing##100##2##(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-7#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#7)(2008-8#3)(2009-1#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
the exit aperture of the##2##5##(2008-3#2)
the exit pupil##2##3##(2008-3#2)
the exit site##8##3##(2007-12#1)(2007-7#4)(2011-2#3)
the exit##19##2##(1994-3#1)(2007-12#1)(2007-7#4)(2008-2#3)(2008-3#7)(2011-2#3)
the exocytotic##4##2##(1990-12#1)(1993-3#1)(2008-12#1)(2008-4#1)
the exogenous application of##3##4##(1990-5#1)(2008-10#1)(2008-4#1)
the exogenous##14##2##(1990-10#1)(1990-5#1)(1993-8#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-10#1)
the exon 7 and 8##2##5##(1993-8#2)
the exon##15##2##(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#6)(1995-6#1)(1997-8#1)(2006-8#1)(2008-9#1)(2012-3#1)
the exons##5##2##(1992-3#2)(1993-8#1)(1997-2#1)(2008-8#1)
the exothermic and spontaneous nature of##2##6##(2008-10#2)
the exotic##2##2##(2009-2#2)
the expanded score##2##3##(1992-6#2)
the expanded uncertainty##2##3##(2008-10#2)
the expanded##14##2##(1991-12#1)(1992-6#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#1)
the expanding##4##2##(1997-8#1)(2008-10#1)(2009-4#1)(2011-1#1)
the expansion of activated##2##4##(2008-10#2)
the expansion of the##5##4##(1997-1#1)(2008-10#2)(2008-4#1)(2013-1#1)
the expansion of##18##3##(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
the expansion order##3##3##(2008-2#3)
the expansion##24##2##(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the expectation of##2##3##(1990-10#1)(2008-12#1)
the expectation that##4##3##(1992-8#1)(1997-1#1)(2008-8#1)(2012-12#1)
the expectation value of##2##4##(2007-11#1)(2009-9#1)
the expectation##9##2##(1990-10#1)(1992-8#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2012-12#1)
the expectation-maximization (EM)##2##3##(2008-2#1)(2012-3#1)
the expectations of mothers##2##4##(2008-9#2)
the expectations of##5##3##(1997-1#1)(2008-9#3)(2013-1#1)
the expectations##7##2##(1997-1#1)(2008-7#1)(2008-9#3)(2011-2#1)(2013-1#1)
the expected and observed##2##4##(2008-9#2)
the expected and##3##3##(2008-10#1)(2008-9#2)
the expected behavior##2##3##(1992-9#1)(2008-7#1)
the expected effect##2##3##(1997-1#1)(1997-2#1)
the expected final##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
the expected increase in##2##4##(2011-2#1)(2013-8#1)
the expected population##2##3##(2008-10#1)(2008-8#1)
the expected response of##2##4##(2008-10#1)(2008-9#1)
the expected results##2##3##(2008-10#1)(2008-4#1)
the expected runtime of##2##4##(2010-2#2)
the expected runtime##3##3##(2010-2#3)
the expected size##2##3##(1993-8#1)(2008-10#1)
the expected sizes##2##3##(1991-5#1)(1995-12#1)
the expected time to extinction##2##5##(2008-9#2)
the expected time to##3##4##(2008-5#1)(2008-9#2)
the expected time##4##3##(2008-10#1)(2008-5#1)(2008-9#2)
the expected value##2##3##(1997-4#1)(2008-10#1)
the expected values##2##3##(1990-6#1)(1995-5#1)
the expected##130##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#3)(2008-10#27)(2008-11#4)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the expense##25##2##(1990-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
the expenses##4##2##(1990-12#1)(2009-10#1)(2012-2#1)(2013-8#1)
the expensive##5##2##(1997-6#1)(2008-10#2)(2009-10#1)(2011-2#1)
the experience and##2##3##(1994-1#1)(2007-9#1)
the experience of a##2##4##(1994-1#1)(1996-12#1)
the experience of being a lecturer practitioner##2##7##(2008-12#2)
the experience of nurses##3##4##(2007-10#1)(2008-1#1)(2008-7#1)
the experience of one##3##4##(1993-12#1)(2008-12#1)(2009-2#1)
the experience of stress##2##4##(2009-7#1)(2012-1#1)
the experience of the##13##4##(1991-6#1)(1992-3#1)(1994-1#1)(1994-12#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
the experience of##56##3##(1990-2#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#2)(1995-1#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#4)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the experience was a##2##4##(2008-1#1)(2008-12#1)
the experience with the##2##4##(2008-10#1)(2012-3#1)
the experience with##8##3##(1995-5#1)(2008-1#2)(2008-10#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-8#1)
the experience##82##2##(1990-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#12)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#4)(2009-10#1)(2009-2#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the experienced##2##2##(2008-9#1)(2009-11#1)
the experiences and perceptions##2##4##(2008-11#1)(2010-10#1)
the experiences and##3##3##(2008-11#1)(2010-10#1)(2011-1#1)
the experiences of a##3##4##(1997-1#1)(2008-11#1)(2010-4#1)
the experiences of nurses studying professional doctorates##2##7##(2013-8#2)
the experiences of the##5##4##(1997-3#1)(2008-12#1)(2009-7#1)(2010-3#1)(2013-1#1)
the experiences of these##2##4##(1997-7#1)(2009-5#1)
the experiences of two clinical##2##5##(2008-11#2)
the experiences of##39##3##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-11#4)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#3)(2010-11#1)(2010-3#3)(2010-4#1)(2011-1#1)(2013-1#2)(2013-8#2)
the experiences##50##2##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#2)(1995-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-12#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#3)(2010-10#1)(2010-11#1)(2010-3#3)(2010-4#1)(2011-1#2)(2012-12#1)(2013-1#4)(2013-8#2)
the experiential##4##2##(1994-9#1)(2008-11#2)(2010-10#1)
the experiment and the##2##4##(1997-3#1)(2008-7#1)
the experiment and##8##3##(1992-9#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-2#2)
the experiment are demonstrated##3##4##(2008-2#1)(2008-3#2)
the experiment are##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the experiment in##2##3##(2007-11#1)(2008-10#1)
the experiment is##3##3##(2007-12#1)(2008-3#2)
the experiment on##2##3##(2008-4#1)(2012-2#1)
the experiment the##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#2)
the experiment was##2##3##(2008-12#1)(2009-8#1)
the experiment were##3##3##(2006-4#1)(2008-5#1)(2008-7#1)
the experiment##95##2##(1992-2#1)(1992-9#3)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(2006-4#1)(2007-11#3)(2007-12#4)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#3)(2012-1#4)(2012-2#3)(2012-8#1)(2013-1#3)(2013-7#3)(2013-8#2)
the experimental and calculated data##2##5##(2008-2#1)(2008-3#1)
the experimental and calculated##3##4##(2008-2#1)(2008-3#2)
the experimental and control groups##3##5##(1991-12#1)(2011-1#1)(2011-2#1)
the experimental and theoretical##5##4##(2008-2#1)(2008-3#3)(2013-8#1)
the experimental and##14##3##(1991-12#1)(2008-2#3)(2008-3#6)(2011-1#1)(2011-2#2)(2013-8#1)
the experimental area##2##3##(2008-10#2)
the experimental basis for##2##4##(2008-7#1)(2013-1#1)
the experimental conditions employed##3##4##(2008-10#3)
the experimental conditions of##2##4##(1992-4#1)(2008-10#1)
the experimental conditions used##2##4##(2008-10#1)(2010-11#1)
the experimental conditions was##2##4##(2008-10#2)
the experimental conditions##35##3##(1992-4#1)(1996-6#1)(2006-4#1)(2008-10#28)(2008-11#2)(2008-3#1)(2010-11#1)
the experimental data and##2##4##(2008-2#1)(2009-6#1)
the experimental data to##4##4##(2008-2#2)(2008-3#1)(2008-7#1)
the experimental data with##3##4##(1996-5#1)(2007-12#1)(2008-3#1)
the experimental data##41##3##(1996-5#2)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-11#1)(2008-2#5)(2008-3#9)(2008-7#4)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
the experimental design##8##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
the experimental error##2##3##(2008-10#1)(2008-3#1)
the experimental evaluation##2##3##(2008-3#1)(2008-6#1)
the experimental evidence##3##3##(1990-8#1)(2007-11#1)(2010-5#1)
the experimental findings##3##3##(1992-3#1)(2008-11#2)
the experimental group and##2##4##(2008-12#2)
the experimental group received##2##4##(2007-11#1)(2010-12#1)
the experimental group##28##3##(1991-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-12#5)(2009-6#2)(2010-12#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
the experimental groups##6##3##(2008-12#1)(2008-5#2)(2012-3#1)(2013-1#2)
the experimental measurements##2##3##(1990-11#1)(2008-3#1)
the experimental model##5##3##(1997-6#1)(2008-12#1)(2008-7#1)(2013-1#2)
the experimental observation of##4##4##(2007-11#3)(2007-12#1)
the experimental observation##5##3##(2007-11#3)(2007-12#1)(2008-11#1)
the experimental observations##2##3##(2008-2#1)(2008-7#1)
the experimental parameters##7##3##(2008-10#6)(2013-8#1)
the experimental period##4##3##(2008-6#1)(2011-2#1)(2012-5#2)
the experimental periods##3##3##(2008-10#2)(2013-1#1)
the experimental result##2##3##(2007-11#1)(2008-11#1)
the experimental results and the##3##5##(2007-11#1)(2008-2#1)(2008-8#1)
the experimental results and##8##4##(1993-11#1)(2007-11#1)(2008-2#3)(2008-8#1)(2009-7#1)(2013-8#1)
the experimental results for##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the experimental results of##3##4##(2008-3#3)
the experimental results show##2##4##(2008-10#1)(2008-3#1)
the experimental results##59##3##(1990-12#1)(1993-11#1)(1995-3#1)(1997-7#1)(2007-11#6)(2007-12#3)(2008-1#1)(2008-10#7)(2008-2#11)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
the experimental set-up##2##3##(2008-10#1)(2008-7#1)
the experimental setup and the##2##5##(2007-11#1)(2008-3#1)
the experimental setup##6##3##(2007-11#1)(2008-3#4)(2010-10#1)
the experimental sorption isotherms##2##4##(2010-4#2)
the experimental spectra##2##3##(2008-3#2)
the experimental studies##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
the experimental study of##2##4##(2007-12#1)(2008-3#1)
the experimental study##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
the experimental system we used##2##5##(1994-10#1)(1996-2#1)
the experimental teat dip##2##4##(1990-6#2)
the experimental treatment##3##3##(1995-2#1)(1997-8#1)(2010-9#1)
the experimental values##5##3##(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
the experimental variables affecting the##2##5##(2008-10#2)
the experimental variables##4##3##(2008-10#4)
the experimental##396##2##(1990-11#1)(1990-12#1)(1990-6#3)(1990-8#2)(1991-12#2)(1991-3#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-6#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#5)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-4#1)(2007-10#1)(2007-11#21)(2007-12#13)(2008-1#4)(2008-10#105)(2008-11#12)(2008-12#8)(2008-2#30)(2008-3#65)(2008-5#8)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#7)(2012-2#4)(2012-3#2)(2012-5#2)(2013-1#12)(2013-7#1)(2013-8#4)
the experimentalist##2##2##(2008-4#1)(2009-5#1)
the experimentally determined##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
the experimentally measured##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-2#1)
the experimentally observed##6##3##(1993-11#1)(1996-2#1)(1997-8#1)(2008-3#1)(2009-5#1)(2012-2#1)
the experimentally obtained##2##3##(2007-12#1)(2008-3#1)
the experimentally##20##2##(1990-7#1)(1993-11#1)(1996-2#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#4)(2009-5#3)(2010-2#1)(2012-2#1)
the experimentation##2##2##(2008-10#1)(2011-1#1)
the experimenter##6##2##(2007-6#3)(2008-11#1)(2008-4#1)(2012-12#1)
the experimenters presented##2##3##(2009-5#2)
the experiments are##2##3##(2008-10#1)(2008-7#1)
the experiments described##3##3##(1991-9#1)(2008-3#1)(2013-7#1)
the experiments in##2##3##(2008-3#1)(2008-4#1)
the experiments was##3##3##(1997-7#1)(2007-12#1)(2008-10#1)
the experiments with##2##3##(1991-12#1)(1996-5#1)
the experiments##65##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-8#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#5)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-9#1)(2010-2#2)(2011-1#2)(2013-7#2)(2013-8#1)
the expert##11##2##(1992-1#1)(1994-1#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-2#1)
the expertise of the##2##4##(1997-8#1)(2011-1#1)
the expertise of##3##3##(1996-1#1)(1997-8#1)(2011-1#1)
the expertise##5##2##(1996-1#1)(1996-2#1)(1997-8#1)(2011-1#1)(2012-3#1)
the experts##8##2##(1996-2#2)(1996-3#2)(2008-4#1)(2010-12#1)(2011-10#1)(2011-2#1)
the experts'##3##2##(1992-9#1)(2008-6#1)(2013-1#1)
the expiratory##2##2##(1996-5#1)(2013-7#1)
the explained variance##2##3##(1993-3#1)(2008-10#1)
the explained##3##2##(1993-3#1)(2008-10#2)
the explanation for##2##3##(2008-5#1)(2011-2#1)
the explanation##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
the explanations##3##2##(1993-6#1)(2007-10#1)(2009-9#1)
the explanatory power of##2##4##(1993-3#1)(2008-10#1)
the explanatory variables in##2##4##(1992-6#1)(1995-2#1)
the explanatory variables##4##3##(1992-6#2)(1995-2#1)(1997-3#1)
the explanatory##7##2##(1992-6#2)(1993-3#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#1)
the explant##2##2##(2008-11#1)(2011-3#1)
the explanted##4##2##(2008-9#2)(2010-1#1)(2010-4#1)
the explants##2##2##(1996-5#1)(2008-8#1)
the explicit goal##2##3##(2008-11#2)
the explicit health guarantees law##2##5##(2011-2#2)
the explicit##10##2##(1995-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
the exploitation of the##2##4##(2008-3#1)(2009-5#1)
the exploitation of##7##3##(2008-10#1)(2008-3#3)(2008-8#1)(2009-11#1)(2009-5#1)
the exploration of the##4##4##(2008-8#2)(2010-8#1)(2013-8#1)
the exploration of##11##3##(1990-3#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-5#1)(2013-8#1)
the exploration##14##2##(1990-3#1)(2008-2#2)(2008-5#2)(2008-8#3)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-5#1)(2013-8#1)
the explosion of information##2##4##(1993-2#1)(2011-2#1)
the explosion of##3##3##(1993-2#1)(2008-2#1)(2011-2#1)
the explosion##4##2##(1993-2#1)(2007-7#1)(2008-2#1)(2011-2#1)
the explosive##2##2##(2007-7#1)(2008-11#1)
the exponent##2##2##(2008-2#1)(2012-2#1)
the exponential growth phase##5##4##(2008-11#2)(2008-7#2)(2011-2#1)
the exponential growth##6##3##(2008-11#2)(2008-7#3)(2011-2#1)
the exponential increase in##3##4##(1995-3#1)(2007-12#1)(2009-11#1)
the exponential model##3##3##(1995-9#1)(2008-10#2)
the exponential phase of##6##4##(1994-8#1)(2008-11#5)
the exponential phase##11##3##(1994-8#1)(2008-11#9)(2011-2#1)
the exponential##40##2##(1994-8#1)(1995-3#1)(1995-9#1)(1996-1#1)(2007-12#1)(2008-10#9)(2008-11#12)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2009-11#1)(2010-4#1)(2011-2#4)
the exposed group##2##3##(1994-5#1)(2009-12#1)
the exposed parts of the##2##5##(2007-7#1)(2008-7#1)
the exposed workers##4##3##(2008-10#1)(2009-12#3)
the exposed##27##2##(1993-12#1)(1994-5#1)(1995-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2010-4#1)(2011-2#2)(2013-1#2)
the exposure dose##2##3##(1992-3#1)(2007-12#1)
the exposure of fibrinogen receptor in thrombin-stimulated platelets##2##8##(1993-8#2)
the exposure of fibrinogen receptor in##3##6##(1993-8#3)
the exposure of the##5##4##(2006-12#1)(2008-10#3)(2008-8#1)
the exposure of##21##3##(1993-8#4)(1994-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-7#1)(2012-2#1)(2013-1#1)
the exposure time is##2##4##(2008-10#1)(2008-3#1)
the exposure time##7##3##(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
the exposure to##12##3##(1991-12#2)(1993-2#1)(1995-4#1)(1996-2#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#2)
the exposure##65##2##(1990-5#1)(1991-12#3)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#4)(1994-11#1)(1994-2#2)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#5)(2008-10#7)(2008-11#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-11#1)(2009-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
the express-FIIAA##2##2##(2008-10#2)
the expressed protein##8##3##(1992-12#1)(1993-6#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#1)(2013-1#1)
the expressed##21##2##(1991-5#2)(1992-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2010-6#1)(2013-1#1)
the expression and function of the##2##6##(1994-8#1)(2007-12#1)
the expression and function of##5##5##(1993-8#1)(1994-8#1)(2007-12#1)(2008-5#1)(2008-6#1)
the expression and purification of##2##5##(2008-4#1)(2009-9#1)
the expression and secretion of##3##5##(1991-9#1)(1996-2#1)(2008-5#1)
the expression and##21##3##(1990-2#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-3#1)(2012-3#1)(2013-8#1)
the expression and/or function of the##2##6##(2008-11#1)(2008-3#1)
the expression cassette##4##3##(1997-4#2)(2008-11#1)(2008-8#1)
the expression data##2##3##(1993-12#1)(2008-7#1)
the expression for the##2##4##(1992-6#1)(2008-3#1)
the expression for##3##3##(1992-6#1)(2008-3#2)
the expression in the##2##4##(1996-12#1)(2009-6#1)
the expression in##6##3##(1993-6#1)(1994-2#1)(1996-12#1)(2008-6#1)(2008-8#1)(2009-6#1)
the expression level and##2##4##(2008-9#1)(2010-5#1)
the expression level of the##4##5##(1997-3#1)(1997-8#1)(2008-10#1)(2008-9#1)
the expression level of##14##4##(1995-11#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2013-8#1)
the expression level##19##3##(1991-9#1)(1995-11#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2010-5#1)(2013-8#1)
the expression levels of specific##2##5##(2008-1#1)(2008-7#1)
the expression levels of these##2##5##(1993-6#1)(2011-2#1)
the expression levels of##11##4##(1991-5#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#1)
the expression levels were##3##4##(2008-8#1)(2008-9#2)
the expression levels##18##3##(1991-5#1)(1993-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)
the expression of 'anxious'##2##4##(1993-3#2)
the expression of APP##2##4##(1993-3#1)(1996-12#1)
the expression of Bcl-2##2##4##(2010-12#1)(2013-8#1)
the expression of Cx43##2##4##(2008-11#1)(2008-6#1)
the expression of ER##2##4##(1995-4#1)(2013-8#1)
the expression of HO-1##3##4##(2008-4#2)(2011-2#1)
the expression of ICAM-1 mRNA##2##5##(2010-1#2)
the expression of IGF-I receptor##2##5##(1996-2#1)(2008-11#1)
the expression of IGF-I##4##4##(1994-2#1)(1996-2#1)(2008-11#2)
the expression of IL-10##2##4##(2011-3#2)
the expression of IL-12 p40 and p35 mRNA##2##8##(2008-8#2)
the expression of IL-12##3##4##(2008-8#3)
the expression of MEDDF##2##4##(2008-8#2)
the expression of MHC##2##4##(2008-11#1)(2008-8#1)
the expression of MMP-2##2##4##(2008-9#2)
the expression of MyoD1##2##4##(1992-8#2)
the expression of PKC isoforms##2##5##(1994-6#1)(1996-5#1)
the expression of SSTR2 in the carcinoid cells##2##8##(2011-2#2)
the expression of TH##2##4##(1996-12#1)(2008-10#1)
the expression of a number of##3##6##(1997-4#1)(2010-8#1)(2012-12#1)
the expression of a reporter gene##2##6##(1994-12#1)(2010-10#1)
the expression of a variety of genes##2##7##(1993-3#1)(1995-12#1)
the expression of a##17##4##(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)
the expression of adhesion molecules##2##5##(1995-5#1)(2008-1#1)
the expression of alpha B-crystallin mRNA in##2##7##(1991-12#2)
the expression of an##5##4##(1990-3#1)(1990-5#1)(1992-3#1)(1994-11#1)(2008-5#1)
the expression of both##3##4##(1993-12#1)(2008-10#1)(2009-12#1)
the expression of c-Met receptor##2##5##(2011-2#2)
the expression of c-myc and##2##5##(1992-8#1)(2008-8#1)
the expression of c-myc##3##4##(1992-8#1)(2008-11#1)(2008-8#1)
the expression of cellular##3##4##(1997-6#1)(2008-11#1)(2010-1#1)
the expression of certain##2##4##(1997-8#1)(2008-9#1)
the expression of cyclins##2##4##(1997-6#1)(2008-4#1)
the expression of exogenous gene##2##5##(2008-9#2)
the expression of foreign##2##4##(1995-5#1)(1997-8#1)
the expression of genes encoding##2##5##(2009-10#1)(2012-2#1)
the expression of genes in##2##5##(2008-10#2)
the expression of genes##10##4##(1994-8#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)
the expression of growth##2##4##(1992-9#1)(2008-11#1)
the expression of heat shock protein##3##6##(1994-11#2)(1994-8#1)
the expression of heat shock##5##5##(1994-11#3)(1994-8#2)
the expression of hsps##2##4##(2012-12#2)
the expression of human##3##4##(1993-9#1)(2008-10#1)(2008-11#1)
the expression of inducible nitric oxide synthase##2##7##(1996-12#1)(2008-5#1)
the expression of inducible##3##4##(1996-12#2)(2008-5#1)
the expression of key##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the expression of lambdaN gene##2##5##(2008-8#2)
the expression of lamins A and C##3##7##(1992-12#3)
the expression of mRNAs##2##4##(1996-12#2)
the expression of many##2##4##(2008-4#1)(2010-7#1)
the expression of matrix##2##4##(2009-5#1)(2013-1#1)
the expression of membrane##2##4##(1992-3#1)(2011-1#1)
the expression of more than 100##2##6##(2010-7#1)(2011-2#1)
the expression of other##5##4##(2008-10#2)(2008-7#2)(2008-8#1)
the expression of p-p53##2##4##(2011-2#2)
the expression of pathogenesis-related##2##4##(2008-10#1)(2011-10#1)
the expression of pro- and anti-apoptotic##2##6##(2009-12#2)
the expression of protein D##2##5##(1992-3#2)
the expression of proteins##2##4##(1992-3#1)(1994-9#1)
the expression of recombinant##4##4##(2008-11#3)(2008-4#1)
the expression of regulatory##2##4##(1994-11#1)(2009-3#1)
the expression of select##2##4##(2008-11#1)(2013-1#1)
the expression of several##7##4##(1991-9#1)(1992-3#2)(1996-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
the expression of some##5##4##(1990-6#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-9#1)
the expression of specific genes##3##5##(1991-12#1)(1994-3#1)(2008-4#1)
the expression of specific##4##4##(1991-12#1)(1994-3#1)(2008-1#1)(2008-4#1)
the expression of the IL-6##2##5##(1990-5#1)(1995-2#1)
the expression of the gene##6##5##(1993-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-5#1)(2009-10#1)
the expression of the genes##3##5##(1991-5#1)(1996-2#1)(1997-8#1)
the expression of the lacZ reporter##2##6##(1997-6#2)
the expression of the major##3##5##(2008-11#1)(2008-5#2)
the expression of the##83##4##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#3)(2007-12#1)(2008-10#4)(2008-11#8)(2008-4#2)(2008-5#5)(2008-8#2)(2008-9#6)(2009-10#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the expression of these genes in##2##6##(1996-12#1)(2008-11#1)
the expression of these genes##3##5##(1995-12#1)(1996-12#1)(2008-11#1)
the expression of these##11##4##(1990-8#1)(1991-9#1)(1994-7#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-1#1)
the expression of this##5##4##(1991-5#1)(1994-8#1)(1996-2#1)(2008-10#1)(2010-2#1)
the expression of three##2##4##(1992-3#1)(2008-10#1)
the expression of topoisomerase##2##4##(1993-8#2)
the expression of type##2##4##(2008-10#1)(2010-6#1)
the expression of various##2##4##(2008-8#1)(2013-1#1)
the expression of which##2##4##(2007-10#1)(2010-11#1)
the expression of##560##3##(1990-11#2)(1990-12#5)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#1)(1991-5#4)(1991-8#1)(1991-9#4)(1992-1#2)(1992-12#4)(1992-3#10)(1992-6#1)(1992-8#9)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#7)(1993-5#2)(1993-6#6)(1993-8#6)(1993-9#3)(1994-11#11)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#8)(1994-9#4)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#2)(1996-12#19)(1996-2#5)(1996-3#1)(1996-5#4)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#8)(1997-7#5)(1997-8#8)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#40)(2008-11#36)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#18)(2008-5#12)(2008-6#5)(2008-7#19)(2008-8#35)(2008-9#25)(2009-10#3)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#20)(2011-3#4)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#16)
the expression pattern of Xmsx-2B##2##5##(2008-6#2)
the expression pattern of the##3##5##(1992-3#1)(2007-12#1)(2008-10#1)
the expression pattern of##12##4##(1992-3#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-1#1)
the expression pattern##16##3##(1992-3#1)(1994-11#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
the expression patterns of##7##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
the expression patterns##8##3##(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
the expression plasmids##3##3##(2008-8#1)(2008-9#2)
the expression profile of##2##4##(2013-1#1)(2013-8#1)
the expression profile##3##3##(2009-6#1)(2013-1#1)(2013-8#1)
the expression profiles of##2##4##(1996-10#1)(1996-8#1)
the expression signals##2##3##(1990-11#1)(1996-12#1)
the expression time of##2##4##(1997-2#1)(2008-9#1)
the expression time##3##3##(1997-2#1)(2008-9#2)
the expression vector##12##3##(1990-5#1)(1991-9#1)(1994-5#2)(1997-6#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
the expression was##3##3##(1997-4#1)(2008-8#1)(2008-9#1)
the expression##715##2##(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#2)(1991-5#6)(1991-8#1)(1991-9#7)(1992-1#2)(1992-12#4)(1992-3#11)(1992-6#2)(1992-8#9)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#7)(1993-5#2)(1993-6#9)(1993-8#7)(1993-9#3)(1994-11#12)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#6)(1994-6#3)(1994-7#2)(1994-8#9)(1994-9#4)(1995-11#3)(1995-12#8)(1995-2#7)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#2)(1996-10#1)(1996-12#21)(1996-2#6)(1996-3#1)(1996-5#6)(1996-8#1)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#9)(1997-7#5)(1997-8#12)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-1#5)(2008-10#48)(2008-11#50)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#21)(2008-5#17)(2008-6#9)(2008-7#27)(2008-8#50)(2008-9#40)(2009-10#4)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#3)(2009-8#4)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#22)(2011-3#4)(2012-1#6)(2012-12#12)(2012-2#9)(2012-3#6)(2013-1#17)(2013-7#3)(2013-8#19)
the expressions of##8##3##(1990-2#1)(2008-1#1)(2008-11#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
the expressions##12##2##(1990-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#2)
the expressive##2##2##(2008-6#1)(2008-9#1)
the expulsion of##2##3##(2008-7#1)(2013-8#1)
the exstrophy-epispadias complex##2##3##(2008-10#2)
the extant##4##2##(2008-1#1)(2008-6#1)(2010-11#1)(2010-3#1)
the extended boundary condition method (EBCM)##2##6##(2008-3#2)
the extended boundary condition method##4##5##(2008-3#4)
the extended##22##2##(1990-8#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-5#1)(1997-2#1)(2007-11#3)(2008-2#1)(2008-3#6)(2008-5#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
the extension of the##16##4##(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-5#1)(2013-1#1)(2013-7#3)
the extension of##27##3##(1991-12#1)(1991-5#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#3)
the extension phase##3##3##(1997-2#3)
the extension##31##2##(1991-12#1)(1991-5#1)(1995-9#1)(1997-2#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#3)
the extensive use of##2##4##(2008-10#1)(2012-2#1)
the extensive##24##2##(1991-2#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
the extensor carpi radialis##2##4##(1996-6#1)(2008-12#1)
the extensor##7##2##(1995-8#1)(1996-6#1)(1997-2#1)(2007-8#2)(2008-12#1)(2010-6#1)
the extent and timing of##2##5##(1993-12#1)(2008-11#1)
the extent and##10##3##(1993-11#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
the extent of DNA##2##4##(1992-3#1)(1994-8#1)
the extent of atherosclerotic lesions in coronary vessels##2##8##(2008-7#2)
the extent of infection##2##4##(2008-10#2)
the extent of its##2##4##(2008-10#2)
the extent of reaction##2##4##(2008-11#1)(2008-7#1)
the extent of such##2##4##(2008-10#1)(2009-5#1)
the extent of surgical resection##2##5##(2008-7#2)
the extent of surgical##4##4##(2008-7#2)(2012-12#1)(2013-1#1)
the extent of the disease##3##5##(1994-9#1)(2010-8#1)(2011-2#1)
the extent of the market##2##5##(1993-2#2)
the extent of the problem##3##5##(1991-6#1)(1995-12#1)(2008-10#1)
the extent of the##21##4##(1991-6#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)
the extent of their##3##4##(1992-6#1)(2008-10#1)(2008-11#1)
the extent of tumors##2##4##(1990-6#1)(2013-1#1)
the extent of##151##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-6#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#30)(2008-11#8)(2008-12#4)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#3)
the extent that##8##3##(1991-8#1)(1992-1#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-3#1)(2012-3#1)
the extent to which a##2##5##(2007-11#1)(2008-11#1)
the extent to which each##2##5##(1995-2#1)(2009-5#1)
the extent to which race##2##5##(2008-11#2)
the extent to which the##13##5##(1991-12#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
the extent to which these##2##5##(2008-3#1)(2010-9#1)
the extent to which they##5##5##(1994-3#1)(1996-2#2)(2010-7#1)(2012-2#1)
the extent to which##69##4##(1990-2#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#9)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
the extent##242##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#2)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#36)(2008-11#18)(2008-12#5)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#7)(2008-9#2)(2009-2#1)(2009-5#5)(2009-7#1)(2009-9#5)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#3)(2013-8#1)
the exterior##2##2##(2008-1#1)(2008-7#1)
the external and internal##2##4##(2007-8#1)(2010-4#1)
the external auditory canal##3##4##(2008-7#2)(2008-9#1)
the external auditory##6##3##(1994-2#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#1)
the external boundary##2##3##(2008-7#2)
the external carotid artery##8##4##(1997-3#2)(1997-6#4)(2006-12#1)(2008-7#1)
the external carotid##12##3##(1996-9#3)(1997-3#2)(1997-6#4)(2006-12#1)(2008-7#1)(2013-1#1)
the external cavity##2##3##(2008-2#1)(2008-3#1)
the external electric field##2##4##(2007-11#1)(2008-2#1)
the external environment and##2##4##(1995-3#1)(2008-5#1)
the external environment##8##3##(1995-3#3)(1995-5#1)(1997-2#1)(2008-5#1)(2008-7#1)(2009-6#1)
the external medium##5##3##(1991-5#1)(2008-3#2)(2008-5#1)(2008-8#1)
the external phloem##2##3##(2008-10#2)
the external surface of##2##4##(1994-11#1)(2008-10#1)
the external surface##4##3##(1994-11#1)(2008-10#3)
the external vertebral venous plexus##2##5##(2011-2#2)
the external##108##2##(1990-11#4)(1990-3#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#3)(1995-6#1)(1996-2#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#4)(2006-12#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#6)(2008-2#4)(2008-3#6)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-4#1)(2011-2#6)(2012-12#1)(2013-1#3)(2013-8#2)
the extinction coefficient k##2##4##(2008-2#2)
the extinction coefficient of the##3##5##(2008-10#1)(2008-3#2)
the extinction coefficient##9##3##(1991-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)
the extinction coefficients##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
the extinction cross sections##2##4##(2008-2#2)
the extinction of##2##3##(2008-8#2)
the extinction ratio of the##3##5##(2008-2#1)(2008-3#2)
the extinction ratio of##5##4##(2008-2#2)(2008-3#2)(2010-4#1)
the extinction ratio##8##3##(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#2)(2010-4#1)
the extinction spectrum##3##3##(2008-3#2)(2009-12#1)
the extinction##41##2##(1991-12#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#11)(2008-3#14)(2008-8#5)(2009-12#1)(2010-4#1)(2013-8#1)
the extinction-to-backscatter##2##2##(2008-2#1)(2008-3#1)
the extinction-to-backscattering ratio##2##3##(2008-3#2)
the extra survival time##2##4##(1995-12#2)
the extra##14##2##(1990-4#1)(1990-5#1)(1991-5#1)(1995-12#2)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2013-1#1)
the extra- and intracellular##3##4##(2010-10#2)(2012-2#1)
the extracellular and##2##3##(1993-12#1)(1994-9#1)
the extracellular cAMP##2##3##(1996-2#1)(1997-3#1)
the extracellular component of the##2##5##(1990-12#1)(1991-9#1)
the extracellular concentrations of##3##4##(1992-7#1)(1994-8#2)
the extracellular domain and##4##4##(1992-12#1)(1993-6#1)(1993-8#1)(1995-5#1)
the extracellular domain of the##6##5##(1990-12#1)(1991-5#1)(1992-12#1)(1996-5#1)(2008-4#1)(2008-8#1)
the extracellular domain of##11##4##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#3)(1994-11#1)(1995-11#1)(1996-5#1)(2008-4#1)(2008-8#1)
the extracellular domain##21##3##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#4)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-8#1)
the extracellular domains of##3##4##(1991-6#2)(2012-12#1)
the extracellular domains##4##3##(1991-6#2)(1995-11#1)(2012-12#1)
the extracellular environment##7##3##(1991-9#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-10#1)(2012-1#1)
the extracellular levels of##2##4##(1994-8#1)(1997-2#1)
the extracellular matrix (ECM)##3##4##(2008-11#1)(2009-7#1)(2010-10#1)
the extracellular matrix and##4##4##(1995-8#1)(2006-6#1)(2008-5#1)(2012-12#1)
the extracellular matrix in##2##4##(2008-1#1)(2008-5#1)
the extracellular matrix is##2##4##(1993-9#1)(2008-9#1)
the extracellular matrix of##3##4##(1991-9#1)(2008-5#1)(2009-8#1)
the extracellular matrix on the##2##5##(1994-8#1)(2008-11#1)
the extracellular matrix on##3##4##(1994-8#1)(2008-11#2)
the extracellular matrix##33##3##(1990-5#1)(1991-9#1)(1993-9#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-3#2)(2006-6#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-1#2)(2012-12#1)(2013-8#1)
the extracellular medium##6##3##(1990-11#1)(1990-2#1)(1991-2#1)(1994-11#1)(2008-4#2)
the extracellular part of the molecule##2##6##(1990-11#1)(1997-9#1)
the extracellular part of##3##4##(1990-11#1)(1993-2#1)(1997-9#1)
the extracellular space is##2##4##(1992-11#1)(2008-7#1)
the extracellular space##8##3##(1992-11#1)(1994-8#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-9#1)(2012-3#1)
the extracellular##136##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#6)(1992-11#1)(1992-12#5)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#5)(1994-9#3)(1995-11#5)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#3)(1997-7#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
the extracorporeal circuit##4##3##(1992-1#1)(2008-1#1)(2008-10#2)
the extracorporeal##7##2##(1991-11#1)(1992-1#2)(2007-8#1)(2008-1#1)(2008-10#2)
the extracranial##6##2##(1992-5#1)(2008-7#4)(2012-3#1)
the extract and##8##3##(1994-2#1)(2008-10#4)(2008-11#2)(2008-5#1)
the extract at##2##3##(1990-2#1)(2013-7#1)
the extract for##2##3##(2008-10#1)(2008-12#1)
the extract in##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
the extract of the##2##4##(1992-3#1)(1994-11#1)
the extract of##6##3##(1992-3#1)(1994-11#1)(2008-5#1)(2013-1#1)(2013-7#2)
the extract showed##3##3##(2008-5#1)(2010-5#1)(2013-7#1)
the extract was##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
the extract were investigated##2##4##(2008-5#2)
the extract were##3##3##(2008-10#1)(2008-5#2)
the extract##55##2##(1990-2#1)(1992-3#2)(1994-11#1)(1994-2#2)(2008-10#17)(2008-11#4)(2008-12#3)(2008-5#8)(2008-8#1)(2009-6#4)(2010-3#1)(2010-5#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#5)
the extractability of##6##3##(1994-8#1)(2008-10#4)(2008-7#1)
the extractability##9##2##(1994-8#1)(2008-10#7)(2008-7#1)
the extractable##8##2##(2008-10#7)(2008-2#1)
the extractant solution##2##3##(2008-10#2)
the extractant##5##2##(2008-10#5)
the extractants##5##2##(2008-10#5)
the extracted complex##3##3##(2008-10#3)
the extracted compounds##2##3##(2012-1#2)
the extracted species##8##3##(2008-10#8)
the extracted##34##2##(1993-6#1)(1994-8#1)(2008-10#21)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-1#3)(2012-2#1)(2013-8#1)
the extracting solvent##3##3##(2008-10#3)
the extracting##6##2##(2008-10#6)
the extraction ability##2##3##(2008-10#2)
the extraction and desorption##3##4##(2008-10#3)
the extraction and determination of molybdenum(VI)##2##6##(2008-10#2)
the extraction and determination of##8##5##(2008-10#8)
the extraction and separation of##2##5##(2008-10#2)
the extraction and##20##3##(2008-10#19)(2012-1#1)
the extraction behavior of##2##4##(2008-10#2)
the extraction behavior##3##3##(2008-10#3)
the extraction chromatography method were##2##5##(2008-10#2)
the extraction chromatography method##3##4##(2008-10#3)
the extraction coil##2##3##(2008-10#2)
the extraction constant##2##3##(2008-10#2)
the extraction constants##2##3##(2008-10#2)
the extraction efficiency and selectivity##2##5##(2008-10#2)
the extraction efficiency and##3##4##(2008-10#3)
the extraction efficiency of the##4##5##(2008-10#4)
the extraction efficiency of these##2##5##(2008-10#2)
the extraction efficiency of##9##4##(2008-10#9)
the extraction efficiency were##2##4##(2008-10#2)
the extraction efficiency##20##3##(2008-10#19)(2012-1#1)
the extraction is##4##3##(2008-10#4)
the extraction mechanism##2##3##(2008-10#2)
the extraction media##2##3##(2008-10#2)
the extraction medium##2##3##(2008-10#2)
the extraction membrane##3##3##(2008-10#3)
the extraction of a##5##4##(2008-10#5)
the extraction of b(5)##2##4##(2008-7#2)
the extraction of both##2##4##(2008-10#2)
the extraction of mercury##2##4##(2008-10#2)
the extraction of metal ions##2##5##(2008-10#2)
the extraction of metals##3##4##(2008-10#2)(2011-2#1)
the extraction of the##11##4##(2008-10#6)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2013-8#1)
the extraction of##84##3##(2008-10#59)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-1#5)(2013-8#1)
the extraction procedure##5##3##(1990-5#1)(2008-10#4)
the extraction procedures##3##3##(2008-10#3)
the extraction process and the##2##5##(2008-10#2)
the extraction process and##3##4##(2008-10#3)
the extraction process using##2##4##(2008-10#1)(2012-1#1)
the extraction process was performed##2##5##(2008-10#2)
the extraction process were##2##4##(2008-10#2)
the extraction process##17##3##(2008-10#16)(2012-1#1)
the extraction rate##3##3##(2008-10#3)
the extraction selectivity for##2##4##(2008-10#2)
the extraction selectivity##3##3##(2008-10#3)
the extraction solution##4##3##(2008-10#4)
the extraction solvent##3##3##(2008-10#3)
the extraction step##3##3##(2008-10#2)(2008-7#1)
the extraction technique##2##3##(1991-12#1)(2008-10#1)
the extraction temperature##2##3##(2008-10#2)
the extraction time##8##3##(2008-10#8)
the extraction vessel##5##3##(2008-10#5)
the extraction was##4##3##(2008-10#4)
the extraction with##3##3##(2008-10#3)
the extraction yield##3##3##(2008-10#3)
the extraction##260##2##(1990-5#1)(1991-12#1)(2007-12#1)(2008-10#225)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#9)(2013-1#1)(2013-8#1)
the extractive fermentation##2##3##(2011-2#2)
the extractive##6##2##(2008-10#4)(2011-2#2)
the extracts and##3##3##(2008-10#2)(2010-3#1)
the extracts from##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
the extracts of##7##3##(1990-11#1)(1990-2#1)(2008-10#4)(2008-5#1)
the extracts was##3##3##(2008-10#2)(2013-1#1)
the extracts were##10##3##(1996-5#1)(2008-10#8)(2008-5#1)
the extracts##49##2##(1990-11#1)(1990-2#1)(1992-8#1)(1996-5#2)(2008-10#28)(2008-11#2)(2008-5#5)(2010-3#2)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
the extraocular##3##2##(1997-3#2)(2011-1#1)
the extraordinary##7##2##(1995-2#1)(2008-2#2)(2008-3#4)
the extrapleural chest wall##2##4##(2012-2#2)
the extrapolated##2##2##(1995-2#1)(2008-2#1)
the extrapolation##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
the extrapyramidal##4##2##(2008-4#1)(2008-7#2)(2008-9#1)
the extreme cloacal malformation##2##4##(2008-10#2)
the extreme heterogeneity##2##3##(1991-6#1)(1997-4#1)
the extreme ultraviolet with##2##4##(2007-11#1)(2008-3#1)
the extreme ultraviolet##10##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)
the extreme##35##2##(1990-8#1)(1991-6#1)(1992-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
the extreme-ultraviolet (EUV)##2##3##(2008-3#2)
the extreme-ultraviolet##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
the extremely high##4##3##(1994-2#1)(2008-11#1)(2008-3#1)(2009-3#1)
the extremely low##3##3##(1993-8#1)(2007-11#1)(2011-2#1)
the extremely small##2##3##(2007-12#1)(2008-9#1)
the extremely##26##2##(1990-7#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#2)(2011-3#1)
the extremes of the##3##4##(2008-5#1)(2008-8#1)(2012-3#1)
the extremes of##5##3##(1997-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-3#1)
the extremes##7##2##(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-3#2)
the extremities and face##2##4##(2013-1#2)
the extremities and##7##3##(2007-12#1)(2007-7#1)(2008-6#2)(2010-6#1)(2013-1#2)
the extremities##26##2##(1990-12#2)(1992-3#1)(1992-6#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#6)(2009-3#1)(2010-3#2)(2010-6#1)(2012-1#1)(2013-1#3)
the extremity##19##2##(1990-12#1)(1992-6#2)(1993-9#1)(2007-11#2)(2008-3#1)(2008-6#4)(2010-3#4)(2011-2#2)(2013-1#2)
the extrinsic risk factors for inpatient falls from##2##8##(2010-10#2)
the extrinsic##4##2##(1995-6#1)(2009-9#1)(2010-10#2)
the extruded##2##2##(2012-2#2)
the extrusion##2##2##(2012-12#1)(2012-2#1)
the eye and##3##3##(1995-3#1)(2007-12#1)(2008-4#1)
the eye field derived##2##4##(2007-12#2)
the eye field##5##3##(2007-12#5)
the eye of the beholder##2##5##(1992-9#1)(2011-2#1)
the eye of the##4##4##(1992-9#1)(1994-2#1)(2009-7#1)(2011-2#1)
the eye##57##2##(1990-3#1)(1991-5#1)(1992-9#1)(1994-2#2)(1995-12#1)(1995-3#1)(1995-9#3)(1997-2#1)(2007-11#1)(2007-12#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-7#1)(2010-1#3)(2010-8#1)(2011-1#3)(2011-2#7)(2011-7#3)(2012-12#2)(2013-8#1)
the eye's##2##2##(2007-11#1)(2007-12#1)
the eye-safe##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the eyeblinks##2##2##(1992-8#2)
the eyelids##2##2##(2006-10#1)(2007-10#1)
the eyes and##3##3##(1996-12#1)(2007-10#1)(2009-10#1)
the eyes of##9##3##(1994-3#1)(2007-12#2)(2008-1#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
the eyes##20##2##(1994-3#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the eyestalk neuroendocrine system##2##4##(2007-12#2)
the eyestalk##5##2##(1994-11#1)(2007-12#2)(2008-5#2)
the fMRI##4##2##(2009-6#1)(2009-9#2)(2012-2#1)
the fabric##2##2##(2008-11#1)(2008-3#1)
the fabricated microspheres##2##3##(2013-1#2)
the fabricated##16##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#2)(2009-11#1)(2013-1#3)
the fabrication and characterization of##2##5##(2007-12#1)(2008-12#1)
the fabrication and##7##3##(2007-12#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-2#1)
the fabrication of a##7##4##(2007-12#1)(2008-10#2)(2008-3#3)(2010-4#1)
the fabrication of##39##3##(2007-11#3)(2007-12#6)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#8)(2008-7#3)(2009-11#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#2)(2013-1#1)
the fabrication process##7##3##(2008-10#1)(2008-2#3)(2008-3#3)
the fabrication technique of##2##4##(2008-2#2)
the fabrication##63##2##(2007-11#4)(2007-12#9)(2008-10#9)(2008-12#3)(2008-2#7)(2008-3#17)(2008-4#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#3)(2013-1#1)
the facades of##2##3##(2008-2#1)(2008-3#1)
the face and##10##3##(1996-11#1)(1996-3#1)(2008-5#3)(2010-1#1)(2010-6#2)(2011-1#1)(2011-2#1)
the face in##2##3##(2007-7#1)(2012-12#1)
the face is##2##3##(2008-3#1)(2010-1#1)
the face of##29##3##(1991-3#1)(1993-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#6)(2012-12#2)
the face##93##2##(1991-3#1)(1993-1#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#11)(2008-7#3)(2008-8#1)(2009-8#2)(2010-1#6)(2010-11#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#9)(2012-2#1)(2012-3#4)(2013-1#4)
the faces##4##2##(2009-9#2)(2010-10#2)
the facet joints##4##3##(1996-9#2)(2009-3#1)(2013-8#1)
the facet##8##2##(1996-9#3)(2008-3#1)(2009-3#1)(2011-2#2)(2013-8#1)
the facets##4##2##(2008-2#2)(2008-3#1)(2008-4#1)
the facial canal##2##3##(2008-9#1)(2011-2#1)
the facial expression of##2##4##(1996-2#1)(2013-8#1)
the facial nerve and##2##4##(2008-9#1)(2011-2#1)
the facial nerve in##2##4##(2008-12#1)(2008-7#1)
the facial nerve##11##3##(2006-12#1)(2008-12#2)(2008-7#1)(2008-9#3)(2011-2#3)(2012-3#1)
the facial skeleton##5##3##(1992-4#1)(2007-12#3)(2012-3#1)
the facial skin##4##3##(2008-5#4)
the facial##41##2##(1992-4#1)(1995-6#2)(1996-2#1)(1996-5#2)(2006-12#1)(2007-12#4)(2008-12#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#4)(2009-1#1)(2009-2#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
the facile##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
the facilitation of##6##3##(1993-11#1)(2008-11#2)(2008-7#1)(2010-10#1)(2012-3#1)
the facilitative##2##2##(1991-12#1)(2008-11#1)
the facilitator##4##2##(1993-12#1)(2008-11#1)(2008-12#2)
the facilitatory effect of##2##4##(1991-2#2)
the facility management staff##2##4##(1992-2#2)
the facility with which##3##4##(2008-7#1)(2013-1#2)
the facility##19##2##(1991-12#3)(1992-2#4)(1992-5#1)(1994-12#2)(1994-3#2)(1996-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2013-1#2)
the fact is##2##3##(1995-2#1)(1996-8#1)
the fact that a number of papers appear to have been plagiarized from other previously published papers##3##17##(2008-10#3)
the fact that a##11##4##(1990-11#1)(1991-2#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)
the fact that both##4##4##(1997-5#1)(2008-10#1)(2009-10#1)(2009-7#1)
the fact that for##2##4##(1994-6#1)(2011-2#1)
the fact that in##4##4##(1991-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
the fact that it is##3##5##(1994-9#1)(2008-10#1)(2012-12#1)
the fact that it##6##4##(1990-3#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
the fact that its##2##4##(1992-9#1)(2008-1#1)
the fact that many of##2##5##(1995-11#1)(2010-3#1)
the fact that many##3##4##(1995-11#1)(2009-4#1)(2010-3#1)
the fact that most##2##4##(2008-1#1)(2008-10#1)
the fact that no##2##4##(1994-8#1)(2008-10#1)
the fact that some of##2##5##(1996-4#1)(2008-3#1)
the fact that some##5##4##(1996-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#1)
the fact that the subject##2##5##(1990-2#1)(2008-12#1)
the fact that the##61##4##(1990-2#1)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-6#1)(1994-8#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
the fact that there are##4##5##(2008-10#1)(2008-11#1)(2008-4#2)
the fact that there##7##4##(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2009-8#1)
the fact that these##4##4##(1990-2#1)(2008-9#1)(2009-2#1)(2011-1#1)
the fact that they are##3##5##(1992-3#1)(2008-11#1)(2008-3#1)
the fact that they##12##4##(1990-11#1)(1992-3#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#2)(2012-3#2)
the fact that this##2##4##(2008-10#1)(2008-3#1)
the fact that##227##3##(1990-11#3)(1990-2#3)(1990-3#1)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-9#3)(1993-1#1)(1993-6#1)(1993-9#2)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(2007-11#4)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#38)(2008-11#17)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#1)
the fact##233##2##(1990-11#3)(1990-2#3)(1990-3#1)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#3)(1992-9#3)(1993-1#1)(1993-6#1)(1993-9#2)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(2007-11#4)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#39)(2008-11#17)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#1)
the factor VIII gene##2##4##(2008-12#2)
the factor is##3##3##(1990-11#1)(1993-6#1)(2008-2#1)
the factor of##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
the factor structure of the##2##5##(2008-10#1)(2009-5#1)
the factor##24##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-11#1)(1993-12#1)(1993-6#2)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-10#1)
the factors affecting the##7##4##(2008-10#5)(2008-7#2)
the factors affecting##12##3##(1990-12#1)(1990-6#1)(2007-10#1)(2008-10#7)(2008-7#2)
the factors and##2##3##(2008-10#2)
the factors associated with the##3##5##(1994-12#1)(2008-1#1)(2013-1#1)
the factors associated with##8##4##(1994-12#1)(1995-3#1)(2008-1#1)(2010-4#1)(2011-2#3)(2013-1#1)
the factors contributing to the##2##5##(1991-1#1)(2009-12#1)
the factors contributing to##7##4##(1991-1#1)(1994-12#1)(2008-10#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-3#1)
the factors for##2##3##(2008-10#1)(2008-7#1)
the factors in##3##3##(1997-8#1)(2009-5#1)(2009-6#1)
the factors influencing##8##3##(1996-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
the factors involved in the##3##5##(1997-6#1)(2009-6#1)(2011-2#1)
the factors involved in##6##4##(1997-6#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-6#1)(2011-2#1)
the factors involved##7##3##(1997-6#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-6#2)(2011-2#1)
the factors limiting##2##3##(2008-2#1)(2008-7#1)
the factors of##4##3##(1996-3#1)(2008-10#2)(2010-2#1)
the factors responsible for##6##4##(1992-12#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-12#1)(2013-8#1)
the factors that are##6##4##(1992-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
the factors that can##2##4##(1992-1#1)(2013-1#1)
the factors that determine##2##4##(2008-7#1)(2011-1#1)
the factors that have##3##4##(1996-2#1)(2012-2#1)(2013-1#1)
the factors that influence the##8##5##(1991-11#1)(1992-2#1)(1995-2#1)(2008-10#2)(2008-6#1)(2010-10#1)(2011-1#1)
the factors that influence##12##4##(1991-11#1)(1992-2#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-1#1)
the factors that influenced the##2##5##(1990-10#1)(1991-2#1)
the factors that##53##3##(1990-10#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-2#2)(1993-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
the factors which were##2##4##(1992-1#1)(2011-2#1)
the factors which##9##3##(1992-1#1)(1992-6#1)(1996-3#1)(2008-10#1)(2008-7#2)(2010-9#2)(2011-2#1)
the factors##154##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-6#1)(1993-1#2)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#22)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#5)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
the facts that##3##3##(1993-11#1)(2008-10#1)(2010-7#1)
the facts##7##2##(1992-3#1)(1993-11#1)(1994-1#1)(1995-1#1)(2008-10#2)(2010-7#1)
the facultative##2##2##(1991-8#1)(2008-12#1)
the faculty##4##2##(1992-1#1)(1993-2#1)(1996-1#1)(2009-10#1)
the fade##2##2##(2008-2#2)
the fading##2##2##(1991-3#1)(2008-2#1)
the faecal occult blood test##2##5##(1993-8#2)
the faecal occult blood##3##4##(1993-8#3)
the faecal##4##2##(1993-8#3)(2008-11#1)
the faeces of##4##3##(1993-2#1)(1996-12#1)(2008-11#1)(2008-5#1)
the failed##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
the failing heart##2##3##(2010-8#1)(2011-2#1)
the failing##3##2##(2010-8#1)(2011-2#2)
the failure of the##6##4##(1991-1#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-8#2)
the failure of##22##3##(1990-8#1)(1991-1#1)(1991-2#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-4#2)(1997-3#2)(2007-11#1)(2008-11#3)(2008-8#3)(2011-3#1)(2012-2#1)
the failure to identify##3##4##(1996-2#1)(2008-2#1)(2008-3#1)
the failure to##6##3##(1996-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
the failure##36##2##(1990-8#1)(1991-1#1)(1991-2#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-3#1)(1996-4#2)(1997-3#2)(2007-11#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#1)(2008-8#4)(2009-7#2)(2011-3#1)(2012-2#2)(2013-8#1)
the fair##2##2##(1993-3#1)(2008-4#1)
the faith##2##2##(2008-1#1)(2008-12#1)
the fall and rise of##2##5##(1990-7#1)(2007-11#1)
the fall and##3##3##(1990-7#1)(2007-11#1)(2008-8#1)
the fall in##3##3##(1991-5#1)(2008-7#1)(2013-1#1)
the fall of 1995 and 1996##2##6##(2008-10#2)
the fall of##12##3##(1991-2#1)(1996-1#1)(2007-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2011-9#1)(2012-3#1)
the fall##31##2##(1990-2#1)(1990-7#1)(1991-2#2)(1991-5#1)(1994-2#1)(1995-2#2)(1996-1#1)(2007-11#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-9#1)(2012-3#1)(2013-1#2)
the fallacy##2##2##(1995-1#1)(2011-2#1)
the fallopian tube##6##3##(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(1994-7#1)
the fallopian##8##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(1994-7#1)(2008-7#1)
the false lumen##3##3##(2008-11#2)(2011-2#1)
the false positive##2##3##(1997-4#2)
the false##10##2##(1997-4#2)(2007-8#1)(2008-11#2)(2008-3#2)(2008-6#1)(2011-2#1)(2012-3#1)
the familial aggregation of MS##2##5##(2011-1#2)
the familial##11##2##(1990-3#1)(1990-9#1)(1997-3#1)(1997-5#1)(2007-10#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#1)
the familiar##8##2##(1990-11#1)(1994-1#1)(2008-2#1)(2008-3#2)(2010-2#1)(2012-3#2)
the families of Type II alcoholics##2##6##(1994-2#2)
the families of Type##3##4##(1994-2#3)
the families of##9##3##(1994-2#4)(2007-6#1)(2008-1#1)(2008-4#1)(2010-1#1)(2010-10#1)
the families##25##2##(1991-11#1)(1992-3#1)(1994-2#4)(1997-2#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-4#2)(2008-5#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-3#2)(2013-8#2)
the family Actinomycetaceae##2##3##(2011-2#2)
the family Amaranthaceae##2##3##(2008-10#2)
the family Aquificaceae##2##3##(2011-2#2)
the family Araceae##5##3##(2008-10#5)
the family Comoviridae##2##3##(2008-10#2)
the family Cucurbitaceae##7##3##(2008-10#7)
the family Enterobacteriaceae##4##3##(2008-10#2)(2010-6#2)
the family Ferrimonadaceae##2##3##(2011-2#2)
the family Intrasporangiaceae##2##3##(2011-2#2)
the family Nocardiopsaceae##2##3##(2011-2#2)
the family Pasteurellaceae Pohl 1981##2##5##(2008-5#2)
the family Potyviridae##10##3##(2008-10#10)
the family Reoviridae##3##3##(1997-4#1)(2008-10#2)
the family Spirochaetaceae##3##3##(2011-2#3)
the family Synergistaceae##5##3##(2011-2#5)
the family Thermoproteaceae##2##3##(2011-2#2)
the family and##8##3##(1995-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2012-12#1)(2013-7#1)
the family are##2##3##(1997-4#1)(2008-12#1)
the family as##2##3##(1990-12#1)(1993-12#1)
the family doctor##2##3##(1990-3#1)(2010-12#1)
the family environment##3##3##(1991-6#1)(2008-7#1)(2012-3#1)
the family health##2##3##(2011-2#1)(2012-3#1)
the family in##2##3##(1991-2#1)(2008-1#1)
the family members##3##3##(1990-10#1)(2008-11#1)(2011-2#1)
the family of mammalian##2##4##(1995-3#2)
the family of##20##3##(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-6#1)(1995-3#2)(1995-6#3)(1996-12#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
the family physician and##2##4##(1993-12#1)(1993-3#1)
the family physician##5##3##(1993-12#1)(1993-3#1)(1995-11#1)(1997-4#2)
the family physician]##2##3##(1996-8#1)(1996-9#1)
the family potyviridae##2##3##(2008-10#2)
the family system##3##3##(2009-11#1)(2013-1#2)
the family##236##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#6)(1997-8#2)(2007-10#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#48)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#3)(2010-9#2)(2011-1#2)(2011-2#56)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#1)
the family's##5##2##(1992-3#1)(1993-12#1)(1994-5#1)(1995-1#2)
the famous##2##2##(2009-7#1)(2013-7#1)
the fan-beam DT##2##3##(2008-3#2)
the fan-beam geometry##2##3##(2008-3#1)(2009-5#1)
the fan-beam##4##2##(2008-3#3)(2009-5#1)
the fantail and eggfish##3##4##(2010-8#3)
the fantail##4##2##(2010-8#4)
the far field##15##3##(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#5)
the far infrared##4##3##(2007-11#1)(2008-3#3)
the far##24##2##(2007-11#6)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#9)(2008-7#1)
the far-field beam##2##3##(2008-2#1)(2008-3#1)
the far-field diffraction pattern##2##4##(2008-3#2)
the far-field diffraction##3##3##(2008-3#3)
the far-field irradiance pattern##2##4##(2008-2#2)
the far-field irradiance##3##3##(2008-2#3)
the far-field performance of##2##4##(2007-12#1)(2008-3#1)
the far-field scattering##3##3##(2008-2#1)(2008-3#2)
the far-field##28##2##(2007-11#2)(2007-12#2)(2008-2#9)(2008-3#15)
the farm was##2##3##(1993-2#1)(2007-6#1)
the farm workers##2##3##(2007-7#1)(2011-2#1)
the farm##12##2##(1990-9#1)(1993-2#1)(1994-3#1)(1994-7#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
the farmer##4##2##(1995-11#1)(1997-7#1)(2008-12#2)
the farmers##2##2##(2011-1#2)
the farming##2##2##(2008-10#1)(2008-12#1)
the farms##2##2##(1996-12#2)
the farnesylated##2##2##(1992-9#1)(2008-10#1)
the fascia##6##2##(2009-1#3)(2009-9#1)(2010-7#1)(2012-2#1)
the fast and##2##3##(2008-3#1)(2008-7#1)
the fast computation of##2##4##(2008-3#2)
the fast rate varied from##2##5##(2008-9#2)
the fast rate##3##3##(2008-9#3)
the fast##46##2##(1991-12#1)(1991-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-12#3)(2008-10#9)(2008-2#2)(2008-3#12)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-8#1)
the fast-Fourier-transform algorithm##2##3##(2008-2#1)(2008-3#1)
the faster##5##2##(1996-2#1)(2008-10#3)(2008-3#1)
the fastest growing##5##3##(1994-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2013-8#1)
the fastest rate##2##3##(2008-10#2)
the fastest##17##2##(1994-3#1)(1995-3#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
the fastest-growing##2##2##(1997-5#1)(2011-2#1)
the fasting glucose##2##3##(1991-7#1)(2008-1#1)
the fasting state##2##3##(1991-5#1)(2008-6#1)
the fasting##7##2##(1991-5#1)(1991-7#1)(1992-6#1)(2008-1#2)(2008-3#1)(2008-6#1)
the fat reserves##2##3##(2009-5#1)(2013-1#1)
the fat##21##2##(1992-3#1)(1995-2#3)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-11#3)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
the fatal##6##2##(1992-9#1)(1993-3#1)(2007-12#1)(2008-7#2)(2011-2#1)
the fate of the##3##4##(2008-10#3)
the fate of##19##3##(1992-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-2#1)
the fate##21##2##(1992-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-2#1)
the father of British microbiology##2##5##(2011-1#2)
the father of##5##3##(2008-10#2)(2011-1#2)(2012-12#1)
the father##8##2##(1994-12#1)(2008-10#2)(2011-1#2)(2012-12#2)(2012-3#1)
the fathers of the##2##4##(1994-6#2)
the fathers##5##2##(1994-6#2)(2009-5#1)(2010-3#2)
the fatigue protocol##2##3##(2013-8#2)
the fatigue##4##2##(1992-2#1)(2013-8#3)
the fatty acid composition of the##3##6##(1991-12#1)(1992-10#1)(2010-4#1)
the fatty acid composition of##5##5##(1991-12#1)(1992-10#1)(1992-12#1)(2010-4#2)
the fatty acid composition##6##4##(1991-12#1)(1992-10#1)(1992-12#1)(2010-4#3)
the fatty acid profile in rabbits##2##6##(2010-4#2)
the fatty acid##20##3##(1990-11#2)(1990-2#1)(1991-12#2)(1992-10#1)(1992-12#1)(1992-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#5)(2011-1#1)
the fatty acids##4##3##(1991-6#1)(2008-10#2)(2011-1#1)
the fatty##25##2##(1990-11#2)(1990-2#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-4#5)(2011-1#2)(2011-2#1)
the fault with an accuracy of##2##6##(2008-3#2)
the fault zone##5##3##(1996-4#5)
the fault##16##2##(1991-12#1)(1996-4#13)(2008-3#2)
the fauna of##2##3##(2008-5#1)(2013-1#1)
the favorable##7##2##(1990-6#1)(1990-8#1)(2008-10#3)(2008-3#1)(2011-2#1)
the favourable##3##2##(1990-8#1)(2008-10#1)(2013-1#1)
the favourite##2##2##(1992-11#1)(2011-2#1)
the fd##2##2##(1994-12#2)
the fdh##2##2##(1995-8#2)
the fear of##6##3##(1991-6#1)(1994-1#1)(1997-3#1)(2008-1#1)(2008-8#1)(2011-1#1)
the fear##9##2##(1991-6#1)(1994-1#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-1#1)
the fears and##2##3##(1995-2#1)(2011-2#1)
the fears expressed by##2##4##(2008-12#1)(2011-2#1)
the fears##5##2##(1995-2#1)(1997-1#1)(2008-12#1)(2011-2#2)
the feasibility and desirability of##2##5##(1992-2#2)
the feasibility and safety of##5##5##(2008-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
the feasibility and utility of##3##5##(2009-12#1)(2013-1#2)
the feasibility and##19##3##(1991-3#1)(1992-2#2)(1996-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#2)
the feasibility for##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
the feasibility of NeutrAvidin-tagged##2##4##(2008-10#2)
the feasibility of a##10##4##(1990-5#1)(1994-8#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-10#1)(2010-12#1)
the feasibility of an##2##4##(2008-3#1)(2011-2#1)
the feasibility of applications##2##4##(2008-3#2)
the feasibility of developing an in vitro##2##7##(2009-7#2)
the feasibility of developing##3##4##(1994-3#1)(2009-7#2)
the feasibility of implementing##2##4##(2007-11#1)(2012-2#1)
the feasibility of such##3##4##(1990-11#1)(2008-11#1)(2008-3#1)
the feasibility of the approach##2##5##(2008-3#1)(2011-2#1)
the feasibility of the method##3##5##(2008-11#1)(2008-3#2)
the feasibility of the new##2##5##(2008-2#1)(2008-8#1)
the feasibility of the##24##4##(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#9)(2008-8#2)(2010-11#1)(2011-2#2)(2013-1#1)
the feasibility of these##2##4##(1992-6#1)(2008-10#1)
the feasibility of this##5##4##(2007-11#2)(2008-10#2)(2013-8#1)
the feasibility of using the##2##5##(2008-10#2)
the feasibility of using##15##4##(1994-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2010-5#1)
the feasibility of##132##3##(1990-11#1)(1990-5#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-3#2)(1997-8#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#22)(2008-11#6)(2008-2#11)(2008-3#23)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
the feasibility##159##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-3#3)(1997-3#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#25)(2008-11#7)(2008-2#11)(2008-3#23)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-8#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#4)
the feasible##2##2##(2008-10#1)(2008-9#1)
the feather##2##2##(1997-6#1)(2008-5#1)
the feature##15##2##(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-7#1)
the features and##6##3##(1994-1#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-2#1)
the features described##2##3##(2008-7#2)
the features of the##14##4##(1990-11#1)(1991-8#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-3#3)(2009-10#1)(2011-2#3)(2012-3#1)(2013-8#1)
the features of this##19##4##(2008-12#1)(2011-2#18)
the features of##51##3##(1990-11#1)(1990-6#1)(1991-8#1)(1992-4#1)(1993-12#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2009-10#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#24)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the features that##3##3##(2008-3#2)(2010-12#1)
the features were##2##3##(2008-5#1)(2009-12#1)
the features##81##2##(1990-11#1)(1990-6#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-1#1)(1995-1#1)(1995-5#1)(1996-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#24)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
the febrile##2##2##(2010-8#1)(2012-2#1)
the feces##5##2##(1990-6#1)(1991-12#1)(2007-10#1)(2007-12#1)(2009-4#1)
the fecundity##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
the fed##4##2##(1991-3#1)(1996-5#1)(2008-3#1)(2012-2#1)
the fed-batch culture##2##3##(2008-11#1)(2008-7#1)
the fed-batch##8##2##(2008-11#3)(2008-6#1)(2008-7#3)(2013-1#1)
the federal budget##2##3##(1993-1#1)(2008-7#1)
the federal government is##2##4##(1997-2#1)(2007-9#1)
the federal government to##3##4##(1991-1#1)(2008-10#1)(2008-11#1)
the federal government##11##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#2)
the federal government's##2##3##(1992-3#1)(2012-3#1)
the federal level##2##3##(1994-12#1)(2008-12#1)
the federal patient anti-dumping statute##2##5##(1993-1#1)(1993-2#1)
the federal##33##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#1)(2010-5#1)(2012-3#1)
the federally##2##2##(1995-2#2)
the fee schedule together##2##4##(1992-1#2)
the fee schedule##4##3##(1992-1#3)(1994-1#1)
the fee##7##2##(1992-1#3)(1993-3#1)(1994-1#1)(1994-12#1)(2013-8#1)
the fee-for-service##4##2##(1993-1#1)(1993-3#1)(1997-2#1)(2006-10#1)
the feed and##2##3##(1997-6#1)(2011-2#1)
the feed solution##4##3##(2008-10#4)
the feed##21##2##(1995-11#1)(1997-3#1)(1997-6#2)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-2#1)
the feedback from##2##3##(2008-8#1)(2009-10#1)
the feedback loop##6##3##(2007-11#2)(2008-3#1)(2009-8#1)(2009-9#1)(2010-5#1)
the feedback##20##2##(1994-12#1)(2007-10#1)(2007-11#4)(2008-2#1)(2008-3#5)(2008-8#3)(2009-10#2)(2009-8#1)(2009-9#1)(2010-5#1)
the feedback-based operation##2##3##(2008-10#2)
the feeder##6##2##(1993-3#1)(1993-9#1)(1997-3#3)(2008-10#1)
the feeding arteries##2##3##(2008-7#2)
the feeding artery##2##3##(2007-7#1)(2008-7#1)
the feeding##22##2##(1994-12#1)(1996-6#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#4)(2008-9#2)(2010-8#4)(2011-2#1)(2012-2#1)
the feeling of##2##3##(1994-1#1)(2008-11#1)
the feelings and##2##3##(2008-9#1)(2012-3#1)
the feelings##3##2##(2008-9#1)(2010-7#1)(2012-3#1)
the feet##13##2##(1994-12#1)(1996-3#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-9#2)(2012-3#1)(2013-1#4)
the felt##2##2##(2007-8#1)(2008-11#1)
the female and male##2##4##(1992-3#1)(2013-1#1)
the female and##3##3##(1992-3#1)(2008-5#1)(2013-1#1)
the female body##3##3##(1991-6#1)(2008-6#1)(2009-10#1)
the female breast##2##3##(1992-3#1)(2007-11#1)
the female genital tracts##2##4##(2008-7#2)
the female genital##6##3##(2007-12#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-3#1)
the female group##2##3##(2008-7#1)(2011-1#1)
the female in##2##3##(1993-2#1)(2008-5#1)
the female parent##2##3##(2008-10#2)
the female rats##2##3##(1994-2#1)(2013-1#1)
the female reproductive tract##2##4##(1996-12#1)(2010-3#1)
the female reproductive##5##3##(1996-12#1)(2007-12#1)(2007-7#1)(2009-12#1)(2010-3#1)
the female sex pheromone##2##4##(1990-8#1)(2008-10#1)
the female sex##3##3##(1990-8#1)(2008-10#2)
the female sternum##4##3##(1995-6#4)
the female##94##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#2)(1992-12#2)(1992-3#6)(1992-4#2)(1992-6#1)(1993-12#1)(1993-2#2)(1994-2#1)(1994-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-12#3)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
the females after##2##3##(1995-3#2)
the females of##2##3##(1993-12#1)(2008-7#1)
the females preferred##2##3##(2013-8#2)
the females##21##2##(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#2)(1995-3#3)(1997-4#2)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2012-12#1)(2013-8#2)
the feminine##2##2##(2009-10#1)(2013-1#1)
the femoral artery##2##3##(2008-10#1)(2008-3#1)
the femoral head##21##3##(1992-6#1)(2006-10#1)(2007-8#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#10)(2009-4#2)
the femoral neck##17##3##(2006-10#3)(2007-11#2)(2007-8#4)(2009-3#5)(2010-3#1)(2011-2#1)(2013-1#1)
the femoral nerve##4##3##(1993-12#1)(2009-3#3)
the femoral vein##2##3##(2012-2#1)(2013-1#1)
the femoral##64##2##(1992-3#1)(1992-6#1)(1993-12#1)(1995-6#1)(2006-10#4)(2007-11#3)(2007-12#1)(2007-8#7)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#18)(2009-4#3)(2010-3#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#6)
the femtosecond regime##3##3##(2007-11#2)(2007-12#1)
the femtosecond##10##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#1)
the femur of##2##3##(2007-11#1)(2009-4#1)
the femur to##2##3##(2008-6#1)(2009-3#1)
the femur##37##2##(1991-11#1)(1995-6#1)(2007-11#12)(2007-2#1)(2007-8#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#4)(2009-4#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#5)
the fenestrated A1##2##3##(2013-8#2)
the fenestrated##4##2##(2010-12#1)(2013-8#3)
the fermentation broth##4##3##(2008-6#2)(2008-7#1)(2012-2#1)
the fermentation of##5##3##(1995-5#1)(2008-6#2)(2008-8#1)(2013-1#1)
the fermentation##21##2##(1995-5#1)(2008-10#2)(2008-6#7)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
the fermented##2##2##(2008-11#1)(2008-8#1)
the fermenting##2##2##(2008-10#2)
the ferret group##2##3##(2008-6#2)
the ferret##7##2##(2008-1#2)(2008-5#1)(2008-6#4)
the ferric siderophore##2##3##(2011-2#2)
the ferric##6##2##(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#3)
the ferricyanide##2##2##(2008-10#2)
the ferritin##5##2##(1990-5#1)(2007-7#1)(2008-1#1)(2013-8#2)
the ferroelectric##2##2##(2008-2#2)
the ferromagnetic##2##2##(1997-7#1)(2007-11#1)
the ferrozine method##2##3##(2008-10#2)
the fertile lemmas##2##3##(2008-5#2)
the fertile##4##2##(1996-3#1)(2008-5#2)(2013-1#1)
the fertility##4##2##(2009-10#1)(2009-12#1)(2010-12#1)(2012-3#1)
the fertilization chamber##2##3##(2007-12#2)
the fertilization##5##2##(1994-11#1)(2007-12#2)(2008-9#1)(2010-8#1)
the fertilized eggs##2##3##(2008-5#1)(2010-5#1)
the festival##2##2##(2009-10#2)
the fetal electrocardiogram##2##3##(1994-5#2)
the fetal hydantoin syndrome##3##4##(1990-5#3)
the fetal immune repertoire##2##4##(2008-10#2)
the fetal or##2##3##(1995-11#1)(2008-10#1)
the fetal sex##9##3##(2013-1#9)
the fetal##37##2##(1990-5#3)(1992-6#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#3)(1995-11#1)(1995-8#1)(1996-5#3)(1997-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2012-2#1)(2013-1#10)
the fetus during##2##3##(2007-10#1)(2011-2#1)
the fetus is##3##3##(1990-9#1)(1993-6#1)(2010-11#1)
the fetus##30##2##(1990-9#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-7#2)(1995-8#3)(1996-11#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-3#1)(2010-11#4)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
the fetus'##2##2##(1993-12#1)(2013-1#1)
the fetuses##6##2##(1991-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2008-11#1)(2012-3#1)
the fever##3##2##(1994-2#1)(2009-6#1)(2013-8#1)
the few cases##2##3##(2008-10#2)
the few cells that##2##4##(2007-12#1)(2008-10#1)
the few studies that##2##4##(2008-11#1)(2011-2#1)
the few studies##3##3##(1990-8#1)(2008-11#1)(2011-2#1)
the few##26##2##(1990-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
the fewest##4##2##(1990-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
the fiber Bragg grating##2##4##(2007-11#1)(2008-3#1)
the fiber Bragg##3##3##(2007-11#2)(2008-3#1)
the fiber PMD##2##3##(2007-11#2)
the fiber and the##7##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
the fiber array##2##3##(2008-2#2)
the fiber as##2##3##(2008-3#1)(2009-7#1)
the fiber cells##3##3##(2008-10#3)
the fiber cladding##3##3##(2007-11#1)(2008-3#2)
the fiber core##10##3##(2007-11#1)(2007-12#7)(2008-3#2)
the fiber end##3##3##(2008-3#3)
the fiber input##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
the fiber is bent##2##4##(2007-11#1)(2008-3#1)
the fiber is##6##3##(2007-11#2)(2008-10#1)(2008-3#3)
the fiber laser##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
the fiber length##2##3##(2007-11#2)
the fiber optic##3##3##(2008-10#3)
the fiber surfaces and##2##4##(2008-11#1)(2009-11#1)
the fiber tip in##2##4##(1992-1#1)(2008-3#1)
the fiber tip##4##3##(1992-1#1)(1995-2#1)(2008-2#1)(2008-3#1)
the fiber to##3##3##(2008-2#2)(2008-3#1)
the fiber was pumped##2##4##(2007-11#2)
the fiber was##9##3##(1991-12#1)(1992-1#1)(2007-11#2)(2008-10#5)
the fiber##166##2##(1991-12#1)(1992-1#3)(1995-2#1)(2007-11#33)(2007-12#30)(2008-10#24)(2008-11#1)(2008-2#18)(2008-3#47)(2008-6#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-4#1)(2013-8#1)
the fiber's##10##2##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#4)
the fiber-optic DNA##2##3##(2008-9#2)
the fiber-optic##10##2##(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#2)(2011-1#1)
the fibers are##2##3##(2007-11#1)(2008-10#1)
the fibers were##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
the fibers##17##2##(1991-12#2)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#2)(2009-11#1)(2009-7#1)(2012-3#1)
the fibre type composition of the##2##6##(2011-2#2)
the fibre type composition##4##4##(2011-2#4)
the fibre##15##2##(2008-10#8)(2008-5#1)(2009-7#1)(2011-2#4)(2013-1#1)
the fibril angle and##2##4##(2008-3#2)
the fibril##5##2##(1994-5#1)(2008-3#3)(2009-8#1)
the fibrillar material is##2##4##(1994-5#2)
the fibrillar material##3##3##(1994-5#3)
the fibrillar##6##2##(1994-5#3)(2008-8#1)(2010-4#2)
the fibrils of##2##3##(1993-2#1)(2008-5#1)
the fibrils##7##2##(1993-2#3)(2008-5#2)(2009-8#2)
the fibrin structure##2##3##(2011-2#2)
the fibrin##4##2##(2010-3#1)(2011-2#3)
the fibrinogen binding##2##3##(1995-2#1)(2006-6#1)
the fibrinogen##7##2##(1990-7#1)(1993-8#1)(1995-2#2)(1997-2#1)(2006-6#1)(2008-10#1)
the fibrinolytic system in##3##4##(1997-1#3)
the fibrinolytic system##4##3##(1994-3#1)(1997-1#3)
the fibrinolytic##7##2##(1993-2#1)(1994-3#1)(1994-5#1)(1997-1#3)(2008-10#1)
the fibroblast##5##2##(1997-4#3)(2008-11#2)
the fibronectin##4##2##(1990-7#2)(1992-12#1)(1993-12#1)
the fibrous matrix##5##3##(2008-11#5)
the fibrous##11##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#6)(2008-5#1)(2011-2#1)
the fideistic probability that God##2##5##(2013-1#2)
the fidelity of##5##3##(2007-12#1)(2008-3#3)(2013-1#1)
the fidelity##6##2##(1994-8#1)(2007-12#1)(2008-3#3)(2013-1#1)
the field analysis of##2##4##(2008-10#2)
the field and the##2##4##(2008-5#1)(2013-1#1)
the field and##17##3##(2008-10#11)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
the field as a##2##4##(1996-2#1)(2008-10#1)
the field as##4##3##(1996-2#1)(2007-12#1)(2008-10#2)
the field by##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
the field distribution of##3##4##(2007-11#1)(2007-12#2)
the field distribution##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
the field distributions##2##3##(2007-12#1)(2008-3#1)
the field experiment##5##3##(2008-10#5)
the field experiments##3##3##(2008-10#2)(2008-9#1)
the field for##6##3##(2008-10#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)
the field from##2##3##(2008-10#2)
the field in the##5##4##(2008-2#1)(2008-3#3)(2010-8#1)
the field in##12##3##(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2010-8#1)
the field is##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-9#1)
the field of health insurance##2##5##(1992-3#2)
the field of health##5##4##(1992-3#2)(1993-2#1)(2010-12#1)(2011-2#1)
the field of mechanotherapy##2##4##(2008-12#2)
the field of periodontology##2##4##(2012-3#2)
the field of practice##3##4##(1994-12#1)(1995-1#2)
the field of psychiatry##2##4##(2008-6#1)(2013-8#1)
the field of radiology##3##4##(1991-1#1)(1992-1#1)(2007-4#1)
the field of routine##2##4##(2008-10#1)(2011-2#1)
the field of science##2##4##(2008-11#1)(2011-2#1)
the field of view is##2##5##(2007-11#1)(2008-3#1)
the field of view of the##3##6##(2008-2#1)(2008-3#2)
the field of view of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
the field of view##16##4##(2007-11#3)(2008-2#2)(2008-3#10)(2008-9#1)
the field of##204##3##(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-6#3)(1991-8#1)(1992-1#2)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-1#3)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#6)(2008-12#7)(2008-2#6)(2008-3#16)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#2)(2013-8#9)
the field results##2##3##(2008-10#2)
the field soil##2##3##(2008-10#2)
the field strength of the##2##5##(1997-7#1)(2008-10#1)
the field strength##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
the field test##2##3##(2008-10#1)(2008-5#1)
the field that results from##2##5##(2007-12#1)(2008-2#1)
the field the##3##3##(2008-10#1)(2011-2#2)
the field to##7##3##(1995-6#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-8#1)
the field was##4##3##(2008-10#4)
the field with##6##3##(1996-6#1)(2008-10#3)(2008-11#1)(2012-3#1)
the field##558##2##(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#1)(1992-1#3)(1992-12#2)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#4)(1994-9#2)(1995-1#3)(1995-12#3)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#5)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2006-10#3)(2007-10#1)(2007-11#10)(2007-12#10)(2007-2#1)(2007-4#5)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#207)(2008-11#12)(2008-12#12)(2008-2#18)(2008-3#35)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#9)(2008-8#8)(2008-9#20)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#6)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#13)(2012-3#5)(2012-8#1)(2013-1#7)(2013-8#9)
the fields in##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
the fields of##24##3##(1996-3#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
the fields##38##2##(1992-11#1)(1996-2#1)(1996-3#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
the fifth and sixth##2##4##(2007-12#1)(2013-7#1)
the fifth and##3##3##(2007-12#1)(2008-10#1)(2013-7#1)
the fifth day after##2##4##(2007-11#2)
the fifth day##5##3##(1993-12#2)(2007-11#2)(2008-12#1)
the fifth discipline of##2##4##(1994-3#2)
the fifth fraction##2##3##(2008-10#1)(2008-6#1)
the fifth harmonic of a##4##5##(2007-11#2)(2008-2#2)
the fifth harmonic of##5##4##(2007-11#2)(2008-2#2)(2008-3#1)
the fifth patient##2##3##(1995-5#1)(1997-3#1)
the fifth postoperative day##3##4##(2007-4#1)(2011-1#1)(2013-1#1)
the fifth subsite##2##3##(1990-7#2)
the fifth year of the##2##5##(1992-12#1)(2008-10#1)
the fifth year##3##3##(1992-12#1)(2008-10#2)
the fifth##60##2##(1990-7#2)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#2)(1994-12#1)(1994-3#2)(1995-2#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
the fifth-order##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
the fight against domestic##2##4##(1993-12#2)
the fight against the##4##4##(1993-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
the fight against##16##3##(1993-12#2)(1993-3#1)(1995-1#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
the fight##19##2##(1993-12#2)(1993-3#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
the figure of##4##3##(2008-10#1)(2008-3#2)(2012-12#1)
the figure##8##2##(1990-6#1)(1992-4#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-12#1)
the figure-of-8 construct##3##3##(2009-3#3)
the figure-of-8##4##2##(2009-3#4)
the figure-of-eight##3##2##(2007-8#3)
the figures of merit of the method##2##7##(2008-10#2)
the figures of merit of the##4##6##(2008-10#4)
the figures of merit##7##4##(2008-10#7)
the figures##10##2##(1996-1#1)(1997-4#1)(2008-10#7)(2008-3#1)
the figuring process##2##3##(2008-3#2)
the filamentous##9##2##(1992-12#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-6#2)(2008-8#1)(2012-2#1)
the filaments##3##2##(1993-12#1)(2008-7#1)(2008-8#1)
the filarial parasite##2##3##(1991-5#1)(1994-11#1)
the filarial##3##2##(1991-5#2)(1994-11#1)
the file##2##2##(1994-1#1)(2008-7#1)
the files of##4##3##(1990-2#1)(1997-8#1)(2008-1#1)(2008-12#1)
the files##6##2##(1990-2#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)
the fill factor##2##3##(2008-2#1)(2008-3#1)
the fill##3##2##(2008-2#1)(2008-3#2)
the filling in##2##3##(2008-3#2)
the filling##3##2##(1993-6#1)(2008-3#2)
the film and the##5##4##(2007-12#1)(2008-10#2)(2008-3#2)
the film and##8##3##(2007-12#1)(2008-10#4)(2008-3#3)
the film by irradiation with##2##5##(2008-2#2)
the film by##3##3##(2007-12#1)(2008-2#2)
the film forming process##2##4##(2008-5#2)
the film is##4##3##(2007-11#1)(2008-10#3)
the film may##2##3##(2008-10#2)
the film surface##2##3##(2007-12#1)(2008-5#1)
the film thickness were##2##4##(2007-12#1)(2008-10#1)
the film thickness##8##3##(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)
the film was##5##3##(2008-10#3)(2010-4#1)(2012-2#1)
the film with##2##3##(2008-10#1)(2008-11#1)
the film##92##2##(1994-12#1)(1996-1#1)(1997-2#2)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#35)(2008-11#2)(2008-2#9)(2008-3#16)(2008-5#7)(2008-7#2)(2009-10#1)(2009-11#1)(2010-4#2)(2012-2#1)(2013-1#1)
the film's##4##2##(2007-12#1)(2008-3#2)(2008-5#1)
the films are##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
the films in the medium##2##5##(2008-10#1)(2008-11#1)
the films in the##3##4##(2008-10#2)(2008-11#1)
the films was##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
the films were##7##3##(2007-11#1)(2008-10#3)(2008-3#2)(2008-8#1)
the films##49##2##(2007-11#3)(2007-12#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#10)(2008-8#2)(2009-11#3)(2013-1#1)
the filter and##3##3##(2008-2#1)(2008-3#2)
the filter is##2##3##(2007-12#1)(2008-2#1)
the filter paper##2##3##(2008-10#1)(2010-8#1)
the filter performance##2##3##(2008-3#2)
the filter resonance##2##3##(2008-2#2)
the filter was##3##3##(1992-6#2)(2008-3#1)
the filter##46##2##(1992-6#2)(2007-12#2)(2008-10#9)(2008-2#13)(2008-3#19)(2010-8#1)
the filter's##2##2##(2008-2#1)(2008-3#1)
the filtered##2##2##(2008-2#1)(2008-3#1)
the filtering##4##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
the filters##7##2##(1992-5#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
the filtrate was##2##3##(1994-5#1)(2008-10#1)
the filtrate##12##2##(1994-5#1)(2008-10#9)(2008-7#2)
the filtrates##3##2##(1992-9#1)(2008-10#2)
the filtration##2##2##(2008-5#1)(2008-9#1)
the fimA and fimF genes##2##5##(2008-10#2)
the fimA and fimF##3##4##(2008-10#3)
the fimA##4##2##(2008-10#4)
the fimbrial##2##2##(2008-10#2)
the final Si layer##2##4##(2007-11#2)
the final analysis##5##3##(1992-3#1)(1996-3#1)(1997-6#1)(2008-4#1)(2012-2#1)
the final concentration of##2##4##(1991-9#1)(2013-1#1)
the final data##2##3##(2008-3#1)(2010-5#1)
the final decision##4##3##(1992-5#1)(1994-3#1)(1995-11#1)(2011-1#1)
the final diagnosis of##4##4##(2008-1#1)(2008-5#1)(2010-6#1)(2012-3#1)
the final diagnosis##7##3##(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#2)
the final disease intensity##2##4##(2008-10#2)
the final disease##3##3##(2008-10#3)
the final follow-up##2##3##(2007-8#1)(2008-9#1)
the final germination percentage of##2##5##(2008-10#2)
the final goal##2##3##(2008-3#2)
the final image##2##3##(2008-3#2)
the final model##4##3##(1992-4#1)(2008-10#2)(2009-7#1)
the final outcome of##3##4##(2007-11#1)(2008-7#1)(2009-5#1)
the final outcome##5##3##(1991-6#1)(2007-11#1)(2008-7#2)(2009-5#1)
the final part of##2##4##(1993-12#1)(2009-8#1)
the final part##3##3##(1993-12#1)(2009-8#1)(2013-1#1)
the final phase of##2##4##(2008-1#1)(2008-5#1)
the final phase##4##3##(2008-1#1)(2008-5#1)(2008-7#1)(2009-11#1)
the final product##14##3##(1990-7#1)(1994-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#2)
the final products##4##3##(1996-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
the final refractive-index##2##3##(2007-11#1)(2007-12#1)
the final restoration##2##3##(2007-12#1)(2008-7#1)
the final result##4##3##(2007-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
the final results##3##3##(2008-10#2)(2008-6#1)
the final section##2##3##(2006-10#1)(2008-4#1)
the final stage of##4##4##(2008-2#1)(2008-7#2)(2010-10#1)
the final stages of##5##4##(1990-5#1)(1997-8#1)(2007-12#1)(2008-5#1)(2013-8#1)
the final step of##4##4##(1993-8#1)(1994-11#1)(2008-2#1)(2008-3#1)
the final step##5##3##(1992-12#1)(1993-8#1)(1994-11#1)(2008-2#1)(2008-3#1)
the final steps of##2##4##(1992-12#1)(1997-7#1)
the final year of##2##4##(2008-11#1)(2008-12#1)
the final##239##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#2)(1996-5#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#45)(2008-11#13)(2008-12#3)(2008-2#7)(2008-3#24)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#14)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#3)(2009-8#5)(2010-10#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
the financial and##4##3##(1992-2#1)(1995-3#1)(2006-5#1)(2008-11#1)
the financial performance of##4##4##(1991-3#1)(1994-12#1)(1994-2#1)(1995-1#1)
the financial world##2##3##(2010-5#2)
the financial##27##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2010-10#1)(2010-2#1)(2010-5#2)(2013-8#1)
the financing of##3##3##(1992-1#1)(1993-2#1)(2008-10#1)
the financing##6##2##(1992-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(2008-10#1)(2012-1#1)
the finding in##2##3##(1997-2#1)(2010-4#1)
the finding of a##5##4##(1990-11#1)(1992-9#1)(1993-9#1)(1996-12#1)(2013-1#1)
the finding of##18##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-9#1)(1993-9#1)(1994-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
the finding that the##7##4##(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#2)
the finding that##24##3##(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-7#1)(2013-1#2)(2013-8#1)
the finding##48##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-7#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
the findings and##3##3##(1996-2#1)(2009-10#1)(2012-3#1)
the findings are discussed##3##4##(1995-1#1)(2007-12#1)(2012-2#1)
the findings are##10##3##(1991-12#1)(1992-12#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
the findings for##4##3##(1993-11#1)(1994-2#1)(1997-1#1)(2008-10#1)
the findings from a study##2##5##(1992-11#1)(2007-12#1)
the findings from##5##3##(1992-11#1)(2007-12#1)(2008-11#1)(2012-3#2)
the findings in the##2##4##(1995-1#1)(1996-7#1)
the findings in##8##3##(1991-8#1)(1995-1#1)(1996-7#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-2#1)
the findings may##2##3##(2008-11#1)(2013-1#1)
the findings obtained##2##3##(1991-2#1)(2008-5#1)
the findings of a survey##2##5##(2008-1#1)(2008-11#1)
the findings of a##12##4##(1991-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-11#3)(2013-8#1)
the findings of recent studies##2##5##(2008-10#1)(2008-3#1)
the findings of recent##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
the findings of research##2##4##(2008-11#1)(2008-7#1)
the findings of the study##2##5##(2007-10#1)(2008-12#1)
the findings of the##9##4##(1990-8#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-3#1)(2011-2#1)
the findings of these##2##4##(1994-9#1)(1996-2#1)
the findings of this pilot study##2##6##(1993-1#1)(2008-7#1)
the findings of this study##4##5##(2008-11#1)(2008-12#1)(2011-1#1)(2013-1#1)
the findings of this##7##4##(1993-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2013-1#1)
the findings of##51##3##(1990-8#1)(1991-12#1)(1993-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#3)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
the findings on##5##3##(1997-3#1)(1997-8#2)(2008-11#1)(2008-12#1)
the findings provide##2##3##(1997-3#1)(2008-11#1)
the findings suggest that##2##4##(2008-7#2)
the findings suggest##4##3##(2007-11#1)(2008-7#2)(2008-8#1)
the findings that##3##3##(1997-3#1)(2008-6#1)(2012-2#1)
the findings to##4##3##(1994-3#1)(1995-1#1)(2008-12#1)(2008-7#1)
the findings were##2##3##(1997-5#1)(2008-11#1)
the findings with##3##3##(1991-2#1)(1994-1#1)(1994-3#1)
the findings##144##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#16)(2008-12#9)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#3)(2009-2#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#5)
the fine and##2##3##(2008-3#1)(2012-1#1)
the fine particle mass##2##4##(1996-2#2)
the fine structure of##3##4##(1992-1#1)(2007-12#1)(2008-7#1)
the fine structure##5##3##(1992-1#1)(2007-11#1)(2007-12#2)(2008-7#1)
the fine##19##2##(1992-1#1)(1992-6#1)(1993-5#1)(1996-2#2)(1997-5#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)
the fine-tuning of##2##3##(1995-9#1)(2013-8#1)
the fine-tuning##3##2##(1995-9#1)(2009-7#1)(2013-8#1)
the finesse of the##2##4##(2008-2#1)(2008-3#1)
the finest##2##2##(2007-4#1)(2008-4#1)
the finger##5##2##(2008-9#3)(2009-2#1)(2010-6#1)
the fingerprint##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
the fingers of##2##3##(2008-5#1)(2009-5#1)
the fingers##5##2##(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-2#1)
the finishing##4##2##(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
the finite sample##2##3##(2009-10#1)(2010-11#1)
the finite size of the##5##5##(2008-2#3)(2008-3#2)
the finite##18##2##(1990-5#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#5)(2009-10#1)(2009-6#1)(2010-11#1)(2013-1#1)(2013-8#1)
the finite-difference time-domain (FDTD) method##2##5##(2007-11#1)(2008-3#1)
the finite-difference time-domain (FDTD)##3##4##(2007-11#1)(2008-3#2)
the finite-difference time-domain method and##2##5##(2008-2#1)(2008-3#1)
the finite-difference time-domain method##8##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
the finite-difference time-domain##13##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#8)
the finite-difference##14##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#9)
the fire origin and at##2##5##(1996-12#2)
the fire##19##2##(1995-6#2)(1996-12#11)(1996-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2010-3#1)
the firefly##2##2##(1997-1#1)(1997-4#1)
the firing of##3##3##(1993-12#1)(2007-8#1)(2008-11#1)
the firing pattern of##2##4##(2008-11#1)(2008-7#1)
the firing process##2##3##(2008-10#2)
the firing rate##5##3##(1995-12#1)(1996-2#1)(2008-11#3)
the firing rates##2##3##(1995-12#1)(2008-11#1)
the firing##18##2##(1993-12#1)(1995-12#2)(1996-2#1)(2007-8#2)(2008-10#3)(2008-11#7)(2008-6#1)(2008-7#1)
the firm##4##2##(1992-3#1)(1993-3#2)(1997-1#1)
the first 10 days to##2##5##(2008-10#2)
the first 10 h##2##4##(2008-10#1)(2008-7#1)
the first 10##7##3##(1991-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-2#1)
the first 100##2##3##(1994-12#1)(2008-10#1)
the first 12 months after##2##5##(2008-3#1)(2009-10#1)
the first 12 months##3##4##(1990-2#1)(2008-3#1)(2009-10#1)
the first 12##6##3##(1990-2#1)(1990-7#1)(2008-3#1)(2009-10#1)(2011-2#2)
the first 15 days##2##4##(1991-6#1)(2008-10#1)
the first 15##7##3##(1990-10#1)(1991-6#1)(1992-8#1)(1994-7#1)(2008-10#2)(2008-2#1)
the first 150 patients##2##4##(1995-11#2)
the first 173##3##3##(1996-5#3)
the first 2 h##2##4##(2008-10#1)(2008-7#1)
the first 2 weeks of##3##5##(2008-10#1)(2008-6#2)
the first 2 weeks##6##4##(2008-10#3)(2008-6#2)(2008-7#1)
the first 2 years after##2##5##(2007-8#1)(2008-7#1)
the first 2 years of##3##5##(1995-1#1)(2008-10#1)(2010-5#1)
the first 2 years##5##4##(1995-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
the first 2##19##3##(1995-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-6#2)(2008-7#3)(2008-9#1)(2010-4#1)(2010-5#1)(2013-1#1)
the first 2-4 weeks##2##4##(1990-10#1)(2007-8#1)
the first 20##5##3##(1994-3#1)(1995-5#1)(2007-8#1)(2008-3#1)(2013-1#1)
the first 24 h##7##4##(1994-8#2)(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
the first 24 hours##3##4##(1992-5#1)(2007-10#1)(2007-7#1)
the first 24 residues##2##4##(1991-10#2)
the first 24##16##3##(1991-10#2)(1992-5#1)(1994-11#1)(1994-8#2)(1995-12#1)(1996-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
the first 25##3##3##(2008-9#2)(2012-2#1)
the first 3 days after##2##5##(2011-2#2)
the first 3 days of##2##5##(2008-11#1)(2010-11#1)
the first 3 days##5##4##(1995-3#1)(2008-11#1)(2010-11#1)(2011-2#2)
the first 3 months after##2##5##(2011-2#1)(2013-1#1)
the first 3 months of life##3##6##(2008-10#1)(2010-6#1)(2011-1#1)
the first 3 months of##5##5##(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
the first 3 months##7##4##(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the first 3 years##2##4##(1991-3#1)(1992-12#1)
the first 3##19##3##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
the first 30##5##3##(1991-8#1)(1996-8#1)(2008-5#2)(2008-7#1)
the first 4 weeks##2##4##(2008-10#1)(2008-7#1)
the first 4##8##3##(1994-8#1)(1995-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)
the first 48 hours##3##4##(2007-10#3)
the first 48##5##3##(1992-12#1)(2007-10#3)(2012-2#1)
the first 5 years##5##4##(1992-1#1)(1994-12#1)(2008-9#1)(2011-2#1)(2012-1#1)
the first 5##10##3##(1992-1#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-6#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
the first 6 months after##3##5##(2011-2#2)(2013-8#1)
the first 6 months of treatment##2##6##(2012-3#1)(2013-8#1)
the first 6 months##5##4##(2011-2#2)(2012-3#1)(2013-8#2)
the first 6 weeks##3##4##(2007-11#2)(2011-1#1)
the first 6##13##3##(1992-4#1)(2007-11#2)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
the first 60##7##3##(1991-9#1)(1992-12#1)(1992-3#3)(1993-3#2)
the first 7 d##2##4##(1994-5#1)(2008-8#1)
the first 7 days after##2##5##(2007-8#1)(2010-4#1)
the first 7 days##6##4##(1997-3#1)(2007-10#2)(2007-7#1)(2007-8#1)(2010-4#1)
the first 7##8##3##(1994-5#1)(1997-3#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-8#1)(2010-4#1)
the first 8##2##3##(1992-1#1)(1992-12#1)
the first Born approximation##3##4##(2007-12#1)(2008-2#2)
the first Born##4##3##(2007-12#1)(2008-2#3)
the first MR##2##3##(2007-10#2)
the first Rytov approximation##3##4##(2008-2#3)
the first Stokes##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the first analytical##2##3##(2008-10#2)
the first and last##4##4##(1997-3#1)(2008-10#2)(2008-8#1)
the first and rate-limiting enzyme##2##5##(1992-8#1)(1993-8#1)
the first and second days##2##5##(2008-5#2)
the first and second period##2##5##(1996-3#2)
the first and second years of##2##6##(1995-8#1)(2008-12#1)
the first and second##28##4##(1990-8#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#3)(2013-8#1)
the first and the second##10##5##(1991-9#1)(1992-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)
the first and the##12##4##(1990-3#1)(1991-9#1)(1992-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)
the first and##54##3##(1990-3#1)(1990-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#3)(2013-8#1)
the first application of##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the first application##8##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
the first assay##2##3##(2008-10#1)(2008-5#1)
the first assessment##4##3##(1993-12#1)(1995-5#1)(2008-10#1)(2009-3#1)
the first atomic##3##3##(1993-11#1)(2007-11#1)(2008-12#1)
the first attempt to##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
the first attempt##6##3##(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2013-8#1)
the first attempts to##2##4##(2008-10#1)(2011-1#1)
the first attempts##3##3##(1990-6#1)(2008-10#1)(2011-1#1)
the first author##2##3##(2007-8#1)(2010-3#1)
the first base of the codon CAA##2##7##(1992-11#1)(1994-8#1)
the first base##3##3##(1992-11#1)(1994-8#1)(2008-10#1)
the first basic##2##3##(1992-2#1)(2008-4#1)
the first being##3##3##(1994-6#1)(2008-2#1)(2008-9#1)
the first biochemical##2##3##(1992-3#1)(1994-11#1)
the first born##2##3##(2007-12#1)(2008-2#1)
the first case and##4##4##(2007-10#2)(2008-5#1)(2010-12#1)
the first case in##3##4##(2007-7#1)(2010-11#1)(2013-1#1)
the first case of a##7##5##(1997-8#1)(2008-12#1)(2009-3#2)(2011-2#1)(2012-12#1)(2013-1#1)
the first case of##30##4##(1994-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-7#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
the first case report of##3##5##(2008-12#1)(2008-6#1)(2009-2#1)
the first case report##4##4##(2008-12#1)(2008-6#1)(2009-2#1)(2012-3#1)
the first case##56##3##(1991-2#1)(1993-2#1)(1994-6#1)(1995-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-12#1)(2007-7#5)(2007-8#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#2)(2009-2#1)(2009-3#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)
the first cases of##2##4##(2011-2#1)(2012-2#1)
the first cause of##3##4##(1996-2#1)(2008-1#1)(2011-3#1)
the first cause##4##3##(1996-2#1)(2008-1#1)(2008-10#1)(2011-3#1)
the first cell##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
the first characterization of##2##4##(1997-4#1)(2010-3#1)
the first characterized##3##3##(1995-6#1)(2008-9#1)(2011-2#1)
the first chemical##2##3##(1992-9#1)(2008-4#1)
the first chemotherapy##2##3##(2007-7#1)(2013-1#1)
the first choice for##3##4##(2011-2#2)(2012-2#1)
the first choice##9##3##(1992-9#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
the first class##2##3##(1994-11#2)
the first clear case##2##4##(2008-10#1)(2008-9#1)
the first clinical application##2##4##(2007-12#1)(2007-8#1)
the first clinical trial##2##4##(2008-5#1)(2010-2#1)
the first clinical##5##3##(1990-12#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-2#1)
the first coding exon##3##4##(1990-8#3)
the first cohort##2##3##(2008-11#1)(2011-2#1)
the first column##3##3##(1990-8#2)(2008-10#1)
the first commercial##2##3##(2008-7#1)(2009-11#1)
the first complete genome sequence of##9##6##(2008-10#1)(2011-2#8)
the first complete genome sequence##11##5##(2008-10#1)(2011-2#10)
the first complete##12##3##(2008-10#1)(2011-2#11)
the first completed genome sequence##15##5##(2011-2#15)
the first completed##17##3##(2011-2#17)
the first comprehensive##5##3##(1996-2#1)(2008-10#1)(2008-8#1)(2013-1#2)
the first constant domain##2##4##(1993-6#2)
the first constant##3##3##(1993-6#2)(2008-10#1)
the first cycle of chemotherapy##2##5##(2008-7#2)
the first cycle of##3##4##(2008-7#3)
the first cycle##4##3##(1990-12#1)(2008-7#3)
the first data##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
the first day of life##3##5##(1990-12#1)(1993-12#2)
the first day of##7##4##(1990-12#2)(1992-5#1)(1993-12#2)(2008-10#1)(2013-1#1)
the first day##13##3##(1990-12#4)(1991-6#1)(1992-5#1)(1993-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
the first days of the##2##5##(2007-8#1)(2008-11#1)
the first days of##6##4##(1990-6#1)(1990-9#1)(1992-6#1)(2007-8#1)(2008-11#1)(2008-7#1)
the first days##8##3##(1990-6#1)(1990-9#1)(1992-6#1)(1992-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
the first decade##2##3##(2011-1#1)(2012-12#1)
the first decades of the##2##5##(2009-10#1)(2011-2#1)
the first definitive evidence##2##4##(1995-2#1)(2008-10#1)
the first demonstration of a##5##5##(1990-12#1)(1993-9#1)(1994-3#1)(2007-12#1)(2008-2#1)
the first demonstration of the##2##5##(2007-11#1)(2008-8#1)
the first demonstration of##20##4##(1990-12#1)(1991-5#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(2007-11#3)(2007-12#5)(2008-10#3)(2008-2#1)(2008-8#1)(2013-1#1)
the first demonstration that##4##4##(1997-2#1)(2008-10#2)(2012-1#1)
the first demonstration##26##3##(1990-12#1)(1991-5#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-1#1)(1997-2#1)(2007-11#3)(2007-12#5)(2008-10#5)(2008-2#1)(2008-8#2)(2012-1#1)(2013-1#1)
the first derivative of the ratio spectra##2##7##(2008-10#2)
the first derivative of the ratio##3##6##(2008-10#3)
the first derivative of the##5##5##(1991-5#1)(2008-10#3)(2008-2#1)
the first derivative of##7##4##(1991-5#1)(2008-10#5)(2008-2#1)
the first derivative spectra D(lambda) and RVI of canopy##2##9##(2008-12#2)
the first derivative spectra##4##4##(2008-10#2)(2008-12#2)
the first derivative##15##3##(1991-5#1)(2008-10#11)(2008-12#2)(2008-2#1)
the first described##3##3##(1994-3#1)(1995-8#1)(2008-10#1)
the first description of the##5##5##(1993-12#1)(1997-8#1)(2008-10#1)(2009-7#1)(2013-8#1)
the first description of##9##4##(1993-12#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-8#1)(2013-8#1)
the first detailed##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
the first differential of##2##4##(2008-3#2)
the first diffraction order##2##4##(2008-2#1)(2008-3#1)
the first dimension##4##3##(2008-10#2)(2008-4#2)
the first direct evidence that##5##5##(1995-2#1)(1996-12#1)(2007-7#1)(2008-10#2)
the first direct##10##3##(1993-3#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#1)
the first documented case##2##4##(2012-2#1)(2013-1#1)
the first documented##5##3##(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
the first dorsal web space##2##5##(2008-9#2)
the first dorsal##3##3##(2008-9#3)
the first dose of medication##2##5##(2008-7#1)(2012-12#1)
the first dose of##7##4##(1995-3#1)(2007-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
the first dose##14##3##(1995-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-7#3)(2008-9#1)(2012-12#4)(2013-1#1)
the first eight##5##3##(1990-11#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-3#1)
the first empirical##2##3##(2008-3#1)(2008-9#1)
the first enzyme in the##2##5##(1997-6#1)(2008-7#1)
the first enzyme in##3##4##(1997-6#1)(2008-7#1)(2009-10#1)
the first enzyme of##2##4##(1990-7#1)(2009-10#1)
the first enzyme##5##3##(1990-7#1)(1997-6#1)(2008-7#1)(2009-10#2)
the first ever##2##3##(2010-12#1)(2012-12#1)
the first evidence for the##2##5##(1991-12#1)(2008-10#1)
the first evidence for##3##4##(1991-12#1)(2008-10#1)(2013-8#1)
the first evidence of##8##4##(1992-2#1)(1992-8#1)(1993-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)
the first evidence that##7##4##(1993-3#1)(1994-5#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-6#1)(2013-1#1)
the first evidence##20##3##(1991-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
the first examination##5##3##(1991-2#1)(1996-6#1)(2007-8#1)(2008-5#1)(2008-7#1)
the first example of a##5##5##(1991-2#1)(1995-2#1)(1996-3#1)(2008-6#1)(2012-3#1)
the first example of such##2##5##(1992-12#1)(1993-11#1)
the first example of##13##4##(1991-2#1)(1992-12#1)(1993-11#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-5#2)(2011-2#1)(2012-3#1)
the first exon and intron##2##5##(1991-6#1)(1993-2#1)
the first exon and##4##4##(1991-5#1)(1991-6#1)(1993-2#1)(1993-6#1)
the first exon##10##3##(1991-5#1)(1991-6#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-10#1)(2009-5#1)(2012-1#1)
the first experiment##9##3##(1996-12#1)(2008-10#6)(2010-8#1)(2013-1#1)
the first experimental demonstration of##4##5##(2007-12#3)(2012-2#1)
the first experimental evidence for##2##5##(2008-11#1)(2008-7#1)
the first experimental evidence of##4##5##(2007-11#1)(2007-12#2)(2008-7#1)
the first experimental evidence##8##4##(1990-2#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-7#2)
the first experimental observation of##3##5##(2007-11#1)(2007-12#2)
the first experimental observation##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
the first experimental##22##3##(1990-2#1)(2007-11#4)(2007-12#9)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)
the first few days after a transient##2##7##(2008-8#2)
the first few days after the##2##6##(1995-11#1)(1997-5#1)
the first few days after##4##5##(1995-11#1)(1997-5#1)(2008-8#2)
the first few days of##3##5##(1990-9#2)(2007-10#1)
the first few days##7##4##(1990-9#2)(1995-11#1)(1997-5#1)(2007-10#1)(2008-8#2)
the first few hours after##3##5##(1995-5#1)(2008-11#1)(2008-6#1)
the first few hours of the##2##6##(2008-10#1)(2011-2#1)
the first few hours##5##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
the first few minutes##2##4##(1996-1#1)(2008-7#1)
the first few years of##2##5##(1996-9#1)(2008-9#1)
the first few##25##3##(1990-9#2)(1991-5#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-9#2)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the first five years of##2##5##(1992-2#1)(2011-2#1)
the first five##8##3##(1990-3#1)(1992-2#1)(1993-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
the first follow-up##2##3##(2008-8#1)(2010-12#1)
the first four years##2##4##(2008-1#1)(2011-1#1)
the first four##9##3##(1993-8#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
the first fusion##2##3##(1991-10#1)(2011-3#1)
the first gene##4##3##(1991-5#1)(1996-12#1)(2008-8#1)(2012-2#1)
the first generation##2##3##(1991-6#1)(2007-11#1)
the first genome sequence##3##4##(2011-2#3)
the first genome##4##3##(2010-8#1)(2011-2#3)
the first glutamatergic##2##3##(2012-2#2)
the first goal##2##3##(2010-8#1)(2012-2#1)
the first grade##2##3##(2008-10#1)(2008-11#1)
the first group of##2##4##(2011-1#1)(2011-2#1)
the first group##18##3##(1990-2#2)(1991-5#1)(1994-12#1)(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)
the first half of 1991##2##5##(1992-3#1)(1993-3#1)
the first half of the twentieth century##4##7##(2009-7#2)(2010-1#1)(2011-2#1)
the first half of the##8##5##(2008-11#1)(2008-12#1)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)
the first half of##13##4##(1990-3#1)(1992-3#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)
the first half##14##3##(1990-3#1)(1992-3#1)(1992-6#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)
the first home##2##3##(1996-5#1)(2010-5#1)
the first hour##2##3##(1992-5#1)(2013-1#1)
the first hyperpolarizability##3##3##(2007-11#1)(2007-12#2)
the first imaging##3##3##(1993-6#1)(2010-6#1)(2012-2#1)
the first in a##5##4##(1993-2#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-4#1)
the first in vivo##2##4##(2009-2#1)(2010-5#1)
the first in##9##3##(1993-2#1)(1993-3#1)(1996-3#1)(2008-10#2)(2008-4#1)(2009-2#1)(2010-5#1)(2012-2#1)
the first indication that##2##4##(2009-2#1)(2010-4#1)
the first infestation##2##3##(1996-12#2)
the first injection of##2##4##(1993-11#1)(2013-8#1)
the first injection##3##3##(1993-11#1)(2011-2#1)(2013-8#1)
the first instance of##3##4##(1993-11#1)(2008-11#1)(2008-12#1)
the first instance##6##3##(1993-11#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#2)
the first international##3##3##(2012-2#1)(2013-8#2)
the first intervention##2##3##(2007-12#1)(2013-1#1)
the first intron of the##3##5##(1991-11#1)(1997-7#1)(2012-3#1)
the first intron of##5##4##(1991-11#1)(1992-6#1)(1997-7#1)(2008-9#1)(2012-3#1)
the first intron##16##3##(1991-11#1)(1991-6#1)(1992-6#1)(1993-2#2)(1993-6#1)(1994-12#1)(1997-7#1)(2008-9#5)(2010-5#1)(2012-3#2)
the first investigation of##2##4##(2007-12#1)(2009-10#1)
the first investigation##5##3##(1996-3#1)(2007-12#1)(2008-6#1)(2009-10#1)(2013-8#1)
the first is##4##3##(1991-9#1)(2008-4#1)(2008-8#1)(2011-2#1)
the first issue of##2##4##(2008-10#1)(2013-8#1)
the first issue##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
the first known##3##3##(1992-5#1)(2011-2#1)(2013-1#1)
the first layer##5##3##(2008-12#1)(2008-2#3)(2008-3#1)
the first line antibiotic according to the local guidelines##2##9##(2013-8#2)
the first line of defense against##2##6##(1993-12#1)(2008-11#1)
the first line of defense##3##5##(1993-12#1)(2008-10#1)(2008-11#1)
the first line of##9##4##(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
the first line##17##3##(1993-12#1)(1994-8#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
the first major##6##3##(1990-12#1)(2007-11#1)(2008-10#3)(2013-1#1)
the first manifestation of the##2##5##(2008-9#1)(2011-2#1)
the first manifestation of##5##4##(1991-3#1)(1996-11#1)(2008-9#2)(2011-2#1)
the first manifestation##6##3##(1991-3#1)(1996-11#1)(2008-9#2)(2011-2#2)
the first measurement##3##3##(2010-5#2)(2012-8#1)
the first measurements of##3##4##(2007-12#1)(2008-2#1)(2008-7#1)
the first measurements##4##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-7#1)
the first member of##3##4##(1990-5#1)(2008-10#1)(2008-8#1)
the first metacarpal##3##3##(2008-9#3)
the first metatarsal##4##3##(2008-12#4)
the first metatarsophalangeal joint##3##4##(2009-10#1)(2010-5#2)
the first method##6##3##(1994-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)
the first mode-locked Yb##2##4##(2007-11#1)(2007-12#1)
the first molecular##2##3##(1997-3#1)(2009-2#1)
the first month of##6##4##(1990-8#1)(1993-2#1)(1996-8#1)(1997-8#1)(2008-9#2)
the first month##10##3##(1990-8#1)(1993-2#2)(1996-8#2)(1997-8#1)(2007-7#1)(2008-9#2)(2009-4#1)
the first months of##3##4##(1990-10#1)(2007-11#1)(2013-1#1)
the first national##2##3##(1997-8#1)(2011-2#1)
the first observation of a##3##5##(2007-11#2)(2007-12#1)
the first observation of##11##4##(1991-5#1)(1993-6#1)(2007-11#4)(2007-12#4)(2008-7#1)
the first observation##15##3##(1991-5#2)(1993-6#1)(2007-11#4)(2007-12#5)(2008-10#1)(2008-3#1)(2008-7#1)
the first observations##2##3##(2007-11#1)(2010-11#1)
the first of a series of##2##6##(2008-5#1)(2008-9#1)
the first of a##4##4##(1994-12#1)(1995-5#1)(2008-5#1)(2008-9#1)
the first of its kind##2##5##(2008-12#1)(2012-2#1)
the first of its##3##4##(1995-12#1)(2008-12#1)(2012-2#1)
the first of the##3##4##(1994-5#1)(2012-12#2)
the first of these##3##4##(1996-2#1)(2008-10#1)(2011-1#1)
the first of##21##3##(1993-1#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
the first one to##2##4##(1992-6#1)(2013-1#1)
the first one##12##3##(1992-6#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-11#2)(2011-2#1)(2013-1#1)
the first operation##5##3##(1991-3#1)(2007-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
the first optical##2##3##(2007-12#2)
the first or second##2##4##(2008-7#2)
the first or##5##3##(1990-8#1)(2008-3#1)(2008-6#1)(2008-7#2)
the first order##10##3##(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#3)(2009-9#1)
the first outbreak##2##3##(2008-5#1)(2011-1#1)
the first part of a##2##5##(2008-11#1)(2013-8#1)
the first part of the##6##5##(1990-3#2)(1992-6#1)(1997-4#1)(2008-1#1)(2008-5#1)
the first part of this##5##5##(2008-10#2)(2008-2#1)(2010-12#1)(2012-2#1)
the first part of##13##4##(1990-3#2)(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
the first part##17##3##(1990-3#2)(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
the first passage##3##3##(2008-10#2)(2008-7#1)
the first patient##4##3##(1990-8#1)(1995-11#1)(2007-7#1)(2009-1#1)
the first peak of##3##4##(1992-11#1)(1996-12#2)
the first peak##6##3##(1991-12#1)(1992-11#1)(1992-9#1)(1996-12#2)(2010-3#1)
the first pediatric case##2##4##(2008-10#1)(2013-1#1)
the first period##7##3##(1992-10#1)(1996-11#1)(2008-10#1)(2011-2#3)(2012-1#1)
the first permanent molars##2##4##(1995-2#1)(2013-1#1)
the first permanent##3##3##(1995-2#1)(2013-1#2)
the first phase of this##2##5##(2007-5#1)(2008-12#1)
the first phase of##5##4##(1993-9#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)
the first phase##14##3##(1990-12#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#2)(2011-3#1)
the first place##7##3##(2008-1#1)(2008-11#1)(2008-9#2)(2009-11#1)(2009-7#1)(2011-2#1)
the first point##2##3##(2008-6#1)(2011-1#1)
the first polar body##3##4##(2008-9#1)(2013-1#2)
the first postnatal week but##2##5##(1997-2#2)
the first postnatal week##3##4##(1997-2#3)
the first postnatal##5##3##(1993-3#1)(1996-5#1)(1997-2#3)
the first postoperative day##3##4##(1990-2#1)(2007-10#1)(2010-4#1)
the first prescription of##2##4##(1996-9#1)(2008-8#1)
the first presentation of##3##4##(2007-8#1)(2008-4#1)(2011-2#1)
the first priority##2##3##(1992-12#1)(2010-8#1)
the first procedure##2##3##(1997-8#1)(2008-10#1)
the first published case##2##4##(1990-12#1)(2008-5#1)
the first published##6##3##(1990-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
the first quantitative##4##3##(1994-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
the first quarter of##2##4##(2008-5#2)
the first reaction##3##3##(2008-10#3)
the first real-time##2##3##(2007-12#1)(2008-7#1)
the first record of##3##4##(1997-4#1)(2008-10#2)
the first record##4##3##(1997-4#1)(2008-10#3)
the first report from##2##4##(2007-9#1)(2008-10#1)
the first report in##3##4##(2008-1#1)(2008-5#1)(2013-8#1)
the first report of this##2##5##(1990-6#1)(1992-3#1)
the first report of##79##4##(1990-6#1)(1990-7#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-5#2)(1995-6#1)(1995-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#25)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
the first report##138##3##(1990-5#1)(1990-6#1)(1990-7#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-8#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#9)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
the first reported case of such a##2##7##(2010-7#1)(2012-2#1)
the first reported case of such an##2##7##(2008-10#1)(2008-11#1)
the first reported case of such##4##6##(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
the first reported case of##22##5##(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the first reported case##24##4##(1991-2#1)(1991-9#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the first reported##31##3##(1991-2#1)(1991-9#1)(1992-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the first representative of Pfam family##3##6##(2010-10#3)
the first round##5##3##(1991-6#2)(1995-12#1)(2007-11#2)
the first saccade##3##3##(2009-2#3)
the first sample##2##3##(2008-10#2)
the first sampling##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
the first season##2##3##(2008-10#2)
the first second##6##3##(2007-8#1)(2013-1#2)(2013-8#3)
the first semester nursing##2##4##(2007-10#2)
the first semester of##2##4##(1991-12#1)(2012-3#1)
the first semester##6##3##(1991-12#1)(2007-10#2)(2008-10#1)(2012-3#2)
the first sequence##4##3##(2008-10#1)(2008-4#1)(2011-2#2)
the first several##2##3##(2007-8#1)(2013-1#1)
the first sign of##3##4##(1993-2#1)(2007-11#1)(2011-2#1)
the first signs of##2##4##(2007-9#1)(2011-2#1)
the first six months##3##4##(1991-6#1)(1996-11#1)(2008-2#1)
the first six##5##3##(1991-6#1)(1993-2#1)(1996-11#1)(2008-2#1)(2011-1#1)
the first sonication##2##3##(2008-10#2)
the first stage involves##2##4##(2012-12#1)(2012-3#1)
the first stage of the##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
the first stage of##6##4##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#2)
the first stage##15##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the first stages of the titration##2##6##(2008-10#2)
the first stages of##3##4##(2008-10#2)(2008-12#1)
the first state##2##3##(1995-12#1)(1996-3#1)
the first step at##2##4##(1997-7#1)(2012-2#1)
the first step being##2##4##(1990-7#1)(2009-4#1)
the first step for##4##4##(1993-8#1)(1996-3#1)(2008-10#1)(2013-1#1)
the first step in a##2##5##(1995-12#1)(2008-10#1)
the first step in the##7##5##(1995-2#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
the first step in##17##4##(1990-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#2)(2009-2#1)(2010-11#1)(2010-9#1)(2011-2#1)
the first step is##2##4##(1995-12#1)(2009-8#1)
the first step of a##2##5##(1997-5#1)(2008-10#1)
the first step of the##3##5##(1992-8#1)(2008-12#1)(2013-8#1)
the first step of##13##4##(1992-8#1)(1994-8#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#2)
the first step toward the development of##2##7##(2009-1#1)(2009-4#1)
the first step toward##4##4##(2008-4#1)(2008-6#1)(2009-1#1)(2009-4#1)
the first step##60##3##(1990-7#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
the first steps of##2##4##(1992-6#1)(2008-2#1)
the first steps##6##3##(1992-6#1)(1996-3#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-2#1)
the first stereoselective step of chiral##2##6##(1994-8#2)
the first structural##4##3##(1991-3#1)(1994-12#1)(2010-10#1)(2013-8#1)
the first study##18##3##(1994-3#1)(1995-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-2#1)(2011-2#2)(2012-3#1)
the first substrate##3##3##(1991-12#1)(1992-3#1)(1995-2#1)
the first successful##5##3##(2007-11#2)(2007-4#1)(2008-7#1)(2008-9#1)
the first such##2##3##(1992-6#1)(2012-2#1)
the first surgical##2##3##(1990-8#1)(2007-11#1)
the first symptom##4##3##(1997-3#1)(2007-11#1)(2008-12#1)(2012-2#1)
the first ten##3##3##(1991-8#1)(2008-10#1)(2008-9#1)
the first tested##2##3##(1995-5#1)(2008-3#1)
the first third of the##2##5##(2008-10#1)(2008-8#1)
the first three cases##2##4##(1997-6#1)(2011-2#1)
the first three days##2##4##(1990-11#1)(2012-2#1)
the first three hours of##2##5##(2008-11#1)(2011-1#1)
the first three months of##2##5##(2007-7#1)(2010-8#1)
the first three months##5##4##(1990-6#1)(2007-7#2)(2008-6#1)(2010-8#1)
the first three orders of##2##5##(2007-11#1)(2008-3#1)
the first three weeks##3##4##(2008-12#1)(2008-5#1)(2008-9#1)
the first three##28##3##(1990-11#1)(1990-5#1)(1990-6#1)(1992-4#1)(1992-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
the first time a##8##4##(2007-11#1)(2007-5#1)(2008-10#3)(2008-6#1)(2009-8#1)(2012-2#1)
the first time for##4##4##(2007-11#1)(2007-12#1)(2010-4#1)(2010-9#1)
the first time in this##4##5##(2007-11#1)(2008-10#1)(2009-9#1)(2013-1#1)
the first time in##34##4##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1993-2#1)(1994-11#2)(1994-12#1)(1995-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#3)
the first time it was given##2##6##(1993-6#2)
the first time it was##3##5##(1993-6#2)(2008-7#1)
the first time it##4##4##(1990-3#1)(1993-6#2)(2008-7#1)
the first time that a##3##5##(2007-12#1)(2009-8#1)(2011-1#1)
the first time that the##7##5##(1995-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
the first time that##33##4##(1991-3#1)(1992-12#1)(1992-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-2#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-8#1)
the first time the##21##4##(1992-3#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
the first time to our knowledge that##2##7##(2008-2#1)(2008-3#1)
the first time to our knowledge##42##6##(2007-11#9)(2007-12#11)(2008-2#7)(2008-3#15)
the first time to the author's knowledge##2##7##(2007-12#1)(2008-2#1)
the first time to the authors' knowledge##11##7##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#2)
the first time to the##14##5##(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#2)
the first time to##68##4##(1992-9#1)(1994-3#1)(2007-11#12)(2007-12#16)(2008-10#4)(2008-2#12)(2008-3#17)(2008-9#2)(2009-7#1)(2011-1#1)(2013-8#1)
the first time##413##3##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#3)(2006-4#1)(2007-1#1)(2007-11#27)(2007-12#36)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#100)(2008-11#6)(2008-12#3)(2008-2#25)(2008-3#32)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#3)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#3)(2012-12#1)(2012-2#11)(2012-3#2)(2012-8#1)(2013-1#20)(2013-8#4)
the first to demonstrate that##2##5##(2008-3#1)(2009-12#1)
the first to demonstrate##5##4##(1990-11#1)(1994-11#1)(2008-3#1)(2009-12#1)(2010-11#1)
the first to describe##3##4##(2008-6#1)(2013-1#2)
the first to investigate the##2##5##(2010-11#1)(2012-3#1)
the first to report##2##4##(2007-12#1)(2013-1#1)
the first to show##4##4##(2007-12#1)(2008-11#1)(2011-2#1)(2013-3#1)
the first to##38##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-12#1)(1993-1#1)(1994-11#1)(1994-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#2)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-3#1)
the first transmembrane##2##3##(1990-12#1)(1992-9#1)
the first treatment##5##3##(1991-6#2)(1993-8#1)(1996-9#1)(2008-1#1)
the first trial##2##3##(2008-5#1)(2008-8#1)
the first trimester of pregnancy##4##5##(1992-2#2)(1994-9#1)(1996-12#1)
the first trimester of##5##4##(1990-6#1)(1992-2#2)(1994-9#1)(1996-12#1)
the first trimester##13##3##(1990-6#1)(1990-9#1)(1992-2#2)(1993-3#2)(1994-9#1)(1996-12#1)(2011-1#1)(2011-2#1)(2013-1#3)
the first tumor##3##3##(1992-9#1)(1997-3#2)
the first twelve months##2##4##(2012-3#2)
the first two decades of##4##5##(2008-8#2)(2010-12#2)
the first two phases of the##3##6##(1996-1#1)(1996-2#1)(2008-3#1)
the first two principal components##3##5##(2008-10#1)(2012-1#1)(2013-7#1)
the first two protocols##2##4##(2008-4#2)
the first two rounds##2##4##(2008-10#2)
the first two weeks of##3##5##(1994-6#1)(2008-10#1)(2010-3#1)
the first two weeks##5##4##(1994-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2010-3#1)
the first two years of their##2##6##(1996-2#1)(2008-11#1)
the first two years of##4##5##(1996-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
the first two years##7##4##(1996-2#1)(2008-1#1)(2008-11#1)(2011-2#3)(2012-2#1)
the first two##58##3##(1990-8#1)(1991-2#1)(1992-4#1)(1993-8#2)(1994-2#3)(1994-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
the first two-thirds of the##2##5##(1994-12#1)(2008-10#1)
the first type of##2##4##(2008-3#1)(2012-2#1)
the first type##6##3##(2008-10#3)(2008-3#1)(2011-2#1)(2012-2#1)
the first upper true leaves at 14 dpi##3##8##(2008-10#3)
the first upper true leaves at 14##4##7##(2008-10#4)
the first upper##5##3##(2008-10#4)(2008-8#1)
the first use of##2##4##(2007-11#1)(2008-3#1)
the first use##4##3##(2007-11#1)(2008-3#3)
the first vaccination##2##3##(1994-9#1)(1995-3#1)
the first wave##2##3##(2010-5#1)(2011-1#1)
the first week after birth##2##5##(1990-12#1)(1996-3#1)
the first week following##2##4##(1991-2#1)(2010-3#1)
the first week of the##2##5##(2007-11#1)(2008-9#1)
the first week of##6##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
the first week##14##3##(1990-12#1)(1991-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
the first weeks of life##2##5##(1993-12#1)(2007-11#1)
the first when##2##3##(1996-5#1)(2008-3#1)
the first with the chief nurse##2##6##(2013-1#2)
the first with##4##3##(2008-4#1)(2011-2#1)(2013-1#2)
the first woman##3##3##(1993-6#1)(2011-2#2)
the first year after the##2##5##(2009-5#1)(2011-2#1)
the first year after transplantation##2##5##(2007-8#1)(2010-8#1)
the first year after##6##4##(2007-8#1)(2007-9#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-2#1)
the first year of Medicare coverage##2##6##(1995-1#2)
the first year of a##2##5##(1995-3#1)(2008-12#1)
the first year of life##11##5##(1994-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(2008-1#2)(2008-12#1)(2008-7#2)(2013-1#1)
the first year of the##7##5##(1991-2#1)(1991-3#1)(1993-11#1)(1993-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
the first year of this##2##5##(1990-11#1)(1997-1#1)
the first year of##34##4##(1990-11#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#4)
the first year##62##3##(1990-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#3)(1997-1#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
the first years of life##2##5##(1995-6#1)(2013-1#1)
the first years of##5##4##(1995-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
the first years##7##3##(1995-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
the first##2598##2##(1990-10#3)(1990-11#10)(1990-12#16)(1990-2#10)(1990-3#6)(1990-4#1)(1990-5#10)(1990-6#7)(1990-7#9)(1990-8#17)(1990-9#4)(1991-10#3)(1991-11#3)(1991-12#8)(1991-2#11)(1991-3#7)(1991-4#1)(1991-5#10)(1991-6#17)(1991-8#3)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#11)(1992-2#8)(1992-3#14)(1992-4#5)(1992-5#6)(1992-6#17)(1992-8#14)(1992-9#9)(1993-1#3)(1993-11#9)(1993-12#11)(1993-2#14)(1993-3#15)(1993-5#1)(1993-6#13)(1993-8#10)(1993-9#3)(1994-1#2)(1994-11#11)(1994-12#19)(1994-2#7)(1994-3#14)(1994-5#5)(1994-6#12)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#4)(1995-11#9)(1995-12#16)(1995-2#10)(1995-3#7)(1995-5#11)(1995-6#14)(1995-8#9)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#16)(1996-2#9)(1996-3#14)(1996-4#1)(1996-5#13)(1996-6#6)(1996-7#3)(1996-8#4)(1996-9#6)(1997-1#5)(1997-2#16)(1997-3#16)(1997-4#6)(1997-5#4)(1997-6#7)(1997-7#6)(1997-8#8)(2006-10#5)(2006-12#1)(2006-4#2)(2007-1#2)(2007-10#19)(2007-11#79)(2007-12#98)(2007-2#2)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#21)(2007-8#30)(2007-9#4)(2008-1#16)(2008-10#399)(2008-11#73)(2008-12#44)(2008-2#77)(2008-3#117)(2008-4#29)(2008-5#56)(2008-6#35)(2008-7#62)(2008-8#45)(2008-9#64)(2009-1#4)(2009-10#14)(2009-11#7)(2009-12#8)(2009-2#10)(2009-3#5)(2009-4#6)(2009-5#7)(2009-6#2)(2009-7#15)(2009-8#10)(2009-9#7)(2010-1#6)(2010-10#8)(2010-11#11)(2010-12#12)(2010-2#6)(2010-3#19)(2010-4#12)(2010-5#17)(2010-6#4)(2010-7#2)(2010-8#14)(2010-9#3)(2011-1#33)(2011-2#137)(2011-3#7)(2011-8#1)(2012-1#9)(2012-12#23)(2012-2#57)(2012-3#37)(2012-8#2)(2013-1#102)(2013-3#1)(2013-7#2)(2013-8#37)
the first- and the second-order##3##5##(2008-2#1)(2008-3#2)
the first-derivative##3##2##(2008-10#3)
the first-dimension gel##2##3##(2008-4#2)
the first-ever##2##2##(1996-2#1)(2007-8#1)
the first-generation##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
the first-line therapy##2##3##(2010-12#2)
the first-line treatment of##2##4##(2011-2#1)(2013-8#1)
the first-line treatment##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
the first-line##12##2##(1997-2#1)(2007-12#1)(2009-8#1)(2010-11#1)(2010-12#5)(2011-2#1)(2012-3#1)(2013-8#1)
the first-order diffracted##2##3##(2008-3#2)
the first-order##19##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#11)
the first-phase##2##2##(1990-2#1)(2008-1#1)
the first-round PCR##3##3##(1997-4#2)(2008-10#1)
the first-round##4##2##(1997-4#2)(2008-10#2)
the first-strand cDNA synthesis##2##4##(1997-2#2)
the first-strand cDNA##3##3##(1994-12#1)(1997-2#2)
the fiscal##5##2##(1991-1#1)(1992-2#1)(1994-2#1)(1995-6#1)(1997-2#1)
the fish and##3##3##(1993-12#1)(1996-5#2)
the fish were##3##3##(2008-12#1)(2010-8#1)(2013-7#1)
the fish##35##2##(1992-8#1)(1993-12#1)(1996-2#1)(1996-5#2)(1997-4#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-7#5)
the fish's##2##2##(2008-7#1)(2010-8#1)
the fishery##5##2##(2007-5#4)(2013-7#1)
the fission of peroxisomes and mitochondria##2##6##(2009-10#2)
the fission yeast Schizosaccharomyces pombe##7##5##(1995-2#1)(1995-8#2)(1995-9#1)(1997-3#1)(2008-9#1)(2009-3#1)
the fission yeast##10##3##(1995-2#1)(1995-8#2)(1995-9#1)(1997-3#1)(2008-7#3)(2008-9#1)(2009-3#1)
the fission##13##2##(1995-2#1)(1995-8#2)(1995-9#1)(1997-3#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-3#1)
the fist##2##2##(2008-4#1)(2011-2#1)
the fistula and##2##3##(1993-5#1)(2013-8#1)
the fistula was##4##3##(1996-9#3)(1997-3#1)
the fistula##23##2##(1993-5#1)(1995-11#2)(1996-12#1)(1996-9#5)(1997-3#3)(2006-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
the fistulas##4##2##(1993-2#1)(1995-11#2)(2008-7#1)
the fit of the##4##4##(2008-10#3)(2010-6#1)
the fit of##5##3##(2008-10#3)(2008-12#1)(2010-6#1)
the fit##15##2##(1996-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-7#1)(2010-6#1)(2013-8#1)
the fitness consequences of##2##4##(2008-8#2)
the fitness of the##2##4##(2008-10#1)(2008-8#1)
the fitness of##9##3##(2008-10#4)(2008-8#3)(2008-9#2)
the fitness##20##2##(2008-10#6)(2008-11#1)(2008-8#7)(2008-9#5)(2013-1#1)
the fitted model##2##3##(2008-10#1)(2008-8#1)
the fitted##5##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
the fitting procedure##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
the fitting##11##2##(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#2)
the five candidate genes##2##4##(1996-8#2)
the five clones##2##3##(1997-7#2)
the five groups##2##3##(1991-6#1)(1993-9#1)
the five major##2##3##(2008-10#1)(2011-1#1)
the five most common##2##4##(2008-10#2)
the five most##5##3##(1993-3#1)(2008-10#3)(2008-11#1)
the five species##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
the five stages##2##3##(1990-10#2)
the five states##2##3##(1993-3#1)(2008-10#1)
the five strains with##2##4##(2011-2#2)
the five teacher actions##2##4##(2008-4#2)
the five types of##2##4##(1993-2#1)(2011-2#1)
the five##102##2##(1990-10#2)(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-5#1)(1997-7#3)(1997-8#1)(2008-1#1)(2008-10#38)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#2)
the five-year##2##2##(1990-5#1)(2008-10#1)
the fixation and##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
the fixation of##4##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-9#1)
the fixation##11##2##(1997-7#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
the fixed interference method (FIM)##2##5##(2008-10#2)
the fixed interference##3##3##(2008-10#3)
the fixed time and##2##4##(2008-10#2)
the fixed##12##2##(1997-2#1)(2008-10#6)(2008-3#3)(2008-7#1)(2009-6#1)
the fixed-pattern noise##2##3##(2008-2#1)(2008-3#1)
the fixed-time##2##2##(2008-10#2)
the fixing process##2##3##(2007-12#1)(2008-2#1)
the fixing##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the flag leaf sheath##2##4##(2008-10#2)
the flag leaf##5##3##(2008-10#4)(2008-12#1)
the flag##6##2##(2008-10#5)(2008-12#1)
the flagellar##2##2##(1994-8#1)(2008-10#1)
the flagellins##3##2##(1990-2#3)
the flagellum##7##2##(2008-10#1)(2008-4#1)(2008-7#5)
the flame atomic absorption spectrometer nebulizer##2##6##(2008-10#2)
the flame atomic absorption spectrometer##4##5##(2008-10#4)
the flame atomic absorption##7##4##(2008-10#7)
the flame atomizer##3##3##(2008-10#3)
the flame composition##2##3##(2008-10#2)
the flame structure##3##3##(2008-3#3)
the flame##33##2##(2008-10#22)(2008-2#2)(2008-3#8)(2012-12#1)
the flame-front##2##2##(2008-2#2)
the flames##3##2##(1994-12#1)(2008-3#2)
the flanking##9##2##(1993-6#1)(1994-11#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)
the flap and##2##3##(2008-9#1)(2009-12#1)
the flap in##2##3##(1991-5#1)(2011-2#1)
the flap##13##2##(1991-5#3)(2007-12#2)(2007-5#1)(2008-4#1)(2008-9#2)(2009-12#1)(2011-2#2)(2012-2#1)
the flaps##6##2##(1990-6#1)(2007-12#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)
the flat group##3##3##(1991-2#3)
the flat##9##2##(1991-2#3)(1995-11#1)(1995-2#1)(2008-10#2)(2008-3#2)
the flat-field##3##2##(2008-3#3)
the flatness##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
the flavonoid##7##2##(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2010-6#1)
the flavonoids##5##2##(1992-5#1)(2007-11#1)(2008-11#3)
the flavor##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
the fleece##3##2##(1997-5#3)
the flesh##2##2##(2008-12#1)(2008-9#1)
the flexibility of the##5##4##(1990-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
the flexibility of##12##3##(1990-3#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-9#1)
the flexibility to##4##3##(1993-12#1)(2008-4#1)(2009-9#1)(2011-1#1)
the flexibility##21##2##(1990-3#1)(1993-11#1)(1993-12#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#2)(2011-1#2)(2011-9#1)
the flexible##5##2##(1996-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
the flexion##3##2##(1997-2#1)(2008-5#1)(2012-2#1)
the flexor and extensor muscle groups##3##6##(2007-8#3)
the flexor carpi ulnaris##2##4##(2008-9#1)(2009-5#1)
the flexor digitorum##5##3##(2008-12#1)(2008-9#2)(2010-5#1)(2012-2#1)
the flexor hallucis longus tendon##2##5##(2010-7#2)
the flexor hallucis longus##3##4##(2009-10#1)(2010-7#2)
the flexor##17##2##(2007-8#3)(2008-12#1)(2008-9#6)(2009-1#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#2)(2012-2#1)
the flexural resonance frequency shift of##2##6##(2009-5#2)
the flexural strength of##3##4##(2008-12#1)(2009-7#2)
the flexural strength##5##3##(2008-12#3)(2009-7#2)
the flexural##8##2##(2008-12#3)(2008-5#1)(2009-5#2)(2009-7#2)
the flight ability##2##3##(2008-6#2)
the flight##10##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-8#1)(2012-3#1)
the floater##2##2##(2008-9#2)
the flocculation##2##2##(1995-6#1)(2008-7#1)
the flock##2##2##(1997-3#1)(1997-6#1)
the flocks##2##2##(1997-3#1)(1997-6#1)
the flood##5##2##(1991-2#1)(2007-11#1)(2008-10#2)(2008-2#1)
the flooding##2##2##(2008-5#1)(2009-10#1)
the floodplain##4##2##(2008-5#1)(2010-8#1)(2013-7#2)
the floods##2##2##(1996-6#2)
the floor by##2##3##(1997-2#2)
the floor of the middle##2##5##(2008-7#1)(2011-2#1)
the floor of the##6##4##(1996-5#1)(1996-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
the floor##18##2##(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#4)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-9#1)(2010-11#2)(2011-2#1)(2013-1#1)
the floral cavity##2##3##(2008-10#2)
the floral organs of Hyacinthus orientalis L##2##7##(2008-8#2)
the floral##8##2##(2008-10#4)(2008-8#4)
the floras of##2##3##(2008-8#2)
the floret##3##2##(2008-10#3)
the floristic##3##2##(2008-8#2)(2013-7#1)
the flotation##3##2##(2008-10#3)
the flow analysis##2##3##(2008-10#2)
the flow and##2##3##(2008-10#1)(2008-3#1)
the flow cell and##3##4##(2008-10#3)
the flow cell of##2##4##(2008-10#2)
the flow cell to##2##4##(2008-10#2)
the flow cell##26##3##(2008-10#26)
the flow cytometer##2##3##(2008-9#2)
the flow cytometric analysis##2##4##(2008-11#1)(2008-9#1)
the flow cytometric##8##3##(1990-12#1)(2008-11#2)(2008-4#1)(2008-9#4)
the flow field##3##3##(2008-11#2)(2008-3#1)
the flow initially##2##3##(2008-10#2)
the flow injection analysis (FIA)##3##5##(2008-10#3)
the flow injection analysis##5##4##(2008-10#5)
the flow injection determination##2##4##(2008-10#2)
the flow injection manifold##2##4##(2008-10#2)
the flow injection system##5##4##(2008-10#5)
the flow injection technique##2##4##(2008-10#2)
the flow injection##21##3##(2008-10#21)
the flow is##2##3##(1991-3#1)(2008-4#1)
the flow line##6##3##(2008-10#6)
the flow of air towards the heart##2##7##(1991-3#2)
the flow of information##2##4##(1994-2#1)(2008-11#1)
the flow of the carrier solution##2##6##(2008-10#2)
the flow of the##4##4##(2008-10#4)
the flow of##30##3##(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1994-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
the flow rate and##3##4##(2008-10#2)(2008-7#1)
the flow rate of the##6##5##(1991-9#1)(2008-10#5)
the flow rate of##11##4##(1991-9#1)(2008-10#10)
the flow rate was##2##4##(2008-10#1)(2011-1#1)
the flow rate##33##3##(1990-12#1)(1991-9#2)(1994-2#1)(2008-10#25)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
the flow rates##3##3##(2008-10#2)(2008-7#1)
the flow set-up##2##3##(2008-10#2)
the flow system in##2##4##(2008-10#2)
the flow system were##2##4##(2008-10#2)
the flow system##24##3##(2008-10#23)(2008-2#1)
the flow through##2##3##(2007-12#1)(2008-11#1)
the flow velocity and the##3##5##(2008-11#1)(2008-3#2)
the flow velocity##7##3##(2007-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#1)
the flow##230##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-9#3)(1992-11#1)(1992-2#1)(1994-2#2)(1995-3#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#140)(2008-11#9)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#8)(2009-11#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the flow-injection determination of##4##4##(2008-10#4)
the flow-injection sandwich ELISA##2##4##(2008-10#2)
the flow-injection##12##2##(2008-10#12)
the flow-rate##5##2##(1991-9#1)(1997-2#1)(2008-10#3)
the flow-through cell##2##3##(2008-10#2)
the flow-through sensor##2##3##(2008-10#2)
the flow-through##6##2##(2008-10#6)
the flower hypanthium##3##3##(2008-10#3)
the flower##8##2##(2008-10#5)(2009-12#2)(2011-10#1)
the flowering plant Senecio isatideus (Asteraceae)##2##6##(1990-7#2)
the flowering plant##3##3##(1990-7#2)(1996-10#1)
the flowering stage##2##3##(2008-12#2)
the flowering##8##2##(1990-7#2)(1996-10#1)(2008-10#1)(2008-12#2)(2008-8#2)
the flowers of P##3##4##(2012-3#3)
the flowers of##4##3##(2012-3#4)
the flowers##9##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#4)
the flowing##7##2##(2008-10#6)(2011-2#1)
the flu##2##2##(2008-11#1)(2010-4#1)
the fluctuating##2##2##(2007-11#1)(2008-3#1)
the fluctuation of the##2##4##(1996-12#1)(2007-11#1)
the fluctuation of##4##3##(1996-12#1)(2007-11#2)(2008-10#1)
the fluctuation##8##2##(1996-12#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-9#2)
the fluctuations in the##4##4##(2008-2#2)(2008-5#1)(2008-8#1)
the fluctuations in##6##3##(1996-4#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)
the fluctuations of##3##3##(1996-4#1)(2008-2#1)(2008-9#1)
the fluctuations##12##2##(1996-4#3)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)
the flue gas##3##3##(2008-10#2)(2008-3#1)
the fluence##2##2##(2008-2#1)(2008-3#1)
the fluid flow##2##3##(2009-11#1)(2010-8#1)
the fluid##24##2##(1990-6#1)(1990-8#1)(1991-8#1)(1996-4#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#7)(2009-11#2)(2010-5#2)(2010-8#1)(2011-2#1)
the fluidic##2##2##(2009-5#2)
the fluidics##2##2##(2008-9#2)
the fluidity of##3##3##(1995-8#1)(2008-7#1)(2008-9#1)
the fluidity##4##2##(1995-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
the fluidized##2##2##(2008-11#2)
the fluids##4##2##(2008-10#2)(2008-7#2)
the fluorescein##4##2##(1990-5#1)(1995-2#1)(2008-10#2)
the fluorescence and the##3##4##(2007-11#2)(2008-3#1)
the fluorescence and##4##3##(2007-11#2)(2008-3#2)
the fluorescence anisotropy of##2##4##(1994-2#1)(2008-10#1)
the fluorescence changes##3##3##(1994-5#1)(1995-5#1)(2008-10#1)
the fluorescence contribution##2##3##(2007-12#1)(2008-3#1)
the fluorescence distribution##2##3##(2008-2#1)(2008-3#1)
the fluorescence emission from##2##4##(2008-9#1)(2009-8#1)
the fluorescence emission maximum at##2##5##(2008-8#2)
the fluorescence emission of##4##4##(2008-10#1)(2008-3#3)
the fluorescence emission##17##3##(2008-10#6)(2008-3#5)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)
the fluorescence energy transfer##2##4##(1994-2#1)(2008-10#1)
the fluorescence enhancement of##4##4##(2008-10#4)
the fluorescence enhancement##6##3##(2008-10#5)(2008-7#1)
the fluorescence excitation##3##3##(2008-10#2)(2008-2#1)
the fluorescence from##2##3##(2008-2#1)(2008-3#1)
the fluorescence image##2##3##(2008-3#2)
the fluorescence intensities##3##3##(2008-10#3)
the fluorescence intensity and the##2##5##(2008-10#2)
the fluorescence intensity and##3##4##(2008-10#3)
the fluorescence intensity of the##9##5##(1990-12#1)(1992-3#1)(1995-6#1)(2008-10#5)(2008-5#1)
the fluorescence intensity of##17##4##(1990-12#1)(1992-3#1)(1994-12#1)(1995-6#1)(2008-10#11)(2008-5#1)(2009-11#1)
the fluorescence intensity ratio##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
the fluorescence intensity##37##3##(1990-12#1)(1992-3#1)(1994-12#1)(1995-6#1)(2008-10#23)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-11#1)(2013-8#1)
the fluorescence is##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the fluorescence lifetime##4##3##(2008-2#1)(2008-3#3)
the fluorescence of the##8##4##(1992-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-9#1)
the fluorescence of##33##3##(1990-5#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-5#1)(2013-8#1)
the fluorescence polarization##2##3##(1993-8#1)(2008-8#1)
the fluorescence properties of##2##4##(1992-6#1)(1997-2#1)
the fluorescence properties##4##3##(1992-6#1)(1994-5#1)(1997-2#1)(2009-2#1)
the fluorescence quantum yield##3##4##(2008-3#3)
the fluorescence quenching##11##3##(2008-10#9)(2008-8#1)(2013-8#1)
the fluorescence reaction between##2##4##(2008-10#2)
the fluorescence resonance energy transfer (FRET)##2##6##(2008-10#2)
the fluorescence resonance energy##3##4##(2008-10#2)(2008-9#1)
the fluorescence signal##7##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
the fluorescence signals##3##3##(2008-10#2)(2008-2#1)
the fluorescence spectra##2##3##(2008-10#2)
the fluorescence spectrum of##2##4##(2007-11#1)(2008-10#1)
the fluorescence spectrum##4##3##(1994-8#1)(2007-11#1)(2008-10#2)
the fluorescence was##2##3##(1990-8#1)(1992-9#1)
the fluorescence yield of##2##4##(2008-2#1)(2008-3#1)
the fluorescence##215##2##(1990-12#1)(1990-5#1)(1990-8#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-2#2)(1997-2#3)(2007-11#4)(2007-12#4)(2008-1#2)(2008-10#95)(2008-11#3)(2008-2#17)(2008-3#33)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#6)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2013-8#3)
the fluorescent dye##6##3##(1990-2#1)(1991-11#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-4#1)
the fluorescent light##3##3##(2007-12#1)(2008-3#2)
the fluorescent phospholipid##3##3##(1992-3#1)(1993-11#1)(1994-5#1)
the fluorescent probe##9##3##(1990-7#1)(1992-3#2)(1992-6#1)(1993-9#1)(1997-7#1)(2008-10#2)(2008-8#1)
the fluorescent reagent##2##3##(1990-8#1)(2008-10#1)
the fluorescent signal of##2##4##(2008-10#1)(2008-11#1)
the fluorescent signal##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
the fluorescent##56##2##(1990-2#1)(1990-7#1)(1990-8#3)(1991-11#1)(1992-3#3)(1992-6#3)(1993-11#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-5#2)(1995-6#1)(1996-6#1)(1997-2#1)(1997-7#3)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2013-1#1)
the fluoride concentration in##2##4##(2008-10#2)
the fluoride##10##2##(2008-10#7)(2008-11#1)(2008-5#1)(2011-1#1)
the fluorimetric method##2##3##(2008-10#2)
the fluorimetric##11##2##(2008-10#11)
the fluorinated##2##2##(2008-10#1)(2009-9#1)
the fluorine ion##2##3##(2008-10#2)
the fluorine##3##2##(2008-10#3)
the fluoro group##2##3##(1991-12#1)(2009-9#1)
the fluorochrome##5##2##(1990-2#1)(1991-6#1)(2008-1#1)(2008-10#1)(2008-12#1)
the fluorogenic##5##2##(1992-9#1)(2008-10#4)
the fluorometric##7##2##(1993-3#1)(2008-10#6)
the fluorophore concentration##3##3##(2007-12#2)(2008-2#1)
the fluorophore##11##2##(1994-2#1)(1995-5#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)
the fluorophores##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
the fluoroquinolones##3##2##(2008-10#2)(2012-2#1)
the fluoxetine-induced elevation##2##3##(1997-6#2)
the flushing reaction##2##3##(1994-5#2)
the flux of##6##3##(1997-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2012-2#1)
the flux through the##2##4##(1994-8#1)(2008-3#1)
the flux##16##2##(1990-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-2#1)
the fluxes##4##2##(2008-10#1)(2008-6#1)(2008-7#2)
the fly ash precipitates##3##4##(2008-10#3)
the fly ash##8##3##(2008-10#7)(2008-3#1)
the fly##22##2##(1996-5#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)
the fmol##2##2##(2008-10#2)
the foam bilayer is##2##4##(1992-5#2)
the foam bilayer##3##3##(1992-5#3)
the foam##11##2##(1992-5#3)(2007-12#1)(2008-10#1)(2008-6#4)(2012-2#2)
the focal distance##2##3##(2008-3#2)
the focal length is##2##4##(2008-3#2)
the focal length of a##3##5##(2008-3#3)
the focal length of the##2##5##(2008-2#1)(2008-3#1)
the focal length of##5##4##(2008-2#1)(2008-3#4)
the focal length##8##3##(2008-2#1)(2008-3#7)
the focal plane of the##3##5##(2007-12#1)(2008-3#2)
the focal plane of##6##4##(2007-12#1)(2008-3#5)
the focal plane##16##3##(2007-12#1)(2008-2#2)(2008-3#12)(2011-2#1)
the focal planes##2##3##(2007-11#1)(2008-3#1)
the focal point of a##2##5##(2008-3#2)
the focal point of the laser##2##6##(2007-12#1)(2008-3#1)
the focal point of the##4##5##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
the focal point of##8##4##(1992-3#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-3#3)
the focal point##17##3##(1992-3#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#9)
the focal position in##2##4##(2008-2#1)(2008-3#1)
the focal position##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
the focal region of a lens##2##6##(2007-11#1)(2007-12#1)
the focal region of a##6##5##(2007-11#2)(2007-12#2)(2008-3#2)
the focal region of the##3##5##(2008-3#3)
the focal region of##9##4##(2007-11#2)(2007-12#2)(2008-3#5)
the focal region##15##3##(2007-11#3)(2007-12#3)(2008-3#9)
the focal spot size##2##4##(2008-2#1)(2012-2#1)
the focal spot##7##3##(2008-2#1)(2008-3#3)(2011-1#1)(2012-2#2)
the focal volume##3##3##(2008-2#1)(2008-3#2)
the focal##89##2##(1992-3#1)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#8)(2008-10#2)(2008-2#11)(2008-3#48)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the foci of##2##3##(1996-3#1)(2007-12#1)
the foci##5##2##(1996-3#1)(2007-11#1)(2007-12#2)(2008-3#1)
the focus and##2##3##(2008-10#1)(2010-8#1)
the focus group##3##3##(1992-2#1)(2008-11#1)(2012-12#1)
the focus groups and##2##4##(2008-12#1)(2012-3#1)
the focus groups##6##3##(1997-3#1)(2008-12#1)(2008-4#1)(2012-3#3)
the focus has##2##3##(2009-4#1)(2013-1#1)
the focus in##2##3##(2008-10#1)(2008-11#1)
the focus of a##2##4##(1995-1#1)(2008-3#1)
the focus of attention##2##4##(1997-2#1)(2010-7#1)
the focus of intense research##2##5##(2010-7#1)(2010-9#1)
the focus of intense##4##4##(2008-6#1)(2008-9#1)(2010-7#1)(2010-9#1)
the focus of many##2##4##(2009-11#1)(2010-3#1)
the focus of much research##2##5##(2008-10#1)(2008-11#1)
the focus of much##3##4##(1993-1#1)(2008-10#1)(2008-11#1)
the focus of the##7##4##(1994-3#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
the focus of this review##4##5##(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
the focus of this##6##4##(2008-10#1)(2008-12#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
the focus of##47##3##(1993-1#1)(1993-12#2)(1994-3#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#1)(2012-2#2)(2013-1#1)
the focus on the##3##4##(1993-11#1)(2008-10#1)(2008-5#1)
the focus on##8##3##(1993-11#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-8#1)
the focus should##2##3##(1997-2#2)
the focus to##2##3##(1994-12#1)(2009-9#1)
the focus##99##2##(1991-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
the focused Gaussian##2##3##(2008-2#2)
the focused intensity##2##3##(2007-11#1)(2008-2#1)
the focused spot##3##3##(2008-2#2)(2008-3#1)
the focused##15##2##(1995-1#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#3)
the focusing effect##2##3##(2008-10#1)(2008-3#1)
the focusing lens##3##3##(2008-3#3)
the focusing##11##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#7)
the foetal##9##2##(1990-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
the foetus and newborn##2##4##(2008-5#2)
the foetus##17##2##(1991-9#2)(1992-4#5)(1992-5#1)(1993-6#1)(1996-11#1)(2008-5#3)(2008-7#2)(2009-8#1)(2011-2#1)
the folate receptor##2##3##(1994-6#2)
the folate##7##2##(1993-12#1)(1994-6#3)(1995-2#2)(2008-10#1)
the fold##4##2##(2008-4#1)(2009-6#1)(2009-9#2)
the folded and##2##3##(1993-11#1)(2009-7#1)
the folded##10##2##(1990-5#1)(1991-6#1)(1992-6#1)(1993-11#3)(2008-2#1)(2009-7#1)(2009-9#1)(2013-1#1)
the folding and##6##3##(1991-6#1)(1994-12#1)(2008-4#2)(2009-6#2)
the folding of the##3##4##(1990-12#1)(1995-3#1)(2007-11#1)
the folding of##6##3##(1990-12#1)(1992-6#2)(1995-3#1)(2007-11#1)(2010-4#1)
the folding pathway##3##3##(1991-6#1)(1992-3#2)
the folding process##3##3##(1991-6#2)(2008-1#1)
the folding reaction##3##3##(1992-3#2)(1992-6#1)
the folding##27##2##(1990-12#1)(1990-7#1)(1991-6#4)(1992-3#4)(1992-6#4)(1994-12#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-4#3)(2008-9#2)(2009-6#2)(2010-4#1)
the foliage of##3##3##(2008-10#3)
the foliage##8##2##(2008-10#8)
the foliar application of##2##4##(2008-10#2)
the foliar##3##2##(2008-10#3)
the follicle cells##7##3##(1991-5#1)(2007-12#1)(2008-6#4)(2008-7#1)
the follicle##14##2##(1990-8#1)(1991-5#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2011-2#3)
the follicles##5##2##(1990-9#1)(2008-12#1)(2012-3#2)(2013-7#1)
the follicular epithelium##2##3##(2008-5#1)(2008-7#1)
the follicular unit-like wigs##2##4##(2012-3#2)
the follicular wall##2##3##(2008-12#1)(2008-7#1)
the follicular##9##2##(2008-12#2)(2008-5#3)(2008-7#2)(2012-3#2)
the follow up##7##3##(1996-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2010-3#1)(2013-1#2)
the follow-up of coronary##2##4##(2011-2#2)
the follow-up of##11##3##(1990-6#1)(1990-9#1)(1991-3#1)(1994-11#1)(1997-4#1)(1997-8#2)(2008-1#1)(2010-6#1)(2011-2#2)
the follow-up period is##2##4##(1996-3#1)(2007-11#1)
the follow-up period was##2##4##(1996-12#1)(2008-3#1)
the follow-up period##17##3##(1991-6#2)(1996-12#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#4)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
the follow-up##56##2##(1990-6#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-6#2)(1992-6#1)(1992-8#1)(1993-10#1)(1994-11#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-8#5)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2013-1#4)(2013-8#2)
the following 10##2##3##(2008-10#2)
the following 3##3##3##(2007-10#2)(2008-10#1)
the following activities##2##3##(1996-12#1)(2009-8#1)
the following advantages##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the following areas##2##3##(1996-3#1)(2008-11#1)
the following article##5##3##(1991-3#2)(1996-2#1)(1997-4#1)(2012-2#1)
the following aspects##2##3##(1994-12#1)(2008-4#1)
the following categories##4##3##(2008-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
the following characteristics of##2##4##(2008-10#1)(2008-3#1)
the following characteristics##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2010-8#1)
the following clinical##3##3##(1997-3#1)(2010-2#1)(2010-6#1)
the following combination of characters##2##5##(2008-5#2)
the following components##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
the following concentrations##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
the following conclusions##7##3##(1990-2#1)(1991-8#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
the following conditions##6##3##(1995-2#1)(1996-5#1)(2008-10#3)(2008-6#1)
the following criteria##4##3##(1992-5#1)(1997-5#1)(2012-12#1)(2013-1#1)
the following data##3##3##(2011-1#1)(2012-2#1)(2012-3#1)
the following day##4##3##(1993-12#1)(1996-6#1)(2008-3#1)(2008-7#1)
the following days##3##3##(1991-6#1)(1991-9#1)(2008-10#1)
the following effects##2##3##(2007-11#1)(2013-1#1)
the following equation##3##3##(2008-10#3)
the following experimental##2##3##(2008-10#2)
the following factors##2##3##(2008-6#1)(2008-7#1)
the following findings##2##3##(1992-3#1)(2006-12#1)
the following five##2##3##(1992-12#1)(1994-12#1)
the following four##7##3##(1991-2#1)(1992-2#1)(1994-5#1)(1996-9#1)(2008-10#1)(2008-9#1)(2010-6#1)
the following functions##2##3##(2008-2#1)(2011-2#1)
the following general##2##3##(1995-11#1)(2008-3#1)
the following goals##2##3##(2007-12#1)(2013-1#1)
the following groups##2##3##(2008-7#1)(2013-1#1)
the following hypothesis##2##3##(2008-9#2)
the following linear##4##3##(2008-10#4)
the following main##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the following means##2##3##(1994-8#1)(2008-11#1)
the following mechanism##2##3##(2008-5#1)(2008-7#1)
the following methods##4##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-6#1)
the following months##4##3##(1993-3#1)(1997-3#2)(2008-7#1)
the following one##2##3##(2008-2#1)(2008-7#1)
the following order of potency##2##5##(1991-2#1)(1995-12#1)
the following order of##4##4##(1991-2#1)(1995-12#2)(2008-10#1)
the following order##17##3##(1991-2#1)(1992-9#1)(1993-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(2008-10#8)(2008-11#1)(2010-3#1)
the following paper##4##3##(1995-5#1)(2008-5#1)(2012-3#1)(2013-1#1)
the following parameters were##2##4##(2008-10#2)
the following parameters##7##3##(1991-12#1)(2008-10#3)(2008-7#2)(2008-8#1)
the following population##2##3##(2012-2#1)(2013-7#1)
the following procedure##2##3##(1990-5#1)(2008-10#1)
the following properties##2##3##(1993-3#1)(2008-10#1)
the following proposed##2##3##(2008-4#1)(2008-7#1)
the following question##3##3##(2008-6#1)(2012-12#1)(2012-3#1)
the following questions##9##3##(1994-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
the following rank order##3##4##(1993-6#1)(1997-2#1)(2008-9#1)
the following reasons##2##3##(1991-2#1)(1992-11#1)
the following results were obtained##2##5##(2008-10#2)
the following results##9##3##(1992-6#1)(2008-10#3)(2008-6#2)(2008-7#1)(2011-2#1)(2012-3#1)
the following risk factors for##2##5##(2008-5#1)(2013-1#1)
the following situations##2##3##(1993-1#1)(2013-1#1)
the following six##2##3##(2008-1#1)(2008-4#1)
the following skin parameters##2##4##(2008-5#2)
the following spring##4##3##(2008-10#3)(2008-8#1)
the following steps##5##3##(1991-12#1)(1994-12#1)(1996-3#1)(2008-2#1)(2008-8#1)
the following text##2##3##(2008-1#1)(2013-1#1)
the following themes##2##3##(2008-12#1)(2012-1#1)
the following three##5##3##(1994-2#1)(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
the following topics##3##3##(1996-1#1)(1996-3#1)(2008-1#1)
the following two##4##3##(1995-2#1)(2008-11#1)(2008-2#1)(2008-8#1)
the following units##2##3##(2008-10#1)(2008-4#1)
the following values##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
the following was##2##3##(1994-12#1)(2008-10#1)
the following week##2##3##(2008-5#1)(2008-9#1)
the following were##3##3##(1997-8#1)(2008-11#1)(2010-11#1)
the following year##5##3##(1994-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
the following##458##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#2)(1990-9#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#5)(1996-2#2)(1996-3#6)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#3)(1997-7#1)(1997-8#2)(2006-12#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#84)(2008-11#13)(2008-12#5)(2008-2#7)(2008-3#11)(2008-4#9)(2008-5#14)(2008-6#13)(2008-7#21)(2008-8#9)(2008-9#16)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#9)(2013-1#21)(2013-7#2)(2013-8#3)
the food bolus##2##3##(2007-12#2)
the food chain##12##3##(1994-3#1)(1995-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
the food industry##7##3##(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-2#2)
the food intake##3##3##(2008-5#1)(2010-6#2)
the food manufacturer has to##2##5##(1994-3#2)
the food supply##5##3##(1990-6#1)(2007-12#2)(2012-1#1)(2012-2#1)
the food web##7##3##(2008-10#1)(2008-8#1)(2008-9#5)
the food##69##2##(1990-6#1)(1990-9#1)(1992-8#1)(1993-9#1)(1994-3#8)(1995-11#1)(1995-5#1)(1997-4#2)(2007-12#5)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#8)(2009-8#1)(2010-4#1)(2010-6#2)(2010-7#2)(2011-2#4)(2012-1#1)(2012-2#5)(2013-7#1)(2013-8#1)
the food-based inhibitor##2##3##(2009-11#2)
the foodborne##2##2##(2011-2#2)
the foot and ankle are##2##5##(2011-2#2)
the foot and ankle##12##4##(2008-12#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#1)
the foot and##14##3##(2008-12#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#5)(2012-3#1)
the foot is##3##3##(2009-10#1)(2010-3#1)(2010-5#1)
the foot protein moiety of the##2##6##(1992-3#2)
the foot protein moiety##3##4##(1992-3#3)
the foot protein##8##3##(1992-3#8)
the foot##51##2##(1992-3#8)(1995-12#1)(2007-11#2)(2008-12#4)(2008-7#1)(2009-10#4)(2009-3#2)(2010-3#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#2)
the for-profit##2##2##(1993-2#1)(2008-12#1)
the forage##3##2##(2008-10#1)(2009-4#1)(2010-8#1)
the foraging##4##2##(2008-8#1)(2008-9#2)(2011-2#1)
the foramen magnum##4##3##(1996-9#2)(2008-7#1)(2011-2#1)
the foramen ovale##2##3##(1996-3#1)(2007-8#1)
the foramen##10##2##(1996-3#1)(1996-9#2)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#3)
the forbidden region##2##3##(2007-12#2)
the forbidden##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
the force in##2##3##(2007-11#1)(2009-4#1)
the force of hepatitis A virus##2##6##(2012-12#2)
the force of infection##3##4##(1994-9#1)(2012-12#2)
the force of##7##3##(1994-9#1)(1995-12#1)(2008-8#1)(2012-12#4)
the force plate##2##3##(2010-12#1)(2010-3#1)
the force##24##2##(1994-9#1)(1995-12#1)(2007-11#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2012-12#4)
the forced expression of##2##4##(2008-11#1)(2011-2#1)
the forced##5##2##(1990-5#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
the forces of##2##3##(2008-9#1)(2009-8#1)
the forces that have##2##4##(1994-12#1)(2008-8#1)
the forces that##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
the forces##14##2##(1993-3#1)(1994-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-3#1)
the fore##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
the forearm##13##2##(1994-6#1)(2007-7#2)(2008-10#1)(2008-5#4)(2008-9#3)(2011-2#2)
the forearms of##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
the forearms##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
the forebrain##6##2##(1993-12#2)(1993-8#1)(1994-8#1)(1995-3#1)(1997-2#1)
the forecast##4##2##(1996-4#1)(2008-10#1)(2008-8#1)(2013-8#1)
the forecasts##2##2##(2008-1#1)(2008-10#1)
the forefront of##5##3##(1994-1#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
the forefront##9##2##(1994-1#1)(1997-8#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2013-1#1)
the foregut##6##2##(1991-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#2)
the forehead of##2##3##(2007-12#1)(2008-5#1)
the forehead than##2##3##(2008-5#2)
the forehead##11##2##(1992-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-5#6)(2010-6#1)
the foreign body response##2##4##(2009-11#2)
the foreign body##4##3##(1990-3#1)(2009-11#2)(2010-4#1)
the foreign gene expression##2##4##(2008-11#2)
the foreign gene##4##3##(1994-12#1)(2008-11#3)
the foreign substances##2##3##(2008-10#2)
the foreign##23##2##(1990-3#1)(1993-6#1)(1994-12#1)(1996-12#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#1)
the forelegs##2##2##(1990-11#1)(2007-12#1)
the forelimbs##6##2##(1992-12#1)(1993-3#1)(1996-6#1)(2011-2#2)(2012-3#1)
the forensic analysis of##3##4##(2008-10#3)
the forensic##6##2##(2008-10#5)(2011-1#1)
the foreseeable future##6##3##(1996-1#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-4#1)
the foreseeable##7##2##(1991-12#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-4#1)
the forest ecosystem services of##2##5##(2008-9#2)
the forest ecosystem##3##3##(2008-5#1)(2008-9#2)
the forest##14##2##(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)
the forests of##3##3##(1996-11#1)(2012-12#1)(2013-7#1)
the forests##4##2##(1994-9#1)(1996-11#1)(2012-12#1)(2013-7#1)
the forgotten##3##2##(1992-2#1)(2008-8#1)(2012-2#1)
the form of a##33##4##(1991-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the form of an##7##4##(1992-6#1)(1994-5#1)(2008-10#3)(2010-5#2)
the form of the##13##4##(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-3#1)
the form of##175##3##(1990-12#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#4)(1995-5#1)(1996-12#2)(1996-3#1)(1997-2#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#44)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#4)(2008-7#11)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-3#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#4)
the form##192##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#4)(1995-5#1)(1996-12#3)(1996-3#1)(1997-2#1)(2007-1#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#46)(2008-11#10)(2008-12#4)(2008-2#7)(2008-3#12)(2008-4#3)(2008-5#5)(2008-7#11)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-3#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#4)
the forma specialis##3##3##(2008-10#3)
the formal potential of the##2##5##(2008-10#2)
the formal potential of##3##4##(2008-10#3)
the formal potential##7##3##(2008-10#7)
the formal##20##2##(1995-2#1)(1997-3#2)(2008-10#11)(2008-2#1)(2008-7#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
the formaldehyde in##2##3##(2008-10#2)
the formaldehyde##6##2##(2008-10#4)(2008-2#2)
the formalin test##3##3##(1995-12#3)
the formalin##4##2##(1995-12#4)
the formalism is##2##3##(2008-3#2)
the formalism of##2##3##(2008-10#1)(2008-3#1)
the formalism##6##2##(1997-2#1)(2008-10#1)(2008-3#4)
the format of##3##3##(1990-2#1)(2011-1#1)(2012-2#1)
the format##4##2##(1990-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
the formation and stabilization of##2##5##(1994-5#1)(2008-10#1)
the formation and subsequent##2##4##(2008-10#2)
the formation and##22##3##(1990-2#1)(1994-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#2)
the formation constant of##2##4##(2008-10#2)
the formation constant##4##3##(2008-10#4)
the formation constants of##4##4##(2008-10#4)
the formation constants##6##3##(2008-10#6)
the formation of (dT)n##2##4##(1995-5#2)
the formation of 1##3##4##(2008-10#3)
the formation of As(III)##2##4##(2008-10#2)
the formation of GS and SAG##2##6##(2008-10#2)
the formation of N-acetylglucosamine##2##4##(1997-1#2)
the formation of NO in##2##5##(1992-5#2)
the formation of R-ibuprofenyl-adenylate##2##4##(1994-8#2)
the formation of [14C]oxalacetate##3##4##(1993-11#3)
the formation of a 1##4##5##(2007-11#1)(2008-10#3)
the formation of a complex with##2##6##(2008-10#2)
the formation of a complex##4##5##(1991-2#1)(2008-10#2)(2008-4#1)
the formation of a new##4##5##(1993-11#1)(1997-2#1)(2008-10#2)
the formation of a stable##3##5##(2007-12#1)(2008-10#1)(2010-12#1)
the formation of a##74##4##(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-5#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-2#2)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#28)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
the formation of actin##2##4##(2008-9#1)(2012-2#1)
the formation of an##13##4##(1992-6#1)(1992-9#1)(1994-5#1)(1995-5#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-6#1)
the formation of apoptotic bodies##4##5##(2008-11#2)(2008-7#1)(2012-3#1)
the formation of ascites##2##4##(1997-7#1)(2011-2#1)
the formation of at least##2##5##(1994-6#1)(1997-4#1)
the formation of beta##2##4##(1991-9#1)(1992-6#1)
the formation of both##6##4##(1992-3#1)(1993-11#1)(1993-6#1)(2006-6#1)(2008-12#1)(2013-1#1)
the formation of complexes##2##4##(1995-5#1)(2008-7#1)
the formation of different##3##4##(2008-10#2)(2008-6#1)
the formation of inositol##2##4##(1990-7#1)(1993-8#1)
the formation of its##2##4##(2008-10#1)(2011-3#1)
the formation of many##2##4##(2007-12#1)(2012-12#1)
the formation of new blood vessels from##2##7##(2010-9#1)(2013-8#1)
the formation of new##5##4##(1990-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2013-8#1)
the formation of normal##3##4##(2010-5#1)(2010-6#1)(2012-1#1)
the formation of only##2##4##(1992-11#1)(2008-10#1)
the formation of optical##2##4##(2007-12#1)(2008-10#1)
the formation of oxygen##2##4##(2008-10#1)(2009-2#1)
the formation of papillae##2##4##(2008-10#2)
the formation of physical##2##4##(2008-10#2)
the formation of pores##2##4##(1994-2#2)
the formation of protein complexes##2##5##(2010-10#1)(2010-9#1)
the formation of reactive species##2##5##(2008-11#2)
the formation of reactive##4##4##(1992-12#1)(2008-11#3)
the formation of secondary##4##4##(1995-5#1)(1995-8#1)(2008-11#1)(2011-2#1)
the formation of significant amounts of##2##6##(1990-5#1)(1996-5#1)
the formation of small##2##4##(1992-3#1)(2008-6#1)
the formation of stable##2##4##(1995-2#1)(2007-5#1)
the formation of such##3##4##(1990-12#1)(1994-2#1)(2008-10#1)
the formation of superoxide anion##2##5##(1995-6#1)(2008-4#1)
the formation of ternary##2##4##(2008-10#2)
the formation of the complex##5##5##(1990-7#1)(2008-10#4)
the formation of the complexes##2##5##(2008-10#1)(2008-5#1)
the formation of the free##2##5##(1991-5#1)(1996-5#1)
the formation of the ion##2##5##(2008-10#2)
the formation of the##84##4##(1990-11#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-3#2)(1991-5#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#4)(1997-2#1)(1997-7#2)(1997-8#1)(2007-12#1)(2008-10#29)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-7#1)
the formation of these##3##4##(1990-12#1)(1991-5#2)
the formation of this##2##4##(1994-8#1)(2007-12#1)
the formation of two##4##4##(1994-8#1)(1997-7#1)(2008-10#2)
the formation of##593##3##(1990-11#4)(1990-12#8)(1990-2#3)(1990-5#9)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#12)(1993-12#2)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#13)(1995-12#3)(1995-2#4)(1995-5#10)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#11)(1997-1#3)(1997-2#6)(1997-4#2)(1997-6#1)(1997-7#7)(1997-8#3)(2006-6#1)(2007-11#6)(2007-12#18)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#165)(2008-11#21)(2008-12#4)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#17)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#7)(2009-12#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#2)
the formation##636##2##(1990-11#4)(1990-12#8)(1990-2#4)(1990-5#9)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#12)(1993-12#2)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#13)(1995-12#3)(1995-2#4)(1995-5#10)(1995-6#3)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#11)(1997-1#3)(1997-2#6)(1997-4#2)(1997-6#1)(1997-7#7)(1997-8#3)(2006-6#1)(2007-11#6)(2007-12#19)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#188)(2008-11#23)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#11)(2008-6#7)(2008-7#19)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#7)(2009-12#3)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#17)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#11)(2012-3#3)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#2)
the formative##2##2##(2008-5#1)(2011-2#1)
the formed complexes##3##3##(2008-10#3)
the formed##19##2##(1991-2#1)(1994-3#1)(2008-10#16)(2011-2#1)
the former German Democratic Republic##2##5##(1992-1#1)(1995-1#1)
the former Soviet Union##2##4##(1995-3#1)(1997-1#1)
the former Soviet##3##3##(1995-3#1)(1997-1#1)(1997-6#1)
the former ammunition plant &quot##2##5##(2008-11#2)
the former and##6##3##(1991-2#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-7#1)
the former being##2##3##(2007-11#1)(2011-2#1)
the former case##2##3##(1990-12#1)(2013-7#1)
the former is a##2##4##(2008-10#1)(2008-8#1)
the former is##5##3##(1990-12#1)(1993-12#1)(1993-9#1)(2008-10#1)(2008-8#1)
the former storage##2##3##(2008-10#2)
the former to##2##3##(2008-1#1)(2009-9#1)
the former##118##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-2#2)(1991-3#1)(1992-1#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
the formerly##2##2##(1995-12#1)(2008-10#1)
the forming of##4##3##(1991-6#1)(1993-12#1)(2008-8#1)(2011-2#1)
the forming##5##2##(1991-6#1)(1993-12#1)(1997-8#1)(2008-8#1)(2011-2#1)
the forms of##5##3##(1991-3#1)(1996-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
the forms##12##2##(1991-3#1)(1991-6#1)(1992-8#1)(1994-3#1)(1996-1#1)(2008-10#2)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#2)
the formula for##2##3##(1996-3#1)(2008-10#1)
the formula presented##2##3##(2008-8#2)
the formula used##2##3##(1994-12#1)(2008-2#1)
the formula##18##2##(1993-3#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-5#4)(2008-8#3)(2010-4#1)(2011-2#1)(2012-3#1)
the formulae##2##2##(1994-2#1)(2008-10#1)
the formulas##2##2##(2008-3#1)(2008-4#1)
the formulated##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
the formulation and##3##3##(1990-9#1)(2008-10#1)(2011-3#1)
the formulation development##2##3##(2008-10#1)(2011-1#1)
the formulation of a##3##4##(2008-11#1)(2008-8#1)(2011-2#1)
the formulation of the##5##4##(1990-8#1)(2008-10#2)(2008-3#1)(2010-1#1)
the formulation of##29##3##(1990-8#1)(1992-8#1)(1993-2#1)(1995-12#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)
the formulation##55##2##(1990-8#1)(1990-9#1)(1992-8#1)(1993-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#13)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#1)
the formulations of##2##3##(2008-5#2)
the formulations was##2##3##(2008-10#1)(2008-5#1)
the formulations##17##2##(2008-10#3)(2008-5#9)(2008-9#1)(2010-3#2)(2010-5#2)
the formulator to##2##3##(2008-5#2)
the formulator##4##2##(2008-10#1)(2008-5#3)
the fornix##6##2##(1991-5#2)(1991-8#1)(1992-11#2)(1993-3#1)
the forthcoming##3##2##(1996-8#1)(2007-8#1)(2012-3#1)
the fortification##3##2##(1997-8#1)(2008-10#1)(2008-11#1)
the forward and reverse reactions##2##5##(1992-3#1)(1992-6#1)
the forward and##4##3##(1992-3#1)(1992-6#1)(2008-2#2)
the forward model##2##3##(2008-3#2)
the forward scattering##3##3##(2008-2#3)
the forward##21##2##(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#5)(2009-11#1)(2010-9#1)
the forward-scattering##2##2##(2008-2#2)
the fossa##2##2##(2008-11#1)(2008-5#1)
the fossil record##2##3##(2008-1#1)(2008-6#1)
the fossil##3##2##(1994-3#1)(2008-1#1)(2008-6#1)
the found results##2##3##(2008-10#1)(2008-9#1)
the found values##2##3##(2008-10#2)
the found##7##2##(2008-10#5)(2008-9#1)(2013-7#1)
the foundation for a more##2##5##(2008-10#1)(2010-9#1)
the foundation for a##6##4##(1992-12#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-9#1)(2012-12#1)
the foundation for further##3##4##(2010-10#1)(2013-1#1)(2013-8#1)
the foundation for future##2##4##(2008-10#1)(2008-4#1)
the foundation for the development##2##5##(2008-9#1)(2013-8#1)
the foundation for the##5##4##(1995-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
the foundation for##24##3##(1992-12#1)(1995-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the foundation of##8##3##(1992-2#1)(1994-1#1)(1994-12#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
the foundation upon which##2##4##(1997-3#1)(2011-2#1)
the foundation##39##2##(1991-1#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the foundations for##2##3##(2008-11#1)(2011-2#1)
the foundations of##2##3##(2008-2#1)(2008-9#1)
the foundations##4##2##(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
the founder of##2##3##(2007-10#1)(2008-10#1)
the founding of the##3##4##(1994-3#1)(1997-2#1)(2008-7#1)
the founding##6##2##(1994-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
the four Botrytis spp##2##4##(2008-10#2)
the four E##2##3##(1995-3#1)(1995-6#1)
the four S compounds##2##4##(2008-10#2)
the four Stokes vectors##2##4##(2007-11#2)
the four Stokes##3##3##(2007-11#2)(2007-12#1)
the four arsenic species##2##4##(2008-10#2)
the four basic##4##3##(1992-1#1)(1992-11#1)(2008-10#1)(2008-3#1)
the four cardinal directions##2##4##(2008-3#1)(2008-5#1)
the four cardinal##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
the four categories of the##3##5##(1994-12#2)(1995-4#1)
the four common##2##3##(1991-5#1)(2008-10#1)
the four compounds##2##3##(2008-10#2)
the four cultivars##2##3##(2008-10#2)
the four different##3##3##(2008-10#3)
the four dimensions of##2##4##(2011-2#2)
the four drug##2##3##(1994-2#1)(2008-10#1)
the four groups##10##3##(1991-8#2)(1992-11#1)(2008-10#1)(2008-7#3)(2011-1#1)(2011-2#2)
the four larval instars##2##4##(2008-5#2)
the four methods##3##3##(2008-10#2)(2013-8#1)
the four most##2##3##(2008-10#2)
the four mutants##2##3##(1994-5#1)(1997-2#1)
the four patients##3##3##(1993-2#1)(2008-6#1)(2009-4#1)
the four populations##3##3##(2008-10#2)(2009-9#1)
the four religious coping##2##4##(2009-11#2)
the four species##2##3##(2008-5#1)(2012-3#1)
the four strains##3##3##(2008-10#3)
the four##222##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-11#3)(1992-3#3)(1992-4#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#2)(1994-7#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#83)(2008-11#1)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-11#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-3#1)(2013-8#5)
the four-channel##3##2##(1996-1#2)(2008-3#1)
the four-dimensional##2##2##(2007-12#1)(2008-3#1)
the four-flux##3##2##(2008-3#3)
the four-step##2##2##(1990-8#1)(2011-2#1)
the four-stranded beta-pleated sheet##2##4##(1997-9#2)
the four-stranded##3##2##(1997-9#3)
the four-wave mixing##2##3##(2008-3#2)
the fourfold##2##2##(2007-11#1)(2008-1#1)
the fourier-transform##2##2##(2008-3#2)
the fourth abdominal##2##3##(2007-12#2)
the fourth and fifth##7##4##(1997-3#2)(2007-12#1)(2008-10#3)(2008-9#1)
the fourth and##9##3##(1997-3#2)(2007-12#1)(2008-10#3)(2008-9#1)(2012-3#1)(2012-9#1)
the fourth case##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
the fourth day##7##3##(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-2#1)
the fourth harmonic of a Nd##2##6##(2008-2#1)(2008-3#1)
the fourth harmonic of a##3##5##(2008-2#1)(2008-3#2)
the fourth harmonic of##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the fourth harmonic##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the fourth order##3##3##(2008-3#3)
the fourth ventricle##8##3##(1996-5#1)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#3)
the fourth year##3##3##(1992-12#2)(1994-12#1)
the fourth##97##2##(1990-2#2)(1990-8#1)(1991-11#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#1)(1997-2#2)(1997-3#3)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#5)
the fourth-order##2##2##(2008-1#1)(2008-3#1)
the fowl##2##2##(1997-6#2)
the fractal##4##2##(2006-10#1)(2008-10#1)(2008-2#2)
the fractal-like##2##2##(2008-10#1)(2012-2#1)
the fraction bound to##2##4##(2008-10#2)
the fraction of cells in the S phase##2##8##(2008-11#1)(2008-9#1)
the fraction of cells##3##4##(1997-4#1)(2008-11#1)(2008-9#1)
the fraction of plasmid-carrying cells##2##5##(2008-7#2)
the fraction of the total##2##5##(1992-2#1)(2008-7#1)
the fraction of the##6##4##(1992-2#1)(1994-3#1)(1995-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
the fraction of##40##3##(1990-8#1)(1991-11#1)(1992-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#3)(2008-9#1)(2011-2#1)(2011-3#1)
the fraction##51##2##(1990-8#1)(1991-11#1)(1992-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#4)(2008-9#1)(2011-2#1)(2011-3#1)
the fractional Fourier transform##6##4##(2008-2#6)
the fractional Fourier##8##3##(2007-12#2)(2008-2#6)
the fractional Hilbert transform for two-dimensional##2##6##(2008-2#2)
the fractional Hilbert transform##4##4##(2008-2#3)(2008-3#1)
the fractional Talbot effect##2##4##(2007-11#2)
the fractional quantum Hall##2##4##(1990-4#1)(1993-5#1)
the fractional##35##2##(1990-4#1)(1993-5#1)(1994-5#1)(1996-4#1)(2007-11#3)(2007-12#2)(2008-2#14)(2008-3#8)(2008-7#3)(2009-12#1)
the fractionation of arsenic##2##4##(2008-10#2)
the fractionation of##5##3##(2008-10#5)
the fractionation##7##2##(2008-10#5)(2008-2#1)(2008-7#1)
the fractions of##10##3##(1991-8#1)(1992-6#1)(1997-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2012-2#1)
the fractions##19##2##(1990-8#1)(1991-8#1)(1992-6#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#2)
the fracture site##2##3##(2008-9#1)(2011-2#1)
the fracture threshold##2##3##(1991-11#1)(1993-11#1)
the fracture toughness of the##2##5##(2008-8#2)
the fracture toughness of##3##4##(2008-8#3)
the fracture toughness##4##3##(2008-8#3)(2009-6#1)
the fracture was##2##3##(1991-6#1)(2007-11#1)
the fracture##29##2##(1991-11#1)(1991-6#1)(1993-11#1)(2007-11#3)(2007-8#5)(2008-5#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-6#1)(2009-7#2)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#1)
the fractured##5##2##(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the fractures##5##2##(2007-11#2)(2007-8#2)(2013-8#1)
the fragile##6##2##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-7#1)
the fragility of##2##3##(1992-6#1)(1995-3#1)
the fragility##3##2##(1992-6#1)(1995-3#2)
the fragment of##3##3##(1991-12#1)(2008-2#1)(2013-1#1)
the fragment was##3##3##(2008-10#2)(2013-1#1)
the fragment##20##2##(1991-12#1)(1992-6#2)(1995-11#1)(1996-2#1)(1997-2#1)(1997-6#2)(2008-10#4)(2008-2#3)(2008-7#2)(2008-8#1)(2013-1#2)
the fragmentation of Cu##3##4##(1997-8#3)
the fragmentation of the##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
the fragmentation of##11##3##(1992-2#1)(1994-10#1)(1996-5#1)(1997-8#5)(2008-10#1)(2008-5#1)(2011-2#1)
the fragmentation##15##2##(1992-2#1)(1994-10#1)(1996-5#1)(1997-8#7)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
the fragments were##3##3##(1993-6#1)(2008-7#1)(2008-9#1)
the fragments##17##2##(1990-7#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2013-7#2)
the fragrance##8##2##(2008-5#8)
the frail elderly##13##3##(1991-12#1)(1993-1#3)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#5)(1995-2#1)
the frame of reference##2##4##(1995-3#2)
the frame of##7##3##(1995-3#2)(2008-10#1)(2008-3#2)(2012-2#1)(2013-1#1)
the frame was##2##3##(2013-1#2)
the frame##11##2##(1995-3#2)(2008-10#1)(2008-3#3)(2012-2#2)(2013-1#3)
the frames##3##2##(2008-3#3)
the framework for##7##3##(1995-6#1)(2007-4#1)(2008-11#1)(2008-5#1)(2010-10#1)(2011-2#2)
the framework in##2##3##(1995-6#1)(2012-2#1)
the framework of a##13##4##(1990-12#1)(1990-8#1)(1992-1#1)(1994-5#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)
the framework of an##2##4##(1995-12#1)(2008-10#1)
the framework of our##3##4##(1993-6#1)(2007-10#1)(2008-2#1)
the framework of the##20##4##(1990-6#1)(1994-6#1)(1995-2#1)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2013-1#1)
the framework of##57##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#1)(2008-7#1)(2009-7#1)(2013-1#1)
the framework##78##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#1)(2008-7#1)(2009-1#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#2)
the framing of##2##3##(2008-4#2)
the framing##3##2##(2008-4#3)
the fraud and abuse##2##4##(1993-1#1)(1993-3#1)
the free ADP##2##3##(1992-3#1)(1994-8#1)
the free amino##3##3##(1990-12#1)(1990-5#1)(2007-11#1)
the free and##5##3##(1994-3#1)(2008-10#2)(2008-6#2)
the free carboxyl##2##3##(1992-12#1)(2008-5#1)
the free chains##2##3##(1991-9#2)
the free concentration of taurine##2##5##(2008-10#2)
the free concentration of##4##4##(2008-10#4)
the free energies of dimer-tetramer assembly##2##6##(1990-8#2)
the free energies of##3##4##(1990-8#3)
the free energy of##7##4##(1990-11#1)(1990-7#1)(1990-8#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-6#1)
the free energy##14##3##(1990-11#1)(1990-7#1)(1990-8#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-6#1)(2010-7#2)(2012-2#1)(2013-1#4)
the free enzyme##4##3##(1993-8#1)(1995-5#1)(2008-7#1)(2011-2#1)
the free hydrogel##2##3##(2010-2#2)
the free ligand##2##3##(1993-11#1)(2008-10#1)
the free market##2##3##(1995-1#1)(2008-7#1)
the free metal##2##3##(2008-10#2)
the free radical scavenger properties of##2##6##(1994-6#1)(2009-8#1)
the free radical scavenger##3##4##(1994-6#1)(1995-8#1)(2009-8#1)
the free radical##6##3##(1994-6#1)(1995-8#1)(2007-11#1)(2008-11#1)(2009-12#1)(2009-8#1)
the free radicals##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
the free spectral range of##2##5##(2007-11#1)(2007-12#1)
the free spectral range##5##4##(2007-11#1)(2007-12#2)(2008-3#1)(2013-8#1)
the free sulfhydryl##2##3##(1993-11#1)(2009-9#1)
the free surface##2##3##(1994-3#1)(2011-2#1)
the free wall of left ventricle##3##6##(2008-7#3)
the free wall of##4##4##(2007-8#1)(2008-7#3)
the free wall##5##3##(2007-8#1)(2008-7#3)(2010-10#1)
the free##127##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-12#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(2006-12#1)(2007-11#4)(2007-12#4)(2007-8#3)(2008-10#23)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#3)(2008-7#6)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-6#1)(2010-7#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
the free-living##3##2##(1994-12#1)(2008-7#2)
the free-running mode##4##3##(2008-2#2)(2008-3#2)
the free-running##11##2##(2008-2#4)(2008-3#7)
the free-space optical systems and##2##5##(2008-3#2)
the free-space optical##3##3##(2008-3#3)
the free-space##12##2##(2007-12#3)(2008-2#1)(2008-3#6)(2009-5#1)(2013-8#1)
the freedom to##2##3##(1997-2#1)(2010-12#1)
the freedom##3##2##(1994-2#1)(1997-2#1)(2010-12#1)
the freely##3##2##(1991-2#1)(2009-9#1)(2013-7#1)
the freerunning period##2##3##(2008-5#2)
the freerunning##3##2##(2008-5#3)
the freestanding##2##2##(2007-12#1)(2007-8#1)
the freezing##2##2##(2009-11#1)(2009-2#1)
the frequencies of the##5##4##(2008-2#2)(2008-3#1)(2011-2#2)
the frequencies of##15##3##(1993-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
the frequencies required##2##3##(1993-3#1)(2008-4#1)
the frequencies##19##2##(1990-3#1)(1993-3#1)(1993-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
the frequency and amplitude of##2##5##(1995-12#1)(2008-2#1)
the frequency and intensity of##3##5##(1995-12#1)(2007-8#1)(2011-2#1)
the frequency and the##6##4##(1997-3#1)(2006-10#1)(2007-11#1)(2008-3#2)(2008-7#1)
the frequency and types of##2##5##(1993-12#1)(1995-1#1)
the frequency and##26##3##(1991-6#1)(1993-12#1)(1995-1#1)(1995-12#2)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-11#1)(2011-2#1)(2013-1#3)
the frequency at##2##3##(1993-9#1)(2008-7#1)
the frequency autocorrelation of the differential group delay##2##8##(2007-12#2)
the frequency autocorrelation##3##3##(2007-11#1)(2007-12#2)
the frequency changes##2##3##(2007-12#1)(2008-10#1)
the frequency chirp##2##3##(2008-3#2)
the frequency comb##3##3##(2007-11#1)(2007-12#2)
the frequency composition of##2##4##(2008-9#2)
the frequency conversion##2##3##(2008-3#2)
the frequency dependence of##3##4##(2007-12#1)(2008-2#1)(2013-7#1)
the frequency distribution##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
the frequency distributions of##2##4##(2008-10#1)(2008-3#1)
the frequency domain##12##3##(1995-11#1)(1995-6#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)
the frequency modulation##2##3##(2008-2#1)(2008-3#1)
the frequency noise##2##3##(2007-11#1)(2007-12#1)
the frequency of 1##2##4##(2008-9#1)(2012-3#1)
the frequency of Caesarean section##2##5##(1991-9#2)
the frequency of a##3##4##(1991-11#1)(2008-3#2)
the frequency of infection##2##4##(2012-12#1)(2012-3#1)
the frequency of light##2##4##(2007-12#1)(2008-3#1)
the frequency of micronucleated erythrocytes##5##5##(2008-9#5)
the frequency of micronucleated##7##4##(1996-12#1)(2008-9#6)
the frequency of new##2##4##(1991-8#1)(1993-11#1)
the frequency of resistant##2##4##(2008-10#1)(2008-8#1)
the frequency of spontaneously##2##4##(2007-12#1)(2010-3#1)
the frequency of the incident##2##5##(2008-2#1)(2008-3#1)
the frequency of the oscillations##2##5##(2007-11#1)(2008-3#1)
the frequency of the virulence##2##5##(2008-10#2)
the frequency of the##21##4##(1993-11#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2009-6#1)(2011-2#2)(2013-1#1)
the frequency of##193##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#25)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#10)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#10)(2012-12#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
the frequency range of##4##4##(1997-2#1)(2007-11#1)(2008-3#2)
the frequency range##9##3##(1997-2#1)(2007-11#5)(2008-10#1)(2008-3#2)
the frequency response of##2##4##(2008-3#1)(2009-5#1)
the frequency response##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
the frequency shift##10##3##(2007-11#2)(2007-12#3)(2008-10#3)(2008-3#2)
the frequency with which##3##4##(1995-3#1)(2008-11#1)(2008-7#1)
the frequency##317##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#22)(2007-12#23)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#6)(2008-10#39)(2008-11#9)(2008-12#4)(2008-2#10)(2008-3#28)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#13)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#5)
the frequency-dependent behavior of photon density waves##2##7##(2008-3#2)
the frequency-dependent##4##2##(2007-12#1)(2008-3#3)
the frequency-doubled##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
the frequency-doubling##2##2##(2008-2#1)(2008-3#1)
the frequency-resolved optical gating##2##4##(2007-12#1)(2008-2#1)
the frequent occurrence of##4##4##(2008-10#1)(2008-6#1)(2010-11#1)(2012-3#1)
the frequent use of##5##4##(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
the frequent##26##2##(1990-6#1)(1992-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
the frequently##3##2##(1996-2#1)(2008-4#1)(2011-1#1)
the fresh material##2##3##(2008-10#2)
the fresh##11##2##(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#2)
the freshly##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
the freshness##2##2##(2008-10#2)
the freshwater snail Biomphalaria pfeifferi##2##5##(2008-8#2)
the freshwater##12##2##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2010-6#1)(2011-2#4)
the friction behavior##2##3##(2008-5#1)(2010-10#1)
the friction between##2##3##(1994-9#1)(2008-3#1)
the friction coefficient of##2##4##(2008-5#1)(2010-4#1)
the friction##9##2##(1994-9#1)(1996-4#1)(2008-3#1)(2008-5#3)(2009-9#1)(2010-10#1)(2010-4#1)
the frictional force##3##3##(2008-5#3)
the frictional##6##2##(2008-5#4)(2010-10#2)
the fringe imager##2##3##(2008-2#1)(2008-3#1)
the fringe imaging##2##3##(2008-2#1)(2008-3#1)
the fringe modulation##3##3##(2007-12#1)(2008-3#2)
the fringe pattern##3##3##(2008-2#2)(2008-3#1)
the fringe patterns##6##3##(2008-2#2)(2008-3#4)
the fringe spacing is##2##4##(2008-2#1)(2008-3#1)
the fringe spacing##4##3##(2008-2#1)(2008-3#3)
the fringe visibility##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the fringe##38##2##(2007-12#3)(2008-2#11)(2008-3#24)
the fringe-projection##2##2##(2008-3#2)
the fringes are##3##3##(2008-2#1)(2008-3#2)
the fringes##10##2##(2007-11#2)(2008-2#3)(2008-3#5)
the frog##11##2##(1990-5#1)(1993-2#1)(1993-3#1)(1993-5#2)(2008-4#3)(2008-7#2)(2010-3#1)
the front and##6##3##(1990-10#1)(2007-12#1)(2008-10#2)(2008-3#2)
the front facet modal reflectivity of##2##6##(2008-3#2)
the front line##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
the front lines##3##3##(1994-1#1)(1995-6#1)(1996-12#1)
the front of the##3##4##(1993-1#1)(2008-10#2)
the front of##4##3##(1993-1#1)(2008-10#2)(2008-7#1)
the front##28##2##(1990-10#1)(1993-1#1)(1994-1#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#7)(2008-7#1)(2009-6#2)(2010-8#1)(2011-2#1)(2012-12#1)
the front-end##2##2##(2008-3#1)(2008-9#1)
the front-line##2##2##(2012-12#2)
the frontal and##5##3##(1992-8#1)(1996-12#1)(2008-5#1)(2008-9#1)(2011-1#1)
the frontal bone##2##3##(2008-7#1)(2012-8#1)
the frontal cortex##10##3##(1991-5#2)(1994-6#3)(1995-2#2)(1995-3#2)(1997-2#1)
the frontal lobe##8##3##(1996-5#1)(1997-2#1)(2008-1#1)(2008-7#1)(2008-9#3)(2011-2#1)
the frontal lobes##3##3##(2008-6#1)(2008-7#2)
the frontal plane##6##3##(2007-10#4)(2010-8#2)
the frontal sinus##7##3##(2006-12#3)(2008-6#1)(2011-2#2)(2012-8#1)
the frontal##54##2##(1991-5#2)(1992-11#1)(1992-8#2)(1994-6#3)(1995-2#2)(1995-3#2)(1996-12#2)(1996-5#2)(1997-2#2)(1997-8#1)(2006-12#4)(2007-10#4)(2007-12#1)(2008-1#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#5)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-8#2)
the frontier##2##2##(1996-5#1)(2008-10#1)
the frontline##3##2##(2010-11#1)(2012-3#2)
the fruit development##5##3##(2008-9#5)
the fruit fly Drosophila melanogaster and the##2##7##(2008-10#1)(2008-7#1)
the fruit fly Drosophila melanogaster##3##5##(1997-7#1)(2008-10#1)(2008-7#1)
the fruit fly Drosophila##4##4##(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)
the fruit fly##8##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-5#1)(2013-8#1)
the fruit is##2##3##(2008-10#2)
the fruit of##6##3##(2008-10#1)(2008-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
the fruit##43##2##(1993-3#1)(1997-7#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#9)(2010-5#1)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
the fruitfly##2##2##(2008-2#1)(2008-9#1)
the fruits of##4##3##(2008-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
the fruits##15##2##(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#1)(2010-3#1)(2012-2#2)(2012-3#1)
the frying##2##2##(2008-10#1)(2008-6#1)
the ftz##2##2##(1993-9#2)
the fucoidan extracts##3##3##(2008-11#3)
the fucosyl##2##2##(1991-12#1)(1993-11#1)
the fuel##3##2##(2008-3#3)
the fulgimide##3##2##(2009-9#3)
the full beam##2##3##(2008-2#1)(2012-2#1)
the full exploitation of##2##4##(2007-11#1)(2011-1#1)
the full genomic##2##3##(1990-12#1)(2008-7#1)
the full length##3##3##(1995-12#1)(1997-7#1)(2008-8#1)
the full phase compensation method##2##5##(2008-3#2)
the full potential of the##2##5##(2008-3#1)(2011-1#1)
the full potential of##7##4##(1994-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
the full range of##9##4##(1997-1#1)(1997-4#1)(2008-10#2)(2008-4#2)(2008-7#2)(2012-2#1)
the full set of reactions##2##5##(2008-10#2)
the full set of##3##4##(2008-10#2)(2010-8#1)
the full spectral##3##3##(2011-2#3)
the full spectrum of##3##4##(2008-10#1)(2009-7#1)(2012-3#1)
the full spectrum##4##3##(2008-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
the full texts##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
the full width at half-maximum of##2##6##(2008-2#2)
the full width at half-maximum##5##5##(2008-2#3)(2008-3#1)(2013-8#1)
the full##119##2##(1990-12#1)(1990-2#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-2#6)(2008-3#15)(2008-4#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#3)
the full-blown disease##2##3##(1997-4#1)(2008-10#1)
the full-length cDNA of##3##4##(1997-7#1)(2008-8#2)
the full-length cDNA##7##3##(1990-2#1)(1993-8#1)(1996-2#1)(1997-7#2)(2008-8#2)
the full-length##31##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)
the full-text##2##2##(1991-2#1)(1994-1#1)
the fully complementary##2##3##(1993-11#1)(2008-10#1)
the fully##21##2##(1990-8#2)(1993-11#1)(1994-11#1)(1994-12#1)(1996-3#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-3#4)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#2)
the fume is##3##3##(2008-10#3)
the fume##5##2##(2008-10#5)
the fumonisin##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
the function and the##3##4##(1994-5#1)(1997-8#1)(2008-10#1)
the function and##12##3##(1992-9#1)(1994-5#1)(1994-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#2)
the function of EDRF1##3##4##(2008-8#2)(2008-9#1)
the function of Smad5##2##4##(2008-8#2)
the function of a##6##4##(2008-1#1)(2008-2#1)(2008-4#3)(2008-7#1)
the function of basonuclin##2##4##(2008-9#2)
the function of human##2##4##(2006-6#1)(2008-11#1)
the function of mitochondrial##2##4##(1997-2#1)(2008-6#1)
the function of novel genes##2##5##(2008-7#2)
the function of retinal##2##4##(2008-8#2)
the function of specific##3##4##(2008-4#2)(2008-7#1)
the function of the NMDA receptor##2##6##(1993-12#2)
the function of the hypopharyngeal gland##2##6##(2008-6#2)
the function of the##44##4##(1990-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-7#3)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the function of these proteins##2##5##(1991-12#1)(2008-11#1)
the function of these##7##4##(1991-12#1)(1995-2#1)(2006-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
the function of##152##3##(1990-11#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#9)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#11)(2008-9#19)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-11#1)(2010-2#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
the function##173##2##(1990-11#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#2)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#8)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#9)(2008-5#2)(2008-6#4)(2008-7#12)(2008-8#12)(2008-9#20)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-11#1)(2010-2#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
the functional 5HT1D alpha gene##2##5##(1993-12#2)
the functional ability of##2##4##(1994-3#1)(2009-12#1)
the functional activity of the##3##5##(2007-11#1)(2008-10#1)(2008-4#1)
the functional activity of##4##4##(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
the functional activity##5##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
the functional analysis of microarrays##2##5##(2008-7#2)
the functional analysis of the##2##5##(2008-11#1)(2009-10#1)
the functional analysis of##6##4##(2008-10#1)(2008-11#2)(2008-7#2)(2009-10#1)
the functional and structural##2##4##(1992-3#1)(1994-8#1)
the functional and##6##3##(1990-3#1)(1992-3#1)(1994-8#1)(2007-12#1)(2008-12#1)(2008-7#1)
the functional behavior of##2##4##(1992-12#1)(2008-9#1)
the functional characterization of##2##4##(1995-2#1)(2008-11#1)
the functional consequences of##7##4##(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2013-1#1)
the functional difference##2##3##(1994-9#1)(1995-6#1)
the functional differences between the##2##5##(1997-2#1)(2012-2#1)
the functional diversity of##5##4##(2008-10#1)(2008-2#1)(2008-4#2)(2012-1#1)
the functional effects of##3##4##(1992-10#1)(1997-4#1)(2007-12#1)
the functional expression of the##2##5##(1993-8#1)(2008-6#1)
the functional expression of##4##4##(1993-8#1)(1994-12#1)(2008-6#1)(2011-2#1)
the functional form of the##3##5##(2007-12#1)(2008-7#1)(2012-2#1)
the functional form##4##3##(2007-12#1)(2008-7#1)(2012-2#2)
the functional group##2##3##(2008-10#2)
the functional groups of##2##4##(2008-10#2)
the functional groups##5##3##(1992-6#1)(2008-10#4)
the functional impact of ET##2##5##(2008-7#2)
the functional importance of##5##4##(1994-5#1)(2009-5#1)(2009-9#1)(2012-6#1)(2013-1#1)
the functional information##2##3##(2007-12#2)
the functional integrity of the##2##5##(2008-8#1)(2012-12#1)
the functional integrity of##3##4##(1990-7#1)(2008-8#1)(2012-12#1)
the functional maturation of the visual##2##6##(2011-2#2)
the functional monomer##3##3##(2008-10#3)
the functional morphology of the##2##5##(2007-12#2)
the functional organization of##2##4##(2008-8#2)
the functional outcome after##2##4##(2008-6#1)(2008-7#1)
the functional outcome##5##3##(2007-11#1)(2008-6#3)(2008-7#1)
the functional properties of the##2##5##(1991-6#1)(2008-6#1)
the functional properties of##10##4##(1990-8#1)(1991-6#1)(1994-8#1)(1995-12#2)(1995-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)
the functional reconstitution##2##3##(1991-5#1)(1995-2#1)
the functional recovery of##3##4##(2008-5#1)(2011-3#1)(2012-1#1)
the functional relationships##2##3##(2008-10#1)(2008-6#1)
the functional response of##2##4##(2008-10#1)(2008-8#1)
the functional response##3##3##(2008-10#1)(2008-8#2)
the functional responses##2##3##(1995-11#1)(2008-6#1)
the functional role of PTHrP on their own##2##8##(1993-3#2)
the functional role of this##2##5##(2008-4#1)(2008-7#1)
the functional role of##21##4##(1993-3#2)(1993-6#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
the functional roles of##3##4##(1993-3#1)(1994-5#1)(2009-10#1)
the functional significance of such##2##5##(1994-3#1)(1994-8#1)
the functional significance of the##2##5##(1995-2#1)(2007-12#1)
the functional significance of this##2##5##(1995-2#1)(2012-2#1)
the functional significance of##13##4##(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-9#1)(2007-12#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#2)(2012-3#1)
the functional state of the##3##5##(1995-12#1)(2010-8#2)
the functional state of##4##4##(1995-12#1)(2010-8#2)(2013-1#1)
the functional status of the neurohypophyseal system in##2##8##(1997-8#2)
the functional status of the##3##5##(1997-8#2)(2008-9#1)
the functional status of##7##4##(1995-2#1)(1997-8#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
the functional status##8##3##(1995-2#1)(1997-8#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
the functional##249##2##(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#7)(1995-6#5)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-8#1)(2008-1#3)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#10)(2008-5#2)(2008-6#11)(2008-7#21)(2008-8#10)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#4)(2012-6#1)(2013-1#7)(2013-8#1)
the functionality of the##5##4##(1995-12#1)(2007-8#1)(2008-10#1)(2012-3#1)(2012-6#1)
the functionality of##8##3##(1990-5#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-3#1)(2012-6#1)
the functionality##12##2##(1990-5#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-5#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#2)
the functionalization##2##2##(2008-10#1)(2010-2#1)
the functionalized##2##2##(2008-10#1)(2011-1#1)
the functionally##3##2##(1990-7#1)(1994-5#1)(2009-10#1)
the functioning of the##10##4##(1992-1#1)(1993-6#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-9#1)
the functioning of##15##3##(1992-1#1)(1993-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2009-9#1)(2012-12#2)(2013-8#1)
the functioning##16##2##(1992-1#1)(1993-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-5#1)(2009-9#1)(2012-12#2)(2013-8#1)
the functions of a##2##4##(2007-11#1)(2007-4#1)
the functions of genes##2##4##(1993-9#1)(2012-3#1)
the functions of the genes##2##5##(1997-8#1)(2008-9#1)
the functions of the##9##4##(1990-3#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-9#1)(2012-12#1)
the functions of##40##3##(1990-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the functions##48##2##(1990-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the fundamental and second-harmonic frequencies##2##5##(2007-11#1)(2007-12#1)
the fundamental and second-harmonic##3##4##(2007-11#1)(2007-12#2)
the fundamental and the second-harmonic##2##5##(2007-12#1)(2008-3#1)
the fundamental and the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the fundamental and##9##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)(2013-8#1)
the fundamental cavity##2##3##(2007-11#1)(2007-12#1)
the fundamental differences##2##3##(2012-7#1)(2013-1#1)
the fundamental frequency##3##3##(2007-11#1)(2007-12#1)(2010-2#1)
the fundamental mode is##2##4##(2007-11#1)(2008-3#1)
the fundamental mode of##3##4##(2007-12#1)(2008-3#2)
the fundamental mode##10##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#5)
the fundamental of a##2##4##(2007-12#2)
the fundamental principles of##2##4##(2008-3#1)(2008-5#1)
the fundamental rovibrational band of CO(2)##2##6##(2007-11#1)(2007-12#1)
the fundamental transverse-mode##2##3##(2007-12#1)(2008-3#1)
the fundamental understanding of the##2##5##(2008-3#1)(2008-7#1)
the fundamental wave##2##3##(2007-12#1)(2008-2#1)
the fundamental wavelength to##3##4##(2007-12#2)(2008-3#1)
the fundamental wavelength##6##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)
the fundamental##120##2##(1991-3#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-3#1)(2007-11#17)(2007-12#21)(2008-10#7)(2008-11#2)(2008-2#12)(2008-3#23)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#2)
the fundamentals of##7##3##(1994-12#3)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
the funding of##3##3##(1994-2#1)(1995-12#1)(1997-7#1)
the funding##8##2##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-2#1)(2010-5#1)
the fundus##4##2##(1991-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
the fungal cell wall##4##4##(2008-10#4)
the fungal genome##4##3##(2008-10#3)(2011-1#1)
the fungal isolates##2##3##(2008-10#2)
the fungal pathogen Leptosphaeria maculans##3##5##(2008-10#2)(2011-10#1)
the fungal pathogen##10##3##(2008-10#8)(2008-4#1)(2011-10#1)
the fungal population was##2##4##(2008-10#1)(2008-12#1)
the fungal population##3##3##(2008-10#2)(2008-12#1)
the fungal##66##2##(1991-5#1)(1992-2#1)(1997-4#1)(2008-10#47)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#2)(2011-10#2)(2012-2#1)(2013-8#1)
the fungi are##2##3##(2008-10#1)(2008-8#1)
the fungi associated with##2##4##(2008-10#2)
the fungi were##2##3##(2008-10#2)
the fungi##23##2##(2008-10#14)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-7#1)(2012-2#1)
the fungicide metalaxyl##5##3##(2008-10#5)
the fungicide was applied##2##4##(2008-10#2)
the fungicide##29##2##(1991-5#2)(2008-10#25)(2008-11#2)
the fungicides##16##2##(1991-5#1)(2008-10#13)(2008-5#1)(2008-6#1)
the fungus Aspergillus##2##3##(2008-10#1)(2008-9#1)
the fungus Botrytis cinerea##2##4##(1991-5#1)(2011-10#1)
the fungus Puccinia triticina##2##4##(2008-10#2)
the fungus Pyrenophora tritici-repentis##2##4##(2008-10#2)
the fungus Trichoderma##2##3##(1992-3#1)(2008-10#1)
the fungus from##2##3##(2008-10#2)
the fungus grew##2##3##(2008-10#2)
the fungus had##2##3##(2008-10#2)
the fungus has been##2##4##(2008-10#1)(2008-5#1)
the fungus is##3##3##(2008-10#3)
the fungus rapidly colonized the##2##5##(2008-10#2)
the fungus that causes##2##4##(2008-10#2)
the fungus that##3##3##(2008-10#3)
the fungus to##5##3##(2008-10#4)(2008-5#1)
the fungus was##12##3##(2008-10#10)(2008-5#1)(2011-2#1)
the fungus##135##2##(1991-4#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-11#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#108)(2008-11#3)(2008-12#1)(2008-5#7)(2008-6#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-10#1)(2011-2#1)
the fur##2##2##(2009-6#2)
the furnace##3##2##(2008-10#3)
the further analysis of##2##4##(1994-11#1)(1996-2#1)
the further development of the##2##5##(1997-4#1)(2011-2#1)
the further development of##9##4##(1991-3#1)(1997-4#1)(1997-8#1)(2008-12#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-8#1)
the further understanding of the##3##5##(1991-12#1)(2008-10#1)(2008-9#1)
the further##38##2##(1990-10#1)(1991-12#1)(1991-3#2)(1993-3#1)(1994-11#1)(1995-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the fused silica##2##3##(2008-2#2)
the fused##9##2##(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-12#1)(2013-1#1)
the fused-silica##2##2##(2007-11#1)(2008-10#1)
the fusiform##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
the fusion between##2##3##(1994-12#1)(2011-3#1)
the fusion gene##2##3##(2008-9#1)(2013-1#1)
the fusion genes##2##3##(2008-8#2)
the fusion of the##3##4##(2008-5#2)(2009-12#1)
the fusion of##16##3##(1991-5#1)(1994-12#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)
the fusion partner##2##3##(1995-2#1)(2012-2#1)
the fusion protein##9##3##(1991-7#1)(1994-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)
the fusion proteins##5##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-8#1)
the fusion##53##2##(1991-5#1)(1991-7#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#2)(2009-12#1)(2009-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#3)
the fusionof pOCs into##2##4##(2008-11#2)
the future a##3##3##(2008-11#1)(2009-5#1)(2009-7#1)
the future and the##2##4##(2011-1#1)(2011-2#1)
the future and##4##3##(1991-1#1)(2008-12#1)(2011-1#1)(2011-2#1)
the future as##4##3##(2008-4#1)(2009-6#1)(2010-11#1)(2012-6#1)
the future development of##4##4##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
the future direction of the##2##5##(1995-1#1)(2013-1#1)
the future direction of##3##4##(1995-1#1)(2008-7#1)(2013-1#1)
the future direction##4##3##(1995-1#1)(2008-7#1)(2011-7#1)(2013-1#1)
the future directions##2##3##(1994-2#1)(2013-1#1)
the future for##6##3##(1990-2#1)(1992-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
the future health##2##3##(1996-1#1)(1996-3#1)
the future holds##2##3##(1996-3#1)(2008-10#1)
the future impact of##2##4##(2008-10#1)(2013-8#1)
the future in##2##3##(2008-12#1)(2008-3#1)
the future is##7##3##(1992-11#1)(1993-11#1)(1993-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
the future of health care##5##5##(1991-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(2008-1#1)
the future of health##7##4##(1991-12#1)(1991-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-1#1)
the future of nursing##2##4##(2008-1#1)(2008-11#1)
the future of our##2##4##(2008-1#1)(2013-1#1)
the future of peer review##2##5##(1991-1#2)
the future of public health##2##5##(1994-1#1)(1995-12#1)
the future of the##11##4##(1991-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-7#1)(2012-12#1)
the future of##55##3##(1991-1#4)(1991-12#1)(1991-3#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-1#2)(1994-3#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-6#1)(2007-4#1)(2007-8#1)(2008-1#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
the future research##2##3##(2009-4#1)(2009-5#1)
the future role of##2##4##(1993-2#1)(2008-1#1)
the future should##3##3##(2007-12#1)(2008-11#1)(2010-4#1)
the future use of##2##4##(2012-12#1)(2012-2#1)
the future was##2##3##(1992-2#1)(2013-1#1)
the future will##3##3##(1992-12#1)(1994-12#1)(1994-2#1)
the future##348##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#10)(1991-12#5)(1991-2#1)(1991-3#4)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#7)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#9)(1993-3#4)(1994-1#3)(1994-12#4)(1994-2#6)(1994-3#3)(1994-6#2)(1995-1#5)(1995-12#4)(1995-2#4)(1995-3#3)(1996-1#5)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#7)(1997-1#10)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#12)(2008-10#20)(2008-11#19)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#5)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#13)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#6)(2012-5#1)(2012-6#1)(2013-1#16)(2013-7#3)(2013-8#2)
the future?##6##2##(1992-2#1)(1993-12#1)(1997-2#1)(2010-12#1)(2011-2#1)(2013-7#1)
the fuzzy##2##2##(2008-10#2)
the g factor and the##2##5##(2008-2#2)
the g factor##3##3##(2008-2#3)
the g##5##2##(1997-7#1)(2008-2#4)
the gabapentin##2##2##(2011-3#2)
the gadd genes##2##3##(1992-12#2)
the gadd##3##2##(1992-12#3)
the gadd153promoter##2##2##(2008-11#2)
the gag##3##2##(1994-12#1)(1994-8#1)(1997-4#1)
the gag-related##2##2##(1995-8#2)
the gain and the##2##4##(2008-2#1)(2008-3#1)
the gain and##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
the gain fiber##2##3##(2007-11#1)(2007-12#1)
the gain margin##4##3##(2008-3#4)
the gain material##2##3##(2007-12#1)(2008-2#1)
the gain medium##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
the gain of##2##3##(2008-12#1)(2013-8#1)
the gain saturation##2##3##(2008-3#2)
the gain##49##2##(1996-3#1)(2007-11#9)(2007-12#5)(2008-12#1)(2008-2#11)(2008-3#17)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
the gains##4##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-2#1)
the gait##6##2##(1996-9#1)(2007-10#1)(2012-12#1)(2013-1#3)
the galactose-proton symport system##2##4##(2008-7#2)
the galanin receptor antagonist##4##4##(1993-3#3)(1994-8#1)
the galanin##5##2##(1993-3#3)(1994-8#2)
the gallbladder is##3##3##(1991-6#1)(2011-2#1)(2013-8#1)
the gallbladder##31##2##(1990-6#3)(1990-9#1)(1991-12#3)(1991-6#2)(1991-8#1)(1992-6#1)(1992-9#1)(1993-9#1)(1996-6#1)(1997-7#1)(1997-8#3)(2008-1#1)(2008-5#1)(2009-3#4)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#3)
the gallstone##2##2##(2008-12#2)
the game##2##2##(2008-9#1)(2010-4#1)
the games##2##2##(1993-3#1)(2012-2#1)
the gamma camera##4##3##(1996-2#2)(2008-1#1)(2009-6#1)
the gamma distribution##2##3##(2008-10#1)(2008-2#1)
the gamma knife##2##3##(2007-5#1)(2008-7#1)
the gamma##22##2##(1990-8#1)(1992-3#1)(1993-12#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
the gamma(0##2##2##(2008-2#2)
the gamma-##2##2##(1992-6#1)(2007-11#1)
the gamut##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
the ganglia of the##2##4##(1990-2#1)(2009-8#1)
the ganglia of##3##3##(1990-2#1)(1991-5#1)(2009-8#1)
the ganglia##5##2##(1990-2#1)(1991-5#1)(1996-5#1)(2008-7#1)(2009-8#1)
the ganglion midline##2##3##(2007-12#2)
the ganglion##4##2##(2007-12#2)(2008-5#1)(2011-2#1)
the ganglioside##6##2##(1990-8#1)(1991-5#2)(1993-9#1)(1994-3#1)(1995-5#1)
the gangliosides##5##2##(1990-11#3)(1990-7#1)(1993-11#1)
the gap between the##5##4##(1997-6#1)(2008-10#1)(2008-2#1)(2009-8#1)(2013-1#1)
the gap between##24##3##(1990-2#1)(1991-1#1)(1993-12#1)(1994-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#2)
the gap in##2##3##(2008-3#1)(2011-2#1)
the gaps in##4##3##(1992-2#1)(1995-12#1)(2010-12#1)(2012-12#1)
the gaps##9##2##(1992-2#1)(1995-12#1)(1997-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#2)(2013-8#1)
the garbage dump##2##3##(2011-2#2)
the garden lizard##2##3##(2008-7#2)
the garden##4##2##(1991-3#1)(2007-1#1)(2008-7#2)
the gas chromatographic##5##3##(2008-10#5)
the gas flow rate##4##4##(2009-11#1)(2013-8#3)
the gas flow##6##3##(2009-11#2)(2012-1#1)(2013-8#3)
the gas phase and##2##4##(2008-10#1)(2008-7#1)
the gas phase##16##3##(1992-9#1)(1996-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-7#1)
the gas pressure##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
the gas temperature##3##3##(2008-3#3)
the gas##61##2##(1992-12#1)(1992-5#1)(1992-9#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-12#3)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#11)(2008-6#2)(2008-7#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#3)
the gaseous species##2##3##(2008-10#2)
the gaseous##9##2##(2007-12#1)(2008-10#7)(2011-1#1)
the gases##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
the gastric body##2##3##(1997-1#1)(2009-3#1)
the gastric emptying rate of##2##5##(1997-4#2)
the gastric emptying##3##3##(1997-4#3)
the gastric inhibitory##2##3##(1997-4#1)(2008-11#1)
the gastric lesions##2##3##(1997-7#1)(2013-8#1)
the gastric mill##2##3##(1995-11#2)
the gastric mucosa in##2##4##(1994-2#1)(2008-1#1)
the gastric mucosa##8##3##(1990-3#1)(1994-2#2)(1996-3#1)(1997-1#1)(1997-7#1)(2008-1#1)(2013-8#1)
the gastric transplant##2##3##(2012-1#2)
the gastric wall##2##3##(2009-8#1)(2010-12#1)
the gastric##46##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#3)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#2)(1995-11#3)(1996-3#1)(1996-5#1)(1997-1#4)(1997-4#5)(1997-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-8#2)(2010-12#1)(2011-2#4)(2012-1#3)(2012-2#1)(2013-8#3)
the gastrin##3##2##(1992-3#1)(1992-8#2)
the gastro-intestinal tract##3##3##(1991-4#1)(2008-10#1)(2010-8#1)
the gastro-intestinal##4##2##(1991-4#1)(2008-10#1)(2010-8#1)(2011-2#1)
the gastrocnemius##6##2##(1995-2#1)(2012-2#1)(2013-1#4)
the gastroenterologist##2##2##(2008-9#1)(2011-2#1)
the gastroesophageal##2##2##(2008-11#1)(2009-3#1)
the gastrointestinal and##2##3##(1992-6#1)(2008-5#1)
the gastrointestinal mucosa##3##3##(1996-3#1)(2008-4#1)(2012-1#1)
the gastrointestinal system##2##3##(2008-11#1)(2012-2#1)
the gastrointestinal tract (GIT)##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
the gastrointestinal tract and the##2##5##(1994-5#1)(2008-7#1)
the gastrointestinal tract and##4##4##(1994-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
the gastrointestinal tract are##2##4##(2008-7#1)(2011-2#1)
the gastrointestinal tract of##5##4##(2011-2#2)(2013-1#3)
the gastrointestinal tract##58##3##(1990-11#2)(1990-8#1)(1991-6#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-1#1)(2009-12#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
the gastrointestinal##77##2##(1990-11#2)(1990-8#1)(1991-6#1)(1992-6#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-6#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2011-1#3)(2011-2#6)(2012-1#6)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
the gate helix##2##3##(2012-2#2)
the gate##11##2##(1991-5#2)(1995-1#1)(2007-11#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-5#1)(2012-2#2)
the gathering of##2##3##(2008-10#1)(2013-1#1)
the gating behaviour of##2##4##(1990-11#1)(2008-7#1)
the gating was##2##3##(1990-11#1)(2008-2#1)
the gating##10##2##(1990-11#2)(2008-2#2)(2008-7#1)(2008-8#4)(2008-9#1)
the gauche conformation##2##3##(2008-8#2)
the gaze##5##2##(2008-11#5)
the gear##2##2##(2008-3#2)
the gel and##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
the gel beads##3##3##(2008-10#2)(2008-7#1)
the gel entrapment carrier##2##4##(2008-7#2)
the gel entrapment##3##3##(2008-7#3)
the gel phase##5##3##(1993-8#1)(2008-10#1)(2010-5#3)
the gel showed##2##3##(2008-11#1)(2010-5#1)
the gel test##5##3##(2011-1#5)
the gel##61##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-8#4)(1996-12#1)(1996-9#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2010-5#5)(2011-1#6)(2011-2#2)
the gel-filtration##2##2##(1990-7#1)(2008-11#1)
the gelatin capsule technique##5##4##(2011-2#5)
the gelatin method##3##3##(2008-11#3)
the gelatin##11##2##(1995-5#1)(2008-11#3)(2008-2#2)(2011-2#5)
the gelation##2##2##(2008-10#2)
the gels are##2##3##(2008-2#1)(2008-7#1)
the gels##6##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-3#1)(2010-4#1)
the geminate recombination##2##3##(1990-8#1)(1995-2#1)
the gender gap##2##3##(1995-5#1)(2010-7#1)
the gender of the##3##4##(1992-3#1)(2009-3#1)(2012-3#1)
the gender of##4##3##(1992-3#1)(2009-3#1)(2012-3#2)
the gender##14##2##(1991-6#1)(1992-3#1)(1994-2#1)(1995-5#1)(1996-12#1)(2007-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
the gender-related##2##2##(2009-11#1)(2011-2#1)
the gendered##2##2##(2007-7#1)(2008-11#1)
the gene and its##2##4##(1994-11#1)(2008-7#1)
the gene and##6##3##(1994-11#1)(1995-8#1)(1996-2#1)(1996-8#1)(2008-7#2)
the gene as##2##3##(1997-2#1)(2010-4#1)
the gene coding for the##5##5##(1992-3#1)(1993-8#1)(1997-3#2)(2008-6#1)
the gene coding for##10##4##(1992-3#2)(1993-8#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-3#2)(2008-6#1)(2010-8#1)
the gene encoding a##3##4##(1994-12#1)(1994-8#1)(1997-3#1)
the gene encoding human##5##4##(1991-6#3)(1994-12#1)(1997-7#1)
the gene encoding the##29##4##(1991-9#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#5)(1995-2#2)(1995-6#1)(1996-12#2)(1996-8#1)(1997-3#2)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2013-1#1)
the gene encoding this##2##4##(1995-6#1)(2008-10#1)
the gene encoding yeast protein kinase C##2##7##(1997-3#2)
the gene encoding yeast##3##4##(1991-6#1)(1997-3#2)
the gene encoding##65##3##(1990-5#1)(1991-12#1)(1991-6#4)(1991-9#2)(1992-12#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#8)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-8#1)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2013-1#1)
the gene expression and##2##4##(1997-8#1)(2010-5#1)
the gene expression in##3##4##(1993-8#1)(1993-9#1)(2008-11#1)
the gene expression level of##2##5##(2008-7#1)(2013-1#1)
the gene expression level##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
the gene expression of##12##4##(1991-5#1)(1992-6#1)(1993-3#3)(1994-12#1)(1995-2#1)(1997-2#1)(2010-3#1)(2013-1#2)(2013-7#1)
the gene expression profile##2##4##(1997-6#1)(2010-11#1)
the gene expression profiles##5##4##(2008-10#3)(2012-1#1)(2013-7#1)
the gene expression##33##3##(1991-5#2)(1992-6#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#2)
the gene family##4##3##(2008-10#2)(2008-8#1)(2010-6#1)
the gene for the##3##4##(1994-8#1)(1994-9#1)(2008-7#1)
the gene for##12##3##(1990-5#1)(1992-8#1)(1994-11#2)(1994-8#2)(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-4#1)
the gene in##6##3##(1991-9#1)(1995-3#1)(1997-1#1)(2008-10#3)
the gene is##11##3##(1990-5#1)(1992-9#1)(1993-2#2)(1993-8#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-5#1)(2008-8#1)(2011-2#1)
the gene itself##2##3##(1993-2#1)(2008-4#1)
the gene level##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
the gene of interest and##2##5##(2008-11#1)(2008-2#1)
the gene of interest is##2##5##(2008-2#1)(2008-4#1)
the gene of interest##7##4##(2008-11#2)(2008-2#4)(2008-4#1)
the gene of##13##3##(1990-12#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
the gene on##3##3##(2008-10#2)(2011-1#1)
the gene ontology##2##3##(2008-7#1)(2011-2#1)
the gene or genes##2##4##(1995-6#1)(2008-10#1)
the gene or##3##3##(1995-6#1)(1996-2#1)(2008-10#1)
the gene order##3##3##(1990-5#1)(1997-2#1)(2013-8#1)
the gene organization##2##3##(1995-11#1)(1996-6#1)
the gene product##5##3##(1992-3#1)(1992-9#1)(1997-2#1)(2008-6#2)
the gene region##3##3##(1992-9#2)(1994-8#1)
the gene responsible for##2##4##(2008-4#2)
the gene responsible##3##3##(1993-6#1)(2008-4#2)
the gene sequences##2##3##(1997-4#1)(2008-5#1)
the gene sets##2##3##(1992-3#1)(2008-7#1)
the gene that encodes the##2##5##(2008-4#1)(2013-1#1)
the gene that encodes##4##4##(1995-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
the gene that##5##3##(1994-8#1)(1995-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
the gene therapy##3##3##(1994-5#1)(2008-5#1)(2013-8#1)
the gene to a##2##4##(1993-2#1)(2008-10#1)
the gene to##5##3##(1993-2#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-2#1)
the gene transfer##6##3##(1997-8#1)(2008-9#5)
the gene was##15##3##(1991-11#1)(1993-9#1)(1996-2#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#2)(2010-2#1)
the gene##363##2##(1990-12#1)(1990-5#6)(1990-7#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-6#5)(1991-9#4)(1992-12#2)(1992-3#7)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#6)(1993-1#1)(1993-12#3)(1993-2#13)(1993-3#7)(1993-6#4)(1993-8#11)(1993-9#4)(1994-11#4)(1994-12#16)(1994-2#1)(1994-5#3)(1994-8#6)(1994-9#1)(1995-11#6)(1995-2#4)(1995-3#2)(1995-6#10)(1995-8#5)(1996-10#1)(1996-12#2)(1996-2#6)(1996-5#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#12)(1997-3#11)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#3)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#6)(2008-2#5)(2008-4#10)(2008-5#8)(2008-6#4)(2008-7#17)(2008-8#10)(2008-9#19)(2009-10#2)(2009-6#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#3)
the gene's##2##2##(1995-2#1)(2008-7#1)
the gene-for-gene model##2##3##(2008-10#2)
the gene-for-gene##6##2##(2008-10#5)(2011-10#1)
the genealogical##2##2##(2008-12#1)(2010-8#1)
the genera##24##2##(1997-4#1)(2008-10#10)(2008-5#2)(2008-6#2)(2008-7#2)(2011-2#1)(2013-7#2)(2013-8#4)
the general amino acid permease##2##5##(1990-5#1)(1995-11#1)
the general amino acid##3##4##(1990-5#2)(1995-11#1)
the general applicability##2##3##(2008-10#1)(2008-9#1)
the general class of##2##4##(2008-5#1)(2008-6#1)
the general health questionnaire##2##4##(2011-1#1)(2013-1#1)
the general health status and##2##5##(2008-10#1)(2008-7#1)
the general health##6##3##(1993-3#1)(2008-10#1)(2008-7#2)(2011-1#1)(2013-1#1)
the general hospital##2##3##(2010-12#1)(2011-2#1)
the general organization of the##2##5##(1991-2#1)(2008-4#1)
the general organization of##3##4##(1991-2#1)(1992-11#1)(2008-4#1)
the general paediatric##2##3##(2008-11#2)
the general pattern of##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
the general population and##4##4##(1992-2#1)(2010-12#1)(2013-1#2)
the general population as well as##3##6##(1992-2#1)(2009-10#1)(2011-2#1)
the general population is##4##4##(1992-11#1)(2007-12#1)(2011-1#1)(2013-8#1)
the general population of the##3##5##(1991-2#1)(1993-9#1)(2008-7#1)
the general population of##6##4##(1991-2#1)(1993-9#1)(2007-12#1)(2008-1#1)(2008-7#2)
the general population##92##3##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-2#3)(1992-9#1)(1993-1#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-3#4)(1997-8#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-1#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-12#3)(2012-3#3)(2013-1#10)(2013-8#3)
the general practitioner in##2##4##(1990-2#1)(1993-11#1)
the general practitioner##14##3##(1990-11#1)(1990-2#1)(1990-3#2)(1992-5#3)(1993-11#1)(1994-6#1)(1995-11#2)(1997-4#1)(2008-11#1)(2012-12#1)
the general practitioners##10##3##(1993-2#4)(1995-5#1)(1997-4#3)(2008-10#1)(2011-2#1)
the general principle##2##3##(1993-9#1)(2008-8#1)
the general principles##3##3##(2007-11#2)(2008-9#1)
the general problem##2##3##(2008-4#1)(2008-7#1)
the general public and##3##4##(2007-12#1)(2007-6#1)(2013-8#1)
the general public in##2##4##(2008-7#1)(2013-1#1)
the general public regarding the##2##5##(2010-12#1)(2012-3#1)
the general public##16##3##(1991-11#1)(1993-2#1)(1996-3#1)(2007-12#3)(2007-6#1)(2008-11#1)(2008-7#3)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the general structure of the##2##5##(2007-12#1)(2013-7#1)
the general structure of##3##4##(2007-12#1)(2008-5#1)(2013-7#1)
the general trend of##2##4##(2008-10#1)(2008-2#1)
the general use of##2##4##(1992-4#1)(2008-8#1)
the general view##2##3##(2008-10#1)(2008-8#1)
the general##299##2##(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#4)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#3)(1995-5#2)(1996-11#1)(1996-12#1)(1996-3#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-6#1)(2007-7#2)(2008-1#9)(2008-10#15)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#9)(2008-5#6)(2008-6#2)(2008-7#21)(2008-8#12)(2008-9#11)(2009-10#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#12)(2011-3#1)(2012-12#9)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#4)
the generalist##3##2##(1993-2#2)(2009-8#1)
the generality of the##4##4##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
the generality of##6##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#3)
the generality##7##2##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#3)(2013-1#1)
the generalizability of the##2##4##(1993-3#1)(2013-8#1)
the generalizability of##4##3##(1993-3#1)(1995-11#1)(2013-8#2)
the generalization capability for##2##4##(2008-3#2)
the generalization of treatment effects##2##5##(2009-9#2)
the generalization of##4##3##(2008-6#1)(2009-9#2)(2010-8#1)
the generalization##7##2##(2008-3#2)(2008-6#1)(2008-9#1)(2009-9#2)(2010-8#1)
the generalized Born##2##3##(2009-12#2)
the generalized Lorenz-Mie theory##6##4##(2008-2#2)(2008-3#4)
the generalized estimating equation##2##4##(1995-9#1)(2012-12#1)
the generalized phase-contrast (GPC) method##2##5##(2007-11#2)
the generalized phase-contrast method##2##4##(2007-11#2)
the generalized phase-contrast##5##3##(2007-11#4)(2008-3#1)
the generalized scidar##2##3##(2008-2#1)(2008-3#1)
the generalized seeing monitor##2##4##(2008-3#2)
the generalized##45##2##(1990-3#1)(1990-8#1)(1991-9#1)(1992-2#1)(1994-2#1)(1995-9#1)(1996-12#3)(1997-2#1)(1997-7#1)(2007-11#6)(2007-12#1)(2008-10#3)(2008-2#7)(2008-3#9)(2008-7#1)(2009-12#2)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
the generally accepted##5##3##(1993-9#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
the generally##10##2##(1993-9#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-7#1)
the generated##25##2##(1990-7#1)(1992-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)
the generation and characterization of##2##5##(2011-2#1)(2012-2#1)
the generation and##12##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
the generation of IP3##2##4##(1990-12#1)(1991-12#1)
the generation of InsP3##2##4##(1994-11#1)(1994-6#1)
the generation of a##9##4##(1992-9#1)(1993-8#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
the generation of an##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
the generation of androstenone##3##4##(2008-5#3)
the generation of arbitrary complex##2##5##(2007-11#1)(2008-3#1)
the generation of data##2##4##(2008-10#1)(2008-5#1)
the generation of free radicals and##2##6##(2008-5#1)(2013-8#1)
the generation of highly##2##4##(2008-2#1)(2009-10#1)
the generation of human##3##4##(1995-12#1)(2008-11#1)(2008-4#1)
the generation of intense##2##4##(2007-12#2)
the generation of large##2##4##(2008-10#1)(2008-3#1)
the generation of new DNA##2##5##(2008-4#1)(2011-2#1)
the generation of new##4##4##(2008-4#1)(2008-7#1)(2011-2#1)(2012-4#1)
the generation of reactive oxygen species##4##6##(2008-1#1)(2008-10#1)(2009-3#1)(2011-1#1)
the generation of stably##2##4##(2008-11#1)(2008-2#1)
the generation of synthetic##2##4##(2008-2#1)(2008-3#1)
the generation of the##11##4##(1990-5#1)(1995-12#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
the generation of transgenic mice##2##5##(2008-4#2)
the generation of transgenic##3##4##(2008-11#1)(2008-4#2)
the generation of##176##3##(1990-12#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-12#2)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-12#2)(1995-9#1)(1996-2#2)(1996-4#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#19)(2007-12#9)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#18)(2008-2#9)(2008-3#10)(2008-4#9)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-9#1)(2012-1#1)(2012-12#2)(2012-3#1)(2012-4#1)(2012-8#1)(2013-8#2)
the generation or##2##3##(1993-12#1)(2012-12#1)
the generation time##2##3##(2008-8#2)
the generation##199##2##(1990-12#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1995-12#2)(1995-9#1)(1996-2#2)(1996-4#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#20)(2007-12#11)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#19)(2008-2#11)(2008-3#12)(2008-4#12)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2012-4#1)(2012-8#1)(2013-8#2)
the generations##2##2##(1992-2#1)(2009-10#1)
the generative##5##2##(2007-12#1)(2008-10#2)(2009-12#1)(2010-4#1)
the generator##6##2##(1992-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)
the generic##9##2##(1990-7#1)(1996-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
the generosity of##2##3##(1996-2#1)(2008-10#1)
the genes and##3##3##(1996-6#1)(2008-8#1)(2008-9#1)
the genes are##4##3##(1992-8#1)(1993-6#1)(1996-2#1)(2008-10#1)
the genes coding for the##2##5##(1994-5#1)(1995-2#1)
the genes coding for##6##4##(1994-5#1)(1995-12#1)(1995-2#1)(1997-6#1)(2008-4#1)(2008-9#1)
the genes contributing to##2##4##(2008-4#1)(2012-3#1)
the genes encoding the##7##4##(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-3#1)(2008-7#1)
the genes encoding##16##3##(1991-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#2)(2010-7#1)
the genes for the##2##4##(2010-11#1)(2011-2#1)
the genes for##12##3##(1990-2#1)(1992-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
the genes identified##2##3##(2007-11#1)(2008-9#1)
the genes in##6##3##(1990-5#1)(1992-3#1)(1996-2#1)(2008-10#2)(2008-4#1)
the genes involved in the##3##5##(1990-5#1)(2008-11#1)(2008-9#1)
the genes involved in##7##4##(1990-5#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-9#2)
the genes involved##10##3##(1990-5#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#2)(2011-1#1)(2013-8#1)
the genes may be##2##4##(1993-3#1)(2008-9#1)
the genes of interest##2##4##(1997-4#1)(2008-8#1)
the genes of##7##3##(1995-12#1)(1997-4#1)(2008-4#1)(2008-8#3)(2013-1#1)
the genes on chromosome VI of##2##6##(1997-6#2)
the genes participating in##2##4##(1996-6#1)(2012-3#1)
the genes related to##2##4##(2011-2#1)(2012-3#1)
the genes responsible for##2##4##(1994-9#1)(2009-6#1)
the genes that encode##4##4##(1993-9#1)(1994-8#1)(1995-6#1)(2008-11#1)
the genes that##9##3##(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(2007-12#1)(2008-11#1)(2009-4#1)
the genes underlying##3##3##(2009-10#2)(2012-3#1)
the genes upregulated##2##3##(2008-7#1)(2009-8#1)
the genes were##4##3##(2008-10#3)(2009-10#1)
the genes with##2##3##(2008-7#1)(2010-5#1)
the genes##144##2##(1990-2#1)(1990-5#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#2)(1996-2#4)(1996-6#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#10)(2009-10#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
the genesis and##2##3##(2008-10#1)(2011-2#1)
the genesis of##15##3##(1991-12#1)(1991-4#1)(1995-8#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#2)(2013-8#1)
the genesis##17##2##(1991-12#1)(1991-4#1)(1995-8#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
the genetic algorithm##2##3##(2008-10#1)(2008-8#1)
the genetic alterations present in osteosarcoma##2##6##(2010-3#2)
the genetic analysis of cystic##2##5##(1990-3#2)
the genetic analysis of##8##4##(1990-3#3)(2008-1#1)(2008-4#1)(2008-7#1)(2010-1#2)
the genetic analysis##9##3##(1990-3#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-1#2)
the genetic and biological diversity of##2##6##(2008-10#2)
the genetic and molecular basis##2##5##(2008-7#1)(2009-5#1)
the genetic and molecular##4##4##(2007-12#1)(2008-6#1)(2008-7#1)(2009-5#1)
the genetic and##16##3##(1997-5#1)(2007-12#1)(2008-10#6)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2011-10#1)
the genetic architecture of the##2##5##(2009-12#1)(2010-12#1)
the genetic architecture of##6##4##(2008-8#3)(2009-12#1)(2010-12#1)(2012-3#1)
the genetic association##3##3##(2008-9#1)(2010-2#1)(2012-2#1)
the genetic background of the##2##5##(2008-2#1)(2012-3#1)
the genetic background of##7##4##(2007-10#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-3#2)
the genetic background##9##3##(1995-12#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-3#2)
the genetic basis for##2##4##(1991-8#1)(2010-4#1)
the genetic basis of glucose homeostasis##2##6##(2008-1#2)
the genetic basis of heterosis##3##5##(2008-4#1)(2008-8#1)(2009-10#1)
the genetic basis of##19##4##(1994-9#1)(1995-12#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#2)(2008-8#3)(2009-10#2)(2009-5#1)(2010-5#1)(2011-1#1)(2012-3#2)
the genetic basis##24##3##(1991-8#1)(1994-9#1)(1995-12#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#3)
the genetic causes of##2##4##(1995-12#1)(1997-7#1)
the genetic causes##3##3##(1995-12#1)(1997-7#1)(2009-6#1)
the genetic characteristics of viral quasispecies##2##6##(2013-8#2)
the genetic characteristics of##4##4##(2011-2#1)(2012-12#1)(2013-8#2)
the genetic code##5##3##(1994-5#1)(1997-6#1)(2008-4#1)(2012-2#2)
the genetic composition of##4##4##(2008-10#3)(2009-8#1)
the genetic consequences of##2##4##(2010-3#1)(2012-3#1)
the genetic constitution of##2##4##(2008-10#2)
the genetic contribution##2##3##(2008-3#1)(2011-2#1)
the genetic control of##3##4##(2008-10#1)(2008-8#2)
the genetic defect##4##3##(1990-11#1)(1990-5#1)(1996-12#1)(2011-1#1)
the genetic distance##3##3##(1997-5#1)(2008-10#2)
the genetic distances between##2##4##(2008-10#1)(2011-1#1)
the genetic distances##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
the genetic diversity among##4##4##(2008-10#4)
the genetic diversity and population##2##5##(2008-10#1)(2013-8#1)
the genetic diversity and##4##4##(2008-10#3)(2013-8#1)
the genetic diversity between##2##4##(1995-2#1)(2008-7#1)
the genetic diversity of the##3##5##(2008-10#2)(2008-6#1)
the genetic diversity of##9##4##(2008-10#7)(2008-6#1)(2010-7#1)
the genetic diversity within the##2##5##(2008-10#2)
the genetic diversity within##3##4##(2008-10#3)
the genetic diversity##26##3##(1995-2#1)(2008-10#19)(2008-12#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
the genetic effects##2##3##(2008-9#1)(2010-4#1)
the genetic evolution##2##3##(1994-12#1)(2013-8#1)
the genetic factors involved in##2##5##(1997-8#1)(2009-5#1)
the genetic factors##3##3##(1997-8#1)(2008-4#1)(2009-5#1)
the genetic heterogeneity of##2##4##(1993-11#1)(2011-1#1)
the genetic heterogeneity##3##3##(1993-11#1)(2007-7#1)(2011-1#1)
the genetic information##2##3##(1995-4#1)(2008-9#1)
the genetic instability##2##3##(1994-6#1)(2008-4#1)
the genetic manipulation of##2##4##(2008-9#2)
the genetic map##14##3##(1992-4#1)(1996-10#1)(1996-12#2)(1996-6#1)(2008-10#6)(2008-5#2)(2012-3#1)
the genetic material##4##3##(1994-5#1)(2007-11#1)(2008-5#1)(2011-2#1)
the genetic mechanism##2##3##(2008-10#2)
the genetic mechanisms##2##3##(1994-11#1)(2008-7#1)
the genetic modification of##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
the genetic modification##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
the genetic pathway##2##3##(2007-12#1)(2008-7#1)
the genetic relationship between##2##4##(2008-10#1)(2008-9#1)
the genetic relationship##3##3##(2008-10#2)(2008-9#1)
the genetic relationships among##2##4##(2008-10#2)
the genetic relationships##4##3##(2008-10#3)(2011-2#1)
the genetic risk of##3##4##(2008-1#2)(2008-7#1)
the genetic risk##4##3##(2008-1#2)(2008-3#1)(2008-7#1)
the genetic structure and##2##4##(2008-10#2)
the genetic structure of M##2##5##(2008-10#2)
the genetic structure of parasite##2##5##(2008-8#1)(2011-2#1)
the genetic structure of these##2##5##(2008-10#1)(2012-3#1)
the genetic structure of##21##4##(2008-10#14)(2008-8#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
the genetic structure##24##3##(2008-10#17)(2008-8#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
the genetic variability among##2##4##(2008-10#1)(2008-5#1)
the genetic variability##6##3##(2007-10#1)(2008-10#4)(2008-5#1)
the genetic variance##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
the genetic variation among##2##4##(2008-10#2)
the genetic variation of##2##4##(2008-10#2)
the genetic variation##12##3##(2008-10#8)(2008-8#1)(2010-1#1)(2010-4#1)(2013-8#1)
the genetic##319##2##(1990-11#1)(1990-3#3)(1990-5#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#2)(1994-9#3)(1995-12#5)(1995-2#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#4)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#6)(2008-10#90)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#20)(2008-9#17)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#8)(2011-10#1)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#14)(2013-1#5)(2013-8#8)
the genetically##8##2##(1991-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)(2013-7#1)
the genetics and physiology of##2##5##(2008-10#2)
the genetics and##4##3##(2008-10#3)(2008-8#1)
the genetics of reproductive isolation##2##5##(2008-8#2)
the genetics of resistance in##3##5##(2008-10#2)(2011-10#1)
the genetics of resistance##4##4##(2008-10#3)(2011-10#1)
the genetics of##17##3##(2007-10#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-8#2)(2011-10#1)(2012-3#2)
the genetics underlying##2##3##(2008-8#1)(2009-4#1)
the genetics##26##2##(2007-10#1)(2008-1#1)(2008-10#12)(2008-4#2)(2008-8#4)(2009-3#1)(2009-4#1)(2009-5#1)(2011-10#1)(2012-3#2)
the geniculate ganglion##2##3##(2011-2#2)
the geniculate##4##2##(2008-11#1)(2011-2#3)
the genital tract##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
the genital##12##2##(1996-12#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
the genitalia##5##2##(1997-3#1)(2008-10#3)(2010-4#1)
the genitourinary##3##2##(1990-6#1)(2007-12#1)(2013-8#1)
the genome and##6##3##(1990-5#1)(2008-10#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
the genome contains##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
the genome evolution##2##3##(2009-5#1)(2012-3#1)
the genome of S##2##4##(1992-6#1)(2008-9#1)
the genome of Synechocystis sp##5##5##(1995-8#1)(1996-8#1)(1997-2#1)(1997-6#2)
the genome of a##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
the genome of the cyanobacterium##2##5##(1995-12#1)(1996-12#1)
the genome of the unicellular cyanobacterium Synechocystis sp##4##8##(1995-6#1)(1995-8#1)(1996-6#2)
the genome of the##13##4##(1990-5#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(1997-3#1)(2008-10#2)(2010-8#1)(2011-2#1)
the genome of##37##3##(1990-11#1)(1990-5#1)(1992-6#1)(1993-11#1)(1994-12#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#2)(2008-10#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-3#1)
the genome organization##2##3##(2008-10#1)(2008-9#1)
the genome sequence of##3##4##(1996-8#1)(2008-7#2)
the genome sequence##5##3##(1996-8#1)(2008-4#1)(2008-7#2)(2011-2#1)
the genome that##5##3##(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-3#1)
the genome to##3##3##(1995-4#1)(2008-11#1)(2009-3#1)
the genome were##3##3##(1990-11#1)(2008-10#2)
the genome##152##2##(1990-11#2)(1990-5#2)(1990-7#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#3)(1993-12#1)(1994-12#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-12#2)(1996-2#2)(1996-6#10)(1996-8#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#6)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-3#3)(2010-8#2)(2010-9#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#1)
the genome-wide##6##2##(2008-2#1)(2008-7#2)(2009-2#1)(2011-2#2)
the genomes of##14##3##(1991-8#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#3)
the genomes##16##2##(1991-8#1)(1997-6#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#3)(2012-12#1)
the genomic DNA of##2##4##(1992-6#1)(2008-10#1)
the genomic DNA##10##3##(1990-12#1)(1992-6#1)(1993-8#2)(1994-12#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-8#1)(2010-7#1)
the genomic RNA of##4##4##(1997-3#1)(2008-10#3)
the genomic RNA##5##3##(1997-3#2)(2008-10#3)
the genomic and##2##3##(1992-3#1)(2010-3#1)
the genomic location of a##2##5##(2008-4#1)(2008-9#1)
the genomic location of##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the genomic location##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
the genomic locus##2##3##(1991-6#1)(1996-6#1)
the genomic sequence data##2##4##(1995-12#1)(2008-1#1)
the genomic sequence of##2##4##(2008-10#1)(2008-9#1)
the genomic sequence##9##3##(1992-3#1)(1993-3#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#1)
the genomic structure of##2##4##(1993-11#1)(1993-12#1)
the genomic structure##4##3##(1993-11#1)(1993-12#2)(2008-7#1)
the genomic##71##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-3#3)(1992-6#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#2)(1995-12#2)(1995-8#1)(1996-12#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the genomics##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
the genotoxic effects of##2##4##(2008-8#1)(2010-5#1)
the genotoxic##3##2##(1997-4#1)(2008-8#1)(2010-5#1)
the genotype GG of rs266729##2##5##(2011-1#2)
the genotype frequencies of##2##4##(2011-1#2)
the genotype frequency of##2##4##(2006-6#1)(2011-1#1)
the genotype of the##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
the genotype of##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
the genotype was##2##3##(1997-7#1)(2012-3#1)
the genotype##19##2##(1997-7#1)(2006-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2011-1#5)(2011-2#1)(2012-3#1)(2013-8#1)
the genotypes and allele frequencies##3##5##(2011-1#3)
the genotypes and##4##3##(2008-4#1)(2011-1#3)
the genotypes of##6##3##(1995-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2012-3#1)
the genotypes##22##2##(1995-6#1)(2008-10#7)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the genotypic composition of##2##4##(2008-10#2)
the genotypic##8##2##(2008-10#5)(2008-8#2)(2008-9#1)
the genotyping uncertainty score##2##4##(2009-8#2)
the genotyping##5##2##(2008-7#1)(2008-9#2)(2009-8#2)
the genre##2##2##(2009-10#1)(2011-2#1)
the gentamicin##2##2##(2008-10#1)(2010-3#1)
the genuine##3##2##(2008-8#1)(2010-11#1)(2012-3#1)
the genus Astyanax##3##3##(2010-8#3)
the genus Bacillus##2##3##(2008-10#1)(2011-2#1)
the genus Begomovirus##5##3##(2008-10#5)
the genus Blechnum##2##3##(2013-7#2)
the genus Borrelia##2##3##(2013-8#2)
the genus Closterovirus##3##3##(2008-10#3)
the genus Drosophila##2##3##(2008-5#1)(2008-8#1)
the genus Gymnodactylus##2##3##(2010-3#2)
the genus Potyvirus##8##3##(2008-10#8)
the genus Puntius Hamilton 1822##5##5##(2008-12#5)
the genus Rymovirus##2##3##(2008-10#2)
the genus Sigmodon##2##3##(2010-4#2)
the genus Streptomyces##2##3##(1991-12#1)(2008-10#1)
the genus Thermocrinis##2##3##(2011-2#2)
the genus Tobamovirus##4##3##(2008-10#4)
the genus Tospovirus##7##3##(2008-10#7)
the genus Trichoderma##3##3##(2008-10#3)
the genus##223##2##(1991-12#1)(1997-2#1)(1997-4#5)(2007-12#1)(2007-7#1)(2008-10#78)(2008-11#1)(2008-12#5)(2008-5#19)(2008-6#8)(2008-8#3)(2008-9#3)(2009-5#2)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#6)(2010-4#2)(2010-8#4)(2011-2#65)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#3)
the geochemical##2##2##(2008-10#2)
the geographic adjustment##2##3##(1991-3#1)(1992-2#1)
the geographic area##3##3##(1991-3#1)(1997-3#1)(2011-2#1)
the geographic distribution of##3##4##(1991-12#1)(2010-3#1)(2012-12#1)
the geographic location##2##3##(2008-10#2)
the geographic origin of##3##4##(2008-10#2)(2011-2#1)
the geographic populations##5##3##(2008-10#5)
the geographic regions##3##3##(2008-10#2)(2008-8#1)
the geographic##35##2##(1991-12#1)(1991-3#5)(1992-2#1)(1994-1#1)(1994-2#1)(1997-3#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-7#1)
the geographical distribution of##3##4##(2008-10#2)(2010-8#1)
the geographical distribution##4##3##(2008-10#2)(2010-8#1)(2013-7#1)
the geographical##16##2##(1996-4#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
the geological##3##2##(1996-6#1)(2008-10#2)
the geometric and##2##3##(2008-3#2)
the geometric focus##3##3##(2008-3#3)
the geometric mean as##2##4##(2011-2#2)
the geometric mean##7##3##(1991-5#3)(2008-8#1)(2011-2#3)
the geometric optical performance##2##4##(2008-2#1)(2008-3#1)
the geometric parameters##2##3##(2008-3#2)
the geometric phase##2##3##(2007-11#2)
the geometric properties of##3##4##(2008-3#2)(2008-6#1)
the geometric##32##2##(1991-5#3)(2007-11#3)(2008-10#3)(2008-2#2)(2008-3#15)(2008-6#1)(2008-8#1)(2011-2#4)
the geometrical optics approximation##2##4##(2008-2#1)(2008-3#1)
the geometrical optics##3##3##(2008-2#2)(2008-3#1)
the geometrical##18##2##(1996-2#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#9)(2009-6#1)(2012-2#1)(2013-8#1)
the geometrical-optics##4##2##(2008-2#2)(2008-3#2)
the geometrically##2##2##(1992-11#1)(2008-2#1)
the geometries of##2##3##(1997-6#1)(2012-2#1)
the geometries##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
the geometry of a##2##4##(2008-10#1)(2008-2#1)
the geometry of the##13##4##(1990-12#1)(1990-5#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-12#1)(2009-9#1)
the geometry of##24##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-5#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)
the geometry##31##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-5#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2013-8#1)
the gerbil##3##2##(1990-7#1)(1992-11#1)(1992-12#1)
the geriatric assessment unit##5##4##(1990-5#4)(2008-7#1)
the geriatric patient##2##3##(1990-9#1)(1991-2#1)
the geriatric population##3##3##(1990-3#1)(1993-5#1)(2009-8#1)
the geriatric##14##2##(1990-3#1)(1990-5#4)(1990-9#1)(1991-2#1)(1992-1#1)(1993-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#2)
the germ cells in the testis of matrinxã##2##8##(2008-7#2)
the germ cells in the##3##5##(2008-7#3)
the germ cells##4##3##(2008-7#3)(2012-12#1)
the germ line##5##3##(1995-2#2)(2009-3#3)
the germ plasm##3##3##(2008-10#3)
the germ##18##2##(1995-2#2)(2008-10#4)(2008-7#5)(2009-10#1)(2009-3#3)(2010-3#1)(2012-12#2)
the germinal vesicle##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
the germinating##2##2##(2008-10#2)
the germination of##7##3##(2007-5#1)(2008-10#3)(2008-12#2)(2011-1#1)
the germination percentage of##2##4##(2008-10#1)(2008-5#1)
the germination##15##2##(2007-5#1)(2008-10#7)(2008-12#2)(2008-5#1)(2011-1#1)(2011-2#3)
the germline##9##2##(1992-10#1)(1995-8#4)(2010-5#2)(2012-3#1)(2013-8#1)
the gerontological profile##2##3##(2012-12#2)
the gestational age##2##3##(1996-12#1)(2008-7#1)
the gestational##5##2##(1993-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(2008-7#1)
the gfp gene##3##3##(1996-6#2)(2008-10#1)
the gfp##5##2##(1996-6#2)(1997-4#2)(2008-10#1)
the ghost pulse##2##3##(2007-11#2)
the giant grouper (Epinephelus lanceolatus)##2##5##(2010-5#2)
the giant grouper##3##3##(2010-5#3)
the giant panda were##2##4##(2008-8#2)
the giant##14##2##(1991-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#2)(2010-5#3)(2011-2#1)(2013-7#2)
the gibbon HBV##3##3##(1993-8#3)
the gill and##2##3##(2008-10#1)(2008-7#1)
the gill##9##2##(2008-10#1)(2008-5#3)(2008-7#5)
the gills and##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
the gills##8##2##(2008-10#1)(2008-12#1)(2008-7#4)(2010-8#1)(2012-3#1)
the gingiva##6##2##(1993-1#2)(2009-8#1)(2012-12#1)(2012-3#2)
the gingival surface##2##3##(1990-10#1)(2012-3#1)
the gingival##5##2##(1990-10#1)(2012-3#3)(2013-1#1)
the girl should##2##3##(1995-6#1)(2012-12#1)
the girl##3##2##(1995-6#2)(2012-12#1)
the girls##3##2##(1991-9#1)(2007-11#1)(2013-1#1)
the given##18##2##(1997-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
the gland cells##2##3##(2007-12#1)(2008-7#1)
the gland opening##4##3##(2007-12#4)
the gland secretion##2##3##(2007-12#1)(2008-7#1)
the gland##21##2##(1991-9#1)(2007-12#13)(2008-7#3)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
the glands are##2##3##(2007-12#2)
the glands##5##2##(2007-12#4)(2008-5#1)
the glandular region##2##3##(2007-12#2)
the glandular##8##2##(1995-6#1)(1997-1#1)(2007-12#5)(2008-7#1)
the glans penis##4##3##(2007-7#3)(2007-8#1)
the glans##5##2##(1991-2#1)(2007-7#3)(2007-8#1)
the glass and##2##3##(2007-12#1)(2009-7#1)
the glass capillary of a##2##5##(2008-10#2)
the glass electrode##4##3##(2008-10#4)
the glass fiber##2##3##(2007-11#1)(2008-10#1)
the glass infiltration mode (under or without vacuum)##2##8##(2009-8#2)
the glass infiltration mode##3##4##(2009-8#3)
the glass pores##2##3##(2008-3#2)
the glass sample##2##3##(2007-12#2)
the glass substrate##2##3##(2008-4#1)(2010-4#1)
the glass surface##3##3##(1991-5#1)(2008-3#1)(2013-1#1)
the glass transition in##2##4##(1995-3#2)
the glass transition temperature of the##2##6##(2008-3#2)
the glass transition temperature##4##4##(1995-3#1)(2008-3#3)
the glass transition##9##3##(1995-3#3)(2008-2#1)(2008-3#3)(2012-2#2)
the glass was##2##3##(2007-12#1)(2008-3#1)
the glass were##2##3##(2007-12#2)
the glass##65##2##(1991-5#1)(1995-3#3)(2007-11#2)(2007-12#13)(2008-10#20)(2008-2#2)(2008-3#13)(2008-4#1)(2009-7#1)(2009-8#3)(2010-2#1)(2010-4#1)(2012-2#3)(2013-1#1)
the glassy carbon electrode (GCE)##3##5##(2008-10#3)
the glassy carbon electrode##14##4##(1995-6#1)(2008-10#13)
the glassy carbon##15##3##(1995-6#1)(2008-10#14)
the glassy##16##2##(1995-3#1)(1995-6#1)(2008-10#14)
the glassy-winged sharpshooter##2##3##(2007-12#2)
the gleaner-opportunist trade-off##2##3##(2008-8#2)
the glenoid##2##2##(2007-11#1)(2011-2#1)
the glial cells##3##3##(1990-7#1)(2008-1#1)(2008-7#1)
the glial##12##2##(1990-7#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#5)(2009-8#1)
the glioblastoma##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
the global analysis##2##3##(2008-7#1)(2011-2#1)
the global and##4##3##(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)
the global budget##3##3##(1993-3#1)(1994-12#1)(2008-11#1)
the global budgets##2##3##(1991-12#1)(2008-11#1)
the global distribution of##2##4##(2009-8#1)(2012-12#1)
the global evolution of##2##4##(1990-9#1)(2008-2#1)
the global gene expression profile of##2##6##(2011-2#2)
the global gene expression##3##4##(2009-12#1)(2011-2#2)
the global genomic##2##3##(2008-11#2)
the global minimum##2##3##(1993-11#1)(2008-3#1)
the global optimum can##2##4##(2008-10#2)
the global optimum##3##3##(2008-10#3)
the global population##3##3##(2007-12#1)(2008-8#2)
the global regulation of##2##4##(2009-6#2)
the global shape##2##3##(2008-4#2)
the global stability##2##3##(1997-2#1)(2008-10#1)
the global sun radiation##2##4##(2011-2#2)
the global##109##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-6#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-7#1)(1997-2#1)(2007-12#3)(2007-5#2)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
the globalization of##3##3##(1996-12#1)(2008-11#1)(2008-7#1)
the globally distributed##2##3##(2008-10#1)(2011-1#1)
the globe to##2##3##(1990-11#1)(2008-10#1)
the globe##12##2##(1990-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
the globin##4##2##(1990-8#2)(2008-10#1)(2008-9#1)
the globular##7##2##(1995-12#2)(1997-4#2)(2009-12#1)(2009-7#1)(2011-2#1)
the globus##2##2##(1993-12#1)(1995-5#1)
the glomerular filtration rate##3##4##(1996-6#1)(2011-2#1)(2013-8#1)
the glomerular##10##2##(1996-6#2)(2007-12#1)(2007-7#2)(2008-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
the glomerulus##2##2##(2007-7#1)(2008-1#1)
the glory##2##2##(2007-11#2)
the gloss uniformity##2##3##(2008-3#2)
the gloss##3##2##(2008-3#3)
the glossa##2##2##(2007-12#2)
the gloves##5##2##(1995-6#3)(2012-2#2)
the glucagon##6##2##(1995-11#2)(2010-11#2)(2011-2#1)(2012-3#1)
the glucagon-evoked##2##2##(1996-2#2)
the glucagon-induced increase of NAD(P)H##2##5##(1996-2#2)
the glucocorticoid receptor##8##3##(1990-11#1)(1991-12#1)(1993-8#2)(1996-12#3)(2008-11#1)
the glucocorticoid##9##2##(1990-11#1)(1991-12#1)(1993-8#2)(1996-12#3)(1997-7#1)(2008-11#1)
the glucose and##2##3##(2008-3#1)(2012-2#1)
the glucose biosensor##5##3##(2008-10#3)(2010-5#2)
the glucose concentration in##2##4##(1994-5#1)(2008-10#1)
the glucose concentration##7##3##(1994-5#1)(2008-10#6)
the glucose consumption rate##2##4##(2008-11#2)
the glucose consumption##3##3##(2008-11#3)
the glucose levels##2##3##(2007-8#1)(2008-5#1)
the glucose oxidase##4##3##(2008-10#4)
the glucose sensors##2##3##(2008-10#2)
the glucose tolerance test##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
the glucose transporter##2##3##(1993-6#1)(1994-2#1)
the glucose uptake##4##3##(2008-11#2)(2008-7#1)(2008-8#1)
the glucose##51##2##(1993-6#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(2007-8#1)(2008-10#25)(2008-11#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-4#1)
the glucosidase##2##2##(1995-5#2)
the glutamate dehydrogenase##3##3##(1992-11#1)(2008-11#1)(2008-8#1)
the glutamate transporter##3##3##(1993-3#1)(1995-11#1)(1996-2#1)
the glutamate##17##2##(1992-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-7#6)(2008-8#2)
the glutamate-induced rise in [Ca2+]i##2##5##(1995-12#2)
the glutamate-induced rise in##3##4##(1995-12#3)
the glutamatergic system is##2##4##(2008-7#2)
the glutamatergic system##5##3##(2008-7#5)
the glutamatergic##6##2##(1997-2#1)(2008-7#5)
the glutamic acid##3##3##(1990-8#1)(2008-10#1)(2009-2#1)
the glutamine##8##2##(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-2#1)
the glutaminolysis##2##2##(2008-11#2)
the glutathione##6##2##(1991-9#1)(1992-11#1)(1994-9#2)(2008-10#1)(2008-11#1)
the gluteal region with##2##4##(1992-2#1)(2011-2#1)
the gluteal region##4##3##(1992-2#1)(2009-9#1)(2010-8#1)(2011-2#1)
the gluteal##5##2##(1992-2#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
the gluten-free##2##2##(1991-2#1)(2007-5#1)
the glutinous cultivars##2##3##(2008-10#2)
the glutinous##3##2##(2008-10#3)
the glycan##4##2##(1990-7#1)(1991-12#1)(1992-9#1)(2008-4#1)
the glycemic index and the glycemic load##2##7##(2008-1#2)
the glycemic##5##2##(2008-1#4)(2011-2#1)
the glycine cleavage complex##2##4##(1997-1#2)
the glycine cleavage##3##3##(1992-10#1)(1997-1#2)
the glycine decarboxylase##2##3##(1990-12#2)
the glycine receptor##4##3##(1992-11#3)(1996-2#1)
the glycine##12##2##(1990-12#2)(1991-2#1)(1992-10#1)(1992-11#3)(1996-2#1)(1996-5#1)(1997-1#2)(2011-1#1)
the glycine-rich##4##2##(1995-6#1)(1997-7#2)(2008-10#1)
the glycolysis##3##2##(2008-11#1)(2009-4#1)(2010-7#1)
the glycolytic flux##2##3##(1992-3#1)(2008-7#1)
the glycolytic pathway##6##3##(1991-9#1)(1996-6#1)(2008-11#1)(2008-7#2)(2012-2#1)
the glycolytic##13##2##(1990-7#1)(1991-9#1)(1992-3#1)(1994-8#2)(1996-6#2)(1997-2#1)(2008-11#1)(2008-7#3)(2012-2#1)
the glycopeptide##2##2##(1990-5#1)(1990-8#1)
the glycopeptidolipid##2##2##(1992-12#2)
the glycoprotein IIb-IIIa##3##3##(1990-5#2)(2006-6#1)
the glycoprotein processing##2##3##(1993-8#2)
the glycoprotein##11##2##(1990-5#2)(1991-11#1)(1993-6#1)(1993-8#3)(1994-8#1)(1995-2#1)(2006-6#1)(2008-7#1)
the glycoproteins##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
the glycosaminoglycan##3##2##(1991-9#2)(2012-3#1)
the glycosidic angle##2##3##(1993-11#1)(1993-3#1)
the glycosidic linkage##4##3##(1990-5#1)(1993-11#2)(2010-5#1)
the glycosidic##8##2##(1990-5#1)(1992-12#1)(1993-11#4)(1993-3#1)(2010-5#1)
the glycosylation of specific proteins##2##5##(2010-11#2)
the glycosylation of##3##3##(1994-11#1)(2010-11#2)
the glycosylation site##3##3##(1990-5#2)(1992-10#1)
the glycosylation sites##2##3##(2008-7#1)(2010-12#1)
the glycosylation##12##2##(1990-5#2)(1992-10#1)(1992-6#1)(1994-11#1)(2008-11#3)(2008-7#1)(2010-11#2)(2010-12#1)
the glyoxalase##2##2##(2008-10#1)(2008-11#1)
the glyoxylate##2##2##(2008-10#1)(2008-7#1)
the go##2##2##(1991-6#1)(2013-8#1)
the goal is to##3##4##(1994-11#1)(2007-11#1)(2009-9#1)
the goal is##4##3##(1994-11#1)(2007-11#1)(2009-8#1)(2009-9#1)
the goal of developing##3##4##(2007-11#1)(2008-11#1)(2011-8#1)
the goal of preventing##2##4##(1993-2#1)(2008-10#1)
the goal of this##3##4##(2008-10#1)(2008-11#1)(2009-10#1)
the goal of##48##3##(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1996-2#1)(1997-1#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-12#2)(2012-2#3)(2013-1#2)
the goal to##2##3##(1994-3#1)(2010-9#1)
the goal##62##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-7#1)(1995-1#1)(1996-2#1)(1997-1#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-8#1)(2010-9#2)(2011-2#1)(2011-8#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
the goals and objectives of##2##5##(1994-12#1)(2007-4#1)
the goals and outcomes##2##4##(1994-3#1)(2012-12#1)
the goals and##6##3##(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(2007-4#1)(2012-12#1)
the goals of care##2##4##(1994-3#2)
the goals of the##2##4##(2008-10#1)(2008-4#1)
the goals of this##2##4##(1994-3#1)(2009-8#1)
the goals of##20##3##(1994-1#1)(1994-2#2)(1994-3#3)(1995-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
the goals##33##2##(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#5)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-7#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the goats##3##2##(1997-8#1)(2008-12#1)(2010-2#1)
the gold electrode modified with a self-assembled monolayer of l-cysteine##2##10##(2008-10#2)
the gold electrode surface##3##4##(2008-10#3)
the gold electrode##7##3##(2008-10#7)
the gold grating##3##3##(2008-2#1)(2008-3#2)
the gold nanoparticles##2##3##(2008-10#1)(2008-7#1)
the gold standard approach##2##4##(2011-1#1)(2011-2#1)
the gold standard for the diagnosis of##2##7##(2008-11#1)(2011-2#1)
the gold standard for##9##4##(2007-12#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
the gold standard in##4##4##(2007-8#1)(2008-1#1)(2011-2#1)(2011-3#1)
the gold standard investigation##2##4##(2008-10#1)(2009-5#1)
the gold standard of##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
the gold standard##37##3##(1996-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
the gold surface of a##2##5##(2008-10#2)
the gold surface##6##3##(2008-10#5)(2013-8#1)
the gold##72##2##(1994-5#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-8#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
the gold/poly(o-PD) electrode##2##3##(2008-10#2)
the golden standard##2##3##(2008-11#2)
the golden##3##2##(1993-2#1)(2008-11#2)
the goldfish##9##2##(1991-2#5)(2008-1#1)(2008-6#1)(2011-2#2)
the gonad##2##2##(2007-12#1)(2008-5#1)
the gonadal sex developments in##2##5##(2008-5#2)
the gonadal##7##2##(2008-11#4)(2008-5#2)(2008-6#1)
the gonads is##2##3##(2009-11#1)(2009-7#1)
the gonads##5##2##(1994-5#1)(2009-11#3)(2009-7#1)
the good performance of##2##4##(2008-10#2)
the good##31##2##(1990-2#1)(1990-9#2)(1991-1#1)(1992-5#1)(1993-12#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2011-2#2)(2013-8#2)
the goodness of the fit##2##5##(2008-10#1)(2013-8#1)
the goodness of the##4##4##(1990-5#1)(2008-10#2)(2013-8#1)
the goodness of##5##3##(1990-5#1)(2008-10#3)(2013-8#1)
the goods##2##2##(2008-10#1)(2011-2#1)
the gorilla##2##2##(1993-8#1)(1995-2#1)
the governing##2##2##(1995-6#1)(2008-2#1)
the government and##4##3##(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)
the government for##2##3##(1997-5#1)(2008-11#1)
the government health##2##3##(2007-7#1)(2008-7#1)
the government of Delhi##2##4##(1994-9#2)
the government of##3##3##(1994-9#2)(2010-4#1)
the government##34##2##(1992-4#1)(1993-1#1)(1993-3#1)(1994-12#3)(1994-7#2)(1994-9#2)(1995-12#1)(1995-3#4)(1995-6#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#3)(2009-10#1)(2010-4#1)(2011-2#1)
the government's##14##2##(1991-12#1)(1993-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(2007-9#1)(2008-11#4)(2010-11#1)(2010-12#1)
the governmental##2##2##(1997-2#1)(2010-11#1)
the grade III##4##3##(2008-12#1)(2013-8#3)
the grade of##4##3##(1990-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
the grade##10##2##(1990-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#5)
the grades##2##2##(2007-12#1)(2008-10#1)
the gradient elution mode with##2##5##(2008-10#2)
the gradient elution##4##3##(2008-10#2)(2011-1#2)
the gradient of##2##3##(2008-2#1)(2008-8#1)
the gradient##22##2##(2007-11#2)(2008-10#10)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2010-8#1)(2011-1#2)
the gradients##4##2##(1995-6#1)(2007-12#1)(2008-3#1)(2008-8#1)
the gradual##11##2##(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2011-2#1)
the graduate students##2##3##(2008-9#1)(2011-2#1)
the graduate##8##2##(1992-2#1)(1993-2#1)(1995-1#1)(2008-11#2)(2008-9#2)(2011-2#1)
the graduates' PLC##2##3##(2007-11#2)
the graft and the##2##4##(2007-11#1)(2007-8#1)
the graft in##3##3##(2007-11#1)(2011-2#2)
the graft with##2##3##(1996-2#1)(2009-10#1)
the graft##22##2##(1996-2#2)(1996-3#1)(2006-6#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-10#1)(2010-3#1)(2011-2#2)(2011-3#2)(2012-12#2)(2013-1#2)
the grafted polymer##3##3##(2008-10#2)(2009-10#1)
the grafted##6##2##(1997-5#1)(2008-10#3)(2009-10#1)(2010-4#1)
the grafting##2##2##(2008-10#1)(2008-5#1)
the grafts##9##2##(1997-8#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
the grain yield##2##3##(2008-10#1)(2008-12#1)
the grain##13##2##(1990-6#1)(1991-12#1)(1995-2#1)(2008-10#5)(2008-12#1)(2008-5#2)(2009-7#1)(2012-1#1)
the grammatical##3##2##(1991-2#2)(2008-4#1)
the grants##2##2##(1996-3#2)
the granular##5##2##(1992-11#1)(1993-12#1)(1995-3#1)(2008-3#1)(2013-8#1)
the granule cell layer##4##4##(1993-9#1)(1995-12#1)(2009-8#1)(2013-8#1)
the granule cell##6##3##(1993-9#1)(1994-8#2)(1995-12#1)(2009-8#1)(2013-8#1)
the granule##12##2##(1992-6#1)(1993-9#1)(1994-8#2)(1995-12#1)(1995-8#3)(2008-6#1)(2009-8#2)(2013-8#1)
the granules##6##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)
the granulin##2##2##(1990-12#2)
the granulocyte##3##2##(1994-11#1)(1994-3#1)(2012-2#1)
the granulosa##9##2##(2008-12#4)(2008-5#3)(2008-8#1)(2008-9#1)
the grape powdery mildew pathogen##2##5##(2008-10#2)
the grape##3##2##(2008-10#3)
the grapevine##2##2##(2008-10#2)
the graph##3##2##(2008-10#1)(2012-2#2)
the graphene sheet##3##3##(2009-11#3)
the graphical##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
the graphite furnace##6##3##(2008-10#6)
the graphite tube and the##2##5##(2008-10#2)
the graphite tube and##3##4##(2008-10#3)
the graphite tube##16##3##(2008-10#16)
the graphite##30##2##(2008-10#30)
the graphs##2##2##(1990-11#1)(1993-2#1)
the grass##5##2##(1992-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
the grasslands##2##2##(2008-5#1)(2013-7#1)
the grating and##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
the grating are##3##3##(2008-3#3)
the grating diffraction##3##3##(2008-2#2)(2008-3#1)
the grating efficiencies##2##3##(2008-2#1)(2008-3#1)
the grating efficiency##3##3##(2008-2#1)(2008-3#2)
the grating formation##2##3##(2007-11#1)(2008-2#1)
the grating grooves##2##3##(2007-12#1)(2008-2#1)
the grating is##7##3##(1995-11#1)(2008-2#2)(2008-3#4)
the grating or##2##3##(2007-12#1)(2008-3#1)
the grating parameters##3##3##(2007-12#1)(2008-3#2)
the grating period##3##3##(2008-3#3)
the grating scale monitor##2##4##(2008-3#2)
the grating separation##3##3##(2008-3#3)
the grating surface##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the grating vector direction##2##4##(2008-2#2)
the grating##130##2##(1995-11#1)(2007-11#17)(2007-12#13)(2008-2#20)(2008-3#79)
the grating's##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
the gratings can be##2##4##(2007-11#1)(2008-3#1)
the gratings to##2##3##(2007-12#1)(2008-2#1)
the gratings##20##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#10)
the gravitational##3##2##(2006-10#2)(2008-5#1)
the gravitational-wave##2##2##(2008-3#2)
the gravity vector##2##3##(2008-11#1)(2009-8#1)
the gravity##6##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-8#1)
the gray##7##2##(1995-6#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)
the gray-scale fabrication of diffractive optical elements##2##7##(2008-3#2)
the gray-scale##4##2##(2007-11#1)(2008-3#3)
the grazing intensity##3##3##(2008-12#3)
the grazing season##8##3##(1991-8#1)(1996-12#2)(2010-2#3)(2012-2#2)
the grazing##15##2##(1991-8#1)(1996-12#4)(2008-12#3)(2008-2#1)(2008-3#1)(2010-2#3)(2012-2#2)
the great amount of##4##4##(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
the great diversity##2##3##(1994-11#1)(2008-5#1)
the great majority of##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
the great majority##6##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)
the great number of##4##4##(1994-6#1)(2008-10#1)(2008-2#1)(2012-12#1)
the great potential of this##2##5##(2008-10#1)(2008-5#1)
the great potential of##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the great sensitivity of##2##4##(1990-12#1)(2008-3#1)
the great tit##2##3##(2008-9#2)
the great variation##2##3##(1997-3#1)(2008-5#1)
the great##58##2##(1990-11#1)(1990-12#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-8#1)(2007-4#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-2#1)(2013-8#2)
the greater dependence##2##3##(1992-8#1)(1997-7#1)
the greater distance##2##3##(1994-5#1)(2012-1#1)
the greater number of##2##4##(2007-6#1)(2008-10#1)
the greater part of##2##4##(2007-12#1)(2008-10#1)
the greater than additive##2##4##(2008-10#2)
the greater the##8##3##(1993-11#1)(1993-12#1)(2007-10#1)(2008-3#1)(2010-10#2)(2010-4#1)(2013-8#1)
the greater##52##2##(1990-12#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
the greatest activity##2##3##(2007-11#1)(2008-10#1)
the greatest amount of##3##4##(1995-12#1)(2007-6#1)(2008-10#1)
the greatest barrier to##2##4##(2008-11#1)(2011-2#1)
the greatest challenge##2##3##(1994-2#1)(2008-10#1)
the greatest contribution to##2##4##(1994-2#1)(2008-10#1)
the greatest decrease##2##3##(2007-10#1)(2008-10#1)
the greatest degree of##2##4##(2007-6#1)(2008-4#1)
the greatest effect##4##3##(2007-2#1)(2008-10#3)
the greatest genetic##2##3##(2008-10#2)
the greatest impact on##2##4##(2008-10#1)(2008-8#1)
the greatest impact##5##3##(2008-10#1)(2008-8#2)(2009-5#1)(2011-2#1)
the greatest improvement in##2##4##(2009-8#1)(2011-2#1)
the greatest increase in##2##4##(2008-10#2)
the greatest likelihood of##3##4##(1992-12#1)(1997-3#1)(2008-8#1)
the greatest number of##8##4##(1990-12#1)(1992-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)
the greatest opportunity for##2##4##(1994-2#1)(2008-4#1)
the greatest potential##2##3##(1993-11#1)(1996-3#1)
the greatest proportion of the##2##5##(2008-2#1)(2008-7#1)
the greatest proportion of##4##4##(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
the greatest reduction in##3##4##(2008-10#1)(2008-3#2)
the greatest reduction##4##3##(1995-11#1)(2008-10#1)(2008-3#2)
the greatest risk of##2##4##(1992-6#1)(2013-8#1)
the greatest risk##5##3##(1992-6#1)(1997-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
the greatest sensitivity##2##3##(2008-10#2)
the greatest##142##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#2)
the green alga##3##3##(1991-12#1)(1994-11#1)(2012-3#1)
the green fluorescence was##2##4##(2008-9#2)
the green fluorescent protein (GFP) gene##2##6##(2008-8#1)(2008-9#1)
the green fluorescent protein (GFP)##6##5##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)
the green fluorescent protein##10##4##(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)
the green fluorescent##11##3##(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)
the green light##2##3##(2008-2#1)(2008-7#1)
the green##39##2##(1991-12#1)(1994-11#1)(1995-5#1)(1996-2#2)(2007-12#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)
the green-light##2##2##(2007-12#2)
the green-yellow##2##2##(2008-2#1)(2011-2#1)
the greenhouse effect##6##3##(1991-6#4)(1992-3#2)
the greenhouse or##3##3##(2008-10#2)(2011-2#1)
the greenhouse##73##2##(1991-6#4)(1992-3#3)(2008-10#63)(2011-2#3)
the grey phenotype##2##3##(2008-8#2)
the grey##6##2##(1995-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2013-1#1)
the grid##2##2##(1996-4#1)(2009-11#1)
the grinding of##2##3##(1990-5#1)(2008-10#1)
the grinding##3##2##(1990-5#1)(2008-10#2)
the grip and hold strength##2##5##(2008-6#2)
the gripping##2##2##(2008-10#2)
the groove##10##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2008-8#1)
the grooves##7##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the gross tumour volume (GTV)##2##5##(2008-2#2)
the gross##15##2##(1993-1#1)(1993-3#1)(1995-5#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)
the ground and##3##3##(2008-10#3)
the ground squirrel jejunum##2##4##(1990-5#2)
the ground squirrel##7##3##(1990-5#2)(2008-8#5)
the ground state##11##3##(1991-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-2#3)(2013-1#1)
the ground states of##2##4##(2008-3#2)
the ground to the##2##4##(2008-10#1)(2008-3#1)
the ground to##3##3##(2008-10#1)(2008-3#2)
the ground##59##2##(1990-5#2)(1990-8#1)(1991-5#1)(1995-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#15)(2008-5#1)(2008-6#1)(2008-8#7)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2012-12#1)(2012-2#4)(2013-1#1)
the ground-based##4##2##(2008-2#2)(2008-3#2)
the ground-state##2##2##(2008-3#1)(2012-2#1)
the grounded theory##2##3##(2008-11#1)(2008-12#1)
the grounds##7##2##(1991-12#1)(1991-7#1)(1992-3#1)(1995-12#1)(1997-4#1)(2011-1#1)(2011-2#1)
the group &quot##3##3##(2009-10#3)
the group I##2##3##(2008-10#1)(2011-2#1)
the group and##6##3##(1996-6#1)(2008-10#3)(2008-11#1)(2008-9#1)
the group as a whole##2##5##(1996-1#1)(2008-7#1)
the group differences##2##3##(1992-6#1)(1994-8#1)
the group level##2##3##(2013-1#1)(2013-8#1)
the group mean##2##3##(2011-2#2)
the group of patients treated with##2##6##(1990-3#1)(2007-11#1)
the group of patients who##4##5##(1992-11#1)(2011-2#2)(2012-3#1)
the group of patients with##5##5##(1990-10#1)(1992-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
the group of patients##15##4##(1990-10#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-8#1)(2007-11#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)
the group of##57##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-3#1)(2007-11#4)(2007-8#2)(2008-10#7)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-3#3)(2013-1#3)
the group practice model##2##4##(1991-1#2)
the group practice##5##3##(1991-1#2)(1994-3#2)(1995-1#1)
the group pretreated with##2##4##(1992-8#1)(1995-12#1)
the group receiving##2##3##(2008-10#2)
the group refractive index##3##4##(2008-2#2)(2008-3#1)
the group size is##3##4##(2008-8#2)(2012-3#1)
the group size##5##3##(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
the group submitted to neoadjuvant##2##5##(2013-8#2)
the group submitted to##3##4##(2013-8#3)
the group that received##2##4##(1993-1#1)(2008-3#1)
the group that##5##3##(1993-1#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-1#1)
the group to##2##3##(2008-10#1)(2008-11#1)
the group treated with##9##4##(1990-6#1)(1991-2#1)(1993-2#1)(1993-9#1)(1995-12#1)(2007-11#1)(2008-8#2)(2013-1#1)
the group treated##11##3##(1990-6#1)(1991-2#1)(1993-2#1)(1993-9#1)(1995-12#1)(2007-11#2)(2008-8#2)(2011-2#1)(2013-1#1)
the group tried to turn several local health clubs into sports medicine clinics##2##13##(1994-3#2)
the group velocity of light in##3##6##(2007-12#1)(2008-2#2)
the group velocity##6##3##(2007-12#2)(2008-2#4)
the group was##2##3##(2008-11#1)(2008-7#1)
the group which started with##2##5##(1991-2#2)
the group who##4##3##(1991-6#1)(1997-3#1)(2008-5#2)
the group with the##2##4##(1995-2#1)(2012-12#1)
the group with##24##3##(1990-10#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1994-12#1)(1995-2#2)(1995-8#2)(1997-5#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
the group without##7##3##(1992-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(2007-8#1)(2008-3#1)
the group younger##2##3##(1991-9#1)(2011-2#1)
the group##227##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#4)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-6#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#9)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#4)(2008-10#20)(2008-11#6)(2008-12#4)(2008-2#8)(2008-3#6)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#10)(2009-10#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#4)(2010-6#2)(2011-1#4)(2011-2#17)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#11)(2013-8#5)
the group's##8##2##(1993-1#1)(1993-3#2)(1994-1#1)(1996-3#1)(1997-3#1)(2010-6#1)(2012-12#1)
the group-delay##2##2##(2007-11#2)
the group-velocity dispersion##2##3##(2007-11#2)
the group-velocity##4##2##(2007-11#4)
the grouper##3##2##(2010-5#3)
the grouping of##2##3##(2008-10#2)
the grouping time##2##3##(1997-3#2)
the grouping##4##2##(1997-3#2)(2008-10#2)
the groups as##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
the groups did not##2##4##(1991-2#1)(1995-11#1)
the groups in##3##3##(1990-3#1)(1990-5#1)(2008-7#1)
the groups involved##2##3##(1990-8#1)(1994-3#1)
the groups of##8##3##(1991-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-12#1)
the groups were##3##3##(2008-11#1)(2008-5#1)(2010-1#1)
the groups with##6##3##(1995-4#1)(1995-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)
the groups##79##2##(1990-3#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-4#1)(1995-8#2)(1996-12#1)(1996-7#1)(1997-7#3)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
the grove##5##2##(2008-10#5)
the grower##2##2##(2008-10#2)
the growing and##2##3##(1996-2#1)(2010-2#1)
the growing cells##3##3##(1991-2#1)(1995-11#1)(1995-2#1)
the growing interest in##4##4##(2008-10#1)(2008-12#1)(2009-7#1)(2010-1#1)
the growing interest##5##3##(2008-10#1)(2008-12#1)(2009-7#1)(2010-1#1)(2013-8#1)
the growing need for##2##4##(1991-10#1)(2013-8#1)
the growing number of##7##4##(1991-1#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-3#1)
the growing pressure on##2##4##(1997-1#1)(2008-12#1)
the growing recognition of the##2##5##(1993-1#1)(2011-1#1)
the growing region##2##3##(2008-10#1)(2008-7#1)
the growing season in the##2##5##(2008-10#2)
the growing season in##3##4##(2008-10#3)
the growing season may##2##4##(2008-10#2)
the growing season##38##3##(2008-10#29)(2009-2#7)(2010-8#1)(2012-5#1)
the growing use of##3##4##(1996-2#1)(2008-3#1)(2009-11#1)
the growing##102##2##(1991-1#1)(1991-10#1)(1991-2#1)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#1)(1994-1#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#2)(1997-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#36)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#8)(2009-7#1)(2009-9#1)(2010-1#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-5#2)(2013-1#2)(2013-8#3)
the growth and development of##10##5##(1994-1#1)(1996-3#1)(2007-12#1)(2008-12#3)(2008-4#3)(2008-8#1)
the growth and differentiation of##5##5##(1991-6#1)(1995-5#1)(2008-4#1)(2008-5#1)(2010-6#1)
the growth and metabolism of##3##5##(1993-5#1)(2008-11#2)
the growth and##42##3##(1991-6#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#1)(2010-8#1)(2012-8#1)(2013-1#2)(2013-8#2)
the growth arrest##2##3##(1992-2#1)(2008-11#1)
the growth behaviour of##2##4##(2008-11#2)
the growth characteristics of##3##4##(1990-3#1)(2008-11#2)
the growth characteristics##4##3##(1990-3#1)(2008-11#3)
the growth conditions##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
the growth cycle##3##3##(1991-9#1)(2008-11#1)(2008-5#1)
the growth factor##12##3##(1990-8#1)(1992-10#1)(1993-3#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)
the growth hormone receptor##3##4##(1990-12#1)(2008-1#1)(2008-4#1)
the growth hormone##7##3##(1990-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
the growth in hospital##2##4##(1992-1#1)(1992-2#1)
the growth in##10##3##(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1995-6#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-4#1)
the growth inhibition of##2##4##(1997-4#1)(2008-5#1)
the growth inhibition##5##3##(1991-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-5#1)
the growth inhibitory activity of N-Ac-4-S-CAP in##2##7##(1992-3#2)
the growth inhibitory effect of##2##5##(1995-2#1)(2008-11#1)
the growth inhibitory effects of##3##5##(1991-12#1)(1997-3#1)(2008-11#1)
the growth inhibitory##10##3##(1991-12#1)(1992-3#3)(1995-2#2)(1996-2#1)(1997-3#1)(2008-11#2)
the growth kinetics##3##3##(2008-11#2)(2008-7#1)
the growth medium and##2##4##(2008-10#2)
the growth medium##19##3##(1990-6#1)(1991-10#1)(1991-11#2)(1994-12#2)(1994-2#1)(1996-6#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-6#1)
the growth of A##4##4##(2008-10#3)(2010-8#1)
the growth of B##3##4##(2008-10#1)(2011-2#2)
the growth of C##2##4##(2008-5#1)(2013-1#1)
the growth of E##2##4##(2008-10#1)(2008-7#1)
the growth of HeLa cells and##2##6##(1997-1#1)(2008-8#1)
the growth of HeLa##3##4##(1992-11#1)(1997-1#1)(2008-8#1)
the growth of M##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
the growth of P##2##4##(2008-10#2)
the growth of R##3##4##(2008-10#3)
the growth of SC115##2##4##(1990-11#2)
the growth of a##4##4##(2008-10#1)(2008-11#2)(2008-2#1)
the growth of an##2##4##(2008-10#1)(2008-9#1)
the growth of bacteria##2##4##(2008-5#1)(2008-7#1)
the growth of both##5##4##(1997-1#1)(2008-10#3)(2008-5#1)
the growth of children##2##4##(2007-11#1)(2008-7#1)
the growth of cultured cells##2##5##(1994-3#1)(2008-11#1)
the growth of health care expenditures##2##6##(1992-1#1)(1995-3#1)
the growth of health care##3##5##(1992-1#1)(1995-1#1)(1995-3#1)
the growth of health##4##4##(1991-2#1)(1992-1#1)(1995-1#1)(1995-3#1)
the growth of human hepatoma##3##5##(2008-11#1)(2008-8#2)
the growth of human##9##4##(1990-7#1)(1993-9#1)(1994-8#1)(2008-11#3)(2008-8#2)(2010-6#1)
the growth of lactic acid bacteria##4##6##(2008-11#4)
the growth of managed care##3##5##(1995-12#1)(1996-2#1)(1997-3#1)
the growth of managed##4##4##(1991-3#1)(1995-12#1)(1996-2#1)(1997-3#1)
the growth of others##2##4##(2008-10#1)(2008-9#1)
the growth of public expenditures##3##5##(1994-2#3)
the growth of the cell##2##5##(1990-5#1)(2008-8#1)
the growth of the fungus##2##5##(2008-10#1)(2009-2#1)
the growth of the human##2##5##(1992-8#1)(1995-8#1)
the growth of the##22##4##(1990-5#1)(1992-8#3)(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#2)(2009-2#1)
the growth of these##4##4##(1993-9#2)(1996-3#1)(2008-10#1)
the growth of tumor cells##2##5##(2008-4#1)(2012-3#1)
the growth of tumors##2##4##(2012-2#1)(2013-8#1)
the growth of vascular##2##4##(1993-3#1)(1994-11#1)
the growth of##209##3##(1990-11#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#2)(1993-3#2)(1993-5#1)(1993-9#3)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-1#3)(1997-3#1)(1997-7#1)(2007-11#3)(2008-10#46)(2008-11#21)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#11)(2008-9#7)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-6#2)(2010-8#5)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#5)(2013-8#4)
the growth or##2##3##(1992-3#1)(2008-9#1)
the growth patterns##2##3##(1992-8#1)(2010-12#1)
the growth performance##7##3##(2010-2#4)(2012-2#3)
the growth period##4##3##(2007-8#2)(2008-11#1)(2010-11#1)
the growth phase of##2##4##(2008-11#2)
the growth phase##6##3##(2008-11#5)(2009-6#1)
the growth plate was##3##4##(2007-11#2)(2012-1#1)
the growth plate##8##3##(2007-11#6)(2012-1#2)
the growth potential##3##3##(1990-3#2)(1991-12#1)
the growth rate and##4##4##(1996-3#1)(2008-11#2)(2008-3#1)
the growth rate of the##4##5##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
the growth rate of##13##4##(1992-2#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-9#1)(2012-2#1)
the growth rate##25##3##(1992-2#1)(1993-9#1)(1996-3#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#3)(2009-9#1)(2012-2#1)
the growth rates of the##2##5##(2008-10#1)(2008-5#1)
the growth rates of##5##4##(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
the growth response##2##3##(1994-12#1)(2008-1#1)
the growth substrate##4##3##(1994-12#1)(2007-11#1)(2008-7#2)
the growth surface##2##3##(2008-11#1)(2009-11#1)
the growth temperature##2##3##(2008-10#1)(2008-7#1)
the growth##466##2##(1990-11#4)(1990-12#2)(1990-3#5)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#5)(1992-4#1)(1992-8#4)(1992-9#3)(1993-12#1)(1993-3#3)(1993-5#2)(1993-9#7)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-6#2)(1997-1#4)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#3)(2007-11#14)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#66)(2008-11#66)(2008-12#12)(2008-2#3)(2008-3#4)(2008-4#11)(2008-5#17)(2008-6#6)(2008-7#18)(2008-8#16)(2008-9#14)(2009-10#3)(2009-11#2)(2009-2#1)(2009-4#2)(2009-6#7)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#6)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#3)(2012-8#2)(2013-1#10)(2013-8#7)
the growth-phase-dependent##2##2##(2009-6#2)
the growth-stimulating effect##2##3##(1995-8#2)
the growth-stimulating##3##2##(1995-8#3)
the gsa-1 gene encoding a G protein##2##7##(1997-7#2)
the gsa-1 gene##3##3##(1997-7#3)
the guanidinium##2##2##(1995-5#1)(2008-2#1)
the guanine nucleotide##2##3##(1991-12#1)(1992-3#1)
the guanine##7##2##(1991-12#1)(1991-5#1)(1992-3#1)(1994-5#1)(2008-10#3)
the guard##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
the guardian of the genome##2##5##(2008-5#1)(2011-2#1)
the guardian##4##2##(1990-11#1)(1992-12#1)(2008-5#1)(2011-2#1)
the guards##4##2##(1995-6#4)
the guest molecules##3##3##(2008-10#2)(2008-2#1)
the guest##9##2##(1997-7#1)(2008-10#5)(2008-2#1)(2013-1#1)(2013-8#1)
the guidance of a##3##4##(2008-11#1)(2008-3#2)
the guidance of the##4##4##(2008-1#1)(2008-3#1)(2009-3#1)(2009-8#1)
the guidance of##13##3##(1993-1#1)(1993-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2009-3#1)(2009-8#1)(2011-2#3)
the guide##9##2##(1996-2#3)(1996-9#1)(2007-12#1)(2008-11#1)(2008-3#3)
the guided light##3##3##(2008-10#3)
the guided mode##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
the guided modes##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
the guided wave##3##3##(2007-11#1)(2008-3#2)
the guided##18##2##(1990-9#1)(2007-11#4)(2007-12#3)(2008-10#4)(2008-3#5)(2013-1#1)
the guideline##10##2##(1995-6#2)(2008-10#4)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
the guidelines and##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
the guidelines for the##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
the guidelines for##7##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
the guidelines of the##2##4##(1991-4#1)(1997-2#1)
the guidelines of##4##3##(1991-3#1)(1991-4#1)(1993-2#1)(1997-2#1)
the guidelines were##2##3##(1990-6#1)(2013-1#1)
the guidelines##35##2##(1990-6#4)(1991-3#1)(1991-4#1)(1992-8#1)(1993-2#1)(1994-2#3)(1996-9#2)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-6#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the guiding principles##2##3##(1995-3#1)(2011-1#1)
the guiding region##2##3##(2007-12#1)(2008-2#1)
the guiding##10##2##(1994-12#1)(1995-3#1)(2007-11#3)(2007-12#3)(2008-2#1)(2011-1#1)
the guinea pig ileum##6##4##(1992-6#1)(1994-11#1)(1995-12#2)(2008-7#2)
the guinea pig##17##3##(1990-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-12#2)(1997-3#3)(2008-10#2)(2008-7#2)
the guinea##18##2##(1990-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-12#2)(1997-3#3)(2008-10#2)(2008-5#1)(2008-7#2)
the guinea-pig ileum##2##3##(1990-5#1)(1997-7#1)
the guinea-pig##7##2##(1990-5#2)(1994-6#1)(1997-4#2)(1997-7#2)
the gulf between##2##3##(2008-5#1)(2010-4#1)
the gum##2##2##(2008-10#1)(2008-5#1)
the gumfoot glue##2##3##(2012-2#2)
the guppy##3##2##(1991-9#1)(2008-8#2)
the gustatory and somatosensory##2##4##(1993-12#2)
the gustatory##3##2##(1993-12#2)(1996-5#1)
the gut lumen##2##3##(2007-12#1)(2008-10#1)
the gut mucosa##3##3##(1995-12#1)(1995-6#1)(2007-12#1)
the gut to##2##3##(2007-12#1)(2008-10#1)
the gut tube on day##3##5##(1993-6#3)
the gut##42##2##(1990-5#1)(1992-6#2)(1993-6#3)(1993-8#1)(1995-12#1)(1995-6#3)(2007-12#5)(2008-10#10)(2008-5#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)
the gynecologic##3##2##(1990-2#1)(1991-3#1)(1993-12#1)
the gynecological##2##2##(1991-2#1)(1996-3#1)
the gyro is##2##3##(2007-12#2)
the gyro##4##2##(2007-12#4)
the gyrotron output##3##3##(2007-9#1)(2011-1#2)
the gyrotron##5##2##(2007-9#3)(2011-1#2)
the h-lamp-2##3##2##(1994-11#3)
the hAT2R mRNA was##2##4##(1994-11#2)
the hAT2R##3##2##(1994-11#3)
the hESC microenvironment##2##3##(2009-3#2)
the hEp##3##2##(1993-12#1)(1993-6#2)
the hIL-6 productivity rate##2##4##(2008-11#2)
the hIL-6##3##2##(2008-11#3)
the hP2Y(1) receptor##5##3##(2008-4#5)
the hP2Y(1)##6##2##(2008-4#6)
the hTERT gene##2##3##(2008-11#2)
the hTERT promoter##2##3##(2008-11#2)
the hTERT##7##2##(2008-11#7)
the habit of smoking##2##4##(1991-9#2)
the habit of##5##3##(1991-9#2)(1995-6#1)(2009-4#1)(2010-12#1)
the habit##7##2##(1991-9#3)(1993-6#1)(1995-6#1)(2009-4#1)(2010-12#1)
the habitat in##2##3##(2008-10#1)(2008-8#1)
the habitat patches##2##3##(2008-8#2)
the habitat##14##2##(2008-10#2)(2008-5#3)(2008-8#5)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
the habitats##4##2##(2007-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
the haemagglutinins##2##2##(2008-5#2)
the haematological parameters##2##3##(2010-4#1)(2013-8#1)
the haematological##3##2##(2010-4#1)(2011-1#1)(2013-8#1)
the haematoma##5##2##(1997-3#1)(2008-7#4)
the haematopoietic##2##2##(2013-8#2)
the haemodynamic##3##2##(1993-10#1)(2011-2#1)(2012-2#1)
the haemoglobin##2##2##(1994-6#1)(2007-11#1)
the haemolymph and##2##3##(1991-5#1)(1995-12#1)
the haemolymph##3##2##(1991-5#2)(1995-12#1)
the hagfish##2##2##(2008-5#2)
the hair and##5##3##(2007-12#1)(2008-5#4)
the hair cycle##3##3##(2008-5#3)
the hair eclipse phenomenon##3##4##(2008-5#3)
the hair fiber##2##3##(2008-5#2)
the hair follicle##5##3##(2008-5#3)(2008-8#1)(2012-2#1)
the hair samples##2##3##(2008-10#1)(2008-5#1)
the hair shaft##2##3##(2008-5#2)
the hair structure##2##3##(2008-5#2)
the hair types##2##3##(2008-5#2)
the hair##57##2##(1993-9#1)(2007-12#1)(2008-10#1)(2008-5#49)(2008-8#2)(2010-6#1)(2012-2#1)(2013-7#1)
the hairy root culture##2##4##(1994-11#1)(2008-10#1)
the hairy##5##2##(1990-7#1)(1990-9#1)(1994-11#1)(2008-10#1)(2008-7#1)
the half neutralization potential by about##2##6##(2008-10#2)
the half of##2##3##(2007-8#1)(2008-11#1)
the half##11##2##(1996-1#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-8#1)
the half-bandgap##2##2##(2007-12#1)(2008-2#1)
the half-coupler##2##2##(2008-2#1)(2008-3#1)
the half-life of the viable cell##2##6##(2008-11#2)
the half-life of the##3##4##(2008-11#2)(2008-8#1)
the half-life of##4##3##(2008-10#1)(2008-11#2)(2008-8#1)
the half-life##5##2##(1995-6#1)(2008-10#1)(2008-11#2)(2008-8#1)
the half-visor group##2##3##(2010-1#2)
the half-visor##4##2##(2010-1#4)
the half-wave##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the halftone##2##2##(2008-3#2)
the halide##2##2##(2008-10#1)(2011-1#1)
the hallmark of the##2##4##(2008-11#1)(2011-2#1)
the hallmark of##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
the hallmark##4##2##(2008-11#1)(2011-2#1)(2012-2#2)
the hallmarks of a##2##4##(1991-6#1)(2009-5#1)
the hallmarks of##5##3##(1991-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
the hallmarks##6##2##(1991-6#1)(1995-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
the hallux valgus deformity##2##4##(2009-10#1)(2012-2#1)
the hallux##3##2##(2009-10#2)(2012-2#1)
the halo##3##2##(2008-2#2)(2008-3#1)
the halogen##2##2##(2008-12#1)(2008-9#1)
the hamster model##2##3##(2008-9#2)
the hamster##14##2##(1990-7#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#2)(1996-9#1)(2008-4#1)(2008-9#3)
the hamstring##2##2##(2007-11#2)
the hand and wrist##2##4##(2012-2#2)
the hand and##10##3##(2007-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
the hand with a##2##4##(1994-11#1)(2011-2#1)
the hand##41##2##(1992-6#1)(1994-11#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#6)(2008-7#2)(2008-9#9)(2009-3#2)(2010-9#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-8#1)
the handheld##2##2##(2009-10#1)(2011-7#1)
the handling of##7##3##(1992-11#1)(2006-10#1)(2008-10#3)(2008-4#1)(2010-8#1)
the hands of the##4##4##(1996-11#1)(1997-5#1)(2008-10#2)
the hands of##10##3##(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
the hands##23##2##(1994-11#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
the hanging mercury drop electrode (HMDE)##5##6##(2008-10#5)
the hanging mercury drop electrode was##3##6##(2008-10#3)
the hanging mercury drop electrode##14##5##(2008-10#14)
the hanging##16##2##(2008-10#15)(2008-11#1)
the haploid genome##2##3##(1990-12#1)(1996-12#1)
the haplotypes##5##2##(1997-5#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
the hapten##5##2##(1990-12#1)(1993-8#1)(1994-8#2)(2008-10#1)
the hard##12##2##(1991-11#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#1)
the hardening##3##2##(2008-10#3)
the hardest##3##2##(1992-5#1)(2007-8#1)(2010-9#1)
the hardness##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
the harmful effects of##2##4##(1991-6#1)(2007-12#1)
the harmful effects##3##3##(1991-6#2)(2007-12#1)
the harmful##6##2##(1991-6#2)(2007-12#1)(2008-1#1)(2008-5#1)(2011-2#1)
the harmonic##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
the harmonics in the##2##4##(2008-3#2)
the harmonics in##3##3##(2008-3#3)
the harmonics##4##2##(2008-3#4)
the harmonious##2##2##(2008-10#1)(2008-5#1)
the harmonization##2##2##(2008-10#1)(2010-8#1)
the harmony##2##2##(2012-12#2)
the harvest of##2##3##(2008-9#1)(2011-1#1)
the harvest##3##2##(2008-9#1)(2011-1#1)(2012-2#1)
the harvested##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
the harvesting time##2##3##(2012-2#2)
the harvesting##7##2##(2008-4#2)(2008-8#2)(2012-12#1)(2012-2#2)
the hatched##3##2##(1992-6#1)(1997-3#1)(2008-5#1)
the hatchers##2##2##(1997-3#2)
the hatchery##4##2##(1997-3#4)
the hazard function##2##3##(2007-8#1)(2008-10#1)
the hazard##8##2##(1996-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
the hazards of##9##3##(1990-11#1)(1991-5#1)(1992-3#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
the hazards##12##2##(1990-11#1)(1991-5#1)(1992-3#1)(1995-9#1)(1996-12#1)(2008-11#3)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
the head and neck region##10##5##(1992-5#1)(1992-9#1)(1997-6#1)(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
the head and neck##28##4##(1990-6#2)(1992-5#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-8#2)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#3)(2013-1#3)(2013-8#4)
the head and the##2##4##(1995-12#1)(2009-6#1)
the head and trunk##2##4##(2007-12#1)(2010-8#1)
the head and##39##3##(1990-6#2)(1992-5#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#2)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#4)
the head by##2##3##(1990-5#1)(2007-12#1)
the head group##3##3##(1994-3#2)(2008-8#1)
the head of the Department of##4##6##(2008-10#4)
the head of the pancreas##3##5##(1990-9#1)(1991-3#1)(2013-1#1)
the head of the##15##4##(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#4)(2008-6#1)(2013-1#1)
the head of##19##3##(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(2007-12#2)(2008-10#6)(2008-6#1)(2012-3#1)(2013-1#1)
the head region##3##3##(1992-6#1)(2007-12#1)(2008-5#1)
the head to the##3##4##(2010-6#1)(2011-1#2)
the head were significantly##2##4##(1991-11#1)(1995-11#1)
the head were##3##3##(1991-11#1)(1995-11#1)(2008-5#1)
the head##110##2##(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-3#2)(1994-6#3)(1994-8#1)(1995-11#5)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#15)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
the head-neck junction##3##3##(2011-2#1)(2013-1#2)
the headquarters##2##2##(2008-10#1)(2008-11#1)
the headspace above the##2##4##(2008-10#2)
the headspace and##2##3##(2008-10#2)
the headspace of##4##3##(2008-10#3)(2008-11#1)
the headspace solvent microextraction##2##4##(2008-10#2)
the headspace##17##2##(2008-10#15)(2008-11#1)(2011-2#1)
the healer##2##2##(1997-6#1)(2008-4#1)
the healing of##5##3##(2007-11#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)
the healing process##5##3##(1996-12#1)(1996-4#1)(2008-5#1)(2008-9#1)(2009-5#1)
the healing##19##2##(1996-12#1)(1996-4#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
the health and well-being of##2##5##(2010-7#1)(2010-9#1)
the health and##17##3##(1991-3#1)(1992-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2010-9#2)(2013-8#1)
the health authorities of the##2##5##(1990-6#1)(2012-12#1)
the health authorities##5##3##(1990-6#1)(1994-3#1)(1994-6#1)(1995-6#1)(2012-12#1)
the health care attorney##2##4##(1992-2#2)
the health care community##3##4##(1992-12#1)(1995-12#1)(1996-12#1)
the health care context##3##4##(1997-3#2)(2008-11#1)
the health care crisis##2##4##(1991-1#1)(1997-3#1)
the health care delivery system##7##5##(1991-1#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2011-1#1)
the health care enterprise##2##4##(1994-12#1)(1996-3#1)
the health care environment##7##4##(1991-3#1)(1993-3#2)(1995-1#4)
the health care field has##2##5##(1993-12#2)
the health care field##8##4##(1993-12#2)(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
the health care financing##2##4##(1992-3#1)(1993-2#1)
the health care industry##22##4##(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#5)(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#2)(1997-3#3)(2008-11#3)
the health care management##3##4##(1994-3#2)(2008-11#1)
the health care needs##3##4##(1994-2#1)(1994-3#1)(1995-12#1)
the health care organization##3##4##(1993-2#1)(1994-12#1)(1994-3#1)
the health care provider##4##4##(1992-2#1)(2008-7#1)(2010-1#1)(2013-1#1)
the health care quality##2##4##(1994-2#1)(1996-2#1)
the health care reform##3##4##(1994-12#1)(1995-3#1)(1996-12#1)
the health care sector##7##4##(1992-1#1)(1992-2#1)(1994-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-7#1)
the health care system and##6##5##(1993-11#1)(1994-2#1)(1996-2#1)(1997-6#1)(2010-4#1)(2011-1#1)
the health care system should encourage##2##6##(1994-3#1)(1996-2#1)
the health care system to##3##5##(1994-2#1)(2008-8#1)(2013-1#1)
the health care system##47##4##(1991-1#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#2)(2007-2#1)(2008-1#2)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the health care systems##2##4##(1994-2#1)(2013-8#1)
the health care team##9##4##(1995-2#2)(1995-3#2)(2008-11#2)(2008-7#2)(2010-4#1)
the health care use##3##4##(1997-3#1)(2013-1#2)
the health care work force##2##5##(1994-2#2)
the health care##191##3##(1991-1#4)(1991-12#3)(1991-2#2)(1991-3#4)(1992-1#2)(1992-12#4)(1992-2#5)(1992-3#3)(1993-11#1)(1993-12#12)(1993-2#4)(1993-3#4)(1993-6#2)(1994-12#7)(1994-2#11)(1994-3#9)(1994-6#1)(1994-8#1)(1995-1#6)(1995-12#4)(1995-2#8)(1995-3#8)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#7)(1996-3#6)(1997-1#3)(1997-2#5)(1997-3#8)(1997-6#2)(1997-8#3)(2007-2#1)(2007-6#1)(2008-1#3)(2008-11#11)(2008-12#1)(2008-7#8)(2008-8#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
the health consequences of##2##4##(1994-6#1)(2008-10#1)
the health consequences##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
the health effects of##4##4##(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
the health effects##5##3##(1990-12#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
the health field##3##3##(1991-2#1)(1996-12#1)(2008-12#1)
the health information##2##3##(1996-1#1)(2007-12#1)
the health insurance industry##2##4##(1992-3#1)(1993-1#1)
the health insurance##7##3##(1992-3#1)(1993-1#1)(1995-12#1)(1997-2#1)(1997-8#1)(2008-7#1)(2013-1#1)
the health maintenance organization (HMO)##3##5##(1994-12#1)(1995-1#1)(1995-12#1)
the health needs of##4##4##(1993-6#1)(1994-3#1)(1997-3#1)(2010-3#1)
the health of children##3##4##(1995-1#1)(2008-11#2)
the health of individuals and##2##5##(1993-3#1)(2008-1#1)
the health of individuals##3##4##(1993-3#1)(2008-1#1)(2012-2#1)
the health of laboratory animals and to provide a stable environment for their maintenance is necessary to reduce unwanted variables or complicating factors in experimentation##2##25##(2008-4#2)
the health of populations##2##4##(1997-3#1)(2008-7#1)
the health of the nation##2##5##(1994-3#1)(2008-11#1)
the health of the population##2##5##(1990-6#1)(2012-12#1)
the health of the public##2##5##(1996-2#1)(2010-6#1)
the health of the##12##4##(1990-6#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-12#1)(2013-1#1)
the health of young##3##4##(1996-12#1)(2008-9#2)
the health of##46##3##(1990-6#1)(1991-1#1)(1991-6#1)(1992-5#1)(1993-3#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#3)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
the health plan##2##3##(1994-3#1)(1997-3#1)
the health policy process##2##4##(1995-2#1)(2008-7#1)
the health policy##3##3##(1995-2#1)(2008-7#1)(2012-2#1)
the health professionals##3##3##(1991-6#1)(2008-11#1)(2008-3#1)
the health professions##2##3##(1992-3#1)(2008-11#1)
the health promotion##2##3##(2008-1#1)(2008-12#1)
the health risks of##2##4##(2008-7#1)(2010-2#1)
the health risks##3##3##(2008-7#2)(2010-2#1)
the health science##2##3##(1994-12#1)(1996-1#1)
the health sciences##5##3##(1992-2#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-12#1)
the health sector is##2##4##(1997-2#1)(2011-2#1)
the health sector##11##3##(1992-1#1)(1994-2#1)(1995-3#1)(1997-2#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
the health service and##2##4##(1996-3#1)(1997-8#1)
the health service##5##3##(1995-6#2)(1996-3#1)(1997-8#1)(2008-12#1)
the health services and##2##4##(1990-8#1)(1996-11#1)
the health services in##2##4##(1990-11#1)(2011-2#1)
the health services industry##2##4##(1993-12#1)(2008-12#1)
the health services##20##3##(1990-11#1)(1990-8#3)(1991-6#3)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#1)(1996-11#2)(1997-3#2)(2008-1#2)(2008-12#1)(2008-7#1)(2011-2#1)
the health state scores##2##4##(2008-7#2)
the health status of the##6##5##(1990-6#2)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#1)
the health status of##14##4##(1990-6#2)(1994-9#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2010-10#1)
the health status##17##3##(1990-6#3)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2010-10#1)
the health system to##2##4##(2012-12#1)(2013-8#1)
the health system##19##3##(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-5#1)(2008-1#3)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the health systems##2##3##(1993-6#1)(2011-2#1)
the health##433##2##(1990-11#1)(1990-12#4)(1990-6#5)(1990-8#3)(1991-1#5)(1991-12#3)(1991-2#3)(1991-3#7)(1991-6#5)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#8)(1992-5#2)(1993-1#2)(1993-11#1)(1993-12#14)(1993-2#4)(1993-3#6)(1993-6#6)(1994-12#11)(1994-2#12)(1994-3#16)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#8)(1995-12#10)(1995-2#13)(1995-3#12)(1995-6#4)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#10)(1996-2#10)(1996-3#12)(1997-1#3)(1997-2#10)(1997-3#14)(1997-4#1)(1997-6#2)(1997-8#6)(2007-12#3)(2007-2#3)(2007-5#1)(2007-6#1)(2008-1#15)(2008-10#5)(2008-11#19)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#22)(2008-8#2)(2008-9#3)(2009-10#2)(2010-1#1)(2010-10#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#7)
the health-care system and##2##4##(2008-7#1)(2011-2#1)
the health-care system##3##3##(2008-7#2)(2011-2#1)
the health-care##6##2##(1993-3#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)
the health-related##7##2##(1996-1#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#1)(2013-7#1)
the healthcare and##2##3##(1996-3#1)(2008-10#1)
the healthcare community##4##3##(1995-2#2)(2011-2#2)
the healthcare industry##8##3##(1991-2#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-2#1)(2007-12#1)(2009-8#1)(2013-8#1)
the healthcare system##8##3##(1991-3#2)(2009-8#1)(2010-2#1)(2011-2#1)(2011-7#1)(2013-1#2)
the healthcare##48##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-6#3)(2009-8#2)(2010-2#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-1#1)(2013-1#2)(2013-8#1)
the healthy control group##3##4##(2008-7#2)(2011-1#1)
the healthy controls##3##3##(1997-8#1)(2010-12#1)(2011-2#1)
the healthy eating##2##3##(2007-3#1)(2009-6#1)
the healthy human##2##3##(2012-2#1)(2012-3#1)
the healthy population##4##3##(2008-1#3)(2013-7#1)
the healthy skin microflora##2##4##(2012-3#2)
the healthy##45##2##(1993-5#1)(1994-3#1)(1994-5#1)(1995-12#1)(1997-6#1)(1997-8#2)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#4)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#5)(2013-8#1)
the hearing loss##2##3##(2011-1#1)(2012-2#1)
the hearing##9##2##(1995-5#1)(2008-4#1)(2008-9#4)(2010-4#1)(2011-1#1)(2012-2#1)
the heart and the##2##4##(2008-5#1)(2013-1#1)
the heart and thoracic aorta##2##5##(2007-8#2)
the heart and##20##3##(1991-5#1)(1994-2#2)(1996-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#5)
the heart are##3##3##(1990-5#1)(1993-12#1)(2011-2#1)
the heart at##2##3##(2008-5#1)(2012-1#1)
the heart during##4##3##(1991-3#1)(2007-8#2)(2010-8#1)
the heart in the##2##4##(1993-12#1)(2013-1#1)
the heart in##4##3##(1993-12#1)(2007-8#1)(2013-1#2)
the heart is##4##3##(1990-3#1)(1995-3#1)(2007-7#1)(2008-7#1)
the heart meridian##2##3##(2008-9#2)
the heart of the##8##4##(1993-11#1)(1994-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
the heart of##20##3##(1993-11#1)(1994-3#1)(1996-12#1)(1996-3#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
the heart rate##8##3##(1990-5#1)(1990-9#1)(1991-6#2)(2008-6#1)(2012-1#1)(2012-2#2)
the heart to##3##3##(1994-11#1)(2008-7#1)(2013-1#1)
the heart valves##2##3##(2006-6#1)(2008-8#1)
the heart was##4##3##(1993-12#1)(2009-11#1)(2013-1#2)
the heart with##3##3##(1991-3#1)(2008-7#1)(2009-1#1)
the heart##168##2##(1990-12#2)(1990-3#1)(1990-5#4)(1990-9#1)(1991-11#2)(1991-3#3)(1991-5#1)(1991-6#3)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#3)(2006-10#1)(2006-6#1)(2007-10#2)(2007-12#3)(2007-4#1)(2007-7#3)(2007-8#12)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#8)(2011-1#4)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#18)(2013-7#1)
the heart's##3##2##(1991-3#1)(2011-1#2)
the heartbeat##4##2##(2008-5#1)(2009-9#1)(2010-5#1)(2010-8#1)
the hearts of##3##3##(1994-5#1)(1995-12#1)(2013-7#1)
the heat and##2##3##(1996-2#1)(2013-1#1)
the heat capacities of##2##4##(1997-2#2)
the heat equation##2##3##(2008-3#2)
the heat of solvation##2##4##(2008-10#2)
the heat of##4##3##(1990-8#1)(2008-10#3)
the heat shock protein 70 homolog##3##6##(2008-10#3)
the heat shock protein 70##4##5##(1995-11#1)(2008-10#3)
the heat shock protein##7##4##(1994-11#1)(1995-11#1)(1996-12#1)(2008-10#3)(2008-7#1)
the heat shock response##5##4##(1994-11#1)(1994-8#1)(2008-7#2)(2010-2#1)
the heat shock transcription factor##2##5##(1994-11#1)(1994-8#1)
the heat shock##18##3##(1992-12#1)(1993-8#1)(1994-11#3)(1994-8#3)(1995-11#1)(1995-2#1)(1996-12#1)(2008-10#3)(2008-7#3)(2010-2#1)
the heat transfer##3##3##(2008-10#1)(2009-11#1)(2011-2#1)
the heat treatment##2##3##(2008-10#1)(2008-11#1)
the heat wave and##2##4##(2011-1#2)
the heat wave##3##3##(2011-1#3)
the heat##58##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-8#2)(1994-11#3)(1994-8#3)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#3)(2009-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#2)
the heat-induced alterations##2##3##(1995-6#2)
the heat-shock protein##2##3##(1994-12#2)
the heat-treated##2##2##(2008-10#2)
the heated##6##2##(2007-12#2)(2008-10#2)(2008-2#1)(2010-9#1)
the heating and##2##3##(2007-11#1)(2008-10#1)
the heating temperature##2##3##(2008-2#1)(2009-11#1)
the heating##8##2##(2007-11#1)(2008-10#4)(2008-2#2)(2009-11#1)
the heaviest##3##2##(1992-10#1)(2008-10#1)(2012-3#1)
the heavy and light chains##2##5##(1994-11#1)(1994-5#1)
the heavy chain of##4##4##(1990-5#1)(1994-5#2)(1995-2#1)
the heavy chain##10##3##(1990-5#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-9#1)(1997-9#2)
the heavy isotope##2##3##(2008-4#1)(2012-3#1)
the heavy metal ions##2##4##(2008-10#2)
the heavy metal##5##3##(1997-4#1)(2008-10#3)(2013-8#1)
the heavy metals##4##3##(1994-3#1)(1995-3#1)(2008-10#1)(2008-12#1)
the heavy##31##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-4#1)(1997-9#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
the heel##2##2##(2009-10#1)(2010-3#1)
the height and##2##3##(2008-3#1)(2008-9#1)
the height of the##5##4##(2007-11#1)(2008-10#2)(2008-2#2)
the height of##7##3##(2007-11#1)(2008-10#2)(2008-2#2)(2009-5#1)(2013-8#1)
the height##19##2##(2007-11#1)(2008-10#3)(2008-2#5)(2008-3#6)(2008-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
the heightened##2##2##(1991-3#1)(2008-7#1)
the heights of these##2##4##(2008-10#1)(2008-3#1)
the helical stability of##2##4##(1993-11#1)(1995-2#1)
the helical structure of##2##4##(2008-10#1)(2013-1#1)
the helical##16##2##(1992-6#2)(1993-11#4)(1995-2#1)(1995-6#2)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#2)(2013-1#1)
the helicase##2##2##(1995-6#1)(2008-11#1)
the helix of the ear##2##5##(2010-8#2)
the helix##13##2##(1992-6#1)(1993-11#2)(1994-5#4)(1995-5#1)(2008-10#1)(2008-2#1)(2010-7#1)(2010-8#2)
the help of a##13##4##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#3)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
the help of the##5##4##(1993-1#1)(2007-4#1)(2008-1#1)(2008-3#1)(2011-1#1)
the help of##45##3##(1992-2#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-6#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#4)(2008-8#2)(2009-5#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the help##46##2##(1992-2#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-6#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#4)(2008-8#2)(2009-5#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the helper strategy##2##3##(2008-10#2)
the helper virus##4##3##(2008-10#4)
the helper##12##2##(1994-12#1)(2008-10#9)(2008-4#2)
the hemagglutination##2##2##(1991-9#1)(1992-9#1)
the hemagglutinin##2##2##(1994-8#2)
the hemangioma##2##2##(1990-9#1)(2011-2#1)
the hematocrit##2##2##(1997-6#1)(2008-1#1)
the hematological##2##2##(2008-1#1)(2008-7#1)
the hematoma was##3##3##(2008-7#1)(2009-3#1)(2012-12#1)
the hematoma##5##2##(2008-7#3)(2009-3#1)(2012-12#1)
the hematopoietic growth##2##3##(2008-11#1)(2008-7#1)
the hematopoietic system##2##3##(1992-9#1)(2011-1#1)
the hematopoietic##7##2##(1992-3#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)
the heme group and##2##4##(1994-5#1)(2010-4#1)
the heme group##4##3##(1994-5#2)(2009-9#1)(2010-4#1)
the heme groups##2##3##(1990-8#1)(1992-12#1)
the heme iron##4##3##(1991-9#1)(1994-5#1)(1994-8#1)(2008-10#1)
the heme##26##2##(1990-8#3)(1991-9#1)(1992-12#1)(1993-11#1)(1993-8#2)(1994-5#6)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2009-9#2)(2010-4#1)(2011-1#1)
the hemimethylated##2##2##(1990-11#2)
the hemin##2##2##(1994-5#2)
the hemispheric volume##2##3##(1995-8#2)
the hemispherical##3##2##(2008-2#1)(2008-3#2)
the hemocytes##3##2##(2008-5#1)(2008-6#2)
the hemodialysis patients##2##3##(2008-1#2)
the hemodialysis##6##2##(2007-7#1)(2008-1#4)(2008-10#1)
the hemodynamic timecourse##2##3##(2008-11#2)
the hemodynamic##9##2##(1992-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-6#1)
the hemodynamics of##2##3##(2008-12#1)(2013-1#1)
the hemodynamics##4##2##(2008-12#1)(2008-7#1)(2010-3#1)(2013-1#1)
the hemoglobin concentration##3##3##(1990-8#1)(2008-3#2)
the hemoglobin##12##2##(1990-8#4)(1993-8#1)(1997-2#1)(2007-10#1)(2008-3#4)(2012-12#1)
the hemolymph of the##2##4##(2007-12#1)(2008-10#1)
the hemolymph of##6##3##(1990-5#1)(1997-2#2)(2007-12#1)(2008-10#2)
the hemolymph##22##2##(1990-5#1)(1997-2#2)(2007-12#2)(2008-10#8)(2008-6#5)(2008-7#3)(2012-2#1)
the hemolysis##3##2##(1990-3#1)(2008-7#2)
the hemolytic##2##2##(1994-12#1)(2008-1#1)
the hemopoietic system##2##3##(2007-4#1)(2013-1#1)
the hemopoietic##5##2##(1992-12#1)(1993-9#1)(2007-4#1)(2008-5#1)(2013-1#1)
the hemorrhage##2##2##(2008-12#1)(2012-3#1)
the hemorrhagic##4##2##(2007-10#1)(2008-7#1)(2010-6#1)(2012-3#1)
the hemostasis##2##2##(2011-1#2)
the heparin##5##2##(1992-3#1)(1995-2#2)(2010-3#1)(2013-1#1)
the heparin-binding site of##2##4##(1995-2#2)
the hepatic arterial##3##3##(1990-3#1)(2013-1#2)
the hepatic artery##2##3##(1997-8#1)(2012-2#1)
the hepatic damage induced by##2##5##(1995-6#1)(2011-2#1)
the hepatic damage##3##3##(1995-6#2)(2011-2#1)
the hepatic endoderm##3##3##(2008-6#3)
the hepatic expression##2##3##(1995-3#1)(2008-6#1)
the hepatic vein closing pressure##2##5##(1991-5#2)
the hepatic vein##3##3##(1991-5#2)(2009-9#1)
the hepatic##48##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#3)(1992-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-12#3)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
the hepatitis A virus##2##4##(2007-12#1)(2008-7#1)
the hepatitis B vaccination##2##4##(1995-2#1)(2007-2#1)
the hepatitis B virus (HBV)##3##5##(1991-11#1)(1997-6#1)(2009-3#1)
the hepatitis B virus##9##4##(1991-11#1)(1993-6#1)(1994-7#1)(1996-12#1)(1997-6#2)(2009-3#1)(2009-7#1)(2012-12#1)
the hepatitis B##13##3##(1991-11#1)(1991-6#1)(1993-6#1)(1994-7#1)(1995-2#1)(1996-12#1)(1997-6#2)(2007-2#1)(2009-3#1)(2009-7#1)(2012-1#1)(2012-12#1)
the hepatitis C virus (HCV)##5##5##(1990-3#1)(1994-8#1)(2008-8#1)(2009-7#1)(2012-2#1)
the hepatitis C virus##8##4##(1990-3#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
the hepatitis C##9##3##(1990-3#1)(1994-11#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
the hepatitis##27##2##(1990-3#1)(1991-11#1)(1991-6#1)(1993-6#1)(1994-11#2)(1994-7#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-4#2)(1997-6#2)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the hepatocellular##3##2##(1990-2#1)(1992-3#2)
the hepatocyte##14##2##(1992-3#1)(1993-8#1)(1995-11#1)(1996-11#1)(2008-11#6)(2008-7#1)(2008-9#3)
the hepatocytes of##2##3##(1993-11#1)(1995-2#1)
the hepatocytes with##2##3##(1993-3#1)(1996-2#1)
the hepatocytes##8##2##(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-2#1)(2008-11#1)(2013-8#1)
the hepatoma cells##2##3##(2008-11#2)
the hepatoma##6##2##(1992-3#1)(1992-8#1)(2008-11#4)
the hepatopancreas##4##2##(2008-6#2)(2008-7#2)
the hepatoprotective##2##2##(2008-11#1)(2013-1#1)
the hepatotoxicity of##3##3##(1990-12#1)(1995-3#1)(2006-10#1)
the heptad repeat##2##3##(1993-11#2)
the heptad##3##2##(1993-11#3)
the heptapeptide##2##2##(1994-2#2)
the herbal medicine##3##3##(2011-2#1)(2012-3#2)
the herbal##6##2##(2010-5#2)(2011-2#1)(2012-3#2)(2013-1#1)
the herbicide 2##3##3##(2008-10#3)
the herbicide##21##2##(2008-10#18)(2008-2#1)(2008-6#1)(2010-1#1)
the herbicides##6##2##(2008-10#3)(2008-11#2)(2008-7#1)
the herd and##2##3##(1996-12#2)
the herd##3##2##(1996-12#2)(2010-4#1)
the hereditary##2##2##(2008-8#1)(2009-12#1)
the heritability of##3##3##(2008-2#1)(2008-8#2)
the heritability##4##2##(2008-10#1)(2008-2#1)(2008-8#2)
the hermaphrodite##5##2##(2007-12#5)
the hermaphroditic##3##2##(2008-9#1)(2010-5#1)(2011-2#1)
the hernia##3##2##(1993-9#1)(2009-8#1)(2012-12#1)
the heteroatom##2##2##(2007-11#2)
the heterochromatic##2##2##(2009-10#2)
the heterocyclic##6##2##(1992-2#1)(1992-6#1)(1995-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
the heterodimer##4##2##(1993-9#1)(1995-8#1)(1997-4#1)(2008-9#1)
the heterodimeric##7##2##(1993-11#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
the heteroduplexes obtained##2##3##(2008-10#2)
the heterodyne mixing efficiency##2##4##(2008-2#2)
the heterodyne##4##2##(2008-2#3)(2008-3#1)
the heterogeneity in##2##3##(1991-9#1)(2013-3#1)
the heterogeneity of the test samples##2##6##(2008-10#2)
the heterogeneity of the test##3##5##(2008-10#3)
the heterogeneity of the##10##4##(1991-12#1)(1994-2#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the heterogeneity of##20##3##(1991-12#1)(1994-2#1)(1994-9#1)(1997-3#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the heterogeneity##28##2##(1991-12#1)(1991-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1997-3#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-3#1)
the heterogeneous electron transfer##3##4##(2008-10#3)
the heterogeneous nature of##3##4##(1993-8#1)(2008-10#1)(2008-11#1)
the heterogeneous populations##2##3##(2008-10#1)(2010-10#1)
the heterogeneous##23##2##(1991-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-6#2)(1996-6#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-3#1)
the heterogenous##2##2##(2008-10#1)(2008-11#1)
the heterologous CP coding region##2##5##(2008-10#2)
the heterologous expression of##2##4##(2008-10#1)(2009-9#1)
the heterologous##23##2##(1990-5#1)(1990-8#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-3#1)(1997-4#2)(2008-10#10)(2008-11#3)(2009-9#1)
the heterologously expressed reductase##2##4##(1996-3#2)
the heterozygote##5##2##(1997-8#1)(2008-10#1)(2008-9#1)(2010-4#1)(2013-1#1)
the heterozygous##2##2##(1995-2#1)(2009-5#1)
the hexagon##2##2##(2008-3#1)(2013-8#1)
the hexagonal column##7##3##(2008-3#7)
the hexagonal##10##2##(1990-2#1)(2007-12#1)(2008-3#8)
the hexamer motif##3##3##(1997-2#3)
the hexamer##9##2##(1994-6#1)(1995-11#1)(1995-8#1)(1997-2#6)
the hexane##2##2##(2008-10#1)(2010-2#1)
the hexanucleotide##3##2##(1990-7#2)(1994-11#1)
the hexapeptide##3##2##(2008-4#1)(2008-5#2)
the hexose##3##2##(1993-3#1)(2010-2#2)
the hidden Markov model (HMM)##2##5##(1996-12#1)(1997-2#1)
the hidden Markov model##4##4##(1996-12#2)(1997-2#2)
the hidden Markov##5##3##(1996-12#2)(1997-2#2)(2008-10#1)
the hidden and##5##3##(2008-10#5)
the hidden image##2##3##(2008-3#2)
the hidden layer and the output layer##3##7##(2010-8#3)
the hidden layer and the##4##5##(2008-10#1)(2010-8#3)
the hidden layer and##5##4##(2008-10#1)(2010-8#4)
the hidden layer##7##3##(2008-10#3)(2010-8#4)
the hidden phase##2##3##(2008-3#2)
the hidden##29##2##(1991-6#1)(1993-2#1)(1995-2#1)(1996-12#2)(1997-2#2)(2008-1#1)(2008-10#10)(2008-3#5)(2008-6#1)(2008-7#1)(2010-8#4)
the hierarchical##7##2##(1991-6#1)(1992-5#2)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
the hierarchy of selenoprotein expression##2##5##(2012-2#2)
the hierarchy of##3##3##(2008-11#1)(2012-2#2)
the hierarchy##6##2##(1993-2#2)(2008-11#1)(2008-12#1)(2012-2#2)
the high SPM##2##3##(2012-2#2)
the high accuracy of the##2##5##(2008-10#2)
the high affinity binding##5##4##(1990-5#1)(1991-2#1)(1997-4#2)(2008-3#1)
the high affinity of##2##4##(2008-9#1)(2010-1#1)
the high affinity site##2##4##(1990-5#1)(1995-11#1)
the high affinity##19##3##(1990-12#1)(1990-5#3)(1991-1#1)(1991-11#1)(1991-2#2)(1994-11#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-4#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)
the high and low energy electronic states of DSKNPH##2##9##(2008-10#2)
the high and low##4##4##(1995-11#1)(2008-10#2)(2010-1#1)
the high and##5##3##(1995-11#1)(2008-10#2)(2008-9#1)(2010-1#1)
the high burden of##2##4##(2008-3#1)(2011-2#1)
the high complexity of##2##4##(2008-1#1)(2008-10#1)
the high complexity##3##3##(2008-1#1)(2008-10#1)(2010-11#1)
the high concentrate diets##2##4##(2009-4#2)
the high concentration groups##2##4##(2008-9#2)
the high concentration of##3##4##(2008-10#2)(2008-3#1)
the high concentration##5##3##(2008-10#2)(2008-3#1)(2008-9#2)
the high content of##2##4##(2008-10#2)
the high cost of the##2##5##(2008-3#1)(2011-2#1)
the high cost of##6##4##(1993-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
the high cost##8##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
the high costs##2##3##(2008-10#1)(2008-9#1)
the high coupling##2##3##(2007-12#1)(2008-2#1)
the high dispersion##2##3##(2007-12#1)(2008-3#1)
the high dissociation##2##3##(2008-10#2)
the high dose of##2##4##(2008-10#1)(2008-7#1)
the high dose##5##3##(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)
the high efficiency##2##3##(2008-2#1)(2008-8#1)
the high elevations##3##3##(2008-10#3)
the high end of the##2##5##(2008-8#2)
the high energy##2##3##(2008-10#1)(2013-8#1)
the high expression of##2##4##(1996-12#1)(2009-9#1)
the high frequency of##9##4##(1990-6#2)(1992-5#1)(1993-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the high frequency##11##3##(1990-6#2)(1990-8#1)(1992-5#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the high genetic##2##3##(2008-10#1)(2013-8#1)
the high homology##2##3##(1992-12#1)(1995-6#1)
the high incidence of##7##4##(1990-2#1)(1992-2#1)(1993-3#1)(1996-11#1)(2009-7#1)(2010-6#1)(2011-2#1)
the high level expression##2##4##(2008-8#2)
the high level of genetic##2##5##(2008-10#1)(2008-8#1)
the high level of##10##4##(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-3#1)(2013-1#1)
the high level##15##3##(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#4)(2009-3#1)(2012-2#2)(2013-1#1)
the high levels of##6##4##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
the high molecular weight##4##4##(1992-10#1)(1995-2#1)(2008-10#1)(2008-5#1)
the high mortality rate##3##4##(1993-6#1)(2007-8#1)(2011-2#1)
the high number of##5##4##(1993-6#1)(2008-10#1)(2008-7#2)(2013-7#1)
the high pH##2##3##(2008-10#2)
the high potential of##2##4##(1995-12#1)(2011-1#1)
the high pressure##2##3##(1996-5#1)(2008-7#1)
the high prevalence of##6##4##(1992-5#1)(1993-6#1)(2007-11#1)(2007-7#2)(2008-3#1)
the high prevalence##7##3##(1992-5#1)(1993-6#1)(2007-11#1)(2007-7#2)(2008-3#1)(2008-8#1)
the high quality of##2##4##(2009-11#1)(2010-11#1)
the high quality##5##3##(2008-10#1)(2009-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
the high rate of##9##4##(1991-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
the high relaxivity##2##3##(2008-7#2)
the high resistance to##3##4##(2007-10#2)(2008-10#1)
the high resolution##4##3##(1997-7#1)(2007-11#1)(2008-7#2)
the high risk foetus##2##4##(1993-6#2)
the high risk group in##2##5##(2007-11#1)(2011-1#1)
the high risk group##6##4##(1994-11#1)(2007-11#2)(2009-8#1)(2011-1#1)(2011-2#1)
the high risk of##4##4##(1997-7#1)(2012-1#1)(2012-3#1)(2013-7#1)
the high risk##16##3##(1991-6#1)(1993-6#2)(1993-9#1)(1994-11#2)(1997-7#1)(2007-11#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
the high salt##4##3##(1995-6#2)(2008-10#2)
the high school##2##3##(1990-3#1)(2008-12#1)
the high selectivity of the##3##5##(2008-10#3)
the high selectivity of##6##4##(2008-10#5)(2010-7#1)
the high sensitivity of the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
the high sensitivity of##7##4##(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)(2013-8#1)
the high sensitivity##10##3##(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2010-5#1)(2013-8#1)
the high separation##2##3##(2008-10#1)(2008-11#1)
the high speed##2##3##(1997-6#1)(2008-10#1)
the high temperature##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
the high throughput screening##2##4##(2009-6#2)
the high throughput##3##3##(1997-4#1)(2009-6#2)
the high values##2##3##(1993-11#1)(2011-2#1)
the high voltage##2##3##(2007-11#1)(2008-10#1)
the high water##2##3##(2008-5#1)(2009-9#1)
the high##371##2##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#4)(2006-10#2)(2007-10#2)(2007-11#10)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#72)(2008-11#10)(2008-12#3)(2008-2#10)(2008-3#19)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#18)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#3)(2010-11#3)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#9)(2011-2#12)(2012-1#4)(2012-12#1)(2012-2#8)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#9)(2013-7#2)(2013-8#7)
the high-##2##2##(2007-12#1)(2008-3#1)
the high-CHO diet##2##3##(2013-8#2)
the high-Q##2##2##(2007-12#1)(2008-3#1)
the high-absorption##2##2##(2008-2#1)(2008-3#1)
the high-affinity##13##2##(1990-5#1)(1992-6#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-7#1)(2009-6#2)(2009-7#1)
the high-density##2##2##(2008-10#1)(2008-8#1)
the high-dispersal##2##2##(2013-1#2)
the high-energy##4##2##(1990-11#1)(2008-3#2)(2008-7#1)
the high-frequency##8##2##(1991-10#1)(1992-9#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
the high-index##3##2##(2007-11#2)(2008-2#1)
the high-level expression of##2##4##(2008-9#2)
the high-level##8##2##(1991-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#2)(2010-7#1)(2013-8#1)
the high-performance liquid chromatographic##2##4##(1991-5#1)(1997-2#1)
the high-performance liquid##4##3##(1991-5#1)(1997-2#1)(2008-10#2)
the high-power##2##2##(2007-12#2)
the high-precision##3##2##(2008-3#3)
the high-pressure liquid##2##3##(2008-10#1)(2008-5#1)
the high-pressure##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
the high-profile##3##2##(2008-7#1)(2009-6#1)(2011-2#1)
the high-resolution##7##2##(1994-3#1)(2008-2#1)(2008-3#4)(2011-1#1)
the high-risk group##2##3##(2009-8#1)(2011-2#1)
the high-risk##7##2##(1991-6#1)(1995-1#1)(2007-8#1)(2009-8#1)(2011-2#3)
the high-speed##2##2##(2008-3#1)(2009-5#1)
the high-spin##2##2##(1992-12#1)(2008-10#1)
the high-temperature##4##2##(2007-12#1)(2008-10#2)(2008-4#1)
the high-throughput##2##2##(2008-10#1)(2008-7#1)
the higher affinity##2##3##(1992-8#1)(1995-2#1)
the higher concentration##3##3##(1993-8#1)(1994-8#1)(2008-10#1)
the higher concentrations##2##3##(2008-5#1)(2013-1#1)
the higher dose of##2##4##(1997-4#2)
the higher dose##5##3##(1994-2#1)(1997-4#2)(2008-5#1)(2012-3#1)
the higher education sector##2##4##(2008-11#1)(2008-12#1)
the higher education##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
the higher incidence of##2##4##(1993-12#1)(2008-1#1)
the higher level of##2##4##(2008-10#1)(2011-2#1)
the higher levels of##2##4##(1996-12#1)(2007-8#1)
the higher levels##3##3##(1996-12#1)(2007-8#1)(2008-10#1)
the higher motor areas##2##4##(2008-1#2)
the higher number of##2##4##(2008-10#1)(2012-3#1)
the higher prevalence##2##3##(2008-3#1)(2008-5#1)
the higher rate of##3##4##(2008-1#1)(2008-10#2)
the higher rates of##2##4##(2008-7#1)(2013-1#1)
the higher risk of##3##4##(1992-8#1)(1993-3#1)(2011-2#1)
the higher risk##4##3##(1992-8#1)(1993-3#1)(2008-7#1)(2011-2#1)
the higher sensitivity of##3##4##(1993-8#1)(2008-10#2)
the higher sensitivity##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
the higher sun radiation##2##4##(2011-2#2)
the higher the resistance##2##4##(2008-10#2)
the higher the##13##3##(1993-11#1)(1993-8#1)(1995-6#1)(1996-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
the higher##151##2##(1990-12#2)(1990-5#2)(1990-9#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-2#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#3)(2006-10#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#4)(2008-10#39)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#7)(2008-5#7)(2008-7#6)(2008-8#3)(2008-9#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#2)
the higher-order##6##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)
the highest EFs for##2##4##(2008-10#2)
the highest GUS activity of##2##5##(2008-9#2)
the highest YAP+##2##3##(2008-9#2)
the highest absolute##2##3##(2008-10#1)(2009-4#1)
the highest achievable##2##3##(2008-1#1)(2008-7#1)
the highest activity##4##3##(2009-6#2)(2010-3#1)(2013-1#1)
the highest affinity for##2##4##(2008-10#1)(2008-5#1)
the highest affinity##4##3##(1997-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
the highest amount of##2##4##(2008-5#1)(2013-1#1)
the highest and lowest disease##2##5##(2008-12#2)
the highest and lowest##6##4##(2008-10#2)(2008-12#2)(2008-7#1)(2012-3#1)
the highest and##8##3##(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2012-3#1)
the highest antioxidant activity##2##4##(2008-10#1)(2013-8#1)
the highest antioxidant##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
the highest average##2##3##(2007-11#1)(2013-1#1)
the highest concentration of##6##4##(1993-11#1)(1995-3#1)(2008-10#2)(2008-9#1)(2013-1#1)
the highest concentration##15##3##(1992-8#1)(1993-11#1)(1995-3#2)(1996-12#1)(2008-10#5)(2008-5#3)(2008-9#1)(2013-1#1)
the highest concentrations in##2##4##(1997-1#1)(2011-2#1)
the highest concentrations##4##3##(1997-1#1)(2008-12#1)(2011-2#1)(2013-7#1)
the highest conversion##2##3##(2007-12#1)(2013-1#1)
the highest correlation##3##3##(2008-10#3)
the highest current signals##2##4##(2008-10#2)
the highest degree of##7##4##(1991-5#1)(1994-7#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
the highest degree##9##3##(1991-5#1)(1994-7#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
the highest disease severity##2##4##(2008-10#2)
the highest disease##5##3##(2008-10#5)
the highest dose to##2##4##(2009-2#2)
the highest dose##11##3##(1992-3#1)(1993-6#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-5#2)(2009-2#2)(2013-8#1)
the highest efficiency##2##3##(2008-10#1)(2008-2#1)
the highest energy##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
the highest expression##3##3##(2008-9#2)(2012-2#1)
the highest frequency of##2##4##(2006-10#1)(2008-10#1)
the highest frequency##6##3##(1995-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)
the highest growth##2##3##(2008-10#1)(2008-5#1)
the highest homology##2##3##(2008-10#1)(2008-8#1)
the highest in the world##4##5##(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)
the highest in the##7##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)
the highest in##17##3##(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the highest incidence in##3##4##(1991-11#1)(1992-4#1)(1994-9#1)
the highest incidence of##6##4##(1990-3#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
the highest incidence##11##3##(1990-3#1)(1991-11#1)(1992-4#1)(1992-9#2)(1993-9#1)(1994-9#2)(2008-10#1)(2008-4#1)(2008-7#1)
the highest intensity##2##3##(1994-12#1)(2011-1#1)
the highest level in##2##4##(1993-3#1)(1997-2#1)
the highest level of virulence##2##5##(2008-10#2)
the highest level of##15##4##(1990-11#1)(1992-9#1)(1994-2#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-8#3)(2010-3#1)
the highest level##20##3##(1990-11#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-8#3)(2010-3#1)
the highest levels of disease##2##5##(2008-10#2)
the highest levels of##13##4##(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-4#1)(2008-10#7)
the highest levels were##2##4##(1997-4#1)(2008-7#1)
the highest levels##19##3##(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-4#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
the highest lipase##2##3##(2008-10#1)(2012-2#1)
the highest mean##3##3##(1990-2#2)(2008-12#1)
the highest mortality##2##3##(1992-5#1)(2010-8#1)
the highest number of##5##4##(2008-10#1)(2008-6#1)(2010-4#1)(2011-2#2)
the highest number##6##3##(2008-10#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#2)
the highest ones##2##3##(1990-8#1)(2008-10#1)
the highest output power##2##4##(2007-11#1)(2008-2#1)
the highest overall##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
the highest percentage of##5##4##(1990-8#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
the highest percentage##8##3##(1990-8#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-7#1)(2013-1#1)
the highest percentages##2##3##(2008-10#1)(2010-6#1)
the highest possible##3##3##(2007-11#2)(2011-2#1)
the highest power##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
the highest priority##2##3##(1994-2#1)(2012-12#1)
the highest proportion##3##3##(1990-11#1)(2013-8#2)
the highest quality##3##3##(1991-12#1)(1996-2#1)(2011-1#1)
the highest rate of##7##4##(1997-8#1)(2008-10#2)(2008-12#2)(2009-5#1)(2013-1#1)
the highest rate##10##3##(1997-8#1)(2006-6#1)(2008-10#2)(2008-12#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
the highest rates of##2##4##(2008-11#1)(2008-7#1)
the highest rates##3##3##(1990-8#1)(2008-11#1)(2008-7#1)
the highest ratings##2##3##(1993-2#1)(2008-10#1)
the highest ratio##2##3##(1993-6#1)(2008-10#1)
the highest ration##2##3##(2010-8#2)
the highest released amount##2##4##(2008-5#2)
the highest reported for##3##4##(1990-12#1)(2008-5#1)(2010-3#1)
the highest reported##9##3##(1990-12#1)(2006-10#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-5#1)(2010-3#1)
the highest risk of##5##4##(1996-6#1)(1997-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
the highest risk##13##3##(1991-6#1)(1993-11#1)(1995-8#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
the highest selectivity##2##3##(2008-10#2)
the highest sensitivity##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)
the highest specific##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2012-2#1)
the highest stability##2##3##(2008-10#1)(2012-2#1)
the highest total##2##3##(2008-9#1)(2011-2#1)
the highest value##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
the highest values in##3##4##(2012-12#1)(2013-7#2)
the highest values of##4##4##(2008-10#2)(2012-12#2)
the highest values##11##3##(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#2)
the highest##513##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#7)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#4)(1994-5#1)(1994-7#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#3)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#16)(2007-12#5)(2007-8#2)(2008-1#5)(2008-10#122)(2008-11#15)(2008-12#21)(2008-2#12)(2008-3#9)(2008-4#3)(2008-5#27)(2008-6#2)(2008-7#10)(2008-8#12)(2008-9#15)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#8)(2011-2#21)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#6)(2012-7#1)(2013-1#24)(2013-7#4)(2013-8#11)
the highlands##5##2##(1991-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
the highlights of the##3##4##(2008-7#1)(2009-3#1)(2010-4#1)
the highlights of this##2##4##(2008-5#2)
the highlights of##5##3##(2008-5#2)(2008-7#1)(2009-3#1)(2010-4#1)
the highlights##6##2##(2008-5#2)(2008-7#2)(2009-3#1)(2010-4#1)
the highly aggressive##2##3##(2008-10#1)(2013-1#1)
the highly birefringent##2##3##(2007-11#1)(2007-12#1)
the highly chlorinated##2##3##(1993-12#2)
the highly conserved##9##3##(1991-9#1)(1992-2#1)(1994-11#2)(1994-12#1)(1994-5#1)(1997-3#1)(2008-8#2)
the highly controversial issue##2##4##(1994-1#2)
the highly fluorescent##2##3##(1991-9#1)(2008-10#1)
the highly parallel##2##3##(2008-3#1)(2012-2#1)
the highly reactive##2##3##(2008-11#2)
the highly selective##4##3##(1996-2#1)(1996-5#1)(2008-10#2)
the highly sensitive##4##3##(1995-8#1)(2008-10#2)(2010-12#1)
the highly specialized##2##3##(1992-9#1)(2012-3#1)
the highly susceptible cv##2##4##(2008-10#2)
the highly susceptible##6##3##(1995-2#1)(2008-10#5)
the highly variable##3##3##(2008-1#1)(2011-2#2)
the highly virulent##3##3##(2008-10#2)(2009-6#1)
the highly##83##2##(1990-5#1)(1991-2#1)(1991-9#2)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#21)(2008-11#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
the highly-conserved##2##2##(1995-5#1)(2009-11#1)
the hilum##2##2##(1997-1#1)(2008-7#1)
the hind leg muscle of##2##5##(1995-2#1)(2008-9#1)
the hind leg##5##3##(1995-2#1)(2007-12#3)(2008-9#1)
the hind legs##2##3##(2007-12#2)
the hind##7##2##(1995-2#1)(2007-12#5)(2008-9#1)
the hindbrain##2##2##(1993-12#1)(2008-3#1)
the hindgut epithelium##4##3##(2007-12#1)(2008-10#3)
the hindgut##7##2##(2007-12#2)(2008-10#5)
the hindlimbs##2##2##(1992-12#1)(1996-6#1)
the hindpaw##2##2##(2009-12#2)
the hinge region##3##3##(1995-11#1)(1995-6#1)(1997-2#1)
the hinge##4##2##(1995-11#1)(1995-6#1)(1997-2#1)(2008-7#1)
the hip and##5##3##(1993-11#1)(1995-5#1)(2007-8#1)(2008-4#1)(2013-1#1)
the hip is##4##3##(2007-11#2)(2007-8#1)(2009-3#1)
the hip joint in##5##4##(2007-11#2)(2007-8#3)
the hip joint was##2##4##(2007-8#1)(2013-8#1)
the hip joint##24##3##(1997-6#2)(2007-11#7)(2007-8#9)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2013-8#1)
the hip joints##3##3##(2007-11#2)(2008-6#1)
the hip was##3##3##(2007-11#1)(2009-3#1)(2013-7#1)
the hip##91##2##(1991-11#1)(1993-11#2)(1995-5#1)(1997-6#2)(2007-11#26)(2007-8#28)(2008-10#1)(2008-11#1)(2008-4#3)(2008-6#3)(2008-8#3)(2009-11#1)(2009-3#6)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#2)
the hippocampal CA1 area##2##4##(2008-11#1)(2009-12#1)
the hippocampal CA1##7##3##(1990-5#1)(1991-10#1)(1992-12#1)(2008-11#3)(2009-12#1)
the hippocampal CA3##2##3##(1995-8#1)(2008-11#1)
the hippocampal formation##5##3##(1995-12#1)(1996-2#1)(1996-7#1)(1997-6#2)
the hippocampal region##5##3##(1992-11#1)(1994-2#1)(1994-3#3)
the hippocampal##32##2##(1990-11#2)(1990-5#3)(1991-10#1)(1992-11#1)(1992-12#1)(1993-5#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-6#3)(2008-11#4)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2013-8#1)
the hippocampi of##2##3##(1995-12#2)
the hippocampi##3##2##(1995-12#3)
the hippocampus after##2##3##(1992-12#1)(1997-3#1)
the hippocampus and in the##3##5##(1995-5#1)(1997-2#1)(2011-2#1)
the hippocampus and in##4##4##(1995-5#1)(1997-2#2)(2011-2#1)
the hippocampus and the entorhinal cortex##2##6##(1994-3#2)
the hippocampus and the entorhinal##3##5##(1992-11#1)(1994-3#2)
the hippocampus and the##7##4##(1992-11#1)(1993-6#1)(1994-3#2)(1995-12#1)(2008-7#1)(2009-6#1)
the hippocampus and##23##3##(1991-12#1)(1992-11#2)(1993-12#1)(1993-6#2)(1994-3#3)(1994-8#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-7#2)(2009-3#1)(2009-6#1)(2011-2#1)(2012-3#1)
the hippocampus are##2##3##(1993-12#1)(2013-8#1)
the hippocampus as well as the##2##6##(2009-12#1)(2013-8#1)
the hippocampus have been##2##4##(2008-7#1)(2013-8#1)
the hippocampus in##4##3##(1994-6#1)(1996-12#1)(2008-7#1)(2013-8#1)
the hippocampus or parahippocampus##2##4##(1990-11#2)
the hippocampus to##2##3##(2008-11#1)(2008-12#1)
the hippocampus##128##2##(1990-11#2)(1990-5#1)(1990-7#4)(1991-10#2)(1991-12#2)(1991-2#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-7#2)(1992-9#1)(1993-12#7)(1993-5#2)(1993-6#6)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-6#5)(1994-8#2)(1995-12#6)(1995-5#4)(1996-11#1)(1996-12#9)(1996-9#2)(1997-2#5)(1997-3#2)(2007-8#4)(2008-10#2)(2008-11#13)(2008-12#1)(2008-4#1)(2008-7#10)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#7)
the hips##8##2##(2006-10#1)(2007-11#3)(2007-8#2)(2010-1#1)(2013-8#1)
the his##3##2##(1990-5#3)
the histamine##7##2##(1992-11#1)(1995-12#3)(1997-1#1)(2008-10#2)
the histidine biosynthetic##2##3##(1990-5#1)(2008-10#1)
the histidine residues##2##3##(1992-6#1)(1992-8#1)
the histidine##7##2##(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-5#1)(1996-8#1)(2008-10#1)
the histogram of##2##3##(2008-3#2)
the histogram##4##2##(2008-3#2)(2008-6#1)(2013-8#1)
the histograms##4##2##(2008-10#1)(2008-2#2)(2008-6#1)
the histologic diagnosis##2##3##(1991-12#1)(1992-12#1)
the histologic response of the primary##2##6##(1992-6#2)
the histologic##15##2##(1990-3#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-8#1)(1995-4#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
the histological and##4##3##(1994-9#1)(2008-9#1)(2009-7#1)(2010-9#1)
the histological diagnosis has##2##4##(2007-4#1)(2013-1#1)
the histological diagnosis##6##3##(2007-4#1)(2008-10#1)(2011-1#1)(2011-7#1)(2013-1#1)(2013-8#1)
the histological examination of the##2##5##(2010-12#1)(2010-6#1)
the histological examination##4##3##(1992-5#1)(2007-10#1)(2010-12#1)(2010-6#1)
the histological findings in##2##4##(1990-11#1)(2007-8#1)
the histological findings of##2##4##(1995-11#1)(2008-1#1)
the histological findings##7##3##(1990-11#1)(1990-7#1)(1994-9#1)(1995-11#1)(2007-8#1)(2008-1#1)(2009-7#1)
the histological type##2##3##(1993-11#1)(2011-2#1)
the histological##40##2##(1990-11#1)(1990-7#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-9#2)(1995-11#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-7#1)(2013-1#1)(2013-8#5)
the histology and##2##3##(1994-9#1)(2008-3#1)
the histology of the##2##4##(1994-1#1)(2009-1#1)
the histology of##5##3##(1994-1#1)(2007-7#1)(2008-10#1)(2009-1#1)(2013-1#1)
the histology##10##2##(1994-1#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2013-1#1)
the histomorphology##2##2##(1997-3#1)(2013-8#1)
the histone kinase##2##3##(1990-7#1)(1992-6#1)
the histone##8##2##(1990-2#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-9#1)(2008-7#1)(2009-12#1)(2009-5#1)
the histopathologic examination##2##3##(1990-10#1)(2008-10#1)
the histopathologic##6##2##(1990-10#1)(2007-10#1)(2008-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
the histopathological changes##2##3##(2008-5#1)(2013-1#1)
the histopathological diagnosis of##2##4##(2011-2#1)(2013-1#1)
the histopathological diagnosis##4##3##(1997-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
the histopathological examination##2##3##(2011-2#1)(2012-12#1)
the histopathological findings##2##3##(2007-8#1)(2011-2#1)
the histopathological##18##2##(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
the histopathology##3##2##(1995-5#1)(2008-6#1)(2013-1#1)
the historic##9##2##(1991-12#1)(1995-12#1)(2007-10#1)(2007-5#1)(2008-10#1)(2009-10#1)(2010-10#1)(2011-2#2)
the historical and##3##3##(1996-2#1)(2009-10#1)(2012-12#1)
the historical background##3##3##(1994-6#1)(2008-9#1)(2012-1#1)
the historical context of World War II##2##7##(2013-1#2)
the historical development of##6##4##(1993-3#1)(1996-3#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
the historical evolution of##3##4##(1996-12#1)(2008-10#2)
the historical perspective##2##3##(1996-1#1)(2008-6#1)
the historical study##2##3##(2008-1#1)(2012-2#1)
the historical##47##2##(1991-6#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-10#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
the history and the##2##4##(1997-3#1)(2007-8#1)
the history and##9##3##(1997-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-1#1)(2011-2#1)
the history of American##2##4##(1994-12#1)(2012-3#1)
the history of falls##2##4##(2010-3#2)
the history of human##2##4##(2008-12#1)(2008-8#1)
the history of medical##2##4##(2010-1#2)
the history of medicine##3##4##(1993-11#1)(1993-6#1)(2008-9#1)
the history of the development of the##2##7##(1996-12#1)(2010-5#1)
the history of the development of##3##6##(1996-12#1)(2010-5#1)(2010-8#1)
the history of the discovery##2##5##(1997-1#1)(2009-10#1)
the history of the##20##4##(1990-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-5#1)
the history of##63##3##(1990-11#1)(1990-6#1)(1991-1#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-8#1)(2007-10#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2010-1#3)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)
the history##88##2##(1990-11#1)(1990-6#1)(1991-1#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#4)(2010-1#4)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
the histotype of metastatic cells##2##5##(1990-2#2)
the histotype of##3##3##(1990-2#3)
the hit##2##2##(2008-3#1)(2008-6#1)
the hit-miss transform##2##3##(2008-3#2)
the hitherto##6##2##(1990-11#2)(1997-4#1)(2008-10#1)(2009-9#1)(2010-10#1)
the hives##3##2##(2008-5#3)
the holding coil to##2##4##(2008-10#2)
the holding coil##5##3##(2008-10#5)
the holding##9##2##(1995-12#1)(2007-11#1)(2008-10#7)
the hole##5##2##(1991-11#1)(2007-11#1)(2007-12#2)(2008-2#1)
the holes##4##2##(2007-11#2)(2007-12#1)(2008-5#1)
the holistic##4##2##(1997-6#2)(2008-1#1)(2013-1#1)
the hollow waveguide##2##3##(2007-11#1)(2007-12#1)
the hollow##7##2##(2007-11#2)(2007-12#1)(2008-11#2)(2008-3#2)
the holoenzyme##7##2##(1990-8#3)(1992-6#1)(1994-3#1)(1995-2#1)(2008-11#1)
the hologram##21##2##(2007-12#4)(2008-2#5)(2008-3#12)
the holograms##6##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
the holographic grating##2##3##(2008-3#2)
the holographic recording##2##3##(2007-12#2)
the holographic reflector##2##3##(2008-3#2)
the holographic##24##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#17)
the holoprotein##2##2##(1993-8#2)
the holy##2##2##(2007-4#1)(2008-12#1)
the home and community##2##4##(1991-1#1)(2009-9#1)
the home and##7##3##(1991-1#1)(1993-1#1)(2007-12#1)(2009-5#2)(2009-9#1)(2013-8#1)
the home care industry##2##4##(1995-3#1)(1997-3#1)
the home care##3##3##(1995-3#1)(1997-3#1)(2011-2#1)
the home environment##3##3##(1991-1#1)(2007-8#1)(2012-2#1)
the home health##3##3##(1995-3#2)(1997-2#1)
the home in##3##3##(1991-12#1)(2007-12#2)
the home is##3##3##(1991-1#1)(2007-12#2)
the home modalities##3##3##(1995-12#3)
the home##56##2##(1990-11#1)(1990-8#1)(1991-1#4)(1991-12#3)(1991-8#2)(1992-2#2)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-8#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-12#8)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-9#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#1)
the home-made##2##2##(2008-10#2)
the homebound elderly##2##3##(1995-12#1)(1997-2#1)
the homebound##4##2##(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)
the homeless##2##2##(2013-8#2)
the homeopathic remedies##2##3##(2008-10#2)
the homeopathic##4##2##(2008-10#4)
the homeostasis model##2##3##(2008-3#2)
the homeostasis of##8##3##(1992-5#1)(1994-12#1)(1995-12#2)(2008-5#1)(2009-10#1)(2012-2#1)(2013-8#1)
the homeostasis##11##2##(1992-5#1)(1994-12#1)(1995-12#2)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
the homeostatic##3##2##(2008-11#1)(2008-7#2)
the homes##3##2##(1995-6#1)(1997-3#1)(2013-1#1)
the hominid##2##2##(1994-3#1)(2008-1#1)
the homo- and heteromeric##2##4##(1995-11#2)
the homodimeric##2##2##(1990-8#1)(2008-11#1)
the homogenate##2##2##(1991-2#1)(1993-12#1)
the homogeneity of the##3##4##(2008-10#2)(2011-1#1)
the homogeneity of##6##3##(2008-10#5)(2011-1#1)
the homogeneous##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
the homogenization##2##2##(2008-10#2)
the homogenous##2##2##(1994-8#1)(2008-10#1)
the homologous antigen##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
the homologous regions##2##3##(1991-6#1)(2008-8#1)
the homologous##30##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-9#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
the homology between##2##3##(1994-9#1)(2009-10#1)
the homology of the##2##4##(2008-9#2)
the homology of##3##3##(2007-12#1)(2008-9#2)
the homology to##2##3##(1990-12#1)(2008-9#1)
the homology##7##2##(1990-12#1)(1994-9#1)(2007-12#1)(2008-9#3)(2009-10#1)
the homozygote##2##2##(1997-8#1)(2008-9#1)
the homozygotes##2##2##(1995-2#1)(2007-7#1)
the homozygous deletion##3##3##(1996-12#2)(2008-12#1)
the homozygous##6##2##(1996-12#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)
the honey bee (Apis mellifera)##2##5##(2008-5#1)(2013-1#1)
the honey bee##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
the honey samples##3##3##(2008-10#3)
the honey##8##2##(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
the honeybee##6##2##(1994-8#2)(2008-7#2)(2008-8#2)
the hook effect##3##3##(2008-3#3)
the hook##4##2##(2007-12#1)(2008-3#3)
the hope of##5##3##(1996-3#1)(2008-6#1)(2009-6#1)(2010-12#1)(2013-8#1)
the hope##9##2##(1992-12#1)(1996-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-8#1)
the hopes of##2##3##(1992-2#1)(2011-2#1)
the horizon of##4##3##(2008-12#1)(2010-8#1)(2012-2#2)
the horizon##7##2##(2008-12#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#3)
the horizontal and the vertical directions##4##6##(2008-2#1)(2008-3#3)
the horizontal and vertical##2##4##(2008-8#1)(2008-9#1)
the horizontal and##6##3##(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)
the horizontal distance between##2##4##(2008-3#1)(2008-5#1)
the horizontal nucleus of the diagonal band of##2##8##(1994-3#2)
the horizontal plane##9##3##(2007-11#2)(2008-3#4)(2008-9#1)(2012-2#2)
the horizontal##40##2##(1990-7#1)(1993-1#2)(1994-3#2)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#13)(2008-5#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2012-2#3)(2013-8#1)
the hormetic intensity##2##3##(2008-7#2)
the hormetic zone##2##3##(2008-7#2)
the hormetic##8##2##(2008-7#8)
the hormonal effects##2##3##(1991-3#1)(2008-11#1)
the hormonal##17##2##(1990-2#1)(1991-3#1)(1992-8#1)(1993-3#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-2#1)(2010-7#1)(2012-12#1)
the hormone in##3##3##(1990-2#1)(1993-6#1)(2010-5#1)
the hormone is##2##3##(2008-10#1)(2008-3#1)
the hormone##26##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
the hormone-dependent##2##2##(1993-1#1)(1993-8#1)
the hormones##6##2##(1994-8#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)
the horse##5##2##(1997-4#1)(2008-10#1)(2010-4#1)(2012-12#2)
the horseradish##2##2##(1991-5#1)(2008-10#1)
the hospice##4##2##(1990-10#2)(2009-7#1)(2010-2#1)
the hospital and the##5##4##(1991-1#1)(1993-1#1)(1993-2#1)(2008-10#1)(2011-2#1)
the hospital and##17##3##(1991-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1995-1#2)(1995-2#2)(1995-6#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#2)
the hospital as a##2##4##(1994-3#1)(1995-2#1)
the hospital as##3##3##(1994-3#1)(1995-2#1)(1996-3#1)
the hospital environment##5##3##(1991-1#1)(1992-3#1)(1996-1#1)(2010-11#1)(2013-8#1)
the hospital for##4##3##(2007-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
the hospital immediately##2##3##(1993-12#1)(2009-3#1)
the hospital in good##2##4##(1993-6#1)(2010-12#1)
the hospital in##5##3##(1991-12#1)(1993-6#1)(2007-11#1)(2008-12#1)(2010-12#1)
the hospital industry has been##2##5##(1992-12#1)(2008-11#1)
the hospital industry##5##3##(1992-12#1)(1994-12#1)(1995-12#1)(2008-11#2)
the hospital information##2##3##(1996-2#1)(2012-3#1)
the hospital is##2##3##(1993-12#1)(2008-11#1)
the hospital laboratory##2##3##(1997-1#1)(2008-10#1)
the hospital or##3##3##(1994-12#1)(2006-10#1)(2013-8#1)
the hospital performance##2##3##(1993-3#2)
the hospital security##3##3##(1993-2#1)(1995-2#1)(1997-2#1)
the hospital services and##2##4##(1993-1#1)(1995-2#1)
the hospital setting##7##3##(1991-1#1)(1991-12#1)(1994-2#1)(1996-2#1)(2008-11#1)(2008-3#1)(2010-9#1)
the hospital stay##2##3##(1990-9#1)(2007-8#1)
the hospital system##2##3##(1996-12#1)(2009-7#1)
the hospital the##2##3##(1995-11#1)(1997-7#1)
the hospital through##2##3##(1996-2#1)(2008-3#1)
the hospital to##5##3##(1994-12#1)(1995-1#1)(1995-12#1)(1996-5#1)(2009-4#1)
the hospital was##2##3##(1995-3#2)
the hospital were##2##3##(2008-12#1)(2009-5#1)
the hospital where##2##3##(1991-7#1)(2008-7#1)
the hospital with##6##3##(1992-3#2)(1996-5#1)(2008-12#1)(2012-12#1)(2013-1#1)
the hospital##240##2##(1990-3#1)(1990-9#2)(1991-1#6)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#8)(1992-3#7)(1992-5#3)(1993-1#4)(1993-12#3)(1993-2#6)(1993-3#4)(1993-6#3)(1994-1#3)(1994-12#6)(1994-2#3)(1994-3#5)(1994-6#1)(1995-1#5)(1995-11#1)(1995-12#7)(1995-2#10)(1995-3#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#8)(1996-3#5)(1996-5#4)(1997-1#1)(1997-2#4)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#9)(2008-12#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#5)
the hospital's medical##2##3##(1994-1#1)(1996-3#1)
the hospital's##27##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#3)(1993-12#2)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(2008-12#2)(2008-3#1)(2010-4#1)(2011-2#1)
the hospital-based##2##2##(2007-10#1)(2008-7#1)
the hospitalization##6##2##(1993-3#1)(1995-1#1)(1995-3#1)(2008-10#1)(2010-10#1)(2011-2#1)
the hospitalizations##2##2##(1995-12#1)(1996-3#1)
the hospitalized##4##2##(1994-12#1)(2007-10#1)(2007-7#1)(2012-2#1)
the hospitals and##2##3##(1991-2#1)(1995-8#1)
the hospitals##19##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-8#1)(1996-1#1)(1997-2#1)(1997-8#1)(2006-8#1)(2008-12#2)(2009-5#1)(2010-8#1)(2011-2#1)
the host against##2##3##(2008-12#1)(2009-5#1)
the host and the pathogen##2##5##(2008-8#1)(2013-1#1)
the host and the##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
the host and##13##3##(1997-4#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
the host animal##3##3##(2008-11#1)(2008-4#2)
the host at##2##3##(2008-10#1)(2013-1#1)
the host by##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
the host cell cytoplasm and##2##5##(2008-7#1)(2011-2#1)
the host cell in##2##4##(2009-6#1)(2013-1#1)
the host cell wall##6##4##(2008-10#5)(2010-3#1)
the host cell##24##3##(1990-2#1)(2008-10#7)(2008-11#6)(2008-7#1)(2008-9#2)(2009-6#2)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#2)
the host cells##3##3##(1994-3#1)(1994-6#1)(2008-10#1)
the host crop##3##3##(2008-10#3)
the host cytoplasm##3##3##(1996-12#2)(2008-10#1)
the host defense system##3##4##(1991-5#1)(1992-10#1)(2013-1#1)
the host defense##5##3##(1991-5#1)(1992-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
the host from##3##3##(2008-10#2)(2008-8#1)
the host genome##3##3##(1993-6#2)(2008-2#1)
the host immune response##2##4##(2011-2#1)(2012-12#1)
the host in##3##3##(2008-10#2)(2011-2#1)
the host infection process##4##4##(2010-10#4)
the host innate immune##2##4##(2008-4#1)(2010-1#1)
the host innate##3##3##(2008-4#1)(2010-1#1)(2012-12#1)
the host is##4##3##(1996-3#1)(2008-10#2)(2008-9#1)
the host might##2##3##(1997-6#1)(2008-8#1)
the host of origin##5##4##(2008-10#3)(2008-4#1)(2008-9#1)
the host of##6##3##(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)
the host or##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
the host organism##3##3##(1991-9#2)(1996-3#1)
the host phytoalexin response##2##4##(2008-10#2)
the host plant##14##3##(2007-12#1)(2008-10#11)(2008-8#1)(2011-2#1)
the host polymer##2##3##(2008-10#1)(2009-2#1)
the host population##11##3##(1994-2#1)(2008-10#4)(2008-8#2)(2008-9#2)(2011-2#2)
the host range expanded##2##4##(2008-11#2)
the host range of##3##4##(1997-4#2)(2008-10#1)
the host range##9##3##(1997-4#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)
the host response to##5##4##(1990-2#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-5#1)
the host response##6##3##(1990-2#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
the host shift##3##3##(2008-8#3)
the host species##7##3##(2008-10#3)(2008-8#4)
the host strain##2##3##(1997-4#1)(2008-9#1)
the host surface##2##3##(2008-10#2)
the host tissues##4##3##(2008-10#4)
the host to##2##3##(2008-10#2)
the host wall##2##3##(2008-10#2)
the host was##2##3##(2008-10#2)
the host##302##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-5#1)(1991-9#2)(1992-10#2)(1992-3#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-2#3)(1996-12#2)(1996-3#2)(1997-4#4)(1997-6#1)(2007-12#11)(2007-6#1)(2008-10#122)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#27)(2008-9#13)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-1#2)(2010-10#6)(2010-3#1)(2011-1#1)(2011-2#17)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#11)(2013-8#2)
the host's immune response##2##4##(2009-9#1)(2013-7#1)
the host's immune##3##3##(2008-5#1)(2009-9#1)(2013-7#1)
the host's##7##2##(2006-6#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2013-7#1)
the host)##2##2##(2008-8#1)(2011-2#1)
the host-free period##3##3##(2008-10#3)
the host-guest##2##2##(2008-10#1)(2010-4#1)
the host-parasite relationship##2##3##(1997-7#1)(2008-10#1)
the host-parasite##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
the host-pathogen interaction##3##3##(2008-10#2)(2013-1#1)
the host-pathogen##4##2##(2008-10#2)(2010-8#1)(2013-1#1)
the host-selective##2##2##(2008-10#2)
the hostage group##2##3##(2008-1#2)
the hosts and##2##3##(2008-10#1)(2012-3#1)
the hosts##7##2##(2007-6#1)(2008-10#4)(2011-2#1)(2012-3#1)
the hosts'##3##2##(1996-12#1)(2008-10#2)
the hot plate test##3##4##(1992-3#1)(1996-2#2)
the hot plate##4##3##(1992-3#1)(1996-2#2)(2010-5#1)
the hot##13##2##(1992-3#1)(1996-2#2)(2008-10#3)(2008-8#2)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
the hour##4##2##(1993-6#1)(2008-10#1)(2012-1#1)(2012-3#1)
the hourly##2##2##(2008-10#2)
the hours immediately##2##3##(1992-8#1)(2010-6#1)
the hours##5##2##(1992-8#1)(1993-5#2)(2010-6#1)(2013-8#1)
the house dust mite##2##4##(2010-5#2)
the house officers##2##3##(1995-6#2)
the house##6##2##(1995-6#2)(2009-10#1)(2010-5#2)(2011-2#1)
the household##10##2##(1991-12#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
the houses##2##2##(1996-3#1)(2007-10#1)
the housing system##2##3##(2010-4#1)(2013-1#1)
the hph##2##2##(2008-10#2)
the hprt locus##2##3##(1997-3#2)
the hprt##4##2##(1996-2#1)(1997-3#3)
the hrp##2##2##(2008-10#2)
the hsp70 expression##2##3##(2013-1#2)
the hsp70##10##2##(1994-11#2)(1994-8#2)(1995-2#1)(1995-6#2)(2013-1#3)
the huge##6##2##(2007-12#1)(2008-10#1)(2010-3#1)(2010-8#2)(2011-2#1)
the human 1##5##3##(1990-12#2)(1993-3#3)
the human A(3) receptor##3##4##(2008-4#3)
the human A(3)##4##3##(2008-4#4)
the human CYP1A1##2##3##(1994-6#1)(2008-11#1)
the human HMG2 gene##2##4##(1995-2#2)
the human IL4##2##3##(1993-2#1)(2008-7#1)
the human LDL receptor##2##4##(1990-11#1)(2008-8#1)
the human LDL##4##3##(1990-11#1)(1992-5#1)(2008-10#1)(2008-8#1)
the human LPL##2##3##(1995-6#1)(2008-11#1)
the human MEKA gene##2##4##(1990-7#2)
the human MNS##2##3##(2008-11#2)
the human T-cell##2##3##(1992-12#1)(1997-2#1)
the human THP-1 cell##2##4##(1993-6#2)
the human TSH receptor##3##4##(1993-3#2)(1996-5#1)
the human X##2##3##(2008-7#1)(2010-5#1)
the human adrenal##2##3##(1990-12#1)(1994-5#1)
the human alpha##2##3##(1995-11#2)
the human alpha-catenin##2##3##(1993-6#2)
the human and animal##3##4##(2010-2#1)(2011-2#1)(2012-1#1)
the human and economic##2##4##(1994-2#1)(2007-12#1)
the human and mouse##4##4##(1993-2#1)(1997-7#1)(2008-7#1)(2012-3#1)
the human and rat##2##4##(1991-12#1)(2008-4#1)
the human and yeast##2##4##(1993-6#2)
the human and##19##3##(1991-12#1)(1991-5#1)(1991-6#1)(1993-2#1)(1993-6#2)(1994-2#1)(1996-12#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
the human androgen receptor##2##4##(1991-9#1)(2008-4#1)
the human apoE##2##3##(1995-6#1)(2008-9#1)
the human auditory##2##3##(1993-9#1)(1995-12#1)
the human beta-myosin heavy chain##2##5##(1992-11#2)
the human body and##5##4##(1991-9#1)(2008-10#1)(2012-3#2)(2013-1#1)
the human body##23##3##(1990-2#1)(1991-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#2)(2011-1#1)(2012-3#2)(2013-1#3)(2013-8#1)
the human brain and##2##4##(2008-7#1)(2012-12#1)
the human brain is##2##4##(1991-5#1)(1996-5#1)
the human brain##17##3##(1991-5#1)(1992-3#1)(1992-6#2)(1993-5#1)(1994-2#1)(1995-12#1)(1996-5#3)(1997-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-7#1)(2012-12#1)
the human breast##3##3##(1993-9#1)(2008-11#1)(2008-3#1)
the human c-fos gene##2##4##(1991-12#2)
the human c-fos##3##3##(1991-12#3)
the human cell##3##3##(1990-11#1)(1994-6#1)(2008-11#1)
the human central nervous system##2##5##(1991-12#1)(1991-7#1)
the human chromosome##3##3##(1996-8#1)(1997-8#1)(2009-9#1)
the human colon cancer cell line##2##6##(1992-8#1)(1997-2#1)
the human colon##4##3##(1992-2#2)(1992-8#1)(1997-2#1)
the human condition and##2##4##(2008-4#1)(2012-3#1)
the human condition is##2##4##(2008-1#1)(2008-10#1)
the human condition##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
the human development##2##3##(2008-8#1)(2008-9#1)
the human dopamine##2##3##(1993-3#1)(1997-5#1)
the human efp##2##3##(1997-7#2)
the human embryonic##3##3##(2008-11#3)
the human endometrium##4##3##(1994-9#3)(2012-3#1)
the human enzyme and##3##4##(1994-8#2)(1995-5#1)
the human enzyme##5##3##(1994-8#3)(1995-2#1)(1995-5#1)
the human erythrocyte membrane##3##4##(1990-12#1)(2008-11#2)
the human erythrocyte##6##3##(1990-11#1)(1990-12#1)(1991-2#2)(2008-11#2)
the human eye##8##3##(2007-11#2)(2007-12#2)(2008-3#2)(2011-7#1)(2013-8#1)
the human ferredoxin gene##2##4##(1991-5#2)
the human gastric##2##3##(1992-8#1)(2008-11#1)
the human gastrointestinal tract##3##4##(2008-4#1)(2010-10#1)(2012-2#1)
the human gene##8##3##(1990-7#1)(1991-6#2)(1991-7#1)(1993-3#1)(1997-7#1)(2008-6#1)(2008-7#1)
the human genome project##2##4##(1995-8#1)(2008-11#1)
the human genome##31##3##(1990-12#1)(1991-2#1)(1991-6#2)(1992-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-4#6)(2008-5#2)(2008-7#7)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the human genomic DNA##2##4##(1992-11#2)
the human glucocorticoid receptor##3##4##(1990-11#1)(1995-2#2)
the human health##4##3##(2008-10#2)(2013-1#2)
the human hepatocyte growth##2##4##(1991-6#2)
the human homolog of##2##4##(1992-9#1)(1994-8#1)
the human homologue of##2##4##(1997-3#1)(1997-7#1)
the human homologue##3##3##(1997-3#1)(1997-7#1)(2009-5#1)
the human host##2##3##(2011-2#1)(2013-1#1)
the human hsp27##3##3##(1993-6#3)
the human hypothalamus##2##3##(1993-12#1)(2008-9#1)
the human immune system##5##4##(2008-10#2)(2008-4#2)(2011-2#1)
the human immunodeficiency virus (HIV)##8##5##(1990-9#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-8#1)(1996-11#1)(2008-5#1)(2012-2#1)
the human immunodeficiency virus in##2##5##(1990-9#1)(1992-6#1)
the human immunodeficiency virus##16##4##(1990-9#2)(1991-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-8#2)(1996-11#1)(1997-7#1)(2007-7#1)(2008-5#1)(2012-2#1)
the human immunodeficiency##19##3##(1990-9#2)(1991-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-8#2)(1996-11#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-5#1)(2009-6#1)(2012-2#1)
the human interleukin-1 receptor antagonist##2##5##(1992-3#1)(2008-5#1)
the human interleukin-1##3##3##(1992-3#1)(1993-8#1)(2008-5#1)
the human large##2##3##(1991-9#1)(1993-9#1)
the human life history##2##4##(2012-2#2)
the human lifespan##2##3##(2012-2#2)
the human likeness of##2##4##(2008-11#2)
the human lung##5##3##(1992-12#1)(1992-9#1)(1994-6#1)(1994-9#1)(2008-11#1)
the human lysosomal##2##3##(1993-8#1)(1994-11#1)
the human major##2##3##(1994-8#1)(1997-9#1)
the human malaria##2##3##(1993-2#1)(2008-8#1)
the human melanoma##2##3##(1994-5#1)(1994-6#1)
the human mind##2##3##(1990-2#1)(1990-6#1)
the human multidrug##2##3##(1994-5#1)(2008-11#1)
the human muscle glycogen phosphorylase gene##3##6##(1991-11#3)
the human neuroblastoma cell##2##4##(1992-5#1)(1996-10#1)
the human observer##2##3##(2010-8#1)(2012-1#1)
the human or##2##3##(1995-11#1)(2008-3#1)
the human organism##2##3##(1990-6#1)(1996-6#1)
the human pathogen##3##3##(1992-8#1)(1995-8#1)(2011-2#1)
the human platelet and##2##4##(1992-8#1)(2008-11#1)
the human platelet##4##3##(1992-8#1)(2006-6#2)(2008-11#1)
the human population##6##3##(2007-12#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
the human protein##4##3##(1991-6#1)(1991-9#1)(1994-8#1)(2009-5#1)
the human respiratory tract##5##4##(1995-12#1)(1997-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
the human retina##4##3##(1990-7#1)(2007-11#3)
the human serotonin 5-HT2 and 5-HT1C##2##6##(1991-12#2)
the human serum##4##3##(1993-3#1)(2008-10#2)(2008-5#1)
the human services##3##3##(1992-1#1)(2008-11#2)
the human skin##10##3##(2008-5#7)(2009-11#1)(2011-2#1)(2012-3#1)
the human species##2##3##(2013-1#1)(2013-7#1)
the human spermidine/spermine N1-acetyltransferase##2##4##(1991-9#1)(1992-10#1)
the human thyrotropin receptor##2##4##(1991-5#1)(1995-12#1)
the human thyrotropin##4##3##(1991-5#2)(1991-9#1)(1995-12#1)
the human##710##2##(1990-11#10)(1990-12#9)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#3)(1991-11#3)(1991-12#11)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#17)(1991-7#4)(1991-9#14)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#5)(1992-2#4)(1992-3#7)(1992-5#4)(1992-6#4)(1992-8#15)(1992-9#3)(1993-11#8)(1993-12#11)(1993-2#3)(1993-3#13)(1993-5#1)(1993-6#12)(1993-8#7)(1993-9#4)(1994-11#5)(1994-12#9)(1994-2#4)(1994-3#1)(1994-5#6)(1994-6#10)(1994-8#17)(1994-9#11)(1995-11#6)(1995-12#8)(1995-2#11)(1995-3#2)(1995-5#2)(1995-6#8)(1995-8#5)(1996-10#2)(1996-11#1)(1996-12#11)(1996-2#5)(1996-5#9)(1996-6#3)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#15)(1997-8#3)(1997-9#5)(2006-6#3)(2007-11#8)(2007-12#5)(2007-7#3)(2008-1#3)(2008-10#17)(2008-11#43)(2008-12#3)(2008-3#8)(2008-4#26)(2008-5#23)(2008-6#1)(2008-7#21)(2008-8#13)(2008-9#16)(2009-10#7)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#9)(2011-2#18)(2011-3#3)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#12)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#2)
the humanitarian##2##2##(2008-1#1)(2009-6#1)
the humanities in the education of health professionals##2##8##(2008-11#2)
the humanities##5##2##(2008-11#4)(2013-8#1)
the humerii##3##2##(2013-8#3)
the humerus##15##2##(1995-6#2)(2007-11#1)(2007-8#1)(2008-7#2)(2010-3#1)(2013-1#1)(2013-8#7)
the humic acid##2##3##(2008-10#1)(2013-8#1)
the humic##5##2##(2008-10#4)(2013-8#1)
the humid tropics##2##3##(2008-9#1)(2010-7#1)
the humid##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
the humidity##3##2##(2008-10#3)
the humoral immune response##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
the humoral immune##6##3##(1996-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
the humoral response##3##3##(1991-12#1)(2007-10#1)(2008-10#1)
the humoral##11##2##(1991-12#1)(1996-9#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2011-1#2)(2011-2#1)
the hurdles that##2##3##(1994-2#1)(2008-4#1)
the hurdles##4##2##(1994-2#1)(2008-4#1)(2009-11#1)(2009-4#1)
the hybrid FBP algorithm##2##4##(2008-2#2)
the hybrid and the##2##4##(2008-3#2)
the hybrid and##3##3##(2008-3#2)(2008-9#1)
the hybrid input-output algorithm##3##4##(2008-3#3)
the hybrid zone##2##3##(2008-8#2)
the hybrid##51##2##(1993-9#1)(1994-12#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#15)(2008-5#1)(2008-8#6)(2008-9#2)(2009-2#2)(2010-4#1)(2011-2#1)(2012-3#2)(2013-8#1)
the hybridization event##3##3##(2008-10#3)
the hybridization kinetics##2##3##(2010-5#2)
the hybridization of the##2##4##(2008-10#1)(2008-7#1)
the hybridization of##4##3##(2008-10#3)(2008-7#1)
the hybridization##18##2##(1993-5#1)(2008-10#12)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#2)
the hybridoma cell##3##3##(2008-10#1)(2008-11#2)
the hybridoma##8##2##(2008-10#1)(2008-11#7)
the hybridomas##2##2##(2008-11#2)
the hybrids and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the hybrids were##2##3##(1992-9#1)(2008-10#1)
the hybrids##11##2##(1992-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-4#1)
the hydatid cyst##2##3##(1991-8#1)(2007-8#1)
the hydatid##3##2##(1991-8#1)(2007-8#1)(2010-12#1)
the hydrated##2##2##(2008-10#2)
the hydration level##2##3##(2008-5#2)
the hydration process##5##3##(2008-10#5)
the hydration state of##3##4##(2008-5#2)(2008-7#1)
the hydration##18##2##(1992-8#1)(2008-10#7)(2008-5#6)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)
the hydraulic##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
the hydride generation##4##3##(2008-10#4)
the hydride##9##2##(1994-11#1)(2008-10#8)
the hydrides##2##2##(2008-10#2)
the hydroalcoholic##2##2##(2008-5#2)
the hydrocarbon chain##4##3##(1990-7#1)(1992-8#1)(2007-12#1)(2008-10#1)
the hydrocarbon chains##5##3##(1992-9#1)(1993-11#2)(1996-8#1)(2007-12#1)
the hydrocarbon##15##2##(1990-7#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#2)(1996-8#1)(2007-12#2)(2008-10#2)(2008-6#2)(2013-1#2)
the hydrocarbons##4##2##(1992-3#1)(2008-10#3)
the hydrodynamic##2##2##(2008-10#1)(2008-2#1)
the hydrogel##13##2##(2008-5#8)(2009-12#1)(2009-7#1)(2010-2#2)(2010-5#1)
the hydrogen bond donating ability of##2##6##(2008-10#2)
the hydrogen bond##6##3##(1992-3#1)(2008-10#3)(2010-7#2)
the hydrogen bonding##3##3##(1992-6#1)(2009-10#1)(2010-7#1)
the hydrogen bonds##2##3##(1992-6#1)(2008-10#1)
the hydrogen exchange##2##3##(1995-2#2)
the hydrogen ion concentration##2##4##(2008-10#2)
the hydrogen peroxide generated##2##4##(2008-10#2)
the hydrogen peroxide##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
the hydrogen production##2##3##(2013-1#2)
the hydrogen##33##2##(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#2)(1995-2#2)(2007-11#1)(2008-10#14)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#3)(2011-2#1)(2013-1#3)
the hydrogen-bonding##3##2##(1991-3#1)(1995-5#1)(2012-2#1)
the hydrolysate##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
the hydrolysates##7##2##(1990-7#1)(2008-5#1)(2008-6#2)(2008-7#2)(2013-1#1)
the hydrolysis and##3##3##(1997-1#1)(2008-10#2)
the hydrolysis of Reactive Red##2##5##(2008-10#2)
the hydrolysis of several##2##4##(1995-5#1)(2008-10#1)
the hydrolysis of the##8##4##(1991-8#1)(1993-11#1)(1994-5#2)(1994-9#1)(2008-10#1)(2008-6#1)(2010-3#1)
the hydrolysis of triglycerides##2##4##(1992-12#1)(1992-3#1)
the hydrolysis of##50##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-8#3)(1994-3#1)(1994-5#7)(1994-9#1)(1995-5#2)(2008-10#8)(2008-6#2)(2008-7#5)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#2)
the hydrolysis process##3##3##(2008-10#2)(2008-11#1)
the hydrolysis product##2##3##(2008-10#1)(2013-1#1)
the hydrolysis products##2##3##(2008-7#1)(2010-3#1)
the hydrolysis rate##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
the hydrolysis##70##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-8#3)(1994-3#1)(1994-5#7)(1994-9#1)(1995-5#2)(1997-1#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#8)(2009-12#1)(2010-3#2)(2011-1#1)(2011-2#3)(2013-1#4)
the hydrolytic##4##2##(1990-7#1)(1995-2#1)(2008-10#1)(2008-12#1)
the hydropathy##4##2##(1990-5#2)(1990-8#1)(2008-1#1)
the hydroperoxo complex##2##3##(1996-2#2)
the hydroperoxo##3##2##(1996-2#3)
the hydrophilic pore edge##2##4##(1990-11#2)
the hydrophilic##16##2##(1990-11#2)(1990-2#2)(1992-3#2)(1993-6#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)
the hydrophobic and##3##3##(2007-11#1)(2008-10#2)
the hydrophobic binding##3##3##(1991-12#1)(1995-5#2)
the hydrophobic cavity of##2##4##(2008-10#2)
the hydrophobic core of the##2##5##(1994-5#1)(1994-6#1)
the hydrophobic core of##5##4##(1994-5#1)(1994-6#1)(1995-2#1)(1997-2#2)
the hydrophobic core##7##3##(1991-5#1)(1991-6#1)(1994-5#1)(1994-6#1)(1995-2#1)(1997-2#2)
the hydrophobic effect##2##3##(2008-10#1)(2008-3#1)
the hydrophobic end##2##3##(1992-3#1)(2008-12#1)
the hydrophobic environment##2##3##(1992-9#1)(1994-9#1)
the hydrophobic interaction##2##3##(2008-10#2)
the hydrophobic leader##2##3##(1991-10#1)(1995-6#1)
the hydrophobic liquid-solid##2##3##(2011-1#2)
the hydrophobic patch##2##3##(1991-11#1)(1993-11#1)
the hydrophobic##56##2##(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2010-2#2)(2011-1#2)
the hydrophobicity of the##8##4##(1993-11#1)(1993-9#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)
the hydrophobicity##10##2##(1993-11#1)(1993-9#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-6#1)(2008-7#1)
the hydroquinone##4##2##(1993-11#1)(2008-10#2)(2008-6#1)
the hydrothermal##3##2##(2008-10#1)(2009-11#1)(2013-8#1)
the hydrous##3##2##(1990-12#1)(2008-10#2)
the hydroxide##4##2##(2008-10#4)
the hydroxy##4##2##(1993-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
the hydroxyapatite##2##2##(2008-7#1)(2011-2#1)
the hydroxyl group##3##3##(1992-6#1)(1993-11#1)(1995-5#1)
the hydroxyl groups of the##3##5##(2007-11#1)(2008-10#1)(2008-8#1)
the hydroxyl groups of##5##4##(2007-11#2)(2008-10#1)(2008-5#1)(2008-8#1)
the hydroxyl radical##7##3##(1990-5#2)(1991-9#1)(1995-2#1)(2008-10#2)(2008-4#1)
the hydroxyl##22##2##(1990-5#2)(1991-9#1)(1992-6#2)(1993-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-11#2)(2008-10#5)(2008-4#1)(2008-5#2)(2008-8#2)
the hydroxylamine##2##2##(1995-3#1)(1995-6#1)
the hygienic##2##2##(2008-6#1)(2010-8#1)
the hygromycin##3##2##(2008-10#2)(2008-11#1)
the hygroscopic effects##2##3##(2013-1#2)
the hyper-Rayleigh##2##2##(2007-12#2)
the hyperaemic FC curve shows a##2##6##(2008-3#2)
the hyperbenthic##2##2##(2008-5#2)
the hypercube##2##2##(2008-2#2)
the hyperdynamic circulation##3##3##(1997-7#1)(2006-10#2)
the hyperfine##2##2##(2007-11#1)(2008-3#1)
the hyperglycemia##2##2##(1991-7#1)(2010-11#1)
the hyperglycemic##3##2##(1990-5#1)(1991-12#1)(1994-2#1)
the hyperparasite##5##2##(2008-10#1)(2008-9#4)
the hyperphosphorylation of HSSB p34##2##5##(1994-8#2)
the hyperplastic##3##2##(1994-3#1)(2008-10#1)(2009-12#1)
the hyperpolarization##2##2##(1990-8#1)(1992-9#1)
the hypersensitive reaction and##2##4##(2008-10#2)
the hypersensitive reaction##7##3##(2008-10#7)
the hypersensitive response (HR)##6##4##(2008-10#6)
the hypersensitive response##10##3##(2008-10#10)
the hypersensitive##18##2##(2008-10#17)(2008-11#1)
the hypersensitivity##3##2##(1995-12#1)(1997-2#1)(2008-7#1)
the hypertension of##2##3##(1997-6#1)(2008-10#1)
the hypertension##4##2##(1993-11#1)(1997-6#1)(2008-10#1)(2008-11#1)
the hypertensive group##2##3##(2008-1#1)(2012-2#1)
the hypertensive##5##2##(2007-8#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
the hyperthermophilic archaeon Pyrococcus furiosus##2##5##(1993-9#1)(1995-5#1)
the hyperthermophilic archaeon##3##3##(1993-9#2)(1995-5#1)
the hyperthermophilic##6##2##(1993-9#2)(1994-12#2)(1995-5#1)(2008-9#1)
the hypertrophic##2##2##(1992-3#1)(2008-5#1)
the hypervariable region##2##3##(1990-7#2)
the hypervariable##4##2##(1990-7#2)(2008-10#2)
the hyperventilation##2##2##(1991-3#2)
the hyphae of##3##3##(2008-10#3)
the hyphae##8##2##(2008-10#7)(2008-7#1)
the hyphal##6##2##(1996-6#1)(2008-11#1)(2008-7#4)
the hyphenation of##2##3##(2008-10#1)(2008-12#1)
the hypocotyl##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
the hypodermal connective tissue strands##2##5##(2008-5#2)
the hypodermis##3##2##(2008-10#1)(2008-5#2)
the hypoglossal canal##2##3##(2011-2#2)
the hypoglossal nerve##2##3##(1993-12#1)(2008-2#1)
the hypoglossal##5##2##(1993-12#2)(2008-2#1)(2011-2#2)
the hypopharyngeal gland##3##3##(2008-6#3)
the hypotensive##4##2##(1990-7#1)(1990-9#1)(1991-5#1)(1994-11#1)
the hypothalamic nuclei##2##3##(1993-5#1)(2007-8#1)
the hypothalamic paraventricular area##2##4##(1993-12#2)
the hypothalamic paraventricular nucleus##5##4##(1993-12#1)(1994-8#2)(1996-12#2)
the hypothalamic paraventricular##7##3##(1993-12#3)(1994-8#2)(1996-12#2)
the hypothalamic##16##2##(1993-12#5)(1993-5#1)(1994-8#4)(1995-5#1)(1996-12#2)(2007-8#1)(2009-6#1)(2012-3#1)
the hypothalamic-pituitary-adrenal (HPA) axis##3##4##(1996-12#1)(2008-4#1)(2013-1#1)
the hypothalamic-pituitary-adrenal axis##5##3##(1994-5#1)(1997-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
the hypothalamic-pituitary-adrenal##8##2##(1994-5#1)(1996-12#1)(1997-2#1)(2008-4#2)(2008-5#1)(2013-1#1)(2013-8#1)
the hypothalamic-pituitary-gonadal axis##2##3##(1994-9#1)(2009-6#1)
the hypothalamus and##4##3##(1990-7#1)(1996-12#1)(1997-3#1)(2013-1#1)
the hypothalamus in##2##3##(1993-12#1)(1997-2#1)
the hypothalamus##35##2##(1990-7#1)(1992-12#1)(1993-12#5)(1993-5#2)(1994-2#5)(1994-5#1)(1994-6#1)(1995-12#6)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)(2008-4#1)(2008-7#2)(2010-6#1)(2011-1#1)(2013-1#2)
the hypothalamus-pituitary-adrenal##2##2##(1990-3#1)(2007-7#1)
the hypothermia##3##2##(1993-12#2)(1995-3#1)
the hypothermic##5##2##(1990-12#1)(1994-2#1)(1996-12#2)(2007-10#1)
the hypotheses that the##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
the hypotheses that##11##3##(1994-3#1)(1996-4#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
the hypotheses##18##2##(1994-3#1)(1996-3#1)(1996-4#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
the hypothesis has##2##3##(2013-1#2)
the hypothesis of a single##2##5##(2008-10#2)
the hypothesis of a##12##4##(1991-12#1)(1991-2#1)(1991-5#1)(1993-5#1)(1994-11#1)(1997-5#1)(2008-10#4)(2009-10#1)(2013-1#1)
the hypothesis of an##4##4##(1994-3#1)(2008-10#2)(2011-2#1)
the hypothesis of random mating##2##5##(2008-10#2)
the hypothesis of the##2##4##(1991-12#1)(2008-6#1)
the hypothesis of##33##3##(1991-12#2)(1991-2#1)(1991-5#1)(1992-5#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-5#1)(2008-10#11)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the hypothesis that a##10##4##(1990-5#1)(1992-6#1)(1993-6#1)(1995-5#1)(2008-10#1)(2008-8#2)(2009-5#1)(2012-1#1)(2013-8#1)
the hypothesis that an##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
the hypothesis that both##3##4##(1997-9#1)(2008-5#1)(2013-7#1)
the hypothesis that it##2##4##(1990-3#1)(2008-10#1)
the hypothesis that nonprofit##2##4##(1992-12#1)(1995-2#1)
the hypothesis that occupational##2##4##(1991-12#1)(2008-10#1)
the hypothesis that repeated##2##4##(1993-12#1)(2010-12#1)
the hypothesis that spatial##2##4##(2008-8#1)(2009-5#1)
the hypothesis that the disease##2##5##(2008-10#2)
the hypothesis that the neural##2##5##(1991-2#1)(2012-1#1)
the hypothesis that the##54##4##(1990-6#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
the hypothesis that there are##2##5##(1997-7#1)(2008-5#1)
the hypothesis that there is a##2##6##(1996-3#1)(2011-2#1)
the hypothesis that there is##3##5##(1996-3#1)(2008-12#1)(2011-2#1)
the hypothesis that there##6##4##(1996-3#1)(1997-7#1)(2008-12#1)(2008-5#1)(2011-2#2)
the hypothesis that they##2##4##(1992-9#1)(2008-5#1)
the hypothesis that this##4##4##(1993-11#1)(1994-10#1)(1996-5#1)(2008-10#1)
the hypothesis that when##2##4##(2009-2#1)(2013-8#1)
the hypothesis that##249##3##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#8)(1995-5#1)(1995-8#2)(1996-12#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#37)(2008-11#5)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#4)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#3)(2013-8#3)
the hypothesis##305##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#8)(1995-3#1)(1995-5#3)(1995-8#2)(1996-12#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#51)(2008-11#6)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#5)(2008-7#10)(2008-8#13)(2008-9#5)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#4)
the hypothesized##5##2##(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-1#1)
the hypothetical##8##2##(1993-12#1)(1994-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-12#1)(2008-9#1)(2009-5#1)
the hypovirulent phenotype##2##3##(2008-10#2)
the hypovirulent##7##2##(2008-10#7)
the hysteresis loop##2##3##(2008-3#2)
the hysteresis##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the hysteroscopic##2##2##(1992-12#1)(1994-9#1)
the i##4##2##(1993-11#1)(1995-11#1)(1996-2#2)
the iCFA##2##2##(1994-8#2)
the iView-GT##2##2##(2009-11#2)
the icEEG data##2##3##(2013-8#2)
the ice storm##3##3##(2008-2#3)
the ice##14##2##(2006-4#1)(2008-10#3)(2008-2#4)(2008-3#6)
the ice-like water##2##3##(2008-5#2)
the ichthyofauna##2##2##(2008-5#1)(2013-7#1)
the icicle##2##2##(2008-2#2)
the idea of a##5##4##(1994-12#1)(2008-3#1)(2010-10#1)(2012-2#1)(2013-8#1)
the idea of compassion##2##4##(2007-10#2)
the idea of the##4##4##(2007-12#1)(2008-3#1)(2008-8#1)(2010-11#1)
the idea of##24##3##(1994-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#3)(2013-8#2)
the idea that a##2##4##(1990-5#1)(1991-9#1)
the idea that the##10##4##(1990-10#1)(1990-5#1)(1993-12#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-5#1)
the idea that##52##3##(1990-10#1)(1990-11#2)(1990-5#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#3)
the idea##82##2##(1990-10#1)(1990-11#2)(1990-5#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#7)(2013-1#3)(2013-8#2)
the ideal and##2##3##(2008-3#1)(2010-10#1)
the ideal estimate##2##3##(2008-3#2)
the ideal of##2##3##(2008-10#1)(2008-5#1)
the ideal##52##2##(1990-7#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#3)(2008-8#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-7#1)(2013-1#3)(2013-8#1)
the ideas##5##2##(1996-1#1)(2007-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
the identical##10##2##(1991-8#1)(1992-8#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-2#1)
the identification and characterization of##2##5##(1994-12#1)(2008-4#1)
the identification and differentiation of##2##5##(2008-10#2)
the identification and quantification of##3##5##(2008-10#2)(2008-5#1)
the identification and##29##3##(1990-7#1)(1991-2#2)(1991-8#1)(1994-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
the identification in##2##3##(2008-10#1)(2009-8#1)
the identification of a high##2##5##(2010-6#1)(2012-3#1)
the identification of a novel##2##5##(2009-6#1)(2009-8#1)
the identification of a##19##4##(1990-11#1)(1991-2#1)(1993-12#2)(1994-8#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
the identification of all##2##4##(2008-9#1)(2011-3#1)
the identification of critical##2##4##(2009-10#1)(2011-1#1)
the identification of different##2##4##(1997-2#1)(2008-2#1)
the identification of four##2##4##(1991-5#1)(2007-7#1)
the identification of functional##3##4##(1992-12#1)(2008-7#2)
the identification of genes involved in##2##6##(2008-10#1)(2009-12#1)
the identification of genes that##2##5##(2008-4#1)(2011-2#1)
the identification of genes##5##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)
the identification of immunotoxicity##2##4##(2008-10#2)
the identification of new biomarkers and the development of##2##9##(2011-2#1)(2012-12#1)
the identification of new drug targets##2##6##(2008-7#1)(2010-12#1)
the identification of new##7##4##(2007-10#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
the identification of novel##7##4##(2008-10#1)(2008-7#2)(2009-4#1)(2010-4#1)(2012-1#1)(2013-1#1)
the identification of other##2##4##(2006-10#1)(2008-10#1)
the identification of patients##2##4##(2007-10#1)(2007-11#1)
the identification of potential##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
the identification of proteins##3##4##(1997-2#1)(2008-1#1)(2008-10#1)
the identification of the three##3##5##(1990-7#1)(2008-10#2)
the identification of the##28##4##(1990-2#1)(1990-7#1)(1995-11#1)(1995-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the identification of these##2##4##(2008-10#1)(2012-2#1)
the identification of this##2##4##(1996-12#1)(2009-10#1)
the identification of two new##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
the identification of two##9##4##(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-9#1)(2008-10#1)(2008-11#2)(2011-2#1)
the identification of##239##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#3)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-12#4)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#48)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#19)(2008-8#3)(2008-9#4)(2009-10#4)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#4)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#4)
the identification##283##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#3)(1991-2#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-12#4)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#3)(2008-10#60)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#7)(2008-6#2)(2008-7#20)(2008-8#3)(2008-9#6)(2009-10#4)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#5)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#8)
the identified genes are##2##4##(2008-7#1)(2011-2#1)
the identified##23##2##(1991-8#1)(1993-12#1)(1993-6#1)(1995-11#1)(2008-10#4)(2008-12#1)(2008-7#3)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
the identities##2##2##(2008-8#1)(2011-2#1)
the identity and diversity of##2##5##(2008-10#1)(2012-2#1)
the identity and##6##3##(1991-2#1)(2008-10#3)(2012-2#2)
the identity crisis##2##3##(1997-3#1)(2008-7#1)
the identity of the upcoming tastant##2##6##(2008-11#2)
the identity of the##22##4##(1990-12#1)(1990-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2010-3#1)(2011-1#2)(2011-2#1)(2013-8#1)
the identity of##32##3##(1990-12#2)(1990-7#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
the identity##46##2##(1990-12#2)(1990-7#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-5#2)(1996-5#1)(1997-3#2)(1997-4#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#4)(2013-8#3)
the ideological##4##2##(1991-6#1)(2008-9#1)(2010-1#1)(2013-1#1)
the ideology of##2##3##(1991-6#1)(2008-10#1)
the idiopathic scoliosis##3##3##(2007-8#3)
the idiopathic##4##2##(2007-8#3)(2012-2#1)
the idiosyncratic##2##2##(2008-10#1)(2008-4#1)
the idler output##2##3##(2007-11#1)(2007-12#1)
the idler waves##2##3##(2007-12#1)(2008-3#1)
the idler##14##2##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#4)
the ileal##3##2##(1996-12#1)(2008-5#1)(2009-12#1)
the ileocecal##3##2##(1990-8#1)(1994-5#1)(2010-12#1)
the ileostomy##3##2##(2009-5#3)
the ileum##6##2##(1993-6#1)(1994-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
the iliac artery##3##3##(2008-3#2)(2012-1#1)
the iliac crest##4##3##(2007-11#1)(2009-9#2)(2010-8#1)
the iliac##13##2##(1991-11#1)(1997-3#1)(2007-11#1)(2008-12#1)(2008-3#2)(2009-3#1)(2009-9#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
the iliacus##4##2##(2006-10#1)(2009-3#3)
the iliotibial##2##2##(2012-2#2)
the ill##3##2##(1990-10#1)(2008-3#1)(2009-9#1)
the illicit##2##2##(2008-10#1)(2012-1#1)
the illness and##5##3##(1992-11#1)(1992-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
the illness in##2##3##(1992-12#1)(2012-2#1)
the illness##28##2##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1996-1#1)(1996-11#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#2)
the illuminated##4##2##(2008-2#1)(2008-3#3)
the illuminating beam##3##3##(2008-2#2)(2008-3#1)
the illuminating##8##2##(2008-2#4)(2008-3#4)
the illumination and##2##3##(2008-2#1)(2008-3#1)
the illumination angle##2##3##(2008-3#2)
the illumination of##3##3##(2008-3#2)(2008-4#1)
the illumination source##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2011-1#1)
the illumination was##2##3##(2008-4#1)(2012-3#1)
the illumination##28##2##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#14)(2008-4#2)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#1)
the illusion of##2##3##(2007-12#1)(2013-1#1)
the illusion##4##2##(1995-1#1)(2007-12#1)(2013-1#1)(2013-8#1)
the ilv3##2##2##(1993-12#2)
the image acquisition##2##3##(2007-11#1)(2008-10#1)
the image analysis##2##3##(2008-10#1)(2010-12#1)
the image and the##4##4##(2008-3#4)
the image and##5##3##(2008-3#5)
the image at##3##3##(2008-2#1)(2010-5#2)
the image by using a##2##5##(2008-2#1)(2008-3#1)
the image by##3##3##(2008-2#2)(2008-3#1)
the image contrast and##2##4##(2008-3#2)
the image contrast##6##3##(2008-3#6)
the image data and##2##4##(2008-6#1)(2012-3#1)
the image data##4##3##(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
the image distribution##3##3##(2008-2#3)
the image field##2##3##(2008-3#2)
the image in##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2013-8#1)
the image is##4##3##(1995-11#1)(1996-2#1)(2008-1#1)(2008-3#1)
the image of a##2##4##(2008-2#1)(2008-3#1)
the image of the object itself##2##6##(2008-3#2)
the image of the pattern##2##5##(2008-3#2)
the image of the##12##4##(1995-1#1)(2008-12#1)(2008-3#7)(2008-6#1)(2009-10#1)(2010-8#1)
the image of##17##3##(1995-1#1)(1996-12#1)(2007-10#1)(2008-12#2)(2008-2#1)(2008-3#8)(2008-6#1)(2009-10#1)(2010-8#1)
the image plane##8##3##(2007-12#1)(2008-2#3)(2008-3#4)
the image processing##2##3##(1995-6#1)(2008-3#1)
the image quality of a##2##5##(2008-2#1)(2008-3#1)
the image quality of##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
the image quality##7##3##(1997-8#1)(2008-2#2)(2008-3#2)(2011-1#2)
the image reconstruction##2##3##(2008-3#2)
the image resolution##2##3##(2007-12#1)(2008-2#1)
the image space##2##3##(2008-6#1)(2011-2#1)
the image##137##2##(1991-12#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#8)(2007-12#5)(2008-1#3)(2008-10#3)(2008-12#4)(2008-2#25)(2008-3#50)(2008-4#1)(2008-6#7)(2009-10#2)(2010-12#3)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-3#1)(2013-8#2)
the image-formation process##2##3##(2007-12#1)(2008-9#1)
the image-guided##2##2##(2009-12#1)(2013-1#1)
the imager and##2##3##(2008-3#2)
the imager##3##2##(2008-3#3)
the images and the##2##4##(2007-12#1)(2010-8#1)
the images are in color##2##5##(2012-2#2)
the images are##9##3##(2008-2#1)(2008-3#5)(2012-2#3)
the images formed by##2##4##(2008-3#2)
the images in##2##3##(2008-3#1)(2011-7#1)
the images of lines##2##4##(2008-2#2)
the images of the##3##4##(2008-2#2)(2011-1#1)
the images of##9##3##(2008-10#1)(2008-2#4)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)
the images##47##2##(1995-11#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#16)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-8#3)(2011-1#1)(2011-7#1)(2012-2#4)(2012-3#1)(2013-8#1)
the imaginary part of the refractive index##2##7##(2008-3#2)
the imaginary part of the##4##5##(2007-11#1)(2008-3#3)
the imaginary part was##2##4##(2008-3#2)
the imaginary part##12##3##(2007-11#1)(2008-3#11)
the imaginary##29##2##(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#18)
the imagination##2##2##(2009-10#1)(2010-7#1)
the imaging and##2##3##(2008-5#1)(2009-11#1)
the imaging capability##2##3##(2008-3#1)(2011-1#1)
the imaging characteristics of##4##4##(1997-8#1)(2008-2#1)(2012-2#2)
the imaging data##2##3##(2012-2#1)(2013-8#1)
the imaging examinations##2##3##(2008-4#1)(2012-12#1)
the imaging features of##2##4##(2008-1#1)(2012-2#1)
the imaging features##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
the imaging findings##5##3##(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
the imaging geometry##2##3##(2007-11#1)(2008-6#1)
the imaging of apoptosis##2##4##(2008-8#2)
the imaging of##10##3##(2008-2#3)(2008-3#2)(2008-8#2)(2010-12#1)(2012-2#2)
the imaging optics##2##3##(2008-3#2)
the imaging performance of##5##4##(2008-2#4)(2008-3#1)
the imaging procedure##2##3##(2007-12#1)(2010-8#1)
the imaging process from##2##4##(2008-2#1)(2008-3#1)
the imaging process##3##3##(2008-2#2)(2008-3#1)
the imaging properties##2##3##(2008-3#2)
the imaging system##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
the imaging##82##2##(1991-12#1)(1997-8#1)(2007-11#3)(2007-12#4)(2008-1#3)(2008-10#1)(2008-2#16)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#2)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#10)(2013-1#1)(2013-8#2)
the imbalance between##2##3##(2008-3#1)(2009-7#1)
the imbalance##3##2##(1994-2#1)(2008-3#1)(2009-7#1)
the imidazole derivative##2##3##(2008-10#2)
the imidazole##6##2##(1995-5#1)(2008-10#3)(2008-8#2)
the imide nitrogen##2##3##(1992-6#1)(2009-9#1)
the iminium in equilibrium with enamine##2##6##(1991-9#2)
the immature brain##2##3##(1996-5#2)
the immature##12##2##(1994-3#1)(1995-8#1)(1996-5#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)
the immediate and the long-term##2##5##(1993-12#1)(2008-12#1)
the immediate and##3##3##(1993-12#1)(2008-12#1)(2013-8#1)
the immediate effects of##3##4##(1991-9#1)(2008-12#1)(2010-12#1)
the immediate outcome of##2##4##(1994-11#1)(1996-9#1)
the immediate postflame zone##2##4##(2008-3#2)
the immediate postoperative period##5##4##(1990-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)
the immediate postoperative##7##3##(1990-3#1)(2007-11#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)
the immediate precursor##2##3##(2008-10#2)
the immediate##60##2##(1990-3#2)(1991-9#2)(1992-4#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1996-2#1)(1996-7#1)(1996-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#4)(2013-8#1)
the immediately postoperative##2##3##(1991-2#2)
the immense##3##2##(2008-11#1)(2010-8#1)(2012-3#1)
the immersed##2##2##(1990-5#1)(2011-1#1)
the immersion##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
the immigrants##4##2##(1992-5#1)(1997-6#1)(2008-8#2)
the immigration##2##2##(2008-10#1)(2012-2#1)
the imminent##4##2##(1991-3#1)(1993-6#1)(2011-1#1)(2013-8#1)
the immobilisation##3##2##(2008-10#3)
the immobilised##5##2##(1997-2#1)(2008-10#4)
the immobility##2##2##(1991-12#1)(2013-1#1)
the immobilization and##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
the immobilization of a##3##4##(2008-10#1)(2009-3#1)(2010-12#1)
the immobilization of polyphenol oxidase##2##5##(2008-10#2)
the immobilization of the##5##4##(2008-10#4)(2010-5#1)
the immobilization of##26##3##(1993-12#1)(2008-10#18)(2008-11#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-8#1)
the immobilization##34##2##(1993-12#1)(2007-11#1)(2008-10#24)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-8#1)
the immobilized Chiralpak IA##2##4##(2008-10#2)
the immobilized HRP##2##3##(2008-10#2)
the immobilized cells##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
the immobilized enzyme was##2##4##(2008-10#1)(2008-7#1)
the immobilized enzyme##5##3##(2008-10#3)(2008-7#1)(2009-10#1)
the immobilized metal##2##3##(1990-8#1)(2008-10#1)
the immobilized oligonucleotide##2##3##(2008-10#2)
the immobilized##49##2##(1990-12#2)(1990-5#1)(1990-8#1)(1993-11#2)(2008-10#30)(2008-11#4)(2008-12#1)(2008-7#6)(2008-8#1)(2009-10#1)
the immortalization of##2##3##(1993-11#1)(2008-11#1)
the immune and##2##3##(2009-6#1)(2012-3#1)
the immune cells##4##3##(1994-5#1)(2008-3#2)(2013-1#1)
the immune complex##2##3##(1996-5#1)(2008-4#1)
the immune inflammatory response##2##4##(2013-1#2)
the immune response against##2##4##(1994-3#1)(2008-9#1)
the immune response and##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
the immune response during##2##4##(2008-11#1)(2009-5#1)
the immune response in##2##4##(1995-5#1)(2008-11#1)
the immune response of##2##4##(1992-9#1)(2008-10#1)
the immune response to hepatitis B vaccine##2##7##(2009-12#1)(2013-1#1)
the immune response to##7##4##(1993-8#1)(1995-5#1)(1997-4#1)(2007-2#1)(2008-2#1)(2009-12#1)(2013-1#1)
the immune response##36##3##(1991-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-5#3)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#5)
the immune responses##7##3##(1992-5#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
the immune stimulatory potential of##2##5##(2008-10#2)
the immune system and##9##4##(1990-11#1)(1990-9#1)(1995-12#1)(1996-11#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-1#1)
the immune system are##4##4##(2008-10#1)(2008-2#1)(2008-5#2)
the immune system in##7##4##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the immune system of##6##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
the immune system through the##2##5##(1997-7#1)(2008-9#1)
the immune system to##3##4##(2009-12#1)(2011-2#1)(2013-7#1)
the immune system##99##3##(1990-11#1)(1990-9#1)(1991-1#1)(1993-12#3)(1993-3#3)(1994-11#1)(1995-12#2)(1996-11#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#11)(2008-5#6)(2008-7#4)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#2)
the immune##179##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#5)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#3)(1995-5#4)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-5#1)(2008-10#36)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#13)(2008-5#8)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#8)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#15)(2013-7#3)
the immunity##3##2##(1994-2#1)(1997-3#1)(2008-7#1)
the immunization status of##2##4##(1996-1#1)(2008-4#1)
the immunization##12##2##(1990-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-8#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#2)
the immunized##4##2##(2008-11#2)(2008-9#2)
the immunoaffinity column##2##3##(2008-10#1)(2008-11#1)
the immunoaffinity##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
the immunoassay##9##2##(2008-10#8)(2010-11#1)
the immunochemical reaction##2##3##(2008-10#2)
the immunochemical##5##2##(1991-12#1)(1994-2#1)(2008-10#3)
the immunocompetent##3##2##(2008-10#1)(2010-12#2)
the immunocompromised##5##2##(2007-12#1)(2008-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
the immunocytochemical##5##2##(1992-10#1)(1996-5#1)(1997-2#1)(2008-9#1)(2011-2#1)
the immunodominant##2##2##(1990-12#1)(1994-8#1)
the immunofluorescence##2##2##(1990-12#1)(1991-3#1)
the immunogenic potential of##2##4##(2008-10#2)
the immunogenicity of##12##3##(1990-12#1)(1995-5#2)(1997-6#1)(2008-10#4)(2008-8#3)(2009-4#1)
the immunogenicity##14##2##(1990-12#1)(1995-5#2)(1997-6#1)(2008-10#5)(2008-12#1)(2008-8#3)(2009-4#1)
the immunoglobulin##15##2##(1991-2#1)(1991-9#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)
the immunohistochemical method##4##3##(1990-5#1)(1996-5#2)(2008-5#1)
the immunohistochemical##7##2##(1990-5#1)(1994-7#2)(1996-5#2)(2008-5#1)(2008-6#1)
the immunologic##4##2##(1995-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
the immunological agglutination##4##3##(1990-12#4)
the immunological barrier##2##3##(2009-10#1)(2012-2#1)
the immunological mechanisms##2##3##(2008-10#1)(2009-5#1)
the immunological##20##2##(1990-12#5)(1991-6#1)(2007-11#1)(2008-10#4)(2008-4#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-2#1)
the immunomodulating properties##2##3##(1991-6#1)(1994-3#1)
the immunomodulating##3##2##(1991-6#1)(1994-3#1)(2008-10#1)
the immunomodulatory activity##2##3##(1991-1#1)(2008-10#1)
the immunomodulatory##5##2##(1991-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
the immunopathogenesis of##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)
the immunoperoxidase##2##2##(1991-8#1)(1997-2#1)
the immunophenotype##2##2##(1991-2#1)(1995-3#1)
the immunopositive##2##2##(2008-6#1)(2013-8#1)
the immunoprecipitated##4##2##(1992-9#1)(2008-2#3)
the immunoprecipitates##3##2##(1992-9#1)(1993-8#1)(1997-6#1)
the immunoprecipitation of##3##3##(1992-9#1)(1997-1#1)(2008-4#1)
the immunoprecipitation##4##2##(1992-9#1)(1994-2#1)(1997-1#1)(2008-4#1)
the immunoreaction between##2##3##(2008-10#2)
the immunoreaction##4##2##(1994-2#1)(2008-10#3)
the immunoreactive##4##2##(1990-7#1)(1993-8#1)(1994-9#1)(1996-2#1)
the immunoreactivity of##2##3##(2008-7#1)(2013-8#1)
the immunoreactivity##5##2##(1992-3#1)(1994-6#1)(1995-12#1)(2008-7#1)(2013-8#1)
the immunosensor##9##2##(2008-10#8)(2008-7#1)
the immunosuppressant##3##2##(1993-8#1)(2010-12#1)(2010-3#1)
the immunosuppressive actions of##2##4##(1993-8#1)(2008-10#1)
the immunosuppressive activity of##2##4##(1990-5#2)
the immunosuppressive effects of CsA##2##5##(1990-12#2)
the immunosuppressive effects of##3##4##(1990-12#2)(2011-1#1)
the immunosuppressive##14##2##(1990-12#2)(1990-5#3)(1991-9#1)(1993-11#1)(1993-8#1)(2008-1#2)(2008-10#2)(2011-1#1)(2011-2#1)
the immunotoxic##2##2##(2008-10#2)
the immunotoxicological potential of##2##4##(2008-10#2)
the impact and##6##3##(1993-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the impact of a single##2##5##(2008-4#1)(2008-7#1)
the impact of a##21##4##(1992-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
the impact of acculturation##2##4##(2007-12#1)(2010-8#1)
the impact of an##2##4##(2007-7#1)(2011-2#1)
the impact of changes##3##4##(1995-12#1)(1995-3#1)(1996-2#1)
the impact of different##4##4##(1996-3#1)(1996-7#1)(2008-12#1)(2012-2#1)
the impact of early##2##4##(2008-4#1)(2009-5#1)
the impact of education##2##4##(2008-11#1)(2008-9#1)
the impact of environmental##2##4##(2008-8#1)(2011-1#1)
the impact of false-negatives##3##4##(2012-12#3)
the impact of foodborne disease##2##5##(2007-12#2)
the impact of imaging on##2##5##(2008-2#2)
the impact of imaging##3##4##(2008-2#2)(2009-11#1)
the impact of medical##2##4##(2008-11#1)(2011-1#1)
the impact of mental##2##4##(2012-3#1)(2013-8#1)
the impact of n-3 PUFAs on##2##6##(2013-1#2)
the impact of obesity on the##2##6##(2011-2#2)
the impact of pandemic influenza##2##5##(2011-2#2)
the impact of selected##2##4##(2007-8#1)(2010-3#1)
the impact of several##3##4##(1996-12#1)(2007-8#1)(2009-7#1)
the impact of shaving on##2##5##(2008-5#2)
the impact of smoking##2##4##(1995-6#1)(1997-7#1)
the impact of stress on##2##5##(1994-2#1)(2012-3#1)
the impact of stress##3##4##(1994-2#1)(2011-2#1)(2012-3#1)
the impact of temperature##2##4##(2011-2#1)(2013-8#1)
the impact of the##49##4##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-1#3)(1994-2#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
the impact of these programs##2##5##(2007-11#1)(2013-1#1)
the impact of these##10##4##(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
the impact of this##8##4##(2008-10#2)(2008-11#3)(2011-2#1)(2012-2#1)(2013-7#1)
the impact of treatment on##3##5##(1992-9#1)(2013-1#2)
the impact of treatment##4##4##(1992-9#1)(2008-2#1)(2013-1#2)
the impact of two##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
the impact of using##2##4##(2008-11#1)(2008-12#1)
the impact of various##2##4##(1993-12#1)(2009-5#1)
the impact of##344##3##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-6#3)(1994-1#5)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#5)(1995-2#2)(1995-3#4)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#25)(2008-11#27)(2008-12#6)(2008-2#13)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#8)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#8)(2011-2#25)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#11)(2012-9#1)(2013-1#21)(2013-7#2)(2013-8#13)
the impact on health##2##4##(1991-2#1)(2007-10#1)
the impact on patient##2##4##(1994-3#1)(2010-2#1)
the impact on the##4##4##(1992-2#1)(1993-1#1)(2008-2#1)(2008-3#1)
the impact on##28##3##(1991-2#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
the impact that the##2##4##(1992-1#1)(2008-12#1)
the impact that##6##3##(1992-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)
the impact these##2##3##(1992-3#1)(2008-9#1)
the impact##399##2##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#4)(1992-12#2)(1992-2#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#4)(1994-1#6)(1994-12#2)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#4)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#5)(1997-6#1)(1997-7#2)(2006-10#2)(2007-10#5)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#29)(2008-11#30)(2008-12#7)(2008-2#15)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#12)(2008-8#12)(2008-9#9)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#9)(2011-2#28)(2011-4#1)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#13)(2012-9#1)(2013-1#22)(2013-7#2)(2013-8#13)
the impacted##2##2##(2010-12#1)(2013-1#1)
the impactor##2##2##(2008-10#1)(2008-3#1)
the impacts of the##2##4##(1996-12#1)(2008-1#1)
the impacts of##12##3##(1992-3#1)(1996-12#1)(1997-5#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-9#2)(2010-10#1)(2013-1#2)
the impacts##13##2##(1992-3#1)(1996-12#1)(1997-5#1)(2008-1#3)(2008-12#1)(2008-5#1)(2008-9#2)(2010-10#1)(2013-1#2)
the impaired##4##2##(2008-10#1)(2008-9#1)(2010-4#1)(2013-8#1)
the impairment in##2##3##(1992-12#1)(2011-1#1)
the impairment of the##2##4##(1995-11#1)(2010-10#1)
the impairment of##16##3##(1991-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-7#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
the impairment##23##2##(1991-6#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-7#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the impedance of##2##3##(1995-11#1)(2008-10#1)
the impedance##3##2##(1995-11#1)(2008-10#2)
the impeller centrifugal pump##2##4##(1992-1#2)
the impeller##4##2##(1992-1#2)(2008-6#1)(2008-8#1)
the impending##3##2##(1992-3#1)(2013-1#1)(2013-8#1)
the imperative of##2##3##(1996-2#1)(1997-1#1)
the imperative to##2##3##(1997-2#1)(2008-11#1)
the imperative##4##2##(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)
the impetus for research into##2##5##(1996-11#1)(1997-7#1)
the impetus for##6##3##(1996-1#1)(1996-11#2)(1997-1#1)(1997-7#1)(2008-12#1)
the implant can be##2##4##(2008-1#1)(2011-2#1)
the implant in##2##3##(2008-9#1)(2009-11#1)
the implant site##2##3##(2008-9#1)(2012-3#1)
the implant was performed##2##4##(2007-11#1)(2008-6#1)
the implant was##4##3##(2007-11#1)(2008-6#1)(2008-9#1)(2013-1#1)
the implant##39##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#16)(2009-11#2)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
the implantable##2##2##(2008-1#1)(2008-12#1)
the implantation of a##2##4##(2012-2#1)(2012-3#1)
the implantation of##9##3##(2007-8#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
the implantation##14##2##(1990-3#1)(2007-11#1)(2007-8#2)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
the implanted twin##2##3##(2008-9#2)
the implanted##10##2##(1994-9#1)(1995-11#1)(1997-4#1)(2007-8#1)(2008-9#4)(2009-3#1)(2012-2#1)
the implants are##2##3##(2009-4#1)(2013-1#1)
the implants were##2##3##(2008-6#1)(2013-1#1)
the implants##11##2##(2008-6#2)(2009-4#1)(2013-1#8)
the implementation and##5##3##(2007-12#2)(2008-10#1)(2011-2#1)(2013-1#1)
the implementation of a##27##4##(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-9#1)(2010-10#2)(2011-1#1)(2012-2#1)(2013-1#3)
the implementation of an##6##4##(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#1)
the implementation of effective##2##4##(1997-2#1)(2008-10#1)
the implementation of evidence-based##2##4##(2008-11#1)(2008-3#1)
the implementation of health##2##4##(2011-1#1)(2013-8#1)
the implementation of new##4##4##(1995-3#1)(2008-10#2)(2011-2#1)
the implementation of programs##2##4##(1994-1#1)(1994-2#1)
the implementation of such##2##4##(2007-12#1)(2010-3#1)
the implementation of the Boston##2##5##(2008-3#2)
the implementation of the new##2##5##(2012-3#2)
the implementation of the##27##4##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-3#2)(2013-1#1)
the implementation of these##3##4##(1994-1#2)(1997-7#1)
the implementation of this approach##2##5##(1996-1#1)(2010-8#1)
the implementation of this##6##4##(1996-1#1)(1996-2#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-8#1)
the implementation of##139##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-6#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-2#4)(1997-3#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#18)(2008-4#2)(2008-7#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
the implementation process##4##3##(1992-2#1)(1996-1#1)(2007-5#1)(2008-11#1)
the implementation strategies##4##3##(2013-1#4)
the implementation##160##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-2#1)(1993-6#1)(1994-1#6)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#2)(1997-2#6)(1997-3#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#9)(2008-12#2)(2008-2#7)(2008-3#18)(2008-4#2)(2008-7#3)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#2)
the implemented##3##2##(2008-3#1)(2011-3#1)(2012-12#1)
the implication is that##2##4##(1996-1#1)(2007-12#1)
the implication of##7##3##(1992-6#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
the implication##10##2##(1992-6#1)(1996-1#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
the implications for health##3##4##(1993-1#1)(1994-3#1)(2008-12#1)
the implications for the##2##4##(1996-1#1)(2008-9#1)
the implications for##15##3##(1993-1#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-3#1)
the implications of a##5##4##(1994-12#1)(1994-2#1)(1995-2#1)(2007-6#1)(2012-12#1)
the implications of such##4##4##(2008-12#1)(2008-8#1)(2009-8#1)(2010-1#1)
the implications of the##6##4##(1995-1#1)(2007-11#1)(2008-3#1)(2008-8#2)(2013-1#1)
the implications of these##6##4##(1991-2#1)(1994-1#1)(1996-2#1)(2008-10#2)(2008-11#1)
the implications of this##6##4##(1991-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#1)
the implications of##45##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#2)(1994-1#2)(1994-12#2)(1994-2#3)(1995-1#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
the implications that##3##3##(1990-2#1)(1991-1#1)(1994-2#1)
the implications##70##2##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-1#2)(1994-12#2)(1994-2#4)(1994-3#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#5)(2008-12#4)(2008-3#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the implicit##3##2##(2007-8#1)(2008-7#1)(2012-12#1)
the importance and##6##3##(1995-1#1)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-3#1)
the importance for##3##3##(1992-4#1)(1993-11#1)(2008-3#1)
the importance given to##2##4##(1995-1#1)(2008-9#1)
the importance of a correct##2##5##(1991-5#1)(2013-1#1)
the importance of a multidisciplinary approach##2##6##(2013-1#2)
the importance of a##21##4##(1991-5#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#4)
the importance of an##6##4##(1990-10#1)(1991-12#1)(1991-2#1)(1993-12#1)(1995-11#1)(2008-4#1)
the importance of assessing##2##4##(2008-10#1)(2011-2#1)
the importance of careful##5##4##(1992-6#1)(1997-3#1)(2006-10#1)(2008-11#1)(2012-2#1)
the importance of clinical##2##4##(2011-1#1)(2012-2#1)
the importance of competition##2##4##(1993-2#1)(2008-9#1)
the importance of concentration##2##4##(2008-7#1)(2010-5#1)
the importance of considering spatial##2##5##(2008-8#2)
the importance of considering the##4##5##(1993-3#1)(2007-12#1)(2011-2#1)(2013-7#1)
the importance of considering##13##4##(1993-3#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
the importance of controlling##2##4##(2008-5#1)(2009-11#1)
the importance of developing##2##4##(2008-11#1)(2009-11#1)
the importance of early recognition and##2##6##(2010-10#1)(2013-1#1)
the importance of early##9##4##(1990-9#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)
the importance of elements##2##4##(1990-11#1)(1990-5#1)
the importance of emergency services]##2##5##(1997-5#2)
the importance of emergency##3##4##(1997-5#2)(2008-12#1)
the importance of evaluating the##2##5##(2008-1#1)(2008-11#1)
the importance of examining ethnic##2##5##(2009-7#1)(2010-10#1)
the importance of examining##3##4##(2009-7#1)(2010-1#1)(2010-10#1)
the importance of exogenous##2##4##(1990-8#1)(2010-10#1)
the importance of genetic##2##4##(2006-10#1)(2011-2#1)
the importance of having##2##4##(2007-9#1)(2008-12#1)
the importance of high##2##4##(2011-1#1)(2013-1#1)
the importance of including##2##4##(2007-11#1)(2008-8#1)
the importance of integrating##2##4##(2010-7#1)(2012-3#1)
the importance of keeping##2##4##(1991-2#1)(2010-4#1)
the importance of lipase activity in M##2##7##(2010-10#2)
the importance of local##3##4##(2008-10#1)(2009-3#1)(2012-2#1)
the importance of maintaining##2##4##(2012-3#1)(2013-1#1)
the importance of major##2##4##(1992-3#1)(1996-6#1)
the importance of matching##3##4##(1995-1#1)(2007-11#1)(2008-3#1)
the importance of monitoring##2##4##(1996-7#1)(1997-2#1)
the importance of patient##2##4##(1993-2#1)(2012-2#1)
the importance of primary##2##4##(2008-10#1)(2010-5#1)
the importance of public health##2##5##(1996-3#1)(2011-2#1)
the importance of quality##2##4##(2008-9#1)(2012-12#1)
the importance of rapid##2##4##(2008-10#1)(2008-8#1)
the importance of recognizing the##2##5##(1993-12#1)(2013-1#1)
the importance of recognizing##4##4##(1993-12#1)(2007-5#1)(2011-1#1)(2013-1#1)
the importance of regular##2##4##(2011-2#1)(2013-8#1)
the importance of research##2##4##(1992-12#1)(2011-2#1)
the importance of school-based##2##4##(2008-9#1)(2009-7#1)
the importance of social##3##4##(2008-11#1)(2009-7#1)(2010-6#1)
the importance of some##3##4##(1997-3#1)(2008-10#1)(2009-6#1)
the importance of spatial##2##4##(2008-10#1)(2008-7#1)
the importance of such a##2##5##(2008-5#1)(2009-8#1)
the importance of such##4##4##(2007-2#1)(2008-10#1)(2008-5#1)(2009-8#1)
the importance of taking into##2##5##(1995-9#1)(2008-12#1)
the importance of taking##4##4##(1995-9#1)(2008-12#2)(2013-8#1)
the importance of the early##2##5##(2008-9#1)(2010-12#1)
the importance of the##48##4##(1990-12#1)(1991-12#1)(1991-3#2)(1991-6#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-9#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#3)
the importance of these molecules##2##5##(2007-5#1)(2008-11#1)
the importance of these##12##4##(1990-2#1)(1991-8#1)(1994-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)
the importance of this##12##4##(1990-5#1)(1991-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-1#1)(2013-1#1)
the importance of two##2##4##(1992-9#1)(2008-7#1)
the importance of understanding the##3##5##(1996-12#1)(2010-12#1)(2013-1#1)
the importance of understanding##5##4##(1996-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
the importance of using##3##4##(1991-6#1)(2008-10#1)(2011-2#1)
the importance of##511##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#4)(1990-9#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#7)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#4)(1993-3#3)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#6)(1996-12#3)(1996-2#2)(1996-3#5)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#2)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#46)(2008-11#39)(2008-12#9)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#18)(2008-8#15)(2008-9#17)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#9)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#10)(2010-11#1)(2010-12#5)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#23)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#12)(2012-3#10)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#5)
the importance that##3##3##(1991-9#1)(1995-1#1)(2010-4#1)
the importance to##2##3##(2008-5#1)(2012-3#1)
the importance##532##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#4)(1990-9#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#8)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#3)(1993-6#2)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#4)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#6)(1996-12#3)(1996-2#2)(1996-3#5)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#2)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#46)(2008-11#40)(2008-12#10)(2008-2#5)(2008-3#10)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#18)(2008-8#15)(2008-9#18)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#9)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#10)(2010-11#1)(2010-12#5)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#24)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#13)(2012-3#12)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#5)
the important and##2##3##(2008-7#1)(2009-7#1)
the important considerations##2##3##(1992-3#1)(2006-5#1)
the important contribution of##2##4##(1997-3#1)(2008-10#1)
the important factors##3##3##(2008-8#1)(2008-9#2)
the important features##2##3##(2008-11#1)(2008-3#1)
the important physiological##2##3##(1992-12#1)(2008-9#1)
the important role of##16##4##(1991-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
the important role played by the##2##6##(2006-10#1)(2012-2#1)
the important role##19##3##(1991-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
the important roles played by##2##5##(1994-12#1)(2008-5#1)
the important roles##4##3##(1994-12#1)(2008-5#1)(2010-11#1)(2012-3#1)
the important##101##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-3#2)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-4#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#3)
the importation of##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
the imposition of##3##3##(2007-11#1)(2008-11#1)(2009-8#1)
the impossibility of##4##3##(1996-12#1)(2007-6#1)(2007-7#1)(2012-2#1)
the impossibility##5##2##(1990-3#1)(1996-12#1)(2007-6#1)(2007-7#1)(2012-2#1)
the impossible return##2##3##(1991-12#2)
the impossible##3##2##(1991-12#2)(1996-1#1)
the impression that##2##3##(1990-6#1)(1991-12#1)
the impression##4##2##(1990-6#1)(1991-12#1)(2009-6#1)(2012-2#1)
the impressive##6##2##(1991-9#1)(1993-12#1)(1994-12#1)(2008-5#2)(2008-8#1)
the imprinted polymer for##2##4##(2008-10#2)
the imprinted polymer##7##3##(2008-10#7)
the imprinted##13##2##(1996-10#1)(2008-10#11)(2008-7#1)
the imprinting##4##2##(1996-10#1)(2008-10#3)
the improved DSCM##2##3##(2008-3#2)
the improved method##3##3##(2008-10#2)(2008-3#1)
the improved survival of##3##4##(2008-11#2)(2008-7#1)
the improved##44##2##(1993-8#1)(1994-9#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-2#5)(2008-3#9)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
the improvement in the##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
the improvement in##14##3##(1992-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
the improvement is##3##3##(1993-11#1)(2008-10#1)(2008-2#1)
the improvement of the##6##4##(1991-6#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-7#1)
the improvement of##35##3##(1990-5#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-5#1)(1994-3#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
the improvement was##3##3##(2007-11#1)(2010-3#1)(2013-1#1)
the improvement##68##2##(1990-5#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#1)(1993-11#1)(1993-5#1)(1994-3#1)(1996-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#3)(2013-1#5)(2013-8#2)
the improvements are##2##3##(2013-1#1)(2013-8#1)
the improvements in##2##3##(2010-7#2)
the improvements##6##2##(1991-12#1)(2008-3#1)(2010-7#2)(2013-1#1)(2013-8#1)
the impulse response from the##2##5##(2008-3#2)
the impulse response##4##3##(2007-11#1)(2008-3#3)
the impulse##6##2##(1990-8#1)(2007-11#1)(2008-3#4)
the impurities##7##2##(2008-10#3)(2010-2#2)(2012-2#1)(2013-1#1)
the in silico prediction of##2##5##(2008-4#1)(2012-3#1)
the in silico prediction##3##4##(2008-4#1)(2012-3#2)
the in situ analysis of##2##5##(2008-10#1)(2008-2#1)
the in situ monitoring of##2##5##(1993-6#1)(2008-3#1)
the in situ spectral distribution of##2##6##(2008-3#2)
the in situ##34##3##(1990-2#1)(1993-6#1)(1996-12#1)(2006-4#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2009-12#1)(2011-2#1)
the in vitro adherence of Candida albicans##2##7##(2008-5#2)
the in vitro and in vivo##5##6##(1990-2#1)(1991-5#1)(2008-5#1)(2009-12#1)(2012-2#1)
the in vitro and in##6##5##(1990-2#1)(1991-5#1)(2008-5#1)(2009-12#2)(2012-2#1)
the in vitro antifungal##2##4##(2008-5#2)
the in vitro antioxidant activity##2##5##(2008-10#1)(2008-5#1)
the in vitro assembled U2 snRNPs##2##6##(1993-8#2)
the in vitro biological activity of##2##6##(2008-8#2)
the in vitro drug release data##2##6##(2010-5#1)(2012-2#1)
the in vitro drug release##4##5##(2010-3#2)(2010-5#1)(2012-2#1)
the in vitro experiments##2##4##(1994-5#1)(2008-5#1)
the in vitro growth##2##4##(1990-3#1)(1992-8#1)
the in vitro model##3##4##(1992-12#1)(1997-4#1)(2008-5#1)
the in vitro phosphorylation of##2##5##(1997-2#2)
the in vitro phosphorylation##3##4##(1993-3#1)(1997-2#2)
the in vitro proliferative response of##2##6##(1991-1#1)(2008-7#1)
the in vitro release##2##4##(1992-3#1)(2008-10#1)
the in vitro selection##2##4##(1990-8#1)(2010-5#1)
the in vitro sensitivity of##2##5##(1991-2#1)(1993-1#1)
the in vitro study of##3##5##(2008-11#1)(2008-4#1)(2013-8#1)
the in vitro system##4##4##(1991-9#1)(1997-4#1)(2008-11#1)(2008-6#1)
the in vitro##109##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#2)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#1)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#2)(2009-6#2)(2009-8#2)(2010-11#1)(2010-3#3)(2010-5#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
the in vivo activity of antimicrobial agents##2##7##(2008-7#2)
the in vivo activity of##3##5##(2007-11#1)(2008-7#2)
the in vivo and in vitro##3##6##(1994-5#1)(2008-5#1)(2011-1#1)
the in vivo effects of##4##5##(1995-12#2)(1995-3#1)(2008-10#1)
the in vivo environment##2##4##(2009-12#2)
the in vivo function of##4##5##(2008-11#1)(2008-9#1)(2009-2#1)(2012-2#1)
the in vivo genotoxicity of 7##2##6##(1996-12#2)
the in vivo role of##2##5##(1994-9#1)(1995-2#1)
the in vivo##72##3##(1990-8#1)(1991-1#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-12#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#1)(1995-8#1)(1996-12#3)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#12)(2008-7#4)(2008-9#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#2)
the in##224##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#3)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-12#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-5#3)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#2)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#30)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#29)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#6)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-3#3)(2010-5#3)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#1)
the in-line##4##2##(2008-10#3)(2008-2#1)
the in-phase and##2##3##(2007-11#1)(2008-3#1)
the in-phase##3##2##(2007-11#1)(2008-3#2)
the in-plane##11##2##(1993-11#1)(1996-2#1)(2007-11#1)(2008-2#2)(2008-3#2)(2009-11#1)(2009-7#1)(2012-2#1)(2013-8#1)
the in-situ##4##2##(2008-10#1)(2013-8#3)
the in-vitro##4##2##(1990-12#2)(2008-4#1)(2008-9#1)
the inability of##9##3##(1990-8#1)(1995-11#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the inability to##13##3##(1994-11#1)(1994-12#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#2)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
the inability##22##2##(1990-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
the inactivated enzyme##3##3##(1991-5#1)(1997-2#1)(2008-5#1)
the inactivated##4##2##(1991-5#1)(1997-2#2)(2008-5#1)
the inactivation kinetics##2##3##(1990-11#1)(2008-8#1)
the inactivation of the enzyme##3##5##(1990-8#1)(1993-8#1)(2011-2#1)
the inactivation of##19##3##(1990-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#3)
the inactivation##26##2##(1990-11#2)(1990-8#2)(1991-5#1)(1991-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#3)
the inactive X and Y##2##5##(1990-3#2)
the inactive X chromosome##2##4##(1991-6#1)(1994-11#1)
the inactive X##4##3##(1990-3#2)(1991-6#1)(1994-11#1)
the inactive mutant##2##3##(1995-12#1)(1995-5#1)
the inactive product##2##3##(1992-6#2)
the inactive##20##2##(1990-3#2)(1991-6#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2010-8#1)(2013-1#1)(2013-8#1)
the inadequacy of the##4##4##(1996-12#1)(2007-8#1)(2009-5#1)(2012-3#1)
the inadequacy of##5##3##(1995-11#1)(1996-12#1)(2007-8#1)(2009-5#1)(2012-3#1)
the inadequate##5##2##(1992-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
the inalienable right to life and##4##6##(2011-2#4)
the inappropriate##6##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-5#1)(2008-10#2)
the inaugural##3##2##(1992-5#1)(2008-7#1)(2008-8#1)
the inbred lines Mo17##2##4##(2008-10#2)
the inbred lines##3##3##(2008-10#2)(2008-5#1)
the inbred##8##2##(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
the incarceration##2##2##(2008-11#1)(2008-9#1)
the incentive##4##2##(1992-3#1)(1995-1#1)(2008-4#1)(2008-7#1)
the incentives of##4##3##(1992-2#1)(1993-12#1)(1995-3#1)(1997-1#1)
the incentives##6##2##(1992-2#2)(1993-12#1)(1995-3#1)(1997-1#1)(1997-2#1)
the incidence and prevalence of##3##5##(1996-11#1)(2008-10#1)(2008-12#1)
the incidence and severity of##8##5##(2007-8#2)(2008-10#4)(2008-5#1)(2012-3#1)
the incidence and types of##2##5##(2008-4#1)(2012-12#1)
the incidence and##26##3##(1991-11#1)(1996-11#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the incidence angle of the##2##5##(2007-11#1)(2008-3#1)
the incidence angle shift##2##4##(2008-10#2)
the incidence angle##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
the incidence function model##2##4##(2008-9#2)
the incidence in##2##3##(2008-7#1)(2012-3#1)
the incidence is approximately##2##4##(2008-10#1)(2008-7#1)
the incidence is##6##3##(2008-10#1)(2008-2#1)(2008-7#3)(2013-1#1)
the incidence of A##2##4##(2008-10#2)
the incidence of BYDV##3##4##(2008-10#3)
the incidence of HCC is##2##5##(2006-10#1)(2013-1#1)
the incidence of HCC##3##4##(2006-10#2)(2013-1#1)
the incidence of T2D##2##4##(2009-3#2)
the incidence of TYLCV##2##4##(2008-10#2)
the incidence of accidental pleurotomy##2##5##(2007-8#2)
the incidence of acute myocardial##2##5##(1990-9#1)(1991-9#1)
the incidence of acute##9##4##(1990-9#1)(1991-9#1)(1996-6#1)(2007-7#2)(2008-1#2)(2008-8#1)(2013-8#1)
the incidence of adverse drug reactions##2##6##(2010-6#1)(2011-2#1)
the incidence of adverse events##2##5##(2008-3#1)(2008-7#1)
the incidence of adverse##6##4##(1997-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
the incidence of and risk factors for##2##7##(2012-12#1)(2012-3#1)
the incidence of bacteremia was##2##5##(1990-2#1)(2007-7#1)
the incidence of both##4##4##(1997-4#1)(2007-10#1)(2008-10#1)(2008-12#1)
the incidence of breast cancer##3##5##(2008-7#1)(2013-7#2)
the incidence of cancer##3##4##(1994-5#1)(2008-4#1)(2008-7#1)
the incidence of cerebral palsy##2##5##(1995-6#2)
the incidence of chronic##2##4##(1992-2#1)(2008-7#1)
the incidence of colon##2##4##(1993-11#1)(2006-8#1)
the incidence of colonic##2##4##(1990-6#1)(2010-8#1)
the incidence of complications##3##4##(2008-1#1)(2012-2#1)(2013-1#1)
the incidence of congenital##2##4##(1990-9#1)(2008-7#1)
the incidence of death from##2##5##(1995-12#1)(2011-2#1)
the incidence of discolored achenes##2##5##(2008-10#2)
the incidence of ectopic##2##4##(1992-4#1)(1994-3#1)
the incidence of fire blight in##2##6##(2008-10#2)
the incidence of fire blight##3##5##(2008-10#3)
the incidence of fractures##2##4##(1995-11#1)(2010-10#1)
the incidence of fruit##3##4##(2008-10#3)
the incidence of heart failure##3##5##(2008-3#1)(2010-8#2)
the incidence of hepatitis##2##4##(2007-12#1)(2007-7#1)
the incidence of hypo-##2##4##(1991-8#2)
the incidence of infection by##2##5##(2008-10#2)
the incidence of infection##5##4##(2007-12#1)(2008-10#3)(2010-10#1)
the incidence of leaf##2##4##(2008-10#2)
the incidence of lethal arrhythmias##2##5##(1995-12#2)
the incidence of malaria##3##4##(2012-12#1)(2012-3#2)
the incidence of malignant melanoma##2##5##(2007-10#1)(2011-2#1)
the incidence of malignant##3##4##(2007-10#1)(2008-8#1)(2011-2#1)
the incidence of melanoma increased by##2##6##(2011-2#2)
the incidence of neurosurgical complications was##2##6##(2012-3#2)
the incidence of positive##2##4##(2008-10#1)(2008-9#1)
the incidence of postoperative stroke##2##5##(2007-8#2)
the incidence of postoperative##4##4##(1991-11#1)(1991-5#1)(2007-8#2)
the incidence of renal##2##4##(1994-5#1)(2011-2#1)
the incidence of seed##4##4##(2008-10#4)
the incidence of southern blight##2##5##(2008-10#2)
the incidence of stems with ray blight##3##7##(2008-10#3)
the incidence of strawberry##2##4##(2008-10#2)
the incidence of stroke in##2##5##(2007-8#2)
the incidence of stroke##4##4##(2007-8#3)(2008-8#1)
the incidence of such##2##4##(1993-3#1)(2012-2#1)
the incidence of sudden infant death syndrome##2##7##(1991-11#1)(1991-9#1)
the incidence of sudden infant death##3##6##(1991-11#1)(1991-9#1)(1992-4#1)
the incidence of surgical site##2##5##(2012-3#2)
the incidence of the disease##3##5##(1991-4#1)(1992-9#1)(2007-7#1)
the incidence of the##9##4##(1990-10#1)(1990-2#1)(1991-4#1)(1992-9#1)(1993-8#1)(2007-7#1)(2008-10#1)(2010-12#1)(2013-8#1)
the incidence of this##3##4##(1993-3#1)(2008-11#1)(2010-5#1)
the incidence of tuberculosis##2##4##(2008-1#1)(2013-1#1)
the incidence of varicocele##2##4##(1990-3#2)
the incidence of which increases##2##5##(2008-4#1)(2011-2#1)
the incidence of##330##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#2)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#2)(2006-10#4)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#7)(2007-8#11)(2008-1#9)(2008-10#62)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#8)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-2#20)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#12)(2013-1#21)(2013-7#2)(2013-8#5)
the incidence or severity of##2##5##(2007-10#1)(2008-10#1)
the incidence or##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
the incidence rate##6##3##(1992-10#1)(1994-11#1)(1996-3#1)(2008-11#1)(2008-12#1)(2011-2#1)
the incidence##402##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#2)(1990-8#1)(1990-9#3)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-8#3)(1991-9#2)(1992-10#3)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#2)(2006-10#4)(2006-8#1)(2007-10#5)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#7)(2007-8#13)(2008-1#10)(2008-10#76)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#23)(2008-8#9)(2008-9#10)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#1)(2011-2#25)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#14)(2013-1#24)(2013-7#2)(2013-8#6)
the incidences of focal##3##4##(2008-9#3)
the incidences of squamous cell papilloma were significantly increased in##2##10##(2008-9#2)
the incidences of squamous cell papilloma were##3##7##(2008-9#3)
the incidences of##13##3##(1992-9#1)(2008-9#11)(2011-2#1)
the incident and the##2##4##(2008-2#1)(2008-3#1)
the incident and##4##3##(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
the incident angle of the input beam in##2##8##(2008-3#2)
the incident angle of##3##4##(2008-10#1)(2008-3#2)
the incident angle##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#5)
the incident beam and##2##4##(2008-3#2)
the incident beam##14##3##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#7)
the incident beams##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
the incident fundamental##2##3##(2007-12#2)
the incident laser beam##5##4##(2007-12#2)(2008-3#3)
the incident laser##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
the incident light##17##3##(2007-11#2)(2007-12#5)(2008-10#2)(2008-3#8)
the incident power##2##3##(2007-12#1)(2008-3#1)
the incident radiation##8##3##(2008-2#4)(2008-3#4)
the incident wave and##2##4##(2008-3#2)
the incident wave##5##3##(2008-2#1)(2008-3#4)
the incident wavelength and##2##4##(2008-3#2)
the incident wavelength##5##3##(2008-2#2)(2008-3#3)
the incident##95##2##(1996-12#1)(2007-11#9)(2007-12#16)(2008-10#5)(2008-11#2)(2008-2#16)(2008-3#44)(2013-1#1)(2013-8#1)
the incidents and##2##3##(2009-10#1)(2013-1#1)
the incidents##3##2##(2008-12#1)(2009-10#1)(2013-1#1)
the incisal##2##2##(2010-3#1)(2012-2#1)
the incision##2##2##(2009-8#1)(2012-12#1)
the incisor##3##2##(1996-3#1)(2009-7#1)(2010-3#1)
the inclination of the##2##4##(2008-2#1)(2008-3#1)
the inclination##3##2##(2008-2#1)(2008-3#2)
the included articles##2##3##(2011-2#1)(2013-1#1)
the included studies##3##3##(2008-10#1)(2010-11#1)(2013-8#1)
the included##7##2##(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
the inclusion ability of##2##4##(2008-10#2)
the inclusion and exclusion criteria and##2##6##(2007-11#1)(2011-2#1)
the inclusion and exclusion criteria##4##5##(2007-11#1)(2009-10#1)(2011-2#2)
the inclusion complex between##2##4##(2008-10#2)
the inclusion complex##10##3##(2008-10#10)
the inclusion constant##3##3##(2008-10#3)
the inclusion criteria and agreed to participate##2##7##(2008-1#1)(2010-6#1)
the inclusion criteria and##3##4##(2008-1#1)(2010-4#1)(2010-6#1)
the inclusion criteria for##2##4##(2008-5#1)(2009-6#1)
the inclusion criteria were##3##4##(2010-6#1)(2012-3#2)
the inclusion criteria##19##3##(2008-1#2)(2008-10#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#2)(2011-2#2)(2012-3#3)(2013-1#2)
the inclusion mechanism of imidazole derivatives in##2##7##(2008-10#2)
the inclusion of additional##2##4##(2008-9#1)(2013-7#1)
the inclusion of covariates##2##4##(1995-2#1)(2011-2#1)
the inclusion of##34##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
the inclusion process##3##3##(2008-10#3)
the inclusion##92##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#39)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)
the inclusions was##2##3##(2008-10#1)(2008-2#1)
the inclusions##8##2##(1997-3#1)(2008-10#5)(2008-2#2)
the incoherent source##2##3##(2007-12#1)(2008-3#1)
the incoherent##16##2##(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#9)
the incoming ligand##2##3##(1995-3#1)(2010-12#1)
the incoming signal##2##3##(2008-2#1)(2011-1#1)
the incoming##17##2##(1995-3#1)(2007-11#2)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#4)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
the incompatibility of##2##3##(2008-1#1)(2013-8#1)
the incompatible (i##2##3##(2008-10#2)
the incompatible##4##2##(1994-9#1)(2008-10#2)(2011-2#1)
the incompetent##2##2##(1991-2#1)(1993-3#1)
the incomplete##9##2##(1992-6#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
the incorporated##2##2##(1993-11#1)(2008-10#1)
the incorporation of a##2##4##(2007-11#1)(2008-3#1)
the incorporation of an##3##4##(1993-8#1)(2007-11#1)(2009-2#1)
the incorporation of both##2##4##(1995-2#1)(1996-3#1)
the incorporation of the##4##4##(1992-11#1)(1992-6#1)(1997-2#1)(2008-10#1)
the incorporation of these##3##4##(1997-2#1)(2008-10#1)(2008-4#1)
the incorporation of##64##3##(1990-11#2)(1990-2#2)(1990-7#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
the incorporation reaction of##2##4##(2008-10#2)
the incorporation values##2##3##(1991-6#1)(2008-11#1)
the incorporation##72##2##(1990-11#3)(1990-2#2)(1990-7#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
the incorrect##4##2##(1997-6#1)(2008-12#1)(2008-2#1)(2008-3#1)
the incoupled light##2##3##(2008-3#2)
the increase and##2##3##(2009-12#1)(2013-1#1)
the increase at##2##3##(2008-5#1)(2009-12#1)
the increase in GFAP##2##4##(1990-7#2)
the increase in [Ca2+]i##2##4##(1990-7#2)
the increase in apoptosis##2##4##(2008-7#2)
the increase in body##2##4##(2011-1#1)(2013-1#1)
the increase in cell number##2##5##(1995-2#1)(1996-2#1)
the increase in cell##4##4##(1990-8#1)(1995-2#1)(1996-2#1)(2009-12#1)
the increase in cytosolic##2##4##(1995-12#1)(2008-10#1)
the increase in diffraction efficiency##2##5##(2008-3#2)
the increase in extracellular##2##4##(1991-12#1)(1994-2#1)
the increase in fluorescence##2##4##(2008-10#1)(2013-7#1)
the increase in mortality##2##4##(1991-3#1)(2008-8#1)
the increase in plasma##3##4##(1990-11#1)(2008-10#1)(2010-10#1)
the increase in protein##2##4##(2008-5#1)(2010-12#1)
the increase in serum##2##4##(2008-10#1)(2008-7#1)
the increase in size##2##4##(1993-12#1)(2013-7#1)
the increase in splenic B7(+) macrophages##2##6##(2008-10#2)
the increase in the levels of##2##6##(1997-2#1)(2008-10#1)
the increase in the number of##5##6##(1991-5#1)(1997-2#1)(2006-10#1)(2008-5#2)
the increase in the rate of##3##6##(1993-11#1)(1994-5#1)(1995-6#1)
the increase in the##29##4##(1990-5#1)(1991-5#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#2)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2011-2#1)(2012-2#1)(2013-1#1)
the increase in##168##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-5#2)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-7#2)(2006-10#3)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#24)(2008-11#12)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#4)
the increase of [Ca(2+)](i)##2##4##(2008-9#2)
the increase of age##2##4##(2011-1#1)(2013-7#1)
the increase of its concentration##3##5##(2008-10#3)
the increase of serum##3##4##(1990-2#1)(1995-3#1)(2010-12#1)
the increase of the##14##4##(2008-10#8)(2008-3#3)(2008-4#1)(2008-8#1)(2011-3#1)
the increase of##73##3##(1990-12#1)(1990-2#2)(1990-5#1)(1992-12#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
the increase was##5##3##(1992-3#1)(1997-7#1)(2008-10#3)
the increase##268##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#3)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-5#2)(1991-9#1)(1992-12#3)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-7#3)(2006-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#5)(2008-10#47)(2008-11#14)(2008-12#5)(2008-3#11)(2008-4#5)(2008-5#15)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#5)(2009-11#2)(2009-12#4)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#6)
the increased activity##3##3##(1990-11#1)(2008-4#1)(2009-4#1)
the increased aggressiveness of##2##4##(2008-10#2)
the increased consumption of##2##4##(2011-1#1)(2012-12#1)
the increased demand##2##3##(1990-6#1)(1997-3#1)
the increased expression of the##2##5##(1994-3#1)(1995-2#1)
the increased expression of##6##4##(1992-8#1)(1994-3#1)(1995-2#2)(1997-7#1)(2012-3#1)
the increased expression##7##3##(1992-8#1)(1994-3#1)(1995-2#2)(1996-12#1)(1997-7#1)(2012-3#1)
the increased frequency of##4##4##(1991-5#1)(1991-9#1)(1992-9#1)(2008-11#1)
the increased incidence of##5##4##(1992-3#1)(1994-5#1)(1996-3#1)(2008-11#1)(2011-2#1)
the increased level##2##3##(2008-12#1)(2011-2#1)
the increased levels of##3##4##(1995-6#1)(2008-6#1)(2012-6#1)
the increased levels##4##3##(1995-6#1)(1997-4#1)(2008-6#1)(2012-6#1)
the increased number of##11##4##(1991-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
the increased number##12##3##(1991-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-6#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
the increased prevalence of##2##4##(1992-3#1)(2008-2#1)
the increased production##2##3##(1992-12#1)(1994-11#1)
the increased rate of##2##4##(1994-3#1)(1996-8#1)
the increased risk of##9##4##(1991-8#1)(1994-3#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#2)
the increased secretion of##2##4##(1993-12#1)(2008-11#1)
the increased shear stress##2##4##(2008-2#1)(2010-10#1)
the increased stability of the##3##5##(1993-11#1)(1997-2#1)(2008-4#1)
the increased stability##4##3##(1993-11#2)(1997-2#1)(2008-4#1)
the increased susceptibility to##3##4##(1991-9#1)(2008-10#2)
the increased susceptibility##4##3##(1991-9#1)(2008-10#3)
the increased uptake##2##3##(1994-5#1)(2006-10#1)
the increased use of##7##4##(1991-11#1)(1991-3#1)(1995-2#1)(1996-1#1)(1996-9#1)(2008-11#1)(2008-12#1)
the increased##169##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#14)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#3)(2013-8#1)
the increases in the efficiency of the##2##7##(1997-2#2)
the increases in the##3##4##(1997-2#2)(2008-5#1)
the increases in##8##3##(1993-9#1)(1997-2#2)(1997-4#1)(2008-12#1)(2008-5#1)(2008-7#2)
the increases of##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
the increases##13##2##(1993-9#1)(1995-12#1)(1997-2#2)(1997-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
the increasing amount of##3##4##(2008-10#1)(2008-9#1)(2009-11#1)
the increasing availability of##3##4##(1992-6#1)(2008-3#1)(2012-2#1)
the increasing demand for##4##4##(1992-3#1)(2008-10#1)(2008-3#1)(2010-4#1)
the increasing demand##5##3##(1992-1#1)(1992-3#1)(2008-10#1)(2008-3#1)(2010-4#1)
the increasing incidence of##4##4##(1996-6#1)(2011-2#3)
the increasing incidence##5##3##(1993-9#1)(1996-6#1)(2011-2#3)
the increasing knowledge##2##3##(2008-1#1)(2008-5#1)
the increasing number of##12##4##(1992-3#1)(1993-2#1)(1997-2#2)(2007-12#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)
the increasing of##3##3##(2008-8#1)(2008-9#2)
the increasing prevalence of##6##4##(1990-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-3#2)
the increasing prevalence##7##3##(1990-6#1)(2006-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-3#2)
the increasing trend##2##3##(1997-7#1)(2008-1#1)
the increasing use of##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-2#1)
the increasing##93##2##(1990-11#1)(1990-6#2)(1991-3#1)(1992-1#2)(1992-3#2)(1992-6#2)(1993-2#2)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#1)(1996-12#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
the increasingly##5##2##(1994-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)
the increment in##4##3##(1990-5#1)(2008-3#1)(2010-10#2)
the increment of##5##3##(1996-2#1)(2008-1#1)(2008-10#2)(2012-2#1)
the increment##11##2##(1990-5#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-10#2)(2012-2#1)
the incremental cost-effectiveness##2##3##(2008-1#1)(2012-12#1)
the incremental##8##2##(1992-9#1)(2008-1#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#3)
the incubation buffer##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
the incubation distribution##2##3##(1992-9#2)
the incubation media##6##3##(1991-2#1)(1992-12#1)(1993-6#1)(1994-2#2)(2008-10#1)
the incubation medium##9##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1995-11#3)(2008-5#1)
the incubation mixture##4##3##(1990-2#2)(1994-5#1)(2011-2#1)
the incubation of##3##3##(1991-3#1)(2008-11#2)
the incubation period of##2##4##(1991-12#1)(1992-8#1)
the incubation period was##2##4##(2008-10#2)
the incubation period##9##3##(1991-12#1)(1992-6#1)(1992-8#1)(2008-10#6)
the incubation solution##2##3##(1994-6#1)(2008-10#1)
the incubation temperature and the##2##5##(2008-10#1)(2011-2#1)
the incubation temperature##5##3##(2008-10#4)(2011-2#1)
the incubation time##6##3##(1990-12#1)(1991-11#1)(2008-10#1)(2008-7#1)(2008-9#2)
the incubation with##4##3##(1992-8#1)(1993-8#1)(1997-8#1)(2008-11#1)
the incubation##60##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#4)(1995-2#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#15)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)
the independence of##2##3##(2008-9#1)(2010-6#1)
the independence##4##2##(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)
the independent action of##2##4##(2008-10#2)
the independent contrast method##2##4##(1997-4#2)
the independent measurements of##2##4##(2008-3#2)
the independent variable##4##3##(2008-10#2)(2008-11#2)
the independent variables##3##3##(1992-1#1)(1994-12#1)(1995-9#1)
the independent##32##2##(1990-8#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-4#2)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#6)(2008-7#1)(2010-5#1)(2012-3#2)(2013-1#1)
the independently determined##2##3##(1997-2#1)(2008-10#1)
the independently##5##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
the index event##2##3##(2008-11#1)(2008-7#1)
the index modulation##2##3##(2007-12#1)(2008-3#1)
the index of dispersion##5##4##(2008-10#5)
the index of refraction and##3##5##(2007-12#1)(2008-3#2)
the index of refraction in the##2##6##(2007-12#1)(2008-3#1)
the index of refraction in##3##5##(2007-12#1)(2008-3#2)
the index of refraction of the##3##6##(2008-3#3)
the index of refraction of##5##5##(2008-2#1)(2008-3#4)
the index of refraction##25##4##(1991-9#1)(2007-12#2)(2008-2#7)(2008-3#15)
the index of the##2##4##(2008-6#1)(2010-2#1)
the index of##42##3##(1990-11#1)(1991-9#1)(1996-12#1)(1996-3#1)(2007-12#2)(2008-10#7)(2008-2#7)(2008-3#16)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-2#1)(2013-1#1)
the index profile##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
the index values of##2##4##(1992-2#2)
the index values##3##3##(1992-2#2)(2008-10#1)
the index##75##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-2#2)(1993-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(2007-11#3)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#24)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2010-11#1)(2010-2#1)(2011-2#2)(2013-1#1)(2013-7#1)
the indexes##2##2##(1991-12#1)(1995-12#1)
the indicated##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
the indication for this##2##4##(1997-5#1)(2013-1#1)
the indication for##10##3##(1993-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
the indication##15##2##(1991-12#1)(1993-6#1)(1993-9#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#2)(2013-1#2)
the indications and contraindications##2##4##(2007-11#1)(2011-2#1)
the indications and##5##3##(1990-9#1)(2007-11#1)(2007-7#1)(2008-7#1)(2011-2#1)
the indications for the use of##3##6##(1990-9#2)(2011-2#1)
the indications for use##2##4##(2008-11#1)(2011-2#1)
the indications for##24##3##(1990-11#1)(1990-8#1)(1990-9#2)(1996-9#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#5)(2009-8#1)(2010-8#1)(2011-10#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
the indications of##2##3##(2008-10#1)(2009-4#1)
the indications##35##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-3#1)(1996-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#6)(2009-4#1)(2009-8#1)(2010-8#1)(2011-10#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
the indicator electrode##4##3##(2008-10#4)
the indicator reaction##2##3##(2008-10#2)
the indicator##26##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1997-3#1)(2008-10#17)(2008-4#1)(2008-9#2)(2011-1#1)
the indicators##6##2##(1994-3#1)(1996-2#2)(2008-10#1)(2009-8#1)(2012-12#1)
the indicatrices##2##2##(2008-3#2)
the indices of refraction of##4##5##(2008-2#2)(2008-3#2)
the indices of##7##3##(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2013-8#1)
the indices##11##2##(2007-11#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2013-8#1)
the indigenous##5##2##(2008-1#1)(2008-10#3)(2010-5#1)
the indirect antiglobulin test##2##4##(1994-6#1)(1994-9#1)
the indirect benefit of##2##4##(1994-2#1)(2008-8#1)
the indirect defenses of##2##4##(2009-8#2)
the indirect determination of##4##4##(2008-10#4)
the indirect method##3##3##(2008-10#1)(2008-11#2)
the indirect nature of the##2##5##(2008-10#2)
the indirect result of##2##4##(1990-11#1)(2008-10#1)
the indirect##28##2##(1990-11#1)(1991-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(2008-10#11)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2011-2#2)(2012-2#1)
the indiscriminate##2##2##(2009-10#1)(2011-2#1)
the individual and##9##3##(1993-12#1)(1997-4#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
the individual chromatographic##2##3##(2008-10#1)(2008-7#1)
the individual components of the##4##5##(1994-2#1)(1997-2#1)(2008-10#2)
the individual components of##6##4##(1992-9#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-12#1)
the individual components##8##3##(1992-9#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)
the individual countries##3##3##(1990-12#3)
the individual drug##2##3##(2012-2#2)
the individual effects##2##3##(2008-10#1)(2008-3#1)
the individual hospital##2##3##(1992-2#1)(2008-11#1)
the individual is##2##3##(1995-9#1)(2007-2#1)
the individual level##6##3##(1996-8#1)(2008-10#1)(2008-8#2)(2009-4#1)(2012-2#1)
the individual or##2##3##(1996-12#1)(2010-4#1)
the individual patch##2##3##(2008-8#2)
the individual patient with##2##4##(2007-12#1)(2008-7#1)
the individual patient##12##3##(1993-12#1)(1996-8#2)(2007-12#1)(2008-7#2)(2009-9#1)(2010-6#1)(2013-1#2)(2013-8#2)
the individual patient's##2##3##(2008-9#1)(2013-8#1)
the individual responses##2##3##(2008-10#1)(2008-4#1)
the individual risk##2##3##(1990-6#1)(2013-8#1)
the individual species##3##3##(2008-10#3)
the individual subunits##2##3##(1991-12#1)(2008-4#1)
the individual with##2##3##(1994-1#1)(1995-3#1)
the individual##221##2##(1990-12#4)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#3)(1997-2#2)(1997-4#4)(1997-9#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#30)(2008-11#11)(2008-12#6)(2008-2#4)(2008-3#11)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#5)
the individual's own##2##3##(2007-6#1)(2008-1#1)
the individual's##9##2##(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-3#1)
the individual-based##2##2##(2008-9#2)
the individual-level##2##2##(2008-8#2)
the individually##2##2##(2008-10#1)(2009-5#1)
the individuals and##2##3##(2007-5#1)(2008-5#1)
the individuals with##2##3##(1994-3#1)(2012-12#1)
the individuals within##2##3##(2009-5#1)(2011-1#1)
the individuals##18##2##(1990-7#1)(1994-3#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the indoor##5##2##(1995-6#1)(2010-5#4)
the indophenol-type reaction method##2##4##(2008-10#2)
the induced coherence##2##3##(2007-12#2)
the induced differentiation of##2##4##(1991-2#1)(2008-9#1)
the induced differentiation##3##3##(1991-2#2)(2008-9#1)
the induced grating##4##3##(2007-11#3)(2008-3#1)
the induced orientation##2##3##(2008-2#2)
the induced ossicles##2##3##(2008-12#2)
the induced polar order##2##4##(2007-12#2)
the induced refractive index##3##4##(2007-12#1)(2008-3#2)
the induced##55##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-7#1)(1992-9#1)(1993-2#1)(1997-4#1)(1997-7#1)(2007-11#7)(2007-12#8)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
the inducer##8##2##(1990-11#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
the inducible##13##2##(1993-6#2)(1993-8#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
the inducing (IN) inoculation##2##4##(2008-10#2)
the inducing##4##2##(1993-6#1)(2008-10#3)
the induction and development of##2##5##(1991-12#1)(2008-10#1)
the induction and maintenance of##3##5##(2008-11#1)(2008-4#1)(2012-2#1)
the induction and##7##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-8#1)(2012-2#1)
the induction by##2##3##(1992-9#1)(2012-12#1)
the induction medium##3##3##(2008-11#3)
the induction of DNA damage##3##5##(1997-4#2)(2008-7#1)
the induction of DNA strand breaks##2##6##(1991-12#1)(1997-4#1)
the induction of DNA##7##4##(1991-12#1)(1997-4#4)(2008-7#2)
the induction of HB-EGF##2##4##(1993-11#1)(1997-1#1)
the induction of JE##2##4##(1994-9#2)
the induction of LTP##4##4##(1995-12#2)(1995-2#1)(2008-7#1)
the induction of Th1-type cytokine producing cells##2##7##(2008-11#2)
the induction of a##2##4##(1995-2#1)(2008-10#1)
the induction of apoptosis in colonic tumour cells##2##8##(1993-9#2)
the induction of apoptosis in##4##5##(1993-9#2)(1994-10#1)(2011-2#1)
the induction of apoptosis##9##4##(1993-9#2)(1994-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#2)
the induction of autogamy##2##4##(2008-12#2)
the induction of both##2##4##(1990-2#1)(2012-12#1)
the induction of bystander##2##4##(2008-7#2)
the induction of differentiation##3##4##(1993-12#1)(2008-11#1)(2008-4#1)
the induction of immune##3##4##(1997-8#1)(2010-5#1)(2012-3#1)
the induction of labor##2##4##(1994-9#1)(2008-11#1)
the induction of long-term potentiation (LTP)##2##6##(1995-12#1)(2008-7#1)
the induction of long-term potentiation##3##5##(1995-12#2)(2008-7#1)
the induction of long-term##4##4##(1995-12#2)(2008-7#1)(2011-2#1)
the induction of metallothionein by cadmium(II) and##2##7##(1991-5#2)
the induction of metallothionein by##3##5##(1991-5#3)
the induction of molecular##2##4##(2008-7#1)(2012-2#1)
the induction of oxidative stress##2##5##(2008-10#1)(2009-12#1)
the induction of oxidative##3##4##(1994-6#1)(2008-10#1)(2009-12#1)
the induction of programmed cell death##2##6##(1993-9#1)(1994-9#1)
the induction of protective immunity##2##5##(2011-2#2)
the induction of protective##3##4##(1997-6#1)(2011-2#2)
the induction of systemic resistance##2##5##(2008-10#2)
the induction of systemic##3##4##(2008-10#3)
the induction of terminal differentiation##2##5##(1990-11#1)(1991-5#1)
the induction of the##10##4##(1991-9#1)(1992-8#2)(1992-9#1)(1994-8#1)(1994-9#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
the induction of this##3##4##(1992-12#2)(1997-2#1)
the induction of##176##3##(1990-11#1)(1990-2#2)(1990-5#2)(1991-12#3)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#3)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#4)(1994-6#3)(1994-8#2)(1994-9#6)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#6)(1997-6#1)(1997-8#1)(2008-10#20)(2008-11#15)(2008-12#4)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#1)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-5#2)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)
the induction or##3##3##(2008-10#2)(2008-11#1)
the induction period##3##3##(2008-10#3)
the induction##208##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#4)(1992-10#1)(1992-12#2)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#3)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#4)(1994-6#3)(1994-8#2)(1994-9#6)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#6)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#29)(2008-11#21)(2008-12#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#1)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-5#2)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#6)
the inductive##3##2##(1995-5#1)(2007-11#1)(2008-11#1)
the inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
the inductively coupled plasma##6##4##(2008-10#6)
the inductively coupled plasma-mass spectrometry (ICP-MS)##2##6##(2008-10#2)
the inductively coupled plasma-mass##3##4##(2008-10#3)
the inductively coupled##9##3##(2008-10#9)
the industrial production of##3##4##(2008-6#1)(2011-2#1)(2012-2#1)
the industrial production##4##3##(1992-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
the industrial##13##2##(1992-11#1)(1993-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
the industrialized world##2##3##(1995-3#1)(2011-2#1)
the industrialized##4##2##(1995-3#1)(2008-10#1)(2010-11#1)(2011-2#1)
the industry and##2##3##(1991-1#1)(2007-8#1)
the industry has##2##3##(2008-11#1)(2008-8#1)
the industry is##3##3##(2008-1#1)(2008-11#1)(2008-12#1)
the industry standard##2##3##(2008-10#1)(2008-11#1)
the industry##29##2##(1990-4#1)(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#3)(1996-3#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
the inefficiencies##2##2##(1991-3#1)(1996-1#1)
the inefficiency of##2##3##(2008-3#2)
the inertial##2##2##(2008-10#1)(2008-11#1)
the inevitable##5##2##(1993-12#1)(2008-3#2)(2008-6#1)(2013-8#1)
the inexorable##2##2##(1993-3#1)(2013-1#1)
the infamous##2##2##(2008-5#1)(2008-7#1)
the infant brain processes##2##4##(2008-11#2)
the infant to##2##3##(2008-11#1)(2012-2#1)
the infant was##2##3##(1991-11#1)(2010-10#1)
the infant##28##2##(1991-11#2)(1992-11#1)(1994-3#1)(1995-3#2)(1995-6#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-2#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#4)
the infant's##6##2##(1992-4#2)(1993-3#1)(2007-11#1)(2009-11#1)(2009-9#1)
the infants were##4##3##(1991-11#1)(1991-2#1)(1993-12#1)(1994-6#1)
the infants##13##2##(1990-5#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-12#2)(1994-6#2)(2007-2#1)(2008-10#1)(2009-9#1)(2012-2#2)
the infants'##4##2##(1991-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
the infarct area##4##3##(1995-12#2)(2007-10#1)(2011-2#1)
the infarct size and the neurological deficit##2##7##(2011-2#2)
the infarct size##5##3##(1997-6#1)(2011-2#4)
the infarct##15##2##(1995-12#3)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#5)(2012-2#1)
the infarcted##3##2##(1996-6#1)(2012-12#1)(2013-1#1)
the infarction was##2##3##(1997-3#1)(2008-1#1)
the infarction##5##2##(1997-3#1)(1997-5#3)(2008-1#1)
the infected cells##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-2#1)
the infected seeds##2##3##(2008-10#2)
the infected subdural hematoma##2##4##(2008-7#2)
the infected tissue was##2##4##(2008-10#2)
the infected tissue##3##3##(2008-10#2)(2011-2#1)
the infected##41##2##(1990-6#1)(1990-9#1)(1991-12#1)(1995-2#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
the infecting##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
the infection and##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
the infection by##2##3##(2008-10#1)(2008-9#1)
the infection control##2##3##(2007-2#1)(2008-1#1)
the infection court##3##3##(2008-10#3)
the infection cycle##2##3##(2008-10#2)
the infection efficiency##2##3##(2008-10#2)
the infection from##2##3##(1996-11#1)(2008-12#1)
the infection in##5##3##(1990-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
the infection is endemic##2##4##(2007-2#1)(2011-2#1)
the infection is##3##3##(2007-2#1)(2011-2#1)(2012-2#1)
the infection of the##4##4##(2007-10#1)(2008-5#1)(2010-10#2)
the infection of##15##3##(1991-3#1)(1994-6#1)(2007-10#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#1)(2011-3#1)
the infection process and##2##4##(2008-10#2)
the infection process##6##3##(2008-10#5)(2011-10#1)
the infection rate##2##3##(1990-3#1)(2012-2#1)
the infection site##2##3##(2008-10#2)
the infection stage##2##3##(2008-10#2)
the infection was##7##3##(1992-6#1)(1996-11#1)(2007-12#1)(2008-10#2)(2011-1#1)(2012-3#1)
the infection##108##2##(1990-3#1)(1990-9#4)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#3)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-11#2)(1997-1#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-2#4)(2008-1#2)(2008-10#34)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
the infections##4##2##(1994-6#1)(2007-10#1)(2008-9#1)(2011-2#1)
the infectious agents##2##3##(2011-2#1)(2012-3#1)
the infectious disease##3##3##(2007-12#1)(2008-7#1)(2010-6#1)
the infectious period##2##3##(2008-10#1)(2011-2#1)
the infectious process##2##3##(2010-6#1)(2011-2#1)
the infectious##18##2##(1995-5#1)(1996-3#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-3#1)
the infective##4##2##(1997-3#1)(2008-10#1)(2011-2#2)
the infectivity of##5##3##(2007-10#1)(2008-10#3)(2013-1#1)
the infectivity##7##2##(1992-9#2)(2007-10#1)(2008-10#3)(2013-1#1)
the infectoria species-group##2##3##(2008-10#2)
the infectoria##3##2##(2008-10#3)
the inference of##4##3##(2008-7#1)(2011-1#2)(2012-3#1)
the inference##6##2##(1991-8#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-3#1)
the inferior competitor##5##3##(2008-8#5)
the inferior frontal##2##3##(1995-5#1)(2008-11#1)
the inferior margin of##2##4##(2007-8#1)(2008-10#1)
the inferior surface of the##2##5##(2007-8#1)(2008-8#1)
the inferior vena cava##14##4##(1993-5#1)(2007-8#6)(2008-11#3)(2008-7#1)(2011-2#1)(2013-1#2)
the inferior vena##15##3##(1993-5#1)(2007-8#6)(2008-11#3)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
the inferior##42##2##(1990-9#1)(1991-12#1)(1992-12#1)(1993-5#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-8#9)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#6)(2009-5#1)(2010-3#1)(2011-2#2)(2013-1#3)
the inferomedial##2##2##(2006-10#1)(2011-2#1)
the inferred##8##2##(1996-6#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2010-8#1)
the infertile group##2##3##(1992-1#1)(1994-9#1)
the infertile##4##2##(1992-1#1)(1994-9#1)(2008-12#1)(2011-1#1)
the infestation with##2##3##(2008-10#2)
the infestation##6##2##(1997-3#1)(2008-10#3)(2008-6#1)(2011-2#1)
the infested soil##2##3##(2008-10#2)
the infested##3##2##(2008-10#3)
the infiltration of PMNLs and MPhi##2##6##(2010-1#2)
the infiltration of##3##3##(2008-5#1)(2010-1#2)
the infinite##4##2##(1994-9#1)(2008-12#1)(2008-3#2)
the infirmary##4##2##(1993-8#1)(2008-10#3)
the inflamed##3##2##(1990-6#1)(2008-9#2)
the inflammation in##2##3##(2008-11#1)(2013-1#1)
the inflammation##7##2##(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
the inflammatory bowel disease##3##4##(1994-2#1)(2010-12#1)(2011-1#1)
the inflammatory cascade##2##3##(2009-12#1)(2010-2#1)
the inflammatory cell infiltrates##2##4##(2013-1#2)
the inflammatory changes##2##3##(2008-1#1)(2008-7#1)
the inflammatory cytokine##3##3##(1990-5#1)(2008-7#1)(2010-8#1)
the inflammatory mediators##2##3##(2011-1#1)(2013-1#1)
the inflammatory process and##2##4##(2006-10#1)(2010-12#1)
the inflammatory process in##2##4##(2008-5#1)(2008-8#1)
the inflammatory process##12##3##(1992-6#3)(1993-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)
the inflammatory processes##2##3##(2012-12#1)(2012-3#1)
the inflammatory reaction##4##3##(1990-7#1)(2008-5#1)(2008-7#1)(2013-8#1)
the inflammatory response and##2##4##(1997-7#1)(2010-2#1)
the inflammatory response in the##2##5##(1994-6#1)(2008-7#1)
the inflammatory response of##2##4##(1990-8#1)(2009-12#1)
the inflammatory response to##2##4##(1994-5#1)(2006-10#1)
the inflammatory response##15##3##(1990-8#1)(1991-8#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-2#1)(2010-8#1)(2012-2#1)
the inflammatory responses of##2##4##(2008-5#1)(2013-1#1)
the inflammatory##65##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-6#3)(1993-1#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-7#1)(1997-8#3)(2006-10#2)(2007-10#1)(2008-1#2)(2008-10#4)(2008-3#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#4)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
the inflection point of##2##4##(2008-8#1)(2013-8#1)
the inflection point##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
the inflection points##2##3##(2008-10#1)(2008-8#1)
the inflection##7##2##(2008-10#4)(2008-8#2)(2013-8#1)
the inflorescence##5##2##(1996-2#1)(2008-10#4)
the inflow##4##2##(1991-11#1)(1994-6#1)(1995-12#1)(2007-12#1)
the influence from the##2##4##(2007-12#1)(2008-10#1)
the influence of a range of##2##6##(1997-2#1)(2007-12#1)
the influence of a##14##4##(1990-12#1)(1993-12#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2012-12#1)(2013-7#1)
the influence of age on##4##5##(2008-8#2)(2008-9#2)
the influence of age##7##4##(1994-8#1)(2008-3#1)(2008-8#2)(2008-9#2)(2010-10#1)
the influence of an external##2##5##(2008-3#2)
the influence of an##6##4##(1993-12#1)(2008-3#2)(2008-5#1)(2009-12#1)(2011-2#1)
the influence of both##2##4##(2007-11#1)(2012-2#1)
the influence of complex##2##4##(2008-10#1)(2011-1#1)
the influence of diabetes on##2##5##(2011-2#1)(2012-3#1)
the influence of dietary##3##4##(1991-6#1)(2008-11#1)(2009-6#1)
the influence of different parameters##2##5##(2008-10#2)
the influence of different##15##4##(1996-12#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
the influence of drought##2##4##(2012-6#1)(2012-9#1)
the influence of elevated##2##4##(2008-10#1)(2008-3#1)
the influence of excess demand##2##5##(1995-2#2)
the influence of fluoro group##2##5##(1991-12#2)
the influence of gravity##2##4##(2006-10#1)(2008-2#1)
the influence of harmonics##2##4##(2008-3#2)
the influence of light##2##4##(2008-10#1)(2008-2#1)
the influence of other##2##4##(2008-10#1)(2008-4#1)
the influence of pH##4##4##(2008-10#2)(2011-2#1)(2013-8#1)
the influence of several experimental##2##5##(2008-10#2)
the influence of several##5##4##(2008-10#4)(2008-11#1)
the influence of sex##2##4##(1992-3#1)(2010-6#1)
the influence of social##2##4##(2008-5#1)(2011-1#1)
the influence of such##2##4##(2008-10#1)(2008-11#1)
the influence of temperature on##3##5##(1990-11#1)(2008-10#2)
the influence of temperature##4##4##(1990-11#1)(2008-10#3)
the influence of the deflection signal on the##2##8##(2008-2#2)
the influence of the other##2##5##(2008-10#1)(2008-3#1)
the influence of the presence of##2##6##(2008-10#1)(2011-2#1)
the influence of the relative position of the scattering layer on##2##11##(2008-2#2)
the influence of the relative##4##5##(1994-11#1)(2008-2#2)(2008-3#1)
the influence of the wavelength##2##5##(2008-2#1)(2008-3#1)
the influence of the##85##4##(1990-12#1)(1990-2#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#15)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-9#1)(2013-7#1)
the influence of these factors##2##5##(2008-10#1)(2008-3#1)
the influence of these parameters on##2##6##(2008-10#1)(2011-2#1)
the influence of these##8##4##(1994-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
the influence of time##2##4##(1993-12#1)(2008-10#1)
the influence of two##2##4##(2007-12#1)(2008-5#1)
the influence of visual##2##4##(2008-5#1)(2009-2#1)
the influence of##416##3##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#2)(1996-4#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#9)(2007-12#5)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#71)(2008-11#24)(2008-12#7)(2008-2#32)(2008-3#36)(2008-4#2)(2008-5#20)(2008-6#3)(2008-7#14)(2008-8#11)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#6)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2012-6#1)(2012-9#2)(2013-1#8)(2013-7#3)(2013-8#11)
the influence on##6##3##(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)(2012-3#1)
the influence that##4##3##(1995-2#1)(2008-2#1)(2008-9#1)(2009-10#1)
the influence##436##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#2)(1996-4#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#3)(2007-11#9)(2007-12#6)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#76)(2008-11#25)(2008-12#7)(2008-2#35)(2008-3#36)(2008-4#2)(2008-5#20)(2008-6#3)(2008-7#15)(2008-8#11)(2008-9#11)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#6)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2012-6#1)(2012-9#2)(2013-1#9)(2013-7#3)(2013-8#11)
the influences of age##2##4##(2007-12#1)(2013-8#1)
the influences of different##2##4##(2008-10#1)(2011-2#1)
the influences of##13##3##(1994-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
the influencing factors of tuberculosis among people living with HIV/AIDS##2##10##(2011-1#2)
the influencing##3##2##(2008-10#1)(2011-1#2)
the influenza pandemic of 2009##2##5##(2011-2#2)
the influenza pandemic of##3##4##(2009-7#1)(2011-2#2)
the influenza pandemic##4##3##(2009-7#1)(2011-1#1)(2011-2#2)
the influenza virus##3##3##(1997-6#1)(2010-5#1)(2012-12#1)
the influenza##16##2##(1992-6#1)(1992-9#1)(1997-6#1)(2007-12#1)(2009-7#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#1)
the influx and efflux##2##4##(2008-5#1)(2012-12#1)
the influx of Ca2+##2##4##(1990-5#2)
the influx of##5##3##(1990-5#2)(1991-9#1)(1997-4#1)(1997-8#1)
the influx##8##2##(1990-5#2)(1991-9#1)(1996-8#1)(1997-4#1)(1997-8#1)(2008-5#1)(2012-12#1)
the informal##2##2##(1994-3#1)(1995-3#1)
the informants##2##2##(2012-3#2)
the information about the##3##4##(2007-10#1)(2008-10#1)(2008-2#1)
the information about##6##3##(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-10#1)(2012-12#1)
the information acquired##2##3##(1991-6#1)(2008-10#1)
the information age##4##3##(1994-1#1)(1996-3#1)(2008-1#1)(2009-5#1)
the information and##4##3##(1994-2#1)(1995-1#1)(1996-3#1)(2008-4#1)
the information appears##2##3##(2007-12#2)
the information available##5##3##(2006-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#1)
the information collected##3##3##(1995-2#1)(2008-11#1)(2012-3#1)
the information content of the##3##5##(2008-2#1)(2008-3#1)(2011-2#1)
the information content of##4##4##(2008-2#2)(2008-3#1)(2011-2#1)
the information entropy##2##3##(2013-8#2)
the information for##2##3##(1990-11#1)(1997-8#1)
the information from the##2##4##(2008-2#1)(2008-5#1)
the information from##3##3##(1997-6#1)(2008-2#1)(2008-5#1)
the information gained in##2##4##(2008-12#1)(2010-11#1)
the information gained##4##3##(2008-10#1)(2008-12#1)(2010-11#1)(2012-2#1)
the information given##2##3##(1993-6#1)(2007-8#1)
the information in the##3##4##(1997-5#1)(2009-10#1)(2011-2#1)
the information in##5##3##(1997-5#1)(2006-5#1)(2008-3#1)(2009-10#1)(2011-2#1)
the information necessary to##3##4##(1994-1#2)(2013-1#1)
the information needs of##5##4##(1991-12#1)(1994-12#1)(1995-1#1)(1997-3#2)
the information needs##6##3##(1991-12#1)(1994-12#1)(1995-1#1)(1997-3#2)(2008-3#1)
the information obtained##4##3##(1994-2#1)(1997-8#1)(2008-10#1)(2010-3#1)
the information of##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
the information on the##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
the information on##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
the information provided by the##2##5##(2010-3#1)(2010-8#1)
the information provided by##6##4##(2008-5#2)(2010-3#1)(2010-6#1)(2010-8#2)
the information provided##7##3##(2008-5#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)
the information retrieval##2##3##(1992-1#1)(2013-8#1)
the information superhighway##2##3##(1995-3#1)(1996-2#1)
the information system##2##3##(1994-2#1)(1996-3#1)
the information systems##3##3##(1993-2#1)(1994-3#1)(2012-3#1)
the information technology##5##3##(1993-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(2008-5#1)
the information that is available##2##5##(2008-2#1)(2008-9#1)
the information that##5##3##(1992-2#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-9#1)
the information they##4##3##(1993-6#1)(2008-9#1)(2009-5#1)(2010-5#1)
the information to##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
the information we##2##3##(2007-4#1)(2008-7#1)
the information##171##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#9)(1996-5#1)(1997-1#1)(1997-3#7)(1997-5#1)(1997-6#2)(1997-8#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#10)(2008-3#14)(2008-4#6)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
the informations##2##2##(1997-3#1)(1997-8#1)
the informative##3##2##(1994-6#1)(2008-10#1)(2008-12#1)
the informed consent##2##3##(2007-11#1)(2010-7#1)
the informed##3##2##(1995-12#1)(2007-11#1)(2010-7#1)
the infrabuccal cavity##3##3##(2007-12#3)
the infrabuccal##4##2##(2007-12#4)
the infraorbital##2##2##(1997-3#1)(2008-5#1)
the infrared (2)F(7/2)-(2)D(5/2)##2##3##(2007-12#2)
the infrared detection##3##3##(2007-11#2)(2008-2#1)
the infrared spectral##3##3##(2008-2#1)(2008-3#2)
the infrared spectrum##2##3##(1990-8#1)(2013-8#1)
the infrared##41##2##(1990-8#1)(1991-1#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-2#8)(2008-3#16)(2013-8#2)
the infrarenal##2##2##(2008-7#1)(2009-8#1)
the infraspinatus##2##2##(2008-12#2)
the infrastructure and##2##3##(1995-12#1)(2008-1#1)
the infrastructure needed to##3##4##(1994-1#1)(1994-9#1)(2012-12#1)
the infrastructure##9##2##(1994-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-1#1)(2008-1#2)(2012-12#1)
the infrequent##3##2##(1993-10#1)(2007-5#1)(2011-1#1)
the infundibulum##2##2##(1992-6#1)(2008-12#1)
the infused##2##2##(1992-3#1)(1993-6#1)
the infusion of##2##3##(1997-2#1)(2010-11#1)
the infusion##12##2##(1992-5#1)(1993-10#2)(1995-12#1)(1997-2#1)(1997-3#1)(2008-7#4)(2010-11#1)(2012-3#1)
the ingenuity pathway analysis##2##4##(2010-12#2)
the ingenuity##3##2##(1993-12#1)(2010-12#2)
the ingested##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
the ingestion of the##2##4##(1992-2#1)(2013-8#1)
the ingestion of##5##3##(1992-2#1)(1993-6#1)(1994-5#1)(2008-5#1)(2013-8#1)
the ingredient##4##2##(2008-5#3)(2012-2#1)
the ingredients##2##2##(2008-10#1)(2008-11#1)
the ingress of##2##3##(1996-2#1)(2008-10#1)
the inguinal##8##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2009-9#2)(2011-2#2)
the inhabitants##2##2##(1991-3#1)(1991-6#1)
the inhalation##2##2##(1996-3#1)(2008-10#1)
the inhaled##7##2##(1990-8#2)(1992-3#1)(1997-1#1)(2007-11#1)(2013-1#1)(2013-8#1)
the inherent characteristics of##2##4##(2008-10#1)(2011-2#1)
the inherent complexity of the##2##5##(2008-6#1)(2009-5#1)
the inherent optical properties of the##2##6##(2008-3#2)
the inherent optical properties of##6##5##(2008-2#1)(2008-3#5)
the inherent optical properties##10##4##(2008-2#3)(2008-3#7)
the inherent properties##2##3##(2008-11#1)(2010-12#1)
the inherent value of##2##4##(1995-2#1)(2010-8#1)
the inherent##51##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
the inherently##3##2##(1992-1#1)(1996-4#1)(2008-3#1)
the inheritance of resistance to##2##5##(2008-10#2)
the inheritance of resistance##3##4##(2008-10#3)
the inheritance of schizophrenic##2##4##(2007-1#2)
the inheritance of the##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
the inheritance of##18##3##(1994-9#1)(1996-12#1)(2007-1#2)(2008-10#7)(2008-12#2)(2008-4#3)(2008-8#1)(2009-5#1)
the inheritance##19##2##(1994-9#1)(1996-12#1)(2007-1#2)(2008-10#7)(2008-12#2)(2008-4#3)(2008-8#1)(2009-5#1)(2011-2#1)
the inherited##3##2##(1997-7#1)(2008-7#2)
the inhibited##2##2##(2008-10#2)
the inhibiting##3##2##(2008-10#1)(2008-8#2)
the inhibition and##2##3##(1995-12#1)(2008-9#1)
the inhibition by the##2##4##(1994-2#1)(2008-9#1)
the inhibition by##9##3##(1990-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(2008-9#4)
the inhibition effect##5##3##(2008-10#5)
the inhibition mechanism##2##3##(1990-11#1)(1992-6#1)
the inhibition of CYP3A4##2##4##(2008-10#1)(2008-8#1)
the inhibition of fungal##2##4##(2008-10#2)
the inhibition of glucocorticoid- and cAMP-stimulated PEPCK gene##2##8##(1995-6#1)(1996-2#1)
the inhibition of osteocalcin synthesis##2##5##(1990-2#2)
the inhibition of phospholipase##2##4##(1994-11#1)(1997-1#1)
the inhibition of protein##3##4##(1994-11#1)(1995-8#2)
the inhibition of the##15##4##(1990-2#1)(1990-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-3#1)(2008-8#1)(2008-9#1)
the inhibition of topoisomerase I##2##5##(2008-11#1)(2008-8#1)
the inhibition of##132##3##(1990-11#1)(1990-2#4)(1990-5#3)(1990-8#2)(1991-12#1)(1991-2#3)(1991-5#3)(1991-8#2)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#4)(1995-8#3)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#9)(2008-9#6)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
the inhibition was##6##3##(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-11#1)(1997-7#1)
the inhibition##178##2##(1990-11#2)(1990-2#5)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#6)(1991-2#4)(1991-5#3)(1991-8#2)(1992-12#1)(1992-3#5)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#4)(1994-11#5)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#5)(1995-8#3)(1996-2#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#3)(1997-8#1)(2007-8#1)(2008-10#17)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#10)(2008-9#11)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)
the inhibitor and##3##3##(1991-3#1)(1991-5#1)(1995-11#1)
the inhibitor is##2##3##(1991-3#1)(1993-3#1)
the inhibitor of protein tyrosine##2##5##(2008-8#2)
the inhibitor of##5##3##(2008-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
the inhibitor was##4##3##(1990-5#1)(1991-3#1)(1993-3#1)(1996-12#1)
the inhibitor##41##2##(1990-11#2)(1990-2#2)(1990-5#1)(1991-3#4)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#2)(1993-8#3)(1994-11#3)(1994-6#1)(1995-11#1)(1995-2#2)(1996-12#1)(2007-7#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the inhibitors and##2##3##(1995-2#1)(1995-3#1)
the inhibitors##19##2##(1990-10#1)(1991-2#1)(1992-10#1)(1992-3#2)(1992-8#3)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-5#1)(2008-8#1)(2009-11#1)(2009-9#1)
the inhibitory action of the##3##5##(1990-11#1)(1994-8#1)(2008-10#1)
the inhibitory action of##4##4##(1990-11#1)(1992-8#1)(1994-8#1)(2008-10#1)
the inhibitory action##6##3##(1990-11#1)(1990-2#1)(1992-8#1)(1994-8#1)(2008-10#1)(2013-7#1)
the inhibitory activity of ochnaflavone##2##5##(1994-11#2)
the inhibitory activity of##3##4##(1994-11#2)(2008-5#1)
the inhibitory activity##7##3##(1990-5#1)(1991-12#1)(1991-9#1)(1994-11#2)(2008-5#2)
the inhibitory effect of acetic acid on##2##7##(2008-6#2)
the inhibitory effect of the##2##5##(1995-6#1)(2008-9#1)
the inhibitory effect of##32##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1997-4#3)(2008-10#5)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-3#1)(2013-1#1)
the inhibitory effect on##2##4##(1990-12#1)(2008-4#1)
the inhibitory effect was##4##4##(1991-9#1)(1995-6#1)(2008-10#1)(2008-9#1)
the inhibitory effect##41##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-4#3)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-3#1)(2013-1#1)
the inhibitory effects of amphetamine on##2##6##(2013-1#2)
the inhibitory effects of##20##4##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#3)
the inhibitory effects on##4##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
the inhibitory effects were##2##4##(1995-11#1)(1996-5#1)
the inhibitory effects##26##3##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#3)
the inhibitory factor##3##3##(1996-2#3)
the inhibitory potency##3##3##(2010-11#2)(2011-2#1)
the inhibitory potential##2##3##(1994-6#1)(1997-3#1)
the inhibitory site##3##3##(1990-11#1)(1990-2#1)(1993-2#1)
the inhibitory##117##2##(1990-11#3)(1990-12#2)(1990-2#5)(1990-5#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#4)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1996-2#5)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#3)(2007-12#1)(2008-10#12)(2008-11#7)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2010-11#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)
the inhomogeneities##2##2##(2008-3#2)
the inhomogeneity of the##4##4##(2008-3#4)
the inhomogeneity of##5##3##(2008-2#1)(2008-3#4)
the inhomogeneity##8##2##(1996-4#1)(2008-2#1)(2008-3#5)(2008-7#1)
the inhomogeneous##7##2##(2008-11#1)(2008-3#6)
the initial F0 is##2##4##(2013-8#2)
the initial Met##2##3##(1993-12#1)(1995-6#1)
the initial analysis##2##3##(2008-10#2)
the initial and terminal##2##4##(1993-11#2)
the initial and##6##3##(1993-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
the initial assessment##4##3##(1993-2#1)(2007-1#1)(2011-1#1)(2012-2#1)
the initial batch##2##3##(1994-5#1)(2008-7#1)
the initial cleavage of##2##4##(1990-9#1)(2008-8#1)
the initial clinical##4##3##(1997-8#1)(2008-7#1)(2008-9#1)(2010-12#1)
the initial concentration of the##2##5##(2008-10#2)
the initial concentration of##4##4##(2008-10#4)
the initial concentration##5##3##(2008-10#5)
the initial conditions##3##3##(2008-11#2)(2008-3#1)
the initial damage##2##3##(1992-9#1)(2008-3#1)
the initial decrease in##2##4##(1991-9#1)(1996-11#1)
the initial delay##2##3##(2011-2#2)
the initial development of##3##4##(2008-12#1)(2008-8#1)(2010-3#1)
the initial diagnosis of##2##4##(2007-8#1)(2011-2#1)
the initial diagnosis##4##3##(1996-3#1)(2007-8#1)(2011-2#1)(2013-8#1)
the initial disease##2##3##(2008-10#2)
the initial distribution##2##3##(2008-3#2)
the initial dose##3##3##(2007-7#1)(2008-11#1)(2008-8#1)
the initial evaluation##6##3##(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#2)
the initial event##2##3##(2007-10#1)(2010-6#1)
the initial fitting session and for the following##2##8##(2008-9#2)
the initial fitting session##3##4##(2008-9#3)
the initial formation of a##2##5##(1990-11#1)(2011-2#1)
the initial frequency##2##3##(2007-12#1)(2008-10#1)
the initial glucose concentration##3##4##(2008-6#2)(2008-7#1)
the initial headspace##2##3##(2011-2#2)
the initial hypothesis##2##3##(1990-7#1)(2008-10#1)
the initial imaging modality##2##4##(2011-2#2)
the initial imaging##3##3##(2011-2#3)
the initial implementation##2##3##(1996-12#1)(2008-7#1)
the initial increase##2##3##(1990-5#1)(2008-10#1)
the initial infection##4##3##(2008-10#4)
the initial infestation in##2##4##(1996-12#2)
the initial inoculum density##2##4##(2008-10#2)
the initial inoculum##4##3##(2008-10#4)
the initial intensity##2##3##(2008-3#2)
the initial leukocytosis##2##3##(2011-2#2)
the initial operation##6##3##(2008-7#1)(2011-2#4)(2012-3#1)
the initial pH of the##3##5##(2008-6#3)
the initial pH##4##3##(2008-6#4)
the initial period##3##3##(2007-8#2)(2011-2#1)
the initial phase of treatment##2##5##(2007-7#1)(2013-8#1)
the initial phase of##7##4##(2007-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
the initial phase##12##3##(1990-6#1)(1990-7#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
the initial plating density##2##4##(1990-7#1)(1996-5#1)
the initial population##2##3##(2008-10#1)(2008-8#1)
the initial presentation of##5##4##(2006-10#1)(2007-5#1)(2008-11#1)(2008-6#1)(2012-12#1)
the initial presentation##8##3##(2006-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2012-12#1)(2012-3#1)
the initial process##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
the initial pulse##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
the initial rate method##2##4##(2008-10#2)
the initial rate of the##2##5##(1990-12#1)(2008-10#1)
the initial rate of uptake##2##5##(1992-6#1)(1995-11#1)
the initial rate of##12##4##(1990-11#1)(1990-12#3)(1992-6#3)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#2)
the initial rate##18##3##(1990-11#1)(1990-12#3)(1992-6#3)(1994-5#1)(1995-11#1)(1995-2#1)(2008-10#7)(2008-7#1)
the initial reactions##2##3##(1991-3#1)(1991-7#1)
the initial reduction##3##3##(1995-6#1)(2010-7#1)(2011-2#1)
the initial release##2##3##(1996-2#1)(2008-10#1)
the initial results of##2##4##(2011-2#1)(2013-1#1)
the initial results##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
the initial sample##2##3##(2008-10#1)(2008-7#1)
the initial sign of##2##4##(1991-2#1)(2011-2#1)
the initial signal##2##3##(2008-4#1)(2008-8#1)
the initial size of##2##4##(1990-11#1)(2008-8#1)
the initial slope of the##2##5##(2008-10#1)(2008-3#1)
the initial stage of the##2##5##(2008-6#1)(2008-7#1)
the initial stage of##7##4##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
the initial stage##8##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
the initial stages of the##5##5##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
the initial stages of##10##4##(2006-12#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-3#1)(2009-8#1)(2009-9#1)(2011-2#1)
the initial stages##11##3##(2006-12#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
the initial state##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
the initial step of##3##4##(1991-9#1)(1992-12#1)(2009-2#1)
the initial step##5##3##(1991-9#1)(1992-12#1)(2008-1#1)(2008-10#1)(2009-2#1)
the initial steps##2##3##(2008-10#1)(2011-3#1)
the initial stress##3##3##(2008-5#3)
the initial therapeutic##2##3##(1993-11#1)(2008-11#1)
the initial treatment of choice##2##5##(1990-9#1)(2013-8#1)
the initial treatment##6##3##(1990-9#1)(1992-3#1)(1993-3#1)(2007-10#1)(2010-8#1)(2013-8#1)
the initial value##2##3##(1990-3#1)(2007-11#1)
the initial##432##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#5)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#4)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#13)(2007-5#3)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#73)(2008-11#16)(2008-12#4)(2008-2#6)(2008-3#18)(2008-4#4)(2008-5#6)(2008-6#13)(2008-7#15)(2008-8#13)(2008-9#9)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#28)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#9)
the initially formed##2##3##(1991-9#1)(1996-5#1)
the initially##8##2##(1991-9#1)(1993-12#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-7#1)
the initiation and control of##2##5##(1993-12#1)(2008-4#1)
the initiation and development of##4##5##(1997-4#1)(2008-10#1)(2008-8#1)(2012-3#1)
the initiation and maintenance of##2##5##(1993-3#1)(2008-7#1)
the initiation and propagation of disease processes in multicellular organisms##2##10##(2008-2#1)(2008-4#1)
the initiation and propagation of the##2##6##(2009-5#1)(2011-1#1)
the initiation and propagation of##4##5##(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)
the initiation and the##2##4##(2008-11#1)(2008-7#1)
the initiation and##19##3##(1992-5#1)(1993-12#1)(1993-3#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
the initiation codons##2##3##(1996-8#2)
the initiation of DNA##2##4##(1990-11#2)
the initiation of PD therapy##2##5##(2011-2#2)
the initiation of highly active antiretroviral therapy (HAART)##2##8##(2009-7#1)(2011-2#1)
the initiation of insulin##2##4##(2011-1#2)
the initiation of lambda plasmid DNA replication##2##7##(1994-11#2)
the initiation of the##9##4##(1992-3#1)(1996-3#1)(2007-7#1)(2008-10#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
the initiation of treatment##2##4##(2010-3#1)(2010-8#1)
the initiation of##57##3##(1990-11#2)(1990-5#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-6#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
the initiation or##2##3##(1993-6#1)(2008-11#1)
the initiation site of##2##4##(2008-6#2)
the initiation sites were##2##4##(1997-6#2)
the initiation##92##2##(1990-11#2)(1990-5#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-6#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#5)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)
the initiative to##2##3##(1992-11#1)(1994-3#1)
the initiative##9##2##(1992-11#1)(1994-12#2)(1994-3#1)(1995-2#1)(2008-1#1)(2008-11#1)(2010-1#1)(2012-2#1)
the initiatives##4##2##(1996-3#1)(2010-12#2)(2013-1#1)
the initiator methionine##2##3##(1990-5#1)(1992-3#1)
the initiator##8##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-3#1)(1994-6#1)(2008-10#1)(2012-12#2)
the injected dose##3##3##(1993-11#1)(2010-1#1)(2013-1#1)
the injected muscle##2##3##(1995-12#2)
the injected sample##3##3##(2008-10#3)
the injected substances##2##3##(2012-1#2)
the injected##21##2##(1991-12#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-12#4)(2008-10#8)(2008-8#1)(2010-1#1)(2012-1#2)(2013-1#1)
the injection and##2##3##(1990-5#1)(2008-9#1)
the injection current##2##3##(2007-12#2)
the injection duration##2##3##(2008-7#2)
the injection of a##2##4##(2008-10#2)
the injection of blood##2##4##(1993-10#1)(2011-2#1)
the injection of##28##3##(1990-5#1)(1990-7#2)(1991-2#1)(1993-10#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#2)(2012-3#1)
the injection rate##2##3##(2008-10#1)(2008-7#1)
the injection site##13##3##(1990-6#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-3#2)(2007-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-2#2)
the injection volume##2##3##(1994-9#1)(2011-1#1)
the injection##82##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-2#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#2)(1996-12#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-7#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-12#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#7)(2012-3#1)(2013-8#1)
the injector and##2##3##(1995-6#1)(2008-10#1)
the injector temperature##2##3##(2008-10#2)
the injector##4##2##(1995-6#1)(2008-10#3)
the injured spinal cord##2##4##(2008-7#2)
the injured##20##2##(1990-6#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-3#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-6#1)(2012-7#1)
the injuries##4##2##(1990-6#1)(1995-8#1)(2008-9#1)(2009-7#1)
the injury rate##3##3##(1997-2#1)(2008-11#2)
the injury##22##2##(1991-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-8#2)(2008-11#2)(2008-9#2)(2009-12#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the ink##2##2##(2008-10#2)
the inlet##3##2##(2008-10#1)(2008-7#2)
the innate and adaptive##2##4##(2006-10#1)(2010-1#1)
the innate and##3##3##(2006-10#1)(2010-1#1)(2013-8#1)
the innate immune response##3##4##(2008-3#1)(2010-1#1)(2013-8#1)
the innate immune system##9##4##(2008-10#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the innate immune##13##3##(2008-10#2)(2008-3#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
the innate##19##2##(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#3)
the inner and outer##4##4##(1990-11#2)(1991-10#1)(2013-8#1)
the inner cell mass of##2##5##(2008-9#2)
the inner cell mass##3##4##(2008-5#1)(2008-9#2)
the inner cell##4##3##(2008-5#1)(2008-9#2)(2010-11#1)
the inner core##5##3##(1995-3#3)(2008-2#1)(2008-8#1)
the inner ear##11##3##(1993-9#1)(1994-9#1)(1995-5#3)(2008-4#2)(2008-9#2)(2011-1#2)
the inner filter effect and##2##5##(2008-10#1)(2008-11#1)
the inner filter effect##4##4##(2008-10#2)(2008-11#2)
the inner layer of the##2##5##(2008-10#1)(2008-8#1)
the inner layer of##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
the inner layers##2##3##(2008-10#1)(2010-8#1)
the inner leaflet##2##3##(2008-11#2)
the inner lipid##2##3##(1991-5#2)
the inner membrane##9##3##(1990-2#2)(1991-10#1)(1992-6#1)(1992-7#1)(1994-8#1)(1997-8#1)(2011-2#1)(2013-8#1)
the inner mitochondrial membrane##6##4##(1990-11#1)(1993-6#2)(1995-2#1)(1996-2#1)(2012-2#1)
the inner mitochondrial##7##3##(1990-11#1)(1993-6#2)(1994-5#1)(1995-2#1)(1996-2#1)(2012-2#1)
the inner nuclear membrane##2##4##(2008-9#1)(2011-2#1)
the inner nuclear##3##3##(1991-10#1)(2008-9#1)(2011-2#1)
the inner part of the##2##5##(1995-3#1)(2008-10#1)
the inner shell##2##3##(2008-8#2)
the inner side of the##2##5##(2008-10#1)(2008-9#1)
the inner surface of the##6##5##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
the inner surface of##8##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2011-2#1)
the inner surface##9##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2011-2#1)
the inner wall of the##2##5##(2008-10#2)
the inner wall of##3##4##(2008-10#3)
the inner wall##5##3##(1997-2#1)(2008-10#3)(2008-9#1)
the inner walls of##3##4##(1997-2#1)(2008-10#2)
the inner##123##2##(1990-11#5)(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#4)(1991-2#2)(1991-5#4)(1992-6#2)(1992-7#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#3)(2008-8#9)(2008-9#7)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-8#2)
the inner-edge polarization of##2##4##(2008-2#2)
the inner-edge polarization##3##3##(2008-2#3)
the innermost GlcNAc##2##3##(1994-5#1)(2008-11#1)
the innermost chorionic layer##2##4##(2007-12#2)
the innermost region I##2##4##(1990-3#2)
the innermost##8##2##(1990-3#2)(1994-5#1)(2007-12#2)(2008-11#1)(2008-7#1)(2011-2#1)
the innervation of##4##3##(1994-9#1)(2008-8#1)(2013-8#2)
the innervation##6##2##(1992-6#1)(1994-9#1)(2007-12#1)(2008-8#1)(2013-8#2)
the innovation##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
the innovative##5##2##(1997-3#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-3#1)
the inocula##4##2##(2008-10#1)(2008-5#3)
the inoculated Fusarium species##2##4##(2008-10#2)
the inoculated control##3##3##(2008-10#3)
the inoculated isolates##2##3##(2008-10#2)
the inoculated leaf##5##3##(2008-10#5)
the inoculated leaves##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
the inoculated plants##2##3##(2008-10#1)(2008-5#1)
the inoculated##38##2##(2008-10#32)(2008-5#4)(2008-8#1)(2012-3#1)
the inoculation site##5##3##(2008-10#5)
the inoculation sites##2##3##(2008-10#2)
the inoculation##18##2##(2008-10#14)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
the inoculum and##2##3##(2008-10#2)
the inoculum density##6##3##(2008-10#6)
the inoculum was##2##3##(2008-10#2)
the inoculum##26##2##(1991-11#1)(2008-10#20)(2008-11#1)(2008-5#1)(2008-7#3)
the inorganic##18##2##(1990-5#1)(1991-11#1)(1993-11#1)(1995-11#1)(2008-10#9)(2008-6#2)(2008-7#2)(2010-4#1)
the inositol ring##2##3##(1993-8#1)(2010-9#1)
the inositol triphosphate##2##3##(1995-11#1)(2012-12#1)
the inositol##9##2##(1990-7#2)(1991-8#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(2010-9#1)(2012-12#1)
the inpatient treatment##2##3##(1991-2#1)(1992-3#1)
the inpatient##8##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(2010-12#1)(2013-1#1)
the input and output##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2010-8#1)
the input and the Fourier planes##3##6##(2008-2#1)(2008-3#2)
the input and the output of##2##6##(2008-3#2)
the input and the output##4##5##(2007-12#1)(2008-3#3)
the input and the reference##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the input and the##12##4##(2007-12#2)(2008-2#2)(2008-3#8)
the input and##18##3##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#9)(2010-8#1)
the input angle##2##3##(2008-2#2)
the input beam##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
the input data##2##3##(2008-6#1)(2010-8#1)
the input image##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the input images##2##3##(2008-2#1)(2008-3#1)
the input laser##2##3##(2008-3#2)
the input layer##5##3##(2008-10#2)(2010-8#3)
the input light intensity##2##4##(2007-11#1)(2007-12#1)
the input light##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
the input noise##2##3##(2007-12#1)(2008-2#1)
the input object##2##3##(2008-3#2)
the input of a##2##4##(2009-11#1)(2013-8#1)
the input of##5##3##(1993-2#1)(2009-11#1)(2010-8#1)(2011-3#1)(2013-8#1)
the input or##3##3##(2008-2#2)(2008-3#1)
the input parameters##2##3##(2008-2#2)
the input plane##5##3##(2007-11#1)(2008-3#4)
the input port##2##3##(2007-12#1)(2008-3#1)
the input pulse##4##3##(2007-11#2)(2007-12#2)
the input pulses##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
the input resistance##3##3##(1992-3#1)(1993-12#2)
the input scene##3##3##(2008-2#1)(2008-3#2)
the input sequences##2##3##(2008-11#1)(2008-9#1)
the input signal##2##3##(2008-3#2)
the input surface##2##3##(2008-3#2)
the input variables##3##3##(2008-10#3)
the input wave##2##3##(2007-11#1)(2007-12#1)
the input##139##2##(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-2#1)(2007-11#17)(2007-12#19)(2008-10#5)(2008-11#4)(2008-2#30)(2008-3#38)(2008-6#4)(2008-9#3)(2009-11#1)(2009-7#1)(2010-5#1)(2010-8#6)(2011-3#1)(2012-2#1)(2013-8#1)
the input-output characteristics of##2##4##(2007-12#1)(2008-8#1)
the input-output##4##2##(2007-12#1)(2008-8#2)(2012-2#1)
the inputs and##2##3##(2008-11#1)(2008-3#1)
the inputs are##2##3##(2008-10#1)(2008-3#1)
the inputs to##2##3##(1993-6#1)(2009-10#1)
the inputs##9##2##(1992-2#1)(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-10#1)
the insect brain##3##3##(2007-12#3)
the insect cell##2##3##(1993-6#1)(2008-11#1)
the insect cells##2##3##(1994-8#1)(2008-10#1)
the insect organs##2##3##(2008-10#2)
the insect wing##2##3##(2007-12#2)
the insect##29##2##(1992-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(2007-12#9)(2008-10#8)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#2)(2012-2#1)
the insect's##3##2##(2008-10#3)
the insecticide##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
the insects##2##2##(2008-10#1)(2008-9#1)
the insensitive##2##2##(2008-10#2)
the insensitivity##3##2##(2008-10#2)(2008-7#1)
the insert##7##2##(1992-6#1)(1994-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)
the inserted T-DNA##2##3##(2008-10#2)
the inserted##12##2##(1990-5#1)(1994-12#1)(1997-2#1)(1997-8#4)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
the insertion loss of##2##4##(2007-11#1)(2008-3#1)
the insertion loss##3##3##(2007-11#1)(2008-3#2)
the insertion of a##6##4##(1994-12#1)(2008-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
the insertion of an##3##4##(1993-10#1)(2007-8#1)(2008-10#1)
the insertion of the##7##4##(2008-10#2)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#1)
the insertion of##29##3##(1991-6#1)(1991-7#1)(1993-10#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
the insertion site##2##3##(1990-11#1)(2013-1#1)
the insertion was##2##3##(2008-10#1)(2009-7#1)
the insertion##46##2##(1990-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1993-10#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#4)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-8#1)
the inserts of##2##3##(1997-3#1)(2008-10#1)
the inserts##4##2##(1997-3#1)(2008-10#2)(2008-5#1)
the inside needle capillary adsorption trap (INCAT)##2##7##(2008-10#2)
the inside needle capillary adsorption trap##3##6##(2008-10#3)
the inside of a##2##4##(2008-2#2)
the inside of the##3##4##(2008-2#1)(2008-3#1)(2009-8#1)
the inside of##6##3##(2008-10#1)(2008-2#3)(2008-3#1)(2009-8#1)
the inside##15##2##(1996-2#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-7#1)
the insight##2##2##(2008-11#1)(2009-10#1)
the insights##3##2##(1991-5#1)(2008-9#1)(2009-5#1)
the insoluble monolayer##2##3##(2008-10#2)
the insoluble##11##2##(1990-5#2)(1994-11#2)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#3)(2009-7#1)
the inspection##2##2##(1993-2#1)(2007-12#1)
the inspiratory##2##2##(1996-5#1)(2011-2#1)
the instability of the##4##4##(1991-12#1)(2008-10#2)(2011-7#1)
the instability of##7##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2011-7#1)
the instability##12##2##(1991-12#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2011-7#1)(2012-3#1)
the installation of a##3##4##(1990-10#1)(2008-10#2)
the installation of##7##3##(1990-10#2)(1990-3#1)(1992-11#1)(1994-3#1)(2008-10#2)
the installation##10##2##(1990-10#2)(1990-3#1)(1992-11#2)(1994-3#2)(2008-10#2)(2008-4#1)
the instant of exposure##3##4##(2008-2#3)
the instant##4##2##(2008-10#1)(2008-2#3)
the instantaneous##14##2##(1990-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2009-9#1)(2010-5#2)(2010-8#2)(2012-2#1)
the instillation of 0##2##4##(2008-7#2)
the institute##2##2##(2009-10#1)(2011-2#1)
the institution and##2##3##(1992-12#1)(1994-1#1)
the institution in##3##3##(1991-3#1)(1993-12#1)(2012-2#1)
the institution of##5##3##(1996-12#1)(1997-2#1)(2010-3#1)(2011-2#2)
the institution to##2##3##(1993-1#1)(2012-12#1)
the institution##25##2##(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#2)(1994-12#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
the institution's##5##2##(1991-3#1)(1994-1#1)(1996-2#2)(1996-3#1)
the institutional setting##2##3##(2008-7#1)(2008-9#1)
the institutional##10##2##(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
the institutionalization of##3##3##(2010-1#2)(2013-1#1)
the institutions##3##2##(1992-2#1)(2012-12#1)(2012-3#1)
the instruction of##2##3##(2009-11#1)(2011-3#1)
the instruction##3##2##(1993-8#1)(2009-11#1)(2011-3#1)
the instructor##2##2##(1994-7#1)(2007-6#1)
the instrument and##3##3##(1994-3#1)(2008-10#1)(2008-3#1)
the instrument are##2##3##(2008-10#1)(2008-3#1)
the instrument at##2##3##(2008-3#1)(2008-9#1)
the instrument can##2##3##(2008-3#2)
the instrument function##3##3##(2008-3#3)
the instrument is##8##3##(2007-11#1)(2008-10#2)(2008-3#4)(2010-12#1)
the instrument of##2##3##(2009-4#1)(2009-9#1)
the instrument performance##2##3##(2008-3#2)
the instrument response##2##3##(2008-2#1)(2008-3#1)
the instrument to##2##3##(2008-3#2)
the instrument was##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
the instrument with##2##3##(2008-2#1)(2012-3#1)
the instrument##101##2##(1992-6#2)(1993-3#1)(1994-3#1)(1997-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#11)(2008-3#43)(2008-9#5)(2009-12#4)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#3)
the instrument's##9##2##(2007-11#1)(2008-10#1)(2008-3#7)
the instrumental detection limit##2##4##(2008-10#1)(2008-3#1)
the instrumental##18##2##(1991-3#1)(2008-10#11)(2008-3#5)(2011-2#1)
the instrumentation##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
the instruments##22##2##(1995-3#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#6)
the instruments'##2##2##(2008-2#1)(2008-3#1)
the insufficient##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
the insufflation gas##2##3##(1992-12#2)
the insula##2##2##(2012-12#2)
the insulin cells##2##3##(2010-11#2)
the insulin gene##3##3##(2008-1#1)(2008-4#1)(2010-11#1)
the insulin producing##2##3##(2010-11#2)
the insulin receptor and##2##4##(1997-6#1)(2008-4#1)
the insulin receptor gene##3##4##(1994-12#3)
the insulin receptor##20##3##(1990-11#2)(1991-12#6)(1992-12#1)(1993-8#1)(1994-12#3)(1995-11#1)(1997-6#1)(2008-4#3)(2010-11#1)(2010-12#1)
the insulin secretion##3##3##(2008-11#3)
the insulin sensitivity##2##3##(2008-3#1)(2008-9#1)
the insulin signaling pathway##4##4##(2008-11#2)(2010-12#2)
the insulin##55##2##(1990-11#2)(1990-12#1)(1991-12#7)(1992-12#1)(1992-3#2)(1992-6#2)(1993-6#2)(1993-8#1)(1994-12#3)(1995-11#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-1#2)(2008-11#5)(2008-3#1)(2008-4#4)(2008-6#1)(2008-9#1)(2010-11#10)(2010-12#3)(2011-1#1)(2012-3#1)
the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes##3##8##(1995-8#3)
the insulin-induced##4##2##(1995-8#3)(2008-10#1)
the insulin-like growth factor##2##4##(1990-9#1)(1992-4#1)
the insulin-like growth##3##3##(1990-9#1)(1992-4#1)(1997-1#1)
the insulin-sensitive##2##2##(1990-8#1)(2010-11#1)
the insulin-stimulated##4##2##(1995-11#1)(1995-6#1)(2008-11#1)(2008-9#1)
the insult##5##2##(1994-2#1)(1996-5#1)(2008-11#1)(2008-7#2)
the insurance industry##3##3##(1993-12#1)(1997-3#1)(2008-7#1)
the insurance##14##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#3)(1993-3#1)(1994-1#1)(1995-1#1)(1997-3#2)(1997-5#1)(2008-11#1)(2008-7#1)
the intact animal##2##3##(1991-2#1)(2008-9#1)
the intact antibody##2##3##(1993-6#1)(1995-2#1)
the intact cells##3##3##(1992-3#1)(1993-9#2)
the intact enzyme##2##3##(1991-5#1)(2008-8#1)
the intact murine##3##3##(2008-10#3)
the intact side of the aged##2##6##(1996-2#2)
the intact side##3##3##(1996-2#3)
the intact##61##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#4)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#8)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-4#1)(2013-1#1)(2013-8#1)
the intake of RS extract##3##5##(2008-11#3)
the intake of saturated fatty acids##2##6##(1990-2#1)(1992-8#1)
the intake of##14##3##(1990-2#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)
the integral of##2##3##(1994-6#1)(2008-7#1)
the integral##13##2##(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(2008-2#2)(2008-3#4)(2008-7#1)(2012-1#1)(2012-12#1)
the integrase##4##2##(1992-6#1)(1994-9#1)(1997-3#2)
the integrated organ##3##3##(2012-3#3)
the integrated platform##4##3##(2008-10#4)
the integrated stress response##2##4##(2008-4#1)(2012-2#1)
the integrated##41##2##(1995-12#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#2)
the integration and##3##3##(2008-11#2)(2009-11#1)
the integration is##2##3##(2007-11#1)(2008-3#1)
the integration of clinical##2##4##(1996-2#1)(1997-3#1)
the integration of multiple##2##4##(2008-11#1)(2012-3#1)
the integration of organic##2##4##(2008-7#1)(2010-5#1)
the integration of the##13##4##(1993-6#1)(1994-9#1)(1996-2#1)(1997-3#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)
the integration of these##2##4##(2008-7#1)(2009-6#1)
the integration of three##2##4##(2008-10#1)(2008-7#1)
the integration of##59##3##(1991-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#3)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
the integration process##2##3##(1997-1#2)
the integration##74##2##(1991-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#2)(1997-1#3)(1997-2#2)(1997-3#3)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#9)(2008-11#5)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
the integrative##6##2##(1992-2#1)(1994-2#1)(1994-3#1)(1996-1#1)(2012-2#1)(2013-8#1)
the integrin##11##2##(1992-12#1)(1992-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-6#1)(1997-2#1)(2006-6#1)(2008-1#1)(2008-5#1)
the integrity and##3##3##(1996-2#1)(1997-4#1)(2008-4#1)
the integrity of 5-HT##2##4##(1993-3#1)(1995-5#1)
the integrity of the##19##4##(1990-2#1)(1990-5#1)(1992-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
the integrity of##36##3##(1990-2#1)(1990-5#2)(1992-3#1)(1993-3#1)(1995-2#2)(1995-5#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
the integrity##39##2##(1990-2#1)(1990-5#2)(1992-3#1)(1993-3#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
the integument##4##2##(1991-2#1)(2007-12#3)
the intein##2##2##(2011-2#1)(2013-1#1)
the intelligentsia##4##2##(2008-12#4)
the intended use##2##3##(1997-1#1)(2010-6#1)
the intended##14##2##(1995-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-6#1)(2012-12#1)
the intense##5##2##(1991-3#1)(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the intensifying##2##2##(2008-10#1)(2010-12#1)
the intensities of the spectral line##2##6##(2013-8#2)
the intensities of the##6##4##(2008-10#1)(2008-3#1)(2008-8#2)(2013-8#2)
the intensities of##8##3##(1994-7#1)(2008-10#1)(2008-3#2)(2008-8#2)(2013-8#2)
the intensity and the phase of##3##6##(2007-11#1)(2007-12#2)
the intensity and the##8##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-9#1)
the intensity and unpleasantness of perceived dyspnea##2##7##(2008-10#2)
the intensity and unpleasantness of##3##5##(2008-10#2)(2008-5#1)
the intensity and##22##3##(1994-2#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
the intensity at##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
the intensity change of the##2##5##(2008-3#2)
the intensity correlation function##2##4##(2008-2#1)(2008-3#1)
the intensity distribution of the##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
the intensity distribution##11##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)
the intensity in##2##3##(2008-2#1)(2008-3#1)
the intensity inside the##2##4##(2008-3#2)
the intensity noise##3##3##(2007-12#2)(2008-3#1)
the intensity noises of the amplified signal and##2##8##(2007-11#2)
the intensity noises of the##3##5##(2007-11#2)(2007-12#1)
the intensity of Fos-like##2##4##(1997-2#2)
the intensity of a##2##4##(2008-3#1)(2008-4#1)
the intensity of an##2##4##(1992-12#1)(2008-4#1)
the intensity of foraging##2##4##(2008-8#2)
the intensity of the contralateral stimulation##2##6##(1993-3#2)
the intensity of the incident##2##5##(2008-3#2)
the intensity of the visual stimulus##2##6##(1992-11#2)
the intensity of the##48##4##(1990-7#1)(1992-11#2)(1993-3#2)(1994-7#1)(1995-12#1)(2007-10#1)(2007-11#4)(2007-12#5)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#10)(2008-5#2)(2008-9#1)(2009-10#1)(2013-7#1)(2013-8#1)
the intensity of##111##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-7#1)(1995-12#4)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#2)(2007-10#1)(2007-11#7)(2007-12#5)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#4)
the intensity profile of the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
the intensity profile of##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
the intensity profile##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
the intensity ratio##2##3##(2008-10#1)(2008-3#1)
the intensity spectrum##2##3##(2007-12#2)
the intensity variation of the light source##3##7##(2008-3#3)
the intensity variation##4##3##(2008-3#4)
the intensity##210##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-3#2)(1994-2#2)(1994-6#1)(1994-7#1)(1995-12#5)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#2)(2007-10#1)(2007-11#19)(2007-12#22)(2007-8#1)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#22)(2008-3#49)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#5)
the intensive care unit (ICU) is##4##6##(2007-8#1)(2010-11#2)(2011-2#1)
the intensive care unit (ICU)##7##5##(2007-8#2)(2008-3#1)(2010-11#2)(2011-2#1)(2012-3#1)
the intensive care unit of##3##5##(2009-3#1)(2010-11#1)(2013-1#1)
the intensive care unit##21##4##(1991-2#1)(2006-10#1)(2007-8#2)(2008-3#2)(2008-4#2)(2008-8#1)(2009-3#1)(2010-11#5)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
the intensive care##27##3##(1991-2#1)(1993-12#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#5)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
the intensive treatment##2##3##(2011-2#2)
the intensive##37##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-12#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#5)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
the intensiveness of##2##3##(1991-12#2)
the intent of the##3##4##(1994-2#1)(2007-4#1)(2009-4#1)
the intent of##8##3##(1994-1#1)(1994-2#1)(1994-3#1)(2007-4#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-5#1)
the intent##9##2##(1994-1#1)(1994-2#1)(1994-3#1)(2007-4#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-5#1)
the intention of##4##3##(1995-3#2)(2008-10#1)(2008-5#1)
the intention to##4##3##(1993-12#1)(2011-1#2)(2013-8#1)
the intention##10##2##(1993-12#2)(1995-3#2)(2008-10#2)(2008-5#1)(2011-1#2)(2013-8#1)
the intentional##4##2##(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
the intentions of##2##3##(1994-3#1)(1995-3#1)
the inter##3##2##(2008-10#1)(2012-3#2)
the inter-vertebral venous plexus##2##4##(2009-6#2)
the inter-war period##2##3##(2008-12#2)
the inter-war##3##2##(2008-12#3)
the interacting##10##2##(2007-11#2)(2007-12#2)(2008-11#2)(2008-8#1)(2009-12#1)(2009-8#1)(2012-2#1)
the interaction and##2##3##(2008-3#1)(2008-8#1)
the interaction between F##2##4##(2008-10#2)
the interaction between P##2##4##(2008-10#2)
the interaction between RIPs and##2##5##(2008-8#2)
the interaction between a##6##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-6#1)
the interaction between antibody##2##4##(2008-1#1)(2009-11#1)
the interaction between hIL-6 and##2##5##(2008-8#2)
the interaction between proteins and##2##5##(1997-2#1)(2008-10#1)
the interaction between proteins##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
the interaction between the two##3##5##(1997-6#1)(2008-10#1)(2012-3#1)
the interaction between the##18##4##(1995-12#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)(2012-3#1)
the interaction between these##2##4##(2008-11#1)(2013-1#1)
the interaction between two##2##4##(2008-10#2)
the interaction between##97##3##(1990-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#2)(2006-6#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#33)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#11)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the interaction effects of##2##4##(2008-10#1)(2008-4#1)
the interaction effects##3##3##(2008-10#2)(2008-4#1)
the interaction is##4##3##(1994-5#1)(1997-7#1)(2008-10#2)
the interaction length of##2##4##(2007-12#1)(2008-3#1)
the interaction length##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the interaction of G##2##4##(1995-6#1)(2008-9#1)
the interaction of a##5##4##(2008-10#2)(2008-2#2)(2008-8#1)
the interaction of different##2##4##(2008-10#1)(2008-9#1)
the interaction of functionalized##2##4##(2008-10#1)(2008-12#1)
the interaction of known##2##4##(2008-11#1)(2008-7#1)
the interaction of ligands with##2##5##(1995-12#1)(2012-2#1)
the interaction of neutral red##2##5##(2008-10#2)
the interaction of protein kinase C##2##6##(1994-5#2)
the interaction of protein##3##4##(1994-5#2)(2008-10#1)
the interaction of proteins##2##4##(2008-10#1)(2011-2#1)
the interaction of the##13##4##(1992-12#1)(1994-2#2)(1994-5#1)(1995-5#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)
the interaction of these##2##4##(1990-2#1)(2008-10#1)
the interaction of two##3##4##(2008-10#2)(2008-8#1)
the interaction of##142##3##(1990-12#1)(1990-2#1)(1990-8#3)(1991-1#2)(1991-5#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#44)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)(2009-4#1)(2009-7#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the interaction was##4##3##(1997-2#2)(2007-10#1)(2008-10#1)
the interaction with the##5##4##(1995-6#1)(2008-10#3)(2008-3#1)
the interaction with##17##3##(1990-8#1)(1992-3#1)(1994-5#1)(1995-5#1)(1995-6#2)(1996-5#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#2)(2010-4#1)(2013-1#1)
the interaction##311##2##(1990-12#2)(1990-2#1)(1990-8#4)(1991-1#2)(1991-2#2)(1991-5#3)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#4)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#5)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#4)(1997-6#4)(1997-7#2)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#5)(2008-1#3)(2008-10#100)(2008-11#9)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#18)(2008-9#9)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the interactional##2##2##(2010-10#1)(2013-8#1)
the interactions among 2##2##4##(2008-10#2)
the interactions among##5##3##(1993-1#1)(2008-10#4)
the interactions between genes##2##4##(2012-3#2)
the interactions between the##7##4##(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-6#1)(2013-8#1)
the interactions between##35##3##(1992-3#1)(1993-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-4#1)(2012-6#2)(2013-1#2)(2013-8#3)
the interactions of the##7##4##(1993-6#1)(1993-8#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-4#1)
the interactions of these##2##4##(2008-4#1)(2012-3#1)
the interactions of##28##3##(1991-9#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-11#1)(2010-4#1)(2010-9#1)(2012-3#1)
the interactions with##2##3##(2008-10#1)(2008-5#1)
the interactions within##2##3##(2008-7#1)(2012-3#1)
the interactions##85##2##(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#2)(1995-6#1)(1997-2#3)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#3)(2010-11#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#4)(2012-4#1)(2012-6#2)(2013-1#2)(2013-8#3)
the interactive nature of the##3##5##(2007-8#1)(2010-11#2)
the interactive##8##2##(2007-8#1)(2008-11#1)(2008-6#1)(2010-11#2)(2010-4#1)(2011-1#1)(2012-12#1)
the interatrial septum##2##3##(2008-11#1)(2009-5#1)
the interautogamous interval (IAI)##2##4##(2008-12#2)
the intercalary segment##2##3##(2007-12#2)
the intercalated##6##2##(1994-5#1)(1997-7#1)(2008-10#3)(2010-4#1)
the intercalation of##4##3##(1993-8#2)(2008-10#1)(2009-6#1)
the intercalation##6##2##(1993-8#2)(2008-10#1)(2008-2#1)(2009-6#1)(2010-4#1)
the intercellular fluid##2##3##(2008-10#2)
the intercellular space of the##2##5##(2008-10#2)
the intercellular space##3##3##(2008-10#2)(2008-5#1)
the intercellular spaces of the##3##5##(2008-10#3)
the intercellular spaces##4##3##(2008-10#4)
the intercellular##17##2##(1993-8#1)(1994-11#1)(2008-10#10)(2008-5#2)(2008-7#3)
the intercept of##2##3##(2008-10#1)(2009-8#1)
the intercept##7##2##(2008-10#6)(2009-8#1)
the interchain##2##2##(1990-5#1)(1993-6#1)
the interchangeability##2##2##(2011-1#1)(2013-1#1)
the interconnect system##2##3##(2008-3#2)
the interconnect##3##2##(2008-3#3)
the interconnection of##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
the interconnection##5##2##(1995-3#1)(2008-2#2)(2008-3#2)
the intercorneocyte##2##2##(2008-5#2)
the intercostal fields were##2##4##(2008-10#2)
the intercostal region##2##3##(2008-10#2)
the intercostal##5##2##(2008-10#4)(2011-2#1)
the interdependence between##3##3##(1992-3#1)(2009-8#2)
the interdependence of##3##3##(1992-12#1)(2008-2#1)(2009-9#1)
the interdependence##6##2##(1992-12#1)(1992-3#1)(2008-2#1)(2009-8#2)(2009-9#1)
the interdialytic##4##2##(2008-1#4)
the interdisciplinary team##2##3##(2008-10#1)(2010-3#1)
the interdisciplinary##5##2##(1991-12#1)(2008-10#1)(2010-3#2)(2010-8#1)
the interdomain##2##2##(1993-2#1)(2009-7#1)
the interest in##8##3##(1992-1#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)
the interest of##9##3##(1993-2#1)(1994-1#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-9#1)
the interest##21##2##(1992-1#1)(1992-6#1)(1993-2#1)(1994-1#2)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#1)
the interesterification##2##2##(2008-6#2)
the interesting##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
the interests of##6##3##(1992-3#2)(1994-2#1)(2008-10#1)(2009-10#1)(2013-1#1)
the interests##7##2##(1992-1#1)(1992-3#2)(1994-2#1)(2008-10#1)(2009-10#1)(2013-1#1)
the interface between the##8##4##(1995-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
the interface between##19##3##(1990-7#1)(1995-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)
the interface is##4##3##(2007-12#2)(2008-3#1)(2012-2#1)
the interface of the##8##4##(1991-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-3#1)
the interface of##16##3##(1991-12#1)(2007-12#1)(2008-10#6)(2008-3#3)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2012-3#1)
the interface##62##2##(1990-7#1)(1991-12#1)(1993-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(2007-11#2)(2007-12#5)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the interfaces##8##2##(1991-5#1)(2007-11#1)(2008-3#6)
the interfacial pressure##2##3##(1994-9#1)(2008-10#1)
the interfacial properties of surface-active samples##2##6##(2008-10#2)
the interfacial properties of##3##4##(2008-10#3)
the interfacial properties##4##3##(1990-2#1)(2008-10#3)
the interfacial tension##2##3##(2008-10#1)(2008-3#1)
the interfacial##20##2##(1990-2#1)(1993-6#1)(1994-3#1)(1994-9#1)(1997-4#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-1#1)
the interference between the##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
the interference between##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
the interference by##3##3##(2008-10#3)
the interference caused by##2##4##(2008-10#2)
the interference effect of##3##4##(2008-10#3)
the interference effect##4##3##(2007-12#1)(2008-10#3)
the interference effects##3##3##(2008-10#1)(2008-3#2)
the interference fringe pattern##2##4##(2008-2#2)
the interference fringe##3##3##(2007-12#1)(2008-2#2)
the interference fringes##5##3##(2008-3#4)(2013-8#1)
the interference from other##2##4##(2008-10#2)
the interference from##9##3##(2008-10#8)(2008-3#1)
the interference is##2##3##(2008-10#1)(2008-2#1)
the interference of ascorbic acid##2##5##(2008-10#2)
the interference of both##2##4##(2008-10#2)
the interference of other##3##4##(2008-10#2)(2008-6#1)
the interference of the##8##4##(2008-10#3)(2008-3#2)(2008-5#1)(2013-1#1)(2013-8#1)
the interference of two##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
the interference of##49##3##(1995-12#1)(2007-11#3)(2007-12#2)(2008-10#28)(2008-2#4)(2008-3#5)(2008-5#2)(2008-6#1)(2009-12#1)(2013-1#1)(2013-8#1)
the interference pattern in##2##4##(2008-1#1)(2008-3#1)
the interference pattern of##2##4##(2008-2#1)(2008-3#1)
the interference pattern##14##3##(2007-11#1)(2008-1#2)(2008-2#3)(2008-3#8)
the interference##124##2##(1995-12#1)(2007-11#8)(2007-12#8)(2008-1#3)(2008-10#51)(2008-2#14)(2008-3#28)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-8#5)
the interferences caused by##4##4##(2008-10#4)
the interferences from##5##3##(2008-10#5)
the interferences in the##2##4##(2008-10#1)(2013-1#1)
the interferences of##2##3##(2008-10#2)
the interferences##19##2##(1990-12#1)(2008-10#16)(2013-1#2)
the interfering##6##2##(1995-3#1)(2008-10#5)
the interferogram##11##2##(2007-11#1)(2008-2#4)(2008-3#6)
the interferograms##5##2##(2008-2#2)(2008-3#3)
the interferometer data##2##3##(2008-3#2)
the interferometer is##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
the interferometer##36##2##(2007-11#5)(2007-12#5)(2008-2#7)(2008-3#19)
the interferometric method##2##3##(2007-12#1)(2008-3#1)
the interferometric monitor for greenhouse gases##2##6##(2008-3#2)
the interferometric signal##3##3##(2008-3#3)
the interferometric##11##2##(2007-11#2)(2007-12#1)(2008-3#8)
the interferometry##2##2##(2008-2#1)(2008-3#1)
the interferon##2##2##(1997-1#1)(2009-5#1)
the interfragmentary contact##2##3##(2013-1#2)
the intergenic region between##2##4##(1996-10#1)(2008-10#1)
the intergenic region##8##3##(1994-11#1)(1996-10#2)(2008-10#5)
the intergenic spacer (IGS) of the##2##6##(2008-10#2)
the intergenic spacer (IGS) region of##2##6##(2008-10#2)
the intergenic spacer (IGS)##4##4##(2008-10#4)
the intergenic spacer##7##3##(2008-10#6)(2008-5#1)
the intergenic##18##2##(1994-11#1)(1996-10#2)(2008-10#13)(2008-5#2)
the interhelix##2##2##(1993-8#1)(1994-6#1)
the interhyoid muscle##6##3##(2011-2#6)
the interhyoid##7##2##(2011-2#7)
the interim##4##2##(1993-3#1)(2008-11#2)(2012-2#1)
the interindividual##2##2##(2008-8#1)(2010-10#1)
the interior of fragments##3##4##(2013-7#3)
the interior of the##8##4##(2007-11#3)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)
the interior of##17##3##(1991-9#1)(1993-11#1)(1994-11#1)(2007-11#3)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-6#1)(2013-7#3)
the interior##32##2##(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#3)(1997-4#1)(2007-11#3)(2008-10#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2013-7#5)
the interlaboratory study##3##3##(2008-10#1)(2008-5#2)
the interlacing##2##2##(2008-2#2)
the interlamellar##2##2##(1997-7#2)
the interlayer##4##2##(1991-5#1)(1996-2#1)(1997-7#1)(2008-6#1)
the interleaved##2##2##(2009-9#2)
the interleukin-2##4##2##(1990-5#1)(1991-9#1)(1992-5#1)(1997-5#1)
the intermediary##3##2##(1991-11#1)(2008-10#2)
the intermediate and##4##3##(1990-9#1)(1993-5#1)(1995-12#1)(2008-7#1)
the intermediate filaments##2##3##(2009-10#1)(2009-8#1)
the intermediate lobe of the##2##5##(1993-5#2)
the intermediate lobe##3##3##(1992-12#1)(1993-5#2)
the intermediate pituitary of the toad##2##6##(1993-5#2)
the intermediate precision##2##3##(2008-10#2)
the intermediate state##2##3##(1995-5#2)
the intermediate steps of##2##4##(2008-3#1)(2010-3#1)
the intermediate was converted to##2##5##(1994-6#1)(2009-9#1)
the intermediate##54##2##(1990-8#2)(1990-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-5#5)(1994-6#2)(1995-12#1)(1995-3#1)(1995-5#3)(1996-5#3)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-3#1)(2010-8#1)(2013-1#1)
the intermediates in##2##3##(1990-8#1)(2008-10#1)
the intermediates##7##2##(1990-8#2)(1994-12#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-6#1)
the intermembrane##2##2##(1994-12#1)(2013-8#1)
the intermittent##3##2##(1996-12#1)(2007-8#1)(2012-2#1)
the intermolecular alignment##2##3##(2008-10#2)
the intermolecular##5##2##(2008-10#4)(2008-4#1)
the internal aldimine bond##2##4##(1992-6#2)
the internal and external##3##4##(1994-3#1)(2008-1#1)(2012-3#1)
the internal and##4##3##(1994-3#1)(2008-1#2)(2012-3#1)
the internal auditory canal##4##4##(2006-12#1)(2008-7#2)(2008-9#1)
the internal bladder##2##3##(2008-10#2)
the internal capsule##3##3##(1996-12#1)(1996-5#1)(2008-7#1)
the internal carotid artery in##3##5##(1995-12#1)(2007-10#1)(2008-7#1)
the internal carotid artery##13##4##(1995-12#1)(1997-3#1)(2006-12#1)(2007-10#1)(2008-7#6)(2011-2#2)(2012-3#1)
the internal consistency##2##3##(2007-12#1)(2012-12#1)
the internal field##5##3##(2008-2#4)(2008-3#1)
the internal intensity##2##3##(2007-12#1)(2008-3#1)
the internal light##2##3##(2008-10#1)(2008-3#1)
the internal mammary##2##3##(2007-8#1)(2013-1#1)
the internal osteosynthesis##2##3##(2007-11#2)
the internal partitioning##2##3##(1991-3#2)
the internal phloem##2##3##(2008-10#2)
the internal reflection##2##3##(2008-10#1)(2008-2#1)
the internal standard method##3##4##(1993-3#1)(2008-10#2)
the internal standard were##2##4##(1996-5#1)(2008-10#1)
the internal standard##15##3##(1993-3#1)(1996-5#1)(2008-1#1)(2008-10#11)(2008-9#1)
the internal structure of the##3##5##(1991-2#1)(2008-2#1)(2009-12#1)
the internal structure##7##3##(1991-2#1)(2008-2#2)(2008-3#2)(2009-12#1)(2013-8#1)
the internal structures of##2##4##(1995-6#1)(2010-8#1)
the internal transcribed spacer (ITS) and##2##6##(2008-10#1)(2010-10#1)
the internal transcribed spacer (ITS) region##9##6##(2008-10#8)(2008-5#1)
the internal transcribed spacer (ITS) regions of##3##7##(2008-10#3)
the internal transcribed spacer (ITS) regions##5##6##(2008-10#5)
the internal transcribed spacer (ITS)##19##5##(2008-10#17)(2008-5#1)(2010-10#1)
the internal transcribed spacer (ITS)-1##2##5##(2008-10#2)
the internal transcribed spacer 1 region of##2##7##(2008-10#2)
the internal transcribed spacer 1 region##3##6##(2008-10#3)
the internal transcribed spacer 1##5##5##(2008-10#5)
the internal transcribed spacer region of the##2##7##(2008-10#2)
the internal transcribed spacer region of##3##6##(2008-10#3)
the internal transcribed spacer region##7##5##(2008-10#7)
the internal transcribed spacer##40##4##(2008-10#38)(2008-5#1)(2010-10#1)
the internal transcribed##42##3##(2008-10#39)(2008-5#1)(2009-2#1)(2010-10#1)
the internal vertebral venous plexus##3##5##(2011-2#3)
the internal##198##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-6#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-5#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#68)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#7)(2008-5#5)(2008-7#11)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#2)
the internalization and##2##3##(1994-6#1)(1995-11#1)
the internalization of sociocultural attitudes##2##5##(2007-12#2)
the internalization of##8##3##(1993-5#1)(1997-1#1)(2007-12#3)(2008-11#3)
the internalization##13##2##(1990-11#1)(1993-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1997-1#1)(2007-12#3)(2008-11#3)
the internalized##2##2##(1990-11#1)(1994-6#1)
the international community##2##3##(1992-5#1)(2013-1#1)
the international literature and##2##4##(2008-10#1)(2008-5#1)
the international literature##8##3##(1991-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-3#1)
the international standards##2##3##(2008-1#1)(2011-1#1)
the international##43##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-5#2)(1993-1#1)(1993-2#1)(1994-8#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
the internet##21##2##(1994-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2009-5#1)(2010-3#1)(2012-3#2)(2013-8#3)
the interns##2##2##(1992-11#1)(1995-6#1)
the interosseous##2##2##(1991-6#1)(2012-3#1)
the interparticle##4##2##(2008-10#2)(2009-11#1)(2009-9#1)
the interpersonal competence##2##3##(2012-3#2)
the interpersonal##6##2##(1991-3#1)(2011-2#1)(2012-3#2)(2013-1#2)
the interphase##4##2##(1990-3#1)(2008-3#1)(2008-9#1)(2009-6#1)
the interplay between##17##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-1#1)
the interplay of##5##3##(2008-5#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-7#1)
the interplay##24##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-7#1)
the interpolated##2##2##(2008-10#2)
the interpretation and##2##3##(1993-3#1)(2010-9#1)
the interpretation of CT##2##4##(1997-8#2)
the interpretation of clinical##2##4##(1992-9#1)(2008-10#1)
the interpretation of the experimental results##2##6##(2008-2#1)(2008-7#1)
the interpretation of the obtained results##2##6##(2008-10#2)
the interpretation of the results##2##5##(2008-10#1)(2008-4#1)
the interpretation of the##23##4##(1994-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-6#1)(2012-2#1)(2013-1#2)
the interpretation of##63##3##(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-8#1)(2012-2#3)(2013-1#2)
the interpretation that the##2##4##(1997-9#1)(2008-11#1)
the interpretation##69##2##(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-8#2)(1997-9#1)(2007-10#1)(2007-11#5)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-2#3)(2013-1#2)
the interrelationship among##2##3##(2008-10#2)
the interrelationship between##3##3##(1995-2#1)(2008-12#1)(2011-2#1)
the interrelationship of##2##3##(1992-12#1)(2007-11#1)
the interrelationship##7##2##(1992-12#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2011-2#1)
the interrelationships among##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
the interrelationships between##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
the interrelationships##8##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#3)
the interrogation of##2##3##(2008-3#1)(2008-7#1)
the interrogation##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
the interruption##3##2##(2008-3#1)(2009-11#1)(2012-12#1)
the interscapular region##2##3##(1992-2#1)(2007-8#1)
the interscapular##3##2##(1992-2#1)(2007-8#1)(2011-2#1)
the intersection of the##3##4##(2008-3#1)(2009-5#1)(2011-2#1)
the intersection of##10##3##(2007-11#2)(2008-11#1)(2008-3#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
the intersection##13##2##(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
the interside difference of the muscle potential latency##2##8##(2008-7#2)
the interspecific##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
the interstitial cell##2##3##(2008-5#2)
the interstitial cells##2##3##(2008-5#1)(2008-6#1)
the interstitial compartment##2##3##(1997-2#1)(2012-7#1)
the interstitial##15##2##(1991-12#1)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-5#4)(2008-6#1)(2008-8#1)(2011-2#1)(2012-7#1)(2013-8#1)
the interval between the##2##4##(1993-6#1)(2008-10#1)
the interval between##5##3##(1993-6#1)(2008-10#2)(2008-2#1)(2008-7#1)
the interval of##5##3##(1991-2#1)(2008-5#2)(2008-7#1)(2013-8#1)
the interval##16##2##(1991-2#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-3#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-7#2)(2013-8#1)
the intervals##2##2##(2008-10#1)(2008-5#1)
the intervening##6##2##(1995-3#1)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
the intervention and##5##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)
the intervention are##3##3##(1995-12#1)(2008-12#1)(2013-1#1)
the intervention group##10##3##(2007-5#2)(2008-12#2)(2008-9#1)(2010-4#3)(2012-3#1)(2013-1#1)
the intervention hospitals##2##3##(1996-1#2)
the intervention of##2##3##(2008-2#1)(2011-9#1)
the intervention to##2##3##(2008-12#1)(2010-4#1)
the intervention was##3##3##(1996-6#1)(2008-2#1)(2008-8#1)
the intervention were##4##3##(2008-12#2)(2011-1#1)(2013-1#1)
the intervention##83##2##(1993-1#1)(1993-11#1)(1993-12#1)(1995-1#2)(1995-12#1)(1996-1#3)(1996-6#1)(1997-2#1)(1997-4#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-12#16)(2008-2#4)(2008-4#6)(2008-6#2)(2008-8#4)(2008-9#3)(2010-10#3)(2010-11#1)(2010-4#4)(2011-1#3)(2011-2#3)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)
the interventional##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
the interventions were##4##3##(2007-12#1)(2009-6#1)(2012-2#2)
the interventions##18##2##(1995-2#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#2)(2009-6#3)(2009-7#1)(2012-2#3)(2013-1#3)
the interventricular septum##2##3##(2007-8#1)(2008-7#1)
the intervertebral disc##13##3##(2007-11#7)(2007-8#4)(2008-11#1)(2012-2#1)
the intervertebral foramen##3##3##(2011-2#1)(2013-8#2)
the intervertebral##19##2##(2007-11#9)(2007-8#4)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
the interview transcripts##4##3##(1993-3#1)(2007-4#1)(2009-5#1)(2013-1#1)
the interview was##3##3##(1990-12#1)(2011-1#1)(2012-3#1)
the interview##20##2##(1990-12#3)(1990-6#1)(1991-6#1)(1992-5#1)(1993-3#1)(1996-3#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2009-5#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#2)
the interviewed##2##2##(2008-9#1)(2013-1#1)
the interviews were##3##3##(2008-12#1)(2011-1#1)(2011-2#1)
the interviews##11##2##(1997-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
the intestinal bacteria##2##3##(1991-12#1)(1995-3#1)
the intestinal brush-border membrane##2##4##(1992-6#1)(2006-12#1)
the intestinal epithelial cell##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
the intestinal epithelial##5##3##(2008-10#2)(2008-11#2)(2011-1#1)
the intestinal epithelium##6##3##(2008-10#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-1#1)
the intestinal immune system##2##4##(2008-11#1)(2009-12#1)
the intestinal lumen##3##3##(1996-6#1)(2011-2#2)
the intestinal microbiota##2##3##(2008-11#1)(2010-5#1)
the intestinal mucosa##5##3##(1992-12#1)(1996-3#1)(1996-6#1)(2008-7#1)(2009-8#1)
the intestinal tract of##2##4##(2007-6#1)(2011-2#1)
the intestinal tract##4##3##(1993-2#1)(1993-9#1)(2007-6#1)(2011-2#1)
the intestinal villi were##2##4##(1993-6#2)
the intestinal wall##2##3##(2008-5#1)(2008-7#1)
the intestinal##61##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-12#3)(1992-6#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-8#3)(1995-3#3)(1996-3#1)(1996-6#2)(1997-8#1)(2006-12#1)(2007-6#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-1#3)
the intestine and##8##3##(1990-2#2)(1995-2#1)(1995-5#1)(2008-10#2)(2008-11#1)(2013-1#1)
the intestine of##2##3##(1995-9#1)(2008-5#1)
the intestine##24##2##(1990-2#2)(1992-6#1)(1993-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-5#6)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
the intestines##4##2##(1992-11#1)(2006-12#1)(2008-10#2)
the intima##2##2##(1997-8#1)(2008-7#1)
the intimal##4##2##(1995-12#1)(2006-6#2)(2010-4#1)
the intimate##2##2##(2009-10#1)(2009-7#1)
the intra- and##7##3##(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2011-2#2)
the intra-##9##2##(1996-2#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)
the intra-abdominal##2##2##(1996-11#1)(2008-10#1)
the intra-operative##2##2##(2007-8#1)(2008-9#1)
the intraabdominal##2##2##(2011-2#2)
the intracavity dispersion##4##3##(2007-11#1)(2007-12#3)
the intracavity power##2##3##(2008-10#1)(2008-3#1)
the intracavity##21##2##(2007-11#3)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#9)
the intracellular Ca++ level##2##4##(1991-9#2)
the intracellular Ca++##3##3##(1991-9#3)
the intracellular Ca2+ concentration##5##4##(1990-2#1)(1990-7#1)(1992-8#2)(1994-6#1)
the intracellular Ca2+##7##3##(1990-2#1)(1990-7#1)(1992-8#2)(1994-3#1)(1994-6#1)(1996-5#1)
the intracellular accumulation of##5##4##(1994-11#1)(1995-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
the intracellular accumulation##6##3##(1994-11#1)(1995-6#1)(2008-11#2)(2008-7#1)(2013-1#1)
the intracellular and##2##3##(1990-12#1)(1994-12#1)
the intracellular calcium##5##3##(1992-6#1)(1994-9#1)(1995-8#1)(2008-4#1)(2010-8#1)
the intracellular compartment##2##3##(1990-7#1)(2010-10#1)
the intracellular concentration##4##3##(1990-5#2)(2007-11#1)(2008-7#1)
the intracellular concentrations of##4##4##(1996-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
the intracellular content of##2##4##(1994-6#1)(2008-11#1)
the intracellular contents of##2##4##(1994-12#2)
the intracellular distribution of##2##4##(2008-11#2)
the intracellular fluorescent##2##3##(2008-4#1)(2008-9#1)
the intracellular free##2##3##(1993-11#1)(1995-8#1)
the intracellular level of##2##4##(1991-9#1)(1994-11#1)
the intracellular nucleotide pools##2##4##(2008-11#2)
the intracellular nucleotide##3##3##(2008-11#3)
the intracellular pH##2##3##(2008-10#1)(2008-11#1)
the intracellular pathways of##2##4##(1995-5#1)(2008-7#1)
the intracellular pool##2##3##(1994-12#1)(2008-5#1)
the intracellular signal##2##3##(1995-11#1)(1997-3#1)
the intracellular signalling##3##3##(1996-2#1)(2008-1#1)(2012-1#1)
the intracellular sodium##2##3##(1992-11#1)(1994-3#1)
the intracellular trafficking##2##3##(1994-8#1)(1995-5#1)
the intracellular##125##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#3)(1991-12#1)(1991-5#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#3)(1994-12#5)(1994-3#3)(1994-6#4)(1994-8#2)(1994-9#3)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#5)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#22)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
the intracerebral infusion##3##3##(2008-7#3)
the intracerebral##4##2##(2008-7#3)(2012-12#1)
the intracluster correlation coefficient##2##4##(1992-9#1)(2008-10#1)
the intracluster correlation##3##3##(1992-9#1)(2008-10#2)
the intracoronary##2##2##(1990-12#1)(2012-2#1)
the intracortical##2##2##(1996-2#1)(2008-11#1)
the intracranial##10##2##(1995-11#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
the intradialytic##2##2##(2008-1#2)
the intraerythrocytic##2##2##(1990-12#1)(1993-8#1)
the intraluminal##2##2##(2007-10#1)(2007-12#1)
the intramedullary nailing##2##3##(2007-11#1)(2013-8#1)
the intramedullary##4##2##(2007-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
the intramembrane##2##2##(1992-9#1)(1994-12#1)
the intramolecular##7##2##(1993-2#1)(1996-5#2)(2008-10#2)(2010-12#1)(2013-1#1)
the intramural##2##2##(2008-10#1)(2013-8#1)
the intramuscular connective tissue##3##4##(2010-2#1)(2013-1#2)
the intramuscular##8##2##(1997-4#1)(2008-8#1)(2010-2#1)(2010-4#3)(2013-1#2)
the intraocular pressure##3##3##(1993-1#1)(2012-12#1)(2013-1#1)
the intraocular##7##2##(1993-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
the intraoperative and##2##3##(2008-10#1)(2013-1#1)
the intraoperative period in##2##4##(2010-5#1)(2010-7#1)
the intraoperative period##4##3##(2010-5#1)(2010-7#1)(2011-3#1)(2013-1#1)
the intraoperative##15##2##(1993-1#1)(1996-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#2)(2011-2#1)(2011-3#1)(2011-7#1)(2013-1#3)
the intraoral##2##2##(1993-12#1)(2007-12#1)
the intraparietal##2##2##(1990-12#1)(2010-5#1)
the intraperitoneal administration of##3##4##(1995-12#2)(2013-1#1)
the intraperitoneal##6##2##(1991-8#1)(1995-12#2)(1996-2#1)(2011-2#1)(2013-1#1)
the intrapulmonary##2##2##(1997-1#1)(2008-1#1)
the intrathecal##3##2##(1997-2#1)(2007-10#1)(2008-12#1)
the intrathoracic goitre##2##3##(1993-5#2)
the intrathoracic##4##2##(1993-5#3)(2007-8#1)
the intrauterine##7##2##(1991-2#1)(1994-3#1)(1994-9#2)(2009-11#2)(2013-1#1)
the intravascular##4##2##(1997-3#1)(2008-11#1)(2008-7#1)(2010-8#1)
the intravenous injection of##3##4##(1992-3#2)(1995-12#1)
the intravenous##6##2##(1992-3#2)(1995-12#1)(2011-2#3)
the intravesical ureter##2##3##(1997-4#1)(2008-10#1)
the intravesical##5##2##(1993-11#1)(1997-4#2)(2008-10#2)
the intricacies of##2##3##(2008-7#1)(2009-7#1)
the intricate##7##2##(1993-5#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
the intrinsic ATPase activity of##2##5##(1992-6#2)
the intrinsic and extrinsic##2##4##(2009-12#1)(2011-2#1)
the intrinsic and##3##3##(2008-5#1)(2009-12#1)(2011-2#1)
the intrinsic complexation constants##2##4##(2008-10#2)
the intrinsic dynamics##2##3##(2008-3#1)(2009-8#1)
the intrinsic fluorescence of the analyte##2##6##(2008-10#2)
the intrinsic fluorescence of##6##4##(1995-6#1)(2008-10#4)(2008-8#1)
the intrinsic fluorescence##11##3##(1995-5#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-8#1)
the intrinsic limitations of##2##4##(2008-2#1)(2008-3#1)
the intrinsic noise##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
the intrinsic properties of the##2##5##(2008-3#1)(2008-7#1)
the intrinsic rate of change with respect to##2##8##(2008-10#2)
the intrinsic rate of disease##2##5##(2008-10#2)
the intrinsic rate of growth##2##5##(2008-8#2)
the intrinsic rate of##6##4##(2008-10#4)(2008-8#2)
the intrinsic viscosity of##2##4##(2008-10#2)
the intrinsic##88##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-6#2)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1997-2#2)(2007-11#5)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#1)(2008-2#3)(2008-3#14)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#5)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
the introduced plasmid##3##3##(1994-9#2)(2008-8#1)
the introduced range##2##3##(2008-8#2)
the introduced##12##2##(1994-9#2)(2008-10#6)(2008-5#1)(2008-8#3)
the introduction and spread of##2##5##(1990-3#1)(2008-10#1)
the introduction and##5##3##(1990-3#1)(1991-4#1)(2008-10#1)(2008-12#2)
the introduction of DNA##2##4##(1993-9#1)(2008-4#1)
the introduction of a new##2##5##(1997-3#1)(2011-1#1)
the introduction of a##15##4##(1997-3#3)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
the introduction of an##5##4##(1990-12#1)(2008-10#1)(2008-11#2)(2008-12#1)
the introduction of diffractive##2##4##(2008-2#1)(2008-3#1)
the introduction of effective##3##4##(2008-7#1)(2010-3#2)
the introduction of hospital choice in Denmark and Norway##2##9##(2008-7#2)
the introduction of new##7##4##(1991-3#1)(1993-1#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
the introduction of the first##2##5##(1991-9#1)(2008-5#1)
the introduction of the integrated organ system-based curriculum##2##8##(2012-3#2)
the introduction of the##31##4##(1990-10#1)(1991-9#1)(1992-3#1)(1993-12#1)(1997-5#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the introduction of this##2##4##(1997-7#1)(2008-10#1)
the introduction of##171##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#3)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1995-11#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#2)(2007-11#4)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#22)(2008-11#12)(2008-12#9)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-3#4)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
the introduction##179##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#4)(1991-4#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1995-11#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#2)(2007-11#5)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#23)(2008-11#12)(2008-12#12)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-3#4)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
the introductory##4##2##(1993-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
the intron##9##2##(1991-5#1)(1992-10#1)(1993-12#2)(1994-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#1)
the intron/exon structure of the##2##5##(1995-12#1)(1996-2#1)
the introns##7##2##(1992-12#1)(1994-12#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-7#1)(2010-9#1)
the intrusion of##2##3##(2008-5#1)(2013-1#1)
the invaded##2##2##(2008-10#1)(2008-12#1)
the invading pathogen##2##3##(2008-10#2)
the invading##6##2##(2008-10#6)
the invaginated##2##2##(2008-10#1)(2008-5#1)
the invariant##3##2##(1995-2#1)(2012-2#2)
the invasion and proliferation of AH109A##2##6##(2008-11#2)
the invasion and##4##3##(1990-11#1)(2008-10#1)(2008-11#2)
the invasion of AH109A cells##4##5##(2008-11#4)
the invasion of a##2##4##(2008-11#1)(2013-8#1)
the invasion of hepatoma cells##2##5##(2008-11#2)
the invasion of the##2##4##(1991-12#1)(2008-10#1)
the invasion of##20##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the invasion probability##2##3##(2013-8#2)
the invasion##34##2##(1990-11#1)(1991-12#1)(1994-9#1)(2007-12#1)(2008-10#5)(2008-11#13)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
the invasive activity of hepatoma cells by##2##7##(2008-11#2)
the invasive activity of rat hepatoma##2##6##(2008-11#2)
the invasive activity of##4##4##(2008-11#4)
the invasive growth of##2##4##(2008-10#1)(2013-1#1)
the invasive##13##2##(1991-11#1)(2007-10#2)(2008-10#2)(2008-11#5)(2008-5#1)(2012-3#1)(2013-1#1)
the invasiveness of##2##3##(1991-2#1)(2011-2#1)
the invasiveness##4##2##(1991-2#1)(2006-10#1)(2011-2#1)(2013-8#1)
the invention of##2##3##(2008-2#1)(2011-1#1)
the inventory##2##2##(2008-7#1)(2013-1#1)
the inverse Gaussian probability distribution is used to model the heartbeat interval##2##12##(2009-9#1)(2010-5#1)
the inverse leafing phenology of##2##5##(2008-5#2)
the inverse of the##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
the inverse problem##3##3##(2008-2#2)(2008-3#1)
the inverse##31##2##(1990-7#1)(1995-11#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-2#6)(2008-3#7)(2008-5#5)(2008-8#1)(2009-9#1)(2010-5#1)
the inverse-scattering problem##2##3##(2007-12#1)(2008-2#1)
the inversion of the##2##4##(1994-2#1)(2008-3#1)
the inversion of##5##3##(1994-2#1)(2008-3#3)(2012-1#1)
the inversion procedure##3##3##(2008-2#1)(2008-3#2)
the inversion results##2##3##(2008-2#1)(2008-7#1)
the inversion##24##2##(1994-2#1)(2008-2#3)(2008-3#14)(2008-7#1)(2012-1#1)(2013-1#3)(2013-8#1)
the invertase##2##2##(2008-10#1)(2008-7#1)
the invertebrate##2##2##(1994-11#1)(2008-8#1)
the inverted extinction profile##2##4##(2008-3#2)
the inverted##9##2##(1990-2#1)(2007-12#1)(2008-2#1)(2008-3#5)(2008-5#1)
the investigated compounds##7##3##(2007-11#1)(2008-10#6)
the investigated samples##2##3##(2008-10#2)
the investigated species##4##3##(2007-12#4)
the investigated##45##2##(1990-11#1)(1990-2#1)(1995-3#2)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2013-8#1)
the investigation and treatment of##2##5##(2007-12#1)(2010-3#1)
the investigation and##6##3##(2006-6#1)(2007-12#2)(2008-10#1)(2010-3#1)(2010-4#1)
the investigation are##2##3##(1991-3#1)(2008-3#1)
the investigation carried out##2##4##(2008-2#1)(2009-10#1)
the investigation of children with##2##5##(1996-6#1)(2013-1#1)
the investigation of large##2##4##(2008-11#1)(2010-12#1)
the investigation of the##8##4##(1991-5#1)(2008-10#5)(2008-4#1)(2010-12#1)
the investigation of##60##3##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1993-1#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-4#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#1)(2010-1#1)(2010-12#3)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
the investigation on##2##3##(2008-11#1)(2013-1#1)
the investigation was##2##3##(2010-11#1)(2011-1#1)
the investigation##82##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1993-1#1)(1993-3#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-4#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
the investigational##3##2##(2006-7#1)(2008-11#1)(2012-12#1)
the investigations of##3##3##(1996-5#1)(1997-7#1)(2008-10#1)
the investigations##8##2##(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-2#1)(2009-5#1)(2013-1#1)
the investigator##8##2##(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
the investment dimension##2##3##(2007-12#2)
the investment in workers##3##4##(2008-8#3)
the investment of the '90s##2##5##(1994-3#2)
the investment of##3##3##(1994-3#2)(1995-1#1)
the investment##15##2##(1994-3#2)(1995-1#1)(2007-12#2)(2008-5#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2012-12#2)
the invitation##2##2##(1992-3#1)(2008-11#1)
the involved area##2##3##(1990-8#1)(2007-12#1)
the involved##22##2##(1990-8#1)(1992-12#1)(1994-7#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
the involvement of G proteins in##3##6##(1991-9#2)(1993-3#1)
the involvement of PKC in##3##5##(1996-12#1)(1997-1#1)(2008-4#1)
the involvement of a##9##4##(1990-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-2#1)
the involvement of an##2##4##(1995-2#1)(1997-3#1)
the involvement of endogenous##4##4##(1994-8#1)(1995-12#1)(2008-11#2)
the involvement of nitric oxide in##2##6##(1996-5#1)(2011-1#1)
the involvement of the frontal lobe##2##6##(2008-9#2)
the involvement of the##19##4##(1990-11#1)(1992-3#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)
the involvement of these##2##4##(1994-5#1)(2008-10#1)
the involvement of this##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)
the involvement of##122##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
the involvement##124##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
the inward K(+) current##4##4##(2008-8#4)
the inward rectifier##2##3##(2008-8#1)(2013-7#1)
the inward##8##2##(1995-12#1)(1997-2#1)(2008-8#5)(2013-7#1)
the iodate##3##2##(2008-10#3)
the iodine administration rate##2##4##(2008-7#2)
the iodine##4##2##(2008-10#1)(2008-7#3)
the iodometric determination##2##3##(2008-10#2)
the iodometric##3##2##(2008-10#3)
the ion associate##5##3##(2008-10#5)
the ion associates##2##3##(2008-10#2)
the ion association##6##3##(2008-10#6)
the ion chamber##2##3##(2009-11#2)
the ion exchange##5##3##(1997-7#1)(2008-10#4)
the ion exchanger sites##3##4##(2008-10#3)
the ion exchanger##8##3##(2008-10#8)
the ion motion##2##3##(2008-10#2)
the ion pair##8##3##(2008-10#7)(2008-5#1)
the ion selectivity##2##3##(1994-6#1)(1995-5#1)
the ion species##2##3##(1990-11#1)(2008-10#1)
the ion##66##2##(1990-11#1)(1990-12#1)(1992-6#1)(1994-6#1)(1995-5#1)(1997-1#2)(1997-7#1)(2008-10#48)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2010-3#1)(2013-8#1)
the ion-association##2##2##(2008-10#2)
the ion-cycle##2##2##(2008-8#2)
the ion-exchange##6##2##(1997-2#1)(2008-10#3)(2008-6#1)(2008-7#1)
the ion-pair complex of##2##4##(2008-10#2)
the ion-pair complex##3##3##(2008-10#3)
the ion-pair extraction constant of##2##5##(2008-10#2)
the ion-pair extraction##4##3##(2008-10#4)
the ion-pair formation##3##3##(2008-10#3)
the ion-pair##15##2##(2008-10#15)
the ion-pairing reagent##2##3##(2008-10#2)
the ion-pairing##6##2##(2008-10#6)
the ion-transporting##2##2##(2008-7#2)
the ionic conduction##2##3##(2008-10#2)
the ionic strength and##6##4##(1990-12#1)(1990-2#1)(2008-10#2)(2009-5#1)(2013-1#1)
the ionic strength but##2##4##(1993-11#1)(2008-10#1)
the ionic strength of the##3##5##(1990-5#1)(1997-2#1)(2008-5#1)
the ionic strength of##4##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
the ionic strength##22##3##(1990-12#1)(1990-2#1)(1990-5#1)(1993-11#1)(1995-2#2)(1997-2#3)(2008-10#10)(2008-5#1)(2009-5#1)(2013-1#1)
the ionic##45##2##(1990-12#1)(1990-2#2)(1990-5#1)(1993-11#1)(1995-2#2)(1996-2#1)(1997-2#3)(1997-7#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#2)(2010-7#1)(2012-2#1)(2013-1#1)
the ionisation of##3##3##(2008-10#3)
the ionisation##5##2##(2008-10#5)
the ionization of##4##3##(1993-11#1)(1995-5#1)(2008-10#2)
the ionization##10##2##(1993-11#1)(1995-5#1)(2008-10#6)(2008-3#1)(2011-1#1)
the ionized##2##2##(1991-5#1)(2011-1#1)
the ionizing radiation##2##3##(1994-12#1)(2008-2#1)
the ionizing##3##2##(1994-12#1)(1995-5#1)(2008-2#1)
the ionomer##2##2##(1990-2#1)(2010-4#1)
the ionophore##8##2##(1993-3#1)(2006-6#1)(2008-10#6)
the ionophores##3##2##(2008-10#3)
the ions##4##2##(2008-10#3)(2008-7#1)
the ipsative method##2##3##(1992-3#2)
the ipsilateral but not##2##4##(1996-5#2)
the ipsilateral internal##2##3##(2006-12#1)(2008-12#1)
the ipsilateral limb##2##3##(2008-7#1)(2012-12#1)
the ipsilateral side##3##3##(1991-2#1)(1993-12#1)(1996-5#1)
the ipsilateral##47##2##(1991-2#1)(1992-3#1)(1993-12#7)(1993-3#4)(1994-12#2)(1995-12#1)(1996-12#4)(1996-5#3)(1997-3#1)(2006-12#2)(2007-10#4)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-3#1)(2012-12#2)(2013-8#1)
the iris and##2##3##(1997-3#1)(2011-1#1)
the iris##5##2##(1996-5#2)(1997-3#1)(2011-1#2)
the iron and##3##3##(1994-5#1)(2008-10#2)
the iron atom##2##3##(1994-5#2)
the iron carrier##4##3##(1995-11#3)(2008-5#1)
the iron chalcogenide##4##3##(2008-10#4)
the iron chelator##2##3##(1990-11#1)(2011-2#1)
the iron concentration##3##3##(1992-8#1)(2008-10#2)
the iron content##2##3##(1992-3#1)(2008-10#1)
the iron overload##2##3##(2013-8#2)
the iron##50##2##(1990-11#1)(1990-12#1)(1990-3#5)(1991-5#2)(1991-6#1)(1992-3#1)(1992-8#2)(1993-11#1)(1994-5#3)(1994-8#1)(1995-11#3)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-5#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#3)
the iron(III) ISE##2##3##(2008-10#2)
the iron(III)##5##2##(1997-7#2)(2008-10#3)
the iron-sulfur##2##2##(1990-5#1)(1995-2#1)
the irradiance and##3##3##(2008-3#2)(2012-3#1)
the irradiance of the##2##4##(2007-11#1)(2008-3#1)
the irradiance of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the irradiance responsivity##2##3##(2008-2#1)(2008-3#1)
the irradiance##18##2##(2007-11#1)(2008-2#2)(2008-3#12)(2008-7#1)(2011-1#1)(2012-3#1)
the irradiances##2##2##(2008-2#1)(2008-3#1)
the irradiated##16##2##(1993-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
the irradiation time##6##3##(2008-10#3)(2008-8#1)(2009-3#1)(2011-2#1)
the irradiation##17##2##(1991-2#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#2)
the irreversible##9##2##(1992-8#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-9#1)(1997-6#1)(2011-2#1)(2012-2#1)
the irrigation season##2##3##(2008-10#2)
the irrigation treatments##2##3##(2008-10#2)
the irrigation##8##2##(2008-10#8)
the irritation potential of##4##4##(2008-5#4)
the irritation##6##2##(2008-5#5)(2011-3#1)
the ischaemic cardiomyopathy group##2##4##(2008-10#2)
the ischaemic##5##2##(2008-10#5)
the ischemia##2##2##(1995-12#1)(2007-8#1)
the ischemic cardiopathy##2##3##(2008-10#2)
the ischemic cascade##2##3##(2008-2#1)(2009-10#1)
the ischemic myocardium##2##3##(2008-10#1)(2008-7#1)
the ischemic stress##2##3##(1996-12#1)(1996-9#1)
the ischemic##22##2##(1992-9#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
the island of##8##3##(1995-6#1)(2008-10#3)(2008-5#1)(2011-1#2)(2011-2#1)
the island##15##2##(1995-6#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-1#4)(2011-2#1)(2013-8#2)
the islet##15##2##(1991-7#1)(1992-6#3)(1995-8#4)(2008-11#1)(2009-8#1)(2010-11#5)
the islets##12##2##(1994-8#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-5#1)(2010-11#6)(2011-2#1)
the isoalloxazine ring of##2##4##(1992-1#1)(1996-8#1)
the isochromatic fringes##2##3##(2008-3#2)
the isochromatic##4##2##(2008-2#1)(2008-3#3)
the isochromatics##2##2##(2008-2#1)(2008-3#1)
the isocitrate##2##2##(2008-10#2)
the isocratic##2##2##(2008-10#2)
the isoelectric point##2##3##(2008-11#1)(2008-7#1)
the isoelectric##5##2##(2008-10#3)(2008-11#1)(2008-7#1)
the isoenzyme##2##2##(1992-3#1)(2008-6#1)
the isoenzymes##2##2##(1991-5#1)(2013-1#1)
the isoflavone glucoside was##2##4##(2008-11#2)
the isoflavone##4##2##(1992-3#1)(1993-12#1)(2008-11#2)
the isoflavones##2##2##(1993-12#1)(2010-1#1)
the isoform difference of mammalian metallothionein##2##6##(1996-12#2)
the isoform##5##2##(1993-11#1)(1996-12#3)(2008-10#1)
the isoforms##4##2##(1992-8#1)(1995-6#1)(1996-12#1)(2008-11#1)
the isogenic wild type##2##4##(1993-3#1)(2008-10#1)
the isolate from##2##3##(2008-10#1)(2008-7#1)
the isolate was##2##3##(2008-10#2)
the isolate##20##2##(1997-6#1)(2008-10#17)(2008-7#1)(2011-2#1)
the isolated gamma subunit##3##4##(2008-8#3)
the isolated hepatocytes##2##3##(1990-11#1)(1996-2#1)
the isolated nuclei##2##3##(2008-2#1)(2008-8#1)
the isolated perfused rat liver##2##5##(1996-12#2)
the isolated perfused rat##4##4##(1990-12#1)(1996-12#3)
the isolated strains##3##3##(1991-3#2)(2007-10#1)
the isolated##84##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-3#4)(1992-6#2)(1993-11#3)(1993-6#3)(1993-8#3)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-12#4)(1996-2#2)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-8#1)(2008-10#5)(2008-11#9)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
the isolates adapted to##2##4##(2008-10#2)
the isolates and##3##3##(2008-10#1)(2008-12#2)
the isolates belonged to##3##4##(2008-10#3)
the isolates could be##2##4##(2008-10#2)
the isolates from the##2##4##(2008-10#1)(2008-5#1)
the isolates from##10##3##(1992-2#1)(1997-4#1)(2008-10#6)(2008-5#2)
the isolates in VCG##4##4##(2008-10#4)
the isolates in##8##3##(2008-10#7)(2008-5#1)
the isolates into two##3##4##(2008-10#3)
the isolates into##5##3##(2008-10#5)
the isolates of F##2##4##(2008-10#2)
the isolates of##9##3##(1990-6#1)(2008-10#6)(2008-12#2)
the isolates tested##2##3##(2008-12#1)(2008-5#1)
the isolates that##3##3##(2008-10#3)
the isolates were able to##2##5##(2011-2#2)
the isolates were identified##2##4##(2007-7#1)(2008-10#1)
the isolates were susceptible to##2##5##(2008-5#2)
the isolates were the##2##4##(1991-8#1)(2008-10#1)
the isolates were##26##3##(1991-8#1)(1996-12#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-5#3)(2008-7#2)(2011-2#3)
the isolates##122##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1996-12#2)(1997-3#1)(1997-4#1)(2007-7#4)(2007-8#1)(2008-10#77)(2008-12#7)(2008-5#8)(2008-6#1)(2008-7#3)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#1)
the isolation and analysis of##2##5##(1993-12#1)(2008-4#1)
the isolation and characterization of a novel##2##7##(1990-12#1)(1993-11#1)
the isolation and characterization of a##4##6##(1990-12#1)(1993-11#1)(1993-12#1)(1994-6#1)
the isolation and characterization of##5##5##(1990-12#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-8#1)
the isolation and culture of##2##5##(2008-11#2)
the isolation and identification of##2##5##(1991-8#1)(2013-1#1)
the isolation and purification of##2##5##(2008-11#1)(2011-1#1)
the isolation and sequencing of##2##5##(1991-6#1)(1997-7#1)
the isolation and##25##3##(1990-12#1)(1991-6#2)(1991-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-4#4)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the isolation of M##2##4##(2008-9#1)(2011-2#1)
the isolation of a cDNA##3##5##(1994-11#1)(1994-8#1)(1995-2#1)
the isolation of a##10##4##(1994-11#2)(1994-8#3)(1995-2#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-1#1)
the isolation of six##2##4##(2010-2#1)(2013-1#1)
the isolation of the##6##4##(1993-9#1)(1996-5#1)(2008-10#3)(2008-2#1)
the isolation of##66##3##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-11#2)(1994-8#3)(1994-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#4)(2011-2#1)(2013-1#1)
the isolation##102##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#15)(2008-11#13)(2008-12#1)(2008-2#2)(2008-4#9)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#5)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
the isomer##3##2##(1996-2#1)(2008-5#1)(2009-9#1)
the isomeric##3##2##(1992-12#1)(1996-5#1)(2008-10#1)
the isomerization##2##2##(1992-6#1)(2008-10#1)
the isomers##3##2##(2008-10#2)(2011-10#1)
the isometric##2##2##(1994-3#1)(1995-12#1)
the isostere##2##2##(1992-8#2)
the isosteric heat##2##3##(2010-4#2)
the isosteric##3##2##(2010-4#3)
the isothermal adsorption##2##3##(1997-2#2)
the isothermal##6##2##(1997-2#4)(2008-10#1)(2009-7#1)
the isotherms##2##2##(1990-8#1)(2008-10#1)
the isotonic solution##2##3##(2008-10#2)
the isotonic##3##2##(2008-10#3)
the isotope dilution method##3##4##(2008-10#3)
the isotope dilution##4##3##(2008-10#4)
the isotope ratio##2##3##(2008-10#2)
the isotope##9##2##(1992-3#1)(1994-5#1)(2008-10#6)(2008-9#1)
the isotopic##2##2##(2008-10#2)
the isotopomer##2##2##(2008-7#2)
the isotropic##7##2##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#4)
the isotype of##2##3##(1990-12#2)
the isotype##3##2##(1990-12#2)(2008-8#1)
the isozyme##4##2##(1991-12#1)(1995-3#1)(2008-10#1)(2012-5#1)
the issue and##3##3##(1991-3#1)(1992-1#1)(1994-1#1)
the issue is##2##3##(2008-10#1)(2008-8#1)
the issue of how##2##4##(1995-12#1)(2008-9#1)
the issue of the##6##4##(1991-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
the issue of whether##2##4##(1992-2#1)(2010-6#1)
the issue of##46##3##(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-6#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
the issue##71##2##(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-1#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#3)
the issues and challenges##2##4##(2007-10#1)(2008-10#1)
the issues and##8##3##(1991-2#1)(1992-1#1)(1992-2#2)(2007-10#1)(2008-10#1)(2009-6#1)(2012-3#1)
the issues associated with the##2##5##(2008-11#2)
the issues associated with##3##4##(2008-10#1)(2008-11#2)
the issues facing##2##3##(1994-1#1)(2008-11#1)
the issues in the process of##2##6##(2012-3#2)
the issues involved in##5##4##(1991-12#2)(1993-2#1)(1995-1#1)(2008-4#1)
the issues involved##6##3##(1991-12#2)(1993-2#1)(1995-1#1)(2008-4#1)(2008-9#1)
the issues of training##2##4##(1993-2#2)
the issues of##14##3##(1991-1#1)(1991-3#1)(1991-7#1)(1993-2#2)(1995-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)
the issues raised##2##3##(1991-2#1)(2008-10#1)
the issues related to##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
the issues surrounding##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
the issues that need to be addressed##8##7##(2013-8#8)
the issues that##17##3##(1991-3#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2013-8#8)
the issues##89##2##(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-7#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#10)
the isthmic part##2##3##(1993-12#2)
the isthmic region of##2##4##(1996-5#2)
the isthmic##5##2##(1993-12#2)(1996-5#3)
the itch associated with dry skin##2##6##(2008-5#2)
the itching##2##2##(2008-5#2)
the item &quot##2##3##(2009-10#1)(2013-1#1)
the item##5##2##(2009-10#1)(2010-10#1)(2012-2#2)(2013-1#1)
the items was##2##3##(2012-2#1)(2013-1#1)
the items##13##2##(1990-11#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2012-2#2)(2013-1#4)
the iteration##3##2##(2008-2#3)
the iterative method##2##3##(2008-10#1)(2008-3#1)
the iterative##13##2##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#7)
the ivyleaf morning glory##2##4##(2008-8#2)
the jackknife##2##2##(2008-10#1)(2011-2#1)
the jaw##10##2##(1997-3#1)(2008-3#1)(2008-7#2)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
the jaws##12##2##(2007-12#3)(2008-1#3)(2012-12#3)(2013-1#3)
the jejunal##3##2##(1991-11#1)(1991-12#1)(1994-6#1)
the jejunum of##2##3##(2008-10#2)
the jejunum was##2##3##(1991-5#1)(1995-3#1)
the jejunum##12##2##(1990-9#1)(1991-5#1)(1992-5#1)(1995-3#2)(2008-10#4)(2012-2#1)(2013-7#2)
the jelly##4##2##(1992-8#2)(2008-8#2)
the jelly-induced##2##2##(1992-8#2)
the jet nebulizer##3##3##(1991-1#3)
the jet##5##2##(1991-1#3)(2007-12#1)(2008-11#1)
the jitter##7##2##(2007-11#3)(2008-3#4)
the job of##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
the job satisfaction of##2##4##(1992-3#1)(2013-1#1)
the job##23##2##(1990-2#1)(1991-2#4)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#4)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
the joining of##2##3##(2007-12#1)(2008-3#1)
the joining##3##2##(2007-12#1)(2008-3#1)(2009-7#1)
the joint action##2##3##(1994-11#1)(2008-5#1)
the joint and##2##3##(2007-11#1)(2008-12#1)
the joint distribution of##2##4##(1997-4#1)(2012-3#1)
the joint distribution##3##3##(1997-4#2)(2012-3#1)
the joint fluid##2##3##(2006-10#1)(2007-11#1)
the joint fractional##2##3##(2008-2#1)(2008-3#1)
the joint is##3##3##(2007-8#2)(2011-1#1)
the joint observing program Intercal_01##2##5##(2008-3#2)
the joint potency of##2##4##(1994-11#2)
the joint transform correlator (JTC)##3##5##(2008-2#1)(2008-3#2)
the joint transform correlator##6##4##(2008-2#2)(2008-3#4)
the joint transform##9##3##(2008-2#3)(2008-3#6)
the joint##70##2##(1991-3#1)(1993-5#1)(1994-11#3)(1994-3#1)(1995-2#1)(1996-9#1)(1997-4#2)(2006-10#1)(2007-11#8)(2007-8#7)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#6)(2008-3#9)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-7#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#2)
the joint-confidence ellipse##2##3##(2008-10#2)
the joints and##2##3##(1990-6#1)(2008-10#1)
the joints of the##2##4##(2009-3#1)(2011-1#1)
the joints of##3##3##(1997-3#1)(2009-3#1)(2011-1#1)
the joints##8##2##(1990-6#1)(1992-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-3#1)(2009-7#1)(2011-1#1)
the journal##19##2##(1991-2#1)(1992-2#1)(1992-4#1)(1993-8#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#2)(2013-1#5)
the journals##5##2##(2011-1#2)(2012-12#3)
the journey##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
the judge##4##2##(1997-5#1)(1997-6#1)(2009-8#2)
the judgments of##2##3##(1993-12#1)(2008-1#1)
the judicial##4##2##(1997-6#1)(1997-8#1)(2008-12#1)(2011-2#1)
the judiciary##3##2##(1995-1#1)(2011-2#2)
the judicious##2##2##(2008-6#1)(2009-3#1)
the jugular vein##4##3##(1997-7#1)(2009-6#2)(2012-3#1)
the jugular##8##2##(1994-7#1)(1996-9#1)(1997-7#1)(2009-6#2)(2011-2#2)(2012-3#1)
the juice sac area##6##4##(2008-10#6)
the juice##10##2##(2008-10#9)(2012-12#1)
the jump sign##2##3##(2008-12#2)
the jump##9##2##(2007-12#3)(2008-12#2)(2008-9#3)(2009-1#1)
the jumping spider##2##3##(2007-12#1)(2009-9#1)
the jumping##3##2##(2007-12#1)(2008-8#1)(2009-9#1)
the jumps##3##2##(1993-11#1)(2006-4#1)(2011-2#1)
the jumyo mutant##2##3##(1990-7#2)
the junction of the##4##4##(2007-12#2)(2007-8#1)(2008-10#1)
the junction of##8##3##(1990-5#1)(1993-9#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-8#1)
the junction##18##2##(1990-5#1)(1993-6#1)(1993-9#1)(1996-12#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
the junctional##4##2##(1990-2#1)(1995-6#2)(1996-12#1)
the jungle##2##2##(2008-10#1)(2012-12#1)
the junior faculty##2##3##(2009-4#2)
the junior##4##2##(2009-4#3)(2009-7#1)
the junk bond##2##3##(1992-11#2)
the junk##3##2##(1992-11#3)
the jury finding##2##3##(1995-6#1)(1996-2#1)
the jury##4##2##(1995-6#2)(1996-2#1)(1996-5#1)
the juvenile##7##2##(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)
the juveniles##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
the juxtamembrane domain##3##3##(1994-6#3)
the kappa agonists##2##3##(1991-1#2)
the kappa statistic##4##3##(1992-8#1)(1995-2#3)
the kappa##11##2##(1991-1#2)(1992-8#1)(1993-12#1)(1993-9#1)(1995-2#3)(1996-12#1)(1997-8#1)(2008-11#1)
the kappa-selective##2##2##(1991-1#1)(1995-12#1)
the karyosome capsule is##2##4##(2007-12#1)(2008-7#1)
the karyosome capsule##4##3##(2007-12#2)(2008-7#2)
the karyosome in##3##3##(2007-12#2)(2008-7#1)
the karyosome##14##2##(2007-12#6)(2008-7#8)
the karyotype of##2##3##(1993-9#1)(2008-12#1)
the karyotype##6##2##(1993-9#1)(1995-2#1)(2007-4#1)(2008-12#1)(2010-3#1)(2013-8#1)
the karyotypes of##3##3##(1994-11#1)(2008-12#1)(2010-3#1)
the karyotypic##3##2##(1993-9#1)(1996-12#1)(2008-5#1)
the kcat values##2##3##(1994-5#1)(1995-6#1)
the kcat was##2##3##(1990-8#1)(1993-9#1)
the kcat##4##2##(1990-8#1)(1993-9#1)(1994-5#1)(1995-6#1)
the keel##3##2##(1997-4#3)
the keratin##4##2##(1991-12#2)(2008-5#1)(2009-10#1)
the keratinocyte##2##2##(1996-2#1)(2008-9#1)
the keratinocytes##5##2##(1990-3#1)(1993-11#1)(1995-11#1)(2008-12#2)
the kernel matrix##2##3##(2008-2#2)
the kernel##6##2##(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
the kernels##2##2##(2008-3#1)(2010-4#1)
the keto acid##2##3##(2008-10#2)
the keto##4##2##(1993-11#1)(2008-10#2)(2008-11#1)
the ketone##2##2##(2007-8#1)(2008-5#1)
the key challenges##2##3##(2010-12#1)(2011-1#1)
the key characteristics of##2##4##(1994-3#1)(2012-3#1)
the key elements in##2##4##(2009-3#1)(2011-1#1)
the key elements of the##2##5##(2008-11#1)(2012-12#1)
the key elements of##3##4##(2008-11#1)(2008-9#1)(2012-12#1)
the key elements to##2##4##(1991-12#1)(2010-8#1)
the key elements##8##3##(1991-12#1)(1993-12#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-12#1)
the key enzyme of##2##4##(2008-10#1)(2009-8#1)
the key enzyme##5##3##(1992-3#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
the key factor in##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
the key factor##6##3##(1994-5#1)(2008-10#1)(2008-3#2)(2010-4#1)(2010-7#1)
the key factors that##3##4##(2007-11#1)(2008-11#2)
the key factors##8##3##(1995-5#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-6#1)(2011-2#1)
the key features of the##2##5##(1997-6#1)(2011-2#1)
the key features of##3##4##(1997-6#1)(2011-2#2)
the key features##5##3##(1994-9#1)(1997-6#1)(2008-8#1)(2011-2#2)
the key for##2##3##(1993-5#1)(2010-8#1)
the key in##2##3##(2008-8#1)(2012-1#1)
the key issues##5##3##(1995-12#1)(1997-2#1)(2008-12#1)(2008-7#1)(2013-8#1)
the key parameters##5##3##(1992-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2013-8#1)
the key results of##2##4##(2008-8#1)(2009-8#1)
the key role of##5##4##(1991-7#1)(2008-9#1)(2013-1#3)
the key step##4##3##(1992-11#1)(1992-8#1)(2007-8#1)(2008-11#1)
the key to effective##2##4##(1997-3#1)(2008-7#1)
the key to improve##2##4##(2011-2#2)
the key to success##3##4##(1994-1#1)(1995-12#2)
the key to the##8##4##(1990-8#1)(1992-2#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-5#1)(2011-9#1)
the key to understanding the##3##5##(2008-1#1)(2008-6#1)(2008-9#1)
the key to##40##3##(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1996-1#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-9#1)(2012-1#1)
the key words##3##3##(2008-1#1)(2011-1#1)(2012-12#1)
the key##209##2##(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-7#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#3)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2006-10#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#12)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#3)(2009-8#6)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#10)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#5)
the keys to##3##3##(1991-12#1)(1996-1#1)(2011-2#1)
the keys##4##2##(1991-12#1)(1996-1#1)(2008-10#1)(2011-2#1)
the keywords &quot##2##3##(2008-7#1)(2013-1#1)
the keywords##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
the kidney and in##2##4##(1994-5#1)(2008-7#1)
the kidney and liver of##2##5##(1990-7#1)(2008-7#1)
the kidney and liver##7##4##(1990-7#1)(1994-5#1)(1995-3#1)(1996-12#1)(2008-12#1)(2008-7#2)
the kidney and lung##2##4##(1997-4#1)(2008-9#1)
the kidney and##19##3##(1990-11#1)(1990-7#1)(1994-5#2)(1995-3#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-2#1)
the kidney function##2##3##(1994-9#1)(2011-2#1)
the kidney in##4##3##(2008-10#2)(2008-7#1)(2012-12#1)
the kidney is##5##3##(1994-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-10#1)
the kidney lead concentration##2##4##(1992-12#2)
the kidney to##2##3##(2010-1#1)(2011-2#1)
the kidney was##2##3##(2008-7#1)(2011-2#1)
the kidney##93##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1992-12#2)(1992-3#1)(1993-9#1)(1994-11#1)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-12#2)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#11)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
the kidneys and the##2##4##(1990-11#1)(1995-3#1)
the kidneys and##5##3##(1990-11#1)(1995-3#1)(1997-6#1)(2007-7#1)(2008-7#1)
the kidneys from##2##3##(1996-3#1)(2013-7#1)
the kidneys of patients##2##4##(1997-1#1)(2010-6#1)
the kidneys of##8##3##(1990-7#1)(1994-5#1)(1997-1#1)(1997-6#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-6#1)
the kidneys were##2##3##(2008-12#1)(2008-5#1)
the kidneys##35##2##(1990-11#1)(1990-7#1)(1993-9#1)(1994-5#1)(1995-3#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(2007-7#4)(2008-1#2)(2008-12#1)(2008-4#7)(2008-5#3)(2008-7#1)(2009-6#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-7#1)
the killed##2##2##(1990-12#1)(2008-7#1)
the killing of##2##3##(1992-9#1)(2008-8#1)
the killing##4##2##(1992-9#1)(2008-8#1)(2008-9#1)(2012-12#1)
the kinase activity##3##3##(1990-7#1)(1993-12#1)(1993-8#1)
the kinase domain##4##3##(1991-12#1)(1995-2#1)(1997-4#1)(2009-8#1)
the kinase in##2##3##(1993-8#1)(2012-3#1)
the kinase inhibitor##3##3##(1992-12#1)(1993-3#1)(1997-4#1)
the kinase reaction##2##3##(1992-12#1)(1993-8#1)
the kinase##31##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-12#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#5)(1995-2#5)(1995-6#1)(1997-4#2)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
the kinases##2##2##(1994-8#1)(2009-8#1)
the kind and the##2##4##(2008-3#1)(2012-12#1)
the kind of##20##3##(1991-6#1)(1992-3#1)(1994-1#1)(1995-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
the kind##23##2##(1991-6#1)(1992-3#1)(1994-1#1)(1995-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
the kinds of##5##3##(1995-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
the kinematic##2##2##(2009-5#1)(2011-2#1)
the kinesin##2##2##(1995-3#2)
the kinetic and##6##3##(1992-3#1)(1992-8#1)(2008-10#2)(2008-2#1)(2008-4#1)
the kinetic constants##3##3##(1991-3#1)(1996-2#1)(2008-10#1)
the kinetic determination of##3##4##(2008-10#3)
the kinetic discrimination##2##3##(2008-10#2)
the kinetic energy of impacting##2##5##(2008-10#2)
the kinetic mechanism##4##3##(1991-9#1)(1995-2#1)(1995-6#2)
the kinetic method##2##3##(2008-10#2)
the kinetic parameters of##2##4##(2009-11#1)(2011-2#1)
the kinetic parameters##12##3##(1990-5#1)(1991-9#1)(1992-3#1)(1994-5#1)(1995-12#2)(2008-10#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
the kinetic properties of##3##4##(1995-2#1)(1997-2#1)(2008-1#1)
the kinetic rate processes##2##4##(2012-2#2)
the kinetic rates##2##3##(2008-6#1)(2010-10#1)
the kinetic stability##2##3##(2008-10#2)
the kinetic##72##2##(1990-5#2)(1991-3#1)(1991-9#2)(1992-12#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#3)(1996-2#2)(1997-2#2)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
the kinetically derived##2##3##(1990-8#2)
the kinetically##3##2##(1990-8#2)(1997-2#1)
the kinetics and##5##3##(1991-5#1)(1995-12#1)(2008-10#2)(2012-2#1)
the kinetics are##2##3##(1993-11#1)(1995-5#1)
the kinetics of antigen##2##4##(1990-12#1)(2008-9#1)
the kinetics of intracellular##2##4##(2008-9#2)
the kinetics of recovery from both macroscopic and##2##8##(2008-8#2)
the kinetics of the assay##2##5##(2010-5#2)
the kinetics of the reaction##3##5##(2008-10#3)
the kinetics of the##22##4##(1990-8#1)(1992-6#2)(1995-9#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-5#2)
the kinetics of##72##3##(1990-12#1)(1990-8#3)(1991-2#1)(1992-5#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-5#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#1)(1997-7#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-12#1)(2009-5#1)(2010-5#5)(2011-2#2)
the kinetics##83##2##(1990-12#1)(1990-8#3)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#3)(1995-12#4)(1995-2#1)(1995-5#2)(1995-9#1)(1997-2#1)(1997-7#1)(2008-10#22)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#3)(2009-12#1)(2009-5#1)(2010-5#6)(2011-2#2)(2012-2#1)
the kinetochores##2##2##(1994-8#2)
the kingdom##4##2##(1997-3#1)(2008-1#3)
the kink##2##2##(1996-4#1)(2008-7#1)
the kinoform size##4##3##(2008-2#4)
the kinoform##8##2##(2008-2#7)(2008-3#1)
the knee and##7##3##(1995-3#1)(2007-8#4)(2009-11#1)(2013-1#1)
the knee are##3##3##(2007-11#1)(2007-8#1)(2012-2#1)
the knee in##6##3##(2007-11#1)(2008-8#2)(2009-3#1)(2012-3#1)(2013-1#1)
the knee is##8##3##(1997-8#4)(2007-8#1)(2010-12#1)(2013-1#2)
the knee joint##22##3##(1997-8#1)(2007-11#5)(2007-8#9)(2009-10#1)(2009-3#3)(2009-4#2)(2013-1#1)
the knee was##8##3##(1997-8#6)(2007-8#1)(2008-8#1)
the knee##116##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-3#3)(1997-8#11)(2007-11#17)(2007-8#26)(2008-11#2)(2008-12#4)(2008-6#1)(2008-8#4)(2009-10#2)(2009-11#1)(2009-3#4)(2009-4#2)(2010-12#4)(2010-3#1)(2011-2#7)(2012-2#9)(2012-3#1)(2013-1#11)
the knees##3##2##(2008-7#1)(2009-3#1)(2013-1#1)
the knowledge about the##4##4##(2007-10#1)(2007-12#1)(2011-2#1)(2012-2#1)
the knowledge about##5##3##(2007-10#1)(2007-12#1)(2007-7#1)(2011-2#1)(2012-2#1)
the knowledge and skills##2##4##(1991-1#1)(2012-12#1)
the knowledge and understanding of the##2##6##(2007-12#1)(2008-10#1)
the knowledge and##15##3##(1991-1#1)(1995-12#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
the knowledge base##2##3##(2008-10#2)
the knowledge gained##2##3##(2008-11#1)(2008-9#1)
the knowledge level##2##3##(2011-1#2)
the knowledge of such##2##4##(2013-1#2)
the knowledge of the##16##4##(1993-11#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
the knowledge of##35##3##(1990-5#1)(1993-11#1)(1996-12#1)(1997-3#2)(2006-10#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
the knowledge on##5##3##(1991-2#1)(2008-8#1)(2012-3#2)(2013-1#1)
the knowledge##86##2##(1990-5#1)(1991-1#1)(1991-2#1)(1993-11#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#1)
the known biology of##2##4##(2008-11#1)(2013-8#1)
the known crystal structure of##2##5##(1992-3#1)(2013-1#1)
the known functional##2##3##(1990-11#1)(2009-5#1)
the known mechanisms##2##3##(2008-7#1)(2008-9#1)
the known##91##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-12#5)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-10#3)(1996-11#1)(1996-12#3)(1996-5#2)(1997-3#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the kringle##2##2##(1993-8#2)
the kuruma prawn##2##3##(2008-5#1)(2008-6#1)
the l-malic acid##2##3##(2008-10#2)
the lab##6##2##(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#2)
the label to the##2##4##(2008-11#1)(2008-12#1)
the label##6##2##(1991-5#1)(1992-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
the labeled rate##3##3##(2008-10#3)
the labeled##15##2##(1990-12#1)(1992-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-2#1)(2008-10#6)(2008-2#1)(2008-4#1)
the labeling index of##3##4##(2008-4#3)
the labeling of##3##3##(1990-2#1)(2008-9#1)(2009-10#1)
the labeling pattern of##3##4##(2008-10#1)(2008-7#2)
the labeling##12##2##(1990-2#1)(2008-10#2)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#2)(2013-1#1)
the labelled antibodies##2##3##(2008-10#2)
the labelled##8##2##(1994-2#1)(1995-12#1)(1996-2#2)(2008-10#3)(2008-5#1)
the labelling##2##2##(1993-12#1)(1997-1#1)
the labial##4##2##(2007-12#4)
the lability of##4##3##(1994-11#1)(1994-12#1)(2008-10#1)(2012-12#1)
the labor force##4##3##(1991-1#2)(1997-2#1)(2008-9#1)
the labor market and##3##4##(1994-3#1)(2011-2#1)(2012-3#1)
the labor market##5##3##(1994-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
the labor##12##2##(1991-1#2)(1994-3#2)(1997-2#1)(2007-2#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
the laboratories of##2##3##(2008-2#1)(2011-1#1)
the laboratories##9##2##(2007-10#1)(2007-7#1)(2008-10#4)(2008-2#1)(2011-1#1)(2011-2#1)
the laboratory and the field##2##5##(2008-10#1)(2008-2#1)
the laboratory and the##4##4##(1993-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
the laboratory and##16##3##(1993-1#1)(1996-4#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#2)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
the laboratory diagnosis of##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
the laboratory for##5##3##(2008-10#1)(2008-11#2)(2008-4#1)(2013-8#1)
the laboratory in##4##3##(2008-10#3)(2008-12#1)
the laboratory mixer##2##3##(2008-5#2)
the laboratory of microbiology##2##4##(2007-12#1)(2010-12#1)
the laboratory of##3##3##(2007-12#1)(2010-12#1)(2011-2#1)
the laboratory population##3##3##(2008-10#3)
the laboratory results##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
the laboratory strain##2##3##(2011-2#1)(2012-3#1)
the laboratory to the##2##4##(2008-10#1)(2008-11#1)
the laboratory to##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
the laboratory##151##2##(1990-3#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-2#1)(1996-4#3)(1996-9#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#45)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#7)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#3)
the laborers##3##2##(2009-12#3)
the laborious##2##2##(2008-10#1)(2008-4#1)
the labour market##3##3##(1995-5#2)(2011-2#1)
the labour##5##2##(1993-3#1)(1993-6#1)(1995-5#2)(2011-2#1)
the labral sensory nerve##2##4##(2007-12#2)
the labral##4##2##(2007-12#4)
the labrum is not##2##4##(2007-12#2)
the labrum is##5##3##(2007-12#5)
the labrum##11##2##(2007-12#11)
the labyrinth##3##2##(2012-2#3)
the lac##8##2##(1990-5#3)(1992-3#1)(1995-2#1)(1995-3#1)(1997-6#1)(2008-10#1)
the lacZ gene##2##3##(1991-7#1)(2008-11#1)
the lacZ##10##2##(1991-7#2)(1997-4#2)(1997-6#2)(1997-7#1)(2008-11#1)(2009-12#1)(2013-1#1)
the lack of a##23##4##(1990-2#1)(1991-10#1)(1993-2#1)(1994-6#1)(1995-3#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-12#1)
the lack of adequate##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
the lack of an##5##4##(1993-12#1)(1995-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
the lack of any##2##4##(2008-5#1)(2013-8#1)
the lack of available##3##4##(1990-9#1)(1992-1#1)(2011-2#1)
the lack of awareness##2##4##(2008-10#1)(2009-4#1)
the lack of correlation##3##4##(2008-10#2)(2008-3#1)
the lack of disease##2##4##(2008-1#1)(2008-10#1)
the lack of education##2##4##(2007-10#1)(2013-8#1)
the lack of effect##3##4##(1995-12#1)(2012-2#1)(2013-1#1)
the lack of evidence##3##4##(2008-11#1)(2008-12#1)(2011-2#1)
the lack of expression of##2##5##(1992-3#1)(2008-9#1)
the lack of information##2##4##(1992-2#1)(2012-2#1)
the lack of knowledge and##2##5##(1990-6#1)(2008-11#1)
the lack of knowledge##3##4##(1990-6#1)(2008-11#1)(2008-5#1)
the lack of local##2##4##(2008-3#1)(2008-5#1)
the lack of molecular markers##2##5##(2008-10#2)
the lack of one##2##4##(1994-8#1)(1997-4#1)
the lack of other##2##4##(1995-6#1)(2008-1#1)
the lack of response##2##4##(2008-8#1)(2013-1#1)
the lack of significant##2##4##(2008-10#2)
the lack of specific##5##4##(1990-3#1)(2008-4#2)(2008-9#1)(2013-8#1)
the lack of standards##2##4##(2008-10#1)(2008-11#1)
the lack of the##3##4##(1994-7#1)(2010-5#1)(2011-2#1)
the lack of true##2##4##(2008-4#1)(2008-9#1)
the lack of understanding##2##4##(2008-11#1)(2010-3#1)
the lack of##201##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-3#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-6#1)(2007-10#2)(2007-11#4)(2007-2#1)(2008-1#2)(2008-10#32)(2008-11#16)(2008-12#5)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#6)
the lacrimal##5##2##(1995-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
the lactam ring##2##3##(1993-8#1)(2007-7#1)
the lactate concentration##2##3##(2008-10#1)(2008-6#1)
the lactate dehydrogenase##3##3##(2008-11#2)(2008-6#1)
the lactate dehydrogenase-B##2##3##(1990-8#2)
the lactate##10##2##(1990-8#2)(1994-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#2)
the lactation##2##2##(1991-11#1)(2012-3#1)
the lactic##2##2##(1997-4#1)(2008-10#1)
the lactose carrier of##3##4##(1994-9#3)
the lactose##5##2##(1993-11#2)(1994-9#3)
the lacunary##2##2##(2008-10#1)(2010-6#1)
the lag and##2##3##(1992-11#1)(2008-11#1)
the lag period##3##3##(2008-10#3)
the lag phase##7##3##(1990-7#1)(1995-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
the lag time##7##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
the lag##23##2##(1990-7#1)(1990-8#1)(1992-11#1)(1995-12#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#3)
the lagging-strand Pol III core##3##5##(1992-3#3)
the lagoon##8##2##(2007-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#3)
the lagoons##2##2##(2010-8#2)
the lake##5##2##(1996-6#2)(2008-10#3)
the lambda##4##2##(1990-5#1)(1995-2#1)(1995-3#2)
the lambs from##2##3##(1991-8#1)(1994-7#1)
the lambs##5##2##(1991-8#1)(1994-7#3)(1996-12#1)
the lamellae##2##2##(2008-7#2)
the lamellar scaffold##2##3##(2012-2#2)
the lamellar##12##2##(1990-12#1)(2008-2#1)(2008-5#4)(2008-8#1)(2012-2#5)
the lamellate##2##2##(2008-7#1)(2010-10#1)
the lamin A tail##2##4##(2011-2#2)
the lamin A##4##3##(1992-12#1)(1993-8#1)(2011-2#2)
the lamin##6##2##(1992-12#1)(1993-8#1)(2008-8#1)(2011-2#3)
the lamina propria##3##3##(1997-1#1)(2008-5#1)(2009-1#1)
the lamina##14##2##(1996-6#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-2#3)(2013-7#1)
the laminar##5##2##(1993-12#1)(1997-2#2)(1997-3#1)(2008-3#1)
the laminin##5##2##(1991-2#1)(1997-1#2)(2013-8#2)
the lamp##4##2##(2008-11#1)(2008-2#3)
the lamprey##6##2##(1993-3#1)(1997-3#5)
the land surface emissivity##2##4##(2013-8#2)
the land##6##2##(1992-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2013-8#2)
the land-groove recording technique##2##4##(2008-3#2)
the land-groove##3##2##(2008-3#3)
the landmark##2##2##(2008-9#1)(2009-7#1)
the landscape of##6##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)
the landscape##13##2##(1994-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#2)(2012-12#1)(2012-9#1)(2013-1#1)
the language of##2##3##(1997-6#1)(2010-4#1)
the language##7##2##(1996-7#1)(1997-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2013-1#2)
the lanthanide ion##2##3##(1990-11#1)(2012-12#1)
the lanthanide metal ions##2##4##(2008-10#2)
the lanthanide metal##3##3##(2008-10#2)(2008-4#1)
the lanthanide##6##2##(1990-11#1)(2008-10#3)(2008-4#1)(2012-12#1)
the lanthanum##2##2##(2008-10#2)
the lap##2##2##(2009-7#1)(2013-1#1)
the laparoscope##3##2##(1992-1#1)(1992-12#1)(1996-3#1)
the laparoscopic##10##2##(1992-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(2008-12#1)(2011-2#1)(2013-1#4)
the laparoscopy group##2##3##(1996-1#2)
the laparoscopy##3##2##(1995-3#1)(1996-1#2)
the laparotomy##2##2##(1990-2#1)(1996-1#1)
the large amount of data##2##5##(2008-1#1)(2008-3#1)
the large amount of##5##4##(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
the large amounts of##3##4##(2008-10#1)(2008-7#2)
the large and##4##3##(1997-6#1)(2007-11#2)(2011-2#1)
the large bubble##2##3##(2008-11#2)
the large difference in##2##4##(2008-11#1)(2008-8#1)
the large difference##3##3##(1994-6#1)(2008-11#1)(2008-8#1)
the large extracellular domain##2##4##(1996-5#1)(2008-4#1)
the large extracellular##4##3##(1996-5#1)(2008-4#2)(2009-8#1)
the large frequency##2##3##(2007-11#2)
the large hospitals##2##3##(2008-4#2)
the large intestine is##2##4##(1991-6#1)(2009-1#1)
the large intestine##8##3##(1990-11#1)(1991-6#1)(1993-9#2)(1995-10#1)(2007-8#1)(2009-1#1)(2011-2#1)
the large majority of##4##4##(1990-3#1)(1991-9#1)(2008-10#1)(2008-3#1)
the large number of##10##4##(1990-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-1#1)(2012-12#1)
the large numbers of##3##4##(1995-8#1)(2007-7#1)(2008-11#1)
the large scale##5##3##(1996-4#1)(2008-10#1)(2008-11#3)
the large size of the##4##5##(1991-3#1)(1995-5#1)(2009-2#1)(2010-3#1)
the large size##5##3##(1991-3#1)(1993-8#1)(1995-5#1)(2009-2#1)(2010-3#1)
the large species##2##3##(1992-9#1)(2008-7#1)
the large subunit (LSU)##2##4##(1995-8#1)(2008-10#1)
the large subunit of the##2##5##(1992-8#1)(1995-12#1)
the large subunit of##3##4##(1992-3#1)(1992-8#1)(1995-12#1)
the large subunit ribosomal##2##4##(1994-12#1)(2010-4#1)
the large subunit##12##3##(1992-3#2)(1992-8#3)(1993-8#1)(1994-12#1)(1995-12#1)(1995-8#1)(2008-10#1)(2010-4#1)(2013-8#1)
the large tumor##2##3##(1994-8#1)(1995-2#1)
the large variety of##2##4##(2008-10#1)(2008-3#1)
the large volume of literature##2##5##(2006-10#1)(2008-10#1)
the large volume of##5##4##(2006-10#1)(2008-10#3)(2010-8#1)
the large##177##2##(1990-11#1)(1990-3#2)(1990-9#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#4)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-8#4)(1993-9#6)(1994-12#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#5)(1996-2#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#7)(2007-12#9)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#20)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
the large-scale##9##2##(1995-12#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2012-2#1)
the largely##2##2##(2009-8#1)(2013-8#1)
the larger number of##2##4##(1992-9#1)(2008-11#1)
the larger the##8##3##(1995-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)
the larger##58##2##(1990-11#1)(1990-5#1)(1991-6#2)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
the largest absolute##2##3##(2009-4#1)(2011-2#1)
the largest amount of##3##4##(1995-11#1)(2009-5#1)(2011-2#1)
the largest and most##3##4##(2008-1#1)(2008-10#2)
the largest and##6##3##(2008-1#1)(2008-10#3)(2013-1#1)(2013-8#1)
the largest group of##3##4##(1995-6#1)(2011-2#1)(2013-1#1)
the largest influence##2##3##(2008-5#1)(2012-2#1)
the largest number of##6##4##(1991-5#1)(1994-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)
the largest relative##2##3##(2008-10#1)(2010-6#1)
the largest single##3##3##(1992-1#1)(1992-6#1)(2008-11#1)
the largest subunit of##3##4##(1995-6#2)(1997-7#1)
the largest##135##2##(1990-11#2)(1991-2#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#5)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-5#2)(1997-6#2)(1997-7#2)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
the larvae of the##3##4##(1992-8#1)(2008-7#1)(2008-8#1)
the larvae of##7##3##(1992-8#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2012-12#1)
the larvae were##2##3##(2008-10#1)(2008-11#1)
the larvae##20##2##(1992-8#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#1)(2010-8#2)(2011-2#2)(2012-12#1)
the larval period and##2##4##(2007-12#1)(2008-7#1)
the larval period##3##3##(2007-12#2)(2008-7#1)
the larval stage at which##2##5##(2008-10#2)
the larval stage##5##3##(2008-10#2)(2008-6#1)(2008-8#2)
the larval##25##2##(1990-3#1)(2007-12#6)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-12#1)
the laryngeal##2##2##(1996-5#1)(1996-8#1)
the larynx has##2##3##(1992-2#1)(1996-12#1)
the larynx##16##2##(1991-4#1)(1992-2#3)(1993-6#3)(1993-8#1)(1996-12#2)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
the lasB-lacZ fusion was##2##4##(1995-2#2)
the laser and the##2##4##(2007-12#1)(2008-3#1)
the laser and##7##3##(1994-12#1)(2007-12#2)(2008-2#1)(2008-3#3)
the laser are##2##3##(2007-11#1)(2008-2#1)
the laser beam intensity##2##4##(2008-2#1)(2008-3#1)
the laser beam is##2##4##(2008-2#1)(2008-3#1)
the laser beam to##2##4##(2008-3#2)
the laser beam##38##3##(1993-3#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#8)(2008-3#18)(2008-9#1)
the laser can##2##3##(2008-2#1)(2012-3#1)
the laser cavities##2##3##(2008-3#2)
the laser cavity and##2##4##(2007-12#1)(2008-3#1)
the laser cavity##11##3##(2007-11#4)(2007-12#3)(2008-3#4)
the laser crystal was##2##4##(2007-12#1)(2008-3#1)
the laser crystal##4##3##(2007-12#1)(2008-3#3)
the laser damage threshold##2##4##(2008-2#1)(2008-3#1)
the laser diode is##2##4##(2007-12#1)(2008-3#1)
the laser diode##11##3##(2007-12#2)(2008-2#2)(2008-3#6)(2010-11#1)
the laser emission##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
the laser energy##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
the laser field##3##3##(2007-12#3)
the laser fluence##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the laser frequency by##2##4##(2008-3#2)
the laser frequency##9##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
the laser gain##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the laser intensity##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the laser irradiance##2##3##(1993-3#1)(2008-3#1)
the laser irradiation##4##3##(2008-3#3)(2013-8#1)
the laser light##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-8#1)
the laser linewidth##3##3##(2008-2#3)
the laser medium##2##3##(2007-12#1)(2008-3#1)
the laser mode##2##3##(2007-12#2)
the laser output power##2##4##(2008-3#2)
the laser output##3##3##(2007-12#1)(2008-3#2)
the laser performance of a##2##5##(2007-12#1)(2008-2#1)
the laser performance##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the laser power##7##3##(1992-12#2)(2008-10#2)(2008-3#3)
the laser produces##3##3##(2007-12#2)(2008-3#1)
the laser pulse and##2##4##(2007-12#1)(2008-3#1)
the laser pulse##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
the laser pulses##2##3##(2007-11#1)(2007-12#1)
the laser radiation##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
the laser resonator##2##3##(2008-2#2)
the laser rod##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the laser safety standards##2##4##(1993-3#2)
the laser source##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
the laser spot##2##3##(2008-2#1)(2008-3#1)
the laser system##3##3##(2007-11#1)(2008-2#2)
the laser was##3##3##(2008-3#2)(2012-3#1)
the laser wave front##2##4##(2008-2#2)
the laser wave##3##3##(2008-2#2)(2008-3#1)
the laser wavelength is##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the laser wavelength##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
the laser with##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
the laser##284##2##(1991-1#1)(1991-3#1)(1992-12#3)(1993-3#4)(1994-12#1)(1995-2#1)(2007-11#30)(2007-12#50)(2008-10#15)(2008-2#58)(2008-3#109)(2008-7#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#3)(2013-8#1)
the laser's##10##2##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)
the laser-heated##3##2##(2008-2#2)(2008-3#1)
the laser-induced damage threshold (LIDT)##2##5##(2007-12#1)(2008-3#1)
the laser-induced damage threshold##3##4##(2007-12#1)(2008-3#2)
the laser-induced##6##2##(2007-12#1)(2008-3#5)
the lasers##5##2##(2007-11#2)(2008-3#2)(2008-7#1)
the lasing mode##2##3##(2007-12#2)
the lasing wavelength##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
the lasing##15##2##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#3)
the last 10 years in##2##5##(2009-5#1)(2013-1#1)
the last 10 years##20##4##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
the last 10##22##3##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
the last 100 years##2##4##(2007-2#1)(2008-4#1)
the last 12 months##4##4##(1994-8#1)(1996-9#1)(2010-1#1)(2011-1#1)
the last 12 years##4##4##(1993-3#1)(1997-3#1)(2008-10#1)(2010-12#1)
the last 12##8##3##(1993-3#1)(1994-8#1)(1996-9#1)(1997-3#1)(2008-10#1)(2010-1#1)(2010-12#1)(2011-1#1)
the last 14 years##2##4##(1991-11#1)(2012-3#1)
the last 14##3##3##(1991-11#1)(2008-7#1)(2012-3#1)
the last 15 years##12##4##(1991-11#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-6#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#2)(2010-3#1)(2012-2#1)
the last 15##13##3##(1991-11#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-6#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#2)(2010-3#1)(2012-2#2)
the last 18 months##4##4##(1990-6#1)(1996-3#1)(1997-3#1)(2008-11#1)
the last 2 decades##4##4##(2007-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
the last 2##9##3##(1990-6#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
the last 20 years##10##4##(1991-4#1)(1992-4#1)(1994-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-11#1)
the last 20##16##3##(1991-4#1)(1992-4#1)(1992-6#1)(1994-12#2)(1994-3#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-8#1)(2009-10#1)(2010-11#1)
the last 25 years##9##4##(1996-1#1)(1996-11#1)(1997-5#1)(2007-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
the last 3 months##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
the last 3 years##2##4##(2007-8#1)(2008-7#1)
the last 3##6##3##(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
the last 30 years##11##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
the last 30##13##3##(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
the last 4 years##2##4##(2008-10#1)(2011-2#1)
the last 40##2##3##(1990-10#1)(1997-7#1)
the last 5 years##7##4##(1996-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-3#2)
the last 5##8##3##(1996-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2012-3#2)
the last 50 years##6##4##(1990-6#1)(1995-2#1)(2007-7#1)(2008-10#2)(2011-2#1)
the last 50##7##3##(1990-6#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
the last 6 months##3##4##(1997-2#1)(2007-7#1)(2011-2#1)
the last 6 years##3##4##(1996-9#1)(1997-4#1)(2008-8#1)
the last 6##6##3##(1996-9#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-8#1)(2011-2#1)
the last 60 years##2##4##(2008-10#1)(2012-12#1)
the last 7##2##3##(2011-2#1)(2012-1#1)
the last case##5##3##(1991-8#2)(1994-9#1)(2008-3#1)(2008-7#1)
the last century##7##3##(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-7#1)
the last days##2##3##(1992-5#2)
the last decade and##4##4##(1992-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
the last decade as##3##4##(2008-4#1)(2009-3#1)(2012-2#1)
the last decade due to the##2##6##(1990-12#1)(2013-1#1)
the last decade in##3##4##(2008-1#1)(2008-7#1)(2011-3#1)
the last decade it has##2##5##(1991-6#1)(2008-4#1)
the last decade the##3##4##(1991-11#1)(1996-3#1)(2011-1#1)
the last decade##92##3##(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#3)(1992-1#2)(1992-11#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#7)
the last decades##14##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-4#2)(2011-2#3)(2012-3#1)(2013-1#2)
the last dose##5##3##(1992-8#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-7#1)
the last egg##2##3##(2008-8#2)
the last few decades##11##4##(1993-9#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#2)(2013-1#1)
the last few years##26##4##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#2)(1994-6#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the last few##38##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-1#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#5)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
the last fifteen##2##3##(2008-1#1)(2009-7#1)
the last fifty years##3##4##(1991-3#1)(2008-8#1)(2010-5#1)
the last five years##2##4##(1996-7#1)(2008-10#1)
the last five##3##3##(1996-3#1)(1996-7#1)(2008-10#1)
the last follow up##2##4##(2009-11#1)(2013-1#1)
the last follow-up##5##3##(1997-3#1)(2008-1#2)(2008-6#2)
the last four##8##3##(1996-1#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#2)
the last frontier##2##3##(1995-1#1)(2008-1#1)
the last half of the##2##5##(2008-10#1)(2008-4#1)
the last half##3##3##(1994-1#1)(2008-10#1)(2008-4#1)
the last hour##2##3##(2008-1#1)(2008-12#1)
the last injection##2##3##(1994-5#1)(1995-5#1)
the last larval##3##3##(1992-6#1)(2007-12#2)
the last month of##3##4##(1996-12#2)(2008-9#1)
the last one and##2##4##(1993-2#1)(2007-7#1)
the last one##8##3##(1993-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
the last part of the##3##5##(1991-12#1)(1994-8#1)(2011-2#1)
the last period of##2##4##(1993-8#1)(1994-3#1)
the last phases##4##3##(1990-3#2)(1990-6#1)(2008-11#1)
the last quarter##2##3##(2008-12#1)(2010-8#1)
the last serum##2##3##(1997-5#2)
the last several years##10##4##(1992-3#1)(1993-2#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)
the last several##12##3##(1992-3#1)(1993-2#1)(1995-2#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)
the last step##2##3##(2008-10#1)(2008-4#1)
the last ten years the##2##5##(1990-6#1)(1996-3#1)
the last ten years##13##4##(1990-11#1)(1990-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1996-11#1)(1996-3#1)(1996-7#1)(2007-11#1)(2008-8#2)(2012-3#1)
the last three decades##4##4##(2008-7#2)(2011-2#2)
the last three years##2##4##(1995-6#1)(2009-4#1)
the last three##12##3##(1991-7#1)(1995-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2011-2#4)(2013-7#1)
the last time##3##3##(1991-3#2)(2012-12#1)
the last trimester of##3##4##(2007-11#2)(2008-5#1)
the last trimester##5##3##(1991-3#1)(1995-8#1)(2007-11#2)(2008-5#1)
the last twenty years##4##4##(1992-4#1)(1995-12#1)(1996-2#1)(2012-2#1)
the last two decades have##2##5##(2007-12#1)(2010-11#1)
the last two decades of##2##5##(2008-6#1)(2013-7#1)
the last two decades##25##4##(1994-3#2)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the last two steps of##2##5##(2010-2#1)(2011-1#1)
the last two years##7##4##(1991-5#1)(1992-3#1)(1996-12#1)(1997-8#1)(2007-4#1)(2008-4#1)(2008-7#1)
the last two##45##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-3#2)(1994-7#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the last year##4##3##(1993-8#1)(1997-3#1)(1997-4#1)(2007-1#1)
the last years##13##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#5)
the last##587##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#4)(1990-6#6)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#5)(1991-12#5)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#5)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#7)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#6)(1996-5#2)(1996-7#2)(1996-9#2)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#5)(1997-8#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#7)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#1)(2008-1#12)(2008-10#46)(2008-11#17)(2008-12#8)(2008-2#4)(2008-3#7)(2008-4#13)(2008-5#15)(2008-6#7)(2008-7#17)(2008-8#14)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#3)(2010-6#4)(2010-8#5)(2010-9#1)(2011-1#11)(2011-2#35)(2011-3#4)(2012-1#5)(2012-12#7)(2012-2#18)(2012-3#9)(2012-7#1)(2013-1#19)(2013-7#3)(2013-8#1)
the late 1800s##2##3##(2008-10#1)(2012-12#1)
the late 1970s and##2##4##(1996-5#1)(2008-12#1)
the late 1970s##5##3##(1995-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2010-3#1)
the late 1980s##8##3##(1992-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
the late 1990s##6##3##(2008-10#3)(2008-7#1)(2010-5#1)(2013-1#1)
the late 19th century##3##4##(1993-12#1)(2007-5#1)(2010-12#1)
the late afternoon and##2##4##(1993-12#1)(2012-6#1)
the late afternoon##3##3##(1993-12#1)(2011-2#1)(2012-6#1)
the late blight##6##3##(2008-10#6)
the late nineteenth century##4##4##(2010-1#3)(2011-2#1)
the late nineteenth##6##3##(2010-1#5)(2011-2#1)
the late phase##5##3##(1990-6#1)(1993-6#1)(1995-11#1)(1995-12#2)
the late stage of##8##4##(1991-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
the late stages of##2##4##(2008-10#1)(2012-3#1)
the late stages##5##3##(2008-10#2)(2009-12#1)(2011-3#1)(2012-3#1)
the late summer##2##3##(2007-12#1)(2008-10#1)
the late##112##2##(1990-6#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-5#2)(1997-8#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2010-1#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)
the late-onset##3##2##(1990-5#2)(1991-3#1)
the latency and##2##3##(1996-5#1)(2009-12#1)
the latency of##5##3##(1990-7#1)(1993-3#1)(1996-5#1)(2008-1#1)(2008-8#1)
the latency to initiate##2##4##(1993-12#2)
the latency to##4##3##(1993-12#2)(2008-11#1)(2010-3#1)
the latency##15##2##(1990-7#1)(1993-12#2)(1993-3#1)(1995-12#1)(1996-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)
the latent period before##2##4##(1990-11#1)(1991-3#1)
the latent period of##2##4##(2008-10#2)
the latent period##6##3##(1990-11#1)(1991-3#1)(2008-10#4)
the latent periods and amplitudes of##2##6##(2008-8#2)
the latent##20##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(2008-10#7)(2008-8#2)(2009-4#1)(2010-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
the later stages because##2##4##(1993-9#1)(2013-1#1)
the later stages of##8##4##(1990-5#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-5#1)(2012-3#1)(2013-8#1)
the later stages##11##3##(1990-5#1)(1993-9#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
the later##28##2##(1990-5#1)(1992-5#1)(1993-9#1)(1996-12#1)(1997-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-5#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
the lateral and medial##3##4##(1996-5#1)(1997-3#1)(2010-11#1)
the lateral and posterior##4##4##(2007-12#1)(2007-8#2)(2013-1#1)
the lateral and##8##3##(1995-5#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-8#2)(2010-11#1)(2013-1#1)
the lateral angle of the patella##4##6##(2007-8#4)
the lateral cerebellomedullary cistern without dural attachment##2##7##(2008-7#2)
the lateral cerebral ventricle##2##4##(1993-12#1)(1995-12#1)
the lateral chest radiograph##2##4##(1997-8#2)
the lateral condensation##2##3##(1991-3#1)(2013-1#1)
the lateral displacements##2##3##(2008-2#1)(2008-3#1)
the lateral film##2##3##(1997-8#2)
the lateral geniculate nucleus##2##4##(1993-12#1)(2008-1#1)
the lateral hypothalamic area##2##4##(1993-6#1)(1994-2#1)
the lateral hypothalamus##8##3##(1991-12#1)(1992-10#1)(1993-6#4)(1996-2#1)(2009-10#1)
the lateral lemniscus##7##3##(1993-12#1)(1997-3#6)
the lateral localization accuracy##2##4##(2008-3#2)
the lateral margins##2##3##(1996-9#1)(2010-8#1)
the lateral nucleus of the amygdala##3##6##(1993-6#3)
the lateral or##2##3##(1995-6#1)(1997-2#1)
the lateral orbital rim##2##4##(2006-12#2)
the lateral orbital wall##2##4##(2008-10#1)(2010-10#1)
the lateral orbital##4##3##(2006-12#2)(2008-10#1)(2010-10#1)
the lateral pallidum##2##3##(2008-7#2)
the lateral perforant path##3##4##(1993-12#3)
the lateral recess##3##3##(2008-7#1)(2011-2#2)
the lateral rectus muscle##2##4##(1993-12#1)(2012-3#1)
the lateral resolution is##2##4##(2008-3#2)
the lateral resolution of the##2##5##(2007-12#1)(2008-3#1)
the lateral resolution##8##3##(2007-11#1)(2007-12#1)(2008-3#6)
the lateral sensillum styloconicum##2##4##(2008-8#2)
the lateral septal##2##3##(1994-2#1)(1997-2#1)
the lateral tunnel##2##3##(2007-8#1)(2010-5#1)
the lateral ventricle##8##3##(1991-12#1)(1992-8#1)(1995-12#1)(1996-7#1)(2008-7#3)(2010-2#1)
the lateral ventricles##4##3##(1991-8#1)(1993-12#1)(1996-5#2)
the lateral wall of the##2##5##(2007-12#1)(2011-2#1)
the lateral wall##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
the lateral##152##2##(1990-7#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#9)(1993-2#1)(1993-6#8)(1994-2#2)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#8)(1997-8#5)(2006-12#2)(2007-11#3)(2007-12#10)(2007-8#7)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#14)(2008-5#2)(2008-7#12)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#3)
the laterality##2##2##(2008-10#1)(2013-1#1)
the laterally##3##2##(1993-12#1)(1994-3#1)(2008-9#1)
the latest advances in##5##4##(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
the latest advances##6##3##(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-7#1)(2012-2#1)
the latest research##4##3##(2007-5#1)(2008-11#1)(2008-5#1)(2013-8#1)
the latest##56##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#1)(2013-7#2)(2013-8#2)
the latex##7##2##(1990-7#1)(2008-10#5)(2008-5#1)
the latissimus dorsi and##2##4##(2012-2#1)(2013-1#1)
the latissimus dorsi##4##3##(1990-9#1)(2012-2#2)(2013-1#1)
the latter 1980s##2##3##(1996-1#2)
the latter analyses##2##3##(2008-10#1)(2009-10#1)
the latter and##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
the latter are##8##3##(1996-5#1)(1997-4#1)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#2)
the latter being a##2##4##(1990-7#1)(2013-1#1)
the latter being the##3##4##(1995-11#1)(2008-6#1)(2012-2#1)
the latter being##9##3##(1990-7#1)(1992-2#1)(1995-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
the latter by##3##3##(1992-12#1)(2008-11#1)(2008-8#1)
the latter can##2##3##(2007-12#1)(2008-2#1)
the latter case##21##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-6#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-8#1)
the latter does##2##3##(2008-2#1)(2011-2#1)
the latter effect is##2##4##(2008-3#1)(2008-5#1)
the latter from##2##3##(2008-10#1)(2008-9#1)
the latter group##8##3##(1991-12#1)(1996-9#1)(2007-1#1)(2008-1#1)(2008-5#2)(2008-7#1)(2011-1#1)
the latter hypothesis##2##3##(1994-9#1)(1997-7#1)
the latter in##4##3##(1991-11#1)(1992-11#1)(1992-8#1)(2008-10#1)
the latter is not##4##4##(1995-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
the latter is of##2##4##(1997-4#1)(2008-10#1)
the latter is##21##3##(1990-11#2)(1990-3#1)(1990-8#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
the latter may be##2##4##(1996-6#1)(2008-1#1)
the latter may##3##3##(1996-6#1)(2008-1#1)(2008-10#1)
the latter method##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
the latter model##2##3##(1993-11#1)(2008-7#1)
the latter of which##2##4##(2010-8#1)(2012-2#1)
the latter only##2##3##(2013-7#1)(2013-8#1)
the latter part of the##4##5##(1994-2#1)(2007-12#1)(2008-10#1)(2008-12#1)
the latter part##5##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
the latter process##2##3##(1995-8#2)
the latter show##2##3##(2007-12#1)(2008-5#1)
the latter species##5##3##(2008-10#2)(2011-2#3)
the latter technique##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
the latter test##2##3##(1992-9#1)(2007-10#1)
the latter three##3##3##(2008-10#2)(2008-8#1)
the latter to a##2##4##(1997-4#1)(2008-11#1)
the latter to be##2##4##(2008-10#1)(2008-2#1)
the latter to##7##3##(1993-11#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the latter two groups##2##4##(1994-2#1)(1996-7#1)
the latter two##9##3##(1990-7#1)(1994-12#1)(1994-2#1)(1996-7#1)(2008-10#3)(2008-8#1)(2009-7#1)
the latter was##10##3##(1991-2#1)(1992-12#1)(1992-5#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-6#1)(2012-2#2)
the latter were##3##3##(1990-8#1)(2008-1#1)(2008-7#1)
the latter with##6##3##(1990-5#1)(1992-1#1)(1996-3#1)(2007-12#1)(2008-6#1)(2011-1#1)
the latter##333##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#6)(1995-8#3)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#4)(1997-8#3)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-5#1)(2008-1#5)(2008-10#54)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#16)(2008-8#12)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#15)(2012-1#3)(2012-2#10)(2012-3#1)(2012-6#1)(2013-1#6)(2013-7#3)(2013-8#3)
the latter's##6##2##(1994-5#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-12#1)(2012-2#1)
the lattice spacing##2##3##(2008-2#1)(2008-3#1)
the lattice##12##2##(1992-4#1)(1993-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#1)(2012-2#2)
the launch##2##2##(2008-3#1)(2011-2#1)
the launched pulse width##2##4##(2008-3#2)
the launched##5##2##(2007-12#1)(2008-3#4)
the launching##2##2##(1991-12#1)(2007-12#1)
the lauric##2##2##(1991-5#1)(2008-10#1)
the lavage##2##2##(2008-5#1)(2010-3#1)
the law and##6##3##(1992-12#1)(1993-2#1)(1994-1#1)(1994-5#1)(1997-8#1)(2008-3#1)
the law of similars##2##4##(1997-6#2)
the law of##8##3##(1990-7#1)(1991-1#1)(1993-6#1)(1997-6#2)(2008-11#1)(2011-2#1)(2012-2#1)
the law regarding##3##3##(1991-1#1)(1992-1#1)(1992-12#1)
the law was##3##3##(1992-1#1)(1997-8#1)(2008-8#1)
the law##46##2##(1990-7#1)(1991-1#2)(1991-9#1)(1992-1#2)(1992-12#3)(1993-2#3)(1993-3#2)(1993-6#4)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-6#3)(1997-8#4)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
the law]##2##2##(1997-3#1)(2008-9#1)
the laws of thermodynamics##2##4##(2008-3#1)(2008-5#1)
the laws of##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
the laws##5##2##(1990-12#1)(1994-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
the lawsuit##4##2##(1992-3#1)(1996-5#3)
the lay##4##2##(2008-10#1)(2009-10#1)(2009-3#1)(2012-12#1)
the layer by##2##3##(2008-2#1)(2013-1#1)
the layer of##3##3##(1997-6#1)(2008-10#2)
the layer structure##2##3##(2008-3#2)
the layer thickness##4##3##(2007-12#1)(2008-10#2)(2010-4#1)
the layer##23##2##(1990-2#1)(1991-5#1)(1994-6#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#10)(2010-4#1)(2013-1#1)
the layer-by-layer##4##2##(2008-10#2)(2010-4#1)(2010-9#1)
the layered structure##2##3##(2007-12#2)
the layered##4##2##(1997-7#1)(2007-12#3)
the layers with##2##3##(2007-11#1)(2008-3#1)
the layers##9##2##(2007-11#1)(2008-3#6)(2008-6#1)(2012-12#1)
the laying##2##2##(2008-9#1)(2012-2#1)
the layout of the##2##4##(2007-12#1)(2008-9#1)
the layout of##4##3##(2007-12#1)(2008-9#1)(2009-6#1)(2012-2#1)
the layout##8##2##(2007-12#1)(2008-2#2)(2008-6#2)(2008-9#1)(2009-6#1)(2012-2#1)
the lazaroid##2##2##(1995-12#2)
the leachates##2##2##(2008-10#2)
the leached##2##2##(2008-10#2)
the leaching of##2##3##(2008-10#2)
the leaching##4##2##(1997-4#1)(2008-10#3)
the lead compound##2##3##(1992-12#1)(2008-5#1)
the lead concentration##2##3##(2008-10#2)
the lead determination##2##3##(2008-10#2)
the lead in##5##3##(1992-1#1)(1995-2#1)(1995-3#1)(1997-7#1)(2012-9#1)
the lead##41##2##(1992-1#1)(1992-12#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1997-7#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-9#1)(2013-8#1)
the leader and##2##3##(2008-1#1)(2008-8#1)
the leader##11##2##(1991-9#1)(1992-5#1)(1992-8#1)(2008-1#3)(2008-11#1)(2008-8#3)(2008-9#1)
the leaders##2##2##(1992-5#1)(2012-2#1)
the leadership of##2##3##(2009-5#1)(2012-1#1)
the leadership##6##2##(1994-2#1)(1997-1#1)(2009-5#1)(2012-1#2)(2013-8#1)
the leading and trailing##2##4##(2008-10#2)
the leading cause of blindness##2##5##(2007-11#1)(2011-1#1)
the leading cause of death and disability##3##7##(1995-11#1)(2008-8#1)(2011-2#1)
the leading cause of death##8##5##(1990-6#1)(1995-11#1)(1997-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
the leading cause of mortality in##2##6##(2008-3#1)(2009-4#1)
the leading cause of##25##4##(1990-6#1)(1995-11#1)(1997-1#1)(2007-11#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the leading causes of death in##2##6##(2007-7#1)(2012-3#1)
the leading causes of death##3##5##(2007-7#1)(2012-3#1)(2013-8#1)
the leading causes of##12##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#3)
the leading edge of the##2##5##(2008-10#1)(2011-2#1)
the leading edge of##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
the leading edge##5##3##(2008-1#1)(2008-10#1)(2011-2#2)(2012-12#1)
the leading##74##2##(1990-6#1)(1991-12#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#6)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#6)
the leaf and##2##3##(2008-10#2)
the leaf area##3##3##(2008-10#2)(2013-7#1)
the leaf blade##2##3##(2008-10#1)(2008-5#1)
the leaf disks##2##3##(2008-10#2)
the leaf extract##2##3##(2008-8#1)(2010-3#1)
the leaf scale##2##3##(2008-10#2)
the leaf sheath##2##3##(2008-10#2)
the leaf spot isolates were##2##5##(2008-10#2)
the leaf spot isolates##3##4##(2008-10#3)
the leaf surface##10##3##(1994-11#1)(2008-10#9)
the leaf##63##2##(1994-11#1)(2008-10#49)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-6#2)(2009-7#1)(2010-3#1)(2013-7#1)
the leaf-drop symptom##3##3##(2008-10#3)
the leafhopper##5##2##(2007-12#1)(2008-10#3)(2011-2#1)
the leaflet and leaf levels##3##5##(2008-10#3)
the leaflet and leaf##5##4##(2008-10#5)
the leaflet and##6##3##(2008-10#5)(2010-8#1)
the leaflet##10##2##(2008-10#9)(2010-8#1)
the leafminer##2##2##(2008-10#1)(2011-2#1)
the leak##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
the leakage of##2##3##(2008-10#2)
the leakage##5##2##(2008-10#2)(2008-2#2)(2012-3#1)
the leaky##2##2##(1997-4#1)(2007-12#1)
the learned##2##2##(2009-11#1)(2009-6#1)
the learners##2##2##(2013-1#1)(2013-8#1)
the learning and##6##3##(1997-2#1)(2008-11#2)(2008-2#1)(2012-12#1)(2012-2#1)
the learning contract marking##2##4##(2008-11#2)
the learning environment##5##3##(2008-11#3)(2008-12#1)(2012-3#1)
the learning needs of##2##4##(2008-12#1)(2010-2#1)
the learning of##5##3##(1994-1#1)(2007-12#1)(2008-11#3)
the learning opportunities##3##3##(2008-11#2)(2010-3#1)
the learning outcomes##4##3##(2008-11#2)(2011-2#1)(2012-12#1)
the learning process##4##3##(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
the learning##53##2##(1992-3#1)(1993-12#2)(1994-1#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the least abundant##2##3##(2008-10#1)(2008-5#1)
the least amount of##2##4##(2007-11#1)(2008-7#1)
the least amount##3##3##(2007-11#1)(2008-7#2)
the least effective inhibitor in##2##5##(1992-5#2)
the least effective##4##3##(1992-5#2)(2008-10#2)
the least number of##2##4##(2008-12#1)(2013-1#1)
the least number##3##3##(2008-12#1)(2008-4#1)(2013-1#1)
the least preferred one##2##4##(2013-8#2)
the least squares##3##3##(2008-10#2)(2008-6#1)
the least studied##2##3##(1993-6#1)(2013-1#1)
the least##85##2##(1991-11#1)(1991-8#1)(1992-2#1)(1992-5#2)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#24)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
the least-squares fit##2##3##(2008-3#2)
the least-squares method##3##3##(2008-2#2)(2008-3#1)
the least-squares##7##2##(2008-2#2)(2008-3#5)
the leaves and##3##3##(2008-10#3)
the leaves increased##2##3##(2008-10#2)
the leaves of Morus alba L##2##6##(2011-3#2)
the leaves of Morus alba##3##5##(2011-3#3)
the leaves of N##2##4##(2010-3#2)
the leaves of the##4##4##(1992-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
the leaves of##22##3##(1990-11#2)(1992-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#2)(2013-8#1)
the leaves were##2##3##(2008-10#2)
the leaves##42##2##(1990-11#2)(1992-2#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-6#1)(2008-8#1)(2010-2#2)(2010-3#4)(2011-1#1)(2011-10#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#2)(2013-8#1)
the leaving group##6##3##(1993-8#5)(1995-5#1)
the lecithin##4##2##(1995-5#1)(2008-10#2)(2008-5#1)
the lectin and egf domains were##2##6##(1993-8#2)
the lectin and##4##3##(1993-8#2)(2008-10#2)
the lectin domain of GMP-140##2##5##(1991-12#2)
the lectin##18##2##(1990-5#1)(1991-12#2)(1992-6#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1995-11#1)(2008-10#5)(2008-4#1)(2012-3#1)
the lectins##5##2##(1990-7#2)(1995-11#3)
the lecture##3##2##(1994-9#2)(2011-1#1)
the lecturer in##3##3##(2008-11#3)
the lecturer practitioner role##2##4##(2008-11#2)
the lecturer practitioner##7##3##(2008-11#5)(2008-12#2)
the lecturer##16##2##(2008-11#13)(2008-12#3)
the lecturer's##2##2##(2008-11#2)
the leech##5##2##(1991-5#2)(1996-12#2)(2008-10#1)
the left BA41/42##2##3##(2008-1#2)
the left adrenal##2##3##(1992-2#1)(2011-2#1)
the left and right muscle##3##5##(2011-2#3)
the left and right##13##4##(1991-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#2)(2010-7#1)(2011-2#3)
the left and the right##2##5##(2007-8#1)(2008-1#1)
the left and##15##3##(1991-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#2)(2010-7#1)(2011-2#3)
the left anterior descending coronary artery (LAD)##2##7##(2007-8#1)(2013-1#1)
the left anterior descending coronary artery##4##6##(2007-8#1)(2008-7#1)(2013-1#1)(2013-7#1)
the left anterior descending##5##4##(1994-11#1)(2007-8#1)(2008-7#1)(2013-1#1)(2013-7#1)
the left anterior##9##3##(1994-11#1)(2007-8#2)(2008-6#1)(2008-7#2)(2009-2#1)(2013-1#1)(2013-7#1)
the left arm of Saccharomyces cerevisiae chromosome##2##7##(1995-9#1)(1996-3#1)
the left arm of chromosome VII of Saccharomyces cerevisiae##3##9##(1995-6#2)(1995-9#1)
the left arm of chromosome VII##4##6##(1995-6#2)(1995-9#1)(1996-6#1)
the left arm of chromosome##11##5##(1993-9#1)(1995-6#3)(1995-9#3)(1996-3#2)(1996-6#2)
the left arm of##17##4##(1993-2#1)(1993-9#1)(1995-6#3)(1995-9#4)(1996-3#4)(1996-6#4)
the left arm##21##3##(1991-3#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-6#3)(1995-9#4)(1996-3#4)(1996-6#4)(2007-12#1)(2009-3#1)
the left atrium##5##3##(2007-8#2)(2008-7#1)(2012-2#1)(2013-1#1)
the left basal ganglia##3##4##(1993-9#3)
the left breast##5##3##(2007-7#1)(2008-10#2)(2011-2#1)(2012-3#1)
the left buttock##2##3##(2012-12#2)
the left cardiac sympathetic nerve##3##5##(2008-9#3)
the left cardiac##4##3##(2007-8#1)(2008-9#3)
the left colon##4##3##(1991-6#1)(1992-6#1)(2006-8#1)(2011-2#1)
the left coronary artery##4##4##(1991-9#1)(1994-11#1)(2007-8#1)(2013-2#1)
the left end of chromosome##2##5##(1996-6#1)(1997-7#1)
the left end of##3##4##(1994-12#1)(1996-6#1)(1997-7#1)
the left eye##11##3##(1993-12#1)(2007-7#1)(2010-10#1)(2011-2#5)(2013-1#2)(2013-8#1)
the left frontal##2##3##(2008-12#1)(2013-1#1)
the left heart bypass##2##4##(2007-8#2)
the left heart##3##3##(1997-1#1)(2007-8#2)
the left hemisphere##5##3##(1996-2#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-11#1)
the left hemithorax##3##3##(2009-4#1)(2013-1#1)(2013-7#1)
the left iliac##2##3##(2008-12#1)(2010-6#1)
the left internal carotid artery##4##5##(1997-6#1)(2008-7#2)(2010-3#1)
the left internal##7##3##(1997-6#1)(2007-8#2)(2008-7#2)(2010-3#1)(2012-3#1)
the left kidney and##4##4##(2008-1#1)(2011-2#1)(2013-1#2)
the left kidney##10##3##(1990-6#1)(2007-7#1)(2008-1#3)(2011-2#2)(2013-1#3)
the left lateral##5##3##(1993-10#1)(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
the left leg##2##3##(1991-3#1)(2012-12#1)
the left limbs##2##3##(2008-7#2)
the left lower lobe##8##4##(1991-3#1)(2007-8#4)(2008-1#1)(2008-6#2)
the left lower##14##3##(1991-3#1)(1993-8#1)(2007-8#4)(2008-1#2)(2008-6#2)(2008-7#1)(2010-11#3)
the left lumbosacral PVM##2##4##(2013-8#2)
the left lung##8##3##(1991-9#1)(2008-1#2)(2008-4#2)(2010-7#1)(2011-2#1)(2013-8#1)
the left main bronchus##2##4##(2008-6#1)(2010-2#1)
the left main coronary artery##2##5##(2007-8#2)
the left main##7##3##(1990-9#2)(2007-8#3)(2008-6#1)(2010-2#1)
the left maxilla##2##3##(2008-6#1)(2013-1#1)
the left middle##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
the left one##2##3##(2007-7#1)(2010-2#1)
the left or right##2##4##(1997-8#1)(2007-4#1)
the left or##5##3##(1997-8#1)(2007-4#2)(2011-2#1)(2013-1#1)
the left ovary##2##3##(1997-8#1)(2010-12#1)
the left pleural##3##3##(1990-5#2)(2012-3#1)
the left posterior##2##3##(1997-6#1)(2009-8#1)
the left pulmonary artery##3##4##(2008-1#1)(2012-12#2)
the left side of the neck##2##6##(2007-7#1)(2012-12#1)
the left side of the##9##5##(1993-6#1)(2007-7#1)(2008-12#2)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)
the left side of##10##4##(1991-3#1)(1993-6#1)(2007-7#1)(2008-12#2)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)
the left side##24##3##(1990-3#1)(1991-3#1)(1993-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-7#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
the left subclavian artery##2##4##(2007-7#1)(2008-11#1)
the left subclavian##3##3##(2007-7#1)(2008-11#1)(2011-2#1)
the left superior temporal##2##4##(1996-2#1)(2012-12#1)
the left superior##3##3##(1996-2#1)(2011-2#1)(2012-12#1)
the left testis and##2##4##(2008-6#1)(2011-2#1)
the left testis##4##3##(2008-10#1)(2008-6#2)(2011-2#1)
the left thigh##4##3##(2007-7#1)(2008-6#2)(2013-1#1)
the left thorax##2##3##(1990-5#1)(2008-12#1)
the left thumb##3##3##(2010-6#3)
the left upper femur##2##4##(2008-6#2)
the left upper lobe##3##4##(2007-8#1)(2008-1#2)
the left upper quadrant##2##4##(1991-12#1)(2012-3#1)
the left upper##11##3##(1991-12#1)(2007-8#1)(2008-1#3)(2008-6#2)(2011-1#1)(2012-3#1)(2013-1#2)
the left ventricle and##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
the left ventricle##28##3##(1991-3#1)(1992-9#1)(1997-8#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-7#2)(2009-12#3)(2010-5#1)(2010-6#1)(2011-1#2)(2012-1#2)(2013-1#7)(2013-8#1)
the left ventricular outflow tract##2##5##(2007-9#1)(2011-1#1)
the left ventricular##14##3##(1990-9#1)(1993-12#1)(1995-3#2)(2007-9#1)(2008-10#1)(2008-12#3)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
the left vertebral artery##2##4##(1996-9#1)(1997-6#1)
the left##399##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#6)(1991-6#2)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#5)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#3)(1995-8#1)(1995-9#4)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#8)(1996-9#1)(1997-1#1)(1997-3#3)(1997-6#4)(1997-7#1)(1997-8#5)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#11)(2007-8#28)(2007-9#2)(2008-1#20)(2008-10#14)(2008-11#11)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#16)(2008-7#21)(2008-9#4)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#5)(2010-5#1)(2010-6#7)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#24)(2012-1#2)(2012-12#15)(2012-2#4)(2012-3#9)(2012-7#1)(2013-1#24)(2013-2#1)(2013-7#2)(2013-8#10)
the left-right##3##2##(2010-3#2)(2011-2#1)
the leg at##2##3##(2007-12#1)(2008-5#1)
the leg muscles##3##3##(2007-12#1)(2013-8#2)
the leg##14##2##(1995-2#1)(1997-2#1)(2007-12#5)(2008-12#1)(2008-5#2)(2008-6#1)(2009-3#1)(2013-8#2)
the legacy##2##2##(1992-3#1)(1995-1#1)
the legal and##4##3##(1992-3#1)(1993-3#1)(1996-1#1)(2008-11#1)
the legal foundation for resisting##2##5##(1991-12#1)(1992-3#1)
the legal framework##2##3##(1996-3#1)(2008-10#1)
the legal limits of##2##4##(2008-12#1)(2013-1#1)
the legal system and##2##4##(1995-1#1)(2008-11#1)
the legal system##7##3##(1991-12#1)(1994-2#1)(1995-1#2)(1996-3#1)(2008-11#1)(2008-8#1)
the legal##36##2##(1991-12#3)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1992-4#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-6#1)(1996-1#1)(1996-3#2)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#2)
the legally##2##2##(2008-10#1)(2010-8#1)
the legislation##7##2##(1991-12#1)(1994-1#1)(1996-5#1)(1997-3#2)(2007-2#1)(2007-9#1)
the legislative process##3##3##(1995-1#1)(1996-1#1)(2012-2#1)
the legislative##7##2##(1994-1#1)(1995-1#1)(1996-1#1)(2007-5#1)(2008-12#1)(2008-3#1)(2012-2#1)
the legitimacy##2##2##(1996-12#1)(2013-1#1)
the legitimate##2##2##(1991-3#1)(2010-8#1)
the legs##10##2##(1997-5#1)(2007-12#2)(2007-2#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
the legume##2##2##(2008-10#1)(2009-8#1)
the length and width gradient parameters##2##6##(2008-10#2)
the length and width##3##4##(2008-10#3)
the length and##13##3##(2007-12#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-9#3)(2010-7#1)
the length of hospital stay##5##5##(1991-12#1)(1994-5#1)(2008-1#1)(2013-1#1)(2013-8#1)
the length of stay##4##4##(1991-1#1)(1992-12#1)(1995-3#1)(2006-10#1)
the length of the adventitious root was##2##7##(2008-12#2)
the length of the stem##2##5##(2008-10#2)
the length of the##56##4##(1991-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the length of time##4##4##(1995-12#1)(1996-12#1)(2008-7#1)(2011-3#1)
the length of##90##3##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
the length scale of the##2##5##(2008-10#1)(2008-3#1)
the length scale of##3##4##(2008-10#2)(2008-3#1)
the length##115##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#3)
the lengthening index##2##3##(2007-8#2)
the lengthening##6##2##(2007-11#2)(2007-8#2)(2009-2#1)(2012-2#1)
the lengths of the##3##4##(2007-12#1)(2008-3#2)
the lengths of which##2##4##(1992-12#1)(2007-11#1)
the lengths of##8##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2013-8#1)
the lengths##10##2##(1992-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#2)
the lengthy##2##2##(1994-8#1)(2008-2#1)
the lens and##3##3##(1991-9#1)(1993-9#1)(2008-11#1)
the lens array##4##3##(2008-3#4)
the lens in##2##3##(2008-3#2)
the lens of##3##3##(1991-9#1)(1993-3#1)(2012-12#1)
the lens##41##2##(1991-9#3)(1992-12#1)(1993-3#1)(1993-9#1)(1994-9#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-2#4)(2008-3#17)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)
the lens-free relay system##2##4##(2008-2#2)
the lenses##7##2##(1991-9#1)(2008-2#1)(2008-3#5)
the lensing signal is##2##4##(2008-2#2)
the lensing signal##3##3##(2008-2#3)
the lensing##4##2##(2008-2#4)
the lenslet##3##2##(2008-3#3)
the leprosy##2##2##(1995-9#2)
the lesion and##11##3##(1990-3#1)(1993-9#1)(1995-8#1)(1997-6#1)(2007-10#1)(2008-6#1)(2008-7#2)(2009-1#1)(2011-2#1)(2012-2#1)
the lesion in the##2##4##(2008-5#1)(2009-6#1)
the lesion in##4##3##(1990-12#1)(2008-5#2)(2009-6#1)
the lesion is##4##3##(1990-3#1)(2007-8#1)(2011-2#1)(2012-2#1)
the lesion was found to be##2##6##(2009-11#1)(2011-2#1)
the lesion was##13##3##(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the lesion with##6##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)
the lesion##132##2##(1990-12#1)(1990-3#2)(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-2#2)(1996-3#4)(1996-5#6)(1996-9#2)(1997-3#1)(1997-6#4)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#4)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#4)(2011-1#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#5)
the lesioned group exhibited##2##4##(1997-6#2)
the lesioned side##3##3##(1991-2#1)(1996-5#1)(1997-2#1)
the lesioned##16##2##(1991-2#1)(1992-11#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-6#5)(2008-11#1)(2008-7#5)
the lesions and##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
the lesions are##2##3##(2007-8#2)
the lesions in##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
the lesions is##2##3##(1991-2#1)(2012-3#1)
the lesions of##2##3##(1997-8#2)
the lesions was##3##3##(1993-2#1)(1995-4#1)(2013-1#1)
the lesions were located##2##4##(1991-8#1)(2007-2#1)
the lesions were##11##3##(1991-8#1)(1995-4#2)(1997-6#1)(2007-2#2)(2007-8#1)(2008-5#2)(2010-6#1)(2013-1#1)
the lesions##57##2##(1990-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-4#3)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
the less aggressive##2##3##(2008-10#2)
the less common##3##3##(1995-12#1)(2008-10#1)(2013-8#1)
the less frequent causes##2##4##(1993-6#1)(2012-2#1)
the less polar##2##3##(1990-2#1)(2012-2#1)
the less stable##4##3##(1997-7#1)(2008-10#1)(2008-4#1)(2009-9#1)
the less toxic##2##3##(1997-4#1)(2007-11#1)
the less##48##2##(1990-2#1)(1990-5#1)(1991-1#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
the lesser##5##2##(1995-6#1)(1997-5#1)(2012-2#2)(2013-1#1)
the lessons learned and##2##4##(1995-12#1)(2009-10#1)
the lessons learned by##2##4##(1994-1#1)(2012-3#1)
the lessons learned from this unsuccessful venture##2##7##(1994-3#2)
the lessons learned from##3##4##(1994-3#2)(2013-1#1)
the lessons learned##10##3##(1993-3#1)(1994-1#1)(1994-3#2)(1995-12#2)(2007-11#1)(2009-10#1)(2012-3#1)(2013-1#1)
the lessons that have##2##4##(1996-12#1)(2009-6#1)
the lessons##19##2##(1993-3#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#2)(1996-12#1)(2007-11#1)(2007-5#1)(2008-12#2)(2009-10#1)(2009-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the let-60 gene##2##3##(1990-11#2)
the let-60##3##2##(1990-11#3)
the let-7##2##2##(2008-1#1)(2012-12#1)
the lethal and##2##3##(2008-10#1)(2008-7#1)
the lethal milk mouse##2##4##(2008-10#2)
the lethal potency##2##3##(2008-5#2)
the lethal##10##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#2)
the lethality##3##2##(1995-12#1)(2008-10#1)(2008-4#1)
the letter##3##2##(2008-4#1)(2008-5#1)(2010-2#1)
the letters##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
the leucine zipper##5##3##(1992-3#3)(1992-8#1)(1993-12#1)
the leucine##8##2##(1992-3#3)(1992-8#1)(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
the leucite##2##2##(2009-7#2)
the leukemia##4##2##(2007-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
the leukemic##3##2##(2008-11#1)(2008-9#1)(2012-12#1)
the leukotriene D4 receptor##2##4##(1993-6#2)
the level and activity of##2##5##(1996-2#1)(2008-11#1)
the level and the##2##4##(1992-6#1)(1996-2#1)
the level and##9##3##(1990-11#1)(1992-6#1)(1993-12#1)(1996-2#2)(2008-11#3)(2012-1#1)
the level at which the##3##5##(1991-12#1)(2007-11#1)(2007-8#1)
the level at##4##3##(1991-12#1)(1997-2#1)(2007-11#1)(2007-8#1)
the level attained##2##3##(2008-10#1)(2008-11#1)
the level in##2##3##(1993-8#1)(2008-12#1)
the level of CaSR mRNA##2##5##(2008-11#2)
the level of DNA damage##2##5##(1992-3#1)(1996-2#1)
the level of DNA##3##4##(1992-3#1)(1996-2#1)(2008-7#1)
the level of RNA##2##4##(2008-9#1)(2012-3#1)
the level of a single##2##5##(1992-12#1)(2008-4#1)
the level of a##4##4##(1990-8#1)(1992-12#1)(1993-11#1)(2008-4#1)
the level of accuracy##2##4##(1993-5#1)(2008-10#1)
the level of active ingredient within the formulation##2##8##(2008-5#2)
the level of antibodies##2##4##(2011-2#1)(2013-1#1)
the level of both##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
the level of circulating##3##4##(1990-5#1)(2008-1#1)(2011-1#1)
the level of cognitive functioning##2##5##(2010-12#1)(2012-12#1)
the level of cognitive##3##4##(2010-12#1)(2010-3#1)(2012-12#1)
the level of contamination##3##4##(2008-1#1)(2008-10#2)
the level of control##5##4##(2008-10#1)(2008-11#1)(2009-11#1)(2010-5#1)(2012-2#1)
the level of depression##2##4##(1990-3#1)(2013-1#1)
the level of discrimination##2##4##(1992-10#2)
the level of disease##2##4##(2008-10#2)
the level of drug resistance##2##5##(1992-2#2)
the level of education##2##4##(2007-8#1)(2013-1#1)
the level of effort allocated to current reproduction should##2##9##(2008-8#2)
the level of effort##3##4##(1995-1#1)(2008-8#2)
the level of expression of the##5##6##(1993-9#1)(2008-10#1)(2008-11#2)(2011-1#1)
the level of expression of##6##5##(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2011-1#1)
the level of expression##10##4##(1992-10#1)(1993-9#1)(1995-2#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)
the level of gene expression##4##5##(1997-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
the level of gene##6##4##(1994-12#1)(1997-4#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
the level of health care##2##5##(1993-3#1)(1996-3#1)
the level of immunological complexes##2##5##(2007-11#2)
the level of increased##2##4##(1992-10#1)(2009-6#1)
the level of inhibition of##2##5##(1990-11#1)(1995-3#1)
the level of knowledge##4##4##(1991-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
the level of large##2##4##(1994-8#1)(2007-8#1)
the level of lipid##3##4##(2008-5#2)(2009-8#1)
the level of mRNA##5##4##(1990-12#1)(1992-3#1)(1993-9#1)(1995-12#1)(2011-1#1)
the level of noise##2##4##(2008-9#2)
the level of occupational therapists' knowledge about patients' rights##3##9##(2013-8#3)
the level of pain##2##4##(2007-11#1)(2007-8#1)
the level of physical activity##3##5##(2012-12#2)(2013-1#1)
the level of physical##4##4##(2011-1#1)(2012-12#2)(2013-1#1)
the level of plasma vWF##2##5##(2007-10#2)
the level of plasma##3##4##(2007-10#3)
the level of protection##2##4##(2008-10#2)
the level of protein tyrosine phosphorylation##2##6##(2012-3#2)
the level of resistance to##2##5##(2008-10#2)
the level of resistance##4##4##(2008-10#4)
the level of serum##3##4##(1991-6#1)(1994-7#2)
the level of social##2##4##(1997-6#1)(2013-1#1)
the level of the individual##2##5##(1994-2#1)(2009-12#1)
the level of the##50##4##(1990-3#1)(1990-7#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-1#1)(2009-12#2)(2010-7#1)(2010-9#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
the level of their##2##4##(2007-6#1)(2008-10#1)
the level of thermal hyperalgesia##2##5##(1995-12#2)
the level of thyroid cartilage##2##5##(2010-12#1)(2012-12#1)
the level of transcription of##2##5##(1996-2#1)(1997-7#1)
the level of transcription##9##4##(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2012-12#1)
the level of understanding was##2##5##(2008-7#2)
the level of zinc##2##4##(2008-10#1)(2008-5#1)
the level of##472##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#5)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#6)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#7)(1996-1#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(2006-6#1)(2007-10#5)(2007-11#5)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#6)(2008-10#66)(2008-11#22)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#18)(2008-8#19)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#8)(2011-2#15)(2012-1#1)(2012-12#9)(2012-2#8)(2012-3#9)(2013-1#19)(2013-8#7)
the level required for##2##4##(1990-8#1)(2008-8#1)
the level set##2##3##(2008-6#1)(2008-9#1)
the level was##3##3##(1992-9#1)(2008-11#1)(2010-3#1)
the level##516##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#5)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#5)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#4)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#6)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#7)(1996-1#2)(1996-12#4)(1996-2#7)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#4)(2006-6#1)(2007-10#5)(2007-11#6)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#9)(2008-1#6)(2008-10#71)(2008-11#28)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#18)(2008-8#20)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#8)(2011-2#16)(2012-1#2)(2012-12#9)(2012-2#8)(2012-3#9)(2013-1#19)(2013-8#7)
the level-set##4##2##(2008-6#3)(2010-2#1)
the levels and##3##3##(1991-2#1)(2008-5#1)(2013-8#1)
the levels attained##2##3##(1992-2#1)(1993-6#1)
the levels decreased##2##3##(1997-6#1)(2008-10#1)
the levels in the##3##4##(2008-10#1)(2009-12#1)(2011-1#1)
the levels in##5##3##(1990-2#1)(2008-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
the levels observed##2##3##(2008-10#1)(2011-2#1)
the levels of GST##2##4##(1997-7#2)
the levels of LH beta mRNA##2##6##(1997-2#2)
the levels of both##2##4##(1992-3#1)(1994-3#1)
the levels of free and##2##5##(1990-7#1)(2008-10#1)
the levels of gene##2##4##(2008-10#1)(2008-9#1)
the levels of glucose##2##4##(2008-12#2)
the levels of mRNA##2##4##(1993-5#1)(2009-12#1)
the levels of serum##2##4##(1994-12#1)(2009-12#1)
the levels of the antioxidant enzymes##2##6##(2013-8#2)
the levels of the##16##4##(1990-12#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#2)(2013-8#2)
the levels of these##2##4##(1994-12#1)(2008-10#1)
the levels of urinary##4##4##(1996-12#1)(2008-10#2)(2009-6#1)
the levels of##178##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-4#1)(1991-5#3)(1992-11#2)(1992-12#4)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#5)(2008-10#27)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#3)(2009-6#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#6)
the levels were##5##3##(1993-3#1)(2007-7#2)(2008-10#1)(2008-12#1)
the levels##207##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#5)(2008-10#33)(2008-11#9)(2008-12#5)(2008-3#3)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#4)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#3)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#7)
the lexical system##2##3##(1991-2#2)
the lexical##3##2##(1991-2#2)(2009-11#1)
the lexicon##2##2##(2008-6#1)(2012-12#1)
the liability##3##2##(1991-12#1)(1993-12#1)(1994-2#1)
the liaison##3##2##(1991-6#1)(1997-2#1)(2008-11#1)
the liberated##2##2##(2008-10#1)(2013-1#1)
the liberation of##6##3##(1995-11#1)(1995-6#1)(1997-7#1)(2008-10#2)(2010-7#1)
the librarian##7##2##(1991-3#2)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)
the librarian's role##3##3##(1991-3#2)(1992-1#1)
the librarian's##6##2##(1991-3#5)(1992-1#1)
the librarians##2##2##(1992-12#2)
the libraries##4##2##(1991-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
the library to##2##3##(1996-3#2)
the library##16##2##(1990-4#1)(1993-1#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#3)(1996-3#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2013-1#1)
the library's##2##2##(1995-3#1)(1996-12#1)
the lichen Ramalina##3##3##(2008-10#1)(2008-11#2)
the lichen##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
the lichens##3##2##(2008-10#3)
the lidar beam##3##3##(2008-3#3)
the lidar data##3##3##(2008-3#3)
the lidar equation##2##3##(2008-2#2)
the lidar measurements##3##3##(2008-2#3)
the lidar receiver##3##3##(2008-2#2)(2008-3#1)
the lidar return signal##3##4##(2008-2#2)(2008-3#1)
the lidar return##6##3##(2008-2#2)(2008-3#4)
the lidar signal power##2##4##(2008-3#2)
the lidar signal##4##3##(2008-2#2)(2008-3#2)
the lidar signals##3##3##(2008-3#3)
the lidar system##2##3##(2008-3#2)
the lidar##62##2##(2007-11#2)(2008-2#21)(2008-3#39)
the life and##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#1)
the life course##6##3##(2009-10#2)(2011-1#1)(2012-12#2)(2013-1#1)
the life cycle of the##3##5##(2008-10#1)(2008-2#1)(2009-3#1)
the life cycle of##9##4##(1994-11#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)
the life cycle##17##3##(1994-11#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-1#1)
the life cycles of##3##4##(2008-10#2)(2012-2#1)
the life cycles##4##3##(2008-10#3)(2012-2#1)
the life expectancy##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)
the life histories of##2##4##(2008-8#1)(2009-6#1)
the life history of the##4##5##(1995-6#1)(2008-11#2)(2008-8#1)
the life history of##6##4##(1995-6#1)(2008-11#2)(2008-8#1)(2009-10#1)(2013-7#1)
the life history##9##3##(1995-6#1)(2008-11#2)(2008-8#2)(2009-10#1)(2009-12#1)(2012-2#1)(2013-7#1)
the life insurance industry##2##4##(1995-1#1)(1995-12#1)
the life insurance##3##3##(1995-1#2)(1995-12#1)
the life of the##5##4##(1995-6#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
the life of##15##3##(1995-5#1)(1995-6#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
the life sciences##3##3##(2008-7#1)(2008-9#1)(2010-7#1)
the life span of High Fivetrade mark cells##2##8##(2008-7#2)
the life span of rats bearing##2##6##(1993-8#2)
the life span of the##3##5##(1991-12#1)(2008-10#1)(2008-7#1)
the life span of##11##4##(1991-12#1)(1992-5#1)(1993-8#2)(2008-10#1)(2008-7#4)(2010-4#1)(2012-2#1)
the life span##17##3##(1991-12#1)(1992-5#1)(1993-8#2)(1994-5#2)(1994-6#1)(2008-10#2)(2008-7#4)(2010-4#1)(2012-2#1)(2012-3#1)(2013-7#1)
the life style##3##3##(1992-11#1)(2008-11#1)(2008-7#1)
the life world##2##3##(2010-10#2)
the life##103##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
the life-course##2##2##(2008-12#1)(2012-3#1)
the life-history traits of the##2##5##(2008-11#1)(2008-8#1)
the life-history traits of##3##4##(2008-11#1)(2008-8#1)(2010-3#1)
the life-history traits##4##3##(2008-11#1)(2008-8#2)(2010-3#1)
the life-history##6##2##(2008-11#1)(2008-8#4)(2010-3#1)
the lifecycle of a##2##4##(2008-10#1)(2010-5#1)
the lifecycle##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
the lifespan##5##2##(2008-7#1)(2008-9#2)(2009-5#1)(2010-7#1)
the lifestyle of##2##3##(1990-9#1)(2007-4#1)
the lifestyle##3##2##(1990-9#1)(2007-4#1)(2009-9#1)
the lifetime accumulated cadmium intake from food##2##7##(1992-12#2)
the lifetime is##2##3##(2008-10#2)
the lifetime of the graphite tube##2##6##(2008-10#2)
the lifetime of the##9##4##(2008-10#4)(2008-7#1)(2009-6#1)(2010-2#2)(2013-8#1)
the lifetime of##16##3##(1992-5#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-2#2)(2013-8#1)
the lifetime prevalence##2##3##(2011-1#1)(2012-12#1)
the lifetime##37##2##(1992-12#2)(1992-5#1)(1992-6#1)(1994-5#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#11)(2008-3#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
the ligament fibers##2##3##(2009-7#2)
the ligament##8##2##(2007-8#1)(2008-6#1)(2009-7#3)(2012-1#1)(2013-1#2)
the ligand and##4##3##(1995-5#1)(2008-10#1)(2008-4#2)
the ligand binding##3##3##(1991-12#1)(1992-9#1)(1996-5#1)
the ligand concentration##3##3##(1997-2#1)(2008-10#2)
the ligand field##2##3##(1997-7#2)
the ligand has been##2##4##(2008-10#2)
the ligand in##2##3##(1990-11#1)(2008-10#1)
the ligand is##7##3##(2008-10#2)(2008-4#4)(2008-7#1)
the ligand structure##2##3##(1993-11#1)(2008-10#1)
the ligand to##2##3##(1990-12#1)(2008-10#1)
the ligand was##3##3##(1993-11#1)(1993-8#1)(2008-10#1)
the ligand with##2##3##(1995-2#1)(2008-8#1)
the ligand##67##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-8#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#6)(1997-4#1)(1997-7#4)(2007-11#1)(2008-10#26)(2008-4#6)(2008-7#1)(2008-8#2)(2010-12#1)
the ligand(s)##2##2##(1994-6#1)(1994-8#1)
the ligand-binding domain of the##3##5##(1991-12#2)(1992-9#1)
the ligand-binding domain of##4##4##(1991-12#2)(1992-9#1)(2008-8#1)
the ligand-binding domain##7##3##(1991-12#2)(1992-9#1)(2008-4#1)(2008-8#3)
the ligand-binding##11##2##(1991-12#2)(1992-9#1)(1993-11#1)(1995-11#1)(1995-2#1)(2008-4#2)(2008-8#3)
the ligand-embedded silica##2##3##(2008-10#2)
the liganded active site##2##4##(1992-6#2)
the liganded##6##2##(1992-6#4)(1992-8#2)
the ligands and the##3##4##(2008-10#2)(2008-5#1)
the ligands and##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
the ligands of##3##3##(1995-2#1)(2008-3#1)(2008-4#1)
the ligands##16##2##(1990-8#1)(1993-11#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2009-7#1)
the ligase-AMP##2##2##(1993-3#2)
the ligation of##5##3##(1990-7#1)(1993-3#1)(2008-2#1)(2008-4#1)(2011-3#1)
the ligation##8##2##(1990-7#1)(1990-8#1)(1993-3#1)(1994-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-3#1)
the light absorption coefficient##2##4##(2008-3#2)
the light absorption##3##3##(2008-3#3)
the light and dark##2##4##(2008-10#1)(2013-7#1)
the light and electron microscope##2##5##(1995-12#1)(2008-7#1)
the light and electron##4##4##(1995-12#1)(2008-4#1)(2008-7#2)
the light and transmission electron##2##5##(2008-7#2)
the light and##11##3##(1995-12#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#4)(2009-8#1)(2013-7#1)
the light beam is##3##4##(2008-2#1)(2008-3#2)
the light beam##5##3##(2008-2#3)(2008-3#2)
the light chain of##3##4##(1993-11#2)(1994-5#1)
the light chain##7##3##(1990-11#2)(1993-11#2)(1994-11#2)(1994-5#1)
the light chains are##2##4##(1993-9#2)
the light distribution##2##3##(2008-3#2)
the light emission##4##3##(1990-8#1)(2008-10#3)
the light field##6##3##(2008-3#6)
the light fluence rate##2##4##(2011-1#2)
the light fluence##3##3##(1992-6#1)(2011-1#2)
the light from a##2##4##(2007-11#1)(2008-3#1)
the light from##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
the light in##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
the light incident##3##3##(2008-2#1)(2008-3#2)
the light intensities and##2##4##(2008-2#1)(2008-3#1)
the light intensities##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
the light intensity##3##3##(2007-12#2)(2008-3#1)
the light of current##2##4##(1995-6#1)(2008-7#1)
the light of the##27##4##(1990-3#2)(1990-8#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2012-2#2)
the light of these##4##4##(1990-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
the light of##78##3##(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-6#2)(1992-12#1)(1993-11#1)(1993-3#3)(1993-9#1)(1994-1#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#2)(1997-4#1)(1997-7#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#7)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#3)(2012-3#4)
the light output##2##3##(2008-2#1)(2008-3#1)
the light period##4##3##(1994-8#1)(1995-11#1)(1997-2#2)
the light phase##2##3##(1993-12#1)(2010-8#1)
the light propagating##2##3##(2007-11#1)(2010-5#1)
the light pulses##2##3##(2008-5#2)
the light reflected from a##2##5##(2007-12#1)(2008-3#1)
the light reflected##3##3##(2007-12#1)(2008-3#2)
the light scattered by the##3##5##(2007-12#1)(2008-3#2)
the light scattered by##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
the light scattered##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
the light scattering intensity##3##4##(2008-10#2)(2008-3#1)
the light scattering##6##3##(2008-10#5)(2008-3#1)
the light source and##4##4##(2007-11#1)(2008-10#3)
the light source are##3##4##(2008-2#1)(2008-3#2)
the light source in##2##4##(2008-3#2)
the light source is##2##4##(2007-11#1)(2007-12#1)
the light source##36##3##(1993-3#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#5)(2008-3#16)(2008-5#1)(2010-5#1)
the light that##2##3##(2008-3#2)
the light transduction##2##3##(1992-3#1)(1992-8#1)
the light transmitted##2##3##(2008-2#1)(2008-3#1)
the light used##3##3##(2007-12#1)(2008-3#1)(2009-5#1)
the light utilization efficiency of##2##5##(2013-8#2)
the light wave##2##3##(2008-2#1)(2008-3#1)
the light##278##2##(1990-11#2)(1990-12#1)(1990-3#3)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#4)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#10)(2007-12#15)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#35)(2008-11#9)(2008-12#1)(2008-2#27)(2008-3#63)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-5#1)(2009-6#4)(2009-8#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-2#5)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#2)
the light-dark##2##2##(1991-9#1)(2008-11#1)
the light-harvesting chlorophyll##2##3##(1995-2#1)(2008-4#1)
the light-harvesting##4##2##(1995-2#1)(2008-10#1)(2008-4#1)(2012-6#1)
the light-scattering data##2##3##(2008-3#2)
the light-scattering properties of##3##4##(2007-11#2)(2008-3#1)
the light-scattering##11##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)
the light-wave##2##2##(2008-2#1)(2008-3#1)
the light/dark transition test##2##4##(2008-8#2)
the light/dark##3##2##(1995-6#1)(2008-8#2)
the lighter##2##2##(2008-10#1)(2008-12#1)
the likelihood for##3##3##(2007-12#2)(2008-8#1)
the likelihood function##2##3##(2008-12#1)(2012-1#1)
the likelihood of a re-infarction##2##5##(2009-6#2)
the likelihood of a##4##4##(2009-5#1)(2009-6#2)(2011-2#1)
the likelihood of an##2##4##(2009-6#1)(2009-8#1)
the likelihood of being##2##4##(2010-10#1)(2011-2#1)
the likelihood of detecting##2##4##(2008-8#1)(2009-8#1)
the likelihood of having##3##4##(1992-2#1)(2010-10#1)(2010-12#1)
the likelihood of their##2##4##(1995-12#1)(2008-9#1)
the likelihood of these##2##4##(2008-8#1)(2010-10#1)
the likelihood of##61##3##(1991-12#1)(1992-12#2)(1992-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1997-3#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-2#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-10#3)(2010-12#2)(2010-3#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the likelihood ratio##6##3##(1996-12#1)(1996-4#1)(2008-10#3)(2008-3#1)
the likelihood that##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-2#1)
the likelihood##86##2##(1991-12#1)(1992-12#2)(1992-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-4#2)(1997-3#3)(2007-12#2)(2007-4#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-7#4)(2008-8#9)(2008-9#3)(2009-2#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-10#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the likelihood-generating function##2##3##(2008-3#2)
the likely cause of##2##4##(1991-12#1)(2008-10#1)
the likely impact of##2##4##(1992-12#1)(1996-2#1)
the likely##19##2##(1991-12#1)(1992-12#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
the limb bud##6##3##(1992-8#1)(1993-12#2)(1995-8#3)
the limb was##3##3##(1994-3#1)(2007-8#1)(2011-3#1)
the limb##30##2##(1990-6#2)(1991-3#1)(1992-8#2)(1993-12#3)(1994-3#2)(1995-8#6)(2007-11#2)(2007-7#1)(2007-8#4)(2008-6#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#2)
the limbic system##6##3##(1992-12#4)(1997-2#1)(2008-6#1)
the limbic##10##2##(1992-12#4)(1996-12#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-6#1)(2008-7#1)
the limbus##3##2##(2008-11#2)(2011-1#1)
the limit of detection (LOD)##2##5##(2008-10#2)
the limit of detection and##2##5##(2008-10#2)
the limit of detection for##3##5##(2008-10#3)
the limit of detection is 0##4##6##(2008-10#4)
the limit of detection is##7##5##(2008-10#5)(2011-1#1)(2013-1#1)
the limit of detection of##4##5##(2008-10#2)(2009-6#1)(2011-2#1)
the limit of detection was 0##3##6##(2008-10#3)
the limit of detection was##9##5##(2008-10#9)
the limit of detection##43##4##(2008-10#37)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)
the limit of determination##2##4##(2008-10#2)
the limit of quantification was##2##5##(2008-10#1)(2008-5#1)
the limit of quantification##11##4##(2008-10#8)(2008-5#3)
the limit of the##3##4##(2007-11#2)(2013-8#1)
the limit of##72##3##(1995-3#1)(2007-11#3)(2007-12#2)(2008-10#50)(2008-2#2)(2008-3#1)(2008-5#3)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
the limit##79##2##(1995-3#1)(2007-11#3)(2007-12#2)(2008-10#50)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#3)
the limitation of the##5##4##(1991-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
the limitation of using##2##4##(2008-10#1)(2011-1#1)
the limitation of##10##3##(1991-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-5#1)(2011-1#1)
the limitation##12##2##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2010-5#1)(2011-1#1)
the limitations and##5##3##(1993-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
the limitations of any##2##4##(2007-11#1)(2012-3#1)
the limitations of existing##2##4##(2008-10#1)(2008-6#1)
the limitations of the##9##4##(1992-3#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2011-2#1)
the limitations of their##2##4##(2008-1#1)(2008-11#1)
the limitations of this study##3##5##(2008-8#1)(2013-1#2)
the limitations of this##5##4##(2008-8#1)(2012-12#1)(2013-1#3)
the limitations of##42##3##(1992-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#3)
the limitations##53##2##(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
the limited amount of##3##4##(1995-2#1)(2009-5#1)(2013-1#1)
the limited availability##2##3##(1994-12#1)(2011-2#1)
the limited data##2##3##(1995-6#1)(2012-12#1)
the limited information##2##3##(1992-11#1)(1994-12#1)
the limited number of studies##2##5##(2008-10#1)(2011-2#1)
the limited number of##7##4##(1996-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
the limited number##8##3##(1996-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
the limited possibility of##2##4##(2008-11#2)
the limited resources##3##3##(1996-2#1)(2007-7#1)(2008-10#1)
the limited##61##2##(1990-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-2#2)(1996-3#1)(1997-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)
the limited-fan-out##2##2##(2008-2#2)
the limiting factor for##2##4##(2008-10#2)
the limiting factor##4##3##(1996-12#1)(2008-10#3)
the limiting step##3##3##(1993-6#1)(1994-11#1)(2008-10#1)
the limiting##24##2##(1990-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#7)(2008-8#1)(2011-2#1)(2013-1#1)
the limits and##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)
the limits of adaptive##2##4##(1996-9#1)(2008-8#1)
the limits of detection (LOD)##3##5##(2008-10#3)
the limits of detection and##3##5##(2008-10#3)
the limits of detection for##2##5##(2008-10#2)
the limits of detection were##6##5##(2008-10#5)(2008-2#1)
the limits of detection##23##4##(2008-10#20)(2008-2#2)(2010-5#1)
the limits of quantification were 0##2##6##(2008-10#2)
the limits of quantification##3##4##(2008-10#2)(2011-1#1)
the limits of the experimental##2##5##(2008-10#1)(2008-3#1)
the limits of the##5##4##(1994-5#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
the limits of##48##3##(1991-6#1)(1993-3#1)(1994-5#1)(1995-5#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#4)(2008-3#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
the limits##56##2##(1991-6#1)(1993-3#1)(1994-5#1)(1995-5#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#6)(2008-3#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
the line and##2##3##(2007-12#1)(2008-2#1)
the line in##2##3##(1991-12#1)(1995-8#1)
the line jitter of##2##4##(2008-3#2)
the line jitter##3##3##(2008-3#3)
the line of sight is##2##5##(2008-2#1)(2008-3#1)
the line of sight of##2##5##(2008-2#1)(2008-3#1)
the line of sight##7##4##(2008-2#3)(2008-3#3)(2008-6#1)
the line of##11##3##(2007-10#1)(2007-11#1)(2008-2#3)(2008-3#5)(2008-6#1)
the line shape of##2##4##(2008-2#2)
the line shape##3##3##(2008-2#3)
the line strength of##2##4##(2008-3#2)
the line strength##5##3##(2008-3#5)
the line was##2##3##(1995-8#1)(2008-10#1)
the line##56##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-9#1)(1995-12#1)(1995-8#2)(1996-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#9)(2008-3#22)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
the line-by-line radiances##2##3##(2008-3#2)
the line-by-line##3##2##(2008-3#3)
the lineage leading to##2##4##(1995-11#1)(2010-4#1)
the lineage##4##2##(1995-11#1)(2007-6#1)(2008-11#1)(2010-4#1)
the lineages##6##2##(1991-9#1)(2008-10#2)(2008-9#1)(2009-2#2)
the linear and the##2##4##(2007-11#1)(2008-2#1)
the linear calibration range##2##4##(2008-10#2)
the linear calibration##4##3##(2008-10#4)
the linear combination of the##3##5##(2007-12#1)(2008-10#1)(2012-12#1)
the linear combination of##4##4##(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
the linear concentration range of##2##5##(2008-10#2)
the linear concentration range##3##4##(2008-10#3)
the linear correlation##2##3##(1997-3#1)(2008-3#1)
the linear determination ranges##2##4##(2008-10#2)
the linear dynamic range of##3##5##(2008-10#3)
the linear dynamic range was##2##5##(2008-10#2)
the linear dynamic range##9##4##(2008-10#9)
the linear dynamic##10##3##(2008-10#10)
the linear electro-optic effect##2##4##(2007-12#1)(2008-2#1)
the linear equation##2##3##(1990-5#1)(2008-10#1)
the linear isotherm approach##2##4##(2008-10#2)
the linear model##3##3##(1992-6#2)(2008-10#1)
the linear no-threshold##2##3##(2013-1#2)
the linear phase##2##3##(2008-2#1)(2008-8#1)
the linear polarization of the##3##5##(2008-2#2)(2008-3#1)
the linear polarization##5##3##(2008-2#4)(2008-3#1)
the linear range for##2##4##(2008-10#2)
the linear range is##4##4##(2008-10#4)
the linear range of the##2##5##(2008-10#2)
the linear range of##6##4##(2008-10#6)
the linear range was from##2##5##(2008-10#2)
the linear range was##6##4##(2008-10#5)(2010-5#1)
the linear range##31##3##(2008-10#30)(2010-5#1)
the linear ranges of the calibration curves were 0##2##9##(2008-10#2)
the linear ranges of##4##4##(2008-10#3)(2011-1#1)
the linear ranges##5##3##(2008-10#4)(2011-1#1)
the linear regression equation##2##4##(2008-10#1)(2008-7#1)
the linear regression methods##2##4##(2008-10#2)
the linear regression##8##3##(2008-10#3)(2008-3#1)(2008-7#1)(2010-5#1)(2013-7#1)(2013-8#1)
the linear relationship between the##5##5##(2008-10#5)
the linear relationship between##8##4##(2008-10#7)(2010-5#1)
the linear relationship##9##3##(2008-10#8)(2010-5#1)
the linear response range##2##4##(2008-10#2)
the linear response##5##3##(2008-10#5)
the linear strain##2##3##(2008-10#2)
the linear transformation##2##3##(2008-3#1)(2008-6#1)
the linear##158##2##(1990-5#1)(1991-5#2)(1992-6#2)(1994-12#3)(1995-9#1)(1997-3#1)(1997-6#1)(2007-11#6)(2007-12#5)(2008-10#85)(2008-11#1)(2008-2#10)(2008-3#16)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2010-1#1)(2010-2#1)(2010-5#3)(2011-1#2)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#1)
the linear-no threshold theory##3##4##(2008-7#3)
the linear-no threshold##4##3##(2008-7#4)
the linearity is maintained in the concentration##4##7##(2008-10#4)
the linearity of the##3##4##(2008-10#2)(2008-3#1)
the linearity of##4##3##(2008-10#3)(2008-3#1)
the linearity range is##2##4##(2008-10#2)
the linearity range##5##3##(2008-10#4)(2011-1#1)
the linearity was##2##3##(2008-10#2)
the linearity##19##2##(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
the linearization##2##2##(2008-2#1)(2008-3#1)
the linearly##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)
the lined seahorse##2##3##(2012-12#2)
the lines homozygous for the##2##5##(2008-10#2)
the lines of the##4##4##(2008-2#1)(2008-3#3)
the lines of##7##3##(2008-2#1)(2008-3#5)(2012-3#1)
the lines##18##2##(2008-10#5)(2008-2#2)(2008-3#8)(2008-8#1)(2008-9#1)(2012-3#1)
the linewidth of a##3##4##(2008-2#3)
the linewidth of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the linewidth of##7##3##(2007-12#1)(2008-2#5)(2008-3#1)
the linewidth##13##2##(2007-12#3)(2008-2#6)(2008-3#4)
the lingual##2##2##(2010-3#1)(2012-2#1)
the linguistic and##3##3##(2010-5#2)(2013-8#1)
the linguistic##6##2##(2010-5#4)(2012-1#1)(2013-8#1)
the lining of##2##3##(2008-10#1)(2010-9#1)
the link between maternal##2##4##(2009-7#1)(2012-2#1)
the link between the##6##4##(1990-11#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-6#1)
the link between these##2##4##(2008-10#1)(2012-2#1)
the link between##31##3##(1990-11#1)(1993-9#1)(1994-5#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-6#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
the link of##2##3##(2012-2#2)
the link to##2##3##(2008-10#1)(2009-4#1)
the link with##2##3##(1990-3#1)(2008-10#1)
the link##45##2##(1990-11#1)(1990-3#1)(1991-3#1)(1993-9#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-3#2)(2008-4#1)(2008-6#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#2)
the linkage between the##2##4##(1990-8#1)(1993-12#1)
the linkage between##6##3##(1990-8#1)(1993-12#1)(1994-12#1)(2008-8#1)(2010-11#1)(2011-1#1)
the linkage disequilibrium##2##3##(2012-3#2)
the linkage of##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
the linkage relationships between##2##4##(1995-8#1)(2008-10#1)
the linkage##28##2##(1990-5#1)(1990-8#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-12#4)(1996-6#2)(1997-5#1)(2008-10#3)(2008-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#4)
the linkages between##3##3##(1994-1#1)(1997-2#1)(2008-10#1)
the linked##3##2##(1994-6#1)(2008-10#1)(2008-8#1)
the linker##3##2##(1992-6#1)(2009-6#1)(2010-5#1)
the linking of##2##3##(2008-10#1)(2008-6#1)
the linking##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
the links between##9##3##(1992-12#2)(1992-4#1)(2008-11#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#1)
the links##12##2##(1992-12#2)(1992-4#1)(2008-11#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
the lipase activity##2##3##(2008-10#2)
the lipase##7##2##(1994-3#1)(1995-5#1)(2008-10#2)(2008-7#1)(2009-8#1)(2012-2#1)
the lipid A##2##3##(1990-5#1)(2011-2#1)
the lipid and##3##3##(2008-3#1)(2009-7#1)(2009-8#1)
the lipid bilayer##13##3##(1990-11#3)(1990-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)
the lipid bilayers##2##3##(2008-5#1)(2010-5#1)
the lipid classes##2##3##(2008-11#1)(2013-1#1)
the lipid composition##7##3##(1990-7#2)(1994-2#1)(1994-6#1)(1995-5#1)(2008-5#1)(2010-5#1)
the lipid content##2##3##(2013-1#1)(2013-7#1)
the lipid core and##2##4##(1990-2#1)(2010-9#1)
the lipid core##3##3##(1990-2#1)(1994-3#1)(2010-9#1)
the lipid coverage##2##3##(2008-5#2)
the lipid levels##2##3##(1991-4#1)(2011-2#1)
the lipid membrane##7##3##(1990-2#1)(1990-7#1)(1994-5#3)(2008-10#1)(2009-12#1)
the lipid metabolism##5##3##(1990-2#1)(1992-11#1)(1994-3#1)(1995-6#1)(2008-11#1)
the lipid monolayer##2##3##(1994-3#1)(2009-12#1)
the lipid peroxidation of##2##4##(1991-5#1)(2008-5#1)
the lipid peroxidation##7##3##(1991-5#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
the lipid phase##6##3##(1990-2#1)(1991-5#2)(1994-3#1)(1994-5#1)(2012-1#1)
the lipid profile##2##3##(2008-4#1)(2012-2#1)
the lipid surface##2##3##(1994-3#1)(1995-5#1)
the lipid vesicles to##2##4##(2008-11#2)
the lipid##124##2##(1990-11#3)(1990-2#7)(1990-5#3)(1990-7#4)(1991-12#2)(1991-4#2)(1991-5#5)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#6)(1994-6#1)(1995-3#1)(1995-5#4)(1995-6#1)(1996-2#2)(1996-3#1)(2007-12#1)(2008-10#9)(2008-11#6)(2008-3#2)(2008-4#2)(2008-5#11)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#4)(2010-12#1)(2010-5#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#3)(2013-7#1)
the lipidic##2##2##(1994-3#1)(2007-8#1)
the lipidized membranes##2##3##(1995-2#2)
the lipids##11##2##(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-5#3)(2008-9#1)(2012-12#1)(2013-1#1)
the lipolytic response##2##3##(1994-6#2)
the lipolytic##4##2##(1991-12#1)(1994-6#2)(2012-1#1)
the lipophilic cationic##2##3##(1993-11#1)(2008-10#1)
the lipophilic##21##2##(1990-11#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-11#1)(2008-10#8)(2008-12#1)(2008-5#5)(2009-2#1)
the lipopolysaccharide##4##2##(1992-12#1)(1995-12#1)(2008-10#1)(2011-2#1)
the lipoprotein##8##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
the lipoproteins##5##2##(1992-3#1)(1995-5#1)(1995-8#1)(2008-4#1)(2008-5#1)
the liposomal membrane##2##3##(1990-12#1)(1990-2#1)
the liposomal surface##3##3##(2008-10#3)
the liposomal vaccine than##3##4##(2007-11#3)
the liposomal vaccine##4##3##(2007-11#4)
the liposomal##10##2##(1990-12#1)(1990-2#1)(2007-11#4)(2008-10#4)
the liposome##5##2##(1994-12#1)(1994-5#1)(1994-9#1)(2008-10#2)
the liposomes but##2##3##(1994-11#1)(2010-5#1)
the liposomes##13##2##(1990-2#1)(1991-5#1)(1994-11#1)(1994-3#2)(1995-2#1)(2008-5#2)(2008-8#2)(2010-5#3)
the liquid chromatography##3##3##(2008-10#3)
the liquid crystalline phase##2##4##(1992-9#2)
the liquid crystalline##4##3##(1992-9#2)(2007-12#1)(2008-7#1)
the liquid junction potential##2##4##(2008-10#2)
the liquid junction##3##3##(2008-10#3)
the liquid membrane and the##2##5##(2008-10#2)
the liquid membrane##4##3##(2008-10#4)
the liquid phase using##3##4##(2008-10#2)(2008-4#1)
the liquid phase was##2##4##(2008-10#2)
the liquid phase##7##3##(2007-12#1)(2008-10#4)(2008-4#1)(2013-1#1)
the liquid propanol##2##3##(2008-3#2)
the liquid sample is##2##4##(2008-10#1)(2008-2#1)
the liquid sample##9##3##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)
the liquid soap and##2##4##(2008-10#2)
the liquid stream##2##3##(2008-10#1)(2008-6#1)
the liquid surface##2##3##(2008-2#1)(2008-3#1)
the liquid##79##2##(1990-12#1)(1992-5#2)(1992-6#2)(1992-9#2)(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#6)(2008-10#34)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the liquid-air interface of##2##4##(2008-10#2)
the liquid-core##2##2##(2008-10#2)
the liquid-crystal cell##2##3##(2007-11#1)(2007-12#1)
the liquid-crystal layer##2##3##(2007-11#1)(2008-3#1)
the liquid-crystal molecules##2##3##(2007-11#1)(2008-3#1)
the liquid-crystal##8##2##(2007-11#4)(2007-12#1)(2008-3#3)
the liquid-gas##2##2##(2008-10#1)(2008-3#1)
the liquid-liquid extraction of##3##4##(2008-10#3)
the liquid-liquid extraction##6##3##(2008-10#6)
the liquid-liquid##8##2##(2008-10#8)
the liquid-phase##2##2##(2008-10#1)(2008-2#1)
the liquid-solid##2##2##(2008-3#1)(2009-8#1)
the liquid/liquid##2##2##(2008-10#2)
the list of##19##3##(1991-9#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-3#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
the list##24##2##(1991-11#3)(1991-9#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
the list-length and strength-based mirror effects##2##6##(2008-6#2)
the listed##2##2##(2008-10#1)(2008-5#1)
the literal##2##2##(2008-11#1)(2008-2#1)
the literature about##5##3##(1990-8#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-8#1)
the literature and our##2##4##(2008-2#1)(2009-5#1)
the literature and own experience##2##5##(2007-11#2)
the literature and the authors'##2##5##(1990-10#1)(2007-11#1)
the literature and the##5##4##(1990-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)
the literature and##50##3##(1990-10#1)(1990-3#1)(1991-1#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-3#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
the literature are##9##3##(1992-12#1)(1994-6#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)
the literature as a##4##4##(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#1)
the literature as well as##4##5##(1996-12#1)(2007-2#1)(2008-1#1)(2008-3#1)
the literature as##13##3##(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
the literature available##2##3##(2008-10#1)(2008-11#1)
the literature before##2##3##(2010-12#1)(2012-12#1)
the literature but##2##3##(2008-2#1)(2011-2#1)
the literature concerning the##4##4##(1990-12#1)(1996-9#1)(2010-9#1)(2011-2#1)
the literature concerning##8##3##(1990-12#1)(1996-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)
the literature demonstrating##2##3##(1997-3#1)(2012-3#1)
the literature describing##3##3##(1997-6#1)(2008-3#1)(2009-10#1)
the literature for each##2##4##(2008-10#1)(2008-3#1)
the literature for the##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
the literature for##13##3##(1991-3#2)(1992-12#1)(1992-9#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
the literature from##6##3##(1996-2#1)(2008-10#3)(2008-7#1)(2008-8#1)
the literature has##4##3##(2008-11#1)(2008-7#1)(2009-9#1)(2010-8#1)
the literature in##11##3##(1991-3#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#2)
the literature is given##3##4##(1991-3#1)(1996-9#1)(2008-3#1)
the literature is##17##3##(1990-3#1)(1991-3#1)(1995-9#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)
the literature of the##4##4##(2008-6#1)(2008-7#2)(2009-8#1)
the literature of##14##3##(1993-12#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-1#1)(2012-3#2)
the literature on health##2##4##(1993-6#1)(2011-2#1)
the literature on spinal##2##4##(2009-3#1)(2011-2#1)
the literature on the effects of##3##6##(1992-12#1)(1993-11#1)(2008-7#1)
the literature on the effects##4##5##(1992-12#1)(1993-11#1)(1996-3#1)(2008-7#1)
the literature on the treatment of##2##6##(1992-1#1)(2011-2#1)
the literature on the use of##2##6##(2013-1#2)
the literature on the##27##4##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-1#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
the literature on this subject##2##5##(1994-9#1)(2008-5#1)
the literature on this topic##2##5##(1993-6#1)(2008-11#1)
the literature on this##6##4##(1990-2#1)(1993-6#1)(1994-9#1)(2008-11#1)(2008-5#1)(2010-8#1)
the literature on##67##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-6#2)(1994-1#1)(1994-9#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#1)
the literature over##2##3##(2009-3#1)(2012-12#1)
the literature provides##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
the literature published from##2##4##(2008-12#1)(2009-8#1)
the literature published##5##3##(2007-11#1)(2008-12#1)(2009-8#1)(2010-8#1)(2012-3#1)
the literature regarding##8##3##(2008-5#1)(2009-3#1)(2012-2#4)(2013-1#1)(2013-8#1)
the literature relating to##3##4##(1997-7#1)(2007-8#1)(2010-12#1)
the literature review##6##3##(2007-10#1)(2007-11#1)(2008-11#3)(2012-2#1)
the literature reviewed##3##3##(1993-2#1)(2008-7#1)(2012-1#1)
the literature shows that##7##4##(1990-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
the literature shows##9##3##(1990-6#1)(1990-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-3#1)
the literature since##2##3##(2008-10#1)(2013-8#1)
the literature suggest##2##3##(1990-6#1)(2009-2#1)
the literature suggests that##4##4##(2008-11#2)(2009-3#1)(2013-1#1)
the literature suggests##5##3##(1992-2#1)(2008-11#2)(2009-3#1)(2013-1#1)
the literature surrounding##2##3##(2008-6#1)(2011-2#1)
the literature that##6##3##(2008-11#1)(2008-3#1)(2010-1#1)(2010-3#1)(2012-2#2)
the literature through##3##3##(1994-2#1)(2010-9#1)(2012-3#1)
the literature to##9##3##(2006-10#1)(2007-4#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
the literature values reported##2##4##(2008-10#1)(2012-12#1)
the literature values##4##3##(2008-10#3)(2012-12#1)
the literature was##8##3##(1995-5#1)(2007-2#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
the literature with##7##3##(1992-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2009-3#1)(2010-10#1)(2013-1#1)
the literature##762##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#5)(1990-5#1)(1990-6#5)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#5)(1991-5#1)(1991-6#3)(1992-1#2)(1992-12#7)(1992-2#2)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#5)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#3)(2006-12#2)(2006-5#1)(2007-10#5)(2007-11#16)(2007-12#5)(2007-2#8)(2007-4#2)(2007-5#6)(2007-6#1)(2007-7#3)(2007-8#15)(2008-1#8)(2008-10#65)(2008-11#43)(2008-12#16)(2008-2#15)(2008-3#27)(2008-4#7)(2008-5#17)(2008-6#18)(2008-7#36)(2008-8#14)(2008-9#18)(2009-1#2)(2009-10#4)(2009-11#2)(2009-2#1)(2009-3#10)(2009-4#2)(2009-5#9)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#4)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#5)(2010-3#12)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#9)(2011-2#40)(2011-3#2)(2012-1#5)(2012-12#11)(2012-2#30)(2012-3#17)(2013-1#49)(2013-7#2)(2013-8#8)
the lithium ions##2##3##(2008-10#2)
the lithium##13##2##(1992-2#2)(1997-7#1)(2008-10#8)(2008-2#2)
the lithography##2##2##(2008-10#1)(2008-2#1)
the litigation process##2##3##(1992-2#2)
the litter##4##2##(1994-8#1)(2008-11#1)(2010-3#1)(2011-2#1)
the little finger##4##3##(2008-9#4)
the little##7##2##(2008-10#2)(2008-9#4)(2010-8#1)
the littoral##5##2##(2008-5#2)(2011-2#1)(2013-7#2)
the live##7##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
the lived experience of##5##4##(2008-11#2)(2009-5#2)(2013-1#1)
the lived experience##6##3##(2008-11#3)(2009-5#2)(2013-1#1)
the lived##7##2##(2008-11#4)(2009-5#2)(2013-1#1)
the liver and in the##2##5##(1990-11#1)(2009-8#1)
the liver and in##3##4##(1990-11#1)(2009-8#1)(2011-2#1)
the liver and small intestine##3##5##(1992-11#3)
the liver and the lung##2##5##(1994-7#2)
the liver and the##6##4##(1990-12#1)(1993-9#1)(1994-7#2)(1995-3#1)(1995-9#1)
the liver and##39##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-11#3)(1992-3#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-7#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-4#2)(1997-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
the liver are##3##3##(1990-11#1)(1994-9#1)(2010-12#1)
the liver as##3##3##(2008-8#1)(2010-5#1)(2010-8#1)
the liver by##5##3##(1995-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
the liver cells##2##3##(1990-2#1)(2008-11#1)
the liver enzyme was##2##4##(1990-7#1)(1992-3#1)
the liver enzyme##4##3##(1990-7#1)(1991-12#1)(1992-3#1)(2008-8#1)
the liver in##10##3##(1990-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-3#1)(1995-2#1)(1996-5#1)(2008-7#1)(2010-11#1)(2010-5#1)
the liver is a##2##4##(1990-10#1)(2008-1#1)
the liver is##8##3##(1990-10#1)(1991-12#1)(2008-1#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-8#1)
the liver of the female##2##5##(2010-5#2)
the liver of the##4##4##(1992-12#1)(1992-9#1)(2010-5#2)
the liver of##20##3##(1990-12#1)(1990-3#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-6#1)(1995-3#2)(1995-6#1)(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#2)(2013-1#1)
the liver or##2##3##(1994-5#1)(2008-7#1)
the liver parenchyma##2##3##(1996-2#1)(2011-2#1)
the liver that##2##3##(1993-12#1)(2009-8#1)
the liver tissue##2##3##(2008-4#1)(2008-7#1)
the liver to##7##3##(1995-8#1)(2008-11#1)(2008-5#2)(2010-11#1)(2012-2#2)
the liver using##3##3##(2009-12#1)(2010-7#1)(2012-1#1)
the liver was##7##3##(1990-11#1)(1993-3#1)(1993-6#1)(1995-6#1)(2008-6#1)(2011-1#2)
the liver were investigated##2##4##(2008-4#1)(2013-1#1)
the liver were##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
the liver with##6##3##(1991-6#1)(1991-7#1)(1996-12#1)(2009-1#1)(2010-12#1)(2013-1#1)
the liver##290##2##(1990-10#2)(1990-11#16)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#3)(1992-11#6)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#6)(1993-5#2)(1993-6#2)(1993-9#1)(1994-2#1)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#8)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-3#2)(1997-4#4)(1997-7#2)(1997-8#4)(2006-10#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#8)(2009-9#1)(2010-11#5)(2010-12#8)(2010-2#1)(2010-5#8)(2010-7#6)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#11)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#2)
the liver-specific##2##2##(2011-2#2)
the liver]##4##2##(1991-3#1)(1992-5#1)(1993-5#1)(1997-7#1)
the livers of selenium-deficient##2##4##(1992-11#2)
the livers of##4##3##(1992-11#2)(2008-10#2)
the livers##5##2##(1992-11#2)(2008-10#2)(2008-8#1)
the lives of##18##3##(1991-2#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(2007-2#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
the lives##19##2##(1991-2#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(2007-2#2)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
the living donation##2##3##(2011-2#2)
the living donor##3##3##(2011-2#3)
the living embryo##2##3##(2008-11#1)(2008-9#1)
the living organisms##2##3##(2008-10#1)(2013-8#1)
the living##25##2##(2007-11#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#7)(2013-8#2)
the lizard##4##2##(2008-8#1)(2010-3#1)(2011-2#2)
the load applied on the pad##2##6##(2008-5#2)
the load##7##2##(2008-10#1)(2008-5#3)(2009-2#1)(2009-5#1)(2010-6#1)
the loaded##4##2##(2008-10#3)(2009-4#1)
the loading and##2##3##(1990-2#1)(2008-10#1)
the loading of the##2##4##(1990-12#1)(2008-10#1)
the loading of##3##3##(1990-12#1)(1995-11#1)(2008-10#1)
the loading rate##2##3##(2008-7#1)(2009-7#1)
the loading##18##2##(1990-12#1)(1990-2#1)(1991-9#1)(1995-11#1)(2006-10#1)(2007-12#2)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#2)(2013-1#1)
the lobster##2##2##(1990-2#1)(2007-12#1)
the local DIC##4##3##(2011-1#4)
the local and regional##2##4##(1997-3#1)(2008-10#1)
the local and##8##3##(1990-5#1)(1991-6#1)(1997-3#1)(2008-10#1)(2008-12#2)(2010-7#1)(2011-2#1)
the local anesthesia##2##3##(1990-5#1)(1992-6#1)
the local anesthetic##2##3##(1993-1#2)
the local authorities##3##3##(1992-11#1)(1992-5#1)(2008-10#1)
the local circuit##3##3##(1996-12#1)(2008-11#2)
the local community##3##3##(1992-6#1)(2009-6#1)(2013-1#1)
the local control rate##3##4##(2007-11#1)(2008-6#2)
the local control##4##3##(1994-2#1)(2007-11#1)(2008-6#2)
the local economy##2##3##(1994-3#1)(2007-5#1)
the local environment##3##3##(2008-1#1)(2008-8#1)(2012-7#1)
the local environmental health services##2##5##(1996-9#2)
the local ethnic minorities##2##4##(2008-8#2)
the local extinction##4##3##(2008-3#1)(2008-8#3)
the local health##2##3##(1994-12#1)(1996-1#1)
the local level##6##3##(1992-2#1)(1994-2#1)(1996-1#1)(2008-10#2)(2008-12#1)
the local lymph node assay##2##5##(2008-5#2)
the local lymph node##3##4##(2008-3#1)(2008-5#2)
the local mean##2##3##(2008-3#2)
the local optical##3##3##(2007-12#1)(2008-3#2)
the local or##2##3##(1992-2#1)(1995-5#1)
the local population##9##3##(1995-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
the local populations##4##3##(2007-2#1)(2008-10#3)
the local production##2##3##(1993-11#1)(2008-4#1)
the local public health##2##4##(1995-12#1)(1997-3#1)
the local reflectance##2##3##(2008-3#2)
the local rf electric field##2##5##(2013-8#2)
the local scale##2##3##(2008-6#1)(2008-8#1)
the local sex ratio##2##4##(2008-9#2)
the local structure##2##3##(1992-6#1)(2008-9#1)
the local temperature##2##3##(2008-3#2)
the local treatment of##3##4##(2007-11#1)(2010-3#2)
the local treatment##4##3##(2007-11#1)(2010-3#2)(2011-2#1)
the local##219##2##(1990-5#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#5)(1993-1#2)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-12#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#5)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#6)(2008-2#8)(2008-3#32)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#12)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#6)
the local-field factor##2##3##(2007-11#2)
the local-field##3##2##(2007-11#2)(2008-3#1)
the locality##4##2##(2008-9#1)(2010-4#1)(2012-3#2)
the localization and##7##3##(2007-11#1)(2008-1#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
the localization of a##2##4##(2007-12#1)(2008-4#1)
the localization of one protein relative to another##2##8##(2008-4#2)
the localization of one##3##4##(1997-2#1)(2008-4#2)
the localization of the##6##4##(1995-6#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2012-3#1)
the localization of these##2##4##(1993-3#1)(2008-10#1)
the localization of##34##3##(1991-12#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-6#2)(1997-2#3)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-5#1)(2010-7#1)(2012-3#1)
the localization##51##2##(1991-12#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-6#2)(1996-12#1)(1997-2#3)(1997-8#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
the localized##11##2##(1992-5#1)(1993-5#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)
the locally##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
the location and extent of##3##5##(2008-2#1)(2011-2#1)(2012-12#1)
the location and##10##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the location of a##2##4##(1994-3#1)(2008-9#1)
the location of the metastasis##2##5##(1991-6#1)(2007-11#1)
the location of the object##2##5##(1995-2#1)(2008-11#1)
the location of the##35##4##(1990-5#1)(1990-8#1)(1991-6#1)(1992-8#1)(1994-1#1)(1995-2#1)(1995-5#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
the location of##69##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-8#2)(1993-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-8#1)(2008-10#7)(2008-11#6)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#3)
the location where the##2##4##(2007-12#1)(2008-2#1)
the location where##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
the location##100##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-6#2)(1992-8#2)(1993-12#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#6)(2008-2#5)(2008-3#12)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#5)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#4)
the locations and##2##3##(1995-2#1)(2008-10#1)
the locations of five##2##4##(1994-8#1)(1997-8#1)
the locations of the##2##4##(2008-2#2)
the locations of##13##3##(1990-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)
the locations were##3##3##(1990-8#1)(2013-8#2)
the locations##20##2##(1990-8#1)(1990-9#1)(1992-5#1)(1994-5#1)(1994-8#1)(1995-2#2)(1997-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2013-1#1)(2013-8#2)
the loci for##2##3##(1993-11#1)(2008-10#1)
the loci of##2##3##(1995-5#1)(1996-8#1)
the loci##10##2##(1993-11#1)(1995-11#1)(1995-5#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2012-12#1)
the locked##2##2##(2007-12#1)(2008-3#1)
the locomotion##2##2##(1993-12#1)(1993-3#1)
the locomotor activity##4##3##(2008-11#1)(2008-5#3)
the locomotor apparatus##2##3##(2007-11#2)
the locomotor response to##3##4##(1993-6#3)
the locomotor rhythm##3##3##(2008-5#1)(2008-6#2)
the locomotor system##6##3##(1990-6#1)(2007-11#3)(2007-8#2)
the locomotor##25##2##(1990-6#1)(1993-12#1)(1993-3#2)(1993-6#3)(2007-11#6)(2007-8#2)(2008-11#1)(2008-5#5)(2008-6#2)(2011-2#1)(2013-1#1)
the locus coeruleus (LC)##2##4##(1995-12#1)(1996-12#1)
the locus coeruleus##8##3##(1995-12#2)(1996-12#1)(1996-5#1)(2008-7#4)
the locus of the##2##4##(1990-3#1)(2010-8#1)
the locus of##8##3##(1990-3#1)(1991-2#1)(1993-3#1)(2007-12#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
the locus##29##2##(1990-3#1)(1991-2#1)(1993-3#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-10#5)(2008-7#4)(2008-8#2)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the locust##10##2##(1994-2#2)(2007-12#8)
the log of the##2##4##(2008-10#2)
the log of##6##3##(1995-8#1)(2008-10#4)(2008-8#1)
the log##14##2##(1995-3#1)(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)
the log-likelihood##2##2##(2008-10#1)(2008-3#1)
the log-log plots##2##3##(2008-10#2)
the log-log##3##2##(2008-10#2)(2008-2#1)
the log-normal model##2##3##(1997-7#2)
the log-normal##3##2##(1997-7#2)(2008-7#1)
the log-odds##2##2##(1997-6#1)(2008-4#1)
the log-rank test##5##3##(2008-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
the log-transformed##2##2##(2008-10#1)(2009-1#1)
the logarithm of the concentration of##2##6##(2008-10#2)
the logarithm of the##12##4##(1994-12#2)(1996-4#2)(2008-10#7)(2008-3#1)
the logarithm of##24##3##(1994-12#2)(1996-4#2)(2008-10#16)(2008-3#1)(2008-8#1)(2009-7#2)
the logarithm##25##2##(1994-12#2)(1996-4#2)(2007-12#1)(2008-10#16)(2008-3#1)(2008-8#1)(2009-7#2)
the logarithmic##5##2##(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
the loggerhead sea turtle##3##4##(1995-3#3)
the logic of the##2##4##(2008-8#1)(2010-11#1)
the logic of##6##3##(2008-10#1)(2008-8#3)(2009-5#1)(2010-11#1)
the logic##10##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-8#4)(2009-5#1)(2009-7#1)(2010-11#1)
the logical##3##2##(2008-11#1)(2008-7#1)(2009-9#1)
the logistic EuroSCORE##2##3##(2007-8#2)
the logistic model##5##3##(1994-11#1)(2008-10#4)
the logistic regression analysis of SSR prevalence##2##7##(2008-10#2)
the logistic regression##4##3##(2008-10#3)(2013-1#1)
the logistic##18##2##(1991-12#1)(1992-9#1)(1994-11#1)(2007-8#3)(2008-10#9)(2008-7#1)(2008-9#1)(2013-1#1)
the logistics##2##2##(1995-2#1)(1995-5#1)
the lone pair##2##3##(2011-2#2)
the long QT syndrome##2##4##(2013-1#2)
the long QT##3##3##(2006-10#1)(2013-1#2)
the long acting##2##3##(1993-6#1)(2007-7#1)
the long arm of chromosome 7##2##6##(2008-9#1)(2010-3#1)
the long arm of chromosome##11##5##(1997-3#1)(1997-5#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-3#1)(2012-12#2)
the long arm of the X chromosome##2##7##(2008-12#1)(2012-1#1)
the long arm of the##3##5##(2008-10#1)(2008-12#1)(2012-1#1)
the long arm of wheat chromosome##2##6##(2008-10#2)
the long arm of wheat##3##5##(2008-10#3)
the long arm of##21##4##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#8)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#2)(2012-1#1)(2012-12#2)
the long arm##23##3##(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-3#2)(2012-1#1)(2012-12#2)
the long arms of##3##4##(1997-8#1)(2008-5#1)(2008-7#1)
the long arms##4##3##(1997-8#1)(2008-5#2)(2008-7#1)
the long axis of##2##4##(2008-2#1)(2009-10#1)
the long bones of the##3##5##(2007-11#1)(2010-3#2)
the long bones##9##3##(2007-11#3)(2008-12#1)(2008-4#1)(2010-3#2)(2010-6#1)(2013-8#1)
the long chain##3##3##(1990-5#1)(1996-7#1)(2012-2#1)
the long run##9##3##(1994-5#1)(1996-1#1)(1997-3#1)(1997-5#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
the long term effects of##2##5##(2008-11#1)(2008-5#1)
the long term in##3##4##(2007-5#1)(2008-8#1)(2013-7#1)
the long term##35##3##(1992-1#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#4)(2013-7#1)(2013-8#1)
the long time##3##3##(1995-11#1)(2007-12#1)(2008-11#1)
the long##131##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-7#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#14)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#1)(2009-9#1)(2010-3#5)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the long-distance transport of##2##4##(2008-10#2)
the long-distance##5##2##(1993-2#1)(2008-10#4)
the long-lasting##4##2##(1992-8#1)(1995-12#2)(2008-3#1)
the long-lived##4##2##(1991-12#2)(2012-3#2)
the long-range##2##2##(1997-2#1)(2007-12#1)
the long-standing##2##2##(2010-2#1)(2012-2#1)
the long-term care##2##3##(1995-3#1)(1997-1#1)
the long-term clinical outcome##2##4##(2012-3#1)(2013-1#1)
the long-term clinical##3##3##(2012-3#2)(2013-1#1)
the long-term effect of##3##4##(2008-7#1)(2009-6#1)(2011-2#1)
the long-term effectiveness of##2##4##(2008-11#1)(2012-2#1)
the long-term effectiveness##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
the long-term effects of##12##4##(1992-10#1)(1995-11#1)(1996-12#1)(1996-7#1)(2008-12#1)(2008-7#1)(2009-1#2)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
the long-term follow-up##2##3##(2006-10#1)(2011-2#1)
the long-term management of##3##4##(1990-6#1)(2008-10#2)
the long-term monitoring of##2##4##(1997-3#1)(2009-4#1)
the long-term outcome of##3##4##(2008-1#1)(2008-11#1)(2013-8#1)
the long-term outcomes##2##3##(1997-2#1)(2011-2#1)
the long-term prognosis of##3##4##(2007-8#1)(2008-3#1)(2011-7#1)
the long-term prognosis##5##3##(1991-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-7#1)
the long-term response##2##3##(1990-2#1)(2008-8#1)
the long-term results##5##3##(1991-3#1)(1992-9#1)(1994-2#1)(2009-8#1)(2013-1#1)
the long-term risk of##2##4##(2007-7#1)(2011-2#1)
the long-term risk##3##3##(2007-7#1)(2008-11#1)(2011-2#1)
the long-term safety outcomes##2##4##(2012-12#2)
the long-term safety##4##3##(2008-8#1)(2012-12#2)(2012-3#1)
the long-term stability of##4##4##(2008-10#2)(2008-11#1)(2008-4#1)
the long-term stability##5##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
the long-term survival of##2##4##(2008-10#1)(2008-9#1)
the long-term survival##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
the long-term treatment of##2##4##(1994-2#1)(2013-1#1)
the long-term treatment with##2##4##(1990-2#1)(1991-12#1)
the long-term treatment##5##3##(1990-2#1)(1991-12#1)(1994-2#1)(2011-2#1)(2013-1#1)
the long-term##120##2##(1990-2#2)(1990-6#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-3#1)(1996-12#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#2)(2009-1#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-2#7)(2011-7#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#1)
the long-time##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
the long-wavelength##2##2##(2007-11#1)(2008-3#1)
the longer term deficit##2##4##(1993-12#2)
the longer term##3##3##(1993-12#2)(2010-1#1)
the longer##22##2##(1990-2#1)(1992-5#1)(1993-12#2)(1995-8#3)(1996-5#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
the longest##21##2##(1990-8#1)(1993-12#1)(1994-3#1)(1996-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-11#1)(2011-2#4)(2012-3#1)
the longevity of the##2##4##(1992-5#1)(2012-2#1)
the longevity of##5##3##(1992-5#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
the longevity##7##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
the longitudinal axis of the##2##5##(2008-7#1)(2011-2#1)
the longitudinal axis of##3##4##(2008-7#1)(2008-9#1)(2011-2#1)
the longitudinal direction##5##3##(2007-12#1)(2008-3#2)(2008-9#1)(2009-7#1)
the longitudinal directions##2##3##(2008-3#2)
the longitudinal effects of##2##4##(2010-7#1)(2011-1#1)
the longitudinal glia##2##3##(2008-7#2)
the longitudinal##35##2##(1991-12#1)(1992-12#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#5)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
the longitudinally##2##2##(2007-12#1)(2008-2#1)
the longterm##2##2##(2007-7#1)(2013-1#1)
the loop between##2##3##(1995-2#1)(2009-11#1)
the loop ligation##2##3##(1995-1#2)
the loop ligature##2##3##(1995-1#2)
the loop of##2##3##(1993-11#1)(2008-10#1)
the loop region##2##3##(1993-8#1)(2008-4#1)
the loop##28##2##(1992-11#1)(1992-3#2)(1993-11#1)(1993-8#1)(1995-1#5)(1995-2#3)(1995-5#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-8#1)(2012-3#1)
the loops##2##2##(1995-3#1)(2008-10#1)
the loss in##2##3##(2008-9#1)(2013-1#1)
the loss level##2##3##(2008-10#1)(2008-2#1)
the loss of B-PE fluorescence in the##2##7##(2008-10#2)
the loss of a##6##4##(1990-8#1)(1991-9#1)(1993-3#1)(1993-6#1)(2008-4#1)(2012-3#1)
the loss of function##2##4##(1997-8#1)(2011-3#1)
the loss of hormone##2##4##(1997-7#2)
the loss of its##2##4##(1997-7#1)(2008-10#1)
the loss of one##2##4##(2008-7#1)(2008-9#1)
the loss of renal##2##4##(1990-2#1)(2011-2#1)
the loss of the##15##4##(1993-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-2#1)(2009-12#1)(2009-8#2)(2012-2#1)(2013-7#1)
the loss of##112##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-6#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#4)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-7#5)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)
the loss##127##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-6#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#4)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-7#5)(1997-8#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)
the losses##8##2##(2007-11#2)(2008-10#2)(2008-3#2)(2013-1#1)(2013-8#1)
the lost of##2##3##(2008-10#1)(2011-2#1)
the lost##6##2##(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
the lot##3##2##(2008-10#3)
the lotion##3##2##(2008-5#3)
the loud##2##2##(2008-8#1)(2013-1#1)
the low Km##3##3##(1990-11#1)(1994-8#1)(1994-9#1)
the low Mr fraction##2##4##(1990-5#2)
the low Mr##3##3##(1990-5#2)(1991-2#1)
the low abundance##2##3##(1996-12#1)(2013-8#1)
the low activity##2##3##(1997-7#1)(2008-7#1)
the low affinity binding##2##4##(1990-5#1)(1991-2#1)
the low affinity##6##3##(1990-5#1)(1991-2#2)(1993-6#1)(2008-7#2)
the low and##3##3##(2008-3#2)(2008-6#1)
the low average##2##3##(1996-4#1)(2011-2#1)
the low back##4##3##(2008-12#3)(2013-8#1)
the low chemical oxygen demand##2##5##(2008-10#2)
the low chromatic sensitivity##2##4##(2008-2#2)
the low concentration and##2##4##(1996-3#1)(2008-6#1)
the low concentration##5##3##(1994-6#1)(1996-3#1)(2008-6#1)(2008-9#1)(2009-8#1)
the low concentrations of##2##4##(2008-10#1)(2010-11#1)
the low consumption of##2##4##(2008-10#1)(2008-5#1)
the low cost of##2##4##(1992-5#1)(2008-10#1)
the low density lipoprotein receptor##4##5##(1990-11#1)(1994-9#1)(1995-2#1)(2013-1#1)
the low density lipoprotein##6##4##(1990-11#1)(1994-9#1)(1995-2#1)(1995-8#2)(2013-1#1)
the low density##7##3##(1990-11#1)(1994-9#1)(1995-2#1)(1995-8#2)(2012-2#1)(2013-1#1)
the low dose ADR therapy##3##5##(1994-7#3)
the low dose ADR##4##4##(1994-7#4)
the low dose group##2##4##(2008-5#1)(2010-1#1)
the low dose##11##3##(1994-7#4)(2008-5#2)(2008-7#4)(2010-1#1)
the low energy##2##3##(2008-10#1)(2008-12#1)
the low frequency##2##3##(2008-10#1)(2013-1#1)
the low incidence of##4##4##(1990-2#1)(1996-11#1)(2010-12#1)(2011-2#1)
the low level of##9##4##(1992-9#1)(1995-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-7#1)
the low molecular weight HA-based hydrogel##2##6##(2008-5#2)
the low molecular weight form of Hsp70##2##7##(1991-9#2)
the low molecular weight##5##4##(1991-9#2)(2008-5#2)(2009-4#1)
the low nanomolar##3##3##(2008-10#2)(2012-2#1)
the low operating##2##3##(2007-12#1)(2008-10#1)
the low percentage of##2##4##(1994-6#1)(2008-10#1)
the low pressure##2##3##(1996-3#2)
the low range##2##3##(1993-8#1)(2008-10#1)
the low rate of##3##4##(1991-9#1)(1996-11#1)(2008-10#1)
the low risk of##2##4##(2011-2#1)(2012-3#1)
the low risk##5##3##(2007-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)
the low sensitivity of##2##4##(1990-3#1)(2011-2#1)
the low sensitivity##4##3##(1990-3#1)(1991-4#1)(2011-2#1)(2012-12#1)
the low temperature##2##3##(1997-2#1)(2008-11#1)
the low##224##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#5)(1990-8#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-9#3)(1992-12#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#4)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-7#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#47)(2008-11#3)(2008-12#5)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#3)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#4)
the low-##2##2##(2008-10#1)(2008-3#1)
the low-CHO diet was##2##4##(2013-8#2)
the low-affinity site##2##3##(1990-11#1)(1994-3#1)
the low-affinity##7##2##(1990-11#1)(1990-8#1)(1994-3#1)(1994-5#2)(1995-12#1)(1996-12#1)
the low-coherence##2##2##(2008-3#2)
the low-density lipoprotein##2##3##(2008-6#1)(2013-1#1)
the low-density##4##2##(2007-12#1)(2008-6#1)(2011-1#1)(2013-1#1)
the low-dose##5##2##(1994-5#2)(1997-7#1)(2008-7#1)(2013-8#1)
the low-energy##2##2##(2008-7#1)(2012-2#1)
the low-frequency##9##2##(1991-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
the low-gain##3##2##(2007-12#1)(2008-3#2)
the low-grade##2##2##(1994-1#2)
the low-molecular-weight##2##2##(1992-11#1)(2008-10#1)
the low-order##3##2##(2008-2#1)(2008-3#2)
the low-pass##2##2##(2007-12#1)(2008-2#1)
the low-power##3##2##(2008-3#2)(2009-5#1)
the low-pressure##3##2##(1995-6#1)(2008-2#1)(2008-3#1)
the low-temperature##7##2##(1990-8#1)(1996-2#2)(2008-10#2)(2008-8#1)(2011-2#1)
the lower abdomen##2##3##(2008-10#1)(2010-5#1)
the lower and upper##3##4##(2012-2#2)(2013-1#1)
the lower and##4##3##(2008-3#1)(2012-2#2)(2013-1#1)
the lower back##2##3##(2008-5#1)(2009-3#1)
the lower cell yield##2##4##(2008-11#2)
the lower cell##3##3##(2008-11#3)
the lower cerebral autoregulatory threshold##2##5##(2008-7#2)
the lower concentration of##2##4##(2012-2#1)(2013-1#1)
the lower cranial nerves##2##4##(2008-7#1)(2011-2#1)
the lower crust##5##3##(1996-4#5)
the lower crustal zone##2##4##(1996-4#2)
the lower detection limit##2##4##(2008-10#2)
the lower dose##3##3##(1994-6#1)(2008-10#1)(2012-3#1)
the lower end of the##3##5##(2008-10#2)(2011-2#1)
the lower esophageal sphincter (LES)##2##5##(2011-2#1)(2013-8#1)
the lower esophageal sphincter##4##4##(1992-6#1)(2011-2#1)(2013-8#2)
the lower expression of##2##4##(1992-3#1)(2008-10#1)
the lower extremities##18##3##(1993-6#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
the lower extremity##10##3##(2008-12#1)(2008-6#3)(2009-1#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the lower female genital tract##3##5##(1990-2#1)(1994-1#1)(1996-12#1)
the lower female reproductive tract##2##5##(1996-12#2)
the lower female##5##3##(1990-2#1)(1994-1#1)(1996-12#3)
the lower genital tract##5##4##(1991-2#2)(1994-1#1)(2011-2#2)
the lower infant mortality rate##2##5##(2013-1#2)
the lower infant mortality##4##4##(2013-1#4)
the lower jaw##3##3##(2007-5#1)(2008-5#1)(2013-1#1)
the lower leg##14##3##(1990-11#2)(1991-3#1)(1994-6#1)(1997-8#2)(2007-11#1)(2007-8#5)(2012-12#2)
the lower level of##4##4##(1993-8#1)(2007-12#1)(2008-10#1)(2013-1#1)
the lower limb##7##3##(1990-6#1)(1995-2#1)(2008-6#1)(2011-2#3)(2013-1#1)
the lower limbs##19##3##(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#2)(1993-5#1)(1997-3#2)(2007-11#1)(2007-8#2)(2008-8#2)(2009-3#1)(2012-1#2)(2012-2#1)
the lower limit of detection##2##5##(2008-10#2)
the lower limit of##6##4##(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)
the lower limit##9##3##(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)
the lower lip##4##3##(1991-8#2)(2013-1#2)
the lower lobe of the right lung##2##7##(2007-7#1)(2007-8#1)
the lower lobe##5##3##(2007-7#1)(2007-8#4)
the lower part of##3##4##(1995-3#1)(2008-10#1)(2008-12#1)
the lower part##5##3##(1993-9#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-12#1)
the lower posterior##2##3##(2011-2#1)(2013-1#1)
the lower rim##3##3##(1996-5#3)
the lower small intestine##2##4##(2008-5#2)
the lower spectrum of illness##2##5##(2011-2#2)
the lower stratosphere##4##3##(2008-3#4)
the lower temperature##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
the lower the##6##3##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-8#2)
the lower values##3##3##(2008-10#1)(2011-2#2)
the lower##280##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#4)(1991-8#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#5)(1996-4#7)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#4)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#13)(2008-1#3)(2008-10#42)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#9)(2008-5#7)(2008-6#5)(2008-7#11)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#18)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#17)(2013-8#5)
the lower-bound##2##2##(2007-12#1)(2008-2#1)
the lower-order structure##2##3##(2011-2#2)
the lowered##4##2##(1997-6#1)(2008-5#2)(2008-7#1)
the lowering of##5##3##(1991-12#1)(1996-2#1)(2008-10#1)(2008-11#2)
the lowest and##2##3##(2007-11#1)(2008-9#1)
the lowest blanks##2##3##(2008-10#2)
the lowest body##2##3##(2008-7#1)(2009-2#1)
the lowest concentration of##3##4##(2008-10#1)(2010-10#1)(2013-8#1)
the lowest concentration##7##3##(1991-12#1)(1991-9#1)(1994-11#1)(2008-10#2)(2010-10#1)(2013-8#1)
the lowest detected##2##3##(2008-10#1)(2009-5#1)
the lowest detection##2##3##(2008-10#2)
the lowest effective##2##3##(1994-9#1)(2009-4#1)
the lowest excited singlet state##4##5##(2008-10#2)(2010-2#2)
the lowest in the##3##4##(1993-8#1)(2008-7#1)(2009-10#1)
the lowest in##8##3##(1991-6#1)(1993-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)
the lowest level in##2##4##(2008-10#2)
the lowest level of##2##4##(1996-12#1)(2008-10#1)
the lowest level##8##3##(1996-12#1)(2008-10#4)(2008-8#1)(2013-1#2)
the lowest levels of##3##4##(2008-10#1)(2010-5#1)(2013-1#1)
the lowest limit of detection##2##5##(2008-10#2)
the lowest limit##3##3##(2008-10#3)
the lowest local extinction probability##2##5##(2008-8#2)
the lowest mean##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
the lowest numbers##2##3##(2008-10#1)(2008-12#1)
the lowest one##2##3##(1990-6#1)(2012-12#1)
the lowest possible##2##3##(2008-11#1)(2008-6#1)
the lowest repetition rate ever##2##5##(2007-11#1)(2007-12#1)
the lowest sensitivity##2##3##(2008-10#2)
the lowest value##2##3##(2008-3#2)
the lowest values##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
the lowest was##4##3##(2008-12#3)(2013-8#1)
the lowest##178##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-6#2)(1991-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#54)(2008-11#3)(2008-12#6)(2008-2#4)(2008-3#10)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
the lowest-cost##2##2##(2008-2#1)(2008-3#1)
the lowest-order##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
the luciferase gene##3##3##(1991-2#1)(2008-11#2)
the luciferase reporter gene##3##4##(1992-9#1)(1996-5#1)(2008-9#1)
the luciferase reporter##4##3##(1992-9#1)(1996-5#1)(2008-9#2)
the luciferase##11##2##(1991-2#1)(1991-9#1)(1992-9#1)(1996-5#1)(1997-2#1)(2008-11#3)(2008-4#1)(2008-9#2)
the luciferases of##2##3##(1990-7#2)
the lucigenin##5##2##(2008-10#5)
the lucigenin-CL system##2##3##(2008-10#2)
the lumbar area##2##3##(1996-3#1)(2012-2#1)
the lumbar region##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
the lumbar segment##2##3##(2007-8#2)
the lumbar spinal canal##2##4##(2008-7#2)
the lumbar spinal cord##3##4##(1990-5#2)(2008-7#1)
the lumbar spinal##5##3##(1990-5#2)(2008-7#3)
the lumbar spine##22##3##(1991-11#2)(1993-11#1)(2007-11#3)(2007-8#1)(2008-12#1)(2008-4#1)(2010-3#4)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)
the lumbar vein##3##3##(2011-2#3)
the lumbar##47##2##(1990-5#2)(1991-11#2)(1993-11#1)(1993-9#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-11#5)(2007-8#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#4)(2010-3#4)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)
the lumbo-sacral spine##4##3##(2007-11#4)
the lumbosacral##8##2##(1997-2#1)(2008-12#1)(2009-9#1)(2010-6#2)(2013-8#3)
the lumen of the stylet extension and##2##7##(2008-10#2)
the lumen of the##12##4##(1993-6#2)(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#3)
the lumen of##17##3##(1993-6#2)(1997-1#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-7#2)(2010-4#1)(2011-2#3)
the lumen##36##2##(1991-12#1)(1992-5#1)(1993-12#2)(1993-6#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-6#1)(2007-12#5)(2007-8#2)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#6)(2010-4#1)(2011-2#4)
the luminaire##2##2##(2008-3#2)
the luminal surface LDL concentration was##2##6##(2008-9#2)
the luminal surface of the##2##5##(1995-11#1)(2008-9#1)
the luminal surface##5##3##(1995-11#1)(2008-9#4)
the luminal surfaces of acinar cells##2##6##(1995-11#2)
the luminal##9##2##(1992-9#1)(1995-11#3)(2008-8#1)(2008-9#4)
the luminance in##2##3##(2008-3#2)
the luminance##4##2##(2008-3#4)
the luminescence##8##2##(1996-12#1)(2008-10#3)(2008-2#3)(2008-7#1)
the luminescent##9##2##(1990-8#1)(1994-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2009-11#1)
the luminescing##2##2##(2008-10#2)
the luminol-H(2)O(2)##2##2##(2008-10#2)
the luminous##3##2##(2008-2#2)(2008-3#1)
the lunar cycle##3##3##(2011-1#3)
the lunar##6##2##(2008-2#1)(2008-3#1)(2011-1#3)(2013-8#1)
the lunate is##2##3##(2012-3#1)(2013-1#1)
the lung after##2##3##(2008-6#1)(2013-7#1)
the lung and##10##3##(1990-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-7#1)(2013-8#1)
the lung are##2##3##(1990-8#1)(2008-6#1)
the lung can be##3##4##(1992-12#2)(2013-7#1)
the lung cancer incidence##3##4##(1996-3#2)(2008-7#1)
the lung cancer##6##3##(1991-2#1)(1996-3#2)(2008-11#1)(2008-7#1)(2013-7#1)
the lung developed##2##3##(1992-2#1)(2007-6#1)
the lung is a##2##4##(1991-2#1)(2010-5#1)
the lung is##3##3##(1991-2#1)(2008-7#1)(2010-5#1)
the lung tissue##3##3##(1991-12#1)(1996-3#1)(2008-10#1)
the lung tissues##2##3##(2008-12#1)(2011-2#1)
the lung were##2##3##(1994-7#1)(2008-8#1)
the lung##140##2##(1990-3#1)(1990-5#4)(1990-8#1)(1991-12#6)(1991-2#4)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#2)(1992-9#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-7#2)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#4)(1997-1#7)(1997-2#1)(2007-12#1)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#7)(2008-7#7)(2008-8#3)(2009-1#2)(2009-3#1)(2010-10#2)(2010-3#4)(2010-5#5)(2010-7#3)(2010-8#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
the lung]##3##2##(1991-9#1)(1997-5#1)(2008-1#1)
the lungfish##3##2##(1993-5#1)(2008-5#2)
the lungs and to the##2##5##(1992-3#1)(2007-11#1)
the lungs and##13##3##(1991-12#1)(1992-3#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-5#2)(2011-2#1)
the lungs are##3##3##(2008-1#1)(2008-5#1)(2010-5#1)
the lungs by##3##3##(1991-9#1)(2008-8#1)(2013-1#1)
the lungs in##4##3##(2008-5#2)(2010-8#1)(2011-1#1)
the lungs of both##2##4##(2008-10#1)(2008-6#1)
the lungs of children##2##4##(1991-12#1)(1997-1#1)
the lungs of##11##3##(1991-12#1)(1991-8#1)(1994-11#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-6#1)(2013-1#3)
the lungs or##2##3##(2007-8#1)(2008-1#1)
the lungs was##4##3##(1996-3#1)(2007-12#2)(2008-10#1)
the lungs were##4##3##(1996-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
the lungs##84##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#3)(1991-8#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#6)(1996-8#1)(1997-1#8)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-8#5)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#10)(2008-6#1)(2008-8#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#4)
the luteal phase##6##3##(1990-8#1)(1991-11#1)(1994-9#2)(2008-5#1)(2012-2#1)
the luteal##8##2##(1990-8#1)(1991-11#1)(1992-9#1)(1994-9#2)(2008-5#1)(2012-2#2)
the luteinized##2##2##(1997-1#1)(2008-5#1)
the lymph node##4##3##(1990-3#1)(1990-5#1)(1990-6#1)(2009-12#1)
the lymph nodes##6##3##(1990-12#1)(1990-9#1)(1996-3#1)(2007-5#1)(2012-3#1)(2013-7#1)
the lymph##10##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1996-3#1)(2007-5#1)(2009-12#1)(2012-3#1)(2013-7#1)
the lymphatic system##2##3##(2008-4#1)(2009-8#1)
the lymphatic vessels##2##3##(2010-1#1)(2013-1#1)
the lymphatic##9##2##(1990-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-12#1)(2013-1#1)
the lymphocyte##6##2##(1991-11#1)(1995-12#2)(2008-11#1)(2008-4#1)(2008-5#1)
the lymphocytes##4##2##(1990-12#1)(1994-12#1)(2008-10#1)(2011-2#1)
the lymphoid organs##2##3##(1996-12#1)(2008-5#1)
the lymphoid patches##2##3##(1992-12#2)
the lymphoid system##2##3##(1994-8#1)(2011-2#1)
the lymphoid tissues##4##3##(1996-12#2)(2008-10#1)(2008-9#1)
the lymphoid##16##2##(1992-12#3)(1994-8#1)(1996-12#3)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
the lysates of##2##3##(1995-6#1)(2010-12#1)
the lysine##5##2##(1995-2#1)(1995-8#1)(2008-4#2)(2008-8#1)
the lysis##3##2##(1992-12#1)(1997-4#1)(2008-2#1)
the lysophosphatidic acid##2##3##(1990-8#1)(1991-2#1)
the lysophospholipase activity in##2##4##(1990-2#2)
the lysosomal enzyme##4##3##(1990-5#1)(1993-8#1)(1996-8#1)(1997-7#1)
the lysosomal##18##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-8#2)(1994-5#1)(1996-8#1)(1997-7#1)(2008-7#3)(2012-12#1)(2012-3#1)
the lysosomes of the##2##4##(1990-5#1)(1991-12#1)
the lysosomes##3##2##(1990-5#1)(1991-12#1)(1992-10#1)
the lysosomotropic##2##2##(1990-7#1)(1992-9#1)
the lysozyme##2##2##(2008-10#2)
the lytic##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
the m = 2 mode##2##5##(2008-3#2)
the m =##3##3##(2008-2#1)(2008-3#2)
the m##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
the m-RNA level##4##3##(1997-1#4)
the m/z 73##2##3##(2008-10#2)
the m/z##5##2##(2008-10#5)
the mAb##4##2##(1997-6#1)(2008-11#3)
the mAbs##3##2##(1997-6#1)(2008-11#1)(2008-8#1)
the mF plasmid##2##3##(1997-2#2)
the mGlu##3##2##(1995-12#2)(2008-7#1)
the mPFC##6##2##(2008-11#1)(2008-6#2)(2008-7#3)
the mRNA encoding##5##3##(1992-9#1)(1993-6#1)(1994-12#1)(2008-11#1)(2008-9#1)
the mRNA expression levels of##3##5##(2008-11#2)(2009-8#1)
the mRNA expression of##5##4##(1996-12#1)(2008-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
the mRNA expression##10##3##(1996-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
the mRNA for the putative##3##5##(1996-12#3)
the mRNA for the##5##4##(1996-12#4)(2008-4#1)
the mRNA for##10##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-6#1)(1996-12#4)(2008-11#1)(2008-4#1)
the mRNA level in the TS##2##6##(2008-11#2)
the mRNA level of the##2##5##(1996-12#1)(2008-11#1)
the mRNA level of##4##4##(1995-11#1)(1996-12#1)(2008-11#1)(2008-8#1)
the mRNA level##15##3##(1994-6#2)(1995-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)
the mRNA levels of##3##4##(1993-3#2)(2008-4#1)
the mRNA levels##4##3##(1991-12#1)(1993-3#2)(2008-4#1)
the mRNA of##5##3##(1991-12#1)(1995-11#1)(2008-10#1)(2010-1#1)(2011-2#1)
the mRNA transcription##3##3##(2008-8#1)(2013-1#2)
the mRNA##78##2##(1990-11#1)(1990-7#1)(1991-12#4)(1991-5#1)(1992-1#1)(1992-11#1)(1992-6#2)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#9)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
the mRNAs for##2##3##(1993-11#1)(1996-12#1)
the mRNAs of##2##3##(1997-6#1)(2008-4#1)
the mRNAs##7##2##(1990-3#1)(1992-6#1)(1993-11#1)(1993-5#1)(1996-12#1)(1997-6#1)(2008-4#1)
the mTOR##2##2##(2011-2#1)(2013-1#1)
the macaque##2##2##(1997-2#1)(2009-10#1)
the machine learning##2##3##(2010-12#2)
the machine##4##2##(2009-11#1)(2010-12#2)(2010-8#1)
the machinery of##2##3##(1992-6#1)(2008-4#1)
the machinery##3##2##(1992-6#1)(2008-4#1)(2008-7#1)
the macro and micro##2##4##(2008-11#1)(2008-9#1)
the macro##3##2##(1994-12#1)(2008-11#1)(2008-9#1)
the macro-##2##2##(1997-1#1)(2008-11#1)
the macrocycle##3##2##(2008-10#2)(2009-10#1)
the macrocyclic size and##2##4##(2008-10#2)
the macrocyclic##8##2##(2008-10#6)(2008-6#2)
the macrolide##2##2##(1990-5#1)(2007-12#1)
the macromolecular composition##2##3##(2008-11#1)(2008-7#1)
the macromolecular##7##2##(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)
the macromolecule##3##2##(1990-8#1)(1997-2#1)(2008-10#1)
the macromolecules##2##2##(1996-5#1)(2008-10#1)
the macrophage respiratory burst by##2##5##(1994-6#2)
the macrophage##9##2##(1990-5#1)(1991-12#1)(1991-5#1)(1994-6#2)(1994-8#1)(1995-6#1)(2008-8#1)(2009-5#1)
the macrophages##6##2##(1990-7#1)(1992-12#1)(1992-5#1)(1995-5#1)(2007-2#1)(2011-2#1)
the macrophyte##3##2##(2013-7#3)
the macroporous##3##2##(2008-10#2)(2008-7#1)
the macroscopic and##2##3##(2008-11#1)(2009-7#1)
the macroscopic scale##2##3##(2009-7#2)
the macroscopic##11##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#3)(2009-7#3)(2012-12#1)
the macrovascular complications##3##3##(2008-1#3)
the macula and##2##3##(2010-2#1)(2011-2#1)
the macula##3##2##(2010-2#1)(2011-2#2)
the macular degeneration##2##3##(2011-2#2)
the magnesium##2##2##(2008-6#1)(2008-8#1)
the magnet##6##2##(2008-10#1)(2008-3#1)(2008-9#2)(2009-5#1)(2010-4#1)
the magnetic and##2##3##(2007-12#1)(2009-11#1)
the magnetic beads##9##3##(1990-12#1)(1995-8#1)(2008-10#7)
the magnetic field in##2##4##(2008-8#2)
the magnetic field##19##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-8#7)(2008-9#1)(2012-1#3)
the magnetic resonance (MR)##3##4##(1995-4#1)(2008-7#1)(2012-2#1)
the magnetic resonance imaging (MRI)##3##5##(1996-11#1)(2008-7#2)
the magnetic resonance imaging##5##4##(1996-11#1)(2007-8#1)(2008-7#2)(2010-8#1)
the magnetic resonance##9##3##(1995-4#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-7#3)(2010-8#1)(2012-2#1)
the magnetic##56##2##(1990-12#1)(1993-5#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#13)(2008-12#2)(2008-3#5)(2008-7#3)(2008-8#7)(2008-9#1)(2009-11#2)(2010-8#1)(2012-1#3)(2012-2#5)(2013-1#1)
the magnetization##8##2##(1996-2#1)(1997-7#1)(2006-4#1)(2008-10#2)(2009-6#2)(2012-12#1)
the magnification##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
the magnitude and direction of##3##5##(2010-8#2)(2013-1#1)
the magnitude and##12##3##(1995-5#1)(1996-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#3)(2013-1#1)
the magnitude estimation of##2##4##(2012-12#2)
the magnitude of dopamine sensing##3##5##(2008-10#3)
the magnitude of n(2)##2##4##(2007-11#1)(2008-2#1)
the magnitude of the changes##2##5##(1992-8#1)(1994-3#1)
the magnitude of the inhibition##2##5##(1995-12#1)(1995-6#1)
the magnitude of the response##2##5##(2008-10#1)(2008-8#1)
the magnitude of the synergistic##2##5##(2008-10#2)
the magnitude of the##66##4##(1990-12#1)(1990-5#3)(1991-12#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-10#14)(2008-2#2)(2008-3#9)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2011-2#3)(2013-8#2)
the magnitude of these##3##4##(1995-3#1)(1997-2#1)(2008-8#1)
the magnitude of this##3##4##(1990-2#1)(2011-2#1)(2012-12#1)
the magnitude of which##3##4##(1991-12#1)(1996-2#1)(2008-8#1)
the magnitude of##129##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#4)(2007-12#5)(2008-10#23)(2008-11#2)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#3)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#2)
the magnitude##156##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#4)(2007-12#6)(2008-10#24)(2008-11#3)(2008-2#9)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#15)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#2)
the magnitudes of the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
the magnitudes of##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
the magnitudes##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
the magnocellular##4##2##(1993-12#1)(1995-12#2)(1996-2#1)
the mail##3##2##(1994-2#1)(1994-3#1)(2007-12#1)
the main acidic carboxypeptidase in human platelets##2##7##(2006-6#2)
the main actors##2##3##(2009-5#1)(2011-1#1)
the main advantage of##2##4##(2008-10#1)(2008-3#1)
the main advantages of the##3##5##(2008-10#2)(2008-3#1)
the main advantages of##6##4##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)
the main advantages##8##3##(2007-11#1)(2008-10#5)(2008-3#1)(2008-7#1)
the main agent##2##3##(1996-3#1)(2013-8#1)
the main aim of##2##4##(2008-8#1)(2010-11#1)
the main aspects of##2##4##(2008-10#1)(2009-7#1)
the main binding##2##3##(1994-2#1)(2013-7#1)
the main cause of death in##3##6##(1994-5#1)(2008-10#1)(2010-3#1)
the main cause of death##4##5##(1991-12#1)(1994-5#1)(2008-10#1)(2010-3#1)
the main cause of the##2##5##(2008-8#1)(2010-12#1)
the main cause of##17##4##(1991-12#1)(1993-5#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
the main cause##20##3##(1991-12#1)(1993-5#1)(1994-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
the main causes of##7##4##(1996-8#1)(1997-3#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
the main causes##10##3##(1996-8#1)(1997-3#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the main chain##4##3##(1995-5#1)(2008-9#2)(2009-7#1)
the main characteristics of##2##4##(1993-11#1)(2013-1#1)
the main characteristics##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
the main clinical##3##3##(1993-2#1)(2013-1#1)(2013-8#1)
the main component of##2##4##(1992-12#1)(2011-2#1)
the main component##6##3##(1992-12#1)(2008-10#3)(2008-8#1)(2011-2#1)
the main components of##4##4##(1992-12#1)(1997-2#1)(2008-10#1)(2011-2#1)
the main components##6##3##(1992-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
the main compound##2##3##(2008-10#1)(2013-1#1)
the main concepts##4##3##(2008-10#1)(2012-12#2)(2013-1#1)
the main concern##2##3##(2008-1#1)(2008-10#1)
the main consequences##2##3##(2009-7#1)(2012-2#1)
the main constituents of##3##4##(2008-10#1)(2008-11#2)
the main constituents##4##3##(2008-10#1)(2008-11#3)
the main contributions##2##3##(1992-10#1)(2008-10#1)
the main degradation##2##3##(2008-10#2)
the main effect of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
the main effects##2##3##(2008-10#1)(2008-5#1)
the main factor##8##3##(1994-5#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2012-12#1)(2013-7#2)
the main factors affecting the##2##5##(2008-10#1)(2008-6#1)
the main factors affecting##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
the main factors in determining the##2##6##(1994-12#1)(2008-10#1)
the main factors in determining##3##5##(1994-12#1)(2008-10#1)(2010-8#1)
the main factors in##4##4##(1994-12#1)(2008-10#1)(2010-8#1)(2011-1#1)
the main factors influencing##2##4##(2008-10#1)(2008-11#1)
the main factors responsible for##2##5##(1991-6#1)(2008-1#1)
the main factors that##3##4##(2008-10#2)(2012-2#1)
the main factors##19##3##(1991-6#1)(1994-12#1)(1994-6#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
the main features of the##4##5##(2007-12#2)(2008-10#1)(2008-3#1)
the main features of##8##4##(1992-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)
the main features##10##3##(1992-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#2)
the main finding##2##3##(1993-12#1)(1996-7#1)
the main findings of##2##4##(1992-3#1)(2008-8#1)
the main findings##4##3##(1992-3#1)(2008-8#1)(2011-1#1)(2012-12#1)
the main focus##3##3##(1995-12#1)(2008-1#1)(2009-5#1)
the main function of the##2##5##(2007-12#1)(2008-7#1)
the main functions of##2##4##(2007-12#1)(2008-4#1)
the main functions##3##3##(1996-5#1)(2007-12#1)(2008-4#1)
the main genes and##2##4##(2008-10#1)(2009-5#1)
the main goal of##3##4##(1991-3#1)(1991-6#1)(2011-2#1)
the main goal##4##3##(1991-3#1)(1991-6#1)(2007-12#1)(2011-2#1)
the main group of##3##4##(1991-9#1)(2008-10#1)(2009-8#1)
the main group##4##3##(1991-9#1)(2008-10#1)(2009-8#1)(2011-1#1)
the main groups##2##3##(1991-6#1)(2008-7#1)
the main indication of##2##4##(2008-1#1)(2010-6#1)
the main indication##3##3##(2008-1#1)(2008-11#1)(2010-6#1)
the main indications##3##3##(1990-3#1)(1991-5#1)(1993-3#1)
the main interfering##2##3##(2008-10#2)
the main limitation of##2##4##(2008-11#1)(2009-10#1)
the main mechanism of##3##4##(2007-11#1)(2008-12#1)(2013-7#1)
the main mechanism##8##3##(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-7#1)
the main metabolites##2##3##(1990-11#1)(1993-12#1)
the main mode##2##3##(2008-2#2)
the main modes of##2##4##(2008-11#1)(2008-8#1)
the main objective of this work##2##6##(2008-10#1)(2013-7#1)
the main objective of this##3##5##(2008-10#1)(2009-10#1)(2013-7#1)
the main objective of##5##4##(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
the main obstacle to##2##4##(2008-3#1)(2010-5#1)
the main optical##2##3##(2008-2#1)(2008-3#1)
the main pancreatic duct##4##4##(2011-2#2)(2012-2#1)(2013-7#1)
the main peak and##2##4##(2008-10#1)(2012-12#1)
the main peak##3##3##(2008-10#2)(2012-12#1)
the main phase transition to lower temperatures##2##7##(2008-10#2)
the main phase transition to lower##3##6##(2008-10#3)
the main phase transition##6##4##(1990-2#1)(1990-7#2)(2008-10#3)
the main photoproducts##2##3##(1992-8#2)
the main plots##2##3##(2008-12#2)
the main points##2##3##(2008-11#1)(2011-2#1)
the main principle of##2##4##(1997-6#1)(2013-8#1)
the main principles##2##3##(2008-11#1)(2008-9#1)
the main problem##3##3##(1994-6#1)(1995-3#1)(2007-8#1)
the main problems##3##3##(1997-6#1)(2008-11#1)(2008-5#1)
the main processes##2##3##(2010-11#1)(2011-2#1)
the main product##2##3##(1990-7#1)(2008-10#1)
the main prognostic##2##3##(1994-6#1)(2011-2#1)
the main properties of the##2##5##(1990-8#1)(2008-10#1)
the main protein##3##3##(1995-6#1)(2011-2#1)(2012-2#1)
the main reason for##6##4##(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#1)
the main reason##9##3##(1990-6#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
the main reasons for the##2##5##(2008-8#1)(2013-1#1)
the main reasons##5##3##(2008-10#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-1#1)
the main risk factor for##2##5##(2011-1#1)(2013-8#1)
the main role in##2##4##(2008-10#1)(2008-4#1)
the main role##3##3##(1990-5#1)(2008-10#1)(2008-4#1)
the main route of##3##4##(1993-12#1)(2007-7#1)(2013-8#1)
the main source of##8##4##(1992-3#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
the main sources of##7##4##(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
the main species##4##3##(2008-10#4)
the main structural##3##3##(1995-2#1)(1997-4#2)
the main study##5##3##(2007-10#1)(2008-2#1)(2010-3#3)
the main substrate##2##3##(1990-5#2)
the main symptom##3##3##(1996-6#1)(2007-8#1)(2008-7#1)
the main symptoms of##2##4##(1996-6#1)(1997-3#1)
the main symptoms##3##3##(1996-6#1)(1997-3#1)(2007-4#1)
the main target organ of##2##5##(1990-5#1)(1992-9#1)
the main target##3##3##(1990-5#1)(1992-9#1)(2008-11#1)
the main theme##4##3##(2008-11#1)(2010-10#3)
the main therapeutic##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
the main topic##2##3##(2011-2#1)(2013-7#1)
the main topics of the##2##5##(2008-10#1)(2012-3#1)
the main transcription start point##2##5##(1990-5#1)(1991-6#1)
the main trunk##2##3##(1996-3#1)(2006-12#1)
the main types of##3##4##(1996-12#1)(2008-10#2)
the main variables affecting the results##2##6##(2008-10#1)(2012-12#1)
the main variables affecting the##3##5##(2008-10#2)(2012-12#1)
the main variables##5##3##(2008-10#3)(2008-5#1)(2012-12#1)
the main vector##6##3##(2008-10#4)(2008-11#1)(2008-5#1)
the main work##2##3##(2008-11#1)(2008-5#1)
the main##582##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#8)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#4)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#4)(1997-6#2)(1997-8#3)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#3)(2007-11#8)(2007-12#9)(2007-4#1)(2007-7#7)(2007-8#8)(2008-1#12)(2008-10#105)(2008-11#30)(2008-12#12)(2008-2#7)(2008-3#25)(2008-4#4)(2008-5#28)(2008-6#2)(2008-7#16)(2008-8#16)(2008-9#6)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#3)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#5)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#14)(2011-2#24)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#13)(2012-3#6)(2013-1#17)(2013-7#8)(2013-8#14)
the mainland##3##2##(1996-6#1)(2008-10#1)(2011-1#1)
the mainstay of treatment for##3##5##(2009-4#1)(2010-4#1)(2011-1#1)
the mainstay of treatment in##2##5##(2008-11#1)(2013-1#1)
the mainstay of treatment##10##4##(2008-11#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-1#1)(2013-1#2)
the mainstay of##24##3##(1995-5#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
the mainstay##26##2##(1995-5#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
the mainstream##6##2##(1994-3#1)(1994-8#1)(1995-1#1)(1997-3#1)(2008-6#1)(2012-2#1)
the maintaining##2##2##(2011-1#2)
the maintenance and##5##3##(1995-3#1)(2008-2#1)(2008-7#2)(2010-5#1)
the maintenance of LTP##2##4##(1997-2#2)
the maintenance of PTSD##2##4##(2008-8#1)(2009-11#1)
the maintenance of a healthy skin##2##6##(2008-5#2)
the maintenance of a##7##4##(2008-5#3)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
the maintenance of body##2##4##(1997-4#1)(2009-6#1)
the maintenance of cell shape and##2##6##(2008-11#1)(2011-2#1)
the maintenance of cell##3##4##(2008-11#2)(2011-2#1)
the maintenance of nodal##2##4##(2008-7#2)
the maintenance of the##8##4##(1991-2#2)(1995-12#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-1#1)
the maintenance of variation under constant selection##2##7##(2012-3#2)
the maintenance of##84##3##(1991-2#2)(1994-8#1)(1995-12#5)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2008-10#3)(2008-11#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#1)
the maintenance phase of##2##4##(1997-2#1)(2008-1#1)
the maintenance phase##3##3##(1997-2#1)(2008-1#1)(2013-8#1)
the maintenance trial##3##3##(2012-2#3)
the maintenance##102##2##(1990-9#1)(1991-2#2)(1994-8#1)(1995-12#5)(1995-3#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#10)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#2)
the maize genome##2##3##(2008-10#1)(2009-10#1)
the maize##12##2##(2008-10#6)(2008-12#1)(2009-10#3)(2011-2#1)(2012-3#1)
the major AT##2##3##(1995-6#2)
the major NORs##3##3##(1993-12#3)
the major advantage##2##3##(1992-9#1)(2007-7#1)
the major agents##2##3##(2008-5#1)(2009-5#1)
the major algal##2##3##(1994-11#1)(2012-2#1)
the major alkaloids##2##3##(2008-10#1)(2012-3#1)
the major and##2##3##(1990-12#1)(2008-9#1)
the major approach##2##3##(1992-6#1)(2008-11#1)
the major arsenic##2##3##(2008-10#2)
the major axis of the##2##5##(2008-2#1)(2008-5#1)
the major axis of##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
the major barrier to##2##4##(1994-1#1)(1997-1#1)
the major binding##2##3##(1993-11#1)(1994-2#1)
the major capsid##3##3##(1994-12#1)(2008-5#1)(2009-5#1)
the major carotenoid##2##3##(2008-10#2)
the major cause of death in##3##6##(2008-3#1)(2011-2#1)(2013-8#1)
the major cause of##10##4##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
the major causes for##2##4##(2008-12#1)(2008-4#1)
the major causes of failure of##2##6##(2008-1#1)(2008-11#1)
the major causes of##8##4##(1990-8#1)(1995-9#1)(2008-1#1)(2008-11#2)(2009-12#1)(2009-4#1)(2011-1#1)
the major causes##12##3##(1990-6#1)(1990-8#1)(1992-9#1)(1995-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2011-1#1)
the major cellular##4##3##(1992-11#1)(1995-8#1)(2008-12#1)(2010-11#1)
the major cellulardeterminant of productivity##2##5##(2008-11#2)
the major challenges in##3##4##(2008-4#1)(2011-1#1)(2011-2#1)
the major classes of##4##4##(2008-11#1)(2008-5#3)
the major coat protein##2##4##(1991-5#1)(1994-12#1)
the major coat##3##3##(1991-5#1)(1994-12#1)(1997-3#1)
the major component of##5##4##(1992-3#1)(1992-6#1)(1993-8#1)(2008-10#1)(2008-7#1)
the major component##8##3##(1992-3#2)(1992-6#1)(1993-8#1)(2008-10#3)(2008-7#1)
the major components of##4##4##(2008-10#1)(2008-5#2)(2008-6#1)
the major components##6##3##(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)
the major compound##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
the major constituents of##3##4##(2008-10#1)(2008-12#1)(2009-8#1)
the major constituents##4##3##(1994-8#1)(2008-10#1)(2008-12#1)(2009-8#1)
the major contributor to##2##4##(2008-1#1)(2008-2#1)
the major degradation product##2##4##(2008-10#2)
the major degradation##4##3##(2008-10#4)
the major design##2##3##(2008-3#2)
the major determinant of##5##4##(1994-6#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-8#1)
the major developments##3##3##(2008-5#1)(2008-9#1)(2012-2#1)
the major difficulties##2##3##(1996-1#1)(2010-9#1)
the major disease##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
the major electronic##2##3##(1997-3#1)(2009-2#1)
the major elements of the##2##5##(1995-6#1)(2008-6#1)
the major elements##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
the major etiological##2##3##(2008-12#1)(2012-3#1)
the major factor in##2##4##(2008-10#2)
the major factor##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)
the major factors in##3##4##(1994-5#1)(1997-6#1)(2008-10#1)
the major factors##8##3##(1994-5#1)(1997-6#1)(2008-1#1)(2008-10#3)(2010-3#1)(2012-2#1)
the major features of the##2##5##(2008-3#1)(2010-5#1)
the major findings##2##3##(2008-5#1)(2011-1#1)
the major form of##3##4##(1993-5#1)(2008-11#1)(2008-4#1)
the major form##4##3##(1992-6#1)(1993-5#1)(2008-11#1)(2008-4#1)
the major fungal##3##3##(2008-10#3)
the major gene##3##3##(2008-10#2)(2013-1#1)
the major groove of##3##4##(1991-2#1)(1995-5#1)(2008-4#1)
the major groove##6##3##(1991-2#1)(1992-4#1)(1992-6#1)(1994-5#1)(1995-5#1)(2008-4#1)
the major groups##2##3##(1991-5#1)(2008-10#1)
the major histocompatibility complex (MHC)##3##5##(1990-5#1)(1997-9#1)(2008-1#1)
the major histocompatibility complex##7##4##(1990-5#2)(1995-2#1)(1997-9#1)(2008-1#2)(2012-12#1)
the major histocompatibility##9##3##(1990-5#2)(1995-2#1)(1997-9#1)(2008-1#2)(2008-4#2)(2012-12#1)
the major ions##2##3##(1994-12#1)(2008-10#1)
the major issues##3##3##(1995-1#1)(1996-12#1)(2013-8#1)
the major limitations##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
the major mechanism of##2##4##(1993-3#1)(2008-8#1)
the major metabolic##2##3##(1990-6#1)(2008-3#1)
the major metabolite##2##3##(1990-12#1)(1991-12#1)
the major occupational##2##3##(1994-3#1)(1995-1#1)
the major one##2##3##(1992-3#1)(2011-2#1)
the major part of the##5##5##(1996-9#1)(1997-7#1)(1997-8#1)(2008-5#1)(2013-1#1)
the major part##6##3##(1996-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-5#1)(2013-1#1)
the major predisposing##2##3##(2012-3#1)(2013-8#1)
the major problem##4##3##(1992-3#1)(1996-8#1)(2008-5#1)(2011-2#1)
the major problems##5##3##(1990-2#1)(1997-2#1)(2008-12#1)(2010-8#1)(2012-12#1)
the major product##7##3##(1990-12#1)(1990-2#1)(1990-5#1)(1995-3#1)(1996-5#1)(2007-11#1)(2009-2#1)
the major protein component of##2##5##(1993-6#1)(1997-8#1)
the major protein##4##3##(1993-6#1)(1993-8#1)(1997-8#1)(2008-4#1)
the major proteins##2##3##(1992-3#1)(2008-6#1)
the major reason for##3##4##(2008-3#1)(2008-8#2)
the major regulation##2##3##(1993-8#1)(1994-11#1)
the major resistance##2##3##(2008-10#2)
the major risk factors of##2##5##(2008-11#1)(2008-7#1)
the major risk factors##3##4##(2008-11#1)(2008-7#1)(2011-1#1)
the major role in##2##4##(1994-8#1)(1997-9#1)
the major role of##3##4##(2008-2#1)(2011-1#1)(2012-2#1)
the major role##5##3##(1994-8#1)(1997-9#1)(2008-2#1)(2011-1#1)(2012-2#1)
the major second##2##3##(1993-6#1)(2008-11#1)
the major site of##4##4##(1990-12#1)(1995-6#1)(1997-8#1)(2010-8#1)
the major source for##2##4##(2008-11#1)(2011-1#1)
the major source of##4##4##(1991-2#1)(2008-3#1)(2010-11#1)(2012-2#1)
the major source##7##3##(1991-2#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-1#1)(2012-2#2)
the major sources of##2##4##(1994-3#1)(2008-10#1)
the major species##3##3##(2008-1#1)(2008-10#1)(2010-11#1)
the major steps##2##3##(2008-7#1)(2008-9#1)
the major sterol##2##3##(1997-2#1)(2008-10#1)
the major substrate##2##3##(1994-8#1)(2008-11#1)
the major vault protein##2##4##(1994-12#1)(2008-11#1)
the major##568##2##(1990-10#1)(1990-12#6)(1990-2#2)(1990-5#5)(1990-6#3)(1990-8#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-8#3)(1994-1#2)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#6)(1994-9#2)(1995-1#3)(1995-12#4)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(1997-9#3)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#14)(2008-10#88)(2008-11#22)(2008-12#15)(2008-2#12)(2008-3#14)(2008-4#18)(2008-5#24)(2008-6#10)(2008-7#17)(2008-8#11)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#12)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#12)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#4)
the majority being##2##3##(2010-2#1)(2013-1#1)
the majority of B cells##2##5##(2008-4#2)
the majority of accessions##2##4##(2008-10#2)
the majority of cardiac##2##4##(2008-12#1)(2010-8#1)
the majority of cases are##2##5##(2008-10#1)(2008-11#1)
the majority of cases##28##4##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1995-11#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
the majority of cells##2##4##(1993-8#1)(1994-2#1)
the majority of control##2##4##(2008-9#1)(2009-6#1)
the majority of individuals##3##4##(1997-5#1)(2013-7#2)
the majority of neurons##2##4##(2008-11#1)(2009-8#1)
the majority of participants##2##4##(2009-8#1)(2012-12#1)
the majority of patients with##6##5##(1993-2#1)(1996-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
the majority of patients##15##4##(1993-2#1)(1994-5#1)(1996-2#1)(1997-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
the majority of samples##3##4##(2008-10#1)(2011-2#2)
the majority of subjects##2##4##(1990-9#1)(2010-8#1)
the majority of the samples##2##5##(2008-10#1)(2009-5#1)
the majority of the studies##2##5##(1996-9#1)(2011-2#1)
the majority of the world's##3##5##(1993-3#1)(2008-5#1)(2008-8#1)
the majority of the##50##4##(1990-11#1)(1990-5#2)(1991-11#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#2)
the majority of them##4##4##(1995-8#1)(2007-5#1)(2008-10#1)(2012-1#1)
the majority of these##6##4##(2008-1#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
the majority of this##2##4##(2008-6#1)(2013-1#1)
the majority of those##2##4##(2008-5#1)(2013-1#1)
the majority of which##4##4##(1991-12#1)(2007-2#1)(2008-10#1)(2009-12#1)
the majority of##243##3##(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#6)(2008-12#5)(2008-3#1)(2008-4#7)(2008-5#11)(2008-6#6)(2008-7#10)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#5)(2010-5#1)(2010-6#4)(2010-8#6)(2011-1#1)(2011-10#1)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#4)
the majority##270##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#32)(2008-11#8)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#11)(2008-6#6)(2008-7#10)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#5)(2010-5#2)(2010-6#4)(2010-8#7)(2011-1#1)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#4)
the make-up##2##2##(2008-7#1)(2011-1#1)
the making of##6##3##(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2013-1#2)
the making##7##2##(1991-1#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2013-1#2)
the malar##2##2##(2008-5#1)(2013-1#1)
the malaria diagnosis network##2##4##(2012-12#2)
the malaria##12##2##(2007-12#1)(2007-2#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#6)
the male and female genital##2##5##(1990-5#1)(2008-7#1)
the male and female reproductive##2##5##(2008-7#1)(2011-2#1)
the male and female##11##4##(1990-5#1)(1992-3#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
the male and##12##3##(1990-5#1)(1992-3#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
the male genital appendages##2##4##(2008-8#2)
the male genital tract##3##4##(2008-4#1)(2012-1#1)(2012-2#1)
the male genital tracts##2##4##(2008-7#2)
the male genital##8##3##(1993-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
the male group##2##3##(2011-1#2)
the male lambs##2##3##(2010-2#2)
the male mice##2##3##(2007-10#1)(2008-9#1)
the male parent##2##3##(2008-10#2)
the male population##2##3##(1993-11#1)(1995-11#1)
the male rats##7##3##(1990-11#1)(1994-2#1)(2008-7#1)(2013-1#4)
the male reproductive system##2##4##(1993-3#1)(2009-10#1)
the male reproductive##4##3##(1993-3#1)(2007-12#1)(2009-10#1)(2011-1#1)
the male stimulatory ability##2##4##(2008-8#2)
the male##101##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-5#2)(1992-2#2)(1992-3#3)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(2007-10#1)(2007-12#4)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#2)(2009-8#1)(2010-2#2)(2010-5#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#5)
the male's##2##2##(2008-8#2)
the male-specific expression of the Slp gene##2##7##(1995-2#2)
the male-specific expression##3##3##(1995-2#3)
the male-to-female sex##2##3##(2008-5#1)(2011-2#1)
the males were##2##3##(1995-3#1)(2013-7#1)
the males##15##2##(1991-2#1)(1993-11#1)(1994-2#2)(1995-3#3)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-7#1)
the malformation##4##2##(1990-8#1)(1990-9#2)(1992-5#1)
the malignancy of##3##3##(1992-9#1)(2012-12#1)(2012-2#1)
the malignancy##8##2##(1990-8#1)(1992-9#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
the malignant transformation of##2##4##(2008-5#1)(2012-12#1)
the malignant##19##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-8#1)(1995-4#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
the malnourished##2##2##(1990-3#1)(2008-11#1)
the malondialdehyde##2##2##(1994-11#1)(2008-10#1)
the mammalian CNS##2##3##(1990-12#1)(1994-2#1)
the mammalian brain##4##3##(1995-6#1)(2007-12#1)(2008-11#2)
the mammalian cell##2##3##(2010-2#1)(2012-2#1)
the mammalian central nervous system##5##5##(1993-12#1)(2008-11#1)(2008-8#2)(2012-2#1)
the mammalian host##3##3##(2008-9#2)(2011-2#1)
the mammalian pineal organ##3##4##(1994-5#3)
the mammalian target of rapamycin (mTOR)##2##6##(2008-8#1)(2013-1#1)
the mammalian testis##2##3##(2012-2#2)
the mammalian##67##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-6#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1997-2#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#1)
the mammary epithelium##2##3##(1995-9#1)(2009-12#1)
the mammary gland##10##3##(1990-12#1)(1992-9#1)(1994-12#1)(1995-9#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-2#2)
the mammary glands##6##3##(1990-11#1)(2012-1#1)(2012-12#4)
the mammary##19##2##(1990-11#1)(1990-12#1)(1992-9#1)(1994-12#1)(1995-9#2)(2008-10#1)(2008-8#1)(2009-12#2)(2012-1#2)(2012-12#5)(2012-2#2)
the man##7##2##(1997-7#1)(2008-12#3)(2008-6#1)(2008-8#1)(2011-2#1)
the managed care industry##2##4##(1994-12#1)(1994-3#1)
the managed care system##7##4##(1994-2#1)(1996-12#1)(2006-10#5)
the managed care##20##3##(1991-3#1)(1992-2#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-3#1)(2006-10#5)(2009-11#1)
the managed##22##2##(1991-3#1)(1992-2#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-3#1)(2006-10#5)(2008-8#1)(2009-11#1)
the management and##8##3##(1992-12#1)(1993-12#1)(1993-3#1)(2006-10#1)(2007-10#1)(2008-3#1)(2009-4#1)(2012-2#1)
the management challenge##2##3##(1992-12#1)(2012-12#1)
the management development##2##3##(1995-12#1)(1996-3#1)
the management in##2##3##(2008-1#1)(2008-10#1)
the management of Fusarium##2##4##(2008-10#2)
the management of a patient##3##5##(2008-12#2)(2008-8#1)
the management of a##9##4##(1994-12#1)(1997-2#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)
the management of acute and chronic##2##6##(2007-12#1)(2008-7#1)
the management of acute coronary##3##5##(2008-3#3)
the management of acute##11##4##(1995-8#1)(2007-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
the management of all##3##4##(1992-2#1)(2010-6#1)(2012-3#1)
the management of an##3##4##(1996-11#1)(1997-6#1)(2008-12#1)
the management of anemia##2##4##(2013-1#2)
the management of asthma##4##4##(2008-11#2)(2010-5#2)
the management of blood##2##4##(1991-1#1)(2008-1#1)
the management of both##2##4##(2007-12#1)(2008-7#1)
the management of cardiac##2##4##(2008-10#1)(2010-8#1)
the management of certain##2##4##(2008-2#1)(2008-3#1)
the management of cervical anastomotic leakage after##2##7##(2007-8#2)
the management of cervical##3##4##(2007-8#2)(2008-7#1)
the management of chemotherapy-induced emesis##2##5##(2008-7#2)
the management of chronic##10##4##(1990-2#1)(1997-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2012-2#1)(2013-1#1)
the management of common##4##4##(2008-11#1)(2008-7#2)(2010-2#1)
the management of critical care units##2##6##(1996-2#2)
the management of critical care##3##5##(1996-2#2)(2007-12#1)
the management of dry skin##2##5##(2008-5#2)
the management of gallbladder cancer##2##5##(2010-12#1)(2013-1#1)
the management of insulin resistance##2##5##(2008-3#2)
the management of lung cancer##2##5##(1996-9#1)(2010-5#1)
the management of medical emergencies##2##5##(2008-1#1)(2010-9#1)
the management of needle pain##2##5##(2008-11#2)
the management of osteosarcoma##2##4##(2008-6#1)(2010-3#1)
the management of pain##6##4##(2007-11#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-12#1)
the management of painful##2##4##(2008-7#1)(2008-8#1)
the management of patients with##25##5##(1990-8#1)(1996-11#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
the management of patients##28##4##(1990-8#1)(1996-11#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
the management of pediatric##6##4##(2006-10#1)(2007-12#1)(2011-1#2)(2012-3#1)(2013-8#1)
the management of postoperative##2##4##(2007-8#1)(2009-2#1)
the management of pulmonary##2##4##(1997-1#1)(2010-3#1)
the management of refractory##2##4##(2011-2#1)(2013-8#1)
the management of severe##5##4##(1991-3#1)(2007-12#1)(2008-11#1)(2008-9#2)
the management of sleep##2##4##(2007-12#1)(2008-11#1)
the management of spontaneous##2##4##(2008-7#1)(2012-1#1)
the management of such patients##2##5##(1995-11#1)(2012-2#1)
the management of such##5##4##(1995-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the management of the disease##3##5##(1997-8#1)(2008-10#2)
the management of the##18##4##(1994-12#1)(1997-3#1)(1997-8#1)(2007-12#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
the management of their##3##4##(1992-3#1)(2008-8#1)(2009-7#1)
the management of these patients##5##5##(1991-2#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
the management of these##8##4##(1991-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
the management of this condition##2##5##(2008-7#1)(2008-8#1)
the management of this disease##3##5##(1991-2#1)(2010-8#1)(2011-2#1)
the management of this##11##4##(1991-2#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
the management of unstable angina##3##5##(1991-9#2)(2008-3#1)
the management of##402##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-12#2)(1993-9#2)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-6#1)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#19)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#11)(2008-10#24)(2008-11#14)(2008-12#11)(2008-2#2)(2008-3#21)(2008-4#4)(2008-5#5)(2008-6#6)(2008-7#33)(2008-8#8)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#5)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#7)(2011-2#20)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#9)(2013-1#23)(2013-7#1)(2013-8#5)
the management strategies##2##3##(2008-3#1)(2011-1#1)
the management team##3##3##(1993-1#2)(1994-3#1)
the management with##2##3##(2008-7#2)
the management##447##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#2)(1993-9#2)(1994-12#3)(1994-3#3)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-6#1)(1997-8#2)(2006-10#3)(2007-10#3)(2007-11#4)(2007-12#19)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#13)(2008-10#25)(2008-11#15)(2008-12#12)(2008-2#2)(2008-3#23)(2008-4#4)(2008-5#6)(2008-6#7)(2008-7#35)(2008-8#8)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#6)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#9)(2011-2#20)(2011-3#2)(2012-1#2)(2012-12#9)(2012-2#12)(2012-3#11)(2013-1#26)(2013-7#1)(2013-8#5)
the manager##3##2##(1993-12#1)(1995-1#1)(2012-3#1)
the managerial##5##2##(1994-12#1)(1994-3#2)(2008-1#1)(2010-10#1)
the managers##3##2##(1994-1#1)(2012-12#1)(2012-3#1)
the managing##4##2##(1996-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
the mandate##2##2##(1993-3#1)(2013-7#1)
the mandates of##2##3##(1991-2#1)(2012-2#1)
the mandible##12##2##(1997-3#1)(2007-5#2)(2008-7#1)(2010-3#1)(2011-7#1)(2012-3#1)(2013-1#5)
the mandibles##2##2##(2007-12#1)(2009-3#1)
the mandibular angle##2##3##(2012-12#2)
the mandibular gingiva##2##3##(2012-3#1)(2013-1#1)
the mandibular nerve##2##3##(2011-2#2)
the mandibular##14##2##(1993-1#1)(2007-12#1)(2008-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
the manganese##6##2##(1993-8#1)(1997-7#1)(2008-10#4)
the mangrove crab##3##3##(2008-7#2)(2013-7#1)
the mangrove##6##2##(2008-11#1)(2008-5#1)(2008-7#2)(2013-7#2)
the manifestation of a##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
the manifestation of these##2##4##(1994-2#1)(2008-11#1)
the manifestation of##16##3##(1994-2#2)(1996-12#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)
the manifestation##18##2##(1994-2#2)(1996-12#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
the manifestations of##2##3##(2006-10#1)(2007-6#1)
the manifold##8##2##(2008-10#7)(2008-11#1)
the manipulation of##12##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#1)
the manipulation##19##2##(1995-12#1)(1995-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)
the manner by which##2##4##(1990-12#1)(1995-12#1)
the manner in which the##6##5##(1992-1#1)(1994-2#1)(2008-1#1)(2008-2#1)(2009-5#1)(2011-1#1)
the manner in which##13##4##(1992-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-5#2)(2010-5#1)(2011-1#1)(2011-2#1)
the manner of##6##3##(1995-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
the manner##23##2##(1990-12#1)(1990-7#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#2)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
the mannitol permease##5##3##(1991-10#5)
the mannitol##7##2##(1991-10#6)(2008-1#1)
the mannose##3##2##(1995-6#1)(2008-10#2)
the mantle##2##2##(1996-2#1)(1996-4#1)
the manual and automated##2##4##(2008-10#2)
the manual methods##3##3##(1991-3#1)(2008-10#2)
the manual##26##2##(1990-5#1)(1991-3#1)(1994-6#3)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#13)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-2#1)
the manufacture of the##2##4##(2008-3#1)(2008-5#1)
the manufacture of##14##3##(1994-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
the manufacture##17##2##(1994-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
the manufacturer to##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
the manufacturer##10##2##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)
the manufacturer's##10##2##(1994-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-7#1)
the manufacturer-recommended##2##2##(2008-6#1)(2010-9#1)
the manufacturers##6##2##(1996-5#1)(1997-3#1)(2008-10#3)(2008-3#1)
the manufacturing industry##2##3##(1992-2#1)(2008-10#1)
the manufacturing of##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
the manufacturing process##7##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
the manufacturing##19##2##(1992-2#1)(1992-3#1)(1995-5#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)
the manure or##2##3##(2008-10#2)
the manure##5##2##(2008-10#5)
the manuscript##3##2##(2009-4#1)(2010-3#1)(2013-1#1)
the many advances in##2##4##(2008-3#1)(2010-3#1)
the many advantages of##4##4##(2007-11#1)(2008-4#1)(2008-5#1)(2010-8#1)
the many applications##3##3##(1991-5#1)(2006-4#1)(2007-12#1)
the many challenges##3##3##(1992-1#1)(1996-3#1)(2010-7#1)
the many different##2##3##(2008-10#1)(2008-9#1)
the many facets of##3##4##(1994-12#1)(2008-2#1)(2010-4#1)
the many factors##3##3##(2008-11#1)(2010-12#1)(2010-3#1)
the many types of##2##4##(2008-9#2)
the many##67##2##(1991-5#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1996-2#1)(1996-3#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
the map##10##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-1#1)
the mapped##2##2##(1996-12#1)(2008-10#1)
the mapping of##7##3##(1990-5#1)(2008-10#2)(2008-11#1)(2013-1#3)
the mapping population##2##3##(2008-10#2)
the mapping##14##2##(1990-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#3)
the maps##4##2##(2007-5#1)(2008-3#1)(2008-7#1)(2008-8#1)
the mares##2##2##(1994-7#1)(2012-3#1)
the margin of safety##2##4##(1994-3#1)(2008-11#1)
the margin of##5##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
the margin##9##2##(1994-12#1)(1994-3#1)(1995-4#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
the marginal sinus##6##3##(1996-9#6)
the marginal survival##2##3##(1995-9#2)
the marginal zone##2##3##(2008-7#1)(2012-1#1)
the marginal##24##2##(1995-9#2)(1996-9#6)(1997-3#2)(2008-5#1)(2008-7#6)(2008-8#3)(2009-8#1)(2010-1#1)(2011-1#1)(2012-1#1)
the margins##8##2##(1995-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-2#1)
the marinated##2##2##(2010-4#2)
the marine boundary layer##2##4##(2008-2#1)(2008-3#1)
the marine environment are##2##4##(2008-10#1)(2008-11#1)
the marine environment##12##3##(1994-9#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-11#7)
the marine ornamental fish and invertebrate##2##6##(2007-5#2)
the marine ornamental##3##3##(2007-5#3)
the marine##33##2##(1994-8#1)(1994-9#1)(1996-2#2)(1997-4#1)(1997-6#1)(2007-5#4)(2008-10#6)(2008-11#9)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
the mark##5##2##(1994-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-7#1)
the marked increase in the##3##5##(1991-11#1)(1994-12#1)(2008-3#1)
the marked##13##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-6#1)(1994-12#1)(1994-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)
the marker and##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
the marker data##2##3##(2008-10#1)(2008-5#1)
the marker##22##2##(1990-6#1)(1995-8#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)
the markers are##2##3##(1996-10#1)(2008-4#1)
the markers in##5##3##(1997-5#2)(2008-10#1)(2008-5#2)
the markers of oxidative stress##2##5##(2013-8#2)
the markers of##4##3##(1997-7#1)(2013-1#1)(2013-8#2)
the markers##22##2##(1995-6#1)(1996-10#1)(1997-5#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#2)(2010-11#1)(2013-1#1)(2013-8#3)
the market and##3##3##(1991-1#1)(1995-1#1)(1997-6#1)
the market for health##2##4##(1994-1#1)(1994-2#1)
the market for medical##2##4##(1990-6#1)(1991-12#1)
the market for##9##3##(1990-6#1)(1991-12#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-2#1)(2007-8#1)(2012-3#1)
the market in##2##3##(1996-5#1)(2008-3#1)
the market place##2##3##(1996-1#1)(2008-11#1)
the market that##2##3##(2008-10#1)(2009-5#1)
the market##56##2##(1990-6#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#2)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
the marketable##2##2##(1992-1#1)(2008-10#1)
the marketed##3##2##(1993-1#1)(2010-5#1)(2012-2#1)
the marketing##6##2##(1993-12#2)(1996-1#1)(1996-3#1)(2008-12#2)
the marketplace##13##2##(1991-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
the marking process##3##3##(2008-11#2)(2013-7#1)
the marking##4##2##(2008-11#2)(2010-8#1)(2013-7#1)
the marks##4##2##(1996-3#1)(2007-11#1)(2008-11#2)
the marriage of##2##3##(2008-11#1)(2008-6#1)
the marriage##6##2##(2008-11#4)(2008-6#1)(2009-11#1)
the marrow##3##2##(1990-12#1)(1991-5#1)(1993-9#1)
the masculine##3##2##(2008-11#1)(2013-1#2)
the mask##10##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)(2010-5#1)
the masking agent##2##3##(2008-10#2)
the masking agents##3##3##(2008-10#3)
the masking##9##2##(2007-12#1)(2008-10#7)(2008-5#1)
the mass and##5##3##(2007-8#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-12#1)
the mass by##2##3##(2008-6#1)(2009-4#1)
the mass concentration##2##3##(2011-1#2)
the mass media##6##3##(1992-2#1)(1994-11#1)(1994-3#1)(1996-11#1)(2007-12#1)(2012-12#1)
the mass of the##4##4##(1990-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
the mass of##15##3##(1990-8#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
the mass spectra of the##2##5##(1991-5#1)(2008-10#1)
the mass spectra##5##3##(1991-5#1)(2008-10#3)(2010-5#1)
the mass spectral##2##3##(2008-10#1)(2011-2#1)
the mass spectrometer##6##3##(2008-1#1)(2008-10#3)(2008-4#1)(2010-7#1)
the mass transfer coefficient was 0##2##6##(2008-7#2)
the mass transfer coefficient##3##4##(2008-7#3)
the mass transfer of##3##4##(1990-12#1)(2008-10#1)(2013-1#1)
the mass transfer##11##3##(1990-12#1)(2008-10#2)(2008-7#3)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
the mass transport##2##3##(2008-10#1)(2008-9#1)
the mass was found##2##4##(2011-2#1)(2013-8#1)
the mass was##8##3##(1990-2#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the mass##103##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-5#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#5)(2008-7#7)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#5)(2013-8#3)
the mass-per-flexible-bond##2##2##(2008-9#2)
the massage##8##2##(2008-10#4)(2008-12#2)(2010-7#2)
the massaged##2##2##(2008-12#1)(2009-3#1)
the masses of the##2##4##(1993-8#1)(2008-10#1)
the masses of##3##3##(1993-8#2)(2008-10#1)
the masses##6##2##(1990-3#1)(1992-6#1)(1993-8#2)(2008-10#2)
the masseter muscle##10##3##(1993-12#1)(1996-2#1)(2008-4#4)(2010-6#1)(2010-9#1)(2013-1#2)
the masseter##12##2##(1993-12#1)(1996-2#1)(2008-4#5)(2010-6#1)(2010-9#1)(2013-1#3)
the massive##5##2##(1993-2#1)(2007-10#1)(2007-12#1)(2009-5#1)(2011-2#1)
the mast##2##2##(2008-10#2)
the master oscillator##2##3##(2007-12#1)(2008-3#1)
the master##5##2##(1994-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
the masticatory system##3##3##(2010-9#2)(2012-12#1)
the masticatory##5##2##(1990-9#1)(2010-9#3)(2012-12#1)
the mastoid cavity##2##3##(2008-9#2)
the mastoid portion of the facial nerve##2##7##(2008-9#2)
the mastoid process##5##3##(2008-7#4)(2008-9#1)
the mastoid region##2##3##(1990-12#1)(2008-6#1)
the mastoid##15##2##(1990-12#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-1#1)
the mat1-1##3##2##(2008-10#3)
the match between##2##3##(2008-3#1)(2008-8#1)
the match##4##2##(2008-3#2)(2008-8#1)(2009-8#1)
the matched##8##2##(1992-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#2)(2013-8#1)
the matching##2##2##(2008-10#2)
the mate##6##2##(2008-8#1)(2008-9#3)(2009-6#2)
the material and the##2##4##(2008-10#1)(2008-3#1)
the material and##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-10#1)
the material constants##2##3##(2008-3#1)(2009-4#1)
the material for##4##3##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
the material from##3##3##(1991-9#1)(1992-3#1)(2008-10#1)
the material is##3##3##(2007-12#2)(2008-4#1)
the material of choice##2##4##(2010-10#1)(2011-3#1)
the material of the##3##4##(2007-11#1)(2010-8#2)
the material of##7##3##(1994-3#1)(2007-11#1)(2008-10#1)(2010-10#1)(2010-8#2)(2011-3#1)
the material pretreated at##3##4##(2013-1#3)
the material properties of##3##4##(2007-11#1)(2008-3#2)
the material properties##4##3##(2007-11#1)(2008-3#2)(2008-7#1)
the material was##6##3##(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#1)
the material##79##2##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-10#1)(1994-3#1)(1995-8#1)(2007-11#7)(2007-12#6)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-8#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
the material's##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the materials and##5##3##(1996-2#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
the materials used##2##3##(2012-3#2)
the materials##24##2##(1990-9#1)(1996-12#1)(1996-2#2)(1997-3#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the maternal age##2##3##(1996-12#1)(2013-1#1)
the maternal and fetal##2##4##(1990-12#1)(2008-10#1)
the maternal and##3##3##(1990-12#1)(1995-12#1)(2008-10#1)
the maternal genome##2##3##(1994-11#2)
the maternal parent##3##3##(2008-5#1)(2010-8#2)
the maternal##30##2##(1990-12#1)(1992-4#1)(1992-5#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2010-8#3)(2011-2#1)(2013-1#4)
the mathematical model of##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
the mathematical model##4##3##(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
the mathematical models##2##3##(2008-6#1)(2009-8#1)
the mathematical##19##2##(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-3#4)(2008-4#1)(2008-6#2)(2009-6#1)(2009-8#1)(2011-2#2)
the mating propensity of males irradiated with##2##7##(2011-2#2)
the mating success of##2##4##(2008-9#2)
the mating system of##2##4##(2008-9#2)
the mating system##5##3##(2008-10#1)(2008-8#1)(2008-9#3)
the mating##22##2##(1990-11#1)(1996-2#1)(1997-4#2)(2008-10#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#6)(2011-2#2)(2012-12#2)
the matric potential##2##3##(2008-10#2)
the matrices##10##2##(1995-12#2)(1996-5#1)(2007-11#1)(2008-10#2)(2008-2#2)(2010-5#1)(2013-1#1)
the matrix and the##3##4##(2008-3#1)(2008-5#1)(2013-7#1)
the matrix and##11##3##(1990-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2013-7#1)
the matrix effect during the method development##2##7##(2010-11#2)
the matrix effect##9##3##(2008-10#5)(2010-11#4)
the matrix elements##3##3##(2008-10#2)(2008-2#1)
the matrix for the##2##4##(2008-10#2)
the matrix in##3##3##(2008-10#3)
the matrix influence##2##3##(2008-10#2)
the matrix interference##4##3##(2008-10#3)(2009-8#1)
the matrix interferences##2##3##(2008-10#2)
the matrix is##3##3##(2008-10#3)
the matrix method##2##3##(1990-8#1)(2008-6#1)
the matrix of the##2##4##(2008-10#1)(2008-5#1)
the matrix of##9##3##(1997-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-7#1)(2013-8#1)
the matrix with##2##3##(2008-10#2)
the matrix##112##2##(1990-2#1)(1990-8#2)(1992-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-2#1)(2007-11#2)(2008-10#56)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2009-6#1)(2009-7#3)(2009-8#1)(2010-11#4)(2010-5#4)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#4)(2013-8#1)
the matter of##2##3##(2007-8#1)(2008-10#1)
the matter##9##2##(1992-1#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-8#1)(2008-10#2)(2010-7#1)
the maturation and##2##3##(2007-3#1)(2011-3#1)
the maturation of##11##3##(1992-12#1)(1993-6#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the maturation process##2##3##(2008-10#1)(2008-5#1)
the maturation##17##2##(1992-12#1)(1993-6#1)(1995-6#1)(1996-5#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
the mature Amy##2##3##(1990-11#2)
the mature and##2##3##(1994-11#1)(1995-12#1)
the mature enzyme##2##3##(1991-9#1)(2009-11#1)
the mature form of##2##4##(1993-2#1)(2008-4#1)
the mature form##5##3##(1991-2#1)(1993-2#1)(1995-8#1)(1997-1#1)(2008-4#1)
the mature hormone##2##3##(1990-12#1)(2008-4#1)
the mature peptide##3##3##(1991-6#1)(1992-12#1)(2008-8#1)
the mature polypeptide##2##3##(1996-10#1)(2009-7#1)
the mature protein##15##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#4)(1993-2#1)(1995-8#1)(1996-10#2)
the mature region of##2##4##(1990-12#1)(1992-12#1)
the mature##78##2##(1990-11#3)(1990-12#6)(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#6)(1993-2#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#2)(1996-10#3)(1997-1#1)(1997-7#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)
the maturing of##2##3##(1995-8#1)(2011-2#1)
the maturing##3##2##(1994-5#1)(1995-8#1)(2011-2#1)
the maturity of social problem-solving skills##2##6##(2009-10#2)
the maturity of the##2##4##(1995-5#1)(2008-3#1)
the maturity of##4##3##(1995-5#1)(2008-3#1)(2009-10#2)
the maxilla and mandible##2##4##(2007-12#1)(2008-12#1)
the maxilla##9##2##(2007-12#2)(2008-12#1)(2008-6#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-7#1)
the maxillae##2##2##(1995-9#1)(2008-6#1)
the maxillary arch##2##3##(2007-12#1)(2008-12#1)
the maxillary sinus##12##3##(1993-1#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
the maxillary##27##2##(1993-1#1)(2007-10#1)(2007-12#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-11#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)
the maxima of##2##3##(2008-10#1)(2010-8#1)
the maxima##3##2##(1994-6#1)(2008-10#1)(2010-8#1)
the maximal cell##2##3##(2008-11#2)
the maximal effect##3##3##(1994-11#1)(1994-6#1)(2008-4#1)
the maximal growth##2##3##(2008-6#1)(2011-1#1)
the maximal level##4##3##(1993-6#1)(1994-11#2)(2008-9#1)
the maximal nonirritating##2##3##(2008-9#2)
the maximal possible##2##3##(2008-3#1)(2008-7#1)
the maximal principal stress##2##4##(2008-7#2)
the maximal response##2##3##(1995-12#1)(2008-3#1)
the maximal##48##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#3)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
the maximally##2##2##(2008-6#1)(2008-7#1)
the maximization of the##2##4##(2008-7#1)(2012-2#1)
the maximization of##3##3##(2008-7#2)(2012-2#1)
the maximum RLS wavelength##2##4##(2008-10#2)
the maximum RLS##3##3##(2008-10#3)
the maximum activity##2##3##(1994-8#1)(1997-2#1)
the maximum amount of information##2##5##(2008-7#2)
the maximum amount of##7##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-5#1)
the maximum and minimum##2##4##(2008-10#2)
the maximum and##4##3##(2008-10#2)(2008-2#2)
the maximum at##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
the maximum average##2##3##(2007-12#1)(2008-3#1)
the maximum binding##2##3##(2008-10#2)
the maximum cell density##3##4##(1993-8#1)(2008-11#1)(2008-7#1)
the maximum cell##4##3##(1993-8#1)(2008-11#2)(2008-7#1)
the maximum concentration##3##3##(1992-3#1)(2008-11#1)(2008-2#1)
the maximum current##2##3##(2008-10#1)(2009-10#1)
the maximum degree of protonation of the##2##7##(2008-10#2)
the maximum degree of##3##4##(2008-10#2)(2008-3#1)
the maximum density##2##3##(2008-10#1)(2008-9#1)
the maximum efficiencies##2##3##(2008-3#2)
the maximum fluorescence##4##3##(1995-5#1)(2008-10#1)(2008-3#1)(2013-8#1)
the maximum force##2##3##(1995-12#1)(2007-8#1)
the maximum gain##2##3##(2007-11#1)(2008-2#1)
the maximum growth rate##2##4##(2008-8#1)(2011-2#1)
the maximum growth##3##3##(2008-8#2)(2011-2#1)
the maximum in##3##3##(1995-5#1)(2008-10#1)(2010-5#1)
the maximum increase##2##3##(1991-8#1)(1997-3#1)
the maximum information density##2##4##(2008-3#2)
the maximum intensity##3##3##(2008-2#2)(2008-3#1)
the maximum likelihood estimators##2##4##(2008-7#1)(2012-3#1)
the maximum likelihood method##2##4##(2008-10#1)(2008-6#1)
the maximum likelihood methods##2##4##(2008-10#1)(2008-6#1)
the maximum likelihood##9##3##(1997-8#1)(2008-10#2)(2008-6#3)(2008-7#1)(2012-1#1)(2012-3#1)
the maximum load##2##3##(2013-1#2)
the maximum luminance##2##3##(2010-9#2)
the maximum metal##2##3##(2008-10#1)(2008-6#1)
the maximum number of##7##4##(1990-8#1)(2007-12#1)(2008-10#4)(2013-8#1)
the maximum number##8##3##(1990-8#1)(2007-12#1)(2008-10#4)(2008-7#1)(2013-8#1)
the maximum of the##5##4##(1992-8#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
the maximum of##9##3##(1992-8#1)(1995-5#1)(1996-5#2)(2008-10#3)(2008-2#1)(2008-3#1)
the maximum output##2##3##(2007-12#1)(2008-2#1)
the maximum pain##2##3##(2007-11#1)(2011-2#1)
the maximum performance##2##3##(2008-10#1)(2008-9#1)
the maximum permissible##4##3##(1993-3#1)(2008-10#2)(2013-1#1)
the maximum possible##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
the maximum power##2##3##(1992-9#1)(2012-2#1)
the maximum pump power##2##4##(2007-12#2)
the maximum rate of##3##4##(1990-7#1)(2008-8#2)
the maximum rate##5##3##(1990-11#1)(1990-7#1)(2008-10#1)(2008-8#2)
the maximum residue##2##3##(2008-10#1)(2008-7#1)
the maximum response##2##3##(2008-11#1)(2008-2#1)
the maximum signal##2##3##(2008-10#1)(2008-3#1)
the maximum spatial resolution##2##4##(2008-3#2)
the maximum spatial##3##3##(2008-2#1)(2008-3#2)
the maximum specific growth rate##2##5##(2008-10#1)(2008-7#1)
the maximum specific##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the maximum temperature##6##3##(1995-6#1)(2008-8#1)(2011-1#4)
the maximum theoretical##2##3##(1990-7#1)(2007-11#1)
the maximum value at##2##4##(1997-2#1)(2010-1#1)
the maximum value##3##3##(1997-2#1)(2008-11#1)(2010-1#1)
the maximum##273##2##(1990-11#1)(1990-7#3)(1990-8#1)(1991-12#2)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#9)(2007-8#2)(2008-1#2)(2008-10#77)(2008-11#10)(2008-12#4)(2008-2#23)(2008-3#20)(2008-4#1)(2008-5#3)(2008-6#9)(2008-7#9)(2008-8#8)(2008-9#5)(2009-10#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#6)
the maximum-likelihood##7##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-8#1)
the maze##6##2##(1993-12#1)(1993-5#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#1)
the meal##4##2##(1996-12#1)(2008-3#1)(2008-7#1)(2010-2#1)
the meals##4##2##(2008-3#1)(2013-1#1)(2013-7#2)
the mean (+/-SD)##3##3##(1993-10#1)(2008-10#1)(2008-7#1)
the mean 24-hour##2##3##(1990-11#2)
the mean DGD##2##3##(2007-12#2)
the mean GSH##4##3##(1990-2#1)(1994-2#3)
the mean Hb##2##3##(2007-7#2)
the mean QTc##2##3##(2008-8#2)
the mean VAS##2##3##(2008-7#1)(2009-3#1)
the mean age##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)
the mean amplitude##2##3##(2009-11#1)(2013-8#1)
the mean and standard deviation of the##4##7##(1994-11#1)(2008-10#1)(2008-3#2)
the mean and the##2##4##(2008-3#1)(2013-1#1)
the mean and##8##3##(1993-9#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-3#3)(2013-1#1)
the mean arterial pressure from##2##5##(2007-9#2)
the mean arterial pressure##5##4##(1994-3#1)(2007-9#2)(2008-7#1)(2013-8#1)
the mean body##2##3##(2008-9#2)
the mean cell numbers##2##4##(2008-11#1)(2012-1#1)
the mean concentration##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
the mean content of##2##4##(2008-10#1)(2008-8#1)
the mean daily##2##3##(1990-12#1)(2008-7#1)
the mean density##2##3##(2008-5#2)
the mean detector response##2##4##(2010-3#2)
the mean diameter##2##3##(2008-11#1)(2008-7#1)
the mean difference##2##3##(2008-10#1)(2011-2#1)
the mean differences##2##3##(2010-3#1)(2011-1#1)
the mean differential group delay of##2##6##(2007-11#2)
the mean disease##2##3##(2008-10#2)
the mean distance##2##3##(2008-10#2)
the mean duration of##3##4##(1996-3#1)(2007-8#1)(2008-7#1)
the mean flow##2##3##(2008-11#1)(2011-2#1)
the mean flux##2##3##(2010-10#2)
the mean free path of the##2##6##(2008-3#2)
the mean free path##4##4##(2008-2#1)(2008-3#3)
the mean hair shaft##2##4##(2008-5#2)
the mean intensity of##3##4##(2008-2#2)(2008-6#1)
the mean intensity##4##3##(2008-2#2)(2008-6#1)(2008-9#1)
the mean intraclass correlation##2##4##(2008-10#2)
the mean length of##2##4##(1991-12#1)(2008-7#1)
the mean level of##2##4##(1993-11#1)(1994-6#1)
the mean level##3##3##(1992-11#1)(1993-11#1)(1994-6#1)
the mean levels of##2##4##(1997-2#1)(2008-1#1)
the mean lifetime##3##3##(2008-8#3)
the mean number of##11##4##(1990-5#1)(1991-6#1)(1992-3#2)(1997-2#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-2#2)
the mean number##12##3##(1990-5#1)(1991-6#2)(1992-3#2)(1997-2#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-2#2)
the mean of scores for the##2##6##(2011-1#2)
the mean of the##9##4##(1994-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-8#1)
the mean of##19##3##(1994-3#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-8#1)(2011-1#2)(2011-2#1)
the mean orientation angle and angular distribution width were##2##9##(2008-10#2)
the mean orientation angle##4##4##(2008-10#4)
the mean rate of##3##4##(2008-3#2)(2008-5#1)
the mean reading level##2##4##(2011-1#2)
the mean recovery##3##3##(1990-11#1)(2008-10#2)
the mean score##2##3##(1995-4#1)(2013-8#1)
the mean serum##2##3##(2008-1#2)
the mean size of##2##4##(2008-9#1)(2012-3#1)
the mean square displacement##2##4##(1992-9#1)(2008-3#1)
the mean square##3##3##(1992-9#1)(2008-3#1)(2012-2#1)
the mean surface##2##3##(2009-11#1)(2011-2#1)
the mean time of##5##4##(1997-4#1)(2007-12#2)(2008-11#1)(2009-3#1)
the mean time to##3##4##(2008-8#2)(2012-12#1)
the mean time##12##3##(1991-6#1)(1992-11#1)(1992-12#1)(1997-4#1)(2007-12#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-12#1)
the mean total##5##3##(2009-10#1)(2010-12#1)(2011-2#2)(2012-1#1)
the mean value and##2##4##(2008-3#2)
the mean value in##3##4##(2007-12#1)(2008-10#2)
the mean value of##5##4##(1993-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
the mean value theorem##2##4##(2008-2#2)
the mean value##16##3##(1993-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#1)(2013-1#1)
the mean values of##2##4##(1993-1#1)(2008-11#1)
the mean values##4##3##(1993-1#1)(2008-10#1)(2008-11#1)(2009-11#1)
the mean velocity##3##3##(1993-12#2)(2008-2#1)
the mean weekly##2##3##(2007-7#1)(2011-2#1)
the mean##342##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#56)(2008-11#14)(2008-12#3)(2008-2#11)(2008-3#32)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#12)(2008-8#12)(2008-9#7)(2009-10#3)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-3#4)(2010-5#1)(2010-7#1)(2011-1#7)(2011-2#19)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#4)
the mean-field##2##2##(2007-12#1)(2008-2#1)
the mean-squared error##2##3##(2008-3#2)
the meaning and##5##3##(1992-2#1)(2008-11#3)(2009-6#1)
the meaning of a##3##4##(1995-2#1)(1996-9#1)(2011-3#1)
the meaning of the##3##4##(2008-2#1)(2008-7#1)(2012-3#1)
the meaning of##23##3##(1990-12#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-3#2)
the meaning##30##2##(1990-12#1)(1992-2#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2008-1#1)(2008-11#6)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-3#2)
the meanings##2##2##(1995-1#1)(2008-7#1)
the means by which health##2##5##(1997-2#1)(1997-3#1)
the means by which##6##4##(1996-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2012-3#1)
the means for##4##3##(1991-6#1)(1992-6#1)(1994-2#1)(2008-3#1)
the means of the##2##4##(2008-2#1)(2011-2#1)
the means of##8##3##(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)
the means to##11##3##(1990-11#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2010-10#1)(2013-8#1)
the means##31##2##(1990-11#1)(1991-6#1)(1992-6#2)(1994-2#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
the meantime##8##2##(1992-3#1)(1995-12#1)(1996-11#1)(2009-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the meanwhile##2##2##(2008-11#2)
the measurable##2##2##(1990-8#1)(1997-5#1)
the measure and##2##3##(2008-11#1)(2012-2#1)
the measure of multilocus correlation##2##5##(2008-10#2)
the measure of multilocus##3##4##(2008-10#3)
the measure of##9##3##(1992-12#1)(1994-9#1)(2008-1#1)(2008-10#5)(2012-3#1)
the measure##22##2##(1990-2#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-6#2)(1996-3#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
the measured Doppler##2##3##(2008-3#1)(2011-1#1)
the measured absorption and the##2##5##(2008-3#2)
the measured absorption##3##3##(2008-3#3)
the measured and predicted datasets##2##5##(2010-8#2)
the measured and predicted##3##4##(2008-2#1)(2010-8#2)
the measured and theoretical##3##4##(2008-10#1)(2008-3#2)
the measured and##9##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)(2010-8#2)
the measured data with##2##4##(2008-3#2)
the measured data##13##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)
the measured frequency##2##3##(2008-2#1)(2008-3#1)
the measured image##2##3##(2008-2#1)(2008-3#1)
the measured intensity data##2##4##(2007-12#2)
the measured intensity##3##3##(2007-12#2)(2008-3#1)
the measured intrinsic vector##2##4##(2008-3#2)
the measured optical##2##3##(2008-3#2)
the measured ozone##2##3##(2008-3#2)
the measured parameters##2##3##(2008-3#2)
the measured phase distribution##2##4##(2008-2#2)
the measured phase##3##3##(2007-11#1)(2008-2#2)
the measured potential##2##3##(2008-10#2)
the measured profile##2##3##(2008-3#2)
the measured radiance##4##3##(2008-2#4)
the measured reflectance##4##3##(2008-2#1)(2008-3#3)
the measured results##4##3##(2008-3#4)
the measured shape##4##3##(2008-2#1)(2008-6#3)
the measured spectra##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the measured spectral##4##3##(2008-2#1)(2008-3#3)
the measured speed of sound is too##2##7##(2008-3#2)
the measured surface##2##3##(2008-3#2)
the measured value##2##3##(2008-3#2)
the measured values##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
the measured wave fronts##2##4##(2008-2#2)
the measured wave##3##3##(2008-2#3)
the measured##193##2##(1992-3#1)(1993-2#1)(1994-12#2)(1995-11#1)(1995-5#1)(1996-12#1)(2007-11#10)(2007-12#12)(2008-10#18)(2008-11#5)(2008-2#42)(2008-3#74)(2008-5#4)(2008-6#3)(2008-7#2)(2008-9#2)(2009-7#1)(2010-8#2)(2011-1#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
the measurement accuracy and##2##4##(2008-3#1)(2012-3#1)
the measurement accuracy##8##3##(2008-2#2)(2008-3#5)(2012-3#1)
the measurement and the##2##4##(2008-3#2)
the measurement and##9##3##(1995-2#1)(2008-1#1)(2008-10#3)(2008-3#4)
the measurement by##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the measurement error is##2##4##(2008-3#1)(2008-7#1)
the measurement error##6##3##(2007-11#1)(2008-12#1)(2008-3#3)(2008-7#1)
the measurement errors##2##3##(1997-8#1)(2007-11#1)
the measurement in##2##3##(2008-10#1)(2008-2#1)
the measurement interferometer##2##3##(2008-3#2)
the measurement is##2##3##(2008-10#1)(2008-2#1)
the measurement of a##7##4##(2008-10#2)(2008-2#1)(2008-3#3)(2010-2#1)
the measurement of benzo[a]pyrene hydroxylase activity and CO reducible cytochrome P450##2##11##(1994-6#2)
the measurement of both the##2##5##(2008-2#1)(2008-5#1)
the measurement of both##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
the measurement of fluorescence##2##4##(2008-10#1)(2008-9#1)
the measurement of optical##4##4##(2008-10#1)(2008-3#3)
the measurement of surface##2##4##(2008-2#2)
the measurement of the fluorescence##2##5##(2008-10#2)
the measurement of the##35##4##(1990-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2010-11#1)(2010-5#1)
the measurement of##189##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1992-11#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-2#2)(1996-12#1)(1997-4#2)(1997-6#1)(2006-6#2)(2007-11#6)(2007-12#2)(2008-1#2)(2008-10#53)(2008-11#4)(2008-2#12)(2008-3#44)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#4)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-2#2)(2010-5#3)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
the measurement process##3##3##(2008-10#3)
the measurement range##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
the measurement results##5##3##(2008-10#2)(2008-3#1)(2009-11#1)(2012-3#1)
the measurement sensitivity##2##3##(2008-3#1)(2008-9#1)
the measurement step##2##3##(2008-10#2)
the measurement system##6##3##(1996-2#1)(2008-10#1)(2008-3#4)
the measurement uncertainty of analytical assays##2##6##(2008-10#2)
the measurement uncertainty of##3##4##(2008-10#3)
the measurement uncertainty##8##3##(2008-10#5)(2008-3#3)
the measurement volume##3##3##(2007-11#1)(2008-3#2)
the measurement was##5##3##(2008-10#5)
the measurement##312##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-2#3)(1996-12#1)(1996-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-6#2)(2007-11#11)(2007-12#2)(2008-1#3)(2008-10#90)(2008-11#6)(2008-12#1)(2008-2#29)(2008-3#89)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#3)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
the measurement-volume effect##3##3##(2008-3#3)
the measurements and##2##3##(2008-3#2)
the measurements are##4##3##(1991-8#1)(2008-3#2)(2008-4#1)
the measurements at##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
the measurements being##2##3##(2008-10#1)(2008-3#1)
the measurements could be##2##4##(2008-2#1)(2008-3#1)
the measurements could##3##3##(2008-2#1)(2008-3#2)
the measurements from##2##3##(2008-12#1)(2008-3#1)
the measurements of the##2##4##(2008-1#1)(2008-6#1)
the measurements of##11##3##(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-7#1)(2012-1#1)
the measurements to##2##3##(2007-12#1)(2008-10#1)
the measurements was##3##3##(2008-10#2)(2012-12#1)
the measurements were##3##3##(1993-11#1)(2008-3#2)
the measurements with##2##3##(2008-2#1)(2008-3#1)
the measurements##71##2##(1991-8#1)(1993-11#1)(1994-11#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#4)(2008-3#27)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-1#2)(2012-12#1)
the measures are##2##3##(1990-2#1)(2008-11#1)
the measures for##2##3##(2008-8#1)(2011-1#1)
the measures of multilocus correlation and association##2##7##(2008-10#2)
the measures of##9##3##(1990-3#1)(1996-12#1)(2008-10#4)(2008-11#1)(2013-1#2)
the measures taken to##2##4##(1996-6#1)(2011-2#1)
the measures taken##3##3##(1996-6#1)(2008-11#1)(2011-2#1)
the measures##24##2##(1990-2#1)(1990-3#1)(1996-12#2)(1996-6#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#1)(2009-1#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
the measuring range of the##2##5##(2008-10#2)
the measuring range of##4##4##(2008-10#4)
the measuring range##6##3##(2008-10#6)
the measuring##16##2##(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
the meat##16##2##(2008-10#5)(2010-4#9)(2013-1#2)
the mechanical and degradation##2##4##(2012-2#2)
the mechanical and##6##3##(1996-3#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-2#2)
the mechanical aspects of##2##4##(2008-3#1)(2012-12#1)
the mechanical behavior of##4##4##(2008-11#1)(2009-7#1)(2012-2#2)
the mechanical behaviour of the##2##5##(2009-7#2)
the mechanical behaviour of##3##4##(2009-7#3)
the mechanical behaviour##4##3##(2009-7#4)
the mechanical function##2##3##(2008-3#1)(2009-7#1)
the mechanical properties of the##8##5##(1996-4#1)(2008-6#1)(2009-7#3)(2011-2#1)(2013-1#2)
the mechanical properties of##18##4##(1996-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#6)(2011-2#2)(2013-1#2)
the mechanical properties##26##3##(1996-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-6#1)(2009-11#1)(2009-7#7)(2010-4#1)(2011-2#2)(2012-2#3)(2013-1#2)
the mechanical stability of##2##4##(1991-12#1)(2008-7#1)
the mechanical strength of##3##4##(2009-7#1)(2010-2#2)
the mechanical strength##4##3##(2009-7#1)(2010-2#2)(2010-4#1)
the mechanical stress##2##3##(2008-3#2)
the mechanical##78##2##(1991-12#1)(1992-3#1)(1995-2#1)(1996-3#2)(1996-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#5)(2008-6#1)(2008-7#4)(2009-11#1)(2009-7#14)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#7)(2013-1#2)
the mechanically##3##2##(1994-12#1)(2008-3#1)(2010-5#1)
the mechanics of the##4##4##(1994-3#1)(2008-9#1)(2010-1#1)(2011-2#1)
the mechanics of##9##3##(1994-3#1)(2007-12#1)(2008-7#4)(2008-9#1)(2010-1#1)(2011-2#1)
the mechanics##10##2##(1994-3#1)(2007-12#1)(2008-7#5)(2008-9#1)(2010-1#1)(2011-2#1)
the mechanism and function of##2##5##(2008-2#1)(2010-12#1)
the mechanism and##9##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
the mechanism by which NRT works##2##6##(2012-3#2)
the mechanism by which the##5##5##(1990-11#1)(1991-11#1)(1993-2#1)(2008-10#1)(2008-5#1)
the mechanism by which this occurs##3##6##(1992-9#1)(2008-11#1)(2013-1#1)
the mechanism by which this##6##5##(1990-7#1)(1992-3#1)(1992-9#1)(2008-11#1)(2010-11#1)(2013-1#1)
the mechanism by which##33##4##(1990-11#2)(1990-5#1)(1990-7#1)(1991-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-11#1)(2011-1#1)(2012-3#2)(2013-1#1)
the mechanism for the##6##4##(1995-3#1)(1996-12#1)(2008-10#1)(2008-3#3)
the mechanism for this##3##4##(2008-11#1)(2008-6#1)(2009-10#1)
the mechanism for##17##3##(1990-11#1)(1995-3#1)(1996-12#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
the mechanism governing the##2##4##(2008-7#1)(2008-8#1)
the mechanism governing##3##3##(1990-8#1)(2008-7#1)(2008-8#1)
the mechanism involved in the##2##5##(2008-7#1)(2012-12#1)
the mechanism involved in##3##4##(1994-2#1)(2008-7#1)(2012-12#1)
the mechanism involved##4##3##(1994-2#1)(2008-7#1)(2009-5#1)(2012-12#1)
the mechanism is##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
the mechanism of action of silicone sheeting##2##7##(2008-9#2)
the mechanism of action of the##4##6##(2008-10#2)(2008-5#1)(2013-8#1)
the mechanism of action of these##2##6##(2008-11#1)(2010-11#1)
the mechanism of action of##21##5##(1990-11#1)(1990-3#1)(1991-5#1)(1994-11#1)(1995-5#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#1)(2013-8#1)
the mechanism of action##26##4##(1990-11#1)(1990-3#1)(1991-5#1)(1993-12#1)(1994-11#1)(1995-5#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-11#2)(2011-2#1)(2013-8#1)
the mechanism of biocontrol of R##2##6##(2008-10#2)
the mechanism of enhancement##2##4##(1991-5#2)
the mechanism of inhibition##2##4##(1992-3#1)(1992-8#1)
the mechanism of insulin##2##4##(1996-5#1)(2010-12#1)
the mechanism of interaction##3##4##(1990-2#2)(2008-10#1)
the mechanism of ischemic preconditioning##2##5##(1996-9#2)
the mechanism of its##2##4##(1997-4#1)(2008-5#1)
the mechanism of proteinase inhibitors##2##5##(1996-12#2)
the mechanism of regulation##3##4##(1990-8#1)(1994-12#1)(2008-11#1)
the mechanism of resistance##3##4##(2008-10#3)
the mechanism of steroid##3##4##(1990-11#1)(1996-2#1)(2008-4#1)
the mechanism of the##15##4##(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-4#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#1)
the mechanism of this##8##4##(1993-9#1)(1994-8#1)(2007-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-8#1)
the mechanism of##175##3##(1990-11#2)(1990-2#2)(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#5)(1991-9#2)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#2)(1997-2#4)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#25)(2008-11#9)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#7)(2009-12#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
the mechanism remains##2##3##(2008-11#1)(2013-1#1)
the mechanism that leads to##2##5##(2011-2#1)(2013-1#1)
the mechanism that##6##3##(2008-11#2)(2008-3#1)(2011-2#2)(2013-1#1)
the mechanism through which##3##4##(1993-6#1)(2008-11#1)(2008-8#1)
the mechanism to##2##3##(1992-3#1)(2008-3#1)
the mechanism underlying the##4##4##(2007-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
the mechanism underlying this##3##4##(2008-10#1)(2010-11#1)(2012-2#1)
the mechanism underlying##11##3##(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
the mechanism whereby##2##3##(1991-12#1)(2008-1#1)
the mechanism##286##2##(1990-11#6)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#5)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#4)(1996-2#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#1)(2008-1#3)(2008-10#35)(2008-11#18)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#8)(2008-7#10)(2008-8#13)(2008-9#10)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#6)
the mechanism(s) of##4##3##(1992-6#1)(1993-8#1)(1994-8#1)(2008-10#1)
the mechanism(s)##9##2##(1992-6#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-1#1)
the mechanism-based##2##2##(1992-6#1)(1992-8#1)
the mechanisms and##12##3##(1990-8#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-8#2)(2011-2#1)(2012-12#2)
the mechanisms are not##2##4##(2008-4#1)(2008-7#1)
the mechanisms are##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
the mechanisms associated with##2##4##(2007-8#2)
the mechanisms behind these##2##4##(2008-11#1)(2012-2#1)
the mechanisms behind##4##3##(2008-11#2)(2010-3#1)(2012-2#1)
the mechanisms by which the antidepressants##2##6##(2010-5#2)
the mechanisms by which##27##4##(1995-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#2)(2011-3#1)(2012-2#2)(2013-1#2)
the mechanisms by##28##3##(1995-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#2)(2011-3#1)(2012-2#3)(2013-1#2)
the mechanisms for##3##3##(2008-6#1)(2009-12#1)(2012-3#1)
the mechanisms governing##3##3##(2008-7#1)(2009-10#1)(2011-1#1)
the mechanisms involved have been##2##5##(1995-2#1)(2010-3#1)
the mechanisms involved in this##2##5##(1993-6#1)(2008-1#1)
the mechanisms involved in##8##4##(1993-6#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)
the mechanisms involved##13##3##(1993-6#1)(1995-2#2)(1997-3#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2010-3#1)(2011-2#1)
the mechanisms leading to##4##4##(1992-9#1)(1995-12#1)(1996-5#1)(2012-1#1)
the mechanisms of action##5##4##(2008-10#2)(2008-7#1)(2010-8#1)(2012-12#1)
the mechanisms of evolution##2##4##(2008-8#1)(2010-3#1)
the mechanisms of heat##2##4##(1994-11#1)(2012-2#1)
the mechanisms of induction##2##4##(2008-8#2)
the mechanisms of probiotic##2##4##(2011-2#1)(2012-1#1)
the mechanisms of the##7##4##(1991-3#1)(1992-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2009-8#2)
the mechanisms of thermal##2##4##(2008-10#1)(2013-1#1)
the mechanisms of##88##3##(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
the mechanisms regulating##5##3##(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-1#1)
the mechanisms responsible for the##2##5##(1994-11#1)(2008-2#1)
the mechanisms responsible for##7##4##(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
the mechanisms that control their##2##5##(2008-10#1)(2008-9#1)
the mechanisms that control##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
the mechanisms that increase##2##4##(1993-3#1)(2012-2#1)
the mechanisms that mediate the##2##5##(1996-2#1)(2011-2#1)
the mechanisms that regulate##2##4##(1995-8#1)(2008-11#1)
the mechanisms that underlie the##2##5##(2008-9#1)(2009-8#1)
the mechanisms that##16##3##(1993-3#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
the mechanisms through which##4##4##(1992-8#1)(2008-4#1)(2010-1#1)(2012-12#1)
the mechanisms underlying the##11##4##(1992-4#1)(1993-8#1)(1995-12#1)(2008-7#1)(2008-9#3)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
the mechanisms underlying these##2##4##(2008-10#1)(2013-8#1)
the mechanisms underlying this##3##4##(2008-1#1)(2008-9#1)(2012-1#1)
the mechanisms underlying##29##3##(1990-5#1)(1992-4#1)(1993-8#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#4)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the mechanisms##238##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#4)(2008-10#21)(2008-11#17)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#19)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#10)(2010-1#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#13)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
the mechanistic basis of##2##4##(1995-8#1)(2011-2#1)
the mechanistic details##2##3##(2010-2#1)(2012-2#1)
the mechanistic##10##2##(1994-12#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#2)
the mechanosensitivity of the##2##4##(2008-12#2)
the medaka Oryzias##2##3##(2008-1#1)(2008-5#1)
the medaka fish##4##3##(1997-9#1)(2008-5#2)(2008-6#1)
the medaka##7##2##(1997-9#1)(2008-1#1)(2008-5#4)(2008-6#1)
the medfly Ceratitis capitata##3##4##(2007-12#3)
the media and##4##3##(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)
the media as well as##3##5##(1996-12#1)(2008-3#1)(2009-5#1)
the media noise##6##3##(2008-2#4)(2008-3#2)
the media of the##2##4##(1993-8#1)(1995-1#1)
the media of##4##3##(1991-5#1)(1993-8#1)(1995-1#1)(2008-3#1)
the media on##3##3##(2007-12#3)
the media with##2##3##(2008-2#1)(2008-8#1)
the media##60##2##(1991-5#1)(1991-9#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-2#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#5)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
the media's##2##2##(1991-1#1)(2007-12#1)
the medial agranular##2##3##(1994-3#2)
the medial antebrachial cutaneous nerve##2##5##(2008-9#2)
the medial collateral ligament##2##4##(2008-8#1)(2012-2#1)
the medial collateral##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
the medial compartment##3##3##(1990-6#1)(1992-3#1)(2013-1#1)
the medial cortex of the##2##5##(2010-3#1)(2011-2#1)
the medial flagellum and##2##4##(2007-12#2)
the medial forebrain bundle##6##4##(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)
the medial gastrocnemius##2##3##(1996-2#1)(2011-1#1)
the medial head of the##2##5##(2007-11#1)(2008-9#1)
the medial part of the##2##5##(2008-7#1)(2009-4#1)
the medial perforant path##3##4##(1993-12#3)
the medial perforant##4##3##(1993-12#3)(1995-12#1)
the medial pontine reticular formation##3##5##(1990-7#3)
the medial prefrontal and##2##4##(1993-12#1)(2008-11#1)
the medial prefrontal cortex and##2##5##(2008-11#2)
the medial prefrontal cortex##10##4##(1994-8#1)(1996-2#2)(1997-2#1)(2008-11#4)(2008-6#2)
the medial prefrontal##13##3##(1991-2#1)(1993-12#1)(1994-8#1)(1996-2#2)(1997-2#1)(2008-11#5)(2008-6#2)
the medial septal area##2##4##(1993-12#1)(2013-8#1)
the medial septal##3##3##(1993-12#2)(2013-8#1)
the medial septum##4##3##(1993-12#3)(1994-3#1)
the medial superior olivary nucleus##4##5##(1997-3#4)
the medial surface of the##2##5##(2007-12#1)(2008-5#1)
the medial surface of##3##4##(2007-12#2)(2008-5#1)
the medial surface##4##3##(2007-12#2)(2008-5#1)(2012-2#1)
the medial temporal lobe##5##4##(1991-10#2)(1992-11#1)(2010-7#2)
the medial temporal##7##3##(1991-10#2)(1992-11#1)(2008-11#1)(2010-7#3)
the medial wall##2##3##(1997-8#1)(2008-9#1)
the medial##121##2##(1990-6#1)(1990-7#5)(1990-9#2)(1991-10#2)(1991-2#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-12#11)(1994-2#1)(1994-3#4)(1994-8#2)(1995-12#5)(1995-6#2)(1996-12#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-11#8)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
the median MoM##2##3##(1996-12#2)
the median P##2##3##(2008-10#2)
the median SP1 (0##2##4##(1995-8#2)
the median age##2##3##(1992-8#1)(2013-1#1)
the median domain##6##3##(2007-12#6)
the median duration##2##3##(2008-6#1)(2008-7#1)
the median follow-up##3##3##(1990-2#1)(1993-11#1)(2012-12#1)
the median nerve with##2##4##(2008-9#2)
the median nerve##11##3##(1992-6#1)(1994-11#1)(2008-9#9)
the median raphe nucleus##3##4##(1991-2#1)(1993-12#2)
the median raphe##4##3##(1991-2#2)(1993-12#2)
the median survival was##2##4##(1990-10#1)(1997-5#1)
the median survival##5##3##(1990-10#1)(1992-9#1)(1997-5#1)(2007-11#1)(2008-10#1)
the median total##2##3##(1994-3#1)(2008-10#1)
the median value was##2##4##(2011-2#2)
the median value##3##3##(1993-11#1)(2011-2#2)
the median##78##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#3)(1997-5#3)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#2)(2008-10#6)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#9)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
the medians##2##2##(1990-8#1)(2012-1#1)
the mediastinal##3##2##(2007-8#1)(2012-3#1)(2013-7#1)
the mediastinum was##2##3##(1990-8#1)(1997-3#1)
the mediastinum##17##2##(1990-8#3)(1991-8#2)(1997-3#1)(2007-8#3)(2008-11#1)(2008-6#4)(2011-2#2)(2012-2#1)
the mediating role of##2##4##(2010-2#1)(2012-3#1)
the mediating##6##2##(2009-7#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
the mediation of##8##3##(1990-12#1)(1991-2#1)(1997-1#1)(1997-4#1)(2008-4#2)(2009-3#1)(2011-2#1)
the mediation##9##2##(1990-12#1)(1991-2#1)(1995-5#1)(1997-1#1)(1997-4#1)(2008-4#2)(2009-3#1)(2011-2#1)
the mediator##4##2##(2008-10#3)(2010-5#1)
the mediators##5##2##(2008-1#1)(2008-10#2)(2009-7#2)
the medical and health##2##4##(2009-10#1)(2013-8#1)
the medical and public health##2##5##(1997-3#1)(2013-8#1)
the medical and surgical##2##4##(1993-3#1)(2007-7#1)
the medical and##14##3##(1991-1#1)(1991-11#1)(1993-3#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-8#3)
the medical care and public health##2##6##(1995-2#1)(2013-8#1)
the medical care system##4##4##(1995-12#3)(1997-3#1)
the medical care##11##3##(1991-12#1)(1991-6#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-3#1)(2007-7#1)(2010-3#1)(2013-8#1)
the medical community##9##3##(1993-6#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-8#2)(2010-6#1)(2010-8#1)(2013-1#1)
the medical devices##2##3##(2008-11#2)
the medical disorder##2##3##(2012-2#2)
the medical examiner##2##3##(1995-3#1)(2011-2#1)
the medical expenditure##2##3##(2010-8#2)
the medical group##5##3##(1991-1#1)(1993-12#1)(1993-6#1)(1994-3#2)
the medical indications##2##3##(1993-11#1)(2007-11#1)
the medical literature regarding##2##4##(2008-6#1)(2013-1#1)
the medical literature##17##3##(1990-8#1)(1992-12#1)(1996-9#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-6#3)(2012-3#1)(2013-1#2)(2013-8#1)
the medical management of##3##4##(1991-2#1)(2012-2#1)(2013-8#1)
the medical management##5##3##(1991-2#1)(1992-9#1)(2008-9#1)(2012-2#1)(2013-8#1)
the medical model##2##3##(1996-12#1)(2009-10#1)
the medical practice##2##3##(1996-2#1)(1997-3#1)
the medical profession##12##3##(1991-11#1)(1991-3#1)(1995-11#1)(1996-11#1)(2008-12#3)(2008-7#2)(2009-10#1)(2009-5#1)(2013-1#1)
the medical provider##3##3##(2013-1#3)
the medical record##5##3##(1991-6#1)(1992-3#1)(1996-2#1)(2007-12#2)
the medical records of##9##4##(1990-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the medical records##13##3##(1990-2#1)(1991-1#1)(1991-7#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the medical resources##2##3##(1990-6#1)(2007-11#1)
the medical school##2##3##(2008-3#1)(2013-1#1)
the medical science##2##3##(2009-7#1)(2010-12#1)
the medical service##2##3##(1993-12#1)(1995-12#1)
the medical services##2##3##(1994-2#1)(1996-12#1)
the medical staff as##2##4##(1991-3#1)(1994-3#1)
the medical staff##18##3##(1991-3#2)(1992-2#3)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#3)(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2012-2#1)
the medical team##4##3##(1997-1#1)(2008-6#1)(2012-2#1)(2013-8#1)
the medical termination of##2##4##(1995-8#2)
the medical treatment of##3##4##(1994-2#1)(1994-9#1)(2007-11#1)
the medical treatment##5##3##(1994-2#1)(1994-9#1)(2007-11#2)(2010-3#1)
the medical##237##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#5)(1991-6#3)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#4)(1993-8#1)(1994-1#2)(1994-2#7)(1994-3#3)(1994-5#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#4)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-5#2)(2007-7#4)(2008-1#3)(2008-10#5)(2008-11#8)(2008-12#7)(2008-3#1)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#6)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#5)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-6#4)(2010-8#4)(2011-2#10)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#10)(2013-8#11)
the medical-legal discourse##2##3##(2009-7#2)
the medical-legal##3##2##(1994-1#1)(2009-7#2)
the medically##4##2##(1992-2#1)(1992-3#1)(2008-1#1)(2013-8#1)
the medication group##2##3##(2008-3#2)
the medication in##2##3##(1996-9#1)(2013-1#1)
the medication prescribed##2##3##(2010-5#2)
the medication##26##2##(1992-12#3)(1995-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
the medications##7##2##(1992-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
the medicinal##2##2##(2008-10#1)(2012-2#1)
the medicine##5##2##(1996-11#1)(1996-3#1)(2008-11#1)(2010-8#1)(2012-3#1)
the medicines##2##2##(2008-11#1)(2011-1#1)
the medieval##2##2##(2008-3#1)(2013-8#1)
the mediodorsal thalamic nucleus##2##4##(1996-5#1)(1997-2#1)
the mediodorsal##3##2##(1996-5#1)(1997-2#2)
the medium SPM##2##3##(2012-2#2)
the medium and the##4##4##(2007-12#1)(2008-10#2)(2011-2#1)
the medium and##18##3##(1994-9#1)(1996-2#1)(1996-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2011-2#1)(2011-3#1)(2012-4#1)(2013-1#1)
the medium as##2##3##(1992-3#1)(2008-3#1)
the medium can##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
the medium composition##3##3##(2008-11#2)(2008-6#1)
the medium containing human serum and basic fibroblast growth factor##2##10##(2008-11#2)
the medium containing only##3##4##(2008-11#3)
the medium containing##15##3##(1997-8#1)(2006-12#1)(2008-11#9)(2008-5#1)(2008-6#2)(2013-1#1)
the medium formulation##2##3##(2008-11#2)
the medium is##4##3##(1991-5#1)(1994-6#1)(2008-2#1)(2008-3#1)
the medium of##7##3##(1991-5#1)(1992-5#1)(2007-10#1)(2008-10#2)(2008-3#2)
the medium or##2##3##(1995-11#1)(2008-10#1)
the medium pH##2##3##(2008-10#2)
the medium perfusion rate##3##4##(2008-11#3)
the medium scattering coefficient##2##4##(2008-2#2)
the medium surface##2##3##(2008-2#1)(2008-3#1)
the medium to##3##3##(2008-11#2)(2008-3#1)
the medium used##2##3##(2008-10#1)(2008-5#1)
the medium was increased##4##4##(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)
the medium was##17##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)
the medium were##2##3##(1996-2#1)(2008-10#1)
the medium with 1##2##4##(2008-8#2)
the medium with##8##3##(1993-12#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)
the medium without##3##3##(1991-9#1)(1992-6#1)(2008-11#1)
the medium##218##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-5#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#1)(1996-2#2)(1996-4#1)(1997-2#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#45)(2008-12#2)(2008-2#13)(2008-3#20)(2008-5#2)(2008-6#11)(2008-7#6)(2008-8#4)(2008-9#1)(2009-8#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-4#1)(2012-7#1)(2013-1#2)(2013-7#3)
the medulla terminalis##2##3##(2007-12#1)(2008-5#1)
the medulla##7##2##(1993-12#1)(1997-2#1)(2007-12#1)(2008-5#3)(2010-9#1)
the medullary cavity##4##3##(1995-6#1)(2010-3#1)(2013-1#2)
the medullary##10##2##(1991-11#1)(1992-8#2)(1995-6#1)(1996-9#1)(2007-7#1)(2010-3#1)(2013-1#3)
the meeting and##2##3##(2008-5#1)(2009-5#1)
the meeting of the##2##4##(2008-8#1)(2009-5#1)
the meeting was##4##3##(1994-9#1)(2008-5#2)(2008-7#1)
the meeting##18##2##(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-5#5)(2008-7#2)(2008-8#1)(2009-5#2)(2010-11#1)(2012-3#1)
the meetings##2##2##(1993-11#1)(1993-3#1)
the megahertz range##2##3##(2008-2#1)(2008-3#1)
the meiosis##2##2##(2008-9#1)(2012-2#1)
the meiotic cell cycle##2##4##(2008-5#1)(2008-9#1)
the meiotic##4##2##(2008-5#2)(2008-7#1)(2008-9#1)
the melanocytes##3##2##(1994-12#1)(1995-2#1)(2008-5#1)
the melanogenesis##2##2##(2008-11#1)(2008-5#1)
the melanogenic##4##2##(1995-2#1)(2008-11#1)(2008-5#2)
the melanoma##3##2##(2007-10#1)(2008-9#1)(2011-2#1)
the melanosome transfer##2##3##(2008-8#2)
the melanotrope cells##4##3##(1993-5#4)
the melatonin biosynthesis in the mammalian pineal organ##2##8##(1994-5#2)
the melatonin biosynthesis in##3##4##(1994-5#3)
the melatonin biosynthesis##4##3##(1994-5#4)
the melatonin receptor##3##3##(1995-3#2)(2009-12#1)
the melatonin##11##2##(1992-3#1)(1994-5#5)(1995-3#2)(2008-10#1)(2008-12#1)(2009-12#1)
the melon aphid##2##3##(2008-10#2)
the melt pool##2##3##(2008-3#2)
the melt##6##2##(2007-12#2)(2008-10#2)(2008-3#2)
the melting point##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
the melting temperature##2##3##(2007-11#1)(2009-3#1)
the melting##10##2##(1992-3#1)(1993-8#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2013-8#1)
the members of the genus##2##5##(2008-10#1)(2011-2#1)
the members of the##9##4##(1993-12#1)(1994-9#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
the members of this##2##4##(1993-6#1)(2010-3#1)
the members of##17##3##(1993-12#1)(1993-6#1)(1994-9#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)
the membership function values##2##4##(2010-8#2)
the membership##5##2##(1994-3#2)(2008-11#1)(2010-8#2)
the membrane anchor##3##3##(1994-8#2)(1997-7#1)
the membrane and the##7##4##(1990-11#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
the membrane and##19##3##(1990-11#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-5#1)(2013-7#1)
the membrane are##2##3##(1994-12#1)(2008-10#1)
the membrane by the##3##4##(1993-8#1)(1994-8#1)(2008-10#1)
the membrane by##6##3##(1993-11#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-4#1)(2010-5#1)
the membrane can be##3##4##(2008-10#2)(2008-2#1)
the membrane can##4##3##(2008-10#3)(2008-2#1)
the membrane electrode##2##3##(2008-10#2)
the membrane environment##2##3##(1991-5#1)(1993-6#1)
the membrane fraction##5##3##(1990-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(2008-11#1)
the membrane having##3##3##(2008-10#3)
the membrane in a##4##4##(1994-6#1)(2008-4#2)(2012-2#1)
the membrane in the##2##4##(1990-11#1)(1992-12#1)
the membrane in##10##3##(1990-11#1)(1992-12#1)(1993-11#1)(1994-6#1)(2008-4#2)(2009-11#1)(2009-9#1)(2011-1#1)(2012-2#1)
the membrane is washed and the antibody-antigen complexes are identified with horseradish peroxidase (HRPO) or alkaline phosphatase enzymes coupled to the secondary anti-IgG antibody (e##2##25##(2008-4#2)
the membrane is##6##3##(1992-12#1)(1994-6#1)(2008-10#1)(2008-4#2)(2010-5#1)
the membrane lipid bilayer##2##4##(1990-7#1)(1992-6#1)
the membrane lipid##3##3##(1990-7#1)(1992-6#1)(1994-11#1)
the membrane localization##2##3##(2008-8#1)(2012-2#1)
the membrane matrix##2##3##(1996-8#1)(2012-2#1)
the membrane of Escherichia coli##2##5##(1991-10#1)(2008-10#1)
the membrane of the##6##4##(1990-12#2)(1993-8#1)(1995-11#1)(2008-8#1)(2008-9#1)
the membrane of##15##3##(1990-12#2)(1991-10#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)
the membrane permeability to##2##4##(1990-5#1)(2008-8#1)
the membrane permeability##3##3##(1990-5#1)(1992-6#1)(2008-8#1)
the membrane potential of##2##4##(1990-5#1)(2008-9#1)
the membrane potential##10##3##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1997-1#1)(2008-9#1)(2013-8#1)
the membrane protein##2##3##(2011-2#2)
the membrane recycling hypothesis##3##4##(1997-1#3)
the membrane sensor has been##2##5##(2008-10#2)
the membrane sensor has##3##4##(2008-10#3)
the membrane spanning region##3##4##(1991-12#2)(1994-9#1)
the membrane surface##4##3##(1991-9#1)(1994-5#1)(1997-2#1)(2012-2#1)
the membrane through a##2##4##(1990-2#1)(1996-3#1)
the membrane topology of proteins##2##5##(1997-7#2)
the membrane was##12##3##(1991-3#1)(1993-12#1)(1994-11#1)(1996-5#1)(2008-10#5)(2008-5#2)(2011-2#1)
the membrane with##3##3##(2008-10#2)(2008-5#1)
the membrane##299##2##(1990-11#4)(1990-12#5)(1990-2#7)(1990-5#7)(1990-7#5)(1991-10#2)(1991-12#2)(1991-3#1)(1991-5#9)(1991-9#2)(1992-11#1)(1992-12#7)(1992-3#4)(1992-6#7)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#8)(1993-9#1)(1994-11#5)(1994-12#7)(1994-2#3)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#1)(1995-11#2)(1995-2#3)(1995-6#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-1#4)(1997-2#2)(1997-4#1)(1997-7#3)(2007-12#2)(2008-1#1)(2008-10#76)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#9)(2008-7#6)(2008-8#7)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-2#1)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#6)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#2)
the membrane-associated##3##2##(1990-2#1)(1992-11#1)(1992-3#1)
the membrane-bound form##2##3##(1991-5#2)
the membrane-bound##11##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-5#3)(1994-11#1)(1995-6#1)(1996-8#1)(2009-7#1)
the membranes and##4##3##(1994-12#1)(1995-6#1)(2008-6#1)(2012-8#1)
the membranes of##6##3##(1990-2#1)(1990-5#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-8#1)
the membranes was##2##3##(1990-11#1)(2008-5#1)
the membranes were##5##3##(1992-3#1)(1993-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
the membranes with##4##3##(1992-7#1)(1993-3#1)(1995-11#1)(2008-10#1)
the membranes##42##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1992-3#2)(1992-6#3)(1992-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#3)(1995-2#1)(1995-6#2)(1996-8#1)(1996-9#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-8#1)
the membranous##3##2##(1994-6#1)(2008-7#1)(2010-8#1)
the memory##15##2##(1992-5#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2010-6#1)(2010-8#1)
the memory-access time##2##3##(2008-3#2)
the men##11##2##(1991-12#2)(1994-11#1)(2008-4#1)(2009-5#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
the men's##2##2##(2008-11#1)(2009-5#1)
the meninges##2##2##(2008-7#1)(2012-3#1)
the meningococcal C conjugate vaccine##2##5##(2010-10#2)
the meningococcal##3##2##(2010-10#3)
the meniscus##5##2##(2007-12#1)(2008-3#4)
the menopause and##2##3##(1991-11#1)(2008-2#1)
the menopause##8##2##(1991-11#1)(1991-4#1)(1991-9#1)(1993-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2011-2#1)
the menstrual##4##2##(1994-7#1)(1994-9#1)(2008-7#1)(2012-3#1)
the mental and physical##2##4##(1996-9#1)(2010-1#1)
the mental and##5##3##(1995-5#1)(1996-9#1)(2010-1#1)(2011-1#1)(2012-3#1)
the mental health care##2##4##(1997-3#1)(2008-2#1)
the mental health of##2##4##(2008-12#1)(2012-12#1)
the mental health system##3##4##(2008-2#3)
the mental health user##2##4##(2008-11#2)
the mental health##23##3##(1992-1#1)(1994-1#1)(1995-1#2)(1997-3#3)(2008-11#6)(2008-12#2)(2008-2#4)(2008-4#1)(2009-6#1)(2010-12#1)(2012-12#1)
the mental healthcare##2##3##(1992-2#1)(1993-12#1)
the mental illness##2##3##(2012-3#2)
the mental nerve##2##3##(2012-3#2)
the mental##41##2##(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-1#2)(1995-5#1)(1996-9#1)(1997-3#3)(2008-11#6)(2008-12#2)(2008-2#4)(2008-4#1)(2008-7#1)(2009-6#2)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#5)
the mentally ill##8##3##(1992-1#1)(1992-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(2008-2#1)(2008-7#1)(2009-7#1)
the mentally retarded in##2##4##(1992-5#1)(1997-8#1)
the mentally retarded##7##3##(1991-1#2)(1992-5#3)(1997-8#2)
the mentally##18##2##(1991-1#2)(1992-1#1)(1992-3#1)(1992-5#3)(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#1)(1997-8#2)(2008-2#1)(2008-7#1)(2009-7#1)(2012-1#1)
the mentioned##10##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)
the mentor##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
the menu##2##2##(1991-12#1)(2008-5#1)
the mercapto ligand##2##3##(2008-10#2)
the mercapto##3##2##(2008-10#3)
the mercury drop##2##3##(2008-10#2)
the mercury electrode and##5##4##(2008-10#5)
the mercury electrode surface##4##4##(2008-10#4)
the mercury electrode##12##3##(1990-5#1)(2008-10#11)
the mercury film##3##3##(2008-10#3)
the mercury is##2##3##(2008-10#2)
the mercury surface##2##3##(2008-10#2)
the mercury##30##2##(1990-5#1)(2008-10#28)(2008-6#1)
the mere##4##2##(2009-6#1)(2009-7#1)(2012-2#1)(2013-8#1)
the merged##2##2##(2008-10#1)(2008-2#1)
the merger##3##2##(1992-3#1)(1996-3#1)(1997-1#1)
the merging of##2##3##(1991-3#1)(1995-2#1)
the merging-zone##2##2##(2008-10#2)
the meridional##3##2##(2008-2#1)(2008-7#2)
the merit function##2##3##(2007-11#1)(2008-2#1)
the merit##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
the merits and##2##3##(2007-12#1)(2008-10#1)
the merits of having##2##4##(1992-5#1)(1992-9#1)
the merits of the##2##4##(2008-3#1)(2010-12#1)
the merits of##14##3##(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
the merits##16##2##(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
the mesencephalic##3##2##(1990-9#1)(1994-2#1)(1997-2#1)
the mesenchymal##4##2##(1990-5#1)(2008-11#1)(2008-9#1)(2011-2#1)
the mesenchyme##4##2##(1993-3#1)(1995-8#1)(2008-6#1)(2009-5#1)
the mesenteric lymph##2##3##(1996-12#1)(2008-5#1)
the mesenteric##9##2##(1992-3#2)(1992-5#1)(1996-12#1)(1996-2#1)(2007-7#1)(2008-5#1)(2010-12#1)(2013-1#1)
the mesentery##3##2##(1990-5#1)(1990-8#1)(2011-2#1)
the mesh##5##2##(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#2)
the meso##2##2##(1994-5#1)(2009-5#1)
the mesocarp and##2##3##(2008-10#2)
the mesocarp##3##2##(2008-10#3)
the mesocortical DA system##3##4##(1996-5#3)
the mesocosm##2##2##(2010-8#1)(2013-1#1)
the mesopause##3##2##(2008-3#3)
the mesophyll##5##2##(2008-10#5)
the mesopores##2##2##(2008-10#2)
the mesoporous##3##2##(2008-10#2)(2010-4#1)
the mesorectum##3##2##(2009-12#3)
the mesostructured tin oxide##2##4##(2008-10#2)
the message about##2##3##(1997-6#1)(2013-8#1)
the message##14##2##(1993-3#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#2)(2010-8#1)(2012-2#1)(2013-8#1)
the messages##3##2##(2007-11#1)(2008-7#1)(2012-3#1)
the messenger RNA##2##3##(1991-12#1)(1996-12#1)
the messenger##3##2##(1991-12#1)(1996-12#1)(2008-1#1)
the meta-analysis of##4##3##(1991-11#1)(1995-2#1)(2008-4#1)(2008-7#1)
the meta-analysis##10##2##(1991-11#1)(1995-2#1)(1996-6#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-3#1)
the metabolic activation##5##3##(1991-5#1)(1991-9#1)(1992-2#1)(1994-6#1)(2008-8#1)
the metabolic and##4##3##(1990-5#1)(1994-12#1)(2008-3#1)(2009-5#1)
the metabolic characteristics of##2##4##(2008-11#1)(2011-3#1)
the metabolic disorder##2##3##(1990-2#2)
the metabolic effect##2##3##(1990-2#1)(2011-1#1)
the metabolic network##3##3##(2008-7#2)(2012-2#1)
the metabolic parameters##2##3##(1990-5#1)(2012-12#1)
the metabolic pathway##2##3##(1993-2#1)(2012-5#1)
the metabolic pathways##2##3##(2008-8#1)(2011-2#1)
the metabolic potential##3##3##(1995-6#1)(2008-11#1)(2009-5#1)
the metabolic state of##4##4##(1996-12#1)(2007-10#1)(2008-7#1)(2010-12#1)
the metabolic syndrome and diabetes##2##5##(2008-1#1)(2008-3#1)
the metabolic syndrome and##12##4##(2008-1#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#2)
the metabolic syndrome are##2##4##(2008-11#1)(2008-3#1)
the metabolic syndrome has##2##4##(2008-6#1)(2011-2#1)
the metabolic syndrome in##8##4##(2008-10#1)(2008-3#5)(2008-5#1)(2011-2#1)
the metabolic syndrome is##4##4##(2008-1#1)(2008-3#2)(2008-6#1)
the metabolic syndrome##83##3##(1990-2#1)(2008-1#19)(2008-10#3)(2008-11#1)(2008-3#30)(2008-5#4)(2008-6#7)(2008-7#2)(2009-3#1)(2010-4#3)(2010-5#3)(2011-1#1)(2011-2#4)(2012-2#3)(2012-5#1)
the metabolic syndrome]##2##3##(1993-2#1)(2012-3#1)
the metabolic##163##2##(1990-11#1)(1990-2#4)(1990-5#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-11#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-1#19)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#37)(2008-4#1)(2008-5#5)(2008-6#9)(2008-7#8)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#2)(2013-1#2)
the metabolism and##6##3##(1993-11#1)(2008-10#1)(2008-7#2)(2013-1#2)
the metabolism of NA##2##4##(2008-8#2)
the metabolism of [125I]ET-1##2##4##(1995-11#2)
the metabolism of domperidone and##2##5##(2011-2#2)
the metabolism of domperidone##3##4##(2011-2#3)
the metabolism of microorganisms##3##4##(2008-5#2)(2012-3#1)
the metabolism of retinol and beta-carotene##2##6##(2009-6#2)
the metabolism of the##5##4##(1991-5#1)(1993-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
the metabolism of##58##3##(1991-12#1)(1991-5#3)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#2)(1994-8#3)(1995-11#2)(2006-10#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2011-1#5)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the metabolism via##2##3##(2008-11#2)
the metabolism##70##2##(1991-12#1)(1991-5#3)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-8#3)(1995-11#2)(2006-10#1)(2008-10#7)(2008-11#6)(2008-3#3)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
the metabolite##9##2##(1991-8#1)(1992-1#1)(1995-12#1)(2008-10#3)(2008-8#1)(2009-12#1)(2010-11#1)
the metabolites of##2##3##(2008-11#1)(2013-1#1)
the metabolites that are##2##4##(2008-10#2)
the metabolites##17##2##(1990-11#1)(1990-5#1)(1990-7#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-7#2)(2009-8#1)(2010-11#1)(2011-3#2)(2013-1#1)
the metabolome##3##2##(2009-8#2)(2012-5#1)
the metacarpophalangeal##3##2##(1992-5#1)(2008-9#2)
the metachromatic##2##2##(2008-9#2)
the metal M##3##3##(2008-10#3)
the metal and##3##3##(2008-10#3)
the metal atom##2##3##(1996-2#2)
the metal atoms##2##3##(1996-2#1)(2007-11#1)
the metal binding##2##3##(2008-10#2)
the metal cations##3##3##(2008-10#3)
the metal center##2##3##(1996-2#2)
the metal centers##2##3##(1997-7#2)
the metal chelate##3##3##(2008-10#3)
the metal cluster##5##3##(1994-5#5)
the metal concentrations##3##3##(1997-4#2)(2008-10#1)
the metal ion in##2##4##(2008-10#2)
the metal ion is##3##4##(2008-10#2)(2010-6#1)
the metal ion##17##3##(1992-11#1)(1992-3#1)(1997-4#1)(2008-10#13)(2010-6#1)
the metal ions and##2##4##(2008-10#1)(2013-1#1)
the metal ions have##2##4##(2008-10#1)(2010-6#1)
the metal ions in##3##4##(2008-10#3)
the metal ions with##2##4##(2008-10#2)
the metal ions##31##3##(2008-10#27)(2010-11#1)(2010-6#1)(2013-1#1)(2013-8#1)
the metal is##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
the metal ring##2##3##(2008-3#2)
the metal species##3##3##(2008-10#2)(2010-11#1)
the metal surface##4##3##(2007-12#2)(2008-5#1)(2008-7#1)
the metal vapour pressure##2##4##(2009-11#2)
the metal was##3##3##(2008-10#3)
the metal##158##2##(1990-9#1)(1991-12#2)(1992-11#2)(1992-3#1)(1994-5#8)(1994-8#1)(1995-3#1)(1996-2#5)(1997-4#3)(1997-7#3)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#99)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2009-11#3)(2009-9#1)(2010-11#4)(2010-5#1)(2010-6#2)(2011-1#1)(2013-1#2)(2013-8#1)
the metal-metal##2##2##(1996-2#1)(1997-7#1)
the metallic cations##2##3##(1990-7#2)
the metallic##13##2##(1990-7#2)(2007-11#1)(2008-10#6)(2008-3#1)(2008-8#1)(2010-6#2)
the metallothionein##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
the metallurgical##2##2##(1991-3#1)(2008-3#1)
the metals are##2##3##(2008-10#1)(2008-5#1)
the metals can be##2##4##(2008-10#2)
the metals were##2##3##(2008-10#2)
the metals##26##2##(1997-7#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#2)(2013-8#1)
the metaphyseal##2##2##(2010-3#2)
the metapopulation dynamics of##2##4##(2008-8#2)
the metapopulation##12##2##(2008-10#2)(2008-8#4)(2008-9#6)
the metastases are##2##3##(2007-11#2)
the metastases##5##2##(2007-11#4)(2013-1#1)
the metastasis in##2##3##(1996-6#1)(2007-11#1)
the metastasis##5##2##(1991-6#1)(1996-6#1)(2007-11#2)(2009-10#1)
the metastatic foci##2##3##(2007-11#1)(2012-1#1)
the metastatic focus##2##3##(1991-6#1)(2007-11#1)
the metastatic lesions##3##3##(2011-2#1)(2013-8#2)
the metastatic melanoma##2##3##(1997-7#1)(2010-6#1)
the metastatic phenotype of##2##4##(1994-5#1)(2009-3#1)
the metastatic potential of##4##4##(1992-9#2)(2008-1#1)(2010-3#1)
the metastatic potential##5##3##(1992-9#2)(2008-1#1)(2010-3#2)
the metastatic process##6##3##(1990-6#1)(1990-8#1)(1993-9#1)(2008-1#1)(2008-4#1)(2010-3#1)
the metastatic##34##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-9#4)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1997-7#1)(2007-11#3)(2008-1#2)(2008-4#1)(2008-7#1)(2009-3#2)(2010-3#3)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#3)
the meteorological##4##2##(2007-11#1)(2008-2#2)(2008-8#1)
the metered-dose inhaler (MDI)##2##4##(1996-2#1)(1997-1#1)
the metering valve is##2##4##(1996-1#2)
the methamphetamine dose##2##3##(1995-3#2)
the methane production##2##3##(2013-1#2)
the methane##4##2##(2008-2#2)(2013-1#2)
the methanogen was##2##3##(2008-7#2)
the methanol concentration##3##3##(1996-5#1)(2008-7#2)
the methanol extract of the##2##5##(2008-11#1)(2012-2#1)
the methanol extract of##3##4##(2008-11#1)(2012-2#1)(2013-8#1)
the methanol extract##4##3##(2008-11#2)(2012-2#1)(2013-8#1)
the methanol##13##2##(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
the methanolic extract##2##3##(2008-12#2)
the methanolic fractions##2##3##(1997-2#2)
the methanolic##7##2##(1997-2#3)(2008-10#1)(2008-11#1)(2008-12#2)
the methionine##5##2##(1995-5#1)(1997-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
the method a##2##3##(2008-10#1)(2008-11#1)
the method allowed##2##3##(1996-12#1)(2008-10#1)
the method allows##2##3##(2008-10#1)(2008-5#1)
the method and its##3##4##(2008-10#2)(2010-9#1)
the method and the results##2##5##(2008-2#1)(2013-8#1)
the method and the##4##4##(2008-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
the method and to##2##4##(2008-3#1)(2010-3#1)
the method and##15##3##(1992-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-9#1)(2013-8#1)
the method are presented##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the method are##20##3##(1990-11#1)(1994-9#1)(1995-12#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-3#4)(2008-9#1)
the method based on reaction with##2##6##(2008-10#2)
the method based on the color reaction of##2##8##(2008-10#2)
the method based on##4##4##(2008-10#4)
the method by measuring##3##4##(2008-10#1)(2008-3#2)
the method by##8##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)
the method can also be##2##5##(1991-5#1)(2008-3#1)
the method can be applied to##2##6##(2008-10#1)(2011-1#1)
the method can be used##3##5##(1996-5#1)(2008-10#1)(2008-2#1)
the method can be##10##4##(1991-5#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
the method can##14##3##(1991-5#2)(1996-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#1)
the method could be##2##4##(2008-10#1)(2008-11#1)
the method could effectively separate##3##5##(2008-10#3)
the method could##6##3##(2008-10#4)(2008-11#1)(2013-8#1)
the method described by##2##4##(2008-11#1)(2012-12#1)
the method described here is##2##5##(2008-11#1)(2008-5#1)
the method described here##6##4##(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#2)
the method described##8##3##(2008-11#2)(2008-4#1)(2008-5#2)(2009-4#2)(2012-12#1)
the method detection##2##3##(2008-10#2)
the method developed##6##3##(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)
the method development##3##3##(2008-10#1)(2010-11#2)
the method does not suffer##2##5##(2008-10#2)
the method does not##3##4##(2008-10#2)(2008-3#1)
the method enables##2##3##(2008-10#1)(2008-3#1)
the method for a##2##4##(2008-2#1)(2008-3#1)
the method for detecting##2##4##(2008-10#1)(2013-8#1)
the method for the determination of##3##6##(2008-10#3)
the method for the##6##4##(2008-10#6)
the method for##32##3##(1992-6#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#2)(2010-11#1)(2013-8#1)
the method has been applied to##3##6##(2008-10#3)
the method has been applied##4##5##(2008-10#4)
the method has been satisfactorily##2##5##(2008-10#2)
the method has been successfully applied to the##3##8##(2008-10#3)
the method has been##17##4##(2008-10#16)(2008-3#1)
the method has##19##3##(2008-10#18)(2008-3#1)
the method in a##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
the method in##16##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#3)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
the method is applied to##2##5##(2008-10#2)
the method is applied##3##4##(2008-10#2)(2008-3#1)
the method is based on the##3##6##(1997-4#1)(2008-2#1)(2008-3#1)
the method is based on##4##5##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
the method is demonstrated##4##4##(2008-10#2)(2008-3#1)(2008-7#1)
the method is free##2##4##(2008-10#2)
the method is in##3##4##(2008-10#2)(2011-1#1)
the method is linear over##2##5##(2008-10#2)
the method is not##2##4##(2008-3#1)(2010-5#1)
the method is sensitive##2##4##(2008-10#1)(2009-5#1)
the method is suitable for the##4##6##(1991-5#1)(2008-10#2)(2008-3#1)
the method is suitable for##8##5##(1991-5#1)(1996-12#1)(2008-10#5)(2008-3#1)
the method is very##2##4##(2007-12#1)(2008-7#1)
the method is##95##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#51)(2008-11#2)(2008-2#6)(2008-3#15)(2008-7#2)(2008-9#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)
the method of 'replenishing qi##2##5##(2013-8#2)
the method of choice for##8##5##(1992-11#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
the method of choice in##2##5##(2007-8#1)(2010-12#1)
the method of choice##13##4##(1992-11#1)(1992-12#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-12#2)(2011-2#1)(2012-3#1)
the method of constant stimuli##4##5##(1990-11#4)
the method of constant##5##4##(1990-11#4)(2013-1#1)
the method of data collection##2##5##(1993-3#1)(2008-11#1)
the method of detection##2##4##(2008-10#2)
the method of preparation##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
the method of principal##2##4##(2009-9#1)(2011-1#1)
the method of standard additions##6##5##(2008-10#6)
the method of standard##7##4##(2008-10#7)
the method of##104##3##(1990-11#6)(1990-12#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-9#1)(2010-12#4)(2010-6#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-3#4)(2013-1#3)(2013-8#4)
the method presented here is##2##5##(2008-10#2)
the method presented##7##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
the method proposed##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
the method provides##5##3##(2007-11#1)(2008-10#2)(2008-3#2)
the method showed##3##3##(1994-11#1)(2008-10#2)
the method shows a##2##4##(2008-10#2)
the method shows##3##3##(2008-10#3)
the method to a##3##4##(2008-2#1)(2008-8#1)(2010-2#1)
the method to be##4##4##(1990-12#1)(2008-10#2)(2008-3#1)
the method to the##10##4##(1995-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
the method to##42##3##(1990-12#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#21)(2008-2#6)(2008-3#6)(2008-8#1)(2009-7#1)(2010-2#1)
the method used for the##2##5##(2008-11#1)(2010-5#1)
the method used for##9##4##(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2010-5#1)(2011-2#1)
the method used to##4##4##(2007-11#1)(2008-10#1)(2010-6#1)(2013-1#1)
the method used##16##3##(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
the method using##3##3##(2008-10#1)(2008-6#1)(2010-7#1)
the method utilized##2##3##(2007-10#1)(2008-10#1)
the method was applicable##2##4##(2008-10#2)
the method was applied to the##2##6##(2008-10#2)
the method was applied to##3##5##(2008-10#2)(2008-3#1)
the method was applied##5##4##(2008-10#4)(2008-3#1)
the method was successfully applied to the determination of##2##9##(2008-10#2)
the method was successfully applied to the##3##7##(2008-10#3)
the method was successfully applied to##4##6##(2008-10#4)
the method was##85##3##(1990-8#1)(1992-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#68)(2008-3#2)(2008-5#2)(2008-8#2)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
the method we##3##3##(2008-2#1)(2008-3#1)(2010-12#1)
the method when applied to##2##5##(2008-10#1)(2008-3#1)
the method with##5##3##(1994-9#1)(2007-11#1)(2008-3#1)(2009-5#1)(2012-1#1)
the method works##2##3##(2008-11#1)(2008-2#1)
the method##724##2##(1990-11#9)(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-5#3)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-7#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#2)(2006-4#1)(2007-10#2)(2007-11#14)(2007-12#8)(2007-8#4)(2008-1#2)(2008-10#371)(2008-11#19)(2008-12#6)(2008-2#30)(2008-3#78)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#9)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-9#3)(2011-1#8)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#11)
the method's##8##2##(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)
the methodological issues##2##3##(2008-12#2)
the methodological problems##3##3##(1992-3#1)(1993-2#1)(1995-8#1)
the methodological##14##2##(1991-11#1)(1992-3#2)(1993-2#1)(1995-8#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
the methodologies##2##2##(1996-9#1)(2008-7#1)
the methodology and##5##3##(1995-3#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
the methodology based on##2##4##(2008-10#2)
the methodology developed##3##3##(2008-10#2)(2008-3#1)
the methodology of##9##3##(1993-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the methodology to##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
the methodology##52##2##(1991-2#1)(1992-3#1)(1993-2#1)(1995-2#2)(1995-3#1)(1996-12#1)(2007-11#1)(2007-5#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the methods and##7##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)(2012-12#1)
the methods are##7##3##(1993-12#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-3#1)(2008-4#1)
the methods described##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)
the methods developed##3##3##(1992-12#1)(2008-10#1)(2008-3#1)
the methods employed##3##3##(1991-3#1)(1994-2#1)(2008-11#1)
the methods for##12##3##(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#3)(2009-11#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
the methods have##2##3##(1994-11#1)(2008-12#1)
the methods of##13##3##(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-7#1)(2010-8#1)(2011-3#1)(2012-12#1)
the methods that use##2##4##(2008-3#2)
the methods that##6##3##(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
the methods to##4##3##(2008-10#3)(2009-10#1)
the methods used for##2##4##(1992-4#1)(2008-10#1)
the methods used in the##2##5##(2008-10#1)(2008-11#1)
the methods used to##3##4##(2008-1#1)(2008-11#1)(2010-5#1)
the methods used##9##3##(1991-2#1)(1992-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-2#1)(2010-5#1)
the methods were##4##3##(2008-10#4)
the methods which##2##3##(2007-11#1)(2008-10#1)
the methods with##2##3##(1997-7#1)(2008-10#1)
the methods##124##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#2)(1997-3#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-10#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#5)(2013-1#2)(2013-8#1)
the methods'##2##2##(2007-11#1)(2010-3#1)
the methoxy##3##2##(1996-5#1)(2008-10#1)(2010-12#1)
the methyl ester##2##3##(1992-10#1)(1994-9#1)
the methyl esters##2##3##(2008-10#1)(2010-12#1)
the methyl group##4##3##(1990-7#1)(1991-5#1)(1992-6#1)(2008-10#1)
the methyl phenyl derivative##2##4##(2007-11#2)
the methyl##17##2##(1990-7#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1994-8#1)(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2010-12#1)(2011-1#1)
the methylated##3##2##(1997-4#1)(2008-10#2)
the methylation of the##3##4##(1994-2#1)(1995-2#1)(2008-9#1)
the methylation of##7##3##(1994-2#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-9#1)(2009-7#1)(2010-11#1)
the methylation patterns of##2##4##(1995-12#1)(2008-7#1)
the methylation##12##2##(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)
the methylene blue##3##3##(2008-10#2)(2008-2#1)
the methylene group##3##3##(1997-1#2)(2011-2#1)
the methylene##7##2##(1997-1#2)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
the methylotrophic yeast##9##3##(1994-11#2)(1994-3#1)(1995-8#1)(1997-4#4)(1997-7#1)
the methyltransferase (MTase)##2##3##(1991-9#1)(1993-9#1)
the methyltransferase##3##2##(1991-9#1)(1993-9#1)(1994-12#1)
the metric##2##2##(2008-3#1)(2008-6#1)
the metrics##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
the metrology##2##2##(2008-2#1)(2008-3#1)
the miR-30 family##2##3##(2010-11#2)
the miRNA##2##2##(2008-1#1)(2013-8#1)
the miRNAs##2##2##(2010-1#1)(2011-2#1)
the mice irradiated at 0##2##5##(2008-7#2)
the mice were treated with##2##5##(2008-7#1)(2008-9#1)
the mice were##9##3##(1995-9#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
the mice##23##2##(1993-12#1)(1995-12#1)(1995-9#2)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2008-9#1)(2010-1#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
the micellar medium##2##3##(2008-10#2)
the micellar system##5##3##(1990-5#5)
the micellar##22##2##(1990-5#5)(1993-11#1)(1994-9#1)(1996-5#2)(1997-2#1)(2008-10#10)(2008-3#1)(2008-8#1)
the micelle##5##2##(1991-8#1)(2008-10#2)(2008-5#1)(2010-7#1)
the micelle-forming##2##2##(1996-5#1)(2008-3#1)
the micelles##4##2##(1990-8#1)(1996-5#1)(2008-5#1)(2008-8#1)
the micro##5##2##(1997-3#1)(2008-10#2)(2011-1#2)
the micro-colorimetric method##2##3##(2008-10#2)
the micro-colorimetric##3##2##(2008-10#3)
the micro-optical##2##2##(2008-2#1)(2008-3#1)
the micro-organism##2##2##(2011-2#2)
the microalgae##2##2##(2013-1#2)
the microanatomical##2##2##(1994-6#1)(2008-5#1)
the microarray##2##2##(2008-4#1)(2008-7#1)
the microarrays##2##2##(2008-7#1)(2010-4#1)
the microbe##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
the microbial complex that incites apple replant disease##2##8##(2008-10#2)
the microbial complex##3##3##(2008-10#3)
the microbial composition##2##3##(2008-10#1)(2010-5#1)
the microbial ecology of##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
the microbial##28##2##(1992-8#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#4)(2008-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
the microbiological##7##2##(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#2)(2012-2#1)(2013-7#1)
the microbiology laboratory##2##3##(2011-2#1)(2013-1#1)
the microbiology##4##2##(1997-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
the microbioreactor##2##2##(2008-11#2)
the microbiota of##2##3##(2011-2#1)(2012-2#1)
the microbiota##5##2##(2011-2#4)(2012-2#1)
the microcarrier##3##2##(2008-11#2)(2008-9#1)
the microcarriers##2##2##(2008-11#2)
the microcatheter##2##2##(2008-7#2)
the microcavity##3##2##(2007-12#2)(2008-3#1)
the microchannel##5##2##(2007-10#1)(2008-10#3)(2009-9#1)
the microchip##9##2##(2007-11#1)(2007-12#1)(2008-10#7)
the microcirculation in##3##3##(1996-3#1)(2009-11#1)(2010-7#1)
the microcirculation##7##2##(1990-8#1)(1996-3#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-7#2)
the microcirculatory##2##2##(1992-9#1)(2008-5#1)
the microcolumn##5##2##(2008-10#5)
the microdialysis probe##3##3##(1997-2#2)(2008-10#1)
the microdialysis technique##2##3##(1995-12#1)(2008-8#1)
the microdialysis##5##2##(1995-12#1)(1997-2#2)(2008-10#1)(2008-8#1)
the microelectrode##6##2##(1993-12#1)(2008-10#4)(2010-2#1)
the microemulsion##2##2##(1996-5#1)(2008-10#1)
the microenvironment of##4##3##(2008-10#3)(2009-4#1)
the microenvironment##11##2##(2008-10#4)(2009-10#1)(2009-3#3)(2009-4#1)(2010-10#2)
the microfine oxides##2##3##(2008-5#2)
the microflora in##2##3##(2008-10#1)(2012-3#1)
the microflora of##2##3##(2008-5#2)
the microflora##5##2##(2008-10#1)(2008-5#2)(2012-1#1)(2012-3#1)
the microfluidic channels##2##3##(2008-3#1)(2010-8#1)
the microfluidic##6##2##(2008-10#3)(2008-3#1)(2009-12#1)(2010-8#1)
the microgels##2##2##(2008-10#2)
the microglial##2##2##(1997-3#1)(2008-4#1)
the microgram##2##2##(2008-10#2)
the micrographs##2##2##(2008-5#1)(2009-7#1)
the microlens##7##2##(2008-10#1)(2008-2#3)(2008-3#3)
the micromechanical properties of##3##4##(2010-4#3)
the micromechanics of the##2##4##(1995-5#1)(2012-2#1)
the micrometer##5##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
the micromolar concentration range##3##4##(1990-12#2)(2008-10#1)
the micromolar concentration##4##3##(1990-12#2)(2008-10#2)
the micromolar##9##2##(1990-12#2)(1990-2#1)(1994-5#1)(1995-5#1)(2008-10#3)(2008-4#1)
the micronucleus frequency##2##3##(1993-8#2)
the micronucleus##3##2##(1993-8#2)(2008-8#1)
the microorganism##4##2##(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#1)
the microorganisms##8##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
the micropylar##5##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-12#2)
the micropyle##3##2##(1994-5#1)(2007-12#1)(2009-8#1)
the microsatellite marker##3##3##(2008-10#3)
the microsatellite##5##2##(2008-10#4)(2008-5#1)
the microscale##2##2##(2010-10#1)(2010-4#1)
the microscope and the##2##4##(2007-11#1)(2010-1#1)
the microscope##16##2##(1993-11#1)(2007-11#2)(2008-2#1)(2008-3#7)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)
the microscope's##3##2##(1992-5#1)(2007-11#1)(2008-3#1)
the microscopic activity##3##3##(2008-11#3)
the microscopic rate constants##2##4##(2008-5#2)
the microscopic##24##2##(1991-6#1)(1993-6#1)(1995-3#2)(1997-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-7#1)(2010-4#1)(2013-1#1)(2013-8#2)
the microsecond time scale##3##4##(1990-8#1)(1995-2#1)(2008-2#1)
the microsecond##4##2##(1990-8#1)(1995-2#1)(2008-2#2)
the microshear bond strength##4##4##(2013-1#4)
the microsomal cytochrome##2##3##(1991-12#1)(1992-11#1)
the microsomal fraction of##4##4##(1990-11#1)(1993-3#1)(1994-11#1)(1997-3#1)
the microsomal fraction##8##3##(1990-11#1)(1993-3#2)(1994-11#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-4#1)
the microsomal oxidative demethylation of##2##5##(1993-8#2)
the microsomal##19##2##(1990-11#2)(1991-12#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(2011-2#1)
the microsomes##4##2##(1991-10#1)(1994-11#1)(1994-8#1)(1997-7#1)
the microspheres##3##2##(2008-2#1)(2008-7#1)(2010-5#1)
the microstructure fiber##2##3##(2007-11#2)
the microstructure of the##3##4##(2008-5#1)(2009-7#2)
the microstructure of##7##3##(2008-10#1)(2008-5#4)(2009-7#2)
the microstructure##19##2##(2007-11#3)(2008-10#1)(2008-3#5)(2008-5#4)(2009-7#6)
the microsurgical##2##2##(2008-9#1)(2012-3#1)
the microsyringe needle##2##3##(2008-10#2)
the microsyringe##3##2##(2008-10#3)
the microtopography of##2##3##(2008-3#1)(2008-5#1)
the microtopography##3##2##(2008-3#1)(2008-5#2)
the microtubule organizing center##2##4##(2008-8#1)(2008-9#1)
the microtubule system##2##3##(2009-10#2)
the microtubule##6##2##(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2012-2#1)
the microvascular response to norepinephrine##2##5##(1994-8#2)
the microvascular##4##2##(1990-5#1)(1994-8#2)(2013-1#1)
the microvasculature of##2##3##(2008-1#1)(2011-2#1)
the microvasculature##4##2##(1991-9#1)(2008-1#1)(2009-10#1)(2011-2#1)
the microvesicles##2##2##(1990-12#2)
the microvillar##2##2##(2007-12#1)(2008-7#1)
the microvilli and##2##3##(1995-2#1)(2008-7#1)
the microvilli of the##2##4##(2007-12#1)(2008-7#1)
the microvilli##8##2##(1995-2#1)(2007-12#3)(2008-7#4)
the microwave and##2##3##(2008-2#1)(2012-12#1)
the microwave digestion##2##3##(2008-10#2)
the microwave oven##2##3##(2008-10#2)
the microwave##18##2##(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
the microwave-assisted##4##2##(2008-10#4)
the microwaves##2##2##(2008-10#1)(2008-3#1)
the micturition reflex##5##3##(1990-5#3)(1992-3#2)
the micturition##6##2##(1990-5#4)(1992-3#2)
the mid 1970s##2##3##(2008-12#1)(2008-5#1)
the mid 1980s##2##3##(1996-1#1)(2008-7#1)
the mid point of the humerus##3##6##(2013-8#3)
the mid to##3##3##(2011-2#1)(2012-3#1)(2013-7#1)
the mid##21##2##(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
the mid-##3##2##(2008-10#3)
the mid-1970s##3##2##(1991-9#1)(1995-8#1)(2007-7#1)
the mid-1980s##4##2##(1990-3#1)(1991-2#1)(2008-1#1)(2010-3#1)
the mid-IR##7##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)
the mid-exponential##2##2##(1996-7#1)(2008-11#1)
the mid-infrared region##7##3##(2007-11#1)(2008-2#3)(2008-3#3)
the mid-infrared wavelength##2##3##(2007-11#1)(2008-3#1)
the mid-infrared##20##2##(2007-11#6)(2007-12#2)(2008-2#4)(2008-3#8)
the mid-point##2##2##(1995-12#1)(2013-8#1)
the mid-region (amino##2##3##(1990-12#1)(1991-9#1)
the mid-region##3##2##(1990-12#1)(1991-9#1)(2008-4#1)
the mid-term##3##2##(2008-10#1)(2009-3#1)(2009-4#1)
the mid-visible##2##2##(2008-2#1)(2008-3#1)
the midbrain##8##2##(1993-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-6#1)(2008-7#2)
the middle and lower Keys##2##5##(2007-5#2)
the middle and lower##3##4##(2007-5#2)(2013-1#1)
the middle and##9##3##(1994-6#1)(2006-12#1)(2007-12#1)(2007-5#2)(2008-7#1)(2008-9#2)(2013-1#1)
the middle cerebral artery (MCA)##4##5##(1996-5#1)(2007-10#1)(2008-12#1)(2008-7#1)
the middle cerebral artery##19##4##(1996-5#1)(1997-6#1)(2007-10#5)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#6)(2010-11#1)
the middle cerebral##20##3##(1996-2#1)(1996-5#1)(1997-6#1)(2007-10#5)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#6)(2010-11#1)
the middle deltoid##2##3##(2009-3#2)
the middle ear##7##3##(1991-3#3)(1995-5#1)(2008-1#1)(2013-1#1)(2013-7#1)
the middle fossa##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
the middle layer##3##3##(2008-8#1)(2010-8#2)
the middle meningeal artery##4##4##(1996-9#2)(2008-12#2)
the middle of the##25##4##(1991-11#2)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#3)(2011-2#1)(2013-7#1)
the middle of##33##3##(1991-11#2)(1991-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-7#3)(2010-4#1)(2011-2#1)(2011-3#1)(2013-7#1)
the middle phase##3##3##(2008-10#3)
the middle portion of##2##4##(1993-6#1)(2008-7#1)
the middle temporal##3##3##(1996-2#1)(2008-9#2)
the middle third of the##3##5##(1991-4#1)(2007-12#2)
the middle to##2##3##(1990-11#1)(2007-5#1)
the middle turbinate##3##3##(2008-5#3)
the middle##137##2##(1990-11#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#2)(1995-6#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(2006-12#2)(2007-10#5)(2007-12#4)(2007-2#1)(2007-5#3)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-7#10)(2008-8#4)(2008-9#5)(2009-10#1)(2009-3#2)(2009-7#4)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#6)(2011-3#1)(2012-12#2)(2013-1#2)(2013-7#2)(2013-8#2)
the midface##5##2##(1996-6#1)(2007-12#2)(2010-8#1)(2012-12#1)
the midget##4##2##(2008-5#4)
the midgut and##5##3##(2008-10#3)(2008-6#1)(2013-1#1)
the midgut epithelium##3##3##(2008-12#2)(2008-7#1)
the midgut of adult##2##4##(2008-10#2)
the midgut##25##2##(1992-3#1)(1997-3#1)(2007-12#5)(2008-10#12)(2008-12#2)(2008-6#1)(2008-7#2)(2013-1#1)
the midline##7##2##(1990-8#1)(2007-12#3)(2008-12#1)(2009-1#1)(2013-1#1)
the midpoint of the##2##4##(1995-2#1)(1997-2#1)
the midpoint of##3##3##(1995-2#1)(1997-2#1)(2008-12#1)
the midpoint potentials##2##3##(2008-10#2)
the midpoint##9##2##(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-2#2)
the midrange market##2##3##(1993-2#2)
the midrange##3##2##(1993-2#2)(2007-12#1)
the midsagittal plane##3##3##(1996-5#2)(1996-7#1)
the midsagittal##6##2##(1995-5#2)(1996-5#2)(1996-7#2)
the midst of the##2##4##(2008-12#1)(2011-1#1)
the midst of##10##3##(1993-12#3)(1993-2#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)
the midwestern##2##2##(2008-10#1)(2011-2#1)
the midwives##2##2##(2009-10#2)
the migraine attack##3##3##(2008-9#3)
the migraine##4##2##(1994-11#1)(2008-9#3)
the migrant##3##2##(2008-12#1)(2008-3#1)(2013-8#1)
the migration of the##3##4##(1997-6#1)(2008-10#1)(2008-9#1)
the migration of##17##3##(1995-12#1)(1995-8#1)(1997-6#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
the migration pool##2##3##(2008-8#2)
the migration route##2##3##(2008-5#1)(2008-6#1)
the migration time and##5##4##(1996-5#1)(2008-10#4)
the migration time##9##3##(1996-5#1)(2008-10#8)
the migration times##2##3##(2008-10#2)
the migration##41##2##(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#2)(1997-6#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
the migration/invasion abilities of breast stromal fibroblasts##2##7##(2013-1#2)
the migratory behavior##2##3##(2008-6#1)(2008-8#1)
the migratory##9##2##(1997-4#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-3#2)
the mild strain##2##3##(2008-10#2)
the mild subgroup##2##3##(2009-2#2)
the mild##10##2##(1993-12#1)(1996-9#1)(2008-10#4)(2008-4#2)(2009-2#2)
the military to##2##3##(1992-3#1)(1995-6#1)
the military##11##2##(1991-3#1)(1992-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-8#1)(2009-8#1)(2011-2#1)
the milk of transgenic##2##4##(1994-5#1)(2008-12#1)
the milk of##6##3##(1994-5#1)(2008-10#2)(2008-12#2)(2013-1#1)
the milk samples were##2##4##(2008-10#2)
the milk samples##4##3##(2008-10#4)
the milk##26##2##(1991-8#1)(1994-5#2)(2008-10#9)(2008-12#3)(2009-8#1)(2010-2#3)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
the millennium##2##2##(2008-4#2)
the millimeter range##2##3##(2007-11#1)(2008-3#1)
the millimeter##4##2##(2007-11#1)(2008-3#2)(2013-7#1)
the millimolar range##3##3##(1992-3#1)(1994-5#1)(1995-5#1)
the millions##2##2##(2008-10#1)(2010-1#1)
the minced##2##2##(2008-10#1)(2008-4#1)
the mind##8##2##(2008-12#1)(2008-5#2)(2009-10#3)(2012-2#2)
the mine##2##2##(2008-10#2)
the mineral content##2##3##(1990-11#1)(2009-7#1)
the mineral soil fraction##2##4##(2008-10#2)
the mineral##14##2##(1990-11#1)(1991-6#1)(1992-3#1)(2008-10#7)(2008-5#1)(2009-7#1)(2010-2#1)(2013-8#1)
the mineralization##5##2##(2008-10#2)(2008-4#1)(2009-7#2)
the mineralized##4##2##(2008-10#1)(2009-8#1)(2013-8#2)
the mineralocorticoid##2##2##(1996-5#1)(2008-8#1)
the mineralogical##4##2##(2008-10#4)
the miniature##5##2##(1992-12#1)(1994-9#1)(2008-10#2)(2009-10#1)
the miniaturization of the##2##4##(2008-10#2)
the miniaturization##3##2##(2008-10#3)
the minicolumn##8##2##(2008-10#8)
the minima of##2##3##(2008-10#1)(2008-11#1)
the minimal amount of##2##4##(2008-10#2)
the minimal number of##2##4##(1994-3#1)(2011-2#1)
the minimal##37##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#2)(1994-12#1)(1994-3#1)(1995-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-2#5)
the minimally invasive##2##3##(2011-2#1)(2013-1#1)
the minimally##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
the minimisation of##2##3##(2008-10#1)(2011-2#1)
the minimization of the##2##4##(2006-6#1)(2008-3#1)
the minimization of##5##3##(2006-6#1)(2008-2#1)(2008-3#3)
the minimization##7##2##(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#4)
the minimum and maximum##2##4##(2008-5#1)(2013-8#1)
the minimum concentration of##2##4##(1993-1#1)(2008-10#1)
the minimum concentration##4##3##(1993-1#1)(2008-10#2)(2008-5#1)
the minimum description length principle##2##5##(2007-11#1)(2008-6#1)
the minimum detectable signal##2##4##(2008-2#2)
the minimum error in##2##4##(2008-10#1)(2008-3#1)
the minimum error##4##3##(2008-10#2)(2008-3#2)
the minimum feature##2##3##(2008-10#1)(2008-3#1)
the minimum infective dose##2##4##(2009-6#2)
the minimum inhibitory concentration (MIC)##2##5##(1991-8#1)(1994-12#1)
the minimum inhibitory concentration##3##4##(1991-8#1)(1994-12#1)(2010-5#1)
the minimum inhibitory##4##3##(1991-8#1)(1994-12#1)(2008-5#1)(2010-5#1)
the minimum number of##9##4##(1992-9#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)
the minimum of##2##3##(2008-10#1)(2008-11#1)
the minimum possible##2##3##(2008-10#1)(2008-3#1)
the minimum required number of index subjects##2##7##(1996-3#2)
the minimum required##4##3##(1996-3#2)(2008-10#2)
the minimum temperature##4##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
the minimum value##2##3##(2009-9#1)(2013-8#1)
the minimum values##3##3##(2008-2#2)(2008-5#1)
the minimum##99##2##(1991-8#2)(1992-3#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(2007-11#2)(2007-4#1)(2008-10#17)(2008-11#3)(2008-2#13)(2008-3#12)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
the minor components##2##3##(2008-10#2)
the minor groove of the##4##5##(1993-1#1)(1994-5#1)(1995-3#1)(1996-2#1)
the minor groove of##7##4##(1992-3#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-4#1)
the minor groove##12##3##(1990-7#1)(1992-3#1)(1993-1#2)(1993-3#1)(1994-5#2)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-4#1)
the minor salivary##2##3##(1991-11#1)(2008-4#1)
the minor##36##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-5#3)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#3)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
the minority of##2##3##(1993-1#1)(2010-12#1)
the minority##7##2##(1993-1#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-8#1)
the minute##8##2##(1992-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2013-7#1)
the mirror is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the mirror neuron system##2##4##(2008-11#2)
the mirror##22##2##(1997-7#1)(2007-11#2)(2007-12#4)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)
the mirrors##11##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)
the misalignment##2##2##(2008-3#2)
the misclassification##3##2##(1992-6#2)(2009-9#1)
the misconceptions##3##2##(2010-3#3)
the mismatch between the##2##4##(2007-12#1)(2008-3#1)
the mismatch negativity (MMN)##3##4##(1995-12#1)(1995-5#1)(2008-9#1)
the mismatch##12##2##(1995-12#1)(1995-5#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-2#1)(2010-8#1)(2013-1#1)
the mismatched##2##2##(2010-11#1)(2011-2#1)
the misogynist##2##2##(2009-10#2)
the missing censoring indicator model##2##5##(2008-10#2)
the missing data##3##3##(1995-12#2)(2009-12#1)
the missing link between##2##4##(1994-3#1)(1997-4#1)
the missing link?##2##3##(1992-1#1)(2009-5#1)
the missing person##2##3##(1995-6#2)
the missing##24##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-6#2)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#2)(2009-5#2)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
the mission of##4##3##(1996-12#1)(2008-7#1)(2012-3#2)
the mission##8##2##(1993-12#1)(1994-1#1)(1996-12#1)(2008-3#2)(2008-7#1)(2012-3#2)
the mite Varroa destructor Anderson##2##5##(2008-6#2)
the mite##3##2##(2008-6#2)(2013-1#1)
the mites##2##2##(1997-5#1)(2008-5#1)
the mitochondria and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
the mitochondria in##3##3##(1994-11#1)(2008-10#1)(2009-11#1)
the mitochondria of##2##3##(1992-9#1)(1997-2#1)
the mitochondria##16##2##(1992-9#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-7#2)(2009-11#2)(2010-3#1)(2011-2#1)
the mitochondrial (mt)##2##3##(1991-6#1)(1993-2#1)
the mitochondrial DNA##12##3##(1990-7#1)(1994-11#5)(1995-6#1)(1996-6#1)(1997-2#1)(2008-10#1)(2009-2#1)(2010-8#1)
the mitochondrial and##3##3##(1991-11#1)(2008-10#1)(2008-7#1)
the mitochondrial citrate synthase##2##4##(1997-4#1)(1997-8#1)
the mitochondrial cytochrome b gene##4##5##(2008-5#1)(2010-4#1)(2010-8#2)
the mitochondrial cytochrome oxidase I##3##5##(2007-12#1)(2011-2#2)
the mitochondrial cytochrome oxidase##5##4##(2007-12#1)(2008-10#1)(2011-2#3)
the mitochondrial cytochrome##9##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#2)(2011-2#3)
the mitochondrial genes##3##3##(1991-6#1)(2008-6#1)(2010-4#1)
the mitochondrial genome and##2##4##(1995-11#1)(1995-6#1)
the mitochondrial genome of the##2##5##(1995-6#1)(1996-10#1)
the mitochondrial genome of##3##4##(1995-6#1)(1996-10#2)
the mitochondrial genome##9##3##(1995-11#1)(1995-12#1)(1995-6#3)(1996-10#2)(2008-2#1)(2009-8#1)
the mitochondrial matrix##3##3##(1994-11#1)(1994-8#1)(2010-12#1)
the mitochondrial membrane and##2##4##(1995-6#1)(2009-9#1)
the mitochondrial membrane potential##4##4##(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
the mitochondrial membrane##9##3##(1990-2#1)(1993-11#1)(1995-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
the mitochondrial membranes##3##3##(1990-2#1)(1994-8#1)(2012-2#1)
the mitochondrial metabolism##3##3##(1994-8#3)
the mitochondrial permeability transition pore##2##5##(2010-3#1)(2012-2#1)
the mitochondrial permeability transition##4##4##(2008-1#2)(2010-3#1)(2012-2#1)
the mitochondrial##110##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#2)(1992-10#2)(1992-11#1)(1993-11#1)(1993-2#2)(1994-11#6)(1994-6#1)(1994-8#7)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#5)(1996-10#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2007-12#4)(2008-1#3)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-8#3)(2011-2#4)(2012-2#6)(2013-1#1)(2013-8#2)
the mitochondrially##2##2##(1995-6#1)(2008-10#1)
the mitogen##4##2##(1991-2#1)(1995-2#1)(2012-2#1)(2013-7#1)
the mitogen-activated protein kinase (MAPK) cascade##2##6##(1995-2#2)
the mitogen-activated protein kinase##3##4##(1995-2#2)(2008-11#1)
the mitogen-activated protein kinases (MAPKs)##2##5##(1995-2#1)(2010-10#1)
the mitogen-activated protein##5##3##(1995-2#3)(2008-11#1)(2010-10#1)
the mitogen-activated##6##2##(1995-2#3)(2008-11#1)(2008-7#1)(2010-10#1)
the mitogenic activity of##3##4##(1990-12#1)(2008-2#1)(2008-4#1)
the mitogenic activity##4##3##(1990-12#1)(1994-11#1)(2008-2#1)(2008-4#1)
the mitogenic effect of##3##4##(1994-12#1)(1997-1#1)(2008-6#1)
the mitogenic effect##4##3##(1994-12#1)(1997-1#1)(2008-11#1)(2008-6#1)
the mitogenic effects of EGF##2##5##(2008-6#2)
the mitogenic effects##3##3##(2008-11#1)(2008-6#2)
the mitogenic response##2##3##(1992-10#1)(1994-12#1)
the mitogenic signal##2##3##(1990-12#1)(2008-4#1)
the mitogenic##18##2##(1990-12#2)(1991-1#1)(1992-10#1)(1992-9#1)(1994-11#1)(1994-12#2)(1995-6#1)(1997-1#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#3)
the mitosene##3##2##(1992-3#3)
the mitotic index##3##3##(1994-6#1)(2008-11#2)
the mitotic spindle##6##3##(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#3)
the mitotic##15##2##(1990-2#1)(1994-6#1)(2008-1#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#4)(2013-1#1)
the mitral annulus##2##3##(2008-10#2)
the mitral position##2##3##(2007-8#1)(2013-1#1)
the mitral valve and##2##4##(2013-1#2)
the mitral valve##15##3##(1994-3#1)(2007-8#3)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#7)
the mitral##23##2##(1990-3#1)(1994-3#1)(2007-8#5)(2008-10#3)(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#8)
the mix of##5##3##(1992-4#1)(1993-1#1)(1996-12#1)(2008-10#1)(2008-11#1)
the mix##6##2##(1992-4#1)(1993-1#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
the mixed culture##5##3##(2008-6#3)(2008-7#2)
the mixed cultures##5##3##(2008-6#1)(2013-1#4)
the mixed dentition##2##3##(2007-12#1)(2012-2#1)
the mixed infections##2##3##(2008-10#1)(2012-3#1)
the mixed inoculum##2##3##(2008-10#2)
the mixed liquor##2##3##(2008-12#2)
the mixed solution##4##3##(2008-10#4)
the mixed strategy##2##3##(2008-8#2)
the mixed type##4##3##(1990-2#1)(1995-4#1)(1996-6#1)(2011-1#1)
the mixed valence##2##3##(1991-5#1)(2009-5#1)
the mixed##70##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#30)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#4)(2008-7#3)(2008-8#2)(2009-5#1)(2009-6#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#4)
the mixed-field##2##2##(1992-9#2)
the mixed-solution method##2##3##(2008-10#2)
the mixing efficiency##3##3##(2008-2#3)
the mixing of##2##3##(2008-10#2)
the mixing process##2##3##(2008-3#1)(2008-5#1)
the mixing time constant##3##4##(2008-7#3)
the mixing time##4##3##(2007-10#1)(2008-7#3)
the mixing##24##2##(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#6)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)
the mixture for##2##3##(1990-12#1)(2008-10#1)
the mixture in##2##3##(1997-8#1)(2008-2#1)
the mixture is cycled many times (usually 30) through temperatures that permit denaturation##2##13##(2008-2#1)(2008-9#1)
the mixture is##5##3##(1990-12#1)(2008-10#2)(2008-2#1)(2008-9#1)
the mixture of 2-propanol##2##4##(2008-10#2)
the mixture of both##2##4##(1990-5#1)(2008-10#1)
the mixture of the##3##4##(1990-7#1)(2008-10#2)
the mixture of##31##3##(1990-5#1)(1990-7#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2011-1#1)(2013-1#1)
the mixture was##2##3##(1997-7#1)(2008-10#1)
the mixture##75##2##(1990-12#2)(1990-5#2)(1990-7#1)(1994-9#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#45)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
the mixtures of##3##3##(2008-10#2)(2008-11#1)
the mixtures##20##2##(1992-5#1)(1993-8#2)(2008-10#15)(2008-11#1)(2008-8#1)
the mobile carrier##2##3##(2008-10#2)
the mobile phase and##6##4##(2008-10#4)(2011-1#2)
the mobile phase as an##2##5##(2008-10#2)
the mobile phase as##3##4##(2008-10#3)
the mobile phase containing##2##4##(2008-10#2)
the mobile phase for##3##4##(1990-8#3)
the mobile phase is##2##4##(2008-10#2)
the mobile phase pH##2##4##(2008-10#2)
the mobile phase was##5##4##(2008-10#5)
the mobile phase water content##2##5##(2008-10#2)
the mobile phase were##3##4##(2008-10#3)
the mobile phase##70##3##(1990-8#4)(1991-5#1)(1991-7#1)(1993-11#1)(1994-9#1)(1995-6#1)(1996-5#3)(2008-10#48)(2011-1#8)(2011-3#1)(2012-3#1)
the mobile phases##5##3##(1996-5#1)(2008-10#2)(2011-1#2)
the mobile##83##2##(1990-8#4)(1991-5#1)(1991-7#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-5#4)(2007-11#1)(2008-10#54)(2011-1#10)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
the mobility of the##4##4##(1993-11#1)(1994-3#1)(2008-10#1)(2010-2#1)
the mobility of##11##3##(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(2008-10#3)(2008-8#2)(2010-2#1)(2011-2#1)
the mobility shift##2##3##(1993-11#2)
the mobility##18##2##(1993-11#3)(1994-3#2)(1994-6#1)(1994-9#1)(2008-10#4)(2008-7#1)(2008-8#2)(2010-2#2)(2011-2#1)(2012-2#1)
the mobilization of##2##3##(1992-3#1)(2007-5#1)
the mobilization##4##2##(1992-3#1)(2007-5#1)(2011-2#2)
the modal behavior##4##3##(2008-2#2)(2008-3#2)
the modal birefringence of single-mode##2##5##(2008-3#2)
the modal birefringence of##3##4##(2008-3#3)
the modal##19##2##(1991-4#1)(2008-12#2)(2008-2#4)(2008-3#12)
the modality of##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
the modality##6##2##(1992-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
the mode field##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
the mode of action of the##3##6##(1997-1#1)(1997-7#1)(2008-10#1)
the mode of action of##10##5##(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-5#1)(2011-2#1)
the mode of cell##2##4##(2008-4#1)(2008-9#1)
the mode of dissemination##2##4##(2008-10#1)(2013-1#1)
the mode of##36##3##(1993-8#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
the mode spacing##2##3##(2007-12#1)(2008-2#1)
the mode##58##2##(1993-8#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#2)(2007-11#4)(2007-12#5)(2007-6#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#4)
the mode-lock frequency##2##3##(2007-12#2)
the mode-locked##3##2##(2007-11#2)(2008-3#1)
the mode-locking##3##2##(2007-11#3)
the model CA3 pyramidal cell##2##5##(2008-11#2)
the model allows##2##3##(2008-2#1)(2013-8#1)
the model also##3##3##(1993-9#1)(2008-10#1)(2008-7#1)
the model and suggests##2##4##(2008-12#1)(2010-5#1)
the model and the##4##4##(1994-2#1)(2008-3#2)(2010-4#1)
the model and##16##3##(1991-1#1)(1992-12#1)(1992-6#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)
the model are##8##3##(1992-12#1)(1996-1#1)(1997-4#1)(1997-8#1)(2008-10#3)(2012-1#1)
the model as a##3##4##(1990-8#1)(2008-11#1)(2013-1#1)
the model as##4##3##(1990-8#1)(1996-3#1)(2008-11#1)(2013-1#1)
the model based on the##3##5##(2007-11#1)(2008-10#1)(2011-1#1)
the model based on##6##4##(1997-7#2)(2007-11#2)(2008-10#1)(2011-1#1)
the model by##4##3##(1995-2#1)(1995-9#1)(2008-10#1)(2008-3#1)
the model can be##5##4##(2008-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
the model can##8##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2013-8#1)
the model compound##3##3##(1995-5#1)(1996-2#1)(2008-10#1)
the model developed##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2010-5#1)
the model for the##7##4##(1993-8#1)(1994-5#1)(1996-1#1)(2008-2#4)
the model for##15##3##(1992-1#1)(1993-8#1)(1994-5#2)(1995-12#1)(1996-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)
the model formulation##2##3##(2008-10#2)
the model further##2##3##(2008-2#1)(2008-3#1)
the model gave a##2##4##(2008-2#1)(2008-7#1)
the model group##3##3##(1990-12#3)
the model has##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
the model in##6##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)
the model include the##2##4##(1997-4#1)(2008-3#1)
the model input##2##3##(2008-3#2)
the model is that##3##4##(1997-8#1)(2008-2#1)(2008-7#1)
the model is##23##3##(1995-5#1)(1997-8#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#1)
the model of the##4##4##(1996-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
the model of##22##3##(1994-2#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
the model or##3##3##(1992-6#1)(2008-10#1)(2010-8#1)
the model organism##2##3##(2008-8#1)(2011-1#1)
the model outputs##2##3##(2008-10#1)(2013-1#1)
the model parameters##8##3##(1994-11#1)(2008-10#1)(2008-3#2)(2008-7#3)(2008-8#1)
the model plant Arabidopsis thaliana##4##5##(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
the model plant Arabidopsis##5##4##(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
the model plant##7##3##(2008-10#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
the model predicted##4##3##(2008-7#3)(2008-9#1)
the model prediction##2##3##(2008-3#1)(2008-7#1)
the model predictions##6##3##(2008-10#2)(2008-2#1)(2008-7#2)(2009-7#1)
the model predicts##2##3##(2008-10#1)(2008-9#1)
the model proposed##2##3##(2008-10#1)(2013-8#1)
the model results##5##3##(1996-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)
the model shows that##2##4##(2008-11#2)
the model simulation and##2##4##(2008-7#2)
the model system of##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
the model system##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
the model that##4##3##(1994-1#1)(1995-2#1)(2008-3#1)(2012-3#1)
the model to a##3##4##(1996-2#1)(2008-7#1)(2013-8#1)
the model to any##2##4##(2008-10#1)(2008-5#1)
the model to include##2##4##(2008-11#1)(2009-7#1)
the model to##21##3##(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-6#1)(2013-8#2)
the model using##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
the model via##2##3##(2008-3#1)(2008-7#1)
the model was used##2##4##(2008-10#1)(2008-3#1)
the model was##14##3##(1992-3#1)(1995-9#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#1)
the model will##2##3##(2007-12#1)(2013-1#1)
the model with##2##3##(2007-11#1)(2008-2#1)
the model##434##2##(1990-12#5)(1990-8#4)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-7#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-9#3)(1996-1#2)(1996-12#3)(1996-2#7)(1996-3#2)(1996-4#5)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#4)(2007-11#8)(2007-12#3)(2008-10#80)(2008-11#24)(2008-12#3)(2008-2#21)(2008-3#51)(2008-5#6)(2008-6#6)(2008-7#45)(2008-8#21)(2008-9#14)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#8)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#16)
the model's predictions##2##3##(1995-2#1)(2008-3#1)
the model's##9##2##(1992-2#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
the model)##2##2##(1997-5#1)(2008-10#1)
the modeled##5##2##(2008-10#1)(2008-3#3)(2013-1#1)
the modeless laser##4##3##(2008-2#4)
the modeling and##2##3##(2008-3#2)
the modeling environment##2##3##(2010-9#2)
the modeling of the##2##4##(2008-3#1)(2009-10#1)
the modeling of##11##3##(2008-10#1)(2008-2#1)(2008-3#5)(2009-10#1)(2009-9#1)(2010-9#1)(2011-2#1)
the modeling##21##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#9)(2008-7#1)(2009-10#1)(2009-9#1)(2010-9#3)(2011-2#1)
the modelling of##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
the modelling##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)(2010-10#1)
the models based on the##2##5##(2007-12#1)(2013-8#1)
the models based on##4##4##(2007-12#1)(2008-10#1)(2013-8#2)
the models for##2##3##(2007-11#1)(2012-3#1)
the models of##4##3##(1997-5#1)(2008-10#2)(2008-11#1)
the models predict##2##3##(2008-8#1)(2008-9#1)
the models to##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2012-8#1)
the models were##3##3##(2008-10#3)
the models with##2##3##(2008-10#1)(2008-5#1)
the models##54##2##(1992-9#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#5)(2009-3#1)(2009-7#2)(2009-8#2)(2010-2#1)(2011-1#1)(2012-3#1)(2012-8#1)(2013-8#6)
the moderate subgroup##2##3##(2009-2#2)
the moderate##8##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#2)(2012-3#1)(2013-1#2)
the moderate-resolution imaging spectroradiometer airborne simulator##2##6##(2008-3#2)
the moderate-resolution imaging##3##3##(2008-3#3)
the moderately##2##2##(2008-1#1)(2008-10#1)
the moderating effects of##4##4##(1996-1#1)(1996-2#1)(2007-12#1)(2011-2#1)
the moderating##7##2##(1996-1#1)(1996-2#1)(2007-12#2)(2008-12#1)(2010-1#1)(2011-2#1)
the modern U##3##3##(2008-9#3)
the modern and##2##3##(2007-6#1)(2008-10#1)
the modern world##2##3##(1996-1#1)(2013-1#1)
the modern##34##2##(1991-5#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-4#1)(2006-4#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-1#2)(2013-1#4)
the modernization##2##2##(2009-7#1)(2012-3#1)
the modes of action##2##4##(2008-10#1)(2010-5#1)
the modes of##7##3##(1992-6#1)(2007-11#1)(2008-10#2)(2009-12#1)(2010-5#1)(2011-2#1)
the modes##10##2##(1992-6#1)(2007-11#1)(2008-10#2)(2008-2#3)(2009-12#1)(2010-5#1)(2011-2#1)
the modest##4##2##(1992-3#1)(2007-12#1)(2008-2#1)(2008-4#1)
the modification and##2##3##(1995-6#1)(2008-10#1)
the modification of the##5##4##(1992-5#1)(1996-5#1)(2008-10#2)(2008-7#1)
the modification of##26##3##(1990-2#1)(1990-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#12)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)
the modification##34##2##(1990-2#1)(1990-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-5#1)(2008-1#1)(2008-10#15)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)
the modifications of##2##3##(1992-5#1)(2008-1#1)
the modifications##4##2##(1992-3#1)(1992-5#1)(2008-1#1)(2008-11#1)
the modified Quad procedure##2##4##(2013-1#2)
the modified Rankin Scale##2##4##(2012-3#2)
the modified Ravitch##2##3##(2007-8#2)
the modified Strehl ratio##2##4##(2008-2#2)
the modified Tessier scheme##2##4##(2008-10#2)
the modified approach##2##3##(2008-3#2)
the modified electrode is##3##4##(1995-6#2)(2008-10#1)
the modified electrode was##3##4##(2008-10#3)
the modified electrode##22##3##(1995-6#3)(2008-10#19)
the modified electrodes##5##3##(2008-10#5)
the modified enzyme##3##3##(1993-6#1)(2008-10#2)
the modified instrument##2##3##(2008-10#1)(2008-3#1)
the modified nucleotide##2##3##(1993-11#1)(2008-2#1)
the modified nucleotides##3##3##(2008-4#1)(2008-8#2)
the modified power law##2##4##(2008-10#2)
the modified protein##3##3##(1993-11#1)(1995-11#1)(1995-2#1)
the modified resin##4##3##(2008-10#4)
the modified screen-printed carbon electrodes##3##5##(2008-10#3)
the modified screen-printed##4##3##(2008-10#4)
the modified silica gel##3##4##(2008-10#3)
the modified silica##4##3##(2008-10#4)
the modified surface##3##3##(2008-10#3)
the modified triangular interferometer##3##4##(2008-3#3)
the modified##162##2##(1990-7#1)(1990-8#2)(1990-9#1)(1991-5#1)(1992-5#1)(1993-11#3)(1993-6#1)(1995-11#1)(1995-2#5)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-10#77)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
the modifier##7##2##(2008-10#7)
the modifiers##5##2##(2008-10#5)
the modifying effect of##2##4##(1992-8#1)(2008-10#1)
the modifying##3##2##(1990-6#1)(1992-8#1)(2008-10#1)
the modular##6##2##(1996-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#2)
the modulated##4##2##(1994-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
the modulating##8##2##(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#1)
the modulation amplitude##2##3##(2008-3#2)
the modulation frequency##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
the modulation in the##2##4##(2008-3#1)(2009-5#1)
the modulation of cell cycle##2##5##(1991-9#1)(2008-11#1)
the modulation of cell##3##4##(1991-9#1)(2008-11#1)(2008-7#1)
the modulation of chromatin##2##4##(2010-2#2)
the modulation of the##8##4##(1992-9#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-3#3)(2008-6#1)
the modulation of##58##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#3)(2010-11#1)(2010-2#2)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
the modulation parameters##3##3##(2008-3#3)
the modulation transfer function (MTF) of a##3##7##(2008-2#3)
the modulation transfer function for##2##5##(2008-3#2)
the modulation transfer function of##3##5##(2008-2#1)(2008-3#2)
the modulation transfer function##10##4##(2008-2#5)(2008-3#5)
the modulation##91##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#7)(2008-3#22)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-2#2)(2011-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
the modulator##4##2##(1993-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
the modulatory action of##2##4##(2008-11#1)(2008-7#1)
the modulatory effect of##3##4##(1993-3#1)(1995-11#1)(2008-8#1)
the modulatory role of##2##4##(1994-8#1)(1996-2#1)
the modulatory##10##2##(1991-1#1)(1993-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
the module##4##2##(1996-7#1)(2008-11#2)(2013-1#1)
the modules##3##2##(1992-12#1)(2008-3#1)(2012-3#1)
the modulus of the coherence function##2##6##(2008-3#2)
the modulus of the##3##4##(2008-2#1)(2008-3#2)
the modulus of##4##3##(2008-2#1)(2008-3#2)(2012-2#1)
the modulus##9##2##(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-7#2)(2010-4#1)(2012-2#1)
the moiré fringes are##2##4##(2008-3#2)
the moiré fringes in Talbot interferometry are##2##7##(2008-3#2)
the moiré fringes in Talbot interferometry##3##6##(2008-3#3)
the moiré fringes in##4##4##(2008-3#4)
the moiré fringes##11##3##(2008-2#1)(2008-3#10)
the moiré pattern##2##3##(2008-3#2)
the moiré profile##3##3##(2008-3#3)
the moiré##18##2##(2008-2#2)(2008-3#16)
the moist samples##2##3##(2008-10#2)
the moist##4##2##(2008-10#4)
the moisture content and##2##4##(2008-12#1)(2009-7#1)
the moisture content##6##3##(2008-10#1)(2008-12#1)(2009-7#1)(2010-4#1)(2013-7#2)
the moisture level##2##3##(2008-10#1)(2008-5#1)
the moisture##12##2##(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-4#1)(2013-7#3)
the moisturizing##2##2##(2008-5#2)
the molar absorption##2##3##(2007-12#1)(2008-4#1)
the molar absorptivities of the##3##5##(2008-10#3)
the molar absorptivities of##4##4##(2008-10#4)
the molar absorptivities##5##3##(2008-10#5)
the molar absorptivity is##2##4##(2008-10#2)
the molar absorptivity of##2##4##(2008-10#2)
the molar absorptivity was##2##4##(2008-10#2)
the molar absorptivity##9##3##(2008-10#9)
the molar ratio of myristic acid to pyrene carboxylic acid##3##10##(2008-10#3)
the molar ratio of the##4##5##(2008-10#3)(2012-2#1)
the molar ratio of##16##4##(2008-10#11)(2008-11#1)(2008-4#1)(2011-2#2)(2012-2#1)
the molar ratio##17##3##(2008-10#12)(2008-11#1)(2008-4#1)(2011-2#2)(2012-2#1)
the molar refractivities of##2##4##(2008-3#2)
the molar##48##2##(1991-9#1)(1992-5#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#30)(2008-11#2)(2008-3#3)(2008-4#4)(2011-2#3)(2012-2#1)
the molding process##2##3##(2008-3#2)
the molding##3##2##(2008-3#2)(2008-5#1)
the mole fraction of the##2##5##(2008-10#2)
the mole fraction of##4##4##(2008-10#4)
the mole fraction##7##3##(1990-8#2)(2008-10#5)
the mole fractions of##2##4##(2008-2#1)(2008-7#1)
the mole fractions##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
the mole##11##2##(1990-8#2)(1992-6#1)(2008-10#6)(2008-2#1)(2008-7#1)
the molecular analysis##2##3##(2009-8#1)(2012-2#1)
the molecular and cellular##9##4##(1997-6#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)
the molecular and##16##3##(1990-5#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)
the molecular bases##2##3##(2008-4#1)(2010-3#1)
the molecular basis for the##2##5##(1991-8#1)(2008-9#1)
the molecular basis for##5##4##(1991-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
the molecular basis of a##2##5##(1993-6#1)(2008-5#1)
the molecular basis of inherited##2##5##(2008-4#1)(2009-5#1)
the molecular basis of the Bohr effect of hemoglobin##2##9##(1990-8#2)
the molecular basis of the Bohr effect##3##7##(1990-8#3)
the molecular basis of the##8##5##(1990-8#3)(1993-2#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#1)
the molecular basis of this##3##5##(2008-10#1)(2008-11#1)(2011-1#1)
the molecular basis of##33##4##(1990-8#3)(1991-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
the molecular basis underlying the##2##5##(2008-11#1)(2009-12#1)
the molecular basis##40##3##(1990-8#3)(1991-2#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-1#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)
the molecular biology of##3##4##(1997-7#1)(2008-6#1)(2010-3#1)
the molecular biology##5##3##(1997-7#1)(2007-5#1)(2008-6#1)(2010-3#1)(2012-3#1)
the molecular changes##4##3##(2008-5#2)(2010-1#1)(2012-2#1)
the molecular characterization of##3##4##(1990-7#1)(2008-10#2)
the molecular clock##2##3##(2008-4#1)(2008-5#1)
the molecular cloning and##2##4##(1991-2#1)(1994-12#1)
the molecular cloning of##3##4##(1991-12#1)(1992-8#1)(1993-12#1)
the molecular cloning##5##3##(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-12#1)
the molecular composition##2##3##(1994-11#1)(2008-11#1)
the molecular design##2##3##(2011-1#1)(2012-2#1)
the molecular details##2##3##(1994-2#1)(2009-6#1)
the molecular determinants of##2##4##(1995-5#1)(1995-8#1)
the molecular distillation process##2##4##(2008-6#2)
the molecular dynamics##4##3##(1992-11#1)(1995-2#1)(2010-2#1)(2012-2#1)
the molecular environment within##2##4##(1990-2#2)
the molecular environment##3##3##(1990-2#2)(2008-2#1)
the molecular events that lead to progressive##2##7##(2008-7#2)
the molecular events that##4##4##(1994-11#1)(2008-7#2)(2009-8#1)
the molecular events##7##3##(1994-11#1)(2008-10#1)(2008-7#3)(2009-8#1)(2010-12#1)
the molecular evolution of##2##4##(2008-1#1)(2012-2#1)
the molecular genetic##2##3##(1995-2#1)(1997-6#1)
the molecular genetics of##4##4##(1997-7#1)(2008-4#1)(2008-7#1)(2010-8#1)
the molecular genetics##7##3##(1997-7#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-3#1)
the molecular interaction between the##2##5##(2008-8#1)(2008-9#1)
the molecular interaction##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the molecular interactions between##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
the molecular layer##6##3##(1993-9#1)(1994-8#1)(1995-12#2)(1996-5#1)(2013-8#1)
the molecular level##27##3##(1992-6#1)(1993-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-2#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
the molecular linkage map##2##4##(2008-5#1)(2008-8#1)
the molecular machinery that##2##4##(1993-12#1)(2008-7#1)
the molecular markers##2##3##(2008-10#2)
the molecular mass of the##3##5##(2008-10#2)(2008-4#1)
the molecular mass##5##3##(1995-3#1)(2008-10#3)(2008-4#1)
the molecular mechanism of the##3##5##(1993-8#1)(1996-4#1)(2009-12#1)
the molecular mechanism of##18##4##(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-3#1)(2012-1#2)
the molecular mechanism underlying the##2##5##(1991-9#1)(2010-12#1)
the molecular mechanism underlying##4##4##(1991-9#1)(2008-4#1)(2010-12#1)(2013-1#1)
the molecular mechanism##25##3##(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#1)
the molecular mechanism(s) that##2##4##(1994-11#1)(2012-2#1)
the molecular mechanisms by which##3##5##(2008-10#1)(2008-9#1)(2013-1#1)
the molecular mechanisms by##4##4##(2008-10#1)(2008-9#1)(2011-3#1)(2013-1#1)
the molecular mechanisms involved in##2##5##(2008-11#1)(2011-1#1)
the molecular mechanisms of##18##4##(1993-2#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)
the molecular mechanisms that##7##4##(1994-2#1)(2008-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
the molecular mechanisms underlying the##2##5##(2008-8#1)(2012-12#1)
the molecular mechanisms underlying##7##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2012-12#1)
the molecular mechanisms##47##3##(1991-6#1)(1993-2#1)(1994-2#1)(1996-2#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)
the molecular orientation##3##3##(2008-10#1)(2008-2#2)
the molecular packing##2##3##(1991-3#1)(1992-6#1)
the molecular pathogenesis of##3##4##(1995-2#1)(2007-12#1)(2010-4#1)
the molecular peak##2##3##(2008-10#2)
the molecular pharmacology and##2##4##(1991-12#1)(2008-4#1)
the molecular pharmacology##3##3##(1991-12#1)(2008-4#1)(2012-12#1)
the molecular processes##2##3##(2010-12#1)(2013-1#1)
the molecular recognition event##2##4##(2009-3#2)
the molecular ruler mechanism##2##4##(2012-2#2)
the molecular scattering##2##3##(2008-2#2)
the molecular signals##2##3##(2008-4#1)(2008-5#1)
the molecular size of antigens##2##5##(1990-12#2)
the molecular size of##3##4##(1990-12#2)(2008-10#1)
the molecular structure of the##4##5##(1994-5#1)(1997-6#1)(2008-10#1)(2008-7#1)
the molecular structure of##7##4##(1991-3#1)(1994-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#2)
the molecular structure##8##3##(1991-3#1)(1994-5#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-7#1)(2012-2#2)
the molecular structures##3##3##(1996-2#1)(2008-10#2)
the molecular surface##3##3##(1994-8#1)(2008-10#1)(2013-1#1)
the molecular weight and##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
the molecular weight of the##4##5##(1991-12#1)(1991-2#1)(1992-12#1)(2008-10#1)
the molecular weight of##10##4##(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)
the molecular weight##21##3##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
the molecular weights of##5##4##(1990-7#1)(1992-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
the molecular##398##2##(1990-12#4)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#3)(1991-12#3)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#5)(1996-4#1)(1996-5#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#5)(1997-8#3)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#47)(2008-11#19)(2008-2#10)(2008-3#3)(2008-4#15)(2008-5#14)(2008-6#5)(2008-7#17)(2008-8#15)(2008-9#13)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#5)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#10)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#20)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#4)
the molecule in##2##3##(2008-10#1)(2008-11#1)
the molecule is##3##3##(1990-5#1)(1997-6#1)(2008-10#1)
the molecule to##2##3##(1995-3#1)(2008-11#1)
the molecule##69##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-3#4)(1995-6#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-8#1)(1997-9#1)(2008-10#7)(2008-11#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-5#1)(2013-1#1)
the molecules are##5##3##(1992-3#1)(1997-7#1)(2008-10#1)(2009-5#1)(2012-2#1)
the molecules from##2##3##(2008-10#1)(2008-7#1)
the molecules in the##2##4##(1992-9#1)(2008-11#1)
the molecules in##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
the molecules tested##2##3##(1995-6#1)(2012-12#1)
the molecules which##2##3##(2008-10#1)(2008-5#1)
the molecules##40##2##(1991-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-7#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#2)(2009-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
the mollusk##2##2##(1994-2#1)(2008-5#1)
the molt cycle of the American crayfish##2##7##(2008-6#2)
the molt cycle##3##3##(2008-6#3)
the molt##5##2##(2008-6#4)(2008-7#1)
the molten globule##2##3##(1993-11#2)
the molten##4##2##(1993-11#2)(2008-3#1)(2010-4#1)
the molybdene blue##2##3##(2008-10#2)
the molybdenum blue method##4##4##(2008-10#4)
the molybdenum blue##6##3##(2008-10#6)
the molybdenum##11##2##(1997-7#1)(2008-10#10)
the moment of ionization##2##4##(2007-12#2)
the moment of##9##3##(1990-3#1)(1990-9#1)(2007-12#2)(2008-11#1)(2008-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
the moment when the##2##4##(2008-9#1)(2009-10#1)
the moment##25##2##(1990-3#2)(1990-9#1)(1995-11#1)(1996-12#1)(1996-4#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-9#1)(2009-10#3)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
the momentary##2##2##(2008-3#1)(2008-5#1)
the moments of##2##3##(2008-3#1)(2008-8#1)
the moments##3##2##(2008-3#2)(2008-8#1)
the momentum of strength in the flexor and extensor muscle groups##2##11##(2007-8#2)
the momentum##4##2##(1994-2#1)(2007-8#2)(2008-3#1)
the money##5##2##(1990-3#1)(1991-1#1)(1992-2#1)(1995-12#1)(1996-2#1)
the monitor##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
the monitored##4##2##(1993-8#1)(2007-12#1)(2008-10#1)(2010-8#1)
the monitoring and##4##3##(1997-4#1)(2007-8#1)(2011-1#1)(2012-12#1)
the monitoring of the##9##4##(1990-11#1)(1992-3#1)(1992-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-8#1)
the monitoring of##40##3##(1990-11#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-6#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
the monitoring##55##2##(1990-11#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-6#1)(1997-2#2)(1997-4#3)(1997-6#1)(2007-7#1)(2007-8#2)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the monitors##2##2##(2008-10#2)
the monkey##11##2##(1991-2#1)(1991-4#1)(1992-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-2#1)(2008-8#3)(2009-5#1)
the monkeys##3##2##(1992-11#1)(1993-6#1)(2011-2#1)
the mono- and##2##3##(2008-10#1)(2008-8#1)
the monoamine neurotransmitters##3##3##(2008-10#3)
the monoamine##8##2##(1993-12#1)(1994-8#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-7#1)
the monoclinic space group##9##4##(1992-8#1)(1996-2#4)(1997-7#3)(2007-11#1)
the monoclinic space##10##3##(1992-8#1)(1996-2#4)(1997-7#4)(2007-11#1)
the monoclinic##13##2##(1992-8#1)(1996-2#4)(1997-7#5)(2007-11#1)(2008-10#1)(2013-1#1)
the monoclonal antibodies##4##3##(1994-3#1)(1994-5#1)(2008-7#1)(2008-8#1)
the monoclonal antibody##11##3##(1990-12#1)(1991-5#1)(1992-12#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#1)
the monoclonal##20##2##(1990-12#1)(1991-5#2)(1992-12#1)(1994-3#1)(1994-5#1)(1995-12#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)
the monocyclic##3##2##(1993-8#1)(2007-11#1)(2008-10#1)
the monocyte IgA Fc receptor##2##5##(1994-8#2)
the monocyte##8##2##(1993-6#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-4#1)(2008-10#1)(2013-1#1)
the monocytes and##2##3##(1993-12#1)(2008-4#1)
the monoesters##5##2##(1992-12#4)(2008-4#1)
the monofunctional##2##2##(1993-12#1)(2008-10#1)
the monolayer and##2##3##(1994-3#1)(2008-10#1)
the monolayer culture##3##3##(2008-11#3)
the monolayer in##4##3##(1992-6#1)(1994-5#1)(2008-10#2)
the monolayer is##4##3##(1994-3#1)(1994-6#2)(2008-10#1)
the monolayer##27##2##(1990-5#2)(1991-3#1)(1992-6#1)(1994-3#4)(1994-5#1)(1994-6#3)(1997-2#2)(2008-10#7)(2008-11#6)
the monolayers##3##2##(1994-3#1)(2007-12#1)(2008-10#1)
the monolith##2##2##(2008-10#2)
the monolithic columns##3##3##(2008-10#3)
the monolithic##6##2##(2008-10#4)(2008-3#2)
the monomer are##2##3##(1992-4#1)(1995-5#1)
the monomer##22##2##(1992-12#4)(1992-4#2)(1995-5#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#3)(2012-1#1)
the monomer--dimer##2##2##(1993-3#2)
the monomeric and##2##3##(1994-11#1)(2008-10#1)
the monomeric form##2##3##(1994-11#1)(1997-2#1)
the monomeric##15##2##(1990-2#1)(1991-7#1)(1994-11#3)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#5)(2009-12#1)(2009-2#1)
the monomers##6##2##(1994-2#1)(1994-5#1)(2008-10#1)(2008-8#1)(2010-12#1)(2013-1#1)
the mononuclear##3##2##(2008-4#3)
the monophyly of##6##3##(2007-12#1)(2008-10#3)(2010-3#2)
the monopolar##3##2##(1992-12#1)(1994-9#1)(2008-9#1)
the monosaccharide sequence##2##3##(1994-3#2)
the monosaccharide##3##2##(1990-8#1)(1994-3#2)
the monosegment##2##2##(2008-10#2)
the monotonic##2##2##(2007-12#1)(2008-10#1)
the month of Ramadan##3##4##(2008-4#3)
the month##11##2##(1994-7#1)(2008-10#1)(2008-3#2)(2008-4#3)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
the monthly##6##2##(2007-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2013-7#2)
the months of November##2##4##(2010-5#1)(2013-8#1)
the months of##4##3##(2007-7#1)(2010-5#1)(2012-3#1)(2013-8#1)
the months##6##2##(1991-12#1)(2007-7#1)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
the mood##5##2##(1991-1#1)(1991-8#1)(2007-6#1)(2008-5#1)(2013-8#1)
the moon##5##2##(2008-2#2)(2008-3#2)(2013-8#1)
the moral##7##2##(1991-12#1)(2008-11#3)(2008-7#1)(2011-2#1)(2012-2#1)
the morbidity and mortality of the population##8##7##(2013-8#8)
the morbidity and mortality of the##9##6##(2012-3#1)(2013-8#8)
the morbidity and mortality of##11##5##(2008-8#1)(2010-8#1)(2012-3#1)(2013-8#8)
the morbidity and mortality##17##4##(1996-9#1)(2006-10#1)(2007-7#2)(2008-8#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#8)
the morbidity and##21##3##(1996-9#1)(1997-8#1)(2006-10#1)(2007-7#3)(2008-8#1)(2009-4#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-8#8)
the morbidity associated with##2##4##(2007-11#1)(2008-7#1)
the morbidity of the##2##4##(2007-8#1)(2008-8#1)
the morbidity of##7##3##(1993-1#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)
the morbidity##34##2##(1991-12#1)(1991-2#1)(1993-1#1)(1996-9#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#3)(2012-3#2)(2013-8#8)
the more accurate##2##3##(1990-11#1)(2008-2#1)
the more acidic##2##3##(1991-2#1)(2008-10#1)
the more aggressive##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
the more basic##2##3##(1990-8#1)(1996-2#1)
the more common##13##3##(1992-12#1)(1992-5#1)(1997-8#1)(2008-12#2)(2008-2#2)(2008-6#1)(2008-9#2)(2009-9#1)(2010-1#1)(2012-2#1)
the more commonly used##4##4##(1997-4#1)(2008-1#1)(2008-4#2)
the more commonly##7##3##(1997-4#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-4#1)
the more complex##5##3##(1992-1#1)(1994-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
the more conventional##3##3##(1994-5#1)(2008-2#1)(2008-3#1)
the more difficult##3##3##(2008-1#1)(2008-3#1)(2012-2#1)
the more effective##2##3##(2008-3#2)
the more efficient##3##3##(2008-10#2)(2012-2#1)
the more frequently##2##3##(1994-5#1)(2008-8#1)
the more general##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
the more hindered Z##2##4##(2007-11#2)
the more important##4##3##(1992-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
the more intense##2##3##(2008-10#2)
the more likely##2##3##(1991-2#1)(1994-5#1)
the more number of##2##4##(1991-2#2)
the more polar##2##3##(1993-11#1)(2008-10#1)
the more recent##6##3##(1997-4#1)(1997-8#1)(2008-5#2)(2008-7#1)(2010-11#1)
the more resistant C57BL/10 mice##2##5##(1996-12#2)
the more resistant##5##3##(1990-2#1)(1996-12#2)(2008-10#2)
the more sensitive##3##3##(1990-8#1)(2008-10#2)
the more serious##2##3##(1990-5#1)(2010-3#1)
the more severe##3##3##(1997-3#1)(2008-4#1)(2012-2#1)
the more significant##4##3##(1995-6#1)(1996-3#1)(2007-12#1)(2009-8#1)
the more susceptible##3##3##(2008-10#2)(2009-5#1)
the more than##4##3##(1991-12#1)(1993-12#1)(1994-3#1)(1995-12#1)
the more the##3##3##(1995-11#1)(2008-5#1)(2013-8#1)
the more traditional##4##3##(1996-3#1)(2008-3#1)(2008-5#1)(2009-11#1)
the more used##2##3##(2008-10#1)(2012-3#1)
the more useful##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
the more widely##2##3##(1992-2#1)(2012-3#1)
the more##211##2##(1990-11#1)(1990-2#1)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#35)(2008-11#7)(2008-12#4)(2008-2#10)(2008-3#14)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#2)(2012-2#6)(2012-3#3)(2012-5#2)(2013-1#3)(2013-8#3)
the morning and##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
the morning##19##2##(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#7)(2009-4#1)(2010-5#1)
the morphine##6##2##(1991-1#1)(1994-8#1)(1995-12#2)(1995-5#1)(2008-10#1)
the morphogenesis of##2##3##(2007-12#1)(2008-11#1)
the morphogenesis##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
the morphogenetic##2##2##(2007-12#1)(2009-6#1)
the morphologic and##2##3##(1992-9#1)(2007-10#1)
the morphologic##5##2##(1991-2#1)(1991-6#1)(1992-9#1)(2007-10#1)(2011-2#1)
the morphological and ultrastructural changes##2##5##(2008-10#2)
the morphological and##11##3##(1992-6#1)(1993-9#1)(1994-12#1)(2008-10#4)(2008-2#1)(2009-2#1)(2011-2#1)(2012-9#1)
the morphological changes and##2##4##(1990-12#1)(2008-5#1)
the morphological changes##6##3##(1990-12#1)(1994-8#1)(1997-8#1)(2008-2#1)(2008-5#1)(2008-9#1)
the morphological characteristics of the##2##5##(2008-5#1)(2008-8#1)
the morphological characteristics##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
the morphological correlation##2##3##(2008-3#2)
the morphological differentiation##2##3##(1994-8#1)(2011-2#1)
the morphological features##3##3##(2008-5#1)(2012-3#1)(2013-7#1)
the morphological##53##2##(1990-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-12#6)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#5)(2012-3#2)(2012-9#1)(2013-7#1)
the morphologically similar##2##3##(2008-10#2)
the morphology and biochemistry of##2##5##(1996-5#1)(2008-7#1)
the morphology and##14##3##(1996-5#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
the morphology of dorsal lips##2##5##(2011-2#2)
the morphology of the substomatal##2##5##(2008-10#2)
the morphology of the##13##4##(2007-12#2)(2007-8#2)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2013-7#1)
the morphology of##32##3##(1991-12#1)(1993-8#1)(1994-2#1)(1995-6#1)(1997-8#1)(2007-12#2)(2007-8#4)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#3)(2013-1#2)(2013-7#1)
the morphology##51##2##(1991-12#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-8#2)(2007-11#1)(2007-12#4)(2007-8#4)(2008-10#10)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
the morphometry of##2##3##(1996-2#1)(2013-1#1)
the morphometry##4##2##(1995-8#1)(1996-2#1)(2009-12#1)(2013-1#1)
the mortality after##2##3##(1990-12#1)(2007-10#1)
the mortality and morbidity##2##4##(1990-8#1)(2010-1#1)
the mortality and##4##3##(1990-8#1)(2008-11#1)(2008-9#1)(2010-1#1)
the mortality associated with##2##4##(2008-10#1)(2010-7#1)
the mortality event##3##3##(2008-5#3)
the mortality in##3##3##(2007-8#1)(2008-1#1)(2011-2#1)
the mortality is##2##3##(1996-9#1)(2011-2#1)
the mortality of dialysis patients##2##5##(2008-1#2)
the mortality of##7##3##(1994-7#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-8#1)
the mortality rate and##2##4##(2007-12#1)(2008-9#1)
the mortality rate of##4##4##(1994-7#1)(2007-12#1)(2008-9#1)(2013-1#1)
the mortality rate was##3##4##(1991-2#1)(1992-9#1)(2008-5#1)
the mortality rate##20##3##(1991-2#1)(1992-9#2)(1994-7#3)(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2012-12#2)(2013-1#1)
the mortality##59##2##(1990-12#3)(1990-8#1)(1991-2#1)(1992-9#2)(1994-5#1)(1994-7#4)(1996-7#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#5)(2010-1#1)(2010-7#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
the mortar preparation did not correspond to the complex##2##9##(2008-10#2)
the morula-like cell##2##3##(2008-5#2)
the morula-like cells##2##3##(2008-5#2)
the morula-like##4##2##(2008-5#4)
the mosaic##2##2##(2008-12#1)(2011-1#1)
the mosquito Aedes##2##3##(2008-5#1)(2011-2#1)
the mosquito##8##2##(2008-5#1)(2010-1#1)(2010-2#1)(2011-2#3)(2011-3#2)
the mosquitoes##2##2##(2008-5#2)
the moss Physcomitrella patens using##3##5##(2010-2#3)
the moss Physcomitrella patens##7##4##(2010-2#7)
the moss##11##2##(2008-10#2)(2008-8#2)(2010-2#7)
the most abundant and##3##4##(1992-9#1)(2010-11#1)(2013-1#1)
the most abundant chemical##2##4##(2013-7#1)(2013-8#1)
the most abundant constituents##2##4##(1997-2#1)(2012-12#1)
the most abundant genotypes##2##4##(2008-10#1)(2008-8#1)
the most abundant protein in##2##5##(2011-2#1)(2013-8#1)
the most abundant##53##3##(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#4)(2013-8#2)
the most abundantly##2##3##(2008-10#1)(2009-10#1)
the most accepted##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
the most accurate and##2##4##(1991-6#1)(2008-3#1)
the most accurate##15##3##(1991-6#1)(1993-11#2)(2007-12#2)(2008-10#2)(2008-3#4)(2008-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
the most active cytotoxic##2##4##(2007-5#1)(2008-11#1)
the most active##24##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-3#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#1)(2013-1#1)(2013-8#1)
the most advanced##4##3##(1992-5#1)(2008-5#1)(2008-8#2)
the most affected##4##3##(1992-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
the most aggressive##6##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-3#1)
the most and##3##3##(1994-12#1)(2008-12#2)
the most apical##2##3##(2008-12#1)(2008-7#1)
the most appropriate diagnostic##2##4##(1990-9#1)(2012-12#1)
the most appropriate methods##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
the most appropriate type of##2##5##(2010-12#1)(2010-8#1)
the most appropriate##45##3##(1990-5#1)(1990-6#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-6#1)(1996-1#2)(1996-2#1)(2007-11#1)(2007-6#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-9#1)(2013-1#1)
the most are##2##3##(2008-4#1)(2013-1#1)
the most attractive##3##3##(1992-3#1)(2008-8#1)(2011-1#1)
the most basal##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
the most basic##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
the most beneficial##2##3##(2008-10#1)(2008-12#1)
the most challenging##9##3##(1991-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2011-2#3)(2012-2#1)
the most characteristic change was##2##5##(2008-10#1)(2008-6#1)
the most characteristic##4##3##(1992-3#1)(1997-8#1)(2008-10#1)(2008-6#1)
the most clinically relevant##2##4##(2008-4#1)(2008-8#1)
the most clinically##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
the most closely##2##3##(2009-12#1)(2011-1#1)
the most common acquired##2##4##(2011-2#1)(2013-1#1)
the most common adverse##2##4##(2008-3#1)(2011-2#1)
the most common and##9##4##(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2013-1#2)
the most common being##2##4##(2008-12#1)(2010-8#1)
the most common benign##3##4##(1993-9#1)(2007-8#1)(2008-10#1)
the most common cancer##2##4##(2007-8#1)(2010-12#1)
the most common causative agent##2##5##(2008-1#1)(2012-3#1)
the most common causative##4##4##(2006-6#1)(2008-1#1)(2012-12#1)(2012-3#1)
the most common cause of acute##2##6##(2008-10#1)(2009-5#1)
the most common cause of##20##5##(1993-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
the most common cause##23##4##(1993-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
the most common causes of##6##5##(1990-6#1)(1997-8#1)(2007-7#1)(2008-7#1)(2010-4#1)(2011-2#1)
the most common childhood##3##4##(2008-9#1)(2011-2#2)
the most common chronic##4##4##(1991-2#1)(2008-1#1)(2008-9#1)(2011-1#1)
the most common clinical sign##2##5##(2008-1#1)(2008-10#1)
the most common clinical##5##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
the most common complaint##2##4##(1990-6#1)(2013-8#1)
the most common complication of##3##5##(1991-6#1)(2007-11#1)(2008-7#1)
the most common complication##4##4##(1991-6#1)(2007-11#1)(2008-7#1)(2008-9#1)
the most common diagnoses##2##4##(1994-6#1)(2012-3#1)
the most common disease##2##4##(2010-12#1)(2011-2#1)
the most common form of primary##3##6##(1991-11#1)(2008-6#1)(2013-1#1)
the most common form of##13##5##(1991-11#1)(1992-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the most common group##2##4##(2009-5#1)(2013-7#1)
the most common histological##5##4##(2008-1#2)(2008-8#1)(2012-2#2)
the most common histopathological##2##4##(2008-1#1)(2011-2#1)
the most common indication for##3##5##(2007-7#1)(2008-1#2)
the most common lysosomal storage disorder##2##6##(2006-10#1)(2008-10#1)
the most common malignancy in##2##5##(2011-2#1)(2013-1#1)
the most common malignancy##5##4##(2008-4#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
the most common mechanism##4##4##(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
the most common mesenchymal##2##4##(2012-12#1)(2012-3#1)
the most common metabolic##2##4##(2007-11#1)(2008-1#1)
the most common method##3##4##(2008-4#1)(2008-9#1)(2012-2#1)
the most common methods of##2##5##(2008-9#1)(2012-3#1)
the most common methods##3##4##(2008-9#1)(2009-11#1)(2012-3#1)
the most common neoplasm of##2##5##(2010-6#1)(2013-7#1)
the most common neoplasm##3##4##(2010-6#1)(2012-3#1)(2013-7#1)
the most common of the##2##5##(2008-11#1)(2008-2#1)
the most common of##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
the most common organism##2##4##(2008-5#1)(2010-6#1)
the most common primary##4##4##(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
the most common problems seen##2##5##(2008-12#1)(2010-12#1)
the most common reasons for##3##5##(2007-10#1)(2010-8#1)(2011-2#1)
the most common reported##2##4##(2007-8#1)(2008-8#1)
the most common risk##2##4##(2007-10#2)
the most common site##3##4##(2007-11#1)(2008-6#1)(2011-2#1)
the most common sources of##2##5##(2008-11#1)(2008-12#1)
the most common species##2##4##(2008-10#1)(2010-8#1)
the most common type of##7##5##(2008-1#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
the most common types##2##4##(2008-1#1)(2008-6#1)
the most common##357##3##(1990-6#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#2)(1993-9#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#7)(2007-11#9)(2007-12#3)(2007-7#4)(2007-8#6)(2008-1#21)(2008-10#24)(2008-11#11)(2008-12#8)(2008-2#4)(2008-3#7)(2008-4#10)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#11)(2011-1#9)(2011-2#36)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#13)(2012-3#8)(2013-1#25)(2013-7#5)(2013-8#9)
the most commonly affected##2##4##(2008-5#1)(2008-6#1)
the most commonly performed##3##4##(2009-7#1)(2011-2#2)
the most commonly prescribed##2##4##(2008-8#1)(2013-8#1)
the most commonly reported##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
the most commonly seen##3##4##(2010-1#1)(2011-1#2)
the most commonly used animal##2##5##(2008-4#1)(2010-12#1)
the most commonly used procedures##2##5##(2008-9#2)
the most commonly used##23##4##(1994-12#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#5)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the most commonly##51##3##(1994-12#2)(1994-9#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
the most competitive##2##3##(1997-1#1)(2011-2#1)
the most complex##5##3##(1995-3#1)(2008-10#3)(2008-9#1)
the most comprehensive##4##3##(1997-3#1)(2007-11#2)(2008-3#1)
the most conservative##3##3##(1992-5#1)(2008-10#1)(2013-1#1)
the most conserved##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
the most consistent##4##3##(2007-11#1)(2008-10#2)(2012-2#1)
the most conspicuous##4##3##(1994-12#1)(2008-12#1)(2008-6#1)(2008-7#1)
the most cost-effective strategy##2##4##(2011-1#1)(2012-12#1)
the most cost-effective way to##2##5##(2008-11#1)(2011-2#1)
the most cost-effective##8##3##(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-12#1)
the most critical issue##2##4##(2008-3#1)(2008-7#1)
the most critical part of the##2##6##(2008-10#1)(2013-8#1)
the most critical##13##3##(1991-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-8#1)
the most crucial##4##3##(1996-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
the most current##4##3##(1995-3#1)(2008-10#1)(2008-12#1)(2012-1#1)
the most damaging##2##3##(2008-10#2)
the most dangerous##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
the most demanding##2##3##(2008-10#1)(2008-2#1)
the most destructive##10##3##(2008-10#8)(2009-2#1)(2013-8#1)
the most detailed##2##3##(2008-7#1)(2008-9#1)
the most devastating##6##3##(1997-7#1)(2008-10#3)(2011-2#1)(2012-3#1)
the most developed##3##3##(1994-2#1)(2006-10#1)(2008-2#1)
the most difficult to##2##4##(2008-8#1)(2011-2#1)
the most difficult##14##3##(1995-1#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
the most direct##5##3##(1997-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-12#1)
the most distinctive features##2##4##(2007-12#1)(2008-12#1)
the most diverse group##2##4##(2008-10#1)(2008-5#1)
the most diverse##5##3##(2008-10#2)(2008-5#1)(2011-2#1)(2013-7#1)
the most diversified##2##3##(2010-3#1)(2012-3#1)
the most dominant##3##3##(2008-3#1)(2011-2#1)(2013-7#1)
the most dreaded complications of##2##5##(2008-11#1)(2008-5#1)
the most economic##2##3##(1994-3#1)(2010-8#1)
the most economical##3##3##(1996-1#1)(2008-3#1)(2009-10#1)
the most effective agent##3##4##(1990-5#1)(1991-3#1)(2008-5#1)
the most effective and##8##4##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
the most effective antibiotics##2##4##(2007-7#1)(2009-6#1)
the most effective drugs for##2##5##(2008-7#2)
the most effective for##2##4##(2008-10#1)(2012-2#1)
the most effective in reducing the##2##6##(2008-10#1)(2008-3#1)
the most effective in##7##4##(1995-12#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-4#1)
the most effective means to control##3##6##(1993-12#1)(2008-10#2)
the most effective means##5##4##(1993-12#1)(2008-10#3)(2008-3#1)
the most effective methods##3##4##(2007-11#1)(2007-8#1)(2011-1#1)
the most effective treatment##2##4##(1993-2#1)(2009-3#1)
the most effective use of##2##5##(2008-10#2)
the most effective##103##3##(1990-5#2)(1991-3#1)(1992-11#1)(1992-5#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-10#1)(2011-1#4)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#3)(2013-8#2)
the most efficacious##3##3##(2010-12#1)(2011-2#2)
the most efficient management##2##4##(1992-2#1)(2008-12#1)
the most efficient method##2##4##(2008-10#2)
the most efficient##18##3##(1992-2#1)(1993-11#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2013-7#1)(2013-8#1)
the most empirical support as a measure##2##7##(2008-9#2)
the most empirical support##3##4##(2008-4#1)(2008-9#2)
the most enduring benefit of a common conceptual definition and measurement for CS is the bridge it provides between research and practice##2##22##(2013-1#2)
the most enduring##3##3##(2012-3#1)(2013-1#2)
the most essential##2##3##(2008-9#1)(2009-12#1)
the most exciting##4##3##(2008-9#2)(2009-6#1)(2010-7#1)
the most expensive##2##3##(1992-12#1)(1993-3#1)
the most extreme##2##3##(2008-8#2)
the most favorable conditions##2##4##(2008-10#2)
the most favorable##7##3##(1997-3#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-6#1)
the most frequent adverse##2##4##(2008-11#1)(2012-3#1)
the most frequent and##3##4##(2008-10#1)(2011-2#2)
the most frequent are##2##4##(1991-4#1)(2011-3#1)
the most frequent bacteria##2##4##(2010-12#1)(2013-1#1)
the most frequent cause of##4##5##(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
the most frequent causes of##3##5##(1990-6#1)(1992-5#1)(2011-2#1)
the most frequent causes##4##4##(1990-6#1)(1992-5#1)(1997-3#1)(2011-2#1)
the most frequent clinical##2##4##(1990-8#1)(2013-1#1)
the most frequent complication##2##4##(2012-2#1)(2013-1#1)
the most frequent diseases##2##4##(1991-12#1)(2010-12#1)
the most frequent of which##2##5##(1993-9#1)(2013-1#1)
the most frequent species##2##4##(2008-5#1)(2008-6#1)
the most frequent symptoms##2##4##(2008-6#1)(2011-2#1)
the most frequent##82##3##(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#11)(2013-8#1)
the most frequently detected##5##4##(2008-10#4)(2011-2#1)
the most frequently diagnosed##2##4##(2011-1#1)(2012-12#1)
the most frequently encountered##3##4##(1997-3#1)(2008-8#1)(2011-3#1)
the most frequently isolated##4##4##(1991-11#1)(2007-7#1)(2008-10#2)
the most frequently observed##4##4##(1997-4#1)(2008-6#1)(2010-1#1)(2010-4#1)
the most frequently prescribed##3##4##(2008-11#2)(2010-5#1)
the most frequently used##14##4##(1992-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(2006-10#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-7#1)
the most frequently##49##3##(1991-11#1)(1992-2#1)(1992-5#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
the most fundamental##3##3##(1990-2#1)(2010-12#1)(2012-2#1)
the most general##6##3##(1990-8#2)(2007-12#1)(2008-3#1)(2010-12#1)(2012-3#1)
the most genetically##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
the most heat##2##3##(2008-10#1)(2011-2#1)
the most highly##6##3##(1991-11#1)(1993-12#1)(1994-6#1)(2007-9#1)(2008-10#1)(2013-1#1)
the most important advances in##2##5##(2010-7#1)(2013-1#1)
the most important and##8##4##(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#2)(2010-7#1)(2012-2#1)
the most important are##2##4##(2008-10#1)(2008-5#1)
the most important aspect##2##4##(2013-7#1)(2013-8#1)
the most important aspects of the##2##6##(2008-4#1)(2013-1#1)
the most important aspects of##4##5##(1992-2#1)(2008-4#1)(2011-7#1)(2013-1#1)
the most important causes of##3##5##(1994-9#1)(2008-11#1)(2011-2#1)
the most important component##2##4##(2008-12#1)(2008-5#1)
the most important determinants##2##4##(1990-12#1)(1994-6#1)
the most important effects##2##4##(1990-12#1)(2008-10#1)
the most important environmental##2##4##(2008-12#1)(2008-5#1)
the most important events##2##4##(2007-8#1)(2008-7#1)
the most important factor in the##2##6##(1992-6#1)(2010-3#1)
the most important factor##4##4##(1992-6#1)(1993-11#1)(2008-3#1)(2010-3#1)
the most important factors affecting##2##5##(1996-2#1)(2008-6#1)
the most important factors for##2##5##(2013-1#1)(2013-8#1)
the most important factors##10##4##(1994-1#2)(1996-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-1#2)(2013-8#1)
the most important is##2##4##(2010-8#1)(2012-3#1)
the most important issues##4##4##(1995-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
the most important mechanisms##2##4##(1994-5#1)(2007-11#1)
the most important ones##2##4##(1994-2#1)(2010-8#1)
the most important original##2##4##(2008-10#1)(2010-7#1)
the most important parameter in##2##5##(1992-5#1)(2008-7#1)
the most important parameter##4##4##(1992-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
the most important parameters##2##4##(2008-10#2)
the most important pathogen##2##4##(2008-10#1)(2011-2#1)
the most important prognostic##2##4##(2011-2#1)(2012-2#1)
the most important recent##2##4##(2008-10#1)(2008-2#1)
the most important risk factor for##2##6##(2008-8#1)(2012-2#1)
the most important risk##4##4##(2008-10#1)(2008-8#1)(2012-2#1)(2013-7#1)
the most important role in##2##5##(2008-10#1)(2008-12#1)
the most important role##3##4##(1996-5#1)(2008-10#1)(2008-12#1)
the most important variables##2##4##(2008-10#2)
the most important weather variable##2##5##(2008-10#2)
the most important##223##3##(1990-12#2)(1990-6#1)(1991-2#1)(1991-3#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#5)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#45)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#5)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-3#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#12)(2011-3#2)(2011-4#1)(2011-7#1)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#5)
the most influential##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
the most informative##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
the most intense##6##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
the most intensive##2##3##(2008-10#1)(2013-1#1)
the most interesting##10##3##(1990-5#1)(1991-6#1)(1994-12#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-8#1)
the most likely cause of##2##5##(2008-1#1)(2008-7#1)
the most likely time##2##4##(1996-11#1)(2011-2#1)
the most likely to##2##4##(1990-2#1)(2009-5#1)
the most likely##25##3##(1990-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
the most limiting##2##3##(2008-10#1)(2012-2#1)
the most logical##2##3##(2007-8#1)(2008-10#1)
the most malignant##3##3##(2008-5#1)(2009-4#1)(2013-1#1)
the most meaningful##2##3##(1993-3#1)(2008-10#1)
the most modern##3##3##(1992-9#1)(2008-10#1)(2008-9#1)
the most northern##2##3##(1993-6#1)(2008-10#1)
the most numerous##3##3##(1991-2#1)(2007-8#1)(2013-7#1)
the most of the##2##4##(1992-6#1)(2011-1#1)
the most of##7##3##(1992-6#1)(1994-12#2)(1996-3#1)(2008-1#1)(2011-1#1)(2012-3#1)
the most often used##2##4##(2008-5#1)(2009-8#1)
the most often##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)
the most painful##3##3##(1996-6#1)(2008-11#1)(2013-1#1)
the most part##24##3##(1990-6#1)(1991-1#1)(1991-3#2)(1992-1#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
the most persistent##2##3##(2007-6#1)(2012-2#1)
the most plausible##3##3##(1990-12#1)(2007-2#1)(2008-3#1)
the most popular method##2##4##(2009-8#1)(2011-2#1)
the most popular##22##3##(1995-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#2)(2010-8#2)(2011-2#1)(2013-1#1)
the most populous##2##3##(1994-9#1)(2011-2#1)
the most positive##3##3##(1996-2#1)(1997-5#1)(2008-5#1)
the most potent activity##2##4##(1994-12#1)(2011-2#1)
the most potent and##2##4##(2008-4#1)(2011-2#1)
the most potent antigen-presenting cells##2##5##(2006-10#1)(2008-5#1)
the most potent in##2##4##(1993-1#1)(2013-8#1)
the most potent inhibitors of##2##5##(1994-11#1)(1994-8#1)
the most potent inhibitors##4##4##(1994-11#1)(1994-8#1)(2010-4#1)(2013-1#1)
the most potent of##2##4##(1994-11#1)(2008-8#1)
the most potent##41##3##(1990-2#1)(1990-7#1)(1991-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#1)
the most powerful predictor##2##4##(2008-3#1)(2011-2#1)
the most powerful##14##3##(1995-2#1)(1995-3#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#3)
the most predominant##3##3##(2009-3#1)(2009-7#1)(2013-8#1)
the most preferred##3##3##(1997-6#1)(2007-8#1)(2013-8#1)
the most prevalent genotype##2##4##(2008-10#2)
the most prevalent##45##3##(1990-5#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-7#2)(2008-1#3)(2008-10#11)(2008-12#1)(2008-5#5)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
the most primitive##7##3##(1994-11#1)(2007-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)
the most probable precursor of##2##5##(1994-5#1)(2008-5#1)
the most probable##12##3##(1991-12#1)(1994-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-1#1)
the most productive##4##3##(1992-8#1)(2008-9#2)(2010-12#1)
the most profound##2##3##(2008-5#2)
the most prominent of##2##4##(1993-1#1)(2009-7#1)
the most prominent##16##3##(1993-1#1)(1993-8#1)(1995-8#1)(1996-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#2)
the most promising and##2##4##(2008-10#1)(2009-3#1)
the most promising candidates##2##4##(2008-10#1)(2013-1#1)
the most promising##17##3##(1997-5#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
the most pronounced##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
the most proximal##2##3##(1997-7#1)(2008-11#1)
the most rapidly##5##3##(1996-2#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
the most recent developments##2##4##(2008-10#1)(2011-2#1)
the most recent literature##4##4##(1991-2#1)(1993-5#1)(2008-8#1)(2010-9#1)
the most recent studies##3##4##(1995-6#1)(2010-5#1)(2012-1#1)
the most recent versions of the##2##6##(1997-8#1)(2011-2#1)
the most recent##48##3##(1991-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the most recently available data##2##5##(1992-3#1)(1993-2#1)
the most recently evolved##2##4##(2008-10#2)
the most recently##10##3##(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
the most recurrent##2##3##(2008-10#1)(2008-7#1)
the most relevant and##2##4##(2009-10#1)(2013-8#1)
the most relevant##17##3##(1993-2#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the most reliable##17##3##(1993-12#3)(1993-2#1)(1993-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-7#1)
the most remarkable##3##3##(1994-3#1)(2008-8#1)(2008-9#1)
the most resistant##9##3##(2008-10#7)(2008-12#1)(2012-2#1)
the most responsive##2##3##(1991-6#1)(1997-3#1)
the most richly##2##3##(1995-12#1)(1997-4#1)
the most robust##7##3##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-11#1)(2012-3#1)
the most salient##3##3##(1994-1#1)(2008-10#1)(2010-5#1)
the most sensible##2##3##(2008-10#1)(2008-6#1)
the most sensitive and##3##4##(2008-1#1)(2008-12#1)(2010-6#1)
the most sensitive of##3##4##(1995-12#1)(2008-10#2)
the most sensitive##35##3##(1990-12#1)(1992-11#1)(1992-9#1)(1995-12#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
the most serious and##3##4##(2006-10#1)(2007-7#1)(2008-10#1)
the most serious complication of##6##5##(1991-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-2#1)(2011-2#1)
the most serious complication##7##4##(1991-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2009-2#1)(2011-2#1)
the most serious##24##3##(1991-11#1)(1991-12#1)(1991-3#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-2#2)
the most severe form##2##4##(1995-9#1)(2012-12#1)
the most severe forms of##2##5##(2008-5#1)(2009-5#1)
the most severe##22##3##(1990-8#1)(1994-9#2)(1995-2#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
the most severely affected##2##4##(2008-8#1)(2011-2#1)
the most severely##4##3##(1996-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
the most significant and##3##4##(1996-5#1)(2008-1#1)(2013-8#1)
the most significant effect##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
the most significant factor##5##4##(1994-3#1)(1996-7#1)(2008-10#2)(2008-8#1)
the most significant##44##3##(1991-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-7#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the most similar##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
the most species-rich##2##3##(2010-6#2)
the most specific##3##3##(2008-11#1)(2008-5#1)(2010-3#1)
the most stable##7##3##(1996-2#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)
the most stressful##3##3##(1992-2#1)(1994-12#1)(2012-1#1)
the most striking##2##3##(1996-11#1)(2008-5#1)
the most studied##4##3##(2008-9#1)(2010-7#1)(2011-2#1)(2013-7#1)
the most successful##10##3##(1994-3#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#2)(2009-2#1)(2009-3#1)(2010-3#1)(2012-2#1)
the most suitable approach for##2##5##(2008-10#2)
the most suitable for the##4##5##(1990-8#1)(2008-8#1)(2009-8#1)(2013-1#1)
the most suitable for##6##4##(1990-8#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-1#1)
the most suitable##32##3##(1990-8#1)(1991-5#1)(1992-10#1)(1993-3#1)(1994-2#1)(1995-8#1)(1996-12#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
the most superficial layers of the##2##6##(2008-5#2)
the most superficial layers##3##4##(2008-5#3)
the most susceptible##9##3##(1994-8#1)(2008-10#6)(2008-12#1)(2013-8#1)
the most tightly bound##2##4##(1990-5#1)(1992-5#1)
the most to##2##3##(2008-10#1)(2008-8#1)
the most toxic##4##3##(2007-11#1)(2008-10#3)
the most used##5##3##(2008-10#2)(2009-1#1)(2012-2#1)(2013-7#1)
the most useful way##2##4##(2008-9#1)(2011-2#1)
the most useful##17##3##(1991-3#1)(1991-6#2)(1992-1#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
the most usual##2##3##(1997-7#1)(2008-12#1)
the most valuable##3##3##(1992-2#1)(1994-5#1)(2008-9#1)
the most variable##4##3##(2008-10#2)(2012-12#1)(2013-7#1)
the most versatile##2##3##(1997-2#1)(2008-2#1)
the most virulent##3##3##(2008-10#3)
the most vulnerable##3##3##(1994-5#1)(1996-1#1)(2008-10#1)
the most widely distributed##4##4##(2008-10#3)(2013-7#1)
the most widely investigated##2##4##(2008-5#1)(2009-8#1)
the most widely used form of##2##6##(1997-1#1)(2008-1#1)
the most widely used##26##4##(1991-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
the most widely##41##3##(1991-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
the most widespread##7##3##(1991-3#1)(1994-3#1)(2008-10#2)(2011-2#1)(2012-2#2)
the most##2236##2##(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#6)(1990-6#10)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#9)(1991-2#7)(1991-3#13)(1991-4#2)(1991-5#1)(1991-6#10)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#8)(1992-3#9)(1992-4#2)(1992-5#12)(1992-6#5)(1992-8#6)(1992-9#8)(1993-1#6)(1993-11#5)(1993-12#12)(1993-2#6)(1993-3#8)(1993-5#4)(1993-6#4)(1993-8#6)(1993-9#3)(1994-1#7)(1994-11#5)(1994-12#15)(1994-2#8)(1994-3#12)(1994-5#7)(1994-6#6)(1994-8#6)(1994-9#6)(1995-1#8)(1995-11#5)(1995-12#11)(1995-2#8)(1995-3#11)(1995-4#1)(1995-5#10)(1995-6#7)(1995-8#3)(1995-9#1)(1996-1#6)(1996-11#4)(1996-12#4)(1996-2#16)(1996-3#10)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#11)(1997-3#11)(1997-4#9)(1997-5#5)(1997-6#5)(1997-7#8)(1997-8#6)(2006-10#10)(2006-6#1)(2006-8#1)(2007-10#11)(2007-11#35)(2007-12#17)(2007-2#5)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#20)(2007-8#22)(2007-9#1)(2008-1#42)(2008-10#378)(2008-11#59)(2008-12#42)(2008-2#24)(2008-3#40)(2008-4#51)(2008-5#74)(2008-6#28)(2008-7#68)(2008-8#55)(2008-9#65)(2009-1#2)(2009-10#6)(2009-11#8)(2009-12#9)(2009-2#9)(2009-3#10)(2009-4#6)(2009-5#14)(2009-6#10)(2009-7#7)(2009-8#16)(2009-9#1)(2010-1#7)(2010-10#9)(2010-11#6)(2010-12#18)(2010-2#3)(2010-3#7)(2010-4#14)(2010-5#10)(2010-6#11)(2010-7#12)(2010-8#35)(2010-9#3)(2011-1#41)(2011-10#2)(2011-2#144)(2011-3#8)(2011-4#1)(2011-7#1)(2012-1#8)(2012-12#33)(2012-2#55)(2012-3#36)(2012-4#1)(2012-9#1)(2013-1#91)(2013-7#28)(2013-8#41)
the mostly##2##2##(2008-8#2)
the motA gene##2##3##(1995-2#2)
the moth##3##2##(2007-12#1)(2008-9#1)(2009-8#1)
the mother and her##2##4##(2008-7#1)(2010-10#1)
the mother and the##3##4##(1997-8#1)(2008-2#1)(2011-1#1)
the mother and##9##3##(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-3#1)
the mother as##2##3##(1991-9#1)(2013-1#1)
the mother of the child##2##5##(1990-10#1)(2012-3#1)
the mother of the##4##4##(1990-10#1)(1997-3#1)(2007-10#1)(2012-3#1)
the mother to##2##3##(2007-8#1)(2008-8#1)
the mother was##2##3##(1990-5#1)(2011-1#1)
the mother##46##2##(1990-10#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-9#2)(1992-10#1)(1993-6#1)(1995-6#2)(1997-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
the mother's##6##2##(1990-10#1)(1992-4#2)(1995-4#1)(2008-11#1)(2008-8#1)
the mother-infant##3##2##(1990-12#1)(2009-11#1)(2009-9#1)
the mother?##2##2##(1990-10#2)
the mothers##22##2##(1990-10#3)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1993-12#1)(1993-6#2)(2008-1#1)(2008-10#1)(2008-4#2)(2009-10#1)(2011-1#4)(2011-2#2)(2012-2#1)
the motif##3##2##(1991-6#1)(1995-1#1)(2008-7#1)
the motile##2##2##(2008-1#1)(2008-5#1)
the motility and##2##3##(1995-8#1)(2013-8#1)
the motility##6##2##(1995-2#1)(1995-8#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
the motion model##3##3##(2008-3#3)
the motion of the##5##4##(1994-3#1)(2008-3#2)(2009-11#1)(2011-1#1)
the motion of##12##3##(1994-3#1)(1996-12#1)(2007-11#2)(2008-3#5)(2009-11#2)(2011-1#1)
the motion##25##2##(1994-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#9)(2008-6#1)(2008-9#1)(2009-11#2)(2011-1#2)(2012-1#1)
the motions of the##3##4##(1997-7#1)(2009-9#1)(2013-1#1)
the motions of##4##3##(1997-7#1)(2008-11#1)(2009-9#1)(2013-1#1)
the motivation for##3##3##(1997-3#1)(2008-3#1)(2010-5#1)
the motivation##8##2##(1993-2#1)(1995-2#1)(1997-3#1)(2008-3#1)(2010-5#1)(2010-9#1)(2011-2#2)
the motivational##9##2##(1993-2#1)(1995-2#1)(1996-5#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-10#1)(2013-1#1)(2013-8#1)
the motivations##2##2##(1993-12#1)(2007-2#1)
the motor and##2##3##(1995-3#1)(2010-7#1)
the motor cortex##4##3##(2008-7#2)(2010-7#2)
the motor nucleus##2##3##(1994-2#1)(1997-2#1)
the motor seizure stage##2##4##(1994-2#2)
the motor##34##2##(1990-5#1)(1991-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-12#1)(1995-3#1)(1996-5#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#7)(2008-9#1)(2010-1#1)(2010-7#4)(2013-1#1)
the mould##2##2##(2008-5#2)
the mountain##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
the mouse MHC##2##3##(1997-9#1)(2008-4#1)
the mouse TrkB##2##3##(2008-9#2)
the mouse and human##4##4##(1991-6#1)(1993-3#1)(1993-6#1)(2008-4#1)
the mouse and rat##3##4##(1990-8#1)(1991-2#1)(1996-5#1)
the mouse and##8##3##(1990-8#1)(1991-2#1)(1991-6#1)(1993-3#1)(1993-6#1)(1996-5#1)(2008-4#1)(2010-11#1)
the mouse bone marrow##2##4##(2008-11#1)(2008-4#1)
the mouse brain##3##3##(1995-3#2)(1996-2#1)
the mouse ear##3##3##(1991-8#1)(1992-9#1)(2008-9#1)
the mouse eye lens##2##4##(1993-2#2)
the mouse genome##6##3##(1993-6#1)(1995-2#1)(1995-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
the mouse liver/bone/kidney-type alkaline phosphatase gene##2##6##(1991-9#2)
the mouse low##2##3##(1993-3#1)(1997-2#1)
the mouse mammary##2##3##(1994-11#1)(2009-12#1)
the mouse model##2##3##(2008-10#1)(2012-12#1)
the mouse myogenic gene Myo-D1##2##5##(1993-2#1)(1994-12#1)
the mouse myogenic gene##3##4##(1993-2#1)(1994-12#2)
the mouse sequence##2##3##(1992-11#1)(1997-9#1)
the mouse skin##2##3##(1992-2#1)(1997-4#1)
the mouse##168##2##(1990-12#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#4)(1991-6#3)(1991-8#1)(1991-9#4)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#7)(1993-5#1)(1993-6#5)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#5)(1997-2#4)(1997-4#2)(1997-8#1)(1997-9#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#18)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-12#2)(2009-5#1)(2010-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the mouth and##3##3##(2011-2#1)(2013-1#2)
the mouth corners##2##3##(2008-5#2)
the mouth in##6##3##(2008-11#2)(2008-5#2)(2012-2#1)(2013-1#1)
the mouth of the spermathecal duct##2##6##(2008-5#2)
the mouth of the##4##4##(2008-11#1)(2008-5#2)(2010-8#1)
the mouth of##5##3##(2008-11#1)(2008-5#2)(2010-8#2)
the mouth##36##2##(1990-12#1)(1990-8#1)(1993-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#5)(2008-5#10)(2010-5#2)(2010-8#2)(2011-2#5)(2012-2#2)(2013-1#4)
the movable##2##2##(2008-3#1)(2008-5#1)
the move##5##2##(1997-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2013-8#1)
the movement of the##7##4##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)
the movement of##23##3##(1991-5#1)(1992-3#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-5#1)(2011-2#3)
the movement patterns of##2##4##(2008-8#1)(2010-5#1)
the movement to##2##3##(1995-3#1)(1997-3#1)
the movement##40##2##(1991-5#1)(1991-6#1)(1992-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-2#3)(2009-5#1)(2010-5#1)(2011-2#3)(2013-1#1)
the movements of##4##3##(2007-12#3)(2008-3#1)
the movements were##2##3##(1994-3#1)(2008-11#1)
the movements##12##2##(1993-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(2007-12#3)(2008-11#2)(2008-3#1)(2010-9#1)(2012-3#1)
the moving##11##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2009-6#1)(2011-2#1)
the mtDNA control region##4##4##(2008-12#1)(2010-8#3)
the mtDNA##8##2##(1994-11#1)(1994-8#1)(1997-2#1)(2008-12#1)(2008-5#1)(2010-8#3)
the mu opioid receptor##2##4##(2008-11#2)
the mu receptor##3##3##(1992-3#1)(1995-6#2)
the mu##8##2##(1991-1#1)(1991-9#1)(1992-3#1)(1995-6#2)(1997-7#1)(2008-11#2)
the mu-##2##2##(1995-11#2)
the mu-opioid receptor##3##3##(1995-11#1)(1996-2#1)(1997-2#1)
the muIMER##2##2##(2008-10#2)
the muM##2##2##(2008-10#2)
the much greater##3##3##(1997-7#1)(2008-10#2)
the much larger##3##3##(1991-9#1)(2008-10#1)(2008-7#1)
the much##14##2##(1991-9#1)(1992-3#1)(1994-1#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-7#1)(2009-8#1)(2013-7#1)(2013-8#1)
the mucin##3##2##(1993-2#1)(1997-7#1)(2013-8#1)
the mucociliary##3##2##(1995-8#1)(1997-1#2)
the mucosa and##3##3##(1990-9#1)(2012-2#1)(2013-1#1)
the mucosa##22##2##(1990-11#1)(1990-5#1)(1990-9#3)(1991-6#1)(1992-5#1)(1997-1#1)(1997-2#1)(2008-4#1)(2008-5#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#2)
the mucosal IgA response##2##4##(2008-11#2)
the mucosal cells##2##3##(1991-12#1)(1994-6#1)
the mucosal layer##2##3##(2008-12#1)(2009-8#1)
the mucosal side##2##3##(2008-1#1)(2008-5#1)
the mucosal##16##2##(1990-5#1)(1991-12#1)(1994-6#1)(1996-3#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-5#3)(2008-6#1)(2009-8#1)(2010-9#1)
the mucous barrier##2##3##(1997-1#2)
the mucous layer##2##3##(1997-1#1)(1997-2#1)
the mucous##5##2##(1997-1#3)(1997-2#1)(2007-8#1)
the multi-bilinear model##2##3##(2008-10#2)
the multi-element determination in##2##4##(2008-10#2)
the multi-element determination##3##3##(2008-10#3)
the multi-element##4##2##(2008-10#4)
the multi-frequency laser##2##3##(2008-10#2)
the multi-organ system##2##3##(1990-11#2)
the multi-step##2##2##(2008-5#1)(2008-8#1)
the multichannel acousto-optic Bragg cell##3##5##(2008-3#3)
the multichannel##5##2##(1997-6#1)(2008-3#4)
the multicommutation approach and##2##4##(2008-10#2)
the multicommutation approach##4##3##(2008-10#4)
the multicopy plasmid##2##3##(1990-11#1)(1995-5#1)
the multicopy##4##2##(1990-11#1)(1995-5#1)(1995-6#1)(2008-6#1)
the multicystic##2##2##(2008-10#1)(2008-5#1)
the multidimensional##6##2##(1995-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-6#1)
the multidisciplinary care##2##3##(2008-10#1)(2010-11#1)
the multidisciplinary team##3##3##(1996-7#1)(2010-3#1)(2011-2#1)
the multidisciplinary##12##2##(1996-3#2)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-3#2)(2011-2#1)(2013-1#2)
the multidomain##2##2##(2008-10#1)(2008-7#1)
the multidrug resistance phenotype##2##4##(2008-11#2)
the multidrug resistance##6##3##(2007-10#1)(2008-11#4)(2012-3#1)
the multidrug transporter##2##3##(2008-11#1)(2008-7#1)
the multidrug##11##2##(2007-10#1)(2008-11#7)(2008-7#1)(2012-2#1)(2012-3#1)
the multidrug-resistant phenotype##2##3##(1995-11#1)(2008-11#1)
the multifaceted##6##2##(2008-10#1)(2008-11#2)(2009-10#1)(2010-12#1)(2013-7#1)
the multifractal##2##2##(2008-8#2)
the multifunctional##5##2##(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#2)
the multilayer coating##5##3##(2008-2#4)(2008-3#1)
the multilayer grating##4##3##(2008-2#1)(2008-3#3)
the multilayer##22##2##(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#12)(2013-1#1)
the multilayers##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
the multimedia##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
the multimeric##2##2##(1997-4#1)(2008-10#1)
the multimerization function of NifA central domain##2##7##(2008-9#2)
the multimerization##3##2##(2008-9#3)
the multimode##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
the multiparas##2##2##(2008-4#2)
the multiphoton fluorescence##2##3##(2007-12#2)
the multiphoton##5##2##(1992-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
the multiple causes##2##3##(2007-12#1)(2011-2#1)
the multiple cloning site##2##4##(1995-8#1)(1997-4#1)
the multiple harvest process##2##4##(2008-11#2)
the multiple regression##2##3##(2008-10#2)
the multiple sites of##2##4##(1993-6#1)(2012-2#1)
the multiple##60##2##(1990-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#1)(1997-4#3)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#4)(2009-1#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
the multiple-scattering images##2##3##(2008-2#2)
the multiple-scattering##9##2##(2007-11#1)(2008-2#4)(2008-3#4)
the multiple-schedule-disrupter paradigm##2##3##(2010-10#2)
the multiplex real-time PCR##2##4##(2008-10#2)
the multiplex##4##2##(2008-10#3)(2013-1#1)
the multiplexing##3##2##(2007-11#1)(2008-2#2)
the multiplication##2##2##(2008-2#1)(2010-11#1)
the multiplicative##2##2##(1996-3#1)(2008-11#1)
the multiplicity of infection##2##4##(1997-3#1)(2008-11#1)
the multiplicity of##7##3##(1990-8#1)(1993-8#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-9#1)(2013-1#1)
the multiplicity##8##2##(1990-8#1)(1993-8#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
the multipolar##2##2##(2008-2#1)(2010-2#1)
the multiresolution histogram##2##3##(2008-6#2)
the multistage process##2##3##(2013-1#2)
the multistage##4##2##(1994-8#1)(2009-11#1)(2013-1#2)
the multitude of##2##3##(2008-4#1)(2008-5#1)
the multivariable##2##2##(2007-11#1)(2013-8#1)
the multivariate analysis##4##3##(2007-8#1)(2008-10#1)(2010-8#1)(2012-2#1)
the multivariate calibration##2##3##(2008-10#2)
the multivariate##20##2##(1992-6#1)(1993-9#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
the multivitamin and##2##3##(1994-6#1)(2009-9#1)
the multivitamin##3##2##(1994-6#1)(2009-9#2)
the multiwavelength##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
the municipal##8##2##(1992-11#1)(1993-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
the municipalities##6##2##(1991-6#1)(1992-2#1)(1996-6#1)(2008-9#1)(2012-12#2)
the municipality of Nordkapp##2##4##(1995-6#2)
the municipality of##11##3##(1990-6#1)(1991-9#1)(1992-10#1)(1995-6#3)(1997-4#1)(2011-2#1)(2012-12#2)(2013-7#1)
the municipality##16##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-10#1)(1995-6#3)(1997-4#1)(2008-7#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-7#1)
the mural##3##2##(1991-12#1)(2008-12#1)(2012-12#1)
the murine and human##2##4##(1993-2#1)(1994-8#1)
the murine##38##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#4)(1997-7#1)(1997-8#1)(2008-11#4)(2008-4#2)(2008-9#2)(2012-2#2)(2013-8#1)
the muscarinic##7##2##(1990-5#2)(1990-9#1)(1993-12#1)(1996-2#1)(1997-4#1)(2011-2#1)
the muscle 12##2##3##(2008-5#2)
the muscle activity##3##3##(2008-5#3)
the muscle and##6##3##(1990-5#1)(1992-11#1)(1997-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
the muscle fibers##3##3##(2008-2#1)(2010-12#1)(2013-1#1)
the muscle potential latency in head magnetic stimulation##2##8##(2008-7#2)
the muscle potential latency##3##4##(2008-7#3)
the muscle potential##4##3##(2008-7#4)
the muscle potentials##2##3##(2008-7#2)
the muscle##52##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the muscle-specific##2##2##(1993-8#1)(1996-2#1)
the muscles of the##7##4##(1996-8#1)(2007-12#2)(2008-9#2)(2010-9#1)(2013-8#1)
the muscles of##8##3##(1996-8#1)(2007-12#2)(2008-9#2)(2010-9#1)(2013-1#1)(2013-8#1)
the muscles##17##2##(1994-2#1)(1996-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-12#1)(2008-5#1)(2008-9#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the muscular##13##2##(1991-5#1)(1997-5#1)(2007-12#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
the musculature##3##2##(2007-12#1)(2011-2#2)
the musculo-skeletal system##2##3##(2007-8#2)
the musculoskeletal system##9##3##(1990-6#1)(1997-6#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-9#1)(2012-12#2)
the musculoskeletal##11##2##(1990-6#1)(1997-6#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-3#2)(2010-9#1)(2012-12#2)
the mushroom bodies##2##3##(2007-12#2)
the mushroom##6##2##(2007-12#3)(2008-10#1)(2008-11#1)(2011-2#1)
the mushrooms##2##2##(1994-9#1)(2008-5#1)
the music##3##2##(2007-6#3)
the mussel##3##2##(1992-6#1)(2008-10#1)(2010-8#1)
the mutagenesis##2##2##(2008-4#1)(2012-3#1)
the mutagenic##6##2##(1993-11#1)(2008-10#2)(2008-11#1)(2008-4#2)
the mutant alpha 1-PI cDNA and the##2##7##(1990-8#2)
the mutant and the wild type##2##6##(2008-10#2)
the mutant and the##3##4##(1994-11#1)(2008-10#2)
the mutant and wild-type##2##4##(1995-5#1)(2008-10#1)
the mutant and##8##3##(1991-9#1)(1994-11#1)(1995-5#1)(2008-10#5)
the mutant characteristics and##2##4##(2008-8#1)(2013-8#1)
the mutant characteristics##3##3##(2008-8#2)(2013-8#1)
the mutant enzyme##9##3##(1990-10#2)(1990-12#1)(1992-6#1)(1995-2#2)(1995-6#2)(1997-7#1)
the mutant enzymes##3##3##(1992-6#1)(1995-2#1)(1995-5#1)
the mutant failed to##2##4##(2008-10#2)
the mutant in##2##3##(1992-9#1)(2008-10#1)
the mutant phenotype##3##3##(1996-3#1)(2008-10#1)(2012-3#1)
the mutant protein##2##3##(1991-12#1)(2011-1#1)
the mutant proteins##4##3##(1993-11#1)(1994-6#1)(1995-2#1)(1995-5#1)
the mutant receptor##2##3##(1992-12#1)(1996-2#1)
the mutant strain##4##3##(2008-10#3)(2011-2#1)
the mutant strains##5##3##(1990-5#2)(2008-10#2)(2008-7#1)
the mutant to##2##3##(1995-5#1)(2008-10#1)
the mutant##108##2##(1990-10#2)(1990-12#4)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-2#5)(1995-5#6)(1995-6#3)(1995-8#2)(1996-2#2)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#26)(2008-4#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
the mutants than##2##3##(2008-10#1)(2008-7#1)
the mutants were##3##3##(1992-12#1)(2008-7#1)(2009-12#1)
the mutants##36##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-9#1)(1997-3#1)(2008-10#7)(2008-12#1)(2008-7#4)(2008-9#4)(2009-12#2)(2011-1#1)(2012-12#1)(2012-3#1)
the mutated gene##2##3##(2008-2#1)(2009-10#1)
the mutated##10##2##(1991-2#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
the mutation at nucleotide##2##4##(1994-11#1)(2007-6#1)
the mutation frequency##5##3##(1997-3#5)
the mutation in the##6##4##(1990-12#1)(1995-5#1)(1995-6#1)(2008-9#1)(2010-3#1)(2012-12#1)
the mutation in##10##3##(1990-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#1)(1995-6#2)(2008-9#1)(2010-3#1)(2012-12#1)
the mutation of the##2##4##(1995-8#1)(1997-2#1)
the mutation of##6##3##(1995-8#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-8#1)(2011-1#1)
the mutation rates##2##3##(1990-8#1)(2008-12#1)
the mutation site##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
the mutation was##2##3##(1995-12#1)(1996-5#1)
the mutation##53##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-2#2)(1997-3#6)(1997-7#2)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#5)(2008-8#2)(2008-9#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the mutational effect of##2##4##(2008-7#2)
the mutational##3##2##(2008-7#2)(2009-5#1)
the mutationally altered enzymes##2##4##(1990-8#2)
the mutationally altered##3##3##(1990-8#3)
the mutations are##2##3##(1997-2#1)(2012-12#1)
the mutations of the##3##4##(1991-9#1)(2008-10#1)(2011-1#1)
the mutations of##5##3##(1991-9#1)(1993-3#1)(1995-5#1)(2008-10#1)(2011-1#1)
the mutations##30##2##(1990-8#2)(1991-10#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-6#5)(1997-2#3)(2008-10#2)(2008-8#2)(2011-1#3)(2012-12#2)(2012-3#1)
the mutual coherence##2##3##(2007-11#1)(2007-12#1)
the mutual information between##2##4##(2008-1#1)(2008-7#1)
the mutual information##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
the mutual interaction of##2##4##(2007-12#1)(2008-9#1)
the mutual##20##2##(1990-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-8#1)
the mycelial growth##3##3##(2008-10#2)(2008-6#1)
the mycelial##6##2##(2008-10#4)(2008-5#1)(2008-6#1)
the mycelium of##3##3##(2008-10#3)
the mycelium was##2##3##(2008-10#2)
the mycelium##11##2##(2008-10#10)(2008-7#1)
the mycobacterial##4##2##(1995-5#2)(2008-9#1)(2012-2#1)
the mycoherbicide##3##2##(2008-10#3)
the mycoparasite##4##2##(2008-10#4)
the mycorrhizal##2##2##(2008-10#1)(2011-1#1)
the mycorrhizosphere##3##2##(2008-10#3)
the mycotoxin##3##2##(2008-10#3)
the mycotoxins##2##2##(2010-3#1)(2010-7#1)
the myelin oligodendrocyte glycoprotein##2##4##(1996-12#2)
the myelin sheath##3##3##(2008-7#3)
the myelin##6##2##(1996-12#2)(2008-7#4)
the myelination##4##2##(1996-5#2)(2008-5#1)(2008-7#1)
the myeloid##3##2##(1992-3#1)(2008-11#2)
the myeloma##3##2##(2008-1#1)(2008-11#1)(2008-3#1)
the myenteric##3##2##(1997-4#1)(2009-12#1)(2013-8#1)
the myocardial beta-adrenergic receptor##2##4##(1997-6#2)
the myocardial calcium##2##3##(1992-9#1)(1996-9#1)
the myocardial infarction##2##3##(1997-3#1)(2012-2#1)
the myocardial##16##2##(1991-9#2)(1992-4#1)(1992-9#1)(1996-9#1)(1997-3#1)(1997-6#2)(2007-8#1)(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the myocardium after##2##3##(2012-1#1)(2012-2#1)
the myocardium and##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
the myocardium is##2##3##(1990-9#1)(2007-8#1)
the myocardium of##2##3##(1996-9#1)(2013-7#1)
the myocardium##26##2##(1990-2#1)(1990-9#2)(1991-9#1)(1992-5#1)(1996-6#1)(1996-9#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#4)(2008-8#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
the myofibrils##2##2##(2009-7#2)
the myogenic activity of##2##4##(1993-8#1)(2008-5#1)
the myogenic cells##2##3##(1992-8#2)
the myogenic factors##2##3##(1995-6#2)
the myogenic##11##2##(1990-8#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-8#1)(1995-6#2)(2008-11#1)(2008-5#2)
the myoid##2##2##(2009-10#2)
the myometrium##2##2##(1994-3#1)(2013-7#1)
the myosin heavy chain##2##4##(2008-5#1)(2008-9#1)
the myosin##7##2##(1990-5#1)(1991-2#1)(1992-4#1)(1994-8#2)(2008-5#1)(2008-9#1)
the myostatin gene on##2##4##(2010-4#2)
the myostatin gene##3##3##(2010-4#3)
the myriad of##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
the myristoylated##2##2##(1990-10#1)(1990-12#1)
the myristoylation##2##2##(1990-12#2)
the mystery of##3##3##(2007-11#1)(2010-8#1)(2011-2#1)
the mystery##5##2##(1990-11#1)(2007-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
the myth##2##2##(1993-3#1)(2008-11#1)
the myths##3##2##(1991-6#1)(1997-1#1)(2009-7#1)
the n##3##2##(1994-5#1)(2007-12#1)(2008-3#1)
the n-3 PUFA content##2##4##(2013-1#2)
the n-butanol fraction##2##3##(2008-10#2)
the nadir##2##2##(1997-6#1)(2008-3#1)
the nafion layer##2##3##(2008-10#2)
the nafion##3##2##(2008-10#3)
the nail##6##2##(2008-5#1)(2008-9#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
the naive##2##2##(1993-12#1)(2008-6#1)
the naked eye##5##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
the naked##7##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#2)
the name Tomato##2##3##(2008-10#2)
the name and##2##3##(1990-9#1)(2010-4#1)
the name of the##4##4##(1990-11#1)(1992-5#1)(1993-12#1)(1995-3#1)
the name of##10##3##(1990-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(2008-10#3)(2011-2#1)(2013-8#1)
the name##42##2##(1990-11#1)(1990-9#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(2007-5#1)(2008-10#22)(2008-11#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the names of##2##3##(2008-10#1)(2012-3#1)
the nano-scale##2##2##(2008-10#1)(2010-9#1)
the nanochannels##2##2##(2008-7#2)
the nanocrystalline##3##2##(2008-10#2)(2008-2#1)
the nanocrystals##3##2##(2007-11#2)(2008-10#1)
the nanofilter##3##2##(2008-10#3)
the nanogap sensor##2##3##(2013-1#2)
the nanogap##4##2##(2013-1#4)
the nanogram level of reactants##2##5##(2008-10#2)
the nanogram level##4##3##(2008-10#4)
the nanogram##6##2##(2008-10#4)(2008-2#1)(2008-4#1)
the nanometer scale##4##3##(2007-12#1)(2008-2#1)(2009-11#1)(2009-12#1)
the nanometer##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#2)(2009-12#1)
the nanomolar concentration range##2##4##(1990-12#2)
the nanomolar concentration##3##3##(1990-12#2)(2008-10#1)
the nanomolar range##4##3##(1992-12#1)(1994-5#1)(1995-5#1)(2008-10#1)
the nanomolar##8##2##(1990-12#2)(1992-12#1)(1994-5#1)(1995-5#1)(2008-10#2)(2008-4#1)
the nanoparticle##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
the nanoparticles are##2##3##(2008-10#1)(2009-2#1)
the nanoparticles##14##2##(2008-10#6)(2008-7#4)(2009-11#2)(2009-2#1)(2010-12#1)
the nanopore##5##2##(2008-7#2)(2009-11#1)(2009-7#2)
the nanoscale and##2##3##(2008-7#1)(2010-4#1)
the nanoscale level##2##3##(2007-12#1)(2009-4#1)
the nanoscale##13##2##(2007-12#1)(2008-7#5)(2009-11#2)(2009-4#1)(2009-5#1)(2010-4#2)(2012-2#1)
the nanosecond time##2##3##(1990-8#2)
the nanosecond##3##2##(1990-8#2)(2008-10#1)
the nanosensor##2##2##(2008-10#2)
the nanosheets##3##2##(2008-10#3)
the nanostructure of the##2##4##(2008-10#1)(2008-3#1)
the nanostructure of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
the nanostructure##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
the nanostructures##2##2##(2009-12#1)(2010-12#1)
the nanotube wall##2##3##(2008-10#1)(2008-7#1)
the nanotube##6##2##(2008-10#2)(2008-7#4)
the nanotubes##4##2##(2008-7#4)
the nanowire##2##2##(2008-7#2)
the nanoworld##2##2##(2008-7#2)
the naphthalene ring##2##3##(2008-10#2)
the naphthalene##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
the naphthyl##2##2##(2008-10#1)(2008-11#1)
the narcotic##3##2##(1996-12#1)(2008-10#2)
the narrative of##4##3##(2008-12#1)(2009-10#1)(2013-1#2)
the narrative##6##2##(2008-12#1)(2009-10#1)(2009-9#1)(2010-3#1)(2013-1#2)
the narrow##7##2##(1992-12#1)(2008-10#1)(2008-2#4)(2008-8#1)
the narrow-band laser##2##3##(2008-2#2)
the narrow-band##6##2##(2007-12#1)(2008-2#3)(2008-3#1)(2008-6#1)
the narrower##3##2##(1995-5#1)(2009-8#1)(2012-12#1)
the narrowest##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
the narrowing of the##2##4##(2008-11#1)(2008-2#1)
the narrowing of##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
the narrowing##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
the nasal airway##3##3##(2008-11#1)(2013-1#2)
the nasal and oral##3##4##(2008-11#2)(2012-12#1)
the nasal cavity##10##3##(1990-6#1)(1992-10#2)(1993-8#1)(2007-4#1)(2007-7#1)(2008-10#1)(2011-1#1)(2013-1#2)
the nasal mucosa##3##3##(1993-8#1)(1996-3#1)(1996-5#1)
the nasal septum##7##3##(2007-5#2)(2009-1#1)(2012-12#4)
the nasal symptom##2##3##(2008-11#1)(2012-3#1)
the nasal##42##2##(1990-6#1)(1990-9#1)(1992-10#2)(1993-8#3)(1993-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#1)(2009-1#1)(2009-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#5)(2012-3#1)(2013-1#5)
the nascent##5##2##(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(2009-5#1)
the nasolabial fold and chin##3##5##(2008-5#3)
the nasolabial fold##4##3##(2008-5#4)
the nasolabial groove##2##3##(2008-5#2)
the nasolabial##7##2##(2007-12#1)(2008-5#6)
the nasopharyngeal##4##2##(1995-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
the nasopharynx##3##2##(1993-12#1)(1995-5#2)
the natal territory##2##3##(2008-8#2)
the natal##3##2##(2008-8#2)(2013-8#1)
the nation##15##2##(1991-11#1)(1991-2#1)(1991-8#1)(1994-3#1)(1995-3#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
the nation's health care##2##4##(1995-2#1)(1996-2#1)
the nation's health##4##3##(1995-2#1)(1996-2#1)(1996-3#1)(1997-6#1)
the nation's largest##2##3##(1994-12#1)(1995-6#1)
the nation's##15##2##(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2011-2#1)
the national agenda##2##3##(2008-1#1)(2008-11#1)
the national and state##2##4##(1995-1#1)(2008-11#1)
the national and##7##3##(1995-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
the national average##7##3##(1992-12#1)(2008-10#4)(2008-11#1)(2008-6#1)
the national health##4##3##(1992-11#1)(1995-12#1)(1996-12#1)(2011-1#1)
the national level##5##3##(1995-2#1)(2007-11#3)(2010-8#1)
the national longitudinal##2##3##(2008-8#1)(2009-8#1)
the national##85##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1996-12#1)(1997-1#2)(1997-4#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
the nationwide##2##2##(1990-12#1)(2013-1#1)
the native EP##2##3##(1990-11#2)
the native and##8##3##(1992-8#1)(1993-8#2)(1994-9#1)(1995-5#1)(2008-1#1)(2008-4#1)(2011-2#1)
the native conformation##2##3##(1992-6#1)(2008-8#1)
the native enzyme from##2##4##(1990-5#1)(1994-8#1)
the native enzyme##19##3##(1990-11#4)(1990-5#3)(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-2#2)(1995-5#1)(1997-4#1)(1997-6#1)(2008-10#1)
the native fluorescence emission##2##4##(2008-10#2)
the native fluorescence of##2##4##(2008-10#2)
the native fluorescence##4##3##(2008-10#4)
the native form of endothelin receptor##2##6##(1990-2#2)
the native form##3##3##(1990-2#2)(2010-5#1)
the native population##2##3##(1992-8#1)(1993-6#1)
the native protein##8##3##(1990-8#2)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
the native state of##3##4##(1992-6#1)(1993-11#2)
the native state##6##3##(1992-3#1)(1992-6#1)(1993-11#3)(1997-4#1)
the native structure##3##3##(1993-11#2)(1997-4#1)
the native##139##2##(1990-11#8)(1990-12#1)(1990-2#4)(1990-5#6)(1990-7#1)(1990-8#3)(1991-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#4)(1992-8#3)(1993-1#1)(1993-11#8)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#3)(1994-5#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#1)(1997-2#2)(1997-4#6)(1997-6#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-6#1)
the natriferic action of##2##4##(2008-8#2)
the natural barriers##2##3##(2008-11#1)(2011-3#1)
the natural course of##2##4##(2009-12#1)(2010-12#1)
the natural course##6##3##(1990-6#1)(1992-9#1)(1997-3#1)(2008-7#1)(2009-12#1)(2010-12#1)
the natural development of the##2##5##(1991-6#1)(1993-11#1)
the natural development of##3##4##(1991-6#1)(1993-11#1)(2008-10#1)
the natural environment##7##3##(2007-5#1)(2008-10#3)(2008-4#1)(2009-6#1)(2011-1#1)
the natural evolution of##3##4##(1991-3#1)(1994-12#1)(1997-8#1)
the natural history and##2##4##(2009-8#1)(2010-12#1)
the natural history of 2DM##2##5##(2010-10#2)
the natural history of the disease##2##6##(1991-6#1)(1993-11#1)
the natural history of the##6##5##(1991-6#1)(1993-11#1)(1996-3#1)(1996-6#1)(2007-2#1)(2012-3#1)
the natural history of this##3##5##(1990-12#1)(1991-6#1)(2008-7#1)
the natural history of##26##4##(1990-12#1)(1991-6#2)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
the natural history##34##3##(1990-12#1)(1991-6#2)(1993-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-6#4)(2008-7#2)(2009-4#1)(2009-8#2)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
the natural killer##2##3##(2008-10#1)(2013-1#1)
the natural ligand##2##3##(2008-11#1)(2010-1#1)
the natural product##3##3##(2009-5#2)(2010-2#1)
the natural products##4##3##(2007-12#1)(2009-10#1)(2010-2#2)
the natural regeneration##2##3##(2008-5#2)
the natural resistance##3##3##(1990-5#1)(2009-6#1)(2010-8#1)
the natural selection##3##3##(2008-8#1)(2010-2#2)
the natural suppressiveness##2##3##(2008-10#2)
the natural variability##2##3##(2008-10#1)(2008-11#1)
the natural water samples##2##4##(2008-10#1)(2008-11#1)
the natural##198##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-6#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#32)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#5)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#3)
the naturally occurring##13##3##(1991-9#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-9#1)(2008-10#3)(2008-2#1)(2008-5#2)(2010-5#1)(2012-2#1)
the naturally##15##2##(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2010-5#1)(2012-2#1)
the naturally-occurring##2##2##(1990-12#1)(2008-5#1)
the nature and content of##2##5##(2008-10#2)
the nature and distribution of##2##5##(1994-3#1)(2010-5#1)
the nature and extent of##6##5##(1996-12#1)(1997-3#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-2#1)
the nature and the##5##4##(1991-2#1)(1992-8#1)(2008-3#1)(2008-5#1)(2010-4#1)
the nature and##43##3##(1991-2#1)(1992-11#1)(1992-8#1)(1993-1#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the nature of a##3##4##(2008-10#2)(2008-2#1)
the nature of complexes##2##4##(2008-10#2)
the nature of each##2##4##(1994-6#1)(2013-1#1)
the nature of inhibitor##2##4##(1994-8#2)
the nature of membrane##2##4##(2008-10#1)(2008-9#1)
the nature of the acid##2##5##(2008-10#2)
the nature of the anion##2##5##(1994-5#1)(2008-10#1)
the nature of the compounds##2##5##(2008-10#1)(2012-12#1)
the nature of the disease##2##5##(1991-3#1)(2013-1#1)
the nature of the membrane##2##5##(2008-10#1)(2008-5#1)
the nature of the relationship between##3##6##(1995-3#1)(2008-2#1)(2008-7#1)
the nature of the right to confidentiality of medical and mental health records##2##13##(1991-12#1)(1992-3#1)
the nature of the##101##4##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-11#2)(1993-5#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#2)(1995-3#3)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
the nature of their##5##4##(1996-2#1)(2010-12#2)(2013-1#2)
the nature of these##7##4##(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
the nature of this##7##4##(1990-5#1)(1993-9#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
the nature of volatile products released by a substance subjected to a controlled temperature program##2##15##(2008-10#2)
the nature of working relationships##2##5##(1996-12#1)(2010-9#1)
the nature of##208##3##(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#4)(1995-1#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#12)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#4)
the nature##263##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#4)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#59)(2008-11#15)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#4)
the navel##2##2##(1996-8#1)(2009-7#1)
the near IR##3##3##(2007-12#2)(2008-3#1)
the near field of a##3##5##(2008-3#2)(2013-8#1)
the near field of##5##4##(2007-11#1)(2008-3#3)(2013-8#1)
the near field##13##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#7)(2013-8#1)
the near future##36##3##(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#4)(2013-1#1)
the near infrared from##2##4##(2007-12#1)(2008-3#1)
the near infrared the##2##4##(2007-11#1)(2008-3#1)
the near infrared##26##3##(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#9)
the near term##3##3##(1994-3#1)(2009-11#1)(2010-12#1)
the near##100##2##(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-5#1)(1997-4#1)(1997-8#1)(2007-11#8)(2007-12#10)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#20)(2008-5#3)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2013-1#2)(2013-8#2)
the near- and the far-field##2##5##(2008-2#1)(2008-3#1)
the near- and the##3##4##(2008-2#1)(2008-3#2)
the near- and##4##3##(2008-2#2)(2008-3#2)
the near-IR excitation##2##3##(2008-2#2)
the near-IR##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
the near-UV##2##2##(2007-12#1)(2008-3#1)
the near-field optical##3##3##(2008-2#1)(2008-3#2)
the near-field##10##2##(2007-12#2)(2008-2#3)(2008-3#5)
the near-future##2##2##(2008-3#2)
the near-infrared (NIR)##2##3##(2008-10#1)(2008-3#1)
the near-infrared and infrared##2##4##(2007-12#1)(2008-3#1)
the near-infrared bands##2##3##(2008-3#2)
the near-infrared region##3##3##(2008-3#1)(2008-5#1)(2009-11#1)
the near-infrared spectral##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the near-infrared##24##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#14)(2008-5#1)(2009-11#1)
the nearby##7##2##(1990-11#1)(1990-5#1)(1991-8#1)(2008-10#4)
the nearest hospital##3##3##(1997-4#2)(2008-3#1)
the nearest##12##2##(1992-12#1)(1997-4#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-1#1)
the nearly##6##2##(1990-11#1)(1992-6#1)(1996-1#1)(2008-2#1)(2008-8#1)(2009-7#1)
the nebulizer of##2##3##(2008-10#2)
the nebulizer##13##2##(1994-12#4)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#6)
the nebulizer-burner system##4##3##(2008-10#4)
the nebulizers##6##2##(1993-2#2)(1995-3#3)(2013-8#1)
the necessary conditions for##2##4##(2008-3#2)
the necessary information##2##3##(2008-5#1)(2012-12#1)
the necessary steps to##2##4##(2008-10#1)(2008-11#1)
the necessary steps##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the necessary##64##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-2#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)
the necessity for a##4##4##(1993-11#1)(2008-10#2)(2009-8#1)
the necessity for further##2##4##(1993-12#1)(1994-6#1)
the necessity for##13##3##(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-10#4)(2009-8#1)(2012-12#1)
the necessity of an##2##4##(1990-6#1)(1997-4#1)
the necessity of external##2##4##(2007-11#1)(2008-2#1)
the necessity of providing##2##4##(1995-1#1)(2008-12#1)
the necessity of the##2##4##(2009-5#1)(2011-1#1)
the necessity of using##4##4##(2007-12#1)(2008-3#1)(2011-1#2)
the necessity of##39##3##(1990-6#1)(1990-8#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#4)(2011-2#1)(2013-1#1)
the necessity to take##2##4##(2007-11#1)(2008-10#1)
the necessity to##11##3##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
the necessity##64##2##(1990-6#1)(1990-8#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-2#3)(2012-12#1)(2013-1#1)
the neck and##6##3##(1994-2#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#2)
the neck of the femur##2##5##(2008-4#1)(2013-1#1)
the neck of the##3##4##(2008-4#1)(2010-5#1)(2013-1#1)
the neck of##4##3##(1991-11#1)(2008-4#1)(2010-5#1)(2013-1#1)
the neck region##4##3##(1992-6#2)(2008-12#1)(2010-11#1)
the neck##50##2##(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-6#1)(1994-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#6)(2009-7#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)
the neck)##2##2##(1993-5#2)
the neck-banded snake Scaphiodontophis annulatus##2##5##(2008-5#2)
the necropsy##2##2##(1996-12#1)(2008-5#1)
the necrosis##5##2##(1992-6#1)(1993-2#1)(2008-10#3)
the necrosis-inducing##2##2##(2008-10#2)
the necrotic area##2##3##(2008-10#1)(2011-2#1)
the necrotic areas##2##3##(2008-10#1)(2008-5#1)
the necrotic##13##2##(2008-10#8)(2008-5#1)(2009-1#1)(2011-2#2)(2012-2#1)
the necrotrophic##4##2##(2008-10#4)
the need and##2##3##(1992-1#1)(1993-3#1)
the need arises##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the need for a better understanding of##2##7##(2008-12#1)(2011-2#1)
the need for a better##4##5##(1991-6#1)(1997-3#1)(2008-12#1)(2011-2#1)
the need for a comprehensive##2##5##(1990-5#1)(1993-3#1)
the need for a more##2##5##(2008-11#1)(2008-2#1)
the need for a new##3##5##(1996-12#1)(1996-2#1)(2008-10#1)
the need for a support network for##2##7##(2011-2#2)
the need for a##60##4##(1990-5#1)(1990-6#1)(1991-6#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the need for active##2##4##(2008-10#1)(2011-2#1)
the need for additional##5##4##(1997-2#1)(2007-12#1)(2008-10#2)(2010-10#1)
the need for allogenic##2##4##(2009-3#2)
the need for alternatives##2##4##(1994-9#1)(2008-11#1)
the need for an##12##4##(1991-3#1)(1992-8#1)(1994-3#1)(1994-9#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
the need for and##5##4##(1992-12#1)(1993-1#1)(1996-1#1)(1997-3#1)(2008-8#1)
the need for any##5##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)
the need for appropriate##3##4##(2007-2#1)(2008-11#1)(2013-8#1)
the need for better##2##4##(1995-2#1)(2007-12#1)
the need for careful##4##4##(1991-2#1)(1995-1#1)(2009-4#1)(2009-8#1)
the need for caution in##2##5##(2008-11#1)(2009-9#1)
the need for caution##4##4##(1991-2#1)(2008-10#1)(2008-11#1)(2009-9#1)
the need for clinical##2##4##(2008-10#1)(2012-2#1)
the need for complementary##2##4##(2006-4#1)(2008-10#1)
the need for considering##2##4##(1997-6#1)(2011-1#1)
the need for continued##3##4##(2008-9#1)(2009-11#1)(2010-1#1)
the need for continuous##2##4##(2006-10#1)(2013-8#1)
the need for custom design and fabrication of application-specific##2##9##(2008-2#2)
the need for developing##2##4##(2007-7#1)(2011-2#1)
the need for drawing##2##4##(2006-10#1)(2007-12#1)
the need for early##2##4##(2009-8#1)(2013-1#1)
the need for education##3##4##(1993-3#1)(1996-7#1)(2011-1#1)
the need for extensive##2##4##(1991-5#1)(2008-10#1)
the need for external##2##4##(1994-9#1)(2007-11#1)
the need for further research##5##5##(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the need for further##13##4##(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
the need for greater##2##4##(1996-1#1)(2012-2#1)
the need for health care##3##5##(1993-2#1)(2008-11#1)(2009-5#1)
the need for health##4##4##(1993-2#1)(2008-11#1)(2008-9#1)(2009-5#1)
the need for immediate##4##4##(2008-10#1)(2010-10#2)(2012-2#1)
the need for increased##6##4##(1997-4#1)(2008-3#2)(2010-10#1)(2011-2#1)(2013-1#1)
the need for large##2##4##(2008-10#1)(2010-8#1)
the need for long term##2##5##(1993-2#1)(2007-10#1)
the need for long-term##2##4##(1992-2#1)(2008-1#1)
the need for management##2##4##(2008-10#2)
the need for more##7##4##(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
the need for new##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
the need for nursing##2##4##(1996-3#1)(2008-11#1)
the need for ongoing##3##4##(1996-2#1)(2008-11#1)(2013-1#1)
the need for other##2##4##(2008-3#1)(2008-9#1)
the need for patients##2##4##(2007-12#1)(2008-12#1)
the need for preventive##2##4##(1995-12#1)(2009-10#1)
the need for prior##2##4##(2008-3#1)(2010-6#1)
the need for quality##2##4##(1993-12#1)(1996-12#1)
the need for rapid##3##4##(1995-8#1)(2008-10#2)
the need for repeated##2##4##(2008-3#1)(2012-2#1)
the need for research into##2##5##(1994-1#1)(2007-10#1)
the need for research##5##4##(1994-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#1)
the need for separation##3##4##(2008-10#1)(2008-4#2)
the need for special##2##4##(1997-8#1)(2007-11#1)
the need for specific##2##4##(2008-1#1)(2013-8#1)
the need for such##3##4##(2007-10#1)(2007-12#1)(2008-9#1)
the need for surgical##2##4##(2008-9#1)(2011-2#1)
the need for tedious##3##4##(2008-10#3)
the need for the##13##4##(1995-11#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-2#2)(2011-1#1)(2013-1#2)
the need for thorough##3##4##(1991-12#1)(1991-2#1)(2008-4#1)
the need for timely##2##4##(1993-12#1)(2012-3#1)
the need for using##2##4##(2007-11#1)(2008-2#1)
the need for##467##3##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#4)(1991-5#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#3)(1994-8#1)(1994-9#3)(1995-1#6)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#8)(1996-12#4)(1996-2#5)(1996-3#4)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#5)(2007-11#12)(2007-12#10)(2007-2#3)(2007-5#2)(2007-7#7)(2007-8#4)(2008-1#10)(2008-10#56)(2008-11#24)(2008-12#13)(2008-2#13)(2008-3#16)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#8)(2008-9#12)(2009-10#2)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#24)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#7)(2013-1#13)(2013-8#7)
the need of a##6##4##(2008-10#3)(2008-11#1)(2011-1#1)(2013-1#1)
the need of further##2##4##(2008-10#1)(2012-3#1)
the need of##24##3##(1990-3#1)(1993-2#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the need to account for##2##5##(2008-10#1)(2008-3#1)
the need to address##2##4##(1991-12#1)(2008-11#1)
the need to be##3##4##(2006-10#1)(2008-12#1)(2012-3#1)
the need to care for##2##5##(1995-12#1)(2008-4#1)
the need to consider the##3##5##(2007-2#1)(2008-7#1)(2010-12#1)
the need to consider##7##4##(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
the need to define##2##4##(2010-5#1)(2013-1#1)
the need to determine##4##4##(1990-5#1)(2008-10#1)(2010-4#1)(2010-6#1)
the need to develop##6##4##(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2008-5#1)
the need to examine##2##4##(1996-12#1)(2008-11#1)
the need to further##2##4##(2010-8#1)(2011-2#1)
the need to identify##3##4##(2008-10#1)(2009-7#1)(2011-2#1)
the need to implement##2##4##(1994-7#1)(2007-12#1)
the need to include##3##4##(2008-11#2)(2008-9#1)
the need to integrate##3##4##(1994-12#1)(2008-3#1)(2009-8#1)
the need to make##2##4##(1991-6#1)(2008-1#1)
the need to modify##2##4##(1991-3#1)(2012-3#1)
the need to preserve##2##4##(2008-3#1)(2008-7#1)
the need to provide##2##4##(1995-2#1)(2013-8#1)
the need to put##2##4##(1991-3#1)(2010-5#1)
the need to recognize and##2##5##(2008-11#1)(2010-9#1)
the need to recognize##5##4##(1994-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)
the need to reduce##2##4##(1996-1#1)(2008-12#1)
the need to seek##2##4##(2007-2#1)(2012-3#1)
the need to strengthen##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
the need to take##2##4##(2008-12#1)(2009-4#1)
the need to understand how##2##5##(2008-3#1)(2010-3#1)
the need to understand##5##4##(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2013-8#1)
the need to use##2##4##(1991-8#1)(2013-1#1)
the need to##150##3##(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-4#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
the need##654##2##(1990-10#1)(1990-11#1)(1990-3#3)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#7)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#5)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-8#3)(1992-9#2)(1993-1#3)(1993-12#5)(1993-2#5)(1993-3#3)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#7)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#11)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#7)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#6)(2007-11#16)(2007-12#14)(2007-2#5)(2007-5#2)(2007-7#8)(2007-8#7)(2008-1#11)(2008-10#79)(2008-11#40)(2008-12#17)(2008-2#15)(2008-3#23)(2008-4#10)(2008-5#8)(2008-6#1)(2008-7#16)(2008-8#11)(2008-9#16)(2009-10#2)(2009-11#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#12)(2011-2#31)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#13)(2012-3#12)(2013-1#21)(2013-7#1)(2013-8#11)
the needed##4##2##(1996-1#1)(2008-1#2)(2008-8#1)
the needle in##2##3##(1997-8#1)(2012-2#1)
the needle into the##2##4##(1990-2#1)(2007-8#1)
the needle into##3##3##(1990-2#1)(2007-8#1)(2008-10#1)
the needle tip##2##3##(2008-10#2)
the needle tract##2##3##(2008-9#2)
the needle##25##2##(1990-2#1)(1991-12#1)(1992-12#2)(1996-6#1)(1997-8#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-7#1)(2008-9#2)(2010-8#4)(2011-2#1)(2012-2#1)
the needles##3##2##(2007-7#2)(2011-10#1)
the needlestick##2##2##(1996-5#1)(2012-12#1)
the needs and expectations of the##3##6##(1995-1#1)(2010-4#1)(2011-1#1)
the needs and interests of##2##5##(1997-1#1)(1997-3#1)
the needs and##10##3##(1995-1#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
the needs for##3##3##(1991-6#1)(1993-3#1)(2013-8#1)
the needs of a##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
the needs of children##4##4##(1992-1#1)(1992-3#1)(1994-1#1)(2008-11#1)
the needs of chronically ill patients##2##6##(1997-1#2)
the needs of different##2##4##(1994-3#1)(2007-5#1)
the needs of its##2##4##(1994-2#1)(1996-3#1)
the needs of our##3##4##(1996-2#1)(1996-3#1)(2008-10#1)
the needs of parents of##2##5##(1992-2#1)(1994-3#1)
the needs of the individual##2##5##(1993-12#1)(2013-8#1)
the needs of the patient and##3##6##(2007-12#1)(2013-1#2)
the needs of the patient##6##5##(1995-1#1)(1995-3#1)(2007-12#1)(2008-1#1)(2013-1#2)
the needs of the##30##4##(1993-1#2)(1993-12#2)(1994-2#1)(1995-1#2)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-7#1)(2013-1#2)(2013-8#1)
the needs of their##4##4##(1993-1#1)(2007-10#1)(2010-3#1)(2013-7#1)
the needs of##100##3##(1991-1#2)(1991-3#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#3)(1993-12#6)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-9#1)(1995-1#4)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#3)(1997-2#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
the needs##119##2##(1991-1#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#3)(1993-12#6)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-9#1)(1995-1#5)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#4)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
the negative and positive##2##4##(2007-11#1)(2008-3#1)
the negative and##3##3##(2007-11#1)(2008-3#1)(2010-1#1)
the negative attitudes##3##3##(2007-2#1)(2008-11#2)
the negative binomial distribution##5##4##(2008-10#4)(2013-1#1)
the negative charge of##2##4##(1990-5#1)(2008-11#1)
the negative charge##3##3##(1990-5#1)(2008-11#1)(2010-5#1)
the negative consequences of##3##4##(1990-6#1)(2007-8#1)(2008-11#1)
the negative consequences##4##3##(1990-6#1)(2007-8#1)(2008-11#1)(2008-6#1)
the negative control##5##3##(1990-6#1)(1997-1#1)(2008-10#2)(2010-5#1)
the negative correlation between##2##4##(1996-12#1)(2008-9#1)
the negative effect of the##3##5##(2007-11#1)(2008-12#1)(2008-3#1)
the negative effect of##7##4##(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
the negative effects of socioeconomic change##2##6##(2008-12#2)
the negative effects of##3##4##(2008-12#2)(2010-7#1)
the negative electrode##2##3##(2009-12#2)
the negative feedback##2##3##(2008-11#1)(2012-2#1)
the negative group##2##3##(2008-1#2)
the negative impact of##7##4##(1991-3#1)(1993-1#1)(1997-1#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
the negative influence##2##3##(2008-10#1)(2008-3#1)
the negative phototropism##2##3##(2008-9#2)
the negative regulatory##2##3##(2008-11#2)
the negative selection of##2##4##(2008-8#2)
the negative slope##3##3##(1990-7#1)(1995-3#2)
the negative stereotype group##2##4##(2008-11#2)
the negative strand##3##3##(1994-8#3)
the negative strands##2##3##(1994-8#2)
the negative##116##2##(1990-5#1)(1990-6#2)(1990-7#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-6#2)(1993-1#1)(1994-2#1)(1994-3#2)(1994-8#5)(1995-12#1)(1995-3#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#16)(2008-11#14)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#7)(2009-12#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#2)
the negative-sense##2##2##(2008-10#1)(2010-5#1)
the negatively charged##5##3##(2008-10#4)(2011-1#1)
the negatively##6##2##(2008-10#4)(2008-11#1)(2011-1#1)
the negatives##3##2##(1995-3#1)(1997-3#1)(2009-12#1)
the negligence of##2##3##(1991-7#1)(1993-12#1)
the negligence##3##2##(1991-7#1)(1992-2#1)(1993-12#1)
the negligible##4##2##(1991-3#1)(1995-11#1)(2007-12#1)(2011-1#1)
the neighbor##2##2##(2007-11#1)(2008-10#1)
the neighbor-joining method##2##3##(2008-10#2)
the neighbor-joining##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
the neighborhood level##2##3##(1990-2#1)(2008-1#1)
the neighborhood##12##2##(1990-2#1)(1996-3#1)(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#2)(2008-5#1)(2009-9#1)(2011-2#1)
the neighborhoods##2##2##(2012-12#1)(2012-2#1)
the neighboring##6##2##(1996-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)
the neighbouring organs##2##3##(2007-12#1)(2008-7#1)
the neighbouring##5##2##(1997-4#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)
the nematic liquid crystal##2##4##(2007-11#1)(2007-12#1)
the nematic##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
the nematode (10 per gram of soil)##2##7##(2008-10#2)
the nematode Caenorhabditis elegans##9##4##(1990-5#1)(1995-3#1)(1996-6#2)(1997-7#1)(2007-8#2)(2008-10#1)(2012-12#1)
the nematode##43##2##(1990-5#1)(1992-9#3)(1993-12#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-6#2)(1997-7#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#24)(2008-8#1)(2010-8#1)(2012-12#1)
the nematode's##2##2##(1993-12#1)(2008-10#1)
the nematodes##10##2##(2008-10#7)(2008-12#1)(2008-8#1)(2013-7#1)
the nematophagous fungus##2##3##(2008-10#2)
the neo##4##2##(1994-9#1)(1997-8#1)(2008-11#1)(2008-8#1)
the neocortex is largely##2##4##(1994-3#1)(2009-5#1)
the neocortex is##3##3##(1994-3#1)(2008-11#1)(2009-5#1)
the neocortex##14##2##(1990-5#1)(1994-3#1)(1997-2#1)(2008-1#2)(2008-11#4)(2009-5#3)(2010-7#2)
the neoformed bone##2##3##(2008-5#2)
the neointima##2##2##(1997-8#1)(2007-8#1)
the neomycin-resistance##2##2##(1994-5#1)(1997-8#1)
the neonatal intensive care unit##5##5##(1993-3#1)(1995-1#1)(1997-3#1)(2008-5#1)(2010-10#1)
the neonatal intensive care##7##4##(1990-6#1)(1993-3#1)(1995-1#1)(1997-3#1)(2008-5#1)(2010-10#1)(2010-8#1)
the neonatal period and##3##4##(1997-3#1)(2011-1#1)(2012-2#1)
the neonatal period##11##3##(1992-2#1)(1992-8#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
the neonatal rat##3##3##(1997-2#2)(2009-12#1)
the neonatal unit##2##3##(1995-5#1)(2008-11#1)
the neonatal##36##2##(1990-6#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#4)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-12#1)(2010-10#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
the neonate and##2##3##(1991-12#1)(1992-6#1)
the neonate##8##2##(1991-12#1)(1992-5#1)(1992-6#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#2)
the neonates##4##2##(1996-9#1)(2011-1#2)(2012-2#1)
the neoplasia##2##2##(1990-6#1)(2012-3#1)
the neoplasm was##2##3##(1992-9#1)(2008-7#1)
the neoplasm##10##2##(1990-10#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-6#1)(1997-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
the neoplasms##2##2##(1990-5#1)(1991-6#1)
the neoplastic cells##6##3##(1992-2#2)(1997-1#1)(2009-1#1)(2009-8#1)(2012-1#1)
the neoplastic##12##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-2#2)(1994-3#1)(1997-1#1)(2009-1#1)(2009-3#1)(2009-8#1)(2012-1#1)(2013-1#1)
the neostriatum##4##2##(1993-3#2)(1994-8#1)(2009-12#1)
the neotropical##3##2##(2008-5#2)(2008-7#1)
the nephrologists##2##2##(2008-1#1)(2008-4#1)
the nephrotic syndrome##13##3##(1996-6#1)(2007-7#4)(2008-1#8)
the nephrotic##15##2##(1996-6#1)(2007-7#5)(2008-1#9)
the nerve fiber##2##3##(1991-10#1)(2010-1#1)
the nerve of##2##3##(2008-5#1)(2011-1#1)
the nerve roots##4##3##(2006-12#1)(2007-8#2)(2012-3#1)
the nerve to##2##3##(2008-9#1)(2010-1#1)
the nerve##25##2##(1990-5#1)(1991-10#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#5)(2010-1#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
the nerves##2##2##(1993-2#1)(2008-5#1)
the nervous and##2##3##(1994-2#1)(1995-12#1)
the nervous system and##5##4##(1995-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
the nervous system are of##2##5##(2008-5#1)(2008-7#1)
the nervous system are##4##4##(2008-5#2)(2008-7#1)(2010-12#1)
the nervous system as##2##4##(2008-2#1)(2013-1#1)
the nervous system can##2##4##(2008-5#1)(2008-7#1)
the nervous system in##3##4##(1994-11#1)(2007-12#2)
the nervous system of the##2##5##(1992-9#1)(1997-6#1)
the nervous system of##4##4##(1992-9#1)(1997-6#1)(2008-7#2)
the nervous system or##2##4##(1991-12#1)(2009-10#1)
the nervous system that##2##4##(2008-9#1)(2012-2#1)
the nervous system was##2##4##(1997-4#1)(2008-5#1)
the nervous system##80##3##(1990-7#2)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#2)(1994-11#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-4#2)(1997-6#4)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#4)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the nervous tissue##3##3##(1990-3#1)(1996-2#1)(2006-12#1)
the nervous##90##2##(1990-3#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#2)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#2)(1997-6#5)(2006-12#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#4)(2009-6#2)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the nest of a##3##4##(2008-8#1)(2008-9#2)
the nest of##4##3##(2008-8#2)(2008-9#2)
the nest##10##2##(1992-6#1)(2008-8#5)(2008-9#4)
the nested##4##2##(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
the nesting##4##2##(1990-8#1)(1995-3#1)(2007-5#1)(2008-6#1)
the nests##2##2##(2007-5#1)(2008-8#1)
the net effect of this##2##5##(2008-10#1)(2008-8#1)
the net effect of##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
the net mucosal-to-serosal##2##3##(2008-6#2)
the net negative##2##3##(2007-11#1)(2008-5#1)
the net result##2##3##(1992-9#1)(2008-5#1)
the net transfer##2##3##(1997-7#1)(2009-9#1)
the net##51##2##(1991-2#1)(1992-9#1)(1993-11#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#4)(2008-9#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the network and the##2##4##(1993-12#1)(2008-3#1)
the network and##5##3##(1993-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
the network are##2##3##(1996-12#1)(2009-8#1)
the network of##5##3##(1996-4#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-2#1)
the network to##5##3##(1993-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
the network was##3##3##(2008-10#2)(2013-1#1)
the network##56##2##(1993-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-3#3)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#10)(2008-2#3)(2008-3#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
the networks of##2##3##(2008-9#1)(2012-2#1)
the networks##13##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-10#1)(2010-4#1)(2012-2#2)
the neural activity##2##3##(2008-11#2)
the neural bases of##2##4##(2008-11#1)(2009-2#1)
the neural basis of##4##4##(2007-12#1)(2008-11#2)(2010-2#1)
the neural basis##5##3##(2007-12#1)(2008-11#2)(2010-2#1)(2012-2#1)
the neural cell##2##3##(1992-6#1)(2009-8#1)
the neural circuitry underlying##2##4##(2008-11#2)
the neural circuitry##5##3##(2008-11#3)(2009-9#1)(2013-8#1)
the neural code##3##3##(2007-12#1)(2013-8#2)
the neural coding##2##3##(2008-11#1)(2008-8#1)
the neural control of##3##4##(1997-4#1)(2007-7#1)(2008-4#1)
the neural control##4##3##(1997-4#1)(2007-12#1)(2007-7#1)(2008-4#1)
the neural correlates of##7##4##(2007-8#2)(2008-11#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
the neural mechanism##2##3##(2008-6#1)(2008-9#1)
the neural mechanisms that##2##4##(2013-1#1)(2013-8#1)
the neural mechanisms underlying##4##4##(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
the neural mechanisms##9##3##(1995-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the neural network analysis##2##4##(2008-8#1)(2010-8#1)
the neural network with##2##4##(2008-10#1)(2008-3#1)
the neural network##13##3##(1997-7#1)(2008-10#7)(2008-3#2)(2008-8#1)(2009-5#1)(2010-8#1)
the neural pathway##2##3##(1996-2#1)(2009-5#1)
the neural precursor cells##3##4##(2007-12#1)(2008-11#2)
the neural responses##2##3##(2008-11#2)
the neural substrates of##2##4##(2008-11#1)(2009-9#1)
the neural##99##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#25)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#2)(2009-5#2)(2009-8#2)(2009-9#2)(2010-2#2)(2010-8#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-7#1)(2013-1#2)(2013-8#4)
the neuraminidase##2##2##(1990-11#2)
the neurite outgrowth##4##3##(1995-6#1)(2008-11#3)
the neurite##6##2##(1995-6#1)(2008-10#1)(2008-11#3)(2008-5#1)
the neuro-muscular##2##2##(2008-9#2)
the neurobiological model##2##3##(2008-6#1)(2013-8#1)
the neurobiological##4##2##(1993-12#1)(2008-2#1)(2008-6#1)(2013-8#1)
the neurobiology of##6##3##(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)
the neurobiology##7##2##(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-10#1)
the neuroblastoma cell line##2##4##(1996-10#1)(2008-7#1)
the neuroblastoma##3##2##(1992-5#1)(1996-10#1)(2008-7#1)
the neurochemical##5##2##(1995-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
the neurocognitive effects##2##3##(2011-1#2)
the neurocognitive##5##2##(2008-11#1)(2008-2#2)(2011-1#2)
the neurodynamics##2##2##(2008-11#2)
the neuroectoderm##2##2##(1997-7#1)(2008-4#1)
the neuroendocrine##9##2##(1997-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
the neuroimaging##2##2##(2011-1#1)(2011-2#1)
the neurologic##4##2##(2008-7#3)(2012-3#1)
the neurological and##2##3##(2008-9#1)(2011-2#1)
the neurological deficit score##2##4##(2008-10#2)
the neurological deficit##7##3##(1997-5#1)(2007-10#1)(2008-10#2)(2011-2#3)
the neurological symptoms were##2##4##(2008-7#2)
the neurological symptoms##3##3##(1991-6#1)(2008-7#2)
the neurological##28##2##(1991-11#1)(1991-6#1)(1992-5#1)(1993-8#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#5)(2008-9#1)(2011-2#4)(2012-3#1)(2013-8#1)
the neurology clinic##2##3##(2008-8#2)
the neuromere##2##2##(2007-12#2)
the neuromeres of the ventral nerve cord##2##7##(2007-12#2)
the neuromodulatory##2##2##(2009-10#2)
the neuromuscular disorders##2##3##(2010-8#1)(2013-1#1)
the neuromuscular junction##5##3##(1992-8#1)(2008-7#2)(2009-11#1)(2009-8#1)
the neuromuscular system##3##3##(2007-12#1)(2008-12#1)(2009-12#1)
the neuromuscular##15##2##(1992-8#1)(1995-12#1)(2007-12#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the neuron is##2##3##(1993-12#2)
the neuron##10##2##(1992-12#1)(1993-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
the neuronal cell##5##3##(1991-12#1)(1993-8#2)(2009-12#1)(2009-8#1)
the neuronal death##2##3##(1990-7#1)(2008-5#1)
the neuronal marker##2##3##(1994-2#1)(2009-10#1)
the neuronal##43##2##(1990-5#1)(1990-7#3)(1991-12#4)(1993-12#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2012-2#2)(2013-1#1)
the neurones##3##2##(1995-12#1)(1996-5#1)(1997-3#1)
the neurons in##2##3##(2008-11#2)
the neurons of the##2##4##(1992-8#1)(2009-12#1)
the neurons of##4##3##(1992-8#1)(1997-2#1)(2008-7#1)(2009-12#1)
the neurons##18##2##(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-5#1)(1994-2#1)(1996-5#1)(1997-2#1)(2008-11#4)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2013-8#1)
the neuropathic##2##2##(1993-9#1)(2008-4#1)
the neuropathologic##2##2##(1991-1#1)(2008-7#1)
the neuropathology of##2##3##(1996-2#1)(2009-10#1)
the neuropeptide Y##3##3##(1995-12#2)(1997-2#1)
the neuropeptide expression##2##3##(1994-2#2)
the neuropeptide##8##2##(1993-3#1)(1994-2#2)(1995-12#2)(1997-2#1)(1997-4#1)(2013-7#1)
the neuropeptides##2##2##(1996-2#1)(2008-4#1)
the neuropharmacological##2##2##(1993-12#1)(2008-4#1)
the neurophysiological##3##2##(1995-8#1)(2008-9#1)(2010-1#1)
the neuropil##3##2##(2008-7#2)(2013-8#1)
the neuroprotective effect of deprenyl##2##5##(2009-12#2)
the neuroprotective effect of##3##4##(2009-12#2)(2012-2#1)
the neuroprotective effect##4##3##(1994-11#1)(2009-12#2)(2012-2#1)
the neuroprotective##6##2##(1994-11#1)(2008-2#1)(2008-7#1)(2009-12#2)(2012-2#1)
the neuropsychological##4##2##(1994-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
the neurosciences##3##2##(1992-12#1)(2009-5#1)(2012-3#1)
the neurosurgical##4##2##(2008-7#2)(2011-2#1)(2012-3#1)
the neurotoxic effects##3##3##(1994-2#1)(2008-7#2)
the neurotoxic##6##2##(1990-7#1)(1994-2#1)(1995-5#2)(2008-7#2)
the neurotoxicity##4##2##(1994-11#1)(1995-5#1)(2007-7#1)(2008-10#1)
the neurotoxin 1-methyl-4-phenylpyridinium (MPP+)##2##4##(1990-5#1)(1996-12#1)
the neurotoxin and##2##3##(1992-3#1)(1993-12#1)
the neurotoxin##12##2##(1990-5#2)(1992-3#2)(1993-12#1)(1994-11#4)(1996-12#1)(2008-5#1)(2008-7#1)
the neurotransmitter dopamine##2##3##(1993-8#1)(2008-10#1)
the neurotransmitter##9##2##(1993-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)
the neurovascular bundle##2##3##(2008-3#1)(2008-9#1)
the neurovascular##4##2##(2008-3#1)(2008-9#1)(2013-1#2)
the neutral and##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
the neutral form##4##3##(2008-10#3)(2011-1#1)
the neutral marker##2##3##(2008-10#1)(2012-3#1)
the neutral##38##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-2#2)(1997-2#1)(2008-10#15)(2008-3#1)(2008-4#2)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the neutralization##2##2##(1995-5#1)(2008-10#1)
the neutralizing capacity of the##2##5##(2008-10#1)(2008-5#1)
the neutrophil##9##2##(1992-8#2)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#2)(2008-10#1)(2012-3#1)
the new AFFFF-MALS##2##3##(2011-2#2)
the new American##2##3##(1995-2#1)(2008-3#1)
the new Medicare##6##3##(1992-1#2)(1992-12#1)(2007-9#2)(2008-4#1)
the new algorithm is##4##4##(2008-10#1)(2008-3#3)
the new algorithm##7##3##(2008-10#2)(2008-2#1)(2008-3#4)
the new and##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
the new approach and##2##4##(2008-10#2)
the new approach reduces##2##4##(2007-12#1)(2008-10#1)
the new approach##11##3##(1995-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)
the new biology##2##3##(1995-10#1)(2008-11#1)
the new cases##2##3##(1997-6#1)(2012-3#1)
the new cell##2##3##(2008-11#2)
the new century##3##3##(1995-9#1)(2008-10#1)(2008-9#1)
the new challenges facing##2##4##(1991-1#1)(1992-3#1)
the new challenges##3##3##(1991-1#1)(1992-3#1)(1994-1#1)
the new classification##2##3##(1991-9#1)(1997-8#1)
the new compounds were##3##4##(1995-3#1)(2008-8#1)(2013-1#1)
the new compounds##8##3##(1992-3#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
the new concept##2##3##(1995-12#1)(2008-8#1)
the new convexity measure##3##4##(2008-6#3)
the new death criterion##2##4##(1991-9#2)
the new design##3##3##(2008-2#1)(2009-6#1)(2012-2#1)
the new devices have##2##4##(1991-12#1)(2012-3#1)
the new dynamic##2##3##(2008-11#1)(2008-6#1)
the new environment##3##3##(1995-5#1)(2008-6#1)(2012-2#1)
the new extractor##2##3##(2008-10#2)
the new filter##3##3##(2008-2#3)
the new formulation##2##3##(2008-10#1)(2008-2#1)
the new generation of optical##2##5##(2008-2#1)(2008-3#1)
the new generation of##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
the new genotypes##2##3##(2008-10#2)
the new guidelines##2##3##(2008-11#1)(2008-3#1)
the new health##2##3##(1992-2#1)(1994-12#1)
the new host##5##3##(2008-8#4)(2012-2#1)
the new kinetically derived##2##4##(1990-8#2)
the new laser##2##3##(2008-2#1)(2008-5#1)
the new law##3##3##(1992-1#1)(1996-5#2)
the new method for##2##4##(2008-10#1)(2008-3#1)
the new method is##3##4##(2008-10#2)(2008-2#1)
the new method##22##3##(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#4)(2008-6#1)
the new methods of##2##4##(2007-11#1)(2008-8#1)
the new methods##4##3##(1997-3#1)(2007-11#1)(2008-1#1)(2008-8#1)
the new millennium##8##3##(1993-2#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-11#1)(2008-4#1)
the new model##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
the new one##3##3##(1996-6#2)(2008-10#1)
the new organizational structure##2##4##(1992-5#1)(1995-1#1)
the new paradigm##2##3##(1991-3#1)(2012-3#1)
the new payment system##2##4##(1992-12#1)(1992-2#1)
the new policy##2##3##(1992-12#1)(2008-2#1)
the new possibilities##2##3##(1991-11#1)(1991-5#1)
the new probes##2##3##(2008-10#2)
the new procedure##2##3##(2008-10#1)(2008-3#1)
the new proposed##2##3##(2007-6#1)(2008-3#1)
the new public health##2##4##(1992-1#2)
the new results##2##3##(2008-2#1)(2008-3#1)
the new schedule##3##3##(1992-2#3)
the new scheme##2##3##(1993-12#1)(2008-3#1)
the new science of##2##4##(1996-3#1)(2009-9#1)
the new scientific##2##3##(2008-11#1)(2010-3#1)
the new situation##2##3##(1996-2#1)(1997-2#1)
the new software##2##3##(1991-2#1)(2008-2#1)
the new species##4##3##(1993-11#1)(2008-10#1)(2008-5#1)(2010-10#1)
the new stationary phase##2##4##(2008-10#2)
the new synthesis of LH beta mRNA##2##7##(1997-2#2)
the new system##5##3##(2007-9#1)(2008-3#2)(2008-9#1)(2010-8#1)
the new task##2##3##(1994-8#1)(2007-12#1)
the new technique##8##3##(2008-11#1)(2008-2#2)(2008-3#5)
the new technology##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
the new test##2##3##(1996-5#1)(2012-1#1)
the new verb##2##3##(2008-4#2)
the new version of##2##4##(1997-2#1)(2008-10#1)
the new word##2##3##(2008-4#2)
the new##484##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-9#6)(1992-1#7)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#5)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#7)(1996-6#3)(1996-8#2)(1997-2#5)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#9)(2008-10#78)(2008-11#24)(2008-12#3)(2008-2#33)(2008-3#42)(2008-4#15)(2008-5#7)(2008-6#9)(2008-7#6)(2008-8#13)(2008-9#7)(2009-10#3)(2009-11#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#15)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#6)(2013-8#1)
the newborn and##2##3##(1994-2#1)(2012-12#1)
the newborn hip##2##3##(2007-11#2)
the newborn rat##2##3##(1990-11#1)(1992-8#1)
the newborn screening##2##3##(2010-8#2)
the newborn##32##2##(1990-11#1)(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-5#1)(2007-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
the newborn's##2##2##(2007-11#1)(2009-9#1)
the newer agents##2##3##(2007-11#1)(2008-5#1)
the newer techniques##2##3##(2008-1#1)(2009-5#1)
the newer##20##2##(1993-3#1)(1994-1#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-6#2)(2012-2#2)(2013-1#2)(2013-7#1)
the newest##5##2##(1991-9#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)
the newly described##8##3##(1993-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2011-1#1)
the newly designed##2##3##(2008-10#1)(2011-2#1)
the newly developed##12##3##(1996-2#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-11#2)
the newly diagnosed##3##3##(2011-2#1)(2013-1#2)
the newly established##4##3##(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
the newly formed##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
the newly found##2##3##(1996-5#1)(2008-10#1)
the newly identified##2##3##(1996-6#1)(1997-3#1)
the newly proposed##6##3##(2008-10#2)(2008-3#3)(2012-12#1)
the newly synthesized##3##3##(1994-9#1)(2007-11#1)(2008-10#1)
the newly##64##2##(1991-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#1)
the news##2##2##(1990-12#1)(1993-12#1)
the newspapers##2##2##(1992-9#2)
the next 10 years##3##4##(1990-2#1)(1997-3#1)(2010-8#1)
the next 10##4##3##(1990-2#1)(1994-11#1)(1997-3#1)(2010-8#1)
the next 15##2##3##(1991-12#1)(2013-8#1)
the next 24 hours##2##4##(1994-9#2)
the next 24##3##3##(1994-9#2)(2008-7#1)
the next 3##5##3##(1991-2#1)(1992-5#1)(1996-2#1)(2008-10#2)
the next 5 years##3##4##(1993-11#1)(2011-2#1)(2012-12#1)
the next 5##4##3##(1993-11#1)(2011-2#2)(2012-12#1)
the next century##5##3##(1995-12#1)(2008-4#3)(2008-9#1)
the next day##4##3##(1996-7#1)(2007-12#1)(2007-8#1)(2013-8#1)
the next decade##12##3##(1991-12#1)(1991-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-9#3)(2011-1#1)
the next decades##2##3##(2008-7#1)(2008-8#1)
the next few decades##2##4##(1996-3#1)(2008-10#1)
the next few years##9##4##(1993-3#1)(1994-12#1)(1994-3#1)(2008-12#1)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#1)
the next few##11##3##(1993-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#1)
the next fifty years##3##4##(2012-3#3)
the next four weeks##2##4##(2008-5#2)
the next four##3##3##(2008-5#2)(2011-2#1)
the next frontier##2##3##(1996-3#1)(2009-9#1)
the next generation of##17##4##(1991-6#1)(1992-3#1)(1996-11#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2012-2#2)(2013-1#1)
the next generation##25##3##(1991-6#1)(1992-3#2)(1996-11#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#3)(2013-1#1)
the next issue of this##2##5##(1992-3#1)(1996-2#1)
the next issue of##3##4##(1992-3#1)(1993-2#1)(1996-2#1)
the next issue##4##3##(1992-3#1)(1993-2#1)(1996-2#1)(2010-5#1)
the next level##3##3##(1995-12#1)(2009-4#1)(2013-8#1)
the next millennium##5##3##(2006-10#1)(2008-10#1)(2008-4#3)
the next month##2##3##(1994-12#1)(2008-7#1)
the next part##2##3##(2010-9#1)(2013-1#1)
the next round of##2##4##(1996-3#1)(2008-11#1)
the next sample##2##3##(1990-8#1)(2008-10#1)
the next season##2##3##(1996-6#1)(2010-4#1)
the next several##3##3##(1995-1#1)(2008-5#1)(2012-12#1)
the next stage##5##3##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
the next step##6##3##(1995-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)
the next ten years##2##4##(1993-12#1)(1993-2#1)
the next three##3##3##(1991-11#1)(2007-7#1)(2012-12#1)
the next two weeks##2##4##(1990-11#1)(2007-11#1)
the next two##5##3##(1990-11#1)(1991-5#1)(1995-12#1)(2007-11#1)(2009-3#1)
the next year##6##3##(1994-1#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-1#2)
the next##213##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#15)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#9)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#4)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
the next-generation##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
the nexus between##3##3##(1991-12#1)(2009-4#1)(2010-10#1)
the nexus##4##2##(1991-12#1)(2008-4#1)(2009-4#1)(2010-10#1)
the ng##2##2##(2008-10#2)
the niche hypothesis##2##3##(2008-9#2)
the niche space##3##3##(2008-1#3)
the niche##10##2##(2008-1#4)(2008-9#3)(2009-3#3)
the niches##2##2##(2008-8#1)(2011-2#1)
the nickel complex##2##3##(2008-10#2)
the nickel##10##2##(1997-7#1)(2007-12#1)(2008-10#8)
the nickel(II)##2##2##(2008-10#2)
the nicotinamide ring##2##3##(1993-11#1)(1994-11#1)
the nicotinamide##3##2##(1993-11#1)(1994-11#1)(1995-2#1)
the nicotinic acetylcholine receptor##2##4##(2008-7#1)(2012-2#1)
the nicotinic acetylcholine##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
the nicotinic receptor##2##3##(1995-11#1)(1996-12#1)
the nicotinic##7##2##(1992-3#1)(1995-11#2)(1996-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
the nidus and##4##3##(2008-7#3)(2008-9#1)
the nidus size##2##3##(2008-7#2)
the nidus##21##2##(1991-2#1)(1996-3#1)(1997-3#1)(2008-3#1)(2008-7#13)(2008-9#3)(2012-3#1)
the night and##2##3##(1997-4#1)(2008-3#1)
the night##13##2##(1991-5#2)(1995-12#2)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-12#1)
the nightly##2##2##(2008-7#1)(2009-8#1)
the nighttime##3##2##(1995-3#1)(2008-3#1)(2013-7#1)
the nigra##5##2##(1990-5#5)
the nigral##3##2##(1992-11#2)(1995-8#1)
the nigrostriatal system##8##3##(1993-5#1)(1994-8#1)(1995-11#1)(2008-7#2)(2012-12#1)(2012-2#2)
the nigrostriatal##12##2##(1992-10#1)(1992-7#1)(1993-5#1)(1994-8#1)(1995-11#1)(1996-12#2)(2008-7#2)(2012-12#1)(2012-2#2)
the nine cultivars##2##3##(2008-5#2)
the nine##28##2##(1992-2#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#2)(2012-3#1)
the nine-amino-acid hemagglutinin peptide sequence##2##5##(1992-9#2)
the nine-amino-acid##3##2##(1992-9#3)
the nineteenth century##11##3##(1991-12#2)(2008-2#1)(2009-10#1)(2009-7#1)(2010-1#2)(2011-2#3)(2012-2#1)
the ninth##4##2##(1992-3#1)(1992-8#1)(1997-7#1)(2011-2#1)
the nipple##4##2##(1994-12#2)(1997-5#1)(2011-2#1)
the nit mutant##2##3##(2008-10#2)
the nitrate##8##2##(1991-9#1)(1993-6#1)(2008-10#5)(2010-4#1)
the nitric oxide donor##2##4##(1997-4#1)(2013-7#1)
the nitric oxide production##2##4##(2008-11#2)
the nitric oxide synthases##2##4##(2008-10#2)
the nitric oxide system##2##4##(2010-8#1)(2012-8#1)
the nitric oxide##13##3##(1995-12#1)(1995-5#1)(1996-11#1)(1997-4#1)(2008-10#2)(2008-11#3)(2009-4#1)(2010-8#1)(2012-8#1)(2013-7#1)
the nitric##14##2##(1995-12#1)(1995-5#1)(1996-11#1)(1997-4#1)(2008-10#3)(2008-11#3)(2009-4#1)(2010-8#1)(2012-8#1)(2013-7#1)
the nitrile##2##2##(2007-11#1)(2007-12#1)
the nitrite concentration##2##3##(2008-10#2)
the nitrite##6##2##(1992-8#1)(2008-10#5)
the nitro group##3##3##(1994-11#1)(1995-6#1)(1996-2#1)
the nitro##6##2##(1994-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#2)
the nitrogen atoms##2##3##(2007-11#1)(2008-10#1)
the nitrogen##16##2##(1992-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#3)(2011-2#1)(2013-8#1)
the nitrogen-centered radical##4##3##(1993-11#4)
the nitrogen-centered##5##2##(1993-11#4)(1997-7#1)
the nitrogen-fixing soil bacterium Azotobacter chroococcum Az12##2##7##(2008-11#2)
the nitroso##2##2##(1996-5#1)(2008-10#1)
the nitrous oxide-acetylene flame##2##4##(2008-10#2)
the nitrous##3##2##(1992-8#1)(2008-10#2)
the nitroxide##2##2##(1993-8#1)(2008-10#1)
the nm23 antibody##2##3##(1993-8#2)
the nm23##3##2##(1993-8#2)(1993-9#1)
the no music control group##2##5##(2007-6#2)
the no##7##2##(2007-6#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)
the no-visor group##2##3##(2010-1#2)
the nociceptive##4##2##(1995-12#1)(1997-2#1)(2008-8#1)(2009-12#1)
the nocturnal##5##2##(2008-3#2)(2008-5#1)(2013-7#2)
the nodD3##2##2##(2008-9#2)
the nodal##3##2##(2007-7#1)(2008-7#1)(2010-4#1)
the node of##2##3##(2007-11#1)(2008-7#1)
the node##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
the nodes##2##2##(2008-1#1)(2008-10#1)
the nodule##7##2##(2008-1#2)(2008-7#4)(2012-3#1)
the nodules##4##2##(1990-7#1)(2008-1#1)(2011-1#1)(2012-3#1)
the noise is##4##3##(2008-11#1)(2008-3#3)
the noise level is##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the noise level##6##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-8#1)
the noise of the data##2##5##(1997-2#1)(2008-3#1)
the noise of##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
the noise spectrum##2##3##(2007-12#1)(2008-3#1)
the noise##50##2##(1996-12#1)(1997-2#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#24)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
the noise-equivalent absorption##2##3##(2008-2#1)(2008-3#1)
the noise-equivalent##3##2##(2008-2#1)(2008-3#2)
the noisy##2##2##(2008-3#1)(2009-8#1)
the nomenclature##4##2##(1990-6#1)(2008-10#1)(2008-4#2)
the nominal##8##2##(1993-3#1)(2008-3#3)(2008-8#2)(2009-12#1)(2011-2#1)
the nomination and##2##3##(1996-10#1)(2008-11#1)
the non irradiated##2##3##(2008-10#2)
the non##11##2##(1991-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2013-8#2)
the non-A##2##2##(1993-8#1)(1997-2#1)
the non-Bayesian analysis##2##3##(2008-10#2)
the non-PTS strain##2##3##(2008-7#2)
the non-additive effects##2##3##(2008-10#2)
the non-additive##3##2##(2008-10#3)
the non-coding strand##2##3##(1990-7#1)(2012-2#1)
the non-coding##5##2##(1990-7#1)(1994-12#1)(2007-12#1)(2008-8#1)(2012-2#1)
the non-collagenous domain of type VII collagen##2##7##(1992-3#2)
the non-covalent##3##2##(1996-12#1)(1996-8#1)(2008-9#1)
the non-demented##2##2##(2008-7#2)
the non-displaced##2##2##(2013-1#2)
the non-entrapped chlorothiazide##2##3##(2008-10#2)
the non-functional iron is converted to a##2##7##(1992-8#2)
the non-invasive##3##2##(1990-11#1)(2008-1#1)(2012-2#1)
the non-ionic surfactant##4##3##(2008-10#4)
the non-ionic##7##2##(1990-11#1)(2008-10#6)
the non-linear Poisson-Boltzmann##2##3##(1997-2#2)
the non-linear and##2##3##(2010-2#1)(2010-8#1)
the non-linear##18##2##(1993-5#1)(1997-2#3)(2008-10#8)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#2)
the non-neovascular##2##2##(2011-1#2)
the non-neural cholinergic system##2##4##(2010-8#2)
the non-phagocytic##2##2##(2009-5#1)(2012-2#1)
the non-pharmacological treatment##2##3##(2008-7#1)(2009-9#1)
the non-pharmacological##3##2##(2008-7#2)(2009-9#1)
the non-phosphorylating##2##2##(1991-12#2)
the non-polar##5##2##(1995-3#1)(2008-10#2)(2010-2#2)
the non-protein##3##2##(2008-7#2)(2012-1#1)
the non-reducing end##2##3##(1995-11#2)
the non-selective##4##2##(1995-12#2)(2008-8#2)
the non-specific##8##2##(1991-11#1)(2008-10#3)(2010-2#1)(2011-1#3)
the non-stimulated##4##2##(1990-7#3)(1995-11#1)
the non-structural protein##2##3##(2008-10#1)(2009-7#1)
the non-sulfated##2##2##(1991-12#1)(1991-2#1)
the non-surgical treatment of developmental dysplasia of the hip##2##9##(2007-8#2)
the non-surgical treatment of##4##4##(1991-8#1)(2007-8#3)
the non-toxic##3##2##(1992-9#1)(2008-10#1)(2011-1#1)
the non-transport group##3##3##(2013-1#3)
the non-treated##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
the nonalternant##2##2##(2008-10#2)
the nonaqueous##2##2##(2008-10#1)(2013-1#1)
the nonautoclaved and the recolonized##2##5##(2008-10#2)
the noncancer##2##2##(1993-11#1)(2008-11#1)
the nonclinical safety assessment##2##4##(2010-11#2)
the nonclinical##3##2##(1993-3#1)(2010-11#2)
the noncoding regions of##2##4##(2008-11#1)(2008-12#1)
the noncoding##3##2##(2007-10#1)(2008-11#1)(2008-12#1)
the nondisabled limb##2##3##(2013-1#2)
the nondisabled##3##2##(2013-1#3)
the nonequilibrium##2##2##(2008-3#2)
the nongenomic##2##2##(1992-12#2)
the nonglutinous cultivar##3##3##(2008-10#3)
the nonhomologous##2##2##(1994-8#1)(2013-1#1)
the nonhost##2##2##(2008-10#2)
the nonhydrolyzable##3##2##(1991-6#1)(1993-6#1)(1995-3#1)
the noninoculated control##4##3##(2008-10#4)
the noninoculated##5##2##(2008-10#5)
the noninvasive##5##2##(2007-10#1)(2007-11#1)(2008-2#1)(2010-9#1)(2012-2#1)
the nonionic detergent##2##3##(1994-11#1)(2013-1#1)
the nonionic##4##2##(1994-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
the nonlasing##2##2##(2007-12#2)
the nonlinear Faraday effect##2##4##(2007-12#2)
the nonlinear Faraday##3##3##(2007-11#1)(2007-12#2)
the nonlinear Schrödinger equation##5##4##(2007-11#3)(2007-12#2)
the nonlinear absorption coefficient##2##4##(2008-3#2)
the nonlinear absorption##3##3##(2008-3#3)
the nonlinear coupling between##2##4##(2007-12#1)(2008-3#1)
the nonlinear coupling##3##3##(2007-12#1)(2008-3#2)
the nonlinear filtering techniques##2##4##(2008-2#2)
the nonlinear index of##2##4##(2007-11#1)(2007-12#1)
the nonlinear joint transform correlator##4##5##(2008-2#4)
the nonlinear least squares##2##4##(2008-7#1)(2011-1#1)
the nonlinear material##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the nonlinear optical properties of##3##5##(2007-11#1)(2008-2#1)(2008-7#1)
the nonlinear optical##7##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-7#1)
the nonlinear phase noise##2##4##(2007-11#2)
the nonlinear phase shift##4##4##(2007-11#3)(2007-12#1)
the nonlinear phase##6##3##(2007-11#5)(2007-12#1)
the nonlinear profile##2##3##(2007-12#2)
the nonlinear refractive index of##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
the nonlinear refractive index##6##4##(2007-11#3)(2007-12#2)(2008-3#1)
the nonlinear relationship between##2##4##(2008-10#1)(2009-2#1)
the nonlinear relationship##3##3##(2008-10#1)(2008-7#1)(2009-2#1)
the nonlinear response of the##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
the nonlinear response of##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
the nonlinear response##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
the nonlinear susceptibility of the##2##5##(2007-11#1)(2008-3#1)
the nonlinear susceptibility##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the nonlinear##114##2##(2007-11#24)(2007-12#32)(2008-10#1)(2008-2#22)(2008-3#24)(2008-6#2)(2008-7#4)(2009-2#1)(2009-5#1)(2009-8#1)(2011-1#1)(2013-8#1)
the nonlinearity of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the nonlinearity of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the nonlinearity was##2##3##(2007-11#1)(2007-12#1)
the nonlinearity##13##2##(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#2)(2008-9#1)
the nonlinearly transformed matched filter for phase-encoded images with##2##9##(2008-2#2)
the nonlinearly transformed matched filter##3##5##(2008-2#3)
the nonlocal equation that##2##4##(2007-11#1)(2007-12#1)
the nonmalignant##2##2##(1990-12#2)
the nonobese patients##3##3##(2011-2#3)
the nonobese##5##2##(2011-2#5)
the nonparametric##6##2##(1997-5#1)(2007-10#1)(2008-10#2)(2009-10#1)(2009-5#1)
the nonparaxial##2##2##(2007-11#1)(2008-2#1)
the nonpathogenic isolates##3##3##(2008-10#3)
the nonpathogenic mutant##2##3##(2008-10#2)
the nonpathogenic##8##2##(2008-10#8)
the nonpolar fraction##2##3##(2013-8#2)
the nonpolar##4##2##(2008-10#1)(2011-1#1)(2013-8#2)
the nonpregnant##2##2##(1990-11#1)(1990-12#1)
the nonprofit form##2##3##(1995-2#2)
the nonprofit hospital##4##3##(1991-1#1)(1992-3#1)(1993-2#1)(1996-2#1)
the nonprofit sector##2##3##(1994-2#2)
the nonprofit##11##2##(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#2)(1995-2#2)(1996-2#1)(1997-1#1)(2008-11#1)
the nonreciprocal phase##2##3##(2008-3#2)
the nonreciprocal##3##2##(2008-3#3)
the nonreducing terminal##4##3##(1994-5#4)
the nonreducing##6##2##(1992-12#1)(1994-5#4)(2008-7#1)
the nonresonant##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
the nonsinusoidal profile of the##2##5##(2008-2#1)(2008-3#1)
the nonspecific lipid-transfer protein##2##4##(1990-5#1)(1992-6#1)
the nonspecific##4##2##(1990-5#1)(1992-6#1)(2008-10#1)(2010-8#1)
the nonstationary##2##2##(2007-12#2)
the nonstructural##6##2##(1994-11#1)(2008-10#4)(2009-7#1)
the nontransformed##3##2##(1995-2#1)(2008-10#2)
the nontransgenic##2##2##(2008-10#2)
the nontreated##2##2##(2008-10#2)
the nonuniform##3##2##(2007-12#1)(2008-2#2)
the nonuniformity of the##3##4##(2008-3#2)(2010-4#1)
the nonuniformity of##4##3##(2008-3#3)(2010-4#1)
the nonuniformity##5##2##(2008-3#4)(2010-4#1)
the nonunion##2##2##(2013-1#1)(2013-8#1)
the nonvector##2##2##(2008-10#2)
the noradrenergic##8##2##(1991-12#1)(1995-12#3)(1995-5#1)(1996-5#1)(2008-6#1)(2012-12#1)
the norm in##2##3##(1992-12#1)(2008-11#1)
the norm##8##2##(1992-12#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-2#1)
the normal ageing process##2##4##(2009-12#2)
the normal allele##4##3##(1994-11#3)(1997-3#1)
the normal and abnormal##4##4##(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
the normal and the##3##4##(1995-12#1)(1996-11#1)(2009-8#1)
the normal and##16##3##(1992-5#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-2#1)
the normal clinical##2##3##(1992-3#1)(2008-10#1)
the normal controls##6##3##(2008-10#3)(2008-11#1)(2008-7#2)
the normal daily##2##3##(2008-5#1)(2010-10#1)
the normal development of##3##4##(1991-9#1)(2010-1#1)(2011-1#1)
the normal development##4##3##(1991-9#1)(2009-4#1)(2010-1#1)(2011-1#1)
the normal dispersion of the##2##5##(2007-11#2)
the normal distribution##2##3##(1993-5#1)(2012-3#1)
the normal function##2##3##(1992-6#1)(2011-2#1)
the normal group##5##3##(1990-12#1)(1995-11#2)(1996-7#2)
the normal growth and##2##4##(2008-5#1)(2013-8#1)
the normal growth##4##3##(1993-11#1)(1996-3#1)(2008-5#1)(2013-8#1)
the normal human##6##3##(1990-7#1)(1994-5#1)(1997-1#1)(2007-7#1)(2010-10#1)(2013-7#1)
the normal liver##3##3##(1990-5#2)(1990-7#1)
the normal mode##4##3##(2008-10#4)
the normal myeloid##2##3##(1991-2#1)(2008-4#1)
the normal or##3##3##(1991-11#1)(1992-5#1)(1993-2#1)
the normal organ##2##3##(2008-10#1)(2008-11#1)
the normal pathway of##3##4##(1991-5#1)(2013-1#2)
the normal plantaris muscle##2##4##(2012-2#2)
the normal population##8##3##(1994-9#1)(1995-5#1)(1996-6#1)(2008-12#1)(2008-6#2)(2010-10#1)(2010-3#1)
the normal post-operative##2##3##(2008-2#1)(2012-2#1)
the normal process of##2##4##(2008-5#1)(2012-2#1)
the normal range##14##3##(1991-5#1)(1992-9#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
the normal rat##8##3##(1996-2#2)(2008-7#2)(2008-8#1)(2008-9#2)(2013-7#1)
the normal response to##2##4##(1992-6#1)(2008-12#1)
the normal sequence##2##3##(1991-7#1)(2007-12#1)
the normal skin##2##3##(2008-5#1)(2008-9#1)
the normal subjects##4##3##(1994-12#1)(1996-5#2)(2011-1#1)
the normal values##3##3##(2008-7#1)(2011-2#1)(2013-3#1)
the normal##261##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#4)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-7#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#2)(1993-6#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#5)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#10)(2008-8#2)(2008-9#11)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#3)(2010-7#1)(2011-1#3)(2011-2#9)(2011-3#2)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#6)(2013-3#1)(2013-7#2)(2013-8#3)
the normal-dispersion region##3##3##(2007-11#1)(2007-12#2)
the normal-dispersion##6##2##(2007-11#2)(2007-12#4)
the normal-incidence##4##2##(2008-2#2)(2008-3#2)
the normalization of##2##3##(1994-9#1)(2008-4#1)
the normalized difference vegetation index##2##5##(2008-8#2)
the normalized##21##2##(1990-7#1)(1993-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#7)(2008-8#2)(2013-1#1)
the normally##4##2##(1995-6#1)(1996-2#1)(2008-11#1)(2013-8#1)
the normals and##2##3##(1993-9#1)(2008-6#1)
the normals##3##2##(1993-9#1)(2008-6#2)
the normative##4##2##(2008-1#1)(2008-12#1)(2009-10#1)(2012-12#1)
the normativity of##2##3##(2012-2#2)
the normotensive group##2##3##(2008-1#1)(2008-7#1)
the normotensive##6##2##(1990-3#1)(1997-6#1)(2008-1#1)(2008-7#1)(2013-8#2)
the normothermic##5##2##(1994-2#1)(1995-12#1)(1996-12#2)(2008-7#1)
the north and##2##3##(2007-1#1)(2008-10#1)
the north central United States##2##5##(2008-10#2)
the north central##3##3##(2008-10#2)(2008-7#1)
the north of##5##3##(2008-10#2)(2008-12#1)(2010-7#1)(2012-2#1)
the north##21##2##(1992-8#1)(2007-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
the north-central region of the United States##4##7##(2008-10#4)
the north-central region##5##3##(2008-10#5)
the north-central##8##2##(2008-10#8)
the north-west of##2##3##(1996-11#2)
the north-west##6##2##(1996-11#2)(2010-8#4)
the north-western zone of the Bogota Savanna##3##7##(2012-12#3)
the north-western zone of the Bogota##4##6##(2012-12#4)
the north-western##7##2##(2008-8#1)(2010-8#2)(2012-12#4)
the northeast of##2##3##(2008-10#1)(2008-12#1)
the northeast##4##2##(1995-6#1)(2008-10#1)(2008-12#1)(2009-2#1)
the northeastern United States##4##4##(1996-1#1)(2008-10#2)(2011-2#1)
the northeastern and##2##3##(2009-7#1)(2011-2#1)
the northeastern##12##2##(1993-3#1)(1996-1#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#2)
the northern Caribbean##2##3##(2008-5#2)
the northern and##2##3##(2008-10#1)(2008-5#1)
the northern part of##6##4##(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2008-5#1)(2011-2#1)
the northern part##7##3##(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
the northern source##2##3##(2008-10#2)
the northern##38##2##(1990-11#1)(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#2)(2007-5#1)(2008-1#1)(2008-10#12)(2008-5#7)(2008-9#1)(2010-8#2)(2011-2#3)(2013-1#2)(2013-8#3)
the northernmost##3##2##(1991-6#1)(2008-10#1)(2009-8#1)
the nose and paranasal sinuses##3##5##(2007-4#1)(2008-3#1)(2013-1#1)
the nose and##5##3##(2007-4#1)(2008-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
the nose##17##2##(2007-12#1)(2007-4#2)(2008-11#2)(2008-3#1)(2008-5#5)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#3)
the nosological classification of##2##4##(1990-6#1)(1991-2#1)
the not-for-profit##2##2##(1992-3#1)(2008-11#1)
the notable##3##2##(1990-3#1)(1991-5#1)(2011-2#1)
the notification process##2##3##(2008-11#1)(2011-2#1)
the notion of standard##2##4##(2009-7#2)
the notion of##15##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2011-1#2)(2013-8#1)
the notion that the##10##4##(1990-8#1)(1992-3#1)(1993-11#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
the notion that##29##3##(1990-2#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the notion##45##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the notochord and floor plate##3##5##(1994-12#3)
the notochord##5##2##(1993-12#1)(1994-12#3)(2008-6#1)
the novalgin##2##2##(2008-10#2)
the novel compounds##2##3##(2008-5#2)
the novel eLOX-3##2##3##(2008-3#2)
the novel host##2##3##(2008-8#1)(2013-1#1)
the novel##76##2##(1990-7#1)(1991-3#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#1)(2010-10#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#2)(2013-1#2)
the novelty filter to##2##4##(2008-2#2)
the novelty filter##4##3##(2008-2#3)(2008-3#1)
the novelty of##2##3##(2008-7#1)(2010-11#1)
the novelty##8##2##(2008-2#4)(2008-3#1)(2008-7#1)(2010-11#1)(2010-9#1)
the novice##3##2##(1991-1#1)(2008-11#1)(2008-7#1)
the now##2##2##(1995-11#1)(2010-4#1)
the nozzle##2##2##(2008-3#1)(2011-1#1)
the nt 8993##2##3##(1994-8#2)
the nt and##2##3##(1990-11#1)(2011-1#1)
the nt##8##2##(1990-11#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#2)(2011-1#1)
the ntra ntrb mutant##4##4##(2009-10#4)
the ntra ntrb##6##3##(2009-10#6)
the nuclear and##4##3##(1994-11#1)(1994-8#1)(2008-10#1)(2008-12#1)
the nuclear envelope and##3##4##(2008-9#1)(2011-2#2)
the nuclear envelope##12##3##(1995-2#1)(2007-12#1)(2008-9#1)(2011-2#9)
the nuclear exclusion of##2##4##(1993-9#1)(2011-2#1)
the nuclear fraction##3##3##(1994-11#1)(1997-7#1)(2011-2#1)
the nuclear genome##5##3##(1995-11#1)(1995-6#2)(2009-10#1)(2010-6#1)
the nuclear genomes of##2##4##(1994-12#1)(1995-11#1)
the nuclear lamina##3##3##(1992-12#1)(2008-8#2)
the nuclear localization signal##2##4##(1991-12#1)(1994-11#1)
the nuclear localization##3##3##(1991-12#1)(1994-11#1)(2009-8#1)
the nuclear membrane##5##3##(1994-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
the nuclear pore complex and##2##5##(1994-11#2)
the nuclear pore complex##5##4##(1994-11#3)(1995-2#2)
the nuclear pore##7##3##(1994-11#3)(1995-2#2)(2011-2#2)
the nuclear proteins##2##3##(1992-11#1)(2008-9#1)
the nuclear rDNA##2##3##(2008-10#2)
the nuclear receptor##7##3##(1994-11#1)(1994-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)
the nuclear ribosomal DNA internal transcribed spacer##2##7##(2008-10#2)
the nuclear ribosomal DNA##5##4##(2008-10#5)
the nuclear ribosomal##10##3##(2008-10#10)
the nuclear scaffold##2##3##(1993-11#1)(1995-8#1)
the nuclear translation elongation factor 1alpha##2##6##(2008-10#2)
the nuclear transport##2##3##(1994-11#1)(2011-2#1)
the nuclear##114##2##(1990-12#2)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#2)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#8)(1994-12#2)(1994-8#3)(1995-11#2)(1995-2#6)(1995-3#1)(1995-6#3)(1995-8#2)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#1)(2011-2#18)(2012-2#1)(2012-3#1)
the nuclear-encoded##3##2##(1990-5#1)(1991-6#1)(2010-4#1)
the nucleation of##2##3##(2008-10#1)(2008-7#1)
the nucleation process##4##3##(1996-4#4)
the nucleation##9##2##(1996-4#6)(2008-10#1)(2008-3#1)(2008-7#1)
the nuclei and##2##3##(1994-8#1)(1997-2#1)
the nuclei are##2##3##(1990-3#1)(2008-1#1)
the nuclei of the##2##4##(1993-6#1)(2008-7#1)
the nuclei of##11##3##(1990-11#2)(1992-3#2)(1993-6#1)(1994-6#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-12#1)
the nuclei##26##2##(1990-11#2)(1990-12#1)(1990-3#1)(1992-3#2)(1993-6#1)(1994-6#2)(1994-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-12#1)
the nucleic acid##6##3##(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-4#1)
the nucleic acids##5##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-9#1)
the nucleic##12##2##(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
the nucleobase##3##2##(1996-5#1)(2008-4#2)
the nucleocapsid (N)##4##3##(2008-10#4)
the nucleocapsid##6##2##(2008-10#5)(2008-5#1)
the nucleolar targeting##2##3##(1994-9#2)
the nucleolar targetting signal##2##4##(1991-2#2)
the nucleolar##8##2##(1991-2#2)(1994-9#2)(2008-10#1)(2008-12#1)(2008-8#2)
the nucleolar-organizing regions of##2##4##(2013-1#2)
the nucleoli##2##2##(1991-12#1)(1992-11#1)
the nucleolus of##2##3##(1994-9#2)
the nucleolus##10##2##(1991-2#3)(1994-9#4)(2008-12#2)(2008-7#1)
the nucleolytic##2##2##(1991-9#2)
the nucleophile##2##2##(2008-7#1)(2010-2#1)
the nucleophilic##2##2##(1995-2#1)(2008-10#1)
the nucleoplasm##2##2##(1991-2#1)(2009-6#1)
the nucleoside##5##2##(1994-8#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-4#1)
the nucleosomes##2##2##(2008-2#1)(2008-8#1)
the nucleotide (nt) sequence of the##2##6##(1993-12#2)
the nucleotide (nt) sequence##3##4##(1993-12#3)
the nucleotide (nt)##5##3##(1993-12#3)(1993-2#1)(1993-6#1)
the nucleotide and amino acid##5##5##(1990-7#1)(1990-8#1)(1995-8#1)(2008-10#1)(2011-1#1)
the nucleotide and the##2##4##(1991-9#1)(2013-8#1)
the nucleotide and##8##3##(1990-7#1)(1990-8#1)(1991-9#1)(1995-8#1)(2008-10#2)(2011-1#1)(2013-8#1)
the nucleotide binding##3##3##(1991-12#1)(2008-10#2)
the nucleotide diversities##2##3##(1994-8#2)
the nucleotide sequence of a##3##5##(1997-3#2)(2008-10#1)
the nucleotide sequence of the pnbA##2##6##(1994-12#2)
the nucleotide sequence of the##20##5##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-12#3)(1995-8#1)(1996-8#1)(1997-2#2)(1997-4#1)(2008-10#3)(2009-2#1)
the nucleotide sequence of this##2##5##(1990-2#1)(1994-9#1)
the nucleotide sequence of##30##4##(1990-11#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-12#3)(1994-9#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(2008-10#5)(2009-2#1)
the nucleotide sequence##46##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-9#2)(1995-12#1)(1995-6#2)(1995-8#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#4)(2008-10#7)(2008-5#1)(2009-2#1)
the nucleotide sequences in##2##4##(1995-2#1)(2008-10#1)
the nucleotide sequences of the##3##5##(2007-6#1)(2008-10#1)(2008-5#1)
the nucleotide sequences of##9##4##(1990-5#1)(1990-8#1)(1993-12#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-5#2)
the nucleotide sequences were##2##4##(2009-5#2)
the nucleotide sequences##16##3##(1990-5#2)(1990-8#1)(1991-2#1)(1993-12#1)(1995-2#1)(1996-8#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-5#2)(2009-5#2)
the nucleotide##95##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#5)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#5)(1997-8#1)(2007-6#1)(2008-10#16)(2008-11#2)(2008-4#2)(2008-5#4)(2008-9#1)(2009-2#1)(2009-5#2)(2011-1#2)(2013-8#3)
the nucleotides##4##2##(1990-5#1)(1990-8#1)(1993-11#1)(2008-11#1)
the nucleus 24##2##3##(2008-9#2)
the nucleus accumbens and##7##4##(1993-12#1)(1993-6#3)(1994-2#1)(1997-7#1)(2008-7#1)
the nucleus accumbens in##2##4##(1991-1#1)(1993-6#1)
the nucleus accumbens produced##2##4##(1991-2#1)(1994-2#1)
the nucleus accumbens was##2##4##(1991-2#1)(1993-6#1)
the nucleus accumbens##51##3##(1991-1#1)(1991-2#5)(1991-5#2)(1993-12#3)(1993-6#10)(1994-2#4)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#3)(1997-7#4)(2008-4#2)(2008-6#2)(2008-7#4)
the nucleus and cytoplasm##3##4##(1995-8#1)(2008-10#1)(2012-12#1)
the nucleus and the cytosol##2##5##(2008-1#1)(2011-2#1)
the nucleus and the##5##4##(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the nucleus and##19##3##(1994-9#2)(1995-8#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-7#4)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
the nucleus are##2##3##(2008-7#1)(2012-2#1)
the nucleus basalis magnocellularis (NBM)##2##5##(1993-3#1)(1995-12#1)
the nucleus basalis magnocellularis##4##4##(1993-12#1)(1993-3#2)(1995-12#1)
the nucleus basalis##5##3##(1992-10#1)(1993-12#1)(1993-3#2)(1995-12#1)
the nucleus in addition to##2##5##(1997-1#2)
the nucleus in the##2##4##(2008-11#1)(2008-9#1)
the nucleus in##8##3##(1997-1#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#3)
the nucleus is##4##3##(1992-11#1)(1993-8#1)(2007-12#1)(2008-7#1)
the nucleus of the solitary tract##3##6##(1993-12#2)(1996-5#1)
the nucleus of the##5##4##(1991-2#1)(1993-12#2)(1996-5#1)(2008-11#1)
the nucleus of##13##3##(1991-2#1)(1992-11#1)(1993-12#2)(1994-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(2008-11#2)(2009-10#1)(2011-1#1)(2011-2#1)
the nucleus or##3##3##(2008-4#1)(2011-2#2)
the nucleus pulposus##4##3##(2007-8#3)(2012-3#1)
the nucleus to regulate##2##4##(2007-12#1)(2008-4#1)
the nucleus to the##5##4##(1992-3#1)(1993-9#1)(2009-10#1)(2009-7#1)(2011-2#1)
the nucleus to##8##3##(1992-3#1)(1993-9#1)(1996-2#1)(2007-12#1)(2008-4#1)(2009-10#1)(2009-7#1)(2011-2#1)
the nucleus tractus solitarius##3##4##(1994-2#1)(1997-2#2)
the nucleus tractus##5##3##(1992-3#2)(1994-2#1)(1997-2#2)
the nucleus with##2##3##(2008-7#2)
the nucleus##193##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#6)(1991-5#3)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#3)(1992-5#1)(1993-12#8)(1993-3#2)(1993-5#1)(1993-6#10)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-7#4)(2007-12#4)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#7)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#17)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-1#3)(2011-2#19)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
the null hypothesis of##3##4##(1995-5#1)(2008-10#2)
the null hypothesis that the##2##5##(1995-9#1)(2008-7#1)
the null hypothesis that##4##4##(1995-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
the null hypothesis##9##3##(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-5#1)(2008-7#1)
the null model when##2##4##(2008-8#2)
the null model##4##3##(1993-12#1)(2008-8#3)
the null##19##2##(1993-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-3#1)
the null-direction##2##2##(2008-8#2)
the nulling##3##2##(2007-11#1)(2008-3#2)
the number and area of##2##5##(1991-6#1)(1995-8#1)
the number and area##3##4##(1991-6#1)(1995-8#2)
the number and distribution of##3##5##(1994-9#1)(2007-12#1)(2008-3#1)
the number and quality of##2##5##(1991-6#1)(2010-3#1)
the number and size of##7##5##(1990-5#1)(1995-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-4#1)
the number and the position of##2##6##(2008-10#1)(2008-2#1)
the number and the size of##2##6##(2008-3#1)(2013-8#1)
the number and the##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
the number and type of##2##5##(2008-11#1)(2008-5#1)
the number and##51##3##(1990-3#1)(1990-5#1)(1991-6#2)(1993-3#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#2)
the number density of##2##4##(2008-3#1)(2010-12#1)
the number density##3##3##(2008-3#2)(2010-12#1)
the number of HIV##2##4##(1993-8#1)(2008-7#1)
the number of HIV-1##2##4##(1990-2#1)(1994-2#1)
the number of ICSS trains##2##5##(1991-2#2)
the number of acceptable solutions##2##5##(2008-3#2)
the number of active##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the number of actual##2##4##(1996-4#1)(2008-12#1)
the number of acute##2##4##(2008-1#1)(2013-8#1)
the number of adult##3##4##(1994-3#1)(1996-12#1)(2008-8#1)
the number of amniocenteses##2##4##(2012-3#2)
the number of antibody##2##4##(2008-4#1)(2008-9#1)
the number of antibody-producing##2##4##(2008-4#2)
the number of apothecia##3##4##(2008-10#3)
the number of ascospores##3##4##(2008-10#3)
the number of available##3##4##(2008-3#1)(2009-10#1)(2010-11#1)
the number of bacteria##4##4##(2008-10#3)(2008-9#1)
the number of bends##2##4##(2009-11#2)
the number of binding sites##3##5##(1995-8#1)(2008-10#1)(2008-3#1)
the number of births##2##4##(1990-6#1)(1995-12#1)
the number of blossoms##2##4##(2008-10#2)
the number of calibration##2##4##(2008-10#1)(2008-3#1)
the number of cardiac##2##4##(2006-10#1)(2007-8#1)
the number of cases of##3##5##(1991-8#1)(1992-11#1)(2008-11#1)
the number of cases reported##2##5##(1990-6#1)(1994-9#1)
the number of cases##14##4##(1990-6#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-9#2)(1994-9#2)(1995-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the number of cells##8##4##(1990-12#1)(1990-3#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
the number of channels##5##4##(2008-3#2)(2008-7#1)(2008-9#2)
the number of colorectal polyps##2##5##(2007-4#1)(2008-11#1)
the number of components##3##4##(2008-10#2)(2008-4#1)
the number of conidia##6##4##(2008-10#6)
the number of contacts##2##4##(1994-6#1)(1995-11#1)
the number of covariates##2##4##(1994-2#1)(2008-8#1)
the number of days##6##4##(1996-1#1)(2008-10#3)(2008-11#1)(2012-2#1)
the number of deaths##3##4##(1990-9#1)(1997-7#2)
the number of desired spatial frequencies##2##6##(2008-3#2)
the number of desired##3##4##(2008-3#3)
the number of detected##2##4##(1996-12#1)(2012-3#1)
the number of diseases##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
the number of dissected lymph nodes on the##2##8##(2011-2#2)
the number of documented##2##4##(1995-12#1)(2008-5#1)
the number of eggs##2##4##(2008-10#1)(2008-8#1)
the number of elderly##2##4##(1991-11#1)(2012-3#1)
the number of electrons##2##4##(2007-12#1)(2008-10#1)
the number of embryos##3##4##(1992-3#1)(2008-12#2)
the number of events##2##4##(1993-12#1)(2008-3#1)
the number of experimental##2##4##(2008-10#2)
the number of experiments##2##4##(2008-4#1)(2008-5#1)
the number of extinctions##2##4##(2008-8#2)
the number of factors##7##4##(2008-10#7)
the number of false##3##4##(1997-2#1)(2008-10#1)(2010-3#1)
the number of female##2##4##(1993-9#1)(2008-10#1)
the number of females##2##4##(2008-9#1)(2013-1#1)
the number of fermentation cycles##2##5##(2008-7#2)
the number of foci##2##4##(2008-10#2)
the number of friends and##2##5##(2009-7#2)
the number of frontal cortical##2##5##(1995-12#2)
the number of genes##5##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)
the number of genotypes observed##2##5##(2008-10#2)
the number of genotypes##3##4##(2008-10#3)
the number of health##2##4##(1990-11#1)(2008-11#1)
the number of healthy##2##4##(2008-10#1)(2012-2#1)
the number of holograms##2##4##(2008-2#1)(2008-3#1)
the number of hospitals##2##4##(2008-11#1)(2011-2#1)
the number of hours##2##4##(2008-10#2)
the number of image pixels##2##5##(2008-3#2)
the number of immigrants##2##4##(1996-6#1)(2008-9#1)
the number of immunizations##2##4##(1995-5#2)
the number of individuals##9##4##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
the number of infected##7##4##(2008-10#7)
the number of intensity petals##2##5##(2007-11#2)
the number of intensity##3##4##(2007-11#2)(2008-3#1)
the number of interventions##2##4##(2007-7#2)
the number of its##2##4##(1990-2#1)(2008-5#1)
the number of layers in the##2##6##(2007-11#1)(2008-3#1)
the number of layers##4##4##(2007-11#1)(2008-10#1)(2008-3#2)
the number of legal abortions##2##5##(1996-11#2)
the number of lesions increased##2##5##(2008-10#2)
the number of lesions per##2##5##(2008-10#2)
the number of lesions##9##4##(1997-6#2)(2008-10#7)
the number of letters to the left##2##7##(2009-2#2)
the number of letters##4##4##(2009-2#4)
the number of live##2##4##(1991-3#1)(2008-11#1)
the number of long-term##2##4##(1994-5#1)(2010-11#1)
the number of longer##2##4##(1994-8#1)(2010-11#1)
the number of loop##2##4##(2011-2#2)
the number of males##2##4##(2008-8#1)(2013-1#1)
the number of maxima##3##4##(2008-9#3)
the number of microorganisms##2##4##(2007-12#1)(2008-5#1)
the number of migrants##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
the number of modes##2##4##(2007-11#1)(2008-3#1)
the number of molecular##2##4##(1990-8#1)(2008-11#1)
the number of molecules of##2##5##(1995-8#1)(2008-11#1)
the number of multiple##2##4##(1997-2#1)(2007-12#1)
the number of new##4##4##(1990-6#1)(1997-6#1)(2008-10#1)(2008-7#1)
the number of ommatidia per eye##2##6##(2007-12#2)
the number of oospores##2##4##(2008-10#2)
the number of parameters##4##4##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
the number of participants##2##4##(2010-11#1)(2010-7#1)
the number of patches##3##4##(2008-8#3)
the number of patients removed from the list##2##8##(1991-11#2)
the number of patients treated##3##5##(1994-5#1)(2008-7#1)(2011-2#1)
the number of patients who##2##5##(2007-8#1)(2012-3#1)
the number of patients with##4##5##(1992-2#1)(1993-1#1)(1994-12#1)(2008-7#1)
the number of patients##22##4##(1991-11#3)(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#2)(1994-5#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the number of peaks##2##4##(1990-2#1)(2008-10#1)
the number of people with dementia##2##6##(2008-6#1)(2013-8#1)
the number of people with##4##5##(1996-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
the number of people##8##4##(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
the number of photons##2##4##(2008-3#1)(2008-4#1)
the number of pixels in the image##2##7##(2008-3#2)
the number of pixels##5##4##(2008-2#1)(2008-3#3)(2008-8#1)
the number of plants visited per time##2##7##(2008-10#2)
the number of points##2##4##(2008-3#2)
the number of positive##2##4##(1990-8#1)(2010-4#1)
the number of potential mates##2##5##(2008-8#2)
the number of potential##3##4##(2008-8#3)
the number of pregnancies##4##4##(2011-2#4)
the number of previous hospitalizations##2##5##(1991-2#2)
the number of previous##3##4##(1991-2#2)(2008-1#1)
the number of procedures##2##4##(1993-12#1)(2011-2#1)
the number of propagules##3##4##(2008-10#3)
the number of publications##2##4##(2007-4#1)(2013-1#1)
the number of race-change mutants##2##5##(2008-10#2)
the number of recorded##2##4##(1997-6#1)(2008-3#1)
the number of reflections##2##4##(2008-3#2)
the number of removed lymph nodes##2##6##(2011-2#2)
the number of residents##2##4##(1991-8#1)(1994-12#1)
the number of response categories##3##5##(2010-1#2)(2012-2#1)
the number of samples##3##4##(2008-10#3)
the number of sclerotia##5##4##(2008-10#5)
the number of seeds##2##4##(2008-8#2)
the number of sessions correlated positively with the academic performance##2##10##(2013-8#2)
the number of sessions##3##4##(2013-8#3)
the number of sexual##3##4##(1990-6#1)(2008-9#1)(2013-1#1)
the number of single cells##3##5##(2008-7#3)
the number of single##4##4##(1993-12#1)(2008-7#3)
the number of sodium ions##2##5##(1991-8#2)
the number of spatial##2##4##(2007-11#1)(2009-9#1)
the number of species in a community##2##7##(2008-8#2)
the number of species in##3##5##(2008-10#1)(2008-8#2)
the number of species of##2##5##(2008-10#2)
the number of species planted##2##5##(2008-9#2)
the number of species##10##4##(2008-10#3)(2008-8#3)(2008-9#2)(2010-3#1)(2013-7#1)
the number of sporangia##2##4##(2008-10#2)
the number of spores##3##4##(1997-4#1)(2008-10#2)
the number of stroke patients##2##5##(2007-10#2)
the number of subjects##4##4##(1990-3#1)(1995-9#2)(2013-8#1)
the number of survivors of##2##5##(2008-11#2)
the number of symptoms##2##4##(2009-9#2)
the number of tests and##2##5##(1994-3#1)(2008-10#1)
the number of tests##4##4##(1994-3#1)(1996-11#1)(2008-10#2)
the number of the##11##4##(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
the number of theoretical plates##2##5##(2008-10#2)
the number of these##2##4##(2008-10#1)(2011-2#1)
the number of total##3##4##(1990-2#1)(2008-7#1)(2008-8#1)
the number of transfused blood units##2##6##(1991-8#2)
the number of traps##2##4##(2013-7#2)
the number of trees to be sampled in the orchard##2##10##(2008-10#2)
the number of trees##3##4##(2008-10#3)
the number of trials required##2##5##(1993-12#1)(2008-11#1)
the number of trials##3##4##(1993-12#1)(1993-3#1)(2008-11#1)
the number of variables##2##4##(2008-10#1)(2008-7#1)
the number of viable##4##4##(1993-3#1)(1995-2#1)(2008-10#1)(2008-11#1)
the number of vines infected at a##2##7##(2008-10#2)
the number of wet-dog shakes##2##5##(1995-12#2)
the number of white##2##4##(2009-7#1)(2013-8#1)
the number of whorl##2##4##(2011-2#2)
the number of wire twists##2##5##(2007-8#2)
the number of women##5##4##(1991-6#1)(1993-6#1)(1993-8#1)(2007-4#1)(2008-11#1)
the number of working hours##2##5##(1990-11#1)(1995-8#1)
the number of working##3##4##(1990-11#1)(1995-8#1)(2008-10#1)
the number of writhes##2##4##(2013-7#2)
the number of years##3##4##(1993-12#2)(1995-8#1)
the number of##998##3##(1990-11#6)(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#6)(1991-12#2)(1991-2#8)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#9)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#13)(1993-2#2)(1993-3#5)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#5)(1995-11#4)(1995-12#15)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#7)(1995-9#5)(1996-1#1)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#13)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#9)(1997-7#8)(1997-8#1)(2006-10#3)(2006-6#1)(2007-10#8)(2007-11#16)(2007-12#15)(2007-2#3)(2007-4#3)(2007-7#3)(2007-8#5)(2008-1#9)(2008-10#194)(2008-11#34)(2008-12#24)(2008-2#21)(2008-3#50)(2008-4#13)(2008-5#20)(2008-6#9)(2008-7#32)(2008-8#47)(2008-9#35)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#9)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#4)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#34)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#13)(2012-4#1)(2013-1#26)(2013-7#12)(2013-8#14)
the number one cause of##3##5##(1997-6#1)(2011-2#1)(2012-2#1)
the number one##4##3##(1997-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
the number or##2##3##(2008-4#1)(2011-2#1)
the number predicted##2##3##(1996-4#1)(2008-2#1)
the number who##2##3##(2008-11#1)(2008-7#1)
the number##1088##2##(1990-11#6)(1990-12#5)(1990-2#4)(1990-3#5)(1990-5#3)(1990-6#6)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#6)(1991-12#2)(1991-2#8)(1991-3#4)(1991-5#2)(1991-6#3)(1991-8#9)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#14)(1993-2#2)(1993-3#6)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#6)(1995-11#4)(1995-12#15)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#5)(1995-8#12)(1995-9#5)(1996-1#1)(1996-11#3)(1996-12#8)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#14)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#10)(1997-7#8)(1997-8#1)(2006-10#3)(2006-6#1)(2007-10#8)(2007-11#16)(2007-12#18)(2007-2#3)(2007-4#3)(2007-7#3)(2007-8#5)(2008-1#9)(2008-10#204)(2008-11#40)(2008-12#24)(2008-2#23)(2008-3#58)(2008-4#16)(2008-5#26)(2008-6#9)(2008-7#33)(2008-8#47)(2008-9#37)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#10)(2010-12#4)(2010-2#2)(2010-3#5)(2010-4#5)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#4)(2011-2#36)(2012-1#2)(2012-12#6)(2012-2#13)(2012-3#13)(2012-4#1)(2013-1#28)(2013-7#13)(2013-8#21)
the numbers of patients##2##4##(1995-2#1)(2008-10#1)
the numbers of##42##3##(1990-5#1)(1993-12#2)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-4#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-11#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-1#1)
the numbers##53##2##(1990-5#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#2)(1996-6#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-11#1)(2010-2#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the numerator##3##2##(1995-3#1)(1996-2#1)(2008-9#1)
the numerical analysis of##4##4##(1990-8#1)(2007-12#2)(2008-10#1)
the numerical analysis##6##3##(1990-8#1)(2007-12#2)(2008-10#1)(2008-9#2)
the numerical aperture (NA) of the focusing##2##7##(2007-11#1)(2008-3#1)
the numerical aperture for##2##4##(2007-11#1)(2008-3#1)
the numerical aperture is##2##4##(2008-3#1)(2013-8#1)
the numerical aperture of the objective lens and the##2##9##(2007-12#2)
the numerical aperture of the##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
the numerical aperture of##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
the numerical aperture##16##3##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#6)(2013-8#1)
the numerical data##2##3##(2008-10#1)(2008-3#1)
the numerical estimates##2##3##(2008-3#2)
the numerical information##2##3##(2008-11#1)(2010-3#1)
the numerical results##4##3##(2008-2#2)(2008-3#2)
the numerical solution##2##3##(2008-7#1)(2008-9#1)
the numerical value of the##2##5##(2008-2#1)(2008-6#1)
the numerical##63##2##(1990-8#1)(1996-4#1)(2007-11#5)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#11)(2008-3#20)(2008-6#3)(2008-7#1)(2008-9#5)(2009-8#1)(2010-3#1)(2012-3#2)(2013-8#1)
the numerically##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
the numerous studies##2##3##(2011-2#1)(2012-3#1)
the numerous##23##2##(1991-4#1)(1991-5#1)(1992-1#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the nurse and the##2##4##(1994-1#1)(2010-7#1)
the nurse cell##2##3##(2007-12#2)
the nurse cells##4##3##(2007-12#2)(2008-10#1)(2008-9#1)
the nurse educator in##2##4##(2008-11#2)
the nurse in##2##3##(2010-3#1)(2011-2#1)
the nurse leader's role##2##4##(2008-1#2)
the nurse##35##2##(1993-2#1)(1994-1#1)(1994-3#1)(1995-3#1)(1997-1#1)(2007-12#5)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-6#2)(2008-9#1)(2010-3#2)(2010-7#2)(2011-2#3)(2012-3#2)(2013-8#1)
the nurse's##4##2##(1990-2#1)(1991-1#1)(2008-1#1)(2012-3#1)
the nursery##3##2##(2008-10#3)
the nurses##19##2##(1990-2#5)(1991-2#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
the nurses'##9##2##(1993-12#1)(1996-2#2)(2007-10#2)(2010-11#2)(2010-2#2)
the nursing and##2##3##(2008-11#1)(2010-10#1)
the nursing care of older adults##2##6##(2008-11#2)
the nursing care of##3##4##(2008-11#3)
the nursing care##6##3##(2007-10#1)(2008-1#1)(2008-11#3)(2012-3#1)
the nursing clinicians'##2##3##(2007-10#2)
the nursing curriculum##8##3##(2008-11#4)(2008-12#3)(2010-3#1)
the nursing education##2##3##(2008-11#1)(2008-12#1)
the nursing home##12##3##(1991-1#2)(1992-1#1)(1992-3#1)(1995-3#1)(1997-2#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-10#1)(2010-11#1)
the nursing homes##2##3##(2008-11#1)(2012-12#1)
the nursing literature##3##3##(1994-3#1)(2013-1#2)
the nursing process##3##3##(2008-12#1)(2008-4#1)(2010-3#1)
the nursing profession is##2##4##(1996-3#1)(2011-1#1)
the nursing profession##8##3##(1994-2#1)(1996-3#1)(2008-11#1)(2008-12#2)(2011-1#2)(2012-3#1)
the nursing staff##5##3##(1991-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)
the nursing workforce##6##3##(2008-11#1)(2008-12#1)(2011-1#2)(2012-3#2)
the nursing##85##2##(1990-10#1)(1990-2#2)(1991-1#3)(1991-11#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-10#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#21)(2008-12#11)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-11#1)(2010-3#2)(2011-1#4)(2012-12#1)(2012-3#8)(2013-1#2)
the nut##2##2##(1995-3#1)(2008-10#1)
the nutrient foramen was##3##4##(2013-8#3)
the nutrient foramen##7##3##(2013-8#7)
the nutrient foramina##2##3##(2013-8#2)
the nutrient##25##2##(1993-9#1)(2008-10#6)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#2)(2013-8#12)
the nutrition##6##2##(1994-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
the nutritional composition of (-) diet simulated that of food consumed by Japanese victims of Itai-Itai disease##2##17##(1997-4#2)
the nutritional composition of (-) diet simulated that of food consumed by Japanese##3##13##(1997-4#3)
the nutritional profile##2##3##(2008-9#2)
the nutritional sciences##3##3##(2012-2#3)
the nutritional status of infants##2##5##(1997-4#1)(2010-5#1)
the nutritional status of the##2##5##(2008-10#1)(2008-7#1)
the nutritional status of##7##4##(1997-4#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)
the nutritional status##11##3##(1991-12#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)
the nutritional value of the##2##5##(1994-3#1)(2010-11#1)
the nutritional value of##5##4##(1994-3#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)
the nutritional##37##2##(1990-2#1)(1991-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1997-4#4)(2007-12#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#4)
the nutritive##2##2##(2007-12#1)(2008-10#1)
the nuts##2##2##(1994-3#1)(2008-10#1)
the nymphs##3##2##(2007-12#3)
the oak##4##2##(2008-10#1)(2008-5#1)(2012-6#1)(2012-9#1)
the obese and##2##3##(2008-10#1)(2012-12#1)
the obese patients##3##3##(2011-1#1)(2011-2#2)
the obese##17##2##(1996-12#3)(2008-10#1)(2009-11#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
the obesity epidemic##2##3##(2012-2#2)
the obesity##3##2##(2009-6#1)(2012-2#2)
the object and the##3##4##(2008-2#2)(2008-3#1)
the object and##5##3##(2008-2#2)(2008-3#2)(2008-5#1)
the object are##2##3##(2008-11#1)(2011-1#1)
the object in##5##3##(1995-2#1)(2007-12#1)(2008-11#2)(2008-2#1)
the object is##10##3##(1996-2#1)(2008-2#1)(2008-3#6)(2009-11#1)(2011-1#1)
the object of##8##3##(1990-12#1)(1991-6#1)(1992-12#1)(1997-6#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-11#1)
the object spectrum phase##2##4##(2008-3#2)
the object spectrum##3##3##(2008-3#3)
the object surface is##2##4##(2008-2#1)(2008-3#1)
the object surface##5##3##(2008-2#1)(2008-3#4)
the object to##5##3##(2008-11#1)(2008-3#2)(2012-12#2)
the object was##2##3##(2007-12#2)
the object##103##2##(1990-12#1)(1991-6#1)(1992-12#1)(1993-6#1)(1995-2#1)(1996-2#2)(1997-6#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#22)(2008-3#35)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)
the object's##3##2##(2008-3#1)(2009-4#1)(2011-1#1)
the objective SCORAD##2##3##(2012-1#2)
the objective function##2##3##(2010-8#1)(2012-3#1)
the objective is to##2##4##(2008-10#2)
the objective is##3##3##(2008-10#3)
the objective lens##11##3##(2007-12#2)(2008-2#3)(2008-3#6)
the objective of this study was to##4##7##(2008-10#2)(2010-2#1)(2010-9#1)
the objective of this##5##4##(2008-10#2)(2009-6#1)(2010-2#1)(2010-9#1)
the objective of##17##3##(1994-2#1)(1994-6#1)(1995-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
the objective signal##2##3##(2008-3#2)
the objective##60##2##(1991-2#1)(1991-6#2)(1992-3#1)(1994-2#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(2007-12#3)(2008-10#10)(2008-2#5)(2008-3#10)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the objectives of the workshop##2##5##(1996-4#1)(2011-2#1)
the objectives of the##4##4##(1996-4#1)(2010-3#1)(2011-2#2)
the objectives of##6##3##(1996-12#1)(1996-4#1)(2008-7#1)(2010-3#1)(2011-2#2)
the objectives##11##2##(1992-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)
the objects and##2##3##(2007-11#1)(2012-12#1)
the objects in the##2##4##(1992-11#1)(2008-3#1)
the objects in##4##3##(1992-11#1)(2008-3#2)(2009-12#1)
the objects of##2##3##(2008-3#1)(2010-10#1)
the objects##14##2##(1992-11#1)(2007-11#1)(2008-2#1)(2008-3#8)(2009-12#1)(2010-10#1)(2012-12#1)
the objects-target##2##2##(2007-11#2)
the obligate parasite##2##3##(2008-10#2)
the obligate##5##2##(1994-12#1)(2008-10#3)(2008-7#1)
the obligation of##2##3##(1993-6#1)(2007-11#1)
the obligation##3##2##(1993-6#1)(2007-11#1)(2008-7#1)
the obligatory##3##2##(1991-11#1)(1997-8#1)(2011-1#1)
the obliteration##3##2##(2008-7#3)
the observation and execution of##2##5##(2008-11#2)
the observation and##3##3##(2008-11#2)(2008-12#1)
the observation height##2##3##(2008-10#2)
the observation of a##8##4##(1991-5#2)(1994-2#1)(1997-2#1)(2007-12#2)(2008-3#1)(2013-1#1)
the observation of abnormal##2##4##(1994-3#1)(2007-11#1)
the observation of clouds and aerosols with the##2##8##(2008-3#2)
the observation of the##5##4##(1990-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
the observation of##46##3##(1990-6#1)(1991-5#2)(1992-9#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-11#6)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
the observation period##14##3##(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-12#1)(2011-1#1)
the observation that the##8##4##(1995-2#1)(1995-9#1)(1997-7#1)(2007-10#1)(2008-6#2)(2008-9#1)(2009-9#1)
the observation that this##2##4##(1992-2#1)(1993-9#1)
the observation that##32##3##(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-9#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
the observation unit##2##3##(2008-3#2)
the observation##116##2##(1990-6#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
the observational##4##2##(1996-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
the observations are##2##3##(2008-2#1)(2012-2#1)
the observations of the##2##4##(1994-1#1)(1995-3#1)
the observations of##4##3##(1990-5#1)(1994-1#1)(1995-3#1)(2007-8#1)
the observations##19##2##(1990-5#1)(1994-1#1)(1995-3#1)(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
the observed and##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)
the observed bands##2##3##(2008-2#1)(2008-3#1)
the observed behavior##5##3##(1990-12#1)(2008-11#1)(2008-3#2)(2010-6#1)
the observed binding##2##3##(1997-6#1)(2008-8#1)
the observed cell cycle arrest##2##5##(1997-3#1)(1997-7#1)
the observed cell##3##3##(1997-1#1)(1997-3#1)(1997-7#1)
the observed changes##3##3##(1993-11#1)(1995-12#1)(2008-10#1)
the observed data##9##3##(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#3)(2011-2#1)
the observed decline in##2##4##(2008-11#1)(2008-7#1)
the observed decrease##2##3##(2008-11#1)(2008-3#1)
the observed difference in##2##4##(1990-8#1)(1993-3#1)
the observed differences in##4##4##(1993-11#1)(1994-2#1)(1995-5#1)(2008-9#1)
the observed differences##6##3##(1993-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(2008-9#1)(2013-1#1)
the observed dynamics##2##3##(1995-5#1)(2008-10#1)
the observed exposure response##3##4##(2008-7#3)
the observed fluorescence##2##3##(1992-6#1)(2008-2#1)
the observed image##2##3##(2008-3#2)
the observed incidence##2##3##(2008-10#2)
the observed increase in##2##4##(2008-4#1)(2009-8#1)
the observed induced##2##3##(2008-10#2)
the observed inhibition##2##3##(1991-9#1)(1992-3#1)
the observed interactions##2##3##(2008-7#1)(2013-8#1)
the observed mortality##2##3##(2007-8#1)(2008-8#1)
the observed number of##2##4##(2008-10#2)
the observed object##2##3##(2007-11#1)(2008-3#1)
the observed patterns of##3##4##(2008-8#2)(2009-7#1)
the observed patterns##8##3##(1994-3#1)(2008-2#1)(2008-8#4)(2009-7#1)(2009-8#1)
the observed products##2##3##(1992-11#1)(2008-6#1)
the observed relationship##2##3##(2008-10#1)(2012-12#1)
the observed results##2##3##(2007-12#1)(2008-4#1)
the observed seroprevalence##2##3##(2011-2#2)
the observed signal##3##3##(1992-6#1)(1997-2#1)(2008-3#1)
the observed similarities##2##3##(1990-5#1)(2008-7#1)
the observed spectral##3##3##(2007-11#1)(2007-12#1)(2009-9#1)
the observed spectrum##2##3##(2008-2#1)(2008-3#1)
the observed surface##2##3##(2008-3#2)
the observed total##2##3##(1995-12#1)(2008-2#1)
the observed values##3##3##(1997-2#1)(2008-10#1)(2010-3#1)
the observed variation##4##3##(1995-3#1)(2008-10#1)(2008-5#1)(2013-7#1)
the observed variations##2##3##(2008-10#1)(2009-7#1)
the observed##262##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-7#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#11)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#43)(2008-11#9)(2008-12#2)(2008-2#10)(2008-3#24)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#14)(2008-8#18)(2008-9#6)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
the observer and##2##3##(2007-11#1)(2008-2#1)
the observer##11##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)
the observer's##2##2##(2008-11#1)(2012-3#1)
the obstacles and##2##3##(2009-5#1)(2012-12#1)
the obstacles faced by##2##4##(1993-2#1)(2012-12#1)
the obstacles to##2##3##(2008-5#1)(2009-5#1)
the obstacles##9##2##(1993-2#1)(1995-3#1)(1996-2#1)(2008-5#1)(2008-7#1)(2009-5#2)(2012-12#2)
the obstetric and##2##3##(1990-3#1)(1992-1#1)
the obstetric##5##2##(1990-3#1)(1991-9#1)(1992-1#1)(1993-10#1)(2011-1#1)
the obstetrical##2##2##(2008-4#1)(2011-2#1)
the obstruction and##2##3##(2007-12#1)(2008-3#1)
the obstruction##8##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the obstructive##3##2##(1992-9#1)(2007-12#1)(2013-1#1)
the obtained data##4##3##(2008-10#1)(2008-5#2)(2011-1#1)
the obtained ones##2##3##(2008-10#1)(2011-2#1)
the obtained results were used on##2##6##(2008-10#2)
the obtained results were##4##4##(2008-10#4)
the obtained results##23##3##(2007-10#1)(2008-10#18)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
the obtained##63##2##(1992-8#1)(1996-10#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#34)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-8#3)
the obtention of##2##3##(1991-12#1)(2008-10#1)
the obvious##4##2##(1994-3#1)(1995-11#1)(2008-7#1)(2008-9#1)
the occasion of his##3##4##(1990-8#1)(1992-5#1)(2008-4#1)
the occasion of##9##3##(1990-8#1)(1992-5#1)(1994-3#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
the occasional failure##2##3##(1994-6#1)(1996-11#1)
the occasional##7##2##(1992-11#1)(1994-6#1)(1996-11#1)(1996-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
the occipital##21##2##(1990-8#1)(1991-12#1)(1992-8#2)(1994-3#1)(1995-12#1)(1996-9#2)(2008-5#1)(2008-7#7)(2010-6#2)(2011-1#1)(2011-2#2)
the occluded##3##2##(1997-3#1)(1997-8#1)(2008-12#1)
the occlusal##3##2##(2008-7#1)(2010-6#1)(2011-2#1)
the occlusion and the##3##4##(1996-6#1)(2008-11#1)(2010-9#1)
the occlusion of the##2##4##(2007-10#1)(2008-12#1)
the occlusion of##3##3##(2007-10#1)(2008-10#1)(2008-12#1)
the occlusion##13##2##(1993-3#1)(1994-11#1)(1996-6#1)(1997-6#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-9#1)
the occupancy of##2##3##(1993-8#1)(2008-2#1)
the occupancy##3##2##(1993-8#1)(2008-11#1)(2008-2#1)
the occupation##5##2##(1990-6#4)(2011-2#1)
the occupational and##2##3##(1996-6#1)(2008-10#1)
the occupational health care unit##2##5##(1995-6#2)
the occupational health##8##3##(1995-2#2)(1995-6#2)(2008-11#1)(2008-7#1)(2011-2#2)
the occupational##15##2##(1990-2#1)(1993-12#1)(1995-2#2)(1995-6#2)(1996-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#3)
the occurrence and degree of##2##5##(1996-11#1)(2008-10#1)
the occurrence and##10##3##(1990-11#1)(1996-11#1)(2008-10#4)(2008-5#2)(2008-8#1)(2012-12#1)
the occurrence in##2##3##(2008-10#2)
the occurrence of DNA##2##4##(1992-3#1)(1997-4#1)
the occurrence of Parkinson's disease##2##5##(2008-7#2)
the occurrence of a##9##4##(1993-11#1)(1993-9#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#3)
the occurrence of acute##2##4##(1992-2#1)(2012-2#1)
the occurrence of adverse##2##4##(1992-1#1)(2009-5#1)
the occurrence of an##3##4##(1994-6#1)(2008-10#1)(2008-8#1)
the occurrence of both##2##4##(2008-10#1)(2008-4#1)
the occurrence of cerebral##2##4##(1996-3#1)(2010-8#1)
the occurrence of chromosomal##2##4##(1990-8#1)(1996-12#1)
the occurrence of diarrhea##2##4##(1992-12#1)(2008-5#1)
the occurrence of flashbacks##2##4##(1996-7#2)
the occurrence of infection##2##4##(2008-10#1)(2008-7#1)
the occurrence of more##2##4##(2008-10#1)(2013-8#1)
the occurrence of oscillations##2##4##(1990-8#2)
the occurrence of several##2##4##(2008-10#1)(2010-5#1)
the occurrence of the actin coronas in the embryo sac during fertilization##2##12##(2008-11#2)
the occurrence of the##13##4##(1991-11#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
the occurrence of this##2##4##(2008-9#1)(2010-5#1)
the occurrence of type##2##4##(2007-8#1)(2009-3#1)
the occurrence of violence##2##4##(2013-8#2)
the occurrence of##191##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-4#3)(1997-6#1)(2007-10#3)(2007-12#7)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#33)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#17)(2008-8#11)(2008-9#5)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
the occurrence##211##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-4#3)(1997-6#1)(2007-10#3)(2007-12#8)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#39)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#18)(2008-8#12)(2008-9#6)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
the ocean and atmosphere##2##4##(2008-2#1)(2008-3#1)
the ocean and##3##3##(2008-2#2)(2008-3#1)
the ocean color and temperature scanner##2##6##(2008-3#2)
the ocean color and##3##4##(2008-3#3)
the ocean color##4##3##(2008-2#1)(2008-3#3)
the ocean##33##2##(1990-8#1)(1996-4#3)(2008-2#14)(2008-3#12)(2008-8#1)(2008-9#1)(2012-2#1)
the ocean's##2##2##(2008-2#1)(2008-3#1)
the oceanic##5##2##(2008-10#1)(2008-2#2)(2010-8#2)
the oceans##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
the octahedral##4##2##(1996-2#1)(1997-7#1)(2008-10#1)(2008-5#1)
the octamer##4##2##(1992-6#1)(1992-8#1)(1994-9#2)
the octameric##2##2##(1992-8#2)
the octanol phase##2##3##(1991-5#2)
the octanol/water##2##2##(1991-5#1)(1996-2#1)
the octapeptide##2##2##(1992-5#1)(1992-6#1)
the octopole##2##2##(2008-10#2)
the ocular bioavailability##2##3##(2011-3#2)
the ocular dominance##2##3##(1994-8#1)(2012-2#1)
the ocular##9##2##(1994-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-3#3)(2012-2#1)
the odds of being##2##4##(2010-6#1)(2011-1#1)
the odds of##9##3##(2007-10#2)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#4)
the odds ratio for##2##4##(1995-8#1)(2012-3#1)
the odds ratio##5##3##(1994-2#1)(1994-9#1)(1995-8#1)(2008-10#1)(2012-3#1)
the odds that##2##3##(1993-5#1)(2011-2#1)
the odds##20##2##(1993-5#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-10#2)(2008-10#1)(2008-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)
the odontogenic keratocyst##6##3##(2007-12#6)
the odontoid process##3##3##(2011-2#3)
the odor##5##2##(1994-8#1)(2008-10#1)(2008-4#1)(2009-8#2)
the oesophagus##15##2##(1990-12#1)(1990-6#1)(1990-9#1)(1993-6#1)(2007-8#2)(2008-1#3)(2008-11#1)(2011-1#1)(2012-2#2)(2013-8#2)
the oestrous##2##2##(1990-8#1)(1994-7#1)
the of##8##2##(2007-11#1)(2007-8#2)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#2)
the off-axis##10##2##(2007-11#2)(2008-3#8)
the off-line##6##2##(2007-12#1)(2008-10#3)(2008-7#2)
the off-resonance##2##2##(2007-11#1)(2008-3#1)
the off-season is##2##3##(2008-10#2)
the off-state##2##2##(2008-3#1)(2008-7#1)
the offending##6##2##(1993-6#1)(2006-10#1)(2008-7#2)(2008-8#1)(2010-5#1)
the offer##2##2##(1996-5#1)(2011-2#1)
the office##7##2##(1990-10#1)(1991-2#1)(1994-12#1)(1995-12#1)(2008-4#1)(2009-8#1)(2011-1#1)
the official Mexican##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
the official method of the##2##5##(2008-10#2)
the official method##6##3##(2008-10#6)
the official methods##3##3##(2008-10#2)(2008-11#1)
the official##24##2##(1991-9#1)(1993-3#1)(1993-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#11)(2008-11#2)(2008-3#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
the offset##3##2##(1996-5#1)(2008-1#1)(2008-2#1)
the offspring of the##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
the offspring of##9##3##(2008-10#2)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#2)
the offspring##20##2##(1996-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
the often##6##2##(1990-11#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
the ogt protein##2##3##(1992-8#2)
the oil extracted from the##2##5##(2008-5#2)
the oil of H##2##4##(2008-11#2)
the oil of##3##3##(2008-11#2)(2008-12#1)
the oil palm biosolid extract for the##2##7##(2011-2#2)
the oil phase##4##3##(2008-5#4)
the oil##30##2##(2007-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#12)(2011-1#2)(2011-2#2)
the oil-water interface##2##3##(2008-5#2)
the oil-water##4##2##(2008-10#2)(2008-5#2)
the oils##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
the oily##2##2##(2008-10#1)(2008-5#1)
the ointment##2##2##(1993-11#1)(2008-12#1)
the old cuticle##2##3##(2008-7#2)
the old host##2##3##(2008-8#2)
the old patient##2##3##(2008-4#1)(2012-3#1)
the old schedule##2##3##(1992-2#2)
the old##30##2##(1990-3#5)(1992-2#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
the older adult population##4##4##(2009-12#2)(2013-1#2)
the older age group##2##4##(1996-11#1)(2008-9#1)
the older animals##2##3##(1994-5#2)
the older control##3##3##(2008-10#3)
the older person##7##3##(1995-1#1)(2010-10#5)(2011-1#1)
the older subjects##2##3##(2008-3#1)(2008-6#1)
the older workers##2##3##(2008-6#2)
the older##42##2##(1990-6#1)(1991-1#3)(1992-9#2)(1994-5#2)(1995-1#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#4)(2008-9#1)(2009-12#2)(2010-10#9)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#2)
the oldest age group##3##4##(2011-2#1)(2012-3#2)
the oldest age##4##3##(1993-12#1)(2011-2#1)(2012-3#2)
the oldest and##3##3##(1996-11#1)(2011-1#1)(2013-1#1)
the oldest old##6##3##(1994-5#2)(2007-10#1)(2010-3#3)
the oldest patients##2##3##(1990-3#1)(2012-3#1)
the oldest##30##2##(1990-3#1)(1993-12#1)(1994-5#2)(1996-11#1)(1996-2#1)(1996-6#1)(2007-10#1)(2008-10#3)(2008-7#2)(2009-7#1)(2010-3#4)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
the oleaginous yeast Yarrowia lipolytica##2##5##(2011-1#2)
the oleaginous yeast##3##3##(1996-6#1)(2011-1#2)
the oleosin knockdown##3##3##(2009-10#3)
the oleosin##4##2##(2009-10#4)
the olfactory bulb and the##3##5##(2009-12#1)(2013-1#2)
the olfactory bulb and##6##4##(1997-4#1)(2008-11#1)(2009-12#2)(2013-1#2)
the olfactory bulb of##4##4##(2008-7#4)
the olfactory bulb##21##3##(1990-7#2)(1997-3#1)(1997-4#1)(2008-11#1)(2008-6#2)(2008-7#5)(2009-12#6)(2012-2#1)(2013-1#2)
the olfactory bulbs##2##3##(1994-2#1)(1996-5#1)
the olfactory epithelium##4##3##(2008-5#3)(2008-6#1)
the olfactory nerve##5##3##(1995-12#4)(2008-5#1)
the olfactory organ of##3##4##(2007-12#2)(2008-5#1)
the olfactory organ##5##3##(2007-12#4)(2008-5#1)
the olfactory receptor##2##3##(2009-12#2)
the olfactory system of the##2##5##(2007-12#1)(2008-6#1)
the olfactory system##4##3##(2007-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
the olfactory tubercle##2##3##(1991-2#2)
the olfactory##54##2##(1990-7#2)(1991-2#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#4)(1996-5#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#7)(2008-11#1)(2008-5#7)(2008-6#4)(2008-7#6)(2009-12#8)(2009-8#1)(2012-2#3)(2013-1#2)
the oligodendrocytes##2##2##(1996-12#1)(2008-7#1)
the oligomer##3##2##(1994-11#1)(1994-5#1)(2011-2#1)
the oligomeric structure of##2##4##(1994-6#1)(1997-8#1)
the oligomeric structure##3##3##(1994-6#1)(1997-8#1)(2008-4#1)
the oligomeric##5##2##(1992-11#1)(1994-6#1)(1995-2#1)(1997-8#1)(2008-4#1)
the oligomerization##2##2##(1990-11#1)(1993-8#1)
the oligonucleotide probe##4##3##(1992-9#1)(2008-10#2)(2008-9#1)
the oligonucleotide##17##2##(1990-2#1)(1992-9#1)(1993-11#1)(1996-12#1)(2008-10#5)(2008-4#6)(2008-9#1)(2012-3#1)
the oligopeptide##2##2##(1991-9#1)(2008-5#1)
the oligosaccharide backbone##2##3##(1993-11#2)
the oligosaccharide##13##2##(1990-9#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#3)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(2008-7#2)
the oligosaccharides##10##2##(1990-7#1)(1990-9#1)(1991-12#1)(1992-10#1)(1993-11#3)(2008-10#2)(2008-11#1)
the omega-3 ethyl ester concentrate##2##5##(2008-3#2)
the omission of##2##3##(2008-1#1)(2009-8#1)
the omission or##2##3##(2008-10#1)(2013-8#1)
the omission##5##2##(2008-1#1)(2008-10#1)(2009-8#1)(2013-8#2)
the omitted##3##2##(1992-6#2)(1993-1#1)
the omnibus##2##2##(1996-3#1)(1997-2#1)
the omnidirectional bandwidth##2##3##(2008-3#2)
the omnidirectional##4##2##(2008-3#4)
the on and off##2##4##(2008-2#1)(2008-3#1)
the on##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
the on-axis##10##2##(2007-11#1)(2008-2#4)(2008-3#5)
the on-column##2##2##(2008-10#2)
the on-going##2##2##(2008-11#1)(2008-3#1)
the on-line column##2##3##(2008-10#2)
the on-line monitoring##2##3##(2008-10#2)
the on-line photochemical##2##3##(2008-10#2)
the on-line precipitation of##2##4##(2008-10#2)
the on-line precipitation##3##3##(2008-10#3)
the on-line removal of##2##4##(2008-10#2)
the on-line speciation##2##3##(2008-10#2)
the on-line wavelet transform##4##4##(2008-10#4)
the on-line##56##2##(2008-10#52)(2008-11#3)(2010-4#1)
the on-site environmental##2##3##(2008-10#2)
the on-site##4##2##(2008-10#3)(2013-8#1)
the oncogene##2##2##(1995-2#1)(2012-12#1)
the oncogenic effects of##2##4##(1991-12#1)(2008-4#1)
the oncogenic##5##2##(1991-12#2)(1991-4#1)(2008-4#1)(2008-7#1)
the oncologic and functional##2##4##(2008-6#2)
the oncologic##4##2##(1991-12#1)(2008-6#3)
the oncological##2##2##(2008-10#1)(2012-3#1)
the oncologist##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2013-8#1)
the oncology##7##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
the oncoprotein Bcl-2##2##3##(2012-2#2)
the one for##2##3##(2007-12#1)(2012-12#1)
the one hand##30##3##(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1994-1#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#2)
the one megabase##2##3##(1995-12#2)
the one obtained##2##3##(1995-3#1)(1996-2#1)
the one of##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
the one that##5##3##(1992-11#1)(2008-1#1)(2008-10#2)(2008-2#1)
the one used##3##3##(1990-8#1)(1992-1#1)(2010-2#1)
the one who##2##3##(1994-1#1)(2007-2#1)
the one with a##2##4##(2008-10#1)(2008-4#1)
the one with##4##3##(2008-10#2)(2008-4#1)(2013-8#1)
the one##93##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#1)(1994-1#2)(1994-12#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-10#2)(2009-11#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
the one- and##2##3##(2008-2#1)(2010-4#1)
the one-beam cross-correlation dynamic light-scattering##2##5##(2008-3#2)
the one-beam##3##2##(2007-12#1)(2008-3#2)
the one-carbon##2##2##(1992-10#1)(2009-12#1)
the one-channel condition##2##3##(2008-9#2)
the one-dimensional sample##2##3##(2007-12#2)
the one-dimensional thermodynamic limit##2##4##(2008-3#2)
the one-dimensional wavelet transform (WT)##2##5##(2008-10#1)(2008-2#1)
the one-dimensional##12##2##(1993-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#4)
the one-electron reduction of##2##4##(1994-8#2)
the one-electron##3##2##(1993-8#1)(1994-8#2)
the one-photon##2##2##(2007-12#1)(2011-1#1)
the one-sided##2##2##(1995-6#1)(2012-1#1)
the one-step##3##2##(2008-2#2)(2008-3#1)
the oneness of##2##3##(2008-8#1)(2012-2#1)
the ones most likely to##2##5##(1993-11#1)(1997-6#1)
the ones obtained by##4##4##(2008-10#4)
the ones obtained##5##3##(2008-10#4)(2008-3#1)
the ones that are##2##4##(1990-2#1)(2008-11#1)
the ones that##5##3##(1990-2#1)(2008-11#2)(2008-4#1)(2008-8#1)
the ones used##2##3##(1997-4#1)(2010-8#1)
the ones who##3##3##(1992-3#2)(2011-1#1)
the ones##32##2##(1990-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1994-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)
the ongoing debate on##2##4##(1991-1#1)(2009-10#1)
the ongoing debate##3##3##(1991-1#1)(2007-7#1)(2009-10#1)
the ongoing development of##2##4##(1994-12#1)(2008-11#1)
the ongoing##33##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#2)(1994-1#1)(1994-12#1)(1996-2#2)(1996-3#1)(1997-6#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
the onion##2##2##(2008-10#2)
the online##3##2##(2008-10#1)(2011-2#2)
the only available##2##3##(2007-8#1)(2010-5#1)
the only choice##2##3##(1994-7#1)(2013-8#1)
the only effective##5##3##(1992-6#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)
the only factor associated with##3##5##(2007-10#1)(2011-1#1)(2013-1#1)
the only factor##8##3##(1991-2#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the only fungus##2##3##(2008-10#2)
the only genotypes##2##3##(2008-10#2)
the only known##8##3##(1991-5#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-2#1)
the only means of##3##4##(1991-2#1)(2008-11#1)(2008-8#1)
the only means##5##3##(1990-11#1)(1991-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
the only method##3##3##(1990-6#1)(2008-10#1)(2008-3#1)
the only one which can##2##5##(1991-11#1)(1997-7#1)
the only one which##3##4##(1991-11#1)(1997-7#1)(2008-7#1)
the only one##9##3##(1990-12#1)(1991-11#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
the only ones with##2##4##(2008-10#2)
the only ones##3##3##(2008-10#2)(2013-1#1)
the only other##2##3##(1993-6#1)(2008-10#1)
the only patient##2##3##(1994-12#1)(1996-6#1)
the only possible##3##3##(1992-5#1)(2007-7#1)(2008-6#1)
the only potentially##2##3##(2011-2#1)(2013-1#1)
the only recognized##2##3##(1992-8#1)(1993-3#1)
the only reliable##2##3##(1994-6#1)(1996-12#1)
the only significant predictor of##2##5##(2008-6#1)(2008-9#1)
the only significant predictor##4##4##(1993-1#1)(2007-10#1)(2008-6#1)(2008-9#1)
the only significant##7##3##(1991-11#1)(1993-1#1)(2007-10#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)
the only source of primary inoculum##2##6##(2008-10#1)(2008-12#1)
the only source of##3##4##(1991-12#1)(2008-10#1)(2008-12#1)
the only species of##2##4##(2010-8#1)(2011-2#1)
the only species##4##3##(1990-2#1)(2010-8#1)(2011-2#2)
the only tool##2##3##(1992-1#1)(2013-1#1)
the only treatment of##2##4##(2007-8#1)(2012-12#1)
the only treatment##8##3##(1991-6#1)(1996-11#1)(2007-8#1)(2008-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
the only two##2##3##(1990-5#1)(2011-2#1)
the only way to##4##4##(1991-11#1)(1994-9#1)(1997-5#1)(2008-9#1)
the only way##8##3##(1991-11#1)(1994-9#2)(1995-1#1)(1997-5#1)(2008-9#1)(2010-6#1)(2010-7#1)
the only##274##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#12)(2008-6#8)(2008-7#4)(2008-8#3)(2008-9#10)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#7)(2013-7#3)(2013-8#5)
the onset and progression of##4##5##(1993-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
the onset and the##2##4##(2007-11#1)(2011-2#1)
the onset and##11##3##(1993-9#1)(1994-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#3)
the onset of Alzheimer's disease##2##5##(1996-5#1)(2008-7#1)
the onset of DNA##2##4##(1994-3#1)(1994-5#1)
the onset of PD##2##4##(2008-7#1)(2011-2#1)
the onset of a##6##4##(1990-9#2)(2008-1#2)(2008-4#1)(2010-6#1)
the onset of cardiovascular##2##4##(1990-5#1)(2008-7#1)
the onset of degradation##2##4##(2008-10#2)
the onset of depression##2##4##(1994-2#1)(2012-3#1)
the onset of diabetes##2##4##(1994-12#1)(2010-10#1)
the onset of disease##5##4##(1994-11#1)(1994-5#1)(1997-3#1)(2008-10#2)
the onset of estrus##2##4##(2013-1#2)
the onset of fatigue##2##4##(2008-5#1)(2010-8#1)
the onset of fever##2##4##(2007-12#1)(2008-11#1)
the onset of pseudothecia maturity##3##5##(2008-10#3)
the onset of puberty##3##4##(1991-1#1)(2008-4#1)(2013-8#1)
the onset of reproductive##3##4##(1996-12#1)(2010-10#1)(2013-1#1)
the onset of stroke##3##4##(2007-10#1)(2008-7#1)(2010-10#1)
the onset of symptoms and the##2##6##(2006-10#1)(2012-12#1)
the onset of symptoms and##6##5##(2006-10#1)(2008-7#1)(2012-12#4)
the onset of symptoms##13##4##(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2012-12#4)
the onset of the AIDS epidemic##2##6##(1990-3#1)(1996-5#1)
the onset of the stationary phase##2##6##(2008-7#1)(2011-2#1)
the onset of the symptoms##3##5##(2008-7#1)(2010-2#1)(2012-12#1)
the onset of the##23##4##(1990-11#1)(1990-3#1)(1995-12#1)(1996-5#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the onset of this##2##4##(2008-5#1)(2013-1#1)
the onset of type 2 diabetes##2##6##(2008-7#1)(2009-12#1)
the onset of type##3##4##(2008-7#1)(2009-12#1)(2011-2#1)
the onset of vitellogenesis##2##4##(2007-12#1)(2008-7#1)
the onset of##193##3##(1990-11#1)(1990-12#2)(1990-3#3)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#5)(1997-2#2)(1997-3#2)(1997-4#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#17)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#8)(2011-7#1)(2012-12#6)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#3)
the onset or##3##3##(2008-4#2)(2011-2#1)
the onset##212##2##(1990-11#1)(1990-12#2)(1990-3#3)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#5)(1997-2#2)(1997-3#2)(1997-4#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#25)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#10)(2008-6#3)(2008-7#18)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#6)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#3)
the ontogeny of##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
the ontogeny##5##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#2)
the ontological##2##2##(2008-7#1)(2010-5#1)
the ontology##3##2##(2008-7#3)
the oocyte and the##2##4##(2008-12#1)(2008-7#1)
the oocyte and##4##3##(1993-6#1)(2007-12#1)(2008-12#1)(2008-7#1)
the oocyte cytoplasm##2##3##(2007-12#1)(2008-7#1)
the oocyte nucleus and##2##4##(2007-12#2)
the oocyte nucleus##6##3##(2007-12#6)
the oocyte##27##2##(1991-12#1)(1991-5#1)(1993-6#1)(1994-9#2)(1997-2#1)(2007-12#11)(2008-10#2)(2008-12#3)(2008-7#2)(2008-8#1)(2013-1#2)
the oocytes##8##2##(1992-11#1)(2007-12#1)(2008-12#1)(2008-8#5)
the oolemma##3##2##(1990-12#3)
the oomycete##4##2##(2008-10#4)
the oospores##2##2##(2008-10#2)
the op mutation##2##3##(1990-5#2)
the open and closed##3##4##(2008-8#1)(2009-9#2)
the open pasture##2##3##(2008-5#2)
the open reading frame (ORF) of##2##6##(1995-8#1)(2013-1#1)
the open reading frame of the##2##6##(1992-6#1)(1995-12#1)
the open reading frame of##5##5##(1992-6#2)(1994-11#1)(1995-12#1)(1996-12#1)
the open reading frame##16##4##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-10#1)(2013-1#1)
the open reading frames (ORFs)##3##5##(1995-12#1)(1996-3#1)(1997-6#1)
the open reading frames##6##4##(1995-12#1)(1996-3#2)(1997-6#1)(2011-1#2)
the open reading##23##3##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#1)(2011-1#3)(2013-1#1)
the open##75##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-3#4)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#3)(2009-9#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#4)
the open-label portion##2##3##(2012-2#2)
the open-label##3##2##(2008-6#1)(2012-2#2)
the opened-mouth from##2##3##(2010-2#2)
the opening angles and residual strains in##2##7##(2008-9#2)
the opening angles and residual strains##3##6##(2008-9#3)
the opening of the##5##4##(2008-6#1)(2008-7#2)(2010-3#1)(2012-2#1)
the opening of##13##3##(1993-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2012-2#1)(2013-1#1)
the opening##23##2##(1993-12#1)(1994-5#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2010-3#1)(2012-2#1)(2013-1#2)
the openness##2##2##(2012-12#1)(2013-8#1)
the operant##3##2##(1990-7#1)(1997-6#1)(2008-8#1)
the operated animal##2##3##(2008-5#2)
the operated joint##5##3##(2007-8#5)
the operated limb##2##3##(2007-8#2)
the operated##14##2##(2007-11#1)(2007-8#8)(2008-5#3)(2011-2#1)(2013-1#1)
the operating characteristics of the##2##5##(2009-5#1)(2012-3#1)
the operating characteristics of##5##4##(2008-2#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
the operating conditions##3##3##(2008-10#2)(2008-7#1)
the operating microscope##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
the operating parameters##2##3##(2008-10#2)
the operating range##2##3##(2007-11#1)(2009-9#1)
the operating ratio are##2##4##(2008-11#2)
the operating room##22##3##(1991-1#3)(1991-2#1)(1996-3#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
the operating table##2##3##(2008-2#1)(2011-2#1)
the operating temperature##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
the operating##60##2##(1991-1#4)(1991-2#1)(1992-12#1)(1996-3#1)(2006-10#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
the operation and##7##3##(1990-2#1)(1994-3#2)(2007-10#1)(2007-8#1)(2008-10#2)
the operation in##2##3##(1991-12#1)(2007-8#1)
the operation is##4##3##(1991-3#1)(1991-5#1)(2007-8#2)
the operation modes##2##3##(2007-12#1)(2012-3#1)
the operation of a diode-pumped##2##5##(2007-12#1)(2008-2#1)
the operation of a##6##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
the operation of an##3##4##(1996-1#1)(1996-12#1)(1997-3#1)
the operation of the##12##4##(1995-12#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2010-11#1)
the operation of this##2##4##(1991-3#1)(2007-11#1)
the operation of##37##3##(1991-3#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#3)(2007-11#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-8#1)(2012-12#1)
the operation the##3##3##(1992-6#1)(2007-10#1)(2008-6#1)
the operation time##2##3##(2007-11#1)(2008-10#1)
the operation was##3##3##(1996-3#1)(2011-2#1)(2012-12#1)
the operation with##2##3##(1990-3#1)(2007-8#1)
the operation without##2##3##(1994-9#1)(2010-8#1)
the operation##128##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#2)(1993-9#4)(1994-11#2)(1994-3#5)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#3)(2006-12#1)(2006-6#2)(2007-10#5)(2007-11#7)(2007-12#3)(2007-8#11)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#1)
the operational and storage stability of##2##6##(2008-10#2)
the operational characteristics##2##3##(2008-10#1)(2008-2#1)
the operational##20##2##(1995-1#1)(1995-6#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)
the operations were##2##3##(1993-6#1)(2009-3#1)
the operations##5##2##(1993-3#1)(1993-6#1)(1996-9#1)(2007-12#1)(2009-3#1)
the operative and##2##3##(2007-8#1)(2011-2#1)
the operative field##3##3##(1995-1#1)(2007-8#1)(2010-8#1)
the operative findings##2##3##(1997-8#1)(2008-9#1)
the operative technique##2##3##(2008-7#1)(2013-8#1)
the operative time##2##3##(2008-10#1)(2011-2#1)
the operative treatment of##8##4##(1991-6#1)(1992-2#2)(2007-11#2)(2007-8#1)(2008-10#1)(2013-1#1)
the operative treatment##9##3##(1991-6#1)(1992-2#2)(2007-11#2)(2007-8#1)(2008-10#2)(2013-1#1)
the operative##37##2##(1990-3#1)(1991-6#1)(1992-1#1)(1992-2#2)(1995-1#1)(1995-5#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-8#8)(2008-10#8)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
the operator in##2##3##(1991-2#1)(2008-9#1)
the operator to##3##3##(2007-8#1)(2008-11#2)
the operator##13##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-9#1)(2013-1#1)
the operator's##2##2##(2008-10#1)(2011-2#1)
the operator-proximal CRP binding##2##4##(1997-6#2)
the operators##2##2##(2008-10#1)(2008-3#1)
the operculum and##2##3##(1996-5#1)(2007-12#1)
the operculum##3##2##(1996-5#1)(2007-12#2)
the ophthalmic artery##4##3##(1996-9#1)(2006-12#1)(2008-7#1)(2012-3#1)
the ophthalmic##8##2##(1993-12#1)(1996-9#1)(2006-12#1)(2008-7#1)(2011-1#1)(2012-3#3)
the ophthalmologist##3##2##(1993-11#1)(2013-1#1)(2013-7#1)
the opiate##2##2##(1991-1#1)(1992-8#1)
the opinion of the nurses##2##5##(1990-2#2)
the opinion of the##6##4##(1990-2#2)(1991-3#1)(1995-6#1)(1996-12#1)(1997-3#1)
the opinion of##10##3##(1990-2#2)(1991-3#1)(1992-1#1)(1993-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(2011-1#1)(2013-1#1)
the opinion that##4##3##(1995-5#1)(2008-1#1)(2008-7#1)(2011-2#1)
the opinion##18##2##(1990-2#2)(1991-3#1)(1992-1#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#3)
the opinions of##7##3##(1990-11#1)(1997-3#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-6#1)
the opinions##8##2##(1990-11#1)(1994-12#1)(1997-3#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-6#1)
the opioid receptor-like##2##3##(1996-2#1)(2008-11#1)
the opioid##8##2##(1991-1#2)(1995-3#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2010-5#1)
the opponent's outcomes##2##3##(2008-11#2)
the opportunistic##2##2##(2007-8#1)(2011-2#1)
the opportunities and##3##3##(1993-1#1)(2013-1#2)
the opportunities for##3##3##(1997-1#1)(2008-1#1)(2012-1#1)
the opportunities##8##2##(1993-1#1)(1993-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2012-1#1)(2013-1#2)
the opportunity cost of##2##4##(1991-2#1)(2013-8#1)
the opportunity for sexual selection##3##5##(2008-8#3)
the opportunity for##14##3##(1994-12#1)(2008-10#1)(2008-11#2)(2008-8#4)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
the opportunity of##3##3##(1991-2#1)(2008-3#1)(2012-3#1)
the opportunity to make##2##4##(1994-1#1)(2008-9#1)
the opportunity to plan##2##4##(1992-4#1)(2013-8#1)
the opportunity to present##2##4##(2008-5#1)(2012-2#1)
the opportunity to study##4##4##(1993-11#1)(2008-2#2)(2009-8#1)
the opportunity to test##2##4##(1994-8#1)(2008-1#1)
the opportunity to##51##3##(1991-6#2)(1992-4#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#4)
the opportunity##74##2##(1991-2#2)(1991-6#2)(1992-4#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-7#1)(2013-8#5)
the opposing##3##2##(1990-5#1)(2008-8#1)(2013-1#1)
the opposite direction of##2##4##(2009-7#1)(2012-2#1)
the opposite direction##8##3##(1991-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-7#2)(2012-2#1)
the opposite effect##3##3##(2007-6#1)(2008-11#1)(2008-3#1)
the opposite end##2##3##(2007-12#1)(2008-10#1)
the opposite limb##2##3##(2007-11#2)
the opposite occurred##3##3##(1991-1#1)(2008-10#1)(2011-2#1)
the opposite of##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
the opposite sex##2##3##(1990-8#1)(2008-9#1)
the opposite side##8##3##(2008-2#2)(2008-3#2)(2008-5#1)(2009-6#2)(2011-1#1)
the opposite was##3##3##(1993-12#1)(2008-7#1)(2012-2#1)
the opposite##65##2##(1990-6#1)(1990-8#2)(1991-1#1)(1991-5#2)(1993-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-4#1)(2013-1#2)(2013-8#1)
the oppositely charged##2##3##(2008-10#1)(2010-7#1)
the optic axis##4##3##(2008-2#2)(2008-3#2)
the optic lobe##4##3##(2007-12#2)(2008-5#2)
the optic nerve##10##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#2)(2012-3#1)
the optic nerves##3##3##(2008-5#2)(2013-8#1)
the optic tectum##4##3##(1990-5#1)(1993-12#1)(1997-3#1)(2008-6#1)
the optic tract and##2##4##(2007-10#1)(2008-7#1)
the optic##36##2##(1990-12#1)(1990-5#1)(1993-12#2)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#7)(2008-5#5)(2008-6#1)(2008-7#5)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
the optical absorption coefficient of##2##5##(2008-3#2)
the optical absorption##6##3##(1990-8#1)(2008-3#5)
the optical analyser TURBISCAN MA 2000##2##6##(2008-10#2)
the optical and##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
the optical arrangement##2##3##(2008-2#1)(2008-3#1)
the optical axis and##2##4##(2008-2#1)(2008-3#1)
the optical axis of the system##2##6##(2008-2#1)(2008-3#1)
the optical axis of the##5##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the optical axis of##6##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
the optical axis with##3##4##(2008-3#3)
the optical axis##24##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#15)
the optical beam##2##3##(2007-11#1)(2007-12#1)
the optical biosensor##3##3##(1997-2#2)(2008-10#1)
the optical buffer##2##3##(2008-3#2)
the optical cavity##3##3##(2007-11#1)(2008-3#2)
the optical characteristics of##4##4##(2008-2#2)(2008-3#2)
the optical characteristics##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the optical characterization of##2##4##(2008-3#2)
the optical coefficients of the two layers and the thickness of the first layer##2##14##(2008-2#2)
the optical coefficients of##3##4##(2008-2#2)(2008-3#1)
the optical coefficients##5##3##(2008-2#4)(2008-3#1)
the optical components##2##3##(2007-11#1)(2008-2#1)
the optical configuration of##3##4##(2008-2#1)(2008-3#2)
the optical configuration##4##3##(2008-2#2)(2008-3#2)
the optical constants and the##3##5##(2008-2#1)(2008-3#2)
the optical constants of the##2##5##(2008-2#1)(2008-3#1)
the optical constants of##6##4##(2008-2#3)(2008-3#3)
the optical constants##18##3##(2008-2#8)(2008-3#10)
the optical contrast between##2##4##(2007-11#1)(2008-2#1)
the optical cross sections##2##4##(2008-2#1)(2008-3#1)
the optical degradation of white paint in a##2##8##(2008-3#2)
the optical density of the##3##5##(2008-10#1)(2008-6#1)(2008-7#1)
the optical density##4##3##(2008-10#2)(2008-6#1)(2008-7#1)
the optical depth##7##3##(2008-2#3)(2008-3#4)
the optical design##2##3##(2008-2#1)(2008-3#1)
the optical disk##4##3##(2008-2#2)(2008-3#2)
the optical domain##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
the optical efficiency##4##3##(2008-2#3)(2008-3#1)
the optical elements##2##3##(2008-3#2)
the optical emission##2##3##(2008-3#1)(2013-8#1)
the optical energy##2##3##(2008-3#1)(2012-2#1)
the optical excitation area##2##4##(2007-11#2)
the optical excitation##3##3##(2007-11#2)(2007-12#1)
the optical feedback##3##3##(2008-3#3)
the optical fiber used##2##4##(2007-11#1)(2008-10#1)
the optical fiber##8##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
the optical field is##2##4##(2007-12#1)(2008-3#1)
the optical field##11##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#4)
the optical frequency##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
the optical functions##2##3##(2007-12#1)(2008-3#1)
the optical gain##2##3##(2008-2#1)(2008-3#1)
the optical implementation of##3##4##(2008-2#1)(2008-3#2)
the optical implementation##4##3##(2008-2#2)(2008-3#2)
the optical interference##2##3##(2013-8#2)
the optical limiting behavior##3##4##(2007-11#2)(2008-3#1)
the optical nonlinearity##3##3##(2007-12#2)(2008-3#1)
the optical parameters##6##3##(2008-2#2)(2008-3#4)
the optical path by the##2##5##(2008-10#1)(2008-3#1)
the optical path difference between##2##5##(2008-2#1)(2008-3#1)
the optical path difference##8##4##(2007-12#1)(2008-2#1)(2008-3#4)(2013-8#2)
the optical path length through the##2##6##(2008-2#1)(2008-3#1)
the optical path length##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
the optical path of the##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
the optical path##22##3##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#9)(2010-2#1)(2013-8#3)
the optical performance of##2##4##(2008-3#2)
the optical performance##4##3##(2008-3#4)
the optical phase##4##3##(2008-2#2)(2008-3#2)
the optical polarization properties of biological##2##6##(2008-3#2)
the optical power supply to the##2##6##(2008-2#2)
the optical power##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the optical probing beam##2##4##(2007-11#1)(2008-3#1)
the optical properties and##3##4##(2008-2#1)(2008-3#1)(2010-9#1)
the optical properties of the##14##5##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2009-2#1)
the optical properties of two-layer##2##5##(2008-3#2)
the optical properties of##47##4##(2007-11#7)(2007-12#2)(2008-10#2)(2008-2#12)(2008-3#22)(2009-2#1)(2011-1#1)
the optical properties##56##3##(2007-11#7)(2007-12#2)(2008-10#2)(2008-2#16)(2008-3#26)(2009-2#1)(2010-9#1)(2011-1#1)
the optical pulse##2##3##(2007-12#1)(2012-2#1)
the optical quality of the##2##5##(2008-3#2)
the optical quality of##3##4##(2008-3#3)
the optical quality##4##3##(2008-3#4)
the optical response##2##3##(1990-8#1)(2008-3#1)
the optical rotation##2##3##(2008-2#1)(2008-3#1)
the optical setup##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
the optical signal##8##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-9#1)
the optical signals##3##3##(2008-3#3)
the optical system to##2##4##(2007-12#1)(2008-10#1)
the optical system##23##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#16)
the optical thickness of the##4##5##(2007-11#1)(2008-3#3)
the optical thickness##8##3##(2007-11#1)(2008-2#3)(2008-3#4)
the optical throughput of##2##4##(2008-3#2)
the optical transmission##2##3##(2008-2#1)(2008-3#1)
the optical transpose interconnection system##2##5##(2008-3#2)
the optical trapping##2##3##(2007-12#1)(2008-3#1)
the optical tunneling##2##3##(2008-3#2)
the optical wavelength##3##3##(2007-11#2)(2008-3#1)
the optical##477##2##(1990-8#4)(1994-5#1)(1997-2#2)(2007-11#45)(2007-12#41)(2008-1#1)(2008-10#19)(2008-2#102)(2008-3#231)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#4)(2013-1#4)(2013-8#6)
the optical-sectioning##2##2##(2007-12#1)(2008-2#1)
the optically addressed##2##3##(2008-3#2)
the optically induced##2##3##(2007-11#1)(2008-3#1)
the optically pure##3##3##(1992-3#1)(1995-3#2)
the optically sensitive##2##3##(2007-12#1)(2008-3#1)
the optically##12##2##(1992-3#1)(1995-3#2)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)(2011-1#1)
the optics##9##2##(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#3)(2008-4#1)
the optima##2##2##(2008-10#2)
the optimal choice##2##3##(2008-10#1)(2012-3#1)
the optimal concentration of##3##4##(1994-11#1)(2008-4#2)
the optimal concentration##4##3##(1994-11#1)(2008-4#2)(2008-8#1)
the optimal conditions for the##3##5##(2008-10#2)(2013-8#1)
the optimal conditions for##6##4##(1991-5#1)(2008-10#4)(2013-8#1)
the optimal conditions##27##3##(1991-5#1)(2008-10#24)(2013-8#2)
the optimal decision##2##3##(2008-10#1)(2012-3#1)
the optimal design##2##3##(2008-3#1)(2010-2#1)
the optimal dosage and##2##4##(1992-9#1)(2013-1#1)
the optimal dosage##5##3##(1992-9#1)(1994-6#1)(2008-4#1)(2012-12#1)(2013-1#1)
the optimal dose##4##3##(1994-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
the optimal duration##2##3##(2012-2#1)(2013-8#1)
the optimal environmental conditions##2##4##(2008-10#1)(2008-3#1)
the optimal extraction##3##3##(2008-10#3)
the optimal filters is##2##4##(2008-6#2)
the optimal harvest time##2##4##(2008-11#1)(2008-7#1)
the optimal level of##3##4##(2008-10#1)(2008-8#2)
the optimal level##4##3##(1996-3#1)(2008-10#1)(2008-8#2)
the optimal medium##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
the optimal method of##2##4##(2008-1#1)(2008-11#1)
the optimal moment##2##3##(2008-10#1)(2008-5#1)
the optimal operating##2##3##(2008-2#1)(2008-5#1)
the optimal pH##2##3##(1994-11#1)(2008-10#1)
the optimal phase##2##3##(2008-3#2)
the optimal region##2##3##(2008-10#1)(2008-5#1)
the optimal solution##3##3##(2007-8#1)(2008-3#1)(2009-7#1)
the optimal strategy##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
the optimal surgical##2##3##(1994-12#1)(2008-12#1)
the optimal therapeutic##3##3##(2009-9#1)(2010-8#1)(2012-2#1)
the optimal therapy for##2##4##(1995-2#1)(2009-8#1)
the optimal time##2##3##(2008-11#1)(2011-2#1)
the optimal timing of##3##4##(2008-3#1)(2008-5#1)(2008-9#1)
the optimal timing##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)
the optimal treatment for##3##4##(2007-8#1)(2008-6#1)(2008-7#1)
the optimal treatment of##2##4##(1995-5#1)(1996-9#1)
the optimal treatment##13##3##(1995-5#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#2)
the optimal value of##2##4##(2008-10#2)
the optimal values##2##3##(2008-3#1)(2008-6#1)
the optimal velocity to moving##2##5##(2008-8#2)
the optimal##236##2##(1991-5#2)(1992-12#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#5)(2007-8#6)(2008-1#1)(2008-10#55)(2008-11#7)(2008-12#1)(2008-2#11)(2008-3#25)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#12)(2008-8#14)(2008-9#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#7)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#6)
the optimisation and##3##3##(2008-10#3)
the optimisation of the##4##4##(2008-10#4)
the optimisation of##7##3##(2008-10#5)(2008-11#2)
the optimisation##14##2##(2008-10#12)(2008-11#2)
the optimised BCR##3##3##(2008-10#3)
the optimised conditions the##2##4##(2008-10#2)
the optimised conditions##5##3##(2008-10#5)
the optimised##12##2##(2008-10#12)
the optimization and##4##3##(2008-10#2)(2008-2#2)
the optimization design of##2##4##(2008-3#2)
the optimization of a##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
the optimization of all##2##4##(2008-10#1)(2008-8#1)
the optimization of experimental##2##4##(2008-10#2)
the optimization of instrumental##2##4##(2008-10#2)
the optimization of metabolic pathways##2##5##(2008-7#2)
the optimization of the##13##4##(1997-2#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)(2011-1#1)
the optimization of##57##3##(1993-11#1)(1997-2#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
the optimization problem##2##3##(2008-2#1)(2008-3#1)
the optimization procedure##2##3##(2008-10#1)(2008-2#1)
the optimization process##4##3##(2008-10#4)
the optimization##86##2##(1993-11#1)(1997-2#1)(2007-12#2)(2008-10#41)(2008-11#1)(2008-2#12)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#2)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
the optimized condition the##2##4##(2008-10#2)
the optimized condition##3##3##(2008-10#3)
the optimized conditions of##3##4##(2008-10#2)(2011-1#1)
the optimized conditions##27##3##(2008-10#21)(2008-12#1)(2011-1#4)(2013-1#1)
the optimized geometrical##2##3##(1993-8#1)(1997-7#1)
the optimized system##4##3##(2007-12#2)(2008-3#2)
the optimized##74##2##(1993-8#2)(1997-7#1)(2007-12#2)(2008-10#47)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-1#5)(2013-1#2)
the optimum SFE##2##3##(2008-10#2)
the optimum amount of##2##4##(1996-9#1)(2007-12#1)
the optimum analytical##2##3##(2008-10#2)
the optimum and##2##3##(2008-10#1)(2008-8#1)
the optimum at##3##3##(2008-10#3)
the optimum beam##2##3##(2008-2#1)(2008-3#1)
the optimum concentration##2##3##(1996-12#1)(2008-10#1)
the optimum condition##7##3##(2008-10#7)
the optimum conditions for the##4##5##(2008-10#4)
the optimum conditions for##11##4##(1994-3#1)(2007-12#2)(2008-10#8)
the optimum conditions found##2##4##(2008-10#2)
the optimum conditions of##2##4##(2008-10#2)
the optimum conditions that##2##4##(2007-12#1)(2008-10#1)
the optimum conditions were##3##4##(2008-10#3)
the optimum conditions##66##3##(1994-3#1)(2007-12#4)(2008-10#61)
the optimum experimental conditions for##2##5##(2008-10#2)
the optimum experimental conditions##7##4##(2008-10#7)
the optimum filter##2##3##(2008-2#2)
the optimum irrigation water##2##4##(2008-12#2)
the optimum operating conditions##2##4##(2008-10#1)(2008-3#1)
the optimum operating##3##3##(2008-10#1)(2008-3#2)
the optimum pH##9##3##(1990-2#1)(1990-7#2)(2008-10#5)(2008-9#1)
the optimum performance##2##3##(2008-3#1)(2010-2#1)
the optimum polarization##2##3##(2008-3#2)
the optimum reaction conditions##3##4##(2008-10#2)(2013-1#1)
the optimum separation##2##3##(2008-10#2)
the optimum temperature for##3##4##(2008-10#2)(2008-6#1)
the optimum temperature##6##3##(2008-10#4)(2008-5#1)(2008-6#1)
the optimum values of the##3##5##(1997-6#1)(2008-10#1)(2008-3#1)
the optimum values of##4##4##(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
the optimum values##5##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
the optimum working conditions##4##4##(2008-10#4)
the optimum##213##2##(1990-2#1)(1990-7#3)(1992-8#1)(1994-12#1)(1994-3#2)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#8)(2008-10#121)(2008-11#2)(2008-12#6)(2008-2#9)(2008-3#26)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the optimums##2##2##(2008-10#1)(2010-10#1)
the option of##9##3##(1997-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
the option to##2##3##(1994-12#1)(2012-3#1)
the option##13##2##(1994-12#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)
the options available##3##3##(1992-12#1)(2008-11#1)(2009-5#1)
the options##9##2##(1992-12#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
the optode##8##2##(2008-10#8)
the optoelectronic imaging##2##3##(2008-3#2)
the optoelectronic##8##2##(2008-2#4)(2008-3#4)
the optogeometrical parameters of##2##4##(2008-3#2)
the optomotor##3##2##(2007-12#2)(2008-8#1)
the oracle property##2##3##(2010-1#2)
the oral administration of##5##4##(1990-6#1)(1992-9#1)(2008-11#1)(2010-10#1)(2012-2#1)
the oral and maxillofacial surgeon##2##5##(2007-12#1)(2008-7#1)
the oral and maxillofacial##5##4##(2007-12#2)(2008-7#3)
the oral and##7##3##(2007-12#2)(2008-7#3)(2011-2#1)(2013-1#1)
the oral cavity and##4##4##(1993-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
the oral cavity is##2##4##(2012-3#1)(2013-1#1)
the oral cavity of##5##4##(1995-9#1)(2013-1#4)
the oral cavity or##3##4##(1991-6#1)(1995-8#1)(2007-12#1)
the oral cavity##40##3##(1990-3#1)(1990-7#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-8#2)(1995-9#1)(1997-4#1)(2007-12#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#2)(2012-3#4)(2013-1#9)
the oral cavity]##2##3##(1990-10#1)(1997-4#1)
the oral delivery of insulin##3##5##(2008-5#1)(2011-1#2)
the oral delivery of##4##4##(2008-5#1)(2008-8#1)(2011-1#2)
the oral environment##2##3##(2007-12#1)(2008-11#1)
the oral health of##2##4##(2009-4#1)(2012-3#1)
the oral health-related quality of##2##5##(2011-2#1)(2011-7#1)
the oral mucosa##2##3##(1991-2#1)(1993-1#1)
the oral positive control##2##4##(2010-5#2)
the oral route##2##3##(2009-4#1)(2012-12#1)
the oral##99##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-8#2)(1995-9#1)(1996-5#1)(1997-4#2)(2007-10#1)(2007-12#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-4#1)(2010-5#3)(2011-1#3)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#11)(2013-8#3)
the orange peel##2##3##(2008-5#2)
the orange##3##2##(2008-10#1)(2008-5#2)
the orange-spotted grouper##3##3##(2010-5#3)
the orbit and frontal sinus##3##5##(2011-2#3)
the orbit##16##2##(1996-6#1)(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#2)(2010-10#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
the orbital angular momentum##2##4##(2007-11#2)
the orbital cavity##2##3##(2008-8#1)(2013-1#1)
the orbital##9##2##(1997-7#1)(2006-12#1)(2007-11#2)(2008-4#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
the orbitofrontal cortex##6##3##(2008-11#1)(2009-10#4)(2012-12#1)
the orbitofrontal##7##2##(2008-11#1)(2009-10#4)(2012-12#2)
the orbitopterional approach in##2##4##(2011-2#2)
the orbitozygomatic craniotomy##2##3##(2006-12#2)
the orbitozygomatic##3##2##(2006-12#2)(2008-7#1)
the orbits##4##2##(1991-6#1)(2011-2#2)(2013-8#1)
the orchard and##3##3##(2008-10#3)
the orchard experiments##2##3##(2008-10#2)
the orchard floor##6##3##(2008-10#6)
the orchard##29##2##(2008-10#29)
the orchards and##2##3##(2008-10#2)
the orchards##5##2##(2008-10#5)
the orchid-bee fauna##2##3##(2008-6#2)
the order Desulfarculales##2##3##(2011-2#2)
the order Spirochaetales##2##3##(2008-9#1)(2013-8#1)
the order in the##4##4##(2008-10#3)(2008-5#1)
the order of 0##8##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-9#1)(2013-1#1)
the order of 1##10##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)
the order of 1%##2##4##(1993-11#1)(2007-12#1)
the order of 10##6##4##(1995-11#1)(1995-6#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-9#1)
the order of 100##7##4##(1996-4#2)(2007-11#1)(2008-10#1)(2008-2#2)(2008-7#1)
the order of 5##4##4##(1992-2#1)(2008-2#1)(2008-3#2)
the order of a few##5##5##(2008-2#1)(2008-3#3)(2009-11#1)
the order of a##6##4##(2008-2#1)(2008-3#3)(2009-11#1)(2009-5#1)
the order of approximately##2##4##(2008-10#1)(2008-2#1)
the order of less than##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
the order of magnitude of the##2##6##(2008-3#2)
the order of magnitude of##4##5##(1993-3#1)(2008-3#3)
the order of several##4##4##(1995-3#1)(1997-6#1)(2008-3#2)
the order of the##11##4##(1991-2#1)(1992-1#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-1#1)(2011-1#1)
the order of##154##3##(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-6#1)(2007-11#6)(2007-12#12)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#14)(2008-3#38)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-9#3)(2011-1#2)(2012-2#1)(2013-1#2)
the order parameter##3##3##(1990-12#1)(1990-2#1)(2008-9#1)
the order##215##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#6)(2007-12#16)(2008-1#1)(2008-10#49)(2008-11#1)(2008-2#14)(2008-3#40)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-9#3)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
the ordered##6##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1995-5#1)(1996-12#1)
the ordering of the##2##4##(1993-11#1)(2008-10#1)
the ordering of##4##3##(1993-11#1)(2008-10#2)(2013-1#1)
the orderly##3##2##(1991-3#1)(2008-8#1)(2009-6#1)
the ordinal##2##2##(1995-9#1)(1997-4#1)
the ordinary serous##2##3##(2008-7#2)
the ordinary##19##2##(1991-6#1)(1992-6#2)(1993-3#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)
the organ of Corti##3##4##(1993-9#2)(1994-6#1)
the organ##12##2##(1990-11#1)(1993-8#1)(1993-9#2)(1994-6#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-1#1)(2011-2#1)
the organelle##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
the organelles##2##2##(1995-6#1)(2008-7#1)
the organic acids##2##3##(1992-3#1)(2008-10#1)
the organic and##2##3##(2008-10#1)(2010-4#1)
the organic compounds##4##3##(2008-10#4)
the organic constituents##2##3##(2008-10#1)(2008-7#1)
the organic fraction of##3##4##(2008-10#3)
the organic fraction##4##3##(2008-10#4)
the organic layer##3##3##(2008-10#3)
the organic matrix##4##3##(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#1)
the organic matter content##2##4##(2008-10#1)(2008-5#1)
the organic matter##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the organic modifier##2##3##(1994-9#1)(1996-5#1)
the organic phase and##2##4##(2008-10#2)
the organic phase is##2##4##(2008-10#1)(2010-4#1)
the organic phase was##3##4##(1992-10#1)(2008-10#2)
the organic phase with##3##4##(2008-10#3)
the organic phase##30##3##(1992-10#1)(1994-3#1)(1994-8#1)(2008-10#25)(2008-7#1)(2010-4#1)
the organic salt##3##3##(2007-12#3)
the organic solvent and##2##4##(1996-5#1)(2008-10#1)
the organic solvent##13##3##(1992-3#1)(1994-12#1)(1996-5#1)(2008-10#10)
the organic##117##2##(1991-9#1)(1992-10#1)(1992-3#2)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-6#2)(1996-5#3)(2007-12#8)(2008-10#72)(2008-11#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2009-7#1)(2010-4#2)(2011-1#1)(2012-8#1)(2013-1#1)(2013-8#2)
the organisation of##3##3##(1990-11#1)(1990-5#1)(1996-12#1)
the organisation##7##2##(1990-11#1)(1990-5#1)(1996-12#1)(2008-11#1)(2008-12#2)(2008-6#1)
the organisation's##2##2##(2007-2#1)(2008-12#1)
the organisations##2##2##(2007-2#1)(2010-3#1)
the organism against##2##3##(1995-5#1)(2008-7#1)
the organism and##5##3##(1994-5#1)(1995-2#1)(2009-12#1)(2011-2#1)(2013-8#1)
the organism as##2##3##(2008-11#1)(2008-7#1)
the organism in##3##3##(1991-11#1)(1996-11#1)(1997-1#1)
the organism is##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#2)
the organism to##4##3##(1990-8#1)(1997-6#1)(2010-2#2)
the organism with##2##3##(2008-10#2)
the organism##71##2##(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1993-2#1)(1994-5#2)(1995-2#1)(1995-5#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-6#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-5#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#2)(2010-11#4)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#12)(2013-1#1)(2013-8#1)
the organism's ability to##2##4##(2008-9#1)(2011-2#1)
the organism's##5##2##(1994-11#1)(1994-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
the organisms were##2##3##(2008-10#1)(2008-11#1)
the organisms##17##2##(1992-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-1#1)
the organization and##14##3##(1990-2#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-2#1)
the organization as well as##2##5##(1995-2#1)(2009-8#1)
the organization as##3##3##(1995-2#1)(2008-1#1)(2009-8#1)
the organization by##2##3##(1992-2#1)(2008-7#1)
the organization in the##2##4##(1993-12#1)(1994-2#1)
the organization in##3##3##(1993-12#1)(1994-2#1)(2008-10#1)
the organization is##4##3##(1992-2#1)(1992-9#1)(1993-1#1)(2008-7#1)
the organization must##2##3##(1994-2#1)(1995-2#1)
the organization of the central##2##5##(1995-5#1)(2007-12#1)
the organization of the gene##2##5##(1994-11#1)(2010-4#1)
the organization of the##21##4##(1992-3#2)(1993-12#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-5#3)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#1)(2013-8#2)
the organization of these##2##4##(2008-2#1)(2008-7#1)
the organization of this##2##4##(1993-6#1)(2009-8#1)
the organization of##47##3##(1992-3#2)(1993-12#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-5#5)(1996-5#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#3)
the organization through the##3##4##(1993-12#1)(1995-12#2)
the organization was##2##3##(1991-2#1)(2007-9#1)
the organization##130##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-6#2)(1993-9#2)(1994-1#7)(1994-11#2)(1994-12#1)(1994-2#6)(1994-5#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#7)(1995-5#5)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#1)(2006-5#1)(2007-12#2)(2007-4#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#3)
the organization's bottom line##3##4##(2008-9#3)
the organization's image##2##3##(2008-11#1)(2008-12#1)
the organization's##11##2##(1993-1#3)(1996-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)
the organization)##2##2##(2008-11#2)
the organizational and##2##3##(1992-2#1)(2008-11#1)
the organizational context##2##3##(2010-8#1)(2012-3#1)
the organizational level##2##3##(1994-12#1)(1996-3#1)
the organizational##22##2##(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#2)(1996-12#2)(1996-2#2)(1996-3#1)(2008-11#2)(2008-12#2)(2008-2#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)
the organizations##5##2##(1994-12#1)(1996-12#1)(2008-11#1)(2013-1#2)
the organoleptic##2##2##(2008-5#1)(2013-8#1)
the organolithium##2##2##(1996-5#2)
the organophosphate##2##2##(2012-12#1)(2013-8#1)
the organophosphorus##2##2##(1997-4#1)(2008-11#1)
the organs involved##2##3##(2008-10#1)(2010-12#1)
the organs of##2##3##(2007-8#1)(2008-7#1)
the organs##7##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-12#1)(2013-8#1)
the ori beta region##2##4##(1994-12#2)
the ori##3##2##(1994-12#2)(1996-6#1)
the orientation and##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
the orientation of caldesmon##2##4##(1994-5#2)
the orientation of its##2##4##(2008-3#2)
the orientation of partially polarized light##2##6##(2008-3#2)
the orientation of the##23##4##(1992-6#1)(1993-11#1)(1996-4#1)(2006-4#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2010-5#1)(2013-8#1)
the orientation of##44##3##(1991-10#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-5#4)(1994-9#1)(1996-4#1)(2006-4#1)(2007-11#5)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#11)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-5#1)(2013-8#1)
the orientation##57##2##(1990-11#1)(1991-10#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-5#4)(1994-9#1)(1995-3#1)(1996-4#1)(2006-4#1)(2007-11#5)(2007-12#2)(2008-10#3)(2008-11#4)(2008-2#4)(2008-3#13)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#2)(2010-5#1)(2012-2#1)(2013-8#1)
the orientational order##2##3##(1990-2#2)
the orientational##5##2##(1990-2#2)(1995-11#1)(2008-2#1)(2008-3#1)
the orientations of##5##3##(1995-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
the origin and evolution of##4##5##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
the origin and history of##2##5##(2007-8#1)(2008-11#1)
the origin and the##5##4##(1993-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
the origin and##24##3##(1992-12#1)(1993-6#1)(1995-11#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#2)(2012-3#2)
the origin of life##3##4##(1995-11#1)(2008-10#2)
the origin of replication##2##4##(1990-11#1)(1994-12#1)
the origin of the left##2##5##(2007-7#1)(2013-8#1)
the origin of the##38##4##(1990-7#1)(1991-3#1)(1992-9#1)(1993-3#1)(1995-11#1)(1996-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
the origin of these species##2##5##(1996-6#1)(2010-3#1)
the origin of these##3##4##(1996-6#1)(2008-3#1)(2010-3#1)
the origin of this##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
the origin of##100##3##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-3#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-11#3)(1996-12#1)(1996-4#2)(1996-6#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#6)(2009-2#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
the origin##134##2##(1990-11#2)(1990-3#1)(1990-7#1)(1990-8#2)(1991-3#1)(1992-12#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-11#4)(1996-12#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#7)(2008-9#4)(2009-2#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
the original N##2##3##(2008-10#2)
the original activity##2##3##(2008-10#1)(2008-5#1)
the original american##2##3##(2006-10#2)
the original and the##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
the original and##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
the original clone##3##3##(2008-11#3)
the original compound##2##3##(2007-11#1)(2008-9#1)
the original concentration of##2##4##(2008-10#2)
the original concentration##3##3##(2008-10#2)(2010-3#1)
the original concept of##2##4##(2010-12#1)(2012-12#1)
the original data##13##3##(1995-5#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-8#2)
the original description of##2##4##(2008-12#1)(2012-3#1)
the original description##4##3##(2008-12#1)(2008-5#1)(2008-6#1)(2012-3#1)
the original dissolved organic matter (DOM)##2##6##(2008-10#2)
the original family##2##3##(1995-5#2)
the original host##2##3##(2008-10#1)(2008-8#1)
the original hypothesis##2##3##(2008-11#1)(2008-9#1)
the original information##2##3##(2008-3#2)
the original line##2##3##(2008-10#1)(2008-11#1)
the original observations##3##3##(1995-2#1)(2008-11#1)(2012-1#1)
the original population##2##3##(2008-10#2)
the original sample and the sample##2##6##(2008-10#2)
the original sample##7##3##(2008-10#4)(2008-11#2)(2008-12#1)
the original scene##2##3##(2008-3#2)
the original sequence##2##3##(1994-12#1)(2008-3#1)
the original serum-free##2##3##(2008-11#2)
the original signal##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
the original source##2##3##(2007-12#1)(2008-3#1)
the original strain##2##3##(2008-10#2)
the original study##3##3##(1994-2#1)(1996-12#1)(2010-8#1)
the original technique##2##3##(2008-3#1)(2009-5#1)
the original version##5##3##(2007-8#1)(2008-2#1)(2012-12#2)(2013-1#1)
the original##251##2##(1990-11#1)(1990-2#4)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-8#3)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#54)(2008-11#14)(2008-12#3)(2008-2#4)(2008-3#30)(2008-5#7)(2008-6#8)(2008-7#6)(2008-8#8)(2008-9#7)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#11)(2013-8#4)
the originality of the##2##4##(1992-6#1)(1997-2#1)
the originality##3##2##(1992-6#1)(1997-2#1)(2010-7#1)
the originally##4##2##(1992-1#1)(1994-12#1)(2008-3#1)(2009-11#1)
the origins of the##2##4##(2008-11#1)(2009-10#1)
the origins of this##2##4##(1992-8#1)(2013-7#1)
the origins of##20##3##(1990-7#2)(1992-8#1)(1993-2#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the origins##23##2##(1990-7#2)(1992-8#1)(1993-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the ornamental##2##2##(2008-10#1)(2008-8#1)
the ornithine##2##2##(2008-7#1)(2010-9#1)
the oro-hypopharynx##2##2##(2012-2#2)
the oropharynx and##2##3##(2008-8#1)(2011-2#1)
the orphan##2##2##(1996-5#1)(2008-7#1)
the ortho##3##2##(2008-10#1)(2008-11#2)
the orthodontic treatment##2##3##(2012-12#1)(2012-3#1)
the orthodontic##3##2##(2012-12#1)(2012-3#1)(2013-8#1)
the orthogonal polarization##3##3##(2008-2#3)
the orthogonal##9##2##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)
the orthogonality##2##2##(2008-3#2)
the orthographic-visual##2##2##(2012-1#2)
the ortholog##2##2##(2008-11#1)(2009-10#1)
the orthopaedic surgeon##2##3##(2007-11#1)(2008-6#1)
the orthopaedic##6##2##(1990-9#1)(2007-11#1)(2008-6#1)(2010-3#1)(2012-12#1)(2013-8#1)
the orthopedic surgeon##2##3##(2007-11#1)(2008-8#1)
the orthopedic##6##2##(2007-11#3)(2007-8#1)(2008-8#1)(2011-2#1)
the orthophosphate##2##2##(2008-10#2)
the orthorhombic space group##3##4##(1992-8#1)(1996-2#2)
the orthorhombic##7##2##(1992-12#1)(1992-8#1)(1993-8#1)(1996-2#2)(2008-8#1)(2013-8#1)
the oscillating##8##2##(2007-12#1)(2008-10#5)(2008-3#1)(2011-2#1)
the oscillation amplitude##5##3##(2008-10#5)
the oscillation period is##2##4##(2010-10#2)
the oscillation period##5##3##(2007-12#1)(2008-10#1)(2010-10#3)
the oscillation threshold##3##3##(2007-12#2)(2008-3#1)
the oscillation##16##2##(2007-12#3)(2008-10#7)(2008-2#1)(2008-3#2)(2010-10#3)
the oscillations##10##2##(1994-11#1)(2007-11#1)(2008-2#3)(2008-3#4)(2012-2#1)
the oscillator and##3##3##(2008-3#3)
the oscillator to##2##3##(2007-12#2)
the oscillator##9##2##(1990-8#1)(2007-12#4)(2008-3#4)
the oscillatory behavior in continuous fermentation of Zymomonas mobilis##2##9##(2008-7#2)
the oscillatory behavior##3##3##(2008-3#1)(2008-7#2)
the oscillatory##9##2##(1995-11#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
the osmium##3##2##(1996-2#2)(2008-10#1)
the osmolality##2##2##(1992-5#1)(2008-11#1)
the osmolarity of the growth medium##4##6##(1991-11#2)(1994-12#2)
the osmolarity of the##5##4##(1991-11#3)(1994-12#2)
the osmolarity##6##2##(1991-11#4)(1994-12#2)
the osmotic pressure##2##3##(2008-11#1)(2009-12#1)
the osmotic stress##2##3##(2008-11#1)(2013-1#1)
the osmotic##10##2##(1990-2#1)(1994-12#2)(1994-2#1)(2008-11#2)(2008-5#1)(2009-12#2)(2013-1#1)
the ossicles##2##2##(2008-9#2)
the ossified cochlea##4##3##(2008-9#4)
the osteoblasts to##2##3##(1993-6#1)(2008-11#1)
the osteoblasts##3##2##(1993-6#2)(2008-11#1)
the osteocalcin gene##2##3##(1993-3#2)
the osteocalcin##3##2##(1992-12#1)(1993-3#2)
the osteoclast##4##2##(1991-11#1)(1993-11#1)(2008-11#1)(2012-1#1)
the osteometric##2##2##(1995-6#1)(2013-8#1)
the osteonecrosis##2##2##(1994-7#1)(2012-12#1)
the osteopathic##2##2##(1991-12#2)
the osteophyte##2##2##(2011-2#2)
the osteophytic##2##2##(2011-2#2)
the osteoporotic##2##2##(2008-12#1)(2008-8#1)
the osteotomy##4##2##(2007-12#1)(2009-10#1)(2011-2#2)
the other 10##3##3##(1990-2#1)(1992-2#1)(2008-12#1)
the other 12##2##3##(2008-7#1)(2008-9#1)
the other 15##2##3##(1991-5#1)(2008-5#1)
the other 2##5##3##(1992-8#1)(1994-7#1)(1995-12#1)(2007-8#1)(2013-1#1)
the other 25##2##3##(1990-5#1)(1991-6#1)
the other 3##4##3##(1990-7#1)(1995-12#1)(1996-5#1)(2013-1#1)
the other 4##4##3##(1994-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
the other 5##2##3##(1993-12#1)(2008-5#1)
the other 9##2##3##(1992-12#1)(2008-12#1)
the other X##2##3##(2008-10#2)
the other a##9##3##(1991-9#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
the other analytes##2##3##(2008-10#2)
the other and##2##3##(1997-3#1)(2008-8#1)
the other at##3##3##(1995-12#1)(2008-2#1)(2013-1#1)
the other by##2##3##(1994-11#1)(1997-7#1)
the other cations##3##3##(2008-10#3)
the other cell lines##2##4##(1990-12#1)(2008-11#1)
the other components of the##2##5##(1991-3#1)(2012-3#1)
the other components of##4##4##(1991-3#1)(2007-6#1)(2010-7#1)(2012-3#1)
the other components##6##3##(1991-3#1)(2007-6#1)(2008-10#2)(2010-7#1)(2012-3#1)
the other conditions##2##3##(1992-9#1)(2013-1#1)
the other contains##2##3##(1993-11#1)(2008-11#1)
the other drugs##4##3##(1990-12#1)(2008-10#2)(2008-8#1)
the other end##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
the other five species##3##4##(2008-9#3)
the other five##10##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#3)(2009-4#1)(2012-1#1)(2013-8#1)
the other flow cells##2##4##(2008-10#2)
the other for the##2##4##(2008-11#1)(2011-2#1)
the other for##6##3##(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
the other four##11##3##(1990-8#1)(1994-6#1)(1995-9#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#4)(2012-2#1)
the other from##7##3##(1990-5#1)(1996-8#1)(2008-10#3)(2008-3#1)(2010-8#1)
the other gene##2##3##(1997-2#1)(2008-10#1)
the other genes##2##3##(2009-10#1)(2012-3#1)
the other genotypes##2##3##(2008-10#1)(2008-8#1)
the other group##12##3##(1991-6#1)(1992-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-11#1)(2010-4#1)(2013-8#1)
the other groups of##2##4##(1991-2#1)(2008-8#1)
the other groups##10##3##(1991-2#1)(1993-12#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-5#1)(2013-7#1)
the other half##6##3##(1995-3#1)(1996-1#1)(2007-11#1)(2008-2#2)(2012-1#1)
the other hand a##2##4##(2008-2#1)(2008-5#1)
the other hand##345##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-12#3)(1993-2#2)(1993-6#2)(1993-8#5)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1997-2#4)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#4)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#53)(2008-11#25)(2008-12#9)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#14)(2008-6#11)(2008-7#13)(2008-8#4)(2008-9#9)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-6#4)(2011-1#5)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
the other in a##5##4##(1991-12#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-7#1)
the other in the##4##4##(2007-8#1)(2008-3#2)(2008-8#1)
the other in##15##3##(1991-12#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-7#1)
the other is##12##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2009-3#1)(2010-8#1)
the other laser##2##3##(2008-3#2)
the other markers##2##3##(2008-1#1)(2012-3#1)
the other membranes##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
the other metal##2##3##(2008-10#2)
the other metals##4##3##(2008-10#3)(2010-11#1)
the other method##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the other methods##3##3##(1994-12#1)(1996-12#1)(2008-2#1)
the other mil/raf genes##2##4##(1993-6#2)
the other milk replacers##2##4##(2010-2#2)
the other minor##2##3##(2008-10#1)(2009-12#1)
the other mirror##2##3##(2008-3#2)
the other mutants##2##3##(1993-11#1)(2008-10#1)
the other one##10##3##(1995-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
the other parameters##2##3##(2008-10#1)(2008-3#1)
the other party to##2##4##(1992-2#1)(2008-8#1)
the other patient##2##3##(1991-2#1)(2013-1#1)
the other patients##5##3##(1990-12#1)(1990-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
the other peptides##2##3##(1991-12#1)(1993-5#1)
the other population##2##3##(2008-8#1)(2008-9#1)
the other populations##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
the other procedures##3##3##(1995-1#1)(2008-10#2)
the other products##2##3##(2007-6#1)(2008-10#1)
the other reactions##2##3##(1991-3#1)(2008-7#1)
the other side of the##2##5##(2008-10#1)(2008-4#1)
the other side of##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
the other side##9##3##(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)
the other six##3##3##(2008-10#2)(2008-5#1)
the other species of##2##4##(2008-6#1)(2011-2#1)
the other species##12##3##(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-5#1)
the other students##2##3##(2008-11#2)
the other subjects##2##3##(2008-5#1)(2011-2#1)
the other three groups##2##4##(2008-7#1)(2009-11#1)
the other three methods##2##4##(2008-10#1)(2008-7#1)
the other three##23##3##(1994-8#1)(1994-9#1)(1997-6#1)(2007-8#2)(2008-10#6)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#3)(2010-2#1)(2013-8#1)
the other treatments##5##3##(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#1)
the other two cases##2##4##(2008-7#1)(2013-1#1)
the other two components##2##4##(1995-3#1)(2008-10#1)
the other two groups##9##4##(1991-11#1)(2007-8#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-1#1)
the other two methods##3##4##(1995-2#1)(2008-10#2)
the other two minority populations##3##5##(2011-1#3)
the other two populations##2##4##(2008-10#2)
the other two##59##3##(1990-11#1)(1991-11#1)(1991-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#1)(2006-12#2)(2007-10#1)(2007-8#1)(2008-10#22)(2008-3#2)(2008-7#3)(2010-2#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
the other type##2##3##(1993-9#1)(2007-11#1)
the other types of##2##4##(1991-1#1)(2008-10#1)
the other types##3##3##(1991-1#1)(2008-10#1)(2008-5#1)
the other variables##3##3##(2008-10#2)(2008-12#1)
the other was##8##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#2)
the other which##4##3##(1990-5#1)(1990-8#2)(1995-6#1)
the other with a##2##4##(1997-6#1)(2008-3#1)
the other with##11##3##(1992-2#1)(1993-11#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
the other##1206##2##(1990-11#5)(1990-12#9)(1990-2#4)(1990-5#11)(1990-6#2)(1990-7#5)(1990-8#9)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#10)(1991-2#6)(1991-3#5)(1991-4#2)(1991-5#4)(1991-6#6)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#7)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#6)(1992-8#9)(1992-9#5)(1993-1#1)(1993-11#8)(1993-12#9)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#5)(1993-8#6)(1993-9#2)(1994-1#4)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#6)(1994-3#6)(1994-5#5)(1994-6#5)(1994-7#3)(1994-8#7)(1994-9#6)(1995-1#3)(1995-11#4)(1995-12#8)(1995-2#11)(1995-3#11)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#8)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#11)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#7)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#4)(2006-12#3)(2006-6#1)(2007-10#1)(2007-11#16)(2007-12#13)(2007-2#1)(2007-6#2)(2007-7#5)(2007-8#11)(2007-9#1)(2008-1#13)(2008-10#262)(2008-11#42)(2008-12#26)(2008-2#24)(2008-3#48)(2008-4#12)(2008-5#48)(2008-6#21)(2008-7#39)(2008-8#34)(2008-9#27)(2009-10#9)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#5)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#7)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#8)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#14)(2011-2#25)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#9)(2012-2#8)(2012-3#10)(2012-5#2)(2013-1#27)(2013-7#5)(2013-8#12)
the other's##2##2##(2008-11#1)(2008-8#1)
the others for##2##3##(2008-10#1)(2008-5#1)
the others in##2##3##(2008-10#2)
the others were##6##3##(1990-11#1)(1990-5#1)(1994-7#1)(1995-2#1)(2007-10#1)(2007-7#1)
the others##44##2##(1990-11#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-7#2)(1994-8#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#13)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-11#1)(2010-4#1)(2013-1#2)
the otherwise##8##2##(1990-7#1)(1990-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2010-8#1)(2012-2#1)
the otolith##5##2##(2008-7#3)(2010-8#2)
the out-of-focus##2##2##(2008-3#2)
the out-of-plane component##2##3##(2008-2#1)(2008-3#1)
the out-of-plane##4##2##(1997-7#1)(2008-2#1)(2008-3#1)(2009-7#1)
the outbreak in##2##3##(2008-12#2)
the outbreak of##4##3##(1997-5#1)(2008-12#1)(2012-12#1)(2013-8#1)
the outbreak strain##2##3##(2008-7#1)(2012-3#1)
the outbreak##20##2##(1996-1#1)(1997-5#1)(2008-12#5)(2008-7#1)(2008-8#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
the outbreaks##3##2##(1992-6#1)(2008-12#1)(2009-2#1)
the outcome and##3##3##(1995-2#1)(2008-7#1)(2012-2#1)
the outcome for patients with##2##5##(2008-9#1)(2010-3#1)
the outcome for##3##3##(1994-6#1)(2008-9#1)(2010-3#1)
the outcome in##2##3##(1994-11#1)(2008-8#1)
the outcome is##4##3##(1990-12#1)(2008-11#1)(2008-9#1)(2011-2#1)
the outcome of competition##2##4##(2008-8#1)(2008-9#1)
the outcome of infections##2##4##(2009-2#2)
the outcome of interest##3##4##(1994-2#1)(2008-7#1)(2012-3#1)
the outcome of patients with##3##5##(2007-5#1)(2008-6#1)(2010-3#1)
the outcome of such##2##4##(2008-12#1)(2009-2#1)
the outcome of the procedure##2##5##(2008-2#1)(2008-7#1)
the outcome of the##16##4##(1992-3#1)(1993-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
the outcome of these##2##4##(2007-8#1)(2008-7#1)
the outcome of this##2##4##(1990-9#1)(2008-6#1)
the outcome of treatment##2##4##(2008-11#1)(2011-1#1)
the outcome of which is##2##5##(2008-9#2)
the outcome of##93##3##(1990-8#1)(1990-9#2)(1991-11#1)(1992-3#1)(1993-1#1)(1993-11#2)(1994-1#3)(1994-12#1)(1994-2#1)(1995-1#1)(1995-9#1)(1997-4#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
the outcome was##3##3##(1997-3#1)(2007-10#1)(2007-11#1)
the outcome##141##2##(1990-12#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-1#2)(1993-11#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#7)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
the outcomes and##2##3##(2008-5#1)(2013-1#1)
the outcomes model##4##3##(2008-4#4)
the outcomes movement##4##3##(1991-12#1)(1994-11#1)(1996-1#1)(1997-1#1)
the outcomes of a##2##4##(2007-10#1)(2008-5#1)
the outcomes of the##2##4##(2007-12#1)(2011-2#1)
the outcomes of these##3##4##(1996-3#1)(2008-9#1)(2010-5#1)
the outcomes of##26##3##(1990-3#1)(1995-3#1)(1996-2#1)(1996-3#3)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the outcomes that##2##3##(1992-12#1)(2008-8#1)
the outcomes##52##2##(1990-3#1)(1991-12#1)(1992-12#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#3)(1997-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
the outdoor air##2##3##(2010-5#2)
the outdoor##4##2##(2008-3#1)(2010-5#2)(2013-8#1)
the outer and inner##2##4##(1990-11#1)(1995-12#1)
the outer cortex##2##3##(2008-10#1)(2008-7#1)
the outer cortical bone##2##4##(1995-6#2)
the outer cortical##3##3##(1995-6#2)(2008-3#1)
the outer covering##2##3##(2008-5#1)(2008-7#1)
the outer dendritic segments##2##4##(2008-7#2)
the outer hair cells (OHCs)##2##5##(1993-9#1)(2008-4#1)
the outer layer of the##3##5##(1992-6#1)(2008-11#1)(2008-7#1)
the outer layer of##4##4##(1992-6#1)(2008-11#1)(2008-12#1)(2008-7#1)
the outer layer##9##3##(1992-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)
the outer layers of the##2##5##(2008-11#1)(2009-8#1)
the outer layers##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
the outer leaflet of the##3##5##(1992-3#1)(1995-2#1)(2009-2#1)
the outer lipid##2##3##(1991-5#1)(1994-11#1)
the outer membrane##15##3##(1990-11#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-8#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#2)
the outer mitochondrial##3##3##(1994-8#1)(2012-2#2)
the outer monolayer of##2##4##(1992-6#1)(2008-11#1)
the outer monolayer##3##3##(1990-11#1)(1992-6#1)(2008-11#1)
the outer nuclear layer##2##4##(1991-10#1)(2010-1#1)
the outer nuclear##5##3##(1991-10#1)(2008-9#2)(2010-1#1)(2011-2#1)
the outer ring##2##3##(2012-2#2)
the outer scale##2##3##(2008-3#2)
the outer surface of a##2##5##(2008-2#1)(2010-10#1)
the outer surface of the##3##5##(1990-2#1)(1997-7#1)(2008-7#1)
the outer surface of##5##4##(1990-2#1)(1997-7#1)(2008-2#1)(2008-7#1)(2010-10#1)
the outer surface##7##3##(1990-2#1)(1994-5#1)(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
the outer surfaces of the##2##5##(2007-12#1)(2008-5#1)
the outer##112##2##(1990-11#5)(1990-2#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-3#3)(1992-6#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-4#1)(1996-5#2)(1997-7#1)(1997-8#5)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#11)(2008-8#1)(2008-9#3)(2009-2#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#6)(2013-8#2)
the outermost SC layer##3##4##(2008-5#3)
the outermost layer of##2##4##(2008-5#2)
the outermost##11##2##(2008-10#4)(2008-5#7)
the outflow of the##2##4##(2007-8#1)(2008-10#1)
the outflow tract##2##3##(1992-9#1)(2013-1#1)
the outflow##4##2##(1992-9#1)(2007-8#1)(2008-10#1)(2013-1#1)
the outgoing##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
the outgroup A##2##3##(2008-10#2)
the outgroup##4##2##(2007-12#2)(2008-10#2)
the outgrowing##2##2##(2007-12#1)(2011-1#1)
the outgrowth of##3##3##(2008-11#2)(2013-1#1)
the outgrowth##5##2##(2008-11#4)(2013-1#1)
the outlet of the##3##4##(2008-10#3)
the outlet of##5##3##(2008-10#5)
the outlet septum##2##3##(2007-8#2)
the outlet##9##2##(2007-8#2)(2008-10#6)(2008-7#1)
the outline##3##2##(1995-6#3)
the outlook for##2##3##(1993-12#1)(1995-1#1)
the outlook##4##2##(1993-12#1)(1993-3#1)(1995-1#1)(1996-5#1)
the outpatient clinic##4##3##(1995-11#1)(1996-3#1)(2008-11#1)(2011-2#1)
the outpatient department of the Mangochi##2##6##(1996-12#2)
the outpatient department of##3##4##(1996-12#2)(1997-3#1)
the outpatient department##6##3##(1991-9#1)(1996-12#2)(1997-3#1)(2008-1#2)
the outpatient setting##5##3##(1993-12#2)(1995-2#1)(2006-10#1)(2008-3#1)
the outpatient##27##2##(1991-9#1)(1992-12#1)(1993-12#3)(1993-2#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#1)(2006-10#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2011-2#2)(2012-3#1)
the output PISHG signal##2##4##(2008-3#2)
the output beam was##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
the output beam##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
the output characteristics of##2##4##(2008-2#1)(2008-3#1)
the output constraints hypothesis##2##4##(2013-8#2)
the output correlation##2##3##(2008-2#1)(2008-3#1)
the output coupler##2##3##(2008-3#2)
the output coupling rate##2##4##(2008-2#2)
the output coupling##3##3##(2008-2#3)
the output energy##2##3##(2007-12#1)(2008-3#1)
the output frequency##2##3##(2007-11#1)(2007-12#1)
the output from the##2##4##(2007-12#1)(2008-3#1)
the output from##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the output layer##7##3##(2008-10#2)(2010-8#5)
the output of a##18##4##(1993-9#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
the output of an##2##4##(2007-12#1)(2008-3#1)
the output of the laser##2##5##(2007-12#1)(2008-2#1)
the output of the##21##4##(1996-2#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#7)(2008-3#5)(2008-9#1)(2009-12#1)
the output of##47##3##(1993-9#1)(1996-2#1)(1997-7#1)(2007-11#6)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#12)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)
the output optical spectrum##2##4##(2013-8#2)
the output optical##3##3##(2007-11#1)(2013-8#2)
the output plane is##2##4##(2008-2#1)(2008-3#1)
the output plane of##2##4##(2008-2#1)(2008-3#1)
the output plane##7##3##(2008-2#2)(2008-3#5)
the output power at##2##4##(2007-12#1)(2008-2#1)
the output power of##2##4##(2007-12#1)(2008-3#1)
the output power##15##3##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#7)
the output pulse##3##3##(2008-2#1)(2008-3#2)
the output pulses##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the output response##2##3##(2007-12#1)(2008-11#1)
the output signal##9##3##(2007-11#3)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)
the output signals##3##3##(2008-2#2)(2008-3#1)
the output spatial beam profile##2##5##(2007-12#1)(2008-3#1)
the output surface##3##3##(2008-2#1)(2008-3#2)
the output wavelength##2##3##(2007-11#1)(2008-3#1)
the output##186##2##(1991-12#1)(1991-6#1)(1993-6#1)(1993-9#1)(1996-2#2)(1997-7#1)(2007-11#20)(2007-12#27)(2008-10#11)(2008-11#3)(2008-2#36)(2008-3#62)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-8#7)(2011-1#1)(2013-1#1)(2013-8#4)
the output-stagnation objects##2##3##(2008-3#2)
the outputs of the##2##4##(2008-10#1)(2012-1#1)
the outputs of##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
the outputs##4##2##(1992-2#1)(2008-10#1)(2008-2#1)(2012-1#1)
the outreach##2##2##(1995-1#1)(2011-1#1)
the outset of##3##3##(1995-1#1)(1995-12#1)(1997-4#1)
the outset##9##2##(1993-1#1)(1995-1#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
the outside of the##6##4##(2007-12#1)(2008-10#2)(2008-8#1)(2012-2#2)
the outside of##7##3##(2007-12#1)(2008-10#3)(2008-8#1)(2012-2#2)
the outside##17##2##(1990-2#1)(1996-12#1)(2007-12#3)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)
the outskirts##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
the outstanding##7##2##(1994-5#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
the outward##3##2##(1995-2#1)(1997-2#1)(2008-3#1)
the oval##2##2##(1997-8#1)(2008-9#1)
the ovarian cyst cavity##2##4##(1992-3#2)
the ovarian follicle##2##3##(1991-9#1)(2008-9#1)
the ovarian follicles##3##3##(2008-12#3)
the ovarian stroma##3##3##(2008-12#3)
the ovarian surface epithelium##2##4##(1995-12#1)(2011-2#1)
the ovarian surface##3##3##(1995-12#1)(2011-2#2)
the ovarian##33##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-3#5)(1993-9#1)(1995-12#1)(1995-8#2)(1996-1#2)(1996-2#1)(2007-12#1)(2008-12#7)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#2)
the ovaries of##2##3##(2008-5#2)
the ovaries##11##2##(1992-3#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
the ovary and hepatopancreas##2##4##(2008-6#2)
the ovary and oviduct##2##4##(2008-12#2)
the ovary and the##2##4##(2008-10#1)(2008-6#1)
the ovary and##10##3##(1993-2#1)(1993-3#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-6#3)(2012-1#1)
the ovary##58##2##(1990-2#1)(1990-7#1)(1991-5#3)(1992-3#1)(1993-2#1)(1993-3#1)(1993-9#4)(1995-12#2)(1996-2#5)(1997-3#1)(1997-8#1)(2007-12#1)(2007-4#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#4)(2008-6#4)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#4)
the over##2##2##(1994-5#1)(2010-8#1)
the over-expression of##2##3##(2007-12#1)(2008-11#1)
the over-expression##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
the overall QOL##3##3##(1994-12#1)(1995-4#2)
the overall Strehl ratio##2##4##(2008-3#2)
the overall agreement##2##3##(2009-8#2)
the overall aim of##2##4##(2008-11#1)(2012-2#1)
the overall average##2##3##(2008-10#1)(2011-2#1)
the overall body##2##3##(2008-5#1)(2012-12#1)
the overall cellular##2##3##(1992-12#1)(2011-2#1)
the overall charge of##2##4##(1991-2#1)(2011-1#1)
the overall degree of##3##4##(1990-8#1)(2009-2#1)(2011-10#1)
the overall density of prey##2##5##(2008-8#2)
the overall economy##5##3##(1992-12#1)(1992-2#1)(1995-3#1)(1997-1#1)(2008-11#1)
the overall effectiveness of##2##4##(2008-10#1)(2012-1#1)
the overall efficiency##2##3##(1995-2#1)(2008-6#1)
the overall enzyme##3##3##(2008-6#2)(2009-5#1)
the overall extent of##2##4##(1991-3#1)(2008-10#1)
the overall extent##3##3##(1991-3#1)(2008-10#1)(2009-2#1)
the overall extraction##3##3##(2008-10#3)
the overall frequency##2##3##(2007-11#1)(2012-2#1)
the overall group##2##3##(2008-10#1)(2010-6#1)
the overall hospital##2##3##(1994-1#1)(2008-4#1)
the overall image##2##3##(2007-11#1)(2008-2#1)
the overall impact of this##2##5##(2008-12#1)(2011-2#1)
the overall improvement##2##3##(1992-6#1)(2011-2#1)
the overall magnitude##2##3##(2008-10#1)(2008-8#1)
the overall management##3##3##(2007-6#1)(2008-7#1)(2008-9#1)
the overall mean##6##3##(2008-10#3)(2008-7#1)(2008-9#2)
the overall optical##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
the overall outcome of the##2##5##(2007-5#1)(2013-1#1)
the overall outcome of##4##4##(2007-10#1)(2007-5#1)(2010-3#1)(2013-1#1)
the overall patient##2##3##(2010-8#1)(2011-2#1)
the overall pattern##2##3##(1994-12#1)(1996-5#1)
the overall performance of##3##4##(2008-5#1)(2008-7#1)(2009-11#1)
the overall performance##4##3##(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)
the overall population##4##3##(1993-5#1)(1995-9#1)(2008-10#1)(2008-7#1)
the overall prevalence of##5##4##(2007-12#3)(2011-2#1)(2012-12#1)
the overall process##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
the overall prognosis##2##3##(2008-12#1)(2008-4#1)
the overall quality of the##4##5##(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)
the overall quality of##6##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)(2013-1#1)
the overall rate of##3##4##(1991-11#1)(1993-11#1)(2008-7#1)
the overall rate##4##3##(1991-11#1)(1993-11#2)(2008-7#1)
the overall reaction##3##3##(1990-7#1)(2008-10#2)
the overall response rate (ORR)##2##5##(2008-10#2)
the overall response##3##3##(1997-1#1)(2008-10#2)
the overall responsibility##2##3##(1993-3#1)(2008-12#1)
the overall results in##2##4##(2007-12#1)(2008-1#1)
the overall risk##3##3##(1994-2#1)(2008-5#1)(2008-7#1)
the overall shape of the##2##5##(2008-3#1)(2012-2#1)
the overall shape of##3##4##(2008-3#1)(2009-11#1)(2012-2#1)
the overall stability of the##2##5##(1992-6#1)(2008-8#1)
the overall stability of##3##4##(1992-6#1)(2008-8#1)(2013-1#1)
the overall stability##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
the overall success of##2##4##(2013-1#2)
the overall survival of##2##4##(2008-6#1)(2013-8#1)
the overall survival##8##3##(1991-4#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
the overall system##4##3##(1994-12#1)(2008-2#2)(2008-3#1)
the overall treatment##3##3##(1991-12#1)(1996-3#1)(2007-12#1)
the overall uncertainty##3##3##(2008-3#2)(2011-2#1)
the overall utilization##2##3##(1993-12#1)(2008-3#1)
the overall yield##2##3##(1996-5#1)(2011-2#1)
the overall##321##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-8#1)(1992-12#3)(1992-2#2)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#51)(2008-11#13)(2008-12#7)(2008-2#8)(2008-3#17)(2008-4#6)(2008-5#11)(2008-6#7)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#4)(2011-10#1)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
the overarching##3##2##(1996-2#1)(1996-3#1)(2011-2#1)
the overcoming of##2##3##(1991-9#1)(1996-9#1)
the overexpressed##5##2##(1994-12#2)(1994-5#2)(2009-8#1)
the overexpression and##2##3##(1995-6#1)(2011-2#1)
the overexpression of p53##2##4##(2008-10#1)(2010-10#1)
the overexpression of the##2##4##(1991-2#1)(1992-12#1)
the overexpression of##10##3##(1991-2#1)(1992-12#1)(1995-6#2)(2008-10#2)(2008-11#2)(2010-10#1)(2011-2#1)
the overexpression##12##2##(1991-2#1)(1992-12#1)(1995-6#3)(2008-10#2)(2008-11#2)(2010-10#1)(2011-2#2)
the overlap between##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-3#1)
the overlap of the##3##4##(2008-10#2)(2008-2#1)
the overlap of two##2##4##(2008-10#2)
the overlap of##7##3##(2008-10#4)(2008-2#1)(2008-3#2)
the overlap##17##2##(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-8#2)(2010-3#1)
the overlapped##3##2##(2008-10#2)(2008-2#1)
the overlapping##18##2##(1996-12#1)(1996-8#1)(2008-10#12)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
the overlay##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
the overload phenomenon##3##3##(2008-7#3)
the overload##5##2##(2008-7#5)
the overlying##5##2##(1990-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-1#1)
the overnight##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
the overpotential##2##2##(2008-10#2)
the overt##2##2##(2010-11#1)(2012-1#1)
the overtone##2##2##(2008-10#1)(2008-3#1)
the overview##2##2##(2009-9#1)(2012-12#1)
the overweight patients##2##3##(2008-10#2)
the overweight##5##2##(1991-12#1)(2008-10#4)
the overwhelming majority of##2##4##(2008-10#1)(2011-2#1)
the overwhelming##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
the oviduct and##2##3##(2008-11#1)(2008-5#1)
the oviduct##8##2##(1990-8#1)(1992-9#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)
the oviductal##3##2##(1997-6#1)(2008-12#2)
the ovine and human PACAP##2##5##(1990-12#2)
the ovine##4##2##(1990-12#2)(1996-12#1)(1997-3#1)
the ovipositor##4##2##(2007-12#4)
the ovoid cells##2##3##(2008-7#2)
the ovum##2##2##(1994-7#1)(1994-8#1)
the own##4##2##(2007-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
the owner of##2##3##(1996-5#1)(2011-4#1)
the owner##4##2##(1994-1#1)(1996-5#1)(2011-4#1)(2013-8#1)
the owners##3##2##(1991-11#1)(2008-5#1)(2013-8#1)
the oxalacetate pool##2##3##(1991-3#2)
the oxalacetate##3##2##(1991-3#2)(1993-11#1)
the oxalate##2##2##(2008-10#2)
the oxidant of choice##2##4##(2007-11#1)(2008-10#1)
the oxidant##18##2##(1995-8#2)(2007-11#3)(2008-10#9)(2008-12#2)(2008-5#1)(2009-9#1)
the oxidants##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
the oxidase##8##2##(1991-2#1)(1993-8#3)(1994-8#1)(1995-2#2)(2008-10#1)
the oxidation and reduction##2##4##(2008-10#2)
the oxidation and##3##3##(1993-9#1)(2008-10#2)
the oxidation current##2##3##(2008-10#2)
the oxidation of HSO(3)(-)##2##4##(2008-10#2)
the oxidation of NO##3##4##(2008-10#3)
the oxidation of a##2##4##(2008-10#2)
the oxidation of ammonia##2##4##(2008-10#2)
the oxidation of ascorbic acid##2##5##(2008-10#2)
the oxidation of glucose and##2##5##(1990-7#1)(2008-10#1)
the oxidation of glucose##3##4##(1990-7#1)(2008-10#2)
the oxidation of iodide##2##4##(2008-10#2)
the oxidation of luminol by##2##5##(2008-10#2)
the oxidation of luminol with hydrogen peroxide##3##7##(2008-10#3)
the oxidation of luminol##6##4##(2008-10#6)
the oxidation of the##7##4##(1993-6#1)(1994-8#1)(2008-10#5)
the oxidation of these##2##4##(2008-10#2)
the oxidation of urea with##2##5##(2008-10#2)
the oxidation of urea##3##4##(2008-10#3)
the oxidation of##119##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(2007-11#2)(2008-10#100)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)
the oxidation peak potential shifts##2##5##(2008-10#2)
the oxidation peak potential##4##4##(2008-10#4)
the oxidation peak##6##3##(2008-10#6)
the oxidation peaks##2##3##(2008-10#2)
the oxidation potential##2##3##(2008-10#2)
the oxidation process##4##3##(2008-10#3)(2008-5#1)
the oxidation reaction of##10##4##(2008-10#10)
the oxidation reaction##13##3##(2008-10#13)
the oxidation state of the##4##5##(1997-7#1)(2008-10#3)
the oxidation state of##7##4##(1992-8#1)(1997-7#1)(2008-10#5)
the oxidation state##11##3##(1992-8#1)(1997-7#1)(2007-11#1)(2008-10#7)(2009-6#1)
the oxidation step##3##3##(2008-10#2)(2012-3#1)
the oxidation##176##2##(1990-12#1)(1990-5#1)(1990-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-7#2)(2007-11#3)(2008-10#148)(2008-11#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-3#1)
the oxidation-reduction##2##2##(1991-8#1)(1995-8#1)
the oxidative burst in neutrophils##2##5##(2008-10#2)
the oxidative burst in##3##4##(1995-6#1)(2008-10#2)
the oxidative burst##12##3##(1995-6#6)(2008-10#6)
the oxidative cleavage of##2##4##(1990-5#2)
the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone with N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3##2##8##(2008-10#2)
the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone##3##6##(2008-10#3)
the oxidative coupling of##6##4##(2008-10#6)
the oxidative coupling reaction of##2##5##(2008-10#2)
the oxidative coupling##8##3##(2008-10#8)
the oxidative damage##3##3##(1997-8#1)(2011-1#1)(2013-1#1)
the oxidative degradation of##2##4##(2008-10#2)
the oxidative iodination of##2##4##(2007-11#2)
the oxidative modification of##2##4##(1990-5#1)(2008-10#1)
the oxidative phosphorylation##3##3##(1990-2#2)(1991-5#1)
the oxidative reaction of##2##4##(2008-10#2)
the oxidative reaction##3##3##(2008-10#3)
the oxidative reactions##2##3##(2008-10#1)(2008-5#1)
the oxidative stress and##2##4##(2011-2#2)
the oxidative stress##7##3##(1993-2#1)(1993-6#1)(2008-5#2)(2009-11#1)(2011-2#2)
the oxidative system##2##3##(2009-12#1)(2011-1#1)
the oxidative##63##2##(1990-11#1)(1990-2#2)(1990-5#3)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-6#6)(1995-8#1)(1997-8#1)(2007-11#2)(2008-10#26)(2008-5#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#2)(2011-2#4)(2013-1#1)
the oxide##8##2##(2007-11#1)(2008-10#3)(2008-3#1)(2009-11#3)
the oxides##2##2##(2008-10#1)(2012-2#1)
the oxidisable fraction##2##3##(2008-10#2)
the oxidized form of##2##4##(2008-10#2)
the oxidized form##3##3##(2008-10#2)(2008-11#1)
the oxidized methionine##2##3##(1995-5#2)
the oxidized##22##2##(1990-5#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-5#2)(1996-2#1)(2007-12#1)(2008-10#8)(2008-11#3)(2009-7#2)
the oxidizing agent##4##3##(2008-10#3)(2012-3#1)
the oxidizing##6##2##(2008-10#4)(2011-2#1)(2012-3#1)
the oxygen A band##2##4##(2008-3#2)
the oxygen affinity##3##3##(1990-8#2)(2013-8#1)
the oxygen atoms from##2##4##(2008-7#1)(2011-2#1)
the oxygen atoms of the##2##5##(1995-5#1)(2007-11#1)
the oxygen atoms##6##3##(1995-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
the oxygen equilibrium properties of##2##5##(1993-8#2)
the oxygen equilibrium##3##3##(1993-8#3)
the oxygen level##2##3##(2008-10#2)
the oxygen tension##2##3##(2008-11#1)(2008-9#1)
the oxygen uptake##2##3##(2013-8#2)
the oxygen##50##2##(1990-5#1)(1990-8#2)(1992-11#1)(1993-11#1)(1993-8#3)(1994-11#1)(1995-5#2)(1997-7#2)(2006-10#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#7)
the oxygen-binding data##3##3##(1990-8#3)
the oxygen-binding##5##2##(1990-8#5)
the oxygen-rich##2##2##(2008-10#1)(2008-11#1)
the oxygenation of##2##3##(1995-6#1)(2008-8#1)
the oxygenation##3##2##(1990-8#1)(1995-6#1)(2008-8#1)
the oyster Crassostrea gigas##2##4##(2008-11#2)
the ozonation##2##2##(1992-5#1)(2008-9#1)
the ozone layer##4##3##(1991-6#2)(1996-1#2)
the ozone profile##2##3##(2008-3#2)
the ozone##18##2##(1991-12#1)(1991-6#2)(1996-1#3)(2008-11#1)(2008-2#2)(2008-3#8)(2010-5#1)
the p and##2##3##(2007-12#1)(2010-3#1)
the p instruments##2##3##(1997-8#2)
the p##10##2##(1994-9#1)(1997-8#2)(2007-11#1)(2007-12#2)(2008-3#1)(2008-6#1)(2010-3#1)(2013-1#1)
the p-polarized##3##2##(2008-3#3)
the p16INK4a and p16beta transcripts##2##5##(1997-7#2)
the p16INK4a##3##2##(1997-7#3)
the p34 subunit of##2##4##(1994-8#2)
the p53 gene in##2##4##(1993-11#2)
the p53 gene##6##3##(1991-11#2)(1993-11#2)(2008-10#2)
the p53 haploinsufficient##3##3##(2008-8#1)(2008-9#2)
the p53 pathway##2##3##(2008-9#1)(2012-12#1)
the p53 tumor suppressor gene##2##5##(1994-8#1)(1996-6#1)
the p53 tumor suppressor##3##4##(1994-5#1)(1994-8#1)(1996-6#1)
the p53##29##2##(1991-11#2)(1992-3#2)(1993-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-9#1)(1996-6#1)(1997-7#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#3)(2011-2#1)(2012-12#1)(2013-7#1)
the pH and ionic strength of the##2##7##(2008-10#2)
the pH and ionic strength##3##5##(1990-12#1)(2008-10#2)
the pH and##9##3##(1990-12#1)(2008-10#7)(2008-3#1)
the pH at##2##3##(2008-10#1)(2008-11#1)
the pH change##2##3##(2008-10#2)
the pH dependence of the##4##5##(1990-5#1)(1992-3#1)(2008-10#2)
the pH dependence of##6##4##(1990-5#1)(1992-3#1)(1993-8#1)(1995-5#1)(2008-10#2)
the pH effect##3##3##(2008-10#3)
the pH in##3##3##(2008-10#3)
the pH of the analyte solution##2##6##(2008-10#2)
the pH of the aqueous##2##5##(2008-10#2)
the pH of the bulk##2##5##(2008-10#1)(2008-6#1)
the pH of the culture medium##2##6##(1994-12#1)(1995-6#1)
the pH of the medium##2##5##(1994-6#1)(2008-10#1)
the pH of the mixed##2##5##(2008-10#1)(2008-6#1)
the pH of the solution##3##5##(1990-5#1)(1990-8#1)(2008-10#1)
the pH of the test solution##2##6##(2008-10#2)
the pH of the##25##4##(1990-5#1)(1990-8#1)(1991-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#2)(2008-10#13)(2008-5#2)(2008-6#2)
the pH of##32##3##(1990-5#1)(1990-8#1)(1991-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#2)(2008-10#16)(2008-11#1)(2008-5#4)(2008-6#2)(2011-1#1)
the pH or##2##3##(1990-5#1)(2013-1#1)
the pH range 1##2##4##(2008-10#2)
the pH range 2##4##4##(2008-10#4)
the pH range 4##5##4##(2008-10#5)
the pH range 5##3##4##(1992-6#1)(2008-10#2)
the pH range 6##3##4##(2008-10#3)
the pH range 7##2##4##(1995-5#1)(2008-10#1)
the pH range from 1 to##2##6##(2008-10#2)
the pH range from 1##3##5##(2008-10#3)
the pH range from##7##4##(2008-10#7)
the pH range of 1##3##5##(2008-10#3)
the pH range of 2##5##5##(2008-10#5)
the pH range of 5##2##5##(2008-10#1)(2013-8#1)
the pH range of##22##4##(2008-10#20)(2008-4#1)(2013-8#1)
the pH range##71##3##(1992-6#1)(1995-5#2)(2008-10#65)(2008-4#1)(2010-8#1)(2013-8#1)
the pH response of##2##4##(2008-10#2)
the pH response##3##3##(2008-10#3)
the pH to##4##3##(1991-8#2)(2008-10#2)
the pH value was##3##4##(2008-10#3)
the pH value##10##3##(1991-8#1)(2008-10#7)(2009-11#1)(2012-2#1)
the pH values##3##3##(2008-10#3)
the pH was##7##3##(1995-5#1)(2008-10#4)(2008-6#1)(2013-8#1)
the pH##214##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#1)(1991-5#1)(1991-8#4)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#4)(1995-6#3)(2008-10#152)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#5)(2009-11#2)(2009-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#4)
the pH-dependent##3##2##(1995-2#1)(2008-6#1)(2008-9#1)
the pH-value##2##2##(2013-1#2)
the pHg/pSILBAγ##2##2##(2011-1#2)
the pK values for##2##4##(1990-8#1)(1991-9#1)
the pK##4##2##(1990-8#1)(1991-9#1)(1994-5#1)(1995-2#1)
the pK(a) of the##2##4##(2008-10#2)
the pK(a) value##2##3##(2007-12#1)(2008-10#1)
the pK(a) values##4##3##(2008-10#4)
the pK(a)##10##2##(2007-12#1)(2008-10#9)
the pKa of the##3##4##(1993-8#2)(1995-5#1)
the pKa##6##2##(1993-8#2)(1994-11#1)(1995-5#1)(1997-2#1)(2008-10#1)
the pKa1##2##2##(1990-5#1)(2008-10#1)
the pMLZ-4 mRNA##2##3##(1993-2#2)
the pO(2)##2##2##(2008-11#2)
the pOSEX##2##2##(1994-12#2)
the pTC##3##2##(2012-2#3)
the pUC19##2##2##(1990-5#1)(1991-9#1)
the pace of##4##3##(1995-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
the pace##7##2##(1992-3#1)(1993-2#1)(1995-2#1)(2009-6#1)(2010-4#1)(2012-2#1)(2012-3#1)
the pacemaker##3##2##(1994-11#1)(1994-2#1)(2008-3#1)
the pacific##4##2##(1994-11#1)(2008-10#2)(2013-1#1)
the package##8##2##(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)
the packaged##2##2##(1991-5#1)(1992-8#1)
the packaging of##2##3##(2008-4#1)(2009-8#1)
the packaging##3##2##(2007-12#1)(2008-4#1)(2009-8#1)
the packed##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
the packed-bedreactor##2##2##(2008-11#2)
the packet loss rate##5##4##(2008-3#5)
the packet##8##2##(2007-12#1)(2008-3#7)
the packing density of##3##4##(2008-3#1)(2008-9#1)(2013-1#1)
the packing##6##2##(2008-10#2)(2008-3#2)(2008-9#1)(2013-1#1)
the paediatric age group##3##4##(2008-11#1)(2013-8#2)
the paediatric age##5##3##(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#2)
the paediatric and##2##3##(2008-9#2)
the paediatric health care##2##4##(2008-11#2)
the paediatric intensive care##2##4##(2010-7#1)(2013-1#1)
the paediatric##31##2##(1996-6#1)(1996-9#1)(2008-10#3)(2008-11#10)(2008-7#1)(2008-9#5)(2009-5#1)(2010-7#2)(2012-2#1)(2013-1#4)(2013-8#2)
the pages of##3##3##(2008-4#1)(2009-10#1)(2011-2#1)
the pain and##3##3##(2008-12#1)(2009-1#1)(2013-1#1)
the pain by##2##3##(1990-3#1)(2007-7#1)
the pain is##4##3##(1990-6#1)(2007-7#1)(2008-7#1)(2008-9#1)
the pain##39##2##(1990-3#1)(1990-6#1)(1991-11#1)(1992-2#2)(1993-1#2)(1996-2#1)(1996-3#1)(2007-11#5)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-4#2)(2012-2#2)(2012-3#1)(2013-1#3)
the painful area##2##3##(2010-7#2)
the painful##4##2##(2007-11#1)(2008-8#1)(2010-7#2)
the paint##4##2##(2007-12#3)(2008-10#1)
the painted surface##4##3##(2008-10#4)
the pair of##2##3##(1995-2#1)(2008-2#1)
the pair##5##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)
the paired t test##2##4##(1990-12#1)(2010-10#1)
the paired t-test##6##3##(2008-10#6)
the paired##11##2##(1990-12#1)(1993-6#1)(2007-2#1)(2008-10#6)(2010-10#1)(2011-2#1)
the pairs of##2##3##(1994-3#1)(2008-3#1)
the pairs##3##2##(1994-3#1)(2008-3#1)(2008-5#1)
the pairwise##2##2##(2011-2#1)(2012-1#1)
the palatal##2##2##(2007-12#1)(2009-7#1)
the palate##4##2##(1991-2#1)(1996-8#1)(2009-1#1)(2012-3#1)
the palea##2##2##(2008-10#2)
the palladium##3##2##(2008-10#3)
the palliative##5##2##(1991-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-9#1)
the palm##8##2##(2008-10#4)(2008-6#3)(2011-2#1)
the palmar arch##2##3##(2008-9#1)(2011-2#1)
the palmar##6##2##(2008-9#4)(2011-2#2)
the palmaris longus##2##3##(2008-9#1)(2009-1#1)
the palmitic acid##2##3##(1991-5#1)(1994-5#1)
the palmitic##3##2##(1991-5#2)(1994-5#1)
the palms##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
the palpebral and##2##3##(2011-1#1)(2013-1#1)
the palsy##2##2##(2006-12#1)(2009-7#1)
the pamphlets##7##2##(1990-2#7)
the pancreas and the##3##4##(1993-3#1)(2008-10#1)(2011-2#1)
the pancreas and##10##3##(1990-6#1)(1991-3#1)(1993-3#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
the pancreas are##2##3##(2013-1#2)
the pancreas may##2##3##(2008-7#1)(2013-7#1)
the pancreas of##5##3##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
the pancreas showed##2##3##(2010-11#1)(2013-1#1)
the pancreas##80##2##(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#7)(1991-3#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-3#2)(1994-3#3)(1994-8#1)(1997-5#1)(2007-10#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#7)(2010-10#1)(2010-11#4)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#15)(2013-7#2)
the pancreatic acinar cells##3##4##(2008-7#1)(2009-7#2)
the pancreatic duct##4##3##(2008-10#2)(2009-7#1)(2011-2#1)
the pancreatic head##6##3##(1990-9#1)(1993-3#1)(2008-10#2)(2008-6#1)(2013-1#1)
the pancreatic islet##2##3##(1991-7#1)(2008-11#1)
the pancreatic juice##2##3##(2009-7#2)
the pancreatic##33##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#2)(2009-7#6)(2010-10#1)(2010-11#2)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
the pancreaticoduodenal##3##2##(1991-6#1)(1995-2#1)(2008-7#1)
the pancreatitis pathway##2##3##(2008-3#2)
the pancreatitis##4##2##(2008-3#2)(2013-8#2)
the pandemic (H1N1) 2009 virus##2##5##(2011-2#2)
the pandemic##6##2##(2008-10#1)(2011-2#5)
the panel of##3##3##(1992-9#1)(2008-10#1)(2012-12#1)
the panel##14##2##(1992-9#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
the panelists##3##2##(2008-5#3)
the panellists##2##2##(2008-5#1)(2010-4#1)
the pap##3##2##(1997-4#2)(2008-3#1)
the paper deals##2##3##(2008-5#1)(2009-6#1)
the paper describes the##2##4##(1992-5#1)(2008-1#1)
the paper describes##3##3##(1992-5#1)(2008-1#1)(2008-11#1)
the paper illustrates##2##3##(1992-9#1)(1996-3#1)
the paper shows##2##3##(2007-12#1)(2010-5#1)
the paper##62##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-5#1)(1992-9#1)(1994-12#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
the papers that##2##3##(1993-12#1)(2013-1#1)
the papers##9##2##(1992-6#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
the papilla##2##2##(2008-5#1)(2011-2#1)
the papillae##3##2##(1993-12#1)(2008-5#1)(2011-2#1)
the papillary##5##2##(1990-9#1)(2008-5#1)(2010-6#2)(2011-2#1)
the parabolic##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
the parabrachial nucleus##2##3##(1993-12#1)(2009-10#1)
the paracetamol##2##2##(2008-10#1)(2010-3#1)
the paracrine##3##2##(2008-6#1)(2009-9#1)(2013-1#1)
the paradigm for##4##3##(1993-1#1)(2008-3#1)(2011-2#1)(2012-3#1)
the paradigm of##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
the paradigm##15##2##(1993-1#1)(1994-12#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the paradox of enrichment##2##4##(2008-8#1)(2008-9#1)
the paradox of##3##3##(2008-8#1)(2008-9#1)(2009-4#1)
the paradox##4##2##(2008-8#1)(2008-9#1)(2009-4#1)(2013-8#1)
the paradoxical##2##2##(2008-5#1)(2011-2#1)
the paraelectric phase##2##3##(2008-2#1)(2008-3#1)
the paraffin##2##2##(2008-5#2)
the parallel wire construct##3##4##(2009-3#3)
the parallel##19##2##(1991-12#1)(1991-5#2)(1997-7#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#3)(2012-2#1)(2013-1#1)(2013-7#1)
the parallel-hole SPECT##2##3##(2009-8#2)
the parallel-slab##3##2##(2008-3#3)
the paramedical##3##2##(1995-1#1)(2007-10#1)(2011-2#1)
the parameter estimates for drip irrigation##2##6##(2008-10#2)
the parameter estimates##6##3##(1992-6#1)(2008-10#5)
the parameter of##3##3##(2008-3#1)(2008-9#2)
the parameter space##4##3##(2007-11#1)(2008-11#1)(2008-6#1)(2010-10#1)
the parameter to be##2##4##(2008-10#2)
the parameter values##3##3##(2008-10#2)(2008-12#1)
the parameter##33##2##(1992-6#2)(2007-11#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
the parameters affecting the##4##4##(1990-12#1)(2008-10#3)
the parameters and##2##3##(2008-12#1)(2009-5#1)
the parameters for the##2##4##(2008-10#1)(2008-3#1)
the parameters for##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
the parameters in the##6##4##(1992-6#1)(1995-9#1)(1997-2#1)(2008-7#1)(2009-8#1)(2010-8#1)
the parameters in##7##3##(1992-6#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-8#1)(2010-8#1)
the parameters needed to##2##4##(2008-10#1)(2008-3#1)
the parameters of a##3##4##(2007-12#1)(2008-3#2)
the parameters of the model##3##5##(2008-10#1)(2008-3#1)(2011-1#1)
the parameters of the##20##4##(1990-2#1)(1992-6#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2011-3#1)
the parameters of##37##3##(1990-2#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-9#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#8)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2013-8#1)
the parameters that affect the reaction were evaluated##2##8##(2008-10#2)
the parameters that affect the##5##5##(2008-10#3)(2008-11#1)(2008-4#1)
the parameters that affect##7##4##(1990-12#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-4#1)
the parameters that characterize the##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the parameters that characterize##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
the parameters that control##2##4##(1995-9#1)(2008-8#1)
the parameters that describe##2##4##(2008-10#1)(2008-3#1)
the parameters that##22##3##(1990-12#1)(1992-3#1)(1995-9#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)
the parameters were##2##3##(1994-8#1)(2008-7#1)
the parameters##119##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-9#2)(1996-2#1)(1997-2#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#30)(2008-11#1)(2008-12#5)(2008-2#6)(2008-3#19)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
the parametric and nonparametric##3##4##(2009-10#3)
the parametric model##2##3##(2008-10#1)(2011-1#1)
the parametric##14##2##(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-10#3)(2010-5#1)(2011-1#1)
the paramount##3##2##(1990-5#1)(1995-12#1)(2008-5#1)
the paranasal sinuses##5##3##(1991-6#1)(2006-12#2)(2008-11#1)(2011-2#1)
the paranasal##6##2##(1991-6#1)(2006-12#2)(2008-11#1)(2011-2#1)(2013-1#1)
the parapharyngeal space##2##3##(2008-7#1)(2011-2#1)
the parasite and##2##3##(1992-9#1)(2012-2#1)
the parasite is##4##3##(1990-2#1)(2007-6#1)(2008-8#1)(2012-12#1)
the parasite life cycle##2##4##(1997-6#1)(2012-3#1)
the parasite species##2##3##(2012-12#2)
the parasite to##2##3##(1996-12#1)(2008-9#1)
the parasite##47##2##(1990-2#1)(1991-2#1)(1992-9#2)(1993-6#1)(1994-11#1)(1996-12#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-6#2)(2008-10#4)(2008-8#5)(2008-9#5)(2009-6#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the parasite's##2##2##(2008-9#1)(2009-8#1)
the parasites of##3##3##(2012-12#1)(2013-1#2)
the parasites##15##2##(1996-12#1)(1997-4#2)(2007-7#2)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-12#1)(2013-1#2)
the parasitic plants##2##3##(2009-8#2)
the parasitic##13##2##(1990-11#1)(1990-7#1)(2007-12#2)(2008-10#2)(2008-8#2)(2008-9#1)(2009-8#2)(2012-2#2)
the parasitism index##2##3##(2008-6#2)
the parasitism##7##2##(2008-6#7)
the parasitoid larva##2##3##(2007-12#2)
the parasitoid larvae##2##3##(2007-12#2)
the parasitoid wasp##2##3##(1992-6#1)(2008-8#1)
the parasitoid##11##2##(1992-6#1)(2007-12#8)(2008-8#1)(2008-9#1)
the parasitoids##3##2##(2007-12#1)(2008-6#2)
the parathyroid##5##2##(1990-6#2)(1990-9#1)(2008-5#2)
the paraventricular nucleus (P &lt##2##5##(1996-12#2)
the paraventricular nucleus##5##3##(1995-12#2)(1996-12#3)
the paraventricular##9##2##(1993-12#1)(1994-2#1)(1995-12#3)(1996-12#4)
the paraxial approximation the##2##4##(2007-11#1)(2008-2#1)
the paraxial approximation##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
the paraxial##12##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#3)
the parenchyma##2##2##(1997-8#1)(2008-10#1)
the parenchymal##2##2##(1996-2#1)(2008-6#1)
the parent compound##8##3##(1990-12#2)(1995-6#1)(2008-11#3)(2008-5#1)(2010-11#1)
the parent compounds##3##3##(1994-3#1)(2008-10#1)(2009-12#1)
the parent drug were##2##4##(2008-10#2)
the parent drug##11##3##(1994-11#1)(1995-3#1)(2008-10#5)(2008-8#1)(2011-3#1)(2013-1#2)
the parent ion##3##3##(2008-10#3)
the parent molecule##2##3##(1992-12#1)(2008-3#1)
the parent strain##2##3##(2008-10#1)(2008-7#1)
the parent##59##2##(1990-12#2)(1990-5#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#18)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-3#1)(2013-1#2)(2013-8#1)
the parent's##2##2##(1993-2#1)(2013-1#1)
the parent-child relationship##3##3##(1992-2#1)(1995-5#1)(1996-9#1)
the parental and##2##3##(2008-10#1)(2008-11#1)
the parental care##4##3##(2008-8#1)(2008-9#3)
the parental generation##2##3##(1997-5#1)(2008-9#1)
the parental isolates##3##3##(2008-10#3)
the parental lines##6##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
the parental origin of the##2##5##(1993-1#1)(1997-3#1)
the parental population##2##3##(1991-4#1)(2011-1#1)
the parental strain##7##3##(1995-8#1)(2008-10#5)(2009-6#1)
the parental##60##2##(1990-8#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#6)(2009-11#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
the parenteral##2##2##(1990-2#1)(2012-12#1)
the parents and the##2##4##(1990-12#1)(2008-10#1)
the parents and##6##3##(1990-12#1)(2008-10#4)(2008-4#1)
the parents of the##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
the parents of##7##3##(1990-2#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
the parents or##3##3##(2007-7#1)(2010-4#1)(2011-2#1)
the parents were##3##3##(1995-12#1)(2008-10#2)
the parents##43##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-4#1)(1995-12#3)(1995-5#1)(1996-2#2)(2006-10#1)(2007-7#2)(2008-10#18)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
the parents'##4##2##(1993-12#1)(1994-3#1)(1995-5#1)(2010-9#1)
the parhelic circle##4##3##(2008-3#4)
the parietal and##3##3##(1995-6#1)(2012-1#1)(2013-8#1)
the parietal cell##3##3##(1995-11#1)(1997-1#2)
the parietal cells##5##3##(1992-3#1)(1992-6#1)(2007-12#1)(2012-1#1)(2013-8#1)
the parietal lobe##3##3##(1997-6#1)(2007-10#1)(2008-7#1)
the parietal##19##2##(1992-3#1)(1992-6#1)(1995-11#1)(1995-6#1)(1997-1#2)(1997-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-1#2)(2013-8#2)
the parish##2##2##(1993-12#2)
the park##3##2##(1994-11#1)(2008-5#1)(2008-8#1)
the parotid gland##12##3##(1991-6#2)(2007-10#1)(2007-5#1)(2008-4#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#4)
the parotid##17##2##(1990-11#1)(1991-6#2)(1993-12#1)(2007-10#2)(2007-5#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
the parsimony##2##2##(2008-4#1)(2010-11#1)
the part I and the part II receiving fibers##2##9##(2008-2#2)
the part of the##7##4##(1990-11#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#2)
the part of##19##3##(1990-11#1)(1992-1#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2011-2#1)(2012-3#1)
the part##27##2##(1990-11#1)(1992-1#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
the partial amino acid##2##4##(1993-9#1)(2008-10#1)
the partial characterization of a##2##5##(1990-2#1)(2008-10#1)
the partial least squares (PLS)##2##5##(2008-10#2)
the partial least squares##4##4##(2007-11#1)(2008-10#3)
the partial least##5##3##(2007-11#1)(2008-10#4)
the partial least-squares##3##3##(2008-10#3)
the partial likelihood##2##3##(1994-9#2)
the partial molar##2##3##(1997-2#1)(2008-10#1)
the partial or complete##2##4##(1991-2#1)(2008-10#1)
the partial positive##2##3##(1992-3#2)
the partial recovery##2##3##(2008-10#2)
the partial##55##2##(1990-2#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-9#1)(1994-9#2)(1996-4#1)(1997-2#2)(1997-7#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2011-3#1)
the partially purified##3##3##(1990-5#1)(1991-12#1)(1992-2#1)
the partially resistant##4##3##(2008-10#4)
the partially unfolded##2##3##(1995-3#2)
the partially##20##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-2#1)(1993-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-2#2)(2007-7#1)(2008-10#4)(2008-5#2)(2010-12#1)
the participant##7##2##(2008-10#1)(2008-12#2)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
the participant's##4##2##(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
the participants had##4##3##(1994-12#1)(2008-10#1)(2010-10#1)(2012-2#1)
the participants in##2##3##(2009-10#1)(2011-2#1)
the participants was##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
the participants were##8##3##(2008-7#1)(2009-6#1)(2009-9#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the participants##48##2##(1991-3#1)(1993-6#1)(1994-12#1)(1995-1#2)(2007-11#3)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
the participants'##9##2##(2007-12#1)(2008-11#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#3)
the participating hospitals##2##3##(1991-2#1)(1994-3#1)
the participating laboratories##2##3##(2008-10#1)(2008-12#1)
the participating students##2##3##(2008-11#1)(2012-12#1)
the participating##14##2##(1991-2#1)(1994-3#1)(1994-6#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
the participation of an##2##4##(2007-8#1)(2008-5#1)
the participation of patients##2##4##(2008-11#1)(2010-4#1)
the participation of the##3##4##(1994-1#1)(2008-8#1)(2009-11#1)
the participation of this##2##4##(1995-6#1)(2008-7#1)
the participation of##25##3##(1990-7#1)(1991-3#1)(1991-5#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-1#1)
the participation##27##2##(1990-7#1)(1991-3#1)(1991-5#1)(1994-1#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#3)(2007-6#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
the particle and the##2##4##(2008-3#2)
the particle and##3##3##(2008-3#2)(2008-7#1)
the particle boundaries##2##3##(2008-3#2)
the particle distribution##2##3##(1992-2#1)(1992-3#1)
the particle parameters##2##3##(2008-3#2)
the particle several##2##3##(2008-3#2)
the particle size and##3##4##(2007-11#2)(2010-5#1)
the particle size distribution##6##4##(1992-2#1)(2007-11#1)(2008-3#3)(2008-7#1)
the particle size is##2##4##(2008-2#1)(2013-8#1)
the particle size of##3##4##(1997-2#1)(2013-8#2)
the particle size##25##3##(1992-2#1)(1997-2#2)(2007-11#4)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2013-8#3)
the particle sizes##2##3##(2008-3#2)
the particle surface##2##3##(2008-10#1)(2013-1#1)
the particle swarm##2##3##(2007-9#2)
the particle volume##2##3##(2008-2#1)(2008-3#1)
the particle was##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
the particle##81##2##(1992-2#2)(1992-3#1)(1994-11#1)(1994-3#1)(1997-2#2)(2007-11#9)(2007-9#2)(2008-10#6)(2008-2#9)(2008-3#32)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-4#2)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
the particle's##2##2##(2007-11#1)(2008-3#1)
the particle-induced error##2##3##(2008-3#2)
the particle-size distribution##2##3##(2008-3#2)
the particle-size##5##2##(2008-2#1)(2008-3#4)
the particles and##3##3##(2008-11#1)(2008-3#2)
the particles are##2##3##(2008-3#2)
the particles in##6##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
the particles that##2##3##(1993-8#1)(2008-3#1)
the particles was##2##3##(2008-10#2)
the particles were##6##3##(1997-1#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-4#1)
the particles##50##2##(1990-12#1)(1992-6#1)(1992-8#1)(1993-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#15)(2008-5#2)(2008-8#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
the particles'##3##2##(2007-11#1)(2008-3#1)(2009-9#1)
the particular case of##2##4##(2008-2#1)(2012-12#1)
the particular challenges##2##3##(1992-3#1)(2008-11#1)
the particular characteristics##2##3##(2008-4#1)(2010-2#1)
the particular functional##2##3##(1993-8#1)(2008-7#1)
the particular##46##2##(1992-3#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#2)
the particularities of##2##3##(2009-4#1)(2013-1#1)
the particularly##2##2##(1996-8#1)(2008-9#1)
the particulate and##2##3##(1996-12#1)(1997-2#1)
the particulate attenuation at##2##4##(2008-3#2)
the particulate attenuation##3##3##(2008-3#3)
the particulate fraction##5##3##(1992-11#2)(1992-8#1)(1994-8#1)(1997-1#1)
the particulate matter##4##3##(2008-10#3)(2008-3#1)
the particulate##19##2##(1991-2#1)(1992-11#2)(1992-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#6)
the parties##3##2##(1990-2#1)(1992-2#1)(2007-4#1)
the partition coefficient of the substrate##2##6##(1990-5#2)
the partition coefficient of the##3##5##(1990-5#2)(2008-10#1)
the partition coefficient of##5##4##(1990-5#2)(2008-10#2)(2012-1#1)
the partition coefficient##9##3##(1990-5#2)(1996-2#1)(2008-10#4)(2008-6#1)(2012-1#1)
the partition coefficients##4##3##(2008-10#3)(2008-7#1)
the partition for various diluents##2##5##(2008-10#2)
the partition of##2##3##(1990-11#1)(2008-11#1)
the partition##22##2##(1990-11#2)(1990-5#2)(1995-8#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-3#1)
the partitioning of##7##3##(2008-10#3)(2008-6#1)(2008-8#2)(2012-2#1)
the partitioning##9##2##(2008-10#5)(2008-6#1)(2008-8#2)(2012-2#1)
the partner##4##2##(2007-8#1)(2008-9#1)(2009-12#1)(2010-5#1)
the partner-affirmation process##2##3##(2009-9#2)
the partners##5##2##(2008-12#2)(2008-6#1)(2008-7#1)(2010-10#1)
the partnership between the##2##4##(2007-10#1)(2010-5#1)
the partnership between##3##3##(2007-10#1)(2010-5#1)(2012-3#1)
the partnership##6##2##(1997-2#2)(2007-10#1)(2009-5#1)(2010-5#1)(2012-3#1)
the partnerships##2##2##(1996-9#1)(1997-2#1)
the parts of the##2##4##(2008-3#1)(2012-2#1)
the parts of##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
the parts##8##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)(2013-1#1)
the party##2##2##(2008-7#1)(2008-8#1)
the parvocellular pathway##2##3##(1996-2#1)(1996-5#1)
the parvocellular##4##2##(1993-12#1)(1996-2#1)(1996-5#1)(1997-2#1)
the pass of##2##3##(2008-10#2)
the passage of a##2##4##(2007-12#1)(2008-10#1)
the passage of the##3##4##(1996-11#1)(2008-2#1)(2008-4#1)
the passage of time##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
the passage of##17##3##(1991-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
the passage to a marine##2##5##(2008-9#2)
the passage##22##2##(1991-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#3)(2010-1#1)(2011-2#2)(2012-2#1)
the passband##2##2##(2008-2#2)
the passiflora##2##2##(2008-10#2)
the passions of##2##3##(2008-12#1)(2008-8#1)
the passions##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
the passivation agent##2##3##(2010-4#2)
the passive sampler##2##3##(2008-10#2)
the passive##20##2##(1992-6#2)(1993-12#1)(1993-3#1)(1995-8#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#2)(2011-2#1)
the past 10 years##18##4##(1992-3#1)(1993-8#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-1#1)(2009-4#1)(2010-8#2)(2012-3#1)(2013-7#1)(2013-8#1)
the past 100 years##2##4##(1997-7#1)(2008-10#1)
the past 100##5##3##(1994-3#1)(1997-7#1)(2008-10#1)(2010-5#1)(2013-8#1)
the past 12 months##7##4##(1995-3#2)(2008-10#1)(2009-5#4)
the past 12 years##2##4##(1993-3#1)(2008-11#1)
the past 12##11##3##(1993-3#1)(1995-3#2)(2008-10#1)(2008-11#1)(2009-5#6)
the past 15 years##10##4##(1997-1#1)(2008-1#1)(2008-11#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
the past 2 decades##2##4##(1992-8#1)(2006-12#1)
the past 2 years##2##4##(1997-6#1)(2008-10#1)
the past 2##6##3##(1992-8#1)(1997-6#1)(2006-12#1)(2008-10#1)(2011-1#1)(2013-8#1)
the past 20 years in##3##5##(1995-12#1)(2008-10#2)
the past 20 years##16##4##(1992-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#1)
the past 20##17##3##(1992-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#1)
the past 25 years##5##4##(1997-1#1)(1997-2#1)(2008-2#1)(2008-7#1)(2012-2#1)
the past 28 years##2##4##(2008-6#1)(2011-1#1)
the past 3 decades##2##4##(2010-3#1)(2012-2#1)
the past 3 months##2##4##(2010-7#1)(2012-3#1)
the past 3 years##2##4##(1994-11#1)(2008-10#1)
the past 3##7##3##(1994-11#1)(1995-11#1)(2008-10#1)(2010-3#1)(2010-7#1)(2012-2#1)(2012-3#1)
the past 30 years##9##4##(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
the past 30##12##3##(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
the past 4 years##2##4##(2007-2#1)(2008-10#1)
the past 40 years##3##4##(2008-11#1)(2010-3#1)(2011-2#1)
the past 5 years##4##4##(1995-3#1)(2008-10#1)(2010-4#1)(2012-3#1)
the past 5##5##3##(1995-3#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
the past 50 years##6##4##(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)
the past and##3##3##(1994-6#1)(2008-12#1)(2008-4#1)
the past century##7##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)(2011-2#1)
the past decade has been##2##5##(2008-10#1)(2008-7#1)
the past decade has##4##4##(1993-12#1)(1994-1#1)(2008-10#1)(2008-7#1)
the past decade in##2##4##(2008-10#2)
the past decade there has been##3##6##(1991-2#1)(2007-12#1)(2008-11#1)
the past decade##78##3##(1991-12#1)(1991-2#1)(1991-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the past decades have##2##4##(2008-5#1)(2011-2#1)
the past decades##10##3##(2008-10#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
the past eight years##2##4##(1997-2#1)(2008-2#1)
the past few decades with##2##5##(2008-10#1)(2013-1#1)
the past few decades##8##4##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
the past few years have##2##5##(1997-8#1)(2008-8#1)
the past few years##33##4##(1992-9#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
the past few##41##3##(1992-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#2)
the past five decades##2##4##(1994-12#1)(2010-8#1)
the past five years##4##4##(1994-2#1)(1995-2#1)(1995-5#1)(2007-9#1)
the past five##6##3##(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(2007-9#1)(2010-8#1)
the past four decades##3##4##(1994-3#1)(1997-1#1)(2011-2#1)
the past four##4##3##(1994-3#1)(1997-1#1)(2008-11#1)(2011-2#1)
the past half century##2##4##(1997-1#1)(2009-5#1)
the past in##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
the past several decades##4##4##(1992-12#1)(2009-7#1)(2011-2#2)
the past several years##16##4##(1991-1#1)(1992-2#1)(1992-3#2)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-7#1)
the past several##20##3##(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1995-12#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#2)
the past six years##2##4##(1995-1#1)(1995-5#1)
the past ten years##4##4##(1990-6#1)(1991-12#1)(1996-3#1)(2008-4#1)
the past three decades##16##4##(1991-12#1)(1992-12#1)(1992-3#1)(1996-2#2)(2008-1#1)(2008-11#3)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#3)(2013-8#1)
the past three years##2##4##(1993-3#1)(2012-3#1)
the past three##18##3##(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-2#2)(2008-1#1)(2008-11#3)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#3)(2012-3#1)(2013-8#1)
the past to##2##3##(1994-3#1)(2008-3#1)
the past twenty years##3##4##(1991-3#1)(1992-1#1)(2013-8#1)
the past two decades##19##4##(1990-6#1)(1992-11#1)(1995-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-12#1)
the past two years##6##4##(1991-2#1)(1992-12#1)(1994-1#1)(1996-8#1)(2011-2#1)(2013-1#1)
the past two##26##3##(1990-6#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-1#1)(1995-1#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#2)
the past year##8##3##(1994-3#1)(1996-2#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-12#1)(2009-9#1)
the past years many##2##4##(1990-9#1)(2008-10#1)
the past years##9##3##(1990-9#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-3#1)(2010-5#1)(2011-2#1)
the past##476##2##(1990-11#1)(1990-12#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#5)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-12#5)(1993-3#5)(1993-8#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#2)(1996-1#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#7)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#4)(2006-12#1)(2007-11#3)(2007-12#8)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#11)(2008-10#49)(2008-11#30)(2008-12#7)(2008-2#3)(2008-3#12)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#19)(2008-8#11)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#12)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#8)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#8)(2011-1#8)(2011-2#28)(2012-1#3)(2012-12#8)(2012-2#10)(2012-3#9)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#7)
the paste##6##2##(2008-10#6)
the pasture trees##4##3##(2008-5#4)
the pasture##7##2##(2008-10#1)(2008-5#4)(2010-2#2)
the patch clamp technique##4##4##(1993-12#1)(1993-3#1)(1994-11#1)(2008-8#1)
the patch occupancy framework##2##4##(2008-8#2)
the patch occupancy##3##3##(2008-8#3)
the patch pipette##2##3##(1993-12#1)(2009-12#1)
the patch##21##2##(1990-3#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(2008-5#2)(2008-8#6)(2008-9#5)(2009-12#1)
the patch-clamp technique##5##3##(1992-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-5#1)
the patch-clamp##6##2##(1992-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-11#1)
the patches##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
the patella##10##2##(2007-11#2)(2007-8#5)(2009-4#1)(2013-1#2)
the patellar tendon##7##3##(2008-9#3)(2009-4#2)(2013-1#2)
the patellar##10##2##(1995-8#1)(1997-8#1)(2008-9#3)(2009-4#2)(2013-1#3)
the patellofemoral joint##3##3##(2007-8#2)(2008-12#1)
the patency and##2##3##(2007-10#1)(2007-7#1)
the patency##5##2##(2007-10#1)(2007-7#2)(2008-1#1)(2011-2#1)
the patent##5##2##(2008-12#1)(2009-11#3)(2013-1#1)
the patented##2##2##(1992-8#1)(2010-7#1)
the paternal##8##2##(1992-8#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
the paternity##2##2##(2008-12#1)(2008-6#1)
the path difference##3##3##(2007-12#1)(2008-3#2)
the path from##2##3##(2009-7#2)
the path length##3##3##(2008-3#3)
the path of the camera##2##5##(2008-6#2)
the path of the##7##4##(2007-11#1)(2008-2#2)(2008-3#1)(2008-6#2)(2010-8#1)
the path of##10##3##(1993-6#1)(2007-11#1)(2008-2#2)(2008-3#3)(2008-6#2)(2010-8#1)
the path to##5##3##(1996-3#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)
the path##33##2##(1993-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#14)(2008-6#3)(2008-7#1)(2009-7#2)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
the path-averaged##2##2##(2007-12#1)(2008-2#1)
the path-length distribution of##2##4##(2008-3#2)
the path-length##3##2##(2007-11#1)(2008-3#2)
the pathobiology##2##2##(2008-7#1)(2011-1#1)
the pathogen Fusarium oxysporum f##2##5##(2008-10#2)
the pathogen and the##8##4##(2007-12#1)(2008-10#7)
the pathogen and##20##3##(2007-12#1)(2008-10#17)(2008-9#1)(2013-1#1)
the pathogen by##5##3##(2008-10#4)(2009-6#1)
the pathogen can be##3##4##(2008-10#3)
the pathogen can##5##3##(2008-10#5)
the pathogen did not##3##4##(2008-10#3)
the pathogen directly##2##3##(2008-10#2)
the pathogen from##3##3##(2008-10#3)
the pathogen had##2##3##(2008-10#2)
the pathogen has##4##3##(2008-10#4)
the pathogen in planta##2##4##(2008-10#2)
the pathogen in##18##3##(2008-10#17)(2008-5#1)
the pathogen is##4##3##(2008-10#3)(2008-8#1)
the pathogen multiplied abundantly through much of the##2##8##(2008-10#2)
the pathogen mycelium##4##3##(2008-10#4)
the pathogen on the##3##4##(2008-10#3)
the pathogen on##7##3##(2008-10#7)
the pathogen population from##2##4##(2008-10#2)
the pathogen population is##2##4##(2008-10#2)
the pathogen population##22##3##(2008-10#21)(2008-8#1)
the pathogen to test##2##4##(2008-10#2)
the pathogen to##7##3##(2008-10#6)(2009-2#1)
the pathogen was found##2##4##(2008-10#2)
the pathogen was##16##3##(2008-10#16)
the pathogen were##8##3##(2008-10#8)
the pathogen within##2##3##(2008-10#2)
the pathogen##309##2##(1994-12#1)(1995-5#2)(1997-3#1)(2007-12#1)(2008-10#280)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#5)(2009-2#1)(2009-6#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
the pathogen's life##2##3##(2008-10#2)
the pathogen's population structure##2##4##(2008-10#2)
the pathogen's##6##2##(2008-10#6)
the pathogenesis and treatment of##3##5##(1990-11#1)(2010-10#1)(2011-1#1)
the pathogenesis and##13##3##(1990-11#1)(1991-11#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
the pathogenesis of AD##3##4##(1992-12#1)(1995-12#1)(2009-5#1)
the pathogenesis of Alzheimer's Disease##2##5##(1993-11#1)(2011-3#1)
the pathogenesis of Alzheimer's##5##4##(1993-11#1)(1993-12#1)(1996-12#1)(1997-2#1)(2011-3#1)
the pathogenesis of COPD##2##4##(2010-5#1)(2013-8#1)
the pathogenesis of MS##2##4##(2008-7#1)(2012-3#1)
the pathogenesis of SLE##2##4##(2008-1#1)(2010-12#1)
the pathogenesis of atherosclerosis and##2##5##(2008-6#1)(2008-7#1)
the pathogenesis of atherosclerosis##5##4##(1994-11#1)(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#1)
the pathogenesis of cancer##3##4##(2007-5#1)(2008-4#1)(2011-1#1)
the pathogenesis of cardiovascular disease##3##5##(1996-11#1)(2008-3#1)(2013-3#1)
the pathogenesis of cardiovascular##4##4##(1996-11#1)(2008-3#1)(2008-7#1)(2013-3#1)
the pathogenesis of common##2##4##(2008-3#1)(2008-7#1)
the pathogenesis of degenerative##2##4##(2012-12#1)(2013-8#1)
the pathogenesis of diabetic##5##4##(2008-1#5)
the pathogenesis of insulin resistance##2##5##(2008-3#1)(2012-2#1)
the pathogenesis of many##3##4##(2006-10#1)(2012-12#1)(2012-2#1)
the pathogenesis of respiratory##2##4##(1991-8#1)(2008-5#1)
the pathogenesis of the disease##2##5##(1992-6#1)(2008-10#1)
the pathogenesis of the##11##4##(1990-11#1)(1991-5#1)(1992-6#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-1#1)
the pathogenesis of these diseases##2##5##(2007-7#1)(2008-7#1)
the pathogenesis of these##5##4##(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)
the pathogenesis of this disease##2##5##(2010-6#1)(2012-1#1)
the pathogenesis of this##7##4##(1992-2#1)(1993-9#1)(2007-10#1)(2009-3#1)(2010-6#1)(2012-1#1)(2013-1#1)
the pathogenesis of##202##3##(1990-11#1)(1990-12#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#2)(2006-6#1)(2007-10#4)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#12)(2008-10#6)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#2)(2009-1#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#11)(2013-3#1)(2013-7#1)(2013-8#7)
the pathogenesis##219##2##(1990-11#2)(1990-12#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#3)(2006-6#1)(2007-10#4)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#13)(2008-10#6)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#15)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#6)(2013-1#11)(2013-3#1)(2013-7#1)(2013-8#8)
the pathogenesis-related##3##2##(2008-10#3)
the pathogenetic mechanism##2##3##(1990-6#1)(2008-3#1)
the pathogenetic##5##2##(1990-6#1)(1997-8#1)(2008-3#1)(2008-8#1)(2010-12#1)
the pathogenic complex##2##3##(1991-9#2)
the pathogenic mechanisms of##2##4##(2008-4#1)(2010-6#1)
the pathogenic mechanisms##3##3##(2008-4#1)(2008-5#1)(2010-6#1)
the pathogenic role of##2##4##(2010-1#1)(2011-1#1)
the pathogenic role##3##3##(2008-5#1)(2010-1#1)(2011-1#1)
the pathogenic specificity on##2##4##(2008-10#2)
the pathogenic##30##2##(1990-7#1)(1991-9#2)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#14)(2008-4#1)(2008-5#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
the pathogenicity of the##3##4##(2008-10#2)(2008-5#1)
the pathogenicity of##14##3##(2008-10#12)(2008-5#1)(2008-6#1)
the pathogenicity##20##2##(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-2#1)
the pathogens and##2##3##(2008-10#2)
the pathogens##21##2##(1991-11#1)(1993-2#1)(2008-10#14)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#2)
the pathologic process##2##3##(1992-8#1)(2008-9#1)
the pathologic tissue of##2##4##(1992-8#2)
the pathologic##13##2##(1991-12#1)(1991-9#1)(1992-8#4)(1993-12#1)(2008-10#1)(2008-9#2)(2010-6#1)(2012-12#1)(2012-3#1)
the pathological and##2##3##(1994-5#1)(2008-7#1)
the pathological changes##7##3##(1990-5#1)(2007-11#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the pathological characteristics of##2##4##(2008-9#1)(2013-8#1)
the pathological conditions associated with##2##5##(2013-1#1)(2013-8#1)
the pathological conditions##4##3##(1994-3#1)(2008-12#1)(2013-1#1)(2013-8#1)
the pathological processes##4##3##(1992-6#1)(2008-11#1)(2008-12#1)(2008-8#1)
the pathological##36##2##(1990-5#1)(1990-6#1)(1992-6#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-3#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
the pathologies##4##2##(1990-5#1)(2011-1#2)(2011-2#1)
the pathologist##6##2##(1991-2#1)(1992-2#1)(1997-5#1)(2007-7#1)(2009-1#1)(2012-2#1)
the pathology and##4##3##(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
the pathology is##2##3##(2008-9#1)(2013-1#1)
the pathology of the##2##4##(2007-8#1)(2008-1#1)
the pathology of##10##3##(1991-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)
the pathology##34##2##(1990-3#1)(1991-3#1)(1992-12#2)(1993-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
the pathomechanisms##2##2##(2007-7#1)(2013-7#1)
the pathophysiologic##5##2##(1993-1#1)(2007-10#1)(2008-10#1)(2008-9#1)(2011-2#1)
the pathophysiological mechanisms##2##3##(2009-2#1)(2011-2#1)
the pathophysiological##5##2##(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-8#1)
the pathophysiology and treatment of##4##5##(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
the pathophysiology and##9##3##(1994-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)
the pathophysiology of bone##2##4##(1992-3#1)(1997-6#1)
the pathophysiology of depression##3##4##(2008-7#2)(2013-1#1)
the pathophysiology of diabetes##2##4##(2008-1#1)(2008-4#1)
the pathophysiology of neuropsychiatric##2##4##(2008-4#1)(2011-1#1)
the pathophysiology of schizophrenia##2##4##(2011-1#2)
the pathophysiology of some##2##4##(2008-1#1)(2011-2#1)
the pathophysiology of the disorder##2##5##(2008-6#1)(2008-9#1)
the pathophysiology of the##3##4##(2008-1#1)(2008-6#1)(2008-9#1)
the pathophysiology of these##2##4##(2011-1#1)(2013-8#1)
the pathophysiology of this##3##4##(2008-5#1)(2009-8#1)(2012-2#1)
the pathophysiology of various##2##4##(2008-11#1)(2008-7#1)
the pathophysiology of##67##3##(1992-3#1)(1993-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#1)(2008-1#7)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
the pathophysiology##88##2##(1992-3#2)(1993-3#1)(1994-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#8)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
the pathotype##4##2##(2008-10#4)
the pathovar##2##2##(2008-10#2)
the pathovars##2##2##(2008-10#2)
the paths of##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
the paths##4##2##(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
the pathway and##2##3##(2010-11#1)(2011-3#1)
the pathway intermediates##2##3##(2008-10#1)(2008-7#1)
the pathway of##8##3##(1996-5#1)(1997-2#1)(2007-12#1)(2008-11#2)(2011-3#1)(2013-8#2)
the pathway that##2##3##(2008-11#1)(2009-8#1)
the pathway##33##2##(1990-7#1)(1994-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-3#5)(2013-8#2)
the pathways by which##4##4##(1997-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
the pathways by##5##3##(1997-2#1)(1997-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
the pathways in##2##3##(1996-2#1)(2008-4#1)
the pathways of##2##3##(1994-11#1)(2013-1#1)
the pathways that##3##3##(2009-12#1)(2009-9#1)(2012-2#1)
the pathways##25##2##(1993-12#1)(1994-11#1)(1995-11#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the patient about##4##3##(1992-1#1)(1992-12#1)(1992-3#1)(2008-3#1)
the patient achieved##2##3##(2007-10#1)(2008-10#1)
the patient also##2##3##(1994-12#1)(2006-12#1)
the patient and his##5##4##(1991-11#1)(1991-6#1)(1996-3#1)(2011-1#1)(2012-12#1)
the patient and his/her##2##4##(2010-3#1)(2010-6#1)
the patient and the clinician##2##5##(2012-12#1)(2012-3#1)
the patient and the family##2##5##(2009-9#1)(2010-3#1)
the patient and the##12##4##(1991-12#1)(1994-2#1)(1995-2#1)(2007-12#1)(2007-6#1)(2008-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
the patient and##49##3##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the patient and/or##2##3##(2008-10#1)(2012-12#1)
the patient as a person##2##5##(2008-3#1)(2013-8#1)
the patient as a##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
the patient as the##3##4##(2007-12#1)(2008-11#1)(2010-12#1)
the patient as##10##3##(1993-12#1)(1996-6#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
the patient at the##3##4##(2008-10#1)(2008-7#1)(2010-5#1)
the patient at##5##3##(1992-2#1)(1992-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
the patient base##2##3##(2007-7#1)(2010-8#1)
the patient became##3##3##(1996-3#2)(2013-1#1)
the patient before##3##3##(1997-4#1)(2011-2#1)(2013-8#1)
the patient being##2##3##(1991-2#1)(1996-9#1)
the patient belongs##2##3##(2009-8#1)(2010-12#1)
the patient by##4##3##(1990-10#1)(1990-11#1)(1994-2#1)(1995-12#1)
the patient came##2##3##(1992-1#1)(1995-3#1)
the patient can##2##3##(1991-6#1)(2007-8#1)
the patient care process##3##4##(1995-3#3)
the patient care##6##3##(1995-12#2)(1995-3#3)(2008-10#1)
the patient complained of##4##4##(2007-8#1)(2009-1#1)(2012-3#1)(2013-1#1)
the patient could##2##3##(1996-2#1)(2012-1#1)
the patient developed a##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
the patient developed an##3##4##(2007-7#1)(2009-3#1)(2011-1#1)
the patient developed multiple##2##4##(2007-6#1)(2011-1#1)
the patient developed##17##3##(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-3#3)(2010-5#1)(2011-1#3)(2011-2#3)(2013-1#1)
the patient did not##5##4##(1997-4#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
the patient died of##2##4##(1991-12#1)(1991-6#1)
the patient died##7##3##(1991-12#1)(1991-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2009-8#1)(2011-2#1)
the patient during the##2##4##(1992-12#1)(2008-10#1)
the patient during##3##3##(1992-12#1)(2008-10#1)(2009-8#1)
the patient failed to##2##4##(1990-2#1)(2008-9#1)
the patient for##4##3##(1990-2#1)(1992-3#1)(1992-6#1)(1996-8#1)
the patient from##4##3##(1992-1#1)(2007-11#1)(2012-2#1)(2013-8#1)
the patient group and##2##4##(2007-8#2)
the patient group##12##3##(1992-4#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#2)(2011-1#3)(2011-2#1)(2012-2#1)
the patient had a##7##4##(1992-6#1)(1994-12#1)(1996-6#1)(2007-10#1)(2008-11#1)(2011-2#2)
the patient had an##4##4##(1991-1#1)(2006-12#1)(2010-7#1)(2012-2#1)
the patient had been##3##4##(1991-3#1)(1994-12#1)(2007-8#1)
the patient had no##2##4##(2008-9#1)(2013-7#1)
the patient had##31##3##(1991-1#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1996-6#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the patient has a##2##4##(1993-11#1)(2008-6#1)
the patient has been##6##4##(1990-5#1)(1991-2#1)(1997-5#1)(2008-1#1)(2008-9#1)(2013-8#1)
the patient has had##2##4##(1993-6#1)(2012-12#1)
the patient has##24##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-5#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the patient in the##4##4##(2007-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
the patient in##13##3##(1990-6#1)(2007-10#1)(2007-8#2)(2008-11#2)(2008-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the patient is in##2##4##(2013-1#1)(2013-8#1)
the patient is not##2##4##(1991-11#1)(1993-2#1)
the patient is referred##2##4##(2008-8#1)(2011-3#1)
the patient is the##2##4##(1992-3#1)(2013-1#1)
the patient is##47##3##(1990-11#1)(1990-3#1)(1991-11#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#2)
the patient of##3##3##(1992-1#1)(2007-11#1)(2013-1#1)
the patient on##3##3##(2008-1#1)(2008-3#1)(2011-2#1)
the patient or the patient's family##2##6##(1995-3#1)(1996-2#1)
the patient or##5##3##(1991-2#1)(1995-3#1)(1996-2#1)(2008-2#1)(2013-8#1)
the patient population##6##3##(1992-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2010-11#1)(2010-12#1)
the patient populations##2##3##(1995-3#1)(2008-11#1)
the patient presented with##4##4##(1997-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
the patient presented##6##3##(1997-5#1)(2007-10#1)(2010-12#1)(2012-12#1)(2013-1#2)
the patient record##2##3##(1992-4#1)(1993-2#1)
the patient recovered##3##3##(1997-2#1)(2011-2#1)(2013-8#1)
the patient relapsed##2##3##(1991-4#1)(2007-4#1)
the patient remains asymptomatic##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
the patient remains##4##3##(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
the patient responded##2##3##(2007-7#1)(2009-8#1)
the patient returned to##3##4##(2008-1#1)(2008-9#1)(2012-12#1)
the patient returned##5##3##(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#2)
the patient revealed a##4##4##(1993-3#1)(1993-6#1)(1994-11#1)(2010-11#1)
the patient satisfaction##2##3##(2008-12#1)(2010-8#1)
the patient should be##7##4##(1992-6#1)(1993-6#1)(1994-12#1)(1996-11#1)(2010-12#1)(2011-2#2)
the patient should##8##3##(1992-6#1)(1993-6#2)(1994-12#1)(1996-11#1)(2010-12#1)(2011-2#2)
the patient showed clinical##2##4##(1990-2#1)(1991-6#1)
the patient showed##5##3##(1990-2#1)(1991-6#1)(1992-5#1)(2008-7#2)
the patient succumbed to##2##4##(2008-6#1)(2012-3#1)
the patient suffered from##3##4##(1993-2#1)(2008-12#1)(2012-12#1)
the patient suffered##4##3##(1993-2#1)(2008-12#2)(2012-12#1)
the patient to the##2##4##(1992-3#1)(1993-9#1)
the patient to##17##3##(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the patient underwent a##3##4##(2009-3#1)(2010-12#1)(2012-2#1)
the patient underwent repeated##2##4##(2006-12#1)(2011-2#1)
the patient underwent##9##3##(1991-11#1)(2006-12#1)(2007-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
the patient was able to##2##5##(1993-1#1)(1993-2#1)
the patient was admitted to##2##5##(2008-4#1)(2013-1#1)
the patient was admitted##4##4##(2008-1#1)(2008-4#1)(2013-1#2)
the patient was asymptomatic##2##4##(1996-3#1)(2013-1#1)
the patient was completely##3##4##(2007-8#1)(2011-2#1)(2012-12#1)
the patient was diagnosed##2##4##(2008-6#1)(2013-8#1)
the patient was discharged##4##4##(1994-9#1)(2007-8#1)(2011-2#1)(2013-8#1)
the patient was found to have##2##6##(2008-6#1)(2013-1#1)
the patient was in##4##4##(1990-5#1)(2007-12#1)(2008-4#1)(2013-8#1)
the patient was mentally##2##4##(1994-12#1)(2011-1#1)
the patient was referred to##4##5##(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)
the patient was referred##8##4##(1991-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)
the patient was treated with##4##5##(1994-6#1)(2006-10#1)(2008-11#1)(2013-1#1)
the patient was treated##5##4##(1994-6#1)(2006-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
the patient was##82##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#2)(1994-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-5#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#6)
the patient were##3##3##(1992-12#1)(1994-11#1)(2007-7#1)
the patient who##3##3##(1993-6#1)(1997-8#1)(2008-8#1)
the patient with acute coronary syndrome##2##6##(2008-10#2)
the patient with diabetes##2##4##(2008-1#1)(2008-4#1)
the patient with##25##3##(1991-12#1)(1992-3#1)(1992-6#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the patient's RBCs##2##3##(1994-12#1)(1994-9#1)
the patient's ability to##2##4##(1991-9#1)(2008-10#1)
the patient's age at##2##4##(2007-8#1)(2013-1#1)
the patient's age##6##3##(1996-1#1)(1996-6#1)(1997-8#1)(2007-8#1)(2012-2#1)(2013-1#1)
the patient's body##2##3##(1991-6#1)(2007-12#1)
the patient's cardiac##2##3##(2007-8#1)(2008-7#1)
the patient's care##2##3##(1997-3#1)(2010-10#1)
the patient's charter##2##3##(1992-2#1)(1992-5#1)
the patient's clinical##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
the patient's condition##3##3##(2007-11#1)(2012-12#1)(2013-8#1)
the patient's culture##2##3##(2011-2#1)(2013-1#1)
the patient's death##2##3##(2008-11#2)
the patient's demographic##2##3##(2007-10#1)(2008-10#1)
the patient's functional##3##3##(2006-5#1)(2007-12#1)(2010-10#1)
the patient's general##3##3##(1996-6#1)(2007-11#1)(2012-2#1)
the patient's health status##4##4##(1994-3#1)(2007-12#1)(2007-8#1)(2008-11#1)
the patient's health##6##3##(1994-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)
the patient's history##4##3##(1990-6#1)(1997-2#1)(2008-11#1)(2008-8#1)
the patient's immune system##2##4##(2008-5#1)(2013-8#1)
the patient's life##6##3##(1990-5#1)(1993-8#1)(2007-11#1)(2010-5#1)(2010-8#1)(2013-8#1)
the patient's medical##4##3##(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
the patient's mouth##2##3##(1995-3#1)(2010-5#1)
the patient's neurological##3##3##(1996-9#1)(2007-10#1)(2008-7#1)
the patient's outcome##2##3##(1995-6#1)(1995-8#1)
the patient's perspective##4##3##(2007-8#1)(2008-11#1)(2008-12#1)(2012-3#1)
the patient's physical and mental##2##5##(2007-11#1)(2007-8#1)
the patient's physical##5##3##(1992-12#1)(2007-11#2)(2007-8#2)
the patient's preoperative##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
the patient's quality of attention##2##5##(2008-10#2)
the patient's quality of life##3##5##(2007-8#1)(2009-9#1)(2013-1#1)
the patient's quality of##5##4##(2007-8#1)(2008-10#2)(2009-9#1)(2013-1#1)
the patient's right to##2##4##(1991-2#1)(1992-12#1)
the patient's risk##2##3##(2008-3#1)(2008-4#1)
the patient's serum and##2##4##(1993-6#1)(1994-6#1)
the patient's serum##5##3##(1992-6#1)(1992-9#1)(1993-6#1)(1994-6#2)
the patient's specific##2##3##(2011-1#1)(2011-2#1)
the patient's symptoms and##2##4##(1991-6#1)(2012-3#1)
the patient's symptoms on##2##4##(2008-9#1)(2012-2#1)
the patient's symptoms##6##3##(1991-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2012-2#1)(2012-3#1)
the patient's treatment##2##3##(2009-11#2)
the patient's##213##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#4)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#7)(2007-12#4)(2007-7#1)(2007-8#9)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#5)(2009-11#2)(2009-3#2)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#9)(2012-12#5)(2012-2#7)(2012-3#3)(2012-8#1)(2013-1#12)(2013-7#1)(2013-8#3)
the patient-focused##2##2##(1992-12#1)(1994-1#1)
the patient-physician relationship##2##3##(1993-3#1)(1995-12#1)
the patient-provider##2##2##(2013-1#2)
the patients admitted##2##3##(2012-3#1)(2013-1#1)
the patients after##3##3##(2007-11#2)(2010-8#1)
the patients and their##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
the patients and##15##3##(1990-8#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-2#1)(1994-11#1)(1996-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
the patients are asymptomatic##2##4##(1993-1#1)(2008-7#1)
the patients are##7##3##(1993-1#1)(1997-4#1)(2007-10#1)(2007-8#2)(2008-7#1)(2010-3#1)
the patients being##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
the patients by##2##3##(2008-11#1)(2012-3#1)
the patients can##2##3##(2008-4#1)(2010-8#1)
the patients completed##2##3##(1991-3#1)(1992-11#1)
the patients could##2##3##(1990-9#1)(2009-10#1)
the patients diagnosed in the##2##5##(2008-1#2)
the patients diagnosed##3##3##(2007-7#1)(2008-1#2)
the patients did not##2##4##(1990-12#1)(2011-1#1)
the patients do##2##3##(1996-9#1)(2008-7#1)
the patients during##2##3##(2009-8#1)(2011-2#1)
the patients experienced##2##3##(2007-11#1)(2010-4#1)
the patients for##3##3##(1993-6#1)(2008-7#1)(2013-8#1)
the patients from##4##3##(2007-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
the patients had a##5##4##(1991-6#1)(1993-2#1)(1995-5#1)(2008-1#1)(2010-6#1)
the patients had an##2##4##(1990-11#1)(2007-8#1)
the patients had been##3##4##(2007-11#1)(2008-6#1)(2011-1#1)
the patients had no##2##4##(1991-6#1)(2008-11#1)
the patients had##35##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#2)(1991-6#2)(1993-12#1)(1993-2#1)(1994-11#1)(1995-5#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
the patients have to be##2##5##(2011-1#1)(2011-2#1)
the patients have##5##3##(2008-10#2)(2010-3#1)(2011-1#1)(2011-2#1)
the patients having##2##3##(1996-2#1)(2008-1#1)
the patients in both groups##2##5##(2007-11#1)(2009-12#1)
the patients in the##6##4##(1990-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1997-5#2)
the patients in this##2##4##(1995-11#1)(2011-2#1)
the patients in##16##3##(1990-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-3#1)(1995-11#1)(1997-5#2)(2007-11#2)(2008-10#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
the patients into##2##3##(1997-2#1)(2011-2#1)
the patients is##3##3##(1990-10#1)(1992-6#1)(2011-2#1)
the patients may##2##3##(1996-9#1)(2008-5#1)
the patients of the##3##4##(1992-6#1)(2008-1#1)(2013-1#1)
the patients of this##2##4##(2008-10#1)(2011-1#1)
the patients of##8##3##(1992-6#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
the patients presenting##2##3##(2013-8#2)
the patients received##5##3##(1990-12#1)(1992-6#1)(2007-11#1)(2008-5#1)(2008-7#1)
the patients receiving##5##3##(1995-4#1)(2008-1#1)(2008-5#1)(2010-7#1)(2013-1#1)
the patients recovered without##2##4##(1997-6#1)(2007-10#1)
the patients recovered##3##3##(1997-6#1)(2007-10#1)(2007-8#1)
the patients referred##2##3##(1992-5#1)(2007-8#1)
the patients reported##6##3##(1991-3#1)(1992-5#2)(1993-2#1)(1995-12#1)(1997-2#1)
the patients responded##2##3##(2007-7#1)(2011-2#1)
the patients suffering from##5##4##(2008-7#4)(2012-12#1)
the patients survived##2##3##(1990-12#1)(2011-2#1)
the patients than in##4##4##(1994-11#1)(2008-7#2)(2011-2#1)
the patients that##3##3##(1995-11#1)(2008-8#1)(2011-2#1)
the patients the##2##3##(1990-9#1)(1992-5#1)
the patients themselves##3##3##(1993-2#1)(1995-2#1)(2007-12#1)
the patients they##3##3##(1991-1#1)(1991-2#1)(2012-3#1)
the patients to##6##3##(1995-11#2)(1995-6#1)(2007-11#1)(2007-7#1)(2008-10#1)
the patients treated in the geriatric assessment unit##2##8##(1990-5#2)
the patients treated with##2##4##(1990-6#1)(1991-4#1)
the patients treated##7##3##(1990-5#2)(1990-6#1)(1991-4#1)(2008-7#2)(2011-1#1)
the patients undergoing##2##3##(2007-9#1)(2011-2#1)
the patients understand##2##3##(2008-7#2)
the patients underwent##4##3##(1990-9#1)(1997-8#1)(2008-4#1)(2013-1#1)
the patients was##24##3##(1991-4#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-4#1)(1996-7#1)(1997-8#1)(2007-7#1)(2008-1#5)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#2)(2011-3#1)(2012-3#1)
the patients were divided into two groups##2##7##(2008-4#1)(2011-1#1)
the patients were divided into##3##5##(2008-4#1)(2011-1#1)(2012-12#1)
the patients were followed up for##3##6##(1995-5#1)(2007-7#1)(2013-8#1)
the patients were male##2##4##(1990-9#1)(2007-8#1)
the patients were on##3##4##(2008-1#1)(2008-4#1)(2012-5#1)
the patients were##53##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#3)(1992-6#1)(1993-1#1)(1993-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
the patients who died##2##4##(1997-4#1)(2012-3#1)
the patients who had##2##4##(1997-3#1)(2007-10#1)
the patients who received##2##4##(2007-7#1)(2008-1#1)
the patients who underwent surgery##2##5##(2008-3#1)(2008-7#1)
the patients who underwent##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
the patients who were##2##4##(1996-11#1)(2012-3#1)
the patients who##22##3##(1990-12#1)(1992-3#1)(1992-6#1)(1995-3#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#2)
the patients with a##4##4##(1990-10#1)(2008-11#1)(2010-3#1)(2011-3#1)
the patients with acute coronary##2##5##(2008-10#2)
the patients with an##2##4##(1992-5#1)(2009-6#1)
the patients with benign##2##4##(1990-9#1)(2011-1#1)
the patients with cancer of the pancreas##4##7##(2008-7#4)
the patients with cancer of the stomach##4##7##(2008-7#4)
the patients with cancer of the##8##6##(2008-7#8)
the patients with chronic##3##4##(2006-10#1)(2008-4#1)(2009-8#1)
the patients with end-stage##2##4##(2008-7#1)(2011-2#1)
the patients with the##3##4##(2007-7#1)(2008-1#1)(2008-12#1)
the patients with vascular##2##4##(1993-2#1)(2013-1#1)
the patients with##93##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-4#1)(1992-11#2)(1992-4#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#17)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
the patients within##3##3##(2008-5#1)(2010-7#2)
the patients without##5##3##(1991-6#1)(1994-7#1)(2007-8#1)(2008-7#2)
the patients##642##2##(1990-10#3)(1990-11#3)(1990-12#9)(1990-2#8)(1990-3#3)(1990-5#4)(1990-6#7)(1990-8#1)(1990-9#11)(1991-1#1)(1991-12#3)(1991-2#6)(1991-3#6)(1991-4#3)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#9)(1992-6#6)(1992-8#2)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#4)(1995-1#1)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#2)(1995-5#5)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#6)(1996-9#7)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-8#9)(2006-10#1)(2007-10#11)(2007-11#22)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#23)(2007-8#21)(2007-9#1)(2008-1#35)(2008-10#25)(2008-11#12)(2008-12#5)(2008-3#4)(2008-4#10)(2008-5#8)(2008-6#5)(2008-7#56)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#2)(2010-12#3)(2010-3#7)(2010-4#2)(2010-6#3)(2010-7#6)(2010-8#9)(2011-1#19)(2011-2#34)(2011-3#4)(2012-12#6)(2012-2#6)(2012-3#13)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#10)
the patients' rights##2##3##(1997-8#1)(2013-8#1)
the patients'##38##2##(1990-2#2)(1991-2#4)(1991-4#1)(1993-2#2)(1993-5#1)(1994-2#1)(1995-4#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#2)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
the patients)##3##2##(1991-4#1)(1994-2#1)(2007-7#1)
the pattern and##6##3##(1991-8#2)(1995-2#1)(1996-4#1)(2008-3#1)(2008-7#1)
the pattern found in##2##4##(1993-11#1)(2007-5#1)
the pattern in##2##3##(1996-4#1)(2007-12#1)
the pattern of distribution##3##4##(1996-3#1)(2008-10#2)
the pattern of expression of the##2##6##(1994-11#1)(1997-4#1)
the pattern of expression of##3##5##(1994-11#1)(1995-12#1)(1997-4#1)
the pattern of selection##2##4##(2008-8#2)
the pattern of the##5##4##(1990-12#1)(1991-2#1)(1994-5#1)(2008-8#1)(2013-8#1)
the pattern of use##2##4##(1996-9#1)(2011-1#1)
the pattern of##76##3##(1990-12#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-10#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
the pattern##104##2##(1990-12#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#10)(2008-9#3)(2009-10#2)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
the patterning of a##2##4##(1996-2#1)(2007-11#1)
the patterning of##3##3##(1996-2#1)(2007-11#1)(2007-12#1)
the patterns of disfluency##3##4##(2008-2#3)
the patterns of##36##3##(1991-12#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2007-7#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
the patterns##46##2##(1991-12#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-7#4)(2008-1#4)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
the paucity of##12##3##(1991-8#1)(1995-1#1)(1997-2#1)(1997-9#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
the paw##2##2##(1994-3#1)(1995-12#1)
the payer##3##2##(1996-1#1)(2008-12#1)(2013-8#1)
the payment for##2##3##(1994-1#1)(2008-11#1)
the payment##7##2##(1992-1#1)(1992-2#1)(1994-1#1)(1994-12#2)(1996-3#1)(2008-11#1)
the payoff##2##2##(1992-2#1)(2008-8#1)
the pea lectin##3##3##(1993-8#3)
the pea##13##2##(1993-6#1)(1993-8#4)(2008-10#7)(2009-8#1)
the peak BMD##2##3##(2010-3#2)
the peak absorption##3##3##(2008-3#3)
the peak and##2##3##(1996-2#1)(1997-2#1)
the peak area of##3##4##(2008-10#2)(2011-1#1)
the peak area ratios##2##4##(2008-10#2)
the peak area##13##3##(1990-8#1)(2008-10#10)(2011-1#2)
the peak areas##2##3##(2011-1#1)(2013-1#1)
the peak at##2##3##(2008-10#1)(2008-11#1)
the peak concentration##2##3##(1992-9#1)(2008-11#1)
the peak current and##5##4##(2008-10#5)
the peak current is proportional to##2##6##(2008-10#2)
the peak current of the##2##5##(2008-10#2)
the peak current of##4##4##(2008-10#4)
the peak current##21##3##(2008-10#21)
the peak currents are linearly proportional to the concentration of##3##10##(2008-10#3)
the peak currents are##4##4##(2008-10#4)
the peak currents##8##3##(2008-10#8)
the peak experiences of psilocybin users##2##6##(2013-8#2)
the peak frequency##2##3##(2008-11#1)(2008-2#1)
the peak grating##2##3##(2008-2#1)(2008-3#1)
the peak height and peak##2##5##(1996-5#1)(2008-10#1)
the peak height and##3##4##(1996-5#1)(2008-10#2)
the peak height##11##3##(1993-8#1)(1996-5#1)(2008-10#9)
the peak heights obtained##4##4##(2008-10#4)
the peak heights##7##3##(2008-10#6)(2008-2#1)
the peak in##3##3##(1997-7#1)(2008-9#2)
the peak intensities##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
the peak intensity of a##2##5##(2008-2#2)
the peak intensity of the##3##5##(2008-2#2)(2008-3#1)
the peak intensity of##5##4##(2008-2#4)(2008-3#1)
the peak intensity##9##3##(2007-11#1)(2008-2#5)(2008-3#3)
the peak latency of the visual evoked potential##2##8##(1995-12#2)
the peak latency of##3##4##(1995-12#2)(2008-7#1)
the peak of spine##2##4##(2007-8#2)
the peak of the##11##4##(1990-11#1)(1995-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-8#1)(2008-9#1)
the peak of##19##3##(1990-11#1)(1991-9#1)(1993-8#1)(1994-5#1)(1995-11#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-2#3)(2008-6#2)(2008-8#1)(2008-9#1)(2013-1#1)
the peak period of fruit susceptibility##2##6##(2008-10#2)
the peak position at maximum height##2##6##(2008-10#2)
the peak position of the##2##5##(2007-11#1)(2008-3#1)
the peak position##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
the peak potential##3##3##(2008-10#3)
the peak potentials##4##3##(2008-10#4)
the peak power##3##3##(2007-11#2)(2007-12#1)
the peak time##2##3##(2008-10#1)(2011-2#1)
the peak value of the##3##5##(2008-3#1)(2008-7#1)(2013-8#1)
the peak values of the##2##5##(2008-3#2)
the peak values of##3##4##(2008-3#2)(2008-8#1)
the peak##198##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-8#2)(1994-5#1)(1995-11#2)(1995-12#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-7#2)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#1)(2007-8#3)(2008-10#88)(2008-11#3)(2008-2#14)(2008-3#17)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-6#1)(2010-3#3)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#3)
the peak-power frequency##2##3##(2008-3#2)
the peak-to-output-energy ratio##2##3##(2008-2#2)
the peak-to-peak##2##2##(2008-10#1)(2008-3#1)
the peaks corresponding to##2##4##(2008-10#2)
the peaks of the##3##4##(2008-10#3)
the peaks of##7##3##(2008-10#6)(2011-2#1)
the peaks were##2##3##(2008-10#2)
the peaks##24##2##(1997-4#1)(2007-12#1)(2008-10#19)(2008-12#1)(2008-3#1)(2011-2#1)
the peasants##2##2##(1993-3#1)(1993-6#1)
the peat##5##2##(2008-10#5)
the pecking behavior##2##3##(2008-6#2)
the pecking##3##2##(2008-6#2)(2009-9#1)
the pecten##3##2##(2008-5#3)
the pectoral##3##2##(1997-6#1)(2008-5#1)(2009-7#1)
the pectoralis major##4##3##(2009-1#1)(2012-2#3)
the pectoralis minor##3##3##(2010-9#2)(2013-1#1)
the pectoralis##7##2##(2009-1#1)(2010-9#2)(2012-2#3)(2013-1#1)
the peculiar##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
the peculiarities of##4##3##(1991-6#1)(2008-10#1)(2008-3#1)(2010-12#1)
the peculiarity of##2##3##(2010-1#1)(2013-7#1)
the pediatric age group##3##4##(2008-4#1)(2009-3#1)(2013-1#1)
the pediatric and##2##3##(1990-6#1)(2009-11#1)
the pediatric patient##2##3##(2008-10#1)(2011-2#1)
the pediatric population##7##3##(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#2)(2013-8#2)
the pediatric##34##2##(1990-6#1)(1992-3#1)(1995-5#1)(1996-1#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
the pediatrician##3##2##(1996-2#1)(2010-3#1)(2013-1#1)
the pediatricians##2##2##(1995-12#1)(2007-12#1)
the pedicle##4##2##(2007-11#2)(2008-7#1)(2011-2#1)
the pedigree##2##2##(2008-10#2)
the peduncle##2##2##(2008-10#2)
the pedunculopontine tegmental nucleus (PPTg)##2##5##(1994-2#1)(1995-12#1)
the pedunculopontine tegmental nucleus##5##4##(1994-2#2)(1994-3#1)(1995-12#1)(2008-7#1)
the pedunculopontine##6##2##(1994-2#2)(1994-3#2)(1995-12#1)(2008-7#1)
the peel##5##2##(2008-10#3)(2008-5#2)
the peer review process##3##4##(1992-12#1)(1993-1#1)(2008-11#1)
the peer##5##2##(1992-12#1)(1993-1#1)(2008-11#1)(2008-8#1)(2009-8#1)
the peer-reviewed##3##2##(2010-8#2)(2012-12#1)
the pellet##2##2##(2008-6#1)(2008-7#1)
the pellets##2##2##(2008-10#2)
the pelvic cavity##3##3##(1992-3#1)(2008-12#1)(2008-7#1)
the pelvic floor##4##3##(2010-12#1)(2011-2#2)(2012-1#1)
the pelvic joint syndrome##2##4##(1990-6#1)(1991-2#1)
the pelvic nerve##2##3##(1992-3#2)
the pelvic region##3##3##(1993-8#1)(2008-10#1)(2012-1#1)
the pelvic##22##2##(1990-5#2)(1990-6#2)(1991-2#1)(1992-3#3)(1993-8#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2011-2#3)(2012-1#2)
the pelvis and##4##3##(1991-11#1)(2007-10#1)(2010-3#1)(2013-1#1)
the pelvis##32##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#2)(2007-10#1)(2007-11#2)(2008-12#1)(2008-6#2)(2008-8#4)(2009-12#1)(2010-3#2)(2011-2#12)(2013-1#2)
the penalized##2##2##(2008-6#1)(2010-5#1)
the penalties##2##2##(1992-2#1)(2013-1#1)
the pendant##2##2##(2007-12#1)(2009-10#1)
the penetration and##2##3##(2008-10#1)(2012-3#1)
the penetration depth of##3##4##(2008-3#2)(2011-1#1)
the penetration depth##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
the penetration of##6##3##(1994-3#1)(2007-12#1)(2008-2#1)(2008-5#2)(2011-2#1)
the penetration pore##3##3##(2008-10#3)
the penetration##20##2##(1991-12#1)(1994-3#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#4)(2011-1#1)(2011-2#1)(2012-3#1)
the penicillin##5##2##(1995-3#1)(2008-10#2)(2011-1#2)
the penile shaft##2##3##(2007-7#1)(2008-10#1)
the penile##6##2##(1992-8#1)(2007-7#1)(2008-10#2)(2011-1#1)(2013-8#1)
the penis and##2##3##(2007-7#1)(2008-10#1)
the penis is##4##3##(1990-12#1)(1992-8#1)(2008-10#1)(2009-5#1)
the penis##22##2##(1990-12#2)(1991-8#1)(1992-8#2)(2007-7#1)(2008-10#5)(2008-6#1)(2009-5#7)(2012-12#1)(2013-1#1)(2013-8#1)
the pentaammine ruthenium(II)##2##3##(2008-10#2)
the pentapeptide##2##2##(1990-7#1)(2008-7#1)
the pentose phosphate pathway (PPP)##2##5##(2008-7#2)
the pentose phosphate pathway##7##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-12#1)
the pentose-phosphate##2##2##(1992-3#1)(2008-11#1)
the people are##2##3##(2010-12#1)(2011-2#1)
the people in the##2##4##(2010-8#1)(2013-8#1)
the people in##3##3##(1995-2#1)(2010-8#1)(2013-8#1)
the people of##3##3##(1995-1#1)(1997-4#1)(2010-8#1)
the people who##3##3##(1996-3#1)(2008-1#1)(2013-8#1)
the people##30##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
the people's##2##2##(2010-10#1)(2012-3#1)
the pepper##3##2##(2008-10#3)
the pepsinogen##2##2##(1995-3#1)(1995-8#1)
the peptidase##2##2##(1990-11#1)(2008-4#1)
the peptide and##4##3##(1993-8#1)(1996-12#1)(2008-10#1)(2008-5#1)
the peptide backbone##4##3##(1990-8#1)(1992-6#1)(1993-11#1)(2008-4#1)
the peptide bond##4##3##(1992-6#1)(1993-11#1)(1995-6#1)(2008-10#1)
the peptide chain##2##3##(1994-9#1)(1996-12#1)
the peptide hormone##2##3##(1995-12#1)(2011-1#1)
the peptide in##5##3##(1992-6#2)(1993-11#1)(2008-6#1)(2012-3#1)
the peptide is##5##3##(1990-11#1)(1994-11#1)(1994-5#1)(1996-5#1)(2008-8#1)
the peptide sequence##5##3##(2008-10#1)(2008-4#3)(2012-12#1)
the peptide substrate##2##3##(1992-11#1)(1993-11#1)
the peptide synthesis of##2##4##(1993-12#1)(2008-10#1)
the peptide synthesis##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
the peptide was##5##3##(1990-7#1)(1991-5#1)(1993-8#1)(2008-10#2)
the peptide with an excess##2##5##(2008-8#2)
the peptide with##3##3##(1992-4#1)(2008-8#2)
the peptide##118##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#1)(1992-9#2)(1993-11#6)(1993-12#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#6)(1996-12#5)(1996-5#2)(1997-4#2)(2007-11#1)(2008-1#1)(2008-10#10)(2008-4#13)(2008-5#2)(2008-6#1)(2008-8#4)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
the peptides are##3##3##(1994-8#1)(1996-5#1)(2008-5#1)
the peptides##29##2##(1990-11#2)(1990-5#1)(1991-2#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#2)(1996-5#1)(1997-2#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2011-2#2)(2012-1#1)
the peptidoglycan##4##2##(1990-7#1)(1995-2#1)(1997-4#1)(2012-2#1)
the peptidolytic reaction##2##3##(1991-9#2)
the peptone##4##2##(2008-7#4)
the per capita growth##2##4##(2008-8#1)(2013-8#1)
the per capita##4##3##(2008-8#3)(2013-8#1)
the per cent##2##3##(1991-2#2)
the per##9##2##(1991-2#2)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#3)(2013-8#1)
the per-cell MPI yield##2##4##(1995-6#2)
the perceived prevalence of##2##4##(2013-1#2)
the perceived quality of##3##4##(2008-11#1)(2009-4#1)(2013-1#1)
the perceived risk of##2##4##(1990-5#1)(1994-3#1)
the perceived social support##2##4##(1992-2#1)(2009-7#1)
the perceived value of##2##4##(1994-1#1)(2012-2#1)
the perceived##39##2##(1990-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
the percent of##5##3##(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2013-7#1)
the percent recoveries were increased##2##5##(2008-10#2)
the percent recovery##3##3##(2008-10#3)
the percent##18##2##(1993-3#1)(1993-8#1)(1996-12#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-7#1)
the percentage and##2##3##(2008-8#1)(2010-1#1)
the percentage content of##2##4##(2008-10#2)
the percentage extraction##2##3##(2008-10#2)
the percentage increment of##2##4##(2011-2#2)
the percentage of all##2##4##(1995-3#1)(2011-2#1)
the percentage of budded cells##2##5##(1996-3#2)
the percentage of cells##3##4##(2008-10#2)(2008-4#1)
the percentage of deaths due to##2##6##(1992-6#1)(2012-2#1)
the percentage of discolored kernels##2##5##(2011-2#2)
the percentage of diseased spikelets##2##5##(2008-10#2)
the percentage of diseased##4##4##(2008-10#4)
the percentage of ear##2##4##(2008-10#1)(2008-9#1)
the percentage of infected##2##4##(2008-10#2)
the percentage of leaf##2##4##(2008-10#2)
the percentage of m5Cyt##2##4##(1991-5#2)
the percentage of parents who##2##5##(1994-2#1)(1994-3#1)
the percentage of patients who##3##5##(1995-1#1)(1995-5#1)(2008-7#1)
the percentage of smokers##2##4##(1991-4#1)(2013-1#1)
the percentage of the##8##4##(1993-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-8#1)
the percentage of water##2##4##(2008-10#1)(2008-5#1)
the percentage of##127##3##(1990-11#1)(1990-6#1)(1991-11#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-10#40)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-3#1)(2010-4#2)(2011-1#4)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#5)
the percentage##149##2##(1990-11#2)(1990-6#1)(1991-11#3)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-10#50)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#13)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#5)
the percentages of the##2##4##(1993-8#1)(2008-11#1)
the percentages of##14##3##(1993-8#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#1)
the percentages##16##2##(1990-12#1)(1993-8#1)(1997-2#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#1)
the perception and interpretation of##2##5##(2008-11#1)(2008-6#1)
the perception and##4##3##(2008-11#2)(2008-6#1)(2011-2#1)
the perception of the##2##4##(2007-12#1)(2012-2#1)
the perception of##28##3##(1992-3#1)(1994-12#1)(1995-1#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-5#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#6)
the perception that##2##3##(1994-7#1)(1996-1#1)
the perception##40##2##(1991-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#6)
the perceptions and##2##3##(2009-5#1)(2010-11#1)
the perceptions of neighborhood##2##4##(2009-9#2)
the perceptions of staff##2##4##(2007-11#2)
the perceptions of##10##3##(2007-11#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-9#1)(2012-3#1)
the perceptions##13##2##(2007-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-9#1)(2012-3#1)
the perceptual encoding##2##3##(2007-8#2)
the perceptual##8##2##(2007-8#3)(2008-3#1)(2008-8#1)(2010-8#1)(2013-8#2)
the perchlorate ion##2##3##(2008-10#2)
the perchlorate##7##2##(2008-10#7)
the percutaneous absorption of##3##4##(2008-5#1)(2011-3#2)
the percutaneous absorption##4##3##(2008-5#2)(2011-3#2)
the percutaneous##12##2##(1991-3#2)(2008-12#1)(2008-5#2)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-8#1)
the perennial##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
the perfect##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#2)
the perforant path##2##3##(1990-5#1)(1990-7#1)
the perforant##3##2##(1990-5#2)(1990-7#1)
the performance and##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
the performance characteristics of##2##4##(2008-2#1)(2008-5#1)
the performance characteristics##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
the performance of SMBG in T2DM##2##6##(2009-11#2)
the performance of SMBG in##3##5##(2009-11#3)
the performance of a diagnostic##2##5##(1996-8#1)(2008-7#1)
the performance of a number of##2##6##(1995-5#1)(2008-3#1)
the performance of a##36##4##(1993-12#1)(1995-5#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#15)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#2)
the performance of an##5##4##(1993-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
the performance of both##4##4##(2008-10#2)(2008-3#2)
the performance of five##3##4##(2008-6#1)(2012-1#1)(2012-2#1)
the performance of four##3##4##(1995-2#1)(2008-3#1)(2011-1#1)
the performance of health care##2##5##(1995-12#1)(1996-2#1)
the performance of health##3##4##(1995-12#1)(1996-12#1)(1996-2#1)
the performance of its##2##4##(1990-11#1)(1993-12#1)
the performance of our##2##4##(2008-3#1)(2008-6#1)
the performance of physicians##2##4##(1996-3#2)
the performance of such##2##4##(2008-2#1)(2008-6#1)
the performance of the algorithm##3##5##(1997-3#1)(2008-2#1)(2008-3#1)
the performance of the device##2##5##(2008-3#2)
the performance of the etalon##2##5##(2008-3#2)
the performance of the method##5##5##(2008-10#1)(2008-2#2)(2010-4#1)(2012-1#1)
the performance of the nonlinear joint transform correlator##2##8##(2008-2#2)
the performance of the optical system##2##6##(2008-2#1)(2008-3#1)
the performance of the proposed method##2##6##(2008-10#1)(2008-3#1)
the performance of the proposed##7##5##(2008-10#3)(2008-2#1)(2008-3#1)(2009-9#1)(2010-8#1)
the performance of the system were##2##6##(2008-10#2)
the performance of the system with##2##6##(2008-10#1)(2008-3#1)
the performance of the system##6##5##(2008-10#4)(2008-3#2)
the performance of the two##3##5##(1991-2#1)(2008-12#1)(2008-5#1)
the performance of the##91##4##(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#17)(2008-3#22)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#1)
the performance of their##2##4##(1994-2#1)(1996-12#1)
the performance of these systems##2##5##(2008-3#2)
the performance of these##6##4##(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)
the performance of this approach##3##5##(2008-3#2)(2012-3#1)
the performance of this system##4##5##(2007-12#1)(2008-10#2)(2008-11#1)
the performance of this##13##4##(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2012-3#1)
the performance of three##2##4##(2008-10#2)
the performance of two##2##4##(1991-2#1)(2008-5#1)
the performance of various##2##4##(2008-10#1)(2008-3#1)
the performance of##293##3##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-11#8)(2007-12#5)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#50)(2008-11#6)(2008-12#3)(2008-2#27)(2008-3#66)(2008-4#3)(2008-5#7)(2008-6#8)(2008-7#6)(2008-9#5)(2009-11#4)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
the performance on the##2##4##(2008-10#2)
the performance on##3##3##(2008-10#2)(2010-3#1)
the performance requirements##2##3##(2008-3#1)(2011-2#1)
the performance was##2##3##(2008-10#1)(2013-1#1)
the performance##335##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#3)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-11#9)(2007-12#5)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#60)(2008-11#8)(2008-12#3)(2008-2#33)(2008-3#69)(2008-4#4)(2008-5#10)(2008-6#9)(2008-7#6)(2008-9#6)(2009-11#4)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#2)
the performance-based ranking within a group of##2##7##(2011-2#2)
the performance-based##3##2##(1996-2#1)(2011-2#2)
the performances of the sensor##2##5##(2008-10#2)
the performances of the##8##4##(2007-8#1)(2008-10#6)(2011-2#1)
the performances of##14##3##(1991-3#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2011-2#1)
the performances##16##2##(1991-3#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
the performed##3##2##(2007-11#1)(2008-10#2)
the perfusate##8##2##(1991-9#3)(1992-3#1)(1996-12#3)(2008-7#1)
the perfused##7##2##(1990-11#2)(1991-3#1)(1991-5#1)(1993-11#1)(1995-3#1)(2008-6#1)
the perfusion of the##3##4##(1996-3#1)(2008-10#1)(2009-11#1)
the perfusion of##8##3##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-8#1)
the perfusion rate##3##3##(2008-11#3)
the perfusion system##3##3##(2008-11#2)(2012-2#1)
the perfusion##23##2##(1992-3#1)(1995-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#9)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#3)(2010-12#1)(2010-8#1)(2012-2#1)
the peri-implantation##2##2##(1994-8#1)(1994-9#1)
the peri-infarct##3##2##(2007-10#2)(2012-12#1)
the periaqueductal gray##2##3##(1993-12#1)(2008-7#1)
the pericardium and##3##3##(2007-8#1)(2008-9#1)(2010-8#1)
the pericardium##7##2##(2007-8#2)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)
the pericarp##2##2##(2008-10#2)
the pericellular##3##2##(1993-12#1)(2008-4#1)(2011-2#1)
the perikarya of##2##3##(1992-3#1)(2008-6#1)
the perikaryon##4##2##(2008-7#4)
the perimeter##2##2##(1995-11#1)(2008-2#1)
the perinatal mortality##3##3##(1990-3#1)(1994-3#1)(1995-6#1)
the perinatal period##6##3##(1993-6#1)(1995-6#1)(2007-2#1)(2009-2#1)(2009-9#1)(2011-2#1)
the perinatal##14##2##(1990-3#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-6#2)(2007-2#2)(2007-7#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-3#1)
the perineal##2##2##(2008-10#1)(2010-12#1)
the perineum##4##2##(2008-10#2)(2008-7#2)
the perinuclear region##2##3##(1992-11#1)(2012-3#1)
the perinuclear space##2##3##(2008-9#1)(2011-2#1)
the perinuclear##9##2##(1992-11#1)(1993-11#1)(2007-12#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
the period 1980##2##3##(1993-6#1)(1997-8#1)
the period 1986-1989##2##3##(1991-8#2)
the period January##4##3##(1990-6#1)(2007-12#1)(2011-2#1)(2013-1#1)
the period July##2##3##(1992-2#1)(2008-1#1)
the period September##2##3##(1995-11#1)(2011-2#1)
the period after##2##3##(1995-12#1)(1995-3#1)
the period and cohort##2##4##(1996-3#2)
the period and##4##3##(1996-3#2)(2008-3#1)(2011-2#1)
the period between##11##3##(1994-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
the period covered##2##3##(1993-1#1)(2008-7#1)
the period following the##2##4##(1993-3#1)(1993-6#1)
the period from 1970##2##4##(1992-1#1)(2008-2#1)
the period from January##3##4##(2007-8#2)(2008-5#1)
the period from November##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the period from October##2##4##(1995-5#1)(2011-3#1)
the period from the initiation of##2##6##(2008-5#2)
the period from the##3##4##(2008-5#3)
the period from##28##3##(1990-3#1)(1992-1#1)(1994-12#1)(1995-5#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
the period in question##2##4##(1990-8#1)(2011-2#1)
the period in which##2##4##(2008-5#1)(2011-2#1)
the period in##5##3##(1990-8#1)(2008-5#2)(2011-2#2)
the period of 1998-2002##2##4##(2007-11#2)
the period of 6 weeks##2##5##(2008-11#1)(2013-1#1)
the period of one year##2##5##(2012-3#1)(2013-8#1)
the period of study##4##4##(2008-12#1)(2008-6#1)(2011-1#1)(2012-12#1)
the period of the##6##4##(1993-6#1)(1996-12#1)(2007-11#2)(2008-10#1)(2008-3#1)
the period of##66##3##(1991-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-7#1)(1996-12#2)(1996-6#2)(1997-4#1)(1997-6#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#1)
the period studied##2##3##(1995-8#1)(2008-10#1)
the period was##3##3##(1997-8#1)(2007-12#1)(2008-5#1)
the period when##4##3##(1996-5#1)(2008-10#1)(2008-6#1)(2008-8#1)
the period##250##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-6#4)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#5)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-6#3)(1996-9#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#11)(2007-12#3)(2007-2#1)(2007-8#4)(2008-1#5)(2008-10#24)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#2)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#7)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#3)
the periodate oxidation of##3##4##(2008-10#3)
the periodic##14##2##(1993-6#1)(1994-3#1)(2007-11#1)(2007-12#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-1#1)
the periodical##2##2##(2008-3#1)(2011-2#1)
the periodically poled##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
the periodically##6##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
the periodicity##3##2##(2008-2#1)(2009-6#1)(2013-8#1)
the periodontal status##2##3##(2013-1#2)
the periodontal##14##2##(1990-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2012-12#2)(2012-3#5)(2013-1#3)
the periods##8##2##(1995-12#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2012-2#1)
the perioperative management of##4##4##(2006-10#1)(2007-8#1)(2012-3#1)(2013-1#1)
the perioperative period##8##3##(1992-3#1)(2006-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the perioperative period]##2##3##(2008-10#1)(2009-5#1)
the perioperative##20##2##(1992-3#1)(1992-5#1)(2006-10#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#3)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
the periorbital area##2##3##(2008-5#2)
the periosteum of the##2##4##(2007-12#1)(2008-9#1)
the periosteum##4##2##(1994-3#1)(2007-12#1)(2008-9#2)
the peripancreatic##2##2##(1990-3#1)(1993-3#1)
the peripheral and##2##3##(1994-11#1)(2010-1#1)
the peripheral areas of##2##4##(2008-11#1)(2009-10#1)
the peripheral benzodiazepine receptor##3##4##(1995-12#1)(2008-8#1)(2012-2#1)
the peripheral blood of##5##4##(1996-12#2)(2007-10#1)(2008-10#1)(2011-1#1)
the peripheral blood##21##3##(1990-3#1)(1990-5#1)(1990-6#1)(1994-11#1)(1996-12#2)(1997-6#1)(2007-10#1)(2008-10#1)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#2)
the peripheral nerve##3##3##(1993-6#1)(2008-7#1)(2009-10#1)
the peripheral nervous system##10##4##(1993-6#2)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-10#1)(2008-7#1)(2009-10#1)(2013-1#1)
the peripheral nicotinic##2##3##(1996-12#1)(1996-2#1)
the peripheral tissues##4##3##(1991-7#2)(1995-12#2)
the peripheral zone##2##3##(1994-3#1)(2011-2#1)
the peripheral##84##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-7#2)(1992-10#1)(1992-3#1)(1993-12#1)(1993-6#3)(1994-11#3)(1994-12#2)(1994-3#1)(1995-12#4)(1995-5#1)(1996-12#4)(1996-2#2)(1996-3#2)(1997-6#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#2)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#6)
the periphery and##2##3##(2008-4#1)(2010-2#1)
the periphery of the##11##4##(1991-11#1)(1991-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#1)
the periphery of##17##3##(1990-8#1)(1991-11#1)(1991-2#1)(1997-8#1)(2007-12#3)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2011-2#2)
the periphery or##2##3##(2008-7#1)(2009-10#1)
the periphery##37##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
the periplasm and##2##3##(1993-9#1)(1994-2#1)
the periplasm of##2##3##(2008-7#1)(2009-6#1)
the periplasm##6##2##(1991-10#1)(1993-9#1)(1994-2#1)(2008-7#1)(2008-8#1)(2009-6#1)
the periplasmic space##5##3##(1990-8#1)(1993-6#1)(1994-8#1)(1997-3#1)(2008-4#1)
the periplasmic##8##2##(1990-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-4#1)(2009-2#1)(2011-2#1)
the perirenal fat##3##3##(2010-4#2)(2013-1#1)
the peristaltic##2##2##(1996-3#1)(2008-10#1)
the peritoneal catheter##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
the peritoneal cavity and##2##4##(2007-12#1)(2008-10#1)
the peritoneal cavity##14##3##(1990-2#1)(1992-2#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-12#2)(2008-6#1)(2011-2#1)(2012-12#1)
the peritoneal##27##2##(1990-2#1)(1992-2#1)(1994-9#2)(1995-3#1)(2007-12#4)(2008-1#5)(2008-10#5)(2008-12#2)(2008-6#1)(2011-2#4)(2012-12#1)
the peritoneum##5##2##(1990-2#1)(1991-12#1)(2007-7#1)(2008-1#1)(2011-2#1)
the peritumoral##2##2##(1990-2#1)(1995-12#1)
the perivenous##4##2##(1990-11#3)(1991-12#1)
the perivitelline##2##2##(1991-5#1)(2008-9#1)
the periwinkle Tympanotonus fuscatus##2##4##(2008-5#2)
the permanence of##2##3##(2008-5#1)(2012-2#1)
the permanent calves##3##3##(1996-12#3)
the permanent##17##2##(1992-2#1)(1992-9#1)(1996-12#3)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2013-1#1)
the permeability of the##5##4##(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
the permeability of##17##3##(1990-5#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1997-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
the permeability##23##2##(1990-11#1)(1990-5#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#2)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
the permeant diffusion coefficient##2##4##(2008-5#2)
the permeant##5##2##(1990-11#2)(1991-5#1)(2008-5#2)
the permeation of##2##3##(2008-10#1)(2011-3#1)
the permeation##6##2##(2008-10#1)(2008-5#3)(2008-8#1)(2011-3#1)
the permissible##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
the permittivity##3##2##(2008-11#1)(2008-3#2)
the peroxidase activity##2##3##(2008-10#2)
the peroxidase##5##2##(2008-10#5)
the peroxidation##3##2##(1990-8#1)(1994-5#1)(2008-5#1)
the peroxidative reaction of SOD##2##5##(1997-8#2)
the peroxidative##3##2##(1997-2#1)(1997-8#2)
the peroxisomal##4##2##(1993-9#1)(1995-2#1)(1995-6#1)(1995-9#1)
the peroxisome proliferator-activated receptor##3##4##(1994-8#1)(2008-5#2)
the peroxisome##4##2##(1994-8#2)(2008-5#2)
the perpetrator##2##2##(2008-11#1)(2011-2#1)
the persimmon tannin gel##2##4##(2008-10#2)
the persimmon##4##2##(2008-10#4)
the persistence of the##4##4##(2008-5#1)(2008-8#1)(2010-6#1)(2013-8#1)
the persistence of##17##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#5)(2009-4#1)(2009-8#1)(2010-6#2)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#2)
the persistence##21##2##(1994-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#5)(2009-4#1)(2009-8#1)(2010-6#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
the persistent##10##2##(1990-9#1)(1997-5#1)(2007-12#1)(2008-11#3)(2008-8#1)(2010-3#1)(2012-12#1)(2012-3#1)
the person responsible for##2##4##(1994-2#1)(2009-2#1)
the person##19##2##(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2009-2#1)(2010-6#1)(2012-2#2)
the person's##2##2##(2010-10#1)(2012-2#1)
the personal and##3##3##(2008-12#1)(2012-1#1)(2012-12#1)
the personal characteristics##2##3##(2009-7#1)(2010-9#1)
the personal tutor##2##3##(2008-11#2)
the personal##21##2##(1990-12#1)(1991-12#1)(1994-3#1)(1995-12#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
the personality and##2##3##(2009-8#1)(2011-1#1)
the personality characteristics##2##3##(2009-5#2)
the personality of##2##3##(2008-8#1)(2012-3#1)
the personality trait of##2##4##(2010-6#1)(2011-2#1)
the personality trait##3##3##(2008-5#1)(2010-6#1)(2011-2#1)
the personality##12##2##(1993-11#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
the personnel and##2##3##(1994-3#2)
the personnel of##2##3##(1996-3#1)(2008-10#1)
the personnel##10##2##(1992-11#1)(1994-11#2)(1994-3#2)(1995-2#1)(1996-3#1)(2008-10#1)(2010-9#2)
the persons##6##2##(1994-11#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
the perspective of a##4##4##(1994-1#1)(1994-12#1)(2008-1#2)
the perspective of perioperative nurse leaders##3##6##(2012-3#3)
the perspective of the##9##4##(1991-12#1)(1992-3#1)(1993-12#1)(2007-11#1)(2008-11#2)(2008-7#1)(2010-3#1)(2012-3#1)
the perspective of##49##3##(1991-12#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2007-11#2)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-10#4)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)
the perspective##53##2##(1991-12#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2007-11#2)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#2)(2008-9#3)(2009-3#1)(2010-10#4)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#1)
the perspectives of##8##3##(1993-1#1)(1997-3#1)(2008-12#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
the perspectives##10##2##(1993-1#1)(1996-3#1)(1997-3#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
the pertinent literature##4##3##(2007-12#1)(2007-7#1)(2012-12#1)(2012-2#1)
the pertinent##14##2##(1990-2#1)(1996-6#1)(2007-12#2)(2007-7#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
the perturbants##2##2##(1994-3#2)
the perturbation of UA on the##2##6##(2008-10#2)
the perturbation of##6##3##(1997-6#1)(2008-10#3)(2008-7#2)
the perturbation##13##2##(1997-6#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#2)
the perturbations##3##2##(1995-5#1)(2007-12#1)(2008-5#1)
the perturbed##2##2##(2008-3#1)(2009-8#1)
the pertussis##2##2##(1997-7#1)(2013-1#1)
the pervasive##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
the pervasiveness of this##2##4##(1995-3#1)(2009-10#1)
the pervasiveness of##3##3##(1994-2#1)(1995-3#1)(2009-10#1)
the pest##6##2##(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
the pesticide##20##2##(2008-10#13)(2008-7#3)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
the pesticides at##2##3##(2008-10#2)
the pesticides##11##2##(2007-5#1)(2008-10#7)(2008-11#3)
the petition of##2##3##(1990-11#1)(1993-9#1)
the petition##3##2##(1990-11#1)(1993-9#1)(1995-6#1)
the petri##2##2##(2008-10#2)
the petrol##2##2##(2008-10#2)
the petrous apex cholesteatoma##2##4##(2011-2#2)
the petrous apex##4##3##(2011-2#4)
the petrous bone and##2##4##(2008-7#1)(2008-8#1)
the petrous bone##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
the petrous##10##2##(2008-7#2)(2008-8#1)(2011-2#6)(2012-12#1)
the petunia##2##2##(1993-6#2)
the pha genes of P##2##5##(2008-6#2)
the pha genes##3##3##(2008-6#3)
the phage display method##2##4##(2008-11#2)
the phage display##3##3##(2008-10#1)(2008-11#2)
the phage lambda##3##3##(1991-6#1)(1995-3#1)(1995-8#1)
the phage##20##2##(1990-5#1)(1990-7#1)(1991-6#1)(1994-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-8#1)(2009-5#1)(2012-2#1)
the phages##2##2##(2012-2#2)
the phagocytic##4##2##(1990-12#2)(1994-6#2)
the phagocytosis of##5##3##(1991-5#1)(2008-4#1)(2008-6#3)
the phagocytosis##7##2##(1991-5#1)(1993-6#1)(2008-4#1)(2008-6#4)
the phantom is##2##3##(2008-5#1)(2011-1#1)
the phantom tissue##2##3##(2009-11#2)
the phantom##15##2##(2008-3#6)(2008-5#3)(2009-11#2)(2010-2#2)(2011-1#1)(2012-12#1)
the phantoms##2##2##(2008-3#1)(2012-1#1)
the pharmaceutical and biotechnology industries##2##5##(2008-10#1)(2008-5#1)
the pharmaceutical and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the pharmaceutical industry and##2##4##(2009-12#1)(2011-2#1)
the pharmaceutical industry in##2##4##(1991-3#1)(2008-10#1)
the pharmaceutical industry is##3##4##(1997-4#1)(2008-10#1)(2009-11#1)
the pharmaceutical industry to##2##4##(1996-2#1)(2009-11#1)
the pharmaceutical industry##27##3##(1991-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#3)(2008-11#5)(2008-5#3)(2009-11#4)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
the pharmaceutical preparations##3##3##(2008-10#3)
the pharmaceutical sector##2##3##(2012-1#1)(2012-2#1)
the pharmaceutical##53##2##(1991-3#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#18)(2008-11#7)(2008-5#4)(2009-11#4)(2009-12#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-8#1)
the pharmacist's##2##2##(1993-2#1)(2010-3#1)
the pharmacists to##2##3##(2010-5#2)
the pharmacists##4##2##(2010-5#2)(2011-1#2)
the pharmacodynamic##2##2##(2008-5#1)(2008-8#1)
the pharmacokinetic parameters were##2##4##(2008-11#1)(2008-5#1)
the pharmacokinetic parameters##4##3##(2008-11#1)(2008-5#1)(2012-2#2)
the pharmacokinetic profile of##2##4##(2008-10#1)(2013-8#1)
the pharmacokinetic study of 6-MP in##2##6##(2008-10#2)
the pharmacokinetic study of##3##4##(2008-10#3)
the pharmacokinetic study##4##3##(2008-10#3)(2008-5#1)
the pharmacokinetic##16##2##(1991-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the pharmacokinetics and pharmacodynamics of##2##5##(1991-2#1)(2008-8#1)
the pharmacokinetics and##3##3##(1991-2#1)(2008-8#2)
the pharmacokinetics of##8##3##(1992-11#1)(2006-10#1)(2008-10#2)(2008-11#2)(2011-2#1)(2012-12#1)
the pharmacokinetics##15##2##(1991-2#1)(1992-11#1)(2006-10#1)(2008-10#2)(2008-11#3)(2008-8#2)(2011-2#3)(2012-12#1)(2012-3#1)
the pharmacologic##5##2##(1991-1#1)(1991-12#1)(1996-9#1)(2007-10#1)(2008-8#1)
the pharmacological actions of##2##4##(1991-1#1)(1995-12#1)
the pharmacological activity##2##3##(1991-8#1)(2008-5#1)
the pharmacological effects##2##3##(1994-5#1)(2013-1#1)
the pharmacological management of##3##4##(2008-3#1)(2008-7#1)(2008-8#1)
the pharmacological profile##2##3##(1990-3#1)(2012-12#1)
the pharmacological properties of##2##4##(1993-3#1)(1993-6#1)
the pharmacological properties##3##3##(1990-3#1)(1993-3#1)(1993-6#1)
the pharmacological treatment of##2##4##(1994-6#1)(2008-7#1)
the pharmacological##27##2##(1990-3#2)(1991-1#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
the pharmacology and##2##3##(1991-2#1)(2007-12#1)
the pharmacology of##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
the pharmacology##10##2##(1991-2#1)(1994-8#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)
the pharmacotherapy of##2##3##(2008-6#1)(2008-8#1)
the pharmacy and##2##3##(2010-3#1)(2011-1#1)
the pharmacy department##2##3##(2008-1#2)
the pharmacy profession##2##3##(1993-2#2)
the pharmacy##18##2##(1993-2#2)(2008-1#2)(2010-3#8)(2011-1#6)
the pharyngeal##2##2##(2010-8#1)(2013-8#1)
the pharynx and the##2##4##(1997-7#1)(2008-9#1)
the pharynx##3##2##(1997-7#1)(2008-9#1)(2011-2#1)
the phase I##5##3##(1995-12#1)(2008-5#2)(2011-2#2)
the phase II##3##3##(1995-12#1)(2008-5#1)(2010-12#1)
the phase and the amplitude of##2##6##(2007-11#1)(2007-12#1)
the phase and the##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
the phase and##9##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
the phase change##5##3##(2007-11#2)(2008-10#1)(2008-3#2)
the phase changes in the##2##5##(2007-11#1)(2008-5#1)
the phase changes##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
the phase coding##2##3##(2008-11#2)
the phase conjugation##2##3##(2008-2#2)
the phase conjugator##2##3##(2007-12#1)(2008-2#1)
the phase correction##2##3##(2008-2#1)(2013-8#1)
the phase diagram##3##3##(2008-5#2)(2012-2#1)
the phase difference between the##4##5##(2007-12#1)(2008-3#3)
the phase difference between two##3##5##(2007-12#1)(2008-3#2)
the phase difference between##9##4##(2007-12#3)(2008-3#6)
the phase difference is##2##4##(2007-11#2)
the phase difference of two##2##5##(2007-12#1)(2008-3#1)
the phase difference of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the phase difference##18##3##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#8)
the phase dispersion##2##3##(2008-2#1)(2008-3#1)
the phase distribution in##2##4##(2008-3#2)
the phase distribution of##2##4##(2007-11#1)(2008-3#1)
the phase distribution##8##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)
the phase distributions of##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
the phase distributions##4##3##(2008-2#2)(2008-3#1)(2011-1#1)
the phase error##3##3##(2008-2#3)
the phase estimator is##2##4##(2008-3#2)
the phase from##2##3##(2007-12#1)(2008-2#1)
the phase function##12##3##(2007-12#1)(2008-2#6)(2008-3#5)
the phase in##3##3##(1990-6#1)(2008-2#2)
the phase is##3##3##(2007-11#1)(2008-3#2)
the phase map##3##3##(2008-2#1)(2008-3#2)
the phase matching##2##3##(2007-11#1)(2007-12#1)
the phase mismatch##5##3##(2008-2#2)(2008-3#3)
the phase model##2##3##(1992-1#1)(1995-2#1)
the phase modulation##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
the phase modulator##2##3##(2007-12#1)(2008-3#1)
the phase noise##2##3##(2007-12#2)
the phase of a##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
the phase of the input##2##5##(2007-12#1)(2008-3#1)
the phase of the##22##4##(1994-2#1)(1997-1#1)(2007-11#5)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#6)
the phase of##41##3##(1994-2#1)(1997-1#1)(1997-3#1)(2007-11#6)(2007-12#9)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#11)(2009-10#1)(2009-5#1)(2013-7#1)
the phase plate##2##3##(2007-11#1)(2008-3#1)
the phase relations##2##3##(2008-2#1)(2008-3#1)
the phase screen##3##3##(2008-3#3)
the phase separation and##2##4##(2008-10#1)(2008-7#1)
the phase separation of##2##4##(1997-6#1)(2008-7#1)
the phase separation##5##3##(1997-6#1)(2008-10#2)(2008-7#2)
the phase shift between##2##4##(2008-2#1)(2008-3#1)
the phase shift of##2##4##(2007-12#1)(2008-3#1)
the phase shift##12##3##(2007-11#4)(2007-12#1)(2008-2#3)(2008-3#4)
the phase shifting##2##3##(2007-11#1)(2008-3#1)
the phase shifts##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the phase singularities##2##3##(2007-11#1)(2008-3#1)
the phase transition of##2##4##(1992-6#1)(2008-8#1)
the phase transition##8##3##(1991-9#1)(1992-6#1)(2007-11#1)(2008-10#3)(2008-8#2)
the phase unwrapping##2##3##(2008-2#1)(2008-3#1)
the phase variation##3##3##(2008-3#3)
the phase##274##2##(1990-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#37)(2007-12#29)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#50)(2008-3#102)(2008-5#8)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-2#3)(2013-7#1)(2013-8#2)
the phase-boundary##2##2##(2008-10#2)
the phase-conjugate##5##2##(2008-2#3)(2008-3#2)
the phase-iterative algorithm##2##3##(2008-2#1)(2008-3#1)
the phase-iterative##3##2##(2008-2#2)(2008-3#1)
the phase-locked##2##2##(2007-11#1)(2008-3#1)
the phase-matched##2##2##(2007-12#2)
the phase-matching angles##2##3##(2007-12#1)(2008-3#1)
the phase-matching condition##8##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
the phase-matching conditions##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
the phase-matching properties of##3##4##(2008-2#1)(2008-3#2)
the phase-matching wavelength##2##3##(2007-12#1)(2008-3#1)
the phase-matching##22##2##(2007-11#2)(2007-12#6)(2008-2#4)(2008-3#10)
the phase-noise power spectral density##2##5##(2007-12#2)
the phase-only##2##2##(2008-3#2)
the phase-resolved##2##2##(2007-11#1)(2011-1#1)
the phase-retrieval##3##2##(2008-2#3)
the phase-separated PNIPAM particles##2##4##(2008-10#2)
the phase-shift plane##2##3##(2008-3#2)
the phase-shift##5##2##(2008-3#5)
the phase-shifting shearing interferometer##2##4##(2007-11#2)
the phase-shifting##5##2##(1994-2#1)(2007-11#2)(2008-3#2)
the phase-unwrapping##4##2##(2008-2#2)(2008-3#2)
the phases of##7##3##(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2013-8#1)
the phases##11##2##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2013-8#1)
the phasing##2##2##(1994-1#1)(2012-3#1)
the phenol##7##2##(1994-12#1)(1994-5#3)(2008-10#1)(2008-2#1)(2008-8#1)
the phenolate ligands##2##3##(1996-2#2)
the phenolate##3##2##(1990-5#1)(1996-2#2)
the phenolic group##2##3##(1990-5#2)
the phenolic##14##2##(1990-5#2)(2008-10#7)(2008-5#2)(2009-6#1)(2010-6#1)(2011-2#1)
the phenology of##4##3##(2008-10#3)(2012-2#1)
the phenols##4##2##(2008-10#4)
the phenomena of##7##3##(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#1)
the phenomena##13##2##(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-10#1)(2010-11#1)
the phenomenology##3##2##(2008-11#1)(2010-6#1)(2010-8#1)
the phenomenon in##3##3##(2007-12#1)(2008-10#1)(2009-10#1)
the phenomenon may##2##3##(2007-11#1)(2008-10#1)
the phenomenon of##29##3##(1996-2#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
the phenomenon was##2##3##(2008-10#1)(2010-3#1)
the phenomenon##50##2##(1993-6#1)(1994-6#1)(1996-2#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
the phenotype of the##2##4##(1994-3#1)(2006-8#1)
the phenotype of##15##3##(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-8#1)(2008-4#2)(2008-8#3)(2009-8#1)(2012-3#1)
the phenotype##31##2##(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-8#1)(2011-1#2)(2012-2#2)(2012-3#3)
the phenotypes of##6##3##(1991-9#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)
the phenotypes were##2##3##(1997-8#1)(2008-5#1)
the phenotypes##14##2##(1991-9#1)(1996-2#1)(1997-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2013-1#2)
the phenotypic and##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
the phenotypic effects of##2##4##(1993-8#1)(2013-1#1)
the phenotypic effects##3##3##(1993-8#1)(2007-12#1)(2013-1#1)
the phenotypic variation in the##2##5##(2008-10#1)(2013-7#1)
the phenotypic variation in##3##4##(2008-10#2)(2013-7#1)
the phenotypic variation##15##3##(2008-10#14)(2013-7#1)
the phenotypic##48##2##(1991-2#1)(1992-2#1)(1993-8#1)(1995-4#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-2#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the phenotypical##2##2##(1995-8#1)(2008-11#1)
the phenoxyl##4##2##(2007-11#2)(2008-10#1)(2008-8#1)
the phenyl ring##5##3##(1994-12#1)(1995-11#1)(1995-5#1)(2008-10#1)(2013-1#1)
the phenyl rings##2##3##(1997-7#2)
the phenyl##8##2##(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-7#2)(2008-10#1)(2013-1#1)
the phenylephrine-induced##3##2##(1990-12#1)(1995-12#1)(1997-7#1)
the pheromone##10##2##(1996-2#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-6#4)
the phi##6##2##(1991-5#1)(2008-11#1)(2008-3#3)(2010-1#1)
the philosophical and##3##3##(2008-7#3)
the philosophical##8##2##(2008-12#1)(2008-4#1)(2008-7#3)(2010-11#1)(2012-2#2)
the philosophy of##4##3##(1991-1#1)(1991-12#1)(1994-12#1)(2012-2#1)
the philosophy##7##2##(1991-1#1)(1991-12#1)(1994-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2012-2#1)
the phlD##3##2##(2008-10#3)
the phloem and##2##3##(2008-10#2)
the phloem cells and##2##4##(2008-10#2)
the phloem cells##3##3##(2008-10#3)
the phloem of##2##3##(2008-10#1)(2008-11#1)
the phloem##16##2##(2008-10#11)(2008-11#4)(2012-2#1)
the phone##2##2##(2011-1#1)(2012-3#1)
the phonetic##2##2##(2010-2#1)(2013-8#1)
the phonological##5##2##(1991-2#2)(2008-2#1)(2008-4#2)
the phonon##2##2##(2008-10#1)(2008-3#1)
the phorbol##6##2##(1990-11#1)(1992-11#1)(1992-9#2)(1996-12#1)(1997-1#1)
the phosphatase activities##4##3##(2008-10#3)(2008-9#1)
the phosphatase activity of##3##4##(2008-10#1)(2008-9#2)
the phosphatase activity##6##3##(1995-2#2)(1997-2#1)(2008-10#1)(2008-9#2)
the phosphatase inhibitor##2##3##(1993-8#1)(1994-9#1)
the phosphatase##21##2##(1992-12#3)(1992-9#3)(1993-8#1)(1994-9#1)(1995-2#4)(1997-2#1)(2008-10#4)(2008-9#3)(2009-8#1)
the phosphate buffer##5##3##(2008-10#4)(2009-10#1)
the phosphate##14##2##(1994-11#2)(2008-10#8)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#1)
the phosphatidylcholine##4##2##(1990-2#1)(1992-6#1)(1993-11#1)(1995-5#1)
the phosphatidylinositol 3-kinase##2##3##(1992-12#1)(2008-1#1)
the phosphatidylinositol pathway in##2##4##(1994-6#1)(1995-2#1)
the phosphatidylinositol##8##2##(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-1#1)
the phosphatidylserine requirement of##2##4##(1990-5#2)
the phosphatidylserine##3##2##(1990-5#2)(1992-6#1)
the phosphine ligands##2##3##(1996-2#2)
the phosphine##4##2##(1996-2#2)(2008-11#1)(2010-5#1)
the phosphodiester##2##2##(1992-8#1)(2008-4#1)
the phosphodiesterase##3##2##(1992-12#2)(1995-12#1)
the phosphoinositide##2##2##(2008-8#1)(2013-1#1)
the phospholipase C##2##3##(1990-11#1)(1994-11#1)
the phospholipase##5##2##(1990-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)
the phospholipid bilayer##2##3##(1991-5#1)(1992-3#1)
the phospholipid composition##2##3##(1992-3#1)(2012-2#1)
the phospholipid fatty##2##3##(1992-12#1)(1992-3#1)
the phospholipid membrane##2##3##(1994-2#1)(2008-10#1)
the phospholipid##24##2##(1990-2#1)(1990-5#2)(1991-5#1)(1992-10#2)(1992-12#1)(1992-3#3)(1992-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
the phospholipid-independent interaction between##2##4##(1994-5#2)
the phospholipids##5##2##(1990-11#1)(1992-10#1)(1993-8#1)(1994-3#1)(2008-10#1)
the phosphomolybdenum blue##3##3##(2008-10#3)
the phosphopeptide is##3##3##(1990-11#3)
the phosphopeptide##5##2##(1990-11#4)(1993-11#1)
the phosphoproteins involved##2##3##(2008-2#1)(2008-4#1)
the phosphoproteins##4##2##(1990-12#1)(1992-10#1)(2008-2#1)(2008-4#1)
the phosphor##3##2##(2008-10#2)(2008-3#1)
the phosphoramidite##4##2##(2008-4#4)
the phosphorescence intensity##2##3##(2008-10#2)
the phosphorescence##11##2##(1992-12#1)(1993-11#1)(2008-10#7)(2008-3#1)(2010-4#1)
the phosphorus##4##2##(1997-7#2)(2008-10#1)(2008-11#1)
the phosphorylated and dephosphorylated forms of##3##6##(1996-5#1)(1997-2#2)
the phosphorylated form of##3##4##(1993-8#1)(1996-12#1)(1997-1#1)
the phosphorylated##16##2##(1990-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#2)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#2)(2008-1#1)(2008-8#1)(2010-12#1)(2012-2#1)
the phosphorylating##3##2##(1991-12#3)
the phosphorylation efficiency by CK-2##2##5##(1992-6#2)
the phosphorylation of the##6##4##(1990-10#1)(1990-11#1)(1996-2#1)(1997-2#1)(2008-9#1)(2011-2#1)
the phosphorylation of##31##3##(1990-10#1)(1990-11#1)(1991-12#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#2)(1996-2#3)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-3#2)(2011-2#1)(2012-3#1)
the phosphorylation site##2##3##(1990-12#1)(2008-8#1)
the phosphorylation state of##5##4##(1994-6#1)(1997-2#2)(2010-11#2)
the phosphorylation##48##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#3)(1995-8#3)(1996-2#3)(1997-1#1)(1997-2#3)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2010-11#2)(2011-2#1)(2012-3#1)
the phosphothreonine##2##2##(1995-2#2)
the photo standard##3##3##(2008-5#3)
the photo-oxidation of##2##3##(2008-10#2)
the photo-oxidation##3##2##(2008-10#3)
the photoacoustic##8##2##(2007-12#1)(2008-2#2)(2008-3#4)(2011-7#1)
the photoactive##6##2##(1991-12#1)(1992-8#3)(2007-12#1)(2008-10#1)
the photobleached##2##2##(2008-1#2)
the photobleaching##2##2##(2008-9#2)
the photocatalytic performance##2##3##(2009-8#2)
the photocatalytic##7##2##(1994-3#1)(2008-10#2)(2009-8#3)(2013-1#1)
the photochemical process##2##3##(2008-10#2)
the photochemical reaction##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
the photochemical##11##2##(1992-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)
the photochromic reaction##2##3##(2009-8#2)
the photoconductive##2##2##(2008-2#2)
the photocurrent generated by##2##4##(2008-10#1)(2010-5#1)
the photocurrent##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
the photocycle of##2##3##(1994-5#2)
the photocycle##3##2##(1994-5#2)(1995-5#1)
the photodamage##2##2##(2008-1#1)(2008-8#1)
the photodegradation##4##2##(2008-10#3)(2008-5#1)
the photodetector and##3##3##(2008-2#3)
the photodetector##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)
the photodiode##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
the photodiodes##2##2##(2007-12#1)(2008-2#1)
the photodissociation of##2##3##(1990-8#1)(2008-2#1)
the photodynamic oxidation of uric acid##2##6##(2008-5#2)
the photodynamic oxidation##3##3##(2008-5#3)
the photodynamic therapy (PDT)##2##4##(1990-11#1)(2012-3#1)
the photodynamic therapy##3##3##(1990-11#1)(2012-3#2)
the photodynamic##10##2##(1990-11#1)(2008-5#6)(2009-4#1)(2012-3#2)
the photoelastic effect##3##3##(2008-3#3)
the photoelastic modulators are##2##4##(2008-2#2)
the photoelastic##6##2##(2008-2#2)(2008-3#4)
the photoexcitation of##2##3##(2007-11#1)(2010-5#1)
the photographic##2##2##(2008-10#1)(2008-3#1)
the photoinduced refractive-index change##2##4##(2007-12#2)
the photoinduced##9##2##(2007-11#2)(2007-12#5)(2008-3#1)(2010-4#1)
the photolabeled##2##2##(1990-11#1)(1993-8#1)
the photolysis##6##2##(1990-11#1)(1995-2#1)(2008-11#1)(2008-3#3)
the photometric##4##2##(2008-10#3)(2008-3#1)
the photomultiplier tube##4##3##(2008-3#4)
the photomultiplier##6##2##(2007-12#1)(2008-3#5)
the photon and##2##3##(2008-3#1)(2012-2#1)
the photon density##2##3##(2008-2#1)(2008-3#1)
the photon diffusion coefficient##2##4##(2007-11#2)
the photon##22##2##(1992-11#1)(2007-11#7)(2008-10#1)(2008-2#4)(2008-3#8)(2012-2#1)
the photon-echo novelty filter##2##4##(2008-2#2)
the photon-echo output##2##3##(2007-12#2)
the photon-echo##4##2##(2007-12#2)(2008-2#2)
the photon-number##3##2##(2007-11#1)(2007-12#2)
the photonic bandgap##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
the photonic crystal waveguide##2##4##(2007-12#2)
the photonic stop band##2##4##(2008-3#2)
the photonic##19##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#7)(2010-6#1)
the photons##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
the photoperiod sensitivity gene##2##4##(1995-6#2)
the photoperiod##4##2##(1995-6#2)(2010-8#2)
the photophysical##3##2##(2008-3#1)(2010-2#1)(2013-8#1)
the photophysics##4##2##(2008-2#1)(2009-6#1)(2010-2#2)
the photoproducts##3##2##(1992-8#1)(2008-10#2)
the photoreceptive##3##2##(2008-5#2)(2012-3#1)
the photoreceptors and the retinal pigment##2##6##(2008-4#1)(2011-2#1)
the photoreceptors##3##2##(2007-5#1)(2008-4#1)(2011-2#1)
the photorefractive crystal##2##3##(2007-11#1)(2008-3#1)
the photorefractive effect##3##3##(2007-12#1)(2008-3#2)
the photorefractive fanning effect##2##4##(2008-2#2)
the photorefractive properties of##2##4##(2007-11#2)
the photorefractive response##2##3##(2007-11#1)(2007-12#1)
the photorefractive##15##2##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#4)
the photoresist##3##2##(2008-3#2)(2008-7#1)
the photosensitivity##4##2##(2007-12#3)(2008-5#1)
the photosensitized solution##2##3##(2008-2#2)
the photosensitizer##5##2##(1992-1#1)(2008-3#1)(2008-5#1)(2009-4#2)
the photosensitizers##4##2##(1992-6#1)(1993-11#2)(2008-11#1)
the photostability of##5##3##(2008-10#1)(2008-5#3)(2009-2#1)
the photosynthetic apparatus##4##3##(2008-10#3)(2012-6#1)
the photosynthetic##13##2##(1990-7#1)(1993-8#1)(1997-6#1)(2008-10#5)(2008-11#1)(2012-1#1)(2012-5#1)(2012-6#1)(2013-8#1)
the photosystem-II##2##2##(1990-5#2)
the photothermal##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
the phrase &quot##2##3##(1996-2#1)(2007-2#1)
the phrase##3##2##(1996-2#1)(2007-2#1)(2012-1#1)
the phrenic nerve to##2##4##(2008-9#2)
the phrenic nerve##3##3##(2008-9#3)
the phycobilisomes##3##2##(1992-3#3)
the phycoerythrin##2##2##(2008-3#1)(2008-8#1)
the phyletic##2##2##(2009-6#1)(2010-3#1)
the phyllosilicate##3##2##(2008-6#3)
the phylogenetic analyses##2##3##(2008-10#1)(2010-3#1)
the phylogenetic history##2##3##(2012-2#1)(2012-3#1)
the phylogenetic relationship among##2##4##(2008-10#1)(2013-1#1)
the phylogenetic relationship##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
the phylogenetic relationships among##2##4##(2008-10#1)(2008-5#1)
the phylogenetic relationships of##2##4##(2008-10#1)(2010-6#1)
the phylogenetic relationships##6##3##(2008-10#3)(2008-5#2)(2010-6#1)
the phylogenetic tree##4##3##(1996-5#1)(2008-8#1)(2013-8#2)
the phylogenetic trees##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
the phylogenetic##36##2##(1994-5#1)(1995-11#1)(1996-5#1)(2007-12#3)(2008-1#3)(2008-10#9)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the phylogeny of##2##3##(2007-12#1)(2008-8#1)
the phylogeny##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-3#1)
the phylum Chloroflexi##2##3##(2011-2#2)
the phylum##15##2##(1992-6#1)(1994-12#1)(1996-5#2)(2011-1#1)(2011-2#7)(2013-8#3)
the physical and chemical mechanisms of##2##6##(2009-11#2)
the physical and chemical mechanisms##3##5##(2009-11#2)(2009-8#1)
the physical and chemical properties of##3##6##(1992-8#1)(2008-3#1)(2011-2#1)
the physical and chemical properties##4##5##(1992-8#1)(2008-3#1)(2011-2#1)(2011-3#1)
the physical and chemical##13##4##(1992-8#1)(2008-10#3)(2008-3#1)(2008-8#2)(2009-11#2)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
the physical and mental health##2##5##(2010-10#1)(2011-2#1)
the physical and mental##3##4##(1994-3#1)(2010-10#1)(2011-2#1)
the physical and psychological##3##4##(2008-2#1)(2008-4#1)(2013-8#1)
the physical and##30##3##(1990-12#1)(1992-8#1)(1994-3#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-8#1)
the physical characteristics of##6##4##(1990-9#1)(1996-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
the physical characteristics##7##3##(1990-9#2)(1996-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
the physical component of##2##4##(2008-5#1)(2008-7#1)
the physical distance##2##3##(2008-9#2)
the physical environment##2##3##(2011-2#1)(2012-3#1)
the physical examination##2##3##(2008-12#1)(2010-8#1)
the physical growth and health of##2##6##(2008-11#2)
the physical growth##3##3##(2008-11#2)(2008-8#1)
the physical health##3##3##(1995-2#1)(2009-6#1)(2010-12#1)
the physical interactions between##2##4##(2007-12#1)(2008-12#1)
the physical map of##4##4##(1995-6#2)(1997-6#1)(1997-8#1)
the physical map##7##3##(1995-6#2)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2012-3#1)
the physical optics##3##3##(2008-2#3)
the physical parameters##2##3##(2007-11#1)(2008-2#1)
the physical principles##3##3##(1996-4#1)(2008-2#1)(2012-2#1)
the physical properties of skin##2##5##(2008-5#2)
the physical properties of the skin##2##6##(2008-5#2)
the physical properties of the##8##5##(1990-9#1)(2008-5#4)(2008-7#1)(2012-2#1)(2013-1#1)
the physical properties of##18##4##(1990-9#1)(1991-1#2)(1992-2#1)(1993-11#1)(1997-2#1)(2008-5#7)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the physical properties##19##3##(1990-9#1)(1991-1#2)(1992-2#1)(1993-11#1)(1997-2#1)(2008-5#7)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the physical space##2##3##(2008-11#1)(2013-1#1)
the physical state of##2##4##(1990-2#1)(2008-4#1)
the physical state##3##3##(1990-2#1)(2008-4#1)(2008-5#1)
the physical structure of##2##4##(2008-2#2)
the physical therapy##2##3##(2008-12#2)
the physical##166##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#3)(1991-1#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-6#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-8#1)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#5)(2008-2#9)(2008-3#12)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
the physical-chemical##2##2##(1992-3#1)(2008-1#1)
the physically##4##2##(2008-2#1)(2008-3#1)(2013-1#2)
the physician and the##3##4##(1990-9#1)(1993-1#1)(1996-6#1)
the physician and##7##3##(1990-9#1)(1992-4#1)(1993-1#1)(1994-2#1)(1996-6#1)(2008-3#1)(2010-7#1)
the physician for##2##3##(1991-9#1)(1997-2#1)
the physician in##5##3##(1991-11#1)(1991-6#1)(1993-2#1)(1995-2#1)(2010-12#1)
the physician is##3##3##(1990-6#1)(1993-8#1)(2012-12#1)
the physician may##2##3##(1992-1#1)(1993-11#1)
the physician or##2##3##(1995-12#1)(2008-12#1)
the physician to##5##3##(1992-9#1)(2008-11#1)(2010-5#1)(2010-8#1)(2013-8#1)
the physician was##2##3##(1992-4#1)(2007-8#1)
the physician##61##2##(1990-6#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-4#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the physician's office##3##3##(1995-12#1)(1996-12#1)(1996-3#1)
the physician's##16##2##(1991-2#1)(1991-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
the physician-hospital##4##2##(1994-1#1)(1994-3#2)(1996-2#1)
the physician-patient relationship##3##3##(1996-12#1)(2008-4#1)(2011-2#1)
the physician-patient##4##2##(1996-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
the physicians in##3##3##(2007-7#1)(2008-1#1)(2008-7#1)
the physicians will##2##3##(1992-1#1)(1994-2#1)
the physicians##19##2##(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-6#1)(2007-7#1)(2008-1#3)(2008-7#1)(2009-5#1)
the physicians'##7##2##(1990-6#1)(1995-2#2)(1996-1#2)(1997-6#1)(2007-10#1)
the physico-chemical properties of##2##4##(1992-6#1)(2008-5#1)
the physico-chemical##7##2##(1992-5#1)(1992-6#1)(1994-12#1)(2008-10#3)(2008-5#1)
the physicochemical properties of the##3##5##(2008-5#2)(2008-8#1)
the physicochemical properties##4##3##(1992-9#1)(2008-5#2)(2008-8#1)
the physicochemical##11##2##(1992-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)
the physics of##3##3##(2008-2#2)(2013-1#1)
the physics underlying##2##3##(2008-3#1)(2009-9#1)
the physics##7##2##(2007-12#1)(2008-2#2)(2008-3#2)(2009-9#1)(2013-1#1)
the physiologic##6##2##(1991-3#1)(1994-11#1)(1994-12#1)(2008-5#1)(2010-6#2)
the physiological and##10##3##(1997-3#1)(2007-2#1)(2008-11#2)(2008-7#3)(2009-12#1)(2012-1#1)(2012-2#1)
the physiological constraints##2##3##(2008-7#2)
the physiological effect of##2##4##(1994-11#1)(2008-10#1)
the physiological function of##3##4##(1997-2#1)(2010-10#1)(2012-2#1)
the physiological function##4##3##(1997-2#2)(2010-10#1)(2012-2#1)
the physiological fusion##2##3##(2012-2#2)
the physiological mechanisms##3##3##(1990-11#1)(2008-5#1)(2012-12#1)
the physiological processes##2##3##(2008-8#1)(2011-2#1)
the physiological properties of##3##4##(2008-5#1)(2008-6#1)(2012-1#1)
the physiological range of##2##4##(1993-6#1)(2008-10#1)
the physiological range##4##3##(1993-6#1)(1995-5#1)(2008-10#2)
the physiological relevance of the##2##5##(1995-11#1)(2009-12#1)
the physiological relevance of##3##4##(1995-11#1)(2007-12#1)(2009-12#1)
the physiological response of the tissues under##2##7##(2013-1#2)
the physiological response of##3##4##(2008-9#1)(2013-1#2)
the physiological responses of##2##4##(1997-8#1)(2013-7#1)
the physiological role of the##2##5##(1994-6#1)(2008-4#1)
the physiological role of##8##4##(1994-6#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-4#2)(2009-8#1)(2011-2#1)
the physiological role##9##3##(1994-6#1)(1995-11#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-4#2)(2009-8#1)(2011-2#1)
the physiological significance of the##4##5##(1991-3#1)(1994-5#1)(1994-6#1)(2010-3#1)
the physiological##120##2##(1990-11#2)(1990-12#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#3)(1995-11#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-2#2)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#1)
the physiologically##4##2##(1990-12#1)(2008-10#2)(2011-1#1)
the physiology and##2##3##(1992-9#1)(2010-3#1)
the physiology of the##10##4##(1990-5#1)(1993-2#1)(1996-2#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
the physiology of##21##3##(1990-5#1)(1993-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
the physiology##24##2##(1990-5#1)(1992-9#1)(1993-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
the physiopathological##5##2##(1992-5#1)(1993-6#1)(1997-3#1)(2007-8#1)(2010-6#1)
the physiopathology of##5##3##(1990-9#1)(1994-9#1)(2008-10#2)(2008-7#1)
the physiopathology##7##2##(1990-9#1)(1992-5#1)(1994-9#1)(2008-10#2)(2008-7#2)
the physiotherapist is##2##3##(1991-2#1)(1992-2#1)
the physiotherapist##4##2##(1991-2#1)(1992-12#1)(1992-2#1)(2010-3#1)
the phytase group##2##3##(2010-2#2)
the phytase##5##2##(2008-4#2)(2010-2#3)
the phytochrome##2##2##(1995-2#1)(2009-8#1)
the phytohormone##2##2##(2008-10#1)(2011-1#1)
the phytopathogenic bacterium##3##3##(2008-10#3)
the phytopathogenic fungus Botryotinia fuckeliana##3##5##(1997-2#2)(1997-4#1)
the phytopathogenic fungus##4##3##(1997-2#2)(1997-4#1)(2009-8#1)
the phytopathogenic##7##2##(1997-2#2)(1997-4#1)(2008-10#3)(2009-8#1)
the phytophagous##2##2##(2008-10#1)(2008-7#1)
the phytoplankton##5##2##(2008-10#1)(2008-2#4)
the phytoplasma##3##2##(2008-10#3)
the phytoplasmas##3##2##(2008-10#3)
the phytoremediation of##2##3##(2008-10#1)(2011-1#1)
the phytoremediation##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
the phytotoxic##2##2##(2008-10#1)(2008-12#1)
the pi##2##2##(1997-7#1)(2011-2#1)
the pi-pi electron interactions##2##4##(2008-10#2)
the picomolar##2##2##(1990-7#1)(2008-7#1)
the picosecond##4##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
the picrate##6##2##(2008-10#6)
the picture of##3##3##(1991-5#1)(2008-7#1)(2012-3#1)
the picture##10##2##(1991-5#1)(1993-12#1)(1993-3#1)(2007-12#1)(2008-4#2)(2008-7#2)(2010-9#1)(2012-3#1)
the piece##2##2##(1997-3#1)(2008-10#1)
the piecewise##2##2##(2008-10#1)(2008-6#1)
the piezoelectric quartz crystal##3##4##(2008-10#3)
the piezoelectric##9##2##(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
the pig industry##2##3##(2008-7#1)(2011-2#1)
the pig louse##2##3##(2007-12#2)
the pig##16##2##(1990-11#3)(1990-9#1)(1991-12#1)(1992-3#1)(1996-12#2)(1996-2#1)(2007-12#2)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
the pigeon##4##2##(1995-12#1)(2007-12#1)(2008-8#2)
the pigment##10##2##(1990-12#1)(1991-12#1)(1992-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)
the pigmentation##2##2##(1991-6#1)(2008-6#1)
the pigmented##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
the pigments##8##2##(2008-10#8)
the pigs##2##2##(2010-2#1)(2011-1#1)
the pill##4##2##(1991-3#1)(1991-6#1)(1993-2#2)
the pillar##2##2##(2008-5#1)(2008-7#1)
the pilocarpine group##2##3##(2006-10#2)
the pilot phase of##2##4##(2010-9#1)(2012-3#1)
the pilot study##9##3##(2007-8#1)(2008-7#1)(2010-3#4)(2011-2#1)(2012-2#1)(2012-3#1)
the pilot##19##2##(1993-1#1)(1994-5#1)(2007-5#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-3#4)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
the pin##3##2##(2007-8#1)(2009-4#2)
the pine weevil##2##3##(2011-10#2)
the pine##3##2##(2008-10#1)(2011-10#2)
the pineal gland of##2##4##(1994-5#1)(1995-11#1)
the pineal gland##14##3##(1994-2#2)(1994-5#6)(1995-11#1)(1995-3#2)(2008-12#1)(2008-5#1)(2013-7#1)
the pineal hormone melatonin (MLT)##2##5##(1992-12#1)(1995-9#1)
the pineal hormone melatonin as a##2##6##(1990-2#1)(1992-12#1)
the pineal hormone melatonin##6##4##(1990-2#2)(1991-6#1)(1992-12#2)(1995-9#1)
the pineal hormone##8##3##(1990-2#3)(1991-6#1)(1992-12#2)(1995-9#1)(2008-5#1)
the pineal organ##5##3##(1994-5#5)
the pineal##35##2##(1990-2#3)(1991-6#1)(1992-12#2)(1994-2#2)(1994-5#16)(1995-11#1)(1995-12#1)(1995-3#2)(1995-9#1)(2008-12#1)(2008-5#2)(2012-2#1)(2013-7#2)
the pinhole##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
the pink shrimp##2##3##(2008-5#2)
the pink##5##2##(2008-10#2)(2008-5#2)(2010-10#1)
the pioneering##2##2##(2007-8#1)(2008-7#1)
the pioneers of##2##3##(2007-12#1)(2012-2#1)
the pioneers##5##2##(1993-6#1)(2007-12#1)(2008-5#1)(2012-2#2)
the pip##2##2##(2008-4#2)
the piperidine##3##2##(1995-3#2)(1995-6#1)
the pipette##2##2##(1995-11#1)(2013-1#1)
the piriform cortex##5##3##(1990-5#1)(1994-3#1)(2012-1#1)(2013-1#2)
the pistachio isolates##2##3##(2008-10#2)
the piston##3##2##(2008-10#1)(2008-3#2)
the pit cell lineage##2##4##(1995-2#1)(1995-6#1)
the pit##4##2##(1995-2#1)(1995-6#1)(2008-10#2)
the pitch of the##3##4##(2008-2#2)(2008-3#1)
the pitch##8##2##(2008-10#1)(2008-2#4)(2008-3#1)(2013-8#2)
the pitfalls of##3##3##(2008-11#2)(2012-2#1)
the pitfalls##8##2##(1993-1#1)(1993-2#1)(1996-12#1)(2008-11#2)(2008-9#2)(2012-2#1)
the pith##2##2##(2008-10#2)
the pits##2##2##(1997-1#1)(2007-12#1)
the pituitary adenylate cyclase##2##4##(1990-7#2)
the pituitary and##3##3##(1993-5#2)(2008-5#1)
the pituitary gland##13##3##(1992-3#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
the pituitary gonadotropes##2##3##(1997-2#2)
the pituitary##41##2##(1990-11#1)(1990-7#3)(1992-10#1)(1992-3#1)(1993-5#5)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#2)(1997-2#2)(1997-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-3#2)(2013-1#2)
the pivot##2##2##(2008-3#2)
the pivotal role of##2##4##(2008-1#1)(2008-7#1)
the pivotal role##4##3##(2008-1#1)(2008-11#2)(2008-7#1)
the pivotal##13##2##(1995-3#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-3#1)
the pixel##6##2##(2007-11#2)(2008-3#3)(2011-2#1)
the pixelated lens##2##3##(2008-3#2)
the pixelated##3##2##(2008-3#3)
the pixels##2##2##(2008-10#1)(2008-3#1)
the place for##2##3##(2011-1#1)(2012-2#1)
the place of the##3##4##(1990-6#1)(2007-11#1)(2007-8#1)
the place of##20##3##(1990-6#2)(1992-12#1)(1994-6#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
the place where##2##3##(2008-10#1)(2013-1#1)
the place##25##2##(1990-6#2)(1992-12#1)(1994-6#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the placebo group##24##3##(1990-3#1)(1991-11#1)(1992-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-2#2)(2013-1#2)
the placebo##35##2##(1990-3#2)(1991-11#1)(1992-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
the placement of a##2##4##(2008-2#1)(2011-2#1)
the placement of dental implants##2##5##(2007-12#1)(2012-12#1)
the placement of the##3##4##(1994-5#1)(2007-8#1)(2009-10#1)
the placement of##20##3##(1990-2#1)(1991-12#1)(1994-5#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#2)(2009-2#2)(2011-2#1)(2012-12#1)
the placement##25##2##(1990-2#1)(1991-12#1)(1994-5#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-6#1)(2009-10#2)(2009-2#2)(2011-2#1)(2012-12#1)
the placenta and##2##3##(2012-12#1)(2013-1#1)
the placenta##11##2##(1990-5#1)(1990-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1995-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#2)
the placental##5##2##(1992-3#1)(1992-8#1)(1995-8#1)(2008-10#1)(2008-4#1)
the places##2##2##(2008-10#1)(2009-7#1)
the placing of##2##3##(2007-12#1)(2008-11#1)
the plain##3##2##(2007-11#2)(2008-6#1)
the plaintiff had##3##3##(1991-7#3)
the plaintiff##5##2##(1991-7#4)(1997-5#1)
the plaintiffs##2##2##(1995-6#1)(1996-5#1)
the plan##13##2##(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-6#3)(1996-3#1)(1997-2#1)(2008-2#2)(2011-1#1)
the planar##7##2##(1993-3#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)
the plane of incidence##8##4##(2008-2#2)(2008-3#6)
the plane of the grating##2##5##(2008-3#2)
the plane of the interference fringes##2##6##(2008-3#2)
the plane of the##16##4##(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2010-6#1)
the plane of##30##3##(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#13)(2009-8#1)(2010-6#1)(2013-8#1)
the plane##36##2##(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#14)(2009-8#1)(2010-6#1)(2012-12#1)(2013-8#1)
the plane-parallel resonator##2##3##(2008-3#2)
the plane-parallel##3##2##(2008-3#3)
the plane-wave##3##2##(2007-12#1)(2008-3#2)
the planet##2##2##(1991-8#1)(2010-5#1)
the planktonic##5##2##(2007-5#1)(2008-3#3)(2009-6#1)
the planned isocenter position during treatment##2##6##(2009-2#2)
the planned##10##2##(1992-1#1)(1992-9#2)(2007-11#1)(2009-2#2)(2010-7#1)(2012-3#2)(2013-1#1)
the planning and##8##3##(1992-12#1)(1993-12#1)(1993-3#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-1#1)
the planning of health services##2##5##(1993-11#1)(1993-6#1)
the planning of##3##3##(1993-11#1)(1993-6#1)(2008-6#1)
the planning process and##3##4##(1992-2#1)(1994-2#1)(1996-1#1)
the planning process##5##3##(1992-2#1)(1994-2#1)(1996-1#2)(2008-2#1)
the planning target volume (PTV)##3##5##(2008-2#2)(2008-6#1)
the planning##28##2##(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2013-1#1)
the plans##3##2##(1996-3#1)(1997-3#1)(2013-1#1)
the plant and animal kingdoms##2##5##(2008-10#1)(2009-6#1)
the plant and animal##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
the plant and the##2##4##(2008-10#2)
the plant and##10##3##(2008-10#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)
the plant availability of##2##4##(1992-3#2)
the plant canopy##2##3##(2008-10#2)
the plant cell##2##3##(2012-1#1)(2013-8#1)
the plant complex##2##3##(2008-5#2)
the plant defense##2##3##(2008-10#2)
the plant expression vectors##2##4##(2008-8#1)(2008-9#1)
the plant extracts##2##3##(2008-5#1)(2011-1#1)
the plant from##2##3##(2008-10#1)(2008-6#1)
the plant genus##2##3##(2008-8#1)(2012-3#1)
the plant growth hormone##2##4##(2008-10#1)(2008-11#1)
the plant hormone##3##3##(2009-6#2)(2011-10#1)
the plant in##3##3##(2008-10#2)(2010-5#1)
the plant kingdom##6##3##(2008-10#1)(2009-12#1)(2009-8#2)(2011-2#1)(2013-8#1)
the plant pathogen##2##3##(2008-10#1)(2010-10#1)
the plant pathogenic##2##3##(2008-11#1)(2009-6#1)
the plant physiologist##2##3##(2008-7#2)
the plant population##2##3##(2008-10#2)
the plant revealed##2##3##(2008-10#2)
the plant roots##2##3##(1992-3#1)(2008-12#1)
the plant species##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
the plant surface##5##3##(2008-10#3)(2008-8#1)(2009-8#1)
the plant tissue##3##3##(2008-10#2)(2013-1#1)
the plant to##3##3##(2008-10#2)(2008-8#1)
the plant was##2##3##(2008-10#1)(2013-7#1)
the plant##160##2##(1990-5#1)(1992-3#4)(1993-3#1)(1994-11#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#67)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#5)(2009-10#3)(2009-12#1)(2009-3#1)(2009-6#6)(2009-8#8)(2010-10#2)(2010-11#1)(2010-5#2)(2011-1#2)(2011-10#2)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
the plant's##3##2##(2008-10#1)(2009-10#1)(2009-8#1)
the plant-parasitic nematode Meloidogyne incognita##2##5##(1994-12#2)
the plant-pathogenic fungus##3##3##(2008-10#3)
the plant-pathogenic##6##2##(2008-10#6)
the plants to##4##3##(2008-10#4)
the plants were evaluated for##2##5##(2008-10#2)
the plants were##6##3##(1997-6#1)(2008-10#4)(2008-12#1)
the plants##46##2##(1995-2#1)(1997-6#1)(2008-10#32)(2008-12#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#2)
the plasma adrenocorticotropic hormone##2##4##(1990-2#1)(2011-2#1)
the plasma and##4##3##(1990-2#1)(1992-6#1)(2008-10#1)(2008-9#1)
the plasma by##2##3##(2008-9#1)(2012-2#1)
the plasma concentration of##5##4##(2008-1#2)(2008-12#1)(2013-8#2)
the plasma concentrations##2##3##(1993-9#1)(2009-4#1)
the plasma exchange efficiency##2##4##(2011-2#2)
the plasma for##5##3##(2008-10#4)(2008-11#1)
the plasma levels of##2##4##(2008-4#1)(2011-2#1)
the plasma levels##3##3##(1995-12#1)(2008-4#1)(2011-2#1)
the plasma membrane and cell wall##2##6##(1997-6#2)
the plasma membrane and cell##3##5##(1997-6#2)(2010-3#1)
the plasma membrane and the##6##5##(1990-12#1)(1991-5#1)(2008-1#1)(2008-11#1)(2009-2#1)(2009-8#1)
the plasma membrane and##15##4##(1990-12#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#1)
the plasma membrane by##7##4##(1992-3#1)(1992-9#1)(1995-6#1)(2008-4#1)(2009-8#1)(2010-11#2)
the plasma membrane fraction##3##4##(1993-8#1)(1994-11#2)
the plasma membrane in##5##4##(1990-11#1)(1992-12#1)(1994-3#1)(2008-7#1)(2009-10#1)
the plasma membrane of eggs##2##5##(2008-8#2)
the plasma membrane of##20##4##(1990-12#3)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#4)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
the plasma membrane proteins##2##4##(1995-12#1)(2008-11#1)
the plasma membrane##109##3##(1990-11#3)(1990-12#5)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#2)(1993-8#1)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#4)(1995-6#2)(1996-3#1)(1997-3#1)(1997-6#3)(2008-1#2)(2008-10#3)(2008-11#8)(2008-4#5)(2008-7#2)(2008-8#7)(2009-10#4)(2009-2#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-3#1)
the plasma membranes of##3##4##(1991-12#1)(1993-6#1)(2010-10#1)
the plasma membranes##4##3##(1991-12#1)(1993-6#1)(1994-5#1)(2010-10#1)
the plasma of##13##3##(1990-7#1)(1992-6#3)(1992-9#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2012-2#1)
the plasma proteome##4##3##(2010-12#4)
the plasma with##2##3##(1994-8#1)(2008-10#1)
the plasma##222##2##(1990-11#4)(1990-12#6)(1990-2#3)(1990-5#1)(1990-7#3)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#6)(1995-12#3)(1995-2#4)(1995-6#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2007-11#2)(2007-12#2)(2008-1#5)(2008-10#25)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#6)(2008-7#4)(2008-8#9)(2008-9#5)(2009-10#5)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#9)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-8#7)
the plasmalemma of the##2##4##(2008-10#2)
the plasmalemma of##3##3##(2008-10#3)
the plasmalemma##9##2##(1997-7#1)(2007-12#1)(2008-10#6)(2008-7#1)
the plasmas##2##2##(2008-3#2)
the plasmic membrane##2##3##(1993-6#2)
the plasmid DNA##3##3##(1990-11#1)(1995-2#1)(2008-8#1)
the plasmid that carried##2##4##(1993-3#2)
the plasmid vector pGEM-T##2##4##(2008-10#1)(2008-9#1)
the plasmid vector##4##3##(1990-5#1)(1992-3#1)(2008-10#1)(2008-9#1)
the plasmid##42##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-3#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-6#1)(1997-2#2)(1997-3#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2010-6#1)(2012-3#1)
the plasmid-based##2##2##(1994-12#1)(1996-8#1)
the plasmids##8##2##(1990-5#1)(1991-9#1)(1994-12#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
the plasminogen activator##2##3##(1994-5#1)(2008-7#1)
the plasminogen##3##2##(1994-5#1)(1995-6#1)(2008-7#1)
the plasmon resonances##2##3##(2008-3#1)(2010-2#1)
the plasmon##3##2##(2007-12#1)(2008-3#1)(2010-2#1)
the plaster##2##2##(2007-12#2)
the plastic surgeon##2##3##(2011-2#1)(2012-2#1)
the plastic surgery population##2##4##(2013-1#2)
the plastic surgery##4##3##(1993-9#1)(2010-8#1)(2013-1#2)
the plastic type##2##3##(2008-8#2)
the plastic##18##2##(1991-3#1)(1993-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
the plasticity of##3##3##(1995-12#1)(1996-12#1)(2012-2#1)
the plasticity##6##2##(1995-12#1)(1996-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
the plasticized PVC membrane##2##4##(2008-10#2)
the plasticizer and##2##3##(2008-10#2)
the plasticizer##6##2##(2008-10#6)
the plastid##7##2##(1997-6#4)(2009-10#1)(2011-2#1)(2013-1#1)
the plastidic##2##2##(1995-8#2)
the plate and the##2##4##(2008-10#2)
the plate diagram sheet##2##4##(2013-1#2)
the plate diagram##3##3##(2013-1#3)
the plate surface##2##3##(2008-8#2)
the plate##21##2##(2008-10#7)(2008-11#2)(2008-3#3)(2008-8#4)(2012-2#1)(2012-3#1)(2013-1#3)
the plate's##2##2##(2007-11#2)
the plateau##11##2##(1990-7#2)(1994-6#3)(2008-10#2)(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#1)
the platelet 5HT2 receptor complex##2##5##(1996-7#2)
the platelet aggregation induced##2##4##(1992-8#1)(1997-7#1)
the platelet aggregation##4##3##(1992-8#2)(1993-3#1)(1997-7#1)
the platelet count##3##3##(2006-6#2)(2013-8#1)
the platelet level##2##3##(2008-8#2)
the platelet lysate##2##3##(2008-11#2)
the platelet membranes##4##3##(1992-6#3)(1993-6#1)
the platelet##34##2##(1990-12#2)(1990-2#1)(1990-5#1)(1992-11#1)(1992-6#3)(1992-8#2)(1993-3#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-7#2)(1997-7#4)(2006-6#6)(2008-11#3)(2008-5#1)(2008-8#2)(2013-8#1)
the platelets and##2##3##(1994-2#1)(2008-7#1)
the platelets##3##2##(1994-2#1)(1997-6#1)(2008-7#1)
the plates##6##2##(2008-10#2)(2008-11#3)(2008-3#1)
the platform can be used##2##5##(2008-2#1)(2013-1#1)
the platform was##2##3##(2008-10#1)(2008-7#1)
the platform##12##2##(2008-10#6)(2008-2#1)(2008-5#2)(2008-7#1)(2009-9#1)(2013-1#1)
the plating##2##2##(2008-10#1)(2008-9#1)
the platinum group elements##5##4##(2008-10#4)(2008-11#1)
the platinum##10##2##(1997-6#1)(2008-10#8)(2008-11#1)
the platysma##2##2##(2007-12#1)(2013-8#1)
the plausibility of##2##3##(2008-9#1)(2012-2#1)
the plausible##2##2##(2008-5#1)(2013-1#1)
the play lady legacy##2##4##(1992-12#2)
the play of##2##3##(1993-12#1)(2008-2#1)
the play##6##2##(1992-12#2)(1993-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
the players##2##2##(1991-12#1)(2009-10#1)
the pleasurable##2##2##(2009-6#1)(2011-2#1)
the pleckstrin homology domain##2##4##(1994-11#2)
the plethora of##6##3##(1991-1#1)(1996-12#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-2#1)
the pleura##13##2##(1991-12#2)(2007-5#2)(2007-8#6)(2010-8#1)(2011-1#2)
the pleural cavity##5##3##(1991-8#1)(1995-6#1)(2007-12#2)(2007-8#1)
the pleural effusion##2##3##(2007-7#1)(2013-8#1)
the pleural##13##2##(1991-8#1)(1995-6#1)(2007-12#5)(2007-7#2)(2007-8#1)(2008-7#1)(2012-2#1)(2013-8#1)
the ploidy##3##2##(1991-6#1)(2008-5#2)
the plot##9##2##(2008-10#8)(2008-3#1)
the plot)##3##2##(2008-10#3)
the plots##8##2##(1995-9#1)(2008-10#6)(2008-12#1)
the plug and##2##3##(2008-10#1)(2009-6#1)
the plug test##3##3##(2013-1#3)
the plug##17##2##(1994-3#1)(2007-10#1)(2008-10#1)(2009-6#11)(2013-1#3)
the plume##5##2##(2008-2#1)(2008-3#4)
the pluripotent##3##2##(1990-5#1)(2008-9#1)(2013-1#1)
the plus-maze##5##2##(1992-7#2)(1993-3#1)(1994-2#1)(2008-11#1)
the pnbA##3##2##(1994-12#3)
the pneumococcal##4##2##(1994-9#1)(2007-6#1)(2008-10#1)(2011-2#1)
the pneumonia##2##2##(1992-3#1)(2013-1#1)
the point mutations##2##3##(2008-10#1)(2008-12#1)
the point of care##3##4##(1997-3#1)(2008-11#1)(2010-8#1)
the point of departure for##2##5##(2007-7#1)(2012-2#1)
the point of inflection##2##4##(2008-10#2)
the point of##48##3##(1990-3#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-1#1)(1997-3#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#3)(2008-7#4)(2009-12#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#3)
the point source##3##3##(2008-10#1)(2008-3#2)
the point that##3##3##(2008-8#1)(2009-8#1)(2013-1#1)
the point where##6##3##(1992-3#1)(1995-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-12#1)
the point##78##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#3)(1993-1#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-3#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-7#5)(2008-8#2)(2009-12#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
the point-of-care##2##2##(1996-1#1)(2010-2#1)
the point-spread function (PSF)##3##4##(2008-2#1)(2008-3#2)
the point-spread function is##2##4##(2008-3#2)
the point-spread function##9##3##(2007-12#1)(2008-2#1)(2008-3#7)
the point-spread functions##2##3##(2008-3#2)
the point-spread##11##2##(2007-12#1)(2008-2#1)(2008-3#9)
the pointing##3##2##(2008-2#2)(2008-3#1)
the points of##3##3##(2008-10#1)(2008-3#2)
the points##14##2##(2007-11#2)(2008-10#2)(2008-3#3)(2008-4#1)(2008-6#1)(2009-2#1)(2012-1#1)(2013-1#3)
the poison##2##2##(2007-12#1)(2008-5#1)
the pol I family##2##4##(1997-8#2)
the pol##3##2##(1995-2#1)(1997-8#2)
the polI family##2##3##(1997-6#2)
the polar coordinates of##2##4##(2008-2#2)
the polar fraction##2##3##(2013-8#2)
the polar head##3##3##(1990-2#1)(1990-5#1)(2008-11#1)
the polar heads##2##3##(1991-5#2)
the polar lipids##2##3##(2008-11#1)(2011-2#1)
the polar##33##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-5#3)(1992-10#1)(1992-3#1)(1992-6#2)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#2)
the polarimeter##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
the polarimetric##2##2##(2008-10#1)(2008-3#1)
the polarity of the##3##4##(1991-5#1)(2008-10#1)(2008-5#1)
the polarity of##6##3##(1991-5#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)
the polarity##9##2##(1991-5#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
the polarizability of##2##3##(1997-6#1)(2007-12#1)
the polarizability##3##2##(1997-6#2)(2007-12#1)
the polarization and##2##3##(2008-2#1)(2013-8#1)
the polarization angle##2##3##(2007-11#1)(2007-12#1)
the polarization characteristics of##2##4##(2008-2#2)
the polarization dependence of Raman gain##2##6##(2007-11#2)
the polarization dependence of##3##4##(2007-11#2)(2008-3#1)
the polarization direction of##3##4##(2008-2#1)(2008-3#2)
the polarization effects##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
the polarization of light##3##4##(2008-2#1)(2008-3#2)
the polarization of the##10##4##(2007-11#2)(2008-2#3)(2008-3#4)(2008-8#1)
the polarization of##22##3##(1990-2#1)(1991-5#1)(2007-11#4)(2008-2#4)(2008-3#8)(2008-8#1)(2008-9#2)(2012-2#1)
the polarization properties of fiber lasers##2##6##(2008-2#2)
the polarization properties of##3##4##(2008-2#2)(2011-1#1)
the polarization properties##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2011-1#1)
the polarization rotation##3##3##(2008-2#2)(2008-3#1)
the polarization sensitivity of the##2##5##(2008-2#1)(2008-3#1)
the polarization sensitivity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the polarization state of an##2##5##(2007-12#1)(2008-3#1)
the polarization state of light##2##5##(2008-3#2)
the polarization state of the incident##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
the polarization state of the##6##5##(2007-12#1)(2008-2#1)(2008-3#4)
the polarization state of##15##4##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#8)
the polarization state##17##3##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#8)
the polarization##101##2##(1990-2#1)(1991-5#1)(1995-5#1)(2007-11#16)(2007-12#12)(2008-2#22)(2008-3#40)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
the polarization-dependent##4##2##(2007-12#1)(2008-3#3)
the polarization-modulated##2##2##(2007-12#1)(2008-3#1)
the polarization-resolved##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
the polarization-state evolution##2##3##(2007-11#2)
the polarization-state##4##2##(2007-11#2)(2008-3#2)
the polarized##10##2##(2008-2#3)(2008-3#4)(2010-8#1)(2012-12#2)
the polarizer##6##2##(2007-12#1)(2008-3#5)
the polarizing activity##2##3##(1991-5#1)(1993-12#1)
the polarizing direction##3##3##(2008-2#3)
the polarizing##8##2##(1991-5#1)(1993-12#1)(2007-11#1)(2008-2#3)(2008-3#2)
the polarographic determination of benzaldehyde##2##5##(2008-10#2)
the polarographic determination of##3##4##(2008-10#3)
the polarographic method##2##3##(2008-10#2)
the polarographic##7##2##(2008-10#7)
the pole##4##2##(1992-9#1)(2011-2#3)
the poles of##2##3##(2008-8#1)(2008-9#1)
the poles##5##2##(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)
the polh##4##2##(1997-4#4)
the police##6##2##(1993-3#1)(1997-8#4)(2009-2#1)
the policies##5##2##(1993-3#1)(2007-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
the policy implications of##2##4##(2008-7#1)(2011-1#1)
the policy implications##3##3##(1993-12#1)(2008-7#1)(2011-1#1)
the policy process##3##3##(1995-1#1)(1995-2#1)(1996-12#1)
the policy##21##2##(1991-12#1)(1992-12#2)(1993-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-6#1)(2008-7#2)(2009-3#3)(2011-1#1)(2011-2#1)
the poling temperature##2##3##(2007-12#2)
the poling##6##2##(2007-12#6)
the political and##4##3##(1994-3#1)(1995-2#1)(2008-2#1)(2012-2#1)
the political process##2##3##(1991-2#1)(1997-1#1)
the political##21##2##(1991-2#1)(1992-1#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#1)
the politics of##6##3##(1992-1#1)(1994-2#1)(2008-10#2)(2009-5#1)(2013-7#1)
the pollen tube##5##3##(2008-11#3)(2009-8#2)
the pollen##11##2##(1996-5#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-8#2)(2012-7#2)
the pollinator##2##2##(2008-8#1)(2012-2#1)
the pollutant##2##2##(2008-10#2)
the pollutants##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
the polluted rivers##2##3##(2008-7#2)
the polluted##4##2##(1996-3#1)(2006-10#1)(2008-7#2)
the poly(A) tail##3##3##(1991-9#1)(1997-2#1)(2008-10#1)
the poly(A)##4##2##(1991-9#1)(1994-11#1)(1997-2#1)(2008-10#1)
the poly(ADP-ribose)##2##2##(1993-12#1)(2008-1#1)
the poly-alanine##2##2##(2012-2#2)
the polyadenylation##3##2##(1992-12#1)(1994-11#1)(2010-4#1)
the polyamine site of the NMDA receptor##2##7##(1996-2#2)
the polyamine site of##3##4##(1996-2#3)
the polyamine##5##2##(1990-7#1)(1996-2#3)(1997-7#1)
the polycationic##5##2##(1994-9#4)(2008-11#1)
the polyclonal##7##2##(1990-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)
the polycrystalline##3##2##(1996-2#1)(2007-12#1)(2008-2#1)
the polycystic ovary syndrome##7##4##(2008-3#3)(2008-4#4)
the polyelectrolyte##2##2##(2008-10#1)(2008-7#1)
the polyethylene##4##2##(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)
the polygon##2##2##(2007-11#1)(2008-2#1)
the polyhedrin gene locus##2##4##(2008-11#1)(2008-8#1)
the polyhedrin gene##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
the polyhedrin promoter##5##3##(1994-11#1)(1997-4#2)(2008-11#2)
the polyhedrin##8##2##(1994-11#1)(1995-12#1)(1997-4#2)(2008-11#3)(2008-8#1)
the polymer aggregates##2##3##(2010-4#2)
the polymer and the##3##4##(1995-6#1)(2008-10#1)(2010-12#1)
the polymer and##5##3##(1995-11#1)(1995-6#1)(2008-10#2)(2010-12#1)
the polymer backbone##3##3##(2007-12#1)(2008-10#1)(2009-10#1)
the polymer coating##3##3##(2008-10#3)
the polymer did##2##3##(2008-11#1)(2010-4#1)
the polymer film##3##3##(2008-10#3)
the polymer films##4##3##(2008-10#2)(2008-2#1)(2010-4#1)
the polymer heteronuclei##2##3##(2011-3#2)
the polymer is##2##3##(2008-10#1)(2008-5#1)
the polymer matrix and##4##4##(2007-12#1)(2009-11#1)(2009-12#1)(2010-4#1)
the polymer matrix during the##2##5##(2008-10#2)
the polymer matrix##13##3##(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#2)(2009-11#1)(2009-12#2)(2010-4#1)
the polymer molecule##2##3##(2008-3#1)(2008-7#1)
the polymer residue##2##3##(2008-5#2)
the polymer to##3##3##(2008-10#2)(2008-11#1)
the polymer##91##2##(1995-11#2)(1995-2#1)(1995-6#2)(2007-11#1)(2007-12#5)(2008-10#35)(2008-11#6)(2008-2#2)(2008-3#4)(2008-5#6)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#1)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#2)(2011-3#2)
the polymer's##2##2##(2007-11#1)(2008-5#1)
the polymerase chain reaction (PCR) and the##2##7##(2008-10#1)(2008-4#1)
the polymerase chain reaction (PCR) to##2##6##(2008-2#1)(2008-4#1)
the polymerase chain reaction (PCR)##18##5##(1990-2#1)(1991-11#1)(1991-2#1)(1994-12#2)(1995-8#2)(1997-7#1)(2008-10#4)(2008-2#2)(2008-4#3)(2008-9#1)
the polymerase chain reaction and##3##5##(1990-8#1)(1994-12#1)(2007-10#1)
the polymerase chain reaction technique##2##5##(1990-12#1)(1991-9#1)
the polymerase chain reaction to##4##5##(1991-9#1)(2008-11#1)(2011-2#2)
the polymerase chain reaction using primers##2##6##(1992-6#1)(1993-2#1)
the polymerase chain reaction with##2##5##(1992-2#1)(1994-11#1)
the polymerase chain reaction##64##4##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#3)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#1)(1995-6#1)(1995-8#2)(1996-9#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-4#3)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
the polymerase chain reaction]##2##4##(1990-8#1)(1996-8#1)
the polymerase chain##67##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#3)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#1)(1995-6#1)(1995-8#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-4#3)(2008-5#1)(2008-9#1)(2011-2#2)(2013-8#1)
the polymerase##77##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-6#3)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-8#2)(1995-6#1)(1995-8#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-4#3)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
the polymeric matrix##8##3##(2008-10#6)(2008-2#1)(2010-4#1)
the polymeric##24##2##(1990-2#1)(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2010-4#1)(2013-1#1)
the polymerization of##3##3##(1990-7#1)(2008-10#1)(2012-2#1)
the polymerization process##3##3##(2008-3#2)(2010-10#1)
the polymerization reaction is##2##4##(2008-2#1)(2010-7#1)
the polymerization##15##2##(1990-7#2)(1994-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
the polymerized##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
the polymers and##3##3##(2008-10#1)(2008-11#2)
the polymers that##2##3##(2007-12#1)(2008-10#1)
the polymers##17##2##(1994-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2013-1#2)
the polymorphic##9##2##(1992-6#2)(1994-9#1)(1995-6#1)(1997-5#1)(2008-10#2)(2008-4#2)
the polymorphism of the##2##4##(2009-5#1)(2013-1#1)
the polymorphism of##4##3##(2008-10#2)(2009-5#1)(2013-1#1)
the polymorphism##6##2##(1995-3#1)(2008-10#2)(2008-9#1)(2009-5#1)(2013-1#1)
the polymorphisms of##2##3##(1997-8#1)(2008-7#1)
the polymorphisms##3##2##(1997-8#1)(2008-7#1)(2013-1#1)
the polynomial##3##2##(2008-3#1)(2008-6#2)
the polyol##2##2##(2008-1#1)(2008-10#1)
the polyoma origin of replication##2##5##(1995-2#2)
the polyoma##3##2##(1995-2#3)
the polyp##2##2##(1993-9#1)(2013-8#1)
the polypeptide chain##9##3##(1991-8#1)(1992-4#1)(1992-8#1)(1994-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-8#1)(2012-1#1)
the polypeptide##17##2##(1990-5#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-8#1)(2009-2#1)(2010-2#1)(2012-1#1)
the polypeptides##2##2##(2008-4#1)(2008-7#1)
the polyploidization##2##2##(1994-11#2)
the polypropylene##4##2##(2008-7#1)(2012-3#3)
the polyps##2##2##(2008-11#1)(2009-12#1)
the polypyrrole film##2##3##(2008-10#2)
the polypyrrole##5##2##(2008-10#5)
the polyradical##2##2##(2008-10#2)
the polysaccharide##3##2##(1994-9#1)(1995-11#1)(2011-2#1)
the polysaccharides##3##2##(2012-12#2)(2012-6#1)
the polysynaptic##2##2##(1996-2#2)
the polyurethane coating##2##3##(2013-8#2)
the polyurethane foam##5##3##(2008-10#5)
the polyurethane##10##2##(2007-7#1)(2008-10#6)(2009-7#1)(2013-8#2)
the pomegranate##2##2##(2013-8#2)
the pons##3##2##(1995-2#1)(1996-5#1)(2007-10#1)
the pontine nuclei##5##3##(2008-11#5)
the pontine reticular formation##3##4##(1990-7#3)
the pontine##8##2##(1990-7#3)(2008-11#5)
the pontomesencephalic reticular formation##2##4##(1997-3#2)
the pontomesencephalic##3##2##(1995-12#1)(1997-3#2)
the pooid-infecting##2##2##(2008-10#2)
the pool of##6##3##(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
the pool##8##2##(1993-3#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
the pooled comparators##2##3##(2012-3#2)
the pooled data##3##3##(2008-10#2)(2008-12#1)
the pooled##12##2##(1993-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#1)(2012-3#2)(2013-1#1)
the poor and##3##3##(1993-3#1)(1994-2#1)(1994-7#1)
the poor prognosis of##2##4##(1991-2#1)(1992-2#1)
the poor prognosis##6##3##(1991-2#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-5#1)(2008-6#1)
the poor response##2##3##(2008-10#1)(2013-1#1)
the poor survival##2##3##(1991-4#1)(2009-10#1)
the poor##46##2##(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-7#1)(1995-12#1)(1995-9#1)(1996-1#3)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-5#2)(2009-7#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
the poorer##2##2##(2008-2#1)(2009-2#1)
the poorest countries##2##3##(1992-5#1)(2008-7#1)
the poorest survival##2##3##(2008-10#1)(2010-3#1)
the poorest##8##2##(1990-2#1)(1992-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2012-12#1)
the poorly##5##2##(1990-2#1)(1991-8#1)(1993-9#1)(1996-4#1)(2013-7#1)
the popliteal artery##2##3##(1991-3#2)
the popliteal##4##2##(1991-3#3)(2008-10#1)
the popular##12##2##(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-9#1)(2013-8#1)
the popularity of##6##3##(1993-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-7#1)
the population and the##4##4##(2007-11#1)(2008-9#1)(2009-7#1)(2013-1#1)
the population and##9##3##(1992-1#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
the population as a whole##2##5##(2008-8#1)(2012-12#1)
the population at large##3##4##(1992-2#2)(2008-4#1)
the population at##6##3##(1992-2#2)(1993-11#1)(1997-6#1)(2008-4#1)(2009-6#1)
the population being##5##3##(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-12#1)
the population between##5##3##(1994-6#1)(2013-8#4)
the population biology of##4##4##(2008-10#3)(2008-8#1)
the population by##4##3##(1991-3#1)(1997-7#1)(2008-1#1)(2012-2#1)
the population data are going to be available in the EMPOP database (www##3##13##(2008-12#3)
the population densities of##6##4##(2007-5#1)(2008-10#4)(2008-7#1)
the population densities##7##3##(2007-5#1)(2008-10#5)(2008-7#1)
the population density and metabolic activity of the##2##8##(2008-10#2)
the population density of the pathogen##2##6##(2008-10#2)
the population density of the##3##5##(2008-10#3)
the population density of##7##4##(2008-10#7)
the population density##9##3##(2008-10#9)
the population during##2##3##(2008-10#2)
the population dynamics of the##2##5##(2007-12#1)(2008-10#1)
the population dynamics of##12##4##(1994-8#1)(2007-12#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
the population dynamics##15##3##(1994-8#1)(2007-12#1)(2008-10#5)(2008-8#3)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#2)
the population from##5##3##(1991-12#1)(2008-10#2)(2008-5#1)(2010-3#1)
the population genetic structure of##3##5##(2008-10#2)(2011-2#1)
the population genetic##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
the population growth rate##2##4##(2008-8#1)(2008-9#1)
the population growth##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the population have##2##3##(1997-1#1)(2008-8#1)
the population in the##5##4##(2008-10#1)(2008-5#1)(2008-6#2)(2011-2#1)
the population in##9##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-1#1)(2011-2#1)
the population is##16##3##(1991-12#1)(1991-9#1)(1994-9#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#2)
the population level##12##3##(1994-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#1)
the population mean##2##3##(1991-3#1)(1992-9#1)
the population of D##3##4##(2008-10#1)(2013-8#2)
the population of Phytophthora infestans##2##5##(2008-10#2)
the population of a##3##4##(1995-9#1)(2007-2#1)(2013-8#1)
the population of the##9##4##(1995-1#1)(1997-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
the population of these##2##4##(1990-6#1)(2012-1#1)
the population of##49##3##(1990-6#1)(1993-5#1)(1993-9#1)(1994-1#1)(1995-1#1)(1995-9#1)(1996-6#1)(1997-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
the population over##2##3##(1990-6#1)(2008-10#1)
the population parameter##2##3##(2008-8#1)(2012-2#1)
the population size of the##2##5##(2008-10#2)
the population size of##5##4##(2008-10#5)
the population size##7##3##(2008-10#5)(2008-5#1)(2008-8#1)
the population spike##6##3##(1990-7#1)(1991-12#3)(1995-12#1)(1996-5#1)
the population structure and the##3##5##(2008-10#2)(2013-7#1)
the population structure and##4##4##(2008-10#3)(2013-7#1)
the population structure of X##2##5##(2008-10#2)
the population structure of##6##4##(2008-10#5)(2011-2#1)
the population structure##11##3##(2008-10#8)(2011-2#2)(2013-7#1)
the population to be##2##4##(1997-2#1)(2008-10#1)
the population to##5##3##(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#2)
the population under study##2##4##(1997-7#1)(2008-1#1)
the population was##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2011-1#1)
the population##387##2##(1990-3#2)(1990-6#3)(1990-7#1)(1991-12#8)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-2#2)(1993-5#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-5#2)(1995-9#1)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2008-1#7)(2008-10#90)(2008-11#7)(2008-12#9)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#29)(2008-9#13)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#17)(2012-1#2)(2012-12#10)(2012-2#5)(2012-3#5)(2012-4#1)(2013-1#10)(2013-7#2)(2013-8#25)
the population's##3##2##(1994-6#1)(2010-8#1)(2011-2#1)
the population-based model##2##3##(2009-8#2)
the population-based studies##2##3##(2007-10#1)(2007-12#1)
the population-based##7##2##(1993-9#2)(2007-10#1)(2007-12#1)(2009-8#2)(2013-1#1)
the population-level model##2##3##(2008-9#2)
the population-level##4##2##(2008-9#3)(2013-8#1)
the population-wide##2##2##(2008-8#2)
the populations from##6##3##(2008-10#5)(2008-8#1)
the populations in##3##3##(2008-10#3)
the populations of the##3##4##(1990-8#1)(2008-10#1)(2008-8#1)
the populations of##12##3##(1990-8#1)(1993-6#1)(1997-2#1)(2008-10#5)(2008-8#3)(2012-2#1)
the populations revealed##2##3##(2008-10#2)
the populations studied##2##3##(2008-1#1)(2008-10#1)
the populations were##4##3##(1997-7#1)(2008-10#2)(2008-5#1)
the populations##54##2##(1990-8#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#27)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the porcine Tex11##3##3##(2012-2#3)
the porcine aortic##2##3##(1990-2#1)(2010-8#1)
the porcine model##2##3##(2009-2#1)(2011-2#1)
the porcine pancreas##2##3##(1990-12#1)(2010-11#1)
the porcine##21##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#3)(1991-6#1)(1993-3#1)(1995-8#1)(1996-12#1)(2008-11#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#4)
the pore and##2##3##(2010-11#1)(2011-2#1)
the pore helix##2##3##(2008-8#2)
the pore size##2##3##(2008-10#1)(2008-5#1)
the pore water##3##3##(2008-10#2)(2013-8#1)
the pore##17##2##(1991-9#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#5)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
the pores of a##2##4##(2008-10#1)(2008-11#1)
the pores of the##5##4##(2008-10#4)(2010-2#1)
the pores of##7##3##(2008-10#5)(2008-11#1)(2010-2#1)
the pores##15##2##(2007-12#1)(2008-10#10)(2008-11#1)(2010-12#1)(2010-2#1)(2013-8#1)
the pork tapeworm Taenia##2##4##(1995-12#1)(2008-7#1)
the pork##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
the porosity of##2##3##(2008-10#1)(2008-7#1)
the porosity##5##2##(2008-10#1)(2008-2#2)(2008-7#1)(2009-7#1)
the porous material##3##3##(2008-3#3)
the porous##9##2##(1990-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-2#2)
the porphyrin system##2##3##(2008-10#2)
the porphyrin to##2##3##(2008-10#1)(2010-6#1)
the porphyrin##16##2##(1991-5#1)(1992-8#1)(1994-5#1)(2008-10#10)(2010-6#3)
the porphyrins##4##2##(1992-9#2)(2008-10#1)(2008-6#1)
the port access##2##3##(2007-8#1)(2008-11#1)
the port##5##2##(2007-7#2)(2007-8#1)(2008-11#1)(2011-2#1)
the portable##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
the portal vein##6##3##(1995-2#1)(1997-4#1)(1997-8#1)(2009-11#2)(2009-9#1)
the portal##12##2##(1993-3#1)(1994-7#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-5#1)(2009-11#2)(2009-2#1)(2009-9#2)(2010-12#1)
the portfolio##2##2##(2012-12#2)
the portion of the##3##4##(1997-6#1)(1997-9#1)(2009-1#1)
the portion of##8##3##(1997-6#1)(1997-7#1)(1997-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)
the portions##2##2##(1994-8#1)(2009-6#1)
the position and the orientation of a##2##7##(2008-2#2)
the position and the orientation of##3##6##(2008-2#3)
the position and##6##3##(2008-10#1)(2008-2#4)(2008-3#1)
the position corresponding to##3##4##(1990-2#1)(1991-12#1)(1996-5#1)
the position described##2##3##(2008-7#1)(2009-6#1)
the position of a##2##4##(1995-5#1)(1997-7#1)
the position of the desired image##3##6##(2008-3#3)
the position of the mouth##2##5##(2008-5#2)
the position of the reference beam##2##6##(2008-3#2)
the position of the##43##4##(1994-3#1)(1995-11#2)(1995-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#13)(2008-5#2)(2008-8#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#2)
the position of##67##3##(1990-12#1)(1990-5#1)(1991-6#1)(1993-6#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#4)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#17)(2008-5#2)(2008-8#4)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)
the position##92##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#4)(2008-10#6)(2008-12#2)(2008-2#10)(2008-3#20)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
the position-specific regulatory element of murine Hoxa-7##2##7##(1997-4#2)
the position-specific##3##2##(1997-4#3)
the positional##5##2##(1995-6#1)(1996-6#1)(2008-3#1)(2008-9#1)(2012-2#1)
the positioning of the##6##4##(1992-6#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-10#1)
the positioning of##8##3##(1992-6#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-3#1)
the positioning##9##2##(1992-6#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-3#1)
the positions and##4##3##(1994-1#1)(1997-2#1)(2008-3#2)
the positions of the##3##4##(1995-8#1)(2007-11#1)(2007-12#1)
the positions of##13##3##(1991-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
the positions##22##2##(1991-8#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#1)(2009-4#1)
the positive and negative aspects of##3##6##(1990-5#1)(2008-11#1)(2009-12#1)
the positive and negative##7##4##(1990-5#1)(1991-4#1)(1997-2#1)(2008-11#2)(2009-12#2)
the positive and##11##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-4#1)(1997-2#1)(2008-11#2)(2009-12#2)(2010-5#1)(2013-1#1)
the positive aspects of##2##4##(1990-9#1)(2011-2#1)
the positive association between##2##4##(2008-11#1)(2010-1#1)
the positive association##3##3##(2008-1#1)(2008-11#1)(2010-1#1)
the positive characteristics of the##2##5##(1990-9#1)(2008-11#1)
the positive charge of##2##4##(1994-3#1)(2011-2#1)
the positive control group##2##4##(1992-2#1)(2013-1#1)
the positive control##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
the positive effect of##3##4##(2008-3#1)(2008-9#1)(2011-1#1)
the positive effect##4##3##(2007-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
the positive effects of##2##4##(2008-10#1)(2008-8#1)
the positive effects##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
the positive electrode##2##3##(2009-12#1)(2013-8#1)
the positive feedback##2##3##(2009-10#1)(2009-8#1)
the positive influence of##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
the positive inotropic action of forskolin##2##6##(1997-7#2)
the positive inotropic action of##3##5##(1997-7#3)
the positive inotropic effect##2##4##(1995-12#1)(2008-5#1)
the positive inotropic effects of##3##5##(1997-7#3)
the positive inotropic##8##3##(1995-12#1)(1997-7#6)(2008-5#1)
the positive or##2##3##(1993-11#1)(2009-11#1)
the positive outcomes##3##3##(1995-1#1)(2008-12#1)(2010-12#1)
the positive predictive value##2##4##(1992-10#1)(2012-2#1)
the positive rate was##2##4##(2011-3#1)(2013-8#1)
the positive rate##3##3##(2011-3#1)(2012-3#1)(2013-8#1)
the positive regulatory##2##3##(1997-1#1)(1997-7#1)
the positive results observed in##2##5##(1992-12#1)(2007-7#1)
the positive results##5##3##(1992-12#1)(2007-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
the positive role of##2##4##(2008-12#1)(2013-1#1)
the positive samples##2##3##(2010-6#1)(2012-12#1)
the positive stereotype group was##2##5##(2008-11#2)
the positive strand##3##3##(1994-8#2)(2008-10#1)
the positive##133##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#2)(1991-4#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-8#4)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#9)(1997-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#4)(2011-3#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
the positively charged##8##3##(1990-5#1)(1991-8#1)(1994-3#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-8#1)
the positively##9##2##(1990-5#1)(1991-8#1)(1994-3#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-6#1)(2008-8#1)
the positivity constraint##2##3##(2013-1#2)
the positivity of##2##3##(2008-5#1)(2013-1#1)
the positivity##5##2##(1990-8#1)(2008-5#1)(2013-1#3)
the possibilities and##4##3##(1997-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
the possibilities for##8##3##(1993-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)
the possibilities of using##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
the possibilities of##20##3##(1991-8#1)(1994-9#1)(1996-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
the possibilities that##2##3##(2008-10#1)(2012-12#1)
the possibilities##38##2##(1991-8#1)(1993-12#1)(1994-9#2)(1996-9#1)(1997-2#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the possibility exists that##3##4##(1994-8#1)(1996-4#1)(2011-2#1)
the possibility for improvement of##2##5##(2008-10#1)(2011-2#1)
the possibility for the##2##4##(2008-10#1)(2008-7#1)
the possibility for##7##3##(2008-1#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)
the possibility of a novel##2##5##(1992-12#1)(1994-12#1)
the possibility of a##24##4##(1990-6#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
the possibility of achieving##2##4##(2008-11#1)(2008-3#1)
the possibility of an##8##4##(1990-12#1)(1990-5#1)(1990-7#1)(1997-8#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-8#1)
the possibility of developing a##2##5##(2008-10#1)(2008-5#1)
the possibility of developing new##2##5##(2007-11#1)(2008-7#1)
the possibility of developing##6##4##(1991-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
the possibility of direct##2##4##(1992-12#1)(2008-10#1)
the possibility of generating##2##4##(2007-11#1)(2008-11#1)
the possibility of growing##2##4##(2008-2#1)(2009-11#1)
the possibility of imaging the##2##5##(2007-11#1)(2012-2#1)
the possibility of increased##2##4##(2008-11#1)(2012-3#1)
the possibility of its##2##4##(1993-8#1)(2008-2#1)
the possibility of making##3##4##(2007-11#1)(2008-7#1)(2008-9#1)
the possibility of measuring##3##4##(1990-8#1)(2008-2#1)(2008-7#1)
the possibility of obtaining##3##4##(1991-12#1)(2008-3#1)(2008-7#1)
the possibility of performing##2##4##(2007-11#1)(2008-7#1)
the possibility of the##6##4##(1990-9#2)(2008-10#1)(2009-5#1)(2011-2#2)
the possibility of their##2##4##(1994-11#1)(2008-10#1)
the possibility of this##2##4##(1990-9#1)(2008-5#1)
the possibility of using a##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
the possibility of using the##5##5##(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
the possibility of using this##2##5##(2008-10#1)(2008-5#1)
the possibility of using##24##4##(1991-8#1)(1993-3#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#3)(2012-2#1)
the possibility of utilizing##2##4##(2008-10#1)(2011-1#1)
the possibility of##257##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-3#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#17)(2007-12#9)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#34)(2008-11#10)(2008-12#4)(2008-2#7)(2008-3#14)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#3)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#4)(2011-2#15)(2011-3#1)(2012-1#1)(2012-2#7)(2012-3#7)(2013-1#8)(2013-8#4)
the possibility that a##3##4##(1992-2#1)(1996-6#1)(2008-10#1)
the possibility that an##2##4##(2008-10#1)(2008-11#1)
the possibility that different##2##4##(1995-11#1)(2008-9#1)
the possibility that it may##2##5##(1991-8#1)(2008-10#1)
the possibility that it##4##4##(1991-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
the possibility that such##2##4##(1991-4#1)(2008-11#1)
the possibility that the##16##4##(1990-12#1)(1992-7#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-9#1)(2008-10#3)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#2)(2013-1#1)
the possibility that these two##2##5##(1996-12#1)(1997-8#1)
the possibility that these##5##4##(1996-12#1)(1997-8#2)(2008-11#1)(2011-2#1)
the possibility that they##2##4##(1995-8#1)(2008-10#1)
the possibility that this##2##4##(1994-8#1)(2008-11#1)
the possibility that##94##3##(1990-12#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-5#1)(1997-8#2)(2006-10#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
the possibility to apply##2##4##(2008-11#1)(2009-8#1)
the possibility to improve##2##4##(2008-10#1)(2008-8#1)
the possibility to use##2##4##(2008-5#1)(2010-12#1)
the possibility to##35##3##(1990-10#1)(1990-2#1)(1996-11#1)(1996-6#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
the possibility##400##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#17)(2007-12#10)(2007-2#4)(2007-5#1)(2007-8#3)(2008-1#6)(2008-10#58)(2008-11#17)(2008-12#4)(2008-2#8)(2008-3#19)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#13)(2008-8#11)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#5)(2010-8#1)(2011-1#5)(2011-2#26)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#8)(2012-3#8)(2013-1#12)(2013-8#5)
the possible adverse effects of##2##5##(2008-8#1)(2012-2#1)
the possible adverse effects##3##4##(2008-8#1)(2012-2#1)(2013-1#1)
the possible application##2##3##(1991-2#1)(2008-10#1)
the possible association between##4##4##(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
the possible association of##2##4##(1992-12#1)(2011-2#1)
the possible association##6##3##(1992-12#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
the possible benefits##2##3##(2007-11#1)(2008-10#1)
the possible causes of##2##4##(2008-7#1)(2008-9#1)
the possible causes##4##3##(1997-8#1)(2008-7#1)(2008-9#1)(2010-8#1)
the possible complications##4##3##(1993-9#1)(1994-3#1)(2008-7#1)(2012-12#1)
the possible effect of the##2##5##(1994-8#1)(2008-10#1)
the possible effect of##4##4##(1994-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
the possible effects of##4##4##(1990-6#1)(1995-12#1)(1996-2#1)(2007-12#1)
the possible effects##5##3##(1990-6#1)(1995-12#1)(1996-2#2)(2007-12#1)
the possible etiology of##2##4##(1990-2#1)(2013-1#1)
the possible existence of##5##4##(1992-3#1)(1992-9#1)(2007-8#1)(2010-11#1)(2012-2#1)
the possible extension##2##3##(1994-12#1)(2008-3#1)
the possible formation of##2##4##(1994-5#1)(2011-2#1)
the possible functional role of##2##5##(2009-10#1)(2013-1#1)
the possible hazards##2##3##(1992-8#1)(2013-1#1)
the possible impact of##3##4##(1995-12#1)(2008-11#1)(2008-8#1)
the possible impact##4##3##(1995-12#1)(2008-11#1)(2008-8#2)
the possible influence of##5##4##(2006-6#2)(2008-10#1)(2012-3#1)(2013-8#1)
the possible influence##6##3##(2006-6#2)(2008-10#1)(2012-3#1)(2013-8#2)
the possible interaction between##2##4##(1993-12#1)(2008-4#1)
the possible interaction of##3##4##(1993-5#1)(1994-11#1)(2012-8#1)
the possible interaction##5##3##(1993-12#1)(1993-5#1)(1994-11#1)(2008-4#1)(2012-8#1)
the possible interactions##3##3##(1993-9#1)(2006-10#1)(2011-1#1)
the possible involvement of##7##4##(1991-9#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-11#1)(2013-7#1)
the possible involvement##8##3##(1991-9#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-11#2)(2013-7#1)
the possible link##2##3##(2008-10#1)(2013-7#1)
the possible mechanism for##2##4##(2008-10#2)
the possible mechanism of the##2##5##(2008-10#1)(2011-3#1)
the possible mechanism of##9##4##(2008-10#5)(2008-5#1)(2008-6#1)(2009-12#1)(2011-3#1)
the possible mechanism##11##3##(2008-10#7)(2008-5#1)(2008-6#1)(2009-12#1)(2011-3#1)
the possible mechanisms##4##3##(2007-10#1)(2008-9#1)(2012-12#1)(2013-7#1)
the possible occurrence of##2##4##(1994-6#1)(2011-2#1)
the possible origin##2##3##(2008-5#1)(2009-7#1)
the possible pathogenic##2##3##(2008-2#1)(2008-7#1)
the possible pathological##2##3##(2008-7#1)(2010-12#1)
the possible physiological##2##3##(1994-11#1)(2009-8#1)
the possible presence of a##2##5##(1994-11#1)(1997-5#1)
the possible presence of##4##4##(1992-3#1)(1994-11#1)(1997-5#1)(2008-10#1)
the possible protective##3##3##(2007-2#1)(2011-2#1)(2012-4#1)
the possible reaction mechanism##2##4##(1990-5#1)(2008-10#1)
the possible reasons for the##2##5##(1996-5#1)(2011-2#1)
the possible reasons for##3##4##(1996-5#1)(2009-5#1)(2011-2#1)
the possible relationship between##2##4##(1993-2#1)(2013-1#1)
the possible relationship with##2##4##(2008-10#1)(2013-1#1)
the possible relationship##4##3##(1993-2#1)(2008-10#1)(2013-1#2)
the possible relevance of this##2##5##(1992-12#1)(2008-9#1)
the possible relevance of##4##4##(1992-12#1)(1992-9#1)(2008-10#1)(2008-9#1)
the possible risk##2##3##(2008-1#1)(2012-2#1)
the possible role of the##3##5##(2007-12#1)(2011-2#1)(2013-8#1)
the possible role of##23##4##(1990-10#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
the possible roles of##5##4##(1996-9#1)(2007-8#1)(2008-7#2)(2012-3#1)
the possible solutions##2##3##(2008-6#1)(2012-3#1)
the possible therapeutic##2##3##(1990-5#1)(2008-7#1)
the possible use of##8##4##(2008-1#1)(2008-10#3)(2008-5#2)(2009-8#2)
the possible##292##2##(1990-10#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#4)(1992-3#3)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#3)(1995-12#3)(1995-5#1)(1995-9#2)(1996-1#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#16)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#5)(2012-4#1)(2012-5#1)(2012-8#2)(2013-1#13)(2013-7#3)(2013-8#9)
the possibly##3##2##(1994-12#1)(2008-3#1)(2010-5#1)
the post##7##2##(1996-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#1)
the post-cataract surgery##2##3##(2010-8#2)
the post-genomic era##5##3##(2008-7#3)(2011-2#1)(2012-3#1)
the post-infusion##2##2##(2008-7#2)
the post-operative##6##2##(1990-9#1)(1993-5#1)(2007-7#1)(2008-11#1)(2008-5#1)(2013-1#1)
the post-reproductive period##5##3##(1997-4#5)
the post-synaptic membrane##2##3##(1997-5#1)(2008-11#1)
the post-transcriptional##3##2##(1993-6#1)(1996-12#1)(2011-2#1)
the post-translational##8##2##(1992-6#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-3#1)(2013-1#1)
the post-transplant##4##2##(2007-11#1)(2008-4#1)(2010-6#1)(2011-3#1)
the posterior and anterior##2##4##(1994-8#1)(2011-7#1)
the posterior cervical##2##3##(1997-6#1)(2012-3#1)
the posterior chest wall##2##4##(2007-8#2)
the posterior circulation##3##3##(1993-3#1)(2008-7#1)(2012-3#1)
the posterior communicating##2##3##(2008-7#2)
the posterior fossa##12##3##(1996-6#2)(1996-9#1)(2008-7#5)(2011-2#4)
the posterior iliac##2##3##(1991-6#1)(2007-10#1)
the posterior inferior cerebellar artery##2##5##(2008-7#2)
the posterior lobe##4##3##(1992-9#2)(1997-8#1)(2012-3#1)
the posterior mediastinum##6##3##(2007-8#2)(2010-12#2)(2011-2#2)
the posterior parietal cortex##3##4##(1994-3#2)(1997-2#1)
the posterior parietal##4##3##(1994-3#2)(1996-2#1)(1997-2#1)
the posterior part of the disc##2##6##(2009-4#2)
the posterior part of the##4##5##(2007-12#1)(2008-2#1)(2009-4#2)
the posterior pituitary##4##3##(1997-8#1)(2007-10#1)(2008-4#1)(2013-1#1)
the posterior portion of##2##4##(1996-7#1)(1997-3#1)
the posterior quadrants##2##3##(1996-7#1)(2009-8#1)
the posterior right##2##3##(2007-8#1)(2008-11#1)
the posterior side##2##3##(1997-8#1)(2008-9#1)
the posterior superior temporal##2##4##(2008-11#2)
the posterior surface##2##3##(2012-1#1)(2013-8#1)
the posterior tongue##2##3##(1993-12#2)
the posterior wall of the##2##5##(1997-8#1)(2008-7#1)
the posterior walls##2##3##(1991-6#2)
the posterior##141##2##(1990-9#2)(1991-2#2)(1991-6#3)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-12#2)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-2#3)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#6)(2007-10#2)(2007-12#13)(2007-5#1)(2007-8#7)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#14)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#4)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#15)(2011-7#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
the postero-medial##4##2##(1993-6#3)(2008-2#1)
the posterobasal##2##2##(1991-3#1)(2013-1#1)
the posterolateral##5##2##(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the postgraduate##2##2##(1992-1#1)(2008-7#1)
the postharvest pathogens##2##3##(2008-10#2)
the postharvest##5##2##(2008-10#5)
the postimplementation##4##2##(2013-1#4)
the postmenopausal##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
the postnatal development of##7##4##(1992-6#1)(1993-12#2)(1996-5#1)(2009-8#1)(2011-2#2)
the postnatal development##8##3##(1992-6#1)(1993-12#2)(1996-5#2)(2009-8#1)(2011-2#2)
the postnatal period##2##3##(2008-10#1)(2009-9#1)
the postnatal##23##2##(1990-5#2)(1992-11#1)(1992-6#1)(1993-12#2)(1994-11#1)(1996-12#1)(1996-5#3)(2008-10#1)(2009-3#1)(2009-8#3)(2009-9#1)(2011-2#2)(2012-2#3)(2012-3#1)
the postoperative course##5##3##(1992-6#1)(1996-8#1)(2006-10#1)(2007-8#2)
the postoperative pain##2##3##(2009-5#1)(2010-6#1)
the postoperative period##9##3##(1990-2#1)(1991-5#1)(1995-5#1)(2007-8#1)(2007-9#2)(2010-10#2)(2013-1#1)
the postoperative time##2##3##(2007-8#1)(2008-5#1)
the postoperative##40##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-6#4)(1994-3#1)(1995-5#1)(1996-6#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-8#6)(2007-9#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#4)
the postpartum period##6##3##(1995-8#1)(1996-3#1)(2007-2#1)(2011-2#1)(2012-2#2)
the postpartum##9##2##(1995-8#1)(1996-3#1)(2007-2#2)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
the postponement of##2##3##(2008-11#1)(2012-12#1)
the postprandial##2##2##(2008-3#1)(2010-8#1)
the postpubertal##2##2##(2008-10#1)(2008-5#1)
the postsynaptic density (PSD)##3##4##(1996-12#2)(2008-11#1)
the postsynaptic density##4##3##(1996-12#2)(2008-11#1)(2012-3#1)
the postsynaptic membrane##3##3##(1996-12#2)(2008-11#1)
the postsynaptic neuron##3##3##(1997-7#2)(2009-8#1)
the postsynaptic##15##2##(1991-12#1)(1992-8#1)(1996-12#5)(1997-2#2)(1997-7#2)(2008-11#2)(2009-8#1)(2012-3#1)
the posttreatment##5##2##(1994-11#1)(1996-5#3)(2008-10#1)
the postulated##10##2##(1990-7#1)(1991-2#1)(1991-9#1)(1995-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-10#1)(2012-12#1)
the potassium channel##3##3##(1994-11#1)(1997-2#1)(2007-7#1)
the potassium##12##2##(1992-3#1)(1994-11#1)(1995-8#1)(1997-2#3)(2007-7#1)(2008-10#4)(2008-3#1)
the potato##12##2##(2008-10#12)
the potencies of##2##3##(1995-11#2)
the potency of iloprost##2##4##(2008-7#2)
the potency of the##4##4##(1995-12#1)(1995-5#2)(2013-1#1)
the potency of##21##3##(1992-3#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(2007-2#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-9#1)(2013-1#2)
the potency##27##2##(1991-8#1)(1992-3#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(2007-2#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#2)
the potent##19##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-3#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
the potential ability of##2##4##(2007-8#1)(2008-10#1)
the potential advantages of##5##4##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
the potential advantages##6##3##(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)
the potential and the depredating capacity of##2##7##(2007-10#2)
the potential applicability of##3##4##(2008-3#1)(2008-8#1)(2010-6#1)
the potential application of this##4##5##(2008-10#3)(2012-3#1)
the potential application of##7##4##(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
the potential application##8##3##(2008-10#4)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
the potential applications of##2##4##(2008-12#1)(2010-11#1)
the potential applications##3##3##(2007-12#1)(2008-12#1)(2010-11#1)
the potential beneficial effects of##2##5##(2008-10#1)(2008-5#1)
the potential benefit of##3##4##(2007-8#1)(2008-9#1)(2009-11#1)
the potential benefits and##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
the potential benefits of##8##4##(1994-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-1#1)(2013-7#1)
the potential benefits##13##3##(1994-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#1)
the potential biological##2##3##(2008-10#1)(2012-3#1)
the potential buffer##4##3##(2008-10#4)
the potential challenges##2##3##(1996-1#1)(2009-9#1)
the potential change##5##3##(2008-10#5)
the potential clinical##2##3##(2008-7#1)(2012-2#1)
the potential consequences of##2##4##(2009-8#1)(2012-2#1)
the potential contribution of##3##4##(2008-1#1)(2008-10#2)
the potential detrimental##2##3##(1995-5#1)(2011-2#1)
the potential distribution of##2##4##(2008-10#1)(2008-8#1)
the potential effectiveness of##3##4##(2008-11#1)(2010-12#1)(2010-8#1)
the potential effects of##2##4##(2008-11#1)(2010-8#1)
the potential efficacy of##2##4##(2012-3#1)(2013-8#1)
the potential efficacy##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
the potential exists##2##3##(1991-9#1)(1995-5#1)
the potential for BDNF##2##4##(2013-1#1)(2013-8#1)
the potential for a##6##4##(1991-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
the potential for establishing a complete series of tomato chromosome##2##10##(2008-5#2)
the potential for establishing##3##4##(2008-5#3)
the potential for greater##2##4##(2008-2#1)(2008-3#1)
the potential for improved outcomes##2##5##(2008-3#1)(2008-9#1)
the potential for improved##3##4##(2008-3#2)(2008-9#1)
the potential for new##2##4##(2008-4#1)(2011-2#1)
the potential for outcrossing##2##4##(2008-10#2)
the potential for simultaneous##2##4##(2008-10#1)(2009-11#1)
the potential for the##9##4##(1991-1#1)(1992-1#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)
the potential for this##2##4##(2008-10#1)(2008-2#1)
the potential for using##2##4##(2008-11#2)
the potential for violence##2##4##(1995-2#1)(1996-12#1)
the potential for##146##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-10#2)(1993-12#1)(1994-11#2)(1994-2#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-12#3)(1996-2#1)(1996-4#1)(1997-1#1)(1997-6#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#2)
the potential gains##2##3##(2010-8#1)(2013-1#1)
the potential genetic##2##3##(1997-5#1)(2011-2#1)
the potential hazards##2##3##(2008-10#1)(2008-11#1)
the potential health risks##2##4##(2008-10#1)(2011-1#1)
the potential health##4##3##(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
the potential impact of the##2##5##(2009-12#1)(2012-12#1)
the potential impact of##8##4##(1997-2#1)(2008-10#1)(2008-8#2)(2009-12#1)(2012-12#1)(2013-8#2)
the potential impact on##3##4##(2008-7#2)(2009-5#1)
the potential impact##13##3##(1992-3#1)(1997-2#1)(2008-10#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
the potential importance of##5##4##(1995-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)
the potential in##3##3##(2008-1#1)(2008-10#2)
the potential influence of the##2##5##(2009-9#1)(2012-12#1)
the potential influence of##4##4##(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
the potential interaction##2##3##(1995-6#1)(2009-9#1)
the potential interference of##2##4##(2008-10#2)
the potential involvement of##2##4##(1995-12#1)(2010-3#1)
the potential liability of##2##4##(1991-12#1)(1992-1#1)
the potential mechanism of##4##4##(2008-10#2)(2011-2#2)
the potential mechanism##5##3##(2008-10#2)(2011-2#2)(2012-3#1)
the potential molecular##2##3##(2008-11#1)(2012-3#1)
the potential morbidity##2##3##(2009-12#1)(2010-8#1)
the potential negative##2##3##(1995-12#1)(2012-2#1)
the potential of Uf##3##4##(1991-8#3)
the potential of a##7##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
the potential of being a##4##5##(2008-10#2)(2008-7#1)(2008-8#1)
the potential of being##5##4##(2008-10#3)(2008-7#1)(2008-8#1)
the potential of integrating##2##4##(1997-2#1)(2008-12#1)
the potential of such##2##4##(1994-5#1)(2011-2#1)
the potential of terahertz##2##4##(2010-5#1)(2012-12#1)
the potential of the technique##2##5##(2007-12#2)
the potential of the##15##4##(1994-5#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#1)
the potential of these##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
the potential of this method##2##5##(1995-8#1)(2008-3#1)
the potential of this technique##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the potential of this##8##4##(1995-8#1)(2007-11#1)(2007-12#1)(2008-3#3)(2011-1#1)(2013-1#1)
the potential of two##2##4##(2008-10#2)
the potential of using##2##4##(2008-10#2)
the potential of working electrode##2##5##(2008-10#2)
the potential of##138##3##(1991-8#3)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-5#2)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#37)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#1)(2012-7#1)(2013-1#5)(2013-8#1)
the potential participants##2##3##(1994-1#1)(2009-6#1)
the potential problems##3##3##(1991-3#1)(1993-2#1)(1995-9#1)
the potential public##2##3##(1991-3#1)(1992-3#1)
the potential range of##2##4##(2008-10#2)
the potential range##5##3##(2008-10#5)
the potential reasons##2##3##(2008-10#1)(2010-9#1)
the potential relationships among##2##4##(2013-8#2)
the potential reproductive rate##2##4##(2008-8#1)(2012-12#1)
the potential risk for##2##4##(2008-10#1)(2011-2#1)
the potential risk of##7##4##(1992-6#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
the potential risk##11##3##(1992-6#1)(1995-5#1)(2008-10#2)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
the potential risks##7##3##(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)
the potential role of the##2##5##(1994-11#1)(2012-12#1)
the potential role of##18##4##(1992-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the potential role##19##3##(1992-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the potential roles of##3##4##(2009-9#1)(2010-3#1)(2013-1#1)
the potential shift##2##3##(1995-5#2)
the potential significance of##2##4##(2008-9#2)
the potential that##2##3##(1992-12#1)(1995-6#1)
the potential therapeutic##3##3##(1992-9#1)(2008-11#1)(2008-7#1)
the potential to affect##2##4##(2008-8#1)(2013-1#1)
the potential to assess##2##4##(1997-8#1)(2011-2#1)
the potential to be an##2##5##(2008-10#2)
the potential to be##18##4##(1991-9#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2012-2#3)
the potential to decrease##2##4##(2008-7#1)(2011-7#1)
the potential to detect##3##4##(1996-4#1)(2008-2#1)(2008-7#1)
the potential to differentiate into##3##5##(2008-11#2)(2008-8#1)
the potential to enhance##6##4##(2007-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
the potential to improve the##3##5##(2008-1#1)(2008-7#1)(2009-8#1)
the potential to improve##5##4##(1994-12#1)(1994-2#1)(2008-1#1)(2008-7#1)(2009-8#1)
the potential to overcome##2##4##(2007-7#1)(2008-1#1)
the potential to permit##2##4##(2008-2#1)(2008-3#1)
the potential to provide a##3##5##(2008-10#1)(2011-7#1)(2012-2#1)
the potential to provide##11##4##(1991-3#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
the potential to reduce the##3##5##(2008-3#1)(2009-10#1)(2010-1#1)
the potential to reduce##8##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-5#1)(2013-1#1)
the potential to revolutionize##2##4##(2012-12#1)(2013-1#1)
the potential to significantly reduce##2##5##(2008-10#1)(2008-2#1)
the potential to significantly##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
the potential to transform##2##4##(2008-11#1)(2008-7#1)
the potential to use##2##4##(1994-8#1)(2008-3#1)
the potential to##168##3##(1991-3#2)(1991-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#23)(2008-11#10)(2008-12#3)(2008-2#9)(2008-3#10)(2008-5#5)(2008-7#8)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-7#4)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#1)
the potential toxicity of##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
the potential toxicological##2##3##(2008-11#1)(2008-12#1)
the potential use of the##2##5##(2008-5#1)(2008-8#1)
the potential use of this##3##5##(2008-7#1)(2008-9#1)(2012-2#1)
the potential use of##14##4##(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-2#1)
the potential use##16##3##(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-2#1)
the potential usefulness of##4##4##(2008-10#2)(2008-7#1)(2009-7#1)
the potential uses of##2##4##(1991-12#1)(2008-10#1)
the potential utility of##6##4##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2010-3#1)(2012-12#1)
the potential utility##7##3##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2010-3#1)(2012-12#1)
the potential value of##4##4##(1995-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
the potential was##2##3##(2008-10#2)
the potential##844##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#6)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#3)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-9#1)(1994-1#4)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#3)(1995-5#8)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#7)(2007-12#14)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#11)(2008-10#168)(2008-11#43)(2008-12#9)(2008-2#17)(2008-3#29)(2008-4#8)(2008-5#35)(2008-6#3)(2008-7#35)(2008-8#28)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#5)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#14)(2011-2#32)(2011-3#2)(2011-7#4)(2012-1#7)(2012-12#15)(2012-2#22)(2012-3#18)(2012-7#1)(2013-1#28)(2013-7#1)(2013-8#15)
the potential-dependent##3##2##(2007-12#3)
the potentialities of##2##3##(2008-10#2)
the potentialities##5##2##(1990-6#1)(2008-10#2)(2009-10#1)(2009-6#1)
the potentiality of##2##3##(2008-10#1)(2010-3#1)
the potentiality##3##2##(1990-10#1)(2008-10#1)(2010-3#1)
the potentially##10##2##(1990-5#1)(1992-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
the potentials of##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
the potentials##7##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-1#1)
the potentiating effect of CGRP##2##5##(1997-4#2)
the potentiating effect of##5##4##(1997-4#3)(2008-4#2)
the potentiating##6##2##(1995-11#1)(1997-4#3)(2008-4#2)
the potentiation of carbon tetrachloride hepatotoxicity by methamphetamine##2##8##(1995-3#2)
the potentiation of carbon##3##4##(1995-3#3)
the potentiation of phagocytosis##3##4##(1993-6#3)
the potentiation of the##2##4##(1995-12#1)(1997-7#1)
the potentiation of##15##3##(1992-8#1)(1993-6#4)(1995-12#1)(1995-3#3)(1996-2#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
the potentiometric determination of##4##4##(2008-10#4)
the potentiometric response characteristics##2##4##(2008-10#2)
the potentiometric response##4##3##(2008-10#4)
the potentiometric selectivity of##5##4##(2008-10#5)
the potentiometric selectivity##8##3##(2008-10#8)
the potentiometric sensor##2##3##(2008-10#2)
the potentiometric titration of VO(2+)##2##5##(2008-10#2)
the potentiometric titration of##14##4##(2008-10#14)
the potentiometric titration##17##3##(2008-10#17)
the potentiometric titrations##2##3##(2008-10#2)
the potentiometric##43##2##(2008-10#43)
the potting mix##4##3##(2008-10#4)
the potting##6##2##(2008-10#6)
the potyvirus##2##2##(2008-10#2)
the pouch##3##2##(1994-9#1)(2008-10#1)(2009-12#1)
the powder to##2##3##(2010-5#1)(2012-2#1)
the powder##10##2##(2008-10#4)(2008-5#1)(2010-5#1)(2011-2#3)(2012-2#1)
the powdery mildew##2##3##(2008-10#2)
the power amplifier##2##3##(2007-12#1)(2008-3#1)
the power and##4##3##(2008-10#1)(2008-2#1)(2010-7#1)(2012-3#1)
the power distribution##2##3##(2008-3#1)(2011-1#1)
the power in the##2##4##(2008-3#2)
the power increases##2##3##(1995-12#1)(2008-3#1)
the power law##4##3##(2008-10#2)(2009-12#1)(2010-5#1)
the power level##2##3##(2007-12#2)
the power of a##4##4##(1997-4#1)(2008-4#1)(2008-8#1)(2012-2#1)
the power of the##11##4##(1996-3#3)(1997-6#1)(2007-11#2)(2008-3#2)(2009-10#1)(2009-5#1)(2010-4#1)
the power of##38##3##(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-5#4)(2009-6#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)
the power series method##2##4##(2008-3#2)
the power spectra##3##3##(2008-3#2)(2008-9#1)
the power spectral density##4##4##(2008-3#2)(2010-8#1)(2012-2#1)
the power spectral##5##3##(2008-3#3)(2010-8#1)(2012-2#1)
the power spectrum is##2##4##(2007-11#1)(2007-12#1)
the power spectrum of the spontaneous##2##6##(2008-3#2)
the power spectrum of the##4##5##(2007-12#1)(2008-3#3)
the power spectrum of##5##4##(2007-12#1)(2008-3#4)
the power spectrum##9##3##(2007-11#1)(2007-12#2)(2008-3#6)
the power to detect##4##4##(2008-4#1)(2012-3#3)
the power to##10##3##(1992-1#1)(1993-3#1)(1994-9#1)(1997-1#1)(2007-11#1)(2008-4#1)(2008-9#1)(2012-3#3)
the power transfer efficiency##3##4##(2010-10#3)
the power transmission##2##3##(2008-10#1)(2008-3#1)
the power##121##2##(1992-1#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#12)(2008-10#5)(2008-11#2)(2008-2#8)(2008-3#25)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#4)(2009-6#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#7)(2013-1#2)
the power-law form of the species-area relationship##2##7##(2008-8#2)
the power-law##3##2##(2008-3#1)(2008-8#2)
the powerful##8##2##(1990-5#1)(1996-12#1)(1997-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
the powers##2##2##(2008-2#1)(2008-8#1)
the ppb##2##2##(2008-10#1)(2008-3#1)
the practical and##3##3##(1996-3#1)(2008-11#1)(2008-6#1)
the practical applicability of##2##4##(2008-10#2)
the practical application of##2##4##(1992-3#1)(1996-8#1)
the practical aspects of##5##4##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2010-3#1)
the practical aspects##6##3##(1993-12#1)(1994-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-3#1)
the practical case of##2##4##(2008-2#2)
the practical cutoff frequency##2##4##(2008-3#2)
the practical difficulties##2##3##(1992-3#1)(2008-11#1)
the practical experiences of##2##4##(1995-12#1)(1995-6#1)
the practical implications of##3##4##(1990-9#1)(2008-11#1)(2008-4#1)
the practical requirements##2##3##(2008-10#1)(2011-1#1)
the practical use of##3##4##(2008-10#1)(2008-3#2)
the practical use##4##3##(1992-5#1)(2008-10#1)(2008-3#2)
the practical##57##2##(1990-9#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(2007-12#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
the practicality of the##3##4##(1990-2#1)(2007-12#1)(2008-3#1)
the practicality of##4##3##(1990-2#1)(2007-12#2)(2008-3#1)
the practicality##5##2##(1990-2#1)(2007-12#2)(2008-3#1)(2008-7#1)
the practice and##2##3##(2011-1#1)(2013-1#1)
the practice of a##2##4##(2008-11#1)(2008-9#1)
the practice of health##2##4##(1993-2#1)(2012-3#1)
the practice of medicine##3##4##(1992-1#1)(1992-2#1)(1993-12#1)
the practice of physical activity##4##5##(2010-11#4)
the practice of public health##3##5##(1996-2#1)(1997-3#1)(2010-8#1)
the practice of##66##3##(1990-6#1)(1991-6#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-3#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#2)(2008-4#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-11#5)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)
the practice setting##3##3##(1993-2#1)(2008-11#2)
the practice##96##2##(1990-3#3)(1990-6#1)(1990-9#1)(1991-6#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#14)(2008-12#2)(2008-4#1)(2008-8#3)(2008-9#4)(2010-1#2)(2010-11#5)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
the practices##2##2##(2008-11#1)(2013-1#1)
the practicing clinician##2##3##(2008-7#1)(2011-2#1)
the practicing##10##2##(1996-3#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
the practise of##2##3##(1994-12#1)(2007-11#1)
the practitioner in the##3##4##(1997-7#1)(2007-11#1)(2008-3#1)
the practitioner in##5##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
the practitioner##13##2##(1990-6#1)(1991-12#1)(1994-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-2#1)
the practitioners##5##2##(2008-1#2)(2008-10#1)(2008-9#1)(2011-2#1)
the practitioners'##2##2##(2008-12#1)(2008-7#1)
the pragmatic##3##2##(2008-12#3)
the pre and post##2##4##(2008-10#1)(2011-3#1)
the pre- and##8##3##(1990-5#1)(1991-1#1)(1996-5#1)(2008-11#1)(2010-8#1)(2012-12#2)(2012-3#1)
the pre-##9##2##(1990-5#1)(1991-1#1)(1994-9#1)(1996-5#1)(2008-11#1)(2010-8#1)(2012-12#2)(2012-3#1)
the pre-averaging method##2##3##(2013-1#2)
the pre-clinical##3##2##(2008-10#1)(2009-7#1)(2013-1#1)
the pre-column##2##2##(2008-10#2)
the pre-concentration of##3##3##(2008-10#3)
the pre-concentration##7##2##(2008-10#7)
the pre-existing##4##2##(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
the pre-operative##2##2##(2007-8#1)(2010-12#1)
the pre-ovulatory ovarian follicle##2##4##(1991-9#2)
the pre-reduction##2##2##(2008-10#1)(2009-6#1)
the pre-reflective self##2##3##(2008-11#2)
the pre-registration curricula##2##3##(2008-11#2)
the pre-registration##3##2##(2008-11#3)
the pre-travel##2##2##(2007-2#2)
the pre-treatment##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)(2011-2#1)
the preS1##3##2##(1993-8#2)(1994-8#1)
the preS2 region##4##3##(1993-8#1)(1997-6#3)
the preS2##5##2##(1993-8#2)(1997-6#3)
the preadipose state##2##3##(1992-9#2)
the precautionary measures##2##3##(2012-3#1)(2013-1#1)
the precautions used by##2##4##(1991-5#1)(2010-3#1)
the precautions##6##2##(1991-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-8#1)
the preceding 12 months##2##4##(2008-10#1)(2012-12#1)
the preceding 3##2##3##(2013-7#1)(2013-8#1)
the preceding 5 years##2##4##(2008-10#2)
the preceding 6 months##2##4##(2013-1#2)
the preceding article##2##3##(1992-1#1)(1992-3#1)
the preceding sinus##2##3##(1996-6#2)
the preceding##23##2##(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-6#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
the precious metals##2##3##(2008-10#2)
the precipitate is##2##3##(2008-10#1)(2008-4#1)
the precipitate##16##2##(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-4#2)(2013-8#1)
the precipitated##6##2##(2008-10#1)(2008-7#2)(2013-1#3)
the precipitates were##2##3##(2008-10#2)
the precipitates##7##2##(2007-11#1)(2008-10#6)
the precipitation of##9##3##(1995-5#1)(2008-10#7)(2009-7#1)
the precipitation reaction##3##3##(2008-10#3)
the precipitation##17##2##(1995-5#1)(2008-10#11)(2008-7#3)(2009-7#1)(2012-2#1)
the precise etiology##2##3##(2008-7#1)(2012-3#1)
the precise form of##2##4##(2008-10#1)(2008-9#1)
the precise localization of##2##4##(2008-3#1)(2008-4#1)
the precise location##2##3##(1993-12#1)(2008-7#1)
the precise measurement##2##3##(1991-8#1)(2008-10#1)
the precise mechanism of##2##4##(2008-10#1)(2010-8#1)
the precise mechanism##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
the precise mechanisms of##2##4##(2010-7#1)(2012-12#1)
the precise mechanisms##3##3##(2008-9#1)(2010-7#1)(2012-12#1)
the precise molecular mechanisms##2##4##(2008-11#1)(2008-7#1)
the precise molecular##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
the precise nature of the##2##5##(1994-1#1)(2008-11#1)
the precise role of##2##4##(1994-8#1)(2010-5#1)
the precise site of##2##4##(2012-2#2)
the precise##65##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-5#2)(1991-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-12#1)(1996-5#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#8)(2008-9#3)(2009-4#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#2)
the precision and accuracy of the##4##6##(2008-10#4)
the precision and accuracy of##6##5##(2008-10#5)(2010-11#1)
the precision and##8##3##(2008-10#5)(2008-3#2)(2010-11#1)
the precision of measurement is##2##5##(2008-10#1)(2008-3#1)
the precision of the method##3##5##(2008-10#3)
the precision of the##15##4##(1992-11#1)(1994-2#1)(1996-12#1)(2008-10#9)(2008-3#2)(2013-1#1)
the precision of this##2##4##(2008-10#1)(2008-2#1)
the precision of##34##3##(1992-11#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#18)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
the precision##63##2##(1992-11#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#42)(2008-2#1)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
the precisions##3##2##(2008-10#3)
the preclinical and clinical##2##4##(1995-5#1)(2009-9#1)
the preclinical and##4##3##(1995-5#1)(2008-8#1)(2009-9#1)(2010-11#1)
the preclinical evaluation of##2##4##(1991-9#1)(2008-10#1)
the preclinical stage##2##3##(1994-3#1)(2010-10#1)
the preclinical##14##2##(1991-9#1)(1994-3#1)(1995-5#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2012-12#1)
the precolumn##4##2##(2008-10#4)
the preconcentration and determination of##3##5##(2008-10#3)
the preconcentration and##13##3##(2008-10#13)
the preconcentration factor##2##3##(2008-10#2)
the preconcentration of Cu##2##4##(2008-10#2)
the preconcentration of the##2##4##(2008-10#2)
the preconcentration of trace metals##3##5##(2008-10#3)
the preconcentration of trace##7##4##(2008-10#7)
the preconcentration of##27##3##(2008-10#27)
the preconcentration step##2##3##(2008-10#2)
the preconcentration system##6##3##(2008-10#6)
the preconcentration time of##2##4##(2008-10#2)
the preconcentration time##3##3##(2008-10#3)
the preconcentration##68##2##(2008-10#68)
the preconditioning response##2##3##(1996-9#2)
the precursor and##2##3##(1994-11#1)(2008-6#1)
the precursor film##3##3##(2009-6#3)
the precursor for##2##3##(2012-1#2)
the precursor of adenoregulin##2##4##(1993-3#2)
the precursor of the##2##4##(1997-1#1)(2008-3#1)
the precursor of##11##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-7#1)(1993-3#2)(1994-6#1)(1996-10#1)(1997-1#1)(2008-10#1)(2008-3#1)
the precursor protein##4##3##(1994-8#1)(1995-2#2)(1997-2#1)
the precursor##41##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-7#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#3)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-6#3)(2012-1#2)(2013-1#1)
the precursors of##3##3##(1992-12#1)(2010-5#1)(2012-2#1)
the precursors##6##2##(1992-12#1)(1992-9#1)(2008-10#1)(2010-5#2)(2012-2#1)
the predator has a##2##4##(2008-9#2)
the predator##12##2##(2008-12#1)(2008-6#2)(2008-8#4)(2008-9#3)(2010-8#2)
the predatory stinkbug Podisus nigrispinus (Dallas)##2##6##(2008-6#2)
the predatory stinkbug##3##3##(2008-6#3)
the predatory##5##2##(2008-6#4)(2011-2#1)
the predefined##4##2##(2008-10#1)(2010-4#1)(2011-2#2)
the predetermination of exponential growth##2##5##(2008-7#2)
the predetermined lung lobe##2##4##(2013-1#2)
the predetermined##3##2##(2009-1#1)(2013-1#2)
the predictability of##3##3##(2008-10#1)(2008-9#1)(2011-7#1)
the predicted aa##2##3##(1991-9#1)(1993-2#1)
the predicted amino acid##5##4##(1991-9#1)(1992-12#1)(1995-8#1)(2008-10#2)
the predicted and the measured##3##5##(2007-12#1)(2008-3#1)(2013-1#1)
the predicted and the##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
the predicted and##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
the predicted concentrations##2##3##(2008-10#2)
the predicted increase##2##3##(1991-2#1)(1992-3#1)
the predicted model##2##3##(1993-8#1)(2008-6#1)
the predicted product of##2##4##(2008-10#1)(2008-9#1)
the predicted protein##2##3##(1993-12#1)(2008-10#1)
the predicted snail##2##3##(2008-8#2)
the predicted transmembrane##2##3##(1992-12#1)(1995-2#1)
the predicted values##2##3##(2008-10#1)(2013-8#1)
the predicted##81##2##(1990-5#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-12#3)(1992-3#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#17)(2008-3#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#4)
the prediction ability of##4##4##(2008-10#4)
the prediction accuracy##2##3##(2008-2#1)(2010-7#1)
the prediction of a new##2##5##(2008-2#1)(2009-8#1)
the prediction of a##3##4##(2007-11#1)(2008-2#1)(2009-8#1)
the prediction of the##7##4##(1990-5#1)(2007-12#2)(2008-10#2)(2008-3#1)(2010-8#1)
the prediction of their##2##4##(2008-6#1)(2012-3#1)
the prediction of these##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
the prediction of##52##3##(1990-5#2)(1993-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-11#5)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
the prediction performance##2##3##(2008-10#1)(2013-1#1)
the prediction that##5##3##(1990-7#1)(2008-5#1)(2008-8#2)(2013-1#1)
the prediction##83##2##(1990-5#2)(1990-7#1)(1993-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-11#6)(2007-12#2)(2007-6#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
the predictions from##2##3##(2008-3#1)(2008-9#1)
the predictions of a##4##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
the predictions of the theory##2##5##(2007-11#1)(2008-8#1)
the predictions of the##6##4##(1990-8#1)(1992-3#1)(2007-11#2)(2008-8#1)(2008-9#1)
the predictions of##18##3##(1990-8#1)(1992-3#1)(1995-3#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#3)(2008-9#1)
the predictions were##2##3##(2008-10#1)(2008-7#1)
the predictions##29##2##(1990-8#1)(1992-3#1)(1995-3#1)(2007-11#5)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#3)(2008-9#3)(2010-8#1)
the predictive ability of the model##2##6##(2008-10#2)
the predictive ability of the##6##5##(2008-10#4)(2008-8#1)(2012-3#1)
the predictive ability of##9##4##(2008-10#6)(2008-8#1)(2012-12#1)(2012-3#1)
the predictive power of the##2##5##(2008-5#1)(2008-7#1)
the predictive power of##4##4##(1992-12#1)(1992-2#1)(2008-5#1)(2008-7#1)
the predictive validity of nursing home pre-admission screens##2##8##(1994-2#2)
the predictive validity of##3##4##(1994-2#2)(1994-3#1)
the predictive validity##4##3##(1994-2#2)(1994-3#1)(2013-1#1)
the predictive value of a positive##2##6##(1990-3#1)(1992-5#1)
the predictive value of a##4##5##(1990-3#1)(1992-5#2)(2011-2#1)
the predictive value of the##2##5##(1992-10#1)(2009-7#1)
the predictive value of##15##4##(1990-3#1)(1991-12#1)(1992-10#1)(1992-5#2)(1995-3#1)(1996-1#1)(2008-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the predictive##37##2##(1990-3#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)
the predictor variable##2##3##(1991-12#1)(2010-12#1)
the predictor##7##2##(1991-12#1)(2008-6#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
the predictors of the##2##4##(2008-11#1)(2012-12#1)
the predictors of##9##3##(1993-1#1)(2006-10#1)(2007-2#1)(2008-11#2)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
the predictors##13##2##(1993-1#1)(1995-12#1)(2006-10#1)(2007-2#1)(2008-11#3)(2009-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
the predisposing factors##3##3##(1997-9#1)(2008-1#1)(2008-5#1)
the predisposing##5##2##(1993-1#1)(1997-9#1)(2008-1#1)(2008-4#1)(2008-5#1)
the predisposition of##2##3##(1991-12#1)(2008-4#1)
the predisposition to##3##3##(1991-12#1)(1993-6#1)(2009-5#1)
the predisposition##6##2##(1991-12#2)(1993-6#1)(2008-4#1)(2009-10#1)(2009-5#1)
the prednisone dose##2##3##(1990-11#2)
the predominance of##12##3##(1990-8#1)(1992-6#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#2)
the predominant cell##2##3##(1995-6#1)(2008-1#1)
the predominant form of##4##4##(1990-11#1)(1992-6#1)(1994-6#1)(2008-11#1)
the predominant form##5##3##(1990-11#1)(1992-6#1)(1994-6#1)(2008-10#1)(2008-11#1)
the predominant isoform of##2##4##(1992-12#1)(1994-8#1)
the predominant mechanism##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
the predominant mode of inheritance##2##5##(2008-10#1)(2011-2#1)
the predominant mode##4##3##(2008-10#3)(2011-2#1)
the predominant organisms##2##3##(2007-12#1)(2007-8#1)
the predominant source##2##3##(2008-10#1)(2010-5#1)
the predominant species##7##3##(1994-11#1)(1996-12#1)(2008-10#4)(2013-8#1)
the predominant##88##2##(1990-11#1)(1991-11#2)(1991-9#1)(1992-12#3)(1992-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-12#3)(1997-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#5)
the predominantly##3##2##(1994-8#1)(2008-10#1)(2011-1#1)
the predominate##2##2##(1994-9#1)(2008-12#1)
the preeminent##2##2##(1994-9#1)(2008-10#1)
the preference for##3##3##(1992-6#1)(2008-5#1)(2013-7#1)
the preference of the##3##4##(1991-6#1)(1992-11#1)(2008-4#1)
the preference of##6##3##(1991-6#1)(1992-11#1)(1992-9#1)(1996-5#1)(2008-10#1)(2008-4#1)
the preference##12##2##(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-7#1)
the preferential##13##2##(1990-11#1)(1992-3#1)(1993-12#2)(1995-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#3)(2011-2#1)
the preferred orientation##3##3##(1995-6#1)(2008-11#1)(2008-8#1)
the preferred strategy##4##3##(2008-5#1)(2012-3#3)
the preferred treatment##3##3##(1996-3#1)(2007-7#1)(2010-3#1)
the preferred##43##2##(1993-10#1)(1993-12#1)(1994-1#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-5#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#4)
the preflexion stage##2##3##(2008-5#2)
the prefrontal area##3##3##(1994-8#1)(1996-2#1)(2011-2#1)
the prefrontal cortex (PFC)##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
the prefrontal cortex of##3##4##(1995-12#1)(2008-10#1)(2009-12#1)
the prefrontal cortex##13##3##(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#3)(2009-12#1)(2012-1#1)(2013-8#2)
the prefrontal lobe##2##3##(2008-11#1)(2012-1#1)
the prefrontal##23##2##(1993-3#2)(1994-8#2)(1995-12#1)(1996-2#2)(1997-2#1)(2008-10#1)(2008-11#4)(2008-7#3)(2009-12#1)(2011-2#1)(2012-1#2)(2013-8#3)
the pregnancy and birth##2##4##(1994-9#1)(2009-10#1)
the pregnancy and##4##3##(1994-9#1)(2008-12#1)(2008-2#1)(2009-10#1)
the pregnancy was##2##3##(1993-3#1)(2008-4#1)
the pregnancy##24##2##(1990-5#1)(1990-8#2)(1991-12#2)(1992-12#1)(1993-3#1)(1994-2#1)(1994-7#1)(1994-9#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-2#4)(2008-4#1)(2009-10#2)(2011-2#1)(2012-3#1)(2013-1#1)
the pregnant patients##2##3##(1993-10#2)
the pregnant state##2##3##(2008-4#2)
the pregnant woman and##2##4##(1992-9#1)(2009-10#1)
the pregnant women##5##3##(1990-2#1)(1997-3#1)(1997-4#1)(2008-12#1)(2012-12#1)
the pregnant##19##2##(1990-2#1)(1992-9#1)(1993-10#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-2#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#3)(2009-10#1)(2012-12#1)
the prejunctional##2##2##(2008-2#1)(2013-1#1)
the prelimbic##2##2##(1993-6#1)(1995-12#1)
the preliminary data##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
the preliminary findings##3##3##(1990-3#1)(2013-1#2)
the preliminary results of##4##4##(2008-1#1)(2008-3#1)(2011-1#1)(2013-8#1)
the preliminary results##6##3##(1990-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-8#1)
the preliminary stage of##2##4##(2008-10#1)(2012-3#1)
the preliminary##25##2##(1990-12#1)(1990-3#1)(1990-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
the premature aging##2##3##(2007-7#1)(2010-2#1)
the premature newborn##2##3##(2009-9#1)(2013-1#1)
the premature##10##2##(1994-8#1)(1994-9#1)(2007-7#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
the premenstrual##2##2##(1994-9#1)(2009-10#1)
the premier##2##2##(2008-4#1)(2011-2#1)
the premise that the##3##4##(1990-8#1)(1994-3#1)(2008-9#1)
the premise that##12##3##(1990-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
the premise##15##2##(1990-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
the premises##2##2##(2008-10#1)(2012-12#1)
the prenatal period##5##3##(1995-5#1)(1996-5#1)(2007-2#1)(2010-5#1)(2012-2#1)
the prenatal##11##2##(1993-10#1)(1993-3#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-5#1)(2012-2#2)(2012-3#1)
the preoperative and postoperative##2##4##(1994-3#1)(2007-8#1)
the preoperative and##3##3##(1994-3#1)(2007-8#1)(2012-3#1)
the preoperative clinical##2##3##(1997-2#1)(2011-2#1)
the preoperative evaluation##2##3##(1990-9#1)(2012-12#1)
the preoperative preparation##2##3##(1992-9#1)(2008-10#1)
the preoperative##30##2##(1990-11#1)(1990-9#2)(1992-9#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#5)(2012-12#1)(2012-3#5)(2013-1#2)(2013-8#1)
the preoptic area##6##3##(1991-5#1)(1992-1#1)(1992-3#1)(1997-3#1)(2008-8#1)(2008-9#1)
the preoptic##7##2##(1991-5#1)(1992-1#1)(1992-3#1)(1993-12#1)(1997-3#1)(2008-8#1)(2008-9#1)
the prepairing and interdimer mechanisms##2##5##(2008-10#2)
the prepairing##4##2##(2008-10#4)
the preparation and##4##3##(2008-10#3)(2008-2#1)
the preparation for##2##3##(1993-2#1)(1995-5#1)
the preparation of a##8##4##(1996-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#1)
the preparation of nuclear##2##4##(2008-2#1)(2008-8#1)
the preparation of the##10##4##(1992-3#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)
the preparation of##116##3##(1990-12#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-2#1)(1997-3#2)(2006-12#1)(2007-11#4)(2008-1#1)(2008-10#24)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#23)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-7#1)
the preparation procedure##2##3##(2008-10#2)
the preparation##143##2##(1990-11#1)(1990-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#4)(1997-2#1)(1997-3#2)(2006-12#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#34)(2008-11#9)(2008-12#3)(2008-2#8)(2008-3#1)(2008-4#24)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-7#1)
the preparations##4##2##(2008-10#1)(2008-5#2)(2008-9#1)
the preparative##3##2##(1996-12#1)(1997-7#1)(2008-9#1)
the preparatory phase##2##3##(1996-2#1)(2010-6#1)
the preparatory##5##2##(1996-2#1)(2010-2#1)(2010-6#1)(2013-8#2)
the prepared Au-NP/SAM-modified electrodes##2##4##(2008-10#2)
the prepared ISFETs##2##3##(2008-10#2)
the prepared##22##2##(2008-10#10)(2008-11#1)(2008-5#3)(2009-11#1)(2010-5#3)(2012-2#3)(2013-8#1)
the preparedness of##2##3##(1996-1#1)(2008-10#1)
the preprophase band##2##3##(2009-10#2)
the prepubertal period##3##3##(2008-4#1)(2011-1#2)
the prepubertal##4##2##(2008-4#1)(2011-1#2)(2012-2#1)
the preregistration internship##2##3##(1995-6#2)
the preregistration##3##2##(1995-6#3)
the prerequisite and##2##3##(2011-2#1)(2013-8#1)
the prerequisite for##2##3##(2007-5#1)(2013-1#1)
the prerequisite##4##2##(2007-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
the prescribed##10##2##(1990-6#1)(1993-11#2)(1995-2#1)(1996-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-11#1)(2011-1#1)
the prescribing of##2##3##(1993-12#1)(2009-3#1)
the prescribing rates##2##3##(2008-11#2)
the prescribing##5##2##(1993-12#1)(2008-11#3)(2009-3#1)
the prescription and##2##3##(2008-3#1)(2008-7#1)
the prescription of##5##3##(1991-11#1)(2008-11#1)(2009-3#1)(2012-2#1)(2012-3#1)
the prescription##12##2##(1991-11#1)(1995-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)(2012-3#1)
the prescriptions##3##2##(1995-11#2)(2008-10#1)
the presence and absence of##45##5##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#12)(2008-11#3)(2008-7#1)(2008-8#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the presence and severity of##3##5##(1991-8#1)(1997-1#1)(1997-8#1)
the presence and the##3##4##(2007-5#1)(2008-10#2)
the presence and##68##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#2)(1997-8#1)(2007-5#1)(2008-10#17)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the presence in this##2##4##(1990-5#1)(2008-10#1)
the presence in##8##3##(1990-5#1)(1993-6#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
the presence of &quot##3##4##(1990-3#1)(2008-5#1)(2009-7#1)
the presence of 0##18##4##(1990-11#1)(1990-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(2008-10#4)(2008-11#2)(2011-2#1)
the presence of 1##17##4##(1990-12#1)(1991-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#5)(2009-12#1)(2009-2#1)
the presence of 10##4##4##(1995-11#1)(1997-3#1)(2010-11#1)(2012-12#1)
the presence of 10(-9) M##2##5##(1990-11#1)(1994-3#1)
the presence of 100##2##4##(1995-11#1)(2008-10#1)
the presence of 2##10##4##(1990-8#2)(1992-6#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#4)
the presence of 50##5##4##(1990-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
the presence of 6##2##4##(1995-12#1)(1995-2#1)
the presence of ATP and##2##5##(1993-6#1)(1995-3#1)
the presence of ATP##13##4##(1990-7#2)(1991-12#1)(1993-11#1)(1993-6#4)(1995-2#1)(1995-3#2)(2008-4#1)(2008-7#1)
the presence of Aspergillus##2##4##(2008-7#1)(2010-4#1)
the presence of B##3##4##(1992-3#1)(2008-10#2)
the presence of Ca(2+)##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
the presence of Ca2+ and##5##5##(1994-11#3)(1995-5#1)(1995-6#1)
the presence of Ca2+##11##4##(1990-8#1)(1993-8#1)(1994-11#3)(1995-5#2)(1995-6#3)(1995-8#1)
the presence of Cd##3##4##(2008-10#2)(2008-11#1)
the presence of DNA##10##4##(1994-2#1)(1994-3#1)(1995-2#1)(2008-10#6)(2008-9#1)
the presence of EDTA##3##4##(1995-6#1)(2008-10#2)
the presence of Fe(III)##2##4##(1997-7#1)(2008-10#1)
the presence of Fusarium##2##4##(2008-10#2)
the presence of G418##2##4##(1995-2#1)(2008-11#1)
the presence of GTP gamma S##2##6##(1991-2#1)(1995-8#1)
the presence of GTP##5##4##(1991-12#2)(1991-2#1)(1995-8#1)(2008-6#1)
the presence of H##2##4##(1997-1#1)(2008-5#1)
the presence of IGF-I##2##4##(2008-11#2)
the presence of K+##2##4##(1991-7#1)(1992-6#1)
the presence of Lewy bodies##2##5##(2008-7#2)
the presence of M##2##4##(2008-10#2)
the presence of Mg2+##2##4##(1995-5#2)
the presence of Mycobacterium tuberculosis##3##5##(1990-9#1)(2012-12#1)(2013-8#1)
the presence of NO##3##4##(1995-11#1)(2008-10#2)
the presence of Na(+)##2##4##(2008-6#1)(2013-1#1)
the presence of Na+##2##4##(1990-11#1)(1990-2#1)
the presence of NaCl##2##4##(1991-12#1)(2008-11#1)
the presence of P##3##4##(2008-10#3)
the presence of PCR inhibitors##3##5##(2008-11#1)(2008-12#2)
the presence of RGD##2##4##(1990-5#1)(1992-12#1)
the presence of Raman scattering##2##5##(2008-3#2)
the presence of SDS##2##4##(1992-12#1)(2008-10#1)
the presence of T-CD4 T cells##2##6##(2012-12#2)
the presence of T1##2##4##(2008-10#1)(2012-12#1)
the presence of Z-D-Phe-L-PheGly##3##4##(1992-3#3)
the presence of a &quot##2##5##(1994-5#1)(2008-5#1)
the presence of a cocaine use disorder##2##7##(2010-6#2)
the presence of a consensus sequence##2##6##(1991-2#1)(2008-10#1)
the presence of a consensus##3##5##(1991-2#1)(1993-2#1)(2008-10#1)
the presence of a conspecific##2##5##(1994-8#1)(2009-6#1)
the presence of a distinct##3##5##(1990-12#1)(1992-8#1)(2007-12#1)
the presence of a high##4##5##(1992-3#1)(2008-10#2)(2012-12#1)
the presence of a large amount of##2##7##(2008-10#1)(2008-6#1)
the presence of a large number of##3##7##(2007-12#1)(2008-10#2)
the presence of a large##6##5##(2007-12#1)(2008-10#4)(2008-6#1)
the presence of a low##2##5##(1995-5#1)(2008-11#1)
the presence of a novel##2##5##(1992-8#1)(1995-6#1)
the presence of a positive##2##5##(1996-5#1)(2010-11#1)
the presence of a protein##2##5##(1991-5#1)(2008-8#1)
the presence of a reducing agent##2##6##(2008-10#2)
the presence of a saturating##2##5##(1990-10#1)(2007-11#1)
the presence of a second charge##2##6##(1996-7#2)
the presence of a second##5##5##(1995-2#1)(1995-3#1)(1996-7#2)(2008-4#1)
the presence of a single class##2##6##(1990-2#1)(1993-12#1)
the presence of a single##10##5##(1990-11#1)(1990-2#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-11#1)(1997-2#1)(2008-10#2)(2010-3#1)
the presence of a small amount##2##6##(1993-8#1)(2008-10#1)
the presence of a small##3##5##(1992-12#1)(1993-8#1)(2008-10#1)
the presence of a spatial##2##5##(2008-3#1)(2008-8#1)
the presence of a thin##2##5##(2008-2#1)(2008-5#1)
the presence of a water##2##5##(2008-10#2)
the presence of a##199##4##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-7#1)(2008-10#44)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)
the presence of aberrations##3##4##(2008-3#3)
the presence of abnormal##3##4##(1990-12#1)(2008-10#1)(2011-2#1)
the presence of acetone##3##4##(2008-10#2)(2008-9#1)
the presence of active##4##4##(1993-12#1)(1994-5#1)(2008-11#2)
the presence of additional##3##4##(1994-8#1)(1997-3#1)(2008-10#1)
the presence of air##3##4##(1991-3#1)(2008-10#1)(2008-6#1)
the presence of alanine##2##4##(1990-2#1)(1992-8#1)
the presence of all##3##4##(1995-2#1)(2008-10#1)(2012-3#1)
the presence of alpha##2##4##(1990-8#1)(2008-5#1)
the presence of altered##2##4##(1997-1#1)(2008-6#1)
the presence of an NADPH##2##5##(1993-8#1)(1995-6#1)
the presence of an androgen binding component##2##7##(1990-11#2)
the presence of an applied##2##5##(2007-12#1)(2008-7#1)
the presence of an excess of##5##6##(2008-10#4)(2008-12#1)
the presence of an exogenous##3##5##(1994-9#1)(2008-10#1)(2008-2#1)
the presence of an extra##2##5##(1990-12#1)(1997-2#1)
the presence of an old##2##5##(2008-10#1)(2008-9#1)
the presence of an unstable##2##5##(2011-2#1)(2013-1#1)
the presence of an##67##4##(1990-11#2)(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(2007-12#2)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
the presence of anions##3##4##(1990-8#2)(2008-10#1)
the presence of any##8##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#1)
the presence of arginine##2##4##(1990-11#1)(1992-9#1)
the presence of asbestos fibres##2##5##(2013-8#2)
the presence of asci##2##4##(2008-10#2)
the presence of ascorbate##3##4##(1993-8#1)(1995-2#1)(2013-1#1)
the presence of associated##2##4##(1997-8#1)(2008-9#1)
the presence of at least##4##5##(1990-11#1)(1990-8#1)(1995-6#1)(2012-3#1)
the presence of atopy##3##4##(2007-7#2)(2012-3#1)
the presence of auxin##2##4##(2009-8#2)
the presence of bFGF and its##2##6##(1994-11#1)(1995-12#1)
the presence of bFGF and##3##5##(1994-11#2)(1995-12#1)
the presence of background noise##2##5##(2008-2#1)(2008-3#1)
the presence of background##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the presence of bacteria##2##4##(2008-10#1)(2008-12#1)
the presence of beta-CD in the##2##6##(1994-3#2)
the presence of beta-CD##6##4##(1994-3#2)(2008-10#4)
the presence of beta-cyclodextrin and##2##5##(2008-10#2)
the presence of bone##3##4##(1991-8#1)(2011-1#2)
the presence of both##14##4##(1991-12#1)(1992-5#1)(2007-2#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)
the presence of bovine serum albumin##6##6##(1993-8#1)(1995-12#3)(2008-10#2)
the presence of caffeine##2##4##(1990-2#1)(2008-10#1)
the presence of calcium##10##4##(1990-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
the presence of catalase##2##4##(1991-9#1)(2008-10#1)
the presence of cell##4##4##(2008-10#3)(2009-8#1)
the presence of cellular##2##4##(2007-8#1)(2013-1#1)
the presence of certain##4##4##(2008-10#1)(2008-11#2)(2008-2#1)
the presence of chronic##3##4##(2008-1#1)(2008-4#1)(2008-7#1)
the presence of circulating##2##4##(1992-3#1)(2008-10#1)
the presence of clinical##2##4##(1992-3#1)(2011-2#1)
the presence of clouds##3##4##(2008-3#3)
the presence of competing##2##4##(1991-5#1)(2007-12#1)
the presence of complex##2##4##(2008-4#1)(2008-5#1)
the presence of copper##9##4##(1995-6#1)(2008-10#8)
the presence of detergents##2##4##(1991-12#1)(1992-7#1)
the presence of developmental##2##4##(1994-1#1)(2012-12#1)
the presence of dibenzo-18-crown-6##2##4##(2008-10#2)
the presence of different##11##4##(1990-5#1)(1991-5#1)(1992-5#1)(2008-10#4)(2008-2#1)(2008-5#2)(2010-4#1)
the presence of disease##4##4##(1994-11#1)(2008-10#2)(2012-2#1)
the presence of each of the##2##6##(1996-5#1)(2011-2#1)
the presence of each##5##4##(1996-5#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
the presence of eggs##4##4##(2007-10#1)(2012-12#2)(2013-1#1)
the presence of eight##2##4##(1997-3#2)
the presence of either##6##4##(1991-8#1)(1995-11#1)(1995-9#1)(1997-3#1)(2008-11#2)
the presence of endogenous##3##4##(1996-12#1)(2008-10#1)(2010-11#1)
the presence of equivalent##2##4##(2009-10#1)(2013-1#1)
the presence of excess unlabeled##2##5##(1995-11#2)
the presence of excess##13##4##(1990-2#1)(1990-5#1)(1991-9#1)(1994-12#1)(1995-11#2)(2008-10#5)(2008-5#1)(2010-5#1)
the presence of exogenous##2##4##(1992-9#1)(1996-2#1)
the presence of extensive##3##4##(1994-12#1)(2010-8#1)(2011-2#1)
the presence of external Ca2+##3##5##(1992-11#1)(1992-12#2)
the presence of external##4##4##(1992-11#1)(1992-12#2)(2007-11#1)
the presence of extracellular##5##4##(1991-5#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-6#1)
the presence of feeder cells##2##5##(1993-9#2)
the presence of four##4##4##(1997-7#1)(2008-10#2)(2010-3#1)
the presence of healthy##2##4##(2008-10#2)
the presence of heparin##3##4##(1990-12#1)(1992-5#1)(2010-8#1)
the presence of high concentrations of##5##6##(1990-12#1)(1994-9#1)(2008-10#2)(2008-4#1)
the presence of high levels of##3##6##(1990-8#1)(1992-9#1)(2008-10#1)
the presence of high##19##4##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)
the presence of higher concentrations##2##5##(2008-10#1)(2009-9#1)
the presence of higher##4##4##(2008-10#1)(2009-9#1)(2010-8#1)(2011-1#1)
the presence of higher-order##2##4##(1994-8#1)(2007-12#1)
the presence of host##2##4##(1997-2#1)(2008-10#1)
the presence of human##5##4##(1990-12#1)(1991-2#1)(2008-10#1)(2009-4#1)(2011-2#1)
the presence of humic##3##4##(2008-10#3)
the presence of hydrogen##8##4##(2007-12#1)(2008-10#7)
the presence of hypochlorite##2##4##(2008-10#2)
the presence of increasing concentrations of##2##6##(1992-12#1)(1995-3#1)
the presence of inflammation##2##4##(2008-7#1)(2013-1#1)
the presence of insulin resistance##2##5##(2008-1#1)(2008-3#1)
the presence of insulin##3##4##(2008-1#1)(2008-3#1)(2008-8#1)
the presence of interfering##3##4##(2008-10#2)(2013-1#1)
the presence of intravascular##2##4##(1991-8#1)(2008-6#1)
the presence of iron##6##4##(1991-5#1)(1995-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
the presence of its##5##4##(1993-8#1)(2008-10#3)(2013-7#1)
the presence of key##2##4##(2011-2#1)(2012-12#1)
the presence of large amounts of##3##6##(2008-10#3)
the presence of large##12##4##(2007-11#3)(2007-12#1)(2008-10#8)
the presence of light##3##4##(1991-2#2)(2008-8#1)
the presence of local##2##4##(2008-10#1)(2008-12#1)
the presence of low##7##4##(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
the presence of lymph node metastasis##2##6##(2011-2#2)
the presence of maltose##2##4##(1994-12#2)
the presence of metastases##2##4##(1990-6#1)(2007-8#1)
the presence of methyl##2##4##(1995-11#1)(2012-2#1)
the presence of misalignment##2##4##(2008-3#2)
the presence of more than one##2##6##(2008-10#1)(2008-5#1)
the presence of more##3##4##(1991-3#1)(2008-10#1)(2008-5#1)
the presence of motion##2##4##(2008-2#1)(2008-6#1)
the presence of multiple scattering##2##5##(2008-2#2)
the presence of multiple##9##4##(1991-5#1)(1991-6#1)(1992-6#1)(2008-10#1)(2008-2#2)(2009-4#1)(2012-2#1)(2013-8#1)
the presence of mutant##2##4##(1993-3#1)(2008-10#1)
the presence of natural##2##4##(1994-11#1)(2008-5#1)
the presence of negatively charged##2##5##(1992-12#1)(2008-1#1)
the presence of nitrate##4##4##(1992-6#1)(2008-10#2)(2008-11#1)
the presence of nitrites##3##4##(2007-10#2)(2008-11#1)
the presence of noise##9##4##(2007-12#1)(2008-2#1)(2008-3#3)(2008-9#2)(2010-10#1)(2011-1#1)
the presence of obstructive##2##4##(2010-6#2)
the presence of oedema##3##4##(2008-7#2)(2013-7#1)
the presence of one##6##4##(1991-9#1)(1994-6#1)(2008-10#3)(2008-8#1)
the presence of optical##2##4##(2008-2#1)(2008-3#1)
the presence of other##19##4##(1991-5#1)(1991-8#1)(1993-8#1)(1997-4#1)(2008-10#10)(2008-4#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)
the presence of oxygen##11##4##(1991-2#1)(1993-6#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-9#1)(2009-3#1)
the presence of ozone##2##4##(2008-10#2)
the presence of perturbations##2##4##(2008-3#2)
the presence of phosphatidylserine and##2##5##(1992-9#1)(1993-8#1)
the presence of picrotoxin##2##4##(1995-12#1)(2008-8#1)
the presence of potassium##3##4##(2007-11#1)(2008-10#2)
the presence of potential##3##4##(2008-10#2)(2011-1#1)
the presence of predators##2##4##(2008-8#2)
the presence of protein kinase##2##5##(1990-7#1)(1994-11#1)
the presence of proteins##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
the presence of rDNA sites##2##5##(2010-8#2)
the presence of rare alleles##3##5##(2012-3#3)
the presence of rare##5##4##(2012-3#5)
the presence of reactive##3##4##(2008-10#1)(2008-4#1)(2009-8#1)
the presence of relatively##3##4##(1990-12#1)(1991-9#1)(2008-10#1)
the presence of residual##3##4##(2008-10#1)(2009-11#1)(2013-8#1)
the presence of saponins##2##4##(2008-10#1)(2013-7#1)
the presence of saturating##3##4##(1995-11#1)(1997-2#1)(2008-8#1)
the presence of serum and##2##5##(1992-11#1)(1997-7#1)
the presence of serum in the##2##6##(1991-5#1)(2008-11#1)
the presence of serum##8##4##(1991-5#1)(1992-11#1)(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#3)
the presence of seven##2##4##(1993-6#1)(2008-10#1)
the presence of several##18##4##(1991-6#1)(1991-9#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-8#1)
the presence of significant##3##4##(1990-5#1)(2008-10#1)(2010-1#1)
the presence of small##4##4##(1993-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
the presence of sodium##23##4##(1990-11#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-10#16)(2008-2#1)(2008-6#1)(2008-9#1)
the presence of some##4##4##(1997-2#1)(2008-10#2)(2010-4#1)
the presence of specific##5##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
the presence of strong##3##4##(2008-10#1)(2008-3#2)
the presence of such##7##4##(1991-12#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
the presence of sugar##2##4##(2008-12#1)(2008-9#1)
the presence of sulfate##2##4##(2008-3#1)(2008-6#1)
the presence of surfactants##5##4##(2008-10#5)
the presence of symptoms##2##4##(2008-10#1)(2013-1#1)
the presence of systematic##2##4##(2007-12#1)(2008-10#1)
the presence of testosterone in the##2##6##(1995-2#1)(2012-2#1)
the presence of the different##3##5##(2008-10#1)(2008-7#1)(2010-3#1)
the presence of the enzyme##2##5##(2008-10#2)
the presence of the jelly coat##2##6##(2008-8#2)
the presence of the other##3##5##(2008-10#2)(2008-12#1)
the presence of the pathogen##2##5##(2008-10#2)
the presence of the substrate##2##5##(2008-3#1)(2008-4#1)
the presence of the traT gene##2##6##(1991-8#2)
the presence of the two##3##5##(1990-7#1)(1994-11#1)(2008-11#1)
the presence of the virus##3##5##(2008-10#3)
the presence of the##156##4##(1990-11#3)(1990-5#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#50)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#8)(2009-11#1)(2009-9#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#4)(2013-1#1)(2013-7#1)(2013-8#1)
the presence of their##3##4##(2008-10#2)(2008-9#1)
the presence of these##9##4##(1991-1#1)(1991-5#1)(1991-8#1)(1995-2#1)(2008-10#1)(2010-4#1)(2011-2#2)(2013-1#1)
the presence of this##9##4##(1993-8#1)(1996-8#1)(1997-2#1)(2008-10#3)(2008-9#1)(2009-9#1)(2013-7#1)
the presence of three##5##4##(1993-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-7#1)
the presence of toxic##2##4##(2008-10#1)(2011-1#1)
the presence of transcripts for##2##5##(1992-9#1)(2008-4#1)
the presence of two classes of##3##6##(1993-1#1)(1994-3#1)(1994-8#1)
the presence of two different##4##5##(1996-2#1)(2008-10#2)(2008-4#1)
the presence of two##33##4##(1990-5#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#2)(1997-2#1)(1997-3#1)(2008-10#10)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the presence of typical##2##4##(2008-5#1)(2012-3#1)
the presence of urea##2##4##(1995-5#1)(2008-10#1)
the presence of various##8##4##(1994-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2008-10#1)(2012-3#1)(2013-8#1)
the presence of viral##2##4##(1993-8#1)(2008-11#1)
the presence of water##2##4##(1990-7#1)(2008-5#1)
the presence of zinc##4##4##(1994-6#1)(2008-10#1)(2010-10#1)(2010-11#1)
the presence of##2495##3##(1990-10#7)(1990-11#17)(1990-12#20)(1990-2#16)(1990-3#2)(1990-5#24)(1990-6#1)(1990-7#10)(1990-8#21)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#19)(1991-2#12)(1991-3#6)(1991-4#1)(1991-5#22)(1991-6#2)(1991-7#1)(1991-8#9)(1991-9#13)(1992-1#1)(1992-11#10)(1992-12#14)(1992-2#4)(1992-3#24)(1992-4#1)(1992-5#7)(1992-6#17)(1992-7#1)(1992-8#12)(1992-9#12)(1993-1#1)(1993-11#13)(1993-12#6)(1993-2#5)(1993-3#11)(1993-5#1)(1993-6#22)(1993-8#30)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#20)(1994-12#13)(1994-2#8)(1994-3#9)(1994-5#20)(1994-6#17)(1994-7#3)(1994-8#18)(1994-9#8)(1995-11#20)(1995-12#18)(1995-2#31)(1995-3#15)(1995-4#1)(1995-5#15)(1995-6#19)(1995-8#14)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#12)(1996-3#6)(1996-4#2)(1996-5#22)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#16)(1997-3#11)(1997-4#17)(1997-5#2)(1997-6#3)(1997-7#14)(1997-8#7)(2006-10#1)(2006-4#1)(2007-10#12)(2007-11#28)(2007-12#36)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#2)(2008-1#15)(2008-10#760)(2008-11#90)(2008-12#27)(2008-2#34)(2008-3#74)(2008-4#45)(2008-5#47)(2008-6#27)(2008-7#41)(2008-8#41)(2008-9#31)(2009-1#2)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#12)(2009-9#15)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#10)(2010-4#12)(2010-5#9)(2010-6#13)(2010-7#1)(2010-8#8)(2011-1#20)(2011-2#54)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#25)(2012-2#20)(2012-3#27)(2013-1#43)(2013-7#8)(2013-8#21)
the presence on##2##3##(2008-5#1)(2013-1#1)
the presence or absence of a##5##6##(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)
the presence or absence of the##8##6##(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#4)(2008-5#1)
the presence or absence of##63##5##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#22)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
the presence or absence##64##4##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#22)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
the presence or the##2##4##(2008-7#1)(2011-2#1)
the presence or##66##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#22)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
the presence##2657##2##(1990-10#7)(1990-11#19)(1990-12#21)(1990-2#17)(1990-3#2)(1990-5#28)(1990-6#2)(1990-7#12)(1990-8#21)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#20)(1991-2#12)(1991-3#7)(1991-4#1)(1991-5#24)(1991-6#3)(1991-7#1)(1991-8#10)(1991-9#14)(1992-1#2)(1992-11#10)(1992-12#15)(1992-2#4)(1992-3#27)(1992-4#2)(1992-5#7)(1992-6#19)(1992-7#1)(1992-8#12)(1992-9#13)(1993-1#1)(1993-11#15)(1993-12#7)(1993-2#6)(1993-3#15)(1993-5#1)(1993-6#23)(1993-8#32)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#21)(1994-12#14)(1994-2#9)(1994-3#10)(1994-5#20)(1994-6#17)(1994-7#3)(1994-8#19)(1994-9#8)(1995-11#22)(1995-12#18)(1995-2#32)(1995-3#16)(1995-4#1)(1995-5#15)(1995-6#21)(1995-8#15)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#12)(1996-3#6)(1996-4#2)(1996-5#23)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#8)(1997-2#16)(1997-3#12)(1997-4#17)(1997-5#2)(1997-6#3)(1997-7#14)(1997-8#9)(2006-10#1)(2006-4#1)(2007-10#13)(2007-11#28)(2007-12#36)(2007-2#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#2)(2008-1#15)(2008-10#805)(2008-11#99)(2008-12#31)(2008-2#36)(2008-3#77)(2008-4#47)(2008-5#53)(2008-6#27)(2008-7#46)(2008-8#48)(2008-9#31)(2009-1#2)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#4)(2009-8#12)(2009-9#15)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#4)(2010-2#3)(2010-3#12)(2010-4#12)(2010-5#9)(2010-6#13)(2010-7#2)(2010-8#8)(2011-1#21)(2011-2#57)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#27)(2012-2#22)(2012-3#28)(2013-1#46)(2013-7#8)(2013-8#21)
the presenceof##2##2##(2008-11#1)(2009-8#1)
the present FDTD program##2##4##(2008-3#2)
the present FDTD##3##3##(2008-3#3)
the present admission##2##3##(1995-3#1)(2007-8#1)
the present analysis##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
the present and##2##3##(1997-1#1)(2011-2#1)
the present approach##3##3##(2007-11#1)(2008-10#2)
the present article##18##3##(1990-6#1)(1995-8#2)(2007-12#1)(2008-10#2)(2008-11#6)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
the present case the##3##4##(1990-5#1)(2008-12#1)(2011-2#1)
the present case##21##3##(1990-5#1)(1994-7#1)(1995-4#1)(1996-2#1)(1997-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#1)
the present data##7##3##(1991-6#1)(1992-7#1)(1993-8#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
the present day##5##3##(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
the present epidemiological situation##2##4##(1990-6#1)(1992-5#1)
the present experiment##5##3##(1992-7#1)(1993-11#1)(1994-3#1)(1997-2#1)(2008-12#1)
the present experimental##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
the present experiments##7##3##(1992-11#1)(1992-8#1)(1993-3#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-5#1)
the present findings suggest that##2##5##(1994-5#1)(1996-12#1)
the present findings##3##3##(1994-5#1)(1996-12#1)(2008-5#1)
the present investigation##19##3##(1990-12#1)(1992-3#1)(1994-6#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2009-4#1)(2010-5#1)(2013-1#3)(2013-8#1)
the present investigations##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
the present knowledge of##2##4##(2008-10#1)(2008-11#1)
the present knowledge##5##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
the present literature##2##3##(2008-1#1)(2012-12#1)
the present method a##2##4##(2008-10#1)(2008-4#1)
the present method have##2##4##(1994-8#1)(2008-10#1)
the present method is##2##4##(2008-10#2)
the present method provided##2##4##(2008-10#2)
the present method were##3##4##(2008-10#3)
the present method with##2##4##(1993-8#1)(2008-10#1)
the present method##34##3##(1993-8#1)(1994-8#1)(1995-3#1)(1996-5#2)(2008-10#28)(2008-4#1)
the present observations##2##3##(2008-3#1)(2013-8#1)
the present of##2##3##(2008-10#1)(2008-9#1)
the present on-going##2##3##(1997-7#1)(2011-1#1)
the present paper develops##2##4##(2008-10#1)(2013-8#1)
the present paper the##5##4##(1990-12#1)(1990-2#1)(1990-6#1)(2008-10#1)(2012-3#1)
the present paper we##8##4##(1991-9#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
the present paper##58##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-9#2)(1992-12#1)(1992-9#1)(1996-4#1)(2007-12#4)(2008-10#21)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#5)
the present procedure##4##3##(2008-10#4)
the present report##8##3##(1993-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#3)(2013-7#1)
the present research##5##3##(2008-12#2)(2008-2#1)(2010-8#1)(2013-8#1)
the present results provide##2##4##(1991-6#1)(1993-6#1)
the present results suggest that##3##5##(1993-6#1)(2008-10#1)(2011-2#1)
the present results##16##3##(1991-5#1)(1991-6#1)(1993-11#1)(1993-6#2)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-7#1)
the present review##20##3##(1994-8#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the present sample##4##3##(1992-9#1)(1996-5#1)(2008-10#1)(2008-8#1)
the present series##3##3##(1990-12#1)(1996-2#1)(2008-7#1)
the present situation and##2##4##(1991-3#1)(2008-1#1)
the present situation in##2##4##(1991-6#1)(2008-10#1)
the present situation##4##3##(1991-3#1)(1991-6#1)(2008-1#1)(2008-10#1)
the present state of the##2##5##(2009-12#1)(2011-3#1)
the present state of##5##4##(1991-3#1)(2008-11#1)(2009-12#1)(2011-3#1)(2013-8#1)
the present status of##2##4##(1997-4#1)(2008-7#1)
the present studies##5##3##(1991-12#1)(1991-2#1)(1992-4#1)(1993-12#1)(2013-1#1)
the present study demonstrated that##2##5##(1994-3#1)(2010-5#1)
the present study examined##2##4##(1994-3#1)(2013-1#1)
the present study indicate that##4##5##(2008-10#2)(2008-12#1)(2010-2#1)
the present study indicated that##2##5##(2008-10#1)(2008-5#1)
the present study indicates##2##4##(1996-9#1)(2009-8#1)
the present study is the##2##5##(2009-12#1)(2012-5#1)
the present study is##18##4##(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
the present study it##3##4##(1990-12#1)(2012-2#2)
the present study may##2##4##(2008-10#1)(2013-1#1)
the present study on##2##4##(1994-11#1)(2008-12#1)
the present study showed##3##4##(2007-8#1)(2008-1#2)
the present study suggest that##6##5##(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-5#1)
the present study suggest##7##4##(1992-8#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-5#1)
the present study that##3##4##(1994-8#1)(1995-12#1)(2008-12#1)
the present study to screen##2##5##(2008-8#1)(2008-9#1)
the present study to##4##4##(2008-2#1)(2008-8#1)(2008-9#1)(2013-7#1)
the present study was##94##4##(1990-8#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#4)(2008-5#7)(2008-7#3)(2009-1#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
the present study we have investigated the##2##7##(1995-12#1)(2012-2#1)
the present study we have investigated##3##6##(1994-2#1)(1995-12#1)(2012-2#1)
the present study we have##12##5##(1991-2#1)(1992-12#1)(1994-2#1)(1995-12#2)(1996-12#1)(1997-2#1)(2007-7#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
the present study we investigated##9##5##(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-8#1)
the present study we##45##4##(1991-2#1)(1992-12#2)(1993-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
the present study were##9##4##(1993-3#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-2#1)(2012-2#1)
the present study##488##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#5)(1993-3#3)(1993-6#5)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#7)(1994-9#3)(1995-11#2)(1995-12#12)(1995-2#4)(1995-3#3)(1995-8#4)(1996-12#5)(1996-2#7)(1996-3#1)(1996-5#7)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#7)(1997-6#2)(1997-7#2)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#49)(2008-11#24)(2008-12#14)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#22)(2008-6#9)(2008-7#11)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#5)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#25)(2011-7#1)(2012-1#6)(2012-12#3)(2012-2#21)(2012-3#10)(2012-5#3)(2013-1#21)(2013-7#6)(2013-8#13)
the present system##6##3##(1994-1#1)(2008-10#3)(2008-2#1)(2008-8#1)
the present technique##2##3##(2008-10#1)(2008-2#1)
the present time that##2##4##(1992-12#1)(2008-6#1)
the present time##19##3##(1991-6#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)
the present work is to##6##5##(1995-2#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-8#1)(2009-12#1)
the present work is##8##4##(1995-2#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)
the present work was##14##4##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-9#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
the present work we##10##4##(1990-12#1)(1992-11#1)(1994-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
the present work##84##3##(1990-11#1)(1990-12#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#38)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
the present##1013##2##(1990-10#2)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#1)(1990-5#7)(1990-6#8)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#8)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#9)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#7)(1993-3#5)(1993-6#9)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#8)(1994-3#6)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#11)(1994-9#4)(1995-11#4)(1995-12#13)(1995-2#7)(1995-3#6)(1995-4#1)(1995-6#1)(1995-8#7)(1995-9#1)(1996-1#2)(1996-12#9)(1996-2#11)(1996-3#4)(1996-4#1)(1996-5#10)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#6)(1997-4#10)(1997-6#2)(1997-7#5)(1997-8#2)(2007-10#5)(2007-11#4)(2007-12#11)(2007-2#1)(2007-5#3)(2007-7#3)(2007-8#8)(2008-1#10)(2008-10#187)(2008-11#48)(2008-12#23)(2008-2#13)(2008-3#13)(2008-4#8)(2008-5#31)(2008-6#14)(2008-7#27)(2008-8#16)(2008-9#11)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#8)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#9)(2010-4#4)(2010-5#9)(2010-6#4)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#42)(2011-3#1)(2011-7#1)(2012-1#9)(2012-12#7)(2012-2#27)(2012-3#19)(2012-5#3)(2012-7#1)(2013-1#37)(2013-7#10)(2013-8#28)
the present-day##4##2##(1997-4#1)(2008-10#1)(2008-3#2)
the presentation and##2##3##(1995-11#1)(2011-2#1)
the presentation of two##2##4##(1992-6#1)(2008-4#1)
the presentation of##19##3##(1991-11#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-2#1)(1997-3#1)(2007-7#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
the presentation##25##2##(1991-11#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-8#1)(2007-7#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
the presentations##5##2##(2006-10#1)(2008-10#1)(2008-5#2)(2010-11#1)
the presented case##2##3##(1990-9#1)(2008-10#1)
the presented method are##2##4##(2008-10#1)(2008-3#1)
the presented method##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
the presented##20##2##(1990-9#1)(1991-12#1)(1995-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
the presenting complaint##2##3##(2010-12#1)(2010-3#1)
the presenting feature of##2##4##(2007-7#1)(2010-6#1)
the presenting feature##3##3##(2007-7#1)(2008-1#1)(2010-6#1)
the presenting sign of##5##4##(2007-2#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)
the presenting symptoms##3##3##(1990-6#1)(1991-11#1)(2008-12#1)
the presenting##17##2##(1990-3#1)(1990-6#1)(1991-11#1)(1993-6#1)(1995-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-12#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
the presequence##2##2##(1991-12#2)
the preservation of a##3##4##(2008-5#1)(2011-2#2)
the preservation of the##2##4##(2008-10#1)(2008-3#1)
the preservation of this##2##4##(2008-10#1)(2008-11#1)
the preservation of##11##3##(1992-8#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)
the preservation##15##2##(1992-8#1)(1997-7#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#2)
the preservative##2##2##(2008-5#2)
the preserved##2##2##(1996-12#1)(2012-1#1)
the presidency##2##2##(1995-1#1)(2012-2#1)
the president##2##2##(1994-9#1)(2008-7#1)
the press in##3##3##(1990-12#1)(2006-10#1)(2009-10#1)
the press releases##2##3##(1996-2#1)(2008-7#1)
the press##11##2##(1990-12#2)(1992-3#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-10#1)(2008-7#1)(2009-10#3)
the pressing##2##2##(1996-3#1)(2008-10#1)
the pressor response induced by##2##5##(1992-8#2)
the pressor response to intravenous (i##2##6##(1992-8#1)(1995-12#1)
the pressor response to##5##4##(1992-8#2)(1995-12#1)(1997-2#2)
the pressor response##7##3##(1992-8#4)(1995-12#1)(1997-2#2)
the pressor##10##2##(1992-8#5)(1995-11#1)(1995-12#1)(1997-2#3)
the pressure and##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
the pressure drop##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
the pressure gradient##2##3##(2009-6#2)
the pressure of##4##3##(1991-12#1)(1994-12#1)(2007-12#1)(2008-10#1)
the pressure on the##2##4##(1997-8#1)(2010-4#1)
the pressure on##5##3##(1995-3#1)(1997-8#1)(2008-2#1)(2010-4#1)(2011-2#1)
the pressure range##2##3##(2008-10#1)(2008-3#1)
the pressure to##3##3##(2008-3#1)(2009-11#1)(2012-2#1)
the pressure##37##2##(1991-12#1)(1991-5#1)(1994-12#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#4)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-8#1)
the pressures##5##2##(1993-2#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-8#1)
the presumably##2##2##(1992-3#1)(2011-2#1)
the presumed##13##2##(1991-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-4#1)(2010-4#1)(2011-2#1)
the presumption##3##2##(1995-1#1)(2012-12#1)(2013-8#1)
the presumptive VU##2##3##(1994-12#2)
the presumptive##7##2##(1991-5#1)(1993-2#1)(1994-12#3)(1997-3#1)(2008-5#1)
the presynaptic nerve terminal##2##4##(1993-3#1)(1996-12#1)
the presynaptic##12##2##(1992-12#1)(1993-3#1)(1994-8#2)(1995-12#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-7#2)(2008-3#1)
the pretherapeutic##2##2##(1990-9#1)(2008-7#1)
the pretreated##5##2##(2008-10#1)(2008-6#1)(2013-1#3)
the pretreatment of a##2##4##(2008-8#1)(2013-1#1)
the pretreatment of the##3##4##(2008-10#2)(2013-8#1)
the pretreatment of##12##3##(1993-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
the pretreatment##19##2##(1992-3#1)(1993-11#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
the prevailing wind##2##3##(2007-12#1)(2008-10#1)
the prevailing##20##2##(1992-3#2)(1993-6#1)(1994-3#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-8#1)
the prevalence and clinical##3##4##(2008-5#1)(2008-9#1)(2013-8#1)
the prevalence and factors associated with##2##6##(2007-7#1)(2013-8#1)
the prevalence and population densities of H##2##7##(2008-10#2)
the prevalence and severity of##3##5##(2007-7#1)(2008-1#1)(2010-6#1)
the prevalence and the##2##4##(1992-2#1)(2011-7#1)
the prevalence and##26##3##(1992-2#1)(1994-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-1#4)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-8#3)
the prevalence in##3##3##(1994-6#1)(1996-3#1)(2010-8#1)
the prevalence of CSDS varied between 11 and 65%##2##9##(2013-8#2)
the prevalence of H##2##4##(2008-1#1)(2011-1#1)
the prevalence of HIV infection among##2##6##(2007-7#1)(2011-2#1)
the prevalence of HIV-1##2##4##(1995-9#1)(2008-2#1)
the prevalence of Japanese cedar pollinosis##2##6##(2012-12#2)
the prevalence of a##2##4##(2010-5#1)(2012-2#1)
the prevalence of anxiety and depressive disorders##2##7##(2009-10#2)
the prevalence of body dissatisfaction among##2##6##(2007-12#2)
the prevalence of body dissatisfaction##3##5##(2007-12#3)
the prevalence of cardiovascular##2##4##(2009-11#2)
the prevalence of chronic##2##4##(2012-3#1)(2013-8#1)
the prevalence of dementia##2##4##(1991-11#1)(2008-7#1)
the prevalence of depression##2##4##(2007-10#1)(2013-8#1)
the prevalence of depressive symptoms in##2##6##(2013-8#2)
the prevalence of depressive symptoms##3##5##(2013-1#1)(2013-8#2)
the prevalence of depressive##6##4##(2009-10#1)(2013-1#1)(2013-8#4)
the prevalence of diabetes##3##4##(2008-7#1)(2013-8#2)
the prevalence of elevated blood##2##5##(1997-4#1)(2008-5#1)
the prevalence of elevated##3##4##(1997-4#1)(2007-7#1)(2008-5#1)
the prevalence of hypertension##3##4##(2008-1#3)
the prevalence of infection##2##4##(1990-9#1)(2011-1#1)
the prevalence of intestinal##2##4##(2009-10#1)(2012-12#1)
the prevalence of migraine was##2##5##(2010-2#2)
the prevalence of migraine##5##4##(2008-9#1)(2010-2#4)
the prevalence of myocardial infarction and stroke##2##7##(2009-9#2)
the prevalence of obesity##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
the prevalence of osteoporosis in##2##5##(2010-3#2)
the prevalence of osteoporosis##3##4##(2010-3#3)
the prevalence of other##2##4##(2008-3#1)(2011-1#1)
the prevalence of overweight and obesity in##2##7##(2008-3#1)(2012-12#1)
the prevalence of overweight and obesity##3##6##(2008-3#1)(2012-12#2)
the prevalence of overweight and##5##5##(2008-3#2)(2012-12#2)(2013-8#1)
the prevalence of pain##2##4##(2010-12#1)(2012-12#1)
the prevalence of risk factors##3##5##(1993-2#1)(2008-12#1)(2013-8#1)
the prevalence of self-reported##2##4##(1990-9#1)(2013-1#1)
the prevalence of seropositivity##2##4##(1991-11#2)
the prevalence of sexual##2##4##(2009-7#1)(2009-9#1)
the prevalence of smoking among##2##5##(1991-4#1)(2009-7#1)
the prevalence of such##3##4##(1995-8#1)(2008-8#1)(2012-2#1)
the prevalence of the MS##2##5##(2008-3#2)
the prevalence of the disease##3##5##(2008-10#2)(2008-9#1)
the prevalence of the##13##4##(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#3)
the prevalence of these##4##4##(1990-9#1)(2007-7#1)(2008-2#1)(2008-5#1)
the prevalence of this##2##4##(1996-12#1)(2010-5#1)
the prevalence of thyroid autoimmunity##2##5##(2008-7#2)
the prevalence of tuberculosis##3##4##(1995-10#1)(2011-1#2)
the prevalence of urinary##2##4##(2007-10#1)(2011-1#1)
the prevalence of##262##3##(1990-12#3)(1990-3#1)(1990-6#3)(1990-9#3)(1991-11#3)(1991-12#2)(1991-4#1)(1992-1#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#4)(1994-9#2)(1995-10#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#3)(1996-7#2)(1996-9#1)(1997-3#4)(1997-4#1)(1997-5#1)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#10)(2007-8#2)(2007-9#1)(2008-1#12)(2008-10#10)(2008-11#2)(2008-12#12)(2008-2#3)(2008-3#8)(2008-5#4)(2008-7#9)(2008-8#9)(2008-9#5)(2009-10#5)(2009-11#3)(2009-12#3)(2009-3#1)(2009-5#4)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#11)(2011-2#13)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#16)
the prevalence rate of GB##2##5##(2013-8#2)
the prevalence rate##5##3##(1991-12#1)(2008-7#1)(2013-8#3)
the prevalence##322##2##(1990-12#3)(1990-3#1)(1990-6#4)(1990-9#3)(1991-11#3)(1991-12#3)(1991-4#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-6#5)(1994-9#2)(1995-10#2)(1995-12#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-7#2)(1996-9#1)(1997-3#4)(1997-4#1)(1997-5#1)(2007-10#4)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#12)(2007-8#2)(2007-9#1)(2008-1#18)(2008-10#12)(2008-11#3)(2008-12#14)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#6)(2009-10#5)(2009-11#4)(2009-12#3)(2009-3#1)(2009-5#5)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#18)(2011-2#18)(2011-7#1)(2012-1#2)(2012-12#10)(2012-2#9)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#22)
the prevalences of##2##3##(1990-12#1)(2008-10#1)
the prevalent cause of##2##4##(2008-5#1)(2008-7#1)
the prevalent trend##2##3##(1994-2#1)(2010-8#1)
the prevalent use of##2##4##(1997-2#1)(1997-6#1)
the prevalent wind##2##3##(2008-5#2)
the prevalent##18##2##(1992-1#1)(1994-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)
the prevent-and-detect##2##2##(2010-7#2)
the preventative##3##2##(2007-12#2)(2011-1#1)
the prevention and control of NCDs##2##6##(2013-8#2)
the prevention and control of##7##5##(1991-5#1)(2008-9#1)(2010-5#1)(2011-2#2)(2013-8#2)
the prevention and management of##3##5##(1990-2#1)(2008-7#2)
the prevention and the##2##4##(1993-11#1)(2007-8#1)
the prevention and treatment of osteoporosis##4##6##(1993-11#2)(1997-6#2)
the prevention and treatment of##18##5##(1993-11#2)(1997-6#2)(2006-10#2)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#2)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
the prevention and treatment##19##4##(1993-11#2)(1997-6#2)(2006-10#2)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#2)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#2)
the prevention and##35##3##(1990-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-11#3)(1995-6#1)(1996-12#1)(1997-6#2)(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#4)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#4)
the prevention of TB##2##4##(2007-2#1)(2009-4#1)
the prevention of cardiac##2##4##(2008-8#1)(2013-8#1)
the prevention of cardiovascular##2##4##(2008-10#1)(2008-7#1)
the prevention of disease##2##4##(2008-1#1)(2008-9#1)
the prevention of human##2##4##(2008-5#1)(2011-2#1)
the prevention of new##2##4##(2008-10#1)(2009-4#1)
the prevention of obesity##4##4##(2008-10#2)(2011-2#2)
the prevention of recurrences of##2##5##(1996-12#1)(2008-1#1)
the prevention of recurrences##3##4##(1996-12#1)(2007-7#1)(2008-1#1)
the prevention of the spread of##2##6##(1996-3#1)(2011-2#1)
the prevention of the##3##4##(1991-9#1)(1996-3#1)(2011-2#1)
the prevention of this##3##4##(1990-3#1)(2007-4#1)(2009-5#1)
the prevention of transmission of##2##5##(1993-3#1)(2010-5#1)
the prevention of##108##3##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
the prevention##150##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-5#1)(1992-9#1)(1993-11#6)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-10#2)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#7)(2008-7#12)(2008-8#1)(2008-9#2)(2009-10#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
the preventive effect of##4##4##(1992-10#1)(2008-5#1)(2009-8#1)(2013-8#1)
the preventive##11##2##(1990-3#1)(1990-9#1)(1992-10#1)(1993-9#1)(1996-2#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-8#1)(2013-8#1)
the previous 12 months##6##4##(1994-12#1)(1997-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2013-1#1)
the previous R-R intervals and##2##5##(2009-9#1)(2010-5#1)
the previous day##2##3##(2011-1#1)(2011-2#1)
the previous decade##3##3##(2008-5#1)(2013-1#2)
the previous dissection##2##3##(2008-11#2)
the previous extraction##2##3##(2007-12#1)(2008-10#1)
the previous method##3##3##(1995-2#1)(1996-5#1)(2008-11#1)
the previous model##2##3##(2008-10#1)(2008-5#1)
the previous models##2##3##(2009-2#1)(2013-1#1)
the previous observation that##2##4##(1991-9#1)(2008-5#1)
the previous observations##2##3##(1991-12#1)(2008-11#1)
the previous one##4##3##(2008-10#1)(2011-2#3)
the previous passage##2##3##(2011-3#2)
the previous reports on##2##4##(1991-9#1)(1992-2#1)
the previous reports##3##3##(1991-9#1)(1992-2#1)(2012-12#1)
the previous six##4##3##(2011-1#3)(2013-1#1)
the previous step##2##3##(1992-3#1)(1995-3#1)
the previous studies##4##3##(2008-10#1)(2010-9#1)(2011-1#2)
the previous study##7##3##(1990-2#1)(1992-6#1)(1993-12#2)(1994-2#1)(1994-3#1)(2008-9#1)
the previous two years##2##4##(2008-5#1)(2011-2#1)
the previous two##3##3##(1991-5#1)(2008-5#1)(2011-2#1)
the previous work##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
the previous year had##2##4##(2008-10#2)
the previous year were##2##4##(2008-10#2)
the previous year##13##3##(1991-3#1)(1994-12#1)(1996-12#1)(2007-5#1)(2008-10#7)(2008-12#2)
the previous year's##2##3##(2008-10#1)(2011-2#1)
the previous##167##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#3)(1992-2#1)(1992-3#1)(1992-6#2)(1993-12#4)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#31)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#12)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#7)(2013-8#2)
the previously characterized##6##3##(1990-5#1)(1991-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#1)
the previously defined##2##3##(1995-2#1)(2008-10#1)
the previously described EC-2##2##4##(2008-10#2)
the previously described##28##3##(1990-5#1)(1991-5#2)(1991-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-6#2)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2010-11#1)(2012-2#1)(2012-3#1)
the previously developed##2##3##(1996-2#1)(2008-10#1)
the previously dominant##2##3##(2008-10#2)
the previously existing##2##3##(2011-2#1)(2013-8#1)
the previously identified##7##3##(1993-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2009-4#1)(2012-3#1)
the previously isolated##2##3##(1990-12#1)(1992-12#1)
the previously known##2##3##(1992-3#1)(1996-6#1)
the previously mapped##2##3##(1994-12#1)(2008-10#1)
the previously observed##2##3##(1993-12#1)(2011-1#1)
the previously proposed##3##3##(1994-3#1)(2008-10#1)(2008-3#1)
the previously published##5##3##(1993-8#1)(1994-12#1)(1995-12#1)(2008-5#1)(2010-2#1)
the previously reported##20##3##(1990-5#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-12#1)
the previously sequenced##4##3##(1991-2#1)(1991-6#1)(1994-12#1)(1997-8#1)
the previously studied##4##3##(1994-2#1)(2007-11#2)(2010-3#1)
the previously synthesized##2##3##(1995-11#2)
the previously used##3##3##(1991-5#1)(2011-2#1)(2012-3#1)
the previously##127##2##(1990-12#1)(1990-5#3)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1995-11#4)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#4)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#3)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the previtellogenic##2##2##(2008-8#1)(2010-5#1)
the prewar and##2##3##(1990-6#1)(2008-11#1)
the prey species##2##3##(2008-8#2)
the prey##18##2##(2007-12#3)(2008-10#1)(2008-12#1)(2008-8#5)(2008-9#5)(2010-8#1)(2012-2#1)(2012-3#1)
the prey's##3##2##(2008-8#2)(2008-9#1)
the prey-to-predator conversion efficiency##2##4##(2008-8#2)
the prg isolates##3##3##(2008-10#3)
the prg pathogens##3##3##(2008-10#3)
the prg##6##2##(2008-10#6)
the price of##12##3##(1990-9#1)(1991-1#1)(1991-4#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-7#1)(1996-12#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
the price##17##2##(1990-9#1)(1991-1#1)(1991-4#1)(1993-1#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-7#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)
the primacy of##2##3##(2009-8#1)(2013-8#1)
the primary afferent##5##3##(1994-8#1)(1995-12#2)(1995-5#1)(1997-3#1)
the primary amine##3##3##(2008-10#2)(2011-1#1)
the primary amino##2##3##(1996-12#1)(2008-10#1)
the primary and metastatic tumor##2##5##(1992-6#2)
the primary and metastatic##4##4##(1992-6#3)(2013-8#1)
the primary and permanent##2##4##(2008-12#1)(2012-2#1)
the primary and secondary##7##4##(1992-6#2)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2011-3#1)
the primary and##24##3##(1991-3#1)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#5)(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
the primary anion##2##3##(1990-5#2)
the primary antibody##5##3##(2008-10#3)(2008-4#2)
the primary approach##2##3##(2008-10#1)(2008-4#1)
the primary auditory cortex##2##4##(2008-11#1)(2013-8#1)
the primary auditory##3##3##(1995-5#1)(2008-11#1)(2013-8#1)
the primary cancer##2##3##(1995-4#1)(2013-8#1)
the primary carbon##2##3##(1994-5#1)(2008-3#1)
the primary care physician##3##4##(1995-2#1)(1997-1#1)(1997-2#1)
the primary care##20##3##(1990-9#1)(1992-7#1)(1993-6#1)(1993-9#1)(1995-11#2)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2010-1#2)(2011-1#1)(2013-1#2)
the primary causative##2##3##(2008-2#1)(2013-8#1)
the primary cause of##5##4##(1996-12#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
the primary cause##6##3##(1996-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
the primary cells##2##3##(2008-11#2)
the primary coating##3##3##(2007-11#3)
the primary component##2##3##(2007-12#1)(2008-10#1)
the primary concern##2##3##(1992-8#1)(1997-2#1)
the primary data##2##3##(1995-8#1)(2008-1#1)
the primary determinant##2##3##(2007-12#1)(2008-10#1)
the primary efficacy##2##3##(2008-7#2)
the primary electron donor##7##4##(1992-6#2)(1993-11#2)(2008-8#3)
the primary emulsifier##2##3##(2008-5#2)
the primary endosperm##3##3##(2008-9#3)
the primary endpoint of##2##4##(2008-5#1)(2010-4#1)
the primary endpoint##3##3##(2008-5#1)(2008-7#1)(2010-4#1)
the primary factor##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
the primary gene##2##3##(1990-5#1)(2009-10#1)
the primary generation##2##3##(1995-3#1)(2008-10#1)
the primary goal##3##3##(2008-9#2)(2013-1#1)
the primary health care##5##4##(1991-6#1)(1995-8#1)(2008-1#2)(2011-2#1)
the primary health services##5##4##(1991-6#1)(1992-11#2)(1994-6#1)(1995-6#1)
the primary health##11##3##(1991-6#2)(1992-11#2)(1994-6#1)(1995-6#1)(1995-8#1)(2008-1#2)(2011-2#1)(2013-8#1)
the primary imaging##2##3##(2008-7#1)(2012-2#1)
the primary immune response##2##4##(2008-10#1)(2008-11#1)
the primary infection##6##3##(2007-10#1)(2008-10#5)
the primary inoculum##4##3##(2008-10#4)
the primary lesion##5##3##(1991-5#1)(1992-2#1)(2007-12#1)(2008-10#1)(2013-8#1)
the primary means of##3##4##(2008-10#2)(2008-5#1)
the primary means##4##3##(2008-10#3)(2008-5#1)
the primary mechanism##2##3##(1997-3#1)(2008-10#1)
the primary motor##2##3##(2008-9#1)(2011-2#1)
the primary olfactory center##2##4##(2007-12#2)
the primary or##2##3##(1990-12#1)(2008-5#1)
the primary particles##2##3##(2008-3#1)(2008-5#1)
the primary pathogenic##2##3##(1992-3#1)(2008-2#1)
the primary photochemical##2##3##(2008-8#1)(2011-1#1)
the primary prevention of##2##4##(2009-4#1)(2010-6#1)
the primary prevention##3##3##(2009-4#1)(2010-12#1)(2010-6#1)
the primary procedure in the##2##5##(1990-11#1)(1990-2#1)
the primary reason for##2##4##(1997-4#1)(1997-7#1)
the primary root##2##3##(2008-5#2)
the primary school##2##3##(2007-5#1)(2008-12#1)
the primary sequence##3##3##(1991-8#1)(1993-2#2)
the primary site of the##2##5##(2012-12#1)(2012-3#1)
the primary site of##5##4##(1991-2#1)(1997-6#1)(2008-10#1)(2012-12#1)(2012-3#1)
the primary site##8##3##(1991-2#1)(1992-12#1)(1997-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
the primary source of##2##4##(2008-1#1)(2008-4#1)
the primary sources##2##3##(1992-6#1)(2008-3#1)
the primary stage##2##3##(1997-3#1)(2007-11#1)
the primary structure of Orpotrin##2##5##(2011-2#2)
the primary structure of goat Mb##2##6##(2010-4#2)
the primary structure of the##10##5##(1990-12#1)(1990-7#1)(1992-3#2)(1994-2#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
the primary structure of##21##4##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1992-3#2)(1992-8#1)(1994-2#1)(1994-9#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#2)(2011-2#2)
the primary structures of##2##4##(1991-6#1)(1993-12#1)
the primary structures##3##3##(1991-6#1)(1993-12#1)(1993-3#1)
the primary success rate##3##4##(1991-3#1)(2008-12#2)
the primary target of##2##4##(2008-1#1)(2008-10#1)
the primary target##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
the primary treatment##2##3##(1991-6#1)(2013-1#1)
the primary tumor and##5##4##(1992-6#1)(1993-1#1)(2008-10#1)(2010-3#2)
the primary tumor to the##2##5##(1990-6#1)(2012-12#1)
the primary tumor was##5##4##(1992-6#2)(1992-8#1)(2008-6#2)
the primary tumor##33##3##(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#1)(1992-6#4)(1992-8#2)(1993-1#1)(1994-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-6#2)(2010-3#6)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
the primary tumour and##2##4##(1997-3#1)(2008-1#1)
the primary tumour##9##3##(1991-6#1)(1995-8#2)(1997-3#1)(2008-1#1)(2008-6#1)(2011-2#1)(2011-3#1)(2013-8#1)
the primary visual cortex (V1)##3##5##(1995-11#1)(2008-11#1)(2012-2#1)
the primary visual cortex of adult##2##6##(1992-10#1)(1993-12#1)
the primary visual cortex of##3##5##(1992-10#1)(1993-12#1)(2008-8#1)
the primary visual cortex##8##4##(1992-10#1)(1993-12#1)(1995-11#2)(2007-9#1)(2008-11#1)(2008-8#1)(2012-2#1)
the primary visual##9##3##(1992-10#1)(1993-12#1)(1995-11#2)(2007-9#1)(2008-11#1)(2008-8#2)(2012-2#1)
the primary wear zone##3##4##(2009-7#3)
the primary##505##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#8)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#6)(1992-6#15)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#10)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#11)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#13)(2008-10#57)(2008-11#19)(2008-12#7)(2008-2#7)(2008-3#16)(2008-4#8)(2008-5#11)(2008-6#7)(2008-7#12)(2008-8#15)(2008-9#12)(2009-10#5)(2009-12#1)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#6)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#24)(2011-3#3)(2012-12#7)(2012-2#12)(2012-3#8)(2013-1#17)(2013-8#13)
the primase##2##2##(1992-3#1)(1994-12#1)
the primate cortical visual system##2##5##(1995-5#2)
the primate endometrium##2##3##(1995-11#2)
the primate visual system##2##4##(1995-5#2)
the primate##12##2##(1995-11#2)(1995-5#5)(1997-2#2)(2008-1#1)(2010-3#1)(2011-2#1)
the prime##11##2##(1991-3#1)(1991-9#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-3#1)(2012-2#1)
the primed##2##2##(1995-2#1)(2008-11#1)
the primer##3##2##(2008-10#1)(2008-4#1)(2009-7#1)
the primers##12##2##(1997-4#1)(1997-7#2)(2008-10#7)(2008-5#2)
the priming effect##2##3##(2008-2#1)(2008-4#1)
the priming##4##2##(1992-8#2)(2008-2#1)(2008-4#1)
the primitive##6##2##(2007-5#1)(2008-9#1)(2010-11#2)(2010-3#1)(2013-1#1)
the primordial##7##2##(2007-12#5)(2012-12#1)(2013-1#1)
the principal cause##2##3##(2008-2#1)(2008-7#1)
the principal component analysis##2##4##(2011-2#1)(2013-8#1)
the principal component of##2##4##(1993-11#1)(2008-10#1)
the principal component##5##3##(1993-11#1)(2008-10#2)(2011-2#1)(2013-8#1)
the principal components of##2##4##(1993-11#1)(2008-6#1)
the principal components##4##3##(1993-11#1)(2008-10#1)(2008-6#1)(2010-8#1)
the principal indices##2##3##(2007-11#1)(2008-3#1)
the principal investigators##2##3##(2010-11#1)(2012-12#1)
the principal plane##4##3##(2008-2#1)(2008-3#3)
the principal refractive indices and##3##5##(2008-2#3)
the principal refractive indices##5##4##(2008-2#4)(2008-3#1)
the principal source of##3##4##(1991-8#1)(2007-12#1)(2008-10#1)
the principal targets for##2##4##(1992-8#1)(2011-2#1)
the principal##89##2##(1990-2#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-5#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the principle features of##2##4##(2007-11#1)(2008-10#1)
the principle of the##5##4##(1997-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
the principle of##36##3##(1992-1#1)(1992-3#1)(1992-4#1)(1996-3#1)(1997-6#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
the principle that the##2##4##(1992-2#1)(2011-2#1)
the principle that##5##3##(1992-2#1)(1994-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
the principle##58##2##(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-6#2)(2007-11#1)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
the principles and practice of##2##5##(1993-12#1)(1997-3#1)
the principles and techniques of##2##5##(1995-1#1)(2007-12#1)
the principles and##12##3##(1992-3#1)(1993-11#1)(1993-12#2)(1995-1#1)(1995-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
the principles discussed##2##3##(2008-4#1)(2010-8#1)
the principles for##3##3##(1991-9#1)(1993-6#1)(2007-8#1)
the principles guiding##2##3##(2008-10#1)(2010-12#1)
the principles of CQI##2##4##(1993-3#1)(1994-1#1)
the principles of induction##2##4##(2011-2#2)
the principles of management of##2##5##(2012-2#2)
the principles of molecular##2##4##(1997-6#1)(2010-9#1)
the principles of the##6##4##(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-9#1)
the principles of##61##3##(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#3)
the principles that##2##3##(2008-2#1)(2012-12#1)
the principles underlying##2##3##(1995-1#1)(2008-11#1)
the principles##93##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#3)(1994-2#1)(1995-1#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#4)(2008-3#5)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#7)(2009-1#1)(2009-3#2)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
the printed##2##2##(1991-5#1)(2007-12#1)
the prion##4##2##(1996-3#2)(1996-5#1)(2008-11#1)
the prior##19##2##(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#1)(2013-1#2)
the priorities of##2##3##(2008-7#1)(2011-2#1)
the priorities##4##2##(1991-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
the priority##9##2##(1996-1#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-1#2)
the prism##6##2##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the prisms##4##2##(2008-3#4)
the pristine##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
the privacy of##2##3##(1996-5#1)(1997-5#1)
the privacy rule requirements##2##4##(2007-12#2)
the privacy rule##5##3##(2007-12#5)
the privacy##10##2##(1991-7#1)(1995-6#1)(1996-5#1)(1997-5#1)(2007-12#6)
the private and public##2##4##(1994-1#1)(1995-12#1)
the private sector##17##3##(1991-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-5#5)(2006-10#1)(2008-1#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
the private##31##2##(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-1#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#5)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#2)(2012-2#2)(2012-3#1)
the privileged##2##2##(2008-1#1)(2009-10#1)
the privileges against disclosure##2##4##(1991-12#1)(1992-3#1)
the pro##2##2##(1995-6#2)
the pro-apoptotic##3##2##(2009-12#2)(2012-12#1)
the pro-domain##2##2##(2008-4#2)
the pro-inflammatory cytokines##2##3##(2008-10#1)(2010-1#1)
the pro-inflammatory##5##2##(2008-10#3)(2010-1#1)(2013-1#1)
the pro-peptide##4##2##(1990-5#4)
the proU##4##2##(1994-12#4)
the probabilities of##3##3##(1991-4#1)(2008-10#1)(2008-9#1)
the probabilities##5##2##(1991-4#1)(1994-11#1)(2008-10#1)(2008-9#1)(2012-3#1)
the probability density function of the##2##6##(2008-3#2)
the probability density##3##3##(2008-2#1)(2008-3#2)
the probability distributions##2##3##(2008-10#1)(2008-2#1)
the probability for##2##3##(2008-11#2)
the probability of a##6##4##(1993-8#1)(1996-3#1)(2008-10#2)(2008-9#1)(2012-3#1)
the probability of being##3##4##(1996-7#1)(2008-8#1)(2010-8#1)
the probability of developing##4##4##(1992-9#2)(2008-4#1)(2012-3#1)
the probability of discordant classification##2##5##(1997-3#2)
the probability of each##2##4##(2008-7#1)(2010-11#1)
the probability of hospitalization##2##4##(1995-2#1)(2008-7#1)
the probability of mortality##3##4##(1997-4#1)(2008-10#2)
the probability of occurrence##3##4##(1997-4#1)(2009-10#1)(2009-8#1)
the probability of offspring survival##2##5##(2008-8#1)(2008-9#1)
the probability of reaching the##2##5##(2008-11#1)(2011-2#1)
the probability of reinforcers for##2##5##(2011-2#2)
the probability of surgery##2##4##(2012-3#2)
the probability of##100##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#4)(1995-2#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#3)(2007-12#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#6)
the probability that a tick infects the##2##7##(2013-8#2)
the probability that a##6##4##(1994-3#1)(1997-4#1)(2008-11#1)(2008-7#1)(2013-8#2)
the probability that caregivers##2##4##(1991-12#2)
the probability that##18##3##(1991-12#2)(1994-11#1)(1994-3#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2013-8#2)
the probability##132##2##(1990-11#1)(1990-8#1)(1991-12#3)(1991-4#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#5)(1995-2#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#4)(1997-9#1)(2007-12#1)(2008-10#22)(2008-11#6)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#10)(2008-8#10)(2008-9#6)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#8)(2011-3#1)(2012-12#2)(2012-3#6)(2013-8#2)
the probability-density##2##2##(2008-2#1)(2008-6#1)
the probable##15##2##(1990-5#1)(1991-11#1)(1992-9#1)(1995-12#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)
the probably##2##2##(2008-11#1)(2012-3#1)
the proband##4##2##(1993-3#1)(2008-11#1)(2010-3#1)(2012-3#1)
the probands##3##2##(1991-11#2)(1994-2#1)
the probe DNA##2##3##(2008-10#1)(2008-5#1)
the probe and the##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
the probe and##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
the probe beam##9##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
the probe cross-sectional area##2##4##(2008-3#2)
the probe is##4##3##(1992-11#1)(2008-2#2)(2010-5#1)
the probe of##2##3##(2008-2#1)(2008-9#1)
the probe pulse##5##3##(2007-11#1)(2007-12#4)
the probe tip##2##3##(2007-12#1)(2011-1#1)
the probe to produce##2##4##(2007-11#1)(2012-3#1)
the probe to##7##3##(1992-6#2)(2007-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
the probe volume##3##3##(2008-3#3)
the probe##97##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1992-11#2)(1992-3#1)(1992-6#5)(1993-2#1)(1995-11#1)(1995-5#1)(1997-7#1)(2007-11#4)(2007-12#11)(2008-10#18)(2008-12#1)(2008-2#8)(2008-3#22)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2010-5#2)(2011-1#2)(2012-3#1)
the probes##15##2##(1994-1#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#2)
the probing of##5##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
the probing##7##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#1)
the probiotic##6##2##(2009-11#1)(2011-2#2)(2013-1#3)
the problem and the##2##4##(1995-1#2)
the problem and##11##3##(1994-1#1)(1995-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-12#1)
the problem by##4##3##(1995-2#1)(2008-10#1)(2008-3#2)
the problem concerning the##2##4##(1990-2#1)(2011-2#1)
the problem has##4##3##(1997-4#1)(2007-11#1)(2008-3#1)(2013-1#1)
the problem is not##2##4##(2008-7#1)(2009-9#1)
the problem is##9##3##(1992-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
the problem of designing##2##4##(2008-2#1)(2010-8#1)
the problem of determining##2##4##(1994-11#1)(2008-10#1)
the problem of finding##2##4##(1992-6#1)(2008-10#1)
the problem of reconstructing##3##4##(2008-3#2)(2011-3#1)
the problem of representing##2##4##(2007-11#1)(2008-7#1)
the problem of the##10##4##(1993-2#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-1#1)(2013-1#2)
the problem of##113##3##(1990-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-7#2)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#10)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
the problem that##4##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the problem to##2##3##(1992-6#1)(1997-5#1)
the problem was##2##3##(2008-10#1)(2011-2#1)
the problem-solving##2##2##(2008-10#1)(2010-11#1)
the problematic##3##2##(1995-1#1)(2008-12#1)(2011-2#1)
the problems and issues##3##4##(1995-3#1)(1997-2#1)(2013-8#1)
the problems and##7##3##(1995-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
the problems associated with the##2##5##(1993-1#1)(2008-2#1)
the problems associated with##9##4##(1993-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
the problems encountered in##3##4##(2007-11#1)(2008-7#1)(2008-9#1)
the problems encountered##6##3##(1990-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)
the problems in##3##3##(1990-6#1)(1994-2#1)(2008-10#1)
the problems inherent in##2##4##(1993-3#1)(2008-6#1)
the problems of diagnosis and##2##5##(1993-9#1)(2008-1#1)
the problems of the##4##4##(1990-5#1)(1991-3#1)(1993-12#1)(1994-2#1)
the problems of##27##3##(1990-11#1)(1990-5#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-6#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#2)(2008-6#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
the problems related to##2##4##(2008-3#1)(2008-8#1)
the problems that##3##3##(1990-2#1)(1993-3#1)(2008-7#1)
the problems with##2##3##(1997-5#1)(2010-12#1)
the problems##89##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#2)
the procathepsin L recognition##2##4##(1995-6#2)
the procathepsin L##3##3##(1995-6#3)
the procedure and the##2##4##(2012-2#1)(2013-8#1)
the procedure and there##2##4##(2007-12#1)(2008-7#1)
the procedure and##15##3##(1992-12#1)(1994-11#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2011-2#2)(2012-2#2)(2013-8#1)
the procedure can be##2##4##(2008-2#1)(2010-5#1)
the procedure can##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
the procedure could##3##3##(1996-9#1)(2008-10#1)(2009-8#1)
the procedure developed##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
the procedure for issuance of a DNR order##2##8##(1992-12#1)(1992-3#1)
the procedure for its##2##4##(2008-10#1)(2008-3#1)
the procedure for##18##3##(1992-12#1)(1992-3#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#1)(2008-9#1)(2010-11#1)
the procedure has##2##3##(1991-12#1)(2007-7#1)
the procedure in##6##3##(1997-3#2)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
the procedure involving##2##3##(2008-10#2)
the procedure is not##2##4##(2008-10#2)
the procedure is##26##3##(1996-12#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
the procedure of choice in##3##5##(2008-11#1)(2009-5#1)(2011-2#1)
the procedure of choice##6##4##(2007-8#1)(2008-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
the procedure of##11##3##(1996-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
the procedure or##2##3##(1995-3#1)(2008-1#1)
the procedure to##3##3##(2008-10#1)(2008-3#2)
the procedure using##2##3##(2007-12#1)(2012-12#1)
the procedure was carried out##2##5##(1991-8#1)(2008-10#1)
the procedure was performed##2##4##(1995-12#1)(2008-10#1)
the procedure was##18##3##(1990-7#1)(1991-8#1)(1995-12#2)(1997-8#1)(2007-8#1)(2008-10#10)(2011-2#1)(2013-1#1)
the procedure were##4##3##(2008-10#3)(2011-2#1)
the procedure with##2##3##(1997-3#1)(2008-10#1)
the procedure##218##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-6#1)(1995-12#4)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#4)(1997-8#2)(2006-6#1)(2007-12#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#59)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#5)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
the procedures and##2##3##(2008-6#1)(2012-1#1)
the procedures are##3##3##(1994-7#1)(2008-4#1)(2010-6#1)
the procedures for##4##3##(1991-1#1)(1991-2#1)(2008-10#1)(2012-3#1)
the procedures in##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
the procedures of##2##3##(1992-9#1)(2008-7#1)
the procedures that##2##3##(1995-3#1)(2010-6#1)
the procedures used in##2##4##(2008-3#1)(2008-7#1)
the procedures used##4##3##(1991-12#1)(2008-3#1)(2008-7#1)(2010-6#1)
the procedures##51##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-9#1)(1994-1#1)(1994-7#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-8#1)(2009-9#1)(2010-6#3)(2010-8#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#2)
the proceedings of the##2##4##(1993-11#1)(2011-2#1)
the proceedings of##3##3##(1993-11#1)(2008-12#1)(2011-2#1)
the proceedings##6##2##(1993-11#1)(1995-6#1)(2007-11#1)(2008-12#1)(2008-8#1)(2011-2#1)
the process and outcomes of##2##5##(1994-2#1)(2012-12#1)
the process and##20##3##(1991-1#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#2)
the process are##2##3##(2008-11#1)(2008-9#1)
the process as##2##3##(1992-3#1)(2008-10#1)
the process by which a##2##5##(2008-11#1)(2010-10#1)
the process by which the##2##5##(2008-4#1)(2010-4#1)
the process by which##8##4##(1995-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-10#1)(2010-4#1)(2011-2#1)
the process by##12##3##(1995-2#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2010-10#1)(2010-4#1)(2011-2#1)
the process for the##2##4##(1994-12#1)(2008-11#1)
the process for##7##3##(1994-12#2)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)
the process has##3##3##(1993-3#1)(1995-1#1)(2008-6#1)
the process in##2##3##(2008-10#2)
the process is##6##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
the process leading to##3##4##(1990-11#1)(1990-5#1)(1996-8#1)
the process may be##2##4##(2008-2#1)(2008-8#1)
the process of adaptation##2##4##(2008-1#1)(2009-6#1)
the process of aging##3##4##(1992-9#1)(1993-12#1)(2008-7#1)
the process of assembly##3##4##(1995-2#2)(2009-11#1)
the process of care and##2##5##(1996-3#2)
the process of care related to acute coronary##2##8##(2008-3#2)
the process of care##6##4##(1996-3#2)(1997-1#1)(2008-3#3)
the process of change##2##4##(2008-11#1)(2008-12#1)
the process of determining##3##4##(2008-11#1)(2008-4#1)(2008-9#1)
the process of drug##2##4##(1997-4#1)(2008-4#1)
the process of finding##2##4##(2008-3#1)(2008-7#1)
the process of health care##2##5##(1996-3#1)(2013-1#1)
the process of hologram formation##3##5##(2008-2#3)
the process of improving##2##4##(1996-2#1)(1997-4#1)
the process of medical staff credentialing##2##6##(1993-12#2)
the process of medical##4##4##(1993-12#2)(2012-3#1)(2013-7#1)
the process of planning##2##4##(2008-11#1)(2008-2#1)
the process of reflection##2##4##(2008-11#1)(2008-12#1)
the process of the##6##4##(1994-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#1)
the process of water##2##4##(1991-5#1)(2008-10#1)
the process of##241##3##(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#7)(2008-10#18)(2008-11#20)(2008-12#12)(2008-2#7)(2008-3#11)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#9)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#7)(2012-3#10)(2013-1#6)(2013-7#2)(2013-8#3)
the process that##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
the process the##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
the process through which##2##4##(1993-12#1)(1996-12#1)
the process under##2##3##(1997-2#1)(2008-3#1)
the process used to develop##3##5##(1994-1#1)(1996-2#2)
the process used to##4##4##(1994-1#1)(1995-1#1)(1996-2#2)
the process used##7##3##(1992-2#1)(1994-1#1)(1995-1#1)(1996-12#1)(1996-2#3)
the process was##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
the process##424##2##(1990-11#2)(1990-5#2)(1990-6#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#9)(1993-3#3)(1993-6#3)(1994-1#3)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#4)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#2)(1996-1#3)(1996-12#5)(1996-2#6)(1996-3#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#5)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#12)(2008-10#43)(2008-11#33)(2008-12#16)(2008-2#14)(2008-3#21)(2008-4#5)(2008-5#14)(2008-6#12)(2008-7#14)(2008-8#13)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#4)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#9)(2012-12#5)(2012-2#10)(2012-3#10)(2013-1#9)(2013-7#2)(2013-8#4)
the processed##7##2##(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-1#1)(2013-1#1)
the processes and outcomes of##2##5##(1993-3#1)(2008-8#1)
the processes and##6##3##(1993-3#1)(1994-1#1)(1995-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
the processes associated with##3##4##(1992-12#1)(1992-8#1)(1993-2#1)
the processes by which##2##4##(2007-12#1)(2009-5#1)
the processes involved in##5##4##(1995-2#1)(1996-12#1)(2008-10#2)(2009-2#1)
the processes involved##7##3##(1995-2#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-9#1)(2009-2#1)
the processes occurring##2##3##(1997-3#1)(2008-10#1)
the processes of disease##2##4##(2008-10#1)(2010-3#1)
the processes of ion##2##4##(2008-10#2)
the processes of##29##3##(1993-8#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the processes responsible for these##2##5##(1996-4#1)(2008-11#1)
the processes responsible for##3##4##(1996-4#1)(2007-12#1)(2008-11#1)
the processes taking place##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
the processes that##6##3##(1992-2#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-5#1)
the processes##79##2##(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-3#2)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#12)(2008-11#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#2)(2009-5#3)(2010-3#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
the processing and presentation of##2##5##(1994-11#2)
the processing and##4##3##(1993-11#1)(1994-11#2)(2013-8#1)
the processing of a##2##4##(1992-8#1)(1995-2#1)
the processing of an##2##4##(2008-1#1)(2010-5#1)
the processing of emotional##2##4##(2008-1#1)(2008-4#1)
the processing of the##5##4##(1992-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2013-8#1)
the processing of##42##3##(1990-12#1)(1990-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-6#2)(1995-2#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#2)
the processing##63##2##(1990-12#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-5#2)(1993-6#2)(1994-11#2)(1995-2#1)(1997-6#1)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#3)
the processivity##2##2##(1994-12#1)(1994-8#1)
the processor##2##2##(2008-3#1)(2008-9#1)
the procurement of vascular stents in interventional radiology##3##8##(2012-2#3)
the procurement##4##2##(2012-2#4)
the produced water##5##3##(2008-10#1)(2008-7#2)(2013-1#2)
the produced##21##2##(1990-5#1)(1997-4#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
the producer cell line##2##4##(1990-5#1)(2008-11#1)
the producer##7##2##(1990-5#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#3)
the producers##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
the producing cells##3##3##(1992-9#2)(2010-11#1)
the producing##5##2##(1992-9#3)(1994-2#1)(2010-11#1)
the product and##3##3##(1995-5#1)(2008-5#2)
the product at##2##3##(2008-10#1)(2008-5#1)
the product can##2##3##(2008-10#1)(2012-2#1)
the product formation##2##3##(1991-5#1)(2008-7#1)
the product has been##2##4##(2008-10#1)(2008-11#1)
the product in##3##3##(1991-7#1)(2008-7#1)(2013-1#1)
the product is##3##3##(1994-3#1)(2008-11#1)(2013-1#1)
the product obtained##2##3##(1990-7#1)(2008-10#1)
the product of ORF7##2##4##(2008-10#2)
the product of reaction##2##4##(2008-10#2)
the product of the effective##2##5##(2007-12#1)(2008-3#1)
the product of the enzymatic reaction##2##6##(1990-8#1)(2008-10#1)
the product of the##27##4##(1990-3#1)(1990-5#1)(1990-8#1)(1992-6#2)(1993-8#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#6)(2010-10#1)(2012-12#1)
the product of this gene##2##5##(1993-8#1)(2008-6#1)
the product of this##3##4##(1993-8#1)(1995-8#1)(2008-6#1)
the product of two##2##4##(2008-3#1)(2011-2#1)
the product of which produces a sensitive##2##7##(2008-10#2)
the product of##51##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-11#1)(1992-6#2)(1993-8#2)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#15)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the product terms of the##2##5##(2008-3#1)(2011-2#1)
the product was##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
the product which##2##3##(1990-7#1)(2008-11#1)
the product##137##2##(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#2)(1993-8#2)(1994-3#3)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#7)(2013-1#3)(2013-8#1)
the product(s)##2##2##(1990-5#1)(2008-7#1)
the production and##15##3##(1996-5#1)(2006-6#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the production costs##2##3##(1994-5#1)(2008-12#1)
the production cycle##2##3##(2008-11#1)(2011-2#1)
the production of Anticarsia gemmatalis##2##5##(2008-11#2)
the production of EPO in##2##5##(2008-11#2)
the production of IL-10##2##4##(1996-12#1)(2011-2#1)
the production of IL-2##2##4##(1992-8#2)
the production of MDA##2##4##(1996-2#2)
the production of ROS##4##4##(1994-5#3)(2008-11#1)
the production of a recombinant##2##5##(1994-12#1)(2008-11#1)
the production of a specific##2##5##(2008-10#1)(2012-2#1)
the production of a##22##4##(1990-12#1)(1990-7#2)(1994-12#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
the production of an##5##4##(1991-6#1)(2007-11#1)(2008-10#1)(2010-6#1)(2012-3#1)
the production of antibodies in##2##5##(1990-12#1)(1993-3#1)
the production of antibodies##7##4##(1990-12#1)(1993-3#1)(1995-5#1)(2008-11#2)(2008-5#1)(2011-2#1)
the production of biologically active##2##5##(1993-6#1)(1997-4#1)
the production of both##2##4##(1994-2#1)(2008-11#1)
the production of butanol##3##4##(2013-1#3)
the production of complex##2##4##(2007-12#1)(2008-7#1)
the production of different##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
the production of ethanol##3##4##(2008-6#1)(2008-7#1)(2008-8#1)
the production of foreign##2##4##(1997-4#2)
the production of free radicals##2##5##(1991-12#1)(2008-10#1)
the production of glucose##2##4##(1997-7#1)(2008-10#1)
the production of high##2##4##(1994-11#1)(2008-10#1)
the production of human##2##4##(2008-11#2)
the production of inositol##2##4##(1990-8#1)(1997-1#1)
the production of monoclonal antibodies##2##5##(2008-11#1)(2008-9#1)
the production of monoclonal antibody##2##5##(2008-11#2)
the production of monoclonal##4##4##(2008-11#3)(2008-9#1)
the production of organic acids##2##5##(2008-10#2)
the production of osteocalcin##2##4##(1990-2#2)
the production of reactive oxygen species and##2##7##(2008-4#1)(2013-8#1)
the production of reactive oxygen species##6##6##(1994-5#1)(2008-10#1)(2008-4#1)(2009-12#1)(2013-8#2)
the production of reactive oxygen##7##5##(1994-5#2)(2008-10#1)(2008-4#1)(2009-12#1)(2013-8#2)
the production of recombinant proteins##8##5##(1997-3#1)(2008-11#7)
the production of recombinant##15##4##(1997-3#1)(1997-7#1)(2008-11#13)
the production of secondary##3##4##(2008-10#3)
the production of secreted##2##4##(1992-9#1)(1997-4#1)
the production of singlet oxygen##3##5##(2008-10#1)(2008-5#2)
the production of the cell##2##5##(1992-9#1)(2008-10#1)
the production of the knowledge on the long-lived elderly##2##9##(2012-3#2)
the production of the##13##4##(1991-5#1)(1992-9#1)(1994-2#1)(2008-10#6)(2008-3#1)(2009-2#1)(2012-3#2)
the production of transgenic##3##4##(1995-2#1)(2008-2#1)(2011-2#1)
the production of two##3##4##(1993-12#1)(2009-2#1)(2010-5#1)
the production of various##4##4##(2008-11#2)(2008-4#2)
the production of viral##2##4##(1994-11#1)(2008-11#1)
the production of##347##3##(1990-12#3)(1990-2#2)(1990-7#3)(1990-8#1)(1991-12#4)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#5)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#9)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#4)(2008-1#4)(2008-10#56)(2008-11#56)(2008-12#7)(2008-2#6)(2008-3#5)(2008-4#9)(2008-5#8)(2008-6#15)(2008-7#13)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-2#8)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#5)
the production phase##3##3##(2008-11#3)
the production plant##2##3##(2008-10#1)(2012-2#1)
the production process##5##3##(2008-11#2)(2012-2#2)(2013-8#1)
the production team##2##3##(2008-11#1)(2008-12#1)
the production##410##2##(1990-12#3)(1990-2#2)(1990-7#3)(1990-8#1)(1991-12#4)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#9)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#2)(2007-11#2)(2007-12#4)(2007-4#1)(2008-1#4)(2008-10#63)(2008-11#70)(2008-12#9)(2008-2#6)(2008-3#6)(2008-4#12)(2008-5#10)(2008-6#17)(2008-7#14)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#3)(2010-2#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-2#12)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#11)
the productions##3##2##(2008-11#1)(2012-3#2)
the productive binding##3##3##(1990-7#2)(1992-6#1)
the productive##7##2##(1990-7#2)(1991-6#1)(1992-6#1)(1993-11#1)(2008-1#1)(2013-1#1)
the productivity and##2##3##(1994-12#1)(2012-3#1)
the productivity of##13##3##(1995-3#1)(2008-10#2)(2008-11#5)(2008-6#2)(2008-7#2)(2012-1#1)
the productivity per##2##3##(2008-11#2)
the productivity##21##2##(1990-11#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-11#10)(2008-6#2)(2008-7#2)(2012-1#1)(2012-3#1)
the products are##2##3##(2008-4#1)(2011-2#1)
the products formed##3##3##(1992-2#1)(2008-10#2)
the products obtained##2##3##(2008-10#1)(2010-12#1)
the products of an##2##4##(1997-8#1)(2008-4#1)
the products of the##5##4##(1991-12#1)(1992-12#1)(1994-12#1)(2008-10#2)
the products of##21##3##(1991-12#2)(1992-12#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)
the products to##2##3##(2010-12#1)(2011-2#1)
the products were##3##3##(1991-2#1)(1995-6#1)(2008-4#1)
the products##61##2##(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-8#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-12#2)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#3)(2011-2#3)(2012-2#1)(2013-8#1)
the profession and##4##3##(1993-1#1)(1994-12#1)(2008-12#1)(2012-3#1)
the profession of##2##3##(1996-1#1)(2008-12#1)
the profession##27##2##(1991-2#1)(1992-12#1)(1993-1#3)(1993-2#1)(1994-12#3)(1995-1#2)(1996-1#2)(2008-1#1)(2008-11#2)(2008-12#3)(2008-8#1)(2012-3#6)(2013-1#1)
the profession's##3##2##(1992-12#2)(2008-12#1)
the professional and##2##3##(2008-9#1)(2010-3#1)
the professional development of##3##4##(2007-10#1)(2010-9#1)(2013-1#1)
the professional development##4##3##(2007-10#1)(2008-11#1)(2010-9#1)(2013-1#1)
the professional model##2##3##(1992-5#2)
the professional training##2##3##(1990-12#1)(1992-3#1)
the professional##36##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-3#4)(1994-1#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
the professional's##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
the professionals who##3##3##(2008-12#1)(2010-1#2)
the professionals##5##2##(1994-1#1)(2008-12#1)(2010-1#2)(2013-1#1)
the professionals' approach towards them##2##5##(2011-2#2)
the professionals' approach##4##3##(2011-2#4)
the professionals'##5##2##(2011-2#4)(2013-1#1)
the professions##5##2##(1995-1#1)(1996-12#1)(1996-3#1)(2009-10#1)(2012-2#1)
the professor##2##2##(1993-2#1)(2011-1#1)
the profile and##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
the profile of a##2##4##(2007-12#1)(2008-3#1)
the profile of the##7##4##(1996-10#1)(2007-12#1)(2008-3#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
the profile of##25##3##(1991-2#2)(1992-2#1)(1994-9#1)(1995-11#1)(1996-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
the profile##41##2##(1991-2#2)(1992-2#1)(1993-8#1)(1994-9#1)(1995-11#1)(1996-1#2)(1996-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#7)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
the profiles obtained##2##3##(2008-12#1)(2008-5#1)
the profiles of the##4##4##(2008-2#1)(2008-3#2)(2008-7#1)
the profiles of##9##3##(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
the profiles##19##2##(1997-3#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
the profiling##2##2##(2008-10#1)(2010-5#1)
the profound##2##2##(2008-11#1)(2013-1#1)
the progenies##2##2##(2008-10#1)(2008-9#1)
the progenitor of the##2##4##(1991-5#1)(2008-10#1)
the progenitor##6##2##(1991-5#1)(1994-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-12#1)
the progeny of the##4##4##(2008-10#3)(2012-2#1)
the progeny of two##2##4##(2008-10#1)(2012-2#1)
the progeny of##14##3##(2008-10#7)(2008-8#3)(2008-9#1)(2010-8#1)(2012-2#2)
the progeny##21##2##(2008-10#10)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-8#1)(2012-2#2)
the progesterone antagonist RU 486##2##5##(1994-9#1)(2008-4#1)
the progesterone receptor##3##3##(1994-12#1)(2008-4#1)(2009-12#1)
the progesterone##6##2##(1994-12#1)(1994-9#1)(2008-4#3)(2009-12#1)
the prognoses of##2##3##(2011-2#1)(2012-3#1)
the prognosis and##5##3##(1991-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
the prognosis for patients##2##4##(2010-3#1)(2011-2#1)
the prognosis for these patients##2##5##(1995-8#1)(2008-5#1)
the prognosis for##10##3##(1995-8#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#2)(2012-2#1)
the prognosis in##2##3##(1996-11#1)(2013-1#1)
the prognosis is good if##2##5##(1996-8#1)(1996-9#1)
the prognosis is##6##3##(1990-8#1)(1996-8#1)(1996-9#1)(1997-3#1)(2007-8#1)(2011-2#1)
the prognosis of patients with##3##5##(2006-10#1)(2007-10#1)(2012-1#1)
the prognosis of patients##4##4##(2006-10#1)(2007-10#1)(2011-2#1)(2012-1#1)
the prognosis of the##3##4##(1990-2#1)(1993-12#1)(1993-2#1)
the prognosis of these##2##4##(1994-6#1)(2010-8#1)
the prognosis of##23##3##(1990-2#1)(1990-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-3#1)
the prognosis remains##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
the prognosis was poor##2##4##(2007-4#1)(2008-6#1)
the prognosis was##7##3##(1990-5#1)(1991-8#1)(1994-12#1)(1995-8#1)(2007-4#1)(2008-1#1)(2008-6#1)
the prognosis##74##2##(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-3#1)(1991-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#2)(2006-10#2)(2007-10#2)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-8#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
the prognostic significance of##3##4##(1993-9#1)(2008-11#1)(2012-3#1)
the prognostic value of##4##4##(1997-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
the prognostic value##6##3##(1997-8#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)
the prognostic##21##2##(1990-6#1)(1990-9#1)(1993-9#1)(1995-9#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-6#2)(2009-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#3)
the program CHARMM##2##3##(1992-12#1)(1995-5#1)
the program and##3##3##(1993-1#1)(2008-11#1)(2008-6#1)
the program at##2##3##(1991-1#1)(1995-2#1)
the program during##2##3##(1993-3#1)(1997-2#1)
the program for##2##3##(1993-2#1)(1996-2#1)
the program has##5##3##(1991-1#1)(1992-2#1)(1995-12#1)(1996-3#1)(2008-11#1)
the program in the past##2##5##(1992-3#1)(1995-1#1)
the program in the##3##4##(1992-3#1)(1995-1#2)
the program in##4##3##(1992-3#1)(1995-1#3)
the program is##4##3##(1993-12#1)(2008-11#2)(2008-4#1)
the program of##2##3##(2007-8#1)(2008-9#1)
the program to##4##3##(1991-2#1)(1995-12#1)(2008-3#1)(2008-7#1)
the program was##6##3##(1992-1#1)(1993-12#1)(1994-12#1)(1997-2#1)(2008-6#1)(2008-9#1)
the program with##2##3##(2008-11#1)(2008-9#1)
the program##109##2##(1991-1#3)(1991-12#4)(1991-2#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#5)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#5)(1996-3#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-5#1)(2007-6#1)(2007-8#1)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2010-11#1)(2010-7#2)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
the program's##5##2##(1995-6#1)(1996-1#1)(2008-6#3)
the programme and##2##3##(2008-11#1)(2008-12#1)
the programme has##2##3##(2008-8#1)(2012-12#1)
the programme is##3##3##(2008-11#1)(2008-12#2)
the programme was##4##3##(2007-2#1)(2008-7#2)(2012-12#1)
the programme##31##2##(1990-11#1)(1993-6#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#6)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
the programme's##2##2##(2008-11#1)(2008-7#1)
the programmed##2##2##(1994-5#1)(2012-2#1)
the programming rate for the##2##5##(2008-10#2)
the programming##5##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-9#1)
the programs are##2##3##(2008-6#1)(2008-9#1)
the programs of the##2##4##(1997-2#1)(2013-1#1)
the programs##20##2##(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-2#3)(2008-6#2)(2008-7#1)(2008-9#3)(2013-1#2)
the progress and##2##3##(2008-7#1)(2010-12#1)
the progress being made##2##4##(2006-10#1)(2008-5#1)
the progress in##4##3##(2007-11#1)(2008-5#2)(2008-7#1)
the progress made by##2##4##(2008-11#1)(2008-9#1)
the progress made in the##2##5##(2008-5#1)(2011-2#1)
the progress made in understanding the##2##6##(2009-2#1)(2011-1#1)
the progress made in##4##4##(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)
the progress made##6##3##(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
the progress of infection with##2##5##(2008-11#2)
the progress of the##3##4##(1991-9#1)(1993-5#1)(1996-4#1)
the progress of this##2##4##(2008-10#1)(2008-9#1)
the progress of##26##3##(1991-9#1)(1993-5#1)(1996-4#1)(1996-5#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#2)(2012-2#1)(2013-8#1)
the progress that has been made##2##6##(2008-5#1)(2008-8#1)
the progress##51##2##(1991-12#2)(1991-9#1)(1992-8#1)(1993-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#4)(2009-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
the progression and##2##3##(1995-12#1)(2008-10#1)
the progression from##2##3##(2008-1#1)(2012-2#1)
the progression of atherosclerosis##2##4##(2008-1#2)
the progression of cardiac dysfunction##2##5##(2011-2#2)
the progression of cell cycle##2##5##(1997-1#1)(2008-8#1)
the progression of chronic renal##2##5##(1994-3#1)(2008-1#1)
the progression of myopia##5##4##(2012-12#5)
the progression of renal insufficiency##2##5##(1990-5#1)(1990-9#1)
the progression of renal##3##4##(1990-5#1)(1990-9#1)(2007-7#1)
the progression of the disease##3##5##(1993-12#1)(1994-5#1)(1996-6#1)
the progression of the##7##4##(1993-12#2)(1994-5#1)(1996-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
the progression of vascular##2##4##(2007-10#1)(2012-12#1)
the progression of##67##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#5)(2008-10#3)(2008-12#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#6)(2013-1#2)(2013-8#4)
the progression##73##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1993-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#6)(2008-10#4)(2008-12#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#2)(2013-8#5)
the progressive hearing loss##2##4##(2012-2#2)
the progressive loss of##3##4##(1990-3#1)(2008-5#2)
the progressive##26##2##(1990-3#1)(1990-8#1)(1991-8#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#2)
the prohormone##3##2##(1992-12#1)(1993-5#1)(2008-4#1)
the proinflammatory##4##2##(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
the proinsulin##2##2##(1995-5#1)(2008-11#1)
the project and##2##3##(1992-2#1)(2008-1#1)
the project are##4##3##(1993-3#1)(1996-1#1)(2008-11#1)(2008-6#1)
the project of##3##3##(2009-7#1)(2012-2#2)
the project team##3##3##(1995-3#3)
the project to##2##3##(1995-2#1)(2008-4#1)
the project was to##2##4##(1997-4#1)(2012-1#1)
the project was##6##3##(1995-3#1)(1997-4#1)(2010-5#1)(2011-9#2)(2012-1#1)
the project were##2##3##(1995-3#1)(2008-11#1)
the project will##2##3##(2009-10#1)(2012-12#1)
the project##60##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-2#2)(1995-3#6)(1996-1#1)(1996-2#1)(1997-3#4)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#3)(2010-5#2)(2010-8#1)(2011-9#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
the projected grating##2##3##(2008-3#2)
the projected##9##2##(2007-11#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-8#1)(2010-11#1)
the projection lens##2##3##(2008-3#2)
the projection neurons of the##4##5##(1995-12#1)(1996-12#2)(2009-12#1)
the projection of the##2##4##(2008-2#1)(2011-2#1)
the projection of##4##3##(2008-2#1)(2008-3#2)(2011-2#1)
the projection##21##2##(1992-10#2)(1995-12#1)(1996-12#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#8)(2008-5#1)(2009-12#1)(2011-2#1)
the projections##3##2##(1991-1#1)(2008-11#1)(2009-5#1)
the projector##3##2##(2008-3#3)
the projects##7##2##(1994-1#1)(1997-2#1)(2008-1#1)(2008-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the prokaryote##2##2##(2008-10#1)(2008-9#1)
the prokaryotic##7##2##(1993-11#1)(1995-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
the prolactin requirement##2##3##(1994-11#2)
the prolactin##4##2##(1990-11#1)(1994-11#2)(2008-4#1)
the proliferating cells##2##3##(1995-12#1)(2008-5#1)
the proliferating##6##2##(1992-9#1)(1993-8#2)(1995-12#1)(2008-5#1)(2009-9#1)
the proliferation and differentiation of##3##5##(2008-5#3)
the proliferation and differentiation##4##4##(1995-2#1)(2008-5#3)
the proliferation and survival of##2##5##(2013-1#2)
the proliferation and##16##3##(1991-12#1)(1993-3#1)(1995-2#2)(2008-11#5)(2008-5#3)(2011-2#2)(2013-1#2)
the proliferation of cell##2##4##(1996-2#1)(2008-5#1)
the proliferation of malignant cells##2##5##(2010-1#2)
the proliferation of mouse##2##4##(1992-5#1)(2008-11#1)
the proliferation of the human##2##5##(1994-6#1)(2008-4#1)
the proliferation of the##13##4##(1993-9#1)(1994-6#1)(2008-11#5)(2008-4#3)(2008-8#1)(2010-11#1)(2011-1#1)
the proliferation of uterine epithelial cells##3##6##(2008-6#3)
the proliferation of vascular##2##4##(1990-12#1)(1997-1#1)
the proliferation of##78##3##(1990-12#2)(1990-5#2)(1990-7#2)(1991-12#2)(1991-3#1)(1992-2#1)(1992-5#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#3)(2007-12#1)(2008-10#1)(2008-11#18)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#2)(2010-1#2)(2010-11#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
the proliferation rate and##2##4##(2008-11#1)(2008-7#1)
the proliferation rate##4##3##(1995-4#1)(2008-11#1)(2008-5#1)(2008-7#1)
the proliferation##106##2##(1990-12#2)(1990-5#2)(1990-7#2)(1991-12#3)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-2#1)(1997-1#3)(2007-12#1)(2008-10#1)(2008-11#26)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#2)(2010-1#2)(2010-11#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
the proliferative activity of##2##4##(1997-7#1)(2008-11#1)
the proliferative activity##3##3##(1990-8#1)(1997-7#1)(2008-11#1)
the proliferative lymphocytes were##2##4##(2008-9#2)
the proliferative lymphocytes##3##3##(2008-9#3)
the proliferative phase##2##3##(1994-9#1)(2011-2#1)
the proliferative response of human##2##5##(1994-8#1)(1995-12#1)
the proliferative response of##3##4##(1994-8#2)(1995-12#1)
the proliferative response##4##3##(1994-8#2)(1995-12#1)(2008-7#1)
the proliferative##27##2##(1990-8#2)(1991-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-7#1)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#4)(2011-2#2)(2012-2#1)
the proline residues##2##3##(1990-5#1)(1995-6#1)
the proline##3##2##(1990-5#1)(1991-5#1)(1995-6#1)
the proline-rich##2##2##(1991-6#1)(2013-8#1)
the prolongation of the##2##4##(1991-3#1)(2008-8#1)
the prolongation of##4##3##(1991-3#1)(2007-11#1)(2008-11#1)(2008-8#1)
the prolonged##11##2##(1995-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
the prominent role of##3##4##(1990-8#1)(2008-10#1)(2008-6#1)
the prominent##10##2##(1990-8#1)(1991-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
the promise and the##2##4##(1994-12#1)(1996-12#1)
the promise of##14##3##(1996-3#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the promise##20##2##(1994-12#1)(1996-12#1)(1996-3#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the promises and##2##3##(2007-4#1)(2010-7#1)
the promises of##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
the promises##6##2##(2007-4#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-7#1)(2010-9#1)
the promising##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
the promontory stimulation test##2##4##(2008-9#2)
the promontory##4##2##(2008-9#4)
the promoter activity##7##3##(1995-2#2)(1995-6#1)(1997-2#3)(1997-7#1)
the promoter and 5' flanking##2##5##(1991-5#1)(1994-11#1)
the promoter and##7##3##(1990-11#2)(1991-5#1)(1993-6#1)(1994-11#1)(1997-4#1)(2011-2#1)
the promoter for the##2##4##(1992-8#1)(1995-2#1)
the promoter for##3##3##(1992-8#1)(1995-2#1)(1995-6#1)
the promoter in##2##3##(1995-6#1)(1997-2#1)
the promoter of the CYP19a gene##2##6##(2009-7#2)
the promoter of the##8##4##(1995-2#1)(1996-12#1)(2008-11#2)(2009-7#2)(2011-2#1)(2012-12#1)
the promoter of##12##3##(1990-11#1)(1995-2#1)(1996-12#1)(2008-11#2)(2008-9#2)(2009-7#2)(2011-2#1)(2012-12#2)
the promoter region of the human##3##6##(1993-3#1)(1994-6#1)(1997-2#1)
the promoter region of the##7##5##(1992-11#1)(1993-3#1)(1994-6#2)(1995-11#1)(1997-2#1)(1997-7#1)
the promoter region of##13##4##(1991-6#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-6#2)(1995-11#1)(1997-2#1)(1997-7#2)(2009-8#1)(2011-2#1)
the promoter region##23##3##(1991-6#3)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#3)(1994-12#2)(1994-6#2)(1995-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(2009-8#1)(2011-1#1)(2011-2#1)
the promoter regions of##3##4##(1993-3#1)(1997-2#2)
the promoter regions##4##3##(1993-3#1)(1997-2#2)(2012-3#1)
the promoter sequence##2##3##(2011-1#2)
the promoter##86##2##(1990-11#3)(1990-5#1)(1991-5#1)(1991-6#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-11#3)(1994-12#2)(1994-6#2)(1995-11#1)(1995-2#5)(1995-6#3)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#9)(1997-4#3)(1997-6#1)(1997-7#3)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-7#2)(2009-8#1)(2010-3#1)(2011-1#5)(2011-2#4)(2012-12#2)(2012-3#2)
the promoter-proximal##2##2##(1997-6#2)
the promoters for the##2##4##(1990-5#1)(1994-11#1)
the promoters of these##2##4##(2008-7#2)
the promoters of##7##3##(1994-6#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)
the promoters##10##2##(1990-5#1)(1992-11#1)(1994-11#1)(1994-6#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)
the promoting effects of##2##4##(1992-9#2)
the promoting##4##2##(1992-9#2)(1993-9#1)(2008-9#1)
the promotion of healthy##2##4##(2010-10#1)(2011-1#1)
the promotion of##23##3##(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#2)(1996-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
the promotion##24##2##(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#2)(1996-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
the promotor##2##2##(1997-8#1)(2008-8#1)
the prompt##4##2##(1994-5#1)(1996-5#1)(2010-10#1)(2013-1#1)
the prone position##11##3##(1992-11#7)(1992-4#3)(2008-7#1)
the prone sleeping position##3##4##(1992-11#2)(1992-4#1)
the prone##14##2##(1992-11#9)(1992-4#4)(2008-7#1)
the prongs##3##2##(1992-11#1)(2008-7#2)
the pronounced##4##2##(2007-11#1)(2008-10#1)(2009-4#1)(2010-4#1)
the proof of##2##3##(1997-4#1)(2011-9#1)
the proof##3##2##(1997-4#1)(2008-5#1)(2011-9#1)
the proopiomelanocortin##3##2##(1993-5#1)(2008-4#2)
the propagating##9##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
the propagation axis##3##3##(2007-12#1)(2008-3#2)
the propagation constants##2##3##(2008-3#2)
the propagation direction##3##3##(2007-11#2)(2008-3#1)
the propagation distance##2##3##(2007-12#2)
the propagation dynamics of##2##4##(2007-12#2)
the propagation of a##5##4##(2007-11#2)(2008-3#1)(2008-4#1)(2009-6#1)
the propagation of femtosecond pulses##2##5##(2007-11#2)
the propagation of intense##3##4##(2007-12#3)
the propagation of the##4##4##(1994-3#1)(2008-10#1)(2008-3#2)
the propagation of##27##3##(1990-5#1)(1994-3#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)
the propagation properties of the##3##5##(2007-12#2)(2008-3#1)
the propagation properties of##4##4##(2007-12#2)(2008-3#2)
the propagation properties##5##3##(2007-12#2)(2008-3#3)
the propagation vector##2##3##(2007-12#1)(2008-2#1)
the propagation##71##2##(1990-5#1)(1991-12#3)(1993-11#1)(1994-3#1)(2007-11#10)(2007-12#14)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#24)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-6#1)(2011-2#1)
the propagator##2##2##(2007-11#2)
the propanol vapor##2##3##(2008-3#2)
the propellant##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
the propensity for##3##3##(1993-6#1)(2008-8#1)(2013-1#1)
the propensity of##7##3##(1991-9#1)(1997-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-1#1)
the propensity score##3##3##(2010-3#1)(2011-1#2)
the propensity to##3##3##(1993-6#1)(2008-4#1)(2009-7#1)
the propensity##16##2##(1991-9#1)(1993-6#2)(1997-2#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-7#2)(2010-3#1)(2011-1#3)(2013-1#1)
the propeptide##5##2##(1991-9#2)(1995-3#3)
the proper assessment##2##3##(1991-3#1)(2008-11#1)
the proper balance##2##3##(1991-12#1)(1997-2#1)
the proper care##2##3##(1994-1#1)(1995-2#1)
the proper choice of##2##4##(2007-12#1)(2008-9#1)
the proper choice##3##3##(2007-12#1)(2008-9#2)
the proper management##2##3##(2010-8#2)
the proper name##2##3##(2013-1#2)
the proper optimum##2##3##(2008-10#2)
the proper selection of##2##4##(2008-11#1)(2010-5#1)
the proper structure##2##3##(1992-3#1)(1996-3#1)
the proper use of these##2##5##(2007-11#1)(2010-9#1)
the proper use of##3##4##(1993-12#1)(2007-11#1)(2010-9#1)
the proper##82##2##(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-2#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
the properly##2##2##(2011-2#1)(2012-3#1)
the properties and##2##3##(1995-5#1)(2008-8#1)
the properties of a##4##4##(1993-11#1)(2008-11#1)(2008-2#1)(2008-5#1)
the properties of an##2##4##(1994-11#1)(2008-3#1)
the properties of both##2##4##(1995-5#1)(2007-11#1)
the properties of highly##2##4##(1992-3#1)(2008-2#1)
the properties of interest##2##4##(2008-11#1)(2008-9#1)
the properties of known##2##4##(1994-12#1)(2008-7#1)
the properties of the membrane##3##5##(1993-8#1)(2008-10#1)(2009-5#1)
the properties of the##34##4##(1990-5#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-8#2)(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)(2010-4#1)(2012-12#1)(2013-1#1)
the properties of these##2##4##(2008-11#1)(2008-3#1)
the properties of waveguides##2##4##(2007-11#1)(2008-2#1)
the properties of##105##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-3#3)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#7)(2008-10#11)(2008-11#7)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-4#3)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
the properties that##2##3##(2007-12#1)(2012-2#1)
the properties##115##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-3#3)(1993-11#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#4)(1995-6#1)(1996-1#2)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#8)(2008-10#13)(2008-11#8)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-4#3)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
the property of##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
the property that##2##3##(1990-8#1)(2007-11#1)
the property##6##2##(1990-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-3#1)
the prophase##2##2##(2009-10#2)
the prophylactic efficacy##2##3##(2010-4#1)(2013-1#1)
the prophylactic use of##2##4##(1990-5#1)(1992-11#1)
the prophylactic##6##2##(1990-2#1)(1990-5#1)(1992-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
the prophylaxis and therapy of candidiasis##2##6##(2008-5#2)
the prophylaxis and treatment of##2##5##(1990-6#1)(2007-12#1)
the prophylaxis and##5##3##(1990-6#1)(2007-12#1)(2008-5#2)(2010-8#1)
the prophylaxis of##7##3##(1991-3#1)(1991-5#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-11#1)
the prophylaxis##12##2##(1990-6#1)(1991-3#1)(1991-5#1)(2007-12#1)(2008-5#4)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)
the propofol##2##2##(1993-1#1)(2009-8#1)
the proportion of P##2##4##(2008-10#2)
the proportion of affected relatives of index##2##7##(1992-9#2)
the proportion of ascospores##2##4##(2008-10#2)
the proportion of disease##2##4##(2008-10#2)
the proportion of diseased##2##4##(2008-10#2)
the proportion of each##4##4##(1996-3#1)(2008-10#2)(2008-4#1)
the proportion of elderly##2##4##(2008-7#2)
the proportion of infested##2##4##(2008-10#2)
the proportion of leaflets##3##4##(2008-10#3)
the proportion of overwintering adult corn flea beetles infested with P##2##11##(2008-10#2)
the proportion of patients achieving##3##5##(2010-8#2)(2013-1#1)
the proportion of patients who##2##5##(2008-7#1)(2009-8#1)
the proportion of patients with##4##5##(1997-6#1)(1997-7#1)(2008-7#1)(2012-12#1)
the proportion of patients##10##4##(1997-6#1)(1997-7#1)(2008-7#3)(2009-8#1)(2010-8#2)(2012-12#1)(2013-1#1)
the proportion of philopatric (and thereby altruistic) individuals##2##8##(2008-8#2)
the proportion of pollen tubes reaching the bottom of the style##2##11##(2009-12#2)
the proportion of subjects with no peristalsis##2##7##(2012-2#2)
the proportion of the##6##4##(2008-10#4)(2008-12#1)(2008-8#1)
the proportion of time spent in##2##6##(2008-8#1)(2011-2#1)
the proportion of time spent##3##5##(2008-8#1)(2011-2#1)(2012-2#1)
the proportion of total##7##4##(1990-5#1)(1995-3#1)(2008-10#1)(2008-8#2)(2010-12#1)(2012-2#1)
the proportion of women##3##4##(1991-8#1)(2009-7#1)(2012-3#1)
the proportion of##142##3##(1990-5#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#37)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#1)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#1)
the proportion##149##2##(1990-5#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#38)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#2)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#5)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#7)(2013-8#2)
the proportional hazard assumption of##2##5##(1997-3#2)
the proportional hazard assumption##3##4##(1997-3#3)
the proportional hazards model##3##4##(1997-8#2)(2008-10#1)
the proportional hazards##4##3##(1997-3#1)(1997-8#2)(2008-10#1)
the proportional##13##2##(1991-4#1)(1992-6#1)(1993-9#1)(1997-3#4)(1997-8#2)(2008-10#2)(2008-9#1)(2011-2#1)
the proportions of the elderly population##2##6##(2008-7#2)
the proportions of the##6##4##(1992-6#1)(2008-10#3)(2008-7#2)
the proportions of##15##3##(1990-12#1)(1991-9#1)(1992-6#2)(1992-9#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-7#2)(2009-7#1)
the proportions##18##2##(1990-12#1)(1991-9#2)(1992-6#2)(1992-9#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-7#2)(2009-7#1)
the proposal that##9##3##(1990-10#1)(1990-11#1)(1990-5#1)(1994-11#1)(1997-2#2)(2009-4#1)(2009-5#1)(2013-8#1)
the proposal##17##2##(1990-10#1)(1990-11#1)(1990-5#1)(1992-2#5)(1994-11#1)(1997-2#2)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2010-4#1)(2013-8#1)
the proposals##2##2##(1992-1#1)(1997-3#1)
the proposed FI##2##3##(2008-10#2)
the proposed algorithm is##4##4##(2008-10#2)(2008-3#2)
the proposed algorithm##8##3##(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2010-8#1)(2012-2#1)
the proposed analysis##2##3##(2008-3#1)(2008-5#1)
the proposed and##3##3##(2008-10#3)
the proposed approach and##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
the proposed approach##17##3##(2007-11#1)(2008-10#7)(2008-3#2)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
the proposed architecture##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-8#1)
the proposed biosensor##3##3##(2008-10#3)
the proposed conditions##2##3##(2008-10#2)
the proposed criteria##2##3##(2006-10#1)(2012-3#1)
the proposed design##2##3##(2010-8#1)(2011-2#1)
the proposed diet##3##3##(2008-3#3)
the proposed electrode##3##3##(2008-10#3)
the proposed electrodes##4##3##(2008-10#4)
the proposed flow##4##3##(2008-10#4)
the proposed flow-injection##2##3##(2008-10#2)
the proposed framework##3##3##(2008-7#1)(2012-2#2)
the proposed genus##2##3##(2008-10#1)(2011-2#1)
the proposed mechanism##3##3##(2008-10#2)(2009-10#1)
the proposed method a##2##4##(2008-10#2)
the proposed method agreed##2##4##(2008-10#2)
the proposed method and the reference procedure##2##7##(2008-10#2)
the proposed method and the##7##5##(2008-10#7)
the proposed method and##15##4##(2008-10#15)
the proposed method are##8##4##(2008-10#6)(2008-3#2)
the proposed method can##2##4##(2008-10#1)(2013-8#1)
the proposed method could be used for##2##7##(2008-10#1)(2008-5#1)
the proposed method could##4##4##(2008-10#3)(2008-5#1)
the proposed method has been applied to##2##7##(2008-10#2)
the proposed method has been##3##5##(2008-10#3)
the proposed method has##4##4##(2007-12#1)(2008-10#3)
the proposed method in##4##4##(2008-10#4)
the proposed method is compared with##2##6##(2008-10#1)(2008-3#1)
the proposed method is##30##4##(2008-10#22)(2008-2#2)(2008-3#5)(2012-3#1)
the proposed method was successfully applied to the##2##8##(2008-10#1)(2012-1#1)
the proposed method was##26##4##(2008-10#23)(2012-1#3)
the proposed method were##5##4##(2008-10#5)
the proposed method with those##2##5##(2008-10#2)
the proposed method with##3##4##(2008-10#2)(2009-5#1)
the proposed method yielded results##2##5##(2008-10#2)
the proposed method##186##3##(2007-11#1)(2007-12#2)(2008-10#152)(2008-2#4)(2008-3#14)(2008-5#1)(2008-9#1)(2009-5#3)(2010-2#1)(2012-1#3)(2012-3#2)(2013-8#2)
the proposed methodology was##3##4##(2008-10#3)
the proposed methodology##13##3##(2008-10#12)(2008-2#1)
the proposed methods##13##3##(2008-10#7)(2008-3#1)(2008-6#1)(2008-8#2)(2010-11#1)(2012-3#1)
the proposed model and##2##4##(2008-10#1)(2009-8#1)
the proposed model##15##3##(1994-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2013-1#2)
the proposed models and##2##4##(2009-5#1)(2009-8#1)
the proposed models##5##3##(1996-3#1)(2008-10#2)(2009-5#1)(2009-8#1)
the proposed nutrition##2##3##(1996-1#2)
the proposed on-line##2##3##(2008-10#2)
the proposed optical system##2##4##(2008-2#2)
the proposed optical##4##3##(2008-2#3)(2008-3#1)
the proposed procedure and##3##4##(2008-10#3)
the proposed procedure can##2##4##(2008-10#2)
the proposed procedure had##2##4##(2008-10#2)
the proposed procedure is##3##4##(2008-10#3)
the proposed procedure were##4##4##(2008-10#4)
the proposed procedure##28##3##(2008-10#25)(2008-3#1)(2008-6#1)(2009-9#1)
the proposed procedures##3##3##(2007-11#1)(2009-10#1)(2013-1#1)
the proposed regulations##2##3##(1991-2#1)(1993-3#1)
the proposed representation##2##3##(2012-2#1)(2013-8#1)
the proposed scheme##4##3##(2007-12#2)(2008-3#2)
the proposed sensor##7##3##(2008-10#6)(2008-3#1)
the proposed sensors##2##3##(2008-10#2)
the proposed spectrophotometric##2##3##(2008-10#2)
the proposed structure##3##3##(2008-10#1)(2008-3#2)
the proposed system can##2##4##(2008-3#1)(2010-8#1)
the proposed system is##6##4##(2008-10#2)(2008-2#1)(2008-3#3)
the proposed system##26##3##(1994-2#2)(2007-11#2)(2008-10#12)(2008-2#1)(2008-3#8)(2010-8#1)
the proposed technique and##2##4##(2008-3#2)
the proposed technique is also##2##5##(2008-3#1)(2008-6#1)
the proposed technique##19##3##(2007-11#2)(2008-10#7)(2008-2#2)(2008-3#7)(2008-6#1)
the proposed techniques are##2##4##(2008-2#1)(2008-3#1)
the proposed techniques##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
the proposed test##2##3##(1997-7#1)(2013-1#1)
the proposed treatment##4##3##(1997-8#4)
the proposed##593##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#2)(1995-9#1)(1996-1#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#5)(2006-10#1)(2007-11#9)(2007-12#11)(2008-10#326)(2008-11#5)(2008-2#30)(2008-3#65)(2008-5#4)(2008-6#7)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#5)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#9)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#8)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#8)(2013-8#4)
the proposita##6##2##(1992-12#5)(1997-3#1)
the proposition that the##2##4##(1991-5#1)(2012-2#1)
the proposition that##7##3##(1991-5#1)(1993-3#1)(2008-10#1)(2009-11#3)(2012-2#1)
the proposition##9##2##(1991-5#1)(1993-3#1)(2007-11#1)(2008-10#1)(2009-11#3)(2012-2#1)(2013-8#1)
the propranolol##3##2##(2009-8#2)(2011-2#1)
the propriety of##2##3##(1994-3#1)(1995-5#1)
the proprioceptors##2##2##(1997-3#1)(2009-1#1)
the propylene oxide production##2##4##(2008-6#2)
the propylene oxide##3##3##(2008-6#3)
the propylene##4##2##(2008-5#1)(2008-6#3)
the proregion##2##2##(1995-6#2)
the pros and cons of each##2##6##(2008-4#1)(2011-2#1)
the pros and cons of the##4##6##(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
the pros and cons of these##3##6##(2011-1#1)(2011-2#1)(2013-1#1)
the pros and cons of##14##5##(1992-1#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the pros and cons##16##4##(1992-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the pros##17##2##(1992-1#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the prospect of greater##2##4##(2008-10#1)(2008-7#1)
the prospect of##10##3##(1991-12#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2012-12#1)(2012-3#1)
the prospect##13##2##(1991-12#1)(1993-12#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2010-12#1)(2012-12#1)(2012-3#1)
the prospective payment system (PPS)##3##5##(1991-2#1)(1992-12#2)
the prospective payment system##13##4##(1991-1#1)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-11#1)
the prospective payment##14##3##(1991-1#2)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-11#1)
the prospective##19##2##(1991-1#2)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-12#1)
the prospects are##2##3##(2008-1#1)(2008-3#1)
the prospects for##10##3##(1990-11#1)(1994-12#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)
the prospects of##4##3##(1997-7#1)(2008-4#1)(2011-7#1)(2013-1#1)
the prospects##17##2##(1990-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-7#1)(2013-1#1)
the prostate gland##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
the prostate specific antigen##2##4##(1994-12#2)
the prostate##23##2##(1990-9#2)(1991-8#2)(1993-8#2)(1994-11#1)(1994-12#2)(1995-3#1)(1995-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-3#2)(2013-1#1)
the prostheses##2##2##(1991-3#1)(2009-1#1)
the prosthesis was##2##3##(2009-3#1)(2009-4#1)
the prosthesis##15##2##(1991-2#2)(1997-6#1)(2007-8#3)(2008-11#1)(2009-1#1)(2009-3#2)(2009-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
the prosthetic group##3##3##(1992-10#1)(1995-3#1)(2008-12#1)
the prosthetic##8##2##(1992-10#1)(1993-2#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-6#1)(2013-8#1)
the protease is##2##3##(1991-9#1)(2008-10#1)
the protease was##2##3##(2008-10#2)
the protease##22##2##(1991-12#1)(1991-9#1)(1992-11#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
the protease-binding##2##2##(1991-11#2)
the proteasomal##3##2##(2008-7#1)(2008-8#2)
the proteasome##7##2##(2008-4#1)(2008-8#4)(2009-7#1)(2013-1#1)
the protectant##2##2##(2008-10#2)
the protected##8##2##(1990-11#1)(1992-12#1)(1995-3#1)(2008-10#2)(2008-3#1)(2013-7#2)
the protection afforded##2##3##(1994-3#1)(2008-5#1)
the protection against W-CI##2##4##(2008-10#2)
the protection against##8##3##(2008-10#3)(2008-11#2)(2008-5#1)(2011-1#1)(2013-8#1)
the protection and##2##3##(1997-1#1)(2013-1#1)
the protection from##2##3##(1994-10#1)(1995-12#1)
the protection of the##6##4##(1995-5#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2013-7#1)
the protection of women and children##2##6##(1990-2#2)
the protection of##17##3##(1990-2#2)(1992-3#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-4#1)(2011-3#1)(2013-7#1)
the protection was##3##3##(2008-10#2)(2013-1#1)
the protection##41##2##(1990-2#2)(1992-3#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#11)(2008-11#4)(2008-5#4)(2008-7#2)(2009-5#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the protective action of##2##4##(1996-2#1)(2008-11#1)
the protective effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion##2##13##(1995-12#2)
the protective effect of male circumcision from HIV infection and##2##10##(2011-1#2)
the protective effect of the##3##5##(1995-12#1)(2008-10#1)(2013-8#1)
the protective effect of##17##4##(1993-2#1)(1995-12#3)(1996-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
the protective effect##19##3##(1993-2#1)(1993-6#1)(1995-12#4)(1996-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
the protective effects of family##2##5##(2010-7#1)(2013-1#1)
the protective effects of##6##4##(1994-2#1)(1994-6#1)(2009-7#1)(2010-7#1)(2012-12#1)(2013-1#1)
the protective effects##8##3##(1994-2#1)(1994-6#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-12#1)(2013-1#1)
the protective efficacy##3##3##(1995-5#1)(2008-5#2)
the protective function##2##3##(2007-11#1)(2013-1#1)
the protective role of##4##4##(2009-6#1)(2013-1#3)
the protective time##3##3##(2008-10#3)
the protective##56##2##(1991-1#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#4)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#5)(2008-7#3)(2008-8#3)(2009-6#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
the protein and lipid##4##4##(1993-11#2)(2008-5#1)(2008-9#1)
the protein and mRNA##2##4##(1992-3#1)(2010-1#1)
the protein and the##5##4##(1992-6#1)(1994-3#1)(1997-2#2)(2009-3#1)
the protein and##22##3##(1990-7#2)(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)
the protein as well as##2##5##(1990-8#1)(2011-2#1)
the protein as##7##3##(1990-5#1)(1990-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(2008-8#1)(2011-2#1)
the protein band##2##3##(2010-3#2)
the protein by##5##3##(1990-5#1)(1991-9#1)(1996-3#1)(1997-2#1)(2008-1#1)
the protein can##3##3##(1997-4#1)(2008-1#1)(2012-12#1)
the protein coding##2##3##(1993-6#1)(1997-4#1)
the protein complexes##2##3##(2008-10#1)(2008-7#1)
the protein components of##2##4##(2008-2#1)(2010-11#1)
the protein components##4##3##(2008-2#1)(2008-7#1)(2010-11#1)(2013-8#1)
the protein composition of##2##4##(1991-2#1)(2008-9#1)
the protein composition##4##3##(1991-2#1)(2008-1#1)(2008-9#1)(2010-11#1)
the protein concentration and##2##4##(1990-7#1)(2009-7#1)
the protein concentration##4##3##(1990-7#1)(1991-11#1)(2008-1#1)(2009-7#1)
the protein content##4##3##(1990-7#1)(2008-4#1)(2010-11#1)(2013-1#1)
the protein core##3##3##(1993-2#1)(1995-5#1)(2009-8#1)
the protein could##2##3##(1990-11#1)(1996-5#1)
the protein encoded by the##3##5##(1993-12#1)(1994-3#1)(1994-6#1)
the protein encoded by##4##4##(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)
the protein encoded##5##3##(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)
the protein expression##4##3##(1993-6#1)(2008-12#1)(2010-12#1)(2013-8#1)
the protein fraction##5##3##(1994-11#2)(2008-10#2)(2011-2#1)
the protein from##5##3##(1992-3#1)(1993-9#1)(2008-10#1)(2008-8#1)(2009-12#1)
the protein has been##2##4##(1991-2#1)(1995-6#1)
the protein has##3##3##(1991-2#1)(1995-6#1)(2009-3#1)
the protein in##9##3##(1991-2#2)(1992-3#1)(1993-6#1)(1995-3#1)(1997-3#1)(2008-10#1)(2009-12#1)(2011-2#1)
the protein is not##2##4##(1992-6#1)(1993-8#1)
the protein is##20##3##(1990-12#1)(1990-7#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-2#2)(2008-4#2)(2008-5#1)(2009-5#1)(2012-12#1)
the protein kinase C (PKC)##5##5##(1990-5#1)(1992-9#1)(1993-6#1)(1995-8#1)(2013-1#1)
the protein kinase C inhibitor##2##5##(1994-11#1)(1995-6#1)
the protein kinase C pathway##2##5##(1995-12#1)(2008-1#1)
the protein kinase C##13##4##(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-1#1)(2013-1#1)
the protein kinase inhibitor##2##4##(1997-2#1)(2008-10#1)
the protein kinase##21##3##(1990-5#1)(1991-2#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#3)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
the protein kinases##2##3##(1994-2#1)(2013-7#1)
the protein level of##2##4##(1997-1#1)(2008-9#1)
the protein level##9##3##(1990-5#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-10#1)(2013-1#1)
the protein levels of##2##4##(2008-11#1)(2011-2#1)
the protein levels##5##3##(1995-5#1)(2008-11#2)(2008-8#1)(2011-2#1)
the protein matrix##4##3##(1990-8#1)(1994-5#1)(2009-6#2)
the protein may be##2##4##(1991-2#1)(1993-8#1)
the protein may##4##3##(1991-2#1)(1993-8#1)(2008-8#1)(2008-9#1)
the protein of interest##6##4##(1992-5#1)(2008-1#2)(2008-4#2)(2008-9#1)
the protein of##7##3##(1992-5#1)(2008-1#2)(2008-12#1)(2008-4#2)(2008-9#1)
the protein part##2##3##(2009-8#2)
the protein phosphorylation##2##3##(1990-12#2)
the protein product##2##3##(1993-12#1)(2008-9#1)
the protein sequence##7##3##(1992-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-11#1)(2011-2#1)
the protein structure##7##3##(1995-2#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-9#1)
the protein substrate##4##3##(1992-11#2)(1995-2#2)
the protein surface##3##3##(1990-5#1)(1995-2#1)(2008-8#1)
the protein synthesis inhibitors##2##4##(1991-5#1)(1994-9#1)
the protein synthesis##3##3##(1991-5#1)(1994-9#1)(2008-11#1)
the protein that##4##3##(1993-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
the protein to the##3##4##(1990-5#2)(1992-3#1)
the protein to##9##3##(1990-5#2)(1991-7#1)(1992-3#1)(1994-11#1)(1995-5#1)(2008-4#1)(2008-9#1)(2012-1#1)
the protein was##12##3##(1990-11#1)(1990-5#2)(1991-9#1)(1992-7#1)(1993-3#1)(1993-9#1)(1997-2#2)(1997-4#1)(2011-2#1)(2013-7#1)
the protein were##3##3##(1993-2#1)(2008-9#1)(2009-11#1)
the protein with##4##3##(1991-5#1)(1994-8#1)(2008-8#1)(2012-2#1)
the protein##452##2##(1990-11#3)(1990-12#8)(1990-2#3)(1990-5#12)(1990-7#6)(1990-8#9)(1991-11#1)(1991-12#1)(1991-2#7)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#4)(1992-11#2)(1992-12#5)(1992-3#10)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#7)(1992-9#1)(1993-11#11)(1993-12#6)(1993-2#4)(1993-3#3)(1993-6#5)(1993-8#5)(1993-9#2)(1994-11#8)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#13)(1994-6#2)(1994-8#11)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#11)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#14)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#8)(2008-10#35)(2008-11#13)(2008-12#2)(2008-2#10)(2008-3#2)(2008-4#23)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#15)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#1)(2010-2#3)(2010-3#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#4)(2013-7#2)(2013-8#3)
the protein's##10##2##(1995-11#2)(1995-2#2)(1997-2#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-10#1)
the protein(s)##4##2##(1992-12#1)(1992-3#1)(1995-8#1)(1997-4#1)
the protein-bound##3##2##(1991-12#1)(1991-9#1)(2010-6#1)
the protein-coding genes##2##3##(2008-7#1)(2011-2#1)
the protein-coding##4##2##(1997-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
the protein-ligand##2##2##(1997-2#1)(2011-3#1)
the protein-tyrosine phosphorylation##2##3##(1992-8#1)(1993-11#1)
the proteinaceous##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
the proteinase##8##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1992-9#1)(1996-2#2)(2008-11#1)
the proteinases##5##2##(1990-5#2)(1993-11#2)(1994-6#1)
the proteins and##2##3##(2008-8#1)(2009-5#1)
the proteins in the##5##4##(1990-11#1)(1990-12#1)(1995-6#1)(2008-10#1)(2008-6#1)
the proteins in##7##3##(1990-11#1)(1990-12#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-6#2)
the proteins involved##2##3##(2008-4#1)(2008-7#1)
the proteins of interest##4##4##(1994-5#1)(2008-4#2)(2008-7#1)
the proteins of the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the proteins of##10##3##(1994-5#1)(1997-6#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2011-2#1)
the proteins that##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
the proteins were##4##3##(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)
the proteins with an alanine substituted at position##2##8##(1992-6#2)
the proteins with an alanine substituted##3##6##(1992-6#3)
the proteins##84##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#2)(1992-6#3)(1993-11#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(2008-1#2)(2008-10#14)(2008-2#1)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#1)
the proteins'##2##2##(1995-5#1)(2008-9#1)
the proteolipid protein##2##3##(1993-6#1)(2008-7#1)
the proteolysis##2##2##(1992-11#1)(1993-11#1)
the proteolytic activity of##2##4##(1992-11#1)(2010-12#1)
the proteolytic activity##5##3##(1992-11#1)(1992-9#2)(2008-6#1)(2010-12#1)
the proteolytic enzyme##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
the proteolytic processing##3##3##(1990-8#1)(1991-9#1)(2007-12#1)
the proteolytic##17##2##(1990-5#1)(1990-8#1)(1991-9#2)(1992-11#1)(1992-9#2)(1994-11#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
the proteome of##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-3#1)
the proteome profiles of##2##4##(2009-6#2)
the proteome##11##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-12#1)(2010-6#1)(2011-3#1)
the proteomic##3##2##(2008-11#1)(2010-12#2)
the proteosomes##2##2##(1990-12#2)
the protexin##2##2##(2010-4#2)
the prothoracic glands##2##3##(1995-11#1)(2008-6#1)
the prothoracic##3##2##(1995-11#2)(2008-6#1)
the protocerebral commissure##3##3##(2007-12#3)
the protocerebral##4##2##(2007-12#4)
the protocerebrum##6##2##(2007-12#5)(2008-9#1)
the protocol for##2##3##(1997-2#1)(2008-4#1)
the protocol is##2##3##(2008-10#1)(2008-9#1)
the protocol to other##2##4##(2008-9#1)(2013-8#1)
the protocol to##4##3##(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
the protocol will##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
the protocol with##2##3##(2009-2#1)(2011-2#1)
the protocol##31##2##(1991-6#1)(1992-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#2)(2010-3#1)(2011-2#4)(2012-3#2)(2013-8#1)
the protocols described##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
the protocols for##3##3##(2008-4#1)(2008-9#2)
the protocols##22##2##(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#6)(2011-2#1)
the protoderm##2##2##(2008-5#1)(2012-1#1)
the protolytic constants##3##3##(2008-10#3)
the protolytic##4##2##(2008-10#4)
the proton gradient##2##3##(1990-2#1)(2008-11#1)
the proton translocation activity of F(0) vesicles##2##7##(2008-8#2)
the proton translocation##3##3##(2008-8#3)
the proton##20##2##(1990-12#1)(1990-2#1)(1990-8#2)(1994-11#1)(1995-2#1)(1995-5#2)(2008-10#4)(2008-11#2)(2008-8#3)(2008-9#1)(2012-12#2)
the protonated amino##2##3##(1995-6#1)(2008-10#1)
the protonated form##3##3##(1991-5#1)(2008-10#2)
the protonated##14##2##(1991-5#1)(1992-6#2)(1995-5#2)(1995-6#1)(2008-10#7)(2009-11#1)
the protonation constants##2##3##(2008-10#2)
the protonation of##5##3##(1991-8#1)(1992-6#1)(2008-10#3)
the protonation##10##2##(1991-8#1)(1992-6#1)(2008-10#7)(2009-9#1)
the protoplasts##2##2##(2008-8#1)(2008-9#1)
the protoporphyrine IX##3##3##(2008-11#3)
the prototype BEF-1 sequence##2##4##(1995-6#2)
the prototype of a##3##4##(1994-9#1)(1996-7#1)(2008-9#1)
the prototype of##6##3##(1994-9#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
the prototype##18##2##(1994-9#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-3#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)
the prototypes##2##2##(2008-5#1)(2010-12#1)
the prototypic##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
the prototypical##3##2##(2008-7#1)(2010-12#1)(2012-2#1)
the protozoa##2##2##(2013-1#2)
the protozoan parasite Entamoeba histolytica##2##5##(2009-7#1)(2009-8#1)
the protozoan parasite##3##3##(2009-6#1)(2009-7#1)(2009-8#1)
the protozoan##8##2##(1992-2#1)(1993-9#2)(2007-12#2)(2009-6#1)(2009-7#1)(2009-8#1)
the proven##2##2##(2008-10#1)(2009-6#1)
the provenance of the cell line##2##6##(2008-11#2)
the provenance of the##3##4##(2008-10#1)(2008-11#2)
the provenance##4##2##(2008-10#2)(2008-11#2)
the provided##2##2##(2008-10#2)
the provider and##2##3##(1995-1#1)(1997-2#1)
the provider community##2##3##(1994-2#1)(1996-2#1)
the provider##16##2##(1993-12#4)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-1#1)(2013-8#1)
the provider's##4##2##(1994-3#1)(2008-11#2)(2013-8#1)
the providers and##2##3##(1996-1#1)(2008-1#1)
the providers of##2##3##(1994-3#1)(1996-2#1)
the providers##6##2##(1994-3#1)(1996-1#1)(1996-2#1)(2008-1#1)(2011-2#1)(2013-8#1)
the providers'##4##2##(1994-1#1)(1994-2#1)(1996-2#1)(2013-8#1)
the province of Misiones##2##4##(2008-5#2)
the province of##26##3##(1992-8#1)(1994-9#2)(1996-3#1)(1996-6#1)(1997-5#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-5#4)(2008-8#2)(2009-10#2)(2009-7#3)(2012-12#1)(2013-1#1)
the province##40##2##(1990-9#1)(1992-10#4)(1992-8#1)(1994-1#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#2)(2009-10#2)(2009-7#3)(2012-12#3)(2013-1#3)
the provinces##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-12#1)
the provincial##8##2##(1991-1#1)(1992-2#1)(1994-12#1)(1995-2#1)(1997-5#1)(2008-8#1)(2012-12#2)
the provision of a##2##4##(1994-2#1)(2008-10#1)
the provision of adequate##2##4##(2008-1#1)(2008-11#1)
the provision of appropriate##2##4##(1995-9#1)(2008-11#1)
the provision of care##2##4##(1995-3#1)(1997-8#1)
the provision of good##2##4##(2008-11#1)(2012-12#1)
the provision of health care services##2##6##(1992-3#1)(1995-2#1)
the provision of health care##4##5##(1992-3#1)(1995-2#1)(1996-3#1)(2012-12#1)
the provision of mental health##2##5##(1994-1#1)(2008-12#1)
the provision of outpatient##2##4##(1993-12#1)(2012-2#1)
the provision of quality##2##4##(1992-2#1)(1994-2#1)
the provision of services##4##4##(1990-2#1)(1993-2#1)(1996-3#1)(2007-12#1)
the provision of specialized##2##4##(1993-2#1)(2008-11#1)
the provision of the##2##4##(1995-1#1)(2012-3#1)
the provision of##68##3##(1990-2#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#3)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
the provision##70##2##(1990-2#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#3)(2008-7#2)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
the provisional##2##2##(1992-12#1)(2013-1#1)
the provisions of the##4##4##(1991-1#1)(1992-1#1)(1993-2#1)(1994-3#1)
the provisions##7##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)
the provocation##3##2##(1990-6#1)(2010-6#1)(2012-3#1)
the provocative##2##2##(2008-4#1)(2008-7#1)
the proximal and distal##3##4##(1997-8#1)(2008-6#1)(2012-12#1)
the proximal and mid left anterior descending artery##2##8##(2008-11#2)
the proximal and middle##2##4##(1992-5#1)(2013-8#1)
the proximal and##7##3##(1992-5#1)(1997-8#1)(2008-11#2)(2008-6#1)(2012-12#1)(2013-8#1)
the proximal composition##2##3##(2012-2#2)
the proximal end of the##4##5##(1995-6#1)(2007-11#1)(2007-8#1)(2008-6#1)
the proximal end of##5##4##(1995-6#1)(2007-11#1)(2007-8#1)(2008-6#1)(2013-8#1)
the proximal end##6##3##(1995-6#1)(2007-11#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-8#1)
the proximal ends of##2##4##(2007-11#1)(2008-5#1)
the proximal epiphysis of the femur##5##6##(2007-11#3)(2007-8#2)
the proximal epiphysis of the##6##5##(2007-11#4)(2007-8#2)
the proximal epiphysis##7##3##(2007-11#5)(2007-8#2)
the proximal femur##13##3##(2007-11#8)(2007-8#1)(2008-6#2)(2009-3#1)(2013-1#1)
the proximal histidine##3##3##(1994-5#1)(1995-2#2)
the proximal humerus of##2##4##(1996-11#1)(2012-3#1)
the proximal humerus##7##3##(1996-11#1)(2007-8#2)(2008-6#3)(2012-3#1)
the proximal interphalangeal##3##3##(2008-9#2)(2011-2#1)
the proximal ligand##2##3##(1994-5#2)
the proximal part of the##2##5##(1991-5#1)(1993-12#1)
the proximal part of##4##4##(1991-5#1)(1993-12#1)(2007-11#1)(2012-2#1)
the proximal part##5##3##(1991-5#1)(1993-12#1)(2007-11#1)(2009-3#1)(2012-2#1)
the proximal portion of the##3##5##(1993-8#1)(2008-7#1)(2011-2#1)
the proximal portion of##5##4##(1993-8#1)(1995-12#1)(1996-8#1)(2008-7#1)(2011-2#1)
the proximal portion##6##3##(1993-8#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-7#1)(2011-2#1)
the proximal region of##2##4##(1993-2#1)(2008-10#1)
the proximal surfaces##2##3##(2008-12#2)
the proximal tubular##3##3##(1994-5#1)(2007-12#1)(2011-2#1)
the proximal tubule##2##3##(1994-5#1)(2008-11#1)
the proximal##115##2##(1990-8#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-8#2)(1994-12#1)(1994-5#7)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#16)(2007-12#3)(2007-8#7)(2008-10#2)(2008-11#3)(2008-12#3)(2008-5#1)(2008-6#7)(2008-7#4)(2008-9#3)(2009-1#1)(2009-3#3)(2009-5#1)(2010-12#2)(2010-3#4)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the proximate biochemical composition and fatty acid##2##7##(2010-11#2)
the proximate##7##2##(1991-5#1)(1992-11#1)(2008-8#1)(2010-11#2)(2010-2#1)(2013-1#1)
the proximity of the##2##4##(2008-11#1)(2011-2#1)
the proximity of##9##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
the proximity##10##2##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
the proxy##2##2##(2011-1#2)
the psbA-trnH##2##2##(2011-2#2)
the psbP gene##2##3##(1996-10#2)
the pseudo-first-order rate##2##3##(1993-8#1)(1994-8#1)
the pseudo-first-order##3##2##(1992-5#1)(1993-8#1)(1994-8#1)
the pseudoaneurysm##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
the pseudocysts##3##2##(1991-8#2)(2013-1#1)
the pseudogene contained##2##3##(1990-8#1)(1997-4#1)
the pseudogene##5##2##(1990-8#2)(1995-11#1)(1997-4#2)
the pseudogenes##4##2##(1990-8#2)(1991-6#2)
the pseudosubstrate##3##2##(1992-9#3)
the psoas##6##2##(1991-3#1)(1996-6#1)(2008-10#2)(2009-2#1)(2009-4#1)
the psychiatric hospital##2##3##(1991-12#1)(1993-2#1)
the psychiatric##22##2##(1991-11#1)(1991-12#1)(1992-2#3)(1993-2#2)(1993-6#1)(1996-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
the psychiatrist##2##2##(2012-12#2)
the psychoactive##2##2##(2008-7#2)
the psychoanalytic##2##2##(2008-4#2)
the psychobiological##3##2##(2008-1#1)(2008-4#1)(2009-9#1)
the psychological and##4##3##(1993-12#1)(1994-9#1)(2008-2#1)(2009-11#1)
the psychological aspects##3##3##(2008-12#1)(2010-11#1)(2013-1#1)
the psychological impact of##2##4##(2008-12#1)(2008-4#1)
the psychological process##3##3##(1990-10#3)
the psychological well-being of the##2##5##(2008-11#1)(2013-1#1)
the psychological##31##2##(1990-10#3)(1993-12#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2009-11#1)(2009-7#1)(2010-11#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#2)
the psychology of##2##3##(2008-12#1)(2013-8#1)
the psychometric properties of the##7##5##(2008-11#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
the psychometric properties of##11##4##(1996-3#1)(2008-11#2)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
the psychometric properties##12##3##(1996-3#1)(2008-11#2)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
the psychometric##15##2##(1990-3#1)(1996-3#1)(2008-11#2)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#3)
the psychomotor##2##2##(1993-6#1)(1994-6#1)
the psychophysical curve##3##3##(2011-2#3)
the psychophysical##8##2##(1991-2#1)(2008-7#1)(2008-9#2)(2011-2#3)(2012-12#1)
the psychophysiological responses to##3##4##(1992-12#3)
the psychosocial care of hospitalized children##2##6##(1991-1#2)
the psychosocial development of children##2##5##(1993-1#2)
the psychosocial impact of##2##4##(1997-5#1)(2008-11#1)
the psychosocial##21##2##(1991-1#2)(1991-2#2)(1992-3#1)(1993-1#3)(1995-5#1)(1996-12#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
the psychotropic##2##2##(2008-10#1)(2008-4#1)
the pteridine##2##2##(1995-2#2)
the pubertal##3##2##(2010-3#1)(2011-1#2)
the public Healthcare Units##2##4##(2008-9#2)
the public about##2##3##(1992-1#1)(1995-1#1)
the public and private sectors to##2##6##(1996-2#1)(1997-3#1)
the public and private sectors##3##5##(1992-12#1)(1996-2#1)(1997-3#1)
the public and private##7##4##(1992-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2011-2#2)(2013-7#1)
the public and##13##3##(1992-12#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-2#2)(1997-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
the public databases##2##3##(1996-10#1)(1997-3#1)
the public domain##6##3##(1994-12#1)(1996-1#1)(1996-2#1)(2008-4#1)(2009-12#1)(2013-1#1)
the public group##2##3##(2006-10#2)
the public health community##4##4##(1995-12#1)(1996-3#1)(1997-1#1)(2008-7#1)
the public health impact of##2##5##(1991-3#1)(1997-3#1)
the public health message##2##4##(1996-3#1)(2008-4#1)
the public health needs of##2##5##(1994-3#1)(1996-3#1)
the public health system in##2##5##(1995-12#1)(1996-2#1)
the public health system##4##4##(1995-12#1)(1996-2#2)(1997-2#1)
the public health##38##3##(1991-2#1)(1991-3#2)(1992-4#1)(1994-3#1)(1995-12#3)(1996-2#4)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
the public in##4##3##(1994-3#1)(1996-12#1)(2011-2#1)(2013-1#1)
the public interest##2##3##(1993-1#1)(1996-12#1)
the public is##4##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
the public on##2##3##(1994-5#1)(2009-4#1)
the public sector##6##3##(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2010-3#1)(2012-12#1)
the public the##2##3##(1995-6#1)(1997-5#1)
the public through##2##3##(2008-9#1)(2013-1#1)
the public to the##2##4##(1991-8#1)(1992-2#1)
the public to##6##3##(1991-8#1)(1992-2#1)(1994-1#1)(1996-4#1)(2008-4#1)(2008-7#1)
the public##157##2##(1991-11#1)(1991-2#1)(1991-3#3)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#7)(1996-2#8)(1996-3#4)(1996-4#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-5#1)(1997-8#2)(2006-10#5)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-12#3)(2009-4#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)
the public's health and##2##4##(1996-3#1)(2010-7#1)
the public's health##3##3##(1996-3#1)(2008-7#1)(2010-7#1)
the public's##12##2##(1991-3#1)(1992-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-8#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-2#1)
the publication of the##4##4##(1996-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
the publication of##9##3##(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
the publication##11##2##(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
the publications##3##2##(2008-1#1)(2010-8#1)(2012-3#1)
the published clone##2##3##(1994-12#2)
the published experimental##2##3##(2008-11#1)(2008-2#1)
the published literature and##3##4##(2010-10#1)(2010-12#2)
the published literature##12##3##(1991-3#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-8#1)(2010-10#1)(2010-12#2)(2012-12#1)
the published relevant##2##3##(2008-3#1)(2008-5#1)
the published sequence##3##3##(1990-7#1)(1993-6#1)(1994-12#1)
the published##43##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-12#3)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-3#2)
the puerperium##2##2##(1992-5#1)(1993-10#1)
the pulling##2##2##(1990-5#1)(2009-7#1)
the pulmonary arteries and##2##4##(2010-5#1)(2010-6#1)
the pulmonary arteries##9##3##(1997-8#1)(2008-10#1)(2008-7#4)(2010-5#1)(2010-6#2)
the pulmonary artery##11##3##(1991-9#1)(1997-8#1)(2008-11#2)(2008-12#1)(2010-10#3)(2010-5#1)(2010-8#2)
the pulmonary autograft##2##3##(2007-8#2)
the pulmonary circulation##3##3##(1992-3#1)(1994-8#1)(2006-10#1)
the pulmonary lesions##2##3##(2008-5#1)(2013-8#1)
the pulmonary vascular##5##3##(1991-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-6#1)
the pulmonary vasculature##2##3##(1997-1#1)(2010-5#1)
the pulmonary veins##2##3##(2008-11#1)(2013-1#1)
the pulmonary##60##2##(1990-5#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-3#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-1#2)(1997-3#1)(1997-8#2)(2006-10#2)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2010-10#3)(2010-5#3)(2010-6#4)(2010-8#4)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the pulp of##2##3##(2008-10#1)(2013-8#1)
the pulp##11##2##(1991-2#3)(2008-10#2)(2008-7#1)(2011-2#3)(2013-8#2)
the pulpotomy##2##2##(2011-2#2)
the pulsatile nature of##2##4##(2008-3#2)
the pulsatile##3##2##(2008-3#2)(2008-7#1)
the pulsatility of##2##3##(1990-9#1)(2007-7#1)
the pulse duration is##3##4##(1991-2#1)(2007-12#1)(2008-3#1)
the pulse duration##13##3##(1991-2#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
the pulse energy and##2##4##(2007-11#2)
the pulse energy##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
the pulse evolution##2##3##(2007-12#2)
the pulse frequency##2##3##(1992-11#1)(2013-1#1)
the pulse intensity##2##3##(2007-12#1)(2008-3#1)
the pulse is##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
the pulse leading-trailing time##2##4##(2008-3#2)
the pulse leading-trailing##3##3##(2008-3#3)
the pulse length##3##3##(1990-5#1)(2007-12#1)(2008-2#1)
the pulse propagation##2##3##(2008-3#2)
the pulse repetition rate##2##4##(2007-12#1)(2008-3#1)
the pulse shape##2##3##(2007-12#1)(2008-2#1)
the pulse spectrum##3##3##(2008-3#3)
the pulse train##4##3##(2007-11#3)(2007-12#1)
the pulse trains##2##3##(2007-11#2)
the pulse width of the##2##5##(2007-12#1)(2012-12#1)
the pulse width of##4##4##(2007-12#1)(2008-3#2)(2012-12#1)
the pulse width when it is##2##6##(2008-3#2)
the pulse width when##3##4##(2008-3#3)
the pulse width##19##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#14)(2012-12#1)
the pulse##110##2##(1990-5#1)(1990-8#1)(1991-2#3)(1992-11#1)(1992-12#1)(1993-1#1)(2007-11#23)(2007-12#30)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#30)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#2)
the pulse-front tilt##2##3##(2007-11#2)
the pulsed##5##2##(1991-3#1)(2008-10#1)(2008-3#3)
the pulses to a##2##4##(2007-12#2)
the pulses to##3##3##(2007-12#2)(2010-11#1)
the pulses##12##2##(1991-5#1)(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)
the pump and the laser##2##5##(2007-12#1)(2008-3#1)
the pump and the signal##2##5##(2007-12#2)
the pump and the##6##4##(2007-12#3)(2008-2#1)(2008-3#2)
the pump and##9##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
the pump beam##13##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#6)
the pump laser##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
the pump power##7##3##(2007-11#4)(2007-12#2)(2008-3#1)
the pump pulse##4##3##(2007-11#3)(2008-2#1)
the pump pulses##2##3##(2007-12#2)
the pump source##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
the pump spectrum##2##3##(2007-11#1)(2007-12#1)
the pump to##2##3##(2007-11#1)(2007-12#1)
the pump wave##2##3##(2007-11#1)(2008-3#1)
the pump##90##2##(1992-1#1)(1992-5#1)(2007-11#25)(2007-12#19)(2008-1#1)(2008-10#9)(2008-2#13)(2008-3#20)(2008-5#1)
the pump's##4##2##(2008-10#3)(2008-3#1)
the pump-power##3##2##(2007-12#2)(2008-3#1)
the pump-to-mode##2##2##(2008-3#2)
the pumped##3##2##(2008-2#1)(2008-3#2)
the pumping of##2##3##(1997-8#1)(2008-3#1)
the pumping source##2##3##(2008-3#2)
the pumping wavelength##2##3##(2008-2#2)
the pumping##14##2##(1997-8#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#4)
the pumps##3##2##(1995-12#1)(2008-10#1)(2010-9#1)
the puncture##2##2##(2011-2#2)
the pupae##2##2##(1990-7#1)(2008-6#1)
the pupal stage##5##3##(2007-12#4)(2008-8#1)
the pupil of##3##3##(2008-2#2)(2008-7#1)
the pupil##8##2##(2008-2#4)(2008-3#2)(2008-7#2)
the pupillary response to##2##4##(2008-7#2)
the pupillary##3##2##(2008-7#2)(2011-1#1)
the purchase of##2##3##(1996-12#1)(2010-9#1)
the purchase##5##2##(1995-2#1)(1996-12#1)(1996-2#1)(2008-11#1)(2010-9#1)
the pure diffusion##3##3##(2008-3#3)
the pure drug##3##3##(2008-10#3)
the pure proband method##4##4##(1997-5#4)
the pure stands##2##3##(2008-10#2)
the pure##37##2##(1990-2#1)(1990-8#1)(1992-5#1)(1994-12#1)(1995-4#1)(1996-2#1)(1997-5#4)(2007-12#4)(2008-10#16)(2008-12#1)(2008-3#3)(2008-5#1)(2009-3#1)(2010-10#1)
the purest##2##2##(2008-11#1)(2008-2#1)
the purge##2##2##(2008-10#1)(2008-5#1)
the purification and##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
the purification of TSP-1##2##4##(2008-1#2)
the purification of multisubunit protein complexes from mammalian cells##2##9##(2008-2#2)
the purification of recombinant##2##4##(2008-1#1)(2008-4#1)
the purification of the##7##4##(1991-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)
the purification of##33##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#2)(1995-3#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-4#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#3)(2008-4#5)(2009-12#1)(2010-10#1)(2012-2#1)
the purification procedure##3##3##(1992-6#1)(2008-10#2)
the purification##43##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-6#1)(1995-3#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-4#1)(2008-1#5)(2008-10#7)(2008-11#4)(2008-2#4)(2008-4#5)(2008-7#1)(2009-12#1)(2010-10#1)(2012-2#1)
the purified RNA##2##3##(1995-5#1)(2008-9#1)
the purified enzyme##13##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-8#2)(1992-9#1)(1993-11#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#1)
the purified protein was##3##4##(1990-5#1)(1994-6#1)(2008-10#1)
the purified protein##10##3##(1990-5#1)(1992-3#2)(1992-8#1)(1994-6#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
the purified rat##2##3##(1990-7#1)(1995-11#1)
the purified recombinant##5##3##(1990-12#1)(1995-2#2)(1997-4#1)(2008-8#1)
the purified##76##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-2#2)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#6)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#2)(2012-2#2)
the purine##9##2##(1992-8#1)(1993-8#1)(1995-3#1)(2008-10#5)(2008-7#1)
the purinergic##3##2##(1990-5#1)(2008-4#1)(2008-6#1)
the purity and##3##3##(2008-10#2)(2008-11#1)
the purity of Hb solutions##2##5##(1992-11#2)
the purity of the##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
the purity of##15##3##(1992-11#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2011-1#3)(2013-1#1)
the purity##20##2##(1992-11#2)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#3)(2013-1#1)
the purple acid phosphatase from##2##5##(1991-8#1)(1992-3#1)
the purple asFP595 and yellow zFP538##2##6##(2009-9#2)
the purple bacterium##2##3##(1993-8#2)
the purple##12##2##(1991-8#1)(1992-3#1)(1993-8#2)(1997-8#1)(2008-10#3)(2009-9#2)(2010-2#1)(2011-2#1)
the purported benefits of##2##4##(1992-2#1)(2012-3#1)
the purported##3##2##(1992-2#1)(2008-5#1)(2012-3#1)
the purpose and the##3##4##(1995-12#1)(1996-9#1)(2008-9#1)
the purpose and##7##3##(1995-1#1)(1995-12#1)(1995-5#1)(1996-9#1)(2008-12#1)(2008-9#1)(2013-1#1)
the purpose for which##2##4##(2008-1#1)(2008-9#1)
the purpose for##3##3##(1992-1#1)(2008-1#1)(2008-9#1)
the purpose of assessing##2##4##(1990-8#1)(2012-2#1)
the purpose of characterizing the##2##5##(1996-12#1)(2008-10#1)
the purpose of characterizing##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
the purpose of finding##2##4##(1994-12#1)(2013-1#1)
the purpose of our##2##4##(2008-1#1)(2008-10#1)
the purpose of providing##3##4##(2011-2#1)(2011-3#1)(2012-3#1)
the purpose of studying the##2##5##(1993-6#1)(2008-10#1)
the purpose of the present##2##5##(1993-12#1)(2008-7#1)
the purpose of the##10##4##(1991-6#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-9#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
the purpose of this review##2##5##(2007-7#1)(2008-5#1)
the purpose of this study was to##3##7##(2008-12#2)(2010-3#1)
the purpose of this study##9##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)(2010-3#1)(2013-1#2)
the purpose of this##14##4##(1995-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2010-12#1)(2010-3#1)(2013-1#2)
the purpose of##98##3##(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#1)(2007-7#2)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2010-10#1)(2010-12#4)(2010-3#3)(2011-2#1)(2011-3#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
the purpose to##2##3##(2008-10#1)(2008-11#1)
the purpose##118##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#2)(2007-7#2)(2008-1#2)(2008-10#18)(2008-11#9)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-1#1)(2010-10#1)(2010-12#4)(2010-3#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
the purposes of the##2##4##(1994-3#1)(1996-9#1)
the purposes of##14##3##(1990-3#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-9#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2013-1#1)
the purposes##16##2##(1990-3#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-9#1)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2013-1#1)
the pursuit of##7##3##(1993-2#1)(1997-3#1)(2008-12#2)(2008-7#1)(2009-5#1)(2011-2#1)
the purview of##3##3##(2008-2#1)(2010-7#1)(2012-1#1)
the pus##2##2##(1993-3#2)
the push-pull TES##2##3##(2008-3#2)
the push-pull##5##2##(2008-2#1)(2008-3#4)
the putamen##3##2##(1995-8#1)(2008-7#2)
the putative DNA##2##3##(1990-11#1)(1997-4#1)
the putative active site of##3##5##(1992-3#1)(2010-10#2)
the putative active site##6##4##(1991-12#1)(1992-12#1)(1992-3#1)(2010-10#3)
the putative glycoprotein##2##3##(1991-2#2)
the putative movement protein##2##4##(2008-10#2)
the putative product##2##3##(1993-2#1)(1997-7#1)
the putative promoter region##2##4##(1996-10#1)(2008-9#1)
the putative promoter##5##3##(1992-6#1)(1996-10#1)(2008-7#1)(2008-9#1)(2009-10#1)
the putative role of the serotoninergic system##2##7##(2008-6#2)
the putative role of the##3##5##(2008-10#1)(2008-6#2)
the putative role of##7##4##(1993-3#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-8#1)
the putative roles of CRMP2 in a panoply of neurodegenerative##2##10##(2013-1#2)
the putative transposable element##2##4##(2008-10#2)
the putative vesicular transporter for acetylcholine##2##6##(1996-12#2)
the putative##115##2##(1990-10#1)(1990-11#3)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#3)(1991-6#1)(1991-9#4)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#5)(1992-9#1)(1993-12#4)(1993-2#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#4)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-9#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
the putatively##4##2##(1990-7#1)(1995-2#1)(2008-10#1)(2008-8#1)
the puzzling##2##2##(1994-11#1)(2008-11#1)
the pyelonephritic##2##2##(2011-2#2)
the pygmy##2##2##(1995-8#1)(2011-2#1)
the pyralid##3##2##(2008-10#3)
the pyramid##5##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-6#2)
the pyramidal##2##2##(1992-1#1)(1996-5#1)
the pyrazine##2##2##(1991-6#1)(1992-10#1)
the pyridine nucleotide##3##3##(1992-1#2)(2009-9#1)
the pyridine ring##3##3##(2007-11#1)(2008-10#1)(2009-11#1)
the pyridine##9##2##(1992-1#2)(1993-8#1)(1994-11#1)(2007-11#1)(2008-10#2)(2009-11#1)(2009-9#1)
the pyridyl##2##2##(1997-7#1)(2008-10#1)
the pyrimidine##4##2##(1990-7#1)(1992-8#1)(1996-5#1)(2008-9#1)
the pyrolysis and atomization##2##4##(2008-10#2)
the pyrolysis of##2##3##(2008-10#2)
the pyrolysis##9##2##(2008-10#8)(2008-3#1)
the pyrrole ring of##2##4##(1992-3#1)(1995-3#1)
the pyrrole##5##2##(1992-3#1)(1994-5#1)(1995-3#1)(1996-5#1)(2008-10#1)
the pyrrole-strapped##2##2##(2011-1#2)
the pyruvate kinase L gene##2##5##(1990-8#2)
the pyruvate kinase##3##3##(1990-8#2)(2008-7#1)
the pyruvate prosthetic group##2##4##(1992-8#2)
the pyruvate##10##2##(1990-8#2)(1992-8#4)(1993-11#1)(1993-8#1)(2008-10#1)(2008-7#1)
the pyruvate-dehydrogenase complex is##3##4##(1991-3#3)
the pyruvate-dehydrogenase complex##4##3##(1991-3#4)
the q##2##2##(1991-6#1)(2007-12#1)
the qkI##2##2##(2012-2#2)
the quadrat and##2##3##(2008-10#2)
the quadrat##10##2##(2008-10#10)
the quadratic and##2##3##(2007-12#2)
the quadratic equation##3##3##(2008-10#2)(2008-2#1)
the quadratic nonlinear##2##3##(2007-12#2)
the quadratic term##2##3##(2008-10#2)
the quadratic##18##2##(2007-11#1)(2007-12#6)(2008-10#6)(2008-2#2)(2008-3#2)(2008-6#1)
the quadrature components of##2##4##(2008-2#1)(2011-1#1)
the quadrature signals##2##3##(2008-2#1)(2008-3#1)
the quadrature##7##2##(2008-2#3)(2008-3#3)(2011-1#1)
the quadriceps was##2##3##(2009-3#1)(2013-1#1)
the quadriceps##10##2##(2007-11#2)(2007-8#3)(2008-4#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
the quadruplex##2##2##(1994-11#1)(2008-12#1)
the qualification of##2##3##(2007-11#1)(2007-8#1)
the qualifications of##2##3##(1992-1#1)(2008-9#1)
the qualitative analysis of##5##4##(1993-3#1)(2008-10#3)(2012-2#1)
the qualitative and##6##3##(1994-12#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)
the qualitative features of##2##4##(1990-8#1)(2008-8#1)
the qualitative research##2##3##(1997-3#1)(2010-10#1)
the qualitative##31##2##(1990-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1997-3#3)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-7#1)
the qualitatively different##2##3##(1996-5#1)(2008-12#1)
the qualitatively##3##2##(1996-5#1)(2008-12#1)(2008-2#1)
the qualities of the##2##4##(2007-12#1)(2008-10#1)
the qualities of##4##3##(2007-12#1)(2008-10#1)(2008-6#1)(2010-11#1)
the qualities##5##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-11#1)
the quality and effectiveness of##2##5##(1993-12#1)(1994-2#1)
the quality and quantity of##3##5##(2008-11#1)(2008-7#1)(2011-10#1)
the quality and safety of##2##5##(2011-2#1)(2013-1#1)
the quality and stability of##2##5##(2007-2#1)(2012-2#1)
the quality and##27##3##(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#2)(2008-9#1)(2009-7#1)(2011-10#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)
the quality assurance##6##3##(2008-10#3)(2008-11#1)(2012-12#2)
the quality control of the##2##5##(1994-1#1)(2012-3#1)
the quality control of##15##4##(1994-1#1)(2008-10#9)(2010-4#1)(2011-1#3)(2012-3#1)
the quality control##22##3##(1992-10#1)(1994-1#1)(2008-10#12)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#4)(2012-3#1)
the quality evaluation of##2##4##(2011-2#1)(2013-8#1)
the quality factor##5##3##(2007-12#3)(2010-4#1)(2013-8#1)
the quality improvement process##3##4##(1993-2#1)(1995-2#2)
the quality improvement##5##3##(1993-2#1)(1994-2#1)(1995-2#2)(1996-2#1)
the quality management##2##3##(1994-1#1)(1996-1#1)
the quality of a##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
the quality of an##2##4##(2008-2#1)(2008-6#1)
the quality of bone##3##4##(1991-11#1)(2007-12#1)(2008-11#1)
the quality of care and##3##5##(1995-12#1)(1996-2#1)(1996-3#1)
the quality of care delivered##2##5##(1997-1#1)(2008-7#1)
the quality of care in##5##5##(1994-12#1)(1996-2#1)(1997-1#1)(2012-3#2)
the quality of care of##2##5##(1991-6#1)(2008-3#1)
the quality of care provided to##2##6##(1996-2#1)(2008-3#1)
the quality of care provided##4##5##(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
the quality of care they provide##2##6##(1996-2#1)(2008-11#1)
the quality of care they##3##5##(1995-2#1)(1996-2#1)(2008-11#1)
the quality of care##31##4##(1991-12#1)(1991-6#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-9#1)(1997-1#2)(1997-2#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#1)(2010-12#1)(2012-3#2)
the quality of clinical##3##4##(1992-2#1)(1997-6#1)(2010-4#1)
the quality of communication##2##4##(2011-2#1)(2013-1#1)
the quality of data##3##4##(2009-11#1)(2012-12#2)
the quality of health care##5##5##(1991-12#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-4#1)
the quality of health services##2##5##(1993-6#1)(1997-1#1)
the quality of health##9##4##(1991-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-7#1)
the quality of hospital care##2##5##(1992-3#1)(1994-3#1)
the quality of hospital##3##4##(1991-3#1)(1992-3#1)(1994-3#1)
the quality of information##2##4##(1991-11#1)(2008-11#1)
the quality of life (QOL)##2##5##(1994-12#1)(2011-2#1)
the quality of life and##7##5##(1991-12#1)(1992-1#1)(2007-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
the quality of life during childhood and##2##7##(2008-9#2)
the quality of life for##7##5##(1994-5#1)(1995-1#1)(1995-12#1)(2008-5#1)(2009-11#1)(2010-4#1)(2010-8#1)
the quality of life in##5##5##(1990-2#1)(1993-6#1)(2008-12#1)(2009-11#1)(2009-9#1)
the quality of life of African American women during the breast cancer treatment phase##2##14##(2008-4#2)
the quality of life of African American##3##7##(2008-4#3)
the quality of life of patients with##2##7##(2008-7#1)(2009-1#1)
the quality of life of patients##3##6##(2007-11#1)(2008-7#1)(2009-1#1)
the quality of life of the patients##2##7##(2007-11#1)(2013-1#1)
the quality of life of the##4##6##(1993-11#1)(2007-11#1)(2010-11#1)(2013-1#1)
the quality of life of##18##5##(1990-10#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-3#1)(2007-11#3)(2007-8#1)(2008-4#3)(2008-7#1)(2009-1#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
the quality of life##63##4##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-5#1)(2007-11#7)(2007-7#4)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
the quality of medical care##5##5##(1991-2#1)(1992-2#2)(1993-3#1)(1996-12#1)
the quality of medical##6##4##(1991-2#1)(1992-2#2)(1993-3#1)(1996-12#1)(1996-3#1)
the quality of nursing care##3##5##(2008-12#1)(2012-12#1)(2012-3#1)
the quality of nursing##4##4##(1996-2#1)(2008-12#1)(2012-12#1)(2012-3#1)
the quality of patient care##6##5##(1993-3#1)(1994-1#1)(1997-1#1)(2008-11#1)(2009-8#1)(2012-3#1)
the quality of patient##7##4##(1993-3#1)(1994-1#1)(1997-1#1)(2008-11#1)(2009-8#1)(2012-3#1)(2013-1#1)
the quality of prenatal care at a##2##7##(1993-3#1)(1995-12#1)
the quality of prenatal care##3##5##(1993-3#1)(1994-3#1)(1995-12#1)
the quality of prenatal##4##4##(1993-3#1)(1994-3#1)(1995-12#1)(1996-6#1)
the quality of service##2##4##(1994-2#1)(2010-8#1)
the quality of services##3##4##(1997-3#1)(2007-4#1)(2013-1#1)
the quality of the data##3##5##(1995-8#1)(2008-3#1)(2013-1#1)
the quality of the images##3##5##(1995-11#1)(2007-11#1)(2008-3#1)
the quality of the local##2##5##(1996-9#1)(2008-8#1)
the quality of the matrix##3##5##(2008-8#3)
the quality of the phase##2##5##(2008-3#1)(2008-8#1)
the quality of the service##2##5##(1993-1#1)(1996-7#1)
the quality of the##69##4##(1990-3#2)(1991-6#2)(1993-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#13)(2008-7#1)(2008-8#5)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
the quality of their lives##2##5##(2008-1#1)(2008-11#1)
the quality of their##7##4##(1992-2#1)(1993-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#1)
the quality of these##2##4##(2007-12#1)(2008-1#1)
the quality of this##2##4##(2008-10#1)(2008-11#1)
the quality of working life##2##5##(1992-3#1)(2008-11#1)
the quality of working##3##4##(1992-3#1)(2008-11#1)(2012-3#1)
the quality of##320##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#4)(1991-9#2)(1992-1#1)(1992-2#4)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#7)(1993-6#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#12)(1996-3#5)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#11)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#2)(2008-1#3)(2008-10#23)(2008-11#17)(2008-12#7)(2008-2#4)(2008-3#20)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#7)(2009-1#1)(2009-11#4)(2009-12#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#9)(2013-1#13)(2013-8#8)
the quality process##2##3##(1993-3#1)(1995-1#1)
the quality system##2##3##(2008-6#1)(2011-2#1)
the quality##421##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-6#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#9)(1993-6#2)(1994-1#3)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#5)(1996-2#13)(1996-3#5)(1996-6#1)(1996-7#2)(1996-9#4)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#11)(2007-12#7)(2007-2#2)(2007-4#1)(2007-7#5)(2007-8#2)(2008-1#4)(2008-10#42)(2008-11#23)(2008-12#7)(2008-2#4)(2008-3#23)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#9)(2009-1#1)(2009-11#5)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-8#4)(2011-1#8)(2011-10#1)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#14)(2012-2#6)(2012-3#13)(2013-1#15)(2013-8#10)
the quantification limit was##2##4##(2008-10#2)
the quantification limit##5##3##(2008-10#5)
the quantification of the##8##4##(2008-10#4)(2008-2#1)(2009-12#1)(2009-9#1)(2011-1#1)
the quantification of##56##3##(1990-12#2)(1992-12#1)(1994-12#2)(2008-1#1)(2008-10#31)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#2)
the quantification##65##2##(1990-12#2)(1992-12#1)(1994-12#2)(2008-1#1)(2008-10#37)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#3)
the quantitation limit was##2##4##(2008-10#2)
the quantitation of the##3##4##(1997-2#1)(2008-10#2)
the quantitation of##17##3##(1997-2#2)(2008-10#13)(2008-4#1)(2009-4#1)
the quantitation##20##2##(1997-2#2)(2008-10#15)(2008-4#1)(2008-5#1)(2009-4#1)
the quantitative analysis of the##2##5##(1997-6#1)(2012-3#1)
the quantitative analysis of##15##4##(1997-6#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-8#1)(2012-3#1)
the quantitative analysis##17##3##(1997-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-8#2)(2012-3#1)
the quantitative and qualitative##2##4##(2008-5#1)(2008-8#1)
the quantitative aspects of the##3##5##(1992-3#1)(1993-12#1)(2008-10#1)
the quantitative aspects of##4##4##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)
the quantitative assessment of##3##4##(1996-12#1)(2008-3#1)(2009-10#1)
the quantitative detection of##2##4##(2008-1#1)(2013-8#1)
the quantitative detection##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
the quantitative determination of##33##4##(1991-2#1)(1997-2#2)(2008-1#1)(2008-10#25)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
the quantitative determination##34##3##(1991-2#1)(1997-2#2)(2008-1#1)(2008-10#26)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
the quantitative evaluation of##6##4##(1991-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#2)
the quantitative extraction of metal ions##3##6##(2008-10#3)
the quantitative extraction of##5##4##(2008-10#5)
the quantitative measurement of##3##4##(2008-10#1)(2009-12#1)(2010-11#1)
the quantitative resistance##2##3##(2008-10#2)
the quantitative results##3##3##(1993-11#1)(2008-10#1)(2012-2#1)
the quantitative sorption of##2##4##(2008-10#2)
the quantitative sorption##3##3##(2008-10#3)
the quantitative trait loci##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
the quantitative trait##4##3##(2008-10#1)(2008-8#1)(2012-3#2)
the quantitative##140##2##(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#65)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#3)(2010-8#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
the quantities of##3##3##(2008-10#3)
the quantities##7##2##(1990-8#1)(2008-10#4)(2008-2#1)(2008-7#1)
the quantity and##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
the quantity of drug##2##4##(1992-3#2)
the quantity of signalling##2##4##(2009-9#2)
the quantity of water##2##4##(2008-10#2)
the quantity of##28##3##(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-10#7)(2008-5#3)(2008-9#2)(2009-4#1)(2009-6#1)(2009-9#2)(2011-1#1)(2013-7#1)
the quantity##36##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#4)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#2)(2011-1#1)(2012-12#1)(2013-7#1)
the quantization##2##2##(2008-3#2)
the quantum dots##6##3##(1995-3#1)(2007-11#2)(2008-7#2)(2009-6#1)
the quantum efficiency##2##3##(2007-11#1)(2007-12#1)
the quantum limit##2##3##(2007-12#1)(2008-3#1)
the quantum mechanical##2##3##(2008-10#1)(2011-2#1)
the quantum yield##2##3##(2008-11#1)(2008-2#1)
the quantum##26##2##(1995-3#1)(2007-11#5)(2007-12#6)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-6#1)(2009-9#2)(2011-2#1)
the quantum-noise##2##2##(2007-11#1)(2007-12#1)
the quartz fiber##2##3##(2008-10#1)(2008-3#1)
the quartz in near ore body rock##2##7##(2013-8#2)
the quartz in the mineralized rock##2##6##(2013-8#2)
the quartz in##5##3##(2013-8#5)
the quartz##19##2##(2007-11#1)(2008-10#6)(2008-3#2)(2008-5#1)(2013-8#9)
the quasi-firm##2##2##(1992-12#2)
the quasi-phase-matching##2##2##(2007-12#1)(2008-3#1)
the quasi-static and the physical optics approximations##2##7##(2008-2#2)
the quasi-static##5##2##(2008-2#3)(2008-3#1)(2010-8#1)
the quasispecies##2##2##(1997-3#1)(2013-1#1)
the quaternary enhancement effect##2##4##(1990-8#1)(1997-2#1)
the quaternary structure of the##3##5##(1990-8#1)(1994-8#1)(1995-5#1)
the quaternary structure of##4##4##(1990-8#1)(1992-2#1)(1994-8#1)(1995-5#1)
the quaternary structure##6##3##(1990-8#1)(1992-2#1)(1994-8#1)(1995-5#1)(2008-4#2)
the quaternary##11##2##(1990-7#1)(1990-8#2)(1992-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-2#1)(2008-4#2)(2013-1#1)
the queen##3##2##(2007-7#1)(2008-5#1)(2008-8#1)
the queen's##2##2##(2008-8#2)
the quencher##2##2##(1992-12#1)(2010-5#1)
the quenching and VET rates##2##5##(2008-2#2)
the quenching effect of the##2##5##(2008-10#1)(2013-8#1)
the quenching effect of##3##4##(2008-10#2)(2013-8#1)
the quenching effect##6##3##(2008-10#4)(2008-4#1)(2013-8#1)
the quenching of the fluorescence##2##5##(2008-10#2)
the quenching of##6##3##(1991-5#1)(1994-12#1)(1995-8#1)(2008-10#3)
the quenching##23##2##(1991-5#1)(1994-12#1)(1995-8#1)(1997-7#1)(2008-10#13)(2008-2#2)(2008-4#1)(2010-4#1)(2013-8#2)
the query##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
the quest for##4##3##(2008-8#3)(2012-3#1)
the quest##5##2##(2008-8#3)(2010-4#1)(2012-3#1)
the question &quot##2##3##(1994-3#1)(2013-1#1)
the question and##2##3##(2008-12#1)(2008-8#1)
the question as to whether##2##5##(2008-10#1)(2012-3#1)
the question as to##3##4##(1995-12#1)(2008-10#1)(2012-3#1)
the question as##4##3##(1995-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
the question if##2##3##(2011-2#2)
the question of how the##2##5##(2008-2#1)(2012-3#1)
the question of how to##2##5##(1996-12#1)(2012-2#1)
the question of how##11##4##(1996-12#1)(2008-10#1)(2008-2#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
the question of the##9##4##(1991-12#1)(1996-3#1)(1997-3#1)(2008-11#2)(2008-9#2)(2009-12#1)(2009-8#1)
the question of what##2##4##(2008-7#1)(2008-9#1)
the question of whether the##4##5##(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
the question of whether this##2##5##(2010-12#1)(2011-2#1)
the question of whether to##2##5##(1996-2#1)(1997-1#1)
the question of whether##16##4##(1991-3#1)(1996-2#2)(1996-8#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-2#2)
the question of##56##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-2#2)(1993-2#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)
the question was##3##3##(1995-8#2)(1997-5#1)
the question whether the##2##4##(1990-9#1)(2008-7#1)
the question whether##5##3##(1990-9#1)(1994-12#1)(1994-8#1)(2007-8#1)(2008-7#1)
the questionable##3##2##(1993-1#1)(2008-12#1)(2010-3#1)
the questionnaire to##2##3##(2008-10#1)(2008-11#1)
the questionnaire was##2##3##(2007-2#1)(2008-7#1)
the questionnaire##30##2##(1992-1#1)(1992-6#1)(1993-2#2)(1996-3#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#2)
the questionnaires and##2##3##(1993-2#1)(1997-3#1)
the questionnaires##10##2##(1990-2#1)(1993-2#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#1)
the questions and##2##3##(2008-7#1)(2013-8#1)
the questions from##2##3##(2008-7#1)(2013-1#1)
the questions of##5##3##(1995-2#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
the questions posed##2##3##(2008-3#1)(2008-7#1)
the questions regarding##2##3##(2011-2#1)(2013-1#1)
the questions that##2##3##(2007-7#1)(2008-7#1)
the questions##33##2##(1990-2#1)(1991-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#5)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
the quick hit method##2##4##(1994-12#2)
the quick##5##2##(1994-12#2)(2008-10#1)(2008-5#1)(2009-11#1)
the quinol##2##2##(1990-11#1)(2008-10#1)
the quinone##4##2##(1991-5#1)(1995-5#1)(1996-5#1)(2008-10#1)
the quorum##2##2##(2008-10#1)(2009-8#1)
the quorum-quenching##2##2##(2008-9#2)
the quotient between##2##3##(2008-10#2)
the quotient of the##2##4##(2008-3#1)(2012-3#1)
the quotient of##4##3##(2008-3#1)(2012-3#2)(2012-6#1)
the quotient##7##2##(1990-8#1)(2008-10#2)(2008-3#1)(2012-3#2)(2012-6#1)
the r(2)##2##2##(2008-10#1)(2008-7#1)
the rDNA##9##2##(2008-10#8)(2008-5#1)
the rGO##3##2##(2013-1#3)
the rH##3##2##(2013-8#3)
the rRNA##5##2##(2008-10#2)(2008-5#1)(2010-4#2)
the rVLM##3##2##(1997-6#3)
the rabbit VLDL receptor cDNA##2##5##(1995-6#2)
the rabbit enzyme##2##3##(1994-8#1)(1995-5#1)
the rabbit is##2##3##(2008-4#1)(2008-9#1)
the rabbit##40##2##(1990-12#2)(1990-6#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#3)(1997-7#2)(2008-10#2)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#6)(2013-1#1)
the rabbits were mated##2##4##(1992-3#2)
the rabbits were##3##3##(1992-3#2)(2010-4#1)
the rabbits##6##2##(1992-3#2)(1993-12#2)(2008-8#1)(2010-4#1)
the race model inequality##2##4##(2008-8#2)
the race model##3##3##(2008-8#3)
the race structure##3##3##(2008-10#3)
the race##14##2##(1991-12#1)(1993-12#1)(2008-10#8)(2008-8#3)(2009-7#1)
the race-specific##2##2##(2008-10#2)
the racemic##2##2##(1995-3#1)(2008-10#1)
the races##3##2##(1997-6#1)(2008-10#2)
the rachis##4##2##(2008-10#4)
the racial##4##2##(2008-1#1)(2008-5#1)(2009-9#1)(2011-2#1)
the radar##3##2##(2008-3#3)
the radial access##2##3##(2011-2#2)
the radial and##3##3##(2008-9#1)(2009-7#1)(2011-2#1)
the radial approach##2##3##(2011-2#2)
the radial arm maze##2##4##(1992-12#1)(2008-4#1)
the radial arm##3##3##(1992-12#1)(2008-4#1)(2008-7#1)
the radial artery is an##2##5##(1990-8#1)(2008-11#1)
the radial artery is##3##4##(1990-8#1)(2008-11#1)(2011-2#1)
the radial artery##18##3##(1990-8#3)(2007-8#5)(2008-11#1)(2008-7#1)(2008-9#3)(2011-2#4)(2013-1#1)
the radial direction##4##3##(2008-2#2)(2008-7#1)(2010-12#1)
the radial distance##2##3##(1995-6#1)(2008-10#1)
the radial forearm flap##2##4##(2007-12#1)(2011-2#1)
the radial forearm##3##3##(2007-12#1)(2011-2#2)
the radial##65##2##(1990-11#1)(1990-8#3)(1992-12#1)(1995-5#1)(1995-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#8)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#5)(2008-9#6)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#14)(2012-2#2)(2013-1#1)
the radiance received##2##3##(2008-2#1)(2008-3#1)
the radiance##12##2##(2008-2#9)(2008-3#3)
the radiant reflectance of##2##4##(2008-3#2)
the radiated##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the radiation and##2##3##(2008-2#1)(2012-2#1)
the radiation at##2##3##(2007-11#1)(2008-10#1)
the radiation burden##2##3##(2012-2#2)
the radiation dose to##2##4##(2008-2#1)(2013-1#1)
the radiation dose##3##3##(2008-2#1)(2008-5#1)(2013-1#1)
the radiation emitted##2##3##(2007-12#1)(2008-10#1)
the radiation field##2##3##(2010-7#2)
the radiation force exerted upon a gold particle##2##8##(2007-12#2)
the radiation from##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
the radiation hormesis##2##3##(2008-7#2)
the radiation induced haematological damage in rats##2##7##(2013-8#2)
the radiation induced haematological##3##4##(2013-8#3)
the radiation induced##4##3##(2013-8#4)
the radiation is##2##3##(2008-2#1)(2008-7#1)
the radiation of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
the radiation on the##3##4##(2008-3#2)(2013-7#1)
the radiation on##4##3##(2008-3#2)(2013-7#2)
the radiation oncologist##3##3##(2009-11#2)(2011-2#1)
the radiation pressure##3##3##(2007-12#2)(2008-2#1)
the radiation sensitivity of##3##4##(2008-9#3)
the radiation treatment##2##3##(2008-7#2)
the radiation was##2##3##(1992-9#1)(2008-2#1)
the radiation##77##2##(1992-9#1)(1996-6#1)(2006-4#1)(2007-11#2)(2007-12#10)(2007-4#1)(2008-10#6)(2008-2#9)(2008-3#12)(2008-5#2)(2008-7#8)(2008-9#3)(2009-10#1)(2009-11#3)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#4)
the radiative forcing##3##3##(2008-2#3)
the radiative properties of##3##4##(2008-2#3)
the radiative transfer equation and##2##5##(2007-12#1)(2008-2#1)
the radiative transfer equation for##2##5##(2008-2#1)(2008-3#1)
the radiative transfer equation##12##4##(2007-12#1)(2008-2#7)(2008-3#4)
the radiative transfer in a##2##5##(2008-10#1)(2008-2#1)
the radiative transfer model##2##4##(2008-3#2)
the radiative transfer theory##3##4##(2008-2#1)(2008-3#2)
the radiative transfer##23##3##(2007-12#3)(2008-10#1)(2008-2#9)(2008-3#10)
the radiative##36##2##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#16)(2008-3#13)
the radiative-transfer##2##2##(2008-2#2)
the radical rearrangement##2##3##(1996-2#1)(1996-5#1)
the radical##19##2##(1995-2#3)(1996-2#4)(1996-5#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2011-1#1)
the radicals##5##2##(1993-3#1)(2007-11#1)(2008-10#2)(2008-2#1)
the radii##2##2##(2011-2#2)
the radio##2##2##(2008-3#1)(2010-7#1)
the radioactive tracer##2##3##(1990-2#1)(1993-8#1)
the radioactive##10##2##(1990-11#1)(1990-2#3)(1992-3#2)(1993-8#1)(1994-5#1)(2007-10#1)(2008-4#1)
the radioactivity of the##2##4##(1993-11#1)(2008-11#1)
the radioactivity##5##2##(1991-3#1)(1993-11#2)(2008-11#1)(2008-4#1)
the radioantigen binding assay##2##4##(1990-12#2)
the radiochemical assay##2##3##(1991-12#2)
the radiograph##2##2##(2008-12#1)(2010-8#1)
the radiographic##2##2##(2008-1#1)(2008-12#1)
the radioisotope and##2##3##(1992-2#2)
the radioisotope##4##2##(1990-11#1)(1990-12#1)(1992-2#2)
the radiolabeled##5##2##(1992-12#1)(1994-11#1)(1994-5#2)(1994-8#1)
the radiolabeling##2##2##(1992-2#1)(2007-10#1)
the radiolabelled##3##2##(1994-12#1)(2007-12#1)(2008-8#1)
the radiolar crown##2##3##(2011-2#2)
the radiologic literature##2##3##(1992-1#1)(1997-8#1)
the radiologic##5##2##(1992-1#1)(1996-1#1)(1997-8#1)(2011-2#1)(2012-12#1)
the radiological diagnosis##2##3##(2007-11#1)(2011-2#1)
the radiological evaluation of##2##4##(2007-8#2)
the radiological features of##3##4##(1992-12#1)(2011-2#1)(2012-2#1)
the radiological##15##2##(1992-12#1)(1993-3#1)(1997-8#1)(2007-11#2)(2007-8#3)(2011-2#3)(2012-2#3)(2012-3#1)
the radiologist to##3##3##(2012-2#3)
the radiologist##9##2##(1991-3#1)(1993-3#1)(2007-4#1)(2009-9#1)(2012-2#5)
the radiologist's##2##2##(2008-8#1)(2010-9#1)
the radiologists##2##2##(2007-8#1)(2008-1#1)
the radiology administrator##3##3##(1992-12#1)(1994-12#1)(1996-3#1)
the radiology department##11##3##(1991-12#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2009-6#1)(2012-2#2)
the radiology manager##4##3##(1991-1#1)(1991-12#1)(1993-2#1)(1994-12#1)
the radiology##24##2##(1991-1#1)(1991-12#2)(1992-12#2)(1993-2#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-3#3)(1996-1#2)(1996-2#1)(1996-3#2)(1997-8#1)(2009-6#1)(2012-2#3)
the radiometric calibration##2##3##(2008-2#1)(2008-3#1)
the radiometric sensitivities of the SeaWiFS##2##6##(2008-3#2)
the radiometric##9##2##(2008-10#1)(2008-2#2)(2008-3#6)
the radionuclide##2##2##(2008-7#1)(2011-1#1)
the radioprotective agent 2-aminoethyl-isothiouronium bromide hydrobromide (AET)##2##7##(1994-5#2)
the radiosensitivity of head and neck cancer patients##2##8##(2008-5#2)
the radiosurgery##3##2##(2008-7#3)
the radiotherapeutic##3##2##(1991-2#1)(1993-9#2)
the radiotherapy##7##2##(1991-8#1)(1992-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)
the radius and the##4##4##(1995-6#2)(2008-3#2)
the radius and##6##3##(1995-6#2)(2007-11#1)(2008-2#1)(2008-3#2)
the radius of curvature of the##2##6##(2008-3#2)
the radius of curvature##3##4##(1990-12#1)(2008-3#2)
the radius of gyration##2##4##(2008-2#1)(2008-3#1)
the radius of the##6##4##(1990-7#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
the radius of##13##3##(1990-12#1)(1990-7#1)(1994-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)
the radius##24##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-4#1)(1994-3#1)(1995-6#3)(1997-7#1)(2007-11#3)(2008-10#1)(2008-2#3)(2008-3#7)(2008-5#1)
the rain##4##2##(2008-10#3)(2008-5#1)
the rainbow trout (Oncorhynchus mykiss)##2##5##(2008-5#1)(2008-6#1)
the rainbow trout##6##3##(1994-5#2)(2008-5#2)(2008-6#2)
the rainbow##14##2##(1994-5#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#2)
the rainfall##2##2##(2007-2#1)(2008-10#1)
the rainwater##2##2##(2008-10#2)
the rainy season##16##3##(1994-9#1)(2007-2#1)(2008-10#2)(2008-5#6)(2008-6#1)(2008-8#1)(2013-7#4)
the rainy##18##2##(1994-9#1)(2007-2#1)(2008-10#2)(2008-5#6)(2008-6#1)(2008-8#2)(2013-7#5)
the raised serum##2##3##(1996-12#1)(2013-1#1)
the raised##3##2##(1996-12#1)(2013-1#2)
the ramp direction of V(c)##2##5##(2008-10#2)
the ramp##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
the random amplified polymorphic DNA (RAPD) technique##2##7##(2008-10#2)
the random amplified polymorphic DNA (RAPD)##3##6##(2008-10#3)
the random amplified polymorphic DNA##4##5##(2008-10#4)
the random effects##2##3##(1996-3#1)(2008-8#1)
the random phase##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the random##36##2##(1990-7#1)(1991-9#1)(1992-10#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#2)(2012-3#1)(2013-8#1)
the randomized##5##2##(1995-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
the randomly##4##2##(1990-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
the randomness##2##2##(2008-10#1)(2010-10#1)
the range 0 degrees##2##4##(2007-12#1)(2008-2#1)
the range 0##100##3##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#85)(2008-2#4)(2008-3#2)(2008-5#1)(2012-1#1)(2012-12#2)
the range 0-0##3##3##(2008-10#2)(2008-6#1)
the range 1##21##3##(2007-11#1)(2008-10#19)(2008-2#1)
the range 1-10##4##3##(2008-10#3)(2010-5#1)
the range 1-5%##2##3##(1992-3#1)(2008-10#1)
the range 10-40##2##3##(1995-2#1)(2008-7#1)
the range 2##10##3##(1992-11#1)(2008-10#9)
the range 3##7##3##(2008-10#7)
the range 5##5##3##(2008-10#5)
the range 5-1000ngmL(-1)##2##3##(2008-10#2)
the range 6##6##3##(2008-10#5)(2008-7#1)
the range and##6##3##(1996-2#1)(2008-10#2)(2008-2#1)(2013-1#1)(2013-8#1)
the range between##10##3##(2008-10#8)(2008-2#1)(2008-3#1)
the range examined##2##3##(2008-10#2)
the range expected for##3##4##(1992-3#2)(2008-7#1)
the range from 0 to 1##2##6##(2008-10#2)
the range from 0 to##3##5##(2008-10#3)
the range from 0##15##4##(1990-12#1)(1992-11#1)(2008-10#8)(2008-3#3)(2010-4#2)
the range from 10 to##2##5##(1990-8#1)(2008-10#1)
the range from 10##3##4##(1990-8#1)(2008-10#1)(2008-2#1)
the range from 2 to##2##5##(2007-7#1)(2008-10#1)
the range from 2##3##4##(2007-7#1)(2008-10#2)
the range from##46##3##(1990-12#1)(1990-2#1)(1990-8#3)(1992-11#1)(2007-11#2)(2007-7#1)(2008-10#23)(2008-2#4)(2008-3#6)(2008-9#1)(2010-4#2)(2011-2#1)
the range in##2##3##(2007-7#1)(2008-2#1)
the range of 0##91##4##(1990-7#3)(1992-8#1)(2008-10#82)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the range of 1##25##4##(1990-5#1)(1994-5#1)(1996-12#1)(1996-5#1)(2008-10#18)(2008-11#1)(2008-3#1)(2011-1#1)
the range of 10##3##4##(1994-8#1)(2008-10#1)(2008-11#1)
the range of 100##3##4##(2008-11#1)(2009-11#1)(2010-11#1)
the range of 2##13##4##(2008-10#13)
the range of 200-400##2##4##(2008-5#2)
the range of 3##7##4##(2008-10#6)(2010-3#1)
the range of 4##8##4##(2008-10#6)(2008-11#1)(2013-1#1)
the range of 5##10##4##(2008-10#10)
the range of 7##5##4##(2008-10#4)(2010-5#1)
the range of 82##2##4##(2008-10#2)
the range of 99##4##4##(2008-10#3)(2011-2#1)
the range of a##2##4##(2007-12#1)(2008-3#1)
the range of applications##2##4##(2008-11#1)(2012-2#1)
the range of concentrations##5##4##(1994-11#1)(2008-10#4)
the range of conditions in##2##5##(2008-10#1)(2008-8#1)
the range of conditions##3##4##(2008-10#1)(2008-8#2)
the range of decision thresholds##3##5##(1997-3#3)
the range of factors##2##4##(1995-3#1)(2008-11#1)
the range of flexion and extension##2##6##(2007-8#2)
the range of forces##2##4##(2007-12#2)
the range of its##2##4##(2008-8#1)(2009-12#1)
the range of low##2##4##(1990-5#1)(2008-10#1)
the range of motion (ROM)##2##5##(2008-12#1)(2009-1#1)
the range of motion##4##4##(2007-8#1)(2008-12#1)(2009-1#1)(2012-3#1)
the range of movement in the hip##2##7##(2007-8#2)
the range of movement##5##4##(2007-8#5)
the range of pH##6##4##(1995-2#1)(2008-10#5)
the range of parameters##3##4##(2008-3#2)(2008-8#1)
the range of temperatures##2##4##(2008-3#1)(2008-8#1)
the range of the optical##2##5##(2008-3#1)(2013-8#1)
the range of the##9##4##(1990-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2013-8#1)
the range of those##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
the range of validity of the##3##6##(2008-2#1)(2008-3#2)
the range of validity of##6##5##(2008-2#2)(2008-3#4)
the range of##461##3##(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#1)(1992-8#1)(1993-1#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#3)(1997-6#1)(2007-11#5)(2007-12#7)(2007-7#1)(2007-8#9)(2008-10#273)(2008-11#11)(2008-12#3)(2008-2#12)(2008-3#20)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#3)(2008-8#17)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#7)(2011-7#1)(2012-1#3)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#3)
the range pH##3##3##(2008-10#3)
the range tested##2##3##(2008-10#1)(2008-11#1)
the range was##3##3##(2006-10#1)(2008-10#2)
the range##863##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#4)(1991-12#1)(1991-2#1)(1991-5#2)(1992-11#2)(1992-3#5)(1992-6#1)(1992-8#1)(1993-1#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#2)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#13)(2007-12#14)(2007-7#3)(2007-8#9)(2008-10#557)(2008-11#15)(2008-12#4)(2008-2#27)(2008-3#37)(2008-4#2)(2008-5#7)(2008-6#7)(2008-7#10)(2008-8#19)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-9#1)(2011-1#4)(2011-2#8)(2011-7#1)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#4)
the range-resolved##2##2##(2008-3#2)
the ranges 0##3##3##(2008-10#3)
the ranges of##20##3##(2007-12#1)(2008-10#12)(2008-2#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the ranges##38##2##(2007-12#3)(2008-10#25)(2008-11#1)(2008-2#3)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
the rank and replace##2##4##(2010-3#2)
the rank and##3##3##(1993-2#1)(2010-3#2)
the rank of##5##3##(2008-10#4)(2012-3#1)
the rank order of potency##2##5##(1993-3#1)(1995-12#1)
the rank order of##6##4##(1993-3#1)(1995-11#2)(1995-12#3)
the rank order##8##3##(1993-3#1)(1995-11#2)(1995-12#3)(1995-8#1)(2009-4#1)
the rank##21##2##(1993-2#1)(1993-3#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-4#1)(2010-3#2)(2012-3#1)
the rank-citation profile##2##3##(2012-2#2)
the ranking##4##2##(1993-12#1)(1997-3#1)(2008-5#1)(2013-8#1)
the ranks of the##2##4##(1995-2#1)(1997-2#1)
the ranks##3##2##(1995-2#1)(1997-2#1)(2010-3#1)
the rap1A##2##2##(1992-11#2)
the rap2A protein##2##3##(1992-11#2)
the raphe nuclei##6##3##(1996-12#1)(2008-7#5)
the raphe##9##2##(1991-12#1)(1996-12#1)(1997-3#1)(2008-7#5)(2012-3#1)
the rapid adherence of##2##4##(2008-10#2)
the rapid analysis of##3##4##(2008-10#2)(2010-9#1)
the rapid and##14##3##(2008-10#8)(2008-7#2)(2008-9#1)(2009-11#1)(2012-1#1)(2012-3#1)
the rapid detection and##2##4##(1993-12#1)(2008-10#1)
the rapid detection of##6##4##(2007-7#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-3#1)
the rapid detection##8##3##(1993-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-3#1)
the rapid determination of##11##4##(2007-12#1)(2008-10#10)
the rapid determination##12##3##(2007-12#1)(2008-10#11)
the rapid development of##9##4##(2007-11#1)(2007-12#1)(2008-10#4)(2009-11#1)(2009-5#1)(2013-8#1)
the rapid expansion of##4##4##(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
the rapid growth in##2##4##(1994-3#1)(2009-3#1)
the rapid growth of##2##4##(2008-7#1)(2010-7#1)
the rapid growth##5##3##(1992-2#1)(1994-3#1)(2008-7#1)(2009-3#1)(2010-7#1)
the rapid identification of##3##4##(2008-9#1)(2010-12#1)(2013-1#1)
the rapid identification##5##3##(2007-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#1)
the rapid increase in##4##4##(2008-10#2)(2008-3#1)(2012-2#1)
the rapid increase of##2##4##(1994-2#1)(2011-2#1)
the rapid increase##6##3##(1994-2#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
the rapid phase##2##3##(1993-11#1)(2008-5#1)
the rapid phosphorylation of##2##4##(1991-5#1)(1993-6#1)
the rapid progress##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
the rapid screening of##3##4##(2008-10#2)(2008-11#1)
the rapid synthesis of##2##4##(1992-8#1)(2008-10#1)
the rapid turnover of##2##4##(1990-7#1)(1993-9#1)
the rapid##169##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#3)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#60)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
the rapidity of##2##3##(2011-1#1)(2011-2#1)
the rapidly growing##6##3##(1990-5#1)(1991-6#1)(1992-3#1)(2007-7#1)(2011-2#1)(2013-1#1)
the rapidly reversible increase##2##4##(1992-3#2)
the rapidly##14##2##(1990-5#1)(1991-6#1)(1992-3#3)(1995-6#2)(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#3)
the rare earth elements##3##4##(2008-10#3)
the rare earth##5##3##(2008-10#5)
the rare earths and##2##4##(2008-10#2)
the rare earths##6##3##(1992-11#1)(2008-10#5)
the rare occurrence of the sexual stage of##2##8##(2008-10#2)
the rare##37##2##(1992-11#1)(1992-2#1)(1992-6#1)(1994-11#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the rarefaction##2##2##(2008-10#1)(2008-3#1)
the rarely##2##2##(1992-5#1)(2008-11#1)
the rarest##3##2##(1997-7#1)(2008-4#1)(2010-3#1)
the rarity of its##2##4##(1991-11#1)(2011-2#1)
the rarity of the disease##2##5##(2007-12#1)(2008-8#1)
the rarity of the##5##4##(1990-5#1)(2007-12#1)(2008-8#1)(2010-5#1)(2013-1#1)
the rarity of this condition and its##2##7##(2010-12#1)(2011-2#1)
the rarity of this##6##4##(1992-5#1)(2007-10#1)(2010-12#1)(2010-5#1)(2011-2#2)
the rarity of##18##3##(1990-5#1)(1991-11#1)(1992-5#1)(1992-8#1)(2007-10#1)(2007-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
the ras genes##2##3##(1992-12#1)(1995-2#1)
the ras##5##2##(1992-12#1)(1992-8#2)(1994-6#1)(1995-2#1)
the rash##2##2##(2008-11#1)(2008-8#1)
the rat AT1 receptor##2##4##(1992-3#2)
the rat AT1##3##3##(1992-3#3)
the rat Gadd45##2##3##(1994-12#2)
the rat PACAP##3##3##(1990-12#3)
the rat SCN##3##3##(1993-12#3)
the rat adrenal gland##2##4##(1990-5#1)(1996-12#1)
the rat adrenal##3##3##(1990-5#1)(1996-12#1)(1996-5#1)
the rat and chick##2##4##(1996-12#2)
the rat and human##4##4##(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)
the rat and mouse AT2R##2##5##(1994-11#1)(1994-9#1)
the rat and mouse##5##4##(1993-8#1)(1994-11#1)(1994-9#1)(2008-4#2)
the rat and##20##3##(1991-2#1)(1991-4#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-4#2)(2008-5#1)
the rat anterior pituitary##2##4##(1992-3#1)(1996-5#1)
the rat aorta##6##3##(1991-9#3)(1994-11#2)(2008-8#1)
the rat at different ages##2##5##(1990-5#1)(1994-2#1)
the rat at##4##3##(1990-5#1)(1993-12#1)(1994-2#1)(2008-8#1)
the rat brain and##2##4##(1994-11#1)(2008-4#1)
the rat brain is##2##4##(1993-8#1)(2008-10#1)
the rat brain using##2##4##(1993-8#1)(2011-1#1)
the rat brain##27##3##(1992-10#1)(1993-12#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#5)(1996-5#1)(1997-2#2)(2008-10#2)(2008-4#1)(2009-9#1)(2011-1#1)
the rat but##3##3##(1992-12#1)(2008-8#1)(2011-2#1)
the rat by##2##3##(1992-6#1)(1993-12#1)
the rat cDNA##2##3##(1992-10#1)(1995-2#1)
the rat cerebral cortex##4##4##(1996-5#2)(1997-2#2)
the rat colon##3##3##(1996-5#1)(1997-4#2)
the rat epididymis##4##3##(1992-3#3)(1992-8#1)
the rat gene encoding##2##4##(1993-6#1)(1993-8#1)
the rat gene##5##3##(1991-2#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-11#1)
the rat genome##3##3##(1991-6#1)(1992-3#1)(1993-8#1)
the rat heart##4##3##(1991-9#1)(2008-7#1)(2013-1#1)(2013-7#1)
the rat high affinity neurotensin receptor##2##6##(1997-2#2)
the rat hippocampus was##2##4##(1990-5#1)(1995-5#1)
the rat hippocampus##7##3##(1990-5#2)(1995-12#2)(1995-5#1)(1996-12#1)(1997-2#1)
the rat hypothalamus##5##3##(1992-12#2)(1993-12#1)(1994-8#1)(1995-12#1)
the rat in order to##2##5##(1993-3#1)(2008-7#1)
the rat in##3##3##(1993-3#1)(1995-12#1)(2008-7#1)
the rat is##5##3##(1991-12#1)(1992-3#1)(1994-8#2)(2008-4#1)
the rat kidney##8##3##(1992-6#1)(1993-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(2012-2#1)
the rat left##2##3##(2008-12#1)(2013-1#1)
the rat liver##7##3##(1990-5#1)(1994-11#1)(1994-6#1)(1996-5#1)(2008-10#2)(2009-8#1)
the rat mammary##2##3##(1995-11#2)
the rat medial##2##3##(1997-2#1)(2013-8#1)
the rat neuronal cell adhesion molecule-encoding gene##2##7##(1993-6#2)
the rat neuronal cell##5##4##(1993-6#2)(2008-11#3)
the rat neuronal##6##3##(1993-6#2)(2008-11#3)(2010-12#1)
the rat neuropeptide Y##2##4##(1992-12#2)
the rat pituitary##5##3##(1992-12#3)(1992-6#1)(1993-11#1)
the rat placenta##2##3##(1995-12#1)(2008-10#1)
the rat spinal cord##4##4##(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)
the rat striatum##4##3##(1996-2#1)(1996-5#3)
the rat testis##2##3##(1990-5#1)(2008-9#1)
the rat trachea##3##3##(2008-9#3)
the rat urinary bladder##2##4##(1992-12#1)(1992-3#1)
the rat was##2##3##(1993-6#1)(2011-2#1)
the rat were investigated##2##4##(1994-2#1)(1995-12#1)
the rat were##3##3##(1994-2#1)(1995-12#1)(1996-5#1)
the rat##463##2##(1990-11#1)(1990-12#6)(1990-3#1)(1990-5#16)(1990-7#7)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#5)(1991-2#8)(1991-4#2)(1991-5#6)(1991-6#4)(1991-7#1)(1991-9#8)(1992-10#2)(1992-11#3)(1992-12#14)(1992-2#1)(1992-3#13)(1992-6#11)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#26)(1993-3#16)(1993-5#2)(1993-6#7)(1993-8#10)(1994-11#12)(1994-12#5)(1994-2#7)(1994-3#3)(1994-5#3)(1994-6#6)(1994-8#11)(1994-9#1)(1995-11#5)(1995-12#36)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-12#17)(1996-2#10)(1996-5#19)(1997-2#16)(1997-4#5)(1997-6#4)(1997-7#4)(2008-10#10)(2008-11#11)(2008-12#3)(2008-4#16)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#8)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#6)(2013-7#2)(2013-8#2)
the rat's##5##2##(1991-2#1)(1992-7#1)(1993-3#1)(2008-12#1)(2008-3#1)
the rate and extent of##4##5##(1992-6#1)(1992-8#1)(2008-10#2)
the rate and the extent of##2##6##(1992-8#1)(1993-6#1)
the rate and the##3##4##(1992-8#1)(1993-6#1)(1994-12#1)
the rate and##12##3##(1992-6#1)(1992-8#2)(1993-6#1)(1994-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)
the rate at which foragers##2##5##(2008-8#2)
the rate at which the##6##5##(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)
the rate at which##18##4##(1992-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#6)(2010-12#1)(2010-8#1)(2013-8#1)
the rate constant for the##3##5##(1990-7#1)(2008-7#1)(2008-8#1)
the rate constant for##4##4##(1990-7#1)(1995-2#1)(2008-7#1)(2008-8#1)
the rate constant of##2##4##(1995-2#1)(1995-6#1)
the rate constant##12##3##(1990-7#1)(1992-6#1)(1995-2#3)(1995-6#1)(1996-12#1)(2008-10#3)(2008-7#1)(2008-8#1)
the rate constants##2##3##(1997-2#1)(2008-10#1)
the rate for the##2##4##(1995-5#1)(1995-6#1)
the rate for##3##3##(1994-2#1)(1995-5#1)(1995-6#1)
the rate in##7##3##(1991-5#1)(1993-11#1)(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#1)
the rate limiting##4##3##(1996-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
the rate of DNA##2##4##(1992-11#1)(1993-8#1)
the rate of Fe(II) uptake##2##5##(1996-2#2)
the rate of aging##2##4##(2008-9#1)(2009-5#1)
the rate of aspartate##2##4##(1990-7#1)(1991-3#1)
the rate of change of##2##5##(2008-8#1)(2009-6#1)
the rate of change##3##4##(2008-8#2)(2009-6#1)
the rate of complications##2##4##(1990-9#1)(2010-7#1)
the rate of decline##2##4##(2008-7#1)(2010-8#1)
the rate of degradation of##3##5##(1990-5#1)(1992-12#1)(2008-10#1)
the rate of development##2##4##(2008-8#1)(2008-9#1)
the rate of disease##3##4##(2008-10#3)
the rate of enzymatic hydrolysis##2##5##(2008-7#1)(2013-1#1)
the rate of gluconeogenesis##2##4##(1991-3#1)(1994-8#1)
the rate of glucose##2##4##(2008-11#1)(2008-6#1)
the rate of growth in##2##5##(1992-2#1)(2013-7#1)
the rate of growth of##2##5##(1990-7#1)(2012-2#1)
the rate of growth##7##4##(1990-7#1)(1992-2#1)(2007-12#1)(2009-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
the rate of hydrolysis of##2##5##(1990-5#1)(1994-11#1)
the rate of hydrolysis##3##4##(1990-5#1)(1994-11#1)(2013-1#1)
the rate of inactivation##2##4##(1993-11#2)
the rate of incorporation of##3##5##(1991-12#1)(1997-1#1)(2008-1#1)
the rate of increase in##3##5##(1990-7#1)(1993-12#1)(2008-9#1)
the rate of increase##5##4##(1990-7#1)(1993-12#1)(1993-3#1)(2008-10#1)(2008-9#1)
the rate of infection##3##4##(2007-10#1)(2008-10#2)
the rate of minors' abortions per 1000##2##7##(1994-2#2)
the rate of neonatal cord blood HBV-DNA##2##7##(2011-1#2)
the rate of oxygen consumption##2##5##(2008-10#1)(2010-11#1)
the rate of phosphorylation of the glycine receptor by##2##9##(1992-11#2)
the rate of population##2##4##(1994-7#1)(2008-10#1)
the rate of progression##2##4##(1991-8#1)(2011-3#1)
the rate of protein##3##4##(1990-11#1)(1990-5#1)(1994-6#1)
the rate of pustule appearance##2##5##(2008-10#2)
the rate of reaction##2##4##(1995-5#1)(2008-10#1)
the rate of recovery##2##4##(2008-11#1)(2008-12#1)
the rate of recurrence##2##4##(2008-10#1)(2013-8#1)
the rate of release##2##4##(1992-3#1)(2008-10#1)
the rate of replication##2##4##(2008-8#2)
the rate of responding##2##4##(1993-6#1)(1997-7#1)
the rate of restenosis##3##4##(1994-11#2)(2008-11#1)
the rate of surface##2##4##(2008-4#1)(2009-12#1)
the rate of the propagation period##2##6##(1991-12#2)
the rate of the##15##4##(1991-12#2)(1992-1#1)(1994-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#1)
the rate of transcription of the##2##6##(1992-1#1)(1992-12#1)
the rate of transport##3##4##(1995-11#1)(2008-10#2)
the rate of tumor##2##4##(1990-7#1)(2013-1#1)
the rate of uptake and##2##5##(1995-11#1)(2008-10#1)
the rate of wound##2##4##(2008-10#1)(2008-11#1)
the rate of##300##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#7)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#4)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-4#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#56)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#12)(2008-8#13)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#7)(2011-3#1)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#5)
the rate##383##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#1)(1991-12#7)(1991-2#1)(1991-3#2)(1991-5#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#3)(1993-11#8)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#4)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#6)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#76)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#16)(2008-8#21)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#8)(2011-3#1)(2012-2#6)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#6)
the rate-determining##2##2##(1997-7#1)(2008-10#1)
the rate-limiting enzyme in the##3##5##(1991-9#1)(2010-2#1)(2012-2#1)
the rate-limiting enzyme in##4##4##(1991-9#1)(1994-11#1)(2010-2#1)(2012-2#1)
the rate-limiting step in hepatic gluconeogenesis##2##6##(1995-6#1)(1996-2#1)
the rate-limiting step in##3##4##(1991-5#1)(1995-6#1)(1996-2#1)
the rate-limiting step of##3##4##(1992-12#1)(2012-2#2)
the rate-limiting step##9##3##(1991-5#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-6#1)(2012-2#2)
the rate-limiting##17##2##(1991-5#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-6#1)(2010-2#1)(2012-2#3)
the ratemeter##3##2##(1996-2#3)
the ratemeter's##2##2##(1996-2#2)
the rates and the##2##4##(1990-5#1)(1990-8#1)
the rates and##5##3##(1990-5#1)(1990-8#1)(2011-2#1)(2012-12#2)
the rates are##2##3##(1995-5#1)(2008-11#1)
the rates at which##2##4##(1992-12#1)(2013-8#1)
the rates of Si increased in the soil##2##8##(2008-10#2)
the rates of lactate production and pyruvate decarboxylation##2##8##(1991-5#2)
the rates of lactate production##3##5##(1991-5#3)
the rates of primary and secondary##3##6##(1996-12#1)(2008-10#2)
the rates of##47##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#3)(1996-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#2)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#2)
the rates##62##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-5#3)(1991-9#1)(1992-12#3)(1992-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#3)(1996-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-11#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#3)
the rather##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
the rating##2##2##(1997-3#1)(2012-2#1)
the ratio 1##7##3##(2008-10#6)(2008-3#1)
the ratio before average##2##4##(2008-2#2)
the ratio between the fluorescence##2##5##(2007-11#1)(2008-10#1)
the ratio between the##13##4##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
the ratio between##22##3##(1991-5#1)(1993-2#1)(1995-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#2)
the ratio derivative##2##3##(2008-10#2)
the ratio index##3##3##(1994-5#2)(1996-5#1)
the ratio of apoptotic cells##2##5##(2008-11#1)(2012-1#1)
the ratio of the number of##2##6##(2008-11#1)(2010-8#1)
the ratio of the total##2##5##(2010-8#1)(2012-1#1)
the ratio of the##47##4##(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-12#4)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-8#1)(2010-10#1)(2010-8#2)(2012-1#1)(2012-2#1)
the ratio of##153##3##(1990-2#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#34)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#19)(2008-4#2)(2008-5#7)(2008-6#2)(2008-8#2)(2008-9#2)(2010-10#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#2)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#5)(2012-7#1)(2013-1#2)
the ratio##222##2##(1990-2#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#64)(2008-11#12)(2008-12#1)(2008-2#9)(2008-3#23)(2008-4#2)(2008-5#9)(2008-6#3)(2008-8#3)(2008-9#3)(2009-1#1)(2010-10#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#2)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#1)
the rational design of##3##4##(2008-10#1)(2009-9#1)(2013-7#1)
the rational##10##2##(1992-1#1)(1992-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2013-7#1)
the rationale and##3##3##(2008-7#1)(2010-11#1)(2011-1#1)
the rationale behind##5##3##(1995-2#1)(2010-8#1)(2011-1#1)(2011-2#2)
the rationale for and##2##4##(2008-3#1)(2009-6#1)
the rationale for##18##3##(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#1)
the rationale##33##2##(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#2)(1996-9#1)(1997-3#1)(2006-7#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)
the ratios of##5##3##(1992-11#1)(1994-9#1)(2008-3#1)(2011-1#1)(2011-2#1)
the ratios were##2##3##(1992-9#1)(1996-2#1)
the ratios##13##2##(1992-11#1)(1992-3#1)(1992-9#1)(1994-9#1)(1996-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
the rats treated with##4##4##(2011-1#2)(2011-2#1)(2013-1#1)
the rats were##9##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#3)(2013-1#2)
the rats with##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
the rats##42##2##(1990-7#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-3#2)(1996-7#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-2#2)(2013-1#5)
the rats'##2##2##(1992-7#1)(2011-3#1)
the raw material##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
the raw materials##6##3##(1994-3#2)(2008-10#4)
the raw##25##2##(1992-5#1)(1994-3#2)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
the ray optics model##4##4##(2008-3#4)
the ray optics##7##3##(2008-2#1)(2008-3#6)
the ray trace##2##3##(2008-3#2)
the ray##14##2##(2008-2#3)(2008-3#10)(2013-8#1)
the ray-optics##3##2##(2008-3#3)
the ray-tracing##4##2##(2008-3#4)
the rays that are##2##4##(2007-11#1)(2007-12#1)
the rays##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
the rbcS genes##2##3##(1993-12#2)
the rbcS##4##2##(1993-12#3)(1994-8#1)
the rbs##2##2##(2011-1#2)
the rdo phenotype##2##3##(2008-9#2)
the rdo##3##2##(2008-9#3)
the re-emergence of##2##3##(2008-8#1)(2011-2#1)
the re-establishment##2##2##(2012-12#1)(2013-1#1)
the re-proteins##2##2##(1997-4#2)
the reach of##7##3##(1996-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-2#1)(2013-1#1)
the reach##8##2##(1994-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-2#1)(2013-1#1)
the reaching##2##2##(1996-2#1)(2008-6#1)
the reactant##5##2##(2008-3#1)(2013-8#4)
the reactants##8##2##(1990-7#1)(1996-2#1)(2007-11#1)(2008-10#3)(2009-11#1)(2013-8#1)
the reacted##2##2##(2008-10#2)
the reaction and the##2##4##(2007-5#1)(2008-10#1)
the reaction and##6##3##(1996-5#1)(2007-11#1)(2007-5#1)(2008-10#2)(2009-2#1)
the reaction between the analytes and##3##6##(2008-10#3)
the reaction between the##5##4##(2008-10#5)
the reaction between##36##3##(1990-5#1)(2008-10#34)(2011-2#1)
the reaction catalyzed by##2##4##(1992-3#1)(2008-10#1)
the reaction center##3##3##(1993-11#1)(1993-8#1)(2008-8#1)
the reaction centre##2##3##(2008-10#2)
the reaction coil##3##3##(2008-10#3)
the reaction conditions##12##3##(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-7#1)(2013-8#1)
the reaction field method##2##4##(2013-1#2)
the reaction field##4##3##(2008-10#1)(2010-12#1)(2013-1#2)
the reaction has##2##3##(2008-10#1)(2008-4#1)
the reaction is##12##3##(1996-5#1)(2008-10#10)(2009-10#1)
the reaction mechanism##4##3##(1995-6#1)(2007-11#1)(2008-10#2)
the reaction mechanisms##4##3##(1992-8#1)(2007-11#1)(2008-10#2)
the reaction media##2##3##(2008-10#2)
the reaction medium and##2##4##(2008-10#2)
the reaction medium##12##3##(1996-5#1)(2008-10#9)(2008-7#2)
the reaction mixture was##2##4##(2008-10#1)(2010-4#1)
the reaction mixture##12##3##(1991-12#1)(1992-9#1)(1994-5#1)(2008-10#6)(2008-4#1)(2008-8#1)(2010-4#1)
the reaction mixtures##2##3##(2008-10#2)
the reaction norm##2##3##(2008-10#1)(2008-8#1)
the reaction of cobalt##2##4##(2008-10#2)
the reaction of luminol with##4##5##(2008-10#4)
the reaction of luminol##5##4##(2008-10#5)
the reaction of mercury##2##4##(2008-10#2)
the reaction of the##8##4##(2008-10#5)(2010-4#1)(2011-1#1)(2013-8#1)
the reaction of##94##3##(1990-11#1)(1990-5#1)(1990-7#1)(1993-11#1)(1993-6#1)(1994-5#3)(1994-6#3)(1995-6#1)(1996-2#1)(1996-5#4)(1997-2#1)(2007-11#3)(2008-10#64)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
the reaction pathway##2##3##(1991-9#1)(2008-1#1)
the reaction pathways##2##3##(1997-6#1)(2008-10#1)
the reaction product##5##3##(1990-7#1)(1990-8#1)(1995-5#1)(2008-10#1)(2008-6#1)
the reaction products was##2##4##(2008-10#1)(2008-4#1)
the reaction products##11##3##(1990-7#2)(1994-6#1)(1996-12#1)(2008-10#4)(2008-4#2)(2009-8#1)
the reaction rate is##2##4##(2008-10#1)(2008-7#1)
the reaction rate was##3##4##(2008-10#2)(2008-7#1)
the reaction rate##12##3##(1990-7#1)(2007-11#1)(2008-10#6)(2008-7#3)(2011-2#1)
the reaction rates of##2##4##(2008-10#1)(2008-9#1)
the reaction rates##3##3##(2008-10#2)(2008-9#1)
the reaction system##7##3##(2008-10#5)(2009-8#1)(2011-1#1)
the reaction temperature##3##3##(2008-10#2)(2011-2#1)
the reaction time of##2##4##(1996-2#1)(2008-10#1)
the reaction time##11##3##(1996-2#1)(1996-5#1)(2008-10#7)(2008-5#2)
the reaction to##5##3##(1990-11#1)(2007-12#1)(2008-10#3)
the reaction vessel##2##3##(2008-10#1)(2008-7#1)
the reaction was also##2##4##(2008-10#2)
the reaction was investigated##2##4##(2008-10#2)
the reaction was##11##3##(1990-6#1)(1992-12#1)(1996-2#1)(2008-10#6)(2008-5#1)(2008-8#1)
the reaction were##8##3##(1994-11#1)(1997-2#1)(2008-10#5)(2008-11#1)
the reaction with##14##3##(1992-3#1)(2008-10#10)(2008-11#2)(2008-5#1)
the reaction##403##2##(1990-11#2)(1990-5#2)(1990-6#1)(1990-7#7)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#3)(1993-8#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#4)(1995-2#3)(1995-5#2)(1995-6#4)(1996-12#1)(1996-2#4)(1996-5#9)(1997-2#3)(1997-6#2)(2007-11#8)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#245)(2008-11#3)(2008-2#2)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#3)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#5)(2013-8#5)
the reactions are##2##3##(1997-5#1)(2008-10#1)
the reactions of the##4##4##(1992-6#1)(2008-10#2)(2012-2#1)
the reactions of##14##3##(1992-6#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
the reactions were##3##3##(2008-10#3)
the reactions with##4##3##(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
the reactions##34##2##(1992-3#1)(1992-6#2)(1994-5#2)(1995-2#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
the reactivation of##4##3##(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
the reactivation##5##2##(1995-6#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
the reactive intermediate##3##3##(1995-6#3)
the reactive oxygen species (ROS)##3##5##(2008-10#2)(2013-1#1)
the reactive oxygen species##5##4##(2008-10#2)(2011-2#1)(2013-1#2)
the reactive oxygen##7##3##(1993-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#2)
the reactive site##4##3##(1991-8#3)(1995-6#1)
the reactive##30##2##(1991-8#3)(1993-6#1)(1994-2#1)(1995-6#4)(1995-8#1)(1997-3#2)(2008-10#8)(2008-11#2)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
the reactivity of the##8##4##(1991-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(2008-10#2)(2012-2#1)(2013-1#1)
the reactivity of##20##3##(1990-12#1)(1990-5#1)(1991-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#2)
the reactivity ratios were##2##4##(2012-12#2)
the reactivity##28##2##(1990-12#2)(1990-5#1)(1991-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#2)
the reactor and##2##3##(2008-11#1)(2008-7#1)
the reactor##16##2##(1991-5#2)(2008-10#5)(2008-11#4)(2008-6#1)(2008-7#2)(2009-2#1)(2013-1#1)
the reactors##3##2##(2008-10#2)(2008-7#1)
the read##2##2##(2008-3#1)(2012-3#1)
the readability and comprehensiveness of##2##5##(2011-1#2)
the reader in##2##3##(1996-2#1)(2008-1#1)
the reader should##4##3##(1992-2#1)(2008-7#3)
the reader to the##2##4##(2008-9#1)(2010-11#1)
the reader to##4##3##(2008-4#1)(2008-9#2)(2010-11#1)
the reader up-to-date on##2##4##(1992-2#1)(2012-3#1)
the reader will be able to##2##6##(2012-12#1)(2012-3#1)
the reader will##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
the reader with a##2##4##(2009-5#1)(2011-2#1)
the reader with##9##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
the reader##31##2##(1992-2#2)(1996-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#3)(2009-12#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
the readers##4##2##(1991-3#1)(2009-12#1)(2011-2#1)(2012-12#1)
the readily available##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
the readily##5##2##(1992-9#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
the readiness for##2##3##(2008-11#1)(2011-2#1)
the readiness##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
the reading frame of##2##4##(1991-1#1)(1994-12#1)
the reading frame##5##3##(1990-7#1)(1991-1#1)(1992-9#1)(1994-12#1)(1997-4#1)
the reading light##2##3##(2008-3#2)
the reading##14##2##(1990-7#1)(1991-1#1)(1992-9#1)(1994-12#1)(1997-4#1)(2008-12#1)(2008-2#2)(2008-3#4)(2011-2#2)
the readings##2##2##(1993-1#1)(2010-7#1)
the readout signal##5##3##(2008-2#1)(2008-3#4)
the readout##16##2##(2008-2#6)(2008-3#9)(2013-8#1)
the reagent and sample##2##4##(2008-10#2)
the reagent and##5##3##(2008-10#5)
the reagent blank##5##3##(2008-10#5)
the reagent concentration##2##3##(2008-10#2)
the reagent in##2##3##(2008-10#2)
the reagent reacts with##2##4##(2008-10#2)
the reagent solution##3##3##(2008-10#3)
the reagent to##2##3##(2008-10#1)(2008-4#1)
the reagent was##2##3##(2008-10#2)
the reagent##55##2##(1990-7#1)(1993-11#1)(2007-10#1)(2008-10#49)(2008-4#1)(2008-5#1)(2008-8#1)
the reagent-injection##2##2##(2008-10#2)
the reagents##24##2##(1994-11#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
the real and the imaginary parts of the##9##8##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)
the real and the imaginary parts of##10##7##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)
the real and the imaginary##12##5##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#5)
the real and the##13##4##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#6)
the real and##16##3##(1997-7#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#7)
the real need##2##3##(1991-2#1)(1993-12#1)
the real part of the aerosol refractive index##2##8##(2008-3#2)
the real part of the complex refractive index to +/-0##2##10##(2008-3#2)
the real part of the complex refractive index##3##8##(2008-3#3)
the real part of the index##2##6##(2008-3#2)
the real part of the refractive index##3##7##(2008-2#1)(2008-3#2)
the real part of the##10##5##(2008-2#1)(2008-3#9)
the real part of##11##4##(2007-11#1)(2008-2#1)(2008-3#9)
the real part##13##3##(2007-11#1)(2008-2#1)(2008-3#11)
the real problem##2##3##(1994-1#1)(2009-4#1)
the real sample##4##3##(2008-10#4)
the real samples##7##3##(2008-10#6)(2008-5#1)
the real world##10##3##(1994-12#2)(1996-4#1)(1997-1#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
the real##92##2##(1991-2#1)(1992-12#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-2#6)(2008-3#22)(2008-5#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
the real-time PCR##4##3##(2008-10#3)(2013-8#1)
the real-time detection##2##3##(2008-10#1)(2009-12#1)
the real-time##19##2##(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#2)(2013-8#4)
the realism of role plays##2##5##(2009-11#2)
the realism of##4##3##(2009-11#3)(2012-2#1)
the realistic##4##2##(1991-12#1)(2007-12#1)(2008-11#1)(2008-5#1)
the realities of##4##3##(2008-11#2)(2010-4#1)(2013-8#1)
the reality has##2##3##(1995-12#1)(1996-3#1)
the reality of the##2##4##(2008-11#2)
the reality of##6##3##(1994-12#2)(2008-11#2)(2009-10#1)(2010-12#1)
the reality##11##2##(1994-1#1)(1994-12#2)(1995-12#1)(1996-3#1)(2008-11#2)(2009-10#1)(2010-10#1)(2010-12#1)(2012-3#1)
the realization of a novel##2##5##(2008-3#2)
the realization of a##8##4##(2007-11#1)(2008-3#5)(2008-7#1)(2011-2#1)
the realization of the##3##4##(1992-3#1)(1992-5#1)(2008-10#1)
the realization of these##2##4##(2008-10#1)(2008-7#1)
the realization of##22##3##(1992-3#1)(1992-5#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
the realization that##3##3##(1994-12#1)(2007-12#1)(2008-10#1)
the realization##25##2##(1992-3#1)(1992-5#1)(1994-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
the realized##4##2##(2008-10#1)(2008-8#3)
the realm of##9##3##(1997-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-8#1)
the rear##8##2##(1996-12#1)(2007-12#3)(2008-10#2)(2008-3#1)(2013-1#1)
the rearing conditions##2##3##(1991-2#2)
the rearing##5##2##(1990-3#2)(1991-2#2)(2007-12#1)
the rearranged##2##2##(1996-5#1)(2012-12#1)
the rearrangement of##3##3##(1994-6#1)(2009-11#1)(2009-12#1)
the rearrangement##7##2##(1993-11#1)(1994-6#1)(1995-3#1)(1996-5#2)(2009-11#1)(2009-12#1)
the reason for the presence of stereoisomers in these systems is not well understood##2##14##(2010-2#2)
the reason for the##9##4##(1992-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#2)
the reason for##18##3##(1992-12#1)(1995-5#1)(1996-12#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-2#2)(2012-3#1)
the reason of##2##3##(2007-11#1)(2013-8#1)
the reason that##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
the reason why##2##3##(2008-10#1)(2010-6#1)
the reason##32##2##(1991-9#1)(1992-1#1)(1992-12#1)(1995-5#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-8#2)(2010-2#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
the reasonable##2##2##(1993-3#1)(2008-3#1)
the reasons behind##2##3##(2007-12#1)(2010-12#1)
the reasons for choosing##2##4##(2008-3#1)(2010-11#1)
the reasons for its##2##4##(2008-7#2)
the reasons for non-attendance##2##4##(1991-6#2)
the reasons for the##6##4##(1994-2#1)(1996-2#1)(2007-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
the reasons for their##2##4##(2008-10#1)(2008-11#1)
the reasons for this##2##4##(2008-10#2)
the reasons for##31##3##(1991-6#3)(1992-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
the reasons why faculty choose not to participate in these courses##2##11##(2013-1#2)
the reasons why people##2##4##(2009-6#1)(2012-12#1)
the reasons why the##2##4##(2008-4#1)(2010-4#1)
the reasons why##11##3##(1991-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-6#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
the reasons##52##2##(1991-2#1)(1991-6#3)(1991-9#1)(1992-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
the recall##2##2##(2010-11#1)(2011-2#1)
the receipt of##3##3##(1990-11#1)(1996-1#1)(2012-12#1)
the receipt##4##2##(1990-11#1)(1996-1#1)(2008-11#1)(2012-12#1)
the receive aperture##2##3##(2008-2#2)
the receive mode of##2##4##(2008-3#2)
the receive##5##2##(2008-2#2)(2008-3#2)(2011-2#1)
the received optical##2##3##(2008-2#1)(2008-3#1)
the received##11##2##(2007-11#1)(2008-2#5)(2008-3#5)
the receiver is calculated##2##4##(2007-11#1)(2008-2#1)
the receiver is##4##3##(2007-11#1)(2008-2#3)
the receiver output##2##3##(2007-11#1)(2008-2#1)
the receiver##43##2##(2007-11#7)(2007-12#1)(2008-10#2)(2008-2#16)(2008-3#15)(2012-3#1)(2013-1#1)
the receiver's##3##2##(2008-2#1)(2008-3#2)
the receiver-stimulator##4##2##(2008-9#2)(2012-2#2)
the receiver/stimulator package##2##3##(2012-2#2)
the receiving phase##3##3##(2008-10#3)
the receiving##5##2##(2008-10#4)(2009-10#1)
the recent advances in the##2##5##(2011-3#1)(2012-2#1)
the recent advances in understanding the##2##6##(2008-5#1)(2012-2#1)
the recent advances in##7##4##(2008-1#1)(2008-5#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
the recent advances##9##3##(2008-1#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
the recent availability of##2##4##(2008-10#1)(2008-4#1)
the recent development in##2##4##(2010-12#1)(2010-8#1)
the recent development of##5##4##(2008-7#1)(2009-5#1)(2010-12#2)(2010-7#1)
the recent development##7##3##(2008-7#1)(2009-5#1)(2010-12#3)(2010-7#1)(2010-8#1)
the recent emergence of##3##4##(2008-10#1)(2008-12#1)(2009-12#1)
the recent finding##2##3##(1990-8#1)(2010-11#1)
the recent findings##2##3##(2008-11#1)(2008-4#1)
the recent identification of##2##4##(2008-10#1)(2008-8#1)
the recent increase in##2##4##(2008-10#1)(2010-1#1)
the recent increase##3##3##(2008-10#2)(2010-1#1)
the recent literature on##2##4##(1991-12#1)(1994-6#1)
the recent literature##12##3##(1990-6#1)(1991-12#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
the recent past and##3##4##(1991-3#2)(2012-5#1)
the recent past##8##3##(1991-3#2)(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-5#1)
the recent progress in the##2##5##(2010-11#1)(2013-1#1)
the recent progress##3##3##(2008-3#1)(2010-11#1)(2013-1#1)
the recent proposition that##2##4##(1995-6#1)(2008-10#1)
the recent research##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2012-12#1)
the recent results of##2##4##(2008-4#1)(2010-3#1)
the recent results##3##3##(2008-4#1)(2010-3#1)(2011-2#1)
the recent studies##2##3##(2009-1#1)(2010-5#1)
the recent trends in##2##4##(2007-7#1)(2008-1#1)
the recent years##9##3##(1994-11#1)(1995-4#1)(1995-5#1)(1997-4#1)(2007-7#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the recent##154##2##(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-4#2)(1997-4#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#5)(2008-10#20)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2012-5#1)(2012-8#1)(2013-1#4)(2013-8#1)
the recently cloned##2##3##(1993-6#1)(2008-4#1)
the recently created##2##3##(1994-12#1)(2011-2#1)
the recently described##7##3##(1992-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2012-2#1)(2013-7#1)
the recently developed technique of##2##5##(2007-12#2)
the recently developed##13##3##(1997-3#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-8#1)
the recently discovered##2##3##(2008-10#1)(2013-1#1)
the recently identified##6##3##(1990-12#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-7#1)
the recently introduced##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
the recently isolated##2##3##(1991-2#1)(2013-8#1)
the recently proposed##6##3##(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)
the recently published##6##3##(1992-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
the recently reported##6##3##(1991-9#1)(1993-12#1)(1995-6#1)(2006-6#1)(2007-12#1)(2008-10#1)
the recently revised##3##3##(1994-5#1)(2009-4#1)(2012-2#1)
the recently solved##2##3##(1997-7#1)(1997-9#1)
the recently##76##2##(1990-12#1)(1991-2#2)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-6#2)(1996-7#1)(1997-3#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-12#7)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
the receptacle area##5##3##(2008-10#5)
the receptacle##6##2##(2008-10#6)
the reception##3##2##(1996-1#1)(2008-11#1)(2012-12#1)
the receptive fields##2##3##(2008-11#1)(2008-8#1)
the receptive stage of the##2##5##(1994-9#2)
the receptive stage##3##3##(1994-9#3)
the receptive##7##2##(1994-9#3)(2008-11#1)(2008-8#2)(2011-1#1)
the receptor activator of nuclear factor##2##6##(2007-8#1)(2010-10#1)
the receptor activator of##3##4##(2007-8#1)(2008-11#1)(2010-10#1)
the receptor affinity##3##3##(1992-12#1)(1996-5#2)
the receptor and##6##3##(1995-6#1)(1995-8#1)(2008-3#1)(2008-4#2)(2011-2#1)
the receptor binding##6##3##(1990-11#1)(1991-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2009-2#1)
the receptor expression##2##3##(2008-4#1)(2010-11#1)
the receptor for##7##3##(1990-11#1)(1992-12#1)(1994-5#1)(2008-7#1)(2010-11#1)(2013-1#2)
the receptor in the##2##4##(1990-11#1)(1994-11#1)
the receptor is##7##3##(1990-11#2)(1993-3#1)(1994-11#1)(1994-8#2)(1995-6#1)
the receptor of##2##3##(2008-8#2)
the receptor on##2##3##(1992-10#1)(2008-11#1)
the receptor was##3##3##(1990-2#1)(1992-8#1)(2008-11#1)
the receptor##125##2##(1990-11#6)(1990-2#2)(1990-4#1)(1990-5#3)(1991-2#1)(1991-5#3)(1992-10#1)(1992-12#4)(1992-3#2)(1992-4#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-6#3)(1993-9#2)(1994-11#4)(1994-12#2)(1994-5#4)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#5)(1997-2#1)(1997-4#2)(1997-7#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
the receptor-bound##3##2##(1993-8#2)(1995-11#1)
the receptors for##4##3##(1993-8#1)(1995-12#1)(1996-2#1)(2008-10#1)
the receptors involved##2##3##(1995-12#1)(2008-7#1)
the receptors of##3##3##(1993-2#2)(2009-8#1)
the receptors were##2##3##(2008-4#2)
the receptors##26##2##(1993-2#2)(1993-8#2)(1995-11#2)(1995-12#3)(1995-3#1)(1996-2#2)(1997-4#1)(2007-12#2)(2008-10#1)(2008-4#5)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
the recessive##7##2##(1990-5#2)(2008-10#2)(2008-11#1)(2008-9#1)(2012-3#1)
the recipient and the##2##4##(2011-2#2)
the recipient and##3##3##(2008-10#1)(2011-2#2)
the recipient enterprises##2##3##(1995-6#2)
the recipient of##2##3##(1994-12#1)(1997-4#1)
the recipient##23##2##(1991-7#1)(1994-12#1)(1995-6#2)(1997-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#5)(2011-3#2)(2012-3#1)(2013-8#1)
the recipient's##6##2##(1990-3#1)(1992-12#2)(1997-5#2)(2007-10#1)
the recipients are##2##3##(2008-1#1)(2011-2#1)
the recipients##4##2##(2008-1#2)(2008-6#1)(2011-2#1)
the reciprocal crosses##2##3##(2009-12#1)(2012-3#1)
the reciprocal of the##6##4##(1990-11#2)(2008-2#1)(2008-3#2)(2008-5#1)
the reciprocal of##7##3##(1990-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
the reciprocal translocation##2##3##(2007-11#1)(2012-12#1)
the reciprocal##22##2##(1990-11#3)(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the reciprocity theorem##4##3##(2008-3#4)
the reciprocity##5##2##(2008-2#1)(2008-3#4)
the recognised##2##2##(2008-10#1)(2008-8#1)
the recognition and treatment of##2##5##(2008-1#1)(2012-3#1)
the recognition and##5##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
the recognition of a##3##4##(1997-8#1)(2007-12#1)(2008-3#1)
the recognition of facial##2##4##(2008-11#1)(2008-5#1)
the recognition of the##6##4##(1993-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-1#1)
the recognition of##36##3##(1991-8#1)(1993-11#1)(1994-9#1)(1995-2#2)(1996-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
the recognition process##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
the recognition sequence##4##3##(1992-10#1)(1994-12#1)(1995-3#1)(1995-8#1)
the recognition site##2##3##(1995-6#2)
the recognition that##5##3##(1991-12#1)(1992-9#1)(2007-12#1)(2008-11#1)(2008-4#1)
the recognition##64##2##(1990-11#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the recombinant DNA##2##3##(2008-8#1)(2008-9#1)
the recombinant Escherichia coli##2##4##(1994-12#2)
the recombinant adenovirus##2##3##(2008-8#1)(2011-2#1)
the recombinant glycoprotein##2##3##(2008-11#1)(2008-7#1)
the recombinant human##8##3##(1990-2#2)(1990-5#2)(1990-8#1)(1994-5#2)(2008-10#1)
the recombinant plasmid##5##3##(1994-3#1)(1997-6#1)(2008-6#1)(2008-8#1)(2011-1#1)
the recombinant protein to##2##4##(2008-10#1)(2008-7#1)
the recombinant protein##15##3##(1990-11#2)(1995-2#1)(2008-10#1)(2008-11#6)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
the recombinant rat##2##3##(1992-8#1)(2008-4#1)
the recombinant thrombolytic##2##3##(2007-11#2)
the recombinant vaccinia virus##3##4##(2008-8#3)
the recombinant vector##2##3##(1994-5#1)(2010-4#1)
the recombinant##92##2##(1990-11#3)(1990-2#2)(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#4)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#1)(1997-4#2)(1997-6#1)(2007-11#2)(2008-10#8)(2008-11#14)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#2)(2009-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#4)(2011-3#1)(2013-1#2)(2013-8#1)
the recombinants##3##2##(1995-2#1)(1997-4#1)(2008-10#1)
the recombination events##2##3##(2008-10#1)(2013-8#1)
the recombination of##4##3##(1991-3#1)(1994-12#1)(1995-8#1)(2013-8#1)
the recombination process##2##3##(2008-4#1)(2013-1#1)
the recombination##16##2##(1991-3#1)(1994-12#1)(1995-12#1)(1995-8#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#4)
the recommendation of the##2##4##(1996-6#1)(2008-8#1)
the recommendation of##5##3##(1996-6#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
the recommendation##6##2##(1991-8#1)(1996-6#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
the recommendations of the##7##4##(2008-1#1)(2008-3#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the recommendations of##10##3##(1995-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the recommendations##21##2##(1990-6#1)(1994-6#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#3)
the recommended daily dietary allowances##2##5##(1997-4#2)
the recommended daily##5##3##(1997-4#2)(2010-4#1)(2010-6#1)(2013-1#1)
the recommended dose of##2##4##(2007-11#1)(2012-2#1)
the recommended level of##2##4##(2008-1#1)(2011-2#1)
the recommended levels for##2##4##(2008-5#1)(2011-2#1)
the recommended levels of HbA1c##3##5##(2011-2#3)
the recommended levels##6##3##(1997-3#1)(2008-5#1)(2011-2#4)
the recommended method##2##3##(2008-10#2)
the recommended procedure##5##3##(2008-10#5)
the recommended values##2##3##(2008-10#2)
the recommended##51##2##(1991-11#1)(1991-9#1)(1993-2#1)(1997-3#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
the reconstituted basement membrane##2##4##(1992-9#1)(2008-11#1)
the reconstituted##20##2##(1990-11#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-6#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-11#3)(2008-4#1)(2008-8#3)(2008-9#2)
the reconstitution of##3##3##(1990-8#1)(1992-3#1)(1994-8#1)
the reconstitution##9##2##(1990-7#1)(1990-8#3)(1992-3#1)(1994-8#1)(1995-8#3)
the reconstructed epidermis##2##3##(2008-5#2)
the reconstructed image##9##3##(2007-11#3)(2008-3#6)
the reconstructed images##3##3##(2007-11#1)(2008-3#2)
the reconstructed optical##2##3##(2008-3#1)(2011-1#1)
the reconstructed wave##3##3##(2008-2#1)(2008-3#2)
the reconstructed##40##2##(2007-11#4)(2007-12#5)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#15)(2008-5#2)(2008-7#1)(2008-9#3)(2009-1#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the reconstruction error##3##3##(2008-3#3)
the reconstruction of a##5##4##(2007-11#1)(2008-3#3)(2012-12#1)
the reconstruction of an##2##4##(1990-3#1)(2008-3#1)
the reconstruction of the##9##4##(1991-5#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2010-8#2)(2012-3#1)
the reconstruction of##34##3##(1990-3#1)(1990-5#1)(1991-5#2)(1993-6#2)(1994-3#1)(1996-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#4)(2008-3#6)(2008-7#1)(2009-11#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
the reconstruction##64##2##(1990-3#2)(1990-5#1)(1991-5#2)(1993-6#2)(1994-3#1)(1996-8#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-11#1)(2008-2#10)(2008-3#16)(2008-7#2)(2008-8#1)(2009-11#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
the reconstructions##2##2##(2008-2#1)(2008-3#1)
the reconstructive ladder##2##3##(2007-12#1)(2011-2#1)
the reconstructive surgeon##6##3##(2007-12#2)(2008-9#1)(2011-2#2)(2012-2#1)
the reconstructive##16##2##(2007-12#7)(2008-10#1)(2008-9#1)(2011-2#5)(2012-2#2)
the record of##5##3##(1995-3#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#1)
the record##9##2##(1995-3#1)(1997-3#1)(1997-5#3)(2007-11#1)(2008-10#1)(2008-4#1)(2013-7#1)
the recorded cases of##2##4##(1990-3#1)(1994-9#1)
the recorded##24##2##(1990-3#1)(1990-8#1)(1993-12#2)(1994-9#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#7)(2008-9#1)(2010-3#1)
the recording and reconstruction##2##4##(2008-2#1)(2008-3#1)
the recording and##6##3##(1993-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
the recording electrodes##2##3##(2008-4#1)(2010-8#1)
the recording layers##2##3##(2008-3#2)
the recording material##2##3##(2007-12#1)(2008-2#1)
the recording material's##2##3##(2008-3#2)
the recording medium##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
the recording of the##2##4##(2008-3#1)(2008-5#1)
the recording of two##2##4##(1997-4#1)(2008-3#1)
the recording of two-color##2##4##(2007-11#1)(2008-3#1)
the recording of volume##2##4##(2008-2#1)(2008-3#1)
the recording of##23##3##(1994-12#1)(1995-12#2)(1996-6#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#8)(2008-5#1)(2010-7#1)(2011-2#1)
the recording parameters##2##3##(2008-3#2)
the recording process##3##3##(2008-1#1)(2008-3#2)
the recording speed##2##3##(2008-2#1)(2008-3#1)
the recording step##2##3##(2007-12#1)(2008-3#1)
the recording##64##2##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#2)(1996-6#1)(1997-4#1)(2007-11#3)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#29)(2008-4#1)(2008-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#1)
the recordings##4##2##(1993-12#1)(2008-3#2)(2008-5#1)
the records from##3##3##(1990-6#1)(1994-3#2)
the records of the##3##4##(1995-6#1)(2008-1#2)
the records of##11##3##(1990-9#1)(1995-6#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
the records##19##2##(1990-6#1)(1990-9#1)(1992-11#1)(1994-3#4)(1995-6#1)(2006-10#1)(2007-7#1)(2008-1#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
the recovered##14##2##(1993-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
the recoveries are##5##3##(2008-10#5)
the recoveries in##2##3##(2008-10#2)
the recoveries obtained##4##3##(1997-6#1)(2008-10#3)
the recoveries of these ions are still over 92%##2##9##(2008-10#2)
the recoveries of##12##3##(2008-10#12)
the recoveries ranged from##2##4##(2008-10#2)
the recoveries ranged##3##3##(2008-10#3)
the recoveries##34##2##(1997-6#1)(2008-10#31)(2011-1#2)
the recoverin##2##2##(1995-6#2)
the recovery and##5##3##(2008-10#4)(2013-1#1)
the recovery from##3##3##(1992-3#1)(2008-8#1)(2010-7#1)
the recovery of activity##2##4##(1992-3#1)(2011-2#1)
the recovery of copper##2##4##(2008-10#2)
the recovery of each##2##4##(2008-10#2)
the recovery of eyestalk posture##2##5##(2008-5#2)
the recovery of lead in##2##5##(2008-10#2)
the recovery of relatives with eating disorders##2##7##(2011-2#2)
the recovery of the##16##4##(1990-7#1)(1991-5#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)
the recovery of trace##2##4##(2008-10#2)
the recovery of##84##3##(1990-7#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(2007-12#2)(2007-6#1)(2008-10#47)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
the recovery percentages##2##3##(2008-10#2)
the recovery period##4##3##(1992-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
the recovery process##8##3##(1991-2#1)(2011-2#1)(2012-2#4)(2013-1#2)
the recovery rate was##2##4##(2008-10#1)(2013-8#1)
the recovery rate##4##3##(2008-10#3)(2013-8#1)
the recovery rates were##2##4##(2008-10#2)
the recovery rates##5##3##(2008-10#5)
the recovery time##2##3##(2007-11#1)(2012-2#1)
the recovery values##2##3##(2008-10#2)
the recovery was##8##3##(1990-8#2)(1995-11#1)(2008-10#4)(2013-8#1)
the recovery were##2##3##(2008-10#2)
the recovery##155##2##(1990-5#2)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1992-3#3)(1992-9#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#84)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#3)
the recruiting of##2##3##(1995-8#1)(2008-5#1)
the recruiting##3##2##(1993-12#1)(1995-8#1)(2008-5#1)
the recruitment and##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2009-5#1)
the recruitment of motor units##2##5##(1996-5#1)(2013-1#1)
the recruitment of##11##3##(1992-6#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-6#2)(2010-3#1)(2013-1#2)
the recruitment##26##2##(1992-6#1)(1993-2#2)(1994-11#1)(1996-2#1)(1996-5#1)(2007-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2009-5#1)(2009-6#2)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
the rectal wall##2##3##(1990-9#1)(2008-10#1)
the rectal##7##2##(1990-9#1)(1992-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
the rectangular hyperbolic yield loss model based on weed density##2##10##(2008-12#2)
the rectangular##4##2##(1995-3#1)(2008-12#2)(2008-3#1)
the rectum and##7##3##(1992-5#1)(2007-8#1)(2008-7#1)(2009-12#1)(2012-1#1)(2012-12#2)
the rectum is##2##3##(2008-7#1)(2012-1#1)
the rectum wall##2##3##(2007-12#1)(2012-1#1)
the rectum##29##2##(1990-10#1)(1992-3#1)(1992-5#2)(1993-8#3)(1993-9#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-7#2)(2009-11#1)(2009-12#1)(2011-2#1)(2012-1#4)(2012-12#5)(2013-8#2)
the rectus abdominis##3##3##(1990-9#1)(2009-6#1)(2012-12#1)
the rectus femoris muscle##3##4##(2008-12#2)(2011-2#1)
the rectus femoris##6##3##(2008-12#2)(2011-2#2)(2012-1#2)
the rectus muscle##2##3##(1991-12#1)(1993-12#1)
the rectus##11##2##(1990-9#1)(1991-12#1)(1993-12#1)(2008-12#2)(2009-6#1)(2011-2#2)(2012-1#2)(2012-12#1)
the recurrence of IBS symptoms after##2##6##(2010-6#2)
the recurrence of the##2##4##(1995-4#1)(2008-3#1)
the recurrence of##12##3##(1995-4#1)(1997-8#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-6#2)(2011-2#3)(2012-2#1)(2013-8#1)
the recurrence rate##3##3##(2007-11#2)(2013-1#1)
the recurrence##17##2##(1994-7#1)(1995-4#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-3#1)(2009-6#1)(2010-6#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
the recurrences##2##2##(1991-6#1)(1996-9#1)
the recurrent nature of complications##2##5##(1995-12#2)
the recurrent##16##2##(1991-11#1)(1991-6#2)(1995-12#2)(1997-4#3)(2007-10#1)(2007-12#1)(2008-2#1)(2008-9#3)(2010-4#1)(2012-12#1)
the recycled HDPE##2##3##(2009-3#2)
the recycling of##7##3##(1991-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-9#1)
the recycling##8##2##(1991-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#3)(2008-9#1)
the red alga Asparagopsis armata##2##5##(2008-10#2)
the red alga##3##3##(2008-10#2)(2008-11#1)
the red and##5##3##(2008-10#1)(2008-3#3)(2008-8#1)
the red blood cell##5##4##(1994-12#1)(1997-6#2)(2008-5#1)(2011-2#1)
the red blood cells of##2##5##(1994-12#1)(2012-2#1)
the red blood cells##4##4##(1994-12#1)(1995-3#1)(2011-2#1)(2012-2#1)
the red blood##9##3##(1994-12#2)(1995-3#1)(1997-6#2)(2008-5#1)(2011-2#2)(2012-2#1)
the red cell##6##3##(1994-12#1)(1994-3#1)(1997-6#1)(2006-6#1)(2008-11#2)
the red cells##3##3##(1994-3#1)(2008-3#2)
the red light##5##3##(2007-12#1)(2008-2#2)(2008-4#1)(2012-2#1)
the red nucleus##8##3##(1992-11#8)
the red poultry mite##2##4##(1997-5#2)
the red side##2##3##(1995-5#1)(2008-3#1)
the red to blue##2##4##(2008-10#2)
the red##63##2##(1992-11#8)(1992-8#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-5#2)(1997-6#3)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#1)(2008-8#3)(2011-2#3)(2012-2#2)(2013-8#1)
the redesign of the##2##4##(1997-3#1)(2008-7#1)
the redesign process##2##3##(1996-3#2)
the redesign##6##2##(1996-3#3)(1997-3#1)(2007-12#1)(2008-7#1)
the redesigning##2##2##(1992-3#1)(2008-11#1)
the redifferentiation of##2##3##(2008-8#1)(2009-3#1)
the redox cycle##2##3##(1992-8#2)
the redox cycling##2##3##(1992-8#1)(2008-11#1)
the redox potential##3##3##(1995-2#1)(1995-5#1)(2008-10#1)
the redox properties of##3##4##(1995-5#1)(2008-9#1)(2010-6#1)
the redox properties##4##3##(1994-5#1)(1995-5#1)(2008-9#1)(2010-6#1)
the redox reaction between naphthol green B and potassium bromate##2##10##(2008-10#2)
the redox reaction between##5##4##(2008-10#5)
the redox reaction##10##3##(2008-10#10)
the redox state of##6##4##(1990-8#1)(1991-2#1)(1994-3#1)(2008-10#1)(2008-5#1)(2009-10#1)
the redox##47##2##(1990-8#1)(1991-2#2)(1992-8#3)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#2)(2008-10#26)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-6#1)
the redox-active##2##2##(2008-10#2)
the reduced and##2##3##(1995-5#1)(2011-2#1)
the reduced expression of##2##4##(2008-5#1)(2012-2#1)
the reduced form of##4##4##(1994-5#1)(2008-10#3)
the reduced form##5##3##(1994-5#1)(2008-10#4)
the reduced glutathione##2##3##(1990-2#1)(1994-9#1)
the reduced oxygen##2##3##(2007-2#1)(2012-2#1)
the reduced pyridine##2##3##(1995-2#1)(1996-2#1)
the reduced risk of##2##4##(2008-9#1)(2009-4#1)
the reduced risk##3##3##(2008-9#1)(2009-4#1)(2012-1#1)
the reduced scattering and absorption coefficients##3##6##(2008-2#2)(2008-3#1)
the reduced scattering coefficient##5##4##(2008-2#2)(2008-3#3)
the reduced scattering##13##3##(2008-2#5)(2008-3#8)
the reduced state##2##3##(1994-8#1)(2008-10#1)
the reduced use of##2##4##(2007-8#1)(2008-10#1)
the reduced##92##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-6#2)(1993-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#7)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
the reducing agent##4##3##(1995-11#1)(2008-10#2)(2011-2#1)
the reducing end of##3##4##(1992-10#1)(1995-11#1)(2011-1#1)
the reducing end##7##3##(1992-10#2)(1992-12#1)(1995-11#3)(2011-1#1)
the reducing of##2##3##(1992-5#1)(2013-8#1)
the reducing sugars##2##3##(2008-10#2)
the reducing##22##2##(1992-10#2)(1992-12#2)(1992-5#1)(1992-6#2)(1994-11#1)(1994-5#1)(1995-11#4)(2008-10#5)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
the reductase##9##2##(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-3#2)(2008-11#2)
the reduction and##4##3##(2008-10#2)(2009-12#1)(2011-2#1)
the reduction in the##11##4##(1992-3#1)(1992-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-3#1)
the reduction in##44##3##(1990-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-6#2)(2007-10#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#3)(2013-8#1)
the reduction is##2##3##(1991-1#1)(2008-10#1)
the reduction mechanism##2##3##(2008-10#2)
the reduction of Cr(VI)##2##4##(2008-10#1)(2011-2#1)
the reduction of dopamine biosynthesis##2##5##(2008-10#1)(2008-11#1)
the reduction of hydrogen##2##4##(2008-10#2)
the reduction of insulin##2##4##(1990-12#1)(2008-3#1)
the reduction of nitrate to nitrite##2##6##(2008-10#2)
the reduction of nitrate to##3##5##(2008-10#3)
the reduction of number of##2##5##(2008-10#1)(2013-7#1)
the reduction of oxygen##3##4##(1995-2#1)(2008-10#1)(2013-8#1)
the reduction of protein##2##4##(1997-2#1)(2008-11#1)
the reduction of risk##2##4##(2009-4#1)(2012-12#1)
the reduction of the##22##4##(1995-12#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#12)(2008-11#3)(2008-2#1)(2009-7#1)(2011-1#1)
the reduction of##130##3##(1990-12#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-3#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#2)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#53)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
the reduction peak current of##2##5##(2008-10#2)
the reduction peak current##3##4##(2008-10#3)
the reduction peak##4##3##(2008-10#4)
the reduction potential of##2##4##(1991-8#1)(2008-10#1)
the reduction product##3##3##(2008-10#3)
the reduction reaction##2##3##(2008-10#1)(2008-8#1)
the reduction was##6##3##(1991-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
the reduction##223##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#2)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-6#3)(1997-2#2)(1997-7#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#89)(2008-11#12)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#3)(2013-7#4)(2013-8#4)
the reductions##2##2##(2008-10#1)(2008-11#1)
the reductive amination of##2##4##(1996-5#2)
the reductive desorption##2##3##(2008-10#2)
the reductive pentosephosphate pathway##3##4##(2008-1#3)
the reductive##11##2##(1995-2#1)(1996-5#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#1)
the redundant signals##3##3##(2008-10#2)(2008-8#1)
the redundant##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
the reef##2##2##(2011-2#1)(2012-12#1)
the reemergence of##2##3##(1992-3#1)(2013-8#1)
the reference arm##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the reference beam is##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
the reference beam to##2##4##(2008-2#1)(2008-3#1)
the reference beam##17##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#11)
the reference beams##2##3##(2008-3#2)
the reference digits##2##3##(2008-3#2)
the reference electrode##2##3##(2008-10#2)
the reference image##3##3##(2008-3#3)
the reference light##3##3##(2007-11#2)(2008-11#1)
the reference materials##4##3##(2008-10#4)
the reference medium##2##3##(2008-3#2)
the reference method##13##3##(2008-10#12)(2012-3#1)
the reference methods##4##3##(2008-10#4)
the reference object##2##3##(2008-2#1)(2008-3#1)
the reference or##3##3##(2008-10#1)(2011-2#2)
the reference procedure##5##3##(2008-10#5)
the reference range##2##3##(1991-2#1)(1993-2#1)
the reference sequence##2##3##(2008-10#1)(2008-12#1)
the reference signal##3##3##(2008-2#3)
the reference solutions##2##3##(2008-10#1)(2008-5#1)
the reference spectrophotometer##3##3##(2008-3#3)
the reference standard##6##3##(1991-5#1)(2008-10#3)(2010-11#1)(2010-4#1)
the reference strain of##2##4##(2008-10#2)
the reference strain##7##3##(2008-10#4)(2008-5#1)(2011-2#2)
the reference strains##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
the reference surface##3##3##(2008-3#3)
the reference values##5##3##(1996-12#1)(2008-10#3)(2010-3#1)
the reference wave##4##3##(2008-3#4)
the reference wavelength##2##3##(2008-2#2)
the reference##177##2##(1990-8#1)(1991-2#1)(1991-5#3)(1993-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-11#6)(2007-12#6)(2008-10#57)(2008-11#3)(2008-12#2)(2008-2#15)(2008-3#50)(2008-5#3)(2009-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the references##4##2##(1994-1#1)(2010-3#1)(2010-9#2)
the referent group##4##3##(1996-6#3)(2008-11#1)
the referent##5##2##(1996-6#3)(2008-11#1)(2013-1#1)
the referral patterns##2##3##(1996-3#1)(2007-2#1)
the referral##9##2##(1995-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-2#2)(2007-8#1)(2011-1#2)
the referred pain area##3##4##(2010-9#3)
the referred pain sensation##2##4##(2008-12#2)
the referred pain##8##3##(2008-12#2)(2008-9#1)(2010-9#5)
the referred##11##2##(1992-3#1)(2008-12#2)(2008-9#2)(2010-8#1)(2010-9#5)
the referring physician##2##3##(1992-3#1)(1993-2#1)
the referring physician's##2##3##(1993-12#1)(1996-1#1)
the referring##6##2##(1992-3#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-3#1)(2008-12#1)
the refinement of the##2##4##(1994-2#1)(2008-10#1)
the refinement of##5##3##(1994-2#1)(1997-7#1)(2008-10#2)(2008-3#1)
the refinement##6##2##(1993-3#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-3#1)
the reflectance at##2##3##(2008-10#1)(2008-3#1)
the reflectance of the##5##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
the reflectance of these##2##4##(2007-11#1)(2008-3#1)
the reflectance of##8##3##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#3)
the reflectance##25##2##(2007-11#3)(2008-10#5)(2008-2#6)(2008-3#11)
the reflectances of the##3##4##(2008-2#2)(2008-3#1)
the reflectances##4##2##(2008-2#2)(2008-3#2)
the reflected beam is##2##4##(2008-2#1)(2008-3#1)
the reflected beam##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the reflected beams##2##3##(2008-3#2)
the reflected light wave##2##4##(2008-3#2)
the reflected light##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the reflected signal##2##3##(2008-3#2)
the reflected##32##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#18)(2010-12#1)
the reflecting##6##2##(2007-11#1)(2008-3#4)(2009-8#1)
the reflection and transmission##2##4##(2007-12#2)
the reflection and##3##3##(2007-12#2)(2008-3#1)
the reflection band##3##3##(2007-11#3)
the reflection coefficient##2##3##(2008-2#1)(2008-3#1)
the reflection function of##2##4##(2008-3#2)
the reflection function##3##3##(2008-2#1)(2008-3#2)
the reflection mode##3##3##(2008-2#3)
the reflection of a##4##4##(2007-11#1)(2008-3#3)
the reflection of atmospheric-emitted##2##4##(2008-3#2)
the reflection of the##2##4##(2007-12#1)(2008-3#1)
the reflection of##13##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#8)
the reflection spectra##2##3##(2007-11#1)(2008-3#1)
the reflection##44##2##(2007-11#7)(2007-12#9)(2008-11#1)(2008-2#9)(2008-3#17)(2013-1#1)
the reflective grating##2##3##(2008-2#1)(2008-3#1)
the reflective##8##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#4)(2012-12#1)
the reflectivity of a##3##4##(2008-2#1)(2008-3#2)
the reflectivity of##9##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
the reflectivity##22##2##(2007-11#4)(2007-12#3)(2008-2#4)(2008-3#11)
the reflectors##3##2##(2008-3#2)(2008-7#1)
the reflex##2##2##(1993-12#1)(2013-1#1)
the reflexes##2##2##(1992-12#1)(2013-1#1)
the refolded##2##2##(1995-2#1)(2009-3#1)
the refolding of##3##3##(1995-8#1)(1997-4#1)(2011-2#1)
the refolding##5##2##(1995-8#1)(1997-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
the reform of health##2##4##(1997-2#1)(2012-12#1)
the reform of##6##3##(1992-12#1)(1997-2#1)(2008-2#2)(2008-8#1)(2012-12#1)
the reform##13##2##(1992-12#1)(1992-5#1)(1994-12#1)(1997-2#2)(2007-5#1)(2008-2#5)(2008-8#1)(2012-12#1)
the reforms##4##2##(1993-2#1)(1995-3#1)(1997-5#1)(2012-1#1)
the refracted##4##2##(2007-11#1)(2008-3#3)
the refraction of##2##3##(2008-3#1)(2008-4#1)
the refraction##6##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-6#1)
the refractive index and absorption##2##5##(2008-2#1)(2008-3#1)
the refractive index and the##8##5##(2008-2#1)(2008-3#6)(2011-1#1)
the refractive index and##12##4##(2007-11#1)(2008-2#2)(2008-3#8)(2011-1#1)
the refractive index is a##2##5##(2008-2#1)(2008-3#1)
the refractive index is##10##4##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#4)
the refractive index n and the##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
the refractive index n and##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
the refractive index n##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
the refractive index of a##5##5##(2008-2#1)(2008-3#4)
the refractive index of the medium##4##6##(2007-11#1)(2008-3#3)
the refractive index of the outer##2##6##(2008-2#1)(2008-3#1)
the refractive index of the surrounding##2##6##(2007-11#1)(2010-2#1)
the refractive index of the##21##5##(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#8)(2009-6#1)(2010-2#1)
the refractive index of thin liquid films with a spectrometer##2##10##(2008-3#2)
the refractive index of water##2##5##(2008-10#1)(2008-3#1)
the refractive index of##41##4##(2007-11#6)(2007-12#2)(2008-10#3)(2008-2#7)(2008-3#21)(2009-6#1)(2010-2#1)
the refractive index was##2##4##(2008-2#1)(2008-3#1)
the refractive index##105##3##(2007-11#12)(2007-12#8)(2008-10#6)(2008-2#24)(2008-3#51)(2009-6#1)(2010-2#1)(2011-1#2)
the refractive indices and##2##4##(2008-2#1)(2008-3#1)
the refractive indices of a##2##5##(2008-3#2)
the refractive indices of the sample##2##6##(2007-12#1)(2008-3#1)
the refractive indices of the##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the refractive indices of##11##4##(2007-12#1)(2008-2#1)(2008-3#9)
the refractive indices##18##3##(2007-12#1)(2008-2#5)(2008-3#12)
the refractive##125##2##(2007-11#12)(2007-12#9)(2008-10#6)(2008-2#30)(2008-3#63)(2009-6#1)(2010-2#1)(2011-1#2)(2012-12#1)
the refractive-index change in##2##4##(2008-3#2)
the refractive-index change##7##3##(2007-11#1)(2007-12#1)(2008-3#5)
the refractive-index difference##3##3##(2008-2#3)
the refractive-index distribution induced##2##4##(2008-3#2)
the refractive-index distribution##4##3##(2008-2#1)(2008-3#3)
the refractive-index modulation##4##3##(2007-11#1)(2008-3#3)
the refractive-index profile##3##3##(2008-2#3)
the refractive-index variation##2##3##(2008-3#2)
the refractive-index##33##2##(2007-11#4)(2007-12#2)(2008-2#9)(2008-3#18)
the refractory periods of##2##4##(1991-2#1)(1994-3#1)
the refractory periods##3##3##(1991-2#1)(1994-3#2)
the refractory##7##2##(1991-2#1)(1994-3#2)(2008-10#1)(2008-11#1)(2008-7#2)
the regenerated gratings##4##3##(2013-8#4)
the regenerated##9##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-8#4)
the regenerating##6##2##(1993-12#1)(1996-2#1)(1997-6#2)(2008-8#1)(2008-9#1)
the regeneration capacity##2##3##(2008-9#2)
the regeneration of the##5##4##(2008-10#2)(2008-5#3)
the regeneration of##10##3##(1992-6#1)(2008-10#2)(2008-11#1)(2008-5#5)(2010-7#1)
the regeneration process##2##3##(2008-11#1)(2012-2#1)
the regeneration##16##2##(1990-11#1)(1992-6#1)(2008-10#3)(2008-11#2)(2008-5#5)(2008-9#2)(2010-7#1)(2012-2#1)
the regenerative##6##2##(1993-3#1)(2007-11#2)(2009-10#1)(2012-12#1)(2013-8#1)
the regime in which##2##4##(2007-11#1)(2007-12#1)
the regime of##2##3##(2007-11#1)(2007-12#1)
the regime##4##2##(2007-11#2)(2007-12#2)
the regimen##6##2##(1994-11#1)(1994-2#1)(2008-3#1)(2008-9#1)(2013-8#2)
the region and##4##3##(1996-6#1)(2008-10#2)(2012-12#1)
the region are##2##3##(2008-10#1)(2012-12#1)
the region between the##4##4##(1992-11#1)(1993-11#1)(1995-12#1)(1997-2#1)
the region between##8##3##(1992-11#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-2#2)(2008-9#1)
the region coding for##2##4##(1991-6#1)(2013-1#1)
the region containing the##2##4##(1996-12#1)(1997-4#1)
the region containing##3##3##(1995-3#1)(1996-12#1)(1997-4#1)
the region downstream of##2##4##(1991-7#1)(1996-12#1)
the region encoding the##2##4##(1997-2#2)
the region for##2##3##(1991-12#1)(2013-1#1)
the region from##2##3##(1996-6#1)(2008-1#1)
the region is##3##3##(2007-7#1)(2008-3#1)(2012-2#1)
the region of chromosome##3##4##(1997-5#1)(2008-10#1)(2012-12#1)
the region of interest##3##4##(2008-3#2)(2010-6#1)
the region of the##24##4##(1990-7#1)(1992-10#1)(1992-12#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
the region of##59##3##(1990-10#1)(1990-12#1)(1990-7#1)(1992-10#1)(1992-12#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-6#1)(2012-12#2)(2012-3#2)(2013-1#2)
the region showed##2##3##(2008-10#2)
the region stained with Evans blue##2##6##(2012-2#2)
the region that is##2##4##(1995-6#1)(2008-10#1)
the region that##4##3##(1995-6#1)(2008-10#3)
the region to##5##3##(1990-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
the region was##4##3##(1995-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
the region were##3##3##(1996-5#1)(2007-10#1)(2008-10#1)
the region where##2##3##(1993-11#1)(2008-10#1)
the region##195##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#3)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-4#1)(1996-5#3)(1996-6#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#5)(1997-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#35)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)
the regional albedo##2##3##(2008-3#2)
the regional hospital##2##3##(1995-5#1)(2008-5#1)
the regional lymph nodes##2##4##(1997-4#1)(2009-1#1)
the regional lymph##3##3##(1997-4#1)(2009-1#1)(2013-8#1)
the regional spread of##2##4##(2008-10#2)
the regional##40##2##(1990-11#1)(1991-12#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-7#2)(2010-6#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
the regions examined##2##3##(1994-2#1)(1995-2#1)
the regions involved in##2##4##(1996-8#1)(1997-7#1)
the regions of the##8##4##(1990-12#1)(1991-12#1)(1993-12#2)(1995-8#1)(2008-2#1)(2008-8#1)(2008-9#1)
the regions of##15##3##(1990-12#1)(1991-12#1)(1993-12#2)(1993-8#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
the regions where##2##3##(2008-11#1)(2008-4#1)
the regions##41##2##(1990-12#1)(1991-12#1)(1992-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2012-2#2)(2013-8#1)
the regioselective##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
the regioselectivity of##2##3##(1994-5#1)(2012-3#1)
the regioselectivity##4##2##(1994-5#1)(1996-5#1)(2008-8#1)(2012-3#1)
the register##8##2##(1995-8#4)(2007-2#2)(2008-11#1)(2008-12#1)
the registered##2##2##(1997-2#1)(2011-2#1)
the registers##2##2##(1995-2#1)(2013-1#1)
the registration of##3##3##(2008-3#1)(2008-5#1)(2010-3#1)
the registration##7##2##(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
the registry##3##2##(1993-5#1)(2008-8#1)(2011-2#1)
the regression analysis##3##3##(2008-10#3)
the regression coefficients##5##3##(1995-9#1)(2008-10#2)(2008-6#1)(2010-11#1)
the regression equation##6##3##(2008-10#5)(2009-11#1)
the regression lines##2##3##(2008-10#2)
the regression model##8##3##(2008-10#3)(2008-11#2)(2008-3#1)(2010-4#1)(2013-8#1)
the regression of the##2##4##(2008-12#1)(2008-8#1)
the regression of##4##3##(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
the regression parameters##3##3##(1992-9#1)(2008-3#1)(2008-7#1)
the regression slope##2##3##(2008-10#1)(2013-1#1)
the regression triplet##2##3##(2008-10#2)
the regression##53##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-9#1)(1995-9#1)(2007-11#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
the regrowth##2##2##(1992-9#1)(1995-11#1)
the regular solution theory##4##4##(2008-10#4)
the regular solution##5##3##(1994-12#1)(2008-10#4)
the regular use of##2##4##(2008-11#1)(2008-5#1)
the regular##22##2##(1994-12#2)(1997-6#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2011-2#1)(2013-7#1)
the regularization parameter##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
the regularization##5##2##(2008-10#1)(2008-3#2)(2008-6#1)(2010-2#1)
the regularized image u(x##2##4##(2008-6#2)
the regularized phase-tracking##2##3##(2008-3#2)
the regularized##5##2##(2008-2#1)(2008-3#2)(2008-6#2)
the regulated and constitutive secretory pathways##2##6##(1992-12#2)
the regulated and##3##3##(1992-12#2)(2008-5#1)
the regulated secretory pathway##4##4##(1990-5#2)(1994-11#2)
the regulated secretory##5##3##(1990-5#2)(1994-11#2)(2010-11#1)
the regulated##17##2##(1990-5#3)(1992-12#2)(1992-3#2)(1994-11#2)(1994-12#1)(1995-2#1)(1997-4#1)(2008-4#2)(2008-5#1)(2010-11#2)
the regulation and##2##3##(2008-5#1)(2010-10#1)
the regulation mechanism of the##2##5##(1997-8#1)(2008-9#1)
the regulation mechanism of##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
the regulation of PEPCK gene expression by insulin##4##8##(1995-6#2)(1996-2#2)
the regulation of PEPCK gene expression##5##6##(1995-6#3)(1996-2#2)
the regulation of PEPCK gene##6##5##(1995-6#3)(1996-2#3)
the regulation of apoptosis##2##4##(1994-10#1)(2008-8#1)
the regulation of cancer##2##4##(2008-11#1)(2012-12#1)
the regulation of cell proliferation##2##5##(2008-4#2)
the regulation of cell##8##4##(1994-12#1)(1995-6#1)(2007-12#1)(2008-4#3)(2008-8#1)(2012-12#1)
the regulation of cellular differentiation##2##5##(2008-7#1)(2008-9#1)
the regulation of cellular##5##4##(1991-5#1)(2007-10#1)(2008-7#2)(2008-9#1)
the regulation of endothelial cell##2##5##(2010-9#1)(2012-3#1)
the regulation of energy homeostasis##2##5##(2008-10#1)(2008-4#1)
the regulation of energy##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)
the regulation of expression of the##2##6##(1996-5#1)(2009-9#1)
the regulation of gene expression##9##5##(1991-6#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the regulation of glucose##2##4##(1992-11#1)(2008-4#1)
the regulation of growth##2##4##(1990-12#1)(1994-8#1)
the regulation of insulin##3##4##(2008-1#1)(2013-1#2)
the regulation of its##2##4##(1995-11#1)(1996-2#1)
the regulation of mitochondrial##2##4##(2008-7#2)
the regulation of photoreceptor##2##4##(1996-2#1)(2008-7#1)
the regulation of proliferation of##2##5##(1992-8#1)(2013-8#1)
the regulation of proliferation##3##4##(1992-8#1)(2013-1#1)(2013-8#1)
the regulation of protein##4##4##(1990-5#1)(1990-8#1)(1992-8#1)(2008-11#1)
the regulation of ribonucleotide##2##4##(1990-2#1)(1993-11#1)
the regulation of spermatogenesis##2##4##(2012-2#2)
the regulation of the##29##4##(1992-11#1)(1992-12#2)(1993-12#1)(1993-5#1)(1993-6#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
the regulation of their expression##3##5##(1994-11#1)(2008-4#1)(2008-8#1)
the regulation of these##6##4##(1990-5#1)(1991-2#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
the regulation of vascular##2##4##(2006-6#1)(2008-5#1)
the regulation of##259##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-6#6)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-5#4)(1993-6#3)(1993-8#3)(1994-10#1)(1994-11#5)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#2)(1996-12#2)(1996-2#9)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#10)(2008-4#16)(2008-5#5)(2008-6#4)(2008-7#13)(2008-8#11)(2008-9#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#3)(2013-8#3)
the regulation##275##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-6#6)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-5#4)(1993-6#3)(1993-8#3)(1994-10#1)(1994-11#6)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#6)(1995-8#2)(1996-12#2)(1996-2#9)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#13)(2008-4#17)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#12)(2008-9#7)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#2)(2010-11#5)(2010-12#3)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#3)(2013-8#3)
the regulations and##2##3##(1991-1#1)(1993-12#1)
the regulations for##2##3##(1991-8#1)(1993-3#1)
the regulations##7##2##(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#2)(1995-6#1)(2008-11#1)
the regulator##9##2##(1990-7#6)(1995-2#2)(2008-7#1)
the regulators##3##2##(1994-12#1)(1995-5#1)(2008-9#1)
the regulatory T##2##3##(2011-2#2)
the regulatory and##2##3##(1992-6#1)(2010-11#1)
the regulatory authority##2##3##(2008-11#2)
the regulatory domain of##3##4##(1990-7#1)(1994-8#1)(1995-6#1)
the regulatory domain##4##3##(1990-7#1)(1994-8#1)(1995-6#1)(1997-6#1)
the regulatory elements##4##3##(1993-5#1)(1994-5#1)(1997-2#1)(1997-7#1)
the regulatory functions of##2##4##(2010-11#1)(2012-1#1)
the regulatory gene##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
the regulatory mechanism for the##2##5##(1995-2#1)(1997-4#1)
the regulatory mechanism for##3##4##(1995-2#1)(1997-4#1)(2011-10#1)
the regulatory mechanism##5##3##(1995-2#1)(1997-2#1)(1997-4#1)(2008-8#1)(2011-10#1)
the regulatory mechanisms of##3##4##(2010-12#1)(2011-2#2)
the regulatory mechanisms##5##3##(1994-8#1)(2008-7#1)(2010-12#1)(2011-2#2)
the regulatory network##2##3##(2008-7#1)(2010-10#1)
the regulatory networks##2##3##(2008-11#1)(2008-7#1)
the regulatory protein##7##3##(1990-7#6)(2009-10#1)
the regulatory proteins of##2##4##(1993-8#1)(1995-8#1)
the regulatory region of##2##4##(1990-7#1)(2008-4#1)
the regulatory regions##2##3##(2008-11#1)(2012-2#1)
the regulatory subunit##4##3##(1990-8#1)(1995-11#1)(1995-2#1)(2008-8#1)
the regulatory##81##2##(1990-7#8)(1990-8#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the rehabilitation manager##2##3##(1993-12#2)
the rehabilitation of##14##3##(1992-12#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-7#2)(2010-3#2)(2011-7#1)(2012-3#1)(2013-1#2)
the rehabilitation process is##2##4##(2007-8#1)(2010-10#1)
the rehabilitation process##7##3##(1996-3#1)(2007-11#1)(2007-8#1)(2010-10#2)(2011-2#1)(2012-12#1)
the rehabilitation program##4##3##(2007-12#1)(2007-8#3)
the rehabilitation##38##2##(1992-12#1)(1993-12#3)(1995-5#3)(1996-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#7)(2008-10#2)(2008-7#2)(2008-9#1)(2010-10#2)(2010-3#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#4)
the rehabilitative##3##2##(2008-10#2)(2013-1#1)
the reimbursement##2##2##(1992-11#1)(1993-12#1)
the reinforcement signal##2##3##(1997-7#1)(2009-8#1)
the reinforcement well##2##3##(1997-6#2)
the reinforcement##5##2##(1997-6#2)(1997-7#1)(2009-10#1)(2009-8#1)
the reinforcer##2##2##(1997-7#2)
the reinforcing effects of##2##4##(1994-2#1)(2008-4#1)
the reinforcing##4##2##(1991-1#1)(1993-6#1)(1994-2#1)(2008-4#1)
the reinnervation of##2##3##(2013-8#2)
the reiterative##2##2##(1991-2#1)(2008-11#1)
the rejection of##3##3##(2008-10#2)(2008-8#1)
the rejections or transfers due to lack of capacity and the random length of stays##2##15##(2010-8#2)
the rejections##3##2##(2008-3#1)(2010-8#2)
the relapse rate##2##3##(2011-2#1)(2013-1#1)
the relapse##5##2##(1990-10#1)(1996-11#1)(2011-2#1)(2013-1#2)
the related literature##2##3##(2008-10#1)(2012-12#1)
the related##45##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-2#2)(1994-6#1)(1995-12#2)(1995-2#3)(1995-6#1)(1996-12#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#3)(2011-3#1)(2012-12#2)(2013-8#2)
the relatedness of##2##3##(1997-4#1)(2008-10#1)
the relatedness##3##2##(1997-4#1)(2008-10#1)(2009-5#1)
the relation between RC teacher practices and##2##7##(2008-12#2)
the relation between RC##3##4##(2008-12#3)
the relation between dietary##2##4##(1994-2#1)(2007-12#1)
the relation between the##13##4##(1991-6#1)(1991-8#1)(1993-5#1)(1995-5#1)(2007-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-2#1)(2010-10#1)(2011-1#1)
the relation between these##3##4##(1991-11#1)(2008-10#1)(2008-3#1)
the relation between##54##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#2)(1991-8#1)(1993-11#2)(1993-5#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-5#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the relation of##7##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-3#1)(2009-5#1)(2012-12#2)
the relation##66##2##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#2)(1991-8#1)(1993-11#2)(1993-5#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
the relational model##2##3##(1996-2#2)
the relational##8##2##(1990-3#1)(1996-2#2)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#1)
the relations among##3##3##(2008-3#2)(2012-12#1)
the relations between the##3##4##(1996-1#1)(1996-2#1)(2010-8#1)
the relations between##9##3##(1995-5#1)(1996-1#1)(1996-2#1)(2008-11#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
the relations##18##2##(1990-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-3#3)(2009-10#1)(2010-2#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
the relationship among##7##3##(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#1)(2013-8#1)
the relationship and the##2##4##(2008-6#1)(2013-8#1)
the relationship and##5##3##(2008-11#1)(2008-6#1)(2009-7#1)(2010-5#1)(2013-8#1)
the relationship between DON and IND##2##6##(2008-10#2)
the relationship between HBV infection and##2##6##(2011-1#2)
the relationship between WICE and##2##5##(1994-7#2)
the relationship between a##7##4##(1991-3#1)(1994-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2013-8#1)
the relationship between analytical precision and concentration##2##7##(2008-10#2)
the relationship between body dissatisfaction and disordered eating##2##8##(2012-2#2)
the relationship between body image##3##5##(2007-12#1)(2009-5#1)(2012-2#1)
the relationship between body##7##4##(2007-12#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-2#3)
the relationship between brain##2##4##(2008-7#1)(2012-2#1)
the relationship between burnout and health care utilization of 238 employed adults##2##12##(1996-2#1)(1997-1#1)
the relationship between burnout##3##4##(1996-2#1)(1997-1#1)(2008-11#1)
the relationship between developmental##2##4##(2008-10#1)(2008-9#1)
the relationship between different##2##4##(1997-6#1)(2012-1#1)
the relationship between disease severity and##2##6##(2008-10#2)
the relationship between disease##3##4##(2008-10#2)(2012-1#1)
the relationship between eating##2##4##(2011-1#1)(2012-2#1)
the relationship between executive function and social outcome in##2##9##(2009-10#2)
the relationship between executive function and social outcome##4##8##(2009-10#4)
the relationship between external##2##4##(2008-4#1)(2011-2#1)
the relationship between family functioning##2##5##(2013-1#2)
the relationship between group size and##3##6##(1994-3#2)(2008-8#1)
the relationship between home range##2##5##(2008-8#2)
the relationship between home##3##4##(1992-2#1)(2008-8#2)
the relationship between host##2##4##(2008-10#2)
the relationship between in##2##4##(1994-2#1)(2009-12#1)
the relationship between incidence##2##4##(2008-10#2)
the relationship between job##3##4##(1996-2#1)(2010-10#2)
the relationship between lipid##2##4##(1994-5#1)(2010-4#1)
the relationship between local##2##4##(1994-2#1)(1996-10#1)
the relationship between molecular##2##4##(2008-10#2)
the relationship between oral lichen planus##2##6##(2008-4#2)
the relationship between oral##3##4##(2008-11#1)(2008-4#2)
the relationship between physical##2##4##(2008-10#1)(2013-1#1)
the relationship between potential##2##4##(2007-12#1)(2008-8#1)
the relationship between protein kinase C and##2##7##(1993-6#1)(2008-11#1)
the relationship between psychological##2##4##(2008-2#1)(2012-2#1)
the relationship between serum##2##4##(2008-7#1)(2013-1#1)
the relationship between sleep loss and RTB##2##7##(2013-1#2)
the relationship between smoking##2##4##(1996-3#1)(2013-1#1)
the relationship between social##4##4##(2009-7#1)(2009-8#1)(2010-2#1)(2013-8#1)
the relationship between spatial##2##4##(2008-11#1)(2008-7#1)
the relationship between species##2##4##(2008-10#1)(2008-8#1)
the relationship between symptom burden and##2##6##(2008-7#2)
the relationship between symptom##3##4##(2007-11#1)(2008-7#2)
the relationship between symptoms and##2##5##(2008-6#1)(2008-7#1)
the relationship between the distribution of##3##6##(1994-2#1)(2008-10#1)(2011-1#1)
the relationship between the number of##3##6##(2008-12#1)(2013-1#1)(2013-8#1)
the relationship between the two##3##5##(2008-11#1)(2009-8#1)(2012-2#1)
the relationship between the variables##2##5##(2008-10#2)
the relationship between the##94##4##(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-3#6)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#6)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#8)
the relationship between theory##2##4##(1996-3#1)(2008-11#1)
the relationship between types of##2##5##(1995-2#1)(1996-2#1)
the relationship between##422##3##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#3)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#6)(1994-3#4)(1994-5#5)(1994-6#1)(1994-7#2)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#3)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#2)(2008-1#2)(2008-10#50)(2008-11#17)(2008-12#11)(2008-2#5)(2008-3#12)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#14)(2008-8#19)(2008-9#12)(2009-10#5)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#5)(2009-7#12)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#13)(2011-10#1)(2011-2#19)(2012-1#4)(2012-12#4)(2012-2#17)(2012-3#2)(2012-5#1)(2013-1#17)(2013-7#1)(2013-8#13)
the relationship is##2##3##(1991-4#1)(1994-2#1)
the relationship of the##14##4##(1990-8#1)(1991-2#1)(1991-3#1)(1995-9#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#3)(2011-3#1)(2012-2#1)
the relationship of these##5##4##(1994-2#1)(1996-12#1)(1996-2#1)(2011-1#1)(2012-1#1)
the relationship of##55##3##(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-2#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-2#1)(2007-4#1)(2008-10#9)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-5#1)(2010-10#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#1)
the relationship to##3##3##(1997-8#1)(2008-6#1)(2013-1#1)
the relationship was##2##3##(2008-10#2)
the relationship with their##2##4##(2008-10#2)
the relationship with##11##3##(1990-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#2)(2012-3#1)
the relationship##528##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#10)(1994-3#4)(1994-5#6)(1994-6#1)(1994-7#2)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#3)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#68)(2008-11#20)(2008-12#13)(2008-2#7)(2008-3#15)(2008-4#5)(2008-5#9)(2008-6#7)(2008-7#17)(2008-8#20)(2008-9#18)(2009-10#6)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#7)(2009-7#13)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#19)(2011-10#1)(2011-2#22)(2011-3#1)(2012-1#7)(2012-12#5)(2012-2#19)(2012-3#3)(2012-5#1)(2013-1#20)(2013-7#1)(2013-8#16)
the relationships among the##4##4##(2008-10#2)(2008-8#1)(2010-5#1)
the relationships among##13##3##(1993-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)
the relationships and##2##3##(1992-12#1)(2013-1#1)
the relationships between physical##2##4##(2008-9#1)(2010-2#1)
the relationships between the##6##4##(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-2#1)
the relationships between these##3##4##(2008-9#1)(2009-12#1)(2011-2#1)
the relationships between##58##3##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#2)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)
the relationships of##3##3##(1996-2#1)(2008-9#1)(2010-6#1)
the relationships##85##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#5)(2009-12#2)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)
the relative S##2##3##(2008-10#2)
the relative abundance and##2##4##(2008-10#1)(2012-6#1)
the relative abundance of different##2##5##(2008-10#1)(2008-8#1)
the relative abundance of##8##4##(1994-11#1)(1994-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-2#1)
the relative abundance##11##3##(1994-11#1)(1994-8#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-2#1)(2012-6#1)
the relative abundances of##2##4##(2008-8#1)(2008-9#1)
the relative activity of##2##4##(2008-11#1)(2010-12#1)
the relative affinity for##2##4##(1996-2#1)(2008-10#1)
the relative affinity##3##3##(1990-7#1)(1996-2#1)(2008-10#1)
the relative amount of##6##4##(1991-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-2#1)(2009-2#1)
the relative amounts of the##2##5##(2008-7#1)(2011-3#1)
the relative amounts of##8##4##(1991-5#1)(1993-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-3#1)
the relative area under the##3##5##(2008-10#3)
the relative binding##2##3##(2008-4#1)(2008-9#1)
the relative content##2##3##(1995-5#1)(2008-11#1)
the relative contribution of both##2##5##(2007-12#1)(2008-10#1)
the relative contribution of each##2##5##(2007-12#1)(2011-2#1)
the relative contribution of leucine residues at the nonequivalent##2##9##(1992-6#2)
the relative contribution of##13##4##(1992-6#2)(1994-2#1)(2007-12#2)(2008-10#3)(2008-8#1)(2009-1#1)(2011-2#1)(2013-1#2)
the relative contribution##14##3##(1992-6#2)(1994-2#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-8#1)(2009-1#1)(2011-2#1)(2013-1#2)
the relative contributions of##7##4##(2007-12#1)(2008-10#4)(2008-12#1)(2008-9#1)
the relative contributions##8##3##(1996-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-9#1)
the relative difference in##2##4##(2008-3#1)(2009-2#1)
the relative differences##2##3##(2008-3#2)
the relative effectiveness of##2##4##(2008-10#1)(2011-2#1)
the relative effects of##3##4##(1992-5#1)(1995-12#1)(2008-10#1)
the relative efficacy and##2##4##(1995-12#1)(2008-7#1)
the relative efficacy of##3##4##(1994-12#1)(2008-10#1)(2011-2#1)
the relative efficacy##5##3##(1994-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
the relative efficiencies##2##3##(1994-12#1)(1994-8#1)
the relative error of##2##4##(2008-10#2)
the relative error##4##3##(2008-10#3)(2013-8#1)
the relative errors##2##3##(2008-10#2)
the relative expression levels##2##4##(2010-12#1)(2011-2#1)
the relative expression of##2##4##(2008-3#1)(2009-11#1)
the relative expression##4##3##(2008-3#1)(2009-11#1)(2010-12#1)(2011-2#1)
the relative fluorescence intensity##2##4##(2008-10#2)
the relative fluorescence##4##3##(2008-10#3)(2008-3#1)
the relative formation##2##3##(2008-10#2)
the relative frequencies of##2##4##(2008-8#2)
the relative frequency of##3##4##(2008-10#1)(2009-5#1)(2011-2#1)
the relative humidity (RH)##2##4##(2008-10#2)
the relative humidity##3##3##(2007-12#1)(2008-10#2)
the relative impact of##2##4##(2008-10#1)(2009-8#1)
the relative impedance##2##3##(2011-2#2)
the relative importance and##2##4##(2007-2#1)(2010-4#1)
the relative importance of a##2##5##(1990-7#1)(2008-8#1)
the relative importance of each of the##2##7##(2007-12#1)(2008-4#1)
the relative importance of each##3##5##(2007-11#1)(2007-12#1)(2008-4#1)
the relative importance of habitat amount and arrangement##2##8##(2008-8#2)
the relative importance of prey for##2##6##(2008-5#2)
the relative importance of the two##2##6##(2008-10#1)(2008-9#1)
the relative importance of the##6##5##(1992-2#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)
the relative importance of various##2##5##(2008-4#1)(2009-4#1)
the relative importance of##33##4##(1990-7#1)(1990-9#1)(1992-2#1)(1994-2#1)(1996-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2010-1#1)(2011-1#1)(2012-3#1)
the relative importance##36##3##(1990-7#1)(1990-9#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
the relative influence of##3##4##(1996-1#1)(1996-3#1)(2008-10#1)
the relative insensitivity##2##3##(2007-12#1)(2008-3#1)
the relative intensity of##5##4##(2008-10#2)(2008-3#1)(2008-8#2)
the relative intensity##6##3##(2008-10#2)(2008-3#1)(2008-8#2)(2013-8#1)
the relative level of the##2##5##(1990-3#1)(1996-12#1)
the relative level of##5##4##(1990-3#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-4#1)
the relative levels of mRNA##2##5##(2008-7#2)
the relative merits of the##2##5##(2008-3#2)
the relative merits of##3##4##(2008-3#2)(2008-4#1)
the relative motion##2##3##(2012-1#2)
the relative performance of the##2##5##(1994-9#1)(2008-10#1)
the relative performance of##5##4##(1994-1#1)(1994-9#1)(2008-10#1)(2011-2#1)(2012-3#1)
the relative performance##6##3##(1994-1#1)(1994-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
the relative phase##4##3##(2007-11#1)(2008-3#3)
the relative phases of the##2##5##(2007-12#2)
the relative phases of##3##4##(2007-12#2)(2008-3#1)
the relative phases##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the relative position of the##3##5##(2008-2#2)(2008-3#1)
the relative position##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
the relative positioning of##2##4##(1995-5#1)(1996-2#1)
the relative potency##2##3##(1992-9#1)(2008-10#1)
the relative power of##2##4##(2007-11#1)(2008-7#1)
the relative power##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
the relative prediction errors##2##4##(2008-10#2)
the relative promoter##2##3##(1991-9#1)(1992-9#1)
the relative proportion of##3##4##(1994-2#1)(2007-12#1)(2008-10#1)
the relative proportions of##2##4##(1995-2#1)(2010-5#1)
the relative rates of##3##4##(1991-12#1)(2008-10#1)(2008-2#1)
the relative rates##4##3##(1991-12#1)(1995-6#1)(2008-10#1)(2008-2#1)
the relative risk of##5##4##(1991-7#1)(1994-2#1)(2007-12#1)(2008-5#1)(2008-8#1)
the relative risk##12##3##(1991-2#1)(1991-3#1)(1991-7#1)(1994-2#1)(1995-2#1)(1997-8#2)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
the relative risks##3##3##(1991-3#1)(1992-12#1)(2008-7#1)
the relative roles of##4##4##(1991-8#1)(2008-10#1)(2008-8#2)
the relative skin sensitizing potency of chemicals##2##7##(2008-5#2)
the relative skin sensitizing potency of##3##6##(2008-5#3)
the relative square error of prediction##2##6##(2008-10#2)
the relative stability of the T structure##2##7##(1990-7#2)
the relative stability of##3##4##(1990-7#2)(2008-8#1)
the relative standard deviation (R##17##5##(2008-10#17)
the relative standard deviation (RSD) is##2##6##(2008-10#2)
the relative standard deviation (RSD) was less than 4##2##9##(2013-8#2)
the relative standard deviation (RSD)##6##5##(2008-10#4)(2013-8#2)
the relative standard deviation for eight replicate measurements##2##8##(2008-10#2)
the relative standard deviation for eight##3##6##(2008-10#3)
the relative standard deviation for the determination of##2##8##(2008-10#2)
the relative standard deviation for##10##5##(2008-10#10)
the relative standard deviation in the ringdown time##2##8##(2008-3#2)
the relative standard deviation in the##3##6##(2008-10#1)(2008-3#2)
the relative standard deviation in##5##5##(2008-10#3)(2008-3#2)
the relative standard deviation is 4##2##6##(2008-10#2)
the relative standard deviation is##8##5##(2008-10#8)
the relative standard deviation of peak##2##6##(2008-10#2)
the relative standard deviation of##8##5##(2008-10#7)(2011-1#1)
the relative standard deviation was 2##2##6##(2008-10#2)
the relative standard deviation was##11##5##(1990-8#1)(2008-10#10)
the relative standard deviation##75##4##(1990-8#1)(2008-10#69)(2008-3#2)(2011-1#1)(2013-8#2)
the relative standard deviations (RSDs)##2##5##(2011-1#2)
the relative standard deviations for##2##5##(2008-10#2)
the relative standard deviations##18##4##(2008-10#14)(2011-1#4)
the relative standard##97##3##(1990-8#1)(2008-10#87)(2008-3#2)(2011-1#5)(2013-8#2)
the relative strength of the##2##5##(2008-3#1)(2008-7#1)
the relative strength of##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
the relative time of##3##4##(2008-12#2)(2009-10#1)
the relative time##4##3##(2007-11#1)(2008-12#2)(2009-10#1)
the relative value##3##3##(1991-12#1)(1993-2#1)(2008-4#1)
the relative variation##2##3##(2008-8#1)(2009-10#1)
the relative weight##2##3##(1994-12#1)(2007-12#1)
the relative##495##2##(1990-3#2)(1990-5#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#5)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#2)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#10)(2007-12#12)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#180)(2008-11#8)(2008-12#6)(2008-2#16)(2008-3#28)(2008-4#12)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#27)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#8)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#5)(2012-6#1)(2013-1#2)(2013-8#5)
the relatively few##2##3##(1995-12#1)(2008-10#1)
the relatively high proportion of##3##5##(1990-12#1)(2008-8#1)(2008-9#1)
the relatively high##14##3##(1990-12#1)(1994-1#1)(1994-12#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
the relatively large##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
the relatively long##2##3##(2007-12#1)(2008-11#1)
the relatively low resolution of##2##5##(2008-10#1)(2008-8#1)
the relatively low##13##3##(1993-9#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2013-1#1)
the relatively short##2##3##(2008-1#1)(2008-2#1)
the relatively slow##2##3##(2008-10#1)(2009-6#1)
the relatively small##5##3##(1991-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
the relatively young##2##3##(2007-10#1)(2008-8#1)
the relatively##64##2##(1990-12#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#9)(2008-11#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
the relatives##3##2##(1994-2#1)(2012-2#1)(2012-3#1)
the relaxant effect of##2##4##(1992-9#1)(2008-12#1)
the relaxation effect##2##3##(2008-10#1)(2008-12#1)
the relaxation of the##2##4##(2008-10#1)(2011-1#1)
the relaxation of##4##3##(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
the relaxation oscillation frequency##3##4##(2007-11#2)(2007-12#1)
the relaxation oscillation period##2##4##(2007-11#1)(2007-12#1)
the relaxation oscillation##5##3##(2007-11#3)(2007-12#2)
the relaxation process##2##3##(2007-12#1)(2008-5#1)
the relaxation time of the##3##5##(2008-3#2)(2009-11#1)
the relaxation time spectrum##3##4##(2008-3#3)
the relaxation time##7##3##(2008-3#6)(2009-11#1)
the relaxation times##3##3##(1995-11#1)(1997-7#1)(2012-7#1)
the relaxation##32##2##(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#2)(1997-7#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-7#1)
the relaxation-oscillation##2##2##(2007-12#2)
the release and permeation of##2##5##(2008-5#2)
the release and##7##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)
the release from##2##3##(1995-12#1)(2008-5#1)
the release of ATP##4##4##(2008-4#2)(2008-5#1)(2009-3#1)
the release of NO##2##4##(2008-10#1)(2008-8#1)
the release of SPS##2##4##(2008-12#2)
the release of a##2##4##(2008-10#1)(2008-11#1)
the release of acetylcholine##2##4##(1993-12#1)(2008-8#1)
the release of adenosine##2##4##(1996-2#2)
the release of anionic polymers##2##5##(2008-12#2)
the release of any##2##4##(2008-10#1)(2008-2#1)
the release of arachidonic acid##2##5##(1996-2#1)(2011-2#1)
the release of calcein##2##4##(1994-11#2)
the release of cyt c##2##5##(2011-2#2)
the release of cytosolic enzymes##2##5##(1991-2#1)(1995-6#1)
the release of dopamine (DA)##2##5##(1992-7#1)(1997-2#1)
the release of dopamine from##2##5##(1997-7#1)(2008-4#1)
the release of dopamine##6##4##(1992-7#1)(1997-2#2)(1997-7#1)(2008-4#1)(2009-6#1)
the release of glutamate##3##4##(1994-8#1)(2008-4#2)
the release of insulin##2##4##(1992-6#1)(2011-1#1)
the release of intracellular##2##4##(2008-11#2)
the release of lactate dehydrogenase##2##5##(1990-5#1)(1995-3#1)
the release of oleic##2##4##(1990-2#2)
the release of physician-specific health care data##2##7##(1994-2#2)
the release of pro-inflammatory mediators##2##5##(2008-11#1)(2008-5#1)
the release of pro-inflammatory##3##4##(2008-11#1)(2008-5#2)
the release of prostacyclin##2##4##(1991-12#1)(1991-5#1)
the release of serotonin##3##4##(1995-12#3)
the release of the##16##4##(1990-11#1)(1990-2#1)(1995-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
the release of##161##3##(1990-11#1)(1990-12#7)(1990-2#5)(1990-5#2)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-8#2)(1995-11#6)(1995-12#5)(1995-3#4)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-2#4)(1997-4#3)(1997-7#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#18)(2008-11#9)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#9)(2008-6#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-6#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#1)(2013-8#5)
the release rate and##2##4##(2008-10#1)(2008-5#1)
the release rate of the##2##5##(1995-12#1)(2009-12#1)
the release rate##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-12#1)
the release##191##2##(1990-11#1)(1990-12#7)(1990-2#6)(1990-5#4)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-8#2)(1995-11#6)(1995-12#7)(1995-3#4)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-2#5)(1997-4#3)(1997-7#3)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#11)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#17)(2008-6#3)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-6#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#2)(2013-8#5)
the released##10##2##(1992-8#1)(1993-6#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#2)
the relevance and##3##3##(2008-9#1)(2010-8#1)(2012-3#1)
the relevance of such##2##4##(1992-12#1)(2008-8#1)
the relevance of the##7##4##(2008-10#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
the relevance of these##8##4##(2008-10#2)(2008-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
the relevance of this##3##4##(2010-12#1)(2010-2#1)(2011-1#1)
the relevance of##43##3##(1990-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the relevance##48##2##(1990-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the relevant chemical##2##3##(2008-10#1)(2009-5#1)
the relevant issues##2##3##(1997-2#1)(2012-3#1)
the relevant literature##8##3##(1994-12#1)(2007-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
the relevant##72##2##(1990-8#2)(1992-1#1)(1993-2#1)(1994-12#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
the reliability and validity of the##5##6##(1993-3#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-12#1)
the reliability and validity of##10##5##(1992-3#1)(1993-11#1)(1993-3#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
the reliability and##14##3##(1992-3#1)(1993-11#1)(1993-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the reliability of a##6##4##(1991-12#1)(1992-12#1)(1994-3#1)(2008-10#3)
the reliability of the method##2##5##(2008-10#1)(2008-7#1)
the reliability of the##17##4##(1990-9#1)(1992-10#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
the reliability of these##3##4##(2008-10#2)(2008-3#1)
the reliability of##50##3##(1990-3#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-3#4)(2008-7#2)(2009-1#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
the reliability##71##2##(1990-3#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#6)(2008-3#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the reliable##8##2##(1991-11#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
the relief of##4##3##(1996-5#1)(2008-7#1)(2009-1#1)(2012-1#1)
the relief##8##2##(1996-5#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-1#1)(2011-2#1)(2012-1#1)
the relocation##4##2##(2007-5#2)(2013-7#2)
the reluctance to##2##3##(2008-5#1)(2008-7#1)
the remainder had##3##3##(2008-6#1)(2008-7#1)(2008-9#1)
the remainder of the##9##4##(1991-12#1)(1992-4#1)(1996-1#1)(2007-6#1)(2008-10#3)(2008-2#1)(2011-1#1)
the remainder of##11##3##(1991-12#1)(1992-4#1)(1996-1#1)(2007-6#1)(2008-10#3)(2008-2#1)(2010-3#1)(2011-1#1)(2012-2#1)
the remainder were maintained as virgin##3##6##(1997-4#3)
the remainder were##4##3##(1997-3#1)(1997-4#3)
the remainder##28##2##(1991-12#1)(1992-4#1)(1993-11#1)(1994-12#1)(1996-1#1)(1997-3#1)(1997-4#3)(2007-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
the remaining 10##2##3##(1991-3#1)(1993-3#1)
the remaining 10%##3##3##(1991-3#1)(2008-1#1)(2008-12#1)
the remaining 14##2##3##(1992-8#1)(2012-3#1)
the remaining 15##2##3##(1995-6#1)(2012-3#1)
the remaining 2##4##3##(1994-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
the remaining 20##2##3##(1996-2#1)(2008-4#1)
the remaining 22##2##3##(1997-3#1)(2012-2#1)
the remaining 23 patients##2##4##(1991-3#1)(1994-9#1)
the remaining 3 patients##2##4##(1993-12#1)(2007-10#1)
the remaining 3##3##3##(1993-12#1)(2007-10#1)(2008-8#1)
the remaining 30##2##3##(1996-1#1)(2013-1#1)
the remaining 5##3##3##(1994-12#1)(1995-4#1)(2007-10#1)
the remaining 7##2##3##(1993-6#1)(2011-2#1)
the remaining four patients##2##4##(1991-8#1)(2008-7#1)
the remaining four##6##3##(1991-12#1)(1991-8#1)(1993-12#1)(2008-10#2)(2008-7#1)
the remaining one##2##3##(2010-3#1)(2011-1#1)
the remaining part of the##3##5##(2008-7#1)(2011-2#2)
the remaining part##4##3##(2008-10#1)(2008-7#1)(2011-2#2)
the remaining patients##3##3##(1990-12#1)(1992-11#1)(2010-6#1)
the remaining seven##2##3##(1995-6#1)(2008-10#1)
the remaining three##2##3##(2008-3#1)(2009-2#1)
the remaining two##6##3##(1992-5#1)(1993-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-2#1)
the remaining were##2##3##(1996-2#1)(2008-4#1)
the remaining##194##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-7#2)(2006-12#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#3)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#7)(2013-8#3)
the remains of##2##3##(2008-10#1)(2008-7#1)
the remarkable stability##2##3##(2008-5#1)(2012-2#1)
the remarkable##15##2##(1992-9#1)(1993-9#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-2#1)
the remarkably##2##2##(2008-6#1)(2012-2#1)
the remineralization of##2##3##(2010-3#1)(2011-2#1)
the remission phase##2##3##(1991-5#1)(2008-5#1)
the remission##7##2##(1991-2#1)(1991-5#1)(1992-2#1)(1992-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
the remnant neck##3##3##(2013-1#3)
the remnant##5##2##(1991-1#2)(2013-1#3)
the remodeling of the##2##4##(2007-11#1)(2008-1#1)
the remodeling##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
the remodelling of##2##3##(1996-2#1)(2008-6#1)
the remodelling##4##2##(1996-2#1)(2008-6#1)(2008-7#2)
the remote##5##2##(1990-5#1)(1995-2#1)(1997-4#2)(2008-2#1)
the remote-sensing reflectance##3##3##(2008-2#1)(2008-3#2)
the remotely sensed##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
the removal of a##2##4##(2008-7#1)(2013-1#1)
the removal of accumulated##2##4##(1991-12#1)(2008-5#1)
the removal of lead from water##2##6##(2011-2#2)
the removal of nonpolar##3##4##(1992-5#3)
the removal of some of##2##5##(2008-5#1)(2009-12#1)
the removal of some##3##4##(2008-5#1)(2009-12#1)(2009-9#1)
the removal of the##18##4##(1990-6#1)(1992-3#1)(1993-9#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-7#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the removal of##78##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-9#3)(2010-7#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the removal##80##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-5#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-9#3)(2010-7#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the renal apical membranes##2##4##(1990-11#2)
the renal arteries##3##3##(1990-9#1)(2008-11#1)(2008-7#1)
the renal artery##6##3##(1992-5#1)(1993-3#1)(2010-12#1)(2010-4#3)
the renal injury##2##3##(1994-5#1)(2008-1#1)
the renal microcirculation##2##3##(1992-8#1)(2013-8#1)
the renal parenchyma##4##3##(1993-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
the renal pelvis and##2##4##(2008-10#1)(2011-2#1)
the renal pelvis##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
the renal setting##2##3##(2007-10#2)
the renal sodium channel##3##4##(1997-3#3)
the renal toxicity##3##3##(1994-5#3)
the renal transplant##5##3##(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)
the renal##87##2##(1990-11#3)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1994-5#5)(1995-11#1)(1995-12#1)(1995-3#3)(1996-6#1)(1997-1#1)(1997-3#4)(2007-10#3)(2007-12#1)(2007-7#7)(2007-8#1)(2008-1#9)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-10#1)(2010-12#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-3#1)(2013-1#6)(2013-8#1)
the renewal##2##2##(2008-5#1)(2008-8#1)
the renewed##2##2##(2008-10#1)(2009-7#1)
the renin angiotensin system##2##4##(2008-11#1)(2012-3#1)
the renin##3##2##(1990-8#1)(2008-11#1)(2012-3#1)
the renin-angiotensin system##5##3##(1990-2#1)(1993-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
the renin-angiotensin-aldosterone system##5##3##(1992-8#1)(1996-6#1)(2010-4#1)(2011-2#1)(2013-8#1)
the renin-angiotensin-aldosterone##7##2##(1992-8#1)(1994-7#1)(1996-6#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
the reorganization of health services##2##5##(1993-6#2)
the reorganization of the##2##4##(2008-7#1)(2008-9#1)
the reorganization of##6##3##(1993-6#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-1#1)
the reorganization##8##2##(1992-5#1)(1993-6#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-1#1)
the reorientation of the##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
the reorientation of##5##3##(1995-5#1)(2008-1#1)(2008-10#2)(2011-2#1)
the reorientation##6##2##(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2011-2#1)
the reoxidation##2##2##(2008-10#2)
the rep-PCR fingerprints##2##3##(2008-10#2)
the rep-PCR##3##2##(2008-10#3)
the repK##2##2##(1997-6#2)
the repair of##14##3##(1992-5#1)(1995-5#1)(2007-8#2)(2008-11#2)(2008-5#2)(2009-3#1)(2010-8#1)(2011-2#3)(2013-8#1)
the repair##26##2##(1992-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(2007-12#1)(2007-8#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-8#1)
the repeat##11##2##(1991-8#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)
the repeatability is##2##3##(2008-10#2)
the repeatability of measurements##4##4##(1996-3#1)(2008-10#3)
the repeatability of the##7##4##(2008-10#6)(2008-3#1)
the repeatability of##15##3##(1996-3#1)(2008-10#11)(2008-3#2)(2010-8#1)
the repeatability##24##2##(1994-9#1)(1996-3#1)(2008-10#19)(2008-3#2)(2010-8#1)
the repeated injection##2##3##(2008-11#1)(2008-8#1)
the repeated##11##2##(1990-3#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
the repeating##4##2##(1990-12#1)(1992-9#1)(1995-11#1)(2011-2#1)
the repeats##2##2##(1996-10#1)(1997-6#1)
the repertoire of##4##3##(1991-2#1)(1995-3#1)(2008-11#1)(2011-1#1)
the repertoire##5##2##(1991-2#1)(1995-3#1)(2008-11#2)(2011-1#1)
the repertory grid technique##2##4##(2010-9#1)(2012-2#1)
the repetition of##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
the repetition rate of a##2##5##(2007-11#1)(2008-3#1)
the repetition rate of##5##4##(2007-11#2)(2008-3#3)
the repetition rate##8##3##(2007-11#3)(2008-2#2)(2008-3#3)
the repetition##12##2##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#2)(2013-1#1)
the repetitive##9##2##(1991-12#1)(1993-11#1)(2008-10#4)(2008-11#1)(2008-5#2)
the replacement of the##4##4##(1994-5#1)(1997-7#1)(2008-3#1)(2008-9#1)
the replacement of##20##3##(1990-5#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-3#2)(1994-5#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)(2013-8#1)
the replacement##27##2##(1990-5#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-8#1)(1994-3#2)(1994-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2012-12#1)(2013-8#1)
the replicase##4##2##(2008-10#1)(2008-9#3)
the replicate analysis##2##3##(2008-10#2)
the replicate##3##2##(2008-10#3)
the replicated##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
the replication and##3##3##(1997-2#1)(2013-1#2)
the replication efficiency##2##3##(2013-1#2)
the replication fork##4##3##(1991-12#2)(1992-3#2)
the replication initiator##2##3##(1997-4#1)(2008-10#1)
the replication of HIV-1##2##4##(2011-3#2)
the replication of##16##3##(1990-7#1)(1994-6#2)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-3#2)
the replication origin##4##3##(1994-11#1)(1994-12#2)(1995-8#1)
the replication terminator protein##2##4##(1993-9#2)
the replication terminator##3##3##(1993-9#3)
the replication##47##2##(1990-11#1)(1990-7#1)(1991-12#2)(1992-3#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-3#2)(2012-3#1)(2013-1#5)
the replicative##3##2##(1993-3#1)(1994-8#1)(2008-10#1)
the report is##2##3##(1990-11#1)(2011-2#1)
the report of##4##3##(1991-11#1)(2008-10#1)(2010-3#1)(2012-2#1)
the report##17##2##(1990-11#2)(1991-11#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)
the reported cases of##4##4##(1994-9#1)(1995-3#1)(2009-3#1)(2011-2#1)
the reported cases##7##3##(1994-9#1)(1995-3#1)(2008-1#1)(2009-3#2)(2011-1#1)(2011-2#1)
the reported clinical##2##3##(2009-8#1)(2010-6#1)
the reported number of##2##4##(2008-7#1)(2013-1#1)
the reported values##2##3##(1990-7#1)(2008-10#1)
the reported##84##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-9#2)(1995-12#2)(1995-3#2)(1995-6#4)(1997-1#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-3#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-3#2)(2013-1#3)(2013-8#2)
the reporter and##2##3##(1997-4#1)(2008-9#1)
the reporter constructs##3##3##(1994-2#3)
the reporter gene was##3##4##(1994-2#1)(1997-4#1)(2008-11#1)
the reporter gene##15##3##(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-9#3)(2011-1#1)
the reporter protein##3##3##(2008-11#2)(2009-5#1)
the reporter##27##2##(1990-12#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#4)(1995-8#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-11#6)(2008-7#1)(2008-9#4)(2009-5#1)(2011-1#1)
the reporting of##7##3##(1996-3#1)(1997-3#1)(2006-10#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
the reporting quality##2##3##(2011-2#2)
the reporting requirements##2##3##(1992-3#2)
the reporting system##2##3##(1996-1#1)(2007-2#1)
the reporting##20##2##(1992-3#2)(1994-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#3)(2013-7#1)(2013-8#1)
the reports of##3##3##(1990-3#1)(2007-8#1)(2008-9#1)
the reports##11##2##(1990-10#1)(1990-3#2)(1991-2#1)(1992-1#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-9#1)
the representation of space##2##4##(2009-10#2)
the representation of##10##3##(1995-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#2)
the representation##12##2##(1995-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#3)(2012-3#1)
the representative##5##2##(2008-10#4)(2013-8#1)
the repression of##5##3##(1992-8#1)(1995-12#1)(2008-10#2)(2008-11#1)
the repressor##7##2##(1990-5#1)(1992-4#1)(1992-6#2)(1994-3#1)(1995-8#1)(2008-11#1)
the reproducibility and accuracy of##2##5##(1991-3#1)(2008-10#1)
the reproducibility and##10##3##(1991-3#1)(2008-10#7)(2009-11#1)(2012-1#1)
the reproducibility is##5##3##(2008-1#1)(2008-10#4)
the reproducibility of the method##4##5##(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
the reproducibility of the##14##4##(1995-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)
the reproducibility of##23##3##(1995-3#1)(2007-10#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-2#1)
the reproducibility was##4##3##(2008-10#4)
the reproducibility##50##2##(1991-3#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#1)
the reproducible##3##2##(2008-10#2)(2008-3#1)
the reproduction cycle of##2##4##(2008-7#2)
the reproduction of##2##3##(2008-10#1)(2009-4#1)
the reproduction##9##2##(2008-10#3)(2008-7#3)(2008-9#1)(2009-4#1)(2010-5#1)
the reproductive age##2##3##(1993-6#1)(2008-3#1)
the reproductive and##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
the reproductive cycle##3##3##(1990-12#2)(2012-12#1)
the reproductive organs##3##3##(2008-12#2)(2008-8#1)
the reproductive performance of##3##4##(2008-10#1)(2008-12#1)(2009-5#1)
the reproductive performance##4##3##(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#1)
the reproductive period and##3##4##(1997-4#2)(2013-1#1)
the reproductive period##6##3##(1997-4#5)(2013-1#1)
the reproductive physiology of##4##4##(2008-7#3)(2010-8#1)
the reproductive potential of##2##4##(2008-10#1)(2008-5#1)
the reproductive potential##5##3##(2008-10#1)(2008-5#1)(2009-12#2)(2013-8#1)
the reproductive success of##8##4##(1996-6#1)(2008-6#1)(2008-9#3)(2010-8#1)(2012-2#1)(2012-3#1)
the reproductive success##9##3##(1996-6#1)(2008-6#1)(2008-9#3)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
the reproductive system##3##3##(2008-4#1)(2008-6#1)(2012-2#1)
the reproductive tract##5##3##(1991-12#1)(1993-2#1)(1994-9#1)(2007-12#1)(2013-1#1)
the reproductive##71##2##(1990-12#2)(1991-1#1)(1991-12#2)(1991-6#1)(1993-2#1)(1993-6#1)(1994-9#1)(1996-6#1)(1997-4#6)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#4)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
the reprogramming of##2##3##(2009-3#1)(2010-7#1)
the repulsion##2##2##(2007-12#1)(2008-10#1)
the request of##9##3##(1990-11#1)(1991-12#1)(1997-4#1)(2008-10#4)(2012-1#1)(2013-8#1)
the request##11##2##(1990-11#1)(1991-12#1)(1995-6#1)(1997-4#1)(2008-10#4)(2008-11#1)(2012-1#1)(2013-8#1)
the required accuracy##2##3##(2008-2#1)(2008-3#1)
the required amount of##2##4##(2008-11#1)(2011-1#1)
the required information##2##3##(2008-3#1)(2008-9#1)
the required level of accuracy##2##5##(2008-10#2)
the required level of confidence##2##5##(2008-10#2)
the required level of##5##4##(2008-10#4)(2008-5#1)
the required number of##2##4##(2008-11#1)(2012-3#1)
the required plastic deformation##3##4##(2008-7#3)
the required precision##2##3##(2008-3#2)
the required sample sizes##3##4##(2012-3#3)
the required sample##5##3##(2008-3#1)(2012-3#4)
the required sensitivity and reproducibility##2##5##(2008-10#1)(2008-8#1)
the required sensitivity and##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
the required sensitivity##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
the required##89##2##(1990-11#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#24)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#1)
the requirement for a##2##4##(1993-12#1)(2007-12#1)
the requirement for##23##3##(1992-8#1)(1993-11#1)(1993-12#1)(1996-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2013-8#1)
the requirement of a##2##4##(2008-10#1)(2013-8#1)
the requirement of##18##3##(1992-10#1)(1994-2#1)(1995-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
the requirement that##3##3##(1992-9#1)(1997-8#1)(2012-3#1)
the requirement to##2##3##(2008-3#1)(2009-10#1)
the requirement was##2##3##(1990-4#1)(2011-2#1)
the requirement##49##2##(1990-4#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-5#1)(1997-8#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#6)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the requirements for the##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
the requirements for##15##3##(1990-8#1)(1997-4#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#2)
the requirements of the##11##4##(1993-3#1)(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#1)
the requirements of##33##3##(1991-3#1)(1992-3#1)(1993-3#2)(1994-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
the requirements to##2##3##(2013-1#1)(2013-8#1)
the requirements under the##2##4##(1991-1#1)(1993-1#1)
the requirements##63##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-3#2)(1994-2#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
the requisite##6##2##(1991-3#1)(1994-2#1)(2008-3#1)(2008-4#2)(2009-10#1)
the rescue effect##2##3##(2008-8#2)
the rescue##6##2##(1992-3#1)(1995-2#1)(2008-4#1)(2008-8#2)(2010-8#1)
the research and development##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
the research and##6##3##(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-8#1)
the research community##4##3##(2008-4#1)(2008-6#1)(2008-7#2)
the research contributions of##2##4##(2008-11#1)(2008-8#1)
the research experience##2##3##(2009-4#2)
the research found##2##3##(1996-3#1)(2012-12#1)
the research has##2##3##(2008-10#1)(2009-9#1)
the research into##2##3##(1997-7#1)(2008-9#1)
the research literature##3##3##(1994-3#1)(2008-4#1)(2013-1#1)
the research of##10##3##(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)
the research on the##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
the research on##8##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the research participants##3##3##(1995-1#2)(2012-2#1)
the research process##7##3##(2008-12#1)(2009-4#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
the research project##2##3##(2007-11#1)(2008-11#1)
the research results##3##3##(1992-1#1)(2013-1#1)(2013-8#1)
the research that##2##3##(2009-1#1)(2010-3#1)
the research was##8##3##(1992-1#1)(1992-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
the research were##3##3##(2008-10#3)
the research##140##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1994-12#2)(1994-3#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#17)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#6)(2009-5#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
the researcher to##5##3##(2008-1#1)(2008-9#1)(2009-5#1)(2009-6#1)(2013-1#1)
the researcher##14##2##(1990-12#1)(1992-12#1)(1992-2#1)(1994-3#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
the researcher's##4##2##(1997-1#1)(1997-6#1)(2008-4#1)(2011-1#1)
the researchers conducted two structured interviews per ward##2##8##(2013-1#2)
the researchers##10##2##(1996-4#1)(2007-10#1)(2008-11#1)(2010-1#1)(2010-3#2)(2010-9#1)(2011-2#1)(2013-1#2)
the resectability##2##2##(2008-7#1)(2013-8#1)
the resected specimen was##2##4##(1992-6#1)(2013-1#1)
the resected specimen##4##3##(1992-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
the resected##7##2##(1992-6#2)(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
the resection and##2##3##(2009-10#1)(2012-2#1)
the resection of the##2##4##(1992-9#1)(2011-2#1)
the resection rate##2##3##(1992-9#1)(2010-3#1)
the resection was##2##3##(2008-10#1)(2009-10#1)
the resection##12##2##(1990-11#1)(1991-3#1)(1992-9#2)(2008-10#1)(2008-5#1)(2009-10#3)(2010-3#1)(2011-2#1)(2012-2#1)
the reserve##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
the reservoir and##2##3##(2008-12#1)(2008-5#1)
the reservoir powder inhaler##3##4##(1996-2#3)
the reservoir##18##2##(1996-2#3)(2008-10#8)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)
the reservoirs##5##2##(2008-5#2)(2011-2#2)(2013-7#1)
the residence of##2##3##(1991-3#1)(2008-8#1)
the residence##5##2##(1991-3#1)(1996-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
the resident microbiota##2##3##(2009-5#1)(2013-1#1)
the resident microflora##3##3##(2008-10#2)(2008-5#1)
the resident##14##2##(1995-6#1)(1996-3#1)(2007-4#1)(2008-10#4)(2008-4#1)(2008-5#3)(2009-5#1)(2011-2#1)(2013-1#1)
the residential##5##2##(1991-12#2)(1996-3#1)(2011-2#2)
the residents of##3##3##(1996-2#1)(2008-12#1)(2013-8#1)
the residents##6##2##(1995-3#1)(1996-2#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-8#1)
the residual effects of##2##4##(1990-3#1)(2009-3#1)
the residual effects##3##3##(1990-3#1)(2008-3#1)(2009-3#1)
the residual##63##2##(1990-3#1)(1990-6#1)(1991-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#14)(2008-12#6)(2008-2#4)(2008-3#8)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-7#2)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
the residue from##2##3##(2008-10#2)
the residue was##2##3##(1995-2#1)(2008-10#1)
the residue##13##2##(1990-12#1)(1995-11#2)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-7#1)(2009-5#1)
the residues from##2##3##(1997-6#1)(2008-8#1)
the residues##12##2##(1990-2#1)(1991-5#1)(1994-5#2)(1995-5#1)(1996-7#1)(1997-6#2)(2008-10#2)(2008-8#1)(2009-7#1)
the resin and the##4##4##(2008-10#3)(2010-4#1)
the resin and##5##3##(2008-10#4)(2010-4#1)
the resin cement##2##3##(2008-8#1)(2013-1#1)
the resin for the##3##4##(2008-10#3)
the resin for##6##3##(2008-10#6)
the resin phase##6##3##(2008-10#6)
the resin was found##2##4##(2008-10#2)
the resin was##9##3##(2008-10#9)
the resin##59##2##(2008-10#55)(2008-12#1)(2008-8#1)(2010-4#1)(2013-1#1)
the resin-phase##4##2##(2008-10#4)
the resins are##2##3##(2008-10#1)(2008-4#1)
the resins##8##2##(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)
the resist##6##2##(2007-12#5)(2010-2#1)
the resistance allele##3##3##(2008-10#3)
the resistance and##3##3##(2008-10#3)
the resistance gene with##2##4##(2008-10#2)
the resistance gene##18##3##(2008-10#14)(2008-5#3)(2012-3#1)
the resistance genes in##2##4##(2008-10#2)
the resistance genes##8##3##(2008-10#8)
the resistance in##2##3##(2008-10#2)
the resistance index##2##3##(1992-6#1)(2012-3#1)
the resistance is##5##3##(2008-10#4)(2011-2#1)
the resistance locus##2##3##(2008-10#2)
the resistance mechanism##3##3##(2008-10#3)
the resistance of LDL to##2##5##(1995-12#1)(1996-3#1)
the resistance of S##2##4##(2008-10#1)(2008-5#1)
the resistance of a##2##4##(2008-10#2)
the resistance of the##4##4##(1990-5#1)(1991-5#1)(1994-11#1)(2008-10#1)
the resistance of##29##3##(1990-5#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-3#1)(2008-10#16)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#1)
the resistance phenotype was##2##4##(2008-10#2)
the resistance rate##2##3##(2008-12#2)
the resistance response and##2##4##(2008-10#2)
the resistance to both##2##4##(2008-10#2)
the resistance to stripe rust was##2##6##(2008-10#2)
the resistance to the##2##4##(2008-10#1)(2009-6#1)
the resistance to##21##3##(1990-5#1)(1990-6#1)(1990-8#1)(1993-3#1)(1993-8#1)(2007-10#1)(2008-10#10)(2008-5#1)(2008-7#1)(2009-6#1)(2011-3#1)(2013-1#1)
the resistance was##4##3##(2008-10#4)
the resistance##131##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#88)(2008-12#4)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)
the resistant accessions CIho##2##4##(2008-10#2)
the resistant and susceptible##4##4##(2008-10#4)
the resistant and##5##3##(2008-10#5)
the resistant cells##2##3##(1992-2#1)(2008-11#1)
the resistant cultivar##7##3##(2008-10#6)(2011-10#1)
the resistant cultivars##8##3##(2008-10#8)
the resistant cv##3##3##(2008-10#2)(2008-6#1)
the resistant cvs##2##3##(2008-10#2)
the resistant genotype##5##3##(2008-10#5)
the resistant genotypes##2##3##(2008-10#2)
the resistant line Hor2596 (CIho 1243)##2##6##(2008-10#2)
the resistant line##4##3##(1992-2#1)(2008-10#3)
the resistant lines were##2##4##(2008-10#2)
the resistant lines##4##3##(2008-10#4)
the resistant parent##6##3##(2008-10#6)
the resistant strains##2##3##(1990-5#1)(2007-7#1)
the resistant winter##2##3##(2008-10#2)
the resistant##98##2##(1990-5#1)(1992-2#2)(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#83)(2008-11#3)(2008-6#1)(2008-9#2)(2011-10#1)(2011-2#2)
the resistivity##2##2##(2010-8#1)(2013-8#1)
the resolution and the##2##4##(2008-2#1)(2008-3#1)
the resolution and##8##3##(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-9#1)
the resolution for##2##3##(2007-12#1)(2012-12#1)
the resolution in the##2##4##(2008-3#2)
the resolution in##4##3##(2008-3#4)
the resolution is##4##3##(2008-2#2)(2008-3#2)
the resolution limits##2##3##(2007-12#1)(2008-3#1)
the resolution of optical##2##4##(2007-12#1)(2008-3#1)
the resolution of overlapping peaks##2##5##(2008-10#2)
the resolution of the measurement of the angle##2##8##(2008-3#2)
the resolution of the##19##4##(1990-6#1)(1997-2#3)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#4)(2010-9#1)
the resolution of this##2##4##(1991-1#1)(2008-10#1)
the resolution of##57##3##(1990-6#1)(1991-1#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#3)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
the resolution reaches##2##3##(2008-2#1)(2008-3#1)
the resolution##98##2##(1990-6#1)(1991-1#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-2#3)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#25)(2008-11#2)(2008-2#7)(2008-3#20)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#2)(2009-5#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)
the resolutions##3##2##(2008-10#2)(2008-3#1)
the resolved##4##2##(1992-12#1)(1995-3#1)(2007-12#1)(2008-2#1)
the resolving power of the##3##5##(2008-10#2)(2008-3#1)
the resolving power##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
the resolving##8##2##(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)
the resonance Raman##2##3##(1990-8#1)(1995-5#1)
the resonance condition##2##3##(2007-11#1)(2008-2#1)
the resonance frequency##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
the resonance light scattering##2##4##(2008-10#2)
the resonance of the##3##4##(2008-2#1)(2008-3#2)
the resonance of##4##3##(1990-8#1)(2008-2#1)(2008-3#2)
the resonance region##2##3##(2008-2#1)(2008-3#1)
the resonance scattering##2##3##(2008-10#2)
the resonance wavelength##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
the resonance##46##2##(1990-8#3)(1995-5#1)(2007-11#6)(2007-12#5)(2008-10#6)(2008-2#7)(2008-3#10)(2009-7#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#3)
the resonances in##2##3##(1992-4#1)(2008-2#1)
the resonances of##2##3##(1996-2#1)(2008-2#1)
the resonances##7##2##(1992-4#1)(1996-2#1)(2007-12#1)(2008-2#3)(2008-3#1)
the resonant frequency of the##2##5##(2007-11#1)(2008-10#1)
the resonant frequency##3##3##(2007-11#1)(2008-10#1)(2009-5#1)
the resonant scattering of light##2##5##(2008-2#2)
the resonant wavelength##3##3##(2007-12#1)(2008-3#2)
the resonant##29##2##(2007-11#5)(2007-12#5)(2008-10#3)(2008-2#3)(2008-3#12)(2009-5#1)
the resonator design##2##3##(2007-12#1)(2008-3#1)
the resonator was##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the resonator##29##2##(2007-11#6)(2007-12#6)(2008-2#6)(2008-3#8)(2009-5#2)(2010-4#1)
the resonators##2##2##(2007-11#1)(2008-3#1)
the resorption##3##2##(2007-11#1)(2008-12#1)(2008-7#1)
the resource##9##2##(1991-1#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-8#4)(2010-4#1)
the resource-based relative value scale (RBRVS)##2##6##(1994-12#2)
the resource-based relative value scale##3##5##(1992-1#1)(1994-12#2)
the resource-based##4##2##(1992-1#1)(1994-12#2)(2008-8#1)
the resources of##3##3##(1996-2#1)(2012-2#2)
the resources they##2##3##(2008-11#1)(2008-12#1)
the resources to##2##3##(1994-9#1)(2011-10#1)
the resources##22##2##(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-4#1)(2011-10#1)(2011-2#1)(2012-2#3)
the respect##3##2##(1997-8#1)(2008-10#2)
the respective enzymes##2##3##(2010-7#1)(2011-2#1)
the respective roles##2##3##(1995-2#1)(2009-8#1)
the respective value of##2##4##(2007-8#1)(2008-10#1)
the respective values were##2##4##(1996-5#1)(2011-2#1)
the respective##88##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-8#3)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-4#1)(2006-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2009-8#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
the respiration rate and##3##4##(1994-11#1)(2011-2#2)
the respiration rate##4##3##(1994-11#1)(2008-6#1)(2011-2#2)
the respiration##5##2##(1994-11#1)(2008-6#1)(2011-1#1)(2011-2#2)
the respiratory activity of##3##4##(2008-10#1)(2008-5#2)
the respiratory burst##6##3##(1990-2#2)(1991-2#1)(1993-6#2)(1994-6#1)
the respiratory chain complexes##2##4##(1994-11#1)(2008-7#1)
the respiratory chain enzyme activities##2##5##(1994-11#2)
the respiratory chain##11##3##(1990-11#1)(1994-11#4)(1995-11#2)(1995-2#1)(2008-7#2)(2011-2#1)
the respiratory control ratio##2##4##(1994-11#1)(1994-12#1)
the respiratory gases##2##3##(1997-1#2)
the respiratory mucosa##2##3##(1993-8#1)(1997-5#1)
the respiratory parameters##2##3##(2008-9#1)(2012-2#1)
the respiratory rate##2##3##(1994-11#1)(1996-3#1)
the respiratory system##9##3##(1992-2#1)(1995-6#1)(1996-3#2)(2007-12#1)(2008-5#2)(2010-7#1)(2013-7#1)
the respiratory tract are##2##4##(1992-3#1)(1994-12#1)
the respiratory tract in##2##4##(1994-12#1)(2008-10#1)
the respiratory tract##19##3##(1992-3#3)(1992-9#1)(1994-12#3)(1996-1#3)(1996-3#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
the respiratory##86##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#6)(1994-12#4)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-3#5)(1996-5#1)(1997-1#3)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#5)(2008-7#3)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
the respondent##3##2##(2012-2#1)(2013-1#2)
the respondents indicated##2##3##(1996-3#1)(2011-2#1)
the respondents##37##2##(1991-6#3)(1992-5#1)(1994-1#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#3)(2008-9#3)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
the responders##5##2##(1990-2#1)(1997-8#2)(2008-6#1)(2011-2#1)
the responding##3##2##(1993-5#1)(1996-9#1)(2008-11#1)
the response at##4##3##(1992-6#1)(1995-11#1)(1996-12#1)(2008-10#1)
the response characteristics of##2##4##(2008-10#1)(2008-3#1)
the response curve##2##3##(1997-2#1)(2008-10#1)
the response for##3##3##(1991-5#1)(2008-10#2)
the response function##2##3##(2008-10#2)
the response in the##2##4##(1994-8#1)(2008-7#1)
the response in##7##3##(1992-8#1)(1994-2#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-7#1)
the response induced##2##3##(1995-12#1)(1996-2#1)
the response is linear##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
the response is not##2##4##(2008-10#1)(2008-8#1)
the response is##9##3##(2007-12#2)(2008-10#4)(2008-3#1)(2008-8#1)(2012-2#1)
the response latency for##2##4##(2008-11#2)
the response mechanism##2##3##(2008-10#2)
the response obtained##2##3##(1995-12#1)(2008-10#1)
the response of a##6##4##(1992-3#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
the response of endothelial cells to##2##6##(2008-11#1)(2010-1#1)
the response of the sensor to##2##6##(2008-10#2)
the response of the sensor##3##5##(2008-10#3)
the response of the##26##4##(1992-12#1)(1992-3#1)(1994-6#1)(1994-8#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2012-3#2)(2013-1#1)
the response of these##2##4##(2008-10#1)(2012-7#1)
the response of##98##3##(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#35)(2008-11#6)(2008-2#5)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2010-1#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#3)(2013-8#1)
the response on##2##3##(1994-11#1)(2008-6#1)
the response properties of##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
the response rate of##2##4##(1997-8#1)(2008-6#1)
the response rate was##3##4##(1991-6#1)(1994-2#1)(2008-6#1)
the response rate##7##3##(1990-6#1)(1991-6#1)(1994-2#1)(1997-8#2)(2008-6#2)
the response rates##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
the response surface##4##3##(2008-10#4)
the response time and##2##4##(2008-10#2)
the response time was##2##4##(2008-10#1)(2008-2#1)
the response time##9##3##(2007-12#1)(2008-10#7)(2008-2#1)
the response to a##4##4##(1993-12#1)(2008-11#1)(2008-4#1)(2009-8#1)
the response to endothelin-1##2##4##(1995-12#2)
the response to the##4##4##(1997-2#1)(2008-1#1)(2008-10#1)(2012-12#1)
the response to therapy##2##4##(1992-8#1)(2012-3#1)
the response to treatment##4##4##(2007-11#1)(2008-1#1)(2008-6#1)(2013-8#1)
the response to##68##3##(1990-11#2)(1990-5#3)(1991-1#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-3#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the response variable##5##3##(2008-10#2)(2008-6#1)(2012-12#2)
the response was linear##2##4##(1996-12#1)(2008-10#1)
the response was##7##3##(1993-12#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
the response##309##2##(1990-11#2)(1990-5#5)(1990-6#1)(1990-7#2)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#5)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#4)(1995-12#5)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#7)(1996-2#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-8#3)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#96)(2008-11#16)(2008-2#6)(2008-3#10)(2008-4#5)(2008-6#7)(2008-7#11)(2008-8#10)(2008-9#4)(2009-10#3)(2009-12#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2011-2#5)(2012-12#5)(2012-2#5)(2012-3#5)(2012-7#1)(2013-1#3)(2013-7#4)(2013-8#2)
the responses and##4##3##(1993-12#1)(2008-10#3)
the responses induced by##2##4##(1991-6#1)(1991-9#1)
the responses observed##2##3##(1997-4#1)(2008-10#1)
the responses of plants to##2##5##(2008-10#1)(2008-8#1)
the responses of the##10##4##(1994-12#1)(1997-2#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)
the responses of##38##3##(1990-11#2)(1990-7#1)(1991-12#1)(1993-6#1)(1994-12#1)(1997-2#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#7)(2009-10#2)(2009-7#1)(2009-8#3)(2012-12#1)(2012-3#1)(2012-5#1)(2012-9#1)
the responses to##12##3##(1990-12#1)(1990-5#1)(1990-7#2)(1992-2#1)(1994-8#1)(1996-1#1)(2007-6#1)(2008-11#2)(2009-8#1)(2013-1#1)
the responses##75##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-1#2)(1997-2#4)(1997-4#1)(2007-6#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#9)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#4)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-5#1)(2012-9#1)(2013-1#2)
the responsibilities of##3##3##(1995-6#1)(2007-12#1)(2010-3#1)
the responsibility for##5##3##(1992-1#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-3#1)
the responsibility of the##4##4##(1991-3#1)(1995-9#1)(2011-1#1)(2012-12#1)
the responsibility of##11##3##(1991-3#1)(1993-1#1)(1994-3#1)(1995-9#1)(1996-3#1)(2008-11#2)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)
the responsibility to##2##3##(1992-11#1)(2012-3#1)
the responsibility##19##2##(1991-3#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-1#2)(1993-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-9#1)(1996-3#1)(2008-11#2)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
the responsible##14##2##(1990-3#1)(1990-6#1)(1992-11#1)(1992-6#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-4#1)
the responsiveness of the##2##4##(1997-3#1)(2008-4#1)
the responsiveness of##6##3##(1994-2#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#1)
the responsiveness to##2##3##(1993-12#1)(2008-6#1)
the responsiveness##9##2##(1992-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-6#1)(2008-7#1)
the responsivity##3##2##(2008-2#1)(2008-3#2)
the rest in##3##3##(1991-11#1)(1997-4#1)(2008-1#1)
the rest of Europe##2##4##(1994-2#1)(1997-6#1)
the rest of the body##4##5##(1992-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
the rest of the health##2##5##(1992-11#1)(2011-2#1)
the rest of the molecule##2##5##(1991-5#1)(1997-2#1)
the rest of the patients##5##5##(1993-5#1)(1995-5#1)(2007-8#1)(2009-2#1)(2011-2#1)
the rest of the population##4##5##(1995-2#1)(2008-10#2)(2011-2#1)
the rest of the province##2##5##(1992-10#2)
the rest of the story##3##5##(1993-12#1)(1997-3#1)(2013-8#1)
the rest of the##58##4##(1990-3#1)(1991-1#1)(1991-5#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#8)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
the rest of##75##3##(1990-3#1)(1991-1#1)(1991-5#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#11)(2012-2#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
the rest##103##2##(1990-3#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#13)(2012-12#1)(2012-2#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#2)
the restart rate##2##3##(2008-7#2)
the restart##3##2##(2008-7#2)(2013-1#1)
the restenosis rate##3##3##(1992-9#1)(2008-12#2)
the restenosis##4##2##(1992-9#1)(1996-8#1)(2008-12#2)
the resting limb##2##3##(2013-8#2)
the resting motor threshold##2##4##(2011-2#2)
the resting##16##2##(1990-6#1)(1991-3#1)(1992-6#1)(1993-12#2)(1994-3#2)(1994-6#1)(1995-5#1)(1997-7#1)(2008-5#1)(2011-2#2)(2013-8#3)
the restoration of an##2##4##(2008-7#1)(2011-2#1)
the restoration of function##3##4##(2007-8#1)(2008-9#2)
the restoration of the##9##4##(2008-10#1)(2008-2#1)(2008-3#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
the restoration of##25##3##(1990-12#1)(1991-12#1)(1991-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
the restoration##28##2##(1990-12#1)(1991-12#1)(1991-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
the restorative role of##3##4##(2008-12#3)
the restorative##5##2##(2008-12#4)(2013-1#1)
the restored image is##2##4##(2008-2#1)(2008-3#1)
the restored images##2##3##(2007-12#1)(2008-2#1)
the restored##7##2##(1991-5#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)
the restricted##7##2##(1992-9#1)(1993-12#1)(2008-10#3)(2008-5#1)(2009-5#1)
the restriction endonuclease##3##3##(1993-12#1)(1993-9#1)(1994-12#1)
the restriction fragment length polymorphism##3##5##(2006-8#1)(2008-10#1)(2008-4#1)
the restriction fragment length polymorphisms analysis of DNA fragments of the open reading##2##13##(2011-1#2)
the restriction fragment length polymorphisms##3##5##(2008-10#1)(2011-1#2)
the restriction fragment length##6##4##(2006-8#1)(2008-10#2)(2008-4#1)(2011-1#2)
the restriction of##2##3##(1994-2#1)(2008-11#1)
the restriction on the##2##4##(2008-3#2)
the restriction##20##2##(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-5#1)(2006-8#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2011-1#2)
the restrictions##2##2##(1990-12#1)(2008-3#1)
the restrictive##4##2##(1991-6#1)(1995-9#1)(2011-1#1)(2012-3#1)
the restructuring##2##2##(1994-12#1)(1996-1#1)
the result for##2##3##(2008-3#1)(2013-1#1)
the result in##2##3##(1995-12#1)(2009-4#1)
the result is##5##3##(1990-12#1)(1994-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
the result of a complex##2##5##(2008-1#1)(2010-12#1)
the result of a##25##4##(1991-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the result of an increase in##2##6##(1997-1#2)
the result of an##5##4##(1997-1#2)(2008-7#1)(2010-3#1)(2010-8#1)
the result of both##2##4##(2008-10#1)(2008-8#1)
the result of changes##2##4##(1992-8#1)(2008-5#1)
the result of differences in##2##5##(2008-10#1)(2012-3#1)
the result of good##2##4##(2012-3#2)
the result of increased##2##4##(1991-3#1)(2008-12#1)
the result of some##2##4##(2008-5#1)(2008-6#1)
the result of the present study##2##6##(2009-12#1)(2012-3#1)
the result of the##23##4##(1990-2#1)(1991-12#1)(1993-11#2)(1994-5#1)(1997-5#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
the result of##156##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-8#1)(2008-1#6)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#4)(2013-8#3)
the result that the##2##4##(1997-8#1)(2007-12#1)
the result that##7##3##(1991-12#1)(1992-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
the result was##5##3##(1990-6#1)(1991-12#1)(2008-10#2)(2013-1#1)
the result##196##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-8#2)(2008-1#6)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#4)(2013-8#4)
the resultant##47##2##(1991-12#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-12#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
the resulted##3##2##(2008-10#3)
the resulting &quot##2##3##(1991-2#1)(2009-10#1)
the resulting astigmatic##2##3##(2008-3#2)
the resulting beam##2##3##(2008-3#2)
the resulting chimeric##2##3##(2008-6#2)
the resulting colonies##2##3##(2008-10#2)
the resulting complexes##2##3##(1997-7#1)(2008-10#1)
the resulting data##4##3##(1995-2#1)(1997-2#1)(2008-10#1)(2009-12#1)
the resulting decrease in##2##4##(1994-8#1)(2008-8#1)
the resulting disease##2##3##(2008-10#1)(2008-9#1)
the resulting molecular##2##3##(2008-10#1)(2012-2#1)
the resulting optical##2##3##(2007-11#1)(2007-12#1)
the resulting output files##2##4##(2008-4#2)
the resulting peptide##2##3##(1994-11#1)(1994-12#1)
the resulting peptides##2##3##(1993-8#1)(2008-4#1)
the resulting phenotypes##2##3##(2008-10#1)(2008-4#1)
the resulting signal##2##3##(2008-2#2)
the resulting solution is##4##4##(2008-10#4)
the resulting solution##5##3##(2008-10#5)
the resulting##207##2##(1990-12#1)(1991-2#3)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#53)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#21)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
the results achieved##4##3##(1991-3#1)(1995-2#1)(1997-6#1)(2009-10#1)
the results already##2##3##(2007-6#1)(2013-1#1)
the results also show that##2##5##(2008-10#1)(2008-5#1)
the results also##6##3##(1992-6#1)(2008-10#3)(2008-2#1)(2008-5#1)
the results and##13##3##(1991-6#1)(1994-3#1)(1995-3#1)(1996-5#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#2)(2011-3#1)
the results are compared with the##6##6##(2008-10#3)(2008-2#2)(2008-3#1)
the results are compared with##11##5##(2008-10#5)(2008-2#2)(2008-3#4)
the results are compared##13##4##(2008-10#7)(2008-2#2)(2008-3#4)
the results are consistent with##2##5##(1996-2#1)(2011-1#1)
the results are discussed in##2##5##(2007-12#1)(2008-2#1)
the results are discussed##4##4##(1996-12#1)(2007-12#1)(2008-2#1)(2012-2#1)
the results are more##2##4##(2008-10#1)(2008-2#1)
the results are##45##3##(1993-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the results based on the##2##5##(2008-2#1)(2008-3#1)
the results being##2##3##(1994-3#1)(2008-11#1)
the results between##2##3##(2010-6#1)(2013-1#1)
the results by molecular replacement##2##5##(2008-8#2)
the results by##4##3##(1996-5#1)(2008-1#1)(2008-8#2)
the results can be interpreted##2##5##(1996-5#1)(2007-12#1)
the results cannot be##2##4##(1996-2#1)(2008-11#1)
the results demonstrated that##3##4##(2008-10#2)(2008-8#1)
the results demonstrated##4##3##(2008-10#3)(2008-8#1)
the results derived##4##3##(1990-12#1)(2007-10#1)(2008-2#1)(2008-3#1)
the results expected##2##3##(1990-7#1)(2013-1#1)
the results for each##2##4##(2008-10#1)(2008-5#1)
the results for the##5##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
the results for##21##3##(1993-12#1)(1995-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#1)
the results found by##2##4##(1994-8#1)(2008-10#1)
the results found##3##3##(1994-8#1)(2008-10#2)
the results from a series of##2##6##(2008-10#1)(2008-11#1)
the results from a##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)
the results from the alternative##2##5##(2008-10#1)(2008-5#1)
the results from the##12##4##(1996-3#1)(2006-10#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)
the results from this study##2##5##(2008-9#1)(2009-9#1)
the results from##30##3##(1994-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
the results have been##2##4##(2008-10#1)(2010-8#1)
the results have##4##3##(2008-10#1)(2010-8#2)(2013-7#1)
the results here##2##3##(2008-3#1)(2008-8#1)
the results highlight the##2##4##(1990-8#1)(2013-1#1)
the results illustrate that the##2##5##(2008-6#1)(2010-8#1)
the results in terms of##3##5##(1994-2#1)(2007-12#1)(2008-7#1)
the results in##11##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
the results indicate a##3##4##(1991-6#1)(1995-5#1)(2011-2#1)
the results indicate that the##4##5##(1990-8#1)(1997-7#1)(2012-2#1)(2013-8#1)
the results indicate that##10##4##(1990-8#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the results indicate the##2##4##(2008-1#1)(2008-12#1)
the results indicate##17##3##(1990-8#1)(1991-12#1)(1991-6#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the results indicated that##5##4##(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
the results indicated##8##3##(1997-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)
the results is##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-7#1)
the results may vary##2##4##(1997-1#1)(2007-4#1)
the results may##5##3##(1997-1#1)(2007-4#1)(2008-7#1)(2012-2#2)
the results obtained after##2##4##(2008-10#2)
the results obtained are##2##4##(2008-10#2)
the results obtained by manual##2##5##(2008-10#1)(2008-2#1)
the results obtained by means of##2##6##(2008-10#2)
the results obtained by the developed##2##6##(2008-10#2)
the results obtained by the two##2##6##(2008-10#2)
the results obtained by the##11##5##(2008-10#11)
the results obtained by this##3##5##(2008-10#2)(2008-3#1)
the results obtained by##29##4##(1990-5#1)(1993-11#1)(2008-10#25)(2008-2#1)(2008-3#1)
the results obtained during##2##4##(2007-11#1)(2011-2#1)
the results obtained for the##3##5##(2008-10#2)(2009-4#1)
the results obtained for##7##4##(2008-10#5)(2009-4#1)(2010-8#1)
the results obtained from in vivo##2##6##(2008-10#1)(2008-11#1)
the results obtained from##8##4##(1995-11#1)(2008-10#3)(2008-11#1)(2008-2#3)
the results obtained have##2##4##(1993-8#1)(1996-11#1)
the results obtained in 20 patients##3##6##(1990-6#1)(2008-9#2)
the results obtained in the analysis of##2##7##(2008-10#2)
the results obtained in the##5##5##(2008-10#4)(2008-5#1)
the results obtained in this##3##5##(1992-2#1)(2008-10#1)(2011-2#1)
the results obtained in##17##4##(1990-6#1)(1992-2#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#2)(2009-5#1)(2011-2#1)(2013-8#1)
the results obtained showed##2##4##(2008-10#2)
the results obtained using the##4##5##(1997-4#1)(2008-10#3)
the results obtained using##6##4##(1997-4#1)(2008-10#5)
the results obtained were##3##4##(2008-10#3)
the results obtained with the proposed method##2##7##(2008-10#2)
the results obtained with the##10##5##(2008-10#8)(2008-3#1)(2013-1#1)
the results obtained with##23##4##(1990-3#1)(1991-6#1)(1992-6#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
the results obtained##129##3##(1990-3#1)(1990-5#1)(1990-6#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-8#2)(1995-11#1)(1996-11#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#77)(2008-11#2)(2008-2#6)(2008-3#4)(2008-5#7)(2008-9#3)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the results of Gram staining##2##5##(2010-6#2)
the results of Western blotting##3##5##(2008-8#1)(2008-9#2)
the results of a clinical study##2##6##(1990-5#2)
the results of a meta-analysis of##2##6##(1997-7#1)(2008-9#1)
the results of a numerical##2##5##(2007-12#1)(2008-3#1)
the results of a previously##2##5##(1992-11#1)(2007-12#1)
the results of a recent survey##3##6##(1992-3#1)(1995-1#1)(1995-2#1)
the results of a study carried out to##2##8##(2007-11#1)(2008-5#1)
the results of a study carried out##3##7##(1993-3#1)(2007-11#1)(2008-5#1)
the results of a study of the##2##7##(1992-5#1)(2009-8#1)
the results of a study of##4##6##(1992-1#1)(1992-5#1)(1996-12#1)(2009-8#1)
the results of a study##11##5##(1992-1#1)(1992-5#1)(1993-3#1)(1996-1#1)(1996-12#2)(2007-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-9#1)
the results of a survey conducted##2##6##(1997-3#1)(2008-11#1)
the results of a survey of##3##6##(1994-12#1)(1994-3#1)(2008-1#1)
the results of a survey##7##5##(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)
the results of a##75##4##(1990-5#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#3)(1996-1#3)(1996-11#1)(1996-12#3)(1997-3#2)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#2)(2009-4#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
the results of an experiment##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
the results of an experimental##2##5##(2007-11#1)(2008-8#1)
the results of an##16##4##(1990-11#1)(1993-2#1)(1997-4#1)(1997-5#1)(2007-11#3)(2008-2#1)(2008-3#4)(2008-6#2)(2008-8#1)(2009-8#1)
the results of any##3##4##(1991-1#1)(2008-7#2)
the results of clinical trials##2##5##(1994-11#1)(1995-1#1)
the results of clinical##3##4##(1994-11#1)(1995-1#1)(2013-1#1)
the results of densitometric tests##2##5##(2007-11#1)(2007-8#1)
the results of different##3##4##(1990-6#1)(2008-11#1)(2008-9#1)
the results of early##2##4##(2007-8#1)(2008-7#1)
the results of empirical##2##4##(2008-8#1)(2008-9#1)
the results of experimental##3##4##(1994-7#1)(2008-2#1)(2008-3#1)
the results of immunohistochemical##2##4##(1997-8#1)(2008-5#1)
the results of in##2##4##(1995-12#1)(2008-3#1)
the results of interviews conducted with##2##6##(1991-12#1)(1996-12#1)
the results of modified##2##4##(2009-5#1)(2011-2#1)
the results of ongoing##4##4##(2008-3#2)(2008-8#1)(2011-1#1)
the results of other##3##4##(1994-2#1)(1997-4#1)(2013-8#1)
the results of our study##2##5##(2008-8#1)(2011-1#1)
the results of our##14##4##(1990-9#1)(1994-11#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2013-1#1)
the results of previous studies##2##5##(2008-10#1)(2008-11#1)
the results of previous##4##4##(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
the results of recent clinical##2##5##(1996-11#1)(2008-8#1)
the results of recent##4##4##(1996-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
the results of research##2##4##(2007-11#1)(2008-2#1)
the results of several##2##4##(2009-4#1)(2012-3#1)
the results of six##2##4##(1991-3#1)(1993-3#1)
the results of studies on##2##5##(2008-10#1)(2008-12#1)
the results of studies##8##4##(1994-5#1)(2006-10#1)(2008-10#3)(2008-12#1)(2009-2#1)(2011-2#1)
the results of study of##2##5##(2013-1#2)
the results of such##2##4##(2013-1#1)(2013-7#1)
the results of surgical treatment##3##5##(2007-8#1)(2008-8#1)(2013-1#1)
the results of that##2##4##(1994-1#1)(2008-12#1)
the results of the annual IAHSS surveys on crime in hospitals for##2##12##(1992-2#1)(1994-2#1)
the results of the first##7##5##(1990-2#1)(1995-3#1)(1996-6#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
the results of the pilot##2##5##(1993-1#1)(2010-9#1)
the results of the present study##2##6##(1996-7#1)(1997-3#1)
the results of the proposed##3##5##(1997-8#1)(2008-10#1)(2012-1#1)
the results of the study##3##5##(2007-10#1)(2008-10#1)(2010-8#1)
the results of the test##2##5##(1991-12#1)(2008-7#1)
the results of the two##3##5##(2008-10#2)(2008-4#1)
the results of the##86##4##(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#3)(1996-7#1)(1997-3#2)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2010-8#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
the results of their research##2##5##(1990-9#1)(1996-1#1)
the results of their##5##4##(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1996-1#1)
the results of theoretical##3##4##(2008-2#1)(2011-1#1)(2013-7#1)
the results of these analyses##2##5##(1995-5#1)(1996-1#1)
the results of these experiments##2##5##(2008-10#2)
the results of these studies##2##5##(2008-7#1)(2011-2#1)
the results of these##10##4##(1995-5#1)(1996-1#1)(1996-11#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
the results of this analysis##2##5##(2008-6#1)(2011-2#1)
the results of this study are##3##6##(1996-12#1)(1996-2#1)(2008-4#1)
the results of this study suggest that##2##7##(2009-4#1)(2009-7#1)
the results of this study##23##5##(1990-12#1)(1990-6#1)(1991-12#1)(1991-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2011-3#1)
the results of this##30##4##(1990-12#1)(1990-6#1)(1991-12#1)(1991-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
the results of treating##2##4##(1996-11#1)(2013-1#1)
the results of treatment##3##4##(1992-5#1)(2008-12#1)(2010-3#1)
the results of two##9##4##(1991-2#1)(1994-3#1)(1997-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
the results of##482##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#6)(1990-8#1)(1990-9#4)(1991-1#2)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#4)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#2)(1994-7#1)(1995-1#4)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#6)(1996-11#5)(1996-12#6)(1996-2#4)(1996-6#4)(1996-7#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(2006-10#2)(2007-10#4)(2007-11#15)(2007-12#8)(2007-7#1)(2007-8#8)(2008-1#4)(2008-10#56)(2008-11#10)(2008-12#9)(2008-2#22)(2008-3#36)(2008-4#7)(2008-5#14)(2008-6#7)(2008-7#13)(2008-8#15)(2008-9#10)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#5)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#17)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#8)
the results on the##2##4##(2008-10#1)(2008-11#1)
the results presented here are##2##5##(1993-6#1)(2008-3#1)
the results presented##4##3##(1993-6#1)(2007-11#1)(2008-3#2)
the results provide##3##3##(1993-6#1)(1995-2#1)(2011-1#1)
the results provided##2##3##(1994-7#1)(2008-10#1)
the results reported by##2##4##(2008-10#1)(2008-6#1)
the results reported in the literature##2##6##(1994-6#1)(2013-1#1)
the results reported in##4##4##(1991-2#1)(1994-6#1)(2008-10#1)(2013-1#1)
the results reported##9##3##(1990-11#1)(1991-2#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
the results revealed that the##2##5##(2008-10#1)(2013-8#1)
the results revealed that##6##4##(1994-11#1)(2008-10#2)(2010-1#1)(2010-3#1)(2013-8#1)
the results should be##3##4##(1990-3#1)(1991-12#1)(2008-3#1)
the results should##4##3##(1990-3#1)(1991-12#1)(2008-3#2)
the results show that the##7##5##(1994-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-7#1)(2012-1#1)
the results show that##12##4##(1992-3#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2010-7#1)(2012-1#1)(2013-7#1)
the results show##17##3##(1992-3#1)(1994-1#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-1#1)(2013-7#1)
the results showed that all##2##5##(2008-10#1)(2010-3#1)
the results showed that the Pb isotopic composition##2##8##(2013-8#2)
the results showed that the##9##5##(2008-10#2)(2008-12#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#2)
the results showed that##15##4##(2008-10#6)(2008-12#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
the results showed##23##3##(1996-12#1)(2008-10#11)(2008-12#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
the results strongly##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
the results suggest a##2##4##(1992-10#1)(2010-4#1)
the results suggest that the##7##5##(1993-12#1)(1993-6#1)(1994-2#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-3#1)
the results suggest that##10##4##(1993-12#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2013-1#1)
the results suggest##12##3##(1992-10#1)(1993-12#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2013-1#1)
the results suggested that the##2##5##(1995-5#1)(2008-10#1)
the results support##3##3##(1994-2#1)(1994-8#1)(2008-11#1)
the results that are##2##4##(2008-10#1)(2008-3#1)
the results that##8##3##(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-8#1)(2011-2#1)
the results to the##2##4##(2008-11#1)(2008-3#1)
the results to those##2##4##(1991-3#1)(1994-2#1)
the results to##12##3##(1991-3#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-7#1)
the results using##3##3##(2008-10#2)(2008-8#1)
the results varied##2##3##(2008-10#1)(2009-12#1)
the results was##6##3##(2007-8#1)(2008-10#3)(2008-3#1)(2009-8#1)
the results were also##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
the results were as follows##2##5##(1990-12#1)(2007-11#1)
the results were compared with the##3##6##(1996-3#1)(2008-10#2)
the results were compared with those obtained by##4##8##(2008-10#2)(2008-2#1)(2008-3#1)
the results were compared with those obtained##6##7##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)
the results were compared with those##8##6##(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
the results were compared with##17##5##(1996-3#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)(2012-1#1)(2012-3#1)
the results were compared##23##4##(1994-3#1)(1996-3#1)(2007-7#1)(2008-10#13)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)(2012-1#1)(2012-3#1)
the results were consistent with##2##5##(2008-10#1)(2008-8#1)
the results were consistent##4##4##(1993-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
the results were in good agreement with those##4##8##(2008-10#4)
the results were in good agreement with##6##7##(2008-10#6)
the results were in##11##4##(2008-10#11)
the results were satisfactory##3##4##(1990-9#1)(2008-10#2)
the results were similar to##2##5##(2008-10#2)
the results were similar##3##4##(2008-10#2)(2008-5#1)
the results were##76##3##(1990-12#1)(1990-9#1)(1992-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#40)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the results when##2##3##(2007-11#1)(2008-9#1)
the results with the##4##4##(1993-11#1)(1997-8#1)(2008-10#1)(2008-3#1)
the results with those obtained by the##2##7##(2008-10#2)
the results with those obtained by##3##6##(2008-10#2)(2008-2#1)
the results with those obtained##4##5##(2008-10#2)(2008-2#1)(2009-3#1)
the results with those of##3##5##(2008-10#2)(2010-11#1)
the results with those##12##4##(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-3#1)(2010-11#1)(2012-3#1)
the results with##26##3##(1993-11#1)(1993-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#1)
the results within##2##3##(2008-3#1)(2010-6#1)
the results##1189##2##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#5)(1990-6#9)(1990-7#1)(1990-8#3)(1990-9#6)(1991-1#2)(1991-12#10)(1991-2#2)(1991-3#6)(1991-5#2)(1991-6#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#2)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#7)(1993-3#3)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#12)(1994-3#8)(1994-5#3)(1994-6#2)(1994-7#3)(1994-8#3)(1995-1#5)(1995-11#2)(1995-12#3)(1995-2#9)(1995-3#6)(1995-5#5)(1995-6#1)(1996-1#6)(1996-11#6)(1996-12#11)(1996-2#6)(1996-3#3)(1996-5#5)(1996-6#5)(1996-7#1)(1997-1#6)(1997-2#6)(1997-3#6)(1997-4#6)(1997-5#4)(1997-6#2)(1997-7#3)(1997-8#6)(2006-10#3)(2006-4#1)(2007-10#9)(2007-11#25)(2007-12#18)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#13)(2008-1#10)(2008-10#291)(2008-11#24)(2008-12#14)(2008-2#52)(2008-3#79)(2008-4#14)(2008-5#38)(2008-6#15)(2008-7#25)(2008-8#31)(2008-9#23)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#4)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#2)(2010-11#6)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#9)(2010-7#2)(2010-8#9)(2010-9#3)(2011-1#13)(2011-2#33)(2011-3#4)(2011-7#2)(2012-1#5)(2012-12#5)(2012-2#15)(2012-3#12)(2012-5#1)(2013-1#33)(2013-7#4)(2013-8#20)
the resumption##2##2##(1996-3#1)(2007-7#1)
the resuscitation of##2##3##(1994-6#2)
the resuscitation##3##2##(1994-6#2)(2008-3#1)
the ret proto-oncogene##2##3##(1991-9#1)(2008-1#1)
the retail##2##2##(1993-3#1)(1997-1#1)
the retailing##2##2##(1994-12#2)
the retained##11##2##(1991-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2009-12#1)
the retardance##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
the retardation of##2##3##(1995-5#1)(2008-2#1)
the retardation##3##2##(1995-5#1)(2008-2#1)(2008-3#1)
the retarder##3##2##(2008-2#2)(2008-3#1)
the retention and separation of##2##5##(2008-10#2)
the retention and##6##3##(2008-10#6)
the retention behavior of##3##4##(1996-5#1)(2008-10#2)
the retention behavior##7##3##(1996-5#1)(2008-10#6)
the retention behaviour##3##3##(1996-5#1)(2008-10#2)
the retention delay##2##3##(1992-10#2)
the retention mechanism##3##3##(2008-10#3)
the retention of some##2##4##(1996-5#1)(2008-10#1)
the retention of the##3##4##(1995-6#1)(2008-10#2)
the retention of##22##3##(1994-1#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-5#2)(1997-4#1)(2008-10#11)(2008-11#1)(2009-6#1)(2010-3#1)(2011-2#1)
the retention performance##2##3##(1994-8#1)(2008-11#1)
the retention process##2##3##(2008-10#2)
the retention time of the##3##5##(2008-10#2)(2008-11#1)
the retention time##5##3##(2008-10#4)(2008-11#1)
the retention times of##2##4##(1992-6#1)(2008-10#1)
the retention times##5##3##(1992-6#3)(2008-10#2)
the retention##70##2##(1992-10#2)(1992-6#3)(1994-1#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#6)(1997-4#1)(2008-10#44)(2008-11#4)(2009-6#1)(2010-3#1)(2011-2#1)
the reticular formation##2##3##(1994-3#1)(1997-2#1)
the reticular lamina##4##3##(1995-5#4)
the reticular##9##2##(1994-3#1)(1995-5#4)(1996-12#1)(1997-2#2)(2013-1#1)
the reticuloendothelial##3##2##(1991-9#1)(1997-7#1)(2010-2#1)
the retina and##4##3##(1994-5#1)(2008-1#1)(2008-2#1)(2011-2#1)
the retina images##2##3##(2011-1#2)
the retina in##2##3##(2008-3#1)(2010-1#1)
the retina of the##2##4##(2008-5#1)(2010-1#1)
the retina of##5##3##(1991-10#1)(1992-3#1)(2008-5#1)(2010-1#2)
the retina##51##2##(1991-10#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-5#2)(1997-2#1)(1997-3#1)(2007-11#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#5)(2009-12#2)(2010-1#5)(2011-1#2)(2011-2#3)(2011-7#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
the retina-specific##2##2##(1994-9#2)
the retinal pigment epithelium##4##4##(2008-4#1)(2008-7#1)(2011-7#2)
the retinal pigment##5##3##(2008-4#1)(2008-7#1)(2011-2#1)(2011-7#2)
the retinal##23##2##(1990-11#1)(1993-12#1)(1995-5#1)(2007-12#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-10#1)(2009-12#3)(2010-10#1)(2011-1#1)(2011-2#3)(2011-7#3)(2012-12#1)
the retinas##3##2##(1990-11#1)(2007-5#2)
the retinitis pigmentosa GTPase##2##4##(2012-12#2)
the retinoic acid receptor##2##4##(1991-9#1)(1992-8#1)
the retinoic acid##4##3##(1990-11#1)(1991-9#1)(1992-8#1)(2013-1#1)
the retinol deficient group##4##4##(1994-8#4)
the retinol deficient##5##3##(1994-8#5)
the retraction##2##2##(1995-12#1)(2008-8#1)
the retrieval algorithm##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
the retrieval error##2##3##(2008-3#2)
the retrieval of marine constituents in##2##6##(2008-2#2)
the retrieval of the##4##4##(2007-12#1)(2008-2#3)
the retrieval of##25##3##(1991-8#1)(2007-12#5)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2010-8#1)
the retrieval procedure##2##3##(2008-2#1)(2008-3#1)
the retrieval##47##2##(1991-8#1)(2007-12#7)(2008-11#1)(2008-2#14)(2008-3#21)(2008-4#1)(2010-8#1)(2013-8#1)
the retrieved aerosol##2##3##(2008-3#2)
the retrieved phase##2##3##(2008-2#1)(2008-3#1)
the retrieved##27##2##(2007-12#3)(2008-2#5)(2008-3#17)(2008-8#2)
the retrograde cannula##3##3##(2007-8#3)
the retrograde##7##2##(1992-12#1)(1996-2#1)(1997-2#1)(2007-8#4)
the retropatellar##2##2##(2008-9#2)
the retroperitoneal cavity##2##3##(2012-12#1)(2012-3#1)
the retroperitoneal##6##2##(2008-10#2)(2008-6#1)(2012-12#1)(2012-3#2)
the retroperitoneum##7##2##(1992-12#1)(2008-6#3)(2009-1#1)(2009-9#1)(2013-1#1)
the retrospective##4##2##(1996-11#1)(2008-11#1)(2012-3#2)
the retroviral##7##2##(1990-2#1)(1990-5#1)(1995-2#1)(2008-11#3)(2008-9#1)
the retrovirus##3##2##(2008-11#2)(2008-5#1)
the return of the##2##4##(1997-3#1)(2008-8#1)
the return of##4##3##(1997-3#1)(2008-1#1)(2008-12#1)(2008-8#1)
the return on##2##3##(1995-12#1)(2008-7#1)
the return##16##2##(1990-9#1)(1992-1#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
the returning traveler##2##3##(2010-12#2)
the returns##2##2##(1994-2#1)(2010-12#1)
the reusability of the##2##4##(2008-10#1)(2010-4#1)
the reuse of##2##3##(2008-1#1)(2010-5#1)
the revealing##2##2##(1997-6#1)(2008-4#1)
the revenue##3##2##(1992-1#1)(1992-12#1)(2007-9#1)
the reverberation##2##2##(2008-11#2)
the reversal of tolerance##2##4##(1996-2#2)
the reversal of##5##3##(1994-9#1)(1996-2#2)(2009-10#1)(2012-12#1)
the reverse flow##2##3##(1992-5#1)(2008-10#1)
the reverse reaction##2##3##(1995-6#1)(2008-3#1)
the reverse transcriptase##2##3##(1994-12#1)(2013-1#1)
the reverse transcription polymerase chain reaction (RT-PCR)##3##7##(2007-10#1)(2008-5#1)(2008-7#1)
the reverse transcription polymerase chain reaction##4##6##(1997-7#1)(2007-10#1)(2008-5#1)(2008-7#1)
the reverse transcription reaction##2##4##(1994-12#2)
the reverse transcription##6##3##(1994-12#2)(1997-7#1)(2007-10#1)(2008-5#1)(2008-7#1)
the reverse##43##2##(1990-8#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-12#4)(1994-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-7#1)(2013-1#1)
the reversed##2##2##(2008-10#1)(2008-8#1)
the reversed-phase##6##2##(2008-10#6)
the reversibility of the sensor##2##5##(2008-10#2)
the reversibility of the##4##4##(2008-10#4)
the reversibility of##6##3##(1993-6#1)(2007-2#1)(2008-10#4)
the reversible conversion of##3##4##(1990-11#1)(1995-2#1)(2008-6#1)
the reversible inhibition of##2##4##(1993-6#1)(2008-10#1)
the reversible##16##2##(1990-11#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#4)(2008-6#1)(2009-5#1)(2010-12#1)
the review and##2##3##(1992-1#1)(2012-3#1)
the review of the##4##4##(1990-6#1)(2007-11#1)(2008-7#1)(2013-1#1)
the review of##15##3##(1990-6#1)(1991-6#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-7#1)(2013-1#1)
the review process##2##3##(1992-1#1)(2012-3#1)
the review##46##2##(1990-6#1)(1991-6#1)(1992-1#3)(1994-8#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#3)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#3)
the reviewed##2##2##(2008-7#1)(2010-4#1)
the revised European##2##3##(2010-11#1)(2011-2#1)
the revised scale##2##3##(2011-1#1)(2012-2#1)
the revised##20##2##(1992-1#2)(1992-2#2)(1993-6#2)(1995-12#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-11#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#1)
the revision of the##6##4##(1992-9#1)(1993-6#1)(2008-10#1)(2008-6#1)(2011-2#1)(2011-3#1)
the revision of##7##3##(1992-9#1)(1993-6#1)(2008-10#1)(2008-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
the revision##11##2##(1990-6#1)(1992-9#1)(1993-6#1)(2008-10#1)(2008-6#1)(2011-2#2)(2011-3#1)(2013-1#3)
the revisions##2##2##(1992-3#1)(2008-11#1)
the reward presentation##2##3##(2009-8#2)
the reward##8##2##(1993-6#1)(1997-6#2)(2008-1#1)(2009-5#1)(2009-8#2)(2010-10#1)
the rewarding properties of a##2##5##(1996-5#1)(2008-4#1)
the rewarding properties##3##3##(1996-5#1)(2008-4#2)
the rewarding##4##2##(1991-1#1)(1996-5#1)(2008-4#2)
the rewards of##2##3##(1995-12#1)(2013-1#1)
the rf##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
the rhabdom##3##2##(2007-12#3)
the rhabdoms##2##2##(2007-12#2)
the rheological behavior##2##3##(2008-5#2)
the rheological properties of##2##4##(2008-5#1)(2011-2#1)
the rheological properties##4##3##(2008-5#3)(2011-2#1)
the rheological##8##2##(1994-8#1)(2008-5#5)(2011-2#2)
the rheology of##3##3##(2008-5#3)
the rheology##4##2##(2008-5#4)
the rhesus monkey##3##3##(1991-1#1)(1993-5#1)(1996-5#1)
the rhesus##4##2##(1991-1#1)(1993-5#1)(1995-11#1)(1996-5#1)
the rhetoric##2##2##(1995-12#1)(2008-11#1)
the rheumatic diseases##4##3##(2008-8#3)(2012-1#1)
the rheumatic##6##2##(1990-12#1)(2008-8#4)(2012-1#1)
the rheumatoid arthritis##2##3##(1990-6#1)(1991-5#1)
the rheumatoid##4##2##(1990-6#1)(1991-5#1)(2007-8#1)(2010-3#1)
the rheumatologist##3##2##(1997-4#1)(1997-6#1)(2007-11#1)
the rhizomes of##2##3##(2008-11#1)(2013-1#1)
the rhizosphere abundance of##2##4##(2008-10#2)
the rhizosphere of apple##2##4##(2008-10#2)
the rhizosphere of crop plants##2##5##(2008-10#2)
the rhizosphere of wheat##4##4##(2008-10#4)
the rhizosphere of##15##3##(2008-10#15)
the rhizosphere populations of##2##4##(2008-10#2)
the rhizosphere soil and##2##4##(2008-10#2)
the rhizosphere soil##3##3##(2008-10#3)
the rhizosphere##36##2##(2008-10#33)(2008-12#2)(2009-8#1)
the rhizospheres of##4##3##(2008-10#4)
the rho A component##2##4##(1994-11#2)
the rho A-rho GDI complex##2##5##(1994-11#2)
the rho proteins##4##3##(1991-2#4)
the rho##10##2##(1991-2#4)(1992-11#1)(1994-11#4)(1995-11#1)
the rhythm of##3##3##(1994-5#1)(2012-2#2)
the rhythm reversal##2##3##(2008-6#2)
the rhythm##9##2##(1994-2#1)(1994-5#1)(2008-5#2)(2008-6#3)(2012-2#2)
the rhythmic bladder contractions##2##4##(1992-3#2)
the rhythmic##3##2##(1992-3#2)(2012-2#1)
the rib##4##2##(1996-2#1)(2007-11#1)(2007-8#1)(2013-1#1)
the ribbon-like structures##3##3##(1992-6#3)
the ribbon-like##6##2##(1992-6#5)(2008-10#1)
the riboflavin##3##2##(2008-9#2)(2012-3#1)
the ribonucleoprotein##2##2##(1995-2#2)
the ribose##3##2##(1995-3#1)(2008-4#2)
the ribosomal DNA##6##3##(2007-12#1)(2008-10#5)
the ribosomal RNA genes##2##4##(2008-10#1)(2008-5#1)
the ribosomal RNA##4##3##(2008-10#2)(2008-5#2)
the ribosomal protein##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
the ribosomal##18##2##(1992-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-8#1)(2012-12#1)
the ribosome binding##2##3##(1992-12#1)(2010-6#1)
the ribosome##13##2##(1992-12#1)(1992-6#1)(1994-6#1)(1997-7#1)(2007-12#3)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-1#1)
the ribosome-activated ATPase activity of EF-3##2##6##(1996-2#2)
the ribosome-inactivating proteins##2##3##(1990-12#2)
the ribozyme activity##2##3##(1994-11#2)
the ribozyme##13##2##(1993-9#3)(1994-11#6)(1997-6#1)(2008-3#1)(2008-9#2)
the ribs##2##2##(1991-11#1)(2013-1#1)
the rice blast fungus##4##4##(2008-10#4)
the rice blast##5##3##(2008-10#5)
the rice cultivar##2##3##(2008-10#2)
the rice genome##11##3##(1996-8#2)(2008-10#1)(2008-8#1)(2008-9#4)(2009-10#3)
the rice##33##2##(1996-8#2)(2008-10#12)(2008-8#3)(2008-9#11)(2009-10#5)
the rich##6##2##(1992-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)
the richest##2##2##(2008-10#1)(2011-3#1)
the richness##2##2##(2008-12#1)(2009-10#1)
the ridge extraction##2##3##(2008-3#2)
the right Fallopian tube##2##4##(2011-1#2)
the right MCA##3##3##(2008-12#3)
the right adrenal gland##3##4##(2008-5#3)
the right adrenal##4##3##(2007-10#1)(2008-5#3)
the right and left##7##4##(1996-2#1)(2008-10#1)(2009-4#2)(2010-6#1)(2013-1#2)
the right and the left##2##5##(1990-11#1)(2008-7#1)
the right and##13##3##(1990-11#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#2)(2010-6#1)(2011-2#2)(2013-1#2)
the right anterior insula##2##4##(2008-11#2)
the right anterior##3##3##(2008-11#2)(2008-8#1)
the right arm of Saccharomyces cerevisiae chromosome VII##4##8##(1996-3#1)(1997-3#3)
the right arm of Saccharomyces cerevisiae chromosome##5##7##(1996-3#1)(1997-3#4)
the right arm of chromosome IX##2##6##(1995-6#2)
the right arm of chromosome VII##4##6##(1995-6#3)(1996-3#1)
the right arm of chromosome##12##5##(1990-12#1)(1995-6#6)(1995-9#1)(1996-3#1)(1996-6#3)
the right arm of##19##4##(1990-12#1)(1993-11#1)(1995-6#6)(1995-9#1)(1996-3#2)(1996-6#3)(1997-3#5)
the right arm##21##3##(1990-12#1)(1993-11#1)(1995-6#6)(1995-9#1)(1996-3#2)(1996-6#4)(1997-3#5)(2010-9#1)
the right atrial##3##3##(1990-12#2)(2007-9#1)
the right atrium and ventricle##3##5##(2008-11#1)(2010-8#1)(2012-3#1)
the right atrium and##7##4##(2007-8#2)(2008-11#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
the right atrium##19##3##(1997-6#1)(2007-8#8)(2008-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-2#2)
the right bank of the##2##5##(2013-7#2)
the right breast##6##3##(1994-12#1)(1994-7#1)(1995-4#2)(2008-10#2)
the right carotid##2##3##(2008-7#1)(2011-1#1)
the right cerebral hemisphere##4##4##(2011-1#2)(2013-8#2)
the right choice##2##3##(1993-1#1)(2007-8#1)
the right colon##3##3##(1991-6#1)(2006-8#2)
the right common iliac artery##2##5##(2006-6#1)(2007-7#1)
the right coronary artery##6##4##(1994-11#1)(2007-8#4)(2013-2#1)
the right coronary system##2##4##(2007-8#2)
the right coronary##9##3##(1994-11#1)(2007-8#7)(2013-2#1)
the right diaphragm##2##3##(2009-8#1)(2010-5#1)
the right end##2##3##(1994-12#1)(1995-6#1)
the right external##2##3##(1996-9#1)(2013-7#1)
the right eye##9##3##(1994-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
the right femoral##3##3##(1993-12#1)(2006-10#1)(2012-1#1)
the right foot##3##3##(2008-12#1)(2008-5#1)(2009-10#1)
the right frontal lobe##4##4##(1996-2#1)(2007-10#3)
the right frontal##5##3##(1996-2#1)(2007-10#3)(2008-7#1)
the right hand##4##3##(1990-11#1)(1997-3#1)(2008-11#1)(2008-7#1)
the right heart##2##3##(1993-5#1)(1997-1#1)
the right hemi-brain##2##3##(2008-7#2)
the right hemisphere in the##2##5##(1996-2#1)(2008-1#1)
the right hemisphere##14##3##(1990-3#4)(1996-2#3)(1996-5#1)(1997-8#2)(2008-1#2)(2008-11#1)(2009-2#1)
the right hepatic##2##3##(1991-6#1)(2013-1#1)
the right internal##2##3##(1996-9#1)(2012-3#1)
the right kidney##4##3##(1990-9#1)(1994-5#1)(2007-10#1)(2007-7#1)
the right lobe of the liver##4##6##(1993-6#1)(2009-8#1)(2010-11#1)(2012-2#1)
the right lobe of##5##4##(1993-6#1)(2008-12#1)(2009-8#1)(2010-11#1)(2012-2#1)
the right lobe##6##3##(1993-6#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-11#1)(2012-2#1)
the right lower lung##3##4##(2008-1#2)(2008-6#1)
the right lower##7##3##(1992-2#1)(2007-8#1)(2008-1#2)(2008-6#1)(2010-6#1)(2013-1#1)
the right lung##6##3##(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-7#1)(2013-1#1)
the right main bronchus##2##4##(1990-12#1)(2007-8#1)
the right medial malleolus##2##4##(2010-6#2)
the right medial##3##3##(2006-10#1)(2010-6#2)
the right middle cerebral artery##6##5##(1996-3#1)(2008-12#1)(2008-7#3)(2013-8#1)
the right middle##13##3##(1996-2#1)(1996-3#2)(2008-1#3)(2008-12#2)(2008-7#3)(2013-1#1)(2013-8#1)
the right one##2##3##(2008-2#1)(2010-2#1)
the right patient##2##3##(1993-12#1)(2010-5#1)
the right place at the right##2##6##(1994-2#1)(2008-11#1)
the right pulmonary##4##3##(1997-5#1)(2007-8#1)(2008-11#1)(2010-10#1)
the right radial##2##3##(2008-11#1)(2011-2#1)
the right renal artery##2##4##(2007-7#2)
the right renal##3##3##(2007-7#2)(2008-1#1)
the right side of the neck and##2##7##(2007-8#1)(2011-2#1)
the right side of the##7##5##(2007-8#1)(2010-4#1)(2011-2#5)
the right side##22##3##(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#6)(2013-7#1)
the right sphenoparietal sinus##3##4##(1996-9#3)
the right subclavian artery##2##4##(2007-8#1)(2008-11#1)
the right subclavian##3##3##(2007-8#1)(2008-11#2)
the right superior##3##3##(1996-7#1)(1996-9#1)(2013-8#1)
the right temporal##2##3##(2008-8#1)(2013-8#1)
the right thigh##3##3##(2007-6#1)(2007-7#1)(2012-3#1)
the right to##14##3##(1990-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-5#1)(2008-7#1)(2009-6#1)(2012-12#1)(2013-1#1)
the right upper##10##3##(1990-9#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#2)
the right ureteric##2##3##(2008-10#2)
the right ventricle and##2##4##(2008-7#1)(2012-2#1)
the right ventricle##12##3##(1995-12#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the right ventricular##3##3##(2007-8#1)(2008-3#1)(2013-2#1)
the right##449##2##(1990-11#6)(1990-12#5)(1990-3#5)(1990-5#3)(1990-6#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#2)(1992-4#2)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-5#1)(1994-7#1)(1994-8#4)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#9)(1995-9#1)(1996-2#6)(1996-3#9)(1996-5#3)(1996-6#4)(1996-7#1)(1996-9#6)(1997-1#2)(1997-3#8)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#9)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#33)(2007-9#1)(2008-1#15)(2008-10#14)(2008-11#21)(2008-12#15)(2008-2#2)(2008-3#4)(2008-5#12)(2008-6#4)(2008-7#22)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#12)(2011-2#25)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#21)(2013-2#4)(2013-7#6)(2013-8#7)
the right-sided cyst##2##3##(2011-2#2)
the rights and##2##3##(1994-3#1)(2008-12#1)
the rights of##5##3##(2008-11#1)(2008-7#3)(2009-11#1)
the rights##10##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-11#1)
the rightward##2##2##(1995-12#1)(2009-10#1)
the rigidity of the##3##4##(2007-11#1)(2008-10#1)(2009-4#1)
the rigidity of##5##3##(2007-11#1)(2008-10#1)(2008-12#2)(2009-4#1)
the rigidity##6##2##(2007-11#1)(2008-10#1)(2008-12#3)(2009-4#1)
the rigorous##9##2##(1991-8#1)(1993-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
the rigors##2##2##(1995-12#1)(2008-1#1)
the rim##3##2##(1996-9#1)(1997-5#1)(2008-11#1)
the ring patterns##2##3##(2008-2#2)
the ring resonator##3##3##(2007-11#2)(2011-1#1)
the ring sinus##2##3##(2011-2#2)
the ring system##2##3##(1993-12#2)
the ring##30##2##(1991-8#2)(1993-12#2)(1994-12#1)(1996-2#1)(2007-11#5)(2008-10#1)(2008-2#7)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#3)(2011-1#3)(2011-2#2)
the ring-disk##2##2##(2008-10#2)
the ring-hydroxylase##2##2##(1993-6#2)
the ripening##4##2##(2008-10#1)(2008-12#3)
the rise and##2##3##(2008-10#1)(2013-1#1)
the rise in [Ca2+] induced by##2##6##(1991-6#2)
the rise in incidence##2##4##(1991-12#1)(1995-2#1)
the rise in temperature##2##4##(2008-2#1)(2008-3#1)
the rise in##17##3##(1990-12#1)(1990-7#1)(1991-12#2)(1991-6#2)(1993-3#1)(1994-2#1)(1995-12#2)(1995-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
the rise of the##2##4##(2008-10#1)(2008-11#1)
the rise of##7##3##(1994-2#2)(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)(2011-1#1)
the rise##37##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-6#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#3)(1995-12#3)(1995-2#1)(1996-7#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
the rising costs of##2##4##(2007-12#1)(2012-3#1)
the rising##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
the risk analysis##4##3##(2008-10#1)(2008-3#1)(2012-2#2)
the risk and##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
the risk assessment##5##3##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)
the risk associated with##2##4##(2008-10#1)(2008-3#1)
the risk benefit##2##3##(2008-4#1)(2009-12#1)
the risk factor of##2##4##(1994-12#1)(2011-1#1)
the risk factor##8##3##(1991-6#1)(1992-11#1)(1994-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)
the risk factors and##5##4##(1993-2#1)(2008-8#1)(2009-7#1)(2010-6#1)(2012-3#1)
the risk factors associated with##7##5##(1996-2#1)(2008-1#1)(2008-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
the risk factors for##11##4##(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
the risk factors of##10##4##(2007-11#1)(2012-2#1)(2013-8#8)
the risk factors##48##3##(1990-6#1)(1993-2#1)(1995-12#1)(1996-2#3)(1997-3#1)(1997-4#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-10#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#9)
the risk for a##2##4##(1997-8#1)(2008-10#1)
the risk for developing##3##4##(2009-8#1)(2010-8#1)(2013-1#1)
the risk for patients##2##4##(2007-7#1)(2008-12#1)
the risk for relapse##2##4##(2007-5#2)
the risk for##26##3##(1995-9#1)(1997-8#1)(2006-10#1)(2007-5#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-2#4)(2013-1#2)(2013-7#1)
the risk group and##2##4##(2011-2#1)(2012-12#1)
the risk group##5##3##(1992-9#1)(2011-2#2)(2012-12#2)
the risk groups##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
the risk in the##2##4##(2008-8#1)(2011-2#1)
the risk in##3##3##(1992-3#1)(2008-8#1)(2011-2#1)
the risk is##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-7#1)(2013-1#1)
the risk manager should##2##4##(1992-2#1)(1994-1#1)
the risk manager##6##3##(1992-2#2)(1993-2#2)(1994-1#2)
the risk manager's role##3##4##(1992-12#1)(1995-1#1)(1996-1#1)
the risk of CVD##2##4##(2008-3#1)(2008-6#1)
the risk of HBV##2##4##(2009-12#1)(2013-8#1)
the risk of HCC in patients##2##6##(2006-10#1)(2008-11#1)
the risk of HCC in##3##5##(2006-10#1)(2008-11#2)
the risk of HIV transmission##2##5##(1995-6#1)(2012-12#1)
the risk of HIV##3##4##(1995-6#2)(2012-12#1)
the risk of NSAID-related gastrointestinal bleeding##2##6##(2006-10#2)
the risk of PIH##2##4##(1994-3#2)
the risk of Parkinson's disease##2##5##(2008-7#1)(2008-8#1)
the risk of a##8##4##(1992-3#1)(1993-11#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2012-2#1)
the risk of adverse pregnancy##2##5##(2011-2#2)
the risk of adverse reactions##2##5##(1991-9#1)(1996-3#1)
the risk of adverse##7##4##(1991-11#1)(1991-9#1)(1996-3#1)(2007-11#1)(2010-6#1)(2011-2#2)
the risk of an##3##4##(1994-3#1)(2008-4#1)(2013-1#1)
the risk of atherosclerosis##2##4##(2008-6#2)
the risk of bias##2##4##(2008-5#1)(2012-2#1)
the risk of bleeding##3##4##(2008-1#1)(2010-8#1)(2013-1#1)
the risk of blood group##2##5##(1992-12#2)
the risk of bovine spongiform encephalopathy (BSE)##2##7##(2011-2#2)
the risk of breast cancer in##2##6##(1991-4#1)(2008-3#1)
the risk of breast cancer##5##5##(1991-4#1)(1994-2#1)(2008-10#1)(2008-3#1)(2009-4#1)
the risk of cancer induction##2##5##(2008-7#1)(2012-2#1)
the risk of cancer##11##4##(1990-8#1)(1994-2#1)(2008-11#1)(2008-7#3)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#2)
the risk of cardiovascular disease##4##5##(1993-11#1)(2008-1#1)(2008-4#1)(2012-2#1)
the risk of cardiovascular##7##4##(1993-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
the risk of cerebral##3##4##(1991-11#1)(2008-7#1)(2013-1#1)
the risk of chronic diseases##2##5##(2010-8#1)(2012-2#1)
the risk of chronic##4##4##(1991-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
the risk of colorectal cancer##3##5##(1993-9#2)(2009-8#1)
the risk of complications and##2##5##(2007-8#1)(2011-2#1)
the risk of complications##7##4##(1990-11#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
the risk of contact##2##4##(1992-9#1)(2007-2#1)
the risk of contamination##3##4##(2008-10#2)(2008-11#1)
the risk of coronary heart disease##2##6##(1996-3#1)(2008-12#1)
the risk of coronary##4##4##(1991-8#1)(1996-3#1)(1996-8#1)(2008-12#1)
the risk of death from##2##5##(2008-7#1)(2011-1#1)
the risk of death##6##4##(1997-3#1)(2008-7#1)(2011-1#2)(2011-3#2)
the risk of developing##14##4##(1995-9#1)(2008-10#1)(2008-11#2)(2008-4#3)(2009-12#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the risk of development##2##4##(2007-10#1)(2013-1#1)
the risk of disease##2##4##(1997-8#1)(2007-2#1)
the risk of early##3##4##(2011-2#2)(2012-3#1)
the risk of fracture##3##4##(2007-8#1)(2008-11#2)
the risk of fractures##3##4##(2007-11#1)(2007-8#1)(2008-4#1)
the risk of future##2##4##(2008-3#1)(2013-8#1)
the risk of gastric cancer in patients with##2##8##(2008-12#2)
the risk of gastric cancer##3##5##(1997-1#1)(2008-12#2)
the risk of gastric##4##4##(1997-1#1)(2008-1#1)(2008-12#2)
the risk of graft##2##4##(2008-8#1)(2011-2#1)
the risk of haemorrhage##2##4##(1992-6#1)(1996-6#1)
the risk of human##3##4##(2008-8#2)(2010-11#1)
the risk of inducing##2##4##(1994-9#1)(2007-8#1)
the risk of infection and##2##5##(2008-1#1)(2008-10#1)
the risk of infection through##2##5##(2008-10#1)(2011-2#1)
the risk of infection##10##4##(1994-6#1)(2007-2#3)(2008-1#1)(2008-10#2)(2011-2#2)(2012-2#1)
the risk of intracranial##2##4##(2011-2#1)(2012-2#1)
the risk of invasive##3##4##(1993-9#1)(2007-12#1)(2008-4#1)
the risk of ischemic stroke among all the samples (OR = 1##2##12##(2011-1#2)
the risk of ischemic stroke among##3##6##(2011-1#3)
the risk of ischemic stroke in Han population from the Northern parts of China##2##14##(2011-1#2)
the risk of ischemic stroke in##3##6##(2011-1#3)
the risk of ischemic stroke##6##5##(2011-1#6)
the risk of ischemic##7##4##(2008-3#1)(2011-1#6)
the risk of late##3##4##(1992-10#1)(2011-2#2)
the risk of liability##3##4##(1992-2#1)(1993-1#1)(1996-3#1)
the risk of major##2##4##(2008-10#1)(2010-1#1)
the risk of microbial##2##4##(1997-4#1)(2011-2#1)
the risk of mortality##2##4##(1994-11#1)(2007-8#1)
the risk of non-compliance##2##4##(2008-10#1)(2012-2#1)
the risk of osteoporosis and##2##5##(1993-11#1)(1994-9#1)
the risk of osteoporosis##3##4##(1993-11#1)(1994-9#1)(2008-4#1)
the risk of perioperative##2##4##(2009-5#2)
the risk of postoperative##3##4##(2007-8#1)(2008-7#1)(2008-8#1)
the risk of primary##2##4##(1991-11#1)(1994-6#1)
the risk of progression##2##4##(2008-9#1)(2013-8#1)
the risk of raised ICP##2##5##(2010-5#2)
the risk of recurrence of choledocholithiasis##2##6##(2008-5#2)
the risk of recurrence of##3##5##(2008-4#1)(2008-5#2)
the risk of recurrence##7##4##(1992-1#1)(1993-9#1)(1996-11#1)(2008-4#1)(2008-5#2)(2011-2#1)
the risk of recurrent##3##4##(2008-3#1)(2008-8#1)(2009-12#1)
the risk of serious##3##4##(2006-10#1)(2008-11#2)
the risk of severe##3##4##(2007-10#1)(2011-1#1)(2011-2#1)
the risk of skeletal##2##4##(2007-11#1)(2008-8#1)
the risk of specific##2##4##(2011-3#1)(2013-1#1)
the risk of stroke##7##4##(1991-11#1)(2007-10#1)(2008-8#3)(2008-9#1)(2011-1#1)
the risk of sudden##2##4##(1992-4#1)(2013-8#1)
the risk of the##6##4##(1990-9#1)(2007-11#1)(2008-12#1)(2009-10#1)(2010-4#1)(2010-8#1)
the risk of transmission##3##4##(1992-6#2)(2013-1#1)
the risk of treatment##2##4##(1993-9#1)(2008-7#1)
the risk of venous##2##4##(1996-3#1)(2007-8#1)
the risk of##427##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#4)(1991-2#2)(1991-4#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#3)(1993-8#2)(1993-9#5)(1994-11#2)(1994-2#3)(1994-3#4)(1994-6#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#7)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#5)(2007-10#5)(2007-11#9)(2007-12#2)(2007-2#7)(2007-5#1)(2007-7#1)(2007-8#14)(2008-1#7)(2008-10#21)(2008-11#16)(2008-12#11)(2008-2#2)(2008-3#10)(2008-4#12)(2008-5#8)(2008-6#4)(2008-7#16)(2008-8#19)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#5)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#14)(2011-2#34)(2011-3#3)(2012-1#2)(2012-12#11)(2012-2#17)(2012-3#2)(2012-6#1)(2013-1#22)(2013-8#12)
the risk to##5##3##(1991-12#1)(2007-2#2)(2010-7#1)(2011-2#1)
the risk##602##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#2)(1991-11#5)(1991-12#1)(1991-2#2)(1991-4#3)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#3)(1992-9#4)(1993-1#2)(1993-11#3)(1993-2#4)(1993-8#2)(1993-9#5)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-6#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#7)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#4)(1997-4#3)(1997-5#1)(1997-8#2)(2006-10#7)(2007-10#5)(2007-11#13)(2007-12#5)(2007-2#10)(2007-5#3)(2007-7#3)(2007-8#15)(2008-1#8)(2008-10#30)(2008-11#23)(2008-12#13)(2008-2#3)(2008-3#15)(2008-4#17)(2008-5#11)(2008-6#5)(2008-7#22)(2008-8#21)(2008-9#8)(2009-10#4)(2009-11#2)(2009-12#6)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#20)(2011-2#49)(2011-3#3)(2012-1#2)(2012-12#15)(2012-2#28)(2012-3#7)(2012-6#1)(2013-1#28)(2013-7#1)(2013-8#22)
the risk/benefit##2##2##(2011-1#1)(2013-1#1)
the risk/return dynamics##2##3##(2008-11#2)
the risk?##2##2##(1994-8#1)(1996-2#1)
the risks and benefits of this##2##6##(2007-9#1)(2011-2#1)
the risks and benefits of##10##5##(1996-12#1)(2007-9#1)(2008-11#2)(2008-7#1)(2010-12#2)(2011-2#2)(2013-1#1)
the risks and##12##3##(1996-12#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#2)(2011-2#2)(2013-1#1)
the risks associated with the##2##5##(2008-10#1)(2008-11#1)
the risks associated with##9##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
the risks for##2##3##(2008-3#1)(2013-8#1)
the risks of a##2##4##(1993-11#1)(1996-2#1)
the risks of the##2##4##(1994-6#1)(2008-4#1)
the risks of##35##3##(1990-5#1)(1991-11#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1996-2#1)(1996-6#1)(2007-2#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
the risks posed##2##3##(2008-11#1)(2010-10#1)
the risks to##2##3##(2008-8#2)
the risks##79##2##(1990-5#1)(1991-11#1)(1992-3#1)(1993-11#1)(1993-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#2)(2013-8#2)
the ritual##2##2##(2009-10#1)(2013-1#1)
the river basin##2##3##(2008-12#1)(2008-5#1)
the river water##5##3##(2008-10#5)
the river##19##2##(1997-4#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#3)(2013-1#1)
the rivers##2##2##(2008-8#1)(2013-8#1)
the rms error##2##3##(2008-2#1)(2008-3#1)
the rms of the##3##4##(2008-3#3)
the rms##17##2##(1992-4#1)(2007-11#1)(2008-2#3)(2008-3#11)(2008-8#1)
the road to##4##3##(1995-1#1)(1995-3#1)(2009-12#1)(2013-8#1)
the road traffic##3##3##(2010-11#2)(2012-2#1)
the road##13##2##(1995-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#2)(2011-1#1)(2012-2#1)(2013-8#1)
the robot design##2##3##(2012-1#2)
the robot##11##2##(2011-1#2)(2011-2#1)(2012-1#7)(2012-2#1)
the robot's##2##2##(2011-1#2)
the robust##10##2##(2008-1#1)(2008-10#5)(2008-12#1)(2009-8#1)(2012-2#1)(2013-7#1)
the robustness of the method##2##5##(2008-10#2)
the robustness of the##12##4##(1997-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2012-3#1)
the robustness of this##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
the robustness of##28##3##(1994-9#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
the robustness to##3##3##(1994-9#1)(2008-3#2)
the robustness##34##2##(1994-9#2)(1995-11#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-3#5)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
the rock certified materials##2##4##(2008-10#2)
the rock##4##2##(1996-4#1)(2008-10#3)
the rocks and##2##3##(2008-10#2)
the rocks##3##2##(2007-5#1)(2008-10#2)
the rockwool##2##2##(2008-10#2)
the rod##13##2##(1990-11#1)(1995-3#1)(1997-2#3)(1997-4#1)(2007-11#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-8#1)
the rod's##4##2##(2008-2#3)(2008-3#1)
the rodent##15##2##(1994-12#1)(1995-12#1)(1995-5#1)(1995-9#2)(1997-2#1)(1997-6#1)(2008-11#2)(2008-4#1)(2010-11#2)(2010-2#2)(2011-1#1)
the rods##2##2##(2008-8#1)(2009-7#1)
the role and function of##2##5##(1990-12#1)(1993-1#1)
the role and##19##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-1#1)(1995-1#1)(1996-2#2)(1997-2#1)(2008-10#2)(2008-12#2)(2009-10#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
the role by##2##3##(1995-2#1)(2012-3#1)
the role for##3##3##(1993-12#1)(1997-3#1)(2010-8#1)
the role of B27##2##4##(1990-11#2)
the role of FcgammaR##2##4##(2008-10#2)
the role of GH##2##4##(1997-8#1)(2012-1#1)
the role of HPV##2##4##(2012-12#1)(2013-1#1)
the role of Helicobacter pylori##2##5##(1992-5#2)
the role of MTs in##2##5##(2008-11#1)(2013-7#1)
the role of P2##2##4##(2008-4#1)(2008-5#1)
the role of TSPO in##2##5##(2012-2#2)
the role of Thr246##2##4##(1993-11#2)
the role of a##4##4##(1993-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
the role of affective##2##4##(2008-1#1)(2008-2#1)
the role of an##3##4##(1990-9#1)(2008-7#1)(2010-4#1)
the role of antiplatelet therapy##2##5##(2008-3#1)(2011-2#1)
the role of attention##2##4##(1996-2#1)(2013-8#1)
the role of atypical antipsychotics in##2##6##(2008-8#2)
the role of biopsy##2##4##(2013-7#2)
the role of commonly used##2##5##(2006-12#1)(2007-7#1)
the role of community##2##4##(2012-12#1)(2012-2#1)
the role of complex##2##4##(1995-2#1)(2008-10#1)
the role of different##5##4##(1997-2#1)(2007-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
the role of early##3##4##(2007-12#1)(2012-2#1)(2013-1#1)
the role of endogenous cytokines##2##5##(1996-12#2)
the role of environmental##2##4##(2007-8#1)(2008-1#1)
the role of epigenetic factors##2##5##(2008-11#1)(2011-9#1)
the role of estrogen##2##4##(2007-10#1)(2008-3#1)
the role of gene##2##4##(2008-8#1)(2012-2#1)
the role of general cognitive style##2##6##(2010-1#2)
the role of general##3##4##(1990-12#1)(2010-1#2)
the role of genes in##3##5##(2008-1#1)(2008-2#1)(2012-3#1)
the role of genetic##2##4##(1997-8#1)(2008-8#1)
the role of health##3##4##(1993-12#1)(2008-11#1)(2010-4#1)
the role of high##2##4##(2008-5#1)(2009-4#1)
the role of hypocalcemia##2##4##(2011-2#2)
the role of insulin and##2##5##(2008-3#1)(2010-11#1)
the role of intracellular##3##4##(1995-8#2)(2009-6#1)
the role of iron##3##4##(1993-11#1)(1996-5#1)(2012-12#1)
the role of mTOR##2##4##(2011-2#1)(2013-1#1)
the role of magnetic resonance##2##5##(2008-8#1)(2011-2#1)
the role of mechanical##2##4##(2007-10#1)(2012-2#1)
the role of mitochondria##2##4##(2008-1#1)(2013-8#1)
the role of molecular chaperones##3##5##(2008-1#1)(2008-4#1)(2008-7#1)
the role of multiple##2##4##(2008-10#1)(2008-11#1)
the role of mutations in the##2##6##(1993-11#1)(2008-7#1)
the role of natural selection##2##5##(2010-4#1)(2010-5#1)
the role of neurotrophins in##2##5##(1994-8#1)(2008-7#1)
the role of nurse##2##4##(2008-11#1)(2010-9#1)
the role of oncogenes in drug resistance##2##7##(2008-11#2)
the role of protein##3##4##(2008-6#1)(2010-12#1)(2013-8#1)
the role of public health##2##5##(1996-2#1)(1997-3#1)
the role of public##3##4##(1996-2#1)(1997-3#1)(2008-12#1)
the role of quality##2##4##(1994-12#1)(2008-10#1)
the role of radiotherapy##2##4##(1993-9#1)(2007-11#1)
the role of relatedness##2##4##(2008-8#1)(2010-4#1)
the role of religion in##2##5##(2009-7#2)
the role of social##4##4##(1991-1#1)(2008-2#1)(2011-2#1)(2012-12#1)
the role of some of the##2##6##(2008-10#1)(2009-10#1)
the role of some##4##4##(1994-9#1)(2008-10#1)(2009-10#1)(2009-11#1)
the role of specific##5##4##(1993-11#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
the role of standby emergency##2##5##(2007-2#2)
the role of stem cells##2##5##(2010-12#1)(2013-7#1)
the role of structural##2##4##(2008-7#1)(2011-3#1)
the role of the VLO in##2##6##(1994-3#2)
the role of the courts##2##5##(1992-12#1)(1992-3#1)
the role of the dietitian in##2##6##(1993-12#1)(1993-3#1)
the role of the different##2##5##(1995-12#1)(2011-2#1)
the role of the gut microbiome##2##6##(2010-5#1)(2011-1#1)
the role of the host in##2##6##(2008-10#1)(2011-2#1)
the role of the media##3##5##(1993-12#1)(1995-1#1)(2008-11#1)
the role of the medical provider##2##6##(2013-1#2)
the role of the medical staff##2##6##(1994-2#2)
the role of the medical##4##5##(1994-2#2)(2013-1#2)
the role of the substrate in##2##6##(2008-10#1)(2008-7#1)
the role of the##129##4##(1990-12#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1993-12#4)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#5)(1995-6#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#2)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#3)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
the role of these factors in##2##6##(2008-2#1)(2013-8#1)
the role of these proteins in##2##6##(1995-2#2)
the role of these##20##4##(1991-2#1)(1992-3#1)(1995-2#2)(1995-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-8#2)
the role of this residue##2##5##(1995-2#2)
the role of this##6##4##(1995-2#2)(2007-8#1)(2008-11#1)(2008-6#1)(2009-12#1)
the role of tumor##2##4##(1990-12#1)(2009-12#1)
the role of two##2##4##(2008-10#1)(2011-2#1)
the role of women##2##4##(1992-12#1)(1993-6#1)
the role of zinc##2##4##(1994-5#1)(2013-7#1)
the role of##785##3##(1990-11#2)(1990-12#7)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#2)(1992-12#6)(1992-2#5)(1992-3#4)(1992-5#3)(1992-6#4)(1992-8#3)(1992-9#3)(1993-11#11)(1993-12#11)(1993-2#1)(1993-3#6)(1993-6#6)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#4)(1995-11#1)(1995-12#8)(1995-2#13)(1995-3#1)(1995-6#3)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#3)(1996-7#2)(1996-8#1)(1997-2#8)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#3)(2007-11#9)(2007-12#11)(2007-2#3)(2007-4#1)(2007-5#5)(2007-7#4)(2007-8#6)(2008-1#15)(2008-10#53)(2008-11#42)(2008-12#16)(2008-2#9)(2008-3#11)(2008-4#16)(2008-5#9)(2008-6#9)(2008-7#28)(2008-8#20)(2008-9#12)(2009-10#7)(2009-11#4)(2009-12#5)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#5)(2009-7#8)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#17)(2011-10#1)(2011-2#40)(2011-3#3)(2011-9#2)(2012-1#6)(2012-12#17)(2012-2#23)(2012-3#15)(2012-6#1)(2013-1#26)(2013-2#1)(2013-7#6)(2013-8#27)
the role played by the##5##5##(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)
the role played by##18##4##(1990-9#1)(1993-12#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#2)(2013-1#1)(2013-8#1)
the role played##19##3##(1990-9#1)(1993-12#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#2)(2013-1#1)(2013-8#1)
the role that##14##3##(1993-1#1)(1993-12#1)(1993-6#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
the role transition##2##3##(2008-11#2)
the role##883##2##(1990-11#2)(1990-12#9)(1990-2#2)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#4)(1991-10#1)(1991-12#3)(1991-2#7)(1991-3#2)(1991-5#3)(1991-6#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#8)(1992-2#5)(1992-3#5)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#11)(1993-12#15)(1993-2#1)(1993-3#6)(1993-6#7)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#5)(1995-11#1)(1995-12#8)(1995-2#15)(1995-3#1)(1995-6#4)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#10)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#3)(2007-11#10)(2007-12#13)(2007-2#3)(2007-4#1)(2007-5#5)(2007-7#5)(2007-8#6)(2008-1#18)(2008-10#59)(2008-11#49)(2008-12#22)(2008-2#10)(2008-3#11)(2008-4#16)(2008-5#10)(2008-6#10)(2008-7#31)(2008-8#20)(2008-9#13)(2009-10#9)(2009-11#6)(2009-12#5)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#5)(2009-7#9)(2009-8#8)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#8)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#7)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#18)(2011-10#1)(2011-2#44)(2011-3#3)(2011-9#2)(2012-1#6)(2012-12#20)(2012-2#23)(2012-3#17)(2012-6#1)(2013-1#32)(2013-2#1)(2013-7#6)(2013-8#29)
the roles and##3##3##(1994-1#1)(1994-2#1)(2010-3#1)
the roles of competition##2##4##(2008-8#1)(2008-9#1)
the roles of lipid##2##4##(1995-12#1)(2011-2#1)
the roles of parents##2##4##(1990-2#1)(2010-10#1)
the roles of the##9##4##(1992-2#1)(1992-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-5#1)(2011-1#1)
the roles of these##3##4##(1995-3#1)(2010-12#1)(2012-12#1)
the roles of##62##3##(1990-12#1)(1990-2#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-3#2)
the roles that##2##3##(2008-7#1)(2008-8#1)
the roles##74##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-12#1)(1994-1#2)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-3#2)
the ronchigram##2##2##(2008-3#2)
the roof##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
the room temperature##5##3##(2008-10#3)(2013-1#2)
the room##7##2##(2008-10#4)(2008-9#1)(2013-1#2)
the room-temperature phosphorescence##2##3##(2008-10#2)
the room-temperature##3##2##(2008-10#2)(2008-2#1)
the root and##6##3##(2008-10#5)(2013-1#1)
the root apical meristem##2##4##(2009-8#2)
the root bark of##4##4##(2008-10#2)(2008-11#1)(2008-12#1)
the root canal filling##2##4##(2013-1#2)
the root canal##8##3##(2008-7#2)(2013-1#6)
the root causes of##2##4##(1995-12#1)(2009-10#1)
the root cortex##3##3##(2008-10#3)
the root epidermis and##2##4##(2008-10#2)
the root fraction and##2##4##(2008-10#2)
the root fraction##3##3##(2008-10#3)
the root is##2##3##(2008-10#2)
the root mean square error of##2##6##(2008-10#2)
the root mean square##6##4##(2008-10#2)(2008-2#1)(2008-3#2)(2012-12#1)
the root of Caragana sinica##2##5##(2008-10#2)
the root of##9##3##(1990-11#1)(2007-12#1)(2008-10#3)(2009-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
the root surface and##2##4##(2008-10#2)
the root surface##4##3##(2008-10#4)
the root system##5##3##(2008-10#5)
the root systems##2##3##(2008-10#2)
the root tip##2##3##(2008-5#1)(2009-6#1)
the root tissues##3##3##(2008-10#3)
the root zone##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
the root##103##2##(1990-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#53)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#5)(2008-9#4)(2009-10#1)(2009-6#3)(2009-8#4)(2009-9#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#1)
the root-knot nematode (Meloidogyne##2##4##(2008-10#2)
the root-knot nematode Meloidogyne javanica##4##5##(2008-10#4)
the root-knot nematode Meloidogyne##6##4##(2008-10#6)
the root-knot nematode##9##3##(2008-10#9)
the root-lesion nematode##3##3##(2008-10#3)
the root-mean-square##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)
the root-mean-squared##2##2##(2008-3#2)
the roots and the##2##4##(2008-10#2)
the roots and##6##3##(2008-10#4)(2008-11#1)(2008-12#1)
the roots of Derris##3##4##(2011-1#3)
the roots of Gordonia chrysandra##2##5##(2010-6#2)
the roots of the##3##4##(1993-12#1)(2011-2#1)(2012-6#1)
the roots of##26##3##(1990-11#2)(1991-1#1)(1993-12#1)(2007-8#1)(2008-10#8)(2008-12#2)(2010-6#2)(2011-1#3)(2011-2#4)(2012-6#1)(2013-1#1)
the roots##57##2##(1990-11#2)(1991-1#1)(1993-12#1)(1995-9#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#4)(2008-7#1)(2008-9#2)(2010-3#1)(2010-6#2)(2011-1#3)(2011-2#6)(2012-5#1)(2012-6#1)(2013-1#1)
the rostral part of area 24c and##2##7##(1996-5#2)
the rostral part of area##3##5##(1996-5#3)
the rostral part of##4##4##(1993-12#1)(1996-5#3)
the rostral ventrolateral medulla##3##4##(1997-2#1)(1997-6#2)
the rostral##16##2##(1990-9#1)(1992-8#1)(1993-12#3)(1993-3#1)(1996-12#1)(1996-5#3)(1997-2#1)(1997-6#2)(2008-7#1)(2011-1#1)(2012-12#1)
the rostral-caudal##2##2##(1997-3#2)
the rotary##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
the rotated##3##2##(2008-3#3)
the rotating##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
the rotation angle##2##3##(2008-2#1)(2008-3#1)
the rotation axis##2##3##(2008-3#2)
the rotation between##2##3##(1993-1#2)
the rotation of the##5##4##(1991-11#1)(1991-5#1)(1996-2#1)(2008-3#1)(2009-8#1)
the rotation of##9##3##(1991-11#1)(1991-5#1)(1993-3#1)(1996-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)
the rotation##28##2##(1991-11#1)(1991-5#1)(1992-9#1)(1993-1#2)(1993-3#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#10)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)
the rotational Raman##3##3##(2007-11#1)(2008-3#2)
the rotational##19##2##(1990-12#1)(1990-2#1)(1990-7#1)(1993-12#3)(1994-3#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#4)
the rotationally sheared##2##3##(2008-3#2)
the rotator cuff##7##3##(1994-2#2)(2007-11#2)(2012-12#2)(2012-2#1)
the rotator##8##2##(1990-3#1)(1994-2#2)(2007-11#2)(2012-12#2)(2012-2#1)
the rotor##2##2##(2008-10#1)(2008-8#1)
the rotor-impeller##2##2##(2008-8#2)
the rough endoplasmic reticulum##3##4##(1992-12#1)(2008-7#2)
the rough surface##2##3##(2008-3#2)
the rough##12##2##(1992-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)
the roughly##2##2##(2007-12#1)(2008-2#1)
the roughness of the##7##4##(2008-2#2)(2008-3#5)
the roughness of##11##3##(2008-2#3)(2008-3#8)
the roughness##12##2##(2008-2#3)(2008-3#9)
the round##2##2##(1996-5#1)(2008-10#1)
the route by which the##2##5##(2008-10#1)(2009-5#1)
the route by which##3##4##(2008-10#2)(2009-5#1)
the route of hysterectomy##2##4##(1994-2#1)(1996-2#1)
the route of##6##3##(1993-6#1)(1994-2#1)(1996-2#1)(2008-1#1)(2008-9#1)(2009-6#1)
the route to and from the breeding##2##7##(2008-5#1)(2008-6#1)
the route##12##2##(1993-6#1)(1994-2#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-12#1)
the routes of##2##3##(1994-5#1)(2013-8#1)
the routes##6##2##(1994-5#1)(1997-7#1)(2009-9#1)(2011-2#2)(2013-8#1)
the routine analysis of##6##4##(2008-10#5)(2008-11#1)
the routine analysis##8##3##(2008-10#6)(2008-11#1)(2011-1#1)
the routine examination of##2##4##(2008-12#1)(2012-2#1)
the routine use of##11##4##(2007-7#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)
the routine##62##2##(1990-2#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-2#2)(1994-3#2)(1994-6#1)(2007-10#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the rows of##3##3##(2007-12#2)(2011-2#1)
the rows##6##2##(2007-12#2)(2008-10#2)(2008-3#1)(2011-2#1)
the royal##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
the rps1##2##2##(2008-10#2)
the rtN236T##2##2##(2013-1#2)
the rubrerythrin##2##2##(1991-12#2)
the rubric of the##2##4##(2008-6#1)(2010-1#1)
the rubric of##3##3##(2008-11#1)(2008-6#1)(2010-1#1)
the ruggedness##2##2##(2008-10#2)
the rule in##3##3##(1997-3#1)(2008-6#1)(2008-8#1)
the rule##11##2##(1990-11#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-3#1)
the rules and##4##3##(1995-6#1)(2008-9#1)(2009-5#1)(2009-9#1)
the rules for##3##3##(1997-3#1)(2008-8#1)(2009-10#1)
the rules governing##2##3##(1995-5#1)(2008-9#1)
the rules of the##2##4##(2007-11#2)
the rules of##8##3##(1995-6#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)
the rules##24##2##(1991-2#1)(1995-5#1)(1995-6#6)(1997-3#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#3)(2013-1#1)
the rules?##2##2##(1994-3#1)(1997-3#1)
the ruling##2##2##(1995-12#1)(1997-5#1)
the rumen##5##2##(2009-4#2)(2011-2#2)(2013-1#1)
the run buffer##2##3##(2008-10#2)
the run##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
the running##7##2##(1993-8#1)(2008-10#3)(2008-3#2)(2010-7#1)
the rupture of a##3##4##(2007-12#1)(2007-6#1)(2008-6#1)
the rupture of foam##2##4##(1992-5#2)
the rupture of the##5##4##(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)
the rupture of##12##3##(1991-5#1)(1992-5#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-5#1)(2012-2#1)
the rupture##21##2##(1991-5#1)(1992-5#3)(1993-12#1)(1995-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#3)(2011-3#1)(2012-2#1)
the ruptured##2##2##(1997-3#1)(2008-7#1)
the rural area of the##2##5##(2008-6#1)(2012-12#1)
the rural areas##3##3##(2008-3#1)(2011-1#2)
the rural participants##2##3##(2008-11#2)
the rural population##2##3##(2011-1#1)(2012-12#1)
the rural setting##2##3##(2007-12#1)(2010-5#1)
the rural##25##2##(1991-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#2)(2009-10#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-12#2)
the rust fungus##5##3##(2008-10#5)
the rust##12##2##(2008-10#12)
the rusts##2##2##(2008-10#2)
the ryanodine receptor##3##3##(1994-8#1)(1994-9#1)(1997-3#1)
the ryanodine##5##2##(1994-8#3)(1994-9#1)(1997-3#1)
the rye##2##2##(2008-5#2)
the s##2##2##(1992-9#1)(2007-11#1)
the sac##5##2##(1995-11#2)(2007-12#2)(2008-6#1)
the saccadic##2##2##(1991-5#1)(1993-12#1)
the saccharin##2##2##(2008-2#1)(2008-5#1)
the sacral bone and##2##4##(2007-11#1)(2013-8#1)
the sacral bone##3##3##(2007-11#2)(2013-8#1)
the sacral##6##2##(2007-11#2)(2008-3#1)(2008-7#2)(2013-8#1)
the sacroiliac joints##4##3##(1990-6#2)(2006-10#1)(2011-2#1)
the sacroiliac##5##2##(1990-6#2)(2006-10#1)(2011-2#2)
the sacrum and##2##3##(1991-11#1)(2011-2#1)
the sacrum##5##2##(1991-11#1)(2008-8#1)(2011-2#2)(2013-8#1)
the safe harbors##2##3##(1991-1#1)(1993-1#1)
the safe use of##5##4##(1994-12#1)(2008-2#2)(2008-8#1)(2010-9#1)
the safe##21##2##(1991-1#1)(1991-3#2)(1993-1#2)(1993-12#1)(1994-12#1)(1996-2#1)(1996-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-1#1)(2011-2#2)
the safest and most##2##4##(2007-11#1)(2008-7#1)
the safest##4##2##(1991-3#1)(2007-11#1)(2008-1#1)(2008-7#1)
the safety and clinical##2##4##(2007-11#1)(2008-7#1)
the safety and effectiveness of##4##5##(2008-10#1)(2008-8#1)(2010-6#1)(2012-2#1)
the safety and effectiveness##5##4##(2008-10#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
the safety and efficacy of oral pilocarpine##2##7##(2006-10#2)
the safety and efficacy of these drugs##2##7##(2008-10#1)(2008-11#1)
the safety and efficacy of##26##5##(1991-11#1)(1994-5#2)(1996-3#1)(1997-3#1)(2006-10#2)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
the safety and##44##3##(1991-11#1)(1992-2#1)(1994-5#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the safety aspects##2##3##(1994-6#2)
the safety of a##2##4##(1990-11#1)(2012-3#1)
the safety of acupuncture##2##4##(2008-10#2)
the safety of the##12##4##(1990-6#1)(1991-3#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the safety of this##2##4##(2008-11#1)(2008-5#1)
the safety of##50##3##(1990-11#1)(1990-6#2)(1991-1#1)(1991-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-4#1)(1995-5#1)(1996-9#1)(1997-3#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
the safety profile of##4##4##(2008-10#1)(2008-6#1)(2008-8#2)
the safety profile##5##3##(2008-10#1)(2008-6#1)(2008-8#3)
the safety##113##2##(1990-11#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-5#2)(1994-6#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#2)(2009-5#2)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#2)
the sag parameter was##2##4##(2008-5#2)
the sag parameter##4##3##(2008-5#4)
the sag treatment lotion##2##4##(2008-5#2)
the sag##7##2##(2008-5#7)
the sagittal and##2##3##(1995-5#1)(2008-3#1)
the sagittal plane##10##3##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-9#1)(2012-1#2)(2013-1#1)
the sagittal##15##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-7#2)(2010-9#1)(2012-1#2)(2013-1#2)(2013-8#2)
the said##3##2##(2008-10#2)(2008-3#1)
the sake of illustration##2##4##(2008-10#2)
the sake of##7##3##(1994-12#1)(2008-10#3)(2008-12#1)(2009-6#1)(2013-8#1)
the sale of##4##3##(1992-11#1)(1992-8#1)(1996-11#1)(2008-9#1)
the salicylate##3##2##(2008-10#3)
the salient features##2##3##(2008-2#1)(2010-5#1)
the salient##4##2##(2008-10#1)(2008-2#1)(2010-5#1)(2010-8#1)
the saline matrix##3##3##(2008-10#3)
the saline##13##2##(1991-6#1)(1995-12#1)(2008-10#5)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
the salinity##4##2##(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
the saliva##4##2##(2008-10#3)(2012-3#1)
the salivary gland is##2##4##(1994-7#1)(2009-3#1)
the salivary gland##10##3##(1994-7#1)(1995-8#1)(2007-12#1)(2008-11#2)(2009-1#1)(2009-3#2)(2013-1#1)(2013-8#1)
the salivary glands is##2##4##(2008-10#1)(2008-4#1)
the salivary glands of##5##4##(2008-10#3)(2008-8#1)(2013-1#1)
the salivary glands##15##3##(2008-10#9)(2008-4#3)(2008-8#1)(2011-2#1)(2013-1#1)
the salivary##31##2##(1993-12#1)(1994-7#1)(1995-8#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-4#3)(2008-8#1)(2009-1#1)(2009-3#2)(2011-2#2)(2013-1#2)(2013-8#2)
the salmon##3##2##(1992-6#1)(1993-3#1)(1995-11#1)
the salt concentration##3##3##(1990-5#1)(1997-2#1)(1997-6#1)
the salt##15##2##(1990-5#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)
the salt-free##2##2##(2008-5#2)
the salting-out##3##2##(1990-5#1)(2008-10#2)
the salts##3##2##(1996-2#1)(1996-5#1)(2010-4#1)
the saltwater crocodile (Crocodylus porosus)##2##5##(2010-3#2)
the salutary##2##2##(1994-3#1)(2013-1#1)
the same 2##2##3##(1994-11#1)(2007-6#1)
the same AFLP##3##3##(2008-10#3)
the same AG##3##3##(2008-10#3)
the same C##2##3##(1991-12#1)(2008-10#1)
the same C-terminal##2##3##(1992-6#1)(2007-6#1)
the same DNA##5##3##(1991-10#1)(1993-12#1)(1994-12#1)(2008-10#1)(2009-10#1)
the same ER##2##3##(1996-9#1)(2009-8#1)
the same N-terminal##2##3##(1994-6#1)(1996-3#1)
the same accuracy##3##3##(1997-6#1)(2008-2#1)(2008-3#1)
the same across##2##3##(2008-4#1)(2010-11#1)
the same action##2##3##(1995-5#1)(2008-5#1)
the same activity##2##3##(1995-5#1)(1997-7#1)
the same age and##4##4##(1990-11#1)(1991-11#1)(2012-2#1)(2013-1#1)
the same age group##5##4##(1990-2#1)(1990-6#1)(2008-1#1)(2011-2#1)(2012-12#1)
the same age groups##2##4##(1991-12#1)(2008-1#1)
the same age in##2##4##(1991-11#1)(2008-1#1)
the same age##22##3##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-9#1)(1995-9#1)(1996-6#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the same amino acid##2##4##(1991-6#1)(1994-12#1)
the same amino##3##3##(1991-6#1)(1994-12#1)(2008-8#1)
the same amount of##7##4##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
the same amount##10##3##(1990-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
the same analysis##2##3##(2008-10#1)(2008-7#1)
the same analyte##3##3##(2008-10#3)
the same analytical##2##3##(2008-10#1)(2013-1#1)
the same and##3##3##(1993-8#1)(1995-12#1)(2007-7#1)
the same animals##2##3##(1993-12#1)(1993-6#1)
the same antibody##3##3##(1993-11#1)(1997-2#1)(2008-7#1)
the same aphid##2##3##(2008-10#2)
the same approach##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
the same area was##2##4##(2008-3#1)(2008-5#1)
the same area##7##3##(1993-6#1)(1995-1#1)(2007-12#1)(2008-3#1)(2008-5#3)
the same areas##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
the same as in##4##4##(1990-5#1)(1991-8#1)(1992-8#1)(2012-12#1)
the same as that in##3##5##(2007-11#1)(2008-8#1)(2008-9#1)
the same as that observed for##2##6##(1995-3#1)(2008-10#1)
the same as that obtained##3##5##(1993-8#1)(2008-10#1)(2008-2#1)
the same as that of the##5##6##(1990-12#1)(1993-9#1)(2008-2#2)(2008-5#1)
the same as that of##13##5##(1990-12#1)(1990-5#1)(1990-7#1)(1993-9#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#2)
the same as that##26##4##(1990-12#1)(1990-5#1)(1990-7#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2010-1#1)
the same as the##17##4##(1991-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
the same as those of##3##5##(1993-6#1)(1994-12#1)(1997-8#1)
the same as those##8##4##(1991-8#1)(1993-6#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
the same as##75##3##(1990-12#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
the same assay##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
the same at##2##3##(2008-10#1)(2008-3#1)
the same band##2##3##(1993-8#1)(2008-2#1)
the same basic##4##3##(1994-12#1)(1996-3#1)(1997-2#1)(2007-12#1)
the same behavior##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
the same binding site##2##4##(1994-5#1)(2008-9#1)
the same binding##3##3##(1994-2#1)(1994-5#1)(2008-9#1)
the same biological##3##3##(1991-5#1)(1992-9#1)(2008-10#1)
the same brain##3##3##(1996-2#1)(2008-6#1)(2010-5#1)
the same breast##4##3##(1991-2#1)(1994-5#2)(1994-7#1)
the same broad##2##3##(1995-12#1)(2008-10#1)
the same buffer##2##3##(2008-10#1)(2008-2#1)
the same but##2##3##(2008-10#2)
the same cell line##3##4##(1992-9#1)(2008-8#1)(2013-1#1)
the same cell##14##3##(1990-12#1)(1992-9#1)(1995-8#1)(2008-10#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-12#1)(2013-1#1)(2013-8#1)
the same cells##7##3##(1990-8#1)(1992-12#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2013-1#1)
the same characteristic##2##3##(1997-8#1)(2009-10#1)
the same characteristics##2##3##(2008-5#1)(2013-1#1)
the same chemical##2##3##(2008-10#2)
the same chromosomal##2##3##(2008-10#2)
the same chromosome##2##3##(2008-10#1)(2008-8#1)
the same clade##4##3##(2008-10#2)(2008-6#1)(2013-8#1)
the same cluster##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)
the same concentration of##5##4##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
the same concentration range##3##4##(1993-12#1)(1994-8#1)(2008-10#1)
the same concentration##15##3##(1992-6#2)(1993-12#1)(1994-8#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)
the same concentrations of##2##4##(1992-7#1)(2008-10#1)
the same concentrations##6##3##(1992-7#1)(1994-8#1)(2008-10#3)(2008-11#1)
the same condition##3##3##(1991-5#1)(1994-9#1)(2006-10#1)
the same conditions as##3##4##(1990-5#1)(1996-2#1)(2008-5#1)
the same conditions for##2##4##(2008-10#1)(2008-12#1)
the same conditions##34##3##(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#2)
the same configuration##2##3##(1991-10#1)(2007-11#1)
the same constant##2##3##(1995-5#1)(2008-3#1)
the same correct##2##3##(1994-3#1)(2011-2#1)
the same crystal##2##3##(2007-12#1)(2013-8#1)
the same cultivar##3##3##(2008-10#3)
the same data##5##3##(1996-12#1)(2007-11#2)(2008-10#1)(2010-4#1)
the same day of##2##4##(1995-5#1)(2013-1#1)
the same day to##2##4##(2008-5#1)(2013-8#1)
the same day##10##3##(1995-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
the same decade##2##3##(1991-8#1)(2012-2#1)
the same degree of##3##4##(1997-8#1)(2008-1#1)(2008-2#1)
the same degree##6##3##(1993-6#1)(1995-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
the same density##3##3##(1994-8#1)(1997-3#1)(2009-4#1)
the same depth of##2##4##(2008-11#1)(2008-2#1)
the same depth##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
the same design##2##3##(2008-2#1)(2010-1#1)
the same detector##3##3##(2007-12#1)(2008-2#2)
the same developmental##4##3##(1994-12#1)(1995-2#1)(2007-12#2)
the same diagnosis##2##3##(2008-11#1)(2010-8#1)
the same direction as the##4##5##(1994-12#1)(2007-12#1)(2008-2#1)(2008-4#1)
the same direction##10##3##(1992-4#1)(1994-12#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-2#1)
the same disease##2##3##(2008-10#1)(2009-9#1)
the same distribution##2##3##(1994-2#1)(2008-3#1)
the same domain##2##3##(1993-8#1)(2009-10#1)
the same dose of##4##4##(1994-8#1)(1995-3#1)(1997-4#1)(2008-5#1)
the same dose##10##3##(1992-5#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-5#1)(2008-6#1)(2010-11#1)
the same doses of##2##4##(1995-12#1)(2008-10#1)
the same doses##6##3##(1995-12#1)(2008-10#1)(2008-8#1)(2008-9#3)
the same drugs##2##3##(1992-6#1)(1995-8#1)
the same effect on##3##4##(1995-1#1)(1995-12#1)(2008-10#1)
the same effect##7##3##(1995-1#1)(1995-12#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)
the same effects##2##3##(1990-2#1)(2008-10#1)
the same electrophoretic mobility##2##4##(1992-6#2)
the same environmental##2##3##(2008-1#1)(2008-10#1)
the same enzyme##3##3##(1994-8#1)(1995-6#1)(2008-11#1)
the same ethnic group##2##4##(1997-8#1)(2008-9#1)
the same experiment##3##3##(1992-6#1)(2007-11#1)(2010-8#1)
the same experimental conditions##9##4##(1990-8#1)(1995-12#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)
the same experimental##15##3##(1990-8#1)(1995-12#2)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2013-8#1)
the same extent##18##3##(1990-12#1)(1991-5#1)(1991-8#1)(1992-11#2)(1993-6#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
the same facility##2##3##(1996-2#1)(2008-6#1)
the same factors as##2##4##(2007-12#1)(2009-11#1)
the same family##11##3##(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#2)
the same fee##2##3##(1993-3#1)(1994-1#1)
the same fiber##4##3##(2007-11#3)(2008-3#1)
the same field##2##3##(1996-12#1)(2008-10#1)
the same final##3##3##(1997-7#1)(2008-3#1)(2010-7#1)
the same flow##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
the same for all##7##4##(1994-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)
the same for both##5##4##(1995-11#1)(1996-2#1)(2008-3#1)(2008-5#1)(2009-6#1)
the same for different##2##4##(2010-10#1)(2013-8#1)
the same for##24##3##(1990-8#1)(1992-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-3#1)(2013-8#1)
the same form of##2##4##(1996-5#1)(2008-10#1)
the same form##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
the same four##2##3##(1997-5#1)(2008-10#1)
the same frequency as the##2##5##(1995-12#1)(2008-3#1)
the same frequency modulation##2##4##(2007-12#2)
the same frequency##10##3##(1995-12#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-7#1)
the same function##3##3##(1995-6#1)(2007-12#1)(2008-1#1)
the same fungal##2##3##(2008-10#2)
the same gene##13##3##(1990-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-8#1)(2007-12#1)(2008-10#5)(2012-3#1)
the same general##2##3##(1997-5#1)(2008-10#1)
the same genes##2##3##(2008-8#1)(2010-12#1)
the same genetic##8##3##(1994-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
the same genotype##8##3##(2008-10#8)
the same group of##2##4##(1993-8#1)(2011-2#1)
the same group##8##3##(1993-8#1)(1995-4#1)(1997-6#1)(2008-10#3)(2010-11#1)(2011-2#1)
the same groups of##2##4##(2008-10#2)
the same haplotype##2##3##(2007-7#1)(2008-10#1)
the same health##2##3##(2008-7#1)(2010-10#1)
the same height##2##3##(2008-3#1)(2008-8#1)
the same high##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
the same hospital##4##3##(1991-2#1)(1991-3#1)(1996-1#1)(1997-8#1)
the same host##7##3##(1997-3#1)(2008-10#5)(2008-9#1)
the same human##2##3##(1994-11#1)(2008-8#1)
the same in both##5##4##(1991-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(2008-11#1)
the same in the two##2##5##(1992-11#1)(2007-11#1)
the same in the##8##4##(1992-11#1)(1993-11#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-5#1)
the same in##25##3##(1991-11#1)(1991-2#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
the same index##2##3##(2007-11#1)(2008-3#1)
the same individual##7##3##(1996-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#2)
the same instrument##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
the same intensity##2##3##(1990-5#1)(2013-1#1)
the same interferogram##3##3##(2008-3#3)
the same internal##2##3##(1997-7#1)(2007-12#1)
the same is true for the##2##6##(2008-3#1)(2012-2#1)
the same is##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
the same isolate##4##3##(2008-10#4)
the same kind of##4##4##(1991-12#1)(1997-3#1)(2008-10#2)
the same laser##2##3##(2008-2#2)
the same leaf##3##3##(2008-10#3)
the same leaves##2##3##(2008-10#1)(2010-3#1)
the same length##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
the same lens##2##3##(2008-2#1)(2008-3#1)
the same lesion##3##3##(2008-10#2)(2008-6#1)
the same lesions##2##3##(2007-10#1)(2008-10#1)
the same level as the##3##5##(1991-11#1)(2008-10#1)(2008-5#1)
the same level as##7##4##(1991-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
the same level of##10##4##(1993-12#1)(1995-2#1)(1995-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-6#1)
the same level##25##3##(1990-12#1)(1991-11#1)(1992-5#1)(1993-12#1)(1995-2#1)(1995-3#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
the same levels as##2##4##(1993-3#1)(1997-6#1)
the same life##2##3##(1995-1#1)(2008-8#1)
the same line##2##3##(1997-7#1)(2007-12#1)
the same linkage##3##3##(1990-12#1)(2008-10#2)
the same location##9##3##(2008-10#4)(2008-2#1)(2008-3#3)(2011-1#1)
the same locations##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
the same locus##6##3##(1997-8#1)(2008-10#4)(2008-7#1)
the same lung##2##3##(1993-12#1)(2011-2#1)
the same mRNA##3##3##(1992-3#1)(1994-6#1)(2011-2#1)
the same manifold##2##3##(2008-10#2)
the same manner##11##3##(1991-5#1)(1992-8#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-6#1)(2012-2#1)
the same mating allele##2##4##(2008-10#2)
the same mating##3##3##(2008-10#3)
the same maximum##2##3##(2008-3#2)
the same mechanism is##2##4##(2008-11#1)(2008-7#1)
the same mechanism of##2##4##(1997-2#1)(2011-2#1)
the same mechanism##9##3##(1993-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
the same mechanisms##2##3##(2007-12#1)(2010-10#1)
the same medium##4##3##(1992-6#1)(2008-10#2)(2008-11#1)
the same membrane##2##3##(2008-10#1)(2012-4#1)
the same method##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
the same methodology##3##3##(1993-6#1)(2007-12#1)(2013-1#1)
the same mitochondrial DNA##3##4##(1991-5#2)(1992-9#1)
the same mode of##2##4##(1992-5#1)(2008-9#1)
the same model##2##3##(2008-2#1)(2008-5#1)
the same moisturizer product containing##2##5##(2008-5#2)
the same molecular##3##3##(1990-5#1)(1994-11#1)(2009-8#1)
the same molecule##2##3##(2007-12#1)(2008-10#1)
the same nerve##2##3##(2008-5#1)(2008-7#1)
the same number of##9##4##(1990-11#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)
the same old##2##3##(1994-1#1)(1995-3#1)
the same on##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the same operating##3##3##(2008-7#1)(2008-8#2)
the same optical path##2##4##(2008-10#1)(2008-2#1)
the same optical##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
the same or a different##2##5##(2008-3#1)(2008-4#1)
the same or mirror images##2##5##(1996-2#2)
the same or similar##2##4##(1991-2#1)(2008-8#1)
the same or##15##3##(1991-2#1)(1993-1#1)(1996-2#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2011-2#1)(2013-1#1)
the same order of magnitude as##5##6##(1991-2#1)(1992-6#1)(2007-11#2)(2008-11#1)
the same order of magnitude##6##5##(1991-2#1)(1992-6#1)(2007-11#2)(2008-11#2)
the same order of##8##4##(1991-2#1)(1992-6#1)(1995-6#1)(2007-11#2)(2008-11#2)(2008-9#1)
the same order##13##3##(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1995-6#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
the same organism##4##3##(1993-6#1)(1997-6#1)(2008-10#1)(2013-1#1)
the same orientation##3##3##(1991-9#1)(1994-12#1)(1997-6#1)
the same outcome##2##3##(1990-10#1)(2012-1#1)
the same pH##2##3##(2008-10#2)
the same parameter##2##3##(2012-2#1)(2013-1#1)
the same parameters##2##3##(1990-5#1)(2008-2#1)
the same particle##2##3##(1997-2#1)(2008-6#1)
the same path##2##3##(2008-2#1)(2009-10#1)
the same pathophysiologic##2##3##(1994-11#1)(2012-3#1)
the same pathotype##3##3##(2008-10#3)
the same pathway##2##3##(2008-10#1)(2008-11#1)
the same pathways##2##3##(2008-10#1)(2008-7#1)
the same patients were##2##4##(1991-4#1)(2008-1#1)
the same patients##6##3##(1991-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
the same pattern as##6##4##(1991-12#1)(1997-7#1)(2008-10#2)(2008-3#1)(2010-8#1)
the same pattern of##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
the same pattern##12##3##(1991-12#1)(1994-9#1)(1995-12#2)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-8#1)
the same peptide##2##3##(1993-9#1)(1995-2#1)
the same performance as##2##4##(2008-10#1)(2008-3#1)
the same performance##3##3##(2008-10#2)(2008-3#1)
the same period in##3##4##(1995-11#1)(1996-11#1)(1996-3#1)
the same period of time##8##5##(1990-11#1)(1991-8#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
the same period of##9##4##(1990-11#1)(1991-8#1)(1992-6#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
the same period##28##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-8#1)(1992-6#2)(1995-1#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
the same phase##3##3##(1996-5#1)(2008-7#1)(2009-10#1)
the same phenotype##5##3##(1992-3#1)(1994-3#1)(2008-10#3)
the same place##2##3##(1993-6#1)(2012-2#1)
the same plane in##2##4##(2008-3#1)(2010-8#1)
the same plane##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
the same plant sample##2##4##(2008-10#2)
the same plant##6##3##(2008-10#6)
the same plasmid##2##3##(1991-9#1)(1994-12#1)
the same plot##2##3##(2008-10#2)
the same point##5##3##(1992-2#1)(1993-12#1)(2007-11#1)(2008-10#1)(2010-12#1)
the same polarization state##2##4##(2007-11#1)(2007-12#1)
the same polarization##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the same polymer##3##3##(2008-10#1)(2008-11#2)
the same pool of##2##4##(1997-6#1)(2008-5#1)
the same pool##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
the same population of##2##4##(1995-12#1)(2008-10#1)
the same population##12##3##(1992-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-10#6)(2012-12#1)
the same position as##3##4##(1990-2#1)(1993-2#1)(2010-3#1)
the same position##7##3##(1990-2#1)(1990-5#1)(1993-2#1)(1995-6#1)(2008-11#1)(2008-8#1)(2010-3#1)
the same precision##2##3##(2008-10#2)
the same primers##3##3##(1997-7#1)(2008-10#2)
the same principles##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
the same procedure##7##3##(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-12#1)
the same procedures##2##3##(1996-12#1)(2008-9#1)
the same process##3##3##(1996-2#1)(1997-3#1)(2008-5#1)
the same product##3##3##(2008-3#1)(2009-10#1)(2009-6#1)
the same products##2##3##(1994-9#1)(2008-11#1)
the same profile##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
the same program##2##3##(2007-11#1)(2007-8#1)
the same properties##2##3##(1992-10#1)(2008-1#1)
the same proportion##2##3##(1991-2#1)(1994-1#1)
the same protein##5##3##(1995-6#1)(1997-4#1)(1997-6#1)(2011-1#1)(2012-2#1)
the same protocol##3##3##(1992-11#1)(2008-7#1)(2009-1#1)
the same qualitative##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
the same quality of##2##4##(2008-11#1)(2008-7#1)
the same quality##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
the same race##3##3##(2008-10#3)
the same range of##2##4##(1995-6#1)(2008-3#1)
the same range##9##3##(1990-11#1)(1991-3#1)(1992-2#1)(1993-8#1)(1995-6#1)(2007-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
the same rapid##2##3##(1990-2#1)(2008-8#1)
the same rate##6##3##(1991-2#1)(1993-6#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)
the same rats##2##3##(1993-12#1)(1993-3#1)
the same reaction##6##3##(1995-11#1)(2007-11#1)(2008-10#3)(2009-3#1)
the same reading frame##2##4##(1991-12#1)(2008-9#1)
the same recognition##2##3##(2007-12#1)(2008-10#1)
the same region of##4##4##(1990-12#1)(1992-11#1)(1994-8#1)(2008-1#1)
the same region##13##3##(1990-12#1)(1991-3#1)(1992-11#1)(1993-8#2)(1994-11#1)(1994-8#1)(2008-1#1)(2008-10#4)(2011-1#1)
the same regions##2##3##(1995-2#1)(2009-5#1)
the same regulatory##2##3##(2009-7#2)
the same resistant##2##3##(2008-10#2)
the same response##2##3##(1997-2#1)(2009-8#1)
the same results as##3##4##(1997-2#1)(2008-11#1)(2008-2#1)
the same results##9##3##(1990-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#2)(2013-7#1)
the same risk##2##3##(2008-1#2)
the same sample for##2##4##(2008-10#1)(2008-3#1)
the same sample of##3##4##(2008-10#3)
the same sample##12##3##(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)
the same samples##9##3##(1993-6#1)(2008-10#7)(2008-3#1)
the same scale##2##3##(2008-1#1)(2008-9#1)
the same scene##3##3##(2008-3#2)(2008-6#1)
the same selective pressures##2##4##(2008-8#1)(2010-3#1)
the same selective##3##3##(2008-8#2)(2010-3#1)
the same sensor##2##3##(2008-10#2)
the same sensory##2##3##(2007-12#1)(2008-11#1)
the same sequence in##2##4##(2008-5#1)(2008-9#1)
the same sequence of##2##4##(2007-12#1)(2008-8#1)
the same sequence##8##3##(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
the same set of##8##4##(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2009-11#1)
the same shape as##2##4##(2008-2#2)
the same shape##3##3##(2008-2#3)
the same single##4##3##(1996-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
the same site and##2##4##(2008-10#1)(2008-8#1)
the same site showed##2##4##(1995-5#1)(2008-7#1)
the same site##18##3##(1990-5#3)(1992-5#1)(1993-11#1)(1995-12#1)(1995-5#3)(2007-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)
the same sites##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
the same sitting##2##3##(2008-8#1)(2009-7#1)
the same size range##2##4##(1994-11#1)(2008-10#1)
the same size##11##3##(1992-9#1)(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)
the same skin surface##2##4##(2008-5#2)
the same slope##2##3##(1995-3#1)(2008-8#1)
the same soil##3##3##(2008-10#3)
the same solid##2##3##(2008-10#1)(2008-7#1)
the same solution##3##3##(2008-10#3)
the same solvent##2##3##(2008-10#1)(2008-5#1)
the same source##5##3##(2008-10#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-8#1)
the same species and##2##4##(2008-7#1)(2012-2#1)
the same species##16##3##(1995-2#1)(2007-6#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2012-2#2)(2013-7#1)
the same specific##2##3##(1995-9#1)(1996-2#1)
the same spectrometer##3##3##(2008-10#1)(2008-3#2)
the same standard##2##3##(2010-12#1)(2012-3#1)
the same stimulus##6##3##(1990-5#1)(1994-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-8#1)
the same strain of##2##4##(2008-5#2)
the same strain##4##3##(1997-6#1)(2008-10#1)(2008-5#2)
the same strains##3##3##(1996-12#1)(2008-10#2)
the same structure and##2##4##(1995-5#1)(2008-10#1)
the same structure##5##3##(1995-5#1)(2008-10#1)(2008-2#2)(2009-7#1)
the same students##2##3##(2008-12#1)(2013-1#1)
the same subgroup##2##3##(1994-12#1)(2010-5#1)
the same surface##2##3##(1990-12#1)(1996-2#1)
the same symptoms##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
the same system##6##3##(2008-10#3)(2008-2#1)(2010-5#1)(2012-2#1)
the same technique##4##3##(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)
the same tendency##3##3##(1996-7#1)(2008-4#1)(2008-5#1)
the same thickness of##2##4##(2006-6#1)(2007-12#1)
the same thickness##3##3##(2006-6#1)(2007-11#1)(2007-12#1)
the same three##2##3##(2008-10#2)
the same time it##2##4##(1990-5#1)(1997-2#1)
the same time of the##2##5##(1994-6#1)(2012-2#1)
the same time period##2##4##(1991-2#1)(2008-10#1)
the same time the##7##4##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
the same time##176##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#23)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#6)(2008-5#8)(2008-6#4)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
the same tissue##5##3##(1992-3#1)(1994-10#1)(1995-11#1)(2008-7#1)(2009-4#1)
the same tissues in##2##4##(2008-4#1)(2008-5#1)
the same tissues##7##3##(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
the same total number of##2##5##(1993-8#1)(2007-11#1)
the same total##4##3##(1993-8#1)(2007-11#1)(2008-4#1)(2011-1#1)
the same training##2##3##(2008-5#1)(2009-1#1)
the same transcriptional orientation##3##4##(1991-9#1)(1996-3#1)(1997-6#1)
the same treatment##11##3##(1993-6#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2012-3#1)(2013-8#1)
the same tumor##4##3##(1991-6#1)(1992-9#1)(2010-11#1)(2011-2#1)
the same two##6##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)
the same type of##10##4##(1992-6#1)(1992-9#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)
the same type##15##3##(1992-6#1)(1992-9#1)(1995-12#1)(1997-4#2)(1997-6#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2009-5#1)
the same types of##3##4##(1991-12#1)(1997-3#1)(2008-10#1)
the same tyrosine##2##3##(1991-12#2)
the same underlying##2##3##(2010-1#1)(2011-1#1)
the same value##2##3##(2008-2#1)(2008-3#1)
the same variables##2##3##(2008-10#1)(2008-11#1)
the same variety##2##3##(2008-10#2)
the same viroids##2##3##(2008-10#2)
the same virus##5##3##(1991-3#1)(2008-10#2)(2008-8#2)
the same volume of##2##4##(1990-7#1)(2012-3#1)
the same volume##5##3##(1990-7#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
the same was##2##3##(2008-7#1)(2011-2#1)
the same water##4##3##(1994-8#1)(2008-10#2)(2008-3#1)
the same wavelength##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
the same way as##15##4##(1991-9#2)(1993-3#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-4#1)
the same way##28##3##(1990-8#1)(1991-9#2)(1993-3#1)(1994-1#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#1)
the same while##2##3##(2008-10#1)(2008-7#1)
the same with##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
the same within##2##3##(1995-5#1)(2008-10#1)
the same year and##2##4##(1990-10#1)(2008-10#1)
the same year##4##3##(1990-10#1)(2008-1#1)(2008-10#2)
the same##2384##2##(1990-10#3)(1990-11#11)(1990-12#13)(1990-2#13)(1990-3#3)(1990-4#2)(1990-5#18)(1990-6#6)(1990-7#5)(1990-8#7)(1990-9#1)(1991-10#2)(1991-11#5)(1991-12#17)(1991-2#9)(1991-3#8)(1991-4#2)(1991-5#12)(1991-6#4)(1991-8#9)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#10)(1992-12#8)(1992-2#7)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#21)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#3)(1993-11#10)(1993-12#15)(1993-2#4)(1993-3#9)(1993-5#1)(1993-6#18)(1993-8#14)(1993-9#7)(1994-1#6)(1994-10#3)(1994-11#10)(1994-12#20)(1994-2#9)(1994-3#11)(1994-5#10)(1994-6#8)(1994-7#2)(1994-8#19)(1994-9#5)(1995-1#7)(1995-11#12)(1995-12#22)(1995-2#24)(1995-3#14)(1995-4#2)(1995-5#25)(1995-6#18)(1995-8#11)(1995-9#4)(1996-1#4)(1996-11#3)(1996-12#9)(1996-2#13)(1996-3#11)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#16)(1997-3#10)(1997-4#13)(1997-5#4)(1997-6#17)(1997-7#10)(1997-8#11)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#10)(2007-11#45)(2007-12#49)(2007-5#2)(2007-6#4)(2007-7#10)(2007-8#10)(2007-9#1)(2008-1#25)(2008-10#526)(2008-11#93)(2008-12#25)(2008-2#65)(2008-3#121)(2008-4#22)(2008-5#80)(2008-6#30)(2008-7#64)(2008-8#74)(2008-9#55)(2009-1#3)(2009-10#13)(2009-11#7)(2009-12#7)(2009-3#2)(2009-4#3)(2009-5#8)(2009-6#10)(2009-7#5)(2009-8#10)(2009-9#5)(2010-1#5)(2010-10#5)(2010-11#5)(2010-12#9)(2010-2#4)(2010-3#9)(2010-4#6)(2010-5#8)(2010-6#1)(2010-7#7)(2010-8#11)(2010-9#1)(2011-1#24)(2011-2#49)(2011-3#2)(2011-7#1)(2012-1#6)(2012-12#20)(2012-2#32)(2012-3#20)(2012-4#2)(2013-1#38)(2013-7#2)(2013-8#28)
the sample and IRE##2##4##(2007-12#2)
the sample and the##9##4##(2008-10#8)(2008-3#1)
the sample and##33##3##(1997-2#1)(2007-12#3)(2008-10#23)(2008-3#3)(2008-7#1)(2009-8#1)(2011-1#1)
the sample and/or##2##3##(2008-10#2)
the sample are##3##3##(2008-10#1)(2008-2#2)
the sample area##2##3##(2010-2#1)(2011-2#1)
the sample arm##2##3##(2007-11#2)
the sample at##2##3##(2007-12#1)(2008-10#1)
the sample before analysis##2##4##(1991-5#1)(2008-10#1)
the sample by##4##3##(2008-10#4)
the sample can be##4##4##(2008-10#3)(2008-2#1)
the sample chamber##5##3##(2008-10#1)(2008-11#3)(2008-9#1)
the sample during##3##3##(1990-5#1)(2007-12#1)(2008-10#1)
the sample for##3##3##(1997-5#1)(2008-10#2)
the sample free##2##3##(1996-12#1)(2008-10#1)
the sample frequency was##2##4##(2008-10#2)
the sample from the##2##4##(2008-10#1)(2008-2#1)
the sample has##2##3##(2008-10#2)
the sample in Study##2##4##(1991-2#2)
the sample in the##2##4##(2008-10#2)
the sample in##12##3##(1991-2#2)(2008-10#9)(2008-9#1)
the sample injected##2##3##(2008-10#2)
the sample injection##4##3##(2008-10#3)(2012-3#1)
the sample into the##2##4##(1990-12#1)(2008-10#1)
the sample into##3##3##(1990-12#1)(2008-10#2)
the sample introduction system##2##4##(2008-10#2)
the sample introduction##4##3##(2008-10#4)
the sample is##24##3##(1995-12#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-12#1)(2008-3#6)(2008-5#1)
the sample matrix was##2##4##(2008-10#2)
the sample matrix##9##3##(2008-10#8)(2008-5#1)
the sample may be##2##4##(2008-10#1)(2013-1#1)
the sample of##4##3##(2008-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
the sample or##2##3##(2008-10#1)(2008-3#1)
the sample pH and sample flow rate##2##7##(2008-10#2)
the sample pH##3##3##(2008-10#3)
the sample plug##4##3##(2008-10#4)
the sample preparation and##2##4##(2008-10#2)
the sample preparation##7##3##(2008-10#6)(2012-12#1)
the sample set##3##3##(2013-8#3)
the sample size for##2##4##(1995-9#1)(2012-12#1)
the sample size is too##2##5##(2007-7#2)
the sample size is##5##4##(2007-7#2)(2008-7#1)(2009-11#1)(2012-3#1)
the sample size##20##3##(1994-9#1)(1995-9#2)(2007-7#2)(2008-10#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)
the sample sizes##2##3##(2008-10#1)(2012-12#1)
the sample solution containing##2##4##(2008-10#2)
the sample solution in##2##4##(2008-10#2)
the sample solution is##2##4##(2008-10#2)
the sample solution through the##2##5##(2008-10#2)
the sample solution to##2##4##(2008-10#2)
the sample solution was injected##2##5##(2008-10#2)
the sample solution was##7##4##(2008-10#7)
the sample solution##39##3##(2008-10#39)
the sample solutions##3##3##(2008-10#3)
the sample stream##2##3##(2008-10#2)
the sample structure##2##3##(2008-3#2)
the sample surface to##2##4##(2007-11#1)(2008-3#1)
the sample surface##13##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#4)(2012-2#1)
the sample through the##2##4##(2008-10#1)(2008-3#1)
the sample through##4##3##(2008-10#3)(2008-3#1)
the sample throughput##8##3##(2008-10#8)
the sample to the##2##4##(2008-10#2)
the sample to##10##3##(2007-12#1)(2008-10#7)(2008-3#1)(2011-2#1)
the sample treated by##2##4##(2008-10#1)(2008-9#1)
the sample treated##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
the sample under##2##3##(2008-3#2)
the sample using##5##3##(2008-10#5)
the sample volume was##2##4##(2008-10#2)
the sample volume##9##3##(1990-12#1)(2008-10#7)(2008-3#1)
the sample was divided##2##4##(2008-12#1)(2008-6#1)
the sample was##15##3##(1997-3#1)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2013-8#1)
the sample were##7##3##(1992-5#1)(1995-5#1)(2007-2#1)(2008-10#2)(2008-12#1)(2012-12#1)
the sample with the highest##2##5##(2008-10#1)(2008-5#1)
the sample with##11##3##(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-5#1)
the sample zone is##4##4##(2008-10#4)
the sample zone##10##3##(2008-10#10)
the sample##541##2##(1990-12#3)(1990-5#1)(1990-8#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-4#2)(2007-11#14)(2007-12#15)(2007-2#2)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#317)(2008-11#4)(2008-12#4)(2008-2#12)(2008-3#55)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#8)(2013-8#8)
the sample's##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
the sample)##6##2##(2008-1#1)(2008-10#2)(2008-2#1)(2009-4#1)(2012-3#1)
the sampled##17##2##(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#3)(2013-7#2)
the samples analyzed##4##3##(2008-10#4)
the samples and the##3##4##(2008-10#3)
the samples and##11##3##(2008-10#9)(2008-11#1)(2008-3#1)
the samples are##8##3##(2008-10#6)(2008-3#2)
the samples by##3##3##(2008-10#3)
the samples collected##4##3##(1992-3#1)(2008-10#2)(2010-8#1)
the samples could##2##3##(2008-10#2)
the samples for##4##3##(2008-10#4)
the samples in a##2##4##(1994-11#1)(2008-10#1)
the samples in##10##3##(1990-8#1)(1994-11#1)(2008-10#6)(2008-3#1)(2012-2#1)
the samples is##3##3##(2008-10#2)(2008-3#1)
the samples of interest##2##4##(2008-10#1)(2008-2#1)
the samples of the##3##4##(1991-1#1)(2008-10#1)(2012-3#1)
the samples of##9##3##(1991-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
the samples on the##2##4##(2008-10#2)
the samples on##3##3##(2008-10#2)(2008-8#1)
the samples prepared##2##3##(1990-7#1)(2008-5#1)
the samples studied##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
the samples to##5##3##(2008-10#1)(2008-3#2)(2009-11#1)(2010-5#1)
the samples using##2##3##(2008-10#2)
the samples was determined##2##4##(2008-10#2)
the samples was##7##3##(2008-10#6)(2013-1#1)
the samples were determined by##3##5##(2008-10#2)(2011-1#1)
the samples were digested##2##4##(2008-10#2)
the samples were inserted into the system on the day##2##10##(2010-6#2)
the samples were##30##3##(2007-11#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)
the samples##234##2##(1990-12#2)(1990-7#2)(1990-8#1)(1991-1#1)(1992-3#1)(1994-11#1)(1994-6#3)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(2007-11#2)(2007-7#2)(2008-10#130)(2008-11#5)(2008-12#6)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#6)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
the sampling arm##2##3##(2008-10#2)
the sampling date##2##3##(1996-12#1)(2008-10#1)
the sampling distribution##2##3##(2008-10#2)
the sampling error##2##3##(2008-10#1)(2008-8#1)
the sampling frequency of##2##4##(2008-10#2)
the sampling frequency was##2##4##(2008-10#2)
the sampling frequency##8##3##(2008-10#8)
the sampling in##2##3##(2008-3#1)(2011-3#1)
the sampling loss##2##3##(2008-10#2)
the sampling period##4##3##(2007-5#1)(2008-10#1)(2008-2#1)(2013-7#1)
the sampling points##5##3##(2008-3#5)
the sampling rate of##2##4##(2008-10#2)
the sampling rate was##4##4##(2008-10#4)
the sampling rate##6##3##(2008-10#6)
the sampling rates##2##3##(2008-10#2)
the sampling throughput##2##3##(2008-10#2)
the sampling time##2##3##(2008-10#2)
the sampling unit##3##3##(2008-10#3)
the sampling variance of##2##4##(2008-10#1)(2008-8#1)
the sampling volume##4##3##(2008-3#4)
the sampling##89##2##(1996-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#52)(2008-11#1)(2008-2#6)(2008-3#13)(2008-8#3)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#3)
the sanatoriums##3##2##(2009-7#3)
the sanctuary area##2##3##(2013-7#2)
the sanctuary##3##2##(2013-7#3)
the sand fly##3##3##(2007-12#1)(2008-7#1)(2010-1#1)
the sand##7##2##(1991-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-1#1)
the sandwich##2##2##(2008-10#2)
the sanitary##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
the sanitation of##2##3##(2009-12#1)(2010-1#1)
the sanitation##3##2##(1997-3#1)(2009-12#1)(2010-1#1)
the saphenous vein##3##3##(2007-7#1)(2007-8#2)
the saphenous##6##2##(1997-3#2)(2007-7#1)(2007-8#3)
the sapphire##2##2##(2008-10#1)(2008-3#1)
the saprophyte##3##2##(1993-9#1)(2008-10#1)(2008-9#1)
the saprophytic stage##2##3##(2008-10#2)
the saprophytic##3##2##(2008-10#3)
the sapwood##2##2##(2008-10#2)
the sarcolemma and the##2##4##(1994-8#1)(2009-7#1)
the sarcolemma##3##2##(1994-8#1)(1996-9#1)(2009-7#1)
the sarcomatous##3##2##(1990-12#1)(1994-5#1)(2011-2#1)
the sarcoplasmic reticulum##8##3##(1990-2#1)(1991-12#2)(1991-9#1)(1992-3#1)(1994-8#1)(2009-7#1)(2013-8#1)
the satellite cell##2##3##(2008-7#1)(2009-3#1)
the satellite##11##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-3#1)
the satisfaction of the##3##4##(2008-2#1)(2010-9#1)(2013-1#1)
the satisfaction of##5##3##(1992-5#1)(2007-10#1)(2008-2#1)(2010-9#1)(2013-1#1)
the satisfaction##7##2##(1992-3#1)(1992-5#1)(2007-10#1)(2007-12#1)(2008-2#1)(2010-9#1)(2013-1#1)
the satisfactory##7##2##(2008-10#3)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
the saturable absorber##4##3##(2008-2#1)(2008-3#3)
the saturated fatty acids##2##4##(1991-12#1)(2008-11#1)
the saturated fatty##3##3##(1991-12#1)(2008-11#1)(2010-4#1)
the saturated##13##2##(1990-2#1)(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#4)(2010-4#1)
the saturation effects##2##3##(2008-3#1)(2008-7#1)
the saturation intensity##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the saturation of##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
the saturation##18##2##(1991-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#8)(2008-7#1)(2011-2#1)(2013-8#1)
the savings##6##2##(1990-4#1)(1992-2#1)(1993-3#1)(1995-2#2)(2011-2#1)
the sawdust of##2##3##(2008-12#2)
the sawdust##3##2##(2008-12#3)
the scFv##2##2##(2008-10#1)(2009-2#1)
the scaffold for##2##3##(2007-12#1)(2009-7#1)
the scaffold must##2##3##(2009-7#2)
the scaffold##9##2##(2007-12#1)(2008-5#1)(2008-7#2)(2009-7#4)(2012-1#1)
the scaffolding##3##2##(2008-11#2)(2009-7#1)
the scalar diffraction theory is##2##5##(2008-2#1)(2008-3#1)
the scalar##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
the scale and##2##3##(2008-9#1)(2012-2#1)
the scale factor##2##3##(2008-2#1)(2008-3#1)
the scale is##2##3##(2008-3#1)(2012-2#1)
the scale of 1-5##2##4##(1990-2#2)
the scale of a##2##4##(2007-12#1)(2012-1#1)
the scale of the data##2##5##(2008-10#1)(2011-1#1)
the scale of the##9##4##(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)
the scale of##23##3##(1990-2#2)(1990-3#1)(1992-1#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
the scale up##2##3##(2008-11#2)
the scale##53##2##(1990-2#2)(1990-3#1)(1992-1#2)(1994-2#1)(1996-3#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#7)(2008-7#2)(2008-8#3)(2008-9#7)(2009-10#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
the scale-up##3##2##(2008-11#2)(2008-7#1)
the scales##6##2##(1990-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
the scaling and##2##3##(2008-10#1)(2013-8#1)
the scaling argument##2##3##(2007-10#2)
the scaling of##3##3##(1993-5#1)(2007-10#1)(2008-3#1)
the scaling##14##2##(1993-5#1)(2007-10#3)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2012-2#1)(2013-8#1)
the scalp and##4##3##(2008-5#2)(2008-7#1)(2013-8#1)
the scalp is##2##3##(2010-5#1)(2010-6#1)
the scalp##28##2##(1992-8#1)(1996-7#1)(2007-7#2)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#5)(2010-6#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
the scan rate##4##3##(2008-10#4)
the scan##16##2##(1995-11#2)(1996-5#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-2#1)(2012-1#2)(2013-1#1)
the scanner##6##2##(1992-11#1)(2008-3#2)(2008-7#1)(2011-1#2)
the scanning electron microscope##2##4##(2008-5#2)
the scanning##17##2##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#1)(2011-2#1)
the scaphoid and##2##3##(2008-9#1)(2012-1#1)
the scaphoid##7##2##(2008-9#5)(2012-1#1)(2013-1#1)
the scar##6##2##(1997-3#1)(2009-6#1)(2012-1#2)(2013-8#2)
the scarce##3##2##(2007-5#1)(2008-7#1)(2012-12#1)
the scarcity of##7##3##(2008-5#1)(2008-9#2)(2011-2#1)(2011-3#2)(2012-12#1)
the scatter##4##2##(1996-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
the scattered field to##3##4##(2007-12#1)(2008-3#2)
the scattered field##8##3##(2007-11#2)(2007-12#1)(2008-3#4)(2009-10#1)
the scattered light and the##2##5##(2007-12#1)(2008-3#1)
the scattered light and##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
the scattered light is##2##4##(2008-2#1)(2008-3#1)
the scattered light##20##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#12)(2011-2#1)
the scattered wave##7##3##(2008-2#1)(2008-3#6)
the scattered##49##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#32)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#1)
the scatterer##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
the scattering and absorption##2##4##(2008-2#1)(2008-3#1)
the scattering and microphysical properties of##2##6##(2008-3#2)
the scattering and the absorption##2##5##(2007-11#1)(2008-3#1)
the scattering and##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
the scattering angle##6##3##(2008-2#2)(2008-3#4)
the scattering by sunlit##2##4##(2008-2#2)
the scattering by##3##3##(2007-11#1)(2008-2#2)
the scattering coefficient##11##3##(2008-2#3)(2008-3#8)
the scattering depth##3##3##(2008-2#1)(2008-3#2)
the scattering from##4##3##(2008-3#4)
the scattering intensity from##2##4##(2007-11#1)(2008-2#1)
the scattering intensity##4##3##(2007-11#1)(2008-2#3)
the scattering layer##4##3##(2008-2#4)
the scattering loss##2##3##(2008-2#1)(2008-3#1)
the scattering matrix elements##2##4##(2008-2#1)(2008-3#1)
the scattering matrix##5##3##(2008-2#1)(2008-3#4)
the scattering measurements##2##3##(2008-3#2)
the scattering medium##8##3##(2008-2#4)(2008-3#4)
the scattering object##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the scattering of an##2##4##(2008-2#1)(2009-10#1)
the scattering of light by##4##5##(2008-3#4)
the scattering of light from##2##5##(2008-2#1)(2008-9#1)
the scattering of light##7##4##(2008-2#1)(2008-3#5)(2008-9#1)
the scattering of##11##3##(2008-2#4)(2008-3#5)(2008-9#1)(2009-10#1)
the scattering particles##2##3##(2008-3#2)
the scattering pattern##4##3##(2008-2#1)(2008-3#3)
the scattering phase function are##2##5##(2008-2#1)(2008-3#1)
the scattering phase function##10##4##(2008-2#4)(2008-3#6)
the scattering phase##11##3##(2008-2#4)(2008-3#7)
the scattering problem##2##3##(2008-2#1)(2008-3#1)
the scattering process##3##3##(2008-2#1)(2008-3#2)
the scattering properties of particles##2##5##(2008-3#2)
the scattering properties of the##4##5##(2008-2#1)(2008-3#3)
the scattering properties of##11##4##(2007-11#1)(2008-2#2)(2008-3#8)
the scattering properties##13##3##(2007-11#1)(2008-2#3)(2008-3#9)
the scattering quantities##2##3##(2008-3#2)
the scattering strength##2##3##(2008-3#2)
the scattering##157##2##(2007-11#5)(2007-12#4)(2008-10#3)(2008-2#54)(2008-3#88)(2008-6#1)(2008-9#1)(2009-10#1)
the scavenging of##2##3##(2011-2#1)(2012-2#1)
the scavenging##4##2##(1995-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
the scenario##4##2##(1996-2#1)(2008-11#2)(2011-2#1)
the scenarios##3##2##(2008-1#1)(2008-6#1)(2009-10#1)
the scene of##5##3##(1991-8#1)(1995-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
the scene##11##2##(1991-8#1)(1995-11#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
the scenes##2##2##(2008-3#1)(2008-8#1)
the scent of##3##3##(2008-4#1)(2008-5#2)
the scent##4##2##(2008-4#1)(2008-5#3)
the schedule of##2##3##(2008-7#1)(2008-8#1)
the schedule##6##2##(1991-6#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
the scheduling##2##2##(1996-1#1)(2009-3#1)
the scheme are##2##3##(1991-12#1)(2008-7#1)
the scheme by##2##3##(2008-10#1)(2008-3#1)
the scheme is##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
the scheme##17##2##(1991-12#1)(1997-7#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2012-2#1)(2013-8#1)
the schemes##4##2##(1993-12#2)(1997-3#1)(2008-3#1)
the schistosomiasis##3##2##(2012-3#3)
the schizo-obsessive subtype##3##3##(2008-3#3)
the schizophrenia##3##2##(1993-9#1)(1995-11#1)(2013-1#1)
the schizophrenic##7##2##(1990-11#2)(1995-11#2)(1996-7#2)(2013-1#1)
the school setting##3##3##(1992-3#1)(1997-2#1)(2008-11#1)
the school system##2##3##(1991-12#1)(1993-11#1)
the school year##4##3##(2008-12#4)
the school##23##2##(1990-6#1)(1991-12#2)(1992-3#1)(1993-1#2)(1993-11#1)(1996-4#1)(1997-2#1)(2008-1#1)(2008-11#2)(2008-12#5)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the school-age##2##2##(1991-2#1)(2011-2#1)
the schools of medicine##2##4##(1991-1#1)(1991-6#1)
the schools##7##2##(1991-1#1)(1991-12#2)(1991-6#1)(1993-8#1)(1997-8#1)(2008-12#1)
the sciatic nerve in the rat##3##6##(1993-12#1)(1995-12#2)
the sciatic nerve was##2##4##(1990-7#1)(1996-2#1)
the sciatic nerve##12##3##(1990-5#1)(1990-7#3)(1993-12#3)(1995-12#2)(1996-2#1)(1996-5#1)(2008-7#1)
the sciatic##15##2##(1990-5#1)(1990-7#3)(1993-12#3)(1995-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-6#1)(2008-7#1)
the science and the##2##4##(1993-11#1)(2009-7#1)
the science and##4##3##(1991-3#1)(1993-11#1)(1995-1#1)(2009-7#1)
the science behind##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
the science of##7##3##(1990-3#1)(1991-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)(2013-8#1)
the science##22##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1995-1#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the sciences##2##2##(2008-11#1)(2012-2#1)
the scientific and##4##3##(1996-12#1)(2008-10#1)(2010-7#1)(2013-1#1)
the scientific basis of##2##4##(2008-10#1)(2012-2#1)
the scientific community to##2##4##(2008-10#1)(2009-5#1)
the scientific community##12##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#2)
the scientific evidence##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
the scientific knowledge##2##3##(2009-10#2)
the scientific literature shows##2##4##(1993-6#1)(2011-1#1)
the scientific literature##14##3##(1993-12#1)(1993-6#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
the scientific negation of##2##4##(2013-1#2)
the scientific production##2##3##(2012-3#2)
the scientific rationale##2##3##(2008-10#1)(2010-12#1)
the scientific validity##2##3##(2008-3#1)(2011-2#1)
the scientific##71##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#1)
the scientist##4##2##(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
the scientists##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
the scintillation##2##2##(2007-12#1)(2008-2#1)
the scissile bond##3##3##(1990-5#1)(1994-5#1)(1995-5#1)
the scoliosis##2##2##(2007-8#2)
the scolopale##2##2##(2008-7#2)
the scope and quality of##2##5##(2008-1#1)(2013-1#1)
the scope and##5##3##(2008-1#2)(2008-10#1)(2013-1#2)
the scope of health services##2##5##(1996-12#1)(1997-2#1)
the scope of practice of##3##5##(1997-3#1)(2007-10#1)(2011-1#1)
the scope of the assay##2##5##(1991-5#1)(1997-4#1)
the scope of the##10##4##(1991-5#1)(1997-4#1)(1997-5#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-3#1)
the scope of their##2##4##(1995-3#1)(1997-7#1)
the scope of this paper##2##5##(2010-6#1)(2013-7#1)
the scope of this review##2##5##(2008-5#1)(2012-12#1)
the scope of this##6##4##(2007-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-7#1)
the scope of##46##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-3#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-7#1)
the scope##52##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-3#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
the score##9##2##(1991-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2012-3#2)(2013-1#1)
the scores of##4##3##(1992-1#1)(2008-1#2)(2009-10#1)
the scores##9##2##(1990-3#1)(1992-1#1)(2008-1#2)(2008-11#2)(2009-10#1)(2010-3#2)
the scoring function##3##3##(2008-7#2)(2011-3#1)
the scoring##6##2##(2008-10#1)(2008-7#2)(2011-3#1)(2012-12#1)(2013-1#1)
the scorpion##7##2##(1990-8#1)(1993-6#1)(2007-12#3)(2008-7#1)(2008-8#1)
the screen is##2##3##(2008-2#1)(2008-3#1)
the screen##11##2##(1992-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)
the screened population##2##3##(1996-12#1)(2008-10#1)
the screened##3##2##(1996-12#1)(2008-10#2)
the screening method##2##3##(2008-10#1)(2012-3#1)
the screening of a##3##4##(1990-12#1)(2008-10#1)(2009-10#1)
the screening of##23##3##(1990-12#1)(1991-7#1)(1996-12#1)(1996-9#1)(1997-3#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-5#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)
the screening process##4##3##(2007-11#1)(2008-11#2)(2010-11#1)
the screening program##2##3##(1992-2#1)(2012-3#1)
the screening test##3##3##(1990-6#1)(1997-2#1)(2012-3#1)
the screening was##2##3##(1990-2#1)(1992-10#1)
the screening##63##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1995-12#1)(1996-12#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-5#2)(2009-10#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
the screw fixation group##2##4##(2009-3#2)
the screw##5##2##(2007-11#2)(2008-8#1)(2009-3#2)
the screwless fixation group##2##4##(2009-3#2)
the screws##4##2##(1991-9#1)(2007-11#1)(2007-8#1)(2008-10#1)
the scrotal##5##2##(1994-8#1)(2008-10#3)(2010-12#1)
the scrotum##4##2##(1990-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
the scs region##2##3##(1995-2#2)
the scs##3##2##(1995-2#3)
the sd-t(t)##2##2##(2008-9#2)
the sea and##2##3##(2008-10#1)(2011-1#1)
the sea surface##8##3##(2008-2#2)(2008-3#6)
the sea urchin##5##3##(1995-6#1)(2008-11#1)(2008-5#1)(2008-8#2)
the sea##30##2##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#5)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#4)(2011-1#1)(2013-7#1)
the seafarers'##2##2##(2011-2#2)
the search for a##4##4##(1993-8#1)(1994-2#1)(1996-2#1)(2008-4#1)
the search for new##7##4##(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
the search for solutions##2##4##(1997-7#1)(2012-2#1)
the search for the ideal##4##5##(1994-3#1)(1996-3#1)(2008-5#1)(2008-6#1)
the search for the##7##4##(1994-3#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
the search for this##2##4##(2008-5#1)(2011-2#1)
the search for##54##3##(1991-12#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#3)(2009-11#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
the search of##7##3##(1994-3#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
the search process##2##3##(1991-2#1)(1996-2#1)
the search to##2##3##(2008-10#1)(2008-7#1)
the search##85##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-6#1)(1996-10#1)(1996-2#2)(1996-3#1)(1997-6#1)(1997-7#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#2)(2009-2#1)(2010-1#1)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
the seas##2##2##(2008-11#1)(2009-7#1)
the season and##2##3##(2008-10#1)(2011-2#1)
the season in##3##3##(2007-5#1)(2008-10#1)(2008-8#1)
the season of ascospore##2##4##(2008-10#2)
the season of the##2##4##(2008-3#1)(2013-8#1)
the season of##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
the season##30##2##(2007-5#3)(2008-10#16)(2008-3#1)(2008-8#7)(2011-2#1)(2012-6#1)(2013-8#1)
the seasonal and##3##3##(2007-1#1)(2008-10#2)
the seasonal variation of##3##4##(2008-10#2)(2012-2#1)
the seasonal##17##2##(2007-1#1)(2008-10#9)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
the seasons of##2##3##(2008-10#1)(2008-5#1)
the seawater##5##2##(2008-10#2)(2008-3#1)(2008-5#2)
the seaweed fly##2##3##(2013-1#2)
the sebum##3##2##(2008-5#3)
the second (external-focus) intervention##2##4##(2013-1#2)
the second European##2##3##(2008-2#1)(2010-12#1)
the second Surgeon-in-Chief##2##3##(2008-8#2)
the second a##2##3##(2008-10#1)(2008-3#1)
the second amino acid##3##4##(1997-2#2)(2008-10#1)
the second and the third##3##5##(1990-3#1)(1991-12#1)(2008-5#1)
the second and third trimesters##2##5##(1993-12#2)
the second and third##15##4##(1990-3#1)(1992-10#1)(1993-12#2)(1995-8#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#2)
the second and##20##3##(1990-12#1)(1990-3#2)(1991-12#1)(1992-10#1)(1993-12#2)(1995-8#1)(1997-3#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#2)
the second angle##2##3##(2008-3#2)
the second assay##2##3##(2008-10#1)(2008-5#1)
the second base of codon##2##5##(1991-12#1)(1994-11#1)
the second base##3##3##(1991-12#1)(1992-8#1)(1994-11#1)
the second being##2##3##(1994-6#1)(2008-2#1)
the second case of##3##4##(2007-8#1)(2010-3#1)(2013-1#1)
the second case##11##3##(2007-8#2)(2008-10#2)(2008-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the second cause of##2##4##(1991-11#1)(2011-3#1)
the second cell##2##3##(1990-11#1)(2007-12#1)
the second cistron##2##3##(1997-8#1)(2008-7#1)
the second cohort##2##3##(1996-3#1)(2013-7#1)
the second column##3##3##(1990-8#1)(2008-10#2)
the second complete genome sequence##3##5##(2011-2#3)
the second completed genome sequence of the family##2##8##(2011-2#2)
the second completed genome sequence of##6##6##(2011-2#6)
the second comprised##2##3##(1996-4#1)(2008-10#1)
the second cycle##2##3##(2007-7#1)(2008-10#1)
the second day of##4##4##(1993-12#2)(2011-1#1)(2012-3#1)
the second day##9##3##(1991-9#1)(1993-12#2)(1995-5#1)(2007-12#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
the second derivative of the##2##5##(2008-10#1)(2008-3#1)
the second derivative##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
the second diffraction order##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
the second dimension##2##3##(2008-10#2)
the second example##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
the second experiment##9##3##(1993-12#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)
the second for##2##3##(2008-10#1)(2008-4#1)
the second generation of##2##4##(2008-10#1)(2008-3#1)
the second generation##6##3##(1991-6#2)(2008-10#2)(2008-3#1)(2013-8#1)
the second grating##2##3##(2008-2#1)(2008-3#1)
the second group were##4##4##(1994-6#1)(2007-11#1)(2007-8#2)
the second group##15##3##(1990-2#1)(1991-5#1)(1994-6#1)(2007-11#1)(2007-8#4)(2008-10#2)(2008-7#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)
the second half of the##8##5##(1991-6#1)(2007-11#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
the second half of##11##4##(1991-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
the second half##13##3##(1991-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
the second harmonic (532 nm)##2##5##(2008-10#1)(2008-3#1)
the second harmonic of the##3##5##(2007-11#1)(2008-2#2)
the second harmonic of##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
the second harmonic was##2##4##(2007-12#2)
the second harmonic##18##3##(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#3)(2013-1#1)
the second has##2##3##(2008-3#1)(2008-5#1)
the second in##8##3##(1993-3#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)
the second instance##2##3##(2008-3#1)(2012-2#1)
the second intron of the##2##5##(1992-8#1)(2012-3#1)
the second intron##3##3##(1992-8#1)(1994-12#1)(2012-3#1)
the second is a##2##4##(1996-4#1)(2008-2#1)
the second is based on##2##5##(2008-2#1)(2008-3#1)
the second is to##2##4##(1996-2#1)(2008-8#1)
the second is##12##3##(1996-2#1)(1996-4#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#2)
the second largest##5##3##(1992-3#1)(1996-2#1)(2008-10#1)(2010-3#1)(2010-6#1)
the second layer##2##3##(1994-5#1)(2008-10#1)
the second leading cause of##5##5##(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#2)
the second leading##6##3##(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
the second measure##2##3##(1996-5#1)(2008-2#1)
the second measurement##3##3##(2008-3#1)(2010-6#1)(2011-1#1)
the second messenger##7##3##(1993-6#2)(1994-12#1)(1995-6#1)(1996-2#1)(2010-11#1)(2013-7#1)
the second method is##2##4##(2008-3#1)(2008-8#1)
the second method##7##3##(2008-10#4)(2008-3#2)(2008-8#1)
the second model##3##3##(1992-6#2)(1996-4#1)
the second month of##2##4##(2008-5#1)(2011-1#1)
the second most common cancer in men##2##7##(2008-11#1)(2013-1#1)
the second most common cancer in##3##6##(2008-11#1)(2008-5#1)(2013-1#1)
the second most common cause of##2##6##(1996-11#1)(2008-11#1)
the second most common##16##4##(1996-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
the second most frequent cause of##2##6##(2008-5#1)(2011-2#1)
the second most frequent##3##4##(1991-6#1)(2008-5#1)(2011-2#1)
the second most important##2##4##(2008-12#1)(2010-10#1)
the second most##25##3##(1991-6#1)(1996-11#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
the second nucleotide##2##3##(1993-12#1)(1997-2#1)
the second objective##2##3##(1992-11#1)(2008-10#1)
the second of##3##3##(1997-1#1)(2007-2#1)(2012-3#1)
the second one##15##3##(1991-3#1)(1994-11#1)(1995-6#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)
the second operation##4##3##(2008-6#1)(2008-7#3)
the second or third##2##4##(2008-10#2)
the second order of##2##4##(2008-3#2)
the second order##6##3##(2008-10#1)(2008-11#2)(2008-3#2)(2009-7#1)
the second outbreak##2##3##(2008-5#1)(2011-2#1)
the second overtone##2##3##(2008-2#2)
the second parity##2##3##(2008-7#1)(2011-2#1)
the second part of the##5##5##(1990-3#2)(2007-8#1)(2008-1#1)(2008-11#1)
the second part of this##2##5##(1997-4#1)(1997-6#1)
the second part of##9##4##(1990-3#2)(1992-12#1)(1993-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-11#1)
the second part##16##3##(1990-3#2)(1992-12#1)(1993-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
the second peak of##2##4##(1992-11#1)(1992-9#1)
the second peak##5##3##(1992-11#1)(1992-9#1)(2008-10#2)(2010-3#1)
the second period##4##3##(2011-2#3)(2013-1#1)
the second phase of the##2##5##(1997-1#1)(2008-6#1)
the second phase of##3##4##(1995-12#1)(1997-1#1)(2008-6#1)
the second phase##7##3##(1990-12#1)(1993-9#1)(1995-12#1)(1997-1#1)(2008-4#1)(2008-6#1)(2013-1#1)
the second promoter is##2##4##(1991-9#2)
the second repeat##2##3##(2008-10#2)
the second report of##3##4##(1996-10#1)(2008-12#1)(2012-3#1)
the second reported case of##3##5##(2008-10#1)(2008-7#1)(2013-1#1)
the second reported case##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
the second residue of##2##4##(1993-8#1)(2008-5#1)
the second round of##2##4##(2007-11#1)(2008-3#1)
the second round##4##3##(1991-6#1)(2007-11#2)(2008-3#1)
the second sampling bout##2##4##(2008-8#2)
the second sampling##3##3##(2008-10#1)(2008-8#2)
the second scan##2##3##(1996-5#1)(2007-10#1)
the second section##6##3##(1991-1#1)(1992-6#1)(2008-4#1)(2010-11#1)(2012-2#2)
the second set##2##3##(2008-10#1)(2008-3#1)
the second simulation##2##3##(1995-5#1)(2008-3#1)
the second stage and##2##4##(2008-12#1)(2009-5#1)
the second stage##8##3##(1990-12#1)(2008-10#1)(2008-12#1)(2009-5#3)(2012-12#1)(2013-8#1)
the second step in##2##4##(1994-12#1)(2012-2#1)
the second step of the reaction##2##6##(1993-3#1)(2008-10#1)
the second step of##3##4##(1993-3#1)(2008-10#1)(2008-6#1)
the second step##14##3##(1993-3#1)(1994-12#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-8#2)(2011-1#1)(2012-2#1)
the second study##8##3##(2008-3#1)(2008-5#1)(2008-6#3)(2011-1#1)(2012-3#1)(2013-1#1)
the second substrate##3##3##(1992-3#1)(1995-2#1)(2008-11#1)
the second time##3##3##(1991-8#1)(2008-3#1)(2008-8#1)
the second to##2##3##(1992-6#1)(2011-1#1)
the second trimester of pregnancy##2##5##(2008-2#1)(2012-2#1)
the second trimester##6##3##(1990-2#1)(1991-6#1)(1993-3#1)(1994-3#1)(2008-2#1)(2012-2#1)
the second week of##4##4##(1992-3#1)(2008-10#1)(2008-8#1)(2009-3#1)
the second week##9##3##(1992-3#2)(1995-5#1)(1997-2#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)
the second with a clinical nurse##2##6##(2013-1#2)
the second with##3##3##(2009-7#1)(2013-1#2)
the second world war##2##4##(1997-6#2)
the second year of life##3##5##(1996-11#1)(2007-8#1)(2008-9#1)
the second year of the##2##5##(2008-10#1)(2010-3#1)
the second year of##5##4##(1996-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-3#1)
the second year##13##3##(1991-8#1)(1996-11#1)(1996-12#3)(2007-8#1)(2008-10#2)(2008-6#2)(2008-9#1)(2010-3#1)(2011-2#1)
the second##691##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#4)(1990-7#4)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#2)(1991-6#6)(1991-8#4)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#9)(1992-4#1)(1992-6#4)(1992-8#4)(1992-9#2)(1993-12#9)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#4)(1995-5#3)(1995-6#8)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#12)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#6)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#4)(2007-11#15)(2007-12#23)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#12)(2008-1#6)(2008-10#108)(2008-11#17)(2008-12#10)(2008-2#21)(2008-3#51)(2008-4#8)(2008-5#19)(2008-6#14)(2008-7#14)(2008-8#23)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#8)(2009-9#1)(2010-10#2)(2010-11#6)(2010-12#4)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#12)(2011-2#29)(2011-3#1)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#25)(2013-7#2)(2013-8#4)
the second-derivative##2##2##(2008-10#2)
the second-generation##2##2##(2008-11#1)(2009-8#1)
the second-harmonic generation##4##3##(2007-12#1)(2008-2#3)
the second-harmonic signal##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
the second-harmonic signals##2##3##(2007-12#2)
the second-harmonic##19##2##(2007-11#3)(2007-12#8)(2008-2#4)(2008-3#4)
the second-harmonic-generation##2##2##(2007-12#2)
the second-line##2##2##(2008-2#1)(2010-12#1)
the second-order nonlinearity of##2##4##(2007-11#1)(2008-3#1)
the second-order polynomial##2##3##(2008-10#1)(2011-1#1)
the second-order rate constant##3##4##(1990-5#1)(1993-8#1)(2008-4#1)
the second-order risk factor##2##4##(2009-7#2)
the second-order##27##2##(1990-5#1)(1993-8#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#2)(2008-3#9)(2008-4#1)(2009-7#2)(2011-1#1)
the second-phase##2##2##(1990-2#1)(1991-5#1)
the secondary and tertiary##2##4##(1995-5#1)(2008-9#1)
the secondary antibody##4##3##(1991-3#1)(2008-4#3)
the secondary endpoint##2##3##(2008-10#1)(2008-5#1)
the secondary headspot cells##3##4##(2007-12#3)
the secondary infection##2##3##(2008-10#1)(2008-12#1)
the secondary nucleus##2##3##(2008-9#2)
the secondary phloem##2##3##(2008-10#2)
the secondary spectrum##4##3##(2008-3#4)
the secondary structure of the##2##5##(1991-5#1)(2008-10#1)
the secondary structure of##9##4##(1991-5#1)(1992-5#1)(1992-8#2)(1993-8#1)(2008-10#3)(2008-7#1)
the secondary structure##17##3##(1991-5#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-8#1)(1994-12#1)(1995-11#1)(2008-10#3)(2008-4#2)(2008-7#2)(2012-2#1)
the secondary structures##2##3##(1993-11#1)(2008-10#1)
the secondary##87##2##(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#2)(1996-2#1)(1996-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#7)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
the secrecy##2##2##(2008-2#1)(2010-12#1)
the secret to##2##3##(1996-2#1)(2008-11#1)
the secreted form of the##2##5##(1991-2#1)(2008-11#1)
the secreted form of##3##4##(1991-2#1)(1992-12#1)(2008-11#1)
the secreted protein##3##3##(1992-5#1)(1997-4#1)(2009-3#1)
the secreted##16##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1997-1#1)(1997-4#2)(2008-10#1)(2008-11#2)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#2)
the secretion and##2##3##(1993-5#1)(2008-7#1)
the secretion of IL-7##2##4##(2008-11#2)
the secretion of beta-endorphin##2##4##(1990-12#1)(1994-9#1)
the secretion of interleukin 7##2##5##(2008-11#2)
the secretion of mutant##2##4##(1990-12#1)(1995-6#1)
the secretion of the##2##4##(2007-12#1)(2008-11#1)
the secretion of this##2##4##(1992-3#1)(1993-3#1)
the secretion of##38##3##(1990-11#1)(1990-12#2)(1990-5#1)(1992-3#2)(1993-12#2)(1993-3#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1997-7#1)(2007-12#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the secretion##50##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-6#1)(1992-3#2)(1993-12#2)(1993-3#2)(1993-5#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-7#1)(2006-6#1)(2007-12#3)(2008-11#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the secretions of##2##3##(1991-5#1)(2008-5#1)
the secretions##3##2##(1991-11#1)(1991-5#1)(2008-5#1)
the secretory activity##2##3##(1993-5#1)(2008-7#1)
the secretory cycle##2##3##(2008-7#2)
the secretory epithelium##2##3##(1995-6#1)(2008-7#1)
the secretory granules##2##3##(1995-8#1)(1996-5#1)
the secretory pathway##9##3##(1992-9#1)(1997-1#2)(2008-1#1)(2008-11#2)(2008-4#1)(2012-2#2)
the secretory response##2##3##(1993-3#1)(1996-5#1)
the secretory##35##2##(1990-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-5#2)(1995-6#1)(1995-8#1)(1996-5#2)(1997-1#2)(1997-3#1)(1997-6#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#5)(2011-2#1)(2012-2#2)
the section of the##2##4##(1996-4#1)(1997-2#1)
the section of##3##3##(1990-2#1)(1996-4#1)(1997-2#1)
the section##8##2##(1990-2#1)(1990-5#2)(1995-2#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-10#1)
the sectional##2##2##(2007-12#1)(2008-3#1)
the sections of##2##3##(2011-1#1)(2012-12#1)
the sections##6##2##(2008-2#1)(2008-4#2)(2009-1#1)(2011-1#1)(2012-12#1)
the sector##4##2##(1995-3#1)(2008-10#1)(2009-10#1)(2013-7#1)
the secured##2##2##(1991-2#2)
the security and##3##3##(1993-2#1)(2008-7#1)(2010-9#1)
the security department##3##3##(1993-2#2)(1995-2#1)
the security of the##2##4##(1993-3#1)(1994-3#1)
the security of##5##3##(1993-3#1)(1994-3#2)(2010-8#1)(2012-3#1)
the security rule##2##3##(2007-12#1)(2008-4#1)
the security##25##2##(1991-1#2)(1992-2#1)(1993-12#1)(1993-2#4)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#2)(1996-2#1)(1997-2#2)(2007-12#2)(2008-4#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-3#1)
the sedentary##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
the sediment##9##2##(1992-3#1)(1996-12#1)(2008-10#4)(2008-5#1)(2013-1#1)(2013-7#1)
the sedimentation rate##3##3##(1993-8#1)(2008-10#2)
the sedimentation##4##2##(1993-8#1)(1997-2#1)(2008-10#2)
the sedimented phase##2##3##(2008-10#2)
the sediments##8##2##(1992-8#1)(2007-5#1)(2008-10#4)(2008-5#1)(2011-2#1)
the seed and##2##3##(2008-10#2)
the seed beam##2##3##(2008-2#2)
the seed coat##4##3##(2008-10#4)
the seed oil##2##3##(2008-11#1)(2009-10#1)
the seed shadow##2##3##(2008-9#2)
the seed treatment##2##3##(2008-10#2)
the seed##47##2##(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-2#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2013-8#2)
the seedborne##2##2##(2008-10#2)
the seeded##2##2##(1994-8#1)(2012-2#1)
the seeder##2##2##(2007-11#1)(2008-2#1)
the seeding##3##2##(2007-11#1)(2008-12#1)(2011-2#1)
the seedling and adult##2##4##(2008-10#2)
the seedling and reproductive stages##2##5##(2008-12#2)
the seedling and##6##3##(2008-10#4)(2008-12#2)
the seedling growth##2##3##(2008-5#2)
the seedling stage##9##3##(2008-10#8)(2008-12#1)
the seedling##19##2##(2008-10#13)(2008-12#3)(2008-5#2)(2009-10#1)
the seedlings were##3##3##(2008-10#2)(2011-10#1)
the seedlings##9##2##(2008-10#6)(2008-5#2)(2011-10#1)
the seeds of Euphorbia lathyris L##5##6##(2011-1#5)
the seeds of##10##3##(1990-11#1)(2007-11#1)(2010-1#1)(2010-12#1)(2011-1#6)
the seeds##17##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#6)(2013-7#1)
the seemingly##4##2##(1995-2#1)(1997-2#1)(2009-3#1)(2012-2#1)
the segment of##2##3##(2008-10#1)(2008-11#1)
the segment##14##2##(1990-5#1)(1997-4#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2009-10#1)
the segmental organization of the##2##5##(2007-12#2)
the segmental##8##2##(2007-11#1)(2007-12#4)(2008-10#1)(2008-7#1)(2012-3#1)
the segmentation of##4##3##(2007-12#3)(2012-1#1)
the segmentation task##2##3##(2009-10#2)
the segmentation##10##2##(2007-11#1)(2007-12#3)(2008-3#1)(2009-10#4)(2012-1#1)
the segmented##3##2##(2008-3#1)(2008-4#1)(2009-7#1)
the segments##7##2##(1995-12#1)(2006-8#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-1#1)
the segregating populations##2##3##(2008-10#1)(2008-8#1)
the segregating##3##2##(2008-10#2)(2008-8#1)
the segregation of the##2##4##(2008-10#1)(2008-5#1)
the segregation of##8##3##(2008-10#7)(2008-5#1)
the segregation##9##2##(2008-10#7)(2008-5#1)(2012-3#1)
the seismicity##4##2##(1996-4#4)
the seizure##8##2##(1992-12#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#2)(2009-9#1)(2010-12#1)
the seizures##3##2##(1994-2#1)(2008-7#1)(2009-9#1)
the selectable marker##2##3##(2008-10#1)(2008-2#1)
the selected conditions##10##3##(2008-10#10)
the selected flow##2##3##(2008-10#2)
the selected frequencies and powers##2##5##(2011-2#2)
the selected genes##2##3##(2008-7#1)(2010-11#1)
the selected ion monitoring (SIM) mode##3##6##(2008-10#3)
the selected ion monitoring##5##4##(2008-10#5)
the selected treatment(s)##2##3##(2012-2#2)
the selected variables##2##3##(2008-10#1)(2013-8#1)
the selected##73##2##(1990-11#1)(1991-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the selection and##6##3##(1992-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
the selection of a##6##4##(1993-1#1)(1993-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
the selection of appropriate##2##4##(2008-9#1)(2012-2#1)
the selection of certain##2##4##(2008-10#1)(2011-2#1)
the selection of clinical##2##4##(1997-1#1)(2008-1#1)
the selection of landmarks##2##4##(2012-12#2)
the selection of patients##3##4##(1994-2#1)(1997-2#1)(2008-7#1)
the selection of suitable##2##4##(2008-3#2)
the selection of surfactants##2##4##(2008-10#1)(2008-5#1)
the selection of the##6##4##(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
the selection of treatment##2##4##(2008-12#1)(2010-1#1)
the selection of variables for the##2##6##(2008-10#2)
the selection of variables##4##4##(1995-9#1)(2008-10#3)
the selection of##81##3##(1990-5#2)(1991-11#1)(1991-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-9#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#2)(2012-2#2)
the selection pressure##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
the selection process and##2##4##(1997-1#1)(1997-4#1)
the selection process##8##3##(1994-2#1)(1997-1#2)(1997-4#1)(2008-10#2)(2008-6#2)
the selection valve##2##3##(2008-10#2)
the selection##118##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-5#1)(1995-5#1)(1995-9#1)(1997-1#4)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-9#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#2)
the selective 5-HT1A receptor##3##4##(1993-3#1)(1995-12#2)
the selective adenosine##2##3##(1995-12#2)
the selective advantage of##2##4##(2008-8#1)(2012-3#1)
the selective and sensitive determination of##3##6##(2008-10#3)
the selective and##5##3##(2008-10#5)
the selective binding##3##3##(1990-12#1)(2008-10#2)
the selective determination of##8##4##(2008-10#8)
the selective extraction of##6##4##(1992-3#1)(2008-10#5)
the selective extraction##9##3##(1992-3#1)(2008-10#8)
the selective forces##3##3##(1992-9#1)(2008-8#1)(2012-12#1)
the selective ion##2##3##(2008-10#2)
the selective mGlu group III##2##5##(1995-12#2)
the selective mGlu group##3##4##(1995-12#3)
the selective##106##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#9)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#44)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#3)
the selectivities##4##2##(2008-10#4)
the selectivity and sensitivity of##2##5##(2008-10#2)
the selectivity and the sensitivity of##2##6##(2008-10#2)
the selectivity and##6##3##(2008-10#5)(2012-12#1)
the selectivity coefficient##2##3##(2008-10#2)
the selectivity coefficients##4##3##(2008-10#4)
the selectivity filter##2##3##(2008-8#2)
the selectivity is##2##3##(2008-10#2)
the selectivity of separation##2##4##(1996-5#1)(2008-10#1)
the selectivity of the method##2##5##(2008-10#2)
the selectivity of the##12##4##(1995-6#1)(1996-5#1)(2008-10#10)
the selectivity of##26##3##(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(2008-10#20)(2008-6#1)
the selectivity ratio of acetone/acetic acid response##2##7##(2008-10#2)
the selectivity was##2##3##(2008-10#2)
the selectivity##70##2##(1994-9#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#2)(2008-10#54)(2008-2#1)(2008-6#1)(2008-8#2)(2012-12#1)(2012-3#1)(2013-7#1)
the selenium present##2##3##(2008-10#2)
the selenium species##2##3##(2008-10#2)
the selenium##10##2##(2008-10#9)(2008-6#1)
the selenocompounds##2##2##(1992-12#1)(2008-10#1)
the selenocysteine tRNA[Ser]Sec##2##3##(1997-2#2)
the self expandable valved stent##2##5##(2007-8#2)
the self##16##2##(1990-3#1)(1994-12#1)(2007-8#2)(2008-11#6)(2008-12#1)(2008-6#2)(2012-12#2)(2012-2#1)
the self-assembled##7##2##(1997-4#1)(2008-10#6)
the self-assembly of##4##3##(2008-10#1)(2008-12#1)(2009-12#1)(2010-4#1)
the self-broadening half-width##2##3##(2008-2#2)
the self-broadening##3##2##(2008-2#2)(2008-3#1)
the self-convergent-width##2##2##(2008-3#2)
the self-directed##2##2##(2008-11#1)(2010-2#1)
the self-esteem##2##2##(2008-11#2)
the self-focusing dynamics of##2##4##(2007-11#1)(2007-12#1)
the self-focusing##3##2##(2007-11#1)(2007-12#2)
the self-help community and##2##4##(1994-1#1)(1996-3#1)
the self-help##4##2##(1994-1#2)(1996-3#2)
the self-imaging property of a##2##5##(2008-2#2)
the self-incompatibility##2##2##(1992-8#1)(2009-10#1)
the self-mixing##2##2##(2008-3#2)
the self-organized##2##2##(2008-1#1)(2011-2#1)
the self-organizing##5##2##(2008-3#3)(2008-5#1)(2008-8#1)
the self-phase modulation of##2##4##(2007-11#1)(2007-12#1)
the self-phase modulation##3##3##(2007-11#1)(2007-12#2)
the self-reference condition##2##3##(2008-9#2)
the self-reference##4##2##(2008-10#1)(2008-9#3)
the sella turcica##2##3##(1991-6#1)(2013-1#1)
the sella##6##2##(1991-6#1)(2006-12#1)(2011-2#2)(2013-1#2)
the sellar##7##2##(2012-3#5)(2013-1#2)
the semantic content of##3##4##(2008-4#1)(2010-12#2)
the semantic network##2##3##(1996-7#2)
the semantic##9##2##(1991-2#2)(1996-7#2)(2008-4#1)(2008-7#1)(2010-12#2)(2010-5#1)
the semantics##2##2##(2008-6#1)(2010-4#1)
the semen##2##2##(1994-8#1)(2013-1#1)
the semi-deep##3##2##(2008-12#3)
the semi-quantitative##2##2##(2008-10#1)(2011-2#1)
the semi-solid W/O/W##2##3##(2008-5#2)
the semi-static and PGA-alginate methods##2##5##(2011-2#2)
the semiclassical##2##2##(1992-8#1)(2010-7#1)
the semiconductor laser##2##3##(2008-3#2)
the semiconductor##9##2##(2007-12#2)(2008-10#3)(2008-3#4)
the seminal receptacle##3##3##(2008-7#3)
the seminal vesicle is##2##4##(2011-2#2)
the seminal vesicle##5##3##(2008-11#2)(2011-2#3)
the seminal vesicles##4##3##(1997-8#1)(2008-7#2)(2012-12#1)
the seminal##19##2##(1991-6#1)(1997-8#2)(2008-11#2)(2008-7#5)(2008-9#2)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)
the seminar##2##2##(1994-1#2)
the seminiferous epithelial cycle##5##4##(2009-10#2)(2012-2#3)
the seminiferous epithelium into the##2##5##(2009-10#1)(2012-2#1)
the seminiferous epithelium via##2##4##(2009-10#1)(2012-2#1)
the seminiferous epithelium##22##3##(2009-10#13)(2012-2#9)
the seminiferous tubule##3##3##(2009-10#1)(2012-2#1)(2013-1#1)
the seminiferous tubules##4##3##(1995-6#1)(2008-7#1)(2009-10#2)
the seminiferous##34##2##(1995-6#1)(2008-7#1)(2009-10#18)(2012-2#13)(2013-1#1)
the semiparametric model##2##3##(2010-11#1)(2011-1#1)
the sender's##2##2##(2012-3#2)
the senescence##2##2##(1991-12#1)(2008-10#1)
the senescent##5##2##(1994-6#1)(1996-9#1)(2013-7#3)
the senile##2##2##(1990-3#1)(2011-2#1)
the senior author's##2##3##(1993-12#1)(2010-8#1)
the senior##7##2##(1993-12#2)(1997-2#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
the sensation of##3##3##(1996-6#1)(2011-2#1)(2012-2#1)
the sense of self##2##4##(2008-11#1)(2010-6#1)
the sense of##12##3##(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2010-6#1)(2012-1#1)(2012-2#1)
the sense##30##2##(1992-8#1)(1994-11#2)(1995-12#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
the sensillum##4##2##(2007-12#2)(2008-7#1)(2010-11#1)
the sensing channel##2##3##(2009-5#2)
the sensing elements##2##3##(2008-10#2)
the sensing layer##2##3##(2008-10#1)(2010-5#1)
the sensing material and##2##4##(2008-10#2)
the sensing material##3##3##(2008-10#3)
the sensing molecules##2##3##(2013-8#2)
the sensing of##3##3##(2008-10#2)(2008-3#1)
the sensing phase##3##3##(2008-10#3)
the sensing system##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
the sensing##47##2##(2007-11#2)(2008-10#31)(2008-2#1)(2008-3#6)(2008-9#1)(2009-5#2)(2010-5#1)(2011-1#1)(2013-8#2)
the sensitive and resistant##2##4##(1991-12#2)
the sensitive and##7##3##(1991-12#2)(1995-6#1)(2008-10#3)(2010-5#1)
the sensitive detection of##3##4##(2008-10#2)(2010-12#1)
the sensitive determination of##9##4##(1992-3#1)(2008-10#7)(2008-2#1)
the sensitive membrane##2##3##(2008-10#2)
the sensitive##41##2##(1991-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-6#1)(1996-6#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#4)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)
the sensitivities for##3##3##(1990-8#2)(2008-10#1)
the sensitivities of reflectance and path length to scattering variations in a diffusive medium##2##14##(2008-3#2)
the sensitivities of the##2##4##(2008-10#2)
the sensitivities of##10##3##(1990-7#1)(1994-11#1)(2008-10#4)(2008-3#4)
the sensitivities were##2##3##(2008-3#1)(2011-1#1)
the sensitivities##20##2##(1990-7#1)(1990-8#2)(1994-11#1)(2008-10#6)(2008-3#7)(2011-1#3)
the sensitivity and limits of detection##2##6##(2008-10#2)
the sensitivity and selectivity##2##4##(2008-10#2)
the sensitivity and specificity of the##7##6##(1994-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
the sensitivity and specificity of this##2##6##(1990-9#1)(2007-2#1)
the sensitivity and specificity of##14##5##(1990-9#1)(1994-11#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the sensitivity and specificity##17##4##(1990-9#1)(1994-11#1)(1996-8#2)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the sensitivity and the##3##4##(2007-12#1)(2008-10#1)(2010-6#1)
the sensitivity and##33##3##(1990-9#1)(1993-3#1)(1994-11#1)(1996-8#2)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the sensitivity by a factor of##2##6##(2008-10#2)
the sensitivity by##5##3##(2008-10#5)
the sensitivity can##2##3##(2008-10#1)(2008-3#1)
the sensitivity enhancement##2##3##(2008-10#2)
the sensitivity for##7##3##(1991-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-1#1)
the sensitivity from##2##3##(2008-10#2)
the sensitivity in##4##3##(1997-3#1)(2008-1#1)(2008-10#2)
the sensitivity is##3##3##(2008-10#2)(2008-2#1)
the sensitivity of Escherichia coli to##2##6##(1990-5#1)(1997-3#1)
the sensitivity of a##4##4##(1995-12#1)(2008-10#2)(2008-7#1)
the sensitivity of both##2##4##(2008-4#1)(2008-8#1)
the sensitivity of human##2##4##(1997-7#1)(2008-5#1)
the sensitivity of measurement##2##4##(2008-3#1)(2008-4#1)
the sensitivity of melanoma cells to##2##6##(2009-4#2)
the sensitivity of neural responses##2##5##(2008-11#2)
the sensitivity of results to the##2##6##(2008-3#1)(2008-8#1)
the sensitivity of the SPR##2##5##(2008-10#2)
the sensitivity of the detection##2##5##(1997-4#1)(2008-10#1)
the sensitivity of the electrode##2##5##(2008-10#2)
the sensitivity of the method to##2##6##(1990-12#1)(2008-3#1)
the sensitivity of the method##14##5##(1990-12#1)(1996-12#1)(2008-10#11)(2008-3#1)
the sensitivity of the methods##2##5##(1990-6#1)(2008-10#1)
the sensitivity of the retrieval##2##5##(2007-12#1)(2008-3#1)
the sensitivity of the sensor##3##5##(2008-10#2)(2008-2#1)
the sensitivity of the tumor##2##5##(2011-1#1)(2012-3#1)
the sensitivity of the##78##4##(1990-12#3)(1990-6#1)(1990-8#1)(1991-6#1)(1992-4#1)(1993-8#2)(1995-11#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the sensitivity of these##2##4##(2008-10#2)
the sensitivity of this##4##4##(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
the sensitivity of##175##3##(1990-12#3)(1990-5#2)(1990-6#1)(1990-8#2)(1991-6#1)(1992-4#1)(1993-8#2)(1994-1#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#3)(1997-2#1)(1997-3#3)(1997-4#4)(1997-7#2)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#54)(2008-11#9)(2008-12#1)(2008-2#9)(2008-3#18)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-4#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
the sensitivity required for##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
the sensitivity required##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
the sensitivity to temperature##2##4##(2008-2#1)(2008-7#1)
the sensitivity to the##3##4##(2008-10#2)(2008-3#1)
the sensitivity to##20##3##(1990-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-7#2)(2012-12#1)
the sensitivity was##3##3##(1996-12#1)(2008-10#2)
the sensitivity##313##2##(1990-12#5)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-6#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1996-12#4)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#6)(1997-4#5)(1997-7#3)(2007-11#2)(2007-12#8)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#115)(2008-11#9)(2008-12#1)(2008-2#17)(2008-3#32)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#4)(2009-1#1)(2009-11#1)(2009-4#3)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#4)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#3)
the sensitized and##2##3##(2008-10#2)
the sensitized##6##2##(2008-10#6)
the sensitizing effect of##4##4##(2008-10#4)
the sensitizing##7##2##(1995-11#1)(2008-10#5)(2008-3#1)
the sensor and##3##3##(2008-2#1)(2008-3#2)
the sensor array##2##3##(2013-1#2)
the sensor can##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
the sensor chip##5##3##(2008-10#5)
the sensor could be##2##4##(2008-10#2)
the sensor could##3##3##(2008-10#3)
the sensor exhibits a##4##4##(2008-10#3)(2008-3#1)
the sensor for##5##3##(2008-10#4)(2010-8#1)
the sensor function##2##3##(2008-3#2)
the sensor has##3##3##(2007-11#1)(2008-10#2)
the sensor in##2##3##(2008-10#2)
the sensor is##15##3##(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#4)
the sensor performance##3##3##(2008-2#1)(2008-3#2)
the sensor platform##2##3##(2010-2#2)
the sensor responds##2##3##(2008-10#2)
the sensor response to##2##4##(2008-10#2)
the sensor response##10##3##(2008-10#9)(2008-3#1)
the sensor sensitivity##2##3##(2008-10#2)
the sensor showed##2##3##(2008-10#2)
the sensor signal##2##3##(2008-10#2)
the sensor signals##2##3##(2007-11#1)(2008-10#1)
the sensor surface##8##3##(1997-2#1)(2008-10#7)
the sensor system was##3##4##(2008-10#2)(2008-7#1)
the sensor system##6##3##(2008-10#5)(2008-7#1)
the sensor tip##2##3##(2008-10#2)
the sensor was found to be##2##6##(2008-10#2)
the sensor was##17##3##(2007-11#1)(2008-10#15)(2008-7#1)
the sensor when##2##3##(2007-11#1)(2008-10#1)
the sensor while##2##3##(2008-10#1)(2008-2#1)
the sensor##187##2##(1993-12#1)(1997-2#1)(2007-11#11)(2007-12#2)(2008-10#124)(2008-2#5)(2008-3#26)(2008-7#2)(2009-11#1)(2009-9#2)(2010-2#5)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
the sensor's##2##2##(2008-10#1)(2008-2#1)
the sensor-measured radiances##2##3##(2008-2#2)
the sensorial##2##2##(2011-1#1)(2011-2#1)
the sensorimotor##6##2##(1993-12#1)(1995-11#1)(1996-2#1)(2007-8#1)(2012-1#1)(2012-12#1)
the sensorineural hearing loss##2##4##(2008-9#1)(2012-2#1)
the sensors coated with##2##4##(2008-10#2)
the sensors##14##2##(2008-10#12)(2008-3#1)(2008-5#1)
the sensory and##2##3##(1990-7#1)(2008-7#1)
the sensory discharge##2##3##(1993-12#2)
the sensory nervous system of the antenna##2##7##(2007-12#2)
the sensory organ##3##3##(1993-12#2)(2008-5#1)
the sensory properties of##2##4##(2008-10#1)(2011-2#1)
the sensory quality##2##3##(2010-4#2)
the sensory system##3##3##(2008-10#2)(2013-8#1)
the sensory traits##2##3##(2013-1#2)
the sensory##44##2##(1990-5#1)(1990-7#1)(1993-12#8)(2007-12#8)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
the sentence##2##2##(2008-2#1)(2010-7#1)
the sentinel##2##2##(2008-1#1)(2008-10#1)
the separate and combined##2##4##(2008-6#1)(2008-9#1)
the separate components##2##3##(1995-5#2)
the separate##15##2##(1990-7#1)(1995-5#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-6#1)
the separated fractions##4##3##(1992-9#1)(2008-10#3)
the separated##12##2##(1992-9#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-8#1)(2010-5#1)
the separately##3##2##(1995-5#2)(2011-3#1)
the separation and detection of##4##5##(2008-10#4)
the separation and detection##10##4##(2008-10#9)(2008-12#1)
the separation and determination of##15##5##(1990-8#1)(2008-10#14)
the separation and determination##16##4##(1990-8#1)(2008-10#15)
the separation and preconcentration of copper(II)##2##6##(2008-10#2)
the separation and preconcentration of the##2##6##(2008-10#2)
the separation and preconcentration of##14##5##(2008-10#14)
the separation and preconcentration##15##4##(2008-10#15)
the separation and quantitation of##2##5##(1997-2#1)(2008-10#1)
the separation and the##2##4##(2008-10#2)
the separation and##58##3##(1990-8#1)(1991-5#1)(1996-5#1)(1997-2#1)(2008-10#50)(2008-12#2)(2008-2#1)(2008-3#1)
the separation between the##8##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-2#1)
the separation between##10##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-6#1)(2009-2#1)
the separation capillary##2##3##(2008-10#2)
the separation channel##3##3##(2008-10#3)
the separation column##2##3##(2008-10#2)
the separation conditions and##2##4##(1990-8#1)(2008-10#1)
the separation conditions##3##3##(1990-8#1)(2008-10#2)
the separation distance between##2##4##(2008-2#2)
the separation distance##4##3##(2008-2#3)(2013-1#1)
the separation efficiency##2##3##(1996-5#1)(2008-10#1)
the separation factor##2##3##(2008-10#2)
the separation mechanism##2##3##(1996-5#1)(2011-2#1)
the separation of DNA fragments##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
the separation of a##2##4##(2008-10#2)
the separation of basic compounds##2##5##(2008-10#2)
the separation of basic##3##4##(1990-8#1)(2008-10#2)
the separation of eprosartan##2##4##(2008-10#2)
the separation of neutral##2##4##(2008-10#2)
the separation of seven##2##4##(1990-8#1)(2008-10#1)
the separation of six##2##4##(2008-10#2)
the separation of some##2##4##(1996-5#1)(2008-10#1)
the separation of the three##2##5##(2008-10#2)
the separation of the##13##4##(1991-9#1)(2008-10#11)(2008-3#1)
the separation of these##2##4##(2008-10#1)(2008-7#1)
the separation of##128##3##(1990-8#3)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-9#6)(1995-6#1)(1996-5#4)(1997-2#1)(2007-11#2)(2007-9#1)(2008-10#88)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#2)(2011-1#1)
the separation procedure##2##3##(1994-9#1)(2008-10#1)
the separation system##2##3##(2008-7#1)(2012-1#1)
the separation was##2##3##(2008-10#2)
the separation##251##2##(1990-8#5)(1991-12#1)(1991-5#3)(1991-6#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-9#7)(1995-3#1)(1995-6#1)(1996-5#9)(1997-2#2)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#173)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-2#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
the separation-of-variables method##2##3##(2008-3#2)
the separations##3##2##(2008-10#2)(2008-4#1)
the septa were##3##3##(2008-7#3)
the septal##2##2##(1994-2#1)(2007-8#1)
the septum and##3##3##(1991-5#2)(2008-10#1)
the septum##17##2##(1991-5#5)(1991-8#1)(1994-2#2)(1994-8#1)(1996-12#2)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)
the sequelae of##4##3##(1996-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
the sequelae##5##2##(1996-3#1)(1997-2#1)(2008-9#1)(2012-3#1)(2013-1#1)
the sequence alignment##3##3##(1992-8#1)(2008-4#1)(2008-7#1)
the sequence analysis of##4##4##(1997-3#1)(2008-10#2)(2008-8#1)
the sequence and expression##2##4##(1992-9#1)(2012-2#1)
the sequence and primer##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
the sequence and##7##3##(1992-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-2#1)
the sequence at##2##3##(1991-11#1)(2008-5#1)
the sequence data##3##3##(2008-10#2)(2008-7#1)
the sequence encoding##2##3##(1995-8#1)(2008-8#1)
the sequence features##2##3##(1995-5#1)(1996-8#1)
the sequence from the##3##4##(1990-7#1)(2008-10#1)(2008-8#1)
the sequence from##5##3##(1990-7#1)(1990-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
the sequence homologous##2##3##(2008-10#1)(2011-1#1)
the sequence homology##3##3##(1993-11#1)(1995-2#1)(2008-9#1)
the sequence in##2##3##(1996-8#1)(1997-3#1)
the sequence of a##12##4##(1990-11#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-6#2)(1994-6#1)(1995-6#1)(1997-3#2)(2008-10#2)
the sequence of events leading##2##5##(1990-9#1)(1993-8#1)
the sequence of events##5##4##(1990-9#1)(1993-8#1)(2008-11#1)(2008-4#1)(2012-3#1)
the sequence of nucleotides##2##4##(1992-8#1)(1995-2#1)
the sequence of one##3##4##(1990-11#1)(1990-12#1)(1990-5#1)
the sequence of the 16S rRNA gene##2##7##(2008-10#2)
the sequence of the##23##4##(1990-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(2008-10#10)(2008-4#2)(2008-8#1)(2012-12#1)(2013-1#1)
the sequence of##81##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
the sequence recognized by##2##4##(1990-11#1)(1994-6#1)
the sequence similarity##2##3##(2008-10#1)(2012-2#1)
the sequence specificity##2##3##(1992-11#1)(2008-11#1)
the sequence tagged site##2##4##(1994-12#1)(2008-10#1)
the sequence was##3##3##(1991-9#1)(1992-11#1)(1996-6#1)
the sequence##185##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-9#5)(1992-10#2)(1992-11#3)(1992-12#2)(1992-3#1)(1992-8#6)(1992-9#3)(1993-11#3)(1993-2#1)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#7)(1994-6#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#4)(1997-2#2)(1997-3#5)(1997-6#3)(1997-7#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#5)(2009-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
the sequence-specific##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
the sequenced##8##2##(1995-8#1)(1996-10#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-8#1)
the sequences are##2##3##(1992-3#1)(2008-8#1)
the sequences in##3##3##(1996-2#1)(1997-6#1)(1997-8#1)
the sequences of 40##2##4##(1995-8#1)(1996-2#1)
the sequences of the rat##2##5##(1994-9#1)(2008-9#1)
the sequences of the##8##4##(1991-2#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-11#1)(1996-6#1)(2008-9#1)(2010-5#1)
the sequences of##21##3##(1991-2#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-11#2)(1995-8#2)(1996-10#2)(1996-2#2)(1996-6#2)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)
the sequences were##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
the sequences with##2##3##(2008-10#1)(2011-3#1)
the sequences within##2##3##(1995-6#1)(1997-3#1)
the sequences##55##2##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-10#2)(1996-2#3)(1996-6#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2008-10#5)(2008-7#1)(2008-8#3)(2008-9#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)
the sequencing and##2##3##(2012-2#1)(2012-3#1)
the sequencing of the##4##4##(1992-8#1)(1995-12#1)(2008-4#1)(2010-8#1)
the sequencing of##9##3##(1992-8#1)(1995-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
the sequencing##13##2##(1992-8#1)(1995-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
the sequential determination of ammonium and nitrate##2##7##(2008-10#2)
the sequential determination of##6##4##(2008-10#6)
the sequential injection system##2##4##(2008-10#2)
the sequential injection##12##3##(2008-10#12)
the sequential methylation of##2##4##(1994-8#2)
the sequential probability ratio test##2##5##(2008-10#2)
the sequential separation of##2##4##(2008-10#2)
the sequential simplex##2##3##(2008-10#2)
the sequential structure of##2##4##(2008-11#2)
the sequential##53##2##(1990-2#1)(1993-8#1)(1994-8#2)(1995-2#2)(1995-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#33)(2008-11#2)(2008-12#2)(2008-4#2)(2011-2#1)
the sequestering##2##2##(2008-10#1)(2009-7#1)
the sera from##5##3##(1991-5#1)(1994-3#2)(2008-8#1)(2013-8#1)
the sera of##10##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-3#2)(1997-4#1)(2008-7#1)
the sera##21##2##(1990-11#1)(1990-12#2)(1991-5#2)(1991-8#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-3#4)(1997-3#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-8#1)
the serendipitous##2##2##(1994-11#1)(2008-7#1)
the serial##7##2##(1991-12#1)(1991-6#1)(1993-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-1#1)
the serial-transfer##3##2##(1997-6#3)
the series of experiments##2##4##(2008-7#1)(2011-2#1)
the series of##12##3##(1992-1#1)(1992-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#1)
the series was##2##3##(1990-2#1)(2011-2#1)
the series with##2##3##(1993-3#1)(1995-5#1)
the series##43##2##(1990-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#2)(2007-11#2)(2008-10#3)(2008-3#2)(2008-4#5)(2008-7#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-3#1)(2011-2#3)(2012-1#1)
the serine protease domain##2##4##(1995-6#2)
the serine protease##3##3##(1995-6#2)(2008-11#1)
the serine proteases##2##3##(1991-6#1)(1993-11#1)
the serine proteinase##2##3##(1993-3#1)(1995-6#1)
the serine receptor##2##3##(1994-5#2)
the serine##16##2##(1990-7#2)(1991-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-6#3)(1997-1#1)(2008-11#1)(2008-4#1)(2009-10#1)
the serine/threonine kinase##3##3##(1994-12#1)(1994-9#1)(1996-2#1)
the serine/threonine protein##2##3##(1991-2#1)(1994-11#1)
the serine/threonine##5##2##(1991-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-2#1)
the serious##12##2##(1990-6#1)(1994-2#1)(1995-8#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-3#1)(2009-6#2)(2012-12#1)(2013-1#1)(2013-8#1)
the seriousness of the##2##4##(1990-3#1)(2013-1#1)
the seriousness of##4##3##(1990-3#1)(1995-6#1)(2012-3#1)(2013-1#1)
the serodiagnosis of##3##3##(1996-12#1)(2007-7#1)(2008-5#1)
the serogroup Y##3##3##(2007-12#3)
the serogroup##5##2##(2007-12#3)(2008-5#1)(2012-2#1)
the serological##8##2##(1991-5#1)(1993-6#1)(1995-12#1)(1997-8#1)(2008-10#3)(2010-4#1)
the seropositive##2##2##(1994-6#1)(2011-2#1)
the seroprevalence##2##2##(2011-2#2)
the serosa membrane##2##3##(2007-12#2)
the serotonergic##3##2##(1995-12#1)(2008-7#1)(2012-3#1)
the serotonin release rate was##2##5##(1995-12#2)
the serotonin release rate##3##4##(1995-12#3)
the serotonin reuptake##2##3##(1991-1#1)(2008-6#1)
the serotonin transporter##4##3##(1996-5#1)(1996-7#1)(2012-3#2)
the serotonin##19##2##(1991-1#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#3)(1996-5#2)(1996-7#1)(2007-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2012-3#2)
the serotype A##2##3##(2007-10#1)(2008-5#1)
the serotype of##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
the serotype##8##2##(1992-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-5#4)
the serratus##3##2##(1992-6#1)(1993-9#1)(2010-9#1)
the serum and urine of the##2##6##(1995-3#2)
the serum and urine##5##4##(1995-3#2)(2006-10#1)(2008-10#1)(2008-7#1)
the serum and##13##3##(1992-6#1)(1994-6#1)(1995-3#2)(1997-8#2)(2006-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)
the serum c-erbB-2 protein level##2##5##(1993-1#2)
the serum cholesterol##2##3##(1991-6#1)(2013-8#1)
the serum concentration of##3##4##(1991-12#1)(1995-3#1)(2007-7#1)
the serum concentrations of##6##4##(1990-3#1)(1991-6#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)
the serum ferritin levels##3##4##(2013-8#3)
the serum ferritin##4##3##(2012-12#1)(2013-8#3)
the serum free##2##3##(1995-12#1)(2008-11#1)
the serum homocysteine##2##3##(2008-11#2)
the serum levels of##8##4##(1992-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the serum neutralisation##2##3##(1991-3#2)
the serum of##16##3##(1990-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-3#1)(1997-4#1)(2007-2#2)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
the serum triglyceride##3##3##(1991-12#3)
the serum##120##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#5)(1991-3#2)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#4)(1996-12#1)(1997-4#2)(1997-5#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#6)
the serum-free medium##4##3##(1990-7#1)(1992-9#2)(2008-11#1)
the serum-free##6##2##(1990-7#1)(1992-9#2)(2008-11#2)(2008-4#1)
the serum-independent cells##2##3##(2008-11#2)
the serum-supplemented##5##2##(2008-11#5)
the service being provided##2##4##(2011-2#2)
the service encounter##2##3##(1992-3#1)(1993-12#1)
the service is##4##3##(1992-11#1)(2008-1#1)(2011-1#1)(2012-2#1)
the service of##5##3##(1996-2#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)
the service##43##2##(1991-1#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#3)(1996-1#1)(1996-2#2)(1996-3#1)(1996-7#2)(1997-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
the service-class approach##2##3##(1996-1#2)
the services of a##2##4##(1995-3#1)(2008-1#1)
the services of##3##3##(1994-1#1)(1995-3#1)(2008-1#1)
the services offered##3##3##(1994-12#1)(1995-1#1)(2007-7#1)
the services provided by##2##4##(1992-1#1)(1995-1#1)
the services provided##3##3##(1992-1#1)(1995-1#2)
the services that##2##3##(1993-12#2)
the services##29##2##(1991-3#1)(1992-1#1)(1992-11#3)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-9#1)(2007-12#1)(2007-7#4)(2008-1#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
the servo system##2##3##(2008-2#1)(2008-3#1)
the servo##3##2##(2008-2#2)(2008-3#1)
the sesquiterpene##2##2##(1995-2#1)(2008-10#1)
the session##7##2##(1991-12#2)(2007-12#1)(2007-8#1)(2008-6#1)(2010-1#1)(2012-3#1)
the sessions##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2013-8#1)
the set of resources##2##4##(2008-8#2)
the set of##25##3##(1994-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#3)(2009-5#1)(2010-1#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#3)
the set up##2##3##(2008-10#2)
the set##42##2##(1990-11#2)(1992-12#1)(1994-9#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#3)(2009-5#2)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
the sets of##5##3##(1990-8#1)(1993-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
the sets##8##2##(1990-8#1)(1993-8#1)(1997-8#1)(2008-9#1)(2009-5#2)(2011-1#1)(2011-2#1)
the setting of a##5##4##(2007-5#1)(2008-4#1)(2008-9#1)(2010-10#1)(2013-8#1)
the setting of the encounters##2##5##(1991-6#2)
the setting of the##4##4##(1991-6#2)(2008-3#1)(2010-4#1)
the setting of##40##3##(1991-2#1)(1991-6#2)(1996-12#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the setting##43##2##(1991-2#1)(1991-6#2)(1994-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the settings##2##2##(2009-6#1)(2012-3#1)
the settlement period##2##3##(2008-9#2)
the settlement##7##2##(1990-12#1)(1995-12#1)(1996-5#1)(1997-5#1)(2008-9#2)(2010-5#1)
the setup is##2##3##(2007-11#1)(2007-12#1)
the setup of##2##3##(2008-3#1)(2013-8#1)
the setup##15##2##(1994-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-3#6)(2008-9#1)(2010-12#1)(2013-8#1)
the seven compounds##2##3##(2008-10#1)(2012-3#1)
the seven metal ions##4##4##(2008-10#4)
the seven metals##2##3##(2008-10#2)
the seven patients who##2##4##(1996-6#1)(2008-1#1)
the seven patients##4##3##(1996-1#1)(1996-6#1)(2008-1#1)(2008-6#1)
the seven strains##2##3##(2008-10#1)(2011-2#1)
the seven##46##2##(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-6#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#18)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#2)
the seventeenth century##4##3##(2009-7#2)(2010-1#1)(2013-8#1)
the seventeenth##5##2##(2009-7#2)(2010-1#1)(2011-2#1)(2013-8#1)
the seventh and eighth##2##4##(2008-10#1)(2011-2#1)
the seventh and##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
the seventh##18##2##(1993-8#1)(1994-11#1)(1994-6#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the several##9##2##(1991-5#1)(1992-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
the severe form of##3##4##(2008-7#2)(2012-3#1)
the severe##23##2##(1992-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-2#1)(2012-3#1)(2013-1#3)
the severely##2##2##(2008-3#1)(2012-3#1)
the severity and##12##3##(1990-12#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
the severity of Fusarium wilt##3##5##(2008-10#3)
the severity of atherosclerosis##2##4##(1991-9#1)(2007-8#1)
the severity of bacterial leaf spot of radish##2##8##(2008-10#2)
the severity of bacterial##3##4##(2008-10#3)
the severity of cardiac##2##4##(2010-4#1)(2010-8#1)
the severity of disability##3##4##(2007-10#1)(2011-2#2)
the severity of disease##4##4##(1994-9#1)(2008-10#2)(2012-3#1)
the severity of leaf##2##4##(2008-10#2)
the severity of non-randomness##2##4##(1995-12#2)
the severity of skin lesions##2##5##(2008-9#2)
the severity of skin##3##4##(2008-5#1)(2008-9#2)
the severity of symptoms at discharge##2##6##(2011-2#2)
the severity of symptoms##5##4##(2008-10#2)(2008-7#1)(2011-2#2)
the severity of the clinical picture##2##6##(1997-6#2)
the severity of the disease but##2##6##(2008-10#1)(2013-1#1)
the severity of the disease##9##5##(1990-9#1)(1991-2#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
the severity of the effects is##2##6##(1991-12#1)(1996-6#1)
the severity of the effects##3##5##(1991-12#1)(1996-6#1)(2009-7#1)
the severity of the##31##4##(1990-9#1)(1991-12#1)(1991-2#1)(1993-1#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#4)(2012-3#1)(2013-1#1)
the severity of their##3##4##(1995-11#1)(2007-6#1)(2008-11#1)
the severity of this condition##2##5##(2010-1#1)(2011-2#1)
the severity of this disease##3##5##(1993-2#1)(2008-10#2)
the severity of this##6##4##(1993-2#1)(2008-10#2)(2009-5#1)(2010-1#1)(2011-2#1)
the severity of##134##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#2)(2007-6#2)(2007-8#3)(2008-10#27)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#3)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#15)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
the severity or##2##3##(2008-5#1)(2012-3#1)
the severity##155##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#2)(1997-8#2)(2007-10#1)(2007-11#2)(2007-6#2)(2007-8#3)(2008-10#29)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#18)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#2)
the sex and age of##2##5##(1994-6#1)(2008-6#1)
the sex and##3##3##(1994-6#1)(2008-6#1)(2008-7#1)
the sex chromosomes##2##3##(2010-3#1)(2010-5#1)
the sex difference in##3##4##(1994-2#1)(2008-3#1)(2008-4#1)
the sex differences##2##3##(2008-4#1)(2012-3#1)
the sex of the##3##4##(1994-7#1)(2008-5#2)
the sex of##5##3##(1994-7#1)(2008-5#2)(2008-8#1)(2013-1#1)
the sex pheromone##4##3##(2007-12#1)(2008-10#2)(2013-8#1)
the sex ratio##4##3##(1991-11#1)(2008-9#1)(2012-3#2)
the sex##34##2##(1990-2#1)(1991-11#1)(1994-2#1)(1994-6#1)(1994-7#2)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#2)(2010-5#1)(2011-1#1)(2012-3#4)(2013-1#2)(2013-8#1)
the sex-related differences in liver ID1##2##6##(1995-12#2)
the sex-related differences##3##3##(1995-12#3)
the sex-specific##3##2##(2010-5#1)(2012-3#1)(2013-8#1)
the sexes as##2##3##(1991-6#1)(2009-10#1)
the sexes in##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
the sexes##25##2##(1991-6#1)(1995-2#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#8)(2009-10#1)(2012-3#2)(2013-7#1)(2013-8#2)
the sexual abuse of##3##4##(1996-11#2)(2009-9#1)
the sexual behaviour of##3##4##(1990-9#1)(1996-11#1)(2008-11#1)
the sexual division of labor##2##5##(1991-6#2)
the sexual division of##3##4##(1991-6#2)(1996-3#1)
the sexual risk##2##3##(2008-12#2)
the sexual stage##4##3##(2008-10#4)
the sexual state##3##3##(2008-10#3)
the sexual##40##2##(1990-9#1)(1991-2#2)(1991-6#2)(1992-9#1)(1993-3#1)(1994-2#1)(1996-11#3)(1996-2#1)(1996-3#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)
the sexually active students##2##4##(2012-12#2)
the sexually##5##2##(1992-3#1)(1995-5#1)(2007-12#1)(2012-12#2)
the shaded##2##2##(2008-9#2)
the shadow image##2##3##(2008-3#2)
the shadow of##3##3##(2008-2#3)
the shadow##8##2##(2008-2#4)(2008-3#3)(2008-6#1)
the shadowing##2##2##(2008-3#2)
the shadows##2##2##(1992-1#1)(2008-2#1)
the shaft of##2##3##(2007-11#1)(2007-12#1)
the shaft##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
the sham and##2##3##(1993-12#1)(1995-11#1)
the sham##6##2##(1993-12#1)(1995-11#1)(2008-5#1)(2011-2#1)(2012-7#1)(2013-1#1)
the sham-operated##2##2##(1996-12#1)(1997-6#1)
the shampoo##8##2##(2008-10#1)(2008-5#7)
the shape and size of##2##5##(2008-5#1)(2010-3#1)
the shape and size##3##4##(2008-5#1)(2010-3#1)(2013-8#1)
the shape and##10##3##(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2013-8#1)
the shape of a##5##4##(1997-7#1)(2008-3#3)(2009-4#1)
the shape of astrocytic networks##2##5##(2008-7#2)
the shape of the object##3##5##(2008-3#3)
the shape of the particle size distribution##2##7##(2008-3#2)
the shape of the particle##3##5##(2007-11#1)(2008-3#2)
the shape of the phase##2##5##(2008-10#1)(2008-2#1)
the shape of the surface##2##5##(2008-2#1)(2008-4#1)
the shape of the survivorship curve##2##6##(2008-9#1)(2011-2#1)
the shape of the##49##4##(1990-8#1)(1991-5#1)(1992-3#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
the shape of##77##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#23)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the shape##102##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-9#2)(1996-5#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#26)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the shapes of the##5##4##(1997-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-5#1)
the shapes of these##2##4##(2008-7#1)(2008-9#1)
the shapes of##12##3##(1996-6#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-5#1)
the shaping##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
the share of health##2##4##(1995-3#1)(1997-3#1)
the share of##7##3##(1991-2#1)(1992-12#1)(1992-2#1)(1995-3#1)(1997-3#1)(2008-7#1)(2013-1#1)
the shared##8##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#3)(2010-11#1)(2012-12#1)
the sharing of##7##3##(1995-3#1)(2008-11#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)
the sharp##9##2##(1990-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
the sharpness of##2##3##(2007-12#1)(2008-3#1)
the shear rate##2##3##(2009-10#1)(2013-1#1)
the shear##11##2##(1996-4#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-10#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
the shear-force value##2##3##(2010-2#2)
the sheath##9##2##(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-5#1)
the sheep##14##2##(1993-6#1)(1993-8#1)(1996-12#3)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)
the shelf life of food products##2##6##(2010-7#1)(2013-1#1)
the shelf life of##3##4##(2010-7#1)(2012-2#1)(2013-1#1)
the shelf life##4##3##(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
the shelf##8##2##(2008-10#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#1)
the shelf-life of##3##3##(2008-5#1)(2013-1#2)
the shell and##2##3##(2008-10#1)(2008-7#1)
the shell of##2##3##(1992-2#1)(1995-2#1)
the shell##13##2##(1992-12#1)(1992-2#1)(1995-2#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2012-2#1)
the shield##2##2##(2008-10#1)(2008-9#1)
the shift from##4##3##(1992-2#1)(1994-11#1)(1995-11#1)(2009-10#1)
the shift in care from##2##5##(1996-2#1)(2008-3#1)
the shift in the##5##4##(1990-5#1)(2007-11#1)(2008-6#1)(2009-2#1)(2011-2#1)
the shift in##13##3##(1990-5#1)(1992-11#1)(1992-9#1)(1993-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-2#1)(2011-2#1)
the shift is##2##3##(2007-11#1)(2008-2#1)
the shift of the##3##4##(1990-7#1)(2008-2#1)(2008-3#1)
the shift of##9##3##(1990-7#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
the shift to##3##3##(1997-2#1)(2008-11#2)
the shift tolerance of the##2##5##(2008-3#2)
the shift##39##2##(1990-5#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2011-2#1)(2013-1#1)
the shifted##4##2##(1993-12#1)(2007-11#1)(2008-2#1)(2008-3#1)
the shifting##6##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)
the shifts in##2##3##(2008-2#2)
the shifts of##2##3##(2007-12#1)(2008-5#1)
the shifts##7##2##(1992-2#1)(2007-12#1)(2008-2#4)(2008-5#1)
the ship##3##2##(1990-6#1)(1992-6#1)(2011-2#1)
the shock##4##2##(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#1)
the shock-probe burying##4##3##(1993-3#4)
the shock-probe##5##2##(1993-3#4)(1994-2#1)
the shockwave##2##2##(2008-11#2)
the shoe-surface interface##3##3##(2013-1#3)
the shoot and root##2##4##(2009-8#2)
the shoot and##3##3##(2008-5#1)(2009-8#2)
the shoot apical meristem##2##4##(2009-8#1)(2012-2#1)
the shoot from##2##3##(2008-10#2)
the shoot pole##2##3##(2012-1#2)
the shoot##12##2##(2008-10#4)(2008-5#1)(2008-8#1)(2009-8#3)(2012-1#2)(2012-2#1)
the shooting##3##2##(1991-3#1)(1995-11#2)
the shoots##2##2##(2008-10#1)(2008-11#1)
the shore##3##2##(1994-11#1)(2008-5#2)
the shoreline##2##2##(2008-10#1)(2008-5#1)
the short C-terminal##2##3##(2008-8#1)(2009-10#1)
the short and long term##3##5##(2007-12#1)(2008-1#1)(2008-8#1)
the short and the##3##4##(2008-3#3)
the short and##6##3##(2007-12#1)(2008-1#1)(2008-3#3)(2008-8#1)
the short arm of chromosome 1B##2##6##(2008-10#2)
the short arm of chromosome 5(1H)##2##6##(2008-10#2)
the short arm of chromosome##13##5##(1997-2#1)(2008-10#9)(2008-4#1)(2012-3#2)
the short arm of##20##4##(1996-2#1)(1997-2#1)(2008-10#15)(2008-4#1)(2012-3#2)
the short arm##22##3##(1996-2#1)(1997-2#1)(2008-10#16)(2008-4#1)(2008-5#1)(2012-3#2)
the short term##7##3##(1993-6#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)
the short time##4##3##(1990-9#1)(2008-10#1)(2009-4#1)(2012-12#1)
the short##81##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-2#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
the short- and long-term##8##4##(1994-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
the short- and long-wavelength##2##4##(2008-2#1)(2008-3#1)
the short- and##11##3##(1994-2#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
the short-##12##2##(1994-2#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
the short-term deficit is##2##4##(1993-12#2)
the short-term effects of##2##4##(1994-6#1)(1997-1#1)
the short-term##22##2##(1993-12#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-4#1)(1997-1#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)
the short-wavelength edge of##2##4##(2007-12#1)(2008-3#1)
the short-wavelength##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the shortage of organs##2##4##(2006-10#1)(2008-1#1)
the shortage of##9##3##(1992-1#1)(1994-1#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#2)
the shortage##10##2##(1992-1#1)(1994-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#2)
the shortcomings##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
the shortening##3##2##(2007-11#2)(2008-11#1)
the shorter##16##2##(1990-2#1)(1990-7#1)(1992-5#1)(1995-12#1)(1995-8#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
the shorter-lived##2##2##(2008-3#1)(2013-8#1)
the shortest C-terminal biologically active fragment##2##6##(1990-12#2)
the shortest possible##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
the shortest pulse duration##3##4##(2007-12#1)(2008-3#2)
the shortest pulse##4##3##(2007-12#2)(2008-3#2)
the shortest time##2##3##(2013-7#1)(2013-8#1)
the shortest##28##2##(1990-12#2)(1991-2#1)(1992-12#2)(1995-2#1)(2007-11#2)(2007-12#6)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-5#2)(2008-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
the shot noise##2##3##(2008-3#2)
the shot##4##2##(1997-8#1)(2007-12#1)(2008-3#2)
the shot-noise limit##6##3##(2007-11#3)(2008-2#1)(2008-3#2)
the shot-noise##8##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
the shot-noise-limited##3##2##(2008-2#2)(2008-3#1)
the shoulder and##3##3##(1990-12#1)(1997-5#1)(2008-9#1)
the shoulder joint##3##3##(1991-4#1)(2008-7#1)(2008-8#1)
the shoulder of##3##3##(1997-5#1)(2008-12#2)
the shoulder##46##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1996-9#1)(1997-5#4)(1997-6#1)(2007-11#16)(2007-8#3)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#2)(2011-2#1)(2012-2#3)(2013-1#4)
the shoulders##4##2##(2007-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
the shrimp##3##2##(2008-5#1)(2013-7#2)
the shrinkage##3##2##(2010-10#1)(2012-2#2)
the shuttle##3##2##(2008-8#3)
the sialic##2##2##(1993-11#1)(2008-11#1)
the sialylation of##2##3##(1990-8#1)(2008-11#1)
the sibling##2##2##(2008-10#1)(2010-9#1)
the siblings##5##2##(1995-12#4)(2011-1#1)
the siblings'##2##2##(1995-12#1)(2011-2#1)
the sick##2##2##(1991-8#1)(1993-9#1)
the sickest##2##2##(1991-3#1)(2008-7#1)
the side branch##3##3##(2007-8#1)(2008-11#2)
the side chain in the protein##2##6##(2008-9#2)
the side chain of##4##4##(1992-1#1)(1994-5#1)(2007-11#1)(2008-10#1)
the side chain##13##3##(1992-1#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#1)(2008-9#2)
the side chains of##4##4##(1990-5#1)(1992-4#1)(1992-6#1)(1993-8#1)
the side chains##11##3##(1990-5#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-8#1)(1995-6#1)(2008-10#2)
the side effect##2##3##(1990-10#1)(2008-7#1)
the side effects and##2##4##(1997-4#1)(2008-1#1)
the side effects associated with##2##5##(1997-3#1)(2008-7#1)
the side effects were##2##4##(1991-8#1)(1996-11#1)
the side effects##15##3##(1991-2#1)(1991-8#1)(1992-12#1)(1993-1#1)(1996-11#1)(1997-3#2)(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#1)
the side of the##9##4##(1995-11#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#2)
the side of##12##3##(1995-11#1)(1995-12#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#2)
the side position##2##3##(1992-4#2)
the side reaction##2##3##(2008-10#2)
the side##75##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#2)(2010-11#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#2)
the side-chain##4##2##(1992-6#1)(1994-5#1)(2008-8#2)
the side-effects##6##2##(1990-2#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)
the sidedness of##2##3##(1990-11#2)
the sidelobes##2##2##(2007-11#2)
the sides of##2##3##(2007-12#1)(2008-10#1)
the sides##3##2##(2007-12#1)(2007-5#1)(2008-10#1)
the sidewall##2##2##(2008-3#2)
the sidewalls of##2##3##(2007-11#1)(2008-10#1)
the sidewalls##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
the sight of##3##3##(1993-6#3)
the sight##4##2##(1993-6#3)(2011-2#1)
the sigma 70##2##3##(1994-12#1)(1995-2#1)
the sigma##10##2##(1991-6#1)(1992-5#1)(1993-12#1)(1994-12#2)(1995-2#2)(1995-6#1)(1996-3#1)(2012-2#1)
the sigma1##2##2##(1995-12#2)
the sigma2##2##2##(1995-12#2)
the sigmoid colon##8##3##(1991-4#2)(1991-6#1)(2006-8#1)(2010-12#2)(2011-2#2)
the sigmoid sinus##2##3##(1996-9#1)(2008-7#1)
the sigmoid##14##2##(1991-4#2)(1991-6#1)(1993-5#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#2)
the sign and magnitude of the##3##6##(1997-7#1)(2008-10#1)(2008-8#1)
the sign and##5##3##(1997-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
the sign of the phase##2##5##(2008-3#2)
the sign of the##11##4##(1997-1#1)(2007-11#2)(2008-3#5)(2008-7#1)(2008-8#1)(2009-7#1)
the sign of##13##3##(1997-1#1)(2007-11#2)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
the sign score regression method##2##5##(1995-2#2)
the sign##23##2##(1995-2#2)(1997-1#1)(1997-7#1)(2007-11#5)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)
the signal and the idler##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the signal and the reference##3##5##(2008-3#3)
the signal and the##12##4##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)
the signal and##20##3##(1997-7#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#7)
the signal at##2##3##(2007-12#1)(2008-2#1)
the signal beam##4##3##(2008-3#4)
the signal becomes##2##3##(2008-3#2)
the signal detected by##2##4##(2007-11#1)(2008-10#1)
the signal field##2##3##(2007-12#1)(2008-3#1)
the signal for##3##3##(1993-12#1)(1995-8#1)(1996-3#1)
the signal from the##2##4##(2007-11#1)(2008-2#1)
the signal from##6##3##(2007-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2012-2#1)
the signal height##2##3##(1993-8#1)(2008-10#1)
the signal in the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
the signal intensities##2##3##(2008-10#1)(2012-3#1)
the signal intensity##11##3##(1996-2#1)(2008-10#2)(2008-3#5)(2008-7#2)(2012-3#1)
the signal is##7##3##(2008-10#2)(2008-2#2)(2008-3#3)
the signal light##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the signal noise##2##3##(2008-10#1)(2008-2#1)
the signal obtained##2##3##(1996-2#1)(2008-2#1)
the signal of the##2##4##(2008-10#2)
the signal of##8##3##(1997-5#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-5#1)
the signal peptide##7##3##(1990-11#1)(1991-6#1)(1991-9#1)(1997-4#2)(2008-6#1)(2010-6#1)
the signal power##3##3##(2008-3#3)
the signal pulses##3##3##(2007-12#2)(2008-2#1)
the signal quality##2##3##(2008-10#1)(2010-8#1)
the signal recognition##2##3##(1995-6#2)
the signal response of##2##4##(2008-10#2)
the signal response##3##3##(1996-2#1)(2008-10#2)
the signal sequence and##5##4##(1991-6#1)(1992-3#1)(1993-9#1)(2008-11#2)
the signal sequence was##2##4##(1991-10#2)
the signal sequence##15##3##(1991-10#3)(1991-6#3)(1992-3#1)(1993-9#4)(2008-11#4)
the signal started to##2##4##(2008-10#1)(2012-3#1)
the signal that##4##3##(1994-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
the signal to be##2##4##(2007-11#1)(2008-2#1)
the signal to noise ratio##2##5##(2008-10#2)
the signal to##10##3##(1991-12#1)(1991-3#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)
the signal transducer and##2##4##(2008-7#1)(2008-8#1)
the signal transducer##4##3##(1996-2#1)(2008-7#1)(2008-8#1)(2009-5#1)
the signal transducing##2##3##(1994-11#1)(2009-4#1)
the signal transduction of##3##4##(1993-3#1)(1995-12#1)(2008-5#1)
the signal transduction pathway##4##4##(1991-12#1)(1994-11#1)(1994-3#1)(1997-2#1)
the signal transduction pathways activated by##2##6##(2008-4#2)
the signal transduction pathways of##2##5##(1996-5#1)(2008-10#1)
the signal transduction pathways##8##4##(1994-11#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#3)
the signal transduction##25##3##(1990-12#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)
the signal was##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
the signal wave##2##3##(2007-11#1)(2008-3#1)
the signal windowed by##2##4##(2007-11#2)
the signal##244##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#3)(1991-12#2)(1991-3#1)(1991-6#4)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#4)(1994-11#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-2#5)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#2)(2007-11#14)(2007-12#18)(2008-10#41)(2008-11#7)(2008-12#2)(2008-2#22)(2008-3#48)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
the signal-carrying##2##2##(2008-1#2)
the signal-sequence cleavage site##3##4##(1991-6#3)
the signal-to-background ratio##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
the signal-to-background##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
the signal-to-noise ratio (SNR) of##2##5##(2008-10#1)(2010-8#1)
the signal-to-noise ratio (SNR)##5##4##(2008-10#2)(2008-3#1)(2009-5#1)(2010-8#1)
the signal-to-noise ratio and##2##4##(2007-11#1)(2008-3#1)
the signal-to-noise ratio in the reconstruction##2##6##(2007-11#1)(2008-3#1)
the signal-to-noise ratio in the##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the signal-to-noise ratio is##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the signal-to-noise ratio of the##4##5##(2008-10#1)(2008-3#3)
the signal-to-noise ratio of##9##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)
the signal-to-noise ratio with##3##4##(2008-2#1)(2008-3#2)
the signal-to-noise ratio##47##3##(2007-11#2)(2007-12#6)(2008-10#6)(2008-2#10)(2008-3#20)(2009-5#1)(2010-8#1)(2012-3#1)
the signal-to-noise##53##2##(2007-11#3)(2007-12#6)(2008-10#8)(2008-2#11)(2008-3#22)(2009-5#1)(2010-8#1)(2012-3#1)
the signaler##2##2##(2008-9#2)
the signaling pathway of p21ras##2##5##(1992-12#2)
the signaling pathway of##4##4##(1992-12#2)(1994-11#1)(2008-11#1)
the signaling pathway##5##3##(1992-12#2)(1994-11#2)(2008-11#1)
the signaling pathways involved##2##4##(2008-10#1)(2012-1#1)
the signaling pathways##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
the signaling##19##2##(1992-12#2)(1994-11#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-1#1)
the signalling##4##2##(1992-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
the signals from##3##3##(2008-10#3)
the signals in##2##3##(2008-3#2)
the signals of##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
the signals##28##2##(1990-11#1)(1992-6#1)(1994-6#1)(1996-4#1)(1997-5#1)(2007-12#2)(2008-10#7)(2008-2#2)(2008-3#6)(2008-8#1)(2009-3#1)(2009-7#1)(2010-7#1)(2013-1#1)(2013-7#1)
the signature##3##2##(1994-12#1)(2008-8#1)(2009-6#1)
the significance level##2##3##(2008-10#1)(2008-12#1)
the significance of differences##2##4##(2007-10#1)(2008-7#1)
the significance of insulin##2##4##(1990-2#1)(2010-11#1)
the significance of positive##2##4##(1992-11#1)(2011-2#1)
the significance of the reported##2##5##(1994-12#1)(2009-8#1)
the significance of the role of##2##6##(2008-10#1)(2013-8#1)
the significance of the##29##4##(1991-9#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
the significance of these##3##4##(2008-3#1)(2008-8#1)(2009-10#1)
the significance of this##6##4##(1993-1#1)(1993-12#1)(1995-5#1)(2009-3#1)(2011-2#1)(2012-3#1)
the significance of##90##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
the significance##96##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
the significant difference in##2##4##(2008-3#1)(2010-8#1)
the significant factors##3##3##(2008-10#3)
the significant increase in the##3##5##(1994-5#1)(1997-4#1)(2009-8#1)
the significant increase in##4##4##(1994-5#1)(1997-4#1)(2009-8#2)
the significant increase##5##3##(1994-5#1)(1997-4#1)(2009-8#3)
the significant role of##3##4##(1992-12#1)(2008-10#1)(2013-8#1)
the significant role##5##3##(1992-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
the significant variables were##2##4##(2008-10#2)
the significant variables##4##3##(2008-10#4)
the significant##71##2##(1992-12#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-10#2)(2007-11#2)(2007-2#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#2)
the significantly higher##2##3##(2008-4#1)(2008-6#1)
the significantly##8##2##(1990-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the signs and symptoms of the##2##6##(1997-7#1)(2007-7#1)
the signs and symptoms of##6##5##(1997-7#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-5#1)
the signs and symptoms##8##4##(1997-7#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-5#1)(2010-12#1)(2011-1#1)
the signs of##7##3##(2008-11#1)(2008-5#3)(2009-7#1)(2011-2#1)(2013-8#1)
the signs##16##2##(1996-9#1)(1997-7#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-5#4)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
the silage##3##2##(1990-6#1)(2012-2#1)(2013-1#1)
the silenced transgenic rice##2##4##(2008-9#2)
the silencing##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
the silent##6##2##(1995-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-1#1)
the silica content##2##3##(2008-10#2)
the silica gel##5##3##(2008-10#5)
the silica surface##4##3##(2008-10#4)
the silica##26##2##(1995-3#1)(2007-12#1)(2008-10#20)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)
the silica-based##2##2##(1997-2#2)
the silicate##2##2##(1995-6#1)(2008-10#1)
the silicon##15##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#3)(2010-4#1)
the silicon-based##2##2##(2007-11#1)(2008-10#1)
the silicone##2##2##(2008-10#1)(2008-5#1)
the silkworm##13##2##(1990-12#2)(1995-11#5)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
the siloxy bilayers##3##3##(2008-10#3)
the siloxy##5##2##(2008-10#5)
the silver##15##2##(1996-2#1)(2008-10#8)(2008-3#5)(2008-5#1)
the similar##11##2##(1993-8#1)(1994-11#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
the similarities and differences between##2##5##(1997-3#1)(2008-11#1)
the similarities and differences##5##4##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
the similarities between the##2##4##(1992-9#1)(2008-11#1)
the similarities between these##2##4##(1993-3#1)(2008-7#1)
the similarities between##6##3##(1992-9#1)(1993-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)
the similarities of##2##3##(2008-5#1)(2011-2#1)
the similarities##13##2##(1992-9#1)(1993-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#2)
the similarity between the##3##4##(1992-8#1)(2008-2#1)(2009-3#1)
the similarity between##5##3##(1992-8#1)(2007-12#1)(2008-2#1)(2009-3#1)(2013-8#1)
the similarity in##2##3##(2008-10#1)(2011-2#1)
the similarity of the##5##4##(1997-3#1)(2008-10#3)(2009-8#1)
the similarity of##7##3##(1997-3#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-8#1)
the similarity to##3##3##(1993-8#1)(1994-12#1)(2008-5#1)
the similarity##19##2##(1992-8#1)(1993-8#1)(1994-12#1)(1995-6#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
the similitude##2##2##(2013-7#2)
the simple determination of##2##4##(2008-10#2)
the simple method of##2##4##(2008-10#1)(2008-3#1)
the simple##43##2##(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-6#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)
the simpler##3##2##(2008-3#1)(2010-8#1)(2011-2#1)
the simplest and most##4##4##(1990-5#1)(2008-10#2)(2008-4#1)
the simplest##19##2##(1990-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-8#1)
the simplex method##3##3##(2008-10#3)
the simplex##4##2##(2008-10#4)
the simplicity and##2##3##(2008-1#1)(2008-4#1)
the simplicity of the##4##4##(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)
the simplicity of this##2##4##(2008-10#2)
the simplicity of##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)
the simplicity##12##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#1)
the simplified##8##2##(1994-2#2)(2007-12#2)(2008-10#1)(2008-2#3)
the simulated and experimental##2##4##(2007-12#1)(2008-10#1)
the simulated annealing method##3##4##(2008-3#2)(2011-1#1)
the simulated annealing##4##3##(2008-3#3)(2011-1#1)
the simulated##24##2##(1994-3#1)(1997-2#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#5)(2009-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
the simulation and the experimental results##2##6##(2008-2#1)(2008-3#1)
the simulation and the##3##4##(2008-2#2)(2008-3#1)
the simulation experiments##2##3##(2008-10#2)
the simulation is##2##3##(2008-2#2)
the simulation of##6##3##(1993-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)
the simulation results for##2##4##(2008-3#1)(2008-8#1)
the simulation results##4##3##(2008-3#3)(2008-8#1)
the simulation##42##2##(1993-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(2008-10#7)(2008-2#10)(2008-3#13)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#2)(2010-8#2)
the simulations and the experiments##2##5##(2008-3#1)(2010-2#1)
the simulations are##2##3##(1992-3#1)(2008-3#1)
the simulations show##3##3##(2008-3#3)
the simulations##21##2##(1992-3#1)(1997-3#1)(2008-10#3)(2008-2#3)(2008-3#10)(2008-9#2)(2010-2#1)
the simultaneous activity of##2##4##(1995-3#1)(2009-3#1)
the simultaneous addition of the##2##5##(2008-10#1)(2009-2#1)
the simultaneous addition of##3##4##(2008-10#1)(2009-2#1)(2009-8#1)
the simultaneous administration of##2##4##(1991-3#1)(1992-6#1)
the simultaneous analysis of##10##4##(1990-8#1)(2008-10#7)(2008-3#1)(2008-4#1)
the simultaneous and##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
the simultaneous assessment of surface##2##5##(2008-9#2)
the simultaneous assessment of##3##4##(2008-12#1)(2008-9#2)
the simultaneous binding of##2##4##(1990-12#1)(1994-5#1)
the simultaneous comparison of##2##4##(2008-2#1)(2008-4#1)
the simultaneous detection of##11##4##(2008-10#7)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
the simultaneous detection##14##3##(2008-10#9)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-3#1)
the simultaneous determination of As##3##5##(2008-10#3)
the simultaneous determination of NA and OH-NA in urine##2##9##(2008-10#2)
the simultaneous determination of Vitamin D(3) and##2##7##(2008-10#2)
the simultaneous determination of both##3##5##(2008-10#3)
the simultaneous determination of copper and##2##6##(2008-10#2)
the simultaneous determination of lead##3##5##(2008-10#3)
the simultaneous determination of nitrite and nitrate in water samples##2##10##(2008-10#2)
the simultaneous determination of nitrite and nitrate in##5##8##(2008-10#5)
the simultaneous determination of nitrite and nitrate##7##7##(2008-10#7)
the simultaneous determination of seven##2##5##(2008-10#2)
the simultaneous determination of the##13##5##(2008-10#11)(2008-2#1)(2008-3#1)
the simultaneous determination of three##3##5##(2008-10#3)
the simultaneous determination of trace amounts of##2##7##(2008-10#2)
the simultaneous determination of trace##5##5##(2008-10#5)
the simultaneous determination of##142##4##(1990-8#3)(1995-3#2)(2008-10#131)(2008-2#2)(2008-3#1)(2009-6#1)(2011-1#2)
the simultaneous determination##143##3##(1990-8#3)(1995-3#2)(2008-10#132)(2008-2#2)(2008-3#1)(2009-6#1)(2011-1#2)
the simultaneous evaluation of##2##4##(2008-2#1)(2008-5#1)
the simultaneous identification and quantitative determination of##2##7##(2008-5#2)
the simultaneous identification and##3##4##(2008-5#2)(2008-9#1)
the simultaneous in##2##3##(2008-10#1)(2008-2#1)
the simultaneous influence of##3##4##(1995-12#1)(2009-1#1)(2009-7#1)
the simultaneous maximization of the peak current and minimization of##2##10##(2008-10#2)
the simultaneous measurement of strain and temperature##2##7##(2008-3#2)
the simultaneous measurement of##7##4##(2008-1#1)(2008-2#2)(2008-3#4)
the simultaneous multielement determination##2##4##(2008-10#2)
the simultaneous presence of##3##4##(1996-5#1)(2006-10#1)(2008-11#1)
the simultaneous saccharification##2##3##(2008-6#2)
the simultaneous separation and##3##4##(2008-10#3)
the simultaneous separation##4##3##(2008-10#4)
the simultaneous spectrophotometric determination of##9##5##(2008-10#9)
the simultaneous use of##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
the simultaneous##289##2##(1990-12#1)(1990-8#4)(1991-3#1)(1992-6#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-3#3)(1996-12#1)(1996-4#1)(1996-5#1)(2006-10#1)(2007-11#3)(2007-12#3)(2008-1#4)(2008-10#196)(2008-11#3)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-1#2)
the simultaneously determined##2##3##(1996-8#1)(2008-2#1)
the simultaneously##3##2##(1996-8#1)(2007-12#1)(2008-2#1)
the sine##2##2##(2007-12#1)(2011-2#1)
the single DNA##2##3##(1993-11#1)(2008-10#1)
the single application##2##3##(2008-10#2)
the single cell gel electrophoresis assay##2##6##(1996-2#1)(1997-4#1)
the single cell gel##3##4##(1996-2#1)(1997-4#1)(2013-1#1)
the single cell level##5##4##(1990-12#1)(1997-4#1)(2007-12#1)(2011-1#1)(2011-2#1)
the single cell##11##3##(1990-12#1)(1994-8#1)(1996-2#1)(1997-4#3)(2007-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
the single cultures##3##3##(2013-1#3)
the single dominant gene##4##4##(2008-10#4)
the single dose##2##3##(2008-7#1)(2011-2#1)
the single most effective##2##4##(1996-12#1)(2008-12#1)
the single most##8##3##(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#1)
the single photon##2##3##(2008-2#1)(2012-2#1)
the single zoospore isolates##3##4##(2008-10#3)
the single##110##2##(1990-12#1)(1990-5#1)(1990-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-5#1)(1995-6#3)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#3)(2009-6#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#2)
the single- and##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
the single-cell##7##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-12#1)
the single-channel##2##2##(1997-6#2)
the single-charged##3##2##(2008-10#3)
the single-crystal##3##2##(2007-12#3)
the single-cycle regime##2##3##(2007-12#2)
the single-frequency##4##2##(2007-12#2)(2008-2#2)
the single-ion##2##2##(2008-10#1)(2010-7#1)
the single-mode fiber##2##3##(2007-12#2)
the single-mode##8##2##(2007-11#3)(2007-12#3)(2008-3#2)
the single-molecule level##2##3##(1997-6#1)(2013-8#1)
the single-molecule##3##2##(1997-6#1)(2008-7#1)(2013-8#1)
the single-pass##4##2##(1997-2#1)(2007-12#2)(2008-3#1)
the single-photon##2##2##(2008-2#1)(2008-3#1)
the single-pulse##3##2##(2007-11#1)(2008-3#2)
the single-scatter##3##2##(2008-3#3)
the single-scattering albedo and the##2##5##(2008-2#2)
the single-scattering albedo##8##3##(2008-2#2)(2008-3#6)
the single-scattering properties of##2##4##(2008-3#2)
the single-scattering##12##2##(2008-2#3)(2008-3#9)
the single-shot##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
the single-stranded DNA##2##3##(1992-3#1)(2008-10#1)
the single-stranded and##2##3##(2008-10#1)(2008-9#1)
the single-stranded##8##2##(1990-5#1)(1992-3#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-9#1)
the singly protonated ions##2##4##(1996-7#2)
the singly resonant##2##3##(2007-11#1)(2007-12#1)
the singly##9##2##(1990-8#1)(1996-2#1)(1996-7#3)(2007-11#1)(2007-12#1)(2008-2#2)
the singular##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
the singularity##2##2##(2007-11#1)(2008-6#1)
the sink##5##2##(2008-10#2)(2008-8#2)(2008-9#1)
the sinonasal region##2##3##(1990-6#1)(2008-8#1)
the sinonasal##4##2##(1990-6#1)(1993-6#1)(2008-8#1)(2011-2#1)
the sinus gland##5##3##(2008-5#2)(2008-6#3)
the sinus##18##2##(1992-6#1)(1996-9#1)(1997-5#3)(2006-12#1)(2007-12#1)(2008-5#2)(2008-6#3)(2008-7#2)(2012-1#1)(2012-8#1)(2013-1#1)(2013-8#1)
the sinuses and##2##3##(2008-7#1)(2011-2#1)
the sinuses##4##2##(2008-7#2)(2011-2#2)
the sinusoidal GSH transporter##2##4##(1995-2#2)
the sinusoidal##7##2##(1990-12#1)(1995-2#2)(2008-11#1)(2008-3#3)
the siphon##2##2##(2008-5#2)
the sipunculid##2##2##(1992-8#2)
the siren's##2##2##(2008-11#1)(2013-1#1)
the sister##4##2##(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
the site II##2##3##(2008-10#2)
the site and##3##3##(1990-8#1)(2007-11#1)(2010-5#1)
the site for##4##3##(1995-8#1)(1997-7#1)(2008-10#1)(2008-5#1)
the site had##2##3##(2008-10#1)(2012-12#1)
the site of a##3##4##(2010-6#2)(2011-2#1)
the site of action##2##4##(1991-2#1)(2011-2#1)
the site of an##2##4##(2006-4#1)(2012-2#1)
the site of application##42##4##(2007-7#1)(2008-9#41)
the site of biological##2##4##(2008-11#1)(2008-5#1)
the site of infection##9##4##(1996-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#2)
the site of injection##5##4##(1992-6#1)(1996-5#1)(2008-1#1)(2011-1#2)
the site of injury##3##4##(1996-5#1)(2008-9#1)(2012-12#1)
the site of inoculation##2##4##(2008-10#2)
the site of the primary##3##5##(1991-6#1)(2008-6#1)(2013-1#1)
the site of the##16##4##(1991-3#1)(1991-6#1)(1993-8#1)(1994-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#1)(2013-1#2)
the site of##143##3##(1990-11#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-5#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#6)(2008-11#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#47)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-9#1)(2013-1#2)(2013-7#1)
the site to##2##3##(2007-12#1)(2012-2#1)
the site where##3##3##(1992-3#1)(2007-12#1)(2013-1#1)
the site##190##2##(1990-11#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-3#5)(1992-6#1)(1993-11#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#48)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
the site(s)##3##2##(1991-9#1)(1995-5#1)(1997-8#1)
the site-directed##3##2##(2008-8#2)(2008-9#1)
the site-specific##2##2##(1992-6#1)(2008-8#1)
the sites and##2##3##(1992-1#1)(1996-5#1)
the sites at which##2##4##(1994-6#1)(2008-5#1)
the sites of##15##3##(1990-5#1)(1991-2#1)(1993-8#1)(1994-5#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-5#1)(2013-7#1)
the sites where##2##3##(2008-4#1)(2011-1#1)
the sites##43##2##(1990-5#1)(1990-8#1)(1991-2#1)(1992-1#1)(1993-11#1)(1993-8#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the sitting position##3##3##(1993-10#2)(2010-9#1)
the sitting##4##2##(1991-8#1)(1993-10#2)(2010-9#1)
the situation and##3##3##(1993-1#1)(1996-3#1)(2013-7#1)
the situation in the##3##4##(1990-6#1)(1991-6#1)(2008-1#1)
the situation in##11##3##(1990-6#1)(1991-6#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the situation of##7##3##(1990-8#1)(2007-11#1)(2008-2#1)(2009-5#1)(2013-1#2)(2013-8#1)
the situation where##2##3##(2008-8#1)(2012-3#1)
the situation##58##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
the situational##2##2##(1994-2#1)(2008-12#1)
the situations##3##2##(2008-9#1)(2010-2#1)(2010-7#1)
the six BC1##2##3##(2008-5#2)
the six common apo-E genotypes##2##5##(2008-10#2)
the six kinds of phthalate esters##2##6##(2008-5#2)
the six patients##3##3##(1992-2#1)(2008-9#1)(2013-8#1)
the six##68##2##(1990-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(2008-1#4)(2008-10#16)(2008-12#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
the six-electron reductive cleavage##2##4##(2010-12#2)
the six-electron##3##2##(1993-8#1)(2010-12#2)
the six-membered##2##2##(1996-2#1)(1997-7#1)
the six-year period##2##3##(1995-5#1)(2011-2#1)
the sixth and seventh in a series##2##7##(1991-1#1)(1992-1#1)
the sixth and seventh##6##4##(1991-1#1)(1992-1#1)(1995-4#1)(1995-8#1)(2007-12#1)(2008-7#1)
the sixth##24##2##(1990-12#1)(1990-6#1)(1991-1#1)(1992-1#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-6#1)(1997-7#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
the size and shape of the##3##6##(2008-2#1)(2010-12#1)(2013-8#1)
the size and shape of##7##5##(1995-5#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#2)(2013-8#1)
the size and the power##2##5##(1996-3#1)(2008-2#1)
the size and the shape##2##5##(2008-3#2)
the size and the##11##4##(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#5)
the size and##38##3##(1992-8#1)(1993-2#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#6)(2008-5#1)(2008-8#2)(2009-10#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the size distribution and##2##4##(2008-2#2)
the size distribution is##2##4##(2008-2#1)(2008-9#1)
the size distribution of##6##4##(1991-12#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
the size distribution##19##3##(1991-12#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#1)(2008-9#2)(2009-5#1)
the size fractionation of##2##4##(2008-10#2)
the size fractionation##3##3##(2008-10#3)
the size of a##13##4##(1992-5#1)(1992-6#1)(1994-11#1)(1994-3#2)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-3#1)(2013-1#1)
the size of both the##2##5##(2008-3#1)(2011-2#1)
the size of conventional##2##4##(2008-3#1)(2008-6#1)
the size of one of the##2##6##(2007-12#2)
the size of particles##2##4##(2007-12#1)(2008-2#1)
the size of the fixed-price region depends upon expectations about hospitals' costs##2##12##(1995-2#2)
the size of the nutrient foramen##2##6##(2013-8#2)
the size of the primary##2##5##(1995-6#1)(2007-5#1)
the size of the segment##2##5##(2008-5#2)
the size of the test##2##5##(2008-10#1)(2010-2#1)
the size of the wax matrix was##2##7##(2008-5#2)
the size of the wax matrix##4##6##(2008-5#4)
the size of the##112##4##(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-5#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#2)(2007-10#4)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
the size of these##2##4##(1996-1#1)(2009-3#1)
the size of##181##3##(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#3)(1997-6#1)(1997-9#1)(2007-10#4)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-2#8)(2008-3#16)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
the size parameter##4##3##(2008-2#2)(2008-3#2)
the size polydispersity of caseins##2##5##(2013-8#2)
the size range of##4##4##(1995-3#1)(2008-3#1)(2008-5#1)(2008-7#1)
the size range##7##3##(1995-3#1)(2008-3#1)(2008-5#1)(2008-7#4)
the size##277##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-2#3)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#4)(1996-6#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(1997-9#1)(2007-10#4)(2007-11#3)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#37)(2008-11#4)(2008-2#24)(2008-3#29)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#7)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#7)
the sizes and##3##3##(1997-6#1)(2007-12#1)(2008-7#1)
the sizes of their##2##4##(1990-7#1)(2007-12#1)
the sizes of##7##3##(1990-7#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-7#1)
the sizes##10##2##(1990-7#1)(1996-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
the skeletal muscle 6-phosphofructo-2-kinase reaction##2##5##(1993-8#2)
the skeletal muscle sodium channel gene##2##6##(1992-3#2)
the skeletal muscle tissue##2##4##(2008-2#2)
the skeletal muscle##13##3##(1991-9#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-8#2)(1994-2#1)(2008-2#2)(2008-7#1)(2008-8#1)(2013-1#1)
the skeletal muscles##2##3##(2008-7#1)(2012-1#1)
the skeletal system##2##3##(2007-11#2)
the skeletal##22##2##(1991-9#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-8#2)(1994-2#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-7#2)(2008-8#1)(2009-7#1)(2012-1#1)(2012-3#2)(2013-1#1)
the skeleton##10##2##(1993-11#5)(1996-5#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
the skew##3##2##(2008-2#1)(2008-8#2)
the skill of##4##3##(2007-11#1)(2008-11#3)
the skill set##3##3##(2007-12#3)
the skill##9##2##(1991-3#1)(2007-11#1)(2007-12#3)(2008-11#3)(2013-8#1)
the skills and processes##2##4##(2008-11#1)(2012-2#1)
the skills and##6##3##(1995-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the skills needed##2##3##(1995-2#1)(2010-5#1)
the skills of##3##3##(2007-12#1)(2008-11#1)(2008-6#1)
the skills to##3##3##(1996-1#1)(2008-11#2)
the skills##22##2##(1993-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1996-1#1)(2007-12#2)(2008-11#4)(2008-12#3)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the skin above##2##3##(1991-5#1)(2012-2#1)
the skin after##3##3##(2008-5#2)(2012-3#1)
the skin against##3##3##(2008-5#2)(2009-6#1)
the skin aging##2##3##(2008-5#2)
the skin and the##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
the skin and##29##3##(1991-11#1)(1991-8#1)(1992-6#2)(1995-12#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#11)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
the skin are##3##3##(2008-11#1)(2008-5#2)
the skin around the##2##4##(2007-8#1)(2008-5#1)
the skin as##2##3##(2008-10#1)(2009-6#1)
the skin barrier##3##3##(2008-5#3)
the skin becomes##2##3##(1992-4#1)(2008-5#1)
the skin but##3##3##(1991-6#1)(2012-2#1)(2012-3#1)
the skin by##4##3##(2008-5#2)(2009-6#1)(2013-1#1)
the skin compatibility of surfactant-based products##2##6##(2008-5#2)
the skin could be##2##4##(2008-5#2)
the skin from##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
the skin grafts##2##3##(2012-3#2)
the skin has##2##3##(2008-5#2)
the skin in##4##3##(2008-10#1)(2008-5#2)(2011-3#1)
the skin infection##2##3##(2008-12#2)
the skin is##8##3##(2008-3#1)(2008-5#3)(2008-9#2)(2009-6#1)(2013-8#1)
the skin lesions##7##3##(1990-3#2)(1991-4#1)(1997-6#2)(2011-2#1)(2013-8#1)
the skin membrane##2##3##(2012-12#2)
the skin model##2##3##(2008-5#1)(2008-6#1)
the skin of a##3##4##(1994-11#2)(2012-3#1)
the skin of patients with##2##5##(1992-8#1)(2012-2#1)
the skin of patients##3##4##(1992-3#1)(1992-8#1)(2012-2#1)
the skin of the##5##4##(1990-6#1)(1994-5#1)(2008-5#2)(2008-7#1)
the skin of##20##3##(1990-6#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2008-3#1)(2008-5#5)(2008-7#2)(2011-3#1)(2012-2#1)(2012-3#1)
the skin or the##2##4##(2008-10#1)(2008-5#1)
the skin or##4##3##(1996-1#1)(2008-10#2)(2008-5#1)
the skin surface by##2##4##(2008-5#2)
the skin surface##26##3##(2008-10#1)(2008-3#1)(2008-5#24)
the skin that##2##3##(2008-5#1)(2012-12#1)
the skin tissue##3##3##(1992-9#1)(1995-11#1)(2008-3#1)
the skin to##5##3##(2008-3#1)(2008-5#4)
the skin type##2##3##(2008-5#1)(2011-2#1)
the skin was##3##3##(2008-11#1)(2008-5#2)
the skin with##2##3##(2008-5#2)
the skin##346##2##(1990-3#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-3#2)(1993-5#1)(1994-11#3)(1994-3#1)(1994-5#1)(1995-11#3)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-6#2)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#175)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#14)(2009-11#1)(2009-4#1)(2009-6#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#8)(2013-1#3)(2013-7#2)(2013-8#5)
the skin's##4##2##(2008-5#4)
the skin-color##3##2##(2008-6#3)
the skull and##3##3##(2007-11#1)(2009-6#1)(2010-12#1)
the skull base and##5##4##(2006-12#2)(2007-12#1)(2011-2#1)(2012-2#1)
the skull base in##2##4##(2008-1#1)(2011-2#1)
the skull base was##2##4##(2011-2#2)
the skull base##17##3##(2006-12#3)(2007-12#1)(2008-1#2)(2008-7#3)(2011-2#7)(2012-2#1)
the skull in##2##3##(1995-6#1)(2012-12#1)
the skull##44##2##(1991-3#1)(1994-2#1)(1995-6#4)(2006-12#5)(2007-11#3)(2007-12#1)(2008-1#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#3)(2010-12#2)(2010-3#1)(2011-2#9)(2012-12#3)(2012-2#1)(2013-1#1)
the sky polarization pattern##2##4##(2007-12#2)
the sky radiance##4##3##(2008-2#3)(2008-3#1)
the sky radiometer##3##3##(2008-2#3)
the sky##18##2##(2007-12#2)(2008-2#11)(2008-3#4)(2012-2#1)
the skylight polarization##2##3##(2008-2#2)
the skylight##3##2##(2008-2#3)
the slab##9##2##(1995-6#3)(2007-11#1)(2007-12#1)(2008-3#4)
the slabs##2##2##(2008-2#2)
the slag##2##2##(2008-10#2)
the slave laser##2##3##(2007-11#1)(2008-2#1)
the slave##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
the sleep##7##2##(1995-12#1)(1996-7#1)(2009-8#3)(2010-8#1)(2011-2#1)
the sleeping time##2##3##(1995-12#2)
the sleeping##5##2##(1992-11#1)(1992-4#1)(1995-12#2)(2010-1#1)
the slice##2##2##(1995-11#1)(2008-4#1)
the slide##3##2##(1991-5#1)(2008-11#1)(2008-8#1)
the slider##3##2##(2008-3#3)
the slides were stained with##2##5##(2008-12#1)(2013-8#1)
the slides##6##2##(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
the sliding of##2##3##(1990-9#1)(2007-11#1)
the sliding##5##2##(1990-9#1)(1991-2#1)(2007-11#1)(2007-12#1)(2008-5#1)
the slight##6##2##(1991-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
the slightest##2##2##(1990-9#1)(2008-11#1)
the slit##7##2##(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)(2013-8#1)
the slope and intercept##2##4##(2008-10#2)
the slope and##3##3##(2008-10#3)
the slope changes##2##3##(2008-10#1)(2008-2#1)
the slope distribution of the rough##2##6##(2008-3#2)
the slope efficiency is##2##4##(2007-12#1)(2008-2#1)
the slope efficiency##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the slope in the##2##4##(2008-3#2)
the slope method##2##3##(2008-3#2)
the slope of the anomalous dispersion##2##6##(2008-2#2)
the slope of the calibration curve##5##6##(2008-10#5)
the slope of the calibration##7##5##(2008-10#7)
the slope of the##27##4##(1993-12#1)(1995-3#1)(1997-2#1)(2008-10#13)(2008-2#3)(2008-3#5)(2008-8#3)
the slope of this##2##4##(1991-5#1)(2007-11#1)
the slope of##32##3##(1991-5#1)(1993-12#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-2#3)(2008-3#6)(2008-8#3)(2009-8#1)
the slope was##3##3##(1995-8#1)(2008-10#2)
the slope##68##2##(1990-11#1)(1991-5#1)(1993-12#1)(1995-3#1)(1995-8#1)(1997-2#2)(2007-11#2)(2007-12#1)(2008-10#28)(2008-2#6)(2008-3#16)(2008-8#3)(2009-8#2)(2010-8#1)(2011-2#1)(2013-8#1)
the slopes of the##6##4##(1996-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#1)
the slopes of##9##3##(1996-5#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-8#1)(2012-3#1)
the slopes##11##2##(1996-5#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-8#1)(2012-3#1)(2013-7#1)
the slow and##2##3##(1997-2#1)(2007-12#1)
the slow component##2##3##(1992-3#1)(2008-3#1)
the slow dissociation of##2##4##(1993-11#1)(2008-4#1)
the slow phase##3##3##(1991-12#1)(2008-4#1)(2008-5#1)
the slow rate##4##3##(1993-8#1)(2008-5#1)(2008-9#2)
the slow segmental relaxation##2##4##(2008-10#2)
the slow variant##2##3##(1991-12#2)
the slow##47##2##(1991-12#5)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-8#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#2)(2007-11#3)(2007-12#2)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-1#1)
the slower##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
the slowest growth##2##3##(1997-1#1)(2008-11#1)
the slowest##11##2##(1990-7#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
the slowing down of the##2##5##(1994-3#1)(2008-10#1)
the slowing##4##2##(1991-12#1)(1994-3#1)(2008-10#1)(2008-8#1)
the slowly varying##3##3##(2007-11#2)(2008-8#1)
the slowly##4##2##(1995-6#1)(2007-11#2)(2008-8#1)
the sludge##2##2##(2008-6#1)(2012-12#1)
the slurry and the##2##4##(2008-10#2)
the slurry sampling technique were##2##5##(2008-10#2)
the slurry sampling##3##3##(2008-10#3)
the slurry##11##2##(2008-10#11)
the small amount of##2##4##(1996-9#1)(2008-10#1)
the small and large##3##4##(1990-11#1)(1994-11#1)(2008-7#1)
the small and##8##3##(1990-11#1)(1994-11#1)(1997-8#1)(2008-10#3)(2008-7#1)(2012-3#1)
the small angle##2##3##(2008-3#2)
the small bowel in##4##4##(1990-8#1)(1991-6#1)(2011-2#2)
the small bowel##21##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-5#2)(1992-9#1)(2008-6#1)(2009-1#1)(2009-4#1)(2010-12#3)(2011-2#4)(2012-2#1)(2013-1#1)
the small dense LDL phenotype##2##5##(2008-3#2)
the small dense##4##3##(2008-3#4)
the small inclination angle##2##4##(2008-3#2)
the small inclination##3##3##(2008-3#3)
the small intestine and##4##4##(1995-3#1)(2008-3#1)(2010-12#1)(2011-2#1)
the small intestine of##6##4##(1991-12#1)(2008-5#1)(2012-2#3)(2013-1#1)
the small intestine##34##3##(1990-11#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-5#1)(1992-6#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1997-3#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#3)(2013-1#5)(2013-7#1)
the small intestine]##3##3##(1990-11#1)(1992-5#2)
the small intestines##2##3##(1993-9#1)(1997-3#1)
the small molecule##3##3##(1994-9#1)(2008-11#1)(2013-8#1)
the small number of patients##4##5##(1994-6#1)(2008-1#1)(2010-5#2)
the small number of##10##4##(1991-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-5#2)
the small numbers##2##3##(1991-12#1)(2008-7#1)
the small population##2##3##(2008-10#1)(2008-8#1)
the small range of##2##4##(2008-10#1)(2009-5#1)
the small sample size##5##4##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
the small sample##6##3##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
the small signal gain and saturation irradiance of the gain medium##2##11##(2008-2#1)(2008-3#1)
the small signal##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the small size of the##4##5##(1991-5#1)(2008-12#1)(2009-3#1)(2010-2#1)
the small size of##7##4##(1991-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-2#1)(2011-2#1)
the small size##10##3##(1991-5#1)(1993-8#2)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-2#1)(2011-2#1)
the small subunit##3##3##(1993-12#1)(1994-8#1)(2013-8#1)
the small##197##2##(1990-11#5)(1990-12#1)(1990-2#2)(1990-8#2)(1991-12#2)(1991-5#5)(1991-6#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#5)(1992-6#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#5)(1997-6#1)(1997-8#2)(2006-4#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#15)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#4)(2009-1#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-2#10)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
the small-angle approximation##6##3##(2008-2#2)(2008-3#4)
the small-angle##9##2##(2008-2#2)(2008-3#5)(2008-5#1)(2009-12#1)
the small-scale##4##2##(1994-8#1)(2008-10#2)(2011-1#1)
the small-signal##4##2##(2008-2#3)(2008-3#1)
the smaller hospitals##2##3##(1990-11#1)(1992-6#1)
the smaller size of the##2##5##(1993-2#1)(2008-7#1)
the smaller the##2##3##(2008-3#1)(2011-2#1)
the smaller##31##2##(1990-11#2)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#2)
the smallest and##2##3##(2008-9#1)(2011-2#1)
the smallest possible##3##3##(1994-9#1)(2007-12#1)(2012-2#1)
the smallest spatial##2##3##(2008-10#2)
the smallest##40##2##(1994-9#1)(1996-2#1)(1997-2#1)(2007-12#5)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#2)(2010-11#1)(2011-2#4)(2012-2#2)(2013-1#1)
the smart cannula##2##3##(2007-8#2)
the smile is##2##3##(2008-7#1)(2012-3#1)
the smoke##3##2##(1996-12#2)(2008-5#1)
the smokers##3##2##(1990-6#1)(1993-2#1)(2008-10#1)
the smoking habit##2##3##(1993-6#1)(2009-5#1)
the smoking habits of##2##4##(2009-5#2)
the smoking habits##3##3##(2009-5#2)(2013-1#1)
the smoking status of##3##4##(2009-5#3)
the smoking##14##2##(1991-1#1)(1991-11#1)(1993-6#1)(1996-3#2)(1997-7#1)(2008-2#1)(2009-5#6)(2013-1#1)
the smooth muscle cells in the##2##6##(1993-2#1)(1995-12#1)
the smooth muscle##9##3##(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-3#1)(2007-8#1)(2011-2#1)
the smooth##17##2##(1990-7#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)
the smoothing##3##2##(2008-2#1)(2009-10#1)(2009-12#1)
the smoothness##2##2##(2007-11#1)(2008-6#1)
the sn-1 acyl chain##2##4##(1990-7#2)
the sn-1##3##2##(1990-7#2)(1995-8#1)
the snail##5##2##(1993-6#2)(2008-12#1)(2009-8#1)(2012-3#1)
the snails##2##2##(2008-11#1)(2008-12#1)
the snake venom##2##3##(1993-3#1)(1997-2#1)
the snake##4##2##(1993-3#1)(1995-5#1)(1997-2#1)(2010-3#1)
the snoRNAs##2##2##(1997-7#1)(2008-1#1)
the so called &quot##3##4##(1990-3#1)(2008-6#1)(2013-1#1)
the so called##7##3##(1990-3#1)(1992-5#1)(2007-11#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
the so##8##2##(1990-3#1)(1992-5#1)(2007-11#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
the so-called &quot##9##3##(1993-6#1)(1994-8#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
the so-called sandwich membrane method##2##5##(2008-10#2)
the so-called##74##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#3)(2009-2#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#1)
the soccer group##2##3##(1996-6#2)
the social and cultural aspects of##2##6##(1993-11#1)(2011-2#1)
the social and cultural##3##4##(1993-11#1)(2008-9#1)(2011-2#1)
the social and economic##2##4##(2008-1#1)(2008-11#1)
the social and political##2##4##(1991-6#1)(1993-11#1)
the social and##13##3##(1991-6#1)(1992-5#1)(1993-11#2)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
the social construction of##3##4##(1991-6#1)(2008-7#1)(2009-4#1)
the social context##3##3##(2008-11#2)(2013-1#1)
the social determinants of health##3##5##(2011-1#1)(2011-2#1)(2013-1#1)
the social determinants of##4##4##(2011-1#1)(2011-2#2)(2013-1#1)
the social elite##2##3##(2008-12#2)
the social environment##2##3##(2009-6#2)
the social insurance system##2##4##(1995-5#1)(1996-8#1)
the social insurance##3##3##(1995-5#1)(1996-12#1)(1996-8#1)
the social isolation##2##3##(1994-12#1)(2012-12#1)
the social norms##2##3##(2007-2#1)(2013-1#1)
the social organization of##2##4##(2008-9#1)(2010-1#1)
the social representation of##2##4##(2008-9#1)(2011-2#1)
the social representations##2##3##(2012-12#1)(2012-3#1)
the social sciences##6##3##(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2012-2#1)
the social security##2##3##(1995-5#2)
the social spider Anelosimus eximius##2##5##(2008-9#2)
the social support##3##3##(1992-3#1)(2011-2#2)
the social validity of##2##4##(1993-1#1)(2009-11#1)
the social welfare##2##3##(1995-3#1)(2008-11#1)
the social worker##2##3##(1995-11#1)(1996-1#1)
the social world##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
the social##120##2##(1991-3#1)(1991-6#4)(1991-9#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-11#2)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#6)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
the social-sexual crossover point##2##4##(2008-9#2)
the social/health maintenance organization##2##4##(1995-2#1)(1997-1#1)
the socialization##2##2##(1992-6#1)(2011-2#1)
the society and the##2##4##(2008-12#1)(2012-2#1)
the society and##3##3##(2008-12#1)(2012-2#2)
the society##15##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)
the society's##2##2##(2012-2#2)
the socio-demographic##2##2##(2008-8#1)(2013-1#1)
the socio-economic##4##2##(2008-1#1)(2008-10#1)(2008-7#2)
the sociodemographic##3##2##(1994-1#1)(2011-2#1)(2012-12#1)
the socioeconomic and##2##3##(1992-12#1)(1996-3#1)
the socioeconomic impact of##2##4##(1996-2#1)(2008-6#1)
the socioeconomic##6##2##(1992-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-12#1)(2008-6#1)
the sociologists##2##2##(2008-12#2)
the socket##4##2##(2008-10#1)(2010-11#1)(2013-1#2)
the sodium channel##2##3##(1992-3#1)(2009-3#1)
the sodium chloride##2##3##(1991-12#1)(2008-10#1)
the sodium pump##2##3##(2008-7#1)(2010-1#1)
the sodium salt##2##3##(1993-8#1)(1995-3#1)
the sodium##26##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-8#1)
the soft independent##2##3##(2008-10#1)(2013-8#1)
the soft palate##3##3##(1990-6#1)(1991-3#1)(2010-5#1)
the soft tissue##11##3##(1994-6#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
the soft tissues of the##2##5##(2008-12#1)(2009-5#1)
the soft tissues##10##3##(1995-3#1)(2008-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#2)(2012-2#1)(2013-1#1)
the soft##35##2##(1990-5#1)(1990-6#1)(1991-3#1)(1994-6#1)(1995-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-8#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#3)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
the soft-tissue##2##2##(2007-12#1)(2010-3#1)
the soft-x-ray range##2##3##(2008-2#1)(2008-3#1)
the soft-x-ray##5##2##(2008-2#3)(2008-3#2)
the software and##2##3##(2008-11#1)(2008-4#1)
the software helps##2##3##(1993-12#2)
the software program##2##3##(1995-6#1)(2010-12#1)
the software##26##2##(1993-12#3)(1995-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
the software's##2##2##(2008-2#1)(2011-1#1)
the soil and##7##3##(2008-10#5)(2008-12#1)(2008-7#1)
the soil by##2##3##(2011-2#1)(2012-12#1)
the soil can##2##3##(2008-11#1)(2010-5#1)
the soil in##2##3##(2008-10#2)
the soil microbial community##5##4##(2008-10#5)
the soil microbial##6##3##(1990-9#1)(2008-10#5)
the soil microflora##3##3##(2008-10#3)
the soil moisture##3##3##(2008-10#1)(2011-1#1)(2012-7#1)
the soil profile##3##3##(2008-10#3)
the soil sample##3##3##(2008-10#3)
the soil samples##5##3##(2008-10#4)(2013-7#1)
the soil surface was##3##4##(2008-10#2)(2010-5#1)
the soil surface##16##3##(2008-10#10)(2008-11#1)(2008-6#2)(2010-5#2)(2011-1#1)
the soil to##2##3##(2008-10#1)(2012-12#1)
the soil was##4##3##(2008-10#2)(2010-3#1)(2012-12#1)
the soil were##2##3##(2008-10#1)(2008-5#1)
the soil with##4##3##(2008-10#3)(2010-5#1)
the soil##146##2##(1990-9#3)(1992-12#1)(1992-3#3)(1995-3#1)(2008-10#84)(2008-11#9)(2008-12#5)(2008-3#1)(2008-5#4)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#2)(2010-3#2)(2010-5#7)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2012-7#1)(2013-7#1)(2013-8#1)
the soilborne pathogen##2##3##(2008-10#2)
the soilborne##10##2##(2008-10#10)
the soils amended with##2##4##(2008-10#2)
the soils##13##2##(2008-10#12)(2008-11#1)
the sol##3##2##(2008-10#3)
the sol-gel##8##2##(2008-10#7)(2010-12#1)
the solar background##2##3##(2008-3#2)
the solar spectrum##5##3##(2008-11#1)(2008-2#2)(2008-3#2)
the solar zenith angle##2##4##(2008-2#2)
the solar##23##2##(1997-5#1)(2007-12#1)(2008-11#1)(2008-2#6)(2008-3#12)(2008-7#1)(2013-8#1)
the solar-reflected spectrum##3##3##(2008-2#3)
the solder##3##2##(2008-3#3)
the sole or##2##3##(1994-8#1)(2011-2#1)
the sole presence of##2##4##(1994-12#1)(2008-10#1)
the sole source of##6##4##(1991-12#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)
the sole##59##2##(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-8#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-7#2)(2008-10#13)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#3)(2008-8#3)(2009-10#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#3)(2011-3#1)(2013-8#1)
the soleus H-reflex##2##3##(1993-12#2)
the soleus##3##2##(1993-12#2)(2013-8#1)
the solid and##2##3##(2008-10#2)
the solid mass consisting of the##3##6##(2008-10#3)
the solid mass is shaken with##2##6##(2008-10#2)
the solid mass##5##3##(2008-10#5)
the solid phase and the##2##5##(1990-12#1)(1997-3#1)
the solid phase extraction (SPE)##3##5##(2008-10#3)
the solid phase extraction of##4##5##(2008-10#4)
the solid phase extraction##9##4##(2008-10#9)
the solid phase with##2##4##(2008-10#2)
the solid phase##32##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1993-2#1)(1994-8#1)(1997-3#1)(2006-12#1)(2008-10#22)(2008-4#1)(2013-1#1)
the solid sample##4##3##(2008-10#3)(2008-3#1)
the solid samples was##2##4##(2008-1#1)(2008-10#1)
the solid state##9##3##(1993-3#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#3)(2008-3#1)
the solid substrate##4##3##(2008-10#4)
the solid support##11##3##(2008-10#9)(2008-4#2)
the solid surface##2##3##(2008-10#1)(2008-11#1)
the solid viewing angle of the sky radiometer##2##8##(2008-2#2)
the solid##99##2##(1990-12#2)(1990-6#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-7#2)(2006-12#1)(2007-11#2)(2008-1#2)(2008-10#63)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-1#1)
the solid-liquid##3##2##(2008-10#2)(2008-7#1)
the solid-phase extraction##3##3##(1992-11#1)(2008-10#2)
the solid-phase synthesis of##3##4##(1997-4#1)(2008-4#2)
the solid-phase##16##2##(1992-11#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#9)(2008-4#3)
the solid-state##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
the solid-support assisted##2##3##(2008-10#2)
the solids##4##2##(2008-10#3)(2013-1#1)
the solitary kidney##2##3##(2012-2#2)
the solitary##7##2##(1992-9#1)(1993-12#2)(1996-5#1)(2008-7#1)(2012-2#2)
the soliton pulse##3##3##(2007-11#3)
the soliton##9##2##(2007-11#6)(2007-12#3)
the solubility and##3##3##(2008-10#3)
the solubility of UV filters##2##5##(2008-5#2)
the solubility of the##3##4##(2008-10#2)(2013-1#1)
the solubility of these compounds##2##5##(2008-5#1)(2011-1#1)
the solubility of##21##3##(2008-10#11)(2008-4#1)(2008-5#3)(2010-4#1)(2010-5#2)(2011-1#1)(2012-2#1)(2013-1#1)
the solubility parameter##2##3##(2008-10#2)
the solubility##35##2##(2008-10#21)(2008-4#2)(2008-5#3)(2010-4#1)(2010-5#3)(2011-1#1)(2012-2#1)(2013-1#3)
the solubilization##2##2##(1990-2#1)(1994-12#1)
the solubilized membrane preparation##2##4##(1991-5#2)
the solubilized membrane##3##3##(1990-2#1)(1991-5#2)
the solubilized##6##2##(1990-2#2)(1990-5#1)(1991-5#2)(1993-11#1)
the soluble and insoluble##2##4##(1997-4#1)(2008-10#1)
the soluble and microsomal##3##4##(1992-6#3)
the soluble and##7##3##(1992-3#1)(1992-6#3)(1994-11#1)(1997-4#1)(2008-10#1)
the soluble b5##2##3##(1992-6#2)
the soluble components of the##2##5##(2008-10#1)(2008-9#1)
the soluble components##3##3##(2008-10#2)(2008-9#1)
the soluble form##2##3##(1992-12#1)(1995-2#1)
the soluble forms##2##3##(1994-11#1)(2008-10#1)
the soluble fraction of##4##4##(1991-7#1)(1991-9#1)(1992-9#1)(1996-12#1)
the soluble fraction##5##3##(1990-2#1)(1991-7#1)(1991-9#1)(1992-9#1)(1996-12#1)
the soluble fumarate reductase##2##4##(1996-8#2)
the soluble protein##5##3##(1994-6#1)(1994-8#1)(1995-2#2)(2008-11#1)
the soluble##51##2##(1990-2#2)(1990-6#1)(1991-7#1)(1991-9#1)(1992-12#5)(1992-3#2)(1992-6#6)(1992-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-2#1)(1997-4#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-9#3)(2013-1#1)
the solute and the##4##4##(1990-8#1)(2008-10#2)(2008-7#1)
the solute is##2##3##(2008-10#1)(2013-1#1)
the solute##23##2##(1990-8#1)(1994-9#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-7#2)(2010-2#3)(2013-1#1)
the solute-solvent##3##2##(2008-10#2)(2010-2#1)
the solutes##8##2##(1996-5#2)(2008-10#6)
the solution and the##2##4##(2008-10#2)
the solution and##6##3##(2008-10#6)
the solution can be##2##4##(1991-3#1)(2008-2#1)
the solution containing the##2##4##(2008-10#2)
the solution containing##3##3##(2008-10#3)
the solution for##3##3##(2008-10#2)(2008-7#1)
the solution from##3##3##(2008-10#2)(2008-2#1)
the solution in##2##3##(1995-3#1)(2008-10#1)
the solution is##7##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)
the solution of a##4##4##(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
the solution of the diffusion equation##2##6##(2008-2#2)
the solution of the##7##4##(2007-12#1)(2008-2#4)(2008-3#1)(2011-2#1)
the solution of##17##3##(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#2)
the solution pH was##2##4##(2008-10#2)
the solution pH##3##3##(2008-10#3)
the solution phase##3##3##(2008-10#3)
the solution structure of##6##4##(1991-11#1)(1994-5#3)(1995-2#1)(1995-8#1)
the solution structure##9##3##(1991-11#1)(1994-5#5)(1995-2#1)(1995-8#1)(2009-7#1)
the solution that##3##3##(1992-12#1)(2009-6#1)(2010-8#1)
the solution to##6##3##(1993-11#1)(1995-1#1)(2008-10#3)(2008-3#1)
the solution was##11##3##(1990-8#1)(2008-10#8)(2008-2#1)(2013-1#1)
the solution were##2##3##(2008-10#2)
the solution will##2##3##(2008-10#1)(2008-2#1)
the solution##163##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#5)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#81)(2008-12#1)(2008-2#16)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
the solution?##3##2##(1995-1#2)(1995-2#1)
the solutions is##3##3##(2008-10#2)(2008-3#1)
the solutions of##6##3##(2008-10#4)(2008-3#1)(2008-5#1)
the solutions to##2##3##(1996-3#1)(2011-2#1)
the solutions##30##2##(1991-1#1)(1991-9#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#18)(2008-3#3)(2008-5#2)(2011-2#1)(2012-12#1)
the solvation structure and##2##4##(2010-7#2)
the solvation##7##2##(2010-2#2)(2010-7#3)(2011-3#1)(2013-1#1)
the solvent and the##3##4##(1996-5#1)(2008-10#2)
the solvent and##4##3##(1996-5#1)(2008-10#3)
the solvent effect on##2##4##(2007-11#1)(2008-10#1)
the solvent extraction##6##3##(1995-2#1)(2008-10#5)
the solvent in##2##3##(1996-2#1)(2008-10#1)
the solvent mixture##2##3##(2008-10#2)
the solvent molecules##3##3##(1997-7#1)(2008-10#2)
the solvent polarity##3##3##(2008-10#2)(2010-2#1)
the solvent systems##3##3##(2008-10#3)
the solvent used to##2##4##(2008-10#1)(2010-4#1)
the solvent was##2##3##(2008-10#1)(2009-9#1)
the solvent##70##2##(1994-11#2)(1995-2#2)(1996-2#3)(1996-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
the solvents were##3##3##(1991-1#1)(2008-10#2)
the solvents##10##2##(1991-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-1#1)
the solvolyses of##3##3##(2011-1#3)
the soma of##2##3##(1990-7#1)(1995-12#1)
the soma##4##2##(1990-7#1)(1995-12#1)(2007-12#1)(2008-11#1)
the somata of##2##3##(1993-12#1)(2009-8#1)
the somatic gonad##3##3##(2007-12#1)(2012-12#2)
the somatic##15##2##(1990-12#1)(1991-12#1)(1991-5#1)(1996-12#1)(2007-12#2)(2008-7#1)(2008-9#3)(2010-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
the somatodendritic##2##2##(1992-3#1)(2008-4#1)
the somatosensory cortex##2##3##(1993-12#1)(2008-5#1)
the somatosensory problems##2##3##(2008-5#2)
the somatosensory##6##2##(1993-12#1)(1994-3#1)(2008-5#4)
the somatostatin##8##2##(1995-2#1)(1995-8#2)(2007-7#1)(2008-7#1)(2010-11#2)(2012-3#1)
the somatotropic axis##2##3##(2010-5#2)
the some##2##2##(2007-7#1)(2011-2#1)
the sometimes##3##2##(1991-12#1)(1996-12#1)(2009-5#1)
the son##2##2##(2007-10#1)(2008-12#1)
the song##2##2##(1997-2#1)(2009-2#1)
the sonication##2##2##(2008-10#1)(2008-5#1)
the sonographic appearance of##2##4##(2008-8#1)(2012-2#1)
the sonographic##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
the soot distribution##3##3##(2008-2#1)(2008-3#2)
the soot##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
the sophisticated##2##2##(2008-5#1)(2011-2#1)
the sorbed##3##2##(2008-10#3)
the sorbent were##3##3##(2008-10#3)
the sorbent##16##2##(2008-10#16)
the sorghum ergot pathogen##2##4##(2008-10#2)
the sorghum pathogen##2##3##(2008-10#2)
the sorghum##5##2##(2008-10#5)
the sorption and##2##3##(2008-10#2)
the sorption capacity of the##2##5##(2008-10#2)
the sorption capacity##3##3##(2008-10#3)
the sorption equilibria##2##3##(2008-10#2)
the sorption of Cu(II)##2##4##(2008-10#2)
the sorption of the##3##4##(2008-10#3)
the sorption of##24##3##(2008-10#24)
the sorption process##3##3##(2008-10#3)
the sorption significantly##2##3##(2008-10#2)
the sorption##50##2##(2008-10#50)
the sorting of##4##3##(2008-7#1)(2008-9#2)(2011-2#1)
the sorting##8##2##(1990-5#1)(1994-2#1)(2008-11#1)(2008-7#1)(2008-9#3)(2011-2#1)
the sound intensity##2##3##(1994-8#1)(2008-8#1)
the sound pressure##2##3##(2008-3#1)(2010-2#1)
the sound speed##3##3##(2007-12#2)(2008-2#1)
the sound velocity##3##3##(2008-2#3)
the sound wave##3##3##(2008-10#1)(2008-2#2)
the sound##24##2##(1992-3#1)(1994-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#9)(2008-3#2)(2008-4#2)(2008-8#1)(2010-2#2)(2011-2#1)(2013-8#1)
the sounds##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
the source (0##2##3##(2008-3#2)
the source and the##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
the source and##8##3##(2007-10#1)(2008-10#2)(2008-3#2)(2008-8#1)(2012-3#1)(2013-1#1)
the source are##3##3##(2008-3#3)
the source coherence length##2##4##(2007-11#1)(2008-3#1)
the source in##2##3##(2007-11#1)(2008-2#1)
the source is##7##3##(2008-2#2)(2008-3#5)
the source of light##2##4##(1993-3#2)
the source of progestin##2##4##(2008-12#2)
the source of the##9##4##(1995-1#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)
the source of this##4##4##(1991-9#1)(2008-12#1)(2008-7#1)(2008-8#1)
the source of##52##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#6)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#2)
the source phase##2##3##(2008-10#2)
the source than the##2##4##(2008-10#2)
the source than##3##3##(2008-10#3)
the source##143##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-12#6)(2008-2#5)(2008-3#30)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
the source-detector##2##2##(2008-3#1)(2011-1#1)
the sources and##2##3##(1995-1#1)(2008-10#1)
the sources for##2##3##(1995-2#1)(2008-4#1)
the sources of##10##3##(1991-2#1)(1992-5#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-12#1)(2012-3#1)
the sources##18##2##(1990-11#1)(1991-2#1)(1992-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
the south of##5##3##(2008-10#4)(2013-8#1)
the south##14##2##(1992-8#1)(1996-8#1)(2007-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#1)
the southeast coast of##2##4##(1991-11#1)(2012-2#1)
the southeast##5##2##(1991-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
the southeastern United States##14##4##(1992-8#1)(1993-1#1)(1994-1#1)(2008-10#5)(2008-5#1)(2011-2#5)
the southeastern##21##2##(1992-8#1)(1993-1#1)(1994-1#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-6#1)(2011-2#5)(2013-8#1)
the southern Gulf of Mexico##3##5##(2008-5#3)
the southern San##2##3##(1996-4#1)(2011-2#1)
the southern part of the California Current##2##7##(2010-8#2)
the southern part of the##3##5##(2008-10#1)(2010-8#2)
the southern part of##6##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-8#2)
the southern##41##2##(1990-6#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-4#2)(1996-8#2)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#6)(2008-3#2)(2008-5#3)(2008-8#3)(2010-1#2)(2010-3#2)(2010-8#6)(2011-2#3)(2012-3#1)(2013-1#1)
the southwest##2##2##(2008-10#1)(2008-9#1)
the southwestern United States##5##4##(1990-8#2)(2008-10#3)
the southwestern##8##2##(1990-8#2)(1992-7#1)(2008-10#4)(2012-3#1)
the sowing date from early spring to##2##7##(2008-10#2)
the soybean and##2##3##(2008-10#2)
the soybean hull flour##2##4##(2012-2#2)
the soybean##17##2##(1990-12#1)(1996-12#1)(2008-10#9)(2008-12#1)(2011-2#3)(2012-2#2)
the spa therapy##2##3##(2008-4#2)
the spa##3##2##(1992-11#1)(2008-4#2)
the space and##2##3##(2007-11#1)(2013-8#1)
the space between the##2##4##(1997-7#1)(2008-10#1)
the space between##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
the space group##3##3##(1993-8#1)(1996-2#1)(2008-8#1)
the space left##2##3##(1992-3#1)(2008-8#1)
the space of##4##3##(2007-12#1)(2008-3#1)(2009-10#1)(2010-2#1)
the space where##2##3##(1991-2#1)(2011-2#1)
the space##30##2##(1991-2#2)(1992-3#1)(1993-8#1)(1996-2#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the space-charge field##3##3##(2007-11#3)
the space-charge##5##2##(2007-11#3)(2007-12#1)(2012-2#1)
the space-charge-field grating##2##3##(2007-11#2)
the spacer in##2##3##(2008-10#2)
the spacer##11##2##(1994-11#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2013-1#1)
the spacing between the##3##4##(2007-11#1)(2008-3#2)
the spacing between##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
the spacing of the##2##4##(2008-2#1)(2008-3#1)
the spacing of##3##3##(2008-2#2)(2008-3#1)
the spacing##14##2##(1994-11#1)(1996-2#1)(2007-11#1)(2008-2#3)(2008-3#7)(2011-2#1)
the span of##3##3##(2006-10#1)(2008-3#2)
the spanning-bus##2##2##(2008-2#2)
the spark##3##2##(2008-1#2)(2008-10#1)
the sparks##2##2##(2008-1#2)
the sparse##2##2##(2008-3#1)(2009-5#1)
the spatial analysis##2##3##(2008-10#2)
the spatial and temporal characteristics##2##5##(2007-12#1)(2008-8#1)
the spatial and temporal expression##2##5##(1996-6#1)(2012-12#1)
the spatial and temporal patterns of##2##6##(2008-10#1)(2008-7#1)
the spatial and temporal##16##4##(1996-6#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-7#1)
the spatial and the temporal##5##5##(2007-11#1)(2007-12#2)(2008-2#2)
the spatial and the##6##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
the spatial and##25##3##(1996-6#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
the spatial arrangement of##4##4##(1994-9#1)(2008-10#1)(2013-1#1)(2013-7#1)
the spatial autocorrelation depends##2##4##(2008-10#2)
the spatial autocorrelation##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
the spatial beam profile##2##4##(2008-3#2)
the spatial beam##3##3##(2007-12#1)(2008-3#2)
the spatial coherence of a##2##5##(2008-2#2)
the spatial coherence of light##2##5##(2008-3#2)
the spatial coherence of##5##4##(2008-2#2)(2008-3#3)
the spatial coherence##12##3##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#4)
the spatial dependence of the##2##5##(2007-11#1)(2008-3#1)
the spatial dependence##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
the spatial distribution of a##2##5##(2008-2#2)
the spatial distribution of human##3##5##(2008-11#1)(2008-8#2)
the spatial distribution of the##9##5##(1995-3#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#2)(2011-1#1)
the spatial distribution of##30##4##(1990-7#1)(1994-9#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-8#3)(2009-10#2)(2011-1#1)(2013-7#2)
the spatial distribution##31##3##(1990-7#1)(1994-9#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-8#3)(2009-10#2)(2011-1#1)(2013-7#2)
the spatial domain by##2##4##(2008-2#1)(2008-3#1)
the spatial domain##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the spatial dynamics of##3##4##(2008-10#3)
the spatial expression##2##3##(1993-2#1)(2008-10#1)
the spatial extent of##2##4##(1996-5#1)(2008-2#1)
the spatial extent##3##3##(1996-5#1)(2007-5#1)(2008-2#1)
the spatial frequencies##2##3##(2007-11#1)(2008-3#1)
the spatial frequency##4##3##(1994-8#1)(2008-3#3)
the spatial heterogeneity##2##3##(2008-10#1)(2008-3#1)
the spatial information##2##3##(2008-3#2)
the spatial learning deficit produced by intraseptal##2##7##(1993-12#2)
the spatial learning deficit produced by##4##6##(1993-12#4)
the spatial learning in##2##4##(2008-9#2)
the spatial learning##7##3##(1993-12#4)(1994-3#1)(2008-9#2)
the spatial light modulator##2##4##(2008-3#2)
the spatial light##3##3##(2008-2#1)(2008-3#2)
the spatial memory##3##3##(1993-5#1)(1997-2#1)(2011-2#1)
the spatial mismatch hypothesis##3##4##(2009-9#3)
the spatial mismatch##4##3##(2009-9#3)(2012-12#1)
the spatial organization of##4##4##(2008-1#1)(2008-7#1)(2009-5#2)
the spatial pattern of##11##4##(2008-10#8)(2008-8#3)
the spatial patterns of the disease and##2##7##(2008-10#2)
the spatial patterns of##7##4##(2008-10#6)(2008-2#1)
the spatial patterns##8##3##(2008-10#6)(2008-2#1)(2008-9#1)
the spatial position of the##2##5##(2007-12#1)(2008-3#1)
the spatial properties of the##2##5##(2008-10#1)(2009-6#1)
the spatial relationships##4##3##(2007-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
the spatial resolution is##2##4##(2007-12#1)(2008-7#1)
the spatial resolution of the##4##5##(2008-10#1)(2008-3#3)
the spatial resolution of##6##4##(2008-10#1)(2008-3#4)(2009-7#1)
the spatial resolution##12##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-7#1)(2011-1#1)
the spatial scale at which##2##5##(2008-10#1)(2012-12#1)
the spatial scale of##2##4##(2008-8#2)
the spatial scale##4##3##(2008-10#1)(2008-8#2)(2012-12#1)
the spatial statistics of##3##4##(2008-3#3)
the spatial structure of a##2##5##(2008-8#1)(2009-2#1)
the spatial structure of the##3##5##(2008-11#1)(2008-8#1)(2013-1#1)
the spatial structure of##8##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2009-2#1)(2013-1#1)
the spatial structure##10##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#4)(2009-2#1)(2013-1#1)
the spatial uniformity##2##3##(2008-3#2)
the spatial##251##2##(1990-7#1)(1992-10#1)(1993-12#4)(1993-2#1)(1993-5#2)(1994-3#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-11#10)(2007-12#18)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#38)(2008-11#3)(2008-2#26)(2008-3#61)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#17)(2008-9#5)(2009-10#5)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#1)(2010-7#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#4)(2013-8#4)
the spatial-frequency plane##2##3##(2008-3#2)
the spatial-frequency##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
the spatially encrypted signal##2##4##(2008-3#2)
the spatially resolved##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the spatially##15##2##(2007-11#1)(2008-2#1)(2008-3#6)(2008-8#4)(2009-9#1)(2011-2#1)(2013-1#1)
the spatio-temporal##6##2##(1995-6#1)(2008-10#2)(2008-11#1)(2009-5#1)(2013-7#1)
the spatiotemporal dynamics of word processing##2##6##(2008-11#2)
the spatiotemporal dynamics of##3##4##(2008-10#1)(2008-11#2)
the spatiotemporal##14##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-2#1)
the spawning of##2##3##(1991-8#1)(2008-11#1)
the spawning##6##2##(1991-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#2)
the speC gene##2##3##(1994-12#2)
the speaker##5##2##(2008-11#1)(2009-10#2)(2013-8#2)
the special care##2##3##(1993-3#1)(1994-3#1)
the special case model##3##4##(2008-8#3)
the special case of##5##4##(2008-10#3)(2008-2#1)(2008-8#1)
the special case##9##3##(1992-6#1)(2008-10#3)(2008-2#1)(2008-8#4)
the special considerations##2##3##(2008-4#1)(2010-6#1)
the special issues##2##3##(2009-9#1)(2010-5#1)
the special needs of##3##4##(1997-2#1)(1997-8#1)(2013-1#1)
the special needs##4##3##(1996-3#1)(1997-2#1)(1997-8#1)(2013-1#1)
the special##43##2##(1990-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#5)(2009-3#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
the specialist in##2##3##(1993-5#1)(2013-1#1)
the specialist##10##2##(1993-12#1)(1993-5#1)(1993-6#1)(1995-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-1#1)
the specialized units##2##3##(1994-8#2)
the specialized##8##2##(1992-6#1)(1993-1#1)(1994-8#2)(1994-9#1)(1995-6#1)(2008-4#1)(2013-1#1)
the specially##2##2##(1997-6#1)(2008-10#1)
the specialty in##2##3##(1997-8#1)(2008-9#1)
the specialty##10##2##(1992-11#1)(1993-1#1)(1995-9#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-9#3)(2012-12#1)
the speciation analysis of##2##4##(2008-10#2)
the speciation analysis##4##3##(2008-10#4)
the speciation and determination of##2##5##(2008-10#2)
the speciation and##4##3##(2008-10#3)(2008-9#1)
the speciation of As(III) and As(V) in##2##7##(2008-10#2)
the speciation of antimony in##3##5##(2008-10#3)
the speciation of antimony##4##4##(2008-10#4)
the speciation of arsenic in##3##5##(2008-10#3)
the speciation of arsenic##5##4##(2008-10#5)
the speciation of chromium in##4##5##(2008-10#4)
the speciation of chromium##6##4##(2008-10#6)
the speciation of##33##3##(2008-10#32)(2008-9#1)
the speciation process##2##3##(2008-8#1)(2009-2#1)
the speciation##50##2##(2008-10#44)(2008-8#1)(2008-9#3)(2009-2#1)(2013-1#1)
the specie##2##2##(2007-10#1)(2008-10#1)
the species and##9##3##(1994-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the species are##6##3##(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
the species composition of##2##4##(2008-9#1)(2011-1#1)
the species composition##5##3##(2008-5#1)(2008-9#1)(2011-1#1)(2013-7#2)
the species examined##4##3##(1993-2#1)(1996-5#2)(2008-7#1)
the species formed##2##3##(2008-10#2)
the species found##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
the species from##2##3##(2008-10#1)(2013-8#1)
the species have a##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
the species in the##4##4##(1996-6#1)(2008-10#2)(2008-5#1)
the species in##9##3##(1996-6#1)(2008-10#3)(2008-5#1)(2008-8#3)(2012-5#1)
the species is##4##3##(2008-10#1)(2008-5#1)(2013-7#2)
the species isolated##2##3##(2008-5#1)(2011-2#1)
the species level##8##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-6#1)
the species number##2##3##(2008-10#1)(2008-8#1)
the species of##10##3##(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2013-7#1)
the species specificity##2##3##(2008-10#2)
the species studied##3##3##(2007-11#1)(2008-8#1)(2010-5#1)
the species that##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
the species was##6##3##(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-5#1)(2013-1#1)
the species were##3##3##(2008-10#2)(2008-5#1)
the species with##3##3##(2008-10#3)
the species##170##2##(1990-5#1)(1990-8#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#5)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#54)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#20)(2008-6#1)(2008-7#2)(2008-8#17)(2008-9#3)(2009-10#1)(2009-8#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2012-5#2)(2012-6#1)(2013-1#1)(2013-7#8)(2013-8#2)
the species'##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
the species-area relationship and##2##4##(2008-8#2)
the species-area relationship##3##3##(2008-8#3)
the species-area##4##2##(2008-8#4)
the species-specific parasitism of##2##4##(2008-10#2)
the species-specific##4##2##(2008-10#3)(2008-9#1)
the specific IgA production rate##3##5##(2008-11#3)
the specific PCR primers##2##4##(2008-10#2)
the specific PCR##3##3##(1996-8#1)(2008-10#2)
the specific activities##2##3##(1991-12#1)(1994-2#1)
the specific activity of##4##4##(1992-11#1)(1995-3#1)(2008-10#1)(2008-4#1)
the specific activity##5##3##(1992-11#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-4#1)
the specific alterations##2##3##(1995-8#1)(2010-1#1)
the specific amplification of##3##4##(1990-3#1)(2008-10#2)
the specific amplification##4##3##(1990-3#1)(2008-10#3)
the specific antibody##2##3##(2007-12#1)(2008-10#1)
the specific approach##2##3##(2008-10#1)(2010-3#1)
the specific binding of##7##4##(1990-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2010-7#1)
the specific binding##10##3##(1990-11#1)(1990-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-7#1)
the specific case of##4##4##(2008-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
the specific cell##3##3##(1994-3#1)(2008-11#1)(2008-7#1)
the specific challenges##2##3##(2008-11#1)(2012-3#1)
the specific characteristics of##3##4##(2008-3#1)(2011-2#1)(2013-8#1)
the specific characteristics##4##3##(1991-3#1)(2008-3#1)(2011-2#1)(2013-8#1)
the specific clinical##2##3##(2008-10#1)(2012-12#1)
the specific conditions##2##3##(2007-11#1)(2008-10#1)
the specific detection of the##2##5##(2008-10#1)(2010-10#1)
the specific detection of##5##4##(2008-10#4)(2010-10#1)
the specific energy dissipation rate and##2##6##(2008-7#2)
the specific energy dissipation rate##7##5##(2008-7#7)
the specific energy dissipation##9##4##(2008-7#9)
the specific energy##10##3##(1990-11#1)(2008-7#9)
the specific enzyme production##2##4##(1994-3#1)(2008-7#1)
the specific expression##2##3##(1994-6#1)(2008-11#1)
the specific features of##2##4##(2008-10#1)(2012-3#1)
the specific features##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
the specific genetic background of##2##5##(2007-10#1)(2008-7#1)
the specific genetic##3##3##(2007-10#1)(2008-7#1)(2008-8#1)
the specific glucose consumption rate##2##5##(2008-11#2)
the specific glucose uptake rate##3##5##(1994-5#3)
the specific glucose##6##3##(1994-5#3)(2008-11#2)(2008-7#1)
the specific growth rate of the##2##6##(1995-9#1)(2008-11#1)
the specific growth rate of##5##5##(1995-9#1)(2008-11#1)(2008-7#2)(2010-11#1)
the specific growth rate##10##4##(1994-5#1)(1995-9#1)(2008-11#3)(2008-7#3)(2008-9#1)(2010-11#1)
the specific growth rates##2##4##(2008-11#1)(2008-7#1)
the specific growth##12##3##(1994-5#1)(1995-9#1)(2008-11#4)(2008-7#4)(2008-9#1)(2010-11#1)
the specific interaction of##2##4##(1993-3#1)(2008-10#1)
the specific interaction##3##3##(1993-3#1)(2008-10#1)(2008-2#1)
the specific ligand##2##3##(2008-6#1)(2008-9#1)
the specific mechanism of##2##4##(1992-9#1)(2008-10#1)
the specific monoclonal antibody production rate##2##6##(2008-11#2)
the specific nature of##3##4##(2007-7#1)(2008-2#1)(2010-2#1)
the specific needs of##4##4##(1996-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
the specific process and presentation of##2##6##(2008-8#2)
the specific productivity of##2##4##(2008-11#2)
the specific productivity##3##3##(2008-11#2)(2008-7#1)
the specific rates of##2##4##(2008-11#2)
the specific recognition of##2##4##(1991-9#1)(2008-10#1)
the specific requirements##2##3##(2008-4#1)(2013-8#1)
the specific role of##4##4##(1991-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
the specific structure of##2##4##(1995-5#1)(2012-2#1)
the specific sugar inhibitor##2##4##(1994-6#2)
the specific treatment##4##3##(2007-10#1)(2008-8#1)(2009-4#1)(2012-12#1)
the specific ways##2##3##(1996-1#1)(2008-10#1)
the specific##326##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#5)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-3#1)(1995-5#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#38)(2008-11#36)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#31)(2008-8#11)(2008-9#12)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#7)
the specification of##5##3##(1990-11#1)(1991-1#1)(1994-3#1)(2008-2#1)(2009-10#1)
the specifications of##2##3##(2008-1#1)(2008-10#1)
the specifications##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
the specificity and sensitivity##2##4##(1996-9#1)(2008-10#1)
the specificity and the##2##4##(1993-6#1)(2008-10#1)
the specificity and##6##3##(1993-6#1)(1996-9#1)(1997-7#1)(2008-10#2)(2012-2#1)
the specificity of a##2##4##(2008-10#1)(2008-2#1)
the specificity of the primers##2##5##(2008-10#2)
the specificity of the##23##4##(1990-7#1)(1990-9#1)(1991-9#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2013-8#1)
the specificity of this##2##4##(1997-2#1)(2008-10#1)
the specificity of##46##3##(1990-7#1)(1990-9#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-3#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-6#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
the specificity was##4##3##(1996-12#3)(1997-3#1)
the specificity##72##2##(1990-2#2)(1990-7#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#4)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-7#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the specifics of##3##3##(1996-2#1)(2008-4#1)(2011-1#1)
the specified##9##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
the specimen was##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
the specimen##24##2##(1991-6#1)(1994-9#1)(1995-3#1)(2007-11#2)(2008-12#1)(2008-3#5)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#3)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the specimens were##5##3##(2008-12#2)(2013-1#1)(2013-7#2)
the specimens##16##2##(1993-3#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-12#5)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#3)
the speckle size##2##3##(2008-3#2)
the speckle##15##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#11)
the spectra is##3##3##(2008-3#2)(2010-2#1)
the spectra obtained##2##3##(2008-10#2)
the spectra of the##5##4##(1994-11#1)(2007-12#1)(2008-10#2)(2008-8#1)
the spectra of##19##3##(1992-8#1)(1993-5#1)(1994-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
the spectra##43##2##(1992-8#1)(1993-5#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-10#16)(2008-12#1)(2008-2#4)(2008-3#9)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
the spectral and spatial##2##4##(2007-12#1)(2008-3#1)
the spectral and the##2##4##(2008-10#1)(2008-3#1)
the spectral and##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
the spectral band##2##3##(2008-3#1)(2012-2#1)
the spectral bandwidth of a##2##5##(2007-11#1)(2008-3#1)
the spectral bandwidth of##3##4##(2007-11#1)(2008-3#2)
the spectral bandwidth standard##2##4##(2008-3#2)
the spectral bandwidth##11##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)
the spectral bandwidths##2##3##(2007-12#1)(2008-3#1)
the spectral behavior of##2##4##(2007-12#1)(2008-3#1)
the spectral changes##2##3##(2008-10#2)
the spectral characteristics of the##2##5##(2008-2#2)
the spectral characteristics of##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
the spectral classification##2##3##(2013-8#2)
the spectral data##4##3##(2008-10#3)(2013-8#1)
the spectral dispersion plane##2##4##(2008-3#2)
the spectral distribution of the##4##5##(2007-11#1)(2008-2#3)
the spectral distribution##6##3##(2007-11#1)(2008-2#3)(2008-3#2)
the spectral domain##7##3##(2007-11#1)(2007-12#2)(2008-2#4)
the spectral features of the##2##5##(2007-12#1)(2008-2#1)
the spectral features##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the spectral frequency##3##3##(2007-11#1)(2008-2#2)
the spectral function##2##3##(2008-2#2)
the spectral information from the##2##5##(2008-2#1)(2008-3#1)
the spectral information in near-field data##2##6##(2008-3#2)
the spectral information##4##3##(2008-2#1)(2008-3#3)
the spectral interference##2##3##(2007-11#1)(2008-10#1)
the spectral line intensity##2##4##(2013-8#2)
the spectral line##5##3##(2008-3#1)(2013-8#4)
the spectral lines##2##3##(2008-3#1)(2013-8#1)
the spectral linewidth##3##3##(2007-12#1)(2008-3#2)
the spectral overlap is##2##4##(2007-12#1)(2008-10#1)
the spectral overlap##3##3##(2007-12#1)(2008-10#2)
the spectral parameters##2##3##(2008-10#1)(2008-2#1)
the spectral phase of##2##4##(2007-12#1)(2008-3#1)
the spectral phase##4##3##(2007-12#3)(2008-3#1)
the spectral profiles##2##3##(1992-12#1)(2008-3#1)
the spectral properties of##5##4##(1994-11#1)(2007-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
the spectral properties##7##3##(1992-1#1)(1994-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
the spectral range from##5##4##(2007-12#2)(2008-10#1)(2008-3#2)
the spectral range of##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
the spectral range##17##3##(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)
the spectral reflectance of##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
the spectral reflectance rho(lambda)##2##4##(2008-12#2)
the spectral reflectance##9##3##(2008-10#1)(2008-12#2)(2008-2#3)(2008-3#3)
the spectral region near##3##4##(2007-11#1)(2008-3#2)
the spectral region##11##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#6)
the spectral regions##2##3##(2008-10#2)
the spectral resolution and##2##4##(2007-12#2)
the spectral resolution##9##3##(2007-12#6)(2008-2#1)(2008-3#2)
the spectral response of a##2##5##(2007-12#1)(2008-2#1)
the spectral response of the##3##5##(2008-2#1)(2008-3#2)
the spectral response of##7##4##(2007-12#2)(2008-2#2)(2008-3#3)
the spectral response##9##3##(2007-12#2)(2008-2#3)(2008-3#4)
the spectral scattering##2##3##(2008-3#2)
the spectral shape of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the spectral shape##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the spectral shapes of##2##4##(2008-2#1)(2008-3#1)
the spectral transmission##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
the spectral width of the##2##5##(2007-12#1)(2008-3#1)
the spectral width##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the spectral##246##2##(1992-1#1)(1992-12#2)(1994-11#1)(1997-7#1)(2007-11#19)(2007-12#35)(2008-10#27)(2008-12#2)(2008-2#52)(2008-3#80)(2008-5#5)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#12)
the spectrally resolved##2##3##(2008-2#1)(2008-3#1)
the spectrally##5##2##(2008-2#2)(2008-3#3)
the spectroelectrochemical##2##2##(2008-10#2)
the spectrofluorimetric determination of##5##4##(2008-10#5)
the spectrofluorimetric##7##2##(2008-10#7)
the spectrograph##2##2##(2008-3#2)
the spectrometer##21##2##(2007-12#3)(2008-10#11)(2008-2#2)(2008-3#5)
the spectrometer's##2##2##(2008-10#2)
the spectrometric##3##2##(2008-10#2)(2008-3#1)
the spectrophotometer##4##2##(2008-10#3)(2008-3#1)
the spectrophotometric and extractive behaviour of##2##6##(2008-10#2)
the spectrophotometric and##4##3##(2008-10#4)
the spectrophotometric determination of lead with##2##6##(2008-10#2)
the spectrophotometric determination of lead##5##5##(2008-10#5)
the spectrophotometric determination of nickel##4##5##(2008-10#4)
the spectrophotometric determination of zinc##2##5##(2008-10#2)
the spectrophotometric determination of##50##4##(2008-10#49)(2010-5#1)
the spectrophotometric method##8##3##(2008-10#5)(2008-5#1)(2013-8#2)
the spectrophotometric##74##2##(1993-9#1)(1995-2#1)(2008-10#68)(2008-5#1)(2010-5#1)(2013-8#2)
the spectroscopic data##2##3##(2008-10#2)
the spectroscopic properties of the##3##5##(1997-2#1)(2008-10#2)
the spectroscopic properties of##4##4##(1994-12#1)(1997-2#1)(2008-10#2)
the spectroscopic##18##2##(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#10)(2008-2#2)(2010-2#2)(2012-12#1)
the spectroscopically##2##2##(2008-5#1)(2012-2#1)
the spectroscopy and##3##3##(2008-7#1)(2010-2#2)
the spectroscopy##5##2##(2007-11#1)(2008-3#1)(2008-7#1)(2010-2#2)
the spectrum and the##2##4##(2008-1#1)(2008-3#1)
the spectrum and##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
the spectrum are##3##3##(2007-11#1)(2008-3#2)
the spectrum as a##2##4##(2007-11#1)(2008-2#1)
the spectrum by##3##3##(2008-10#1)(2008-3#2)
the spectrum from##2##3##(2007-12#1)(2008-3#1)
the spectrum is##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
the spectrum of disease##2##4##(1991-12#1)(2012-2#1)
the spectrum of free molecule##2##5##(2008-10#2)
the spectrum of the##8##4##(1996-2#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
the spectrum of##37##3##(1990-5#1)(1991-12#1)(1991-2#1)(1994-12#1)(1994-6#1)(1996-2#1)(1997-3#2)(1997-8#2)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
the spectrum was##2##3##(2008-10#1)(2013-8#1)
the spectrum##94##2##(1990-5#3)(1991-12#1)(1991-2#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-3#2)(1997-8#2)(2007-11#9)(2007-12#7)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#9)(2008-3#19)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
the specular##10##2##(2007-11#2)(2008-2#2)(2008-3#5)(2011-2#1)
the speech and language skills of##2##6##(2008-9#2)
the speech and language##3##4##(2007-8#1)(2008-9#2)
the speech of##2##3##(2008-2#1)(2013-8#1)
the speech processor##3##3##(2008-9#3)
the speech##13##2##(2007-8#1)(2008-2#2)(2008-9#9)(2013-8#1)
the speed and##6##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
the speed of ascent##2##4##(1992-2#2)
the speed of eating##2##4##(1993-12#2)
the speed of propagation of ultrasound shear waves##2##8##(2008-5#2)
the speed of sound and the thermal diffusivity##2##8##(2008-3#2)
the speed of sound and##3##5##(2008-3#3)
the speed of the##4##4##(2007-11#1)(2008-2#1)(2008-6#1)(2011-2#1)
the speed of##25##3##(1992-2#2)(1993-12#2)(1994-8#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#2)
the speed with which##2##4##(2008-3#1)(2012-12#1)
the speed##35##2##(1992-2#2)(1993-12#2)(1994-8#1)(1996-12#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
the spending##4##2##(1995-12#2)(1997-2#1)(1997-3#1)
the spent beads are##2##4##(2008-10#2)
the spent culture medium##2##4##(1995-6#1)(2008-11#1)
the spent##5##2##(1995-6#1)(2008-10#2)(2008-11#2)
the sperm acrosome reaction and##2##5##(1992-8#1)(2008-8#1)
the sperm acrosome reaction##3##4##(1992-8#1)(2008-8#2)
the sperm acrosome##5##3##(1992-8#1)(2008-8#4)
the sperm cells##2##3##(2008-12#1)(2009-8#1)
the sperm head##3##3##(1992-5#1)(1994-8#1)(2012-2#1)
the sperm stored in the##2##5##(2008-8#2)
the sperm##30##2##(1991-11#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-8#5)(2007-12#2)(2008-12#1)(2008-7#4)(2008-8#8)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#3)
the spermatheca##11##2##(2008-5#1)(2008-6#5)(2008-8#1)(2012-12#4)
the spermathecae##5##2##(2007-12#2)(2008-7#1)(2008-8#2)
the spermathecal duct##3##3##(2008-5#3)
the spermathecal ducts##2##3##(2008-8#2)
the spermathecal##6##2##(2007-12#1)(2008-5#3)(2008-8#2)
the spermatic cord and##2##4##(2008-6#2)
the spermatic cord##4##3##(2008-10#1)(2008-6#3)
the spermatic##5##2##(2007-5#1)(2008-10#1)(2008-6#3)
the spermatid##2##2##(2008-7#1)(2012-2#1)
the spermatogenic##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
the spermatozoa during##2##3##(2007-12#1)(2011-1#1)
the spermatozoa##11##2##(2007-12#2)(2008-7#3)(2008-8#2)(2011-1#4)
the spermatozoal##2##2##(2008-7#1)(2011-1#1)
the spermogonial##2##2##(2008-10#2)
the spermosphere##3##2##(2008-10#3)
the sphenoid sinus##7##3##(2008-7#3)(2011-2#2)(2012-3#2)
the sphenoid##11##2##(2008-10#3)(2008-7#4)(2011-2#2)(2012-3#2)
the sphere##11##2##(1991-6#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#3)
the spheres##2##2##(2008-3#1)(2008-5#1)
the spherical aberration of##2##4##(2008-3#2)
the spherical aberration##5##3##(2008-2#1)(2008-3#3)(2009-5#1)
the spherical##18##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)
the sphingomyelin pathway##2##3##(1995-12#2)
the sphingosine##2##2##(1993-8#1)(1994-3#1)
the spice##2##2##(2012-3#2)
the spicules and##2##3##(2007-12#2)
the spider Agelenopsis aperta##2##4##(1990-5#1)(1993-11#1)
the spider##10##2##(1990-5#1)(1993-11#1)(2007-12#5)(2008-5#2)(2008-9#1)
the spike train##4##3##(2008-11#1)(2009-8#3)
the spike trains##2##3##(2008-11#1)(2009-8#1)
the spike##18##2##(1992-3#3)(1997-3#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#5)(2013-8#1)
the spiked levels##2##3##(2011-1#2)
the spiked samples##5##3##(2008-10#5)
the spiked water##2##3##(2008-10#2)
the spiked##23##2##(2008-10#21)(2011-1#2)
the spiking procedure##2##3##(2008-10#2)
the spiking##5##2##(2008-10#3)(2011-1#1)(2013-8#1)
the spin labels##2##3##(1993-8#2)
the spin vector##2##3##(2008-2#2)
the spin##12##2##(1993-8#3)(2008-10#1)(2008-2#2)(2008-7#4)(2009-5#2)
the spin-trap##2##2##(1990-12#1)(1991-2#1)
the spinach##6##2##(1992-3#1)(2008-10#5)
the spinal canal##9##3##(2006-12#1)(2007-11#2)(2007-8#3)(2008-12#1)(2009-3#1)(2011-2#1)
the spinal column##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
the spinal cord and##9##4##(1990-7#1)(1992-12#1)(1994-8#2)(1996-2#1)(1996-5#1)(2007-11#1)(2008-7#1)(2009-3#1)
the spinal cord by##2##4##(1994-8#1)(1995-12#1)
the spinal cord dorsal horn##3##5##(1993-12#1)(1994-8#1)(2008-4#1)
the spinal cord in##2##4##(1996-5#1)(2008-7#1)
the spinal cord is##3##4##(2008-4#1)(2008-5#1)(2011-1#1)
the spinal cord##69##3##(1990-5#2)(1990-7#4)(1991-5#2)(1991-6#1)(1992-12#1)(1993-12#2)(1994-8#5)(1995-12#3)(1995-5#1)(1996-12#3)(1996-2#2)(1996-5#6)(1996-9#1)(1997-3#1)(2007-10#2)(2007-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#11)(2009-11#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
the spinal nerve##2##3##(2008-4#1)(2011-2#1)
the spinal nerves by##2##4##(2008-7#2)
the spinal tract of the trigeminal nerve##2##7##(1996-5#2)
the spinal##105##2##(1990-5#2)(1990-7#4)(1991-5#2)(1991-6#1)(1992-12#2)(1993-12#2)(1994-8#5)(1995-12#3)(1995-5#1)(1996-12#3)(1996-2#2)(1996-5#8)(1996-9#1)(1997-2#2)(1997-3#1)(2006-12#1)(2007-10#2)(2007-11#4)(2007-8#5)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#5)(2008-7#19)(2008-9#1)(2009-11#1)(2009-3#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the spindle##7##2##(1991-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)(2011-2#2)
the spine and##11##3##(1991-11#1)(1993-11#1)(1993-12#1)(2007-11#2)(2008-3#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)
the spine head volume##2##4##(2008-11#2)
the spine##45##2##(1990-12#1)(1990-6#2)(1991-11#1)(1991-6#1)(1993-11#1)(1993-12#1)(1996-6#1)(2007-11#16)(2007-8#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#1)
the spiny##2##2##(2007-12#1)(2010-11#1)
the spiral gradient dilution method##2##5##(2008-10#2)
the spiral##9##2##(1994-9#1)(1995-5#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
the spiralin##2##2##(2008-10#2)
the spirit of the##2##4##(1992-12#1)(1997-8#1)
the spirit of##4##3##(1992-12#1)(1994-11#1)(1997-8#1)(2009-10#1)
the spirit##5##2##(1992-12#1)(1994-11#1)(1997-8#1)(2009-10#1)(2010-7#1)
the spiritual needs of##3##4##(2008-11#2)(2011-1#1)
the spiritual##7##2##(1995-5#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#2)
the spirochetes##2##2##(1997-4#1)(2008-9#1)
the spittle bug Philaenus spumarius##2##5##(2007-12#2)
the splanchnic##2##2##(1996-3#1)(2008-6#1)
the spleen and the##2##4##(1990-3#1)(2011-2#1)
the spleen and##11##3##(1990-12#2)(1990-3#1)(1995-3#1)(1997-6#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)
the spleen##45##2##(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#4)(2008-9#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
the splenectomy##2##2##(1994-9#2)
the splenic PFC response to SRBCs##2##6##(1993-12#2)
the splenic artery aneurysm##2##4##(2011-2#2)
the splenic artery##4##3##(2008-7#1)(2011-2#3)
the splenic flexure##3##3##(2008-12#1)(2013-8#2)
the splenic##11##2##(1993-12#3)(2008-12#1)(2008-7#1)(2011-2#4)(2013-8#2)
the splenocytes##2##2##(2008-11#1)(2008-8#1)
the splice acceptor site##2##4##(1993-11#1)(1995-12#1)
the splice site##3##3##(1994-9#1)(1995-12#2)
the splice##7##2##(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#3)(2011-1#1)
the splicing of##4##3##(1991-5#1)(1991-9#1)(1993-8#1)(1995-6#1)
the splicing process##2##3##(1991-9#2)
the splicing##6##2##(1991-5#1)(1991-9#3)(1993-8#1)(1995-6#1)
the splint##2##2##(1991-6#2)
the split between##3##3##(1993-6#1)(2013-8#2)
the split##9##2##(1993-6#1)(2007-11#1)(2008-1#1)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#2)
the split-window##2##2##(2008-2#1)(2008-3#1)
the splitting##3##2##(1990-5#1)(2008-2#2)
the spondarthritides##2##2##(1990-6#2)
the spondyloarthropathies##2##2##(1990-11#1)(2006-10#1)
the sponge##2##2##(2011-2#1)(2012-2#1)
the sponge-like mycelial mass##2##4##(2008-10#2)
the sponges##3##2##(1994-3#3)
the spontaneous activity##2##3##(1997-7#1)(2008-11#1)
the spontaneous decomposition##2##3##(1990-11#2)
the spontaneous firing##2##3##(2008-6#2)
the spontaneous level##4##3##(1994-2#1)(2008-7#3)
the spontaneous regression of a hypervascular##2##6##(2008-1#2)
the spontaneous theta rhythm in the cat##2##7##(1993-9#2)
the spontaneous transfer of##2##4##(1992-3#2)
the spontaneous##47##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1992-3#2)(1992-6#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2011-2#1)(2013-1#1)
the spontaneously hypertensive rat##2##4##(1994-8#1)(1997-2#1)
the spontaneously hypertensive##3##3##(1994-8#1)(1997-2#1)(2009-9#1)
the spontaneously##5##2##(1992-9#1)(1994-8#1)(1997-2#1)(2009-3#1)(2009-9#1)
the sporadic form##2##3##(1997-3#1)(2008-7#1)
the sporadic##4##2##(1990-12#1)(1997-3#1)(2008-7#2)
the spore##14##2##(1995-6#1)(2008-10#10)(2008-3#1)(2010-1#1)(2011-2#1)
the spores##8##2##(2008-10#6)(2010-3#1)(2011-2#1)
the sporulating##2##2##(2008-10#2)
the sporulation curve##2##3##(2008-10#2)
the sporulation of##3##3##(2008-10#3)
the sporulation##11##2##(2008-10#10)(2011-2#1)
the spot size##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
the spot##9##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2013-8#1)
the spotlight##3##2##(2008-7#1)(2009-7#1)(2010-5#1)
the spots of##2##3##(2008-10#1)(2008-3#1)
the spots##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the spouse##3##2##(1993-3#1)(2009-5#2)
the spout##2##2##(2008-4#2)
the spray##6##2##(1996-3#1)(2008-10#3)(2008-3#2)
the spread of AIDS in##2##5##(1997-6#2)
the spread of AIDS##7##4##(1990-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1997-6#3)
the spread of HIV##7##4##(1996-11#1)(1997-5#1)(1997-6#3)(2008-1#1)(2011-1#1)
the spread of a disease##2##5##(2008-10#1)(2011-2#1)
the spread of a##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
the spread of disease##5##4##(2008-10#4)(2008-8#1)
the spread of infection##5##4##(2007-6#1)(2007-7#1)(2010-3#2)(2011-2#1)
the spread of infectious diseases##2##5##(2010-5#1)(2013-8#1)
the spread of sexually transmitted##2##5##(1994-3#1)(2011-2#1)
the spread of the disease##2##5##(2007-7#1)(2010-4#1)
the spread of the##7##4##(1990-6#1)(1994-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-4#1)
the spread of tuberculosis##2##4##(2009-7#1)(2011-2#1)
the spread of##77##3##(1990-2#1)(1990-6#2)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#7)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-8#6)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the spread##82##2##(1990-2#1)(1990-6#2)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#7)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#20)(2008-12#1)(2008-2#1)(2008-8#6)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the spreading of##3##3##(2007-11#1)(2007-12#1)(2009-10#1)
the spreading panicle##2##3##(2009-10#2)
the spreading##7##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-10#3)
the spring and autumn##2##4##(2011-2#1)(2013-1#1)
the spring and fall##3##4##(2008-10#3)
the spring and##7##3##(2008-10#4)(2011-2#1)(2012-3#1)(2013-1#1)
the spring of 1991##2##4##(1992-4#1)(1996-12#1)
the spring of 2000##3##4##(2008-10#3)
the spring of##19##3##(1992-4#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-2#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-3#1)
the spring season##2##3##(2008-10#1)(2012-3#1)
the spring##40##2##(1992-4#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2010-8#3)(2011-2#4)(2011-9#1)(2012-3#3)(2013-1#1)(2013-8#1)
the sputtering##2##2##(2008-3#1)(2009-5#1)
the sputum of a##2##4##(2011-2#2)
the sputum##5##2##(1992-5#1)(1997-1#1)(2008-3#1)(2011-2#2)
the squamous##4##2##(1993-8#1)(1997-5#1)(2009-3#1)(2012-12#1)
the square of the##12##4##(1990-7#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#6)
the square of##13##3##(1990-7#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#6)
the square root of the scan rate##2##7##(2008-10#2)
the square root of the##5##5##(2007-12#2)(2008-10#2)(2008-3#1)
the square root of##8##4##(2007-12#3)(2008-10#2)(2008-3#2)(2008-9#1)
the square wave##6##3##(2008-10#5)(2011-2#1)
the square##34##2##(1990-7#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#9)(2008-2#3)(2008-3#13)(2008-9#1)(2011-2#1)
the square-wave##3##2##(2008-10#3)
the squared##2##2##(2008-12#1)(2011-3#1)
the squares of these##2##4##(2008-6#1)(2008-8#1)
the squares of##3##3##(2007-11#1)(2008-6#1)(2008-8#1)
the squirrel Sciurus variegatoides##2##4##(2008-5#2)
the squirrel##3##2##(2008-5#2)(2008-7#1)
the ssDNA##2##2##(1991-5#1)(1995-2#1)
the sspE##2##2##(1996-8#2)
the stabilisation of##2##3##(2007-11#1)(2007-8#1)
the stabilisation##5##2##(2007-11#2)(2007-8#1)(2008-10#2)
the stabilities of the##2##4##(1993-11#1)(2008-4#1)
the stabilities##3##2##(1993-11#1)(2008-10#1)(2008-4#1)
the stability and reproducibility of the##2##6##(2008-10#1)(2008-12#1)
the stability and reproducibility of##3##5##(2008-10#2)(2008-12#1)
the stability and the##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
the stability and##14##3##(1992-5#1)(1994-8#1)(1995-5#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)
the stability constant for##2##4##(2008-10#2)
the stability constant of the##2##5##(2008-10#2)
the stability constant of##3##4##(2008-10#3)
the stability constant##6##3##(2008-10#6)
the stability constants of the##6##5##(2008-10#6)
the stability constants of##10##4##(2008-10#10)
the stability constants##13##3##(2008-10#13)
the stability of a##4##4##(2008-5#2)(2008-9#1)(2012-2#1)
the stability of an##2##4##(1992-6#1)(2007-8#1)
the stability of hermaphroditism##2##4##(2008-8#2)
the stability of the electrode##2##5##(2008-10#2)
the stability of the knee joint##2##6##(2007-8#2)
the stability of the native state of##2##7##(1992-6#1)(1993-11#1)
the stability of the native##3##5##(1992-6#1)(1993-11#1)(1994-5#1)
the stability of the system##2##5##(2008-10#1)(2010-11#1)
the stability of the vesicles##2##5##(1990-2#1)(2008-5#1)
the stability of the##58##4##(1990-2#1)(1990-5#1)(1991-11#1)(1992-6#4)(1993-11#3)(1994-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
the stability of these##6##4##(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)
the stability of this##2##4##(1991-5#1)(2008-8#1)
the stability of##136##3##(1990-2#3)(1990-5#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#6)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#36)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)
the stability##183##2##(1990-2#3)(1990-5#2)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#8)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2007-11#3)(2007-12#1)(2007-8#3)(2008-10#66)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#11)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)
the stability-indicating##2##2##(2011-1#1)(2012-12#1)
the stabilization and##2##3##(1990-8#1)(2008-12#1)
the stabilization of the##5##4##(1991-6#1)(1992-5#1)(2007-12#1)(2008-3#1)(2011-1#1)
the stabilization of##11##3##(1990-8#1)(1991-6#1)(1992-5#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-1#1)
the stabilization##17##2##(1990-8#2)(1991-6#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-1#1)
the stabilizing##7##2##(1991-7#1)(1992-3#1)(1992-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-4#1)
the stable##30##2##(1991-11#1)(1991-5#1)(1992-3#1)(1993-3#1)(1995-2#2)(1995-5#1)(1997-1#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2011-2#3)(2012-2#1)(2013-8#1)
the stably##2##2##(2008-11#2)
the stack##2##2##(2008-2#1)(2008-3#1)
the stacking##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
the staff and##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)
the staff in##3##3##(1991-12#1)(1996-2#1)(2011-1#1)
the staff of##2##3##(1991-2#1)(1996-1#1)
the staff##19##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-12#3)(2008-4#1)(2011-1#1)(2013-1#1)
the stage I##4##3##(1993-11#1)(2007-8#1)(2013-8#2)
the stage for the##4##4##(2008-7#2)(2008-9#1)(2011-2#1)
the stage for##11##3##(1996-2#1)(1997-2#1)(2007-5#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
the stage of allantois formation##2##5##(2008-11#2)
the stage of cell##2##4##(1992-9#1)(2008-9#1)
the stage of development##3##4##(1996-8#1)(2007-12#1)(2008-8#1)
the stage of its##2##4##(1992-2#1)(2008-10#1)
the stage of the disease##3##5##(1991-6#1)(1992-8#1)(1995-8#1)
the stage of the##5##4##(1990-8#1)(1991-6#1)(1992-8#1)(1995-8#1)(2008-12#1)
the stage of##39##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-8#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#2)
the stage##61##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#3)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#4)
the staged##2##2##(2007-12#1)(2007-8#1)
the stages in the development of##2##6##(2007-11#1)(2010-8#1)
the stages in the##4##4##(2007-11#1)(2007-8#1)(2010-2#1)(2010-8#1)
the stages of##7##3##(1990-6#1)(1993-6#1)(1997-4#1)(2008-12#1)(2009-2#1)(2013-1#2)
the stages##14##2##(1990-6#1)(1993-6#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-8#1)(2013-1#2)
the staging and##3##3##(1990-9#1)(2010-3#1)(2012-12#1)
the staging of##5##3##(2007-4#1)(2008-2#2)(2012-12#1)(2013-1#1)
the staging##11##2##(1990-12#1)(1990-9#1)(2007-4#1)(2008-10#1)(2008-2#2)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
the stain##2##2##(2008-9#1)(2010-5#1)
the stained##5##2##(1995-4#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
the staining intensity##2##3##(1991-5#1)(1996-2#1)
the staining##9##2##(1991-2#1)(1991-5#1)(1992-11#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-9#3)
the stains##2##2##(1990-7#1)(1996-11#1)
the staircase procedure##2##3##(1990-11#2)
the staircase##4##2##(1990-11#2)(2007-10#1)(2008-2#1)
the stakeholder##3##2##(1995-1#1)(2008-1#1)(2008-10#1)
the stakeholders in##2##3##(2008-6#1)(2012-12#1)
the stakeholders##4##2##(1991-12#1)(2008-12#1)(2008-6#1)(2012-12#1)
the stalk##4##2##(1997-8#1)(2008-10#2)(2011-2#1)
the stance##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
the standard FVC maneuver##2##4##(2008-7#2)
the standard addition method was##2##5##(2008-10#2)
the standard addition method##16##4##(2008-10#16)
the standard addition methodology##4##4##(2008-10#4)
the standard addition technique##6##4##(1991-12#1)(2008-10#5)
the standard addition##30##3##(1991-12#1)(2008-10#28)(2013-8#1)
the standard additions method##11##4##(2008-10#11)
the standard and##3##3##(2007-12#1)(2009-2#1)(2012-3#1)
the standard approach##4##3##(1990-6#1)(2008-11#1)(2008-8#2)
the standard curve was##3##4##(2008-10#3)
the standard curve##4##3##(2008-10#3)(2010-11#1)
the standard design##2##3##(1994-9#2)
the standard deviation (S##2##4##(2008-10#2)
the standard deviation (SD)##3##4##(2008-5#1)(2009-11#1)(2012-5#1)
the standard deviation of blank##2##5##(2008-10#2)
the standard deviation of the##23##5##(2007-11#1)(2008-10#14)(2008-2#2)(2008-3#6)
the standard deviation of##28##4##(2007-11#1)(2008-10#19)(2008-2#2)(2008-3#6)
the standard deviation##49##3##(1995-6#1)(2007-11#1)(2008-10#28)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-9#1)(2009-11#1)(2010-9#1)(2012-5#1)(2013-8#2)
the standard deviations##2##3##(1993-9#1)(2008-10#1)
the standard error##2##3##(2007-10#1)(2008-10#1)
the standard errors of##2##4##(2008-10#1)(2008-7#1)
the standard errors##3##3##(1995-9#1)(2008-10#1)(2008-7#1)
the standard first-line##2##3##(2010-12#1)(2013-1#1)
the standard for##4##3##(1991-1#1)(1996-12#1)(2007-10#1)(2008-11#1)
the standard method for##3##4##(2008-3#1)(2008-4#1)(2010-3#1)
the standard method of##2##4##(2007-8#1)(2011-2#1)
the standard method##12##3##(1992-12#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#2)
the standard methods##2##3##(2008-10#2)
the standard of care for##4##5##(1993-12#1)(2007-12#1)(2008-6#1)(2009-12#1)
the standard of care##9##4##(1991-12#1)(1993-12#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-1#1)
the standard of##13##3##(1990-11#1)(1991-12#1)(1993-12#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-1#1)
the standard plate count##2##4##(1997-4#2)
the standard procedure##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
the standard reference material##4##4##(2008-10#4)
the standard reference##8##3##(2008-1#1)(2008-10#5)(2010-3#1)(2011-1#1)
the standard slurries##2##3##(2008-10#2)
the standard solution##2##3##(2008-10#2)
the standard solutions##2##3##(2008-10#2)
the standard spectrophotometric##2##3##(2008-10#2)
the standard technique##3##3##(2011-7#1)(2012-12#1)(2012-2#1)
the standard therapy##2##3##(1994-12#1)(2010-7#1)
the standard treatment for##4##4##(2007-10#1)(2011-2#2)(2012-3#1)
the standard treatment in##2##4##(1991-8#1)(2011-2#1)
the standard treatment##10##3##(1991-8#1)(1995-9#1)(1997-3#1)(2007-10#1)(2008-10#1)(2011-2#3)(2012-3#2)
the standard##357##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#2)(1992-12#2)(1992-5#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-9#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-3#4)(1997-4#2)(1997-8#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#2)(2007-8#5)(2008-1#2)(2008-10#136)(2008-11#11)(2008-12#4)(2008-2#20)(2008-3#28)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#8)(2012-5#1)(2013-1#4)(2013-8#4)
the standardised mortality ratio##2##4##(2008-8#2)
the standardised##4##2##(2008-8#2)(2009-8#1)(2011-1#1)
the standardization of##4##3##(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#1)
the standardization##7##2##(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#4)
the standardized area under##2##4##(2008-10#2)
the standardized patients' rating of##2##5##(2008-8#2)
the standardized terminology provided the nurses greater ease in their selection of nursing diagnoses and interventions in planning patient care##2##20##(2013-1#2)
the standardized variance##2##3##(2008-10#1)(2008-8#1)
the standardized##17##2##(1991-3#1)(1993-9#1)(1997-1#1)(2008-10#3)(2008-5#1)(2008-8#4)(2011-2#2)(2012-2#1)(2013-1#3)
the standards for##5##3##(1996-3#1)(2007-11#1)(2008-3#1)(2010-4#1)(2011-2#1)
the standards of the##2##4##(1991-8#1)(2011-2#1)
the standards of##7##3##(1991-3#1)(1991-8#1)(1992-2#1)(1997-8#1)(2008-9#1)(2011-2#2)
the standards##22##2##(1991-3#1)(1991-8#1)(1992-2#1)(1994-3#2)(1995-2#2)(1996-3#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2010-4#1)(2011-2#3)
the standing position##2##3##(1990-6#1)(1997-4#1)
the standing##6##2##(1990-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
the standpoint of##7##3##(1995-12#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-9#1)
the starch granules##2##3##(2009-8#1)(2013-8#1)
the starch##6##2##(1995-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-8#1)
the starfish##3##2##(1992-8#3)
the stars##2##2##(2008-2#1)(2011-2#1)
the start codon of the##2##5##(2008-10#1)(2008-8#1)
the start codon##5##3##(1990-5#1)(1991-6#2)(2008-10#1)(2008-8#1)
the start of a new##2##5##(1996-6#1)(2008-11#1)
the start of a##8##4##(1993-6#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
the start of on-orbit operations##2##5##(2008-3#2)
the start of the study##4##5##(2008-5#1)(2010-11#1)(2010-3#1)(2012-2#1)
the start of the trial##2##5##(2008-10#1)(2011-2#1)
the start of the##21##4##(1990-6#1)(1991-5#1)(1994-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
the start of treatment##9##4##(1990-2#1)(1990-9#1)(1991-2#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-12#3)
the start of##62##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-9#1)(1993-12#3)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
the start position##3##3##(2008-6#3)
the start site of##3##4##(1991-5#1)(1992-3#1)(1992-8#1)
the start##77##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#4)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
the starting and##2##3##(2008-10#2)
the starting material##9##3##(1990-12#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#1)
the starting point for##2##4##(1996-12#1)(2008-11#1)
the starting values##2##3##(2008-2#2)
the starting##30##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-5#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#2)(2010-4#1)(2012-3#1)
the startle##7##2##(1991-12#1)(2008-11#4)(2008-4#2)
the state and federal##2##4##(1994-3#1)(2010-9#1)
the state and local level##4##5##(1996-12#1)(1997-2#2)(2011-9#1)
the state and local##5##4##(1996-12#1)(1996-2#1)(1997-2#2)(2011-9#1)
the state and##9##3##(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2010-9#1)(2011-9#1)
the state in##4##3##(1995-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the state legislature##2##3##(1991-8#1)(1995-2#1)
the state of health##2##4##(1992-3#1)(1994-9#1)
the state of knowledge##2##4##(2008-10#1)(2010-5#1)
the state of polarization of the##2##6##(2008-2#1)(2008-3#1)
the state of polarization##8##4##(2007-11#1)(2008-2#3)(2008-3#4)
the state of the art in##2##6##(2007-8#1)(2010-9#1)
the state of the art of##3##6##(2008-5#1)(2009-12#1)(2012-2#1)
the state of the art##8##5##(1993-3#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-9#1)(2012-2#1)
the state of the##19##4##(1990-2#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-3#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#1)(2010-9#1)(2012-2#1)
the state of##81##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#4)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
the state public health regulations##2##5##(1995-2#2)
the state space##2##3##(2008-11#2)
the state##139##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-2#5)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#8)(2011-9#1)(2012-2#2)(2013-1#2)(2013-8#2)
the state's##8##2##(1991-8#1)(1992-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
the state-of-the-art in##2##3##(2008-10#1)(2008-11#1)
the state-of-the-art of##2##3##(2008-10#1)(2008-9#1)
the state-of-the-art##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
the stated##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
the statement##4##2##(2008-6#1)(2009-8#1)(2013-1#2)
the states of##9##3##(1990-2#1)(1991-12#1)(1994-3#1)(1997-8#1)(2008-3#2)(2008-5#2)(2010-3#1)
the states##19##2##(1990-2#1)(1991-12#2)(1994-3#1)(1995-12#1)(1995-2#2)(1996-1#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-3#1)
the static and the dynamic##2##5##(2008-2#1)(2008-3#1)
the static and##4##3##(2008-2#2)(2008-3#2)
the static culture##2##3##(2008-11#2)
the static images##2##3##(2013-1#2)
the static imaging##2##3##(2008-10#2)
the static interference##2##3##(2013-8#2)
the static mercury drop electrode##4##5##(2008-10#4)
the static##31##2##(1993-9#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#2)(2013-8#3)
the stationarity assumption##2##3##(2008-8#2)
the stationary phase of##2##4##(2008-10#1)(2008-11#1)
the stationary phase was##4##4##(2008-10#3)(2008-7#1)
the stationary phase##35##3##(1990-7#1)(1997-2#1)(2008-10#21)(2008-11#2)(2008-7#6)(2011-1#2)(2011-2#2)
the stationary##43##2##(1990-7#1)(1996-5#2)(1997-2#1)(2008-10#22)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#7)(2008-8#1)(2011-1#2)(2011-2#2)
the statistic is##2##3##(1997-3#1)(2013-8#1)
the statistic##9##2##(1992-6#1)(1997-3#2)(2008-10#2)(2011-2#1)(2013-8#3)
the statistical analysis of the##2##5##(2008-10#1)(2009-11#1)
the statistical analysis of##5##4##(1997-4#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-12#1)
the statistical analysis##11##3##(1996-7#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-12#1)(2013-8#2)
the statistical artifact##2##3##(2008-8#2)
the statistical distribution of##2##4##(2008-1#1)(2009-10#1)
the statistical evaluation##2##3##(2008-11#1)(2011-2#1)
the statistical model##2##3##(2010-5#1)(2013-8#1)
the statistical power of the##2##5##(1992-9#1)(1994-2#1)
the statistical power##4##3##(1992-9#1)(1994-2#1)(2008-8#1)(2012-3#1)
the statistical properties of the##4##5##(2007-11#2)(2008-2#1)(2012-3#1)
the statistical properties of##5##4##(2007-11#2)(2008-2#1)(2008-3#1)(2012-3#1)
the statistical sampling##2##3##(1992-2#2)
the statistical significance of##3##4##(1990-6#1)(2008-4#1)(2010-8#1)
the statistical significance##4##3##(1990-6#1)(2008-4#1)(2010-8#1)(2011-2#1)
the statistical uncertainty##2##3##(2008-10#2)
the statistical##70##2##(1990-6#1)(1990-8#1)(1990-9#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-7#1)(1997-4#2)(2007-11#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#3)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#5)
the statistically significant##3##3##(2008-8#1)(2009-8#1)(2011-2#1)
the statistics of##3##3##(2008-3#2)(2008-8#1)
the statistics##4##2##(1991-2#1)(2008-3#2)(2008-8#1)
the statocysts##2##2##(2008-7#1)(2011-2#1)
the status exchange hypothesis##2##4##(2012-12#2)
the status of the##15##4##(1993-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-6#1)(2009-12#1)(2012-1#1)
the status of these##2##4##(1994-1#1)(2008-11#1)
the status of##46##3##(1992-8#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#4)
the status quo##2##3##(2008-7#1)(2010-12#1)
the status##50##2##(1992-8#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)
the statute and##2##3##(1993-1#1)(1994-2#1)
the statute of##2##3##(1996-5#2)
the statute##8##2##(1993-1#3)(1993-2#1)(1994-2#1)(1996-5#3)
the statutory framework in New York State for the issuance of DNR orders##2##13##(1992-12#1)(1992-3#1)
the statutory##7##2##(1992-12#3)(1992-3#1)(1995-1#1)(1997-7#1)(2008-10#1)
the stay##4##2##(1992-12#4)
the steady state levels of##2##5##(1991-12#1)(1997-2#1)
the steady state##13##3##(1990-5#1)(1991-12#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#4)
the steady##15##2##(1990-5#1)(1991-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2012-1#1)
the steady-state concentration##2##3##(2008-10#1)(2008-6#1)
the steady-state level of##5##4##(1992-1#1)(1992-9#1)(1993-6#1)(1997-1#1)(2008-10#1)
the steady-state levels of##4##4##(1994-5#1)(1994-6#2)(2008-8#1)
the steady-state response##2##3##(2007-9#2)
the steady-state stability##2##3##(2007-12#2)
the steady-state##30##2##(1992-1#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
the steel##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
the steep slopes##2##3##(2008-10#1)(2008-12#1)
the steep##6##2##(1995-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)
the steering committee##2##3##(1995-12#1)(1997-3#1)
the stem cell niche##3##4##(2009-3#1)(2009-8#1)(2012-2#1)
the stem cell population##3##4##(2008-11#2)(2010-7#1)
the stem cell##13##3##(1992-12#1)(1994-11#1)(2008-11#4)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-7#1)(2012-2#1)
the stem of##3##3##(2008-10#1)(2008-9#1)(2009-6#1)
the stem to##3##3##(2008-10#3)
the stem##50##2##(1992-12#1)(1992-3#2)(1994-11#1)(2008-10#22)(2008-11#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the stems##4##2##(2008-10#3)(2008-11#1)
the stenosis##9##2##(1990-3#2)(1995-3#1)(2007-10#2)(2007-8#2)(2008-8#1)(2013-1#1)
the stent##10##2##(1990-8#1)(1994-11#1)(2008-1#1)(2008-11#1)(2008-7#5)(2010-12#1)
the stents##2##2##(2008-7#1)(2013-1#1)
the step cycle##2##3##(1997-2#1)(2007-12#1)
the step size##3##3##(1995-3#1)(2008-3#1)(2011-2#1)
the step##13##2##(1990-11#1)(1991-9#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#4)(2011-2#1)
the step-index##2##2##(2008-3#2)
the stepping##2##2##(1993-12#1)(2013-1#1)
the steps and##2##3##(2010-1#1)(2011-2#1)
the steps for##3##3##(2008-2#1)(2008-4#1)(2012-3#1)
the steps in the##2##4##(2008-1#1)(2008-10#1)
the steps in##3##3##(1992-1#1)(2008-1#1)(2008-10#1)
the steps involved in##5##4##(1992-3#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-4#1)
the steps of the##3##4##(1995-9#1)(2008-3#1)(2008-9#1)
the steps of##5##3##(1995-9#1)(2008-3#1)(2008-4#2)(2008-9#1)
the steps taken to develop##2##5##(1993-1#1)(2010-11#1)
the steps taken##3##3##(1993-1#1)(2010-11#1)(2011-2#1)
the steps to##2##3##(2011-2#1)(2012-12#1)
the steps##31##2##(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-9#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)
the stepwise##7##2##(1995-6#1)(1996-7#1)(2008-10#2)(2008-11#1)(2009-5#1)(2009-9#1)
the stereo##2##2##(2008-2#2)
the stereochemical outcome##2##3##(1995-5#1)(2008-7#1)
the stereochemical##5##2##(1992-7#1)(1992-8#1)(1995-5#1)(2008-10#1)(2008-7#1)
the stereochemistry of the##2##4##(1990-8#1)(1995-5#1)
the stereochemistry of##4##3##(1990-8#1)(1995-5#1)(1996-5#1)(2011-2#1)
the stereocilia of##2##3##(1993-9#2)
the stereoisomers##3##2##(1995-3#1)(2010-2#2)
the stereoselective##2##2##(2007-11#1)(2009-12#1)
the stereoselectivity of##2##3##(1995-5#1)(2008-10#1)
the stereospecific##2##2##(1994-5#1)(2008-10#1)
the steric hindrance##3##3##(2008-10#1)(2012-2#2)
the steric##11##2##(1991-5#1)(1992-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#3)(2012-2#2)(2013-1#1)
the sterile production##2##3##(2012-2#2)
the sterile##8##2##(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#2)
the sterilization##2##2##(1996-8#1)(2008-3#1)
the sternum and##2##3##(2007-8#2)
the sternum##6##2##(2007-8#4)(2012-2#2)
the steroid binding domain of##2##5##(1991-12#1)(1992-12#1)
the steroid binding domain##3##4##(1991-12#2)(1992-12#1)
the steroid binding##4##3##(1990-12#1)(1991-12#2)(1992-12#1)
the steroid hormone receptor##2##4##(1995-6#1)(2008-4#1)
the steroid hormone##3##3##(1995-6#1)(2008-10#1)(2008-4#1)
the steroid##26##2##(1990-11#3)(1990-12#1)(1991-12#2)(1991-5#3)(1992-12#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-6#1)(1997-1#2)(2007-11#1)(2008-10#2)(2008-11#3)(2008-4#2)(2010-2#1)(2012-2#1)
the steroidogenic##2##2##(1990-11#1)(1995-12#1)
the steroids tested##3##3##(1990-11#1)(1994-9#1)(1996-2#1)
the steroids##4##2##(1990-11#1)(1994-9#1)(1996-2#1)(2011-1#1)
the sterol##6##2##(1990-11#1)(1992-3#1)(2008-10#3)(2008-12#1)
the stick insect##3##3##(2007-12#3)
the stick##7##2##(2007-12#3)(2008-5#2)(2009-2#2)
the stiffness and##2##3##(2008-5#1)(2009-7#1)
the stiffness of##4##3##(2008-2#1)(2008-8#1)(2009-4#1)(2013-7#1)
the stiffness##11##2##(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#2)(2012-2#1)(2013-1#2)(2013-7#1)
the stigma and##3##3##(2008-10#2)(2010-8#1)
the stigma##6##2##(2008-10#4)(2008-6#1)(2010-8#1)
the stigmas##2##2##(2008-10#2)
the stigmata of##2##3##(2008-3#1)(2010-6#1)
the still##3##2##(1996-11#1)(2007-12#1)(2009-7#1)
the stillage##2##2##(2008-6#1)(2011-2#1)
the stimulated emission##2##3##(2008-10#1)(2008-2#1)
the stimulated##9##2##(1990-7#1)(1993-11#1)(1995-8#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)
the stimulated-emission##3##2##(2007-11#2)(2008-3#1)
the stimulating effect##3##3##(1994-8#1)(2008-11#1)(2012-3#1)
the stimulating##7##2##(1992-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
the stimulation by##5##3##(1992-11#1)(1995-8#2)(1997-6#1)(2008-4#1)
the stimulation of gene##3##4##(1991-6#1)(1994-11#1)(1997-6#1)
the stimulation of glucose utilization##2##5##(1994-8#2)
the stimulation of human##2##4##(1992-3#1)(1994-11#1)
the stimulation of the##2##4##(1992-9#1)(1997-2#1)
the stimulation of##33##3##(1990-12#2)(1991-12#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#3)(1994-8#2)(1995-12#2)(1995-2#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#5)(2008-9#1)(2010-1#1)(2010-8#1)
the stimulation site##3##3##(1996-5#2)(2008-9#1)
the stimulation##62##2##(1990-12#2)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-9#1)(1993-11#1)(1993-3#3)(1994-11#3)(1994-2#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#2)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#5)(2009-8#3)(2010-1#1)(2010-10#1)(2010-8#1)
the stimulator##2##2##(2010-7#1)(2012-3#1)
the stimulatory action of L-histidine on protein synthesis##2##8##(2008-11#2)
the stimulatory actions of L-leucine and KIC##3##7##(2008-11#3)
the stimulatory and inhibitory##2##4##(1991-5#1)(1994-3#1)
the stimulatory effect of##3##4##(1994-5#1)(1994-6#1)(1997-8#1)
the stimulatory effect##6##3##(1990-12#1)(1992-3#1)(1994-5#1)(1994-6#1)(1997-8#1)(2008-11#1)
the stimulatory##21##2##(1990-12#2)(1991-5#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-11#6)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
the stimuli and##2##3##(2008-7#1)(2008-9#1)
the stimuli at##2##3##(1992-11#2)
the stimuli were presented##2##4##(1992-11#1)(2008-5#1)
the stimuli were##5##3##(1992-11#1)(1993-3#1)(1995-11#1)(2008-5#1)(2008-9#1)
the stimuli##22##2##(1992-11#4)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#2)(2013-8#1)
the stimulus was##2##3##(1990-5#1)(2008-5#1)
the stimulus##29##2##(1990-5#2)(1991-1#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-2#1)(2007-12#1)(2007-9#5)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2010-4#1)(2010-5#1)(2013-8#1)
the stipule##2##2##(2008-5#2)
the stir bar##3##3##(2008-10#3)
the stirred tank##3##3##(2008-10#1)(2008-11#2)
the stirred##5##2##(2008-10#2)(2008-11#3)
the stirring##2##2##(2008-10#1)(2008-11#1)
the stochastic GMM sampler##2##4##(2012-3#2)
the stochastic nature of##3##4##(1997-5#1)(2008-8#1)(2008-9#1)
the stochastic##13##2##(1995-5#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)
the stock##5##2##(1991-1#1)(2008-5#1)(2010-3#2)(2010-8#1)
the stoichiometric composition of the chelate is 1##2##8##(2008-10#2)
the stoichiometric##15##2##(1994-12#1)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-7#3)
the stoichiometry and##3##3##(2008-10#1)(2010-5#1)(2012-2#1)
the stoichiometry is##2##3##(1992-2#1)(1994-11#1)
the stoichiometry of the##6##4##(1993-8#1)(2008-10#4)(2008-7#1)
the stoichiometry of##13##3##(1991-5#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#1)
the stoichiometry##22##2##(1991-5#2)(1992-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)
the stolbur phytoplasma##3##3##(2008-10#3)
the stomach and##9##3##(1991-4#1)(1994-2#1)(1996-3#1)(1997-1#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)
the stomach contents##2##3##(1992-12#1)(2011-2#1)
the stomach in##4##3##(1990-8#1)(1991-6#1)(1993-9#1)(1997-1#1)
the stomach mucosa##2##3##(1992-9#2)
the stomach of##2##3##(1997-1#1)(2011-2#1)
the stomach##77##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-6#1)(1993-9#2)(1994-2#1)(1995-12#1)(1996-3#1)(1997-1#5)(2007-5#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-5#6)(2008-6#1)(2008-7#10)(2009-3#3)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the stomach]##3##2##(1990-11#1)(1990-6#1)(1991-11#1)
the stomachs of##2##3##(2008-5#1)(2010-8#1)
the stomata##2##2##(2008-10#2)
the stomatopod##2##2##(2007-12#2)
the stone##9##2##(1994-5#1)(1997-4#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
the stones were##2##3##(1991-3#1)(2013-7#1)
the stones##3##2##(1991-3#1)(2011-2#1)(2013-7#1)
the stool##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
the stools##3##2##(1991-6#1)(2009-1#1)(2011-1#1)
the stop band##3##3##(2007-12#1)(2008-2#2)
the stop codon of##3##4##(1994-12#1)(1997-6#1)(1997-7#1)
the stop codon##4##3##(1994-12#1)(1997-6#1)(1997-7#1)(2008-9#1)
the stop##8##2##(1994-12#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
the stopped-flow and##2##3##(2008-10#2)
the stopped-flow mixing technique was used##2##6##(2008-10#2)
the stopped-flow mixing technique##5##4##(2008-10#5)
the stopped-flow##9##2##(2008-10#9)
the storage and##2##3##(2008-10#1)(2008-7#1)
the storage capacity and##2##4##(2007-12#1)(2008-3#1)
the storage capacity of##2##4##(2007-12#1)(2008-3#1)
the storage capacity##4##3##(2007-12#2)(2008-3#2)
the storage for##2##3##(1993-12#1)(2013-7#1)
the storage of##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-8#1)
the storage period##2##3##(2008-11#1)(2012-2#1)
the storage stability of the##2##5##(2008-10#1)(2008-5#1)
the storage temperature##2##3##(2008-10#1)(2012-2#1)
the storage time of##2##4##(2007-12#1)(2008-3#1)
the storage time##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
the storage##44##2##(1991-8#1)(1993-12#1)(1995-12#1)(1997-7#1)(2007-12#4)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#3)(2009-7#1)(2010-11#1)(2010-4#1)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
the stored##6##2##(1994-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
the stories##2##2##(2008-11#1)(2008-12#1)
the storm##5##2##(1993-3#1)(2007-3#1)(2008-11#1)(2011-2#2)
the story of##7##3##(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#2)(2011-3#1)(2013-8#1)
the story so far##2##4##(1991-8#1)(2008-7#1)
the story##13##2##(1991-8#1)(1993-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#2)(2011-3#1)(2013-8#2)
the straight line##4##3##(2008-10#4)
the straight##9##2##(1996-5#1)(1996-6#1)(2008-10#5)(2008-7#1)(2009-6#1)
the strain T21##2##3##(2008-8#2)
the strain is##2##3##(1993-3#1)(2008-6#1)
the strain of##5##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)
the strain or the##2##4##(2008-3#1)(2008-5#1)
the strain rate##2##3##(1996-4#1)(2009-7#1)
the strain sensitivity##2##3##(2008-3#1)(2013-8#1)
the strain##42##2##(1991-9#1)(1993-3#1)(1996-12#1)(1996-4#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#2)(2013-8#3)
the strain-induced##2##2##(2008-3#2)
the strains and##4##3##(2008-10#2)(2008-5#1)(2010-4#1)
the strains from##4##3##(1992-2#1)(2008-10#2)(2008-7#1)
the strains in##2##3##(2008-10#1)(2008-5#1)
the strains into##2##3##(2008-10#2)
the strains isolated##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
the strains of##2##3##(2008-10#1)(2013-1#1)
the strains that were##2##4##(2008-10#2)
the strains that##3##3##(2008-10#3)
the strains was##2##3##(1991-3#1)(2008-10#1)
the strains were##9##3##(1996-12#1)(2007-10#1)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
the strains##66##2##(1991-3#1)(1992-2#1)(1993-12#1)(1996-12#3)(1997-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#40)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the strains'##4##2##(2008-10#3)(2008-6#1)
the strand##4##2##(1993-12#1)(1994-9#1)(2008-10#1)(2009-11#1)
the strapped##2##2##(2011-1#2)
the strategic plan##5##3##(1992-3#3)(1994-2#1)(1997-1#1)
the strategic planning process of##2##5##(1994-2#1)(1996-1#1)
the strategic planning process##8##4##(1991-2#1)(1994-2#4)(1996-1#1)(1997-1#2)
the strategic planning##10##3##(1991-2#1)(1994-2#5)(1994-3#1)(1996-1#1)(1997-1#2)
the strategic##30##2##(1991-2#1)(1991-8#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#9)(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-1#4)(2007-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-3#1)
the strategies and##4##3##(1995-3#1)(1996-1#1)(1997-7#1)(2008-11#1)
the strategies employed to##2##4##(2008-10#1)(2011-2#1)
the strategies employed##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
the strategies for##2##3##(2008-2#1)(2008-8#1)
the strategies of##3##3##(2007-2#1)(2010-8#1)(2011-3#1)
the strategies that##2##3##(2008-4#1)(2011-2#1)
the strategies##27##2##(1991-12#1)(1992-1#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
the strategy and##2##3##(1996-1#1)(2008-2#1)
the strategy for the##2##4##(1990-12#1)(1992-8#1)
the strategy of##8##3##(1990-6#1)(1991-1#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
the strategy##34##2##(1990-12#1)(1990-6#1)(1991-1#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#4)(2011-2#3)
the stratification of##2##3##(2013-8#2)
the stratification##3##2##(2007-7#1)(2013-8#2)
the stratigraphic record##2##3##(1997-5#2)
the stratigraphic##3##2##(1997-5#2)(2010-6#1)
the stratosphere##6##2##(1991-5#1)(1991-6#1)(2008-2#2)(2008-3#2)
the stratospheric aerosol##5##3##(2008-2#5)
the stratospheric##7##2##(1996-1#1)(2008-2#5)(2008-3#1)
the stratum corneum (SC)##5##4##(2008-10#1)(2008-5#4)
the stratum corneum and##3##4##(2008-5#3)
the stratum corneum lipids##6##4##(2008-5#6)
the stratum corneum of human skin##2##6##(2008-10#1)(2008-5#1)
the stratum corneum of##3##4##(2008-10#1)(2008-5#2)
the stratum corneum was##3##4##(1992-8#2)(2008-5#1)
the stratum corneum water##2##4##(2008-5#2)
the stratum corneum were##2##4##(2008-5#1)(2012-2#1)
the stratum corneum with##2##4##(2008-5#2)
the stratum corneum##69##3##(1992-8#2)(2008-10#2)(2008-5#62)(2010-8#1)(2012-2#2)
the stratum##71##2##(1992-8#2)(1995-12#1)(2008-10#2)(2008-5#63)(2010-8#1)(2012-2#2)
the straw##3##2##(2008-10#1)(2013-1#2)
the streak##2##2##(2008-2#1)(2008-3#1)
the stream of##5##3##(2008-10#1)(2008-9#1)(2010-10#3)
the stream was##2##3##(2008-10#2)
the stream##13##2##(1995-3#1)(2008-10#6)(2008-9#1)(2009-8#1)(2010-10#3)(2012-12#1)
the streams##4##2##(1993-6#1)(2008-10#3)
the street##2##2##(1996-5#1)(2008-11#1)
the streets##3##2##(1992-5#1)(1995-8#1)(2012-2#1)
the strength and direction of##2##5##(1994-8#1)(2008-8#1)
the strength and##7##3##(1994-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-9#1)(2013-8#1)
the strength of an##2##4##(2008-3#1)(2010-4#1)
the strength of evidence##5##4##(2009-6#1)(2011-1#1)(2012-12#3)
the strength of selection on##2##5##(2008-8#1)(2008-9#1)
the strength of selection##7##4##(2008-8#4)(2008-9#1)(2010-4#1)(2013-1#1)
the strength of the adhesive bond##2##6##(2010-4#2)
the strength of the adhesive##3##5##(2010-4#3)
the strength of the evidence##2##5##(2008-7#1)(2008-8#1)
the strength of the relationship between##2##6##(1994-11#1)(2009-7#1)
the strength of the thermal lens##2##6##(2008-3#2)
the strength of the##29##4##(1993-1#1)(1994-11#1)(1996-4#1)(1997-1#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-2#1)(2010-4#3)(2011-2#1)
the strength of their##2##4##(1997-1#1)(2008-4#1)
the strength of this##2##4##(2007-12#1)(2008-2#1)
the strength of##72##3##(1990-5#1)(1993-1#1)(1994-11#1)(1995-5#1)(1996-4#1)(1997-1#2)(1997-8#3)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-7#2)(2008-8#12)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-4#5)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
the strength##87##2##(1990-5#1)(1993-1#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-8#3)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#13)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#5)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#3)
the strengthening of the##2##4##(1997-8#1)(2008-1#1)
the strengthening of##3##3##(1997-8#1)(2008-1#1)(2011-2#1)
the strengthening##5##2##(1997-8#1)(2008-1#1)(2009-7#2)(2011-2#1)
the strengths and challenges of##2##5##(2008-12#2)
the strengths and limitations of the##2##6##(2012-2#1)(2013-1#1)
the strengths and limitations of##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
the strengths and weakness of the##2##6##(2009-1#1)(2012-2#1)
the strengths and weaknesses of the##2##6##(1992-12#1)(1994-1#1)
the strengths and weaknesses of##4##5##(1992-12#1)(1994-1#1)(2008-11#1)(2011-2#1)
the strengths and weaknesses##5##4##(1992-12#1)(1994-1#1)(2008-11#1)(2009-4#1)(2011-2#1)
the strengths and##13##3##(1992-12#1)(1994-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-1#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
the strengths of the##3##4##(1995-9#1)(1996-2#1)(2008-8#1)
the strengths of these##2##4##(2010-3#1)(2012-2#1)
the strengths of##7##3##(1995-9#1)(1996-2#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
the strengths##22##2##(1991-1#1)(1992-12#1)(1994-1#1)(1995-9#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#3)(2013-1#2)
the streptavidin##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
the streptococcal species##2##3##(2011-1#2)
the stress and strain characteristics##2##5##(2009-4#2)
the stress and strain##3##4##(2008-7#1)(2009-4#2)
the stress and##5##3##(1995-1#1)(2008-7#1)(2009-4#2)(2013-7#1)
the stress field##3##3##(1996-4#1)(2008-2#1)(2008-7#1)
the stress in the##2##4##(2009-7#1)(2010-11#1)
the stress in##3##3##(2009-7#1)(2010-11#1)(2011-2#1)
the stress of##9##3##(1994-12#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)(2013-7#1)(2013-8#1)
the stress regimen##4##3##(2008-11#4)
the stress response to##5##4##(1995-8#3)(1997-2#1)(2008-11#1)
the stress response##7##3##(1995-8#3)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)
the stress tensor##3##3##(2007-11#2)(2008-3#1)
the stress##64##2##(1992-1#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-8#3)(1996-4#3)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-9#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#4)(2013-8#2)
the stress-induced##4##2##(1994-2#2)(1995-12#1)(2007-11#1)
the stressed##6##2##(1995-6#1)(2008-11#1)(2008-3#1)(2009-7#1)(2013-1#2)
the stresses##6##2##(1996-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)
the stressful##3##2##(2008-11#2)(2012-3#1)
the stressor##7##2##(1993-6#2)(1994-12#1)(2008-11#2)(2008-4#1)(2013-8#1)
the stressors##3##2##(1993-6#1)(2011-2#1)(2012-3#1)
the stressosome##4##2##(2009-8#4)
the stretch##5##2##(1990-2#1)(1990-7#1)(1993-9#1)(2008-3#1)(2008-8#1)
the stretch-induced phosphorylation##2##3##(1990-11#2)
the stretch-induced##4##2##(1990-11#2)(1990-12#1)(1990-8#1)
the stretched##2##2##(2008-3#1)(2012-2#1)
the stretching of##2##3##(2007-11#1)(2008-7#1)
the stretching##7##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)
the stria##4##2##(1993-12#1)(1994-2#1)(2008-9#1)(2009-8#1)
the striatal dopamine transporter##3##4##(1996-2#3)
the striatal##10##2##(1993-9#1)(1994-8#1)(1996-2#4)(1996-5#1)(1997-2#1)(2008-7#2)
the striate##3##2##(1994-8#1)(2008-11#1)(2008-8#1)
the striatum and the nucleus accumbens##4##6##(1996-12#2)(1997-3#2)
the striatum and the##5##4##(1996-12#2)(1996-5#1)(1997-3#2)
the striatum and##9##3##(1991-6#1)(1993-12#1)(1996-12#2)(1996-5#2)(1997-3#2)(2008-7#1)
the striatum##39##2##(1991-4#1)(1991-6#3)(1992-7#2)(1993-12#1)(1993-9#1)(1994-2#2)(1995-12#4)(1996-12#4)(1996-5#4)(1997-2#2)(1997-3#2)(2008-10#1)(2008-7#7)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#2)
the strict##7##2##(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2012-2#1)
the strictly##3##2##(1996-6#1)(2007-8#1)(2009-7#1)
the stricture##2##2##(2008-2#1)(2010-12#1)
the striking##10##2##(1997-7#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
the string##2##2##(2007-7#1)(2013-1#1)
the stringency of##2##3##(1995-5#1)(2010-12#1)
the stringent requirements##2##3##(1996-1#1)(2009-5#1)
the stringent##4##2##(1996-1#1)(2008-10#1)(2008-11#1)(2009-5#1)
the strip##5##2##(2007-12#1)(2008-10#2)(2008-5#1)(2012-3#1)
the stripe rust##2##3##(2008-10#2)
the stripe wear##2##3##(2009-7#2)
the stripe##5##2##(2007-12#1)(2008-10#2)(2009-7#2)
the stripping chronopotentiometric##2##3##(2008-10#2)
the stripping of##3##3##(2008-10#3)
the stripping response##2##3##(2008-10#2)
the stripping##14##2##(2008-10#14)
the stroke##15##2##(1995-5#1)(2007-10#2)(2007-8#1)(2008-11#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
the stroma##5##2##(1994-2#1)(1997-3#1)(2008-11#1)(2008-12#1)(2013-8#1)
the stromal cells##2##3##(1994-9#1)(2011-1#1)
the stromal##5##2##(1994-9#1)(1995-11#1)(2007-11#1)(2008-8#1)(2011-1#1)
the strong absorption##2##3##(2008-10#1)(2008-3#1)
the strong and the weak##2##5##(2007-11#1)(2007-12#1)
the strong correlation##2##3##(1993-8#1)(2008-10#1)
the strong influence of##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
the strong spectral##2##3##(2008-10#2)
the strong##63##2##(1990-7#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#5)(2008-7#1)(2008-8#5)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
the stronger##5##2##(1995-2#1)(2008-10#2)(2008-3#1)(2012-3#1)
the strongest association##3##3##(2007-10#1)(2008-10#1)(2008-6#1)
the strongest inhibitor##2##3##(1995-5#1)(2011-2#1)
the strongest inhibitory##2##3##(1990-2#1)(2008-10#1)
the strongest predictors of##2##4##(2007-12#1)(2012-12#1)
the strongest##55##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1995-5#2)(1996-2#2)(1997-3#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the strongly##10##2##(1993-11#1)(1994-9#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-5#1)(2012-2#1)(2012-3#1)
the strontium##2##2##(2008-10#2)
the structural alterations##2##3##(2008-8#1)(2011-2#1)
the structural and functional##9##4##(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
the structural and##12##3##(1995-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
the structural basis for##4##4##(1992-10#1)(1992-4#1)(1995-2#1)(1997-4#1)
the structural basis of##6##4##(1994-8#1)(1997-9#2)(2008-4#1)(2008-9#1)(2009-7#1)
the structural basis##12##3##(1992-10#1)(1992-4#1)(1993-8#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-9#2)(2008-4#2)(2008-9#1)(2009-7#1)
the structural behavior##2##3##(2008-10#1)(2008-2#1)
the structural change of the##2##5##(2008-10#1)(2008-8#1)
the structural change of##3##4##(2008-10#1)(2008-8#2)
the structural changes occurring##2##4##(1991-3#1)(1994-2#1)
the structural changes that occur##2##5##(2008-3#1)(2012-12#1)
the structural changes##8##3##(1991-3#1)(1993-9#1)(1994-2#1)(1997-6#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
the structural characteristics of##2##4##(2008-4#1)(2008-8#1)
the structural characterization of the##2##5##(1997-2#1)(2008-4#1)
the structural characterization##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
the structural components##2##3##(1997-8#1)(2009-10#1)
the structural data##2##3##(1990-12#1)(2009-2#1)
the structural determinants##2##3##(1992-12#1)(2008-8#1)
the structural differences##2##3##(1997-7#1)(2007-11#1)
the structural elements##3##3##(1996-5#1)(2008-9#1)(2010-4#1)
the structural features of##5##4##(1992-10#1)(1994-11#1)(1996-10#1)(2008-8#1)(2009-5#1)
the structural features##9##3##(1992-10#1)(1994-11#1)(1994-5#1)(1996-10#1)(1997-7#1)(2008-10#2)(2008-8#1)(2009-5#1)
the structural formula of##2##4##(1992-9#1)(1995-6#1)
the structural gene encoding##2##4##(1993-9#1)(2008-5#1)
the structural gene of CS3 subunit##2##6##(2008-8#2)
the structural gene##6##3##(1993-9#1)(1994-12#1)(1997-4#1)(2008-5#1)(2008-8#2)
the structural information##3##3##(2007-12#1)(2012-2#1)(2013-1#1)
the structural integrity of the##2##5##(1990-12#1)(2008-7#1)
the structural integrity of##3##4##(1990-12#1)(2008-7#1)(2008-9#1)
the structural interactions##2##3##(2012-2#2)
the structural organization of the##3##5##(2008-10#1)(2008-5#1)(2009-8#1)
the structural organization of##7##4##(1993-2#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-12#1)
the structural organization##9##3##(1990-5#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-12#1)
the structural parameters of##2##4##(2008-10#1)(2008-3#1)
the structural parameters##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
the structural protein##3##3##(1993-9#1)(1995-2#1)(2008-10#1)
the structural requirements for##2##4##(1992-9#1)(2011-2#1)
the structural requirements##3##3##(1992-9#1)(1994-5#1)(2011-2#1)
the structural similarity of##2##4##(1991-6#1)(2008-10#1)
the structural stability of##3##4##(1995-8#3)
the structural##155##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#1)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#2)(2007-11#4)(2007-12#4)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#5)(2008-7#5)(2008-8#9)(2008-9#3)(2009-10#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
the structurally normal heart##2##4##(2009-5#1)(2009-7#1)
the structurally related##7##3##(1990-5#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-5#1)(2008-10#1)(2011-2#1)
the structurally similar##2##3##(1990-5#1)(1995-3#1)
the structurally##15##2##(1990-5#2)(1991-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(2008-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)
the structure and dynamics of the##2##6##(1991-5#1)(2008-4#1)
the structure and dynamics of##5##5##(1991-5#2)(1992-3#1)(2008-4#2)
the structure and expression##2##4##(1992-6#1)(1997-6#1)
the structure and function of proteins##3##6##(1997-4#1)(2008-2#1)(2008-4#1)
the structure and function of the##6##6##(2008-10#2)(2008-5#1)(2008-7#2)(2010-12#1)
the structure and function of##23##5##(1992-11#1)(1992-3#1)(1995-6#2)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)
the structure and the##5##4##(1995-6#2)(2008-10#1)(2008-3#2)
the structure and##64##3##(1990-5#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-6#4)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the structure at##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
the structure determination of##2##4##(2008-4#1)(2012-8#1)
the structure in the##2##4##(2008-4#1)(2008-5#1)
the structure in##3##3##(2008-4#1)(2008-5#2)
the structure is##8##3##(1992-4#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-8#1)
the structure of DNA##2##4##(2007-11#1)(2008-4#1)
the structure of a typical plant MADS box gene##2##9##(1997-2#1)(1997-8#1)
the structure of a##11##4##(1990-7#1)(1992-9#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
the structure of an##2##4##(1990-9#1)(2008-10#1)
the structure of both##2##4##(2008-10#1)(2008-12#1)
the structure of its##2##4##(1990-5#1)(2011-2#1)
the structure of the##74##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-1#1)(2007-12#3)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
the structure of these##2##4##(2009-9#1)(2012-12#1)
the structure of two##2##4##(1992-4#1)(2008-3#1)
the structure of which##2##4##(2008-11#1)(2008-7#1)
the structure of##160##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-11#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2008-10#15)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the structure shows##2##3##(1995-5#1)(2007-12#1)
the structure was##4##3##(1992-3#1)(1995-5#1)(2007-11#1)(2010-10#1)
the structure##308##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#4)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#8)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#3)(1992-9#3)(1993-11#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#4)(1994-11#1)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#6)(1995-5#3)(1995-6#5)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#9)(2007-12#11)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#10)(2008-12#5)(2008-2#6)(2008-3#16)(2008-4#17)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#9)(2009-11#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#4)
the structure-activity##4##2##(1991-3#1)(1994-11#1)(2008-11#1)(2008-4#1)
the structure-function relationship of##3##4##(1994-11#1)(2008-5#1)(2008-8#1)
the structure-function relationships in##2##4##(1990-7#1)(1994-8#1)
the structure-function relationships##3##3##(1990-7#1)(1992-8#1)(1994-8#1)
the structure-function##8##2##(1990-7#1)(1992-8#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-5#2)(2008-8#1)
the structure-property##2##2##(2007-11#1)(2009-7#1)
the structured##5##2##(2008-11#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)
the structures and emulsifying properties of caseins##3##7##(2013-8#3)
the structures and##7##3##(2007-5#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-8#3)
the structures involved##2##3##(2008-5#1)(2011-2#1)
the structures of substrates##2##4##(1994-8#1)(2008-10#1)
the structures of the##5##4##(1996-5#1)(2008-10#2)(2008-4#2)
the structures of##19##3##(1990-7#1)(1992-9#1)(1994-8#2)(1995-3#1)(1996-5#2)(2008-10#5)(2008-4#3)(2008-7#1)(2008-8#2)(2010-6#1)
the structures that##2##3##(1992-11#1)(2008-7#1)
the structures##42##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-4#1)(1992-9#1)(1994-3#1)(1994-8#3)(1995-3#1)(1996-5#2)(2006-12#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#3)
the structuring of##5##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(2008-10#1)
the structuring##8##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
the struggle##2##2##(1995-2#1)(2009-10#1)
the student and the##2##4##(2008-11#2)
the student experience##4##3##(2008-11#4)
the student nurse##2##3##(2008-11#2)
the student to##2##3##(2008-12#1)(2012-2#1)
the student##26##2##(1993-1#1)(1996-2#1)(2008-11#18)(2008-12#3)(2008-7#1)(2010-3#1)(2012-2#1)
the student's##5##2##(2008-11#4)(2009-7#1)
the students and##6##3##(2008-11#2)(2008-12#1)(2010-3#1)(2013-8#2)
the students delivered between##2##4##(2013-1#2)
the students in##5##3##(1992-6#1)(2008-11#3)(2008-12#1)
the students to##3##3##(1993-1#1)(2008-11#1)(2013-8#1)
the students were##3##3##(2008-11#1)(2008-12#1)(2010-3#1)
the students##64##2##(1991-9#1)(1992-6#7)(1993-1#1)(1993-3#4)(2008-11#24)(2008-12#4)(2009-5#1)(2010-10#1)(2010-3#3)(2012-3#1)(2013-1#7)(2013-8#10)
the students' experiences##4##3##(2008-11#2)(2008-12#1)(2009-8#1)
the students' needs##3##3##(1995-1#1)(2008-12#1)(2012-3#1)
the students' perceptions of##3##4##(2008-11#2)(2012-3#1)
the students' perceptions##4##3##(2008-11#2)(2009-7#1)(2012-3#1)
the students'##25##2##(1995-1#1)(2008-11#9)(2008-12#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2012-3#5)(2013-8#2)
the studied HS##2##3##(2008-10#2)
the studied area##2##3##(1991-6#1)(2008-10#1)
the studied case##2##3##(2008-10#1)(2008-2#1)
the studied compounds##5##3##(2008-10#4)(2008-5#1)
the studied conditions##2##3##(2008-10#1)(2013-1#1)
the studied drugs with##2##4##(2008-10#2)
the studied drugs##5##3##(2008-10#5)
the studied gene##2##3##(2008-2#1)(2012-3#1)
the studied metals##3##3##(2008-10#3)
the studied parameters##2##3##(2008-12#1)(2008-7#1)
the studied population##4##3##(2008-3#1)(2009-1#1)(2010-8#1)(2013-1#1)
the studied species##2##3##(2008-7#1)(2009-2#1)
the studied##96##2##(1990-6#1)(1991-6#1)(1993-2#1)(1994-2#1)(1996-5#1)(1997-2#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-10#49)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2009-1#1)(2009-2#2)(2010-3#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#6)(2013-8#2)
the studies are##3##3##(1992-3#1)(2008-12#1)(2011-2#1)
the studies have##2##3##(2008-10#1)(2012-3#1)
the studies in the##2##4##(2008-12#1)(2011-1#1)
the studies is##3##3##(1996-9#1)(2011-1#1)(2011-2#1)
the studies of##12##3##(1992-3#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2011-2#1)
the studies on##7##3##(1994-6#1)(2008-10#3)(2008-8#1)(2012-1#1)(2013-7#1)
the studies reported##2##3##(2008-10#1)(2011-2#1)
the studies suggest##2##3##(1990-6#1)(2012-3#1)
the studies that have##2##4##(1992-3#1)(2007-8#1)
the studies we##2##3##(2008-3#2)
the studies##79##2##(1990-6#1)(1992-11#2)(1992-3#4)(1993-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-9#5)(1997-1#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)
the study and application of##2##5##(2008-10#1)(2008-5#1)
the study and therapy of testicular##2##6##(2007-5#2)
the study and were##3##4##(2008-11#1)(2011-2#2)
the study and##27##3##(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
the study are##6##3##(1997-8#1)(2007-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
the study area##14##3##(1995-9#2)(2008-12#4)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the study areas##2##3##(1995-3#1)(2013-1#1)
the study as##2##3##(1992-11#1)(1997-5#1)
the study by##4##3##(2008-10#2)(2008-12#1)(2009-6#1)
the study cohort and a##2##5##(2009-10#2)
the study cohort and##3##4##(2009-10#3)
the study cohort##4##3##(2009-10#4)
the study consisted of##2##4##(2008-10#1)(2012-1#1)
the study counties##2##3##(1991-3#2)
the study design and##3##4##(2007-7#1)(2009-4#1)(2011-1#1)
the study design##8##3##(1997-7#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#1)
the study duration##2##3##(2012-3#2)
the study findings##3##3##(1991-12#1)(1993-12#1)(2008-7#1)
the study focuses on##2##4##(2008-11#1)(2010-12#1)
the study for##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the study found##2##3##(1995-3#1)(2011-2#1)
the study group and##2##4##(2009-10#1)(2011-1#1)
the study group was##2##4##(2007-7#1)(2008-1#1)
the study group##17##3##(1991-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-6#2)(2009-10#4)(2011-1#3)(2013-1#1)
the study groups##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
the study has##3##3##(1997-3#1)(2008-12#1)(2011-2#1)
the study have since##2##4##(1997-1#1)(2007-10#1)
the study in which##2##4##(2010-9#1)(2012-2#1)
the study in##6##3##(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2012-2#1)
the study included##6##3##(1992-2#1)(1996-1#2)(1997-8#1)(2008-11#1)(2010-3#1)
the study indicates##2##3##(1990-2#1)(2013-8#1)
the study is the##2##4##(2007-11#1)(2010-11#1)
the study is##26##3##(1990-2#1)(1993-3#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-3#3)(2013-1#2)(2013-8#1)
the study of a##7##4##(1990-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2012-3#1)
the study of an##2##4##(2008-7#1)(2013-8#1)
the study of ancient##2##4##(2008-10#2)
the study of biofilms##2##4##(2008-9#2)
the study of bladder tumors and##2##6##(2007-10#2)
the study of cell##2##4##(2008-1#1)(2008-9#1)
the study of cerebral##2##4##(1990-5#1)(2008-7#1)
the study of cholesterol##2##4##(1993-3#1)(2013-1#1)
the study of colloidal##2##4##(2007-11#1)(2008-3#1)
the study of evolution##2##4##(2008-8#1)(2010-5#1)
the study of fundamental##2##4##(2007-11#1)(2008-7#1)
the study of gene expression and##2##6##(2008-4#1)(2008-9#1)
the study of gene expression##3##5##(2008-4#2)(2008-9#1)
the study of gene##4##4##(2007-6#1)(2008-4#2)(2008-9#1)
the study of human disease##2##5##(2008-4#1)(2008-7#1)
the study of human##8##4##(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2012-3#1)
the study of its##2##4##(1990-7#1)(2008-7#1)
the study of local##2##4##(2008-7#1)(2013-8#1)
the study of neural##2##4##(2008-4#1)(2008-7#1)
the study of other##3##4##(2007-12#1)(2008-3#1)(2012-3#1)
the study of plant##3##4##(2008-9#1)(2013-8#2)
the study of specific##2##4##(1995-6#1)(2008-7#1)
the study of the mechanism of##2##6##(1991-5#1)(2008-9#1)
the study of the optical##3##5##(2008-3#3)
the study of the regulation of##2##6##(1991-9#1)(2008-11#1)
the study of the relationship##2##5##(2008-10#1)(2008-8#1)
the study of the##53##4##(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1994-11#2)(1994-9#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
the study of these##5##4##(1994-8#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
the study of two##4##4##(1990-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
the study of##314##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-9#4)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-6#1)(2007-7#3)(2008-1#7)(2008-10#49)(2008-11#14)(2008-12#2)(2008-2#10)(2008-3#16)(2008-4#19)(2008-5#3)(2008-6#1)(2008-7#18)(2008-8#12)(2008-9#18)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#8)(2011-3#3)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#6)(2013-8#6)
the study on##4##3##(2008-10#2)(2008-9#1)(2010-3#1)
the study participants##5##3##(2008-12#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
the study patients and controls##2##5##(2008-1#2)
the study patients were##3##4##(2007-7#1)(2008-1#2)
the study patients##11##3##(2007-7#1)(2008-1#9)(2013-1#1)
the study period for##2##4##(2006-8#2)
the study period was##3##4##(2006-8#1)(2010-3#1)(2012-12#1)
the study period##50##3##(1992-5#1)(1994-12#1)(1997-5#1)(2006-8#8)(2007-10#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#2)
the study population was##4##4##(2007-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
the study population##18##3##(1990-2#1)(1993-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
the study provided##2##3##(1992-12#1)(2007-7#1)
the study reported##3##3##(1992-3#1)(2011-2#1)(2013-8#1)
the study results##4##3##(1992-12#1)(2007-7#1)(2007-8#1)(2008-7#1)
the study showed good##2##4##(1990-6#1)(2008-10#1)
the study showed that##6##4##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the study showed##9##3##(1990-6#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the study site##3##3##(2008-10#2)(2008-5#1)
the study sites##3##3##(2008-12#2)(2012-12#1)
the study subjects##6##3##(1990-8#1)(1992-12#1)(1994-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
the study the##3##3##(2007-8#1)(2008-12#2)
the study to##10##3##(1991-2#1)(1992-12#1)(1992-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#1)(2012-3#1)
the study using##2##3##(2008-3#1)(2008-7#1)
the study was descriptive##2##4##(1993-3#1)(2010-3#1)
the study was retrospective##2##4##(2007-11#1)(2012-3#1)
the study was##110##3##(1990-2#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-12#2)(1996-3#2)(1996-6#1)(1996-9#3)(1997-8#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#5)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#3)
the study were##19##3##(1990-10#2)(1991-1#1)(1992-12#1)(1992-3#1)(1996-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-1#1)(2012-3#2)
the study will##2##3##(2007-7#1)(2011-2#1)
the study with##2##3##(2008-10#1)(2008-3#1)
the study would##2##3##(1994-5#1)(1994-9#1)
the study##1108##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#7)(1991-6#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#2)(1992-9#1)(1993-1#6)(1993-12#8)(1993-2#3)(1993-3#4)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#8)(1996-12#5)(1996-3#7)(1996-5#3)(1996-6#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#5)(2006-10#2)(2006-6#1)(2006-8#10)(2007-10#14)(2007-11#21)(2007-12#10)(2007-2#4)(2007-5#4)(2007-6#2)(2007-7#30)(2007-8#16)(2007-9#1)(2008-1#32)(2008-10#100)(2008-11#44)(2008-12#31)(2008-2#11)(2008-3#28)(2008-4#23)(2008-5#37)(2008-6#9)(2008-7#61)(2008-8#26)(2008-9#60)(2009-10#10)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#7)(2010-10#3)(2010-11#8)(2010-12#2)(2010-2#3)(2010-3#12)(2010-4#5)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#9)(2010-9#4)(2011-1#33)(2011-10#1)(2011-2#55)(2011-3#5)(2012-1#3)(2012-12#15)(2012-2#19)(2012-3#26)(2013-1#48)(2013-7#3)(2013-8#20)
the study's##4##2##(1995-1#2)(1996-1#1)(2012-3#1)
the stump##3##2##(1991-6#1)(2007-11#1)(2007-8#1)
the stunned##2##2##(1996-9#2)
the stunning##3##2##(1996-9#1)(2011-1#2)
the style##5##2##(2008-10#2)(2009-12#3)
the stylet is##2##3##(2010-8#2)
the stylet##4##2##(2008-10#2)(2010-8#2)
the sub##4##2##(2007-8#1)(2008-10#2)(2008-12#1)
the sub-groups##3##2##(2007-7#1)(2008-2#2)
the sub-isoforms of##2##3##(2008-10#2)
the sub-nanogram##2##2##(2008-10#2)
the sub-surface##2##2##(2009-7#2)
the subacute##4##2##(1994-12#1)(2008-8#1)(2011-2#2)
the subapical##2##2##(2008-10#1)(2008-7#1)
the subarachnoid space##9##3##(2008-7#9)
the subarachnoid##15##2##(1995-11#1)(2007-10#1)(2008-7#12)(2009-6#1)
the subcapsular space##2##3##(2013-1#2)
the subcapsular##4##2##(2012-2#1)(2012-3#1)(2013-1#2)
the subcellular distribution of the##2##5##(1993-9#1)(1996-5#1)
the subcellular distribution of##3##4##(1993-9#1)(1994-10#1)(1996-5#1)
the subcellular localization of##5##4##(1992-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)
the subcellular locations of##2##4##(2008-4#1)(2011-2#1)
the subcellular targeting##2##3##(2012-12#2)
the subcellular##15##2##(1992-6#1)(1993-9#1)(1994-10#1)(1996-5#1)(1996-9#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#3)
the subchannel##2##2##(2007-11#2)
the subclass##3##2##(1993-12#1)(2008-8#1)(2009-9#1)
the subclavian artery##5##3##(1993-3#2)(2008-7#2)(2009-3#1)
the subclavian vein##3##3##(2008-1#1)(2012-2#2)
the subclavian##9##2##(1993-3#2)(2008-1#1)(2008-7#3)(2009-3#1)(2012-2#2)
the subclavicular approach##2##3##(2012-12#2)
the subclavicular##3##2##(2012-12#3)
the subcontinent##2##2##(2007-2#1)(2008-10#1)
the subcutaneous tissue##3##3##(2008-5#1)(2008-9#1)(2011-1#1)
the subcutaneous##11##2##(1990-12#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
the subesophageal ganglion##4##3##(2007-12#1)(2008-5#2)(2008-9#1)
the subfamily Pooideae##3##3##(2008-10#2)(2008-8#1)
the subfamily##9##2##(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-3#1)(2013-7#1)(2013-8#1)
the subfields##2##2##(1995-3#2)
the subfornical organ##3##3##(1994-2#2)(2008-4#1)
the subgingival##2##2##(2008-12#1)(2008-5#1)
the subgroup I##2##3##(2008-10#2)
the subgroup of##5##3##(2006-10#1)(2008-10#1)(2008-5#2)(2008-8#1)
the subgroup##12##2##(1994-12#1)(2006-10#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)
the subgroups##2##2##(1991-6#1)(2008-7#1)
the subisolates##2##2##(2008-10#2)
the subjacent##2##2##(1997-3#1)(2008-1#1)
the subject and##3##3##(1995-12#1)(1997-2#1)(2008-11#1)
the subject group##2##3##(2007-10#2)
the subject has##2##3##(2008-11#1)(2011-2#1)
the subject is##5##3##(1994-11#1)(1996-12#1)(2008-9#1)(2010-4#1)(2010-8#1)
the subject matter##2##3##(2008-11#1)(2008-12#1)
the subject of a##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
the subject of increasing##2##4##(1996-3#1)(2011-2#1)
the subject of the##4##4##(1992-2#1)(1993-6#1)(2009-7#1)(2011-1#1)
the subject of this##2##4##(2008-10#1)(2011-2#1)
the subject of##42##3##(1990-2#1)(1991-1#1)(1992-2#2)(1993-11#1)(1993-6#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-7#1)
the subject to relax in the later part of expiration##2##10##(2008-7#2)
the subject to##4##3##(1995-12#1)(2008-7#2)(2013-1#1)
the subject was##4##3##(1991-3#1)(1996-3#1)(2008-12#1)(2008-9#1)
the subject##97##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#4)(2009-1#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
the subject's own##2##3##(2007-6#1)(2013-8#1)
the subject's##10##2##(1992-1#1)(1994-8#1)(2007-6#2)(2008-11#1)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
the subjective fluctuation##2##3##(2013-1#2)
the subjective magnitude of##2##4##(1992-12#2)
the subjective night##3##3##(1994-2#1)(1995-12#1)(2008-5#1)
the subjective norm##2##3##(1993-12#2)
the subjective##24##2##(1990-3#1)(1992-12#2)(1993-12#2)(1994-2#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-9#1)(2008-5#3)(2008-9#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the subjects had##3##3##(2008-6#1)(2008-7#1)(2012-12#1)
the subjects have##2##3##(1992-3#1)(2008-3#1)
the subjects of this study##2##5##(2007-7#2)
the subjects of##3##3##(2007-7#2)(2012-3#1)
the subjects were##11##3##(1991-2#1)(1992-1#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-5#1)(2008-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
the subjects with##6##3##(2008-5#3)(2008-7#3)
the subjects##75##2##(1990-10#4)(1990-3#2)(1991-2#4)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-1#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2006-8#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#8)(2008-6#2)(2008-7#9)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#4)
the subjects'##3##2##(2008-4#1)(2011-2#1)(2013-8#1)
the submandibular##5##2##(1995-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
the submental##3##2##(2013-1#3)
the submerged##2##2##(2008-5#1)(2011-2#1)
the submicrometer##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
the submillimeter##5##2##(2008-2#3)(2008-3#2)
the submucosa##4##2##(1993-12#1)(1995-3#1)(2008-1#1)(2011-2#1)
the submucosal plane##2##3##(1993-9#2)
the submucosal##5##2##(1992-2#1)(1993-9#2)(2008-1#1)(2008-12#1)
the suboccipital##2##2##(2008-7#1)(2010-9#1)
the suborder##2##2##(1993-3#1)(2011-2#1)
the subordinate##2##2##(2008-8#2)
the subphase##6##2##(1991-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-2#2)
the subpopulation##2##2##(2008-10#2)
the subpopulations##3##2##(1995-12#1)(2008-10#2)
the subregions##4##2##(2007-8#1)(2008-3#3)
the subscales##3##2##(2007-2#1)(2010-11#1)(2012-2#1)
the subscapularis and infraspinatus insertions##2##5##(2012-12#2)
the subscapularis##3##2##(2012-12#3)
the subscripts s and p##2##5##(2008-3#2)
the subscripts##3##2##(2008-10#1)(2008-3#2)
the subsequent 12##2##3##(2008-1#1)(2011-2#1)
the subsequent 2##2##3##(1996-2#1)(2011-1#1)
the subsequent detection of##2##4##(2008-10#1)(2008-7#1)
the subsequent development of##6##4##(1991-12#1)(1992-10#1)(1993-6#1)(1997-6#1)(2008-10#1)(2008-7#1)
the subsequent immune response##2##4##(2008-4#2)
the subsequent oxidative##2##3##(2008-10#1)(2008-11#1)
the subsequent reaction of the##2##5##(1992-8#1)(2008-10#1)
the subsequent reaction of##3##4##(1992-8#1)(2008-10#2)
the subsequent reaction##5##3##(1991-11#1)(1992-8#1)(1993-3#1)(2008-10#2)
the subsequent##124##2##(1990-11#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#4)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the subset of##7##3##(1992-10#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-2#1)
the subset##9##2##(1992-10#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
the subspecies##2##2##(2008-10#2)
the subspecies-specific##2##2##(2008-10#1)(2011-1#1)
the substance P##2##3##(1993-8#1)(2013-8#1)
the substance in##2##3##(2008-10#1)(2008-5#1)
the substance of##3##3##(1993-12#1)(2008-5#1)(2013-1#1)
the substance##17##2##(1990-6#2)(1993-12#1)(1993-8#1)(1995-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-9#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
the substances##12##2##(1993-12#1)(1994-12#1)(1995-2#2)(1997-2#1)(2007-12#1)(2008-10#2)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
the substantia nigra (SN) and##2##5##(1994-2#1)(2012-2#1)
the substantia nigra (SN)##3##4##(1994-2#1)(2008-7#1)(2012-2#1)
the substantia nigra and the ventral##2##6##(1996-12#1)(2008-7#1)
the substantia nigra and the##4##5##(1996-12#1)(2008-7#3)
the substantia nigra and##6##4##(1996-12#1)(2008-7#5)
the substantia nigra in##2##4##(1992-10#1)(1995-5#1)
the substantia nigra pars compacta (SNpc)##2##6##(1995-3#1)(1996-12#1)
the substantia nigra pars compacta##4##5##(1995-3#1)(1996-12#2)(2008-7#1)
the substantia nigra pars reticulata##2##5##(1995-2#1)(2008-12#1)
the substantia nigra pars##6##4##(1995-2#1)(1995-3#1)(1996-12#2)(2008-12#1)(2008-7#1)
the substantia nigra##33##3##(1990-5#3)(1992-10#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#4)(1997-3#1)(1997-7#1)(2008-12#1)(2008-7#9)(2012-12#1)(2012-2#1)
the substantia##34##2##(1990-5#3)(1992-10#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#4)(1997-2#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-7#9)(2012-12#1)(2012-2#1)
the substantial impact##2##3##(2008-8#1)(2012-12#1)
the substantial##11##2##(1991-3#1)(1991-5#1)(1994-8#1)(1997-1#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
the substituent##5##2##(1994-5#1)(2007-11#1)(2008-10#3)
the substituents of##2##3##(1997-7#1)(2008-10#1)
the substituents##6##2##(1992-8#1)(1996-2#1)(1997-7#2)(2008-10#1)(2009-7#1)
the substituted##5##2##(1993-11#1)(1995-2#1)(1996-5#1)(1997-6#1)(2008-10#1)
the substitution of##12##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2011-1#1)
the substitution pattern##2##3##(2008-10#2)
the substitution reaction##2##3##(2008-10#2)
the substitution##22##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)
the substomatal##3##2##(2008-10#3)
the substrate and the##4##4##(1994-5#1)(2008-4#1)(2012-2#1)(2013-8#1)
the substrate and##12##3##(1994-5#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
the substrate are##3##3##(1992-3#1)(2007-12#1)(2008-2#1)
the substrate as##2##3##(2008-10#1)(2008-2#1)
the substrate at##2##3##(1991-9#1)(2008-10#1)
the substrate binding##4##3##(1992-11#1)(1992-6#1)(1994-5#1)(1995-5#1)
the substrate by##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
the substrate catechol##2##3##(2008-10#2)
the substrate concentration##3##3##(2008-5#2)(2010-10#1)
the substrate during##2##3##(1992-3#1)(2008-5#1)
the substrate for the##2##4##(1992-9#1)(1995-11#1)
the substrate for##6##3##(1992-9#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#1)
the substrate from##2##3##(2008-10#2)
the substrate in##7##3##(1990-5#1)(1994-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
the substrate into##2##3##(1990-5#1)(1994-11#1)
the substrate is##6##3##(1992-6#1)(1994-3#1)(2008-1#1)(2008-2#2)(2008-3#1)
the substrate of##4##3##(2008-10#2)(2009-9#1)(2013-1#1)
the substrate reactivity##2##3##(2008-7#2)
the substrate specificities##2##3##(1994-12#1)(2010-3#1)
the substrate specificity of##5##4##(1990-5#1)(1990-8#1)(2008-4#1)(2008-7#1)(2013-1#1)
the substrate specificity##9##3##(1990-5#3)(1990-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
the substrate surface##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
the substrate to the##2##4##(1994-5#1)(2008-2#1)
the substrate to##5##3##(1994-5#1)(2008-2#1)(2008-3#2)(2008-6#1)
the substrate was##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
the substrate with##2##3##(2008-10#1)(2008-3#1)
the substrate##181##2##(1990-11#2)(1990-12#1)(1990-5#8)(1990-8#4)(1990-9#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#6)(1992-6#5)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#4)(1994-6#1)(1995-11#1)(1995-2#3)(1995-5#2)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#2)(2008-2#11)(2008-3#23)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#13)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
the substrate's##4##2##(1996-2#1)(2008-3#3)
the substrate-binding site of##3##4##(1992-8#2)(1995-3#1)
the substrate-binding site##4##3##(1992-6#1)(1992-8#2)(1995-3#1)
the substrate-binding##5##2##(1992-6#1)(1992-8#2)(1995-3#1)(2008-6#1)
the substrates and##2##3##(1991-3#1)(1992-3#1)
the substrates is##2##3##(1990-7#1)(2008-10#1)
the substrates##20##2##(1990-7#3)(1991-3#1)(1992-3#1)(1993-6#2)(1993-8#1)(1994-5#4)(1994-6#1)(1996-2#1)(2008-10#4)(2008-3#1)(2010-12#1)
the substratum##3##2##(2007-5#1)(2008-11#1)(2008-9#1)
the subsurface##4##2##(1997-5#1)(2008-2#1)(2009-8#2)
the subsynovial connective tissue (SSCT)##2##5##(2008-9#2)
the subsynovial connective tissue##3##4##(2008-9#3)
the subtalar joint##2##3##(2010-3#1)(2012-2#1)
the subthalamic nucleus (STN)##2##4##(2009-8#1)(2010-12#1)
the subthalamic nucleus##5##3##(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)
the subtle##3##2##(2010-10#1)(2010-11#1)(2013-8#1)
the subtraction of##2##3##(2008-3#2)
the subtraction##5##2##(1995-4#2)(2008-3#3)
the subunit composition of##3##4##(1990-5#1)(1991-10#1)(2008-4#1)
the subunit interface##3##3##(1990-8#2)(1995-2#1)
the subunit##14##2##(1990-5#1)(1990-8#3)(1991-10#1)(1991-12#2)(1992-8#2)(1995-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)
the subunits of##2##3##(2008-2#1)(2011-2#1)
the subunits##10##2##(1990-8#1)(1991-12#1)(1992-3#3)(2008-2#1)(2008-9#2)(2009-9#1)(2011-2#1)
the suburban##2##2##(2008-10#1)(2008-3#1)
the subwavelength##2##2##(2007-11#2)
the success and##5##3##(1997-6#1)(2007-12#1)(2008-7#1)(2010-11#2)
the success of TQM applications##2##5##(2008-12#2)
the success of a##2##4##(1991-2#1)(2008-12#1)
the success of an##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
the success of percutaneous##2##4##(1990-8#1)(2008-12#1)
the success of the##7##4##(1990-9#1)(1994-2#1)(1996-3#1)(2008-11#1)(2010-8#1)(2012-2#2)
the success of their##3##4##(1991-8#1)(1992-3#1)(1994-12#1)
the success of these##2##4##(2008-10#1)(2008-11#1)
the success of this approach##2##5##(2008-11#1)(2009-6#1)
the success of this##8##4##(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2013-8#1)
the success of treatment##2##4##(2008-11#1)(2008-5#1)
the success of##84##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-12#3)(1994-2#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#4)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#9)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
the success or failure of##4##5##(2008-10#2)(2008-12#1)(2008-4#1)
the success rate for##3##4##(1991-12#1)(2008-3#1)(2011-2#1)
the success rate over##2##4##(2008-11#2)
the success rate##10##3##(1991-12#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
the success##106##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-3#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#4)(1997-6#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#11)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#5)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
the successful application of##6##4##(1995-11#1)(1995-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
the successful cloning##2##3##(1991-5#1)(2010-6#1)
the successful implementation of##5##4##(1992-1#1)(1994-3#1)(2008-10#1)(2008-7#1)(2010-3#1)
the successful implementation##6##3##(1992-1#1)(1994-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-3#1)
the successful management of a##3##5##(2007-8#2)(2008-10#1)
the successful management of##6##4##(1994-3#1)(2007-8#2)(2008-10#1)(2011-2#2)
the successful operation of##2##4##(2008-3#2)
the successful outcome of##2##4##(1991-6#1)(2008-11#1)
the successful treatment of##2##4##(1994-6#1)(2009-10#1)
the successful use of##4##4##(1990-8#1)(2007-8#1)(2008-10#1)(2008-11#1)
the successful##75##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-3#1)(1997-4#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)
the successive cultures##2##3##(2008-11#2)
the successive determination of##4##4##(2008-10#4)
the successive##13##2##(1990-6#1)(1995-12#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)
the successive-order-of-scattering##2##2##(2008-3#2)
the succinate##2##2##(1990-11#1)(1993-11#1)
the such##2##2##(2008-10#1)(2008-12#1)
the sudden infant death syndrome (SIDS)##3##6##(1991-11#1)(1992-11#1)(1993-12#1)
the sudden infant death syndrome##6##5##(1991-11#1)(1992-11#1)(1993-12#2)(2009-8#1)(2013-1#1)
the sudden##14##2##(1991-11#1)(1991-9#1)(1992-11#2)(1993-12#2)(1996-11#1)(2008-10#3)(2009-8#1)(2010-5#1)(2013-1#2)
the sufferers##2##2##(2009-7#1)(2010-8#1)
the suffering of##2##3##(1991-8#1)(2008-9#1)
the suffering##3##2##(1991-8#1)(2008-12#1)(2008-9#1)
the sufficient##2##2##(2008-10#1)(2012-12#1)
the sugar beet##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
the sugar moiety##3##3##(1992-6#1)(1995-12#1)(2008-4#1)
the sugar recovery##2##3##(2013-1#2)
the sugar##21##2##(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2011-1#1)(2013-1#2)
the sugars##5##2##(1990-2#1)(2008-10#2)(2008-6#1)(2011-1#1)
the suggested##12##2##(1992-2#1)(1992-8#1)(1993-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
the suggestion of##2##3##(2008-10#1)(2008-6#1)
the suggestion that the##3##4##(1990-11#1)(1993-12#1)(1995-6#1)
the suggestion that##14##3##(1990-11#1)(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#2)(1995-6#1)(1995-8#1)(1997-4#1)(2007-12#2)(2008-7#1)(2011-2#1)(2013-1#1)
the suggestion##19##2##(1990-11#2)(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
the suggestions made##2##3##(1994-11#1)(2011-2#1)
the suicidal act##3##3##(2010-6#3)
the suicidal##8##2##(2008-7#1)(2010-6#7)
the suicide rates of##2##4##(2013-1#2)
the suicide rates##4##3##(1991-12#1)(1996-1#1)(2013-1#2)
the suicide##6##2##(1991-12#1)(1996-1#1)(2008-9#1)(2010-6#1)(2013-1#2)
the suitability of a##2##4##(1992-6#1)(2007-11#1)
the suitability of different##2##4##(2008-10#1)(2013-1#1)
the suitability of the##14##4##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-1#1)
the suitability of these##2##4##(1996-3#1)(2008-2#1)
the suitability of this##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
the suitability of##42##3##(1992-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-8#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
the suitability##43##2##(1992-6#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-11#2)(2007-8#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
the suitable##9##2##(2007-11#1)(2008-10#5)(2008-3#1)(2008-8#1)(2012-12#1)
the sulcal##4##2##(1994-3#3)(1996-5#1)
the sulfate anion##2##3##(2008-10#2)
the sulfate ion##4##3##(2008-10#4)
the sulfate##9##2##(1992-12#1)(2008-10#6)(2008-7#1)(2011-2#1)
the sulfated##2##2##(1991-2#1)(1992-10#1)
the sulfhydryl group of##2##4##(1995-5#1)(2009-11#1)
the sulfhydryl group##4##3##(1995-5#1)(1995-6#1)(2008-10#1)(2009-11#1)
the sulfhydryl##9##2##(1992-12#1)(1992-6#2)(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-11#1)
the sulfide##2##2##(1991-8#1)(2008-10#1)
the sulfonic##2##2##(2008-10#2)
the sulfonylureas##2##2##(1992-3#2)
the sulfur atoms##2##3##(1995-3#1)(1996-5#1)
the sulfur##7##2##(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-11#1)
the sulphate##2##2##(2012-7#2)
the sulphonylureas##2##2##(1994-8#2)
the sulphur##2##2##(2008-10#2)
the sulphuric acid##2##3##(2008-10#2)
the sum frequency##2##3##(2007-12#1)(2008-2#1)
the sum of all##3##4##(1991-12#1)(1995-3#1)(2008-10#1)
the sum of its##2##4##(2008-11#1)(2008-3#1)
the sum of the concentrations of##2##6##(2008-10#2)
the sum of the concentrations##3##5##(2008-10#3)
the sum of the##17##4##(1990-6#1)(1991-12#1)(1995-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#1)
the sum of##39##3##(1990-6#1)(1991-12#2)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)
the sum##49##2##(1990-6#1)(1991-12#2)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-3#2)(2010-8#1)(2011-2#1)
the summary of##2##3##(1994-11#1)(2012-3#1)
the summary##3##2##(1994-11#1)(2008-5#1)(2012-3#1)
the summation of##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
the summation##5##2##(2007-11#1)(2008-10#1)(2008-2#2)(2009-8#1)
the summed##2##2##(2008-12#1)(2012-2#1)
the summer and##2##3##(2008-5#2)
the summer months##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
the summer of 1991##2##4##(1995-11#1)(1997-1#1)
the summer of 2000##2##4##(2008-10#1)(2008-11#1)
the summer of##14##3##(1990-9#1)(1991-1#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-1#1)
the summer##32##2##(1990-9#1)(1991-1#1)(1995-1#1)(1995-11#2)(1996-1#1)(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2011-1#1)(2013-8#2)
the sun and##5##3##(1991-6#1)(1994-3#2)(2008-2#1)(2008-3#1)
the sun protection##2##3##(2008-5#2)
the sun##20##2##(1991-6#3)(1992-7#1)(1993-3#1)(1994-3#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-8#1)(2011-2#4)
the sun's##2##2##(1991-8#1)(2009-8#1)
the sunburn##2##2##(2008-5#2)
the sunflower##2##2##(2008-10#2)
the sunlight intensity##4##3##(2008-6#4)
the sunlight##6##2##(2008-5#1)(2008-6#4)(2011-2#1)
the sunscreen derived from##2##4##(2008-5#2)
the sunscreen tester##2##3##(2008-5#2)
the sunscreen##8##2##(2008-5#8)
the super family##2##3##(2009-10#1)(2013-8#1)
the super modified simplex##2##4##(2008-10#2)
the super##6##2##(1991-12#1)(2007-12#1)(2008-10#2)(2009-10#1)(2013-8#1)
the superconducting##5##2##(1992-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
the supercontinuum from##2##3##(2007-11#2)
the supercontinuum##4##2##(2007-11#4)
the supercritical##3##2##(2008-10#1)(2009-6#1)(2012-2#1)
the superfamily of##5##3##(1992-11#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-11#1)
the superfamily##6##2##(1992-11#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
the superficial and deep##2##4##(1993-12#1)(2011-2#1)
the superficial femoral vein##2##4##(2007-7#1)(2008-1#1)
the superficial femoral##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
the superficial layer##3##3##(1996-12#1)(2008-2#2)
the superficial##28##2##(1990-5#1)(1992-6#1)(1993-12#2)(1994-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-5#7)(2008-9#1)(2011-2#3)(2011-3#1)(2013-8#1)
the superior colliculus##4##3##(1991-5#3)(1993-3#1)
the superior competitor##2##3##(2008-8#2)
the superior lumbar space##2##4##(1993-9#2)
the superior mesenteric##8##3##(1990-3#1)(1991-5#1)(2007-5#1)(2012-3#1)(2013-1#4)
the superior parietal lobule##2##4##(1996-2#1)(1996-5#1)
the superior performance of##2##4##(2007-8#1)(2008-2#1)
the superior sagittal sinus##2##4##(1997-3#1)(2008-7#1)
the superior temporal sulcus##3##4##(2008-11#2)(2009-10#1)
the superior temporal##4##3##(1996-7#1)(2008-11#2)(2009-10#1)
the superior vena cava (SVC)##2##5##(2007-8#1)(2011-2#1)
the superior vena cava##8##4##(2007-7#1)(2007-8#4)(2008-12#1)(2008-7#1)(2011-2#1)
the superior##60##2##(1990-3#1)(1991-5#4)(1991-6#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#7)
the superiority of one##2##4##(1996-9#1)(2012-12#1)
the superiority of the##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
the superiority of##13##3##(1994-6#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
the superiority##15##2##(1994-6#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
the superlattice##2##2##(2007-12#2)
the supermodes##2##2##(2007-11#1)(2008-3#1)
the supernatant and##3##3##(2008-11#3)
the supernatant fraction##4##3##(1992-12#2)(1995-3#1)(2008-10#1)
the supernatant is##2##3##(2008-10#1)(2008-4#1)
the supernatant of the##2##4##(2008-10#1)(2008-2#1)
the supernatant of##7##3##(1994-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2013-1#1)
the supernatant was##6##3##(1990-2#1)(2008-10#3)(2008-11#1)(2008-5#1)
the supernatant##34##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#1)(1994-2#2)(1995-3#1)(1995-6#1)(2008-10#7)(2008-11#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#1)(2013-8#1)
the supernatants##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
the supernumerary spacing##2##3##(2008-3#2)
the supernumerary##4##2##(1990-5#1)(2008-3#3)
the superoxide anion and##2##4##(1990-5#1)(2008-11#1)
the superoxide anion##7##3##(1990-5#2)(1993-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
the superoxide dismutase##2##3##(1990-11#1)(1990-5#1)
the superoxide radical##2##3##(1990-5#1)(1992-12#1)
the superoxide##14##2##(1990-11#1)(1990-5#5)(1991-12#1)(1992-12#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-5#1)
the superposition of##4##3##(2008-3#4)
the superposition##5##2##(2008-3#5)
the supersonic##2##2##(2008-3#2)
the superstrate##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the superstructure##2##2##(2008-2#1)(2008-3#1)
the supervised##2##2##(2008-3#1)(2010-9#1)
the supervision of a##2##4##(2008-11#1)(2012-12#1)
the supervision of##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
the supervision##5##2##(1992-11#1)(1995-6#1)(2008-11#1)(2008-12#1)(2012-12#1)
the supine position##4##3##(2010-3#1)(2011-2#2)(2012-3#1)
the supine##6##2##(1992-4#1)(1994-3#1)(2010-3#1)(2011-2#2)(2012-3#1)
the supplement on##2##3##(2008-9#1)(2011-1#1)
the supplement##8##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#4)
the supplemental##3##2##(1994-1#1)(2008-7#1)(2013-7#1)
the supplementation of##2##3##(2008-11#2)
the supplementation##6##2##(2008-11#3)(2008-5#1)(2008-8#1)(2011-1#1)
the supply of transplantable##2##4##(1991-3#2)
the supply of volunteers##2##4##(1994-3#2)
the supply of##21##3##(1991-2#1)(1991-3#3)(1991-9#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-9#1)(2012-2#1)
the supply##23##2##(1991-2#1)(1991-3#3)(1991-9#1)(1992-3#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#4)(1994-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
the support and##2##3##(1992-12#1)(1994-12#1)
the support for##2##3##(2008-11#1)(2010-8#1)
the support group##2##3##(2007-8#1)(2008-11#1)
the support of a##3##4##(1991-2#1)(2007-8#1)(2008-2#1)
the support of the##3##4##(1997-6#1)(2008-1#1)(2008-6#1)
the support of##18##3##(1991-2#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)
the support received##2##3##(1992-3#1)(2011-2#1)
the support##52##2##(1990-2#1)(1990-7#2)(1991-2#1)(1992-12#2)(1992-3#2)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-6#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
the supported##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
the supporting electrolyte was##2##4##(2008-10#2)
the supporting electrolyte##9##3##(2008-10#9)
the supporting##20##2##(1994-12#1)(1994-3#1)(1996-1#1)(2007-8#1)(2008-10#12)(2008-6#1)(2009-4#1)(2010-5#1)(2012-3#1)
the supportive##6##2##(1997-2#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#2)
the supports##2##2##(1997-3#1)(2008-10#1)
the supposed##3##2##(1994-11#1)(2007-7#1)(2008-10#1)
the suppressed##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
the suppression of B##2##4##(2008-10#2)
the suppression of disease##3##4##(1997-8#1)(2008-10#2)
the suppression of the##7##4##(1993-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
the suppression of##47##3##(1990-12#1)(1991-5#1)(1992-12#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#18)(2008-11#6)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#4)(2009-8#1)(2010-1#1)(2010-2#1)
the suppression##52##2##(1990-12#1)(1991-5#1)(1992-12#1)(1993-12#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#19)(2008-11#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#5)(2009-8#1)(2010-1#1)(2010-2#1)
the suppressive effect of##2##4##(2008-10#1)(2008-5#1)
the suppressive effect##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
the suppressive effects of##4##4##(1994-10#1)(1996-5#1)(2008-10#1)(2008-5#1)
the suppressive effects##5##3##(1994-10#1)(1996-5#1)(2008-10#2)(2008-5#1)
the suppressive soil##4##3##(2008-10#4)
the suppressive##14##2##(1994-10#1)(1996-5#1)(2008-10#8)(2008-4#1)(2008-5#2)(2009-8#1)
the suppressiveness of##2##3##(2008-10#2)
the suprachiasmatic nucleus##3##3##(1993-12#1)(1994-5#1)(1997-6#1)
the suprachiasmatic##4##2##(1993-12#1)(1994-2#1)(1994-5#1)(1997-6#1)
the supraclavicular##3##2##(1997-8#1)(2008-7#2)
the suprahepatic inferior vena cava##2##5##(1992-9#2)
the supramaximal inhibition of pancreatic##2##5##(1992-8#2)
the supramaximal##3##2##(1992-8#2)(2013-8#1)
the supraoptic nucleus##2##3##(1993-12#1)(1995-12#1)
the suprapubic##2##2##(1994-9#1)(2008-10#1)
the supraslice region##2##3##(2012-1#2)
the supraspinal##2##2##(1997-2#2)
the supraspinatus##2##2##(1991-4#1)(1992-9#1)
the surface LIDT##2##3##(2007-11#2)
the surface and the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the surface and##17##3##(1997-1#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-9#2)(2009-3#1)(2013-1#1)
the surface are##2##3##(2008-3#2)
the surface area of the##2##5##(1997-2#1)(2008-9#1)
the surface area of##3##4##(1997-2#1)(2008-5#1)(2008-9#1)
the surface area##8##3##(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#2)
the surface boron doped diamond electrode##2##6##(2008-10#2)
the surface by##2##3##(2008-3#1)(2010-12#1)
the surface characteristics of the##3##5##(1992-3#1)(2008-11#1)(2008-3#1)
the surface concentration of##2##4##(1991-8#1)(2008-10#1)
the surface coverage##2##3##(2008-10#2)
the surface dose##3##3##(2008-3#3)
the surface figure##2##3##(2008-3#2)
the surface flux density##2##4##(2008-2#2)
the surface flux##3##3##(2008-10#1)(2008-2#2)
the surface from##2##3##(2008-2#1)(2008-5#1)
the surface in##2##3##(2008-10#1)(2008-3#1)
the surface is##8##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)
the surface layers##3##3##(2008-3#1)(2008-5#2)
the surface may be##2##4##(1996-4#1)(2008-3#1)
the surface modification##3##3##(2008-10#3)
the surface morphologies of##2##4##(2008-10#1)(2008-2#1)
the surface morphology of##2##4##(2008-3#1)(2008-7#1)
the surface morphology##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
the surface of Au##2##4##(2008-8#1)(2009-11#1)
the surface of CCPE##2##4##(2008-10#2)
the surface of a disposable carbon screen-printed electrode##2##8##(2008-10#2)
the surface of a glassy carbon electrode##5##7##(1990-12#1)(2008-10#4)
the surface of a thin##2##5##(2008-2#1)(2008-3#1)
the surface of a##35##4##(1990-12#1)(1990-5#1)(2007-12#2)(2008-10#16)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)
the surface of an##6##4##(2008-10#3)(2008-3#2)(2010-5#1)
the surface of both##2##4##(1993-6#1)(2008-10#1)
the surface of human##4##4##(1994-11#1)(1995-2#1)(1996-2#2)
the surface of infected##3##4##(2008-10#3)
the surface of lipstick##2##4##(2008-5#2)
the surface of one of##2##5##(2008-1#1)(2008-3#1)
the surface of silica gel##3##5##(2008-10#3)
the surface of solid##2##4##(1994-8#1)(2008-11#1)
the surface of target cells and##2##6##(2010-10#1)(2011-1#1)
the surface of target cells##3##5##(2006-10#1)(2010-10#1)(2011-1#1)
the surface of the cells##2##5##(2008-10#1)(2013-1#1)
the surface of the lipid##2##5##(1994-3#1)(2008-11#1)
the surface of the membrane##4##5##(2008-10#2)(2008-4#2)
the surface of the modified electrodes##2##6##(2008-10#2)
the surface of the modified##3##5##(2008-10#3)
the surface of the molecule##2##5##(2008-4#2)
the surface of the skin##3##5##(2008-3#1)(2008-5#2)
the surface of the solid##2##5##(1990-12#1)(2008-10#1)
the surface of the##110##4##(1990-12#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#3)(1994-3#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#46)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
the surface of these##3##4##(2007-11#1)(2008-11#1)(2009-12#1)
the surface of zoosporangia##2##4##(2008-10#2)
the surface of##269##3##(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-3#1)(1994-8#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#3)(2007-12#6)(2007-6#1)(2008-1#1)(2008-10#113)(2008-11#11)(2008-12#1)(2008-2#8)(2008-3#17)(2008-4#8)(2008-5#13)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#2)
the surface or the##2##4##(2007-11#1)(2008-2#1)
the surface or##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
the surface plane##2##3##(2007-12#1)(2008-3#1)
the surface plasmon resonance##2##4##(1995-12#1)(2008-10#1)
the surface pressure##3##3##(1994-3#1)(1994-6#1)(1997-2#1)
the surface profile of##2##4##(2007-12#1)(2008-2#1)
the surface profile##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the surface reflectance##4##3##(2008-2#1)(2008-3#3)
the surface residues##2##3##(2008-10#2)
the surface roughness of the##2##5##(2008-3#2)
the surface roughness of##3##4##(2008-10#1)(2008-3#2)
the surface roughness parameters##2##4##(2009-7#2)
the surface roughness##10##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-7#2)
the surface shape of##2##4##(2008-3#2)
the surface species##2##3##(2008-10#1)(2008-2#1)
the surface structure and the##2##5##(2007-12#1)(2013-1#1)
the surface structure of##2##4##(1997-6#1)(2008-11#1)
the surface structure##4##3##(1997-6#1)(2007-12#1)(2008-11#1)(2013-1#1)
the surface temperature##2##3##(2008-7#2)
the surface tension and viscosity of##2##6##(2008-3#1)(2013-8#1)
the surface tension lowering of##2##5##(2008-10#2)
the surface tension lowering##3##4##(2008-10#3)
the surface tension##12##3##(2008-10#7)(2008-3#1)(2008-8#1)(2009-6#1)(2010-2#1)(2013-8#1)
the surface through##2##3##(2008-2#1)(2008-3#1)
the surface to the##3##4##(2008-3#1)(2008-6#1)(2009-12#1)
the surface to##4##3##(2008-3#2)(2008-6#1)(2009-12#1)
the surface topology##2##3##(2008-10#1)(2008-2#1)
the surface velocity of##4##4##(2008-2#2)(2008-3#2)
the surface was determined##2##4##(2008-10#1)(2008-3#1)
the surface was##7##3##(1991-5#1)(2008-10#4)(2008-11#1)(2008-3#1)
the surface were##2##3##(2008-11#1)(2009-7#1)
the surface which##4##3##(2008-5#2)(2009-7#1)(2013-8#1)
the surface with a##2##4##(2008-10#1)(2008-3#1)
the surface with##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
the surface##583##2##(1990-12#5)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-3#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#12)(2007-12#17)(2007-6#1)(2008-1#1)(2008-10#174)(2008-11#20)(2008-12#1)(2008-2#36)(2008-3#92)(2008-4#13)(2008-5#36)(2008-6#6)(2008-7#14)(2008-8#9)(2008-9#5)(2009-11#5)(2009-12#2)(2009-3#2)(2009-6#3)(2009-7#9)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#10)(2013-8#9)
the surface-plasmon resonance##2##3##(2008-3#2)
the surface-plasmon##4##2##(2008-2#1)(2008-3#3)
the surface-reflected radiance##2##3##(2008-3#2)
the surfaces and##3##3##(2008-7#1)(2013-8#2)
the surfaces of contact between##2##5##(1994-5#2)
the surfaces of the##8##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#1)
the surfaces of these##2##4##(2008-10#1)(2008-5#1)
the surfaces of##19##3##(1994-11#1)(1994-5#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-3#1)(2010-7#1)(2010-8#1)(2013-1#1)
the surfaces##32##2##(1994-11#1)(1994-5#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#2)
the surfactant and the##2##4##(2008-10#1)(2008-5#1)
the surfactant and##5##3##(2008-10#1)(2008-5#2)(2009-12#2)
the surfactant concentration##2##3##(2008-10#2)
the surfactant in the##2##4##(1996-5#1)(2008-10#1)
the surfactant solution##2##3##(2008-10#1)(2008-5#1)
the surfactant##33##2##(1990-11#1)(1990-12#1)(1994-9#1)(1996-5#2)(1997-1#1)(1997-2#1)(2008-10#15)(2008-5#6)(2008-7#1)(2009-12#3)(2013-8#1)
the surfactant-rich phase##7##3##(2008-10#5)(2008-7#2)
the surfactants##10##2##(1996-5#2)(2008-10#3)(2008-5#4)(2012-2#1)
the surge of##2##3##(2011-1#1)(2012-2#1)
the surgeon and##3##3##(2007-11#1)(2007-12#2)
the surgeon in##3##3##(1993-9#1)(2008-10#1)(2012-12#1)
the surgeon is##2##3##(1993-11#1)(2007-12#1)
the surgeon to##9##3##(1992-12#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
the surgeon##44##2##(1992-12#2)(1993-1#1)(1993-11#1)(1993-9#1)(1996-12#1)(2007-11#3)(2007-12#5)(2007-8#4)(2007-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)
the surgeon's experience##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
the surgeon's##7##2##(1990-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-5#1)(2011-2#1)
the surgeons##7##2##(1993-9#1)(2007-11#1)(2008-7#2)(2008-9#1)(2009-7#1)(2013-1#1)
the surgery and the##2##4##(2008-7#1)(2009-4#1)
the surgery and##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
the surgery of##4##3##(2008-7#2)(2008-9#2)
the surgery##36##2##(1990-9#1)(1994-2#1)(2006-12#1)(2007-11#5)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#3)(2013-8#1)
the surgical and##2##3##(2008-9#1)(2011-2#1)
the surgical approach to##2##4##(2008-10#1)(2010-8#1)
the surgical approach##6##3##(1990-6#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
the surgical aspects##2##3##(2008-10#1)(2012-2#1)
the surgical field##5##3##(1996-1#1)(2008-9#2)(2010-8#1)(2012-12#1)
the surgical indications##4##3##(1990-6#1)(1991-6#1)(2010-12#1)(2013-1#1)
the surgical intervention is##2##4##(1991-3#1)(1995-5#1)
the surgical intervention##5##3##(1991-3#1)(1993-5#1)(1995-5#1)(2013-1#1)(2013-8#1)
the surgical management of breast carcinoma##2##6##(1994-12#2)
the surgical management of breast##3##5##(1994-12#2)(2008-1#1)
the surgical management of the##2##5##(2010-3#1)(2013-1#1)
the surgical management of##12##4##(1994-12#2)(2008-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#2)
the surgical management##13##3##(1992-1#1)(1994-12#2)(2008-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#2)
the surgical margin achieved##2##4##(2008-6#2)
the surgical methods##2##3##(2007-8#1)(2008-9#1)
the surgical outcome##3##3##(1991-2#1)(2010-3#1)(2013-8#1)
the surgical procedure##14##3##(1990-9#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the surgical procedures##4##3##(1996-9#1)(2007-11#1)(2012-12#1)(2012-2#1)
the surgical repair##2##3##(2010-3#1)(2013-1#1)
the surgical site##3##3##(2008-10#1)(2010-3#1)(2010-6#1)
the surgical technique and##2##4##(1997-2#1)(2013-1#1)
the surgical technique##4##3##(1997-2#1)(2007-7#1)(2009-3#1)(2013-1#1)
the surgical techniques##4##3##(1990-3#1)(1990-6#2)(1992-9#1)
the surgical treatment by##2##4##(1990-5#1)(2010-7#1)
the surgical treatment of cancer of the##2##7##(1990-3#1)(1990-9#1)
the surgical treatment of##15##4##(1990-3#2)(1990-9#1)(1991-3#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#2)
the surgical treatment was##2##4##(1990-3#1)(1993-9#1)
the surgical treatment##27##3##(1990-3#3)(1990-5#1)(1990-9#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
the surgical##158##2##(1990-3#4)(1990-5#2)(1990-6#4)(1990-9#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#3)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-9#2)(1997-2#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#8)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#6)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#17)(2011-3#2)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#11)(2013-8#4)
the surgically resected##2##3##(2008-7#2)
the surgically##5##2##(1990-6#1)(1992-9#1)(2008-7#2)(2010-3#1)
the surprising##2##2##(2008-10#1)(2012-2#1)
the surrogate##2##2##(1995-6#1)(2008-10#1)
the surrounding area##3##3##(1995-11#2)(2007-11#1)
the surrounding environment##6##3##(1993-3#1)(1995-6#1)(2008-7#1)(2010-10#1)(2013-1#2)
the surrounding matrix##2##3##(2008-8#2)
the surrounding media##3##3##(2008-3#1)(2010-2#1)(2011-1#1)
the surrounding medium##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
the surrounding normal tissue##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the surrounding normal##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
the surrounding soft##2##3##(2008-9#2)
the surrounding structures##3##3##(1993-6#1)(2007-12#1)(2012-2#1)
the surrounding tissue##3##3##(1990-11#1)(1997-4#1)(2013-1#1)
the surrounding tissues##5##3##(1990-6#1)(1993-11#1)(2007-12#1)(2011-2#1)(2012-12#1)
the surrounding##81##2##(1990-11#1)(1990-6#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1995-11#2)(1995-3#1)(1995-6#3)(1996-4#1)(1997-4#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#5)(2008-9#2)(2009-11#1)(2009-6#2)(2010-10#1)(2010-2#2)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)
the surroundings##4##2##(1995-2#1)(1996-3#1)(2008-3#1)(2009-7#1)
the surveillance of##5##3##(1995-3#1)(2007-7#1)(2008-10#1)(2010-4#1)(2012-3#1)
the surveillance##16##2##(1992-9#2)(1995-3#1)(1996-11#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-8#2)
the survey and##2##3##(2008-10#1)(2010-3#1)
the survey responses##3##3##(1993-1#1)(1995-1#1)(2008-12#1)
the survey were##4##3##(1991-12#1)(1996-1#1)(2007-7#1)(2008-10#1)
the survey##63##2##(1990-3#4)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#3)(1995-12#3)(1995-3#1)(1995-8#1)(1996-1#3)(1997-1#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#7)(2008-5#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
the surveyed##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
the survival and growth of##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
the survival and##16##3##(1993-9#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-12#1)
the survival curve##5##3##(1995-3#4)(1997-4#1)
the survival function##2##3##(1995-12#1)(2008-10#1)
the survival of cultured##2##4##(1996-5#1)(2013-7#1)
the survival of patients with##4##5##(2008-11#1)(2008-2#1)(2008-6#1)(2010-3#1)
the survival of patients##6##4##(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-8#1)
the survival of the##10##4##(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the survival of##62##3##(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#2)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#6)(2008-6#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
the survival rate of##3##4##(1991-12#1)(2010-8#1)(2011-2#1)
the survival rate##12##3##(1991-12#1)(1994-5#1)(1995-3#1)(1997-7#2)(2008-11#1)(2008-6#1)(2010-3#1)(2010-8#1)(2011-2#3)
the survival time of##4##4##(1992-3#1)(2007-11#1)(2008-8#1)(2013-1#1)
the survival time##6##3##(1992-3#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-8#1)(2013-1#1)
the survival was##2##3##(2008-9#1)(2013-7#1)
the survival##123##2##(1990-12#1)(1990-3#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-7#1)(1995-12#2)(1995-3#5)(1996-12#2)(1996-2#1)(1996-5#2)(1997-4#4)(1997-7#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#3)(2013-8#1)
the surviving##13##2##(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(2007-7#1)(2008-5#1)(2008-9#4)(2010-11#1)(2010-4#1)
the survivorship##5##2##(2008-8#1)(2008-9#2)(2011-2#2)
the susceptibility levels##2##3##(2008-12#1)(2012-12#1)
the susceptibility of the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the susceptibility of##23##3##(1991-12#1)(1992-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the susceptibility to##15##3##(1990-6#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#5)(2011-2#3)(2013-8#1)
the susceptibility##49##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-8#2)(2007-12#1)(2008-10#10)(2008-12#3)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#7)(2011-2#5)(2012-12#2)(2012-3#1)(2013-8#1)
the susceptible and##2##3##(2008-10#2)
the susceptible control##2##3##(2008-10#2)
the susceptible controls##2##3##(2008-10#1)(2011-2#1)
the susceptible cultivar##11##3##(2008-10#11)
the susceptible cultivars##2##3##(2008-10#2)
the susceptible cv##8##3##(2008-10#8)
the susceptible genotype##4##3##(2008-10#4)
the susceptible genotypes##2##3##(2008-10#2)
the susceptible inbred B73 and##2##5##(2008-10#2)
the susceptible line##2##3##(2008-10#2)
the susceptible parent B73##2##4##(2008-10#2)
the susceptible parent##7##3##(2008-10#7)
the susceptible plants##2##3##(2008-10#2)
the susceptible##73##2##(1994-9#1)(1996-12#1)(2008-10#67)(2008-5#2)(2011-10#1)(2011-2#1)
the suspect##2##2##(1996-11#1)(2013-1#1)
the suspected##7##2##(1990-6#1)(1997-3#1)(2007-12#1)(2008-4#1)(2009-1#1)(2011-2#1)(2012-2#1)
the suspended particulate##2##3##(2008-10#1)(2008-2#1)
the suspended##9##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-7#1)
the suspension culture##5##3##(2008-11#5)
the suspension##14##2##(1990-12#1)(2007-12#1)(2008-10#3)(2008-11#8)(2008-6#1)
the suspensor##2##2##(2009-8#2)
the suspicion of##5##3##(2007-10#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-1#1)
the suspicion##6##2##(2007-10#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
the sustainability of treatment programs##2##5##(2012-2#2)
the sustainability of##6##3##(1997-7#1)(2009-8#1)(2012-2#4)
the sustainable growth rate system##2##5##(2008-4#2)
the sustainable##3##2##(2008-12#1)(2008-4#2)
the sustained##6##2##(1991-8#1)(1994-6#1)(1997-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
the suture##2##2##(1996-3#1)(2008-5#1)
the sweating##2##2##(2008-5#1)(2009-12#1)
the sweep rate was##2##4##(2008-10#2)
the sweep##3##2##(2007-12#1)(2008-10#2)
the sweetness of##2##3##(2008-10#1)(2008-5#1)
the sweetpotato##2##2##(2008-10#1)(2011-2#1)
the swelling##4##2##(2008-10#1)(2008-5#1)(2010-11#1)(2013-8#1)
the swim##3##2##(1990-8#1)(1997-4#1)(2010-5#1)
the swing##3##2##(2010-3#1)(2011-2#2)
the swing-bed##2##2##(1991-1#1)(1994-2#1)
the switch between##3##3##(1990-11#1)(2008-10#1)(2009-8#1)
the switch from##2##3##(2008-1#1)(2011-1#1)
the switch in##2##3##(1992-11#1)(1997-2#1)
the switch to##3##3##(2008-11#1)(2009-3#1)(2013-1#1)
the switch##15##2##(1990-11#1)(1992-11#1)(1996-7#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
the switched##2##2##(1992-3#1)(2008-2#1)
the switching voltage##2##3##(2008-2#1)(2008-7#1)
the switching##11##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)(2008-7#2)(2011-1#1)
the swollen lamellar##2##3##(2008-5#2)
the swollen##8##2##(2008-10#1)(2008-12#1)(2008-5#3)(2009-5#1)(2011-2#1)(2012-12#1)
the syconia of##2##3##(2008-10#2)
the syllable##3##2##(2013-8#3)
the sylvatic##2##2##(2009-7#2)
the symbiont##4##2##(2007-12#1)(2008-10#1)(2011-2#2)
the symbiosis##2##2##(2008-8#1)(2009-8#1)
the symbiotic##4##2##(2007-12#1)(2008-11#3)
the symbolic##3##2##(1991-12#1)(2008-3#1)(2011-3#1)
the symmetric##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
the symmetrical selection##3##3##(1997-5#3)
the symmetrical##6##2##(1993-11#1)(1997-5#3)(2007-12#1)(2008-10#1)
the symmetrically##2##2##(2009-2#1)(2012-3#1)
the symmetry constraint##2##3##(2008-3#2)
the symmetry of the##2##4##(1997-7#1)(2007-11#1)
the symmetry of##5##3##(1997-7#1)(2007-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
the symmetry##9##2##(1997-2#1)(1997-7#1)(2007-11#2)(2008-3#3)(2008-8#1)(2013-8#1)
the sympathetic innervation##4##3##(1994-5#3)(1995-3#1)
the sympathetic nerve##2##3##(1993-1#1)(1994-5#1)
the sympathetic sprouting in the##2##5##(2008-9#2)
the sympathetic##19##2##(1990-12#1)(1990-9#1)(1991-2#1)(1993-1#1)(1994-5#4)(1995-12#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#1)
the sympathovagal##2##2##(2011-2#1)(2012-2#1)
the symphysis pubis##3##3##(1994-3#1)(2012-12#2)
the symphysis##4##2##(1990-6#1)(1994-3#1)(2012-12#2)
the symposium##8##2##(2008-10#1)(2008-5#7)
the symptom complex##2##3##(1991-11#1)(1997-2#1)
the symptom of##2##3##(2013-8#2)
the symptom severity##2##3##(2008-10#2)
the symptom##13##2##(1991-11#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#3)(2013-8#3)
the symptomatic##8##2##(1990-6#1)(1993-1#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
the symptomatology of##2##3##(1997-8#1)(2009-10#1)
the symptomatology##8##2##(1990-11#1)(1992-11#1)(1996-9#1)(1997-8#1)(2008-10#1)(2009-10#1)(2009-9#1)(2013-1#1)
the symptoms and signs of##3##5##(1990-2#1)(2008-10#1)(2011-3#1)
the symptoms and##11##3##(1990-2#1)(1991-12#1)(1992-9#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)(2011-3#2)
the symptoms are##3##3##(1995-8#1)(2010-8#1)(2012-2#1)
the symptoms as##2##3##(2011-1#1)(2011-2#1)
the symptoms disappeared after##2##4##(1997-6#1)(2008-5#1)
the symptoms disappeared##3##3##(1991-2#1)(1997-6#1)(2008-5#1)
the symptoms in##2##3##(1997-8#1)(2008-10#1)
the symptoms may##2##3##(2010-8#1)(2013-1#1)
the symptoms of psychosis##3##4##(2007-6#3)
the symptoms of this##2##4##(1997-3#1)(2008-7#1)
the symptoms of##31##3##(1993-6#1)(1994-12#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-6#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2013-8#2)
the symptoms##107##2##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-6#3)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#6)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the synapse##7##2##(1991-12#1)(2008-7#2)(2009-11#1)(2009-8#2)(2009-9#1)
the synapsins##3##2##(1994-8#3)
the synaptic cleft##3##3##(1991-12#1)(2008-3#1)(2008-7#1)
the synaptic vesicle##2##3##(1996-12#1)(2008-1#1)
the synaptic##14##2##(1991-12#1)(1991-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
the synchronization of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
the synchronization##7##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)
the synchronized##4##2##(2007-11#1)(2008-11#1)(2013-1#2)
the synchronous##5##2##(2008-10#2)(2008-3#3)
the syndrome and##4##3##(1990-2#1)(1992-5#1)(2007-11#1)(2008-1#1)
the syndrome is##3##3##(1990-2#1)(2008-7#1)(2008-8#1)
the syndrome of##6##3##(1990-9#1)(1993-11#1)(1995-5#1)(1997-3#1)(2011-1#1)(2013-8#1)
the syndrome##37##2##(1990-2#4)(1990-9#2)(1991-11#1)(1991-12#1)(1992-5#2)(1993-11#2)(1995-5#1)(1995-8#1)(1997-3#3)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the syndromes##3##2##(1990-5#1)(2008-10#1)(2011-1#1)
the synergic effect##2##3##(2008-10#1)(2008-11#1)
the synergism of##2##3##(1994-6#1)(2008-8#1)
the synergism##6##2##(1994-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
the synergistic action of##2##4##(1992-9#1)(2008-4#1)
the synergistic effect of##3##4##(2008-10#1)(2008-11#1)(2012-6#1)
the synergistic effect##5##3##(2008-10#3)(2008-11#1)(2012-6#1)
the synergistic##14##2##(1992-9#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-6#1)
the synergy between##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
the syngeneic##2##2##(1992-9#2)
the synonymy of##2##3##(2008-10#2)
the synovial fluid##2##3##(2011-1#2)
the synovial joints##2##3##(2012-2#1)(2012-3#1)
the synovial##13##2##(1992-3#1)(1992-4#1)(1993-2#1)(1994-8#1)(1996-6#1)(2008-5#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
the syntenic##2##2##(2008-10#2)
the syntheses of##4##3##(1991-6#1)(2008-10#1)(2008-12#1)(2009-5#1)
the syntheses##5##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)
the synthesis and characterization of a##2##6##(2008-10#1)(2010-4#1)
the synthesis and characterization of##5##5##(2008-10#2)(2008-4#2)(2010-4#1)
the synthesis and degradation of##2##5##(2011-2#1)(2013-1#1)
the synthesis and release of##4##5##(1994-9#1)(1995-11#1)(2008-9#1)(2013-7#1)
the synthesis and##26##3##(1992-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the synthesis of 5'-deoxyxanthosine##2##4##(1990-8#2)
the synthesis of a series of##2##6##(2008-12#1)(2009-12#1)
the synthesis of a##7##4##(1995-6#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-12#1)(2012-2#1)
the synthesis of an##2##4##(1996-5#1)(2009-5#1)
the synthesis of cell##2##4##(2008-10#1)(2008-6#1)
the synthesis of modified##2##4##(2008-2#1)(2012-2#1)
the synthesis of natural##3##4##(1992-11#2)(2009-10#1)
the synthesis of new##4##4##(2008-10#1)(2008-4#1)(2010-4#1)(2010-5#1)
the synthesis of nucleoside##2##4##(2008-4#2)
the synthesis of oligodeoxyribonucleotides##2##4##(2008-4#2)
the synthesis of osteocalcin##2##4##(1990-2#2)
the synthesis of other##2##4##(2008-7#1)(2009-8#1)
the synthesis of polypeptides##2##4##(2008-7#1)(2008-9#1)
the synthesis of several##3##4##(1991-9#1)(1995-11#1)(2008-11#1)
the synthesis of some aromatic esters##2##6##(2008-5#2)
the synthesis of some##4##4##(2007-11#1)(2008-4#1)(2008-5#2)
the synthesis of the##17##4##(1990-11#2)(1990-5#2)(1991-10#1)(1991-9#2)(1992-12#1)(1992-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-8#1)(2009-9#1)
the synthesis of##191##3##(1990-11#4)(1990-2#5)(1990-5#4)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-5#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#5)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-8#1)(2007-11#6)(2007-12#1)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#17)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#5)(2009-11#4)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-8#1)
the synthesis process##3##3##(2008-10#3)
the synthesis##242##2##(1990-11#4)(1990-2#5)(1990-5#4)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-5#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#4)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#5)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-8#1)(2007-11#6)(2007-12#3)(2008-10#24)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#22)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#5)(2009-10#5)(2009-11#5)(2009-12#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#5)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
the synthesized WCX##2##3##(2008-10#2)
the synthesized compounds were##4##4##(2007-11#2)(2008-4#1)(2008-5#1)
the synthesized compounds##7##3##(2007-11#3)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
the synthesized proteins##3##3##(1993-2#1)(2008-1#1)(2008-7#1)
the synthesized resin##3##3##(2008-10#3)
the synthesized##30##2##(1993-2#1)(2007-11#4)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the synthetic SOD/catalase mimetic##2##4##(2008-5#2)
the synthetic activity of##2##4##(1993-12#1)(1994-8#1)
the synthetic glucocorticoid##3##3##(1991-5#1)(1992-12#1)(1995-8#1)
the synthetic peptide to a carrier protein##3##7##(2008-2#1)(2008-4#2)
the synthetic peptide##5##3##(1994-5#1)(2008-2#1)(2008-4#3)
the synthetic reaction##2##3##(1990-8#1)(2008-10#1)
the synthetic sunscreen##4##3##(2008-5#4)
the synthetic##67##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#7)(2009-12#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
the syrB gene##4##3##(2008-10#4)
the syringe##5##2##(2008-10#4)(2013-1#1)
the system achieved a detection limit##2##6##(2008-10#2)
the system allows##2##3##(2008-2#1)(2008-3#1)
the system and the##6##4##(1996-1#1)(2008-10#3)(2008-3#1)(2012-3#1)
the system and to##6##4##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)
the system and##22##3##(1994-12#1)(1994-2#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#3)(2010-12#1)(2012-3#1)
the system are##5##3##(1993-3#1)(2007-11#1)(2007-12#1)(2008-3#2)
the system as a##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
the system as##10##3##(1991-2#1)(1994-1#1)(2007-11#1)(2008-10#4)(2008-5#1)(2010-4#1)(2012-2#1)
the system at##2##3##(2008-10#2)
the system by##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the system can be##4##4##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
the system can##10##3##(1990-2#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-9#1)
the system components##3##3##(2008-3#2)(2008-9#1)
the system could##2##3##(2008-10#2)
the system described##2##3##(1990-12#1)(2008-10#1)
the system design##2##3##(2008-2#1)(2008-3#1)
the system directly##3##3##(1996-1#1)(2008-3#1)(2008-5#1)
the system for the##3##4##(2008-5#2)(2008-9#1)
the system for##13##3##(1990-8#1)(1993-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)
the system from##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
the system has been applied to the##2##7##(1994-12#1)(2008-10#1)
the system has been##6##4##(1992-9#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)
the system has the potential to be##2##7##(2007-11#1)(2008-2#1)
the system has the potential to##3##6##(2007-11#1)(2008-2#2)
the system has##14##3##(1992-9#1)(1994-12#2)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2010-8#1)(2013-8#1)
the system in order to##2##5##(1995-3#1)(2011-1#1)
the system in##9##3##(1990-2#1)(1992-1#1)(1994-2#1)(1995-3#1)(2007-8#1)(2008-10#3)(2011-1#1)
the system include##2##3##(1994-12#1)(2007-8#1)
the system is capable of##2##5##(2008-10#1)(2008-3#1)
the system is in##2##4##(2008-10#2)
the system is##44##3##(1994-1#1)(2007-11#2)(2007-12#6)(2008-10#12)(2008-11#3)(2008-2#9)(2008-3#8)(2008-8#1)(2009-6#1)(2011-2#1)
the system level##2##3##(2008-2#1)(2008-3#1)
the system measures##2##3##(2007-12#1)(2008-10#1)
the system modulation transfer function##2##5##(2008-2#1)(2008-3#1)
the system nonuniformity##3##3##(2008-3#3)
the system of choice##2##4##(1997-4#1)(2008-11#1)
the system of reversed##2##4##(1990-5#2)
the system of service capacity and activities##2##7##(2013-8#2)
the system of service capacity and##10##6##(2013-8#10)
the system of##39##3##(1990-5#2)(1996-2#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-8#21)
the system on##4##3##(1992-11#1)(2010-6#2)(2010-8#1)
the system output##2##3##(2008-2#1)(2008-9#1)
the system over##2##3##(2008-10#2)
the system parameters and##3##4##(2008-2#1)(2008-3#2)
the system parameters##5##3##(2008-2#1)(2008-3#4)
the system performance##2##3##(2008-10#1)(2008-3#1)
the system produces##2##3##(2007-11#1)(2008-10#1)
the system response##2##3##(2007-11#1)(2008-2#1)
the system size##2##3##(2008-2#2)
the system such##2##3##(2008-10#1)(2008-3#1)
the system to##18##3##(1992-12#2)(1992-2#1)(1993-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2009-12#1)(2010-10#1)
the system using a##4##4##(2008-10#2)(2008-3#2)
the system was illustrated##2##4##(2008-10#1)(2012-3#1)
the system was##29##3##(1994-1#1)(1994-12#1)(1995-3#1)(1997-1#1)(2007-5#1)(2008-10#19)(2008-11#1)(2008-2#1)(2010-6#1)(2012-3#1)(2013-8#1)
the system were##10##3##(1992-12#1)(2008-10#8)(2008-12#1)
the system will be##4##4##(1992-12#1)(1994-3#1)(2008-10#1)(2008-2#1)
the system will##8##3##(1992-12#2)(1992-3#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
the system with delay and##2##5##(2013-8#2)
the system with##11##3##(2008-10#4)(2008-2#1)(2008-3#2)(2009-4#1)(2013-8#3)
the system without##3##3##(2008-10#3)
the system##524##2##(1990-12#2)(1990-2#3)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#7)(1993-8#1)(1994-1#5)(1994-12#5)(1994-2#4)(1994-3#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1996-1#3)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#11)(2007-12#16)(2007-2#1)(2007-5#2)(2007-8#3)(2007-9#1)(2008-10#149)(2008-11#16)(2008-12#3)(2008-2#49)(2008-3#74)(2008-4#1)(2008-5#11)(2008-6#5)(2008-7#4)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#2)(2010-6#3)(2010-8#3)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#27)
the system's##17##2##(1991-12#1)(1994-1#2)(1995-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
the systematic analysis of##2##4##(1993-3#1)(2008-7#1)
the systematic errors##4##3##(1990-8#1)(2008-3#3)
the systematic##22##2##(1990-8#1)(1991-3#1)(1993-3#1)(1994-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-1#1)(2011-3#1)
the systematization of##2##3##(2012-3#1)(2013-1#1)
the systemic acquired##2##3##(2008-10#2)
the systemic circulation##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
the systemic development of symptoms##2##5##(2008-10#2)
the systemic effects##2##3##(2010-12#1)(2011-2#1)
the systemic##36##2##(1990-11#1)(1993-12#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)
the systems and##2##3##(2008-7#2)
the systems of##2##3##(2008-5#1)(2013-1#1)
the systems under##2##3##(2008-10#2)
the systems were##3##3##(2008-10#2)(2008-8#1)
the systems##35##2##(1991-1#2)(1994-1#1)(1994-3#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
the systolic and diastolic blood##2##5##(2008-12#1)(2008-3#1)
the systolic and diastolic pressures##2##5##(1990-8#1)(2010-4#1)
the systolic and diastolic##7##4##(1990-8#1)(1996-3#1)(1996-6#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-7#1)
the systolic##8##2##(1990-8#1)(1996-3#1)(1996-6#1)(1997-6#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-7#1)
the t(2g) and e(g) orbitals##3##5##(1997-7#3)
the t(2g)##7##2##(1997-7#7)
the t-PA secretion##2##3##(2008-11#2)
the t-PA##3##2##(1994-3#1)(2008-11#2)
the t-test##3##2##(2008-10#2)(2008-11#1)
the tMCAO##2##2##(2011-2#2)
the tRNA##4##2##(1992-11#1)(1992-6#2)(1993-11#1)
the tRNA[Ser]Sec gene##2##3##(1997-2#2)
the tRNA[Ser]Sec##3##2##(1997-2#3)
the table##13##2##(1993-2#1)(1995-2#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-12#1)(2013-1#1)
the tablet##4##2##(2008-10#2)(2010-5#2)
the tablets##5##2##(2008-10#3)(2012-2#2)
the tachykinin family##3##3##(1990-12#1)(1991-5#2)
the tactile perception##2##3##(2008-5#2)
the tactile##5##2##(1997-2#1)(2008-5#3)(2009-8#1)
the tag##3##2##(1995-2#1)(2008-11#1)(2013-8#1)
the tagging##3##2##(2008-10#2)(2012-3#1)
the tail domain of##3##4##(1990-11#2)(2009-7#1)
the tail domain##4##3##(1990-11#3)(2009-7#1)
the tail of the##4##4##(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
the tail of##6##3##(1993-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
the tail region##2##3##(2011-1#2)
the tail vein##2##3##(1997-2#1)(2008-1#1)
the tail##28##2##(1990-11#3)(1993-1#2)(1994-3#1)(1995-12#2)(1995-3#1)(1997-2#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-1#3)(2012-2#2)(2013-1#1)
the tail-flick response##3##3##(1992-3#3)
the tail-flick##4##2##(1992-3#4)
the tailored##2##2##(2009-6#1)(2010-10#1)
the tails of##2##3##(1997-4#1)(2012-3#1)
the tails##4##2##(1994-3#1)(1997-4#2)(2012-3#1)
the take-all##2##2##(2008-10#2)
the taken-for-granted##2##2##(2008-12#1)(2013-1#1)
the talks##2##2##(2008-7#2)
the talo-crural joint##3##3##(2007-11#2)(2007-8#1)
the talonavicular joint##2##3##(2010-3#2)
the talonavicular##3##2##(2009-10#1)(2010-3#2)
the tamarillo isolates##2##3##(2008-10#2)
the tammar wallaby##2##3##(1992-8#1)(1996-5#1)
the tandem repeat##2##3##(1992-11#1)(1997-7#1)
the tandem##8##2##(1992-11#2)(1996-5#2)(1997-7#1)(2008-10#2)(2008-7#1)
the tangent##2##2##(2008-3#1)(2012-2#1)
the tangential##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
the tangerine##2##2##(2008-10#2)
the tank##3##2##(2008-8#1)(2009-9#2)
the tantalizing possibility that##3##4##(2008-5#1)(2008-8#1)(2009-8#1)
the tantalizing##4##2##(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
the taper angle##2##3##(2008-2#2)
the taper##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
the tapered##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
the tapering##2##2##(2008-2#1)(2008-7#1)
the tapestry chamber##2##3##(2012-2#2)
the tapestry##3##2##(2012-2#3)
the taproot##2##2##(2008-10#2)
the target DNA and##2##4##(1992-3#1)(2008-10#1)
the target DNA##7##3##(1992-3#1)(2008-10#4)(2008-4#2)
the target VOCs##2##3##(2008-10#2)
the target amount##2##3##(1993-12#2)
the target analyte##5##3##(2008-10#5)
the target analytes##5##3##(2008-10#4)(2013-1#1)
the target and the##3##4##(1995-1#1)(2008-7#1)(2010-5#1)
the target and##6##3##(1995-1#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-5#1)
the target area##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
the target cell##5##3##(2008-11#2)(2008-5#1)(2011-1#2)
the target cells##9##3##(1990-12#1)(1993-6#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)
the target compounds##7##3##(2007-11#1)(2008-10#5)(2013-1#1)
the target for##4##3##(1992-9#1)(2008-4#1)(2008-7#2)
the target gas##2##3##(2008-3#2)
the target gene as##2##4##(2008-10#2)
the target gene##7##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
the target genes of##2##4##(2008-9#1)(2012-12#1)
the target genes##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
the target group##2##3##(2010-12#1)(2012-2#1)
the target image##3##3##(2008-3#2)(2012-1#1)
the target is##3##3##(2008-3#2)(2009-11#1)
the target object##2##3##(2008-3#1)(2012-2#1)
the target of##6##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
the target organ##4##3##(1990-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
the target organism##2##3##(2008-10#1)(2012-3#1)
the target population##8##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
the target protein##6##3##(1997-2#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-9#1)
the target region##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
the target sequence##10##3##(1993-11#1)(1994-12#2)(2008-10#2)(2008-2#2)(2008-4#2)(2008-9#1)
the target sequences##2##3##(2008-10#1)(2013-8#1)
the target site##3##3##(1990-11#2)(2007-8#1)
the target therapy of##2##4##(2010-8#1)(2011-2#1)
the target tissue##3##3##(2008-10#1)(2009-11#1)(2009-7#1)
the target volume##3##3##(2008-2#1)(2009-11#2)
the target was##2##3##(2008-10#1)(2012-2#1)
the target word##2##3##(2009-8#2)
the target##268##2##(1990-11#3)(1990-12#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-5#2)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#59)(2008-11#13)(2008-2#14)(2008-3#25)(2008-4#11)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#6)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#7)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#4)
the target's##4##2##(2008-11#1)(2008-3#1)(2009-10#1)(2010-7#1)
the target-site##2##2##(2008-10#2)
the targeted##14##2##(1994-12#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
the targeting of##6##3##(1995-5#1)(1996-5#1)(2008-11#2)(2009-7#1)(2009-8#1)
the targeting##11##2##(1993-9#1)(1994-8#1)(1995-5#1)(1996-5#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)
the targets for##5##3##(1994-9#1)(1997-2#1)(2008-4#2)(2011-3#1)
the targets of##4##3##(1991-5#1)(2008-1#1)(2008-11#2)
the targets##20##2##(1991-5#1)(1994-9#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
the task is##2##3##(2008-10#1)(2008-3#1)
the task of##14##3##(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
the task was##2##3##(1993-3#1)(2008-6#1)
the task##49##2##(1991-1#1)(1991-2#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-8#4)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#2)(2007-6#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the tasks of##2##3##(1990-3#1)(2011-2#1)
the tasks were##2##3##(1991-6#1)(2008-11#1)
the tasks##12##2##(1990-3#1)(1991-6#1)(1992-11#1)(1993-12#1)(1995-12#1)(2008-11#2)(2008-4#1)(2009-10#1)(2011-2#2)(2012-2#1)
the taste sensing##2##3##(2008-10#2)
the taste##11##2##(1991-3#2)(1993-12#1)(1996-5#1)(2008-10#5)(2010-5#1)(2013-1#1)
the tau 1 core##3##4##(1995-2#3)
the tau b method##2##4##(1995-2#2)
the tau##7##2##(1993-6#1)(1995-2#5)(2008-9#1)
the tax##3##2##(2008-6#1)(2008-8#2)
the taxa##3##2##(2008-10#1)(2010-3#1)(2012-2#1)
the taxonomic##9##2##(1994-3#2)(1997-4#1)(2008-10#2)(2008-12#1)(2010-10#1)(2010-8#1)(2013-7#1)
the taxonomy of the##3##4##(2008-10#2)(2013-7#1)
the taxonomy of##7##3##(2008-10#3)(2008-5#1)(2008-7#1)(2010-10#1)(2013-7#1)
the tea##3##2##(1995-9#1)(2008-10#2)
the teacher##3##2##(1992-9#1)(2011-2#1)(2012-1#1)
the teacher's##3##2##(2008-11#2)(2011-2#1)
the teachers##3##2##(1991-12#1)(1994-6#1)(2008-11#1)
the teaching and learning of##3##5##(2008-11#2)(2008-12#1)
the teaching and learning##7##4##(2008-11#4)(2008-12#2)(2013-8#1)
the teaching and training of##2##5##(1997-7#1)(2008-11#1)
the teaching and##9##3##(1997-7#1)(2008-11#5)(2008-12#2)(2013-8#1)
the teaching of posterior composites##2##5##(2009-2#2)
the teaching of##8##3##(2008-11#2)(2009-2#4)(2010-1#1)(2013-1#1)
the teaching##26##2##(1992-1#1)(1995-1#1)(1997-7#1)(2007-4#1)(2008-10#1)(2008-11#8)(2008-12#5)(2009-2#4)(2010-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
the team and##2##3##(1993-3#1)(2009-6#1)
the team concept##2##3##(2008-10#2)
the team##28##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#4)(1996-3#1)(1997-2#1)(2007-5#2)(2008-10#4)(2008-11#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#3)(2011-2#1)(2011-8#1)
the team's##2##2##(1993-12#1)(1997-2#1)
the teams##3##2##(1994-1#1)(2007-12#1)(2012-3#1)
the tear film##2##3##(2009-4#1)(2011-2#1)
the tear##5##2##(2009-4#2)(2011-2#1)(2013-8#2)
the technical advances##2##3##(2008-6#1)(2010-9#1)
the technical aspects of##3##4##(1997-8#1)(2006-10#1)(2013-8#1)
the technical characteristics##2##3##(1996-1#1)(2007-8#1)
the technical details##3##3##(2008-9#1)(2010-8#1)(2012-3#1)
the technical problems##2##3##(1997-2#1)(2007-8#1)
the technical##37##2##(1992-11#1)(1992-3#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the technique allows for##2##4##(2007-12#1)(2008-3#1)
the technique allows##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
the technique and the##2##4##(1990-10#1)(1994-2#1)
the technique and##12##3##(1990-10#1)(1990-11#1)(1992-12#1)(1994-2#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-7#1)
the technique are##7##3##(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-1#1)
the technique can be used##2##5##(2007-11#1)(2008-3#1)
the technique can be##6##4##(1993-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
the technique can##7##3##(1993-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-8#1)
the technique could##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the technique described##3##3##(1996-12#1)(2007-12#1)(2008-2#1)
the technique employed##2##3##(2008-10#1)(2010-4#1)
the technique has##2##3##(2008-2#1)(2010-7#1)
the technique in##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
the technique is##22##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2009-5#1)(2010-9#1)(2011-1#2)
the technique may##3##3##(1992-2#1)(2006-6#1)(2008-3#1)
the technique of choice for##4##5##(1991-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
the technique of choice##5##4##(1991-5#1)(1995-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
the technique of laser##2##4##(1991-12#1)(2008-3#1)
the technique of optical##2##4##(2007-12#2)
the technique of##38##3##(1990-10#1)(1991-12#1)(1991-5#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-3#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
the technique offers##2##3##(2008-7#1)(2008-8#1)
the technique presented##2##3##(2008-3#1)(2010-3#1)
the technique proposed##2##3##(2008-10#1)(2008-3#1)
the technique requires##2##3##(1996-12#1)(2007-11#1)
the technique to measure##2##4##(2008-2#1)(2008-3#1)
the technique to##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
the technique used to##2##4##(2008-10#1)(2008-3#1)
the technique used##6##3##(1990-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
the technique was used##2##4##(2008-10#1)(2008-5#1)
the technique was##10##3##(1991-2#1)(1991-5#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-5#1)
the technique with##2##3##(1997-4#1)(2008-10#1)
the technique##200##2##(1990-10#2)(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#2)(1995-11#2)(1995-12#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-6#1)(2007-11#8)(2007-12#16)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#20)(2008-3#41)(2008-4#5)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
the technique's##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the techniques and##6##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)
the techniques are##6##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)
the techniques available##2##3##(2008-10#1)(2008-4#1)
the techniques for the##2##4##(2008-2#1)(2008-4#1)
the techniques for##5##3##(2008-2#1)(2008-4#1)(2008-9#2)(2011-2#1)
the techniques of##12##3##(1996-1#1)(1997-4#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2010-2#1)(2010-8#1)
the techniques that##3##3##(1995-5#1)(2008-10#1)(2008-9#1)
the techniques used##4##3##(2008-10#1)(2008-2#1)(2009-10#1)(2010-8#1)
the techniques were##2##3##(2008-10#1)(2008-8#1)
the techniques##52##2##(1991-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-4#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-3#1)
the technological development of##2##4##(2008-12#1)(2010-8#1)
the technological##11##2##(1992-11#1)(1992-2#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-7#1)(2010-8#1)
the technologies##5##2##(2008-1#1)(2008-11#2)(2011-1#1)(2011-3#1)
the technologist##2##2##(1994-6#1)(1995-3#1)
the technology and##3##3##(2007-2#1)(2008-4#1)(2008-7#1)
the technology in##2##3##(2008-10#2)
the technology is##4##3##(2008-11#2)(2008-3#1)(2011-2#1)
the technology of##4##3##(1997-5#1)(2008-3#1)(2009-6#1)(2013-8#1)
the technology to##4##3##(2008-10#2)(2008-9#2)
the technology##36##2##(1992-11#1)(1994-12#1)(1994-2#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#4)(2009-12#1)(2009-6#1)(2011-2#1)(2013-8#1)
the teenage##2##2##(2008-9#1)(2009-7#1)
the teeth in##2##3##(2012-3#1)(2013-1#1)
the teeth were##2##3##(2009-7#1)(2013-1#1)
the teeth##12##2##(1995-3#1)(1995-9#1)(1997-4#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the teicoplanin##3##2##(2008-10#3)
the telencephalon##13##2##(1994-3#2)(1995-12#1)(1996-5#8)(2008-6#1)(2012-3#1)
the teleost##3##2##(1993-5#1)(1995-2#1)(2008-7#1)
the telephone##4##2##(1996-5#1)(2008-9#1)(2013-1#2)
the telephone-administered HUI2/3##2##3##(2007-10#2)
the telescope s##2##3##(2008-3#2)
the telescope##10##2##(1991-2#1)(2008-3#9)
the telia##2##2##(2008-10#2)
the telomerase activity in##2##4##(2008-9#2)
the telomerase activity##4##3##(2008-9#3)(2010-2#1)
the telomerase complex##2##3##(2008-11#2)
the telomerase##6##2##(2008-11#2)(2008-9#3)(2010-2#1)
the telomere##4##2##(1997-5#1)(2008-11#1)(2008-8#1)(2011-1#1)
the telomeres##3##2##(1991-7#1)(1997-6#2)
the telomeric region of##2##4##(1994-11#1)(1995-2#1)
the telomeric region##5##3##(1994-11#1)(1995-2#1)(2008-11#2)(2010-8#1)
the telomeric##10##2##(1993-3#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)
the telomerized##2##2##(2008-11#2)
the temperate and tropical isolates##3##5##(2008-10#3)
the temperate and##4##3##(2008-10#3)(2008-8#1)
the temperate isolates##3##3##(2008-10#3)
the temperate zone##2##3##(2008-10#1)(2012-3#1)
the temperate##12##2##(2007-7#1)(2008-10#7)(2008-8#2)(2012-2#1)(2012-3#1)
the temperature and pressure##3##4##(2008-2#1)(2008-3#2)
the temperature and the##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
the temperature and time##2##4##(2008-5#1)(2011-1#1)
the temperature and##15##3##(1990-2#1)(1992-2#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2011-1#1)
the temperature attained in the##2##5##(1995-6#1)(2008-10#1)
the temperature dependence of the refractive index##2##7##(2008-2#1)(2008-3#1)
the temperature dependence of the##14##5##(1994-12#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#5)
the temperature dependence of##24##4##(1990-7#1)(1994-12#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#9)(2009-12#1)
the temperature distribution##5##3##(2008-2#1)(2008-3#3)(2008-7#1)
the temperature effect on##2##4##(2013-7#2)
the temperature effect##8##3##(2007-11#1)(2008-10#3)(2008-3#1)(2012-5#1)(2013-7#2)
the temperature field##3##3##(2008-3#3)
the temperature in the capillary##2##5##(2008-10#2)
the temperature in the##5##4##(2008-10#2)(2008-11#1)(2008-3#2)
the temperature increases##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
the temperature is raised##2##4##(1995-2#1)(2008-11#1)
the temperature is##8##3##(1995-2#3)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the temperature of the##6##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-11#1)
the temperature of##9##3##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2010-11#1)
the temperature profiles##2##3##(2008-2#2)
the temperature program##2##3##(2008-10#1)(2012-1#1)
the temperature range of##5##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-9#1)
the temperature range##14##3##(1990-2#1)(1994-12#2)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2009-9#1)
the temperature ranges##2##3##(2008-10#2)
the temperature rise##2##3##(2008-3#2)
the temperature sensitivity of##4##4##(2008-3#1)(2008-8#1)(2008-9#2)
the temperature sensitivity##6##3##(1995-2#1)(2008-3#2)(2008-8#1)(2008-9#2)
the temperature to##5##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)
the temperature was##6##3##(2008-10#4)(2009-2#1)(2011-2#1)
the temperature##185##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#3)(1994-5#2)(1995-2#5)(1995-6#3)(1996-12#1)(1997-2#3)(1997-6#2)(1997-7#1)(2007-11#5)(2007-12#7)(2008-1#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-2#22)(2008-3#47)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-5#3)(2013-7#5)(2013-8#1)
the temperature-dependent##5##2##(2007-12#1)(2008-3#2)(2013-7#1)(2013-8#1)
the temperature-induced##3##2##(1990-2#1)(2008-3#2)
the temperature-sensitive (ts) phenotype##2##4##(1994-12#1)(2008-10#1)
the temperature-sensitive phenotype##2##3##(1994-12#1)(1997-3#1)
the temperature-sensitive##5##2##(1994-12#2)(1997-3#1)(2008-10#1)(2008-11#1)
the temperatures##6##2##(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
the template DNA##2##3##(1993-3#1)(2008-8#1)
the template molecule##3##3##(2008-10#3)
the template##22##2##(1993-3#1)(1994-8#3)(2008-10#8)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
the temporal Talbot effect##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the temporal and geographical##2##4##(1990-8#1)(2008-10#1)
the temporal and spatial dynamics of##2##6##(2008-10#2)
the temporal and spatial##8##4##(1996-12#1)(2007-12#2)(2008-10#4)(2010-9#1)
the temporal and##13##3##(1990-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-8#1)(2010-9#1)
the temporal bone##10##3##(2006-12#3)(2008-6#1)(2008-8#2)(2008-9#2)(2011-2#2)
the temporal broadening of##2##4##(2008-3#2)
the temporal changes##2##3##(1997-2#1)(2008-7#1)
the temporal coherence of##2##4##(2007-11#1)(2008-3#1)
the temporal coherence##3##3##(2007-11#2)(2008-3#1)
the temporal correlation##2##3##(1992-3#1)(2008-3#1)
the temporal cortex##5##3##(1993-12#1)(1993-6#1)(1996-12#1)(1997-2#1)(2008-9#1)
the temporal course of##2##4##(1996-7#1)(2009-8#1)
the temporal distribution of##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
the temporal dynamics of##5##4##(2008-10#3)(2008-8#1)(2009-8#1)
the temporal evolution of the##6##5##(2007-12#1)(2008-10#1)(2008-2#4)
the temporal evolution of##10##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)
the temporal expression##2##3##(2008-10#1)(2012-3#1)
the temporal instability##2##3##(2007-12#1)(2008-9#1)
the temporal lobe##6##3##(1991-12#1)(1996-7#1)(2008-4#1)(2008-7#1)(2011-2#2)
the temporal organization of sleep spindles##2##6##(2009-8#2)
the temporal oscillations##2##3##(2007-11#1)(2008-2#1)
the temporal pattern of##2##4##(1992-3#1)(1997-8#1)
the temporal position##2##3##(2007-11#1)(2007-12#1)
the temporal profile of the##2##5##(2008-3#2)
the temporal profile##3##3##(2008-3#3)
the temporal region##3##3##(2008-9#2)(2009-1#1)
the temporal relationship between##2##4##(1994-2#1)(2006-6#1)
the temporal resolution of##3##4##(1995-2#1)(2007-11#1)(2007-12#1)
the temporal resolution##7##3##(1995-2#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-9#1)
the temporal response##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the temporal separation##2##3##(1992-11#1)(2007-12#1)
the temporal sequence of##2##4##(1995-3#1)(2012-12#1)
the temporal sequence##3##3##(1995-3#1)(2012-12#1)(2012-2#1)
the temporal##165##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-11#2)(1992-3#3)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#2)(1996-7#4)(1997-2#2)(1997-8#2)(2006-12#3)(2006-6#1)(2007-10#1)(2007-11#15)(2007-12#15)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#15)(2008-3#18)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#10)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#5)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the temporally##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2010-5#1)
the temporary##7##2##(1992-9#1)(1997-3#1)(2008-11#2)(2008-8#1)(2009-11#1)(2009-3#1)
the temporo-parietal##2##2##(2008-11#2)
the temporomandibular joint##2##3##(1993-1#1)(1996-2#1)
the ten patients##3##3##(2008-6#1)(2008-7#2)
the ten##16##2##(1990-11#1)(1990-2#1)(1992-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-5#1)(2013-7#1)(2013-8#2)
the ten-year OS rate was##3##5##(1993-1#3)
the tenants##2##2##(1993-1#2)
the tendency for the##2##4##(1994-3#1)(2008-1#1)
the tendency for##3##3##(1994-3#1)(1997-4#1)(2008-1#1)
the tendency of##5##3##(1994-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
the tendency to##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
the tendency##16##2##(1994-2#1)(1994-3#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
the tendon##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
the tenets of##3##3##(1994-12#1)(2010-4#1)(2011-1#1)
the tensile properties of the##2##5##(2008-5#1)(2009-7#1)
the tensile properties of##4##4##(2008-5#2)(2009-7#2)
the tensile strength##3##3##(2008-5#2)(2008-7#1)
the tensile##10##2##(2008-12#1)(2008-5#5)(2008-7#1)(2009-7#3)
the tension between##2##3##(2008-7#1)(2009-5#1)
the tension##8##2##(1990-8#1)(1991-12#1)(2006-12#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
the tensions##3##2##(2008-8#1)(2009-10#2)
the tensor fasciae##2##3##(2009-3#2)
the tensor##6##2##(2007-11#1)(2008-5#3)(2009-3#2)
the tentative##2##2##(2008-10#1)(2011-2#1)
the tenth day##2##3##(2008-12#1)(2011-1#1)
the tenth##7##2##(1996-12#1)(1996-2#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
the tentorium cerebelli##2##3##(1997-3#1)(2011-2#1)
the tentorium##3##2##(1997-3#1)(2007-12#1)(2011-2#1)
the terahertz##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2012-2#1)
the terahertz-band##2##2##(2013-8#2)
the teratogenicity of##2##3##(1993-12#1)(2013-1#1)
the terbium##2##2##(2008-10#2)
the term &quot##13##3##(1990-11#1)(1990-6#1)(1992-5#1)(2007-10#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
the term 'scalp'##2##3##(2008-9#2)
the term##47##2##(1990-11#2)(1990-6#1)(1992-5#1)(1993-2#1)(1993-8#2)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
the terminal differentiation##2##3##(1993-6#1)(2008-5#1)
the terminal ends of the ILSs##2##6##(2008-7#2)
the terminal ileum##4##3##(1992-5#1)(1997-1#1)(2007-8#1)(2008-12#1)
the terminal patient##2##3##(1993-2#1)(1995-3#1)
the terminal region of the short##2##6##(2008-7#1)(2012-3#1)
the terminal region of the##3##5##(2008-7#1)(2008-9#1)(2012-3#1)
the terminal##60##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1992-12#2)(1992-5#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-1#2)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)
the terminating electrolyte##2##3##(2008-10#2)
the terminating##3##2##(1997-4#1)(2008-10#2)
the termination of##7##3##(1995-8#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
the termination##9##2##(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-9#2)(2011-1#1)
the termini of##3##3##(1990-5#1)(1992-6#1)(1997-8#1)
the terminology of##4##3##(1990-11#1)(2013-1#2)(2013-7#1)
the terminology##5##2##(1990-11#1)(2008-7#1)(2013-1#2)(2013-7#1)
the terminus region##3##3##(1995-2#3)
the termites##2##2##(2011-2#1)(2013-8#1)
the terms &quot##3##3##(2009-9#1)(2011-2#2)
the terms of the##4##4##(1993-12#1)(1995-12#1)(1996-1#1)(2008-3#1)
the terms of##7##3##(1993-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-3#1)
the terms##17##2##(1993-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#2)(2013-1#1)
the ternary complex##7##3##(1993-8#1)(1994-5#1)(1995-5#1)(2008-10#3)(2008-3#1)
the ternary complexes##4##3##(2008-10#3)(2010-6#1)
the ternary system##4##3##(2008-10#3)(2008-3#1)
the ternary##21##2##(1993-8#1)(1994-5#1)(1995-5#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-6#1)
the terrestrial##8##2##(1990-5#1)(1995-6#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)
the territory of the##3##4##(1992-2#1)(1995-12#1)(1996-3#1)
the territory of##7##3##(1992-2#1)(1995-12#1)(1996-3#1)(2008-8#1)(2011-2#1)(2013-8#2)
the territory##9##2##(1992-2#1)(1995-12#1)(1996-3#1)(2008-8#3)(2011-2#1)(2013-8#2)
the tertiary and quaternary##2##4##(1997-2#2)
the tertiary structure of the##3##5##(1990-12#1)(1990-5#1)(2008-10#1)
the tertiary structure of##4##4##(1990-12#1)(1990-5#1)(1992-12#1)(2008-10#1)
the tertiary structure##5##3##(1990-12#1)(1990-5#1)(1992-12#1)(2008-10#1)(2008-4#1)
the tertiary##12##2##(1990-12#1)(1990-5#1)(1992-12#1)(1995-2#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-2#1)
the test agent##2##3##(1997-4#1)(2008-10#1)
the test and the##3##4##(2008-1#1)(2008-3#2)
the test and##4##3##(2008-1#1)(2008-3#2)(2011-2#1)
the test case##2##3##(1992-3#1)(2008-3#1)
the test compounds##5##3##(1996-5#1)(2008-11#1)(2008-4#2)(2011-1#1)
the test data##2##3##(2008-10#2)
the test dose##2##3##(1992-2#1)(2008-7#1)
the test group##3##3##(1994-8#1)(2007-7#1)(2008-12#1)
the test in##2##3##(2008-10#1)(2008-7#1)
the test is##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
the test material##2##3##(1990-12#1)(2008-11#1)
the test of time##2##4##(2008-1#1)(2008-2#1)
the test of##6##3##(1992-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-2#1)
the test period##3##3##(1996-4#1)(2008-10#1)(2011-1#1)
the test results##6##3##(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-8#1)
the test sample##6##3##(2008-10#5)(2008-9#1)
the test samples##6##3##(1990-12#1)(2008-10#4)(2008-4#1)
the test set##4##3##(2008-10#2)(2008-6#1)(2010-2#1)
the test site##2##3##(2008-10#1)(2008-5#1)
the test solution##4##3##(2008-10#3)(2008-5#1)
the test solutions##3##3##(2008-10#3)
the test statistic##3##3##(1992-9#1)(1995-9#1)(2012-1#1)
the test statistics##2##3##(1995-2#1)(2012-3#1)
the test subject##2##3##(1997-5#2)
the test subject's##2##3##(1997-5#2)
the test system##2##3##(1992-9#1)(2008-11#1)
the test using##2##3##(2008-11#1)(2008-12#1)
the test was##2##3##(1996-12#1)(2008-2#1)
the test##185##2##(1990-12#2)(1990-6#1)(1991-12#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#4)(1997-3#1)(1997-4#2)(1997-5#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#48)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#16)(2008-4#6)(2008-5#15)(2008-6#2)(2008-7#6)(2008-9#3)(2009-10#1)(2009-12#2)(2010-2#2)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
the test's##3##2##(1996-5#1)(1997-3#1)(2009-12#1)
the tested bacterial##2##3##(2010-3#1)(2012-3#1)
the tested compounds##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
the tested concentrations##2##3##(2008-11#1)(2008-7#1)
the tested range##2##3##(2007-8#1)(2008-10#1)
the tested sample##2##3##(2008-10#2)
the tested samples##3##3##(1997-4#1)(2008-10#2)
the tested##57##2##(1995-12#2)(1995-5#1)(1996-7#1)(1997-4#1)(2007-8#1)(2008-10#21)(2008-11#6)(2008-12#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
the tester strains##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
the tester##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)
the testes and the##2##4##(1990-7#1)(2008-7#1)
the testes and##4##3##(1990-2#1)(1990-7#1)(2008-5#1)(2008-7#1)
the testes of##3##3##(2008-5#2)(2008-7#1)
the testes##14##2##(1990-2#1)(1990-7#1)(1997-6#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#3)
the testicles##2##2##(2008-10#2)
the testicular##5##2##(1996-5#1)(2008-10#1)(2009-11#1)(2010-5#1)(2013-8#1)
the testimony##3##2##(1994-2#1)(1996-2#1)(2011-2#1)
the testing of a##2##4##(2008-10#1)(2010-2#1)
the testing of##16##3##(1993-3#1)(1995-9#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2010-2#1)(2012-2#1)
the testing##34##2##(1990-11#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-9#1)(1996-11#1)(1996-6#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
the testis and##5##3##(1991-1#1)(1992-12#1)(2008-10#2)(2008-7#1)
the testis is a##3##4##(1992-12#1)(2007-8#1)(2011-2#1)
the testis is##6##3##(1992-12#1)(2007-8#1)(2009-10#2)(2011-2#1)(2012-2#1)
the testis was##4##3##(1992-12#1)(2008-9#1)(2011-2#2)
the testis##51##2##(1991-1#2)(1991-6#1)(1992-12#4)(1992-6#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-3#1)(2007-5#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#2)(2009-10#7)(2009-11#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#7)(2013-7#1)
the testosterone displacement##3##3##(2008-10#3)
the testosterone##4##2##(1995-2#1)(2008-10#3)
the tests of##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
the tests which##2##3##(2011-2#1)(2013-8#1)
the tests##27##2##(1990-3#1)(1990-9#1)(1996-1#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the tetracycline antibiotics##2##3##(2008-10#2)
the tetracycline##7##2##(1994-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2011-1#1)
the tetragonal##2##2##(1996-2#1)(2008-10#1)
the tetraheme cytochrome subunit##2##4##(1993-8#2)
the tetraheme cytochrome##3##3##(1993-8#2)(1994-5#1)
the tetrahydropyridine##2##2##(1992-11#1)(1996-12#1)
the tetramer##5##2##(1994-11#2)(2008-10#1)(2008-9#2)
the tetrameric Adair##2##3##(1990-8#2)
the tetrameric##6##2##(1990-8#2)(1992-3#1)(1995-12#1)(1996-2#1)(2008-10#1)
the tetramerization mechanism##2##3##(1993-8#2)
the tetramerization##3##2##(1993-8#3)
the tetrapeptide##7##2##(1990-11#1)(1991-5#2)(1993-9#1)(1994-5#1)(1997-3#2)
the tetraploid##6##2##(2008-10#2)(2008-11#1)(2008-5#2)(2009-9#1)
the tetraploids##2##2##(2008-5#2)
the tetraspanin##2##2##(2009-8#2)
the text of##2##3##(2011-1#1)(2011-2#1)
the text##11##2##(2008-10#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the textural##2##2##(2008-5#1)(2008-6#1)
the thalamic##5##2##(1993-12#1)(1997-2#2)(2008-1#1)(2010-1#1)
the thalamus and basal ganglia##2##5##(2008-7#1)(2009-6#1)
the thalamus and##3##3##(2008-1#1)(2008-7#1)(2009-6#1)
the thalamus##6##2##(2008-1#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-3#2)
the thallium##3##2##(1996-2#2)(2008-10#1)
the the##7##2##(1990-5#1)(1990-7#1)(1995-6#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-7#1)
the theca interna##2##3##(1995-12#2)
the theca##4##2##(1995-12#2)(2008-12#1)(2008-8#1)
the theca-interstitial cells##2##3##(2008-5#2)
the theca-interstitial##3##2##(2008-5#3)
the thecogen cell##2##3##(2007-12#2)
the theme of the##2##4##(2008-11#1)(2009-10#1)
the theme##4##2##(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)
the themes identified##2##3##(2008-11#2)
the themes that##2##3##(1995-12#1)(2008-11#1)
the themes##5##2##(1995-12#1)(2007-12#1)(2008-11#3)
the thenar##2##2##(2008-5#1)(2009-1#1)
the theological##2##2##(2008-4#1)(2013-1#1)
the theorems##3##2##(1990-7#2)(2010-3#1)
the theoretical analyses##3##3##(2008-3#2)(2010-2#1)
the theoretical analysis and##2##4##(2008-3#2)
the theoretical analysis##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2013-8#1)
the theoretical and empirical##2##4##(1993-3#1)(1996-6#1)
the theoretical and experimental results##3##5##(2007-11#2)(2008-10#1)
the theoretical and experimental##5##4##(1997-2#1)(2007-11#3)(2008-10#1)
the theoretical and practical##3##4##(1997-4#1)(2008-9#1)(2010-8#1)
the theoretical and##12##3##(1993-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-8#1)
the theoretical concepts##2##3##(2008-7#1)(2011-2#1)
the theoretical construction of##2##4##(1991-6#1)(2008-3#1)
the theoretical design##3##3##(2008-3#3)
the theoretical findings##2##3##(2008-3#1)(2013-8#1)
the theoretical framework##5##3##(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)
the theoretical knowledge of holistic care##2##6##(2008-11#2)
the theoretical knowledge##3##3##(2008-11#3)
the theoretical limit##2##3##(2007-12#2)
the theoretical maximum##2##3##(2008-10#1)(2008-3#1)
the theoretical model##2##3##(2008-3#2)
the theoretical performance##2##3##(2008-2#1)(2008-3#1)
the theoretical prediction##11##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#4)(2012-3#1)
the theoretical predictions##8##3##(1992-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-2#1)
the theoretical properties of##2##4##(2010-1#1)(2012-3#1)
the theoretical resolution##2##3##(2008-2#1)(2008-3#1)
the theoretical results##8##3##(2007-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2010-5#1)
the theoretical treatment##2##3##(2008-2#2)
the theoretical underpinnings of the approach and##2##7##(1996-1#1)(1996-2#1)
the theoretical underpinnings of##3##4##(1991-12#1)(1996-1#1)(1996-2#1)
the theoretical underpinnings##4##3##(1991-12#1)(1996-1#1)(1996-2#1)(2009-6#1)
the theoretical value##4##3##(1994-3#1)(2007-12#1)(2008-3#2)
the theoretical##137##2##(1990-5#1)(1991-12#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#6)(2007-12#8)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#15)(2008-3#38)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-2#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
the theoretically##5##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
the theories and##2##3##(2010-1#1)(2012-3#1)
the theories of##5##3##(1993-2#1)(1993-6#1)(2010-10#1)(2013-1#2)
the theories##9##2##(1993-2#1)(1993-6#1)(1997-6#1)(2008-4#1)(2010-1#1)(2010-10#1)(2012-3#1)(2013-1#2)
the theory and practice of##2##5##(1995-1#1)(1997-3#1)
the theory and show the utility of the##2##8##(2008-3#2)
the theory and the experiment##3##5##(2008-3#3)
the theory and the##4##4##(1990-12#1)(2008-3#3)
the theory and##13##3##(1990-12#1)(1995-1#1)(1997-3#1)(2008-2#2)(2008-3#6)(2008-8#1)(2012-3#1)
the theory by##2##3##(2008-2#1)(2008-3#1)
the theory developed##2##3##(2007-10#1)(2008-8#1)
the theory in##2##3##(2008-3#1)(2009-5#1)
the theory is##3##3##(1991-1#1)(2008-2#1)(2008-3#1)
the theory of the##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
the theory of##36##3##(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
the theory that creativity is a##2##6##(1995-1#2)
the theory that##9##3##(1992-4#1)(1995-1#2)(2007-6#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-12#1)
the theory##88##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-4#1)(1995-1#3)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#6)(2008-3#19)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#4)
the theory-practice gap##7##3##(2008-11#7)
the theory-practice##8##2##(2008-11#7)(2012-3#1)
the therapeutic application of##2##4##(2007-10#1)(2010-3#1)
the therapeutic applications of##2##4##(2010-5#1)(2013-1#1)
the therapeutic applications##3##3##(2008-5#1)(2010-5#1)(2013-1#1)
the therapeutic approach is##2##4##(1990-12#2)
the therapeutic approach to##2##4##(1990-3#1)(2008-1#1)
the therapeutic approach##6##3##(1990-12#2)(1990-3#1)(1991-6#1)(1997-7#1)(2008-1#1)
the therapeutic benefit##2##3##(1994-3#1)(2008-2#1)
the therapeutic effect of##2##4##(1994-9#1)(2008-3#1)
the therapeutic effect##3##3##(1994-9#1)(1997-4#1)(2008-3#1)
the therapeutic efficacy of##4##4##(1991-8#1)(1995-6#1)(2012-12#1)(2013-1#1)
the therapeutic efficacy##5##3##(1990-3#1)(1991-8#1)(1995-6#1)(2012-12#1)(2013-1#1)
the therapeutic gene##2##3##(2008-11#1)(2008-5#1)
the therapeutic implications##2##3##(2008-5#1)(2008-7#1)
the therapeutic milieu and##2##4##(1993-2#1)(2010-5#1)
the therapeutic milieu##3##3##(1993-2#2)(2010-5#1)
the therapeutic options##3##3##(1993-5#1)(2006-10#1)(2008-5#1)
the therapeutic potential of##8##4##(2007-6#1)(2008-11#1)(2009-3#1)(2012-12#2)(2012-2#2)(2013-8#1)
the therapeutic protein##2##3##(2008-10#1)(2008-5#1)
the therapeutic ratio##3##3##(1992-3#1)(1997-1#1)(2008-10#1)
the therapeutic relationship##2##3##(2008-3#1)(2011-1#1)
the therapeutic response to##2##4##(2008-10#1)(2009-11#1)
the therapeutic response##3##3##(1991-2#1)(2008-10#1)(2009-11#1)
the therapeutic role of##2##4##(1994-6#1)(2013-1#1)
the therapeutic strategy##2##3##(1992-6#1)(2008-4#1)
the therapeutic use of##2##4##(1996-11#1)(2013-8#1)
the therapeutic value of##2##4##(1996-9#1)(1997-4#1)
the therapeutic##102##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#4)(1993-5#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2013-1#5)(2013-8#3)
the therapeutical##3##2##(1990-5#1)(1995-12#1)(2012-7#1)
the therapist##3##2##(1991-12#1)(2008-12#1)(2012-2#1)
the therapy and##2##3##(2008-1#1)(2008-5#1)
the therapy has been##2##4##(1994-2#1)(1996-8#1)
the therapy in##2##3##(2007-7#1)(2011-1#1)
the therapy is##3##3##(1991-12#1)(1997-3#1)(2008-4#1)
the therapy of cancer##2##4##(1994-5#1)(2013-8#1)
the therapy of patients affected##2##5##(1993-6#1)(2008-1#1)
the therapy of patients##3##4##(1993-6#1)(2008-1#1)(2009-8#1)
the therapy of##29##3##(1990-2#1)(1990-3#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-7#2)(2008-9#1)(2009-8#2)(2010-2#1)(2011-3#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the therapy program##2##3##(1991-2#2)
the therapy##58##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-2#3)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-10#2)(2007-11#2)(2007-7#2)(2008-1#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#3)(2010-2#1)(2011-1#2)(2011-2#4)(2011-3#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
the thermal conductivities##2##3##(2008-3#2)
the thermal conductivity of##2##4##(2008-3#2)
the thermal degradation##2##3##(2008-10#1)(2008-3#1)
the thermal diffusivity##4##3##(2008-3#4)
the thermal effect in the##2##5##(2008-3#2)
the thermal effect##3##3##(2008-3#3)
the thermal infrared##3##3##(2008-3#3)
the thermal lens and the##2##5##(2008-2#1)(2008-3#1)
the thermal lens##9##3##(2008-2#4)(2008-3#5)
the thermal offset##2##3##(2008-3#2)
the thermal phase##2##3##(1994-3#1)(2008-10#1)
the thermal range##2##3##(2008-8#2)
the thermal stability of the##2##5##(1993-6#1)(2007-12#1)
the thermal stability of##6##4##(1993-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
the thermal stability##7##3##(1993-6#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
the thermal##81##2##(1993-6#1)(1994-3#1)(1994-8#1)(1996-6#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#8)(2008-2#13)(2008-3#35)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#3)(2012-6#1)(2013-8#1)
the thermal-lens interference##2##3##(2008-3#2)
the thermal-lens##3##2##(2008-10#1)(2008-3#2)
the thermally induced##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
the thermally##6##2##(1992-6#1)(2008-10#1)(2008-2#2)(2008-3#2)
the thermo-optic effect##2##3##(2008-3#2)
the thermo-optic##5##2##(2008-2#2)(2008-3#3)
the thermodynamic activity of##2##4##(1991-11#1)(2008-5#1)
the thermodynamic data##3##3##(2008-10#3)
the thermodynamic equilibrium##2##3##(2008-10#2)
the thermodynamic parameters (Tm##2##4##(1990-7#2)
the thermodynamic parameters were##2##4##(1993-8#1)(2008-10#1)
the thermodynamic parameters##6##3##(1990-7#2)(1993-8#1)(1995-5#1)(2008-10#2)
the thermodynamic##37##2##(1990-7#2)(1990-8#1)(1991-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-8#2)(1995-5#2)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#15)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#2)
the thermodynamically##3##2##(1996-2#1)(2008-10#1)(2012-2#1)
the thermodynamics of##3##3##(1991-8#1)(1992-5#1)(2008-10#1)
the thermodynamics##4##2##(1991-8#1)(1992-5#1)(1997-2#1)(2008-10#1)
the thermoelastic response of##2##4##(2007-12#2)
the thermoelastic##3##2##(2007-12#2)(2008-3#1)
the thermolabile##2##2##(1994-12#1)(2008-4#1)
the thermolytic##2##2##(2008-10#1)(2008-4#1)
the thermometer##2##2##(2008-2#2)
the thermoregulatory##2##2##(1994-2#2)
the thermostability of##3##3##(1991-5#1)(2008-10#1)(2010-9#1)
the thermotropic phase behavior##2##4##(1990-7#2)
the thermotropic##3##2##(1990-7#2)(2008-5#1)
the thesis##2##2##(2008-11#1)(2011-2#1)
the theta parameter of the beta-binomial distribution##2##7##(2008-10#2)
the theta phase##2##3##(2008-11#2)
the theta##6##2##(2008-10#2)(2008-11#4)
the theta-pulse stimulation with the parameter of##2##7##(2008-9#2)
the thiamazole##2##2##(1994-3#2)
the thiamine concentration##2##3##(2008-10#2)
the thiamine##3##2##(2008-1#1)(2008-10#2)
the thiazolidine##2##2##(1995-3#1)(2008-10#1)
the thick##4##2##(1990-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
the thickened##3##2##(2008-5#2)(2011-2#1)
the thickening##2##2##(2008-10#1)(2010-10#1)
the thickness and the##6##4##(2008-10#1)(2008-3#5)
the thickness and##9##3##(2008-10#2)(2008-3#6)(2008-5#1)
the thickness distribution##2##3##(2007-12#1)(2008-7#1)
the thickness of the GaAs crystal##2##6##(2008-2#2)
the thickness of the film##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
the thickness of the final##2##5##(2007-11#2)
the thickness of the first layer##3##6##(2008-2#3)
the thickness of the hologram##2##5##(2007-12#1)(2008-3#1)
the thickness of the layer##2##5##(1991-5#1)(2008-3#1)
the thickness of the unstirred layer in the##4##8##(1991-5#4)
the thickness of the unstirred##5##5##(1991-5#5)
the thickness of the##47##4##(1991-5#6)(1994-3#1)(1996-5#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#10)(2008-3#8)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#2)
the thickness of##59##3##(1991-5#6)(1994-11#1)(1994-3#1)(1996-5#1)(2007-11#3)(2007-12#4)(2008-10#9)(2008-11#1)(2008-2#11)(2008-3#13)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#2)
the thickness or the refractive index##2##6##(2007-12#1)(2008-3#1)
the thickness##86##2##(1991-5#6)(1994-11#1)(1994-3#1)(1996-5#1)(2007-11#5)(2007-12#6)(2008-10#12)(2008-11#1)(2008-2#15)(2008-3#26)(2008-5#4)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#2)
the thicknesses and##2##3##(2008-2#1)(2008-3#1)
the thicknesses##5##2##(2008-2#1)(2008-3#4)
the thigh and##2##3##(2007-11#1)(2007-6#1)
the thigh in##2##3##(2007-11#1)(2009-3#1)
the thigh##17##2##(1991-3#2)(1991-6#1)(1997-3#1)(2007-11#6)(2007-6#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-3#1)(2013-1#1)
the thin filament##2##3##(2008-2#1)(2008-6#1)
the thin film##3##3##(2008-10#2)(2008-2#1)
the thin films##4##3##(2008-3#4)
the thin##19##2##(1991-5#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)
the thin-film##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the thin-layer##2##2##(2008-10#1)(2013-1#1)
the thinnest##4##2##(2007-12#1)(2008-5#1)(2009-7#1)(2011-1#1)
the thiobarbituric acid method##2##4##(1990-8#1)(1992-11#1)
the thiobarbituric acid##3##3##(1990-8#1)(1992-11#1)(2008-5#1)
the thiocyanate concentration##2##3##(2008-10#2)
the thiocyanate##6##2##(2008-10#6)
the thiocyanato-complexes formed##2##3##(2008-10#2)
the thiocyanato-complexes##3##2##(2008-10#3)
the thiol groups##2##3##(2008-10#1)(2011-2#1)
the thiol##8##2##(1991-9#2)(1995-6#1)(2008-10#3)(2008-11#1)(2011-2#1)
the thiols##4##2##(1993-12#1)(2008-10#3)
the thiopurine##2##2##(2010-12#2)
the third and fourth derivatives##2##5##(2008-10#2)
the third and fourth##10##4##(1990-8#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2011-1#1)
the third and##14##3##(1990-8#1)(1993-8#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#1)
the third brain##2##3##(2007-12#2)
the third cause of##2##4##(2008-10#1)(2013-1#1)
the third completed genome sequence of a member of the##2##10##(2011-2#2)
the third component of##2##4##(1992-12#1)(2009-11#1)
the third component##3##3##(1992-12#1)(2008-10#1)(2009-11#1)
the third cycle##3##3##(1990-8#1)(2012-12#2)
the third day##2##3##(1995-3#1)(1995-8#1)
the third degree##2##3##(1996-5#1)(2011-2#1)
the third dose##3##3##(1991-5#1)(1995-3#2)
the third exon##2##3##(1992-3#1)(1993-6#1)
the third experiment##3##3##(2008-10#3)
the third extraction##2##3##(2008-10#2)
the third generation##3##3##(2007-7#1)(2008-10#2)
the third group##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
the third harmonic of##2##4##(2007-11#2)
the third harmonic##4##3##(2007-11#3)(2008-3#1)
the third injection##4##3##(2011-1#1)(2013-1#1)(2013-8#2)
the third instar larvae of transgenic D##2##7##(2013-1#2)
the third is##4##3##(1991-11#1)(1996-4#1)(2008-2#1)(2008-8#1)
the third layer##2##3##(2008-12#2)
the third member of##2##4##(1994-12#1)(2008-2#1)
the third month##3##3##(1996-6#1)(2007-11#1)(2011-1#1)
the third most common cause of##2##6##(1991-6#1)(2012-2#1)
the third most common##4##4##(1991-6#1)(2007-4#1)(2010-8#1)(2012-2#1)
the third most##7##3##(1991-6#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
the third one##2##3##(2007-12#1)(2008-10#1)
the third order##2##3##(2008-2#1)(2009-7#1)
the third overall Adair##2##4##(1990-8#2)
the third part of##2##4##(2008-10#1)(2008-7#1)
the third part##5##3##(2008-10#1)(2008-7#2)(2009-8#1)(2013-8#1)
the third position##3##3##(1990-12#1)(1997-4#1)(2008-11#1)
the third stage##3##3##(1990-3#1)(2008-12#1)(2009-5#1)
the third step##2##3##(1995-5#1)(2009-8#1)
the third study##3##3##(1994-2#1)(2011-2#1)(2013-1#1)
the third thoracic##2##3##(2007-12#1)(2013-1#1)
the third to the##2##4##(1992-6#1)(2008-6#1)
the third trimester of pregnancy##3##5##(1990-12#1)(2007-2#1)(2011-2#1)
the third trimester of##4##4##(1990-12#1)(2007-2#1)(2010-6#1)(2011-2#1)
the third trimester##12##3##(1990-12#2)(1990-6#1)(1990-9#1)(1993-12#1)(1993-3#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2010-6#1)(2011-2#1)
the third ventricle##9##3##(1990-7#1)(1991-8#1)(1996-7#2)(2008-7#5)
the third week##2##3##(1993-12#1)(2012-2#1)
the third world##3##3##(1990-12#1)(1995-6#1)(2008-10#1)
the third year of##2##4##(1992-12#1)(2008-10#1)
the third year##6##3##(1992-12#2)(2008-10#3)(2008-11#1)
the third zinc##2##3##(1991-2#1)(1995-5#1)
the third##243##2##(1990-12#4)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#2)(1995-2#1)(1995-3#5)(1995-5#7)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#36)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-8#1)(2011-1#4)(2011-2#13)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#4)
the third- and fifth-order##2##4##(2007-11#2)
the third- and##3##3##(2007-11#2)(2008-3#1)
the third-harmonic##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
the third-order nonlinear optical response##2##5##(2007-11#1)(2007-12#1)
the third-order nonlinear optical##3##4##(2007-11#1)(2007-12#2)
the third-order nonlinear##5##3##(2007-11#2)(2007-12#3)
the third-order##15##2##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#3)(2008-7#1)(2010-7#1)
the thirty##4##2##(1995-6#1)(2008-12#3)
the thoracic and##2##3##(2010-8#1)(2012-2#1)
the thoracic aorta##8##3##(1997-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-8#1)(2011-2#1)
the thoracic descending aorta##2##4##(1997-8#1)(2010-8#1)
the thoracic inlet##2##3##(1990-3#1)(2011-2#1)
the thoracic spine##3##3##(2008-12#1)(2008-8#2)
the thoracic stiffness##2##3##(2008-9#2)
the thoracic##42##2##(1990-3#1)(1991-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1995-12#2)(1996-3#1)(1997-8#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-8#5)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)
the thoraco-lumbar##2##2##(2007-11#2)
the thoracolumbar spine##4##3##(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
the thoracolumbar##7##2##(1995-11#1)(1997-6#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-3#1)
the thorax of the##3##4##(1992-6#1)(2008-6#1)(2013-1#1)
the thorax##18##2##(1991-12#1)(1992-6#1)(1993-3#1)(1996-1#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
the thorny skate##2##3##(2009-4#1)(2010-8#1)
the thorough##2##2##(1994-5#1)(1997-8#1)
the thousands of##3##3##(1992-11#1)(2008-7#1)(2009-12#1)
the threat of##11##3##(1994-2#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
the threat##13##2##(1994-2#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#1)
the threats##2##2##(1991-1#1)(2008-10#1)
the three &quot##2##3##(1991-2#1)(1996-1#1)
the three BCTV strains##2##4##(2008-10#2)
the three age groups##2##4##(1994-11#1)(2008-7#1)
the three agents##2##3##(2008-10#1)(2008-7#1)
the three amino acid##2##4##(2008-10#1)(2008-8#1)
the three analytes##4##3##(2008-10#4)
the three basic##2##3##(1991-6#1)(2007-12#1)
the three bilirubins##2##3##(2008-10#2)
the three cases##3##3##(2007-12#2)(2008-5#1)
the three castes##3##3##(2008-8#3)
the three clades##2##3##(2008-10#1)(2009-6#1)
the three classes##2##3##(2008-11#1)(2010-8#1)
the three clonal lineages##3##4##(2008-10#1)(2009-2#2)
the three components of the##2##5##(2008-10#1)(2008-2#1)
the three components##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
the three compounds##4##3##(1992-11#2)(2008-10#1)(2011-2#1)
the three conditions##3##3##(2008-11#3)
the three core functions##2##4##(1996-3#2)
the three countries##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
the three criteria##2##3##(2008-8#1)(2012-2#1)
the three cultivars##2##3##(2008-10#1)(2008-12#1)
the three different methods##2##4##(2008-10#2)
the three different##9##3##(2008-10#6)(2008-3#2)(2008-7#1)
the three diseases##2##3##(2008-10#2)
the three distinct##2##3##(2008-10#2)
the three dyes##3##3##(2008-10#3)
the three environments##2##3##(2008-10#2)
the three experimental groups##2##4##(1997-2#1)(1997-6#1)
the three experimental##3##3##(1997-2#1)(1997-6#1)(2008-10#1)
the three fractions##3##3##(1992-12#1)(1993-8#1)(2008-10#1)
the three genera##4##3##(1996-6#2)(1997-4#1)(2008-10#1)
the three genes##2##3##(1995-6#1)(2008-10#1)
the three groups in##3##4##(1994-12#1)(2009-10#1)(2012-2#1)
the three groups of##5##4##(1995-12#1)(2008-10#3)(2008-5#1)
the three groups were##2##4##(1993-1#1)(2008-10#1)
the three groups##37##3##(1991-9#1)(1993-1#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#2)
the three human##5##3##(1993-12#1)(1994-6#2)(2008-10#1)(2008-3#1)
the three independent##2##3##(1995-8#1)(2008-9#1)
the three kinds of##3##4##(2008-10#2)(2008-9#1)
the three largest cities in##2##5##(2008-10#2)
the three largest##3##3##(2008-10#2)(2008-12#1)
the three lineages##2##3##(2009-2#2)
the three main##12##3##(1994-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
the three major classes of ionotropic glutamate receptors##2##8##(1995-11#2)
the three major classes of##3##5##(1995-11#2)(2008-4#1)
the three major classes##4##4##(1994-2#1)(1995-11#2)(2008-4#1)
the three major##17##3##(1990-5#1)(1992-11#1)(1994-2#1)(1995-11#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
the three metals##3##3##(2008-10#3)
the three methods are##2##4##(2008-10#2)
the three methods used##2##4##(2008-10#1)(2012-3#1)
the three methods##10##3##(1993-2#1)(2008-10#6)(2008-12#1)(2012-1#1)(2012-3#1)
the three microsatellite##2##3##(2008-4#1)(2008-5#1)
the three most common##2##4##(2007-2#1)(2011-2#1)
the three most##6##3##(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
the three other##3##3##(1993-3#1)(1996-12#1)(2008-10#1)
the three patients##4##3##(2008-3#1)(2011-2#2)(2013-1#1)
the three periods after surgery##2##5##(1995-4#2)
the three phases of the##2##5##(2008-11#1)(2013-8#1)
the three phases of##3##4##(1991-3#1)(2008-11#1)(2013-8#1)
the three possible##2##3##(1993-8#1)(2008-10#1)
the three practices##3##3##(2010-11#3)
the three principal##2##3##(1997-7#1)(2008-3#1)
the three products##2##3##(1990-7#1)(1996-3#1)
the three proteins##5##3##(1991-2#1)(1994-8#2)(1995-5#1)(1997-2#1)
the three receptor subtypes##2##4##(1994-6#1)(2007-11#1)
the three regions##3##3##(1990-7#1)(2013-1#2)
the three remaining##3##3##(1992-11#1)(1992-5#1)(1993-2#1)
the three samples##2##3##(1992-6#1)(2008-10#1)
the three scales##3##3##(2008-10#2)(2011-1#1)
the three species##6##3##(1992-8#1)(2011-3#3)(2012-8#1)(2012-9#1)
the three stages##2##3##(2012-12#1)(2013-8#1)
the three strains##4##3##(1993-9#1)(1995-6#1)(2008-10#1)(2008-7#1)
the three studied##3##3##(2008-10#3)
the three tests##2##3##(1992-10#1)(2008-12#1)
the three treatment##2##3##(1997-3#1)(2008-10#1)
the three types of##13##4##(1990-6#1)(1994-12#1)(1995-11#1)(1996-2#2)(1997-4#1)(2008-10#4)(2009-7#2)(2009-9#1)
the three types##14##3##(1990-6#1)(1992-1#1)(1994-12#1)(1995-11#1)(1996-2#2)(1997-4#1)(2008-10#4)(2009-7#2)(2009-9#1)
the three uplift intervals of the##2##6##(2008-9#2)
the three viruses##2##3##(2008-10#2)
the three years##2##3##(2010-8#1)(2011-2#1)
the three##590##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-2#5)(1991-3#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#4)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#1)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#2)(1996-1#3)(1996-12#5)(1996-2#5)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#3)(1997-8#1)(1997-9#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#165)(2008-11#14)(2008-12#14)(2008-2#7)(2008-3#14)(2008-4#7)(2008-5#18)(2008-6#2)(2008-7#17)(2008-8#15)(2008-9#11)(2009-10#8)(2009-12#1)(2009-2#5)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#4)(2010-12#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#7)(2011-2#14)(2011-3#4)(2012-1#3)(2012-12#4)(2012-2#11)(2012-3#4)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#8)
the three-dimensional (3-D)##2##3##(2008-3#1)(2008-8#1)
the three-dimensional intensity distribution##2##4##(2008-2#1)(2008-3#1)
the three-dimensional shape##2##3##(2008-2#1)(2008-3#1)
the three-dimensional structure of the##4##5##(1990-7#1)(1990-8#1)(1993-8#1)(1997-4#1)
the three-dimensional structure of##8##4##(1990-7#1)(1990-8#1)(1993-8#1)(1995-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2013-1#1)
the three-dimensional structure##10##3##(1990-7#1)(1990-8#1)(1993-11#1)(1993-8#1)(1995-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
the three-dimensional structures of##2##4##(1995-2#1)(2008-9#1)
the three-dimensional##54##2##(1990-7#1)(1990-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-2#3)(1997-4#1)(2007-11#5)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#14)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2010-7#1)(2010-8#1)(2013-1#1)
the three-month##3##2##(1991-6#1)(2008-5#1)(2013-1#1)
the three-step technique##3##3##(2009-8#3)
the three-step##5##2##(1994-8#1)(2008-10#1)(2009-8#3)
the three-way data##2##3##(2008-10#2)
the three-way##3##2##(2008-10#3)
the three-year##5##2##(1997-3#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)
the threefold##2##2##(2008-10#1)(2008-2#1)
the threshold and##2##3##(2007-12#1)(2008-8#1)
the threshold concentration##2##3##(1993-12#2)
the threshold dose##3##3##(2008-10#2)(2008-7#1)
the threshold energy##2##3##(2007-12#1)(2008-3#1)
the threshold fluence##2##3##(2008-3#2)
the threshold for induction of##2##5##(1994-2#1)(1995-2#1)
the threshold for##12##3##(1994-2#1)(1995-11#1)(1995-2#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-1#1)
the threshold if the##2##4##(2008-10#2)
the threshold of##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
the threshold power for##2##4##(2007-12#2)
the threshold value##4##3##(1996-8#1)(2008-10#2)(2009-8#1)
the threshold voltage##2##3##(2008-7#1)(2009-5#1)
the threshold##66##2##(1990-11#1)(1991-4#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-2#2)(1996-8#1)(1997-2#1)(2007-12#7)(2008-10#15)(2008-2#1)(2008-3#13)(2008-7#4)(2008-8#2)(2008-9#4)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
the thresholds##5##2##(2008-10#1)(2008-4#2)(2008-8#1)(2012-2#1)
the thrips##4##2##(2008-10#4)
the thrombin##5##2##(1990-7#2)(1995-5#2)(1997-7#1)
the thrombogenic##2##2##(1994-5#1)(2008-8#1)
the thrombolytic##4##2##(1990-12#1)(1994-3#1)(2008-3#1)(2008-8#1)
the thrombosis##2##2##(1997-2#1)(1997-6#1)
the thrombotic##8##2##(1990-3#1)(1997-1#1)(2006-6#2)(2008-3#1)(2008-7#1)(2010-6#1)(2012-3#1)
the thrombus was##4##3##(1990-8#2)(2011-2#1)(2013-1#1)
the thrombus##7##2##(1990-8#4)(2010-6#1)(2011-2#1)(2013-1#1)
the through-thickness##3##2##(2009-7#3)
the throughput was##2##3##(2007-9#1)(2008-10#1)
the throughput##10##2##(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#4)
the thrower's elbow is##2##4##(2008-8#2)
the thumb##8##2##(1990-8#1)(2008-9#6)(2010-7#1)
the thylakoid##6##2##(1990-5#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-11#2)
the thylakoids##2##2##(1991-12#1)(2009-7#1)
the thymic##11##2##(1991-8#2)(1993-12#1)(1995-5#1)(2007-8#1)(2008-8#2)(2013-7#4)
the thymidine analogue##2##3##(1993-11#1)(1996-5#1)
the thymidine uptake##2##3##(1994-3#1)(2008-5#1)
the thymidine##7##2##(1993-11#1)(1993-12#1)(1994-3#1)(1996-5#1)(2007-11#1)(2008-4#1)(2008-5#1)
the thymine##3##2##(1991-7#1)(1992-3#1)(1992-6#1)
the thymus and##5##3##(1993-3#2)(1997-9#2)(2008-10#1)
the thymus gland##2##3##(2008-7#1)(2013-7#1)
the thymus of##2##3##(1994-5#1)(1997-7#1)
the thymus##30##2##(1991-12#1)(1991-8#1)(1993-3#2)(1994-5#2)(1997-5#2)(1997-7#3)(1997-9#3)(2008-10#7)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#2)(2013-7#2)
the thyroid and##3##3##(2008-4#1)(2009-3#1)(2013-8#1)
the thyroid gland was##2##4##(2011-1#2)
the thyroid gland##20##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-2#1)(1993-5#2)(1996-3#1)(1997-2#1)(2008-12#1)(2008-7#1)(2008-9#2)(2011-1#3)(2012-1#2)(2013-1#3)
the thyroid glands of##2##4##(1990-2#1)(1995-12#1)
the thyroid hormone##4##3##(1994-11#2)(1997-7#1)(2008-1#1)
the thyroid state##2##3##(2007-8#2)
the thyroid##55##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1992-2#3)(1992-8#4)(1993-5#2)(1994-11#2)(1995-12#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-8#3)(2008-1#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#3)(2011-1#5)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
the thyroids##3##2##(2008-7#2)(2012-1#1)
the thyrotropin receptor (TSHr)##2##4##(1994-11#1)(2008-4#1)
the thyrotropin receptor##6##3##(1994-11#4)(1996-5#1)(2008-4#1)
the thyrotropin##7##2##(1992-12#1)(1994-11#4)(1996-5#1)(2008-4#1)
the tibia##25##2##(2007-11#3)(2007-12#2)(2007-8#1)(2008-12#1)(2008-6#3)(2008-9#1)(2009-3#7)(2009-7#1)(2010-3#2)(2011-2#1)(2013-1#1)(2013-8#2)
the tibial##12##2##(1990-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#2)
the tick##8##2##(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#2)(2010-10#1)(2013-8#1)
the tidal##2##2##(2010-8#1)(2013-7#1)
the tide of##2##3##(1991-1#1)(2009-5#1)
the tight association##2##3##(1990-2#1)(2009-2#1)
the tight skin (TSK)##2##4##(1997-8#2)
the tight##13##2##(1990-2#1)(1990-7#2)(1992-3#1)(1993-11#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-2#1)
the tight-binding method##2##3##(2007-11#1)(2008-10#1)
the tight-junctional##2##2##(2008-11#2)
the tightly bound##2##3##(1992-3#1)(1992-6#1)
the tightly##9##2##(1992-3#1)(1992-6#3)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)
the tiled regression method##2##4##(2012-3#2)
the tillage##2##2##(2008-10#2)
the tilt angle of##3##4##(2008-2#1)(2008-3#2)
the tilt angle##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
the tilt estimator##2##3##(2008-2#2)
the tilt of the##4##4##(1994-5#1)(2008-2#2)(2008-3#1)
the tilt##20##2##(1994-5#1)(2007-11#2)(2008-2#8)(2008-3#9)
the tilting angle##2##3##(2008-2#2)
the time a##2##3##(1993-3#1)(1996-3#1)
the time after the##2##4##(1996-6#1)(2008-7#1)
the time after##3##3##(1994-10#1)(1996-6#1)(2008-7#1)
the time and frequency##2##4##(2007-11#1)(2008-3#1)
the time and##16##3##(1990-9#1)(1992-12#1)(1994-1#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-9#1)
the time available##2##3##(1996-12#2)
the time but##2##3##(2008-11#1)(2008-7#1)
the time constant of##2##4##(1997-7#1)(2013-8#1)
the time constants##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
the time course and##2##4##(2008-9#1)(2013-1#1)
the time course of ChL##2##5##(2008-10#2)
the time course of changes##2##5##(1997-3#1)(2013-1#1)
the time course of the##6##5##(1995-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
the time course of##21##4##(1991-5#1)(1992-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
the time course##26##3##(1991-2#1)(1991-5#1)(1992-8#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#3)
the time courses of##2##4##(2008-10#1)(2008-7#1)
the time delay of##3##4##(2007-11#2)(2007-12#1)
the time delay##7##3##(1996-6#1)(2007-11#2)(2007-12#2)(2008-3#1)(2009-9#1)
the time dependence of the##5##5##(1993-8#1)(2007-12#2)(2008-2#2)
the time dependence of##6##4##(1993-8#1)(2007-12#2)(2008-10#1)(2008-2#2)
the time difference between##2##4##(1994-3#1)(2008-10#1)
the time domain##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)
the time duration of##2##4##(1992-8#1)(2008-10#1)
the time elapsed##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
the time elapsing between##2##4##(1994-3#2)
the time evolution of the##2##5##(2008-1#1)(2013-8#1)
the time evolution of##4##4##(2008-1#1)(2008-2#1)(2010-4#1)(2013-8#1)
the time factor##2##3##(1994-11#1)(2008-10#1)
the time for##7##3##(1994-1#1)(1997-4#1)(2008-10#3)(2008-12#1)(2010-9#1)
the time frame##3##3##(2008-11#1)(2010-8#1)(2012-3#1)
the time from muzzle##2##4##(1997-6#2)
the time from the##2##4##(1997-6#2)
the time from##8##3##(1997-6#4)(2007-8#1)(2008-10#2)(2008-3#1)
the time in##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
the time interval between##4##4##(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
the time interval##7##3##(1997-8#1)(2008-10#2)(2008-3#1)(2008-9#2)(2013-1#1)
the time intervals between##4##4##(1997-6#1)(2007-12#1)(2008-3#1)(2010-8#1)
the time intervals##5##3##(1997-6#1)(2007-12#1)(2008-3#1)(2010-8#1)(2012-1#1)
the time is ripe to##2##5##(2009-5#1)(2013-1#1)
the time it takes to##2##5##(1993-3#1)(2010-5#1)
the time necessary for the##3##5##(2008-10#2)(2008-4#1)
the time necessary##4##3##(2008-10#3)(2008-4#1)
the time needed for##5##4##(1991-3#1)(1995-3#1)(2008-10#2)(2008-3#1)
the time needed##6##3##(1991-3#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-3#1)
the time of a##2##4##(2008-10#2)
the time of birth##3##4##(2008-11#1)(2008-5#1)(2012-3#1)
the time of contact##2##4##(2008-10#1)(2008-11#1)
the time of day##5##4##(2008-10#1)(2008-5#1)(2009-8#2)(2012-5#1)
the time of delivery##3##4##(1994-6#1)(2008-4#2)
the time of diagnosis##13##4##(1990-10#2)(1992-3#1)(1993-1#1)(1994-10#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-3#1)
the time of discharge##3##4##(2008-11#1)(2008-3#1)(2012-12#1)
the time of disease onset##2##5##(2008-10#2)
the time of exposure##2##4##(2007-12#1)(2012-2#1)
the time of infection##2##4##(2008-10#1)(2008-11#1)
the time of initial##4##4##(1992-2#1)(2007-11#1)(2008-6#1)(2012-3#1)
the time of injection##2##4##(1995-5#1)(2010-7#1)
the time of injury##3##4##(2008-9#2)(2011-2#1)
the time of its##2##4##(2007-7#1)(2008-3#1)
the time of onset##3##4##(1990-5#1)(2008-10#1)(2008-4#1)
the time of sampling##4##4##(1991-5#1)(1992-12#1)(2008-10#1)(2008-5#1)
the time of surgery##8##4##(1990-8#1)(1991-3#1)(1993-11#1)(2007-11#2)(2008-7#1)(2011-2#2)
the time of surgical##2##4##(1990-8#1)(1992-5#1)
the time of the analysis##2##5##(1990-6#1)(2010-3#1)
the time of the whole##2##5##(2008-10#2)
the time of the##35##4##(1990-3#1)(1990-6#2)(1991-12#2)(1991-2#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
the time of their##5##4##(1995-6#1)(1996-12#1)(2010-1#1)(2012-3#1)(2013-8#1)
the time of transplantation##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
the time of writing##2##4##(1992-9#1)(2011-2#1)
the time of##225##3##(1990-10#3)(1990-11#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-12#6)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-5#2)(1995-6#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#4)(2007-12#3)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#33)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#7)(2009-1#1)(2009-2#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#6)(2013-8#1)
the time period studied##2##4##(2008-10#1)(2010-11#1)
the time period##10##3##(1991-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-9#2)(2009-2#2)(2010-11#1)(2011-2#1)
the time periods##3##3##(2007-2#1)(2007-8#1)(2012-3#1)
the time ratio##2##3##(2007-11#1)(2008-3#1)
the time required for the##3##5##(2008-10#3)
the time required for##15##4##(2007-12#1)(2008-10#10)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
the time required to complete##2##5##(1993-12#1)(2008-10#1)
the time required to##12##4##(1993-12#1)(1995-12#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-8#1)(2011-2#2)
the time required##28##3##(1993-12#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#3)
the time scale of##4##4##(1994-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
the time scale##5##3##(1994-12#1)(2007-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
the time series of the scattered light##2##7##(2008-3#2)
the time series of##3##4##(2008-2#1)(2008-3#2)
the time since the##2##4##(1991-11#1)(2008-10#1)
the time since##3##3##(1991-11#1)(2008-10#1)(2010-12#1)
the time spent in##3##4##(2007-10#1)(2009-10#1)(2011-2#1)
the time spent on##2##4##(1993-12#1)(2013-1#1)
the time spent##7##3##(1993-12#1)(2007-10#1)(2009-10#1)(2009-4#1)(2011-2#2)(2013-1#1)
the time structure##2##3##(2008-11#2)
the time taken for##3##4##(2008-10#2)(2011-2#1)
the time taken to##2##4##(1990-11#1)(2007-7#1)
the time taken##7##3##(1990-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
the time that##2##3##(1997-2#1)(2008-10#1)
the time the##10##3##(1991-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1996-5#1)(2008-3#1)(2011-2#1)(2013-8#1)
the time to extinction of##2##5##(2008-9#2)
the time to onset of convulsions##2##6##(1993-12#2)
the time to reach##2##4##(2008-8#1)(2011-2#1)
the time to##25##3##(1990-7#1)(1991-2#1)(1993-12#2)(1994-3#1)(1996-4#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#2)
the time variation of##2##4##(2008-3#1)(2011-2#1)
the time when the##4##4##(2007-8#1)(2008-10#3)
the time when##11##3##(2007-8#1)(2008-10#7)(2008-9#2)(2011-2#1)
the time##579##2##(1990-10#3)(1990-11#4)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#6)(1992-5#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#8)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#2)(1996-9#3)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#6)(1997-7#2)(1997-8#3)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#15)(2007-2#1)(2007-7#7)(2007-8#9)(2007-9#1)(2008-1#9)(2008-10#99)(2008-11#24)(2008-12#3)(2008-2#8)(2008-3#24)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#16)(2008-8#11)(2008-9#22)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#2)(2011-2#28)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#10)(2012-5#1)(2013-1#17)(2013-8#4)
the time- and##3##3##(2008-3#3)
the time-averaged##4##2##(2008-3#2)(2008-8#1)(2012-3#1)
the time-averaging##2##2##(2008-3#2)
the time-consuming##3##2##(1995-6#1)(2008-10#2)
the time-correlated##2##2##(2007-11#1)(2008-3#1)
the time-course##2##2##(1994-8#1)(2013-8#1)
the time-dependence##2##2##(1992-12#1)(2008-7#1)
the time-dependent response##2##3##(1997-7#1)(2010-2#1)
the time-dependent##20##2##(1992-11#1)(1995-6#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#2)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)
the time-depth dependence of##2##4##(2008-3#2)
the time-depth##3##2##(2008-3#3)
the time-domain demodulation technique##2##4##(2007-11#1)(2007-12#1)
the time-domain##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
the time-resolved##4##2##(2008-2#1)(2008-3#3)
the time-varying##4##2##(2008-2#2)(2008-3#2)
the timecourse of responses##2##4##(2008-11#2)
the timecourse of the##2##4##(2008-11#2)
the timecourse of##6##3##(1993-8#1)(2008-11#5)
the timeline##3##2##(2008-1#1)(2008-9#1)(2010-12#1)
the timely##7##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)
the times of##2##3##(2006-12#1)(2013-1#1)
the times##8##2##(1992-2#1)(1996-4#1)(1997-4#1)(2006-12#1)(2008-10#2)(2009-9#1)(2013-1#1)
the timescales of##2##3##(1997-5#1)(2008-8#1)
the timing and##7##3##(2007-12#2)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
the timing error of##2##4##(2007-12#2)
the timing jitter##2##3##(2007-11#2)
the timing of apothecium##2##4##(2008-10#2)
the timing of surgery##2##4##(2007-12#1)(2010-8#1)
the timing of the##12##4##(1995-12#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)
the timing of their##2##4##(1994-7#1)(1995-5#1)
the timing of##50##3##(1992-12#1)(1993-12#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#2)(1997-5#1)(1997-6#1)(2007-12#4)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-2#1)(2012-3#1)(2012-6#1)
the timing##69##2##(1990-5#1)(1992-12#1)(1993-12#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#2)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#5)(2011-2#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
the tinea unguium of the toenails##2##6##(2008-5#2)
the tinnitus##3##2##(1996-6#2)(2010-7#1)
the tiny##2##2##(1994-9#1)(2013-1#1)
the tip of a##11##4##(1990-9#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-7#1)
the tip of an##2##4##(2007-12#1)(2008-10#1)
the tip of the breast##2##5##(1994-12#2)
the tip of the microsyringe##2##5##(2008-10#2)
the tip of the sensillum##2##5##(2007-12#1)(2010-11#1)
the tip of the##32##4##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-7#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-12#1)
the tip of##48##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-7#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#15)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-12#1)
the tip##63##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-2#2)(1995-3#1)(1996-7#1)(2007-11#4)(2007-12#9)(2007-7#1)(2007-8#1)(2008-10#17)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#1)
the tip-sample##4##2##(2007-12#2)(2008-3#1)(2012-2#1)
the tipping point##2##3##(2012-2#2)
the tips of the##3##4##(1991-12#1)(2008-7#2)
the tips of##5##3##(1991-12#1)(2008-10#1)(2008-7#2)(2010-3#1)
the tips##7##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-3#1)(2011-2#1)
the tissue and##2##3##(2008-3#1)(2011-1#1)
the tissue compatibility of##2##4##(2012-3#2)
the tissue distribution of##2##4##(1992-9#1)(2008-4#1)
the tissue distribution##3##3##(1992-9#1)(2008-4#1)(2008-7#1)
the tissue from which##2##4##(1992-9#1)(2008-11#1)
the tissue is##5##3##(2008-1#1)(2008-10#1)(2008-3#3)
the tissue of##3##3##(1990-7#1)(2007-12#1)(2012-2#1)
the tissue sample##2##3##(1996-12#1)(2009-8#1)
the tissue specific expression##2##4##(1994-11#1)(2008-8#1)
the tissue specific##3##3##(1994-11#1)(2008-8#1)(2008-9#1)
the tissue surface##10##3##(2008-2#2)(2008-3#5)(2009-11#1)(2011-1#1)(2013-1#1)
the tissue was##2##3##(2008-11#1)(2008-9#1)
the tissue##107##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-12#6)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#20)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
the tissue-specific##4##2##(1993-12#1)(1997-6#1)(2008-10#1)(2010-7#1)
the tissues adjacent to##2##4##(2008-10#1)(2009-4#1)
the tissues and##4##3##(1996-3#1)(2008-11#1)(2008-3#1)(2008-8#1)
the tissues examined##4##3##(1991-5#1)(1993-12#1)(2008-10#2)
the tissues of##5##3##(1993-12#1)(2008-12#2)(2008-3#1)(2009-7#1)
the tissues studied##2##3##(1996-5#1)(2008-5#1)
the tissues##47##2##(1990-12#1)(1990-5#1)(1991-5#1)(1993-1#1)(1993-12#2)(1994-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
the titanium surface##2##3##(2013-1#2)
the titanium##8##2##(2008-10#1)(2008-11#2)(2008-5#1)(2009-11#1)(2010-4#1)(2013-1#2)
the titer of##5##3##(1992-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
the titer##7##2##(1992-12#1)(1992-9#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
the titers of##4##3##(2008-4#2)(2008-9#1)(2010-3#1)
the titers##5##2##(2008-4#2)(2008-8#1)(2008-9#1)(2010-3#1)
the title &quot##3##3##(1993-2#2)(1995-3#1)
the title and##2##3##(2008-4#1)(2013-1#1)
the title compounds##7##3##(1994-3#1)(1997-4#1)(2007-11#2)(2008-10#1)(2011-1#1)(2012-3#1)
the title of##2##3##(2007-5#1)(2010-11#1)
the title##18##2##(1993-2#2)(1994-3#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#2)
the titrant solution##4##3##(2008-10#4)
the titrant##21##2##(2008-10#21)
the titrated##2##2##(2008-10#2)
the titration cell##2##3##(2008-10#2)
the titration curves##2##3##(1991-8#1)(2008-10#1)
the titration of##5##3##(1991-9#1)(1996-12#1)(2008-10#3)
the titration to##2##3##(2008-10#2)
the titration##31##2##(1991-8#1)(1991-9#1)(1996-12#1)(2008-10#28)
the toad##4##2##(1993-5#2)(2008-5#1)(2008-6#1)
the tobacco hornworm##2##3##(1991-12#1)(2008-7#1)
the tobacco##15##2##(1991-12#1)(1991-6#1)(1992-2#1)(1993-6#1)(1996-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-7#1)(2011-2#1)
the tolerability of##4##3##(1991-2#1)(1992-11#1)(1994-6#1)(2008-3#1)
the tolerability##6##2##(1991-2#2)(1992-11#1)(1994-6#1)(2008-3#1)(2008-4#1)
the tolerance amount of other##2##5##(2008-10#2)
the tolerance limits##2##3##(2008-10#2)
the tolerance of##3##3##(2008-3#2)(2011-1#1)
the tolerance to##2##3##(1997-2#1)(2008-2#1)
the tolerance##19##2##(1990-5#1)(1997-2#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-5#1)(2011-1#1)
the tolerant##4##2##(2008-10#3)(2011-10#1)
the toll-like receptor##3##3##(2008-3#1)(2009-8#1)(2013-8#1)
the tomato and##2##3##(2008-10#2)
the tomato##8##2##(1995-2#1)(2008-10#4)(2008-8#1)(2010-4#1)(2011-2#1)
the tomographic##2##2##(2007-11#1)(2008-2#1)
the tone##2##2##(1991-9#1)(2008-10#1)
the tongue and##4##3##(1993-1#2)(1997-6#1)(2013-1#1)
the tongue##17##2##(1993-1#3)(1995-9#1)(1997-4#1)(1997-6#1)(2007-8#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#3)
the tonoplast##3##2##(2008-10#2)(2008-11#1)
the tool for##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
the tool was##2##3##(2008-11#1)(2008-12#1)
the tool##15##2##(2007-11#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
the tools of##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
the tools that are##2##4##(2008-3#1)(2008-9#1)
the tools that##3##3##(1996-12#1)(2008-3#1)(2008-9#1)
the tools to##7##3##(1993-12#2)(1996-12#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
the tools##24##2##(1993-12#2)(1996-1#2)(1996-12#2)(1996-3#1)(1996-6#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#3)(2009-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the tooth structure##2##3##(2008-7#1)(2010-10#1)
the tooth with##2##3##(2008-7#1)(2011-2#1)
the tooth##14##2##(1991-2#1)(1996-2#1)(1997-4#2)(2008-5#1)(2008-7#3)(2009-4#1)(2010-10#1)(2011-2#2)(2013-1#2)
the top and the bottom##4##5##(2008-2#2)(2008-3#2)
the top and##5##3##(2008-12#1)(2008-2#2)(2008-3#2)
the top component##2##3##(1992-8#1)(2008-9#1)
the top five##2##3##(2008-12#1)(2012-2#1)
the top of the atmosphere##2##5##(2008-2#2)
the top of the##14##4##(1990-7#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)
the top of##20##3##(1990-7#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-8#1)(2010-6#1)(2013-8#1)
the top port##2##3##(2008-6#2)
the top predator##2##3##(2008-8#1)(2008-9#1)
the top surface of the##2##5##(2008-3#1)(2008-7#1)
the top three##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
the top##71##2##(1990-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
the top-down modulation of##2##4##(2013-8#2)
the top-layer optical properties##2##4##(2008-2#1)(2008-3#1)
the top-layer##3##2##(2008-2#1)(2008-3#2)
the top1##2##2##(1995-5#2)
the topic is##2##3##(1994-2#1)(2012-2#1)
the topic of noneconomic damages in medical malpractice cases##2##9##(1991-1#1)(1992-1#1)
the topic of##11##3##(1991-1#1)(1992-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2012-2#1)
the topic was##2##3##(2008-10#1)(2012-3#1)
the topic##30##2##(1991-1#1)(1992-1#1)(1992-2#1)(1994-2#3)(1996-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
the topical application of##3##4##(1991-8#1)(2008-5#2)
the topical application##5##3##(1991-8#1)(2008-12#1)(2008-5#3)
the topical treatment of##3##4##(1990-6#2)(2010-8#1)
the topical##9##2##(1990-6#2)(1991-8#1)(1994-2#1)(2008-12#1)(2008-5#3)(2010-8#1)
the topics of##3##3##(1995-2#1)(1996-2#1)(2011-1#1)
the topics##12##2##(1994-2#2)(1995-2#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-3#1)
the topographic##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
the topographical##4##2##(1994-2#2)(2008-3#2)
the topography of##5##3##(1990-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
the topography##10##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-1#1)
the topoisomerase##4##2##(1994-6#1)(1994-8#1)(1995-3#1)(2008-5#1)
the topological charges of##2##4##(2007-11#1)(2007-12#1)
the topological##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
the topologically##2##2##(2007-12#1)(2010-2#1)
the topology and##3##3##(1997-7#1)(2008-10#1)(2009-5#1)
the topology of the##4##4##(1990-11#1)(1995-6#1)(2008-7#1)(2013-1#1)
the topology of##6##3##(1990-11#1)(1992-4#1)(1995-6#1)(2008-3#1)(2008-7#1)(2013-1#1)
the topology##9##2##(1990-11#1)(1992-4#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)
the torcular##2##2##(1996-9#2)
the torque##4##2##(1993-12#1)(2008-3#2)(2013-1#1)
the torsion##2##2##(2008-4#1)(2011-2#1)
the torture##2##2##(1996-3#1)(2013-1#1)
the total DNA##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
the total Medicaid##2##3##(1991-3#1)(1992-3#1)
the total RNA##3##3##(2008-10#2)(2008-7#1)
the total TEQ##2##3##(2008-10#2)
the total absorption##3##3##(2008-3#3)
the total acid##2##3##(2008-10#1)(2008-3#1)
the total acidity##2##3##(2008-10#2)
the total amino##2##3##(2010-4#2)
the total amount of##25##4##(1990-7#1)(1991-6#1)(1991-9#1)(1995-6#1)(1996-12#3)(2008-10#8)(2008-11#2)(2008-8#4)(2009-5#2)(2010-2#1)(2010-4#1)
the total amount##27##3##(1990-7#1)(1991-6#1)(1991-9#1)(1995-6#1)(1996-12#3)(1996-5#1)(2008-10#9)(2008-11#2)(2008-8#4)(2009-5#2)(2010-2#1)(2010-4#1)
the total analysis time##2##4##(2008-10#2)
the total analytical system##2##4##(2010-7#2)
the total antioxidant activity##2##4##(2008-10#2)
the total antioxidant capacity of##2##5##(2008-10#1)(2009-6#1)
the total antioxidant capacity##3##4##(2008-10#2)(2009-6#1)
the total antioxidant##5##3##(2008-10#4)(2009-6#1)
the total area of erosions and the level of thiobarbituric acid-reactive substances##2##12##(1995-12#2)
the total area of erosions and##4##6##(1995-12#4)
the total area of##5##4##(1995-12#4)(2008-6#1)
the total area##7##3##(1995-12#4)(2008-6#1)(2008-8#1)(2012-1#1)
the total arsenic##2##3##(2008-10#2)
the total assay time##3##4##(1996-12#1)(2008-10#1)(2010-5#1)
the total atmospheric##2##3##(1991-6#1)(2008-3#1)
the total backscattering##2##3##(2008-3#2)
the total bacterial##3##3##(1992-2#1)(2008-8#1)(2010-4#1)
the total biomass##3##3##(2008-7#3)
the total body##2##3##(1992-2#1)(2013-1#1)
the total cell##4##3##(1994-12#1)(1994-8#1)(2008-1#1)(2008-11#1)
the total chromatography##2##3##(2008-10#2)
the total concentration of the##2##5##(2008-10#2)
the total concentration of##9##4##(2008-10#8)(2012-1#1)
the total concentration##10##3##(2008-10#9)(2012-1#1)
the total content of##2##4##(1992-6#1)(2008-10#1)
the total content##3##3##(1992-6#1)(2008-10#2)
the total costs##2##3##(1992-12#1)(2011-1#1)
the total decomposition##2##3##(2008-10#2)
the total density##2##3##(2008-10#1)(2008-8#1)
the total depolarization##2##3##(2008-3#2)
the total dissolved##2##3##(2008-10#2)
the total dose##6##3##(2007-10#2)(2007-9#1)(2008-7#1)(2013-1#2)
the total dye content##2##4##(2008-10#2)
the total endoscopic##2##3##(2007-8#1)(2008-11#1)
the total energy##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
the total enthalpy##2##3##(1994-3#1)(2008-2#1)
the total error##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the total evaporation##2##3##(2008-10#2)
the total flow##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
the total foamate volume##2##4##(2008-6#2)
the total glucose metabolism##2##4##(2008-3#2)
the total graftectomy (TGE)##2##4##(2011-3#2)
the total group##2##3##(2008-8#1)(2009-1#1)
the total hip##2##3##(2010-3#1)(2013-1#1)
the total internal reflection##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
the total intracellular##3##3##(1990-12#1)(1994-3#1)(1995-11#1)
the total length##3##3##(1996-10#1)(1997-8#1)(2008-5#1)
the total mass##2##3##(1994-12#1)(2008-10#1)
the total measured##2##3##(2007-8#1)(2008-3#1)
the total nitrogen##2##3##(2008-11#1)(2013-1#1)
the total number of carbon atoms in##2##7##(1990-7#1)(2008-10#1)
the total number of deaths in##2##6##(1991-9#1)(2011-3#1)
the total number of offspring##2##5##(2008-8#1)(2008-9#1)
the total number of patients##2##5##(1992-6#1)(1995-2#1)
the total number of sensor-reference data pairs was approximately##2##9##(2009-9#2)
the total number of##52##4##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#2)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
the total number##53##3##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#2)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
the total numbers##2##3##(2007-5#1)(2011-2#1)
the total of##11##3##(1991-8#1)(1992-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
the total optical##2##3##(2008-3#1)(2010-12#1)
the total organic##2##3##(2008-10#2)
the total population of Antioquia##2##5##(2012-12#2)
the total population of##7##4##(1995-3#2)(1996-5#1)(2008-1#1)(2008-5#1)(2012-12#2)
the total population##21##3##(1994-2#1)(1994-3#1)(1995-3#2)(1996-5#1)(1996-6#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-8#3)
the total production of##2##4##(1992-3#1)(2007-12#1)
the total protein##7##3##(1993-12#1)(2008-10#3)(2008-6#3)
the total proteins##4##3##(1996-8#1)(2008-8#3)
the total quality management process##2##5##(1994-1#1)(1994-2#1)
the total quality management##3##4##(1994-1#1)(1994-2#1)(1995-3#1)
the total quality##4##3##(1992-12#1)(1994-1#1)(1994-2#1)(1995-3#1)
the total reflectance##2##3##(2008-3#2)
the total sample##6##3##(1994-3#1)(2008-10#1)(2008-5#2)(2011-1#1)(2012-12#1)
the total score##3##3##(1991-9#1)(2007-12#1)(2010-10#1)
the total selenium content##2##4##(2008-10#2)
the total serum##2##3##(1993-2#1)(2006-6#1)
the total spin##2##3##(1997-7#1)(2008-10#1)
the total sulphur content##2##4##(2008-10#2)
the total surface area##3##4##(1997-1#1)(2008-3#1)(2010-10#1)
the total surfactant concentration##2##4##(2008-10#1)(2008-5#1)
the total uncertainty##2##3##(2008-10#1)(2008-3#1)
the total variability##2##3##(2008-10#2)
the total variance##17##3##(1993-8#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
the total volume of##2##4##(1990-5#1)(2012-12#1)
the total##620##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#5)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#9)(1992-6#6)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#6)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#5)(2007-12#13)(2007-5#4)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#165)(2008-11#19)(2008-12#3)(2008-2#16)(2008-3#41)(2008-4#5)(2008-5#23)(2008-6#10)(2008-7#19)(2008-8#23)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#7)(2011-10#1)(2011-2#16)(2011-3#3)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#4)(2012-8#1)(2013-1#14)(2013-7#4)(2013-8#8)
the total-internal-reflection##2##2##(2008-2#1)(2008-3#1)
the totality of the##3##4##(1993-8#1)(1996-6#1)(2009-8#1)
the totally##3##2##(1990-3#1)(2008-9#1)(2011-1#1)
the tough##4##2##(1994-12#1)(1996-1#1)(1996-3#1)(2008-8#1)
the town of Cabar##3##4##(2011-2#3)
the town of##7##3##(1995-1#1)(2008-10#1)(2008-9#1)(2011-2#3)(2012-12#1)
the town##9##2##(1990-2#1)(1995-1#1)(2008-10#1)(2008-9#1)(2011-2#3)(2012-12#2)
the tox(-) isolates##2##3##(2008-10#2)
the toxic effect of##3##4##(1992-6#1)(1993-5#1)(2010-2#1)
the toxic effect##4##3##(1992-6#1)(1993-5#1)(2008-10#1)(2010-2#1)
the toxic effects of hydrogen peroxide##2##6##(1991-9#2)
the toxic effects of##15##4##(1990-5#1)(1991-9#2)(1993-9#2)(1994-5#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#1)
the toxic effects##16##3##(1990-5#1)(1991-9#2)(1993-9#2)(1994-5#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2010-4#1)(2013-1#1)
the toxic fraction##2##3##(2008-10#2)
the toxic potency of the##2##5##(1996-12#2)
the toxic potency##4##3##(1996-12#4)
the toxic substance##2##3##(2008-5#2)
the toxic##45##2##(1990-5#1)(1991-9#2)(1992-6#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-5#2)(1995-3#1)(1996-12#4)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-5#4)(2008-7#3)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
the toxicities##2##2##(2008-11#1)(2013-1#1)
the toxicity and##3##3##(1995-8#1)(2008-6#1)(2008-7#1)
the toxicity of Hg2+##3##4##(1992-11#3)
the toxicity of a##2##4##(1992-3#1)(2011-2#1)
the toxicity of the##8##4##(1995-3#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2013-1#1)
the toxicity of these##2##4##(2008-5#1)(2010-4#1)
the toxicity of##35##3##(1992-11#3)(1992-3#1)(1993-12#1)(1994-5#2)(1995-3#2)(1995-8#2)(1996-12#3)(2007-2#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#2)
the toxicity##53##2##(1990-5#1)(1992-11#3)(1992-3#1)(1993-12#1)(1994-5#2)(1995-3#3)(1995-5#1)(1995-8#3)(1996-12#4)(2007-11#1)(2007-2#1)(2008-10#10)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
the toxicity-based SQG##2##3##(2012-1#2)
the toxicological and##2##3##(2008-11#1)(2013-1#1)
the toxicological##8##2##(1996-12#1)(2008-10#4)(2008-11#1)(2013-1#2)
the toxicology##7##2##(1990-5#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#2)
the toxin also##2##3##(1994-2#1)(2008-10#1)
the toxin has been##2##4##(2008-10#1)(2008-8#1)
the toxin in##2##3##(2008-10#2)
the toxin is##3##3##(1991-5#1)(2008-10#2)
the toxin produced by##2##4##(2008-10#2)
the toxin sequence##3##3##(1994-2#1)(2010-6#2)
the toxin##36##2##(1991-12#1)(1991-5#1)(1994-2#4)(1995-8#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#2)(2011-2#1)(2012-12#1)
the toxins to##2##3##(2008-11#1)(2009-2#1)
the toxins##9##2##(1990-5#1)(1993-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)
the traT gene and##2##4##(1991-8#2)
the traT gene##7##3##(1991-8#7)
the trabecular##2##2##(2008-7#1)(2009-7#1)
the trace analysis of##4##4##(2008-10#3)(2008-3#1)
the trace determination of##4##4##(2008-10#4)
the trace element##3##3##(2008-10#2)(2011-2#1)
the trace elements##3##3##(2008-10#2)(2008-5#1)
the trace level##3##3##(2008-1#1)(2008-10#2)
the trace maker##2##3##(2013-1#2)
the trace metal extraction by EDTA##2##6##(2008-10#2)
the trace metal##3##3##(2008-10#2)(2008-5#1)
the trace##34##2##(2008-1#1)(2008-10#21)(2008-3#2)(2008-5#4)(2009-5#1)(2011-2#1)(2013-1#4)
the trace-back operation##2##3##(2008-3#2)
the tracer##8##2##(1990-12#1)(1990-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-5#1)
the trachea and##3##3##(1993-8#1)(2008-9#1)(2010-10#1)
the trachea##18##2##(1991-11#1)(1993-8#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-8#3)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-10#1)(2013-1#1)
the tracheae##3##2##(2007-12#3)
the tracheal bronchial##2##3##(1997-1#2)
the tracheal system of##2##4##(2007-12#2)
the tracheal walls##3##3##(2007-12#3)
the tracheal##14##2##(1993-8#1)(1996-3#2)(1997-1#2)(1997-6#1)(2007-12#5)(2008-1#1)(2008-10#1)(2013-1#1)
the tracheobronchial tree##2##3##(2007-8#1)(2010-12#1)
the tracheobronchial##4##2##(1996-1#1)(1997-1#1)(2007-8#1)(2010-12#1)
the tracings##2##2##(1994-3#1)(2008-4#1)
the track using##2##3##(2008-3#1)(2010-12#1)
the track##5##2##(2008-2#1)(2008-3#3)(2010-12#1)
the tracked##6##2##(2007-11#1)(2008-6#1)(2009-12#2)(2011-1#1)(2012-2#1)
the tracking system is##2##4##(2008-2#2)
the tracking system##3##3##(2008-2#3)
the tracking##8##2##(1992-6#1)(2008-2#7)
the tract of##2##3##(1996-12#1)(1996-3#1)
the tract##3##2##(1996-12#1)(1996-3#1)(1997-3#1)
the trade-off between the##2##4##(2008-3#2)
the trade-off between##9##3##(1991-5#1)(1995-2#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2012-3#1)
the trade-off##12##2##(1991-5#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2012-3#1)
the trade-offs between##3##3##(1996-1#1)(2008-3#1)(2008-9#1)
the trade-offs that##2##3##(2008-3#1)(2010-3#1)
the trade-offs##8##2##(1996-1#1)(2008-3#2)(2008-8#2)(2008-9#2)(2010-3#1)
the tradeoff##2##2##(2008-9#1)(2012-1#1)
the tradition##2##2##(2007-8#1)(2008-2#1)
the traditional &quot##3##3##(1995-8#1)(2007-5#2)
the traditional approach of##2##4##(2008-11#1)(2008-4#1)
the traditional clinical##2##3##(1994-1#1)(2008-1#1)
the traditional concept of##2##4##(2008-1#1)(2008-7#1)
the traditional concept##3##3##(2008-1#1)(2008-7#1)(2008-8#1)
the traditional cost-based approach in##2##5##(1992-1#2)
the traditional curriculum##2##3##(2012-3#2)
the traditional financial and management subjects##2##6##(1996-1#2)
the traditional liquid-liquid separation##2##4##(2008-10#2)
the traditional method based on##2##5##(2007-8#1)(2012-1#1)
the traditional method##4##3##(2007-8#2)(2010-8#1)(2012-1#1)
the traditional methods of##3##4##(1991-12#1)(2008-10#1)(2010-11#1)
the traditional methods##5##3##(1991-12#1)(2008-10#3)(2010-11#1)
the traditional model##3##3##(2008-4#2)(2010-5#1)
the traditional relationship##2##3##(1995-1#1)(2012-2#1)
the traditional risk factors##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
the traditional technique##3##3##(2011-2#3)
the traditional techniques##2##3##(2008-10#1)(2008-4#1)
the traditional view##2##3##(2007-8#1)(2008-10#1)
the traditional##147##2##(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#3)(1992-5#1)(1993-2#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#7)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#1)
the traditionally##2##2##(2008-1#1)(2008-10#1)
the traditions of##2##3##(2009-10#1)(2009-6#1)
the traffic##5##2##(1992-6#1)(2008-8#4)
the trafficking and##2##3##(2008-5#1)(2008-8#1)
the trafficking of##4##3##(1990-2#1)(1997-1#1)(2008-7#1)(2012-2#1)
the trafficking##7##2##(1990-2#1)(1997-1#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
the tragedy##2##2##(1991-12#1)(2010-1#1)
the trail of##2##3##(1992-2#1)(2013-8#1)
the trail##3##2##(1992-2#1)(2008-8#1)(2013-8#1)
the trailing film##5##3##(2009-6#5)
the trailing##6##2##(2007-12#1)(2009-6#5)
the train##2##2##(2008-1#1)(2008-2#1)
the trained and##2##3##(2013-1#2)
the trained female rats##2##4##(2013-1#2)
the trained##9##2##(1995-1#1)(2008-10#1)(2008-12#1)(2010-8#1)(2013-1#5)
the training and##5##3##(1996-12#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-10#1)
the training content##2##3##(2007-12#1)(2008-9#1)
the training context##2##3##(2008-10#1)(2008-5#1)
the training data set##2##4##(2008-10#2)
the training data##3##3##(2008-10#2)(2010-9#1)
the training images##2##3##(2008-3#2)
the training of medical graduates##3##5##(1992-1#1)(1994-12#1)(2009-10#1)
the training of medical##7##4##(1992-1#2)(1994-12#2)(1994-6#1)(2009-10#1)(2012-3#1)
the training of##21##3##(1991-12#1)(1992-1#2)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the training or##2##3##(1994-1#1)(2008-3#1)
the training program was##2##4##(1991-2#1)(2008-4#1)
the training program##4##3##(1991-2#1)(2007-4#1)(2008-1#1)(2008-4#1)
the training requirements of##2##4##(1996-2#2)
the training sample##2##3##(2010-5#1)(2013-8#1)
the training set##3##3##(2008-10#2)(2008-9#1)
the training##76##2##(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
the trait##15##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#6)(2009-4#1)(2012-3#4)(2013-1#1)
the traits of##2##3##(1997-4#1)(2008-9#1)
the traits under##2##3##(1997-4#1)(2008-8#1)
the traits##13##2##(1997-4#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#3)(2012-3#1)
the trajectories of##4##3##(1993-12#1)(1996-12#1)(2008-3#1)(2011-1#1)
the trajectory at the L5-S1 than at the L4-L5 level##2##10##(1996-6#2)
the trajectory of HIV##2##4##(1997-2#1)(2007-7#1)
the trajectory of##5##3##(1996-12#1)(1997-2#1)(2007-7#1)(2008-3#2)
the trajectory##10##2##(1996-12#1)(1996-6#3)(1997-2#1)(2007-7#1)(2008-3#3)(2011-2#1)
the trance##2##2##(2009-10#2)
the trans Golgi##2##3##(1992-12#1)(1993-6#1)
the trans isomer##4##3##(1991-5#3)(1996-5#1)
the trans##13##2##(1990-9#1)(1991-5#4)(1992-12#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#2)
the trans-4-(trifluoromethyl)-2##2##2##(1996-5#2)
the trans-Golgi network##4##3##(1992-12#1)(2008-1#2)(2009-10#1)
the trans-Golgi##5##2##(1992-12#1)(1997-2#1)(2008-1#2)(2009-10#1)
the trans-acting##3##2##(1995-6#1)(2008-10#1)(2008-9#1)
the trans-membrane##2##2##(2008-11#1)(2008-8#1)
the trans-sinusal frontal approach##2##4##(2006-12#2)
the transactivation##5##2##(1993-8#3)(1995-6#2)
the transactivators##2##2##(2008-11#2)
the transcatheter##4##2##(1997-8#1)(2006-10#1)(2010-8#1)(2013-1#1)
the transconjugant##2##2##(2008-10#2)
the transcranial##4##2##(2010-5#2)(2011-2#1)(2012-1#1)
the transcribed strand of##2##4##(1994-8#2)
the transcribed##6##2##(1993-6#1)(1994-8#2)(1997-4#1)(2008-11#2)
the transcript levels of##2##4##(1997-7#1)(2011-1#1)
the transcript of##2##3##(1991-5#1)(2008-6#1)
the transcript##16##2##(1990-5#1)(1991-5#3)(1991-9#2)(1993-12#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-7#2)(2008-6#1)(2011-1#1)(2013-8#1)
the transcription factor##25##3##(1991-9#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-11#4)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
the transcription factors##5##3##(1993-6#1)(1997-7#2)(2008-1#1)(2010-1#1)
the transcription initiation site##2##4##(1990-12#1)(1997-7#1)
the transcription initiation##3##3##(1990-12#1)(1995-6#1)(1997-7#1)
the transcription level##2##3##(2008-11#1)(2008-8#1)
the transcription of genes##2##4##(2008-4#1)(2008-9#1)
the transcription of the##14##4##(1991-12#2)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#2)(1997-8#2)(2008-11#1)
the transcription of##35##3##(1990-5#1)(1991-12#2)(1992-10#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-6#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#1)
the transcription rate of alpha(1B)-AR##2##5##(2008-4#2)
the transcription rate of##4##4##(1992-3#1)(1992-9#1)(2008-4#2)
the transcription rate##5##3##(1992-3#1)(1992-9#1)(2008-11#1)(2008-4#2)
the transcription start point (tsp)##6##5##(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#2)
the transcription start point##10##4##(1991-6#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#2)(1997-4#1)(1997-6#1)
the transcription start site was##2##5##(1991-7#1)(2008-9#1)
the transcription start site##7##4##(1991-11#1)(1991-7#1)(1994-8#2)(1995-2#2)(2008-9#1)
the transcription start##19##3##(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-12#2)(1994-8#2)(1995-2#2)(1997-4#1)(1997-6#1)(2008-9#1)
the transcription##110##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-11#4)(1994-12#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-2#4)(1995-6#4)(1995-9#1)(1997-4#3)(1997-6#2)(1997-7#7)(1997-8#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)
the transcriptional activation of##7##4##(1995-11#2)(1995-8#1)(1996-12#2)(2008-10#1)(2009-8#1)
the transcriptional activation##8##3##(1994-9#1)(1995-11#2)(1995-8#1)(1996-12#2)(2008-10#1)(2009-8#1)
the transcriptional activator##4##3##(1990-11#1)(2012-3#2)(2013-1#1)
the transcriptional activity of##5##4##(1995-8#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
the transcriptional co-activator##2##3##(2011-2#1)(2013-1#1)
the transcriptional control of##3##4##(1994-12#1)(1995-2#1)(2011-2#1)
the transcriptional induction of the##3##5##(1994-9#1)(2008-11#1)(2011-1#1)
the transcriptional induction of##4##4##(1994-9#2)(2008-11#1)(2011-1#1)
the transcriptional machinery##2##3##(2008-6#1)(2013-1#1)
the transcriptional regulation of the##2##5##(1993-6#1)(2008-11#1)
the transcriptional regulation of##5##4##(1991-12#1)(1993-6#1)(1996-12#1)(2008-11#1)(2011-2#1)
the transcriptional regulation##6##3##(1991-12#1)(1992-12#1)(1993-6#1)(1996-12#1)(2008-11#1)(2011-2#1)
the transcriptional response##2##3##(1994-8#1)(2011-2#1)
the transcriptional start site##3##4##(1995-11#1)(1995-6#1)(1996-12#1)
the transcriptional start##5##3##(1990-11#1)(1991-2#1)(1995-11#1)(1995-6#1)(1996-12#1)
the transcriptional status of the##2##5##(1995-2#1)(1997-7#1)
the transcriptional status of##3##4##(1995-2#1)(1997-7#1)(2013-1#1)
the transcriptional##72##2##(1990-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-11#3)(1995-2#3)(1995-6#2)(1995-8#4)(1996-12#4)(1997-7#1)(2008-10#2)(2008-11#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#3)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#6)(2013-7#1)
the transcriptome##6##2##(2008-10#1)(2008-7#1)(2012-2#3)(2013-8#1)
the transcripts in##2##3##(1996-8#1)(1997-7#1)
the transcripts##8##2##(1990-8#1)(1991-9#1)(1994-12#1)(1996-8#1)(1997-2#2)(1997-7#2)
the transdermal##4##2##(1992-8#1)(2008-3#2)(2008-5#1)
the transduced genes##2##3##(1997-8#1)(2008-8#1)
the transducer surface##2##3##(2008-10#2)
the transducer##6##2##(2008-10#4)(2008-3#2)
the transducers##2##2##(2008-10#1)(2009-5#1)
the transduction of signals##2##4##(1992-3#1)(1995-2#1)
the transduction of##7##3##(1990-12#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(2010-10#2)
the transduction##8##2##(1990-12#1)(1992-3#1)(1994-11#2)(1994-8#1)(1995-2#1)(2010-10#2)
the transepithelial##2##2##(2008-5#1)(2011-2#1)
the transesterification##2##2##(2008-7#1)(2013-1#1)
the transfectant##2##2##(1993-8#1)(1997-2#1)
the transfectants##2##2##(1992-9#1)(1993-1#1)
the transfected DNA##2##3##(1995-2#1)(2008-2#1)
the transfected cells##4##3##(1992-9#1)(1994-8#1)(1995-5#1)(2008-11#1)
the transfected##12##2##(1992-9#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-11#2)(2008-2#2)
the transfection efficiency of##2##4##(2008-11#1)(2008-9#1)
the transfection of##4##3##(1994-11#1)(2008-11#2)(2008-2#1)
the transfection##12##2##(1991-5#1)(1994-11#1)(1995-2#1)(2008-1#2)(2008-11#5)(2008-2#1)(2008-9#1)
the transfer coefficient##2##3##(1991-5#1)(2008-10#1)
the transfer efficiency##3##3##(2008-10#1)(2008-9#2)
the transfer function of##2##4##(2008-2#2)
the transfer of a##2##4##(1992-10#1)(2008-9#1)
the transfer of material from##2##5##(2008-3#2)
the transfer of the radical to acetylphosphinate##2##7##(1995-2#2)
the transfer of the##7##4##(1990-11#1)(1993-11#1)(1994-12#1)(1995-2#2)(2008-10#2)
the transfer of##41##3##(1990-11#1)(1990-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#4)(1993-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
the transfer process##3##3##(1992-3#1)(2007-12#2)
the transfer samples##2##3##(2008-10#2)
the transfer##71##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-5#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-12#4)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
the transferability of##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
the transferase##3##2##(1995-5#3)
the transferred##5##2##(1990-7#1)(2007-12#2)(2008-10#1)(2008-8#1)
the transferrin receptor##2##3##(1990-8#1)(1993-11#1)
the transferrin##3##2##(1990-11#1)(1990-8#1)(1993-11#1)
the transform##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
the transformant##4##2##(1991-9#1)(1995-12#1)(2011-1#2)
the transformants and the wild type##2##6##(2008-10#2)
the transformants was##2##3##(1997-2#1)(2008-10#1)
the transformants##13##2##(1990-5#1)(1990-8#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-8#2)
the transformation frequency##4##3##(2008-10#1)(2008-7#3)
the transformation occurs##2##3##(2012-12#1)(2013-1#1)
the transformation of the##2##4##(1995-4#1)(2008-2#1)
the transformation of##18##3##(1990-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1995-4#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
the transformation##38##2##(1990-5#1)(1990-7#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#2)(1995-4#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
the transformations of##2##3##(2008-10#1)(2010-4#1)
the transformations##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)
the transformed cell##4##3##(1993-6#1)(1994-11#1)(2008-11#1)(2008-8#1)
the transformed cells##4##3##(1990-12#1)(1992-9#1)(2008-11#2)
the transformed data##2##3##(1994-11#1)(2008-7#1)
the transformed phenotype##4##3##(1995-6#2)(1997-1#1)(2008-8#1)
the transformed signals##2##3##(2008-10#2)
the transformed yeast##2##3##(1990-8#1)(1995-2#1)
the transformed##25##2##(1990-12#1)(1990-8#2)(1992-9#1)(1993-6#1)(1994-11#2)(1995-2#1)(1995-6#2)(1997-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)
the transforming DNA##3##3##(1990-5#1)(2008-10#2)
the transforming growth##3##3##(1994-11#1)(2008-11#1)(2011-2#1)
the transforming plasmid##2##3##(2008-10#2)
the transforming potential of##2##4##(1994-8#1)(1995-2#1)
the transforming##15##2##(1990-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#7)(2008-11#1)(2011-2#1)
the transfusion##4##2##(1996-9#3)(1997-5#1)
the transgene in##3##3##(1995-2#1)(2008-10#2)
the transgene product##2##3##(2008-10#2)
the transgene was##3##3##(1990-8#1)(1995-2#1)(2008-12#1)
the transgene##28##2##(1990-8#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1997-4#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-8#2)(2012-3#1)
the transgenes and the##2##4##(2008-11#1)(2008-9#1)
the transgenes and##3##3##(1994-5#1)(2008-11#1)(2008-9#1)
the transgenes can be##2##4##(2008-10#1)(2011-1#1)
the transgenes##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
the transgenic line##2##3##(2008-10#2)
the transgenic lines##3##3##(2008-10#3)
the transgenic mice##5##3##(1990-11#1)(1992-11#2)(1995-2#2)
the transgenic tobacco##2##3##(2008-8#1)(2008-9#1)
the transgenic##26##2##(1990-11#1)(1992-11#3)(1992-8#1)(1993-12#1)(1995-2#3)(1995-8#1)(2006-12#1)(2008-10#7)(2008-8#4)(2008-9#3)(2010-5#1)
the transient absorption##2##3##(2008-8#1)(2008-9#1)
the transient behavior##2##3##(2008-3#1)(2008-7#1)
the transient dynamics##2##3##(2008-8#1)(2009-5#1)
the transient expression##2##3##(2008-11#2)
the transient increase##2##3##(1992-6#1)(1997-2#1)
the transient nature of##2##4##(1996-2#1)(2008-10#1)
the transient potential change##2##4##(2008-10#2)
the transient response of##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
the transient response##5##3##(2008-2#1)(2008-3#3)(2012-2#1)
the transient##52##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#2)(1994-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#3)(2008-10#8)(2008-11#4)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2012-2#2)
the transit of the##2##4##(1992-3#1)(2008-7#1)
the transit of##4##3##(1992-3#1)(1997-7#1)(2008-7#1)(2012-2#1)
the transit time##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
the transit times##2##3##(2007-11#2)
the transit##11##2##(1992-3#1)(1996-10#1)(1997-7#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#1)
the transition between##5##3##(1996-6#1)(2007-11#1)(2008-7#1)(2009-7#1)(2009-8#1)
the transition from a##2##4##(1996-1#1)(1996-3#1)
the transition from stimulation to inhibition occurred when an average of##2##11##(2008-10#2)
the transition from the##2##4##(1990-12#1)(2008-11#1)
the transition from##27##3##(1990-12#1)(1992-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the transition is##2##3##(1995-2#1)(2009-12#1)
the transition matrix##2##3##(2008-3#2)
the transition metal and the##2##5##(2008-10#1)(2010-12#1)
the transition metal##4##3##(1997-7#1)(2008-10#2)(2010-12#1)
the transition of##4##3##(1997-2#1)(2008-11#1)(2008-3#2)
the transition state of##2##4##(1991-9#1)(2010-4#1)
the transition state##10##3##(1990-5#3)(1991-9#1)(1995-2#2)(1996-5#1)(2008-4#1)(2009-5#1)(2010-4#1)
the transition states##3##3##(1992-6#1)(1996-5#1)(2012-12#1)
the transition temperature##2##3##(1990-2#1)(1997-7#1)
the transition time from##2##4##(2008-11#1)(2010-5#1)
the transition to adulthood##3##4##(2009-7#2)(2011-2#1)
the transition to parenthood##2##4##(2007-2#2)
the transition to specialist##2##4##(2008-11#2)
the transition to##22##3##(1991-12#1)(1996-12#1)(1997-2#2)(1997-6#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-11#5)(2009-7#2)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the transition zone##4##3##(1990-7#2)(1991-5#1)(2013-7#1)
the transition##114##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#3)(1995-2#4)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-6#1)(1997-7#3)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#10)(2008-2#2)(2008-3#8)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
the transitional##5##2##(1990-12#1)(2008-11#1)(2009-7#1)(2010-4#1)(2010-5#1)
the transitions##3##2##(2008-2#1)(2011-3#1)(2013-7#1)
the transketolase##2##2##(1992-3#2)
the translated##2##2##(1992-12#1)(1994-6#1)
the translation initiation codon##5##4##(1992-11#2)(1993-3#1)(1997-6#2)
the translation initiation site##4##4##(1996-5#1)(1997-2#2)(1997-7#1)
the translation initiation sites of##4##5##(1996-8#1)(1997-2#1)(1997-6#2)
the translation initiation sites##9##4##(1996-8#4)(1997-2#2)(1997-6#3)
the translation initiation##20##3##(1992-11#2)(1993-3#1)(1996-5#1)(1996-8#4)(1997-2#4)(1997-6#5)(1997-7#2)(2013-7#1)
the translation of the##4##4##(1997-8#1)(2008-7#1)(2009-11#1)(2012-2#1)
the translation of##17##3##(1995-12#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
the translation start site##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
the translation start##5##3##(1990-11#1)(1997-8#1)(2008-11#1)(2008-9#1)(2012-2#1)
the translation##52##2##(1990-11#1)(1990-5#1)(1992-11#2)(1993-3#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-8#4)(1997-2#4)(1997-3#1)(1997-6#5)(1997-7#2)(1997-8#2)(2007-11#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the translational machinery##2##3##(1994-8#1)(2008-9#1)
the translational motion of##2##4##(2008-3#1)(2010-4#1)
the translational start##3##3##(1990-11#1)(1992-10#1)(2008-4#1)
the translational temperature##2##3##(2007-11#1)(2008-2#1)
the translational##21##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#2)(1992-10#1)(1992-8#1)(1994-11#1)(1994-8#2)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#2)(2011-1#1)
the translocated##3##2##(1993-2#2)(2011-2#1)
the translocation of the##3##4##(1990-7#1)(2008-10#1)(2012-2#1)
the translocation of toxin B##2##5##(2007-12#2)
the translocation of##19##3##(1990-7#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#2)
the translocation##29##2##(1990-7#1)(1991-5#2)(1992-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-6#1)(1997-8#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#2)
the translucency##2##2##(2012-2#2)
the transmembrane domain of##3##4##(1992-12#2)(2008-11#1)
the transmembrane domain##9##3##(1990-7#1)(1991-9#1)(1992-12#2)(1995-2#1)(2008-11#1)(2009-10#2)(2012-2#1)
the transmembrane helices##2##3##(2008-4#2)
the transmembrane potential##2##3##(1994-12#2)
the transmembrane region##3##3##(1990-11#1)(1991-2#1)(1991-9#1)
the transmembrane regions##2##3##(1994-8#1)(2012-2#1)
the transmembrane segments of##2##4##(1990-5#1)(2012-2#1)
the transmembrane##30##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#2)(1992-12#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-4#1)(2008-11#2)(2008-4#3)(2008-7#1)(2009-10#2)(2012-2#3)
the transmissibility of##2##3##(2008-10#2)
the transmissible##3##2##(2008-10#3)
the transmission and##4##3##(1991-9#1)(2007-12#1)(2008-3#2)
the transmission dynamics of HIV-1##2##5##(1992-9#2)
the transmission efficiency of##3##4##(2008-10#2)(2008-3#1)
the transmission electron microscope##2##4##(2008-7#1)(2009-7#1)
the transmission electron##4##3##(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)
the transmission grating##2##3##(2007-12#2)
the transmission intensity##2##3##(2008-10#1)(2008-8#1)
the transmission is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the transmission of S##2##4##(2008-10#1)(2008-8#1)
the transmission of a##3##4##(2008-3#3)
the transmission of light##2##4##(2008-2#1)(2008-3#1)
the transmission of prion##2##4##(1997-3#1)(2008-11#1)
the transmission of the##5##4##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
the transmission of##49##3##(1990-11#1)(1994-8#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#12)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#3)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#2)
the transmission phenotype##3##3##(2008-10#3)
the transmission properties##2##3##(2007-11#1)(2008-3#1)
the transmission rate##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
the transmission rates##2##3##(2008-5#1)(2013-8#1)
the transmission spectra of the##2##5##(2007-11#1)(2008-3#1)
the transmission spectra of##3##4##(2007-11#1)(2008-3#2)
the transmission spectrum of##2##4##(2008-3#2)
the transmission spectrum##3##3##(2007-12#1)(2008-3#2)
the transmission##119##2##(1990-11#1)(1991-9#1)(1992-9#2)(1994-8#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#7)(2007-12#11)(2007-7#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#31)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#3)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
the transmissivity of##2##3##(2007-11#1)(2008-3#1)
the transmittance of a##2##4##(2008-2#1)(2008-3#1)
the transmittance of the##2##4##(2007-12#1)(2008-3#1)
the transmittance of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the transmittance##11##2##(2007-12#1)(2008-2#4)(2008-3#6)
the transmitted and reflected##2##4##(2007-11#1)(2008-3#1)
the transmitted and the##3##4##(2008-2#1)(2008-3#2)
the transmitted and##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
the transmitted beam##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
the transmitted field##2##3##(2007-11#1)(2008-3#1)
the transmitted laser##3##3##(2007-12#1)(2008-3#2)
the transmitted light of the FBG##2##6##(2007-12#2)
the transmitted light##8##3##(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)
the transmitted optical##3##3##(2008-2#2)(2008-3#1)
the transmitted##39##2##(2007-11#4)(2007-12#7)(2008-1#2)(2008-10#3)(2008-2#9)(2008-3#14)
the transmitter and receiver##2##4##(2008-2#1)(2008-3#1)
the transmitter and the receiver##2##5##(2007-11#2)
the transmitter and##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
the transmitter##12##2##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#3)
the transmitting##2##2##(2008-8#1)(2012-2#1)
the transnitrosation reaction##2##3##(1995-5#2)
the transparency of the##2##4##(2008-7#1)(2011-1#1)
the transparency##3##2##(2007-12#1)(2008-7#1)(2011-1#1)
the transparent##6##2##(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
the transpetrosal approach##2##3##(2008-7#2)
the transpetrosal##3##2##(2008-7#3)
the transplant team##2##3##(2007-11#1)(2011-3#1)
the transplant teams##2##3##(2011-2#1)(2011-3#1)
the transplant##12##2##(1994-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2011-2#4)(2011-3#3)
the transplantation of##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
the transplantation##10##2##(1995-9#1)(1996-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#3)(2012-12#1)
the transplanted cells##2##3##(2010-11#1)(2012-12#1)
the transplanted##9##2##(1991-5#1)(1992-2#2)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)
the transport activity##2##3##(1995-8#1)(2008-11#1)
the transport and##4##3##(2008-10#1)(2008-7#1)(2009-7#1)(2013-1#1)
the transport group##2##3##(2013-1#2)
the transport mean free path##5##5##(2008-2#2)(2008-3#3)
the transport of##28##3##(1990-12#2)(1992-3#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#2)(2011-2#1)(2011-3#5)(2012-2#1)
the transport scattering##4##3##(2008-2#2)(2008-3#2)
the transport system##2##3##(1992-3#1)(2008-10#1)
the transport##66##2##(1990-11#1)(1990-12#2)(1991-5#1)(1992-3#3)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#6)(2008-7#5)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#2)(2011-2#1)(2011-3#6)(2012-2#1)(2012-8#1)(2013-1#3)
the transporter##5##2##(1994-6#1)(1995-2#1)(1995-6#1)(2008-8#2)
the transporters##2##2##(2008-7#1)(2008-8#1)
the transposable element##3##3##(2008-10#2)(2008-9#1)
the transposase##2##2##(1995-8#1)(2012-3#1)
the transposon##8##2##(1993-12#1)(1997-2#1)(2008-10#5)(2008-9#1)
the transradial access##2##3##(2011-2#2)
the transradial##5##2##(2011-2#5)
the transtheoretical model##2##3##(2013-1#2)
the transthyretin##2##2##(1992-8#2)
the transverse coherence##2##3##(2008-3#2)
the transverse colon##2##3##(1993-9#2)
the transverse concentration gradient##2##4##(2008-10#2)
the transverse momenta##2##3##(2007-11#2)
the transverse resolution of three-dimensional##2##5##(2007-12#2)
the transverse resolution##3##3##(2007-12#2)(2008-3#1)
the transverse sinus##4##3##(1996-9#1)(2006-12#1)(2008-7#2)
the transverse##43##2##(1991-2#1)(1993-3#1)(1993-9#2)(1995-6#1)(1996-9#1)(2006-12#1)(2007-11#6)(2007-12#5)(2008-10#3)(2008-2#4)(2008-3#11)(2008-7#2)(2008-9#2)(2012-2#2)(2013-1#1)
the transversely heated graphite atomizer##2##5##(2008-10#2)
the trap and##2##3##(2008-10#1)(2009-8#1)
the trap##10##2##(2007-11#2)(2008-10#4)(2008-2#2)(2009-8#2)
the trapped pulse##2##3##(2007-11#2)
the trapped##4##2##(2007-11#2)(2008-10#1)(2010-8#1)
the trapping of##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
the trapping theory##2##3##(2008-11#2)
the trapping##12##2##(1992-3#1)(1992-9#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)
the traps##2##2##(1991-3#1)(2013-7#1)
the trauma of##3##3##(1994-2#1)(2008-10#1)(2010-5#1)
the trauma##10##2##(1993-5#1)(1994-2#1)(2007-10#1)(2007-8#2)(2008-10#2)(2010-1#1)(2010-5#1)(2013-1#1)
the traumatic##7##2##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-1#2)(2012-2#1)
the traveller##5##2##(1993-8#2)(2007-2#2)(2008-11#1)
the travelling##2##2##(2010-8#1)(2011-2#1)
the treated cells##2##3##(1991-5#1)(1992-6#1)
the treated embryos##3##3##(2008-11#2)(2008-12#1)
the treated group##3##3##(1990-11#1)(1991-5#1)(2007-8#1)
the treated mice##5##3##(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#2)
the treated patients##4##3##(1996-3#1)(2006-10#1)(2007-7#1)(2013-8#1)
the treated tissue##2##3##(2008-3#1)(2009-11#1)
the treated women##2##3##(1994-12#2)
the treated##58##2##(1990-11#1)(1991-5#2)(1992-6#1)(1992-9#1)(1994-12#2)(1995-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
the treating physician to##2##4##(2011-1#1)(2011-2#1)
the treating physician##8##3##(1993-12#1)(1996-3#1)(2006-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the treating##15##2##(1993-12#2)(1996-3#1)(2006-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the treatment and management of patients with##2##7##(2008-4#1)(2013-8#1)
the treatment and prevention of##9##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
the treatment and the##3##4##(1990-3#1)(1992-6#1)(2011-2#1)
the treatment and##32##3##(1990-3#1)(1991-11#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-8#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-5#2)(2010-6#2)(2011-2#2)(2012-12#1)(2013-8#1)
the treatment armamentarium for##2##4##(1991-12#1)(2008-9#1)
the treatment as well as##2##5##(1990-3#1)(2008-11#1)
the treatment as##3##3##(1990-3#1)(1992-2#1)(2008-11#1)
the treatment choice##2##3##(1995-11#1)(2012-2#1)
the treatment comparison##2##3##(2008-8#2)
the treatment effect##7##3##(1992-6#1)(1994-11#1)(1996-6#2)(1997-4#1)(2008-10#1)(2012-1#1)
the treatment effects##2##3##(2011-2#1)(2012-2#1)
the treatment facilities available##2##4##(1996-11#1)(1997-8#1)
the treatment field##2##3##(2007-10#1)(2008-6#1)
the treatment for##5##3##(1997-3#1)(2007-11#2)(2008-5#1)(2010-1#1)
the treatment group had substantively and statistically significantly higher health care utilization (including primary and preventive care as well as hospitalizations)##2##21##(2013-1#2)
the treatment group had##3##4##(2009-4#1)(2013-1#2)
the treatment group selected by the lottery was about 25 percentage points more likely to have insurance than the control group that was not selected##2##25##(2013-1#2)
the treatment group##9##3##(2008-10#1)(2009-4#2)(2010-7#1)(2011-2#1)(2013-1#4)
the treatment groups were##2##4##(1991-8#1)(2008-10#1)
the treatment groups##9##3##(1991-2#1)(1991-8#1)(1992-5#1)(1994-12#3)(2008-10#2)(2012-12#1)
the treatment is##5##3##(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-7#1)
the treatment of CML##2##4##(1997-3#1)(2012-12#1)
the treatment of CNS##2##4##(2008-7#1)(2012-2#1)
the treatment of Crohn's disease##3##5##(1994-6#1)(2010-12#1)(2013-1#1)
the treatment of HIV##5##4##(1995-12#1)(1995-3#1)(2006-10#1)(2008-5#2)
the treatment of NSCLC##3##4##(2010-8#1)(2012-1#1)(2013-8#1)
the treatment of OCD##3##4##(2008-3#1)(2008-6#2)
the treatment of PD##5##4##(2008-7#5)
the treatment of Parkinson's disease##6##5##(1992-3#1)(1995-12#1)(1996-3#2)(2008-10#1)(2008-7#1)
the treatment of RA##3##4##(2008-5#1)(2013-8#2)
the treatment of a variety of##2##6##(2008-5#1)(2013-8#1)
the treatment of a##8##4##(1991-2#1)(1992-6#1)(1994-2#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the treatment of acne vulgaris##5##5##(1997-8#1)(2007-7#2)(2010-8#2)
the treatment of acute stroke##3##5##(2007-10#2)(2009-11#1)
the treatment of acute##17##4##(1990-5#1)(1991-3#1)(1992-3#1)(1994-2#1)(1995-6#1)(1997-7#1)(2007-10#3)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
the treatment of advanced##13##4##(1990-12#3)(1991-4#1)(1993-6#1)(1994-7#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-8#1)(2012-1#1)
the treatment of alcohol dependence##2##5##(1991-12#1)(2008-2#1)
the treatment of arterial##3##4##(1993-11#1)(1996-3#1)(2011-2#1)
the treatment of asthma##6##4##(1992-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)
the treatment of atherosclerosis##2##4##(2009-5#2)
the treatment of benign##4##4##(1990-6#1)(1994-11#1)(2008-5#1)(2011-2#1)
the treatment of bleeding##2##4##(1992-6#1)(2013-1#1)
the treatment of bone metastases##2##5##(2007-11#1)(2008-7#1)
the treatment of both##3##4##(1991-3#1)(2010-1#1)(2013-1#1)
the treatment of breast cancer##7##5##(1992-5#1)(1993-1#1)(1993-11#2)(1995-11#1)(1996-11#1)(2011-1#1)
the treatment of breast##10##4##(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#1)(1995-11#1)(1996-11#1)(2008-3#1)(2011-1#1)
the treatment of bronchial asthma]##2##5##(1996-7#1)(2013-8#1)
the treatment of bronchial##3##4##(1996-7#1)(2008-1#1)(2013-8#1)
the treatment of cachexia##2##4##(2008-10#1)(2008-5#1)
the treatment of cancer##14##4##(1993-3#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
the treatment of cardiac##2##4##(1990-9#1)(2008-5#1)
the treatment of cellulite##2##4##(2008-5#2)
the treatment of certain##2##4##(2006-12#1)(2008-6#1)
the treatment of childhood obesity##2##5##(2008-3#1)(2011-2#1)
the treatment of childhood##4##4##(2008-11#2)(2008-3#1)(2011-2#1)
the treatment of children with##3##5##(2006-10#1)(2007-12#1)(2011-2#1)
the treatment of children##4##4##(2006-10#1)(2007-12#1)(2008-4#1)(2011-2#1)
the treatment of choice for##14##5##(1991-9#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#1)(2013-1#2)
the treatment of choice in##9##5##(1990-9#1)(1992-12#1)(1994-3#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the treatment of choice when##2##5##(1990-2#1)(1997-2#1)
the treatment of choice##39##4##(1990-2#1)(1990-6#2)(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#2)(1994-12#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-6#4)(2010-8#1)(2011-2#3)(2013-1#3)(2013-8#1)
the treatment of chronic hepatitis C##2##6##(2009-5#1)(2012-12#1)
the treatment of chronic hepatitis##3##5##(2009-5#1)(2009-8#1)(2012-12#1)
the treatment of chronic myeloid leukemia##2##6##(2010-11#2)
the treatment of chronic##21##4##(1993-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
the treatment of cocaine##2##4##(1991-1#2)
the treatment of cystic fibrosis##2##5##(1991-2#1)(2007-6#1)
the treatment of deep##2##4##(2010-5#1)(2012-3#1)
the treatment of dental##3##4##(1995-9#1)(2008-7#1)(2013-1#1)
the treatment of depression and##2##5##(2012-12#1)(2012-2#1)
the treatment of depression##4##4##(2008-4#1)(2008-6#1)(2012-12#1)(2012-2#1)
the treatment of developmental dysplasia of the hip##2##8##(2007-8#2)
the treatment of developmental##4##4##(2007-8#4)
the treatment of diabetes##3##4##(2008-4#1)(2010-12#1)(2012-3#1)
the treatment of direct##2##4##(1990-6#1)(1996-1#1)
the treatment of disease##2##4##(2009-3#1)(2009-7#1)
the treatment of dry##2##4##(2006-10#1)(2008-5#1)
the treatment of early##4##4##(1995-8#1)(2008-7#2)(2011-2#1)
the treatment of epilepsy##4##4##(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
the treatment of essential##3##4##(1990-9#1)(1992-8#1)(2008-7#1)
the treatment of femoral##2##4##(2007-8#1)(2008-7#1)
the treatment of fractures with##2##5##(2007-8#2)
the treatment of fractures##4##4##(2007-8#3)(2008-9#1)
the treatment of glioblastoma multiforme##2##5##(1995-9#1)(2011-3#1)
the treatment of heart failure##8##5##(1990-3#2)(1996-6#1)(2008-5#2)(2009-10#2)(2012-3#1)
the treatment of human##4##4##(2008-5#1)(2010-3#1)(2013-1#1)(2013-7#1)
the treatment of hyperhomocysteinemia##2##4##(2008-3#2)
the treatment of hypertension##13##4##(1990-6#1)(1991-5#1)(1992-8#4)(1993-11#1)(1993-3#1)(1995-11#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)
the treatment of infection##4##4##(1994-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
the treatment of infectious##2##4##(1990-2#1)(1996-11#1)
the treatment of inflammatory##7##4##(1995-12#1)(2008-3#1)(2009-1#1)(2010-5#1)(2011-1#2)(2012-12#1)
the treatment of ischemic heart disease##2##6##(2010-6#2)
the treatment of ischemic##3##4##(2010-6#2)(2013-1#1)
the treatment of localized##3##4##(1995-2#1)(2012-3#1)(2013-1#1)
the treatment of locally advanced##3##5##(1992-3#1)(1995-9#1)(2009-5#1)
the treatment of lumbar##4##4##(2007-8#3)(2008-8#1)
the treatment of malaria##4##4##(2008-10#1)(2009-6#1)(2011-2#2)
the treatment of male##2##4##(1996-11#1)(2007-10#1)
the treatment of malignant##8##4##(1991-2#1)(1991-6#1)(1992-12#2)(1993-9#1)(1997-5#1)(2007-5#1)(2011-2#1)
the treatment of many##4##4##(2008-3#1)(2008-4#1)(2008-9#1)(2011-3#1)
the treatment of mental disorders##2##5##(2008-6#1)(2011-2#1)
the treatment of mental##3##4##(2008-6#1)(2011-2#2)
the treatment of metabolic##2##4##(1997-4#1)(2008-3#1)
the treatment of metastatic##5##4##(1990-2#1)(1994-5#1)(2007-11#1)(2010-3#1)(2012-3#1)
the treatment of neuropathic pain##6##5##(1997-3#1)(2006-12#1)(2008-9#3)(2010-7#1)
the treatment of osteomyelitis##3##4##(2010-6#3)
the treatment of osteoporosis##10##4##(1991-11#1)(1993-11#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
the treatment of osteosarcoma##3##4##(2010-3#3)
the treatment of patients by a mixture of oxygen and ozone - has been used for many years as a method ancillary to basic treatment##2##25##(2007-11#1)(2007-8#1)
the treatment of patients with severe##2##6##(1992-1#1)(1993-1#1)
the treatment of patients with##21##5##(1990-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1993-1#1)(1993-12#1)(1995-9#1)(1996-11#1)(1996-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)
the treatment of patients##25##4##(1990-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1993-1#1)(1993-12#1)(1995-9#1)(1996-11#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#1)
the treatment of postmenopausal osteoporosis##2##5##(1993-11#1)(2012-2#1)
the treatment of primary and##2##5##(1992-11#1)(2013-1#1)
the treatment of primary##5##4##(1990-3#1)(1992-11#1)(2008-4#1)(2013-1#2)
the treatment of pseudoexfoliation glaucoma##2##5##(2011-2#2)
the treatment of psoriasis##4##4##(2007-11#1)(2008-5#1)(2008-6#1)(2011-1#1)
the treatment of psychiatric##2##4##(2013-1#1)(2013-8#1)
the treatment of rectal##2##4##(2009-12#1)(2011-2#1)
the treatment of recurrent##3##4##(1996-9#1)(2006-10#1)(2012-3#1)
the treatment of refractory##3##4##(2006-12#1)(2013-8#2)
the treatment of renal##4##4##(1992-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
the treatment of rheumatoid arthritis##6##5##(1990-6#1)(1991-8#1)(2006-10#1)(2008-5#2)(2008-8#1)
the treatment of schizophrenia and related psychotic disorders##2##8##(2008-6#2)
the treatment of schizophrenia and##6##5##(2008-5#1)(2008-6#2)(2008-8#2)(2011-2#1)
the treatment of schizophrenia##13##4##(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#3)(2011-2#1)(2012-12#1)
the treatment of several##6##4##(2007-4#1)(2008-11#2)(2009-1#1)(2010-11#1)(2011-1#1)
the treatment of severe coxarthrosis##2##5##(2013-1#2)
the treatment of severe sepsis##3##5##(2007-12#3)
the treatment of severe##11##4##(1990-8#1)(2007-12#3)(2007-8#1)(2008-5#2)(2008-8#1)(2009-9#1)(2013-1#2)
the treatment of some##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
the treatment of spinal##3##4##(2007-11#2)(2008-7#1)
the treatment of stage I##2##5##(2007-8#2)
the treatment of stage##5##4##(1994-8#1)(2007-11#1)(2007-8#2)(2009-10#1)
the treatment of such##4##4##(1990-9#1)(2011-1#1)(2013-1#2)
the treatment of superficial##2##4##(2011-1#1)(2012-3#1)
the treatment of systemic##3##4##(1997-2#1)(2008-11#1)(2008-7#1)
the treatment of the chronic##2##5##(2007-8#1)(2008-5#1)
the treatment of the##24##4##(1991-12#1)(1991-2#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-7#1)
the treatment of these patients##4##5##(1995-2#1)(2007-8#2)(2011-1#1)
the treatment of these##11##4##(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
the treatment of this disease##5##5##(1993-6#1)(2007-8#1)(2008-10#1)(2009-7#1)(2010-3#1)
the treatment of this##12##4##(1991-9#1)(1993-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
the treatment of treatment-resistant##3##4##(2008-12#1)(2012-12#2)
the treatment of tuberculosis##4##4##(1996-3#1)(2008-10#1)(2008-8#2)
the treatment of type##2##4##(1996-11#1)(2011-3#1)
the treatment of various diseases##2##5##(2008-10#2)
the treatment of various##4##4##(2008-10#2)(2010-5#1)(2011-1#1)
the treatment of vesicoureteral reflux##2##5##(2007-9#1)(2008-10#1)
the treatment of wastewater##2##4##(2008-12#1)(2008-7#1)
the treatment of##988##3##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#5)(1990-5#2)(1990-6#11)(1990-8#1)(1990-9#6)(1991-1#3)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#7)(1991-9#5)(1992-1#5)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#8)(1992-9#4)(1993-1#2)(1993-11#6)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#5)(1993-8#1)(1993-9#5)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1995-9#6)(1996-1#4)(1996-10#1)(1996-11#6)(1996-12#1)(1996-2#4)(1996-3#8)(1996-6#3)(1996-7#2)(1996-9#4)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#7)(2006-12#3)(2007-10#5)(2007-11#31)(2007-12#14)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#42)(2007-9#4)(2008-1#14)(2008-10#30)(2008-11#23)(2008-12#2)(2008-2#9)(2008-3#21)(2008-4#14)(2008-5#53)(2008-6#25)(2008-7#44)(2008-8#24)(2008-9#16)(2009-1#5)(2009-10#7)(2009-11#3)(2009-12#5)(2009-3#6)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#8)(2010-1#2)(2010-10#5)(2010-11#9)(2010-12#5)(2010-2#1)(2010-3#12)(2010-4#2)(2010-5#5)(2010-6#14)(2010-7#1)(2010-8#12)(2010-9#2)(2011-1#20)(2011-10#1)(2011-2#56)(2011-3#6)(2011-7#2)(2012-1#5)(2012-12#17)(2012-2#18)(2012-3#22)(2013-1#50)(2013-7#3)(2013-8#15)
the treatment options and##3##4##(1996-9#1)(2008-3#1)(2008-6#1)
the treatment options##7##3##(1993-8#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
the treatment or##4##3##(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
the treatment outcome##4##3##(2007-8#1)(2008-11#1)(2010-1#1)(2012-12#1)
the treatment outcomes##2##3##(2011-2#2)
the treatment period##9##3##(1990-11#1)(1992-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
the treatment plan##5##3##(1992-10#1)(2008-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
the treatment process##4##3##(1992-5#1)(2008-10#1)(2009-6#1)(2011-1#1)
the treatment program for##2##4##(1994-6#1)(2011-1#1)
the treatment program##3##3##(1993-1#1)(1994-6#1)(2011-1#1)
the treatment protocol##3##3##(2007-8#1)(2013-1#1)(2013-8#1)
the treatment protocols##2##3##(2013-1#1)(2013-8#1)
the treatment regime##4##3##(2011-1#2)(2011-2#1)(2012-12#1)
the treatment regimen##4##3##(1991-2#1)(1994-12#1)(2008-7#1)(2012-3#1)
the treatment results in##3##4##(2011-2#3)
the treatment results of patients##2##5##(2007-11#1)(2011-2#1)
the treatment results of##6##4##(2007-11#2)(2008-7#1)(2011-2#3)
the treatment results##14##3##(2007-11#2)(2008-7#2)(2011-2#10)
the treatment should be##2##4##(1991-9#1)(1997-6#1)
the treatment team##2##3##(1992-3#1)(2008-1#1)
the treatment to##4##3##(1994-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the treatment was unsuccessful##2##4##(1995-11#1)(2012-3#1)
the treatment was##12##3##(1992-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(2007-7#1)(2008-6#1)(2009-7#1)(2010-1#1)(2012-3#2)(2013-1#1)
the treatment with the##3##4##(1990-2#1)(2008-11#1)(2008-5#1)
the treatment with##15##3##(1990-2#1)(1991-6#1)(1992-11#1)(1992-8#2)(1993-3#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
the treatment##1282##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#6)(1990-3#7)(1990-5#2)(1990-6#11)(1990-8#1)(1990-9#7)(1991-1#4)(1991-11#8)(1991-12#4)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#12)(1991-9#6)(1992-1#5)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#6)(1992-8#11)(1992-9#4)(1993-1#3)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#5)(1993-8#3)(1993-9#5)(1994-11#6)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#3)(1995-11#7)(1995-12#10)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1995-9#6)(1996-1#4)(1996-10#1)(1996-11#8)(1996-12#2)(1996-2#4)(1996-3#8)(1996-4#1)(1996-6#5)(1996-7#2)(1996-9#6)(1997-1#3)(1997-2#3)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#3)(2006-10#7)(2006-12#3)(2006-8#1)(2007-10#6)(2007-11#54)(2007-12#17)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#47)(2007-9#4)(2008-1#18)(2008-10#44)(2008-11#27)(2008-12#8)(2008-2#11)(2008-3#23)(2008-4#17)(2008-5#59)(2008-6#30)(2008-7#58)(2008-8#27)(2008-9#20)(2009-1#5)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#6)(2009-4#7)(2009-5#7)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#8)(2010-1#5)(2010-10#5)(2010-11#12)(2010-12#8)(2010-2#1)(2010-3#13)(2010-4#3)(2010-5#7)(2010-6#16)(2010-7#2)(2010-8#12)(2010-9#3)(2011-1#31)(2011-10#1)(2011-2#85)(2011-3#6)(2011-7#2)(2012-1#6)(2012-12#23)(2012-2#25)(2012-3#31)(2013-1#66)(2013-7#4)(2013-8#21)
the treatments with##2##3##(2008-10#2)
the treatments##28##2##(1993-3#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1997-4#1)(2008-10#10)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#2)(2012-2#1)(2012-5#1)(2012-9#1)
the tree canopy##7##3##(2008-10#7)
the tree was##2##3##(1995-3#1)(2008-10#1)
the tree##31##2##(1991-1#1)(1994-11#1)(1995-3#1)(2008-10#17)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
the trees##8##2##(2008-10#6)(2008-8#1)(2011-2#1)
the trehalose##4##2##(1993-8#2)(2008-10#1)(2013-1#1)
the trellis diagram##2##3##(2008-3#2)
the trellis##3##2##(2008-10#1)(2008-3#2)
the trend for##2##3##(2011-1#1)(2013-1#1)
the trend in##8##3##(1993-2#1)(1995-12#1)(1995-9#1)(1996-3#2)(2008-11#1)(2008-8#2)
the trend of##3##3##(1995-6#1)(2008-4#1)(2009-12#1)
the trend##29##2##(1990-11#1)(1991-3#1)(1992-8#1)(1993-2#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
the trends in the##2##4##(2008-3#1)(2008-5#1)
the trends in##8##3##(1991-4#1)(1991-8#1)(1993-9#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
the trends of##2##3##(1994-12#1)(2012-12#1)
the trends##18##2##(1991-3#1)(1991-4#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-6#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-3#1)
the triad of##3##3##(2006-10#1)(2008-8#1)(2011-1#1)
the triad##4##2##(2006-10#1)(2008-8#1)(2010-1#1)(2011-1#1)
the trial and##2##3##(2007-7#1)(2008-7#1)
the trial court##3##3##(1990-11#1)(1992-12#1)(1997-5#1)
the trial was##2##3##(2008-8#1)(2009-4#1)
the trial would##2##3##(2008-3#1)(2009-6#1)
the trial##52##2##(1990-11#1)(1990-2#2)(1991-3#3)(1992-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-5#2)(1996-5#1)(1997-4#2)(1997-5#1)(1997-7#2)(2007-7#3)(2008-10#5)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#6)(2009-4#2)(2009-6#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the trials##15##2##(1994-9#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)
the triangle##5##2##(2008-6#4)(2011-2#1)
the triangular distal wedge##2##4##(2012-12#2)
the triangular##4##2##(2008-10#1)(2008-3#1)(2012-12#2)
the tricarboxylic acid (TCA) cycle##2##5##(1993-6#1)(2012-1#1)
the tricarboxylic acid cycle##4##4##(2008-7#4)
the tricarboxylic acid##6##3##(1993-6#1)(2008-7#4)(2012-1#1)
the triceps brachii##2##3##(2008-5#1)(2012-3#1)
the triceps surae muscle##2##4##(1990-7#1)(2007-11#1)
the triceps surae##3##3##(1990-7#1)(2007-11#1)(2010-3#1)
the triceps##8##2##(1990-7#1)(2007-11#3)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
the trichloromethyl radical##3##3##(1993-3#3)
the trichothecenes##2##2##(2008-10#1)(2008-8#1)
the triclinic space group P&amp##2##5##(1996-2#1)(1997-7#1)
the triclinic space group##4##4##(1996-2#1)(1997-7#1)(2007-11#2)
the triclinic##5##2##(1996-2#1)(1997-7#2)(2007-11#2)
the tricuspid valve##5##3##(1997-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2012-12#1)
the tricuspid##7##2##(1997-2#1)(2007-12#1)(2007-7#1)(2007-8#3)(2012-12#1)
the tricyclic##4##2##(1996-5#3)(2008-2#1)
the trifluoromethyl##2##2##(2007-12#1)(2008-10#1)
the trifunctional##3##2##(1993-12#2)(2008-10#1)
the trigeminal (V)##2##3##(1996-5#1)(1997-6#1)
the trigeminal ganglion##6##3##(1996-2#1)(1997-3#2)(2008-6#1)(2008-7#1)(2011-2#1)
the trigeminal nerve##8##3##(1990-12#1)(1996-5#2)(2011-2#5)
the trigeminal##22##2##(1990-12#1)(1990-9#1)(1993-1#1)(1996-2#1)(1996-5#3)(1997-2#2)(1997-3#2)(1997-6#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#6)
the trigeminally induced apnoea##2##4##(1996-5#2)
the trigger##4##2##(1996-2#1)(2008-9#1)(2010-8#1)(2012-3#1)
the triggering of##6##3##(2008-12#1)(2008-8#2)(2010-6#1)(2013-1#2)
the triggering##10##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2010-5#1)(2010-6#1)(2013-1#2)
the triggers##2##2##(1997-1#1)(2008-11#1)
the triglyceride levels##2##3##(2008-1#1)(2013-1#1)
the triiodide##2##2##(2008-10#2)
the trimer##3##2##(1994-2#1)(1994-6#1)(2008-8#1)
the trimeric##2##2##(1991-12#1)(2008-8#1)
the tripartite##2##2##(2008-4#1)(2013-1#1)
the tripeptide##3##2##(1992-10#1)(2008-4#1)(2011-1#1)
the tripeptides##2##2##(1990-8#1)(1994-5#1)
the triphosphate##2##2##(1992-8#1)(1996-5#1)
the triple helix##5##3##(1997-4#1)(2009-7#2)(2013-1#2)
the triple integration##2##3##(2008-10#2)
the triple##15##2##(1990-10#2)(1994-12#1)(1996-12#1)(1997-4#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-7#2)(2013-1#2)
the triplet##4##2##(1997-7#1)(2008-10#1)(2008-8#1)(2010-4#1)
the triplex formation##2##3##(1993-8#2)
the triplex##6##2##(1993-8#3)(1995-5#3)
the triploid##3##2##(2008-5#2)(2009-12#1)
the trisaccharide##2##2##(1994-5#2)
the tritocerebral commissure##2##3##(2007-12#2)
the tritocerebral##4##2##(2007-12#4)
the trivalent cation##2##3##(1997-2#1)(2008-10#1)
the trivalent ion##2##3##(2008-10#2)
the trivalent##11##2##(1997-2#1)(2008-10#9)(2008-12#1)
the trochlea##2##2##(2011-2#2)
the trolox##2##2##(2008-10#1)(2008-5#1)
the trophectoderm##3##2##(2008-11#1)(2012-12#2)
the trophic##8##2##(1991-12#1)(1993-3#1)(1997-1#1)(1997-2#1)(2008-5#2)(2008-8#1)(2013-7#1)
the trophoblast##3##2##(1995-8#1)(2012-1#1)(2012-12#1)
the tropical Pacific##2##3##(1990-8#1)(2007-5#1)
the tropical and subtropical##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
the tropical and##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
the tropical dry forest##2##4##(2008-5#1)(2013-7#1)
the tropical isolates##3##3##(2008-10#3)
the tropical##28##2##(1990-8#1)(1991-12#1)(1992-8#1)(1996-12#1)(1996-2#1)(2007-5#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-5#1)(2013-7#4)
the tropics and subtropics##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
the tropics and##4##3##(2008-10#1)(2011-2#2)(2012-3#1)
the tropics##15##2##(1995-12#2)(1996-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
the troponin##3##2##(1991-12#1)(1995-6#1)(2008-7#1)
the tropopause##2##2##(2008-3#2)
the troposphere and##4##3##(2008-2#1)(2008-3#3)
the troposphere##9##2##(1992-3#1)(2007-11#1)(2008-2#4)(2008-3#3)
the tropospheric##3##2##(2008-3#3)
the trp operator##3##3##(1992-6#1)(1994-3#2)
the trp repressor##7##3##(1992-6#3)(1992-8#4)
the trp##12##2##(1992-6#4)(1992-8#4)(1994-3#3)(1994-6#1)
the true absorption and endogenous fecal excretion of zinc##2##9##(2010-2#2)
the true absorption##3##3##(2010-2#3)
the true colonization incidence of blossoms##2##6##(2008-10#2)
the true exposure response is##2##5##(2008-7#2)
the true incidence of##2##4##(2007-2#1)(2008-8#1)
the true incidence##3##3##(2007-2#1)(2008-8#1)(2011-1#1)
the true lumen##5##3##(2007-8#3)(2008-11#2)
the true offset##2##3##(2008-3#2)
the true phase##2##3##(2008-2#2)
the true surface or wave-front deformation##2##6##(2008-3#2)
the true value##2##3##(2008-2#1)(2008-9#1)
the true##89##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-2#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#14)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#3)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#1)(2013-7#1)
the truly##5##2##(1994-2#1)(1995-6#1)(1996-12#1)(2008-10#2)
the truncated##7##2##(1992-9#1)(1993-6#2)(1994-8#1)(1996-12#1)(1997-8#1)(2008-8#1)
the trunk and extremities##2##4##(2007-7#1)(2010-6#1)
the trunk and##5##3##(2007-7#2)(2008-5#1)(2010-6#1)(2011-2#1)
the trunk in##3##3##(1995-8#1)(2007-8#1)(2008-10#1)
the trunk of##2##3##(2008-5#1)(2008-7#1)
the trunk##24##2##(1991-12#1)(1995-8#5)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-5#3)(2008-6#3)(2008-7#1)(2010-6#2)(2011-2#1)
the trust of##2##3##(2008-8#1)(2012-3#1)
the trust##6##2##(1996-1#1)(1997-4#1)(2008-8#1)(2012-3#2)(2013-8#1)
the trypsin##2##2##(1990-12#1)(1994-3#1)
the trypsin-like peptidase##2##3##(2008-5#2)
the trypsin-like##3##2##(2008-5#3)
the tryptic digest of##2##4##(1990-8#1)(1997-2#1)
the tryptic##6##2##(1990-5#1)(1990-8#1)(1992-10#1)(1993-8#1)(1997-2#1)(2008-10#1)
the tryptophan##6##2##(1992-8#1)(1994-6#1)(2008-10#2)(2008-3#1)(2010-5#1)
the ts##3##2##(1990-5#2)(1994-12#1)
the tsunami##2##2##(2010-8#1)(2013-1#1)
the tsx##3##2##(1990-11#3)
the tuatara##3##2##(2010-3#3)
the tubal##2##2##(1990-2#2)
the tube and##3##3##(2008-7#1)(2010-5#1)(2011-1#1)
the tube is##2##3##(2008-10#1)(2008-3#1)
the tube lifetime##2##3##(2008-10#2)
the tube test##5##3##(2011-1#5)
the tube##29##2##(1994-9#2)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#6)(2013-8#1)
the tubercle bacillus##2##3##(2008-9#1)(2013-1#1)
the tubercle##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
the tuberculin##2##2##(1990-6#1)(2013-1#1)
the tuberculosis (TB)##2##3##(2010-4#2)
the tuberculosis##5##2##(2007-8#1)(2008-10#1)(2010-4#2)(2013-8#1)
the tubes through##2##3##(1996-8#1)(2008-7#1)
the tubes##10##2##(1992-6#1)(1996-8#1)(2008-7#4)(2011-1#2)(2012-2#2)
the tubing##3##2##(2008-10#2)(2011-1#1)
the tubular electrode##3##3##(2008-10#3)
the tubular##7##2##(2008-10#3)(2008-7#1)(2009-1#1)(2011-2#1)(2013-7#1)
the tubulin##5##2##(1991-5#1)(1993-8#2)(1995-5#1)(2008-11#1)
the tubulo-interstitial##2##2##(2008-1#1)(2008-4#1)
the tumor and its##2##4##(1990-9#1)(2012-2#1)
the tumor and the##2##4##(1993-11#1)(1996-11#1)
the tumor and##14##3##(1990-2#1)(1990-9#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-11#1)(2007-11#2)(2008-11#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
the tumor bed##2##3##(2007-11#2)
the tumor cell##6##3##(1993-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#2)
the tumor cells were##3##4##(2009-8#1)(2010-6#1)(2012-1#1)
the tumor cells##16##3##(1991-6#1)(1992-9#2)(1993-8#1)(1994-5#1)(1994-7#1)(1997-1#2)(2008-1#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-2#1)
the tumor growth##3##3##(1994-12#1)(1994-9#1)(2010-1#1)
the tumor had##3##3##(1993-6#1)(1994-12#1)(1995-4#1)
the tumor in##6##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-1#1)
the tumor is##6##3##(1992-2#1)(1992-8#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-6#1)
the tumor mass##2##3##(1993-11#1)(2011-1#1)
the tumor microenvironment in##2##4##(2011-1#1)(2013-1#1)
the tumor microenvironment##14##3##(2009-3#2)(2010-11#1)(2010-3#1)(2011-1#4)(2013-1#5)(2013-8#1)
the tumor necrosis##2##3##(1992-8#1)(2013-1#1)
the tumor promoter##2##3##(1991-5#1)(2012-3#1)
the tumor spheroid##3##3##(2008-11#3)
the tumor stroma##2##3##(1994-2#1)(2011-1#1)
the tumor suppressor gene p53##2##5##(1994-9#1)(2008-10#1)
the tumor suppressor gene##4##4##(1994-9#1)(2008-10#1)(2011-2#2)
the tumor suppressor p53##2##4##(2007-8#1)(2009-7#1)
the tumor suppressor##9##3##(1994-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
the tumor tissue##3##3##(1992-9#2)(2010-12#1)
the tumor volumes##2##3##(1992-9#1)(1994-12#1)
the tumor was a##2##4##(1992-2#1)(2011-2#1)
the tumor was composed of a##2##6##(2013-1#1)(2013-8#1)
the tumor was composed of##5##5##(1991-8#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
the tumor was composed##6##4##(1991-8#1)(2008-12#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
the tumor was diagnosed as##3##5##(1994-7#1)(1995-4#1)(2013-8#1)
the tumor was on the left##2##6##(2011-2#2)
the tumor was on the##3##5##(2011-2#3)
the tumor was##36##3##(1990-5#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-11#1)(1994-7#5)(1995-4#1)(2006-12#2)(2007-11#1)(2008-12#3)(2008-7#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#2)
the tumor##237##2##(1990-2#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#3)(1992-1#1)(1992-10#1)(1992-2#2)(1992-8#2)(1992-9#13)(1993-11#5)(1993-6#2)(1993-8#1)(1993-9#4)(1994-12#3)(1994-2#1)(1994-5#4)(1994-6#1)(1994-7#6)(1994-9#3)(1995-4#3)(1996-11#1)(1997-1#3)(1997-8#1)(2006-12#6)(2007-10#2)(2007-11#9)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#3)(2008-11#11)(2008-12#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#7)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#4)(2009-3#8)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-5#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#11)(2011-2#16)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#18)(2013-8#6)
the tumor-associated##3##2##(1993-9#2)(2008-11#1)
the tumor-bearing##2##2##(2008-8#1)(2013-8#1)
the tumoral##2##2##(2010-9#1)(2011-2#1)
the tumorigenic phenotype##2##3##(1992-9#2)
the tumorigenic##6##2##(1990-11#1)(1992-9#3)(1994-12#1)(2008-11#1)
the tumors that##2##3##(2006-12#1)(2011-2#1)
the tumors were##4##3##(1993-1#1)(1993-5#1)(2013-1#2)
the tumors##29##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#2)(1992-2#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-5#1)(1994-6#1)(2006-12#2)(2007-4#1)(2008-1#1)(2008-6#1)(2010-3#1)(2011-2#2)(2013-1#6)(2013-8#1)
the tumour and the##3##4##(1991-11#1)(2008-7#2)
the tumour and##6##3##(1991-11#1)(2008-2#1)(2008-4#1)(2008-7#3)
the tumour cells##2##3##(1991-6#1)(1995-12#1)
the tumour is##2##3##(1997-3#1)(2008-6#1)
the tumour microenvironment##2##3##(2009-4#1)(2010-7#1)
the tumour to##2##3##(2008-9#1)(2009-4#1)
the tumour was##8##3##(2008-6#1)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
the tumour##64##2##(1990-5#2)(1991-11#2)(1991-6#2)(1992-5#1)(1993-8#1)(1995-12#1)(1997-3#2)(2007-11#4)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#9)(2008-7#22)(2008-9#1)(2009-4#2)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
the tumours##14##2##(1990-12#2)(1991-11#1)(1993-5#1)(2006-8#8)(2008-10#1)(2013-1#1)
the tunability of the##2##4##(2007-12#1)(2008-10#1)
the tunability##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
the tunable output##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
the tunable##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
the tungsten coil##3##3##(2008-10#3)
the tungsten wire##3##3##(2008-10#3)
the tungsten##12##2##(2007-12#1)(2008-10#11)
the tunic##4##2##(2008-5#2)(2008-7#2)
the tunica propria##3##3##(2009-10#3)
the tunica##5##2##(2008-10#1)(2008-11#1)(2009-10#3)
the tuning element##2##3##(2008-2#2)
the tuning range of##3##4##(2008-2#3)
the tuning range##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
the tuning##13##2##(2007-11#1)(2008-2#9)(2008-3#2)(2012-3#1)
the tunnel##8##2##(1991-12#1)(1994-11#2)(1995-1#1)(2007-12#2)(2009-10#1)(2011-3#1)
the tunneling##6##2##(1995-2#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-4#1)
the turbid media##2##3##(2008-3#2)
the turbid medium##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
the turbid##11##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#6)
the turbidity of the membrane##2##5##(2008-10#2)
the turbidity of the##3##4##(1990-12#1)(2008-10#2)
the turbidity##5##2##(1990-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
the turbulence##5##2##(2007-12#1)(2008-3#4)
the turbulence-induced##2##2##(2008-2#1)(2008-3#1)
the turbulent##5##2##(2007-12#1)(2008-3#2)(2008-7#1)(2008-8#1)
the turkey GH##2##3##(1990-12#2)
the turn of the year##2##5##(1990-12#1)(1997-3#1)
the turn of the##6##4##(1990-12#1)(1997-3#2)(2008-7#1)(2010-1#1)(2011-2#1)
the turn of##8##3##(1990-12#1)(1997-3#3)(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)
the turn##11##2##(1990-12#1)(1994-5#1)(1995-6#1)(1997-3#3)(2008-1#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)
the turning##2##2##(1995-12#1)(2008-12#1)
the turnover of LH beta mRNA##2##6##(1997-2#2)
the turnover of##6##3##(1993-11#1)(1993-3#1)(1997-2#2)(2008-10#1)(2008-4#1)
the turnover##9##2##(1991-1#1)(1993-11#1)(1993-3#1)(1995-12#1)(1997-2#2)(2008-10#2)(2008-4#1)
the twentieth century##9##3##(2008-10#1)(2008-8#1)(2009-7#2)(2010-1#2)(2011-2#3)
the twentieth##11##2##(2008-10#2)(2008-8#1)(2009-7#2)(2010-1#3)(2011-2#3)
the twenty##2##2##(1997-7#1)(2009-8#1)
the twenty-first century##7##3##(1994-2#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-3#1)(2008-12#1)
the twin##5##2##(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
the twist##3##2##(2007-11#1)(2008-2#2)
the twisted##4##2##(1990-9#2)(1993-11#2)
the twitch responses of the electrically stimulated##2##7##(1990-5#2)
the twitch##3##2##(1990-5#2)(2013-8#1)
the two ATP-binding motifs##2##4##(1996-2#2)
the two IGF-I##2##3##(1992-9#1)(1994-2#1)
the two States##3##3##(1992-3#3)
the two aberrated wave fronts##2##5##(2008-3#2)
the two adjacent##2##3##(1994-2#1)(2008-3#1)
the two agents##2##3##(2008-8#2)
the two alternative##2##3##(1997-4#1)(2008-8#1)
the two antibodies##2##3##(1991-2#1)(1995-6#1)
the two antigens##2##3##(1992-8#1)(2008-10#1)
the two approaches to##2##4##(2008-5#1)(2011-2#1)
the two approaches##6##3##(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#2)
the two are##4##3##(2008-3#2)(2008-4#1)(2012-3#1)
the two areas##2##3##(2008-10#1)(2008-8#1)
the two arms##3##3##(2007-12#1)(2008-3#1)(2010-3#1)
the two axes##2##3##(2008-3#2)
the two beams##4##3##(2007-12#1)(2008-3#3)
the two bladder##2##3##(2008-10#2)
the two breakpoints of##2##4##(2013-1#2)
the two can be##2##4##(2008-10#1)(2010-8#1)
the two case##2##3##(1993-12#1)(2008-4#1)
the two cases##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2011-1#1)
the two catalytic##2##3##(1991-9#1)(1995-5#1)
the two categories of##2##4##(2008-10#1)(2013-1#1)
the two cell lines were##2##5##(2008-11#1)(2008-9#1)
the two cell lines##10##4##(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)(2012-12#1)
the two cell##13##3##(1990-11#1)(1993-3#1)(1995-11#1)(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)(2012-12#1)
the two chambers##2##3##(2008-8#1)(2011-2#1)
the two chromium##2##3##(2008-10#2)
the two classes of##4##4##(1994-6#1)(1995-6#1)(2008-10#1)(2008-2#1)
the two clones##2##3##(2008-10#2)
the two communities##2##3##(2010-3#1)(2012-2#1)
the two complexes##3##3##(1992-4#1)(1996-2#1)(2008-10#1)
the two component regulatory##2##4##(2008-8#1)(2010-10#1)
the two component##3##3##(1994-2#1)(2008-8#1)(2010-10#1)
the two components##6##3##(1995-3#1)(2007-12#2)(2007-8#1)(2008-6#1)(2008-8#1)
the two compounds in##2##4##(2008-10#2)
the two compounds##3##3##(2008-10#3)
the two conditions##6##3##(1990-2#1)(1993-6#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-6#1)
the two constituent##2##3##(2007-12#1)(2008-7#1)
the two cytologists##2##3##(2008-6#2)
the two days##3##3##(2008-3#2)(2008-5#1)
the two dietary##2##3##(1991-12#1)(2008-12#1)
the two different forms of##2##5##(1994-8#1)(2012-12#1)
the two different##17##3##(1991-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2012-12#1)
the two diseases##9##3##(1994-8#1)(2007-7#1)(2008-10#7)
the two distinct##2##3##(1996-2#1)(2008-10#1)
the two domains##3##3##(1991-9#2)(1995-6#1)
the two drug##2##3##(1990-2#1)(2010-3#1)
the two drugs##11##3##(1990-5#1)(1990-9#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2010-3#1)(2012-2#1)
the two dyes##2##3##(2008-2#2)
the two earlier##2##3##(1994-2#1)(2008-10#1)
the two effects##2##3##(1990-8#1)(2008-5#1)
the two electrode##2##3##(1993-12#1)(2007-12#1)
the two electrodes##5##3##(2007-12#1)(2008-10#4)
the two enantiomers##2##3##(2008-10#2)
the two environments##2##3##(2008-8#1)(2010-5#1)
the two enzymes##4##3##(1990-5#1)(1995-5#1)(2008-10#1)(2008-11#1)
the two etched##2##3##(2008-3#1)(2008-5#1)
the two events##2##3##(1991-8#1)(1995-6#1)
the two examinations##3##3##(1996-11#1)(2008-11#1)(2008-4#1)
the two excitation beams##2##4##(2008-3#2)
the two excitation##3##3##(2008-3#3)
the two experimental##4##3##(1996-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
the two experiments##2##3##(2008-10#2)
the two factors##2##3##(2008-10#1)(2008-7#1)
the two fetuses##2##3##(1992-6#2)
the two field##2##3##(2007-11#1)(2008-10#1)
the two fields##2##3##(1991-2#1)(1997-3#1)
the two first-order reactions model##3##5##(2008-10#3)
the two fish species##2##4##(2008-12#1)(2010-8#1)
the two forms of##6##4##(1991-12#1)(1991-8#1)(2007-11#1)(2008-10#2)(2010-5#1)
the two forms##9##3##(1991-12#1)(1991-8#1)(1995-5#1)(2007-11#1)(2008-10#2)(2010-5#1)(2012-1#2)
the two formulations of##2##4##(1996-1#2)
the two fungi##3##3##(2008-10#3)
the two genes are##2##4##(1994-11#1)(2008-10#1)
the two genes##11##3##(1990-11#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-8#2)(1997-7#1)(2008-10#1)(2008-9#1)(2009-8#1)
the two genotypes##3##3##(2008-10#2)(2008-4#1)
the two grating planes##5##4##(2008-3#5)
the two groups and##2##4##(2008-10#1)(2012-2#1)
the two groups did not differ##3##6##(1991-3#1)(2010-4#1)(2011-1#1)
the two groups in##6##4##(1990-2#1)(1990-6#1)(1995-4#1)(2007-11#2)(2008-7#1)
the two groups of animals##2##5##(1992-11#1)(2008-5#1)
the two groups of isolates##2##5##(2008-10#2)
the two groups of patients##4##5##(1990-11#1)(1990-12#1)(1990-5#1)(2008-10#1)
the two groups of##16##4##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1995-12#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
the two groups was##6##4##(1996-5#1)(2008-1#1)(2008-7#2)(2011-1#1)(2011-2#1)
the two groups were comparable##2##5##(2007-7#1)(2009-11#1)
the two groups were##9##4##(1992-12#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
the two groups with##2##4##(2007-8#1)(2013-1#1)
the two groups##117##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-3#2)(1997-6#3)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#6)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
the two halves##2##3##(1990-11#1)(1997-7#1)
the two helices##4##3##(1991-5#1)(1993-1#3)
the two higher##2##3##(1992-11#1)(2008-3#1)
the two highest##2##3##(1994-2#1)(2008-1#1)
the two hospitals##2##3##(1993-6#1)(1994-1#1)
the two hosts##4##3##(2008-10#3)(2010-2#1)
the two images##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
the two indices##3##3##(2008-3#1)(2008-8#2)
the two input##3##3##(2007-12#2)(2008-3#1)
the two instruments##6##3##(2008-10#1)(2008-3#5)
the two interfering beams##2##4##(2007-11#1)(2008-3#1)
the two irrigation##2##3##(2008-10#2)
the two is##3##3##(1991-3#1)(2011-2#2)
the two isoforms of##2##4##(1991-12#1)(1995-2#1)
the two isoforms##4##3##(1991-12#1)(1995-2#1)(1995-8#1)(2012-2#1)
the two isolates of##2##4##(2008-10#1)(2008-5#1)
the two isolates were##2##4##(2008-10#2)
the two isolates##9##3##(2008-10#7)(2008-5#1)(2009-6#1)
the two kinds of NK cells##2##6##(2008-8#2)
the two kinds of##6##4##(2008-10#3)(2008-8#3)
the two largest lineages##2##4##(2008-10#2)
the two layers##5##3##(2008-12#1)(2008-2#2)(2008-3#2)
the two levels##2##3##(2008-7#1)(2008-8#1)
the two ligands##4##3##(1996-2#1)(1997-2#2)(2008-10#1)
the two lines##2##3##(2008-10#1)(2008-3#1)
the two locations##3##3##(2008-1#1)(2008-10#2)
the two main##16##3##(1992-3#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-1#2)
the two major production areas##2##5##(2008-10#2)
the two major##24##3##(1990-12#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-6#1)(2011-2#1)
the two materials##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
the two mechanisms##5##3##(2008-10#2)(2008-3#1)(2008-9#2)
the two mentioned##2##3##(2008-10#1)(2008-12#1)
the two metals##5##3##(1991-5#1)(2008-10#4)
the two methods are##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
the two methods of analysis##3##5##(2008-10#2)(2012-7#1)
the two methods was##2##4##(1995-2#1)(2008-10#1)
the two methods were##6##4##(2008-10#5)(2013-7#1)
the two methods##39##3##(1992-12#1)(1992-6#1)(1995-2#1)(1996-1#1)(1996-5#1)(2007-7#1)(2008-10#20)(2008-11#1)(2008-2#4)(2008-3#4)(2010-5#1)(2012-7#1)(2013-1#1)(2013-7#1)
the two models##6##3##(2007-10#1)(2008-10#3)(2008-5#1)(2009-8#1)
the two modes of##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
the two modes##4##3##(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
the two molecules##2##3##(1994-8#1)(2008-8#1)
the two monolayers##3##3##(1990-11#1)(2007-12#2)
the two monomers##2##3##(1992-4#1)(2012-2#1)
the two morphologically##2##3##(2008-10#1)(2008-8#1)
the two most important##3##4##(1991-2#1)(1992-5#1)(2008-5#1)
the two most##16##3##(1991-2#1)(1991-8#1)(1992-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
the two myosin isozymes##2##4##(1996-9#2)
the two new##2##3##(2008-11#1)(2008-5#1)
the two organisms##2##3##(2008-10#1)(2008-7#1)
the two other##8##3##(1990-5#1)(1994-12#1)(1996-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
the two pairs of phycocyanobilins##2##5##(1994-5#2)
the two parameters alpha and gamma##2##6##(2008-6#2)
the two parameters##3##3##(2008-11#1)(2008-6#2)
the two parties##3##3##(1991-6#1)(1994-1#1)(2008-8#1)
the two patches##2##3##(1992-10#2)
the two pathogens##4##3##(2008-10#3)(2010-4#1)
the two patient groups##2##4##(1996-5#1)(2008-3#1)
the two peptides##4##3##(1991-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
the two periods##3##3##(2011-2#2)(2012-3#1)
the two perpendicular##2##3##(2008-2#1)(2008-3#1)
the two phases was##2##4##(1991-6#1)(2008-10#1)
the two phases##7##3##(1991-6#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
the two polymers##2##3##(2008-10#2)
the two populations##7##3##(1992-10#1)(2008-10#4)(2008-11#1)(2008-8#1)
the two possible##2##3##(1992-3#1)(2008-10#1)
the two preparations##3##3##(1992-8#1)(1992-9#1)(1996-2#1)
the two previously##2##3##(1991-12#1)(2008-9#1)
the two primary##3##3##(2008-4#1)(2013-1#2)
the two procedures##9##3##(1996-2#1)(2008-10#5)(2012-12#2)(2012-2#1)
the two products##4##3##(1994-8#1)(1995-6#1)(2008-10#1)(2008-5#1)
the two proteins are##2##4##(1991-9#1)(2008-4#1)
the two proteins##15##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-9#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(2008-2#1)(2008-4#2)(2009-10#1)(2012-2#1)
the two protocols##3##3##(2008-4#2)(2008-9#1)
the two quinones##2##3##(1994-11#2)
the two races##2##3##(2008-10#2)
the two receptor domains##2##4##(1993-6#2)
the two receptor##4##3##(1991-12#1)(1993-6#2)(2008-11#1)
the two regions##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
the two remaining##2##3##(2008-10#1)(2008-8#1)
the two resistance genes##2##4##(2008-10#2)
the two resistance##3##3##(2008-10#3)
the two samples##4##3##(2008-10#1)(2008-2#1)(2010-1#1)(2011-2#1)
the two seasons##4##3##(2008-10#2)(2008-5#2)
the two senior authors##2##4##(2008-9#1)(2012-2#1)
the two sequences##2##3##(1993-3#1)(2008-4#1)
the two series of##3##4##(1995-11#1)(1995-3#1)(2008-10#1)
the two series##5##3##(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)
the two sets of data##2##5##(2008-10#1)(2008-11#1)
the two sets of##6##4##(1994-9#1)(2008-10#3)(2008-11#1)(2013-1#1)
the two sexes##2##3##(1991-6#1)(2008-5#1)
the two single##3##3##(1995-6#2)(2008-10#1)
the two sites##4##3##(1993-3#1)(1997-7#1)(2008-10#1)(2013-7#1)
the two soils##4##3##(1993-8#1)(2008-10#2)(2008-6#1)
the two species and##2##4##(1991-6#1)(2008-10#1)
the two species are##3##4##(2008-10#2)(2011-2#1)
the two species of##2##4##(2008-10#1)(2008-8#1)
the two species were##4##4##(1994-11#1)(2008-10#2)(2008-6#1)
the two species##42##3##(1991-6#2)(1993-12#1)(1994-11#2)(1994-3#1)(1996-2#1)(1996-5#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#6)(2011-2#2)(2012-3#1)(2012-5#1)(2012-8#1)
the two specific##2##3##(2008-11#1)(2009-2#1)
the two strains##9##3##(1993-11#1)(1996-5#1)(2007-6#1)(2008-10#3)(2009-6#1)(2011-1#1)(2013-1#1)
the two strategies##2##3##(1997-4#1)(2010-7#1)
the two strongest##2##3##(2008-10#1)(2010-12#1)
the two structures##2##3##(1994-3#1)(2008-10#1)
the two study##3##3##(1991-11#1)(2010-4#1)(2013-7#1)
the two subgroups of RA##2##5##(2008-7#2)
the two subgroups of patients##2##5##(1994-3#1)(2008-7#1)
the two subgroups of##4##4##(1994-3#1)(2008-7#3)
the two subgroups##6##3##(1994-3#1)(2008-10#2)(2008-7#3)
the two substrate molecules##2##4##(1992-3#2)
the two substrate##3##3##(1992-3#2)(1994-5#1)
the two substrates##5##3##(1994-5#2)(1997-2#1)(2008-7#2)
the two subunits of##2##4##(1992-9#1)(1993-8#1)
the two subunits##10##3##(1990-8#1)(1991-10#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(2010-5#3)
the two surfaces was##2##4##(2010-10#2)
the two surfaces##3##3##(2008-12#1)(2010-10#2)
the two systems##8##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
the two tasks##4##3##(1991-2#1)(1994-8#1)(2008-11#1)(2008-9#1)
the two taxa are##2##4##(2008-10#1)(2008-7#1)
the two taxa##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the two techniques in##2##4##(1997-8#1)(2008-8#1)
the two techniques##11##3##(1995-5#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#1)
the two technologies##2##3##(2008-9#1)(2011-2#1)
the two terminal##4##3##(1993-11#1)(1997-3#1)(2008-10#2)
the two terrestrial##2##3##(2008-7#2)
the two tests##3##3##(1991-6#1)(1993-6#1)(1994-8#1)
the two time##2##3##(1996-11#1)(2008-3#1)
the two toxins##2##3##(1993-12#1)(2011-1#1)
the two training approaches##2##4##(2013-8#2)
the two treatment##6##3##(1992-6#1)(1992-9#1)(1995-4#1)(1997-7#1)(2008-5#1)(2008-6#1)
the two trials##3##3##(1993-12#1)(2008-10#2)
the two tryptophan residues in##2##5##(1991-5#1)(1992-6#1)
the two tryptophan residues##3##4##(1991-5#1)(1992-6#1)(1993-11#1)
the two types of##15##4##(1991-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-8#1)
the two types##17##3##(1991-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2011-2#1)(2013-8#1)
the two variables##2##3##(2008-7#1)(2013-7#1)
the two variants##3##3##(1990-6#3)
the two varieties of##2##4##(2008-10#1)(2008-5#1)
the two viruses##8##3##(2007-6#1)(2008-10#6)(2008-9#1)
the two wavelengths##3##3##(2008-2#2)(2008-3#1)
the two weeks##2##3##(1992-5#1)(1993-3#1)
the two years##3##3##(2008-10#2)(2008-5#1)
the two##1534##2##(1990-11#7)(1990-12#6)(1990-2#7)(1990-3#3)(1990-5#7)(1990-6#4)(1990-7#7)(1990-8#6)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#16)(1991-2#5)(1991-3#3)(1991-5#3)(1991-6#11)(1991-7#1)(1991-8#6)(1991-9#9)(1992-10#3)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#15)(1992-4#2)(1992-5#4)(1992-6#8)(1992-8#4)(1992-9#8)(1993-1#6)(1993-11#8)(1993-12#11)(1993-2#3)(1993-3#8)(1993-6#11)(1993-8#8)(1994-1#2)(1994-11#10)(1994-12#6)(1994-2#7)(1994-3#4)(1994-5#15)(1994-6#4)(1994-7#1)(1994-8#11)(1994-9#4)(1995-1#2)(1995-11#5)(1995-12#8)(1995-2#12)(1995-3#6)(1995-4#2)(1995-5#10)(1995-6#10)(1995-8#5)(1995-9#1)(1996-1#6)(1996-11#3)(1996-12#4)(1996-2#19)(1996-3#3)(1996-5#13)(1996-6#2)(1996-7#2)(1996-9#4)(1997-1#2)(1997-2#9)(1997-3#5)(1997-4#6)(1997-6#6)(1997-7#11)(1997-8#3)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#25)(2007-12#39)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#12)(2008-10#332)(2008-11#42)(2008-12#15)(2008-2#43)(2008-3#111)(2008-4#26)(2008-5#42)(2008-6#16)(2008-7#40)(2008-8#53)(2008-9#38)(2009-10#4)(2009-11#3)(2009-12#7)(2009-2#1)(2009-3#1)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#14)(2011-2#40)(2011-3#1)(2012-1#6)(2012-12#9)(2012-2#23)(2012-3#14)(2012-5#5)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#26)(2013-7#5)(2013-8#11)
the two-class case##2##3##(2008-6#2)
the two-component##3##2##(1995-5#1)(1996-12#2)
the two-dimensional case##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the two-dimensional measurement principle##2##4##(2008-3#2)
the two-dimensional measurement##3##3##(2008-3#3)
the two-dimensional shadowing function##2##4##(2008-3#2)
the two-dimensional system##2##3##(2008-3#2)
the two-dimensional##36##2##(1990-9#1)(1995-2#1)(1995-5#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#18)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
the two-hybrid##2##2##(2008-4#1)(2008-8#1)
the two-kernel approach##2##3##(2008-3#2)
the two-layer##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the two-lens##2##2##(2008-2#2)
the two-mirror##2##2##(2007-12#1)(2008-2#1)
the two-month##2##2##(1994-3#1)(2013-1#1)
the two-peptide lantibiotic lacticin 3147##2##5##(2011-1#2)
the two-phase##7##2##(2008-10#6)(2011-1#1)
the two-photon absorption##2##3##(2008-2#1)(2009-11#1)
the two-photon fluorescence##3##3##(2008-3#3)
the two-photon interaction##2##3##(2008-3#2)
the two-photon##18##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#9)(2009-11#1)
the two-point equal-time##2##3##(2007-12#2)
the two-point##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
the two-stage##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
the two-state model##3##3##(1990-7#1)(1997-2#2)
the two-state##5##2##(1990-7#1)(1990-8#1)(1993-11#1)(1997-2#2)
the two-step##6##2##(1991-8#1)(2008-10#4)(2008-3#1)
the two-wave mixing##2##3##(2008-3#2)
the two-wave##4##2##(2008-3#3)(2009-7#1)
the two-wavelength##3##2##(2008-2#1)(2008-3#2)
the two-way text##2##3##(2010-8#2)
the two-way##4##2##(2008-10#1)(2010-10#1)(2010-8#2)
the two-year##2##2##(1995-2#1)(1996-3#1)
the tympanic membrane##3##3##(1991-3#2)(2007-10#1)
the tympanic##5##2##(1991-3#2)(2007-10#1)(2008-2#1)(2008-4#1)
the tympanum##2##2##(2006-12#1)(2008-2#1)
the type 1##3##3##(1992-3#1)(2008-1#1)(2008-3#1)
the type 2##4##3##(2007-12#1)(2008-1#1)(2012-12#2)
the type I (III) beta-turn##2##5##(1992-5#2)
the type I IGF receptor##2##5##(2008-11#1)(2008-6#1)
the type I IGF receptors##2##5##(2008-6#2)
the type I IGF##4##4##(2008-11#1)(2008-6#3)
the type I enzyme##2##4##(1995-3#2)
the type I error rates##2##5##(2013-1#2)
the type I error##3##4##(2012-3#1)(2013-1#2)
the type I##16##3##(1990-2#2)(1992-5#2)(1995-2#1)(1995-3#2)(2008-11#1)(2008-3#1)(2008-6#3)(2012-3#1)(2013-1#3)
the type II receptor##2##4##(1997-2#1)(2008-9#1)
the type II##12##3##(1991-10#1)(1995-11#1)(1995-2#3)(1995-3#2)(1997-2#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
the type III secretion system##2##5##(2009-8#1)(2013-1#1)
the type and concentration of##2##5##(2008-10#2)
the type and extent of##2##5##(1995-12#1)(2007-11#1)
the type and##26##3##(1995-12#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-1#1)
the type genus of the family##3##6##(2011-2#3)
the type of TH cell##2##5##(1995-5#2)
the type of bone##2##4##(2007-12#1)(2008-4#1)
the type of diabetes##2##4##(1993-2#2)
the type of equipment##2##4##(2008-10#1)(2008-4#1)
the type of fracture##4##4##(2007-8#2)(2011-2#2)
the type of information##2##4##(2008-11#1)(2012-12#1)
the type of interaction##3##4##(1995-11#1)(1997-2#1)(2008-10#1)
the type of malignancy##2##4##(2008-10#1)(2008-7#1)
the type of nanomaterial used##2##5##(2008-10#2)
the type of program##2##4##(1993-12#1)(1997-1#1)
the type of response##2##4##(2008-10#1)(2012-3#1)
the type of surgical##3##4##(1990-12#1)(1997-2#1)(2013-1#1)
the type of symptom##2##4##(2008-10#1)(2009-9#1)
the type of the##15##4##(1992-9#1)(1993-12#1)(1995-11#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
the type of treatment##3##4##(1993-11#1)(1993-6#1)(2011-2#1)
the type of##177##3##(1990-12#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-6#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-7#1)(1995-11#5)(1995-5#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#6)(2007-12#3)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#24)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
the type or##3##3##(1996-6#1)(2008-10#1)(2009-7#1)
the type species of the genus##26##6##(1997-2#1)(2008-10#1)(2011-2#24)
the type species of the##29##5##(1997-2#1)(2008-10#2)(2011-2#26)
the type species##33##3##(1997-2#1)(2008-10#3)(2008-9#1)(2011-2#28)
the type strain of##6##4##(1997-3#1)(2008-10#1)(2011-2#4)
the type strain##9##3##(1997-3#1)(2008-10#2)(2011-2#4)(2012-2#1)(2012-3#1)
the type##313##2##(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#4)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-11#6)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#9)(2007-12#4)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#42)(2008-11#14)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#6)(2008-5#6)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#50)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#1)
the type(s) of##2##3##(2008-10#1)(2008-11#1)
the types and amounts of##2##5##(1992-3#1)(2008-5#1)
the types and##6##3##(1992-3#1)(2007-11#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-3#1)
the types of##47##3##(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#3)(1993-1#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the types##56##2##(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the typical appearance of##2##4##(2007-4#1)(2012-2#1)
the typical case##2##3##(2010-9#1)(2012-3#1)
the typical clinical##4##3##(1995-2#1)(2007-7#1)(2008-10#1)(2008-7#1)
the typical form of##2##4##(2008-4#1)(2008-7#1)
the typical medical practice##2##4##(1996-2#1)(1996-3#1)
the typical pattern of##2##4##(1995-8#1)(2010-10#1)
the typical symptoms##2##3##(1995-2#1)(2012-12#1)
the typical##72##2##(1992-2#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#4)(2009-1#1)(2010-10#1)(2010-6#2)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
the typology##2##2##(1991-6#1)(1994-2#1)
the tyrosinase##6##2##(1994-12#2)(1997-4#2)(2008-10#1)(2008-5#1)
the tyrosine kinase activity of##3##5##(1992-8#1)(2009-7#1)(2011-2#1)
the tyrosine kinase inhibitor##6##4##(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-6#1)
the tyrosine kinase##14##3##(1991-12#1)(1991-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-12#2)(2007-12#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
the tyrosine phosphorylation and activation of##2##6##(1992-8#1)(1996-2#1)
the tyrosine phosphorylation and##3##4##(1992-8#1)(1995-6#1)(1996-2#1)
the tyrosine phosphorylation of##2##4##(1992-3#1)(1992-8#1)
the tyrosine phosphorylation##5##3##(1992-3#1)(1992-8#2)(1995-6#1)(1996-2#1)
the tyrosine protein kinase activity##2##5##(1991-11#1)(1992-3#1)
the tyrosine##29##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#3)(1992-8#3)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
the tyrosyl##6##2##(1990-2#1)(1991-12#1)(1992-12#1)(1993-11#2)(1997-3#1)
the u-PA##2##2##(1993-12#1)(1994-3#1)
the ubiquitin##4##2##(1995-12#1)(2008-9#2)(2011-3#1)
the ubiquitin-dependent##4##2##(1994-9#1)(1995-6#1)(2009-7#2)
the ubiquitin-extension protein##2##3##(1997-2#2)
the ubiquitous##11##2##(1992-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
the ugly##5##2##(2007-8#1)(2008-7#3)(2011-2#1)
the ulcer##4##2##(1996-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
the ulna##4##2##(1995-6#1)(2011-2#2)(2013-1#1)
the ulnar nerve and##2##4##(1992-6#1)(2008-9#1)
the ulnar nerve##11##3##(1992-6#2)(2008-12#1)(2008-9#8)
the ulnar##17##2##(1992-6#2)(1997-3#1)(2007-11#1)(2008-12#1)(2008-9#12)
the ultimate goal of##3##4##(2008-7#1)(2010-9#1)(2012-2#1)
the ultimate goal##6##3##(1992-1#1)(2008-7#2)(2009-9#1)(2010-9#1)(2012-2#1)
the ultimate outcome##2##3##(1997-3#1)(2008-11#1)
the ultimate##34##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-3#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
the ultra##2##2##(2008-10#2)
the ultrafast nonlinear interferometer##2##4##(2008-2#2)
the ultrafast##6##2##(2007-12#2)(2008-2#2)(2008-3#1)(2012-8#1)
the ultrafiltration##3##2##(2008-1#1)(2011-2#2)
the ultramarathon##3##2##(2013-8#3)
the ultrashort##3##2##(2007-11#1)(2008-3#2)
the ultrasmall##2##2##(2007-11#1)(2007-12#1)
the ultrasonic beam##4##3##(2007-12#2)(2008-3#2)
the ultrasonic inhaler##2##3##(1993-2#2)
the ultrasonic method##2##3##(1997-6#2)
the ultrasonic power##3##3##(2008-10#1)(2013-8#2)
the ultrasonic##28##2##(1991-1#3)(1993-2#2)(1997-6#2)(2007-11#1)(2007-12#5)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2010-8#1)(2013-8#3)
the ultrasound examination##2##3##(2007-11#2)
the ultrasound##8##2##(1996-11#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)
the ultrasound-assisted##2##2##(2008-10#2)
the ultrastructural level##4##3##(1995-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
the ultrastructural##13##2##(1992-3#1)(1995-6#2)(2008-10#1)(2008-5#2)(2008-7#3)(2009-11#1)(2011-2#3)
the ultrastructure and##2##3##(1995-6#1)(2008-10#1)
the ultrastructure of the##5##4##(2007-12#4)(2008-5#1)
the ultrastructure of##10##3##(2007-12#4)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)
the ultrastructure##13##2##(1995-6#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)
the ultratrace##2##2##(2008-10#1)(2008-3#1)
the ultraviolet light##2##3##(2007-12#1)(2008-3#1)
the ultraviolet region of##3##4##(2008-2#3)
the ultraviolet region##10##3##(1990-5#1)(2007-11#2)(2008-10#1)(2008-2#5)(2008-3#1)
the ultraviolet zenith##2##3##(2008-3#2)
the ultraviolet##31##2##(1990-5#1)(1991-8#1)(2007-11#5)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#12)(2008-5#1)(2011-2#1)
the umbilical area##2##3##(2008-10#2)
the umbilical cord arteries##2##4##(2009-8#2)
the umbilical cord##4##3##(1997-3#1)(2009-8#3)
the umbilical profile##2##3##(2013-1#2)
the umbilical ring and##2##4##(2013-1#2)
the umbilical ring##3##3##(2013-1#3)
the umbilical vein##3##3##(1990-8#2)(1996-3#1)
the umbilical##18##2##(1990-8#3)(1995-6#1)(1996-3#1)(1997-3#1)(2008-10#4)(2009-8#3)(2013-1#5)
the umbilicus##3##2##(2010-6#2)(2011-2#1)
the umbrella##8##2##(1997-8#1)(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
the unaffected##6##2##(2007-10#1)(2007-11#3)(2008-9#1)(2010-3#1)
the unattended##4##2##(2010-5#4)
the unavailability of##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
the unavailability##4##2##(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
the unavoidable##2##2##(2007-7#1)(2008-3#1)
the unbalanced##2##2##(2008-5#2)
the unblocked##3##2##(1994-5#2)(2008-4#1)
the unborn child##2##3##(2008-2#2)
the unbound fraction of drugs##2##5##(2008-8#2)
the unbound radioactivity##2##3##(1990-12#1)(2008-4#1)
the unbound##6##2##(1990-12#1)(1993-12#1)(1996-5#1)(2008-4#1)(2008-8#2)
the uncertainties and##2##3##(1995-12#1)(2008-3#1)
the uncertainties in the##2##4##(1995-6#1)(2008-3#1)
the uncertainties##14##2##(1995-12#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#7)
the uncertainty associated with the##3##5##(2008-10#3)
the uncertainty associated##4##3##(2008-10#4)
the uncertainty in##6##3##(1992-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
the uncertainty of the##7##4##(1992-5#1)(2007-12#1)(2008-10#1)(2008-3#3)(2012-12#1)
the uncertainty of##11##3##(1992-5#1)(1994-1#1)(2007-12#1)(2008-10#3)(2008-3#4)(2012-12#1)
the uncertainty##31##2##(1992-5#2)(1994-1#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#2)(2012-2#1)
the unchanged##3##2##(1992-11#1)(2008-10#1)(2011-2#1)
the uncoated TMFE##2##3##(2008-10#2)
the uncoated##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
the uncomplexed tetrol I-1##2##4##(2008-10#2)
the uncomplexed tetrol##3##3##(2008-10#3)
the uncomplexed##5##2##(1994-2#1)(2008-10#4)
the unconditioned stimulus##2##3##(1993-12#1)(1995-12#1)
the unconjugated##3##2##(1990-11#1)(1992-3#1)(2008-10#1)
the uncontrolled##3##2##(1997-2#1)(2009-2#1)(2013-8#1)
the uncorrected##4##2##(1990-3#1)(2008-10#1)(2008-3#2)
the uncoupling##3##2##(1992-3#1)(2008-9#1)(2010-5#1)
the undepleted ground-state population density##2##5##(2008-3#2)
the under-five syntactic categories##2##4##(2008-2#2)
the under-five##3##2##(2008-2#3)
the undergraduate curriculum##4##3##(2011-2#3)(2013-1#1)
the undergraduate##11##2##(1991-1#1)(1991-6#1)(2008-11#1)(2008-12#2)(2010-2#1)(2011-2#3)(2012-1#1)(2013-1#1)
the underground##3##2##(2008-1#2)(2010-4#1)
the underlined##2##2##(1995-8#1)(2008-8#1)
the underlying abnormality##2##3##(2007-12#2)
the underlying assumptions##3##3##(1995-1#1)(2010-8#1)(2012-2#1)
the underlying cause of##3##4##(2008-1#1)(2008-3#1)(2010-10#1)
the underlying cause##6##3##(2008-1#3)(2008-3#1)(2010-10#2)
the underlying chemical##2##3##(1991-8#1)(2008-10#1)
the underlying collagen network##2##4##(2009-10#2)
the underlying condition##2##3##(2008-11#1)(2008-3#1)
the underlying differences##2##3##(2008-5#1)(2008-7#1)
the underlying disease process##3##4##(1997-4#1)(2008-3#1)(2011-2#1)
the underlying disease##11##3##(1995-9#1)(1997-4#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#3)(2011-3#2)
the underlying genetic##3##3##(2007-10#1)(2008-4#1)(2012-12#1)
the underlying genetics##2##3##(2008-10#1)(2008-8#1)
the underlying mechanism of##3##4##(1995-12#1)(2009-12#1)(2010-7#1)
the underlying mechanism##8##3##(1995-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-7#1)(2012-2#2)
the underlying mechanisms of the##2##5##(1996-7#1)(2008-10#1)
the underlying mechanisms of##7##4##(1995-12#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
the underlying mechanisms##11##3##(1993-1#1)(1994-8#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#1)(2013-1#1)
the underlying molecular mechanism##2##4##(1997-5#1)(2012-2#1)
the underlying molecular##5##3##(1997-5#1)(2007-7#2)(2012-2#2)
the underlying pathophysiological##2##3##(1990-2#1)(2008-3#1)
the underlying pathophysiology of##3##4##(2008-7#1)(2012-2#1)(2012-3#1)
the underlying pathophysiology##4##3##(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
the underlying principles##3##3##(2008-9#3)
the underlying regulatory##2##3##(1994-8#1)(2010-3#1)
the underlying##178##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-3#1)(1996-7#2)(1997-4#2)(1997-5#2)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#4)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#4)(2013-8#5)
the underreporting##2##2##(2012-12#2)
the underserved##2##2##(2008-11#2)
the understanding and treatment of##2##5##(1994-5#1)(2008-4#1)
the understanding and##6##3##(1994-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-2#1)
the understanding of how these##2##5##(2008-10#1)(2008-7#1)
the understanding of how##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
the understanding of the mechanisms##2##5##(1997-3#1)(2009-1#1)
the understanding of the nature of##3##6##(1994-11#1)(1995-1#1)(2008-6#1)
the understanding of the pathogenesis of##5##6##(1994-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
the understanding of the##46##4##(1990-6#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-5#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
the understanding of##88##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-5#2)(1995-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
the understanding##98##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#2)(1995-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#5)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-7#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#2)
the understory##6##2##(2008-5#1)(2008-8#2)(2008-9#3)
the underutilization of##2##3##(2010-4#1)(2011-2#1)
the underwater##2##2##(2008-10#1)(2008-3#1)
the underweight women##2##3##(1991-12#1)(2007-7#1)
the undesired##2##2##(2008-10#1)(2008-9#1)
the undifferentiated##3##2##(2008-11#2)(2008-9#1)
the undiluted##2##2##(1991-12#1)(2008-10#1)
the undrugged##2##2##(1992-7#1)(1993-3#1)
the unedited##2##2##(1993-12#2)
the uneven distribution##2##3##(1994-6#1)(2008-1#1)
the uneven##4##2##(1994-6#1)(2007-7#1)(2008-1#1)(2012-12#1)
the unexpected##4##2##(1992-3#1)(1996-3#1)(2010-3#1)(2011-1#1)
the unfavorable##5##2##(1992-2#1)(2008-7#2)(2011-2#1)(2013-8#1)
the unfolded protein##3##3##(1993-11#1)(1997-2#2)
the unfolded state##4##3##(1993-11#2)(1997-2#2)
the unfolded##9##2##(1990-7#2)(1993-11#3)(1997-2#4)
the unfolding of##3##3##(1995-5#1)(2008-4#2)
the unfolding##9##2##(1995-2#1)(1995-3#1)(1995-5#3)(2007-12#1)(2008-4#2)(2008-9#1)
the unfractionated bone cells##2##4##(2008-11#2)
the unfractionated##3##2##(1991-2#1)(2008-11#2)
the unheated##2##2##(2008-2#1)(2008-3#1)
the unicellular##6##2##(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#3)
the unidirectional##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
the unified concept##2##3##(2008-7#2)
the unified##3##2##(2008-7#2)(2010-11#1)
the uniform##7##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-9#1)
the uniformity and##2##3##(2008-12#1)(2008-5#1)
the uniformity of the##3##4##(2008-2#1)(2008-3#2)
the uniformity of##4##3##(2008-2#1)(2008-3#3)
the uniformity##8##2##(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2013-1#1)
the uniformly##4##2##(2008-1#1)(2009-7#2)(2012-2#1)
the unilateral##3##2##(1996-12#2)(2008-11#1)
the unimodal##2##2##(2008-10#2)
the uninfected##2##2##(1991-12#1)(2008-10#1)
the uninitiated##3##2##(1996-2#1)(2008-9#1)(2010-2#1)
the uninoculated control##2##3##(2008-10#2)
the uninsured and##3##3##(1994-2#1)(1995-12#1)(2008-11#1)
the uninsured##17##2##(1992-2#2)(1993-2#1)(1994-2#1)(1995-1#2)(1995-12#2)(1996-1#1)(2008-11#8)
the unintentional##2##2##(2013-1#1)(2013-8#1)
the union of surgeon and machine##2##6##(2011-2#2)
the union of##3##3##(1995-3#1)(2011-2#2)
the union##10##2##(1995-12#4)(1995-3#1)(2007-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
the unique ability of##4##4##(1997-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
the unique ability to##4##4##(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
the unique ability##8##3##(1997-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
the unique advantages of##2##4##(2007-12#1)(2008-3#1)
the unique biology of##2##4##(2008-5#1)(2010-4#1)
the unique capability##2##3##(2008-4#1)(2011-7#1)
the unique characteristics of the##2##5##(2008-8#1)(2011-2#1)
the unique characteristics of##7##4##(1990-11#1)(1996-3#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
the unique combination of##2##4##(2006-12#1)(2010-6#1)
the unique features of such a device for scientific aims##2##10##(2007-12#1)(2008-2#1)
the unique features of##5##4##(1994-3#1)(2007-12#1)(2008-2#1)(2009-6#1)(2012-2#1)
the unique features##7##3##(1991-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-6#1)(2012-2#1)
the unique nature of##2##4##(2008-8#1)(2013-8#1)
the unique needs of##3##4##(1994-3#2)(2010-8#1)
the unique properties of##8##4##(2007-11#2)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)
the unique property of##2##4##(1995-2#1)(1996-2#1)
the unique requirements##2##3##(2008-11#1)(2008-3#1)
the unique##105##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
the uniqueness and##2##3##(2007-11#1)(2012-12#1)
the uniqueness constraint is##2##4##(2008-9#2)
the uniqueness constraint##4##3##(2008-9#4)
the uniqueness of each##2##4##(2008-11#1)(2008-9#1)
the uniqueness of the##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
the uniqueness of##6##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)
the uniqueness##13##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-9#5)(2012-12#1)(2012-3#1)
the unit and##2##3##(2007-10#2)
the unit cell##4##3##(1992-9#1)(1996-2#1)(2008-3#1)(2008-7#1)
the unit is##5##3##(2008-11#1)(2008-4#3)(2008-9#1)
the unit of##6##3##(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2012-2#1)(2012-3#1)
the unit provides##2##3##(2008-9#2)
the unit##46##2##(1990-9#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(2007-10#4)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#9)(2008-7#3)(2008-8#1)(2008-9#4)(2010-2#1)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
the unitary##4##2##(1997-7#1)(2008-3#1)(2008-4#1)(2010-4#1)
the units of##2##3##(2008-5#1)(2008-9#1)
the units##14##2##(1995-6#3)(2008-1#1)(2008-5#1)(2008-9#2)(2010-5#3)(2011-2#4)
the unity of##3##3##(2008-4#1)(2010-4#1)(2010-8#1)
the univalent##2##2##(2008-10#2)
the univariate model##3##3##(2009-8#3)
the univariate##9##2##(1994-11#1)(2006-10#1)(2008-10#3)(2009-8#4)
the universal standardization project##2##4##(1997-8#2)
the universal##17##2##(1997-8#2)(2008-10#6)(2008-12#1)(2008-8#2)(2009-11#1)(2010-12#1)(2011-2#3)(2012-12#1)
the universalist##2##2##(2011-2#2)
the universally##2##2##(2008-11#1)(2009-6#1)
the universe##10##2##(1995-6#1)(1996-12#1)(2008-12#3)(2008-4#2)(2010-3#1)(2010-9#1)(2013-1#1)
the universities of##2##3##(2008-1#1)(2013-8#1)
the universities##3##2##(2008-1#1)(2008-10#1)(2013-8#1)
the university health##2##3##(2010-5#1)(2011-2#1)
the university##22##2##(1991-2#1)(1993-2#1)(1995-1#1)(1996-12#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the unknown parameters##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
the unknown##24##2##(1990-12#1)(1991-3#1)(1992-2#1)(1993-3#1)(1995-6#1)(2007-11#1)(2007-12#4)(2008-10#6)(2008-3#3)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
the unknowns of##2##3##(2008-2#1)(2008-3#1)
the unknowns##4##2##(1993-11#1)(2008-2#1)(2008-3#2)
the unlabeled##2##2##(1992-11#1)(2008-10#1)
the unlabelled##2##2##(1992-9#1)(2012-12#1)
the unliganded form##2##3##(1995-5#2)
the unliganded##4##2##(1990-8#1)(1995-5#3)
the unloaded##2##2##(1991-5#1)(2008-10#1)
the unmasking of##2##3##(1996-5#1)(2008-8#1)
the unmodified##9##2##(1991-9#1)(1995-2#2)(2008-10#4)(2008-3#1)(2009-7#1)
the unnatural##2##2##(1992-12#1)(1994-6#1)
the unoccupied##2##2##(2008-8#2)
the unpaired##2##2##(1997-7#1)(2007-12#1)
the unperturbed##2##2##(2007-11#1)(2008-3#1)
the unprecedented##2##2##(1996-2#1)(2009-5#1)
the unpredictable##6##2##(2007-8#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)
the unprotected##4##2##(1996-8#1)(2008-3#1)(2013-7#2)
the unproteolyzed##3##2##(1995-11#3)
the unprotonated##3##2##(1991-9#2)(2008-10#1)
the unpurified##2##2##(1994-8#1)(2008-10#1)
the unquantified##3##2##(2008-4#3)
the unreamed##2##2##(2009-3#1)(2013-8#1)
the unreinforced licks##2##3##(2008-11#2)
the unrelated##3##2##(1995-2#1)(1997-3#1)(2012-3#1)
the unrestricted##2##2##(2007-12#1)(2009-10#1)
the unresurfaced patella##2##3##(2013-1#2)
the unretained##3##2##(2008-10#3)
the unsatisfactory##2##2##(1992-8#1)(2008-10#1)
the unsaturated##3##2##(1994-9#1)(1995-11#1)(2009-9#1)
the unsaturation##2##2##(1992-6#1)(2008-10#1)
the unscreened control and the symmetrical selection methods##2##8##(1997-5#2)
the unsprayed##2##2##(2008-10#1)(2011-2#1)
the unstable resonator##2##3##(2007-12#1)(2008-3#1)
the unstable##5##2##(2007-12#1)(2007-6#1)(2008-3#2)(2009-4#1)
the unstructured##2##2##(2008-11#1)(2010-5#1)
the unsuccessful##2##2##(1995-6#1)(2008-11#1)
the untrained female rats##2##4##(2013-1#2)
the untrained##4##2##(2013-1#3)(2013-8#1)
the untranslated##4##2##(1994-8#1)(1995-8#1)(2008-10#2)
the untreated control##6##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-7#1)
the untreated controls##3##3##(1997-4#2)(2008-10#1)
the untreated dwarf##2##3##(1995-12#2)
the untreated##27##2##(1990-11#1)(1991-12#1)(1992-12#1)(1995-12#2)(1995-6#2)(1996-12#1)(1997-4#3)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#3)(2011-2#1)(2012-12#1)(2013-7#2)
the unusual##29##2##(1990-8#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-3#1)(1997-6#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
the unusually large##2##3##(1992-12#1)(2008-10#1)
the unusually##3##2##(1992-12#1)(2008-10#1)(2008-8#1)
the unwanted##10##2##(1992-1#1)(1997-2#1)(2008-2#1)(2008-3#3)(2008-9#4)
the unweighted pair group method##2##5##(2008-10#2)
the unweighted##3##2##(1992-12#1)(2008-10#2)
the unwrapped phase##2##3##(2008-2#1)(2008-3#1)
the unwrapped##4##2##(2008-2#2)(2008-3#2)
the unwrapping process##2##3##(2008-2#1)(2008-3#1)
the unwrapping##4##2##(2008-2#1)(2008-3#3)
the up-regulation of##8##3##(1992-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2013-1#3)
the up-to-date##2##2##(1993-5#1)(2012-1#1)
the upcoming tastant##3##3##(2008-11#3)
the upcoming##5##2##(2008-11#3)(2008-3#1)(2012-2#1)
the updated##4##2##(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
the upper Keys##4##3##(2007-5#4)
the upper abdomen##2##3##(1991-6#1)(2010-12#1)
the upper aerodigestive tract##3##4##(2008-1#1)(2009-5#1)(2013-1#1)
the upper and lower airways##3##5##(1992-11#1)(2012-12#2)
the upper and lower extremity##2##5##(2007-11#1)(2012-3#1)
the upper and lower parts of the##2##7##(2008-10#2)
the upper and lower parts##3##5##(2008-10#2)(2008-12#1)
the upper and lower respiratory##2##5##(1992-11#1)(2008-1#1)
the upper and lower##14##4##(1990-11#1)(1992-11#2)(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-3#1)
the upper and##17##3##(1990-11#1)(1992-11#2)(1992-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
the upper arm##2##3##(2007-7#1)(2008-5#1)
the upper atmosphere##3##3##(2008-3#3)
the upper back##2##3##(2012-2#2)
the upper boundary##2##3##(2007-12#1)(2008-2#1)
the upper chamber##2##3##(2008-11#2)
the upper crust fault zone##2##5##(1996-4#2)
the upper crust##5##3##(1996-4#5)
the upper extremities##5##3##(1991-4#1)(1997-4#1)(2007-7#1)(2007-8#1)(2010-3#1)
the upper extremity of##2##4##(1991-11#1)(2007-7#1)
the upper extremity##11##3##(1991-11#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-2#3)
the upper gastrointestinal tract##4##4##(2007-5#1)(2012-1#2)(2013-1#1)
the upper gastrointestinal##5##3##(1996-3#1)(2007-5#1)(2012-1#2)(2013-1#1)
the upper lasing level##3##4##(2008-3#3)
the upper layer##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)
the upper layers of the##2##5##(1992-3#1)(1994-5#1)
the upper limb##6##3##(1991-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-1#2)
the upper limit of normal##2##5##(2008-1#1)(2012-3#1)
the upper limit of the##4##5##(1993-2#1)(2008-2#2)(2013-1#1)
the upper limit of##6##4##(1993-2#1)(2008-1#1)(2008-2#2)(2012-3#1)(2013-1#1)
the upper limit##10##3##(1993-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2012-3#1)(2013-1#2)
the upper lip##2##3##(1995-12#1)(2011-2#1)
the upper lobe##3##3##(1991-9#1)(2008-4#1)(2013-1#1)
the upper mantle##2##3##(1991-8#1)(1995-6#1)
the upper ocean##3##3##(2008-2#1)(2008-3#2)
the upper or lower##2##4##(2008-10#1)(2008-12#1)
the upper part of the##4##5##(1991-9#1)(2008-10#1)(2008-5#1)(2009-4#1)
the upper part of##5##4##(1991-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
the upper part##6##3##(1991-9#1)(1993-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
the upper phase##6##3##(2008-10#4)(2011-1#2)
the upper respiratory tract and##2##5##(2008-5#1)(2012-12#1)
the upper respiratory tract##6##4##(1990-8#1)(1995-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
the upper side of the##3##5##(2007-11#1)(2008-10#2)
the upper tail##2##3##(1993-9#2)
the upper trapezium muscle with##2##5##(2010-6#1)(2010-9#1)
the upper trapezius muscle##2##4##(2010-9#2)
the upper trapezius##5##3##(2010-9#5)
the upper troposphere##4##3##(2008-2#1)(2008-3#3)
the upper urinary tract##2##4##(1991-9#1)(2011-2#1)
the upper##230##2##(1990-11#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1993-2#2)(1993-5#1)(1993-9#4)(1994-2#1)(1994-5#1)(1994-7#3)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#5)(1996-6#1)(1997-4#2)(1997-6#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-5#7)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#40)(2008-11#2)(2008-12#5)(2008-2#8)(2008-3#14)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#1)(2008-9#5)(2009-1#2)(2009-11#1)(2009-4#2)(2009-5#4)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#3)(2010-8#2)(2010-9#6)(2011-1#4)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#2)
the upper-half of the face##5##5##(2010-1#5)
the uppermost##6##2##(2007-7#1)(2008-10#3)(2008-5#2)
the upregulation of##10##3##(1994-6#1)(1997-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-12#2)(2013-1#1)
the upstream activating sequence##2##4##(1991-9#1)(1996-3#1)
the upstream of##2##3##(1997-6#1)(2008-9#1)
the upstream region##2##3##(1991-9#1)(1997-2#1)
the upstream regulatory element##2##4##(1997-2#1)(1997-6#1)
the upstream regulatory##3##3##(1993-2#1)(1997-2#1)(1997-6#1)
the upstream##25##2##(1990-8#1)(1991-6#1)(1991-9#3)(1993-12#1)(1993-2#1)(1993-9#1)(1995-2#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#2)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#4)(2010-6#1)(2013-1#1)
the uptake and##8##3##(1990-11#1)(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-9#2)
the uptake of Ca2+ and##2##5##(1994-11#2)
the uptake of a##2##4##(1994-8#1)(2007-11#1)
the uptake of bile acids##2##5##(1992-3#1)(1994-12#1)
the uptake of glucose##2##4##(1992-6#1)(2008-11#1)
the uptake of mercury from amalgam fillings based on urinary##2##10##(1995-6#2)
the uptake of the##3##4##(1997-1#1)(2008-11#1)(2011-1#1)
the uptake of##46##3##(1990-7#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#2)(1995-11#3)(1995-2#1)(1995-6#3)(1996-12#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-1#1)(2012-2#1)
the uptake rates##2##3##(2008-10#2)
the uptake system##2##3##(2008-10#2)
the uptake was##2##3##(1990-2#1)(1997-2#1)
the uptake##68##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#2)(1995-11#3)(1995-2#2)(1995-6#3)(1996-12#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-7#2)(2008-8#1)(2008-9#4)(2011-1#1)(2012-1#1)(2012-2#1)
the upward and downward##2##4##(2008-2#1)(2008-3#1)
the upward##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
the upwelling irradiance##2##3##(2008-2#1)(2008-3#1)
the upwelling radiance##5##3##(2008-2#3)(2008-3#2)
the upwelling spectral radiance##2##4##(2008-2#2)
the upwelling##11##2##(2008-2#7)(2008-3#4)
the uranium##3##2##(2008-10#3)
the urban and##2##3##(1991-6#1)(2008-3#1)
the urban environment##2##3##(2007-10#1)(2008-10#1)
the urban##22##2##(1990-2#1)(1991-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-6#3)(2009-10#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
the urea##8##2##(1991-9#1)(1993-11#1)(1995-6#2)(2008-10#2)(2008-7#1)(2013-8#1)
the urea-induced##2##2##(1990-7#1)(1995-5#1)
the uremic##2##2##(2008-1#1)(2008-5#1)
the ureter is a##2##4##(2007-10#1)(2009-5#1)
the ureter##13##2##(1997-3#3)(1997-4#1)(2007-10#1)(2008-10#1)(2009-5#3)(2011-2#1)(2013-7#3)
the ureteric orifices##2##3##(2008-10#2)
the urethra and##3##3##(2008-10#2)(2013-1#1)
the urethra##12##2##(1990-7#2)(1991-2#1)(1996-12#1)(2008-10#4)(2012-12#1)(2012-3#1)(2013-1#2)
the urethral cases##2##3##(2008-10#2)
the urethral meatus##2##3##(1992-1#2)
the urethral plate is##2##4##(2008-10#1)(2009-5#1)
the urethral plate##4##3##(2008-10#2)(2009-5#2)
the urethral##14##2##(1990-7#1)(1992-1#2)(1996-11#1)(2008-10#6)(2008-7#1)(2009-5#2)(2013-1#1)
the urgency of##2##3##(1996-1#1)(2012-2#1)
the urgency##4##2##(1996-1#1)(2008-10#1)(2011-3#1)(2012-2#1)
the urgent need for##2##4##(2010-12#1)(2012-12#1)
the urgent need##3##3##(1994-2#1)(2010-12#1)(2012-12#1)
the urgent##6##2##(1994-2#1)(1996-2#1)(2007-10#1)(2008-10#1)(2010-12#1)(2012-12#1)
the uridine##3##2##(1993-8#1)(1995-8#1)(2008-11#1)
the urinary bladder cancer##3##4##(2011-2#3)
the urinary bladder is##2##4##(2009-7#2)
the urinary bladder of##4##4##(1992-12#1)(2007-7#2)(2012-2#1)
the urinary bladder was##2##4##(1993-2#1)(2012-12#1)
the urinary bladder##28##3##(1991-6#1)(1992-12#2)(1993-2#2)(1993-9#2)(1996-12#1)(1997-2#2)(2007-7#2)(2008-10#1)(2008-7#1)(2009-5#1)(2009-7#3)(2011-2#6)(2012-12#2)(2012-2#2)
the urinary excretion of##8##4##(1990-5#1)(1991-12#1)(1994-5#4)(1995-3#1)(2008-7#1)
the urinary excretion##9##3##(1990-5#1)(1991-12#1)(1994-5#4)(1995-3#1)(2008-7#1)(2009-11#1)
the urinary sediment##2##3##(1997-7#2)
the urinary tract##15##3##(1990-11#2)(1992-9#1)(1996-12#2)(2007-5#2)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the urinary##71##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-2#2)(1993-8#2)(1993-9#2)(1994-5#5)(1995-12#1)(1995-3#1)(1996-12#4)(1997-2#2)(1997-7#2)(2007-12#1)(2007-5#2)(2007-7#2)(2008-10#7)(2008-7#3)(2009-11#1)(2009-5#1)(2009-7#3)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#4)(2013-8#2)
the urine culture##2##3##(2007-7#1)(2008-1#1)
the urine matrix##2##3##(2008-10#2)
the urine of the##2##4##(2007-7#1)(2008-7#1)
the urine of##11##3##(1990-12#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-7#1)(2008-7#1)
the urine sample##4##3##(1990-2#1)(2008-10#3)
the urine samples##4##3##(1996-2#1)(2008-10#3)
the urine##58##2##(1990-12#5)(1990-2#1)(1991-11#1)(1991-12#2)(1992-3#2)(1992-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-3#3)(1996-12#2)(1996-2#2)(1997-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#15)(2008-12#1)(2008-7#4)(2009-7#2)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the urogenital sinus##2##3##(2008-10#2)
the urogenital##7##2##(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#1)(2012-3#1)
the urological##3##2##(2008-10#2)(2008-7#1)
the urothelium and##2##3##(1992-12#1)(2013-8#1)
the urothelium##3##2##(1992-12#1)(2012-1#1)(2013-8#1)
the usability of##2##3##(2007-12#1)(2012-12#1)
the usable##2##2##(2007-8#1)(2008-2#1)
the usage of the##5##4##(1993-6#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)
the usage of this##2##4##(2009-3#1)(2011-2#1)
the usage of##15##3##(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#2)(2011-2#2)(2012-2#1)(2013-1#1)
the usage##16##2##(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the use and monitoring of##2##5##(2007-7#1)(2012-12#1)
the use and##11##3##(1997-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the use of &quot##3##4##(1996-3#1)(2010-5#1)(2012-12#1)
the use of DNA as##2##5##(2008-11#1)(2013-8#1)
the use of DNA##6##4##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#2)(2013-8#1)
the use of Fourier##2##4##(2008-10#1)(2008-2#1)
the use of GFP##2##4##(1996-6#1)(2008-11#1)
the use of HH therapy##2##5##(2007-10#2)
the use of HPLC##2##4##(1991-5#2)
the use of KT following musculoskeletal injury##2##7##(2013-1#2)
the use of KT##3##4##(2013-1#3)
the use of MRI##2##4##(1995-1#1)(2007-11#1)
the use of Medicare##2##4##(1994-2#1)(1994-3#1)
the use of N##2##4##(2008-10#1)(2011-1#1)
the use of SIT##3##4##(2011-2#3)
the use of SPC##2##4##(1995-2#2)
the use of TCAM##2##4##(2009-6#2)
the use of a TD##2##5##(2007-7#2)
the use of a combination of##4##6##(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
the use of a computer##2##5##(2008-11#1)(2008-3#1)
the use of a different##2##5##(1990-7#1)(1992-2#1)
the use of a high-speed##2##5##(2008-1#1)(2008-3#1)
the use of a less##2##5##(2007-11#1)(2008-10#1)
the use of a measure##2##5##(2008-8#1)(2009-11#1)
the use of a novel##2##5##(2007-11#1)(2008-9#1)
the use of a patient##2##5##(1995-2#1)(2008-12#1)
the use of a protocol##2##5##(1997-1#1)(2007-11#1)
the use of a set of##2##6##(2008-10#2)
the use of a simple##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
the use of a single##5##5##(1995-8#1)(2008-10#2)(2008-6#1)(2009-10#1)
the use of a##177##4##(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#4)(2007-10#1)(2007-11#8)(2007-12#9)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#24)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#4)
the use of adaptive optics##2##5##(2007-12#1)(2011-1#1)
the use of adjuvant##2##4##(1994-8#1)(1995-4#1)
the use of an##37##4##(1990-3#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)
the use of and##2##4##(1991-3#1)(1996-2#1)
the use of animal##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
the use of animals in##3##5##(1996-12#1)(2007-3#1)(2008-10#1)
the use of animals##4##4##(1990-12#1)(1996-12#1)(2007-3#1)(2008-10#1)
the use of anticoagulants##2##4##(2012-12#2)
the use of antiplatelet##2##4##(2007-8#1)(2008-8#1)
the use of appropriate##4##4##(1994-9#1)(2008-11#2)(2012-12#1)
the use of automated##4##4##(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)
the use of bare##2##4##(1997-4#1)(2008-12#1)
the use of bone##5##4##(2007-4#1)(2008-1#1)(2008-8#1)(2010-6#1)(2012-12#1)
the use of both##10##4##(1997-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
the use of calcium##3##4##(1990-3#1)(2008-4#1)(2012-12#1)
the use of cardiac##3##4##(1995-8#1)(2008-3#1)(2009-4#1)
the use of certain##2##4##(1992-8#1)(1994-12#1)
the use of combination##4##4##(2008-2#1)(2008-6#1)(2012-3#2)
the use of combined##2##4##(2008-10#2)
the use of communication strategies##2##5##(2012-3#2)
the use of community##2##4##(1996-1#1)(2012-12#1)
the use of computer software##2##5##(2008-9#2)
the use of computer##3##4##(2008-9#2)(2010-8#1)
the use of conventional##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
the use of cosmetics##2##4##(2008-5#2)
the use of critical##2##4##(1995-12#2)
the use of cultivars##2##4##(2008-10#2)
the use of data##3##4##(1996-3#1)(2010-8#1)(2011-2#1)
the use of detergents##2##4##(1990-12#1)(2008-4#1)
the use of different methods##3##5##(2008-10#1)(2008-5#1)(2012-2#1)
the use of different polyadenylation site signals##2##7##(1990-2#2)
the use of different##17##4##(1990-2#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-12#1)(2012-2#1)
the use of digital##3##4##(2008-3#1)(2008-7#1)(2010-8#1)
the use of direct##3##4##(2007-12#1)(2008-10#1)(2010-8#1)
the use of dried##2##4##(1994-6#1)(2010-11#1)
the use of early##2##4##(1991-3#1)(2008-11#1)
the use of electronic##3##4##(2008-1#1)(2009-10#1)(2010-8#1)
the use of electrospinning for TE applications##2##7##(2010-10#2)
the use of enoxaparin in##2##5##(2008-3#2)
the use of enoxaparin##3##4##(2007-10#1)(2008-3#2)
the use of existing##3##4##(2008-11#1)(2012-12#1)(2012-3#1)
the use of experimental##2##4##(2008-8#1)(2010-2#1)
the use of fast##2##4##(2008-3#1)(2008-6#1)
the use of feedback##2##4##(2009-10#2)
the use of first##2##4##(1991-12#1)(2008-10#1)
the use of flow cytometry##2##5##(2008-9#2)
the use of flow##3##4##(2008-10#1)(2008-9#2)
the use of fluorescent##2##4##(2008-4#1)(2008-9#1)
the use of food##2##4##(1991-12#1)(1996-12#1)
the use of force##2##4##(1995-5#1)(1995-6#1)
the use of four##2##4##(1995-2#1)(2007-11#1)
the use of functional##2##4##(2008-5#1)(2008-9#1)
the use of general##2##4##(2008-10#1)(2008-9#1)
the use of genetically##3##4##(2008-8#1)(2008-9#1)(2011-1#1)
the use of geospatial data##3##5##(2008-8#3)
the use of glycoprotein IIb/IIIa inhibitors##2##6##(2008-3#2)
the use of heating##2##4##(1990-2#2)
the use of high performance##2##5##(2008-10#1)(2008-7#1)
the use of high##8##4##(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)
the use of highly sensitive##2##5##(2007-5#1)(2008-3#1)
the use of highly##5##4##(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2009-5#1)
the use of home health services##2##6##(1995-3#2)
the use of home##3##4##(1995-3#2)(2009-6#1)
the use of homologous blood##3##5##(1992-3#1)(1996-9#2)
the use of homologous##4##4##(1992-3#1)(1996-9#2)(2010-8#1)
the use of hospital##5##4##(1991-1#1)(1991-2#1)(1993-11#1)(1994-2#2)
the use of host##2##4##(1991-9#1)(2008-10#1)
the use of human##3##4##(1992-5#1)(2008-4#1)(2013-1#1)
the use of immunosuppressive##2##4##(1994-5#1)(2006-10#1)
the use of implants##2##4##(1996-3#1)(2007-11#1)
the use of inexpensive##2##4##(1991-9#1)(2008-10#1)
the use of information technology in##2##6##(2008-10#2)
the use of information##5##4##(1992-2#1)(1996-12#1)(2008-10#2)(2013-1#1)
the use of infrared##2##4##(2007-12#1)(2008-10#1)
the use of insulin##2##4##(2008-1#1)(2009-11#1)
the use of interventions to prevent infections after knee arthroplasty##2##10##(2011-2#2)
the use of interventions to prevent infections##3##7##(2011-2#3)
the use of intravenous##2##4##(2007-9#1)(2010-3#1)
the use of invasive##2##4##(2007-4#1)(2011-2#1)
the use of irony in young men's stories about romantic##2##10##(2009-5#2)
the use of laboratory tests##2##5##(1991-2#1)(1994-12#1)
the use of laboratory##4##4##(1991-2#1)(1993-2#1)(1994-12#1)(2008-10#1)
the use of laparoscopic##2##4##(1993-3#1)(2011-2#1)
the use of laparoscopy##2##4##(2011-2#2)
the use of laser##3##4##(1991-9#1)(2008-10#2)
the use of less##3##4##(2008-3#1)(2011-1#1)(2011-2#1)
the use of limited##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
the use of liquid##3##4##(2008-10#1)(2008-4#1)(2010-7#1)
the use of live##2##4##(2009-5#1)(2010-8#1)
the use of living##2##4##(1991-3#1)(2008-11#1)
the use of long-term##2##4##(1996-6#1)(2008-4#1)
the use of magnetic##2##4##(2007-7#1)(2010-11#1)
the use of magneto-optical modulation##2##5##(2008-3#2)
the use of medical##7##4##(1992-12#1)(1993-6#1)(1996-6#1)(2007-10#1)(2008-11#2)(2008-4#1)
the use of metformin##2##4##(2008-1#1)(2012-3#1)
the use of microteaching##3##4##(2008-11#3)
the use of models##2##4##(2008-10#1)(2008-3#1)
the use of modern##2##4##(1990-6#1)(2008-10#1)
the use of modified##2##4##(2008-10#1)(2011-2#1)
the use of molecular##4##4##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
the use of monoclonal antibodies##2##5##(1993-6#1)(1995-3#1)
the use of monoclonal##3##4##(1993-6#1)(1995-3#1)(1997-7#1)
the use of more##6##4##(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
the use of multidimensional##2##4##(1995-5#1)(2012-3#1)
the use of multinuclear MRS##2##5##(2012-2#2)
the use of multiple##5##4##(1991-3#1)(2008-10#3)(2008-4#1)
the use of multivariate##2##4##(2008-10#2)
the use of neoadjuvant##2##4##(2013-8#2)
the use of new##3##4##(1991-12#1)(2008-11#1)(2013-8#1)
the use of nine##2##4##(1991-1#1)(2008-10#1)
the use of nonlinear##2##4##(2007-11#2)
the use of novel##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
the use of on-line##2##4##(2008-10#1)(2010-4#1)
the use of one##2##4##(2008-4#1)(2012-12#1)
the use of only##5##4##(2008-10#1)(2008-3#2)(2008-9#1)(2010-6#1)
the use of optical##2##4##(2007-5#1)(2008-3#1)
the use of oral contraceptives##3##5##(1991-8#1)(2008-11#2)
the use of oral##4##4##(1991-8#1)(2008-11#2)(2008-3#1)
the use of organic solvents##2##5##(2008-10#1)(2008-5#1)
the use of organic##3##4##(2008-10#2)(2008-5#1)
the use of pathways##2##4##(2008-3#2)
the use of patient satisfaction##2##5##(1996-1#2)
the use of pediatric medicines and##3##6##(2008-9#3)
the use of personal##2##4##(1994-3#1)(2009-5#1)
the use of planar##2##4##(2007-12#1)(2008-3#1)
the use of prenatal care##3##5##(1992-2#1)(1993-3#2)
the use of principal##3##4##(2008-10#1)(2009-9#1)(2010-5#1)
the use of probiotic##2##4##(2008-5#1)(2009-12#1)
the use of prophylactic##5##4##(2008-3#1)(2008-7#2)(2012-1#1)(2012-3#1)
the use of psychoactive substances##2##5##(2008-1#1)(2013-1#1)
the use of psychotherapeutic interventions##2##5##(2008-6#1)(2013-8#1)
the use of pulsed##2##4##(1992-3#1)(2012-3#1)
the use of resistant cultivars##2##5##(2008-10#2)
the use of robots in##2##5##(2012-1#1)(2013-1#1)
the use of satellite##2##4##(2008-10#1)(2008-9#1)
the use of selective##2##4##(2008-10#1)(2008-12#1)
the use of serum##2##4##(1994-11#1)(2008-11#1)
the use of services and##2##5##(1991-2#1)(1993-3#1)
the use of services##3##4##(1991-2#1)(1993-3#1)(1995-3#1)
the use of several different##2##5##(1995-2#1)(2008-1#1)
the use of several##6##4##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)
the use of simple##5##4##(1992-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
the use of simulations##2##4##(2008-12#1)(2008-3#1)
the use of single-mode##2##4##(2008-2#1)(2008-3#1)
the use of small##2##4##(2008-3#1)(2008-5#1)
the use of social##2##4##(2009-12#1)(2012-2#1)
the use of specific##4##4##(2008-10#1)(2008-4#1)(2009-11#1)(2009-9#1)
the use of statistical##2##4##(1993-3#1)(2009-7#1)
the use of stopped-flow##2##4##(2008-10#2)
the use of storytelling and narrative in medicine##2##8##(2008-11#2)
the use of storytelling##3##4##(2008-11#3)
the use of such a##2##5##(2007-12#1)(2012-3#1)
the use of such##4##4##(1993-12#1)(2007-12#1)(2008-11#1)(2012-3#1)
the use of synthetic##5##4##(2008-2#1)(2008-4#2)(2008-8#1)(2011-2#1)
the use of systemic##3##4##(1997-3#1)(2008-11#1)(2008-7#1)
the use of targeted##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
the use of techniques##2##4##(2007-12#1)(2009-12#1)
the use of technology##3##4##(2008-11#2)(2008-12#1)
the use of temporal##2##4##(2008-3#1)(2008-9#1)
the use of the initial##2##5##(2009-6#2)
the use of the standard##2##5##(2008-10#2)
the use of the technique##2##5##(2007-11#1)(2009-5#1)
the use of the tool##2##5##(2008-11#2)
the use of the##152##4##(1990-12#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#2)(2007-10#2)(2007-11#6)(2007-12#7)(2007-8#5)(2008-1#1)(2008-10#39)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the use of their##2##4##(2008-10#1)(2008-5#1)
the use of these agents##3##5##(2007-12#1)(2008-3#2)
the use of these methods##2##5##(1996-2#1)(2008-7#1)
the use of these systems##2##5##(2008-10#2)
the use of these##26##4##(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1995-12#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-6#1)(2013-1#1)
the use of this instrument##2##5##(2007-8#1)(2008-11#1)
the use of this model##2##5##(2008-10#1)(2008-11#1)
the use of this technique##2##5##(2008-2#1)(2011-2#1)
the use of this technology for##2##6##(2008-7#2)
the use of this technology##3##5##(2008-7#2)(2013-1#1)
the use of this treatment##2##5##(1992-1#1)(2007-7#1)
the use of this##32##4##(1990-9#1)(1992-1#1)(1992-12#1)(1994-3#1)(1996-5#1)(1997-4#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-7#1)(2013-1#1)
the use of three##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
the use of three-way##2##4##(2008-10#2)
the use of time-consuming##2##4##(2008-10#1)(2008-4#1)
the use of total##3##4##(1995-3#1)(2008-1#1)(2008-3#1)
the use of traditional##3##4##(2008-12#2)(2009-11#1)
the use of tranilast for##2##5##(2008-5#2)
the use of two##12##4##(1990-12#1)(1991-3#1)(1991-5#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
the use of unhealthy weight control methods##3##7##(2012-2#3)
the use of urban##2##4##(1992-12#1)(1995-11#1)
the use of various##6##4##(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-12#1)
the use of vitamin##5##4##(1992-9#1)(2007-7#2)(2008-1#2)
the use of##1777##3##(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#3)(1990-5#7)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#13)(1991-2#6)(1991-3#8)(1991-5#5)(1991-6#2)(1991-8#5)(1991-9#3)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#9)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#10)(1994-3#14)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#6)(1995-1#4)(1995-11#5)(1995-12#9)(1995-2#12)(1995-3#12)(1995-4#1)(1995-5#8)(1995-6#5)(1995-8#4)(1995-9#2)(1996-1#6)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#9)(1996-5#3)(1996-6#7)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#11)(1997-4#9)(1997-6#2)(1997-7#6)(1997-8#1)(2006-10#6)(2006-4#1)(2006-8#1)(2007-10#12)(2007-11#41)(2007-12#44)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#9)(2007-8#20)(2007-9#3)(2008-1#22)(2008-10#333)(2008-11#91)(2008-12#35)(2008-2#41)(2008-3#108)(2008-4#51)(2008-5#39)(2008-6#26)(2008-7#63)(2008-8#24)(2008-9#39)(2009-1#1)(2009-10#9)(2009-11#9)(2009-12#7)(2009-2#6)(2009-3#4)(2009-4#3)(2009-5#13)(2009-6#9)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#8)(2010-4#7)(2010-5#13)(2010-6#8)(2010-7#2)(2010-8#19)(2010-9#3)(2011-1#18)(2011-10#2)(2011-2#62)(2011-3#5)(2011-7#1)(2012-1#7)(2012-12#29)(2012-2#30)(2012-3#35)(2012-7#1)(2013-1#53)(2013-8#22)
the use##1805##2##(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#3)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#13)(1991-2#6)(1991-3#8)(1991-5#5)(1991-6#2)(1991-8#5)(1991-9#3)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#9)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#11)(1994-3#14)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#6)(1995-1#4)(1995-11#5)(1995-12#9)(1995-2#12)(1995-3#12)(1995-4#1)(1995-5#8)(1995-6#5)(1995-8#4)(1995-9#2)(1996-1#6)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#9)(1996-5#3)(1996-6#7)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#12)(1997-4#9)(1997-6#2)(1997-7#6)(1997-8#1)(2006-10#6)(2006-4#1)(2006-8#1)(2007-10#12)(2007-11#41)(2007-12#44)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#10)(2007-8#22)(2007-9#3)(2008-1#22)(2008-10#338)(2008-11#94)(2008-12#35)(2008-2#41)(2008-3#108)(2008-4#52)(2008-5#39)(2008-6#27)(2008-7#63)(2008-8#25)(2008-9#39)(2009-1#1)(2009-10#9)(2009-11#9)(2009-12#7)(2009-2#6)(2009-3#5)(2009-4#3)(2009-5#13)(2009-6#9)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#8)(2010-4#7)(2010-5#13)(2010-6#8)(2010-7#2)(2010-8#19)(2010-9#3)(2011-1#18)(2011-10#2)(2011-2#64)(2011-3#5)(2011-7#1)(2012-1#7)(2012-12#32)(2012-2#30)(2012-3#35)(2012-7#1)(2013-1#55)(2013-8#25)
the used##10##2##(1993-2#1)(1994-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
the useful life##2##3##(2008-10#1)(2008-2#1)
the useful lifetime of##2##4##(2008-10#1)(2009-11#1)
the useful##9##2##(2008-10#3)(2008-2#5)(2009-11#1)
the usefulness and limitations of##2##5##(2008-4#1)(2012-12#1)
the usefulness and##8##3##(1990-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
the usefulness of US##2##4##(2010-12#1)(2012-2#1)
the usefulness of a##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
the usefulness of antibiotic prophylaxis##2##5##(1992-6#2)
the usefulness of our method##2##5##(2008-3#2)
the usefulness of our##4##4##(2007-8#1)(2008-11#1)(2008-3#2)
the usefulness of the proposed method##2##6##(2007-11#1)(2008-3#1)
the usefulness of the proposed##4##5##(2007-11#1)(2008-10#2)(2008-3#1)
the usefulness of the##23##4##(1990-5#1)(1991-3#1)(1993-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
the usefulness of this approach##2##5##(1997-6#1)(2011-1#1)
the usefulness of this method for##2##6##(1993-12#1)(2012-3#1)
the usefulness of this##10##4##(1993-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
the usefulness of two-dimensional##2##4##(1993-9#1)(2011-2#1)
the usefulness of##96##3##(1990-5#2)(1991-3#2)(1992-1#1)(1992-6#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-4#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-4#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
the usefulness##104##2##(1990-2#1)(1990-5#2)(1991-3#2)(1992-1#1)(1992-6#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-4#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-4#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
the user and##2##3##(1996-7#1)(2008-6#1)
the user controls##2##3##(1996-7#2)
the user interface##2##3##(2010-8#2)
the user may be##2##4##(1993-3#1)(2011-2#1)
the user may##4##3##(1993-3#1)(2008-4#2)(2011-2#1)
the user to##12##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#3)(2008-9#2)(2009-12#1)(2011-2#1)
the user##43##2##(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-3#2)(1996-7#3)(1997-1#2)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#4)(2008-6#4)(2008-7#1)(2008-9#3)(2009-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-8#1)
the user's##3##2##(1993-10#1)(2008-10#1)(2008-3#1)
the users and the##2##4##(1995-2#1)(2013-1#1)
the users of##4##3##(1997-6#1)(2008-11#2)(2012-12#1)
the users##14##2##(1991-1#1)(1992-1#1)(1995-2#1)(1997-1#1)(1997-6#2)(2008-10#1)(2008-11#2)(2012-12#1)(2012-2#2)(2013-1#2)
the users'##3##2##(1997-3#1)(2012-3#2)
the uses and##2##3##(1993-2#1)(2009-9#1)
the uses of##10##3##(1991-12#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)
the uses##13##2##(1991-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)
the usual assumptions##3##3##(1997-8#1)(2008-2#1)(2009-12#1)
the usual complication##2##3##(1991-3#1)(2008-12#1)
the usual nasal cannula##2##4##(1992-11#2)
the usual procedure##2##3##(1990-8#1)(2008-3#1)
the usual##82##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#3)(2006-10#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
the usually##7##2##(1992-6#1)(1995-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-11#1)
the uterine cavity##5##3##(1993-12#1)(1994-9#1)(1996-1#1)(2010-9#1)(2012-3#1)
the uterine cervix##7##3##(1990-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#2)(2011-2#1)
the uterine##29##2##(1990-6#2)(1991-3#1)(1993-1#1)(1993-12#3)(1994-9#5)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-11#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
the uteroplacental##2##2##(1992-4#1)(1994-3#1)
the uterus in a##2##4##(2008-10#1)(2012-1#1)
the uterus in##3##3##(2007-11#1)(2008-10#1)(2012-1#1)
the uterus is##2##3##(2007-11#1)(2011-2#1)
the uterus##28##2##(1990-10#1)(1993-1#1)(1994-9#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-6#1)(2009-4#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
the uterus)##2##2##(2011-2#2)
the utilisation of##7##3##(1993-8#1)(2008-10#3)(2008-11#1)(2012-12#1)(2012-2#1)
the utility and##4##3##(1993-1#1)(1995-1#2)(2009-8#1)
the utility of a##3##4##(1996-7#1)(2011-2#1)(2012-3#1)
the utility of new##2##4##(1997-6#1)(2008-6#1)
the utility of studying##2##4##(2008-8#1)(2009-10#1)
the utility of the method##2##5##(2008-3#2)
the utility of the new##2##5##(2008-3#2)
the utility of the proposed##2##5##(2008-3#2)
the utility of the##26##4##(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
the utility of these##3##4##(2008-10#1)(2013-1#2)
the utility of this approach##2##5##(2008-3#1)(2010-5#1)
the utility of this##8##4##(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-5#1)
the utility of##90##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-10#8)(2008-11#7)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)
the utility##98##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2008-10#9)(2008-11#7)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#6)
the utilization of a##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
the utilization of medical##2##4##(1996-2#1)(1996-6#1)
the utilization of the##5##4##(2008-10#1)(2008-2#1)(2008-7#2)(2011-2#1)
the utilization of##35##3##(1990-8#1)(1991-12#1)(1994-11#1)(1995-3#2)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
the utilization##36##2##(1990-8#1)(1991-12#1)(1994-11#1)(1995-3#2)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
the utmost##2##2##(2008-3#1)(2012-3#1)
the vWF gene##2##3##(2008-12#2)
the vacancy##3##2##(1993-1#1)(2008-9#2)
the vaccinal strain (H8)##2##4##(1997-6#2)
the vaccinal strain##3##3##(1997-6#3)
the vaccinated##9##2##(1994-2#3)(1995-5#1)(1995-9#2)(1997-6#1)(2008-11#1)(2011-2#1)
the vaccination##6##2##(1995-9#1)(2007-3#1)(2009-12#1)(2011-2#3)
the vaccine strain A/PER/16/09##2##4##(2013-8#2)
the vaccine strain##3##3##(2013-8#3)
the vaccine##30##2##(1990-3#1)(1990-9#1)(1993-3#1)(1994-2#1)(1994-9#3)(1995-5#5)(1995-9#1)(1996-12#1)(1997-6#2)(2008-10#1)(2008-11#2)(2010-4#1)(2011-2#4)(2013-1#2)(2013-8#4)
the vaccine-derived##2##2##(2007-10#2)
the vaccines##4##2##(1995-5#2)(2010-4#1)(2011-2#1)
the vaccinia##3##2##(1997-3#1)(2008-2#2)
the vacuolar component##2##3##(1995-3#2)
the vacuolar##6##2##(1994-6#2)(1994-8#1)(1995-3#2)(2008-11#1)
the vacuole##8##2##(1993-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-10#3)(2011-2#1)
the vacuoles##2##2##(2008-7#2)
the vacuum disc##3##3##(2012-2#3)
the vacuum##5##2##(2007-11#1)(2007-8#1)(2012-2#3)
the vagal hepatic##2##3##(1996-5#2)
the vagina and the##2##4##(1996-12#2)
the vagina##12##2##(1990-10#1)(1990-2#1)(1991-12#2)(1993-1#1)(1994-1#1)(1996-12#3)(1996-9#1)(2009-10#1)(2013-1#1)
the vaginal apex##2##3##(2009-2#1)(2010-12#1)
the vaginal sensilla##2##3##(2008-8#2)
the vaginal wall##2##3##(1991-12#1)(1996-12#1)
the vaginal##17##2##(1991-12#2)(1991-3#1)(1992-12#1)(1995-1#1)(1996-12#1)(1996-9#1)(2008-10#3)(2008-5#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-3#2)
the vagus nerve##4##3##(1993-12#2)(1995-12#1)(2008-1#1)
the vagus##8##2##(1993-12#5)(1994-2#1)(1995-12#1)(2008-1#1)
the valence of##3##3##(2008-2#3)
the valence##9##2##(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)
the valid##2##2##(2008-3#1)(2008-7#1)
the validated##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
the validation data##2##3##(2008-10#2)
the validation of a##4##4##(1997-2#1)(2008-10#1)(2009-7#1)(2013-1#1)
the validation of the##2##4##(2007-12#1)(2008-10#1)
the validation of this##2##4##(2008-10#1)(2008-5#1)
the validation of##11##3##(1997-2#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-7#1)(2013-1#1)
the validation process##2##3##(2008-8#1)(2008-9#1)
the validation results of##2##4##(2008-10#2)
the validation set##2##3##(1995-9#1)(2008-10#1)
the validation##29##2##(1995-1#1)(1995-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
the validity and reliability of##3##5##(1994-2#1)(2007-10#1)(2010-9#1)
the validity and##7##3##(1994-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)
the validity of a##2##4##(2008-3#1)(2009-9#1)
the validity of certain of the research data identified in the articles##3##12##(2008-10#3)
the validity of results##2##4##(2008-10#1)(2008-11#1)
the validity of such a##2##5##(2008-10#1)(2008-3#1)
the validity of such an##2##5##(2008-11#1)(2008-3#1)
the validity of such##4##4##(2008-10#1)(2008-11#1)(2008-3#2)
the validity of the method##4##5##(2007-12#1)(2008-10#3)
the validity of the model##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
the validity of the two-state model##2##6##(1997-2#2)
the validity of the##43##4##(1990-10#1)(1990-8#1)(1992-6#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#4)(2009-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
the validity of these##3##4##(2008-3#1)(2010-12#1)(2012-2#1)
the validity of this approach##3##5##(2007-12#1)(2008-2#1)(2008-5#1)
the validity of this##8##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2009-11#1)
the validity of##90##3##(1990-10#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#2)(2007-10#1)(2007-11#2)(2007-12#5)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
the validity##101##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#2)(2007-10#2)(2007-11#2)(2007-12#6)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#10)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
the valley##6##2##(2008-10#6)
the valuable contribution##2##3##(1992-2#1)(1997-3#1)
the value and##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
the value at##3##3##(1995-8#1)(2008-10#1)(2011-1#1)
the value chain model##2##4##(1997-3#2)
the value expected for##2##4##(1992-3#1)(2007-11#1)
the value measured##2##3##(1997-2#1)(2008-2#1)
the value observed in##2##4##(2008-10#2)
the value obtained for##2##4##(1995-11#1)(2008-10#1)
the value obtained##6##3##(1990-8#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)
the value of a##3##4##(1990-7#1)(2008-11#1)(2012-1#1)
the value of delta C/CL##2##5##(1990-7#2)
the value of future reproduction##2##5##(2008-8#2)
the value of monitoring##2##4##(1994-7#1)(1995-3#1)
the value of role modelling##2##5##(2008-12#2)
the value of the apparent##2##5##(1990-11#1)(2008-10#1)
the value of the##36##4##(1990-11#1)(1990-2#1)(1992-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the value of this##4##4##(1990-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
the value of using##3##4##(1992-2#1)(1995-2#1)(2008-11#1)
the value of##156##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#13)(2008-12#6)(2008-2#5)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-3#1)(2010-4#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
the value that##3##3##(1993-2#1)(2007-12#1)(2008-3#1)
the value##198##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-8#3)(2008-1#5)(2008-10#19)(2008-11#16)(2008-12#6)(2008-2#7)(2008-3#19)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-7#1)(2013-8#2)
the values are##2##3##(2008-10#2)
the values between##2##3##(2011-2#1)(2012-3#1)
the values calculated##2##3##(1995-3#1)(2008-6#1)
the values determined for##2##4##(2008-2#1)(2008-5#1)
the values determined##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
the values for the##2##4##(1994-11#1)(1997-2#1)
the values for##13##3##(1990-5#1)(1991-5#1)(1992-11#1)(1994-11#1)(1994-5#1)(1997-2#2)(1997-7#1)(2008-3#1)(2008-5#2)(2010-12#1)(2013-1#1)
the values obtained by##5##4##(2008-10#3)(2008-3#1)(2010-4#1)
the values obtained from##5##4##(1992-2#1)(2008-10#3)(2008-3#1)
the values obtained in##2##4##(2008-10#1)(2008-12#1)
the values obtained##17##3##(1992-2#1)(2008-10#12)(2008-12#1)(2008-3#2)(2010-4#1)
the values of K(f)##2##4##(2008-10#2)
the values of the control coefficients##2##6##(1990-7#2)
the values of the control##4##5##(1990-7#2)(2008-12#1)(2008-4#1)
the values of the correlation function##2##6##(2008-3#2)
the values of the distribution##2##5##(2008-10#2)
the values of the##26##4##(1990-7#2)(1994-1#1)(1994-3#1)(1995-5#1)(2007-11#3)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)
the values of these##2##4##(2008-12#2)
the values of which##2##4##(1991-12#1)(2008-10#1)
the values of##60##3##(1990-6#1)(1990-7#3)(1991-12#2)(1992-8#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-3#1)(2007-11#4)(2008-1#1)(2008-10#16)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-7#1)(2008-8#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
the values predicted##2##3##(2007-11#1)(2008-8#1)
the values were##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
the values##126##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-12#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#5)(2008-1#1)(2008-10#37)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#3)
the valve##13##2##(1990-11#1)(1991-12#1)(1997-5#1)(2007-8#1)(2008-10#3)(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#1)
the valves##2##2##(1997-2#1)(2008-10#1)
the valvula cerebelli##2##3##(1993-12#2)
the vampire's##2##2##(2008-5#2)
the van der Waals surface##2##5##(2013-1#2)
the van der Waals##5##4##(1995-3#1)(2007-11#1)(2008-3#1)(2013-1#2)
the van##8##2##(1995-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2013-1#2)
the vanadium adsorption##2##3##(2008-10#2)
the vanadium##8##2##(2008-10#8)
the vanadium(V)-catalyzed##2##2##(2008-10#2)
the vanguard of##3##3##(1991-2#1)(2008-9#1)(2013-8#1)
the vapor phase##2##3##(2008-10#1)(2008-8#1)
the vapor##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
the vaporization##6##2##(2007-8#1)(2008-10#4)(2008-3#1)
the vapour pressure of the##4##5##(2008-5#3)(2009-11#1)
the vapour pressure of##5##4##(2008-5#4)(2009-11#1)
the vapour pressure##6##3##(2008-5#5)(2009-11#1)
the vapour##8##2##(1992-11#1)(2008-10#1)(2008-5#5)(2009-11#1)
the vapours##2##2##(1991-6#1)(2008-10#1)
the var##3##2##(2008-12#1)(2008-5#2)
the variability among##2##3##(2008-10#2)
the variability and##3##3##(1997-7#1)(2008-10#2)
the variability between different tests based on the same principle##2##10##(2008-10#2)
the variability between##5##3##(1993-12#1)(2008-10#4)
the variability in disease##2##4##(2008-10#2)
the variability in the##5##4##(1991-12#1)(2008-10#2)(2009-4#1)(2010-2#1)
the variability in##15##3##(1991-12#1)(1992-6#1)(2007-3#1)(2008-10#6)(2008-3#1)(2008-8#2)(2009-4#1)(2010-2#1)(2013-7#1)
the variability of in vivo##2##5##(2008-11#1)(2011-1#1)
the variability of the##9##4##(1990-11#2)(1994-11#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
the variability of##28##3##(1990-11#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-9#1)(1997-3#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)
the variability##65##2##(1990-11#2)(1990-8#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-9#1)(1997-3#1)(1997-7#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-7#1)
the variable Zagreb##2##3##(2007-11#2)
the variable loop##2##3##(1993-11#2)
the variable region of the##2##5##(2008-10#1)(2008-8#1)
the variable region##5##3##(2008-10#3)(2008-11#1)(2008-8#1)
the variable##40##2##(1990-8#1)(1992-3#4)(1992-6#1)(1993-11#2)(1993-6#1)(1995-12#1)(2007-11#4)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
the variables affecting the##2##4##(2008-10#2)
the variables affecting##3##3##(2008-10#3)
the variables considered##2##3##(2008-10#1)(2012-12#1)
the variables examined were##2##4##(1993-8#1)(2011-2#1)
the variables have been##3##4##(2008-10#3)
the variables related to##2##4##(1995-2#1)(2008-10#1)
the variables studied were##2##4##(2008-10#1)(2008-11#1)
the variables that##5##3##(1991-12#1)(1994-7#1)(1995-1#1)(2008-10#1)(2010-5#1)
the variables to be optimized and##2##6##(2008-10#1)(2008-11#1)
the variables to be##3##4##(2008-10#2)(2008-11#1)
the variables were##2##3##(2008-10#1)(2011-2#1)
the variables##43##2##(1991-12#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-2#1)(2008-10#20)(2008-11#3)(2008-5#1)(2010-5#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
the variance and##2##3##(2008-10#1)(2008-8#1)
the variance estimated from a standard formula##2##7##(2012-1#2)
the variance in##31##3##(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#2)(2007-10#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#4)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the variance of area estimates was##2##6##(1997-3#2)
the variance of the number of infected plants##2##8##(2008-10#2)
the variance of the##12##4##(1992-6#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#1)(2010-3#1)(2012-3#1)
the variance of##18##3##(1992-6#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#1)(2009-2#1)(2009-5#1)(2010-3#1)(2012-3#1)
the variance was##2##3##(2008-10#1)(2008-6#1)
the variance##74##2##(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-1#2)(1997-3#2)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#14)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#4)(2009-2#1)(2009-5#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#4)(2012-3#4)(2013-1#3)(2013-8#1)
the variances of##2##3##(2008-10#1)(2012-3#1)
the variances##4##2##(2008-10#2)(2012-3#2)
the variant pI6##2##3##(1991-12#2)
the variant proteins##2##3##(1995-5#1)(2008-7#1)
the variant##18##2##(1990-10#1)(1990-8#2)(1991-12#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-5#1)(2008-12#1)(2008-7#2)(2008-8#2)(2011-2#2)
the variation in Bragg wavelength is 0##2##7##(2013-8#2)
the variation in the##7##4##(1995-11#1)(1995-9#1)(2008-10#3)(2008-2#1)(2008-3#1)
the variation in##50##3##(1993-3#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-5#1)(2008-10#14)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#3)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
the variation observed##2##3##(2008-10#1)(2009-12#1)
the variation of a##3##4##(2008-2#1)(2009-5#1)(2012-3#1)
the variation of the refractive-index##2##5##(2008-2#2)
the variation of the##17##4##(1997-7#1)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#2)(2008-5#1)(2013-1#1)(2013-8#1)
the variation of##33##3##(1991-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#10)(2008-3#3)(2008-5#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#5)
the variation was##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
the variation within a##2##4##(2008-10#1)(2008-4#1)
the variation within##3##3##(2008-10#2)(2008-4#1)
the variation##113##2##(1991-11#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#35)(2008-12#3)(2008-2#14)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#8)
the variational##4##2##(2007-12#1)(2009-9#2)(2012-3#1)
the variations in the##7##4##(1993-2#1)(2008-10#2)(2008-3#1)(2009-6#1)(2013-8#2)
the variations in##14##3##(1990-8#1)(1991-11#1)(1993-2#1)(1994-9#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-6#1)(2011-2#1)(2013-8#2)
the variations of##3##3##(1992-3#1)(2008-10#2)
the variations##19##2##(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#1)(1994-9#1)(2007-7#1)(2008-10#4)(2008-3#3)(2008-9#2)(2009-6#1)(2011-2#1)(2013-8#2)
the varices##2##2##(2011-2#2)
the varicocele##2##2##(1990-3#2)
the varied##3##2##(1991-12#1)(2008-9#1)(2010-11#1)
the varieties of##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2013-8#1)
the varieties##7##2##(1997-3#1)(2008-10#2)(2008-12#3)(2013-8#1)
the variety of##14##3##(1992-1#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#2)
the variety##18##2##(1990-6#1)(1992-1#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)
the various anxiety disorders##2##4##(1991-2#1)(2013-8#1)
the various aspects of the##2##5##(1996-12#1)(2011-2#1)
the various aspects of##3##4##(1996-12#1)(2007-11#1)(2011-2#1)
the various biological##2##3##(2011-2#1)(2013-8#1)
the various causes##2##3##(2008-7#1)(2012-2#1)
the various cell##2##3##(2008-10#1)(2008-6#1)
the various components of the##2##5##(2008-3#1)(2008-6#1)
the various components of##6##4##(1995-3#1)(1996-3#1)(2008-3#2)(2008-6#1)(2011-2#1)
the various components##7##3##(1995-3#1)(1996-3#1)(2007-12#1)(2008-3#2)(2008-6#1)(2011-2#1)
the various environmental##2##3##(2008-10#1)(2012-1#1)
the various factors that##3##4##(1990-3#1)(1992-2#1)(2013-1#1)
the various factors##4##3##(1990-3#1)(1992-2#1)(2012-12#1)(2013-1#1)
the various forms of##2##4##(2010-10#1)(2013-8#1)
the various groups of##2##4##(1994-11#1)(2012-2#1)
the various groups##3##3##(1994-11#1)(2008-7#1)(2012-2#1)
the various healthcare##2##3##(1992-12#1)(1993-12#1)
the various highly##2##3##(1992-9#1)(2008-10#1)
the various histological##3##3##(1996-9#2)(2012-1#1)
the various isolates##3##3##(2008-10#2)(2008-5#1)
the various levels of##2##4##(1991-11#1)(2008-10#1)
the various levels##3##3##(1991-11#1)(2008-10#1)(2012-2#1)
the various locations##2##3##(2007-12#1)(2008-7#1)
the various methodologies##2##3##(1995-2#1)(2008-10#1)
the various methods##5##3##(1992-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
the various options##2##3##(1993-9#1)(2008-10#1)
the various parameters##4##3##(2008-10#2)(2008-3#1)(2011-7#1)
the various participants##2##3##(1995-1#1)(2007-12#1)
the various physical##2##3##(2008-3#1)(2009-11#1)
the various proteins##2##3##(1993-3#1)(1995-5#1)
the various scattering##2##3##(2008-2#1)(2008-3#1)
the various sites##2##3##(2008-10#1)(2008-5#1)
the various species##3##3##(1996-2#1)(2008-10#1)(2010-12#1)
the various stages of##2##4##(1993-11#1)(1997-4#1)
the various stages##3##3##(1993-11#1)(1997-4#1)(2009-10#1)
the various studies##3##3##(1994-2#1)(2008-9#1)(2010-10#1)
the various techniques##5##3##(2008-10#2)(2008-11#2)(2009-1#1)
the various tests##2##3##(1991-5#1)(2011-2#1)
the various treatment##2##3##(1997-3#1)(2008-10#1)
the various types of##6##4##(1992-12#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
the various types##7##3##(1992-12#1)(1993-3#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
the various ways##3##3##(1996-2#1)(2008-12#1)(2008-5#1)
the various##299##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-12#4)(1992-2#2)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-5#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-9#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-7#3)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#4)(2007-12#10)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#48)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#15)(2008-4#2)(2008-5#14)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#11)(2011-7#1)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#9)
the varying##7##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-7#1)
the vas deferens##7##3##(1994-8#2)(1997-8#1)(2008-10#4)
the vas##12##2##(1994-8#7)(1997-8#1)(2008-10#4)
the vascular bed##2##3##(1997-1#1)(2008-3#1)
the vascular bundles and##2##4##(2008-10#2)
the vascular bundles##4##3##(2008-10#4)
the vascular cambium##3##3##(2008-10#3)
the vascular cylinder##2##3##(2008-10#2)
the vascular elements##2##3##(2008-10#2)
the vascular endothelial cell##2##4##(1991-9#1)(2009-7#1)
the vascular endothelial growth factor##2##5##(1992-3#1)(2012-1#1)
the vascular endothelial##5##3##(1991-9#1)(1992-3#1)(1997-1#1)(2009-7#1)(2012-1#1)
the vascular network of##2##4##(2008-5#1)(2011-2#1)
the vascular network##5##3##(2008-11#3)(2008-5#1)(2011-2#1)
the vascular permeability##2##3##(1991-9#1)(1992-12#1)
the vascular smooth muscle cells##3##5##(1995-11#1)(2008-7#1)(2009-1#1)
the vascular smooth muscle##5##4##(1991-9#1)(1995-11#1)(1995-12#1)(2008-7#1)(2009-1#1)
the vascular supply##2##3##(2007-11#1)(2007-12#1)
the vascular system of the##2##5##(2008-10#2)
the vascular system##6##3##(2008-10#4)(2009-2#1)(2010-8#1)
the vascular territory##2##3##(2007-10#1)(2012-3#1)
the vascular tissue##2##3##(2008-10#2)
the vascular tissues##6##3##(2008-10#6)
the vascular wall##4##3##(1990-8#1)(1992-9#1)(2008-7#1)(2010-5#1)
the vascular##92##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#3)(1991-9#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1995-11#1)(1995-12#2)(1996-11#1)(1997-1#3)(1997-3#1)(1997-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
the vascularized##2##2##(2008-9#1)(2009-3#1)
the vasculature and##2##3##(1991-9#1)(2008-3#1)
the vasculature of##2##3##(1997-3#1)(2009-2#1)
the vasculature to##2##3##(1991-2#1)(2013-1#1)
the vasculature##10##2##(1991-2#1)(1991-9#1)(1997-3#1)(2008-3#2)(2008-7#2)(2009-2#1)(2013-1#1)(2013-8#1)
the vasoconstriction##2##2##(1991-6#1)(1995-12#1)
the vasodilator##3##2##(1993-3#1)(2008-10#1)(2009-5#1)
the vasopressin V1 receptor antagonist##2##5##(1995-12#2)
the vasopressin V1##3##3##(1995-12#3)
the vasopressin##6##2##(1994-11#2)(1994-2#1)(1995-12#3)
the vast amount of information##3##5##(1993-12#1)(2008-10#1)(2008-7#1)
the vast amount of##4##4##(1993-12#1)(2008-10#1)(2008-7#1)(2009-12#1)
the vast majority of##17##4##(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)
the vast majority##19##3##(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#1)
the vast##33##2##(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2012-2#1)
the vastus lateralis##4##3##(2010-4#4)
the vault##3##2##(2007-11#1)(2008-5#2)
the vector and the##3##4##(1990-7#1)(1994-11#1)(2008-11#1)
the vector and##5##3##(1990-7#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
the vector of##2##3##(2007-12#1)(2010-1#1)
the vector specificity##3##3##(2008-10#3)
the vector##57##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#19)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)
the vector's##2##2##(2008-8#2)
the vectorial##4##2##(1993-6#1)(2007-11#1)(2008-3#2)
the vectors##9##2##(1991-12#1)(1993-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#2)(2013-8#1)
the vegetation##7##2##(2008-5#1)(2008-8#2)(2013-7#1)(2013-8#3)
the vegetative and reproductive##2##4##(2008-5#1)(2008-8#1)
the vegetative##11##2##(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#3)(2009-12#1)
the vehicle control group##3##4##(2008-9#3)
the vehicle control groups##8##4##(2008-9#8)
the vehicle control##13##3##(2008-9#12)(2010-1#1)
the vehicle controls##33##3##(2008-9#33)
the vehicle for##2##3##(1992-12#1)(2010-10#1)
the vehicle##68##2##(1992-12#1)(1994-8#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-9#45)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
the vehicles##4##2##(1991-3#1)(2008-5#3)
the vein and##2##3##(1992-12#1)(2008-1#1)
the vein of Labbé##2##4##(2006-12#2)
the vein of##3##3##(1996-6#1)(2006-12#2)
the vein##9##2##(1992-12#1)(1996-6#1)(2006-12#2)(2007-7#1)(2008-1#1)(2008-7#1)(2012-3#2)
the veins##2##2##(1995-11#1)(2008-10#1)
the velocity and the##4##4##(2007-12#1)(2008-3#3)
the velocity difference##2##3##(2008-3#2)
the velocity field##4##3##(2008-2#1)(2009-5#3)
the velocity gradient##3##3##(2008-3#3)
the velocity is##2##3##(2007-11#1)(2008-3#1)
the velocity of the##4##4##(2008-11#1)(2008-3#2)(2008-8#1)
the velocity of##12##3##(1993-9#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-8#1)(2009-8#1)(2012-1#2)
the velocity##41##2##(1992-9#1)(1993-9#1)(1994-5#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#17)(2008-8#1)(2009-5#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)
the vena cava##3##3##(1992-9#1)(2010-4#2)
the venom of the##4##4##(1990-5#1)(1993-6#1)(1994-8#1)(1995-5#1)
the venom of##10##3##(1990-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#2)(1995-8#1)(2008-5#2)(2008-8#1)
the venom##19##2##(1990-5#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-8#2)(1995-5#2)(1995-8#1)(1997-7#1)(2008-5#3)(2008-7#3)(2008-8#1)
the venous side##2##3##(2007-7#1)(2008-3#1)
the venous system##2##3##(2011-2#2)
the venous##16##2##(1994-9#1)(1996-9#3)(2007-7#1)(2008-3#1)(2008-7#2)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)
the ventilator##5##2##(1995-12#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the ventral and dorsal##2##4##(2007-12#1)(2012-2#1)
the ventral forearm##2##3##(2008-5#2)
the ventral hippocampus##5##3##(1995-12#4)(2013-8#1)
the ventral nerve cord##7##4##(1997-7#1)(2007-12#4)(2008-5#1)(2008-9#1)
the ventral nerve##8##3##(1997-7#1)(2007-12#5)(2008-5#1)(2008-9#1)
the ventral radius##2##3##(2009-5#2)
the ventral side of the##5##5##(1991-5#1)(2007-12#2)(2008-5#2)
the ventral striatum##5##3##(1993-6#5)
the ventral surface##2##3##(2008-5#1)(2011-2#1)
the ventral tegmental area (VTA) and##2##6##(1996-5#1)(2009-8#1)
the ventral tegmental area (VTA)##8##5##(1993-12#3)(1996-12#1)(1996-5#1)(2008-7#2)(2009-8#1)
the ventral tegmental area##15##4##(1993-12#4)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#3)(2009-8#1)
the ventral##83##2##(1990-11#1)(1990-7#2)(1991-5#1)(1993-12#9)(1993-6#6)(1995-12#4)(1995-5#1)(1996-12#4)(1996-5#1)(1997-2#2)(1997-3#3)(1997-7#2)(2007-10#1)(2007-12#11)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#12)(2008-7#4)(2008-9#3)(2009-12#2)(2009-5#3)(2009-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
the ventricles of##2##3##(1992-11#1)(2008-7#1)
the ventricles##5##2##(1992-11#1)(2008-6#1)(2008-7#2)(2013-1#1)
the ventricular rate##3##3##(2010-12#2)(2012-3#1)
the ventricular##15##2##(1990-9#1)(1991-12#1)(1991-4#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-12#2)(2012-3#1)
the ventrolateral orbital cortex##2##4##(1994-3#2)
the ventrolateral striatum##2##3##(1997-6#2)
the ventrolateral##10##2##(1992-11#1)(1993-3#1)(1993-9#2)(1994-2#2)(1994-3#2)(1997-6#2)
the ventromedial and lateral hypothalamus##2##5##(1990-7#2)
the ventromedial and##4##3##(1990-7#2)(1991-2#1)(1994-2#1)
the ventromedial prefrontal cortex##3##4##(2008-11#2)(2013-1#1)
the ventromedial##10##2##(1990-7#2)(1991-2#1)(1994-2#3)(2008-11#2)(2008-4#1)(2013-1#1)
the venue##2##2##(2008-5#1)(2012-2#1)
the veracity of##2##3##(1997-1#1)(2010-3#1)
the verbal##2##2##(2008-10#1)(2013-1#1)
the verdict and##2##3##(1995-12#1)(1997-5#1)
the verification of the##2##4##(2007-10#1)(2008-3#1)
the verification of##4##3##(2007-10#1)(2008-3#3)
the verification##8##2##(1997-6#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#3)
the vernalization##2##2##(2009-8#1)(2012-3#1)
the versatility and##3##3##(2008-10#2)(2009-11#1)
the versatility of the##3##4##(2008-10#1)(2008-2#1)(2012-6#1)
the versatility of##10##3##(2007-12#1)(2008-10#5)(2008-2#1)(2008-7#1)(2010-12#1)(2012-6#1)
the versatility##14##2##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-6#1)
the versican proteoglycan##2##3##(2008-11#2)
the vertebrae##9##2##(1991-11#1)(2007-11#6)(2008-11#1)(2008-7#1)
the vertebral artery##7##3##(1991-8#1)(1993-3#2)(2008-12#1)(2008-7#2)(2012-12#1)
the vertebral bodies##6##3##(1997-3#1)(2007-11#2)(2007-8#1)(2008-7#1)(2012-1#1)
the vertebral body##8##3##(2007-11#3)(2007-8#3)(2012-1#1)(2012-2#1)
the vertebral column##10##3##(1997-2#1)(2007-11#4)(2007-8#2)(2011-2#2)(2013-1#1)
the vertebral venous plexus##2##4##(2011-2#2)
the vertebral venous plexuses##2##4##(2011-2#2)
the vertebral venous##4##3##(2011-2#4)
the vertebral##42##2##(1991-11#1)(1991-8#2)(1993-3#2)(1995-3#2)(1997-2#1)(1997-3#1)(2007-11#9)(2007-8#6)(2008-12#2)(2008-7#4)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
the vertebrate lineage##2##3##(2008-1#1)(2012-12#1)
the vertebrate retina##2##3##(1994-12#1)(1995-5#1)
the vertebrate##19##2##(1990-5#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#1)(2010-9#1)(2012-12#2)(2013-1#1)
the vertebrates##3##2##(2007-7#1)(2008-7#1)(2011-1#1)
the vertebrobasilar artery##3##3##(1997-3#1)(2008-7#1)(2012-3#1)
the vertebrobasilar##5##2##(1991-3#1)(1997-3#1)(2008-2#1)(2008-7#1)(2012-3#1)
the vertex##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
the vertical and##3##3##(1992-2#1)(1997-6#1)(2008-3#1)
the vertical column##2##3##(1991-5#1)(2008-3#1)
the vertical dimension##2##3##(2009-11#1)(2010-3#1)
the vertical distribution of##3##4##(2008-11#1)(2008-3#2)
the vertical lobe##2##3##(2008-7#1)(2009-8#1)
the vertical profiles of##2##4##(2008-11#1)(2008-3#1)
the vertical resolution##3##3##(2008-3#3)
the vertical section##2##3##(2009-7#2)
the vertical smoothing##2##3##(2008-2#1)(2008-3#1)
the vertical structure of##2##4##(2008-2#2)
the vertical##51##2##(1991-3#1)(1991-5#1)(1992-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#19)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-3#1)
the vertically##3##2##(2008-3#2)(2010-8#1)
the vertiginous##3##2##(2008-2#2)(2013-1#1)
the very beginning##2##3##(2007-11#1)(2011-2#1)
the very early##5##3##(2007-11#1)(2008-10#2)(2009-7#1)(2009-8#1)
the very first##2##3##(1994-1#1)(2008-12#1)
the very high##6##3##(1991-12#1)(1993-8#1)(1997-7#1)(2008-10#2)(2012-1#1)
the very low density lipoprotein##2##5##(1995-6#2)
the very low##10##3##(1990-6#1)(1991-12#1)(1992-10#1)(1995-6#2)(1997-2#1)(2008-10#2)(2008-2#1)(2013-1#1)
the very nature of##3##4##(2007-11#1)(2008-8#1)(2009-4#1)
the very##69##2##(1990-2#1)(1990-6#1)(1991-12#3)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-6#2)(1997-2#2)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-4#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#3)
the vesicle##7##2##(1990-2#1)(1991-10#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-8#1)(2008-11#1)
the vesicles and##2##3##(2008-10#1)(2008-8#1)
the vesicles were##2##3##(1990-11#1)(1992-3#1)
the vesicles##18##2##(1990-11#2)(1990-12#1)(1990-2#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#2)
the vesicular monoamine transporter##2##4##(1995-12#2)
the vesicular stomatitis virus##3##4##(1994-8#1)(1997-4#2)
the vesicular##12##2##(1991-10#1)(1992-7#1)(1994-8#1)(1995-12#2)(1997-4#2)(2008-11#1)(2008-5#1)(2009-8#3)
the vessel and##2##3##(1993-8#1)(2012-3#1)
the vessel wall and##3##4##(2008-3#1)(2008-4#2)
the vessel wall##9##3##(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2011-1#1)
the vessel##32##2##(1990-8#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-2#1)(1997-3#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)
the vessels in##2##3##(1996-12#1)(2013-8#1)
the vessels##11##2##(1996-12#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
the vestibular and##2##3##(1991-2#2)
the vestibular system##3##3##(1995-8#2)(2009-9#1)
the vestibular##10##2##(1990-10#1)(1990-6#1)(1991-2#2)(1995-5#1)(1995-8#2)(2009-9#1)(2011-2#2)
the viability and##9##3##(1990-6#1)(1992-2#1)(1994-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-6#1)
the viability of cells##2##4##(2008-4#1)(2009-12#1)
the viability of human##3##4##(2008-7#2)(2013-1#1)
the viability of sclerotia##3##4##(2008-10#3)
the viability of sporangia##2##4##(2008-10#2)
the viability of the cultures##2##5##(2008-11#2)
the viability of the method##3##5##(2008-10#3)
the viability of the##11##4##(1992-1#1)(1992-5#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#3)(2011-2#1)
the viability of using eSRT##2##5##(2008-9#2)
the viability of##37##3##(1992-1#1)(1992-5#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2013-1#2)
the viability test##2##3##(2008-11#1)(2012-12#1)
the viability was##2##3##(2008-11#2)
the viability##57##2##(1990-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-1#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#12)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-9#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-6#1)(2013-1#2)
the viable cell concentration##2##4##(2008-11#1)(2008-7#1)
the viable cell density##3##4##(1994-5#1)(2008-11#2)
the viable cell##7##3##(1994-5#1)(2008-11#5)(2008-7#1)
the viable##12##2##(1994-5#1)(2008-10#1)(2008-11#7)(2008-7#1)(2012-2#1)(2012-3#1)
the vial##4##2##(2008-3#3)(2008-8#1)
the vibration of the##3##4##(1995-5#1)(2008-3#2)
the vibration##10##2##(1995-5#1)(2007-11#1)(2008-2#3)(2008-3#5)
the vibrational spectrum##2##3##(2007-11#1)(2010-7#1)
the vibrational##11##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the vicarious calibration of the##2##5##(2008-3#2)
the vicinity of the##24##4##(1990-11#1)(1990-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(2007-11#4)(2008-10#5)(2008-3#2)(2008-7#1)(2009-12#1)(2009-7#1)
the vicinity of this##2##4##(1995-3#1)(2008-3#1)
the vicinity of##52##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)
the vicinity##56##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-1#1)(2013-8#1)
the victim tigress##2##3##(2011-1#2)
the victim##9##2##(1992-5#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-1#2)(2011-2#1)
the victims of a mass disaster##2##6##(1995-11#2)
the victims of##8##3##(1991-12#1)(1992-12#1)(1995-11#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
the victims##12##2##(1991-12#1)(1991-2#1)(1992-12#1)(1995-11#2)(1996-11#1)(2007-2#1)(2009-6#2)(2011-2#1)(2012-12#1)(2013-1#1)
the video##8##2##(1992-12#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
the videos##2##2##(1993-12#1)(2008-10#1)
the videotape##2##2##(1995-12#2)
the videotapes##2##2##(1993-2#2)
the view of a##3##4##(1994-1#1)(1995-2#1)(2008-6#1)
the view of the##4##4##(1994-8#2)(2012-12#1)(2012-3#1)
the view of##14##3##(1994-1#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
the view that the major##2##5##(1995-5#1)(1997-9#1)
the view that the##10##4##(1990-12#1)(1990-5#1)(1994-11#1)(1995-5#1)(1997-6#1)(1997-9#1)(2007-8#2)(2008-1#1)(2009-9#1)
the view that##37##3##(1990-12#1)(1990-5#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
the view to##2##3##(2008-10#1)(2011-2#1)
the view##56##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-2#2)(1995-5#1)(1996-5#3)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-7#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#2)
the viewer##2##2##(2008-11#1)(2008-3#1)
the viewing angle of##3##4##(2007-11#2)(2008-2#1)
the viewing angle##4##3##(2007-11#2)(2008-1#1)(2008-2#1)
the viewing area##2##3##(2008-2#1)(2008-3#1)
the viewing resolution##2##3##(2007-11#2)
the viewing##13##2##(2007-11#4)(2008-1#1)(2008-2#2)(2008-3#6)
the viewpoint of the##3##4##(1990-6#1)(1996-9#1)(2013-8#1)
the viewpoint of##15##3##(1990-6#1)(1991-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#2)
the viewpoint##18##2##(1990-6#1)(1991-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#2)
the viewpoints of the##2##4##(2007-6#1)(2008-6#1)
the viewpoints of##4##3##(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)
the views and##2##3##(2008-11#1)(2010-10#1)
the views of the##4##4##(1991-1#1)(1996-9#1)(1997-3#1)(2011-1#1)
the views of##9##3##(1990-12#1)(1991-1#1)(1996-9#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
the views##12##2##(1990-12#1)(1991-1#1)(1996-9#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-3#1)
the village of##3##3##(2008-10#1)(2012-12#2)
the village##7##2##(1994-3#1)(2008-10#1)(2008-8#2)(2012-12#2)(2013-8#1)
the villages##4##2##(1991-12#1)(1996-12#1)(2012-1#1)(2012-12#1)
the villus tip##2##3##(1990-12#1)(1991-12#1)
the villus##5##2##(1990-12#1)(1991-12#4)
the vinca##2##2##(1995-5#2)
the vinegar##2##2##(2008-10#1)(2008-5#1)
the vines##2##2##(2008-10#2)
the vinyl group##3##3##(2008-10#2)(2013-1#1)
the vinyl##4##2##(2008-10#3)(2013-1#1)
the violation of##3##3##(2012-2#1)(2013-8#2)
the viral DNA##2##3##(1991-5#1)(1997-3#1)
the viral E1 helicase##2##4##(1994-8#2)
the viral E1##3##3##(1994-8#2)(2008-9#1)
the viral G protein##2##4##(1993-6#2)
the viral RNA##6##3##(1997-2#1)(2008-10#3)(2008-9#1)(2009-11#1)
the viral capsid protein##2##4##(2008-10#1)(2009-8#1)
the viral capsid##4##3##(1995-2#2)(2008-10#1)(2009-8#1)
the viral coat protein##3##4##(2008-10#2)(2008-8#1)
the viral envelope##2##3##(1994-8#2)
the viral genome##8##3##(1991-6#1)(1994-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
the viral genomic RNA##2##4##(1992-6#1)(2008-11#1)
the viral infection##2##3##(2008-10#1)(2010-6#1)
the viral life cycle##3##4##(1994-8#1)(1995-2#1)(2010-1#1)
the viral mRNA##2##3##(1992-12#2)
the viral nucleocapsid##2##3##(1992-12#1)(2008-10#1)
the viral protein##2##3##(2008-10#1)(2008-8#1)
the viral replication##3##3##(1994-8#1)(2008-10#2)
the viral##109##2##(1990-8#1)(1991-5#4)(1991-6#1)(1992-12#5)(1992-2#1)(1992-6#3)(1993-6#2)(1994-11#2)(1994-12#1)(1994-8#7)(1995-2#8)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(2007-10#2)(2007-7#1)(2008-10#31)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#5)(2008-9#5)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the virga##3##2##(2008-6#3)
the virion##3##2##(1992-8#1)(1993-12#1)(2008-10#1)
the virions##2##2##(1992-8#1)(1994-7#1)
the viroid##3##2##(2008-10#3)
the virtual##8##2##(1997-3#1)(2006-10#1)(2008-3#2)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
the virtues##2##2##(1991-12#1)(2012-2#1)
the virulence and##2##3##(2008-10#2)
the virulence factors##3##3##(2007-10#1)(2008-10#1)(2008-9#1)
the virulence of a##2##4##(1996-12#1)(2008-10#1)
the virulence of the##3##4##(2008-10#2)(2008-7#1)
the virulence of##16##3##(1996-12#2)(2008-10#8)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2013-1#1)
the virulence or avirulence genes##2##5##(2008-10#2)
the virulence or##3##3##(2008-10#3)
the virulence spectrum##2##3##(2008-10#2)
the virulence##36##2##(1996-12#2)(2007-10#1)(2007-12#1)(2008-10#23)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
the virulent genotype##2##3##(2008-10#2)
the virulent isolates##3##3##(2008-10#3)
the virulent##14##2##(1994-12#1)(2008-10#11)(2008-8#1)(2008-9#1)
the virus (strain) with the##2##5##(2008-10#2)
the virus and##7##3##(1994-8#1)(1996-11#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-2#1)
the virus as freshly emerged##2##5##(2008-10#2)
the virus as##5##3##(1990-2#1)(2008-10#3)(2008-11#1)
the virus by##4##3##(2008-10#4)
the virus does not##2##4##(2008-10#1)(2008-8#1)
the virus from the##2##4##(2008-10#1)(2011-1#1)
the virus from##7##3##(1990-11#1)(2007-6#1)(2008-10#4)(2011-1#1)
the virus genome##2##3##(2008-10#2)
the virus has##2##3##(2007-12#1)(2008-10#1)
the virus in a##2##4##(2008-10#2)
the virus in the##2##4##(1991-2#1)(2012-3#1)
the virus in##16##3##(1991-2#1)(2007-8#1)(2008-10#9)(2008-8#1)(2008-9#1)(2011-1#2)(2012-3#1)
the virus is##8##3##(1993-11#1)(2007-2#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)
the virus moved to##2##4##(2008-10#2)
the virus per plant visit##2##5##(2008-10#2)
the virus population##2##3##(2008-10#2)
the virus that causes##2##4##(1994-3#1)(2010-10#1)
the virus that##3##3##(1994-3#1)(2007-12#1)(2010-10#1)
the virus to##4##3##(1992-5#1)(2008-10#2)(2011-3#1)
the virus was##13##3##(1991-2#1)(1997-6#2)(2008-10#10)
the virus##196##2##(1990-11#2)(1990-2#2)(1991-2#2)(1991-5#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-3#1)(1994-8#4)(1995-12#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(2007-10#2)(2007-12#4)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#99)(2008-11#6)(2008-12#4)(2008-4#1)(2008-5#5)(2008-8#3)(2008-9#8)(2009-11#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#8)(2011-2#1)(2011-3#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
the virus-infected##2##2##(2008-10#2)
the viruses were##5##3##(2007-12#3)(2008-10#1)(2011-2#1)
the viruses##21##2##(1995-5#1)(2007-10#1)(2007-12#3)(2007-6#1)(2008-10#11)(2010-4#1)(2011-2#2)(2012-2#1)
the visceral##6##2##(1990-2#1)(1990-8#1)(1995-3#1)(1997-6#1)(2007-12#1)(2007-5#1)
the viscoelastic properties of##2##4##(2008-3#1)(2012-2#1)
the viscoelastic##4##2##(2007-12#1)(2008-3#1)(2009-7#1)(2012-2#1)
the viscoelasticity##2##2##(2008-10#2)
the viscosity and##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
the viscosity of shampoo##3##4##(2008-5#3)
the viscosity of the##8##4##(2008-10#4)(2008-6#2)(2008-7#1)(2013-1#1)
the viscosity of##15##3##(1994-11#3)(2008-10#4)(2008-5#4)(2008-6#2)(2008-7#1)(2013-1#1)
the viscosity##26##2##(1994-11#3)(2007-11#3)(2008-1#1)(2008-10#8)(2008-5#6)(2008-6#2)(2008-7#1)(2011-1#1)(2013-1#1)
the viscous##3##2##(2008-12#1)(2008-7#1)(2009-6#1)
the visibility depth##2##3##(2008-3#2)
the visibility of the##3##4##(1995-3#1)(2008-2#1)(2008-3#1)
the visibility of##6##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-7#1)
the visibility##10##2##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#6)(2010-7#1)
the visible absorption spectrum##2##4##(1993-11#1)(2008-10#1)
the visible absorption##3##3##(1992-1#1)(1993-11#1)(2008-10#1)
the visible and infrared##2##4##(2008-3#1)(2013-8#1)
the visible and near-infrared##5##4##(2007-11#1)(2008-2#3)(2008-3#1)
the visible and the infrared##2##5##(2007-11#1)(2008-3#1)
the visible and the##8##4##(2007-11#1)(2008-2#1)(2008-3#6)
the visible and##19##3##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#11)(2013-8#1)
the visible band##2##3##(2008-3#2)
the visible range##8##3##(1993-11#1)(2007-11#2)(2008-2#2)(2008-3#2)(2009-11#1)
the visible region of the spectrum##2##6##(2007-11#1)(2008-10#1)
the visible region of the##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
the visible region##16##3##(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#6)(2008-3#1)
the visible spectral range##3##4##(2007-11#1)(2008-3#2)
the visible spectral##5##3##(2007-11#1)(2008-3#3)(2013-8#1)
the visible spectrum of##2##4##(2008-10#2)
the visible spectrum##8##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
the visible to the##2##4##(2007-12#1)(2008-2#1)
the visible##105##2##(1992-1#1)(1993-11#2)(1994-5#1)(1997-7#1)(2007-11#11)(2007-12#12)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#20)(2008-3#39)(2009-11#1)(2009-12#1)(2013-1#1)(2013-8#2)
the vision for the##2##4##(1994-3#1)(2008-6#1)
the vision into##2##3##(1992-12#1)(2008-12#1)
the vision of##3##3##(2008-3#1)(2009-12#1)(2013-1#1)
the vision##13##2##(1991-3#1)(1992-12#1)(1994-3#1)(2008-12#4)(2008-3#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
the visionary##2##2##(2008-7#1)(2013-1#1)
the visit of##2##3##(1992-2#1)(2012-12#1)
the visit##5##2##(1992-2#1)(1996-1#1)(2008-1#1)(2012-12#1)(2012-3#1)
the visual analog scale##2##4##(2008-10#1)(2008-6#1)
the visual analogue##2##3##(2007-11#1)(2011-2#1)
the visual and the##2##4##(2008-3#1)(2013-8#1)
the visual and##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
the visual cortex of adult##2##5##(1995-12#2)
the visual cortex##12##3##(1990-8#2)(1992-10#1)(1995-12#3)(1996-2#1)(2007-8#1)(2008-11#1)(2009-5#1)(2011-2#2)
the visual environment##2##3##(1995-5#1)(2008-2#1)
the visual field##5##3##(1992-6#1)(2008-9#1)(2011-2#2)(2012-3#1)
the visual input##7##3##(1991-2#7)
the visual learning##2##3##(2008-8#2)
the visual system##11##3##(1993-12#1)(1994-8#1)(1995-5#3)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#2)
the visual##88##2##(1990-8#2)(1991-2#9)(1992-10#1)(1992-11#3)(1992-12#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#5)(1995-5#4)(1995-8#1)(1996-2#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-5#1)(2010-9#3)(2011-2#7)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#5)
the visualisation of##2##3##(2008-1#1)(2012-2#1)
the visualisation##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
the visualization of##6##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#1)
the visualization##9##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-8#1)(2009-6#1)(2012-3#1)
the visually##2##2##(2008-2#1)(2008-7#1)
the vital dye##3##3##(1992-11#1)(2008-11#1)(2008-9#1)
the vital records database##2##4##(2012-12#2)
the vital##21##2##(1992-11#1)(1993-12#1)(1994-2#2)(1994-7#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the vitality of the##4##4##(1990-3#1)(1991-5#2)(2008-11#1)
the vitality of##5##3##(1990-3#1)(1991-5#2)(1994-7#1)(2008-11#1)
the vitality##7##2##(1990-3#1)(1991-5#2)(1994-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
the vitamin C##4##3##(1992-9#1)(2008-10#2)(2011-1#1)
the vitamin D analogue##2##4##(1993-11#2)
the vitamin D receptor (VDR)##3##5##(1995-2#1)(2008-7#1)(2012-12#1)
the vitamin D receptor##5##4##(1995-2#2)(2008-1#1)(2008-7#1)(2012-12#1)
the vitamin D##12##3##(1992-1#1)(1993-11#2)(1995-2#2)(2008-1#2)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
the vitamin##29##2##(1991-12#1)(1992-1#1)(1992-9#2)(1993-11#2)(1994-6#1)(1995-2#2)(1997-7#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#4)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#2)
the vitamins##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
the vitelline coat##3##3##(1993-6#2)(2008-6#1)
the vitelline envelope##2##3##(1994-5#1)(2008-12#1)
the vitelline##6##2##(1993-6#2)(1994-5#1)(2008-10#1)(2008-12#1)(2008-6#1)
the vitiligo-like depigmentation##2##3##(2010-6#2)
the vitreous and##2##3##(2008-1#1)(2011-2#1)
the viviparous##2##2##(2007-12#1)(2008-7#1)
the vocabulary intervention##2##3##(2011-2#2)
the vocabulary##6##2##(2008-7#2)(2008-9#1)(2011-2#3)
the vocal cord and##2##4##(1991-4#1)(2008-2#1)
the vocal cord##3##3##(1991-4#2)(2008-2#1)
the vocal pattern##2##3##(2008-8#2)
the vocal##9##2##(1991-4#2)(2008-11#1)(2008-2#1)(2008-8#3)(2009-9#1)(2012-2#1)
the vocalization##3##2##(2010-2#3)
the voice##5##2##(2008-2#1)(2008-9#2)(2010-8#1)(2011-1#1)
the void space##2##3##(2008-11#1)(2008-7#1)
the void volume of##2##4##(1990-12#1)(2008-10#1)
the void##5##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
the volar forearm##4##3##(2008-5#4)
the volar##10##2##(2008-10#1)(2008-5#4)(2008-9#4)(2011-2#1)
the volatile compounds##3##3##(2008-10#3)
the volatile profiles of##2##4##(2011-10#2)
the volatile##18##2##(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-8#1)(2011-10#2)(2012-3#1)
the volatiles##3##2##(2008-10#3)
the volatility matrix##2##3##(2012-12#2)
the volatility of##2##3##(1991-12#1)(2008-10#1)
the volatility##4##2##(1991-12#1)(2008-10#1)(2012-12#2)
the volcanic##2##2##(2008-2#2)
the voltage sensor in domain-2##2##5##(2008-8#2)
the voltage sensor paddle##2##4##(2010-12#2)
the voltage sensor##5##3##(2008-8#2)(2010-12#3)
the voltage##13##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#3)(2010-12#3)
the voltage-dependent Ca2+##2##3##(1992-7#1)(1995-12#1)
the voltage-dependent L-type Ca2+##3##4##(1995-12#3)
the voltage-dependent##6##2##(1992-7#1)(1995-11#1)(1995-12#4)
the voltage-gated##2##2##(2008-8#1)(2010-12#1)
the voltammetric behavior of##3##4##(2008-10#3)
the voltammetric behavior##4##3##(2008-10#4)
the voltammetric behaviour of##2##4##(2008-10#2)
the voltammetric behaviour##3##3##(2008-10#3)
the voltammetric data##2##3##(2008-10#2)
the voltammetric determination of##4##4##(2008-10#4)
the voltammetric method##3##3##(2008-10#3)
the voltammetric peak##2##3##(2008-10#2)
the voltammetric response##4##3##(2008-10#4)
the voltammetric##34##2##(2008-10#34)
the voltammograms##3##2##(2008-10#3)
the volume absorption coefficient##2##4##(2008-2#2)
the volume and##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
the volume flow##2##3##(2008-11#2)
the volume fraction of##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
the volume fraction##4##3##(2008-11#2)(2008-2#1)(2008-3#1)
the volume fractions of the##2##5##(2008-2#1)(2008-3#1)
the volume holographic##2##3##(2007-11#1)(2007-12#1)
the volume of blood##2##4##(2009-6#1)(2011-1#1)
the volume of ejaculate##2##4##(1997-8#2)
the volume of the##15##4##(1990-11#1)(1990-12#1)(1995-12#1)(1996-7#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
the volume of these##2##4##(1992-12#1)(2008-2#1)
the volume of tissue##2##4##(1991-2#1)(1996-5#1)
the volume of##51##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-8#2)(2007-10#2)(2007-12#3)(2007-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-5#1)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)
the volume ratio##2##3##(2008-10#2)
the volume regulation of human##2##5##(1990-2#2)
the volume scattering function##2##4##(2008-2#1)(2008-3#1)
the volume scattering##3##3##(2008-2#2)(2008-3#1)
the volume which is##2##4##(2007-12#1)(2008-11#1)
the volume##94##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-8#2)(2007-10#2)(2007-11#2)(2007-12#8)(2007-2#1)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#9)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)
the volumes of##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
the volumes##7##2##(1995-8#1)(2008-10#1)(2008-3#2)(2009-11#1)(2009-2#1)(2011-2#1)
the volumetric productivity##2##3##(2008-11#2)
the volumetric spatial decomposition##2##4##(2008-7#2)
the volumetric thickness profile##2##4##(2007-11#2)
the volumetric titration##2##3##(2008-10#2)
the volumetric##15##2##(2007-11#2)(2008-10#5)(2008-11#5)(2008-7#2)(2011-1#1)
the voluminous##2##2##(2008-11#1)(2008-12#1)
the voluntary##7##2##(1990-12#1)(1993-12#2)(1994-2#1)(1996-2#1)(1996-9#1)(2013-1#1)
the volunteer experience##2##3##(1992-3#1)(1994-3#1)
the volunteer##15##2##(1991-1#1)(1991-2#3)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(1996-3#2)(2008-12#1)(2008-5#1)
the volunteers were##2##3##(1996-5#1)(2008-5#1)
the volunteers##7##2##(1995-11#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-5#3)
the volunteers'##2##2##(2008-5#1)(2013-1#1)
the vomeronasal##2##2##(1992-8#1)(2008-6#1)
the von##4##2##(2007-8#1)(2008-12#1)(2008-3#1)(2010-8#1)
the vortex structure of##2##4##(2007-12#2)
the vulnerability of the##4##4##(1995-11#1)(2009-4#1)(2012-2#1)(2013-7#1)
the vulnerability of##8##3##(1990-5#1)(1995-11#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
the vulnerability to##2##3##(2008-10#1)(2013-7#1)
the vulnerability##11##2##(1990-5#1)(1995-11#1)(2008-10#1)(2008-5#1)(2009-4#2)(2012-2#1)(2013-1#2)(2013-7#2)
the vulnerable##8##2##(1996-12#1)(2007-11#1)(2008-8#2)(2012-2#3)(2013-1#1)
the vulva##15##2##(1992-3#4)(1994-1#1)(1996-12#3)(1997-7#1)(2007-12#2)(2008-10#2)(2008-7#2)
the w##3##2##(1991-5#3)
the wafer##4##2##(1992-6#2)(2007-12#1)(2008-7#1)
the wafers##2##2##(1992-6#1)(2008-3#1)
the waist##2##2##(2008-2#2)
the waist-to-hip ratio (WHR)##2##4##(2007-12#2)
the waist-to-hip ratio##3##3##(1990-9#1)(2007-12#2)
the waiting list##6##3##(1991-11#1)(1993-2#1)(1997-1#2)(2011-2#1)(2011-3#1)
the waiting time##4##3##(1991-11#2)(2008-5#1)(2012-2#1)
the waiting##16##2##(1991-11#5)(1993-2#1)(1996-2#1)(1997-1#2)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
the waiver##11##2##(1991-1#1)(1992-2#4)(1993-1#1)(1993-9#1)(1996-12#1)(1997-2#3)
the wake of##5##3##(1991-3#1)(1995-1#1)(2008-1#1)(2008-4#1)(2011-2#1)
the walking legs of a scorpion##2##6##(2007-12#2)
the walking legs##4##3##(2007-12#4)
the walking##7##2##(2007-12#7)
the wall acceleration##2##3##(2009-6#2)
the wall of the##9##4##(1990-11#1)(1993-9#1)(1997-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
the wall of##11##3##(1990-11#1)(1993-9#1)(1997-2#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
the wall shear##2##3##(2008-11#2)
the wall surface##2##3##(2008-10#1)(2008-7#1)
the wall##39##2##(1990-11#1)(1990-9#1)(1993-9#1)(1997-2#1)(1997-3#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#4)(2009-1#1)(2009-11#2)(2009-6#6)(2009-7#1)(2011-2#1)(2012-2#2)
the walls of all##2##4##(2007-12#2)
the walls of the##8##4##(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-1#1)
the walls of##15##3##(1996-5#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-9#1)(2011-1#1)
the walls##22##2##(1994-3#1)(1996-5#2)(2007-10#1)(2007-12#4)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#2)(2009-11#1)(2011-1#1)
the war##8##2##(1990-6#2)(2008-10#2)(2008-6#1)(2009-7#1)(2013-1#2)
the ward and##3##3##(2008-11#2)(2012-2#1)
the ward##6##2##(2007-11#1)(2008-11#2)(2010-8#2)(2012-2#1)
the wards##13##2##(2010-3#7)(2010-8#1)(2013-1#4)(2013-8#1)
the warfarin##2##2##(2011-1#1)(2012-12#1)
the warm##3##2##(1995-3#1)(2008-10#1)(2008-9#1)
the warning##3##2##(1995-5#1)(2012-3#1)(2013-8#1)
the washed water##2##3##(2008-10#2)
the washing of##2##3##(1993-3#1)(2008-7#1)
the washing##3##2##(1993-3#1)(1997-2#1)(2008-7#1)
the washout##2##2##(2008-11#1)(2008-7#1)
the waste##6##2##(1997-2#1)(2008-10#3)(2008-12#1)(2010-8#1)
the wastewater##6##2##(2008-10#4)(2013-1#2)
the water activity##2##3##(2008-7#2)
the water barrier##3##3##(2008-5#3)
the water body##2##3##(2008-2#1)(2008-3#1)
the water column##8##3##(2007-5#1)(2008-2#3)(2008-3#2)(2008-8#1)(2012-2#1)
the water content in the##3##5##(2008-10#2)(2008-5#1)
the water content is##2##4##(2008-10#2)
the water content of the stratum corneum##2##7##(2008-5#2)
the water content of the##4##5##(2008-10#1)(2008-3#1)(2008-5#2)
the water content of##5##4##(2008-10#1)(2008-3#1)(2008-5#3)
the water content##17##3##(2008-10#11)(2008-3#2)(2008-5#4)
the water extract##2##3##(2008-10#1)(2008-5#1)
the water extracts of propolis##2##5##(2008-11#2)
the water extracts of##3##4##(2008-10#1)(2008-11#2)
the water flow##2##3##(2008-11#1)(2013-1#1)
the water fraction##3##3##(2007-5#1)(2008-10#2)
the water from##2##3##(2008-10#1)(2011-2#1)
the water maze task##3##4##(1994-3#1)(1997-2#1)(2008-4#1)
the water maze##9##3##(1993-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-3#1)
the water molecules##3##3##(1992-9#1)(1995-5#1)(2008-10#1)
the water phase##2##3##(1991-5#1)(1993-11#1)
the water quality of##3##4##(2008-10#2)(2013-8#1)
the water quality##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
the water rat##3##3##(2008-5#3)
the water resistance of##2##4##(2008-5#2)
the water sample and##2##4##(2008-10#2)
the water sample##5##3##(2008-10#5)
the water samples##7##3##(2008-10#6)(2013-8#1)
the water surface tension (gamma(H(2)O))##2##5##(2008-5#2)
the water surface##5##3##(1990-11#1)(2008-10#2)(2008-5#2)
the water to##2##3##(1994-12#1)(2008-10#1)
the water used##2##3##(2008-10#1)(2012-3#1)
the water vapor##2##3##(1991-5#1)(2008-3#1)
the water was##2##3##(1992-11#1)(2008-10#1)
the water##155##2##(1990-11#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-5#4)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-3#1)(1995-5#2)(1996-6#1)(1997-2#2)(1997-6#1)(2007-12#1)(2007-5#2)(2008-10#50)(2008-11#7)(2008-2#8)(2008-3#17)(2008-4#1)(2008-5#20)(2008-7#2)(2008-8#3)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
the water-immersion##2##2##(2008-3#2)
the water-leaving radiance##3##3##(2008-3#3)
the water-leaving##5##2##(2008-2#1)(2008-3#4)
the water-miscible##2##2##(2008-10#2)
the water-oxidation complex##2##3##(1990-5#2)
the water-soluble fraction##5##3##(1991-9#1)(2008-11#4)
the water-soluble##9##2##(1991-9#1)(1992-2#1)(2008-10#1)(2008-11#4)(2008-5#2)
the water-vapor mixing ratio##4##4##(2008-3#4)
the water-vapor##7##2##(2008-3#7)
the water-window##2##2##(2007-12#1)(2008-3#1)
the wave aberration##3##3##(2007-12#2)(2008-2#1)
the wave front under test##2##5##(2008-3#2)
the wave front under##4##4##(2008-3#4)
the wave front##15##3##(2007-12#1)(2008-2#2)(2008-3#12)
the wave fronts##8##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#2)
the wave propagation##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
the wave##42##2##(1991-5#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#7)(2008-3#21)(2008-7#1)
the wave-front aberrations##2##3##(2007-11#1)(2008-3#1)
the wave-front distortion##2##3##(2007-12#1)(2008-2#1)
the wave-front phase##2##3##(2008-3#2)
the wave-front quality##2##3##(2008-3#2)
the wave-front shape##3##3##(2008-2#1)(2008-3#2)
the wave-front##25##2##(2007-11#5)(2007-12#1)(2008-2#6)(2008-3#13)
the wave-number##2##2##(2008-2#1)(2008-3#1)
the waveform##2##2##(1994-2#1)(2008-10#1)
the waveguide at##2##3##(2007-11#1)(2008-3#1)
the waveguide birefringence##2##3##(2008-2#2)
the waveguide can be##2##4##(2008-3#2)
the waveguide can##3##3##(2007-12#1)(2008-3#2)
the waveguide is##3##3##(2007-12#1)(2008-3#2)
the waveguide structure##2##3##(2007-11#1)(2007-12#1)
the waveguide surface##6##3##(2008-10#3)(2008-3#3)
the waveguide was##2##3##(2007-11#2)
the waveguide##55##2##(1992-3#1)(2007-11#7)(2007-12#8)(2007-9#1)(2008-10#5)(2008-2#10)(2008-3#23)
the waveguides##9##2##(2007-11#1)(2008-2#4)(2008-3#2)(2013-8#2)
the waveguiding properties##2##3##(2008-2#2)
the waveguiding##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
the wavelength and##4##3##(2007-11#2)(2008-3#2)
the wavelength at##2##3##(2008-3#2)
the wavelength dependence of the##6##5##(2007-11#1)(2008-2#2)(2008-3#3)
the wavelength dependence of##7##4##(2007-11#1)(2008-2#3)(2008-3#3)
the wavelength in##2##3##(2008-2#1)(2008-3#1)
the wavelength interval##3##3##(2008-10#1)(2008-3#2)
the wavelength is##2##3##(2008-3#2)
the wavelength of a##2##4##(2008-3#2)
the wavelength of light##3##4##(2007-11#1)(2008-3#2)
the wavelength of the incident beam##2##6##(2007-11#1)(2007-12#1)
the wavelength of the incident##5##5##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
the wavelength of the laser##3##5##(2008-2#2)(2008-3#1)
the wavelength of the light##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the wavelength of the radiation##2##5##(2006-4#1)(2008-3#1)
the wavelength of the##24##4##(1995-5#1)(2006-4#1)(2007-11#6)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#8)
the wavelength of##41##3##(1995-5#1)(2006-4#1)(2007-11#8)(2007-12#6)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#14)
the wavelength range 0##2##4##(2007-11#1)(2008-3#1)
the wavelength range from##6##4##(2007-11#1)(2008-2#4)(2008-5#1)
the wavelength range of##6##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
the wavelength range##39##3##(2007-11#9)(2007-12#1)(2008-10#3)(2008-2#13)(2008-3#12)(2008-5#1)
the wavelength to be##2##4##(2007-12#1)(2008-3#1)
the wavelength was##3##3##(2007-11#1)(2008-10#2)
the wavelength##151##2##(1995-5#1)(2006-4#2)(2007-11#28)(2007-12#12)(2008-10#18)(2008-11#1)(2008-2#27)(2008-3#61)(2008-5#1)
the wavelength-dependent##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
the wavelengths corresponding to##2##4##(2008-10#1)(2008-3#1)
the wavelengths of##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
the wavelengths##14##2##(1990-2#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#4)(2012-2#1)
the wavelet##6##2##(2007-11#1)(2008-10#3)(2008-3#2)
the wavelet-packet noise-reduction process##2##4##(2008-3#2)
the wavenumber##4##2##(2008-1#1)(2008-10#2)(2009-5#1)
the wax matrix in##2##4##(2008-5#2)
the wax matrix was##3##4##(2008-5#3)
the wax matrix##9##3##(2008-5#9)
the way for a##4##4##(1992-1#1)(1995-3#1)(1995-4#1)(2011-1#1)
the way for the##4##4##(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
the way for##18##3##(1992-1#1)(1992-8#1)(1995-3#1)(1995-4#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-1#4)(2011-2#1)(2012-2#1)
the way forward##2##3##(2009-10#1)(2012-12#1)
the way in which the##6##5##(1992-1#1)(1993-8#1)(1997-7#1)(2008-11#2)(2008-5#1)
the way in which they##3##5##(1997-4#1)(2011-2#1)(2012-2#1)
the way in which we##2##5##(2008-7#1)(2008-8#1)
the way in which##26##4##(1992-1#1)(1993-2#1)(1993-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-5#2)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#2)
the way in##29##3##(1992-1#1)(1993-2#1)(1993-8#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-5#1)(2011-2#3)(2012-2#2)
the way it is##2##4##(1992-3#1)(2009-10#1)
the way it##3##3##(1992-12#1)(1992-3#1)(2009-10#1)
the way of##10##3##(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-5#1)(2013-8#1)
the way that health care##2##5##(1996-2#1)(1997-5#1)
the way that##9##3##(1991-1#1)(1996-2#1)(1997-5#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-5#1)(2012-12#1)
the way the##10##3##(1997-4#1)(2006-10#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-6#1)(2010-11#1)
the way they##11##3##(1994-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-8#1)
the way to a##4##4##(1991-1#1)(1996-1#1)(2007-11#1)(2008-7#1)
the way to the##2##4##(2010-7#1)(2011-1#1)
the way to##17##3##(1990-6#1)(1991-1#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
the way toward##2##3##(1992-12#1)(2008-8#1)
the way we##5##3##(2008-12#1)(2009-8#1)(2011-2#2)(2013-7#1)
the way?##2##2##(2011-1#1)(2012-2#1)
the ways in which it can be##2##7##(2008-8#1)(2012-3#1)
the ways in which the##2##5##(1995-3#1)(2009-5#1)
the ways in which##15##4##(1991-3#1)(1992-12#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
the ways that##2##3##(2007-4#1)(2010-12#1)
the ways to##2##3##(2008-5#1)(2008-8#1)
the ways##28##2##(1991-3#1)(1992-11#1)(1992-12#1)(1995-3#1)(1997-2#1)(2007-4#2)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
the weak RLS of##2##4##(2008-10#2)
the weak coupling##2##3##(2007-11#1)(2008-3#1)
the weak signal##3##3##(2008-10#3)
the weak##39##2##(1990-12#1)(1992-6#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#15)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2013-1#1)(2013-8#1)
the weak-scattering##2##2##(2007-11#1)(2007-12#1)
the weakened##2##2##(1995-9#1)(2008-10#1)
the weaker##9##2##(1991-6#1)(1994-6#1)(1995-5#1)(1995-6#1)(2007-10#1)(2007-9#1)(2012-12#1)(2012-3#2)
the weakest##9##2##(1995-12#1)(1996-2#1)(2007-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-3#2)
the weakly emetic strain IH41385##2##5##(2011-2#2)
the weakly##8##2##(1992-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#2)
the weakness##2##2##(2008-12#1)(2012-12#1)
the weaknesses of##3##3##(1997-3#1)(2011-1#1)(2011-2#1)
the wealth of##5##3##(1993-1#1)(2006-10#1)(2007-12#1)(2009-5#1)(2011-10#1)
the wear##3##2##(2007-8#1)(2008-5#1)(2009-7#1)
the wearer's##2##2##(2010-8#2)
the weather##4##2##(1992-3#1)(2008-10#2)(2008-3#1)
the web##6##2##(2008-12#1)(2008-7#4)(2008-9#1)
the wedge angle##2##3##(2008-2#2)
the wedge##6##2##(2008-2#4)(2008-3#2)
the wee1+##2##2##(1991-2#1)(1994-12#1)
the weed##6##2##(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
the weeds##2##2##(2008-10#1)(2008-12#1)
the week following##2##3##(1990-12#1)(1996-8#1)
the week of##3##3##(1995-6#2)(1996-5#1)
the week##10##2##(1990-12#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-8#1)(2009-11#2)(2011-1#1)(2013-8#1)
the weekend##3##2##(1994-3#3)
the weekly##4##2##(2008-11#1)(2013-1#3)
the weevil##3##2##(2008-10#3)
the weighing##2##2##(2008-10#1)(2008-7#1)
the weight and##3##3##(1996-8#1)(2008-5#1)(2012-3#1)
the weight concentration##2##3##(1996-3#2)
the weight factors##2##3##(2008-3#2)
the weight loss##2##3##(2008-6#1)(2012-2#1)
the weight of a##3##4##(1996-8#2)(2010-9#1)
the weight of the##11##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-1#1)(2012-12#4)(2013-1#1)
the weight of##21##3##(1991-12#1)(1996-8#2)(1997-1#1)(2008-10#4)(2008-11#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-9#1)(2010-9#2)(2012-12#4)(2013-1#1)
the weight##43##2##(1991-12#1)(1991-2#1)(1993-2#1)(1996-3#2)(1996-8#3)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-9#1)(2010-7#1)(2010-9#2)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
the weighted average##3##3##(1992-12#1)(2011-2#1)(2013-8#1)
the weighted mean of##2##4##(2008-10#2)
the weighted mean##3##3##(2008-10#2)(2011-2#1)
the weighted##15##2##(1992-12#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#2)(2012-1#2)(2013-8#1)
the weighting##2##2##(2008-3#1)(2010-8#1)
the weights of##3##3##(1994-8#1)(1996-12#1)(2008-3#1)
the weights##9##2##(1992-12#1)(1993-1#1)(1994-8#1)(1996-12#1)(2007-11#2)(2008-2#1)(2008-3#1)(2010-8#1)
the welfare of##2##3##(2008-10#1)(2013-1#1)
the welfare##6##2##(1996-8#3)(2008-10#1)(2011-1#1)(2013-1#1)
the well documented##2##3##(1992-12#1)(1995-12#1)
the well known##5##3##(1991-2#1)(1992-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
the well##22##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-12#2)(2008-10#2)(2008-11#6)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
the well-being of##7##3##(1992-3#2)(1995-12#1)(2007-2#1)(2010-11#1)(2010-5#1)(2011-2#1)
the well-differentiated##2##2##(1990-3#1)(1992-2#1)
the well-documented##2##2##(1996-1#1)(2009-7#1)
the well-established##4##2##(2008-10#3)(2008-2#1)
the well-known endemic##2##3##(1996-11#2)
the well-known##39##2##(1991-8#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-11#2)(1997-7#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-12#1)(2013-1#1)
the well-proven##2##2##(1990-10#1)(1997-6#1)
the well-studied##2##2##(2008-9#1)(2010-2#1)
the west coast of the##2##5##(2010-8#2)
the west coast of##3##4##(2009-12#1)(2010-8#2)
the west of##4##3##(1996-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
the west##14##2##(1995-10#1)(1996-11#1)(1997-3#1)(2007-5#2)(2008-10#3)(2009-12#1)(2010-8#3)(2012-12#1)(2013-8#1)
the western Atlantic##2##3##(1992-8#1)(2008-5#1)
the western North Atlantic##2##4##(2008-2#1)(2008-3#1)
the western flower thrips (Frankliniella occidentalis)##2##6##(2008-10#1)(2009-8#1)
the western flower thrips##4##4##(2008-10#2)(2009-8#1)(2011-2#1)
the western world##6##3##(1990-2#1)(1996-2#1)(2008-1#2)(2008-11#1)(2008-2#1)
the western##32##2##(1990-2#1)(1991-12#1)(1992-8#1)(1994-8#1)(1996-2#1)(1997-7#1)(2007-5#1)(2008-1#5)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
the wet period##3##3##(2008-10#2)(2008-5#1)
the wet season##7##3##(2007-5#5)(2008-5#2)
the wet##16##2##(1997-2#1)(2007-5#5)(2008-10#5)(2008-5#4)(2010-8#1)
the wetting##8##2##(2008-10#3)(2008-5#2)(2009-11#1)(2010-4#1)(2012-2#1)
the wheat chromosomes##2##3##(2008-5#1)(2008-8#1)
the wheat cv##2##3##(2008-10#2)
the wheat germ##2##3##(2008-10#2)
the wheat leaf##2##3##(2008-10#2)
the wheat rhizosphere##6##3##(2008-10#6)
the wheat##33##2##(1991-12#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-7#1)
the wheelchair##4##2##(2009-3#1)(2013-1#3)
the whispering-gallery modes of a##2##5##(2007-11#1)(2007-12#1)
the whispering-gallery modes of##3##4##(2007-11#2)(2007-12#1)
the whispering-gallery modes##5##3##(2007-11#3)(2007-12#2)
the whispering-gallery##6##2##(2007-11#3)(2007-12#2)(2011-1#1)
the white cloud mountain minnow##2##5##(2010-5#2)
the white matter and##2##4##(1991-12#1)(1995-5#1)
the white matter of the##2##5##(2008-6#1)(2011-1#1)
the white matter##16##3##(1990-5#1)(1991-12#2)(1995-12#1)(1995-5#2)(1996-11#2)(2008-11#1)(2008-6#1)(2010-12#3)(2010-9#1)(2011-1#1)(2012-12#1)
the white pine blister rust##3##5##(2008-10#3)
the white pine##4##3##(2008-10#4)
the white rot##2##3##(2008-6#1)(2009-9#1)
the white##37##2##(1990-5#1)(1991-12#2)(1992-8#1)(1994-3#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-11#2)(1997-5#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-12#3)(2010-5#2)(2010-9#1)(2011-1#2)(2012-12#2)(2013-7#1)
the whitefly Bemisia tabaci##3##4##(2008-10#2)(2011-2#1)
the whitefly##6##2##(2008-10#5)(2011-2#1)
the whitening##4##2##(2008-3#1)(2008-5#2)(2011-2#1)
the whole analysis##2##3##(2008-10#2)
the whole analytical procedure##3##4##(2008-10#3)
the whole analytical##4##3##(2008-10#4)
the whole analyzed group##2##4##(2011-2#2)
the whole animal##2##3##(1991-9#1)(2008-7#1)
the whole blood##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
the whole body##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
the whole cell##3##3##(1993-12#1)(1993-3#1)(2008-11#1)
the whole coding##2##3##(1997-4#1)(2008-8#1)
the whole country##4##3##(1992-2#2)(2007-8#1)(2008-10#1)
the whole experiment##3##3##(1995-5#1)(2008-5#1)(2012-2#1)
the whole family##2##3##(1997-4#1)(2008-10#1)
the whole field##3##3##(2008-3#2)(2011-2#1)
the whole genome##7##3##(2008-10#1)(2008-7#4)(2010-3#1)(2012-3#1)
the whole group of##2##4##(1990-6#1)(2007-11#1)
the whole group##11##3##(1990-6#1)(1993-12#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#2)(2010-3#2)(2012-12#1)
the whole image##3##3##(2008-3#1)(2010-8#2)
the whole length of##2##4##(2007-12#1)(2008-10#1)
the whole life##2##3##(1994-6#1)(2010-8#1)
the whole method##3##3##(2008-10#2)(2008-11#1)
the whole molecule##3##3##(1990-8#1)(1991-9#1)(1997-8#1)
the whole object##2##3##(2008-2#1)(2008-3#1)
the whole of##3##3##(2007-5#1)(2008-10#2)
the whole organism##3##3##(2008-2#1)(2008-7#1)(2010-9#1)
the whole period of##3##4##(1992-5#1)(2007-8#1)(2008-8#1)
the whole period##4##3##(1992-5#1)(2007-8#1)(2008-2#1)(2008-8#1)
the whole plant##3##3##(2008-10#3)
the whole population##7##3##(1992-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
the whole procedure##6##3##(2008-10#4)(2008-11#1)(2011-2#1)
the whole process of##6##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
the whole process##7##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
the whole processes##2##3##(1994-3#1)(2008-11#1)
the whole region##3##3##(1994-3#1)(1997-7#1)(2007-10#1)
the whole series of##3##4##(1992-10#1)(2007-8#1)(2009-7#1)
the whole set of##3##4##(2008-10#2)(2008-3#1)
the whole set##4##3##(2008-10#2)(2008-3#1)(2010-2#1)
the whole spectral range##2##4##(2007-11#1)(2007-12#1)
the whole spectrum of##2##4##(2008-10#1)(2008-5#1)
the whole study##2##3##(2007-7#1)(2008-8#1)
the whole system##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the whole working##2##3##(2008-10#1)(2013-8#1)
the whole world##2##3##(2008-10#1)(2011-2#1)
the whole##274##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#3)(1993-1#1)(1993-12#4)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#62)(2008-11#7)(2008-12#1)(2008-2#11)(2008-3#16)(2008-4#3)(2008-5#7)(2008-7#10)(2008-8#7)(2008-9#4)(2009-10#2)(2009-11#2)(2009-4#3)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#4)(2013-8#6)
the whole-cell configuration##2##3##(1993-3#1)(1995-5#1)
the whole-cell##9##2##(1992-11#1)(1993-3#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-8#2)(2009-12#1)(2011-3#1)
the whole-mount preparation##2##3##(2008-8#2)
the wide &quot##2##3##(1993-3#2)
the wide pH range##3##4##(2008-10#3)
the wide range of applications##2##5##(2008-10#1)(2008-7#1)
the wide range of##11##4##(1990-2#1)(1991-11#1)(1992-3#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-7#1)(2013-1#1)
the wide range##15##3##(1990-2#1)(1991-11#1)(1992-3#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-7#1)(2013-1#1)
the wide spectrum of##3##4##(1990-6#1)(1991-2#1)(2008-8#1)
the wide use of##2##4##(2007-8#1)(2008-2#1)
the wide variety of##5##4##(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
the wide##58##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#2)(1993-3#2)(1994-3#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
the wide-angle airborne laser ranging system##2##6##(2008-3#2)
the wide-spread##3##2##(1992-6#1)(2009-4#1)(2013-8#1)
the widely assumed##2##3##(1990-6#1)(2013-1#1)
the widely used##14##3##(1994-1#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
the widely##25##2##(1990-6#1)(1992-8#1)(1994-1#1)(1995-2#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
the wider church##2##3##(2010-2#2)
the wider community##3##3##(2010-4#1)(2011-2#1)(2012-3#1)
the wider impacts of##2##4##(2011-1#2)
the wider##23##2##(1994-8#1)(1995-5#1)(1996-11#1)(2007-5#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
the widespread distribution of##4##4##(2008-10#1)(2008-11#1)(2008-4#2)
the widespread occurrence##2##3##(2008-10#1)(2008-9#1)
the widespread presence of##2##4##(1994-8#1)(2008-7#1)
the widespread use of##10##4##(1993-12#1)(1997-8#1)(2008-10#2)(2008-7#3)(2011-1#2)(2012-2#1)
the widespread use##11##3##(1993-12#1)(1997-8#1)(2008-10#2)(2008-7#3)(2011-1#2)(2012-12#1)(2012-2#1)
the widespread##34##2##(1990-7#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#5)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
the widest##7##2##(1992-2#1)(1992-8#1)(1995-5#1)(2008-10#2)(2008-5#1)(2009-11#1)
the width of the 95%##2##5##(2008-10#2)
the width of the##26##4##(1993-12#1)(1993-9#1)(1997-3#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#8)(2008-5#1)(2011-2#1)(2013-8#1)
the width of##30##3##(1993-12#1)(1993-9#1)(1994-9#1)(1997-3#1)(2007-11#4)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#9)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
the width##36##2##(1993-12#1)(1993-9#1)(1994-9#1)(1997-3#1)(2007-11#5)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#11)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
the wild cell##2##3##(2008-8#2)
the wild strain##2##3##(1997-2#1)(2008-10#1)
the wild type and the##2##5##(2008-10#1)(2008-8#1)
the wild type and##5##4##(2008-10#2)(2008-11#1)(2008-8#2)
the wild type in##2##4##(2008-10#2)
the wild type protein##3##4##(1992-8#1)(2008-11#2)
the wild type strain IRC-3##2##5##(2008-8#2)
the wild type strain##4##4##(1991-2#1)(2008-8#2)(2008-9#1)
the wild type under##2##4##(2008-10#1)(2010-10#1)
the wild type was##3##4##(1990-5#1)(2008-10#2)
the wild type##49##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1992-6#1)(1992-8#1)(1993-11#3)(1993-3#3)(1993-8#1)(1995-5#1)(1997-2#1)(1997-7#1)(1997-8#2)(2008-10#17)(2008-11#3)(2008-8#6)(2008-9#1)(2009-6#1)(2010-10#1)(2013-8#1)
the wild##70##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1992-6#1)(1992-8#1)(1993-11#3)(1993-3#3)(1993-8#1)(1995-5#1)(1997-2#2)(1997-7#1)(1997-8#2)(2008-10#24)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#9)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#3)(2010-5#1)(2012-3#1)(2013-8#1)
the wild-type A##2##3##(2008-10#2)
the wild-type Kulm##2##3##(2008-10#2)
the wild-type LCAT##2##3##(1993-8#2)
the wild-type and mutant##3##4##(1992-8#1)(2008-10#2)
the wild-type and##11##3##(1992-8#1)(1994-12#1)(1995-2#2)(1996-10#1)(1997-3#1)(2008-10#2)(2008-8#3)
the wild-type enzyme##29##3##(1990-10#4)(1990-8#3)(1991-5#1)(1992-6#4)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#4)(1995-6#6)(2008-4#2)
the wild-type isolate##4##3##(2008-10#4)
the wild-type level##3##3##(1995-2#2)(2009-6#1)
the wild-type protein##4##3##(1994-5#1)(1994-6#1)(2011-1#1)(2011-2#1)
the wild-type sequence##2##3##(1991-9#1)(1997-3#1)
the wild-type strain on soybean and##2##6##(2008-10#2)
the wild-type strain on##3##4##(2008-10#3)
the wild-type strain##20##3##(2008-10#16)(2008-6#1)(2008-7#2)(2009-6#1)
the wild-type strains##2##3##(2008-10#2)
the wild-type virus##3##3##(2008-10#3)
the wild-type##131##2##(1990-10#4)(1990-5#2)(1990-8#3)(1991-10#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-9#2)(1992-4#1)(1992-6#7)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#5)(1994-6#2)(1994-8#2)(1995-12#1)(1995-2#13)(1995-5#3)(1995-6#6)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#2)(2008-10#37)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#4)(2011-1#1)(2011-2#1)(2012-2#2)
the wildtype##3##2##(2008-7#2)(2012-2#1)
the will to##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
the will##4##2##(2008-11#1)(2008-4#1)(2009-11#1)(2011-2#1)
the willingness of##5##3##(1996-2#1)(2007-10#2)(2007-7#1)(2008-1#1)
the wilt##2##2##(2008-10#2)
the wilt-resistant one##2##3##(2008-10#2)
the wilt-susceptible##2##2##(2008-10#2)
the wind##13##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#2)
the window of##4##3##(2008-10#2)(2008-5#1)(2010-5#1)
the window##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
the windows of##2##3##(2008-3#1)(2013-1#1)
the windows##4##2##(2008-3#2)(2008-6#1)(2013-1#1)
the winds##2##2##(1992-3#1)(2008-2#1)
the wine samples##2##3##(2008-10#2)
the wine##9##2##(2008-10#9)
the wing##4##2##(2007-12#2)(2009-4#1)(2009-5#1)
the wings of the##2##4##(2008-3#2)
the wings##6##2##(1990-9#1)(1991-12#1)(2008-3#3)(2013-8#1)
the winter and spring##2##4##(2008-10#1)(2008-11#1)
the winter and##4##3##(1995-11#1)(2008-10#2)(2008-11#1)
the winter of##5##3##(1996-9#1)(2007-6#1)(2008-2#1)(2008-5#1)(2010-8#1)
the winter skate##2##3##(2009-4#1)(2010-8#1)
the winter wheat##2##3##(2008-10#2)
the winter##38##2##(1991-8#1)(1995-11#3)(1995-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#4)(2008-8#1)(2009-11#1)(2009-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#3)
the winters##2##2##(2008-9#1)(2010-8#1)
the wire closure##2##3##(2007-8#2)
the wire nut technique resulted in significantly higher number of##2##10##(2011-2#2)
the wire nut technique##4##4##(2011-2#4)
the wire##11##2##(2007-8#3)(2008-3#1)(2011-2#4)(2012-1#3)
the wireless link##2##3##(2010-10#2)
the wireless##6##2##(2010-10#2)(2010-2#1)(2010-8#3)
the wish##2##2##(1991-11#1)(2013-1#1)
the wishes of the patient##2##5##(1990-11#1)(1991-2#1)
the wishes of##3##3##(1990-11#1)(1991-2#1)(1993-3#1)
the witches'-broom##2##2##(2008-10#2)
the withdrawal of the##2##4##(1992-6#1)(1997-6#1)
the withdrawal of##6##3##(1992-6#1)(1996-2#2)(1997-6#1)(2008-11#1)(2008-5#1)
the withdrawal##11##2##(1991-12#3)(1992-6#1)(1996-2#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
the within day##2##3##(2008-10#1)(2010-12#1)
the within##3##2##(1993-5#1)(2008-10#1)(2010-12#1)
the within- and##2##3##(2008-8#2)
the woman##8##2##(1991-6#2)(1993-3#1)(1993-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(2013-1#1)
the woman's##2##2##(2008-1#1)(2009-5#1)
the women and##2##3##(2008-12#1)(2010-3#1)
the women were##8##3##(1991-6#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-8#2)
the women who##2##3##(2007-2#1)(2011-2#1)
the women##41##2##(1990-8#2)(1991-2#1)(1991-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-6#2)(1997-2#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-5#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-3#3)(2011-1#3)(2011-2#3)(2013-1#2)(2013-8#2)
the women's experience of##2##4##(1996-1#1)(2008-1#1)
the women's##13##2##(1991-4#1)(1994-3#2)(1995-8#1)(1996-1#2)(1996-3#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-12#1)(2012-12#1)
the wood surface##2##3##(2010-4#2)
the wood##11##2##(2008-10#1)(2008-3#2)(2009-8#2)(2010-4#2)(2013-8#4)
the wooden##2##2##(2008-10#1)(2013-1#1)
the wool##3##2##(2008-10#3)
the word &quot##2##3##(2007-10#1)(2008-1#1)
the word type##2##3##(2009-11#2)
the word##22##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-5#2)(2007-10#1)(2007-12#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-5#3)(2009-11#2)(2009-12#1)(2012-2#1)(2013-8#2)
the words##2##2##(1994-1#1)(2008-2#1)
the work done##2##3##(2008-9#1)(2009-11#1)
the work environment and##3##4##(2012-12#2)(2012-3#1)
the work environment##4##3##(1997-3#1)(2012-12#2)(2012-3#1)
the work force by the##2##5##(1997-2#2)
the work force to##2##4##(1992-12#1)(2007-12#1)
the work force##6##3##(1992-12#2)(1995-2#1)(1997-2#2)(2007-12#1)
the work of other##2##4##(1995-2#1)(2007-11#1)
the work of the##6##4##(1997-3#1)(2008-10#1)(2008-11#3)(2009-11#1)
the work of##41##3##(1991-6#1)(1992-11#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
the work place##5##3##(1993-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2009-12#1)
the work process##2##3##(1991-6#1)(2008-9#1)
the work related##2##3##(2008-11#1)(2008-12#1)
the work reported here##4##4##(1991-5#1)(1995-8#1)(2008-5#1)(2011-2#1)
the work shows##2##3##(2008-10#1)(2008-5#1)
the work was##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
the work without overstepping the mark'##2##6##(2007-10#2)
the work##116##2##(1991-12#2)(1991-5#1)(1991-6#2)(1992-11#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-8#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)
the work-related##3##2##(2008-7#2)(2010-5#1)
the work-up of##3##3##(2006-10#1)(2008-6#1)(2013-1#1)
the work-up##4##2##(2006-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
the workers##9##2##(1995-3#1)(1996-3#2)(2007-8#1)(2008-1#1)(2009-12#1)(2012-12#1)(2013-1#2)
the workers'##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
the workflow##2##2##(2008-3#1)(2008-9#1)
the workforce##13##2##(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#3)(2012-12#6)(2012-2#1)
the workhorse##3##2##(2011-2#1)(2012-2#2)
the working alliance##2##3##(2008-4#2)
the working calibration curve##2##4##(2008-10#2)
the working calibration##4##3##(2008-10#4)
the working conditions##2##3##(2008-10#1)(2008-6#1)
the working electrode and the##2##5##(2008-10#2)
the working electrode in the##2##5##(2008-10#2)
the working electrode is##2##4##(2008-10#2)
the working electrode surface##2##4##(2008-10#2)
the working electrode##21##3##(2008-10#21)
the working electrodes##2##3##(2008-10#2)
the working environment##3##3##(1995-2#1)(1995-8#1)(2008-6#1)
the working group##2##3##(1993-2#1)(2008-5#1)
the working of the##4##4##(2008-10#2)(2008-3#1)(2012-2#1)
the working of##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
the working potentials##2##3##(2008-10#2)
the working range of the##3##5##(2008-10#2)(2008-3#1)
the working range of##4##4##(2008-10#3)(2008-3#1)
the working range##8##3##(2008-10#7)(2008-3#1)
the working##75##2##(1991-3#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-10#44)(2008-11#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the workload##2##2##(1995-2#1)(2008-10#1)
the workplace and##3##3##(2007-2#1)(2008-11#1)(2012-12#1)
the workplace setting##2##3##(2008-11#1)(2008-12#1)
the workplace##42##2##(1991-12#2)(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#2)(1997-4#1)(2007-2#1)(2008-10#2)(2008-11#7)(2008-12#3)(2008-6#2)(2008-9#4)(2009-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#3)
the works of##4##3##(2007-8#1)(2008-12#1)(2009-10#1)(2009-7#1)
the workshop model##2##3##(1992-5#2)
the workshop on##4##3##(1992-1#1)(2008-10#3)
the workshop##19##2##(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#3)(1996-2#1)(1996-4#1)(2008-10#4)(2008-11#2)(2011-2#1)(2012-2#1)(2013-8#3)
the workshops##9##2##(2008-12#6)(2008-5#1)(2011-2#2)
the workup##2##2##(2008-11#1)(2008-3#1)
the world and are##2##4##(2009-5#1)(2010-5#1)
the world and##12##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#3)(2010-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
the world are##5##3##(1996-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-1#1)
the world as##2##3##(2007-8#1)(2011-2#1)
the world by the year##2##5##(1994-9#2)
the world fleet##2##3##(2008-11#2)
the world in which##2##4##(2008-11#1)(2011-2#1)
the world in##10##3##(1996-7#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)
the world including##2##3##(2008-12#1)(2011-2#1)
the world is##5##3##(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
the world literature##2##3##(1992-2#1)(2008-6#1)
the world of##15##3##(1993-1#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-12#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
the world over##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
the world with##3##3##(2007-7#1)(2008-7#1)(2010-4#1)
the world##262##2##(1990-11#1)(1990-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-1#2)(1994-2#3)(1994-3#1)(1994-9#6)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(2006-10#1)(2006-12#2)(2007-10#5)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#9)(2008-10#40)(2008-11#16)(2008-12#9)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#18)(2012-12#4)(2012-2#5)(2012-3#4)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#7)
the world's largest##3##3##(2007-5#1)(2008-5#1)(2009-4#1)
the world's leading##2##3##(1995-2#1)(2011-2#1)
the world's most##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
the world's population##6##3##(1994-9#1)(2008-3#1)(2008-5#2)(2009-10#1)(2013-7#1)
the world's##29##2##(1990-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
the world)##3##2##(1990-6#1)(2011-3#2)
the world]##3##2##(1993-8#1)(2008-10#1)(2008-8#1)
the worldwide##12##2##(1993-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
the worsening##2##2##(2007-11#1)(2013-1#1)
the worst case##2##3##(2007-7#1)(2008-3#1)
the worst images##2##3##(2007-11#2)
the worst of times##2##4##(1991-6#1)(2008-11#1)
the worst prognosis##2##3##(1995-8#1)(1996-9#1)
the worst##23##2##(1990-6#1)(1991-4#1)(1991-6#1)(1993-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#2)(2013-8#1)
the worst-case##2##2##(2008-1#1)(2008-3#1)
the wound area##2##3##(2008-10#1)(2008-11#1)
the wound healing##2##3##(2008-11#1)(2009-12#1)
the wound site##6##3##(2008-10#4)(2008-9#1)(2012-3#1)
the wound was##2##3##(1991-6#1)(2008-11#1)
the wound##27##2##(1990-2#1)(1991-3#1)(1991-6#2)(1996-9#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
the wound-healing##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
the wound-inducible##2##2##(2008-10#1)(2008-9#1)
the wounded##2##2##(2008-10#1)(2009-7#1)
the wounding of##2##3##(2008-10#1)(2008-7#1)
the wounding##3##2##(2008-10#1)(2008-7#2)
the wounds##3##2##(1992-6#1)(2007-8#1)(2008-10#1)
the wr##2##2##(1996-12#2)
the wrapped phase gradient##2##4##(2008-2#1)(2008-3#1)
the wrapped phase##3##3##(2008-2#2)(2008-3#1)
the wrapped##5##2##(2008-2#4)(2008-3#1)
the wrist is##2##3##(2008-1#1)(2008-9#1)
the wrist##13##2##(2007-7#1)(2008-1#4)(2008-12#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-3#1)
the write##3##2##(2008-2#1)(2008-3#2)
the writer##2##2##(1995-2#1)(2008-6#1)
the writing beams##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the writing of this article##2##5##(1991-1#1)(2008-4#1)
the writing of this##3##4##(1991-1#1)(2008-4#1)(2011-2#1)
the writing of##5##3##(1991-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-7#1)
the writing power##2##3##(2008-3#2)
the writing##17##2##(1991-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2010-10#2)(2011-2#1)(2013-7#1)
the writings of##2##3##(2008-10#1)(2008-12#1)
the written##5##2##(1991-6#1)(1993-2#1)(2007-11#1)(2008-11#1)(2009-9#1)
the wrong##7##2##(1995-6#1)(2008-2#1)(2010-11#1)(2010-12#2)(2010-8#1)(2013-8#1)
the wt##2##2##(1990-5#2)
the wv##2##2##(1996-12#2)
the x and##3##3##(2007-12#2)(2008-3#1)
the x##6##2##(2007-12#3)(2008-3#3)
the x-p##2##2##(2007-12#2)
the x-ray energy##2##3##(2008-3#2)
the x-ray radiographs##3##3##(2008-3#3)
the x-ray##15##2##(1991-6#1)(2007-11#1)(2008-2#1)(2008-3#8)(2010-1#2)(2012-1#1)(2012-12#1)
the xenografted##2##2##(2008-11#2)
the xylanase##2##2##(1993-3#1)(2008-6#1)
the xylem vessels of##2##4##(2007-12#1)(2008-10#1)
the xylem vessels##4##3##(2007-12#2)(2008-10#2)
the xylem##14##2##(2007-12#2)(2008-10#9)(2008-11#3)
the xylose reductase##2##3##(2008-6#2)
the xylose##7##2##(2008-6#6)(2012-3#1)
the y##3##2##(2007-12#1)(2008-3#2)
the year 2000 and beyond##3##5##(1993-2#1)(1997-3#1)(2008-1#1)
the year 2000 targets##2##4##(1994-3#2)
the year 2000##34##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-3#2)(1994-9#3)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-3#3)(1997-6#4)(2008-1#2)(2008-11#1)(2008-12#1)(2010-5#2)(2011-1#2)(2012-2#1)
the year 2001##3##3##(2007-6#2)(2008-5#1)
the year 2002##2##3##(2008-12#2)
the year 2004##3##3##(1996-2#2)(2010-8#1)
the year 2005##2##3##(1996-2#1)(2008-11#1)
the year 2010##3##3##(2007-2#1)(2011-1#1)(2011-2#1)
the year 2015##3##3##(1994-9#1)(2008-8#2)
the year 2020##2##3##(2008-1#1)(2009-10#1)
the year 2035##2##3##(1994-7#1)(1994-9#1)
the year and the##2##4##(2008-5#2)
the year and##6##3##(1994-7#1)(2008-10#2)(2008-5#2)(2008-9#1)
the year before the##2##4##(1990-12#1)(2010-12#1)
the year in which##2##4##(1994-3#1)(2011-2#1)
the year in##4##3##(1994-3#1)(2008-12#1)(2011-2#1)(2013-8#1)
the year of the##3##4##(2008-10#2)(2013-8#1)
the year of##10##3##(1990-5#1)(2008-10#5)(2008-12#1)(2009-7#1)(2013-8#2)
the year offollow up##2##4##(2013-8#2)
the year##145##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-2#2)(1993-3#2)(1994-3#3)(1994-6#1)(1994-7#2)(1994-9#5)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#4)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#4)(2007-10#2)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#4)(2008-5#9)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#7)
the year-end ethnic achievement gap##2##5##(2008-12#2)
the yearly##4##2##(1991-6#1)(1992-2#1)(1994-12#1)(2008-10#1)
the years 1987-88##2##3##(1995-6#2)
the years 1995##2##3##(1996-1#1)(2007-11#1)
the years ahead##4##3##(1992-2#1)(1994-3#1)(1995-1#1)(1996-9#1)
the years from##2##3##(1993-3#1)(2011-2#1)
the years of##3##3##(1997-2#1)(2007-2#1)(2012-12#1)
the years to come##6##4##(1994-6#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-6#1)
the years to##7##3##(1994-6#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-6#1)(2010-8#1)
the years##99##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-2#2)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-3#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-11#5)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#4)
the yeast Candida tropicalis##2##4##(1990-5#1)(1991-9#1)
the yeast Candida##5##3##(1990-5#1)(1991-9#1)(1997-2#1)(2008-10#2)
the yeast Kex2 protease##2##4##(1992-12#2)
the yeast Saccharomyces cerevisiae##12##4##(1990-7#1)(1991-12#1)(1992-11#1)(1993-3#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-5#1)
the yeast Saccharomyces##13##3##(1990-7#1)(1991-12#1)(1992-11#1)(1993-3#1)(1994-3#1)(1995-5#1)(1995-6#2)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-5#1)
the yeast and##3##3##(1991-9#1)(1994-8#1)(2008-6#1)
the yeast cell cycle##2##4##(1991-5#1)(2010-1#1)
the yeast cell##5##3##(1991-5#1)(1993-8#1)(1994-11#1)(2008-8#1)(2010-1#1)
the yeast expression vector##2##4##(1995-2#1)(2008-9#1)
the yeast genome##7##3##(1990-5#1)(1993-9#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
the yeast strain##2##3##(2008-10#1)(2008-6#1)
the yeast tubulin##2##3##(1993-8#2)
the yeast##114##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#4)(1993-9#3)(1994-11#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#3)(1995-5#2)(1995-6#4)(1995-8#2)(1996-2#3)(1996-3#2)(1996-6#1)(1997-2#3)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#3)(2008-10#16)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#2)
the yeast-phase##3##2##(2008-5#3)
the yeasts##2##2##(2008-10#1)(2012-3#1)
the yellow##2##2##(1997-1#1)(2007-12#1)
the yellow-naped amazon##2##3##(2009-9#2)
the yellow-ripe##2##2##(2008-10#2)
the yet##3##2##(1995-9#1)(2008-2#1)(2011-2#1)
the yield and##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
the yield components##3##3##(2008-10#1)(2008-12#2)
the yield of DSB##3##4##(1995-2#3)
the yield of enzymatic hydrolysis of short cattle tendons##2##9##(2008-5#2)
the yield of recombinant protein##2##5##(1993-2#1)(2011-2#1)
the yield of the##4##4##(1994-8#1)(2008-10#1)(2009-12#1)(2012-1#1)
the yield of##24##3##(1993-2#1)(1994-8#1)(1995-2#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#1)(2012-4#1)
the yield strength of##2##4##(2009-7#1)(2012-12#1)
the yield strength##3##3##(2009-7#1)(2012-12#1)(2012-2#1)
the yield was##2##3##(2008-11#2)
the yield##41##2##(1993-2#1)(1994-11#1)(1994-8#1)(1995-2#3)(1996-12#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-4#1)
the yielding period##2##3##(2008-6#2)
the yields of##8##3##(1990-8#1)(1994-1#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
the yields were##2##3##(2007-11#1)(2008-10#1)
the yields##12##2##(1990-8#1)(1994-1#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2012-1#1)(2013-1#1)
the yolk sac of##2##4##(2008-5#1)(2008-9#1)
the yolk sac##4##3##(1997-4#1)(2007-12#1)(2008-5#1)(2008-9#1)
the yolk##6##2##(1997-4#1)(2007-12#2)(2008-5#1)(2008-9#1)(2010-5#1)
the young and old##2##4##(1991-12#1)(1997-3#1)
the young and##3##3##(1991-12#1)(1997-3#1)(1997-6#1)
the young children##2##3##(1994-12#1)(2008-9#1)
the young##36##2##(1990-7#1)(1991-11#2)(1991-12#1)(1994-12#1)(1994-5#2)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-7#1)
the younger and##4##3##(1992-9#3)(2011-2#1)
the younger group##2##3##(2008-3#1)(2008-6#1)
the younger##27##2##(1991-1#1)(1992-8#1)(1992-9#3)(1994-6#4)(1996-6#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
the youngest leaves##2##3##(2008-10#2)
the youngest##16##2##(1992-6#1)(1995-4#1)(1996-2#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-9#1)(2013-8#1)
the youth##2##2##(2008-9#1)(2012-2#1)
the youths##2##2##(2008-12#1)(2009-7#1)
the z axis##3##3##(2008-3#3)
the z##5##2##(2007-12#1)(2008-1#1)(2008-3#3)
the zNosetrade mark##3##3##(2008-10#3)
the zebrafish##9##2##(1991-9#2)(1993-12#1)(2008-4#1)(2008-7#4)(2012-3#1)
the zenith##7##2##(1990-7#1)(2008-2#3)(2008-3#3)
the zero order of##2##4##(2008-2#1)(2008-3#1)
the zero order##5##3##(2008-2#2)(2008-3#3)
the zero point##2##3##(2008-2#2)
the zero term##2##3##(2008-10#2)
the zero velocity##2##3##(2008-3#1)(2008-8#1)
the zero##21##2##(1991-5#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#5)(2008-8#1)
the zero-birefringence polymer##2##3##(2008-3#2)
the zero-crossing##3##2##(2008-10#3)
the zero-dispersion wavelength##3##3##(2007-11#2)(2007-12#1)
the zero-dispersion##4##2##(2007-11#2)(2007-12#2)
the zero-order##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
the zeros##2##2##(2007-12#1)(2008-2#1)
the zeta potential##2##3##(2008-5#2)
the zeta##3##2##(1993-6#1)(2008-5#2)
the zeta-potential##2##2##(1997-6#1)(2009-11#1)
the zigzag##4##2##(2008-10#1)(2008-3#3)
the zinc atom##2##3##(1991-5#1)(1997-7#1)
the zinc deficiency in##2##4##(2008-10#1)(2008-11#1)
the zinc extraction##3##3##(2008-10#3)
the zinc finger region of##2##5##(1990-11#1)(1991-10#1)
the zinc finger region##3##4##(1990-11#2)(1991-10#1)
the zinc finger##6##3##(1990-11#2)(1991-10#1)(1992-6#1)(2007-12#1)(2008-8#1)
the zinc##30##2##(1990-11#2)(1991-10#1)(1991-5#3)(1992-6#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2012-12#1)
the zinc-binding motif##2##3##(2008-1#2)
the zinc-binding##3##2##(2008-1#2)(2013-7#1)
the zinc-finger domain##2##3##(1995-2#2)
the zinc-finger##3##2##(1991-9#1)(1995-2#2)
the zircon##2##2##(2008-10#2)
the zirconia##2##2##(2008-10#1)(2009-8#1)
the zona glomerulosa##2##3##(1990-5#1)(2008-4#1)
the zona##5##2##(1990-5#2)(2008-4#2)(2008-8#1)
the zonal##2##2##(2008-10#1)(2008-4#1)
the zone of injury##2##4##(2008-9#2)
the zone of##10##3##(1992-12#1)(2008-10#5)(2008-7#1)(2008-9#3)
the zone plates##2##3##(2008-2#1)(2008-3#1)
the zone##20##2##(1991-3#1)(1992-12#1)(1994-12#1)(1996-2#1)(1996-4#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2011-2#1)
the zoological##2##2##(2007-6#1)(2011-1#1)
the zoonotic##2##2##(2010-10#1)(2013-1#1)
the zwitterionic##5##2##(1991-5#1)(1993-11#1)(1994-9#1)(2007-11#1)(2008-10#1)
the zymogen##2##2##(1995-2#1)(1997-4#1)
the zymotic fluid##2##3##(2008-8#2)
the {010}##2##2##(2008-7#2)
the {110}##2##2##(2008-7#2)
the β(2)-AR##2##2##(2009-9#2)
the β(2)-adrenergic receptor##3##3##(2009-9#1)(2012-2#2)
the β-cell##4##2##(2010-10#1)(2010-11#2)(2012-12#1)
the β-cells##2##2##(2010-11#2)
the β-sheet##2##2##(2012-2#2)
the χ(2) rates##2##3##(2011-1#2)
the##311756##1##(1990-10#204)(1990-11#1235)(1990-12#1218)(1990-2#1034)(1990-3#597)(1990-4#34)(1990-5#1505)(1990-6#682)(1990-7#873)(1990-8#1208)(1990-9#555)(1991-1#504)(1991-10#100)(1991-11#536)(1991-12#1763)(1991-2#1210)(1991-3#935)(1991-4#152)(1991-5#1140)(1991-6#984)(1991-7#136)(1991-8#595)(1991-9#1000)(1992-1#554)(1992-10#268)(1992-11#734)(1992-12#1501)(1992-2#876)(1992-3#1885)(1992-4#237)(1992-5#625)(1992-6#1479)(1992-7#66)(1992-8#1035)(1992-9#1048)(1993-1#563)(1993-10#54)(1993-11#1201)(1993-12#2087)(1993-2#951)(1993-3#1388)(1993-5#295)(1993-6#1246)(1993-7#1)(1993-8#1256)(1993-9#729)(1994-1#568)(1994-10#47)(1994-11#1274)(1994-12#1787)(1994-2#1451)(1994-3#1485)(1994-5#1240)(1994-6#979)(1994-7#214)(1994-8#1502)(1994-9#902)(1995-1#574)(1995-10#12)(1995-11#1140)(1995-12#2130)(1995-2#2141)(1995-3#1445)(1995-4#107)(1995-5#1379)(1995-6#1773)(1995-8#962)(1995-9#296)(1996-1#705)(1996-10#88)(1996-11#358)(1996-12#1905)(1996-2#1928)(1996-3#1187)(1996-4#304)(1996-5#1543)(1996-6#612)(1996-7#243)(1996-8#282)(1996-9#457)(1997-1#815)(1997-2#2056)(1997-3#1841)(1997-4#1417)(1997-5#529)(1997-6#1148)(1997-7#1382)(1997-8#1081)(1997-9#100)(2006-10#412)(2006-11#3)(2006-12#190)(2006-4#68)(2006-5#21)(2006-6#146)(2006-7#8)(2006-8#58)(2006-9#3)(2007-1#44)(2007-10#1183)(2007-11#5674)(2007-12#6969)(2007-2#427)(2007-3#19)(2007-4#156)(2007-5#500)(2007-6#244)(2007-7#1238)(2007-8#2405)(2007-9#177)(2008-1#3175)(2008-10#57814)(2008-11#11516)(2008-12#4133)(2008-2#9154)(2008-3#18182)(2008-4#4558)(2008-5#8342)(2008-6#3502)(2008-7#9877)(2008-8#7037)(2008-9#6540)(2009-1#226)(2009-10#1497)(2009-11#983)(2009-12#1015)(2009-2#556)(2009-3#800)(2009-4#669)(2009-5#1237)(2009-6#925)(2009-7#1367)(2009-8#1639)(2009-9#848)(2010-1#608)(2010-10#885)(2010-11#972)(2010-12#1333)(2010-2#799)(2010-3#1378)(2010-4#1238)(2010-5#1347)(2010-6#853)(2010-7#676)(2010-8#2019)(2010-9#478)(2011-1#3659)(2011-10#67)(2011-2#10197)(2011-3#546)(2011-4#23)(2011-6#1)(2011-7#109)(2011-8#5)(2011-9#15)(2012-1#1179)(2012-12#3182)(2012-2#5170)(2012-3#3934)(2012-4#29)(2012-5#90)(2012-6#57)(2012-7#72)(2012-8#40)(2012-9#31)(2013-1#7767)(2013-2#13)(2013-3#11)(2013-7#1195)(2013-8#4573)
the(15)N##2##1##(2008-11#2)
theaccuracy##2##1##(2008-2#2)
theadhesion##2##1##(2008-11#2)
theaflavin##2##1##(2008-11#2)
theanine##6##1##(2008-11#6)
theater##8##1##(1996-12#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
theatre in the##2##3##(2008-10#1)(2012-3#1)
theatre##13##1##(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#4)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#2)
thebasolateral##2##1##(2008-11#2)
theca and granulosa##2##3##(1995-8#1)(2008-12#1)
theca cells of##2##3##(2008-8#1)(2008-9#1)
theca cells##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
theca interna and##2##3##(1995-12#1)(1995-8#1)
theca interna##3##2##(1995-12#2)(1995-8#1)
theca layers were##2##3##(2008-12#2)
theca##11##1##(1990-8#1)(1995-12#2)(1995-8#2)(2008-12#4)(2008-8#1)(2008-9#1)
theca-interstitial##4##1##(2008-5#4)
thecontrol##2##1##(2008-11#1)(2011-1#1)
theculture##2##1##(2008-11#2)
thedevelopment of##2##2##(2008-11#2)
thedevice##2##1##(2008-11#2)
theeffect of the##2##3##(2008-11#2)
theeffect of##3##2##(2008-11#3)
theexperimental##2##1##(2008-11#1)(2008-2#1)
theexperiments##2##1##(2008-2#2)
thefrequency##2##1##(2013-8#2)
theft##11##1##(1991-3#2)(1993-2#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-9#2)(2012-1#1)(2012-12#1)
thefts##2##1##(1991-3#1)(1996-12#1)
thegdhA##3##1##(2008-8#3)
thein vitro nucleosome reconstitution##2##4##(2008-8#2)
thein vitro##5##2##(2008-7#1)(2008-8#4)
theincubation##2##1##(2008-11#2)
theinitial##2##1##(2008-11#2)
their &quot##5##2##(1990-4#1)(1992-3#1)(2008-3#1)(2008-8#1)(2012-3#1)
their 3'##2##2##(2008-10#1)(2008-8#1)
their 401(k)##2##2##(2011-2#2)
their 5##2##2##(1994-6#1)(1995-3#1)
their 5' termini##2##3##(2008-4#1)(2008-8#1)
their 5'##5##2##(1993-8#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
their BAL fluid##2##3##(2008-10#2)
their BAL##3##2##(2008-10#3)
their C-terminal##4##2##(1993-11#1)(1993-8#1)(1994-5#1)(2010-7#1)
their C-termini##2##2##(1994-12#1)(2009-7#1)
their C-terminus##2##2##(1994-11#1)(2008-9#1)
their CPs' leadership##2##3##(2009-5#2)
their DNA binding##4##3##(1991-12#1)(1992-11#1)(1995-8#1)(2013-1#1)
their DNA##10##2##(1991-12#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
their F1 hybrids##2##3##(2008-5#2)
their G-protein##2##2##(2008-7#1)(2009-8#1)
their GPs##2##2##(1997-4#1)(2011-1#1)
their HIV status##5##3##(1996-5#1)(2010-4#3)(2011-2#1)
their HIV##7##2##(1994-9#1)(1996-5#1)(2010-4#3)(2011-2#1)(2013-1#1)
their ICU stay##2##3##(2011-2#2)
their Medicare##3##2##(1996-3#2)(1997-2#1)
their N-hydroxy##3##2##(1992-6#3)
their PLC##2##2##(2007-11#2)
their abilities to stimulate##2##4##(1992-10#1)(2009-12#1)
their abilities to##11##3##(1992-10#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-7#2)(2008-10#2)(2008-9#1)(2009-12#2)
their abilities##13##2##(1992-10#1)(1993-8#1)(1996-12#1)(1996-2#1)(1997-7#2)(2008-10#4)(2008-9#1)(2009-12#2)
their ability to act as##3##5##(1990-11#1)(1995-3#1)(2008-10#1)
their ability to act##4##4##(1990-11#1)(1995-3#1)(2008-10#2)
their ability to activate##2##4##(1992-6#1)(1996-3#1)
their ability to be##3##4##(1992-12#1)(1994-5#1)(2008-10#1)
their ability to bind to##3##5##(1990-2#1)(1994-6#1)(2007-11#1)
their ability to bind##4##4##(1990-2#1)(1994-6#1)(2007-11#1)(2008-9#1)
their ability to cause##3##4##(1997-6#1)(2008-10#2)
their ability to compete with##2##5##(1993-3#1)(2013-7#1)
their ability to detect##6##4##(1997-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#2)
their ability to extract##2##4##(2008-10#1)(2009-8#1)
their ability to form##3##4##(1992-2#1)(2008-10#1)(2010-12#1)
their ability to functionally##2##4##(1993-11#1)(2012-3#1)
their ability to grow in##2##5##(2008-10#1)(2010-4#1)
their ability to grow##3##4##(2008-10#2)(2010-4#1)
their ability to increase the##2##5##(2009-4#1)(2013-8#1)
their ability to induce##6##4##(1990-5#1)(2008-10#4)(2008-4#1)
their ability to infect##3##4##(2008-10#2)(2010-10#1)
their ability to influence##2##4##(1995-12#1)(2013-7#1)
their ability to inhibit the##3##5##(1995-11#1)(2008-10#1)(2008-11#1)
their ability to inhibit##11##4##(1992-12#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
their ability to modulate##2##4##(1994-11#1)(2008-3#1)
their ability to move##2##4##(2007-12#1)(2008-10#1)
their ability to penetrate##2##4##(1997-1#1)(2009-10#1)
their ability to predict##2##4##(2009-4#1)(2010-1#1)
their ability to prevent##2##4##(1992-10#1)(1994-8#1)
their ability to produce##7##4##(1991-12#1)(1991-2#1)(1993-6#1)(2008-10#3)(2011-2#1)
their ability to reduce##3##4##(1991-2#1)(2008-5#1)(2008-7#1)
their ability to respond to##2##5##(1995-1#1)(1997-3#1)
their ability to selectively##2##4##(2012-2#1)(2013-1#1)
their ability to serve as##2##5##(1992-9#1)(2008-10#1)
their ability to transmit##5##4##(2008-10#5)
their ability to use##2##4##(2008-9#1)(2009-3#1)
their ability to##172##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#3)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#39)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
their ability##174##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#3)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#39)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
their absence##2##2##(2008-10#1)(2008-8#1)
their abundance in##2##3##(2007-11#1)(2008-10#1)
their abundance##5##2##(1994-9#1)(2007-11#1)(2008-10#2)(2012-3#1)
their abundant##2##2##(2012-2#1)(2013-1#1)
their academic##4##2##(2008-12#1)(2011-2#1)(2013-8#2)
their acceptance##2##2##(1993-2#1)(2008-8#1)
their access to##5##3##(2008-1#1)(2008-7#1)(2008-8#2)(2011-2#1)
their accuracy##5##2##(2008-10#2)(2008-7#1)(2011-7#1)(2012-2#1)
their action on##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
their action##9##2##(1991-5#1)(1992-12#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)
their actions are##2##3##(2008-4#2)
their actions##10##2##(1993-5#1)(1993-8#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-1#1)(2013-7#1)
their activation and##2##3##(2008-10#1)(2010-8#1)
their activation##6##2##(1995-12#1)(1996-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-8#1)
their active##6##2##(1990-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
their activities in##2##3##(2007-12#1)(2012-3#1)
their activities##14##2##(1993-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#3)(2009-5#2)(2010-3#1)(2012-12#1)(2012-3#1)
their activity##11##2##(1992-5#1)(1994-6#1)(1995-2#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-5#1)
their actual##8##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2009-9#1)(2011-2#1)
their adequacy##2##2##(1992-12#1)(2008-5#1)
their administration##3##2##(2007-7#1)(2008-1#1)(2011-3#1)
their admission to##2##3##(1990-3#1)(1995-1#1)
their admission##3##2##(1990-3#1)(1995-1#1)(2008-11#1)
their adoption##2##2##(1994-12#1)(2011-2#1)
their adult##7##2##(1995-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#2)
their advantages and disadvantages##3##4##(2008-12#1)(2008-2#1)(2012-3#1)
their advantages and##6##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-3#1)
their advantages over the##2##4##(2009-11#1)(2011-2#1)
their advantages##12##2##(1995-3#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-3#1)
their adverse##3##2##(2009-12#1)(2011-1#1)(2012-3#1)
their advisors##2##2##(2008-11#1)(2010-3#1)
their affinity for##4##3##(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)
their affinity##7##2##(1992-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-4#1)
their age and##4##3##(1990-8#1)(2008-12#1)(2012-12#2)
their age ranged from##2##4##(2007-7#1)(2008-4#1)
their age##16##2##(1990-8#1)(1991-12#1)(1994-2#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
their aggressiveness##2##2##(2008-10#2)
their agreement with##2##3##(2007-11#1)(2008-3#1)
their alcohol use##2##3##(2008-11#1)(2009-8#1)
their alcohol##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
their all-trans isomers##2##3##(1991-5#2)
their amino acid composition##2##4##(2008-7#1)(2012-1#1)
their amino acid sequences##3##4##(1992-12#1)(1992-6#1)(1994-11#1)
their amino acid##6##3##(1992-12#1)(1992-6#1)(1994-11#1)(1997-2#1)(2008-7#1)(2012-1#1)
their amino##10##2##(1991-10#1)(1992-12#1)(1992-6#1)(1994-11#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-1#1)
their amino-terminal##2##2##(1994-11#1)(1997-6#1)
their amounts##2##2##(1994-11#1)(2008-12#1)
their analgesic##2##2##(2008-11#1)(2010-6#1)
their analysis by##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
their analysis may##4##3##(1992-12#1)(1997-8#1)(2008-2#1)(2008-4#1)
their analysis##9##2##(1992-12#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2013-8#1)
their analytical##6##2##(2008-10#5)(2008-5#1)
their anatomic##2##2##(2008-12#1)(2008-9#1)
their ancestor##2##2##(2008-8#1)(2010-8#1)
their annual##3##2##(1995-2#1)(2008-11#1)(2009-10#1)
their antagonism##2##2##(2008-10#2)
their anti-tumor activity##2##3##(2008-11#1)(2012-12#1)
their anti-tumor##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
their antibacterial activities##4##3##(1994-2#1)(2010-3#1)(2012-3#2)
their antibacterial##5##2##(1994-2#1)(2010-3#1)(2011-1#1)(2012-3#2)
their antibiotic##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
their antibody##2##2##(1995-5#1)(2008-11#1)
their antimicrobial##7##2##(2007-7#2)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#2)
their antioxidant##3##2##(2008-10#1)(2008-11#2)
their antiproliferative##2##2##(1995-2#1)(2013-1#1)
their antitumor activity##2##3##(2007-11#1)(2008-11#1)
their antiviral##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
their apical##6##2##(2007-12#2)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
their apparent##7##2##(1991-8#1)(1996-12#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
their appearance##7##2##(1992-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-4#1)(2012-2#2)
their applicability for##2##3##(1991-1#1)(2008-10#1)
their applicability to##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2012-3#1)
their applicability##9##2##(1991-1#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)(2012-3#1)
their application for##2##3##(2008-10#2)
their application in the##2##4##(1992-8#1)(2008-3#1)
their application in##11##3##(1992-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-1#1)
their application to##19##3##(1990-7#1)(1994-2#1)(1995-3#2)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#2)
their application##40##2##(1990-7#1)(1992-8#1)(1994-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-11#1)(2011-2#2)(2013-8#1)
their applications to##7##3##(1992-12#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
their applications##21##2##(1992-11#1)(1992-12#1)(1992-5#1)(1996-11#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-7#1)(2012-12#1)
their appointments##3##2##(1995-1#1)(2012-3#2)
their approach to##2##3##(1993-1#1)(1994-12#1)
their approach##5##2##(1993-1#1)(1994-12#1)(1995-1#1)(1996-8#1)(2008-11#1)
their approaches to##2##3##(1993-3#1)(2011-1#1)
their appropriate##5##2##(1990-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
their aqueous solutions under similar conditions##2##6##(2008-10#2)
their aqueous solutions##3##3##(2008-10#3)
their aqueous##4##2##(2008-10#4)
their area##2##2##(2008-5#1)(2008-7#1)
their areas of##2##3##(1996-2#1)(2013-8#1)
their arrival in##2##3##(2008-5#1)(2012-2#1)
their arrival##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
their assessment##2##2##(2010-12#1)(2012-2#1)
their assignment##2##2##(2008-11#1)(2009-7#1)
their associated##17##2##(1991-3#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#1)(2011-2#1)
their association and##2##3##(1991-5#1)(2008-8#1)
their association with the##5##4##(1996-12#1)(1996-2#1)(2008-7#1)(2008-9#1)(2010-2#1)
their association with##25##3##(1994-11#1)(1996-12#3)(1996-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
their association##32##2##(1991-5#1)(1994-11#1)(1996-12#3)(1996-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
their associations with##2##3##(2013-1#1)(2013-8#1)
their asthma symptoms##2##3##(2009-6#1)(2012-12#1)
their asthma##5##2##(1993-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-12#1)
their atomic absorption spectrometric determinations##2##5##(2008-10#2)
their atomic absorption##3##3##(2008-10#3)
their atomic##4##2##(2008-10#3)(2011-2#1)
their attendant##2##2##(2010-8#1)(2011-2#1)
their attention on##3##3##(1993-6#1)(2008-10#1)(2012-12#1)
their attention##5##2##(1993-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
their attitude towards##2##3##(1996-9#1)(2010-3#1)
their attitude##4##2##(1996-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
their attitudes and##2##3##(1994-2#1)(2008-12#1)
their attitudes toward##2##3##(1992-1#1)(2008-7#1)
their attitudes##7##2##(1992-1#1)(1993-3#1)(1994-2#1)(1996-6#1)(2008-12#1)(2008-7#2)
their atypical morphology##2##3##(2008-10#1)(2012-12#1)
their availability##2##2##(1994-6#1)(2008-7#1)
their average##3##2##(1993-12#1)(2008-9#1)(2010-3#1)
their avoidance##2##2##(2007-12#1)(2009-9#1)
their awareness of##3##3##(1993-12#1)(1995-12#1)(2010-8#1)
their axon##2##2##(1997-3#1)(2007-12#1)
their axons##2##2##(2007-12#2)
their background##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
their bacterial##2##2##(2008-10#1)(2013-1#1)
their basal##4##2##(2007-12#1)(2008-7#2)(2013-1#1)
their basic##5##2##(1993-1#1)(1996-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
their beam##2##2##(2007-11#1)(2007-12#1)
their behavior during##2##3##(1991-2#1)(1993-12#1)
their behavior in##2##3##(1994-9#1)(2008-7#1)
their behavior##12##2##(1990-7#1)(1991-2#2)(1993-12#1)(1994-9#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)
their behaviour##4##2##(1991-2#1)(2008-6#1)(2008-7#1)(2009-9#1)
their behavioural##2##2##(2008-9#2)
their being##2##2##(1995-12#1)(1995-3#1)
their belief that##2##3##(2008-12#2)
their belief##3##2##(1990-12#1)(2008-12#2)
their beneficial effects##3##3##(1992-8#1)(2013-7#1)(2013-8#1)
their beneficial##5##2##(1992-8#1)(2008-10#1)(2008-5#1)(2013-7#1)(2013-8#1)
their benefit##3##2##(1992-3#1)(1994-3#2)
their benefits##7##2##(1992-1#1)(1995-3#1)(1997-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
their best##2##2##(2009-7#1)(2012-12#1)
their binding affinities##2##3##(1995-11#1)(2008-8#1)
their binding affinity##2##3##(1992-11#1)(1997-6#1)
their binding site##2##3##(1992-6#1)(1995-12#1)
their binding to##3##3##(1994-3#1)(1995-8#1)(2009-5#1)
their binding##20##2##(1992-11#1)(1992-6#2)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
their biochemical##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
their biological activities##3##3##(1991-9#1)(2011-1#1)(2013-1#1)
their biological activity##2##3##(1991-5#1)(1995-2#1)
their biological effects##3##3##(1994-6#1)(2008-10#1)(2009-12#1)
their biological functions##3##3##(1993-9#1)(2008-9#1)(2009-2#1)
their biological properties##2##3##(2008-10#1)(2008-11#1)
their biological roles##2##3##(2008-11#1)(2008-7#1)
their biological##27##2##(1991-5#1)(1991-9#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2011-1#1)(2013-1#1)
their biology##2##2##(2009-8#1)(2010-8#1)
their biophysical##3##2##(1997-6#1)(2008-10#1)(2012-3#1)
their birth##2##2##(1992-5#1)(2007-2#1)
their blood##3##2##(1990-11#1)(2010-11#1)(2013-8#1)
their boards##3##2##(1993-1#1)(1994-2#1)(1995-3#1)
their bodies##11##2##(2008-10#2)(2008-5#1)(2008-9#5)(2009-5#2)(2010-10#1)
their body size##3##3##(2007-12#3)
their body weight##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
their body##18##2##(1991-11#1)(1991-12#1)(2007-12#7)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
their bone marrow##3##3##(1994-10#1)(1994-5#1)(2010-1#1)
their brain##2##2##(2008-11#1)(2008-5#1)
their branches##2##2##(1990-9#1)(1997-8#1)
their broad spectrum##2##3##(2008-10#1)(2011-2#1)
their broad##4##2##(1995-5#1)(2008-10#2)(2011-2#1)
their brood##2##2##(2008-6#1)(2008-9#1)
their business##4##2##(1991-3#1)(1992-3#1)(1997-2#1)(2008-11#1)
their buying##2##2##(1994-12#1)(1994-3#1)
their calls##2##2##(2013-7#2)
their capabilities##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
their capability to##7##3##(1993-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
their capacities##5##2##(1994-3#1)(2007-6#1)(2008-11#1)(2008-5#2)
their capacity for##2##3##(1996-2#1)(1997-1#1)
their capacity to differentiate##2##4##(1990-5#1)(2012-12#1)
their capacity to##18##3##(1990-5#2)(1991-11#1)(1991-2#2)(1994-5#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
their capacity##21##2##(1990-5#2)(1991-11#1)(1991-2#2)(1992-1#1)(1994-5#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
their care is##2##3##(2008-11#1)(2010-10#1)
their care##13##2##(1992-11#1)(1997-2#1)(2007-12#1)(2008-11#2)(2010-10#3)(2010-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
their care-givers##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
their career##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
their careers##3##2##(1995-2#2)(2007-8#1)
their caregivers##7##2##(1992-3#1)(1996-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
their caring role##2##3##(2011-1#2)
their caring roles##2##3##(2009-5#2)
their caring##4##2##(2009-5#2)(2011-1#2)
their case##2##2##(1995-12#1)(1996-2#1)
their catalytic domains##3##3##(1992-6#1)(1992-7#1)(1993-5#1)
their catalytic##6##2##(1992-6#1)(1992-7#1)(1993-5#1)(1993-6#1)(1997-3#1)(2008-10#1)
their causes##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
their cell size##2##3##(2008-11#2)
their cell surface##2##3##(1994-3#1)(2008-11#1)
their cell##14##2##(1994-3#1)(1994-6#1)(2006-12#1)(2007-12#1)(2008-11#5)(2008-6#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-8#1)
their cellular functions##2##3##(2008-8#1)(2009-8#1)
their cellular##6##2##(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2012-12#1)
their central##5##2##(1992-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
their chains##2##2##(2008-10#1)(2008-8#1)
their challenge##3##2##(2008-10#2)(2010-12#1)
their chances##2##2##(2008-10#1)(2008-9#1)
their changes during##2##3##(2008-10#1)(2012-2#1)
their changes in##2##3##(2008-10#1)(2010-11#1)
their changes##6##2##(1992-6#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-2#1)
their characteristic##2##2##(1992-8#1)(2012-2#1)
their characteristics##6##2##(1994-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
their chelates##2##2##(2008-10#2)
their chemical composition##2##3##(2008-10#1)(2013-8#1)
their chemical properties##4##3##(2008-10#2)(2008-11#2)
their chemical##18##2##(1990-3#1)(1990-5#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#2)(2009-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
their child##18##2##(1990-12#1)(1993-12#2)(1995-1#2)(1995-12#1)(1996-11#1)(1996-3#2)(1997-2#1)(2008-2#1)(2008-9#2)(2010-6#1)(2010-8#1)(2012-2#3)
their child's##16##2##(1993-12#1)(1995-1#3)(1995-12#1)(2008-11#4)(2008-9#1)(2009-6#1)(2010-6#1)(2010-9#3)(2012-2#1)
their childbearing##2##2##(2009-12#1)(2013-1#1)
their children and##5##3##(1991-3#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-12#1)
their children in##5##3##(1994-2#1)(2008-12#1)(2009-6#3)
their children to##3##3##(1994-9#1)(2012-12#2)
their children##44##2##(1990-2#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#2)(1996-1#2)(2008-12#1)(2008-6#1)(2009-11#1)(2009-6#3)(2009-7#3)(2010-10#3)(2010-5#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#1)
their children's teeth after##2##4##(2008-9#2)
their children's##14##2##(1994-3#1)(1995-1#4)(1996-5#1)(2008-9#2)(2009-7#4)(2010-3#1)(2012-12#1)
their choice of##3##3##(1993-6#1)(1996-11#1)(2008-9#1)
their choice##6##2##(1993-6#1)(1996-11#1)(1996-2#1)(2008-9#2)(2012-3#1)
their choices##4##2##(1993-12#1)(1997-3#1)(2009-10#1)(2012-2#1)
their chosen##2##2##(2011-1#1)(2012-1#1)
their chromosomal##2##2##(1997-6#1)(2008-9#1)
their classical##3##2##(1995-11#2)(2008-4#1)
their classification##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
their clients##9##2##(1992-1#1)(1993-12#1)(1993-3#1)(2008-5#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
their clinic##2##2##(2008-10#1)(2009-10#1)
their clinical and##4##3##(2008-11#1)(2009-6#1)(2011-2#2)
their clinical appearance##2##3##(1996-6#1)(2008-5#1)
their clinical course##2##3##(2007-12#1)(2010-6#1)
their clinical effects##2##3##(2008-6#1)(2011-2#1)
their clinical experience##2##3##(1993-9#1)(2008-12#1)
their clinical implications##2##3##(2012-2#1)(2013-1#1)
their clinical manifestations##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
their clinical placement##2##3##(1996-2#1)(2007-10#1)
their clinical placements##4##3##(1995-3#1)(2008-12#2)(2010-3#1)
their clinical practice##3##3##(2008-11#1)(2009-11#1)(2012-2#1)
their clinical presentation##2##3##(2007-12#1)(2008-7#1)
their clinical relevance##2##3##(2008-4#1)(2010-5#1)
their clinical use##2##3##(2007-7#1)(2012-12#1)
their clinical utility##2##3##(2008-8#1)(2010-12#1)
their clinical##59##2##(1992-6#1)(1993-9#2)(1995-10#1)(1995-3#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-6#1)(2007-10#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
their coevolutionary relationship##2##3##(2009-8#1)(2012-3#1)
their cognate##5##2##(1993-6#1)(1996-12#1)(2008-4#1)(2009-10#1)(2009-9#1)
their cognitive and##2##3##(1991-2#1)(2009-10#1)
their cognitive##9##2##(1991-2#1)(1991-6#1)(2008-11#2)(2009-10#3)(2010-1#1)(2012-2#1)
their collection##3##2##(1996-12#1)(2008-12#1)(2008-8#1)
their colonization##2##2##(2008-10#1)(2008-5#1)
their colony##3##2##(2008-10#2)(2013-1#1)
their color##2##2##(2008-10#1)(2012-2#1)
their combination##8##2##(1992-2#1)(2008-10#2)(2009-8#1)(2011-1#1)(2012-5#1)(2012-7#1)(2012-9#1)
their comments##2##2##(2008-11#1)(2008-9#1)
their commercial##3##2##(1996-12#1)(2010-5#1)(2011-2#1)
their commitment to##2##3##(1994-12#1)(2011-2#1)
their commitment##3##2##(1993-12#1)(1994-12#1)(2011-2#1)
their common##5##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)
their communication with##2##3##(2008-12#1)(2011-2#1)
their communication##6##2##(1995-3#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#2)
their communities##12##2##(1992-12#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-12#1)(2008-1#1)(2009-6#1)(2011-2#1)(2013-1#1)
their community##3##2##(1991-3#1)(1995-3#1)(2008-7#1)
their comparability##2##2##(2008-3#1)(2008-8#1)
their comparison with the##2##4##(2008-10#2)
their comparison with##3##3##(2008-10#2)(2008-3#1)
their comparison##6##2##(2008-10#4)(2008-3#2)
their compensation##2##2##(1991-12#1)(2008-4#1)
their competence##2##2##(1995-5#1)(1997-8#1)
their competitors##2##2##(1993-1#1)(1996-3#1)
their complementarity##2##2##(1994-8#1)(2008-10#1)
their complementary##4##2##(1993-12#1)(2008-10#2)(2011-2#1)
their complete##5##2##(1996-10#1)(2007-12#1)(2008-10#1)(2010-3#1)(2012-1#1)
their complex##2##2##(1995-2#1)(2008-3#1)
their complexation with##2##3##(2008-10#2)
their complexation##3##2##(2008-10#3)
their complexes with##6##3##(1992-3#1)(2008-10#5)
their complexes##9##2##(1992-3#1)(2008-10#7)(2010-7#1)
their complications##3##2##(2007-8#1)(2012-12#1)(2013-8#1)
their component##2##2##(2008-10#1)(2008-11#1)
their components##6##2##(2008-10#5)(2012-3#1)
their composite##2##2##(1996-1#1)(2008-10#1)
their composition##6##2##(1994-3#1)(2008-10#3)(2008-11#1)(2008-7#1)
their concentration is##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
their concentration##8##2##(2008-10#5)(2008-11#1)(2009-4#1)(2011-2#1)
their concentrations in##2##3##(2008-10#2)
their concentrations were##4##3##(1992-5#1)(1992-6#1)(2012-2#1)(2013-1#1)
their concentrations##16##2##(1992-5#1)(1992-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#2)
their concerns##4##2##(1991-2#1)(1995-2#1)(2010-8#1)(2011-2#1)
their condition##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
their conduct##2##2##(1994-3#1)(1995-3#1)
their conformational##3##2##(1992-8#1)(2008-3#1)(2013-1#1)
their conformations##2##2##(1990-8#1)(1995-2#1)
their connection with##2##3##(2007-11#1)(2012-12#1)
their connection##4##2##(1990-11#1)(2007-11#1)(2010-7#1)(2012-12#1)
their consent##6##2##(1993-6#1)(1995-12#1)(2009-4#2)(2009-6#1)(2011-2#1)
their consequences##6##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
their conservation##2##2##(2008-10#1)(2008-7#1)
their constituents##2##2##(2007-11#1)(2008-10#1)
their consumption##4##2##(1991-9#1)(2008-10#1)(2009-12#1)(2011-1#1)
their content is##2##3##(2007-5#1)(2008-10#1)
their content was##2##3##(1990-6#1)(2008-10#1)
their content##6##2##(1990-6#1)(2007-5#1)(2008-10#3)(2012-2#1)
their contents and##2##3##(1992-12#1)(2012-3#1)
their contents##6##2##(1992-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
their continuing##2##2##(1995-12#1)(2008-8#1)
their continuous##2##2##(1994-12#1)(2008-11#1)
their contribution to the##4##4##(2008-10#2)(2008-12#1)(2008-5#1)
their contribution to##8##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
their contribution##11##2##(1994-3#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
their contributions to##3##3##(2008-9#2)(2011-1#1)
their contributions##4##2##(2008-9#2)(2011-1#1)(2012-3#1)
their control##7##2##(1991-5#1)(1992-12#1)(2008-12#3)(2008-6#1)(2012-2#1)
their controls##3##2##(1991-3#1)(1996-5#1)(2008-10#1)
their coping##2##2##(1994-12#1)(2009-7#1)
their core##2##2##(1996-2#1)(2009-12#1)
their correct##2##2##(2008-10#2)
their correlation with##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
their correlation##7##2##(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#2)
their corresponding##20##2##(1992-8#2)(1993-11#1)(1993-6#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-8#1)(2013-1#1)
their cost##3##2##(1993-12#1)(1994-12#1)(2008-10#1)
their costs##2##2##(2007-4#1)(2013-1#1)
their counterparts from##2##3##(2008-10#1)(2009-6#1)
their counterparts in other##2##4##(2007-6#1)(2008-11#1)
their counterparts in##5##3##(1996-3#1)(2007-6#1)(2008-11#2)(2008-7#1)
their counterparts with##2##3##(2008-12#1)(2012-3#1)
their counterparts##11##2##(1996-3#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-6#1)(2012-3#1)
their countries##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
their coupled##2##2##(2008-9#1)(2012-2#1)
their coupling to##2##3##(1996-5#1)(2006-12#1)
their coupling##3##2##(1996-5#1)(2006-12#1)(2007-11#1)
their course##4##2##(2008-11#3)(2012-12#1)
their critical##6##2##(1995-3#1)(2008-11#2)(2008-3#1)(2012-2#1)(2013-1#1)
their cultural##2##2##(2008-12#1)(2010-8#1)
their culture##4##2##(1991-12#1)(1994-1#1)(2008-11#1)(2008-9#1)
their current##20##2##(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-1#1)(2009-9#1)(2010-4#1)(2012-12#1)(2013-1#1)
their curricula##2##2##(1996-2#1)(2012-3#1)
their curriculum##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
their curvatures##2##2##(2008-9#1)(2011-1#1)
their customers##3##2##(1992-12#1)(1994-12#1)(1997-1#1)
their customers'##3##2##(1992-1#3)
their cytokines##2##2##(2008-4#1)(2013-1#1)
their cytoplasm##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
their cytotoxic##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
their cytotoxicity##2##2##(2008-11#1)(2013-1#1)
their daily lives##3##3##(1993-3#1)(2008-2#1)(2008-9#1)
their daily##17##2##(1993-3#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
their data##7##2##(1990-5#1)(1997-1#1)(2008-3#3)(2008-7#2)
their databases##2##2##(1996-12#1)(2008-8#1)
their daughters against##2##3##(2011-1#2)
their daughters##8##2##(1992-4#1)(2008-12#1)(2008-5#1)(2011-1#5)
their death by##2##3##(2008-10#1)(2011-2#1)
their death##5##2##(1995-6#1)(2008-10#2)(2010-4#1)(2011-2#1)
their decision##7##2##(1996-2#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
their decision-making##3##2##(1992-2#1)(2010-10#1)(2011-1#1)
their decisions##2##2##(1993-12#1)(2008-11#1)
their deficiencies##2##2##(1996-2#1)(2008-4#1)
their degradation products##4##3##(1990-7#1)(2008-10#1)(2013-1#2)
their degradation##7##2##(1990-7#1)(2008-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2013-1#2)
their degree of##8##3##(1990-11#1)(1991-5#1)(1993-9#1)(1995-3#1)(1997-3#1)(2008-9#2)(2013-1#1)
their demands and##2##3##(2009-10#1)(2013-1#1)
their demands##5##2##(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2013-1#1)
their demographic##4##2##(1991-1#1)(2007-7#1)(2010-3#1)(2011-2#1)
their dendrites##2##2##(1997-3#1)(2008-8#1)
their density##2##2##(1992-3#1)(2008-1#1)
their dependence on the##2##4##(1996-5#1)(2008-3#1)
their dependence on##5##3##(1996-5#1)(2008-10#1)(2008-3#3)
their deployment##2##2##(2008-10#1)(2011-2#1)
their derivatives##7##2##(2008-10#3)(2008-11#2)(2008-5#1)(2010-11#1)
their descendants##2##2##(2008-5#1)(2009-3#1)
their descriptions of##2##3##(2008-11#1)(2008-12#1)
their desensitization##2##2##(2008-4#1)(2013-1#1)
their design##4##2##(2009-2#1)(2010-1#1)(2011-2#1)(2012-2#1)
their desired##2##2##(1993-2#1)(2010-5#1)
their destabilization##2##2##(1990-8#1)(1997-3#1)
their destinations##3##2##(1995-2#1)(1996-5#1)(2011-2#1)
their detection at##2##3##(2008-10#1)(2008-11#1)
their detection limits##2##3##(2008-10#2)
their detection rates##2##3##(2010-12#1)(2012-2#1)
their detection with##2##3##(1994-10#1)(2008-9#1)
their detection##20##2##(1994-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
their determination by electrothermal##2##4##(2008-10#2)
their determination by inductively coupled plasma atomic emission spectrometry##3##9##(2008-10#3)
their determination by inductively coupled##4##5##(2008-10#4)
their determination by##17##3##(2008-10#17)
their determination in##6##3##(2008-10#6)
their determination##27##2##(2008-10#26)(2009-8#1)
their development and##5##3##(1992-6#1)(1996-2#1)(2008-1#1)(2008-4#1)(2011-2#1)
their development is##4##3##(1997-7#1)(2007-12#1)(2008-7#1)(2010-4#1)
their development were##2##3##(2008-10#1)(2008-5#1)
their development##30##2##(1992-2#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2013-1#1)
their developmental##4##2##(1991-2#1)(1994-9#1)(2008-11#1)(2008-8#1)
their diagnosis##9##2##(1996-2#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-7#1)(2010-9#1)(2012-3#2)(2013-1#1)
their diagnostic and##2##3##(1992-10#1)(2010-4#1)
their diagnostic##4##2##(1992-10#1)(2008-10#1)(2010-4#1)(2012-12#1)
their diameters##3##2##(2008-3#2)(2008-7#1)
their diet with##2##3##(2008-5#2)
their diet##14##2##(1990-6#3)(2008-1#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#1)
their dietary habits##2##3##(1992-8#1)(2008-1#1)
their dietary##4##2##(1992-8#1)(2008-1#1)(2008-3#1)(2010-6#1)
their difference##3##2##(2008-10#2)(2008-12#1)
their differences in##2##3##(1995-1#1)(2008-10#1)
their differences##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
their different##20##2##(1990-11#1)(1992-12#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)
their differential##4##2##(1991-11#1)(1995-12#1)(2008-10#1)(2010-6#1)
their differentiation into##2##3##(1995-12#1)(2008-8#1)
their differentiation##9##2##(1992-12#1)(1995-12#1)(2008-11#1)(2008-4#2)(2008-8#2)(2012-2#1)(2012-4#1)
their diffusion##2##2##(1993-8#1)(2009-2#1)
their digestive##2##2##(2008-5#1)(2012-12#1)
their dimensions##2##2##(2008-10#2)
their direct determination without previous separation##2##6##(2008-10#2)
their direct##6##2##(1992-8#1)(1994-2#1)(2008-10#2)(2008-5#1)(2010-11#1)
their direction##2##2##(2008-7#1)(2010-10#1)
their directions##2##2##(1993-3#1)(2008-2#1)
their discharge##3##2##(1993-12#2)(2010-10#1)
their discovery##4##2##(2008-7#2)(2010-5#1)(2013-1#1)
their discrimination##2##2##(2008-10#1)(2010-2#1)
their disease and the##2##4##(2007-8#1)(2008-7#1)
their disease and##4##3##(1990-6#1)(2007-8#1)(2008-7#1)(2011-1#1)
their disease within##2##3##(2007-11#1)(2010-12#1)
their disease##23##2##(1990-6#2)(1991-2#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-1#1)
their dispersal##2##2##(2008-8#2)
their disposal##3##2##(1994-3#1)(2008-10#1)(2012-12#1)
their distal##3##2##(2008-7#2)(2012-3#1)
their distance to##2##3##(2008-11#1)(2008-9#1)
their distinct##2##2##(2008-10#1)(2012-12#1)
their distribution and##3##3##(2008-10#2)(2011-2#1)
their distribution in the##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
their distribution in##6##3##(1996-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2013-1#1)(2013-8#1)
their distribution is##2##3##(1995-8#1)(2008-10#1)
their distribution##18##2##(1990-5#1)(1995-8#1)(1996-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
their distributions##3##2##(1991-8#1)(1993-12#1)(1997-2#1)
their divergence##2##2##(1996-4#1)(2012-3#1)
their diverse##3##2##(1993-1#1)(2008-10#1)(2013-8#1)
their diversity and##2##3##(2008-11#1)(2013-7#1)
their doctors##2##2##(1990-6#1)(2011-1#1)
their documentation##2##2##(2008-7#1)(2012-2#1)
their drinking##3##2##(2008-10#2)(2010-7#1)
their dry##2##2##(2008-5#1)(2010-6#1)
their dual##2##2##(2010-10#1)(2013-8#1)
their duties##3##2##(1995-1#1)(1996-12#1)(2008-6#1)
their early##8##2##(1996-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#2)
their eating##2##2##(1993-6#1)(2010-7#1)
their ecological and##2##3##(2008-9#1)(2012-5#1)
their ecological##4##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-5#1)
their economic##4##2##(1991-2#1)(1994-1#2)(2008-10#1)
their education and##2##3##(1992-12#1)(2010-8#1)
their education##5##2##(1992-12#1)(2008-11#2)(2010-8#1)(2013-1#1)
their effect on the##10##4##(2008-10#8)(2008-11#1)(2008-7#1)
their effect on##38##3##(1991-3#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-11#1)(1996-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
their effect##43##2##(1991-3#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
their effective use##2##3##(1991-2#1)(1994-1#1)
their effective##3##2##(1991-2#1)(1994-1#1)(2008-9#1)
their effectiveness and##2##3##(2008-9#1)(2013-1#1)
their effectiveness as##2##3##(2008-11#1)(2013-1#1)
their effectiveness in##2##3##(2008-6#1)(2011-2#1)
their effectiveness is##2##3##(2012-12#1)(2013-8#1)
their effectiveness to##3##3##(2008-7#1)(2012-2#2)
their effectiveness##25##2##(1992-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
their effects and##2##3##(2008-10#2)
their effects are##2##3##(1994-8#1)(2008-9#1)
their effects by##2##3##(1994-11#1)(2008-4#1)
their effects on LDL metabolism##2##5##(1993-6#2)
their effects on the##15##4##(1990-11#1)(1993-6#1)(1993-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#3)(2010-5#1)(2011-2#1)
their effects on##54##3##(1990-11#2)(1990-5#1)(1991-12#1)(1991-3#1)(1992-10#1)(1993-6#3)(1993-8#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
their effects via##2##3##(1990-8#1)(1994-8#1)
their effects##73##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-10#1)(1992-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-8#2)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#2)(2008-10#13)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#3)(2010-5#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
their efficacy and##6##3##(1990-2#1)(1993-11#1)(2008-5#1)(2012-2#1)(2013-1#2)
their efficacy in##5##3##(2008-10#2)(2009-7#1)(2011-2#1)(2013-7#1)
their efficacy##20##2##(1990-2#1)(1991-3#1)(1993-11#2)(1994-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#3)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
their efficiency##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
their efficient##2##2##(1992-12#1)(2008-11#1)
their effort##2##2##(1990-12#1)(1993-12#1)
their efforts in##2##3##(1995-1#1)(2009-1#1)
their efforts on##2##3##(1997-1#1)(2010-5#1)
their efforts to##8##3##(1995-3#1)(1996-3#2)(2009-4#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)
their efforts##17##2##(1991-8#1)(1995-1#1)(1995-3#1)(1996-3#2)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
their eggs##4##2##(2007-12#1)(2008-9#1)(2013-1#2)
their electrical##2##2##(2008-10#1)(2012-2#1)
their electrocatalytic##2##2##(2008-10#2)
their electrochemical detection##2##3##(2008-10#2)
their electrochemical##5##2##(2008-10#4)(2008-8#1)
their electronic##2##2##(1990-5#1)(2007-12#1)
their elimination##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
their emission##2##2##(2008-10#1)(2008-9#1)
their employees##6##2##(1992-3#1)(1993-3#1)(1995-1#1)(1996-12#1)(2007-2#1)(2008-11#1)
their employment##4##2##(1995-1#2)(2007-12#1)(2009-9#1)
their encoding##2##2##(2008-10#1)(2013-1#1)
their endogenous ligands##2##3##(2008-7#1)(2009-7#1)
their endoscopic##2##2##(2008-5#1)(2010-9#1)
their energy##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
their enhanced##3##2##(1993-6#1)(1995-12#1)(2008-10#1)
their enrollment decisions after##2##4##(2009-6#2)
their entire##3##2##(1992-11#1)(2008-11#1)(2008-5#1)
their environment to##3##3##(1992-12#1)(2008-10#2)
their environment##20##2##(1992-12#1)(1994-3#1)(1996-12#2)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
their environmental##4##2##(1990-12#1)(1992-3#1)(2008-10#2)
their environments##5##2##(1991-1#1)(1994-11#1)(2008-11#1)(2008-9#1)(2011-2#1)
their enzymatic activity##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
their enzymatic##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
their epidemiology##2##2##(2009-4#1)(2010-3#1)
their epitope##2##2##(1993-1#1)(2011-2#1)
their epitopes##4##2##(1993-1#1)(1997-7#1)(2008-8#2)
their essential##2##2##(2008-1#1)(2008-8#1)
their estimation##2##2##(1997-7#1)(2008-10#1)
their estrogen receptor##4##3##(2008-11#4)
their etiology##3##2##(1997-8#1)(2011-1#1)(2011-2#1)
their evaluation in##3##3##(1992-9#1)(2006-6#1)(2008-5#1)
their evaluation of##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
their evaluation##9##2##(1992-9#1)(1995-2#1)(2006-6#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-5#1)
their evolution##4##2##(2008-1#1)(2008-7#1)(2010-3#1)(2010-5#1)
their evolutionary relationships##2##3##(2010-2#1)(2013-8#1)
their evolutionary##10##2##(1996-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
their exact##2##2##(2008-3#1)(2008-4#1)
their excellent##3##2##(1997-8#1)(2009-7#1)(2010-4#1)
their exchange##2##2##(1997-1#1)(2008-10#1)
their existence##4##2##(1993-5#1)(1997-6#1)(1997-8#1)(2008-8#1)
their existing##6##2##(1993-2#1)(1994-1#1)(2008-11#1)(2008-5#1)(2011-3#1)(2013-8#1)
their expectations##7##2##(1992-12#1)(1994-1#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
their experience about##2##3##(1990-5#1)(1992-5#1)
their experience in##3##3##(1990-5#1)(1991-6#1)(1993-5#1)
their experience of the##3##4##(1993-9#1)(1996-9#1)(1997-6#1)
their experience of##9##3##(1990-3#1)(1990-9#1)(1992-6#1)(1993-5#1)(1993-9#1)(1996-9#2)(1997-6#1)(2009-5#1)
their experience with the##2##4##(1990-8#1)(2006-12#1)
their experience with this##2##4##(1993-3#1)(2008-11#1)
their experience with##7##3##(1990-8#1)(1991-2#1)(1991-3#1)(1993-3#1)(2006-12#2)(2008-11#1)
their experience##27##2##(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#2)(1992-6#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-2#1)(1995-1#1)(1996-9#2)(1997-6#1)(2006-12#2)(2008-11#1)(2009-5#3)
their experiences in caring for##2##5##(2010-8#1)(2011-2#1)
their experiences in the##2##4##(1995-12#1)(2009-12#1)
their experiences in##5##3##(1995-12#1)(2007-11#1)(2009-12#1)(2010-8#1)(2011-2#1)
their experiences of being##2##4##(2008-11#1)(2010-10#1)
their experiences of##4##3##(1993-1#1)(2008-11#1)(2009-5#1)(2010-10#1)
their experiences with the##2##4##(2007-7#1)(2013-7#1)
their experiences with##10##3##(1995-12#1)(1996-1#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#1)(2013-7#1)
their experiences##28##2##(1993-1#1)(1994-1#1)(1995-12#2)(1996-1#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-12#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
their experimental##3##2##(2008-10#1)(2008-3#2)
their expertise and##2##3##(2008-9#1)(2011-2#1)
their expertise##5##2##(2008-1#1)(2008-11#2)(2008-9#1)(2011-2#1)
their exposure to##5##3##(1991-12#1)(1995-3#1)(2006-5#1)(2008-2#1)(2012-12#1)
their expression in##5##3##(1993-8#1)(1994-12#1)(2008-8#1)(2010-11#1)(2011-2#1)
their expression of##7##3##(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#2)(2011-2#1)(2012-2#1)
their expression patterns in##2##4##(1997-7#1)(2008-10#1)
their expression patterns##5##3##(1993-9#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)
their expression profiles##2##3##(1993-8#1)(2008-4#1)
their expression was##2##3##(1995-11#1)(2011-2#1)
their expression##39##2##(1990-12#1)(1992-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)
their extensive##2##2##(2008-3#1)(2011-2#1)
their external##3##2##(1993-12#1)(1995-2#1)(2007-12#1)
their extracellular environment##2##3##(2011-1#1)(2013-8#1)
their extracellular##7##2##(1993-8#1)(1997-1#1)(2008-11#1)(2011-1#3)(2013-8#1)
their extraction##3##2##(2007-8#1)(2008-10#1)(2009-8#1)
their eyes##3##2##(1995-11#1)(2010-10#1)(2011-1#1)
their fabrication##3##2##(2008-10#1)(2008-3#2)
their facilitation##2##2##(2008-11#1)(2010-10#1)
their failure##4##2##(1994-9#1)(1995-5#1)(2008-11#1)(2008-8#1)
their families and##5##3##(1990-6#1)(1996-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
their families##63##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#3)(1992-3#3)(1992-4#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#4)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-11#13)(2008-7#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)
their family members and friends##2##5##(1996-3#2)
their family members##6##3##(1992-2#1)(1996-3#2)(2008-11#2)(2009-6#1)
their family##17##2##(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-3#2)(2007-12#1)(2008-11#2)(2008-12#2)(2008-9#1)(2009-12#1)(2009-6#2)(2013-1#2)
their family's##2##2##(1996-1#1)(2007-2#1)
their fatty acid##2##3##(2008-10#1)(2008-11#1)
their feeding##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
their feelings about##2##3##(1992-3#1)(2008-5#1)
their feelings##3##2##(1992-3#1)(2008-1#1)(2008-5#1)
their field of##3##3##(2008-2#1)(2008-5#1)(2008-6#1)
their fields##3##2##(1996-2#1)(2008-10#1)(2009-11#1)
their final post-stressed vowels##2##4##(2009-11#2)
their final##7##2##(1996-3#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-11#2)(2009-9#1)
their financial##6##2##(1995-1#1)(2008-11#1)(2008-7#1)(2010-10#2)(2010-5#1)
their findings##2##2##(1993-12#1)(1993-3#1)
their finger##2##2##(2009-2#2)
their first HIV test##2##4##(2009-5#2)
their first clinical placement##4##4##(2008-12#2)(2012-12#2)
their first clinical##6##3##(2008-10#1)(2008-12#3)(2012-12#2)
their first encounter##2##3##(2008-11#2)
their first months##2##3##(1992-1#1)(2013-1#1)
their first practice placement##3##4##(2008-11#3)
their first practice##4##3##(2008-11#3)(2008-9#1)
their first pregnancy##3##3##(2012-12#3)
their first test##2##3##(2009-5#2)
their first year of##5##4##(1992-1#1)(2007-10#1)(2011-1#2)(2013-1#1)
their first year##6##3##(1992-1#1)(2007-10#1)(2009-4#1)(2011-1#2)(2013-1#1)
their first##51##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-5#1)(1994-2#1)(1997-2#1)(1997-6#2)(2007-10#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#5)(2013-1#5)
their fitness##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
their flame atomic absorption spectrometric determinations##2##6##(2008-10#2)
their flame atomic absorption spectrometric##3##5##(2008-10#3)
their flanking##2##2##(1993-8#1)(1997-7#1)
their fluidity##2##2##(1990-12#1)(1991-9#1)
their fluorescence##2##2##(2009-12#1)(2013-8#1)
their fluorescent##2##2##(1993-11#1)(2008-10#1)
their focal##2##2##(2008-3#2)
their folding##4##2##(1993-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
their food##2##2##(1996-3#1)(2013-7#1)
their formation##10##2##(1991-3#1)(1991-9#1)(1993-8#1)(1994-12#1)(2008-10#4)(2008-3#1)(2012-12#1)
their former##3##2##(2009-10#1)(2012-3#1)(2013-1#1)
their fragile##2##2##(2009-10#1)(2009-7#1)
their fragment##2##2##(2008-10#1)(2008-12#1)
their fragmentation##2##2##(2008-10#1)(2012-3#1)
their free##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2013-7#1)
their frequency##5##2##(1994-6#1)(2007-11#1)(2008-4#1)(2008-9#1)(2013-8#1)
their friends##4##2##(1995-1#1)(2009-7#3)
their full##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
their full-term peers##3##3##(2008-11#3)
their fully##2##2##(1995-5#1)(2009-5#1)
their function and##5##3##(2007-12#1)(2008-5#2)(2010-10#1)(2010-11#1)
their function##20##2##(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-9#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#2)
their functional status##2##3##(1995-3#1)(2008-7#1)
their functional##16##2##(1990-8#1)(1993-12#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
their functionality##2##2##(2008-3#1)(2008-7#1)
their functioning##2##2##(2012-12#1)(2012-3#1)
their functions and adjustments##2##4##(2008-1#1)(2008-4#1)
their functions and##5##3##(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#2)
their functions in##2##3##(2010-10#1)(2012-12#1)
their functions##12##2##(1995-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-1#2)(2012-12#2)
their fundamental##4##2##(2007-12#1)(2009-10#1)(2009-8#1)(2013-1#1)
their further##6##2##(1996-3#1)(2008-10#2)(2009-7#1)(2012-2#1)(2013-8#1)
their future contributions##2##3##(1993-2#2)
their future##9##2##(1992-6#1)(1993-2#2)(1993-3#1)(1996-2#1)(2010-12#1)(2012-2#2)(2013-7#1)
their gas##2##2##(2008-10#1)(2011-2#1)
their gene expression##4##3##(2008-10#1)(2009-2#1)(2012-2#1)(2012-3#1)
their gene products##2##3##(1997-4#1)(2008-7#1)
their gene##9##2##(1997-4#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-2#1)(2012-2#1)(2012-3#1)
their general health##3##3##(1996-6#1)(2011-2#1)(2013-1#1)
their general practitioner##2##3##(1992-5#1)(1994-11#1)
their general##11##2##(1991-11#1)(1992-5#1)(1994-11#1)(1995-12#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
their generally##2##2##(1992-12#1)(2008-5#1)
their genes##2##2##(2008-11#1)(2008-4#1)
their genetic relationship##2##3##(2008-10#1)(2008-12#1)
their genetic##13##2##(1992-10#1)(2007-5#1)(2008-10#5)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)
their genome##4##2##(1996-6#1)(1997-2#1)(1997-6#1)(2009-2#1)
their genomic DNA##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
their genomic##5##2##(1995-8#1)(2008-10#2)(2008-7#1)(2010-3#1)
their geographic origin##2##3##(1994-3#1)(2008-10#1)
their geographic##5##2##(1994-3#1)(2008-10#3)(2010-10#1)
their geographical##5##2##(2008-10#2)(2008-8#2)(2009-6#1)
their germination##2##2##(2008-10#1)(2011-2#1)
their goals##6##2##(1994-3#1)(1996-3#2)(2007-2#1)(2008-12#1)(2008-9#1)
their good##3##2##(1995-8#1)(2008-7#1)(2010-4#1)
their grafts##2##2##(2008-1#1)(2008-4#1)
their greatest##2##2##(1996-11#1)(2008-4#1)
their group##5##2##(1990-12#1)(1997-4#1)(2008-1#1)(2011-2#1)(2012-12#1)
their group's##3##2##(1991-3#1)(2008-5#1)(2009-8#1)
their growth and##2##3##(1996-12#1)(2008-9#1)
their growth in##4##3##(1990-7#1)(1990-8#1)(2008-10#1)(2011-2#1)
their growth promoting activities##2##4##(2008-11#1)(2008-9#1)
their growth rate##3##3##(2008-11#1)(2009-10#2)
their growth##30##2##(1990-7#1)(1990-8#1)(1992-3#1)(1992-9#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-6#1)(2011-2#1)(2012-2#1)
their hand##5##2##(2008-6#2)(2008-9#3)
their hands##5##2##(1997-4#1)(2010-4#1)(2010-5#1)(2012-12#2)
their health and##6##3##(1994-3#1)(1997-1#1)(1997-3#1)(2008-12#1)(2012-2#1)(2013-1#1)
their health care expenditures##2##4##(1994-1#1)(1995-2#1)
their health care##7##3##(1994-1#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-10#1)(2012-3#1)(2013-7#1)
their health status and##2##4##(1996-2#1)(2010-10#1)
their health status##6##3##(1996-2#1)(2008-9#1)(2010-10#2)(2011-2#2)
their health##42##2##(1991-6#1)(1993-1#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-3#2)(2007-12#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-9#1)(2009-6#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-9#3)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
their healthcare##8##2##(2007-12#2)(2008-3#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-1#1)
their healthy##2##2##(1996-3#1)(2013-1#1)
their hearing peers##2##3##(2008-9#1)(2012-2#1)
their hearing##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
their heavy##2##2##(1997-4#1)(2008-4#1)
their high affinity for##3##4##(2008-10#1)(2008-7#1)(2013-7#1)
their high levels of##2##4##(2008-1#1)(2010-2#1)
their high##30##2##(1991-12#1)(1995-11#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-2#1)(2013-1#1)(2013-7#1)
their higher##5##2##(1990-11#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-8#1)
their highest##2##2##(2010-3#1)(2013-7#1)
their histologic##3##2##(1990-2#1)(1994-1#1)(2010-3#1)
their history and##2##3##(2010-12#1)(2012-2#1)
their history##5##2##(2008-11#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-2#1)
their home and##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
their home##9##2##(1990-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
their homes and##3##3##(2009-9#1)(2012-2#1)(2013-1#1)
their homes##13##2##(1990-12#1)(1991-12#1)(1993-3#2)(1995-1#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
their homologous##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
their homologues##2##2##(1995-8#1)(2011-2#1)
their hospital##7##2##(1991-12#1)(1992-1#1)(1993-2#1)(1995-2#1)(1995-6#2)(2008-7#1)
their hospitals##2##2##(1996-9#1)(2008-12#1)
their host##14##2##(2008-10#6)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#2)
their hosts##16##2##(1997-7#2)(2008-10#4)(2008-8#4)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
their house##2##2##(1992-12#1)(1993-1#1)
their human##3##2##(1991-6#1)(1993-2#1)(1997-7#1)
their husbands and their newborns##2##5##(2011-1#2)
their husbands and##3##3##(2008-9#1)(2011-1#2)
their husbands from##2##3##(1994-6#1)(2011-1#1)
their husbands##6##2##(1994-6#1)(2008-9#2)(2011-1#3)
their husbands'##3##2##(2008-9#3)
their hybrid##2##2##(2008-9#1)(2010-3#1)
their hydrolysis products##2##3##(2008-10#2)
their hydrolysis##5##2##(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)
their ideas##2##2##(2008-12#1)(2013-1#1)
their identification and##2##3##(2008-11#1)(2009-4#1)
their identification by##2##3##(2008-1#1)(2008-10#1)
their identification##12##2##(1992-11#1)(1992-6#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-3#1)
their identities##2##2##(2007-11#1)(2008-9#1)
their identity##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
their illness and##2##3##(1992-12#1)(1993-3#1)
their illness##11##2##(1992-12#2)(1993-12#1)(1993-3#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
their immature##3##2##(2006-5#1)(2009-7#1)(2013-8#1)
their immediate##4##2##(1996-2#2)(2008-9#1)(2010-12#1)
their immunogenicity##3##2##(1990-12#1)(2008-10#1)(2010-12#1)
their immunoglobulin##2##2##(1994-3#1)(1995-2#1)
their impact in##2##3##(2008-7#1)(2011-2#1)
their impact on the##11##4##(1994-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-7#1)(2012-2#1)(2013-1#1)
their impact on##33##3##(1992-1#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
their impact##40##2##(1992-1#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#4)(1996-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
their impacts##2##2##(2008-7#1)(2011-2#1)
their implantation and##2##3##(2009-10#1)(2012-2#1)
their implantation##3##2##(2009-10#1)(2012-1#1)(2012-2#1)
their implants##2##2##(2008-9#1)(2012-2#1)
their implementation##7##2##(1991-1#1)(1994-2#1)(1997-7#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
their implications for##16##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
their implications in##3##3##(1990-6#1)(2008-7#1)(2013-8#1)
their implications to##2##3##(2007-7#1)(2008-5#1)
their implications##25##2##(1990-6#1)(1995-1#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
their import##2##2##(1994-6#1)(2008-8#1)
their importance as##2##3##(2008-7#2)
their importance for the##2##4##(2008-10#1)(2010-6#1)
their importance for##4##3##(2008-10#2)(2010-10#1)(2010-6#1)
their importance in##7##3##(1995-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
their importance to##2##3##(1993-3#1)(2008-7#1)
their importance##18##2##(1993-3#1)(1995-1#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-7#3)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
their improvement##2##2##(1995-2#1)(2008-7#1)
their in vitro growth##2##4##(2008-10#2)
their in vitro##8##3##(1995-3#1)(2008-10#3)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
their in vivo##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
their in##13##2##(1995-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
their inability to##2##3##(2010-8#1)(2011-2#1)
their inception##2##2##(1997-3#1)(2009-9#1)
their incidence##2##2##(1992-9#1)(2013-7#1)
their inclusion##2##2##(1996-5#1)(2008-5#1)
their income##5##2##(1996-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-8#1)
their incorporation into##2##3##(2008-10#1)(2008-7#1)
their incorporation##3##2##(2008-10#2)(2008-7#1)
their increased##5##2##(1993-12#2)(2008-9#1)(2012-12#1)(2012-2#1)
their increasing use##2##3##(2008-11#1)(2008-8#1)
their increasing##8##2##(1994-3#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#1)
their independent##2##2##(2008-4#1)(2008-8#1)
their indications##3##2##(1993-2#1)(2007-8#1)(2010-8#1)
their individual##11##2##(1992-1#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)
their induction##2##2##(1994-8#1)(2011-2#1)
their infants##8##2##(1991-11#1)(1991-2#1)(1992-12#1)(1995-1#1)(2007-2#1)(2009-11#1)(2009-9#2)
their infection##3##2##(2008-10#1)(2010-11#1)(2010-12#1)
their infectivity##2##2##(2008-10#1)(2008-9#1)
their influence on the##3##4##(2008-10#2)(2013-8#1)
their influence on##11##3##(1994-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
their influence##16##2##(1994-8#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
their influences on##2##3##(2008-8#1)(2013-1#1)
their information##3##2##(1992-11#1)(1996-9#1)(1997-3#1)
their inherent##8##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)
their inhibition##2##2##(1992-8#1)(1993-8#1)
their inhibitory activities##2##3##(1992-6#1)(1995-3#1)
their inhibitory activity##4##3##(1992-8#1)(2008-4#1)(2011-1#1)(2013-1#1)
their inhibitory effect##2##3##(1993-12#1)(1994-5#1)
their inhibitory effects on##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
their inhibitory##12##2##(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
their initial##17##2##(1993-12#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
their insertion##2##2##(2008-2#1)(2013-1#1)
their instability##2##2##(1995-3#1)(2012-3#1)
their institution##2##2##(1992-1#1)(1995-1#1)
their institution's##2##2##(1996-1#1)(1996-2#1)
their institutions##4##2##(1991-12#1)(1994-1#1)(1994-3#1)(2009-5#1)
their instruments##2##2##(2010-3#2)
their insulin secretion##2##3##(1994-12#1)(2010-11#1)
their insulin-sensitizing##2##2##(2008-3#1)(2013-1#1)
their intake##2##2##(1993-12#1)(2008-4#1)
their integrated##3##2##(2007-12#1)(2009-4#1)(2011-2#1)
their integration##6##2##(1994-3#1)(2008-11#2)(2009-12#1)(2009-9#1)(2011-7#1)
their intended use##2##3##(2007-11#1)(2011-2#1)
their intended##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
their interaction in##2##3##(2007-11#1)(2008-8#1)
their interaction with nuclear##2##4##(2008-10#1)(2011-2#1)
their interaction with other##2##4##(1995-2#1)(2012-3#1)
their interaction with the##2##4##(1995-2#1)(2012-1#1)
their interaction with##23##3##(1990-12#1)(1990-2#2)(1990-5#1)(1992-11#1)(1994-2#1)(1995-2#2)(1995-5#1)(1995-6#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
their interaction##39##2##(1990-12#1)(1990-2#2)(1990-5#1)(1992-11#1)(1993-11#1)(1994-2#1)(1995-2#2)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#3)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
their interactions with the##3##4##(2010-2#1)(2010-5#1)(2012-1#1)
their interactions with##10##3##(1990-12#1)(1992-11#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)
their interactions##26##2##(1990-12#1)(1992-11#1)(1994-9#1)(2007-2#1)(2007-6#1)(2008-10#9)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)
their interest##3##2##(2007-12#1)(2010-9#1)(2013-8#1)
their interests##3##2##(1992-3#1)(2008-11#1)(2008-6#1)
their interference##2##2##(2007-11#1)(2008-10#1)
their internal##6##2##(1994-3#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-6#1)
their interpersonal##2##2##(1993-2#1)(2008-12#1)
their interpretation##6##2##(1993-3#1)(1995-5#1)(2008-10#2)(2008-8#1)(2013-8#1)
their interpretations##2##2##(2008-11#2)
their intracellular##2##2##(2008-8#1)(2010-5#1)
their intrinsic##5##2##(2007-11#1)(2008-10#1)(2009-3#1)(2009-8#1)(2010-10#1)
their introduction in##2##3##(2008-7#1)(2010-12#1)
their introduction##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
their invasion##2##2##(2008-11#2)
their investigation##2##2##(1995-6#1)(2013-1#1)
their investment in sexual reproduction##2##5##(2012-3#2)
their involvement in##8##3##(1994-11#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)
their involvement##12##2##(1994-11#1)(1994-12#1)(1995-3#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)
their ionic##2##2##(2008-10#1)(2013-1#1)
their ionized##2##2##(2008-10#2)
their isolation##2##2##(2006-12#1)(2007-7#1)
their job satisfaction##3##3##(1995-1#1)(1995-2#1)(2013-1#1)
their job##13##2##(1990-12#2)(1991-11#2)(1995-1#1)(1995-2#1)(1997-2#2)(2010-9#1)(2013-1#3)(2013-8#1)
their jobs##11##2##(1991-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#1)(1997-3#2)(2007-12#1)(2008-12#1)
their joint##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
their journey##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
their karyotypes##2##2##(2008-12#1)(2010-3#1)
their key##3##2##(2008-3#1)(2012-1#1)(2012-3#1)
their kinetic properties##2##3##(1993-8#1)(1996-5#1)
their kinetic##5##2##(1993-8#1)(1996-5#1)(2008-10#2)(2008-12#1)
their knowledge and skills in##2##5##(2008-11#1)(2008-7#1)
their knowledge and##10##3##(1993-2#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-1#1)(2011-3#1)(2011-7#1)(2012-12#1)
their knowledge of##6##3##(1994-12#1)(1996-6#1)(2008-11#1)(2011-1#1)(2013-1#2)
their knowledge##25##2##(1993-2#1)(1994-12#1)(1996-6#1)(1997-3#1)(2008-11#7)(2008-12#2)(2008-7#2)(2009-5#1)(2010-9#1)(2011-1#2)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
their known##2##2##(1995-5#1)(2008-5#1)
their lack of toxicity##2##4##(1991-12#1)(2008-10#1)
their lack of##3##3##(1991-12#1)(2008-10#2)
their large size and##2##4##(2008-4#1)(2012-3#1)
their large size##3##3##(2008-4#1)(2009-11#1)(2012-3#1)
their large##10##2##(1993-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
their larger##2##2##(2007-12#1)(2008-10#1)
their last##4##2##(1990-6#1)(1991-2#1)(1994-2#1)(1994-9#1)
their learning and##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
their learning in##2##3##(2012-3#1)(2013-1#1)
their learning needs##3##3##(1992-12#1)(2008-11#1)(2012-3#1)
their learning##20##2##(1991-2#1)(1992-12#1)(2008-11#7)(2008-12#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
their legal##2##2##(1995-1#1)(2008-11#1)
their length##5##2##(1990-6#1)(2008-9#2)(2010-4#1)(2012-2#1)
their lesion##2##2##(1991-1#1)(1995-11#1)
their level of resistance##2##4##(2008-10#2)
their level of##16##3##(1993-2#2)(1994-2#1)(1996-1#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-2#1)(2010-5#1)(2013-8#2)
their levels of##4##3##(1995-2#1)(1996-12#1)(2008-10#2)
their levels##7##2##(1993-6#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2012-1#1)
their liability##2##2##(1995-2#1)(1997-5#1)
their life in the##2##4##(1994-11#1)(2008-7#1)
their life in##3##3##(1994-11#1)(2007-1#1)(2008-7#1)
their life span##2##3##(2008-10#1)(2010-8#1)
their life##23##2##(1993-9#1)(1994-11#1)(2007-1#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
their lifetime##6##2##(1990-6#2)(1990-8#1)(2008-8#1)(2009-5#1)(2010-10#1)
their lifetimes##3##2##(2008-8#1)(2008-9#2)
their ligands##7##2##(2008-11#1)(2008-4#3)(2008-5#1)(2009-8#1)(2013-1#1)
their likelihood of##3##3##(1992-12#1)(2008-11#1)(2008-8#1)
their likelihood##5##2##(1992-12#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-9#1)
their limitations and##2##3##(2008-10#1)(2011-2#1)
their limitations##10##2##(2008-10#2)(2008-11#2)(2008-9#1)(2009-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
their limited##3##2##(1996-4#1)(1997-9#1)(2011-2#1)
their limits##3##2##(1996-5#1)(2008-8#1)(2012-2#1)
their line##2##2##(2008-3#1)(2008-6#1)
their lineages##2##2##(2007-12#2)
their linear##4##2##(1994-6#1)(1997-3#1)(2008-11#1)(2008-7#1)
their lipid##2##2##(2008-11#1)(2008-4#1)
their lives as##2##3##(2008-11#1)(2013-1#1)
their lives##20##2##(1990-2#1)(1992-1#1)(1993-3#1)(1994-9#1)(1995-1#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#2)
their living##4##2##(1997-3#1)(2009-6#1)(2011-2#2)
their local##7##2##(1996-3#1)(1997-3#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)
their localization and##2##3##(2008-8#1)(2010-9#1)
their localization##4##2##(1994-3#1)(2008-7#1)(2008-8#1)(2010-9#1)
their location in the##2##4##(2008-4#1)(2008-9#1)
their location in##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
their location within##2##3##(2008-12#1)(2008-7#1)
their location##7##2##(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#1)
their locations##6##2##(2007-8#1)(2008-3#1)(2009-7#1)(2010-10#1)(2013-1#2)
their long##6##2##(1993-8#1)(2008-10#1)(2008-8#1)(2011-1#2)(2012-2#1)
their long-term##11##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
their longest##2##2##(2008-3#1)(2011-2#1)
their longitudinal##3##2##(2008-3#1)(2010-1#1)(2013-1#1)
their low##11##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-4#1)(2013-1#2)
their lower##4##2##(1994-11#1)(2007-11#1)(2008-12#1)(2012-12#1)
their mRNA##2##2##(1995-2#1)(2008-9#1)
their main##11##2##(1995-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)
their maintenance##4##2##(1991-12#1)(2008-4#2)(2013-1#1)
their male##5##2##(1991-6#1)(1995-6#1)(1997-6#1)(2009-1#1)(2010-5#1)
their malignant##2##2##(2008-12#1)(2011-2#1)
their management##18##2##(1995-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-3#1)(2013-8#2)
their mandate##2##2##(2011-2#2)
their manufacture##2##2##(2008-10#1)(2013-1#1)
their marketing##2##2##(2008-12#2)
their mate##2##2##(2008-8#1)(2009-6#1)
their material##2##2##(2008-10#1)(2009-11#1)
their mates##3##2##(2008-9#2)(2012-3#1)
their matrix##3##2##(2008-10#1)(2012-2#2)
their maturation##3##2##(2006-10#1)(2008-4#1)(2013-1#1)
their mature##2##2##(1995-2#1)(2008-8#1)
their maximal##2##2##(1990-5#1)(2013-8#1)
their maximum##5##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
their mean##5##2##(1997-3#1)(2008-2#1)(2008-3#1)(2009-7#2)
their measurement##3##2##(1995-2#1)(2009-11#1)(2012-8#1)
their mechanical properties##2##3##(2009-7#1)(2011-1#1)
their mechanical stability in bioreactors##2##5##(2008-7#2)
their mechanical##6##2##(2008-7#2)(2009-7#2)(2011-1#1)(2012-2#1)
their mechanism of action##4##4##(1992-8#1)(1993-8#1)(2011-2#1)(2012-12#1)
their mechanism of##7##3##(1992-8#1)(1993-8#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
their mechanism##8##2##(1992-8#1)(1993-8#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
their mechanisms are##2##3##(2008-10#1)(2008-4#1)
their mechanisms in##2##3##(2008-5#1)(2009-2#1)
their mechanisms of action and##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
their mechanisms of action are##2##5##(1995-12#1)(2008-7#1)
their mechanisms of action##10##4##(1995-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
their mechanisms of##11##3##(1995-12#1)(1995-5#1)(2008-10#3)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
their mechanisms##16##2##(1995-12#1)(1995-5#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#3)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
their medial post-stressed vowels##2##4##(2009-11#2)
their median##2##2##(1991-2#2)
their medical staff##3##3##(1991-1#1)(1994-1#1)(1994-3#1)
their medical##8##2##(1991-1#1)(1992-2#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(2007-12#1)(2013-8#1)
their medication##12##2##(1993-11#1)(2007-7#1)(2008-11#4)(2008-3#1)(2010-1#1)(2011-1#3)(2012-12#1)
their medications##2##2##(2008-11#1)(2008-8#1)
their members##4##2##(1991-2#1)(1993-1#1)(2007-4#1)(2008-11#1)
their membership##2##2##(2008-1#1)(2013-1#1)
their membrane##3##2##(1991-9#1)(2011-1#2)
their membranes##2##2##(2008-10#2)
their memory##2##2##(2008-12#1)(2008-7#1)
their mental health##3##3##(2008-12#1)(2010-8#1)(2012-3#1)
their mental##5##2##(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
their mentor##2##2##(2008-11#1)(2012-3#1)
their merits and##3##3##(2008-8#1)(2010-12#1)(2013-1#1)
their merits##4##2##(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
their metabolic##7##2##(1993-1#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2011-1#1)
their metabolism##4##2##(1990-5#1)(1994-3#1)(2006-10#1)(2012-3#1)
their metabolites are##3##3##(2008-10#1)(2008-11#2)
their metabolites##13##2##(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#4)(2013-1#1)
their metal##7##2##(2008-10#6)(2008-5#1)
their methods##2##2##(1993-2#1)(2007-11#1)
their microenvironment##2##2##(2010-10#1)(2013-8#1)
their migration into the##2##4##(1997-8#1)(2008-11#1)
their migration##5##2##(1997-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-8#1)
their mitochondrial##2##2##(1990-12#1)(1995-11#1)
their mixture##6##2##(2008-10#6)
their mixtures##7##2##(2008-10#7)
their mobility##3##2##(2007-11#1)(2008-11#1)(2010-1#1)
their mode of action##2##4##(2009-6#1)(2011-2#1)
their mode of##4##3##(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
their modest##2##2##(1991-6#1)(2008-3#1)
their modulation by##3##3##(1993-2#1)(2008-5#1)(2008-7#1)
their modulation##4##2##(1993-2#1)(2008-2#1)(2008-5#1)(2008-7#1)
their molecular size##2##3##(1991-7#1)(2008-7#1)
their molecular weight##3##3##(2008-4#2)(2008-5#1)
their molecular##19##2##(1990-12#1)(1990-2#1)(1991-7#1)(1992-6#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
their monitoring in##2##3##(2008-10#2)
their more##8##2##(1995-3#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#4)
their morphological##6##2##(1996-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
their morphologies##2##2##(2008-11#2)
their morphology and##2##3##(2008-11#1)(2008-6#1)
their morphology##8##2##(2008-11#3)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)
their mortality##2##2##(2007-7#1)(2008-5#1)
their most important##2##3##(1996-1#1)(1996-3#1)
their most##13##2##(1991-2#1)(1991-3#1)(1994-1#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-4#1)(2008-6#2)(2009-5#2)(2011-2#1)(2013-1#1)
their mother##6##2##(1994-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-5#1)(2013-1#1)
their mothers and##2##3##(1997-5#1)(2008-2#1)
their mothers##12##2##(1990-11#1)(1990-2#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-7#2)(2011-1#1)(2012-12#1)(2013-8#1)
their mothers' smoking##2##3##(2009-5#2)
their mothers'##4##2##(2007-2#1)(2009-5#2)(2009-7#1)
their motility##3##2##(1997-7#1)(2008-4#1)(2013-8#1)
their motivation for##2##3##(1990-6#1)(2012-1#1)
their motivations##2##2##(1993-12#2)
their movement##2##2##(1993-6#1)(2007-11#1)
their multiple##2##2##(1993-12#1)(2008-9#1)
their muscle##2##2##(2008-11#1)(2008-7#1)
their mutual interactions##2##3##(1992-8#1)(2008-9#1)
their mutual##5##2##(1992-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
their natal##2##2##(2008-8#1)(2008-9#1)
their native##13##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#4)(2010-9#1)(2011-2#1)(2013-8#1)
their natural function##2##3##(2008-7#1)(2010-12#1)
their natural##19##2##(1995-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
their naturally occurring##2##3##(1990-2#1)(2008-4#1)
their nature and##4##3##(1995-1#1)(1996-2#1)(2008-10#1)(2012-2#1)
their nature##6##2##(1990-7#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
their need##3##2##(1992-3#1)(2008-3#1)(2010-2#1)
their needs in##2##3##(1993-2#1)(2012-12#1)
their needs##13##2##(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(2008-11#2)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
their negative##5##2##(1991-6#1)(1992-2#1)(1995-2#1)(2012-12#1)(2013-8#1)
their neighborhoods##2##2##(2007-9#1)(2009-9#1)
their network##2##2##(1996-12#1)(1996-2#1)
their neural##2##2##(1997-6#1)(2008-5#1)
their neutral##2##2##(2008-10#1)(2012-2#1)
their new##5##2##(1991-3#1)(1992-1#1)(2008-11#1)(2010-4#1)(2013-1#1)
their newborn##3##2##(2007-12#1)(2007-2#1)(2008-8#1)
their nontransgenic littermates##4##3##(1992-11#1)(1992-8#3)
their normal counterparts##4##3##(1991-8#1)(2008-6#1)(2008-9#1)(2010-7#1)
their normal##18##2##(1991-8#1)(1993-3#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
their nuclei##4##2##(1992-3#1)(2008-3#1)(2008-8#1)(2008-9#1)
their nucleotide sequences##4##3##(1990-5#1)(1997-6#1)(1997-8#1)(2008-8#1)
their nucleotide##6##2##(1990-5#1)(1993-6#1)(1997-6#1)(1997-8#1)(2008-8#1)(2013-8#1)
their number and##2##3##(1995-12#1)(2008-10#1)
their number##8##2##(1992-5#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
their numbers in##2##3##(1994-3#1)(2010-10#1)
their nursing actions##2##3##(2008-11#1)(2012-3#1)
their nursing role##2##3##(2013-1#2)
their nursing##8##2##(2008-11#2)(2008-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
their objections to##2##3##(1995-5#1)(2008-11#1)
their objectives##2##2##(2007-7#1)(2011-2#1)
their observations##2##2##(1994-2#1)(2008-9#1)
their occupational##2##2##(1991-3#1)(2009-12#1)
their occurrence and##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
their occurrence##7##2##(1990-9#1)(1991-5#1)(1994-3#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
their offspring##13##2##(2008-2#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
their ongoing##2##2##(2008-7#1)(2013-1#1)
their online##2##2##(1993-2#1)(2008-12#1)
their onset and##2##3##(2007-7#1)(2013-1#1)
their operation##5##2##(1992-11#1)(1996-2#1)(2007-12#2)(2009-5#1)
their operational##2##2##(1991-12#1)(2010-9#1)
their operations##3##2##(1992-12#1)(1993-2#1)(1994-3#1)
their opinion of##2##3##(1990-5#1)(1991-2#1)
their opinion##3##2##(1990-5#1)(1991-2#1)(1992-2#1)
their opinions##2##2##(1995-5#1)(2013-8#1)
their opportunities for##2##3##(1995-12#1)(2012-2#1)
their opposite effects on##2##4##(1991-2#1)(1994-9#1)
their optical properties##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
their optical##12##2##(1997-7#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-4#1)
their optimal##7##2##(1995-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
their optimum values##2##3##(2007-11#1)(2008-10#1)
their optimum##3##2##(2007-11#1)(2008-10#1)(2009-11#1)
their oral##2##2##(1990-2#1)(2012-1#1)
their organic##2##2##(2008-10#2)
their organization##6##2##(1994-1#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-9#1)
their organization's##2##2##(1992-12#1)(1995-3#1)
their organizations to##2##3##(1995-3#1)(1997-1#1)
their organizations##8##2##(1992-2#1)(1993-2#1)(1994-1#1)(1995-3#1)(1996-3#2)(1997-1#1)(2013-1#1)
their orientation##9##2##(1991-5#1)(1993-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-9#1)
their origin and##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
their origin##12##2##(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)
their original positions##3##3##(1992-9#1)(1996-10#1)(2007-5#1)
their original##16##2##(1992-5#1)(1992-9#1)(1996-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)
their origins##9##2##(1991-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-5#1)
their osteogenic##2##2##(2008-11#1)(2008-5#1)
their outcome##3##2##(2010-11#1)(2010-3#2)
their outcomes##4##2##(1996-2#1)(1996-4#1)(2008-11#1)(2011-3#1)
their outer##4##2##(1995-12#2)(2008-10#1)(2008-7#1)
their output##3##2##(1995-11#1)(1995-3#1)(2008-3#1)
their overall health##2##3##(2008-7#1)(2013-8#1)
their overall stability constants##2##4##(2008-10#2)
their overall treatment##2##3##(1993-2#1)(2013-1#1)
their overall##18##2##(1991-2#1)(1993-2#1)(1996-3#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#1)
their overexpression##2##2##(2013-1#2)
their own and their##3##4##(2010-8#1)(2012-3#2)
their own care##2##3##(1992-3#1)(2013-1#1)
their own data##2##3##(2008-7#1)(2008-9#1)
their own facilities##2##3##(1994-1#1)(1995-1#1)
their own health##8##3##(1991-12#1)(1994-2#1)(1994-6#1)(1996-6#3)(2008-6#1)(2013-7#1)
their own healthcare##3##3##(2007-12#2)(2008-8#1)
their own homes##5##3##(1991-8#2)(1996-5#1)(2010-10#2)
their own institution##2##3##(1994-3#1)(2009-4#1)
their own or##2##3##(2008-7#1)(2009-12#1)
their own personal##3##3##(1992-3#1)(2008-11#2)
their own practices##3##3##(1991-6#1)(1993-3#1)(2007-5#1)
their own professional##2##3##(2008-11#2)
their own requirements##2##3##(1993-2#1)(1994-3#1)
their own right##4##3##(1990-12#1)(1992-2#1)(2010-10#1)(2010-7#1)
their own signal##2##3##(2008-4#1)(2008-8#1)
their own use##2##3##(1994-12#1)(2008-11#1)
their own values and##2##4##(2008-12#1)(2010-5#1)
their own values##4##3##(1993-2#1)(2008-12#2)(2010-5#1)
their own words##5##3##(2008-4#1)(2008-6#1)(2011-2#3)
their own##199##2##(1990-12#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#2)(1993-1#3)(1993-12#3)(1993-2#5)(1993-3#5)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#7)(1995-2#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#2)(1997-3#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#14)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#4)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#8)(2013-1#3)(2013-7#1)
their oxidation##4##2##(2008-10#4)
their pain##7##2##(2007-11#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-6#3)
their parameters##3##2##(2008-3#2)(2008-6#1)
their parasites##3##2##(2008-1#1)(2008-8#1)(2012-3#1)
their parasitic##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
their parent##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
their parental##7##2##(1995-12#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-5#1)
their parents and##2##3##(2009-11#1)(2012-2#1)
their parents were##3##3##(1995-2#1)(2007-7#1)(2008-3#1)
their parents##37##2##(1990-12#2)(1990-9#1)(1991-2#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#2)(2007-7#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#3)
their participation in the##4##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
their participation in##7##3##(1994-1#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
their participation##11##2##(1992-12#1)(1994-1#1)(1994-8#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#2)
their particular##6##2##(1992-12#1)(2007-12#1)(2008-10#1)(2009-5#1)(2009-9#1)(2013-1#1)
their partner##6##2##(1995-6#1)(2007-12#2)(2008-8#1)(2010-5#1)(2012-12#1)
their partners from##2##3##(2008-12#2)
their partners in a##2##4##(2008-9#1)(2011-2#1)
their partners in##3##3##(2007-2#1)(2008-9#1)(2011-2#1)
their partners##13##2##(2007-2#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#2)(2013-1#2)
their parts##2##2##(2008-9#1)(2013-1#1)
their pastoral##2##2##(1991-2#1)(2010-9#1)
their pathogenesis##2##2##(2008-4#1)(2011-2#1)
their pathogenic potential##2##3##(2008-10#1)(2011-1#1)
their pathogenic##3##2##(2007-6#1)(2008-10#1)(2011-1#1)
their pathogenicity in##2##3##(2008-10#1)(2012-3#1)
their pathogenicity on##3##3##(2008-10#3)
their pathogenicity##7##2##(2008-10#6)(2012-3#1)
their pathogens##3##2##(2008-10#2)(2009-5#1)
their pathological##2##2##(1991-12#1)(2008-6#1)
their pathotype##2##2##(2008-10#2)
their patient volume##2##3##(1994-2#1)(1997-1#1)
their patient##6##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1997-1#1)
their patients and##8##3##(1991-11#1)(1992-2#1)(1995-3#1)(1997-3#1)(2008-11#1)(2009-9#1)(2012-1#1)(2013-1#1)
their patients in##2##3##(1990-2#1)(2006-7#1)
their patients to##3##3##(1997-6#1)(2010-9#1)(2011-1#1)
their patients with##2##3##(1995-3#1)(1997-3#1)
their patients##55##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#4)(2008-3#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
their patients'##7##2##(1993-12#1)(1994-2#1)(1997-2#1)(2008-7#2)(2008-8#1)(2012-12#1)
their pattern of##2##3##(2008-11#1)(2012-3#1)
their pattern##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
their patterns of##5##3##(1994-2#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#1)
their peak experiences##2##3##(2013-8#2)
their peak##6##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#3)
their peers##11##2##(1993-1#1)(1997-1#1)(2008-11#2)(2008-9#1)(2009-7#2)(2012-1#1)(2013-1#2)(2013-8#1)
their pension plans##2##3##(1993-3#2)
their perceived##7##2##(1996-2#1)(2008-11#3)(2010-9#2)(2011-2#1)
their perception of the##3##4##(1991-2#1)(1992-11#1)(1992-12#1)
their perception of##6##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(2010-8#1)(2013-7#1)
their perception##8##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(2008-11#1)(2008-6#1)(2010-8#1)(2013-7#1)
their perceptions and##2##3##(1992-2#1)(2012-3#1)
their perceptions of the##6##4##(1993-1#1)(2007-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#1)
their perceptions of their##2##4##(1992-1#1)(2008-9#1)
their perceptions of##15##3##(1992-1#1)(1993-1#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
their perceptions##19##2##(1992-1#1)(1992-2#1)(1993-1#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)
their percutaneous##2##2##(2008-5#1)(2010-12#1)
their performance as##3##3##(2007-11#2)(2008-10#1)
their performance has been##2##4##(2007-11#1)(2009-6#1)
their performance has##3##3##(2007-11#1)(2008-2#1)(2009-6#1)
their performance in##9##3##(1991-2#1)(1993-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2012-2#1)
their performance of##2##3##(1992-11#1)(2008-10#1)
their performance on##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
their performance was##3##3##(1993-12#1)(2008-7#1)(2008-8#1)
their performance##44##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#3)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-6#1)(2009-9#1)(2010-8#1)(2012-2#3)
their performances##2##2##(1997-7#1)(2008-3#1)
their peripheral##2##2##(1991-3#1)(2008-5#1)
their periphery##2##2##(1992-9#1)(2009-11#1)
their personal experience##2##3##(1990-5#1)(1990-9#1)
their personal experiences##2##3##(2008-12#1)(2010-3#1)
their personal##18##2##(1990-5#1)(1990-9#1)(1991-3#1)(1992-6#1)(1993-1#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-9#1)(2007-11#1)(2007-7#2)(2008-11#2)(2008-12#1)(2009-5#1)(2010-3#1)
their personnel##2##2##(2007-2#2)
their perspective on##2##3##(1994-1#1)(2009-9#1)
their perspective##6##2##(1994-1#1)(2007-3#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#1)
their pharmaceutical preparations##3##3##(2008-10#3)
their pharmaceutical##7##2##(2008-10#7)
their pharmacokinetics##2##2##(2007-11#1)(2013-1#1)
their phenotypic##3##2##(2008-7#1)(2010-3#1)(2013-1#1)
their phylogenetic##4##2##(1993-11#1)(1997-6#1)(2008-7#1)(2010-10#1)
their physical and##2##3##(1990-9#1)(2012-12#1)
their physical properties##2##3##(2008-11#1)(2008-5#1)
their physical##13##2##(1990-9#1)(1991-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
their physician##6##2##(1993-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)
their physicians for##2##3##(2006-5#1)(2008-11#1)
their physicians##12##2##(1990-8#1)(1991-1#1)(1996-3#1)(1997-6#1)(2006-5#1)(2008-11#2)(2008-6#1)(2009-5#2)(2010-8#1)(2012-3#1)
their physico-chemical properties##5##3##(2008-10#2)(2008-5#2)(2012-1#1)
their physicochemical parameters##2##3##(1996-5#1)(2008-10#1)
their physicochemical properties##3##3##(1996-5#1)(2008-5#2)
their physicochemical##5##2##(1996-5#2)(2008-10#1)(2008-5#2)
their physiological functions##2##3##(1994-9#1)(2008-4#1)
their physiological##9##2##(1994-9#1)(1996-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-1#1)(2012-12#1)(2012-2#1)
their place in##4##3##(1994-3#1)(2008-11#1)(2008-2#1)(2012-12#1)
their place of##2##3##(2008-10#1)(2010-10#1)
their place##7##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-10#1)(2012-12#1)
their placement##5##2##(2008-4#1)(2012-12#1)(2013-1#3)
their places of##2##3##(2010-10#1)(2013-1#1)
their plans##3##2##(1994-1#1)(1996-3#1)(2008-6#1)
their plant##2##2##(2008-10#1)(2008-8#1)
their plasma##4##2##(1990-12#1)(1993-11#1)(1994-6#1)(2012-2#1)
their polarization##2##2##(2007-11#1)(2008-2#1)
their poor##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
their population density##2##3##(2008-9#1)(2013-8#1)
their population##5##2##(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
their populations##3##2##(1994-3#1)(1995-3#1)(2008-10#1)
their position and##2##3##(2007-11#1)(2011-2#1)
their position in##2##3##(1994-3#1)(2013-8#1)
their position##6##2##(1994-3#1)(2007-11#1)(2010-9#1)(2011-2#2)(2013-8#1)
their positions##2##2##(2007-12#1)(2008-11#1)
their positive##3##2##(1995-6#1)(2008-10#1)(2011-1#1)
their possibility##2##2##(2008-10#1)(2013-1#1)
their possible role##2##3##(2010-4#1)(2011-2#1)
their possible roles in the##2##5##(1993-12#1)(2008-7#1)
their possible##26##2##(1993-1#1)(1993-12#1)(1997-5#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)
their potencies to##2##3##(1993-12#1)(1995-11#1)
their potencies##5##2##(1992-3#1)(1992-8#1)(1993-12#1)(1995-11#1)(2009-10#1)
their potency##4##2##(1990-12#1)(1995-11#1)(1997-3#1)(2008-8#1)
their potential applications##5##3##(2009-4#1)(2009-5#1)(2010-4#1)(2013-1#2)
their potential as##2##3##(2008-11#1)(2013-1#1)
their potential for##7##3##(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
their potential impact on##2##4##(2008-1#1)(2008-10#1)
their potential role in##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
their potential to increase##2##4##(1995-3#1)(1996-11#1)
their potential to##10##3##(1993-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
their potential toxic##2##3##(2008-10#2)
their potential use##3##3##(2008-10#1)(2009-8#2)
their potential##62##2##(1990-6#1)(1993-6#1)(1993-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#5)
their practical applications##2##3##(2010-12#1)(2011-2#1)
their practical##4##2##(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
their practice patterns##2##3##(1994-2#1)(2008-11#1)
their practice##17##2##(1994-2#1)(1995-3#1)(1996-1#1)(1996-7#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-11#5)(2008-12#2)(2010-3#1)(2010-8#1)(2011-2#1)
their practices and##2##3##(1996-2#1)(2008-6#1)
their practices##11##2##(1993-12#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-9#3)
their precise##4##2##(1993-6#1)(2008-3#1)(2012-2#1)(2012-3#1)
their precursors##2##2##(1995-3#1)(2008-10#1)
their predicted##3##2##(1993-1#1)(1993-9#1)(2008-7#1)
their predominant##2##2##(2008-10#1)(2008-12#1)
their preference##2##2##(1993-6#1)(2007-6#1)
their preferences of##2##3##(2010-2#1)(2013-8#1)
their preferences##3##2##(2008-8#1)(2010-2#1)(2013-8#1)
their preferred##4##2##(1995-11#1)(2007-6#1)(2008-9#1)(2009-6#1)
their pregnancies##3##2##(2007-12#1)(2010-3#1)(2013-1#1)
their pregnancy##2##2##(1990-6#1)(2013-1#1)
their preparation##3##2##(1995-11#1)(2009-10#1)(2012-1#1)
their prescribed##2##2##(2008-11#1)(2010-1#1)
their prescribing##2##2##(2008-11#2)
their presence in##4##3##(1996-1#1)(2007-12#1)(2008-9#1)(2013-8#1)
their presence##14##2##(1994-5#1)(1995-3#1)(1996-1#2)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
their present##3##2##(1990-6#1)(1993-3#1)(1995-3#1)
their presumed##2##2##(1997-3#1)(2007-12#1)
their preterm##2##2##(1992-2#1)(1994-12#1)
their prevalence##5##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
their prevention and treatment##3##4##(2008-8#1)(2009-10#1)(2011-2#1)
their prevention and##4##3##(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)
their previous##7##2##(1994-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-10#1)
their primary##16##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1995-2#1)(1995-3#1)(1997-9#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
their probiotic##2##2##(2008-5#1)(2012-2#1)
their problems##5##2##(1991-2#1)(1991-6#1)(1995-3#1)(1995-9#1)(2006-10#1)
their processes##4##2##(1992-6#1)(2007-12#1)(2008-4#1)(2008-7#1)
their product##2##2##(1997-4#1)(2008-11#1)
their production as##2##3##(1991-12#1)(1997-7#1)
their production##14##2##(1991-12#1)(1994-11#1)(1995-5#1)(1996-2#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#2)(2012-2#1)
their products and services##2##4##(1994-1#1)(1994-3#1)
their products##12##2##(1994-1#1)(1994-3#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-5#2)(2009-5#1)(2009-7#1)(2012-1#1)
their profession##5##2##(1991-3#1)(1992-1#1)(1995-2#1)(2008-7#1)(2012-2#1)
their professional development##2##3##(2008-11#1)(2013-8#1)
their professional practice##3##3##(1997-7#1)(2008-1#1)(2013-1#1)
their professional##17##2##(1997-7#1)(2008-1#2)(2008-11#6)(2008-2#1)(2010-1#1)(2010-10#1)(2010-5#2)(2013-1#2)(2013-8#1)
their progeny##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
their prognosis and##3##3##(1994-7#1)(2008-3#1)(2012-2#1)
their prognostic##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
their program##3##2##(2007-10#1)(2007-9#1)(2011-2#1)
their programs##5##2##(1991-3#1)(1992-3#1)(1994-2#1)(1995-1#1)(2008-10#1)
their progression to##3##3##(2008-1#1)(2010-8#1)(2013-1#1)
their project##2##2##(1991-1#2)
their projects##2##2##(2012-2#1)(2012-3#1)
their prokaryotic##2##2##(2008-7#1)(2009-2#1)
their proliferative##4##2##(1992-5#1)(2008-4#1)(2008-5#1)(2008-7#1)
their promoter regions##3##3##(1994-11#1)(1997-2#1)(2008-8#1)
their promoter##6##2##(1992-9#1)(1994-11#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-8#1)
their promoters##2##2##(2008-7#1)(2012-3#1)
their propagation##2##2##(1993-12#1)(2008-9#1)
their proper##4##2##(1994-9#1)(2008-1#1)(2008-11#1)(2011-2#1)
their properties##13##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2011-2#1)
their protection##2##2##(2013-1#2)
their protective##5##2##(1995-12#2)(2008-12#1)(2008-7#1)(2009-8#1)
their protein##3##2##(1992-6#1)(2008-5#1)(2011-2#1)
their providers##3##2##(1995-1#1)(2008-12#1)(2013-1#1)
their psychological##2##2##(2007-7#1)(2008-2#1)
their psychosocial##2##2##(1991-1#1)(2009-5#1)
their purification##5##2##(1995-12#1)(2008-4#4)
their purpose##3##2##(1993-12#1)(1997-1#1)(2008-3#1)
their putative##3##2##(1992-5#1)(2008-11#1)(2012-2#1)
their quality is##2##3##(1991-6#1)(2007-7#1)
their quality of life and##3##5##(2008-6#1)(2009-11#1)(2011-2#1)
their quality of life##10##4##(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#3)(2013-7#1)(2013-8#1)
their quality of##11##3##(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#3)(2013-7#1)(2013-8#2)
their quality##18##2##(1991-6#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#3)
their quantification##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
their range##2##2##(2009-4#1)(2013-1#1)
their rank order##2##3##(1990-11#1)(2009-12#1)
their rapid##7##2##(1991-4#1)(1992-10#1)(1992-2#1)(1996-6#1)(2008-10#1)(2010-7#1)(2011-1#1)
their rate of##2##3##(2008-10#1)(2008-11#1)
their rate##4##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
their rates of##3##3##(1991-11#1)(1996-2#1)(2013-8#1)
their reaction with##6##3##(2008-10#5)(2008-5#1)
their reaction##9##2##(1994-6#1)(2007-11#1)(2008-10#6)(2008-5#1)
their reactions to##2##3##(2008-10#2)
their reactions with##5##3##(1996-2#1)(2008-10#1)(2008-11#3)
their reactions##9##2##(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#3)
their reactivity with##2##3##(2008-10#1)(2010-11#1)
their reactivity##4##2##(1994-9#1)(2008-10#2)(2010-11#1)
their recently##2##2##(2008-9#1)(2012-3#1)
their receptor##2##2##(2008-1#1)(2008-9#1)
their receptors are##4##3##(2008-1#1)(2008-4#3)
their receptors in the##4##4##(1996-12#1)(2008-4#1)(2008-5#1)(2009-8#1)
their receptors in##8##3##(1996-12#1)(1997-2#1)(2008-4#1)(2008-5#3)(2009-8#1)(2013-1#1)
their receptors##25##2##(1990-11#1)(1991-12#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-4#6)(2008-5#3)(2009-8#3)(2011-2#3)(2012-12#1)(2013-1#1)
their reciprocal##3##2##(2008-12#2)(2008-5#1)
their recovery##4##2##(2008-10#3)(2012-3#1)
their reduction potentials##2##3##(1990-5#1)(1995-5#1)
their reduction##7##2##(1990-5#1)(1993-8#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-10#2)
their reference##3##2##(2008-12#1)(2008-3#1)(2008-5#1)
their regenerative potential##2##3##(2010-8#1)(2012-12#1)
their regenerative##4##2##(2008-7#1)(2010-8#1)(2012-12#1)(2012-7#1)
their regulation of##2##3##(2008-10#1)(2013-7#1)
their regulation##9##2##(1993-12#1)(1995-12#1)(2008-10#4)(2008-8#1)(2012-2#1)(2013-7#1)
their regulatory##4##2##(1991-3#1)(2009-10#1)(2010-1#1)(2011-1#1)
their relation to##7##3##(1991-12#1)(1991-6#1)(1993-5#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-3#1)
their relation##8##2##(1991-12#1)(1991-6#1)(1993-5#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-3#1)(2011-1#1)
their relations with##2##3##(2010-1#1)(2010-6#1)
their relations##3##2##(2008-11#1)(2010-1#1)(2010-6#1)
their relationship to other##2##4##(2008-10#1)(2012-2#1)
their relationship to##16##3##(1990-11#1)(1990-9#1)(1992-6#1)(1993-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
their relationship with their##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
their relationship with##13##3##(1994-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2012-2#3)(2012-9#1)(2013-1#2)(2013-7#1)
their relationship##32##2##(1990-11#1)(1990-9#1)(1992-6#1)(1993-1#1)(1994-8#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-1#1)(2012-2#5)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
their relationships to the##2##4##(1995-1#1)(2011-1#1)
their relationships to##6##3##(1995-1#1)(2008-10#1)(2008-7#2)(2009-4#1)(2011-1#1)
their relationships with##6##3##(1994-12#1)(1995-9#1)(1997-2#1)(2008-7#1)(2012-3#1)(2013-7#1)
their relationships##17##2##(1994-12#1)(1995-1#1)(1995-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
their relative contribution to##2##4##(2008-3#1)(2008-7#1)
their relative contributions##2##3##(2012-3#1)(2013-8#1)
their relative importance##2##3##(2008-8#2)
their relative strengths and weaknesses##2##5##(2007-8#1)(2008-4#1)
their relative##33##2##(1990-3#1)(1990-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1997-3#1)(2007-8#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
their relatively##3##2##(2008-5#1)(2009-4#1)(2010-10#1)
their relatives##5##2##(1991-6#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-11#1)
their relatives'##3##2##(2007-8#1)(2010-10#1)(2012-12#1)
their relaxation rate##2##3##(1991-8#2)
their release##5##2##(1990-12#1)(1991-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
their relevance to the##2##4##(2008-11#1)(2008-3#1)
their relevance to##6##3##(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-1#1)
their relevance##10##2##(1996-1#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)
their reliability##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
their remarkable##5##2##(1996-1#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
their removal##3##2##(1990-2#1)(1995-2#1)(2008-11#1)
their renal function##2##3##(2008-1#1)(2008-4#1)
their renal##3##2##(2008-1#2)(2008-4#1)
their repercussions on##2##3##(2006-10#1)(2009-7#1)
their replacements##2##2##(1996-1#1)(1996-12#1)
their replication##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
their reproducibility##3##2##(2008-10#2)(2008-5#1)
their reproductive##7##2##(2008-10#1)(2008-8#2)(2009-7#1)(2010-8#1)(2013-8#2)
their research and##2##3##(1993-2#1)(2010-8#1)
their research##8##2##(1990-9#1)(1993-2#1)(1996-1#1)(2008-11#2)(2008-12#1)(2010-8#1)(2012-2#1)
their resistance levels##2##3##(2008-10#1)(2008-6#1)
their resistance to the##2##4##(1993-2#1)(2012-3#1)
their resistance to##6##3##(1993-2#1)(2008-10#3)(2008-8#1)(2012-3#1)
their resistance##11##2##(1993-2#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
their resolution##4##2##(1993-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
their resources##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
their respective controls##2##3##(1994-6#1)(2008-10#1)
their respective##71##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#2)(1992-12#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(2007-12#1)(2008-10#18)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-4#1)(2012-12#1)(2012-3#1)(2013-1#3)
their respiratory##2##2##(1995-6#1)(2008-5#1)
their response and##2##3##(1997-4#1)(2011-1#1)
their response to the##3##4##(2008-10#1)(2009-9#1)(2013-8#1)
their response to##16##3##(1990-11#1)(1994-5#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
their response##23##2##(1990-11#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
their responses to the##2##4##(2008-5#1)(2013-8#1)
their responses to##9##3##(1990-7#1)(1994-9#2)(1995-11#1)(2008-10#2)(2008-5#1)(2010-8#1)(2013-8#1)
their responses##16##2##(1990-7#1)(1994-9#2)(1995-11#1)(1996-7#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
their responsiveness to##3##3##(1990-7#1)(1994-5#1)(1995-12#1)
their responsiveness##4##2##(1990-7#1)(1994-5#1)(1994-9#1)(1995-12#1)
their restricted##2##2##(1992-3#1)(2010-8#1)
their results##10##2##(1993-2#1)(1994-1#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-3#2)(2013-7#1)
their retention and##2##3##(1996-5#1)(2008-10#1)
their retention times##2##3##(2008-10#2)
their retention##8##2##(1996-5#2)(2008-10#6)
their return to##2##3##(2007-2#2)
their right to##2##3##(1995-2#1)(2008-1#1)
their right##5##2##(1995-2#1)(2008-1#1)(2008-6#1)(2012-12#1)(2013-1#1)
their rights##3##2##(1996-7#1)(2008-11#1)(2008-12#1)
their risk factors##2##3##(2011-2#1)(2013-8#1)
their risk of##2##3##(2008-7#1)(2012-2#1)
their risk##9##2##(1995-9#3)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
their robustness to##2##3##(1997-5#1)(1997-7#1)
their role and##4##3##(1990-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
their role as##3##3##(1993-6#1)(2008-11#1)(2010-1#1)
their role in the transmission of##2##6##(2010-1#2)
their role in the##9##4##(1993-11#1)(1994-12#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-1#2)
their role in##40##3##(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
their role##55##2##(1990-12#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(2006-10#2)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
their roles and##2##3##(1995-3#1)(2011-1#1)
their roles in##13##3##(1994-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2011-1#2)(2011-2#2)
their roles##19##2##(1993-2#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2011-1#3)(2011-2#3)(2012-12#1)
their romantic##2##2##(2009-5#1)(2009-9#1)
their roots and##2##3##(2008-10#1)(2008-12#1)
their roots##6##2##(2008-10#4)(2008-12#1)(2012-2#1)
their rural##3##2##(2007-12#1)(2010-5#1)(2011-2#1)
their safety and##2##3##(2008-4#1)(2013-1#1)
their safety##9##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
their salaries##2##2##(1991-3#1)(1995-3#1)
their satisfaction and##3##3##(1994-2#1)(2007-10#1)(2011-2#1)
their satisfaction with##6##3##(1993-12#1)(1993-3#1)(1996-2#1)(2010-2#2)(2011-2#1)
their satisfaction##10##2##(1990-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(2007-10#1)(2010-2#2)(2011-2#2)
their school##5##2##(2007-12#1)(2008-11#1)(2009-7#1)(2010-8#2)
their scientific##2##2##(1992-6#1)(2009-10#1)
their screening##2##2##(1997-4#1)(2010-8#1)
their search##3##2##(2008-11#1)(2008-8#2)
their second##6##2##(1995-3#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
their secondary structures##2##3##(2006-12#1)(2009-11#1)
their secondary##3##2##(1991-6#1)(2006-12#1)(2009-11#1)
their secretion##2##2##(1990-2#1)(1994-9#1)
their selection of##3##3##(2010-6#1)(2013-1#2)
their selectivity##4##2##(2008-10#4)
their sensations##2##2##(2008-10#1)(2008-5#1)
their sensibility to auxin##2##4##(2008-8#2)
their sensing##2##2##(2008-10#2)
their sensitivity to mutation##2##4##(1994-5#1)(1997-3#1)
their sensitivity to##17##3##(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#7)(2008-11#3)(2010-1#1)
their sensitivity##21##2##(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2010-1#1)(2013-8#1)
their separation and detection##2##4##(2008-10#2)
their separation and##3##3##(2008-10#3)
their separation from##3##3##(2008-10#2)(2008-3#1)
their separation##7##2##(2008-10#6)(2008-3#1)
their separations##2##2##(2008-10#1)(2008-2#1)
their sequence##5##2##(1995-12#2)(2008-4#1)(2008-6#1)(2012-2#1)
their sequences were##3##3##(1995-6#1)(1996-10#1)(2008-5#1)
their sequences##5##2##(1995-6#1)(1996-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
their series##2##2##(1995-2#1)(2008-10#1)
their serum##2##2##(2007-10#1)(2011-1#1)
their serum-cholesterol##4##2##(1990-6#4)
their service##4##2##(1992-1#1)(1992-12#1)(1996-2#1)(2012-3#1)
their services##7##2##(1992-2#1)(1992-3#1)(1995-3#1)(1996-1#1)(1997-2#2)(2008-11#1)
their severity##4##2##(1995-12#1)(2008-3#1)(2010-4#1)(2013-1#1)
their sex##5##2##(1995-5#1)(1996-4#1)(2008-10#1)(2008-3#1)(2009-5#1)
their sexual and##2##3##(2008-11#1)(2009-7#1)
their sexual##8##2##(1995-1#1)(2008-11#1)(2008-12#2)(2009-5#1)(2009-7#1)(2011-2#2)
their shape##7##2##(1993-11#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
their shorter##2##2##(2011-2#1)(2013-1#1)
their sibling##3##2##(2008-12#3)
their siblings##2##2##(2007-8#1)(2010-9#1)
their side effects##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
their side##4##2##(2008-10#1)(2008-12#1)(2009-5#1)(2010-10#1)
their significance for##4##3##(1990-9#1)(1992-11#1)(2008-12#1)(2008-8#1)
their significance##10##2##(1990-9#1)(1991-11#1)(1992-11#1)(1993-2#1)(2008-10#1)(2008-12#2)(2008-8#1)(2012-2#2)
their significant and##2##3##(2008-8#1)(2012-12#1)
their significant##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
their similarity to##3##3##(1995-12#1)(1995-3#1)(2008-7#1)
their similarity##4##2##(1995-12#1)(1995-3#1)(2008-7#1)(2008-8#1)
their simple##2##2##(2008-10#1)(2008-7#1)
their simultaneous##6##2##(1993-8#1)(2008-10#4)(2008-7#1)
their sites of action##2##4##(1990-5#1)(2008-11#1)
their size and##3##3##(1992-3#1)(1994-9#1)(1995-3#1)
their size##15##2##(1990-6#1)(1991-6#1)(1992-3#2)(1994-9#1)(1995-3#1)(1997-6#1)(2006-12#1)(2008-10#4)(2008-7#2)(2008-9#1)
their sizes##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
their skills and##2##3##(1993-1#1)(1993-3#1)
their skills in##2##3##(2008-12#1)(2008-9#1)
their skills##8##2##(1993-1#1)(1993-3#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-8#1)
their skin##9##2##(2008-5#8)(2012-12#1)
their small size##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
their smoking habits##2##3##(1991-11#1)(1995-6#1)
their smoking status##2##3##(2011-2#2)
their smoking##4##2##(1991-11#1)(1995-6#1)(2011-2#2)
their social and economic##2##4##(1996-4#1)(2009-7#1)
their social and##4##3##(1996-4#1)(2009-7#2)(2013-8#1)
their social##16##2##(1992-3#1)(1995-1#1)(1996-4#1)(1997-2#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-5#1)(2009-7#2)(2011-2#1)(2012-12#2)(2013-8#1)
their solubility##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
their solution##3##2##(1991-3#1)(2007-12#1)(2008-9#1)
their solutions##4##2##(2008-10#2)(2008-9#2)
their sorption##2##2##(2008-10#2)
their sources##4##2##(1995-3#1)(1997-1#1)(1997-3#1)(1997-6#1)
their spatial distribution##5##3##(2008-2#1)(2008-8#2)(2013-7#1)(2013-8#1)
their spatial##13##2##(1993-3#1)(1997-4#1)(2008-10#4)(2008-2#2)(2008-8#2)(2010-10#1)(2013-7#1)(2013-8#1)
their special##3##2##(1993-5#1)(2008-10#1)(2009-8#1)
their speciality##2##2##(2008-11#1)(2008-2#1)
their speciation##2##2##(2008-10#2)
their species##4##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
their specific##17##2##(1991-8#1)(1993-3#1)(1997-2#1)(2006-6#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
their specificities##2##2##(1995-3#1)(2008-11#1)
their specificity##3##2##(2008-10#2)(2008-7#1)
their spectra##2##2##(2008-10#1)(2008-3#1)
their spectral properties##2##3##(2008-1#1)(2008-10#1)
their spectral##7##2##(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)
their speech##3##2##(2007-7#1)(2008-4#1)(2008-9#1)
their spinal##4##2##(1996-5#4)
their spiritual##3##2##(2010-2#1)(2013-1#2)
their sport##2##2##(2008-5#1)(2009-11#1)
their spread##2##2##(2013-1#1)(2013-8#1)
their stability and##4##3##(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
their stability constants##4##3##(2008-10#3)(2008-5#1)
their stability##15##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
their stabilization##2##2##(2009-7#1)(2013-1#1)
their staff in##2##3##(1994-6#1)(1995-2#1)
their staff##6##2##(1993-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(2008-7#1)(2009-11#1)
their stage of##3##3##(1993-11#1)(1996-2#1)(2008-4#1)
their standard##3##2##(1997-4#1)(2008-10#2)
their stated accuracy##3##3##(2008-3#3)
their status##2##2##(2013-1#2)
their stay##3##2##(1992-1#1)(2013-1#2)
their stimulatory effects##2##3##(1990-12#1)(1990-5#1)
their stimulatory##5##2##(1990-12#1)(1990-5#1)(2008-11#2)(2008-8#1)
their strain##2##2##(2008-10#1)(2013-1#1)
their strengths and weaknesses##2##4##(2008-6#1)(2008-9#1)
their strengths and##4##3##(1996-3#1)(2008-6#1)(2008-9#1)(2011-1#1)
their stroke protective effect##2##4##(2008-8#2)
their stroke##3##2##(2008-8#3)
their strong##4##2##(1995-8#1)(1997-2#1)(2007-7#1)(2009-10#1)
their structural##10##2##(1991-2#1)(1991-9#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-1#1)(2012-12#1)
their structure and function##3##4##(1995-2#1)(2008-4#1)(2009-8#1)
their structure and##5##3##(1995-2#1)(1996-12#1)(2007-11#1)(2008-4#1)(2009-8#1)
their structure##8##2##(1995-2#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#3)(2009-8#1)
their structures have been##2##4##(1996-2#1)(2012-2#1)
their structures##12##2##(1995-2#1)(1996-2#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
their student##2##2##(1992-6#1)(2013-8#1)
their students may##2##3##(2007-2#1)(2008-12#1)
their students##10##2##(2007-2#1)(2008-11#1)(2008-12#6)(2010-3#1)(2011-2#1)
their studies##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)
their study and##3##3##(1990-5#1)(2008-10#2)
their study##9##2##(1990-5#1)(1992-3#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)
their subsequent reaction with##2##4##(2008-10#2)
their subsequent##19##2##(1997-5#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#2)(2011-1#1)(2011-2#1)
their substrate##2##2##(2010-3#1)(2010-6#1)
their subsystems##2##2##(2008-2#1)(2008-3#1)
their success##6##2##(1992-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-3#1)
their successful##2##2##(1996-2#1)(2009-5#1)
their sucking instinct##2##3##(2007-10#2)
their suggestions##2##2##(1994-2#1)(2008-6#1)
their suitability for##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
their suitability##5##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
their sum##2##2##(1993-12#1)(2008-3#1)
their superior##2##2##(1997-1#1)(2011-2#1)
their surface##10##2##(1994-2#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
their surfaces##2##2##(2008-2#1)(2008-7#1)
their surgery##4##2##(1994-2#1)(1995-1#1)(2012-3#1)(2013-1#1)
their surgical##2##2##(1993-9#1)(2013-8#1)
their surrounding##4##2##(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)
their surroundings##2##2##(2008-10#1)(2008-3#1)
their survival and##2##3##(1993-9#1)(2013-7#1)
their survival##13##2##(1993-9#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2010-3#1)(2012-7#1)(2013-7#1)
their susceptibility to the##4##4##(1990-2#1)(2008-8#1)(2008-9#2)
their susceptibility to##13##3##(1990-2#1)(1994-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-10#1)(2012-3#1)
their susceptibility##15##2##(1990-2#1)(1994-5#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-10#1)(2012-3#1)(2013-1#1)
their swimming##3##2##(1992-6#1)(1995-6#2)
their symptoms##7##2##(1993-11#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
their synergistic##2##2##(1992-2#1)(2011-2#1)
their synthesis and##2##3##(1991-12#1)(2008-10#1)
their synthesis##4##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-8#1)
their synthetic##2##2##(2008-10#1)(2008-5#1)
their target cells##2##3##(1995-2#1)(2009-8#1)
their target genes##4##3##(1994-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
their target##8##2##(1994-8#1)(1995-2#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)
their targets##7##2##(1993-9#1)(1994-2#1)(2008-9#1)(2009-8#1)(2010-6#1)(2012-2#2)
their teachers##3##2##(2008-12#3)
their teaching##3##2##(1995-1#1)(2008-11#2)
their technical##2##2##(1990-11#1)(1995-1#1)
their technological##3##2##(2008-7#2)(2010-4#1)
their teeth##3##2##(1991-6#1)(1995-9#1)(1997-2#1)
their temperature##3##2##(1995-5#1)(2008-2#1)(2008-3#1)
their temporal##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
their ternary chelates##2##3##(2008-10#2)
their theoretical##2##2##(2008-3#1)(2010-10#1)
their therapeutic effect##2##3##(2008-4#1)(2009-12#1)
their therapeutic implications##2##3##(2008-1#1)(2009-3#1)
their therapeutic potential##2##3##(2011-1#1)(2012-12#1)
their therapeutic##15##2##(1995-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
their therapy##2##2##(2008-5#1)(2013-1#1)
their thermal##2##2##(2008-2#1)(2008-3#1)
their thickness##2##2##(2007-11#1)(2010-2#1)
their thicknesses##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
their thoughts##2##2##(1992-4#1)(2009-4#1)
their three##6##2##(1997-9#1)(2007-1#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-12#1)
their threshold##2##2##(1993-12#1)(2008-10#1)
their thyroid function##2##3##(2008-7#1)(2011-1#1)
their thyroid stimulating antibody (TSAb)##2##5##(1991-12#1)(1991-5#1)
their thyroid##4##2##(1991-12#1)(1991-5#1)(2008-7#1)(2011-1#1)
their time and##2##3##(1991-12#1)(1994-1#1)
their time##15##2##(1990-12#1)(1991-12#1)(1994-1#1)(1994-2#2)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-8#2)(2012-2#1)
their tissue distribution##2##3##(1993-6#1)(2008-4#1)
their tolerance to##2##3##(2012-5#2)
their tolerance##4##2##(2008-10#1)(2008-12#1)(2012-5#2)
their total##14##2##(1992-5#1)(1996-3#3)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-9#1)
their toxic##2##2##(1994-3#1)(2008-3#1)
their toxicity to##2##3##(2008-10#2)
their toxicity##7##2##(1995-3#1)(1997-1#1)(2008-10#4)(2008-11#1)
their toxicological##2##2##(2008-10#1)(2011-1#1)
their traditional##8##2##(1991-12#1)(1996-1#2)(1997-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2012-3#1)
their training##10##2##(1992-12#1)(1992-6#1)(1994-3#2)(2008-11#4)(2012-3#1)(2013-1#1)
their transcription##2##2##(1997-7#2)
their transcriptional##2##2##(1990-5#1)(2008-7#1)
their transcripts##3##2##(1993-2#1)(1994-2#1)(1997-2#1)
their transfection##2##2##(2008-9#1)(2010-8#1)
their transfer##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
their transition##2##2##(1991-5#1)(2008-3#1)
their translation initiation##2##3##(1997-2#1)(2008-11#1)
their translation##3##2##(1997-2#1)(2008-11#1)(2008-9#1)
their transmission to##2##3##(1990-11#1)(2013-1#1)
their transport##3##2##(1990-11#1)(1991-5#1)(2012-2#1)
their treatment and##3##3##(1991-2#1)(2006-10#1)(2013-1#1)
their treatment regimen##2##3##(2008-3#1)(2012-3#1)
their treatment##22##2##(1991-2#1)(1992-10#1)(1992-5#2)(1993-12#1)(1995-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
their two##3##2##(1993-6#1)(2007-12#1)(2013-1#1)
their ultimate##2##2##(2007-12#1)(2011-2#1)
their underlying##5##2##(2008-1#1)(2008-8#2)(2009-11#1)(2011-1#1)
their understanding and##2##3##(1992-12#1)(2008-1#1)
their understanding of the##3##4##(1994-12#1)(1996-3#1)(2008-12#1)
their understanding of##8##3##(1994-12#1)(1996-3#1)(2008-10#1)(2008-12#5)
their understanding##11##2##(1992-12#1)(1994-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#5)(2009-12#1)
their undifferentiated##2##2##(2011-2#1)(2013-1#1)
their unique characteristics##2##3##(1992-1#1)(2010-8#1)
their unique combination of##3##4##(1996-1#1)(2012-2#1)(2013-1#1)
their unique properties##2##3##(1993-3#1)(2008-10#1)
their unique requirements##2##3##(2010-7#1)(2010-8#1)
their unique##23##2##(1992-1#1)(1993-3#2)(1994-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)(2013-1#2)
their unusual##2##2##(1996-4#1)(2008-4#1)
their uptake by##2##3##(1996-2#1)(2013-8#1)
their usage in##3##3##(1990-11#1)(2008-10#2)
their usage##7##2##(1990-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
their use and##3##3##(2007-7#1)(2008-9#1)(2010-8#1)
their use are##2##3##(2008-11#1)(2008-4#1)
their use as a##2##4##(2010-6#1)(2011-2#1)
their use as##12##3##(1992-3#1)(1993-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
their use for##7##3##(1995-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
their use in clinical practice##2##5##(1997-7#1)(2009-12#1)
their use in the##5##4##(1991-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#1)
their use in##21##3##(1991-12#1)(1992-3#1)(1994-12#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
their use is##5##3##(2008-10#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#1)
their use of##11##3##(1990-9#1)(1996-1#1)(1996-2#1)(1996-9#1)(2007-11#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
their use to##2##3##(2008-12#1)(2008-9#1)
their use was##2##3##(1990-2#1)(2010-3#1)
their use with##2##3##(2008-6#1)(2012-2#1)
their use##100##2##(1990-2#1)(1990-9#1)(1991-12#2)(1992-12#1)(1992-3#2)(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-4#2)(1997-7#1)(2007-11#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#12)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
their usefulness in##7##3##(1990-3#1)(1991-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
their usefulness to##2##3##(1995-6#1)(2011-1#1)
their usefulness##15##2##(1990-3#1)(1991-6#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
their users##2##2##(1995-3#1)(2011-2#1)
their usual##6##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
their utility and##2##3##(2008-10#1)(2010-4#1)
their utility for##2##3##(1993-12#1)(2008-10#1)
their utility in##2##3##(2008-7#1)(2011-2#1)
their utility##9##2##(1993-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-2#1)
their utilization in##2##3##(2008-10#1)(2009-5#1)
their utilization##3##2##(2008-10#1)(2009-5#1)(2011-1#1)
their validity##11##2##(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#4)
their value to the##2##4##(1992-3#1)(2010-3#1)
their value to##3##3##(1992-3#1)(1995-2#1)(2010-3#1)
their value##4##2##(1992-3#1)(1995-2#1)(2008-11#1)(2010-3#1)
their values and##2##3##(1990-7#1)(1995-1#1)
their values##4##2##(1990-7#1)(1995-1#1)(2008-3#1)(2008-7#1)
their variability##2##2##(2008-12#1)(2008-7#1)
their varied##2##2##(2008-11#1)(2008-7#1)
their varietal origin##2##3##(2008-10#2)
their various##4##2##(1994-3#1)(2008-10#1)(2008-4#1)(2009-11#1)
their vectors##2##2##(2008-10#1)(2008-8#1)
their very##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
their viability and##2##3##(2008-10#1)(2008-7#1)
their viability##5##2##(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
their view##3##2##(1993-1#1)(2007-7#1)(2008-6#1)
their views of##2##3##(2009-9#1)(2013-1#1)
their views on##2##3##(1997-3#1)(2013-8#1)
their views##10##2##(1992-4#1)(1994-1#1)(1995-12#1)(1997-3#1)(2008-12#3)(2009-9#1)(2013-1#1)(2013-8#1)
their virulence##4##2##(2008-10#3)(2013-1#1)
their virus-free##2##2##(2008-10#2)
their vision more than##2##4##(2007-12#1)(2011-2#1)
their vision##4##2##(2007-12#1)(2008-1#1)(2011-2#2)
their visual##2##2##(2009-3#1)(2011-2#1)
their volatile##2##2##(2008-10#1)(2008-8#1)
their voltammetric##2##2##(2008-10#2)
their voluntary##2##2##(1993-12#1)(1996-2#1)
their vulnerability##2##2##(2007-8#1)(2008-9#1)
their water##4##2##(2008-10#2)(2008-5#2)
their way into##2##3##(2007-7#1)(2008-11#1)
their way to##2##3##(1993-6#1)(2013-8#1)
their way##10##2##(1992-1#1)(1993-6#1)(1994-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
their ways##2##2##(2010-10#1)(2010-9#1)
their weight##3##2##(1993-2#1)(2011-2#1)(2013-1#1)
their well being##2##3##(1995-1#1)(2008-1#1)
their well##3##2##(1995-1#1)(2008-1#1)(2013-1#1)
their well-being##2##2##(2008-6#1)(2010-10#1)
their wide##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
their widespread##2##2##(2008-10#1)(2008-7#1)
their wild##2##2##(2008-10#1)(2008-11#1)
their wild-type##3##2##(2008-10#2)(2008-8#1)
their willingness to##3##3##(1994-3#1)(2008-11#1)(2009-9#1)
their wives/partners during labour##3##4##(2010-3#3)
their work and##2##3##(1996-1#1)(2008-7#1)
their work environment##2##3##(2008-12#1)(2009-10#1)
their work##26##2##(1991-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-6#2)(1996-1#3)(1996-9#1)(1997-1#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-7#3)(2009-10#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#1)
their working##5##2##(1991-3#1)(1992-6#1)(1994-1#1)(2008-10#1)(2008-9#1)
their workplace##5##2##(1991-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
their worlds##2##2##(2008-11#1)(2009-5#1)
their writing##2##2##(2008-11#1)(2010-6#1)
their yield##2##2##(2009-7#1)(2011-10#1)
their younger##4##2##(1997-3#1)(2008-11#1)(2010-9#1)(2013-1#1)
their youth##2##2##(1996-12#1)(2008-9#1)
their##9148##1##(1990-10#1)(1990-11#24)(1990-12#34)(1990-2#24)(1990-3#12)(1990-4#2)(1990-5#35)(1990-6#29)(1990-7#15)(1990-8#15)(1990-9#15)(1991-1#16)(1991-10#1)(1991-11#14)(1991-12#47)(1991-2#54)(1991-3#35)(1991-4#2)(1991-5#15)(1991-6#21)(1991-7#5)(1991-8#13)(1991-9#16)(1992-1#40)(1992-10#7)(1992-11#20)(1992-12#58)(1992-2#24)(1992-3#46)(1992-4#5)(1992-5#19)(1992-6#45)(1992-7#1)(1992-8#26)(1992-9#14)(1993-1#33)(1993-11#23)(1993-12#64)(1993-2#50)(1993-3#49)(1993-5#10)(1993-6#30)(1993-8#28)(1993-9#24)(1994-1#37)(1994-10#2)(1994-11#28)(1994-12#49)(1994-2#55)(1994-3#71)(1994-5#17)(1994-6#24)(1994-7#2)(1994-8#30)(1994-9#26)(1995-1#70)(1995-10#2)(1995-11#30)(1995-12#61)(1995-2#65)(1995-3#75)(1995-4#1)(1995-5#27)(1995-6#41)(1995-8#15)(1995-9#8)(1996-1#50)(1996-10#3)(1996-11#11)(1996-12#56)(1996-2#64)(1996-3#63)(1996-4#6)(1996-5#38)(1996-6#19)(1996-7#8)(1996-8#3)(1996-9#15)(1997-1#32)(1997-2#47)(1997-3#47)(1997-4#34)(1997-5#10)(1997-6#34)(1997-7#35)(1997-8#17)(1997-9#3)(2006-10#12)(2006-12#9)(2006-5#4)(2006-6#4)(2006-7#1)(2007-1#5)(2007-10#41)(2007-11#95)(2007-12#164)(2007-2#27)(2007-3#2)(2007-4#5)(2007-5#8)(2007-6#12)(2007-7#49)(2007-8#36)(2007-9#4)(2008-1#87)(2008-10#1178)(2008-11#503)(2008-12#202)(2008-2#98)(2008-3#205)(2008-4#185)(2008-5#267)(2008-6#91)(2008-7#302)(2008-8#242)(2008-9#260)(2009-1#5)(2009-10#57)(2009-11#44)(2009-12#40)(2009-2#22)(2009-3#25)(2009-4#30)(2009-5#76)(2009-6#38)(2009-7#72)(2009-8#58)(2009-9#48)(2010-1#30)(2010-10#73)(2010-11#21)(2010-12#43)(2010-2#25)(2010-3#82)(2010-4#46)(2010-5#51)(2010-6#32)(2010-7#23)(2010-8#79)(2010-9#40)(2011-1#156)(2011-10#5)(2011-2#332)(2011-3#13)(2011-4#1)(2011-7#4)(2011-9#1)(2012-1#40)(2012-12#151)(2012-2#205)(2012-3#153)(2012-4#5)(2012-5#7)(2012-7#3)(2012-8#2)(2012-9#3)(2013-1#345)(2013-7#37)(2013-8#135)
theirs##2##1##(1991-9#1)(2011-3#1)
thelytokous populations from leek##2##4##(2008-10#2)
thelytokous populations##3##2##(2008-10#3)
them &quot##2##2##(2008-10#1)(2010-5#1)
them a##11##2##(1993-12#1)(1993-9#1)(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2012-12#1)
them about their##2##3##(2010-5#1)(2012-3#1)
them about##5##2##(1994-3#1)(1996-6#1)(2010-5#1)(2012-2#1)(2012-3#1)
them according to##2##3##(2010-2#1)(2012-12#1)
them after##2##2##(2007-4#1)(2009-6#1)
them against##5##2##(1994-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
them all##2##2##(1993-2#1)(1994-8#1)
them also##2##2##(2008-7#1)(2013-1#1)
them an important##3##3##(2008-5#1)(2008-9#1)(2010-12#1)
them an##7##2##(1997-1#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
them and a##2##3##(1991-12#1)(2008-12#1)
them and the##5##3##(1994-2#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
them and their##3##3##(2008-11#1)(2013-1#2)
them and##29##2##(1990-6#1)(1991-12#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#4)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
them are##30##2##(1990-6#1)(1991-5#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
them as a##4##3##(1994-11#1)(2008-10#1)(2010-10#1)(2012-12#1)
them as the##4##3##(1990-12#1)(1993-12#1)(1995-2#1)(2008-10#1)
them as##30##2##(1990-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
them at risk of##2##4##(2008-11#1)(2012-12#1)
them at risk##3##3##(2007-4#1)(2008-11#1)(2012-12#1)
them at the##2##3##(2008-3#1)(2008-8#1)
them at##10##2##(1992-1#1)(1993-9#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
them attractive##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
them back##2##2##(1994-9#1)(2008-8#1)
them because of##2##3##(2008-7#1)(2012-12#1)
them being##8##2##(1990-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2013-1#1)
them by##13##2##(1990-10#1)(1994-1#1)(1994-8#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)
them can##4##2##(1991-9#1)(2008-3#1)(2008-9#1)(2013-8#1)
them correctly##2##2##(1993-12#1)(2008-12#1)
them develop##3##2##(1993-2#1)(1997-8#1)(2010-10#1)
them difficult to##2##3##(2008-10#1)(2009-6#1)
them early##2##2##(1995-12#1)(2007-12#1)
them easily##2##2##(2008-11#1)(2010-12#1)
them easy to##2##3##(2008-3#1)(2011-2#1)
them efficiently##2##2##(2008-10#1)(2012-2#1)
them excellent##2##2##(2007-12#1)(2008-6#1)
them feel##3##2##(1991-3#1)(1996-1#1)(2012-12#1)
them for the##5##3##(1992-1#1)(1994-9#1)(2008-12#1)(2008-7#1)(2010-3#1)
them for their##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
them for##15##2##(1992-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
them from each other##2##4##(1991-1#1)(2008-10#1)
them from other types##2##4##(2008-2#1)(2008-9#1)
them from other##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
them from the##5##3##(1994-5#1)(1997-7#1)(2008-2#1)(2009-9#1)(2013-1#1)
them from##35##2##(1991-1#1)(1992-8#1)(1993-12#2)(1994-5#1)(1995-2#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
them has been##2##3##(2008-2#1)(2011-2#1)
them has yet##2##3##(2008-10#1)(2009-5#1)
them has##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#2)
them have been##5##3##(1990-3#1)(1997-8#1)(2008-3#1)(2009-10#1)(2010-1#1)
them have##11##2##(1990-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
them having##3##2##(1993-2#1)(2011-2#2)
them ideal##2##2##(1992-3#1)(2008-7#1)
them if##4##2##(1994-3#2)(2008-1#2)
them immediately##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
them in a##11##3##(1994-3#1)(1995-1#1)(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
them in order to##2##4##(1996-9#1)(2008-10#1)
them in the context of##3##5##(1993-12#1)(2008-12#1)(2010-7#1)
them in the##14##3##(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-6#1)(2010-7#1)(2012-2#1)
them in their##2##3##(1994-3#1)(2008-10#1)
them in##59##2##(1992-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#4)(1995-1#2)(1995-12#2)(1995-3#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
them into the##2##3##(2008-11#1)(2008-7#1)
them into##19##2##(1990-8#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#2)
them is##14##2##(1992-3#1)(1992-9#1)(1996-11#1)(1997-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-2#1)(2009-3#1)(2011-2#2)
them less##3##2##(1994-12#1)(2008-1#1)(2008-3#1)
them may be##3##3##(1995-8#1)(2008-1#1)(2011-1#1)
them may##7##2##(1995-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
them more##7##2##(1994-9#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
them of the##2##3##(2011-2#1)(2012-3#1)
them of##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
them on a##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
them on the##3##3##(1996-3#1)(2008-9#1)(2009-9#1)
them on##12##2##(1995-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)
them only##2##2##(2008-10#1)(2011-2#1)
them or with##2##3##(2008-10#1)(2008-3#1)
them or##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
them particularly##2##2##(2008-4#1)(2010-7#1)
them showed##7##2##(1992-12#1)(1995-12#1)(1995-8#1)(2008-5#2)(2010-2#1)(2013-8#1)
them successfully##2##2##(1991-2#1)(2008-11#1)
them suitable for##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2010-7#1)
them suitable##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)
them than##2##2##(1995-1#1)(2010-9#1)
them the##13##2##(1994-3#1)(2007-12#1)(2008-10#4)(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
them their##3##2##(2008-10#1)(2008-8#1)(2010-9#1)
them there##3##2##(1992-5#1)(1993-6#1)(2013-1#1)
them through the##3##3##(1992-12#1)(2008-10#1)(2008-6#1)
them through##6##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
them to a##4##3##(2008-10#2)(2009-12#1)(2011-1#1)
them to achieve##3##3##(1993-12#1)(2010-3#1)(2013-8#1)
them to be used##2##4##(2008-3#1)(2008-9#1)
them to be##15##3##(1991-12#2)(1991-5#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
them to become more##2##4##(1997-3#1)(2011-1#1)
them to become##4##3##(1997-3#1)(2008-7#1)(2010-9#1)(2011-1#1)
them to develop##2##3##(1997-2#1)(2010-3#1)
them to do##2##3##(1997-3#1)(2008-9#1)
them to examine##2##3##(1993-12#1)(2008-12#1)
them to improve their##2##4##(2011-2#1)(2012-1#1)
them to return to##2##4##(2009-10#1)(2010-3#1)
them to seek more information##2##5##(1996-1#1)(2008-12#1)
them to the##14##3##(1990-7#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1997-6#1)(2007-7#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
them to their individual##2##4##(1992-1#1)(1995-3#1)
them to their##3##3##(1992-1#1)(1995-3#1)(2008-12#1)
them to undergo##2##3##(1994-3#1)(2009-9#1)
them to##145##2##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#4)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
them two##2##2##(1992-6#1)(2011-2#1)
them under##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
them useful##4##2##(1990-2#1)(2008-10#1)(2008-4#1)(2010-7#1)
them was##9##2##(1993-5#1)(1994-11#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
them we##2##2##(2008-1#1)(2011-2#1)
them well##2##2##(2008-10#2)
them were found to be##2##5##(2007-11#1)(2008-10#1)
them were found##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
them were##61##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-2#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
them while##3##2##(1995-6#1)(2008-10#1)(2010-10#1)
them with a##5##3##(1991-8#1)(2007-7#1)(2008-10#1)(2011-2#2)
them with other##2##3##(2008-4#1)(2011-3#1)
them with the##8##3##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
them with##47##2##(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#2)(1994-11#2)(1996-12#1)(1997-1#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#3)(2008-9#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)
them within##2##2##(1992-12#1)(2008-10#1)
them without##3##2##(1995-5#1)(2008-8#1)(2010-8#1)
them would##2##2##(1996-12#1)(2008-7#1)
them##1422##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#5)(1990-6#7)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#4)(1991-11#5)(1991-12#9)(1991-2#7)(1991-3#7)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#6)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#12)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#21)(1993-2#13)(1993-3#7)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#6)(1994-1#6)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#14)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#5)(1995-1#10)(1995-10#1)(1995-11#3)(1995-12#18)(1995-2#9)(1995-3#4)(1995-5#3)(1995-6#7)(1995-8#4)(1995-9#2)(1996-1#5)(1996-11#2)(1996-12#7)(1996-2#7)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#9)(1997-7#10)(1997-8#3)(1997-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#5)(2007-11#22)(2007-12#16)(2007-2#6)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#14)(2007-8#6)(2008-1#21)(2008-10#170)(2008-11#48)(2008-12#26)(2008-2#20)(2008-3#31)(2008-4#24)(2008-5#39)(2008-6#17)(2008-7#47)(2008-8#33)(2008-9#45)(2009-10#8)(2009-11#3)(2009-12#9)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#14)(2009-6#7)(2009-7#4)(2009-8#3)(2009-9#9)(2010-1#4)(2010-10#8)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#12)(2010-4#8)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#18)(2010-9#6)(2011-1#26)(2011-2#72)(2011-3#3)(2012-1#11)(2012-12#32)(2012-2#25)(2012-3#25)(2012-4#2)(2013-1#59)(2013-7#13)(2013-8#25)
them&quot##2##1##(1996-1#1)(1997-6#1)
them)##5##1##(2007-11#1)(2008-10#1)(2009-6#1)(2009-9#1)(2010-6#1)
them?##3##1##(1994-3#1)(2007-11#1)(2008-7#1)
them?]##2##1##(1990-12#1)(1990-2#1)
thematic analysis of##3##3##(2008-11#1)(2012-12#1)(2012-2#1)
thematic analysis##11##2##(2008-11#2)(2008-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)
thematic area##2##2##(2010-10#2)
thematic areas##2##2##(2010-10#2)
thematic content analysis##6##3##(2008-11#2)(2008-12#1)(2009-10#1)(2009-3#1)(2010-10#1)
thematic content##7##2##(1994-2#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-3#1)(2010-10#1)
thematic focus##2##2##(2011-2#2)
thematic matrix##2##2##(2008-4#2)
thematic##36##1##(1994-2#1)(2007-2#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#5)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)
theme and##2##2##(2008-7#1)(2009-10#1)
theme in##6##2##(1994-12#1)(2008-11#1)(2008-4#1)(2009-7#1)(2009-8#1)(2012-12#1)
theme is that the##2##4##(1996-2#1)(2007-8#1)
theme is##3##2##(1996-2#1)(2007-8#1)(2008-11#1)
theme of the meeting##2##4##(2008-11#1)(2008-5#1)
theme of the##5##3##(1993-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)
theme of this##2##3##(2008-11#1)(2008-5#1)
theme of##11##2##(1993-3#1)(1995-3#1)(2008-11#3)(2008-12#2)(2008-5#2)(2009-10#1)(2012-3#1)
theme that is##2##3##(2008-6#1)(2009-10#1)
theme that##3##2##(2008-6#1)(2009-10#2)
theme to##2##2##(2008-12#1)(2009-11#1)
theme was##2##2##(2010-5#1)(2013-1#1)
theme##51##1##(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#6)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-1#2)
themed##2##1##(2011-2#1)(2012-1#1)
themedium##2##1##(2008-11#2)
themes and##4##2##(2008-12#1)(2008-4#1)(2010-3#1)(2010-9#1)
themes are##7##2##(2007-12#1)(2008-11#2)(2008-7#1)(2009-10#3)
themes emerged from the##7##4##(1994-12#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
themes emerged from##8##3##(1994-12#1)(2008-11#2)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
themes emerged##17##2##(1994-12#1)(2008-11#4)(2008-12#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
themes for##2##2##(1995-3#1)(2008-1#1)
themes from the##2##3##(2008-11#1)(2013-1#1)
themes identified##4##2##(1993-3#1)(2008-11#3)
themes in##4##2##(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
themes include##2##2##(1996-2#1)(1997-1#1)
themes included##2##2##(2009-5#1)(2012-3#1)
themes of the##2##3##(1996-1#1)(2008-7#1)
themes of##5##2##(1996-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#1)
themes regarding##2##2##(2008-6#1)(2010-5#1)
themes related to##2##3##(2010-11#1)(2011-2#1)
themes that##7##2##(1995-12#1)(1996-2#1)(2008-11#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
themes to##4##2##(1996-1#1)(2008-11#1)(2008-12#1)(2010-11#1)
themes were identified from the##2##5##(2008-11#1)(2011-1#1)
themes were identified##8##3##(1992-2#1)(2008-11#2)(2009-6#1)(2011-1#2)(2012-2#1)(2012-3#1)
themes were##11##2##(1992-2#1)(1995-3#1)(2008-11#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#2)(2012-2#1)(2012-3#1)
themes##112##1##(1991-2#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-11#17)(2008-12#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#5)(2009-4#1)(2009-5#7)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#1)
themselves and their##10##3##(1992-1#1)(1992-3#1)(2007-10#1)(2007-2#1)(2008-12#2)(2009-11#1)(2010-11#1)(2012-2#1)(2012-3#1)
themselves and##17##2##(1992-1#2)(1992-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-11#1)(2009-5#1)(2010-11#1)(2010-3#2)(2012-2#1)(2012-3#1)
themselves are##4##2##(1997-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
themselves as being##2##3##(2009-12#1)(2010-2#1)
themselves as##17##2##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-1#1)(2007-12#1)(2008-11#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
themselves at risk##2##3##(1990-3#1)(2009-12#1)
themselves at##4##2##(1990-3#1)(2007-7#1)(2008-9#1)(2009-12#1)
themselves can##2##2##(2008-10#1)(2008-11#1)
themselves during##2##2##(2008-1#1)(2012-3#1)
themselves for##2##2##(1997-1#1)(2006-6#1)
themselves from##4##2##(1991-3#1)(2007-7#1)(2009-5#1)(2012-2#1)
themselves in a##6##3##(1993-12#2)(1997-5#1)(2007-10#1)(2008-1#1)(2008-11#1)
themselves in the##4##3##(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
themselves in##16##2##(1991-11#1)(1993-12#2)(1994-12#1)(1995-5#1)(1997-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
themselves may be##3##3##(2008-1#1)(2010-1#1)(2012-2#1)
themselves on##4##2##(1994-8#2)(2008-12#2)
themselves or##4##2##(1990-6#1)(1991-12#1)(2008-10#1)(2010-2#1)
themselves through##2##2##(2007-12#1)(2008-10#1)
themselves to be overweight##2##4##(1997-7#1)(2007-7#1)
themselves to be##5##3##(1997-7#1)(2007-11#1)(2007-7#1)(2011-2#1)(2012-2#1)
themselves to##21##2##(1991-3#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
themselves with the##2##3##(1995-2#1)(2008-10#1)
themselves with##3##2##(1995-2#1)(1996-3#1)(2008-10#1)
themselves##250##1##(1990-3#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1994-1#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-1#3)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#1)(1997-9#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#5)(2008-1#5)(2008-10#16)(2008-11#25)(2008-12#9)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#5)(2009-7#5)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
then 0##2##2##(2008-3#1)(2008-7#1)
then 100##2##2##(2008-3#1)(2011-2#1)
then a##16##2##(1990-12#1)(1992-1#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
then accomplished by##2##3##(1996-5#1)(2008-10#1)
then act as a##2##4##(2008-10#1)(2008-7#1)
then activated##3##2##(1992-6#2)(1996-12#1)
then added to the##2##4##(2008-11#2)
then added to##5##3##(1994-2#1)(2008-11#2)(2008-8#2)
then added##7##2##(1990-12#1)(1994-2#1)(2008-11#2)(2008-6#1)(2008-8#2)
then after##6##2##(1996-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
then again##2##2##(2008-12#1)(2008-2#1)
then aggregate##2##2##(2008-7#1)(2008-8#1)
then allowed to##2##3##(2008-10#1)(2008-9#1)
then allowing##2##2##(2008-10#2)
then allows##2##2##(2008-10#1)(2008-3#1)
then also##2##2##(1994-5#1)(2008-10#1)
then an##6##2##(2008-10#4)(2008-11#1)(2008-3#1)
then analyze the##2##3##(2008-3#1)(2013-8#1)
then analyzed by##5##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-4#1)
then analyzed##9##2##(1994-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)
then analyzes##2##2##(1996-12#1)(2012-3#1)
then answered##2##2##(1993-2#2)
then appear##2##2##(1993-2#1)(2008-7#1)
then appeared##2##2##(2007-4#1)(2008-10#1)
then applied and##2##3##(2008-5#2)
then applied for##2##3##(2008-10#2)
then applied to a##3##4##(1992-12#1)(2008-3#1)(2008-6#1)
then applied to the##11##4##(1996-3#1)(2008-10#5)(2008-3#2)(2008-4#1)(2009-11#1)(2010-3#1)
then applied to##27##3##(1991-9#1)(1992-12#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#1)(2009-11#1)(2009-2#1)(2010-3#1)(2012-2#2)
then applied##33##2##(1991-9#1)(1992-12#1)(1996-3#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-2#1)(2010-3#1)(2012-12#1)(2012-2#2)
then are##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
then asked##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
then assessed##7##2##(1997-5#1)(2008-10#3)(2008-2#1)(2013-1#2)
then at##4##2##(1992-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
then attempted to identify##2##4##(1996-3#1)(2010-8#1)
then be a##2##3##(1994-5#1)(2008-10#1)
then be extended to##2##4##(2010-10#1)(2012-3#1)
then be integrated##2##3##(2008-2#1)(2008-3#1)
then be used for##3##4##(1997-4#1)(2008-9#1)(2009-3#1)
then be used to##8##4##(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-11#1)
then be used##11##3##(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#2)(2009-3#1)(2010-11#1)
then be##52##2##(1990-11#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#7)(2008-3#4)(2008-4#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
then becomes##2##2##(1994-2#1)(2012-3#1)
then been##2##2##(1997-2#1)(2008-11#1)
then briefly##2##2##(2008-10#1)(2008-4#1)
then by##8##2##(1992-3#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
then calculated for##2##3##(2008-10#1)(2008-9#1)
then calculated##3##2##(1992-9#1)(2008-10#1)(2008-9#1)
then carried out to##2##4##(1994-3#1)(2008-10#1)
then carried out##4##3##(1994-3#1)(2008-10#1)(2009-6#1)(2010-4#1)
then carried##5##2##(1994-3#1)(2008-10#2)(2009-6#1)(2010-4#1)
then cells are##3##3##(2008-8#3)
then challenged##2##2##(1997-3#1)(2008-10#1)
then classified by##2##3##(2008-10#1)(2008-5#1)
then cleaved##2##2##(1994-12#1)(2008-4#1)
then collected##2##2##(2008-10#2)
then combined##4##2##(2007-11#1)(2008-2#1)(2008-4#1)(2012-1#1)
then compared to the##3##4##(2008-10#2)(2008-2#1)
then compared to##7##3##(1993-11#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)
then compared with the##7##4##(1995-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
then compared with##10##3##(1995-6#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2012-2#2)
then compared##24##2##(1993-11#1)(1993-9#1)(1994-8#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-2#2)
then confirmed by##3##3##(2008-8#1)(2010-12#1)(2012-12#1)
then confirmed##5##2##(2008-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-12#1)
then consider##2##2##(1992-1#1)(2008-8#1)
then considered##3##2##(1991-1#1)(2008-3#1)(2010-11#1)
then converted to a##2##4##(1992-12#1)(2008-10#1)
then converted to##5##3##(1992-12#1)(1994-12#2)(1994-3#1)(2008-10#1)
then converted##6##2##(1992-12#1)(1994-12#2)(1994-3#1)(2007-11#1)(2008-10#1)
then correlated with##2##3##(2008-12#1)(2008-8#1)
then could be##2##3##(2008-10#1)(2008-3#1)
then covered##2##2##(2008-10#1)(2008-9#1)
then declined##11##2##(1995-3#1)(2008-10#10)
then decreased significantly##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
then decreased##15##2##(1992-5#1)(1993-11#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-8#2)(2010-5#2)(2011-1#1)
then decreasing##2##2##(1992-3#1)(1997-7#1)
then demonstrate##2##2##(2008-10#1)(2008-7#1)
then depends on the##2##4##(2008-3#1)(2008-8#1)
then describe##7##2##(1992-6#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
then described##4##2##(1994-2#1)(2008-3#1)(2008-4#2)
then describes the##2##3##(1995-3#1)(2008-4#1)
then describes##4##2##(1994-1#1)(1995-3#1)(2008-4#1)(2013-1#1)
then determine##2##2##(2008-9#1)(2009-4#1)
then determined by##10##3##(1993-12#1)(2008-10#7)(2008-4#1)(2008-5#1)
then determined##18##2##(1990-6#1)(1993-12#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#1)
then developed##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)(2010-8#1)
then diluted##2##2##(1990-12#1)(2008-10#1)
then directly##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
then discuss the##4##3##(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)
then discuss##8##2##(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
then discussed##3##2##(1991-12#1)(2008-3#1)(2009-12#1)
then divided##2##2##(2007-8#1)(2008-10#1)
then eluted from the##2##4##(2008-10#2)
then eluted from##3##3##(2008-10#3)
then eluted with 1 M##2##5##(2008-10#2)
then eluted with##5##3##(2008-10#5)
then eluted##11##2##(1990-12#1)(2008-10#10)
then employed to##2##3##(2008-8#1)(2011-2#1)
then estimated##2##2##(1995-3#1)(2008-3#1)
then evaluated in##6##3##(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2012-3#1)
then evaluated##13##2##(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-3#2)
then examined##8##2##(1992-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
then examines##3##2##(2008-1#1)(2008-7#1)(2012-12#1)
then exhibited##2##2##(1996-12#1)(2008-4#1)
then exit##3##2##(2008-3#1)(2012-12#1)(2012-3#1)
then expanded to##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
then exposed to##4##3##(1991-5#1)(2008-10#1)(2009-9#1)(2012-2#1)
then extended##2##2##(1994-12#1)(1997-4#1)
then extracted by##4##3##(2008-10#3)(2013-1#1)
then extracted in##2##3##(2008-10#1)(2008-5#1)
then extracted with##2##3##(2008-10#1)(2008-11#1)
then extracted##12##2##(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
then extrapolating##2##2##(2008-1#1)(2008-10#1)
then find##2##2##(2007-12#1)(2010-5#1)
then fitted with a##2##4##(2008-3#1)(2009-12#1)
then fitted##3##2##(2008-3#2)(2009-12#1)
then follow##2##2##(2009-3#1)(2010-8#1)
then followed by a##2##4##(1992-12#1)(2008-11#1)
then followed by##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
then followed the##2##3##(1995-11#1)(2010-1#1)
then followed##7##2##(1992-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-2#1)
then formed##3##2##(2007-12#1)(2008-10#2)
then further##2##2##(2007-12#1)(2012-1#1)
then fused##2##2##(2008-11#1)(2010-5#1)
then generated##3##2##(2007-11#1)(2008-2#1)(2011-2#1)
then given##2##2##(1993-12#1)(1997-7#1)
then gradually decreased##3##3##(1990-7#1)(2008-11#1)(2008-7#1)
then gradually##5##2##(1990-7#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
then had##4##2##(1992-9#1)(2007-8#1)(2008-11#1)(2009-9#1)
then he##2##2##(1991-2#1)(2013-1#1)
then identified at##2##3##(2008-4#1)(2011-2#1)
then identified##5##2##(1995-6#1)(1997-7#1)(2008-4#1)(2010-11#1)(2011-2#1)
then identify##2##2##(2008-6#1)(2009-8#1)
then imaged##2##2##(2007-11#1)(2008-7#1)
then immediately##2##2##(2007-7#1)(2008-10#1)
then in the presence of##2##5##(2008-10#2)
then in the##3##3##(2008-10#3)
then in##13##2##(1994-2#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-9#1)(2011-2#2)
then incorporated##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
then increased to##2##3##(1995-12#1)(2011-2#1)
then increased##14##2##(1992-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
then increases##2##2##(2008-12#1)(2008-2#1)
then incubated at##2##3##(1994-8#1)(1997-7#1)
then incubated in##2##3##(1993-8#1)(1994-8#1)
then incubated##7##2##(1992-12#1)(1993-8#1)(1994-8#2)(1997-7#1)(2008-10#1)(2010-3#1)
then induced##3##2##(1993-6#1)(2007-8#1)(2010-6#1)
then inhibited##2##2##(1993-11#1)(1994-5#1)
then inserted##2##2##(1991-12#1)(2008-8#1)
then introduce##2##2##(2008-7#1)(2012-3#1)
then introduced into##2##3##(2008-4#1)(2008-8#1)
then introduced##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
then is##7##2##(2008-10#5)(2008-8#1)(2012-2#1)
then it is##5##3##(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)(2013-1#1)
then it##12##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-6#1)(2013-1#3)
then its##5##2##(1994-12#1)(1997-5#1)(2008-10#3)
then joined##2##2##(2008-8#1)(2012-3#1)
then kept on##2##3##(1992-9#1)(2011-2#1)
then labeled with##2##3##(1997-2#1)(2008-8#1)
then ligated##2##2##(1993-12#1)(2008-8#1)
then little##2##2##(2008-12#1)(2012-2#1)
then loaded##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
then made a##2##3##(1995-6#1)(2008-11#1)
then made##5##2##(1995-6#1)(2008-11#1)(2008-2#1)(2010-3#1)(2011-2#1)
then matched##2##2##(2008-7#1)(2008-8#1)
then measured at##2##3##(2008-10#1)(2010-5#1)
then measured the##3##3##(2008-3#1)(2008-5#2)
then measured##10##2##(1990-12#2)(1991-3#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-5#1)(2013-1#1)
then merged with##5##3##(2008-10#5)
then mixed with##4##3##(2008-10#3)(2011-3#1)
then modified##3##2##(1996-2#1)(2008-7#1)(2008-9#1)
then monitored spectrophotometrically##2##3##(2008-10#2)
then monitored##6##2##(1995-2#1)(2008-10#4)(2010-2#1)
then moved to the##2##4##(2008-5#1)(2008-8#1)
then new##2##2##(2008-10#1)(2012-2#1)
then obtained##2##2##(2008-11#1)(2008-5#1)
then on##5##2##(1994-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
then one has a##3##4##(2008-10#3)
then packaged##2##2##(2008-7#1)(2010-1#1)
then passed through a##2##4##(2008-10#2)
then passed through##3##3##(2008-10#3)
then passed##4##2##(2008-10#3)(2008-4#1)
then performed to##2##3##(2008-11#1)(2008-4#1)
then performed with a##2##4##(1997-7#1)(2011-2#1)
then performed##10##2##(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#3)(2012-3#1)
then placed##3##2##(2008-10#2)(2008-11#1)
then precipitated##2##2##(1996-12#1)(2007-11#1)
then prepared##2##2##(2008-10#1)(2008-4#1)
then present##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
then presented with##2##3##(2007-5#1)(2009-4#1)
then presented##7##2##(2006-12#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#1)
then probed##2##2##(2007-12#1)(2008-4#1)
then proceed to##2##3##(1992-12#1)(2008-11#1)
then produced by##2##3##(1994-2#1)(2010-5#1)
then produced##3##2##(1990-2#1)(1994-2#1)(2010-5#1)
then propose##2##2##(2008-2#1)(2008-3#1)
then provide##2##2##(2009-8#1)(2011-2#1)
then provided##2##2##(2008-12#1)(2008-4#1)
then provides##2##2##(1996-5#1)(2008-11#1)
then purified##6##2##(1994-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
then quantified##3##2##(1996-6#1)(2008-10#2)
then quantitatively##4##2##(2008-10#3)(2008-3#1)
then rapidly##6##2##(1993-12#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
then rated##2##2##(2008-5#1)(2009-4#1)
then reached##2##2##(2008-5#1)(2011-2#1)
then react with##2##3##(2008-10#1)(2012-2#1)
then reacted##3##2##(2007-11#1)(2008-4#2)
then reacts with##2##3##(1996-2#1)(2008-10#1)
then reacts##3##2##(1996-2#1)(1997-7#1)(2008-10#1)
then received##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
then reconstructed by##2##3##(1992-3#1)(2008-3#1)
then reconstructed##5##2##(1992-3#1)(2008-2#1)(2008-3#3)
then recorded##2##2##(2008-10#2)
then recovered##2##2##(1991-12#1)(2008-10#1)
then reduced at##2##3##(2008-10#2)
then reduced to##4##3##(2007-7#1)(2008-10#2)(2011-1#1)
then reduced##10##2##(1995-3#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#1)(2011-1#2)
then removed##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
then repeated in##2##3##(1993-2#1)(2008-10#1)
then repeated##4##2##(1993-2#1)(2008-10#3)
then report##3##2##(2008-2#1)(2008-3#1)(2009-9#1)
then require##2##2##(1991-12#1)(2008-3#1)
then required##2##2##(2008-9#1)(2011-2#1)
then retrieved##2##2##(2008-2#1)(2010-8#1)
then returned to the##3##4##(1994-5#1)(2008-10#1)(2008-9#1)
then returned to##4##3##(1993-12#1)(1994-5#1)(2008-10#1)(2008-9#1)
then review##3##2##(2008-7#1)(2013-8#2)
then reviews##2##2##(1993-12#1)(2012-12#1)
then sacrificed##4##2##(1997-4#3)(2008-10#1)
then scanned##2##2##(2007-12#1)(2010-5#1)
then selected##2##2##(2008-8#1)(2012-2#1)
then selectively##2##2##(2008-10#1)(2011-1#1)
then sent##2##2##(2008-10#1)(2010-8#1)
then separated by##3##3##(1997-2#1)(2008-10#2)
then separated##7##2##(1990-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-5#1)
then sequentially##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
then served##2##2##(1995-1#1)(2008-10#1)
then show how##3##3##(1993-12#1)(2008-10#1)(2008-2#1)
then show that##4##3##(2008-2#1)(2008-3#1)(2010-3#1)(2013-8#1)
then show##9##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2013-8#1)
then shown to be##2##4##(2008-10#1)(2013-8#1)
then shown##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
then spread to##2##3##(2008-10#1)(2011-1#1)
then spread##3##2##(2008-10#2)(2011-1#1)
then stained##2##2##(1990-12#1)(2011-2#1)
then started##5##2##(1995-3#2)(1997-2#1)(2010-8#1)(2013-8#1)
then stored holographically in a##2##5##(2008-3#2)
then stored##3##2##(2008-10#1)(2008-3#2)
then stripped from the disk with a minimal amount of##2##10##(2008-10#2)
then stripped from the disk##3##5##(2008-10#3)
then stripped##4##2##(2008-10#3)(2008-3#1)
then subjected to a##3##4##(1995-6#1)(2008-12#1)(2009-4#1)
then subjected to##9##3##(1991-5#1)(1995-6#2)(2008-10#1)(2008-12#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-3#1)
then submitted to##3##3##(1990-10#1)(2008-11#1)(2008-12#1)
then subtracted from the##2##4##(2008-2#1)(2008-5#1)
then taken##3##2##(2008-3#1)(2008-5#1)(2012-12#1)
then tested on##2##3##(2008-10#1)(2012-1#1)
then tested under##2##3##(2008-10#1)(2008-2#1)
then tested##11##2##(1991-9#1)(1993-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-1#1)
then the formaldehyde##2##3##(2008-10#2)
then the##73##2##(1992-8#1)(1993-2#1)(1993-8#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-4#1)(1997-1#1)(1997-6#2)(2007-11#1)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#2)
then their##2##2##(2008-12#1)(2013-1#1)
then they were concentrated##2##4##(2008-10#2)
then they were##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2012-3#1)
then they##10##2##(1990-6#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
then this##2##2##(1993-6#1)(2008-8#1)
then to a##2##3##(1997-6#1)(2007-8#1)
then to be##2##3##(2008-3#1)(2011-1#1)
then to the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
then to##30##2##(1993-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#3)(2013-1#1)
then transfected##2##2##(2008-11#1)(2008-5#1)
then transferred to##5##3##(1994-5#1)(2008-10#2)(2008-12#1)(2013-1#1)
then transferred##7##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-1#1)
then transformed into##2##3##(2008-10#1)(2008-3#1)
then transformed##4##2##(2008-10#1)(2008-3#1)(2008-4#2)
then treated with ammonium##2##4##(2008-10#2)
then treated with##7##3##(1992-3#1)(2006-10#1)(2008-10#3)(2008-7#1)(2011-2#1)
then treated##8##2##(1992-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-7#1)(2011-2#1)
then turn##2##2##(1992-3#1)(2008-8#1)
then undergo##2##2##(1997-7#1)(2008-6#1)
then undergoes##5##2##(1990-5#1)(1991-12#1)(2009-10#2)(2009-7#1)
then underwent##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
then use##3##2##(2007-4#1)(2008-2#1)(2008-9#1)
then used as##8##3##(1991-2#1)(1993-11#1)(1997-1#1)(1997-7#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)
then used for the##2##4##(2008-10#1)(2008-5#1)
then used for##7##3##(1992-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2011-1#1)
then used in the##3##4##(2008-10#2)(2008-3#1)
then used in##5##3##(1994-1#1)(2007-11#1)(2008-10#2)(2008-3#1)
then used to analyze##3##4##(2008-10#2)(2008-3#1)
then used to calculate the##2##5##(1997-7#1)(2008-10#1)
then used to calculate##3##4##(1997-7#1)(2008-10#1)(2008-2#1)
then used to isolate##2##4##(1991-5#1)(2008-8#1)
then used to predict##3##4##(2008-3#1)(2008-7#1)(2009-6#1)
then used to##42##3##(1991-5#1)(1992-12#1)(1995-5#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
then used##70##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-1#1)(1995-2#1)(1995-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#3)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
then verified##2##2##(1995-2#1)(2008-2#1)
then viewed##2##2##(2007-11#1)(2008-4#1)
then was developed##2##3##(2008-10#1)(2008-11#1)
then was##16##2##(1993-11#1)(1996-5#1)(2006-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
then we##3##2##(2008-2#1)(2012-12#1)(2013-1#1)
then were##13##2##(1993-11#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-9#3)(2009-3#1)
then what##2##2##(1995-3#1)(2007-7#1)
then with a##3##3##(2007-12#1)(2008-9#1)(2009-8#1)
then with##9##2##(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)
then##1738##1##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#6)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#2)(1991-5#4)(1991-6#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#9)(1992-5#3)(1992-6#7)(1992-8#4)(1992-9#7)(1993-1#1)(1993-11#7)(1993-12#13)(1993-2#11)(1993-3#3)(1993-6#4)(1993-8#6)(1993-9#1)(1994-1#3)(1994-12#8)(1994-2#13)(1994-3#11)(1994-5#6)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#13)(1995-3#12)(1995-5#4)(1995-6#8)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#13)(1996-2#8)(1996-3#4)(1996-4#1)(1996-5#9)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#11)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#15)(1997-8#3)(2006-10#1)(2006-12#3)(2007-10#5)(2007-11#25)(2007-12#30)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#13)(2008-1#18)(2008-10#391)(2008-11#72)(2008-12#32)(2008-2#53)(2008-3#108)(2008-4#50)(2008-5#54)(2008-6#21)(2008-7#53)(2008-8#73)(2008-9#45)(2009-10#7)(2009-11#5)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#11)(2009-9#9)(2010-1#5)(2010-10#2)(2010-11#5)(2010-12#3)(2010-2#5)(2010-3#9)(2010-4#3)(2010-5#12)(2010-6#2)(2010-7#3)(2010-8#17)(2010-9#1)(2011-1#21)(2011-2#49)(2011-3#3)(2012-1#10)(2012-12#12)(2012-2#28)(2012-3#21)(2013-1#44)(2013-7#3)(2013-8#23)
thenar flap##4##2##(2008-9#4)
thenar muscle##2##2##(2007-11#1)(2008-9#1)
thenar muscles##2##2##(2007-11#1)(2009-1#1)
thenar##10##1##(2007-11#2)(2008-5#1)(2008-9#6)(2009-1#1)
thence##2##1##(2007-10#1)(2008-10#1)
thenoyltrifluoroacetone and##2##2##(2008-10#2)
thenoyltrifluoroacetone##3##1##(2008-10#3)
theobromine and##2##2##(2008-10#2)
theobromine##3##1##(2008-10#3)
theological##4##1##(2008-4#1)(2009-11#2)(2013-1#1)
theology##2##1##(2008-12#1)(2013-1#1)
theophylline and##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
theophylline in##4##2##(2008-10#3)(2013-8#1)
theophylline to##2##2##(2007-8#2)
theophylline was##3##2##(2008-1#2)(2008-10#1)
theophylline##34##1##(1990-8#3)(1990-9#1)(1991-2#2)(2007-8#4)(2008-1#6)(2008-10#14)(2010-11#1)(2013-8#3)
theorem for##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
theorem to##2##2##(2007-12#1)(2008-3#1)
theorem we##2##2##(2008-2#1)(2013-8#1)
theorem##21##1##(1995-2#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#11)(2008-9#1)(2013-8#1)
theorems##14##1##(1990-12#1)(1990-7#2)(2008-2#4)(2008-7#1)(2010-3#6)
theoretic##7##1##(1991-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2013-1#2)
theoretical advantages of##2##3##(2008-3#1)(2010-11#1)
theoretical advantages##4##2##(1993-1#1)(1997-3#1)(2008-3#1)(2010-11#1)
theoretical analyses and the##2##4##(2008-3#1)(2010-2#1)
theoretical analyses and##3##3##(2008-3#2)(2010-2#1)
theoretical analyses##8##2##(2008-2#1)(2008-3#6)(2010-2#1)
theoretical analysis and an experimental##2##5##(2008-2#1)(2008-3#1)
theoretical analysis and experimental results are given##2##7##(2008-3#2)
theoretical analysis and##9##3##(2007-11#2)(2008-2#1)(2008-3#4)(2010-2#1)(2013-8#1)
theoretical analysis has##2##3##(2007-12#1)(2008-3#1)
theoretical analysis is##2##3##(2008-2#1)(2008-3#1)
theoretical analysis of the##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
theoretical analysis of this##2##4##(1997-3#1)(2008-3#1)
theoretical analysis of##12##3##(1993-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)
theoretical analysis##40##2##(1993-12#1)(1993-9#1)(1997-3#1)(2007-11#4)(2007-12#2)(2008-2#8)(2008-3#20)(2010-2#1)(2013-8#2)
theoretical and clinical##4##3##(1993-3#1)(2008-11#2)(2012-3#1)
theoretical and empirical##6##3##(1993-3#1)(1996-3#1)(1996-6#1)(2008-2#1)(2008-8#1)(2008-9#1)
theoretical and experimental investigation of the##2##6##(2007-12#1)(2008-3#1)
theoretical and experimental investigation of##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
theoretical and experimental results##10##4##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
theoretical and experimental studies##2##4##(2007-11#1)(2008-2#1)
theoretical and experimental##25##3##(1997-2#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#10)(2013-1#2)
theoretical and practical##8##3##(1990-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
theoretical and professional##2##3##(2010-10#2)
theoretical and the experimental##2##4##(2008-3#1)(2009-12#1)
theoretical and the##3##3##(2008-3#2)(2009-12#1)
theoretical and##55##2##(1990-12#1)(1993-3#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-12#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#14)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2010-10#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)
theoretical approach##5##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
theoretical approaches##4##2##(1996-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
theoretical aspects of##2##3##(2008-10#1)(2009-12#1)
theoretical aspects##4##2##(1993-6#1)(2008-10#2)(2009-12#1)
theoretical assessment of##2##3##(2008-10#2)
theoretical background for the##2##4##(2008-2#1)(2009-5#1)
theoretical background##6##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
theoretical basis for##3##3##(1992-3#1)(2013-8#2)
theoretical basis##4##2##(1992-3#1)(1997-3#1)(2013-8#2)
theoretical calculation with the##2##4##(2008-2#1)(2008-3#1)
theoretical calculation##6##2##(2007-11#1)(2008-2#2)(2008-3#1)(2011-1#2)
theoretical calculations##11##2##(2007-11#1)(2008-10#1)(2008-3#5)(2008-6#1)(2010-2#2)(2013-1#1)
theoretical concepts##4##2##(1996-3#1)(2008-12#1)(2008-7#1)(2011-2#1)
theoretical consequences##2##2##(2008-8#2)
theoretical considerations##9##2##(1993-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2010-10#1)(2010-12#1)
theoretical context##2##2##(1995-1#1)(2008-11#1)
theoretical data##4##2##(2008-3#3)(2009-11#1)
theoretical derivation##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
theoretical description##5##2##(2008-2#2)(2008-3#3)
theoretical design##4##2##(2008-3#4)
theoretical development##2##2##(2008-12#1)(2008-2#1)
theoretical diffraction##2##2##(2007-12#1)(2008-3#1)
theoretical discussion##2##2##(2008-3#1)(2010-1#1)
theoretical efficiency##3##2##(1990-7#1)(2007-11#1)(2008-3#1)
theoretical estimates##2##2##(2007-11#1)(2012-2#1)
theoretical expansion##2##2##(2008-3#2)
theoretical expectation##2##2##(2007-11#1)(2008-9#1)
theoretical expectations##8##2##(1995-2#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)
theoretical expressions##3##2##(2007-11#1)(2008-2#1)(2010-2#1)
theoretical findings##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
theoretical formalism##3##2##(2008-3#3)
theoretical formulas for##2##3##(2008-2#1)(2008-3#1)
theoretical foundation##2##2##(2008-8#1)(2010-1#1)
theoretical foundations##3##2##(1995-2#1)(2008-12#1)(2008-3#1)
theoretical framework for##3##3##(2008-4#1)(2008-8#2)
theoretical framework of##3##3##(2009-11#1)(2011-2#1)(2013-8#1)
theoretical framework to##4##3##(1992-3#1)(2008-1#1)(2008-7#1)(2012-3#1)
theoretical framework##20##2##(1992-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
theoretical frameworks##5##2##(2008-12#1)(2009-6#2)(2010-9#1)(2012-3#1)
theoretical ideas##2##2##(1995-6#1)(2011-2#1)
theoretical interest##2##2##(1992-5#1)(2008-4#1)
theoretical investigation of the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
theoretical investigation##5##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
theoretical investigations of##2##3##(2008-2#2)
theoretical investigations##3##2##(2008-11#1)(2008-2#2)
theoretical issues##3##2##(1991-12#1)(1993-12#1)(2008-7#1)
theoretical knowledge of holistic care into practice##2##7##(2008-11#2)
theoretical knowledge of holistic care into##3##6##(2008-11#3)
theoretical knowledge of holistic care##4##5##(2008-11#4)
theoretical knowledge of##6##3##(1997-4#1)(2008-11#4)(2010-10#1)
theoretical knowledge##9##2##(1997-4#1)(2008-1#1)(2008-11#6)(2010-10#1)
theoretical limit##3##2##(2007-12#2)(2008-4#1)
theoretical limitations##2##2##(1990-12#1)(2007-8#1)
theoretical limits##2##2##(2007-12#1)(2008-3#1)
theoretical maximum##5##2##(2008-10#2)(2008-3#1)(2008-6#2)
theoretical minimum##2##2##(2008-3#2)
theoretical model based on##2##4##(2007-11#1)(2008-10#1)
theoretical model for the##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
theoretical model for##8##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
theoretical model is##6##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
theoretical model of the##4##4##(1996-3#1)(2008-3#2)(2008-9#1)
theoretical model of##8##3##(1996-3#1)(2007-12#1)(2008-3#3)(2008-9#1)(2009-11#1)(2009-9#1)
theoretical model that##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
theoretical model was##2##3##(2008-10#1)(2008-12#1)
theoretical model##52##2##(1990-12#1)(1994-3#1)(1996-2#1)(1996-3#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#18)(2008-5#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#1)
theoretical modeling of##2##3##(2007-12#1)(2008-3#1)
theoretical modeling##3##2##(2007-12#1)(2008-3#2)
theoretical models of##5##3##(2008-4#1)(2008-8#1)(2009-7#1)(2009-9#1)(2012-2#1)
theoretical models that##5##3##(1996-4#1)(2007-12#1)(2008-3#1)(2013-1#2)
theoretical models##22##2##(1990-12#1)(1995-6#1)(1996-4#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-7#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
theoretical notions##2##2##(1992-3#1)(2008-12#1)
theoretical ones##2##2##(2008-3#2)
theoretical perspectives##2##2##(2008-9#1)(2010-7#1)
theoretical plate##4##2##(1994-9#1)(2008-10#3)
theoretical plates was##3##3##(2008-10#3)
theoretical plates##7##2##(1994-9#1)(1996-5#1)(2008-10#5)
theoretical point##5##2##(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
theoretical prediction of##2##3##(2007-12#1)(2008-3#1)
theoretical prediction##13##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#6)(2012-3#1)
theoretical predictions and##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
theoretical predictions are##2##3##(2008-10#1)(2008-3#1)
theoretical predictions for the##2##4##(2007-12#2)
theoretical predictions for##3##3##(2007-12#2)(2008-3#1)
theoretical predictions that##2##3##(1995-2#1)(2008-3#1)
theoretical predictions##55##2##(1992-6#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-11#5)(2007-12#10)(2008-10#4)(2008-2#6)(2008-3#16)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#2)(2012-3#2)(2013-1#1)
theoretical principles of##2##3##(2008-10#1)(2008-11#1)
theoretical profiles##2##2##(2008-3#2)
theoretical properties of##3##3##(2009-9#1)(2010-1#1)(2012-3#1)
theoretical rationale##2##2##(2008-6#2)
theoretical relation##2##2##(2008-10#1)(2008-7#1)
theoretical resolution is##2##3##(2008-2#1)(2008-3#1)
theoretical resolution##3##2##(2008-2#1)(2008-3#2)
theoretical result##3##2##(2007-12#1)(2008-8#1)(2010-7#1)
theoretical results are##2##3##(2007-12#1)(2008-8#1)
theoretical results for##2##3##(2007-11#1)(2008-3#1)
theoretical results from##2##3##(2008-2#1)(2008-3#1)
theoretical results indicate that##2##4##(2008-2#1)(2008-8#1)
theoretical results of##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
theoretical results##29##2##(2007-11#3)(2007-12#2)(2008-11#1)(2008-2#7)(2008-3#13)(2008-8#2)(2010-5#1)
theoretical risk##2##2##(2008-7#1)(2011-2#1)
theoretical sensitivity##2##2##(2008-2#1)(2008-3#1)
theoretical simulation##2##2##(2008-10#1)(2008-3#1)
theoretical simulations##3##2##(2008-10#2)(2008-3#1)
theoretical skin##2##2##(2008-5#2)
theoretical studies have##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
theoretical studies##9##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2013-1#1)
theoretical study of a##2##4##(2008-2#1)(2008-3#1)
theoretical study of##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
theoretical study##15##2##(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2010-10#2)(2010-2#1)(2012-2#1)
theoretical treatment of the##2##4##(2008-2#1)(2008-3#1)
theoretical treatment of##4##3##(2008-2#1)(2008-3#2)(2009-8#1)
theoretical treatment##6##2##(2008-2#3)(2008-3#2)(2009-8#1)
theoretical upper limit##2##3##(2007-12#2)
theoretical value of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
theoretical value##9##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)
theoretical values of##2##3##(2008-10#1)(2008-6#1)
theoretical values##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)
theoretical work##2##2##(1992-3#1)(2008-2#1)
theoretical yield##3##2##(2008-6#3)
theoretical##722##1##(1990-12#4)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#2)(1995-2#4)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#1)(2007-11#39)(2007-12#40)(2007-8#2)(2008-1#5)(2008-10#58)(2008-11#20)(2008-12#13)(2008-2#81)(2008-3#184)(2008-4#5)(2008-5#8)(2008-6#17)(2008-7#10)(2008-8#24)(2008-9#20)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#4)(2009-8#1)(2009-9#7)(2010-1#5)(2010-10#7)(2010-11#2)(2010-12#1)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#16)(2013-1#14)(2013-7#2)(2013-8#10)
theoretically analyze the##3##3##(2007-12#1)(2008-3#2)
theoretically analyze##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
theoretically analyzed##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
theoretically and experimentally by##2##4##(2007-11#1)(2007-12#1)
theoretically and experimentally that the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
theoretically and experimentally that##7##4##(2007-12#1)(2008-2#2)(2008-3#4)
theoretically and experimentally the##3##4##(2007-11#1)(2008-3#2)
theoretically and experimentally##44##3##(2007-11#6)(2007-12#6)(2008-10#2)(2008-2#7)(2008-3#23)
theoretically and numerically analyzed##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
theoretically and##53##2##(1990-7#1)(1997-6#1)(2007-11#6)(2007-12#9)(2008-10#2)(2008-2#8)(2008-3#25)(2009-9#1)
theoretically as##2##2##(2008-2#1)(2008-8#1)
theoretically be##2##2##(2008-8#1)(2013-1#1)
theoretically by##5##2##(1990-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
theoretically calculated values##3##3##(2008-3#3)
theoretically calculated##8##2##(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#4)
theoretically estimated##2##2##(2008-2#1)(2008-3#1)
theoretically examined##2##2##(2008-2#1)(2008-3#1)
theoretically expected##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
theoretically for the##2##3##(2007-11#1)(2008-10#1)
theoretically for##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
theoretically investigated##3##2##(2007-11#1)(2007-12#2)
theoretically modeled##2##2##(2008-2#1)(2008-3#1)
theoretically predicted##4##2##(1990-12#1)(2008-10#2)(2008-3#1)
theoretically studied by##2##3##(2007-11#1)(2008-10#1)
theoretically studied##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
theoretically that the##5##3##(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
theoretically that##6##2##(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
theoretically the##2##2##(2008-10#1)(2008-8#1)
theoretically to##2##2##(2007-11#1)(2008-11#1)
theoretically##179##1##(1990-12#1)(1990-7#2)(1994-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(2007-11#17)(2007-12#21)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#27)(2008-3#63)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-9#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#3)
theories about##6##2##(1995-1#1)(2007-8#1)(2008-11#1)(2010-1#1)(2010-10#1)(2010-8#1)
theories and practices##2##3##(1992-2#1)(2009-8#1)
theories and the##3##3##(2008-2#2)(2011-2#1)
theories and##10##2##(1992-2#1)(1993-12#1)(2008-10#1)(2008-2#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
theories are needed##2##3##(2009-8#2)
theories are##5##2##(1997-6#1)(2007-8#1)(2008-2#1)(2009-8#2)
theories can be##2##3##(2008-6#1)(2010-6#1)
theories emphasizing the##2##3##(2007-12#2)
theories for improvement##2##3##(1994-12#2)
theories for##5##2##(1992-2#1)(1994-12#2)(2008-2#2)
theories have been proposed##2##4##(2009-12#1)(2011-1#1)
theories have been##3##3##(2008-3#1)(2009-12#1)(2011-1#1)
theories have##5##2##(2008-3#1)(2008-5#1)(2009-12#1)(2010-10#1)(2011-1#1)
theories in##3##2##(2008-12#1)(2009-8#1)(2012-3#1)
theories is##2##2##(1994-1#1)(2008-3#1)
theories of aging##3##3##(1994-5#1)(2008-3#1)(2008-9#1)
theories of autism##2##3##(2008-11#1)(2013-1#1)
theories of prosody##2##3##(2010-9#2)
theories of the##2##3##(1990-7#1)(1997-6#1)
theories of these##3##3##(2008-3#1)(2013-1#2)
theories of##44##2##(1990-12#1)(1990-7#2)(1993-2#2)(1993-6#2)(1994-1#1)(1994-5#1)(1995-1#1)(1996-3#1)(1997-6#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-9#2)(2012-12#2)(2013-1#3)
theories on##2##2##(1992-3#1)(1995-6#1)
theories that##6##2##(2007-12#1)(2008-3#1)(2008-9#2)(2010-9#1)(2012-1#1)
theories were##2##2##(2008-11#1)(2010-1#1)
theories##137##1##(1990-12#1)(1990-7#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-1#4)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#4)(2007-10#1)(2007-11#1)(2007-12#6)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-1#4)(2010-10#7)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#5)
theorists##6##1##(1994-3#1)(1995-3#1)(1996-2#1)(2008-12#1)(2009-10#2)
theorize##3##1##(2009-10#2)(2009-6#1)
theorized##5##1##(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
theorizing##2##1##(2008-12#1)(2010-10#1)
theory about##2##2##(2008-8#1)(2010-1#1)
theory allows##2##2##(2008-1#1)(2008-10#1)
theory and a##2##3##(2008-2#1)(2008-3#1)
theory and an##2##3##(2008-3#1)(2012-2#1)
theory and applications to molecular systems##2##6##(2013-1#2)
theory and applications##4##3##(2010-11#1)(2012-3#1)(2013-1#2)
theory and clinical##3##3##(1993-12#1)(1997-2#1)(2012-3#1)
theory and computer##2##3##(2008-2#1)(2008-3#1)
theory and experiment##16##3##(1992-5#1)(1992-6#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#4)(2008-5#1)
theory and experimental results##2##4##(2007-12#1)(2008-3#1)
theory and experimental##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
theory and its application##2##4##(1993-2#1)(2008-11#1)
theory and its##3##3##(1993-2#1)(1997-6#1)(2008-11#1)
theory and other##2##3##(2009-6#1)(2010-6#1)
theory and practice in##2##4##(1991-6#1)(2012-3#1)
theory and practice##16##3##(1991-6#1)(1995-1#1)(1997-3#2)(2008-11#4)(2008-12#5)(2008-8#1)(2012-3#2)
theory and present##2##3##(1993-12#1)(2008-2#1)
theory and research##6##3##(1991-12#1)(2008-11#1)(2008-5#3)(2010-2#1)
theory and suggest that##2##4##(2011-2#1)(2013-1#1)
theory and the experimental results##2##5##(1990-12#1)(2008-2#1)
theory and the##12##3##(1990-12#1)(1994-2#1)(2008-2#1)(2008-3#6)(2008-5#1)(2009-6#1)(2012-3#1)
theory and##132##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-12#5)(1993-2#3)(1993-3#2)(1994-2#1)(1995-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#6)(2008-2#16)(2008-3#31)(2008-4#1)(2008-5#5)(2008-8#6)(2008-9#1)(2009-11#1)(2009-6#4)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#6)
theory approach##9##2##(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#2)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
theory are compared with##3##4##(2008-3#3)
theory are used##4##3##(2008-2#1)(2008-3#2)(2012-12#1)
theory are##13##2##(2007-11#1)(2008-2#1)(2008-3#7)(2008-8#1)(2009-9#1)(2010-10#1)(2012-12#1)
theory as well as##2##4##(2008-3#2)
theory as##4##2##(1990-8#1)(2008-11#1)(2008-3#2)
theory at##2##2##(1992-8#1)(2008-10#1)
theory based on##4##3##(2007-11#1)(2008-2#2)(2011-2#1)
theory based##5##2##(2007-11#1)(2008-2#2)(2011-2#1)(2013-8#1)
theory behind##2##2##(2008-2#1)(2013-8#1)
theory building##2##2##(2008-5#2)
theory by using##2##3##(2008-3#1)(2008-9#1)
theory by##7##2##(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)
theory can be used##2##4##(2008-2#1)(2008-3#1)
theory can be##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)
theory can##6##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-3#1)
theory cannot##2##2##(2008-8#1)(2012-2#1)
theory concerning##2##2##(2007-12#1)(2010-1#1)
theory contends that##2##3##(2008-1#1)(2012-12#1)
theory could be##2##3##(2008-10#1)(2010-6#1)
theory developed##3##2##(1993-2#1)(2007-10#1)(2008-8#1)
theory development##4##2##(2008-8#2)(2009-8#2)
theory explaining the##2##3##(2007-10#1)(2012-12#1)
theory for a new##2##4##(2008-10#1)(2008-3#1)
theory for an##2##3##(2008-2#2)
theory for the##6##3##(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
theory for##37##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#18)(2008-8#3)(2009-2#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
theory framework##2##2##(2012-12#1)(2012-3#1)
theory from##2##2##(2007-11#1)(2008-8#1)
theory gives##2##2##(2008-10#1)(2008-3#1)
theory has been##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
theory has##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#1)
theory in practice##2##3##(2008-12#2)
theory in the##2##3##(1994-2#1)(2008-11#1)
theory in##16##2##(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-3#1)(2013-1#1)
theory indicates that the##2##4##(1991-11#1)(2008-8#1)
theory into practice##2##3##(1997-4#1)(2008-11#1)
theory is applied to##2##4##(2008-3#2)
theory is applied##3##3##(2008-2#1)(2008-3#2)
theory is described##2##3##(2008-3#1)(2009-10#1)
theory is developed from##2##4##(1990-8#1)(2008-3#1)
theory is developed##4##3##(1990-8#1)(2008-3#3)
theory is illustrated##2##3##(1991-1#1)(2008-2#1)
theory is presented for the##2##5##(1990-8#1)(2008-10#1)
theory is presented##6##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-3#2)
theory is proposed for##2##4##(1990-5#1)(2008-2#1)
theory is proposed##3##3##(1990-5#1)(2008-2#1)(2013-8#1)
theory is shown to##2##4##(2008-2#1)(2008-3#1)
theory is that##2##3##(2008-2#1)(2008-8#1)
theory is used to##6##4##(2007-11#1)(2008-10#1)(2008-3#3)(2012-12#1)
theory is##52##2##(1990-5#1)(1990-8#3)(1991-1#2)(1995-9#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-2#8)(2008-3#20)(2008-5#1)(2008-8#2)(2009-10#1)(2009-6#1)(2009-9#2)(2011-1#1)(2012-12#1)(2013-8#1)
theory method was##2##3##(2007-10#1)(2013-1#1)
theory method##5##2##(2007-10#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
theory methods##2##2##(2010-7#1)(2013-1#1)
theory of a##3##3##(2006-12#1)(2007-11#1)(2008-2#1)
theory of aging is##2##4##(2009-12#1)(2013-8#1)
theory of aging##6##3##(1994-6#1)(2009-12#2)(2013-8#3)
theory of energy coding##2##4##(2008-11#2)
theory of image formation##2##4##(2008-2#1)(2008-3#1)
theory of image##3##3##(2008-2#1)(2008-3#2)
theory of knowledge##2##3##(1996-1#2)
theory of light##2##3##(2007-11#2)
theory of management##2##3##(1996-1#1)(2008-1#1)
theory of mind##7##3##(2008-11#2)(2008-12#2)(2012-1#2)(2013-1#1)
theory of molecular evolution##2##4##(1994-8#1)(1997-6#1)
theory of multiple##2##3##(1992-3#1)(2008-2#1)
theory of nationalism##2##3##(2011-1#2)
theory of radiation##2##3##(2008-3#1)(2008-7#1)
theory of stochastic##2##3##(2008-10#1)(2008-8#1)
theory of the double-edge technique##2##5##(2008-2#1)(2008-3#1)
theory of the inalienable right to life and liberty is enforced by the Thirteenth Amendment##2##15##(2011-2#2)
theory of the inalienable right to life and liberty##3##9##(2011-2#3)
theory of the speckle velocimeter##2##5##(2008-3#2)
theory of the##16##3##(2007-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2011-2#4)(2012-3#1)
theory of this##4##3##(1990-8#1)(2007-12#1)(2008-3#2)
theory of three-dimensional radiance measurements##2##5##(2008-2#2)
theory of##158##2##(1990-12#1)(1990-5#1)(1990-8#3)(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-1#3)(1997-5#1)(1997-6#1)(2006-12#1)(2007-11#8)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#12)(2008-3#27)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#4)(2009-6#1)(2009-8#1)(2009-9#3)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#7)
theory often##2##2##(2008-8#1)(2008-9#1)
theory on##6##2##(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)(2013-1#1)
theory or##2##2##(2008-2#1)(2009-8#1)
theory predictions##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
theory predicts that##4##3##(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
theory predicts##6##2##(1993-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2012-3#1)
theory provides a##2##3##(1994-3#1)(2008-3#1)
theory provides##5##2##(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
theory reveals that##2##3##(2008-2#1)(2008-8#1)
theory reveals##3##2##(2008-2#2)(2008-8#1)
theory show that the##2##4##(2008-3#2)
theory show that##3##3##(2008-3#3)
theory shows that##2##3##(2008-3#1)(2012-3#1)
theory suggests that##2##3##(2008-8#1)(2011-2#1)
theory that describes##2##3##(2008-2#1)(2009-5#1)
theory that the##2##3##(1992-4#1)(2008-7#1)
theory that##25##2##(1992-4#1)(1995-1#2)(2007-11#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
theory to describe the##2##4##(2007-11#1)(2008-3#1)
theory to describe##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
theory to explain the##2##4##(2007-11#1)(2009-3#1)
theory to practice in##2##4##(2008-11#2)
theory to practice##11##3##(1996-2#1)(2008-11#8)(2008-12#1)(2008-6#1)
theory to show##2##3##(2007-11#1)(2008-8#1)
theory to the##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
theory to##48##2##(1991-1#1)(1993-3#2)(1996-1#1)(1996-2#1)(1997-3#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#5)(2008-6#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2010-9#1)(2012-2#1)
theory tools##2##2##(1996-3#2)
theory using##2##2##(2008-11#1)(2008-9#1)
theory was##4##2##(1990-5#1)(2008-11#1)(2010-8#1)(2012-12#1)
theory we##2##2##(1995-6#1)(2008-3#1)
theory which##3##2##(1990-12#1)(1996-1#1)(1997-8#1)
theory while##2##2##(1995-1#1)(2008-1#1)
theory with practice##3##3##(1991-2#1)(1993-12#1)(2008-11#1)
theory with##10##2##(1991-2#1)(1993-12#1)(1993-5#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
theory##987##1##(1990-11#1)(1990-12#3)(1990-5#5)(1990-8#7)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#2)(1993-12#6)(1993-2#6)(1993-3#5)(1993-5#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#4)(1995-2#1)(1995-3#2)(1995-6#5)(1995-9#1)(1996-1#7)(1996-2#7)(1996-3#4)(1996-5#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#5)(2007-11#40)(2007-12#34)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#5)(2008-1#14)(2008-10#56)(2008-11#48)(2008-12#22)(2008-2#108)(2008-3#212)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#20)(2008-8#54)(2008-9#22)(2009-10#4)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#10)(2009-7#6)(2009-8#10)(2009-9#12)(2010-1#5)(2010-10#6)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#5)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#16)(2012-2#11)(2012-3#20)(2013-1#23)(2013-7#1)(2013-8#17)
theory's##3##1##(1995-2#1)(2008-10#1)(2008-2#1)
theory)##2##1##(2010-1#1)(2013-8#1)
theory-based problem-solving approach##2##3##(2010-10#2)
theory-based##8##1##(1995-3#1)(1997-1#1)(2008-6#1)(2010-10#2)(2013-1#3)
theory-driven research##2##2##(2009-8#2)
theory-driven##5##1##(2008-2#1)(2009-8#2)(2011-1#2)
theory-of-mind##4##1##(2008-9#4)
theory-practice gap##8##2##(2008-11#8)
theory-practice##10##1##(2008-11#8)(2012-3#1)(2013-1#1)
theory?##3##1##(1990-8#1)(2008-8#1)(2010-1#1)
theother two carriers##2##3##(2008-11#2)
theother##3##1##(2008-11#3)
thepresence of##4##2##(2008-11#4)
thepresence##6##1##(2008-11#5)(2013-8#1)
theprimary cells##2##2##(2008-11#2)
theproduction of##2##2##(2008-11#2)
theranostic agents##2##2##(2012-12#2)
therapeutic action##2##2##(1994-8#1)(2007-11#1)
therapeutic activity of##2##3##(1990-2#1)(2013-1#1)
therapeutic activity##4##2##(1990-2#1)(1993-9#1)(1996-3#1)(2013-1#1)
therapeutic administration of##2##3##(1991-12#1)(2012-1#1)
therapeutic advantage in##2##3##(1990-12#1)(1994-12#1)
therapeutic advantages##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
therapeutic agent for##2##3##(2008-7#1)(2012-2#1)
therapeutic agent##8##2##(1992-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-2#1)
therapeutic agents against##2##3##(1994-12#1)(2008-8#1)
therapeutic agents are##2##3##(2010-11#1)(2010-5#1)
therapeutic agents for the##2##4##(2009-12#1)(2009-6#1)
therapeutic agents for##7##3##(1992-12#1)(1994-11#1)(2007-5#1)(2009-12#1)(2009-6#1)(2012-12#1)(2012-2#1)
therapeutic agents has##2##3##(2008-10#1)(2012-12#1)
therapeutic agents have##2##3##(2008-7#1)(2010-5#1)
therapeutic agents that##2##3##(2008-7#1)(2010-7#1)
therapeutic agents to treat##2##4##(2008-1#1)(2008-7#1)
therapeutic agents to##4##3##(2008-1#1)(2008-3#1)(2008-7#1)(2010-11#1)
therapeutic agents##40##2##(1990-9#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-1#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-11#2)(2010-5#4)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
therapeutic alliance##6##2##(2008-11#1)(2008-2#1)(2008-6#2)(2011-1#1)(2013-1#1)
therapeutic alternative in##2##3##(1992-4#1)(1995-11#1)
therapeutic alternative##4##2##(1992-4#1)(1994-11#1)(1995-11#1)(2011-2#1)
therapeutic alternatives##2##2##(2007-8#1)(2013-8#1)
therapeutic and diagnostic##3##3##(2008-11#1)(2008-5#1)(2012-2#1)
therapeutic and preventive##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
therapeutic and prognostic##2##3##(1993-5#1)(2010-7#1)
therapeutic and prophylactic##2##3##(2009-10#1)(2009-7#1)
therapeutic and##20##2##(1993-5#2)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
therapeutic antibodies are##2##3##(2008-11#1)(2013-8#1)
therapeutic antibodies on##2##3##(2008-11#2)
therapeutic antibodies##12##2##(2008-11#9)(2010-11#2)(2013-8#1)
therapeutic antibody##3##2##(2008-10#1)(2010-11#1)(2013-8#1)
therapeutic application of##3##3##(2007-10#1)(2010-3#1)(2013-1#1)
therapeutic application##8##2##(1991-1#1)(1997-1#1)(2007-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
therapeutic applications for##2##3##(1994-5#1)(2008-4#1)
therapeutic applications in##2##3##(2013-1#2)
therapeutic applications of##4##3##(2008-3#1)(2010-5#1)(2013-1#2)
therapeutic applications##22##2##(1994-5#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-12#1)(2009-2#1)(2009-3#2)(2010-5#2)(2013-1#5)
therapeutic approach and##3##3##(1990-2#1)(1992-12#1)(2008-10#1)
therapeutic approach for the##2##4##(2008-10#1)(2010-6#1)
therapeutic approach for##7##3##(1992-12#1)(1992-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
therapeutic approach in##6##3##(1990-6#1)(1991-3#1)(1996-11#1)(2012-12#2)(2012-3#1)
therapeutic approach is##3##3##(1990-12#2)(1993-5#1)
therapeutic approach to##12##3##(1990-2#1)(1990-3#1)(1992-12#1)(1992-9#1)(1996-3#1)(2008-1#2)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
therapeutic approach##48##2##(1990-12#3)(1990-2#2)(1990-3#2)(1990-6#1)(1991-3#1)(1991-6#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-5#2)(1994-5#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
therapeutic approach]##2##2##(1991-6#1)(1997-3#1)
therapeutic approaches for##6##3##(1990-5#1)(1991-9#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)
therapeutic approaches in the##2##4##(2010-5#1)(2012-2#1)
therapeutic approaches may##2##3##(2008-11#1)(2008-6#1)
therapeutic approaches to these##2##4##(2006-10#1)(2008-4#1)
therapeutic approaches to##8##3##(2006-10#1)(2008-1#2)(2008-4#1)(2008-7#1)(2010-11#2)(2013-1#1)
therapeutic approaches which##2##3##(1991-7#1)(2008-5#1)
therapeutic approaches##39##2##(1990-5#2)(1991-7#1)(1991-9#1)(1992-5#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#3)(2010-5#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
therapeutic aspects and##2##3##(1990-9#1)(2007-8#1)
therapeutic aspects##9##2##(1990-9#2)(1992-5#1)(1993-6#1)(2007-12#1)(2007-8#2)(2008-12#1)(2012-3#1)
therapeutic benefit of##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
therapeutic benefit##13##2##(1990-6#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-4#1)(2013-1#3)(2013-8#1)
therapeutic benefits##4##2##(2008-10#1)(2008-3#1)(2009-11#1)(2013-1#1)
therapeutic challenge##8##2##(1995-11#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-6#1)(2010-11#1)(2010-5#1)(2012-2#1)
therapeutic choice##3##2##(1994-6#1)(2008-1#1)(2010-8#1)
therapeutic choices##3##2##(2007-11#1)(2012-2#1)(2012-3#1)
therapeutic communication skills as##2##4##(2008-11#2)
therapeutic communication##4##2##(2008-11#4)
therapeutic communities##2##2##(2008-6#1)(2012-2#1)
therapeutic compliance##3##2##(1993-11#3)
therapeutic compounds##3##2##(1994-5#1)(2008-11#1)(2011-1#1)
therapeutic consequences##2##2##(1990-11#1)(1995-4#1)
therapeutic considerations]##2##2##(1991-6#2)
therapeutic decision of##2##3##(1993-11#1)(2011-2#1)
therapeutic decision##5##2##(1990-2#1)(1993-11#1)(2007-10#1)(2011-2#1)(2012-3#1)
therapeutic decisions in##2##3##(2010-12#2)
therapeutic decisions##6##2##(2008-8#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-8#1)
therapeutic developments##2##2##(1991-3#1)(2008-8#1)
therapeutic diets##2##2##(1993-3#1)(1995-2#1)
therapeutic difficulties##4##2##(1993-2#1)(2007-5#1)(2008-10#1)(2009-5#1)
therapeutic doses of##2##3##(1991-11#1)(2008-6#1)
therapeutic doses##7##2##(1991-11#2)(1992-11#1)(2008-6#1)(2008-7#1)(2008-8#2)
therapeutic drug monitoring##5##3##(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#2)
therapeutic drug##7##2##(2008-3#1)(2008-6#2)(2008-8#1)(2010-11#2)(2012-2#1)
therapeutic drugs for##4##3##(2010-12#1)(2011-1#3)
therapeutic drugs##13##2##(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#4)
therapeutic effect in##2##3##(1991-3#1)(2009-12#1)
therapeutic effect of a##2##4##(1994-9#1)(1996-3#1)
therapeutic effect of##7##3##(1990-5#1)(1994-9#1)(1996-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
therapeutic effect##19##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#1)(1994-9#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)(2012-3#2)
therapeutic effectiveness of##3##3##(1996-12#1)(2008-7#1)(2009-3#1)
therapeutic effectiveness##6##2##(1990-3#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2013-8#1)
therapeutic effects of##3##3##(1991-8#1)(2012-1#1)(2013-1#1)
therapeutic effects##15##2##(1991-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
therapeutic efficacy and##3##3##(1990-2#1)(1990-3#1)(1991-6#1)
therapeutic efficacy of the##2##4##(2007-11#1)(2012-12#1)
therapeutic efficacy of##11##3##(1990-5#1)(1991-8#1)(1991-9#1)(1995-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#1)
therapeutic efficacy##24##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2012-12#1)(2013-1#2)
therapeutic efforts##2##2##(2008-1#1)(2013-1#1)
therapeutic emplotment##2##2##(2013-1#2)
therapeutic endoscopy##3##2##(1990-2#1)(1991-11#1)(2010-6#1)
therapeutic environments has##2##3##(2012-2#2)
therapeutic equivalence##2##2##(2007-12#1)(2008-11#1)
therapeutic exercise##3##2##(2008-12#2)(2012-1#1)
therapeutic failure##3##2##(1993-11#1)(2008-10#1)(2012-2#1)
therapeutic genes##3##2##(1993-2#1)(2008-5#1)(2008-8#1)
therapeutic goals##2##2##(2011-2#1)(2012-5#1)
therapeutic gold standard##2##3##(2008-10#2)
therapeutic group##4##2##(2008-11#3)(2011-2#1)
therapeutic hypothermia##4##2##(2007-10#2)(2008-3#1)(2008-8#1)
therapeutic implications for the##2##4##(2008-7#1)(2011-2#1)
therapeutic implications for##4##3##(1991-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
therapeutic implications in##3##3##(1997-1#1)(2008-1#1)(2012-2#1)
therapeutic implications of##3##3##(1992-6#1)(2007-8#1)(2013-7#1)
therapeutic implications##23##2##(1991-3#1)(1991-7#1)(1992-6#1)(1994-6#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#6)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
therapeutic in##2##2##(1992-3#1)(2012-2#1)
therapeutic index##3##2##(1996-9#1)(1997-1#1)(2008-8#1)
therapeutic indications##2##2##(1994-6#1)(2012-2#1)
therapeutic interest##2##2##(1995-3#1)(2011-2#1)
therapeutic intervention in##3##3##(1990-7#1)(1994-8#1)(2010-3#1)
therapeutic intervention of##2##3##(2010-12#1)(2012-2#1)
therapeutic intervention to##2##3##(1993-5#1)(2010-3#1)
therapeutic intervention##25##2##(1990-3#1)(1990-7#1)(1991-9#1)(1993-5#1)(1994-8#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)
therapeutic interventions for##2##3##(1997-4#1)(2013-1#1)
therapeutic interventions to##2##3##(2010-8#1)(2011-2#1)
therapeutic interventions##24##2##(1997-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
therapeutic levels##2##2##(1990-8#1)(2008-3#1)
therapeutic lifestyle##2##2##(2008-1#1)(2010-6#1)
therapeutic management of##3##3##(1992-8#1)(2012-2#1)(2012-3#1)
therapeutic management##9##2##(1992-8#1)(1995-11#2)(2007-6#1)(2007-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
therapeutic measure##2##2##(1991-12#1)(2008-3#1)
therapeutic measures##3##2##(1990-6#1)(2011-2#1)(2012-2#1)
therapeutic medical applications##2##3##(1994-2#1)(2013-7#1)
therapeutic medical##3##2##(1994-2#1)(2007-8#1)(2013-7#1)
therapeutic methods##6##2##(1990-6#1)(1995-11#1)(1995-5#1)(2008-10#1)(2009-8#1)(2013-1#1)
therapeutic milieu##4##2##(1993-2#2)(2010-5#1)(2013-1#1)
therapeutic misconception##3##2##(2009-6#2)(2012-2#1)
therapeutic modalities are##3##3##(2007-7#1)(2008-2#1)(2009-4#1)
therapeutic modalities for##2##3##(1993-1#1)(1994-10#1)
therapeutic modalities##12##2##(1993-1#1)(1993-2#1)(1994-10#1)(1995-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
therapeutic modality for##4##3##(2007-7#3)(2013-1#1)
therapeutic modality in##2##3##(2007-7#2)
therapeutic modality##11##2##(1993-2#1)(2007-7#5)(2008-7#1)(2008-8#1)(2010-10#1)(2010-6#1)(2013-1#1)
therapeutic needs##2##2##(1992-3#1)(2012-3#1)
therapeutic opportunities##2##2##(2011-2#1)(2012-2#1)
therapeutic option for patients with##2##5##(2007-8#1)(2013-8#1)
therapeutic option for##7##3##(2007-8#1)(2009-9#1)(2011-2#1)(2011-3#2)(2013-8#2)
therapeutic option in##3##3##(2008-3#1)(2010-12#2)
therapeutic option##18##2##(1997-3#1)(2007-7#1)(2007-8#3)(2008-3#1)(2009-5#1)(2009-9#1)(2010-12#4)(2011-2#1)(2011-3#2)(2013-8#3)
therapeutic options available##2##3##(2010-8#1)(2011-2#1)
therapeutic options for the##2##4##(2008-5#1)(2010-8#1)
therapeutic options for##7##3##(2008-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
therapeutic options in##2##3##(2009-5#1)(2011-3#1)
therapeutic options of the##2##4##(1992-12#1)(1993-5#1)
therapeutic options to##2##3##(2006-10#1)(2008-3#1)
therapeutic options##26##2##(1990-12#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-5#2)(2006-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#3)(2011-1#3)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)
therapeutic outcome##2##2##(1996-7#1)(2008-11#1)
therapeutic outcomes##5##2##(2009-3#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
therapeutic parameters##3##2##(2010-8#3)
therapeutic perspectives##2##2##(2008-7#2)
therapeutic plasma exchange##2##3##(2011-2#2)
therapeutic plasma##3##2##(2011-2#2)(2012-12#1)
therapeutic possibilities##4##2##(1990-6#1)(1990-8#1)(1991-11#1)(2008-10#1)
therapeutic potential as##2##3##(1992-3#1)(2008-7#1)
therapeutic potential for##2##3##(2009-3#1)(2012-2#1)
therapeutic potential in##3##3##(1997-1#1)(2008-5#1)(2012-12#1)
therapeutic potential of##12##3##(2007-6#1)(2008-11#3)(2008-7#1)(2009-3#1)(2012-12#3)(2012-2#2)(2013-8#1)
therapeutic potential##28##2##(1990-9#1)(1992-3#1)(1995-12#1)(1997-1#1)(2007-6#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-3#2)(2009-8#1)(2011-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
therapeutic principle##2##2##(1993-11#1)(1994-6#1)
therapeutic problem##3##2##(1993-5#1)(2007-11#1)(2008-7#1)
therapeutic problem]##2##2##(1991-8#1)(1992-6#1)
therapeutic problems##3##2##(1997-2#2)(2008-7#1)
therapeutic procedure##3##2##(2007-11#1)(2008-7#1)(2013-1#1)
therapeutic procedures are##4##3##(1993-9#1)(1996-3#2)(2007-11#1)
therapeutic procedures##13##2##(1991-9#1)(1993-3#1)(1993-9#1)(1996-3#3)(2007-11#1)(2007-8#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
therapeutic product##2##2##(2008-10#1)(2012-12#1)
therapeutic products##7##2##(2008-10#1)(2008-11#4)(2012-12#2)
therapeutic progress##2##2##(2007-8#1)(2008-9#1)
therapeutic properties##2##2##(2008-6#1)(2013-1#1)
therapeutic protein in##2##3##(2008-11#2)
therapeutic protein##7##2##(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)
therapeutic proteins##10##2##(1996-1#1)(2008-10#4)(2008-11#4)(2013-8#1)
therapeutic protocol##2##2##(1995-12#1)(2013-1#1)
therapeutic purposes##4##2##(1994-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
therapeutic range##3##2##(1990-5#1)(1992-8#1)(2008-10#1)
therapeutic ranges##2##2##(1991-11#1)(2007-11#1)
therapeutic regimen for##2##3##(2009-9#1)(2013-7#1)
therapeutic regimen##7##2##(1991-9#1)(1992-8#1)(1993-2#1)(1994-9#1)(2007-7#1)(2009-9#1)(2013-7#1)
therapeutic regimens##6##2##(2008-1#2)(2008-6#2)(2011-2#1)(2012-3#1)
therapeutic relationship##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
therapeutic repair##2##2##(2009-9#2)
therapeutic research##2##2##(2008-11#1)(2008-4#1)
therapeutic resistance##5##2##(1993-1#2)(2008-7#1)(2009-3#1)(2012-12#1)
therapeutic response to##3##3##(1997-1#1)(2008-10#1)(2009-11#1)
therapeutic response##11##2##(1991-2#1)(1997-1#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#1)
therapeutic results##5##2##(1996-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)
therapeutic role##3##2##(1994-6#1)(2013-1#1)(2013-7#1)
therapeutic roles##5##2##(2008-3#1)(2010-5#1)(2011-2#2)(2012-2#1)
therapeutic services##2##2##(1993-2#1)(2008-11#1)
therapeutic significance##2##2##(1995-12#1)(2008-11#1)
therapeutic strategies are##4##3##(1992-3#1)(2008-7#1)(2008-8#1)(2010-5#1)
therapeutic strategies for the treatment of##2##6##(2011-2#1)(2013-1#1)
therapeutic strategies for the##4##4##(2010-2#1)(2011-2#1)(2011-9#1)(2013-1#1)
therapeutic strategies for##12##3##(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#3)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2011-9#1)(2013-1#1)
therapeutic strategies have been##2##4##(2010-11#1)(2013-1#1)
therapeutic strategies to##4##3##(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)
therapeutic strategies##46##2##(1990-6#1)(1992-3#1)(1995-2#1)(1996-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#2)(2011-2#4)(2011-3#1)(2011-9#1)(2012-2#2)(2013-1#4)(2013-8#1)
therapeutic strategy for the treatment of##2##6##(2008-7#1)(2009-3#1)
therapeutic strategy for##7##3##(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#3)(2012-2#1)
therapeutic strategy in##2##3##(1991-5#1)(2008-7#1)
therapeutic strategy of##2##3##(2008-4#1)(2012-3#1)
therapeutic strategy to reduce##2##4##(2010-2#1)(2011-2#1)
therapeutic strategy to##3##3##(2010-2#1)(2011-2#1)(2013-1#1)
therapeutic strategy##20##2##(1991-5#1)(1992-6#1)(2008-1#1)(2008-4#1)(2008-7#3)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#1)
therapeutic study##2##2##(1993-11#1)(1994-2#1)
therapeutic success##5##2##(2007-7#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
therapeutic successes##2##2##(1990-3#1)(2007-9#1)
therapeutic system)##2##2##(1992-8#2)
therapeutic target for the treatment of##3##6##(2008-1#1)(2012-2#1)(2013-1#1)
therapeutic target for##8##3##(2008-1#2)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#1)
therapeutic target in##3##3##(2008-5#1)(2009-5#1)(2012-2#1)
therapeutic target##18##2##(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
therapeutic targeting##2##2##(2009-9#1)(2012-12#1)
therapeutic targets and biomarkers##2##4##(2013-1#2)
therapeutic targets for##2##3##(2008-5#1)(2011-1#1)
therapeutic targets in human##2##4##(2010-12#1)(2012-2#1)
therapeutic targets in##5##3##(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
therapeutic targets##28##2##(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#3)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
therapeutic techniques##2##2##(2008-12#1)(2008-7#1)
therapeutic tool for##3##3##(1990-5#1)(1994-6#1)(2008-1#1)
therapeutic tool##8##2##(1990-5#1)(1994-6#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)
therapeutic tools##2##2##(2008-1#1)(2011-2#1)
therapeutic treatment##3##2##(2008-1#1)(2008-3#1)(2008-8#1)
therapeutic trials##4##2##(1991-6#1)(2007-10#1)(2008-7#1)(2011-2#1)
therapeutic use of##7##3##(1992-9#1)(1996-11#1)(2008-7#2)(2012-12#1)(2013-8#2)
therapeutic use##18##2##(1990-3#1)(1992-9#1)(1993-8#1)(1996-11#1)(2007-7#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
therapeutic uses##2##2##(1991-2#1)(2012-12#1)
therapeutic utility##2##2##(2008-7#1)(2013-8#1)
therapeutic vaccine##3##2##(1993-3#1)(2007-12#1)(2007-7#1)
therapeutic vaccines##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
therapeutic value of cranberries in##2##5##(1997-4#2)
therapeutic value of##6##3##(1996-9#1)(1997-4#2)(2007-7#1)(2012-3#2)
therapeutic value##12##2##(1991-9#1)(1993-2#1)(1996-9#1)(1997-4#2)(2007-7#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2012-3#2)
therapeutic window of##2##3##(2008-3#1)(2010-6#1)
therapeutic window##3##2##(2008-3#1)(2008-5#1)(2010-6#1)
therapeutic work##2##2##(1990-6#1)(2012-12#1)
therapeutic##1195##1##(1990-11#1)(1990-12#6)(1990-2#8)(1990-3#8)(1990-5#8)(1990-6#9)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#2)(1991-11#6)(1991-12#2)(1991-2#4)(1991-3#5)(1991-5#2)(1991-6#7)(1991-7#2)(1991-8#3)(1991-9#7)(1992-11#1)(1992-12#6)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#6)(1992-9#2)(1993-1#3)(1993-11#9)(1993-12#2)(1993-2#10)(1993-3#4)(1993-5#9)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#7)(1994-8#7)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#5)(1995-2#6)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-11#7)(1996-12#1)(1996-2#1)(1996-3#9)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#3)(2007-10#8)(2007-11#18)(2007-12#8)(2007-2#2)(2007-5#3)(2007-6#2)(2007-7#20)(2007-8#21)(2007-9#1)(2008-1#26)(2008-10#40)(2008-11#73)(2008-12#14)(2008-2#7)(2008-3#25)(2008-4#25)(2008-5#34)(2008-6#24)(2008-7#58)(2008-8#23)(2008-9#11)(2009-1#2)(2009-10#4)(2009-11#6)(2009-12#7)(2009-2#2)(2009-3#13)(2009-4#5)(2009-5#8)(2009-6#7)(2009-7#4)(2009-8#7)(2009-9#8)(2010-10#4)(2010-11#16)(2010-12#15)(2010-2#3)(2010-3#7)(2010-4#1)(2010-5#15)(2010-6#11)(2010-7#5)(2010-8#9)(2010-9#1)(2011-1#19)(2011-2#62)(2011-3#6)(2011-7#1)(2011-9#1)(2012-1#4)(2012-12#34)(2012-2#53)(2012-3#24)(2012-5#1)(2013-1#69)(2013-7#10)(2013-8#26)
therapeutical agents##2##2##(1994-11#2)
therapeutical##18##1##(1990-5#1)(1990-6#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-12#1)(2007-11#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-11#1)(2012-7#1)
therapeutically relevant##2##2##(1997-1#1)(2008-12#1)
therapeutically to##2##2##(2008-1#1)(2008-10#1)
therapeutically##18##1##(1990-9#1)(1994-5#1)(1995-2#2)(1995-3#1)(1997-1#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#2)
therapeutics and##2##2##(2008-11#1)(2008-7#1)
therapeutics for##5##2##(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#2)
therapeutics in##4##2##(2008-10#2)(2008-8#1)(2011-1#1)
therapeutics is##3##2##(2008-10#2)(2011-3#1)
therapeutics to##3##2##(2008-11#2)(2013-1#1)
therapeutics##67##1##(1991-9#1)(1992-12#1)(1994-5#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-11#5)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#2)(2011-1#4)(2011-2#4)(2011-3#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#4)
theraphy##3##1##(2007-11#1)(2007-8#2)
therapies against##2##2##(2008-8#1)(2009-12#1)
therapies aimed at##2##3##(2008-7#1)(2013-8#1)
therapies also##2##2##(2008-7#1)(2010-5#1)
therapies and##11##2##(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
therapies are needed##2##3##(2007-12#1)(2008-5#1)
therapies are##19##2##(1991-12#1)(1993-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
therapies based on the##2##4##(1994-9#1)(2008-11#1)
therapies based on##3##3##(1994-9#1)(1995-4#1)(2008-11#1)
therapies by##4##2##(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
therapies can be##2##3##(2012-2#1)(2013-8#1)
therapies can##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
therapies continue to be##2##4##(2008-3#1)(2013-1#1)
therapies directed##2##2##(2007-11#1)(2009-12#1)
therapies for acute##2##3##(2006-7#2)
therapies for cardiovascular disease##2##4##(2006-10#1)(2012-12#1)
therapies for cardiovascular##3##3##(2006-10#1)(2012-12#2)
therapies for patients with##2##4##(2010-6#1)(2012-1#1)
therapies for patients##3##3##(2006-7#1)(2010-6#1)(2012-1#1)
therapies for the frail elderly##2##5##(1995-1#2)
therapies for the treatment of##3##5##(2008-4#1)(2010-11#1)(2011-2#1)
therapies for the##7##3##(1995-1#2)(2008-4#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
therapies for##48##2##(1995-1#2)(1995-10#1)(1996-2#3)(1997-6#1)(1997-7#1)(2006-10#1)(2006-7#4)(2008-1#2)(2008-10#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
therapies had##2##2##(1997-6#1)(2008-3#1)
therapies has##3##2##(2010-6#1)(2011-1#1)(2011-2#1)
therapies have been##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
therapies have not##2##3##(2008-2#1)(2010-12#1)
therapies have##10##2##(2006-10#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
therapies in the treatment of##2##5##(2010-6#1)(2011-2#1)
therapies in the##5##3##(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
therapies in##19##2##(1990-5#1)(1997-6#1)(2007-1#1)(2008-11#2)(2008-4#1)(2008-7#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)
therapies include##2##2##(2011-2#1)(2013-1#1)
therapies including##2##2##(2010-12#1)(2013-1#1)
therapies into##2##2##(2008-6#1)(2009-11#1)
therapies is##8##2##(1997-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-3#1)
therapies may be##3##3##(1993-2#1)(2010-12#1)(2013-8#1)
therapies may##5##2##(1993-2#1)(2010-12#2)(2013-7#1)(2013-8#1)
therapies of##9##2##(1991-6#1)(1995-11#2)(2008-2#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
therapies on symptoms of##2##4##(2008-10#1)(2010-12#1)
therapies on the##2##3##(1993-2#1)(2009-5#1)
therapies on##7##2##(1993-2#2)(2008-10#1)(2008-7#1)(2009-5#1)(2010-12#2)
therapies should##2##2##(2007-11#1)(2011-2#1)
therapies such as##3##3##(2008-3#1)(2008-8#1)(2009-10#1)
therapies targeting##3##2##(2008-4#1)(2008-5#1)(2009-12#1)
therapies that specifically##2##3##(2009-12#1)(2010-4#1)
therapies that##10##2##(1995-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
therapies to improve##2##3##(2008-3#1)(2010-3#1)
therapies to##10##2##(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
therapies used##2##2##(2007-11#1)(2008-7#1)
therapies will##2##2##(2008-11#1)(2010-11#1)
therapies would be##2##3##(2008-7#1)(2009-6#1)
therapies##409##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-2#6)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#14)(1997-7#1)(2006-10#5)(2006-7#6)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#4)(2008-1#7)(2008-10#8)(2008-11#21)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#10)(2008-5#10)(2008-6#11)(2008-7#23)(2008-8#12)(2008-9#3)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#6)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#7)(2010-12#17)(2010-3#4)(2010-4#1)(2010-5#11)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#26)(2011-3#1)(2012-1#4)(2012-12#13)(2012-2#14)(2012-3#8)(2013-1#34)(2013-7#2)(2013-8#8)
therapist##20##1##(1991-12#1)(1993-12#1)(1995-1#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-7#1)(2009-10#2)(2010-9#1)(2011-2#1)(2012-2#5)(2013-7#1)
therapist's##2##1##(1991-3#1)(2009-3#1)
therapists and##3##2##(1995-12#1)(2013-8#2)
therapists are##3##2##(1992-12#1)(1992-3#2)
therapists have##2##2##(1992-3#1)(2008-12#1)
therapists in the##3##3##(1993-12#1)(2008-6#1)(2012-2#1)
therapists in##7##2##(1992-3#1)(1993-12#2)(1993-2#1)(2008-12#1)(2008-6#1)(2012-2#1)
therapists to##3##2##(1991-3#1)(1992-12#1)(2012-2#1)
therapists were##4##2##(1993-12#1)(1996-2#1)(2010-7#1)(2013-1#1)
therapists who##3##2##(1991-12#1)(2012-12#1)(2012-2#1)
therapists with##3##2##(1991-12#1)(1993-12#1)(2008-12#1)
therapists working##2##2##(1991-12#1)(1993-12#1)
therapists##69##1##(1990-12#1)(1991-12#3)(1991-2#1)(1991-3#2)(1992-12#3)(1992-3#5)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#4)(1996-2#3)(2008-10#2)(2008-11#2)(2008-12#6)(2008-4#4)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#11)(2013-1#2)(2013-8#4)
therapists'##9##1##(1995-12#1)(1995-3#2)(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#3)
therapy (ART)##7##2##(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#2)
therapy (CBT)##4##2##(2007-12#2)(2011-2#1)(2012-2#1)
therapy (CRT)##2##2##(2008-10#1)(2010-6#1)
therapy (ECT) and##2##3##(2011-1#2)
therapy (ECT)##3##2##(2011-1#2)(2012-12#1)
therapy (MT)##2##2##(2008-10#1)(2013-1#1)
therapy (PDT) with##2##3##(1994-1#1)(2007-8#1)
therapy (PDT)##22##2##(1990-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-1#1)(2007-8#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#4)(2010-8#1)(2012-3#3)(2013-8#2)
therapy (PT)##2##2##(2012-2#1)(2013-8#1)
therapy (RT)##2##2##(2008-6#1)(2013-1#1)
therapy (n =##2##3##(2008-6#2)
therapy (n##3##2##(2008-6#2)(2013-1#1)
therapy -##3##2##(2007-11#1)(2007-8#1)(2008-11#1)
therapy a##3##2##(1995-2#1)(2007-11#2)
therapy after##13##2##(1992-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-12#4)(2010-7#1)(2011-2#2)(2011-3#1)
therapy against##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
therapy allows##2##2##(2008-1#1)(2013-8#1)
therapy alone##6##2##(1991-6#1)(2008-1#1)(2008-7#2)(2010-12#1)(2012-12#1)
therapy also##7##2##(1994-9#1)(1995-6#1)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
therapy among##3##2##(2008-3#1)(2012-12#2)
therapy and a##3##3##(1997-4#1)(2008-3#1)(2008-8#1)
therapy and administration of##2##4##(2011-2#1)(2013-8#1)
therapy and avoidance of##2##4##(2008-10#1)(2011-2#1)
therapy and changes in##2##4##(1992-9#1)(2008-8#1)
therapy and drug-eluting##2##3##(2008-11#1)(2011-2#1)
therapy and for##2##3##(2009-9#1)(2013-1#1)
therapy and had##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
therapy and its##5##3##(1991-2#1)(1994-6#1)(1996-11#1)(2007-7#1)(2013-7#1)
therapy and management##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
therapy and may##2##3##(2006-10#1)(2009-9#1)
therapy and occupational##3##3##(2010-3#1)(2010-9#2)
therapy and prevention of##2##4##(1991-2#1)(2008-5#1)
therapy and progression of##2##4##(2008-1#1)(2008-11#1)
therapy and rehabilitation##2##3##(1995-5#1)(2012-12#1)
therapy and surgical##3##3##(2007-11#1)(2008-4#1)(2008-7#1)
therapy and the##7##3##(1992-5#1)(1995-4#1)(2008-6#1)(2008-7#1)(2011-2#3)
therapy and tissue engineering##7##4##(2008-11#1)(2008-5#3)(2012-12#2)(2012-2#1)
therapy and to##2##3##(2006-10#1)(2012-2#1)
therapy and use of##3##4##(1990-11#1)(2010-6#1)(2012-1#1)
therapy and vaccination##3##3##(2008-11#2)(2012-2#1)
therapy and volume treatment in elective##2##6##(1990-11#2)
therapy and##175##2##(1990-11#3)(1990-5#2)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#5)(1991-3#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#2)(1995-1#1)(1995-4#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#6)(2008-11#7)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-4#2)(2009-9#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#5)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#4)
therapy approach##4##2##(1994-5#1)(1995-2#1)(2013-1#1)(2013-8#1)
therapy are discussed##6##3##(1991-8#1)(1992-9#1)(1993-6#2)(2008-4#1)(2008-9#1)
therapy are not##2##3##(1995-4#1)(2011-1#1)
therapy are to improve##2##4##(1996-3#1)(2012-1#1)
therapy are##29##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-6#2)(1994-5#1)(1994-7#1)(1995-4#1)(1996-3#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
therapy as a##9##3##(1991-3#1)(1991-8#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2013-8#3)
therapy as the##2##3##(2009-8#1)(2013-1#1)
therapy as well as##3##4##(1990-6#1)(2008-7#1)(2012-2#1)
therapy as##21##2##(1990-6#1)(1991-3#1)(1991-8#1)(1994-6#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#3)
therapy at home##2##3##(1995-2#1)(2012-2#1)
therapy at##9##2##(1995-2#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-8#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-8#1)
therapy based on the##2##4##(2008-8#1)(2011-2#1)
therapy based on##4##3##(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
therapy based##8##2##(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#2)(2010-9#1)(2011-2#1)(2013-1#1)
therapy because of adverse##2##4##(2008-1#1)(2012-12#1)
therapy because of its##2##4##(1994-5#1)(2011-2#1)
therapy because of##4##3##(1994-5#1)(2008-1#1)(2011-2#1)(2012-12#1)
therapy began##2##2##(2008-7#1)(2012-2#1)
therapy but##4##2##(1993-8#1)(1993-9#1)(2010-11#1)(2013-1#1)
therapy by using##3##3##(1994-3#1)(2007-9#1)(2012-1#1)
therapy by##18##2##(1992-6#1)(1994-3#1)(1994-5#1)(1996-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-1#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
therapy can be applied##2##4##(1995-8#1)(2008-6#1)
therapy can be effective##2##4##(2008-1#1)(2008-8#1)
therapy can be##12##3##(1994-7#1)(1995-8#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
therapy can##17##2##(1994-7#1)(1995-8#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
therapy clinical trial for##4##4##(1994-5#1)(2008-5#2)(2010-10#1)
therapy combined with##2##3##(1991-2#1)(2008-1#1)
therapy continued##2##2##(1994-6#1)(2011-2#1)
therapy could##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)
therapy decreases##2##2##(2007-5#1)(2008-7#1)
therapy depends on the##2##4##(2008-7#1)(2013-1#1)
therapy depends on##4##3##(2007-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
therapy did not##4##3##(1997-2#1)(2007-10#1)(2008-6#1)(2013-1#1)
therapy due to the##2##4##(2008-10#1)(2008-5#1)
therapy due to##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
therapy during##4##2##(1990-5#1)(2007-2#1)(2008-11#1)(2013-1#1)
therapy effect##2##2##(2010-12#1)(2011-1#1)
therapy fails##2##2##(1990-9#1)(2011-2#1)
therapy failure##2##2##(2010-12#1)(2013-1#1)
therapy failures##3##2##(2008-8#1)(2011-2#2)
therapy followed##2##2##(2008-6#1)(2012-12#1)
therapy following surgery##3##3##(1994-3#2)(2008-7#1)
therapy following##5##2##(1994-12#1)(1994-3#2)(2008-7#1)(2011-2#1)
therapy for HIV##2##3##(2010-12#1)(2012-2#1)
therapy for a##3##3##(1997-4#1)(2008-10#1)(2008-6#1)
therapy for active##2##3##(2010-12#2)
therapy for acute ischemic stroke##3##5##(2006-7#1)(2007-10#1)(2008-8#1)
therapy for acute##7##3##(1997-8#2)(2006-7#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-4#1)
therapy for advanced non-small cell lung cancer##2##7##(1994-12#1)(2010-8#1)
therapy for advanced##4##3##(1993-12#1)(1994-12#1)(2010-12#1)(2010-8#1)
therapy for asthma##2##3##(1996-2#1)(2008-3#1)
therapy for bone metastases##2##4##(2007-11#1)(2010-3#1)
therapy for bone##3##3##(1997-6#1)(2007-11#1)(2010-3#1)
therapy for breast cancer##2##4##(1994-7#1)(2013-8#1)
therapy for cancer##3##3##(1994-5#2)(2008-5#1)
therapy for children##3##3##(2009-10#1)(2012-2#1)(2013-8#1)
therapy for chronic hepatitis##2##4##(2009-3#1)(2009-8#1)
therapy for chronic##6##3##(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
therapy for colorectal cancer##2##4##(2008-8#1)(2013-1#1)
therapy for depression##2##3##(2011-3#1)(2012-2#1)
therapy for diabetes##2##3##(2009-11#1)(2012-12#1)
therapy for early##4##3##(1994-12#1)(1997-7#1)(2010-12#1)(2012-2#1)
therapy for fistulizing##2##3##(2010-12#2)
therapy for heart failure##2##4##(2010-8#2)
therapy for hypertension##6##3##(1993-9#3)(1994-6#1)(2008-3#1)(2008-8#1)
therapy for inflammatory##2##3##(1994-6#1)(2010-5#1)
therapy for management of##2##4##(2008-3#1)(2011-2#1)
therapy for metastatic renal cell carcinoma##2##6##(1991-8#1)(1993-12#1)
therapy for mild##2##3##(1992-6#1)(2008-10#1)
therapy for multiple##2##3##(2008-6#1)(2008-7#1)
therapy for osteoporosis##2##3##(1991-3#1)(2008-8#1)
therapy for patients who##2##4##(1997-7#1)(2013-1#1)
therapy for patients with##10##4##(1997-7#1)(2007-10#2)(2008-11#3)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
therapy for patients##17##3##(1997-7#2)(2007-10#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
therapy for preventing##2##3##(2007-7#1)(2012-2#1)
therapy for primary##4##3##(1992-12#1)(2010-12#1)(2011-1#1)(2012-2#1)
therapy for prostate cancer##2##4##(2010-10#1)(2013-8#1)
therapy for pulmonary##2##3##(2008-1#1)(2013-1#1)
therapy for recurrent##2##3##(1994-1#1)(2013-1#1)
therapy for rheumatoid arthritis##4##4##(1997-5#1)(2006-10#1)(2007-11#1)(2008-8#1)
therapy for the treatment of##5##5##(1994-7#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
therapy for the##13##3##(1992-2#2)(1994-7#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
therapy for those##2##3##(2007-2#1)(2011-2#1)
therapy for wound and scar management##2##6##(2012-3#2)
therapy for##246##2##(1990-2#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-12#3)(1994-5#7)(1994-6#3)(1994-7#2)(1995-1#2)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2006-10#4)(2006-7#2)(2007-10#4)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-3#4)(2008-5#6)(2008-6#9)(2008-7#9)(2008-8#11)(2008-9#3)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#15)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#15)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#5)
therapy given##2##2##(2008-7#1)(2010-3#1)
therapy had##6##2##(1994-12#1)(1994-7#1)(1995-4#1)(2008-3#1)(2008-7#1)(2012-12#1)
therapy has become##3##3##(2007-10#1)(2007-7#1)(2010-5#1)
therapy has been advocated##2##4##(1996-3#1)(2009-6#1)
therapy has been reported##2##4##(2011-2#1)(2012-12#1)
therapy has been##15##3##(1991-6#1)(1992-10#1)(1994-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(2007-11#1)(2008-1#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
therapy has##36##2##(1990-11#1)(1991-6#1)(1992-10#1)(1993-3#1)(1994-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2009-11#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
therapy have been reported##3##4##(1994-6#1)(1996-6#1)(2007-5#1)
therapy have been##6##3##(1994-6#1)(1996-6#1)(2007-5#2)(2008-9#1)(2010-8#1)
therapy have##15##2##(1992-3#1)(1994-6#1)(1994-7#1)(1996-6#1)(2007-5#2)(2007-8#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-6#2)(2010-8#1)(2011-2#1)
therapy improves##2##2##(2008-4#1)(2010-8#1)
therapy in Parkinson's disease##2##4##(2008-7#2)
therapy in a large##2##4##(1996-3#1)(2009-9#1)
therapy in a##10##3##(1993-12#1)(1994-6#1)(1996-3#1)(2007-10#1)(2009-11#1)(2009-9#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)
therapy in accordance with##2##4##(2008-3#1)(2011-1#1)
therapy in adults##2##3##(1996-11#1)(2009-7#1)
therapy in advanced##2##3##(1990-10#1)(2009-10#1)
therapy in all##2##3##(1990-3#1)(2012-3#1)
therapy in breast cancer##2##4##(1993-11#1)(2007-10#1)
therapy in breast##4##3##(1992-11#1)(1993-11#1)(2007-10#1)(2013-8#1)
therapy in cardiovascular##2##3##(1991-9#1)(2008-3#1)
therapy in children with##3##4##(2008-1#1)(2009-7#1)(2011-2#1)
therapy in children##4##3##(2008-1#1)(2009-7#2)(2011-2#1)
therapy in chronic hepatitis##2##4##(1995-10#1)(2013-1#1)
therapy in chronic##9##3##(1991-6#1)(1992-11#1)(1995-10#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
therapy in clinical##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
therapy in general##2##3##(1991-6#1)(2008-10#1)
therapy in metastatic colorectal cancer##2##5##(1990-2#1)(1992-12#1)
therapy in metastatic##4##3##(1990-2#1)(1992-12#1)(2011-2#1)(2011-3#1)
therapy in oral cancer##2##4##(2013-8#2)
therapy in osteomyelitis##2##3##(2010-6#2)
therapy in patients with severe##2##5##(2009-6#1)(2013-1#1)
therapy in patients with##18##4##(1994-12#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
therapy in patients##21##3##(1994-12#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
therapy in postmenopausal##3##3##(2012-3#2)(2013-1#1)
therapy in selected patients##2##4##(1994-6#1)(2011-3#1)
therapy in selected##3##3##(1994-6#1)(2010-12#1)(2011-3#1)
therapy in severe##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
therapy in steroid##2##3##(2007-7#2)
therapy in stroke##3##3##(2008-8#3)
therapy in the Netherlands##2##4##(2008-12#2)
therapy in the management of##2##5##(2007-12#1)(2007-7#1)
therapy in the prevention##2##4##(1993-11#1)(2006-10#1)
therapy in the treatment of##5##5##(1992-5#1)(1992-6#1)(1995-9#1)(2008-10#1)(2011-3#1)
therapy in the use of##2##5##(2009-6#2)
therapy in the##36##3##(1990-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1995-5#1)(1995-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#3)(2008-6#1)(2009-11#1)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#2)
therapy in this age group##2##5##(1997-1#2)
therapy in this setting##2##4##(2011-2#1)(2013-1#1)
therapy in this##8##3##(1993-12#1)(1997-1#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
therapy in type 1##2##4##(2008-1#2)
therapy in vivo##2##3##(2011-1#1)(2012-12#1)
therapy in women##3##3##(1996-9#1)(2008-7#1)(2012-3#1)
therapy in##267##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-11#6)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#5)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-7#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#7)(2008-10#6)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#13)(2009-10#4)(2009-11#2)(2009-4#1)(2009-6#3)(2009-7#6)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#7)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#21)(2011-3#4)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#11)(2013-1#12)(2013-7#1)(2013-8#8)
therapy included##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
therapy including cyclophosphamide##2##3##(1990-12#1)(1995-4#1)
therapy including##8##2##(1990-12#1)(1991-9#1)(1995-4#2)(2008-10#1)(2008-12#1)(2010-6#1)(2011-1#1)
therapy interventions##4##2##(2007-6#1)(2008-12#1)(2012-2#1)(2013-1#1)
therapy is a promising##5##4##(1991-9#1)(2008-11#1)(2008-6#1)(2010-6#1)(2012-7#1)
therapy is a##12##3##(1990-11#1)(1990-12#1)(1991-9#1)(1995-4#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-6#1)(2012-12#1)(2012-3#1)(2012-7#1)
therapy is also##2##3##(2007-11#1)(2010-3#1)
therapy is an important##2##4##(2009-10#1)(2012-3#1)
therapy is an##4##3##(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#1)
therapy is associated with a##2##5##(2008-7#1)(2010-12#1)
therapy is available##2##3##(1996-3#1)(2006-10#1)
therapy is clearly##2##3##(1993-11#1)(2007-7#1)
therapy is described##2##3##(2007-12#1)(2012-3#1)
therapy is effective in the treatment##2##6##(1994-9#1)(2007-11#1)
therapy is effective in##5##4##(1994-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
therapy is effective##7##3##(1994-9#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
therapy is emphasized##2##3##(1991-11#1)(1995-2#1)
therapy is important##2##3##(2007-10#1)(2007-2#1)
therapy is indicated##2##3##(2007-5#1)(2008-10#1)
therapy is initiated##2##3##(2008-7#1)(2011-2#1)
therapy is more##2##3##(2007-12#1)(2012-12#1)
therapy is necessary##2##3##(1990-10#1)(2007-12#1)
therapy is not indicated for##2##5##(1994-9#1)(2010-6#1)
therapy is not related to##2##5##(1996-2#1)(2008-5#1)
therapy is not##8##3##(1994-9#1)(1996-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-6#1)(2013-8#1)
therapy is recommended##2##3##(1990-2#1)(2006-10#1)
therapy is required##3##3##(2008-1#1)(2011-2#2)
therapy is the mainstay of treatment##2##6##(2010-12#1)(2010-4#1)
therapy is the mainstay of##3##5##(1997-1#1)(2010-12#1)(2010-4#1)
therapy is the use of##2##5##(2007-9#1)(2013-8#1)
therapy is the##14##3##(1990-6#1)(1991-6#1)(1993-8#1)(1997-1#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#2)(2010-4#2)(2011-2#1)(2013-8#1)
therapy is to##3##3##(2012-3#1)(2013-8#2)
therapy is##119##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(2006-10#3)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#6)(2008-7#5)(2008-8#1)(2009-10#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#3)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#3)(2013-8#5)
therapy leads to##2##3##(2008-1#1)(2008-7#1)
therapy management of##2##3##(2008-12#2)
therapy management##6##2##(2008-12#4)(2009-3#2)
therapy may be an effective##2##5##(2008-1#1)(2012-3#1)
therapy may be used##2##4##(2007-10#1)(2008-1#1)
therapy may be##13##3##(1997-7#1)(2007-10#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-3#2)
therapy may have a##2##4##(2008-1#1)(2011-2#1)
therapy may have##3##3##(1997-1#1)(2008-1#1)(2011-2#1)
therapy may##26##2##(1994-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
therapy measures##2##2##(1996-1#2)
therapy might be##4##3##(2008-11#1)(2008-4#1)(2011-1#1)(2012-3#1)
therapy might##5##2##(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
therapy monitoring##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
therapy must be##4##3##(1993-9#1)(1997-5#1)(2010-12#1)(2011-2#1)
therapy must##6##2##(1993-9#1)(1994-6#1)(1996-1#1)(1997-5#1)(2010-12#1)(2011-2#1)
therapy not only##2##3##(2007-11#1)(2008-7#1)
therapy of CVI##2##3##(2011-3#2)
therapy of acute##6##3##(1990-12#1)(1990-9#1)(1991-3#1)(1994-2#2)(2007-7#1)
therapy of brain tumors##2##4##(1993-6#1)(1995-2#1)
therapy of brain##3##3##(1993-6#1)(1995-2#1)(2008-7#1)
therapy of breast cancer##5##4##(1993-11#2)(1993-2#1)(1996-11#1)(2012-3#1)
therapy of cancer and other diseases##3##6##(1994-5#3)
therapy of cancer##8##3##(1994-5#4)(2008-7#1)(2008-8#2)(2013-8#1)
therapy of chronic##4##3##(1997-1#1)(2008-1#1)(2011-2#2)
therapy of hypertension##3##3##(1990-2#1)(1997-8#1)(2008-1#1)
therapy of lung##2##3##(1991-9#1)(2013-8#1)
therapy of oral##2##3##(1990-2#1)(2009-12#1)
therapy of patients with##2##4##(2011-1#2)
therapy of patients##5##3##(1993-6#1)(2008-1#1)(2009-8#1)(2011-1#2)
therapy of the##3##3##(1994-5#1)(2008-1#1)(2008-7#1)
therapy of these##5##3##(1990-6#1)(1995-2#1)(2007-5#1)(2008-7#1)(2010-1#1)
therapy of this##5##3##(1990-2#1)(1991-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
therapy of tumors##2##3##(2008-7#1)(2011-2#1)
therapy of##190##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#6)(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#6)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-11#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#3)(2007-7#3)(2007-8#2)(2008-1#9)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#1)(2009-12#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#10)(2011-3#7)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#6)
therapy offers##2##2##(2008-3#1)(2012-12#1)
therapy on survival time##2##4##(2007-11#2)
therapy on the##11##3##(1990-7#1)(1992-6#1)(1993-2#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-8#2)
therapy on##37##2##(1990-7#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-9#1)(1997-5#2)(2006-10#1)(2007-10#1)(2007-11#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
therapy or the##2##3##(1991-8#1)(2011-2#1)
therapy or##18##2##(1991-8#1)(1992-3#1)(1993-3#1)(1995-5#1)(2007-10#2)(2007-12#2)(2008-1#2)(2008-3#1)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-3#1)
therapy other than##2##3##(2008-8#1)(2010-1#1)
therapy outcome in##2##3##(2010-12#1)(2012-2#1)
therapy outcome##5##2##(2010-12#1)(2012-2#4)
therapy over##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
therapy period##2##2##(1991-6#1)(2008-12#1)
therapy planning##4##2##(1991-4#1)(2012-2#3)
therapy practices##3##2##(1991-12#2)(2010-9#1)
therapy predicts##2##2##(2008-9#1)(2011-2#1)
therapy presenting##2##2##(2010-7#1)(2012-1#1)
therapy products##3##2##(2008-11#1)(2013-1#2)
therapy program##4##2##(1991-2#2)(1995-3#1)(1996-3#1)
therapy progress##6##2##(2012-2#6)
therapy protocol with##2##3##(1994-5#1)(2011-2#1)
therapy protocol##5##2##(1994-5#2)(2007-11#1)(2009-8#1)(2011-2#1)
therapy protocols##4##2##(1991-12#1)(1994-5#1)(2008-1#1)(2008-11#1)
therapy proves##2##2##(1994-6#1)(2011-2#1)
therapy received##2##2##(1990-12#1)(1995-2#1)
therapy reduces##2##2##(2008-12#1)(2008-3#1)
therapy regarding##2##2##(1997-8#1)(2011-1#1)
therapy remain##3##2##(1997-3#1)(2008-8#2)
therapy remains##2##2##(1997-3#1)(2012-2#1)
therapy represents a promising##2##4##(2010-3#1)(2012-3#1)
therapy represents an##2##3##(1995-8#1)(2010-6#1)
therapy represents##4##2##(1995-8#1)(2010-3#1)(2010-6#1)(2012-3#1)
therapy requires##2##2##(2010-10#1)(2012-2#1)
therapy research##2##2##(1996-1#1)(2008-12#1)
therapy response##3##2##(2008-4#1)(2008-7#1)(2010-12#1)
therapy results in##3##3##(2008-6#1)(2011-1#1)(2011-2#1)
therapy results##4##2##(2008-6#1)(2011-1#1)(2011-2#2)
therapy seems to be##2##4##(2008-11#1)(2008-8#1)
therapy seems##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
therapy services in##2##3##(1996-3#1)(2013-7#1)
therapy services##10##2##(1996-3#1)(2007-7#1)(2013-7#7)(2013-8#1)
therapy sessions##3##2##(1995-1#1)(2013-1#2)
therapy should be considered for##2##5##(2008-1#1)(2009-8#1)
therapy should be considered##3##4##(2008-1#1)(2009-8#1)(2010-12#1)
therapy should be##11##3##(1990-9#1)(1996-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2009-8#2)(2010-12#1)(2011-2#3)
therapy should start##2##3##(1990-2#1)(1993-2#1)
therapy should##16##2##(1990-2#1)(1990-9#1)(1993-2#1)(1996-6#1)(1996-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2009-8#2)(2010-12#2)(2011-2#4)
therapy showed##3##2##(2007-7#2)(2008-8#1)
therapy since##5##2##(1990-9#2)(1993-1#1)(2008-6#1)(2013-8#1)
therapy still##2##2##(1994-7#1)(2010-12#1)
therapy student##2##2##(2008-7#1)(2009-7#1)
therapy study##2##2##(2011-2#1)(2012-3#1)
therapy such as##2##3##(1990-3#1)(2009-10#1)
therapy than##5##2##(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)
therapy that##8##2##(1990-12#1)(1992-3#1)(1992-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
therapy the only##2##3##(1994-7#1)(2007-8#1)
therapy the##5##2##(1992-6#1)(1994-7#1)(2007-10#1)(2007-8#1)(2011-2#1)
therapy through##2##2##(2009-9#1)(2012-10#1)
therapy to be##4##3##(2008-11#2)(2008-5#1)(2008-6#1)
therapy to improve##4##3##(1994-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
therapy to prevent##4##3##(1991-3#1)(1996-6#1)(2008-1#1)(2010-3#1)
therapy to the##4##3##(1991-12#1)(2008-12#1)(2008-7#1)(2013-1#1)
therapy to treat##5##3##(1997-1#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-3#1)
therapy to##42##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-5#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
therapy treatment##7##2##(1994-3#3)(2008-12#3)(2012-12#1)
therapy trials##7##2##(1997-1#1)(2007-11#1)(2008-8#2)(2012-2#3)
therapy use##3##2##(2008-11#1)(2010-8#1)(2011-1#1)
therapy used to##2##3##(2008-7#1)(2013-8#1)
therapy used##3##2##(2008-4#1)(2008-7#1)(2013-8#1)
therapy using strontium 89##3##4##(2007-11#3)
therapy using##19##2##(1993-11#2)(2007-10#1)(2007-11#5)(2008-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#2)
therapy was continued##2##3##(1990-2#1)(1997-2#1)
therapy was delivered##2##3##(1991-2#1)(2008-6#1)
therapy was initiated and##2##4##(2012-3#1)(2013-8#1)
therapy was initiated##3##3##(2008-4#1)(2012-3#1)(2013-8#1)
therapy was performed##2##3##(1990-10#1)(2007-11#1)
therapy was started##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
therapy was##61##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-6#1)(1994-7#2)(1997-2#2)(2006-10#1)(2007-11#7)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#4)
therapy were given##2##3##(1992-10#1)(1994-7#1)
therapy were##20##2##(1990-12#1)(1992-10#1)(1994-7#3)(1994-8#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
therapy when##3##2##(1992-1#1)(2008-11#1)(2008-3#1)
therapy which##7##2##(1994-3#1)(1995-12#1)(1997-2#1)(2008-6#1)(2008-7#1)(2010-7#1)(2010-8#1)
therapy will##7##2##(1991-8#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-8#1)(2010-3#2)
therapy with a##8##3##(1992-9#1)(1993-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
therapy with azithromycin##2##3##(2007-12#1)(2008-10#1)
therapy with conventional##2##3##(2008-5#1)(2010-5#1)
therapy with cyclophosphamide##2##3##(1993-9#1)(2008-1#1)
therapy with intravenous##2##3##(2008-5#1)(2013-1#1)
therapy with low-dose##2##3##(1993-12#1)(2011-2#1)
therapy with mechanical##2##3##(2008-12#1)(2013-1#1)
therapy with recombinant##3##3##(1996-8#1)(2007-7#1)(2011-2#1)
therapy with that##2##3##(1994-7#1)(2009-8#1)
therapy with the frail elderly##2##5##(1995-1#1)(1995-2#1)
therapy with the##6##3##(1990-6#1)(1995-1#1)(1995-2#1)(2008-8#1)(2010-12#1)(2010-8#1)
therapy with##135##2##(1990-11#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#2)(1992-11#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#11)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#15)(2013-8#5)
therapy within##4##2##(2007-9#1)(2008-12#1)(2010-10#1)(2012-3#1)
therapy without##3##2##(1994-8#1)(2007-12#1)(2012-12#1)
therapy would be##2##3##(2011-1#1)(2011-2#1)
therapy##3268##1##(1990-10#7)(1990-11#16)(1990-12#11)(1990-2#10)(1990-3#7)(1990-5#12)(1990-6#21)(1990-7#1)(1990-8#5)(1990-9#11)(1991-1#1)(1991-11#3)(1991-12#8)(1991-2#24)(1991-3#13)(1991-4#2)(1991-5#3)(1991-6#18)(1991-8#14)(1991-9#8)(1992-1#3)(1992-10#6)(1992-11#8)(1992-12#9)(1992-2#12)(1992-3#9)(1992-4#2)(1992-5#7)(1992-6#13)(1992-7#1)(1992-8#14)(1992-9#6)(1993-1#6)(1993-11#26)(1993-12#17)(1993-2#16)(1993-3#7)(1993-6#9)(1993-8#12)(1993-9#17)(1994-1#2)(1994-11#5)(1994-12#19)(1994-2#11)(1994-3#32)(1994-5#37)(1994-6#26)(1994-7#21)(1994-8#8)(1994-9#8)(1995-1#6)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#16)(1995-3#8)(1995-4#10)(1995-5#11)(1995-6#5)(1995-8#7)(1995-9#4)(1996-1#6)(1996-11#20)(1996-2#7)(1996-3#28)(1996-6#12)(1996-7#1)(1996-8#5)(1996-9#8)(1997-1#17)(1997-2#19)(1997-3#10)(1997-4#9)(1997-5#6)(1997-6#6)(1997-7#11)(1997-8#18)(2006-10#24)(2006-12#1)(2006-7#3)(2007-1#1)(2007-10#44)(2007-11#68)(2007-12#35)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#11)(2007-6#5)(2007-7#64)(2007-8#36)(2007-9#4)(2008-1#97)(2008-10#76)(2008-11#95)(2008-12#49)(2008-2#10)(2008-3#63)(2008-4#42)(2008-5#75)(2008-6#67)(2008-7#154)(2008-8#87)(2008-9#24)(2009-1#2)(2009-10#15)(2009-11#22)(2009-12#12)(2009-2#6)(2009-3#12)(2009-4#18)(2009-5#17)(2009-6#8)(2009-7#16)(2009-8#24)(2009-9#10)(2010-1#13)(2010-10#16)(2010-11#12)(2010-12#71)(2010-2#3)(2010-3#40)(2010-4#17)(2010-5#19)(2010-6#35)(2010-7#9)(2010-8#29)(2010-9#11)(2011-1#51)(2011-10#1)(2011-2#236)(2011-3#21)(2011-7#1)(2012-1#26)(2012-10#1)(2012-12#67)(2012-2#109)(2012-3#85)(2012-4#2)(2012-5#2)(2012-7#2)(2013-1#144)(2013-7#20)(2013-8#97)
therapy&quot##2##1##(2009-12#1)(2013-8#1)
therapy) and##2##2##(1994-8#1)(1996-11#1)
therapy)##8##1##(1994-8#1)(1996-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#2)
therapy-induced##5##1##(2008-7#2)(2009-10#1)(2010-11#1)(2011-2#1)
therapy-related##4##1##(1997-8#1)(2008-6#1)(2008-7#2)
therapy-resistant##2##1##(1997-8#1)(2011-1#1)
therapy?##8##1##(1994-8#1)(1995-8#1)(2007-12#1)(2008-11#1)(2009-12#1)(2009-5#2)(2011-2#1)
therapy?]##3##1##(1990-9#1)(1994-3#2)
therapy]##35##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#3)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-2#1)(1993-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-8#1)(2007-6#1)(2008-1#2)(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)
there a need for##3##4##(1991-1#1)(2008-10#1)(2009-4#1)
there a need##4##3##(1991-1#1)(1991-3#1)(2008-10#1)(2009-4#1)
there a place for##3##4##(1995-1#1)(2008-11#2)
there a relationship between##3##4##(1992-2#1)(1995-12#1)(2012-2#1)
there a##49##2##(1990-10#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
there also exists a##2##4##(1994-12#1)(2008-9#1)
there also##3##2##(1994-12#1)(1996-2#1)(2008-9#1)
there an association?##2##3##(2007-7#1)(2008-1#1)
there an##6##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-10#1)
there any##10##2##(1991-3#1)(1991-4#1)(1991-8#1)(1994-1#1)(1996-9#1)(2007-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)
there appeared to be##2##4##(2008-12#1)(2011-2#1)
there appeared##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
there appears to be a##2##5##(1990-5#1)(2012-2#1)
there appears to be an##2##5##(2008-5#1)(2011-2#1)
there appears to be little##2##5##(2008-11#1)(2008-12#1)
there appears to be no##2##5##(2008-11#1)(2008-7#1)
there appears to be##10##4##(1990-5#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
there appears##11##2##(1990-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
there are 12##2##3##(1992-6#1)(2013-1#1)
there are 3##2##3##(1994-2#1)(2008-11#1)
there are a few reports##2##5##(2007-12#1)(2012-1#1)
there are a number of potentially##2##6##(1993-11#1)(2006-10#1)
there are a number of##12##5##(1993-11#1)(1995-4#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-12#1)(2012-3#1)
there are a wide##2##4##(2008-4#1)(2008-5#1)
there are a##20##3##(1993-11#1)(1995-4#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
there are additional##2##3##(2008-9#1)(2010-5#1)
there are advantages##2##3##(1997-3#1)(2008-9#1)
there are also some##2##4##(1995-3#1)(2008-12#1)
there are also##11##3##(1995-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-2#1)
there are any##2##3##(2008-10#1)(2012-2#1)
there are approximately##3##3##(1996-12#1)(2008-10#1)(2012-12#1)
there are at least two##3##5##(2007-6#1)(2012-2#2)
there are at least##8##4##(1992-8#2)(1993-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2012-2#2)
there are both##2##3##(1991-1#1)(2008-10#1)
there are certain##5##3##(1992-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
there are challenges##2##3##(2008-12#1)(2013-8#1)
there are clear##2##3##(1995-1#1)(2013-8#1)
there are concerns about##2##4##(1997-1#1)(2007-8#1)
there are concerns that##2##4##(2008-11#1)(2009-3#1)
there are concerns##4##3##(1997-1#1)(2007-8#1)(2008-11#1)(2009-3#1)
there are considerable##2##3##(2009-7#1)(2013-8#1)
there are currently##4##3##(1996-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
there are differences in the##2##5##(1997-2#1)(2008-10#1)
there are differences in##6##4##(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2009-3#1)(2013-1#1)
there are differences##7##3##(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2009-3#1)(2010-7#1)(2013-1#1)
there are different##4##3##(1997-7#2)(2008-10#1)(2008-3#1)
there are discrepancies between##2##4##(1995-3#1)(1996-1#1)
there are distinct differences##2##4##(1994-9#1)(2011-2#1)
there are distinct##3##3##(1994-9#1)(1996-12#1)(2011-2#1)
there are drawbacks##2##3##(1995-1#1)(2008-9#1)
there are few data##3##4##(2009-10#1)(2010-12#1)(2012-3#1)
there are few reports##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
there are few##17##3##(1993-2#2)(1993-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
there are fewer##2##3##(1990-11#1)(2012-2#1)
there are functional##3##3##(1994-2#1)(1994-3#1)(2012-3#1)
there are high##2##3##(2008-10#1)(2011-1#1)
there are important##3##3##(1995-3#1)(1995-5#1)(2011-10#1)
there are indeed##3##3##(1995-2#1)(2006-12#2)
there are indications that##4##4##(1993-3#1)(1997-5#1)(2006-6#1)(2008-4#1)
there are insufficient##2##3##(1997-6#1)(2008-11#1)
there are large##2##3##(2008-2#1)(2008-7#1)
there are limitations to##2##4##(2009-5#1)(2009-8#1)
there are many factors##2##4##(1991-12#1)(2009-1#1)
there are many potential##2##4##(2008-11#1)(2010-3#1)
there are many similarities between the two countries##2##8##(1993-3#1)(2008-7#1)
there are many##32##3##(1991-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
there are more##6##3##(1996-3#1)(2008-1#1)(2008-4#2)(2008-8#1)(2009-8#1)
there are multiple##6##3##(1991-2#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-6#1)(2011-2#1)
there are new##2##3##(2006-7#1)(2008-11#1)
there are nine##2##3##(2008-5#1)(2008-8#1)
there are no data##2##4##(1990-2#1)(2008-12#1)
there are no definitive##2##4##(2008-10#1)(2010-5#1)
there are no guidelines##2##4##(2008-11#1)(2012-3#1)
there are no published##3##4##(1990-2#1)(2007-8#1)(2013-1#1)
there are no reports##3##4##(2008-5#1)(2012-12#1)(2013-1#1)
there are no signs of##3##5##(1994-6#1)(1994-9#1)(2008-6#1)
there are no##62##3##(1990-2#2)(1990-9#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#4)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
there are not##3##3##(2008-4#1)(2008-5#1)(2009-8#1)
there are now##5##3##(1991-11#1)(2007-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
there are numerous evidence based studies about protective role of exercise against chronic diseases such as cardio- respiratory diseases##2##19##(2013-1#2)
there are numerous##6##3##(1994-11#1)(2008-10#1)(2008-4#1)(2009-12#1)(2013-1#2)
there are only a few##4##5##(2007-12#1)(2008-11#1)(2013-1#1)(2013-7#1)
there are only few##3##4##(2008-11#1)(2009-7#1)(2011-2#1)
there are only four##2##4##(2008-10#1)(2009-5#1)
there are only isolated##2##4##(2008-10#1)(2013-8#1)
there are only two##2##4##(1991-12#1)(1995-6#1)
there are only##17##3##(1991-12#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-5#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
there are other##4##3##(1994-1#1)(1996-11#1)(2011-2#1)(2012-3#1)
there are patients##2##3##(1990-12#1)(1992-5#1)
there are reasons##2##3##(1995-2#1)(2008-5#1)
there are relatively few##2##4##(1996-2#1)(2008-6#1)
there are reports##2##3##(2008-2#1)(2013-1#1)
there are serious##2##3##(1993-8#1)(2013-1#1)
there are several reasons##2##4##(2008-2#1)(2012-1#1)
there are several##20##3##(1993-3#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
there are significant challenges##2##4##(2008-12#1)(2009-12#1)
there are significant differences between##2##5##(1992-2#1)(2008-5#1)
there are significant differences in the##2##6##(1995-2#1)(2013-1#1)
there are significant differences##5##4##(1992-2#1)(1995-2#1)(2008-5#1)(2010-12#1)(2013-1#1)
there are significant##12##3##(1992-2#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
there are significantly fewer hospitals##2##5##(1994-2#2)
there are so many##2##4##(2008-11#1)(2011-1#1)
there are some differences##2##4##(2007-12#1)(2008-3#1)
there are some##16##3##(1991-1#2)(1992-3#1)(1995-3#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
there are specific##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
there are still few##2##4##(2008-10#1)(2010-10#1)
there are still many##4##4##(1990-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
there are still some##2##4##(2008-10#1)(2008-7#1)
there are still##15##3##(1990-11#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#2)(2013-1#2)
there are substantial##2##3##(1995-6#1)(2009-10#1)
there are three##6##3##(1993-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-5#1)
there are two &quot##2##4##(1995-3#1)(2008-5#1)
there are two different##2##4##(2008-10#2)
there are two types of##2##5##(2008-3#1)(2008-7#1)
there are two types##3##4##(1993-12#1)(2008-3#1)(2008-7#1)
there are two##24##3##(1992-3#1)(1993-12#2)(1993-3#1)(1994-5#2)(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2011-3#1)
there are unique##3##3##(2008-2#1)(2010-12#1)(2013-1#1)
there are very few##3##4##(1996-12#1)(2008-5#1)(2008-8#1)
there are very##4##3##(1996-12#1)(2007-11#1)(2008-5#1)(2008-8#1)
there are##541##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#4)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#4)(1995-12#1)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#8)(2007-12#9)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#9)(2008-10#51)(2008-11#24)(2008-12#9)(2008-2#12)(2008-3#18)(2008-4#13)(2008-5#18)(2008-6#5)(2008-7#26)(2008-8#18)(2008-9#17)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-5#4)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#7)(2010-3#2)(2010-4#2)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#13)(2012-3#10)(2012-5#1)(2013-1#19)(2013-7#1)(2013-8#7)
there be##6##2##(1993-12#1)(1994-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
there being##2##2##(1995-12#1)(2008-10#1)
there can be no##2##4##(1992-2#1)(2008-1#1)
there can be##6##3##(1992-2#1)(1995-1#1)(2008-1#1)(2008-12#1)(2008-8#2)
there could be##3##3##(1997-6#1)(2009-12#1)(2009-3#1)
there differences in##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
there differences##4##2##(2007-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
there exist##13##2##(1990-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
there exists a##11##3##(1990-12#1)(1990-5#1)(1992-2#1)(1996-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
there exists an##3##3##(1990-12#1)(2011-2#2)
there exists##17##2##(1990-12#2)(1990-5#1)(1992-2#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#4)(2013-1#1)
there for##5##2##(2007-8#1)(2008-10#1)(2010-11#2)(2012-12#1)
there had been##3##3##(1996-1#1)(2007-11#1)(2008-6#1)
there had##4##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-6#1)
there has been a constant##2##5##(2008-10#1)(2011-1#1)
there has been a decrease in##2##6##(2008-11#1)(2013-1#1)
there has been a dramatic##2##5##(2006-10#1)(2008-11#1)
there has been a great deal of##2##7##(1992-9#1)(2008-10#1)
there has been a growing##2##5##(2007-12#1)(2008-1#1)
there has been a rapid increase in the number of##2##10##(2008-10#1)(2013-8#1)
there has been a renewed##2##5##(1996-3#1)(2009-11#1)
there has been a resurgence##2##5##(1997-7#1)(2008-11#1)
there has been a significant increase in##2##7##(1995-1#1)(2011-2#1)
there has been a substantial##2##5##(2008-5#1)(2011-2#1)
there has been a##40##4##(1990-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-4#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
there has been an increase in the##2##7##(2010-8#1)(2012-3#1)
there has been an increase in##3##6##(2008-11#1)(2010-8#1)(2012-3#1)
there has been an increase##4##5##(2008-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
there has been an increasing interest in##2##7##(2008-10#1)(2012-12#1)
there has been an##9##4##(2008-10#1)(2008-11#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#3)
there has been considerable interest in##2##6##(1991-9#1)(2006-10#1)
there has been considerable interest##3##5##(1991-9#1)(2006-10#1)(2009-1#1)
there has been considerable##5##4##(1991-9#1)(1992-1#1)(2006-10#1)(2008-11#1)(2009-1#1)
there has been growing interest in the##3##7##(2008-11#1)(2008-7#2)
there has been increased##2##4##(2008-1#1)(2013-1#1)
there has been increasing interest in the##3##7##(2008-3#1)(2008-7#2)
there has been increasing interest in##4##6##(1991-2#1)(2008-3#1)(2008-7#2)
there has been limited##5##4##(2008-10#1)(2008-8#2)(2009-10#1)(2011-2#1)
there has been little##9##4##(1991-4#1)(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#1)
there has been much##2##4##(2008-3#1)(2008-7#1)
there has been no recurrence##2##5##(1990-11#1)(2008-7#1)
there has been no report##2##5##(2008-11#1)(2012-3#1)
there has been no##16##4##(1990-11#1)(1990-6#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-9#1)(2010-8#1)(2012-3#4)(2013-1#1)
there has been only##2##4##(2008-9#1)(2010-6#1)
there has been recent##2##4##(1997-8#1)(2010-1#1)
there has been some##3##4##(1994-2#1)(2008-5#1)(2008-8#1)
there has been very little##2##5##(2008-10#1)(2012-2#1)
there has been very##3##4##(2008-10#1)(2012-2#2)
there has been##121##3##(1990-11#2)(1990-6#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#12)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-4#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#5)(2013-7#1)(2013-8#1)
there has not##2##3##(1990-7#1)(2009-1#1)
there has##129##2##(1990-11#2)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#11)(2008-11#13)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-4#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#7)(2013-7#1)(2013-8#1)
there have been a number of##3##6##(2008-11#1)(2008-7#1)(2013-1#1)
there have been a##4##4##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
there have been advances in##2##5##(1992-2#1)(2011-2#1)
there have been few reports##3##5##(2008-8#1)(2012-12#1)(2012-3#1)
there have been few studies of the##2##7##(1993-12#1)(2008-7#1)
there have been few##9##4##(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)
there have been no empirical##2##5##(2008-5#1)(2008-7#1)
there have been no incidents of##2##6##(1994-2#1)(2007-8#1)
there have been no reports##2##5##(1994-6#1)(2010-12#1)
there have been no significant##2##5##(2013-1#1)(2013-7#1)
there have been no studies##2##5##(2008-11#1)(2008-7#1)
there have been no##20##4##(1994-2#1)(1994-6#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
there have been only##2##4##(1992-2#1)(2013-1#1)
there have been several reports##2##5##(2010-6#1)(2012-3#1)
there have been significant advances in the##2##7##(1990-11#1)(2007-12#1)
there have been significant developments in##2##6##(2008-11#1)(2013-8#1)
there have been significant##6##4##(1990-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2013-8#1)
there have been very few##2##5##(2008-7#2)
there have been##71##3##(1990-11#1)(1991-3#1)(1992-2#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
there have##74##2##(1990-11#1)(1991-3#2)(1992-2#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
there in a##2##3##(2008-5#1)(2012-3#1)
there is a brief##2##4##(2009-9#2)
there is a clear need for##2##6##(2007-8#1)(2008-10#1)
there is a clear##4##4##(2007-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
there is a close##2##4##(2008-3#1)(2008-8#1)
there is a complete##2##4##(1993-8#1)(1994-9#1)
there is a considerable##5##4##(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2010-9#1)
there is a correlation between##2##5##(2008-10#1)(2011-2#1)
there is a cost##2##4##(2008-10#1)(2008-8#1)
there is a critical##2##4##(2011-2#2)
there is a dearth of##3##5##(2008-11#2)(2008-12#1)
there is a decrease in##2##5##(2008-10#1)(2011-2#1)
there is a difference##2##4##(2010-10#1)(2012-2#1)
there is a good##4##4##(1991-3#1)(1993-1#1)(2008-10#1)(2008-6#1)
there is a gradual##2##4##(1994-8#1)(2009-11#1)
there is a great need to##2##6##(2008-10#1)(2009-11#1)
there is a great need##3##5##(1994-9#1)(2008-10#1)(2009-11#1)
there is a great##4##4##(1994-9#1)(2008-10#2)(2009-11#1)
there is a growing body of##3##6##(2008-12#1)(2010-8#1)(2012-2#1)
there is a growing interest in##3##6##(2008-11#1)(2010-5#1)(2013-1#1)
there is a growing need for##2##6##(2008-11#1)(2012-2#1)
there is a growing need##3##5##(2008-11#1)(2010-12#1)(2012-2#1)
there is a growing##14##4##(1996-1#1)(1996-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
there is a high incidence of##3##6##(1992-2#1)(1997-3#1)(2008-8#1)
there is a high prevalence of##2##6##(2008-6#1)(2013-1#1)
there is a high##13##4##(1992-2#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
there is a higher##3##4##(1996-3#1)(2009-1#1)(2011-2#1)
there is a lack of data##2##6##(2008-8#1)(2011-2#1)
there is a lack of##10##5##(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)
there is a large##5##4##(2007-1#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)
there is a marked##3##4##(1992-3#1)(2008-8#1)(2008-9#1)
there is a more##2##4##(1997-4#1)(2008-9#1)
there is a need for more##3##6##(1995-2#1)(2008-12#1)(2008-4#1)
there is a need for##22##5##(1993-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-12#1)(2011-1#3)(2011-2#1)(2013-1#4)
there is a need to develop##2##6##(2012-2#2)
there is a need to provide##2##6##(2007-7#1)(2013-8#1)
there is a need to solidify the terminology of and measurements for CS in nursing##2##15##(2013-1#2)
there is a need to##24##5##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
there is a need##48##4##(1993-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
there is a negative##3##4##(1993-8#1)(1994-5#1)(2008-5#1)
there is a paucity of data##2##6##(2008-10#1)(2011-2#1)
there is a paucity of evidence regarding##2##7##(2008-6#1)(2010-12#1)
there is a paucity of##9##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
there is a possibility of##3##5##(2010-8#1)(2011-2#1)(2012-12#1)
there is a pressing need for##2##6##(2008-12#1)(2013-1#1)
there is a progressive##2##4##(2007-12#1)(2013-7#1)
there is a range of##2##5##(2007-12#1)(2008-1#1)
there is a real##2##4##(1995-12#1)(2008-11#1)
there is a reasonable##2##4##(1991-1#1)(1991-9#1)
there is a relatively##2##4##(1994-6#1)(2008-5#1)
there is a risk of##4##5##(1997-3#1)(2007-2#1)(2008-3#1)(2010-5#1)
there is a risk##5##4##(1997-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-5#1)
there is a sharp rise in##2##6##(1992-3#1)(2010-12#1)
there is a sharp##3##4##(1992-3#1)(2009-4#1)(2010-12#1)
there is a significant##7##4##(1994-2#1)(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
there is a simple##2##4##(2008-6#1)(2009-11#1)
there is a single##2##4##(2008-1#1)(2008-5#1)
there is a strong correlation between##2##6##(1997-1#1)(2011-2#1)
there is a strong##11##4##(1991-2#1)(1995-5#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2010-8#1)(2011-2#1)
there is a tendency##2##4##(2011-2#1)(2013-7#1)
there is a therapeutic##2##4##(2010-6#1)(2013-1#1)
there is a threshold##4##4##(2008-10#1)(2008-8#2)(2010-1#1)
there is a trade-off between the##2##6##(2008-2#1)(2008-3#1)
there is a trade-off between##5##5##(2007-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
there is a tremendous##2##4##(2008-1#1)(2011-2#1)
there is a very##2##4##(1995-5#1)(2008-10#1)
there is a weak##2##4##(2009-5#1)(2010-3#1)
there is a wide##2##4##(2008-12#1)(2008-5#1)
there is a##345##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#8)(2008-10#22)(2008-11#16)(2008-12#10)(2008-2#6)(2008-3#15)(2008-4#5)(2008-5#8)(2008-6#6)(2008-7#11)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#7)(2011-2#23)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#6)
there is also a high##2##5##(2008-8#1)(2011-2#1)
there is also a##4##4##(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
there is also an increase in the##2##7##(1990-7#1)(2011-2#1)
there is also an##3##4##(1990-7#1)(1996-8#1)(2011-2#1)
there is also some##3##4##(1990-2#1)(1991-6#1)(2008-8#1)
there is also##12##3##(1990-2#1)(1990-7#1)(1991-6#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-8#1)(2011-2#2)
there is always the possibility that##2##6##(2008-9#2)
there is always##4##3##(2008-3#1)(2008-9#2)(2010-4#1)
there is ample evidence##2##4##(2008-3#1)(2008-7#1)
there is an apparent##2##4##(2008-3#1)(2010-1#1)
there is an increase in the##3##6##(2007-8#1)(2008-11#1)(2010-12#1)
there is an increase##4##4##(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
there is an increased risk of##2##6##(2009-12#1)(2011-1#1)
there is an increased##4##4##(1994-5#1)(2009-12#1)(2010-8#1)(2011-1#1)
there is an increasing##2##4##(2008-5#1)(2009-5#1)
there is an opportunity to##2##5##(2008-12#1)(2013-1#1)
there is an optimum##3##4##(2008-2#2)(2008-3#1)
there is an urgent need for##2##6##(2008-10#1)(2008-11#1)
there is an urgent need to##3##6##(2008-1#1)(2008-11#1)(2012-1#1)
there is an urgent need##5##5##(2008-1#1)(2008-10#1)(2008-11#2)(2012-1#1)
there is an urgent##7##4##(2008-1#1)(2008-10#1)(2008-11#3)(2012-1#1)(2013-7#1)
there is an##72##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-11#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
there is any##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
there is as##2##3##(2009-7#1)(2012-12#1)
there is clear##2##3##(2008-6#1)(2010-11#1)
there is concern that##2##4##(1994-9#1)(2008-8#1)
there is concern##3##3##(1994-9#1)(2008-7#1)(2008-8#1)
there is considerable variation in the##2##6##(1991-11#1)(2011-2#1)
there is considerable variation in##3##5##(1991-11#1)(2011-2#1)(2013-1#1)
there is considerable##13##3##(1991-11#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#2)
there is controversy about##2##4##(2010-11#1)(2011-2#1)
there is currently no##3##4##(1996-1#1)(2011-2#2)
there is currently##5##3##(1996-1#1)(2008-11#1)(2011-2#2)(2012-3#1)
there is direct##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
there is disagreement##2##3##(1997-7#1)(2009-3#1)
there is emerging evidence##2##4##(1994-5#1)(2008-4#1)
there is enough##3##3##(2007-2#1)(2008-7#1)(2009-8#1)
there is evidence for##2##4##(2008-7#1)(2012-3#1)
there is evidence of an##2##5##(1996-5#1)(2008-11#1)
there is evidence of##6##4##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)
there is evidence that the##2##5##(1992-7#1)(2006-10#1)
there is evidence that##11##4##(1992-7#1)(1995-12#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-5#1)(2013-7#1)
there is evidence to##2##4##(2007-12#1)(2010-2#1)
there is evidence##25##3##(1992-7#1)(1994-9#1)(1995-12#1)(1996-5#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
there is general agreement that##3##5##(1994-8#1)(2008-11#1)(2008-6#1)
there is general##4##3##(1994-8#1)(2008-11#1)(2008-6#1)(2008-8#1)
there is good agreement##2##4##(2008-10#1)(2008-2#1)
there is good evidence##2##4##(2008-7#1)(2009-6#1)
there is good##5##3##(2008-10#2)(2008-2#1)(2008-7#1)(2009-6#1)
there is great##3##3##(2008-11#1)(2009-7#1)(2010-10#1)
there is greater##2##3##(1990-11#1)(2008-10#1)
there is growing evidence to##2##5##(2008-2#1)(2008-7#1)
there is growing evidence##3##4##(2008-2#1)(2008-7#1)(2009-10#1)
there is growing##4##3##(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)
there is highly##2##3##(2008-2#1)(2012-3#1)
there is hope##2##3##(1990-2#1)(2008-12#1)
there is increased##3##3##(1997-1#1)(2007-7#1)(2010-11#1)
there is increasing evidence that##3##5##(1992-9#1)(2008-1#1)(2008-7#1)
there is increasing evidence##5##4##(1992-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
there is increasing interest in##2##5##(2010-10#1)(2010-7#1)
there is increasing##9##3##(1992-9#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-2#1)
there is interest in##2##4##(1991-3#1)(2012-12#1)
there is lack of##2##4##(2008-5#1)(2011-10#1)
there is limited empirical##2##4##(2012-3#1)(2013-8#1)
there is limited information on##3##5##(2009-3#1)(2011-2#1)(2012-1#1)
there is limited information##4##4##(2009-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
there is limited##8##3##(1992-1#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
there is little consensus##3##4##(1995-1#1)(2008-10#1)(2008-11#1)
there is little evidence that##2##5##(2008-7#1)(2012-1#1)
there is little evidence to##4##5##(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
there is little evidence##6##4##(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
there is little experimental evidence##2##5##(2008-10#1)(2008-8#1)
there is little information##2##4##(2007-10#1)(2009-4#1)
there is little or no##3##5##(2008-8#1)(2011-2#1)(2013-8#1)
there is little##39##3##(1992-6#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-4#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
there is more to##3##4##(1995-1#1)(2008-7#1)(2012-3#1)
there is more##6##3##(1994-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
there is much##4##3##(1994-1#1)(2006-10#1)(2007-12#1)(2009-12#1)
there is no &quot##2##4##(1993-8#1)(2008-10#1)
there is no clear##3##4##(1996-3#1)(2008-5#1)(2013-1#1)
there is no consensus on##2##5##(2008-7#1)(2012-2#1)
there is no consensus regarding the##3##6##(1994-12#1)(2008-11#1)(2012-2#1)
there is no consensus regarding##4##5##(1994-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
there is no consensus##8##4##(1994-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-8#1)
there is no convincing evidence##2##5##(1992-2#1)(2007-8#1)
there is no correlation between##2##5##(1994-5#1)(2011-2#1)
there is no cure##2##4##(2010-11#2)
there is no definitive##3##4##(2008-4#1)(2008-9#1)(2010-12#1)
there is no difference in##2##5##(2008-6#1)(2011-1#1)
there is no doubt that##3##5##(2009-12#1)(2011-2#2)
there is no doubt##4##4##(2008-7#1)(2009-12#1)(2011-2#2)
there is no effective##3##4##(1990-2#1)(1995-9#1)(2012-2#1)
there is no evidence for an##2##6##(2008-11#1)(2012-3#1)
there is no evidence for##4##5##(2007-6#1)(2007-8#1)(2008-11#1)(2012-3#1)
there is no evidence of##7##5##(1990-2#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-7#1)(2013-1#1)
there is no evidence that##5##5##(1997-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-12#1)
there is no evidence to##2##5##(2007-8#1)(2008-10#1)
there is no evidence##20##4##(1990-2#1)(1992-2#1)(1994-3#1)(1995-11#1)(1997-3#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
there is no general##2##4##(2008-7#1)(2008-8#1)
there is no genetic##2##4##(2008-5#1)(2011-2#1)
there is no increase in##2##5##(1997-1#1)(2007-8#1)
there is no information available##2##5##(2008-10#1)(2013-7#1)
there is no information on##2##5##(2008-10#1)(2008-5#1)
there is no information##4##4##(2008-10#2)(2008-5#1)(2013-7#1)
there is no known##3##4##(1995-6#1)(2011-1#1)(2013-1#1)
there is no need for##2##5##(2008-10#1)(2008-2#1)
there is no need to##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
there is no need##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
there is no report##2##4##(2012-12#1)(2013-8#1)
there is no reported##2##4##(2012-2#2)
there is no significant difference##4##5##(2008-10#2)(2008-9#2)
there is no significant##7##4##(1990-2#1)(1990-6#1)(2008-10#2)(2008-9#2)(2009-5#1)
there is no simple##2##4##(2008-8#1)(2009-6#1)
there is no specific treatment##2##5##(2011-2#1)(2013-1#1)
there is no standard method##2##5##(1997-4#1)(2013-1#1)
there is no such##2##4##(2008-2#1)(2008-3#1)
there is no universal##2##4##(2007-11#1)(2013-1#1)
there is no##204##3##(1990-11#1)(1990-2#3)(1990-6#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-6#1)(2007-8#7)(2008-1#3)(2008-10#17)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-5#4)(2009-6#2)(2009-7#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#4)(2011-2#11)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#4)
there is not a##3##4##(2007-11#1)(2008-11#1)(2011-2#1)
there is not enough##2##4##(2007-7#1)(2008-3#1)
there is not##8##3##(1996-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
there is now##6##3##(1990-2#1)(1992-5#1)(1994-12#1)(2010-1#1)(2011-2#1)(2012-12#1)
there is one##3##3##(1994-9#1)(2008-3#1)(2008-8#1)
there is only one possible mode of##2##7##(2008-3#2)
there is only one report##2##5##(2008-12#1)(2013-8#1)
there is only one##5##4##(2008-11#1)(2008-12#1)(2008-3#2)(2013-8#1)
there is only##6##3##(2008-11#1)(2008-12#1)(2008-3#2)(2013-1#1)(2013-8#1)
there is potential for##2##4##(2008-10#1)(2011-1#1)
there is potential##3##3##(2008-10#2)(2011-1#1)
there is progressive##2##3##(1993-6#1)(2008-7#1)
there is reduced##2##3##(1997-8#1)(2008-7#1)
there is room for##3##4##(1996-2#1)(2008-3#1)(2011-1#1)
there is significant##8##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
there is some evidence of##2##5##(2007-2#1)(2011-2#1)
there is some evidence that##3##5##(1993-1#1)(1996-2#1)(2007-2#1)
there is some evidence to suggest that##2##7##(2008-3#1)(2013-1#1)
there is some evidence##7##4##(1993-1#1)(1996-2#1)(2007-2#2)(2008-3#1)(2011-2#1)(2013-1#1)
there is some##14##3##(1992-11#1)(1993-1#1)(1996-2#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2013-1#1)
there is still a large##2##5##(1991-12#1)(2011-2#1)
there is still a long way to go before##2##9##(1995-11#1)(2012-3#1)
there is still a need for##5##6##(2008-10#1)(2008-4#1)(2008-5#2)(2013-1#1)
there is still a need##6##5##(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)
there is still a##13##4##(1991-12#1)(1995-11#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
there is still much##4##4##(1990-9#1)(2007-12#1)(2008-11#1)(2009-1#1)
there is still no##4##4##(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
there is still##34##3##(1990-9#1)(1991-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
there is strong evidence that##2##5##(2008-1#1)(2008-8#1)
there is strong evidence##3##4##(2008-1#1)(2008-8#1)(2013-1#1)
there is strong##8##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#3)(2009-8#1)(2013-1#1)
there is substantial##6##3##(1992-2#1)(1994-3#2)(1997-5#1)(2008-3#1)(2012-2#1)
there is surprisingly little##2##4##(2008-11#1)(2009-4#1)
there is the need##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
there is the##8##3##(1990-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-1#1)
there is uncertainty##2##3##(2008-8#2)
there is up to##2##4##(1992-8#1)(2008-1#1)
there is value in##2##4##(2009-1#1)(2012-12#1)
there is variation##2##3##(2008-10#1)(2012-3#1)
there is very little##5##4##(2007-8#1)(2008-7#2)(2008-8#1)(2009-8#1)
there is##1034##2##(1990-11#4)(1990-2#7)(1990-3#3)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#6)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#5)(1994-5#7)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#2)(1995-11#6)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#8)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#2)(1997-3#6)(1997-4#4)(1997-5#6)(1997-6#1)(1997-7#3)(1997-8#5)(1997-9#1)(2006-10#3)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#15)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#17)(2008-1#21)(2008-10#74)(2008-11#45)(2008-12#25)(2008-2#18)(2008-3#39)(2008-4#19)(2008-5#23)(2008-6#17)(2008-7#45)(2008-8#51)(2008-9#28)(2009-1#3)(2009-10#6)(2009-11#6)(2009-12#7)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#10)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#4)(2010-1#7)(2010-10#7)(2010-11#7)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#10)(2010-6#4)(2010-7#3)(2010-8#10)(2010-9#2)(2011-1#19)(2011-10#1)(2011-2#56)(2011-3#1)(2012-1#4)(2012-12#17)(2012-2#29)(2012-3#21)(2013-1#45)(2013-7#9)(2013-8#21)
there may be a##10##4##(1991-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#1)(1996-12#1)(2008-1#1)(2008-9#1)(2013-7#1)(2013-8#1)
there may be an##2##4##(2007-7#1)(2008-7#1)
there may be no##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
there may be other##3##4##(1997-1#1)(1997-7#1)(2008-2#1)
there may be two##3##4##(1997-4#1)(2008-10#1)(2009-11#1)
there may be##40##3##(1991-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
there may##45##2##(1991-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
there might be a##2##4##(2010-10#1)(2012-12#1)
there might be##5##3##(2008-8#1)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)
there must be##9##3##(1996-12#1)(1997-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
there must##10##2##(1996-12#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
there no##2##2##(2010-6#1)(2012-3#1)
there occurred##2##2##(2009-6#1)(2012-3#1)
there other##2##2##(1996-1#1)(2010-12#1)
there remain significant##3##3##(2007-2#1)(2008-6#2)
there remain##7##2##(2007-2#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#2)
there remains considerable##2##3##(2008-11#1)(2008-7#1)
there remains##6##2##(1992-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
there seems to be a##7##5##(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2012-1#1)
there seems to be no##2##5##(1996-2#1)(2008-10#1)
there seems to be##9##4##(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2012-1#1)
there seems##10##2##(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2010-7#1)(2012-1#1)
there should be a##3##4##(1992-6#1)(1995-2#1)(2008-7#1)
there should be##8##3##(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
there still exists##2##3##(1991-8#1)(2008-8#1)
there still##4##2##(1991-8#1)(2008-4#1)(2008-6#1)(2008-8#1)
there to be##2##3##(2008-10#1)(2008-8#1)
there to##4##2##(1992-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
there was a 12%##2##4##(2012-1#1)(2013-1#1)
there was a clear##2##4##(1991-2#1)(2012-1#1)
there was a close##2##4##(1992-11#1)(1993-1#1)
there was a concentration##2##4##(1990-11#1)(2013-1#1)
there was a decrease in##4##5##(1991-12#1)(1991-8#1)(1993-12#1)(1995-12#1)
there was a decrease##6##4##(1991-12#1)(1991-8#1)(1993-12#1)(1995-12#1)(2008-1#1)(2008-3#1)
there was a delay##2##4##(2008-10#1)(2012-6#1)
there was a direct relationship between##2##6##(2008-10#2)
there was a dose-dependent reduction##2##5##(1992-12#1)(1995-12#1)
there was a fall in##2##5##(1997-1#1)(2008-7#1)
there was a general##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
there was a good correlation between the##2##7##(1990-7#1)(2008-5#1)
there was a good##3##4##(1990-7#1)(2008-10#1)(2008-5#1)
there was a graded reduction in the rate of##2##9##(2008-5#2)
there was a gradual decrease in##2##6##(1990-11#1)(2008-11#1)
there was a greater##2##4##(1997-6#1)(2008-11#1)
there was a high##5##4##(1990-5#1)(1994-12#1)(2008-12#1)(2008-5#1)(2008-6#1)
there was a higher frequency of##2##6##(2008-7#1)(2013-7#1)
there was a higher##6##4##(1992-4#1)(1993-11#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-7#1)
there was a large##2##4##(1994-2#1)(2008-7#1)
there was a linear relationship between##2##6##(2007-2#1)(2008-10#1)
there was a linear##3##4##(2007-2#1)(2008-10#1)(2008-12#1)
there was a little difference in##2##6##(2008-11#1)(2013-8#1)
there was a marked##3##4##(2007-12#1)(2008-11#1)(2008-6#1)
there was a mild##2##4##(1990-11#1)(2012-2#1)
there was a permanent##2##4##(2008-11#1)(2008-9#1)
there was a positive correlation##2##5##(1990-10#1)(2008-10#1)
there was a positive##3##4##(1990-10#1)(1996-3#1)(2008-10#1)
there was a reduction in##2##5##(1990-5#1)(2013-8#1)
there was a reduction of##2##5##(2008-10#1)(2013-1#1)
there was a reduction##4##4##(1990-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
there was a shift##2##4##(1991-12#1)(2008-1#1)
there was a significant association##2##5##(2008-12#1)(2012-12#1)
there was a significant correlation between##2##6##(2007-10#1)(2008-6#1)
there was a significant correlation##3##5##(2007-10#1)(2008-6#1)(2013-1#1)
there was a significant decrease in the##4##7##(2007-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
there was a significant decrease in##7##6##(2007-7#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-8#2)
there was a significant decrease##8##5##(2007-7#1)(2008-10#2)(2008-8#2)(2012-2#1)(2013-8#2)
there was a significant difference between##2##6##(1995-5#1)(2009-8#1)
there was a significant effect##2##5##(1996-12#1)(2008-12#1)
there was a significant increase in##6##6##(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#2)(2013-8#1)
there was a significant increase of##2##6##(1995-8#1)(2012-2#1)
there was a significant increase##9##5##(1994-7#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
there was a significant reduction in the##2##7##(1996-1#1)(2008-10#1)
there was a significant reduction in##5##6##(1993-1#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-5#1)
there was a significant reduction##6##5##(1993-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-5#1)
there was a significant##43##4##(1990-5#1)(1993-1#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(2007-10#1)(2007-7#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
there was a significantly##2##4##(1996-12#1)(2010-7#1)
there was a similar##2##4##(1994-8#1)(2008-7#1)
there was a single##2##4##(2007-8#1)(2008-9#1)
there was a small but##2##5##(1992-2#1)(2008-9#1)
there was a small##3##4##(1992-2#1)(2008-9#1)(2012-1#1)
there was a statistical##2##4##(2006-6#1)(2008-3#1)
there was a statistically significant difference between the##2##8##(2007-6#1)(2009-8#1)
there was a statistically significant difference between##3##7##(2007-12#1)(2007-6#1)(2009-8#1)
there was a statistically significant difference##4##6##(2007-12#1)(2007-6#1)(2009-8#1)(2013-8#1)
there was a statistically significant reduction in##2##7##(2007-8#2)
there was a statistically significant##8##5##(1993-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2009-8#1)(2011-2#1)(2013-8#1)
there was a strong correlation##3##5##(1991-6#1)(1994-8#1)(2008-10#1)
there was a strong##7##4##(1991-6#1)(1994-8#2)(1995-6#1)(2008-10#1)(2008-9#1)(2010-6#1)
there was a substantial##2##4##(1991-6#1)(1992-2#1)
there was a tendency for##2##5##(1991-2#1)(2007-12#1)
there was a tendency##3##4##(1991-2#1)(2007-12#1)(2008-11#1)
there was a trend toward##2##5##(2008-10#1)(2009-3#1)
there was a trend towards##2##5##(2008-6#1)(2009-3#1)
there was a trend##6##4##(1992-11#1)(1996-6#1)(2008-10#1)(2008-6#1)(2009-3#2)
there was a wide##3##4##(1997-3#1)(2012-3#1)(2013-1#1)
there was a##231##3##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1992-11#3)(1992-12#1)(1992-2#3)(1992-4#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#28)(2008-11#9)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#8)(2009-2#1)(2009-3#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#8)
there was also evidence##2##4##(1991-8#1)(2008-11#1)
there was also##3##3##(1991-8#1)(1994-8#1)(2008-11#1)
there was an improvement in##3##5##(2008-5#2)(2008-7#1)
there was an improvement##4##4##(2008-5#3)(2008-7#1)
there was an increase in the##3##6##(2008-11#1)(2008-9#1)(2013-8#1)
there was an increase in##7##5##(1992-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-8#1)
there was an##29##3##(1992-12#1)(1992-2#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
there was any##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
there was clearly##2##3##(2008-10#1)(2012-12#1)
there was considerable##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
there was evidence of##2##4##(1992-5#1)(1995-5#1)
there was evidence##3##3##(1992-5#1)(1995-5#1)(2013-1#1)
there was genetic##2##3##(2007-10#1)(2008-9#1)
there was good##3##3##(1991-7#1)(2011-1#1)(2012-3#1)
there was gradual##2##3##(2008-10#1)(2011-2#1)
there was great##2##3##(1994-3#1)(2009-7#1)
there was greater##2##3##(2008-10#2)
there was less##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
there was little or no##2##5##(1994-12#1)(2008-6#1)
there was little##15##3##(1990-11#1)(1994-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)
there was marked##2##3##(1996-11#1)(2008-7#1)
there was minimal##3##3##(1993-12#1)(2008-11#1)(2010-6#1)
there was more##3##3##(1993-6#1)(1994-9#1)(2010-5#1)
there was no association##2##4##(2008-12#1)(2010-8#1)
there was no change in the##5##6##(1990-5#1)(1991-2#1)(1996-12#1)(2007-11#1)(2008-3#1)
there was no change in##7##5##(1990-5#1)(1991-2#1)(1996-12#2)(2007-11#1)(2008-3#1)(2013-8#1)
there was no change##8##4##(1990-5#1)(1991-2#1)(1996-12#2)(2007-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
there was no clear##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2011-1#1)
there was no correlation between##4##5##(1993-2#1)(1995-11#1)(2011-2#2)
there was no correlation with##2##5##(2008-6#1)(2013-1#1)
there was no correlation##7##4##(1993-2#1)(1995-11#1)(2008-6#1)(2011-2#3)(2013-1#1)
there was no difference between the##4##6##(1990-2#1)(1990-5#1)(1990-7#1)(2007-10#1)
there was no difference between##5##5##(1990-2#1)(1990-5#1)(1990-7#1)(2007-10#2)
there was no difference in the##4##6##(2008-12#1)(2008-8#1)(2009-11#1)(2013-8#1)
there was no difference in##13##5##(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
there was no difference##20##4##(1990-2#1)(1990-5#1)(1990-7#1)(1992-12#1)(1994-12#1)(1997-3#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
there was no effect##3##4##(1990-5#1)(1995-2#1)(2008-10#1)
there was no evidence for##2##5##(2011-1#1)(2011-2#1)
there was no evidence of a significant difference in the##2##10##(1996-7#1)(2013-1#1)
there was no evidence of carcinogenic activity of##5##8##(2008-8#1)(2008-9#4)
there was no evidence of carcinogenic##6##6##(2008-8#1)(2008-9#5)
there was no evidence of##20##5##(1990-3#1)(1991-1#1)(1991-6#1)(1996-7#1)(1997-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#6)(2013-1#2)(2013-8#1)
there was no evidence that##2##5##(1996-3#1)(2008-9#1)
there was no evidence##24##4##(1990-3#1)(1991-1#1)(1991-6#1)(1996-3#1)(1996-7#1)(1997-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#7)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
there was no increase in##2##5##(1991-3#1)(1995-11#1)
there was no indication of##2##5##(1990-5#1)(2008-10#1)
there was no mortality##2##4##(1997-8#1)(2008-7#1)
there was no other##2##4##(2008-7#1)(2009-9#1)
there was no recurrence##4##4##(2007-11#2)(2012-2#1)(2013-1#1)
there was no reduction of##2##5##(1992-12#1)(1996-12#1)
there was no reduction##3##4##(1992-12#1)(1996-12#1)(2008-10#1)
there was no relationship between the##3##6##(1991-11#1)(2008-12#1)(2008-8#1)
there was no relationship between##5##5##(1991-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
there was no significant change##3##5##(2011-1#1)(2011-2#1)(2013-1#1)
there was no significant correlation between##2##6##(2007-10#1)(2008-10#1)
there was no significant correlation##3##5##(2006-6#1)(2007-10#1)(2008-10#1)
there was no significant difference among##2##6##(2008-10#1)(2013-1#1)
there was no significant difference between the##5##7##(1997-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
there was no significant difference between##11##6##(1991-8#2)(1997-8#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#2)(2013-8#1)
there was no significant difference in the##6##7##(1990-7#1)(1991-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
there was no significant difference in##16##6##(1990-7#1)(1991-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#2)
there was no significant difference##35##5##(1990-7#1)(1991-8#3)(1992-9#1)(1994-2#1)(1994-3#1)(1997-8#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
there was no significant increase in##2##6##(1997-6#1)(2008-2#1)
there was no significant increase##3##5##(1997-6#1)(2008-11#1)(2008-2#1)
there was no significant interaction##2##5##(2008-10#2)
there was no significant relationship##2##5##(2007-5#1)(2008-10#1)
there was no significant##58##4##(1990-7#1)(1991-8#3)(1992-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#2)(1997-6#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
there was no statistical difference between##3##6##(1996-6#1)(2008-10#1)(2013-1#1)
there was no statistical difference##4##5##(1991-5#1)(1996-6#1)(2008-10#1)(2013-1#1)
there was no statistical##5##4##(1991-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
there was no statistically significant difference in##3##7##(1994-2#1)(2008-11#1)(2008-12#1)
there was no statistically significant difference##4##6##(1994-2#1)(2008-11#1)(2008-12#1)(2009-12#1)
there was no statistically##5##4##(1994-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-12#1)
there was no##222##3##(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-12#2)(1992-3#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-8#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#5)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#14)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#5)(2011-1#7)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#6)
there was not a##2##4##(2008-10#1)(2008-12#1)
there was one##3##3##(1995-11#1)(2008-10#2)
there was only a##2##4##(1997-1#1)(2011-2#1)
there was only##5##3##(1993-8#1)(1994-8#1)(1997-1#1)(1997-2#1)(2011-2#1)
there was reduced##2##3##(2008-7#1)(2010-8#1)
there was significant##10##3##(1991-8#1)(1996-5#1)(2008-10#2)(2008-9#2)(2009-4#1)(2009-7#1)(2010-4#1)(2013-1#1)
there was some evidence of##2##5##(2008-10#1)(2010-8#1)
there was some evidence##3##4##(1994-3#1)(2008-10#1)(2010-8#1)
there was some##10##3##(1991-12#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
there was the##2##3##(1996-2#1)(2010-3#1)
there was variability##2##3##(2008-10#1)(2013-1#1)
there was##662##2##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#7)(1990-7#3)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#7)(1992-11#4)(1992-12#4)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#6)(1993-9#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-7#2)(1994-8#7)(1994-9#2)(1995-11#4)(1995-12#6)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#5)(1996-1#1)(1996-11#3)(1996-12#8)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#4)(2006-6#2)(2006-8#1)(2007-10#6)(2007-11#9)(2007-12#5)(2007-2#1)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#109)(2008-11#30)(2008-12#14)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#23)(2008-6#9)(2008-7#18)(2008-8#12)(2008-9#32)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-7#6)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#9)(2011-1#15)(2011-10#1)(2011-2#24)(2011-3#1)(2012-1#5)(2012-12#7)(2012-2#11)(2012-3#14)(2012-6#1)(2013-1#31)(2013-7#2)(2013-8#16)
there were 11##2##3##(2007-8#1)(2008-10#1)
there were 12##2##3##(1990-6#1)(2007-7#1)
there were 56##2##3##(2007-8#1)(2013-8#1)
there were a##5##3##(2008-5#2)(2008-9#2)(2012-12#1)
there were also##2##3##(2008-5#1)(2009-5#1)
there were any##2##3##(1994-12#1)(2008-11#1)
there were differences in the##2##5##(1996-2#1)(2008-10#1)
there were differences in##3##4##(1996-2#1)(2008-10#1)(2013-1#1)
there were differences##4##3##(1996-2#1)(2008-10#1)(2010-3#1)(2013-1#1)
there were different##2##3##(1992-8#1)(2008-8#1)
there were eight##2##3##(1992-2#1)(1997-3#1)
there were few##2##3##(1995-3#1)(2008-10#1)
there were fewer##2##3##(2008-10#2)
there were five##3##3##(1994-12#1)(2007-7#1)(2008-10#1)
there were four##4##3##(2006-12#1)(2007-11#1)(2008-10#2)
there were increased incidences of##2##5##(2008-9#2)
there were little##2##3##(1994-11#1)(1997-7#1)
there were many instances##2##4##(2008-10#1)(2008-7#1)
there were many##8##3##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#2)
there were more##2##3##(2008-10#2)
there were no differences between##2##5##(2011-2#1)(2013-1#1)
there were no differences in the##2##6##(2008-7#1)(2013-8#1)
there were no differences in##6##5##(1990-11#1)(1994-9#1)(2008-10#1)(2008-7#2)(2013-8#1)
there were no differences##10##4##(1990-11#1)(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
there were no recurrences##2##4##(1991-6#1)(1995-5#1)
there were no significant changes in##3##6##(2008-3#1)(2008-7#1)(2011-2#1)
there were no significant differences between##2##6##(2008-12#1)(2011-2#1)
there were no significant differences found##2##6##(2007-6#1)(2008-12#1)
there were no significant differences in the##2##7##(2012-2#1)(2013-1#1)
there were no significant differences in##8##6##(1991-2#1)(1993-1#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
there were no significant differences##16##5##(1991-2#1)(1993-1#1)(1996-2#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
there were no significant effects##2##5##(2008-11#1)(2011-2#1)
there were no significant##24##4##(1991-2#1)(1993-1#1)(1996-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
there were no signs of##3##5##(1993-1#1)(1993-6#1)(2011-2#1)
there were no statistically significant differences between transdermal and oral granisetron##2##11##(2010-12#2)
there were no statistically significant differences between##3##7##(2010-12#2)(2013-1#1)
there were no statistically significant##4##5##(2008-10#1)(2010-12#2)(2013-1#1)
there were no treatment-related##2##4##(2008-9#2)
there were no##75##3##(1990-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-1#2)(1993-12#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#4)(2010-12#2)(2011-2#9)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#3)
there were normal levels of##2##5##(2008-5#1)(2011-2#1)
there were only##2##3##(2007-8#1)(2008-7#1)
there were seven##2##3##(2008-1#1)(2008-5#1)
there were several##3##3##(2008-1#1)(2008-12#1)(2008-5#1)
there were significant difference##2##4##(2008-12#1)(2008-7#1)
there were significant differences among##3##5##(1993-2#1)(2012-3#1)(2013-8#1)
there were significant differences between##3##5##(2008-10#1)(2008-12#1)(2009-12#1)
there were significant differences in##3##5##(1995-12#1)(2007-12#1)(2008-10#1)
there were significant differences##10##4##(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2009-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
there were significant interactions##2##4##(2008-10#2)
there were significant##22##3##(1993-12#1)(1993-2#1)(1994-8#2)(1995-12#1)(1996-1#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-3#1)(2012-3#1)(2013-8#1)
there were similarities##2##3##(1994-12#1)(1997-3#1)
there were some differences##2##4##(2008-5#1)(2012-12#1)
there were some##6##3##(1993-5#1)(1994-12#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
there were statistically significant##2##4##(2008-7#1)(2011-2#1)
there were strong##2##3##(2007-10#1)(2008-8#1)
there were two##5##3##(1992-8#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
there were##265##2##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-5#2)(1993-6#5)(1993-8#2)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#8)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2008-1#9)(2008-10#32)(2008-11#3)(2008-12#11)(2008-3#3)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#16)(2008-8#4)(2008-9#12)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-7#1)(2010-8#2)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#7)(2013-1#8)(2013-8#5)
there will be a##2##4##(2008-1#1)(2008-9#1)
there will be##9##3##(1993-2#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
there will not##2##3##(1990-10#1)(1994-3#1)
there will##11##2##(1990-10#1)(1993-2#1)(1994-3#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
there would be no##2##4##(1992-12#1)(2008-10#1)
there would be##3##3##(1992-12#1)(2008-10#1)(2011-2#1)
there would##5##2##(1992-12#1)(1995-1#1)(2008-10#2)(2011-2#1)
there##3048##1##(1990-10#3)(1990-11#20)(1990-12#7)(1990-2#12)(1990-3#6)(1990-5#11)(1990-6#7)(1990-7#7)(1990-8#3)(1990-9#4)(1991-1#9)(1991-11#5)(1991-12#12)(1991-2#12)(1991-3#11)(1991-4#2)(1991-5#4)(1991-6#7)(1991-7#2)(1991-8#13)(1991-9#3)(1992-1#4)(1992-11#9)(1992-12#11)(1992-2#19)(1992-3#10)(1992-4#1)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#10)(1992-9#6)(1993-1#8)(1993-10#1)(1993-11#5)(1993-12#17)(1993-2#11)(1993-3#10)(1993-5#3)(1993-6#12)(1993-8#15)(1993-9#3)(1994-1#6)(1994-11#4)(1994-12#20)(1994-2#16)(1994-3#16)(1994-5#9)(1994-6#5)(1994-7#2)(1994-8#16)(1994-9#14)(1995-1#11)(1995-11#10)(1995-12#16)(1995-2#21)(1995-3#8)(1995-4#2)(1995-5#9)(1995-6#8)(1995-8#8)(1995-9#1)(1996-1#13)(1996-11#6)(1996-12#22)(1996-2#21)(1996-3#17)(1996-4#1)(1996-5#10)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#12)(1997-2#10)(1997-3#17)(1997-4#7)(1997-5#13)(1997-6#10)(1997-7#13)(1997-8#15)(1997-9#1)(2006-10#8)(2006-12#3)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#16)(2007-11#41)(2007-12#41)(2007-2#13)(2007-4#2)(2007-5#4)(2007-6#7)(2007-7#20)(2007-8#38)(2007-9#1)(2008-1#57)(2008-10#305)(2008-11#142)(2008-12#71)(2008-2#35)(2008-3#82)(2008-4#47)(2008-5#84)(2008-6#39)(2008-7#133)(2008-8#107)(2008-9#107)(2009-1#6)(2009-10#15)(2009-11#12)(2009-12#15)(2009-2#6)(2009-3#16)(2009-4#8)(2009-5#18)(2009-6#4)(2009-7#17)(2009-8#13)(2009-9#10)(2010-1#14)(2010-10#13)(2010-11#13)(2010-12#25)(2010-2#4)(2010-3#19)(2010-4#6)(2010-5#19)(2010-6#15)(2010-7#7)(2010-8#34)(2010-9#3)(2011-1#44)(2011-10#3)(2011-2#144)(2011-3#3)(2011-4#1)(2012-1#16)(2012-12#45)(2012-2#79)(2012-3#71)(2012-5#1)(2012-6#1)(2013-1#118)(2013-7#16)(2013-8#54)
there's##4##1##(1991-11#1)(1993-12#1)(1993-2#1)(2008-9#1)
thereafter every##2##2##(1993-2#1)(1994-2#1)
thereafter injected##2##2##(1993-5#1)(2008-10#1)
thereafter to##4##2##(1993-9#1)(2008-3#1)(2011-2#1)(2012-2#1)
thereafter with##2##2##(1993-11#1)(2012-2#1)
thereafter##71##1##(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#4)
thereby acting as a platform for communication between peers and the wider public##3##13##(2010-12#3)
thereby alleviating the need for##2##5##(2008-10#1)(2008-2#1)
thereby allowing a##2##3##(2008-10#1)(2008-2#1)
thereby allowing##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-5#1)
thereby also##2##2##(2008-7#1)(2008-8#1)
thereby becoming##2##2##(2010-3#1)(2012-2#1)
thereby causing##2##2##(1994-9#1)(2011-2#1)
thereby confirming##2##2##(2008-10#1)(2008-8#1)
thereby contributing to##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
thereby controlling##3##2##(2008-3#1)(2008-8#1)(2009-2#1)
thereby creating a##2##3##(2008-3#1)(2012-3#1)
thereby creating##3##2##(2008-11#1)(2008-3#1)(2012-3#1)
thereby decreasing##2##2##(1992-1#1)(1993-8#1)
thereby demonstrating that##2##3##(1992-11#1)(2008-10#1)
thereby demonstrating##3##2##(1990-5#1)(1992-11#1)(2008-10#1)
thereby eliminating##2##2##(2008-3#1)(2012-2#1)
thereby enabling the##2##3##(2008-10#1)(2012-12#1)
thereby enabling##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
thereby enhancing##5##2##(1997-7#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
thereby ensuring##2##2##(1992-8#1)(2009-8#1)
thereby facilitating##5##2##(1990-3#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
thereby generating##3##2##(1992-12#1)(2008-10#1)(2008-2#1)
thereby identifying##3##2##(1995-3#1)(1997-7#1)(2012-2#1)
thereby implying##2##2##(1992-9#1)(1997-8#1)
thereby improving the##4##3##(2006-10#1)(2008-2#1)(2008-7#2)
thereby improving##7##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#3)(2009-11#1)
thereby increasing the##2##3##(1993-12#1)(2008-7#1)
thereby increasing##6##2##(1993-12#1)(1994-8#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
thereby indicating##3##2##(1994-3#1)(1995-6#1)(2010-8#1)
thereby inducing##2##2##(2009-6#2)
thereby killing all distal leaves##2##5##(2008-10#2)
thereby leading to the##3##4##(2008-3#1)(2011-2#1)(2013-8#1)
thereby leading to##5##3##(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
thereby limiting the##2##3##(2008-10#1)(2012-2#1)
thereby limiting##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
thereby making##2##2##(1992-12#1)(2013-1#1)
thereby maximizing##2##2##(2007-12#1)(2008-2#1)
thereby offering##2##2##(2008-10#1)(2010-8#1)
thereby permitting##2##2##(1990-12#1)(1990-5#1)
thereby presenting a##2##3##(2010-2#1)(2012-12#1)
thereby preventing##6##2##(1995-3#1)(2008-10#1)(2008-8#1)(2009-7#1)(2013-1#2)
thereby producing##4##2##(1990-11#1)(2008-11#1)(2008-8#1)(2009-10#1)
thereby promoting##2##2##(2008-10#1)(2012-2#1)
thereby providing a##2##3##(2008-12#1)(2010-11#1)
thereby providing the##2##3##(2011-2#1)(2013-8#1)
thereby providing##10##2##(1993-6#1)(1994-11#1)(1996-12#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#2)(2013-8#1)
thereby reduce##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
thereby reducing the risk of##2##5##(2008-10#1)(2011-2#1)
thereby reducing the##8##3##(1997-7#1)(2008-10#3)(2008-6#1)(2009-9#1)(2010-11#1)(2011-2#1)
thereby reducing##17##2##(1991-12#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
thereby regulating##2##2##(1994-12#1)(2012-2#1)
thereby suggesting the##2##3##(1997-2#1)(2012-2#1)
thereby suggesting##3##2##(1997-2#1)(2012-2#2)
thereby verifying##3##2##(1991-8#1)(2008-10#2)
thereby##290##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#36)(2008-11#10)(2008-12#3)(2008-2#10)(2008-3#12)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#11)(2008-8#16)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#12)(2012-12#6)(2012-2#20)(2012-3#3)(2013-1#10)(2013-8#5)
therefore a##21##2##(1993-11#1)(1993-2#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-6#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
therefore all##2##2##(1996-1#1)(2008-7#1)
therefore an##6##2##(1990-10#1)(1994-3#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-8#1)
therefore appears to be##2##4##(1990-2#1)(1992-11#1)
therefore appears to##3##3##(1990-2#1)(1992-11#1)(1992-3#1)
therefore appears##6##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(2008-10#1)
therefore as##4##2##(1996-1#1)(2007-11#1)(2008-10#1)(2009-2#1)
therefore be a##3##3##(1992-11#1)(2008-9#1)(2012-12#1)
therefore be at##2##3##(1990-5#1)(1997-3#1)
therefore be beneficial##2##3##(1990-10#1)(2013-1#1)
therefore be considered##5##3##(1991-5#1)(1991-9#1)(2007-8#1)(2008-8#1)(2009-3#1)
therefore be useful in##2##4##(1990-8#1)(2008-12#1)
therefore be useful##4##3##(1990-8#1)(2008-11#1)(2008-12#1)(2010-7#1)
therefore be##61##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-3#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
therefore become##3##2##(2007-12#1)(2008-6#1)(2008-7#1)
therefore been##18##2##(1990-11#1)(1994-3#1)(2008-10#2)(2008-11#7)(2008-3#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
therefore can be considered as##2##5##(2008-5#1)(2011-2#1)
therefore can be##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-2#1)
therefore can##8##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
therefore cannot be##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
therefore cannot##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#2)
therefore classified##2##2##(1994-11#1)(2008-10#1)
therefore concluded that##6##3##(1991-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
therefore considered to##2##3##(1990-7#1)(2008-10#1)
therefore considered##5##2##(1990-7#1)(2008-10#1)(2008-5#2)(2008-8#1)
therefore control##2##2##(1994-8#1)(2008-9#1)
therefore demonstrated##2##2##(1991-12#1)(2008-10#1)
therefore established##2##2##(2008-11#1)(2008-5#1)
therefore examined##3##2##(1995-5#1)(1996-7#1)(2012-3#1)
therefore explored##2##2##(1994-11#1)(2010-3#1)
therefore focus##2##2##(1994-5#1)(2011-2#1)
therefore has the##2##3##(2008-3#1)(2008-9#1)
therefore has##9##2##(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#2)(2011-7#1)(2013-1#1)
therefore have##5##2##(1990-8#1)(1993-12#1)(2008-11#1)(2008-6#1)(2011-2#1)
therefore help##2##2##(2008-5#1)(2013-1#1)
therefore in##2##2##(2008-2#1)(2009-12#1)
therefore increase##2##2##(1993-11#1)(2012-3#1)
therefore indicate##2##2##(1992-5#1)(1997-4#1)
therefore investigated##4##2##(1990-3#1)(1992-2#1)(2008-7#1)(2009-5#1)
therefore is a useful##2##4##(1990-5#1)(1993-3#1)
therefore it can be##2##4##(1994-3#1)(2008-3#1)
therefore it is necessary to##2##5##(2008-11#1)(2013-8#1)
therefore it is##6##3##(2008-11#1)(2008-12#1)(2008-7#1)(2012-1#1)(2012-7#1)(2013-8#1)
therefore it##11##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-7#1)(2013-8#1)
therefore its value as a##2##5##(1991-12#1)(2009-8#1)
therefore its##4##2##(1991-12#1)(2009-8#2)(2012-6#1)
therefore likely to be##3##4##(1991-6#1)(2008-10#1)(2008-8#1)
therefore likely to##5##3##(1991-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
therefore likely##7##2##(1991-6#1)(1992-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
therefore make##2##2##(2008-2#1)(2010-6#1)
therefore more likely to##2##4##(1992-3#1)(2011-3#1)
therefore more##5##2##(1992-3#1)(1995-11#1)(2008-10#2)(2011-3#1)
therefore necessary that##2##3##(1991-3#1)(2012-3#1)
therefore necessary to use##2##4##(1990-2#1)(1990-3#1)
therefore necessary##8##2##(1990-2#1)(1990-3#2)(1990-8#1)(1991-3#1)(2008-10#1)(2010-4#1)(2012-3#1)
therefore not##10##2##(1992-12#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-9#2)(2009-3#1)(2010-7#1)
therefore of great importance##2##4##(2009-1#1)(2010-11#1)
therefore of great##3##3##(2009-1#1)(2010-11#1)(2011-1#1)
therefore of##8##2##(1990-9#1)(2008-3#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-1#1)
therefore offers a##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
therefore promote##2##2##(1994-10#1)(2012-3#1)
therefore proposed##2##2##(1991-11#1)(2008-10#1)
therefore provide a##2##3##(1992-8#1)(2009-5#1)
therefore provide##5##2##(1992-8#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-5#1)
therefore provides##3##2##(1990-8#1)(2008-9#1)(2012-12#1)
therefore recommended##4##2##(1992-6#1)(1994-3#1)(2010-2#1)(2011-2#1)
therefore remains##2##2##(1990-7#1)(2008-6#1)
therefore represents a new##2##4##(2008-10#1)(2011-2#1)
therefore represents a##4##3##(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
therefore represents an##2##3##(2008-11#1)(2009-5#1)
therefore represents##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
therefore required##4##2##(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
therefore requires##3##2##(1992-4#1)(2008-10#1)(2008-11#1)
therefore reviewed##2##2##(1993-3#1)(2008-6#1)
therefore seems to##2##3##(1991-3#1)(2012-2#1)
therefore serve as##2##3##(2008-8#1)(2012-3#1)
therefore should be##2##3##(2007-11#1)(2008-10#1)
therefore should##3##2##(2007-11#1)(2008-10#1)(2009-4#1)
therefore specific##3##2##(1996-5#1)(2008-10#1)(2008-2#1)
therefore studied##4##2##(1990-5#1)(1992-8#1)(1994-8#1)(2008-10#1)
therefore suggested##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
therefore suitable for##2##3##(2008-10#1)(2008-4#1)
therefore tested the##2##3##(2008-1#1)(2010-10#1)
therefore that the##6##3##(1990-5#1)(1990-8#1)(1991-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
therefore that##10##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1995-11#1)(2008-10#2)(2008-5#1)(2010-2#1)(2013-1#1)
therefore the prosthesis##2##3##(1991-2#2)
therefore the##28##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#1)(2010-3#1)(2013-8#1)
therefore they##4##2##(2008-2#1)(2008-3#1)(2011-2#2)
therefore this##2##2##(1993-9#1)(1995-8#1)
therefore to##9##2##(1990-5#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-8#1)
therefore used##3##2##(1994-6#1)(1995-11#1)(2008-6#1)
therefore with##2##2##(2008-10#1)(2008-2#1)
therefore##927##1##(1990-10#2)(1990-11#7)(1990-12#7)(1990-2#3)(1990-3#7)(1990-4#2)(1990-5#10)(1990-7#3)(1990-8#8)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#3)(1991-9#3)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#4)(1994-8#4)(1994-9#3)(1995-11#7)(1995-12#9)(1995-2#7)(1995-3#2)(1995-5#8)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-2#4)(1996-5#4)(1996-6#3)(1996-7#2)(1997-1#3)(1997-2#1)(1997-3#7)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#5)(2006-10#3)(2006-6#2)(2007-10#1)(2007-11#9)(2007-12#9)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#9)(2008-10#126)(2008-11#45)(2008-12#15)(2008-2#26)(2008-3#34)(2008-4#11)(2008-5#26)(2008-6#18)(2008-7#36)(2008-8#26)(2008-9#38)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#7)(2011-1#6)(2011-2#41)(2011-3#3)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#21)(2012-3#16)(2012-6#1)(2012-7#2)(2013-1#27)(2013-8#13)
therefrom##2##1##(2008-3#1)(2008-8#1)
therein##5##1##(1992-3#1)(1994-8#1)(2008-3#1)(2008-4#1)(2008-9#1)
therelative##2##1##(2008-11#2)
thereof are##2##2##(1995-2#1)(2011-1#1)
thereof##27##1##(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
thermal (85)Rb vapor##3##3##(2007-11#3)
thermal ablation of##2##3##(2010-8#1)(2012-12#1)
thermal ablation##4##2##(2007-12#1)(2009-4#1)(2010-8#1)(2012-12#1)
thermal acoustics (LITA)##2##3##(2007-12#1)(2008-3#1)
thermal acoustics##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
thermal analgesia and##2##3##(2013-8#2)
thermal analgesia##3##2##(2013-8#3)
thermal analysis of##3##3##(2008-10#3)
thermal analysis##10##2##(2007-11#1)(2008-10#9)
thermal and mechanical##3##3##(2008-2#1)(2008-7#2)
thermal and##18##2##(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#3)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
thermal annealing##5##2##(2007-11#2)(2008-2#2)(2012-2#1)
thermal asymmetric interlaced PCR (TAIL-PCR) technique##2##6##(2008-10#1)(2008-8#1)
thermal behavior of##2##3##(2008-2#1)(2008-9#1)
thermal behavior##3##2##(2007-12#1)(2008-2#1)(2008-9#1)
thermal behaviour##2##2##(2008-10#2)
thermal birefringence##2##2##(2007-11#1)(2008-3#1)
thermal boundary##3##2##(1995-6#1)(2008-3#2)
thermal characteristics of##4##3##(2007-8#1)(2008-2#1)(2008-3#2)
thermal characteristics##5##2##(2007-8#1)(2008-2#1)(2008-3#3)
thermal characterization of##2##3##(2008-3#2)
thermal chopping##2##2##(2008-3#2)
thermal conditions##3##2##(1996-5#1)(2008-6#2)
thermal conductance##2##2##(2008-3#2)
thermal conductivities##3##2##(2008-3#3)
thermal conductivity detector##3##3##(2008-10#2)(2011-1#1)
thermal conductivity of the##2##4##(2008-2#1)(2008-3#1)
thermal conductivity of##4##3##(2008-2#1)(2008-3#3)
thermal conductivity##14##2##(1997-5#1)(2008-10#3)(2008-2#1)(2008-3#7)(2011-1#1)(2013-1#1)
thermal conductivity)##2##2##(2008-3#2)
thermal constraint on activity##2##4##(2008-8#2)
thermal constraints on activity##2##4##(2008-8#2)
thermal constraints##3##2##(2008-8#3)
thermal contribution to the nonlinear refractive index of air at##2##10##(2007-12#2)
thermal control##2##2##(2008-3#2)
thermal cycling##2##2##(2008-2#1)(2011-2#1)
thermal damage##4##2##(1991-2#1)(2008-3#2)(2012-2#1)
thermal decay##2##2##(2007-11#1)(2007-12#1)
thermal decomposition of a##2##4##(2008-10#2)
thermal decomposition of##5##3##(1996-12#1)(2008-10#4)
thermal decomposition##12##2##(1996-12#1)(2007-11#1)(2008-10#9)(2008-6#1)
thermal deformations are##2##3##(2008-3#2)
thermal deformations of mirror##3##4##(2008-3#3)
thermal deformations of##4##3##(2008-3#4)
thermal deformations##7##2##(2008-3#7)
thermal degradation of the##2##4##(2008-10#1)(2008-3#1)
thermal degradation of##3##3##(2008-10#2)(2008-3#1)
thermal degradation##4##2##(2008-10#2)(2008-3#2)
thermal denaturation temperature##2##3##(1992-8#1)(2007-11#1)
thermal denaturation##12##2##(1991-5#1)(1992-8#1)(1993-11#2)(1993-8#2)(1997-2#2)(2007-11#1)(2008-4#1)(2008-9#2)
thermal desorption##10##2##(2008-10#8)(2010-5#2)
thermal detectors##2##2##(2008-3#2)
thermal diffusion##3##2##(2007-12#1)(2008-3#2)
thermal diffusivity##8##2##(2008-3#7)(2013-1#1)
thermal effects in##3##3##(2007-12#1)(2008-2#2)
thermal effects##15##2##(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#5)(2013-1#1)
thermal emission and##2##3##(2008-3#2)
thermal emission from##2##3##(2008-3#2)
thermal emission##7##2##(1991-5#1)(2008-2#1)(2008-3#5)
thermal energy##4##2##(2008-11#1)(2008-3#1)(2009-10#1)(2012-6#1)
thermal equilibrium at##2##3##(2008-3#2)
thermal equilibrium##3##2##(2008-11#1)(2008-3#2)
thermal evaporation##2##2##(2008-2#1)(2008-3#1)
thermal expansion##8##2##(2008-10#1)(2008-2#3)(2008-3#3)(2010-4#1)
thermal fixing of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
thermal fixing##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
thermal fluctuations##3##2##(2008-3#3)
thermal gradient##4##2##(2008-3#3)(2011-2#1)
thermal gradients##3##2##(2008-2#1)(2008-3#2)
thermal gratings##4##2##(2007-12#1)(2008-3#3)
thermal hyperalgesia in##3##3##(1995-12#1)(1996-5#2)
thermal hyperalgesia##10##2##(1995-12#5)(1996-5#4)(2008-7#1)
thermal inactivation of the##2##4##(1995-8#1)(2008-10#1)
thermal inactivation of##6##3##(1995-8#1)(2008-10#4)(2010-4#1)
thermal inactivation##9##2##(1995-2#1)(1995-8#1)(2008-10#6)(2010-4#1)
thermal induced digestion##2##3##(2008-10#2)
thermal infrared detectors##2##3##(2007-11#2)
thermal infrared##9##2##(2007-11#2)(2008-3#7)
thermal initiation##5##2##(2008-10#5)
thermal injury##7##2##(1995-1#1)(2008-9#6)
thermal ionization mass spectrometry##4##4##(1992-3#1)(1992-7#1)(2008-10#2)
thermal lens (TL)##2##3##(2008-3#2)
thermal lens and##4##3##(2008-2#1)(2008-3#3)
thermal lens effect##2##3##(2008-2#1)(2008-3#1)
thermal lens spectrometer##4##3##(2008-10#3)(2008-2#1)
thermal lens spectrometry (TLS)##2##4##(2008-10#2)
thermal lens spectrometry##8##3##(2008-10#8)
thermal lens##32##2##(2008-10#13)(2008-2#7)(2008-3#12)
thermal lensing and##2##3##(2007-11#1)(2008-3#1)
thermal lensing effect##4##3##(2008-2#2)(2008-3#2)
thermal lensing in##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
thermal lensing##29##2##(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#6)(2008-3#13)
thermal loading in##4##3##(2008-2#3)(2008-3#1)
thermal loading##10##2##(2008-2#7)(2008-3#3)
thermal luminescence##2##2##(2008-3#2)
thermal melting##2##2##(1993-8#1)(1995-2#1)
thermal method of##2##3##(2008-10#1)(2013-1#1)
thermal model##2##2##(2008-3#2)
thermal noise##4##2##(1991-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
thermal nonlinearities##3##2##(2007-12#2)(2008-3#1)
thermal offset##3##2##(2008-3#3)
thermal or mechanical##2##3##(2008-10#1)(2008-7#1)
thermal or##6##2##(1994-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-9#1)
thermal oxidation of##2##3##(2008-10#2)
thermal parameters##3##2##(2008-3#2)(2013-1#1)
thermal phase behaviour of##2##4##(1994-3#2)
thermal phase##4##2##(1994-3#2)(2007-12#1)(2008-10#1)
thermal poling##2##2##(2007-11#1)(2007-12#1)
thermal preferences##2##2##(2011-2#2)
thermal probe##2##2##(2008-2#1)(2013-8#1)
thermal process##2##2##(2011-2#2)
thermal processing of##2##3##(2011-2#2)
thermal processing##5##2##(2008-2#1)(2011-2#4)
thermal profiles##2##2##(2008-3#1)(2008-5#1)
thermal properties of##2##3##(2008-3#2)
thermal properties##5##2##(2008-3#4)(2009-3#1)
thermal reaction##3##2##(2008-10#2)(2008-3#1)
thermal refractive-index coefficients of 7##2##5##(2008-2#2)
thermal requirements##3##2##(2008-6#2)(2008-8#1)
thermal resistance##2##2##(2007-12#1)(2008-12#1)
thermal response##2##2##(1990-7#1)(2007-10#1)
thermal sensitivity##2##2##(2008-7#1)(2008-8#1)
thermal shift##2##2##(2007-12#2)
thermal stabilisation##2##2##(2008-10#2)
thermal stability and##3##3##(1994-8#1)(2008-2#1)(2011-1#1)
thermal stability of the##4##4##(1993-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
thermal stability of##15##3##(1993-6#1)(1995-2#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#2)(2011-1#1)(2011-2#1)
thermal stability##32##2##(1993-6#1)(1994-8#2)(1995-2#1)(1995-8#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#2)(2011-1#4)(2011-2#2)(2012-2#1)
thermal stabilization of tellurium in graphite furnaces##2##7##(2008-10#2)
thermal stabilization of##4##3##(2008-10#4)
thermal stabilization##5##2##(2008-10#5)
thermal stress##4##2##(1990-2#1)(1994-11#2)(2012-2#1)
thermal time##2##2##(2008-10#2)
thermal transients##2##2##(2007-12#2)
thermal treatment##3##2##(1996-5#1)(2007-11#1)(2008-10#1)
thermal unfolding##3##2##(1997-2#3)
thermal##613##1##(1990-2#2)(1990-7#3)(1991-1#1)(1991-2#3)(1991-5#2)(1992-12#1)(1992-3#2)(1992-7#3)(1992-8#2)(1993-11#2)(1993-6#1)(1993-8#4)(1994-11#3)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#5)(1995-2#5)(1995-6#1)(1995-8#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#7)(1996-6#1)(1997-2#5)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#26)(2007-12#36)(2007-8#1)(2008-1#1)(2008-10#123)(2008-11#4)(2008-12#1)(2008-2#65)(2008-3#167)(2008-4#4)(2008-5#4)(2008-6#8)(2008-7#7)(2008-8#13)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-4#4)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#17)(2012-12#2)(2012-2#7)(2012-6#1)(2013-1#8)(2013-8#7)
thermal-expansion coefficient##2##2##(2007-11#1)(2008-3#1)
thermal-induced mask##2##2##(2008-2#2)
thermal-lens technique##2##2##(2007-12#2)
thermal-lens##8##1##(2007-12#3)(2008-10#2)(2008-3#3)
thermal-lensing##2##1##(2007-11#1)(2008-3#1)
thermal-mending##2##1##(2010-4#2)
thermally activated##3##2##(2008-3#1)(2008-7#1)(2011-1#1)
thermally boosted pumping##2##3##(2008-3#2)
thermally denatured##3##2##(1995-3#1)(2008-10#2)
thermally desorbed##4##2##(2008-10#3)(2010-5#1)
thermally evaporated##3##2##(2008-2#2)(2009-12#1)
thermally excited##2##2##(2008-3#2)
thermally induced birefringence in##2##4##(2007-12#1)(2008-3#1)
thermally induced birefringence##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
thermally induced##18##2##(1992-6#1)(1994-5#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#8)
thermally overexpanded fiber##2##3##(2008-2#2)
thermally poled##5##2##(2007-11#2)(2007-12#3)
thermally stable##2##2##(1996-2#1)(2008-10#1)
thermally stimulated##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
thermally##74##1##(1990-7#1)(1992-6#1)(1994-5#1)(1995-3#1)(1996-2#2)(2007-11#4)(2007-12#8)(2008-10#16)(2008-2#13)(2008-3#17)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#2)
thermionic##2##1##(1992-8#1)(2009-6#1)
thermistor##2##1##(2008-10#1)(2008-3#1)
thermistors##2##1##(2008-3#2)
thermo##4##1##(2008-10#2)(2011-2#1)(2013-8#1)
thermo-chemical pre-treatments##3##2##(2013-1#3)
thermo-chemical##4##1##(2013-1#4)
thermo-optic effect##3##2##(2007-11#1)(2008-3#2)
thermo-optic phase shifters##2##3##(2008-2#2)
thermo-optic##12##1##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#4)
thermo-optical properties##3##2##(2008-3#3)
thermo-optical##6##1##(2008-10#1)(2008-2#1)(2008-3#4)
thermo-sensitive genic male-sterile##2##3##(2008-8#2)
thermoTRP channels##2##2##(2008-7#2)
thermocellum cell extracts##2##3##(2008-6#2)
thermocellum##10##1##(1991-5#3)(2008-6#4)(2013-1#3)
thermochemolysis##2##1##(2013-1#2)
thermocouple measurements##3##2##(2008-2#1)(2008-3#2)
thermocouple##10##1##(2008-10#2)(2008-2#2)(2008-3#5)(2009-11#1)
thermocycling##2##1##(1997-6#1)(2008-12#1)
thermodynamic activation parameters##2##3##(1992-3#1)(2008-10#1)
thermodynamic analysis of##3##3##(1997-2#2)(2007-12#1)
thermodynamic analysis##5##2##(1990-7#1)(1993-8#1)(1997-2#2)(2007-12#1)
thermodynamic and kinetic constants##2##4##(2008-10#2)
thermodynamic and kinetic parameters##2##4##(1993-8#1)(2008-4#1)
thermodynamic and kinetic##5##3##(1993-8#1)(2008-10#2)(2008-4#1)(2009-11#1)
thermodynamic and##8##2##(1993-8#1)(2008-10#4)(2008-4#1)(2009-11#1)(2009-9#1)
thermodynamic characteristics##3##2##(1993-8#1)(2008-10#2)
thermodynamic constants of##2##3##(2008-10#2)
thermodynamic constants##3##2##(2008-10#3)
thermodynamic control##2##2##(2013-1#2)
thermodynamic data##9##2##(1991-6#1)(2008-10#8)
thermodynamic dissociation constant##3##3##(2008-10#3)
thermodynamic dissociation##4##2##(2008-10#4)
thermodynamic driving force##2##3##(2009-11#1)(2009-7#1)
thermodynamic effect##2##2##(1990-8#1)(2008-8#1)
thermodynamic effects of##2##3##(1990-8#1)(1995-5#1)
thermodynamic equilibrium##8##2##(1995-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#1)
thermodynamic functions of##2##3##(1992-5#1)(2008-10#1)
thermodynamic functions##3##2##(1992-5#1)(2008-10#2)
thermodynamic limit##3##2##(2008-3#3)
thermodynamic measurements##2##2##(2008-1#1)(2008-10#1)
thermodynamic methods##2##2##(1995-6#1)(2009-11#1)
thermodynamic model of inorganic arsenic##3##5##(2008-10#3)
thermodynamic model##5##2##(2008-10#5)
thermodynamic parameters and##2##3##(1996-2#1)(2008-10#1)
thermodynamic parameters associated##2##3##(1995-5#1)(2008-10#1)
thermodynamic parameters for the##3##4##(1992-3#1)(1997-2#1)(2008-10#1)
thermodynamic parameters for##6##3##(1992-3#1)(1997-2#1)(2008-10#4)
thermodynamic parameters of##4##3##(1992-3#1)(2008-10#3)
thermodynamic parameters were calculated##2##4##(2008-10#2)
thermodynamic parameters were##4##3##(1993-8#1)(2008-10#3)
thermodynamic parameters##30##2##(1990-7#2)(1991-8#1)(1992-3#2)(1993-8#1)(1995-5#2)(1996-2#1)(1997-2#1)(2008-10#20)
thermodynamic properties of##3##3##(1990-8#1)(1991-5#1)(2008-10#1)
thermodynamic properties##6##2##(1990-8#1)(1991-5#2)(1992-6#1)(2008-10#2)
thermodynamic quantities##2##2##(2008-10#2)
thermodynamic stability and structure of##2##5##(1995-5#1)(2007-11#1)
thermodynamic stability of##5##3##(1992-3#1)(2008-10#2)(2008-9#1)(2012-2#1)
thermodynamic stability##11##2##(1990-8#1)(1992-3#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-9#2)(2012-1#1)(2012-2#1)
thermodynamic study##3##2##(1990-8#1)(2008-10#2)
thermodynamic theory##2##2##(1990-8#2)
thermodynamic##166##1##(1990-7#3)(1990-8#9)(1990-9#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#4)(1992-5#3)(1992-6#1)(1993-11#3)(1993-8#4)(1994-12#1)(1995-2#1)(1995-5#6)(1995-6#1)(1996-2#2)(1997-2#8)(1997-4#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#75)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
thermodynamical##2##1##(1990-8#1)(1994-12#1)
thermodynamically favored##3##2##(1993-11#1)(2008-7#1)(2009-10#1)
thermodynamically stable##2##2##(2008-9#1)(2012-2#1)
thermodynamically##14##1##(1992-5#1)(1993-11#2)(1994-8#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2012-2#1)
thermodynamics of the##5##3##(1990-8#1)(1991-8#1)(1993-3#1)(2008-10#2)
thermodynamics of##11##2##(1990-8#1)(1991-8#1)(1992-5#1)(1993-3#1)(2008-10#3)(2008-8#2)(2008-9#1)(2010-7#1)
thermodynamics##27##1##(1990-8#2)(1991-8#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-11#2)(1997-2#3)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-7#1)
thermoelastic##4##1##(2007-12#2)(2008-3#2)
thermoelectric##3##1##(2007-11#1)(2008-3#1)(2008-9#1)
thermogenesis and##2##2##(2013-1#2)
thermogenesis in##2##2##(2013-1#2)
thermogenesis##14##1##(1995-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#3)(2012-3#1)(2013-1#5)
thermogenic nutritional supplement##4##3##(2013-8#4)
thermogenic response##2##2##(1994-2#2)
thermogenic##9##1##(1994-2#2)(2008-4#1)(2009-8#1)(2012-12#1)(2013-8#4)
thermogram##4##1##(1993-11#3)(2008-10#1)
thermograms##10##1##(1990-7#2)(1993-11#6)(1997-7#1)(2011-3#1)
thermographic results##5##2##(1993-11#5)
thermographic##9##1##(1990-6#1)(1993-11#6)(2008-3#2)
thermography in##2##2##(1990-2#1)(2008-10#1)
thermography is##2##2##(1993-11#2)
thermography##12##1##(1990-2#3)(1993-11#3)(1994-5#2)(2008-10#2)(2008-5#1)(2011-1#1)
thermogravimetric analysis (TGA) and##3##4##(2008-10#2)(2009-3#1)
thermogravimetric analysis (TGA)##6##3##(2008-10#5)(2009-3#1)
thermogravimetric analysis##10##2##(1995-11#1)(2008-10#8)(2009-3#1)
thermogravimetric measurements##3##2##(2007-12#1)(2008-10#2)
thermogravimetric##17##1##(1995-11#1)(2007-12#1)(2008-10#13)(2009-3#1)(2010-4#1)
thermogravimetry##2##1##(2007-11#1)(2008-10#1)
thermolabile##6##1##(1992-12#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
thermoluminescence##2##1##(1996-4#1)(1997-8#1)
thermoluminescent dosimeters##3##2##(1995-9#1)(2007-10#2)
thermolysin have been##2##3##(1994-5#2)
thermolysin##9##1##(1993-8#1)(1994-5#8)
thermolysis##4##1##(1996-5#1)(2008-10#2)(2010-5#1)
thermolytic##5##1##(2008-10#1)(2008-4#4)
thermomechanical##2##1##(1991-3#1)(2008-6#1)
thermometer is##2##2##(2008-2#2)
thermometer ranging from 20##2##4##(2008-2#2)
thermometer##13##1##(2008-2#7)(2010-5#4)(2013-1#1)(2013-7#1)
thermometers##4##1##(2008-2#1)(2011-2#1)(2013-1#2)
thermometry is##2##2##(2008-3#2)
thermometry##9##1##(1992-7#1)(1992-8#1)(2008-2#3)(2008-3#4)
thermooptical##2##1##(2008-10#1)(2008-3#1)
thermophila##9##1##(1994-12#3)(2008-10#1)(2008-3#3)(2012-3#2)
thermophile##2##1##(1992-11#1)(2011-2#1)
thermophilic bacterium##2##2##(1994-12#1)(2013-1#1)
thermophilic genus##2##2##(2011-2#2)
thermophilic##16##1##(1990-3#1)(1990-7#1)(1994-11#1)(1994-12#1)(1996-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#4)(2013-1#3)
thermophilus##3##1##(1990-7#3)
thermoplastic##2##1##(2008-3#1)(2012-12#1)
thermoreflectance data##2##2##(2008-3#2)
thermoregulation in##2##2##(2009-8#1)(2011-2#1)
thermoregulation##15##1##(1992-3#1)(2007-10#1)(2008-5#1)(2008-9#2)(2009-8#3)(2011-2#6)(2013-1#1)
thermoregulatory effects of##2##3##(1994-2#2)
thermoregulatory responses##2##2##(1992-3#2)
thermoregulatory##9##1##(1992-3#2)(1994-2#5)(1997-6#1)(2007-10#1)
thermosensitive TRP##2##2##(2013-1#2)
thermosensitive ion channels##2##3##(2013-1#2)
thermosensitive##6##1##(2007-12#2)(2013-1#4)
thermosensitivity of##2##2##(1994-8#1)(2008-8#1)
thermosensitivity##3##1##(1994-8#1)(1995-8#1)(2008-8#1)
thermospray flame furnace atomic absorption spectrometry##2##6##(2008-10#2)
thermostabilities##3##1##(1990-8#1)(1992-8#2)
thermostability of proteins##2##3##(1991-5#1)(1997-4#1)
thermostability of##7##2##(1991-5#1)(1992-8#1)(1997-4#2)(2008-10#1)(2010-9#1)(2011-1#1)
thermostability##13##1##(1991-5#1)(1992-8#1)(1995-5#1)(1997-4#3)(2008-10#3)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
thermostable D-hydantoinase##2##2##(2008-7#2)
thermostable DNA##3##2##(1995-8#1)(2008-2#1)(2008-9#1)
thermostable alpha-amylase from Bacillus licheniformis##3##5##(1997-4#3)
thermostable alpha-amylase##4##2##(1997-4#3)(2008-7#1)
thermostable enzyme##2##2##(1994-12#1)(2008-10#1)
thermostable polymerase##2##2##(1994-11#1)(1995-8#1)
thermostable##21##1##(1994-11#1)(1994-12#1)(1995-12#1)(1995-8#2)(1997-4#3)(2008-10#3)(2008-2#1)(2008-7#3)(2008-9#2)(2011-1#2)(2011-2#1)(2013-1#1)
thermotherapy##5##1##(2008-10#1)(2008-12#1)(2008-2#3)
thermotolerance development in##2##3##(1994-8#2)
thermotolerance development##3##2##(1994-8#3)
thermotolerance##6##1##(1994-8#3)(1995-8#2)(2011-2#1)
thermotolerant##3##1##(1995-8#2)(2008-6#1)
thermotropic phase behavior of##2##4##(1990-7#1)(1993-8#1)
thermotropic phase behavior##4##3##(1990-7#2)(1993-8#1)(2008-8#1)
thermotropic##7##1##(1990-7#2)(1993-8#1)(2008-10#2)(2008-5#1)(2008-8#1)
thesame##2##1##(2008-11#1)(2008-2#1)
thesaurus##2##1##(1996-3#1)(2008-7#1)
these &quot##4##2##(1990-4#1)(2008-1#1)(2008-10#1)(2009-7#1)
these 1##2##2##(1996-5#1)(2007-11#1)
these 10##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
these 16 patients##2##3##(1997-8#1)(2007-7#1)
these 2##10##2##(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1997-2#1)(2008-7#1)(2009-1#1)(2011-2#1)(2013-7#1)
these 3##3##2##(1990-6#1)(1991-3#1)(2009-11#1)
these 3'##2##2##(2007-12#1)(2008-4#1)
these 4##2##2##(2008-7#1)(2009-12#1)
these 44##2##2##(2008-6#1)(2013-1#1)
these 5 patients##2##3##(1991-11#1)(1992-9#1)
these 5##3##2##(1991-11#1)(1992-9#1)(2011-2#1)
these 6##3##2##(1991-9#1)(2008-12#1)(2013-1#1)
these Alu##2##2##(1991-5#1)(1995-3#1)
these BI-BS-resistant isolates##2##3##(2008-10#2)
these BSC's are##2##3##(2008-2#1)(2008-3#1)
these BSC's##3##2##(2008-2#1)(2008-3#2)
these CFC replacements##2##3##(1992-3#2)
these DNA##4##2##(1995-5#1)(1995-6#1)(2008-10#2)
these DNA-lipids##2##2##(2008-10#2)
these GIS projects##2##3##(2008-8#2)
these MDIs##2##2##(1992-3#1)(1996-1#1)
these NPs can be##2##4##(2010-5#1)(2012-6#1)
these NPs##3##2##(2010-5#2)(2012-6#1)
these ORFs##6##2##(1991-9#1)(1995-12#1)(1995-9#1)(1997-3#2)(2008-10#1)
these PCR products##2##3##(2008-10#2)
these PCR##4##2##(1991-9#1)(2008-10#2)(2008-12#1)
these QTL##4##2##(2008-10#1)(2009-5#1)(2011-1#1)(2012-3#1)
these RNAs##3##2##(1991-2#1)(1997-3#1)(2008-10#1)
these SNPs##2##2##(2008-11#1)(2012-3#1)
these abnormalities##8##2##(1993-8#1)(1996-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)
these absorption##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
these achievements##2##2##(2008-12#1)(2010-8#1)
these acids were##2##3##(2007-11#1)(2008-5#1)
these actions of##2##3##(2008-11#1)(2008-8#1)
these actions##8##2##(1994-11#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-2#1)
these active##2##2##(2008-10#1)(2008-5#1)
these activities and##2##3##(1994-2#1)(2011-2#1)
these activities##20##2##(1990-11#1)(1991-1#1)(1991-5#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
these adducts##3##2##(1994-5#1)(1994-8#1)(2008-12#1)
these advances##7##2##(2008-10#1)(2008-3#2)(2010-3#1)(2010-6#1)(2012-2#1)(2013-8#1)
these adverse##7##2##(1991-11#1)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#2)
these age-related##2##2##(1991-12#1)(2012-3#1)
these agents are##6##3##(1990-2#1)(1991-3#1)(1993-11#1)(2008-7#1)(2013-1#2)
these agents at##2##3##(1992-12#1)(2008-10#1)
these agents has##3##3##(1990-2#1)(2007-12#1)(2011-2#1)
these agents have##3##3##(2006-10#1)(2007-11#1)(2008-8#1)
these agents in##7##3##(1995-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-4#1)
these agents is##3##3##(2007-4#1)(2008-3#1)(2010-3#1)
these agents were##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
these agents##76##2##(1990-2#6)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-3#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
these ages##2##2##(1993-12#1)(2008-9#1)
these agonists##3##2##(1993-6#1)(1995-11#1)(1996-9#1)
these aims##5##2##(2008-11#2)(2010-8#1)(2011-2#1)(2012-2#1)
these alcohols##2##2##(1992-6#1)(1995-2#1)
these algorithms##2##2##(2008-3#1)(2008-9#1)
these alkaloids##2##2##(2008-10#1)(2011-3#1)
these allegations##6##2##(2008-10#6)
these alleles##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
these alterations in##2##3##(1996-12#1)(2008-2#1)
these alterations##16##2##(1990-2#1)(1991-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#1)
these altered##2##2##(1995-2#1)(1995-5#1)
these alternative outcomes may##2##4##(2008-8#2)
these alternative##5##2##(2008-10#1)(2008-8#2)(2010-11#1)(2010-4#1)
these amino##4##2##(1990-5#1)(1995-6#1)(2008-10#2)
these analyses are##2##3##(1994-1#1)(2008-10#1)
these analyses##16##2##(1992-6#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-5#1)
these analytes##9##2##(1996-5#2)(2008-10#7)
these analytical##2##2##(2008-10#1)(2008-3#1)
these anatomical##2##2##(2008-6#1)(2011-2#1)
these and other issues##2##4##(1995-12#1)(2008-12#1)
these and other questions##3##4##(1992-12#1)(2008-3#1)(2012-2#1)
these and other##20##3##(1992-12#1)(1992-2#1)(1992-9#2)(1995-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
these and the##3##3##(2008-10#1)(2009-4#1)(2013-8#1)
these and##35##2##(1990-5#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
these angiogenic inhibitors##2##3##(2008-1#2)
these animals are##2##3##(1994-5#1)(2008-5#1)
these animals##21##2##(1990-5#1)(1991-12#1)(1992-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-3#1)(1996-12#4)(1996-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#2)(2010-6#1)
these anions##3##2##(1990-8#1)(1991-8#1)(2008-10#1)
these anisotropic##2##2##(2007-12#1)(2008-10#1)
these antibiotics##4##2##(2007-7#1)(2008-10#2)(2008-11#1)
these antibodies are##3##3##(1991-2#1)(1995-12#1)(2008-10#1)
these antibodies##19##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-11#2)(1997-7#2)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
these antiestrogen binding sites##2##4##(2008-11#2)
these antigens in##2##3##(1994-7#1)(2011-2#1)
these antigens##6##2##(1994-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)
these antioxidants##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
these apparently##2##2##(1993-12#1)(2011-2#1)
these applications##5##2##(1997-7#1)(2008-1#1)(2008-11#1)(2010-12#1)(2012-2#1)
these approaches are##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2010-5#1)
these approaches to##3##3##(1995-5#1)(2008-11#1)(2008-7#1)
these approaches##24##2##(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2012-2#2)(2013-1#2)(2013-8#1)
these are also##2##3##(2008-10#1)(2008-7#1)
these are discussed##3##3##(1993-3#1)(2008-1#1)(2012-2#1)
these are due##2##3##(1995-12#1)(2008-4#1)
these are important##3##3##(2008-10#1)(2009-12#1)(2010-10#1)
these are not##2##3##(2008-10#1)(2010-9#1)
these are present##2##3##(1990-5#1)(2008-10#1)
these are the##5##3##(1995-2#1)(2010-11#1)(2011-2#1)(2012-2#2)
these are##67##2##(1990-10#1)(1990-5#1)(1991-3#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-11#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#7)(2012-3#1)(2013-7#1)(2013-8#1)
these areas and##2##3##(2008-11#1)(2010-10#1)
these areas requires##2##3##(2008-4#1)(2008-9#1)
these areas were##3##3##(1997-2#1)(2011-1#1)(2013-7#1)
these areas##36##2##(1992-1#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
these arrangements##3##2##(1993-1#1)(1996-3#1)(1997-2#1)
these arrays##2##2##(2008-3#1)(2008-8#1)
these articles##4##2##(1994-12#1)(1997-2#1)(2011-2#1)(2013-1#1)
these as##3##2##(2008-12#1)(2008-5#1)(2012-12#1)
these aspects of##3##3##(2007-12#2)(2008-11#1)
these aspects##9##2##(2007-12#2)(2008-10#3)(2008-11#2)(2011-2#1)(2013-1#1)
these assay##2##2##(1991-2#1)(2008-4#1)
these assays is##2##3##(2008-9#2)
these assays may also be used to determine the concentration of a particular chemical##2##14##(2008-4#1)(2008-9#1)
these assays provide##3##3##(2008-4#2)(2008-9#1)
these assays##24##2##(1992-3#1)(1992-9#1)(1996-12#1)(1997-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#4)(2008-9#6)(2011-1#1)
these assessments##4##2##(1995-5#1)(2007-12#1)(2008-11#1)(2013-8#1)
these associations are##2##3##(2008-4#1)(2013-8#1)
these associations have##2##3##(2008-1#1)(2008-4#1)
these associations is##2##3##(1997-2#1)(2012-12#1)
these associations were between##2##4##(2008-10#2)
these associations were##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
these associations##16##2##(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-4#2)(2009-7#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
these assumptions##4##2##(1995-1#1)(2008-2#1)(2008-3#1)(2008-9#1)
these attacks##2##2##(2011-2#1)(2012-2#1)
these attitudes##3##2##(1990-11#1)(1996-2#1)(2010-10#1)
these attributes##4##2##(1994-3#1)(2008-10#1)(2008-8#1)(2009-12#1)
these atypical##2##2##(2007-11#1)(2011-1#1)
these authors##2##2##(2008-4#1)(2009-3#1)
these averages##2##2##(1996-6#1)(2008-10#1)
these background##2##2##(2008-2#1)(2008-3#1)
these bacteria were not##2##4##(2008-10#1)(2008-11#1)
these bacteria were##4##3##(1993-2#1)(2008-10#2)(2008-11#1)
these bacteria##17##2##(1993-2#1)(1997-2#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-9#2)(2011-2#1)
these bands##8##2##(1995-5#1)(1996-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)
these barriers##8##2##(1994-11#1)(2008-10#1)(2009-11#1)(2010-11#2)(2011-1#1)(2013-1#2)
these basic##3##2##(1993-12#1)(1994-6#1)(2008-11#1)
these beams##3##2##(2007-12#2)(2008-2#1)
these behaviors##9##2##(1993-6#1)(1994-2#1)(2008-4#3)(2009-4#1)(2010-9#1)(2012-12#1)(2013-1#1)
these being##3##2##(1995-2#1)(2011-1#1)(2011-2#1)
these beneficial effects##2##3##(2008-7#2)
these benefits are##2##3##(1997-8#1)(2008-10#1)
these benefits##10##2##(1991-8#1)(1995-1#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-1#1)
these biases##3##2##(1997-5#1)(2008-8#1)(2012-12#1)
these binding sites##2##3##(1990-5#1)(1995-8#1)
these binding##5##2##(1990-5#1)(1994-8#1)(1995-8#1)(2010-7#1)(2011-2#1)
these biogeological##2##2##(1995-3#2)
these biological##6##2##(2008-10#1)(2008-11#1)(2008-4#2)(2010-6#1)(2011-2#1)
these brain areas##2##3##(1991-2#1)(1994-3#1)
these brain regions are##2##4##(2010-5#1)(2010-6#1)
these brain regions##3##3##(2008-6#1)(2010-5#1)(2010-6#1)
these brain##6##2##(1991-2#1)(1994-3#1)(2007-8#1)(2008-6#1)(2010-5#1)(2010-6#1)
these cDNA clones##4##3##(1990-12#1)(1993-11#1)(2008-11#1)(2008-8#1)
these cDNAs are##2##3##(1993-6#1)(1993-8#1)
these cDNAs##5##2##(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)
these calculations##4##2##(2008-2#1)(2008-3#3)
these calibration##3##2##(2008-10#2)(2008-3#1)
these campaigns##3##2##(2008-3#1)(2008-9#2)
these can be##6##3##(1995-3#1)(2006-10#1)(2008-3#1)(2008-5#2)(2012-2#1)
these can##13##2##(1995-12#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
these cancers##5##2##(1990-8#1)(2008-11#1)(2008-4#2)(2013-1#1)
these candidates is selected using information from silent amino acid substitutions##2##11##(2008-4#2)
these carbohydrate groups##2##3##(1993-8#2)
these carbohydrate##3##2##(1993-11#1)(1993-8#2)
these case reports##2##3##(2008-11#1)(2011-2#1)
these case studies##2##3##(2008-10#1)(2008-11#1)
these case##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
these cases and##3##3##(1992-2#1)(2008-11#1)(2012-12#1)
these cases should be##2##4##(2008-10#1)(2010-8#1)
these cases should##3##3##(2007-7#1)(2008-10#1)(2010-8#1)
these cases the##6##3##(1994-9#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-8#1)
these cases##71##2##(1990-6#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-6#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
these catalysts##2##2##(2013-1#2)
these categories of##2##3##(1995-6#1)(2008-11#1)
these categories##8##2##(1991-2#1)(1995-6#1)(2007-4#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-3#1)
these cations##3##2##(1990-2#1)(1990-7#1)(2008-10#1)
these cell lines are##2##4##(1992-4#1)(2008-4#1)
these cell lines##12##3##(1990-5#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-6#1)(1995-6#1)(2008-11#2)(2008-4#1)
these cell types##4##3##(1991-9#1)(2008-4#1)(2008-7#1)(2012-2#1)
these cell##22##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-6#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-7#1)(2010-3#1)(2012-2#1)
these cells after##2##3##(1995-3#1)(1996-5#1)
these cells and##4##3##(1993-12#1)(1994-11#1)(2008-10#1)(2012-1#1)
these cells are##6##3##(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)
these cells could##2##3##(2008-10#1)(2013-1#1)
these cells have##3##3##(2008-7#1)(2008-9#2)
these cells in a##3##4##(2008-11#2)(2010-1#1)
these cells in the##4##4##(1992-9#2)(1996-12#1)(2009-5#1)
these cells in##13##3##(1991-2#1)(1992-9#2)(1995-2#1)(1996-12#1)(1997-8#1)(2008-11#2)(2009-5#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
these cells into##2##3##(2008-3#1)(2008-9#1)
these cells is##4##3##(1992-12#1)(1994-12#1)(1994-9#1)(2008-11#1)
these cells may##3##3##(1990-8#1)(2008-9#1)(2010-1#1)
these cells produce##2##3##(1996-9#1)(2008-9#1)
these cells represents##2##3##(2008-6#1)(2008-9#1)
these cells showed that##2##4##(1995-6#1)(2008-7#1)
these cells showed##3##3##(1994-9#1)(1995-6#1)(2008-7#1)
these cells that##3##3##(1995-2#1)(2008-11#1)(2010-11#1)
these cells to##5##3##(1993-5#1)(1994-11#1)(1996-2#1)(2008-10#1)(2009-3#1)
these cells was##5##3##(1991-6#1)(1992-9#1)(1994-6#1)(1995-8#1)(2008-8#1)
these cells were shown to##2##5##(2008-8#1)(2013-1#1)
these cells were##13##3##(1992-12#1)(1992-6#1)(1993-3#1)(1996-12#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
these cells with##6##3##(1991-9#1)(1992-9#1)(1993-6#1)(1995-12#1)(2008-11#1)(2008-8#1)
these cells##204##2##(1990-11#1)(1990-12#2)(1990-2#5)(1990-5#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#5)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#5)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#4)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#1)(1995-6#3)(1995-8#3)(1996-12#3)(1996-2#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#27)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#7)(2008-9#11)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
these cellular##5##2##(1990-11#1)(1992-11#1)(1995-2#1)(2011-1#1)(2012-12#1)
these centers##3##2##(1996-12#1)(1997-2#1)(2008-1#1)
these challenges##25##2##(1994-12#1)(1995-1#1)(1996-2#2)(1997-1#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-10#1)(2009-12#2)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
these challenging##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
these changes and the##2##4##(2012-2#1)(2013-8#1)
these changes and##4##3##(1991-3#1)(2009-8#1)(2012-2#1)(2013-8#1)
these changes are##4##3##(1992-6#1)(2007-10#1)(2012-2#1)(2013-8#1)
these changes can be##2##4##(2007-12#1)(2009-9#1)
these changes can##3##3##(1991-2#1)(2007-12#1)(2009-9#1)
these changes could be##2##4##(1995-12#1)(2008-3#1)
these changes in the##4##4##(1990-2#1)(1992-3#1)(2007-11#1)(2007-8#1)
these changes in##11##3##(1990-12#1)(1990-2#1)(1990-3#1)(1992-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
these changes is the##2##4##(1995-1#1)(2007-10#1)
these changes occurred##4##3##(1994-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
these changes on##3##3##(1992-1#1)(2007-11#1)(2010-2#1)
these changes to##2##3##(2008-10#1)(2008-9#1)
these changes were not##2##4##(2011-1#1)(2012-1#1)
these changes were##7##3##(1993-11#1)(1996-12#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-1#1)
these changes##74##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#2)(2009-9#2)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#2)(2013-7#1)(2013-8#2)
these channels in##2##3##(1994-11#1)(2008-8#1)
these channels##12##2##(1994-11#3)(1994-2#1)(1995-11#1)(2008-5#2)(2008-7#1)(2008-8#4)
these characteristics at##2##3##(2008-2#1)(2008-7#1)
these characteristics of##2##3##(2007-11#1)(2007-12#1)
these characteristics##20##2##(1991-3#1)(1996-10#1)(1996-2#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#1)
these characters##3##2##(2007-1#1)(2008-8#1)(2008-9#1)
these chemical##2##2##(2008-10#1)(2008-2#1)
these chemicals in##3##3##(1993-3#1)(2008-10#2)
these chemicals##14##2##(1993-3#1)(2008-10#9)(2008-11#3)(2008-2#1)
these children and##3##3##(1995-3#1)(2008-11#1)(2008-4#1)
these children was##2##3##(2008-2#1)(2008-6#1)
these children were##3##3##(1990-12#1)(1993-12#1)(1996-1#1)
these children##28##2##(1990-12#1)(1990-2#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-9#1)(2010-2#1)(2011-2#5)
these chiral##3##2##(2008-3#1)(2009-10#2)
these chromosomes##5##2##(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2008-7#1)
these circumstances the##2##3##(1990-8#1)(1993-12#1)
these circumstances##14##2##(1990-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-8#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#2)(2012-12#1)
these claims##2##2##(2009-2#1)(2013-8#1)
these classes##4##2##(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)
these clients##2##2##(2011-1#1)(2012-2#1)
these clinical##9##2##(1994-12#1)(1997-2#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-7#2)
these clinically##3##2##(1995-2#1)(2009-10#1)(2009-5#1)
these clonal##2##2##(2008-10#1)(2008-6#1)
these clones##6##2##(1991-12#1)(1996-6#1)(1997-4#1)(1997-8#2)(2008-11#1)
these clusters are##3##3##(1993-11#1)(1997-8#1)(2008-10#1)
these clusters##9##2##(1993-11#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
these coated##2##2##(1995-2#1)(2008-10#1)
these coatings##2##2##(2008-2#1)(2008-3#1)
these coefficients##2##2##(2008-2#1)(2008-3#1)
these cohorts of##2##3##(2013-1#2)
these cohorts##4##2##(2007-7#1)(2008-10#1)(2013-1#2)
these colonies##3##2##(2008-10#2)(2009-8#1)
these columns##2##2##(1997-3#1)(2008-10#1)
these combinations##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
these common##5##2##(1991-5#1)(1993-12#1)(1994-11#1)(2008-7#1)(2009-6#1)
these communications##2##2##(2008-4#2)
these communities##5##2##(2008-10#1)(2008-9#1)(2010-10#1)(2010-9#1)(2013-7#1)
these comparisons##8##2##(1995-1#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
these compartments##4##2##(1996-2#1)(2008-1#1)(2008-4#2)
these complex##7##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-11#1)
these complexes are##3##3##(2008-10#2)(2008-5#1)
these complexes have been determined##2##5##(1992-9#1)(2008-10#1)
these complexes have been##3##4##(1992-9#1)(1997-7#1)(2008-10#1)
these complexes##21##2##(1992-9#2)(1993-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-7#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)
these complications as well as##2##5##(2011-2#1)(2012-12#1)
these complications##12##2##(1991-5#1)(1993-5#1)(1996-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
these components are##2##3##(2008-11#1)(2011-2#1)
these components can##3##3##(2008-10#1)(2010-1#1)(2012-3#1)
these components for##2##3##(2008-8#1)(2011-1#1)
these components to##2##3##(2008-7#1)(2009-7#1)
these components##34##2##(1994-1#1)(1994-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-7#2)(2008-8#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#1)
these compounds and##9##3##(1990-7#2)(2008-10#3)(2008-4#1)(2008-8#1)(2009-8#1)(2010-11#1)
these compounds are##13##3##(1991-9#1)(1992-8#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-8#1)(2012-3#1)(2013-1#2)
these compounds at##2##3##(1993-12#1)(1995-3#1)
these compounds by##2##3##(2008-10#2)
these compounds can be##2##4##(1992-8#1)(2008-10#1)
these compounds can##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
these compounds have##2##3##(1994-3#1)(2011-1#1)
these compounds in##18##3##(1990-12#1)(1990-5#1)(1994-2#1)(2008-10#12)(2008-5#2)(2010-5#1)
these compounds is##2##3##(2008-10#2)
these compounds possess##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
these compounds to##3##3##(1993-11#1)(2008-10#2)
these compounds was determined by##2##5##(2008-10#1)(2012-2#1)
these compounds was found to be##3##6##(1993-11#1)(1995-3#1)(2008-10#1)
these compounds was##15##3##(1993-11#1)(1995-3#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2012-2#1)
these compounds were##14##3##(1990-11#1)(1990-8#1)(1991-5#1)(1993-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#2)
these compounds with##7##3##(1991-5#1)(1992-11#1)(2008-10#2)(2009-7#1)(2009-9#1)(2012-3#1)
these compounds##162##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#3)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-3#3)(1995-5#1)(1995-6#1)(2006-6#1)(2007-11#7)(2008-10#65)(2008-11#8)(2008-4#2)(2008-5#5)(2008-8#4)(2009-10#2)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#3)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)
these computational##2##2##(2008-11#1)(2012-2#1)
these concentrations##4##2##(1996-5#1)(2008-10#1)(2008-11#2)
these concepts are##2##3##(2008-10#1)(2008-9#1)
these concepts to##2##3##(2008-7#1)(2012-2#1)
these concepts##11##2##(1996-1#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
these concerns are##3##3##(2008-12#2)(2008-5#1)
these concerns is##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
these concerns##15##2##(1994-1#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
these conclusions##4##2##(1990-11#1)(1993-12#1)(2008-7#1)(2008-9#1)
these conditions are##7##3##(1991-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#1)
these conditions could##2##3##(2008-10#1)(2008-5#1)
these conditions is##3##3##(1994-2#1)(2009-11#1)(2012-7#1)
these conditions the##5##3##(1993-3#1)(2008-10#3)(2008-3#1)
these conditions were##3##3##(1994-7#1)(2008-8#2)
these conditions##130##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-9#2)(1996-2#1)(1997-2#1)(1997-7#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-2#2)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
these conidia##2##2##(2008-10#2)
these connections##3##2##(1994-8#1)(2008-11#1)(2009-8#1)
these connectors##2##2##(2008-3#2)
these conserved##4##2##(1995-2#1)(1995-6#1)(2012-2#1)(2012-3#1)
these considerations##3##2##(1991-3#1)(1993-12#1)(2011-1#1)
these constants##4##2##(2008-10#4)
these constituents##2##2##(1995-6#1)(2008-7#1)
these constraints##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
these constructs##5##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
these consumers##2##2##(1996-1#1)(2008-8#1)
these contained##2##2##(2008-8#1)(2011-2#1)
these contexts##3##2##(2010-9#1)(2012-12#1)(2012-3#1)
these contrasting##2##2##(2008-11#1)(2013-8#1)
these contributions##3##2##(2008-2#2)(2008-3#1)
these controls##2##2##(1990-3#1)(2008-7#1)
these controversies?##2##2##(2008-11#2)
these conventional##4##2##(2007-11#1)(2009-9#1)(2010-9#1)(2013-1#1)
these correlations were##2##3##(2008-10#1)(2011-10#1)
these correlations##5##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-10#1)
these costs are##2##3##(1992-3#1)(2008-8#1)
these costs##3##2##(1992-3#1)(1995-11#1)(2008-8#1)
these countries##16##2##(1991-4#1)(1992-5#1)(1993-9#1)(1994-12#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
these couplers##3##2##(2007-11#1)(2008-2#2)
these courses are##2##3##(1994-12#1)(1995-1#1)
these courses were##2##3##(1992-12#1)(2013-1#1)
these courses##7##2##(1992-12#1)(1994-12#2)(1995-1#1)(2013-1#3)
these creams##2##2##(2008-5#2)
these criteria are##2##3##(2008-2#1)(2013-8#1)
these criteria##16##2##(1993-8#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
these critical##3##2##(1995-2#1)(2011-1#1)(2013-1#1)
these crops##2##2##(2008-10#2)
these crystals##3##2##(1992-9#1)(2007-11#1)(2008-4#1)
these cultivars##2##2##(2008-10#2)
these cultural##2##2##(1995-1#1)(2008-1#1)
these culture##2##2##(2008-10#1)(2008-9#1)
these cultures were##2##3##(2008-11#2)
these cultures##10##2##(1990-7#1)(1991-5#1)(1995-12#1)(2008-11#5)(2010-2#1)(2013-1#1)
these curricula##2##2##(2008-12#1)(2011-2#1)
these curves##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
these cytokine-secreting vaccines##2##3##(1997-4#2)
these cytokines are##3##3##(1992-8#1)(2006-10#1)(2008-3#1)
these cytokines##8##2##(1990-2#1)(1992-8#1)(1994-11#1)(1996-12#1)(2006-10#2)(2008-3#1)(2008-9#1)
these data a##2##3##(1997-8#1)(2012-12#1)
these data are##5##3##(1997-2#1)(2008-4#2)(2009-4#1)(2013-1#1)
these data as##2##3##(1994-6#1)(2008-10#1)
these data can##2##3##(1993-12#1)(2008-3#1)
these data demonstrate that##4##4##(1995-12#1)(1997-1#1)(2008-4#1)(2009-6#1)
these data highlight##2##3##(2012-2#1)(2013-8#1)
these data indicate that##5##4##(1994-5#1)(1997-2#1)(2007-10#1)(2008-4#2)
these data is##5##3##(1993-11#1)(1995-9#1)(2007-12#1)(2008-4#1)(2013-1#1)
these data provide evidence that##2##5##(2008-10#1)(2008-9#1)
these data provide evidence##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
these data provide##5##3##(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
these data show that##2##4##(2008-5#1)(2008-7#1)
these data show##4##3##(1991-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
these data suggest that##12##4##(1990-7#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
these data suggest##14##3##(1990-7#1)(1990-8#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
these data support##3##3##(1993-12#1)(1994-2#1)(1994-8#1)
these data the##4##3##(1990-7#1)(1997-4#1)(2008-3#1)(2012-3#1)
these data to##6##3##(1994-2#1)(1995-3#1)(1996-12#1)(2008-3#1)(2008-8#2)
these data we##3##3##(1996-6#1)(2007-11#1)(2012-2#1)
these data will##3##3##(1992-12#1)(2008-4#1)(2010-9#1)
these data with##2##3##(1992-10#1)(2008-7#1)
these data##129##2##(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-12#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-9#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
these databases##5##2##(1997-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)
these days##3##2##(2007-9#1)(2008-12#1)(2008-5#1)
these deaths##3##2##(1990-6#1)(1992-6#1)(2010-8#1)
these decisions##5##2##(1993-2#1)(1994-3#2)(2008-5#1)(2010-3#1)
these deficits are##2##3##(1993-12#1)(2012-1#1)
these deficits##4##2##(1992-11#1)(1993-12#1)(2008-7#1)(2012-1#1)
these deformities##2##2##(2007-12#1)(2010-11#1)
these derivatives##3##2##(1992-9#1)(1997-2#1)(2012-3#1)
these detectors##2##2##(2007-12#1)(2008-2#1)
these determinations##3##2##(2008-10#2)(2008-8#1)
these developments##6##2##(1991-2#1)(1993-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-12#1)
these devices are##4##3##(2007-11#1)(2007-12#1)(2008-6#1)(2010-11#1)
these devices##25##2##(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-11#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2013-8#1)
these diabetic patients##2##3##(2008-1#1)(2008-8#1)
these diabetic##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
these diagnoses##2##2##(1990-12#1)(2012-12#1)
these dietary##3##2##(2008-5#1)(2010-1#1)(2012-12#1)
these diets##2##2##(1996-12#1)(2008-10#1)
these differences and##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2012-2#1)
these differences are##3##3##(1994-1#1)(2007-11#1)(2008-3#1)
these differences can be##2##4##(2010-8#1)(2012-1#1)
these differences can##3##3##(1991-12#1)(2010-8#1)(2012-1#1)
these differences in##8##3##(1992-3#1)(1993-12#1)(1994-2#1)(2008-8#3)(2011-2#1)(2012-2#1)
these differences may be related to the##2##7##(1997-7#1)(2011-2#1)
these differences may be##3##4##(1997-7#1)(2008-10#1)(2011-2#1)
these differences may##4##3##(1993-2#1)(1997-7#1)(2008-10#1)(2011-2#1)
these differences were##5##3##(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#1)
these differences##51##2##(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#2)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#2)
these different manifestations##2##3##(2011-2#1)(2012-12#1)
these different##20##2##(1990-12#1)(1992-3#1)(1992-4#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
these differentiations##2##2##(2007-5#2)
these difficult patients##2##3##(2007-8#2)
these difficult##3##2##(2007-8#2)(2008-11#1)
these difficulties##5##2##(1994-11#1)(2007-8#1)(2008-7#1)(2009-10#1)(2011-2#1)
these dimensions##3##2##(1994-2#1)(1996-2#1)(1997-3#1)
these direct##2##2##(2008-3#1)(2008-4#1)
these disciplines##3##2##(1996-12#1)(2008-11#1)(2010-3#1)
these discussions##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
these disease##4##2##(2008-10#1)(2008-3#2)(2010-4#1)
these diseased##2##2##(1993-2#1)(2008-10#1)
these diseases are##8##3##(1995-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
these diseases##44##2##(1990-11#1)(1990-6#1)(1992-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
these disorders and##2##3##(1992-1#1)(2006-10#1)
these disorders are##5##3##(1997-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-3#1)
these disorders in##2##3##(1997-3#1)(2010-5#1)
these disorders is##2##3##(2008-1#1)(2008-7#1)
these disorders##40##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-12#1)(1994-10#1)(1994-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-1#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-8#1)
these disparate##2##2##(2008-9#1)(2013-8#1)
these dissociation##2##2##(1994-6#1)(2008-10#1)
these distinct##4##2##(1994-8#1)(2008-10#1)(2008-12#1)(2009-10#1)
these diverse##6##2##(1991-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)
these doctors##2##2##(1996-3#1)(1997-8#1)
these domains is##2##3##(1992-4#1)(2008-5#1)
these domains##5##2##(1992-4#1)(2008-12#1)(2008-5#2)(2008-7#1)
these doses##4##2##(1995-12#1)(2007-7#1)(2008-11#1)(2008-7#1)
these drawbacks##4##2##(2008-7#1)(2010-5#1)(2010-6#1)(2013-1#1)
these drugs are##7##3##(1991-9#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
these drugs could##2##3##(1994-5#1)(2013-8#1)
these drugs during pregnancy##2##4##(2008-7#1)(2012-2#1)
these drugs have##4##3##(2006-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
these drugs in the##6##4##(1996-3#1)(2007-11#2)(2008-10#1)(2010-6#1)(2012-2#1)
these drugs in##12##3##(1991-8#1)(1996-3#1)(2007-11#2)(2008-10#2)(2008-7#1)(2010-6#3)(2012-2#1)(2013-1#1)
these drugs may##6##3##(1993-2#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-4#1)
these drugs##80##2##(1990-3#1)(1991-1#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-5#3)(1995-11#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#2)(2007-11#2)(2008-10#13)(2008-11#4)(2008-3#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#3)(2010-6#3)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
these during##2##2##(1995-5#1)(2006-12#1)
these dyes##4##2##(2008-10#2)(2008-9#1)(2010-2#1)
these dynamics##2##2##(2007-12#1)(2010-3#1)
these dysfunctions##3##2##(1993-2#1)(2008-10#1)(2013-1#1)
these early##6##2##(1990-8#1)(1994-6#1)(1994-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
these effects and##6##3##(1997-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)
these effects are not##3##4##(2008-10#1)(2008-7#1)(2010-5#1)
these effects are##11##3##(1990-11#1)(1992-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-5#1)(2012-2#1)
these effects is##5##3##(1994-8#1)(2008-2#2)(2008-3#1)(2008-5#1)
these effects might##2##3##(1996-5#1)(2008-9#1)
these effects of##3##3##(2008-10#2)(2008-8#1)
these effects were##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
these effects##76##2##(1990-11#1)(1990-6#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#10)(2008-11#5)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#7)(2008-9#3)(2009-11#1)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)
these efforts have been##2##4##(2008-6#1)(2009-5#1)
these efforts have##3##3##(1995-2#1)(2008-6#1)(2009-5#1)
these efforts##8##2##(1992-3#1)(1995-2#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#1)
these eight##5##2##(1997-7#1)(2008-10#2)(2008-7#1)(2011-3#1)
these electrodes in##3##3##(2008-10#3)
these electrodes##10##2##(2008-10#10)
these elements are##4##3##(1995-8#1)(2008-10#1)(2010-9#1)(2013-1#1)
these elements in##5##3##(1990-5#1)(2008-10#3)(2009-6#1)
these elements were##2##3##(2008-10#1)(2012-3#1)
these elements##33##2##(1990-5#1)(1993-6#1)(1994-2#1)(1995-8#2)(2007-11#1)(2007-12#2)(2008-10#16)(2008-3#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
these emerging##2##2##(1992-1#1)(2012-2#1)
these employees##2##2##(1992-12#1)(2011-2#1)
these endocrine organs##2##3##(1990-7#2)
these endogenous##2##2##(1990-7#1)(1994-5#1)
these engineered##2##2##(2008-11#1)(2009-5#1)
these enlarged##2##2##(2009-10#2)
these entities##7##2##(1993-1#1)(1996-3#1)(2008-3#2)(2010-7#1)(2012-12#1)(2013-8#1)
these enzymatic##2##2##(1995-3#1)(2008-10#1)
these enzyme##2##2##(1991-2#1)(2008-10#1)
these enzymes and##2##3##(1997-3#1)(2013-8#1)
these enzymes as##2##3##(1995-3#1)(2008-6#1)
these enzymes in the##2##4##(1995-11#1)(2006-6#1)
these enzymes in##6##3##(1990-7#1)(1991-11#1)(1995-11#1)(1995-3#1)(2006-6#1)(2008-11#1)
these enzymes may##2##3##(2008-11#1)(2008-4#1)
these enzymes##42##2##(1990-3#1)(1990-7#4)(1990-8#2)(1991-11#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-5#1)(1994-8#3)(1995-11#1)(1995-3#2)(1997-3#1)(2006-6#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-4#4)(2008-5#1)(2008-6#2)(2011-1#1)(2012-12#1)(2013-8#1)
these epidemics##2##2##(2008-10#2)
these epithelial##2##2##(1991-12#1)(2007-12#1)
these equations were##2##3##(2008-10#1)(2008-11#1)
these equations##7##2##(2008-10#2)(2008-11#1)(2008-3#3)(2011-2#1)
these error##3##2##(2008-3#2)(2008-6#1)
these errors##9##2##(2008-2#1)(2008-3#7)(2009-9#1)
these essential##3##2##(2008-10#1)(2009-5#1)(2012-2#1)
these esters##2##2##(1993-8#1)(2008-5#1)
these estimates##8##2##(1993-1#1)(1993-9#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)
these estimators##2##2##(1992-6#1)(1997-7#1)
these ethical##2##2##(1995-1#1)(2008-7#1)
these evaluations##2##2##(2009-11#1)(2013-1#1)
these events are##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
these events can##2##3##(2008-9#1)(2012-12#1)
these events##17##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#1)(2008-10#3)(2008-4#1)(2008-9#3)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
these ex vivo##2##3##(2008-7#2)
these examples##3##2##(1996-4#1)(2008-12#1)(2008-3#1)
these exchanges##2##2##(2008-12#1)(2012-12#1)
these experiences##5##2##(1994-12#1)(2013-1#2)(2013-8#2)
these experimental conditions##7##3##(1991-1#1)(1991-12#1)(1996-5#1)(2008-10#3)(2008-5#1)
these experimental results##2##3##(1991-12#1)(2008-10#1)
these experimental##13##2##(1991-1#1)(1991-12#2)(1996-5#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2013-1#1)
these experiments are##3##3##(1990-11#1)(2006-4#1)(2011-3#1)
these experiments illustrate##2##3##(1993-11#1)(2008-3#1)
these experiments suggest##2##3##(1992-10#1)(2007-12#1)
these experiments##37##2##(1990-11#1)(1990-12#1)(1992-10#1)(1992-3#2)(1993-11#1)(1994-2#1)(1994-3#2)(1995-6#1)(2006-4#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)
these explosives##3##2##(2008-10#3)
these exposures##4##2##(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)
these expressions##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
these external##2##2##(2008-8#2)
these extracts were##2##3##(2008-10#1)(2013-1#1)
these extracts##6##2##(1994-12#1)(2008-10#2)(2008-5#2)(2013-1#1)
these extremely##3##2##(2007-8#1)(2008-1#1)(2012-2#1)
these facial##3##2##(1993-1#2)(2008-11#1)
these facilities##3##2##(1992-12#1)(2009-11#1)(2013-1#1)
these factors and the Snail density##2##6##(2011-1#2)
these factors and the##3##4##(1994-9#1)(2011-1#2)
these factors and##9##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-1#2)(2013-8#1)
these factors are##9##3##(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
these factors as##2##3##(1995-5#1)(2008-4#1)
these factors can##4##3##(2008-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
these factors has##2##3##(1991-8#1)(2007-12#1)
these factors have##3##3##(2008-10#2)(2013-8#1)
these factors in##9##3##(1991-2#1)(1994-12#1)(2008-12#2)(2008-2#1)(2011-1#1)(2011-2#2)(2013-8#1)
these factors is##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)
these factors might##2##3##(2008-1#1)(2008-10#1)
these factors should be considered in##2##6##(1997-4#1)(2008-12#1)
these factors to##4##3##(1995-3#1)(1996-12#2)(2008-9#1)
these factors were##4##3##(1997-7#1)(2008-11#1)(2008-12#2)
these factors##91##2##(1990-12#1)(1990-3#1)(1991-11#2)(1991-2#1)(1991-8#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
these facts##4##2##(1992-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
these families are##2##3##(2010-8#1)(2011-2#1)
these families##12##2##(1994-9#1)(1997-5#1)(1997-9#1)(2006-6#1)(2008-10#2)(2008-5#2)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)
these fascinating##2##2##(2010-9#1)(2012-12#1)
these fears##2##2##(2011-2#1)(2012-12#1)
these features to##2##3##(1991-12#1)(2007-12#1)
these features were##2##3##(2008-3#1)(2012-2#1)
these features##16##2##(1991-12#1)(1991-2#1)(1991-9#1)(1994-6#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#2)(2010-12#1)(2012-2#1)
these fibers##3##2##(2007-11#2)(2008-2#1)
these fibrils##2##2##(1993-2#1)(2008-1#1)
these fields##6##2##(1993-3#1)(1995-6#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-7#1)
these figures of merit##2##4##(2008-10#1)(2008-3#1)
these figures##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
these films##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
these filters are##4##3##(2007-11#1)(2008-3#3)
these filters in##2##3##(2008-2#1)(2008-7#1)
these filters##8##2##(2007-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)
these findings and the##2##4##(2008-11#1)(2008-4#1)
these findings and##7##3##(2007-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-9#1)(2013-1#1)
these findings are discussed##10##4##(1991-2#1)(1993-1#1)(1994-2#1)(2008-1#1)(2008-12#1)(2009-5#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
these findings are##16##3##(1991-2#1)(1992-1#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#2)
these findings by##2##3##(2008-8#1)(2010-3#1)
these findings could be##2##4##(2011-1#1)(2012-2#1)
these findings demonstrate##3##3##(1990-5#1)(2008-5#1)(2012-12#1)
these findings have##2##3##(2010-12#1)(2012-2#1)
these findings highlight##2##3##(2011-2#1)(2013-7#1)
these findings illustrate##3##3##(2008-8#1)(2012-2#2)
these findings in the##2##4##(2008-10#1)(2009-8#1)
these findings in##9##3##(1994-10#1)(1994-11#1)(1996-3#1)(2008-10#2)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)
these findings indicate that##6##4##(1993-12#1)(1993-3#1)(1996-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
these findings indicate##7##3##(1993-12#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
these findings is that##2##4##(1995-8#1)(2007-12#1)
these findings is##3##3##(1995-8#1)(2007-12#1)(2009-7#1)
these findings might##2##3##(2008-10#1)(2013-1#1)
these findings show that##4##4##(2008-7#2)(2008-9#1)(2012-2#1)
these findings suggest that the##4##5##(1991-2#1)(1992-6#1)(2008-11#1)(2008-8#1)
these findings suggest that##13##4##(1990-7#1)(1991-2#1)(1992-6#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
these findings suggest##14##3##(1990-7#1)(1991-2#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
these findings the##3##3##(1990-8#1)(2008-10#2)
these findings to the##3##4##(1994-2#1)(2007-5#1)(2008-10#1)
these findings to##7##3##(1994-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)
these findings we##3##3##(1991-5#1)(2010-2#1)(2011-2#1)
these findings were##3##3##(2007-12#1)(2008-11#1)(2010-1#1)
these findings##173##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#3)(1991-5#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-12#4)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#7)(2012-12#1)(2012-2#11)(2013-1#8)(2013-7#1)(2013-8#8)
these five species##2##3##(2008-10#1)(2008-6#1)
these five##15##2##(1990-2#1)(1993-11#1)(1993-8#1)(1995-6#1)(1996-10#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
these fluctuations##3##2##(1996-4#1)(2008-12#1)(2008-2#1)
these fluids##2##2##(2008-4#1)(2011-2#1)
these foods##4##2##(1992-10#1)(2008-10#2)(2012-1#1)
these forces##3##2##(1994-12#1)(1996-2#1)(2007-12#1)
these foreign##2##2##(1997-7#1)(2007-5#1)
these forms of##2##3##(2008-7#1)(2008-9#1)
these forms##7##2##(1990-12#1)(1990-2#1)(1991-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-1#1)
these formulas##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
these formulations##3##2##(2008-5#2)(2010-5#1)
these four##30##2##(1990-7#1)(1993-1#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(2008-10#12)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
these fractions from##2##3##(1990-5#1)(2008-10#1)
these fractions##7##2##(1990-12#1)(1990-5#1)(1997-2#2)(2008-10#2)(2008-11#1)
these fractures##5##2##(1991-9#2)(2012-2#1)(2013-1#2)
these fragments to##2##3##(1992-6#1)(1993-11#1)
these fragments##7##2##(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(2008-11#1)(2008-8#1)
these from##2##2##(2008-1#1)(2008-8#1)
these functional##3##2##(2010-12#1)(2012-2#2)
these functions are##2##3##(2012-12#1)(2013-1#1)
these functions could##2##3##(1996-2#1)(2008-10#1)
these functions##20##2##(1990-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
these fungi##14##2##(1993-2#1)(2008-10#9)(2008-12#1)(2008-8#1)(2013-1#2)
these gaze##2##2##(2008-11#1)(2010-10#1)
these gels##2##2##(2008-8#1)(2009-9#1)
these gene##7##2##(1993-8#1)(2006-10#1)(2008-4#1)(2008-6#1)(2012-12#2)(2013-1#1)
these genera##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
these genes and##2##3##(2008-10#2)
these genes are##8##3##(1990-8#1)(1992-3#1)(2008-8#1)(2009-8#2)(2010-3#1)(2011-2#1)(2013-8#1)
these genes as##2##3##(1991-6#1)(1993-12#1)
these genes can be##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
these genes could be##2##4##(2007-11#1)(2008-10#1)
these genes in##10##3##(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-8#1)(2011-2#1)
these genes is##2##3##(2008-9#1)(2009-8#1)
these genes may play##3##4##(2008-7#2)(2008-9#1)
these genes may##6##3##(1990-3#1)(2008-10#1)(2008-7#2)(2008-9#2)
these genes to##3##3##(1991-5#1)(2008-10#2)
these genes were##9##3##(1996-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-8#1)
these genes##100##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-3#4)(1992-6#2)(1992-9#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#4)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-4#3)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#2)(2009-6#1)(2009-8#6)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
these genetic effects##2##3##(2009-7#1)(2010-4#1)
these genetic##4##2##(2008-10#2)(2009-7#1)(2010-4#1)
these genomic##4##2##(1997-3#1)(2008-11#1)(2008-7#2)
these genotypes##3##2##(2008-10#3)
these giant neurons##2##3##(2007-12#2)
these giant##3##2##(2007-12#2)(2008-5#1)
these girls##2##2##(2008-1#1)(2008-4#1)
these global##2##2##(2008-7#1)(2008-9#1)
these goals and to##2##4##(2011-2#1)(2013-1#1)
these goals##10##2##(1991-1#1)(1993-1#1)(1996-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
these gratings are##2##3##(2007-12#1)(2008-3#1)
these gratings##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
these grouping##2##2##(1993-8#1)(2008-4#1)
these groups at##2##3##(2008-11#1)(2008-7#1)
these groups for##2##3##(1991-12#1)(2007-10#1)
these groups in##2##3##(1995-3#1)(1997-7#1)
these groups of##2##3##(2008-10#1)(2008-11#1)
these groups was##2##3##(2011-2#1)(2012-12#1)
these groups were##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
these groups##39##2##(1990-6#1)(1991-12#3)(1992-2#1)(1992-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-7#1)
these growth factors##3##3##(1992-9#2)(2010-10#1)
these growth##5##2##(1992-9#2)(2008-11#1)(2008-6#1)(2010-10#1)
these guidelines to##3##3##(1993-12#1)(1996-12#1)(2012-1#1)
these guidelines##12##2##(1992-12#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2010-8#1)(2012-1#1)
these guldehnes will##2##3##(2008-3#2)
these guldehnes##3##2##(2008-3#3)
these had##12##2##(1990-11#1)(1990-6#1)(1994-2#1)(1995-9#1)(1996-11#4)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)
these has##2##2##(1992-1#1)(1997-7#1)
these have a##2##3##(1992-5#1)(2008-7#1)
these have##12##2##(1992-5#1)(1993-6#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2013-1#1)
these health##8##2##(1990-2#1)(1995-2#1)(1996-12#1)(2008-4#2)(2010-3#1)(2010-8#1)(2011-1#1)
these heuristic algorithms##3##3##(2010-2#3)
these high risk patients##2##4##(2008-10#1)(2012-12#1)
these high##6##2##(1990-12#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
these high-risk##2##2##(2007-2#1)(2007-8#1)
these highly purified##2##3##(1995-2#1)(2008-1#1)
these highly##12##2##(1990-11#1)(1990-7#1)(1993-1#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-5#3)(2010-6#1)(2011-2#1)
these homologs##2##2##(1991-12#1)(2008-10#1)
these hormones##7##2##(1990-3#1)(1992-10#1)(1995-11#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
these hospitals##4##2##(1992-12#1)(1992-2#1)(1993-12#1)(2012-2#1)
these hosts##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
these human##4##2##(1990-5#1)(1992-8#1)(1994-5#1)(1994-8#1)
these hybridomas##2##2##(1994-9#1)(2008-11#1)
these hybrids##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
these hydrogels##2##2##(2008-5#1)(2009-9#1)
these hypotheses##8##2##(2008-6#1)(2008-8#2)(2008-9#3)(2012-3#1)(2013-1#1)
these ideas##8##2##(1992-3#1)(1993-3#1)(2007-11#1)(2008-7#2)(2008-8#3)
these images##5##2##(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2012-2#1)
these imaging procedures for##2##4##(2007-11#2)
these imaging##4##2##(1991-12#1)(2007-11#2)(2013-8#1)
these immortalized T cell lines##2##5##(2008-11#2)
these immunological##3##2##(2007-11#1)(2010-8#1)(2013-7#1)
these implants##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
these important##8##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-3#1)(2011-2#1)
these improvements were not##2##4##(2007-12#1)(2007-2#1)
these improvements were##3##3##(2007-12#1)(2007-2#1)(2008-7#1)
these improvements##6##2##(1992-3#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-7#1)
these in the##2##3##(2010-3#1)(2013-1#1)
these in vitro##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
these in vivo and in vitro studies##2##7##(1991-9#1)(1994-8#1)
these in vivo##3##3##(1991-9#1)(1994-8#1)(2007-11#1)
these in##14##2##(1991-9#1)(1993-12#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#2)
these include##4##2##(2007-12#1)(2008-11#1)(2008-9#1)(2010-3#1)
these increases##8##2##(1990-10#1)(1992-3#1)(1993-3#1)(1996-1#1)(2008-10#2)(2009-11#1)(2011-2#1)
these indications##2##2##(1997-2#1)(2008-5#1)
these indicators##6##2##(1992-10#1)(1994-2#2)(2007-4#1)(2010-4#1)(2012-12#1)
these indices##7##2##(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
these individual##2##2##(2008-10#1)(2008-11#1)
these individuals are##3##3##(2008-10#1)(2008-12#1)(2010-11#1)
these individuals in##2##3##(1995-1#1)(2008-11#1)
these individuals##22##2##(1991-11#1)(1991-12#2)(1995-1#1)(1995-3#2)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#2)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
these induced##3##2##(1995-11#1)(2008-7#1)(2009-10#1)
these infants##6##2##(1992-3#2)(2008-11#1)(2011-1#1)(2011-2#2)
these infections are##2##3##(2010-6#1)(2011-2#1)
these infections##14##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#4)(2013-8#1)
these infiltrating##2##2##(1997-3#1)(2008-11#1)
these influences##3##2##(1990-2#1)(2009-9#1)(2010-4#1)
these inhibitions##2##2##(1992-12#1)(2008-11#1)
these inhibitors##13##2##(1991-2#1)(1992-12#1)(1992-6#4)(1992-8#1)(1993-12#1)(1994-12#1)(1997-3#1)(2006-6#1)(2008-1#1)(2009-11#1)
these inhibitory##3##2##(1991-9#1)(1992-2#1)(2008-10#1)
these initial##5##2##(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
these initiatives##2##2##(1995-3#1)(1996-2#1)
these injuries##10##2##(1990-6#1)(1991-3#1)(1994-3#2)(2007-8#1)(2008-8#1)(2008-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
these innovative##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
these inputs##2##2##(2008-4#1)(2012-2#1)
these insights##2##2##(2010-1#1)(2011-2#1)
these institutions##2##2##(1997-1#1)(2009-7#1)
these instruments##9##2##(1991-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)
these integral##2##2##(2009-2#1)(2012-2#1)
these integration##2##2##(2008-10#1)(2008-12#1)
these interactions can##3##3##(1990-11#1)(2007-12#1)(2008-3#1)
these interactions##23##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-9#1)(1993-1#1)(1994-5#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
these intermediate##2##2##(2009-9#2)
these intervention strategies##2##3##(1997-2#1)(2008-7#1)
these interventions##9##2##(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#4)(2013-1#1)
these into##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
these intracellular##2##2##(1990-2#1)(2008-4#1)
these investigations##8##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-1#1)(2012-12#1)
these investments##2##2##(1994-2#1)(1996-1#1)
these ionic##2##2##(1994-2#1)(2008-10#1)
these ions are##4##3##(2008-10#3)(2008-4#1)
these ions in##3##3##(2008-10#3)
these ions with##3##3##(1996-7#1)(2008-10#2)
these ions##19##2##(1996-7#2)(2008-10#16)(2008-4#1)
these is the##2##3##(1992-11#1)(2008-4#1)
these is##8##2##(1992-11#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
these islands##5##2##(1990-5#1)(2008-8#2)(2008-9#2)
these isoforms##4##2##(1990-12#2)(1994-8#1)(2008-10#1)
these isolates in the##2##4##(2008-10#2)
these isolates in##3##3##(2008-10#3)
these isolates were##10##3##(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
these isolates##39##2##(1995-12#1)(2007-6#1)(2008-10#31)(2008-12#1)(2008-5#2)(2008-6#1)(2010-4#1)(2013-8#1)
these issues and##6##3##(2007-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-11#1)
these issues are##3##3##(1991-3#1)(1994-2#1)(2008-3#1)
these issues may##2##3##(2008-1#1)(2009-5#1)
these issues using##2##3##(2008-6#1)(2009-10#1)
these issues with##3##3##(1996-3#1)(2010-5#1)(2012-2#1)
these issues##54##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
these judgments##2##2##(2008-6#1)(2009-5#1)
these key##4##2##(1993-1#1)(2009-8#1)(2010-8#1)(2010-9#1)
these kinases##4##2##(1996-2#1)(2008-11#1)(2008-9#1)(2012-12#1)
these kinds of##4##3##(2008-11#2)(2008-2#1)(2012-2#1)
these kinetic##3##2##(1992-8#1)(1995-6#1)(1995-8#1)
these large##8##2##(1992-12#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
these last##4##2##(1990-5#1)(2008-10#2)(2011-2#1)
these latter##5##2##(2008-10#1)(2008-7#2)(2009-3#1)(2012-3#1)
these layered##2##2##(2007-8#1)(2008-10#1)
these leaves##3##2##(2008-10#2)(2013-7#1)
these lesions is presented##2##4##(1991-6#1)(2008-7#1)
these lesions is##6##3##(1991-6#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
these lesions##37##2##(1990-6#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#4)(2009-12#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-8#1)
these less##4##2##(2006-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
these levels of##2##3##(2008-10#1)(2008-11#1)
these levels were##2##3##(2008-10#2)
these levels##9##2##(1990-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2013-1#1)
these libraries##3##2##(1993-1#2)(2008-5#1)
these ligands##7##2##(1991-11#1)(1993-11#1)(1993-8#1)(1994-11#1)(2008-10#1)(2008-4#2)
these light##3##2##(1991-8#1)(1993-9#1)(2011-7#1)
these limitations##16##2##(1994-12#1)(1996-11#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-6#1)(2012-3#1)(2013-8#1)
these limits are##2##3##(1995-9#1)(2008-3#1)
these limits##3##2##(1995-9#1)(2008-3#2)
these lines was##2##3##(2008-10#2)
these lines##11##2##(1992-12#1)(2006-10#1)(2008-10#6)(2008-11#1)(2009-9#1)(2012-3#1)
these links##2##2##(2009-7#1)(2012-2#1)
these lipids##6##2##(1990-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-5#1)
these lipoproteins##2##2##(1990-8#1)(1994-6#1)
these loci##12##2##(1991-6#1)(1993-6#1)(1994-9#2)(1995-2#1)(2008-10#4)(2008-5#1)(2009-10#1)(2013-8#1)
these losses##2##2##(2008-10#2)
these low##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
these lower##2##2##(1994-8#1)(2012-3#1)
these mAbs##2##2##(1994-5#1)(1996-12#1)
these machines##2##2##(2008-2#1)(2008-3#1)
these main##2##2##(2008-11#1)(2008-8#1)
these major##2##2##(2008-10#1)(2008-7#1)
these mammals##2##2##(2008-5#1)(2008-7#1)
these mammary##2##2##(1991-2#1)(1992-9#1)
these markers##15##2##(1991-2#1)(1994-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
these materials and##2##3##(2008-2#1)(2009-5#1)
these materials is##3##3##(2008-11#1)(2008-3#1)(2009-7#1)
these materials##29##2##(1995-3#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
these matrices##4##2##(2008-10#3)(2008-3#1)
these matters##2##2##(1990-6#1)(1997-6#1)
these may be##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2010-3#1)
these may##14##2##(1990-8#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-1#1)(2009-5#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
these measurements to##3##3##(2008-9#1)(2009-2#1)(2013-1#1)
these measurements##23##2##(1993-12#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#10)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
these measures and##2##3##(2008-9#1)(2009-5#1)
these measures are##2##3##(1992-9#1)(1995-2#1)
these measures to##3##3##(1996-12#1)(2008-8#1)(2009-10#1)
these measures with##2##3##(1990-2#1)(2007-12#1)
these measures##20##2##(1990-2#1)(1992-11#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-12#2)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)
these mechanisms and##2##3##(1994-12#1)(2010-5#1)
these mechanisms have##2##3##(2008-1#1)(2009-2#1)
these mechanisms in##4##3##(2007-12#1)(2007-8#1)(2011-2#2)
these mechanisms may##2##3##(2008-11#1)(2011-2#1)
these mechanisms##29##2##(1990-2#1)(1993-9#1)(1994-12#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#2)
these media to##2##3##(2008-2#1)(2012-2#1)
these media##11##2##(1991-8#1)(2008-10#1)(2008-12#2)(2008-2#2)(2009-10#1)(2009-7#1)(2010-6#1)(2012-2#2)
these mediators##2##2##(1990-9#1)(2010-5#1)
these medical##2##2##(1990-11#1)(2008-11#1)
these medicaments##2##2##(1997-2#2)
these medications##6##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-2#1)
these medicines##3##2##(2013-8#3)
these membrane##3##2##(1994-12#1)(2008-11#1)(2009-9#1)
these membranes##5##2##(1991-5#1)(1992-7#1)(2008-10#2)(2009-8#1)
these men##4##2##(1996-11#2)(2008-4#1)(2009-12#1)
these mental disorders##2##3##(2012-1#2)
these mental##4##2##(1991-8#1)(2012-1#2)(2013-8#1)
these metabolic##4##2##(1990-2#1)(2008-11#2)(2008-3#1)
these metabolites##6##2##(1991-5#1)(1994-8#2)(2008-10#1)(2008-11#1)(2012-2#1)
these metal ions are##4##4##(2008-10#4)
these metal ions in##6##4##(2008-10#6)
these metal ions is##2##4##(2008-10#2)
these metal ions were##5##4##(2008-10#5)
these metal ions with##2##4##(2008-10#2)
these metal ions##28##3##(2008-10#27)(2008-5#1)
these metal##29##2##(2008-10#27)(2008-5#1)(2010-11#1)
these metals were##3##3##(1997-4#1)(2008-10#2)
these metals##20##2##(1997-4#1)(2008-10#15)(2008-12#1)(2009-10#1)(2011-1#2)
these methodological##3##2##(2008-12#1)(2010-6#1)(2011-1#1)
these methodologies##2##2##(1990-8#1)(1994-12#1)
these methods are##12##3##(1995-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)
these methods can##2##3##(2008-10#1)(2008-8#1)
these methods could be##2##4##(2008-2#1)(2008-4#1)
these methods have been##2##4##(1996-12#1)(2008-10#1)
these methods have##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
these methods in##4##3##(2008-8#1)(2009-11#1)(2010-12#1)(2013-8#1)
these methods is##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
these methods may##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
these methods provide##3##3##(1991-2#1)(2009-11#1)(2011-2#1)
these methods to a number of##2##6##(2008-10#1)(2010-8#1)
these methods to a##3##4##(2008-10#1)(2010-3#1)(2010-8#1)
these methods to##9##3##(1994-8#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)
these methods were##3##3##(2008-10#3)
these methods##93##2##(1991-2#1)(1992-1#1)(1992-6#3)(1992-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#3)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
these miRNAs##2##2##(2010-7#1)(2013-8#1)
these mice##10##2##(1993-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-6#1)(2012-12#1)(2013-1#1)
these microbes##3##2##(2008-10#2)(2011-2#1)
these microorganisms##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
these microvesicles##2##2##(1990-12#1)(1997-3#1)
these might##2##2##(2008-4#1)(2010-5#1)
these mines##3##2##(2008-10#3)
these minima##2##2##(2007-11#1)(2008-3#1)
these mitogens##2##2##(1992-4#1)(2008-4#1)
these modalities##6##2##(1995-5#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
these model##3##2##(1995-9#1)(2008-10#1)(2008-4#1)
these models and##3##3##(2008-4#2)(2013-1#1)
these models are##6##3##(1996-4#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-2#1)
these models may##2##3##(2008-7#1)(2008-8#1)
these models to##4##3##(1997-7#1)(2008-8#1)(2010-3#1)(2012-4#1)
these models using##3##3##(2007-11#1)(2008-6#1)(2008-8#1)
these models was##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
these models##47##2##(1991-5#1)(1992-9#1)(1993-12#1)(1994-3#1)(1996-4#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#5)(2012-4#1)(2013-1#1)
these modes and##2##3##(2007-12#1)(2011-1#1)
these modifications is##2##3##(1994-8#1)(2008-10#1)
these modifications##7##2##(1991-12#1)(1992-3#1)(1994-8#1)(2008-10#2)(2009-5#1)(2009-8#1)
these modified##10##2##(1990-8#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2010-3#1)
these modules##2##2##(2008-3#1)(2012-2#1)
these molecular##7##2##(2007-8#1)(2008-1#1)(2008-2#1)(2009-5#1)(2013-1#3)
these molecules at##2##3##(2008-10#1)(2008-4#1)
these molecules may##3##3##(1991-3#1)(2008-1#1)(2008-5#1)
these molecules##29##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#5)(2008-5#5)(2009-10#1)(2010-10#1)(2012-12#2)(2013-8#1)
these monolayers were##2##3##(1992-6#1)(2007-12#1)
these more##2##2##(1991-3#1)(2008-7#1)
these motifs##3##2##(1993-12#1)(2008-4#1)(2013-1#1)
these multiple##4##2##(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)
these muscles##2##2##(1994-11#1)(2009-1#1)
these mutant strains##2##3##(2009-10#1)(2012-3#1)
these mutant##5##2##(1992-8#1)(1993-3#1)(1994-5#1)(2009-10#1)(2012-3#1)
these mutants have##2##3##(1993-11#1)(1995-8#1)
these mutants##20##2##(1990-7#2)(1992-6#1)(1993-11#2)(1995-2#2)(1995-8#2)(1997-3#1)(1997-4#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)
these mutations are##2##3##(1993-11#1)(2013-1#1)
these mutations were##2##3##(1993-3#1)(1997-3#1)
these mutations##19##2##(1990-5#1)(1990-8#1)(1993-11#2)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-11#2)(2008-7#3)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
these nanoparticles##6##2##(2008-7#2)(2009-2#1)(2010-6#2)(2013-1#1)
these natural##5##2##(1992-3#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-8#1)
these needs are##2##3##(1994-2#1)(2010-2#1)
these needs##7##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(2009-12#1)(2010-2#1)(2013-1#1)
these nematodes##3##2##(1994-12#1)(2008-9#2)
these neo-epitopes##2##2##(2013-8#2)
these neoplasms is##2##3##(1991-4#1)(2010-8#1)
these neoplasms##8##2##(1990-5#2)(1991-4#1)(1991-6#1)(2007-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
these networks##5##2##(1994-12#1)(1996-3#1)(2008-7#2)(2009-9#1)
these neurological##3##2##(1995-12#1)(2007-7#1)(2008-6#1)
these neurones##2##2##(1995-12#1)(1996-5#1)
these neurons are##2##3##(1990-11#1)(2013-8#1)
these neurons were##2##3##(1993-12#2)
these neurons##22##2##(1990-11#1)(1991-12#1)(1992-3#1)(1993-12#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
these neuropeptides##2##2##(1995-11#1)(2008-5#1)
these new drugs##2##3##(2012-12#2)
these new methods##2##3##(2008-10#1)(2010-1#1)
these new retroviral vectors##2##4##(1997-8#2)
these new technologies##2##3##(2008-11#1)(2010-7#1)
these new##47##2##(1990-5#1)(1991-1#1)(1993-2#1)(1995-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(1997-9#1)(2007-12#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
these newly##2##2##(2008-3#1)(2010-6#1)
these nine##3##2##(1996-3#1)(2008-10#2)
these noises##2##2##(2007-12#1)(2008-3#1)
these nontraditional##3##2##(1996-12#2)(2008-3#1)
these normal variants##2##3##(2010-1#2)
these novel inclusions##3##3##(2008-10#3)
these novel proteolysis##2##3##(2012-3#2)
these novel##19##2##(1995-6#1)(1997-8#1)(2008-10#6)(2008-4#2)(2008-7#2)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
these nuclear proteins are##2##4##(1992-12#1)(1994-12#1)
these nuclear##6##2##(1991-12#1)(1992-12#1)(1994-12#1)(2007-12#1)(2008-4#1)(2012-3#1)
these numbers##2##2##(2009-8#1)(2013-1#1)
these nurses##5##2##(2008-1#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-8#1)
these nutrients##2##2##(2008-11#1)(2013-1#1)
these objectives##6##2##(1994-3#1)(1995-2#1)(1997-3#1)(2008-7#1)(2010-3#1)(2010-4#1)
these objects##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
these observations and##2##3##(1995-5#1)(2008-7#1)
these observations are##5##3##(1995-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)
these observations reveal that##2##4##(2008-10#1)(2012-12#1)
these observations##34##2##(1990-12#1)(1993-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)
these obstacles##5##2##(1994-12#1)(1996-1#1)(1996-3#1)(2008-11#1)(2009-5#1)
these occurred##2##2##(2008-9#1)(2009-8#1)
these often##3##2##(2008-12#1)(2008-9#1)(2013-8#1)
these older##2##2##(2008-4#1)(2012-12#1)
these oligonucleotides##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
these operational##2##2##(1996-3#1)(2008-8#1)
these optical##5##2##(1990-8#1)(2007-11#1)(2008-3#3)
these optimized conditions##2##3##(2008-10#2)
these optimized##3##2##(2008-10#2)(2008-6#1)
these options##5##2##(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#1)
these organelles##2##2##(1994-5#1)(2009-8#1)
these organisms are##2##3##(2008-7#1)(2008-8#1)
these organisms is##4##3##(2007-7#2)(2008-9#1)(2013-7#1)
these organisms##20##2##(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#4)(2011-2#4)(2012-2#1)(2013-7#1)
these organizational##2##2##(1992-12#1)(2007-6#1)
these organizations##7##2##(1991-3#1)(1992-12#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(2011-2#1)
these organs##9##2##(1990-11#1)(1991-5#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-1#1)
these oscillations##2##2##(2013-8#2)
these other##4##2##(1994-12#1)(1995-1#1)(2011-2#1)(2012-3#1)
these outbreaks##4##2##(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#1)
these outcomes##4##2##(1994-12#1)(2009-11#1)(2009-7#1)(2013-1#1)
these pairs##2##2##(1990-9#2)
these papers##9##2##(2007-8#7)(2008-1#1)(2008-7#1)
these parameter values##2##3##(2008-10#1)(2008-7#1)
these parameters and##2##3##(2007-12#1)(2008-10#1)
these parameters are##6##3##(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#2)
these parameters by##2##3##(2008-2#1)(2010-3#1)
these parameters for##4##3##(1992-6#1)(2008-10#1)(2008-2#2)
these parameters have been##2##4##(1997-2#1)(2008-2#1)
these parameters have##3##3##(1997-2#1)(2008-2#1)(2010-12#1)
these parameters in the##2##4##(1990-2#1)(2012-3#1)
these parameters in##5##3##(1990-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2012-3#1)
these parameters increased with##2##4##(1997-4#1)(2008-5#1)
these parameters increased##3##3##(1997-4#1)(2008-12#1)(2008-5#1)
these parameters is##2##3##(2008-3#1)(2008-7#1)
these parameters of##2##3##(1997-2#1)(2008-10#1)
these parameters to##2##3##(2008-3#1)(2013-8#1)
these parameters using##2##3##(2008-8#1)(2013-3#1)
these parameters were##2##3##(1991-5#1)(2008-10#1)
these parameters##69##2##(1990-2#1)(1990-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-3#1)(2013-8#1)
these parasites##8##2##(2007-12#1)(2007-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#2)
these parents##2##2##(1993-1#1)(2008-10#1)
these participants##4##2##(2008-5#1)(2009-11#1)(2010-8#1)(2013-1#1)
these particles##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
these particular##2##2##(1997-7#1)(2008-10#1)
these pathogens are##3##3##(2008-10#2)(2008-9#1)
these pathogens##21##2##(1995-5#2)(2007-12#1)(2007-7#1)(2008-10#10)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
these pathologies##6##2##(1991-9#1)(2008-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
these pathovars##2##2##(2008-10#2)
these paths##2##2##(2008-3#1)(2008-8#1)
these pathways has##2##3##(1996-2#1)(2009-12#1)
these pathways##20##2##(1990-8#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-6#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-7#1)
these patient groups##2##3##(1993-2#1)(2009-10#1)
these patient populations##2##3##(1995-2#1)(2012-2#1)
these patient##5##2##(1993-2#1)(1995-2#1)(2008-8#1)(2009-10#1)(2012-2#1)
these patients and the##2##4##(2007-10#1)(2011-2#1)
these patients and their##2##4##(1991-6#1)(2009-9#1)
these patients and##10##3##(1991-6#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#2)
these patients are not##2##4##(2009-5#1)(2013-1#1)
these patients are##15##3##(1990-6#1)(1990-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#2)(2011-1#1)(2013-1#2)
these patients as##3##3##(1992-9#1)(2008-7#1)(2012-3#1)
these patients at##2##3##(1993-3#1)(2013-1#1)
these patients does not##2##4##(2012-2#1)(2013-1#1)
these patients for##3##3##(1990-2#1)(2007-12#1)(2011-1#1)
these patients had##12##3##(1990-12#1)(1991-4#1)(1992-2#1)(1995-2#1)(2007-10#2)(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
these patients has##2##3##(1995-8#1)(2008-1#1)
these patients in##2##3##(2012-12#1)(2013-1#1)
these patients is##8##3##(1990-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-12#1)
these patients may be##2##4##(2008-1#1)(2012-12#1)
these patients may##4##3##(2008-1#1)(2011-1#1)(2012-12#1)(2013-1#1)
these patients received##2##3##(1992-5#1)(1993-1#1)
these patients should be##2##4##(1996-11#1)(2008-7#1)
these patients to the##2##4##(2008-1#1)(2008-3#1)
these patients to##4##3##(2008-1#1)(2008-3#1)(2008-4#1)(2010-6#1)
these patients was##9##3##(1991-3#1)(1993-10#1)(1994-3#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#1)(2012-3#1)
these patients were##15##3##(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1994-9#1)(1996-9#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-1#3)
these patients will##2##3##(2010-3#1)(2012-1#1)
these patients with##2##3##(2007-8#1)(2011-2#1)
these patients##294##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#3)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#7)(1991-8#3)(1992-12#4)(1992-2#3)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-8#3)(1996-11#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-8#3)(2006-10#4)(2006-12#1)(2006-7#1)(2007-10#6)(2007-11#6)(2007-12#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#22)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#20)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#3)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#14)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#16)(2013-8#3)
these patients'##2##2##(2008-1#1)(2008-3#1)
these patterns##15##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#4)(2009-8#1)(2013-1#1)
these peaks##7##2##(1990-5#2)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)
these people##5##2##(1995-11#1)(2008-1#1)(2008-2#1)(2009-7#1)(2012-12#1)
these peptides in##2##3##(1994-8#1)(2009-6#1)
these peptides were##2##3##(1991-5#1)(1994-8#1)
these peptides##28##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#3)(1991-5#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
these perceptions##2##2##(1996-3#1)(2007-11#1)
these persons##5##2##(1991-6#1)(1994-2#1)(1994-9#1)(2012-2#2)
these phase##3##2##(2007-11#1)(2008-3#2)
these phases##3##2##(1996-2#1)(2008-12#1)(2013-8#1)
these phenomena is not##2##4##(2008-1#1)(2008-11#1)
these phenomena##25##2##(1991-1#1)(1991-12#1)(1993-6#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2010-3#1)(2013-1#1)
these phosphoramidites##2##2##(2008-4#2)
these physical##2##2##(2008-11#1)(2008-5#1)
these physicians##2##2##(1991-12#1)(1991-2#1)
these physiological##5##2##(1997-6#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-7#1)
these pieces##2##2##(1995-3#1)(2008-10#1)
these plans##2##2##(1992-3#1)(2008-12#1)
these plants were##3##3##(2008-10#3)
these plants##18##2##(2008-10#15)(2009-8#1)(2010-3#1)(2011-1#1)
these plasmids##5##2##(1991-7#1)(1995-8#1)(2008-5#2)(2008-9#1)
these plastic##2##2##(1995-4#1)(2008-2#1)
these plots##4##2##(2008-10#3)(2010-12#1)
these points##4##2##(2008-2#1)(2008-3#1)(2009-5#1)(2011-10#1)
these policies##5##2##(1993-3#1)(1995-1#2)(1997-7#1)(2008-7#1)
these polymer particles##2##3##(2008-10#2)
these polymers##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
these polymorphic##3##2##(1996-8#1)(2008-9#1)(2013-8#1)
these polypeptides##2##2##(1995-6#1)(2008-11#1)
these populations are##4##3##(2008-10#3)(2008-8#1)
these populations was##3##3##(2008-10#2)(2013-1#1)
these populations##31##2##(1994-9#1)(1996-11#1)(2008-1#2)(2008-10#14)(2008-4#1)(2008-8#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#1)
these positions##3##2##(1993-10#1)(1993-8#1)(2009-10#1)
these positive##2##2##(1994-12#1)(2008-8#1)
these possibilities##3##2##(1992-12#1)(1994-5#1)(2009-8#1)
these potential##8##2##(1992-3#1)(1993-11#1)(1994-5#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
these potentially##2##2##(1995-12#1)(2011-2#1)
these practices##5##2##(1991-12#1)(2008-4#2)(2008-9#1)(2010-5#1)
these precursors##2##2##(2008-5#1)(2013-1#1)
these predicted##2##2##(2008-7#1)(2008-8#1)
these predictions in##4##3##(1993-12#1)(2008-8#1)(2008-9#1)(2010-2#1)
these predictions##13##2##(1993-12#1)(1997-7#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#1)
these preferences##3##2##(2009-9#1)(2012-12#1)(2012-3#1)
these preliminary results##5##3##(1990-12#1)(1992-6#1)(2008-10#1)(2008-7#1)(2010-12#1)
these preliminary##10##2##(1990-12#1)(1992-6#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)
these premises##2##2##(2009-6#1)(2010-4#1)
these preparations##3##2##(1990-12#1)(1991-9#1)(2011-1#1)
these previous##2##2##(2008-8#1)(2011-2#1)
these previously##2##2##(2007-11#1)(2008-10#1)
these primary##2##2##(1991-2#1)(2008-11#1)
these primers##6##2##(1993-12#1)(2008-10#5)
these principal##2##2##(2008-3#1)(2012-2#1)
these principles##7##2##(1992-2#1)(1993-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#2)
these probes##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
these problems and##2##3##(2008-1#1)(2009-2#1)
these problems are##5##3##(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-8#1)
these problems by##5##3##(1991-3#1)(1992-12#1)(1996-1#1)(2007-11#1)(2008-10#1)
these problems in##3##3##(2008-8#2)(2011-2#1)
these problems##54##2##(1991-11#1)(1991-3#2)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-1#2)(1996-3#2)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
these procedures are##5##3##(2007-8#1)(2008-10#3)(2008-4#1)
these procedures can be##2##4##(1991-6#1)(1993-3#1)
these procedures in##2##3##(2011-2#1)(2012-12#1)
these procedures were##2##3##(1991-8#1)(2008-8#1)
these procedures##32##2##(1991-6#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#2)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
these processes and##2##3##(2010-10#1)(2010-12#1)
these processes are not##2##4##(2008-8#1)(2009-3#1)
these processes are##8##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
these processes at the molecular level##2##6##(2011-2#1)(2012-2#1)
these processes is##4##3##(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
these processes##54##2##(1990-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#6)
these product##2##2##(2008-5#1)(2009-7#1)
these products are##2##3##(2006-12#1)(2012-2#1)
these products##26##2##(1992-10#1)(1992-5#1)(1993-11#2)(1997-3#1)(2006-12#2)(2008-10#8)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-1#1)(2012-2#3)
these professionals##3##2##(1993-2#2)(2008-11#1)
these profiles##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
these programmes##3##2##(2008-11#1)(2008-12#1)(2012-1#1)
these programs are##2##3##(1994-2#1)(2013-1#1)
these programs##23##2##(1991-1#1)(1991-12#1)(1993-1#1)(1994-12#2)(1994-2#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-5#1)(2009-6#1)(2011-3#2)(2012-12#1)(2013-1#4)
these projections##2##2##(2008-7#1)(2009-8#1)
these projects##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
these promoters##3##2##(1995-2#1)(1997-4#2)
these properties are##6##3##(1992-8#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
these properties##19##2##(1991-3#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-2#1)
these proteases##3##2##(1994-6#2)(2012-3#1)
these protein##6##2##(1990-5#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2013-1#1)
these proteins and##2##3##(2009-8#2)
these proteins are##11##3##(1992-8#1)(1993-2#1)(1994-11#1)(1994-5#2)(1997-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
these proteins in the##2##4##(1996-5#1)(2013-8#1)
these proteins in##11##3##(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#2)(1996-5#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
these proteins was##2##3##(1993-6#1)(1997-6#1)
these proteins were##5##3##(1992-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-5#1)
these proteins##77##2##(1990-11#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-5#1)(1992-8#2)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-6#2)(1997-7#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
these protocols can be used in##2##6##(2007-10#1)(2008-4#1)
these protocols can be##3##4##(2007-10#1)(2008-4#2)
these protocols##11##2##(1994-3#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-4#4)(2008-9#2)
these proved to be##3##4##(1991-8#1)(1995-3#1)(2007-8#1)
these providers##3##2##(1997-1#1)(1997-2#2)
these publications##3##2##(2008-1#1)(2010-8#1)(2011-2#1)
these purified##3##2##(1994-6#2)(2008-4#1)
these purposes##7##2##(1993-12#2)(2008-10#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)
these putative##5##2##(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)
these quality##2##2##(2008-5#1)(2012-2#1)
these quantitative traits##2##3##(2008-10#1)(2008-12#1)
these quantitative##4##2##(1996-11#1)(2008-10#1)(2008-12#1)(2008-2#1)
these quantities##3##2##(1990-8#1)(2008-3#2)
these questions are##2##3##(1996-1#1)(2008-8#1)
these questions##15##2##(1991-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-7#3)(2008-8#2)(2012-3#1)(2013-1#1)
these ranges##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
these rapid##2##2##(2008-9#1)(2010-8#1)
these rare##6##2##(2007-5#1)(2007-8#2)(2010-1#1)(2010-12#1)(2011-2#1)
these rat##3##2##(1991-12#1)(1992-12#1)(1993-5#1)
these rates##7##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#2)(2012-12#1)
these ratings##2##2##(1991-3#1)(1995-12#1)
these rats##3##2##(1991-6#1)(1993-12#1)(1994-8#1)
these reaction##2##2##(1996-5#1)(2008-11#1)
these reactions are##4##3##(1990-12#1)(1993-6#1)(2008-4#1)(2010-8#1)
these reactions has##2##3##(1996-2#1)(2008-10#1)
these reactions in##3##3##(1996-12#1)(2008-10#2)
these reactions is##2##3##(2008-11#1)(2008-7#1)
these reactions##18##2##(1990-12#1)(1990-3#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-8#2)
these reagents##7##2##(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#1)(2012-2#1)
these reasons##17##2##(1997-3#1)(2006-7#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
these recent##2##2##(2008-3#1)(2010-7#1)
these receptors and##4##3##(1993-2#1)(1996-2#1)(2009-8#1)(2011-2#1)
these receptors are##3##3##(1993-2#1)(2008-7#1)(2012-1#1)
these receptors in##2##3##(1993-9#1)(2008-10#1)
these receptors is##2##3##(1996-12#1)(2008-4#1)
these receptors may##4##3##(1995-12#1)(1997-5#1)(2008-4#1)(2008-5#1)
these receptors was##2##3##(1995-12#1)(2008-10#1)
these receptors##39##2##(1991-12#2)(1991-5#2)(1992-3#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#4)(1996-12#2)(1996-2#1)(1997-5#1)(2008-10#2)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
these recombinant viruses##2##3##(2008-10#2)
these recombinant##4##2##(2008-10#2)(2012-3#2)
these recommendations##8##2##(1994-2#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-8#1)
these reconstructions##2##2##(2008-2#1)(2008-6#1)
these records##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
these reference materials##2##3##(2008-10#2)
these reference##4##2##(2008-10#3)(2008-2#1)
these reflexes##2##2##(1992-12#1)(1993-12#1)
these regional##2##2##(2007-12#1)(2008-12#1)
these regions are##2##3##(2007-12#1)(2010-5#1)
these regions may##2##3##(1991-12#1)(1993-8#1)
these regions##32##2##(1991-10#2)(1991-12#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-5#1)(1997-6#2)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#3)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#1)
these regulations##2##2##(1993-3#1)(1994-1#1)
these regulatory elements in##2##4##(1993-12#2)
these regulatory##5##2##(1993-12#2)(1994-12#1)(2008-11#1)(2011-2#1)
these relations##3##2##(2008-3#3)
these relationships are##2##3##(2008-10#1)(2012-2#1)
these relationships differ##2##3##(1990-11#1)(2008-8#1)
these relationships were##3##3##(2009-4#1)(2010-1#1)(2013-7#1)
these relationships##27##2##(1990-11#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-6#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
these repeats##3##2##(1992-10#1)(1992-3#1)(2008-10#1)
these reported##2##2##(2009-8#1)(2011-2#1)
these reports to##2##3##(1991-1#1)(2013-1#1)
these reports##11##2##(1991-1#1)(1991-3#1)(1994-3#1)(2007-10#1)(2008-11#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
these requirements are##2##3##(2008-3#1)(2008-5#1)
these requirements##12##2##(1991-12#1)(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2013-1#1)
these research##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
these residues in the##3##4##(1993-8#1)(1995-5#1)(1996-5#1)
these residues##10##2##(1992-4#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#3)(1996-5#1)
these resistance##2##2##(2008-10#2)
these resistant##4##2##(1995-11#1)(1997-4#1)(2008-10#2)
these resonances##3##2##(2007-11#2)(2008-3#1)
these resources##6##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
these response##2##2##(2008-11#1)(2010-2#1)
these responses##14##2##(1990-5#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#1)
these results also##2##3##(1996-12#1)(2009-9#1)
these results and the##4##4##(1990-2#1)(1992-6#1)(2008-10#1)(2008-2#1)
these results and##11##3##(1990-2#1)(1992-6#1)(1993-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#1)
these results are consistent with previous##2##6##(1992-9#1)(2008-10#1)
these results are consistent with##3##5##(1991-12#1)(1992-9#1)(2008-10#1)
these results are discussed##4##4##(1991-12#1)(2008-11#1)(2008-2#1)(2013-7#1)
these results are##11##3##(1991-12#2)(1991-5#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-11#1)(2013-7#1)
these results could##2##3##(2011-2#1)(2012-12#1)
these results demonstrate that exposure to##2##6##(2008-10#2)
these results demonstrate that the##2##5##(1994-3#1)(1995-12#1)
these results demonstrate that##6##4##(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#2)(2009-10#1)
these results demonstrate the##2##4##(1993-6#1)(2008-11#1)
these results demonstrate##10##3##(1993-6#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)
these results imply that##2##4##(2008-4#1)(2009-8#1)
these results in other populations##2##5##(2012-2#1)(2013-1#1)
these results in the##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
these results in##7##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
these results indicate that the##5##5##(1992-12#1)(1994-8#1)(2008-10#3)
these results indicate that##21##4##(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2011-2#1)
these results indicate##24##3##(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-8#1)(1995-2#1)(1996-12#1)(2008-10#7)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
these results may##2##3##(1991-5#1)(2008-7#1)
these results need##2##3##(2008-1#1)(2009-7#1)
these results provide##10##3##(1991-2#1)(1992-3#2)(1994-8#1)(1997-2#1)(2008-8#1)(2009-9#1)(2010-6#1)(2010-8#2)
these results show that##3##4##(1993-8#1)(2008-4#1)(2008-7#1)
these results show##4##3##(1993-8#1)(2007-12#1)(2008-4#1)(2008-7#1)
these results suggest that a##3##5##(1993-6#1)(1996-3#1)(2009-10#1)
these results suggest that the##8##5##(1990-12#1)(1993-6#1)(1994-12#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
these results suggest that##35##4##(1990-12#2)(1990-2#1)(1991-12#1)(1993-11#1)(1993-6#2)(1994-12#2)(1994-7#1)(1994-8#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#2)(2007-10#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
these results suggest the##2##4##(1990-12#1)(1994-5#1)
these results suggest##41##3##(1990-12#3)(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-6#2)(1994-12#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#2)(2007-10#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
these results support the##3##4##(1990-11#1)(1995-12#1)(2009-8#1)
these results the##4##3##(2008-12#1)(2008-3#1)(2008-5#2)
these results to the##4##4##(1991-12#1)(2007-11#1)(2008-3#2)
these results to##14##3##(1990-5#1)(1990-7#1)(1991-12#1)(1994-3#1)(1995-3#1)(2007-11#2)(2008-10#2)(2008-3#4)(2013-7#1)
these results was##2##3##(2010-1#1)(2012-12#1)
these results we##5##3##(1992-6#1)(2008-10#2)(2008-5#1)(2013-1#1)
these results were##5##3##(1997-4#1)(2008-11#2)(2008-8#1)(2012-12#1)
these results will##2##3##(2008-10#1)(2012-3#1)
these results with##7##3##(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
these results##317##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#7)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-3#1)(1993-6#5)(1993-8#4)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-7#2)(1994-8#5)(1995-12#3)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#55)(2008-11#14)(2008-12#4)(2008-2#7)(2008-3#13)(2008-4#4)(2008-5#14)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#9)(2012-12#4)(2012-2#5)(2012-3#4)(2012-9#1)(2013-1#8)(2013-7#3)(2013-8#3)
these rice##3##2##(1996-8#1)(2008-10#1)(2009-10#1)
these risk factors are##2##4##(2009-4#1)(2011-1#1)
these risk factors##9##3##(2007-10#1)(2008-1#1)(2008-4#1)(2009-4#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
these risk##10##2##(2007-10#1)(2008-1#1)(2008-4#1)(2009-4#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
these risks may be##2##4##(2008-11#1)(2008-7#1)
these risks##6##2##(1993-3#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-3#1)
these roles##11##2##(1994-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
these roots##2##2##(2008-10#1)(2009-8#1)
these round cells##2##3##(1996-5#2)
these routes of##2##3##(2008-5#1)(2012-12#1)
these routes##4##2##(2008-5#1)(2009-11#1)(2011-2#1)(2012-12#1)
these same##22##2##(1991-5#1)(1992-12#1)(1992-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)
these samples by##2##3##(2008-10#2)
these samples is##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
these samples was##6##3##(2008-10#5)(2008-7#1)
these samples were##3##3##(2008-10#3)
these samples##32##2##(1991-12#1)(1994-11#1)(1994-8#1)(2007-7#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
these seaweeds##3##2##(2008-11#3)
these second-generation##2##2##(1991-12#1)(2012-12#1)
these sensilla##3##2##(2008-8#1)(2010-11#2)
these sensors##8##2##(2008-10#7)(2008-7#1)
these sequence##3##2##(1994-11#1)(1995-3#1)(2008-8#1)
these sequences are##3##3##(1996-12#1)(2008-7#1)(2008-9#1)
these sequences to##2##3##(2008-10#2)
these sequences were##3##3##(2008-10#1)(2008-7#1)(2010-10#1)
these sequences##18##2##(1990-12#1)(1993-6#1)(1995-2#1)(1996-12#2)(1997-4#1)(2008-10#6)(2008-7#3)(2008-9#1)(2010-10#1)(2012-2#1)
these services are##2##3##(1991-12#1)(1992-12#1)
these services in##3##3##(1994-1#2)(1997-1#1)
these services##19##2##(1991-12#2)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#3)(1995-2#2)(1997-1#1)(1997-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
these sets##3##2##(1992-12#1)(2008-3#1)(2010-9#1)
these settings##9##2##(1991-1#1)(1996-12#1)(1996-2#1)(2006-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)
these seven##7##2##(1991-12#1)(2008-10#5)(2009-5#1)
these sex##2##2##(1997-3#1)(2008-10#1)
these sexual##3##2##(1995-6#1)(2008-1#1)(2008-5#1)
these short-term##2##2##(1995-11#1)(2008-10#1)
these shortcomings##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
these should be##2##3##(2009-4#1)(2010-1#1)
these show##2##2##(1994-9#1)(2008-3#1)
these showed##3##2##(1993-5#1)(2007-7#1)(2012-12#1)
these signal##2##2##(2008-9#1)(2011-3#1)
these signaling##4##2##(2008-3#1)(2008-9#1)(2009-9#1)(2013-8#1)
these signalling##2##2##(1996-2#1)(2009-3#1)
these signals are##2##3##(2008-2#1)(2010-8#1)
these signals##16##2##(1994-12#1)(1995-12#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-8#1)
these signatures##2##2##(2009-6#1)(2013-1#1)
these significant##2##2##(1991-3#1)(2010-4#1)
these signs are##2##3##(1993-2#1)(2007-7#1)
these signs##4##2##(1993-2#1)(2007-7#1)(2008-1#1)(2010-8#1)
these similarities##2##2##(1992-11#1)(2008-7#1)
these simulations with##2##3##(1993-11#1)(2008-2#1)
these simulations##7##2##(1993-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-3#1)
these sites##25##2##(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#3)(2013-7#1)
these situations##4##2##(1992-6#1)(1994-6#1)(2010-4#1)(2012-3#1)
these six##6##2##(1991-3#1)(1993-12#1)(1994-6#1)(2008-12#1)(2010-4#1)(2011-3#1)
these small##2##2##(2008-2#1)(2008-5#1)
these socially##2##2##(2007-5#1)(2012-12#1)
these societies##3##2##(1992-1#1)(2008-10#1)(2009-12#1)
these soft##2##2##(2008-12#1)(2010-2#1)
these soils##4##2##(1992-3#1)(2008-10#2)(2013-7#1)
these soluble##2##2##(1995-2#1)(2008-4#1)
these solutions are##2##3##(2008-3#1)(2008-8#1)
these solutions##9##2##(1997-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
these solvents can be##2##4##(2008-10#2)
these solvents##8##2##(1995-2#1)(2008-10#6)(2008-3#1)
these sources are used##2##4##(1995-12#1)(2008-10#1)
these sources of##2##3##(1992-6#1)(2008-1#1)
these sources##9##2##(1992-6#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)
these species and##6##3##(2008-10#3)(2008-5#2)(2010-12#1)
these species are##7##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)
these species in the##3##4##(2008-10#1)(2008-5#2)
these species in##5##3##(2008-10#2)(2008-5#2)(2010-8#1)
these species show##2##3##(2008-10#1)(2011-2#1)
these species##58##2##(1993-12#1)(1996-6#2)(1997-7#2)(2007-12#2)(2008-10#21)(2008-11#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-2#2)(2012-2#1)
these specific##10##2##(1990-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#3)(2010-8#1)
these spectra##3##2##(2008-10#2)(2010-2#1)
these spectral##3##2##(1994-6#1)(1995-5#1)(2008-3#1)
these spontaneous##2##2##(1994-11#1)(2012-2#1)
these stages##5##2##(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
these standards##3##2##(1993-12#1)(2007-12#1)(2011-2#1)
these states##4##2##(1991-8#1)(2007-11#1)(2008-8#1)(2012-2#1)
these statistical results##2##3##(1996-12#1)(2008-7#1)
these statistics##3##2##(1995-3#1)(1997-1#1)(2008-10#1)
these steps and##2##3##(2008-4#1)(2008-9#1)
these steps##6##2##(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
these steroids##9##2##(1990-11#1)(1990-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-9#1)(2012-3#1)
these sterols##2##2##(1997-2#1)(2008-10#1)
these stimuli##4##2##(1990-12#1)(1995-12#1)(2008-10#1)(2012-7#1)
these stores##2##2##(1997-7#1)(2008-7#1)
these strains are##4##3##(1993-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
these strains was##3##3##(2008-10#3)
these strains were##4##3##(1996-5#1)(2008-10#3)
these strains##31##2##(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-5#1)(2008-10#17)(2008-8#2)(2009-6#1)(2012-3#2)(2013-8#3)
these strategies##18##2##(1991-6#1)(1992-2#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-3#1)
these stresses##2##2##(2008-7#1)(2008-8#1)
these structural and functional##2##4##(1995-6#1)(2008-1#1)
these structural##5##2##(1992-8#1)(1995-6#1)(2008-1#1)(2010-2#2)
these structures are##2##3##(2007-11#1)(2008-7#1)
these structures in##4##3##(1993-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
these structures##24##2##(1990-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
these students##8##2##(2008-10#1)(2008-11#4)(2010-3#1)(2011-2#1)(2013-8#1)
these studies and##2##3##(2008-10#2)
these studies are consistent with the##2##6##(1997-1#1)(2007-8#1)
these studies are##11##3##(1991-9#1)(1994-11#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-2#1)
these studies can be used##2##5##(2008-10#1)(2011-2#1)
these studies demonstrate that##3##4##(1995-2#1)(2008-10#2)
these studies demonstrate##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
these studies demonstrated##2##3##(1991-3#1)(2008-10#1)
these studies have been##3##4##(2008-5#1)(2008-7#1)(2011-1#1)
these studies have##8##3##(1991-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-8#1)
these studies in##4##3##(1995-3#1)(1995-9#1)(2008-9#1)(2010-12#1)
these studies indicate##2##3##(2008-1#1)(2008-10#1)
these studies is that##2##4##(1997-2#1)(2008-7#1)
these studies is##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2009-6#1)
these studies provide##7##3##(1991-9#1)(1992-11#1)(2008-10#1)(2008-5#2)(2010-11#1)(2010-4#1)
these studies revealed##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
these studies suggest that##6##4##(1994-3#1)(2008-10#2)(2008-2#1)(2010-12#1)(2010-5#1)
these studies support##2##3##(1994-2#1)(2008-5#1)
these studies the##2##3##(1994-2#1)(2008-10#1)
these studies were##3##3##(2009-11#1)(2012-12#2)
these studies##139##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-11#4)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#4)(2009-11#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#2)
these study##2##2##(2007-2#1)(2008-4#1)
these subgroups##3##2##(1996-3#1)(2007-8#1)(2010-12#1)
these subjects##15##2##(1991-11#1)(1995-4#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2012-2#1)
these sublines##3##2##(1997-4#1)(2008-11#2)
these substances##14##2##(1990-12#1)(1990-3#1)(1991-9#1)(1992-3#1)(1994-3#1)(1994-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2009-7#1)(2010-6#1)
these substitutions##5##2##(1990-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#1)
these substrates##8##2##(1990-11#1)(1991-9#1)(1992-3#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-6#1)
these subunits##2##2##(1993-11#1)(2009-9#1)
these supporting##2##2##(1995-12#1)(2008-1#1)
these surfaces##7##2##(2007-12#1)(2008-2#2)(2008-3#2)(2011-2#1)(2013-1#1)
these symptoms in##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
these symptoms##14##2##(1991-8#1)(1996-4#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2010-12#1)(2011-2#1)
these syndromes##6##2##(1996-6#1)(1997-5#1)(2008-3#1)(2009-12#2)(2012-2#1)
these synthetic##4##2##(1993-8#1)(2008-10#1)(2008-6#1)(2013-7#1)
these systems and##3##3##(1996-1#1)(2010-10#1)(2012-2#1)
these systems are##4##3##(1994-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
these systems has##2##3##(2008-11#1)(2010-4#1)
these systems have been##2##4##(2009-9#1)(2010-11#1)
these systems have##5##3##(1997-7#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-11#1)
these systems in##5##3##(1994-1#1)(1997-1#1)(2008-3#2)(2008-8#1)
these systems is##6##3##(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#2)(2011-7#1)
these systems must be##2##4##(1994-3#1)(1997-3#1)
these systems will##2##3##(1993-3#1)(1997-3#1)
these systems##66##2##(1990-12#1)(1990-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#5)(1997-6#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)
these targets##3##2##(2009-12#3)
these tasks##5##2##(2008-11#2)(2010-5#1)(2010-8#1)(2012-12#1)
these taxa##5##2##(2008-10#1)(2010-3#4)
these teams##3##2##(1994-2#1)(2008-11#1)(2011-1#1)
these techniques are##8##3##(1991-3#1)(1991-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-6#1)
these techniques can be##2##4##(2008-7#1)(2008-9#1)
these techniques can##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
these techniques have been##2##4##(2010-8#1)(2010-9#1)
these techniques have##3##3##(2010-8#1)(2010-9#2)
these techniques is##6##3##(1994-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-11#1)
these techniques##55##2##(1991-3#2)(1991-9#1)(1994-11#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
these technologies for##2##3##(2008-11#2)
these technologies##7##2##(2008-10#1)(2008-11#3)(2008-7#1)(2010-1#1)(2010-7#1)
these teeth##2##2##(2008-7#1)(2010-3#1)
these terms##8##2##(1995-1#1)(2008-2#1)(2008-3#1)(2010-5#2)(2011-2#3)
these test##3##2##(1997-3#1)(1997-4#1)(2008-10#1)
these tests are##2##3##(2008-10#1)(2010-3#1)
these tests is##2##3##(2008-12#1)(2008-2#1)
these tests##26##2##(1991-6#1)(1993-12#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2009-8#1)(2010-3#1)(2011-2#3)
these the##3##2##(1995-5#1)(1995-8#1)(2008-7#1)
these themes are probably##2##4##(2009-10#2)
these themes##3##2##(2009-10#3)
these theoretical##4##2##(1997-3#1)(2008-2#1)(2010-3#1)(2012-3#1)
these theories##4##2##(2007-8#1)(2008-2#1)(2010-1#1)(2010-10#1)
these therapeutic##6##2##(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
these therapies##11##2##(1990-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
these three aspects##2##3##(1994-12#1)(2012-3#1)
these three conditions##2##3##(2008-11#1)(2013-1#1)
these three countries##2##3##(2008-7#1)(2010-12#1)
these three hosts##3##3##(2008-10#3)
these three ions##2##3##(2008-10#2)
these three lineages##2##3##(2008-10#2)
these three parameters##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
these three##83##2##(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-1#2)(1997-2#1)(1997-7#2)(2007-2#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#4)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
these thresholds##2##2##(2008-4#2)
these time##2##2##(2013-8#2)
these times##3##2##(2008-1#1)(2008-10#1)(2011-3#1)
these tissues##22##2##(1990-11#1)(1990-12#2)(1991-1#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2009-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
these to##6##2##(1994-1#2)(1997-4#1)(2008-10#1)(2008-8#1)(2013-8#1)
these tools##11##2##(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#1)
these trace elements##2##3##(2008-10#1)(2008-12#1)
these traditional##2##2##(2008-1#1)(2012-12#1)
these traits is##2##3##(2012-3#2)
these traits##10##2##(2007-12#1)(2008-10#1)(2008-8#2)(2008-9#2)(2012-3#3)(2013-1#1)
these trajectories##3##2##(1997-3#1)(2008-7#1)(2009-9#1)
these transcription factors##4##3##(1995-12#1)(2008-9#1)(2012-3#2)
these transcription##5##2##(1995-12#1)(2008-9#1)(2011-2#1)(2012-3#2)
these transcripts##4##2##(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
these transducers##2##2##(2008-10#1)(2009-5#1)
these transfected##2##2##(2008-11#1)(2008-8#1)
these transformations##2##2##(1995-2#1)(2011-1#1)
these transformed##2##2##(1995-2#2)
these transgenic##3##2##(2008-10#3)
these transient##2##2##(2007-11#1)(2008-11#1)
these transitions##6##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-12#1)(2009-5#1)
these treatment##4##2##(2008-4#1)(2010-8#2)(2013-1#1)
these treatments##13##2##(1990-5#1)(1993-7#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-7#1)(2010-1#2)(2012-12#1)
these trees##3##2##(2008-10#2)(2012-6#1)
these trials are##2##3##(1996-11#1)(2008-5#1)
these trials##9##2##(1995-2#1)(1996-11#1)(1997-4#1)(2008-5#1)(2008-6#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
these tumor##4##2##(1990-12#1)(1992-9#1)(2008-8#1)(2010-2#1)
these tumors and##4##3##(1992-5#1)(1993-6#1)(2012-12#1)(2013-8#1)
these tumors are##2##3##(2008-7#1)(2012-12#1)
these tumors##29##2##(1990-10#1)(1991-8#1)(1992-5#1)(1993-6#1)(1995-2#1)(1997-1#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-9#3)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
these tumours##4##2##(1997-3#1)(2008-2#1)(2008-7#1)(2013-8#1)
these two agents##2##3##(2008-10#1)(2009-6#1)
these two approaches##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2013-1#1)
these two aspects##2##3##(1993-12#1)(1996-5#1)
these two assays##2##3##(1994-12#1)(2008-10#1)
these two cell types##2##4##(1992-9#1)(2012-12#1)
these two complexes##2##3##(1997-7#1)(2012-12#1)
these two components##5##3##(1994-12#1)(1996-9#1)(2008-3#2)(2012-12#1)
these two compounds##2##3##(1991-9#1)(2011-3#1)
these two conditions##2##3##(2010-4#1)(2012-3#1)
these two dimeric impurities##2##4##(2010-2#2)
these two disciplines##2##3##(1996-1#1)(2008-11#1)
these two diseases##4##3##(2008-10#1)(2012-12#1)(2012-3#2)
these two disorders##3##3##(2007-2#1)(2009-7#1)(2012-3#1)
these two distinct##2##3##(2008-7#2)
these two drugs##3##3##(1990-5#1)(1993-8#1)(1995-12#1)
these two factors##7##3##(1992-12#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
these two families of##2##4##(1993-12#1)(1994-5#1)
these two families##3##3##(1990-3#1)(1993-12#1)(1994-5#1)
these two forms of##2##4##(1992-12#1)(2008-7#1)
these two forms were##2##4##(1994-11#1)(2009-7#1)
these two forms##5##3##(1992-12#1)(1994-11#1)(2007-7#1)(2008-7#1)(2009-7#1)
these two fractions are##2##4##(1990-12#1)(1991-2#1)
these two functions in##2##4##(2008-10#1)(2008-11#1)
these two functions##5##3##(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
these two genera##4##3##(2008-10#4)
these two genes##5##3##(1991-5#1)(1991-9#1)(1993-12#1)(1994-11#1)(2008-1#1)
these two groups were##3##4##(1990-2#1)(1992-11#1)(2008-10#1)
these two groups##12##3##(1990-2#1)(1991-12#1)(1992-11#2)(1992-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
these two herbs##3##3##(1992-2#3)
these two hormones##2##3##(2008-6#1)(2011-2#1)
these two important##2##3##(1991-12#1)(1995-1#1)
these two isolates##4##3##(1991-8#1)(2008-10#2)(2012-2#1)
these two lines##2##3##(1997-8#1)(2008-10#1)
these two materials##2##3##(2008-3#1)(2008-5#1)
these two measures##2##3##(2008-9#2)
these two methods##10##3##(1995-9#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)
these two molecules##2##3##(2008-7#1)(2010-10#1)
these two new##2##3##(1996-2#1)(2008-5#1)
these two parameters##8##3##(1992-6#1)(1994-5#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-7#1)
these two phenomena##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
these two populations##5##3##(2008-10#2)(2008-11#2)(2008-5#1)
these two processes##4##3##(1995-2#1)(2009-2#1)(2009-8#1)(2011-2#1)
these two proteins were##2##4##(1995-2#1)(2008-5#1)
these two proteins##8##3##(1990-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-5#1)
these two reactions##2##3##(1993-12#1)(2008-10#1)
these two receptor##2##3##(1994-11#1)(2008-7#1)
these two regions##3##3##(1993-11#1)(2008-10#1)(2008-7#1)
these two sites##3##3##(2007-6#1)(2008-5#2)
these two species##10##3##(1994-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(2006-11#1)(2008-10#2)(2008-5#1)(2011-2#2)
these two strains##2##3##(2008-10#1)(2008-7#1)
these two syndromes##2##3##(1995-5#1)(2009-12#1)
these two systems##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
these two techniques##2##3##(2007-8#1)(2008-1#1)
these two types of##12##4##(1990-7#1)(1992-8#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-2#1)(2012-3#1)
these two types##14##3##(1990-7#1)(1992-8#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2012-3#1)
these two variables##3##3##(2008-10#2)(2013-8#1)
these two viruses##3##3##(2007-6#1)(2008-10#2)
these two wheat##2##3##(2008-12#2)
these two##390##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#3)(1990-8#3)(1991-12#6)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#9)(1993-2#1)(1993-8#1)(1994-11#4)(1994-12#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#5)(1997-7#4)(1997-8#2)(1997-9#1)(2006-11#1)(2007-11#1)(2007-12#6)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#70)(2008-11#16)(2008-12#3)(2008-2#7)(2008-3#21)(2008-4#5)(2008-5#17)(2008-6#4)(2008-7#16)(2008-8#7)(2008-9#8)(2009-10#5)(2009-12#4)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2013-1#8)(2013-8#2)
these type of##3##3##(1991-3#1)(1996-6#1)(2008-10#1)
these type##4##2##(1991-3#1)(1996-6#1)(2008-10#2)
these types of data##3##4##(1997-8#1)(2008-1#2)
these types of##17##3##(1991-1#1)(1991-3#1)(1992-2#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
these types##19##2##(1991-1#1)(1991-3#1)(1992-2#1)(1993-2#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
these unique##7##2##(1992-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-11#1)(2012-2#1)
these units are##2##3##(1992-11#1)(1995-5#1)
these units##6##2##(1992-11#1)(1994-9#1)(1995-5#1)(1995-9#1)(2008-10#1)(2013-1#1)
these unusual##3##2##(1991-8#1)(1996-5#1)(2012-2#1)
these useful##2##2##(1994-11#1)(2009-9#1)
these uses##2##2##(1991-5#1)(2012-3#1)
these vaccines##2##2##(2008-11#1)(2011-2#1)
these vacuoles##2##2##(2007-12#1)(2008-11#1)
these values are##5##3##(1997-2#1)(2008-10#3)(2008-3#1)
these values were similar##2##4##(1996-12#1)(2008-7#1)
these values were##7##3##(1990-12#1)(1992-12#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
these values with##2##3##(2008-10#1)(2008-3#1)
these values##31##2##(1990-12#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2013-1#1)
these variables and##3##3##(2008-10#2)(2008-8#1)
these variables are##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
these variables to##2##3##(2008-4#1)(2012-2#1)
these variables were##5##3##(1993-8#1)(1996-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
these variables will##2##3##(1993-1#1)(2008-5#1)
these variables with##2##3##(1993-2#1)(2007-12#1)
these variables##38##2##(1991-6#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#3)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
these variants##7##2##(1990-6#1)(1992-9#1)(1993-6#1)(1995-6#2)(1997-7#1)(2013-1#1)
these variations are##3##3##(1997-2#1)(2007-10#1)(2008-8#1)
these variations in##2##3##(2008-7#1)(2011-2#1)
these variations##8##2##(1993-1#1)(1997-2#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
these varieties##2##2##(2008-12#1)(2009-10#1)
these various##12##2##(1990-9#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
these vectors##9##2##(1990-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1997-4#2)(2008-10#1)(2008-2#1)
these very high risk patients##2##5##(2008-1#2)
these very##4##2##(1997-2#1)(2008-1#2)(2009-6#1)
these vesicles##3##2##(1991-2#1)(2009-2#1)(2013-7#1)
these viruses##18##2##(1995-2#1)(1995-6#1)(1997-6#1)(2007-6#1)(2008-10#11)(2008-11#1)(2013-1#1)(2013-8#1)
these volatiles in##2##3##(1990-11#2)
these volatiles##4##2##(1990-11#2)(2008-10#2)
these volumes##2##2##(2008-10#1)(2008-2#1)
these vulnerable##2##2##(2008-12#1)(2009-5#1)
these was##5##2##(1990-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
these waveguides had high##2##4##(2008-2#2)
these waveguides##3##2##(2007-12#1)(2008-2#2)
these wavelengths##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
these waves##2##2##(2008-3#2)
these were applied to##2##4##(2008-10#1)(2011-2#1)
these were found to##4##4##(1995-12#1)(1997-2#1)(2008-10#2)
these were not##4##3##(2008-10#3)(2010-3#1)
these were the##3##3##(1993-6#1)(2008-10#1)(2010-11#1)
these were used##2##3##(2009-12#1)(2012-2#1)
these were##62##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-4#1)(1992-2#2)(1993-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#4)
these will be##4##3##(2008-11#3)(2012-2#1)
these will##6##2##(2008-11#3)(2009-5#1)(2012-2#2)
these wines##2##2##(2008-10#2)
these with the##2##3##(1992-12#1)(2008-3#1)
these with##5##2##(1992-12#1)(2007-6#1)(2008-3#2)(2011-1#1)
these women may##2##3##(2007-2#1)(2011-2#1)
these women##17##2##(1990-3#1)(1991-9#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-12#1)(1997-7#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-9#2)(2011-2#2)(2012-12#1)(2013-1#1)
these workers##5##2##(1991-12#1)(1997-2#1)(2008-6#1)(2009-12#2)
these working##2##2##(1994-12#1)(2008-10#1)
these years##7##2##(1990-6#1)(1992-5#1)(1997-3#1)(2008-10#1)(2010-1#1)(2011-2#1)(2013-7#1)
these yeasts##4##2##(2008-5#2)(2013-1#2)
these youth##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
these##10399##1##(1990-10#8)(1990-11#35)(1990-12#59)(1990-2#42)(1990-3#19)(1990-4#2)(1990-5#47)(1990-6#19)(1990-7#34)(1990-8#38)(1990-9#15)(1991-1#20)(1991-10#2)(1991-11#16)(1991-12#75)(1991-2#43)(1991-3#36)(1991-4#5)(1991-5#46)(1991-6#30)(1991-7#2)(1991-8#28)(1991-9#39)(1992-1#13)(1992-10#11)(1992-11#20)(1992-12#57)(1992-2#30)(1992-3#73)(1992-4#8)(1992-5#15)(1992-6#43)(1992-7#2)(1992-8#34)(1992-9#44)(1993-1#25)(1993-10#2)(1993-11#46)(1993-12#81)(1993-2#34)(1993-3#35)(1993-5#9)(1993-6#41)(1993-7#1)(1993-8#44)(1993-9#16)(1994-1#20)(1994-10#4)(1994-11#49)(1994-12#71)(1994-2#57)(1994-3#48)(1994-5#44)(1994-6#40)(1994-7#7)(1994-8#58)(1994-9#41)(1995-1#26)(1995-10#1)(1995-11#37)(1995-12#71)(1995-2#103)(1995-3#47)(1995-4#3)(1995-5#46)(1995-6#44)(1995-8#25)(1995-9#13)(1996-1#30)(1996-10#4)(1996-11#19)(1996-12#68)(1996-2#61)(1996-3#35)(1996-4#10)(1996-5#41)(1996-6#14)(1996-7#5)(1996-8#5)(1996-9#13)(1997-1#23)(1997-2#69)(1997-3#52)(1997-4#46)(1997-5#10)(1997-6#19)(1997-7#56)(1997-8#36)(1997-9#3)(2006-10#26)(2006-11#1)(2006-12#9)(2006-4#1)(2006-6#7)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#32)(2007-11#124)(2007-12#164)(2007-2#15)(2007-3#2)(2007-4#10)(2007-5#19)(2007-6#9)(2007-7#42)(2007-8#58)(2007-9#3)(2008-1#140)(2008-10#1601)(2008-11#456)(2008-12#131)(2008-2#205)(2008-3#394)(2008-4#237)(2008-5#277)(2008-6#115)(2008-7#419)(2008-8#289)(2008-9#248)(2009-1#7)(2009-10#91)(2009-11#35)(2009-12#65)(2009-2#19)(2009-3#26)(2009-4#20)(2009-5#64)(2009-6#34)(2009-7#44)(2009-8#65)(2009-9#56)(2010-1#27)(2010-10#36)(2010-11#46)(2010-12#48)(2010-2#40)(2010-3#64)(2010-4#38)(2010-5#50)(2010-6#39)(2010-7#19)(2010-8#72)(2010-9#28)(2011-1#128)(2011-10#3)(2011-2#351)(2011-3#20)(2011-7#4)(2012-1#51)(2012-12#129)(2012-2#231)(2012-3#133)(2012-4#1)(2012-6#2)(2012-7#4)(2012-8#1)(2012-9#1)(2013-1#254)(2013-3#1)(2013-7#39)(2013-8#155)
thesecretion##2##1##(2008-11#2)
theses##8##1##(1991-6#1)(1992-3#2)(2007-8#1)(2008-2#2)(2012-3#1)(2013-1#1)
thesis that##3##2##(1996-5#1)(2008-11#1)(2009-4#1)
thesis##11##1##(1994-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
thestandard##2##1##(2008-11#1)(2008-2#1)
theta &lt##2##2##(2008-2#1)(2008-3#1)
theta 0##4##2##(1995-5#4)
theta = 0##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
theta parameter of the beta-binomial distribution##3##6##(2008-10#3)
theta parameter of the beta-binomial##4##5##(2008-10#4)
theta phase precession in##3##4##(2008-11#3)
theta phase precession##5##3##(2008-11#5)
theta phase##8##2##(2008-11#8)
theta rhythm in##4##3##(1993-9#3)(2008-11#1)
theta rhythm##8##2##(1993-12#1)(1993-9#3)(2008-11#4)
theta##72##1##(1991-12#4)(1993-12#1)(1993-9#5)(1995-5#4)(1996-3#4)(1996-7#1)(1997-5#1)(2007-12#5)(2008-10#14)(2008-11#15)(2008-2#1)(2008-3#8)(2008-8#2)(2010-2#1)(2010-7#1)(2012-2#1)(2013-8#4)
theta(0)##4##1##(2008-2#4)
theta(i) = 30##2##3##(2008-2#2)
theta(i)##5##1##(2008-2#3)(2008-3#2)
theta(m) for##2##2##(2008-3#2)
theta(m)##3##1##(2008-3#3)
theta)##2##1##(2008-10#1)(2008-3#1)
thetaiotaomicron##2##1##(1997-2#2)
they accumulate##2##2##(2008-10#1)(2008-11#1)
they act in##2##3##(2008-8#1)(2009-8#1)
they act##6##2##(1992-2#1)(1992-9#1)(1994-9#1)(2008-5#1)(2008-8#1)(2009-8#1)
they actually##3##2##(1994-3#1)(1996-3#1)(2008-5#1)
they affect##7##2##(1991-3#1)(1996-1#1)(1996-3#1)(2008-10#1)(2010-3#1)(2012-3#1)(2013-7#1)
they again##2##2##(2008-12#1)(2008-5#1)
they aggregate##2##2##(1995-8#1)(2008-10#1)
they agree with the##2##4##(2008-10#1)(2008-2#1)
they aim to##2##3##(2008-6#1)(2011-2#1)
they all have##2##3##(2008-10#1)(2008-12#1)
they all##10##2##(1992-11#1)(1995-1#1)(1995-11#1)(2008-10#3)(2008-12#1)(2011-2#1)(2011-7#1)(2013-8#1)
they allow for##2##3##(2008-4#1)(2011-2#1)
they allow to##2##3##(2008-10#2)
they allow##11##2##(1992-3#1)(1996-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
they also offer##2##3##(2008-7#2)
they also show##2##3##(1994-5#1)(1994-8#1)
they also##29##2##(1990-3#1)(1992-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#2)
they analyze##3##2##(1990-6#1)(1993-3#1)(2008-12#1)
they and the##2##3##(1996-2#1)(2007-12#1)
they and##6##2##(1994-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-9#1)(2011-2#1)
they anticipate##2##2##(2010-12#1)(2013-8#1)
they appear to##4##3##(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
they appear##8##2##(1991-5#1)(1995-12#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
they appeared to##3##3##(1993-1#1)(1997-8#1)(2008-11#1)
they appeared##4##2##(1993-1#1)(1997-8#1)(2008-11#1)(2010-8#1)
they applied##2##2##(1995-2#1)(2013-1#1)
they are a##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
they are able to##3##4##(2008-8#1)(2010-10#1)(2011-2#1)
they are affected##3##3##(1995-5#1)(2008-10#1)(2008-2#1)
they are all##4##3##(1994-6#1)(1996-10#1)(2010-11#1)(2012-2#1)
they are also called anticholinesterase agents##2##6##(2013-1#2)
they are also##11##3##(1991-2#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#3)
they are applied##3##3##(1991-8#1)(2008-10#1)(2008-3#1)
they are associated with##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
they are at##2##3##(2011-3#1)(2012-12#1)
they are based##3##3##(2007-11#1)(2007-2#1)(2008-8#1)
they are called##3##3##(1997-3#1)(2007-12#1)(2008-10#1)
they are characterized by##2##4##(2008-10#1)(2009-1#1)
they are clinically asymptomatic##2##4##(2012-3#2)
they are colonized by##2##4##(2013-1#1)(2013-8#1)
they are considered##4##3##(1993-8#1)(2008-2#1)(2009-4#1)(2013-8#1)
they are consistent with##2##4##(1991-5#1)(2009-5#1)
they are designed to##2##4##(2008-7#1)(2011-2#1)
they are designed##5##3##(1996-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
they are differentiated from##2##4##(2008-4#1)(2010-12#1)
they are difficult to##3##4##(2008-4#1)(2012-2#2)
they are easily##2##3##(2008-10#1)(2008-4#1)
they are effective##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)
they are exposed to##2##4##(2008-10#1)(2009-12#1)
they are extremely##2##3##(2008-3#1)(2008-6#1)
they are fairly##3##3##(2008-4#1)(2010-11#1)(2011-1#1)
they are far from being fully utilized in the protein science community##2##12##(2008-2#1)(2008-4#1)
they are far from being##3##5##(2008-2#1)(2008-4#1)(2009-5#1)
they are far from##5##4##(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)
they are feasible##2##3##(2013-1#1)(2013-8#1)
they are found##2##3##(1993-9#1)(1994-3#1)
they are generally##2##3##(1996-2#1)(2008-10#1)
they are handled##2##3##(2008-10#1)(2008-2#1)
they are homologous to##2##4##(2008-10#2)
they are in a##2##4##(1994-3#1)(2008-7#1)
they are in the##2##4##(1997-1#1)(2008-8#1)
they are in##12##3##(1994-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2013-7#1)
they are incorporated into##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
they are increasingly##2##3##(1993-2#1)(2009-5#1)
they are indeed##2##3##(2008-10#1)(2011-2#1)
they are influenced##2##3##(2012-2#1)(2013-1#1)
they are introduced##4##3##(1995-5#1)(2008-7#1)(2008-8#2)
they are involved in the##2##5##(1997-3#1)(2011-2#1)
they are less##3##3##(1994-5#1)(2007-12#1)(2011-2#1)
they are likely to be##3##5##(1992-6#1)(2008-10#1)(2008-4#1)
they are likely to##5##4##(1992-6#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
they are likely##6##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
they are made##2##3##(1995-5#1)(1996-6#1)
they are more##6##3##(1992-10#1)(1994-5#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-12#1)
they are morphologically##2##3##(2008-11#1)(2010-3#1)
they are most##6##3##(1994-9#1)(1995-8#1)(2006-10#1)(2008-8#2)(2009-8#1)
they are much more##2##4##(1990-11#1)(2009-12#1)
they are not a##2##4##(2008-7#1)(2013-1#1)
they are not##28##3##(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-12#1)(1994-3#1)(1996-11#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
they are now##2##3##(1997-1#1)(2009-5#1)
they are of##2##3##(2008-11#1)(2008-7#1)
they are often##4##3##(2008-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
they are present##2##3##(2007-12#1)(2008-11#1)
they are presented##3##3##(1992-2#1)(2007-8#1)(2008-3#1)
they are properly##2##3##(1995-12#1)(1996-3#1)
they are quite##3##3##(1993-12#1)(2008-10#1)(2010-12#1)
they are regarded as##2##4##(2012-2#2)
they are regulated in##2##4##(1997-2#1)(2011-2#1)
they are responsible##2##3##(1995-1#1)(1996-12#1)
they are routinely used##2##4##(2008-12#1)(2008-9#1)
they are safe##2##3##(2008-7#1)(2011-2#1)
they are separated##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
they are shifted##2##3##(1995-8#1)(2009-4#1)
they are similar##2##3##(1994-6#1)(2008-7#1)
they are still##2##3##(2008-1#1)(2008-8#1)
they are sufficient##2##3##(1993-12#1)(2008-9#1)
they are suitable##2##3##(2008-10#1)(2009-11#1)
they are taken##2##3##(2008-9#1)(2011-3#1)
they are the##10##3##(1991-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-1#1)
they are to be##4##4##(1996-3#1)(2007-11#1)(2008-1#1)(2012-2#1)
they are to##19##3##(1992-11#1)(1992-3#1)(1994-2#3)(1994-9#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-3#1)(2007-11#1)(2008-1#2)(2008-12#2)(2008-9#1)(2012-12#1)(2012-2#1)
they are typically##2##3##(2008-7#1)(2011-2#1)
they are unable to##3##4##(2008-1#1)(2008-11#1)(2013-1#1)
they are used in##2##4##(2008-3#1)(2010-12#1)
they are used##7##3##(1991-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-5#1)
they are useful##3##3##(2008-11#1)(2010-11#1)(2010-4#1)
they are usually##2##3##(2007-8#1)(2012-3#1)
they are very similar##2##4##(2007-11#1)(2008-8#1)
they are very##5##3##(2007-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)
they are##532##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#4)(1991-8#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#8)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#5)(1994-3#6)(1994-5#3)(1994-6#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#1)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#2)(2007-11#7)(2007-12#16)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#47)(2008-11#16)(2008-12#9)(2008-2#15)(2008-3#17)(2008-4#21)(2008-5#4)(2008-6#9)(2008-7#23)(2008-8#21)(2008-9#13)(2009-1#1)(2009-11#2)(2009-12#3)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#2)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#5)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#20)(2011-3#2)(2011-7#2)(2012-1#2)(2012-12#7)(2012-2#12)(2012-3#12)(2013-1#18)(2013-7#1)(2013-8#7)
they argue##2##2##(1993-1#1)(2008-1#1)
they arise##3##2##(2008-9#1)(2012-1#1)(2012-2#1)
they attach to##2##3##(2008-11#2)
they avoided##2##2##(2008-12#2)
they be##7##2##(1991-12#1)(1992-5#1)(1996-12#1)(2006-10#1)(2009-8#1)(2010-11#1)(2010-5#1)
they became##6##2##(1990-2#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-11#1)
they become##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-4#1)
they believe##4##2##(1990-2#1)(1993-1#1)(1995-1#1)(2012-3#1)
they believed##2##2##(2009-4#1)(2013-1#1)
they belong to a##2##4##(2008-4#1)(2008-8#1)
they belong to##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
they belong##6##2##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
they belonged to##2##3##(1992-11#1)(2008-10#1)
they bind##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
they both##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
they bring##2##2##(1996-3#1)(2009-5#1)
they buy##2##2##(2010-4#1)(2012-2#1)
they calculated##2##2##(1993-2#1)(1996-6#1)
they can also be##2##4##(2008-10#1)(2008-4#1)
they can also##5##3##(1993-11#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
they can be of great value in##2##7##(2009-8#1)(2013-8#1)
they can be used as##2##5##(1996-2#1)(2009-7#1)
they can be used for##2##5##(1992-8#1)(2008-9#1)
they can be used in##2##5##(1994-12#1)(2013-1#1)
they can be used to investigate##2##6##(1990-7#1)(2012-3#1)
they can be used to##4##5##(1990-12#1)(1990-7#1)(2008-3#1)(2012-3#1)
they can be used##12##4##(1990-12#1)(1990-7#1)(1992-8#1)(1994-12#1)(1995-6#1)(1996-2#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
they can be##54##3##(1990-12#3)(1990-7#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
they can cause##2##3##(1990-6#1)(2008-8#1)
they can easily be##2##4##(1994-3#1)(2008-10#1)
they can expect##3##3##(2007-2#1)(2009-9#1)(2013-1#1)
they can help##2##3##(2008-2#1)(2008-5#1)
they can influence the##2##4##(1996-3#1)(2008-7#1)
they can no longer##2##4##(1997-5#1)(2009-10#1)
they can reach##2##3##(2008-5#1)(2011-2#1)
they can undergo##2##3##(1994-11#1)(2008-8#1)
they can work##2##3##(1994-1#1)(2011-1#1)
they can##132##2##(1990-12#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-3#2)(1992-3#1)(1992-8#1)(1993-11#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#2)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#9)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#7)(2009-10#3)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
they cannot##6##2##(1992-3#1)(1994-12#1)(1997-5#1)(2007-11#1)(2010-12#1)(2010-4#1)
they carry##4##2##(1996-2#1)(2007-11#1)(2008-10#1)(2012-3#1)
they cause##10##2##(1990-9#1)(1997-7#1)(2008-10#4)(2008-8#1)(2011-2#2)(2012-12#1)
they choose##2##2##(1991-3#1)(2012-1#1)
they chose to##2##3##(2008-7#1)(2009-6#1)
they chose##3##2##(2008-7#1)(2009-6#1)(2010-2#1)
they clearly##2##2##(2008-12#1)(2013-8#1)
they completed##2##2##(2007-12#1)(2008-12#1)
they connect##2##2##(2008-8#1)(2009-7#1)
they consider to be important##2##5##(1996-1#1)(2011-2#1)
they consider##7##2##(1996-1#1)(2008-11#1)(2008-8#1)(2011-2#4)
they considered##2##2##(2008-11#1)(2009-6#1)
they constitute##2##2##(2008-12#1)(2008-3#1)
they consumed##3##2##(1992-8#1)(2010-8#1)(2012-12#1)
they contain a##2##3##(2008-3#1)(2013-1#1)
they contain##8##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#3)
they contained##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
they continue to##3##3##(2008-10#1)(2013-1#2)
they contribute##2##2##(2008-10#1)(2009-5#1)
they could be##14##3##(1996-9#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
they could not##3##3##(1996-6#1)(2010-8#1)(2013-8#1)
they could potentially##2##3##(2008-10#1)(2009-7#1)
they could##36##2##(1990-2#1)(1991-9#1)(1992-4#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
they covered##2##2##(2008-5#1)(2013-8#1)
they create##3##2##(1994-12#1)(1997-1#1)(2011-2#1)
they created##2##2##(1996-9#1)(2008-5#1)
they deemed##2##2##(2008-1#1)(2008-5#1)
they delay##2##2##(2008-1#1)(2010-12#1)
they demonstrate a##2##3##(1993-1#1)(2008-7#1)
they demonstrate that##2##3##(2008-7#1)(2008-9#1)
they demonstrate##6##2##(1993-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)
they depend##2##2##(1993-6#1)(2008-2#1)
they describe the##2##3##(1991-3#1)(2012-12#1)
they describe##5##2##(1990-5#1)(1991-3#1)(1993-9#1)(1995-1#1)(2012-12#1)
they deserve##2##2##(1994-12#1)(2010-11#1)
they develop##9##2##(1990-7#1)(1993-1#1)(1995-3#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
they developed##3##2##(1993-10#1)(1993-12#2)
they did in##2##3##(1993-12#1)(2008-10#1)
they did not change##2##4##(2008-10#1)(2012-12#1)
they did not have##2##4##(2009-10#1)(2012-12#1)
they did not##22##3##(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#2)(2010-4#1)(2012-12#4)
they did##30##2##(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-7#1)(1995-11#1)(1995-6#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2010-4#1)(2012-12#4)
they didn't##2##2##(1993-12#1)(1996-2#1)
they differ##5##2##(1996-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-11#1)
they differed##2##2##(2008-10#1)(2010-8#1)
they discuss the##3##3##(1997-3#1)(2007-8#1)(2010-8#1)
they discuss##4##2##(1993-12#1)(1997-3#1)(2007-8#1)(2010-8#1)
they display##4##2##(1993-12#1)(1994-8#1)(2008-7#1)(2010-3#1)
they displayed##3##2##(1993-6#1)(2008-11#1)(2012-12#1)
they distinguished##2##2##(1992-12#1)(2008-6#1)
they do in##3##3##(1993-12#1)(1994-9#1)(1995-1#1)
they do it##2##3##(2008-6#1)(2009-8#1)
they do not act##2##4##(1993-8#1)(2010-10#1)
they do not bind##2##4##(1995-5#1)(2008-10#1)
they do not give##2##4##(2008-10#1)(2012-3#1)
they do not have##2##4##(2008-5#1)(2012-12#1)
they do not provide##2##4##(1992-3#1)(2008-10#1)
they do not require##2##4##(2007-12#1)(2008-4#1)
they do not##49##3##(1991-6#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
they do##71##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
they either##5##2##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
they elicit##2##2##(1994-11#1)(2008-11#1)
they emerge##3##2##(2008-10#1)(2009-5#1)(2010-7#1)
they emphasize the##2##3##(1992-5#1)(1996-6#1)
they emphasize##3##2##(1992-5#1)(1996-6#1)(2010-12#1)
they enable##2##2##(2008-10#1)(2011-2#1)
they encounter##4##2##(1996-1#1)(2008-6#1)(2010-8#1)(2013-8#1)
they encountered##4##2##(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
they engage in##2##3##(2008-12#1)(2008-6#1)
they enhance##3##2##(1995-6#1)(1996-11#1)(2011-2#1)
they establish##3##2##(2008-1#1)(2008-11#1)(2008-2#1)
they evaluate##2##2##(1993-3#1)(2009-6#1)
they evolve##2##2##(2008-2#1)(2010-3#1)
they exert##4##2##(2008-11#1)(2008-4#1)(2010-10#1)(2013-1#1)
they exhibit a##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
they exhibit##14##2##(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
they exhibited##5##2##(1991-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
they exist##2##2##(2010-3#1)(2012-3#1)
they experience##2##2##(1994-11#1)(2008-5#1)
they experienced##9##2##(2008-11#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
they explain##2##2##(1990-3#1)(1994-8#1)
they explore##2##2##(1993-12#1)(2008-12#1)
they face##6##2##(1994-2#1)(2007-7#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
they fail to##4##3##(1995-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
they failed##3##2##(1996-5#1)(2007-8#1)(2010-8#1)
they fall##3##2##(1990-5#1)(1993-3#1)(2008-11#1)
they feel##5##2##(2008-3#1)(2011-2#2)(2012-1#1)(2012-3#1)
they fell##2##2##(2007-6#1)(2008-5#1)
they felt##5##2##(1994-3#1)(1996-3#1)(2008-1#1)(2008-11#2)
they find that##3##3##(1992-2#2)(1994-3#1)
they find##5##2##(1992-2#2)(1994-3#1)(2007-8#1)(2012-2#1)
they fit into##2##3##(1992-12#1)(2008-12#1)
they focus##2##2##(1994-3#1)(2010-7#1)
they followed##2##2##(1994-3#1)(2008-12#1)
they form a##2##3##(1994-3#1)(2008-10#1)
they form##9##2##(1994-3#1)(1995-2#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-12#1)
they formed a##2##3##(2008-11#1)(2008-7#1)
they formed##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
they found##2##2##(2008-12#1)(2012-12#1)
they fully##2##2##(2008-10#1)(2008-7#1)
they function##5##2##(1993-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)
they gained##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
they generate##5##2##(1994-6#1)(1995-2#1)(1996-2#1)(2008-4#1)(2008-9#1)
they get##2##2##(2008-8#1)(2009-10#1)
they give##2##2##(1994-8#1)(1995-2#1)
they go##2##2##(2010-5#1)(2011-2#1)
they grew##2##2##(1994-7#1)(1995-2#1)
they grow##2##2##(2008-8#1)(2010-12#1)
they had a higher##2##4##(1992-5#1)(2010-10#1)
they had a##5##3##(1992-5#1)(1994-3#1)(2009-3#1)(2010-10#1)(2010-3#1)
they had been##5##3##(1992-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-7#1)
they had experienced##2##3##(2007-4#1)(2012-1#1)
they had in##2##3##(2010-1#1)(2012-3#1)
they had not##2##3##(1995-5#1)(2008-8#1)
they had received##6##3##(1994-2#1)(1995-6#1)(1997-2#1)(2007-7#1)(2013-1#2)
they had to##3##3##(1994-3#1)(2010-3#1)(2012-12#1)
they had##71##2##(1991-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#4)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-11#3)(2008-12#2)(2008-5#2)(2008-8#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
they have a##14##3##(1990-8#1)(1991-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
they have also##3##3##(2008-1#1)(2008-10#1)(2009-5#1)
they have an##7##3##(1997-2#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2012-3#1)
they have become##5##3##(1997-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-5#1)
they have been successfully##2##4##(2011-2#1)(2012-12#1)
they have been##28##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#6)(2008-8#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#2)
they have carried out##2##4##(1993-3#1)(1996-2#1)
they have evolved##2##3##(2008-8#1)(2008-9#1)
they have fundamentally some problems in different features##2##8##(2013-1#2)
they have gained##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
they have no##2##3##(2008-1#1)(2008-3#1)
they have not been##3##4##(1997-3#1)(2008-3#1)(2012-12#1)
they have not yet##2##4##(2008-5#2)
they have not##6##3##(1995-1#1)(1997-3#1)(2008-3#1)(2008-5#2)(2012-12#1)
they have presented hypersensitivity reactions##2##5##(2008-8#1)(2011-1#1)
they have received##2##3##(1994-12#1)(2010-4#1)
they have the##6##3##(1992-1#1)(1994-12#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
they have to be replaced##2##5##(1996-11#1)(2008-10#1)
they have to be##4##4##(1996-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
they have to##9##3##(1993-9#1)(1996-11#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-6#1)(2012-2#1)
they have##159##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#6)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#2)(2007-12#3)(2008-1#7)(2008-10#12)(2008-11#7)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#4)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
they held##2##2##(2008-12#1)(2010-3#1)
they help##3##2##(1995-3#1)(2008-11#1)(2008-9#1)
they highlight the##2##3##(1990-5#1)(1995-11#1)
they hope to##2##3##(1991-1#1)(1992-12#1)
they hope##3##2##(1991-1#1)(1992-12#1)(2007-3#1)
they identified##2##2##(2007-10#1)(2007-12#1)
they imply##2##2##(1990-12#1)(2008-9#1)
they improve##2##2##(2008-4#1)(2011-2#1)
they include##3##2##(1997-3#1)(2008-11#2)
they increase the##3##3##(1990-12#1)(1991-2#1)(2008-10#1)
they increase##5##2##(1990-12#1)(1990-8#1)(1991-2#1)(2007-12#1)(2008-10#1)
they indicate that##2##3##(1991-9#1)(1995-12#1)
they indicate##3##2##(1991-9#1)(1994-2#1)(1995-12#1)
they induce##7##2##(1990-2#1)(1994-6#1)(1995-5#1)(2008-10#3)(2010-10#1)
they infect##2##2##(2008-10#1)(2008-11#1)
they influence the##2##3##(1997-2#1)(2008-5#1)
they influence##3##2##(1997-2#1)(2008-5#1)(2013-1#1)
they ingest##2##2##(1995-12#1)(2007-2#1)
they inhibit the##2##3##(1994-11#1)(1995-8#1)
they inhibit##3##2##(1994-11#1)(1995-8#1)(1997-1#1)
they inhibited the##2##3##(1990-8#1)(1997-1#1)
they inhibited##4##2##(1990-8#1)(1995-3#1)(1997-1#1)(2008-10#1)
they intended to##2##3##(1991-3#1)(2009-10#1)
they interact with##4##3##(1994-2#1)(2008-8#1)(2009-10#1)(2011-2#1)
they interact##10##2##(1994-2#1)(2008-4#1)(2008-8#2)(2009-10#2)(2010-5#1)(2011-2#2)(2012-3#1)
they know##2##2##(1991-12#1)(2008-5#1)
they lack##2##2##(2008-5#1)(2012-2#1)
they lacked the##2##3##(2008-10#1)(2008-8#1)
they lacked##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
they later##2##2##(1994-5#1)(2008-11#1)
they lay##2##2##(2008-12#1)(2008-8#1)
they leach from supply pipes into drinking water and##2##9##(2008-10#2)
they liked##2##2##(1992-3#1)(2012-2#1)
they live##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
they lived##2##2##(2008-7#1)(2013-1#1)
they looked##2##2##(2007-12#2)
they lost##3##2##(1990-2#1)(1992-2#1)(1994-12#1)
they made the##2##3##(2008-1#1)(2009-6#1)
they made##7##2##(1995-12#1)(1997-3#1)(2008-1#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-3#1)
they maintain##2##2##(2009-8#1)(2012-2#1)
they make##5##2##(1991-2#1)(1993-1#1)(1995-2#1)(1996-12#1)(2008-1#1)
they may also be##3##4##(2008-4#2)(2010-5#1)
they may also serve as a transformative model for emerging EMR/EHR requirements##2##12##(2010-8#2)
they may also##7##3##(1995-5#1)(2008-4#2)(2008-5#1)(2010-5#1)(2010-8#2)
they may be related to##2##5##(2008-6#1)(2008-7#1)
they may be the##2##4##(2008-9#1)(2010-12#1)
they may be##22##3##(1990-3#1)(1991-3#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
they may become symptomatic##2##4##(2008-10#1)(2010-12#1)
they may become##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
they may benefit##3##3##(2007-12#2)(2010-3#1)
they may constitute##2##3##(1991-12#1)(2008-10#1)
they may continue to##2##4##(2007-12#1)(2013-1#1)
they may have##5##3##(1991-2#1)(1992-2#1)(1993-3#1)(2008-5#1)(2009-8#1)
they may increase##2##3##(2008-7#2)
they may not be##3##4##(2006-10#1)(2008-4#1)(2011-2#1)
they may play a role in##2##6##(1992-6#1)(2008-10#1)
they may play a##3##4##(1992-6#1)(2008-10#1)(2008-11#1)
they may provide##3##3##(1995-6#1)(2008-3#1)(2012-3#1)
they may reduce the##2##4##(1996-12#1)(2008-9#1)
they may represent##2##3##(2008-7#1)(2012-2#1)
they may result##2##3##(1995-11#1)(2008-7#1)
they may##97##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
they mediate##2##2##(1995-12#1)(2013-1#1)
they met##3##2##(2007-12#1)(2010-10#1)(2012-1#1)
they might also##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
they might be##8##3##(1990-6#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)
they might not##2##3##(1996-3#1)(2008-10#1)
they might##18##2##(1990-6#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)
they migrate##2##2##(2007-12#1)(2008-4#1)
they modify the##2##3##(1994-1#1)(2008-3#1)
they modify##3##2##(1994-1#1)(1994-9#1)(2008-3#1)
they must adopt standards and enforce requirements that are at least as effective as federal requirements##3##16##(1993-12#1)(1993-2#1)(1993-3#1)
they must also##2##3##(1992-3#1)(2012-12#1)
they must be##7##3##(1994-2#1)(1997-5#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-6#1)
they must use##2##3##(1994-1#1)(1994-3#1)
they must##23##2##(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-12#2)(2013-1#1)
they need to be##3##4##(1996-1#1)(1996-3#1)(2011-2#1)
they need to##9##3##(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2008-11#1)(2010-5#1)(2011-2#2)
they need##14##2##(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-2#1)(2008-11#2)(2008-2#1)(2010-5#1)(2011-2#2)(2012-12#1)
they needed more help##2##4##(1994-1#1)(1997-2#1)
they needed##3##2##(1994-1#1)(1997-2#1)(1997-6#1)
they not only##2##3##(1993-3#1)(2008-7#1)
they now##2##2##(1994-3#1)(1996-3#1)
they occur in the##2##4##(1994-12#1)(1996-5#1)
they occur in##4##3##(1992-6#1)(1994-12#1)(1996-5#1)(2010-8#1)
they occur##11##2##(1990-9#1)(1992-6#1)(1994-12#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-8#1)
they occurred##2##2##(2007-8#1)(2011-2#1)
they offer a##4##3##(1991-1#1)(1991-12#1)(2008-10#1)(2008-7#1)
they offer the##2##3##(2008-8#1)(2009-4#1)
they offer valuable##2##3##(2008-8#1)(2012-2#1)
they offer##11##2##(1991-1#1)(1991-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-4#1)(2012-12#1)(2012-2#1)
they offered##2##2##(1996-1#1)(2010-3#1)
they often##7##2##(1993-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
they only##4##2##(2008-5#1)(2009-9#1)(2013-1#2)
they operate##2##2##(2007-12#1)(2008-9#1)
they originate##3##2##(1992-3#1)(1997-1#1)(2008-7#1)
they ought to##2##3##(1992-12#1)(2008-7#1)
they overlap##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
they participate in##2##3##(1995-8#1)(2011-2#1)
they participate##3##2##(1993-1#1)(1995-8#1)(2011-2#1)
they participated in##3##3##(2007-12#1)(2010-11#1)(2011-2#1)
they passed##2##2##(1992-8#1)(2008-10#1)
they perceive##4##2##(2008-10#1)(2008-11#1)(2012-3#2)
they perceived as##4##3##(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
they perceived##9##2##(1992-2#1)(1994-12#1)(2008-11#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-8#1)
they performed##4##2##(1991-2#1)(1996-2#1)(2008-5#1)(2010-3#1)
they plan and##2##3##(2008-1#1)(2011-2#1)
they play a role in##2##5##(2008-7#1)(2012-2#1)
they play a##5##3##(1991-9#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-2#1)
they play an important role in##2##6##(1991-3#1)(2011-2#1)
they play an##3##3##(1991-3#1)(2010-11#1)(2011-2#1)
they play##10##2##(1991-3#1)(1991-9#1)(1995-2#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
they point##2##2##(1990-2#1)(2013-1#1)
they possess a##2##3##(1991-6#1)(1996-2#1)
they possess##6##2##(1991-6#1)(1996-2#1)(2008-10#1)(2008-7#2)(2010-8#1)
they practice##3##2##(1994-1#1)(2007-7#1)(2008-11#1)
they preferred##4##2##(2008-8#1)(2009-9#2)(2013-1#1)
they present##7##2##(1991-5#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
they presented a##2##3##(2008-10#1)(2008-5#1)
they presented##6##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#2)(2013-7#1)
they produce##6##2##(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
they produced##4##2##(1992-11#1)(1993-8#1)(2008-10#1)(2008-5#1)
they provide a##3##3##(1991-12#1)(2008-10#1)(2010-9#1)
they provide an##2##3##(1990-3#1)(2008-3#1)
they provide information##2##3##(1997-1#1)(2008-9#1)
they provide the##2##3##(2008-9#1)(2010-9#1)
they provide##22##2##(1990-3#1)(1991-12#1)(1992-2#1)(1995-12#1)(1996-2#1)(1997-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-9#2)(2011-2#1)(2012-3#1)
they pursue##2##2##(1991-2#1)(1995-1#1)
they raise##2##2##(1995-5#1)(2010-11#1)
they rarely##2##2##(1994-1#1)(1996-9#1)
they reach##3##2##(1996-6#1)(2006-10#1)(2011-2#1)
they reached##5##2##(1991-9#1)(1992-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
they react with##2##3##(2008-10#2)
they read##2##2##(2013-1#1)(2013-8#1)
they realize##2##2##(1997-1#1)(2008-3#1)
they really##2##2##(2008-5#1)(2013-8#1)
they receive at##2##3##(1992-3#1)(1995-2#1)
they receive##7##2##(1992-3#1)(1995-2#1)(1995-6#1)(2008-12#2)(2009-5#1)(2013-1#1)
they received a##2##3##(1993-10#1)(2008-10#1)
they received##8##2##(1993-10#1)(1993-6#1)(1994-7#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-7#1)
they reduce##5##2##(1993-8#1)(1994-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
they reduced##2##2##(2008-10#2)
they reflect##2##2##(1996-4#1)(2008-11#1)
they relate to##11##3##(1991-2#1)(1993-3#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2013-8#1)
they related?##2##2##(2006-10#1)(2008-11#1)
they remain##5##2##(1994-12#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-2#1)
they remained in the##2##4##(1993-3#1)(2008-9#1)
they remained##3##2##(1993-3#1)(2008-5#1)(2008-9#1)
they report##2##2##(1991-3#1)(2007-7#1)
they represent a##2##3##(1993-6#1)(1995-2#1)
they represent##12##2##(1992-6#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#3)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#2)
they require##8##2##(1994-3#1)(1996-2#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
they resemble##2##2##(1990-5#1)(2007-12#1)
they respond##4##2##(1994-5#1)(2008-7#1)(2010-10#1)(2013-7#1)
they reveal##6##2##(1991-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-8#1)
they secrete##2##2##(2008-7#2)
they see##3##2##(1991-12#1)(1992-11#1)(2012-3#1)
they seem to##2##3##(2008-12#1)(2012-5#1)
they seemed to##2##3##(2010-10#1)(2011-1#1)
they serve as##2##3##(1991-2#1)(1996-1#1)
they serve##13##2##(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-1#1)(2008-11#1)(2012-1#1)
they share##13##2##(1995-2#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-7#1)(2012-12#1)
they shared##4##2##(1996-11#1)(2008-10#2)(2010-11#1)
they should be used##2##4##(2008-11#1)(2011-2#1)
they should be##13##3##(1992-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#2)
they should##18##2##(1992-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
they show an##2##3##(1995-12#1)(2008-3#1)
they show##8##2##(1991-1#1)(1991-5#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)
they showed a##4##3##(1993-3#1)(1993-8#1)(1994-8#1)(2008-11#1)
they showed different##2##3##(2008-10#2)
they showed the##2##3##(2008-11#1)(2011-2#1)
they showed##14##2##(1991-3#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2011-2#1)(2013-1#1)
they significantly##3##2##(1997-1#1)(2008-1#1)(2008-8#1)
they spare##2##2##(2008-11#1)(2008-8#1)
they specifically##2##2##(1997-1#1)(2012-2#1)
they spend##2##2##(1992-12#1)(2013-8#1)
they spent##2##2##(2007-2#1)(2009-9#1)
they start##3##2##(2007-7#1)(2009-12#1)(2010-5#1)
they started##2##2##(2008-8#1)(2010-2#1)
they still##9##2##(1993-12#1)(1994-1#1)(1995-6#1)(1995-9#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-3#1)
they subsequently##2##2##(1997-3#1)(2010-8#1)
they successfully##2##2##(1992-3#1)(2011-2#1)
they suggest that##5##3##(1991-5#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-4#1)
they suggest##7##2##(1991-5#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
they support the##3##3##(1991-2#1)(2010-5#1)(2012-2#1)
they switch##2##2##(1992-3#1)(2006-10#1)
they take##2##2##(1996-11#1)(2013-1#1)
they tend to##2##3##(2008-11#1)(2013-8#1)
they tend##3##2##(2008-11#1)(2011-3#1)(2013-8#1)
they tended to##2##3##(2007-2#1)(2008-11#1)
they think##2##2##(1994-2#1)(2013-1#1)
they thought##3##2##(1997-4#1)(2007-12#1)(2010-4#1)
they told##2##2##(1995-6#1)(2009-10#1)
they too##3##2##(2008-3#1)(2008-4#1)(2009-7#1)
they trigger##2##2##(2011-2#1)(2012-3#1)
they try to##2##3##(1991-12#1)(2010-5#1)
they undergo##4##2##(1991-3#1)(1997-7#1)(2008-1#1)(2008-11#1)
they underline##2##2##(1991-6#1)(1993-6#1)
they understood##2##2##(1993-12#1)(2008-11#1)
they underwent##5##2##(1994-11#1)(1995-4#1)(2007-8#1)(2008-6#1)(2013-1#1)
they use##12##2##(1991-1#1)(1993-12#1)(1997-3#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
they used##4##2##(1993-2#1)(2008-10#1)(2008-3#1)(2010-3#1)
they usually##6##2##(2008-10#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
they varied##2##2##(2008-11#1)(2012-3#1)
they viewed##2##2##(2008-12#1)(2012-2#1)
they want##4##2##(1994-12#1)(1996-8#1)(1997-2#1)(2012-3#1)
they wanted to##2##3##(2011-2#1)(2013-1#1)
they wanted##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
they were &quot##3##3##(1994-1#1)(2008-7#2)
they were HIV-positive##2##3##(1995-6#1)(1997-5#1)
they were able to##2##4##(1993-5#1)(2008-9#1)
they were able##3##3##(1993-5#1)(2008-11#1)(2008-9#1)
they were all##2##3##(2008-10#1)(2008-8#1)
they were also##5##3##(1995-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
they were applied##2##3##(2009-10#1)(2011-2#1)
they were characterized by##2##4##(2007-11#1)(2008-12#1)
they were concentrated##3##3##(1993-12#1)(2008-10#2)
they were considered to##2##4##(1994-6#1)(2008-7#1)
they were considered##3##3##(1994-6#1)(1996-2#1)(2008-7#1)
they were contaminated##2##3##(2008-11#2)
they were derived##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
they were employed##2##3##(2008-10#1)(2008-11#1)
they were exposed to##4##4##(1990-2#1)(1996-9#1)(2008-10#1)(2008-5#1)
they were found to be##2##5##(2008-5#1)(2010-7#1)
they were found##3##3##(2008-5#1)(2010-7#1)(2013-1#1)
they were further##2##3##(2008-10#1)(2008-5#1)
they were given##2##3##(1996-5#1)(2009-10#1)
they were identical to##2##4##(2008-10#2)
they were in##5##3##(2008-10#1)(2008-5#2)(2009-12#1)(2010-3#1)
they were inoculated##2##3##(2008-10#2)
they were isolated from##2##4##(2008-10#1)(2008-5#1)
they were isolated##4##3##(2008-10#3)(2008-5#1)
they were less##2##3##(2008-3#1)(2013-8#1)
they were managing##2##3##(1994-1#2)
they were more##4##3##(2006-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
they were not##15##3##(1993-2#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#1)(2013-1#3)
they were of##2##3##(1991-2#1)(2008-10#1)
they were performing##2##3##(1994-3#1)(2008-11#1)
they were placed##2##3##(2007-7#1)(2008-10#1)
they were related##2##3##(1993-12#1)(2007-12#1)
they were satisfied with##3##4##(1990-2#1)(2007-10#1)(2008-9#1)
they were separated##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
they were significantly##3##3##(1995-12#1)(2007-1#1)(2008-7#1)
they were slower##2##3##(1993-6#1)(2007-12#1)
they were tested for their##2##5##(1993-6#1)(2008-10#1)
they were tested##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
they were the##5##3##(1995-12#1)(1996-2#1)(2008-12#1)(2008-7#1)(2009-11#1)
they were then##2##3##(1993-12#1)(2008-7#1)
they were to##3##3##(1997-6#1)(2008-9#1)(2013-1#1)
they were trained##2##3##(1994-3#1)(2008-9#1)
they were treated##2##3##(1997-3#1)(1997-4#1)
they were under##2##3##(1995-5#1)(2013-8#1)
they were used for##2##4##(2008-10#2)
they were used in the##2##5##(2008-10#1)(2011-2#1)
they were used in##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
they were used to##3##4##(1993-8#1)(2008-10#1)(2011-2#1)
they were used##9##3##(1993-8#1)(2008-10#5)(2008-11#1)(2011-2#2)
they were well##2##3##(1990-7#1)(1991-4#1)
they were##319##2##(1990-10#1)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#5)(1993-2#1)(1993-5#1)(1993-6#4)(1993-8#4)(1994-1#3)(1994-11#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#4)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#73)(2008-11#15)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#2)(2010-1#2)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#12)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#6)
they will be##9##3##(1991-12#1)(1992-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
they will have##3##3##(1994-2#1)(2008-10#2)
they will##28##2##(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2013-8#1)
they work with##3##3##(1993-1#1)(2009-6#1)(2011-1#1)
they work##8##2##(1993-1#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-11#1)(2009-6#1)(2010-12#1)(2011-1#1)
they would be##4##3##(1994-1#1)(1994-9#1)(2010-8#1)(2012-12#1)
they would like to##3##4##(1991-2#1)(2010-10#1)(2011-1#1)
they would not##2##3##(1992-2#1)(2008-1#1)
they would otherwise##2##3##(1997-1#1)(2008-8#1)
they would##30##2##(1990-6#2)(1991-2#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-4#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
they##2950##1##(1990-10#1)(1990-11#5)(1990-12#8)(1990-2#12)(1990-3#7)(1990-5#7)(1990-6#10)(1990-7#4)(1990-8#4)(1990-9#5)(1991-1#7)(1991-11#1)(1991-12#20)(1991-2#23)(1991-3#19)(1991-4#1)(1991-5#9)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#8)(1992-12#16)(1992-2#17)(1992-3#29)(1992-4#2)(1992-5#5)(1992-6#9)(1992-8#8)(1992-9#5)(1993-1#14)(1993-10#2)(1993-11#4)(1993-12#28)(1993-2#16)(1993-3#17)(1993-5#2)(1993-6#14)(1993-8#11)(1993-9#5)(1994-1#13)(1994-11#11)(1994-12#23)(1994-2#19)(1994-3#33)(1994-5#11)(1994-6#7)(1994-7#4)(1994-8#9)(1994-9#8)(1995-1#18)(1995-10#1)(1995-11#10)(1995-12#18)(1995-2#32)(1995-3#11)(1995-4#1)(1995-5#19)(1995-6#18)(1995-8#7)(1995-9#2)(1996-1#21)(1996-10#1)(1996-11#10)(1996-12#17)(1996-2#27)(1996-3#24)(1996-4#2)(1996-5#12)(1996-6#8)(1996-7#2)(1996-8#5)(1996-9#6)(1997-1#21)(1997-2#25)(1997-3#28)(1997-4#9)(1997-5#8)(1997-6#13)(1997-7#6)(1997-8#10)(2006-10#11)(2006-8#1)(2007-1#1)(2007-10#14)(2007-11#22)(2007-12#56)(2007-2#17)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#6)(2007-7#15)(2007-8#16)(2008-1#40)(2008-10#301)(2008-11#132)(2008-12#55)(2008-2#49)(2008-3#61)(2008-4#70)(2008-5#80)(2008-6#37)(2008-7#112)(2008-8#92)(2008-9#65)(2009-1#2)(2009-10#17)(2009-11#10)(2009-12#10)(2009-2#2)(2009-3#4)(2009-4#11)(2009-5#27)(2009-6#14)(2009-7#9)(2009-8#18)(2009-9#12)(2010-1#7)(2010-10#15)(2010-11#18)(2010-12#21)(2010-2#6)(2010-3#27)(2010-4#20)(2010-5#18)(2010-6#3)(2010-7#13)(2010-8#26)(2010-9#6)(2011-1#26)(2011-2#120)(2011-3#4)(2011-7#4)(2012-1#14)(2012-12#50)(2012-2#57)(2012-3#53)(2012-5#1)(2013-1#92)(2013-7#11)(2013-8#40)
they're##3##1##(1992-11#1)(2010-9#1)(2013-1#1)
thiabendazole and fuberidazole##2##3##(2008-10#2)
thiabendazole##11##1##(2008-10#11)
thiacrown ether##2##2##(2008-10#2)
thiamazole##3##1##(1994-3#3)
thiamethoxam##2##1##(2011-2#2)
thiamin transport##3##2##(1990-2#3)
thiamin##10##1##(1990-2#5)(1995-6#3)(2008-10#1)(2010-9#1)
thiamine and##4##2##(2008-1#2)(2012-4#2)
thiamine deficiency in##2##3##(2008-1#2)
thiamine deficiency##4##2##(2008-1#4)
thiamine disulfide##2##2##(1994-11#2)
thiamine##44##1##(1994-11#2)(2008-1#13)(2008-10#24)(2008-7#1)(2009-7#2)(2012-4#2)
thiamine[Symbol##2##1##(2008-11#2)
thiazide diuretic alone)##2##3##(2009-9#2)
thiazide diuretic##4##2##(2009-9#4)
thiazide diuretics and##2##3##(1992-11#1)(1994-12#1)
thiazide diuretics##3##2##(1992-11#1)(1994-12#1)(2009-9#1)
thiazide##8##1##(1992-11#1)(1994-12#1)(2008-10#1)(2009-9#5)
thiazole##3##1##(1995-3#1)(2006-6#1)(2008-10#1)
thiazolidine##3##1##(1995-3#2)(2008-10#1)
thiazolidinediones (TZDs)##2##2##(2008-1#1)(2010-10#1)
thiazolidinediones##8##1##(2008-1#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
thick CsI)##2##2##(2011-1#2)
thick and##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)
thick ascending##2##2##(1990-2#1)(2007-7#1)
thick collagenous capsule##2##3##(2011-2#2)
thick filament loss##2##3##(2008-7#2)
thick film semiconductor sensor##2##4##(2008-10#2)
thick film##6##2##(2008-10#4)(2008-12#1)(2008-3#1)
thick films##2##2##(2007-2#1)(2008-3#1)
thick insulating coatings##2##3##(2008-10#2)
thick layer of##2##3##(2007-12#2)
thick layers of##2##3##(2008-3#1)(2008-7#1)
thick layers##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
thick medium##2##2##(2007-12#1)(2008-3#1)
thick nasal discharge##2##3##(2011-2#2)
thick polymer films##2##3##(2008-10#2)
thick polymer##3##2##(2008-10#3)
thick scattering##4##2##(2008-3#4)
thick uniaxial##2##2##(2008-3#2)
thick walled##2##2##(2012-12#1)(2012-2#1)
thick with a##2##3##(1995-11#1)(2008-3#1)
thick with##3##2##(1995-11#1)(2008-2#1)(2008-3#1)
thick##139##1##(1990-2#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-3#2)(1997-5#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#18)(2008-11#1)(2008-12#3)(2008-2#23)(2008-3#29)(2008-5#2)(2008-7#5)(2008-9#1)(2009-11#1)(2009-5#4)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
thick)##7##1##(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#2)(2010-9#1)
thick-film carbon##4##2##(2008-10#4)
thick-film semiconductor sensor##2##3##(2008-10#2)
thick-film##6##1##(2008-10#6)
thick-walled##4##1##(2007-12#1)(2008-10#1)(2010-3#1)(2013-1#1)
thicken##2##1##(2008-5#1)(2008-8#1)
thickened##15##1##(1990-3#1)(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#4)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
thickening and##8##2##(1995-12#2)(2008-10#2)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
thickening of dura matter##2##4##(2012-2#2)
thickening of the bowel wall##2##5##(1992-5#1)(2012-2#1)
thickening of the##13##3##(1992-5#1)(1996-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-5#3)(2011-1#1)(2012-1#1)(2012-2#1)
thickening of##19##2##(1990-9#1)(1992-5#1)(1996-3#2)(1997-5#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#3)
thickening was##2##2##(2008-10#1)(2011-2#1)
thickening##52##1##(1990-9#1)(1991-12#3)(1992-5#2)(1994-8#1)(1995-12#5)(1995-8#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-7#3)(2008-1#1)(2008-10#7)(2008-5#4)(2008-7#1)(2008-9#1)(2010-10#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
thicker and##2##2##(2007-11#1)(2008-10#1)
thicker than the##2##3##(2007-12#1)(2008-3#1)
thicker than##6##2##(1997-3#1)(2007-12#1)(2008-3#3)(2008-8#1)
thicker##27##1##(1991-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-3#5)(2008-5#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-3#1)
thickness (CIMT)##2##2##(2012-3#1)(2013-8#1)
thickness (ET)##2##2##(1994-9#1)(1996-2#1)
thickness (IMT) in##2##3##(2008-3#1)(2011-2#1)
thickness (IMT) of##2##3##(2008-1#1)(2011-1#1)
thickness (IMT)##6##2##(2008-1#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
thickness (P##2##2##(2008-5#1)(2010-2#1)
thickness (r = -0##3##4##(1995-8#1)(2012-2#2)
thickness (r =##4##3##(1995-8#2)(2012-2#2)
thickness 0##5##2##(2007-12#1)(2008-10#1)(2009-8#3)
thickness 2##2##2##(2009-8#2)
thickness and group refractive index##3##5##(2008-3#3)
thickness and optical constants##2##4##(2008-3#2)
thickness and optical##3##3##(2008-3#3)
thickness and the##11##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#7)(2011-1#1)
thickness and##57##2##(1994-3#1)(1995-3#1)(1995-5#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#19)(2008-5#6)(2008-7#1)(2008-9#1)(2009-1#1)(2010-2#1)(2011-1#2)(2011-2#4)(2011-7#1)(2013-1#1)
thickness are##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
thickness as##2##2##(2008-3#2)
thickness at##5##2##(2008-2#2)(2008-3#2)(2013-1#1)
thickness but with##2##3##(2008-3#1)(2009-7#1)
thickness but##3##2##(1993-11#1)(2008-3#1)(2009-7#1)
thickness by##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
thickness control##2##2##(2008-3#2)
thickness d##3##2##(2007-11#1)(2008-3#2)
thickness dependence of##2##3##(2008-2#1)(2008-3#1)
thickness distribution of##3##3##(1994-12#1)(2007-12#2)
thickness distribution##5##2##(1994-12#1)(2007-12#2)(2008-3#1)(2008-7#1)
thickness fluctuations in##2##3##(2008-3#2)
thickness for##10##2##(1995-3#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2010-12#1)
thickness from##3##2##(2008-2#2)(2011-1#1)
thickness in patients##2##3##(2008-7#1)(2013-1#1)
thickness in##8##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#3)
thickness increased##2##2##(2008-10#1)(2009-10#1)
thickness increases##2##2##(2008-3#1)(2008-5#1)
thickness is a##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
thickness is determined##2##3##(2008-3#1)(2009-5#1)
thickness is##15##2##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2013-1#1)
thickness larger than##2##3##(2008-2#1)(2008-3#1)
thickness measurement##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
thickness measurements##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
thickness modulation##3##2##(2008-2#3)
thickness of 1##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
thickness of 3##2##3##(1997-8#1)(2007-11#1)
thickness of metal##2##3##(2007-12#1)(2008-10#1)
thickness of the GaAs crystal##3##5##(2008-2#3)
thickness of the film##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
thickness of the first##4##4##(2008-2#3)(2011-2#1)
thickness of the secondary perimysium##2##5##(2010-2#2)
thickness of the unstirred layer in the##5##7##(1991-5#5)
thickness of the unstirred##6##4##(1991-5#6)
thickness of the##83##3##(1990-12#1)(1991-5#7)(1992-6#1)(1993-8#1)(1994-3#1)(1995-6#1)(1996-5#1)(2007-11#4)(2007-12#6)(2008-10#8)(2008-11#2)(2008-2#15)(2008-3#16)(2008-5#3)(2008-7#2)(2008-9#2)(2009-5#1)(2009-9#2)(2010-2#2)(2010-8#1)(2011-2#2)(2012-2#2)(2013-8#2)
thickness of thin films##2##4##(2008-2#2)
thickness of##132##2##(1990-12#1)(1991-5#7)(1992-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-5#1)(1997-8#1)(2006-6#1)(2007-11#8)(2007-12#11)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#25)(2008-5#5)(2008-7#3)(2008-9#2)(2009-5#2)(2009-7#2)(2009-9#2)(2010-2#2)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#3)
thickness on the##3##3##(2008-10#2)(2010-4#1)
thickness on##6##2##(2008-10#4)(2008-2#1)(2010-4#1)
thickness or##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
thickness over##3##2##(2008-3#3)
thickness produces##2##2##(2007-12#1)(2008-3#1)
thickness profile##3##2##(2007-11#3)
thickness should##2##2##(2008-3#1)(2008-9#1)
thickness skin##4##2##(2013-1#3)(2013-8#1)
thickness than##2##2##(2008-10#1)(2008-3#1)
thickness that is##2##3##(2007-11#1)(2008-3#1)
thickness that##4##2##(2007-11#1)(2008-3#3)
thickness to##5##2##(2007-12#1)(2008-3#3)(2013-1#1)
thickness values##2##2##(2007-12#1)(2013-1#1)
thickness variations##2##2##(2007-11#1)(2008-5#1)
thickness varies##2##2##(2007-12#1)(2008-3#1)
thickness was found to be##2##5##(2008-10#2)
thickness was found to##3##4##(2008-10#3)
thickness was measured##2##3##(1996-2#1)(2007-12#1)
thickness was##13##2##(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-3#1)(2011-2#2)(2013-1#1)
thickness were##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
thickness with##3##2##(2008-2#2)(2008-3#1)
thickness##537##1##(1990-12#1)(1990-8#1)(1991-5#7)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#3)(1996-5#1)(1997-3#1)(1997-8#2)(2006-4#1)(2006-6#1)(2007-11#30)(2007-12#31)(2007-8#1)(2008-1#2)(2008-10#64)(2008-11#10)(2008-12#5)(2008-2#68)(2008-3#129)(2008-5#26)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#5)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#7)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#18)(2011-7#1)(2012-12#2)(2012-2#11)(2012-3#3)(2013-1#20)(2013-7#1)(2013-8#6)
thickness)##5##1##(1993-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
thickness-modulated designs##4##2##(2008-2#1)(2008-3#3)
thickness-modulated##5##1##(2008-2#1)(2008-3#4)
thickness-profile measurement##2##2##(2007-11#1)(2008-3#1)
thickness]##2##1##(2012-3#1)(2013-1#1)
thicknesses (0##2##2##(2007-12#1)(2012-2#1)
thicknesses and##4##2##(2008-2#2)(2008-3#2)
thicknesses are##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
thicknesses of the##3##3##(2008-2#1)(2008-3#2)
thicknesses of##14##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#9)
thicknesses were##2##2##(2008-10#1)(2008-3#1)
thicknesses##47##1##(2007-12#3)(2008-10#4)(2008-12#2)(2008-2#12)(2008-3#21)(2009-10#2)(2009-6#1)(2012-2#2)
thigh muscle##2##2##(1996-12#1)(2008-12#1)
thigh pain##2##2##(2012-3#1)(2013-1#1)
thigh##49##1##(1991-3#2)(1991-6#1)(1992-2#1)(1993-9#1)(1996-12#1)(1997-3#1)(2007-11#8)(2007-6#2)(2007-7#2)(2008-12#5)(2008-5#6)(2008-6#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
thighs and buttocks##2##3##(2008-5#2)
thighs and##4##2##(2007-10#1)(2008-5#2)(2010-6#1)
thighs##5##1##(2007-10#1)(2008-5#3)(2010-6#1)
thigmotaxis##4##1##(1994-3#4)
thiirane##2##1##(1996-5#2)
thimerosal##6##1##(1995-5#1)(1997-2#2)(2008-10#2)(2008-5#1)
thin and medium-thick clouds##2##4##(2008-2#2)
thin and medium-thick##3##3##(2008-2#3)
thin and thick##2##3##(2007-12#1)(2008-10#1)
thin and##17##2##(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-5#6)(2008-7#1)(2009-6#1)(2013-1#1)
thin aplanatic achromatic doublets##2##4##(2008-3#2)
thin body##2##2##(2007-12#2)
thin cirrus clouds##4##3##(2008-3#4)
thin coronary sections were obtained##2##5##(2012-3#2)
thin coronary sections##3##3##(2012-3#3)
thin crystal##2##2##(2007-11#1)(2008-2#1)
thin crystals##2##2##(2008-2#2)
thin diffractive elements##2##3##(2008-3#2)
thin filament##5##2##(1995-6#1)(1997-7#1)(2008-2#2)(2008-6#1)
thin filaments##5##2##(1991-5#1)(1995-2#2)(1997-7#1)(2008-7#1)
thin film coated##2##3##(2008-10#1)(2008-3#1)
thin film electrode##6##3##(2008-10#5)(2008-12#1)
thin film electrodes##5##3##(2008-10#5)
thin film is##2##3##(2007-11#1)(2008-3#1)
thin film of##9##3##(2007-11#1)(2008-10#7)(2008-3#1)
thin film on##3##3##(2007-12#1)(2008-2#1)(2012-3#1)
thin film upon##2##3##(2008-3#2)
thin film was##2##3##(2008-10#2)
thin film with##2##3##(2008-10#1)(2008-3#1)
thin film##66##2##(2007-11#10)(2007-12#2)(2008-1#1)(2008-10#33)(2008-12#1)(2008-2#3)(2008-3#11)(2009-4#2)(2009-6#1)(2009-7#1)(2012-3#1)
thin films and bulk##2##4##(2007-11#1)(2008-3#1)
thin films and##7##3##(2007-11#2)(2008-2#2)(2008-3#3)
thin films at##2##3##(2007-12#1)(2008-3#1)
thin films can##2##3##(2008-2#1)(2008-3#1)
thin films constructed of nanowires of small organic molecules##2##9##(2009-11#2)
thin films deposited on##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
thin films deposited##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
thin films for##2##3##(2008-3#2)
thin films from##2##3##(2008-2#1)(2008-3#1)
thin films grown by##2##4##(2007-11#1)(2007-12#1)
thin films has been##2##4##(2008-10#1)(2008-3#1)
thin films in the##2##4##(2008-2#1)(2008-3#1)
thin films is##4##3##(2007-12#1)(2008-3#3)
thin films of ion-beam-deposited SiC##2##5##(2008-3#2)
thin films of##7##3##(2008-10#1)(2008-2#3)(2008-3#2)(2010-2#1)
thin films on##2##3##(2007-12#1)(2008-3#1)
thin films prepared by##2##4##(2008-10#1)(2008-3#1)
thin films that##2##3##(2007-12#1)(2008-3#1)
thin films using##2##3##(2008-10#1)(2008-2#1)
thin films were##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
thin films with##6##3##(2007-12#1)(2008-3#4)(2013-8#1)
thin films##107##2##(1990-8#1)(1992-8#1)(2007-11#6)(2007-12#11)(2008-10#16)(2008-2#18)(2008-3#46)(2009-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
thin foil mirrors##2##3##(2008-3#2)
thin glass films##2##3##(2008-2#2)
thin glass##3##2##(2008-2#2)(2008-3#1)
thin glass-ceramic rod##2##3##(2008-10#2)
thin gold films##2##3##(2008-10#1)(2008-3#1)
thin gold##3##2##(2008-10#1)(2008-3#2)
thin high-index##2##2##(2008-3#2)
thin layer chromatogram##2##3##(2008-12#1)(2013-1#1)
thin layer chromatography and the##2##5##(2008-10#1)(2008-11#1)
thin layer chromatography and##4##4##(2008-10#2)(2008-11#1)(2012-2#1)
thin layer chromatography##17##3##(1992-3#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2009-7#2)(2009-8#1)(2010-5#2)(2012-2#2)
thin layer on the##2##4##(2008-10#1)(2008-6#1)
thin layer on##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
thin layer##32##2##(1992-3#1)(1992-9#1)(1994-11#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-7#2)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
thin layers of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
thin layers##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)
thin lipid##2##2##(1992-6#1)(2008-11#1)
thin liquid films##4##3##(1992-5#1)(2008-10#1)(2008-3#2)
thin liquid##6##2##(1992-5#1)(2008-10#2)(2008-3#2)(2009-6#1)
thin membrane##2##2##(2007-12#1)(2008-10#1)
thin mercury film electrode##2##4##(2008-10#2)
thin mercury film electrodes is demonstrated##2##6##(2008-10#2)
thin mercury film electrodes##4##4##(2008-10#4)
thin mercury film##6##3##(2008-10#6)
thin mercury##7##2##(2008-10#6)(2008-3#1)
thin metal film##3##3##(2007-12#2)(2009-7#1)
thin metal##4##2##(2007-12#2)(2008-3#1)(2009-7#1)
thin metallic wires##3##3##(2008-3#3)
thin metallic##4##2##(2008-3#4)
thin oxide##2##2##(2008-10#1)(2009-11#1)
thin planar##2##2##(2007-11#1)(2007-12#1)
thin plastic foils##2##3##(1997-6#1)(2008-1#1)
thin plate##2##2##(2008-3#2)
thin polymer films##2##3##(1990-8#1)(2008-10#1)
thin sample##2##2##(2007-12#1)(2008-3#1)
thin sections of##2##3##(2007-12#1)(2008-10#1)
thin sections##5##2##(2007-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
thin tissue sections##3##3##(2008-3#1)(2010-11#2)
thin transparent plate##2##3##(2008-2#2)
thin walls##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
thin words##3##2##(2007-12#3)
thin##477##1##(1990-4#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-5#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(2007-11#24)(2007-12#41)(2008-1#3)(2008-10#98)(2008-11#8)(2008-12#4)(2008-2#46)(2008-3#124)(2008-4#2)(2008-5#19)(2008-6#3)(2008-7#12)(2008-8#1)(2008-9#3)(2009-11#5)(2009-12#1)(2009-4#2)(2009-6#3)(2009-7#6)(2009-8#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#7)(2012-3#6)(2013-1#3)(2013-8#4)
thin-and-beautiful##3##1##(2007-12#3)
thin-element##2##1##(2008-2#1)(2008-3#1)
thin-film OWG##2##2##(2008-10#2)
thin-film coatings##3##2##(2008-2#1)(2008-3#2)
thin-film deposition##4##2##(2008-3#2)(2008-7#1)(2010-5#1)
thin-film glass plates##2##3##(2007-11#2)
thin-film interference effects##2##3##(2008-3#2)
thin-film interference##5##2##(2008-3#4)(2008-5#1)
thin-film layer##2##2##(2008-2#1)(2008-3#1)
thin-film layers##5##2##(2008-2#1)(2008-3#4)
thin-film optical##2##2##(2008-2#1)(2008-3#1)
thin-film planar waveguide (PWG) evanescently coupled by a##2##8##(2008-2#1)(2008-3#1)
thin-film planar waveguide##3##3##(2008-2#1)(2008-3#2)
thin-film polarizing beam splitter##2##4##(2008-3#2)
thin-film stacks##2##2##(2008-3#2)
thin-film structure##2##2##(2008-2#1)(2008-3#1)
thin-film##84##1##(1990-8#1)(2007-11#7)(2007-12#3)(2008-10#8)(2008-2#18)(2008-3#40)(2008-5#1)(2008-7#4)(2010-4#1)(2010-5#1)
thin-films##2##1##(2008-10#2)
thin-layer chromatographic##2##2##(1990-5#1)(2008-10#1)
thin-layer chromatography (TLC)##5##3##(1992-11#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-4#1)
thin-layer chromatography##20##2##(1990-11#1)(1990-12#1)(1992-11#1)(1993-9#1)(1994-3#1)(1996-2#2)(1996-5#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-6#1)(2012-2#1)(2013-1#2)
thin-layer chromatography-densitometric##2##2##(2012-3#2)
thin-layer radial flow##2##3##(2008-10#2)
thin-layer##39##1##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1993-9#1)(1994-3#1)(1996-2#2)(1996-5#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#2)(2013-1#2)
thin-layered dual-band electrochemical cell##2##4##(2008-10#2)
thin-lens##2##1##(2008-3#2)
thin-section electron microscopy##2##3##(2008-10#1)(2008-11#1)
thin-section##4##1##(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
thin-sectioned##2##1##(2008-9#2)
thin-walled##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
thing##7##1##(1995-12#1)(1996-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-11#1)
things and##2##2##(1996-3#2)
things as##4##2##(1995-1#1)(2007-11#1)(2012-2#1)(2012-3#1)
things better##2##2##(1994-1#1)(2011-2#1)
things in##3##2##(2007-11#1)(2012-3#2)
things that##2##2##(1996-1#1)(2008-7#1)
things to come##2##3##(1991-8#1)(2008-7#1)
things to consider##2##3##(1995-1#1)(1995-2#1)
things to##4##2##(1991-8#1)(1995-1#1)(1995-2#1)(2008-7#1)
things##44##1##(1990-2#1)(1991-2#1)(1991-3#2)(1991-8#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#2)(1996-1#2)(1996-3#4)(1996-6#2)(1997-8#1)(2007-11#3)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)
think about##7##2##(2008-6#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-8#1)
think of##4##2##(1991-1#1)(1995-6#1)(1996-11#1)(2013-8#1)
think tank##2##2##(1994-1#1)(2008-6#1)
think that it is##2##4##(2008-5#1)(2012-2#1)
think that the##6##3##(1990-11#1)(1995-6#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-7#1)
think that##11##2##(1990-11#1)(1992-5#1)(1995-6#1)(1997-3#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
think the##2##2##(2007-12#1)(2011-2#1)
think##45##1##(1990-11#1)(1991-1#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-6#3)(2008-8#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#2)
think?##3##1##(2008-11#1)(2008-8#1)(2013-1#1)
thinkers##2##1##(1993-3#1)(1995-1#1)
thinking about##14##2##(1992-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#3)(2008-8#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
thinking and the##2##3##(1994-2#1)(2008-8#1)
thinking and##12##2##(1992-3#1)(1994-2#1)(1995-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2012-12#4)(2012-2#1)
thinking into##2##2##(1991-12#1)(2008-8#1)
thinking is a##2##3##(2008-12#1)(2013-1#1)
thinking is##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
thinking may##3##2##(2008-12#1)(2008-8#1)(2009-7#1)
thinking of##4##2##(1996-3#1)(2008-10#1)(2008-11#2)
thinking on##4##2##(1994-1#1)(1995-1#1)(2008-7#1)(2009-8#1)
thinking that##2##2##(2010-11#1)(2012-1#1)
thinking to##2##2##(1994-12#1)(2007-11#1)
thinking toward##2##2##(2008-1#1)(2012-12#1)
thinking within##2##2##(2008-12#1)(2010-11#1)
thinking##113##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#3)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#26)(2008-12#17)(2008-2#1)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#1)
thinks##5##1##(1994-1#1)(1997-3#1)(2008-11#1)(2008-2#1)(2010-12#1)
thinned##2##1##(1997-3#1)(2011-2#1)
thinner than those of##2##4##(1991-12#1)(2011-1#1)
thinner than##4##2##(1991-12#1)(2008-5#1)(2011-1#1)(2011-3#1)
thinner##20##1##(1991-12#1)(1994-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#2)(2013-1#2)
thinness##9##1##(1991-12#1)(2007-12#7)(2008-3#1)
thinnest##6##1##(2007-12#3)(2008-5#1)(2009-7#1)(2011-1#1)
thinning and##4##2##(2008-10#1)(2009-7#1)(2011-2#1)(2013-8#1)
thinning by##2##2##(1996-2#2)
thinning of the##6##3##(1997-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-2#1)
thinning of##7##2##(1997-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
thinning the##2##2##(2008-3#2)
thinning##28##1##(1996-1#1)(1996-2#2)(1997-3#1)(2008-10#3)(2008-3#3)(2008-5#5)(2008-6#1)(2008-9#1)(2009-6#1)(2009-7#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
thioacetate 11##2##2##(1996-5#2)
thioacetyl styrene##2##2##(2008-12#2)
thioamide##4##1##(2008-10#3)(2011-2#1)
thiobarbituric acid reactive substance (TBARS)##2##5##(1994-6#1)(2012-2#1)
thiobarbituric acid reactive substance##3##4##(1994-6#1)(1995-12#1)(2012-2#1)
thiobarbituric acid reactive substances (TBARS) in##2##6##(1993-2#1)(1995-3#1)
thiobarbituric acid reactive substances (TBARS)##6##5##(1993-2#1)(1995-3#1)(2008-10#2)(2011-2#2)
thiobarbituric acid reactive substances in##2##5##(1992-3#1)(2008-10#1)
thiobarbituric acid reactive substances##11##4##(1992-3#2)(1993-2#1)(1995-3#1)(2008-10#3)(2011-2#3)(2012-2#1)
thiobarbituric acid reactive##15##3##(1992-3#2)(1993-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(2008-10#3)(2010-5#1)(2011-2#3)(2012-2#2)
thiobarbituric acid##20##2##(1990-8#1)(1992-11#1)(1992-3#2)(1993-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#3)(2012-2#2)
thiobarbituric acid-reactive substances##4##3##(1995-12#4)
thiobarbituric acid-reactive##5##2##(1995-12#4)(2012-5#1)
thiobarbituric##25##1##(1990-8#1)(1992-11#1)(1992-3#2)(1993-2#1)(1994-6#1)(1995-12#5)(1995-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-5#1)
thiocarbohydrazide##2##1##(2008-10#2)
thiocarbonohydrazide (PSTH) immobilized on an anion-exchange resin##2##7##(2008-10#2)
thiocarbonohydrazide and##2##2##(2008-10#2)
thiocarbonohydrazide##5##1##(2008-10#5)
thiochrome##3##1##(2008-10#3)
thioctic acid##4##2##(2008-10#3)(2008-5#1)
thiocyanate and##4##2##(1990-12#1)(1996-2#1)(2008-10#2)
thiocyanate complex##3##2##(2008-10#3)
thiocyanate complexes##3##2##(2008-10#3)
thiocyanate concentration##3##2##(2008-10#3)
thiocyanate in##6##2##(2008-10#6)
thiocyanate ion##3##2##(2008-10#3)
thiocyanate ions##4##2##(2008-10#4)
thiocyanate solution##5##2##(2008-10#5)
thiocyanate which##2##2##(2008-10#2)
thiocyanate with##3##2##(2008-10#3)
thiocyanate##71##1##(1990-12#2)(1991-12#1)(1993-2#1)(1996-2#1)(1996-5#1)(2007-12#3)(2008-10#59)(2008-12#2)(2009-11#1)
thiocyanate-selective##3##1##(2008-10#3)
thiocyanates##4##1##(2007-11#2)(2008-10#2)
thiocyanato-complexes formed##3##2##(2008-10#3)
thiocyanato-complexes##6##1##(2008-10#6)
thioester of##3##2##(1990-5#2)(1990-7#1)
thioester##5##1##(1990-5#2)(1990-7#1)(1994-8#2)
thioesters##2##1##(1990-5#1)(1994-8#1)
thioether methyltransferase##3##2##(1994-8#3)
thioether##9##1##(1994-8#5)(2008-4#1)(2009-11#1)(2013-1#2)
thioethers##3##1##(1994-8#1)(2008-11#2)
thioglycolate##3##1##(2008-4#1)(2008-5#2)
thioglycolic acid (TGA)##2##3##(1992-8#1)(2009-6#1)
thioglycolic acid##7##2##(1992-8#1)(2008-10#3)(2009-6#2)(2012-3#1)
thioglycollic acid##2##2##(1996-2#1)(2008-10#1)
thioglycosides##3##1##(2008-12#2)(2009-12#1)
thioguanine##2##1##(1991-4#1)(1994-11#1)
thiohemiacetal##3##1##(1991-5#3)
thiol and##2##2##(2008-10#1)(2008-9#1)
thiol compounds##7##2##(1991-9#1)(1992-8#1)(1996-2#1)(2008-10#4)
thiol derivatives##3##2##(2008-10#3)
thiol functionalities##2##2##(2008-10#1)(2008-4#1)
thiol group##4##2##(1990-11#1)(1995-6#1)(2008-10#1)(2010-11#1)
thiol groups in##2##3##(2008-1#1)(2008-5#1)
thiol groups of##2##3##(2008-10#1)(2011-2#1)
thiol groups to##2##3##(2008-10#1)(2008-4#1)
thiol groups##20##2##(1991-12#1)(1991-9#2)(1992-3#1)(2008-1#2)(2008-10#7)(2008-4#2)(2008-5#2)(2009-9#1)(2010-11#1)(2011-2#1)
thiol methyltransferase##3##2##(1994-8#3)
thiol to##2##2##(1995-5#1)(2008-2#1)
thiol##84##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-9#8)(1992-11#2)(1992-12#1)(1992-3#4)(1992-8#1)(1994-8#6)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(2007-11#2)(2008-1#2)(2008-10#28)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#2)(2010-11#3)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
thiol-activated##2##1##(1991-3#1)(1996-12#1)
thiol-containing agents##3##2##(1991-9#3)
thiol-containing drugs##2##2##(2008-10#2)
thiol-containing##8##1##(1991-9#3)(2008-10#4)(2008-4#1)
thiol-dependent##2##1##(1991-12#1)(1992-9#1)
thiol-ene chemistry##3##2##(2010-12#3)
thiol-functionalized mesoporous sorbent##3##3##(2008-10#3)
thiol-functionalized##4##1##(2008-10#3)(2009-9#1)
thiolactic acid##2##2##(2008-10#2)
thiolase##3##1##(1991-12#3)
thiolate##3##1##(1990-5#1)(1993-11#1)(2008-10#1)
thiolate-ligated heme##2##2##(2009-9#2)
thiolated##3##1##(2008-10#3)
thiolates##2##1##(2008-10#2)
thiolic##4##1##(1995-6#1)(2008-10#3)
thiols amperometric##2##2##(2008-10#2)
thiols and##2##2##(2008-10#2)
thiols associated with##2##3##(1993-12#2)
thiols in##4##2##(1991-9#1)(1995-5#1)(2008-10#2)
thiols oxidation##2##2##(2008-10#2)
thiols to##2##2##(1994-5#1)(1995-5#1)
thiols were##2##2##(1992-11#1)(2008-10#1)
thiols##55##1##(1991-3#2)(1991-9#8)(1992-11#6)(1993-12#2)(1994-5#1)(1995-5#2)(1995-6#1)(2008-10#22)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#3)(2010-11#3)
thion analogues##2##2##(1992-11#2)
thionin##2##1##(2008-10#1)(2008-4#1)
thionine##2##1##(2008-10#2)
thiono##2##1##(2008-10#1)(2008-4#1)
thiopental##7##1##(1990-12#3)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
thiophanate-methy1##5##1##(2008-10#5)
thiophanate-methyl##7##1##(2008-10#7)
thiophene##4##1##(1992-10#1)(2008-10#2)(2010-2#1)
thiophosphate##2##1##(2008-4#1)(2012-2#1)
thiophosphonoacetate##2##1##(2008-4#2)
thiophosphorus insecticides##2##2##(2008-10#2)
thiopurine##4##1##(2010-12#3)(2013-1#1)
thiopurines##2##1##(2010-12#1)(2013-1#1)
thioredoxin and##2##2##(1991-2#1)(1993-11#1)
thioredoxin does not affect the unfolded state##2##7##(1993-11#2)
thioredoxin f##2##2##(1990-12#2)
thioredoxin m##3##2##(1990-12#3)
thioredoxin reductase activity##2##3##(2009-9#2)
thioredoxin reductase##7##2##(1990-12#2)(2008-10#1)(2009-9#2)(2010-11#1)(2012-2#1)
thioredoxin reductases##3##2##(2009-10#1)(2009-9#2)
thioredoxin##26##1##(1990-12#9)(1991-2#1)(1993-11#3)(1993-9#1)(2008-10#1)(2008-7#1)(2009-10#2)(2009-9#5)(2010-11#1)(2012-2#2)
thioredoxin-2##2##1##(2012-2#2)
thioredoxins##5##1##(1990-12#2)(2009-10#3)
thioridazine##6##1##(2008-10#2)(2008-3#1)(2008-7#2)(2010-8#1)
thiorphan##3##1##(1996-2#2)(1997-4#1)
thiosemicarbazone##11##1##(2007-11#1)(2008-10#10)
thiosulfate and##3##2##(2008-10#3)
thiosulfate##14##1##(1992-12#1)(1997-7#1)(2008-10#9)(2008-6#1)(2011-2#2)
thiosulfinates##2##1##(2008-10#2)
thiosulphate in the##2##3##(2008-10#2)
thiosulphate##5##1##(2008-10#5)
thiotaurine##2##1##(2008-5#2)
thiotrophic##2##1##(2009-8#2)
thiourea and##3##2##(2008-10#3)
thiourea for##2##2##(2008-10#2)
thiourea from the##2##3##(2008-10#2)
thiourea##32##1##(1993-8#1)(1995-12#1)(1995-2#1)(2008-10#25)(2011-2#3)(2013-1#1)
thiourea)##2##1##(2008-10#2)
thioxanthones##4##1##(2012-3#4)
thioxanthonic derivatives##2##2##(2012-3#2)
thiram##10##1##(2008-10#10)
third ORF##3##2##(1996-6#1)(2008-10#2)
third alternate protocol##2##3##(2008-4#2)
third and fourth##12##3##(1990-8#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2011-1#1)
third and##18##2##(1990-8#2)(1993-8#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
third beam##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
third case##6##2##(2006-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
third cases##2##2##(2007-11#1)(2008-8#1)
third component of the##2##4##(2008-10#1)(2009-11#1)
third component of##3##3##(1992-12#1)(2008-10#1)(2009-11#1)
third component##6##2##(1991-8#1)(1992-12#1)(1994-5#1)(2008-10#2)(2009-11#1)
third consisted of##2##3##(1990-3#1)(2011-1#1)
third day##3##2##(1992-5#1)(1995-3#1)(1995-8#1)
third degree##4##2##(1996-5#1)(2007-11#1)(2008-1#1)(2011-2#1)
third derivative##3##2##(2008-10#3)
third domain##2##2##(1991-8#1)(2009-7#1)
third generation cephalosporins##2##3##(2007-7#2)
third generation##14##2##(1990-3#1)(1993-2#1)(1995-9#1)(1996-11#3)(2007-7#4)(2008-10#2)(2008-5#1)(2012-2#1)
third grade##4##2##(2008-12#3)(2012-3#1)
third group##11##2##(1994-6#1)(1996-1#1)(2007-11#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
third harmonic generation##2##3##(2013-1#2)
third harmonic of a##2##4##(2007-11#1)(2008-3#1)
third harmonic of##3##3##(2007-11#2)(2008-3#1)
third harmonic##7##2##(2007-11#3)(2008-3#2)(2013-1#2)
third in a series of##2##5##(2008-4#1)(2008-5#1)
third in a series##4##4##(1993-12#1)(1994-3#1)(2008-4#1)(2008-5#1)
third instar larvae##3##3##(1996-5#1)(2013-1#2)
third is##5##2##(1991-11#1)(1996-4#1)(2008-2#1)(2008-8#1)(2012-3#1)
third level##2##2##(2008-11#1)(2008-6#1)
third line hormonotherapy##3##3##(1993-1#3)
third line therapies##2##3##(1993-1#2)
third line therapy##2##3##(1992-6#2)
third line##8##2##(1992-2#1)(1992-6#2)(1993-1#5)
third member of the##3##4##(1990-7#1)(1993-12#1)(2008-2#1)
third member of##4##3##(1990-7#1)(1993-12#1)(1994-12#1)(2008-2#1)
third method is##2##3##(1995-2#1)(2008-8#1)
third method##7##2##(1995-2#1)(2008-10#4)(2008-8#1)(2010-4#1)
third millennium##3##2##(2008-10#2)(2012-9#1)
third molar##5##2##(2011-2#1)(2012-12#1)(2013-1#3)
third month for two years##2##5##(1997-8#2)
third month##5##2##(1996-6#1)(1997-8#2)(2007-11#1)(2011-1#1)
third occipital condyle##3##3##(2013-1#3)
third of all##3##3##(1996-3#1)(2008-12#1)(2008-8#1)
third of patients##3##3##(2009-4#1)(2011-2#1)(2012-1#1)
third of that##2##3##(1990-5#1)(1993-6#1)
third of the face##2##4##(2007-12#1)(2012-12#1)
third of the##22##3##(1991-4#1)(1992-3#1)(1993-10#1)(1994-2#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
third of them##2##3##(2007-7#1)(2011-2#1)
third of these##2##3##(2011-2#1)(2013-1#1)
third of##51##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#3)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
third one is##2##3##(1990-7#1)(2010-2#1)
third one##5##2##(1990-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
third order##3##2##(2007-11#1)(2008-2#1)(2009-7#1)
third part##8##2##(2008-10#1)(2008-4#2)(2008-7#2)(2009-8#1)(2012-2#1)(2013-8#1)
third parties##5##2##(1991-1#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-5#1)
third party payers##2##3##(1992-1#1)(1996-12#1)
third party payors##2##3##(1991-1#1)(1992-12#1)
third party##9##2##(1991-1#1)(1992-1#1)(1992-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
third patient presented##2##3##(2008-1#1)(2008-7#1)
third patient##7##2##(1997-6#1)(2008-1#1)(2008-7#2)(2009-1#1)(2012-12#1)(2013-1#1)
third phase##3##2##(1993-12#1)(2008-10#2)
third population##2##2##(2006-10#1)(2008-10#1)
third showed##2##2##(1997-4#1)(2008-1#1)
third stage##5##2##(1990-3#1)(2008-12#1)(2009-5#1)(2013-1#2)
third study##6##2##(1994-2#1)(2007-2#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
third support protocols##2##3##(2008-4#2)
third the##3##2##(1994-9#1)(2008-2#1)(2008-7#1)
third to##5##2##(1992-6#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-6#1)
third traits##2##2##(1997-4#2)
third trimester of pregnancy##6##4##(1990-12#1)(1992-10#1)(2007-2#1)(2008-12#2)(2011-2#1)
third trimester of##7##3##(1990-12#1)(1992-10#1)(2007-2#1)(2008-12#2)(2010-6#1)(2011-2#1)
third trimester##22##2##(1990-12#2)(1990-6#1)(1990-9#1)(1992-10#1)(1993-12#1)(1993-3#1)(1995-8#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#2)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
third type of##3##3##(1991-1#2)(2010-12#1)
third type##5##2##(1991-1#2)(1997-3#1)(2010-12#1)(2011-2#1)
third ventricle##11##2##(1990-7#1)(1991-8#1)(1993-12#1)(1996-7#2)(2008-7#5)(2012-12#1)
third were##2##2##(2008-10#1)(2012-3#1)
third year of##3##3##(1992-12#1)(2008-10#1)(2008-3#1)
third year student nurses##2##4##(2008-11#2)
third year##11##2##(1992-12#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)
third##585##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#7)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#9)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#7)(1993-10#2)(1993-12#13)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#5)(1995-3#5)(1995-5#7)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-2#4)(1997-3#3)(1997-4#12)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2006-10#2)(2006-12#1)(2007-10#3)(2007-11#13)(2007-12#18)(2007-2#3)(2007-4#1)(2007-7#9)(2007-8#2)(2008-1#5)(2008-10#75)(2008-11#12)(2008-12#18)(2008-2#13)(2008-3#13)(2008-4#12)(2008-5#11)(2008-6#5)(2008-7#17)(2008-8#13)(2008-9#6)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#5)(2009-8#2)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#6)(2010-8#3)(2011-1#10)(2011-2#24)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#7)(2012-5#1)(2012-9#1)(2013-1#36)(2013-8#5)
third-##6##1##(2007-11#2)(2007-12#1)(2008-3#3)
third-generation##7##1##(1991-3#1)(2008-10#1)(2008-3#1)(2011-2#3)(2013-1#1)
third-harmonic generation (THG) microscopy##2##4##(2008-3#2)
third-harmonic generation (THG) of##2##4##(2007-12#1)(2008-3#1)
third-harmonic generation (THG)##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
third-harmonic generation in a periodically poled##2##6##(2007-12#2)
third-harmonic generation in##4##3##(2007-11#2)(2007-12#2)
third-harmonic generation##20##2##(2007-11#5)(2007-12#11)(2008-3#4)
third-harmonic##24##1##(2007-11#6)(2007-12#11)(2008-3#7)
third-harmonic-generation##3##1##(2007-11#2)(2007-12#1)
third-level##3##1##(1990-11#1)(1994-5#1)(2012-12#1)
third-line##3##1##(1997-3#1)(2010-12#2)
third-order aberration theory##2##3##(2008-3#2)
third-order aberrations##2##2##(2008-3#2)
third-order design##2##2##(2008-2#2)
third-order dispersion##4##2##(2007-11#3)(2007-12#1)
third-order grating coupler##2##3##(2008-3#2)
third-order molecular##2##2##(2007-12#2)
third-order nonlinear absorption##2##3##(2007-11#2)
third-order nonlinear optical response of Au nanocrystals embedded in##2##9##(2007-11#2)
third-order nonlinear optical response##3##4##(2007-11#2)(2007-12#1)
third-order nonlinear optical susceptibility##3##4##(2007-11#2)(2007-12#1)
third-order nonlinear optical##8##3##(2007-11#5)(2007-12#2)(2008-3#1)
third-order nonlinear susceptibility##2##3##(2007-12#2)
third-order nonlinear##14##2##(2007-11#7)(2007-12#6)(2008-3#1)
third-order optical nonlinearities##2##3##(2008-10#2)
third-order optical nonlinearity##2##3##(2007-11#1)(2007-12#1)
third-order optical##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
third-order processes##2##2##(2007-11#2)
third-order susceptibilities##2##2##(2007-12#2)
third-order susceptibility##2##2##(2007-12#1)(2010-7#1)
third-order##55##1##(1993-8#1)(1996-5#1)(2007-11#14)(2007-12#17)(2008-10#2)(2008-2#3)(2008-3#15)(2008-7#1)(2010-7#1)
third-party payers##3##2##(1994-12#1)(1994-2#1)(1995-1#1)
third-party reimbursement for##2##3##(1997-1#2)
third-party##9##1##(1991-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-1#2)(2008-7#1)(2008-9#1)
third-year orchard block##2##3##(2008-10#2)
third-year orchard##3##2##(2008-10#3)
third-year##6##1##(1994-3#1)(2008-10#3)(2010-8#1)(2013-1#1)
thirdly##7##1##(1995-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-2#1)(2012-12#1)
thirds of the##9##3##(1992-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)
thirds of##13##2##(1991-11#1)(1992-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
thirds##17##1##(1991-11#1)(1992-3#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
thirteen cases##2##2##(2008-10#1)(2012-2#1)
thirteen##29##1##(1992-6#2)(1994-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
thirtieth##2##1##(2010-8#1)(2013-1#1)
thirty cases##2##2##(2013-8#2)
thirty minutes##2##2##(1991-12#2)
thirty patients##2##2##(2007-7#1)(2007-8#1)
thirty positive##2##2##(1992-11#2)
thirty years##3##2##(1996-3#1)(2008-9#1)(2013-1#1)
thirty##32##1##(1991-12#2)(1992-11#2)(1992-12#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-12#6)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
thirty-eight##2##1##(2008-10#1)(2011-2#1)
thirty-four clinical samples##2##3##(2013-8#2)
thirty-three##3##1##(1993-1#1)(2008-10#1)(2011-2#1)
thirty-two##3##1##(1990-6#1)(1997-6#1)(2008-11#1)
this &quot##27##2##(1990-3#1)(1990-8#2)(1991-8#1)(1992-12#1)(1993-1#1)(1993-11#1)(1994-2#3)(1995-5#1)(1996-2#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
this 5##2##2##(2008-12#1)(2008-8#1)
this A2 population##2##3##(2008-10#2)
this CRE##2##2##(2013-1#2)
this DNA fragment##4##3##(1991-9#1)(2008-10#1)(2008-8#2)
this DNA##8##2##(1991-9#1)(1993-8#1)(2008-10#2)(2008-4#1)(2008-8#2)(2012-3#1)
this ELISA##3##2##(2007-2#1)(2008-11#2)
this Institution##2##2##(2008-9#2)
this Letter##2##2##(2007-11#1)(2007-12#1)
this MRI##2##2##(2008-7#2)
this N-glycosylation##2##2##(2013-1#2)
this ORF##2##2##(1996-8#2)
this PCR assay##2##3##(2008-10#2)
this PCR##3##2##(1994-12#1)(2008-10#2)
this QTL##4##2##(2008-10#4)
this State##2##2##(2008-9#2)
this ToLCV is##2##3##(2008-10#2)
this a##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
this ability is##2##3##(2006-6#1)(2008-10#1)
this ability##10##2##(1990-11#1)(1990-2#1)(1995-2#1)(1995-5#1)(2006-6#1)(2008-10#1)(2008-8#1)(2008-9#3)
this abnormal##4##2##(1992-1#1)(2008-5#1)(2008-7#2)
this accumulation##2##2##(2008-10#1)(2009-12#1)
this accuracy##3##2##(2008-2#2)(2008-3#1)
this acid##2##2##(2008-10#2)
this act##3##2##(2007-10#1)(2007-2#1)(2008-8#1)
this action of##3##3##(1992-6#1)(1995-12#2)
this action was not##2##4##(1990-8#1)(1995-2#1)
this action was##3##3##(1990-8#1)(1993-3#1)(1995-2#1)
this action##11##2##(1990-8#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-12#2)(1995-2#1)(1996-12#1)(2008-5#1)(2012-3#1)
this activation##6##2##(1990-5#1)(1993-12#1)(1994-2#1)(1996-12#1)(2012-12#1)(2013-8#1)
this active##2##2##(2007-12#1)(2008-6#1)
this activity has##2##3##(1994-8#1)(2008-7#1)
this activity in##2##3##(1992-3#1)(1996-3#1)
this activity is##4##3##(1992-10#1)(1994-9#1)(1995-5#1)(2008-4#1)
this activity was##2##3##(1992-12#1)(2008-10#1)
this activity##21##2##(1990-2#1)(1992-10#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-12#2)
this acute##2##2##(1994-12#1)(2013-1#1)
this adaptive response##2##3##(2008-5#1)(2011-1#1)
this adaptive##3##2##(2008-3#1)(2008-5#1)(2011-1#1)
this added##2##2##(1992-3#1)(1997-8#1)
this addendum##10##2##(2009-8#9)(2013-1#1)
this adverse##2##2##(1995-5#1)(2007-12#1)
this affects##2##2##(1991-3#1)(2013-1#1)
this age category##2##3##(2008-5#1)(2011-1#1)
this age group##15##3##(1991-8#1)(1992-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-1#4)(1997-4#1)(2007-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
this age##28##2##(1991-8#1)(1992-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1997-1#4)(1997-4#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
this agent in the##2##4##(1991-9#1)(2009-9#1)
this agent in##3##3##(1991-9#1)(1995-12#1)(2009-9#1)
this agent was##3##3##(1990-10#1)(1992-11#1)(2009-2#1)
this agent##19##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1995-12#2)(1995-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#4)(2009-2#1)(2009-9#1)(2012-2#1)(2013-8#1)
this aggressive##3##2##(2008-12#1)(2010-3#1)(2012-1#1)
this agreement is##2##3##(2008-2#1)(2008-3#1)
this aim##8##2##(1991-2#1)(1996-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
this algorithm is##4##3##(2008-2#2)(2008-3#2)
this algorithm##15##2##(2007-11#2)(2008-2#6)(2008-3#5)(2011-1#1)(2013-8#1)
this allele##2##2##(1995-8#1)(2013-1#1)
this allows for##2##3##(2008-10#1)(2008-3#1)
this allows##6##2##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#2)
this alone##2##2##(1990-6#1)(2012-12#1)
this already##2##2##(1994-2#1)(2008-5#1)
this also applies to##2##4##(1996-2#1)(2010-3#1)
this also##7##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#2)
this alteration in##2##3##(2008-2#1)(2008-6#1)
this alteration##4##2##(2007-8#1)(2008-2#1)(2008-6#1)(2013-1#1)
this alternative##3##2##(1992-1#1)(1993-8#1)(2008-5#1)
this altitude##2##2##(2007-7#1)(2008-8#1)
this amino acid##4##3##(1992-8#2)(2007-6#1)(2008-3#1)
this amino##5##2##(1992-8#2)(1994-12#1)(2007-6#1)(2008-3#1)
this amount##2##2##(1996-11#1)(2010-4#1)
this an##4##2##(1994-5#1)(1995-9#1)(2007-10#1)(2010-5#1)
this analog##3##2##(1992-12#1)(1992-6#1)(2008-3#1)
this analysis is##8##3##(1994-11#1)(1995-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-11#1)(2012-2#1)
this analysis of the##2##4##(1992-2#1)(2012-3#1)
this analysis to the##2##4##(1992-3#1)(1997-8#1)
this analysis to##4##3##(1992-3#1)(1997-8#1)(2008-10#1)(2009-12#1)
this analysis were##2##3##(2008-10#1)(2008-11#1)
this analysis##60##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1994-11#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
this analytical method##2##3##(2008-10#2)
this analytical procedure##2##3##(2008-10#2)
this analytical technique##2##3##(2008-10#2)
this analytical##8##2##(2008-10#8)
this ancient##2##2##(2008-9#1)(2009-8#1)
this and other##12##3##(1993-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#2)(2008-9#2)(2013-1#1)
this and similar##4##3##(2008-6#1)(2010-10#1)(2011-1#1)(2011-2#1)
this and the##2##3##(2008-9#1)(2011-2#1)
this and##23##2##(1990-8#1)(1993-1#1)(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#4)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
this angle##5##2##(2007-12#1)(2007-8#2)(2008-3#1)(2008-7#1)
this animal##7##2##(1992-12#1)(1997-4#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
this anomaly##8##2##(1991-8#1)(1991-9#1)(1993-9#1)(2008-11#2)(2008-7#1)(2013-1#1)(2013-2#1)
this antagonism##2##2##(2008-10#1)(2012-3#1)
this antibiotic##2##2##(1990-2#1)(1991-3#1)
this antibody##8##2##(1991-2#1)(1993-12#1)(1995-12#1)(2008-10#2)(2008-6#1)(2013-1#2)
this antigen##4##2##(1991-11#1)(2008-11#2)(2008-8#1)
this apparatus##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
this apparent##10##2##(1994-11#2)(2007-12#1)(2008-1#2)(2008-6#1)(2009-4#1)(2009-6#1)(2009-9#1)(2012-12#1)
this apparently##3##2##(1997-1#1)(2008-10#2)
this appendix##4##2##(2008-4#2)(2008-9#2)
this application are##2##3##(2008-10#1)(2009-11#1)
this application##10##2##(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-6#1)
this approach and##6##3##(1997-1#1)(1997-7#1)(2008-2#2)(2008-4#1)(2013-8#1)
this approach are also##2##4##(2008-12#1)(2008-2#1)
this approach are##9##3##(1994-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2010-11#1)(2010-5#1)
this approach can be##3##4##(1997-1#1)(2008-11#1)(2011-2#1)
this approach can##8##3##(1995-6#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
this approach for the##2##4##(1994-5#1)(2009-10#1)
this approach for##6##3##(1992-9#1)(1994-5#1)(2007-12#1)(2008-3#1)(2009-10#1)(2010-8#1)
this approach has been##3##4##(2012-3#1)(2013-1#2)
this approach has##7##3##(1997-7#1)(2007-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
this approach in the##2##4##(2008-10#1)(2008-5#1)
this approach in##6##3##(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
this approach is less##2##4##(2008-8#1)(2011-2#1)
this approach is limited##3##4##(2008-3#1)(2012-3#2)
this approach is not##2##4##(2008-10#1)(2010-8#1)
this approach is that the##3##5##(2008-4#1)(2011-2#1)(2012-1#1)
this approach is that##8##4##(2008-2#1)(2008-4#2)(2009-2#1)(2010-7#1)(2011-2#1)(2012-1#2)
this approach is the##2##4##(2008-10#1)(2008-11#1)
this approach is##35##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#2)
this approach may##2##3##(1993-2#1)(1997-4#1)
this approach need to be##2##5##(2008-5#1)(2008-9#1)
this approach of##2##3##(2008-3#1)(2011-2#1)
this approach provides a##2##4##(2008-1#1)(2008-10#1)
this approach the##2##3##(2008-12#1)(2008-2#1)
this approach to identify##2##4##(1992-2#1)(2012-2#1)
this approach to learning##2##4##(2008-11#2)
this approach to study##2##4##(2008-4#1)(2009-12#1)
this approach to##16##3##(1992-2#1)(1996-12#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
this approach we##4##3##(2008-3#3)(2008-5#1)
this approach were##2##3##(1997-6#1)(2008-10#1)
this approach will ultimately##2##4##(2009-6#1)(2010-12#1)
this approach will##3##3##(2007-11#1)(2009-6#1)(2010-12#1)
this approach with a##2##4##(2007-11#1)(2008-8#1)
this approach with##6##3##(2007-11#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-9#1)
this approach yields##2##3##(2008-3#2)
this approach##219##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-2#15)(2008-3#16)(2008-4#9)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#10)(2012-1#4)(2012-12#1)(2012-2#11)(2012-3#8)(2013-1#5)(2013-8#2)
this approximation the##2##3##(2008-3#2)
this approximation##6##2##(2008-3#5)(2013-1#1)
this are discussed##5##3##(1991-4#1)(1994-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
this are##9##2##(1991-4#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
this area and##8##3##(1990-5#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2013-8#1)
this area for##2##3##(2008-10#1)(2008-12#1)
this area in##5##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
this area is##10##3##(1994-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-9#1)
this area may be##3##4##(1992-12#1)(2008-10#1)(2012-12#1)
this area may##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2012-12#1)
this area of influence was somewhat elliptical##2##7##(2008-10#2)
this area of research##5##4##(1997-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-7#1)
this area of study##2##4##(1990-12#1)(2012-2#1)
this area of##20##3##(1990-12#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#1)(2010-7#1)(2012-1#1)(2012-2#2)
this area to##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
this area was##2##3##(1994-2#1)(2007-12#1)
this area##144##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#13)(2008-12#6)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#5)(2011-9#1)(2012-1#3)(2012-12#4)(2012-2#3)(2012-9#1)(2013-1#4)(2013-7#2)(2013-8#4)
this argument##3##2##(2008-1#1)(2008-8#1)(2009-11#1)
this arrangement##4##2##(1996-2#1)(2008-11#1)(2008-3#1)(2008-4#1)
this array##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
this arrhythmia##2##2##(2007-8#1)(2010-12#1)
this article I##3##3##(1992-2#1)(2009-6#1)(2010-3#1)
this article a##4##3##(1995-12#1)(2007-11#1)(2008-11#1)(2013-8#1)
this article addresses##2##3##(1994-12#1)(2008-9#1)
this article also##3##3##(1995-12#1)(2010-9#1)(2013-8#1)
this article an##2##3##(2008-1#1)(2008-11#1)
this article and##4##3##(1992-1#2)(1992-2#1)(2008-2#1)
this article are##8##3##(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
this article can##2##3##(2006-5#1)(2008-7#1)
this article considers##2##3##(2009-7#1)(2010-2#1)
this article describes the##2##4##(2011-2#1)(2012-3#1)
this article describes##3##3##(1992-12#1)(2011-2#1)(2012-3#1)
this article discusses the##2##4##(1992-1#1)(2008-7#1)
this article discusses##5##3##(1992-1#1)(1993-3#2)(2008-7#1)(2010-7#1)
this article evaluates##2##3##(2007-12#1)(2008-2#1)
this article examines the##2##4##(1995-3#1)(2008-11#1)
this article examines##6##3##(1993-1#1)(1995-1#1)(1995-3#1)(2008-11#1)(2012-12#1)(2012-2#1)
this article explores the##2##4##(1996-12#1)(2008-11#1)
this article focuses on the##2##5##(1992-12#1)(1993-2#1)
this article include##3##3##(1996-2#1)(1997-1#1)(2010-7#1)
this article includes##2##3##(1991-1#1)(2008-12#1)
this article is an##8##4##(1992-1#1)(2008-11#5)(2008-7#1)(2012-3#1)
this article is on##3##4##(2008-10#1)(2008-12#1)(2010-2#1)
this article is that##2##4##(2007-8#1)(2008-7#1)
this article is to##77##4##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#3)
this article is##98##3##(1992-1#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#4)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#3)
this article presents the##3##4##(1996-1#1)(1996-2#1)(2013-1#1)
this article presents##4##3##(1996-1#1)(1996-2#1)(2008-5#1)(2013-1#1)
this article proposes##2##3##(1993-1#1)(2012-3#1)
this article provides##2##3##(1994-1#1)(2008-7#1)
this article reviews##2##3##(2008-4#1)(2008-7#1)
this article suggests##3##3##(1991-3#1)(1994-1#1)(1994-2#1)
this article the##8##3##(1990-3#2)(1992-3#1)(1993-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2012-3#1)
this article was##14##3##(1991-2#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
this article we##40##3##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1994-1#1)(1995-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-8#1)
this article will address##2##4##(1996-1#1)(2008-1#1)
this article will focus on the##2##6##(1995-12#1)(2008-5#1)
this article will##12##3##(1992-4#1)(1994-1#1)(1995-12#1)(1996-1#2)(2008-1#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)
this article##620##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#1)(1991-1#9)(1991-12#6)(1991-2#9)(1991-3#9)(1991-9#1)(1992-1#13)(1992-11#1)(1992-12#9)(1992-2#11)(1992-3#6)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#6)(1993-11#1)(1993-12#7)(1993-2#6)(1993-3#7)(1994-1#13)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#6)(1995-1#7)(1995-12#7)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#1)(1996-1#7)(1996-12#1)(1996-2#12)(1996-3#5)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#9)(2008-10#26)(2008-11#39)(2008-12#9)(2008-2#5)(2008-3#5)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#29)(2008-8#22)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#7)(2010-8#7)(2010-9#8)(2011-1#9)(2011-2#27)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#12)(2012-2#31)(2012-3#18)(2013-1#17)(2013-7#1)(2013-8#10)
this as a##7##3##(1995-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-3#2)
this as##8##2##(1995-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#2)
this aspect of##6##3##(1994-3#1)(1995-5#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
this aspect##8##2##(1994-3#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
this assay is 0##2##4##(2008-10#1)(2008-11#1)
this assay is##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
this assay system##3##3##(1991-2#2)(2008-11#1)
this assay was##3##3##(1995-11#1)(1996-5#1)(2013-1#1)
this assay##41##2##(1990-12#3)(1991-12#2)(1991-2#3)(1991-9#3)(1992-12#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-4#1)(2008-10#11)(2008-11#4)(2008-4#3)(2008-5#3)(2008-7#1)(2010-2#1)(2011-3#1)(2013-1#1)
this assemblage##2##2##(2011-1#1)(2012-2#1)
this assertion##2##2##(2008-9#1)(2011-2#1)
this assessment##5##2##(1995-1#1)(2008-10#2)(2008-11#1)(2011-3#1)
this assignment##3##2##(1997-6#1)(2008-3#1)(2013-1#1)
this association is explained by##2##5##(2009-7#1)(2013-1#1)
this association is##5##3##(1991-5#1)(1997-1#1)(2009-10#1)(2009-7#1)(2013-1#1)
this association was not statistically significant##2##6##(2012-12#2)
this association was##3##3##(2008-12#1)(2012-12#2)
this association##23##2##(1991-12#1)(1991-5#1)(1993-12#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-7#1)(2012-12#2)(2013-1#3)
this assumption and##3##3##(2008-3#1)(2008-8#1)(2012-3#1)
this assumption is##3##3##(1994-11#1)(2008-2#1)(2011-2#1)
this assumption##21##2##(1990-8#2)(1994-11#1)(1995-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
this asymmetric##4##2##(1993-8#1)(1997-3#1)(2007-12#1)(2009-2#1)
this average eigenvector##2##3##(2008-2#2)
this background##4##2##(1991-6#1)(2008-9#1)(2010-3#2)
this bacterial##5##2##(2008-10#3)(2008-5#1)(2008-9#1)
this bacterium was##2##3##(2008-10#1)(2011-2#1)
this bacterium##9##2##(1993-8#1)(2008-10#5)(2008-9#2)(2011-2#1)
this balance##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
this band was##2##3##(1995-11#2)
this barrier##5##2##(1992-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
this basic##7##2##(2008-1#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-8#1)(2010-9#1)(2013-8#1)
this basis##10##2##(1990-11#1)(1992-3#1)(1995-6#1)(2008-10#3)(2008-2#2)(2009-4#1)(2011-2#1)
this batch##2##2##(2008-6#1)(2013-8#1)
this be##4##2##(2007-12#1)(2009-10#1)(2012-12#2)
this beam##2##2##(2008-3#1)(2008-9#1)
this behavior##14##2##(1992-12#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
this behavioral##4##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)
this behaviour##6##2##(1993-12#1)(2008-10#1)(2008-11#2)(2009-9#1)(2010-8#1)
this behavioural##2##2##(1993-11#1)(1995-12#1)
this being the##3##3##(1992-12#1)(1992-9#1)(2008-5#1)
this being##6##2##(1992-12#1)(1992-9#1)(1996-12#1)(2008-2#1)(2008-5#1)(2008-8#1)
this belief##2##2##(2008-10#1)(2013-1#1)
this beneficial effect##2##3##(1995-3#1)(2008-10#1)
this beneficial##3##2##(1995-3#1)(2008-10#2)
this benefit##7##2##(1991-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
this beta##2##2##(1994-11#2)
this bias##3##2##(1994-2#1)(1996-8#1)(2009-10#1)
this binding is##3##3##(1994-12#1)(1995-2#1)(2008-10#1)
this binding was##2##3##(1991-12#1)(1996-12#1)
this binding##13##2##(1990-5#1)(1991-12#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-10#1)
this bioactive##2##2##(1994-8#1)(2008-5#1)
this bioassay##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
this biochemical##3##2##(1990-8#1)(1992-12#1)(2011-2#1)
this biocontrol agent##2##3##(2008-10#2)
this biocontrol##3##2##(2008-10#3)
this biological control agent##2##4##(2008-10#2)
this biological control##3##3##(2008-10#3)
this biological##8##2##(1994-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2012-2#1)
this biomechanical##2##2##(2009-3#1)(2012-2#1)
this biosensor##2##2##(2008-10#2)
this birefringence##2##2##(2008-2#1)(2008-3#1)
this bond##2##2##(1990-5#1)(1991-5#1)
this book##3##2##(2008-10#2)(2008-2#1)
this brain##2##2##(1995-2#1)(2013-1#1)
this branch##2##2##(2007-11#1)(2007-8#1)
this brief review##4##3##(1992-2#1)(2008-5#1)(2008-7#2)
this brief##9##2##(1992-2#1)(1996-11#1)(2006-6#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2013-1#1)
this by##9##2##(1993-12#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
this cDNA was##2##3##(1990-12#1)(1991-5#1)
this cDNA##11##2##(1990-12#5)(1991-5#1)(1992-8#1)(1993-11#2)(2008-6#1)(2008-8#1)
this calibration method##2##3##(2008-2#1)(2010-3#1)
this calibration technique##2##3##(2008-10#2)
this calibration##6##2##(2008-10#4)(2008-2#1)(2010-3#1)
this can be achieved##3##4##(1993-9#1)(2007-8#1)(2012-12#1)
this can be explained##2##4##(1992-6#1)(2008-2#1)
this can be used##2##4##(2008-8#1)(2010-5#1)
this can be##17##3##(1991-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-4#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#1)(2012-12#1)
this can have##2##3##(1991-11#1)(2012-2#1)
this can##26##2##(1991-11#1)(1991-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-4#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)
this cancer and##2##3##(2009-4#1)(2013-8#1)
this cancer##10##2##(1992-5#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
this capability##2##2##(2012-2#1)(2013-1#1)
this capacity##5##2##(1993-11#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-2#1)
this carrier##3##2##(1992-3#1)(1995-6#1)(2008-10#1)
this cascade##3##2##(2007-12#1)(2008-5#1)(2012-12#1)
this case and##4##3##(1993-5#1)(1996-3#1)(2009-3#1)(2012-12#1)
this case are presented##2##4##(2008-10#1)(2011-2#1)
this case as##4##3##(2008-7#1)(2009-3#1)(2010-6#1)(2013-1#1)
this case because##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
this case could##2##3##(2007-9#1)(2008-2#1)
this case highlights the##2##4##(2008-7#1)(2011-1#1)
this case is that##3##4##(1997-4#1)(2008-1#1)(2010-6#1)
this case is##6##3##(1997-4#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-6#1)(2013-7#1)
this case of##2##3##(2008-7#1)(2010-2#1)
this case report suggests##2##4##(2012-12#1)(2012-2#1)
this case report was##2##4##(2010-6#1)(2013-8#1)
this case report##27##3##(1996-8#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
this case represents a##2##4##(2008-7#1)(2012-1#1)
this case series##2##3##(2008-12#1)(2013-1#1)
this case study##11##3##(1991-1#1)(1992-3#1)(1992-6#1)(1993-1#2)(1994-1#2)(1996-1#1)(2010-5#1)(2012-12#2)
this case the##14##3##(1992-6#1)(1995-12#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2013-8#1)
this case to##2##3##(2007-8#1)(2012-3#1)
this case was##6##3##(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
this case##207##2##(1990-6#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#3)(1993-1#2)(1993-12#1)(1993-5#1)(1994-1#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#4)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#7)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#4)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#4)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#3)
this category of patients##2##4##(1991-3#1)(1991-8#1)
this category of##3##3##(1991-3#1)(1991-8#1)(2008-6#1)
this category##5##2##(1991-3#1)(1991-8#1)(2008-2#1)(2008-6#1)(2012-1#1)
this causes##2##2##(2008-10#1)(2008-11#1)
this cavity##2##2##(2008-3#2)
this ceiling##2##2##(2008-11#1)(2013-7#1)
this cell line and##2##4##(1997-6#1)(2008-11#1)
this cell line is##3##4##(1990-5#1)(1993-9#1)(1994-8#1)
this cell line was##2##4##(2008-11#2)
this cell line##13##3##(1990-5#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-8#1)(1997-6#1)(2008-11#6)
this cell##20##2##(1990-5#2)(1991-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#7)(2008-3#1)(2011-2#1)
this cellular##4##2##(1995-2#2)(2008-7#1)(2011-2#1)
this center##2##2##(2007-8#1)(2008-1#1)
this central##2##2##(2008-7#1)(2011-2#1)
this century##5##2##(1995-8#1)(1996-11#1)(1997-5#1)(2007-8#1)(2008-11#1)
this challenge##10##2##(1993-12#1)(1993-2#1)(1994-12#1)(1997-1#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2012-3#1)
this challenging problem##2##3##(2010-8#1)(2011-2#1)
this challenging##7##2##(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#2)(2013-1#1)
this change and##2##3##(1996-12#2)
this change in##5##3##(2008-10#2)(2008-2#1)(2008-7#1)(2010-3#1)
this change is##2##3##(2008-10#1)(2011-3#1)
this change was##3##3##(1996-9#1)(1997-8#1)(2013-7#1)
this change##24##2##(1992-3#1)(1993-11#1)(1994-1#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-3#1)(2013-7#1)
this channel in##2##3##(1996-2#1)(2009-12#1)
this channel##5##2##(1991-9#1)(1996-2#1)(1997-3#1)(2009-12#1)(2009-8#1)
this chapter##19##2##(2008-4#5)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2013-1#2)
this character##2##2##(2008-11#1)(2008-8#1)
this chemical##3##2##(2008-10#2)(2008-11#1)
this chemically##2##2##(1994-9#1)(2008-10#1)
this chemistry##2##2##(2008-4#1)(2012-12#1)
this child##3##2##(2008-9#1)(2009-7#1)(2011-2#1)
this chromatographic##3##2##(2008-10#2)(2008-5#1)
this chromosomal##3##2##(1997-2#1)(2008-7#1)(2009-10#1)
this chromosome##7##2##(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-7#1)
this chronic##3##2##(1992-2#1)(1993-8#1)(2009-11#1)
this circulation##2##2##(1996-1#2)
this claim##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
this class of compounds##3##4##(1993-8#2)(2008-10#1)
this class of proteins##2##4##(1994-12#1)(2008-11#1)
this class of##25##3##(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-12#1)(1995-5#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
this class##30##2##(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-12#1)(1995-5#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
this classification##3##2##(1990-11#1)(1992-7#1)(1997-8#1)
this cleavage##3##2##(1991-9#1)(1994-8#1)(2008-5#1)
this client group##3##3##(1997-7#1)(2008-11#1)(2008-7#1)
this clinic##3##2##(2008-2#2)(2009-10#1)
this clinical##14##2##(1990-3#1)(1993-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
this clone is##2##3##(1993-6#2)
this clone was##2##3##(1995-2#1)(2008-8#1)
this clone##13##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-3#1)(1993-6#3)(1994-8#2)(1995-2#2)(2008-10#1)(2008-8#1)
this cluster##2##2##(1992-12#1)(2008-12#1)
this code##2##2##(1992-11#1)(1992-2#1)
this cohort##7##2##(1994-12#1)(1994-5#1)(1997-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
this collaboration##2##2##(1991-2#1)(1996-3#1)
this column##12##2##(2007-2#9)(2008-10#2)(2011-2#1)
this combination has##2##3##(1995-5#1)(2010-12#1)
this combination is##3##3##(2008-7#1)(2009-6#1)(2011-2#1)
this combination##15##2##(1995-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
this combined##8##2##(1991-3#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
this commentary##4##2##(2008-12#1)(2009-5#2)(2012-2#1)
this commissure##2##2##(2007-12#2)
this common and##3##3##(1991-8#1)(2006-10#1)(2012-12#1)
this common##9##2##(1991-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
this communication##14##2##(1990-2#1)(1991-5#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2012-8#1)
this community##3##2##(2008-11#2)(2011-2#1)
this comparative##2##2##(1993-12#1)(2011-2#1)
this comparison##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
this compensatory##2##2##(2010-11#1)(2010-7#1)
this competition##2##2##(2008-8#1)(2008-9#1)
this complex and##4##3##(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
this complex disorder##3##3##(2008-7#2)(2009-7#1)
this complex is##3##3##(1995-11#1)(2008-10#2)
this complex##43##2##(1990-5#1)(1990-7#2)(1991-5#1)(1992-3#1)(1992-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-10#1)(2008-10#7)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
this complexity##6##2##(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
this complicated##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
this complication has##2##3##(1997-3#1)(2008-7#1)
this complication is##2##3##(1991-3#1)(2013-1#1)
this complication##25##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#1)(1997-3#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#2)(2011-3#1)(2013-1#4)
this component of##2##3##(1996-2#1)(2008-5#1)
this component##6##2##(1996-2#2)(2008-10#2)(2008-5#1)(2008-7#1)
this composite material##2##3##(2007-11#1)(2007-12#1)
this composite polymer##2##3##(2008-10#2)
this composite##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
this compound in##4##3##(1990-8#1)(2008-10#2)(2011-2#1)
this compound may##2##3##(1993-9#1)(1995-2#1)
this compound was##4##3##(1991-8#1)(2008-10#2)(2012-2#1)
this compound##30##2##(1990-8#1)(1991-5#1)(1991-8#2)(1992-11#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-2#3)(1995-3#1)(1997-1#1)(2008-10#13)(2008-5#2)(2011-2#1)(2012-2#1)
this comprehensive review##3##3##(2008-8#1)(2010-2#1)(2010-8#1)
this comprehensive##8##2##(1992-3#1)(1995-1#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#2)(2013-1#1)
this concentration of##2##3##(1993-3#1)(2008-10#1)
this concentration range##3##3##(1992-3#1)(2008-10#2)
this concentration##14##2##(1992-12#1)(1992-3#1)(1993-3#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
this concept has##2##3##(1992-1#1)(1992-12#1)
this concept in##3##3##(1995-2#1)(2008-11#1)(2009-5#1)
this concept is##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)
this concept##17##2##(1992-1#1)(1992-12#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
this concern##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
this conclusion is##2##3##(1994-12#1)(2012-3#1)
this conclusion##3##2##(1994-12#1)(2008-9#1)(2012-3#1)
this condition and##5##3##(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
this condition can##2##3##(2008-10#1)(2008-11#1)
this condition from##2##3##(2008-11#1)(2011-1#1)
this condition in##6##3##(1996-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-11#1)(2012-12#1)
this condition is##11##3##(2007-12#1)(2007-8#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
this condition may be##2##4##(2012-2#1)(2013-1#1)
this condition may##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
this condition should be##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
this condition should##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
this condition##100##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-5#1)(1994-9#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-5#4)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#4)
this conductance are##2##3##(1990-7#1)(1996-2#1)
this conference##4##2##(1997-8#1)(2008-5#1)(2009-5#1)(2010-4#1)
this configuration is##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
this configuration##16##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#5)(2013-1#1)(2013-8#1)
this confirms##2##2##(1991-3#1)(2006-10#1)
this conflict is##2##3##(1995-5#1)(2008-8#1)
this conflict##4##2##(1995-5#1)(2008-8#3)
this congenital##2##2##(2008-7#1)(2008-9#1)
this connection##2##2##(1996-8#1)(2012-3#1)
this consensus##5##2##(1992-1#1)(2007-12#1)(2008-8#1)(2009-6#1)(2013-1#1)
this conserved##5##2##(1992-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-4#1)
this constant##2##2##(1994-5#1)(2012-3#1)
this construct##9##2##(1995-2#2)(1995-3#1)(1997-8#1)(2010-6#2)(2012-1#1)(2012-2#1)(2013-1#1)
this content##2##2##(1997-2#1)(2008-12#1)
this context##49##2##(1994-11#1)(1994-3#1)(1995-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
this continuum##2##2##(1991-12#1)(2011-2#1)
this contributes to##4##3##(1994-11#1)(1996-2#1)(2007-7#1)(2009-3#1)
this contribution##7##2##(2008-1#2)(2008-10#3)(2008-3#1)(2011-2#1)
this control##2##2##(1990-6#1)(2008-11#1)
this controversy##4##2##(1991-5#1)(1995-5#1)(2008-9#1)(2009-12#1)
this conversion##2##2##(1992-8#1)(2009-12#1)
this correlates with##2##3##(1995-12#1)(2010-8#1)
this correlation##8##2##(1991-6#1)(1992-6#1)(2008-10#2)(2008-12#2)(2008-3#1)(2013-8#1)
this cost##4##2##(1991-1#1)(1991-12#1)(1994-2#1)(2008-9#1)
this could be a##2##4##(1993-1#1)(2013-1#1)
this could be##8##3##(1993-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
this could##14##2##(1993-1#1)(1994-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
this country##31##2##(1991-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-8#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#3)(2010-6#1)(2012-12#1)(2012-3#1)
this coupling##2##2##(2007-11#1)(2008-10#1)
this course##2##2##(2008-1#1)(2008-11#1)
this crisis##2##2##(2008-10#1)(2009-5#1)
this criterion##3##2##(1991-6#1)(1995-2#1)(2008-3#1)
this critical period##2##3##(2007-11#1)(2008-10#1)
this critical##7##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-7#1)
this crop##4##2##(2008-10#2)(2010-10#2)
this cross##8##2##(1994-12#1)(2008-10#4)(2008-4#1)(2009-11#1)(2013-8#1)
this cross-sectional study was##3##4##(2008-10#1)(2010-2#1)(2012-12#1)
this cross-sectional study##11##3##(2008-1#1)(2008-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#1)
this cross-sectional##12##2##(2008-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#1)
this current##5##2##(1991-9#1)(1996-2#1)(2008-12#1)(2010-3#1)(2013-1#1)
this cycle##4##2##(1996-2#1)(2008-9#2)(2013-1#1)
this cytokine##5##2##(1992-8#1)(1993-6#1)(1994-9#1)(2008-10#1)(2008-4#1)
this cytotoxic##2##2##(1991-9#1)(1996-12#1)
this damage##2##2##(2010-2#1)(2011-2#1)
this dangerous##3##2##(1994-3#1)(1995-5#1)(2007-10#1)
this data and##2##3##(1997-4#1)(2012-1#1)
this data is##3##3##(1992-12#1)(1997-1#1)(2008-10#1)
this data##21##2##(1991-12#1)(1992-12#1)(1996-1#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
this database##5##2##(1996-3#1)(2008-10#1)(2010-2#1)(2010-5#2)
this date##2##2##(1990-6#1)(2008-10#1)
this day##3##2##(1991-1#1)(2010-12#1)(2010-8#1)
this debilitating disease##2##3##(2008-9#1)(2009-3#1)
this debt##2##2##(1994-2#2)
this decade##2##2##(1996-1#1)(2008-5#1)
this decapeptide sequence##2##3##(1992-11#2)
this decision##5##2##(1991-12#1)(1992-2#1)(1994-3#1)(1997-1#1)(2008-6#1)
this decline was##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
this decline##10##2##(1990-5#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#2)(2013-1#1)
this decrease in##2##3##(2008-10#1)(2009-6#1)
this decrease##7##2##(1993-9#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)
this defect##2##2##(1997-7#1)(2008-1#1)
this deficit##5##2##(1994-3#2)(2008-9#2)(2013-1#1)
this definition##2##2##(1993-1#1)(2008-3#1)
this deformity##2##2##(1990-9#1)(2007-11#1)
this degradation##2##2##(2008-10#2)
this degree of##2##3##(1993-5#1)(2008-5#1)
this deletion##3##2##(1991-9#1)(1993-12#1)(2012-12#1)
this dementia##2##2##(2008-9#2)
this demonstration##2##2##(2007-11#1)(2008-3#1)
this department##3##2##(1990-12#1)(2007-12#1)(2010-3#1)
this dependence##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2009-8#1)
this derivative##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
this descriptive##4##2##(2007-2#1)(2010-4#1)(2010-5#1)(2012-12#1)
this desensitization##2##2##(1992-3#2)
this design##14##2##(1992-9#1)(1994-2#1)(2008-10#1)(2008-2#2)(2008-3#4)(2009-10#2)(2010-2#1)(2010-5#1)(2010-8#1)
this detection system##2##3##(2008-10#2)
this detection##5##2##(2008-10#5)
this detector##4##2##(2008-10#3)(2008-3#1)
this detergent##2##2##(1992-3#1)(2012-2#1)
this determination##5##2##(1990-7#1)(1991-11#1)(2008-10#3)
this devastating disease process##2##4##(2008-11#2)
this devastating disease##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
this devastating illness##2##3##(2008-7#1)(2009-8#1)
this devastating##8##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-8#1)(2010-3#1)
this development##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
this developmental##2##2##(2009-8#1)(2011-2#1)
this device can##3##3##(1996-9#1)(2007-12#1)(2008-10#1)
this device has##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
this device in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
this device##25##2##(1994-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
this diagnosis in##2##3##(1992-4#1)(1997-8#1)
this diagnosis##18##2##(1990-9#1)(1991-12#1)(1991-9#2)(1992-4#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)(2013-1#3)
this diagnostic##4##2##(1990-6#1)(1990-9#1)(2011-1#1)(2012-3#1)
this dichotomy##2##2##(2008-8#1)(2009-8#1)
this did not appear to##2##5##(2008-11#1)(2008-9#1)
this did not reach statistical significance##2##6##(2008-6#1)(2008-7#1)
this did not##10##3##(1996-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
this diet##3##2##(1995-3#1)(2008-3#1)(2013-1#1)
this difference can##2##3##(1992-11#1)(2012-3#1)
this difference in##5##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-3#1)(2009-12#1)
this difference is##2##3##(2008-8#1)(2011-2#1)
this difference was not statistically significant (P&gt##2##7##(2009-3#2)
this difference was not statistically significant##3##6##(1991-6#1)(2009-3#2)
this difference was not##5##4##(1991-6#1)(2008-10#1)(2009-3#2)(2010-12#1)
this difference was##7##3##(1991-6#1)(1993-2#1)(2008-10#1)(2009-3#3)(2010-12#1)
this difference##22##2##(1991-11#1)(1991-6#1)(1992-11#1)(1993-2#1)(1994-3#1)(1994-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#3)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
this differential##3##2##(1994-2#1)(2008-3#1)(2012-8#1)
this difficulty##3##2##(2010-12#1)(2012-1#1)(2012-2#1)
this direction##8##2##(1997-6#1)(2007-7#1)(2008-3#2)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
this disabling and##2##3##(2008-2#1)(2011-2#1)
this discharge##2##2##(2007-12#1)(2008-10#1)
this discipline in##2##3##(1991-6#1)(2007-8#1)
this discipline##4##2##(1991-6#1)(1994-12#1)(2007-8#1)(2013-8#1)
this discussion##10##2##(1992-2#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#4)(2009-9#1)(2010-3#1)
this disease and##6##3##(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-5#1)
this disease are##7##3##(1990-12#1)(1990-6#1)(1992-2#1)(1992-6#1)(1997-8#1)(2008-1#1)(2008-10#1)
this disease by##2##3##(2007-8#1)(2011-2#1)
this disease has been##2##4##(2008-1#1)(2008-5#1)
this disease has##3##3##(2008-1#1)(2008-5#1)(2010-6#1)
this disease is##8##3##(1991-6#1)(1991-9#1)(1994-8#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)
this disease may##3##3##(1993-11#1)(1996-12#1)(2010-6#1)
this disease process##3##3##(1995-9#1)(2008-7#1)(2013-1#1)
this disease still##2##3##(1995-1#1)(2011-2#1)
this disease to##2##3##(2008-10#1)(2010-6#1)
this disease was##3##3##(2008-10#3)
this disease##160##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#4)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#33)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#4)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#2)(2010-5#3)(2010-6#3)(2010-8#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
this disinfecting treatment leads to the formation of halogenated by-products##2##10##(2008-10#2)
this disorder and##2##3##(2007-11#1)(2008-7#1)
this disorder are##3##3##(1997-2#1)(1997-3#1)(2008-7#1)
this disorder in##2##3##(2010-11#1)(2011-2#1)
this disorder is##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)
this disorder##44##2##(1990-3#1)(1992-3#1)(1994-5#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
this distance##4##2##(1996-6#1)(2007-10#1)(2007-12#1)(2013-1#1)
this distinction is##2##3##(2008-11#1)(2009-8#1)
this distinction##5##2##(2008-11#3)(2008-3#1)(2009-8#1)
this distribution##6##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
this diverse##2##2##(2008-10#1)(2013-8#1)
this document##6##2##(1993-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
this does not##3##3##(1990-8#1)(2008-5#1)(2011-2#1)
this domain of##2##3##(1991-6#1)(2008-2#1)
this domain##12##2##(1990-11#1)(1991-10#1)(1991-3#1)(1991-6#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
this donor site##2##3##(2008-7#1)(2011-2#1)
this dose of##3##3##(1992-3#1)(1994-8#1)(1995-3#1)
this dose##8##2##(1990-6#1)(1992-12#1)(1992-3#1)(1994-8#1)(1995-3#1)(1997-8#1)(2009-6#1)(2013-1#1)
this drawback can be##2##4##(2008-2#1)(2008-3#1)
this drawback##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
this drug in##7##3##(1991-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)
this drug is##2##3##(2007-10#1)(2010-2#1)
this drug was##2##3##(2008-5#1)(2012-3#1)
this drug##28##2##(1990-10#1)(1990-8#1)(1991-12#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
this dsRNA##5##2##(2008-10#5)
this dual-image mode for gated##2##5##(2008-3#2)
this dye##3##2##(1994-12#1)(2008-9#1)(2013-1#1)
this dynamic##2##2##(2008-8#1)(2009-12#1)
this earlier##2##2##(2008-2#1)(2008-8#1)
this early##2##2##(1990-5#1)(1991-2#1)
this editorial##2##2##(2010-12#1)(2010-5#1)
this effect and##4##3##(1996-2#1)(1997-4#1)(2007-12#1)(2008-2#1)
this effect can be##3##4##(2008-3#3)
this effect could be##2##4##(2007-12#1)(2013-8#1)
this effect for##2##3##(2007-11#1)(2008-10#1)
this effect has##2##3##(1994-9#1)(1995-8#1)
this effect in a##2##4##(2007-12#1)(2013-8#1)
this effect in##5##3##(1990-6#1)(1991-1#1)(2007-12#1)(2008-9#1)(2013-8#1)
this effect is dependent on##3##5##(1992-8#1)(1997-2#1)(2008-5#1)
this effect is mediated via##2##5##(1993-6#1)(2008-8#1)
this effect is mediated##3##4##(1993-3#1)(1993-6#1)(2008-8#1)
this effect is not##4##4##(1992-9#1)(2008-10#1)(2008-3#1)(2012-3#1)
this effect is##23##3##(1990-11#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2012-3#1)
this effect may be mediated##2##5##(1994-8#1)(2008-5#1)
this effect may be##5##4##(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
this effect may##6##3##(1994-8#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
this effect might##2##3##(1991-2#1)(2008-7#1)
this effect of##7##3##(1990-12#1)(1991-1#1)(1993-12#1)(1994-6#1)(1995-12#1)(2008-8#1)(2008-9#1)
this effect on##5##3##(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
this effect to##2##3##(1992-8#1)(2007-12#1)
this effect was also##2##4##(1990-5#1)(2013-1#1)
this effect was not##6##4##(1997-7#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-10#1)(2012-2#1)
this effect was reversed##2##4##(1990-5#1)(2009-11#1)
this effect was##25##3##(1990-5#2)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#3)(2009-11#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
this effect##150##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-8#2)(1996-2#3)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#2)(2007-10#1)(2007-11#6)(2007-12#6)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#7)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
this effective##2##2##(1996-6#1)(2008-5#1)
this effort##7##2##(1990-6#1)(1992-1#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
this elderly##2##2##(2007-10#1)(2011-1#1)
this electrode and##2##3##(2008-10#2)
this electrode is##3##3##(2008-10#3)
this electrode##19##2##(2008-10#19)
this element is##3##3##(2008-10#2)(2013-1#1)
this element##17##2##(1995-6#1)(2008-10#13)(2009-9#1)(2010-12#1)(2013-1#1)
this elevation##3##2##(2007-7#1)(2008-10#2)
this embryonic##2##2##(2008-11#1)(2013-1#1)
this emergent##2##2##(2010-4#1)(2013-8#1)
this emerging##5##2##(1992-2#1)(2007-4#1)(2008-10#1)(2012-1#1)(2012-2#1)
this end##48##2##(1993-11#1)(1993-8#2)(1994-2#1)(1995-1#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
this energy range##2##3##(2007-11#1)(2008-2#1)
this enhanced##2##2##(1993-3#1)(1995-5#1)
this enhancement was##3##3##(1994-9#1)(1996-12#1)(2008-11#1)
this enhancement##7##2##(1994-9#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
this enormous##2##2##(2011-2#1)(2013-8#1)
this entity in##2##3##(2007-8#1)(2012-3#1)
this entity##16##2##(1990-10#1)(1993-8#1)(1993-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
this environment##7##2##(1993-2#1)(1994-2#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-6#1)
this enzymatic activity##2##3##(1995-12#1)(2011-1#1)
this enzymatic##5##2##(1990-11#1)(1990-5#1)(1995-12#1)(2011-1#2)
this enzyme activity##6##3##(1994-2#1)(2008-10#1)(2008-3#1)(2008-6#2)(2013-1#1)
this enzyme and the##2##4##(1992-8#1)(2008-10#1)
this enzyme and##3##3##(1991-12#1)(1992-8#1)(2008-10#1)
this enzyme in the##3##4##(1990-7#1)(1994-6#1)(1997-7#1)
this enzyme in##9##3##(1990-7#1)(1991-5#1)(1994-6#1)(1994-8#2)(1997-7#1)(2008-10#1)(2008-5#1)(2011-3#1)
this enzyme is not##3##4##(1992-10#1)(1995-6#1)(2012-6#1)
this enzyme is##6##3##(1990-11#1)(1992-10#1)(1992-9#1)(1995-6#1)(2008-7#1)(2012-6#1)
this enzyme to##3##3##(1993-5#1)(1994-8#1)(2008-10#1)
this enzyme was##5##3##(1990-5#1)(1991-11#1)(1992-6#1)(2008-6#1)(2008-7#1)
this enzyme##74##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#6)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#4)(1997-8#1)(2006-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2009-7#1)(2010-2#1)(2011-3#1)(2012-2#1)(2012-6#1)(2013-1#1)
this enzyme's##2##2##(1990-5#1)(1994-3#1)
this epidemic##4##2##(2007-7#1)(2008-1#1)(2009-4#1)(2011-2#1)
this equation is##2##3##(2008-2#1)(2008-3#1)
this equation##7##2##(1994-9#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#1)
this equilibrium##2##2##(2008-5#1)(2012-12#1)
this era of##2##3##(1995-2#1)(1997-3#1)
this era##3##2##(1994-3#1)(1995-2#1)(1997-3#1)
this error is##2##3##(2008-3#2)
this error##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)
this essay##7##2##(1995-1#1)(2007-5#1)(2008-12#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
this estimate##2##2##(1995-6#1)(2008-9#1)
this evaluation##10##2##(1992-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
this event is##5##3##(1991-5#1)(1993-11#1)(1994-10#1)(1994-9#1)(2007-12#1)
this event##13##2##(1991-5#1)(1992-3#1)(1993-11#1)(1994-10#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
this evidence and##2##3##(2008-3#1)(2009-5#1)
this evidence##5##2##(2008-12#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-4#1)
this evolution##2##2##(2007-12#1)(2008-12#1)
this evolutionary##2##2##(2008-8#1)(2008-9#1)
this examination##5##2##(1992-12#1)(1992-5#1)(1994-2#1)(2008-10#1)(2013-8#1)
this example##6##2##(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
this excess##2##2##(1991-11#1)(1991-12#1)
this exchange##2##2##(1990-11#1)(1995-2#1)
this exciting##6##2##(1991-3#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
this exercise##5##2##(1993-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
this expansion##4##2##(1991-3#1)(1992-1#1)(2008-3#1)(2009-8#1)
this expectation##2##2##(2008-7#1)(2009-8#1)
this expensive##2##2##(1994-12#1)(2011-2#1)
this experience##11##2##(1993-3#2)(1994-3#1)(1996-11#1)(2008-11#4)(2008-12#1)(2008-6#1)(2012-3#1)
this experiment is that##2##4##(1995-3#1)(2008-3#1)
this experiment is##4##3##(1995-3#1)(2008-2#1)(2008-3#2)
this experiment was##5##3##(1993-12#2)(1997-2#1)(2008-12#1)(2009-4#1)
this experiment##33##2##(1992-1#1)(1993-12#3)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-8#1)(2009-4#2)(2010-10#1)(2010-2#1)(2012-1#1)
this experimental design##3##3##(2008-10#1)(2008-7#1)(2009-2#1)
this experimental model##3##3##(1993-2#1)(1994-2#1)(2008-7#1)
this experimental##12##2##(1993-2#1)(1994-2#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)
this explanation##2##2##(2008-3#1)(2010-10#1)
this exploratory study##4##3##(2008-10#1)(2009-10#1)(2010-6#1)(2013-8#1)
this exploratory##6##2##(1992-2#1)(2008-10#1)(2009-10#1)(2010-5#1)(2010-6#1)(2013-8#1)
this exposure##2##2##(2008-12#1)(2010-11#1)
this expression##5##2##(1995-12#1)(1996-10#1)(1996-2#1)(1997-4#1)(2008-11#1)
this extension##3##2##(1992-5#1)(2008-3#2)
this extensive##2##2##(1990-8#1)(2012-3#1)
this extra##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
this extract##5##2##(2008-11#1)(2008-5#3)(2009-6#1)
this fact##8##2##(1997-5#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
this factor can##2##3##(1990-11#1)(1993-6#1)
this factor in##2##3##(1991-8#1)(2012-1#1)
this factor may##2##3##(1994-12#1)(2009-3#1)
this factor was##2##3##(2007-12#1)(2008-10#1)
this factor##21##2##(1990-11#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-3#1)(2012-1#1)(2012-12#1)
this failure##3##2##(2008-10#1)(2009-10#1)(2010-11#1)
this family and##2##3##(1991-2#1)(2007-1#1)
this family into##2##3##(2008-6#1)(2010-1#1)
this family is##2##3##(1997-3#1)(2008-10#1)
this family of compounds##2##4##(2008-6#1)(2010-5#1)
this family of proteins##3##4##(1990-5#1)(1996-9#1)(2010-10#1)
this family of##15##3##(1990-5#1)(1992-5#1)(1996-12#1)(1996-9#1)(2008-4#1)(2008-6#3)(2008-9#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)
this family##53##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-7#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
this fatty acid##2##3##(1993-8#1)(1993-9#1)
this feature is##2##3##(2008-6#1)(2011-2#1)
this feature##11##2##(1994-12#1)(1996-5#1)(1996-9#1)(2007-12#2)(2008-3#1)(2008-6#2)(2010-5#1)(2011-2#2)
this fermentation##2##2##(2008-11#1)(2008-6#1)
this fiber##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
this field is in##2##4##(2007-2#1)(2008-8#1)
this field is presented##2##4##(1997-7#1)(2008-11#1)
this field is##10##3##(1992-9#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-12#1)
this field##71##2##(1990-9#1)(1991-4#1)(1992-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#3)
this figure of merit##2##4##(2007-11#1)(2007-12#1)
this figure##8##2##(1990-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2012-3#1)
this film##2##2##(2007-11#1)(2008-10#1)
this final##2##2##(1996-3#1)(2008-10#1)
this finding are discussed##2##4##(2008-6#1)(2008-9#1)
this finding in##4##3##(1992-8#1)(2008-12#1)(2009-6#1)(2012-2#1)
this finding is##2##3##(1992-2#1)(2008-1#1)
this finding may be##2##4##(2008-3#1)(2012-3#1)
this finding may##4##3##(1990-2#1)(2008-11#1)(2008-3#1)(2012-3#1)
this finding to##2##3##(2009-5#1)(2010-4#1)
this finding##34##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-9#1)(1992-2#2)(1992-8#1)(1993-6#3)(1994-11#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-4#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
this first##7##2##(1991-12#1)(1992-12#1)(2011-1#1)(2012-2#2)(2013-1#2)
this fish##3##2##(1990-8#1)(2008-10#1)(2012-3#1)
this fishery is##2##3##(2007-5#1)(2008-5#1)
this fishery##3##2##(2007-5#2)(2008-5#1)
this flap##5##2##(2007-12#5)
this flow is##2##3##(2011-2#2)
this flow##6##2##(1990-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#2)
this focus##2##2##(2008-9#1)(2010-9#1)
this form of cell death##2##5##(2008-1#1)(2008-7#1)
this form of##18##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#2)
this form##24##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#2)
this formula##4##2##(2008-2#1)(2008-3#1)(2008-5#2)
this fossil##2##2##(2013-1#2)
this foundation##2##2##(1993-12#1)(2007-12#1)
this fraction##7##2##(1992-3#1)(1997-1#1)(2008-12#2)(2008-9#1)(2011-2#1)(2013-7#1)
this fracture##3##2##(1991-9#1)(2009-1#1)(2013-1#1)
this fragment as probe##2##4##(1990-12#1)(2008-8#1)
this fragment as##3##3##(1990-12#1)(2008-8#2)
this fragment was##2##3##(1990-5#1)(2008-8#1)
this fragment##12##2##(1990-12#1)(1990-5#2)(1991-9#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#3)(2012-12#1)
this framework##10##2##(1990-6#1)(1991-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2012-3#1)(2013-1#1)
this free##2##2##(1993-9#1)(2008-12#1)
this function##11##2##(1990-3#1)(1994-2#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-3#1)
this functional##8##2##(1993-2#1)(2008-10#2)(2008-7#2)(2010-10#1)(2011-1#1)(2013-8#1)
this fundamental##3##2##(2010-10#1)(2011-2#1)(2012-2#1)
this fungal##4##2##(2008-10#4)
this fungus in##2##3##(2008-10#2)
this fungus##22##2##(2008-10#18)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)
this further##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
this gap##6##2##(2008-11#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-9#1)(2013-8#1)
this gel##2##2##(2008-10#1)(2008-4#1)
this gene in the##2##4##(2008-10#1)(2008-8#1)
this gene in##8##3##(1993-11#1)(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-8#1)(2013-1#1)
this gene is##8##3##(1990-12#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#1)
this gene may##2##3##(1993-8#1)(2008-2#1)
this gene was##9##3##(1994-6#1)(2008-10#2)(2008-12#1)(2008-8#4)(2011-1#1)
this gene were##2##3##(1993-2#1)(1995-11#1)
this gene##69##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#5)(1996-2#1)(1997-3#1)(1997-7#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-6#1)(2009-8#1)(2011-1#1)(2013-1#1)
this general##4##2##(2008-1#1)(2008-3#2)(2012-3#1)
this genetic variation##2##3##(2008-10#1)(2010-4#1)
this genetic##8##2##(1996-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
this genomic sequence##2##3##(2008-8#2)
this genomic##4##2##(1997-4#1)(2008-8#2)(2013-8#1)
this genotype##5##2##(2008-10#2)(2008-12#1)(2008-4#2)
this genus##11##2##(2008-10#3)(2008-5#2)(2008-9#2)(2010-10#2)(2013-1#2)
this geometry##2##2##(2008-3#2)
this gives##2##2##(2008-2#1)(2008-3#1)
this gland##2##2##(1993-8#1)(2012-12#1)
this global##2##2##(2008-9#1)(2010-8#1)
this goal by##2##3##(2008-2#1)(2008-9#1)
this goal is##3##3##(1995-3#1)(1996-1#1)(2008-7#1)
this goal##28##2##(1992-12#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#2)(1997-3#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-3#3)(2012-2#1)(2012-3#1)
this gradient##4##2##(1990-11#1)(2008-10#1)(2008-2#1)(2010-3#1)
this grating##2##2##(2008-2#1)(2008-3#1)
this group and##2##3##(2008-11#1)(2008-6#1)
this group can be##2##4##(2010-12#1)(2011-2#1)
this group is##3##3##(1990-3#1)(2008-5#1)(2009-5#1)
this group may##2##3##(2008-2#1)(2008-5#1)
this group of children##3##4##(1992-1#1)(2008-9#1)(2012-2#1)
this group of patients##16##4##(1990-2#2)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1996-9#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-3#1)
this group of plants##2##4##(2008-11#1)(2013-7#1)
this group of##36##3##(1990-2#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1996-9#1)(1997-5#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-7#1)
this group was##5##3##(1990-9#1)(1995-2#1)(2008-1#1)(2008-9#1)(2013-1#1)
this group were##2##3##(1995-12#1)(2008-12#1)
this group##133##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#3)(1996-11#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#8)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#4)(2008-7#2)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-8#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#5)(2013-8#2)
this grouping was##2##3##(2008-10#2)
this grouping##6##2##(1997-4#1)(2008-10#3)(2009-4#1)(2010-12#1)
this growing movement##2##3##(2008-3#2)
this growing##3##2##(2008-3#2)(2010-6#1)
this growth factor##3##3##(1990-5#1)(1992-3#1)(1997-7#1)
this growth##6##2##(1990-5#1)(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
this guide##2##2##(1997-3#2)
this habitat##2##2##(2008-5#1)(2013-1#1)
this has been a##2##4##(2008-11#1)(2012-12#1)
this has been##8##3##(1994-2#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
this has led to##2##4##(1997-7#1)(2011-2#1)
this has not been##2##4##(1993-2#1)(2013-8#1)
this has##27##2##(1993-2#1)(1994-2#1)(1997-7#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
this health##2##2##(2010-12#1)(2011-1#1)
this heterogeneity##3##2##(1990-12#1)(2008-8#1)(2008-9#1)
this high risk group##2##4##(1995-4#1)(2009-2#1)
this high##6##2##(1991-6#1)(1995-4#1)(2008-11#1)(2009-2#2)(2013-1#1)
this high-risk population##2##3##(2010-3#1)(2013-1#1)
this high-risk##3##2##(2007-8#1)(2010-3#1)(2013-1#1)
this highly##11##2##(1991-1#1)(1992-3#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)
this historical##2##2##(2011-2#1)(2013-8#1)
this hologram##2##2##(2008-3#2)
this homography##2##2##(2008-6#2)
this hormone is##2##3##(2008-10#1)(2013-8#1)
this hormone##6##2##(1991-6#1)(1993-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2013-8#1)
this hospital##6##2##(1990-11#1)(1990-3#1)(1995-3#2)(2008-8#1)(2011-2#1)
this host##7##2##(2008-10#4)(2009-2#2)(2010-3#1)
this human##4##2##(1992-10#1)(1994-11#1)(1995-3#1)(2008-10#1)
this hypothesis by##5##3##(1993-6#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)
this hypothesis is##2##3##(2008-8#1)(2012-3#1)
this hypothesis using##2##3##(2009-8#1)(2011-2#1)
this hypothesis was##2##3##(2008-10#1)(2013-1#1)
this hypothesis##60##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
this idea is##2##3##(1995-6#1)(2011-2#1)
this idea##10##2##(1995-12#1)(1995-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
this ideal##2##2##(2008-3#1)(2013-1#1)
this identification##2##2##(2008-10#1)(2008-12#1)
this illness##7##2##(1990-9#1)(1992-2#1)(1993-3#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)
this imaging modality##2##3##(2010-8#1)(2013-1#1)
this imaging technique##2##3##(2008-3#1)(2013-1#1)
this imaging##4##2##(2008-3#1)(2010-8#1)(2013-1#2)
this imbalance##3##2##(2008-1#1)(2010-12#1)(2013-8#1)
this immunosuppressive effect##2##3##(2008-3#1)(2008-4#1)
this impairment##7##2##(1991-2#1)(1995-2#1)(1995-5#1)(2008-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
this implementation##2##2##(1996-1#1)(2008-2#1)
this implies##3##2##(2007-7#1)(2009-10#1)(2010-3#1)
this important##25##2##(1992-3#1)(1994-3#2)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#1)
this impression##2##2##(2008-11#1)(2008-8#1)
this improvement is##2##3##(2008-10#1)(2008-3#1)
this improvement the##2##3##(2007-12#1)(2008-3#1)
this improvement##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
this in terms of the##2##5##(1997-3#1)(2008-8#1)
this in the##3##3##(2007-8#1)(2012-1#1)(2013-7#1)
this in turn##4##3##(1990-12#1)(2008-12#2)(2010-4#1)
this in vitro model##2##4##(2008-10#1)(2008-5#1)
this in vitro system##2##4##(1994-8#1)(2008-11#1)
this in vitro##9##3##(1994-8#1)(2008-10#2)(2008-11#3)(2008-5#2)(2011-2#1)
this in vivo##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
this in##29##2##(1990-11#1)(1990-12#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
this include##2##2##(2008-11#1)(2011-1#1)
this includes##2##2##(2008-3#1)(2012-2#1)
this inconsistency##2##2##(2008-3#1)(2008-5#1)
this increase in the##2##4##(2007-8#1)(2008-7#1)
this increase in##8##3##(1990-10#1)(1991-2#1)(1994-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#1)
this increase is##7##3##(1991-3#1)(1992-12#1)(1993-8#1)(2008-11#2)(2011-1#1)(2012-2#1)
this increase was not##2##4##(2009-12#1)(2012-2#1)
this increase was##8##3##(1990-11#1)(1995-12#1)(1995-5#1)(1996-5#1)(2008-12#1)(2008-4#1)(2009-12#1)(2012-2#1)
this increase##34##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-5#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
this increased##15##2##(1990-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-12#1)
this increasingly##2##2##(2008-4#1)(2011-2#1)
this index##6##2##(1991-6#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#1)
this indicates that##2##3##(2006-6#1)(2008-6#1)
this indicates##4##2##(2006-6#1)(2008-6#1)(2009-2#1)(2009-4#1)
this indication##8##2##(1992-5#1)(1994-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)
this indicator##2##2##(2013-1#2)
this indirect##2##2##(2008-10#1)(2008-7#1)
this induced##2##2##(1991-3#1)(2008-11#1)
this induction##5##2##(1992-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(2012-12#1)
this infection##10##2##(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-2#2)(2010-12#1)(2012-2#1)(2013-1#1)
this infectious##2##2##(1995-5#1)(2008-12#1)
this information and##3##3##(1992-12#1)(1995-8#1)(2008-7#1)
this information can be##2##4##(1996-3#1)(1997-3#1)
this information can##5##3##(1996-1#1)(1996-3#1)(1997-3#1)(2008-6#1)(2011-2#1)
this information has##3##3##(1995-12#1)(1995-3#1)(2008-5#1)
this information in##3##3##(1991-11#1)(2008-11#1)(2008-7#1)
this information is critical for##2##5##(2008-10#1)(2008-9#1)
this information is##6##3##(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-9#1)
this information to##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
this information will##3##3##(2008-12#1)(2008-4#1)(2012-2#1)
this information with##2##3##(1997-4#1)(2013-1#1)
this information##54##2##(1991-11#1)(1992-11#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)
this infrequent##3##2##(1990-12#1)(1992-6#1)(2012-3#1)
this inhibition by##3##3##(1990-7#1)(1995-8#1)(2008-11#1)
this inhibition of##2##3##(1993-8#1)(1995-11#1)
this inhibition was##3##3##(1991-5#1)(1992-9#1)(1994-11#1)
this inhibition##13##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-7#1)
this inhibitor##5##2##(1992-8#1)(1992-9#2)(1995-12#1)(2010-2#1)
this inhibitory effect##2##3##(1990-7#1)(1995-11#1)
this inhibitory##5##2##(1990-7#1)(1995-11#1)(2008-10#2)(2008-7#1)
this initial interaction##2##3##(1995-6#1)(2013-1#1)
this initial##4##2##(1992-12#1)(1995-6#1)(1997-5#1)(2013-1#1)
this initiative##4##2##(1991-12#1)(2008-11#1)(2009-3#1)(2013-8#1)
this injection##2##2##(1994-9#1)(2008-10#1)
this injury##4##2##(2012-12#1)(2012-2#1)(2013-1#2)
this innovative##2##2##(2008-11#1)(2008-12#1)
this insect##5##2##(2007-12#1)(2008-6#1)(2008-7#2)(2011-10#1)
this instance##2##2##(1993-11#1)(2008-10#1)
this institution##5##2##(1991-9#1)(2008-6#1)(2008-8#3)
this instruction##2##2##(1991-12#1)(2008-12#1)
this instrument in##2##3##(2007-11#1)(2012-2#1)
this instrument##20##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2009-12#1)(2010-11#1)(2012-2#1)
this integration##2##2##(2008-8#1)(2008-9#1)
this integrative##3##2##(1994-2#1)(2008-9#1)(2013-1#1)
this inter-organ##2##2##(2010-11#2)
this interaction in##4##3##(2008-9#1)(2009-8#1)(2012-1#1)(2012-2#1)
this interaction is##2##3##(2008-10#2)
this interaction##18##2##(1990-2#1)(1994-2#1)(1995-2#2)(1995-6#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
this interdependence##2##2##(2009-8#2)
this interesting##3##2##(1993-8#1)(2008-3#1)(2008-9#1)
this interference##2##2##(2008-10#1)(2010-6#1)
this interferometer##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
this international project##2##3##(2008-4#1)(2010-3#1)
this international##4##2##(2008-4#1)(2010-3#1)(2011-10#1)(2011-2#1)
this interpretation##3##2##(1990-7#1)(1994-12#1)(2008-11#1)
this interval##3##2##(1991-2#1)(2008-8#1)(2008-9#1)
this intervention##13##2##(1990-9#1)(1995-1#2)(1997-2#1)(1997-5#1)(2008-11#1)(2008-3#2)(2008-4#2)(2010-4#1)(2010-7#1)(2012-12#1)
this interview##2##2##(2010-6#1)(2010-8#1)
this intriguing##2##2##(2008-1#1)(2010-12#1)
this invasive procedure##2##3##(2007-7#1)(2010-8#1)
this inversion##3##2##(2008-3#3)
this invertebrate##2##2##(2008-10#1)(2013-1#1)
this investigation to##2##3##(2008-10#1)(2008-11#1)
this investigation was##8##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
this investigation##47##2##(1990-3#1)(1990-6#1)(1991-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
this involvement##4##2##(1993-3#1)(2006-10#1)(2007-12#1)(2008-4#1)
this ion##5##2##(1994-8#1)(1996-7#1)(2008-10#3)
this is a new##2##4##(1995-8#1)(2008-8#1)
this is a##28##3##(1990-11#1)(1990-8#1)(1991-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
this is accomplished##2##3##(2008-2#1)(2008-4#1)
this is achieved##3##3##(2008-9#1)(2010-4#1)(2012-1#1)
this is also##3##3##(2008-11#1)(2008-2#2)
this is an##10##3##(1991-12#1)(1993-1#1)(2008-1#2)(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
this is applied to##2##4##(1995-8#1)(1997-8#1)
this is associated with##2##4##(1994-8#1)(1997-1#1)
this is associated##3##3##(1994-8#1)(1997-1#1)(2012-12#1)
this is considered##2##3##(1991-9#1)(2011-2#1)
this is done##2##3##(1996-1#1)(2013-1#1)
this is due to the##5##5##(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
this is due to##9##4##(1997-6#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
this is due##12##3##(1990-8#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#2)(2013-1#1)
this is especially##2##3##(2008-2#1)(2011-3#1)
this is found as a single transcript of 1##2##9##(1996-6#2)
this is known as the##2##5##(2008-2#2)
this is likely to##2##4##(2008-7#1)(2011-2#1)
this is no longer##2##4##(2009-5#1)(2010-9#1)
this is not a##5##4##(1994-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
this is not the case##2##5##(2008-3#1)(2010-3#1)
this is not the##4##4##(1995-8#1)(2008-3#1)(2010-3#1)(2012-12#1)
this is not##22##3##(1994-2#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-8#1)
this is now##3##3##(1997-4#1)(2010-12#1)(2013-1#1)
this is only the second##3##5##(2008-11#1)(2011-2#1)(2012-2#1)
this is only##5##3##(1993-12#1)(1996-4#1)(2008-11#1)(2011-2#1)(2012-2#1)
this is taken##2##3##(2007-12#1)(2008-10#1)
this is that##4##3##(2008-12#1)(2008-2#1)(2009-8#1)(2010-12#1)
this is the case##6##4##(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
this is the first case of##7##6##(1997-8#1)(2007-12#1)(2007-7#2)(2010-3#1)(2012-3#2)
this is the first case##9##5##(1997-8#1)(2007-12#1)(2007-7#3)(2010-3#1)(2012-3#3)
this is the first demonstration of an##3##7##(2007-12#1)(2008-10#1)(2013-1#1)
this is the first demonstration of##6##6##(2007-11#1)(2007-12#2)(2008-10#2)(2013-1#1)
this is the first description of##2##6##(2008-10#2)
this is the first experimental evidence of a subsecond##2##9##(2007-11#1)(2007-12#1)
this is the first published##2##5##(1990-12#1)(2008-10#1)
this is the first report concerning the##2##7##(1995-11#1)(2008-5#1)
this is the first report concerning##3##6##(1995-11#1)(2008-5#1)(2011-1#1)
this is the first report describing##2##6##(1994-12#1)(2008-10#1)
this is the first report of a##9##7##(1992-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#2)
this is the first report of an##3##7##(1991-9#1)(2007-8#1)(2013-1#1)
this is the first report of such##2##7##(2007-10#1)(2011-1#1)
this is the first report of the##5##7##(2008-10#3)(2008-2#1)(2013-1#1)
this is the first report of##33##6##(1991-9#1)(1992-2#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-9#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
this is the first report on the##5##7##(2008-10#3)(2008-12#1)(2008-9#1)
this is the first report on##8##6##(1994-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)
this is the first report##51##5##(1991-9#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
this is the first reported case of##8##7##(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)
this is the first reported case##9##6##(1991-9#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)
this is the first reported##10##5##(1991-9#1)(2007-10#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)
this is the first study##3##5##(2008-10#2)(2011-2#1)
this is the first time##2##5##(2007-11#1)(2007-12#1)
this is the first##102##4##(1990-12#1)(1991-9#2)(1992-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#2)
this is the highest##2##4##(2007-12#1)(2008-3#1)
this is the most common##2##5##(2007-7#1)(2012-2#1)
this is the most##4##4##(2007-7#1)(2008-10#2)(2012-2#1)
this is the only##3##4##(2008-2#1)(2010-7#1)(2011-2#1)
this is the second##2##4##(2011-2#1)(2013-1#1)
this is the youngest##2##4##(1995-4#1)(2010-9#1)
this is the##136##3##(1990-12#1)(1991-9#3)(1992-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-4#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#6)(2013-8#2)
this is true##2##3##(1996-4#1)(2008-12#1)
this is widely##2##3##(2007-6#1)(2009-3#1)
this is##323##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#2)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#3)(2006-10#4)(2007-10#2)(2007-11#6)(2007-12#11)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#7)(2008-10#48)(2008-11#11)(2008-12#4)(2008-2#14)(2008-3#9)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#9)(2009-1#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#6)(2011-2#17)(2011-3#2)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#9)(2013-1#12)(2013-7#1)(2013-8#5)
this isolate##5##2##(2008-10#3)(2008-7#1)(2012-2#1)
this isolated##2##2##(2010-3#1)(2013-1#1)
this isomerization reaction##2##3##(1992-6#2)
this issue and##2##3##(2007-10#1)(2012-2#1)
this issue by##4##3##(1996-1#1)(1997-3#1)(2008-7#1)(2009-8#1)
this issue in##2##3##(1997-8#1)(2008-11#1)
this issue of Molecular Ecology##2##5##(2013-1#2)
this issue of##12##3##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-11#1)(2008-6#1)(2009-9#1)(2010-11#1)(2013-1#2)
this issue##80##2##(1990-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-6#1)(1994-12#2)(1995-1#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#4)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#13)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
this it##4##2##(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
this joint##2##2##(2007-12#1)(2010-4#1)
this journal##8##2##(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-6#1)(2007-10#1)(2008-7#1)(2013-1#1)
this key##3##2##(1994-3#1)(2010-11#2)
this kinase##7##2##(1990-7#1)(1992-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(2010-11#1)
this kind of patients##2##4##(2007-10#1)(2013-7#1)
this kind of sample##2##4##(2008-10#2)
this kind of surgery##2##4##(1991-3#1)(2007-11#1)
this kind of treatment##5##4##(1993-3#1)(2007-8#2)(2008-12#1)(2008-4#1)
this kind of##49##3##(1990-10#1)(1990-6#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-3#3)(1994-12#1)(1996-12#1)(1996-6#1)(1996-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#6)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-7#1)
this kind##64##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-3#3)(1994-12#2)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-8#3)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2013-7#1)
this knowledge has##2##3##(2011-2#1)(2012-2#1)
this knowledge in a##2##4##(1990-6#1)(2007-12#1)
this knowledge may##2##3##(2013-1#2)
this knowledge to##4##3##(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)
this knowledge##22##2##(1990-10#1)(1990-6#1)(1991-2#1)(1992-5#1)(1995-5#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#2)(2012-2#2)(2013-1#3)
this laboratory demonstrated##2##3##(1995-12#1)(2008-10#1)
this laboratory##11##2##(1990-11#1)(1991-3#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-12#1)(2008-10#3)(2008-6#1)(2008-7#1)
this lack of##3##3##(1990-12#1)(1994-2#1)(2011-2#1)
this lack##4##2##(1990-12#1)(1994-2#1)(2011-2#1)(2013-8#1)
this laparoscopic##2##2##(1994-2#1)(1996-2#1)
this large##9##2##(1996-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)
this largely##2##2##(1991-11#1)(2010-10#1)
this laser source##2##3##(2007-11#1)(2007-12#1)
this laser system##3##3##(2008-2#3)
this laser##20##2##(2007-11#4)(2007-12#5)(2008-2#6)(2008-3#4)(2009-5#1)
this last##9##2##(1994-2#1)(1997-3#1)(2008-10#4)(2008-5#2)(2013-8#1)
this late##2##2##(2008-12#1)(2008-7#1)
this latter group##5##3##(1992-5#2)(1993-8#1)(2008-10#1)(2008-7#1)
this latter##17##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-8#1)(1995-12#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
this layer##2##2##(2007-12#1)(2009-7#1)
this leads to##4##3##(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
this leads##5##2##(1997-6#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
this learning##2##2##(2008-11#1)(2010-5#1)
this led to##2##3##(2008-3#1)(2008-9#1)
this length##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
this lesion##15##2##(1990-9#1)(1991-6#2)(1994-8#1)(1995-5#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#2)(2013-1#3)
this letter##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
this level of##7##3##(1991-9#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)
this level##15##2##(1991-9#1)(1992-5#1)(1994-2#1)(1996-1#2)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#1)
this library##4##2##(1990-11#1)(1997-8#1)(2008-8#1)(2011-1#1)
this lidar##2##2##(2008-3#2)
this life-threatening##2##2##(2012-2#1)(2013-1#1)
this ligand##4##2##(1992-9#1)(2006-6#1)(2008-10#2)
this light##2##2##(2008-2#1)(2008-4#1)
this limit##2##2##(2008-3#1)(2012-12#1)
this limitation by##2##3##(2008-12#1)(2008-2#1)
this limitation##14##2##(1994-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2012-2#1)
this limited##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
this line##4##2##(1991-5#1)(2008-10#2)(2008-3#1)
this linear##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
this link was##2##3##(1993-9#1)(2008-4#1)
this link##4##2##(1993-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
this lipid##3##2##(1993-12#1)(1994-11#1)(2008-10#1)
this list##2##2##(1996-3#1)(2008-10#1)
this literature##10##2##(1992-12#1)(1993-1#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)
this local##4##2##(2008-10#1)(2009-8#1)(2010-11#1)(2012-7#1)
this localization##4##2##(1994-12#1)(2009-4#1)(2011-2#1)(2012-2#1)
this locally##2##2##(1990-5#1)(2007-8#1)
this location is##2##3##(1994-12#1)(2008-5#1)
this location##6##2##(1994-12#1)(1996-9#1)(2008-10#3)(2008-5#1)
this locus##11##2##(1993-11#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-12#1)
this long##3##2##(1992-3#1)(2008-1#1)(2011-2#1)
this longitudinal##3##2##(1995-12#1)(2010-1#1)(2012-3#1)
this loop##3##2##(1995-2#1)(2008-8#1)(2009-6#1)
this loss of##2##3##(1990-5#2)
this loss##5##2##(1990-5#2)(2007-12#1)(2008-2#1)(2008-3#1)
this low##4##2##(1994-7#1)(2008-10#3)
this lower##2##2##(2008-7#1)(2010-1#1)
this mRNA##3##2##(1992-12#1)(1992-6#1)(1994-11#1)
this magnitude##5##2##(1993-12#1)(1993-9#1)(1996-2#1)(2008-10#1)(2013-1#1)
this major##3##2##(2008-11#2)(2009-6#1)
this malformation##5##2##(2008-10#1)(2008-7#1)(2009-5#2)(2012-3#1)
this malignancy##4##2##(2007-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
this management##4##2##(1991-3#1)(2013-1#1)(2013-7#2)
this manner##14##2##(1991-3#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#2)
this manuscript##16##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
this map##2##2##(1997-8#1)(2008-5#1)
this marine##2##2##(2009-10#1)(2011-2#1)
this marker##4##2##(1990-2#1)(1992-9#1)(2008-10#2)
this material has been##2##4##(1990-9#1)(2008-8#1)
this material is##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
this material was##2##3##(2008-10#1)(2008-3#1)
this material were##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
this material##24##2##(1990-9#2)(1991-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
this matrix##8##2##(2007-12#3)(2008-10#4)(2008-3#1)
this matter##7##2##(1997-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
this may affect##2##3##(1997-3#1)(2008-5#1)
this may also lead to##2##5##(2008-10#1)(2008-7#1)
this may be a disadvantage in patients##2##7##(1992-3#1)(2008-5#1)
this may be a##4##4##(1992-3#1)(1997-5#1)(2008-5#1)(2008-8#1)
this may be difficult##2##4##(1992-3#1)(2011-1#1)
this may be due to##3##5##(1993-2#1)(2008-7#1)(2011-2#1)
this may be##26##3##(1990-5#1)(1991-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1997-5#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#1)(2011-1#2)(2011-2#1)(2013-1#2)
this may cause##6##3##(2008-10#1)(2008-11#4)(2008-8#1)
this may explain why##2##4##(2008-10#1)(2008-8#1)
this may have on##2##4##(2008-8#1)(2012-2#1)
this may have##6##3##(1990-6#1)(1997-5#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-7#1)
this may indicate##2##3##(1996-6#1)(2008-7#1)
this may lead to##2##4##(2008-10#2)
this may reflect a##2##4##(1996-12#1)(2006-10#1)
this may reflect##3##3##(1996-12#1)(2006-10#1)(2008-11#1)
this may represent a##2##4##(2011-2#1)(2012-12#1)
this may##65##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-5#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#6)(2008-8#5)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
this mean##3##2##(2008-10#1)(2012-3#1)(2013-7#1)
this means##3##2##(1990-2#1)(1993-6#1)(2012-2#1)
this measure of##2##3##(1995-5#1)(2010-6#1)
this measure##4##2##(1995-5#1)(2007-12#1)(2008-3#1)(2010-6#1)
this measurement##4##2##(1995-1#1)(2008-2#1)(2008-9#2)
this mechanism are##2##3##(1995-8#1)(2011-2#1)
this mechanism can be##2##4##(2007-12#1)(2008-9#1)
this mechanism is##3##3##(1992-8#1)(2008-5#1)(2009-3#1)
this mechanism of##2##3##(1997-6#1)(2008-11#1)
this mechanism##23##2##(1990-12#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#1)
this media##2##2##(2008-10#2)
this medication##3##2##(1996-8#1)(2008-5#1)(2010-5#1)
this medium was##2##3##(2008-10#2)
this medium##9##2##(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
this meeting was##5##3##(2008-5#4)(2008-8#1)
this meeting##16##2##(2008-2#1)(2008-5#11)(2008-8#1)(2009-4#2)(2011-2#1)
this membrane##7##2##(1990-8#1)(1997-1#1)(2008-10#5)
this metabolic pathway##5##3##(1994-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
this metabolic##8##2##(1994-8#1)(1995-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
this metabolism##3##2##(1992-10#1)(2008-11#1)(2008-7#1)
this metabolite##2##2##(1991-1#1)(1991-9#1)
this metal##7##2##(1994-8#1)(1996-12#1)(2008-10#4)(2008-5#1)
this metastatic##2##2##(1992-8#2)
this method a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
this method allows##2##3##(2008-2#1)(2008-4#1)
this method and the results##2##5##(2008-10#2)
this method and the##5##4##(1992-4#1)(1997-4#1)(2007-11#1)(2008-10#2)
this method and##10##3##(1990-3#1)(1992-4#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)
this method are##17##3##(1992-4#1)(1997-2#1)(2008-10#8)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)
this method by##4##3##(2007-12#1)(2008-3#2)(2008-7#1)
this method can be applied to determine##2##7##(1994-9#1)(2008-10#1)
this method can be applied to##5##6##(1994-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
this method can be used##3##5##(2007-12#1)(2008-3#2)
this method can be##13##4##(1992-5#1)(1994-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2011-2#1)(2012-2#1)
this method can##17##3##(1992-5#1)(1994-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-2#1)
this method could##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
this method does not##3##4##(1996-3#1)(2008-10#2)
this method due to##2##4##(1997-2#1)(2008-10#1)
this method for the##6##4##(1994-5#1)(2008-10#3)(2008-12#1)(2012-3#1)
this method for##14##3##(1992-4#1)(1993-12#1)(1994-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-3#1)
this method has##9##3##(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
this method in##8##3##(1994-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-6#1)
this method is 0##2##4##(2008-10#2)
this method is not sensitive##2##5##(2011-2#1)(2013-8#1)
this method is not##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
this method is##48##3##(1990-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#7)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#2)
this method may be##2##4##(1992-5#1)(2010-7#1)
this method may##3##3##(1992-5#1)(2010-7#1)(2012-2#1)
this method might##4##3##(1990-9#1)(2007-10#1)(2008-10#1)(2008-11#1)
this method of##11##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
this method provides##2##3##(2008-3#1)(2008-7#1)
this method reduces the##2##4##(1991-2#1)(2008-10#1)
this method requires##4##3##(1990-11#1)(1991-7#1)(2008-10#1)(2008-3#1)
this method showed good##2##4##(2008-10#2)
this method the##12##3##(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#7)
this method to a##2##4##(2008-2#1)(2009-5#1)
this method to the##2##4##(2008-10#2)
this method to##23##3##(1994-9#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)
this method was##23##3##(1990-2#1)(1991-5#1)(1995-2#2)(2008-10#16)(2008-11#1)(2008-7#1)(2008-8#1)
this method we##5##3##(1990-12#1)(2007-11#1)(2008-3#2)(2008-5#1)
this method were better than those obtained##2##7##(2008-10#2)
this method were compared with##3##5##(2008-10#3)
this method were in good agreement with the##2##8##(2008-10#2)
this method were in good agreement with##4##7##(2008-10#4)
this method were in##6##4##(2008-10#4)(2008-5#1)(2013-8#1)
this method were##16##3##(1990-2#1)(1990-8#1)(2008-10#11)(2008-4#1)(2008-5#1)(2013-8#1)
this method will##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
this method with##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
this method##417##2##(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#2)(1990-7#1)(1990-8#5)(1990-9#2)(1991-2#1)(1991-3#2)(1991-5#3)(1991-7#1)(1992-2#1)(1992-4#3)(1992-5#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#4)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#14)(2007-12#12)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#149)(2008-11#15)(2008-12#4)(2008-2#22)(2008-3#54)(2008-4#12)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#5)
this methodology in##2##3##(1992-3#1)(2009-8#1)
this methodology is##2##3##(1992-12#1)(2008-2#1)
this methodology##25##2##(1992-12#1)(1992-3#1)(1996-12#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-4#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
this microchip##2##2##(2008-10#2)
this microenvironment##2##2##(1994-9#1)(2012-3#1)
this microorganism##5##2##(2007-12#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
this might be a##2##4##(1994-2#1)(2007-5#1)
this might be##3##3##(1994-2#1)(1995-8#1)(2007-5#1)
this might explain##2##3##(2008-10#1)(2008-8#1)
this might lead to##2##4##(1991-6#1)(2013-1#1)
this might##9##2##(1991-6#1)(1994-2#1)(1995-8#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
this mini-review##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)
this minimum##3##2##(1992-9#1)(1997-3#1)(2008-3#1)
this missing##3##2##(2008-8#1)(2010-5#1)(2012-3#1)
this mixture##5##2##(1997-7#1)(2008-10#3)(2010-11#1)
this modality is##2##3##(2007-7#1)(2008-1#1)
this modality##4##2##(1997-1#1)(2007-7#1)(2008-1#1)(2010-9#1)
this mode of##3##3##(1994-6#1)(1996-2#1)(2008-10#1)
this mode##5##2##(1994-6#1)(1996-2#1)(2007-12#1)(2008-10#2)
this model and##6##3##(1993-2#1)(2007-12#3)(2009-10#1)(2013-1#1)
this model are##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
this model has##3##3##(2008-12#1)(2009-7#1)(2012-2#1)
this model have##2##3##(1990-7#1)(1992-11#1)
this model is that##2##4##(1995-1#1)(2008-10#1)
this model is##13##3##(1995-1#1)(1996-4#1)(1997-1#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-3#1)
this model of##4##3##(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)
this model provides##2##3##(2008-12#1)(2008-2#1)
this model study##2##3##(2008-10#1)(2008-3#1)
this model system##3##3##(2008-11#1)(2008-9#1)(2010-1#1)
this model the##4##3##(2008-2#1)(2008-3#3)
this model to the##2##4##(2008-2#1)(2011-2#1)
this model to##8##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
this model was##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
this model with##3##3##(2008-3#2)(2010-10#1)
this model##133##2##(1990-7#2)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-4#3)(1997-1#2)(1997-3#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#5)(2008-2#7)(2008-3#14)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
this modeling framework##2##3##(2009-12#1)(2010-9#1)
this modeling##3##2##(2008-8#1)(2009-12#1)(2010-9#1)
this modern##2##2##(2008-4#1)(2008-5#1)
this modification##8##2##(1991-1#1)(1991-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)
this modified electrode were##2##4##(2008-10#2)
this modified electrode##5##3##(2008-10#5)
this modified method##2##3##(1994-12#1)(2008-10#1)
this modified##13##2##(1990-11#1)(1994-12#2)(1997-4#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)
this modulation##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
this module##4##2##(2008-11#2)(2008-12#1)(2012-12#1)
this molecular##7##2##(1992-3#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-8#1)(2009-8#1)
this molecule as##2##3##(1993-9#1)(1996-2#1)
this molecule has been##2##4##(1993-2#1)(1993-6#1)
this molecule has##3##3##(1993-2#1)(1993-3#1)(1993-6#1)
this molecule##19##2##(1991-5#1)(1991-6#2)(1991-9#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-2#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
this moment##4##2##(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
this morbid condition##2##3##(1997-8#2)
this more##2##2##(2008-10#1)(2008-5#1)
this morphology##2##2##(2010-10#1)(2013-1#1)
this most##2##2##(1993-3#1)(2009-9#1)
this motif##4##2##(1991-7#1)(1992-4#1)(1995-6#1)(2009-7#1)
this mouse model##5##3##(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
this mouse##6##2##(1991-1#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
this mucin##3##2##(1992-11#3)
this multidisciplinary##2##2##(2008-8#1)(2009-9#1)
this multivariate regression##2##3##(2008-10#2)
this multivariate##3##2##(1992-12#1)(2008-10#2)
this murine##2##2##(1992-8#1)(2008-6#1)
this must be##2##3##(1990-3#1)(2007-8#1)
this mutant##6##2##(1990-5#1)(1991-2#1)(1993-12#1)(1994-11#1)(1997-2#1)(2009-10#1)
this mutation in##3##3##(1996-5#1)(2008-2#2)
this mutation is##3##3##(1991-12#1)(1997-2#1)(2006-8#1)
this mutation##18##2##(1990-5#1)(1991-12#1)(1991-8#2)(1995-2#2)(1995-9#1)(1996-5#1)(1997-2#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)
this mycotoxin##2##2##(2008-10#1)(2011-2#1)
this native##2##2##(2008-10#1)(2011-2#1)
this need##6##2##(1992-3#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
this nematode##2##2##(1990-5#1)(2008-10#1)
this neoplasm##6##2##(1991-4#1)(1992-2#2)(1992-5#1)(1994-2#1)(2008-9#1)
this network##3##2##(2008-2#1)(2008-4#1)(2008-8#1)
this neural##2##2##(1994-11#1)(2010-11#1)
this neutral##2##2##(1996-2#1)(2008-10#1)
this new algorithm##4##3##(2008-2#1)(2008-3#3)
this new century##2##3##(2008-1#2)
this new detector##2##3##(2008-10#2)
this new development##2##3##(1997-4#1)(2008-3#1)
this new gene##2##3##(2008-10#2)
this new instrumental##2##3##(2007-12#1)(2008-10#1)
this new method is##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
this new method##12##3##(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2009-9#1)(2010-9#1)(2013-8#1)
this new model will##2##4##(1992-1#1)(1996-12#1)
this new model##3##3##(1992-1#1)(1995-1#1)(1996-12#1)
this new modified##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
this new sensor##2##3##(2008-10#2)
this new species##2##3##(2008-10#2)
this new technique##10##3##(1990-3#1)(1990-9#1)(2007-11#2)(2008-10#1)(2008-3#4)(2013-1#1)
this new technology##4##3##(2008-11#1)(2010-7#1)(2011-2#1)(2011-7#1)
this new territory##2##3##(1994-2#1)(2008-11#1)
this new type of##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
this new##140##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#29)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#17)(2008-5#3)(2008-7#2)(2008-8#5)(2009-10#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#4)(2011-7#2)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
this newly developed cylindrical encoder##2##5##(2008-3#2)
this newly developed method##7##4##(2008-10#7)
this newly developed##9##3##(2008-10#7)(2008-3#2)
this newly discovered##2##3##(1994-12#1)(2008-10#1)
this newly identified gene (or allele)##2##6##(2008-10#2)
this newly identified##3##3##(2008-10#2)(2008-7#1)
this newly##16##2##(1994-12#1)(2008-10#11)(2008-3#3)(2008-7#1)
this noise##2##2##(2007-11#1)(2010-8#1)
this nonlinear##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
this nonlinearity##2##2##(2007-11#1)(2008-3#1)
this normal##2##2##(1993-3#1)(2008-3#1)
this notion##3##2##(1992-3#1)(2010-5#1)(2011-2#1)
this novel approach##5##3##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-1#1)
this novel technique##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
this novel##42##2##(1990-12#1)(1992-12#1)(1993-8#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#2)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
this nucleotide##2##2##(1990-12#1)(1993-6#1)
this nucleus##2##2##(1995-12#1)(1997-6#1)
this number##5##2##(1990-12#1)(2007-11#1)(2009-5#1)(2010-10#1)(2012-2#1)
this numerical##2##2##(2007-11#1)(2008-3#1)
this objective is##3##3##(1993-2#1)(2008-3#1)(2010-12#1)
this objective##7##2##(1993-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)
this observation is discussed##3##4##(1993-6#1)(1995-12#1)(2007-6#1)
this observation##26##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
this occurred##2##2##(1995-12#1)(2011-2#1)
this occurs in##2##3##(2008-1#2)
this occurs##15##2##(1992-9#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
this oil##4##2##(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
this on the##2##3##(1994-2#1)(2008-10#1)
this on##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
this one is##2##3##(2007-8#1)(2013-1#1)
this one##7##2##(2007-8#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#2)
this open##2##2##(2007-7#1)(2008-6#1)
this operation##9##2##(1990-6#1)(1990-9#1)(1991-5#1)(1994-3#1)(2007-8#1)(2008-3#3)(2009-12#1)
this opportunity##5##2##(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(2008-6#1)
this optical biosensor##2##3##(2008-10#2)
this optical##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
this optimal##2##2##(2008-5#1)(2008-8#1)
this optimization problem##2##3##(1992-12#1)(2012-1#1)
this optimization##3##2##(1992-12#1)(2008-2#1)(2012-1#1)
this optimized##2##2##(2008-10#1)(2008-11#1)
this optimum##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
this option##6##2##(1992-2#1)(1993-11#1)(1995-12#1)(2007-7#1)(2011-2#1)(2012-2#1)
this order##4##2##(1995-11#1)(1997-8#1)(2007-11#1)(2008-10#1)
this organ##6##2##(1996-12#1)(2007-12#2)(2008-10#2)(2008-5#1)
this organelle##5##2##(2008-11#3)(2008-9#1)(2009-5#1)
this organism are##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
this organism is##2##3##(1997-7#1)(2008-9#1)
this organism##42##2##(1990-6#1)(1991-9#1)(1993-2#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#18)(2012-12#1)(2012-3#1)
this organism's##2##2##(2008-7#1)(2012-2#1)
this organization##3##2##(1991-2#1)(2008-11#1)(2009-10#1)
this oscillation##2##2##(2008-10#1)(2009-5#1)
this outcome is##2##3##(1992-2#1)(2013-1#1)
this outcome##5##2##(1992-2#1)(1994-2#1)(2008-12#1)(2008-8#1)(2013-1#1)
this overview##6##2##(2008-11#1)(2008-4#3)(2011-1#1)(2011-2#1)
this pH the##2##3##(1994-3#1)(2008-11#1)
this pH##5##2##(1994-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
this painful##2##2##(2008-12#1)(2009-2#1)
this pair##2##2##(1993-3#1)(2008-3#1)
this paper I##5##3##(1995-12#1)(1995-9#1)(2008-7#1)(2013-1#2)
this paper a##9##3##(1994-12#1)(2008-10#6)(2008-11#2)
this paper also##2##3##(1995-9#1)(2008-9#1)
this paper are##14##3##(1992-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2013-7#1)(2013-8#1)
this paper argues that##2##4##(2008-12#1)(2013-1#1)
this paper as##11##3##(2008-12#1)(2011-2#9)(2013-8#1)
this paper assesses##2##3##(2008-7#1)(2009-7#1)
this paper compares the##2##4##(1997-4#1)(2013-8#1)
this paper describes##4##3##(1996-12#1)(1996-3#1)(2008-12#1)(2008-9#1)
this paper discusses##2##3##(1991-12#1)(2012-3#1)
this paper examines the##4##4##(2008-10#1)(2008-11#1)(2011-2#2)
this paper examines##5##3##(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#2)
this paper explores##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
this paper have##2##3##(2007-12#1)(2008-11#1)
this paper investigates##2##3##(2008-10#1)(2008-11#1)
this paper is an##3##4##(2007-11#1)(2012-2#1)(2012-3#1)
this paper is that##3##4##(1994-11#1)(2008-11#2)
this paper is the##3##4##(2008-10#2)(2010-10#1)
this paper is to##66##4##(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)
this paper is##86##3##(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-5#1)(1994-1#1)(1994-11#1)(1996-3#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#6)(2008-11#11)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
this paper offers##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
this paper presents a##2##4##(2010-1#1)(2010-8#1)
this paper presents##3##3##(2008-9#1)(2010-1#1)(2010-8#1)
this paper proposes a##2##4##(2008-6#1)(2012-2#1)
this paper reviews##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
this paper the##15##3##(1990-3#1)(1992-9#2)(1993-3#1)(1995-1#1)(1996-3#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-3#1)(2013-1#1)
this paper to##4##3##(1994-5#1)(1995-12#1)(2007-10#1)(2008-10#1)
this paper was to##9##4##(1991-9#1)(1992-2#1)(2008-11#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
this paper was##12##3##(1991-9#1)(1992-2#1)(1994-9#1)(2008-10#2)(2008-11#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
this paper we describe##14##4##(1990-12#1)(1990-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
this paper we##91##3##(1990-11#1)(1990-12#1)(1990-8#2)(1993-12#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-8#1)(1995-9#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#10)(2013-8#6)
this paper will##4##3##(1991-5#1)(2008-11#1)(2008-12#2)
this paper##762##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#5)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#1)(1992-9#4)(1993-1#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#5)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#6)(1997-6#1)(1997-7#5)(1997-8#4)(2006-6#1)(2007-10#5)(2007-11#13)(2007-12#12)(2007-2#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#9)(2008-10#182)(2008-11#51)(2008-12#24)(2008-2#11)(2008-3#9)(2008-4#3)(2008-5#12)(2008-6#16)(2008-7#17)(2008-8#3)(2008-9#12)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#9)(2009-8#5)(2009-9#9)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#6)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#15)(2010-9#2)(2011-1#14)(2011-2#33)(2011-3#3)(2012-1#5)(2012-12#9)(2012-2#18)(2012-3#12)(2013-1#35)(2013-7#4)(2013-8#19)
this paradigm##10##2##(1992-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-8#1)
this parallel##2##2##(1990-8#1)(2009-6#1)
this parameter are##2##3##(1995-6#1)(2008-3#1)
this parameter was##2##3##(1990-12#1)(1997-2#1)
this parameter##14##2##(1990-12#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
this parasite##4##2##(2007-12#1)(2008-10#1)(2009-5#1)(2010-4#1)
this part of the##5##4##(1996-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2013-1#1)
this part of##6##3##(1996-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)
this part##7##2##(1996-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
this particular group of##3##4##(1990-8#1)(1996-2#1)(2008-11#1)
this particular type of##3##4##(1990-11#1)(2008-3#1)(2009-1#1)
this particular##25##2##(1990-11#1)(1990-8#1)(1993-1#1)(1995-5#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)
this particulate##2##2##(1995-5#1)(2008-3#1)
this pathogen can##2##3##(2008-10#2)
this pathogen have##3##3##(2008-10#3)
this pathogen in##4##3##(2008-10#3)(2008-9#1)
this pathogen into##2##3##(2008-10#1)(2011-2#1)
this pathogen is##2##3##(2007-7#1)(2008-10#1)
this pathogen##36##2##(2007-7#1)(2008-10#29)(2008-9#2)(2009-8#2)(2011-2#1)(2012-3#1)
this pathogenic##2##2##(2008-10#2)
this pathology##21##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-3#2)(2013-1#3)
this pathovar##4##2##(2008-10#4)
this pathway include##2##3##(2008-10#1)(2008-8#1)
this pathway may##2##3##(1995-12#1)(2011-2#1)
this pathway##22##2##(1993-3#1)(1994-11#1)(1994-8#2)(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-3#2)(2011-2#2)(2011-3#1)(2013-1#1)
this patient as##2##3##(2013-1#2)
this patient for##2##3##(1997-2#1)(2008-1#1)
this patient group##5##3##(1996-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
this patient is##3##3##(2011-1#1)(2012-12#1)(2012-3#1)
this patient population##17##3##(1992-5#1)(2008-10#1)(2008-2#1)(2008-7#3)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
this patient with##2##3##(2011-2#2)
this patient##59##2##(1992-5#2)(1993-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#7)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-2#1)(2013-8#2)
this patient's##5##2##(1997-6#1)(2007-10#1)(2009-5#1)(2010-3#1)(2013-1#1)
this pattern is##2##3##(2008-7#1)(2012-3#1)
this pattern of##2##3##(1996-4#1)(1997-7#1)
this pattern##11##2##(1996-4#1)(1997-7#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-3#1)
this peak by##2##3##(2008-10#2)
this peak##4##2##(1992-3#1)(2008-10#3)
this peculiar##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
this peptide is##2##3##(1994-12#1)(2008-10#1)
this peptide was##5##3##(1990-12#1)(1997-3#2)(1997-8#1)(2008-10#1)
this peptide##27##2##(1990-12#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-3#2)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2012-12#1)
this percentage was##2##3##(1990-5#1)(2012-2#1)
this percentage##6##2##(1990-2#1)(1990-5#1)(1992-6#1)(1995-5#1)(2012-2#1)(2013-8#1)
this perception##3##2##(1991-2#1)(1996-6#1)(2013-1#1)
this performance##3##2##(1993-1#1)(2008-2#1)(2008-7#1)
this period and##2##3##(2008-11#1)(2012-3#1)
this period of##5##3##(1993-2#1)(1994-3#1)(1995-3#2)(2008-3#1)
this period showed##2##3##(2008-11#1)(2008-7#1)
this period the##2##3##(2008-5#1)(2008-8#1)
this period##54##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#4)(1997-1#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#1)(2010-5#1)(2011-2#8)(2011-9#1)(2012-2#1)(2012-3#2)
this perspective##12##2##(1992-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)
this phase II study##3##4##(2008-10#1)(2008-6#2)
this phase II##4##3##(2008-10#1)(2008-6#2)(2012-2#1)
this phase of the##2##4##(1992-4#1)(2009-10#1)
this phase##20##2##(1992-4#1)(2007-11#3)(2008-10#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2012-2#1)
this phenolic substance##2##3##(2008-5#2)
this phenomenon are##3##3##(1992-1#1)(1997-6#1)(2007-11#1)
this phenomenon has been##2##4##(2008-10#1)(2008-8#1)
this phenomenon has##3##3##(2008-10#2)(2008-8#1)
this phenomenon in detail##2##4##(1993-11#1)(2013-8#1)
this phenomenon in##7##3##(1993-11#1)(1995-11#1)(2008-12#1)(2008-7#1)(2013-1#2)(2013-8#1)
this phenomenon is unknown##2##4##(1992-9#1)(2008-7#1)
this phenomenon is##11##3##(1992-8#1)(1992-9#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
this phenomenon may be##2##4##(1991-6#1)(2008-7#1)
this phenomenon may##4##3##(1991-6#1)(1992-12#1)(1992-2#1)(2008-7#1)
this phenomenon of##2##3##(1994-8#1)(2009-8#1)
this phenomenon remains to be##2##5##(2008-7#1)(2012-3#1)
this phenomenon remains##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
this phenomenon was##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
this phenomenon were##2##3##(1990-2#1)(2008-3#1)
this phenomenon##87##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
this phenotype is##2##3##(2012-3#2)
this phenotype##6##2##(1994-11#1)(2007-2#2)(2012-3#3)
this phenotypic plasticity##2##3##(2008-9#1)(2012-12#1)
this phenotypic##4##2##(1995-2#1)(2008-9#1)(2012-12#1)(2012-3#1)
this photograding##2##2##(2008-5#2)
this phylum##3##2##(2008-10#1)(2013-8#2)
this physical##2##2##(2007-11#1)(2008-1#1)
this physiologically##2##2##(1990-12#1)(2008-4#1)
this pilot study##22##3##(1993-1#1)(1995-3#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
this pilot##25##2##(1993-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
this plant##16##2##(1990-7#1)(1994-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-10#1)(2011-3#1)(2013-7#1)
this plasmid##5##2##(1993-9#1)(1997-3#2)(2008-10#2)
this platform##4##2##(1995-12#1)(2008-10#1)(2008-11#2)
this point is##3##3##(2008-10#1)(2008-4#1)(2010-6#1)
this point it##2##3##(1992-2#1)(1994-2#1)
this point mutation##2##3##(1990-8#1)(1993-11#1)
this point##21##2##(1990-8#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)
this polarimeter##2##2##(2008-2#1)(2008-3#1)
this policy##5##2##(1992-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
this polymer##4##2##(1996-5#1)(2008-5#1)(2009-12#1)(2011-1#1)
this polymorphism in##2##3##(1993-9#1)(2006-6#1)
this polymorphism##6##2##(1993-9#1)(2006-6#2)(2008-12#2)(2008-6#1)
this polypeptide##2##2##(1993-8#1)(2008-4#1)
this population and##6##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-2#1)
this population have##3##3##(1994-6#1)(2008-11#1)(2009-4#1)
this population is##9##3##(1994-2#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
this population may##3##3##(2008-10#1)(2011-2#2)
this population of##2##3##(1995-11#1)(2008-10#1)
this population was##4##3##(1991-6#1)(2008-10#2)(2008-7#1)
this population##105##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-6#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1996-1#2)(2007-10#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-11#5)(2009-12#1)(2009-4#1)(2009-5#3)(2010-10#2)(2010-2#1)(2010-8#3)(2011-1#2)(2011-2#7)(2012-12#6)(2012-3#2)(2013-1#8)(2013-7#1)
this position in##2##3##(1995-2#1)(1997-3#1)
this position##18##2##(1990-12#1)(1992-11#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-8#2)(1997-2#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#3)(2009-8#1)
this possibility further##2##3##(1990-5#1)(2008-9#1)
this possibility##15##2##(1990-5#2)(1992-2#1)(1992-6#1)(1993-6#1)(1994-3#1)(1996-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-10#1)(2013-1#2)(2013-8#1)
this potential is##2##3##(2007-11#1)(2009-3#1)
this potential##11##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
this potentially##5##2##(1991-8#1)(1992-12#1)(2009-12#1)(2010-3#1)(2011-2#1)
this potentiation##2##2##(1993-6#1)(1995-3#1)
this practice##9##2##(1990-2#2)(1991-6#1)(1992-1#1)(2007-10#1)(2008-11#1)(2009-11#1)(2013-1#1)(2013-8#1)
this prediction##13##2##(1990-12#1)(1990-5#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-2#1)(2013-1#1)(2013-8#1)
this preliminary investigation##5##3##(1995-2#1)(2008-12#1)(2008-9#2)(2011-2#1)
this preliminary study##6##3##(1993-12#1)(1996-5#1)(2008-10#2)(2008-7#1)(2013-1#1)
this preliminary##14##2##(1993-12#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
this preparation##4##2##(1990-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
this present study##2##3##(2008-10#2)
this present##3##2##(2008-10#2)(2008-8#1)
this presentation##5##2##(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
this presynaptic inhibition##2##3##(1995-11#2)
this previous##2##2##(1992-12#1)(1995-1#1)
this previously unknown##2##3##(2008-3#1)(2010-4#1)
this primary##2##2##(1996-12#1)(2011-1#1)
this primitive##2##2##(1992-2#1)(1994-8#1)
this principle##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
this probability##2##2##(1991-12#1)(2008-10#1)
this probe##3##2##(1990-11#1)(2008-10#2)
this problem and to##2##4##(2008-10#1)(2008-8#1)
this problem and##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2012-12#1)
this problem are##2##3##(2007-11#1)(2008-1#1)
this problem by##5##3##(1991-9#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-2#1)
this problem can be##2##4##(1996-5#1)(1997-4#1)
this problem has##2##3##(1995-5#1)(2007-11#1)
this problem have##2##3##(2008-6#1)(2010-1#1)
this problem is to##2##4##(1993-12#1)(2008-7#1)
this problem is##4##3##(1993-12#1)(2008-10#1)(2008-7#1)(2010-11#1)
this problem was##2##3##(1990-11#1)(2008-10#1)
this problem##98##2##(1990-11#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#2)
this procedure and##2##3##(1997-2#1)(2013-1#1)
this procedure are##4##3##(1990-9#1)(1994-9#1)(2007-11#1)(2013-8#1)
this procedure for the##2##4##(2008-10#2)
this procedure for##4##3##(2008-10#3)(2009-10#1)
this procedure has##2##3##(2008-10#1)(2009-5#1)
this procedure in##2##3##(1990-8#1)(2008-12#1)
this procedure is##12##3##(2007-8#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#1)(2013-1#1)
this procedure should##2##3##(2008-11#1)(2008-9#1)
this procedure to##3##3##(2008-10#2)(2008-4#1)
this procedure was##2##3##(2008-10#1)(2013-8#1)
this procedure were##2##3##(2008-10#2)
this procedure##85##2##(1990-2#1)(1990-8#1)(1990-9#2)(1993-12#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-10#1)(1997-2#2)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-6#3)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
this process and##6##3##(1994-2#1)(1994-3#1)(1996-7#1)(2008-2#1)(2010-3#1)(2012-1#1)
this process can be##2##4##(2007-11#1)(2010-4#1)
this process can##4##3##(1992-3#1)(2007-11#1)(2010-4#1)(2010-8#1)
this process has been##3##4##(2008-1#1)(2011-2#1)(2012-12#1)
this process has not been##2##5##(1995-8#1)(2008-11#1)
this process has##5##3##(1995-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
this process in the##2##4##(2007-11#1)(2013-1#1)
this process in##8##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2013-1#1)
this process is that##2##4##(1993-12#1)(2010-1#1)
this process is##18##3##(1990-6#1)(1991-1#1)(1991-3#1)(1993-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)
this process may##3##3##(1992-3#1)(2008-5#1)(2010-12#1)
this process of##3##3##(1991-6#1)(1993-3#1)(1995-6#1)
this process requires##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
this process to be##3##4##(1990-7#1)(2007-11#1)(2008-2#1)
this process to##5##3##(1990-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
this process were##4##3##(1991-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
this process with##2##3##(2008-1#1)(2008-7#1)
this process##146##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#5)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
this processes##2##2##(1991-6#1)(2013-7#1)
this product##5##2##(2008-10#2)(2008-5#2)(2010-8#1)
this production##2##2##(1997-2#1)(2008-11#1)
this profession##2##2##(1990-2#1)(1994-12#1)
this professional paper##8##3##(1993-1#1)(1993-3#1)(1994-3#2)(1997-1#4)
this program has##2##3##(1995-12#1)(1996-2#1)
this program is##3##3##(1993-1#1)(2008-11#1)(2011-2#1)
this program##21##2##(1990-12#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-1#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
this programme##7##2##(1990-11#1)(2008-11#2)(2008-12#1)(2008-7#3)
this progress##3##2##(1990-11#1)(2008-11#1)(2010-5#1)
this project was conducted##2##4##(1996-2#1)(2008-11#1)
this project was##14##3##(1991-9#1)(1994-3#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
this project##29##2##(1991-9#1)(1992-12#1)(1994-3#1)(1995-3#4)(1995-6#1)(1996-2#1)(1997-4#1)(2007-11#2)(2007-4#2)(2008-1#2)(2008-11#2)(2008-12#4)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
this proliferation##2##2##(1995-2#1)(2008-11#1)
this prolonged##2##2##(1994-8#1)(2008-6#1)
this promise##2##2##(2008-11#1)(2010-10#1)
this promoter##9##2##(1990-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1995-6#2)(1996-6#1)(2007-11#1)(2008-10#1)
this property##15##2##(1992-3#1)(1994-6#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
this proportion##2##2##(1990-6#1)(2009-2#1)
this proposal##4##2##(1991-2#1)(1994-12#1)(2008-10#1)(2013-8#1)
this proposed method##2##3##(2008-10#2)
this proposed technique##2##3##(2008-10#2)
this proposed##12##2##(1996-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-9#1)
this prospective cohort study##3##4##(2008-12#1)(2008-3#1)(2010-5#1)
this prospective study##7##3##(1997-3#1)(2008-1#2)(2008-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
this prospective##19##2##(1997-3#3)(2007-10#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2010-5#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
this protection was##3##3##(1992-5#1)(1995-12#1)(2008-10#1)
this protection##6##2##(1992-5#1)(1995-12#1)(1997-7#1)(2008-10#2)(2011-2#1)
this protective##2##2##(2008-7#1)(2010-5#1)
this protein and##4##3##(1994-11#1)(1995-2#1)(1997-4#1)(1997-6#1)
this protein could##2##3##(1994-5#1)(1994-6#1)
this protein in##9##3##(1990-5#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-8#1)(1997-2#1)(2008-10#1)
this protein is##4##3##(1991-9#1)(1994-11#1)(1994-7#1)(2012-12#1)
this protein to##6##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-6#1)(2008-10#1)
this protein was also##2##4##(1993-6#1)(1996-12#1)
this protein was##5##3##(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)
this protein##72##2##(1990-11#2)(1990-12#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-11#4)(1992-12#2)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-6#3)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#3)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-10#6)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-12#1)(2013-1#3)
this proteolytic pathway##3##3##(1992-12#1)(1994-11#1)(1994-9#1)
this proteolytic##4##2##(1992-12#1)(1994-11#1)(1994-9#1)(2008-5#1)
this protocol is##2##3##(2008-4#1)(2008-9#1)
this protocol##14##2##(1990-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#3)
this pseudogene##4##2##(1993-2#1)(1993-6#2)(1994-11#1)
this publication##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
this pump##2##2##(2007-12#1)(2008-2#1)
this purpose a##3##3##(1991-3#1)(2008-10#1)(2008-3#1)
this purpose is##2##3##(2008-2#1)(2013-1#1)
this purpose##129##2##(1990-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#39)(2008-11#6)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#8)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-2#6)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#4)(2013-8#2)
this putative##4##2##(1990-11#1)(1994-9#1)(1997-5#1)(2009-10#1)
this qualification##2##2##(2008-11#1)(2011-2#1)
this qualitative study##7##3##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#2)
this qualitative##9##2##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#2)
this quantitative approach##2##3##(2008-10#2)
this quantitative##3##2##(1991-11#1)(2008-10#2)
this quantity is##2##3##(1995-5#1)(2012-12#1)
this quantity##5##2##(1995-5#1)(1997-3#1)(2008-10#1)(2008-3#1)(2012-12#1)
this question by##2##3##(2008-8#1)(2012-2#1)
this question##26##2##(1991-12#1)(1994-11#1)(1994-3#1)(1997-2#1)(2007-10#1)(2008-11#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
this randomized##5##2##(2008-5#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
this range of##3##3##(1992-8#2)(1996-12#1)
this range##18##2##(1991-8#1)(1992-8#2)(1996-12#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-9#1)
this rapidly##3##2##(1994-3#1)(2010-5#1)(2013-1#1)
this rare case##4##3##(1991-2#1)(2007-7#1)(2008-12#1)(2008-7#1)
this rare disease##4##3##(2010-3#2)(2013-1#2)
this rare lesion##2##3##(1993-12#1)(2013-1#1)
this rare mutation##2##3##(2008-2#1)(2011-1#1)
this rare##43##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
this rat model##2##3##(2008-4#1)(2012-2#1)
this rat##3##2##(2008-4#1)(2008-5#1)(2012-2#1)
this rate is##2##3##(2007-2#1)(2008-8#1)
this rate of##2##3##(1992-5#1)(2008-6#1)
this rate was##3##3##(1992-6#1)(2010-3#1)(2011-1#1)
this rate##9##2##(1992-5#1)(1992-6#1)(1993-9#1)(2007-2#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-3#1)
this ratio can be##2##4##(2008-2#1)(2008-3#1)
this ratio was##2##3##(1993-8#1)(2012-2#1)
this ratio##6##2##(1993-8#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
this rationale##2##2##(1994-8#1)(2008-5#1)
this reaction as##2##3##(1992-6#1)(2008-10#1)
this reaction is##4##3##(1992-6#1)(2008-10#1)(2012-12#1)(2013-8#1)
this reaction system##2##3##(2008-10#1)(2013-1#1)
this reaction##29##2##(1990-7#1)(1991-9#1)(1992-6#2)(1994-8#1)(1995-6#1)(2007-10#1)(2008-10#15)(2008-4#1)(2008-7#1)(2009-10#2)(2012-12#1)(2013-1#1)(2013-8#1)
this reagent was##2##3##(2008-10#1)(2012-2#1)
this reagent##9##2##(1996-5#1)(2008-10#5)(2008-4#2)(2012-2#1)
this realignment##2##2##(1991-3#1)(1993-3#1)
this reality##2##2##(2010-12#1)(2011-2#1)
this rearrangement##2##2##(1995-3#1)(1995-8#1)
this reason we##5##3##(1992-2#1)(1992-5#1)(1997-6#1)(2008-1#1)(2010-5#1)
this reason##46##2##(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-6#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
this recent##2##2##(2008-10#1)(2008-6#1)
this receptor in##4##3##(1990-11#1)(1991-2#1)(1994-12#1)(2008-5#1)
this receptor is##6##3##(1990-12#1)(1995-11#1)(1996-5#1)(2007-10#1)(2008-5#2)
this receptor##26##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#3)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#3)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-4#3)(2008-5#3)
this reciprocal##2##2##(2009-7#1)(2010-3#1)
this recognition##2##2##(1995-2#1)(2008-11#1)
this recombinant##4##2##(1995-11#1)(2008-11#1)(2008-6#1)(2010-11#1)
this recombination##2##2##(1996-10#1)(2009-2#1)
this recommendation##4##2##(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
this reduced model##2##3##(2008-6#2)
this reduced##3##2##(2007-11#1)(2008-6#2)
this reduction is##2##3##(1995-5#1)(2007-12#1)
this reduction##13##2##(1991-6#1)(1993-11#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2012-2#1)
this reflection##4##2##(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
this regard##34##2##(1991-12#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-2#1)
this regime##4##2##(1992-8#1)(2007-11#2)(2008-6#1)
this regimen##3##2##(1990-12#1)(1992-8#1)(2008-10#1)
this region by##2##3##(1991-12#1)(1993-8#1)
this region in the##2##4##(1994-6#1)(2008-10#1)
this region in##8##3##(1990-6#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-11#1)
this region is##9##3##(1990-12#1)(1990-6#1)(1990-8#1)(1993-11#1)(1993-12#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-5#1)
this region of chromosome##2##4##(1997-5#1)(2008-10#1)
this region of the##5##4##(1993-2#1)(1993-3#1)(1994-5#1)(1997-4#1)(2008-10#1)
this region of##9##3##(1993-2#1)(1993-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-5#1)
this region was##2##3##(1990-12#1)(2008-9#1)
this region were##2##3##(2008-1#1)(2008-12#1)
this region##116##2##(1990-12#2)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-8#3)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#5)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
this regular##3##2##(1991-2#1)(1992-2#1)(2009-8#1)
this regulation is dependent##2##4##(2008-8#2)
this regulation is##5##3##(1993-5#1)(1996-2#1)(2008-8#2)(2009-8#1)
this regulation##8##2##(1991-5#1)(1993-5#1)(1994-2#1)(1995-11#1)(1996-2#1)(2008-8#2)(2009-8#1)
this regulatory##9##2##(1991-2#1)(1991-5#1)(1992-12#1)(1995-2#1)(1995-8#1)(1997-9#1)(2008-11#1)(2008-8#1)(2011-1#1)
this relation##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
this relationship are##5##3##(1995-1#1)(1995-3#1)(2008-10#1)(2008-2#1)(2012-1#1)
this relationship between##2##3##(1994-5#1)(2013-1#1)
this relationship in##2##3##(1994-5#1)(2012-2#1)
this relationship is##3##3##(2008-4#1)(2008-8#1)(2009-5#1)
this relationship was##4##3##(1993-12#1)(2008-10#1)(2010-10#1)(2010-9#1)
this relationship##34##2##(1993-12#1)(1994-5#3)(1995-1#1)(1995-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)
this relatively##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
this remains a##2##3##(2008-11#1)(2012-2#1)
this remains##4##2##(2008-11#1)(2008-4#1)(2009-11#1)(2012-2#1)
this remarkable##2##2##(1992-3#1)(1993-12#1)
this report a method##2##4##(1992-8#1)(2008-10#1)
this report a##3##3##(1992-8#1)(2008-10#1)(2011-1#1)
this report an##2##3##(2008-10#2)
this report are##2##3##(1991-12#1)(2008-10#1)
this report is##13##3##(1992-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)
this report reviews##2##3##(1991-2#1)(2011-10#1)
this report the##5##3##(1994-11#1)(2008-5#1)(2009-10#1)(2009-5#1)(2013-1#1)
this report was##4##3##(1993-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
this report we present##5##4##(2008-4#1)(2008-7#2)(2008-9#1)(2012-2#1)
this report we##26##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-9#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#4)
this report will##2##3##(2008-7#1)(2008-9#1)
this report##136##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#2)(2007-10#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#3)(2013-8#2)
this represents one of the most##2##6##(2008-10#1)(2008-5#1)
this represents the##2##3##(2008-10#1)(2010-5#1)
this represents##6##2##(2007-10#1)(2008-10#2)(2008-5#1)(2010-5#1)(2010-9#1)
this requirement##9##2##(1996-4#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-10#1)(2009-8#1)(2013-1#1)
this requires##4##2##(1993-11#1)(2007-7#1)(2008-11#1)(2008-8#1)
this research a##2##3##(2008-12#1)(2008-7#1)
this research has##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
this research in##2##3##(2009-5#1)(2010-11#1)
this research might##2##3##(2007-12#1)(2010-4#1)
this research was##27##3##(1990-9#1)(1994-3#2)(2007-11#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
this research were##8##3##(1990-10#1)(1995-2#1)(2008-1#1)(2008-10#4)(2010-3#1)
this research##97##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-1#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#13)(2008-2#3)(2008-3#6)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
this residue in##2##3##(1995-2#2)
this residue to alanine##2##4##(1995-5#1)(1995-6#1)
this residue to##3##3##(1993-8#1)(1995-5#1)(1995-6#1)
this residue##16##2##(1990-8#2)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-5#1)(1995-2#4)(1995-5#1)(1995-6#1)
this resin##2##2##(2008-10#1)(2008-7#1)
this resistance can be##2##4##(2008-10#1)(2009-9#1)
this resistance is##2##3##(2008-10#1)(2011-2#1)
this resistance to##2##3##(2008-10#2)
this resistance was##2##3##(2008-10#2)
this resistance##14##2##(2008-10#9)(2008-11#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-3#1)
this resonator type##2##3##(2007-11#1)(2008-3#1)
this resource##3##2##(1991-2#1)(2008-7#1)(2013-1#1)
this respect##29##2##(1991-6#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
this response is not##2##4##(1991-5#1)(1992-8#1)
this response was##4##3##(1994-3#1)(1995-3#1)(2008-8#1)(2010-8#1)
this response##26##2##(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-8#2)(2012-2#1)
this result and##3##3##(1990-11#1)(1995-9#1)(2008-9#1)
this result in the##3##4##(1991-3#1)(1992-3#1)(2008-9#1)
this result is##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
this result##42##2##(1990-11#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-6#1)(1995-9#1)(1996-5#2)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#3)(2008-9#5)(2009-12#1)(2010-5#1)(2011-2#2)
this resulted in the##4##4##(1990-12#1)(1992-6#1)(1993-10#1)(2008-9#1)
this resulted in##7##3##(1990-12#1)(1992-6#1)(1993-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
this results in a##3##4##(1992-5#1)(2008-10#2)
this results in##5##3##(1992-5#1)(2008-10#3)(2008-6#1)
this results##6##2##(1992-5#1)(2008-10#3)(2008-6#1)(2010-2#1)
this retrospective analysis##4##3##(1996-11#1)(2008-1#1)(2011-1#1)(2011-2#1)
this retrospective study##20##3##(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)
this retrospective##27##2##(1996-11#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-6#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
this review aims to##2##4##(2011-1#1)(2012-2#1)
this review also##2##3##(2009-10#1)(2010-10#1)
this review are to##4##4##(1990-11#1)(2007-8#1)(2008-10#1)(2008-8#1)
this review are##8##3##(1990-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)
this review article##14##3##(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
this review focuses on##2##4##(1990-6#1)(2012-12#1)
this review focuses##3##3##(1990-6#1)(1997-2#1)(2012-12#1)
this review we provide##2##4##(2011-2#1)(2012-2#1)
this review we##44##3##(1996-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#7)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
this review will##11##3##(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-6#1)(2011-1#1)(2013-8#1)
this review##356##2##(1990-11#1)(1990-6#1)(1992-5#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#10)(2008-10#28)(2008-11#22)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#9)(2008-5#9)(2008-6#6)(2008-7#32)(2008-8#15)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#3)(2010-3#1)(2010-5#7)(2010-6#5)(2010-7#6)(2010-8#2)(2010-9#2)(2011-1#13)(2011-2#24)(2011-3#4)(2012-1#6)(2012-12#9)(2012-2#19)(2012-3#10)(2013-1#18)(2013-8#12)
this rise##2##2##(1997-8#1)(2010-12#1)
this risk analysis##2##3##(1997-4#1)(2012-2#1)
this risk is##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
this risk##19##2##(1992-9#1)(1994-12#1)(1994-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
this role is##4##3##(1992-9#1)(1993-3#1)(1997-7#1)(2012-2#1)
this role##12##2##(1992-9#1)(1993-3#2)(1994-8#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-2#1)
this route##7##2##(1993-11#1)(1994-9#1)(1995-12#1)(2008-10#1)(2011-2#2)(2012-12#1)
this rule##3##2##(1992-1#1)(1996-5#1)(2007-11#1)
this ruling##2##2##(1994-2#1)(1997-5#1)
this rust##2##2##(2008-10#2)
this same group##2##3##(2008-6#1)(2013-8#1)
this same##14##2##(1990-11#1)(1992-12#1)(1994-12#1)(1995-3#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
this sample of##4##3##(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
this sample was##2##3##(1994-12#1)(1997-2#1)
this sample##18##2##(1994-12#1)(1997-2#1)(2007-2#1)(2008-10#5)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
this sampling##2##2##(2008-10#2)
this scale##4##2##(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#1)
this scanner##2##2##(1992-11#1)(2008-3#1)
this scattering##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
this scenario##2##2##(2008-10#1)(2008-7#1)
this schedule of##2##3##(1990-2#1)(2008-8#1)
this schedule##4##2##(1990-2#1)(1990-8#1)(1991-6#1)(2008-8#1)
this scheme are##3##3##(2007-12#2)(2008-2#1)
this scheme to##2##3##(2007-12#1)(2008-11#1)
this scheme##22##2##(1994-12#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)
this screening##3##2##(1991-3#1)(2007-11#1)(2008-6#1)
this search##3##2##(2010-8#1)(2011-2#2)
this second##8##2##(1992-1#1)(1994-1#1)(1994-3#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)
this secondary##2##2##(1993-11#1)(2008-10#1)
this section##4##2##(1993-3#1)(2008-2#1)(2008-4#2)
this sector##3##2##(1991-12#1)(2008-5#1)(2009-3#1)
this segment##6##2##(1995-3#1)(2007-12#1)(2008-9#1)(2009-10#2)(2011-2#1)
this selection##2##2##(2008-11#1)(2008-8#1)
this selective##2##2##(1996-5#1)(2008-2#1)
this sense##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
this sensing##2##2##(2008-10#2)
this sensitive##3##2##(1990-7#1)(2007-7#1)(2008-12#1)
this sensitivity##4##2##(1992-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
this sensor can be##2##4##(2008-10#2)
this sensor can##3##3##(2008-10#2)(2008-2#1)
this sensor system##2##3##(2008-10#2)
this sensor was##2##3##(2008-10#1)(2008-7#1)
this sensor were##2##3##(2008-10#2)
this sensor##16##2##(2007-11#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-7#1)
this sensory##3##2##(2009-12#2)(2011-2#1)
this separation##3##2##(2008-10#2)(2011-2#1)
this sequence for##2##3##(1997-9#1)(2007-12#1)
this sequence is##4##3##(1991-11#1)(1993-8#1)(1995-6#1)(2008-8#1)
this sequence show##2##3##(1992-6#1)(1997-4#1)
this sequence##30##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-9#2)(1995-6#1)(1996-12#3)(1997-3#1)(1997-4#1)(1997-9#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-8#1)(2009-10#1)(2011-2#1)
this series of##8##3##(1990-7#1)(1992-4#1)(1992-8#1)(1995-8#1)(1996-10#1)(1997-1#1)(2008-10#1)(2008-5#1)
this series##35##2##(1990-7#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-3#4)(1995-8#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#3)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
this serious complication##2##3##(2007-7#1)(2013-1#1)
this serious problem##2##3##(1995-5#1)(2011-2#1)
this serious##6##2##(1995-5#1)(2007-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
this service and##2##3##(1995-1#1)(1995-3#1)
this service##4##2##(1993-12#1)(1995-1#1)(1995-3#1)(2007-8#1)
this set of##6##3##(1992-2#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-1#1)
this set##8##2##(1992-2#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-1#1)
this setting##30##2##(1992-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
this setup##3##2##(2008-3#2)(2008-7#1)
this shift in##2##3##(1993-6#1)(2008-7#1)
this shift##11##2##(1993-6#1)(1996-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
this short article##2##3##(1997-4#1)(2008-9#1)
this short review##3##3##(2008-7#3)
this short##12##2##(1992-6#1)(1993-12#1)(1994-12#1)(1995-1#1)(1997-4#1)(2008-1#1)(2008-7#3)(2008-9#1)(2011-2#1)(2013-1#1)
this should be##5##3##(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
this should##7##2##(1992-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
this showed##2##2##(1990-3#1)(1992-10#1)
this side effect##2##3##(2008-11#1)(2008-7#1)
this side##3##2##(1992-1#1)(2008-11#1)(2008-7#1)
this signal##4##2##(2008-3#2)(2009-9#1)(2012-3#1)
this signaling##3##2##(1997-4#1)(2009-6#1)(2011-1#1)
this simple##17##2##(1991-4#1)(1993-12#1)(1997-1#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)
this single##7##2##(1992-8#1)(1993-6#1)(1996-12#1)(2008-2#1)(2009-8#2)(2013-1#1)
this single-blind##2##2##(1990-3#1)(2012-2#1)
this site has been##2##4##(1995-2#1)(2013-8#1)
this site is##3##3##(1990-5#1)(1992-3#1)(2012-2#1)
this site may##3##3##(1991-12#1)(1997-3#1)(2010-11#1)
this site were##2##3##(2008-3#1)(2008-5#1)
this site##24##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-3#2)(1995-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-8#1)
this situation##21##2##(1990-12#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
this skin##3##2##(2008-5#2)(2011-2#1)
this small study##3##3##(2007-10#1)(2008-11#2)
this small##9##2##(1996-9#1)(2007-10#1)(2007-8#1)(2008-11#3)(2010-5#1)(2012-12#1)(2012-3#1)
this social##2##2##(2008-11#1)(2008-9#1)
this solution with##2##3##(2008-10#1)(2008-2#1)
this solution##11##2##(2007-12#1)(2008-10#7)(2008-2#2)(2008-9#1)
this solvent##2##2##(2008-5#1)(2008-7#1)
this sort##2##2##(1992-3#1)(1995-3#1)
this source##9##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
this special issue of##2##4##(1994-3#1)(2009-8#1)
this special issue##3##3##(1994-3#1)(2009-8#1)(2010-4#1)
this special population##2##3##(1996-3#1)(2008-6#1)
this special##15##2##(1991-4#1)(1991-6#1)(1992-6#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
this specialized##2##2##(2008-10#1)(2008-11#1)
this species and##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
this species are##4##3##(1994-8#1)(2008-8#2)(2013-1#1)
this species difference##2##3##(1996-5#1)(1997-7#1)
this species exhibits##2##3##(2008-9#1)(2013-7#1)
this species for##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
this species has a##2##4##(1992-10#1)(2008-8#1)
this species has##3##3##(1992-10#1)(2008-8#1)(2010-3#1)
this species in##6##3##(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2013-7#1)
this species is##8##3##(2008-10#1)(2008-12#3)(2008-5#1)(2008-8#1)(2009-8#1)(2012-6#1)
this species may##3##3##(1992-8#1)(2008-6#1)(2013-8#1)
this species of fish##2##4##(2010-8#1)(2012-3#1)
this species was##2##3##(2007-6#1)(2012-12#1)
this species##102##2##(1990-11#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-10#18)(2008-11#2)(2008-12#7)(2008-5#17)(2008-6#4)(2008-7#2)(2008-8#10)(2008-9#2)(2009-8#3)(2009-9#1)(2010-3#3)(2010-8#3)(2011-2#3)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#5)(2013-8#2)
this species'##2##2##(2009-8#1)(2010-8#1)
this specific group##2##3##(2007-12#1)(2008-7#1)
this specific##14##2##(1993-3#1)(1994-12#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-5#1)
this spectral range##2##3##(2008-3#2)
this spectral region##8##3##(1991-5#1)(2007-12#1)(2008-2#2)(2008-3#4)
this spectral##10##2##(1991-5#1)(2007-12#1)(2008-2#2)(2008-3#6)
this stage of##2##3##(2008-1#1)(2008-10#1)
this stage##17##2##(1994-2#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
this standard##4##2##(1990-11#1)(1992-9#1)(2008-10#2)
this state is##2##3##(1995-3#1)(2008-4#1)
this state##7##2##(1991-5#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-4#1)(2009-9#1)
this statistical##2##2##(2008-9#1)(2013-8#1)
this step##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
this steroid##3##2##(1994-8#1)(2008-4#1)(2012-3#1)
this stimulation##5##2##(1990-11#1)(1991-12#1)(1993-12#1)(1995-2#1)(1995-8#1)
this strain was##2##3##(2008-10#1)(2012-2#1)
this strain##17##2##(1992-5#1)(1995-6#1)(2007-10#1)(2008-10#9)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)
this strategy and##2##3##(2008-6#1)(2008-9#1)
this strategy has been successful in##2##6##(1997-2#1)(2011-2#1)
this strategy is##4##3##(2008-11#1)(2008-3#1)(2008-6#1)(2012-12#1)
this strategy to##2##3##(1993-12#1)(2008-8#1)
this strategy##27##2##(1993-12#1)(1994-6#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
this stress##5##2##(1992-12#2)(1995-12#1)(2008-11#1)(2011-2#1)
this structural##4##2##(1992-12#1)(1992-6#1)(1993-8#1)(2008-8#1)
this structure##16##2##(1991-11#1)(1991-5#2)(1992-12#1)(1993-6#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-11#1)
this study a##8##3##(1993-2#1)(2008-10#3)(2008-3#1)(2009-7#1)(2010-4#1)(2010-8#1)
this study aimed to##3##4##(2009-11#1)(2011-1#1)(2013-1#1)
this study also##4##3##(1991-12#1)(1997-2#1)(2008-10#1)(2010-11#1)
this study and the##4##4##(1990-6#1)(2008-10#1)(2008-5#1)(2009-2#1)
this study and##15##3##(1990-6#1)(1991-2#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2011-1#1)(2013-1#1)
this study are##32##3##(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#3)
this study because##3##3##(2008-1#2)(2013-1#1)
this study can be used##2##5##(2008-12#1)(2013-1#1)
this study can be##3##4##(1995-9#1)(2008-12#1)(2013-1#1)
this study can##4##3##(1995-9#1)(2008-12#1)(2013-1#2)
this study clearly##3##3##(2008-10#2)(2008-11#1)
this study confirmed##2##3##(2010-3#1)(2012-12#1)
this study could be##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
this study could##8##3##(2008-10#3)(2008-12#1)(2008-3#1)(2013-1#2)(2013-8#1)
this study demonstrate that##5##4##(1994-6#1)(2008-10#3)(2008-5#1)
this study demonstrate##8##3##(1994-6#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-5#1)(2008-8#1)
this study demonstrated that the##2##5##(1994-11#1)(2008-7#1)
this study demonstrated that##7##4##(1992-9#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)
this study demonstrated##9##3##(1992-9#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-1#1)
this study demonstrates the##3##4##(2009-12#1)(2009-5#1)(2009-9#1)
this study demonstrates##5##3##(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)
this study did not##2##4##(2008-12#1)(2013-1#1)
this study do not##2##4##(2008-5#1)(2008-7#1)
this study enabled us to##2##5##(2008-10#2)
this study examined##4##3##(2008-6#1)(2009-11#1)(2009-4#1)(2009-5#1)
this study examines the##4##4##(1994-2#1)(2007-12#1)(2009-5#1)(2011-2#1)
this study examines##5##3##(1994-2#1)(2007-12#1)(2008-12#1)(2009-5#1)(2011-2#1)
this study explores##2##3##(2008-1#1)(2010-10#1)
this study had##3##3##(1990-6#1)(1992-2#1)(2013-8#1)
this study has found##2##4##(1997-2#1)(2008-8#1)
this study has##10##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
this study have been##2##4##(1991-1#1)(2008-10#1)
this study have##9##3##(1991-1#1)(2008-10#4)(2008-6#1)(2009-8#1)(2011-2#2)
this study in##3##3##(1995-3#1)(2008-5#1)(2011-2#1)
this study indicate that the##3##5##(1996-3#1)(2006-6#1)(2009-7#1)
this study indicate that##18##4##(1990-5#1)(1990-6#1)(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#3)(2008-6#2)(2009-7#1)(2011-1#1)(2011-2#2)
this study indicate the##2##4##(2008-11#1)(2008-12#1)
this study indicate##20##3##(1990-5#1)(1990-6#1)(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2009-7#1)(2011-1#1)(2011-2#2)
this study indicated##5##3##(1993-12#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
this study indicates that##2##4##(2008-6#1)(2010-8#1)
this study indicates##3##3##(2008-10#1)(2008-6#1)(2010-8#1)
this study is an##4##4##(1997-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
this study is that##4##4##(1995-11#1)(1997-8#1)(2008-3#1)(2013-1#1)
this study is the##7##4##(1994-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
this study is to##87##4##(1992-12#1)(1992-2#1)(1995-4#1)(1996-1#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
this study is##119##3##(1992-12#1)(1992-2#1)(1994-6#1)(1995-11#1)(1995-4#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#2)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#6)
this study it is##2##4##(2008-11#1)(2008-2#1)
this study it##4##3##(1994-11#1)(1996-12#1)(2008-11#1)(2008-2#1)
this study may be useful for##2##6##(2008-10#1)(2008-2#1)
this study may be useful##3##5##(1996-2#1)(2008-10#1)(2008-2#1)
this study may be##4##4##(1996-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
this study may##8##3##(1996-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
this study of##6##3##(1992-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(2009-6#1)(2009-9#1)
this study provide##4##3##(2008-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
this study provided##2##3##(2008-7#1)(2009-11#1)
this study provides evidence##2##4##(1995-12#1)(2008-10#1)
this study provides further##2##4##(1994-8#1)(2008-7#1)
this study provides##10##3##(1994-8#1)(1995-12#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
this study represent##2##3##(2008-1#1)(2008-10#1)
this study reveal##2##3##(2009-10#1)(2009-9#1)
this study revealed that##7##4##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)
this study revealed##8##3##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)
this study should be useful##2##5##(2008-10#1)(2010-4#1)
this study should be##4##4##(1995-5#1)(1996-8#1)(2008-10#1)(2010-4#1)
this study should##6##3##(1995-5#1)(1996-12#1)(1996-8#1)(2008-10#2)(2010-4#1)
this study show that the##3##5##(2007-10#1)(2008-10#1)(2010-8#1)
this study show that##10##4##(1990-12#1)(2007-10#1)(2008-10#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
this study show##14##3##(1990-12#1)(2007-10#1)(2008-10#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
this study showed a##2##4##(1997-4#1)(2007-2#1)
this study showed that the##2##5##(1997-2#1)(2008-12#1)
this study showed that##11##4##(1997-2#1)(2007-7#1)(2008-10#2)(2008-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
this study showed##20##3##(1997-2#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-12#5)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
this study shows that the##2##5##(1995-6#1)(2008-5#1)
this study shows that##4##4##(1995-6#1)(2008-12#1)(2008-5#1)(2013-1#1)
this study shows##5##3##(1995-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
this study sought to##3##4##(1992-11#1)(2007-11#1)(2008-11#1)
this study suggest that the##4##5##(1990-2#1)(1992-6#1)(1994-2#1)(2011-2#1)
this study suggest that this##2##5##(1996-1#1)(2008-3#1)
this study suggest that##27##4##(1990-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
this study suggest##29##3##(1990-2#1)(1991-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
this study suggested that##4##4##(1992-2#1)(1995-4#1)(2008-6#1)(2011-3#1)
this study suggested##5##3##(1992-2#1)(1995-4#1)(2008-6#1)(2009-5#1)(2011-3#1)
this study suggests that the##2##5##(2008-8#1)(2011-2#1)
this study suggests that##7##4##(1995-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
this study support the hypothesis that##2##6##(2008-10#1)(2008-5#1)
this study support##3##3##(1991-9#1)(2008-10#1)(2008-5#1)
this study that##4##3##(2007-10#1)(2008-10#1)(2008-9#1)(2010-6#1)
this study the effects of##2##5##(2008-1#1)(2010-5#1)
this study the##24##3##(1990-5#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#2)(2012-3#1)
this study to determine the prevalence##2##6##(2007-7#1)(2008-1#1)
this study to determine##5##4##(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)
this study to evaluate the##3##5##(1990-2#1)(2007-7#1)(2009-10#1)
this study to evaluate##5##4##(1990-2#2)(2007-7#1)(2008-1#1)(2009-10#1)
this study to identify##3##4##(1990-11#1)(2008-12#1)(2010-11#1)
this study to##26##3##(1990-11#1)(1990-2#2)(1995-12#1)(1996-12#1)(1996-2#2)(2007-10#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
this study was conducted to determine if##2##7##(1995-3#1)(2008-10#1)
this study was conducted##4##4##(1995-3#1)(2008-10#2)(2011-1#1)
this study was done to##3##5##(2008-5#1)(2010-7#1)(2013-8#1)
this study was planned to##2##5##(2012-3#1)(2013-1#1)
this study was that##4##4##(2008-10#1)(2009-7#1)(2011-1#1)(2013-1#1)
this study was the##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
this study was to examine the##24##6##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
this study was to examine##34##5##(1991-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-6#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
this study was to##557##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-8#2)(1993-1#1)(1993-12#5)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#7)(2006-8#2)(2007-10#15)(2007-11#8)(2007-12#2)(2007-2#3)(2007-6#5)(2007-7#6)(2007-8#18)(2008-1#4)(2008-10#42)(2008-11#19)(2008-12#30)(2008-3#4)(2008-4#7)(2008-5#37)(2008-6#13)(2008-7#23)(2008-8#8)(2008-9#22)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#5)(2011-1#12)(2011-2#35)(2011-7#1)(2012-1#6)(2012-12#5)(2012-2#16)(2012-3#14)(2012-4#1)(2012-7#1)(2013-1#36)(2013-3#1)(2013-7#8)(2013-8#14)
this study was##604##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-8#2)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#3)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#7)(2006-8#2)(2007-10#15)(2007-11#9)(2007-12#3)(2007-2#3)(2007-6#6)(2007-7#10)(2007-8#19)(2008-1#5)(2008-10#47)(2008-11#20)(2008-12#32)(2008-3#4)(2008-4#7)(2008-5#38)(2008-6#14)(2008-7#24)(2008-8#8)(2008-9#22)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#9)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#6)(2011-1#14)(2011-2#41)(2011-7#1)(2012-1#6)(2012-12#5)(2012-2#16)(2012-3#15)(2012-4#1)(2012-7#1)(2013-1#39)(2013-3#1)(2013-7#8)(2013-8#15)
this study we investigated##6##4##(1991-2#1)(1993-3#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-7#1)
this study we##86##3##(1990-11#2)(1990-5#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#6)(2013-7#2)
this study were##73##3##(1990-10#2)(1991-2#1)(1993-12#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-8#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#7)
this study will be helpful##2##5##(2007-8#1)(2008-5#1)
this study will be##3##4##(2007-8#1)(2008-5#1)(2010-11#1)
this study will facilitate##2##4##(2008-10#2)
this study will##10##3##(2007-8#2)(2008-10#3)(2008-5#3)(2010-1#1)(2010-11#1)
this study with##3##3##(2008-11#1)(2008-12#1)(2009-5#1)
this study would##2##3##(1997-3#1)(2009-10#1)
this study##2138##2##(1990-10#3)(1990-11#5)(1990-12#7)(1990-2#5)(1990-3#1)(1990-5#6)(1990-6#5)(1990-7#1)(1990-8#3)(1991-1#3)(1991-11#4)(1991-12#13)(1991-2#8)(1991-3#3)(1991-4#2)(1991-6#3)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#7)(1992-2#7)(1992-3#6)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#10)(1993-2#3)(1993-3#9)(1993-6#4)(1993-8#8)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#11)(1994-2#11)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#6)(1995-1#5)(1995-11#3)(1995-12#9)(1995-2#10)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#10)(1995-8#4)(1995-9#2)(1996-1#8)(1996-12#16)(1996-2#8)(1996-3#3)(1996-5#2)(1996-6#3)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#12)(1997-3#11)(1997-4#4)(1997-6#7)(1997-7#4)(1997-8#18)(2006-12#2)(2006-6#1)(2006-8#2)(2007-10#27)(2007-11#15)(2007-12#10)(2007-2#9)(2007-5#1)(2007-6#8)(2007-7#31)(2007-8#31)(2008-1#23)(2008-10#336)(2008-11#98)(2008-12#99)(2008-2#9)(2008-3#32)(2008-4#15)(2008-5#95)(2008-6#39)(2008-7#64)(2008-8#32)(2008-9#42)(2009-10#10)(2009-11#13)(2009-12#6)(2009-2#13)(2009-3#8)(2009-4#10)(2009-5#23)(2009-6#10)(2009-7#17)(2009-8#8)(2009-9#8)(2010-1#5)(2010-10#8)(2010-11#8)(2010-12#13)(2010-2#10)(2010-3#19)(2010-4#16)(2010-5#6)(2010-6#9)(2010-7#12)(2010-8#33)(2010-9#7)(2011-1#39)(2011-10#1)(2011-2#120)(2011-3#4)(2011-7#1)(2012-1#15)(2012-12#21)(2012-2#52)(2012-3#49)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#3)(2013-1#125)(2013-3#1)(2013-7#18)(2013-8#34)
this study's##3##2##(2010-10#1)(2012-3#1)(2013-1#1)
this study)##2##2##(1991-3#1)(2013-1#1)
this subject is##2##3##(2009-6#1)(2013-8#1)
this subject##15##2##(1992-1#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-6#2)(2009-8#1)(2013-8#1)
this subpopulation##3##2##(1993-5#1)(1995-11#1)(2008-12#1)
this subset is##2##3##(2008-9#1)(2010-8#1)
this subset of patients##2##4##(2008-12#1)(2010-12#1)
this subset of##3##3##(1996-12#1)(2008-12#1)(2010-12#1)
this subset##7##2##(1995-2#1)(1996-12#1)(2008-12#1)(2008-9#2)(2010-12#1)(2010-8#1)
this substance##5##2##(2008-11#3)(2010-5#1)(2013-8#1)
this substrate##7##2##(1991-12#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-11#1)
this subunit from##2##3##(1993-12#1)(2009-7#1)
this subunit##4##2##(1993-12#1)(1995-2#1)(2009-7#1)(2012-2#1)
this success##4##2##(1991-5#1)(2008-10#1)(2009-5#1)(2010-10#1)
this suggested##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
this suggests that##6##3##(1992-3#1)(1993-11#1)(1997-9#1)(2007-12#1)(2008-9#1)(2009-11#1)
this suggests##7##2##(1992-3#1)(1993-11#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-11#1)
this summary##2##2##(1992-6#1)(1997-2#1)
this superfamily##2##2##(1995-2#1)(2011-1#1)
this supplement##2##2##(1994-2#1)(2008-5#1)
this support##4##2##(1990-8#1)(1994-2#1)(2007-11#1)(2008-5#1)
this surface##2##2##(1994-12#1)(2008-10#1)
this surgery##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
this surgical##3##2##(2007-8#1)(2013-1#2)
this survey to##2##3##(2007-8#1)(2013-1#1)
this survey##32##2##(1990-3#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-2#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-1#2)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#1)
this suspicion##3##2##(1992-8#1)(1995-5#1)(2013-1#1)
this switch##5##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
this syndrome are##2##3##(1991-5#1)(2013-1#1)
this syndrome in##2##3##(2008-1#1)(2008-12#1)
this syndrome is##3##3##(2008-12#2)(2008-3#1)
this syndrome##28##2##(1991-5#2)(1994-12#1)(1995-12#2)(1997-3#1)(1997-6#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#4)(2008-3#2)(2008-7#4)(2011-2#1)(2012-2#1)(2013-1#4)
this synergistic##2##2##(2008-10#1)(2008-4#1)
this system allowed the##2##4##(2008-10#2)
this system and##2##3##(2007-11#1)(2011-1#1)
this system are##5##3##(1990-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
this system can##4##3##(2008-10#1)(2008-2#2)(2010-8#1)
this system for##6##3##(1994-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
this system has##2##3##(2008-9#1)(2009-11#1)
this system in##2##3##(1993-12#1)(2008-3#1)
this system include##2##3##(1997-4#1)(2011-2#1)
this system is##16##3##(1992-3#1)(1994-6#1)(1997-3#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-6#1)(2009-8#1)
this system of##2##3##(1993-2#1)(2010-2#1)
this system provided##2##3##(1995-12#1)(2008-10#1)
this system to##6##3##(1993-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
this system was##6##3##(1997-8#1)(2008-10#3)(2008-12#1)(2008-3#1)
this system were##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
this system##162##2##(1990-11#2)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-8#2)(2007-10#1)(2007-11#5)(2007-12#5)(2008-10#42)(2008-11#14)(2008-12#1)(2008-2#14)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-2#2)(2010-8#3)(2011-1#2)(2011-2#1)(2012-3#3)(2013-1#1)
this systematic review##5##3##(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
this systematic##7##2##(2008-10#2)(2008-6#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
this target##4##2##(1992-12#2)(2008-2#1)(2008-9#1)
this task was##2##3##(1994-3#1)(2009-10#1)
this task##25##2##(1991-2#1)(1993-3#2)(1994-2#1)(1994-3#3)(1996-2#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)
this teaching##2##2##(2008-11#1)(2009-2#1)
this technical##3##2##(2007-7#1)(2008-9#1)(2012-2#1)
this technique a##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
this technique allows##2##3##(2007-11#1)(2012-12#1)
this technique and##7##3##(1995-1#1)(1997-1#1)(2008-11#1)(2008-7#3)(2008-8#1)
this technique are compared with##2##5##(2007-12#1)(2008-3#1)
this technique are##9##3##(1991-3#1)(1993-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
this technique as a##5##4##(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
this technique by##3##3##(2007-12#1)(2008-3#2)
this technique can be##4##4##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
this technique can##11##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
this technique could##2##3##(2008-3#1)(2008-5#1)
this technique for the##2##4##(2007-12#1)(2008-10#1)
this technique for##13##3##(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#1)
this technique has been##2##4##(1991-11#1)(2008-10#1)
this technique has improved##2##4##(2008-7#1)(2011-2#1)
this technique has##8##3##(1991-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#1)
this technique in the##5##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
this technique in##11##3##(1993-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#3)
this technique is also##2##4##(2008-10#2)
this technique is##26##3##(1990-9#1)(1991-9#1)(1997-7#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#5)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#2)
this technique it is possible to##2##6##(2007-12#1)(2008-3#1)
this technique on##2##3##(2008-11#1)(2008-2#1)
this technique particularly##2##3##(1991-5#1)(2008-3#1)
this technique showed##2##3##(2007-10#1)(2008-10#1)
this technique the##3##3##(2007-11#1)(2008-9#1)(2012-2#1)
this technique to measure the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
this technique to##24##3##(1993-3#1)(1995-2#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
this technique was##2##3##(2007-11#1)(2008-11#1)
this technique we##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
this technique will be##2##4##(2007-11#1)(2007-12#1)
this technique will##3##3##(2007-11#1)(2007-12#1)(2012-2#1)
this technique with##5##3##(2008-2#1)(2008-3#2)(2008-7#1)(2012-2#1)
this technique##248##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-10#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#18)(2007-12#24)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#38)(2008-11#10)(2008-12#1)(2008-2#24)(2008-3#40)(2008-4#3)(2008-5#6)(2008-7#9)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#5)(2013-8#3)
this technology and##3##3##(2008-4#1)(2011-2#1)(2012-12#1)
this technology in##4##3##(1991-11#1)(1996-1#1)(2008-10#1)(2008-11#1)
this technology is##4##3##(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
this technology to##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
this technology will##2##3##(2008-10#2)
this technology##41##2##(1991-11#1)(1992-12#1)(1993-12#2)(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#9)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2010-8#4)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
this temperature##3##2##(1995-11#1)(2008-3#1)(2008-7#1)
this tendency##3##2##(1992-1#1)(2007-10#1)(2011-1#1)
this term##3##2##(1992-5#1)(2011-2#2)
this territory##2##2##(1996-3#1)(2011-2#1)
this test the##2##3##(1994-3#1)(2008-5#1)
this test was##2##3##(2007-7#1)(2011-2#1)
this test##28##2##(1990-3#1)(1991-11#1)(1992-11#2)(1992-7#1)(1993-11#1)(1994-3#1)(1997-2#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#3)
this the##10##2##(1992-12#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#2)
this theme##2##2##(1992-3#1)(2008-8#1)
this theoretical study##2##3##(2010-10#1)(2012-2#1)
this theoretical##4##2##(1993-1#1)(2008-1#1)(2010-10#1)(2012-2#1)
this theory and##2##3##(1993-2#1)(2013-1#1)
this theory##15##2##(1993-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
this therapeutic method##2##3##(1995-5#1)(2013-1#1)
this therapeutic##5##2##(1992-12#1)(1995-5#1)(2007-12#1)(2011-2#1)(2013-1#1)
this therapy##14##2##(1990-9#1)(1993-11#1)(2007-12#1)(2007-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
this third##4##2##(1991-1#1)(1992-2#1)(2008-4#1)(2012-2#1)
this three-part##2##2##(1995-2#1)(2008-7#1)
this threshold##6##2##(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#1)
this time in##2##3##(2008-6#1)(2011-2#1)
this time period##2##3##(2008-6#1)(2008-9#1)
this time point##2##3##(2008-5#1)(2009-8#1)
this time showed##2##3##(1992-5#1)(1996-9#1)
this time the##3##3##(1995-8#1)(2008-11#1)(2013-1#1)
this time was##2##3##(1990-2#1)(1995-3#1)
this time##58##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-2#1)(2011-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
this tissue##12##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-9#2)(1993-3#1)(1994-6#1)(1995-12#1)(2008-7#1)(2013-1#2)
this to be achieved##2##4##(1992-9#1)(2008-11#1)
this to be##5##3##(1992-9#1)(2008-11#2)(2008-9#1)(2011-2#1)
this to the change in##2##5##(2008-4#1)(2009-12#1)
this to the##4##3##(2007-7#1)(2008-11#1)(2008-4#1)(2009-12#1)
this to##20##2##(1992-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#2)(2009-2#1)(2011-2#1)(2012-1#1)
this tool to##2##3##(2012-7#1)(2013-8#1)
this tool##9##2##(1993-12#2)(1995-2#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-8#1)
this topic and##2##3##(2008-10#1)(2008-4#1)
this topic##29##2##(1990-11#1)(1993-5#1)(1993-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
this toxic##4##2##(1992-8#1)(2008-10#2)(2013-1#1)
this toxicity##3##2##(1992-3#1)(2008-10#2)
this toxin is##2##3##(1995-8#1)(2008-10#1)
this toxin##3##2##(1995-8#1)(2008-10#2)
this trace##3##2##(2008-12#1)(2008-5#1)(2012-2#1)
this trade-off##4##2##(2008-8#4)
this traditional##3##2##(1995-2#2)(2009-7#1)
this training##3##2##(1991-8#1)(2011-2#1)(2012-2#1)
this trait##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
this trajectory##2##2##(2011-7#1)(2013-1#1)
this transcript##2##2##(1991-9#1)(1992-8#1)
this transcriptional##3##2##(1992-12#1)(1994-11#1)(2008-7#1)
this transfer##2##2##(1995-11#1)(2008-2#1)
this transgenic##2##2##(1990-11#1)(2008-10#1)
this transition##10##2##(1994-12#1)(1994-2#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)
this translational##2##2##(1992-12#1)(1992-3#1)
this transmission##2##2##(2007-12#1)(2013-1#1)
this transport##4##2##(1992-6#1)(1997-1#1)(1997-7#1)(2008-6#1)
this transporter##3##2##(1995-6#1)(1995-8#1)(1996-5#1)
this treatment and##2##3##(2008-10#1)(2012-12#1)
this treatment is##2##3##(1993-6#1)(2010-10#1)
this treatment modality for##2##4##(1997-1#1)(2007-7#1)
this treatment modality##3##3##(1994-3#1)(1997-1#1)(2007-7#1)
this treatment option##3##3##(1994-3#1)(2008-1#1)(2008-6#1)
this treatment with##2##3##(1995-2#1)(2008-9#1)
this treatment##41##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-10#2)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
this trend is##3##3##(2007-7#1)(2008-1#1)(2008-11#1)
this trend was##2##3##(2012-2#1)(2012-3#1)
this trend##12##2##(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
this trial##11##2##(1991-9#1)(1994-12#1)(1994-7#1)(1995-4#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
this tripeptide##2##2##(1992-10#1)(2011-1#1)
this triple##2##2##(1990-12#1)(2011-2#1)
this tumor are##2##3##(1990-10#1)(2013-1#1)
this tumor was##2##3##(2010-11#1)(2012-1#1)
this tumor##22##2##(1990-10#1)(1992-10#1)(1992-12#1)(1992-9#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-1#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#1)
this tumour is##2##3##(2011-2#1)(2013-7#1)
this tumour##6##2##(1990-6#1)(1992-5#1)(2010-3#1)(2011-2#1)(2013-7#2)
this tutorial##4##2##(1993-12#1)(1993-3#1)(1994-12#1)(2012-12#1)
this two##2##2##(2011-2#1)(2012-12#1)
this type is##4##3##(1990-5#1)(1997-3#1)(2008-10#1)(2011-2#1)
this type of activity##2##4##(2008-11#1)(2008-8#1)
this type of alkaloid##2##4##(2011-3#2)
this type of analysis is##2##5##(2008-9#2)
this type of assessment##2##4##(2008-11#1)(2008-9#1)
this type of education##2##4##(2008-11#1)(2008-12#1)
this type of event##2##4##(1993-3#1)(2012-2#1)
this type of laser##2##4##(2007-12#1)(2010-1#1)
this type of planning##2##4##(1993-3#1)(1994-1#1)
this type of reagent##2##4##(2008-10#2)
this type of research##4##4##(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
this type of study##3##4##(1997-7#1)(2008-10#1)(2010-6#1)
this type of treatment##3##4##(1991-11#1)(1992-3#1)(1993-2#1)
this type of tumor##2##4##(1990-2#1)(2011-2#1)
this type of##122##3##(1990-2#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#3)(1994-11#1)(1994-6#2)(1994-8#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#15)(2008-11#7)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#6)(2009-1#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
this type##145##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#3)(1991-5#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#3)(1994-11#1)(1994-5#2)(1994-6#3)(1994-8#2)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#16)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#6)(2009-1#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
this typically##2##2##(2008-12#1)(2008-7#1)
this uncommon condition##2##3##(2007-8#1)(2013-7#1)
this uncommon disease##4##3##(1993-5#1)(2007-2#1)(2008-12#1)(2008-7#1)
this uncommon##14##2##(1993-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
this understanding##3##2##(2008-10#1)(2008-12#2)
this unique combination##2##3##(2008-3#1)(2012-3#1)
this unique population##2##3##(2013-1#2)
this unique##17##2##(1991-5#1)(1993-11#1)(1994-9#1)(1996-2#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#2)
this unit addresses##2##3##(2008-2#1)(2008-4#1)
this unit describes an##2##4##(2008-4#2)
this unit describes preparation of##2##5##(2008-4#2)
this unit describes##11##3##(2008-2#4)(2008-4#6)(2008-9#1)
this unit discusses the##4##4##(2008-4#3)(2008-9#1)
this unit discusses##5##3##(2008-4#4)(2008-9#1)
this unit is a##2##4##(2008-2#1)(2008-9#1)
this unit is##24##3##(2008-2#1)(2008-4#13)(2008-9#9)(2010-8#1)
this unit presents##2##3##(2008-4#2)
this unit should be##2##4##(2008-1#1)(2008-9#1)
this unit##204##2##(1990-11#1)(2008-1#6)(2008-2#24)(2008-4#123)(2008-9#47)(2010-7#1)(2010-8#1)(2012-3#1)
this unusual##15##2##(1993-11#1)(1996-2#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
this use##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
this valuable##2##2##(1993-1#1)(2008-10#1)
this value and##2##3##(1991-5#1)(2008-3#1)
this value is##2##3##(1996-7#1)(2008-1#1)
this value was##5##3##(1990-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
this value##11##2##(1990-7#1)(1991-5#1)(1996-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
this variability##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
this variable##4##2##(2008-10#4)
this variant##4##2##(1991-12#1)(2008-9#1)(2009-12#1)(2010-12#1)
this variation can##2##3##(1993-3#1)(2008-8#1)
this variation in##2##3##(2008-10#1)(2009-5#1)
this variation##15##2##(1993-3#1)(1995-3#1)(1997-3#1)(2008-10#7)(2008-3#1)(2008-8#1)(2009-5#1)(2011-3#1)(2012-2#1)
this vector system##2##3##(1996-12#1)(1997-4#1)
this vector##10##2##(1994-12#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#3)
this versatile##2##2##(2008-11#1)(2010-2#1)
this very rare##2##3##(2007-8#1)(2008-6#1)
this very##11##2##(1995-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-12#1)
this video##2##2##(2008-10#1)(2008-8#1)
this view##5##2##(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#2)
this viewpoint##2##2##(1994-3#1)(2008-6#1)
this viral##2##2##(1995-2#1)(1997-3#1)
this virus as a##2##4##(2008-10#1)(2011-2#1)
this virus is##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
this virus may be##2##4##(2008-10#1)(2008-11#1)
this virus was##2##3##(2008-10#2)
this virus##23##2##(1991-3#1)(1992-6#2)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
this vital##3##2##(1993-1#1)(1995-12#1)(2008-11#1)
this vitamin##2##2##(1990-3#1)(2012-3#1)
this voltammetric method##3##3##(2008-10#3)
this voltammetric peak##2##3##(2008-10#2)
this voltammetric##5##2##(2008-10#5)
this volume##8##2##(1990-3#1)(1992-6#1)(1994-6#1)(2008-11#2)(2008-2#2)(2008-3#1)
this vulnerable population##4##3##(2008-12#1)(2009-5#1)(2009-9#2)
this vulnerable##5##2##(2008-12#1)(2009-5#1)(2009-9#2)(2011-1#1)
this was a##7##3##(1993-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
this was accompanied by a##3##5##(1992-9#1)(1994-8#1)(2008-11#1)
this was accompanied by##4##4##(1992-9#1)(1994-8#1)(2008-11#1)(2009-6#1)
this was associated with##6##4##(1993-12#1)(1994-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
this was confirmed by##2##4##(2007-11#1)(2008-7#1)
this was confirmed##3##3##(1995-2#1)(2007-11#1)(2008-7#1)
this was due to##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
this was not the case##2##5##(1994-5#1)(2008-11#1)
this was not##15##3##(1990-6#1)(1992-2#1)(1993-12#1)(1994-5#1)(1996-1#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2011-1#1)(2013-1#1)
this was the##7##3##(1992-2#1)(1993-1#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-2#2)
this was true##3##3##(1996-5#1)(2006-4#1)(2012-2#1)
this was##92##2##(1990-5#1)(1990-6#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-12#5)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#5)(2008-3#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)
this water##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
this water-soluble##2##2##(1994-5#1)(2008-10#1)
this wavelength range##4##3##(2007-11#2)(2008-3#2)
this wavelength##9##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#3)
this way a##4##3##(1990-9#1)(1992-6#1)(2008-2#1)(2008-8#1)
this way for##2##3##(2008-10#1)(2008-2#1)
this way the##6##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
this way##92##2##(1990-9#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-2#2)(1997-8#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-4#1)(2013-1#1)(2013-8#1)
this we have##2##3##(2008-7#1)(2008-9#1)
this we##10##2##(1993-12#1)(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)
this were##2##2##(1996-5#1)(2009-5#1)
this widely##2##2##(1991-12#1)(2009-5#1)
this will allow##2##3##(2008-10#1)(2008-5#1)
this will be a##2##4##(1997-2#1)(2008-11#1)
this will be achieved##2##4##(2007-10#1)(2008-5#1)
this will be##7##3##(1997-2#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)
this will help##2##3##(2008-7#1)(2011-2#1)
this will lead to##2##4##(2007-6#1)(2011-2#1)
this will provide##2##3##(1995-2#1)(2007-2#1)
this will##26##2##(1992-3#1)(1995-2#2)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#2)(2012-12#1)(2013-8#1)
this with a##4##3##(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
this with##8##2##(2006-10#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2012-2#2)
this work a##8##3##(2008-10#6)(2011-2#1)(2012-2#1)
this work focuses on##2##4##(1995-12#1)(2008-10#1)
this work for##5##3##(1995-5#1)(2008-10#4)
this work has##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
this work in##3##3##(2008-10#2)(2010-11#1)
this work is##28##3##(1990-7#1)(2007-11#3)(2008-10#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
this work shows that##2##4##(2008-10#1)(2008-5#1)
this work was##51##3##(1993-12#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#12)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
this work we##27##3##(1990-5#1)(1991-12#1)(1991-5#2)(1992-8#1)(1997-2#1)(2008-10#7)(2008-11#5)(2009-8#1)(2010-2#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
this work##362##2##(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#3)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-4#1)(1997-2#4)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#3)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#172)(2008-11#13)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#21)(2008-6#9)(2008-7#8)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#9)(2011-3#3)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#7)(2013-8#3)
this workshop##2##2##(2008-11#1)(2011-2#1)
this world##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
this would indicate that##2##4##(1990-2#1)(2008-5#1)
this would indicate##3##3##(1990-2#1)(2008-10#1)(2008-5#1)
this would##9##2##(1990-2#1)(1994-5#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
this year##10##2##(1993-5#1)(1996-2#1)(1996-3#1)(2008-4#3)(2008-5#1)(2008-7#3)
this year's##5##2##(1991-2#1)(1995-3#1)(2008-7#1)(2009-6#1)(2010-11#1)
this yeast##3##2##(1996-12#1)(2008-7#1)(2009-12#1)
this young##4##2##(1997-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
this zone##4##2##(1997-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
this zoonosis##2##2##(2012-12#1)(2013-1#1)
this##18011##1##(1990-10#14)(1990-11#69)(1990-12#74)(1990-2#49)(1990-3#30)(1990-5#80)(1990-6#41)(1990-7#34)(1990-8#54)(1990-9#26)(1991-1#28)(1991-10#3)(1991-11#32)(1991-12#82)(1991-2#68)(1991-3#65)(1991-4#9)(1991-5#59)(1991-6#49)(1991-7#7)(1991-8#33)(1991-9#60)(1992-1#45)(1992-10#16)(1992-11#42)(1992-12#103)(1992-2#65)(1992-3#99)(1992-4#20)(1992-5#34)(1992-6#74)(1992-7#4)(1992-8#58)(1992-9#50)(1993-1#43)(1993-10#3)(1993-11#49)(1993-12#118)(1993-2#51)(1993-3#81)(1993-5#16)(1993-6#73)(1993-8#68)(1993-9#34)(1994-1#32)(1994-10#2)(1994-11#66)(1994-12#95)(1994-2#94)(1994-3#81)(1994-5#52)(1994-6#49)(1994-7#5)(1994-8#86)(1994-9#41)(1995-1#46)(1995-10#1)(1995-11#51)(1995-12#100)(1995-2#136)(1995-3#75)(1995-4#7)(1995-5#65)(1995-6#77)(1995-8#46)(1995-9#13)(1996-1#61)(1996-10#6)(1996-11#17)(1996-12#89)(1996-2#94)(1996-3#59)(1996-4#14)(1996-5#38)(1996-6#27)(1996-7#9)(1996-8#16)(1996-9#20)(1997-1#64)(1997-2#86)(1997-3#94)(1997-4#72)(1997-5#25)(1997-6#44)(1997-7#60)(1997-8#79)(1997-9#5)(2006-10#35)(2006-12#10)(2006-4#2)(2006-5#2)(2006-6#13)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#94)(2007-11#274)(2007-12#338)(2007-2#48)(2007-3#1)(2007-4#12)(2007-5#22)(2007-6#23)(2007-7#111)(2007-8#144)(2007-9#4)(2008-1#226)(2008-10#2672)(2008-11#817)(2008-12#414)(2008-2#441)(2008-3#680)(2008-4#360)(2008-5#536)(2008-6#249)(2008-7#612)(2008-8#421)(2008-9#431)(2009-1#18)(2009-10#108)(2009-11#63)(2009-12#68)(2009-2#55)(2009-3#67)(2009-4#49)(2009-5#111)(2009-6#64)(2009-7#81)(2009-8#121)(2009-9#75)(2010-1#33)(2010-10#78)(2010-11#81)(2010-12#97)(2010-2#51)(2010-3#109)(2010-4#64)(2010-5#102)(2010-6#66)(2010-7#59)(2010-8#153)(2010-9#43)(2011-1#211)(2011-10#5)(2011-2#690)(2011-3#36)(2011-4#1)(2011-7#10)(2011-9#2)(2012-1#79)(2012-12#216)(2012-2#375)(2012-3#280)(2012-4#1)(2012-5#4)(2012-6#4)(2012-7#7)(2012-8#2)(2012-9#2)(2013-1#616)(2013-2#2)(2013-3#1)(2013-7#96)(2013-8#245)
thistle##5##1##(2008-10#3)(2008-5#1)(2011-2#1)
thomasi##5##1##(2007-12#5)
thoracic CT scanning##2##3##(1991-3#2)
thoracic CT##4##2##(1991-3#2)(1997-8#1)(2007-10#1)
thoracic airsacculitis##2##2##(2010-4#2)
thoracic and abdominal##4##3##(1996-12#1)(2011-2#1)(2012-2#1)(2013-3#1)
thoracic and cardiovascular surgery##4##4##(2007-8#3)(2010-8#1)
thoracic and lumbar##3##3##(2008-12#1)(2008-7#2)
thoracic and##15##2##(1991-6#1)(1996-12#1)(2006-10#1)(2007-8#3)(2008-12#1)(2008-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-3#1)
thoracic anesthesia##2##2##(2006-10#2)
thoracic aorta and abdominal aorta) in##2##6##(1997-8#2)
thoracic aorta and##3##3##(1997-8#2)(2013-3#1)
thoracic aorta dissection##2##3##(2013-8#2)
thoracic aorta in##2##3##(1992-9#1)(2009-8#1)
thoracic aorta to femoral artery bypass##3##6##(2007-8#3)
thoracic aorta to##6##3##(2007-8#3)(2008-7#2)(2010-12#1)
thoracic aorta without##2##3##(2007-8#1)(2011-1#1)
thoracic aorta##31##2##(1990-2#1)(1992-9#1)(1995-11#1)(1997-8#4)(2007-2#1)(2007-8#7)(2008-10#2)(2008-12#1)(2008-7#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-3#1)(2013-8#2)
thoracic aorta)##2##2##(1997-8#1)(2010-8#1)
thoracic aortic surgery##2##3##(2010-8#2)
thoracic aortic surgery]##2##3##(2010-8#2)
thoracic aortic##9##2##(1995-12#1)(2007-8#1)(2008-11#1)(2010-12#2)(2010-8#4)
thoracic artery (ITA)##2##3##(2007-8#2)
thoracic artery##10##2##(2007-8#9)(2011-2#1)
thoracic cage##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
thoracic cavity##4##2##(2010-8#1)(2012-3#1)(2013-1#2)
thoracic chaetigers##2##2##(2008-5#2)
thoracic computed tomography (CT)##2##4##(2008-7#1)(2012-2#1)
thoracic cord##2##2##(1995-12#1)(2008-7#1)
thoracic diseases##3##2##(2010-8#3)
thoracic drainage##5##2##(2007-8#1)(2010-8#4)
thoracic duct##3##2##(2008-4#1)(2012-3#2)
thoracic emergencies##3##2##(2012-2#3)
thoracic epidural##2##2##(2006-10#1)(2007-9#1)
thoracic esophagus##2##2##(2008-5#2)
thoracic injuries##4##2##(2007-8#2)(2008-1#1)(2010-9#1)
thoracic injury##2##2##(2007-8#1)(2013-1#1)
thoracic kidney##2##2##(2011-2#2)
thoracic kyphoscoliosis##2##2##(1991-3#1)(2008-8#1)
thoracic kyphosis##4##2##(2007-11#4)
thoracic or abdominal##2##3##(1990-5#1)(2012-2#1)
thoracic outlet syndrome##2##3##(2008-9#1)(2011-3#1)
thoracic pedicle##2##2##(2009-3#1)(2012-12#1)
thoracic radiation therapy##2##3##(2008-10#1)(2008-6#1)
thoracic radiation##3##2##(2008-10#2)(2008-6#1)
thoracic region##3##2##(1996-3#1)(2008-11#1)(2012-3#1)
thoracic sclerites##4##2##(2007-12#1)(2013-1#3)
thoracic scoliosis##4##2##(2007-11#1)(2007-8#3)
thoracic segments##2##2##(2007-12#2)
thoracic spinal cord##4##3##(1993-12#2)(2008-12#1)(2008-7#1)
thoracic spinal##8##2##(1993-12#2)(2008-12#3)(2008-7#1)(2012-12#1)(2013-1#1)
thoracic spine thrust manipulation and##2##5##(2008-12#2)
thoracic spine##12##2##(2007-11#1)(2008-12#6)(2008-8#2)(2009-8#1)(2012-12#2)
thoracic stiffness##3##2##(2008-9#3)
thoracic surgery in the##2##4##(2007-8#1)(2012-12#1)
thoracic surgery in##5##3##(1990-12#1)(1991-2#1)(2006-10#1)(2007-8#1)(2012-12#1)
thoracic surgery##28##2##(1990-12#1)(1991-2#2)(2006-10#3)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#1)(2010-8#6)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
thoracic surgical procedures##5##3##(2007-8#3)(2010-8#2)
thoracic surgical##8##2##(1993-12#2)(2007-8#3)(2010-8#2)(2013-1#1)
thoracic to##2##2##(2007-12#1)(2011-2#1)
thoracic trauma##4##2##(2007-11#1)(2012-2#2)(2013-1#1)
thoracic vertebra##2##2##(2007-12#1)(2008-6#1)
thoracic vertebrae##2##2##(2007-11#1)(2011-2#1)
thoracic wall##4##2##(1991-5#1)(1992-6#1)(2008-6#1)(2012-2#1)
thoracic wounds##2##2##(1990-2#1)(2012-2#1)
thoracic##296##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#4)(1993-7#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#2)(1997-8#10)(2006-10#8)(2006-12#1)(2007-10#1)(2007-11#10)(2007-12#7)(2007-2#1)(2007-8#45)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#13)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#8)(2008-8#5)(2008-9#4)(2009-3#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#27)(2010-9#2)(2011-1#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#16)(2012-3#7)(2013-1#15)(2013-3#4)(2013-8#5)
thoracic/thoracolumbar level##4##2##(2012-3#4)
thoracic/thoracolumbar##6##1##(2012-3#6)
thoracis##4##1##(2007-8#2)(2010-4#2)
thoraco-lumbar##3##1##(2007-11#3)
thoracoabdominal##5##1##(2008-12#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-3#1)
thoracolumbar and lumbar scoliosis##2##4##(2008-8#2)
thoracolumbar and lumbar##4##3##(2008-8#4)
thoracolumbar##14##1##(1995-11#1)(1997-6#1)(2008-7#1)(2008-8#5)(2009-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
thoracolumbosacral##2##1##(2012-3#2)
thoracoscope##2##1##(2007-8#1)(2010-8#1)
thoracoscopic and abdominal open surgery##2##5##(2011-2#2)
thoracoscopic and##3##2##(2008-7#1)(2011-2#2)
thoracoscopic esophagectomy##2##2##(2010-8#2)
thoracoscopic internal mammary artery##2##4##(2007-8#2)
thoracoscopic lung##2##2##(2010-11#1)(2010-8#1)
thoracoscopic resection##2##2##(2007-8#2)
thoracoscopic surgery##8##2##(2007-8#2)(2008-1#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-7#1)
thoracoscopic thymectomy##5##2##(2007-8#2)(2010-8#1)(2012-12#2)
thoracoscopic##35##1##(1997-4#1)(2006-10#1)(2007-8#14)(2008-1#1)(2008-7#1)(2010-11#1)(2010-8#8)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
thoracoscopy was##2##2##(2007-8#1)(2010-8#1)
thoracoscopy##9##1##(1991-3#1)(2007-8#3)(2008-5#1)(2010-8#2)(2013-1#2)
thoracotomy and laminectomy##2##3##(2007-8#2)
thoracotomy and##11##2##(1993-3#1)(2007-8#4)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
thoracotomy in##2##2##(1990-12#1)(2007-8#1)
thoracotomy to##2##2##(2007-8#2)
thoracotomy##53##1##(1990-12#2)(1991-6#1)(1993-3#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#28)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
thoracotomy)##2##1##(1990-12#1)(2007-8#1)
thorax and##3##2##(2007-12#1)(2010-4#1)(2012-2#1)
thorax have##2##2##(1997-8#1)(2012-2#1)
thorax of the trace##2##4##(2013-1#2)
thorax of the##4##3##(1992-6#1)(2008-6#1)(2013-1#2)
thorax##30##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-3#2)(1996-1#1)(1997-8#2)(2007-12#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#3)
thorium and uranium##2##3##(2008-10#2)
thorium and##6##2##(2008-10#6)
thorium content##2##2##(2008-10#2)
thorium##28##1##(2008-10#25)(2010-5#1)(2013-1#2)
thorium(IV) and uranium(VI)##3##3##(2008-10#3)
thorium(IV) in##2##2##(2008-10#2)
thorium(IV)##10##1##(2008-10#10)
thornei and##2##2##(2008-10#2)
thornei##5##1##(2008-10#5)
thorough analysis of##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
thorough and##3##2##(1993-12#1)(1993-3#1)(2011-1#1)
thorough debridement##2##2##(2012-2#1)(2013-8#1)
thorough evaluation of patients##2##4##(1991-2#1)(2008-7#1)
thorough examination of##2##3##(1997-8#1)(2008-4#1)
thorough examination##3##2##(1997-8#1)(2008-4#1)(2013-8#1)
thorough investigation of the##2##4##(2010-2#1)(2013-1#1)
thorough investigation of##4##3##(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
thorough investigation##7##2##(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
thorough investigations##2##2##(2007-10#1)(2013-1#1)
thorough physical examination##2##3##(1991-12#1)(2006-10#1)
thorough review of the##3##4##(1993-1#1)(2006-5#1)(2008-4#1)
thorough review##4##2##(1993-1#1)(1993-12#1)(2006-5#1)(2008-4#1)
thorough search for##2##3##(1994-5#1)(2008-7#1)
thorough understanding of the##7##4##(1995-12#1)(2007-12#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
thorough understanding of##16##3##(1993-1#1)(1995-12#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
thorough##92##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-12#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-3#2)(1997-8#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
thoroughly characterized##3##2##(2013-1#3)
thoroughly discussed##2##2##(2008-10#1)(2013-1#1)
thoroughly investigated##6##2##(2008-10#4)(2010-4#1)(2013-1#1)
thoroughly studied##6##2##(1990-5#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#2)
thoroughly tested##2##2##(2008-10#1)(2011-1#1)
thoroughly##46##1##(1990-5#1)(1991-1#1)(1995-1#1)(1997-4#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#3)
thoroughness##4##1##(1990-6#1)(1995-12#1)(1996-1#1)(1997-3#1)
those achieved by the##3##4##(1993-6#1)(2008-10#1)(2008-12#1)
those achieved by##7##3##(1993-6#1)(2008-10#5)(2008-12#1)
those achieved using##3##3##(1991-3#1)(2008-10#2)
those achieved with##5##3##(1991-3#1)(2007-12#1)(2008-10#3)
those achieved##17##2##(1991-2#1)(1991-3#2)(1993-6#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-8#1)
those activities##2##2##(1994-2#1)(2011-2#1)
those adolescents with##2##3##(2011-1#1)(2012-12#1)
those affected by the##2##4##(2010-5#1)(2011-1#1)
those affected by##3##3##(2010-5#1)(2011-1#1)(2013-8#1)
those affected##7##2##(1993-2#1)(1995-1#1)(2008-1#1)(2010-5#1)(2011-1#1)(2013-8#2)
those affecting##2##2##(1994-12#1)(2008-10#1)
those after##2##2##(2007-8#1)(2008-8#1)
those against##2##2##(1993-8#1)(1993-9#1)
those aged##10##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1994-5#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
those agents that##2##3##(1990-2#1)(2008-5#1)
those already##3##2##(1990-11#1)(2008-2#1)(2009-8#1)
those animals that##2##3##(2008-5#2)
those animals##3##2##(2008-3#1)(2008-5#2)
those approaches##2##2##(2008-10#1)(2009-5#1)
those appropriate to##2##3##(2008-2#2)
those are##2##2##(2011-2#1)(2012-3#1)
those arising from##2##3##(1995-11#1)(2010-5#1)
those arising##3##2##(1994-3#1)(1995-11#1)(2010-5#1)
those aspects##2##2##(1991-12#1)(2011-1#1)
those associated with the##4##4##(1992-12#1)(2007-9#1)(2008-10#1)(2008-2#1)
those associated with##11##3##(1992-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
those at a##2##3##(1994-3#1)(2008-11#1)
those at risk##3##3##(1994-12#1)(2008-1#1)(2011-2#1)
those at the##9##3##(1993-2#1)(1994-12#1)(1996-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2013-8#1)
those at##30##2##(1992-11#1)(1992-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#2)
those attending##4##2##(1993-2#1)(1995-12#1)(2008-10#1)(2008-9#1)
those attitudes##2##2##(2007-7#1)(2008-12#1)
those based on the##2##4##(1997-4#1)(2013-8#1)
those based on##14##3##(1997-3#1)(1997-4#1)(2008-10#6)(2008-2#1)(2008-5#3)(2008-7#1)(2013-8#1)
those before the##2##3##(2007-5#1)(2008-10#1)
those before##5##2##(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)
those being##3##2##(2008-3#1)(2010-12#1)(2010-5#1)
those belonging to##2##3##(1993-3#1)(1996-12#1)
those between##6##2##(1995-6#1)(2007-5#1)(2008-9#1)(2009-10#3)
those born##3##2##(1992-2#1)(2008-11#1)(2011-1#1)
those by the##4##3##(2008-10#4)
those by##10##2##(2008-10#8)(2010-5#1)(2012-1#1)
those calculated from the##2##4##(1990-8#1)(2008-2#1)
those calculated from##3##3##(1990-8#1)(2008-2#1)(2008-5#1)
those calculated using##2##3##(1992-12#1)(2008-8#1)
those calculated##9##2##(1990-5#1)(1990-8#1)(1992-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#2)
those cases with##3##3##(1990-3#1)(1995-11#1)(2006-12#1)
those cases##11##2##(1990-3#1)(1994-9#1)(1995-11#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-4#1)
those caused by##12##3##(1991-9#1)(1996-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)
those cells##8##2##(1991-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-9#2)(2012-2#1)
those changes##3##2##(1993-1#1)(1993-12#1)(2007-11#1)
those characteristics##3##2##(1991-3#1)(2008-7#1)(2013-7#1)
those collected##7##2##(2008-10#4)(2008-3#1)(2009-4#1)(2012-3#1)
those coming from##2##3##(1992-3#1)(2008-10#1)
those common##2##2##(2008-10#1)(2008-7#1)
those commonly##3##2##(1990-9#1)(1995-12#1)(2007-7#1)
those compounds##3##2##(1995-12#1)(1997-4#1)(2008-10#1)
those computed by##3##3##(2008-3#3)
those concerning##4##2##(1992-12#1)(2008-5#1)(2008-7#2)
those conditions##5##2##(1993-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
those considered##2##2##(1990-5#1)(2009-2#1)
those consisting##2##2##(2007-12#1)(2008-5#1)
those containing##15##2##(1990-2#1)(1995-3#1)(1996-5#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-9#1)(2010-4#1)(2012-1#1)
those corresponding to##2##3##(2008-10#1)(2008-3#1)
those covered##2##2##(1996-2#1)(2008-5#1)
those cultured in##2##3##(2008-11#2)
those cultured##3##2##(2008-11#2)(2009-9#1)
those currently##5##2##(1994-1#1)(1994-3#1)(2008-10#2)(2008-11#1)
those data##3##2##(2008-5#1)(2008-7#1)(2011-1#1)
those derived from##5##3##(2008-10#3)(2008-3#1)(2010-7#1)
those derived##6##2##(2007-10#1)(2008-10#3)(2008-3#1)(2010-7#1)
those described for the other##2##5##(2008-5#2)
those described for the##4##4##(1994-11#1)(2008-5#2)(2011-2#1)
those described for##5##3##(1993-6#1)(1994-11#1)(2008-5#2)(2011-2#1)
those described in##4##3##(1995-11#1)(2006-10#1)(2008-10#1)(2012-3#1)
those described##15##2##(1990-6#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(2006-10#1)(2008-10#3)(2008-5#2)(2011-2#1)(2012-3#1)
those detected in##4##3##(1995-12#2)(2008-10#2)
those determined by the##3##4##(2008-10#2)(2011-2#1)
those determined by##7##3##(2008-10#4)(2008-3#2)(2011-2#1)
those determined using##3##3##(2008-10#3)
those determined##16##2##(1990-9#1)(1992-9#2)(1994-8#1)(2008-10#9)(2008-3#2)(2011-2#1)
those developing##2##2##(1992-12#1)(2009-12#1)
those diagnosed with##5##3##(2008-7#1)(2011-2#4)
those diagnosed##7##2##(2008-7#1)(2011-2#6)
those differences##3##2##(1991-9#1)(1994-12#1)(2008-10#1)
those discharged##3##2##(1995-3#2)(2008-10#1)
those diseases##5##2##(1996-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2010-4#1)
those drugs##2##2##(2007-8#1)(2011-1#1)
those due to##4##3##(1996-5#1)(2008-10#2)(2008-11#1)
those during##2##2##(1994-11#1)(2008-10#1)
those effects##5##2##(2007-7#1)(2008-2#1)(2011-2#2)(2013-7#1)
those elements##2##2##(2008-10#2)
those elicited by the##2##4##(1995-5#1)(2008-10#1)
those elicited by##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
those encoded by the##2##4##(1990-12#1)(2008-9#1)
those encoding the##2##3##(2008-10#1)(2008-11#1)
those encoding##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
those encountered in##2##3##(2006-6#1)(2012-2#1)
those engaged with##2##3##(2008-9#1)(2012-1#1)
those entities##2##2##(1991-3#1)(1991-8#1)
those estimated##3##2##(2008-10#3)
those evoked##2##2##(1996-5#1)(2012-12#1)
those expected for##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
those expected##6##2##(1996-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)
those expenses##2##2##(1991-9#1)(1992-12#1)
those experiencing##2##2##(2008-6#1)(2012-2#1)
those exposed to##9##3##(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#3)
those exposed##13##2##(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#5)
those expressed##2##2##(1992-10#1)(2008-9#1)
those extracted##2##2##(2008-10#1)(2012-8#1)
those factors##7##2##(1992-3#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-11#1)(2011-2#1)
those fed a##2##3##(2008-11#2)
those fed the##3##3##(2010-2#2)(2012-2#1)
those fed##8##2##(1990-7#1)(2008-11#2)(2008-6#1)(2010-2#2)(2012-12#1)(2012-2#1)
those findings##3##2##(2008-6#1)(2009-4#1)(2009-5#1)
those flanking the##2##3##(1991-6#1)(1994-5#1)
those following##2##2##(2008-10#1)(2008-7#1)
those for the reference method##2##5##(2008-10#2)
those for the tetrabutylammonium salts##2##5##(1995-5#2)
those for the##18##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1993-8#1)(1995-5#2)(1995-6#1)(1996-2#2)(1997-8#1)(2008-10#3)(2008-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
those for##58##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-3#1)(1993-8#1)(1995-3#1)(1995-5#2)(1995-6#4)(1996-2#2)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#6)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
those formed by##3##3##(1994-2#1)(2008-10#1)(2012-2#1)
those formed##5##2##(1994-2#1)(2008-10#1)(2010-11#1)(2012-2#2)
those found by##7##3##(2008-10#7)
those found in other##2##4##(2008-11#1)(2010-12#1)
those found in the##5##4##(1991-9#1)(1993-12#1)(2008-10#1)(2008-7#2)
those found in##21##3##(1990-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
those found on crabgrass##2##4##(2008-10#2)
those found on##5##3##(2008-10#4)(2008-5#1)
those found with##2##3##(2008-3#1)(2008-5#1)
those found##40##2##(1990-2#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
those from a##9##3##(1992-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
those from conventional##5##3##(2007-11#1)(2008-10#3)(2008-11#1)
those from mice##2##3##(2008-11#2)
those from normal##2##3##(1992-11#1)(1993-8#1)
those from other##5##3##(2007-11#1)(2008-10#3)(2008-6#1)
those from the##22##3##(1990-7#1)(1992-6#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
those from##98##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-6#2)(1996-12#2)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#33)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
those functions##2##2##(1996-2#1)(2011-2#1)
those generally##2##2##(1991-3#1)(2008-5#1)
those generated by##3##3##(1995-8#1)(2008-10#1)(2013-1#1)
those generated##5##2##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
those genes##6##2##(1994-5#1)(2008-10#3)(2008-7#1)(2012-3#1)
those given by the##4##4##(1994-9#1)(2008-10#2)(2008-3#1)
those given by##9##3##(1994-9#1)(2008-10#5)(2008-3#3)
those given##13##2##(1992-7#1)(1994-9#1)(1995-5#1)(2008-10#6)(2008-3#3)(2008-7#1)
those groups that##3##3##(1993-12#1)(1994-1#2)
those groups##6##2##(1993-12#2)(1994-1#2)(2008-7#1)(2009-7#1)
those grown in the##2##4##(2008-10#2)
those grown in##5##3##(1996-12#1)(2008-10#3)(2009-12#1)
those grown##9##2##(1993-6#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2009-12#1)
those having a##2##3##(1992-1#1)(2008-7#1)
those having##16##2##(1992-1#2)(1995-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#2)(2011-2#1)
those holding##2##2##(1993-2#1)(2010-8#1)
those identified by the##2##4##(1994-2#1)(2012-12#1)
those identified##6##2##(1991-2#1)(1992-12#1)(1994-2#1)(2008-10#1)(2010-4#1)(2012-12#1)
those implanted##2##2##(2008-9#2)
those imposed by the##3##4##(2011-2#1)(2012-2#2)
those imposed by##4##3##(1994-3#1)(2011-2#1)(2012-2#2)
those in Group 2##2##4##(2011-1#1)(2011-2#1)
those in Group I##2##4##(1992-11#1)(2013-1#1)
those in Group##5##3##(1992-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
those in a##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
those in control rats##3##4##(1995-11#1)(1995-3#1)(2007-10#1)
those in control##4##3##(1995-11#1)(1995-3#1)(2007-10#1)(2012-12#1)
those in group##2##3##(1996-3#1)(2010-7#1)
those in other##8##3##(1990-5#1)(1993-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-1#1)
those in our##2##3##(1994-11#1)(1997-3#1)
those in the control group##6##5##(2007-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
those in the control##8##4##(2007-11#1)(2008-12#1)(2008-9#2)(2011-1#1)(2011-2#2)(2013-8#1)
those in the group of##2##5##(2008-7#1)(2013-1#1)
those in the group##3##4##(1994-12#1)(2008-7#1)(2013-1#1)
those in the other##2##4##(1991-11#1)(2007-7#1)
those in the right##2##4##(1990-3#1)(1996-3#1)
those in the##83##3##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-7#2)(1997-3#2)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-3#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
those in which##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)
those in whom##2##3##(2008-11#1)(2008-7#1)
those in##211##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#3)(1997-3#4)(1997-6#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#34)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#10)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#3)(2013-8#3)
those included##2##2##(2008-10#1)(2013-1#1)
those individuals##2##2##(2007-7#1)(2009-5#1)
those induced by MHT##2##4##(2011-2#2)
those induced by the##2##4##(2008-10#1)(2008-8#1)
those induced by##18##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1995-5#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#2)
those infected with the##2##4##(1993-1#1)(1996-2#1)
those infected with##4##3##(1993-1#1)(1996-2#1)(2009-8#1)(2011-2#1)
those infected##7##2##(1993-1#1)(1996-2#1)(2008-10#2)(2009-5#1)(2009-8#1)(2011-2#1)
those injured##2##2##(1995-3#1)(2013-1#1)
those interested in##5##3##(1991-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
those investigators##2##2##(2008-2#1)(2008-4#1)
those involved in the##3##4##(2008-11#1)(2009-10#1)(2011-1#1)
those involved in##11##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-12#1)
those involved##15##2##(1994-1#1)(1995-8#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-12#2)
those involving the##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
those involving##12##2##(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
those isolated##3##2##(1992-11#1)(1992-9#1)(1996-6#1)
those issues##2##2##(1992-1#1)(2012-2#1)
those leading##2##2##(1991-4#1)(2012-12#1)
those lesions that##2##3##(2008-7#1)(2012-2#1)
those lesions##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
those likely to##2##3##(2008-5#1)(2011-2#1)
those lines##3##2##(2008-10#2)(2010-3#1)
those living in##3##3##(2008-10#2)(2013-1#1)
those living##4##2##(2008-10#2)(2013-1#2)
those low on##2##3##(2007-12#1)(2010-2#1)
those made by##2##3##(2008-10#1)(2008-3#1)
those made##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)
those managing##2##2##(1994-1#1)(2008-11#1)
those measured in##2##3##(1994-8#1)(1995-12#1)
those measured##7##2##(1990-11#1)(1990-8#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-3#1)
those mediated by type I AMPA receptors were##2##8##(1996-2#2)
those medical conditions##2##3##(2010-1#1)(2011-2#1)
those medical##4##2##(1991-3#1)(1995-12#1)(2010-1#1)(2011-2#1)
those modified##2##2##(2008-10#2)
those most##3##2##(1992-5#1)(2007-4#1)(2010-12#1)
those mothers##2##2##(2007-2#1)(2008-8#1)
those necessary##2##2##(1995-2#1)(2010-12#1)
those needing##3##2##(1994-1#1)(2008-12#1)(2011-2#1)
those needs##2##2##(1994-1#1)(2011-1#1)
those normally used##2##3##(2008-3#1)(2010-1#1)
those normally##3##2##(1994-9#1)(2008-3#1)(2010-1#1)
those not receiving##2##3##(2008-3#1)(2011-2#1)
those not registered##2##3##(1994-9#1)(2008-6#1)
those not##20##2##(1990-6#1)(1992-12#1)(1993-1#3)(1994-2#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
those now##2##2##(1992-2#1)(1992-6#1)
those observed after##3##3##(1995-5#1)(1997-2#1)(2008-5#1)
those observed during##2##3##(1994-3#1)(2013-7#1)
those observed for##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)
those observed in control##2##4##(1994-6#1)(2010-4#1)
those observed in the##8##4##(1996-2#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-2#1)
those observed in##29##3##(1990-12#1)(1990-5#1)(1991-5#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-8#2)(2006-10#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#2)
those observed with##4##3##(1992-12#1)(2008-10#2)(2012-3#1)
those observed##49##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#2)(1993-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#2)(2006-10#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-7#1)
those obtained at the##2##4##(2008-10#2)
those obtained at##5##3##(2007-11#1)(2008-10#3)(2008-5#1)
those obtained by HPLC##3##4##(2008-10#3)
those obtained by ICP-AES##4##4##(2008-10#4)
those obtained by a conventional##4##5##(2008-10#3)(2008-5#1)
those obtained by a##14##4##(2008-10#11)(2008-2#1)(2008-5#2)
those obtained by conventional##6##4##(2008-10#3)(2008-3#1)(2008-5#1)(2012-3#1)
those obtained by gas chromatography##2##5##(2008-10#2)
those obtained by high performance liquid chromatography (HPLC)##3##8##(2008-10#3)
those obtained by inductively coupled plasma##2##6##(2008-10#2)
those obtained by other authors using##2##6##(2008-7#2)
those obtained by other##5##4##(2008-10#2)(2008-5#1)(2008-7#2)
those obtained by the conventional##3##5##(2008-10#3)
those obtained by the reference##3##5##(2008-10#3)
those obtained by the standard##3##5##(2008-10#3)
those obtained by the traditional##2##5##(2008-10#1)(2008-11#1)
those obtained by the##42##4##(1990-8#1)(1997-7#1)(2008-10#37)(2008-11#2)(2012-2#1)
those obtained by using a##2##5##(2008-10#2)
those obtained by using the##3##5##(2008-10#2)(2010-4#1)
those obtained by using##6##4##(2008-10#5)(2010-4#1)
those obtained by##142##3##(1990-8#1)(1992-3#1)(1994-12#1)(1997-7#2)(2008-10#113)(2008-11#3)(2008-2#4)(2008-3#7)(2008-5#4)(2008-7#3)(2010-4#1)(2012-2#1)(2012-3#1)
those obtained for the##3##4##(1993-8#1)(2008-10#2)
those obtained for##7##3##(1993-8#1)(1995-5#1)(2008-10#4)(2009-3#1)
those obtained from a##3##4##(1994-11#1)(2008-10#2)
those obtained from the##2##4##(2008-10#2)
those obtained from##22##3##(1990-12#1)(1994-11#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
those obtained in a##4##4##(2008-10#1)(2008-11#2)(2013-1#1)
those obtained in our##2##4##(1994-2#1)(2008-3#1)
those obtained in the##5##4##(1995-12#1)(2008-10#3)(2008-3#1)
those obtained in vivo##2##4##(1990-8#1)(1993-9#1)
those obtained in##26##3##(1990-5#2)(1990-8#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#3)(2013-1#1)
those obtained on the##2##4##(2008-10#1)(2008-3#1)
those obtained on##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)
those obtained previously##3##3##(1992-3#1)(1993-11#1)(2008-10#1)
those obtained using a##7##4##(1990-8#1)(2008-10#6)
those obtained using the##7##4##(2008-10#6)(2008-5#1)
those obtained using##26##3##(1990-8#1)(1995-6#1)(2008-10#22)(2008-5#1)(2008-7#1)
those obtained with a##10##4##(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)
those obtained with other##2##4##(2007-11#1)(2008-10#1)
those obtained with the microscopic method##2##6##(2008-10#2)
those obtained with the standard##2##5##(2008-10#1)(2009-3#1)
those obtained with the##13##4##(2008-10#11)(2008-11#1)(2009-3#1)
those obtained with##53##3##(1992-6#1)(1994-9#1)(1996-8#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#36)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)
those obtained without##2##3##(2007-12#1)(2008-10#1)
those obtained##300##2##(1990-12#1)(1990-5#2)(1990-8#3)(1992-3#2)(1992-6#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#4)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#206)(2008-11#7)(2008-2#9)(2008-3#16)(2008-5#8)(2008-6#2)(2008-7#6)(2009-11#1)(2009-3#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
those occurring during##2##3##(2008-10#1)(2009-12#1)
those occurring##4##2##(1992-10#1)(2008-10#1)(2009-12#1)(2012-12#1)
those of ALDH3m##2##3##(1992-8#2)
those of Cu##2##3##(1995-3#1)(2008-10#1)
those of F##2##3##(2008-10#2)
those of H##2##3##(1997-6#1)(2008-8#1)
those of P##3##3##(2008-10#2)(2008-5#1)
those of PAH##2##3##(2008-11#2)
those of T##2##3##(1992-8#1)(2011-2#1)
those of TSWV and INSV##2##5##(2008-10#2)
those of WT##2##3##(2008-9#1)(2013-8#1)
those of a control##3##4##(1990-12#1)(1990-6#1)(2008-10#1)
those of a##26##3##(1990-12#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#11)(2008-2#1)(2008-3#1)(2012-2#2)(2013-1#1)
those of adult##2##3##(1993-3#1)(1997-7#1)
those of age-matched##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
those of all##2##3##(2008-10#1)(2008-4#1)
those of an##4##3##(2008-10#4)
those of another##2##3##(2008-10#2)
those of any##2##3##(2008-10#1)(2012-2#1)
those of authentic##2##3##(2008-10#2)
those of bovine##3##3##(1993-11#1)(1993-8#1)(1994-8#1)
those of carrageenan##2##3##(2008-7#2)
those of commercial##2##3##(2008-10#1)(2010-4#1)
those of control subjects##2##4##(2007-10#1)(2007-11#1)
those of control##8##3##(1993-1#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-10#1)
those of controls##4##3##(1991-6#1)(1996-11#1)(2008-7#1)(2008-9#1)
those of conventional##9##3##(1992-3#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)
those of earlier##2##3##(1996-7#1)(2007-12#1)
those of endogenous##2##3##(1990-8#1)(2008-10#1)
those of films##2##3##(2008-12#1)(2008-3#1)
those of glutathione reductase##2##4##(1992-1#2)
those of group II##3##4##(2008-10#3)
those of group##4##3##(2008-10#4)
those of healthy controls##2##4##(2009-8#1)(2013-8#1)
those of healthy##5##3##(1995-11#1)(2008-10#2)(2009-8#1)(2013-8#1)
those of human##4##3##(1991-3#1)(1992-6#1)(1993-5#1)(2008-10#1)
those of its##4##3##(1995-11#1)(1997-6#1)(2008-10#1)(2013-8#1)
those of known##2##3##(2008-10#2)
those of lathosterol##2##3##(1992-6#2)
those of mammalian##4##3##(1992-12#1)(1993-6#1)(1997-4#1)(1997-7#1)
those of morphine were##2##4##(1995-11#2)
those of native##4##3##(1991-9#1)(1993-8#1)(2008-5#1)(2008-8#1)
those of normal##6##3##(1994-12#1)(1994-2#1)(1996-12#1)(2008-3#1)(2008-5#1)(2010-11#1)
those of other fungal##3##4##(1997-2#2)(2008-10#1)
those of other known##2##4##(1990-2#1)(1997-6#1)
those of other tospoviruses##3##4##(2008-10#3)
those of other##46##3##(1990-11#1)(1990-2#1)(1990-3#1)(1992-11#1)(1993-11#1)(1994-5#1)(1995-5#1)(1996-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
those of others are##2##4##(1996-3#1)(2009-9#1)
those of pattern##2##3##(2008-5#2)
those of previous##7##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)(2011-2#1)
those of previously##3##3##(1993-11#1)(1996-7#1)(2007-11#1)
those of primary##2##3##(2008-5#1)(2013-8#1)
those of recent##3##3##(1997-6#1)(2007-11#1)(2008-7#1)
those of spheres##2##3##(2008-2#1)(2008-3#1)
those of the &quot##2##4##(1991-4#2)
those of the 15-##2##4##(1994-3#2)
those of the 25 degrees C-grown##3##6##(2008-5#3)
those of the control group##6##5##(1994-3#1)(2008-9#4)(2013-8#1)
those of the control groups##5##5##(2008-9#5)
those of the control##16##4##(1994-11#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#9)(2012-2#1)(2013-8#1)
those of the controls throughout##2##5##(2008-8#1)(2008-9#1)
those of the controls##11##4##(1992-9#1)(2008-10#1)(2008-8#3)(2008-9#6)
those of the conventional##3##4##(2008-10#2)(2010-4#1)
those of the corresponding##5##4##(1993-8#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-3#1)
those of the first##2##4##(2008-3#1)(2010-8#1)
those of the human##3##4##(1991-6#1)(1997-7#1)(2008-3#1)
those of the latter##2##4##(2008-2#1)(2008-8#1)
those of the more##2##4##(2008-3#1)(2008-8#1)
those of the normal controls##4##5##(2008-10#2)(2008-7#2)
those of the other##7##4##(1993-6#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
those of the parental##2##4##(1991-12#1)(2008-5#1)
those of the standard##2##4##(2008-12#1)(2010-11#1)
those of the vehicle control##4##5##(2008-9#4)
those of the vehicle controls throughout the study##2##8##(2008-9#2)
those of the vehicle controls##26##5##(2008-9#26)
those of the vehicle##30##4##(2008-9#30)
those of the wild type##2##5##(1997-8#1)(2013-8#1)
those of the wild-type##7##4##(1990-10#1)(1993-8#1)(1995-2#2)(2008-10#3)
those of the##234##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1991-11#2)(1991-12#2)(1991-4#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#3)(1995-3#1)(1995-5#4)(1995-8#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#16)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#46)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#4)
those of their##5##3##(1990-7#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-3#1)
those of tospoviruses##2##3##(2008-10#2)
those of two##3##3##(1997-4#1)(2008-10#1)(2009-4#1)
those of wild-type##6##3##(1992-1#1)(1993-11#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-8#1)
those of younger##2##3##(2008-11#1)(2010-4#1)
those of##791##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#7)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#3)(1991-9#2)(1992-1#5)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#6)(1992-6#6)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#10)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#7)(1995-12#1)(1995-2#9)(1995-3#4)(1995-5#8)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#2)(1997-2#10)(1997-3#2)(1997-4#6)(1997-6#11)(1997-7#9)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#11)(2007-12#16)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#177)(2008-11#16)(2008-12#9)(2008-2#12)(2008-3#42)(2008-4#3)(2008-5#25)(2008-6#7)(2008-7#23)(2008-8#22)(2008-9#55)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#4)(2010-2#3)(2010-3#1)(2010-4#8)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#7)(2011-2#20)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#8)
those on placebo##3##3##(1991-3#1)(2008-5#1)(2008-6#1)
those on the##6##3##(1996-6#1)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#1)
those on##28##2##(1991-3#1)(1993-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#4)(2008-6#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
those only##2##2##(2008-3#1)(2010-1#1)
those originating##3##2##(1990-8#1)(2008-10#1)(2008-6#1)
those oscillations##2##2##(2013-8#2)
those over##4##2##(1990-12#1)(1993-6#1)(2007-2#1)(2008-2#1)
those papers##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
those parameters##3##2##(1995-2#1)(2008-5#1)(2012-2#1)
those participants##3##2##(2011-1#1)(2012-1#1)(2013-7#1)
those pathways##2##2##(2010-4#1)(2012-3#1)
those patients at##2##3##(2011-2#1)(2013-1#1)
those patients that##3##3##(2012-1#3)
those patients who did not##2##5##(2007-10#1)(2011-2#1)
those patients who##10##3##(1991-2#1)(2007-10#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
those patients with##7##3##(1995-3#1)(2007-10#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
those patients##40##2##(1990-12#1)(1991-1#1)(1991-2#1)(1995-3#1)(1996-12#1)(2007-10#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#4)
those payers##2##2##(1992-1#1)(1994-12#1)
those people##2##2##(2008-7#1)(2013-1#1)
those performed##2##2##(1991-6#1)(1997-4#1)
those performing##3##2##(2008-10#2)(2008-4#1)
those persons##2##2##(2007-10#1)(2008-10#1)
those planning to##2##3##(1993-1#1)(2007-2#1)
those planning##4##2##(1993-1#1)(1995-1#1)(2007-2#1)(2012-2#1)
those plants##2##2##(2008-10#1)(2008-5#1)
those policies##2##2##(2008-12#1)(2012-3#1)
those policy##2##2##(1995-1#1)(2013-7#1)
those positive##2##2##(1990-11#1)(2009-11#1)
those predicted by the##2##4##(2008-3#1)(2008-8#1)
those predicted by##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#2)
those predicted##10##2##(1994-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)
those preferring eager strategies##3##4##(2009-9#3)
those preferring vigilant strategies##2##4##(2009-9#2)
those preferring##5##2##(2009-9#5)
those prepared##3##2##(2008-10#2)(2008-11#1)
those present in the##2##4##(2008-11#1)(2008-7#1)
those present in##4##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
those present##5##2##(1991-5#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
those presenting to the emergency department##2##6##(2007-10#1)(2008-3#1)
those presenting with acute##2##4##(2008-7#2)
those presenting with##4##3##(2008-1#2)(2008-7#2)
those presenting##10##2##(2007-10#2)(2008-1#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
those previous##2##2##(2007-11#1)(2008-5#1)
those previously obtained##2##3##(2008-10#2)
those previously reported in##2##4##(2008-10#1)(2008-9#1)
those previously reported##7##3##(1994-11#1)(1995-5#1)(2006-10#1)(2008-10#3)(2008-9#1)
those previously##16##2##(1991-12#1)(1991-6#1)(1994-11#1)(1995-5#1)(1995-6#1)(2006-10#1)(2008-10#6)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
those problems##6##2##(1997-1#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
those produced by##6##3##(1992-8#1)(1997-7#1)(2008-10#3)(2008-11#1)
those produced in##3##3##(2008-10#3)
those produced on##2##3##(2008-10#2)
those produced##11##2##(1992-8#1)(1997-7#1)(2008-10#8)(2008-11#1)
those programs##2##2##(1994-3#1)(2008-12#1)
those properties##2##2##(2011-1#1)(2012-2#1)
those proposed by the##2##4##(2008-2#1)(2013-1#1)
those proposed##3##2##(2008-12#1)(2008-2#1)(2013-1#1)
those proteins with##2##3##(2008-4#1)(2008-7#1)
those proteins##4##2##(1990-7#1)(2008-4#1)(2008-7#1)(2009-12#1)
those provided by the##5##4##(2008-10#3)(2008-4#2)
those provided by##8##3##(2008-10#5)(2008-3#1)(2008-4#2)
those providing##3##2##(2007-2#1)(2008-12#1)(2010-10#1)
those publications##2##2##(1995-8#1)(2010-7#1)
those receiving##11##2##(1993-9#1)(1994-12#1)(1995-4#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
those recently##4##2##(1991-11#1)(1993-3#1)(1996-12#1)(2008-2#1)
those recorded in##2##3##(1994-6#1)(2010-8#1)
those recorded##4##2##(1994-6#1)(1997-5#1)(2008-10#1)(2010-8#1)
those regions that##2##3##(1994-2#1)(2010-4#1)
those regions##6##2##(1991-6#1)(1991-9#1)(1994-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
those regulated##2##2##(1993-5#1)(1997-2#1)
those regulating##2##2##(1996-2#1)(2008-6#1)
those related to the##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)
those related to##10##3##(1991-6#1)(1995-6#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
those related##11##2##(1991-6#1)(1995-6#1)(2008-10#1)(2008-7#3)(2008-8#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
those relationships##2##2##(1997-1#2)
those released##3##2##(2008-11#2)(2008-4#1)
those reported by##4##3##(1994-5#1)(2008-10#3)
those reported for other##2##4##(1991-8#1)(2008-5#1)
those reported for##5##3##(1991-8#1)(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
those reported from other##2##4##(2008-1#1)(2010-6#1)
those reported in literature##2##4##(2008-10#2)
those reported in the literature##6##5##(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
those reported in##14##3##(1991-3#1)(1993-12#1)(1995-12#1)(1997-2#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2012-2#1)
those reported previously##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
those reported recently##2##3##(2007-11#1)(2008-10#1)
those reported##36##2##(1991-3#1)(1991-8#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-12#2)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
those reporting##3##2##(2008-12#1)(2008-5#1)(2010-8#1)
those required for##4##3##(1994-3#1)(2007-11#1)(2009-8#1)(2013-1#1)
those required to inhibit##2##4##(1990-7#1)(1995-2#1)
those required to##5##3##(1990-7#1)(1992-11#1)(1995-2#1)(1997-7#1)(2008-10#1)
those required##11##2##(1990-7#1)(1992-11#1)(1994-3#2)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
those residues##3##2##(1990-7#1)(1997-8#1)(2012-2#1)
those resources##2##2##(2008-7#2)
those respondents##2##2##(2009-11#1)(2009-4#1)
those responsible for##2##3##(1991-12#1)(2006-6#1)
those resulting from##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
those resulting##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
those results##4##2##(2006-10#1)(2008-10#1)(2008-3#2)
those same##2##2##(1990-2#1)(1997-3#1)
those samples that were##2##4##(2008-10#1)(2008-3#1)
those samples that##4##3##(2008-10#3)(2008-3#1)
those samples##6##2##(2008-10#5)(2008-3#1)
those seeking##4##2##(1992-1#1)(1995-12#1)(2008-1#1)(2011-2#1)
those seen in the##5##4##(1994-5#1)(1996-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
those seen in##9##3##(1990-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
those seen with##6##3##(2006-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
those seen##21##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2011-2#1)(2012-3#2)
those sent by their TD peers##2##6##(2012-3#2)
those services##2##2##(1993-12#1)(1997-2#1)
those showing##2##2##(2008-7#1)(2009-8#1)
those shown##2##2##(1997-4#1)(2007-9#1)
those sites##2##2##(2008-12#1)(2008-5#1)
those species##6##2##(1997-4#1)(2008-10#3)(2008-8#1)(2010-4#1)
those specimens##3##2##(2009-4#1)(2009-7#1)(2013-8#1)
those stimuli that act &quot##2##5##(1997-1#2)
those stored at##2##3##(2008-10#1)(2012-2#1)
those studies##6##2##(1993-11#1)(1996-12#2)(2008-2#1)(2008-4#1)(2009-4#1)
those subjects with##2##3##(1991-5#2)
those subjects##6##2##(1991-5#2)(1992-3#1)(1995-4#1)(1997-6#1)(2008-12#1)
those suffering from##2##3##(1992-11#1)(2008-7#1)
those surveyed##3##2##(1995-12#1)(1997-3#1)(2008-1#1)
those taken at the end of R-5 or##2##8##(1997-4#2)
those taken by##2##3##(2007-10#1)(2010-7#1)
those taken##5##2##(1997-4#2)(2007-10#1)(2008-10#1)(2010-7#1)
those targeting##2##2##(2008-10#1)(2009-12#1)
those teams##2##2##(1995-2#1)(2011-1#1)
those techniques that##2##3##(2008-7#1)(2010-12#1)
those tested##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
those that appear##2##3##(2009-3#1)(2011-2#1)
those that applied##2##3##(2008-10#2)
those that are##16##3##(1992-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
those that arise##2##3##(1997-2#1)(2012-2#1)
those that bind only##2##4##(1997-3#2)
those that can be##2##4##(2008-2#1)(2008-7#1)
those that can##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
those that did not##4##4##(2007-10#1)(2007-11#1)(2007-12#1)(2011-2#1)
those that do not##3##4##(1994-2#1)(1997-3#1)(2008-12#1)
those that had##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
those that have##7##3##(1993-12#1)(1993-3#1)(1996-2#1)(2008-10#2)(2009-10#1)(2009-3#1)
those that occur##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
those that received##2##3##(1995-5#1)(2008-10#1)
those that represent##2##3##(2007-2#1)(2009-11#1)
those that respond##2##3##(2012-2#2)
those that use##2##3##(2008-3#1)(2008-9#1)
those that were not##2##4##(2008-7#1)(2008-9#1)
those that were##8##3##(1992-6#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)
those that would##2##3##(1993-3#1)(2008-9#1)
those that##114##2##(1991-5#2)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#4)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#4)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#12)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#2)(2009-3#4)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
those three populations##2##3##(2008-10#1)(2011-1#1)
those three##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
those to##3##2##(1996-5#1)(2008-8#1)(2010-4#1)
those traditionally##2##2##(2008-9#1)(2012-12#1)
those treated with primary PCI##2##5##(2008-3#2)
those treated with##17##3##(1991-3#1)(1993-2#2)(1995-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#3)(2012-12#1)
those treated##23##2##(1991-3#1)(1992-9#1)(1993-2#2)(1995-12#1)(1995-5#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#2)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
those two##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
those under##4##2##(1991-12#1)(1993-2#1)(2008-10#1)(2011-2#1)
those undergoing##3##2##(1991-3#1)(2008-7#2)
those used for##3##3##(1990-11#1)(2008-11#1)(2011-2#1)
those used in a##2##4##(2007-12#1)(2008-7#1)
those used in the##3##4##(2008-11#1)(2009-3#1)(2010-3#1)
those used in##10##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)
those used##15##2##(1990-11#1)(1994-8#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2011-2#1)
those using other##2##3##(1997-3#1)(2011-2#1)
those using the##2##3##(1993-2#1)(2010-6#1)
those using##13##2##(1992-1#1)(1993-2#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
those values##2##2##(1993-12#1)(2008-2#1)
those variables##2##2##(1992-6#1)(2008-8#1)
those were##5##2##(2008-10#2)(2008-12#1)(2010-8#1)(2012-2#1)
those where##4##2##(1992-6#1)(2008-9#1)(2009-7#1)(2010-5#1)
those which are##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2013-8#1)
those which had##2##3##(1992-2#1)(2013-8#1)
those which##15##2##(1992-2#1)(1994-2#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#2)
those who are not##2##4##(1995-12#1)(2008-11#1)
those who are##20##3##(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
those who can##2##3##(1996-2#1)(2008-3#1)
those who continued##2##3##(1991-3#1)(2008-11#1)
those who did not##10##4##(1990-11#1)(1993-3#1)(2007-10#2)(2007-2#2)(2007-7#1)(2008-11#1)(2008-7#1)(2013-1#1)
those who did##11##3##(1990-11#1)(1993-3#2)(2007-10#2)(2007-2#2)(2007-7#1)(2008-11#1)(2008-7#1)(2013-1#1)
those who do not##4##4##(2007-10#1)(2008-4#1)(2009-12#1)(2011-2#1)
those who do##6##3##(1994-3#1)(2007-10#1)(2008-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
those who engaged in##2##4##(2009-10#1)(2013-1#1)
those who had no##2##4##(2008-11#1)(2012-3#1)
those who had not##5##4##(1993-1#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-9#1)
those who had##23##3##(1990-6#1)(1993-1#1)(1993-3#1)(1995-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#3)
those who have##8##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
those who initiated PT on##2##5##(2012-2#2)
those who made##2##3##(1992-1#1)(2009-10#1)
those who need to##2##4##(1993-2#1)(2008-3#1)
those who need##4##3##(1991-3#1)(1993-2#1)(1995-1#1)(2008-3#1)
those who never##4##3##(1990-8#1)(1996-1#1)(2009-5#2)
those who received them##2##4##(1990-6#1)(1993-3#1)
those who received##6##3##(1990-6#2)(1991-4#1)(1993-3#1)(2008-11#1)(2008-6#1)
those who reported##3##3##(1993-1#1)(1994-1#1)(2013-8#1)
those who take##2##3##(1995-1#1)(2008-11#1)
those who were not##3##4##(1992-2#1)(2007-2#2)
those who were##21##3##(1990-2#1)(1992-2#2)(1993-1#1)(1993-3#1)(1997-8#1)(2007-2#2)(2008-1#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
those who wish to##2##4##(1991-12#1)(1991-5#1)
those who work##3##3##(1996-12#1)(2010-10#1)(2013-1#1)
those who##192##2##(1990-11#1)(1990-2#1)(1990-6#4)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#7)(1994-1#4)(1994-12#1)(1994-2#2)(1994-3#4)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#6)(2007-7#3)(2008-1#5)(2008-10#3)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#4)
those whose##11##2##(1992-3#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
those wishing to##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
those with 1##2##3##(2008-10#1)(2008-11#1)
those with LBP##2##3##(2012-12#1)(2012-2#1)
those with a history of##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
those with a normal##2##4##(2008-10#1)(2008-5#1)
those with a positive##2##4##(2008-9#1)(2010-8#1)
those with a##27##3##(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
those with an##7##3##(1991-8#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
those with atherosclerotic##2##3##(2007-10#1)(2013-8#1)
those with chronic##2##3##(2008-1#1)(2012-3#1)
those with conventional##2##3##(2007-11#1)(2010-3#1)
those with darker##2##3##(2010-8#2)
those with early##2##3##(2009-8#1)(2011-2#1)
those with effect##2##3##(2008-7#1)(2012-3#1)
those with family##2##3##(2008-7#1)(2010-11#1)
those with high##2##3##(2008-12#1)(2012-2#1)
those with higher##8##3##(1991-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
those with hypertension##2##3##(2008-8#1)(2013-1#1)
those with known##2##3##(2008-11#1)(2013-8#1)
those with low##6##3##(1991-2#1)(1994-8#1)(2007-7#1)(2008-1#1)(2009-2#1)(2011-1#1)
those with no##9##3##(1991-2#1)(1993-1#1)(1994-2#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2013-8#1)
those with normal##7##3##(1990-2#2)(1991-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
those with physical illnesses##2##4##(2009-4#1)(2010-12#1)
those with positive##2##3##(1993-3#1)(2012-2#1)
those with primary##3##3##(2008-6#2)(2013-1#1)
those with severe##2##3##(2008-7#1)(2010-5#1)
those with stable##2##3##(1990-2#1)(1994-8#1)
those with strong##3##3##(1993-12#2)(1996-2#1)
those with the##10##3##(1990-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2012-2#2)
those with various##2##3##(2008-3#1)(2008-7#1)
those with very##2##3##(2010-11#1)(2011-1#1)
those with##270##2##(1990-12#1)(1990-2#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#5)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-8#4)(1994-9#1)(1995-3#6)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#9)(2008-10#17)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#21)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#4)(2011-1#7)(2011-2#15)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#5)
those without a##2##3##(2008-9#1)(2013-8#1)
those without previous##2##3##(1996-12#1)(2013-8#1)
those without thyroid disorders##2##4##(2013-1#2)
those without##39##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#5)
those working in##3##3##(2008-12#1)(2008-5#1)(2011-2#1)
those working##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
those##3815##1##(1990-10#1)(1990-11#11)(1990-12#15)(1990-2#18)(1990-3#6)(1990-5#18)(1990-6#11)(1990-7#9)(1990-8#18)(1990-9#10)(1991-1#5)(1991-10#1)(1991-11#7)(1991-12#27)(1991-2#13)(1991-3#19)(1991-4#6)(1991-5#15)(1991-6#14)(1991-7#1)(1991-8#5)(1991-9#9)(1992-1#17)(1992-10#4)(1992-11#12)(1992-12#18)(1992-2#9)(1992-3#25)(1992-4#1)(1992-5#1)(1992-6#19)(1992-7#1)(1992-8#12)(1992-9#11)(1993-1#13)(1993-11#15)(1993-12#21)(1993-2#17)(1993-3#24)(1993-5#3)(1993-6#9)(1993-8#15)(1993-9#14)(1994-1#14)(1994-11#11)(1994-12#29)(1994-2#21)(1994-3#28)(1994-5#12)(1994-6#5)(1994-7#2)(1994-8#20)(1994-9#9)(1995-1#9)(1995-11#14)(1995-12#28)(1995-2#19)(1995-3#26)(1995-4#2)(1995-5#22)(1995-6#17)(1995-8#10)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#27)(1996-2#26)(1996-3#10)(1996-4#1)(1996-5#13)(1996-6#4)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#7)(1997-2#23)(1997-3#26)(1997-4#23)(1997-5#4)(1997-6#20)(1997-7#21)(1997-8#14)(2006-10#11)(2006-12#2)(2006-6#3)(2007-10#31)(2007-11#45)(2007-12#56)(2007-2#19)(2007-4#2)(2007-5#4)(2007-6#6)(2007-7#17)(2007-8#14)(2007-9#3)(2008-1#40)(2008-10#806)(2008-11#114)(2008-12#53)(2008-2#67)(2008-3#142)(2008-4#35)(2008-5#114)(2008-6#40)(2008-7#143)(2008-8#77)(2008-9#124)(2009-10#13)(2009-11#9)(2009-12#10)(2009-2#6)(2009-3#13)(2009-4#15)(2009-5#20)(2009-6#11)(2009-7#17)(2009-8#18)(2009-9#11)(2010-1#9)(2010-10#11)(2010-11#12)(2010-12#13)(2010-2#8)(2010-3#17)(2010-4#26)(2010-5#12)(2010-6#8)(2010-7#7)(2010-8#25)(2010-9#1)(2011-1#50)(2011-2#138)(2011-3#2)(2012-1#18)(2012-12#46)(2012-2#66)(2012-3#49)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#80)(2013-7#14)(2013-8#46)
though a number of##2##4##(1997-4#1)(2008-12#1)
though a##10##2##(1991-8#1)(1992-6#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
though an##3##2##(2008-2#1)(2008-7#1)(2013-8#1)
though at##2##2##(1993-6#1)(2012-1#1)
though in##2##2##(1993-3#1)(2008-10#1)
though it has lower##2##4##(2008-9#1)(2012-12#1)
though it has##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
though it is possible that##2##5##(1991-6#1)(2011-2#1)
though it is##9##3##(1991-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
though it was##3##3##(1991-1#1)(1992-6#1)(2008-10#1)
though it##29##2##(1991-1#1)(1991-5#1)(1991-6#1)(1992-6#1)(1994-3#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-8#1)(2013-8#1)
though its##3##2##(2007-12#1)(2008-5#1)(2009-6#1)
though less##2##2##(2008-10#1)(2012-3#1)
though modestly##2##2##(1992-3#1)(2010-5#1)
though more##4##2##(1993-1#1)(1994-3#1)(2011-2#1)(2013-1#1)
though most##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
though no##2##2##(1997-4#1)(2007-11#1)
though not statistically significant##2##4##(2008-10#1)(2010-3#1)
though not##9##2##(1992-5#1)(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)
though often##2##2##(2007-4#1)(2009-8#1)
though only##2##2##(2008-10#1)(2010-2#1)
though rare##2##2##(2011-2#2)
though results##2##2##(1997-1#1)(2009-5#1)
though similar##2##2##(2010-4#1)(2011-2#1)
though some##2##2##(2008-10#1)(2008-12#1)
though the number of##2##4##(1995-6#1)(2007-8#1)
though the two##2##3##(2007-7#1)(2013-8#1)
though the##62##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-2#3)(1997-7#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#1)
though there is some evidence that##2##6##(1993-1#1)(2007-2#1)
though there is##5##3##(1993-1#1)(1997-1#1)(2007-2#1)(2008-1#1)(2013-8#1)
though there##8##2##(1991-1#1)(1993-1#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-5#1)(2013-8#2)
though these##4##2##(1991-12#1)(1991-3#1)(2009-7#1)(2012-2#1)
though they##8##2##(1993-12#1)(1993-2#1)(1993-5#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-10#1)
though this##11##2##(1993-3#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-6#2)(2008-10#1)(2009-11#1)(2010-8#2)(2012-2#1)
though to a##2##3##(2008-10#1)(2013-1#1)
though to##6##2##(1992-5#1)(1993-8#1)(1994-3#1)(1997-4#1)(2008-10#1)(2013-1#1)
though unlikely##2##2##(1994-11#1)(2011-2#1)
though with##2##2##(1990-3#1)(2012-2#1)
though##322##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#3)(1992-6#3)(1992-9#3)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#5)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#4)(1997-7#3)(1997-8#3)(2007-10#4)(2007-11#8)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#49)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#2)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#13)(2012-3#1)(2012-8#1)(2013-1#7)(2013-7#2)(2013-8#7)
thought about##3##2##(2008-6#1)(2008-7#1)(2010-10#1)
thought and##11##2##(1993-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-8#2)
thought as##4##2##(2010-8#1)(2012-2#1)(2012-3#2)
thought experiments##2##2##(1992-3#1)(2008-8#1)
thought in##6##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-5#1)
thought intrusion##2##2##(2012-3#2)
thought of as##5##3##(1997-7#1)(2008-10#2)(2008-5#1)(2010-8#1)
thought of##9##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)
thought on##2##2##(2006-12#1)(2011-3#1)
thought processes##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
thought suppression and cognitive##2##4##(2009-11#2)
thought suppression and##3##3##(2009-11#2)(2012-3#1)
thought suppression##9##2##(2009-11#5)(2012-3#4)
thought that a##3##3##(2007-5#1)(2008-5#1)(2010-12#1)
thought that the##7##3##(1990-2#1)(1990-3#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-3#1)(2011-2#1)
thought that##25##2##(1990-2#2)(1990-3#1)(1990-6#1)(1991-9#1)(1993-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
thought the##3##2##(1996-1#1)(2008-9#1)(2013-1#1)
thought they were##2##3##(2008-10#1)(2011-2#1)
thought they##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
thought to act as an##2##5##(1990-7#1)(2008-4#1)
thought to act as##4##4##(1990-7#1)(1996-12#1)(2008-4#1)(2012-2#1)
thought to act##5##3##(1990-7#1)(1993-9#1)(1996-12#1)(2008-4#1)(2012-2#1)
thought to be a##14##4##(1992-11#1)(1995-12#1)(1995-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)
thought to be also##2##4##(1996-2#1)(2008-11#1)
thought to be an##5##4##(1991-7#1)(1993-3#2)(2011-2#1)(2012-12#1)
thought to be associated with##3##5##(1994-11#1)(2008-11#1)(2008-5#1)
thought to be caused by##2##5##(1990-11#1)(2009-6#1)
thought to be due to##3##5##(1990-6#1)(2011-1#1)(2012-2#1)
thought to be due##4##4##(1990-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
thought to be important##5##4##(1990-11#1)(1997-4#1)(2008-7#1)(2008-8#2)
thought to be initiated by##3##5##(2008-11#1)(2008-4#2)
thought to be involved in the##4##6##(1993-9#1)(1994-6#1)(2008-10#1)(2008-8#1)
thought to be involved in##7##5##(1993-9#1)(1994-6#1)(1995-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
thought to be involved##9##4##(1993-9#1)(1994-6#1)(1995-8#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-10#1)
thought to be mediated##2##4##(2008-4#1)(2008-8#1)
thought to be of importance##3##5##(2006-6#1)(2011-2#2)
thought to be of##4##4##(2006-6#1)(2011-2#2)(2013-1#1)
thought to be responsible for##2##5##(1990-5#1)(2008-10#1)
thought to be secondary to##2##5##(1991-9#1)(2008-1#1)
thought to be the cause of##2##6##(1990-11#1)(2008-7#1)
thought to be the major##2##5##(2008-7#1)(2010-12#1)
thought to be the only##2##5##(1994-9#1)(2010-12#1)
thought to be the##11##4##(1990-11#1)(1991-8#1)(1993-6#1)(1994-9#1)(2007-10#1)(2008-11#1)(2008-7#2)(2010-12#2)(2012-12#1)
thought to be useful##2##4##(1993-1#1)(2008-11#1)
thought to be##122##3##(1990-11#3)(1990-5#3)(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-1#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#9)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#6)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
thought to belong to##2##4##(1992-3#1)(2008-9#1)
thought to contribute to the##2##5##(2008-10#1)(2008-5#1)
thought to contribute to##5##4##(2008-10#1)(2008-5#1)(2008-7#2)(2012-2#1)
thought to exist##2##3##(1990-8#1)(2008-10#1)
thought to function##2##3##(2008-9#1)(2009-3#1)
thought to have a##2##4##(1997-1#1)(2012-3#1)
thought to have##6##3##(1993-9#1)(1995-3#1)(1997-1#1)(2008-9#1)(2010-6#1)(2012-3#1)
thought to involve the red nucleus##2##6##(1992-11#2)
thought to involve##7##3##(1991-12#1)(1992-11#2)(2008-5#1)(2008-9#1)(2009-1#1)(2013-8#1)
thought to mediate##2##3##(1995-2#1)(2008-6#1)
thought to modify##2##3##(1995-2#2)
thought to occur##6##3##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
thought to play a role in##2##6##(1993-3#1)(1995-12#1)
thought to play a##8##4##(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
thought to play an important role in##4##7##(1995-8#1)(2008-4#1)(2008-5#1)(2010-11#1)
thought to play important roles in##3##6##(2009-2#1)(2010-11#1)(2011-2#1)
thought to play important##4##4##(2009-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
thought to play##16##3##(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-11#2)(2011-2#2)(2013-1#1)
thought to reflect the##3##4##(1997-1#1)(2008-2#1)(2009-9#1)
thought to represent the##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
thought to represent##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
thought to result from##7##4##(1995-6#1)(1996-9#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)
thought to result##8##3##(1995-6#1)(1996-9#1)(1997-8#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)
thought to underlie##2##3##(2009-8#1)(2013-8#1)
thought to work##2##3##(2008-5#1)(2013-1#1)
thought to##248##2##(1990-11#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#5)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-12#3)(1995-2#5)(1995-3#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#18)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#15)(2008-6#7)(2008-7#13)(2008-8#11)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
thought was##2##2##(1994-2#1)(2010-5#1)
thought were##2##2##(2008-12#1)(2010-4#1)
thought##382##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#5)(1992-12#2)(1992-3#3)(1992-4#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#4)(1995-2#5)(1995-3#4)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#24)(2008-11#20)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#9)(2008-5#20)(2008-6#10)(2008-7#14)(2008-8#13)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#12)(2013-1#13)(2013-7#2)(2013-8#10)
thoughtful##7##1##(1992-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
thoughtfully##2##1##(1992-3#1)(2011-2#1)
thoughts about##7##2##(1991-12#1)(2008-2#1)(2009-7#1)(2010-10#2)(2010-11#1)(2011-2#1)
thoughts and behaviors##3##3##(2008-11#2)(2009-9#1)
thoughts and feelings about physical activity and##2##7##(2009-6#2)
thoughts and feelings##4##3##(2009-6#2)(2012-12#1)(2013-1#1)
thoughts and##11##2##(2008-11#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
thoughts on how##2##3##(1997-3#1)(2010-11#1)
thoughts on##6##2##(1992-4#1)(1993-2#1)(1995-1#1)(1997-3#1)(2008-6#1)(2010-11#1)
thoughts##40##1##(1991-12#1)(1992-4#1)(1993-2#2)(1995-1#2)(1995-12#1)(1996-9#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
thousand in##6##2##(2012-3#2)(2013-7#4)
thousand##58##1##(1990-12#2)(1992-6#1)(1994-2#1)(1995-6#2)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#2)(2008-5#3)(2008-7#6)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-7#4)
thousands of genes in##2##4##(2008-7#1)(2011-3#1)
thousands of genes simultaneously##2##4##(2008-10#1)(2008-7#1)
thousands of genes##6##3##(2008-10#1)(2008-4#1)(2008-7#3)(2011-3#1)
thousands of people##2##3##(2008-10#1)(2008-7#1)
thousands of##53##2##(1991-2#1)(1992-11#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#3)
thousands##56##1##(1991-2#1)(1992-11#1)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#3)
thread##10##1##(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
threaded##4##1##(2007-8#3)(2012-3#1)
threadfin Eleutheronema tetradactylum##2##3##(2010-8#2)
threads##4##1##(1991-2#1)(1993-12#1)(2011-1#1)(2012-3#1)
threat because of the##2##4##(1995-11#1)(2008-11#1)
threat for##3##2##(2008-1#1)(2008-12#1)(2012-12#1)
threat from##2##2##(2008-10#1)(2008-8#1)
threat in the##4##3##(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
threat in##8##2##(2007-12#1)(2008-4#1)(2009-10#1)(2011-1#2)(2011-2#2)(2013-8#1)
threat of##19##2##(1991-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-5#1)(2007-2#1)(2008-10#5)(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
threat processing##2##2##(2012-2#2)
threat stimuli##3##2##(2008-4#1)(2009-4#2)
threat to health##3##3##(1997-5#1)(2008-3#1)(2013-8#1)
threat to lettuce##2##3##(2008-10#2)
threat to public health##3##4##(2007-2#1)(2010-4#1)(2013-1#1)
threat to the local people##2##5##(2008-7#2)
threat to the##12##3##(1992-1#1)(1994-1#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-7#2)(2009-5#1)(2011-2#2)(2012-2#1)
threat to##40##2##(1990-2#1)(1990-6#1)(1992-1#1)(1993-6#1)(1994-1#1)(1996-3#1)(1997-3#1)(1997-5#2)(2007-2#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
threat was##3##2##(1996-12#1)(2010-1#1)(2012-2#1)
threat##115##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-3#1)(1992-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#3)(2007-12#2)(2007-2#3)(2007-7#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#2)
threat-related and##3##2##(2008-2#3)
threat-related information##2##2##(2008-2#1)(2012-2#1)
threat-related##6##1##(2008-2#4)(2012-2#2)
threaten the##4##2##(1995-6#1)(1996-2#1)(2007-2#1)(2008-11#1)
threaten to##4##2##(1994-12#1)(1996-8#1)(2008-3#1)(2008-7#1)
threaten##14##1##(1994-12#1)(1995-6#1)(1996-2#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
threatened by the##2##3##(2008-10#1)(2013-1#1)
threatened by##5##2##(1995-2#1)(2008-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
threatened species##2##2##(2013-1#1)(2013-7#1)
threatened the##3##2##(2008-10#1)(2008-4#1)(2010-1#1)
threatened##31##1##(1990-12#1)(1990-2#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
threatening disease##2##2##(2007-2#1)(2011-1#1)
threatening##40##1##(1992-11#1)(1994-12#1)(1995-5#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-12#2)(2008-8#1)(2009-11#2)(2009-4#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
threatening)##2##1##(2008-2#1)(2013-1#1)
threatens the##7##2##(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-3#1)
threatens##12##1##(1995-3#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-3#1)
threats from##2##2##(2008-10#2)
threats in the##2##3##(2008-10#1)(2010-12#1)
threats of##2##2##(2008-10#2)
threats or##2##2##(1991-2#1)(1993-1#1)
threats to hospital##2##3##(1997-2#1)(2008-11#1)
threats to##12##2##(1991-3#1)(1992-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
threats##32##1##(1991-1#2)(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
three &quot##3##2##(1991-2#1)(1991-3#1)(1996-1#1)
three (2##2##2##(2008-1#1)(2012-2#1)
three (3##3##2##(2007-8#1)(2008-1#2)
three (5%)##3##2##(2008-1#2)(2008-3#1)
three 2-min exposures to##2##4##(1994-3#2)
three Army##2##2##(2012-2#2)
three B##4##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
three Chinese##2##2##(2008-10#1)(2008-12#1)
three DNA##5##2##(2008-10#2)(2008-7#2)(2008-8#1)
three E##2##2##(1997-7#1)(2011-2#1)
three European oak species (Quercus robur##2##6##(2012-5#1)(2012-7#1)
three F(2)##2##2##(2008-10#2)
three Finnish patients##2##3##(1991-7#2)
three Finnish##3##2##(1991-7#3)
three French##2##2##(2008-10#2)
three Fusarium species##2##3##(2008-10#2)
three MEKA-like proteins##2##3##(1993-3#2)
three QTL##2##2##(2008-10#1)(2012-3#1)
three QTLs for##2##3##(2008-8#1)(2008-9#1)
three RAPD markers##2##3##(2008-10#1)(2008-5#1)
three T-flask tests##2##3##(2008-11#2)
three abamectin resistance-correlated oligonucleotides##2##4##(2011-2#2)
three active##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
three activities##2##2##(1992-12#1)(1997-3#1)
three additional##8##2##(1991-8#1)(1994-8#1)(1995-12#1)(2008-10#4)(2012-2#1)
three affected##2##2##(1997-7#1)(2011-2#1)
three after##4##2##(1995-3#1)(1997-8#2)(2012-3#1)
three age groups##3##3##(1994-11#1)(2008-7#2)
three agents##7##2##(2008-10#6)(2008-7#1)
three ages##2##2##(1996-2#1)(2008-10#1)
three alternative##3##2##(1992-12#1)(2009-3#1)(2012-2#1)
three amino acid residues of##2##5##(2008-11#1)(2008-8#1)
three amino acid residues##4##4##(1993-11#1)(2008-11#1)(2008-8#2)
three amino acid##7##3##(1992-3#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
three amino##8##2##(1991-9#1)(1992-3#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
three amphiphilic forms##2##3##(1990-5#2)
three analogues##2##2##(1992-6#1)(2013-1#1)
three analyses##2##2##(2008-10#1)(2008-2#1)
three analytes##12##2##(2008-10#12)
three and a half months##2##5##(1990-6#1)(2008-9#1)
three and a half##3##4##(1990-6#1)(2008-4#1)(2008-9#1)
three and five year##2##4##(2008-1#2)
three and five##4##3##(2008-1#2)(2008-9#1)(2009-8#1)
three and four##4##3##(1990-8#1)(2007-7#1)(2008-10#1)(2013-8#1)
three and six months after##2##5##(1993-3#1)(2011-2#1)
three and six##4##3##(1993-3#1)(1997-3#1)(2008-5#1)(2011-2#1)
three and two##5##3##(2006-6#1)(2007-7#1)(2008-10#2)(2008-3#1)
three and##28##2##(1990-6#1)(1990-8#1)(1993-3#1)(1997-3#1)(2006-6#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-8#1)
three animals##2##2##(2007-8#1)(2011-2#1)
three antibiotics##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
three antibodies##4##2##(1990-12#1)(1994-9#1)(1995-12#1)(1996-12#1)
three antigens##2##2##(2008-5#1)(2013-8#1)
three approaches##6##2##(2008-10#3)(2008-6#2)(2012-2#1)
three are##7##2##(1995-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#2)(2012-3#1)
three areas in the##2##4##(2008-10#1)(2008-12#1)
three areas##6##2##(1992-2#1)(1993-12#1)(2008-10#1)(2008-12#2)(2008-9#1)
three arsenic species in##2##4##(2008-10#2)
three arsenic species##3##3##(2008-10#3)
three articles##4##2##(1996-12#1)(1996-3#1)(2011-2#1)(2012-12#1)
three aspects of##4##3##(2007-12#1)(2012-3#2)(2013-1#1)
three aspects##5##2##(1994-12#1)(2007-12#1)(2012-3#2)(2013-1#1)
three assessment methods##2##3##(2008-10#2)
three assessment##3##2##(2007-8#1)(2008-10#2)
three avirulence##2##2##(2008-10#2)
three axes##2##2##(2007-12#1)(2008-3#1)
three bacterial##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
three bands##2##2##(1991-12#1)(2008-10#1)
three basic matrices##3##3##(2007-11#1)(2007-12#2)
three basic##11##2##(1991-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-1#2)
three batches##3##2##(2008-11#2)(2013-1#1)
three bays##2##2##(2008-10#2)
three beams##2##2##(2008-3#2)
three beta##3##2##(1992-8#1)(2008-11#1)(2010-12#1)
three biosensors##2##2##(2008-10#2)
three bond coupling constants##2##4##(1992-4#2)
three broad##4##2##(1991-2#1)(1991-3#1)(1997-1#1)(2011-2#1)
three cDNAs were##3##3##(1992-8#2)(1993-2#1)
three case studies##4##3##(1991-1#1)(1991-12#1)(1996-1#1)(2010-5#1)
three case study organizations##2##4##(1996-1#2)
three case##7##2##(1991-1#1)(1991-12#1)(1996-1#3)(2010-3#1)(2010-5#1)
three cases and##2##3##(2007-8#1)(2009-5#1)
three cases of##16##3##(1991-11#1)(1993-9#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
three cases the##2##3##(1991-12#1)(1992-11#1)
three cases with##2##3##(1994-12#1)(2007-7#1)
three cases##64##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-11#2)(1997-3#4)(1997-6#1)(1997-8#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
three categories of##6##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)
three categories##17##2##(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-1#1)(2011-2#2)
three cations##3##2##(2008-10#3)
three cell lines##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
three cell##5##2##(1990-12#1)(1995-6#1)(2008-11#1)(2008-7#1)(2012-2#1)
three centers##2##2##(2008-4#1)(2008-5#1)
three cephalosporin antibiotics##2##3##(2008-10#2)
three certified reference materials##2##4##(2008-10#2)
three channels##5##2##(2008-10#3)(2008-2#1)(2008-8#1)
three children with##2##3##(2007-12#1)(2011-2#1)
three children##6##2##(1991-6#1)(2007-1#1)(2007-12#3)(2011-2#1)
three clades##4##2##(2008-10#3)(2009-6#1)
three classes of##11##3##(1992-9#1)(1994-9#1)(1995-2#2)(1995-8#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
three classes##16##2##(1992-9#1)(1994-9#1)(1995-2#2)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-8#2)
three clinical trials that##2##4##(2007-12#1)(2008-6#1)
three clinical trials##4##3##(2007-12#1)(2008-6#1)(2008-8#1)(2012-3#1)
three clinical##6##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-3#1)
three clonal lineages##5##3##(2008-10#3)(2009-2#2)
three clones##2##2##(1994-11#1)(1997-7#1)
three closely related##2##3##(1990-12#1)(2009-5#1)
three clusters##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
three colorants##3##2##(2008-10#3)
three combinations##2##2##(2008-10#1)(2013-1#1)
three commercial##10##2##(1992-2#1)(2008-10#8)(2008-3#1)
three commercially important species##2##4##(2013-7#2)
three commercially##3##2##(1991-3#1)(2013-7#2)
three common##5##2##(2008-10#1)(2008-3#1)(2009-9#1)(2011-2#2)
three community##2##2##(2011-2#1)(2012-2#1)
three compartments##2##2##(2008-4#1)(2012-2#1)
three compatible hosts##2##3##(2008-10#2)
three component##3##2##(2008-10#1)(2008-4#1)(2011-3#1)
three components of the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
three components of##7##3##(1990-7#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)
three components##17##2##(1990-7#1)(1992-12#1)(1994-3#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-6#1)(2012-3#1)(2013-1#1)
three compounds were##2##3##(1995-2#1)(2011-1#1)
three compounds##14##2##(1990-8#1)(1992-11#2)(1995-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#1)
three concentration levels of##2##4##(2008-10#2)
three concentration levels##4##3##(2008-10#3)(2011-3#1)
three concurrent##2##2##(1993-12#1)(2008-5#1)
three conditions##10##2##(1993-6#1)(1995-5#1)(2008-11#5)(2011-2#1)(2013-1#1)(2013-8#1)
three configurations##2##2##(2008-10#2)
three consecutive days and##2##4##(1995-3#1)(2010-12#1)
three consecutive days##3##3##(1992-3#1)(1995-3#1)(2010-12#1)
three consecutive years##2##3##(2008-10#1)(2008-5#1)
three consecutive##15##2##(1991-3#1)(1992-3#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
three conserved regions##2##3##(1994-12#1)(1995-6#1)
three conserved##4##2##(1993-6#1)(1994-12#1)(1995-6#1)(1996-12#1)
three continuous##2##2##(1992-6#1)(2012-3#1)
three control##3##2##(1991-6#1)(2008-5#1)(2010-4#1)
three controlled clinical##2##3##(1991-6#1)(2012-2#1)
three copies of the##2##4##(1994-11#1)(2008-10#1)
three copies of##4##3##(1994-11#1)(2008-10#2)(2009-7#1)
three core functions##3##3##(1996-3#2)(1997-2#1)
three countries##10##2##(1996-3#1)(2008-10#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-12#3)(2012-3#1)
three cowpea cultivars##2##3##(2008-12#2)
three cows##3##2##(1997-4#2)(2011-2#1)
three criteria##5##2##(1995-2#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-2#1)
three cultivars##6##2##(2008-10#4)(2008-12#1)(2012-2#1)
three culture##2##2##(2008-11#1)(2013-7#1)
three daily##2##2##(2008-7#1)(2013-1#1)
three dairy##2##2##(1992-2#1)(2012-12#1)
three databases##2##2##(1994-3#2)
three days after##4##3##(1990-12#1)(2007-12#1)(2008-5#1)(2013-1#1)
three days of##5##3##(2007-12#2)(2008-5#1)(2012-2#2)
three days##20##2##(1990-11#1)(1990-12#1)(1991-5#1)(1994-2#1)(2007-12#4)(2008-12#1)(2008-5#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
three decades ago##3##3##(2008-1#1)(2008-2#1)(2011-1#1)
three decades##29##2##(1991-12#1)(1992-12#1)(1992-3#1)(1996-2#2)(1997-1#1)(1997-3#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
three definitions of##2##3##(1997-5#1)(2008-2#1)
three degrees of##2##3##(2007-12#1)(2008-10#1)
three dependent variables##2##3##(1995-12#2)
three detection##2##2##(2008-10#1)(2008-3#1)
three dialysis sessions##2##3##(2007-7#2)
three died##2##2##(2007-8#1)(2008-7#1)
three differences##3##2##(1990-8#1)(1993-6#1)(2008-10#1)
three different academic##2##3##(2008-11#1)(2009-5#1)
three different batches##2##3##(2008-11#2)
three different biological##2##3##(2007-5#1)(2012-3#1)
three different classes##2##3##(1994-8#1)(2008-10#1)
three different densities##2##3##(2008-11#1)(2008-9#1)
three different environments##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
three different forms of##3##4##(1991-11#1)(1993-6#1)(2008-10#1)
three different groups of##2##4##(1997-2#1)(2008-7#1)
three different groups##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
three different hosts##3##3##(2008-10#3)
three different ion##2##3##(2008-3#2)
three different methods##5##3##(1996-5#1)(2008-10#3)(2009-8#1)
three different polymers##3##3##(2008-5#1)(2012-2#2)
three different production##2##3##(2008-11#1)(2012-2#1)
three different promoters##2##3##(1990-11#1)(2008-7#1)
three different signals##2##3##(2008-10#1)(2008-3#1)
three different sites in##3##4##(2008-10#2)(2008-8#1)
three different sites##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
three different species of##2##4##(2008-10#1)(2010-11#1)
three different steps##2##3##(1997-4#1)(2010-2#1)
three different strains of##3##4##(1996-5#1)(2008-5#1)(2011-1#1)
three different types of##6##4##(1991-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-8#1)
three different wavelengths##2##3##(2008-2#1)(2008-3#1)
three different ways##2##3##(1995-6#1)(2008-10#1)
three different##226##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-5#2)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-10#65)(2008-11#15)(2008-12#5)(2008-2#9)(2008-3#15)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
three diketopiperazines##2##2##(2008-10#2)
three dimensional structure##3##3##(1990-7#1)(2008-4#1)(2012-1#1)
three dimensional##19##2##(1990-7#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-8#1)
three dimensionally##3##2##(2007-12#1)(2008-3#2)
three dimensions of##2##3##(2008-10#1)(2012-12#1)
three dimensions##21##2##(1994-3#1)(1995-1#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-3#7)(2008-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
three discrete##2##2##(1997-2#1)(2008-5#1)
three distinct clades##3##3##(2008-10#2)(2009-8#1)
three distinct clusters were##2##4##(2008-10#2)
three distinct clusters##3##3##(2008-10#3)
three distinct groups of##2##4##(1996-2#1)(2009-4#1)
three distinct groups##4##3##(1996-2#1)(2008-10#1)(2009-4#1)(2011-2#1)
three distinct peaks##2##3##(1994-3#1)(2008-10#1)
three distinct subgroups##2##3##(2008-10#2)
three distinct subtypes##2##3##(1993-11#1)(2008-1#1)
three distinct##51##2##(1991-2#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
three distinctive##3##2##(1997-2#1)(2008-12#1)(2010-8#1)
three disulfide bonds##2##3##(1994-2#1)(1995-2#1)
three disulfide##3##2##(1994-2#1)(1995-2#1)(2008-8#1)
three domains##6##2##(1992-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)
three doses of E##2##4##(1994-7#2)
three doses of##5##3##(1994-7#2)(1995-12#1)(1995-3#1)(2011-2#1)
three doses##7##2##(1994-7#2)(1995-12#1)(1995-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
three dots##3##2##(1996-8#1)(2008-10#2)
three drug##2##2##(2008-1#1)(2008-10#1)
three drugs##5##2##(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#1)
three dyes##6##2##(2008-10#5)(2008-3#1)
three effects##2##2##(2008-3#1)(2008-5#1)
three elements##5##2##(2008-10#3)(2008-3#1)(2008-4#1)
three environments##3##2##(1997-7#1)(2008-10#2)
three enzymatic##2##2##(1996-5#1)(2008-10#1)
three enzyme##2##2##(2008-10#2)
three enzymes##8##2##(1997-4#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)
three equally##2##2##(2007-11#1)(2008-3#1)
three essential##5##2##(1991-2#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-2#1)
three ethnic groups##3##3##(2011-2#3)
three ethnic##4##2##(2011-1#1)(2011-2#3)
three evidence-based postoperative pain assessment practices##2##6##(2010-11#2)
three examples of##4##3##(1994-1#1)(1994-9#1)(2007-12#1)(2008-10#1)
three examples##6##2##(1994-1#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
three exchanges##2##2##(2007-12#2)
three exons##5##2##(1990-7#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-2#1)
three experimental groups##6##3##(1996-2#1)(1997-2#1)(1997-6#2)(2008-12#1)(2011-2#1)
three experimental##8##2##(1996-2#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-12#1)(2010-10#1)(2011-2#1)
three experiments##9##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-1#1)
three extracts##2##2##(2008-5#2)
three factors##8##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-7#1)
three families##4##2##(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)
three females##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
three field##5##2##(2007-6#1)(2008-10#3)(2013-8#1)
three fields##3##2##(2007-8#1)(2008-10#2)
three fluoroquinolones##2##2##(2008-10#2)
three focus groups##2##3##(2008-11#1)(2012-3#1)
three for P450 2C12##2##4##(1993-6#2)
three for##4##2##(1993-6#2)(2008-9#2)
three forms##4##2##(1990-12#1)(1991-2#1)(1992-8#1)(2008-10#1)
three formulations were tested for in vitro drug release pattern##2##10##(2010-3#2)
three formulations##4##2##(2008-10#1)(2008-5#1)(2010-3#2)
three fractions##5##2##(1991-5#1)(1992-12#1)(1993-8#1)(1995-6#1)(2008-10#1)
three from the##2##3##(2008-5#1)(2008-9#1)
three from##3##2##(1997-4#1)(2008-5#1)(2008-9#1)
three functional##4##2##(1995-2#1)(1995-3#1)(2007-12#1)(2008-4#1)
three functions##2##2##(1995-12#1)(2008-7#1)
three fungal##2##2##(2007-7#1)(2008-10#1)
three fungicides##3##2##(2008-10#3)
three further##2##2##(2008-11#1)(2011-2#1)
three fusion##2##2##(2008-5#1)(2008-8#1)
three genera##6##2##(1995-2#1)(1996-6#2)(1997-4#1)(2008-10#1)(2010-7#1)
three general##2##2##(2008-4#1)(2011-2#1)
three generations##2##2##(2007-7#1)(2011-1#1)
three genes##10##2##(1994-12#2)(1995-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#2)(2011-2#1)
three genetic##3##2##(1995-3#1)(2008-10#2)
three genetically distinct##2##3##(2008-10#2)
three genetically##3##2##(2008-10#3)
three genomes##2##2##(2008-5#1)(2008-9#1)
three genotypes##2##2##(2008-12#1)(2013-8#1)
three genotypic##3##2##(2008-10#3)
three geographic##2##2##(2008-10#2)
three geographical##2##2##(2008-10#2)
three goals of##2##3##(1996-1#2)
three goals##4##2##(1995-12#1)(1996-1#2)(2008-9#1)
three grade levels##2##3##(2012-12#1)(2013-8#1)
three groups according to the##7##5##(1996-6#1)(2007-6#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)
three groups according##8##3##(1996-6#1)(2007-6#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
three groups did not differ##2##5##(2009-9#1)(2010-7#1)
three groups in##4##3##(1994-12#1)(2009-10#1)(2009-11#1)(2012-2#1)
three groups of##20##3##(1991-12#1)(1993-1#1)(1994-1#1)(1995-12#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
three groups on##2##3##(2008-10#1)(2013-8#1)
three groups showed##2##3##(2008-7#1)(2010-3#1)
three groups were##4##3##(1993-1#1)(1995-5#1)(2008-10#1)(2012-5#1)
three groups##115##2##(1991-1#1)(1991-12#1)(1991-9#1)(1993-1#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-6#1)(2006-6#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-12#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#5)(2009-11#1)(2009-3#1)(2009-9#1)(2010-3#2)(2010-4#3)(2010-7#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-2#5)(2012-3#1)(2012-5#3)(2013-1#4)(2013-8#5)
three growth##2##2##(1993-11#1)(2008-12#1)
three guilds##2##2##(2008-8#2)
three habitats##2##2##(2008-10#2)
three had##9##2##(1991-12#1)(1992-3#1)(1997-5#1)(2007-8#3)(2008-8#2)(2012-12#1)
three haptens##2##2##(2008-10#2)
three have##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
three herbicides##2##2##(2008-10#2)
three highly##5##2##(1995-2#1)(2008-10#2)(2008-3#2)
three homogeneous##2##2##(2007-12#1)(2008-10#1)
three homozygous##2##2##(1993-6#1)(2007-7#1)
three hospitals in##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
three hospitals##5##2##(2008-10#1)(2008-9#2)(2012-3#1)(2013-1#1)
three host##3##2##(2008-10#2)(2010-4#1)
three hosts##4##2##(2008-10#4)
three hours of##3##3##(1990-7#1)(2008-11#1)(2011-1#1)
three hours##9##2##(1990-7#1)(1996-11#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#2)
three human alpha##2##3##(1994-6#2)
three human##12##2##(1991-6#1)(1993-12#1)(1994-6#3)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)
three hundred##2##2##(2011-2#1)(2013-8#1)
three identical##2##2##(2008-10#1)(2008-5#1)
three ilarviruses##2##2##(2008-10#2)
three important##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
three in the##2##3##(1994-12#1)(2008-10#1)
three in##8##2##(1994-12#1)(1995-8#1)(1996-6#1)(2007-5#1)(2008-10#3)(2011-2#1)
three incoherent feed-forward##2##3##(2008-11#2)
three independent analysis of a##2##5##(2008-10#2)
three independent variables##2##3##(1997-7#1)(2007-10#1)
three independent##31##2##(1991-12#1)(1991-2#1)(1995-6#2)(1995-8#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#1)(2012-1#1)
three individual##2##2##(2007-10#1)(2012-3#1)
three individuals tossed a ball##2##5##(2008-11#2)
three individuals##4##2##(2008-11#2)(2008-8#1)(2012-12#1)
three internal##2##2##(1993-6#1)(2010-4#1)
three interrelated##2##2##(1992-12#1)(2013-1#1)
three introns and encodes a##2##5##(1993-6#1)(1996-10#1)
three introns and##3##3##(1993-6#1)(1994-11#1)(1996-10#1)
three introns of##3##3##(1993-3#1)(1994-12#1)(1995-8#1)
three introns##11##2##(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-8#2)(1996-10#1)(1997-2#1)(2010-5#1)
three islands##2##2##(2008-10#2)
three isoflavone aglycones##2##3##(2008-10#2)
three isoforms of pIGFBP-3##2##4##(1991-12#2)
three isoforms of##5##3##(1991-12#2)(1995-2#1)(2008-1#1)(2008-10#1)
three isoforms##6##2##(1991-12#2)(1995-2#1)(2008-1#1)(2008-10#1)(2010-12#1)
three isolates of T##2##4##(2008-10#2)
three isolates of nucleopolyhedrovirus of Helicoverpa armigera##2##7##(2008-12#2)
three isolates of##8##3##(2008-10#4)(2008-12#2)(2008-6#1)(2013-1#1)
three isolates were##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
three isolates##24##2##(1997-4#1)(2007-12#1)(2008-10#17)(2008-12#2)(2008-6#1)(2011-1#1)(2013-1#1)
three key##7##2##(1991-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-3#1)(2013-8#1)
three kinds of media##2##4##(2008-10#2)
three kinds of##11##3##(1992-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#1)
three kinds##12##2##(1992-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#2)
three known##3##2##(2007-1#1)(2008-5#1)(2009-7#1)
three labeled##2##2##(1990-11#1)(2008-10#1)
three large##6##2##(1994-9#1)(1995-12#1)(1997-2#1)(2008-7#1)(2009-10#1)(2011-2#1)
three laser##3##2##(2008-2#1)(2008-3#2)
three layer##3##2##(2008-10#2)(2009-5#1)
three layers of nodes was trained##4##6##(2008-10#4)
three layers of##5##3##(2008-10#4)(2010-8#1)
three layers##10##2##(2008-10#6)(2008-2#1)(2010-8#3)
three leafhopper species##2##3##(2008-10#2)
three lesions##3##2##(2008-11#1)(2008-6#2)
three levels of the health##2##5##(1994-12#1)(2008-1#1)
three levels of##7##3##(1994-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
three levels##12##2##(1994-12#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
three light##4##2##(1991-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
three lineages##4##2##(2008-10#2)(2009-2#2)
three linear##2##2##(2008-10#1)(2008-3#1)
three lines##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
three locations##3##2##(2008-10#3)
three loci##4##2##(2008-10#4)
three longitudinal##2##2##(2008-3#2)
three low-copy##2##2##(2008-10#1)(2013-1#1)
three main areas##2##3##(2008-11#1)(2012-3#1)
three main##37##2##(1994-5#1)(1996-1#1)(1997-2#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2012-9#1)
three major lineages##2##3##(2008-6#1)(2010-6#1)
three major lines of##2##4##(2010-1#1)(2013-8#1)
three major loci##2##3##(2008-10#1)(2009-4#1)
three major metabolites##2##3##(1990-8#1)(2008-7#1)
three major##48##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#2)(1995-11#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
three males##2##2##(1992-9#1)(2010-8#1)
three marine##2##2##(1990-7#1)(2008-2#1)
three markers##3##2##(1995-12#1)(1997-8#1)(2008-11#1)
three measurement##2##2##(2010-10#1)(2010-7#1)
three measures of durability##2##4##(2008-10#2)
three measures of##4##3##(2007-12#1)(2008-10#2)(2008-4#1)
three measures##6##2##(1995-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-11#1)
three mechanisms##2##2##(2008-10#1)(2013-7#1)
three media##3##2##(2008-10#3)
three medications##2##2##(1997-3#1)(2010-11#1)
three meiotic mutants##2##3##(2008-5#2)
three members of the##5##4##(1994-12#1)(1996-12#1)(1997-5#1)(2009-6#1)(2013-1#1)
three members of##6##3##(1994-12#1)(1996-12#2)(1997-5#1)(2009-6#1)(2013-1#1)
three members##7##2##(1993-12#1)(1994-12#1)(1996-12#2)(1997-5#1)(2009-6#1)(2013-1#1)
three membrane##2##2##(1994-12#1)(2009-7#1)
three metal ions##2##3##(2008-10#2)
three metals##5##2##(2008-10#5)
three methods for the##2##4##(1994-12#1)(2010-4#1)
three methods for##5##3##(1994-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)
three methods of##2##3##(2008-10#2)
three methods were##3##3##(1993-2#1)(1994-12#1)(2008-10#1)
three methods##28##2##(1991-3#1)(1993-2#3)(1994-12#2)(2008-10#9)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-1#2)(2012-3#1)
three methylxanthines##2##2##(2008-10#2)
three micronutrients##2##2##(2007-11#2)
three minor##3##2##(1997-4#1)(2008-11#1)(2009-10#1)
three minority populations##2##3##(2011-1#2)
three model##5##2##(2008-11#1)(2012-12#4)
three models of##2##3##(2007-10#1)(2008-4#1)
three models##7##2##(2007-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
three modes of##2##3##(2008-3#1)(2013-1#1)
three modes##4##2##(1992-3#1)(2008-3#2)(2013-1#1)
three molecular##3##2##(1990-8#1)(2008-10#2)
three molecules##2##2##(1992-4#2)
three monoclonal antibodies##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
three month##3##2##(1990-2#1)(1990-3#1)(1990-6#1)
three months after surgery##2##4##(1993-3#1)(2007-7#1)
three months after##7##3##(1990-5#1)(1991-11#1)(1992-9#1)(1993-3#1)(1996-3#1)(2007-7#1)(2008-1#1)
three months and##10##3##(1990-12#1)(1990-6#1)(1991-11#1)(1993-3#1)(1993-6#1)(2008-11#2)(2008-12#1)(2013-1#2)
three months from##2##3##(2010-2#1)(2013-1#1)
three months later##2##3##(1992-6#1)(2010-3#1)
three months of age##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
three months of treatment##2##4##(2010-8#2)
three months of##11##3##(1991-8#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-8#2)(2012-2#2)(2013-1#2)
three months were##2##3##(2007-2#1)(2008-6#1)
three months##70##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1991-11#4)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-2#1)(1996-3#3)(1997-8#1)(2007-2#2)(2007-7#4)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#12)
three months'##3##2##(1990-9#1)(1992-9#1)(2008-11#1)
three more##2##2##(1994-12#1)(1994-2#1)
three morphological types##2##3##(1996-6#1)(2008-12#1)
three morphological##3##2##(1996-6#1)(2008-12#1)(2008-7#1)
three most common##3##3##(2007-2#1)(2011-2#1)(2013-1#1)
three most##10##2##(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
three mutant antibodies##2##3##(1992-8#2)
three mutant##3##2##(1992-8#2)(1993-3#1)
three mutants was##2##3##(2008-10#2)
three mutants##6##2##(1993-11#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-9#1)
three natural##3##2##(1995-2#1)(2008-10#2)
three nebulizers##3##2##(1996-12#3)
three neurotrophic factors##2##3##(2013-1#2)
three new##14##2##(1991-2#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-10#5)(2008-2#1)(2012-2#1)(2013-1#1)
three nights##2##2##(2008-3#2)
three novel##6##2##(1991-9#1)(1996-6#1)(2008-10#1)(2010-1#1)(2012-3#1)(2013-1#1)
three nuclear##2##2##(1993-11#1)(1993-3#1)
three numerical##2##2##(1992-6#1)(2008-2#1)
three oak species##2##3##(2012-6#1)(2012-9#1)
three objectives##3##2##(1993-12#1)(1995-12#1)(1996-1#1)
three occasions##4##2##(1993-1#1)(1994-12#1)(2007-12#1)(2013-1#1)
three of five##2##3##(2008-10#2)
three of four##8##3##(1991-12#1)(1992-11#1)(2008-10#4)(2011-2#2)
three of six##5##3##(1997-4#2)(2008-10#2)(2008-3#1)
three of the five##2##4##(1997-1#1)(2008-10#1)
three of the four##12##4##(1990-8#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
three of the most##2##4##(1997-7#1)(2010-6#1)
three of the six##3##4##(1991-6#1)(1992-2#1)(2008-5#1)
three of the##43##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-9#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
three of them##7##3##(1991-5#1)(1992-3#1)(1997-9#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-11#1)
three of these events##2##4##(1992-11#1)(2008-10#1)
three of these##14##3##(1991-12#1)(1992-11#1)(1993-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)
three of which were##4##4##(2008-10#3)(2008-7#1)
three of which##9##3##(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)
three of whom##2##3##(1991-11#1)(2008-9#1)
three of##94##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#2)(1992-11#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-9#2)(2006-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)
three open reading frames##2##4##(2008-10#2)
three operationalizations of burnout phase##2##5##(1997-1#2)
three operationalizations##3##2##(1997-1#3)
three opioid##2##2##(1996-12#2)
three optical parameters that##2##4##(2008-3#2)
three optical parameters##3##3##(2008-3#3)
three optical##4##2##(2008-3#3)(2013-8#1)
three options##4##2##(1995-1#1)(1997-4#2)(2008-10#1)
three or five##3##3##(1991-3#1)(2008-10#2)
three or four##3##3##(1997-2#1)(2008-11#1)(2008-3#1)
three or more children##2##4##(1997-2#2)
three or more##12##3##(1997-2#3)(2007-7#1)(2008-10#3)(2008-5#1)(2010-11#1)(2011-1#1)(2013-8#2)
three or##22##2##(1991-3#1)(1995-12#1)(1996-12#1)(1997-2#4)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2010-11#1)(2011-1#1)(2013-8#2)
three orchards##2##2##(2008-10#2)
three orders in the magnitude##2##5##(2008-10#1)(2008-11#1)
three orders of magnitude and the##3##6##(2008-10#3)
three orders of magnitude##17##4##(1991-5#1)(2008-10#14)(2008-7#1)(2012-3#1)
three orders of##19##3##(1991-5#1)(2007-11#1)(2008-10#14)(2008-3#1)(2008-7#1)(2012-3#1)
three orders##21##2##(1991-5#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
three organ##2##2##(2008-8#2)
three organizations##2##2##(1996-1#2)
three organs##2##2##(2008-7#1)(2008-9#1)
three orthogonal##2##2##(1997-7#1)(2008-3#1)
three other##20##2##(1990-12#2)(1990-3#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)
three out of five##3##4##(1996-12#1)(1996-5#1)(2008-11#1)
three out of the##2##4##(2008-10#1)(2008-9#1)
three out of##6##3##(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
three oxysterols##2##2##(1993-6#2)
three pH values##2##3##(2008-10#1)(2008-5#1)
three pairs of##2##3##(2008-10#1)(2008-7#1)
three pairs##4##2##(1994-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
three parallel##4##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
three parameter##2##2##(2008-10#1)(2008-2#1)
three parameters##12##2##(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-9#1)(2013-8#2)
three partial##2##2##(2006-4#1)(2008-6#1)
three parts##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#1)
three passes##2##2##(2008-10#1)(2008-7#1)
three pathogenic##2##2##(2008-10#1)(2008-11#1)
three pathotypes of##2##3##(2008-10#2)
three patients and##2##3##(2008-11#1)(2008-6#1)
three patients had a##2##4##(1990-9#1)(1992-2#1)
three patients had##5##3##(1990-9#1)(1992-2#1)(2007-7#1)(2007-8#1)(2008-3#1)
three patients presented with##2##4##(2007-8#1)(2008-7#1)
three patients underwent##2##3##(1994-3#1)(2007-8#1)
three patients were##4##3##(2007-12#1)(2008-12#1)(2011-2#2)
three patients who##4##3##(1997-6#1)(2008-11#2)(2013-1#1)
three patients with##15##3##(1990-8#1)(1993-11#1)(1993-8#1)(1996-9#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
three patients##62##2##(1990-8#2)(1990-9#2)(1991-8#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-6#1)(1996-9#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#7)(2012-1#1)(2012-2#2)(2013-1#3)
three patterns##2##2##(2008-10#1)(2010-4#1)
three peaks##2##2##(1991-2#1)(2008-10#1)
three peptides were##2##3##(1997-4#1)(2012-1#1)
three peptides##5##2##(1996-12#1)(1997-4#1)(2008-6#1)(2012-1#2)
three percent of##5##3##(2007-7#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#1)
three periods##5##2##(1995-4#2)(2008-10#1)(2008-2#1)(2010-8#1)
three pesticides##4##2##(2008-10#4)
three pharmaceutical##2##2##(2008-10#2)
three phase fluidized bed reactor##2##5##(2008-7#2)
three phase maps##2##3##(2008-3#2)
three phase##5##2##(2008-3#2)(2008-7#2)(2009-11#1)
three phases in##2##3##(1992-6#1)(2009-7#1)
three phases of##4##3##(1991-3#1)(1993-12#1)(2008-11#1)(2013-8#1)
three phases##12##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-8#1)(2013-8#1)
three physical parameters##2##3##(2008-12#1)(2008-7#1)
three planes##2##2##(2008-6#1)(2008-9#1)
three plant species##3##3##(2008-10#2)(2013-8#1)
three plant##5##2##(2008-10#3)(2011-2#1)(2013-8#1)
three plants##2##2##(2008-10#1)(2008-9#1)
three plays##2##2##(1993-3#2)
three plowing##2##2##(2008-12#2)
three points##2##2##(1990-10#1)(2007-12#1)
three populations of##2##3##(1995-2#1)(2010-8#1)
three populations##11##2##(1995-2#1)(1997-3#1)(2008-10#4)(2010-8#1)(2011-1#1)(2012-7#2)(2013-8#1)
three ports##2##2##(2007-7#1)(2007-8#1)
three positions##2##2##(1993-6#1)(2008-7#1)
three positively charged residues##2##4##(1997-8#2)
three possible##5##2##(1993-8#1)(2008-10#2)(2008-8#1)(2011-1#1)
three potato cultivars##2##3##(2008-10#2)
three potato##3##2##(2008-10#3)
three potential##5##2##(1990-5#1)(1991-12#1)(2007-11#1)(2008-11#1)(2008-7#1)
three previously sequenced##2##3##(1996-6#1)(2008-10#1)
three previously##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
three primary##6##2##(1992-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-5#1)
three primer##2##2##(2008-10#1)(2008-5#1)
three primers##3##2##(2008-10#1)(2010-4#2)
three principal##4##2##(1997-7#1)(2008-3#2)(2009-10#1)
three processes##3##2##(2008-11#1)(2008-2#2)
three products##3##2##(1990-7#1)(1996-3#1)(2008-5#1)
three prominent##2##2##(1996-3#1)(2008-10#1)
three promising formulations##2##3##(2010-3#2)
three promising##3##2##(2010-3#2)(2012-5#1)
three proteases##2##2##(2008-10#1)(2008-11#1)
three protein##4##2##(1991-6#1)(1994-6#1)(1995-2#1)(2009-8#1)
three proteins share##2##3##(1991-5#1)(1995-5#1)
three proteins were##2##3##(1993-2#1)(2010-12#1)
three proteins##14##2##(1991-2#1)(1991-5#1)(1993-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
three quantitative##2##2##(2008-9#1)(2012-2#1)
three quarters of##2##3##(2007-2#1)(2012-2#1)
three quarters##3##2##(1997-8#1)(2007-2#1)(2012-2#1)
three questions##3##2##(1996-1#1)(2007-2#1)(2008-8#1)
three races##4##2##(2008-10#3)(2009-12#1)
three randomized controlled trials and##2##5##(2012-12#2)
three randomized controlled trials##4##4##(2009-4#1)(2012-12#3)
three randomized##8##2##(2008-1#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#3)
three reaction##2##2##(2008-10#1)(2008-3#1)
three reading frames##2##3##(1994-12#1)(1997-9#1)
three real samples##3##3##(2008-10#3)
three real##5##2##(2008-10#4)(2008-6#1)
three recordings##2##2##(1990-8#2)
three reference##2##2##(2008-10#1)(2008-3#1)
three regions of the##2##4##(1994-12#1)(1997-2#1)
three regions of##8##3##(1990-5#1)(1990-7#1)(1994-12#1)(1994-8#1)(1997-2#1)(2007-12#1)(2011-2#1)(2012-2#1)
three regions##16##2##(1990-5#1)(1990-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#2)
three related##5##2##(2007-11#1)(2008-10#3)(2008-7#1)
three remaining##4##2##(1992-11#1)(1992-5#1)(1993-2#1)(2008-10#1)
three replicate##3##2##(2008-10#1)(2010-2#1)(2013-7#1)
three replicates##5##2##(2008-10#5)
three replications##5##2##(2008-10#2)(2008-12#2)(2010-4#1)
three representative##6##2##(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
three resistance##2##2##(2008-10#1)(2008-8#1)
three resistant##2##2##(1996-5#1)(2008-10#1)
three resources##4##2##(2008-8#1)(2011-2#3)
three restriction fragment length polymorphism (RFLP) markers##2##7##(1995-6#1)(2008-9#1)
three restriction fragment length polymorphism (RFLP)##3##6##(1995-6#1)(2008-10#1)(2008-9#1)
three restriction##4##2##(1995-6#1)(2008-10#2)(2008-9#1)
three rounds of##3##3##(1991-3#1)(2008-10#1)(2009-6#1)
three rounds##5##2##(1991-3#1)(1997-7#1)(2008-10#2)(2009-6#1)
three routes to##2##3##(1997-7#1)(2008-8#1)
three rows of##2##3##(2008-10#1)(2008-5#1)
three samples##6##2##(1992-6#1)(1994-6#1)(2008-10#3)(2008-2#1)
three sampling sites##2##3##(2008-5#1)(2013-7#1)
three scales of##2##3##(2008-10#2)
three scales##6##2##(2008-10#3)(2011-1#2)(2013-7#1)
three scenarios##2##2##(2008-8#1)(2012-2#1)
three seasons##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
three segments##5##2##(1991-5#1)(1994-12#1)(2007-12#1)(2008-3#1)(2013-8#1)
three selected##3##2##(1993-11#1)(1996-6#1)(2008-10#1)
three separate##18##2##(1991-3#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#2)(2012-2#1)(2013-1#2)
three sequential##3##2##(1996-5#1)(2008-10#1)(2009-11#1)
three serial##2##2##(1996-5#1)(2011-1#1)
three sessions##2##2##(2008-4#1)(2013-1#1)
three sets of##7##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2010-5#1)
three sets##8##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-7#1)(2010-5#1)
three sexual##2##2##(2008-5#1)(2013-1#1)
three shampoos##2##2##(2008-5#2)
three short##5##2##(1993-2#1)(1993-3#1)(1997-4#1)(1997-6#1)(2010-11#1)
three showed##2##2##(1991-3#1)(2013-1#1)
three showing##2##2##(2008-5#1)(2013-8#1)
three signals##3##2##(1997-3#2)(2007-11#1)
three significant##2##2##(2007-12#2)
three single##2##2##(2008-9#1)(2013-1#1)
three sites##8##2##(1992-3#1)(1994-1#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-7#1)
three soils##6##2##(2008-10#6)
three solenoid valves##2##3##(2008-10#2)
three sources##5##2##(1997-6#1)(2008-10#3)(2009-9#1)
three spatial dimensions##3##3##(2007-11#1)(2008-3#2)
three species in##2##3##(2011-2#1)(2012-8#1)
three species of##14##3##(1992-8#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#2)(2010-8#1)(2013-1#1)
three species were##5##3##(2008-10#2)(2011-3#1)(2012-8#1)(2013-7#1)
three species##40##2##(1990-5#1)(1992-8#1)(1993-2#1)(1997-4#1)(2007-12#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#3)(2010-8#1)(2011-2#2)(2011-3#5)(2012-8#2)(2012-9#1)(2013-1#1)(2013-7#1)
three spectroscopic##2##2##(2008-10#2)
three spherical mirrors##2##3##(2008-3#2)
three stages of##2##3##(2011-2#1)(2012-12#1)
three stages##12##2##(1996-3#1)(1997-8#1)(2008-10#1)(2008-4#3)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
three standard reference materials##2##4##(2008-10#2)
three standard##7##2##(2008-10#6)(2012-2#1)
three step##2##2##(2008-1#1)(2008-10#1)
three steps from##4##3##(1993-12#1)(2008-10#1)(2008-4#1)(2010-6#1)
three steps##8##2##(1993-12#1)(1996-12#1)(2008-10#2)(2008-4#2)(2010-6#1)(2010-9#1)
three strains of the##3##4##(2008-10#2)(2008-11#1)
three strains of##10##3##(1994-2#1)(2008-10#7)(2008-11#1)(2008-8#1)
three strains were##3##3##(2008-10#2)(2008-7#1)
three strains##21##2##(1993-9#1)(1994-2#3)(1995-6#1)(2008-10#11)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)
three strategies##2##2##(2008-10#1)(2008-8#1)
three structures##2##2##(2008-4#1)(2013-7#1)
three studied##5##2##(2008-10#5)
three studies##6##2##(2007-12#1)(2008-9#1)(2009-2#1)(2011-2#2)(2013-1#1)
three subfamilies##2##2##(1992-8#1)(1995-3#1)
three subgroups##4##2##(1995-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
three subjects##4##2##(2008-7#2)(2008-9#1)(2009-3#1)
three subpopulations##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
three substrates##5##2##(1994-5#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
three subtypes of##2##3##(1993-12#1)(2013-8#1)
three subtypes##4##2##(1993-12#1)(2007-12#1)(2010-12#1)(2013-8#1)
three subunits##2##2##(2008-9#1)(2009-2#1)
three successive years##3##3##(2008-10#3)
three successive##10##2##(1994-2#1)(1996-12#1)(2007-10#1)(2008-10#6)(2008-11#1)
three such##3##2##(1992-1#1)(2007-11#1)(2007-12#1)
three surface treatment methods##2##4##(2009-8#2)
three surface##4##2##(1995-8#1)(2009-2#1)(2009-8#2)
three surveys##2##2##(1991-9#1)(2007-7#1)
three susceptible##2##2##(2008-10#2)
three systems##2##2##(1992-1#1)(2008-10#1)
three tRNA genes##2##3##(1995-6#2)
three tasks##3##2##(1993-12#1)(1996-7#1)(2009-8#1)
three teaching hospitals##2##3##(2010-3#2)
three techniques##3##2##(2008-10#2)(2009-4#1)
three test emulsions##3##3##(2008-5#3)
three test##5##2##(1996-8#1)(2008-5#3)(2010-5#1)
three tested##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
three tests##4##2##(1992-10#1)(1996-3#1)(2008-10#1)(2008-12#1)
three themes##6##2##(1996-1#1)(2008-11#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
three times a day##3##4##(2008-8#1)(2012-2#1)(2013-1#1)
three times a week for##4##5##(1991-3#1)(1996-6#1)(2008-5#1)(2010-4#1)
three times a week##6##4##(1991-3#1)(1992-2#1)(1996-6#1)(2007-8#1)(2008-5#1)(2010-4#1)
three times a year##2##4##(2008-10#1)(2013-8#1)
three times a##11##3##(1991-3#1)(1992-2#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
three times as many##2##4##(1991-2#1)(1995-1#1)
three times as##4##3##(1990-2#1)(1991-2#1)(1995-1#1)(1995-2#1)
three times at##2##3##(2008-10#1)(2010-5#1)
three times before##3##3##(1996-5#1)(2008-10#1)(2010-4#1)
three times daily##2##3##(1991-12#1)(2012-12#1)
three times during the##5##4##(1996-5#1)(2008-10#3)(2008-12#1)
three times greater than##2##4##(1990-9#1)(2008-10#1)
three times greater##4##3##(1990-9#1)(2008-10#2)(2008-2#1)
three times higher than##3##4##(1993-3#1)(2008-2#1)(2008-5#1)
three times higher##4##3##(1993-3#1)(1995-12#1)(2008-2#1)(2008-5#1)
three times in##2##3##(1994-2#1)(2010-3#1)
three times larger##2##3##(2008-10#1)(2008-2#1)
three times lower##2##3##(1992-9#1)(2008-10#1)
three times more##8##3##(1990-2#1)(1991-12#1)(1991-2#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
three times per week##5##4##(2007-7#2)(2008-1#1)(2008-10#1)(2010-10#1)
three times per##7##3##(2007-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#1)
three times standard deviation of the blank##2##7##(2008-10#2)
three times the standard deviation of the blank##7##8##(2008-10#7)
three times the standard deviation of the##11##7##(2008-10#11)
three times the standard deviation of##14##6##(2008-10#14)
three times the standard deviation##15##5##(2008-10#15)
three times the##20##3##(1992-3#1)(2008-1#1)(2008-10#15)(2008-2#2)(2008-8#1)
three times to##2##3##(1994-8#1)(2008-10#1)
three times##113##2##(1990-12#1)(1990-2#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#37)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
three tissues##3##2##(1990-11#1)(2008-3#2)
three to eight##2##3##(2008-5#1)(2008-7#1)
three to five times##2##4##(2008-10#2)
three to five##5##3##(1992-5#1)(1994-9#1)(2008-10#2)(2009-8#1)
three to four##8##3##(1991-8#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2013-1#1)
three to six##5##3##(1992-6#1)(1992-8#1)(1993-6#1)(2008-1#1)(2011-1#1)
three to##25##2##(1990-2#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
three tomato##4##2##(2008-10#4)
three traits##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
three transcription factors##3##3##(1994-11#1)(2008-11#1)(2013-8#1)
three transient##2##2##(1992-12#1)(1995-9#1)
three treatment classes##2##3##(2008-10#2)
three treatment groups##2##3##(1997-3#1)(2013-1#1)
three treatment##6##2##(1997-3#1)(2008-10#2)(2009-7#1)(2010-11#1)(2013-1#1)
three treatments were##2##3##(2008-10#2)
three treatments##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
three trials on##2##3##(2008-10#1)(2008-12#1)
three trials##9##2##(2008-1#1)(2008-10#4)(2008-12#3)(2010-8#1)
three types of friends##2##4##(2009-7#2)
three types of kenkey##2##4##(1997-4#2)
three types of minimax optimal designs##2##6##(2009-9#2)
three types of##54##3##(1990-6#1)(1990-8#1)(1991-5#1)(1994-12#1)(1995-11#2)(1995-3#1)(1996-2#3)(1997-4#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
three types##62##2##(1990-6#1)(1990-8#2)(1991-5#1)(1992-1#1)(1994-12#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-2#3)(1996-6#1)(1997-4#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
three typical##2##2##(2008-10#1)(2009-4#1)
three unique##2##2##(2011-2#1)(2013-1#1)
three units##2##2##(1991-2#2)
three unrelated##3##2##(1991-12#1)(2008-10#2)
three unusual##2##2##(2008-8#1)(2012-2#1)
three variables##4##2##(1995-1#1)(2008-12#1)(2008-7#1)(2011-2#1)
three varieties of##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
three varieties##5##2##(2008-12#3)(2008-3#1)(2008-9#1)
three vessel##2##2##(1994-11#1)(2007-8#1)
three veterinary##2##2##(2008-10#1)(2010-4#1)
three victims##2##2##(1995-3#1)(1996-11#1)
three villages##2##2##(2008-10#2)
three viruses##4##2##(2008-10#4)
three was##5##2##(1990-6#1)(2008-10#4)
three wavelength##2##2##(2007-11#1)(2008-3#1)
three wavelengths##7##2##(2007-11#2)(2008-2#3)(2008-3#2)
three ways##4##2##(1996-4#1)(2008-10#1)(2010-2#1)(2012-1#1)
three week##5##2##(1992-6#2)(1994-6#1)(2008-5#1)(2012-12#1)
three weeks after##3##3##(1994-3#1)(1995-2#1)(2008-9#1)
three weeks of the##2##4##(2008-5#1)(2008-9#1)
three weeks of##5##3##(2008-12#1)(2008-5#2)(2008-9#1)(2010-4#1)
three weeks##26##2##(1991-3#1)(1991-6#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-12#1)(2008-5#4)(2008-7#2)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
three well-known##2##2##(2008-2#2)
three were found to##2##4##(1993-6#1)(2008-10#1)
three were of grade##2##4##(2013-8#2)
three were##15##2##(1993-6#1)(1995-4#1)(1997-8#1)(2007-9#1)(2008-10#6)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
three wheat##3##2##(2008-10#2)(2008-12#1)
three wire twists##2##3##(2007-8#2)
three with##8##2##(1992-5#1)(1992-6#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
three workshops##2##2##(2008-12#2)
three year old##3##3##(2007-7#1)(2007-8#1)(2009-7#1)
three year##9##2##(1991-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
three years after##2##3##(2007-8#1)(2008-1#1)
three years in##3##3##(1990-8#1)(1991-6#1)(2010-8#1)
three years later##3##3##(1991-6#2)(2008-8#1)
three years of age##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
three years of follow-up##2##4##(1995-5#1)(2008-11#1)
three years of##8##3##(1991-4#1)(1995-1#2)(1995-5#1)(2008-11#2)(2008-9#1)(2012-3#1)
three years was##3##3##(2007-8#2)(2008-1#1)
three years##49##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#4)(1992-1#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#3)(1995-5#2)(1995-6#1)(1996-9#1)(2007-11#1)(2007-8#3)(2008-1#5)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#2)
three zones##3##2##(2007-12#1)(2011-2#1)(2013-8#1)
three##4323##1##(1990-10#1)(1990-11#8)(1990-12#18)(1990-2#9)(1990-3#5)(1990-5#17)(1990-6#10)(1990-7#14)(1990-8#19)(1990-9#7)(1991-1#5)(1991-10#2)(1991-11#11)(1991-12#25)(1991-2#27)(1991-3#14)(1991-4#2)(1991-5#13)(1991-6#20)(1991-7#5)(1991-8#7)(1991-9#13)(1992-1#7)(1992-10#2)(1992-11#15)(1992-12#15)(1992-2#10)(1992-3#15)(1992-4#7)(1992-5#9)(1992-6#18)(1992-8#18)(1992-9#8)(1993-1#4)(1993-11#21)(1993-12#19)(1993-2#16)(1993-3#16)(1993-6#24)(1993-8#10)(1993-9#5)(1994-1#6)(1994-11#10)(1994-12#29)(1994-2#14)(1994-3#15)(1994-5#10)(1994-6#14)(1994-7#2)(1994-8#10)(1994-9#10)(1995-1#8)(1995-11#11)(1995-12#27)(1995-2#29)(1995-3#17)(1995-4#3)(1995-5#15)(1995-6#21)(1995-8#14)(1995-9#2)(1996-1#15)(1996-10#2)(1996-11#5)(1996-12#27)(1996-2#21)(1996-3#14)(1996-4#1)(1996-5#16)(1996-6#20)(1996-7#4)(1996-8#5)(1996-9#8)(1997-1#13)(1997-2#20)(1997-3#29)(1997-4#30)(1997-5#9)(1997-6#15)(1997-7#17)(1997-8#20)(1997-9#4)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#38)(2007-12#85)(2007-2#9)(2007-4#1)(2007-5#10)(2007-6#6)(2007-7#36)(2007-8#43)(2007-9#2)(2008-1#50)(2008-10#1058)(2008-11#146)(2008-12#86)(2008-2#81)(2008-3#148)(2008-4#50)(2008-5#144)(2008-6#48)(2008-7#125)(2008-8#86)(2008-9#98)(2009-1#1)(2009-10#19)(2009-11#10)(2009-12#7)(2009-2#15)(2009-3#8)(2009-4#7)(2009-5#13)(2009-6#5)(2009-7#18)(2009-8#16)(2009-9#11)(2010-1#3)(2010-10#14)(2010-11#20)(2010-12#27)(2010-2#19)(2010-3#21)(2010-4#25)(2010-5#15)(2010-6#12)(2010-7#7)(2010-8#33)(2010-9#3)(2011-1#54)(2011-2#133)(2011-3#11)(2012-1#16)(2012-12#31)(2012-2#79)(2012-3#50)(2012-5#5)(2012-6#2)(2012-7#3)(2012-8#2)(2012-9#3)(2013-1#106)(2013-7#21)(2013-8#61)
three)##3##1##(1990-2#1)(1994-6#1)(2012-12#1)
three- and##3##2##(1997-3#1)(2007-11#1)(2008-10#1)
three- to fourfold##3##3##(1992-11#1)(1997-3#1)(2009-4#1)
three- to##5##2##(1992-11#1)(1993-2#1)(1997-3#1)(2007-12#1)(2009-4#1)
three-##10##1##(1992-11#1)(1993-2#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-4#1)
three-aspherical-mirror imaging##2##2##(2008-3#2)
three-aspherical-mirror##3##1##(2008-3#3)
three-beam##2##1##(2008-2#1)(2008-3#1)
three-by-three-tree quadrats##2##2##(2008-10#2)
three-cavity##2##1##(2008-3#2)
three-channel##3##1##(1995-3#1)(2008-10#1)(2008-3#1)
three-color##4##1##(2008-2#1)(2008-4#1)(2008-9#2)
three-component##11##1##(1996-7#1)(2008-10#4)(2008-2#4)(2012-3#2)
three-day##4##1##(1991-2#1)(1997-8#1)(2008-8#1)(2011-2#1)
three-dimensional (3-D) display##2##3##(2007-11#1)(2007-12#1)
three-dimensional (3-D) object recognition##2##4##(2008-3#2)
three-dimensional (3-D) sensing##2##3##(2008-3#2)
three-dimensional (3-D)##36##2##(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#19)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
three-dimensional (3D) imaging##2##3##(2007-11#1)(2007-12#1)
three-dimensional (3D) structure of##2##4##(2008-8#2)
three-dimensional (3D) structure##3##3##(2008-7#1)(2008-8#2)
three-dimensional (3D)##32##2##(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#8)(2008-7#1)(2008-8#2)(2009-11#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#1)
three-dimensional CT angiography##2##3##(2008-7#2)
three-dimensional CT##3##2##(1995-2#1)(2008-7#2)
three-dimensional Monte Carlo##2##3##(2008-3#2)
three-dimensional X-ray##3##2##(2010-2#3)
three-dimensional aggregate##2##2##(2008-10#1)(2008-11#1)
three-dimensional arrangement of##2##3##(1995-6#1)(2008-7#1)
three-dimensional bright and long-lasting phosphorescence in a##2##7##(2008-3#2)
three-dimensional cell##2##2##(2008-11#1)(2010-11#1)
three-dimensional compound parabolic##2##3##(2008-3#2)
three-dimensional computed tomography##2##3##(1995-2#1)(2010-8#1)
three-dimensional conformal radiotherapy##2##3##(1995-8#1)(2013-1#1)
three-dimensional coordinate##2##2##(2008-4#1)(2010-3#1)
three-dimensional cultures##2##2##(2008-11#1)(2012-4#1)
three-dimensional deformation field##2##3##(2008-3#2)
three-dimensional density##2##2##(2006-4#1)(2008-4#1)
three-dimensional display##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
three-dimensional eye movements##2##3##(1991-5#2)
three-dimensional finite element##2##3##(2009-7#1)(2011-2#1)
three-dimensional flow##2##2##(1996-12#1)(2008-6#1)
three-dimensional fluorescence lifetime imaging microscope that##2##6##(2007-12#2)
three-dimensional fluorescence##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
three-dimensional growth and##3##3##(2008-10#1)(2008-11#2)
three-dimensional hematopoietic##2##2##(2008-11#2)
three-dimensional image##2##2##(2008-2#1)(2008-5#1)
three-dimensional images##9##2##(2007-11#6)(2007-12#1)(2008-3#2)
three-dimensional imaging and##3##3##(2007-11#1)(2007-12#2)
three-dimensional imaging of##2##3##(2008-3#2)
three-dimensional imaging with##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
three-dimensional imaging##19##2##(2007-11#5)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-9#1)
three-dimensional incoherent##2##2##(2007-12#1)(2008-2#1)
three-dimensional information##3##2##(2007-12#1)(2008-3#2)
three-dimensional integral imaging##3##3##(2007-11#3)
three-dimensional keys##2##2##(2007-12#2)
three-dimensional location of##2##3##(2008-3#2)
three-dimensional model of##2##3##(1991-6#1)(2008-3#1)
three-dimensional model##3##2##(1991-6#1)(2008-3#1)(2008-5#1)
three-dimensional network##4##2##(2007-11#1)(2008-7#1)(2012-2#2)
three-dimensional numerical##2##2##(2007-12#1)(2008-3#1)
three-dimensional object recognition with##2##4##(2008-3#2)
three-dimensional object recognition##6##3##(2007-11#2)(2008-3#4)
three-dimensional object##13##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#8)
three-dimensional optical data-storage density in a two-photon bleaching polymer##2##9##(2008-2#2)
three-dimensional optical##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
three-dimensional pattern of##2##3##(2007-12#1)(2009-10#1)
three-dimensional phase##2##2##(2008-3#2)
three-dimensional photonic crystals##3##3##(2007-11#3)
three-dimensional photonic##5##2##(2007-11#3)(2007-12#1)(2012-2#1)
three-dimensional point-spread function##2##3##(2008-2#1)(2008-3#1)
three-dimensional profile##3##2##(2007-11#1)(2008-3#2)
three-dimensional profilometry by##2##3##(2007-12#1)(2008-3#1)
three-dimensional profilometry##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
three-dimensional protein##2##2##(1990-11#1)(1995-2#1)
three-dimensional quantitative##2##2##(2009-3#1)(2011-3#1)
three-dimensional reconstruction of##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
three-dimensional reconstruction##8##2##(2007-12#1)(2007-8#3)(2008-2#1)(2008-3#1)(2008-4#1)(2011-7#1)
three-dimensional reconstructions##2##2##(2007-11#1)(2008-11#1)
three-dimensional refractive-index##3##2##(2007-11#3)
three-dimensional resolution##2##2##(2007-12#1)(2008-3#1)
three-dimensional shape measurement of##2##4##(2008-3#2)
three-dimensional shape measurement##4##3##(2008-3#4)
three-dimensional shape##8##2##(2008-2#1)(2008-3#6)(2008-8#1)
three-dimensional shapes##2##2##(2008-3#1)(2008-7#1)
three-dimensional space##7##2##(1997-2#1)(2008-2#2)(2008-3#4)
three-dimensional spatial##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
three-dimensional structural##2##2##(2008-8#1)(2012-12#1)
three-dimensional structure and##2##3##(2008-7#1)(2008-8#1)
three-dimensional structure of the##5##4##(1990-7#1)(1990-8#1)(1993-8#1)(1997-4#1)(2008-7#1)
three-dimensional structure of##16##3##(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-4#2)(1997-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
three-dimensional structure##24##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-11#2)(1993-6#1)(1993-8#1)(1995-2#1)(1997-4#2)(1997-6#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
three-dimensional structures of##3##3##(1995-2#1)(2007-11#1)(2008-9#1)
three-dimensional structures##5##2##(1995-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
three-dimensional surface##5##2##(2008-3#4)(2008-5#1)
three-dimensional system##2##2##(2007-12#1)(2007-8#1)
three-dimensional temperature##3##2##(2008-3#3)
three-dimensional topography##2##2##(2008-2#2)
three-dimensional ultrasonography##2##2##(2013-1#2)
three-dimensional vector##3##2##(2008-3#2)(2008-6#1)
three-dimensional##478##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#6)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#6)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#4)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-4#1)(2007-11#47)(2007-12#41)(2007-8#9)(2008-1#1)(2008-10#12)(2008-11#14)(2008-2#48)(2008-3#147)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#14)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#13)(2011-3#1)(2011-7#2)(2012-12#2)(2012-2#10)(2012-3#3)(2012-4#2)(2013-1#12)(2013-8#2)
three-dimensionally##3##1##(2007-11#1)(2007-12#1)(2008-10#1)
three-drug regimen##2##2##(1996-11#1)(2010-3#1)
three-drug##3##1##(1996-11#2)(2010-3#1)
three-electrode cell##3##2##(2008-10#3)
three-electrode system##3##2##(2008-10#3)
three-electrode##7##1##(2008-10#6)(2009-9#1)
three-element##2##1##(2007-12#1)(2008-2#1)
three-fold higher##2##2##(2008-10#1)(2008-7#1)
three-fold increase##3##2##(1993-11#1)(1993-12#1)(2008-7#1)
three-fold##14##1##(1993-11#1)(1993-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
three-fourths of the##4##3##(1994-1#1)(1995-1#1)(1997-2#1)(1997-5#1)
three-generation##4##1##(2008-10#3)(2009-12#1)
three-helix##2##1##(2008-7#2)
three-hole chromatomembrane cell##2##3##(2008-10#2)
three-hole##3##1##(2008-10#3)
three-hospital##2##1##(1994-3#1)(2007-9#1)
three-judge panel##4##2##(1995-12#1)(1995-6#1)(1997-5#2)
three-layer feed-forward##2##2##(2008-10#1)(2008-2#1)
three-layer##8##1##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
three-layered##5##1##(2007-12#1)(2008-10#3)(2008-12#1)
three-level atomic##2##2##(2007-11#2)
three-level##12##1##(1992-1#1)(1994-3#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-5#1)(2011-2#1)
three-line manifold##2##2##(2008-10#2)
three-line##3##1##(1995-2#1)(2008-10#2)
three-mirror cavity##2##2##(2008-3#2)
three-mirror configuration##2##2##(2007-11#1)(2007-12#1)
three-mirror##7##1##(2007-11#1)(2007-12#1)(2008-3#5)
three-month period##2##2##(1991-6#1)(2013-1#1)
three-month##9##1##(1991-6#2)(1993-11#1)(1994-6#1)(1997-4#1)(2008-5#1)(2012-3#1)(2013-1#2)
three-parameter logistic##2##2##(2008-10#2)
three-parameter##5##1##(1992-1#1)(2008-10#2)(2008-6#1)(2013-8#1)
three-part##6##1##(1994-12#1)(1995-1#1)(1995-2#2)(2007-8#1)(2008-7#1)
three-phase##3##1##(2007-5#1)(2008-10#1)(2013-1#1)
three-photon##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
three-photon-absorption autocorrelation##2##2##(2007-12#2)
three-point##2##1##(2008-10#1)(2008-12#1)
three-port##3##1##(2007-11#2)(2007-12#1)
three-quarters of the##2##3##(1996-3#1)(1996-6#1)
three-quarters of##3##2##(1996-3#1)(1996-6#1)(2008-9#1)
three-quarters##4##1##(1996-3#1)(1996-6#1)(2008-9#1)(2013-8#1)
three-spined##3##1##(2008-9#1)(2010-8#2)
three-stage##9##1##(1991-6#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-6#2)
three-state##4##1##(1993-8#1)(1997-2#1)(2008-3#2)
three-step process##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
three-step sequential extraction procedure for the fractionation of##2##8##(2008-10#2)
three-step sequential extraction procedure##4##4##(2008-10#4)
three-step sequential extraction##5##3##(2008-10#5)
three-step##19##1##(1994-12#1)(1994-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#3)(2011-2#2)(2012-3#1)(2013-1#1)
three-stranded##2##1##(1997-9#2)
three-terminal molecular##2##2##(2009-11#2)
three-terminal##5##1##(2008-3#2)(2008-7#1)(2009-11#2)
three-vessel coronary disease##2##3##(2007-8#2)
three-vessel##3##1##(2007-8#3)
three-wave parametric##2##2##(2007-11#1)(2007-12#1)
three-wave##4##1##(2007-11#3)(2007-12#1)
three-wavelength Raman-lidar observations##2##3##(2008-3#2)
three-wavelength##9##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)
three-way data##7##2##(2008-10#7)
three-way interaction##3##2##(2008-10#1)(2009-5#1)(2010-2#1)
three-way partial least squares##2##4##(2008-10#2)
three-way solenoid valves##6##3##(2008-10#6)
three-way solenoid##7##2##(2008-10#7)
three-way##36##1##(2007-12#1)(2008-10#32)(2009-5#1)(2010-2#1)(2013-1#1)
three-week##4##1##(2008-2#1)(2009-6#1)(2011-3#1)(2013-8#1)
three-year educational programme##2##3##(2008-11#2)
three-year educational##3##2##(2008-11#3)
three-year period##6##2##(1993-3#1)(1997-1#1)(1997-3#1)(2007-7#1)(2011-2#1)(2012-2#1)
three-year##23##1##(1990-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-11#6)(2008-12#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
threefold higher##2##2##(2008-10#1)(2008-2#1)
threefold to##2##2##(2007-11#1)(2008-5#1)
threefold##25##1##(1992-11#1)(1993-12#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
three months##2##1##(2012-2#2)
threonine and tyrosine residues##2##4##(1990-11#1)(1994-11#1)
threonine and##4##2##(1990-11#1)(1993-8#1)(1994-11#1)(2008-5#1)
threonine residue##5##2##(1990-5#1)(1991-12#1)(1993-11#1)(1993-6#1)(2008-8#1)
threonine residues##4##2##(1991-12#1)(1993-3#1)(1994-9#1)(2008-11#1)
threonine##32##1##(1990-11#1)(1990-5#1)(1991-12#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-9#1)(1996-2#1)(1997-8#6)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2013-7#1)
threshold (&lt##2##2##(2007-11#1)(2008-2#1)
threshold (LNT) model for##2##4##(2008-7#1)(2013-1#1)
threshold (LNT) model##3##3##(2008-7#2)(2013-1#1)
threshold (LNT)##4##2##(2008-7#3)(2013-1#1)
threshold and the##2##3##(2008-11#1)(2008-8#1)
threshold and##9##2##(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
threshold are##2##2##(2008-3#1)(2008-7#1)
threshold as a##2##3##(2007-11#1)(2008-3#1)
threshold as##7##2##(2007-11#1)(2007-12#2)(2008-3#1)(2008-8#2)(2010-11#1)
threshold at##7##2##(1990-6#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-2#2)(2008-3#1)
threshold behavior##2##2##(2007-11#2)
threshold between the##2##3##(2008-10#1)(2009-12#1)
threshold concentration of##5##3##(1993-12#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#1)
threshold concentration##10##2##(1990-8#1)(1992-9#1)(1993-12#3)(1994-9#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#1)
threshold concentrations##4##2##(1993-12#2)(2008-10#2)
threshold conditions##2##2##(2008-10#1)(2008-8#1)
threshold criteria##2##2##(2008-2#1)(2008-3#1)
threshold current##6##2##(1993-12#1)(2007-11#1)(2008-2#1)(2008-3#3)
threshold density##2##2##(2008-10#1)(2008-8#1)
threshold dose##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
threshold effect##7##2##(2008-10#1)(2008-3#2)(2008-8#2)(2010-1#2)
threshold effects##2##2##(2008-7#1)(2008-9#1)
threshold energy##4##2##(2007-12#2)(2008-3#2)
threshold exists##2##2##(2007-11#1)(2008-11#1)
threshold for the##5##3##(1990-8#1)(2007-11#1)(2008-3#3)
threshold for##34##2##(1990-8#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-2#2)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-3#7)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
threshold in a##2##3##(2008-8#1)(2013-8#1)
threshold in the##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
threshold in##10##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
threshold is##16##2##(1996-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#2)(2008-9#1)(2009-5#1)
threshold level##8##2##(2007-11#1)(2008-10#3)(2008-2#1)(2010-10#1)(2011-1#2)
threshold levels##3##2##(2008-10#2)(2008-9#1)
threshold limit values##2##3##(1991-12#1)(1991-4#1)
threshold limit##3##2##(1991-12#1)(1991-4#1)(2008-10#1)
threshold measurements##2##2##(1990-11#1)(1993-12#1)
threshold migration rate##2##3##(2008-8#2)
threshold of 0##2##3##(2008-10#1)(2008-2#1)
threshold of the##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
threshold of##39##2##(1996-5#1)(2007-11#3)(2007-12#3)(2008-10#10)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
threshold or##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
threshold power##5##2##(2007-12#2)(2008-2#3)
threshold pump power##3##3##(2007-12#1)(2008-2#2)
threshold pump##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
threshold temperature##3##2##(2008-3#1)(2008-6#1)(2010-4#1)
threshold to##11##2##(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-12#2)(2012-1#1)
threshold value##11##2##(1992-6#1)(1996-8#3)(2008-10#6)(2009-8#1)
threshold values are##2##3##(2008-10#1)(2013-8#1)
threshold values##8##2##(1992-6#1)(1997-2#1)(2008-10#4)(2008-2#1)(2013-8#1)
threshold varies##2##2##(2008-1#1)(2008-8#1)
threshold was##13##2##(1993-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2012-1#1)
threshold when##2##2##(2008-10#1)(2008-3#1)
threshold##483##1##(1990-11#3)(1990-6#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#11)(1993-3#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#3)(1997-2#3)(1997-4#1)(1997-5#2)(2007-10#1)(2007-11#27)(2007-12#32)(2007-7#1)(2008-1#5)(2008-10#87)(2008-11#6)(2008-12#3)(2008-2#31)(2008-3#71)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#27)(2008-8#23)(2008-9#17)(2009-11#1)(2009-12#3)(2009-5#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#8)(2011-2#10)(2012-1#4)(2012-12#1)(2012-2#8)(2012-3#2)(2012-9#1)(2013-1#7)(2013-8#8)
threshold&quot##4##1##(1990-3#1)(1991-11#3)
threshold)##3##1##(2008-2#1)(2008-7#1)(2009-4#1)
threshold-like##2##1##(2008-7#2)
thresholding is##2##2##(2008-2#1)(2008-3#1)
thresholding technique##3##2##(2007-11#1)(2009-10#1)(2011-1#1)
thresholding##17##1##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#5)(2009-10#1)(2010-4#2)(2010-8#1)(2011-1#1)
thresholds and the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
thresholds and##11##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2012-2#1)
thresholds are##4##2##(2008-4#1)(2008-8#1)(2012-2#2)
thresholds by##2##2##(1993-1#1)(2008-2#1)
thresholds for##11##2##(1996-3#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-1#1)
thresholds in##7##2##(1997-2#1)(2006-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
thresholds of##10##2##(2008-10#1)(2008-3#4)(2008-4#2)(2008-9#2)(2012-12#1)
thresholds that##3##2##(2007-12#1)(2008-3#1)(2008-4#1)
thresholds to##7##2##(1992-11#2)(1993-1#3)(1995-6#1)(2008-10#1)
thresholds was##2##2##(1993-12#1)(1997-3#1)
thresholds were##4##2##(1992-11#1)(1993-12#1)(2008-2#1)(2011-2#1)
thresholds##125##1##(1992-11#4)(1993-1#4)(1993-12#5)(1994-2#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#7)(1997-5#3)(2006-12#1)(2007-11#2)(2007-12#3)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#14)(2008-4#11)(2008-7#9)(2008-8#6)(2008-9#11)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
thrice weekly##2##2##(1990-5#1)(1990-7#1)
thrice##5##1##(1990-5#1)(1990-7#1)(2007-12#1)(2008-12#1)(2013-1#1)
thrifty genes##2##2##(2008-1#2)
thrifty genes&quot##2##2##(2008-1#2)
thrifty##4##1##(2008-1#4)
thrips produced on##2##3##(2008-10#2)
thrips resistance##2##2##(2008-10#2)
thrips species##4##2##(2008-10#4)
thrips that##2##2##(2008-10#2)
thrips were##3##2##(2008-10#3)
thrips##46##1##(2007-12#1)(2008-10#40)(2009-8#3)(2011-2#2)
thrive in the##2##3##(1996-1#1)(1997-1#1)
thrive##17##1##(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-2#1)(2012-3#1)
thriving##3##1##(1994-12#1)(2008-7#1)(2012-2#1)
throat and##3##2##(1992-6#1)(1996-8#1)(2008-1#1)
throat pack##3##2##(2008-2#1)(2012-12#2)
throat specialists##5##2##(1990-12#1)(1993-2#4)
throat swabs were collected from##2##5##(2013-8#2)
throat##22##1##(1990-12#1)(1992-6#1)(1993-2#4)(1995-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#3)(2012-12#2)(2013-8#3)
thrombectomy and##2##2##(2008-1#1)(2011-2#1)
thrombectomy in##2##2##(1997-8#1)(2011-2#1)
thrombectomy of##3##2##(2007-7#1)(2011-2#2)
thrombectomy with##2##2##(1996-6#1)(2013-8#1)
thrombectomy##16##1##(1996-6#1)(1997-8#1)(2007-7#1)(2008-1#2)(2011-2#9)(2013-8#2)
thrombelastographic##2##1##(1997-4#2)
thrombendarterectomy##3##1##(2011-2#3)
thrombi in##3##2##(1997-3#1)(2008-1#1)(2010-10#1)
thrombi or##2##2##(2008-7#1)(2011-1#1)
thrombi##19##1##(1995-8#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2012-3#1)(2013-8#2)
thrombin and##7##2##(1990-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-7#1)(2007-10#1)
thrombin binding##2##2##(1994-11#1)(2009-12#1)
thrombin in##3##2##(1992-8#1)(1997-2#1)(2008-4#1)
thrombin inhibitor##8##2##(1991-9#2)(1994-5#1)(1995-5#1)(2008-5#1)(2012-12#1)(2013-1#2)
thrombin injection##3##2##(2008-7#3)
thrombin or##3##2##(1991-12#1)(1993-6#1)(1997-7#1)
thrombin receptor##4##2##(1992-4#1)(1997-7#3)
thrombin stimulation##4##2##(1990-8#1)(1992-12#1)(1993-8#1)(1997-7#1)
thrombin was also inhibited by##2##5##(1992-8#2)
thrombin##94##1##(1990-5#4)(1990-7#7)(1990-8#1)(1991-12#1)(1991-9#8)(1992-12#3)(1992-4#6)(1992-6#7)(1992-8#4)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#5)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#1)(1997-2#3)(1997-7#9)(2006-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#3)(2009-3#1)(2012-12#1)(2013-1#4)(2013-8#1)
thrombin-antithrombin##2##1##(1991-3#2)
thrombin-induced##3##1##(1991-9#1)(1992-8#1)(1995-11#1)
thrombin-like##3##1##(1994-9#1)(2008-5#2)
thrombin-stimulated##5##1##(1992-8#1)(1993-8#2)(1995-11#1)(2008-8#1)
thrombo-embolic##5##1##(1990-8#1)(1997-6#2)(2008-12#1)(2008-7#1)
thrombo-embolism##2##1##(2007-8#1)(2008-8#1)
thromboangiitis obliterans##2##2##(1996-8#1)(2006-10#1)
thromboangiitis##3##1##(1990-8#1)(1996-8#1)(2006-10#1)
thrombocyte count##2##2##(1990-2#1)(1995-3#1)
thrombocyte##3##1##(1990-2#1)(1995-3#2)
thrombocytes##8##1##(1990-2#2)(2008-7#1)(2013-1#5)
thrombocytopaenia##2##1##(2008-7#1)(2008-8#1)
thrombocytopenia (HIT) is a serious##2##5##(2008-10#1)(2013-1#1)
thrombocytopenia (HIT) is##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
thrombocytopenia (HIT)##5##2##(1997-2#1)(2008-10#1)(2010-3#1)(2013-1#2)
thrombocytopenia and##6##2##(1991-11#1)(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
thrombocytopenia in##3##2##(1996-11#1)(2008-11#1)(2008-8#1)
thrombocytopenia is##2##2##(1997-2#1)(2008-11#1)
thrombocytopenia that##2##2##(2006-10#1)(2010-5#1)
thrombocytopenia type II##2##3##(2007-8#1)(2013-1#1)
thrombocytopenia##55##1##(1990-10#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-6#2)(1994-3#1)(1995-3#1)(1996-11#1)(1997-2#4)(1997-7#1)(2006-10#2)(2006-6#1)(2007-2#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#8)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#6)
thrombocytopenic purpura and##3##3##(2007-7#1)(2008-4#1)(2012-2#1)
thrombocytopenic purpura##15##2##(1991-3#2)(1992-5#1)(1995-3#2)(1997-8#2)(2006-10#1)(2006-6#1)(2007-7#1)(2008-4#1)(2009-7#1)(2012-2#1)(2012-3#2)
thrombocytopenic##17##1##(1991-3#2)(1991-4#1)(1992-5#1)(1995-3#2)(1997-8#2)(2006-10#1)(2006-6#2)(2007-7#1)(2008-4#1)(2009-7#1)(2012-2#1)(2012-3#2)
thrombocytosis##9##1##(1990-11#1)(1990-12#4)(1997-7#2)(2006-6#1)(2011-2#1)
thromboembolic complications##8##2##(1990-12#1)(1990-9#1)(1997-6#1)(2007-8#2)(2013-1#3)
thromboembolic disease##7##2##(1996-3#1)(1996-9#1)(2007-8#2)(2010-10#1)(2012-2#2)
thromboembolic event##4##2##(2007-8#1)(2008-7#1)(2010-6#1)(2013-8#1)
thromboembolic events##6##2##(1994-3#1)(2007-8#2)(2008-10#1)(2008-7#1)(2013-1#1)
thromboembolic pulmonary hypertension (CTEPH) is##3##5##(2010-6#3)
thromboembolic pulmonary hypertension (CTEPH)##7##4##(2010-6#7)
thromboembolic pulmonary hypertension##10##3##(2009-10#1)(2010-10#1)(2010-6#7)(2013-1#1)
thromboembolic pulmonary hypertension]##8##3##(2010-6#8)
thromboembolic pulmonary##19##2##(2009-10#1)(2010-10#2)(2010-6#15)(2013-1#1)
thromboembolic risk##3##2##(2008-7#3)
thromboembolic##58##1##(1990-12#1)(1990-9#1)(1991-3#1)(1992-9#1)(1994-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-8#7)(2007-9#1)(2008-10#2)(2008-7#7)(2008-8#1)(2009-10#1)(2010-10#4)(2010-3#1)(2010-6#16)(2010-8#1)(2012-2#2)(2013-1#5)(2013-8#1)
thromboembolism (VTE)##5##2##(2007-10#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
thromboembolism after##4##2##(2007-10#1)(2007-8#1)(2013-1#2)
thromboembolism and##6##2##(1990-9#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-7#2)
thromboembolism guidebook##2##2##(2008-3#2)
thromboembolism in##9##2##(1993-5#2)(2007-8#2)(2008-12#2)(2008-7#1)(2010-11#2)
thromboembolism prophylaxis##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
thromboembolism##62##1##(1990-12#2)(1990-9#1)(1993-5#5)(1994-3#1)(1996-11#3)(1997-2#1)(1997-5#4)(2006-10#1)(2007-10#4)(2007-2#1)(2007-8#7)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-6#1)(2008-7#6)(2010-11#3)(2010-6#3)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
thromboendarterectomy##3##1##(2010-6#3)
thrombogenesis##4##1##(2006-6#2)(2007-8#1)(2013-1#1)
thrombogenic##6##1##(1994-5#1)(1996-9#2)(2008-6#1)(2008-7#1)(2008-8#1)
thrombolysis and##2##2##(1997-8#1)(2007-10#1)
thrombolysis for##4##2##(2007-10#3)(2008-8#1)
thrombolysis has been##2##3##(2007-10#2)
thrombolysis has##3##2##(1994-3#1)(2007-10#2)
thrombolysis in acute##3##3##(1990-12#1)(2007-10#1)(2009-11#1)
thrombolysis in##6##2##(1990-12#1)(1996-6#1)(2007-10#1)(2008-8#1)(2009-11#1)(2009-6#1)
thrombolysis is##5##2##(1990-12#1)(1994-11#1)(1996-6#1)(2007-10#1)(2007-9#1)
thrombolysis of##5##2##(1993-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2013-8#1)
thrombolysis with##2##2##(2007-10#1)(2009-11#1)
thrombolysis##56##1##(1990-12#2)(1990-3#4)(1991-3#1)(1992-2#1)(1993-2#1)(1994-11#2)(1994-3#3)(1996-6#5)(1997-3#1)(1997-8#2)(2007-10#17)(2007-9#4)(2008-2#1)(2008-5#1)(2008-8#5)(2009-11#2)(2009-6#1)(2011-2#1)(2013-8#2)
thrombolysis'##2##1##(2008-11#2)
thrombolysis-eligible##3##1##(2008-3#2)(2009-11#1)
thrombolysis]##2##1##(1992-5#1)(1994-11#1)
thrombolytic agent for##2##3##(2008-7#1)(2012-2#1)
thrombolytic agent##4##2##(2008-7#3)(2012-2#1)
thrombolytic agents are##2##3##(1994-11#1)(2008-7#1)
thrombolytic agents##5##2##(1994-11#1)(2007-10#1)(2007-11#1)(2008-7#2)
thrombolytic and##2##2##(2007-9#1)(2008-3#1)
thrombolytic therapy for patients with##4##5##(2008-11#3)(2009-11#1)
thrombolytic therapy for##7##3##(1997-8#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-11#1)
thrombolytic therapy in##2##3##(1994-6#1)(2008-8#1)
thrombolytic therapy##24##2##(1993-9#1)(1994-6#1)(1995-3#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-8#1)(2007-9#2)(2008-11#4)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2013-7#1)
thrombolytic treatment##4##2##(1990-3#1)(2007-10#2)(2008-3#1)
thrombolytic##48##1##(1990-12#1)(1990-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-3#1)(1997-8#1)(2007-10#6)(2007-11#4)(2007-8#1)(2007-9#3)(2008-11#4)(2008-3#7)(2008-6#1)(2008-7#7)(2008-8#3)(2009-11#1)(2012-2#1)(2013-7#1)
thrombolytics is##2##2##(2006-7#1)(2008-2#1)
thrombolytics##9##1##(1997-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-2#2)(2008-8#1)
thrombomodulin##5##1##(1990-5#4)(1997-2#1)
thrombophilia##2##1##(1992-3#1)(2010-3#1)
thrombophlebitis##2##1##(1995-1#1)(2013-1#1)
thrombopoietin##5##1##(2008-4#1)(2008-8#3)(2012-12#1)
thromboprophylaxis##3##1##(2010-11#1)(2013-1#2)
thrombosed##9##1##(1995-11#1)(1996-3#1)(1997-3#2)(1997-8#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
thromboses of##2##2##(2008-1#1)(2011-2#1)
thromboses##10##1##(1991-3#1)(1997-5#1)(2006-10#1)(2008-1#2)(2010-1#1)(2010-12#1)(2011-2#3)
thrombosis (DVT)##6##2##(1993-5#1)(1997-8#1)(2007-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
thrombosis after##6##2##(1990-6#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)
thrombosis and##16##2##(1990-3#1)(1992-12#1)(1993-9#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
thrombosis associated with##2##3##(2007-8#1)(2008-12#1)
thrombosis following##2##2##(1990-9#1)(2007-2#1)
thrombosis in a##4##3##(2007-10#1)(2008-7#1)(2009-1#1)(2013-1#1)
thrombosis in the##5##3##(2006-6#1)(2008-1#1)(2011-2#2)(2013-8#1)
thrombosis in vivo##2##3##(2006-6#1)(2008-9#1)
thrombosis in##23##2##(1990-8#1)(1992-9#1)(1996-6#1)(2006-6#2)(2007-10#1)(2008-1#2)(2008-7#1)(2008-9#3)(2009-1#1)(2010-11#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
thrombosis is a##2##3##(2007-8#1)(2013-8#1)
thrombosis is##8##2##(1990-8#1)(1992-9#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-12#1)(2013-8#1)
thrombosis may##3##2##(1996-9#1)(2008-7#1)(2010-6#1)
thrombosis occurring##2##2##(2008-11#1)(2012-3#1)
thrombosis of a major trunk (MCA##2##6##(1997-3#2)
thrombosis of the##5##3##(1991-11#1)(1993-2#1)(1996-6#1)(1997-6#1)(2006-12#1)
thrombosis of##13##2##(1991-11#1)(1993-2#1)(1994-6#1)(1996-6#2)(1997-3#2)(1997-6#2)(2006-12#1)(2011-2#2)(2012-12#1)
thrombosis or##2##2##(2007-12#1)(2007-7#1)
thrombosis related to##2##3##(1994-3#1)(2010-6#1)
thrombosis related##3##2##(1994-3#1)(2007-2#1)(2010-6#1)
thrombosis that##3##2##(2006-10#1)(2007-10#1)(2007-2#1)
thrombosis with##4##2##(1995-5#1)(1997-8#1)(2008-10#1)(2008-8#1)
thrombosis##187##1##(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#3)(1992-9#2)(1993-2#1)(1993-5#1)(1993-9#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-5#1)(1996-6#4)(1996-9#1)(1997-2#3)(1997-3#5)(1997-6#4)(1997-8#4)(2006-10#2)(2006-12#1)(2006-6#5)(2007-10#11)(2007-11#1)(2007-12#1)(2007-2#4)(2007-7#3)(2007-8#6)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#14)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#3)(2010-8#1)(2011-2#17)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
thrombospondin (TSP)##2##2##(1993-6#1)(1993-9#1)
thrombospondin 1##6##2##(1994-5#6)
thrombospondin##13##1##(1991-2#1)(1993-6#2)(1993-9#2)(1994-5#6)(1997-7#1)(2009-7#1)
thrombotic and##2##2##(2007-7#1)(2011-2#1)
thrombotic complications##3##2##(2007-8#1)(2008-5#1)(2011-2#1)
thrombotic endocarditis##4##2##(1996-11#4)
thrombotic event##2##2##(2010-6#1)(2012-12#1)
thrombotic events##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
thrombotic microangiopathy##2##2##(2008-1#1)(2013-8#1)
thrombotic occlusion##3##2##(1996-2#1)(2011-1#1)(2013-1#1)
thrombotic occlusions##3##2##(2011-2#3)
thrombotic response##2##2##(2006-6#1)(2008-4#1)
thrombotic risk##3##2##(2008-12#1)(2010-11#1)(2010-3#1)
thrombotic thrombocytopenic purpura and##2##4##(2007-7#1)(2008-4#1)
thrombotic thrombocytopenic purpura##6##3##(1991-3#1)(1995-3#2)(2007-7#1)(2008-4#1)(2009-7#1)
thrombotic vegetation##2##2##(2006-6#2)
thrombotic##54##1##(1990-3#1)(1991-3#1)(1991-9#1)(1995-3#2)(1996-11#4)(1996-2#1)(1997-1#1)(2006-6#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-6#3)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
thromboxane (TX)##2##2##(1992-12#1)(1992-8#1)
thromboxane A2 mimetic##2##3##(1993-11#1)(2008-8#1)
thromboxane A2##10##2##(1990-3#2)(1990-8#1)(1991-5#1)(1992-9#2)(1993-11#3)(2008-8#1)
thromboxane B2 and##2##3##(1991-8#1)(1995-12#1)
thromboxane B2 concentration##2##3##(1990-12#2)
thromboxane B2##13##2##(1990-12#5)(1990-3#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-5#1)
thromboxane in##2##2##(1990-12#1)(1994-6#1)
thromboxane synthase##3##2##(1991-5#3)
thromboxane##40##1##(1990-12#6)(1990-3#3)(1990-5#2)(1990-8#1)(1991-5#4)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#4)(1993-3#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)
thromboxanes##3##1##(1990-3#1)(2006-6#1)(2008-4#1)
thrombus and##3##2##(2007-8#2)(2008-8#1)
thrombus formation and##2##3##(1996-8#1)(2012-2#1)
thrombus formation at##2##3##(2006-6#2)
thrombus formation##14##2##(1991-9#1)(1996-8#1)(2006-6#8)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
thrombus in the##5##3##(2007-9#1)(2011-2#4)
thrombus in##9##2##(2007-9#1)(2008-7#1)(2008-9#1)(2011-2#6)
thrombus was##5##2##(1990-8#2)(2011-2#1)(2013-1#2)
thrombus##60##1##(1990-8#4)(1991-9#1)(1992-9#1)(1996-8#1)(1997-6#1)(2006-6#8)(2007-2#1)(2007-8#5)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-2#1)(2010-6#1)(2011-2#13)(2012-2#1)(2013-1#5)(2013-8#1)
through &quot##2##2##(2008-8#1)(2013-7#1)
through 10##2##2##(1995-1#1)(2008-3#1)
through 12##2##2##(2009-7#1)(2013-1#1)
through 16##2##2##(2007-12#1)(2009-7#1)
through 1984##4##2##(1990-6#1)(1991-3#1)(1991-4#1)(1993-3#1)
through 1986##4##2##(1991-12#2)(1991-2#1)(1991-3#1)
through 1987 for##2##3##(1991-12#1)(1993-12#1)
through 1987##4##2##(1991-12#1)(1993-1#1)(1993-12#2)
through 1988##6##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-3#1)(1996-3#1)
through 1989##4##2##(1992-12#2)(1993-6#1)(1994-2#1)
through 1991##2##2##(1996-1#1)(1997-2#1)
through 1996##8##2##(1997-4#1)(2008-1#1)(2008-10#5)(2008-9#1)
through 2##3##2##(1992-6#1)(2008-3#1)(2009-8#1)
through 2001##2##2##(2008-10#2)
through 2003##2##2##(2008-10#1)(2008-7#1)
through 2004##2##2##(2008-4#1)(2008-8#1)
through 6##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
through April##2##2##(1992-6#1)(2008-10#1)
through August 1994##2##3##(1994-9#2)
through August##5##2##(1994-9#2)(2008-10#2)(2008-8#1)
through BABO##2##2##(2008-9#2)
through Ca2+ channels##2##3##(1993-12#2)
through Congress##2##2##(1996-5#1)(2007-9#1)
through D)##2##2##(2008-10#1)(2012-2#1)
through December##7##2##(1990-6#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
through February##2##2##(1992-8#1)(2009-9#1)
through Gene##2##2##(2008-4#1)(2010-7#1)
through January##3##2##(1997-1#1)(2008-5#1)(2012-12#1)
through July##4##2##(2008-10#2)(2009-2#1)(2010-9#1)
through June##4##2##(1995-1#1)(1996-2#1)(2007-10#1)(2008-3#1)
through March##2##2##(1991-5#1)(2008-7#1)
through NMDA##2##2##(1997-6#1)(2009-12#1)
through October##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
through September##3##2##(1991-3#1)(2007-7#1)(2011-2#1)
through X-ray##3##2##(2008-10#2)(2013-8#1)
through a 0##7##3##(1997-8#1)(2008-10#2)(2008-12#2)(2008-5#2)
through a Fabry-Perot##2##3##(2008-2#2)
through a PTFE membrane into an acceptor stream##2##8##(2008-10#2)
through a bleaching medium##2##4##(2007-11#2)
through a case study of the##2##6##(2008-7#1)(2011-2#1)
through a case study of##3##5##(2008-3#1)(2008-7#1)(2011-2#1)
through a case study##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
through a case##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
through a catheter##2##3##(1993-10#1)(2008-10#1)
through a cell##3##3##(2007-12#2)(2008-10#1)
through a central##2##3##(1991-5#1)(2011-2#1)
through a collaborative##2##3##(1994-3#1)(2008-10#1)
through a combination of##10##4##(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
through a comparison with##3##4##(2008-10#1)(2013-1#2)
through a complex##2##3##(2008-6#1)(2010-11#1)
through a continuous##2##3##(1993-3#1)(2008-10#1)
through a critical##2##3##(2008-11#1)(2009-9#1)
through a defect##2##3##(2011-2#2)
through a detailed##2##3##(2008-10#1)(2011-7#1)
through a direct##3##3##(2008-8#1)(2008-9#1)(2009-7#1)
through a fiber with##2##4##(2008-3#2)
through a fiber##3##3##(2008-3#3)
through a film##2##3##(2007-11#1)(2008-11#1)
through a formal##2##3##(1994-12#2)
through a given##2##3##(2008-3#2)
through a glass##2##3##(2008-10#2)
through a highly scattering##2##4##(2007-12#1)(2008-2#1)
through a highly##4##3##(1993-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
through a home-made##2##3##(2008-10#2)
through a layer##2##3##(2008-10#1)(2008-2#1)
through a lesion of their spinal pathway##2##7##(1996-5#2)
through a linear polarizing filter##2##5##(2008-2#1)(2008-3#1)
through a liquid membrane##3##4##(2008-10#3)
through a liquid##4##3##(2007-12#1)(2008-10#3)
through a long##2##3##(2008-10#1)(2008-7#1)
through a longitudinal##2##3##(2009-5#1)(2013-1#1)
through a mechanism other than##2##5##(2008-6#1)(2008-9#1)
through a mechanism##8##3##(1991-2#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
through a medium##2##3##(2007-11#1)(2008-3#1)
through a membrane##2##3##(2008-10#2)
through a model of##2##4##(2008-3#1)(2008-7#1)
through a modification of the##2##5##(2008-10#1)(2013-1#1)
through a modification##3##3##(2008-10#2)(2013-1#1)
through a national##3##3##(1993-12#1)(1995-12#1)(2008-11#1)
through a network of##2##4##(2008-7#1)(2012-3#1)
through a novel mechanism##2##4##(2012-3#1)(2013-8#1)
through a novel##6##3##(1993-5#1)(2008-10#1)(2009-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
through a one-step##2##3##(2008-10#1)(2008-4#1)
through a phase mask##2##4##(2007-11#1)(2008-2#1)
through a post-transcriptional mechanism##2##4##(1992-1#2)
through a posterior##2##3##(2008-9#1)(2012-12#1)
through a posterolateral thoracotomy##2##4##(2007-12#1)(2010-12#1)
through a posterolateral##3##3##(2007-12#1)(2010-12#1)(2010-3#1)
through a process that##3##4##(1994-2#1)(2008-10#2)
through a process##5##3##(1994-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
through a range of##4##4##(2007-12#2)(2008-11#1)(2008-12#1)
through a reaction coil to a##2##6##(2008-10#2)
through a reaction coil##3##4##(2008-10#3)
through a receptor##4##3##(1991-5#1)(1993-8#2)(1995-2#1)
through a retrospective##3##3##(1995-12#1)(2010-7#1)(2011-2#1)
through a sample##2##3##(2007-11#1)(2008-10#1)
through a scattering medium##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
through a scattering##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
through a selective##2##3##(1994-12#1)(2008-7#1)
through a series of##8##4##(1990-7#1)(1993-3#1)(1994-6#1)(1996-3#1)(2007-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
through a set of##3##4##(2008-10#1)(2008-3#1)(2011-3#1)
through a similar##2##3##(1990-12#1)(2008-10#1)
through a simple example##2##4##(2007-12#1)(2013-8#1)
through a simple##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
through a single##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
through a single-mode fiber##2##4##(2007-11#1)(2008-3#1)
through a single-mode optical fiber##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
through a single-mode##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
through a small##4##3##(1990-2#1)(1991-12#1)(1996-8#1)(2011-2#1)
through a specific##2##3##(1990-12#1)(1995-11#1)
through a stratified##3##3##(1996-8#1)(2008-3#2)
through a subwavelength aperture##2##4##(2007-12#1)(2008-7#1)
through a supported liquid membrane##2##5##(2008-10#1)(2012-1#1)
through a survey##2##3##(2011-2#1)(2012-3#1)
through a tank##2##3##(2008-2#1)(2008-6#1)
through a turbid##2##3##(2007-11#1)(2007-12#1)
through a variety of mechanisms##3##5##(2007-5#1)(2008-3#1)(2011-2#1)
through a variety of##9##4##(1994-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-2#1)
through a video assisted mini-thoracotomy in##2##6##(2013-1#2)
through a volar approach##2##4##(2008-9#2)
through a web##2##3##(2008-7#2)
through a working##2##3##(2008-10#2)
through a##561##2##(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#3)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-3#4)(1993-5#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#6)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#2)(2007-10#2)(2007-11#26)(2007-12#36)(2007-5#1)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#90)(2008-11#18)(2008-12#12)(2008-2#30)(2008-3#40)(2008-4#9)(2008-5#9)(2008-6#8)(2008-7#27)(2008-8#4)(2008-9#11)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#19)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#3)(2012-12#10)(2012-2#10)(2012-3#5)(2013-1#15)(2013-8#5)
through activation of the##2##4##(2008-1#1)(2013-8#1)
through activation of##12##3##(1994-11#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-4#2)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
through adolescence##3##2##(1995-3#1)(1997-7#1)(2008-11#1)
through air##2##2##(2007-12#1)(2008-10#1)
through all##2##2##(1990-5#1)(2010-2#1)
through alternative##2##2##(1993-11#1)(2008-12#1)
through an analysis of##2##4##(2008-12#1)(2009-5#1)
through an effective##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
through an electrochemical##2##3##(2008-10#2)
through an example##2##3##(2008-4#1)(2010-6#1)
through an experimental##2##3##(2008-3#2)
through an incision##2##3##(2012-12#2)
through an increase in##3##4##(1995-11#1)(1997-1#1)(2008-4#1)
through an increase##4##3##(1995-11#1)(1997-1#1)(2008-4#1)(2008-5#1)
through an independent##2##3##(1993-3#1)(2008-10#1)
through an infinite##2##3##(2007-11#1)(2008-2#1)
through an interaction##2##3##(1992-6#1)(1995-2#1)
through an interface##3##3##(2007-12#2)(2008-3#1)
through an internal##2##3##(2007-7#1)(2008-6#1)
through an inverse-modeling##2##3##(2008-2#1)(2008-3#1)
through an optical fiber##3##4##(2007-12#1)(2008-3#2)
through an optical##9##3##(2007-12#4)(2008-2#2)(2008-3#2)(2008-5#1)
through an##126##2##(1990-11#1)(1990-8#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1997-1#1)(2007-11#2)(2007-12#12)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#25)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#4)
through analysis of##4##3##(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
through animal studies##2##3##(2011-2#1)(2012-2#1)
through animal##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
through anion##2##2##(2008-10#1)(2008-4#1)
through another##2##2##(1996-8#1)(2007-12#1)
through anthesis##2##2##(2008-10#2)
through application of##2##3##(2007-8#1)(2008-10#1)
through application##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
through appropriate##2##2##(1995-3#1)(2008-5#1)
through areas of##2##3##(2008-9#1)(2009-10#1)
through artificial##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
through atmospheric turbulence##4##3##(2008-2#1)(2008-3#3)
through behavioural testing##2##3##(2008-9#2)
through better##3##2##(2008-1#1)(2009-11#1)(2013-8#1)
through binding to the##3##4##(1995-2#2)(2008-9#1)
through binding to##4##3##(1995-2#2)(2008-11#1)(2008-9#1)
through binding##5##2##(1995-2#2)(2008-11#2)(2008-9#1)
through both the##2##3##(2008-10#1)(2009-7#1)
through both##13##2##(1990-12#1)(1991-11#1)(1991-3#1)(1995-6#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-6#1)(2012-2#1)
through breast milk##4##3##(2011-1#1)(2012-2#2)(2013-1#1)
through bulk potting mix##2##4##(2008-10#2)
through bulk##4##2##(2008-10#3)(2008-3#1)
through caecal microflora of rats##2##5##(1993-8#2)
through careful##2##2##(1991-3#1)(1993-12#1)
through case##2##2##(2008-10#1)(2010-4#1)
through cell division##2##3##(1994-5#1)(2009-2#1)
through cell##8##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2011-3#1)
through changes in the##2##4##(2008-1#1)(2008-3#1)
through changes in##6##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
through charge##2##2##(1994-5#1)(2008-10#1)
through chemical##3##2##(2008-10#2)(2008-4#1)
through chimneys##3##2##(2008-9#3)
through cirrus clouds##3##3##(2008-3#3)
through classical##2##2##(2008-2#1)(2008-3#1)
through clinical##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
through clouds##2##2##(2008-2#1)(2008-3#1)
through combinatorial##2##2##(1997-4#1)(2008-4#1)
through common##2##2##(2008-1#1)(2008-5#1)
through community##2##2##(1996-3#1)(2008-11#1)
through community-based##2##2##(1995-1#1)(2008-10#1)
through comparison with##5##3##(1996-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
through comparison##6##2##(1996-12#1)(2008-10#2)(2008-2#1)(2009-5#1)(2011-2#1)
through comparisons with##2##3##(2008-3#1)(2013-7#1)
through comparisons##4##2##(2008-3#1)(2011-3#1)(2013-1#1)(2013-7#1)
through competitive exclusion##2##3##(2008-10#2)
through competitive##5##2##(1993-3#1)(2008-10#2)(2008-7#1)(2008-8#1)
through complex terrain##2##3##(2007-12#2)
through complex##5##2##(2007-12#2)(2008-10#1)(2010-6#1)(2011-2#1)
through compound parabolic##2##3##(2007-12#1)(2013-8#1)
through computer simulations##2##3##(2008-3#1)(2008-7#1)
through computer##4##2##(2006-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
through computerized##2##2##(1997-2#1)(2012-2#1)
through contaminated##2##2##(2007-7#1)(2008-10#1)
through continuous##3##2##(1992-8#1)(1993-1#1)(2012-7#1)
through convenience##2##2##(2011-2#1)(2013-8#1)
through correlation of##2##3##(2008-11#2)
through critical##3##2##(2007-11#1)(2008-11#1)(2010-10#1)
through crop##2##2##(2008-10#1)(2008-7#1)
through cross-phase modulation##2##3##(2007-11#2)
through cyclic voltammetry##2##3##(2008-10#2)
through data##4##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
through deconvolution##2##2##(1997-3#1)(2008-3#1)
through delivery##2##2##(2007-12#1)(2009-9#1)
through development##2##2##(2008-11#1)(2008-8#1)
through different mechanisms##4##3##(1995-2#1)(1995-8#1)(2008-11#1)(2008-7#1)
through different##10##2##(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-3#1)
through differential##2##2##(2008-2#1)(2008-4#1)
through direct##6##2##(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
through directly##2##2##(1996-3#1)(2008-10#1)
through disease##2##2##(2008-10#1)(2012-2#1)
through down-regulation of##4##3##(1993-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
through drinking water##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
through drip irrigation systems##4##4##(2008-10#4)
through each##6##2##(1992-5#1)(2008-1#1)(2008-3#1)(2009-7#1)(2011-1#1)(2013-7#1)
through early April##2##3##(1992-6#2)
through early##3##2##(1992-6#2)(2009-6#1)
through education##6##2##(1991-1#1)(1995-3#1)(2007-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
through educational##4##2##(1996-3#1)(2008-11#2)(2013-1#1)
through effective##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-12#1)
through either##5##2##(1993-8#1)(2008-2#2)(2008-8#1)(2010-8#1)
through electroabsorption spectroscopy##2##3##(2007-12#2)
through electronic##2##2##(2007-11#1)(2008-2#1)
through endothelial cell monolayers##2##4##(2008-10#2)
through endothelial##3##2##(2008-10#3)
through enhanced##2##2##(1997-6#1)(2008-10#1)
through enhancement of##2##3##(2008-11#1)(2010-10#1)
through ether-type polyurethane membrane##2##4##(2008-10#2)
through every##2##2##(2008-11#1)(2010-8#1)
through evolution##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
through examining##3##2##(2008-11#1)(2008-12#1)(2011-1#1)
through experimental##2##2##(2008-3#1)(2012-2#1)
through expert##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
through exposure to##2##3##(2008-12#1)(2008-5#1)
through expression of##2##3##(1991-3#1)(2013-1#1)
through extensive##4##2##(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
through family##2##2##(2010-7#1)(2013-8#1)
through field##2##2##(2008-10#1)(2008-11#1)
through flexible##2##2##(2007-12#1)(2012-3#1)
through focus##2##2##(1994-12#1)(2012-1#1)
through four##4##2##(1994-3#1)(1996-3#1)(2008-1#1)(2008-11#1)
through fracture##2##2##(2008-10#1)(2008-6#1)
through full sib-pair mating##2##4##(2012-3#2)
through functional##2##2##(2008-5#1)(2008-9#1)
through fused silica##2##3##(2007-11#1)(2008-3#1)
through gene##3##2##(1991-11#1)(2008-4#1)(2009-5#1)
through genetic##6##2##(2008-10#4)(2008-2#1)(2011-2#1)
through genomic##2##2##(2008-11#1)(2008-5#1)
through greater##2##2##(2008-6#1)(2009-6#1)
through group##2##2##(2009-3#1)(2012-12#1)
through health care##2##3##(1991-3#1)(1995-2#1)
through health##5##2##(1991-3#1)(1994-1#1)(1995-2#2)(2012-1#1)
through highly scattering media##2##4##(2008-3#2)
through highly scattering##3##3##(2008-2#1)(2008-3#2)
through highly##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
through his##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
through homogeneous##2##2##(2008-3#1)(2010-12#1)
through homologous recombination##2##3##(2008-8#1)(2012-2#1)
through homologous##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
through human tissue##2##3##(2007-11#1)(2008-3#1)
through human##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)
through improved##2##2##(1993-12#1)(1995-2#1)
through in situ##2##3##(2007-12#1)(2010-8#1)
through in##6##2##(2007-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)
through in-person##2##2##(1994-2#1)(2009-7#1)
through incorporation##2##2##(2008-10#1)(2008-11#1)
through increased##5##2##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
through increasing the##3##3##(1991-5#1)(1994-12#1)(2010-2#1)
through increasing##4##2##(1991-5#1)(1994-12#1)(2008-8#1)(2010-2#1)
through induced##2##2##(1991-3#1)(2008-10#1)
through induction of##2##3##(1993-8#1)(2008-10#1)
through induction##3##2##(1993-8#1)(1997-1#1)(2008-10#1)
through inhibition of##8##3##(1994-11#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-5#1)(2011-1#1)(2013-1#2)
through inhibition##9##2##(1992-6#1)(1994-11#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-5#1)(2011-1#1)(2013-1#2)
through intact##3##2##(2008-5#2)(2008-9#1)
through integrating##2##2##(2011-2#1)(2012-2#1)
through interaction with the##4##4##(1994-12#1)(1996-2#1)(2007-11#1)(2008-8#1)
through interaction with##6##3##(1993-6#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-8#1)(2009-2#1)
through international##2##2##(2008-10#1)(2008-11#1)
through interviews##2##2##(2008-11#1)(2008-9#1)
through intramolecular##2##2##(1992-6#1)(1996-5#1)
through it##5##2##(1992-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2013-8#1)
through its effects on##2##4##(2008-12#1)(2012-3#1)
through its##43##2##(1990-12#1)(1991-5#2)(1991-9#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-5#1)(1996-8#1)(1997-7#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
through joint##2##2##(1992-4#1)(1996-5#1)
through large##3##2##(2007-11#2)(2011-2#1)
through large-core microstructured fibers##2##4##(2007-11#2)
through large-core optical fibers##2##4##(2008-3#2)
through large-core##4##2##(2007-11#2)(2008-3#2)
through learning##2##2##(1993-6#1)(2012-3#1)
through linear##2##2##(2007-11#1)(2011-1#1)
through lipid##2##2##(1992-6#1)(1993-11#1)
through local##2##2##(1997-3#1)(2008-5#1)
through loss of##2##3##(1996-5#1)(2012-3#1)
through loss##3##2##(1996-5#1)(2011-2#1)(2012-3#1)
through lower##2##2##(1991-12#1)(1997-1#1)
through male##2##2##(2008-8#2)
through managed##2##2##(1995-1#1)(1997-3#1)
through manual##2##2##(2008-8#1)(2012-1#1)
through many##7##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
through market##2##2##(1994-2#1)(1995-1#1)
through materials##2##2##(2008-3#1)(2010-7#1)
through measurement of##4##3##(2008-10#1)(2008-3#2)(2009-5#1)
through measuring the##2##3##(1995-3#1)(2008-10#1)
through measuring##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
through mechanical##2##2##(2009-5#1)(2012-3#1)
through mechanisms of##2##3##(1995-6#1)(2008-9#1)
through mechanisms such as##2##4##(1997-2#1)(2008-11#1)
through mechanisms that##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
through mechanisms##8##2##(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2013-1#1)
through median sternotomy##3##3##(2007-8#3)
through medical##2##2##(1991-3#1)(2012-2#1)
through membrane##3##2##(2008-10#3)
through membranes##2##2##(1990-5#1)(1992-3#1)
through mental##2##2##(2008-6#1)(2012-2#1)
through metabolic##4##2##(2008-11#1)(2009-5#1)(2012-2#1)(2013-7#1)
through metaphase##2##2##(1991-5#1)(1994-8#1)
through minimally invasive##2##3##(2008-9#1)(2013-1#1)
through mitosis##2##2##(1995-2#1)(2009-8#1)
through modification of##3##3##(2008-10#1)(2013-1#2)
through modulation of the##3##4##(2007-12#1)(2008-8#1)(2013-8#1)
through modulation of##8##3##(1992-6#2)(2007-12#1)(2008-1#1)(2008-8#2)(2012-3#1)(2013-8#1)
through molecular##6##2##(1991-5#1)(1994-11#1)(2008-10#3)(2012-2#1)
through monitoring##2##2##(2008-10#2)
through more appropriate##2##3##(1996-3#1)(2012-3#1)
through more than##2##3##(2008-5#1)(2010-1#1)
through more##6##2##(1993-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2010-1#1)(2012-3#1)
through most##3##2##(1992-5#1)(2008-8#1)(2013-8#1)
through mouth and##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
through movement##2##2##(2008-2#2)
through multiple##9##2##(1992-3#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-2#1)
through multivariate##3##2##(1990-3#1)(2008-10#1)(2009-4#1)
through mutation##2##2##(1997-3#1)(2008-4#1)
through new##2##2##(1991-1#1)(2010-4#1)
through nitric oxide##2##3##(1996-11#1)(2008-1#1)
through noncovalent##2##2##(2008-7#1)(2010-4#1)
through novel##2##2##(2008-10#1)(2008-8#1)
through nuclear##4##2##(1994-6#1)(2008-11#1)(2011-2#2)
through numerical##2##2##(2007-11#1)(2007-12#1)
through numerous##2##2##(1996-9#1)(2011-1#1)
through observation##3##2##(1991-1#1)(2007-12#1)(2012-3#1)
through octadecyl silica membrane disks modified with##2##7##(2008-10#2)
through of##2##2##(2008-10#1)(2008-3#1)
through one##2##2##(1997-6#1)(2008-10#1)
through ontogeny##3##2##(2010-8#3)
through operational##2##2##(1996-3#1)(2012-3#1)
through optical fibers##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
through optical##6##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-5#1)
through or##2##2##(2007-12#1)(2008-3#1)
through oral##2##2##(2008-11#1)(2008-7#1)
through orange to red (very##2##5##(2012-2#2)
through other##2##2##(1997-2#1)(2008-10#1)
through our##3##2##(1993-1#1)(2007-8#1)(2008-7#1)
through out the##2##3##(2007-7#1)(2008-10#1)
through pH##2##2##(2008-10#1)(2008-9#1)
through paracrine##3##2##(2011-2#1)(2012-7#1)(2013-1#1)
through participation##2##2##(1992-6#1)(2008-12#1)
through partnership working##2##3##(2008-11#2)
through passive neutral membranes##2##4##(2008-10#2)
through passive##3##2##(2008-10#2)(2012-12#1)
through patient##2##2##(1996-3#1)(2008-7#1)
through periodic##3##2##(1991-12#1)(2007-12#1)(2008-10#1)
through personal interviews##2##3##(2008-12#1)(2008-2#1)
through personal##4##2##(1994-1#1)(2008-12#1)(2008-2#1)(2010-5#1)
through phosphorylation by##2##3##(1995-2#1)(1997-1#1)
through phosphorylation of##2##3##(2008-11#1)(2011-1#1)
through phosphorylation##6##2##(1992-11#1)(1995-2#1)(1997-1#1)(2008-11#1)(2011-1#1)(2011-2#1)
through photorefractive##2##2##(2007-11#1)(2007-12#1)
through physical##3##2##(2007-6#1)(2008-5#1)(2013-1#1)
through plaque##2##2##(2013-8#2)
through point mutations##2##3##(2008-8#1)(2010-8#1)
through pollen##3##2##(2008-10#1)(2008-8#2)
through pores in##2##3##(1997-6#1)(2008-2#1)
through pores##4##2##(1997-6#1)(2008-11#1)(2008-2#1)(2008-6#1)
through port##2##2##(2007-11#1)(2011-2#1)
through predictive##2##2##(2010-3#1)(2012-2#1)
through pregnancy##2##2##(2012-12#1)(2012-2#1)
through primary##3##2##(1991-8#1)(2008-7#1)(2010-8#1)
through professional##3##2##(1994-12#1)(1996-1#1)(2013-8#1)
through promoting##2##2##(1994-10#1)(2008-5#1)
through promotion of##2##3##(1992-8#1)(2013-1#1)
through proper##3##2##(2007-11#1)(2008-2#1)(2013-1#1)
through protein##2##2##(1992-11#1)(2011-2#1)
through protein-protein interactions##2##3##(2008-4#1)(2008-8#1)
through protein-protein##4##2##(2008-4#1)(2008-7#1)(2008-8#1)(2011-3#1)
through public##3##2##(2008-8#1)(2013-1#2)
through quality##2##2##(1993-12#1)(1995-12#1)
through quantitative##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
through recent##3##2##(1997-4#1)(2008-7#1)(2009-10#1)
through recombination##2##2##(2008-10#1)(2011-2#1)
through reduced##3##2##(2008-5#1)(2008-9#1)(2009-5#1)
through reduction##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
through reflection##2##2##(2008-11#2)
through reflective##2##2##(2008-11#2)
through regional##2##2##(2008-10#1)(2008-7#1)
through regulating the##2##3##(2011-3#1)(2013-7#1)
through regulation of##2##3##(2010-11#1)(2013-1#1)
through regulation##4##2##(1991-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
through research##5##2##(1992-1#1)(2008-1#1)(2008-12#1)(2008-4#1)(2013-8#1)
through restructuring##2##2##(1995-1#1)(2008-6#1)
through retrospective##2##2##(1996-6#1)(2012-3#1)
through right##2##2##(2012-1#1)(2013-7#1)
through scattering media by##2##4##(2007-12#1)(2008-2#1)
through scattering media with##2##4##(2007-12#2)
through scattering media##10##3##(2007-12#6)(2008-2#3)(2008-3#1)
through scattering##11##2##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#1)
through seed##3##2##(2008-10#2)(2008-8#1)
through selected##2##2##(2008-10#1)(2008-9#1)
through selection in##2##3##(2008-8#2)
through selection##3##2##(1995-5#1)(2008-8#2)
through selective##6##2##(1993-6#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-8#2)
through semi-structured##3##2##(2012-3#1)(2013-7#1)(2013-8#1)
through several##10##2##(1994-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2010-9#1)(2011-1#1)
through sexual##5##2##(1993-6#1)(1997-5#2)(2008-10#1)(2008-8#1)
through shared##4##2##(2008-1#1)(2008-8#2)(2008-9#1)
through signal##2##2##(1992-2#1)(2013-7#1)
through signaling##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
through simple##2##2##(2007-11#1)(2008-3#1)
through simulation studies##2##3##(2008-3#1)(2012-3#1)
through simulation##3##2##(2008-3#1)(2012-3#2)
through site-directed mutagenesis##2##3##(1990-7#1)(1991-10#1)
through small##2##2##(2007-11#1)(2008-7#1)
through social##2##2##(1994-2#1)(2008-11#1)
through software##2##2##(1996-3#1)(2008-10#1)
through soil##3##2##(2008-10#3)
through some##5##2##(2008-12#1)(2008-2#3)(2009-9#1)
through specific receptors##2##3##(1991-12#1)(1996-5#1)
through specific##8##2##(1990-5#1)(1991-12#1)(1993-6#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-8#1)(2011-1#1)
through stimulation##2##2##(2008-10#1)(2008-8#1)
through stomata##3##2##(2008-10#3)
through storage period##2##3##(2012-2#2)
through storage##3##2##(2012-2#3)
through strategic##2##2##(1994-3#1)(2009-9#1)
through studies of##3##3##(1997-4#1)(2008-10#2)
through such##4##2##(1995-1#2)(1995-3#1)(1997-7#1)
through suppression of##5##3##(1993-6#1)(2008-10#1)(2011-2#2)(2012-2#1)
through systemic##4##2##(1994-8#1)(2008-10#1)(2011-2#2)
through targeting##3##2##(2007-11#1)(2008-11#1)(2009-11#1)
through team##4##2##(1997-3#1)(2008-6#3)
through tests##2##2##(1993-5#1)(2013-1#1)
through the ASA##2##3##(1997-6#2)
through the Golgi is##2##4##(2009-2#2)
through the Golgi##4##3##(2009-2#4)
through the Internet##7##3##(1995-1#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-8#2)
through the Lucent Technologies-Advanced Research Projects##2##6##(2008-2#1)(2008-3#1)
through the National Institutes of##2##5##(1997-5#1)(2008-1#1)
through the National##3##3##(1997-5#1)(2008-1#1)(2008-3#1)
through the Shc SH2 domain##2##5##(1997-7#2)
through the action of##5##4##(1993-3#1)(1994-3#1)(2008-11#1)(2008-3#1)(2010-5#1)
through the action##6##3##(1993-3#1)(1994-3#1)(1996-2#1)(2008-11#1)(2008-3#1)(2010-5#1)
through the activation of a##3##5##(1992-8#1)(1993-8#1)(1995-6#1)
through the activation of##6##4##(1992-8#1)(1993-8#1)(1995-6#1)(2008-4#1)(2008-7#1)(2009-12#1)
through the activity of##2##4##(2009-3#1)(2012-3#1)
through the addition of##3##4##(1994-9#1)(2008-10#1)(2009-9#1)
through the analysis of the##2##5##(1992-9#1)(2011-2#1)
through the analysis of##5##4##(1992-9#1)(2008-10#3)(2011-2#1)
through the anus##3##3##(2007-2#1)(2013-1#2)
through the apical##2##3##(2008-10#1)(2008-8#1)
through the application of##6##4##(1992-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
through the atmosphere##3##3##(2008-2#2)(2008-3#1)
through the authors'##2##3##(2008-11#1)(2009-11#1)
through the beam##3##3##(2008-2#1)(2008-3#2)
through the biological and##2##4##(2008-12#1)(2008-3#1)
through the body##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
through the cartridge##2##3##(2008-10#2)
through the cell cycle##3##4##(1993-8#1)(2008-11#1)(2008-9#1)
through the cell##8##3##(1993-8#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-9#1)
through the classical##2##3##(1994-11#1)(2008-8#1)
through the clinical##2##3##(2009-6#1)(2013-8#1)
through the column##6##3##(2008-10#5)(2008-9#1)
through the combination of##5##4##(2008-10#3)(2008-11#1)(2008-3#1)
through the controlled##2##3##(2007-12#1)(2012-2#1)
through the course of##2##4##(1997-6#1)(2008-10#1)
through the creation of a##2##5##(2010-9#1)(2011-2#1)
through the cuticle and##2##4##(2008-10#2)
through the cuticle##3##3##(2007-12#1)(2008-10#2)
through the deployment of##2##4##(2008-10#2)
through the design and synthesis of##2##6##(1994-12#1)(2010-12#1)
through the design##3##3##(1994-12#1)(2008-10#1)(2010-12#1)
through the detector##3##3##(2008-10#2)(2008-3#1)
through the determination of the##3##5##(2008-10#3)
through the determination of##7##4##(2008-10#6)(2011-1#1)
through the development of##6##4##(1993-12#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
through the development##8##3##(1993-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
through the device##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
through the dialysis##2##3##(1992-3#2)
through the different##2##3##(2008-1#1)(2008-7#1)
through the digestive##2##3##(2008-10#1)(2013-1#1)
through the effects of##2##4##(1992-3#1)(2008-8#1)
through the electro-optic effect##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
through the emergency##2##3##(2007-10#1)(2008-3#1)
through the end of##2##4##(2008-2#1)(2008-7#1)
through the entire##4##3##(1992-6#1)(1996-6#1)(2008-2#1)(2008-7#1)
through the epidermal##2##3##(2008-10#2)
through the epidermis##2##3##(2008-10#2)
through the expression of##2##4##(2008-10#1)(2011-1#1)
through the eyes of##2##4##(2008-1#1)(2011-2#1)
through the eyes##3##3##(2008-1#1)(2009-10#1)(2011-2#1)
through the fiber##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
through the first##3##3##(1994-12#1)(2008-10#1)(2010-5#1)
through the flood water##2##4##(2008-10#2)
through the flow cell##3##4##(2008-10#3)
through the flow##4##3##(2008-10#4)
through the following##2##3##(1994-8#1)(2008-10#1)
through the food chain##3##4##(1995-11#1)(2008-10#1)(2013-8#1)
through the formation of a##2##5##(2008-10#2)
through the formation of##8##4##(2008-10#6)(2009-11#1)(2010-8#1)
through the implementation of##4##4##(1997-7#1)(2008-10#1)(2008-11#2)
through the inclusion of##2##4##(2008-10#1)(2010-1#1)
through the induction of##3##4##(1995-2#1)(2009-12#1)(2010-5#1)
through the inhibition of##5##4##(1993-11#1)(1993-8#1)(2008-11#1)(2009-12#1)(2011-1#1)
through the interaction between##2##4##(2007-11#1)(2012-3#1)
through the interaction##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
through the interpretation##2##3##(1995-12#1)(2010-9#1)
through the intestinal##2##3##(1993-9#1)(2006-12#1)
through the introduction of##2##4##(2008-10#2)
through the left##2##3##(1991-12#1)(2008-12#1)
through the lens##2##3##(2008-3#1)(2012-12#1)
through the liquid membrane##2##4##(2008-10#2)
through the liquid##3##3##(2008-10#2)(2010-8#1)
through the loss of##2##4##(2008-10#1)(2008-11#1)
through the mass##3##3##(1993-3#1)(2007-12#1)(2008-3#1)
through the measurement of##2##4##(1990-8#1)(2008-5#1)
through the mediation of##2##4##(1990-12#1)(2009-3#1)
through the medium##2##3##(2007-10#1)(2007-12#1)
through the membrane##8##3##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#4)(2010-4#1)
through the membranes##2##3##(2008-6#2)
through the metabolism of microorganisms##2##5##(2008-5#2)
through the microcolumn##2##3##(2008-10#2)
through the microdialysis probe##2##4##(1997-2#1)(2008-10#1)
through the nanopore##2##3##(2008-7#2)
through the opposite##2##3##(2007-12#1)(2008-3#1)
through the optical##2##3##(2008-10#1)(2008-3#1)
through the ovarian stroma##2##4##(2008-12#2)
through the ovarian##3##3##(2008-12#3)
through the pages of##2##4##(2008-4#1)(2011-2#1)
through the peritoneal membrane##3##4##(2008-10#3)
through the peritoneal##4##3##(2008-1#1)(2008-10#3)
through the plant##2##3##(2008-10#2)
through the plasma membrane##3##4##(1991-12#1)(1994-3#1)(1997-6#1)
through the plasma##4##3##(1991-12#1)(1994-3#1)(1997-6#1)(2010-10#1)
through the population##4##3##(2008-8#1)(2009-6#1)(2012-3#1)(2013-8#1)
through the pores##2##3##(2007-12#1)(2010-2#1)
through the practice of##2##4##(1996-2#1)(2008-10#1)
through the process of##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
through the production of##3##4##(2008-10#2)(2012-3#1)
through the progressive##2##3##(1994-2#1)(2012-2#1)
through the promotion of##2##4##(2008-10#1)(2013-1#1)
through the protein##2##3##(1994-5#1)(2008-1#1)
through the provision of##2##4##(1997-2#1)(2010-10#1)
through the reaction##3##3##(2008-10#2)(2011-2#1)
through the regulation of##3##4##(1994-11#1)(2008-7#1)(2012-7#1)
through the release of##2##4##(2008-12#1)(2009-3#1)
through the right##2##3##(2008-11#2)
through the root##2##3##(2008-10#2)
through the rotation of##2##4##(1993-3#1)(2008-8#1)
through the same fiber##2##4##(2007-11#1)(2008-3#1)
through the same##6##3##(1995-12#1)(2007-11#1)(2008-3#2)(2010-10#1)(2013-1#1)
through the sample##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
through the scalp##2##3##(2010-5#1)(2010-7#1)
through the second##2##3##(1994-12#1)(2007-12#1)
through the secretory pathway##3##4##(1997-1#1)(2008-1#1)(2008-4#1)
through the sensing##2##3##(2008-10#1)(2009-5#1)
through the skin and##2##4##(2008-10#1)(2008-5#1)
through the skin##5##3##(2008-10#2)(2008-5#2)(2009-11#1)
through the so-called##2##3##(2007-12#1)(2010-2#1)
through the soil and##2##4##(2008-10#2)
through the specific##2##3##(2008-10#1)(2009-7#1)
through the standard##2##3##(2008-10#1)(2008-9#1)
through the stem##3##3##(2008-10#3)
through the stoichiometric##2##3##(2008-10#1)(2008-7#1)
through the strong##2##3##(2008-10#2)
through the study of##2##4##(2008-10#1)(2008-7#1)
through the stylar canal and##2##5##(2008-10#2)
through the stylar canal##3##4##(2008-10#3)
through the surface##3##3##(2008-10#1)(2008-3#2)
through the system##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
through the test section##4##4##(2008-2#1)(2008-3#3)
through the test##5##3##(2008-1#1)(2008-2#1)(2008-3#3)
through the tip of##2##4##(2008-4#1)(2010-8#1)
through the two##3##3##(2008-10#2)(2008-3#1)
through the use of a##9##5##(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#3)(2013-8#1)
through the use of an##3##5##(1996-1#1)(2008-10#1)(2012-2#1)
through the use of the##3##5##(1996-3#1)(2008-3#1)(2008-6#1)
through the use of##57##4##(1991-12#1)(1991-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
through the use##58##3##(1991-12#1)(1991-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
through the waveguide##2##3##(2008-3#2)
through the whole##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
through the year 2000##3##4##(1991-9#1)(1992-3#1)(1995-6#1)
through the year##5##3##(1991-9#1)(1992-3#1)(1995-6#1)(1996-2#1)(2008-9#1)
through the##955##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#5)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#5)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#8)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#4)(1995-12#11)(1995-2#4)(1995-3#6)(1995-6#4)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#8)(1996-3#7)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#7)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#11)(1997-7#10)(1997-8#3)(2006-12#2)(2007-10#2)(2007-11#16)(2007-12#30)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#12)(2008-10#206)(2008-11#30)(2008-12#19)(2008-2#22)(2008-3#72)(2008-4#22)(2008-5#22)(2008-6#12)(2008-7#39)(2008-8#17)(2008-9#22)(2009-10#2)(2009-11#6)(2009-12#7)(2009-2#6)(2009-3#4)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#7)(2010-7#4)(2010-8#9)(2010-9#3)(2011-1#9)(2011-2#23)(2011-3#2)(2012-1#2)(2012-12#8)(2012-2#15)(2012-3#8)(2012-7#1)(2012-8#1)(2013-1#18)(2013-7#3)(2013-8#10)
through their ability to##2##4##(1996-1#1)(2011-2#1)
through their effects on##2##4##(2008-10#1)(2008-8#1)
through their roots showed##2##4##(2008-10#2)
through their roots##3##3##(2008-10#3)
through their unique##2##3##(1996-1#1)(2008-3#1)
through their##38##2##(1990-11#1)(1992-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(2008-10#9)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#3)(2009-2#1)(2009-4#2)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)
through these##12##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-1#1)
through thin##4##2##(1992-6#1)(1997-6#1)(2007-11#1)(2008-3#1)
through this method##2##3##(2008-10#1)(2008-7#1)
through this process##2##3##(1994-2#1)(2008-1#1)
through this##20##2##(1991-9#1)(1992-8#1)(1994-2#1)(1996-1#1)(1997-1#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2011-10#1)(2012-12#1)(2013-1#1)
through three major##2##3##(2008-10#1)(2010-12#1)
through three##8##2##(1992-2#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-12#1)
through time##10##2##(2008-10#5)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
through time)##2##2##(1992-9#1)(2008-10#1)
through tissue##3##2##(1991-2#1)(2007-12#2)
through tissues for##2##3##(2007-11#2)
through to##7##2##(1995-3#1)(2006-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2013-1#1)
through topical##2##2##(1992-2#1)(1997-8#1)
through total quality management##2##4##(1994-1#1)(1996-2#1)
through total##3##2##(1994-1#1)(1996-2#1)(2008-2#1)
through tunnels##2##2##(2009-10#2)
through turbid media##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
through turbid##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
through two##14##2##(1990-8#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)
through two-photon##2##2##(2007-12#2)
through type##2##2##(1995-6#1)(2008-9#1)
through ultrasound##2##2##(2012-3#1)(2013-1#1)
through use of##5##3##(2007-10#1)(2008-10#1)(2008-3#2)(2013-1#1)
through variation of##2##3##(2007-12#1)(2008-10#1)
through various##6##2##(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-1#1)
through vertical##2##2##(2008-2#1)(2008-3#1)
through videoconferencing##2##2##(2008-11#2)
through voltage-dependent##2##2##(1990-12#1)(1994-11#1)
through volume and limit of detection##3##6##(2008-10#3)
through volume##4##2##(2008-10#4)
through voluntary##2##2##(1994-12#1)(2008-10#1)
through water##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
through weak##2##2##(2008-2#1)(2008-3#1)
through which the##8##3##(1993-11#1)(2008-10#4)(2008-5#1)(2010-4#1)(2012-2#1)
through which to##2##3##(2008-11#1)(2009-7#1)
through which##39##2##(1990-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#3)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
through wounds##2##2##(2008-10#2)
through##3872##1##(1990-10#1)(1990-11#8)(1990-12#12)(1990-2#6)(1990-3#4)(1990-5#5)(1990-6#2)(1990-7#9)(1990-8#4)(1990-9#1)(1991-1#10)(1991-10#1)(1991-11#3)(1991-12#21)(1991-2#7)(1991-3#18)(1991-4#1)(1991-5#13)(1991-6#4)(1991-8#4)(1991-9#6)(1992-1#8)(1992-10#2)(1992-11#9)(1992-12#10)(1992-2#6)(1992-3#16)(1992-4#2)(1992-5#6)(1992-6#18)(1992-8#12)(1992-9#8)(1993-1#6)(1993-10#1)(1993-11#15)(1993-12#22)(1993-2#3)(1993-3#21)(1993-5#4)(1993-6#16)(1993-8#13)(1993-9#9)(1994-1#10)(1994-10#1)(1994-11#22)(1994-12#26)(1994-2#21)(1994-3#21)(1994-5#8)(1994-6#6)(1994-7#1)(1994-8#13)(1994-9#8)(1995-1#19)(1995-11#11)(1995-12#29)(1995-2#26)(1995-3#19)(1995-5#5)(1995-6#17)(1995-8#6)(1995-9#1)(1996-1#16)(1996-10#1)(1996-11#4)(1996-12#13)(1996-2#19)(1996-3#27)(1996-4#2)(1996-5#26)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#19)(1997-2#17)(1997-3#12)(1997-4#15)(1997-5#6)(1997-6#20)(1997-7#18)(1997-8#9)(2006-10#2)(2006-12#7)(2006-6#1)(2007-1#1)(2007-10#8)(2007-11#100)(2007-12#153)(2007-2#2)(2007-5#5)(2007-6#4)(2007-7#14)(2007-8#26)(2007-9#5)(2008-1#51)(2008-10#656)(2008-11#143)(2008-12#70)(2008-2#115)(2008-3#233)(2008-4#75)(2008-5#93)(2008-6#41)(2008-7#128)(2008-8#108)(2008-9#93)(2009-1#1)(2009-10#20)(2009-11#19)(2009-12#14)(2009-2#13)(2009-3#12)(2009-4#8)(2009-5#23)(2009-6#13)(2009-7#27)(2009-8#17)(2009-9#14)(2010-1#8)(2010-10#19)(2010-11#14)(2010-12#12)(2010-2#8)(2010-3#6)(2010-4#13)(2010-5#16)(2010-6#7)(2010-7#11)(2010-8#29)(2010-9#9)(2011-1#40)(2011-10#1)(2011-2#118)(2011-3#10)(2011-7#2)(2011-9#1)(2012-1#16)(2012-10#1)(2012-12#51)(2012-2#72)(2012-3#54)(2012-7#4)(2012-8#1)(2013-1#118)(2013-7#17)(2013-8#48)
through-bond##2##1##(2007-11#1)(2008-9#1)
through-put of##2##2##(2008-10#2)
through-space##3##1##(2007-11#1)(2008-10#1)(2008-9#1)
through-thickness##5##1##(2008-7#1)(2009-7#4)
throughout Africa##2##2##(2008-10#1)(2012-2#1)
throughout Europe##2##2##(2008-10#1)(2008-7#1)
throughout India##2##2##(2008-10#1)(2011-2#1)
throughout North##2##2##(2007-10#1)(2008-11#1)
throughout Ontario##2##2##(1994-1#1)(2007-12#1)
throughout Russia##2##2##(1997-1#1)(2008-12#1)
throughout a year##2##3##(1995-5#1)(2008-5#1)
throughout a##14##2##(1995-5#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
throughout adult life##2##3##(2008-7#1)(2010-11#1)
throughout all the##2##3##(2008-9#1)(2013-1#1)
throughout all##8##2##(1992-3#1)(1995-11#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
throughout an##5##2##(1993-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-2#1)
throughout both studies##3##3##(2008-9#3)
throughout both##5##2##(1991-12#1)(1997-7#1)(2008-9#3)
throughout by##2##2##(1992-11#1)(2008-3#1)
throughout childhood##2##2##(2009-8#1)(2013-8#1)
throughout development##6##2##(1993-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
throughout each##3##2##(2008-10#1)(2013-8#2)
throughout evolution##6##2##(1993-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
throughout his life##2##3##(1996-3#2)
throughout his##3##2##(1992-3#1)(1996-3#2)
throughout its##3##2##(1990-11#1)(2008-10#1)(2008-2#1)
throughout life##5##2##(1996-3#1)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
throughout most of the##2##4##(2008-10#1)(2008-9#1)
throughout most of##3##3##(2008-10#1)(2008-9#2)
throughout much of the##2##4##(2008-10#1)(2008-3#1)
throughout much of##4##3##(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)
throughout our##3##2##(2008-5#2)(2011-2#1)
throughout pregnancy##2##2##(1994-3#1)(1996-11#1)
throughout the 24-hour##2##3##(1992-8#1)(2008-3#1)
throughout the Caribbean##2##3##(1996-6#1)(2009-7#1)
throughout the European Union##2##4##(2011-2#1)(2013-8#1)
throughout the SNOM##2##3##(2008-3#2)
throughout the United States and##3##5##(2007-12#1)(2008-10#2)
throughout the United States##9##4##(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2012-12#1)(2013-1#1)
throughout the United##10##3##(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2012-12#1)(2013-1#1)(2013-8#1)
throughout the animal kingdom##2##4##(2007-12#1)(2009-8#1)
throughout the body##4##3##(1995-5#1)(1996-1#1)(1997-1#1)(2008-12#1)
throughout the brain##3##3##(1990-7#1)(1993-12#2)
throughout the case##2##3##(2009-9#1)(2011-2#1)
throughout the cell cycle##2##4##(1995-2#1)(2009-2#1)
throughout the cell##4##3##(1995-2#1)(2008-1#1)(2009-2#1)(2009-8#1)
throughout the continuum of care##2##5##(1994-12#1)(1997-2#1)
throughout the cortex of##2##4##(1992-9#1)(1996-5#1)
throughout the country##6##3##(1995-1#1)(1996-1#1)(2008-11#2)(2013-1#2)
throughout the course and##2##4##(2008-11#2)
throughout the course of the##3##5##(1992-6#1)(1995-3#1)(2008-7#1)
throughout the course##6##3##(1992-6#1)(1995-3#1)(2008-11#3)(2008-7#1)
throughout the culture period##3##4##(1993-3#1)(2008-11#2)
throughout the culture##4##3##(1993-3#1)(2008-11#3)
throughout the cytoplasm##3##3##(1994-10#1)(2008-11#1)(2013-1#1)
throughout the day##4##3##(1994-6#1)(2007-7#1)(2008-5#2)
throughout the duration of##2##4##(1996-2#1)(2008-8#1)
throughout the embryo##2##3##(1995-3#1)(2008-8#1)
throughout the entire##8##3##(1992-12#1)(1996-12#2)(2008-10#2)(2008-3#1)(2008-9#1)(2012-1#1)
throughout the experiment and##4##4##(1992-9#1)(2008-10#1)(2012-2#2)
throughout the experiment##8##3##(1992-9#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-2#2)(2013-1#1)
throughout the first##2##3##(1996-5#1)(2008-11#1)
throughout the gastrointestinal tract##2##4##(1995-11#1)(1997-1#1)
throughout the genome##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
throughout the grazing period##2##4##(1996-12#2)
throughout the grazing season##2##4##(1996-12#1)(2012-2#1)
throughout the grazing##4##3##(1996-12#3)(2012-2#1)
throughout the growing season in##2##5##(2008-10#2)
throughout the growing season##7##4##(2008-10#7)
throughout the health care##2##4##(1994-3#1)(2008-7#1)
throughout the history of##2##4##(2008-1#1)(2008-11#1)
throughout the life##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
throughout the nation##2##3##(1995-3#1)(2008-3#1)
throughout the nervous system##2##4##(1992-9#1)(2008-4#1)
throughout the organization##9##3##(1992-12#1)(1994-1#2)(1995-1#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-1#1)
throughout the period##4##3##(1991-12#1)(1992-3#1)(2008-5#2)
throughout the plant##3##3##(2008-10#3)
throughout the plot##2##3##(2008-10#2)
throughout the procedure##3##3##(1992-1#1)(2010-7#2)
throughout the range of##2##4##(2008-3#1)(2012-3#1)
throughout the region##2##3##(2007-5#1)(2009-2#1)
throughout the research##2##3##(2010-8#1)(2013-1#1)
throughout the soil profile##2##4##(2008-10#2)
throughout the study and##2##4##(2008-12#1)(2008-9#1)
throughout the study period##4##4##(2008-10#2)(2008-8#1)(2013-1#1)
throughout the study##19##3##(1993-12#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-5#1)(2012-3#1)(2013-1#1)
throughout the system##2##3##(1992-1#1)(1994-1#1)
throughout the time period##2##4##(2008-9#1)(2010-11#1)
throughout the treatment##3##3##(2008-10#1)(2011-1#2)
throughout the tropical##2##3##(2007-5#1)(2010-5#1)
throughout the whole##3##3##(2007-12#1)(2008-10#1)(2009-11#1)
throughout the world and##2##4##(2008-10#1)(2013-8#1)
throughout the world in##3##4##(2008-1#1)(2008-8#1)(2008-9#1)
throughout the world##34##3##(1990-11#1)(1994-3#1)(1994-9#1)(1996-1#2)(2007-10#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
throughout the year and##2##4##(1994-7#1)(2008-10#1)
throughout the year with##3##4##(2008-10#3)
throughout the year##16##3##(1991-12#1)(1994-7#1)(1995-1#1)(2007-10#1)(2008-10#6)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
throughout the##369##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#4)(1991-5#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#4)(1993-12#5)(1993-3#1)(1993-8#1)(1994-1#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#7)(1995-5#1)(1996-1#6)(1996-12#8)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-7#2)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#1)(2007-5#4)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#71)(2008-11#16)(2008-12#5)(2008-2#7)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#19)(2008-8#13)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#6)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#5)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#7)
throughout their##8##2##(1993-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2013-8#1)
throughout this paper##2##3##(1992-12#1)(2008-11#1)
throughout this##6##2##(1991-5#1)(1992-12#1)(1995-2#1)(2008-11#1)(2008-9#1)(2010-10#1)
throughout treatment##3##2##(2008-10#1)(2008-6#1)(2009-7#1)
throughout##553##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#5)(1991-5#4)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-6#2)(1992-8#2)(1992-9#6)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-10#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#7)(1995-5#3)(1996-1#7)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#4)(1996-5#4)(1996-6#1)(1997-1#5)(1997-2#5)(1997-3#3)(1997-6#2)(1997-7#3)(2006-10#2)(2007-10#4)(2007-11#2)(2007-12#16)(2007-2#2)(2007-4#1)(2007-5#4)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#103)(2008-11#21)(2008-12#11)(2008-2#9)(2008-3#16)(2008-4#5)(2008-5#15)(2008-6#5)(2008-7#25)(2008-8#18)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#8)(2011-2#24)(2012-1#1)(2012-12#2)(2012-2#13)(2012-3#5)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#14)
throughput analysis of the##2##4##(2008-10#2)
throughput analysis of##3##3##(2008-10#2)(2008-4#1)
throughput and##14##2##(1995-1#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2011-1#1)(2012-2#1)
throughput for the##2##3##(2008-10#2)
throughput is##10##2##(1994-3#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)
throughput of 10h(-1)##3##3##(2008-10#3)
throughput of 20 samples##2##4##(2008-10#2)
throughput of 20##4##3##(2008-10#4)
throughput of 25h(-1)##2##3##(2008-10#2)
throughput of 40##4##3##(2008-10#4)
throughput of 50##2##3##(2008-10#2)
throughput of 60##2##3##(2008-10#2)
throughput of 7##2##3##(2008-10#2)
throughput of the##7##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)
throughput of##62##2##(2008-10#51)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)
throughput rate##4##2##(2008-10#4)
throughput screening##13##2##(2007-11#1)(2008-10#8)(2009-6#2)(2010-12#2)
throughput technologies##2##2##(2008-11#1)(2012-3#1)
throughput was 20##2##3##(2008-10#2)
throughput was##17##2##(2007-9#1)(2008-10#16)
throughput##215##1##(1992-11#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2007-11#2)(2007-12#2)(2007-9#2)(2008-10#137)(2008-11#5)(2008-2#11)(2008-3#11)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-4#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#3)
throughputs of##2##2##(2008-10#1)(2008-3#1)
throughputs##8##1##(2008-10#3)(2008-3#3)(2008-7#2)
throw caution##2##2##(2006-10#1)(2008-11#1)
throw light on##3##3##(1992-8#1)(2008-1#1)(2010-3#1)
throw##9##1##(1992-8#1)(1997-3#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-8#1)
thrower's elbow##3##2##(2008-8#3)
throwing money##2##2##(2008-7#2)
throwing##5##1##(2008-7#2)(2008-8#2)(2009-1#1)
thrown##3##1##(2008-11#1)(2009-10#1)(2011-2#1)
thrush (Turdus chrysolaus)##2##3##(1997-4#2)
thrush##5##1##(1997-4#2)(2008-9#2)(2010-5#1)
thrust manipulation and##3##3##(2008-12#3)
thrust manipulation##6##2##(2007-11#1)(2008-12#5)
thrust to the##2##3##(1994-1#1)(2007-11#1)
thrust to##3##2##(1994-1#1)(2007-11#1)(2009-9#1)
thrust##20##1##(1992-6#1)(1994-1#1)(1994-9#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-12#6)(2008-2#1)(2009-9#1)(2010-8#2)(2012-2#1)(2013-1#1)
thuiswonende##3##1##(2012-12#3)
thulium laser##3##2##(2008-2#1)(2008-3#2)
thulium##4##1##(2008-2#2)(2008-3#2)
thulium-doped##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
thumb spica##2##2##(2008-9#2)
thumb with##3##2##(2007-11#1)(2008-3#1)(2010-6#1)
thumb##40##1##(1990-8#1)(1995-12#1)(1996-2#2)(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#18)(2009-10#1)(2010-6#4)(2010-7#2)(2011-1#1)
thumbs##2##1##(2008-12#1)(2012-3#1)
thuringiensis##20##1##(1993-12#2)(1993-8#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#4)(2013-1#4)
thus 3##2##2##(1994-12#1)(2008-1#1)
thus a very##2##3##(2008-10#1)(2008-2#1)
thus a##22##2##(1990-12#1)(1991-5#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
thus achieving##2##2##(1996-1#1)(2008-10#1)
thus adding##2##2##(1990-8#1)(1996-1#1)
thus affecting##2##2##(2008-1#1)(2008-5#1)
thus affording##2##2##(2007-11#1)(2008-10#1)
thus aiding##2##2##(2008-11#1)(2010-12#1)
thus aimed##2##2##(2012-12#2)
thus allowing a##2##3##(2009-10#1)(2010-4#1)
thus allowing##11##2##(1993-12#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-10#1)(2010-12#1)(2010-4#1)
thus allows##2##2##(2008-10#1)(2009-8#1)
thus also##7##2##(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#2)(2010-5#1)
thus always##2##2##(1994-12#1)(1996-2#1)
thus apparently##2##2##(2008-10#1)(2010-2#1)
thus appear to be##2##4##(1992-6#1)(1994-11#1)
thus appear to##5##3##(1992-6#1)(1994-11#1)(1994-8#1)(2007-11#1)(2008-10#1)
thus appears that##2##3##(1990-7#1)(2008-7#1)
thus appears to be##2##4##(1990-12#1)(1993-9#1)
thus appears to##4##3##(1990-12#1)(1990-5#1)(1993-12#1)(1993-9#1)
thus appears##6##2##(1990-12#1)(1990-5#1)(1990-7#1)(1993-12#1)(1993-9#1)(2008-7#1)
thus are##5##2##(1990-12#1)(2008-4#1)(2009-5#1)(2010-4#1)(2012-12#1)
thus assuring##2##2##(2008-10#1)(2008-5#1)
thus avoiding the necessity of##2##5##(2008-3#2)
thus avoiding the##8##3##(1991-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-8#1)(2012-12#1)
thus avoiding##12##2##(1991-11#1)(1991-8#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-8#1)(2012-12#1)
thus be used for##2##4##(2008-10#2)
thus be used##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
thus be##27##2##(1990-6#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
thus become##3##2##(2006-6#1)(2007-6#1)(2008-10#1)
thus been##3##2##(1990-2#1)(1995-6#1)(2008-2#1)
thus being the##2##3##(2008-5#1)(2012-3#1)
thus being##6##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
thus can be used##4##4##(2008-11#2)(2008-2#1)(2012-3#1)
thus can be##6##3##(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
thus can##8##2##(1993-2#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
thus causing##3##2##(2008-11#1)(2008-3#2)
thus concluded that##2##3##(1994-9#1)(2009-8#1)
thus confirm the##2##3##(1991-8#1)(1997-6#1)
thus confirming the##3##3##(1990-7#1)(1994-6#1)(2013-1#1)
thus confirming##6##2##(1990-7#1)(1994-6#1)(2008-10#1)(2012-2#1)(2012-6#1)(2013-1#1)
thus considered to##2##3##(2008-11#1)(2010-3#1)
thus constitute##2##2##(1990-11#1)(2009-10#1)
thus constitutes##3##2##(2007-12#1)(2009-6#1)(2012-2#1)
thus constructed##2##2##(2008-11#1)(2008-8#1)
thus contribute to##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
thus contributing to##4##3##(1990-8#1)(1992-2#1)(2008-10#1)(2013-1#1)
thus creating a##2##3##(1991-6#1)(2008-10#1)
thus creating the##2##3##(1990-5#1)(2011-1#1)
thus creating##4##2##(1990-5#1)(1991-6#1)(2008-10#1)(2011-1#1)
thus decreasing the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
thus decreasing##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
thus defining##2##2##(2008-10#1)(2009-10#1)
thus demonstrating the##5##3##(2008-10#2)(2008-11#1)(2009-12#1)(2011-2#1)
thus determined##6##2##(1991-2#1)(1993-11#1)(1994-5#1)(2008-10#3)
thus developed##2##2##(2008-10#1)(2012-2#1)
thus differed##2##2##(1992-8#1)(2008-7#1)
thus do not##2##3##(2008-11#1)(2012-3#1)
thus eliminating the##3##3##(2007-11#1)(2008-10#1)(2010-1#1)
thus eliminating##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2010-1#1)
thus enabling the##2##3##(2008-10#1)(2010-6#1)
thus enabling##8##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)(2013-8#1)
thus enhances##2##2##(2007-12#1)(2012-3#1)
thus ensuring##4##2##(2008-12#1)(2008-3#2)(2010-7#1)
thus established##2##2##(2008-10#1)(2008-11#1)
thus establishing##2##2##(2007-12#1)(2008-10#1)
thus examined##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
thus extending the##2##3##(1996-12#1)(2007-12#1)
thus extending##3##2##(1996-12#1)(2007-12#1)(2013-8#1)
thus facilitate##3##2##(1996-6#1)(2009-4#1)(2013-1#1)
thus facilitating the##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
thus facilitating##9##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
thus far in the##2##4##(2008-10#1)(2011-2#1)
thus far in##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
thus far reported in the literature##2##6##(2008-2#1)(2008-3#1)
thus far reported##4##3##(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
thus far##39##2##(1990-2#1)(1991-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-5#2)(2007-12#2)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
thus for##2##2##(2008-5#1)(2010-8#1)
thus formed is##2##3##(2007-11#1)(2008-7#1)
thus formed##5##2##(2007-11#1)(2008-10#3)(2008-7#1)
thus forming##3##2##(1994-5#1)(2007-12#1)(2009-8#1)
thus found##2##2##(1994-12#1)(2008-2#1)
thus generated##3##2##(1995-12#1)(2008-11#1)(2008-6#1)
thus giving rise to##3##4##(1991-9#1)(2008-1#1)(2009-1#1)
thus giving##6##2##(1991-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-1#1)
thus greatly##2##2##(2008-10#1)(2008-3#1)
thus has##2##2##(2008-10#1)(2010-5#1)
thus have##6##2##(1991-12#1)(1993-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
thus identified##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
thus identifying##3##2##(1994-8#1)(1995-9#1)(2011-3#1)
thus illustrating the##2##3##(1997-2#1)(2008-10#1)
thus implicating##2##2##(2010-10#1)(2012-2#1)
thus implying##3##2##(1990-5#1)(2008-11#1)(2008-8#1)
thus improving the##2##3##(2007-8#1)(2008-10#1)
thus improving##6##2##(1994-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
thus increasing the##7##3##(1993-2#1)(1995-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-3#1)
thus increasing##10##2##(1992-3#1)(1993-2#1)(1994-8#1)(1995-1#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-3#1)
thus indicate that##3##3##(1990-5#1)(1995-2#1)(2008-10#1)
thus indicate##6##2##(1990-5#1)(1994-6#1)(1995-2#2)(1996-5#1)(2008-10#1)
thus indicating a##4##3##(1991-12#1)(1992-12#1)(1995-11#1)(2008-10#1)
thus indicating that these##2##4##(1990-2#1)(1995-5#1)
thus indicating that##4##3##(1990-2#1)(1991-5#1)(1995-3#1)(1995-5#1)
thus indicating the possibility of using mild conditions for sample preparation instead of intensive treatments inherent with the digestion##2##19##(2008-10#2)
thus indicating the possibility of using##3##6##(2008-10#3)
thus indicating the##7##3##(1990-8#1)(1994-6#1)(2008-10#4)(2008-8#1)
thus indicating##17##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(2008-10#5)(2008-12#1)(2008-8#1)(2010-6#1)
thus it is##3##3##(2008-11#1)(2008-4#1)(2009-5#1)
thus it##12##2##(1994-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-1#1)
thus keeping##2##2##(1991-6#1)(2008-3#1)
thus leading to a##3##4##(1993-9#1)(2008-6#1)(2011-2#1)
thus leading to##6##3##(1992-8#1)(1993-9#1)(2008-2#1)(2008-6#1)(2011-2#2)
thus leading##9##2##(1992-8#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#2)
thus likely to have##2##4##(1995-5#1)(2008-8#1)
thus likely to##3##3##(1995-5#1)(2008-8#1)(2009-9#1)
thus likely##7##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-8#2)(2009-9#1)(2011-2#1)
thus limiting the##2##3##(1994-2#1)(1997-2#1)
thus limiting##5##2##(1994-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2012-12#1)
thus lowering##2##2##(2008-10#1)(2008-11#1)
thus making it possible to##2##5##(1997-2#1)(2013-7#1)
thus making it##6##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-7#1)
thus making the##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
thus making them##2##3##(2008-10#1)(2008-2#1)
thus making##19##2##(1991-8#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
thus many##2##2##(1991-6#1)(2008-11#1)
thus may be##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
thus may##12##2##(1995-11#2)(1995-3#1)(1995-9#1)(1996-10#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
thus minimizing the##2##3##(2008-10#1)(2008-4#1)
thus minimizing##4##2##(2008-10#2)(2008-4#1)(2011-9#1)
thus more likely to##2##4##(2007-4#1)(2008-8#1)
thus more##3##2##(1992-3#1)(2007-4#1)(2008-8#1)
thus not only##2##3##(1990-2#1)(1997-7#1)
thus not##6##2##(1990-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
thus obtained was##2##3##(1991-5#1)(2008-10#1)
thus obtained##10##2##(1990-3#1)(1991-5#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#5)
thus of##4##2##(2008-3#1)(2008-6#1)(2010-9#1)(2011-2#1)
thus offer##3##2##(2007-12#1)(2008-8#1)(2009-10#1)
thus offering a##2##3##(2008-9#1)(2011-2#1)
thus offering##5##2##(1994-9#1)(2008-5#2)(2008-9#1)(2011-2#1)
thus overcoming##4##2##(2008-10#2)(2008-3#1)(2008-4#1)
thus permitting##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)
thus play an important role in##2##6##(1992-8#1)(2008-9#1)
thus playing a##2##3##(2009-9#1)(2013-1#1)
thus posing##3##2##(1994-1#1)(2008-12#1)(2012-3#1)
thus possible to##4##3##(1990-2#1)(1990-8#1)(2008-10#1)(2008-11#1)
thus present##2##2##(1992-3#1)(2007-8#1)
thus preventing##4##2##(1991-2#1)(1997-6#1)(2008-10#1)(2012-2#1)
thus produced##3##2##(1994-7#1)(2008-3#2)
thus producing##3##2##(2008-3#2)(2008-5#1)
thus proposed##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
thus provide a##5##3##(1991-8#1)(2007-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
thus provide the##2##3##(1995-8#1)(2008-4#1)
thus provide##11##2##(1991-8#1)(1995-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-3#1)(2013-1#1)
thus provided##2##2##(2008-10#1)(2008-8#1)
thus provides a##3##3##(1995-6#1)(1996-8#1)(2008-10#1)
thus provides##6##2##(1994-5#1)(1995-6#1)(1996-8#1)(1997-6#1)(2008-10#1)(2012-2#1)
thus providing a##8##3##(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-10#1)
thus providing evidence for the##2##5##(1991-5#1)(1992-12#1)
thus providing evidence that##3##4##(2008-10#2)(2008-11#1)
thus providing evidence##5##3##(1991-5#1)(1992-12#1)(2008-10#2)(2008-11#1)
thus providing the##2##3##(1995-2#1)(2008-10#1)
thus providing##26##2##(1991-5#1)(1992-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
thus proving##2##2##(2008-10#1)(2012-12#1)
thus raising the##2##3##(1994-8#1)(1995-11#1)
thus raising##3##2##(1994-8#1)(1995-11#1)(2010-8#1)
thus realized##2##2##(2008-10#2)
thus recommended##2##2##(1991-4#1)(2008-10#1)
thus reducing the need for##2##5##(2007-11#1)(2008-3#1)
thus reducing the##6##3##(1990-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-8#1)
thus reducing##8##2##(1990-6#1)(2007-11#1)(2008-10#3)(2008-3#1)(2009-8#1)(2010-2#1)
thus reflects##2##2##(1992-3#1)(2013-1#1)
thus rendering the##2##3##(2008-10#1)(2008-7#1)
thus rendering##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
thus represent##2##2##(1995-11#1)(2008-10#1)
thus representing a##2##3##(2008-5#1)(2008-8#1)
thus representing##3##2##(1996-5#1)(2008-5#1)(2008-8#1)
thus represents a##2##3##(1993-8#1)(2007-12#1)
thus represents an##2##3##(1994-11#1)(2007-11#1)
thus represents##4##2##(1993-8#1)(1994-11#1)(2007-11#1)(2007-12#1)
thus requiring an##2##3##(2008-10#2)
thus restoring##2##2##(1993-8#1)(2008-7#1)
thus restricting##2##2##(2010-4#1)(2013-1#1)
thus resulting in##3##3##(2007-6#1)(2008-3#1)(2010-4#1)
thus revealing##2##2##(1994-3#1)(2013-1#1)
thus saving##2##2##(2008-7#1)(2008-8#1)
thus seem##2##2##(1990-9#1)(2008-12#1)
thus seems##2##2##(1995-11#1)(1996-3#1)
thus separate the##2##3##(1994-3#1)(2011-2#1)
thus showed##2##2##(1992-11#1)(2008-11#1)
thus showing that##2##3##(2007-12#1)(2011-2#1)
thus showing the##2##3##(2008-10#1)(2011-2#1)
thus showing##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2011-2#2)
thus subjecting##2##2##(1992-3#1)(2013-1#1)
thus substantially##2##2##(2008-7#1)(2011-1#1)
thus suggesting a##2##3##(1995-12#1)(2007-7#1)
thus suggesting an##2##3##(1992-8#1)(2012-3#1)
thus suggesting that a##2##4##(1994-6#1)(1995-12#1)
thus suggesting that the##2##4##(1995-2#1)(2008-7#1)
thus suggesting that##9##3##(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-5#1)(2008-7#2)(2008-8#1)
thus suggesting##15##2##(1992-8#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(2007-7#1)(2008-5#1)(2008-7#3)(2008-8#1)(2012-3#1)
thus suggests that##2##3##(1995-11#1)(1996-7#1)
thus supporting the##2##3##(2007-7#1)(2011-2#1)
thus suppressing the##2##3##(2008-10#1)(2008-3#1)
thus that the##2##3##(2007-11#1)(2008-10#1)
thus the detection##2##3##(2008-10#1)(2008-3#1)
thus the##39##2##(1991-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#2)(2010-6#1)(2012-1#1)(2013-1#2)(2013-8#2)
thus there is##2##3##(1994-5#1)(2008-10#1)
thus they##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
thus this##2##2##(2008-8#1)(2013-1#1)
thus to##10##2##(1996-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
thus was##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
thus well##2##2##(2008-3#1)(2008-4#1)
thus yielding##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
thus##1158##1##(1990-11#2)(1990-12#5)(1990-2#7)(1990-3#2)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#7)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#4)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#2)(1992-3#10)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#7)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#5)(1994-5#9)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#2)(1995-11#9)(1995-12#8)(1995-2#9)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#5)(1995-9#3)(1996-1#3)(1996-10#1)(1996-12#11)(1996-2#4)(1996-3#1)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#6)(1997-5#5)(1997-6#7)(1997-7#4)(1997-8#2)(2006-6#1)(2007-10#2)(2007-11#17)(2007-12#33)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#13)(2008-10#187)(2008-11#51)(2008-12#15)(2008-2#31)(2008-3#62)(2008-4#22)(2008-5#34)(2008-6#15)(2008-7#34)(2008-8#48)(2008-9#20)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#5)(2009-3#5)(2009-4#3)(2009-5#7)(2009-6#6)(2009-7#1)(2009-8#11)(2009-9#3)(2010-1#3)(2010-10#5)(2010-12#8)(2010-2#4)(2010-3#7)(2010-4#6)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#27)(2011-3#5)(2011-9#1)(2012-1#1)(2012-12#16)(2012-2#27)(2012-3#14)(2012-4#1)(2012-6#1)(2013-1#31)(2013-7#4)(2013-8#19)
thwart##2##1##(2008-7#1)(2011-2#1)
thylakoid bioassay##3##2##(2008-11#3)
thylakoid membrane protein##3##3##(2008-8#3)
thylakoid membrane##4##2##(1992-3#1)(2008-8#3)
thylakoid membranes of##2##3##(1990-5#1)(1991-12#1)
thylakoid membranes was##2##3##(1997-4#2)
thylakoid membranes##8##2##(1990-5#1)(1991-12#1)(1994-11#1)(1997-4#4)(2009-10#1)
thylakoid redox##2##2##(2009-10#2)
thylakoid##22##1##(1990-5#1)(1991-12#2)(1992-3#1)(1994-11#1)(1997-4#4)(2008-10#2)(2008-11#3)(2008-8#4)(2009-10#4)
thylakoid-like features##2##2##(1997-6#2)
thylakoids##7##1##(1991-12#3)(1997-6#1)(2008-11#1)(2009-10#1)(2009-7#1)
thymectomy and##2##2##(1997-5#1)(2008-5#1)
thymectomy was the most##2##4##(2012-12#2)
thymectomy with the##2##3##(2007-8#2)
thymectomy##19##1##(1997-5#1)(2007-8#11)(2008-5#1)(2010-8#1)(2012-12#5)
thymi##2##1##(1995-12#1)(2008-10#1)
thymic atrophy##4##2##(2008-10#4)
thymic cyst##4##2##(2007-8#4)
thymic dendritic cells##4##3##(2008-8#4)
thymic epithelial##2##2##(2008-8#1)(2012-12#1)
thymic function##2##2##(1991-12#1)(1993-12#1)
thymic involution##6##2##(1993-12#1)(2008-10#1)(2008-7#1)(2013-7#3)
thymic lymphosarcoma cells##3##3##(1992-8#3)
thymic lymphosarcoma##6##2##(1992-8#4)(1995-11#2)
thymic medulla##2##2##(2008-8#2)
thymic##62##1##(1991-12#1)(1991-5#1)(1991-8#2)(1992-2#1)(1992-8#4)(1993-12#2)(1995-11#2)(1995-5#1)(1997-9#1)(2007-8#6)(2008-10#11)(2008-7#4)(2008-8#11)(2008-9#1)(2009-5#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#6)
thymidine analog##2##2##(2008-4#2)
thymidine analogue##3##2##(1993-11#1)(1996-5#1)(2013-1#1)
thymidine in##2##2##(1993-12#2)
thymidine incorporation##5##2##(1990-12#1)(1991-12#1)(1992-3#1)(1994-3#2)
thymidine into##3##2##(1991-5#2)(1992-8#1)
thymidine kinase 1##2##3##(2011-2#2)
thymidine kinase##8##2##(1992-8#2)(1993-8#2)(1996-5#1)(2007-11#1)(2011-2#2)
thymidine uptake##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
thymidine were##2##2##(2008-11#1)(2011-1#1)
thymidine##46##1##(1990-12#1)(1991-12#1)(1991-5#6)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#7)(1993-3#1)(1993-8#2)(1994-10#1)(1994-3#3)(1996-5#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#2)(2008-9#2)(2011-1#1)(2011-2#2)(2013-1#1)
thymidine)##2##1##(2008-11#1)(2008-2#1)
thymidylate synthase inhibitor##2##3##(1994-8#2)
thymidylate synthase##10##2##(1990-7#2)(1993-11#4)(1994-8#2)(2008-5#1)(2009-9#1)
thymine and##3##2##(1992-3#1)(1996-5#1)(2008-10#1)
thymine dimer repair-enhancing##2##3##(2008-11#2)
thymine methyl##3##2##(1992-6#2)(1993-11#1)
thymine was also##2##3##(1991-5#1)(2008-10#1)
thymine##20##1##(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#4)(1992-6#3)(1992-8#1)(1993-11#1)(1996-5#2)(2008-10#2)(2008-11#3)(2011-1#1)
thymines##4##1##(1992-3#1)(1993-11#3)
thymocyte apoptosis##2##2##(2008-10#2)
thymocyte development##5##2##(2008-10#2)(2008-8#1)(2010-2#2)
thymocyte proliferation##3##2##(1991-12#1)(2008-10#2)
thymocyte subpopulations##2##2##(2008-10#2)
thymocyte##23##1##(1990-5#1)(1991-12#2)(1992-9#1)(1995-8#1)(2008-10#15)(2008-8#1)(2010-2#2)
thymocytes and##5##2##(1992-8#1)(1994-3#1)(1997-7#1)(2008-9#1)(2013-7#1)
thymocytes exposed to##2##3##(1991-12#1)(1995-5#1)
thymocytes from##4##2##(1992-9#1)(1995-5#1)(2008-10#2)
thymocytes to##5##2##(1991-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(2008-10#1)
thymocytes were##2##2##(2008-10#1)(2008-8#1)
thymocytes##56##1##(1990-12#1)(1990-5#5)(1991-12#2)(1992-8#4)(1992-9#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#3)(1997-7#3)(2008-10#8)(2008-8#13)(2008-9#5)(2012-12#2)(2013-7#1)
thymol and carvacrol in honey##2##5##(2008-10#2)
thymol and carvacrol##3##3##(2008-10#3)
thymol and##4##2##(1997-2#1)(2008-10#3)
thymol blue and##2##3##(2008-10#2)
thymol blue##8##2##(2008-10#8)
thymol##18##1##(1997-2#2)(2008-10#13)(2008-12#2)(2012-2#1)
thymoma on CT##2##3##(2007-8#2)
thymoma##11##1##(1994-2#1)(2007-8#6)(2008-12#1)(2012-12#2)(2013-1#1)
thymomas with##2##2##(2007-8#1)(2008-12#1)
thymomas##3##1##(2007-8#1)(2008-12#1)(2012-12#1)
thymopentin treatment##2##2##(1990-2#1)(1991-3#1)
thymopentin##8##1##(1990-2#2)(1991-3#6)
thymostimulin in patients with##2##4##(1991-5#1)(1992-5#1)
thymostimulin##6##1##(1990-2#2)(1991-5#3)(1992-5#1)
thymulin##2##1##(2013-7#2)
thymus Hsc70 protein##2##3##(1995-6#2)
thymus after##2##2##(2008-10#2)
thymus and spleen weights##2##4##(2008-10#2)
thymus and spleen were##2##4##(1993-3#1)(2010-7#1)
thymus and spleen##7##3##(1993-3#1)(1995-12#2)(2008-10#3)(2010-7#1)
thymus and##19##2##(1992-8#1)(1993-12#1)(1993-3#2)(1995-12#2)(1997-9#2)(2008-10#6)(2008-11#1)(2008-5#2)(2010-7#1)(2012-1#1)
thymus atrophy##3##2##(2008-10#1)(2008-5#2)
thymus by##2##2##(1997-4#1)(2008-10#1)
thymus in##2##2##(1997-7#1)(2008-5#1)
thymus involution##3##2##(2008-10#2)(2013-7#1)
thymus lymphocytes##3##2##(1994-3#3)
thymus tissue##3##2##(2008-4#2)(2011-2#1)
thymus weight##2##2##(2008-10#2)
thymus weights##2##2##(2008-10#1)(2008-9#1)
thymus##127##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-3#3)(1994-5#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#5)(1997-4#2)(1997-5#2)(1997-7#3)(1997-9#3)(2007-11#1)(2007-5#1)(2008-10#42)(2008-11#1)(2008-4#4)(2008-5#10)(2008-7#2)(2008-8#4)(2008-9#3)(2009-2#1)(2010-2#3)(2010-7#1)(2011-2#3)(2012-1#1)(2013-7#3)
thymuses##2##1##(2008-10#2)
thyrocytes and C cells##3##4##(2012-3#3)
thyrocytes to##2##2##(2012-3#2)
thyrocytes##9##1##(1990-12#1)(1991-8#1)(2012-3#6)(2013-8#1)
thyroglobulin secreted##2##2##(1992-12#2)
thyroglobulin##13##1##(1991-5#3)(1992-12#4)(1992-8#2)(1993-3#2)(1995-12#1)(2013-1#1)
thyroid adenoma##3##2##(2012-1#3)
thyroid and##4##2##(2008-4#1)(2009-3#1)(2009-4#1)(2013-8#1)
thyroid antibodies##3##2##(1991-8#1)(1996-11#1)(2007-8#1)
thyroid autoantibodies##3##2##(1990-5#1)(1991-8#1)(2008-7#1)
thyroid autoimmunity and##2##3##(2008-7#2)
thyroid autoimmunity##3##2##(2008-7#3)
thyroid cancer and the##2##4##(2008-5#1)(2013-1#1)
thyroid cancer cell##2##3##(1992-8#1)(2008-4#1)
thyroid cancer is##2##3##(1990-6#1)(2008-4#1)
thyroid cancer##27##2##(1990-10#1)(1990-3#2)(1990-6#1)(1992-8#4)(2008-10#1)(2008-12#2)(2008-4#5)(2008-5#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#5)
thyroid cancers##5##2##(1992-8#1)(2008-4#3)(2013-1#1)
thyroid carcinoma and##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
thyroid carcinoma cells##4##3##(1992-6#2)(1993-3#1)(1993-8#1)
thyroid carcinoma in a##2##4##(1990-6#2)
thyroid carcinoma in##5##3##(1990-6#2)(2012-3#3)
thyroid carcinoma were treated##2##4##(1990-10#1)(2013-1#1)
thyroid carcinoma with##2##3##(2012-3#1)(2013-1#1)
thyroid carcinoma##42##2##(1990-10#2)(1990-3#3)(1990-6#3)(1990-8#3)(1992-6#2)(1993-3#3)(1993-8#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2012-3#9)(2013-1#6)
thyroid carcinoma]##2##2##(2008-10#1)(2008-7#1)
thyroid carcinomas##4##2##(1992-6#1)(1993-3#1)(2008-5#1)(2013-1#1)
thyroid cartilage##4##2##(2008-2#1)(2010-12#1)(2012-12#1)(2013-7#1)
thyroid cell##3##2##(1992-8#3)
thyroid cells##7##2##(1991-12#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-11#2)
thyroid deficiency##3##2##(2013-1#3)
thyroid disease is##2##3##(2008-6#1)(2013-1#1)
thyroid disease##9##2##(1990-6#1)(1993-5#2)(2007-5#1)(2008-6#2)(2010-11#1)(2011-1#1)(2013-1#1)
thyroid diseases##4##2##(2008-6#1)(2013-1#3)
thyroid disorders##10##2##(2008-4#1)(2008-6#2)(2013-1#7)
thyroid doses##3##2##(1993-9#3)
thyroid dysfunction in##2##3##(2008-4#1)(2008-7#1)
thyroid dysfunction was##2##3##(1991-8#1)(2008-7#1)
thyroid dysfunction##14##2##(1991-8#3)(2008-4#2)(2008-6#4)(2008-7#2)(2012-12#1)(2013-1#2)
thyroid follicular##2##2##(2008-7#1)(2009-8#1)
thyroid function and##3##3##(1991-8#1)(1994-11#1)(2012-2#1)
thyroid function in##5##3##(2008-11#1)(2008-4#2)(2008-7#1)(2013-1#1)
thyroid function test##3##3##(2008-4#1)(2011-1#1)(2012-2#1)
thyroid function tests##3##3##(2008-4#1)(2008-7#1)(2011-1#1)
thyroid function##28##2##(1991-8#2)(1994-11#1)(2008-11#1)(2008-4#6)(2008-6#3)(2008-7#7)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#3)
thyroid gland and##2##3##(1996-3#1)(2008-9#1)
thyroid gland in##3##3##(2008-12#1)(2008-7#1)(2012-1#1)
thyroid gland##37##2##(1990-3#1)(1990-5#3)(1990-8#1)(1992-2#1)(1993-3#4)(1993-5#3)(1993-9#1)(1996-3#2)(1997-2#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#4)(2011-1#3)(2012-1#2)(2013-1#6)
thyroid glands of##3##3##(1990-2#1)(1990-5#1)(1995-12#1)
thyroid glands##4##2##(1990-2#1)(1990-5#1)(1995-12#1)(2011-2#1)
thyroid homeostasis##3##2##(2013-1#3)
thyroid hormone 3##2##3##(1990-12#1)(1992-12#1)
thyroid hormone and TSH levels##2##5##(2008-4#2)
thyroid hormone and##3##3##(1994-11#1)(2008-4#2)
thyroid hormone in##2##3##(1994-11#1)(2009-12#1)
thyroid hormone levels in##2##4##(2008-7#1)(2009-12#1)
thyroid hormone levels##5##3##(1997-3#1)(2008-4#1)(2008-7#2)(2009-12#1)
thyroid hormone receptor##13##3##(1990-8#2)(1991-2#2)(1993-3#1)(1993-8#2)(1994-11#3)(2008-4#1)(2008-7#1)(2013-1#1)
thyroid hormone replacement##4##3##(2008-5#1)(2011-1#2)(2012-2#1)
thyroid hormone response element##2##4##(1990-8#1)(1993-8#1)
thyroid hormone##64##2##(1990-12#1)(1990-3#1)(1990-8#3)(1991-2#4)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#6)(1993-8#3)(1994-11#7)(1995-12#1)(1995-2#2)(1995-8#3)(1996-5#2)(1997-3#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#6)(2009-12#2)(2011-1#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
thyroid hormones and prostaglandin E2##2##5##(2011-2#2)
thyroid hormones and##6##3##(1995-8#1)(1997-3#1)(2011-2#2)(2012-2#2)
thyroid hormones in##2##3##(2012-1#1)(2012-2#1)
thyroid hormones##18##2##(1990-3#2)(1990-8#1)(1993-12#1)(1995-8#1)(1997-3#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-1#1)(2012-2#4)(2013-8#2)
thyroid hyperplasia##2##2##(2008-4#1)(2012-12#1)
thyroid in##6##2##(1992-2#2)(1994-11#1)(2008-6#1)(2009-3#1)(2011-1#1)
thyroid is##2##2##(2008-12#1)(2012-3#1)
thyroid lobectomy##2##2##(2012-12#2)
thyroid lobes were##2##3##(1991-12#2)
thyroid lobes##5##2##(1991-12#4)(2012-3#1)
thyroid mass##3##2##(2008-12#2)(2009-3#1)
thyroid morphology##2##2##(2008-7#2)
thyroid nodule##4##2##(1992-9#1)(1994-5#1)(2008-12#1)(2011-1#1)
thyroid nodules##10##2##(1990-6#1)(1997-2#1)(2011-1#4)(2012-3#3)(2013-7#1)
thyroid parenchyma##2##2##(2008-12#1)(2008-7#1)
thyroid remnant ablation##2##3##(2013-1#2)
thyroid remnant##3##2##(2008-5#1)(2013-1#2)
thyroid response##2##2##(1991-7#1)(1994-11#1)
thyroid slices##4##2##(1994-11#2)(1994-6#2)
thyroid state##3##2##(2007-8#2)(2009-12#1)
thyroid stimulating activities##3##3##(1991-12#1)(1991-9#2)
thyroid stimulating autoantibodies##2##3##(1992-12#2)
thyroid stimulating hormone (TSH)##4##4##(1990-8#1)(1994-9#1)(1995-5#1)(2008-6#1)
thyroid stimulating hormone##5##3##(1990-8#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-6#1)
thyroid stimulating##13##2##(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-12#2)(1994-9#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-6#1)
thyroid storm##3##2##(2012-12#3)
thyroid tissue specimens from patients with##2##6##(2012-1#2)
thyroid tissue##7##2##(1991-8#1)(1992-8#1)(1994-11#1)(2008-11#1)(2008-12#1)(2012-1#2)
thyroid tumor##2##2##(1992-2#1)(1994-12#1)
thyroid tumors##4##2##(1990-2#1)(1990-3#1)(2008-7#1)(2012-1#1)
thyroid tumours##2##2##(1994-11#2)
thyroid was##2##2##(1990-2#1)(1990-7#1)
thyroid##474##1##(1990-10#3)(1990-12#3)(1990-2#3)(1990-3#10)(1990-5#6)(1990-6#10)(1990-7#3)(1990-8#10)(1991-12#8)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#9)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-6#4)(1992-8#15)(1992-9#1)(1993-12#2)(1993-3#15)(1993-5#5)(1993-8#6)(1993-9#6)(1994-11#18)(1994-12#2)(1994-5#1)(1994-6#4)(1994-9#1)(1995-12#7)(1995-2#2)(1995-5#1)(1995-8#4)(1996-11#2)(1996-3#2)(1996-5#2)(1997-2#2)(1997-3#3)(1997-7#1)(2007-5#1)(2007-8#6)(2008-1#10)(2008-10#9)(2008-11#4)(2008-12#13)(2008-2#1)(2008-4#26)(2008-5#6)(2008-6#17)(2008-7#33)(2008-9#4)(2009-12#3)(2009-3#5)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#15)(2011-2#4)(2012-1#12)(2012-12#11)(2012-2#10)(2012-3#17)(2013-1#55)(2013-7#3)(2013-8#8)
thyroid-stimulating hormone##3##2##(2007-5#1)(2008-4#1)(2012-3#1)
thyroid/steroid receptor superfamily##2##3##(1994-12#2)
thyroidal##2##1##(1991-5#2)
thyroidectomized##4##1##(1991-9#1)(1995-12#1)(2008-7#2)
thyroidectomy and##2##2##(1992-2#1)(2013-1#1)
thyroidectomy is the##3##3##(1990-9#1)(1993-6#1)(2011-2#1)
thyroidectomy is##4##2##(1990-9#1)(1993-6#1)(2011-2#1)(2012-12#1)
thyroidectomy##28##1##(1990-2#1)(1990-9#4)(1992-2#1)(1992-5#1)(1993-6#2)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#6)(2012-12#3)(2013-1#4)(2013-7#1)
thyroiditis and##7##2##(1990-6#1)(1991-8#1)(1995-12#1)(2007-5#2)(2008-12#1)(2009-3#1)
thyroiditis in##2##2##(1995-12#2)
thyroiditis is##2##2##(1990-5#1)(2008-12#1)
thyroiditis with##2##2##(1991-8#1)(2008-6#1)
thyroiditis##28##1##(1990-5#2)(1990-6#3)(1991-8#3)(1995-12#4)(1995-3#1)(1996-12#1)(2007-5#2)(2007-7#2)(2008-12#5)(2008-6#2)(2009-3#1)(2011-2#1)(2013-1#1)
thyroiditis]##3##1##(1990-6#1)(1991-11#1)(2013-1#1)
thyroids of fasted##2##3##(2008-7#2)
thyroids of##4##2##(2008-7#3)(2013-8#1)
thyroids##7##1##(1994-11#1)(1995-12#1)(2008-7#3)(2012-1#1)(2013-8#1)
thyronine##2##1##(1991-5#1)(1992-11#1)
thyropathic women with##2##3##(2013-1#2)
thyropathic women##3##2##(2013-1#3)
thyroperoxidase##3##1##(1990-7#2)(1995-12#1)
thyrostatic-induced##2##1##(1994-3#2)
thyrotoxic periodic paralysis##2##3##(2007-5#2)
thyrotoxicosis associated with##2##3##(2008-4#1)(2008-7#1)
thyrotoxicosis##7##1##(2007-5#1)(2008-4#1)(2008-7#3)(2011-2#1)(2012-12#1)
thyrotropin (TSH) receptor##3##3##(1991-5#1)(1991-9#1)(1992-12#1)
thyrotropin (TSH)##6##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(2011-1#1)(2013-1#1)
thyrotropin receptor (TSHr)##3##3##(1994-11#2)(2008-4#1)
thyrotropin receptor##14##2##(1991-12#2)(1991-5#1)(1991-9#1)(1994-11#6)(1995-12#2)(1996-5#1)(2008-4#1)
thyrotropin releasing hormone (TRH)##3##4##(1992-6#1)(1995-5#1)(2007-7#1)
thyrotropin##40##1##(1991-12#6)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-11#11)(1994-6#3)(1995-12#3)(1995-5#1)(1996-5#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
thyrotropin-releasing hormone (TRH)##2##3##(1992-2#1)(2008-4#1)
thyrotropin-releasing hormone##9##2##(1992-2#2)(1992-8#1)(1993-11#1)(1993-8#2)(1994-2#1)(2008-4#1)(2013-7#1)
thyroxin##3##1##(2008-1#1)(2012-3#1)(2013-1#1)
thyroxine (T4) and triiodothyronine (T3)##2##5##(1991-12#1)(2008-7#1)
thyroxine (T4)##5##2##(1991-12#1)(1992-12#1)(2008-6#2)(2008-7#1)
thyroxine and a##2##3##(2007-8#1)(2013-8#1)
thyroxine and##3##2##(2007-8#1)(2008-11#1)(2013-8#1)
thyroxine binding globulin (TBG)##2##4##(1990-2#2)
thyroxine transport##2##2##(1993-12#2)
thyroxine##34##1##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#4)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#5)(1997-5#1)(2007-5#1)(2007-8#3)(2008-11#2)(2008-6#2)(2008-7#2)(2009-12#1)(2010-8#1)(2012-3#1)(2013-8#3)
thyroxine-treated rats##9##2##(1995-12#9)
thérapeutique##4##1##(2011-2#2)(2013-1#2)
thérapeutiques##2##1##(2009-4#1)(2011-2#1)
tiapride##2##1##(2008-10#2)
tiazofurin##4##1##(1990-10#1)(1993-8#2)(1995-3#1)
tibia -##2##2##(2007-11#2)
tibia and##4##2##(2007-11#1)(2008-8#1)(2009-3#1)(2012-1#1)
tibia in##2##2##(2009-3#1)(2012-2#1)
tibia of##2##2##(2008-7#1)(2009-7#1)
tibia was##2##2##(2012-1#1)(2013-1#1)
tibia were##2##2##(2012-1#1)(2012-12#1)
tibia##58##1##(1992-11#3)(1992-3#1)(2007-11#10)(2007-12#2)(2007-8#3)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#8)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#2)
tibiae##5##1##(2007-7#1)(2008-11#1)(2008-5#2)(2012-12#1)
tibial arteries##3##2##(1990-11#1)(1990-6#1)(1991-3#1)
tibial artery##6##2##(1991-8#1)(2008-12#1)(2009-3#2)(2013-1#2)
tibial bone##2##2##(2009-7#1)(2011-2#1)
tibial component##2##2##(2007-8#1)(2009-3#1)
tibial defect following##2##3##(2008-6#2)
tibial diaphyseal##2##2##(2007-11#2)
tibial dyschondroplasia##3##2##(1991-9#1)(1997-3#2)
tibial fractures complicated by##2##4##(2007-8#2)
tibial fractures##4##2##(2007-8#3)(2009-3#1)
tibial nerve##3##2##(2010-3#1)(2010-5#1)(2012-2#1)
tibial osteotomy##4##2##(1990-6#1)(2011-2#2)(2013-1#1)
tibial plateau fractures##3##3##(2009-4#1)(2013-1#2)
tibial plateau leveling osteotomy##2##4##(2012-3#2)
tibial plateau##7##2##(2008-10#1)(2009-4#1)(2012-3#2)(2013-1#3)
tibial shaft fracture##2##3##(2009-3#2)
tibial shaft fractures##2##3##(2012-2#2)
tibial shaft##8##2##(2007-8#1)(2009-3#2)(2010-11#2)(2012-2#2)(2013-8#1)
tibial tendon insufficiency##2##3##(2008-8#2)
tibial tendon##4##2##(1990-9#2)(2008-8#2)
tibial translation##5##2##(2008-12#2)(2012-3#3)
tibial tubercle##3##2##(2008-9#2)(2012-2#1)
tibial##85##1##(1990-11#1)(1990-6#4)(1990-9#2)(1991-3#1)(1991-8#1)(1991-9#2)(1996-6#1)(1997-3#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-12#4)(2008-6#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#12)(2009-4#1)(2009-7#1)(2010-11#2)(2010-3#2)(2010-5#2)(2011-2#4)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#1)
tibialis anterior##4##2##(1995-12#1)(2012-3#2)(2013-8#1)
tibialis group##2##2##(2008-5#2)
tibialis##8##1##(1995-12#1)(1995-2#1)(2008-4#1)(2008-5#2)(2012-3#2)(2013-8#1)
tibias##3##1##(1992-11#1)(2007-11#1)(2009-3#1)
tibiocalcaneal fusion##3##2##(2009-3#3)
tibiotarsal##2##1##(1996-8#1)(2010-3#1)
tibiotarsus##2##1##(1997-3#2)
tibolone##3##1##(2008-10#3)
tic##3##1##(2008-12#1)(2008-2#1)(2011-2#1)
tick and##2##2##(1997-7#1)(2013-8#1)
tick eggs##3##2##(2010-10#3)
tick habitat suitability##2##3##(2008-8#2)
tick species were collected from dogs##2##6##(2011-1#2)
tick species##6##2##(2008-8#2)(2011-1#3)(2013-8#1)
tick vector##2##2##(1994-6#1)(2008-8#1)
tick##50##1##(1994-3#3)(1994-6#1)(1996-11#2)(1996-12#5)(1996-8#1)(1997-7#2)(2007-2#1)(2008-10#1)(2008-12#3)(2008-8#12)(2008-9#1)(2010-1#3)(2010-10#6)(2011-1#3)(2012-3#1)(2013-1#1)(2013-8#4)
tick-borne disease##2##2##(2008-10#1)(2010-1#1)
tick-borne diseases##3##2##(2010-1#2)(2013-8#1)
tick-borne encephalitis##4##2##(2007-2#1)(2008-8#2)(2011-1#1)
tick-borne pathogen##3##2##(2013-8#3)
tick-borne##14##1##(2007-2#2)(2008-10#1)(2008-11#1)(2008-8#2)(2010-1#3)(2011-1#1)(2013-8#4)
ticketing##5##1##(2013-8#5)
tickets##3##1##(1992-2#1)(1993-12#2)
ticking##2##1##(1997-1#1)(2007-12#1)
ticks and##4##2##(1991-11#1)(1997-7#1)(2013-1#2)
ticks on##5##2##(1996-12#2)(2008-8#2)(2011-1#1)
ticks were##2##2##(1997-4#1)(2010-1#1)
ticks##37##1##(1991-11#1)(1994-3#1)(1996-11#2)(1996-12#4)(1997-4#3)(1997-7#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#4)(2010-1#6)(2010-10#1)(2011-1#3)(2011-2#1)(2013-1#4)(2013-8#2)
ticlopidine##8##1##(1991-3#5)(1996-11#1)(1996-3#1)(2008-3#1)
tics or tourettism##2##3##(2008-7#2)
tics##5##1##(2008-4#1)(2008-7#3)(2011-2#1)
tidal breathing##2##2##(2013-1#2)
tidal flats##2##2##(2007-5#1)(2008-5#1)
tidal transport##3##2##(2007-5#3)
tidal volume##5##2##(1996-2#2)(1996-5#1)(2012-2#1)(2013-7#1)
tidal volume)##2##2##(1991-12#1)(2013-7#1)
tidal##23##1##(1991-12#1)(1996-2#2)(1996-5#1)(2007-5#4)(2008-5#2)(2010-8#3)(2012-2#1)(2013-1#6)(2013-7#3)
tide of suicide in##2##4##(2009-5#2)
tide of##4##2##(1991-1#1)(2008-10#1)(2009-5#2)
tides and##3##2##(1992-7#1)(2007-5#1)(2013-1#1)
tides##5##1##(1992-7#2)(2007-5#1)(2013-1#2)
tie##13##1##(1990-4#1)(1991-12#1)(1993-12#1)(1995-1#1)(1996-2#1)(2008-2#1)(2011-2#5)(2012-12#2)
tie-down sutures##2##2##(2012-2#2)
tied to a##2##3##(1996-5#1)(2008-4#1)
tied to the##5##3##(2007-11#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#1)
tied to##14##2##(1992-3#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-12#1)
tied##17##1##(1992-3#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#4)(2012-12#1)
tier##8##1##(1990-12#1)(1990-3#4)(2007-7#1)(2008-10#1)(2011-1#1)
tiered approach##2##2##(2008-5#2)
tiered##4##1##(1996-2#1)(2008-3#1)(2008-5#2)
ties the##2##2##(2008-3#1)(2008-6#1)
ties to##4##2##(2008-2#4)
ties with##2##2##(1990-4#1)(2011-2#1)
ties##19##1##(1990-4#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-1#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
tigers (Panthera tigris)##3##3##(1996-12#1)(2009-4#2)
tigers##13##1##(1996-12#1)(2009-4#12)
tight and##5##2##(1990-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
tight association##3##2##(1990-2#1)(2009-2#1)(2012-2#1)
tight binding##3##2##(1992-11#1)(1992-6#1)(1995-6#1)
tight clusters separate from clusters formed by##2##7##(2008-10#2)
tight clusters##3##2##(2008-10#2)(2008-11#1)
tight control of##2##3##(2006-10#1)(2008-11#1)
tight control##5##2##(2006-10#2)(2008-11#1)(2009-8#1)(2012-2#1)
tight glycemic control##3##3##(2009-11#2)(2010-12#1)
tight junction disruption during##2##4##(2011-2#2)
tight junction disruption##3##3##(2011-2#3)
tight junction##6##2##(2007-12#1)(2008-11#1)(2011-2#3)(2012-2#1)
tight junctions and##2##3##(2008-11#1)(2009-10#1)
tight junctions##8##2##(2008-11#1)(2008-7#1)(2009-10#2)(2011-2#3)(2012-2#1)
tight turn as the##2##4##(1990-11#2)
tight##84##1##(1990-11#3)(1990-2#1)(1990-7#2)(1990-8#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-3#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#2)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-5#1)(2011-10#1)(2011-2#6)(2012-2#5)(2012-3#1)(2013-8#3)
tight-binding inhibition##2##2##(1992-8#1)(1993-8#1)
tight-binding inhibitor##2##2##(1993-11#1)(2010-4#1)
tight-binding##11##1##(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-8#1)(2007-11#2)(2008-10#3)(2010-4#1)
tightening##2##1##(1993-3#1)(1995-1#1)
tighter##3##1##(1991-9#1)(1993-7#1)(2011-1#1)
tightly associated to##2##3##(1992-6#1)(1994-12#1)
tightly associated with##5##3##(1992-3#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
tightly associated##9##2##(1992-3#1)(1992-6#3)(1994-12#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
tightly bound to##3##3##(1990-5#2)(1995-6#1)
tightly bound##14##2##(1990-10#1)(1990-5#3)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-4#2)
tightly control##3##2##(1996-1#1)(2008-11#1)(2009-8#1)
tightly controlled by##3##3##(1993-8#1)(2012-2#2)
tightly coupled to##5##3##(1994-11#1)(1997-1#1)(2008-11#1)(2008-8#1)(2012-3#1)
tightly coupled##6##2##(1994-11#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-8#1)(2012-3#1)
tightly focused##5##2##(2007-12#1)(2008-3#3)(2009-5#1)
tightly linked to the##5##4##(1995-6#1)(2008-10#2)(2013-7#1)(2013-8#1)
tightly linked to##9##3##(1995-2#1)(1995-6#1)(2008-10#5)(2013-7#1)(2013-8#1)
tightly linked##13##2##(1995-2#1)(1995-6#1)(1997-3#1)(2008-10#8)(2013-7#1)(2013-8#1)
tightly packed##9##2##(1994-5#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#3)
tightly regulated##13##2##(1994-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
tightly to the##3##3##(1992-3#1)(1994-12#1)(2008-10#1)
tightly to##5##2##(1992-3#2)(1994-12#1)(2008-10#1)(2008-9#1)
tightly##113##1##(1990-10#1)(1990-5#3)(1991-12#1)(1991-5#2)(1992-11#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#6)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-5#3)(1994-6#1)(1995-2#3)(1995-6#3)(1996-1#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
tightness in##2##2##(1995-8#1)(2012-2#1)
tightness of the##2##3##(2006-10#1)(2008-10#1)
tightness##8##1##(1995-8#1)(2006-10#1)(2008-10#2)(2008-2#1)(2010-9#1)(2012-2#1)(2013-7#1)
tigress was##2##2##(2011-1#2)
tigress##5##1##(2011-1#5)
tijdens een multidisciplinair overleg##2##4##(2012-12#2)
tilapia Oreochromis aureus##2##3##(2008-5#2)
tilapia Oreochromis##4##2##(2008-5#2)(2010-8#2)
tilapia population##2##2##(2008-5#2)
tilapia##18##1##(1994-11#2)(2008-12#4)(2008-5#7)(2010-8#2)(2013-7#3)
tiled regression##4##2##(2012-3#4)
tiled##5##1##(2008-2#1)(2012-3#4)
tiles deployed##2##2##(2007-5#2)
tiles##6##1##(2007-5#4)(2008-10#2)
tiling##8##1##(1997-2#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#2)
till delivery##2##2##(2012-12#1)(2012-3#1)
till now##2##2##(2011-1#1)(2011-2#1)
till the adult##2##3##(1990-7#1)(2008-10#1)
till the end of##3##4##(1996-3#1)(2007-8#1)(2008-10#1)
till the last##2##3##(2008-10#1)(2013-1#1)
till the##15##2##(1990-7#1)(1991-2#1)(1994-6#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
till today##2##2##(2011-3#1)(2013-1#1)
till##42##1##(1990-7#1)(1991-2#1)(1991-5#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-11#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#3)(2010-4#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
tillage and soil texture##3##4##(2008-10#3)
tillage and##10##2##(2008-10#9)(2008-12#1)
tillage had##2##2##(2008-10#1)(2008-12#1)
tillage in##2##2##(2008-10#2)
tillage information##3##2##(2008-10#3)
tillage on##3##2##(2008-10#3)
tillage practices##6##2##(2008-10#6)
tillage system##3##2##(2008-10#2)(2008-12#1)
tillage systems##6##2##(2008-10#6)
tillage than in##2##3##(2008-10#2)
tillage treatment##3##2##(2008-10#3)
tillage treatments##6##2##(2008-10#6)
tillage was##4##2##(2008-10#2)(2008-12#2)
tillage x texture interaction##2##4##(2008-10#2)
tillage##89##1##(2008-10#75)(2008-12#14)
tilled fields##3##2##(2008-10#3)
tilled##10##1##(2008-10#10)
tiller elongation##2##2##(2008-10#2)
tiller##5##1##(2008-10#4)(2008-9#1)
tillering##9##1##(2008-10#5)(2008-12#3)(2008-9#1)
tillers##4##1##(2008-10#2)(2008-9#2)
tilt and the##2##3##(2008-2#1)(2008-3#1)
tilt and##9##2##(2007-11#2)(2008-2#6)(2008-3#1)
tilt angle of##5##3##(2008-12#1)(2008-2#2)(2008-3#2)
tilt angle##11##2##(2007-11#1)(2008-12#2)(2008-2#4)(2008-3#4)
tilt angles##5##2##(2007-12#1)(2008-1#1)(2008-3#3)
tilt compensation##2##2##(2008-2#1)(2008-3#1)
tilt components##3##2##(2008-2#3)
tilt errors##3##2##(2008-2#2)(2008-3#1)
tilt estimation##2##2##(2008-2#1)(2008-3#1)
tilt in##2##2##(2007-11#1)(2008-9#1)
tilt is##3##2##(2008-2#2)(2008-3#1)
tilt of the##7##3##(1994-5#1)(2008-2#4)(2008-3#2)
tilt of##11##2##(1994-5#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)
tilt on the##3##3##(2007-11#2)(2008-2#1)
tilt on##5##2##(1993-1#1)(2007-11#2)(2008-2#2)
tilt produces##2##2##(2008-2#2)
tilt sensing error##2##3##(2008-3#2)
tilt the##2##2##(2008-2#1)(2012-1#1)
tilt towards the##2##3##(1991-2#2)
tilt##110##1##(1991-2#2)(1993-1#5)(1994-5#1)(2007-11#11)(2007-12#2)(2008-1#1)(2008-12#2)(2008-2#47)(2008-3#35)(2008-7#1)(2008-9#2)(2012-1#1)
tilt-shift error##2##2##(2008-3#2)
tilt-shift##4##1##(2008-3#4)
tilted fiber gratings##2##3##(2008-3#2)
tilted fiber##3##2##(2008-3#3)
tilted implants##2##2##(2011-7#2)
tilted mirror##2##2##(2007-11#2)
tilted planar waveguide gratings##2##4##(2008-3#2)
tilted to##2##2##(2007-11#1)(2008-3#1)
tilted with respect to the##5##5##(1996-2#1)(2008-2#2)(2008-3#2)
tilted##48##1##(1996-2#1)(2007-11#3)(2007-12#4)(2008-2#15)(2008-3#19)(2008-5#1)(2011-7#3)(2013-1#1)(2013-8#1)
tilted-columnar biaxial##2##2##(2008-3#2)
tilted-columnar##3##1##(2008-3#3)
tilting is##2##2##(1996-2#2)
tilting the##3##2##(2007-11#1)(2008-3#2)
tilting##12##1##(1996-2#2)(2007-11#2)(2008-2#2)(2008-3#3)(2010-8#1)(2011-2#1)(2011-7#1)
tilts of##2##2##(2008-2#1)(2008-3#1)
tilts##3##1##(1997-2#1)(2008-2#1)(2008-3#1)
timber and##2##2##(2011-2#1)(2013-7#1)
timber value##2##2##(2008-10#1)(2008-9#1)
timber##9##1##(2008-10#2)(2008-9#3)(2011-2#2)(2013-7#2)
timbre##4##1##(2013-1#2)(2013-8#2)
time &gt##2##2##(2007-10#1)(2008-10#1)
time &lt##4##2##(2008-10#3)(2008-3#1)
time (&gt##2##2##(2008-10#1)(2008-7#1)
time (0##2##2##(2008-11#1)(2008-12#1)
time (10 min)##2##3##(2008-10#1)(2008-11#1)
time (10##3##2##(2008-10#2)(2008-11#1)
time (15##2##2##(1995-11#1)(2008-10#1)
time (2##2##2##(2008-10#1)(2011-2#1)
time (4##2##2##(1993-8#1)(2008-10#1)
time (5##3##2##(2008-10#3)
time (6##2##2##(1996-2#1)(2008-10#1)
time (MTT)##2##2##(2007-10#1)(2012-3#1)
time (P &lt##2##3##(2010-2#1)(2010-3#1)
time (P##3##2##(1990-3#1)(2010-2#1)(2010-3#1)
time (RT)##5##2##(2008-11#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)
time (an##2##2##(2008-3#1)(2008-8#1)
time (and##2##2##(1994-3#1)(2009-2#1)
time (approximately##3##2##(2008-3#1)(2010-3#2)
time (from##3##2##(1990-12#1)(2008-10#1)(2012-1#1)
time (i##3##2##(2008-10#2)(2008-4#1)
time (in##2##2##(2008-3#1)(2008-5#1)
time (t(1/2))##3##2##(2008-10#3)
time (time##2##2##(2008-5#1)(2010-8#1)
time 0##2##2##(2008-5#1)(2009-7#1)
time 3##3##2##(2008-11#3)
time T##3##2##(2008-7#2)(2008-9#1)
time a##11##2##(1990-6#1)(1993-3#1)(1996-3#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-6#1)(2009-8#1)(2012-2#1)
time about##2##2##(1990-10#1)(1990-2#1)
time according to##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
time across the##3##3##(1995-3#1)(2008-10#2)
time after addition of##3##4##(1991-5#1)(2008-10#2)
time after planting##2##3##(2008-10#2)
time after surgery##2##3##(1990-12#1)(2007-11#1)
time after the##6##3##(1996-6#1)(1997-2#1)(1997-4#1)(2008-3#1)(2008-7#1)(2011-2#1)
time after##39##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-5#1)(1994-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-5#1)(2008-10#11)(2008-3#3)(2008-7#1)(2011-2#2)(2012-3#2)(2013-1#2)
time allocated##2##2##(1990-2#1)(2008-5#1)
time allocation##2##2##(2008-5#1)(2008-8#1)
time along##2##2##(1996-4#1)(2011-1#1)
time an##3##2##(1996-12#1)(2008-5#1)(2010-3#1)
time analysis##2##2##(2008-10#2)
time and a##4##3##(2008-10#2)(2008-11#1)(2009-7#1)
time and accuracy##3##3##(2008-3#1)(2009-2#1)(2010-8#1)
time and an##2##3##(2007-12#1)(2008-10#1)
time and applied##2##3##(2008-10#2)
time and cost of##2##4##(2008-10#1)(2013-1#1)
time and cost##5##3##(2008-10#2)(2009-8#1)(2013-1#2)
time and costs##2##3##(2008-10#2)
time and dose-dependent##2##3##(1990-12#1)(1994-11#1)
time and effort##3##3##(1994-3#1)(1996-3#1)(2008-10#1)
time and energy##2##3##(1992-3#1)(2008-8#1)
time and flow rate##2##4##(2008-10#2)
time and flow##3##3##(2008-10#3)
time and frequency##3##3##(2007-11#1)(2008-3#1)(2009-9#1)
time and from##2##3##(2008-10#2)
time and good##2##3##(2008-10#2)
time and in##4##3##(1991-11#1)(1997-4#1)(2008-10#2)
time and low##2##3##(2008-10#1)(2009-7#1)
time and magnitude##2##3##(1996-4#1)(2008-3#1)
time and mass##2##3##(2008-10#1)(2008-5#1)
time and may be##2##4##(1991-5#1)(2008-9#1)
time and money##3##3##(1995-2#1)(1997-2#1)(2008-4#1)
time and number of##3##4##(2008-10#2)(2010-8#1)
time and peak##4##3##(2008-10#4)
time and physical##2##3##(2008-10#1)(2013-1#1)
time and place##2##3##(1992-11#1)(2011-1#1)
time and potential##5##3##(2008-10#5)
time and power##2##3##(2008-10#1)(2008-3#1)
time and reached##2##3##(1993-8#1)(2008-10#1)
time and resources and##2##4##(2010-9#1)(2012-2#1)
time and resources##4##3##(1996-11#1)(2010-9#1)(2012-2#1)(2013-8#1)
time and social##2##3##(2008-10#1)(2013-1#1)
time and solvent##4##3##(2008-10#4)
time and space##10##3##(1996-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2013-1#1)
time and staff##2##3##(1992-3#1)(2008-11#1)
time and temperature were##2##4##(2008-10#2)
time and temperature##6##3##(2008-10#5)(2008-11#1)
time and the##26##3##(1991-5#1)(1992-12#1)(1994-11#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
time and then##2##3##(2008-10#1)(2008-4#1)
time and those##2##3##(1992-12#1)(1997-3#1)
time and to##3##3##(1995-3#1)(2008-12#1)(2012-12#1)
time and with##6##3##(1990-12#1)(2008-11#1)(2008-3#2)(2011-1#2)
time and##309##2##(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-9#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#130)(2008-11#14)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#3)
time approximately##3##2##(2008-10#2)(2010-1#1)
time are##14##2##(1991-2#1)(1992-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-8#1)(2013-1#1)(2013-8#1)
time as a function of##3##5##(1996-2#1)(1997-4#1)(2007-12#1)
time as a##6##3##(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-2#1)
time as the##10##3##(1993-12#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-5#1)(2012-3#1)
time as well as the##2##5##(1992-6#1)(1994-12#1)
time as well as##5##4##(1990-5#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-5#1)
time as##31##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)
time associating with##2##3##(2009-9#2)
time at a##2##3##(2008-10#1)(2012-3#1)
time at which##6##3##(1996-12#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#1)
time at##25##2##(1990-4#1)(1990-5#1)(1991-2#1)(1992-8#1)(1994-3#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
time available for##2##3##(1996-12#1)(2012-12#1)
time available to escape##2##4##(1996-12#2)
time available##6##2##(1996-12#3)(2008-8#2)(2012-12#1)
time average##3##2##(2007-12#1)(2008-3#2)
time averaging##3##2##(2008-3#3)
time based on##2##3##(2013-1#2)
time based##3##2##(1994-5#1)(2013-1#2)
time because of##4##3##(1992-9#1)(2008-1#1)(2008-10#1)(2009-11#1)
time because##6##2##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
time before the onset of##2##5##(1990-3#1)(1990-8#1)
time before the##3##3##(1990-3#1)(1990-8#1)(2008-6#1)
time before##7##2##(1990-3#1)(1990-8#1)(1994-3#1)(1996-3#1)(1997-8#1)(2008-5#1)(2008-6#1)
time being##2##2##(1996-8#1)(2008-10#1)
time between 5 and##2##4##(2008-10#2)
time between implants##2##3##(2012-2#2)
time between the two##2##4##(2007-12#1)(2013-8#1)
time between the##7##3##(2007-12#2)(2008-10#2)(2008-11#1)(2012-12#1)(2013-8#1)
time between##20##2##(1995-6#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
time but##5##2##(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)
time by 3 orders of magnitude from##2##7##(2008-2#1)(2008-3#1)
time by a##8##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-11#1)(2012-2#1)
time by an##2##3##(2008-10#1)(2008-3#1)
time by approximately##2##3##(2008-10#1)(2008-2#1)
time by##36##2##(1991-11#1)(1992-12#1)(1993-11#1)(1994-12#1)(1996-5#1)(1997-3#1)(2007-11#2)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#7)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#2)(2013-1#1)
time can be##7##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
time can##10##2##(1996-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)
time cells##2##2##(2008-11#1)(2008-8#1)
time compared with the##2##4##(2008-3#1)(2010-1#1)
time compared with##4##3##(2007-12#1)(2008-3#1)(2008-9#1)(2010-1#1)
time compared##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-1#1)
time constant is##3##3##(2008-3#2)(2008-7#1)
time constant of##5##3##(1995-5#1)(1996-5#1)(1997-7#1)(2008-10#1)(2013-8#1)
time constant##21##2##(1992-6#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#4)(2010-2#1)(2011-2#1)(2013-8#1)
time constants associated with##3##4##(2008-11#1)(2008-2#2)
time constants of##2##3##(1997-2#1)(2008-2#1)
time constants##12##2##(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#2)(2008-8#1)
time constraints of##2##3##(2007-10#1)(2008-12#1)
time constraints##7##2##(1991-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2012-12#1)
time consuming and##12##3##(1990-12#1)(1991-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2011-2#3)(2013-8#1)
time consuming##39##2##(1990-12#1)(1990-2#1)(1991-12#1)(1993-8#1)(1994-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-8#1)
time consumption##2##2##(2008-10#2)
time control##2##2##(2008-10#1)(2008-3#1)
time correlation##2##2##(2007-11#1)(2008-3#1)
time corresponding to the##2##4##(1990-8#1)(2008-10#1)
time cost##2##2##(2008-6#1)(2008-9#1)
time could##3##2##(2008-10#2)(2008-11#1)
time course and##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
time course for##3##3##(1993-6#1)(1995-2#1)(1995-6#1)
time course of cell physiology##2##5##(2008-11#2)
time course of changes in##2##5##(1997-3#1)(2009-11#1)
time course of changes##3##4##(1997-3#1)(2009-11#1)(2013-1#1)
time course of the##8##4##(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
time course of##38##3##(1990-5#1)(1991-5#1)(1992-8#1)(1993-11#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
time course studies##2##3##(1995-12#1)(2008-11#1)
time course to that of##2##5##(1995-2#1)(2008-10#1)
time course to that##3##4##(1995-2#1)(2008-10#1)(2013-1#1)
time course##62##2##(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#7)(2013-8#1)
time courses of##7##3##(1992-11#1)(1993-11#1)(1995-6#1)(2008-10#3)(2008-7#1)
time courses##12##2##(1991-2#1)(1992-11#1)(1993-11#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)
time curve##5##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
time curves##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
time data from##2##3##(1997-4#1)(2008-8#1)
time data##9##2##(1997-4#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
time decreased##2##2##(2008-10#1)(2010-8#1)
time decreases##3##2##(1990-7#1)(2008-8#2)
time delay and##2##3##(2008-10#1)(2013-8#1)
time delay between##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
time delay of a##2##4##(2007-11#1)(2008-2#1)
time delay of##5##3##(1993-6#1)(2007-11#2)(2007-12#1)(2008-2#1)
time delay##23##2##(1993-6#1)(1996-6#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2009-9#2)(2010-10#1)(2011-1#1)(2013-8#1)
time delays are##3##3##(2008-2#1)(2008-3#2)
time delays with##2##3##(2007-11#1)(2008-3#1)
time delays##9##2##(1997-2#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#4)(2010-9#1)
time dependence##8##2##(1993-8#1)(1994-8#1)(2007-12#2)(2008-10#2)(2008-2#2)
time dependency##3##2##(1992-3#1)(2008-10#2)
time dependent and##4##3##(2008-10#3)(2008-7#1)
time dependent##13##2##(1991-12#1)(1991-9#1)(1992-3#2)(1997-8#1)(2007-2#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
time detection##3##2##(2008-10#1)(2008-2#2)
time did not affect##2##4##(2008-12#1)(2008-7#1)
time did not##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
time did##4##2##(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
time difference##3##2##(1994-3#1)(2008-10#1)(2008-9#1)
time differences in##2##3##(2008-5#1)(2009-5#1)
time displacement##2##2##(2007-11#2)
time distribution##2##2##(2008-10#1)(2008-7#1)
time domain by##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
time domain##14##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-10#1)(2010-8#1)(2013-7#1)
time domains##2##2##(2007-11#1)(2008-2#1)
time dramatically##2##2##(2008-3#2)
time due to##2##3##(2008-10#1)(2009-8#1)
time duration of &lt##2##4##(2008-10#2)
time duration of##4##3##(1992-8#1)(2008-10#3)
time duration##6##2##(1992-8#1)(1995-3#1)(2007-11#1)(2008-10#3)
time during the##4##3##(2008-7#1)(2008-9#1)(2009-11#1)(2013-1#1)
time during which##2##3##(2008-10#1)(2009-12#1)
time during##12##2##(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-1#2)
time effect##2##2##(1996-6#1)(2013-8#1)
time elapsed##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
time evolution##5##2##(2008-1#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
time factor in##2##3##(2008-10#2)
time factor##3##2##(1994-11#1)(2008-10#2)
time factors##2##2##(2007-10#1)(2011-1#1)
time following diagnosis##2##3##(1997-3#1)(2008-6#1)
time for a##7##3##(1991-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)
time for analysis##2##3##(2008-10#2)
time for germination##2##3##(2008-10#1)(2008-12#1)
time for health##2##3##(2007-2#1)(2008-1#1)
time for its##2##3##(2008-10#1)(2008-8#1)
time for one##3##3##(2008-10#3)
time for patients##3##3##(1991-11#1)(1997-4#1)(2010-8#1)
time for the first##2##4##(2008-3#1)(2012-12#1)
time for the##19##3##(1991-11#1)(1992-4#1)(1995-3#1)(1997-4#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
time for this##2##3##(2008-10#2)
time for##122##2##(1990-12#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-3#4)(1996-12#1)(1996-3#2)(1997-4#3)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#33)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#3)
time frame##14##2##(1992-3#1)(1996-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
time frames for##2##3##(1993-1#1)(1997-3#1)
time frames##5##2##(1993-1#1)(1997-3#1)(2008-11#1)(2012-2#1)(2012-3#1)
time from onset of symptoms to##2##6##(2008-3#1)(2013-1#1)
time from renal failure to##2##5##(1995-12#2)
time from the##9##3##(1997-6#2)(2007-11#1)(2008-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
time from##44##2##(1990-5#1)(1992-11#1)(1994-7#1)(1995-12#3)(1995-5#1)(1997-6#4)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#4)
time gate##2##2##(2007-11#1)(2007-12#1)
time gating##8##2##(2007-11#1)(2007-12#3)(2008-2#4)
time had##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
time has a##2##3##(1995-12#1)(2008-10#1)
time has been##2##3##(2008-10#1)(2012-1#1)
time has come##4##3##(1990-4#1)(1991-2#1)(1996-12#1)(1996-3#1)
time has elapsed##2##3##(2007-5#1)(2010-12#1)
time has##13##2##(1990-4#1)(1991-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-5#1)(2008-10#4)(2008-8#1)(2010-12#1)(2012-1#1)
time have been##3##3##(2008-10#3)
time history and##2##3##(2008-3#2)
time horizon##7##2##(2008-11#4)(2008-9#2)(2009-8#1)
time how##2##2##(1993-6#1)(1996-12#1)
time imaging##2##2##(1995-2#1)(2008-7#1)
time in Europe##2##3##(2008-10#1)(2012-3#1)
time in a##6##3##(1990-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2012-3#1)
time in academic activities##2##4##(2009-7#2)
time in both##3##3##(2008-9#1)(2009-11#1)(2012-1#1)
time in comparison to##2##4##(2008-10#1)(2008-12#1)
time in medical##2##3##(2008-5#1)(2011-2#1)
time in patients with##2##4##(2008-7#2)
time in relation to##2##4##(2008-10#1)(2013-1#1)
time in the United States##2##5##(2008-10#1)(2010-12#1)
time in the future##2##4##(1992-3#1)(1992-6#1)
time in the presence of##4##5##(1997-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
time in the##43##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-3#2)(1992-6#1)(1993-12#1)(1995-3#1)(1996-3#1)(1997-2#3)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#4)
time in this##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-1#1)
time in which##2##3##(1991-12#1)(2008-11#1)
time in##160##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#20)(2008-11#7)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-7#7)(2009-8#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#2)
time increased##4##2##(2007-10#1)(2008-9#1)(2009-7#1)(2010-2#1)
time induced by##2##3##(1995-12#1)(2010-9#1)
time interactions were##2##3##(2013-1#2)
time interval between the##3##4##(2007-12#1)(2008-9#1)(2011-2#1)
time interval between##9##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#3)(2011-1#1)(2011-2#1)
time interval from##4##3##(1994-3#1)(2008-9#1)(2013-1#2)
time interval##28##2##(1994-3#3)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-7#1)(2008-9#5)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
time intervals after##4##3##(2008-10#3)(2008-5#1)
time intervals before and after##2##5##(2008-12#1)(2012-2#1)
time intervals between##5##3##(1997-6#2)(2007-12#1)(2008-3#1)(2010-8#1)
time intervals##37##2##(1994-3#1)(1995-12#1)(1996-12#1)(1997-6#2)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#3)(2008-7#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
time into##6##2##(1994-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)
time is 3##2##3##(2008-10#2)
time is a##3##3##(1997-4#1)(2008-11#1)(2013-8#1)
time is given##2##3##(2006-12#1)(2008-10#1)
time is less than##2##4##(2008-2#1)(2008-3#1)
time is often##2##3##(1992-12#1)(2008-8#1)
time is##58##2##(1991-11#2)(1992-12#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
time it has##2##3##(1997-2#1)(2008-9#1)
time it is##3##3##(1990-12#1)(1990-3#1)(2008-2#1)
time it takes##3##3##(1993-3#1)(2008-3#1)(2010-5#1)
time it##12##2##(1990-12#1)(1990-3#1)(1990-5#1)(1993-3#1)(1993-6#2)(1997-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)
time lag##2##2##(1997-3#1)(2008-8#1)
time lags##2##2##(2008-8#2)
time lapse##4##2##(1994-3#1)(2008-10#2)(2009-6#1)
time limits##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
time line of##2##3##(2008-11#1)(2013-1#1)
time line##3##2##(2008-11#1)(2009-5#1)(2013-1#1)
time locking##2##2##(2008-10#2)
time lost##2##2##(1992-5#1)(2010-3#1)
time management effectiveness##3##3##(1992-2#3)
time management##5##2##(1992-2#4)(2011-2#1)
time markers##2##2##(2008-10#1)(2012-12#1)
time may be##3##3##(1994-9#1)(2008-2#1)(2008-9#1)
time may##5##2##(1994-9#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
time measurements##3##2##(1990-2#1)(1996-5#1)(2008-5#1)
time microscope##2##2##(2007-12#2)
time necessary for the##4##4##(2008-10#3)(2008-4#1)
time necessary for##5##3##(2008-10#3)(2008-4#1)(2008-5#1)
time necessary to##4##3##(2008-10#3)(2013-1#1)
time necessary##9##2##(2008-10#6)(2008-4#1)(2008-5#1)(2013-1#1)
time needed for##7##3##(1991-3#1)(1995-3#1)(2008-10#2)(2008-3#2)(2012-3#1)
time needed##8##2##(1991-3#1)(1995-3#1)(1997-2#1)(2008-10#2)(2008-3#2)(2012-3#1)
time no##2##2##(1996-6#1)(2008-5#1)
time of 0##2##3##(1990-7#1)(2008-2#1)
time of 1##4##3##(2008-10#4)
time of 10 min##5##4##(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)
time of 10 s##2##4##(2008-10#1)(2008-2#1)
time of 10##9##3##(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
time of 100 ms##2##4##(2008-3#2)
time of 10min##3##3##(2008-10#3)
time of 10s##2##3##(2008-10#2)
time of 12##3##3##(1991-3#1)(2007-8#1)(2008-3#1)
time of 120 s##6##4##(2008-10#6)
time of 15##5##3##(2008-10#2)(2008-9#1)(2013-8#2)
time of 2##2##3##(1997-3#1)(2008-10#1)
time of 20 s##3##4##(2008-10#2)(2008-3#1)
time of 20##5##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
time of 22##2##3##(2008-11#1)(2011-2#1)
time of 24##2##3##(1990-8#1)(2008-7#1)
time of 2min##2##3##(2008-10#2)
time of 3 min##2##4##(2008-10#2)
time of 3##7##3##(2008-10#6)(2011-2#1)
time of 30 min##3##4##(1991-5#1)(2008-10#2)
time of 30##4##3##(1991-5#1)(2008-10#3)
time of 30s and##2##4##(2008-10#2)
time of 4 h##2##4##(1996-2#1)(2008-10#1)
time of 4##4##3##(1996-2#1)(2008-10#3)
time of 40##2##3##(1990-9#1)(2008-3#1)
time of 5 min##5##4##(2008-10#5)
time of 5##6##3##(2008-10#5)(2008-11#1)
time of 60 min##2##4##(2008-6#1)(2010-2#1)
time of 60 s##4##4##(2008-10#3)(2008-3#1)
time of 60##6##3##(2008-10#3)(2008-3#1)(2008-6#1)(2010-2#1)
time of 8##2##3##(2008-10#1)(2008-3#1)
time of 9##3##3##(2008-10#1)(2008-7#1)(2010-3#1)
time of X##2##3##(2008-10#2)
time of a##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
time of about##8##3##(2008-10#7)(2008-11#1)
time of administration##2##3##(1993-5#1)(2008-5#1)
time of an##2##3##(2008-3#1)(2008-8#1)
time of analysis and##2##4##(2008-10#2)
time of analysis##7##3##(2008-10#6)(2008-8#1)
time of approximately##5##3##(1991-9#1)(2008-10#3)(2008-2#1)
time of both##2##3##(2007-11#1)(2011-2#1)
time of contact##5##3##(2008-10#4)(2008-11#1)
time of day on##2##4##(1992-3#1)(1993-12#1)
time of day preference were##2##5##(2007-12#2)
time of day preference##4##4##(2007-12#4)
time of day##16##3##(1992-11#1)(1992-3#1)(1993-12#1)(2007-12#6)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-7#1)(2012-5#1)
time of death##2##3##(1994-11#1)(1997-3#1)
time of diagnosis##14##3##(1990-10#2)(1992-3#1)(1992-5#1)(1993-1#1)(1994-10#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-3#1)
time of exposure to##3##4##(1995-5#1)(1996-12#1)(2008-10#1)
time of exposure##6##3##(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2012-2#1)(2012-4#1)
time of flight mass spectrometry##6##5##(2008-10#4)(2008-11#2)
time of flight##10##3##(2007-12#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)
time of follow-up was##2##4##(2009-3#1)(2013-1#1)
time of follow-up##6##3##(1997-2#1)(2007-11#2)(2009-3#1)(2009-4#1)(2013-1#1)
time of hospitalization##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
time of incubation##3##3##(1990-12#1)(1991-5#1)(1992-12#1)
time of infection##5##3##(2008-10#4)(2008-11#1)
time of initial diagnosis##2##4##(2007-11#1)(2008-11#1)
time of initial##5##3##(1992-2#1)(2007-11#1)(2008-11#1)(2008-6#1)(2012-3#1)
time of injury##4##3##(1993-2#1)(2008-9#2)(2011-2#1)
time of inoculation##4##3##(2008-10#4)
time of less than##7##4##(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2013-1#1)
time of maximum##2##3##(2008-11#1)(2010-2#1)
time of mice##2##3##(1992-3#1)(1996-2#1)
time of onset and##2##4##(2008-10#1)(2008-4#1)
time of onset of##2##4##(1990-5#1)(2008-5#1)
time of onset##5##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-5#1)
time of our##2##3##(2008-3#1)(2011-2#1)
time of patients##5##3##(2007-11#4)(2008-7#1)
time of phase##2##3##(2008-10#2)
time of referral##2##3##(2008-1#1)(2008-11#1)
time of reperfusion##3##3##(1990-3#1)(1996-9#2)
time of sampling##5##3##(1991-5#1)(1992-12#1)(2008-10#2)(2008-5#1)
time of study##2##3##(2010-11#1)(2011-2#1)
time of survival##2##3##(2007-11#1)(2011-2#1)
time of testing##2##3##(2008-9#2)
time of the biosensor##2##4##(2008-10#2)
time of the first##2##4##(1995-12#1)(2008-10#1)
time of the gas##2##4##(2007-12#1)(2008-10#1)
time of the order##2##4##(1990-12#1)(2007-11#1)
time of the proposed##3##4##(2008-10#2)(2012-2#1)
time of the##105##3##(1990-12#1)(1990-3#2)(1990-6#2)(1990-7#1)(1991-12#2)(1991-2#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-11#9)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#31)(2008-11#6)(2008-2#1)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#2)(2013-8#1)
time of their##7##3##(1992-8#1)(1995-6#1)(1996-12#1)(1997-2#1)(2010-1#1)(2012-3#1)(2013-8#1)
time of transplantation##4##3##(2008-1#1)(2008-4#1)(2008-9#1)(2012-7#1)
time of treatment##2##3##(1995-11#1)(2008-2#1)
time of year##2##3##(2008-10#1)(2010-3#1)
time of##655##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#4)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#6)(1992-5#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-5#3)(1995-6#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-9#5)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#28)(2007-12#20)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#7)(2008-10#226)(2008-11#27)(2008-12#3)(2008-2#5)(2008-3#31)(2008-4#7)(2008-5#12)(2008-6#5)(2008-7#16)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#6)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#9)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#17)(2013-7#1)(2013-8#4)
time off cardioplegia##2##3##(1996-9#2)
time off##4##2##(1992-2#1)(1996-9#2)(2008-5#1)
time on dialysis##2##3##(1991-6#1)(2010-5#1)
time on the determination of##2##5##(2008-10#2)
time on the extraction##2##4##(2008-10#1)(2011-1#1)
time on the##18##3##(1996-2#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-5#3)(2008-8#2)(2011-1#1)(2011-2#1)
time on##42##2##(1991-2#1)(1991-6#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#4)(2008-5#8)(2008-8#2)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
time or##17##2##(1991-11#1)(1991-3#1)(1993-11#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-3#1)
time over a##2##3##(2006-4#1)(2008-2#1)
time over which##2##3##(1995-6#1)(2010-8#1)
time over##5##2##(1995-6#1)(2006-4#1)(2008-2#1)(2010-11#1)(2010-8#1)
time per sample##3##3##(2008-10#3)
time per##6##2##(2008-10#3)(2008-7#1)(2010-8#1)(2011-2#1)
time period from##2##3##(2006-8#1)(2010-4#1)
time period in##2##3##(2007-10#1)(2008-9#1)
time period of##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
time period required##2##3##(2008-10#1)(2012-1#1)
time period##45##2##(1991-2#1)(1991-4#1)(1993-11#1)(1996-3#1)(2006-8#2)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#7)(2009-2#3)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)
time periods after##2##3##(2007-2#1)(2008-10#1)
time periods and##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
time periods is##2##3##(1995-6#1)(2008-10#1)
time periods##27##2##(1991-11#1)(1995-6#1)(1996-11#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-11#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-8#2)
time point at which##2##4##(2008-11#1)(2008-7#1)
time point for##2##3##(1997-3#1)(2010-5#1)
time point of##2##3##(1997-2#1)(2012-2#1)
time point##24##2##(1993-11#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#2)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)
time points after##2##3##(2011-3#1)(2012-1#1)
time points and##6##3##(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-4#1)
time points during the##2##4##(2011-2#1)(2012-1#1)
time points from##2##3##(2008-4#1)(2012-1#1)
time points in##3##3##(1990-7#1)(2010-1#1)(2013-7#1)
time points of##2##3##(2008-7#1)(2013-1#1)
time points were##3##3##(2013-1#2)(2013-8#1)
time points##57##2##(1990-7#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#3)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#9)(2011-3#1)(2012-1#4)(2012-2#1)(2012-3#1)(2012-4#2)(2013-1#5)(2013-7#1)(2013-8#1)
time profile##3##2##(2008-10#1)(2010-11#2)
time range##2##2##(1997-2#1)(1997-6#1)
time ranged from##3##3##(2007-11#1)(2008-9#1)(2012-12#1)
time release##2##2##(2008-5#2)
time required for complete##2##4##(2008-7#1)(2010-7#1)
time required for data##2##4##(2007-12#1)(2008-3#1)
time required for the analysis of##2##6##(2008-10#2)
time required for the analysis##3##5##(2008-10#3)
time required for the##10##4##(1997-3#1)(2008-10#8)(2008-3#1)
time required for##37##3##(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#20)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
time required to exchange##2##4##(2011-2#2)
time required to gather##2##4##(2011-2#2)
time required to##20##3##(1993-12#2)(1995-12#1)(1996-5#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#4)
time required##62##2##(1993-12#2)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#28)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#4)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#1)
time requirements##2##2##(2007-11#1)(2009-3#1)
time resolution and##2##3##(2008-3#2)
time resolution is##4##3##(2008-2#1)(2008-3#3)
time resolution of the polarization##2##5##(2007-11#1)(2007-12#1)
time resolution of##9##3##(1992-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
time resolution##25##2##(1992-6#1)(2006-4#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#12)
time resolved##6##2##(1991-3#1)(2008-10#3)(2008-7#1)(2009-6#1)
time resources##4##2##(2010-3#1)(2012-2#3)
time response##3##2##(2007-12#1)(2008-3#2)
time resting##2##2##(1994-8#1)(2008-5#1)
time resulted in##3##3##(1992-5#1)(2008-11#1)(2008-7#1)
time revealed##2##2##(2008-11#1)(2009-1#1)
time reversal of the##2##4##(2007-12#2)
time reversal of##3##3##(2007-12#3)
time reversal##4##2##(2007-12#4)
time saving##2##2##(2007-7#1)(2008-10#1)
time savings##3##2##(1994-12#1)(1994-2#1)(2007-7#1)
time scale of##9##3##(1994-11#1)(1994-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
time scale##26##2##(1990-2#2)(1990-8#2)(1991-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
time scales of a few to 30 years##2##8##(1996-4#2)
time scales of##6##3##(1996-4#2)(2008-2#1)(2008-3#3)
time scales##24##2##(1990-8#1)(1995-2#1)(1995-5#1)(1996-4#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2009-7#2)(2009-8#1)(2010-3#1)(2011-1#1)(2013-8#2)
time schedule##3##2##(1993-11#1)(2008-12#1)(2008-6#1)
time separation##4##2##(2008-2#1)(2008-3#3)
time series analysis##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
time series data##5##3##(1993-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
time series methods##2##3##(2010-7#1)(2010-8#1)
time series of glucose readings from##2##6##(2009-9#2)
time series of##17##3##(1992-9#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-9#5)(2011-2#1)(2012-3#1)(2013-1#2)
time series##49##2##(1991-10#1)(1992-9#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#4)(2009-9#7)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
time showed no##2##3##(1996-9#1)(2009-7#1)
time showed##4##2##(1992-5#1)(1996-9#2)(2009-7#1)
time significant##2##2##(1992-12#1)(1992-6#1)
time significantly##2##2##(2008-3#1)(2011-3#1)
time since diagnosis##3##3##(1993-9#1)(1996-2#1)(2008-9#1)
time since the##3##3##(1991-11#1)(2008-10#2)
time since##13##2##(1990-9#1)(1991-11#1)(1991-12#1)(1993-9#1)(1996-2#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)
time span of##2##3##(1997-4#1)(2008-10#1)
time span##5##2##(1997-4#1)(2008-10#2)(2008-11#1)(2009-7#1)
time spent in a##4##4##(2008-8#3)(2009-7#1)
time spent in the##3##4##(1993-2#1)(2011-2#2)
time spent in##11##3##(1993-2#1)(2007-10#1)(2008-11#1)(2008-8#3)(2009-10#1)(2009-7#1)(2011-2#3)
time spent on the##2##4##(2008-10#1)(2008-5#1)
time spent on##7##3##(1993-12#1)(1995-11#2)(2008-10#1)(2008-5#1)(2013-1#2)
time spent##28##2##(1993-12#1)(1993-2#1)(1995-11#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#4)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#4)(2012-2#4)(2013-1#3)
time step##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)
time structure##3##2##(1994-5#1)(2008-11#2)
time structured##3##2##(2012-12#3)
time survival##2##2##(1992-5#1)(2013-8#1)
time t##4##2##(1995-12#1)(1997-4#1)(2008-10#1)(2010-8#1)
time taken for the##2##4##(1993-2#1)(2008-10#1)
time taken for##6##3##(1992-12#1)(1993-2#1)(2007-2#1)(2008-10#2)(2011-2#1)
time taken to##3##3##(1990-11#1)(2007-7#1)(2013-1#1)
time taken##12##2##(1990-11#1)(1992-12#1)(1993-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
time tests##2##2##(2007-7#1)(2011-1#1)
time than the##5##3##(1993-3#1)(2008-10#2)(2008-3#1)(2013-8#1)
time than those##2##3##(2008-12#1)(2008-3#1)
time than##18##2##(1990-5#1)(1991-6#1)(1993-3#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2013-8#1)
time that the##9##3##(1995-6#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
time that these##2##3##(2009-5#1)(2010-3#1)
time that##48##2##(1990-4#1)(1991-3#1)(1992-12#2)(1992-8#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#4)(2013-8#1)
time the##55##2##(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
time their##2##2##(2010-10#1)(2013-1#1)
time there has been a##2##5##(1990-11#1)(1997-1#1)
time there##4##2##(1990-11#2)(1997-1#1)(1997-4#1)
time they had##3##3##(1996-2#1)(2010-3#1)(2012-12#1)
time they##8##2##(1991-9#1)(1996-2#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
time through##2##2##(1995-2#1)(2008-7#1)
time to AT##2##3##(2013-1#2)
time to a##3##3##(1995-12#1)(1995-9#1)(2008-10#1)
time to achieve a target weight##2##6##(2013-1#2)
time to achieve a##3##4##(2008-10#1)(2013-1#2)
time to achieve##4##3##(2008-10#1)(2012-2#1)(2013-1#2)
time to be##7##3##(1991-3#1)(1994-12#1)(2008-10#3)(2008-9#1)(2013-1#1)
time to determine the##2##4##(2008-10#2)
time to determine##3##3##(2008-1#1)(2008-10#2)
time to develop##2##3##(2008-10#1)(2009-10#1)
time to diagnosis##3##3##(2011-2#2)(2013-8#1)
time to disease progression##2##4##(1997-8#1)(2008-10#1)
time to disease##3##3##(1997-8#1)(2008-10#2)
time to do##2##3##(1995-6#1)(2013-8#1)
time to event data##2##4##(1995-9#1)(1997-8#1)
time to event##3##3##(1995-9#1)(1997-8#1)(2011-2#1)
time to exhaustion##5##3##(2008-5#1)(2013-8#4)
time to extinction of##3##4##(2008-9#3)
time to extinction##5##3##(2008-9#5)
time to failure##2##3##(1997-7#1)(2009-10#1)
time to first##3##3##(1997-4#1)(2008-2#1)(2008-6#1)
time to growth##2##3##(2011-2#2)
time to inflection point (t(ip))##2##5##(2008-10#2)
time to initial symptoms##2##4##(2008-10#2)
time to learn new##2##4##(1993-12#1)(1996-3#1)
time to learn##3##3##(1993-12#1)(1994-3#1)(1996-3#1)
time to local##2##3##(2008-6#1)(2010-3#1)
time to onset of##3##4##(1993-12#2)(2012-3#1)
time to peak##3##3##(1997-7#1)(2008-7#1)(2012-12#1)
time to progression was 6##2##5##(1990-10#1)(1991-2#1)
time to progression was##6##4##(1990-10#1)(1990-2#1)(1991-2#1)(1993-1#1)(2008-10#1)(2013-1#1)
time to progression##8##3##(1990-10#1)(1990-2#1)(1991-2#1)(1993-1#1)(2008-10#2)(2008-3#1)(2013-1#1)
time to provide##2##3##(1993-2#1)(2008-12#1)
time to reach a##2##4##(2007-10#1)(2008-8#1)
time to reach##6##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)
time to reduce##2##3##(2007-7#1)(2013-1#1)
time to the##20##3##(1995-2#1)(1996-4#1)(1997-4#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#1)(2010-3#1)(2012-3#1)
time to time##6##3##(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
time to treatment##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
time to union was##3##4##(2009-10#1)(2013-8#2)
time to##278##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-2#4)(1991-3#1)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#1)(1995-9#2)(1996-3#4)(1996-4#2)(1996-5#1)(1997-4#2)(1997-7#3)(1997-8#2)(2007-10#2)(2007-11#12)(2007-12#18)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#3)(2008-12#5)(2008-2#13)(2008-3#23)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#10)(2009-10#4)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#8)(2012-8#1)(2013-1#16)(2013-8#12)
time travel is##2##3##(2013-8#2)
time travel##7##2##(2007-2#1)(2013-8#6)
time trend##3##2##(1990-12#1)(1995-5#1)(2008-11#1)
time trends##2##2##(1993-12#1)(1997-7#1)
time until##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
time up to##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
time use##3##2##(2013-1#3)
time used for##2##3##(1992-3#1)(2008-10#1)
time used##3##2##(1992-3#1)(2008-10#2)
time using a##2##3##(2008-10#2)
time using##10##2##(1995-12#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
time variation of##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
time variation##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
time varying##5##2##(1997-7#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-12#1)
time versus##2##2##(2008-10#1)(2008-5#1)
time was &lt##2##3##(2008-10#2)
time was 10##4##3##(1990-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
time was 15 minutes##2##4##(1991-1#1)(1994-9#1)
time was 15##3##3##(1991-1#1)(1994-9#1)(2008-6#1)
time was 3##2##3##(1991-2#1)(2008-10#1)
time was 4##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
time was 5##4##3##(1990-11#1)(2007-11#1)(2008-10#1)(2008-12#1)
time was 50##2##3##(1994-2#1)(2008-10#1)
time was 6 min##2##4##(1996-1#1)(2008-10#1)
time was 6##4##3##(1996-1#1)(2007-11#1)(2008-10#1)(2013-8#1)
time was achieved##3##3##(2008-10#1)(2008-3#2)
time was calculated##2##3##(2008-10#1)(2008-6#1)
time was developed##2##3##(2008-10#1)(2008-3#1)
time was discussed##2##3##(2008-10#1)(2013-8#1)
time was less than##4##4##(2008-1#1)(2008-10#2)(2012-3#1)
time was longer in##3##4##(1996-1#1)(2013-8#2)
time was lower than##2##4##(2008-10#2)
time was much more##2##4##(1990-2#1)(2011-2#1)
time was much##4##3##(1990-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
time was observed in##2##4##(2007-11#1)(2008-10#1)
time was observed##3##3##(2007-11#2)(2008-10#1)
time was prolonged##2##3##(2007-11#1)(2008-11#1)
time was reduced##4##3##(2008-10#3)(2009-7#1)
time was significantly##3##3##(2007-8#1)(2008-5#1)(2012-2#1)
time was the most##2##4##(2009-4#1)(2012-12#1)
time was the##3##3##(2009-4#1)(2012-12#1)(2013-1#1)
time was used by##3##4##(2007-7#3)
time was used##6##3##(1997-2#1)(2007-7#3)(2008-10#1)(2008-12#1)
time was##120##2##(1990-11#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-2#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-3#2)(1996-1#2)(1996-2#1)(1997-2#1)(2007-11#8)(2007-12#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#6)
time we##4##2##(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
time were comparable##2##3##(2008-10#2)
time were determined##2##3##(2008-12#1)(2008-2#1)
time were evaluated and##2##4##(2008-10#2)
time were examined##2##3##(2007-7#1)(2008-10#1)
time were investigated##4##3##(2008-10#4)
time were obtained##2##3##(1995-3#1)(2008-10#1)
time were optimised##2##3##(2008-10#2)
time were optimized##3##3##(2008-10#3)
time were studied##2##3##(2008-10#2)
time were##43##2##(1993-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#20)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
time when compared with##2##4##(1991-5#1)(2012-2#1)
time when the##8##3##(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-9#1)
time when##39##2##(1991-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#3)(2009-10#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
time which##4##2##(1993-8#1)(1996-9#1)(2008-9#1)(2010-4#1)
time while##5##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
time window for##2##3##(2007-10#1)(2008-8#1)
time window of the##2##4##(2008-3#1)(2012-7#1)
time window of##3##3##(2008-3#2)(2012-7#1)
time window##11##2##(1997-1#1)(2007-10#3)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2012-7#1)
time with the##8##3##(1994-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)
time with##34##2##(1990-5#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-8#1)
time within##3##2##(2008-10#2)(2012-12#1)
time without##2##2##(2008-10#1)(2009-11#1)
time##5302##1##(1990-10#8)(1990-11#13)(1990-12#18)(1990-2#21)(1990-3#8)(1990-4#4)(1990-5#16)(1990-6#6)(1990-7#5)(1990-8#17)(1990-9#6)(1991-1#7)(1991-10#1)(1991-11#21)(1991-12#21)(1991-2#22)(1991-3#18)(1991-4#2)(1991-5#10)(1991-6#11)(1991-7#1)(1991-8#6)(1991-9#5)(1992-1#6)(1992-10#3)(1992-11#11)(1992-12#23)(1992-2#12)(1992-3#29)(1992-4#1)(1992-5#8)(1992-6#12)(1992-8#14)(1992-9#14)(1993-1#8)(1993-10#1)(1993-11#11)(1993-12#26)(1993-2#10)(1993-3#13)(1993-5#2)(1993-6#10)(1993-8#8)(1993-9#4)(1994-1#8)(1994-10#2)(1994-11#12)(1994-12#17)(1994-2#18)(1994-3#27)(1994-5#8)(1994-6#11)(1994-7#5)(1994-8#9)(1994-9#9)(1995-1#7)(1995-10#2)(1995-11#11)(1995-12#35)(1995-2#15)(1995-3#29)(1995-4#1)(1995-5#14)(1995-6#17)(1995-8#4)(1995-9#6)(1996-1#9)(1996-11#6)(1996-12#28)(1996-2#24)(1996-3#29)(1996-4#14)(1996-5#16)(1996-6#8)(1996-7#6)(1996-8#1)(1996-9#16)(1997-1#4)(1997-2#29)(1997-3#26)(1997-4#31)(1997-5#3)(1997-6#12)(1997-7#11)(1997-8#13)(2006-10#3)(2006-12#2)(2006-4#3)(2006-8#4)(2007-1#4)(2007-10#29)(2007-11#121)(2007-12#139)(2007-2#10)(2007-4#3)(2007-5#8)(2007-6#3)(2007-7#32)(2007-8#49)(2007-9#3)(2008-1#41)(2008-10#1313)(2008-11#213)(2008-12#74)(2008-2#113)(2008-3#288)(2008-4#39)(2008-5#142)(2008-6#61)(2008-7#128)(2008-8#133)(2008-9#124)(2009-1#4)(2009-10#20)(2009-11#21)(2009-12#7)(2009-2#16)(2009-3#11)(2009-4#15)(2009-5#16)(2009-6#10)(2009-7#31)(2009-8#33)(2009-9#28)(2010-1#18)(2010-10#11)(2010-11#11)(2010-12#25)(2010-2#18)(2010-3#38)(2010-4#16)(2010-5#25)(2010-6#14)(2010-7#17)(2010-8#35)(2010-9#8)(2011-1#45)(2011-10#1)(2011-2#169)(2011-3#13)(2011-4#1)(2011-7#1)(2012-1#17)(2012-12#48)(2012-2#104)(2012-3#66)(2012-4#3)(2012-5#2)(2012-6#1)(2012-7#4)(2012-8#4)(2013-1#173)(2013-7#7)(2013-8#87)
time&quot##6##1##(2008-8#1)(2011-2#2)(2012-12#3)
time'##2##1##(1995-3#1)(2008-10#1)
time) and##5##2##(2008-10#4)(2011-1#1)
time) are optimized##2##3##(2008-10#2)
time) for##2##2##(2008-2#1)(2008-3#1)
time) of##3##2##(1995-12#1)(2008-10#1)(2008-2#1)
time) showed##2##2##(2008-10#1)(2008-7#1)
time) was##2##2##(2008-10#1)(2008-11#1)
time) were investigated##2##3##(2008-10#2)
time) were##5##2##(2008-10#5)
time)##49##1##(1992-3#1)(1992-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-8#1)(2013-1#1)
time- and concentration-dependent##8##3##(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-8#1)(1997-1#2)(2008-9#1)
time- and dose-dependent##9##3##(1990-5#1)(1991-5#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(2010-1#1)
time- and space-resolved##2##3##(2008-2#1)(2008-3#1)
time- and##32##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-1#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-9#1)(2010-1#1)
time-##36##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-1#3)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-9#1)(2010-1#1)
time-activity##5##1##(2008-5#1)(2008-8#3)(2012-2#1)
time-averaged Strehl ratio##2##3##(2008-2#1)(2008-3#1)
time-averaged##8##1##(1993-11#1)(2008-2#1)(2008-3#3)(2008-8#2)(2012-3#1)
time-bandwidth product##2##2##(2007-12#1)(2008-3#1)
time-based flow injection (FI) method for on-line preconcentration and determination of##2##11##(2008-10#2)
time-based flow injection (FI)##3##4##(2008-10#3)
time-based flow##5##2##(2008-10#5)
time-based technique##2##2##(2008-10#2)
time-based##17##1##(2008-10#15)(2008-5#1)(2013-7#1)
time-consuming and do not##2##4##(2008-10#1)(2012-2#1)
time-consuming and##14##2##(1995-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
time-consuming##64##1##(1990-12#1)(1992-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#2)(1995-6#1)(2007-12#1)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-7#1)
time-correlated single-photon counting##3##3##(2008-3#3)
time-correlated##6##1##(2007-11#1)(2007-12#2)(2008-3#3)
time-course experiments##2##2##(1995-2#1)(2008-7#1)
time-course gene expression data##2##4##(2010-1#1)(2010-10#1)
time-course##17##1##(1993-3#1)(1994-11#1)(1994-8#2)(1995-2#2)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-1#1)(2010-10#1)(2013-8#2)
time-delay and##2##2##(2008-2#1)(2008-3#1)
time-delay##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
time-delayed##7##1##(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)
time-dependency##5##1##(2008-7#5)
time-dependent and##3##2##(1992-3#1)(2008-11#1)(2009-2#1)
time-dependent concentrations##2##2##(2008-2#1)(2009-9#1)
time-dependent covariate##2##2##(1992-9#1)(1997-3#1)
time-dependent decrease in##2##3##(1993-9#1)(2011-2#1)
time-dependent decrease##3##2##(1993-9#1)(1994-8#1)(2011-2#1)
time-dependent effect##2##2##(2008-7#1)(2011-2#1)
time-dependent factors##2##2##(2008-10#2)
time-dependent inactivation##2##2##(1991-5#1)(1991-9#1)
time-dependent inhibition of##2##3##(1993-6#1)(1993-8#1)
time-dependent loss of##2##3##(1992-11#1)(1996-12#1)
time-dependent manner##18##2##(1991-5#1)(1992-3#1)(1994-9#2)(1996-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
time-dependent photon##2##2##(2008-2#1)(2008-3#1)
time-dependent response of##3##3##(1997-7#1)(2008-10#1)(2012-2#1)
time-dependent response##4##2##(1997-7#1)(2008-10#1)(2010-2#1)(2012-2#1)
time-dependent signal##2##2##(2008-2#2)
time-dependent##109##1##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-11#8)(2008-2#13)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-2#1)(2009-9#1)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
time-differential sensor##2##2##(2008-2#2)
time-differential##3##1##(2008-2#3)
time-division demultiplexing and spatial pulse routing##2##6##(2007-11#2)
time-division demultiplexing##3##2##(2007-11#3)
time-division multiplexed##5##2##(2007-11#3)(2008-3#2)
time-division multiplexing##5##2##(2007-11#4)(2008-3#1)
time-division##14##1##(2007-11#10)(2007-12#1)(2008-3#3)
time-division-multiplexed##4##1##(2008-2#1)(2008-3#3)
time-domain and##2##2##(2011-7#1)(2013-1#1)
time-domain calculations##4##2##(2007-11#1)(2007-12#2)(2009-12#1)
time-domain demodulation##3##2##(2007-11#1)(2007-12#2)
time-domain method##10##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)(2013-8#2)
time-domain optical##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
time-domain reflectometry##5##2##(2007-12#1)(2008-3#3)(2011-1#1)
time-domain simulation##2##2##(2007-11#2)
time-domain spectroscopy (THz-TDS)##2##3##(2012-2#1)(2013-8#1)
time-domain spectroscopy##6##2##(2007-12#1)(2008-3#1)(2010-5#2)(2012-2#1)(2013-8#1)
time-domain##76##1##(2007-11#13)(2007-12#13)(2008-2#6)(2008-3#30)(2009-12#1)(2010-5#2)(2011-1#2)(2011-7#3)(2012-2#1)(2013-1#1)(2013-8#4)
time-efficient##2##1##(1995-1#1)(2008-2#1)
time-expanded##2##1##(2007-7#2)
time-frequency domain##2##2##(2008-10#1)(2010-8#1)
time-frequency signal##2##2##(2007-12#1)(2008-3#1)
time-frequency##10##1##(2007-12#2)(2008-10#2)(2008-3#3)(2010-8#3)
time-gated##7##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
time-gating##2##1##(2007-12#1)(2008-3#1)
time-independent##2##1##(2008-3#1)(2012-2#1)
time-integrative##2##1##(2008-3#2)
time-invariant##3##1##(2008-3#2)(2009-8#1)
time-kill##2##1##(2008-5#2)
time-lapse microscopy##5##2##(2008-11#3)(2008-8#1)(2008-9#1)
time-lapse studies##4##2##(1995-9#2)(2008-11#1)(2008-9#1)
time-lapse##15##1##(1994-8#1)(1995-11#1)(1995-9#2)(2008-11#6)(2008-8#1)(2008-9#3)(2012-12#1)
time-of-flight (TOF) and##2##3##(2008-10#2)
time-of-flight (TOF)##5##2##(1997-2#1)(2008-10#3)(2008-7#1)
time-of-flight mass spectrometer##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
time-of-flight mass spectrometry (GC x GC-IDTOFMS)##2##6##(2008-10#2)
time-of-flight mass spectrometry (GC x##3##5##(2008-10#3)
time-of-flight mass spectrometry detection##2##4##(2008-10#2)
time-of-flight mass spectrometry##18##3##(2008-10#13)(2008-11#1)(2011-2#1)(2011-3#1)(2012-3#2)
time-of-flight mass##24##2##(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#2)
time-of-flight##37##1##(1997-2#1)(2008-10#22)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)
time-point##2##1##(2012-3#1)(2013-1#1)
time-points##3##1##(2008-5#1)(2008-6#1)(2011-2#1)
time-range##2##1##(2008-3#2)
time-related##2##1##(1995-2#1)(2007-12#1)
time-resolution##3##1##(2008-10#2)(2008-3#1)
time-resolved Fourier transform##2##3##(2008-3#2)
time-resolved Shpol'skii spectrometry##4##3##(2008-10#4)
time-resolved fluorescence measurements##2##3##(2007-12#1)(2009-2#1)
time-resolved fluorescence spectra##2##3##(2008-10#1)(2008-8#1)
time-resolved fluorescence spectroscopy##2##3##(2008-10#1)(2008-3#1)
time-resolved fluorescence##13##2##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-1#1)
time-resolved fluoroimmunoassay for##2##3##(1990-8#1)(2008-10#1)
time-resolved fluoroimmunoassay of##3##3##(2008-10#3)
time-resolved fluoroimmunoassay##9##2##(1990-8#1)(2008-10#8)
time-resolved imaging##3##2##(2007-12#1)(2008-3#2)
time-resolved measurements of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
time-resolved measurements of##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
time-resolved measurements##8##2##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
time-resolved optical tomography##3##3##(2007-11#1)(2008-3#2)
time-resolved optical##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-9#1)
time-resolved photoacoustic technique##2##3##(2008-3#2)
time-resolved photoacoustic##3##2##(1990-8#1)(2008-3#2)
time-resolved predamage##2##2##(2007-12#1)(2008-3#1)
time-resolved reflectance spectroscopy##3##3##(2007-12#1)(2008-3#2)
time-resolved reflectance##8##2##(2007-12#3)(2008-2#1)(2008-3#4)
time-resolved signals##2##2##(2008-3#2)
time-resolved spectroscopic##2##2##(2008-2#1)(2009-3#1)
time-resolved spectroscopy##4##2##(2008-10#1)(2008-2#2)(2009-3#1)
time-resolved terahertz spectroscopy##2##3##(2007-12#2)
time-resolved transmission##2##2##(2008-3#2)
time-resolved transmittance measurements##2##3##(2008-3#2)
time-resolved transmittance##5##2##(2008-2#1)(2008-3#4)
time-resolved trasmittance##2##2##(2008-3#2)
time-resolved x-ray diffraction##2##3##(2007-11#2)
time-resolved##120##1##(1990-2#1)(1990-8#3)(1991-5#1)(1992-6#3)(1997-2#1)(2007-1#1)(2007-11#8)(2007-12#15)(2008-10#28)(2008-11#3)(2008-2#9)(2008-3#36)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
time-response##3##1##(1994-9#1)(2008-3#1)(2008-7#1)
time-scale##2##1##(2008-11#1)(2012-2#1)
time-scales##2##1##(2008-11#1)(2010-10#1)
time-series analyses##2##2##(1992-12#1)(1995-12#1)
time-series analysis##2##2##(1995-12#2)
time-series measurements##3##2##(2008-2#1)(2008-3#2)
time-series##17##1##(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#3)(1997-1#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-11#2)(2009-9#1)(2011-2#1)
time-space##2##1##(1996-4#1)(2008-3#1)
time-temperature##2##1##(1995-3#1)(2011-2#1)
time-tested##3##1##(2007-12#1)(2008-9#1)(2009-4#1)
time-to-peak values##3##2##(2008-4#3)
time-varying data##3##2##(2008-3#2)(2008-6#1)
time-varying magnetic fields##3##3##(1992-3#3)
time-varying phase##2##2##(2007-11#1)(2008-3#1)
time-varying##22##1##(1992-3#4)(2007-11#1)(2008-2#4)(2008-3#9)(2008-6#2)(2010-1#1)(2011-2#1)
time-weighted##2##1##(1993-1#1)(2008-5#1)
time-window##2##1##(1994-8#1)(2008-8#1)
time?##10##1##(1992-2#1)(1993-5#1)(1994-2#1)(2008-12#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-5#1)(2013-8#1)
time?]##4##1##(1991-11#1)(1992-11#1)(1994-6#1)(2008-4#1)
time]##4##1##(1991-9#1)(1996-3#1)(2012-1#1)(2013-1#1)
timecourse of activation within##2##4##(2008-11#2)
timecourse of activation##3##3##(2008-11#3)
timecourse of##9##2##(1993-8#2)(2008-11#7)
timecourse##12##1##(1993-8#2)(2008-11#10)
timed up and##2##3##(2010-3#1)(2012-12#1)
timed##13##1##(1990-5#1)(1993-9#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
timeframe##2##1##(2008-8#1)(2009-10#1)
timeline for##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
timeline of##2##2##(2010-12#1)(2012-12#1)
timeline##10##1##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-12#2)(2013-1#1)
timeliness of##4##2##(2007-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
timeliness##10##1##(1994-2#1)(1995-12#1)(1995-3#2)(2007-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-3#1)
timely and accurate##3##3##(1992-12#1)(1995-12#1)(2008-10#1)
timely and efficient##2##3##(2008-10#1)(2008-9#1)
timely and##11##2##(1992-12#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-1#2)(2012-12#1)
timely diagnosis##3##2##(1991-12#1)(2008-12#1)(2011-2#1)
timely identification##2##2##(2008-10#1)(2011-2#1)
timely information on##2##3##(1996-1#1)(1997-3#1)
timely information##4##2##(1995-3#1)(1996-1#1)(1997-3#1)(2008-11#1)
timely intervention##2##2##(1997-2#1)(1997-7#1)
timely manner##6##2##(1993-1#1)(1994-12#1)(1997-3#1)(2008-10#1)(2010-5#1)(2011-2#1)
timely recognition of the##2##4##(2008-7#1)(2011-1#1)
timely referral to##3##3##(2008-7#1)(2008-8#1)(2010-9#1)
timely source##2##2##(1997-3#1)(2011-2#1)
timely to##2##2##(2008-10#1)(2008-11#1)
timely treatment##4##2##(2007-2#1)(2009-4#1)(2012-3#1)(2013-1#1)
timely use of##2##3##(2008-11#1)(2008-7#1)
timely##99##1##(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#2)(1995-3#2)(1996-1#2)(1996-2#2)(1997-2#2)(1997-3#5)(1997-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-4#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)
timepoints##2##1##(2008-5#1)(2012-2#1)
timer##3##1##(2008-10#2)(2009-1#1)
times (15##2##2##(1993-6#1)(2013-1#1)
times (versus##2##2##(2008-10#2)
times 1##2##2##(1992-6#1)(2008-11#1)
times a day for##2##4##(1990-9#1)(1996-2#1)
times a day##8##3##(1990-9#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
times a day)##2##3##(1992-11#1)(2011-1#1)
times a week for 6##2##5##(2008-5#1)(2009-1#1)
times a week for##6##4##(1991-3#1)(1996-6#1)(2008-5#2)(2009-1#1)(2010-4#1)
times a week##10##3##(1990-8#1)(1991-3#1)(1992-2#1)(1996-6#1)(2007-8#1)(2008-5#2)(2009-1#1)(2010-4#1)(2013-1#1)
times a week)##2##3##(1994-6#1)(1996-6#1)
times a year##4##3##(1997-3#1)(1997-4#1)(2008-10#1)(2013-8#1)
times a##26##2##(1990-8#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-2#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
times above##2##2##(2008-3#2)
times after inoculation##2##3##(2008-10#2)
times after##16##2##(1994-1#1)(1994-5#1)(1994-7#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-1#2)
times and an increase in##2##5##(2008-10#1)(2011-1#1)
times and higher##2##3##(2008-12#1)(2012-2#1)
times and that##2##3##(2008-8#1)(2008-9#1)
times and the##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
times and##53##2##(1993-11#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
times are##15##2##(1992-6#1)(1993-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-6#1)
times as high as##2##4##(2007-8#1)(2008-2#1)
times as high##3##3##(1990-2#1)(2007-8#1)(2008-2#1)
times as likely to##2##4##(1995-2#2)
times as many##3##3##(1991-2#1)(1992-9#1)(1995-1#1)
times as much as##2##4##(1994-9#1)(2007-12#1)
times as much##3##3##(1994-9#1)(2007-12#1)(2008-10#1)
times as##21##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#2)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
times at the##3##3##(2007-11#1)(2010-5#1)(2013-1#1)
times at which##2##3##(1990-2#1)(2008-7#1)
times at##16##2##(1990-2#1)(1992-11#1)(1993-6#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-1#1)
times before##7##2##(1994-8#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-4#1)(2010-8#1)
times below##2##2##(2008-10#1)(2010-9#1)
times better for##2##3##(2008-10#1)(2008-2#1)
times better than##2##3##(2007-12#1)(2010-5#1)
times better##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2010-5#1)
times between##8##2##(1994-9#1)(1995-9#1)(1997-6#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-12#1)
times by the same##2##4##(2008-10#1)(2013-1#1)
times by##5##2##(2008-10#1)(2008-11#2)(2010-8#1)(2013-1#1)
times can be##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
times compared with##2##3##(1995-1#1)(2007-11#1)
times daily##6##2##(1991-12#1)(1992-8#1)(2007-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
times daily)##4##2##(1991-9#1)(1995-3#2)(1997-6#1)
times during a period of##2##5##(2007-2#1)(2008-10#1)
times during development##2##3##(1993-9#1)(2012-3#1)
times during the season##2##4##(2008-10#1)(2008-8#1)
times during the##11##3##(1991-5#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#1)(2010-8#1)
times during##23##2##(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-3#1)
times each year##2##3##(2008-10#2)
times each##4##2##(2008-10#3)(2008-5#1)
times even on##2##3##(2007-9#1)(2008-3#1)
times faster than a##2##4##(2007-11#1)(2008-3#1)
times faster than between two##2##5##(2008-11#2)
times faster than the##4##4##(1996-2#1)(2008-10#1)(2008-3#2)
times faster than##17##3##(1994-1#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-6#1)(2008-8#1)(2009-6#1)
times faster##22##2##(1994-1#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2012-3#2)
times for Mn2+##2##3##(1995-6#2)
times for a##2##3##(2008-3#1)(2012-2#1)
times for each##3##3##(2009-8#1)(2010-6#1)(2013-1#1)
times for the formation of##2##5##(2008-10#2)
times for the##6##3##(1995-11#2)(2008-10#3)(2008-6#1)
times for##41##2##(1995-11#2)(1995-6#3)(1996-2#1)(1997-4#1)(2007-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
times from the##2##3##(2008-5#1)(2008-8#1)
times from##9##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
times greater at##2##3##(1992-8#1)(2008-10#1)
times greater for##4##3##(2008-10#1)(2008-2#1)(2009-5#1)(2013-8#1)
times greater in##2##3##(2008-10#2)
times greater than that of the##4##6##(2008-10#1)(2008-3#2)(2010-2#1)
times greater than that##5##4##(2008-10#1)(2008-3#2)(2009-6#1)(2010-2#1)
times greater than the##4##4##(1991-2#1)(1995-2#1)(1996-2#1)(2008-10#1)
times greater than those##2##4##(1993-1#1)(2008-5#1)
times greater than##20##3##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1993-1#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-3#4)(2008-5#1)(2009-6#1)(2010-2#1)
times greater##34##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2009-5#1)(2009-6#1)(2010-2#1)(2012-3#2)(2013-8#1)
times have##2##2##(1997-7#1)(2008-10#1)
times higher among##3##3##(1995-12#2)(2012-3#1)
times higher compared with##2##4##(2008-8#1)(2011-2#1)
times higher for##2##3##(2008-10#1)(2008-2#1)
times higher in##7##3##(1990-11#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
times higher than expected##2##4##(1990-12#1)(2008-12#1)
times higher than in##4##4##(1991-5#1)(1992-8#1)(2007-11#1)(2012-3#1)
times higher than that for##2##5##(2008-2#1)(2008-3#1)
times higher than that of the culture under 5% CO(2) supply##2##11##(2008-11#2)
times higher than that of the##6##6##(2007-11#1)(2008-11#2)(2008-6#1)(2011-3#1)(2013-8#1)
times higher than that of##13##5##(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)(2013-8#1)
times higher than that##20##4##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)(2013-8#1)
times higher than the##6##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)
times higher than those from##2##5##(2008-11#2)
times higher than those of the##2##6##(1993-8#1)(1994-11#1)
times higher than those of##4##5##(1993-3#1)(1993-8#1)(1994-11#1)(1997-8#1)
times higher than those##7##4##(1993-3#1)(1993-8#1)(1994-11#1)(1997-8#1)(2008-11#3)
times higher than##47##3##(1990-12#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
times higher with an African##2##5##(1993-6#2)
times higher with##4##3##(1993-6#2)(2008-10#1)(2008-6#1)
times higher##80##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#4)(1995-4#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-8#4)
times in a##3##3##(2007-8#1)(2008-11#1)(2010-3#1)
times in each##2##3##(1994-2#1)(2008-10#1)
times in the past##2##4##(1992-12#1)(2008-12#1)
times in the##14##3##(1991-3#1)(1992-12#1)(1994-5#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)(2012-1#2)(2012-3#1)
times in##46##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#2)(1996-5#1)(1997-4#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
times increase in the##2##4##(2008-3#1)(2008-8#1)
times increase in##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
times increase##5##2##(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
times increased level of##2##4##(1992-6#2)
times indicate##2##2##(1997-7#1)(2008-5#1)
times larger than that##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
times larger than the##4##4##(1997-6#1)(2007-12#1)(2008-3#2)
times larger than those##2##4##(2007-12#1)(2008-10#1)
times larger than##12##3##(1997-6#1)(2007-12#4)(2008-10#3)(2008-3#3)(2009-5#1)
times larger##16##2##(1997-6#1)(2007-12#6)(2008-10#4)(2008-2#1)(2008-3#3)(2009-5#1)
times less than##2##3##(1995-12#1)(2008-4#1)
times less##12##2##(1990-8#1)(1995-12#3)(1995-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)
times longer than##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
times longer##7##2##(1993-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
times lower in##2##3##(1993-12#1)(2008-7#1)
times lower than that of the##2##6##(1995-2#1)(2008-10#1)
times lower than that of##3##5##(1992-9#1)(1995-2#1)(2008-10#1)
times lower than that##5##4##(1992-9#1)(1995-2#1)(2008-10#2)(2011-2#1)
times lower than the##4##4##(1990-11#1)(1990-8#1)(2008-10#2)
times lower than those of##3##5##(1990-6#1)(2008-10#1)(2008-11#1)
times lower than those##5##4##(1990-6#1)(2008-10#2)(2008-11#2)
times lower than##16##3##(1990-11#1)(1990-6#1)(1990-8#1)(1992-9#1)(1995-2#1)(2008-10#7)(2008-11#3)(2011-2#1)
times lower##20##2##(1990-11#1)(1990-6#1)(1990-8#1)(1992-9#2)(1993-12#1)(1994-6#1)(1995-2#1)(2008-10#7)(2008-11#3)(2008-7#1)(2011-2#1)
times measurements)##2##2##(2008-10#2)
times meter##2##2##(2008-2#1)(2008-3#1)
times more common in##2##4##(1990-2#1)(1992-2#1)
times more common##3##3##(1990-2#1)(1992-2#1)(2008-1#1)
times more dead##2##3##(2008-10#2)
times more effective than##2##4##(1992-3#2)
times more efficient than##2##4##(1990-5#1)(2008-8#1)
times more frequent##3##3##(1990-8#1)(1993-12#1)(1997-3#1)
times more likely to be##2##5##(2008-11#1)(2008-8#1)
times more likely to have##3##5##(1991-12#1)(2008-9#1)(2011-2#1)
times more likely to intend to resume tobacco##2##8##(2007-12#2)
times more likely to##12##4##(1991-12#1)(1994-7#1)(2007-12#2)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
times more often than##2##4##(1994-12#1)(2008-3#1)
times more potent than the##2##5##(1992-4#1)(1994-5#1)
times more potent than##3##4##(1992-12#1)(1992-4#1)(1994-5#1)
times more potent##5##3##(1992-12#1)(1992-4#1)(1994-5#1)(1995-12#1)(2008-7#1)
times more sensitive than the##3##5##(2008-10#3)
times more sensitive than##5##4##(2008-10#5)
times more than the##2##4##(2008-8#1)(2013-1#1)
times more than##5##3##(1991-2#1)(1992-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
times more##61##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
times of 2##2##3##(2008-10#1)(2008-3#1)
times of 30 and##3##4##(2008-10#3)
times of 30##4##3##(1996-5#1)(2008-10#3)
times of 4##2##3##(2008-10#1)(2008-2#1)
times of acute academic##2##4##(2012-1#2)
times of ambulances to##3##4##(2010-3#3)
times of ambulances##4##3##(2010-3#4)
times of flight##2##3##(2008-2#1)(2008-3#1)
times of tarabine PFS and adriblastina were##2##7##(2008-10#2)
times of that of##2##4##(2008-3#1)(2008-9#1)
times of that##5##3##(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)
times of the##14##3##(1994-3#2)(2008-10#5)(2008-11#2)(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
times of##88##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-11#3)(2008-1#1)(2008-10#24)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-3#6)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-7#1)(2013-1#3)(2013-8#1)
times on test items##2##4##(2009-12#2)
times on##6##2##(1992-6#1)(2008-10#2)(2008-2#1)(2009-12#2)
times over the##4##3##(1997-6#1)(2008-10#2)(2009-12#1)
times over##5##2##(1997-6#1)(2008-10#2)(2008-12#1)(2009-12#1)
times per day for##2##4##(1992-3#1)(2008-5#1)
times per day##5##3##(1992-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
times per week for 2 h per day##2##8##(2008-10#2)
times per week for##4##4##(2008-10#2)(2013-1#1)(2013-8#1)
times per week##11##3##(2007-7#3)(2008-1#1)(2008-10#2)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
times per year had a relative risk of##2##8##(1993-9#2)
times per year##3##3##(1993-9#2)(2011-2#1)
times per##25##2##(1992-3#1)(1993-9#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
times ranging from##2##3##(2007-12#1)(2008-10#1)
times ranging##3##2##(2007-12#1)(2008-10#2)
times reported by Mills##2##4##(2008-10#2)
times reported##3##2##(2008-10#3)
times required for infection##2##4##(2008-10#2)
times required for##3##3##(2008-10#2)(2008-3#1)
times required to##2##3##(2008-10#1)(2011-2#1)
times required##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
times shorter than those##2##4##(2007-12#1)(2008-10#1)
times slower than the##2##4##(1992-6#1)(2008-10#1)
times slower than##3##3##(1992-6#1)(2007-11#1)(2008-10#1)
times smaller than that for##2##5##(2008-3#1)(2012-2#1)
times smaller than that of##2##5##(2008-10#1)(2008-2#1)
times smaller than that##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
times smaller than the##2##4##(2008-7#1)(2009-5#1)
times smaller than##7##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)
times smaller##8##2##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2012-2#1)
times stronger than that of##2##5##(1996-2#1)(2008-8#1)
times stronger than##5##3##(1996-2#1)(2008-11#2)(2008-8#1)(2012-2#1)
times stronger##6##2##(1996-2#1)(2008-11#2)(2008-8#1)(2009-7#1)(2012-2#1)
times than##8##2##(1995-11#1)(2008-10#2)(2008-6#1)(2012-3#3)(2013-1#1)
times that in the medium containing only FCS##2##8##(2008-11#2)
times that in the##3##4##(2008-11#3)
times that of a##3##4##(2008-2#1)(2008-3#2)
times that of chromium(VI)##2##4##(2008-10#2)
times that of the##6##4##(1991-9#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
times that of##21##3##(1991-9#1)(1993-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(2006-10#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
times that##34##2##(1991-12#1)(1991-8#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)
times the control##3##3##(2008-10#1)(2010-3#2)
times the free-space Planck density##2##5##(2007-12#2)
times the level of##2##4##(1996-2#1)(2009-4#1)
times the level##3##3##(1992-3#1)(1996-2#1)(2009-4#1)
times the maximum##2##3##(2008-2#2)
times the normal##2##3##(1992-9#1)(2007-12#1)
times the root-mean-square##2##3##(2008-10#1)(2008-8#1)
times the standard deviation of the reagent blank) is##2##9##(2008-10#2)
times the standard deviation of the##12##6##(2008-10#12)
times the standard deviation of##15##5##(2008-10#15)
times the standard deviation##16##4##(2008-10#16)
times the total##2##3##(2007-12#1)(2013-1#1)
times the##73##2##(1990-6#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-5#1)(2007-11#2)(2007-12#7)(2007-6#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#11)(2008-3#4)(2008-8#1)(2009-12#1)(2009-4#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
times they##3##2##(1996-2#1)(1997-1#1)(2012-12#1)
times those##4##2##(1990-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
times threshold##2##2##(2008-3#2)
times through##2##2##(2008-10#2)
times throughout the##4##3##(1992-1#1)(2008-5#1)(2010-3#1)(2012-3#1)
times to the##2##3##(1996-4#1)(2007-12#1)
times to##19##2##(1990-12#2)(1994-8#1)(1996-4#1)(1997-4#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#2)(2010-3#1)(2012-1#2)(2013-8#1)
times under##2##2##(2008-8#1)(2010-6#1)
times was##3##2##(2008-10#2)(2010-3#1)
times weekly##3##2##(2007-7#1)(2008-7#1)(2010-8#1)
times were determined##2##3##(2008-2#1)(2010-2#1)
times were established##2##3##(2008-10#1)(2012-12#1)
times were required##2##3##(1990-11#1)(2013-1#1)
times were##29##2##(1990-11#1)(1991-12#1)(1991-5#1)(1993-6#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-5#3)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#2)(2013-1#1)
times when##5##2##(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
times which are##2##3##(1994-3#1)(2010-3#1)
times which##3##2##(1994-3#1)(1995-3#1)(2010-3#1)
times with different##2##3##(1993-8#1)(2008-3#1)
times with the##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)
times with##16##2##(1992-3#1)(1993-6#1)(1993-8#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#1)
times within##7##2##(1990-7#1)(1997-8#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-2#1)
times without##2##2##(2008-10#2)
times##1348##1##(1990-11#7)(1990-12#7)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#7)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#4)(1991-5#6)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#7)(1992-4#1)(1992-6#11)(1992-8#3)(1992-9#8)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#5)(1993-6#9)(1993-8#4)(1993-9#4)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#6)(1994-5#5)(1994-6#2)(1994-7#2)(1994-8#6)(1994-9#5)(1995-1#3)(1995-11#7)(1995-12#10)(1995-2#7)(1995-3#6)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#10)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#6)(1997-4#10)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#4)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#29)(2007-12#34)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#14)(2008-10#326)(2008-11#65)(2008-12#20)(2008-2#47)(2008-3#80)(2008-4#7)(2008-5#27)(2008-6#16)(2008-7#30)(2008-8#31)(2008-9#21)(2009-1#1)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#7)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#21)(2010-4#3)(2010-5#4)(2010-6#7)(2010-7#3)(2010-8#9)(2010-9#2)(2011-1#16)(2011-2#24)(2011-3#5)(2012-1#9)(2012-12#12)(2012-2#14)(2012-3#18)(2012-7#2)(2013-1#34)(2013-7#1)(2013-8#18)
times)##8##1##(2008-10#4)(2008-5#1)(2008-9#2)(2009-2#1)
times]##2##1##(1992-3#1)(1993-3#1)
timescale##7##1##(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#2)
timescales##12##1##(1997-5#1)(2008-10#1)(2008-8#3)(2008-9#5)(2013-1#2)
timetables##3##1##(2008-11#3)
timing and initial dosage##2##4##(2008-7#2)
timing and##24##2##(1994-5#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-12#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
timing are##2##2##(1996-3#1)(2009-7#1)
timing error##3##2##(2007-12#3)
timing for##7##2##(1993-6#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2010-12#1)(2013-1#1)
timing information can be##2##4##(2008-1#2)
timing information##5##2##(2008-1#5)
timing jitter between two independent##2##5##(2007-11#2)
timing jitter is##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
timing jitter of##4##3##(2007-11#3)(2008-3#1)
timing jitter##22##2##(2007-11#15)(2007-12#3)(2008-3#4)
timing jitters##2##2##(2007-12#1)(2008-3#1)
timing of diagnosis and##2##4##(1991-11#1)(2010-12#1)
timing of such an##2##4##(1997-5#1)(2008-11#1)
timing of surgery##4##3##(2007-12#1)(2009-5#1)(2010-8#1)(2013-1#1)
timing of the##19##3##(1993-12#1)(1995-12#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
timing of those##2##3##(1993-12#1)(2010-3#1)
timing of##110##2##(1991-11#1)(1991-8#1)(1992-12#1)(1993-12#3)(1993-3#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-3#1)(1997-2#2)(1997-5#1)(1997-6#1)(2007-12#5)(2008-1#2)(2008-10#21)(2008-11#10)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#3)(2013-8#3)
timing shifts##2##2##(2007-11#2)
timing##230##1##(1990-5#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#1)(1995-5#2)(1996-3#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#23)(2007-12#17)(2007-8#1)(2008-1#7)(2008-10#28)(2008-11#14)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#15)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#4)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#4)(2012-6#1)(2013-1#7)(2013-8#4)
timings##2##1##(2008-10#2)
timopheevii subsp##7##2##(2008-10#7)
timothy grass##2##2##(2008-6#1)(2012-2#1)
tin (ll) etiopurpurin dichloride##2##4##(1992-1#2)
tin and nickel##3##3##(2008-10#3)
tin and titanium##2##3##(2008-10#2)
tin and##7##2##(2008-10#6)(2008-12#1)
tin determination##2##2##(2008-10#2)
tin in marine materials##2##4##(2008-10#2)
tin in##11##2##(2008-10#11)
tin is##3##2##(2008-10#3)
tin oxide thin films##2##4##(2008-10#2)
tin oxide thin##3##3##(2008-10#3)
tin oxide with high##2##4##(2008-10#2)
tin oxide##23##2##(2007-12#1)(2008-10#12)(2008-12#2)(2008-2#3)(2008-3#1)(2009-11#1)(2009-12#1)(2010-5#1)(2010-6#1)
tin protoporphyrin##2##2##(1995-2#2)
tin slag samples##2##3##(2008-10#2)
tin##82##1##(1992-1#2)(1995-2#2)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#61)(2008-12#3)(2008-2#3)(2008-3#2)(2009-11#1)(2009-12#2)(2010-11#1)(2010-5#1)(2010-6#1)
tin(II)##6##1##(2008-10#6)
tin(II)-strong phosphoric##2##2##(2008-10#2)
tin(IV)##5##1##(2008-10#5)
tinctorius L##2##2##(2008-12#1)(2012-12#1)
tinctorius##4##1##(2008-11#2)(2008-12#1)(2012-12#1)
tinctures##2##1##(2008-10#2)
tinea capitis in##2##3##(2008-5#2)
tinea capitis##5##2##(2008-5#5)
tinea corporis gladiatorum##2##3##(2012-3#2)
tinea corporis##6##2##(2007-7#2)(2008-5#2)(2012-3#2)
tinea cruris and corporis##2##4##(2007-7#2)
tinea cruris and##3##3##(2007-7#3)
tinea cruris##4##2##(2007-7#3)(2008-5#1)
tinea unguium of the toenails##3##5##(2008-5#3)
tinea unguium##5##2##(2008-5#5)
tinea##26##1##(2007-7#5)(2008-5#18)(2012-3#3)
tingling##3##1##(1995-12#1)(2008-7#1)(2010-6#1)
tinidazole##5##1##(1996-2#5)
tinman##2##1##(1995-6#2)
tinned fish consumption##3##3##(2008-1#3)
tinned fish##5##2##(2008-1#5)
tinned##6##1##(2008-1#6)
tinnitus and sudden##2##3##(1995-6#2)
tinnitus and##7##2##(1994-9#1)(1995-6#2)(1996-6#1)(2006-12#1)(2008-7#1)(2012-3#1)
tinnitus patients##2##2##(1996-6#1)(2012-12#1)
tinnitus##33##1##(1994-9#1)(1995-6#5)(1996-6#5)(2006-12#4)(2008-7#3)(2008-9#2)(2010-7#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
tiny defects##2##2##(2008-3#2)
tiny##21##1##(1991-9#1)(1993-12#1)(1994-9#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
tiopronin##4##1##(1994-5#4)
tiotropium##4##1##(1997-1#1)(2010-5#3)
tip and a##2##3##(2007-12#1)(2008-3#1)
tip and sample##2##3##(1994-9#1)(2008-3#1)
tip and##12##2##(1994-9#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)
tip blight disease##2##3##(2008-10#2)
tip by##2##2##(2008-10#2)
tip for##2##2##(2008-3#2)
tip growth##2##2##(2008-10#2)
tip in a##2##3##(2007-12#1)(2008-10#1)
tip in##5##2##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
tip is##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
tip necrosis##4##2##(2008-10#4)
tip of a##13##3##(1990-9#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-7#1)
tip of an##3##3##(2007-12#2)(2008-10#1)
tip of the##37##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-7#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#9)(2008-5#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-12#1)
tip of##58##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(2007-11#1)(2007-12#9)(2007-7#1)(2007-8#1)(2008-10#20)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-12#1)
tip relative to blade##2##4##(2009-12#2)
tip shapes by##2##3##(2008-10#2)
tip to##3##2##(1997-4#1)(2008-10#1)(2009-7#1)
tip was##3##2##(2008-2#1)(2009-6#1)(2009-7#1)
tip were##2##2##(2008-10#1)(2008-8#1)
tip with##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-1#1)
tip##206##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#3)(2006-10#1)(2007-11#4)(2007-12#17)(2007-7#1)(2007-8#1)(2008-10#56)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#15)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#7)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)
tip)##3##1##(2008-6#1)(2008-9#1)(2012-3#1)
tip-sample distance##3##2##(2007-12#2)(2008-2#1)
tip-sample##6##1##(2007-12#3)(2008-2#1)(2008-3#1)(2012-2#1)
tip-to-surface##2##1##(2008-5#2)
tipburn##3##1##(2008-10#3)
tipped##2##1##(2008-3#1)(2012-3#1)
tipping##4##1##(2008-10#1)(2012-2#3)
tips and##2##2##(1994-9#1)(2011-1#1)
tips are##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
tips for##9##2##(1993-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
tips of the##4##3##(1991-12#1)(2008-7#3)
tips of##14##2##(1991-12#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-3#1)(2010-6#1)
tips on how##2##3##(1994-1#1)(1995-2#1)
tips on##4##2##(1991-12#1)(1994-1#1)(1995-2#1)(2007-11#1)
tips to##2##2##(1992-1#1)(2008-10#1)
tips was##2##2##(2008-5#1)(2008-8#1)
tips were##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
tips##80##1##(1991-12#2)(1991-8#1)(1992-1#1)(1993-12#2)(1994-1#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#5)(1997-1#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-3#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)
tirapazamine##2##1##(1997-4#2)
tiredness and##4##2##(1992-12#1)(1995-5#1)(2013-7#1)(2013-8#1)
tiredness##5##1##(1992-12#1)(1995-5#1)(1997-6#1)(2013-7#1)(2013-8#1)
tirotropin releasing hormone##3##3##(1991-3#3)
tissu##2##1##(2007-8#1)(2008-11#1)
tissue (NIST SRM##2##3##(2008-10#2)
tissue DNA##3##2##(1996-12#1)(2008-4#1)(2011-2#1)
tissue RNA##2##2##(1994-12#1)(1996-12#1)
tissue V content and##3##4##(2011-2#3)
tissue V content##4##3##(2011-2#4)
tissue ablation is##2##3##(2008-3#2)
tissue ablation##3##2##(1993-1#1)(2008-3#2)
tissue abnormalities##2##2##(2010-6#1)(2011-1#1)
tissue absorption##3##2##(2007-12#1)(2008-2#2)
tissue accumulation##3##2##(1991-9#1)(1992-3#1)(2012-2#1)
tissue acidification##2##2##(2008-10#2)
tissue adjacent to the##2##4##(1997-3#1)(2008-10#1)
tissue affected by##2##3##(1993-2#1)(1995-12#1)
tissue affected##3##2##(1993-2#1)(1994-2#1)(1995-12#1)
tissue after##8##2##(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-3#1)(2012-1#1)(2013-1#1)
tissue allotransplantation##2##2##(2008-9#1)(2011-2#1)
tissue also##2##2##(2008-10#1)(2008-5#1)
tissue and 1##2##3##(1996-12#1)(2011-1#1)
tissue and an##2##3##(2007-12#1)(2009-11#1)
tissue and are##2##3##(2010-11#1)(2011-1#1)
tissue and arterial saturation##2##4##(2007-12#2)
tissue and cell##2##3##(1991-12#1)(2008-4#1)
tissue and cells##2##3##(2008-9#2)
tissue and in##2##3##(1990-2#1)(2008-1#1)
tissue and its##3##3##(1990-9#1)(2007-8#1)(2013-1#1)
tissue and organs##2##3##(2008-5#1)(2012-2#1)
tissue and possibly##2##3##(1993-11#1)(2008-5#1)
tissue and the##8##3##(1990-9#1)(1995-6#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
tissue and##111##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-9#3)(1991-11#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-12#6)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#3)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-11#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
tissue and/or##3##2##(2008-10#1)(2008-4#1)(2009-6#1)
tissue appears to##2##3##(1994-6#1)(2007-12#1)
tissue architecture and##2##3##(2008-1#1)(2009-5#1)
tissue architecture##4##2##(2008-1#1)(2008-5#1)(2009-5#1)(2010-9#1)
tissue are##9##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-10#1)(2012-2#1)
tissue around the##2##3##(2008-5#1)(2013-1#1)
tissue around##3##2##(2008-5#2)(2013-1#1)
tissue as a##7##3##(2008-10#2)(2008-3#1)(2009-2#1)(2009-7#1)(2011-1#1)(2013-1#1)
tissue as the##2##3##(1992-12#1)(2008-10#1)
tissue as well as##2##4##(2008-4#1)(2008-5#1)
tissue as##18##2##(1991-12#1)(1992-12#1)(1996-12#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
tissue at the##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
tissue at##10##2##(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2013-1#1)(2013-8#1)
tissue autofluorescence##3##2##(2008-3#1)(2011-1#2)
tissue available##2##2##(2007-12#1)(2013-1#1)
tissue balance##2##2##(2013-1#2)
tissue based on##3##3##(2007-12#1)(2008-10#1)(2009-10#1)
tissue based##5##2##(2007-12#1)(2008-10#3)(2009-10#1)
tissue before##4##2##(1994-5#1)(1995-12#1)(2008-2#1)(2011-2#1)
tissue behavior##3##2##(2008-9#2)(2010-9#1)
tissue biopsies##2##2##(2008-1#1)(2008-7#1)
tissue biopsy##4##2##(2008-1#1)(2009-3#1)(2010-6#1)(2012-1#1)
tissue block radiography##3##3##(1997-8#3)
tissue block##4##2##(1997-8#3)(2013-1#1)
tissue blocks##2##2##(1997-8#1)(2009-8#1)
tissue blot##4##2##(2008-10#3)(2008-7#1)
tissue but not##2##3##(2008-12#1)(2010-4#1)
tissue but##3##2##(2008-12#1)(2008-8#1)(2010-4#1)
tissue by inhibiting##2##3##(1990-2#1)(2008-10#1)
tissue by the##3##3##(1990-3#1)(2008-10#1)(2012-2#1)
tissue by use of##3##4##(2007-12#2)(2008-3#1)
tissue by##25##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-12#1)(2007-12#2)(2008-10#13)(2008-3#2)(2008-4#1)(2010-11#1)(2012-2#2)
tissue cGMP levels##3##3##(1990-12#3)
tissue cGMP##4##2##(1990-12#4)
tissue can be##2##3##(2008-2#1)(2008-3#1)
tissue can##5##2##(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
tissue caused by##2##3##(2008-10#1)(2008-2#1)
tissue causing##2##2##(2012-3#1)(2013-1#1)
tissue cells##5##2##(1990-11#1)(1996-2#1)(2007-8#2)(2008-5#1)
tissue changes##2##2##(2008-12#1)(2013-8#1)
tissue characterization##3##2##(2007-12#1)(2010-11#1)(2011-1#1)
tissue collagenase##2##2##(1994-3#2)
tissue collapse was##2##3##(2008-10#2)
tissue colonization##2##2##(2008-10#2)
tissue compared to##2##3##(2008-10#1)(2012-1#1)
tissue compartments##2##2##(2008-3#1)(2011-1#1)
tissue compatibility##3##2##(2012-3#3)
tissue components##3##2##(2008-3#1)(2012-3#2)
tissue concentration##2##2##(1992-6#1)(1996-12#1)
tissue concentrations##3##2##(1994-5#1)(2008-8#1)(2012-2#1)
tissue constituents##2##2##(2007-12#2)
tissue constructs##3##2##(2009-9#1)(2010-10#1)(2013-1#1)
tissue containing##2##2##(2008-2#1)(2010-6#1)
tissue contains##3##2##(2008-11#1)(2008-3#1)(2010-4#1)
tissue content of##2##3##(1997-7#1)(2013-7#1)
tissue content##5##2##(1996-12#2)(1997-7#2)(2013-7#1)
tissue context##2##2##(2008-7#2)
tissue contrast and##3##3##(2008-1#1)(2008-8#1)(2012-12#1)
tissue contrast##6##2##(2007-4#1)(2008-1#2)(2008-8#1)(2010-12#1)(2012-12#1)
tissue could##3##2##(1992-3#1)(1997-3#1)(2010-8#1)
tissue coverage##5##2##(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#2)
tissue culture and##3##3##(1992-2#1)(1993-11#1)(1997-3#1)
tissue culture cells##8##3##(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#3)
tissue culture media##2##3##(2008-10#1)(2008-9#1)
tissue culture medium##2##3##(2008-10#1)(2008-7#1)
tissue culture of##2##3##(1991-2#1)(2008-11#1)
tissue culture plates##2##3##(2008-10#1)(2008-11#1)
tissue culture system##2##3##(2008-11#1)(2008-9#1)
tissue culture##56##2##(1991-2#1)(1992-2#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-9#1)(1994-6#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#13)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#9)(2011-2#2)(2011-3#1)(2012-3#1)(2012-5#1)
tissue cultures##6##2##(1991-9#1)(2008-11#3)(2012-3#1)(2013-1#1)
tissue cytosols##3##2##(1995-11#3)
tissue damage is##4##3##(1990-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
tissue damage was##2##3##(2013-1#2)
tissue damage##24##2##(1990-12#1)(1990-5#1)(1992-3#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
tissue defect##4##2##(2007-8#1)(2008-9#2)(2011-2#1)
tissue defects of the##2##4##(2011-2#2)
tissue defects##5##2##(2007-8#1)(2010-6#1)(2011-2#2)(2012-12#1)
tissue derived from##2##3##(2007-12#1)(2012-2#1)
tissue destruction##8##2##(1990-11#1)(1992-12#1)(2007-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
tissue development in##2##3##(2008-5#1)(2012-2#1)
tissue development##9##2##(1990-4#1)(1993-6#1)(2008-5#1)(2010-10#1)(2011-2#2)(2012-2#3)
tissue diagnosis##6##2##(1992-6#1)(1995-1#1)(1995-3#1)(2008-1#1)(2008-3#1)(2010-11#1)
tissue differentiation##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)
tissue discs##2##2##(2008-10#2)
tissue diseases##7##2##(1991-9#1)(1995-5#2)(2008-8#1)(2012-1#1)(2013-1#2)
tissue disorder##2##2##(2008-5#1)(2010-6#1)
tissue disorders##3##2##(1992-1#1)(2010-3#1)(2012-3#1)
tissue distribution and##2##3##(1990-5#1)(2008-4#1)
tissue distribution of##7##3##(1991-2#1)(1992-9#1)(1993-11#1)(1995-3#1)(1995-6#1)(1997-7#1)(2008-4#1)
tissue distribution##23##2##(1990-5#1)(1991-2#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-7#2)(2008-4#5)(2008-7#1)(2010-5#2)
tissue due to##2##3##(1992-3#1)(2008-10#1)
tissue during##5##2##(1990-11#1)(1991-2#1)(2008-10#1)(2009-11#1)(2010-3#1)
tissue effects##3##2##(1990-5#2)(2011-2#1)
tissue elements##2##2##(2008-2#1)(2010-6#1)
tissue engineered##3##2##(2007-8#1)(2008-5#1)(2012-3#1)
tissue engineering and cell##2##4##(2011-3#1)(2013-1#1)
tissue engineering and regeneration##2##4##(2010-10#1)(2013-1#1)
tissue engineering and regenerative medicine applications##2##6##(2012-5#1)(2012-6#1)
tissue engineering and regenerative medicine##8##5##(2008-5#2)(2009-7#1)(2010-10#2)(2012-5#2)(2012-6#1)
tissue engineering and##13##3##(2008-5#2)(2009-7#1)(2010-10#3)(2011-3#2)(2012-5#2)(2012-6#1)(2013-1#2)
tissue engineering applications##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#2)
tissue engineering as##3##3##(2010-9#1)(2012-3#2)
tissue engineering in##4##3##(2008-11#1)(2008-5#2)(2009-7#1)
tissue engineering is##2##3##(2010-10#1)(2012-12#1)
tissue engineering scaffold##2##3##(2009-11#2)
tissue engineering using##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
tissue engineering##79##2##(2007-12#2)(2008-10#1)(2008-11#8)(2008-5#14)(2009-11#3)(2009-12#2)(2009-5#1)(2009-7#9)(2010-10#9)(2010-8#1)(2010-9#3)(2011-2#2)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-5#3)(2012-6#1)(2012-8#2)(2013-1#4)
tissue environment##4##2##(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)
tissue examined##2##2##(1994-2#1)(2008-10#1)
tissue expander##2##2##(1993-11#1)(2011-2#1)
tissue expression and##3##3##(1992-3#1)(1997-4#1)(2009-4#1)
tissue expression##4##2##(1991-9#1)(1992-3#1)(1997-4#1)(2009-4#1)
tissue extracts##14##2##(1990-11#2)(1990-5#1)(1991-8#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-3#1)(2008-10#4)(2008-11#1)(2012-1#1)
tissue factor (TF)##2##3##(1994-9#1)(1995-6#1)
tissue factor and##3##3##(1991-12#1)(1994-9#1)(2010-3#1)
tissue factor##14##2##(1991-12#5)(1992-10#1)(1994-9#2)(1995-6#2)(2007-2#1)(2008-10#1)(2008-7#1)(2010-3#1)
tissue fibrosis##2##2##(2008-9#2)
tissue flaps##3##2##(2007-12#2)(2008-9#1)
tissue fluorescence##4##2##(2008-3#2)(2011-1#2)
tissue followed by##2##3##(2008-10#1)(2008-4#1)
tissue for the##4##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
tissue for##18##2##(1991-2#1)(1992-12#2)(1996-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2011-1#1)(2012-8#1)
tissue formation##4##2##(2008-9#1)(2009-12#1)(2010-9#1)(2012-12#1)
tissue formed##2##2##(2008-11#1)(2010-8#1)
tissue fragments##2##2##(2008-5#1)(2012-3#1)
tissue from a##4##3##(1994-11#1)(1996-5#1)(2008-3#1)(2009-4#1)
tissue from the##7##3##(1992-6#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-2#1)
tissue from##31##2##(1991-2#1)(1991-5#3)(1992-3#1)(1992-6#1)(1992-9#1)(1994-11#2)(1994-8#1)(1996-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2013-1#1)
tissue function##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
tissue growth factor (CTGF)##2##4##(2012-1#1)(2013-1#1)
tissue growth factor##4##3##(2012-1#2)(2013-1#1)(2013-8#1)
tissue growth in##2##3##(2007-8#1)(2008-9#1)
tissue growth##9##2##(1994-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-1#2)(2013-1#1)(2013-8#1)
tissue handling##3##2##(2007-12#1)(2009-5#2)
tissue has##3##2##(2008-4#1)(2008-5#2)
tissue have been##2##3##(1994-8#1)(2011-1#1)
tissue have##4##2##(1994-8#1)(2008-5#1)(2011-1#1)(2013-1#1)
tissue healing##4##2##(1992-6#1)(2008-6#1)(2009-8#2)
tissue heterogeneity##3##2##(2007-12#1)(2008-4#1)(2013-1#1)
tissue homeostasis and##2##3##(2008-5#1)(2008-7#1)
tissue homeostasis##5##2##(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)
tissue homogenate and gelatin##2##4##(2008-10#2)
tissue homogenate##15##2##(2007-6#1)(2008-10#9)(2008-5#2)(2010-8#2)(2012-3#1)
tissue homogenates##10##2##(1993-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-4#3)
tissue hormones and appetite and body weight regulators##2##8##(2013-8#2)
tissue hormones##4##2##(2012-3#1)(2013-8#3)
tissue hypoxia##2##2##(2011-1#1)(2012-2#1)
tissue imaging##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
tissue in a##3##3##(1994-11#1)(1995-9#1)(2008-10#1)
tissue in patients with##3##4##(1991-12#1)(1995-12#1)(2013-1#1)
tissue in response to##2##4##(2008-1#1)(2008-7#1)
tissue in the absence of##2##5##(1996-12#1)(2008-10#1)
tissue in the##17##3##(1996-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
tissue in vivo##4##3##(1995-12#1)(2008-3#3)
tissue in which the##2##4##(1996-5#1)(2008-10#1)
tissue in##58##2##(1991-12#1)(1991-4#1)(1994-11#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#3)(1996-5#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
tissue included##3##2##(2008-10#2)(2010-10#1)
tissue indicated##2##2##(2008-10#1)(2008-7#1)
tissue indicating##2##2##(2009-4#1)(2011-2#1)
tissue induced##2##2##(2007-8#1)(2008-11#1)
tissue inflammation and##3##3##(2011-2#1)(2012-2#2)
tissue inflammation##8##2##(1997-2#1)(2008-12#2)(2011-2#1)(2012-2#3)(2013-1#1)
tissue inhibitor of metalloproteinase##6##4##(1990-8#2)(2008-5#1)(2008-9#1)(2010-1#1)(2012-1#1)
tissue inhibitor of metalloproteinases-2##3##4##(1992-2#2)(2013-1#1)
tissue inhibitor of##16##3##(1990-8#2)(1992-2#2)(1994-5#2)(1997-4#1)(2008-5#2)(2008-9#2)(2010-1#2)(2010-6#1)(2012-1#1)(2013-1#1)
tissue inhibitors of metalloproteinases##2##4##(1992-9#2)
tissue inhibitors of##3##3##(1992-9#2)(2013-1#1)
tissue injuries##2##2##(1994-2#1)(2008-11#1)
tissue injury##18##2##(1990-2#2)(1991-9#1)(1994-11#1)(1995-2#3)(1997-1#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-3#2)(2011-2#2)(2013-1#1)
tissue interactions##3##2##(2008-3#1)(2008-6#2)
tissue interfaces##2##2##(2008-7#2)
tissue into the##3##3##(1994-5#1)(2012-2#1)(2013-8#1)
tissue into##5##2##(1993-12#1)(1994-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
tissue is described##2##3##(2008-12#1)(2008-4#1)
tissue is very##2##3##(2008-10#1)(2008-3#1)
tissue is##32##2##(1990-12#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
tissue layer##2##2##(2008-2#1)(2008-7#1)
tissue layers##8##2##(1993-11#1)(2008-3#4)(2008-7#1)(2012-1#2)
tissue lesions##7##2##(1994-5#1)(2007-11#1)(2008-6#1)(2009-11#1)(2012-2#3)
tissue level##4##2##(1992-1#1)(2008-7#1)(2010-9#1)(2013-1#1)
tissue levels of##3##3##(1995-11#1)(2008-3#1)(2008-4#1)
tissue levels##6##2##(1992-3#1)(1995-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
tissue loss##4##2##(2008-6#3)(2011-2#1)
tissue mass##6##2##(2011-1#2)(2012-2#2)(2013-1#2)
tissue material##2##2##(2008-9#1)(2013-8#1)
tissue may be##5##3##(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
tissue microarray##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
tissue microarrays##2##2##(2008-4#1)(2009-4#1)
tissue microstructure##2##2##(2010-4#1)(2012-2#1)
tissue mineralization##2##2##(2008-11#2)
tissue model##3##2##(1992-3#1)(2008-11#1)(2008-3#1)
tissue models##4##2##(2008-3#1)(2008-7#2)(2011-1#1)
tissue morphology and##2##3##(2008-3#1)(2008-5#1)
tissue morphology##3##2##(2008-3#1)(2008-5#1)(2011-1#1)
tissue motion##3##2##(2008-10#1)(2008-3#1)(2010-6#1)
tissue nitrogen##3##2##(2008-10#3)
tissue obtained from##2##3##(1993-3#1)(2012-2#1)
tissue obtained##6##2##(1992-12#1)(1993-3#2)(2007-12#1)(2012-2#1)(2013-7#1)
tissue of bulgy##2##3##(2012-12#2)
tissue of interest##2##3##(2009-11#1)(2012-2#1)
tissue of the##11##3##(1994-9#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
tissue of transgenic tomato##2##4##(2008-10#2)
tissue of transgenic##3##3##(2008-10#2)(2008-9#1)
tissue of##53##2##(1990-7#1)(1992-2#1)(1992-8#2)(1993-8#1)(1994-11#2)(1994-9#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
tissue on the##2##3##(1990-10#1)(2009-4#1)
tissue on##6##2##(1990-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)
tissue optical properties from##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
tissue optical properties in##2##4##(2008-2#1)(2008-3#1)
tissue optical properties##11##3##(2007-12#1)(2008-2#2)(2008-3#6)(2011-1#2)
tissue optical##12##2##(2007-12#1)(2008-2#2)(2008-3#7)(2011-1#2)
tissue or cells##2##3##(1991-12#1)(2013-8#1)
tissue or organ##3##3##(1994-11#1)(2008-9#1)(2012-12#1)
tissue or##15##2##(1991-12#2)(1994-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#2)
tissue organization and##2##3##(2008-5#1)(2009-5#1)
tissue organization##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
tissue overgrowth##2##2##(2008-9#2)
tissue oximeter based on##2##4##(2008-3#2)
tissue oxygen##3##2##(1996-3#2)(2009-11#1)
tissue penetration##2##2##(1997-8#1)(2010-10#1)
tissue perfusion during##2##3##(2007-7#2)
tissue perfusion##6##2##(2007-7#3)(2008-1#1)(2008-7#1)(2011-2#1)
tissue phantom for a##2##4##(2008-3#2)
tissue phantom##5##2##(2008-3#4)(2011-1#1)
tissue phantoms containing##4##3##(2007-12#2)(2008-2#1)(2011-1#1)
tissue phantoms##8##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2011-1#1)
tissue pieces##2##2##(2008-9#1)(2011-1#1)
tissue plasminogen activator (rt-PA)##2##4##(2007-10#1)(2008-7#1)
tissue plasminogen activator for##2##4##(2007-5#1)(2008-7#1)
tissue plasminogen activator##28##3##(1991-9#2)(1992-12#2)(1997-2#2)(2007-10#5)(2007-5#1)(2007-9#2)(2008-11#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-6#1)(2013-8#1)
tissue plasminogen##29##2##(1991-9#2)(1992-12#2)(1997-2#2)(2007-10#5)(2007-5#1)(2007-9#2)(2008-11#2)(2008-7#6)(2008-8#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-6#1)(2013-8#1)
tissue polypeptide antigen##2##3##(1990-8#2)
tissue preparations##2##2##(1990-7#1)(1993-1#1)
tissue preservation in##2##3##(2008-10#1)(2012-2#1)
tissue preservation##4##2##(1996-3#1)(2008-10#2)(2012-2#1)
tissue procurement##2##2##(2010-9#2)
tissue protective##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
tissue protein biomarkers##2##3##(2010-9#2)
tissue protein##4##2##(2010-9#3)(2013-1#1)
tissue reconstruction##5##2##(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#1)(2012-8#1)
tissue recovery##2##2##(2008-5#1)(2008-7#1)
tissue regeneration and##5##3##(1993-2#1)(2010-3#1)(2012-12#1)(2012-3#2)
tissue regeneration##22##2##(1990-9#1)(1993-2#1)(2008-10#1)(2008-5#1)(2009-12#2)(2009-5#1)(2010-10#4)(2010-3#1)(2012-12#2)(2012-3#4)(2013-1#3)(2013-8#1)
tissue regions##2##2##(2009-8#1)(2011-1#1)
tissue remained##3##2##(1990-5#1)(2008-10#2)
tissue remains##2##2##(1991-2#1)(2010-9#1)
tissue remodeling##3##2##(2012-2#2)(2012-3#1)
tissue renewal##2##2##(2011-1#2)
tissue repair##13##2##(1993-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-1#4)
tissue research##2##2##(1992-7#1)(1996-2#1)
tissue resident effector memory CD8+##2##5##(2013-8#2)
tissue resident##3##2##(2013-8#3)
tissue resulting##2##2##(2008-8#1)(2009-4#1)
tissue sample##4##2##(1996-12#1)(2007-12#1)(2009-8#1)(2013-1#1)
tissue samples and##2##3##(2007-11#1)(2012-3#1)
tissue samples from##3##3##(1995-12#1)(2008-6#1)(2011-2#1)
tissue samples of##3##3##(1996-12#1)(2009-4#1)(2010-12#1)
tissue samples on##2##3##(2008-10#1)(2012-3#1)
tissue samples were obtained##2##4##(1994-9#1)(2011-2#1)
tissue samples were##3##3##(1994-9#1)(2010-1#1)(2011-2#1)
tissue samples##32##2##(1994-9#1)(1995-12#1)(1996-12#2)(1996-9#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#3)
tissue sarcomas##34##2##(1992-12#3)(1993-9#1)(2008-6#28)(2009-3#1)(2011-2#1)
tissue scaffolds##2##2##(2009-7#1)(2010-9#1)
tissue section##3##2##(1996-12#2)(2008-11#1)
tissue sections of##5##3##(1993-9#1)(2008-4#1)(2010-11#1)(2010-3#1)(2012-2#1)
tissue sections to##2##3##(1993-11#1)(1994-9#1)
tissue sections##24##2##(1991-5#1)(1993-11#1)(1993-9#1)(1994-7#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#5)(2008-5#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
tissue selenium##3##2##(1993-12#3)
tissue showed that##2##3##(2008-10#1)(2008-8#1)
tissue showed##6##2##(1991-8#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
tissue site##2##2##(1991-3#1)(2009-9#1)
tissue slices##6##2##(1991-11#1)(1993-12#1)(2008-8#1)(2011-1#1)(2011-3#2)
tissue slides##2##2##(2008-4#1)(2009-4#1)
tissue source##2##2##(1991-8#1)(2008-1#1)
tissue sources (e##2##3##(2008-4#2)
tissue sources##4##2##(2008-1#1)(2008-4#3)
tissue sparing##2##2##(1994-12#1)(2009-4#1)
tissue specific expression##4##3##(1991-9#1)(1993-11#1)(1994-11#1)(2008-8#1)
tissue specific##12##2##(1990-12#1)(1991-9#1)(1993-11#2)(1993-8#1)(1994-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
tissue specificity of##2##3##(1993-6#1)(2008-9#1)
tissue specificity##5##2##(1991-5#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
tissue specimens##11##2##(1994-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-1#2)(2013-8#1)
tissue stiffness##2##2##(2009-6#1)(2009-7#1)
tissue structure and composition##2##4##(2008-3#1)(2012-2#1)
tissue structure and##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
tissue structure##9##2##(2007-11#4)(2007-8#1)(2008-3#2)(2009-12#1)(2012-2#1)
tissue structures##6##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)
tissue support##2##2##(2008-7#1)(2012-3#1)
tissue surface##11##2##(2008-2#2)(2008-3#5)(2009-11#1)(2011-1#1)(2013-1#2)
tissue surrounding##2##2##(2008-5#1)(2013-8#1)
tissue survival##2##2##(2008-7#1)(2008-9#1)
tissue susceptibility to##3##3##(2008-10#2)(2008-8#1)
tissue than in##3##3##(1997-4#1)(2008-10#1)(2009-11#1)
tissue than the##3##3##(1991-8#1)(1995-12#1)(2013-1#1)
tissue than##7##2##(1991-8#1)(1995-12#1)(1997-4#1)(2008-10#2)(2009-11#1)(2013-1#1)
tissue that developed##2##3##(2008-10#1)(2008-6#1)
tissue that is##2##3##(2008-5#1)(2008-7#1)
tissue that##13##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
tissue thickness##5##2##(2008-3#3)(2008-5#2)
tissue to be##2##3##(1996-12#1)(2011-2#1)
tissue to the##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
tissue to##21##2##(1990-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
tissue toxicity##2##2##(1993-1#1)(2008-2#1)
tissue transfer##5##2##(2007-12#1)(2008-4#1)(2011-2#2)(2012-12#1)
tissue transglutaminase##3##2##(1994-9#1)(2008-1#1)(2008-9#1)
tissue trauma##3##2##(2007-8#1)(2008-12#1)(2009-11#1)
tissue tropisms##3##2##(2008-10#1)(2008-5#2)
tissue tumors##6##2##(1994-6#1)(2007-8#1)(2011-1#1)(2011-2#3)
tissue tumours##9##2##(2008-6#6)(2012-2#3)
tissue type##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)
tissue types##7##2##(1993-2#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
tissue under##6##2##(2008-10#1)(2008-2#2)(2008-7#1)(2009-7#1)(2011-1#1)
tissue until##2##2##(2008-10#1)(2013-1#1)
tissue uptake of##2##3##(1993-11#1)(1994-5#1)
tissue uptake##3##2##(1992-9#1)(1993-11#1)(1994-5#1)
tissue using a##3##3##(1990-2#1)(2008-10#2)
tissue using both conventional##2##4##(2008-9#2)
tissue using the##2##3##(2007-8#1)(2010-3#1)
tissue using##13##2##(1990-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-1#2)
tissue vaporized##2##2##(1991-2#2)
tissue via##2##2##(2007-12#1)(2008-5#1)
tissue viability##3##2##(1994-5#1)(2007-7#1)(2011-2#1)
tissue was also##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
tissue was associated with##2##4##(2008-10#2)
tissue was examined##2##3##(2011-2#1)(2013-1#1)
tissue was found to##2##4##(2008-3#1)(2008-4#1)
tissue was found##4##3##(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)
tissue was measured##3##3##(2007-10#1)(2008-3#1)(2012-2#1)
tissue was much##2##3##(1993-11#1)(2008-9#1)
tissue was removed##2##3##(2008-11#1)(2012-3#1)
tissue was studied##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
tissue was##53##2##(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
tissue water content##2##3##(2008-10#1)(2012-12#1)
tissue water##5##2##(1996-5#1)(2008-10#2)(2008-7#1)(2012-12#1)
tissue were developed##2##3##(2008-10#2)
tissue were measured##2##3##(2008-10#1)(2008-3#1)
tissue were##21##2##(1990-2#1)(1992-9#1)(1993-8#1)(1994-5#1)(1996-5#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
tissue when##2##2##(2008-10#1)(2009-6#1)
tissue where they##2##3##(2008-1#1)(2008-4#1)
tissue where##4##2##(1994-12#1)(2007-10#1)(2008-1#1)(2008-4#1)
tissue with high##2##3##(2008-10#1)(2008-11#1)
tissue with the##2##3##(2008-10#2)
tissue with##22##2##(1993-12#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-5#1)(2011-2#2)(2013-7#1)
tissue within the##4##3##(2006-12#1)(2008-10#1)(2009-12#1)(2010-5#1)
tissue within##5##2##(2006-12#1)(2008-10#1)(2009-12#1)(2009-5#1)(2010-5#1)
tissue without##5##2##(1997-5#1)(2008-10#3)(2013-8#1)
tissue yielded##2##2##(2007-7#1)(2008-2#1)
tissue##2650##1##(1990-10#1)(1990-11#16)(1990-12#14)(1990-2#15)(1990-3#2)(1990-4#1)(1990-5#11)(1990-6#2)(1990-7#4)(1990-8#6)(1990-9#4)(1991-11#5)(1991-12#19)(1991-2#15)(1991-3#1)(1991-4#1)(1991-5#8)(1991-6#2)(1991-8#6)(1991-9#10)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#18)(1992-2#8)(1992-3#17)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#4)(1992-9#16)(1993-1#6)(1993-11#20)(1993-12#9)(1993-2#6)(1993-3#9)(1993-5#1)(1993-6#5)(1993-8#4)(1993-9#10)(1994-10#2)(1994-11#15)(1994-12#5)(1994-2#11)(1994-3#9)(1994-5#14)(1994-6#7)(1994-7#2)(1994-8#5)(1994-9#7)(1995-1#1)(1995-11#11)(1995-12#13)(1995-2#9)(1995-3#9)(1995-4#1)(1995-5#7)(1995-6#14)(1995-8#2)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#33)(1996-2#6)(1996-3#6)(1996-5#11)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#14)(1997-4#12)(1997-5#4)(1997-6#4)(1997-7#7)(1997-8#9)(2006-10#1)(2006-12#2)(2007-10#11)(2007-11#30)(2007-12#60)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#10)(2007-8#35)(2007-9#2)(2008-1#28)(2008-10#330)(2008-11#81)(2008-12#30)(2008-2#52)(2008-3#141)(2008-4#84)(2008-5#93)(2008-6#93)(2008-7#85)(2008-8#30)(2008-9#85)(2009-1#1)(2009-10#7)(2009-11#24)(2009-12#12)(2009-2#5)(2009-3#17)(2009-4#19)(2009-5#15)(2009-6#7)(2009-7#23)(2009-8#13)(2009-9#7)(2010-1#5)(2010-10#24)(2010-11#11)(2010-12#7)(2010-2#4)(2010-3#19)(2010-4#9)(2010-5#4)(2010-6#19)(2010-7#2)(2010-8#19)(2010-9#22)(2011-1#61)(2011-2#95)(2011-3#5)(2012-1#23)(2012-12#27)(2012-2#83)(2012-3#46)(2012-5#4)(2012-6#1)(2012-8#6)(2013-1#106)(2013-7#11)(2013-8#38)
tissue) and##2##2##(1995-12#1)(2013-1#1)
tissue)##7##1##(1995-12#1)(1996-12#1)(2008-12#1)(2008-3#1)(2010-12#1)(2013-1#2)
tissue- and cell-specific##2##3##(1992-9#1)(1994-5#1)
tissue-##6##1##(1992-9#1)(1994-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
tissue-based##2##1##(2008-4#1)(2013-1#1)
tissue-derived stem##2##2##(2010-11#2)
tissue-derived##3##1##(2008-11#1)(2010-11#2)
tissue-engineered##8##1##(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#1)
tissue-engineering##2##1##(2008-11#1)(2013-8#1)
tissue-equivalent##3##1##(1993-9#1)(2008-3#2)
tissue-isolated##2##1##(2013-7#2)
tissue-like##7##1##(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#4)
tissue-simulating phantoms##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
tissue-simulating##6##1##(2008-2#2)(2008-3#3)(2011-1#1)
tissue-specific and##4##2##(1990-11#1)(1990-7#1)(1993-12#1)(1993-6#1)
tissue-specific expression of the##2##4##(1990-11#1)(1990-8#1)
tissue-specific expression of##7##3##(1990-11#2)(1990-8#1)(1993-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
tissue-specific expression##8##2##(1990-11#2)(1990-8#1)(1993-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-7#1)
tissue-specific gene##2##2##(2008-7#1)(2012-7#1)
tissue-specific genes##2##2##(1996-10#1)(2008-11#1)
tissue-specific manner##8##2##(1990-12#1)(1991-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-4#1)(2011-2#1)
tissue-specific regulatory##2##2##(1991-11#1)(1993-12#1)
tissue-specific variations##2##2##(1991-5#1)(1996-10#1)
tissue-specific##53##1##(1990-11#4)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#3)(1996-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#3)(2008-9#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#1)
tissue-specificity##2##1##(1996-10#1)(2008-8#1)
tissue-type mast cells##2##3##(1992-3#2)
tissue-type plasminogen activator##7##3##(1991-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(2006-7#1)(2008-11#1)(2008-8#1)
tissue-type plasminogen##9##2##(1991-3#1)(1995-6#2)(1995-8#2)(1997-1#1)(2006-7#1)(2008-11#1)(2008-8#1)
tissue-type##12##1##(1991-3#1)(1992-3#2)(1994-3#1)(1995-6#2)(1995-8#2)(1997-1#1)(2006-7#1)(2008-11#1)(2008-8#1)
tissue/cell##2##1##(1997-4#1)(2008-7#1)
tissue?##3##1##(1990-8#1)(2009-10#1)(2009-5#1)
tissuelike media##2##2##(2007-11#2)
tissuelike phantoms##3##2##(2008-3#3)
tissuelike scattering##3##2##(2008-3#3)
tissuelike turbid media##2##3##(2008-3#2)
tissuelike##13##1##(2007-11#2)(2008-3#11)
tissues (e##2##2##(1992-3#1)(2008-5#1)
tissues (liver##2##2##(1990-11#1)(2008-10#1)
tissues (n =##2##3##(2008-4#2)
tissues adjacent to##3##3##(2008-10#2)(2009-4#1)
tissues after the##2##3##(2008-10#1)(2013-1#1)
tissues after##9##2##(1992-9#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
tissues against##2##2##(1994-11#1)(1994-5#1)
tissues and a##2##3##(1991-5#1)(2012-12#1)
tissues and cell lines##3##4##(1993-8#1)(1994-6#1)(2008-9#1)
tissues and cells##4##3##(1992-9#1)(2008-7#1)(2008-9#1)(2013-8#1)
tissues and cultures##2##3##(2008-10#1)(2010-10#1)
tissues and for##2##3##(2008-11#1)(2013-1#1)
tissues and is##4##3##(1993-3#1)(1995-6#1)(2008-10#1)(2010-12#1)
tissues and organs##10##3##(1996-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
tissues and the##5##3##(2008-2#1)(2008-3#1)(2009-10#1)(2010-8#1)(2013-1#1)
tissues and##103##2##(1990-11#1)(1991-12#1)(1991-5#2)(1992-9#2)(1993-11#1)(1993-3#4)(1993-8#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#2)
tissues are##19##2##(1994-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2009-7#1)(2009-8#2)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
tissues around the##2##3##(2009-4#1)(2013-8#1)
tissues as well as##2##4##(1997-1#1)(2008-11#1)
tissues as##12##2##(1991-2#1)(1991-6#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)
tissues at the##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
tissues at##11##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
tissues based on##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
tissues but##4##2##(1994-12#1)(2008-10#1)(2008-9#2)
tissues by Northern blot analysis##2##5##(1993-2#1)(1995-6#1)
tissues by Northern blot##3##4##(1990-11#1)(1993-2#1)(1995-6#1)
tissues by flow cytometry##2##4##(2008-11#1)(2008-9#1)
tissues by high-performance liquid chromatography##2##5##(2008-10#1)(2009-8#1)
tissues by the##2##3##(1992-11#1)(2008-10#1)
tissues by##23##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-6#1)(1996-3#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)
tissues can be##8##3##(1994-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2013-8#1)
tissues can##11##2##(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2013-8#1)
tissues collected from##2##3##(2008-10#1)(2013-7#1)
tissues collected##3##2##(2008-10#2)(2013-7#1)
tissues compared##2##2##(2010-12#1)(2013-1#1)
tissues contained##2##2##(1990-12#1)(1995-11#1)
tissues containing##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
tissues could##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
tissues demonstrated the##2##3##(2007-12#1)(2012-3#1)
tissues demonstrated##3##2##(1993-3#1)(2007-12#1)(2012-3#1)
tissues during the##2##3##(1994-5#1)(2012-1#1)
tissues during##6##2##(1990-5#1)(1994-5#1)(2008-3#1)(2010-5#1)(2012-1#1)(2012-2#1)
tissues examined##12##2##(1991-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1997-4#2)(2008-10#3)(2008-12#1)(2008-9#1)
tissues except the##2##3##(1995-2#1)(1996-3#1)
tissues except##5##2##(1992-9#1)(1995-2#1)(1996-3#1)(2010-5#1)(2011-2#1)
tissues for the##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
tissues for##15##2##(1990-11#1)(1994-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
tissues from the##3##3##(1994-11#1)(2008-10#1)(2008-6#1)
tissues from##25##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-11#2)(1996-9#2)(1997-3#1)(2008-10#4)(2008-3#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
tissues have been##2##3##(2008-2#1)(2010-12#1)
tissues have##8##2##(1990-11#1)(1991-2#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)
tissues in both##2##3##(2008-10#1)(2013-1#1)
tissues in the##8##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
tissues in vivo##3##3##(1994-12#1)(2008-2#1)(2008-3#1)
tissues in which the##2##4##(1990-8#1)(2012-3#1)
tissues in##32##2##(1990-12#1)(1990-8#1)(1992-2#1)(1994-12#2)(1995-12#1)(1996-12#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
tissues including the##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)
tissues including##9##2##(1990-12#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-5#1)(2012-3#1)
tissues indicated##3##2##(1994-12#1)(2008-7#1)(2008-9#1)
tissues infected with##2##3##(2008-10#2)
tissues involved##3##2##(1990-3#1)(1992-11#1)(2010-6#1)
tissues is a##2##3##(1996-10#1)(2010-5#1)
tissues is discussed##2##3##(2007-12#1)(2008-10#1)
tissues is frequently##2##3##(2010-6#1)(2013-8#1)
tissues is##20##2##(1991-2#1)(1991-7#1)(1994-8#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2013-8#1)
tissues it is##3##3##(1992-12#1)(2008-4#1)(2008-8#1)
tissues it##4##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
tissues may be##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
tissues may##5##2##(1990-8#1)(2008-10#2)(2008-12#1)(2012-12#1)
tissues of Astacus##2##3##(2008-12#2)
tissues of embryos##2##3##(1992-9#1)(2009-7#1)
tissues of five##2##3##(1994-2#1)(2008-10#1)
tissues of snails##2##3##(2008-12#2)
tissues of the infected##2##4##(2008-10#1)(2008-9#1)
tissues of the##22##3##(1992-8#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-4#2)(2007-7#1)(2008-10#3)(2008-12#4)(2008-4#1)(2008-6#2)(2008-9#1)(2009-5#1)(2010-6#1)(2010-9#1)(2013-8#1)
tissues of transgenic##2##3##(1993-12#1)(2008-11#1)
tissues of young##2##3##(1990-5#1)(2007-7#1)
tissues of##76##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-12#1)(1991-8#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#2)(1997-6#1)(2007-7#2)(2008-10#14)(2008-11#1)(2008-12#12)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#2)(2012-3#1)(2013-1#1)(2013-8#2)
tissues on the##2##3##(1992-1#1)(2009-6#1)
tissues on##3##2##(1992-1#1)(1993-12#1)(2009-6#1)
tissues or organs##4##3##(2007-4#1)(2008-11#1)(2009-12#1)(2010-9#1)
tissues or##13##2##(1991-11#1)(1991-3#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2009-12#1)(2010-9#1)(2011-2#1)
tissues revealed that the##2##4##(1992-11#1)(1992-9#1)
tissues revealed that##3##3##(1992-11#1)(1992-12#1)(1992-9#1)
tissues revealed##6##2##(1992-11#1)(1992-12#1)(1992-9#1)(2008-10#2)(2012-2#1)
tissues showed##4##2##(1991-12#1)(1991-8#1)(2008-10#2)
tissues shows##2##2##(2008-7#1)(2008-9#1)
tissues studied##5##2##(1990-11#2)(1990-3#1)(1996-5#1)(2008-5#1)
tissues such as##15##3##(1990-11#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)
tissues surrounding the##2##3##(2008-12#1)(2008-5#1)
tissues surrounding##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
tissues tested##4##2##(1991-2#1)(1992-8#1)(1993-6#1)(1994-11#1)
tissues than##6##2##(1992-9#2)(2008-10#1)(2008-4#1)(2010-12#1)(2012-3#1)
tissues that are##2##3##(2008-3#1)(2008-7#1)
tissues that have##2##3##(2008-9#1)(2012-2#1)
tissues that##11##2##(1992-9#1)(1997-7#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2012-2#1)
tissues to##12##2##(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
tissues under##4##2##(2010-6#1)(2012-2#1)(2013-1#2)
tissues using a##3##3##(1991-5#1)(1991-9#1)(1994-11#1)
tissues using the##2##3##(1990-7#1)(1997-7#1)
tissues using##12##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-9#1)(1994-11#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
tissues was performed##2##3##(2008-3#1)(2008-9#1)
tissues was##16##2##(1992-9#1)(1993-11#1)(1994-5#1)(1995-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
tissues were also##2##3##(1990-11#1)(2009-12#1)
tissues were determined##2##3##(2008-3#1)(2008-4#1)
tissues were examined##3##3##(1993-9#1)(2008-6#1)(2008-7#1)
tissues were studied for##2##4##(1991-2#1)(2008-10#1)
tissues were successfully##2##3##(2008-3#1)(2008-7#1)
tissues were##35##2##(1990-11#2)(1990-3#1)(1991-2#2)(1992-9#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#2)
tissues when##3##2##(2010-12#2)(2013-1#1)
tissues where##4##2##(1991-12#1)(1994-9#1)(2008-10#1)(2012-2#1)
tissues which##6##2##(1994-12#1)(1995-3#1)(2008-10#1)(2010-8#1)(2013-1#2)
tissues with a##2##3##(2008-11#1)(2008-7#1)
tissues with the##3##3##(1990-12#1)(1994-5#1)(2007-11#1)
tissues with##15##2##(1990-12#1)(1993-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
tissues within##4##2##(2008-10#2)(2008-7#1)(2010-8#1)
tissues without##2##2##(2008-3#1)(2010-6#1)
tissues would##2##2##(1997-8#1)(2013-1#1)
tissues##1253##1##(1990-10#1)(1990-11#21)(1990-12#13)(1990-2#2)(1990-3#4)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-11#3)(1991-12#13)(1991-2#10)(1991-3#4)(1991-5#8)(1991-6#5)(1991-7#3)(1991-8#5)(1991-9#6)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#20)(1993-1#1)(1993-11#6)(1993-12#7)(1993-2#3)(1993-3#12)(1993-5#2)(1993-6#3)(1993-8#6)(1993-9#4)(1994-11#14)(1994-12#9)(1994-2#10)(1994-3#2)(1994-5#12)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#4)(1995-11#4)(1995-12#12)(1995-2#6)(1995-3#1)(1995-6#7)(1995-8#7)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#9)(1997-3#5)(1997-4#8)(1997-6#3)(1997-7#9)(1997-8#5)(1997-9#1)(2007-11#13)(2007-12#16)(2007-4#3)(2007-7#5)(2007-8#3)(2008-1#17)(2008-10#227)(2008-11#41)(2008-12#26)(2008-2#14)(2008-3#52)(2008-4#41)(2008-5#20)(2008-6#14)(2008-7#46)(2008-8#23)(2008-9#50)(2009-10#6)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#12)(2010-1#1)(2010-10#7)(2010-11#4)(2010-12#16)(2010-2#1)(2010-3#13)(2010-4#5)(2010-5#5)(2010-6#6)(2010-7#2)(2010-8#13)(2010-9#9)(2011-1#14)(2011-10#1)(2011-2#23)(2011-3#1)(2012-1#5)(2012-12#17)(2012-2#26)(2012-3#21)(2013-1#36)(2013-7#2)(2013-8#15)
tissues)##5##1##(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#2)
tissular##4##1##(1990-5#1)(1992-12#1)(2008-11#2)
tit Parus##5##2##(1994-3#2)(2008-9#3)
tit##12##1##(1994-3#3)(2008-5#1)(2008-8#3)(2008-9#5)
titanate##10##1##(1990-4#1)(2008-2#8)(2009-11#1)
titania##4##1##(2008-10#3)(2010-4#1)
titanium and tin##2##3##(2008-10#2)
titanium and##4##2##(2008-10#2)(2008-11#1)(2009-7#1)
titanium atoms##2##2##(2008-8#1)(2010-4#1)
titanium bearing##3##2##(2008-10#3)
titanium dental##2##2##(2009-7#2)
titanium determination##2##2##(2008-10#2)
titanium dioxide (TiO(2))##4##3##(2008-10#1)(2008-5#2)(2009-11#1)
titanium dioxide by##2##3##(2008-10#2)
titanium dioxide##22##2##(2007-12#1)(2008-10#14)(2008-5#4)(2009-11#2)(2012-2#1)
titanium fibermesh##2##2##(2008-11#2)
titanium foil##3##2##(2009-11#3)
titanium in##3##2##(2008-10#3)
titanium mesh##5##2##(2008-7#2)(2011-2#3)
titanium metal backing##2##3##(2008-5#2)
titanium metal##3##2##(2008-5#3)
titanium miniplates##2##2##(2008-7#2)
titanium oxide films##4##3##(2008-2#2)(2008-8#2)
titanium oxide##16##2##(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#5)(2010-4#3)
titanium substrate##2##2##(2008-11#1)(2009-11#1)
titanium trichloride##4##2##(2008-10#4)
titanium##123##1##(1994-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#50)(2008-11#6)(2008-2#4)(2008-3#3)(2008-5#10)(2008-7#7)(2008-8#6)(2009-11#6)(2009-7#7)(2010-4#4)(2011-2#3)(2012-2#5)(2013-1#6)
titanium(IV) from##2##2##(2008-10#2)
titanium(IV) has##2##2##(2008-10#2)
titanium(IV)##6##1##(2008-10#6)
titanyl##12##1##(2006-4#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#3)
titer against ND##2##3##(2008-12#2)
titer against##3##2##(2008-12#3)
titer and PFC##2##3##(2008-11#2)
titer and##8##2##(1992-9#1)(1995-11#1)(2008-10#2)(2008-11#4)
titer could##2##2##(2008-10#1)(2008-11#1)
titer for##2##2##(2008-9#1)(2012-3#1)
titer in the##3##3##(2007-10#1)(2008-4#2)
titer in##5##2##(1992-9#1)(2007-10#1)(2008-10#1)(2008-4#2)
titer of##18##2##(1992-12#1)(1992-9#2)(1994-9#1)(1995-3#1)(1995-5#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
titer was determined##2##3##(2008-10#1)(2013-8#1)
titer was##7##2##(2008-10#1)(2008-11#3)(2010-1#1)(2012-3#1)(2013-8#1)
titer##86##1##(1990-11#1)(1991-8#1)(1992-12#2)(1992-9#5)(1993-3#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-3#1)(1995-5#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-2#1)(2008-10#12)(2008-11#25)(2008-12#5)(2008-2#2)(2008-4#4)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
titer) and##2##2##(2008-10#1)(2011-3#1)
titered##2##1##(2008-9#2)
titering##3##1##(2008-2#1)(2008-4#1)(2008-9#1)
titers against##2##2##(2008-12#1)(2012-3#1)
titers are##3##2##(1995-5#1)(2007-10#1)(2013-8#1)
titers by##3##2##(2008-10#1)(2008-11#2)
titers for canine parvovirus type-2##2##5##(2012-3#2)
titers in the##4##3##(1992-8#1)(2008-6#1)(2010-12#1)(2011-2#1)
titers in##10##2##(1992-8#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)
titers of antibodies to##2##4##(1992-8#1)(2009-12#1)
titers of antibodies##3##3##(1992-8#1)(2009-12#1)(2012-3#1)
titers of##17##2##(1992-8#1)(1994-8#1)(1995-11#1)(1996-11#1)(2008-11#3)(2008-4#3)(2008-9#2)(2009-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-3#1)
titers were##7##2##(1992-5#1)(1995-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
titers##76##1##(1990-12#1)(1990-7#1)(1992-5#2)(1992-8#2)(1994-12#2)(1994-8#2)(1995-11#2)(1995-5#1)(1996-11#1)(2007-10#5)(2008-10#12)(2008-11#15)(2008-12#4)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
title compound##4##2##(1992-9#1)(2008-10#2)(2013-1#1)
title compounds##10##2##(1994-3#1)(1997-4#1)(2007-11#2)(2008-10#1)(2011-1#3)(2011-3#1)(2012-3#1)
title##33##1##(1991-12#1)(1992-9#1)(1993-2#3)(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-5#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#4)
titles and abstracts##2##3##(2011-2#2)
titles and##3##2##(2008-11#1)(2011-2#2)
titles##10##1##(1993-2#1)(1995-9#1)(1996-12#1)(2008-11#2)(2008-7#1)(2011-2#4)
titrant and##3##2##(2008-10#3)
titrant are##2##2##(2008-10#2)
titrant concentration##3##2##(2008-10#3)
titrant containing a lipophilic##2##4##(2008-10#2)
titrant flow##2##2##(2008-10#2)
titrant is##3##2##(2008-10#3)
titrant to##2##2##(2008-10#2)
titrant##46##1##(2008-10#44)(2008-11#2)
titrants##4##1##(1992-6#1)(2008-10#3)
titratable acidity##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
titratable##5##1##(2008-5#2)(2009-11#1)(2011-2#1)(2013-1#1)
titrate##6##1##(1992-6#1)(2008-10#1)(2008-3#1)(2009-11#2)(2010-8#1)
titrated bases##2##2##(2008-10#2)
titrated delay values##2##3##(2011-2#2)
titrated potentiometrically with##2##3##(2007-11#1)(2008-10#1)
titrated with##7##2##(1991-8#1)(1994-5#1)(1995-2#1)(1996-12#1)(2008-10#3)
titrated##29##1##(1991-8#1)(1993-6#1)(1994-5#2)(1995-2#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-7#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-8#1)
titrating##4##1##(2008-10#3)(2008-4#1)
titration and the##2##3##(2008-10#2)
titration and##13##2##(2008-10#13)
titration as well##2##3##(2008-10#2)
titration at##2##2##(2008-10#2)
titration calorimetry##5##2##(1992-10#1)(1994-5#1)(1997-2#2)(2008-10#1)
titration cell##3##2##(2008-10#3)
titration curve##4##2##(1992-8#1)(2008-10#3)
titration curves were obtained##2##4##(2008-10#2)
titration curves##5##2##(1991-8#1)(2008-10#4)
titration data##8##2##(1995-2#1)(2008-10#7)
titration end-point##3##2##(2008-10#3)
titration for the determination of##2##5##(2008-10#2)
titration for##4##2##(2008-10#4)
titration has been##4##3##(2008-10#4)
titration in the##2##3##(1991-1#1)(2008-10#1)
titration in##4##2##(1991-1#1)(2008-10#3)
titration is described##2##3##(2008-10#2)
titration is##8##2##(2008-10#8)
titration method for determination of##2##5##(2008-10#2)
titration method for##4##3##(2008-10#4)
titration method is##2##3##(2008-10#2)
titration method##20##2##(1995-2#1)(2008-10#19)
titration of copper##2##3##(2008-10#2)
titration of some##2##3##(2008-10#2)
titration of the##5##3##(1997-2#1)(2008-10#4)
titration of thiocyanate##2##3##(2008-10#2)
titration of virus##2##3##(2008-11#1)(2008-9#1)
titration of weak acids in##2##5##(2008-10#2)
titration of weak acids##3##4##(2008-10#3)
titration of##70##2##(1990-5#1)(1991-9#1)(1996-12#1)(1997-2#1)(2008-10#56)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#2)(2009-8#1)(2013-1#1)
titration procedure##2##2##(2008-10#1)(2011-1#1)
titration protocols##2##2##(2008-10#2)
titration rate##2##2##(2008-10#2)
titration scores##2##2##(1994-3#2)
titration system for the determination of##2##6##(2008-10#2)
titration system##5##2##(2008-10#5)
titration technique##2##2##(1997-2#1)(2008-10#1)
titration time##2##2##(2008-10#2)
titration to##3##2##(2008-10#2)(2008-7#1)
titration using an##2##3##(2008-10#2)
titration using##4##2##(2008-10#4)
titration was used##2##3##(2008-10#2)
titration was##7##2##(2008-10#6)(2008-7#1)
titration were##4##2##(2008-10#4)
titration with a##2##3##(2008-10#1)(2011-2#1)
titration with##14##2##(1995-5#1)(2008-10#10)(2008-7#2)(2011-2#1)
titration##268##1##(1990-5#1)(1990-9#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#1)(1994-3#2)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#4)(1997-7#1)(2007-6#1)(2008-10#229)(2008-11#2)(2008-4#6)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
titration)##4##1##(2008-10#4)
titration-reagent##2##1##(2008-10#2)
titrations and the##2##3##(2008-10#2)
titrations and##4##2##(2008-10#4)
titrations are##2##2##(2008-10#2)
titrations in##3##2##(2008-10#3)
titrations is##2##2##(2008-10#2)
titrations made in##2##3##(2008-10#2)
titrations of calcium##2##3##(2008-10#2)
titrations of non-growing cells##2##4##(1991-11#2)
titrations of phenothiazine derivatives in aqueous micellar##2##7##(2008-10#2)
titrations of##16##2##(1991-11#2)(1995-2#2)(1996-12#1)(2008-10#11)
titrations the pH##2##3##(2008-10#2)
titrations were##5##2##(2008-10#5)
titrations with a##2##3##(2008-10#2)
titrations with##6##2##(2008-10#6)
titrations##69##1##(1991-11#2)(1991-5#1)(1994-5#1)(1995-2#2)(1996-12#1)(2007-11#1)(2008-10#60)(2011-1#1)
titre &gt##2##2##(2007-7#2)
titre in the##3##3##(2007-10#1)(2008-11#1)(2012-2#1)
titre of##3##2##(1993-9#1)(1996-12#1)(2007-7#1)
titre##23##1##(1991-5#1)(1993-9#1)(1995-12#1)(1996-12#1)(1997-6#2)(2007-10#1)(2007-7#4)(2008-11#10)(2008-8#1)(2012-2#1)
titres greater than or equal to 1##2##7##(1990-2#2)
titres greater than or equal to##3##6##(1990-2#2)(1991-8#1)
titres in trachea##2##3##(1997-6#2)
titres in##4##2##(1997-3#1)(1997-6#2)(2007-7#1)
titres of##5##2##(1994-12#1)(1996-12#1)(2008-7#3)
titres were##2##2##(1997-6#1)(2008-5#1)
titres##30##1##(1990-2#2)(1991-11#1)(1991-12#1)(1991-8#1)(1994-12#1)(1994-8#1)(1996-12#2)(1997-3#1)(1997-6#7)(2007-6#1)(2007-7#2)(2008-11#2)(2008-5#1)(2008-7#4)(2009-6#2)(2011-2#1)
titrimetric method##5##2##(2008-10#5)
titrimetric methods##2##2##(2008-10#2)
titrimetric##15##1##(2008-10#15)
titrimetry##3##1##(2008-10#2)(2010-5#1)
tits (Parus##2##2##(2008-5#2)
tits Parus##2##2##(2008-8#2)
tits were##3##2##(2008-5#3)
tits##27##1##(1994-3#6)(2008-5#15)(2008-8#6)
tm##2##1##(2007-11#2)
tn and##2##2##(1996-2#2)
tn##4##1##(1996-2#4)
tnrRPE-CM##2##1##(1996-5#2)
to $1##3##2##(1992-2#1)(1993-3#1)(2008-6#1)
to $12##2##2##(1992-1#1)(1994-2#1)
to $2##4##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-6#1)
to $8##2##2##(2007-12#1)(2008-11#1)
to &gt##26##2##(1993-11#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-3#2)(2008-10#10)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
to &lt##30##2##(1994-8#1)(1994-9#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#2)
to &quot##57##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
to (1)##7##2##(1994-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-1#1)
to (3##2##2##(1992-11#1)(1992-6#1)
to (a)##6##2##(1992-3#1)(1997-2#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
to (i) a##2##3##(2008-10#1)(2008-3#1)
to (i) distinguish##2##3##(2008-10#2)
to (i)##18##2##(1990-9#1)(1995-2#1)(2008-10#10)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
to +/-##2##2##(1992-11#2)
to +/-0##3##2##(2007-11#1)(2008-3#2)
to +0##3##2##(2008-10#3)
to +421##2##2##(1991-9#2)
to +80 degrees##2##3##(2008-3#2)
to -0##13##2##(2007-12#1)(2008-10#7)(2010-4#3)(2013-1#2)
to -100 is essential for##2##5##(1995-6#2)
to -100##3##2##(1995-6#3)
to -15 mmHg##2##3##(1991-3#2)
to -15##4##2##(1991-3#2)(1995-2#1)(2009-5#1)
to -2##5##2##(2008-10#1)(2013-8#4)
to -20##2##2##(1995-2#1)(2008-10#1)
to -22##3##2##(1992-12#1)(1993-3#1)(1993-8#1)
to -4##2##2##(1995-2#1)(2008-10#1)
to -5##3##2##(1995-2#1)(2011-1#1)(2013-8#1)
to -60 degrees C##2##4##(2008-3#2)
to -60##3##2##(1991-5#1)(2008-3#2)
to 0 degrees##4##3##(2007-12#1)(2008-10#1)(2009-3#1)(2009-9#1)
to 0##413##2##(1990-10#1)(1990-11#5)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-12#3)(1993-6#1)(1993-8#2)(1993-9#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#176)(2008-11#13)(2008-12#5)(2008-2#10)(2008-3#24)(2008-4#1)(2008-5#15)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#7)(2010-5#2)(2010-6#3)(2010-8#2)(2011-1#7)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#8)
to 0%##3##2##(1990-2#1)(2008-10#1)(2008-2#1)
to 06##2##2##(2008-10#1)(2012-12#1)
to 0600##2##2##(1992-11#1)(2008-10#1)
to 1 January##2##3##(1996-1#2)
to 1 M##2##3##(1995-2#1)(1997-2#1)
to 1 MHz##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
to 1 g##2##3##(2008-10#1)(2008-11#1)
to 1 in##2##3##(2008-10#1)(2008-3#1)
to 1 mM##5##3##(1992-12#1)(1992-6#1)(2008-10#3)
to 1 mg l(-1)##2##4##(2008-10#2)
to 1 microM##5##3##(1990-2#2)(1992-3#1)(1993-8#1)(1993-9#1)
to 1 ml of##2##4##(2008-10#1)(2008-12#1)
to 1 ml##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to 1 mol of##2##4##(1990-2#1)(2008-6#1)
to 1 mol##3##3##(1990-2#1)(2008-6#1)(2010-4#1)
to 1 month##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
to 1 mug##2##3##(2008-10#2)
to 1 x##6##3##(1992-8#1)(2008-10#3)(2008-2#1)(2009-3#1)
to 1 year##2##3##(1990-12#1)(2008-10#1)
to 1##445##2##(1990-11#1)(1990-12#2)(1990-2#7)(1990-7#4)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-8#4)(1993-9#7)(1994-11#3)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-7#2)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#14)(2007-12#16)(2007-8#3)(2008-1#2)(2008-10#187)(2008-11#15)(2008-12#4)(2008-2#4)(2008-3#12)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#5)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#9)(2012-12#4)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#6)(2013-8#6)
to 1%##10##2##(2007-5#1)(2007-7#1)(2008-10#5)(2008-2#1)(2011-1#1)(2012-3#1)
to 1)##2##2##(1995-11#1)(2008-7#1)
to 1-2##3##2##(1992-9#1)(1994-3#1)(2013-8#1)
to 1/100##2##2##(1997-4#1)(2008-10#1)
to 10 and##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
to 10 days after inoculation##2##5##(2008-10#2)
to 10 days##7##3##(1992-12#1)(1996-12#1)(2008-10#2)(2009-7#1)(2010-8#1)(2012-12#1)
to 10 m##2##3##(2008-10#1)(2011-2#1)
to 10 mM##4##3##(1993-3#1)(1995-11#1)(1995-3#1)(2008-10#1)
to 10 mg##6##3##(1990-11#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#1)
to 10 microM##6##3##(1991-11#1)(1991-5#1)(1994-5#1)(1995-11#1)(1997-4#2)
to 10 mm in diameter)##2##5##(2008-10#2)
to 10 mm in##4##4##(1990-2#2)(2008-10#2)
to 10 mm##5##3##(1990-2#2)(2008-10#2)(2008-2#1)
to 10 months##2##3##(1991-8#1)(2008-10#1)
to 10 muM##4##3##(2008-10#3)(2008-7#1)
to 10 mug##3##3##(2008-10#2)(2008-11#1)
to 10 mum##2##3##(2007-12#1)(2008-2#1)
to 10 nM##3##3##(1992-3#1)(1993-9#2)
to 10 percent of the##2##5##(1992-3#1)(1995-6#1)
to 10 times higher##3##4##(1995-11#1)(2007-12#1)(2013-8#1)
to 10 years##8##3##(1991-4#1)(1996-5#1)(2007-8#1)(2008-10#2)(2010-2#1)(2011-2#1)(2012-12#1)
to 10##165##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-8#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#3)(1993-3#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#2)(2007-10#2)(2007-11#5)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#60)(2008-11#10)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#3)
to 10% and##2##3##(2008-3#1)(2011-1#1)
to 10% are##2##3##(2008-3#1)(2013-1#1)
to 10% of patients##2##4##(1991-9#1)(2009-12#1)
to 10% of the original##2##5##(2008-6#1)(2010-8#1)
to 10% of the##4##4##(1990-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
to 10% of##10##3##(1990-2#1)(1991-9#1)(1993-6#1)(1996-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-4#1)(2010-8#1)
to 10%##33##2##(1990-2#1)(1990-6#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#6)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-8#2)(2011-1#1)(2013-1#1)
to 10%)##3##2##(2008-10#3)
to 10(-1) M##2##3##(2008-10#2)
to 10(-1)##4##2##(2008-10#4)
to 10(-1)M##2##2##(2008-10#2)
to 10(-2)moll(-1) for##2##3##(2008-10#2)
to 10(-3) M##2##3##(2008-10#1)(2008-5#1)
to 10(-5) M##3##3##(1997-4#1)(2008-10#2)
to 10(-5)##5##2##(1991-9#1)(1997-4#1)(2008-10#2)(2011-2#1)
to 10(-6) M##4##3##(1994-9#2)(1995-12#1)(2008-4#1)
to 10(-6)##5##2##(1994-9#2)(1995-12#1)(1997-4#1)(2008-4#1)
to 10(-7) M##3##3##(1991-5#1)(2008-10#2)
to 10(-7)##5##2##(1991-5#1)(1997-4#2)(2008-10#2)
to 10(-8)##2##2##(1997-4#1)(2009-6#1)
to 10(12)##2##2##(1994-12#1)(1996-7#1)
to 10(3) times##2##3##(2008-3#1)(2008-4#1)
to 10(3)##5##2##(1990-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
to 10(4)##3##2##(1995-9#1)(2008-10#2)
to 10(5) cgs##2##3##(2008-10#2)
to 10(5)##7##2##(2008-10#5)(2008-11#1)(2008-2#1)
to 10(6)##7##2##(1995-2#1)(2008-10#5)(2008-3#1)
to 10(7) CFU##2##3##(2008-10#2)
to 10(7)##4##2##(2008-10#4)
to 10-##2##2##(1991-12#1)(2008-10#1)
to 10-fold##2##2##(1994-8#1)(2012-2#1)
to 100 GHz##2##3##(2007-11#1)(2008-3#1)
to 100 and##2##3##(2008-10#2)
to 100 degrees C##2##4##(1997-2#1)(2013-8#1)
to 100 degrees##3##3##(1997-2#1)(2008-2#1)(2013-8#1)
to 100 mM##2##3##(1992-7#1)(2008-10#1)
to 100 mg##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
to 100 microM##3##3##(1992-12#1)(1995-5#1)(2008-10#1)
to 100 microM)##2##3##(1991-5#1)(1992-9#1)
to 100 muM##3##3##(2008-10#3)
to 100 mug l(-1)##3##4##(2008-10#3)
to 100 mug##6##3##(2008-10#6)
to 100 nM##2##3##(1995-11#1)(2008-11#1)
to 100 ng/ml)##2##3##(2008-6#2)
to 100##88##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#4)(2007-12#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
to 100% and##4##3##(2007-8#1)(2008-10#1)(2009-7#1)(2011-2#1)
to 100% for##7##3##(2008-10#5)(2008-5#1)(2011-2#1)
to 100% nucleotide##2##3##(2008-10#1)(2008-5#1)
to 100% of the##2##4##(1993-8#1)(2008-10#1)
to 100% of##7##3##(1993-8#1)(2008-10#4)(2008-5#1)(2008-9#1)
to 100% oxygen at 4##2##5##(1993-12#2)
to 100% were##2##3##(2008-10#2)
to 100% with##2##3##(2008-10#2)
to 100%##65##2##(1990-11#1)(1990-5#1)(1991-2#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-3#1)(1997-2#2)(1997-3#2)(2007-8#1)(2008-10#37)(2008-11#1)(2008-3#1)(2008-5#5)(2008-9#2)(2009-7#2)(2011-2#3)(2012-3#1)
to 100%)##7##2##(2008-10#5)(2010-10#1)(2010-6#1)
to 100)##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
to 1000 nm##4##3##(2007-12#2)(2008-3#2)
to 1000 ppm##2##3##(2008-10#2)
to 1000 times##2##3##(1997-5#1)(2008-12#1)
to 1000##24##2##(1991-12#1)(1994-8#1)(1997-5#1)(2007-12#5)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-1#1)
to 101##8##2##(2008-10#8)
to 101%##5##2##(2008-10#5)
to 102##9##2##(1990-3#1)(1993-2#1)(2008-10#6)(2011-1#1)
to 102% for##3##3##(2008-10#3)
to 102%##7##2##(2008-10#7)
to 103##4##2##(1992-11#1)(1997-4#1)(2008-10#2)
to 103% for Sb(V)##2##4##(2008-10#2)
to 103% for##4##3##(2008-10#4)
to 103%##11##2##(2008-10#10)(2011-1#1)
to 104##4##2##(2008-10#3)(2011-1#1)
to 104%##8##2##(2008-10#8)
to 105##7##2##(1990-2#1)(1990-7#1)(1996-7#1)(2008-10#2)(2009-3#1)(2012-1#1)
to 105% for##2##3##(2008-10#2)
to 105%##4##2##(2008-10#4)
to 1050##2##2##(1994-11#1)(2007-11#1)
to 106##7##2##(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
to 106% and##2##3##(2008-10#1)(2011-1#1)
to 106% for##3##3##(2008-10#3)
to 106%##5##2##(2008-10#4)(2011-1#1)
to 1064 nm##3##3##(2007-11#2)(2008-3#1)
to 107%##3##2##(2008-10#2)(2011-1#1)
to 108##7##2##(1990-6#1)(1994-8#1)(2007-7#1)(2008-10#4)
to 109%##2##2##(2008-10#1)(2008-5#1)
to 11 and##3##3##(2008-10#2)(2011-2#1)
to 11 degrees C##2##4##(2008-10#2)
to 11 degrees##3##3##(2008-10#3)
to 11##37##2##(1992-5#1)(1995-12#2)(2007-2#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2011-2#2)(2012-12#2)(2012-3#2)
to 11%##4##2##(1991-2#1)(2008-1#1)(2008-10#2)
to 11-fold##2##2##(1992-12#1)(1995-11#1)
to 110 degrees C##3##4##(1992-8#1)(2008-10#1)(2010-2#1)
to 110 degrees##4##3##(1992-8#1)(2008-10#1)(2010-2#1)(2012-2#1)
to 110##10##2##(1992-12#1)(1992-8#1)(2008-10#4)(2010-2#1)(2012-2#2)(2013-1#1)
to 110%##5##2##(2008-10#5)
to 1100##2##2##(2008-11#2)
to 112##3##2##(1991-9#1)(2008-10#2)
to 112%##3##2##(2008-10#3)
to 113##3##2##(1994-7#1)(2008-10#1)(2011-1#1)
to 117##5##2##(2007-11#1)(2008-1#2)(2008-11#1)(2009-4#1)
to 117% for##2##3##(2008-10#2)
to 12 days##2##3##(2007-3#1)(2008-10#1)
to 12 h after##2##4##(2008-10#2)
to 12 h##3##3##(2008-10#3)
to 12 km##3##3##(2008-2#2)(2008-3#1)
to 12 mg##2##3##(2008-10#2)
to 12 months##5##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-10#1)
to 12 weeks##4##3##(1994-9#1)(1997-5#1)(2008-10#1)(2013-1#1)
to 12 years##4##3##(1992-1#1)(1993-1#1)(2009-9#1)(2012-3#1)
to 12 years)##2##3##(1990-2#1)(2012-2#1)
to 12##77##2##(1990-2#2)(1990-7#1)(1991-12#1)(1992-1#1)(1992-3#2)(1993-1#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to 12%##4##2##(1996-5#1)(2006-12#1)(2008-3#1)(2008-5#1)
to 120 cm in##2##4##(2008-10#2)
to 120 cm##4##3##(2008-10#4)
to 120 degrees C##2##4##(2008-10#1)(2008-3#1)
to 120 h##2##3##(2007-6#1)(2008-8#1)
to 120##21##2##(1990-7#1)(1993-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
to 120%##5##2##(2008-10#5)
to 1200##5##2##(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
to 121##3##2##(2008-2#2)(2010-2#1)
to 121%##2##2##(2008-10#2)
to 124##2##2##(1991-3#1)(2011-2#1)
to 125##4##2##(2008-11#1)(2008-2#2)(2008-9#1)
to 128 +/-##2##3##(1995-3#1)(2008-5#1)
to 128##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
to 129##2##2##(1997-6#1)(2008-3#1)
to 13 months##2##3##(1992-5#1)(2012-3#1)
to 13 years##2##3##(1995-3#1)(2010-9#1)
to 13##28##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-6#1)(1995-11#2)(1995-3#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-3#2)(2008-7#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to 13-fold##3##2##(1995-11#1)(1996-5#1)(2013-1#1)
to 130##5##2##(1990-10#1)(1993-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
to 1300##2##2##(1991-5#1)(2008-10#1)
to 133##2##2##(1991-6#1)(2008-8#1)
to 135##2##2##(1993-8#1)(1997-2#1)
to 138##3##2##(1994-9#1)(2007-11#1)(2012-12#1)
to 139##2##2##(2008-4#1)(2013-7#1)
to 14 days##6##3##(1992-5#1)(2008-10#4)(2009-12#1)
to 14 mm)##2##3##(2007-8#1)(2012-1#1)
to 14 weeks##2##3##(1997-6#1)(2008-10#1)
to 14 years of age##2##5##(2012-12#1)(2013-1#1)
to 14 years##7##3##(1991-2#1)(2007-8#1)(2009-3#1)(2012-12#1)(2013-1#3)
to 14##53##2##(1990-6#1)(1991-2#1)(1992-5#1)(1993-6#1)(1994-9#2)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-5#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#5)
to 14%##3##2##(1997-2#1)(2013-1#1)(2013-8#1)
to 140##4##2##(2007-10#1)(2008-10#1)(2008-8#1)(2010-8#1)
to 1400##3##2##(2008-10#2)(2008-3#1)
to 143##2##2##(2008-11#1)(2008-2#1)
to 144##2##2##(2008-10#2)
to 15 and##2##3##(1990-6#1)(2010-8#1)
to 15 cm##2##3##(2008-5#1)(2013-8#1)
to 15 day##2##3##(2008-10#1)(2011-2#1)
to 15 days##6##3##(2007-6#1)(2008-10#1)(2008-5#3)(2008-9#1)
to 15 degrees C##2##4##(2008-10#2)
to 15 degrees##3##3##(2008-10#3)
to 15 mM##2##3##(1990-5#1)(2008-7#1)
to 15 mg##3##3##(1992-8#1)(2008-10#2)
to 15 mug##2##3##(2008-10#2)
to 15 percent of the##2##5##(1992-3#1)(2011-2#1)
to 15 percent of##3##4##(1992-3#1)(1995-12#1)(2011-2#1)
to 15 percent##4##3##(1992-3#1)(1995-12#1)(1997-1#1)(2011-2#1)
to 15 years##6##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)
to 15##72##2##(1990-5#1)(1990-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to 15% for##2##3##(2008-10#1)(2012-2#1)
to 15% of##2##3##(1991-4#1)(1995-8#1)
to 15%##14##2##(1991-4#1)(1991-5#1)(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
to 15-fold##4##2##(1993-6#2)(1995-8#1)(2008-10#1)
to 15-year-old##2##2##(2012-12#2)
to 150##20##2##(1993-1#1)(1995-2#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2011-1#1)
to 1500##6##2##(1991-5#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-7#1)
to 152##3##2##(1996-2#1)(2008-10#1)(2011-2#1)
to 155##2##2##(2008-3#1)(2008-9#1)
to 158##2##2##(1991-6#1)(2008-2#1)
to 16 days##2##3##(2008-10#2)
to 16 h of##2##4##(2008-10#1)(2008-11#1)
to 16 h##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
to 16 weeks after##2##4##(2008-10#2)
to 16 years of age##2##5##(2009-10#1)(2013-1#1)
to 16 years##4##3##(2007-8#1)(2009-10#1)(2010-5#1)(2013-1#1)
to 16##40##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-1#1)(2013-1#4)(2013-8#2)
to 16%##3##2##(1990-6#1)(1993-9#1)(2008-8#1)
to 16-fold##2##2##(1994-11#1)(2008-11#1)
to 160 degrees##2##3##(2008-3#1)(2011-1#1)
to 160##5##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
to 1600##3##2##(2007-12#2)(2008-10#1)
to 167##2##2##(1990-11#1)(2008-7#1)
to 168##4##2##(1992-8#2)(1993-12#1)(2009-5#1)
to 16q12##2##2##(1997-2#2)
to 17 patients##2##3##(1994-1#1)(2013-1#1)
to 17 years old##2##4##(2008-9#1)(2012-12#1)
to 17 years##4##3##(2008-9#1)(2012-12#2)(2012-3#1)
to 17##27##2##(1990-5#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
to 17%##4##2##(1991-11#1)(1993-3#1)(2010-6#1)(2013-1#1)
to 170##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
to 171 m##2##3##(2008-10#2)
to 175##5##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
to 18 days##4##3##(2008-10#3)(2008-11#1)
to 18 degrees C but not at##2##7##(2008-10#2)
to 18 degrees C##5##4##(2008-10#5)
to 18 h##3##3##(1995-11#1)(2008-10#2)
to 18 months##2##3##(2011-2#1)(2013-1#1)
to 18 years##3##3##(2009-7#1)(2011-2#1)(2012-3#1)
to 18##45##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#2)(2008-3#2)(2009-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
to 18%##2##2##(2008-10#1)(2011-2#1)
to 180 days##2##3##(1990-12#1)(2008-10#1)
to 180##7##2##(1990-12#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
to 1800 degrees C##2##4##(2008-2#2)
to 1800##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
to 183##2##2##(2007-8#1)(2008-10#1)
to 185##2##2##(2008-6#1)(2008-9#1)
to 188##2##2##(1995-12#1)(2012-12#1)
to 19 days##2##3##(2007-8#1)(2008-12#1)
to 19 m/s##2##3##(1993-3#2)
to 19 years##4##3##(2008-1#2)(2008-11#1)(2011-1#1)
to 19##27##2##(1993-3#2)(1995-2#1)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to 19%##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
to 190##2##2##(1992-12#1)(2008-10#1)
to 192##2##2##(2007-10#1)(2012-2#1)
to 195##3##2##(2008-3#1)(2010-4#1)(2010-6#1)
to 1981##2##2##(1991-9#1)(1994-1#1)
to 1985##4##2##(1990-2#1)(1992-10#1)(1992-9#1)(1994-7#1)
to 1986##2##2##(1991-2#1)(2008-10#1)
to 1987##7##2##(1991-2#1)(1991-4#1)(1992-1#2)(1992-5#1)(1994-2#1)(1995-9#1)
to 1988 were##2##3##(1990-3#1)(1993-12#1)
to 1988##9##2##(1990-12#3)(1990-3#1)(1990-5#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-6#1)
to 1989 to##2##3##(1996-1#1)(2008-10#1)
to 1989##15##2##(1991-12#1)(1991-5#1)(1991-9#2)(1992-11#1)(1993-8#1)(1994-3#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-10#2)
to 1990##8##2##(1991-12#2)(1993-3#1)(1994-2#1)(1996-4#1)(1997-8#1)(2008-1#1)(2008-10#1)
to 1991##8##2##(1993-2#1)(1993-9#1)(1994-3#1)(2008-10#3)(2008-5#1)(2012-12#1)
to 1992##13##2##(1993-12#2)(1993-6#1)(1995-2#1)(1995-3#3)(1996-1#2)(1996-3#1)(1996-5#1)(2008-10#2)
to 1993##13##2##(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-6#3)(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
to 1994##9##2##(1995-11#1)(1995-12#1)(1997-1#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-7#1)
to 1995 and##2##3##(2008-10#2)
to 1995##13##2##(1997-3#2)(1997-6#1)(1997-8#1)(2008-10#8)(2008-6#1)
to 1995)##3##2##(1996-6#1)(1997-3#1)(2008-10#1)
to 1996 and##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
to 1996##27##2##(1994-1#1)(1996-11#3)(1996-9#1)(1997-6#3)(2008-10#14)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)
to 1997 were##2##3##(2008-10#2)
to 1997##20##2##(2007-12#1)(2008-1#1)(2008-10#17)(2008-5#1)
to 1998 were##2##3##(2008-9#1)(2011-2#1)
to 1998##26##2##(2007-12#6)(2008-1#2)(2008-10#12)(2008-11#1)(2008-9#2)(2011-1#2)(2011-2#1)
to 1998)##2##2##(2008-10#2)
to 1999 and##3##3##(2008-10#3)
to 1999 were##3##3##(2008-10#2)(2008-9#1)
to 1999##22##2##(2007-12#2)(2008-1#1)(2008-10#16)(2008-9#2)(2012-2#1)
to 1x10(-1)moldm(-3) and -58##2##4##(2008-10#2)
to 1x10(-1)moldm(-3) and##5##3##(2008-10#5)
to 1x10(-2) M##3##3##(2008-10#3)
to 1x10(-2)##4##2##(2008-10#4)
to 1x10(-3)##2##2##(2008-10#2)
to 1x10(-3)M with slopes of##2##5##(2008-10#2)
to 1x10(-5) g ml(-1) for##2##5##(2008-10#2)
to 1x10(-5)##7##2##(2008-10#7)
to 1x10(-6)molL(-1)##2##2##(2008-10#2)
to 2 ATA oxygen##2##4##(1993-12#2)
to 2 and##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
to 2 h after##2##4##(1991-2#1)(2008-10#1)
to 2 h##4##3##(1991-2#1)(2008-10#3)
to 2 hours##5##3##(1993-8#1)(1994-3#2)(2007-8#1)(2012-12#1)
to 2 mg l(-1)##2##4##(2008-10#2)
to 2 months after##2##4##(1996-12#1)(2007-10#1)
to 2 months##6##3##(1996-12#2)(2007-10#1)(2008-10#1)(2012-12#1)(2012-3#1)
to 2 mum##2##3##(1993-2#1)(2007-11#1)
to 2 weeks##4##3##(1990-12#1)(2008-10#2)(2013-1#1)
to 2 x##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
to 2 years##6##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)
to 2##251##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#3)(1991-11#1)(1991-2#2)(1991-5#2)(1992-12#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#3)(1996-12#3)(1996-2#4)(1996-5#3)(1996-7#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#90)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#9)(2008-5#4)(2008-7#6)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#6)
to 2%##8##2##(1993-8#1)(1995-2#1)(2008-10#4)(2008-5#1)(2009-3#1)
to 2-4##2##2##(2008-4#1)(2010-12#1)
to 2-5A-dependent##2##2##(1990-2#2)
to 2-cm##2##2##(2008-10#1)(2008-5#1)
to 2-phosphoenolpyruvate##2##2##(1990-5#2)
to 2-year##2##2##(2007-8#1)(2008-9#1)
to 20 and##2##3##(2008-10#1)(2008-3#1)
to 20 days##4##3##(1991-8#1)(2008-1#1)(2008-10#2)
to 20 degrees C##3##4##(2007-8#1)(2008-10#2)
to 20 degrees C)##2##4##(2008-10#2)
to 20 degrees##6##3##(2007-8#1)(2008-10#4)(2013-1#1)
to 20 mM##2##3##(1991-12#1)(2011-2#1)
to 20 mg##2##3##(1991-2#1)(2008-10#1)
to 20 minutes##2##3##(2008-10#1)(2013-8#1)
to 20 muM##2##3##(2008-10#1)(2008-11#1)
to 20 samples##2##3##(2008-10#2)
to 20 times##2##3##(2008-10#1)(2008-6#1)
to 20 weeks##2##3##(2008-9#1)(2011-2#1)
to 20 years##3##3##(1991-12#1)(1993-2#1)(1996-5#1)
to 20##79##2##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
to 20% of all##2##4##(2009-6#1)(2013-1#1)
to 20% of##7##3##(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-1#1)(2013-1#1)
to 20%##24##2##(1997-3#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#2)
to 20%)##2##2##(1992-9#1)(2008-10#1)
to 20-30%##2##2##(1994-5#1)(2008-12#1)
to 20-fold##2##2##(1991-9#1)(1992-9#1)
to 20/100 in##2##3##(2010-9#1)(2011-1#1)
to 20/100##3##2##(2010-10#1)(2010-9#1)(2011-1#1)
to 200##31##2##(1990-2#1)(1990-8#1)(1992-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)
to 200-fold##4##2##(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)
to 2000 and##2##3##(2007-12#1)(2008-10#1)
to 2000 mg##2##3##(2008-10#1)(2008-5#1)
to 2000 were##2##3##(2008-10#2)
to 2000##31##2##(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#19)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
to 2001##16##2##(2006-10#1)(2007-11#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#6)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
to 2002##8##2##(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)
to 2003##11##2##(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)
to 2004 was##2##3##(2008-3#1)(2008-7#1)
to 2004##13##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
to 2004)##3##2##(2008-10#3)
to 2005##18##2##(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#3)(2011-2#2)
to 2006 in##2##3##(2009-3#1)(2012-12#1)
to 2006##9##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
to 2006)##2##2##(2008-11#1)(2011-2#1)
to 2007 were##2##3##(2009-5#1)(2011-2#1)
to 2007##15##2##(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2013-1#1)(2013-8#1)
to 2008##17##2##(2009-2#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#2)
to 2009##17##2##(2011-2#4)(2011-9#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#1)
to 2009)##2##2##(2012-2#1)(2012-5#1)
to 2009]##2##2##(2012-2#1)(2012-3#1)
to 200muM##3##2##(2008-10#3)
to 2010 and##2##3##(2013-1#2)
to 2010 showed that##2##4##(2012-3#2)
to 2010 were##2##3##(2012-3#2)
to 2010##15##2##(2011-7#2)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#4)(2013-8#2)
to 2010]##2##2##(2012-3#2)
to 2011##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
to 2012##2##2##(2013-1#1)(2013-8#1)
to 21 after##2##3##(1993-11#1)(2008-10#1)
to 21 days old)##2##4##(2008-10#1)(2010-4#1)
to 21 days##5##3##(2007-10#1)(2008-10#3)(2010-4#1)
to 21 degrees C##3##4##(2008-10#2)(2008-5#1)
to 21##27##2##(1991-12#1)(1993-11#1)(1994-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-5#3)(2008-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
to 21%##2##2##(2007-5#1)(2008-10#1)
to 21-day##2##2##(2008-10#2)
to 21-hydroxylase##3##2##(1992-8#1)(2008-1#1)(2010-2#1)
to 210 +/-##2##3##(2008-10#2)
to 210##5##2##(1991-3#1)(2008-10#3)(2008-2#1)
to 22 degrees C##5##4##(2008-10#4)(2008-11#1)
to 22##16##2##(1991-8#2)(1991-9#1)(1994-3#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2012-12#2)
to 22%##4##2##(2008-10#3)(2008-11#1)
to 220##2##2##(1995-3#1)(2010-4#1)
to 225##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
to 23##12##2##(1992-3#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2013-8#1)
to 23%##3##2##(1995-8#1)(1996-3#1)(2010-6#1)
to 230##4##2##(1997-6#1)(2007-12#1)(2008-10#2)
to 2300##2##2##(2008-10#1)(2010-8#1)
to 24 degrees C##3##4##(2008-10#2)(2008-5#1)
to 24 h after##2##4##(1995-5#1)(2008-10#1)
to 24 h of##2##4##(2008-10#2)
to 24 h##12##3##(1993-5#1)(1995-5#1)(2008-10#8)(2008-7#1)(2011-2#1)
to 24 h)##2##3##(2008-10#1)(2009-3#1)
to 24 hours of##2##4##(2011-1#2)
to 24 hours##6##3##(2007-10#3)(2008-7#1)(2011-1#2)
to 24 months##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
to 24 weeks##2##3##(2008-10#1)(2010-4#1)
to 24##47##2##(1993-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#1)(2007-10#3)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-8#1)
to 24% of the##2##4##(1990-2#1)(2008-10#1)
to 24% of##3##3##(1990-2#1)(1994-3#1)(2008-10#1)
to 24%##5##2##(1990-2#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)
to 24-h##4##2##(1995-11#1)(2008-10#2)(2011-2#1)
to 24-hour##2##2##(1990-11#1)(1991-12#1)
to 240##5##2##(1992-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)
to 241##2##2##(2008-10#1)(2010-6#1)
to 25 days of##3##4##(2007-6#1)(2008-10#2)
to 25 days##4##3##(2007-6#1)(2008-10#2)(2008-7#1)
to 25 degrees C and##2##5##(2008-10#2)
to 25 degrees C for##2##5##(2008-10#2)
to 25 degrees C##15##4##(2008-10#15)
to 25 degrees##16##3##(2008-10#16)
to 25 in##2##3##(2008-10#1)(2009-8#1)
to 25 months##2##3##(1991-8#1)(1997-5#1)
to 25 mug##2##3##(2008-10#1)(2008-11#1)
to 25##57##2##(1991-5#1)(1991-8#1)(1993-1#1)(1993-8#1)(1995-3#1)(1996-5#1)(1997-5#1)(2007-11#2)(2007-6#1)(2008-10#28)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-8#1)(2012-12#1)(2013-8#1)
to 25% of##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
to 25% strain##2##3##(2010-4#2)
to 25%##15##2##(1995-12#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-7#1)(2013-1#1)
to 250##10##2##(1990-2#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-5#1)
to 2500 nm##3##3##(2008-2#2)(2008-3#1)
to 2500##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
to 25nM##2##2##(2008-10#2)
to 26##20##2##(1994-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
to 26% of##2##3##(1996-1#1)(2007-12#1)
to 26%##9##2##(1990-11#1)(1994-12#2)(1996-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to 27 days##2##3##(2008-10#2)
to 27##19##2##(1992-1#2)(1993-12#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
to 27%##2##2##(2008-10#1)(2008-5#1)
to 28 days##4##3##(2007-10#3)(2010-11#1)
to 28 degrees C for##2##5##(2008-10#2)
to 28 degrees C##7##4##(2008-10#6)(2011-2#1)
to 28##33##2##(1993-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-10#3)(2007-8#1)(2008-1#2)(2008-10#10)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
to 28% of the##2##4##(2008-10#1)(2008-11#1)
to 28%##5##2##(1993-9#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-11#1)
to 280##5##2##(2007-12#2)(2008-10#1)(2008-2#2)
to 280-nm light##3##3##(1995-5#3)
to 280-nm##4##2##(1995-5#4)
to 29 in##2##3##(1993-6#1)(1997-4#1)
to 29 mgxl(-1)##2##3##(2008-5#2)
to 29##8##2##(1993-12#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)
to 29%##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
to 2mugL(-1)##2##2##(2008-10#2)
to 2x10(-3) M for##3##4##(2008-10#3)
to 3 and##2##3##(2008-10#2)
to 3 days in##3##4##(2007-10#2)(2008-10#1)
to 3 days##12##3##(1991-6#1)(2007-10#2)(2008-10#6)(2008-11#1)(2008-7#2)
to 3 mM##2##3##(2008-10#1)(2011-2#1)
to 3 mm##2##3##(2007-7#1)(2012-3#1)
to 3 months##2##3##(2007-2#1)(2008-10#1)
to 3 orders of magnitude##2##5##(2008-2#1)(2008-3#1)
to 3 weeks##5##3##(1997-6#1)(2008-10#2)(2009-5#1)(2012-12#1)
to 3 x 10(7)##2##4##(2008-10#1)(2008-11#1)
to 3 x##3##3##(2008-10#2)(2008-11#1)
to 3 years##5##3##(1991-8#2)(1997-8#1)(2010-4#1)(2013-1#1)
to 3##179##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#5)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-7#1)(2008-10#60)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
to 3% of control##2##4##(1994-8#1)(1994-9#1)
to 3% of##5##3##(1990-7#1)(1992-5#1)(1994-8#1)(1994-9#1)(2010-3#1)
to 3%##11##2##(1990-7#1)(1992-5#1)(1994-8#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
to 3' end##3##3##(2008-10#1)(2008-8#2)
to 3'##4##2##(2008-10#1)(2008-11#1)(2008-8#2)
to 3)##3##2##(1990-12#1)(1992-4#1)(2008-10#1)
to 3-fold##5##2##(1990-12#1)(1993-6#1)(1994-11#1)(1995-2#1)(2008-11#1)
to 3-fold)##2##2##(1994-5#1)(1995-11#1)
to 3-pentadecylcatechol##2##2##(2008-10#2)
to 30 days##6##3##(1990-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
to 30 degrees C and##2##5##(2008-10#2)
to 30 degrees C##9##4##(2008-10#9)
to 30 degrees##11##3##(2007-8#1)(2008-10#9)(2008-3#1)
to 30 km##2##3##(2008-2#1)(2008-3#1)
to 30 mM##3##3##(1995-2#1)(1997-1#1)(2007-11#1)
to 30 mg##4##3##(2006-10#1)(2008-10#3)
to 30 min##8##3##(1990-12#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#3)(2013-1#1)
to 30 min)##3##3##(1990-8#1)(2012-3#2)
to 30 mug l(-1)##2##4##(2008-10#2)
to 30 mul##2##3##(2008-10#2)
to 30 nm##2##3##(2008-10#1)(2009-5#1)
to 30 s##2##3##(2008-10#1)(2008-7#1)
to 30 times higher##2##4##(1993-8#1)(1995-8#1)
to 30 times##3##3##(1993-8#1)(1995-8#1)(2008-1#1)
to 30 years##6##3##(1996-4#2)(1997-8#1)(2007-11#1)(2010-8#1)(2012-12#1)
to 30##108##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#2)(1997-4#1)(1997-8#3)(2006-10#3)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#41)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2009-5#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
to 30% in##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
to 30% of the##6##4##(1991-5#1)(1994-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
to 30% of##12##3##(1991-5#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
to 30%##25##2##(1991-5#1)(1994-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
to 300 degrees C##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
to 300 nM##2##3##(1994-11#1)(2008-8#1)
to 300##13##2##(1990-12#1)(1992-11#1)(1994-11#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
to 31 degrees C##2##4##(2008-10#1)(2008-11#1)
to 31##16##2##(1990-12#1)(1994-3#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2013-8#1)
to 31%##3##2##(1993-3#1)(2007-12#1)(2013-1#1)
to 310##2##2##(2008-10#1)(2008-3#1)
to 32 degrees C##9##4##(1991-2#1)(1997-7#1)(2008-10#5)(2008-11#2)
to 32 samples##2##3##(2008-10#2)
to 32##30##2##(1991-2#1)(1993-11#1)(1993-3#1)(1995-6#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)
to 32%##5##2##(2008-10#5)
to 33##10##2##(1994-11#1)(1996-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
to 33% of##2##3##(2008-10#1)(2010-12#1)
to 33%##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
to 334 AA##2##3##(2008-8#2)
to 34##13##2##(1992-9#2)(1994-6#1)(1994-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
to 34%##3##2##(2007-7#1)(2008-10#1)(2010-8#1)
to 340##2##2##(1996-12#1)(2008-10#1)
to 35 degrees C##4##4##(2008-10#4)
to 35 degrees C)##2##4##(2008-10#2)
to 35 degrees##6##3##(2008-10#6)
to 35##28##2##(1991-3#1)(1993-8#1)(1994-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#11)(2008-5#2)(2009-3#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#4)
to 35% of##2##3##(1990-5#1)(2008-10#1)
to 35%##7##2##(1990-5#1)(1996-5#1)(2008-10#3)(2009-7#1)(2012-2#1)
to 350##7##2##(1990-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-2#1)
to 36 h##2##3##(2008-10#1)(2008-11#1)
to 36 mg##2##3##(2008-10#1)(2008-2#1)
to 36 months##2##3##(1990-6#1)(2011-2#1)
to 36##21##2##(1990-6#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2011-2#3)(2013-1#1)
to 36%##4##2##(2008-10#3)(2008-7#1)
to 360##4##2##(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#1)
to 365##2##2##(1990-12#1)(1995-6#1)
to 366 mOsmol kg-1##3##4##(2008-11#3)
to 366 mOsmol##4##3##(2008-11#4)
to 366##6##2##(1992-10#1)(2008-11#4)(2008-7#1)
to 37 degrees C##9##4##(1993-9#2)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#1)
to 37 degrees##10##3##(1993-9#2)(1996-12#1)(2008-10#4)(2008-11#2)(2008-4#1)
to 37##26##2##(1993-12#1)(1993-8#1)(1993-9#2)(1996-12#1)(1997-6#1)(2007-6#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
to 37%##4##2##(1991-11#1)(2008-11#1)(2008-4#1)(2013-8#1)
to 3700##2##2##(1991-12#1)(2007-11#1)
to 38##10##2##(1990-11#1)(1993-12#1)(1996-2#1)(2007-8#1)(2008-10#4)(2009-7#1)(2013-8#1)
to 38% for##2##3##(1997-2#1)(2007-7#1)
to 38% in##2##3##(2008-10#1)(2013-1#1)
to 38%##6##2##(1997-2#1)(2007-7#1)(2008-10#3)(2013-1#1)
to 380##3##2##(1997-4#2)(2008-10#1)
to 39 degrees##2##3##(2007-12#1)(2008-10#1)
to 39##16##2##(1991-9#1)(1992-9#1)(1993-12#1)(1994-9#1)(2007-12#3)(2007-5#1)(2008-10#5)(2008-5#1)(2012-12#1)(2012-2#1)
to 39%##2##2##(1991-3#1)(2008-10#1)
to 3D##5##2##(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#1)
to 4 days after##2##4##(2008-10#1)(2009-3#1)
to 4 days##6##3##(2008-10#4)(2008-11#1)(2009-3#1)
to 4 groups##2##3##(2008-12#1)(2013-1#1)
to 4 h##3##3##(1993-3#1)(1994-8#1)(1997-2#1)
to 4 mm##2##3##(1996-6#1)(2008-7#1)
to 4 months after##4##4##(2008-1#1)(2010-5#1)(2013-1#2)
to 4 months##9##3##(1991-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-5#1)(2013-1#2)
to 4 patients##2##3##(1993-9#1)(2009-8#1)
to 4 times##2##3##(1992-3#1)(1993-9#1)
to 4 weeks##10##3##(2008-10#7)(2008-11#1)(2008-5#1)(2010-9#1)
to 4 years##6##3##(1996-11#1)(2007-11#2)(2008-10#1)(2008-9#1)(2011-2#1)
to 4##158##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#4)(1995-5#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#46)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#7)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#2)
to 4% and##2##3##(2008-3#1)(2008-9#1)
to 4%##9##2##(1990-6#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)(2012-3#1)
to 4)##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
to 4-fold##2##2##(1990-10#1)(1992-9#1)
to 4-fold)##2##2##(1993-1#1)(1993-11#1)
to 40 degrees C##3##4##(1994-12#1)(2008-10#1)(2011-2#1)
to 40 mg daily##2##4##(1994-3#1)(2008-1#1)
to 40 microM paraoxon##2##4##(1996-12#2)
to 40 nm##2##3##(2008-2#1)(2009-7#1)
to 40 percent##3##3##(1995-1#1)(2008-11#1)(2008-3#1)
to 40 years##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
to 40##50##2##(1992-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#3)(2011-2#2)(2012-2#1)(2013-1#2)
to 40% in##4##3##(1995-1#1)(2008-10#2)(2008-2#1)
to 40% of the##2##4##(2008-7#2)
to 40% of##6##3##(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)
to 40%##24##2##(1992-3#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-8#1)
to 400 ng##2##3##(1990-8#1)(2008-10#1)
to 400 nm##3##3##(2008-10#2)(2008-5#1)
to 400##19##2##(1990-8#1)(1992-8#1)(1994-3#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2012-2#1)
to 41##9##2##(1997-1#1)(2008-1#2)(2008-10#3)(2011-1#1)(2011-2#1)(2012-3#1)
to 41%##4##2##(1995-2#1)(2008-10#2)(2009-12#1)
to 410##2##2##(2008-10#1)(2009-11#1)
to 42 additional##2##3##(2008-10#1)(2008-5#1)
to 42 degrees##2##3##(2008-10#2)
to 42##20##2##(1990-3#1)(1991-9#1)(1994-9#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2010-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
to 42%##2##2##(2008-10#2)
to 43##6##2##(1991-3#1)(1991-8#1)(1995-12#1)(2008-1#1)(2008-3#1)(2012-3#1)
to 43%##4##2##(1993-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
to 44##6##2##(1995-3#1)(2008-10#4)(2013-1#1)
to 44%##2##2##(2007-10#1)(2008-10#1)
to 440##2##2##(2008-10#1)(2008-11#1)
to 45 degrees C##3##4##(2008-10#2)(2008-6#1)
to 45 nm in diameter##2##5##(1994-3#1)(2008-10#1)
to 45 years##4##3##(1991-5#1)(1997-4#1)(2012-2#1)(2013-1#1)
to 45##22##2##(1991-5#1)(1994-3#1)(1997-4#1)(2008-10#9)(2008-5#1)(2008-6#2)(2008-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
to 45%##5##2##(2008-10#2)(2008-9#1)(2012-3#2)
to 450 nm##2##3##(2008-10#1)(2008-3#1)
to 450##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
to 46##7##2##(1991-5#1)(1997-2#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#1)
to 47##8##2##(1995-1#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
to 47% of##2##3##(1992-6#1)(1993-8#1)
to 47%##5##2##(1992-6#1)(1993-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
to 48 degrees C##3##4##(1995-8#1)(2008-3#1)(2011-2#1)
to 48 degrees##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
to 48 h after##2##4##(2008-10#2)
to 48 h of##2##4##(2008-10#2)
to 48 h##8##3##(2008-10#8)
to 48 hours##4##3##(1992-4#1)(1993-12#1)(1994-6#1)(2010-12#1)
to 48##32##2##(1991-5#1)(1992-4#1)(1993-12#2)(1994-6#1)(1995-8#1)(1996-5#2)(2007-11#1)(2008-1#1)(2008-10#14)(2008-3#2)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
to 48%##3##2##(2008-10#1)(2013-1#1)(2013-7#1)
to 48-fold##2##2##(1995-11#2)
to 482##2##2##(1997-4#1)(2008-3#1)
to 49 years##2##3##(1995-9#1)(2010-3#1)
to 49##5##2##(1992-9#1)(1995-9#1)(2008-7#1)(2010-3#1)(2012-8#1)
to 49%##6##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
to 495 nm##2##3##(2008-10#1)(2008-3#1)
to 495##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
to 5 cm##4##3##(1992-5#1)(2013-1#2)(2013-8#1)
to 5 days##5##3##(1991-5#1)(2007-6#1)(2008-10#3)
to 5 degrees C##3##4##(2008-10#1)(2011-2#2)
to 5 km##2##3##(2008-2#1)(2008-3#1)
to 5 mg##2##3##(2008-3#1)(2012-12#1)
to 5 ml##2##3##(2008-10#2)
to 5 mm##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
to 5 months##3##3##(2008-10#1)(2013-1#2)
to 5 ng/ml##2##3##(1990-12#1)(2008-10#1)
to 5 nm##2##3##(2008-10#1)(2008-7#1)
to 5 weeks##6##3##(1994-2#1)(2008-10#4)(2011-2#1)
to 5 x##5##3##(1990-2#1)(2008-10#3)(2008-3#1)
to 5 years postoperatively##2##4##(2012-12#1)(2013-1#1)
to 5 years##8##3##(1991-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2012-12#3)(2013-1#1)
to 5##191##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-8#5)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#77)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2010-1#2)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
to 5% of the##2##4##(2008-10#2)
to 5% of##7##3##(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)
to 5%##20##2##(1991-2#1)(1994-6#1)(1996-1#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-4#1)
to 5%)##4##2##(1995-3#1)(2008-10#1)(2008-6#1)(2012-3#1)
to 5)##2##2##(1991-5#1)(2010-6#1)
to 5-HT##4##2##(1994-2#1)(1995-12#1)(1996-12#1)(2008-2#1)
to 5-fluorouracil##2##2##(1990-12#1)(1993-1#1)
to 5-fold##5##2##(1990-12#1)(1990-5#1)(1993-9#1)(1994-6#1)(2010-1#1)
to 5-methyltryptophan##3##2##(1994-6#3)
to 50 and##3##3##(2008-10#2)(2008-5#1)
to 50 days##2##3##(2008-10#2)
to 50 degrees C and##2##5##(1990-2#1)(2008-10#1)
to 50 degrees C for##2##5##(2008-10#1)(2008-7#1)
to 50 degrees C##10##4##(1990-2#1)(1991-5#1)(2008-10#4)(2008-3#1)(2008-6#2)(2008-7#1)
to 50 degrees##11##3##(1990-2#1)(1991-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)
to 50 mg##4##3##(1990-11#1)(1997-7#1)(2008-5#2)
to 50 muM##4##3##(2008-10#4)
to 50 nM##2##3##(1990-2#1)(2008-10#1)
to 50 ng##2##3##(2008-10#1)(2009-6#1)
to 50##76##2##(1990-11#1)(1990-2#4)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#4)(2008-7#3)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-2#1)
to 50% in##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
to 50% of plants##2##4##(2008-10#2)
to 50% of the##3##4##(1991-12#1)(2007-10#1)(2008-10#1)
to 50% of##14##3##(1991-12#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2013-8#2)
to 50%##40##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#3)(2012-12#2)(2013-8#3)
to 50-fold##2##2##(1990-5#1)(1993-3#1)
to 500 mg##3##3##(2008-10#2)(2008-11#1)
to 500 microM##2##3##(1994-11#1)(1995-11#1)
to 500 nm##2##3##(2008-10#1)(2008-2#1)
to 500##25##2##(1990-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-2#1)
to 500mg##2##2##(1995-3#1)(2008-3#1)
to 500ngml(-1) of##2##3##(2008-10#2)
to 500ngml(-1)##3##2##(2008-10#3)
to 501##2##2##(1993-2#1)(2011-2#1)
to 51##3##2##(1990-5#1)(1990-9#1)(1994-8#1)
to 51%##2##2##(1994-6#1)(2008-10#1)
to 52##4##2##(1990-10#1)(2006-8#1)(2008-10#2)
to 52% for##2##3##(2008-3#1)(2010-6#1)
to 52%##6##2##(1993-8#1)(2008-10#1)(2008-3#2)(2010-6#1)(2012-1#1)
to 53##3##2##(1990-12#1)(1995-6#1)(2008-10#1)
to 53%##7##2##(1994-1#1)(2008-10#4)(2010-3#1)(2011-1#1)
to 530##2##2##(2007-12#1)(2008-10#1)
to 54##12##2##(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
to 54%##2##2##(2008-8#1)(2010-8#1)
to 55 degrees C##3##4##(2008-10#3)
to 55 degrees##5##3##(2007-8#1)(2008-10#3)(2008-9#1)
to 55 years##2##3##(1991-5#2)
to 55##14##2##(1991-5#2)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
to 55%##2##2##(1993-6#1)(2008-10#1)
to 55%)##2##2##(2008-10#1)(2011-2#1)
to 55-75%##2##2##(2010-10#1)(2010-3#1)
to 550##6##2##(1993-1#1)(2008-10#2)(2008-3#2)(2012-12#1)
to 56##8##2##(2008-10#4)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
to 56%##4##2##(2008-10#3)(2013-1#1)
to 567##2##2##(1994-9#1)(2007-12#1)
to 57 years##3##3##(1991-4#1)(2008-1#1)(2008-12#1)
to 57##8##2##(1990-12#1)(1991-4#1)(2008-1#3)(2008-12#1)(2008-8#1)(2009-7#1)
to 57%##3##2##(1994-10#1)(2007-12#1)(2008-10#1)
to 570##2##2##(2008-10#1)(2011-2#1)
to 58##3##2##(1996-1#1)(2008-11#1)(2009-8#1)
to 584##2##2##(2008-3#2)
to 59 years##4##3##(1990-6#1)(2007-11#1)(2007-12#1)(2013-1#1)
to 59##6##2##(1990-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2013-1#1)
to 590 nm for##2##4##(2008-2#2)
to 5S rRNA##2##3##(1997-7#2)
to 6 days##7##3##(2008-10#3)(2008-11#4)
to 6 months of##3##4##(2007-10#1)(2008-10#1)(2010-6#1)
to 6 months##10##3##(1992-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-6#1)(2011-2#1)(2013-1#2)
to 6 weeks after##2##4##(1996-8#1)(2008-10#1)
to 6 weeks of##2##4##(2008-10#1)(2008-9#1)
to 6 weeks postbloom##3##4##(2008-10#3)
to 6 weeks##15##3##(1996-5#1)(1996-6#1)(1996-8#1)(2007-7#2)(2008-10#7)(2008-5#1)(2008-9#1)(2013-1#1)
to 6 x##2##3##(1990-12#1)(2008-10#1)
to 6 years##4##3##(1996-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
to 6##129##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-10#43)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
to 6% of the##2##4##(1990-3#1)(2008-10#1)
to 6% of##3##3##(1990-3#1)(2008-10#1)(2010-5#1)
to 6%##6##2##(1990-3#1)(2008-10#2)(2010-5#1)(2012-3#1)(2013-7#1)
to 6)##3##2##(1990-11#1)(2008-10#1)(2011-2#1)
to 6-8##3##2##(1994-2#1)(1995-5#1)(2007-12#1)
to 6-fold##3##2##(1994-8#1)(1997-4#1)(2011-2#1)
to 60 days##4##3##(1997-5#1)(2006-5#1)(2008-9#1)(2013-1#1)
to 60 degrees C and##3##5##(2008-10#2)(2008-3#1)
to 60 degrees C##7##4##(2008-10#4)(2008-3#1)(2008-6#2)
to 60 degrees##9##3##(2008-10#5)(2008-3#1)(2008-6#2)(2008-9#1)
to 60 min##2##3##(2008-10#1)(2008-3#1)
to 60 minutes twice daily##2##5##(2007-10#2)
to 60 minutes##3##3##(1996-9#1)(2007-10#2)
to 60 months##2##3##(2008-12#2)
to 60 to##2##3##(1993-1#1)(2007-11#1)
to 60 years##6##3##(1990-3#1)(1997-4#1)(2008-1#1)(2008-8#1)(2010-7#1)(2013-1#1)
to 60##58##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-1#2)(1995-3#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-7#1)(2012-2#1)(2013-1#3)
to 60% of the##5##4##(1994-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2009-10#1)
to 60% of##8##3##(1994-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)
to 60%##23##2##(1990-6#1)(1992-12#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
to 600 mg##2##3##(2008-10#1)(2008-9#1)
to 600 nm##2##3##(1994-5#1)(2008-10#1)
to 600 s##2##3##(1991-2#1)(1996-7#1)
to 600##14##2##(1991-2#1)(1994-5#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-10#6)(2008-3#2)(2008-9#1)
to 6000##3##2##(2008-3#3)
to 61##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
to 61%##3##2##(1995-11#1)(2009-4#1)(2013-8#1)
to 62##6##2##(1993-3#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
to 62%##2##2##(1996-10#1)(2008-4#1)
to 63##8##2##(1991-7#1)(1995-5#1)(2007-7#1)(2008-10#4)(2011-2#1)
to 64##11##2##(1992-12#1)(1994-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
to 64%##2##2##(1993-3#1)(2008-10#1)
to 65 deg##2##3##(2008-3#2)
to 65##21##2##(1990-5#1)(1991-11#2)(1991-5#1)(1992-6#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
to 65% of##3##3##(1993-11#1)(1994-5#1)(2008-10#1)
to 65%##9##2##(1990-3#1)(1993-11#1)(1993-12#1)(1994-5#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
to 650##2##2##(2008-10#2)
to 66##7##2##(1990-6#1)(1996-1#1)(2008-1#1)(2008-10#4)
to 66%##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
to 67##4##2##(1992-3#1)(1997-6#1)(2008-10#2)
to 67% for##2##3##(1995-3#1)(2008-11#1)
to 67%##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
to 67%)##3##2##(1994-8#1)(2008-10#2)
to 68##7##2##(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
to 68%##4##2##(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
to 69 years##4##3##(1996-2#1)(2007-11#1)(2012-12#2)
to 69##9##2##(1990-8#1)(1993-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-8#1)
to 69%##2##2##(2007-10#1)(2008-10#1)
to 6th##2##2##(2010-5#1)(2011-2#1)
to 7 days##9##3##(1997-4#2)(1997-5#1)(2007-10#2)(2008-10#2)(2008-7#1)(2009-5#1)
to 7 months##2##3##(1991-4#1)(2008-10#1)
to 7 weeks##5##3##(1997-6#1)(2008-10#3)(2013-1#1)
to 7 years##2##3##(1996-11#1)(1996-5#1)
to 7##94##2##(1990-11#1)(1990-3#1)(1991-4#1)(1992-10#2)(1992-8#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(2006-10#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#31)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
to 7% of##2##3##(2008-10#1)(2010-1#1)
to 7%##8##2##(1994-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)(2010-4#1)(2012-12#1)
to 70 degrees C##3##4##(2008-10#2)(2008-3#1)
to 70 degrees##4##3##(2008-10#2)(2008-3#1)(2008-6#1)
to 70 percent##2##3##(1994-3#1)(1995-3#1)
to 70##14##2##(1991-4#1)(1992-9#1)(1994-3#1)(1995-3#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
to 70% of the##2##4##(2008-10#2)
to 70% of##8##3##(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2013-8#2)
to 70%##18##2##(1991-4#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#2)
to 70)##2##2##(1990-3#1)(2008-1#1)
to 700 K##2##3##(2008-10#2)
to 700 nm##2##3##(2008-2#1)(2008-3#1)
to 700##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
to 71##4##2##(1990-5#1)(2008-1#1)(2008-11#1)(2009-3#1)
to 71%##3##2##(1996-5#1)(2008-10#1)(2011-1#1)
to 72 h after##4##4##(2008-10#4)
to 72 h##5##3##(2008-10#5)
to 72 hours##4##3##(1990-6#1)(1992-2#1)(1993-11#1)(1994-11#1)
to 72##18##2##(1990-6#1)(1992-2#2)(1993-11#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-12#1)(2008-10#8)(2008-3#1)(2010-8#1)
to 72%##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
to 73##6##2##(1992-2#1)(1995-3#1)(2008-10#2)(2008-3#1)(2013-8#1)
to 73%##5##2##(2008-10#4)(2012-3#1)
to 730##2##2##(2008-10#1)(2008-3#1)
to 74 years##2##3##(1991-9#1)(2008-7#1)
to 74##9##2##(1991-9#1)(1993-9#1)(1994-6#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-12#1)
to 74%##4##2##(1996-9#1)(2008-10#2)(2011-2#1)
to 75 degrees C##2##4##(2008-3#1)(2008-6#1)
to 75 microM##2##3##(1993-6#2)
to 75 years##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
to 75##21##2##(1991-6#1)(1992-6#1)(1993-6#2)(1994-7#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to 75%##8##2##(1993-1#1)(2008-10#3)(2010-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
to 75%)##2##2##(2008-10#1)(2013-8#1)
to 750##2##2##(2008-10#1)(2008-3#1)
to 76##7##2##(1991-11#1)(1993-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
to 76%##3##2##(1997-1#1)(2008-10#1)(2008-7#1)
to 77 K##3##3##(2007-12#1)(2010-2#2)
to 77##7##2##(1990-2#1)(2007-12#1)(2008-10#2)(2010-2#2)(2013-1#1)
to 77% in##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to 77%##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
to 78##7##2##(1990-2#1)(1991-12#1)(1992-9#1)(2007-12#1)(2008-10#3)
to 78%##4##2##(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
to 79 years##2##3##(2007-11#1)(2013-1#1)
to 79 yr##2##3##(2008-7#2)
to 79##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)(2013-7#1)
to 79%##2##2##(1990-2#1)(2008-10#1)
to 8 days after inoculation##2##5##(2008-10#2)
to 8 days##4##3##(1997-3#1)(2008-10#3)
to 8 h##4##3##(1992-10#1)(1992-8#1)(1995-11#1)(2008-10#1)
to 8 mM##2##3##(1993-8#1)(1994-11#1)
to 8 weeks of##4##4##(1991-3#1)(1992-11#1)(2008-10#1)(2011-2#1)
to 8 weeks##10##3##(1991-3#1)(1992-11#1)(2008-10#5)(2009-11#1)(2009-5#1)(2011-2#1)
to 8 years##4##3##(2009-6#1)(2009-7#1)(2010-11#1)(2012-12#1)
to 8##97##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
to 8% of##2##3##(2008-6#1)(2013-8#1)
to 8%##9##2##(1991-5#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-8#1)
to 80 degrees C for##2##5##(2008-10#2)
to 80 degrees C##3##4##(2008-10#2)(2008-3#1)
to 80 degrees##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
to 80 min##4##3##(1997-1#1)(2008-11#1)(2008-3#1)(2012-12#1)
to 80 years##4##3##(1996-7#1)(2007-10#1)(2007-11#1)(2008-1#1)
to 80##26##2##(1991-9#1)(1992-11#1)(1992-8#1)(1996-1#1)(1996-7#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#2)(2012-12#1)
to 80% in##2##3##(2008-7#1)(2012-12#1)
to 80% of patients##2##4##(2010-3#1)(2010-4#1)
to 80% of the##5##4##(1994-3#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
to 80% of##12##3##(1994-11#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
to 80%##29##2##(1992-3#1)(1994-11#1)(1994-3#3)(1996-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2010-3#1)(2010-4#1)(2012-12#2)(2013-1#2)(2013-8#1)
to 80%)##3##2##(2008-10#3)
to 800 nm##4##3##(2008-2#3)(2008-3#1)
to 800##14##2##(1990-12#1)(2008-10#3)(2008-2#5)(2008-3#2)(2008-7#1)(2012-12#1)(2012-2#1)
to 800muM##2##2##(2008-10#2)
to 81##7##2##(2007-10#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
to 81%##6##2##(2008-10#2)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#1)
to 82 years##2##3##(1990-6#1)(2011-2#1)
to 82##7##2##(1990-6#1)(1995-3#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
to 82%##2##2##(2007-8#1)(2012-12#1)
to 83 per##2##3##(1990-12#1)(2013-8#1)
to 83##5##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-8#1)
to 83%##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
to 84 years##2##3##(2011-2#1)(2013-1#1)
to 84##9##2##(1990-11#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2011-2#2)(2013-1#1)
to 84%##3##2##(2008-10#3)
to 85##10##2##(1993-2#1)(1996-7#1)(2008-10#2)(2008-11#2)(2008-8#1)(2012-3#1)(2013-1#2)
to 85% in##2##3##(2009-8#1)(2010-5#1)
to 85% relative humidity##3##4##(2008-10#1)(2008-2#2)
to 85%##13##2##(1995-4#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)
to 85%)##2##2##(2008-3#1)(2012-3#1)
to 850 nm##2##3##(2007-12#1)(2008-2#1)
to 850##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)
to 86%##5##2##(2008-10#4)(2008-3#1)
to 860##2##2##(2009-7#1)(2011-7#1)
to 865##2##2##(1991-9#1)(2008-2#1)
to 87 years##2##3##(1997-3#1)(1997-8#1)
to 87##6##2##(1990-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-11#1)(2011-2#1)
to 87%##3##2##(2007-8#1)(2008-10#1)(2009-7#1)
to 88##2##2##(1996-12#1)(2010-4#1)
to 89##8##2##(1990-8#1)(1991-11#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-6#1)(2012-3#1)
to 89%##3##2##(2008-10#2)(2011-2#1)
to 8x10(-5) M##2##3##(2008-10#2)
to 9 days##3##3##(1995-11#1)(2008-10#2)
to 9 months##4##3##(1995-2#1)(2007-8#1)(2011-2#1)(2012-3#1)
to 9 years##4##3##(2007-8#1)(2008-12#1)(2008-4#1)(2012-1#1)
to 9##62##2##(1990-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-6#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
to 9% of##3##3##(1997-2#1)(2010-6#1)(2011-2#1)
to 9%##5##2##(1997-2#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
to 90 days##4##3##(1990-12#1)(1994-6#1)(1997-4#1)(2008-10#1)
to 90 degrees C##2##4##(1990-2#1)(2008-10#1)
to 90 degrees##4##3##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
to 90 h##2##3##(1994-12#1)(2008-10#1)
to 90 min##2##3##(1994-2#1)(2008-11#1)
to 90 nM##2##3##(1990-2#2)
to 90 years##2##3##(1997-6#1)(2008-1#1)
to 90##39##2##(1990-12#1)(1990-2#3)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-6#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
to 90% of patients##2##4##(2008-6#1)(2012-2#1)
to 90% of the##5##4##(1990-9#1)(2008-10#3)(2008-11#1)
to 90% of##10##3##(1990-9#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-2#1)
to 90% with##2##3##(1991-5#1)(1993-6#1)
to 90%##25##2##(1990-3#1)(1990-9#1)(1991-5#1)(1993-6#1)(1994-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
to 900 nm##2##3##(2007-12#1)(2008-3#1)
to 900##9##2##(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)
to 91##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#2)
to 91%##3##2##(2008-10#1)(2008-6#1)(2010-5#1)
to 91%)##2##2##(2008-10#1)(2012-3#1)
to 92 years##2##3##(1994-6#1)(2007-7#1)
to 92##10##2##(1991-11#1)(1993-8#1)(1994-6#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)
to 92% of the##4##4##(1995-8#2)(1996-6#1)(2008-11#1)
to 92%##6##2##(1992-3#1)(1995-8#2)(1996-6#1)(2008-11#1)(2008-6#1)
to 93##7##2##(1993-1#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-11#1)
to 93% of##2##3##(1994-11#1)(2008-10#1)
to 93%##7##2##(1994-11#1)(1996-12#1)(2008-10#3)(2011-2#2)
to 94##9##2##(2007-10#1)(2008-10#4)(2009-9#1)(2010-9#1)(2011-1#2)
to 94%##5##2##(1990-11#1)(2008-10#3)(2008-12#1)
to 95 percent##2##3##(1992-12#1)(1995-3#1)
to 95##10##2##(1991-5#1)(1992-12#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
to 95% and##2##3##(2008-10#2)
to 95% of##2##3##(1993-1#1)(2011-2#1)
to 95% oxygen##2##3##(2008-3#2)
to 95%##12##2##(1990-10#1)(1993-1#1)(1994-3#1)(2008-10#4)(2008-3#2)(2009-8#1)(2011-2#1)(2013-8#1)
to 95%)##2##2##(1994-12#1)(2008-10#1)
to 950##2##2##(2007-7#1)(2010-4#1)
to 96 h##6##3##(2008-10#5)(2008-12#1)
to 96##11##2##(1993-8#1)(2008-10#9)(2008-12#1)
to 96%##6##2##(1994-5#1)(2008-10#4)(2011-1#1)
to 960##2##2##(1997-6#1)(2008-10#1)
to 97 years##2##3##(1993-12#1)(1995-6#1)
to 97##10##2##(1993-12#1)(1995-6#1)(2008-10#4)(2012-3#1)(2013-1#2)(2013-8#1)
to 97% in##2##3##(2008-10#2)
to 97%##6##2##(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#1)
to 98##15##2##(1992-11#2)(2008-10#8)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
to 98% nucleotide identities and##2##5##(2008-10#2)
to 98% of##2##3##(2008-10#2)
to 98%##13##2##(2008-10#11)(2008-6#1)(2008-7#1)
to 988##2##2##(1992-9#1)(2012-1#1)
to 99##16##2##(1997-8#1)(2008-10#11)(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
to 99% for##3##3##(2008-10#3)
to 99% of the##2##4##(2008-10#2)
to 99% of##4##3##(2008-10#4)
to 99%##11##2##(2008-10#10)(2009-6#1)
to 99%)##3##2##(2008-10#2)(2012-3#1)
to ?0##2##2##(2008-2#1)(2008-3#1)
to A beta##6##3##(1994-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)
to A##27##2##(1990-8#1)(1992-8#1)(1994-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#13)(2008-4#1)(2008-8#1)(2011-2#1)
to A506##2##2##(2008-10#2)
to AA##3##2##(1991-8#1)(1992-12#1)(2008-10#1)
to ABA##2##2##(2009-8#2)
to ACh##2##2##(2009-12#1)(2012-3#1)
to AChE##3##2##(1992-12#1)(1994-5#2)
to AD##3##2##(2008-7#1)(2009-10#1)(2009-11#1)
to ADP##7##2##(1990-11#2)(1991-8#1)(2008-4#1)(2008-7#1)(2013-1#2)
to ADR##2##2##(1990-2#1)(2008-11#1)
to AG-6##2##2##(2008-10#2)
to AH##2##2##(1993-8#1)(2009-7#1)
to AI-2##3##2##(2008-9#3)
to AIDS##18##2##(1990-11#1)(1990-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-9#1)(1997-3#1)(1997-6#2)(2008-12#1)(2009-7#1)(2010-8#2)(2012-2#2)
to ALL-1##2##2##(1997-7#2)
to AMP##3##2##(2008-4#2)(2009-2#1)
to ANN##2##2##(2008-10#2)
to ANP##2##2##(1990-12#1)(1992-3#1)
to ASA##2##2##(2008-10#1)(2010-7#1)
to AT(1) receptor##2##3##(2008-9#2)
to AT1##2##2##(1991-9#1)(1994-9#1)
to AT2##3##2##(1991-12#1)(1991-9#1)(1995-12#1)
to ATP##13##2##(1990-5#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#2)(1997-8#1)(2008-4#3)(2008-5#1)(2008-7#1)
to Absorption##2##2##(2008-3#2)
to AcNPV##2##2##(1997-3#1)(1997-4#1)
to Adult##2##2##(2009-11#1)(2011-2#1)
to Aflatoxin Contamination by Aspergillus flavus##2##6##(2008-10#2)
to Aflatoxin##3##2##(2008-10#3)
to Africa##3##2##(2007-2#2)(2008-10#1)
to African##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
to African-American hair##3##3##(2008-5#3)
to African-American##4##2##(2008-11#1)(2008-5#3)
to Ag##2##2##(1991-5#1)(2013-1#1)
to Al##6##2##(2008-10#3)(2013-8#3)
to Ala##3##2##(1992-3#1)(1995-2#1)(1995-6#1)
to Alternaria##2##2##(2008-10#2)
to Alzheimer's disease##3##3##(1992-12#1)(2008-7#1)(2013-8#1)
to America##2##2##(1993-6#1)(2008-11#1)
to American##2##2##(1991-3#1)(1994-3#1)
to An##3##2##(2007-12#2)(2008-11#1)
to Anaplasma marginale##2##3##(1996-12#2)
to AngII##2##2##(1990-12#2)
to Aphanomyces root rot##4##4##(2008-10#4)
to Aphanomyces##5##2##(2008-10#5)
to Apple##2##2##(2008-10#2)
to April 2006##2##3##(2008-10#1)(2010-5#1)
to April 2008##2##3##(2009-8#1)(2011-2#1)
to April##14##2##(1990-3#1)(1991-2#1)(1994-6#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-7#1)
to Arabidopsis##3##2##(2012-2#2)(2012-3#1)
to Arg at position##2##4##(1992-8#1)(2008-10#1)
to Arg##4##2##(1991-9#1)(1992-8#2)(2008-10#1)
to As##3##2##(2008-10#3)
to As(III)##5##2##(2008-10#5)
to As(V)##4##2##(2008-10#4)
to Asn##3##2##(1992-10#1)(1995-2#1)(2008-8#1)
to Aspergillus flavus##4##3##(2008-10#4)
to Aspergillus##11##2##(1993-8#1)(1997-3#1)(2008-1#1)(2008-10#8)
to Assess the##4##3##(1992-3#1)(1994-12#1)(2008-10#1)(2012-12#1)
to Assess##9##2##(1990-4#1)(1992-3#1)(1994-12#1)(2008-10#4)(2009-9#1)(2012-12#1)
to August##12##2##(1991-12#1)(1995-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
to Australia##5##2##(2007-2#3)(2008-10#1)(2011-2#1)
to B##19##2##(1991-11#2)(1994-12#1)(1995-5#1)(2007-12#2)(2008-10#10)(2008-6#1)(2011-2#2)
to B-MYB##3##2##(2011-2#3)
to BCR-ABL##2##2##(2011-2#1)(2012-12#1)
to BGYMV-MX##2##2##(2008-10#2)
to BMI##2##2##(1991-11#1)(2013-8#1)
to BPMV##2##2##(2008-10#2)
to BSA and##3##3##(1991-5#1)(2008-10#2)
to BSA##8##2##(1991-5#1)(2008-10#6)(2008-3#1)
to BTH##2##2##(2008-10#2)
to BYDV##5##2##(2008-10#3)(2008-8#2)
to Bacillus##3##2##(2008-10#1)(2011-2#2)
to Bacterial Wilt Caused by Ralstonia solanacearum##3##7##(2008-10#3)
to Bacterial##5##2##(2008-10#5)
to Be##2##2##(2012-1#1)(2012-3#1)
to Be?##2##2##(2009-3#1)(2012-3#1)
to Bean common mosaic necrosis virus##2##6##(2008-10#2)
to Bean common mosaic##3##4##(2008-10#3)
to Bean##4##2##(2008-10#4)
to Beet curly top virus##2##5##(2008-10#2)
to Beet##3##2##(2008-10#3)
to Bergen##3##2##(1990-6#1)(1992-6#2)
to Berlin##2##2##(1995-1#1)(2007-2#1)
to Bipolaris##2##2##(2008-10#2)
to Borrelia burgdorferi##3##3##(1990-2#1)(1991-11#1)(2011-2#1)
to Botrytis cinerea in##2##4##(2008-10#2)
to Botrytis cinerea##4##3##(2008-10#4)
to Botrytis##5##2##(2008-10#5)
to Brassica##2##2##(2008-10#2)
to Brazil##2##2##(2008-2#1)(2011-2#1)
to Brazilian and##2##3##(1991-6#1)(2008-11#1)
to Bs##2##2##(1994-12#2)
to Bt##2##2##(2011-2#2)
to C##35##2##(1991-9#1)(1992-6#1)(1992-8#1)(1996-12#1)(2007-10#1)(2007-12#1)(2008-10#18)(2008-12#4)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#2)
to C2##4##2##(1995-5#1)(2012-3#3)
to C923##2##2##(2008-10#2)
to CA-CRC##2##2##(2011-2#2)
to CAA##2##2##(1994-8#2)
to CAAs##2##2##(2008-10#2)
to CAV in##2##3##(2008-5#2)
to CAV##4##2##(2008-5#4)
to CC##4##2##(1991-8#1)(2008-11#3)
to CCSV NP##2##3##(2008-10#2)
to CCSV##3##2##(2008-10#3)
to CD127##3##2##(2013-1#3)
to CD40##2##2##(2008-10#1)(2012-2#1)
to CDC##3##2##(1992-6#2)(1997-2#1)
to CDDP##4##2##(1993-9#2)(2008-4#1)(2013-1#1)
to CDV##3##2##(2008-12#3)
to CEO##2##2##(1995-2#1)(2008-1#1)
to CF##2##2##(1992-10#2)
to CFA##2##2##(2012-2#2)
to CGRP##2##2##(1992-6#2)
to CHD or##2##3##(1990-3#2)
to CHO cells##2##3##(2010-12#2)
to CHV2-NB58##2##2##(2008-10#2)
to CI##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
to CK-MM3##2##2##(1991-2#2)
to CMV##6##2##(1992-6#2)(1994-11#1)(2008-10#2)(2010-12#1)
to CNS##4##2##(1990-9#1)(1991-12#1)(1997-3#1)(2011-2#1)
to CO##5##2##(1990-5#1)(1992-2#1)(1996-2#1)(2008-10#2)
to CO(2)##4##2##(2008-10#3)(2011-2#1)
to CO2##2##2##(1996-12#1)(2008-6#1)
to COPD##3##2##(2008-1#1)(2010-5#1)(2012-12#1)
to COX-2 selective and non-selective NSAIDs##2##6##(2011-2#2)
to CPT##2##2##(1994-8#2)
to CQI##2##2##(1993-2#1)(1994-3#1)
to CRC screening##4##3##(2013-1#4)
to CRH##2##2##(1992-6#1)(1994-9#1)
to CT##5##2##(1990-12#1)(1995-3#1)(2008-7#2)(2012-12#1)
to CTEPH##2##2##(2010-6#2)
to CZE##2##2##(1996-5#2)
to Ca(2+)##4##2##(2008-10#3)(2012-2#1)
to Ca2+ entry##2##3##(1994-8#1)(1995-11#1)
to Ca2+##14##2##(1990-7#1)(1990-8#2)(1991-8#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-2#2)(2008-8#1)
to California##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2012-1#1)
to Canadian##4##2##(1993-12#1)(1994-1#1)(1995-3#1)(2011-2#1)
to Candida##2##2##(2008-5#2)
to Care##3##2##(2011-1#1)(2012-3#2)
to Cd##4##2##(1990-5#1)(1997-4#1)(2008-7#1)(2008-9#1)
to Central##3##2##(2008-1#1)(2008-10#1)(2013-7#1)
to Cercospora##2##2##(2008-10#1)(2012-3#1)
to Cereal yellow dwarf virus##2##5##(2008-10#2)
to Children's##2##2##(1995-12#1)(2013-8#1)
to Chile##2##2##(2007-1#1)(2013-1#1)
to Chinese##4##2##(1991-9#1)(1997-4#1)(2008-8#1)(2011-2#1)
to Class II##2##3##(1991-2#1)(2008-11#1)
to Class##3##2##(1991-2#1)(1996-3#1)(2008-11#1)
to Clinic##2##2##(1995-6#1)(2008-10#1)
to Clostridium##3##2##(2007-8#1)(2011-2#2)
to Clover yellow vein virus##2##5##(2008-10#2)
to CoQ10##2##2##(1991-5#1)(2013-1#1)
to Colletotrichum gloeosporioides##2##3##(2008-10#2)
to Colletotrichum truncatum##2##3##(2008-10#2)
to Colletotrichum##6##2##(2008-10#6)
to Colonization by##2##3##(2008-10#2)
to Compare##2##2##(2008-10#1)(2009-5#1)
to Con A##2##3##(1991-12#2)
to Congress on##2##3##(1991-1#1)(1993-3#1)
to Congress##8##2##(1990-8#1)(1991-1#2)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)
to Control##4##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
to Costa Rica##3##3##(2008-5#3)
to Costa##6##2##(2008-5#5)(2011-2#1)
to Cp1##2##2##(2008-10#2)
to Cp2##2##2##(2008-10#2)
to Cr(III)##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
to Cr(VI) by##2##3##(2008-10#2)
to Cr(VI)##8##2##(2008-10#8)
to Cr1##3##2##(2008-10#3)
to Cr2##4##2##(2008-10#4)
to Crohn's disease##2##3##(1996-2#1)(2007-12#1)
to Cronartium quercuum f##2##4##(2008-10#2)
to Cronartium##5##2##(2008-10#5)
to Cry1Ac and##2##3##(2011-2#2)
to Cryphonectria hypovirus##3##3##(2008-10#3)
to Cu##2##2##(2013-8#2)
to Cu(2+)##2##2##(2008-10#1)(2008-12#1)
to Cu(II)##5##2##(2008-10#5)
to Cuba##2##2##(1996-11#1)(2007-12#1)
to Cucumber##2##2##(2008-10#2)
to D##4##2##(1991-8#1)(2008-10#1)(2009-8#1)(2013-8#1)
to D-amphetamine##2##2##(1993-6#2)
to DBA/1 mice##2##3##(2008-11#2)
to DCA##2##2##(2008-10#2)
to DEP extracts##2##3##(2008-10#2)
to DEP##3##2##(2008-10#3)
to DES##5##2##(2008-10#5)
to DHD##2##2##(1994-3#2)
to DIBOA##2##2##(2008-10#2)
to DNA and##7##3##(1992-12#1)(1992-3#1)(1994-8#2)(1996-2#1)(1997-2#1)(2008-10#1)
to DNA damage##13##3##(1995-2#3)(1995-5#1)(1997-4#2)(2008-8#1)(2009-5#1)(2011-2#3)(2013-1#2)
to DNA from##2##3##(1991-9#1)(2008-10#1)
to DNA in##4##3##(1990-11#1)(1992-8#1)(1995-3#1)(2008-8#1)
to DNA synthesis##3##3##(1997-7#1)(2008-11#1)(2012-2#1)
to DNA was##3##3##(1993-8#1)(1994-3#1)(1994-6#1)
to DNA##87##2##(1990-11#4)(1990-5#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#4)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-3#2)(1993-8#3)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#7)(1995-3#2)(1995-5#2)(1995-8#2)(1996-2#2)(1997-2#1)(1997-4#4)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-1#3)
to DNA-damaging agents in##2##4##(1992-12#1)(1997-4#1)
to DNA-damaging agents##6##3##(1992-12#3)(1995-8#2)(1997-4#1)
to DNR##2##2##(1992-3#1)(1996-3#1)
to DP IV##2##3##(1993-8#2)
to DP##3##2##(1993-8#2)(2008-7#1)
to DR3##2##2##(1995-11#1)(2012-2#1)
to December 1988##2##3##(1990-9#1)(1991-2#1)
to December 1989##3##3##(1991-6#1)(1992-5#1)(1992-6#1)
to December 1990##3##3##(1993-5#1)(1994-1#1)(1995-3#1)
to December 1994##2##3##(1996-2#1)(2007-10#1)
to December 2002##2##3##(2007-11#1)(2007-8#1)
to December 2004##2##3##(2010-6#1)(2011-2#1)
to December 2005##2##3##(2008-8#1)(2010-3#1)
to December 2006##2##3##(2011-2#2)
to December 2007##2##3##(2013-7#1)(2013-8#1)
to December 2010##2##3##(2011-7#1)(2013-1#1)
to December 31##3##3##(1993-9#1)(2007-8#1)(2013-7#1)
to December##37##2##(1990-9#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1995-3#2)(1996-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-2#2)(2008-4#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#4)(2011-7#1)(2013-1#2)(2013-7#3)(2013-8#1)
to Define##2##2##(2008-11#1)(2010-5#1)
to Delta(7)-PGA(1) methyl ester##2##4##(2008-11#2)
to Detect and Quantify##2##4##(2008-10#2)
to Didymella rabiei##2##3##(2008-10#2)
to Different##3##2##(2008-10#2)(2010-12#1)
to Doppler-broadened##3##2##(2008-2#3)
to Doppler-free##2##2##(2008-3#2)
to Dr##3##2##(1995-12#1)(2008-2#1)(2008-7#1)
to Dy3+##2##2##(1990-11#2)
to E##21##2##(1993-12#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-12#1)(1997-6#1)(2006-10#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
to E1 and E3##2##4##(2008-10#2)
to E1 and##3##3##(2008-10#2)(2008-11#1)
to E2##6##2##(1990-11#5)(2008-10#1)
to EBV##3##2##(1994-8#1)(2007-2#1)(2008-5#1)
to EC##4##2##(1990-2#2)(2013-8#2)
to ECII##3##2##(2008-11#3)
to EDTA##2##2##(1993-3#1)(2013-1#1)
to EGF##8##2##(1991-12#3)(1991-2#1)(1992-8#1)(1994-6#3)
to EGTA##2##2##(1994-2#1)(2008-8#1)
to ESRD##6##2##(1995-1#1)(1996-2#1)(2007-7#2)(2008-1#2)
to ET##4##2##(1990-2#1)(1994-9#1)(1996-2#1)(2008-7#1)
to ET-1##2##2##(1990-2#1)(1992-9#1)
to ETAAS##3##2##(2008-10#3)
to Earth##2##2##(2008-3#2)
to Eastern##2##2##(1990-6#1)(2012-3#1)
to England##2##2##(2010-1#1)(2011-1#1)
to Enneking##2##2##(2007-11#2)
to Ery+##3##2##(1990-5#3)
to Escherichia coli##4##3##(1994-12#1)(1994-5#1)(1996-12#1)(1996-6#1)
to Eu(2+)##4##2##(2007-12#4)
to Europe##5##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#2)
to European##7##2##(2008-1#1)(2008-10#4)(2010-10#1)(2011-2#1)
to Examine the##2##3##(2012-12#1)(2012-2#1)
to Examine##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
to F##18##2##(1997-8#1)(2008-10#17)
to F-ddI##2##2##(1995-3#2)
to FDH-N##2##2##(1992-6#2)
to FHB was##2##3##(2008-10#2)
to FHB##10##2##(2008-10#8)(2011-10#2)
to FIA##4##2##(2008-10#4)
to FISH##2##2##(2008-9#2)
to FR1064##2##2##(2008-10#2)
to Fe oxides##2##3##(2008-10#2)
to Fe##3##2##(1996-2#1)(2008-10#2)
to Fe(II) by##2##3##(2008-10#2)
to Fe(II)##10##2##(1995-6#1)(2008-10#9)
to Fe(III)##6##2##(2008-10#6)
to February 1992##2##3##(2008-2#1)(2008-5#1)
to February 2002##2##3##(2007-7#1)(2008-1#1)
to February 2009##2##3##(2011-2#2)
to February##22##2##(1990-12#1)(1991-2#1)(1994-12#1)(1997-8#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#2)(2010-8#2)(2011-2#2)(2013-7#1)
to Florida##2##2##(2008-10#1)(2011-2#1)
to FucT-IV##2##2##(1992-8#2)
to Fusarium graminearum##3##3##(2008-10#3)
to Fusarium head blight##3##4##(2008-10#3)
to Fusarium oxysporum##2##3##(2008-10#2)
to Fusarium wilt##8##3##(2008-10#8)
to Fusarium##18##2##(2008-10#18)
to G##11##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2012-12#2)
to G-proteins##3##2##(1992-6#1)(1996-5#2)
to G418##2##2##(1995-2#1)(2008-11#1)
to GABAA##4##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)
to GC##4##2##(1996-12#1)(2008-10#2)(2008-12#1)
to GC-MS##2##2##(2008-10#2)
to GC/MS##2##2##(2008-10#2)
to GDP##2##2##(1994-12#1)(1995-5#1)
to GH##5##2##(1993-3#1)(2008-3#3)(2010-8#1)
to GLAD##3##2##(2011-2#3)
to GM-CSF##2##2##(1992-3#1)(1992-8#1)
to GPIb does not##2##4##(1993-3#2)
to GRH##2##2##(1992-6#2)
to GTP##4##2##(1991-9#1)(1994-12#1)(2008-3#1)(2008-4#1)
to Gerbils##2##2##(2010-11#2)
to Germany##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
to Gln##2##2##(1992-3#1)(1992-9#1)
to Gly and beta-Ala##2##4##(1995-5#2)
to Gly##3##2##(1992-6#1)(1995-5#2)
to Gram##2##2##(2007-7#2)
to Grapevine berry inner necrosis virus##2##6##(2008-10#2)
to Grapevine##3##2##(2008-10#3)
to Greece##2##2##(2008-11#1)(2011-2#1)
to Group 1##3##3##(2008-10#1)(2011-2#2)
to Group##5##2##(1995-12#1)(2008-10#2)(2011-2#2)
to Guignardia bidwellii##2##3##(2008-10#2)
to H##6##2##(1996-12#1)(2008-10#2)(2008-5#2)(2011-10#1)
to H(2)O(2)##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
to H1N1##2##2##(2012-12#2)
to HBO##4##2##(1993-12#4)
to HBV##4##2##(2008-10#1)(2009-8#1)(2012-12#2)
to HCV##3##2##(1995-10#1)(2012-2#1)(2013-8#1)
to HCl##3##2##(2008-10#1)(2009-10#2)
to HG##4##2##(2008-10#1)(2008-7#3)
to HIV care##3##3##(2012-12#3)
to HIV infection##5##3##(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-8#1)
to HIV##22##2##(1990-6#1)(1991-11#1)(1991-5#1)(1996-11#1)(1996-5#2)(1997-5#2)(2008-5#2)(2008-7#2)(2009-5#1)(2009-7#2)(2011-1#1)(2012-12#5)(2013-8#1)
to HIV-1##9##2##(1990-9#1)(1992-11#1)(1993-3#2)(1994-11#1)(1994-6#1)(2009-4#1)(2013-1#2)
to HIV/AIDS##5##2##(1995-2#1)(1997-6#2)(2007-7#1)(2010-8#1)
to HLA##2##2##(1997-3#1)(2007-6#1)
to HMOs##2##2##(1993-3#1)(1995-12#1)
to HNG##2##2##(2012-12#2)
to HPLC and##2##3##(1993-6#1)(2008-10#1)
to HPLC##10##2##(1993-6#1)(1996-5#1)(2008-10#8)
to HS##2##2##(1991-9#1)(1996-2#1)
to Hashimoto's##3##2##(2011-2#2)(2013-1#1)
to Hawaii##3##2##(1992-2#1)(2007-5#1)(2008-10#1)
to Health Care##2##3##(1996-3#1)(2008-11#1)
to Health##6##2##(1996-3#1)(2008-10#1)(2008-11#3)(2012-2#1)
to Helicobacter pylori##2##3##(1997-1#1)(2011-2#1)
to Hg##2##2##(1990-5#1)(2008-10#1)
to Hg(0)##2##2##(2008-10#2)
to Hg(II)##2##2##(2008-10#2)
to Hmong##2##2##(2008-12#2)
to Hoogsteen##2##2##(1993-11#2)
to Hospital##2##2##(2008-12#1)(2013-8#1)
to Human Health##2##3##(2009-4#1)(2012-2#1)
to Human##3##2##(2009-4#1)(2010-12#1)(2012-2#1)
to I##5##2##(1992-12#1)(2007-11#1)(2008-5#1)(2008-6#2)
to IB-49##3##2##(2008-10#3)
to IBV infection##2##3##(1997-6#1)(2008-5#1)
to IBV##5##2##(1997-3#1)(1997-6#2)(2008-5#2)
to IC-17 was conferred by a single dominant gene##2##9##(2008-10#2)
to IC-17 was##3##3##(2008-10#3)
to IC-17##4##2##(2008-10#4)
to ICAM-1##3##2##(1995-2#1)(1995-6#1)(1996-2#1)
to ICD-10##3##2##(2006-10#1)(2012-12#1)(2012-2#1)
to ICH##3##2##(2007-10#1)(2008-10#1)(2008-8#1)
to ICP-MS##2##2##(2008-10#2)
to ICU##2##2##(2009-5#1)(2012-3#1)
to ICs and##2##3##(2008-8#2)
to ICs##4##2##(2008-8#4)
to IFN##3##2##(2008-11#2)(2009-8#1)
to IGF-I##6##2##(1991-5#1)(1993-6#2)(1997-1#1)(2008-11#2)
to IHDA##2##2##(1992-10#2)
to IL-1 beta-induced anorexia##2##4##(1996-12#2)
to IL-1##3##2##(1990-5#1)(1996-12#2)
to IL-2##3##2##(1992-5#1)(1993-8#1)(2008-4#1)
to IL-3##2##2##(1990-12#1)(2008-4#1)
to IL-6##2##2##(1994-2#1)(1995-12#1)
to IL-8##3##2##(1990-5#2)(1994-11#1)
to IP##3##2##(1992-7#1)(2008-7#2)
to IP3##2##2##(1990-12#1)(2008-8#1)
to IPO323##2##2##(2008-10#2)
to IPSB##2##2##(1996-1#2)
to IR interference##2##3##(2011-2#2)
to IR##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#2)
to IS##3##2##(1993-12#1)(2012-3#1)(2012-5#1)
to IV##2##2##(1995-12#1)(2008-5#1)
to IVF##2##2##(1994-12#1)(2008-11#1)
to Identify##4##2##(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
to IgG##3##2##(1994-2#1)(1996-3#1)(2008-10#1)
to IgG-Fc##2##2##(2013-1#2)
to Ile)##2##2##(1992-8#1)(1995-6#1)
to Improve##4##2##(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
to Indian##2##2##(2008-5#1)(2011-1#1)
to Infection##2##2##(2008-10#2)
to January 2009##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
to January 2010##2##3##(2012-12#1)(2013-7#1)
to January##15##2##(1991-8#1)(1994-9#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
to Japanese##4##2##(1996-5#1)(2008-10#1)(2008-12#1)(2012-12#1)
to July 2000##2##3##(2008-3#2)
to July##16##2##(1990-2#1)(1991-2#1)(1994-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-6#2)(2013-1#1)
to June 2005##3##3##(2008-11#1)(2008-12#1)(2008-8#1)
to June##25##2##(1991-2#1)(1993-12#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
to K+##4##2##(1990-11#1)(1991-5#1)(2008-4#1)(2008-8#1)
to KB cell line##2##4##(2008-12#2)
to KCl##5##2##(1995-12#3)(2008-10#1)(2008-8#1)
to KLH in the dog##2##5##(2008-10#2)
to KLH##9##2##(2008-10#8)(2008-9#1)
to L##2##2##(2008-10#1)(2010-8#1)
to L-glutamate##4##2##(1996-5#2)(1997-2#2)
to LDL oxidation during copper-catalyzed oxidative modification and its##2##9##(1991-12#2)
to LDL oxidation during copper-catalyzed oxidative modification##3##7##(1991-12#3)
to LDL##5##2##(1991-12#3)(1991-2#1)(1994-9#1)
to LPS##9##2##(1993-6#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)
to LSD##3##2##(2008-10#3)
to LT##2##2##(1994-2#1)(2011-3#1)
to Latin##2##2##(1993-6#1)(1997-7#1)
to Leaf##3##2##(2008-10#3)
to Lee##2##2##(1993-3#1)(2008-4#1)
to Leptosphaeria maculans##6##3##(2008-10#6)
to Leu##2##2##(1995-8#1)(2008-8#1)
to Leydig cells##2##3##(1996-5#2)
to Lys##4##2##(1990-11#1)(1992-8#1)(1993-12#1)(2008-10#1)
to M##40##2##(1992-12#2)(1993-3#1)(2007-12#1)(2008-10#22)(2008-6#2)(2008-7#1)(2008-9#2)(2010-6#1)(2011-10#2)(2011-2#2)(2012-2#3)(2013-7#1)
to MBT##2##2##(2008-10#2)
to MCI##2##2##(2008-5#2)
to MDT##2##2##(2007-7#1)(2009-5#1)
to MHC##2##2##(1994-11#1)(1995-5#1)
to MMV##2##2##(2008-10#2)
to MPTP##2##2##(1990-7#2)
to MRI fields##2##3##(1992-3#2)
to MRI##4##2##(1990-5#1)(1992-3#2)(2013-1#1)
to MS##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)
to MStV##4##2##(2008-10#4)
to MT##5##2##(1993-12#1)(2008-10#4)
to MTBE##2##2##(2008-12#2)
to Magnaporthe grisea##3##3##(2008-10#3)
to Magnaporthe##4##2##(2008-10#3)(2013-8#1)
to Magoh##2##2##(2012-2#2)
to Major##2##2##(1994-11#1)(2008-10#1)
to Maori##2##2##(2008-1#2)
to March 2002##2##3##(2007-8#1)(2008-1#1)
to March 2003##3##3##(2007-8#1)(2008-12#1)(2008-9#1)
to March 2010##3##3##(2011-2#2)(2013-7#1)
to March##24##2##(1993-12#1)(1996-5#1)(1996-6#1)(2007-8#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-5#4)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#2)(2013-8#2)
to May 2006##2##3##(2008-11#1)(2012-2#1)
to May##17##2##(1990-10#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-2#2)(2013-7#3)
to MeOH##2##2##(2008-10#2)
to Medicaid##7##2##(1991-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)
to Medicare and Medicaid beneficiaries##2##5##(1991-3#1)(1996-2#1)
to Medicare beneficiaries##7##3##(1991-2#1)(1991-3#3)(1992-2#1)(1994-12#1)(1995-12#1)
to Medicare##19##2##(1991-2#1)(1991-3#6)(1992-2#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-3#1)(2008-11#1)
to Medicare's##2##2##(1991-1#1)(1997-2#1)
to Melampsora larici-populina##5##3##(2008-10#5)
to Melampsora medusae##2##3##(2008-10#2)
to Melampsora##7##2##(2008-10#7)
to Ministry of##2##3##(2008-10#1)(2012-12#1)
to Mn(2+)##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
to Monitor##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
to Mycobacterium tuberculosis##2##3##(1996-11#1)(2010-5#1)
to Mycobacterium##6##2##(1991-11#1)(1996-11#1)(2007-12#2)(2007-7#1)(2010-5#1)
to Mycosphaerella graminicola in##2##4##(2008-10#1)(2011-10#1)
to Mycosphaerella graminicola##4##3##(2008-10#3)(2011-10#1)
to Mycosphaerella##5##2##(2008-10#4)(2011-10#1)
to N##4##2##(1995-3#1)(2008-10#3)
to N-methyl-D-aspartate##3##2##(1990-7#1)(1990-8#1)(1992-8#1)
to N-methyl-N'-nitro-N-nitrosoguanidine##2##2##(1992-3#1)(1995-9#1)
to N1-acetylspermidine##2##2##(1995-2#2)
to N2O##3##2##(1992-3#1)(1992-8#1)(1993-1#1)
to NA##3##2##(2008-10#1)(2008-8#2)
to NADH##2##2##(1992-6#1)(2008-10#1)
to NCDs##4##2##(2012-12#2)(2013-8#2)
to NE##2##2##(2008-3#1)(2008-4#1)
to NEM##2##2##(1995-8#2)
to NF-kappa B##2##3##(1991-7#1)(1992-12#1)
to NGF##5##2##(1991-12#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-11#1)
to NH(3)##2##2##(2008-10#2)
to NH4Cl##2##2##(1992-6#2)
to NL-3 K##3##3##(2008-10#3)
to NMDA##5##2##(1992-8#1)(1996-5#3)(2008-7#1)
to NO##6##2##(1992-3#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-7#1)
to NUV and H2O2##2##4##(1990-5#2)
to NaCl and##2##3##(2009-10#1)(2013-1#1)
to NaCl##4##2##(2008-10#2)(2009-10#1)(2013-1#1)
to Nafion-coated##2##2##(2008-10#2)
to National##2##2##(2008-7#1)(2011-9#1)
to Nd##2##2##(2008-2#1)(2008-3#1)
to NeutrAvidin##3##2##(2008-10#3)
to New Zealand##5##3##(2007-12#1)(2007-2#1)(2008-8#3)
to New##8##2##(1996-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#3)(2009-5#1)
to Ni(2+)##2##2##(2013-1#2)
to Ni3S2##2##2##(1994-5#1)(1995-3#1)
to North America##4##3##(1992-9#1)(2008-10#1)(2008-8#1)(2009-2#1)
to North##5##2##(1992-9#1)(2008-10#2)(2008-8#1)(2009-2#1)
to Northern##2##2##(2008-7#2)
to Norway##2##2##(1997-6#1)(2008-10#1)
to Norwegian##4##2##(1991-2#1)(1993-2#1)(1995-5#1)(1997-8#1)
to November 2000##2##3##(2007-2#1)(2007-7#1)
to November##9##2##(1996-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
to O(3)##3##2##(2008-3#1)(2008-5#2)
to OA##2##2##(1992-3#1)(1994-11#1)
to OH##3##2##(2007-11#1)(2008-3#2)
to ONOO(-)##2##2##(2008-7#2)
to October 2003##2##3##(2008-10#1)(2008-12#1)
to October##16##2##(1991-12#1)(1996-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2012-12#3)(2013-7#1)(2013-8#1)
to Other##2##2##(2008-10#2)
to P##56##2##(1991-5#1)(2008-10#44)(2008-5#3)(2008-8#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
to PAEC##3##2##(2008-8#3)
to PBL##2##2##(1995-12#1)(2011-1#1)
to PC##2##2##(1992-9#1)(2013-1#1)
to PC12 cells##2##3##(2008-11#1)(2008-4#1)
to PCR amplification##2##3##(1996-12#1)(2008-10#1)
to PCR##6##2##(1996-12#1)(1996-8#1)(2008-10#3)(2012-2#1)
to PD##5##2##(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#2)
to PEP##2##2##(1995-5#2)
to PIP(3)##2##2##(2008-11#2)
to PIP2##2##2##(1993-8#1)(2008-8#1)
to PKC##2##2##(1994-6#1)(1996-9#1)
to PMA##3##2##(1993-6#1)(1994-8#1)(1997-1#1)
to PMD##2##2##(2007-12#1)(2008-3#1)
to PPARalpha and##2##3##(2008-1#1)(2008-5#1)
to PPARgamma##3##2##(2008-5#3)
to PPD##2##2##(2007-2#1)(2012-3#1)
to PPI##2##2##(2013-1#2)
to PR##2##2##(1991-3#1)(2013-1#1)
to PSA##2##2##(2008-12#1)(2012-12#1)
to PSV subgroup##2##3##(2008-10#2)
to PSV##3##2##(2008-10#3)
to PSV-W##2##2##(2008-10#2)
to PTCA##2##2##(2006-8#1)(2007-8#1)
to PTH##3##2##(1990-11#2)(1997-7#1)
to PVC ratio##2##3##(2008-10#2)
to PVC##3##2##(2008-10#3)
to PVY##2##2##(2008-10#2)
to Paget's disease##2##3##(2008-6#1)(2010-3#1)
to Pakistan##2##2##(2008-12#1)(2012-2#1)
to Pb(2+) in##2##3##(2008-10#2)
to Pb(2+)##3##2##(2008-10#3)
to Pd(2 +)##2##3##(2008-10#2)
to Pepper##2##2##(2008-10#2)
to Philippine##2##2##(2008-10#2)
to Physical##3##2##(2010-3#1)(2011-2#1)(2012-3#1)
to Phytophthora root rot##2##4##(2008-10#2)
to Phytophthora##6##2##(2008-10#6)
to Polish##2##2##(2012-12#1)(2012-3#1)
to Postharvest##2##2##(2008-10#2)
to Powdery Mildew##2##3##(2008-10#2)
to Predict##2##2##(2009-11#1)(2013-8#1)
to Produce##2##2##(2008-10#2)
to Professor##5##2##(1990-8#1)(2008-10#1)(2008-5#2)(2012-3#1)
to Protect##2##2##(2008-10#2)
to Pseudomonas syringae pv##2##4##(2008-10#1)(2009-6#1)
to Pseudomonas syringae##3##3##(2008-10#2)(2009-6#1)
to Pseudomonas##8##2##(2007-12#2)(2008-10#4)(2009-6#1)(2013-1#1)
to Ptr ToxA in##2##4##(2008-10#2)
to Ptr ToxA##8##3##(2008-10#8)
to Ptr ToxB##2##3##(2008-10#2)
to Ptr##11##2##(2008-10#11)
to Puccinia hordei and##2##4##(2008-10#2)
to Puccinia hordei##3##3##(2008-10#3)
to Puccinia sorghi##2##3##(2008-10#2)
to Puccinia##7##2##(2008-10#7)
to Pyrenophora tritici-repentis Race##2##4##(2008-10#2)
to Pythium##4##2##(2008-10#4)
to QA##2##2##(1991-1#1)(1992-12#1)
to Quantify##3##2##(2008-10#3)
to R##12##2##(2008-10#11)(2008-3#1)
to R1881##2##2##(1990-11#2)
to RA##3##2##(2010-12#1)(2012-1#1)(2012-3#1)
to RC##2##2##(2008-10#1)(2011-1#1)
to RH##4##2##(2008-10#3)(2008-2#1)
to RNA from##2##3##(1994-11#1)(2008-10#1)
to RNA silencing##2##3##(2008-10#2)
to RNA##9##2##(1990-11#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-3#2)(2008-10#3)
to RNase A##2##3##(1992-11#2)
to RNase##4##2##(1990-5#1)(1990-7#1)(1992-11#2)
to RP-HPLC##2##2##(1996-5#1)(2008-10#1)
to RTSV##2##2##(2008-10#2)
to Reduce##2##2##(2010-1#1)(2012-3#1)
to Regulate##2##2##(2008-10#1)(2012-12#1)
to Resistance##3##2##(2008-10#3)
to Rhizoctonia root rot##2##4##(2008-10#2)
to Rhizoctonia##4##2##(2008-10#4)
to Rio##2##2##(1992-5#1)(2013-7#1)
to Rpc1##2##2##(2008-10#2)
to S phase##2##3##(1994-5#1)(1995-2#1)
to S##30##2##(1990-11#2)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1997-7#2)(2007-6#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)
to S-naproxen##4##2##(1994-3#4)
to S1##2##2##(1994-5#1)(1995-6#1)
to SA##5##2##(1993-6#1)(2008-10#4)
to SACI##2##2##(2008-11#2)
to SAH##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
to SCMV##2##2##(2008-10#2)
to SDS-PAGE##5##2##(1992-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
to SEM##2##2##(2008-11#1)(2013-1#1)
to SFE##2##2##(2008-10#2)
to SHR##3##2##(2006-8#2)(2011-1#1)
to SLea##3##2##(1991-12#3)
to SLex##2##2##(1991-12#2)
to SMV##2##2##(2008-10#2)
to SNP##2##2##(2009-7#1)(2013-1#1)
to SP##2##2##(1997-3#1)(2008-11#1)
to SRBC##2##2##(2008-10#2)
to SRBCs##3##2##(1993-12#2)(2008-6#1)
to SRH##2##2##(2011-2#2)
to STB in##3##3##(2008-10#3)
to STB##10##2##(2008-10#10)
to Saccharomyces cerevisiae##2##3##(1996-6#1)(2008-2#1)
to Salmonella typhimurium##3##3##(2008-10#1)(2009-5#2)
to Salmonella##10##2##(1990-3#1)(1996-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2009-5#2)(2011-2#1)
to Sb(3+)##2##2##(2008-10#2)
to Sb(III)##4##2##(2008-10#4)
to Schwann##2##2##(1995-2#1)(2008-7#1)
to Sclerotinia sclerotiorum##3##3##(2008-10#3)
to Sclerotinia trifoliorum##7##3##(2008-10#7)
to Sclerotinia##10##2##(2008-10#10)
to Sclerotium rolfsii in##3##4##(2008-10#3)
to Sclerotium rolfsii##6##3##(2008-10#6)
to Se##2##2##(2008-10#1)(2012-2#1)
to Se(IV)##9##2##(2008-10#9)
to Sepharose 4B##2##3##(1993-12#1)(2011-2#1)
to Sepharose##8##2##(1991-8#1)(1992-12#1)(1993-12#1)(2008-1#1)(2008-4#3)(2011-2#1)
to September in##2##3##(1996-12#1)(2008-12#1)
to September##13##2##(1996-12#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-12#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#2)
to Septoria tritici blotch##4##4##(2008-10#4)
to Septoria tritici##5##3##(2008-10#5)
to Septoria##9##2##(2008-10#9)
to Shack-Hartmann##2##2##(2007-11#1)(2008-3#1)
to SilicoSec##2##2##(2008-12#2)
to Sitisi##2##2##(2008-1#2)
to SnTox1##2##2##(2008-10#2)
to Sorghum##2##2##(2008-10#2)
to South##4##2##(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
to Southern##3##2##(1994-11#1)(1997-7#1)(2008-10#1)
to Spain##2##2##(1993-8#1)(2009-10#1)
to Spodoptera frugiperda 21##2##4##(2008-11#2)
to States##2##2##(1991-2#1)(1994-3#1)
to Stewart's##3##2##(2008-10#3)
to Streptococcus##2##2##(2007-7#1)(2013-8#1)
to Study##2##2##(2008-10#2)
to T cells##3##3##(2008-4#2)(2008-9#1)
to T##15##2##(1991-12#1)(1995-6#1)(1996-2#1)(2008-10#5)(2008-12#2)(2008-4#2)(2008-5#1)(2008-9#2)
to T-toxin##2##2##(2008-10#2)
to T1##2##2##(1991-12#1)(2008-10#1)
to T1D##2##2##(2010-5#1)(2013-8#1)
to T2##3##2##(2008-12#1)(2009-3#1)(2012-12#1)
to T3##2##2##(1996-5#1)(2008-10#1)
to T4##2##2##(1991-9#1)(2007-2#1)
to T60 for##2##3##(2013-8#2)
to TA##2##2##(1997-8#1)(2008-3#1)
to TB##2##2##(1996-3#1)(2013-1#1)
to TCDD##2##2##(2008-10#2)
to TCE##2##2##(2008-10#2)
to TGF beta##3##3##(1992-8#2)(1995-12#1)
to TGF-beta 1##3##3##(1990-5#1)(1990-8#1)(1992-3#1)
to TI arcuate neurones##2##4##(1992-8#2)
to TKI##2##2##(2010-4#1)(2012-1#1)
to TMA##2##2##(2008-10#2)
to TMV##2##2##(2008-10#2)
to TNDR selection##2##3##(2008-10#2)
to TNF alpha##3##3##(1994-6#1)(1995-2#2)
to TNF cytotoxicity##2##3##(1992-7#2)
to TNF in##3##3##(1992-9#1)(1997-7#1)(2011-2#1)
to TNF##10##2##(1992-7#2)(1992-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1997-7#1)(2011-2#2)
to TPA##7##2##(1991-8#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-9#1)(1996-5#1)
to TPO1 and##2##3##(1995-12#2)
to TRAIL##3##2##(2009-9#2)(2012-2#1)
to TRAIL-induced apoptosis##2##3##(2009-9#2)
to TRH##3##2##(1991-6#1)(1993-2#1)(1994-2#1)
to TSH##4##2##(1990-12#1)(1992-12#1)(1993-3#1)(2008-4#1)
to TSWV infection##2##3##(2008-10#2)
to TSWV##5##2##(2008-10#5)
to TYLCV##4##2##(2008-10#4)
to Takayasu's arteritis##2##3##(1997-8#2)
to Tapesia yallundae##2##3##(2008-10#2)
to Test##3##2##(2008-10#1)(2012-12#2)
to Th2##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
to Thatcher##2##2##(2008-10#2)
to Thr##3##2##(1993-3#1)(1994-8#1)(2008-8#1)
to Time##2##2##(2008-10#1)(2008-12#1)
to TnC##2##2##(1995-5#2)
to Tomato bushy stunt virus (TBSV)##2##6##(2008-10#2)
to Tomato yellow leaf curl virus (TYLCV)##3##7##(2008-10#3)
to Tomato##7##2##(2008-10#7)
to Treatment##2##2##(2008-5#1)(2009-9#1)
to Trp##2##2##(1993-11#1)(1993-9#1)
to Two##2##2##(2008-10#2)
to Type 1 diabetes##2##4##(2008-1#1)(2010-9#1)
to U##2##2##(1996-3#1)(2008-10#1)
to UK##2##2##(2007-2#1)(2012-12#1)
to UPLC##2##2##(2008-10#1)(2011-1#1)
to US##3##2##(1997-2#1)(2008-8#1)(2009-2#1)
to USEPA##2##2##(2008-10#2)
to UV light##8##3##(1994-6#2)(1997-3#1)(2007-12#1)(2008-10#2)(2008-5#2)
to UV radiation##6##3##(1993-3#2)(2008-1#1)(2008-2#1)(2008-5#2)
to UV##19##2##(1993-3#2)(1994-6#2)(1995-8#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#5)(2011-2#1)
to UV-C treatment##2##3##(2008-10#1)(2009-10#1)
to UV-C##5##2##(1995-12#1)(2008-10#1)(2008-12#1)(2009-10#2)
to UVA##2##2##(2008-5#1)(2009-6#1)
to UVB damage##2##3##(2008-5#2)
to UVB##6##2##(2008-5#6)
to Uncover##2##2##(2008-10#1)(2008-11#1)
to V##11##2##(2008-10#10)(2009-8#1)
to VCG##4##2##(2008-10#4)
to VI##3##2##(1993-8#1)(1994-2#2)
to VIP##3##2##(1995-11#3)
to VLDL##4##2##(1990-8#1)(1993-6#3)
to VOCs##2##2##(2008-10#2)
to VPA##2##2##(2008-7#1)(2011-1#1)
to Verticillium wilt##2##3##(2008-10#2)
to Verticillium##4##2##(2008-10#4)
to Vickers##2##2##(2008-12#1)(2009-7#1)
to W##4##2##(2007-2#1)(2008-10#3)
to WHO##3##2##(1996-11#1)(2007-8#1)(2011-2#1)
to WSMoV##2##2##(2008-10#2)
to WT##3##2##(2010-2#1)(2012-3#1)(2013-1#1)
to Walking-in-Place##2##2##(2012-2#2)
to Water##2##2##(2008-10#2)
to Watermelon mosaic virus##2##4##(2008-10#2)
to Watermelon silver mottle virus##2##5##(2008-10#2)
to Watermelon##4##2##(2008-10#4)
to Western##2##2##(2007-7#1)(2012-2#1)
to Wheat##2##2##(2008-10#2)
to White##4##2##(2008-11#1)(2009-9#1)(2011-2#2)
to World Health Organization (WHO)##3##5##(2008-10#1)(2010-10#1)(2012-12#1)
to X##10##2##(1993-6#1)(1996-6#1)(2007-12#1)(2008-10#7)
to X-ray##2##2##(2008-10#1)(2008-5#1)
to Xa21 and##2##3##(2008-10#2)
to Xa21##6##2##(2008-10#6)
to Xanthomonas campestris pv##4##4##(2008-10#4)
to Xanthomonas##5##2##(2008-10#5)
to Xq28##2##2##(1993-6#1)(2012-3#1)
to Y-branch##2##2##(2008-3#2)
to ZP##3##2##(2013-1#3)
to [(TPP)Ru(NO)(py)](+)##2##2##(1996-2#2)
to [D-Arg2]hGRF(1-29)NH2##2##2##(1990-2#2)
to a &quot##6##3##(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
to a 0##2##3##(2008-10#1)(2008-2#1)
to a 1##6##3##(1990-5#1)(1992-6#1)(1993-9#1)(1997-4#1)(2008-10#1)(2011-2#1)
to a 1%##2##3##(2008-3#2)
to a 10%##2##3##(1997-3#1)(2008-10#1)
to a 100##2##3##(1994-5#1)(2009-8#1)
to a 15##2##3##(1994-2#1)(2008-10#1)
to a 2##5##3##(2007-11#1)(2008-11#1)(2008-3#2)(2013-7#1)
to a 20%##2##3##(1996-3#1)(2011-2#1)
to a 3##3##3##(1995-6#1)(2008-10#2)
to a 30%##2##3##(2008-6#1)(2010-6#1)
to a 4##2##3##(2008-3#1)(2009-10#1)
to a 5##3##3##(1996-1#1)(2008-10#1)(2010-5#1)
to a 500-fold##2##3##(2008-1#1)(2008-2#1)
to a 6-fold##2##3##(1995-11#1)(1995-2#1)
to a 60##2##3##(1992-11#1)(1996-12#1)
to a DNA##2##3##(1992-8#1)(2008-2#1)
to a German##2##3##(2008-12#1)(2010-4#1)
to a Gly##2##3##(1994-12#1)(1997-3#1)
to a Pyrenophora##2##3##(2008-10#2)
to a UK regional infectious diseases unit##2##7##(2007-2#2)
to a basic##3##3##(2008-10#2)(2009-8#1)
to a belief##2##3##(1996-12#1)(2009-6#1)
to a better understanding of the##7##6##(1990-12#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-3#1)
to a better understanding of##14##5##(1990-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-3#1)(2011-1#1)
to a better understanding##15##4##(1990-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-3#1)(2011-1#1)
to a better##23##3##(1990-12#1)(1993-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)
to a biotinylated##3##3##(2008-10#2)(2009-12#1)
to a blind##2##3##(1990-5#1)(1992-11#1)
to a blood##2##3##(1997-7#1)(2008-9#1)
to a body##2##3##(2008-11#1)(2009-8#1)
to a broad range of##8##5##(2008-10#3)(2008-11#3)(2008-8#1)(2011-2#1)
to a broad spectrum of##2##5##(2008-10#1)(2008-11#1)
to a broad##11##3##(2007-11#1)(2008-10#4)(2008-11#4)(2008-8#1)(2011-2#1)
to a calibration##2##3##(2008-10#1)(2008-3#1)
to a candidate##2##3##(1992-3#1)(1995-2#1)
to a capillary##2##3##(1997-2#1)(2008-10#1)
to a carboxylic##2##3##(1995-5#1)(2008-10#1)
to a carrier##5##3##(1995-5#1)(1997-3#1)(2008-2#1)(2008-4#2)
to a cell##4##3##(1994-8#1)(2008-11#2)(2009-5#1)
to a central##4##3##(1991-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
to a certain degree##2##4##(1990-11#1)(2008-12#1)
to a certain extent by##2##5##(2008-3#1)(2011-1#1)
to a certain extent##5##4##(2008-3#1)(2008-8#1)(2011-1#2)(2013-8#1)
to a certain##15##3##(1990-11#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-1#2)(2013-8#1)
to a certified reference##2##4##(2008-10#2)
to a chain##2##3##(1995-2#1)(1997-7#1)
to a change in the##4##5##(1992-3#1)(1993-8#1)(2007-11#1)(2008-10#1)
to a change in##12##4##(1990-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#2)
to a change of the##3##5##(2008-10#1)(2008-11#1)(2008-2#1)
to a change##16##3##(1990-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)
to a changing environment##2##4##(1996-3#1)(2008-7#1)
to a changing##3##3##(1992-11#1)(1996-3#1)(2008-7#1)
to a chemical##3##3##(2008-10#2)(2013-1#1)
to a chromosomal##2##3##(1995-3#1)(2008-6#1)
to a chronic##3##3##(1994-5#1)(2008-12#1)(2013-1#1)
to a class##2##3##(2008-5#1)(2008-8#1)
to a clinical##5##3##(1992-12#1)(1995-3#1)(2010-2#1)(2012-2#1)(2012-3#1)
to a collection of##2##4##(2008-6#1)(2009-5#1)
to a colourless##2##3##(1993-12#1)(2008-10#1)
to a combination of a##2##5##(2008-10#1)(2008-11#1)
to a combination of##12##4##(1991-7#1)(1994-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-1#1)(2013-1#1)
to a combined##2##3##(1995-8#1)(2008-1#1)
to a comment##2##3##(2007-12#1)(2010-6#1)
to a commercial##3##3##(1990-3#1)(2008-10#1)(2009-11#1)
to a common##12##3##(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
to a community-based##2##3##(1993-12#1)(2010-9#1)
to a complete##7##3##(1991-6#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
to a complex##3##3##(1990-12#1)(2006-10#1)(2008-10#1)
to a comprehensive##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
to a computer##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
to a concentration of 3##3##5##(1990-5#1)(2008-11#1)(2011-1#1)
to a concentration of##12##4##(1990-5#1)(1991-5#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
to a concentration##16##3##(1990-5#1)(1991-5#1)(1994-5#1)(2008-10#8)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
to a condition##2##3##(2008-2#1)(2008-4#1)
to a considerable##2##3##(1990-8#1)(2010-3#1)
to a constant##2##3##(1991-9#1)(2009-7#1)
to a control group of##2##5##(2012-3#1)(2013-8#1)
to a control group##8##4##(1990-5#1)(2007-12#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
to a control##11##3##(1990-5#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#2)
to a controlled##3##3##(1996-1#1)(2008-10#2)
to a conventional##9##3##(1991-6#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-7#1)
to a converging##2##3##(2008-2#2)
to a correlation between##3##4##(2008-10#1)(2008-7#1)(2009-10#1)
to a corresponding##5##3##(1997-7#1)(2008-5#1)(2009-10#1)(2011-2#2)
to a critical##2##3##(2008-10#1)(2012-2#1)
to a crystallographic R-factor of##3##5##(1992-4#1)(1993-8#1)(1997-4#1)
to a culture of##2##4##(1990-11#1)(2011-2#1)
to a culture##3##3##(1990-11#1)(1996-7#1)(2011-2#1)
to a data set##2##4##(1997-4#1)(2008-10#1)
to a data##5##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to a decrease in the##14##5##(1990-5#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-4#1)(2013-1#1)
to a decrease in##33##4##(1990-5#1)(1990-6#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#5)(2008-3#2)(2008-5#3)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
to a decrease of##4##4##(1993-12#1)(2008-6#1)(2008-7#1)(2010-1#1)
to a decrease##38##3##(1990-5#1)(1990-6#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#6)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
to a decreased##7##3##(1990-11#1)(1990-7#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)
to a deeper##2##3##(1997-1#1)(2008-3#1)
to a defect in##2##4##(2008-5#1)(2008-9#1)
to a defect##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
to a defective##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
to a deficiency in the##2##5##(1993-3#1)(2013-1#1)
to a deficiency in##5##4##(1993-3#1)(1994-11#1)(2013-1#3)
to a deficiency of##3##4##(1990-8#1)(2009-5#1)(2011-2#1)
to a deficiency##8##3##(1990-8#1)(1993-3#1)(1994-11#1)(2009-5#1)(2011-2#1)(2013-1#3)
to a defined##3##3##(1990-8#1)(2008-10#2)
to a definition of the##2##5##(1996-9#1)(2008-10#1)
to a degree##2##3##(2008-3#1)(2008-9#1)
to a delay##2##3##(1991-3#1)(2009-5#1)
to a density of##2##4##(1994-8#1)(2008-11#1)
to a depth of##4##4##(2007-12#1)(2008-10#2)(2013-7#1)
to a desired##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2012-2#1)
to a detailed##2##3##(1991-12#1)(2008-9#1)
to a detection limit of##2##5##(1990-12#1)(2007-12#1)
to a detection limit##3##4##(1990-12#1)(2007-12#1)(2008-2#1)
to a detector##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
to a diagnosis of##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
to a diameter of##3##4##(1990-8#1)(2007-11#1)(2008-3#1)
to a difference in##4##4##(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)
to a difference##6##3##(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
to a different##12##3##(1992-2#1)(1994-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
to a differential##2##3##(1992-11#1)(2008-7#1)
to a direct action##2##4##(1991-6#1)(1992-6#1)
to a direct##10##3##(1990-5#2)(1991-3#1)(1991-6#1)(1992-6#1)(2008-10#3)(2008-11#1)(2009-7#1)
to a discipline##2##3##(2008-10#1)(2013-8#1)
to a disease##3##3##(1997-5#1)(2008-10#1)(2008-4#1)
to a distinct##4##3##(1994-9#1)(2008-10#2)(2008-7#1)
to a diverse array of##2##5##(2011-9#1)(2012-2#1)
to a diverse##5##3##(1997-3#1)(2007-12#1)(2009-6#1)(2011-9#1)(2012-2#1)
to a doctor##3##3##(1997-2#1)(2009-5#2)
to a dose of##3##4##(1997-3#1)(2008-6#1)(2009-11#1)
to a dose##4##3##(1997-3#1)(2008-10#1)(2008-6#1)(2009-11#1)
to a double##2##3##(1991-6#1)(1993-8#1)
to a dramatic##3##3##(1990-5#1)(1996-6#1)(1997-1#1)
to a duration of##2##4##(2007-12#1)(2008-2#1)
to a dynamic##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
to a factor of##7##4##(1990-11#1)(1992-3#1)(1995-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
to a failure in##2##4##(1995-2#1)(2012-12#1)
to a failure##4##3##(1994-12#1)(1995-2#1)(2008-5#1)(2012-12#1)
to a false##2##3##(2008-11#1)(2008-2#1)
to a family of##7##4##(1994-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#1)
to a fast##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
to a favorable##3##3##(1994-5#1)(1995-5#1)(2007-10#1)
to a few hours##2##4##(2010-12#1)(2010-8#1)
to a few minutes##2##4##(1996-12#1)(2008-10#1)
to a few##15##3##(1996-12#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
to a fiber##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
to a final##4##3##(1990-12#1)(1997-7#2)(2008-7#1)
to a finite##2##3##(1996-4#1)(1997-3#1)
to a fixed amount of##2##5##(1991-5#2)
to a fixed##7##3##(1991-5#2)(1991-6#1)(1994-2#1)(2007-12#1)(2010-1#1)(2013-1#1)
to a flame##4##3##(2008-10#4)
to a flattop beam##2##4##(2008-3#2)
to a flow cell##2##4##(2008-10#2)
to a flow injection##2##4##(2008-10#2)
to a flow##9##3##(2008-10#7)(2008-3#1)(2008-4#1)
to a flow-cell##2##3##(2008-10#2)
to a flow-injection##3##3##(2008-10#3)
to a fluorescent##2##3##(2008-10#1)(2008-4#1)
to a focal##2##3##(2008-3#1)(2008-8#1)
to a form of##2##4##(1991-9#1)(2011-2#1)
to a form that##2##4##(1991-5#1)(1992-8#1)
to a form##4##3##(1991-5#1)(1991-9#1)(1992-8#1)(2011-2#1)
to a fraction of##2##4##(1995-5#1)(2008-8#1)
to a frequency##2##3##(2007-11#1)(2008-8#1)
to a full##4##3##(1992-8#1)(1997-3#1)(2012-2#1)(2013-8#1)
to a functional##5##3##(1992-8#1)(1996-1#1)(2006-10#1)(2008-5#1)(2013-1#1)
to a further##3##3##(1994-11#1)(1997-1#1)(2007-2#1)
to a future##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
to a gas##2##3##(2008-10#2)
to a gene##5##3##(1993-3#1)(1995-11#1)(1996-6#1)(2008-5#1)(2008-7#1)
to a general##4##3##(2007-12#1)(2011-2#1)(2013-1#2)
to a generalized##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
to a genetic##4##3##(1993-6#1)(2008-10#2)(2008-8#1)
to a genetically##2##3##(1990-2#1)(1995-11#1)
to a geriatric##2##3##(1990-3#1)(1992-12#1)
to a given##15##3##(1990-11#1)(1991-5#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2011-2#1)(2012-2#1)
to a glass substrate##2##4##(2008-10#1)(2008-3#1)
to a glutamine##2##3##(1995-5#1)(2008-5#1)
to a good##3##3##(1991-1#1)(2008-12#1)(2008-3#1)
to a gradual##2##3##(2008-2#1)(2011-2#1)
to a great extent##13##4##(1990-12#2)(1992-3#1)(1992-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#2)
to a great##16##3##(1990-12#2)(1992-3#1)(1992-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#2)
to a greater degree than the##2##6##(1995-11#1)(2008-4#1)
to a greater degree than##4##5##(1991-6#1)(1995-11#1)(2008-10#1)(2008-4#1)
to a greater degree##7##4##(1991-6#1)(1992-3#1)(1993-11#1)(1995-11#1)(2008-10#1)(2008-4#1)(2009-6#1)
to a greater extent in##4##5##(1990-3#1)(1991-5#1)(1992-9#1)(2008-7#1)
to a greater extent than##7##5##(1990-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(2009-8#1)(2009-9#1)(2010-6#1)
to a greater extent##15##4##(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2013-1#1)
to a greater frequency of##2##5##(2008-5#1)(2010-11#1)
to a greater understanding of the##2##6##(2008-11#1)(2008-6#1)
to a greater understanding of##4##5##(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
to a greater##36##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#3)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#2)(2013-1#1)
to a greenhouse##2##3##(2008-10#2)
to a group of##14##4##(1992-5#1)(1994-2#1)(1995-5#2)(1996-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
to a group##17##3##(1992-5#1)(1994-2#1)(1994-5#1)(1995-5#2)(1996-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
to a growing##6##3##(2008-10#1)(2008-11#2)(2010-3#1)(2010-4#1)(2013-8#1)
to a half of##2##4##(2013-1#2)
to a halt##2##3##(1995-8#1)(2008-7#1)
to a health care##2##4##(1994-12#1)(2010-4#1)
to a health##4##3##(1994-12#1)(1994-9#1)(2010-4#1)(2013-1#1)
to a healthy##3##3##(2011-2#3)
to a heterologous promoter##2##4##(1997-3#2)
to a high degree of##5##5##(2008-10#1)(2008-3#2)(2008-5#1)(2010-7#1)
to a high degree##7##4##(1995-2#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-7#1)
to a high level of##2##5##(1997-4#1)(2008-10#1)
to a high level##6##4##(1995-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2013-1#1)
to a high mortality rate##2##5##(2010-12#1)(2011-2#1)
to a high rate of##4##5##(1991-9#1)(2008-6#1)(2010-11#1)(2011-2#1)
to a high##32##3##(1991-9#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
to a higher level##2##4##(2008-10#1)(2008-12#1)
to a higher power##2##4##(2008-12#1)(2012-3#1)
to a higher##23##3##(1991-6#1)(1992-2#1)(1993-8#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#4)(2008-7#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#1)
to a highly conserved##3##4##(1990-2#1)(1992-11#1)(1995-2#1)
to a highly sensitive##2##4##(2008-10#1)(2008-2#1)
to a highly##9##3##(1990-2#1)(1992-11#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#2)
to a homogeneous##2##3##(1996-7#1)(2008-7#1)
to a horizontal##2##3##(2008-2#1)(2008-3#1)
to a hospital##6##3##(1993-12#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-11#1)
to a host##3##3##(2008-10#2)(2008-8#1)
to a human##3##3##(1997-7#1)(2008-3#1)(2009-2#1)
to a hydraulic##2##3##(2008-2#1)(2008-3#1)
to a hypotonic challenge##2##4##(1990-2#2)
to a hypotonic##4##3##(1990-2#4)
to a key##2##3##(1992-11#1)(2009-8#1)
to a kinetic##2##3##(1991-3#1)(2007-1#1)
to a known##7##3##(1992-8#1)(1992-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)
to a lack of information##2##5##(2008-6#1)(2012-2#1)
to a lack of##11##4##(1995-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
to a large degree##2##4##(2008-10#1)(2008-9#1)
to a large extent##10##4##(1992-6#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
to a large number of##6##5##(1994-5#1)(2008-10#3)(2008-7#1)(2008-8#1)
to a large percentage of the##3##6##(2012-12#1)(2013-1#2)
to a large##44##3##(1990-12#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-8#1)(2007-11#2)(2007-8#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to a larger extent than##2##5##(2009-8#1)(2011-2#1)
to a larger extent##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
to a larger##9##3##(1993-6#1)(1996-1#1)(2008-10#3)(2008-7#2)(2009-8#1)(2011-2#1)
to a later##2##3##(1992-6#1)(2008-7#1)
to a less invasive test##2##5##(2013-1#2)
to a less##5##3##(1994-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
to a lesser degree##11##4##(1991-12#1)(1992-3#1)(1994-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
to a lesser extent in##3##5##(1995-12#1)(1997-2#1)(1997-9#1)
to a lesser extent than##5##5##(1991-12#2)(1995-8#1)(2008-10#1)(2012-2#1)
to a lesser extent##63##4##(1990-12#2)(1990-5#1)(1991-12#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)
to a lesser##76##3##(1990-12#2)(1990-5#1)(1991-12#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#2)(1997-7#1)(1997-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
to a lethal##3##3##(1995-5#1)(1997-4#1)(2008-12#1)
to a level below the##2##5##(2008-7#2)
to a level of##3##4##(2007-7#1)(2008-11#1)(2009-6#1)
to a level##12##3##(1993-12#1)(1997-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-6#1)(2012-3#1)
to a light##3##3##(1994-2#1)(2007-11#1)(2012-12#1)
to a limited number of##2##5##(2007-11#1)(2008-2#1)
to a limited##6##3##(1995-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
to a line##2##3##(2008-10#1)(2008-3#1)
to a linear increase##2##4##(2008-11#1)(2012-2#1)
to a linear##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
to a liquid##2##3##(2008-10#1)(2008-7#1)
to a liquid-crystal##2##3##(2008-2#1)(2008-3#1)
to a local##6##3##(1993-1#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
to a long##3##3##(2008-11#1)(2010-6#1)(2010-8#1)
to a longer##2##3##(1994-8#1)(2008-7#1)
to a loss of##6##4##(1990-5#1)(1992-12#2)(2008-11#2)(2008-3#1)
to a loss##7##3##(1990-5#1)(1992-12#2)(2007-7#1)(2008-11#2)(2008-3#1)
to a low level##5##4##(1995-11#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
to a low##16##3##(1992-3#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-7#3)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)
to a lower level in##2##5##(1990-3#1)(2008-7#1)
to a lower temperature##2##4##(1995-8#1)(2008-7#1)
to a lower##16##3##(1990-3#1)(1993-5#1)(1994-3#1)(1995-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-7#3)(2009-9#1)(2013-1#1)
to a magnification##2##3##(2008-3#1)(2008-9#1)
to a major gene##3##4##(2008-10#2)(2008-8#1)
to a major quantitative trait locus##2##6##(2008-10#2)
to a major##10##3##(1991-5#1)(1991-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#1)(2010-5#1)
to a managed care##2##4##(1996-12#1)(1996-2#1)
to a marked##5##3##(1994-8#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-5#1)
to a mass spectrometer##3##4##(2008-10#2)(2008-4#1)
to a mass##5##3##(2008-10#3)(2008-4#1)(2012-2#1)
to a massive##2##3##(2008-7#1)(2009-6#1)
to a maximum of 2##3##5##(1994-5#1)(2008-10#1)(2008-5#1)
to a maximum of##9##4##(1990-3#1)(1994-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2009-9#1)
to a maximum##19##3##(1990-3#1)(1993-3#1)(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-5#1)(2009-11#1)(2009-8#1)(2009-9#1)
to a mean of##2##4##(1990-11#1)(2013-1#1)
to a mean##4##3##(1990-11#1)(1995-12#1)(2008-10#1)(2013-1#1)
to a measurable##2##3##(1995-12#1)(2007-11#1)
to a median of##3##4##(1990-2#2)(1997-3#1)
to a medical service##2##4##(2007-2#1)(2008-3#1)
to a medical##3##3##(2007-2#1)(2007-9#1)(2008-3#1)
to a membrane##7##3##(1991-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-4#3)
to a mild##2##3##(2007-2#1)(2008-4#1)
to a miniature##2##3##(2008-1#1)(2012-12#1)
to a minimum##11##3##(1990-11#1)(1992-12#1)(2007-11#1)(2007-5#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
to a mixed meal##2##4##(1994-12#1)(2012-3#1)
to a mixture of##3##4##(1995-3#1)(2008-10#2)
to a model for##2##4##(1992-3#1)(1993-8#1)
to a model##7##3##(1992-3#1)(1993-8#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-3#1)
to a modified##2##3##(1993-11#1)(2008-6#1)
to a modulated##2##3##(2008-3#1)(2008-5#1)
to a molar ratio of##2##5##(1990-5#1)(1992-12#1)
to a molar##3##3##(1990-5#1)(1992-12#1)(2011-2#1)
to a molecule##2##3##(2008-4#1)(2010-7#1)
to a monoclonal##2##3##(1993-8#1)(2008-5#1)
to a more aggressive##2##4##(2013-1#2)
to a more##38##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1997-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
to a much lesser extent##2##5##(1990-11#1)(2008-11#1)
to a much##6##3##(1990-11#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-11#2)
to a multimode##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
to a mutation in##3##4##(2008-10#2)(2008-9#1)
to a mutation##4##3##(2008-10#3)(2008-9#1)
to a nadir of##2##4##(1991-8#1)(2007-12#1)
to a narrow##4##3##(1997-1#1)(2008-2#2)(2008-3#1)
to a national health##2##4##(1993-12#1)(2008-7#1)
to a national##4##3##(1992-12#2)(1993-12#1)(2008-7#1)
to a need##2##3##(1996-3#1)(2007-11#1)
to a negative##3##3##(1990-8#1)(2007-12#1)(2008-8#1)
to a negligible##3##3##(2008-3#2)(2009-10#1)
to a network##2##3##(1990-12#1)(2008-7#1)
to a new and##2##4##(2008-11#2)
to a new category of##2##5##(1995-6#1)(2008-2#1)
to a new family##2##4##(2007-11#1)(2013-8#1)
to a new level of##2##5##(1994-2#1)(1997-3#1)
to a new##52##3##(1990-2#1)(1990-8#1)(1992-12#1)(1992-9#2)(1993-2#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to a newly##2##3##(2008-10#1)(2011-1#1)
to a non-specific##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
to a nonlinear##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
to a nonuniform##2##3##(2008-2#1)(2008-3#1)
to a normal level##2##4##(1991-5#1)(2007-8#1)
to a normal##5##3##(1991-5#1)(1992-5#1)(1994-8#1)(2007-8#1)(2009-7#1)
to a normalized##2##3##(2008-3#1)(2008-6#1)
to a novel##8##3##(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#1)(2013-1#1)
to a nuclear##2##3##(1997-7#1)(2008-7#1)
to a number of different##2##5##(1990-12#1)(1994-2#1)
to a number of factors##2##5##(2008-10#1)(2008-7#1)
to a number of other##2##5##(1992-12#1)(2008-7#1)
to a number of the##2##5##(2008-2#1)(2010-8#1)
to a number of##37##4##(1990-12#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-2#1)(1996-3#1)(1996-5#1)(2006-10#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
to a nursing home##2##4##(1994-2#1)(2010-10#1)
to a one##2##3##(1993-12#1)(2008-11#1)
to a pair of##2##4##(2008-11#1)(2008-3#1)
to a panel of##2##4##(1992-11#1)(1992-9#1)
to a parallel##4##3##(1991-5#1)(2008-3#1)(2008-5#1)(2013-1#1)
to a part in##2##4##(2008-3#2)
to a partial##4##3##(1994-6#1)(1995-2#1)(1996-8#1)(2008-9#1)
to a partially##2##3##(1993-11#1)(1996-5#1)
to a particular##22##3##(1991-9#1)(1993-12#1)(1995-5#1)(1996-2#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-4#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
to a patient with##6##4##(2008-11#3)(2009-5#1)(2012-3#1)(2013-1#1)
to a patient##7##3##(2008-11#3)(2009-5#1)(2012-3#1)(2013-1#2)
to a patient's##2##3##(2008-9#1)(2012-3#1)
to a pattern of##2##4##(1993-6#1)(2008-2#1)
to a peak##6##3##(1994-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-7#1)
to a pediatric##3##3##(2008-7#1)(2010-11#1)(2011-2#1)
to a peptide##3##3##(1990-5#1)(1995-6#1)(2008-5#1)
to a person##2##3##(2010-8#1)(2011-2#1)
to a personal computer##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2010-8#1)
to a phase change of##2##5##(2007-11#1)(2008-10#1)
to a phase##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
to a phylogenetically##2##3##(2008-10#1)(2011-2#1)
to a physical##2##3##(1997-2#1)(2008-12#1)
to a plastic##2##3##(1990-10#1)(1990-12#1)
to a plateau##2##3##(2008-10#1)(2008-9#1)
to a point where##2##4##(1996-3#1)(2010-3#1)
to a point##4##3##(1995-5#1)(1996-3#1)(2008-3#1)(2010-3#1)
to a polar##2##3##(1995-2#1)(2008-3#1)
to a polymeric##2##3##(2008-10#1)(2008-5#1)
to a polypeptide of##2##4##(1990-5#1)(1995-6#1)
to a population of##3##4##(1995-2#1)(2008-10#1)(2011-2#1)
to a population##5##3##(1995-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
to a position##3##3##(1994-12#1)(1994-8#1)(2008-5#1)
to a positive##4##3##(1997-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
to a possible##3##3##(1990-8#1)(1991-2#1)(2010-3#1)
to a power##3##3##(2008-7#3)
to a practical##3##3##(1997-7#1)(2008-2#1)(2012-3#1)
to a precise##2##3##(1993-9#1)(1994-9#1)
to a predator##4##3##(2008-6#1)(2008-8#2)(2010-8#1)
to a predefined##2##3##(1993-1#1)(2012-12#1)
to a predetermined##2##3##(1993-12#1)(2012-2#1)
to a prescribed##2##3##(2008-3#1)(2008-7#1)
to a previous##3##3##(2008-10#2)(2012-3#1)
to a previously proposed##2##4##(2008-10#1)(2008-3#1)
to a previously published##2##4##(1992-6#1)(2010-2#1)
to a previously reported##2##4##(1993-8#1)(2007-8#1)
to a previously##9##3##(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-2#1)
to a primary##4##3##(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
to a product##2##3##(1996-8#1)(2008-5#1)
to a progressive##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
to a projected##2##3##(1996-1#1)(2007-11#1)
to a proper##2##3##(1996-11#1)(2008-3#1)
to a proposed##2##3##(2008-3#1)(2008-6#1)
to a protein of##3##4##(1995-8#1)(1996-10#1)(2008-1#1)
to a protein##10##3##(1992-3#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-4#1)
to a psychiatric##3##3##(2009-7#1)(2011-2#1)(2012-12#1)
to a putative##5##3##(1992-8#1)(1996-6#1)(1997-3#1)(2008-7#1)(2012-2#1)
to a pyrethroid##2##3##(1997-5#2)
to a quantitative##2##3##(2008-3#2)
to a quarter of the##2##5##(2007-11#1)(2012-1#1)
to a questionnaire##6##3##(1990-6#1)(1996-1#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
to a random sample of##3##5##(1991-3#1)(2009-4#1)(2011-1#1)
to a random##5##3##(1991-12#1)(1991-3#1)(2008-2#1)(2009-4#1)(2011-1#1)
to a randomized sample of##2##5##(1993-2#1)(1995-12#1)
to a randomized##3##3##(1993-2#1)(1995-12#1)(1997-4#1)
to a range of##14##4##(1990-12#1)(1992-6#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-4#1)(2010-5#1)
to a range##15##3##(1990-12#1)(1992-6#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2010-5#1)
to a rapid and##3##4##(1990-12#1)(1997-1#1)(2010-6#1)
to a rapid##6##3##(1990-12#2)(1990-8#1)(1997-1#1)(2008-11#1)(2010-6#1)
to a rapidly##2##3##(1994-12#1)(2013-8#1)
to a rare##2##3##(2008-11#1)(2008-12#1)
to a reaction##2##3##(2010-2#1)(2013-1#1)
to a reactive##2##3##(2008-10#1)(2008-7#1)
to a real##2##3##(2008-10#1)(2008-8#1)
to a reasonable##3##3##(1990-8#1)(1992-2#1)(2008-2#1)
to a recent##7##3##(1990-6#1)(1995-5#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-12#1)(2012-2#1)
to a recently described##2##4##(1991-7#1)(2013-1#1)
to a recently##3##3##(1991-7#1)(1992-8#1)(2013-1#1)
to a recipient strain##2##4##(2008-10#2)
to a recorded##2##3##(2008-5#1)(2011-2#1)
to a reduced##6##3##(1995-12#2)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
to a reduction in the##11##5##(1991-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#3)(2013-8#1)
to a reduction in##21##4##(1990-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-3#6)(2008-7#1)(2013-8#1)
to a reduction of##7##4##(1991-2#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)
to a reduction##28##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-3#1)(2008-10#4)(2008-11#2)(2008-3#6)(2008-5#1)(2008-7#2)(2010-4#1)(2013-8#1)
to a reference material##2##4##(1996-9#1)(2008-10#1)
to a reference##6##3##(1996-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
to a referral##2##3##(1994-6#1)(2012-2#1)
to a regime##2##3##(2007-11#1)(2008-12#1)
to a region of chromosome##2##5##(1993-12#1)(1994-11#1)
to a region of##6##4##(1990-5#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-6#1)(2012-2#1)
to a region##7##3##(1990-5#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-6#1)(2008-10#1)(2012-2#1)
to a regional hospital##2##4##(1995-5#2)
to a related##2##3##(2008-10#1)(2011-2#1)
to a relative##2##3##(2008-10#1)(2009-5#1)
to a relatively##4##3##(1992-6#1)(1993-6#1)(2007-12#1)(2008-9#1)
to a renewed interest in##2##5##(2011-2#2)
to a reported##2##3##(1990-2#1)(2011-1#1)
to a resolution##2##3##(1992-9#1)(2010-10#1)
to a response##5##3##(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
to a restricted##2##3##(1994-2#1)(2008-3#1)
to a retained##2##3##(2008-12#1)(2012-2#1)
to a reverse##3##3##(1991-8#1)(1997-6#1)(2008-9#1)
to a review of##2##4##(2008-10#1)(2008-11#1)
to a revised##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
to a rise in##4##4##(1994-12#1)(1994-6#1)(2011-2#1)(2013-8#1)
to a river##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
to a role for##4##4##(1991-9#1)(1992-7#1)(1995-8#1)(2008-7#1)
to a role##5##3##(1991-9#1)(1992-7#1)(1995-8#1)(2008-4#1)(2008-7#1)
to a ruptured##2##3##(2008-7#1)(2013-8#1)
to a safer##2##3##(1997-4#1)(2008-11#1)
to a sample of##5##4##(1994-2#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)
to a sample##12##3##(1992-8#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)
to a scattering##2##3##(2007-12#1)(2008-3#1)
to a scientific##2##3##(2009-10#1)(2009-5#1)
to a second tone##2##4##(1996-5#2)
to a second##10##3##(1990-11#1)(1992-3#1)(1996-5#2)(1997-3#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
to a secondary##5##3##(1995-6#1)(2008-3#2)(2008-6#2)
to a sensitive##2##3##(2008-10#2)
to a separate##2##3##(2008-10#1)(2008-7#1)
to a separation##2##3##(2008-10#1)(2008-3#1)
to a sequence of##2##4##(1995-6#1)(1996-2#1)
to a sequence##8##3##(1992-8#1)(1993-6#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-7#1)
to a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides##2##5##(2008-10#2)
to a series of##9##4##(1990-2#1)(1991-9#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#3)(2013-1#1)
to a series##10##3##(1990-2#1)(1991-9#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#3)(2010-11#1)(2013-1#1)
to a serine##3##3##(1995-2#2)(2008-10#1)
to a service##2##3##(1991-12#2)
to a set of##15##4##(1992-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
to a set point##2##4##(2008-6#2)
to a set##17##3##(1992-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
to a severe##5##3##(1997-6#1)(2008-2#1)(2011-1#2)(2013-1#1)
to a shallow##3##3##(2011-2#2)(2013-8#1)
to a sharp##4##3##(1993-3#1)(2007-12#1)(2009-6#1)(2012-2#1)
to a shear stress##3##4##(2008-11#2)(2010-1#1)
to a shear##4##3##(2008-11#3)(2010-1#1)
to a shearing interferometer##2##4##(2008-3#2)
to a shift in the##4##5##(1990-7#1)(1993-12#1)(2008-10#1)(2008-2#1)
to a shift##7##3##(1990-7#1)(1993-12#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
to a short##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
to a short-term##2##3##(1995-12#1)(2007-12#1)
to a signal##4##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
to a significant decrease in the##2##6##(1994-6#1)(2008-11#1)
to a significant decrease in##5##5##(1994-6#1)(2008-10#1)(2008-11#2)(2009-11#1)
to a significant degree##2##4##(2008-11#1)(2008-4#1)
to a significant enhancement##2##4##(1997-2#1)(2007-12#1)
to a significant extent##3##4##(1991-6#1)(2008-4#1)(2008-7#1)
to a significant improvement of the##2##6##(2008-10#1)(2008-3#1)
to a significant improvement##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
to a significant increase in##3##5##(1993-12#1)(2007-11#1)(2013-8#1)
to a significant increase##4##4##(1993-12#1)(2007-11#1)(2008-11#1)(2013-8#1)
to a significant reduction in##4##5##(2008-10#1)(2008-7#1)(2009-4#1)(2011-10#1)
to a significant reduction of##2##5##(2008-10#1)(2008-6#1)
to a significant reduction##6##4##(2008-10#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-10#1)
to a significant##33##3##(1991-6#1)(1993-12#1)(1994-1#1)(1994-6#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2011-10#1)(2011-2#1)(2013-1#3)(2013-8#2)
to a significantly higher##2##4##(2008-5#2)
to a significantly##5##3##(1995-2#1)(1997-9#1)(2007-8#1)(2008-5#2)
to a similar degree as##2##5##(2008-7#1)(2012-12#1)
to a similar degree##6##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
to a similar extent in##2##5##(1994-6#1)(2013-8#1)
to a similar extent##4##4##(1990-8#1)(1994-6#1)(1995-11#1)(2013-8#1)
to a similar##17##3##(1990-12#1)(1990-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
to a simple##12##3##(1991-3#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
to a simplified##2##3##(1992-8#1)(2012-2#1)
to a simulated##4##3##(2009-7#1)(2012-3#2)(2013-1#1)
to a single gene##2##4##(1990-12#1)(2008-8#1)
to a single image##2##4##(2007-11#1)(2008-2#1)
to a single##52##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#12)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2010-12#1)(2011-10#1)(2011-2#2)(2013-1#1)
to a single-mode fiber##2##4##(2008-2#1)(2008-3#1)
to a single-mode##4##3##(2008-2#2)(2008-3#2)
to a sinusoidal##2##3##(2008-2#1)(2009-4#1)
to a site##2##3##(2008-10#1)(2008-5#1)
to a slow##2##3##(2008-3#1)(2008-7#1)
to a slowly##2##3##(1990-5#1)(1997-6#1)
to a small amount of##2##5##(2008-2#1)(2010-12#1)
to a small area of##2##5##(1991-8#1)(2008-5#1)
to a small area##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
to a small molecule target##2##5##(2008-4#2)
to a small number of##2##5##(2008-10#1)(2008-8#1)
to a small##23##3##(1990-5#1)(1990-8#1)(1991-8#1)(1992-8#1)(1995-3#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
to a smaller extent##2##4##(1995-11#1)(2008-10#1)
to a smaller##4##3##(1995-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
to a sodium atom##2##4##(1996-2#2)
to a solid##5##3##(2008-2#1)(2008-3#1)(2008-4#2)(2013-1#1)
to a solution of##2##4##(2008-11#1)(2008-3#1)
to a solution##4##3##(1994-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
to a source##2##3##(1996-4#1)(2008-5#1)
to a special##2##3##(1992-6#1)(1996-8#1)
to a specialist##4##3##(1995-3#1)(2008-11#1)(2013-8#2)
to a species##3##3##(1992-10#1)(2008-10#2)
to a specific region##2##4##(1993-9#1)(2011-2#1)
to a specific target##2##4##(2008-7#1)(2008-9#1)
to a specific##38##3##(1990-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-12#1)(1995-9#1)(1997-7#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
to a spherical##2##3##(2007-12#1)(2008-3#1)
to a stable##8##3##(1990-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(2007-12#2)(2008-6#1)(2008-8#1)
to a stage##2##3##(2008-7#1)(2009-10#1)
to a standard##12##3##(1990-12#1)(1996-8#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
to a standardized##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
to a steady##2##3##(1993-12#1)(2010-3#1)
to a steady-state##2##3##(1995-6#1)(2009-5#1)
to a stimulation##2##3##(2008-5#2)
to a stimulus##3##3##(2008-11#1)(2010-5#1)(2013-1#1)
to a strong##4##3##(1997-3#1)(2008-10#2)(2009-5#1)
to a structure##2##3##(1993-8#1)(2008-6#1)
to a study of the##2##5##(2007-11#1)(2009-5#1)
to a study of##4##4##(1993-3#1)(1997-8#1)(2007-11#1)(2009-5#1)
to a study on##2##4##(2008-11#1)(2008-2#1)
to a study##6##3##(1993-3#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-5#1)
to a subsequent##2##3##(1991-9#1)(1995-5#1)
to a subset of patients##2##5##(1997-8#1)(2008-7#1)
to a subset of##3##4##(1997-8#2)(2008-7#1)
to a substantial##5##3##(1992-2#1)(1993-6#1)(2008-10#1)(2011-2#1)(2012-2#1)
to a substrate##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
to a successful##5##3##(1991-12#1)(1996-1#1)(2008-1#1)(2008-9#1)(2009-9#1)
to a sudden##2##3##(1995-6#1)(2008-11#1)
to a suitable##2##3##(2008-10#1)(2008-8#1)
to a suppression##2##3##(1993-12#1)(2011-1#1)
to a surface plasmon##2##4##(2008-10#1)(2008-3#1)
to a surface##5##3##(2008-10#1)(2008-3#2)(2008-9#1)(2013-8#1)
to a survey##2##3##(1994-1#1)(2008-10#1)
to a suspension of##2##4##(1990-11#1)(2008-10#1)
to a system of##2##4##(2007-11#1)(2008-10#1)
to a system##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-6#1)
to a systematic##2##3##(2009-8#1)(2010-4#1)
to a target##3##3##(2008-2#2)(2008-3#1)
to a temperature##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
to a tertiary care hospital##2##5##(1997-3#1)(2008-3#1)
to a tertiary##3##3##(1997-3#1)(2008-3#1)(2012-2#1)
to a theoretical model##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
to a theoretical##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
to a third##2##3##(1990-5#1)(2008-10#1)
to a threshold##2##3##(2008-8#1)(2009-8#1)
to a time##2##3##(2007-11#1)(2007-12#1)
to a total of##5##4##(1990-11#1)(1997-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
to a total##8##3##(1990-11#1)(1991-2#1)(1992-10#1)(1997-2#1)(2008-10#1)(2008-6#1)(2009-11#1)(2012-2#1)
to a toxicant##2##3##(2008-9#2)
to a transient##2##3##(1997-1#1)(2008-10#1)
to a two-chain##2##3##(1992-12#2)
to a typical##5##3##(2007-12#1)(2008-3#1)(2008-6#2)(2008-7#1)
to a tyrosine residue##2##4##(1992-1#1)(1993-11#1)
to a ubiquitous##2##3##(1994-8#1)(2008-10#1)
to a unique##5##3##(1991-11#1)(1992-3#1)(2008-2#1)(2008-4#1)(2012-2#1)
to a value##4##3##(1992-3#1)(1992-8#1)(2008-3#1)(2009-5#1)
to a variable##3##3##(1993-6#1)(1997-3#1)(2012-2#1)
to a variation##2##3##(2007-12#1)(2008-3#1)
to a variety of other##2##5##(2008-4#1)(2008-9#1)
to a variety of stimuli##2##5##(1992-11#1)(2008-4#1)
to a variety of##46##4##(1992-11#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-5#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-2#3)(2012-3#1)
to a very stable##2##4##(2008-10#2)
to a very##6##3##(2008-10#5)(2010-10#1)
to a vicious cycle of##2##5##(1994-2#1)(2012-12#1)
to a visual##3##3##(1996-2#1)(2008-10#2)
to a warm##2##3##(2012-4#1)(2012-6#1)
to a weak##3##3##(1994-11#1)(1997-7#1)(2007-5#1)
to a well##2##3##(2008-10#1)(2011-1#1)
to a wide array of##2##5##(2008-10#1)(2009-8#1)
to a wide range of##10##5##(1990-2#1)(1992-11#1)(1994-6#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#2)
to a wide spectrum of##3##5##(2008-6#1)(2008-7#1)(2011-2#1)
to a wide variety of other##2##6##(2008-10#1)(2011-3#1)
to a wide variety of##7##5##(1995-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-3#1)(2012-3#1)
to a wide##27##3##(1990-2#1)(1991-12#1)(1992-11#1)(1994-6#1)(1995-3#1)(1997-3#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#3)(2011-3#1)(2012-3#1)
to a wider##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
to a woman##2##3##(1991-12#1)(1993-11#1)
to a working##2##3##(2008-10#1)(2008-2#1)
to a##3482##2##(1990-10#4)(1990-11#17)(1990-12#24)(1990-2#17)(1990-3#8)(1990-5#28)(1990-6#4)(1990-7#6)(1990-8#18)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#22)(1991-2#5)(1991-3#12)(1991-5#18)(1991-6#21)(1991-7#3)(1991-8#8)(1991-9#12)(1992-1#3)(1992-10#3)(1992-11#13)(1992-12#15)(1992-2#6)(1992-3#21)(1992-4#1)(1992-5#3)(1992-6#18)(1992-7#1)(1992-8#25)(1992-9#9)(1993-1#5)(1993-11#13)(1993-12#33)(1993-2#11)(1993-3#13)(1993-5#2)(1993-6#16)(1993-8#20)(1993-9#8)(1994-1#4)(1994-11#12)(1994-12#17)(1994-2#28)(1994-3#15)(1994-5#19)(1994-6#13)(1994-7#1)(1994-8#18)(1994-9#7)(1995-1#1)(1995-11#14)(1995-12#24)(1995-2#32)(1995-3#23)(1995-5#23)(1995-6#21)(1995-8#15)(1995-9#2)(1996-1#12)(1996-10#2)(1996-11#4)(1996-12#14)(1996-2#17)(1996-3#14)(1996-4#3)(1996-5#16)(1996-6#7)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#15)(1997-2#22)(1997-3#31)(1997-4#16)(1997-5#6)(1997-6#14)(1997-7#27)(1997-8#7)(1997-9#2)(2006-10#3)(2006-12#2)(2007-1#1)(2007-10#8)(2007-11#59)(2007-12#84)(2007-2#8)(2007-4#1)(2007-5#7)(2007-6#2)(2007-7#12)(2007-8#23)(2007-9#3)(2008-1#25)(2008-10#566)(2008-11#156)(2008-12#32)(2008-2#109)(2008-3#210)(2008-4#63)(2008-5#94)(2008-6#50)(2008-7#143)(2008-8#63)(2008-9#62)(2009-1#2)(2009-10#14)(2009-11#18)(2009-12#7)(2009-2#2)(2009-3#6)(2009-4#8)(2009-5#22)(2009-6#13)(2009-7#13)(2009-8#16)(2009-9#9)(2010-1#7)(2010-10#11)(2010-11#15)(2010-12#7)(2010-2#6)(2010-3#14)(2010-4#12)(2010-5#14)(2010-6#10)(2010-7#8)(2010-8#12)(2010-9#9)(2011-1#38)(2011-10#2)(2011-2#104)(2011-3#2)(2011-9#1)(2012-1#6)(2012-12#33)(2012-2#58)(2012-3#36)(2012-4#1)(2012-6#1)(2013-1#98)(2013-7#5)(2013-8#48)
to abandon the##2##3##(1991-6#1)(2007-11#1)
to abandon their##2##3##(1996-6#1)(2008-9#1)
to abandon##7##2##(1991-6#1)(1993-1#1)(1993-9#1)(1996-6#1)(2007-11#1)(2007-2#1)(2008-9#1)
to abdominal hysterectomy##2##3##(1995-3#1)(2013-1#1)
to abdominal##9##2##(1992-6#1)(1993-12#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2010-8#2)(2013-1#1)
to aberrant##2##2##(1995-9#1)(2009-12#1)
to ablate##4##2##(1991-2#1)(2007-12#1)(2008-5#1)(2013-1#1)
to abnormal##9##2##(1992-6#1)(1994-9#1)(1997-7#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
to abolish the##2##3##(1990-11#1)(1992-7#1)
to abolish##4##2##(1990-11#1)(1992-7#1)(1997-5#1)(2007-8#1)
to abortion##5##2##(1990-8#1)(1992-6#1)(1993-3#1)(1996-8#1)(2013-1#1)
to about 0##4##3##(1990-7#1)(2008-10#3)
to about 2##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
to about 20##3##3##(1997-4#1)(2008-10#2)
to about 4##4##3##(1996-6#1)(1997-4#1)(2008-10#1)(2012-12#1)
to about 40%##2##3##(1994-8#1)(2010-8#1)
to about 5##2##3##(1995-5#1)(2008-7#1)
to about one##2##3##(2008-10#1)(2008-7#1)
to about##50##2##(1990-7#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-4#2)(1996-6#2)(1997-4#2)(1997-6#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-7#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
to abrogate##2##2##(2008-11#1)(2008-8#1)
to abscess formation##2##3##(2006-10#1)(2012-2#1)
to absolute##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2010-8#1)
to absorb##6##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
to absorbed##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
to absorption and emission##2##4##(2008-10#1)(2008-3#1)
to absorption of##3##3##(2007-11#1)(2008-3#2)
to absorption##10##2##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#4)
to abuse##3##2##(1993-12#1)(1995-5#1)(1996-2#1)
to academic achievement##2##3##(2009-7#1)(2010-1#1)
to academic knowledge##2##3##(1996-3#1)(2011-2#1)
to academic##9##2##(1996-3#1)(2007-4#1)(2007-8#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
to accelerate bone healing##2##4##(2008-5#2)
to accelerate the##11##3##(1994-2#1)(1995-2#1)(2008-10#5)(2008-2#1)(2008-6#1)(2010-5#1)(2012-3#1)
to accelerate##20##2##(1994-2#1)(1995-2#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2012-3#2)
to accelerated##2##2##(1992-8#1)(2011-1#1)
to accept the##8##3##(1992-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-6#1)(1997-8#1)(2008-11#1)
to accept##24##2##(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2009-5#1)(2012-3#1)
to acceptable##2##2##(2008-12#1)(2008-5#1)
to acceptance##2##2##(2012-12#1)(2013-8#1)
to accepted##6##2##(1991-11#1)(1994-3#2)(2007-11#1)(2008-12#1)(2008-7#1)
to acceptor##3##2##(1994-5#1)(2008-10#1)(2009-10#1)
to access and utilise##2##4##(2008-11#1)(2008-4#1)
to access and##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)
to access site##2##3##(2007-7#1)(2011-2#1)
to access the##9##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2010-5#1)(2011-1#1)
to access to##3##3##(1996-3#1)(2008-1#1)(2013-1#1)
to access##44##2##(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#2)
to acclimate to##2##3##(2012-5#1)(2013-1#1)
to accommodate a##2##3##(2008-11#1)(2012-3#1)
to accommodate both##3##3##(1992-2#2)(1997-2#1)
to accommodate the##7##3##(1994-3#2)(2007-12#2)(2010-10#1)(2011-3#1)(2013-8#1)
to accommodate these##3##3##(1992-1#1)(2008-10#1)(2008-6#1)
to accommodate this##2##3##(1994-3#1)(2010-10#1)
to accommodate##42##2##(1992-1#1)(1992-2#2)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#3)(1995-2#1)(1995-6#2)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
to accompany##5##2##(1992-11#1)(1992-12#1)(2008-3#1)(2009-5#1)(2012-2#1)
to accompanying##2##2##(2007-8#1)(2008-12#1)
to accomplish the##7##3##(1995-12#1)(2008-10#2)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#1)
to accomplish this##8##3##(1992-3#1)(1994-2#1)(1996-12#1)(2008-4#1)(2008-9#2)(2012-2#1)(2013-1#1)
to accomplish##32##2##(1991-1#1)(1992-1#1)(1992-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#2)(2013-1#2)
to account for a##2##4##(1997-7#1)(2008-2#1)
to account for changes in##2##5##(2008-10#2)
to account for differences in##2##5##(1991-3#1)(2012-2#1)
to account for most##2##4##(1995-6#1)(2008-10#1)
to account for multiple##2##4##(2008-3#2)
to account for the effects of##2##6##(2008-10#2)
to account for the##33##4##(1990-8#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-12#2)(2007-4#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
to account for this##2##4##(1992-2#1)(1997-3#1)
to account for varying##2##4##(2008-10#1)(2010-11#1)
to account for##72##3##(1990-8#3)(1991-12#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to account##74##2##(1990-8#3)(1991-12#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to accountability##2##2##(1997-3#1)(2011-2#1)
to accounts##2##2##(1994-2#1)(2011-1#1)
to accredit##2##2##(1994-12#1)(2008-11#1)
to accrue##2##2##(1992-12#1)(2010-3#1)
to accumulate in the food chain##2##6##(2008-10#2)
to accumulate in the##4##4##(2008-10#2)(2010-2#1)(2011-2#1)
to accumulate in##7##3##(2008-10#3)(2008-11#1)(2009-3#1)(2010-2#1)(2011-2#1)
to accumulate the##2##3##(1994-5#1)(2008-10#1)
to accumulate##27##2##(1990-2#1)(1994-5#2)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
to accumulation of##5##3##(1992-4#1)(1994-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
to accumulation##7##2##(1992-4#1)(1993-9#1)(1994-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
to accuracy##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
to accurate##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
to accurately assess the##3##4##(2008-7#1)(2009-11#1)(2011-2#1)
to accurately assess##4##3##(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
to accurately determine##3##3##(1994-3#1)(2008-10#1)(2012-2#1)
to accurately evaluate the##2##4##(1991-12#1)(2008-10#1)
to accurately identify##3##3##(2008-10#1)(2009-7#1)(2010-3#1)
to accurately measure##2##3##(2007-12#1)(2008-10#1)
to accurately predict the##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
to accurately predict##5##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
to accurately##35##2##(1991-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
to acesulfame potassium##5##3##(2008-9#5)
to acetaldehyde##3##2##(1994-5#1)(2008-10#1)(2009-8#1)
to acetate##2##2##(2008-6#1)(2009-10#1)
to acetic acid##4##3##(1992-11#1)(2009-8#1)(2012-2#2)
to acetoin##3##2##(2013-1#3)
to acetone##2##2##(2008-10#1)(2009-12#1)
to acetyl-CoA##2##2##(1995-6#1)(2013-1#1)
to acetylated forms of ganglioside GD3##2##6##(1992-9#2)
to acetylcholine##2##2##(2009-12#1)(2013-8#1)
to acetylcholinesterase##2##2##(1997-7#1)(2008-9#1)
to achieve a further##2##4##(1992-3#1)(1994-3#1)
to achieve a good##3##4##(1993-12#1)(2008-10#1)(2008-5#1)
to achieve a high##6##4##(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
to achieve a maximum##2##4##(2008-10#1)(2008-3#1)
to achieve a more##2##4##(1991-9#1)(1996-1#1)
to achieve a satisfactory##2##4##(2007-8#1)(2013-7#1)
to achieve a suitable##2##4##(2011-2#2)
to achieve a therapeutic##2##4##(1992-3#1)(2010-6#1)
to achieve a##56##3##(1991-9#1)(1992-3#2)(1992-9#1)(1993-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
to achieve accurate##2##3##(1994-2#1)(2008-2#1)
to achieve adequate##4##3##(2006-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
to achieve all##3##3##(1994-2#1)(2008-11#1)(2012-2#1)
to achieve an##14##3##(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
to achieve and maintain##2##4##(2008-10#1)(2010-12#1)
to achieve and##4##3##(2008-10#1)(2008-11#2)(2010-12#1)
to achieve appropriate##2##3##(2008-10#1)(2013-1#1)
to achieve best##2##3##(1995-5#1)(2008-3#1)
to achieve better##2##3##(1997-8#1)(2013-1#1)
to achieve clinical##2##3##(1992-6#1)(2009-4#1)
to achieve complete##4##3##(2008-11#1)(2010-12#1)(2010-9#1)(2011-2#1)
to achieve desired##2##3##(2008-1#1)(2008-10#1)
to achieve different##2##3##(2008-10#1)(2008-3#1)
to achieve early detection of##2##5##(2008-10#1)(2009-4#1)
to achieve excellent##2##3##(2008-3#1)(2008-9#1)
to achieve full##2##3##(1992-12#1)(2008-10#1)
to achieve functional##2##3##(2011-2#1)(2012-2#1)
to achieve good##2##3##(2007-11#1)(2011-1#1)
to achieve greater##5##3##(1993-1#1)(1994-1#1)(2007-12#1)(2008-11#1)(2008-3#1)
to achieve high resolution##2##4##(2008-10#1)(2008-3#1)
to achieve high sensitivity##2##4##(2008-10#1)(2008-3#1)
to achieve high##11##3##(1990-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#1)
to achieve improved##3##3##(1996-2#1)(2008-3#1)(2013-1#1)
to achieve in##2##3##(2008-11#1)(2013-1#1)
to achieve its##4##3##(1991-12#1)(1996-3#1)(2007-4#1)(2011-1#1)
to achieve maximal##2##3##(1995-8#1)(2008-2#1)
to achieve maximum##4##3##(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
to achieve more##2##3##(1992-3#1)(2010-11#1)
to achieve optimal##5##3##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
to achieve quality##2##3##(1991-3#1)(1996-2#1)
to achieve rapid##2##3##(2008-11#1)(2012-12#1)
to achieve safe##2##3##(2010-12#1)(2011-2#1)
to achieve satisfactory results##2##4##(2010-12#2)
to achieve satisfactory##3##3##(2008-7#1)(2010-12#2)
to achieve stable##2##3##(2007-12#1)(2008-7#1)
to achieve successful##2##3##(2008-9#1)(2013-1#1)
to achieve target##2##3##(2008-1#1)(2013-1#1)
to achieve the best##7##4##(1990-3#1)(2007-11#1)(2008-10#3)(2008-4#1)(2013-8#1)
to achieve the desired##4##4##(2007-12#1)(2008-7#1)(2009-10#1)(2009-8#1)
to achieve the goal of##2##5##(2008-11#1)(2008-3#1)
to achieve the necessary##2##4##(1994-12#1)(2008-11#1)
to achieve the objectives of##2##5##(1996-12#1)(2011-2#1)
to achieve the same##3##4##(2007-12#2)(2011-2#1)
to achieve the##54##3##(1990-11#1)(1990-3#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-12#2)(1995-1#1)(1996-12#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#2)(2013-8#2)
to achieve their##6##3##(1994-12#1)(2007-2#1)(2010-3#2)(2011-2#2)
to achieve these##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
to achieve this aim##2##4##(1996-7#1)(2012-3#1)
to achieve this goal##4##4##(2008-12#1)(2009-10#2)(2012-3#1)
to achieve this##13##3##(1990-11#1)(1991-3#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#2)(2010-10#1)(2010-3#1)(2012-3#2)
to achieve very##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
to achieve##393##2##(1990-11#2)(1990-12#3)(1990-3#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#14)(2007-12#15)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#42)(2008-11#26)(2008-12#7)(2008-2#18)(2008-3#34)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#5)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#6)
to achievement of##2##3##(2008-12#1)(2010-5#1)
to achieving a##4##3##(1991-12#1)(1996-3#1)(2008-3#1)(2012-1#1)
to achieving##17##2##(1991-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-3#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
to acid hydrolysis##3##3##(1992-12#1)(2008-10#1)(2012-12#1)
to acid##14##2##(1990-2#1)(1992-12#1)(1992-6#1)(1996-12#1)(1996-9#1)(2008-10#5)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
to acid-base##3##2##(2008-10#3)
to acidic##7##2##(1990-7#1)(2008-10#4)(2009-11#1)(2012-9#1)
to acidify the##2##3##(1992-6#1)(2011-1#1)
to acknowledge the##2##3##(2008-12#1)(2012-3#1)
to acknowledge##8##2##(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-11#1)(2008-11#1)(2008-12#1)(2012-3#1)
to acoustic stimuli##2##3##(1996-2#1)(2008-4#1)
to acquire a##8##3##(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
to acquire an##2##3##(2007-7#1)(2009-9#1)
to acquire and##4##3##(1994-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
to acquire new##2##3##(2007-2#1)(2008-11#1)
to acquire quantitative##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
to acquire such##2##3##(2008-3#1)(2008-7#1)
to acquire the##6##3##(1990-9#1)(1992-11#1)(2008-10#3)(2008-4#1)
to acquire##45##2##(1990-9#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-3#2)(1996-1#1)(1996-12#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
to acrinathrin##2##2##(2011-2#2)
to acrylic acid##2##3##(2008-6#2)
to act as a scaffold##2##5##(2012-2#1)(2012-8#1)
to act as a##12##4##(1991-9#1)(1995-2#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#1)(2012-8#1)(2013-1#1)
to act as an##5##4##(1990-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
to act as inhibitors##2##4##(1990-11#1)(1991-11#1)
to act as substrates for##2##5##(1994-5#1)(1995-3#1)
to act as##34##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#2)
to act at##2##3##(1990-5#1)(1995-3#1)
to act differently##2##3##(2008-10#1)(2010-12#1)
to act in##4##3##(1993-1#1)(1995-3#1)(2008-10#1)(2008-8#1)
to act on the##2##4##(1993-9#1)(2007-11#1)
to act on##4##3##(1990-12#1)(1993-9#1)(2007-11#1)(2008-6#1)
to act through##3##3##(1991-12#1)(1995-11#1)(2008-3#1)
to act##67##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#2)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#3)(2012-1#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#2)
to actin filament##2##3##(1991-5#1)(2008-11#1)
to actin filaments##2##3##(1993-8#1)(1997-7#1)
to actin was##2##3##(1993-8#1)(1997-7#1)
to actin##17##2##(1991-5#1)(1992-4#1)(1993-8#5)(1994-12#1)(1994-5#3)(1995-2#1)(1997-7#2)(2008-11#1)(2008-6#1)(2011-2#1)
to acting##3##2##(1993-11#1)(2007-11#1)(2007-8#1)
to action##9##2##(1991-2#1)(1992-2#1)(1993-12#2)(1996-1#1)(1997-2#1)(2009-1#1)(2009-5#1)(2011-1#1)
to activate a##5##3##(1993-3#1)(1996-2#1)(1996-3#1)(2009-8#2)
to activate amygdala neurons##2##4##(1997-7#2)
to activate and##2##3##(1997-3#1)(2008-4#1)
to activate human##2##3##(2008-10#1)(2013-1#1)
to activate protein kinase##2##4##(1991-9#1)(2010-11#1)
to activate the receptor##2##4##(1992-4#1)(1995-3#1)
to activate the##20##3##(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#2)(1993-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2009-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
to activate transcription##3##3##(1994-8#1)(1995-2#1)(2010-8#1)
to activate##70##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-7#2)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
to activated monocytes##2##3##(1993-9#1)(2012-2#1)
to activated##6##2##(1993-8#1)(1993-9#1)(1995-12#1)(1997-3#1)(2008-4#1)(2012-2#1)
to activation of the##8##4##(1992-12#1)(1992-6#1)(1997-6#1)(2008-11#2)(2008-4#2)(2008-8#1)
to activation of##18##3##(1990-5#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-6#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#2)(2010-3#1)(2012-3#1)
to activation##22##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-3#1)(2012-3#1)
to active##12##2##(1993-11#1)(1994-11#1)(1994-6#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-12#2)(2010-5#1)(2012-2#1)
to actively##12##2##(1995-3#1)(1997-1#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
to activin A##6##3##(1992-6#3)(1994-9#3)
to activity of##2##3##(1992-3#1)(2009-8#1)
to activity##9##2##(1992-3#1)(1993-6#1)(2006-10#1)(2008-10#1)(2009-3#2)(2009-8#1)(2013-1#2)
to actual##4##2##(1992-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
to actually##5##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
to acuity##2##2##(1996-1#1)(2011-2#1)
to acupuncture##3##2##(1993-3#1)(1997-6#1)(2006-10#1)
to acute hypoxia##2##3##(1995-12#2)
to acute myelocytic leukemia##2##4##(2008-7#1)(2011-2#1)
to acute myocardial infarction##2##4##(2012-1#1)(2013-1#1)
to acute myocardial##3##3##(1996-9#1)(2012-1#1)(2013-1#1)
to acute psychological stress##2##4##(2008-11#1)(2011-2#1)
to acute##48##2##(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-9#1)(2009-5#3)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
to adapt a##3##3##(2007-11#1)(2008-5#2)
to adapt better##2##3##(1997-2#1)(2008-1#1)
to adapt the##7##3##(1994-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-12#1)
to adapt their##3##3##(2008-11#2)(2011-1#1)
to adapt themselves to##2##4##(2008-1#1)(2013-1#1)
to adapt to a##2##4##(2008-11#1)(2008-7#1)
to adapt to new##2##4##(1995-3#1)(2008-10#1)
to adapt to the##4##4##(2008-10#1)(2008-8#2)(2012-6#1)
to adapt to##15##3##(1994-12#1)(1994-8#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2009-6#1)(2012-2#1)(2012-6#1)
to adapt##40##2##(1994-12#2)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#4)(2009-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
to adaptation to##2##3##(2011-2#1)(2012-3#1)
to adaptation##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
to adaptations to##2##3##(2008-12#1)(2011-2#1)
to adaptive##4##2##(2008-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
to add a##5##3##(1997-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
to add in the##2##4##(2008-10#1)(2009-9#1)
to add the##2##3##(2008-10#1)(2012-3#1)
to add to the##2##4##(2008-7#1)(2009-7#1)
to add to##3##3##(2008-7#1)(2008-9#1)(2009-7#1)
to add##19##2##(1997-1#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#2)
to adding##2##2##(2008-7#1)(2013-7#1)
to addition of##3##3##(1993-6#1)(1994-6#1)(2008-11#1)
to addition##4##2##(1993-6#1)(1994-6#1)(2007-12#1)(2008-11#1)
to additional information##2##3##(1996-5#1)(2008-4#1)
to additional##11##2##(1996-5#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
to additive##2##2##(2008-2#1)(2008-3#1)
to address NCDs##3##3##(2012-12#1)(2013-8#2)
to address a##3##3##(1994-2#1)(1996-1#1)(2008-12#1)
to address concerns##2##3##(2012-1#1)(2012-3#1)
to address gaps in##3##4##(1995-12#1)(2008-11#1)(2012-12#1)
to address health disparities##2##4##(2011-2#1)(2012-3#1)
to address health##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
to address issues##4##3##(2008-1#1)(2010-5#1)(2012-12#1)(2012-3#1)
to address many##2##3##(2007-5#1)(2011-1#1)
to address problems##2##3##(1993-12#1)(1994-3#1)
to address quality issues and##2##5##(1994-2#2)
to address questions##2##3##(2008-7#1)(2013-8#1)
to address several##2##3##(2008-7#1)(2012-3#1)
to address some of##2##4##(2007-12#1)(2008-12#1)
to address specific##3##3##(1992-1#1)(2008-12#1)(2013-1#1)
to address the issue##5##4##(1991-12#1)(1992-1#1)(1993-2#1)(2011-2#1)(2013-1#1)
to address the issues##3##4##(1991-1#1)(1991-3#1)(1997-3#1)
to address the lack of##2##5##(1992-1#1)(2011-2#1)
to address the multiple##2##4##(2010-3#1)(2012-12#1)
to address the need for##2##5##(2008-4#1)(2008-7#1)
to address the needs of##3##5##(1993-12#1)(2008-11#1)(2010-8#1)
to address the problem of##2##5##(1997-1#1)(2008-1#1)
to address the problem##3##4##(1997-1#1)(1997-3#1)(2008-1#1)
to address the problems of##2##5##(2010-9#1)(2013-8#1)
to address the question##4##4##(1991-12#1)(2008-12#1)(2009-3#1)(2012-12#1)
to address the questions of##2##5##(2008-11#1)(2012-3#1)
to address the##64##3##(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-3#1)(2010-12#2)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#4)
to address them##2##3##(1995-2#1)(2009-5#1)
to address these issues##3##4##(2008-1#1)(2008-11#1)(2013-1#1)
to address these problems##4##4##(2008-12#1)(2008-8#1)(2009-9#1)(2013-8#1)
to address these questions##2##4##(2008-11#1)(2013-1#1)
to address these##28##3##(1996-3#1)(1997-2#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-10#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#10)
to address this issue##5##4##(1995-8#1)(1996-1#1)(2008-11#2)(2012-3#1)
to address this need##2##4##(1997-2#1)(2008-11#1)
to address this problem##4##4##(1993-3#1)(2008-7#1)(2011-2#2)
to address this question##2##4##(2008-11#1)(2008-8#1)
to address this##23##3##(1992-6#1)(1993-3#1)(1995-8#1)(1996-1#1)(1997-2#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
to address varying##2##3##(2008-10#1)(2010-8#1)
to address whether##2##3##(1997-2#1)(2009-12#1)
to address##201##2##(1990-11#1)(1991-1#1)(1991-12#2)(1991-3#2)(1992-1#3)(1992-11#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1994-12#1)(1994-2#5)(1994-3#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(2007-12#1)(2007-5#1)(2008-1#6)(2008-10#3)(2008-11#14)(2008-12#12)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-10#2)(2011-2#9)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#10)(2013-1#7)(2013-8#19)
to addressing##6##2##(1994-1#1)(1997-2#2)(2008-7#2)(2012-2#1)
to adenine##3##2##(1992-11#1)(1993-11#1)(2008-10#1)
to adenosine by##2##3##(2008-4#1)(2008-5#1)
to adenosine##14##2##(1993-11#1)(1995-12#2)(1997-3#1)(1997-7#1)(2008-4#5)(2008-5#2)(2012-3#2)
to adenylate##4##2##(1993-5#1)(1993-6#1)(2008-4#2)
to adequate##3##2##(2008-1#1)(2009-6#1)(2013-8#1)
to adequately##10##2##(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-11#2)
to adhere to and##2##4##(2008-9#1)(2009-5#1)
to adhere to the##2##4##(2008-10#1)(2008-4#1)
to adhere to##16##3##(1990-12#1)(1995-9#1)(1996-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-5#1)(2012-2#1)(2012-3#1)
to adhere##20##2##(1990-12#1)(1995-9#1)(1996-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#4)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
to adherence##4##2##(2008-7#2)(2008-9#1)(2011-1#1)
to adherent##3##2##(2008-4#1)(2010-11#1)(2011-1#1)
to adiposity and##2##3##(1996-11#1)(2012-5#1)
to adjacent structures##2##3##(1993-3#1)(2009-3#1)
to adjacent##15##2##(1992-6#1)(1993-3#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-7#2)(2009-3#1)(2012-2#1)
to adjust for##7##3##(1990-8#1)(1991-2#1)(1994-3#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-3#1)
to adjust the##13##3##(1991-12#1)(1994-9#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-8#2)(2008-9#1)(2011-3#1)
to adjust their##2##3##(2009-12#1)(2012-3#1)
to adjust##35##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#2)(2008-3#4)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-7#1)
to adjuvant chemotherapy##2##3##(1993-11#1)(1993-9#1)
to adjuvant##3##2##(1992-12#1)(1993-11#1)(1993-9#1)
to adjuvants)##2##2##(2007-11#2)
to administer and##2##3##(1997-2#1)(2010-7#1)
to administer medications##2##3##(2007-10#1)(2008-12#1)
to administer##17##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
to administration of##4##3##(2008-10#1)(2008-3#1)(2008-9#2)
to administration##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)
to administrative##3##2##(1992-12#1)(1994-2#1)(1996-3#1)
to admission##2##2##(2009-4#1)(2010-12#1)
to admit##4##2##(1991-12#1)(1992-6#1)(1994-3#1)(1997-1#1)
to adolescence##2##2##(2012-12#1)(2012-3#1)
to adolescent girls##2##3##(2011-2#1)(2013-1#1)
to adolescent##6##2##(1996-12#1)(2009-7#3)(2011-2#1)(2013-1#1)
to adolescents##6##2##(1995-12#1)(1996-6#1)(2008-9#1)(2009-5#1)(2013-1#2)
to adolescents'##4##2##(2009-11#2)(2009-7#2)
to adopt PBL##2##3##(2008-12#2)
to adopt a##9##3##(1993-3#1)(1994-11#1)(1994-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-3#1)
to adopt an##2##3##(1993-1#1)(2010-11#1)
to adopt in##2##3##(1994-5#1)(2008-8#1)
to adopt the##10##3##(1990-2#2)(1995-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#1)(2013-1#1)
to adopt them for##2##4##(2008-10#1)(2008-11#1)
to adopt##48##2##(1990-2#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-1#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
to adoption##2##2##(1997-1#1)(2008-6#1)
to adrenalectomy##2##2##(2012-12#2)
to adrenergic##2##2##(1991-12#1)(2007-10#1)
to adriamycin plus##2##3##(1993-8#2)
to adriamycin##4##2##(1990-2#1)(1991-4#1)(1993-8#2)
to adsorb##3##2##(2007-11#1)(2008-10#2)
to adult##8##2##(1990-11#1)(1993-12#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
to adulthood##9##2##(1996-5#1)(2008-8#1)(2009-7#2)(2011-2#4)(2012-2#1)
to adults##9##2##(2008-10#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#2)
to advance our understanding of##2##5##(2010-5#1)(2013-1#1)
to advance the##5##3##(1994-12#1)(2008-11#2)(2010-3#1)(2013-1#1)
to advance##20##2##(1994-12#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#2)
to advanced##7##2##(1991-12#1)(1995-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-1#1)(2012-2#1)
to advances in##7##3##(2008-10#3)(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
to advances##8##2##(2008-10#3)(2008-11#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-8#1)
to advantages and##2##3##(2008-4#1)(2011-2#1)
to advantages##4##2##(2008-10#1)(2008-4#1)(2011-2#2)
to adverse effects##2##3##(2007-11#1)(2011-1#1)
to adverse##14##2##(1992-11#1)(1994-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#3)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)
to adversely affect##2##3##(2008-10#1)(2012-1#1)
to advice##2##2##(1990-10#1)(1992-4#1)
to advise##4##2##(1992-9#1)(1995-6#1)(1996-3#1)(2007-2#1)
to advocate##2##2##(2011-1#1)(2013-1#1)
to advocating##2##2##(1991-1#1)(2008-10#1)
to aerial##2##2##(2008-10#2)
to aerosol##6##2##(1992-3#1)(1997-2#1)(2008-2#1)(2008-3#3)
to aerosols##6##2##(1992-3#1)(2008-11#1)(2008-2#2)(2008-3#2)
to affect IBa##2##3##(1995-12#2)
to affect a##3##3##(2008-5#1)(2010-12#1)(2013-7#1)
to affect patient##2##3##(2008-3#1)(2010-3#1)
to affect sexual##3##3##(1993-8#1)(2012-3#2)
to affect the##25##3##(1990-2#1)(1990-5#1)(1991-6#1)(1993-9#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to affect##96##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1995-12#3)(1995-2#1)(1995-8#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#7)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
to affected##2##2##(2009-8#1)(2012-12#1)
to affinity##2##2##(1991-12#1)(1992-11#1)
to affirm##2##2##(1991-12#1)(1996-3#1)
to afford a##2##3##(1995-11#1)(2012-12#1)
to afford the##3##3##(1997-6#1)(2007-11#1)(2008-11#1)
to afford##19##2##(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-11#6)(2008-10#1)(2008-11#3)(2009-12#1)(2009-9#1)(2012-12#1)
to aflatoxin##10##2##(2008-10#8)(2013-1#2)
to agarose##3##2##(1993-8#2)(2012-2#1)
to age and##4##3##(1992-2#1)(2007-10#1)(2013-1#2)
to age at##3##3##(1994-6#1)(2008-9#2)
to age of##2##3##(1994-2#1)(1996-7#1)
to age##39##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1996-7#1)(1997-3#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-4#1)(2011-2#4)(2013-1#3)(2013-8#1)
to age-related##3##2##(1994-6#1)(2008-7#1)(2013-7#1)
to agents that##2##3##(1993-11#1)(1994-5#1)
to agents##3##2##(1993-11#1)(1994-5#1)(1995-12#1)
to aggregate##2##2##(2008-10#1)(2008-6#1)
to aggression##3##2##(2008-11#3)
to aging##8##2##(1990-3#1)(1991-12#1)(1994-5#3)(2008-10#1)(2009-5#1)(2012-2#1)
to agonist##2##2##(1992-5#1)(2008-9#1)
to agonists##3##2##(1991-8#1)(1992-3#1)(2008-9#1)
to agree with the##2##4##(2007-12#1)(2007-7#1)
to agree with##10##3##(2007-12#2)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#4)
to agree##19##2##(1991-12#1)(1992-2#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#7)(2008-8#1)(2012-12#1)
to agricultural workers##2##3##(2008-11#1)(2008-12#1)
to agricultural##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)
to agriculture##4##2##(1990-2#1)(1994-6#1)(1997-4#1)(2010-4#1)
to aid clinical##2##3##(2008-5#1)(2011-2#1)
to aid in the##6##4##(1992-3#1)(2007-12#1)(2008-3#1)(2009-2#1)(2012-2#1)(2013-1#1)
to aid in##16##3##(1992-3#2)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
to aid the development of##3##5##(2008-1#1)(2008-9#1)(2009-12#1)
to aid the##8##3##(1992-9#1)(1993-6#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-12#1)(2013-1#1)
to aid##42##2##(1992-3#2)(1992-9#1)(1993-6#1)(1993-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
to air is##2##3##(2007-12#1)(2008-3#1)
to air warming and##2##4##(2012-5#1)(2012-6#1)
to air warming##4##3##(2012-5#1)(2012-6#2)(2012-9#1)
to air##19##2##(1995-3#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2012-5#1)(2012-6#2)(2012-9#1)
to airborne##2##2##(1994-9#1)(2008-3#1)
to airway epithelial cells##4##4##(1994-11#2)(1994-5#2)
to airway##8##2##(1994-11#2)(1994-5#2)(1995-12#1)(1997-1#1)(2010-7#1)(2012-3#1)
to alanine##12##2##(1992-8#1)(1994-5#1)(1995-5#4)(1995-6#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
to alarm##2##2##(2008-10#1)(2010-8#1)
to albumin and##2##3##(2008-10#2)
to albumin##5##2##(1990-12#1)(1995-5#1)(2008-10#2)(2008-11#1)
to alcohol abuse##2##3##(1992-12#1)(2012-2#1)
to alcohol or other##2##4##(2009-11#1)(2009-9#1)
to alcohol or##3##3##(1994-2#1)(2009-11#1)(2009-9#1)
to alcohol##16##2##(1991-1#1)(1992-12#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-1#2)(2012-2#2)
to alcoholism##10##2##(1994-2#3)(1996-11#1)(1997-5#2)(2007-8#2)(2008-11#1)(2008-6#1)
to alcohols##2##2##(2008-6#1)(2010-7#1)
to aldosterone##3##2##(1990-11#1)(2008-4#2)
to alert researchers to##2##4##(2008-4#1)(2009-7#1)
to alert the##4##3##(1992-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
to alert##9##2##(1991-8#1)(1992-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
to alfalfa depends on##2##4##(2008-10#2)
to alfalfa##3##2##(2008-10#3)
to algorithms for##2##3##(2008-3#2)
to align the##2##3##(1992-1#1)(1994-3#1)
to align##12##2##(1992-1#1)(1993-1#1)(1994-3#1)(2008-2#1)(2008-3#5)(2008-4#1)(2011-1#1)(2013-1#1)
to aliphatic##2##2##(2008-10#1)(2009-5#1)
to alkali and alkaline##2##4##(2008-10#2)
to alkali##6##2##(1994-3#1)(2008-10#5)
to alkaline hydrolysis##2##3##(2008-10#1)(2008-11#1)
to alkaline phosphatase##5##3##(1990-12#1)(1991-10#1)(2008-10#1)(2008-11#1)(2012-1#1)
to alkaline##14##2##(1990-12#1)(1990-8#1)(1991-10#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-9#1)(2012-1#1)
to alkylating agents##5##3##(2008-11#4)(2010-3#1)
to all antibiotics##2##3##(2007-7#1)(2011-2#1)
to all areas of the##2##5##(1996-1#1)(2008-12#1)
to all existing##2##3##(2008-10#1)(2008-5#1)
to all health##2##3##(1996-3#1)(2008-11#1)
to all isolates##2##3##(2008-10#2)
to all its##2##3##(2008-10#1)(2008-9#1)
to all kinds of##3##4##(1990-2#1)(1994-1#1)(2008-2#1)
to all known##2##3##(1992-3#1)(2008-5#1)
to all of the##6##4##(1995-5#1)(1997-6#1)(2008-10#3)(2008-5#1)
to all of##8##3##(1995-11#1)(1995-5#1)(1996-8#1)(1997-6#1)(2008-10#3)(2008-5#1)
to all other age groups##2##5##(1996-5#1)(2011-2#1)
to all other##8##3##(1990-7#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-3#1)(2011-2#1)
to all patients##7##3##(1994-3#1)(1996-3#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
to all plant##2##3##(2008-11#1)(2008-7#1)
to all pregnant women##2##4##(1994-6#1)(2010-8#1)
to all products##2##3##(2007-6#2)
to all races of##2##4##(2008-10#2)
to all races##5##3##(2008-10#5)
to all six##2##3##(2008-3#1)(2010-4#1)
to all tested##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
to all the offspring##2##4##(2008-8#2)
to all the##19##3##(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1995-8#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-8#2)(2009-12#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
to all three fungicides##2##4##(2008-10#2)
to all three##11##3##(1991-7#1)(1995-12#1)(1996-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2011-2#1)
to all types of##7##4##(2007-10#1)(2007-12#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
to all##208##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-6#3)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#11)(2008-7#8)(2008-8#5)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#1)(2010-3#3)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
to allergens##2##2##(1992-3#1)(2009-5#1)
to allergy##2##2##(1996-3#1)(2008-11#1)
to alleviate the##4##3##(1992-8#1)(2007-12#1)(2007-8#1)(2008-9#1)
to alleviate these##2##3##(1991-9#1)(2007-11#1)
to alleviate##19##2##(1991-2#2)(1991-9#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#2)(2012-2#1)
to alleviating##2##2##(1993-9#1)(2010-6#1)
to allocate more##2##3##(1992-1#1)(2008-5#1)
to allocate resources##3##3##(1993-2#1)(2007-7#1)(2008-10#1)
to allocate##8##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
to allow a##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
to allow an##2##3##(2008-10#1)(2009-12#1)
to allow both the##2##4##(2008-3#2)
to allow for identification and##2##5##(2008-10#1)(2011-2#1)
to allow for more##2##4##(1992-3#1)(2011-2#1)
to allow for the##8##4##(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
to allow for##30##3##(1992-3#1)(1994-11#1)(1994-5#1)(1997-4#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#5)(2013-8#2)
to allow independent##2##3##(2007-12#1)(2009-2#1)
to allow its##2##3##(2008-10#1)(2008-5#1)
to allow rapid##2##3##(2008-10#1)(2010-5#1)
to allow sequential##2##3##(2008-10#2)
to allow simultaneous##2##3##(2008-11#1)(2009-10#1)
to allow the determination of##3##5##(2008-10#2)(2008-2#1)
to allow the quantification of##2##5##(1992-12#1)(2008-2#1)
to allow the simultaneous##2##4##(2008-10#1)(2008-9#1)
to allow the##25##3##(1990-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-6#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
to allow their##2##3##(1996-5#1)(2008-10#1)
to allow them to##2##4##(2007-10#1)(2012-12#1)
to allow users to##2##4##(2008-11#1)(2008-7#1)
to allow visualization of##3##4##(1995-12#1)(2008-1#1)(2008-4#1)
to allow##144##2##(1990-2#1)(1990-8#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#31)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#16)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
to almost complete##2##3##(1995-8#1)(2008-10#1)
to almost completely##2##3##(2008-11#1)(2008-4#1)
to almost##13##2##(1990-2#1)(1993-11#1)(1995-8#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)
to alpha 2 interferon##2##4##(1990-12#2)
to alpha 2M##2##3##(1993-3#2)
to alpha##10##2##(1990-12#2)(1992-10#1)(1993-3#2)(1993-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)
to alpha- and##2##3##(1991-12#1)(1993-5#1)
to alpha-amylase##3##2##(1990-3#3)
to alpha-helix##3##2##(1992-6#2)(2008-9#1)
to alpha-lactalbumin##2##2##(2008-10#2)
to alpha-tocopherol##2##2##(1991-12#1)(2008-5#1)
to alpha-tomatine##2##2##(2008-10#2)
to already##2##2##(2008-10#1)(2009-7#1)
to also consider##2##3##(2011-3#1)(2012-2#1)
to also##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
to alter the conformation of##2##5##(2008-6#1)(2012-2#1)
to alter the##24##3##(1990-7#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#2)(2010-8#1)(2012-2#2)
to alter their##2##3##(2008-11#1)(2009-7#1)
to alter##46##2##(1990-2#1)(1990-7#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#2)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to alteration in##2##3##(2009-8#1)(2012-2#1)
to alteration##3##2##(2009-10#1)(2009-8#1)(2012-2#1)
to alterations in the##3##4##(1990-2#1)(1995-3#1)(1997-2#1)
to alterations in##10##3##(1990-2#1)(1995-3#1)(1996-6#1)(1997-2#1)(2007-7#1)(2008-7#3)(2009-12#1)(2012-2#1)
to alterations of##3##3##(1996-5#1)(2008-11#1)(2008-8#1)
to alterations##13##2##(1990-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-12#1)(2012-2#1)
to altered##13##2##(1990-5#1)(1992-8#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-10#1)(2012-7#1)(2013-8#1)
to alternating##2##2##(2008-10#1)(2008-9#1)
to alternative food##3##3##(2008-8#3)
to alternative models of##2##4##(2007-12#1)(2008-10#1)
to alternative settings##2##3##(1993-5#1)(1995-1#1)
to alternative##12##2##(1992-2#1)(1992-6#1)(1993-5#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#3)(2008-9#1)
to altitudes##2##2##(2008-3#2)
to aluminum##3##2##(1991-5#1)(1996-3#1)(2008-10#1)
to always##2##2##(2013-1#1)(2013-8#1)
to ambient air##2##3##(2008-11#1)(2008-3#1)
to ambient conditions##2##3##(1993-12#1)(2008-10#1)
to ambient temperature##2##3##(2008-2#1)(2012-7#1)
to ambient##12##2##(1993-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-2#1)(2012-7#1)
to ambulatory##2##2##(1995-12#1)(2011-2#1)
to ameliorate the signs##2##4##(2008-5#2)
to ameliorate the##5##3##(2008-5#3)(2010-7#1)(2011-2#1)
to ameliorate##12##2##(1996-7#1)(2008-1#1)(2008-5#3)(2008-7#3)(2010-7#1)(2011-2#2)(2013-8#1)
to amensal##2##2##(2008-12#2)
to amidoxime groups##2##3##(2008-10#2)
to amiloride##4##2##(1990-2#1)(1991-5#3)
to amino acid changes##2##4##(2008-5#1)(2013-1#1)
to amino acid##7##3##(1991-10#1)(1992-12#1)(1992-3#1)(1993-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
to amino acids##2##3##(1992-12#1)(1994-8#1)
to amino##9##2##(1991-10#1)(1992-12#2)(1992-3#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
to aminoglycosides##6##2##(1995-2#4)(2008-12#1)(2009-8#1)
to ammonia and##2##3##(2008-10#2)
to ammonia in##2##3##(2008-10#1)(2011-2#1)
to ammonia##7##2##(1993-8#1)(2008-10#3)(2008-7#2)(2011-2#1)
to ammonium ion##2##3##(2008-10#2)
to ammonium##5##2##(1992-11#1)(2008-10#4)
to amoxicillin##2##2##(2007-7#1)(2008-12#1)
to amperometric detection of##3##4##(2008-10#3)
to amperometric##5##2##(2008-10#5)
to amphotericin B##6##3##(1992-6#1)(2007-7#1)(2008-5#4)
to amphotericin##7##2##(1992-6#2)(2007-7#1)(2008-5#4)
to ampicillin and##2##3##(2008-10#1)(2012-3#1)
to ampicillin##8##2##(1990-6#2)(2007-12#1)(2008-10#1)(2010-8#2)(2012-3#2)
to ampicillin-sulbactam##2##2##(2013-8#2)
to amplified##2##2##(1992-8#1)(2008-10#1)
to amplify DNA##4##3##(1990-7#1)(2008-10#3)
to amplify a##6##3##(1992-8#1)(1993-8#1)(2008-10#3)(2009-8#1)
to amplify an##2##3##(1991-9#1)(2008-10#1)
to amplify and sequence##2##4##(1993-12#1)(2007-6#1)
to amplify and##3##3##(1991-9#1)(1993-12#1)(2007-6#1)
to amplify sequences##2##3##(1992-6#1)(2008-10#1)
to amplify the##14##3##(1991-7#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-1#1)
to amplify##49##2##(1990-7#1)(1991-7#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-5#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#22)(2008-11#2)(2008-4#2)(2008-8#2)(2009-4#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
to amplitude and##2##3##(2007-12#2)
to amplitude##3##2##(2007-11#1)(2007-12#2)
to amputation##4##2##(2008-6#2)(2010-3#1)(2012-3#1)
to an MDI##2##3##(1996-1#1)(1997-1#1)
to an RNA##3##3##(1994-8#1)(2008-4#2)
to an abdominal##2##3##(2009-4#1)(2011-2#1)
to an accelerated##2##3##(2008-10#2)
to an acceptable##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
to an acceptor stream##2##4##(2008-10#2)
to an accumulation of##4##4##(1995-6#1)(2008-1#1)(2008-6#1)(2009-10#1)
to an accuracy of##10##4##(2008-1#1)(2008-2#2)(2008-3#7)
to an accuracy##12##3##(2008-1#1)(2008-2#3)(2008-3#8)
to an acidic##3##3##(2008-10#3)
to an action##2##3##(1994-2#1)(2013-1#1)
to an activation##2##3##(2008-4#1)(2008-5#1)
to an active##6##3##(1991-9#2)(1992-12#1)(2007-8#1)(2008-6#1)(2009-9#1)
to an acute##5##3##(1994-5#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)
to an additional##4##3##(1992-3#1)(2007-12#1)(2008-10#1)(2010-8#1)
to an adjuvant##2##3##(2012-2#2)
to an adult##2##3##(1996-3#1)(2006-10#1)
to an affinity##2##3##(1993-6#1)(2008-4#1)
to an alteration in##2##4##(1993-12#1)(1994-8#1)
to an alternative##2##3##(1997-7#1)(2008-10#1)
to an altitude##2##3##(2008-3#2)
to an analogous##2##3##(2008-7#1)(2012-12#1)
to an anesthetized##2##3##(2008-4#1)(2008-9#1)
to an antibiotic##2##3##(1997-3#1)(2008-11#1)
to an antigen of interest##2##5##(2008-10#1)(2008-4#1)
to an antigen##3##3##(2008-10#2)(2008-4#1)
to an apparent##2##3##(1990-12#1)(1994-5#1)
to an apparently##2##3##(1990-11#1)(1990-7#1)
to an appropriate##2##3##(1996-3#1)(2008-10#1)
to an aqueous##2##3##(2008-10#2)
to an arbitrary##5##3##(1997-2#1)(2008-3#2)(2008-6#1)(2009-11#1)
to an arthrodesis##2##3##(2008-6#1)(2010-5#1)
to an artificial##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
to an atomic transition##2##4##(2007-12#1)(2008-2#1)
to an atomic##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
to an automatic##2##3##(2008-10#1)(2008-3#1)
to an autosomal##2##3##(2008-12#1)(2011-3#1)
to an average of 6##2##5##(1994-12#1)(2008-9#1)
to an average##4##3##(1994-12#1)(2008-6#1)(2008-9#2)
to an earlier##2##3##(2008-10#1)(2011-1#1)
to an effective##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
to an efficiency of##3##4##(2007-12#2)(2008-3#1)
to an efficient##2##3##(2008-3#1)(2009-12#1)
to an electric field##2##4##(2007-12#1)(2009-12#1)
to an electrical##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
to an electrochemical##3##3##(2008-10#2)(2012-1#1)
to an electrostatic##3##3##(1996-5#1)(2008-10#1)(2009-5#1)
to an emerging##2##3##(2011-2#1)(2013-1#1)
to an end##2##3##(2008-9#1)(2013-8#1)
to an endemic##4##3##(2007-2#1)(2008-10#2)(2011-2#1)
to an enhanced##3##3##(1995-12#1)(2012-1#1)(2012-12#1)
to an enhancement of the##3##5##(1992-9#1)(1993-12#1)(2007-12#1)
to an enhancement of##4##4##(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#1)
to an enhancement##6##3##(1992-9#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
to an enriched##4##3##(1991-12#1)(1992-11#3)
to an enrichment##2##3##(2008-10#1)(2009-4#1)
to an entire##2##3##(2008-3#1)(2011-2#1)
to an enzyme##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
to an equivalent##2##3##(2008-10#2)
to an established##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
to an estimated##6##3##(1991-11#1)(1995-2#2)(1997-7#1)(2008-11#1)(2011-2#1)
to an exact solution##2##4##(2007-12#1)(2008-2#1)
to an exact##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
to an experimental##3##3##(1994-3#1)(2008-12#1)(2008-4#1)
to an exponential##2##3##(2008-10#1)(2012-2#1)
to an extended##2##3##(2008-10#1)(2008-3#1)
to an extension##2##3##(2007-7#1)(2008-5#1)
to an extent that##3##4##(1990-11#1)(1994-6#1)(2008-10#1)
to an extent##8##3##(1990-11#1)(1990-9#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)
to an external##2##3##(2007-12#1)(2008-7#1)
to an extremely##3##3##(1990-6#1)(2008-2#1)(2011-2#1)
to an ideal##2##3##(2007-12#1)(2008-2#1)
to an immobilized##2##3##(1990-12#1)(1996-12#1)
to an immune response to the##2##6##(1994-11#1)(2008-11#1)
to an immunological##2##3##(1990-5#1)(1991-2#1)
to an impairment##2##3##(1994-3#1)(2008-11#1)
to an important##4##3##(1991-9#1)(2007-11#1)(2007-12#1)(2012-2#1)
to an improved##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)
to an improvement in the##2##5##(2008-2#1)(2008-7#1)
to an improvement in##3##4##(2008-2#2)(2008-7#1)
to an improvement of the##2##5##(2008-10#2)
to an improvement##6##3##(1990-2#1)(2008-10#2)(2008-2#2)(2008-7#1)
to an in##2##3##(1992-8#1)(2008-5#1)
to an in-frame stop codon (UAA)##2##6##(1990-11#1)(1992-11#1)
to an incidence of##2##4##(1991-11#1)(2007-2#1)
to an increase in the##14##5##(1990-5#2)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-8#1)(2011-2#2)(2012-2#1)
to an increase in##40##4##(1990-12#1)(1990-5#2)(1992-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-6#1)(1997-1#1)(1997-7#3)(2007-12#2)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)
to an increase of the##6##5##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)
to an increase of##12##4##(1991-12#2)(1991-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2009-11#1)(2011-2#1)
to an increase##52##3##(1990-12#1)(1990-5#2)(1991-12#2)(1991-6#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-6#1)(1997-1#1)(1997-7#3)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-11#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)
to an increased##15##3##(1990-7#1)(1990-8#1)(1992-8#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-5#1)
to an increasing number of##2##5##(1992-3#1)(1997-4#1)
to an increasing##4##3##(1990-8#1)(1992-3#1)(1997-4#1)(2008-7#1)
to an individual##3##3##(1991-2#1)(2008-3#1)(2012-3#1)
to an individual's##2##3##(1997-3#1)(2012-3#1)
to an inductively coupled plasma##2##5##(2008-10#2)
to an infection##2##3##(2008-11#1)(2010-6#1)
to an infectious##2##3##(2007-12#1)(2012-2#1)
to an inhibition of##2##4##(1990-8#2)
to an initial##2##3##(1991-6#1)(2010-6#1)
to an inpatient##2##3##(1991-2#1)(2008-7#1)
to an integrated##4##3##(1995-1#1)(1995-3#1)(2008-10#1)(2012-3#1)
to an intensive care unit##3##5##(1991-11#1)(1995-12#1)(2012-12#1)
to an interaction of##2##4##(1994-5#1)(1997-7#1)
to an interaction with##2##4##(1992-5#1)(1996-5#1)
to an interaction##5##3##(1992-5#1)(1994-5#1)(1996-5#1)(1997-7#1)(2008-10#1)
to an internal##2##3##(2008-7#1)(2008-8#1)
to an intracellular##2##3##(1991-2#1)(2009-10#1)
to an invasive##2##3##(2008-3#1)(2012-2#1)
to an investigation##2##3##(2008-10#1)(2008-12#1)
to an ion##2##3##(1994-8#1)(2008-10#1)
to an irradiance##2##3##(2007-12#1)(2008-3#1)
to an isolate##2##3##(2008-10#2)
to an object and##2##4##(2008-11#1)(2008-3#1)
to an open##2##3##(1994-6#1)(2010-3#1)
to an optical##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
to an optical-to-optical efficiency of##2##5##(2008-2#2)
to an optimal##2##3##(2008-5#1)(2009-7#1)
to an optimum##2##3##(1991-3#1)(2008-10#1)
to an organic##2##3##(2008-10#2)
to an unbranched##2##3##(2007-12#1)(2010-11#1)
to an undamaged##2##3##(1995-2#1)(2009-4#1)
to an underlying##2##3##(2008-4#1)(2011-1#1)
to an understanding of the##2##5##(1994-8#1)(2011-2#1)
to an understanding of##5##4##(1994-8#1)(2008-9#3)(2011-2#1)
to an urban##2##3##(2013-1#2)
to an##717##2##(1990-11#6)(1990-12#9)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#2)(1991-11#3)(1991-12#6)(1991-2#7)(1991-3#2)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#5)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#7)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#6)(1994-8#5)(1995-1#1)(1995-12#4)(1995-2#8)(1995-3#6)(1995-5#2)(1995-6#8)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#7)(1997-8#3)(2006-10#2)(2007-10#2)(2007-11#10)(2007-12#24)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#113)(2008-11#25)(2008-12#8)(2008-2#27)(2008-3#51)(2008-4#18)(2008-5#22)(2008-6#8)(2008-7#22)(2008-8#11)(2008-9#13)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#3)(2010-8#1)(2011-1#7)(2011-2#23)(2011-3#2)(2012-1#2)(2012-12#10)(2012-2#14)(2012-3#5)(2013-1#23)(2013-7#3)(2013-8#2)
to anakinra##2##2##(2012-2#2)
to analogous##3##2##(1992-5#1)(1994-5#1)(2008-10#1)
to analyse and##2##3##(1990-12#1)(2008-11#1)
to analyse the relationship##2##4##(2007-10#1)(2009-5#1)
to analyse the##30##3##(1990-2#1)(1993-2#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-5#1)(2013-8#1)
to analyse their##2##3##(2008-5#1)(2009-5#1)
to analyse whether##2##3##(1992-12#1)(2010-3#1)
to analyse##70##2##(1990-12#1)(1990-2#1)(1991-6#1)(1992-12#2)(1993-2#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2009-5#3)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
to analyses of##2##3##(2008-10#1)(2008-4#1)
to analyses##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
to analysis by##4##3##(2008-10#4)
to analysis of##17##3##(1993-12#1)(2007-12#1)(2008-10#10)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
to analysis##34##2##(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-4#2)(2008-9#1)(2010-2#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
to analytical##10##2##(2008-10#6)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
to analytically##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
to analyze a##6##3##(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
to analyze an##2##3##(2008-10#1)(2008-3#1)
to analyze and##6##3##(1991-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-6#1)
to analyze changes in##2##4##(2008-5#1)(2009-1#1)
to analyze experimental data##2##4##(2008-4#1)(2013-8#1)
to analyze genetic##2##3##(2008-10#1)(2011-2#1)
to analyze human##2##3##(2008-11#1)(2011-2#1)
to analyze in##2##3##(1997-3#1)(2013-1#1)
to analyze its##2##3##(2008-11#1)(2012-2#1)
to analyze some##2##3##(2008-3#1)(2009-10#1)
to analyze such##2##3##(2008-10#1)(2008-3#1)
to analyze the activity of##2##5##(1994-12#1)(2008-7#1)
to analyze the collected data##2##5##(1992-1#1)(1992-3#1)
to analyze the data##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
to analyze the distribution##2##4##(2008-8#2)
to analyze the dynamics of##2##5##(1997-1#1)(2008-8#1)
to analyze the effect of##5##5##(1995-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
to analyze the expression##2##4##(2008-7#1)(2011-2#1)
to analyze the genetic##2##4##(2008-10#1)(2011-2#1)
to analyze the long-term##2##4##(2008-9#1)(2012-3#1)
to analyze the protein##2##4##(2008-1#1)(2010-12#1)
to analyze the relationship between##2##5##(2007-8#1)(2010-2#1)
to analyze the relationship##3##4##(2007-8#1)(2010-2#1)(2011-1#1)
to analyze the results of##2##5##(2012-3#1)(2013-1#1)
to analyze the results##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
to analyze the spatial##2##4##(2007-7#1)(2008-10#1)
to analyze the variability##2##4##(2008-10#2)
to analyze the##112##3##(1992-1#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#7)(2011-7#1)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#2)
to analyze##265##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-3#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#53)(2008-11#14)(2008-12#4)(2008-2#10)(2008-3#16)(2008-4#9)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#12)(2008-9#11)(2009-1#1)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#13)(2011-7#1)(2012-2#7)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#1)
to analyzing##9##2##(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2012-3#1)
to anatomical##6##2##(1991-12#2)(2009-9#1)(2010-6#1)(2011-2#2)
to anchor##6##2##(1990-7#1)(1991-2#1)(1994-12#1)(2008-10#2)(2009-7#1)
to and following##2##3##(1990-11#1)(1995-3#1)
to and from the##6##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)
to and from##13##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-6#1)
to and in##2##3##(2010-11#1)(2012-3#1)
to and to##2##3##(2008-12#1)(2009-5#1)
to and##101##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-9#2)(1992-3#2)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-3#2)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#3)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)
to androgen##2##2##(2008-4#1)(2009-5#1)
to androgens##4##2##(1990-5#2)(1995-12#2)
to anemia##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
to aneurysm##2##2##(2007-7#1)(2010-4#1)
to angiotensin II##4##3##(1990-12#2)(1992-9#1)(2008-9#1)
to angiotensin##10##2##(1990-12#2)(1991-12#2)(1992-9#2)(1994-2#1)(1995-12#2)(2008-9#1)
to animal testing##2##3##(2008-10#1)(2008-5#1)
to animal##12##2##(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)
to animals##8##2##(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
to anion exchange chromatography and integrated pulsed electrochemical detection##2##9##(2008-7#2)
to anion##3##2##(1990-8#1)(2008-7#2)
to anionic##2##2##(1995-2#1)(2008-10#1)
to anneal##2##2##(2008-4#1)(2009-5#1)
to annotate##2##2##(2008-9#1)(2013-1#1)
to annual##2##2##(1994-2#1)(2008-10#1)
to anomalous##4##2##(1992-8#1)(2008-3#2)(2012-2#1)
to anorexia nervosa##2##3##(1992-11#1)(2007-8#1)
to another class of##2##4##(1995-6#1)(2008-5#1)
to another in a##2##4##(1991-3#1)(2009-10#1)
to another in##3##3##(1991-3#1)(1994-2#1)(2009-10#1)
to another one##2##3##(2008-10#1)(2008-3#1)
to another##61##2##(1990-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
to anoxia##2##2##(1991-2#1)(1994-12#1)
to answer a##3##3##(2007-4#1)(2007-7#1)(2013-1#1)
to answer questions##3##3##(1991-3#1)(2008-11#1)(2008-5#1)
to answer the following question##2##5##(2012-12#1)(2012-3#1)
to answer the following questions##2##5##(1994-8#1)(1997-3#1)
to answer the following##4##4##(1994-8#1)(1997-3#1)(2012-12#1)(2012-3#1)
to answer the question of##2##5##(2009-8#1)(2010-4#1)
to answer the question##4##4##(2007-8#1)(2009-8#1)(2010-4#1)(2011-2#1)
to answer the##21##3##(1994-8#1)(1997-3#1)(2007-8#10)(2008-10#2)(2008-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
to answer these##2##3##(2008-8#1)(2010-3#1)
to answer##40##2##(1990-8#1)(1991-3#1)(1992-2#1)(1994-1#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-4#1)(2007-7#2)(2007-8#10)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
to antagonize the##2##3##(1995-12#1)(1997-2#1)
to antagonize##10##2##(1994-9#1)(1995-12#3)(1997-2#2)(2008-10#1)(2010-10#1)(2012-12#1)(2013-7#1)
to anterior##5##2##(2008-7#3)(2011-2#2)
to anthesis##8##2##(2008-10#8)
to anthracnose resistance##2##3##(2008-10#2)
to anthracnose##9##2##(2008-10#9)
to anthracyclines##2##2##(1991-6#1)(1993-12#1)
to anthropogenic##2##2##(2007-5#1)(2012-2#1)
to anti-TB treatment##2##3##(1996-3#1)(2011-1#1)
to anti-cancer##2##2##(2008-9#1)(2012-12#1)
to antibacterial##2##2##(1991-3#1)(1992-5#1)
to antibiotic therapy##2##3##(2008-1#1)(2012-1#1)
to antibiotic##6##2##(2008-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
to antibiotics and##2##3##(2007-7#1)(2013-7#1)
to antibiotics in##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
to antibiotics of##2##3##(1990-6#1)(2013-8#1)
to antibiotics##23##2##(1990-12#1)(1990-6#1)(1995-3#1)(1997-4#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
to antibodies against##2##3##(1992-12#1)(1997-6#1)
to antibodies##7##2##(1992-12#1)(1995-11#1)(1997-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-7#1)
to antibody##2##2##(1997-1#1)(2007-5#1)
to anticancer drugs##4##3##(2008-11#2)(2009-6#1)(2012-12#1)
to anticancer##7##2##(1992-2#1)(2008-11#3)(2008-7#1)(2009-6#1)(2012-12#1)
to anticipate##7##2##(1993-9#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
to antidepressant##2##2##(2008-4#1)(2008-6#1)
to antiestrogens##2##2##(2008-11#1)(2012-12#1)
to antifungal##3##2##(2008-10#1)(2008-5#2)
to antigen##3##2##(1991-5#1)(1992-3#1)(1997-1#1)
to antigenic stimulation##2##3##(1997-1#1)(2008-11#1)
to antigens of##2##3##(1992-9#1)(1996-12#1)
to antigens##3##2##(1992-9#1)(1996-12#1)(2008-10#1)
to antihypertensive##2##2##(2008-3#1)(2012-12#1)
to antiinflammatory##2##2##(2008-10#1)(2011-2#1)
to antimicrobial agents##4##3##(1991-2#1)(1991-8#1)(2008-7#1)(2012-12#1)
to antimicrobial##7##2##(1991-2#1)(1991-8#1)(2007-12#1)(2008-7#1)(2012-12#2)(2013-1#1)
to antimicrobials##2##2##(2010-4#1)(2013-8#1)
to antimony##2##2##(2008-10#1)(2012-12#1)
to antineoplastic drugs##3##3##(2013-1#3)
to antineoplastic##4##2##(2008-11#1)(2013-1#3)
to antioxidant##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
to antiretroviral therapy##2##3##(2009-4#1)(2010-11#1)
to antiretroviral##7##2##(2008-4#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-3#1)(2012-12#2)
to ants##2##2##(2008-10#2)
to any desired##4##3##(2007-12#1)(2008-3#2)(2008-9#1)
to any extent##2##3##(1990-6#1)(1995-6#1)
to any given##2##3##(2007-6#1)(2009-5#1)
to any known##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
to any major##2##3##(2008-10#1)(2011-2#1)
to any of the##11##4##(1992-11#1)(1992-6#1)(1993-6#1)(1997-3#1)(2007-12#1)(2008-10#4)(2011-1#1)(2013-8#1)
to any one of the##2##5##(1994-1#1)(1996-10#1)
to any one of##3##4##(1991-8#1)(1994-1#1)(1996-10#1)
to any one##4##3##(1991-8#1)(1994-1#1)(1996-10#1)(2008-10#1)
to any other##11##3##(1993-12#1)(1995-2#1)(1996-12#2)(1996-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
to any reported genes##4##4##(1995-8#2)(1996-10#1)(1996-2#1)
to any researcher##2##3##(2008-7#1)(2008-9#1)
to any single##2##3##(1995-2#1)(1996-12#1)
to any##106##2##(1990-11#1)(1990-6#1)(1991-1#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#4)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#4)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(2007-12#4)(2007-6#2)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#7)(2013-8#1)
to anyone##3##2##(1992-1#1)(1993-12#1)(1995-1#1)
to aorta##2##2##(2007-8#1)(2012-3#1)
to aortic##5##2##(1991-6#1)(1992-12#1)(2007-8#1)(2009-6#1)(2013-8#1)
to apo B-containing##2##3##(1995-8#2)
to apomorphine##2##2##(1995-12#1)(2008-7#1)
to apoptosis and##2##3##(2008-7#1)(2010-11#1)
to apoptosis in##2##3##(1994-10#1)(2008-7#1)
to apoptosis induced by##3##4##(1994-11#1)(2008-11#1)(2013-1#1)
to apoptosis induction##2##3##(2008-8#2)
to apoptosis##22##2##(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#2)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#1)
to apparent homogeneity from##2##4##(1990-12#1)(1996-5#1)
to apparent homogeneity##6##3##(1990-12#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-2#1)
to apparent##8##2##(1990-12#1)(1990-8#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-2#1)(2013-8#1)
to appeal to the##2##4##(1991-2#1)(2012-2#1)
to appear after##2##3##(2007-7#1)(2008-10#1)
to appear##8##2##(1995-8#1)(2007-7#1)(2008-10#3)(2008-2#1)(2011-2#1)(2013-1#1)
to apple##9##2##(2008-10#9)
to application of the##4##4##(1990-7#1)(2008-10#2)(2008-3#1)
to application of##8##3##(1990-7#2)(2008-10#4)(2008-3#1)(2012-3#1)
to application##10##2##(1990-7#2)(2008-10#5)(2008-3#1)(2011-2#1)(2012-3#1)
to applications in##2##3##(2008-2#1)(2008-4#1)
to applications##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
to applied##3##2##(1992-6#1)(1996-1#1)(2007-12#1)
to apply a##9##3##(1991-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2011-1#1)
to apply an##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
to apply and##2##3##(2012-3#1)(2013-1#1)
to apply at##2##3##(1997-7#1)(2007-7#1)
to apply for##3##3##(1991-3#1)(2013-1#2)
to apply it##2##3##(2008-11#1)(2008-4#1)
to apply molecular##2##3##(2008-10#1)(2008-4#1)
to apply the principles of##2##5##(2008-11#2)
to apply the principles##3##4##(2008-11#2)(2013-1#1)
to apply the##13##3##(1997-3#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-10#1)(2013-1#1)
to apply their knowledge in##2##5##(1997-3#1)(2008-12#1)
to apply their##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
to apply them##3##3##(1990-12#1)(1995-3#1)(2013-8#1)
to apply these##4##3##(1996-3#1)(2008-10#1)(2009-10#1)(2013-7#1)
to apply this method##3##4##(2008-10#2)(2008-4#1)
to apply this##10##3##(1993-9#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-4#1)
to apply to##6##3##(1997-3#1)(1997-8#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-7#1)
to apply##89##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#3)(1997-7#2)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
to applying##2##2##(2008-3#2)
to appraise the##2##3##(1996-9#1)(2008-10#1)
to appraise##4##2##(1993-12#1)(1994-12#1)(1996-9#1)(2008-10#1)
to appreciate the##3##3##(1991-12#1)(2008-8#1)(2010-4#1)
to appreciate##4##2##(1991-12#1)(1995-12#1)(2008-8#1)(2010-4#1)
to approach the##7##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-1#1)
to approach##11##2##(1991-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
to appropriate##11##2##(1991-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)
to appropriately##6##2##(1996-3#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
to approx##3##2##(1991-6#1)(2008-6#2)
to approximate the##7##3##(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#1)
to approximate##10##2##(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
to approximately 0##8##3##(1991-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
to approximately 1##2##3##(2008-10#1)(2008-7#1)
to approximately 10##2##3##(2008-11#1)(2010-5#1)
to approximately 10%##3##3##(1992-6#1)(2008-10#1)(2008-2#1)
to approximately 15##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
to approximately 2##2##3##(1992-8#1)(2008-2#1)
to approximately 200##2##3##(2008-11#1)(2008-2#1)
to approximately 3 x##2##4##(2008-11#1)(2008-2#1)
to approximately 3##3##3##(1997-4#1)(2008-11#1)(2008-2#1)
to approximately 40##2##3##(1990-11#1)(2008-3#1)
to approximately 45##2##3##(1995-6#1)(2008-4#1)
to approximately 50%##2##3##(2008-10#2)
to approximately half##2##3##(1990-9#1)(2008-3#1)
to approximately the same##2##4##(1994-8#1)(2008-7#1)
to approximately three##2##3##(1995-5#1)(2008-2#1)
to approximately##76##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#1)(1991-11#2)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#10)(2008-3#6)(2008-4#1)(2008-7#6)(2008-9#1)(2010-5#1)(2012-12#1)
to aquatic##2##2##(2008-10#1)(2008-12#1)
to aqueous solution##2##3##(2008-10#2)
to aqueous##6##2##(2008-10#4)(2008-2#2)
to arachidonate##2##2##(1990-2#2)
to arachidonic acid##5##3##(1993-8#1)(1994-5#1)(1995-11#1)(1997-7#1)(2007-10#1)
to arbitrary##3##2##(2008-2#1)(2008-8#1)(2012-2#1)
to archaeological##2##2##(1995-6#1)(2008-10#1)
to area##2##2##(2008-10#1)(2013-8#1)
to areas of##4##3##(2007-12#1)(2008-11#1)(2008-8#1)(2010-5#1)
to areas that##2##3##(1996-5#1)(2008-10#1)
to areas##8##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-5#1)
to argon##4##2##(1993-1#2)(2008-10#2)
to argue##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
to arise due to##2##4##(2011-1#1)(2013-1#1)
to arise from the##4##4##(2007-12#1)(2008-5#1)(2010-5#1)(2013-7#1)
to arise from##13##3##(1990-7#1)(1994-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
to arise in##2##3##(1990-6#1)(2008-4#1)
to arise through##3##3##(1992-6#1)(2007-10#1)(2008-10#1)
to arise##27##2##(1990-6#1)(1990-7#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to around##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
to arrange##3##2##(1990-12#1)(1996-11#1)(2007-11#1)
to arrest the cell cycle##2##5##(2008-9#1)(2012-12#1)
to arrest the##3##3##(1996-12#1)(2008-9#1)(2012-12#1)
to arrest##7##2##(1996-12#1)(1997-3#1)(2006-6#1)(2007-9#1)(2008-6#1)(2008-9#1)(2012-12#1)
to arrival##2##2##(2008-10#1)(2008-7#1)
to arrive at a##2##4##(2011-2#1)(2013-8#1)
to arrive at the correct diagnosis##2##6##(2010-12#1)(2013-1#1)
to arrive at the##3##4##(1995-1#1)(2010-12#1)(2013-1#1)
to arrive at##9##3##(1994-9#1)(1995-1#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
to arrive##11##2##(1994-9#1)(1995-1#1)(1997-7#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
to arsenate##2##2##(2008-10#2)
to arsenic##3##2##(2008-10#2)(2011-2#1)
to arsenosugars##2##2##(2008-10#2)
to artemisinin##2##2##(1995-3#1)(1997-4#1)
to arterial##8##2##(1995-8#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2012-12#1)
to artichoke##4##2##(2008-10#4)
to articles##3##2##(2008-10#1)(2013-8#2)
to articulate knowing in practice##2##5##(2008-12#2)
to articulate the##3##3##(2008-5#1)(2012-1#1)(2012-2#1)
to articulate##7##2##(2008-11#1)(2008-12#3)(2008-5#1)(2012-1#1)(2012-2#1)
to artificial selection##2##3##(2008-8#1)(2008-9#1)
to artificial##9##2##(1992-12#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-7#1)
to as a##6##3##(1991-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-4#1)
to as few as##2##4##(1995-3#1)(2008-10#1)
to as great as##2##4##(2008-2#1)(2008-3#1)
to as high as##7##4##(2008-10#1)(2008-2#2)(2008-3#4)
to as low as##2##4##(2007-11#1)(2008-10#1)
to as much as##4##4##(1992-12#1)(2008-2#2)(2008-3#1)
to as the &quot##6##4##(1991-2#1)(1996-1#1)(1996-12#1)(2008-11#1)(2009-10#1)(2011-2#1)
to as the##16##3##(1991-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2011-2#1)(2012-12#1)
to as##127##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#15)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#4)(2010-4#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
to asbestos in the##2##4##(1991-12#1)(1997-5#1)
to asbestos in##4##3##(1991-12#3)(1997-5#1)
to asbestos used in railroads##3##5##(1991-12#3)
to asbestos used in##4##4##(1991-12#4)
to asbestos##14##2##(1991-12#10)(1992-11#1)(1993-9#1)(1995-2#1)(1997-5#1)
to ascertain how##3##3##(1994-1#1)(1995-3#1)(1996-9#1)
to ascertain if##3##3##(1992-3#1)(2007-11#1)(2011-2#1)
to ascertain that##2##3##(2008-10#1)(2008-7#1)
to ascertain the effect of##2##5##(2008-11#1)(2013-8#1)
to ascertain the##23##3##(1990-5#1)(1991-12#1)(1994-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to ascertain their##2##3##(2008-10#1)(2008-12#1)
to ascertain whether##6##3##(1992-8#1)(1995-5#1)(1997-4#1)(2007-8#1)(2008-11#1)(2010-8#1)
to ascertain which##2##3##(2006-6#1)(2011-1#1)
to ascertain##48##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to ascospore progeny under##2##4##(2008-10#2)
to ascospore##3##2##(2008-10#3)
to ascribe##2##2##(2008-7#1)(2012-2#1)
to asexual reproduction##2##3##(2008-10#1)(2012-3#1)
to asexual##3##2##(2008-10#1)(2010-2#1)(2012-3#1)
to ask##8##2##(1994-1#1)(1994-2#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
to asparagine##3##2##(1991-12#1)(1995-8#1)(2008-10#1)
to aspartame##5##2##(2008-8#5)
to aspartic acid##2##3##(1995-2#1)(2007-6#1)
to aspects of##2##3##(2008-3#1)(2010-8#1)
to aspiration##4##2##(1993-10#2)(1993-3#1)(2010-12#1)
to aspirin##6##2##(1991-11#1)(2008-8#3)(2010-4#1)(2011-1#1)
to assay the##4##3##(1997-4#1)(2008-10#3)
to assay##26##2##(1991-5#2)(1993-1#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)
to assemble a##3##3##(1993-8#1)(2008-10#1)(2008-9#1)
to assemble and##2##3##(2008-1#1)(2008-10#1)
to assemble the##4##3##(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
to assemble##14##2##(1993-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-2#2)(2011-2#1)(2012-2#1)
to asses##7##2##(1996-12#1)(2007-11#2)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
to assess QoL##2##3##(2008-10#1)(2011-2#1)
to assess a new##2##4##(1996-9#1)(2007-7#1)
to assess a##5##3##(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)
to assess airway##2##3##(1997-1#1)(2008-10#1)
to assess and compare##2##4##(2011-2#1)(2012-12#1)
to assess and##7##3##(1992-3#1)(1996-2#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
to assess at##2##3##(2007-8#1)(2008-8#1)
to assess biological##2##3##(2008-11#1)(2011-2#1)
to assess both the##2##4##(1994-6#1)(2008-10#1)
to assess both##3##3##(1994-6#1)(2008-10#2)
to assess cell##2##3##(2008-11#1)(2012-2#1)
to assess changes in##5##4##(1996-2#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)
to assess differences in##4##4##(1991-1#1)(2007-8#1)(2008-10#1)(2013-1#1)
to assess differences##5##3##(1991-1#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
to assess different aspects of##2##5##(2008-4#1)(2012-2#1)
to assess different##3##3##(1997-4#1)(2008-4#1)(2012-2#1)
to assess efficacy of##2##4##(2008-10#1)(2008-5#1)
to assess exposure##2##3##(2010-5#1)(2011-2#1)
to assess for##2##3##(2009-7#1)(2012-3#1)
to assess genetic##3##3##(2008-10#3)
to assess global##2##3##(2012-12#1)(2013-1#1)
to assess how##3##3##(1997-2#1)(2010-6#1)(2010-8#1)
to assess in vitro the##2##5##(2008-5#1)(2008-9#1)
to assess in vitro##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
to assess its##9##3##(1992-2#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-4#1)(2013-1#1)
to assess local##3##3##(1993-1#1)(1995-12#1)(2011-1#1)
to assess multiple##2##3##(2009-10#1)(2012-3#1)
to assess nutritional improvement##2##4##(2013-1#2)
to assess nutritional##3##3##(2013-1#3)
to assess our##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
to assess patient##2##3##(1997-2#1)(2013-1#1)
to assess patients##3##3##(1995-1#1)(2012-2#1)(2013-1#1)
to assess potential##4##3##(2008-10#1)(2009-11#1)(2010-6#1)(2011-2#1)
to assess risk##3##3##(1996-12#1)(2008-12#1)(2008-4#1)
to assess severity of##2##4##(2008-9#2)
to assess steric##2##3##(1992-10#1)(1995-3#1)
to assess the ability of pre-registration nursing students' to##2##9##(2008-11#2)
to assess the ability of##5##5##(1991-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
to assess the accuracy of the##2##6##(2008-10#1)(2008-2#1)
to assess the accuracy of##3##5##(1994-3#1)(2008-10#1)(2008-2#1)
to assess the accuracy##4##4##(1994-3#1)(2008-10#2)(2008-2#1)
to assess the action of##2##5##(2008-4#2)
to assess the applicability of##2##5##(1995-1#1)(1995-11#1)
to assess the capacity of##2##5##(2010-10#1)(2013-8#1)
to assess the contribution of##2##5##(2008-10#1)(2013-1#1)
to assess the current##2##4##(1994-12#1)(2008-10#1)
to assess the degree of##7##5##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)
to assess the degree##8##4##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)
to assess the effect of a##3##6##(1997-7#1)(2008-3#1)(2008-5#1)
to assess the effect of##15##5##(1994-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to assess the effect##16##4##(1994-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
to assess the effectiveness of the##3##6##(1993-1#1)(1994-8#1)(2011-3#1)
to assess the effectiveness of this##2##6##(2007-11#1)(2008-3#1)
to assess the effectiveness of##10##5##(1990-2#1)(1993-1#1)(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
to assess the effects of the##3##6##(1990-8#1)(1995-12#1)(2008-10#1)
to assess the effects of##13##5##(1990-12#1)(1990-8#1)(1991-5#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
to assess the efficacy of##5##5##(1992-9#1)(2008-1#1)(2009-2#1)(2012-3#1)(2013-1#1)
to assess the efficacy##8##4##(1992-9#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-2#1)(2012-3#1)(2013-1#1)
to assess the evidence##2##4##(2008-2#1)(2013-8#1)
to assess the extent of##3##5##(1992-6#1)(2008-8#1)(2013-1#1)
to assess the extent##5##4##(1992-6#1)(1995-3#1)(2008-8#1)(2009-5#1)(2013-1#1)
to assess the feasibility and##2##5##(1992-2#1)(2007-10#1)
to assess the feasibility of##5##5##(1993-12#1)(1995-11#1)(1997-8#1)(2007-8#1)(2008-11#1)
to assess the feasibility##7##4##(1992-2#1)(1993-12#1)(1995-11#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-11#1)
to assess the general##2##4##(2008-3#1)(2008-7#1)
to assess the genetic diversity##2##5##(2008-10#1)(2008-7#1)
to assess the genetic##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
to assess the growth##2##4##(2008-10#1)(2009-4#1)
to assess the impact of the##2##6##(1991-12#1)(1993-6#1)
to assess the impact of##18##5##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
to assess the impact##20##4##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
to assess the independent##2##4##(1993-3#1)(2013-1#1)
to assess the influence of##9##5##(1993-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2013-1#1)
to assess the knowledge##2##4##(2011-1#1)(2013-1#1)
to assess the magnitude of##3##5##(2008-11#1)(2010-8#1)(2013-8#1)
to assess the needs##2##4##(1993-12#1)(2012-12#1)
to assess the perceived##2##4##(1994-2#1)(2013-8#1)
to assess the performance of##2##5##(1996-3#1)(2008-4#1)
to assess the performance##3##4##(1996-3#1)(1997-3#1)(2008-4#1)
to assess the possibility of##3##5##(2011-2#1)(2012-3#1)(2013-1#1)
to assess the possible##3##4##(2008-11#1)(2012-3#1)(2012-8#1)
to assess the potential of##2##5##(2008-3#1)(2012-1#1)
to assess the potential##12##4##(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-1#1)(2012-3#1)
to assess the predictive##2##4##(2012-12#2)
to assess the presence of##2##5##(2008-5#1)(2010-1#1)
to assess the presence##4##4##(2008-5#2)(2010-1#1)(2012-2#1)
to assess the prevalence of##7##5##(2007-7#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#2)(2013-8#1)
to assess the prevalence##8##4##(2007-7#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to assess the quality of##7##5##(1991-3#1)(1993-6#1)(1996-9#1)(2008-10#2)(2012-3#1)(2013-1#1)
to assess the relationship##3##4##(2008-6#1)(2008-9#1)(2013-1#1)
to assess the relative importance of##3##6##(2008-10#1)(2008-7#1)(2009-4#1)
to assess the relative##11##4##(1993-2#1)(1995-12#1)(1996-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)
to assess the results##2##4##(1990-6#1)(2008-7#1)
to assess the risk of##7##5##(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
to assess the risk##8##4##(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
to assess the robustness of##2##5##(2008-4#1)(2013-1#1)
to assess the role of##3##5##(1995-11#1)(2007-7#1)(2008-2#1)
to assess the safety and##2##5##(2007-11#1)(2009-12#1)
to assess the safety##3##4##(2007-11#1)(2008-5#1)(2009-12#1)
to assess the sand/rub resistance of##2##6##(2008-5#2)
to assess the severity of##2##5##(1995-11#1)(2013-1#1)
to assess the skin##2##4##(2008-5#2)
to assess the true##2##4##(1995-12#1)(2012-3#1)
to assess the usefulness of##3##5##(1990-5#1)(1996-3#1)(2013-1#1)
to assess the usefulness##4##4##(1990-5#1)(1996-3#1)(2011-2#1)(2013-1#1)
to assess the validity of the##2##6##(2008-10#1)(2008-3#1)
to assess the viability of the##3##6##(1997-4#1)(2008-10#2)
to assess the##371##3##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#3)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#3)(2007-10#4)(2007-11#5)(2007-12#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#54)(2008-11#11)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#10)(2008-5#24)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#17)(2012-8#1)(2013-1#18)(2013-7#4)(2013-8#10)
to assess their association with##2##5##(1996-12#1)(2008-8#1)
to assess their function##2##4##(1992-8#1)(2008-4#1)
to assess their##19##3##(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
to assess to what##2##4##(2008-11#2)
to assess treatment##2##3##(1991-6#1)(2008-3#1)
to assess tumor##2##3##(1991-8#1)(2008-8#1)
to assess water quality##2##4##(2007-5#1)(2008-10#1)
to assess water-contact##2##3##(2008-8#2)
to assess whether an##2##4##(1991-6#1)(2007-10#1)
to assess whether the##4##4##(2008-10#1)(2012-2#2)(2013-1#1)
to assess whether these##2##4##(2008-6#1)(2008-7#1)
to assess whether##24##3##(1991-6#1)(1993-12#1)(1994-3#2)(1995-11#1)(1997-4#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
to assess which##2##3##(1993-2#1)(2012-2#1)
to assess##711##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#8)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#8)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#3)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#6)(1995-5#2)(1996-1#3)(1996-12#5)(1996-2#6)(1996-3#3)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#5)(1997-7#2)(1997-8#4)(2006-10#2)(2007-10#8)(2007-11#9)(2007-12#2)(2007-5#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#103)(2008-11#30)(2008-12#17)(2008-2#8)(2008-3#14)(2008-4#18)(2008-5#39)(2008-6#5)(2008-7#26)(2008-8#19)(2008-9#16)(2009-10#4)(2009-11#6)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#36)(2011-3#1)(2011-8#1)(2012-1#6)(2012-12#14)(2012-2#19)(2012-3#24)(2012-8#1)(2013-1#37)(2013-7#4)(2013-8#17)
to assessing##4##2##(1991-1#1)(1997-2#1)(2008-10#1)(2008-8#1)
to assessment and treatment##2##4##(1992-1#1)(2011-1#1)
to assessment##5##2##(1992-1#1)(1993-1#1)(2008-11#1)(2008-9#1)(2011-1#1)
to assign the##4##3##(1992-9#1)(1996-2#3)
to assign##15##2##(1991-5#1)(1992-9#1)(1993-11#1)(1995-3#1)(1996-2#3)(1996-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
to assimilate the##2##3##(2008-11#1)(2013-1#1)
to assimilate##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
to assist clinicians##2##3##(2007-12#1)(2012-12#1)
to assist dental educational researchers in##2##6##(2013-1#2)
to assist families##2##3##(1997-2#1)(2011-1#1)
to assist in the##7##4##(2007-2#1)(2008-12#1)(2008-4#2)(2008-7#1)(2012-12#1)(2012-3#1)
to assist in their##2##4##(2008-7#1)(2013-8#1)
to assist in##24##3##(1993-12#1)(1993-8#1)(1995-1#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to assist the##14##3##(1991-12#1)(1995-1#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-7#1)
to assist them##2##3##(1995-1#1)(1995-12#1)
to assist with##2##3##(2009-6#1)(2013-1#1)
to assist##90##2##(1991-12#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-1#3)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#2)(2007-12#3)(2007-2#1)(2007-5#1)(2008-1#6)(2008-10#10)(2008-11#4)(2008-12#7)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
to assisted##2##2##(2010-12#1)(2012-2#1)
to assisting##3##2##(1991-12#1)(2008-10#1)(2010-2#1)
to associate a##3##3##(1993-6#1)(2008-10#1)(2009-8#1)
to associate with the##3##4##(1992-8#1)(1993-11#1)(2008-10#1)
to associate with##5##3##(1992-8#1)(1993-11#1)(2008-10#1)(2008-7#1)(2009-9#1)
to associate##16##2##(1990-11#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-9#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-8#3)(2009-9#1)(2012-3#1)
to associated##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
to association##2##2##(2008-8#1)(2013-1#1)
to associations between##2##3##(2008-12#1)(2012-3#1)
to assume a##3##3##(1992-1#1)(2010-10#1)(2012-2#1)
to assume responsibility for##2##4##(1992-3#1)(1995-12#1)
to assume that the##2##4##(1991-6#1)(2008-5#1)
to assume that##10##3##(1991-1#1)(1991-6#2)(1992-12#1)(2008-11#2)(2008-2#1)(2008-5#3)
to assume the##3##3##(1996-2#1)(1997-7#1)(2008-7#1)
to assume##24##2##(1991-1#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-2#1)
to assumptions##3##2##(1995-12#1)(2008-8#1)(2009-9#1)
to assure a##3##3##(2010-11#1)(2010-9#1)(2011-1#1)
to assure that##5##3##(1994-2#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-3#1)
to assure the delivery of##2##5##(1993-12#1)(1994-12#1)
to assure the##6##3##(1993-12#1)(1994-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
to assure##25##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
to asthma##9##2##(1992-3#1)(1997-2#2)(2007-11#1)(2007-6#2)(2008-3#1)(2008-8#1)(2013-1#1)
to asymmetric##4##2##(2008-2#1)(2008-5#1)(2008-8#1)(2010-6#1)
to at least 100 ng ml(-1)##2##6##(2008-10#2)
to at least 100##4##4##(2008-10#4)
to at least one##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
to at least two##2##4##(1993-8#1)(1995-2#1)
to at least##25##3##(1993-8#1)(1995-2#2)(1995-3#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to at##26##2##(1992-12#1)(1993-8#1)(1995-2#2)(1995-3#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to atherosclerosis and##2##3##(1995-12#1)(2008-1#1)
to atherosclerosis##8##2##(1995-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-4#1)(2013-8#1)
to atherosclerotic##2##2##(2008-4#1)(2011-1#1)
to athletes##2##2##(2008-5#2)
to athletes' health##2##3##(1993-3#1)(2010-7#1)
to atmospheric pressure##2##3##(1990-7#1)(2008-10#1)
to atmospheric##9##2##(1990-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)
to atomic absorption or atomic##2##5##(2008-10#2)
to atomic absorption##3##3##(2008-10#3)
to atomic##8##2##(1994-8#1)(2008-10#5)(2008-2#1)(2008-4#1)
to atopic##2##2##(1996-8#1)(2008-7#1)
to atrial fibrillation##2##3##(2008-12#1)(2010-4#1)
to attach to the##2##4##(2008-10#1)(2011-1#1)
to attach to##3##3##(2008-10#2)(2011-1#1)
to attach##7##2##(1994-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-1#1)
to attachment##2##2##(1991-12#1)(2008-7#1)
to attack by##2##3##(2008-10#1)(2008-9#1)
to attack##8##2##(2008-10#2)(2008-12#1)(2008-9#2)(2009-10#1)(2010-1#1)(2011-10#1)
to attain a##5##3##(1993-3#1)(1994-8#1)(1997-8#1)(2008-1#1)(2008-8#1)
to attain the desired##2##4##(2008-3#1)(2009-6#1)
to attain the##8##3##(2008-10#5)(2008-3#1)(2009-6#1)(2010-9#1)
to attain##26##2##(1993-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-7#1)
to attempt to answer##2##4##(1990-8#1)(1992-2#1)
to attempt to##6##3##(1990-8#1)(1992-2#1)(1994-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
to attempt##9##2##(1990-10#1)(1990-8#1)(1992-2#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-8#1)
to attend more than##2##4##(2008-5#1)(2008-7#1)
to attend the##2##3##(2007-10#1)(2012-2#1)
to attend to the##2##4##(1997-8#1)(2008-11#1)
to attend to##3##3##(1997-8#1)(2008-11#1)(2013-1#1)
to attend##16##2##(1992-2#1)(1992-5#1)(1993-3#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
to attention##2##2##(1996-2#1)(2008-11#1)
to attenuate the##8##3##(1992-8#1)(1993-12#2)(1993-8#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)
to attenuate##18##2##(1990-5#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-9#1)(1996-5#1)(1997-1#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
to attitudes toward##3##3##(2009-7#1)(2011-1#1)(2013-1#1)
to attitudes##6##2##(2007-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
to attract##12##2##(1990-2#1)(1990-4#1)(1994-1#2)(1995-3#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2013-1#1)
to augment the##7##3##(1993-6#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#2)
to augment##16##2##(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
to autism##2##2##(2011-2#1)(2012-3#1)
to autoimmune##5##2##(2008-10#2)(2008-7#1)(2009-3#1)(2011-2#1)
to automate##6##2##(2008-10#3)(2008-3#1)(2010-10#1)(2011-2#1)
to automated##7##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)
to automatically##4##2##(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
to automation##5##2##(1995-12#1)(1996-3#1)(2008-10#3)
to auxin##4##2##(2008-8#3)(2009-8#1)
to available##6##2##(1991-8#1)(1992-3#1)(2007-12#1)(2009-4#1)(2013-1#1)(2013-8#1)
to average##19##2##(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#3)(2008-9#10)(2011-2#1)
to averaging##2##2##(2007-12#1)(2008-2#1)
to avert##5##2##(1997-4#2)(2008-10#1)(2008-5#1)(2011-2#1)
to avian##6##2##(2007-6#2)(2008-5#2)(2008-8#1)(2012-3#1)
to avirulent##2##2##(1995-2#1)(2008-10#1)
to avoid a##7##3##(1994-1#1)(1994-2#1)(2008-6#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
to avoid and##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
to avoid any##2##3##(2008-3#1)(2008-4#1)
to avoid complications##3##3##(1991-6#1)(2011-2#1)(2012-12#1)
to avoid distal endothelial##2##4##(2007-8#2)
to avoid excessive##3##3##(2007-8#1)(2008-10#2)
to avoid interferences##2##3##(2008-10#2)
to avoid it##2##3##(1997-3#1)(2012-12#1)
to avoid misdiagnosis##2##3##(2008-6#1)(2011-2#1)
to avoid or##3##3##(1991-12#1)(1991-6#1)(2008-10#1)
to avoid postoperative retroauricular deformity##3##5##(2008-7#3)
to avoid potential##2##3##(1997-2#1)(2008-5#1)
to avoid the complications of##2##5##(1991-8#1)(2011-2#1)
to avoid the effect of##2##5##(2008-10#1)(2008-8#1)
to avoid the negative##2##4##(2008-11#1)(2008-9#1)
to avoid the risk of##2##5##(1993-8#1)(1994-11#1)
to avoid the use of##2##5##(2008-7#1)(2011-2#1)
to avoid the##35##3##(1991-8#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-11#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
to avoid them##4##3##(1995-2#1)(2007-8#1)(2010-8#1)(2011-2#1)
to avoid underestimation of##2##4##(1990-2#1)(2011-2#1)
to avoid unnecessary surgery##2##4##(2012-2#2)
to avoid unnecessary##5##3##(1993-6#1)(2009-6#1)(2010-8#1)(2012-2#2)
to avoid##220##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-2#5)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#32)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#8)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#1)(2011-2#15)(2011-3#1)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#6)(2013-7#5)(2013-8#4)
to avoiding##2##2##(1992-12#1)(2008-8#1)
to axillary##3##2##(2007-8#1)(2008-5#2)
to ayahuasca use##2##3##(2008-7#1)(2013-8#1)
to azoles##2##2##(2008-5#2)
to azoxymethane##2##2##(1993-11#1)(2011-2#1)
to b##2##2##(2008-10#2)
to bFGF##4##2##(1995-12#2)(2008-11#2)
to background##6##2##(1993-5#1)(1995-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)
to backscattering##3##2##(2008-2#2)(2008-3#1)
to bacteria##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-3#1)
to bacterial blight##5##3##(2008-10#3)(2008-8#1)(2009-10#1)
to bacterial canker##7##3##(2008-10#7)
to bacterial lipopolysaccharide##3##3##(1993-8#1)(2008-10#1)(2011-1#1)
to bacterial pathogens##4##3##(2008-10#4)
to bacterial##36##2##(1990-8#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)(2013-8#2)
to balance both##2##3##(2010-5#1)(2012-6#1)
to balance the##4##3##(1995-6#1)(2008-11#1)(2008-3#1)(2008-7#1)
to balance##10##2##(1992-12#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#1)(2012-6#1)
to balloon##3##2##(1994-11#1)(1997-8#1)(2008-11#1)
to ban##2##2##(1996-8#1)(2010-9#1)
to band##5##2##(1992-11#1)(2008-12#1)(2008-2#1)(2013-1#1)(2013-7#1)
to bariatric surgery##2##3##(1993-3#1)(2010-8#1)
to barley in the##2##4##(2008-10#2)
to barley yellow dwarf virus (BYDV)##3##6##(2008-10#2)(2008-8#1)
to barley yellow dwarf virus##4##5##(2008-10#3)(2008-8#1)
to barley##9##2##(2008-10#8)(2008-8#1)
to baroreceptor##3##2##(1990-5#2)(1997-2#1)
to basal levels##3##3##(1996-12#1)(2008-10#1)(2012-1#1)
to basal values##2##3##(1990-7#1)(1991-6#1)
to basal##10##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1996-12#1)(1997-1#1)(2008-10#1)(2012-1#1)(2012-3#1)
to base##17##2##(1992-11#1)(1992-12#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
to baseline at##2##3##(1990-7#1)(2013-1#1)
to baseline levels within##2##4##(1990-10#1)(1991-12#1)
to baseline levels##3##3##(1990-10#1)(1991-12#1)(2012-2#1)
to baseline values##2##3##(2013-1#1)(2013-8#1)
to baseline##19##2##(1990-10#1)(1990-7#1)(1991-12#1)(1993-1#1)(1994-3#1)(2007-11#1)(2008-6#1)(2008-7#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
to basic##16##2##(1992-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#1)(2013-1#2)
to batch cultures##2##3##(2008-11#2)
to batch##4##2##(2008-11#3)(2008-7#1)
to bats##2##2##(2007-12#1)(2009-8#1)
to bcl-2##2##2##(1993-3#1)(1994-3#1)
to be &gt##7##3##(1996-2#1)(2007-7#1)(2008-10#4)(2008-8#1)
to be &lt##8##3##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#2)
to be &quot##7##3##(1991-3#1)(2008-11#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
to be (2##3##3##(2008-2#1)(2008-3#2)
to be (3##3##3##(2008-10#2)(2008-3#1)
to be 0##71##3##(1990-6#1)(1990-7#1)(1990-8#1)(1994-6#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-10#48)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
to be 1##49##3##(1992-2#1)(1993-11#1)(1994-5#1)(1995-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
to be 10##10##3##(1990-12#1)(1992-12#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-8#1)
to be 10-fold##2##3##(1992-9#1)(1995-11#1)
to be 100% and##2##4##(1996-12#1)(2007-8#1)
to be 100%##5##3##(1994-12#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-9#1)
to be 110##2##3##(2007-12#1)(2008-10#1)
to be 15##3##3##(1997-3#1)(2008-10#1)(2008-6#1)
to be 16##5##3##(1997-6#1)(2008-10#1)(2009-9#1)(2012-2#2)
to be 2##39##3##(1992-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-10#28)(2008-2#4)(2008-3#1)(2008-5#1)(2011-1#1)
to be 20 nm##2##4##(2008-3#1)(2009-9#1)
to be 21##2##3##(2008-10#1)(2012-3#1)
to be 23##2##3##(1990-7#1)(1993-8#1)
to be 3##18##3##(1990-12#1)(1993-8#1)(1997-2#1)(2007-11#1)(2008-10#10)(2008-3#3)(2012-2#1)
to be 30##3##3##(1993-12#1)(2007-11#1)(2008-3#1)
to be 4##19##3##(1990-5#1)(1993-1#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-10#11)(2012-3#1)
to be 5##13##3##(1997-2#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-1#1)
to be 6##8##3##(1991-2#1)(1992-2#1)(2008-10#4)(2008-11#1)(2013-8#1)
to be 62##2##3##(2008-10#2)
to be 65##2##3##(1992-11#1)(2008-3#1)
to be 7##8##3##(1991-5#1)(2007-11#2)(2007-12#1)(2008-10#4)
to be 8##5##3##(1994-5#1)(2008-10#3)(2008-3#1)
to be 80%##2##3##(2007-11#1)(2008-3#1)
to be 87##2##3##(1990-11#1)(2008-10#1)
to be 9##4##3##(1991-5#1)(1995-11#1)(2008-10#2)
to be 90%##2##3##(2007-8#1)(2008-3#1)
to be 99##7##3##(1996-12#1)(2008-10#5)(2013-1#1)
to be F##2##3##(2008-10#2)
to be Neisseria##2##3##(2013-1#2)
to be a &quot##2##4##(2008-10#1)(2009-7#1)
to be a beneficial##2##4##(1997-1#1)(2010-12#1)
to be a benign tumor##2##5##(2008-10#1)(2008-12#1)
to be a better##2##4##(1996-1#1)(2008-10#1)
to be a case of##2##5##(2007-7#1)(2012-2#1)
to be a cause of##3##5##(1994-6#1)(2008-11#1)(2009-5#1)
to be a cavernous##2##4##(2008-10#1)(2011-1#1)
to be a central##2##4##(2010-10#1)(2013-1#1)
to be a challenge to##2##5##(1992-1#1)(2008-6#1)
to be a challenge##3##4##(1992-1#1)(2008-6#1)(2011-1#1)
to be a close##2##4##(1995-2#1)(2010-10#1)
to be a common feature of##2##6##(1991-10#1)(1991-9#1)
to be a common feature##3##5##(1991-10#1)(1991-9#1)(2008-10#1)
to be a common##9##4##(1991-10#1)(1991-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2011-1#2)
to be a complex##2##4##(1992-2#1)(1995-12#1)
to be a consequence of##2##5##(1992-6#1)(1997-3#1)
to be a constant##3##4##(1992-12#1)(2007-12#1)(2008-3#1)
to be a contributory cause##2##5##(1993-2#1)(1994-2#1)
to be a cost-effective##2##4##(2008-10#1)(2008-7#1)
to be a critical##2##4##(1994-2#1)(2010-7#1)
to be a crucial##2##4##(1991-12#1)(2010-12#1)
to be a direct##2##4##(1994-8#1)(2008-11#1)
to be a factor##2##4##(1991-3#1)(2008-10#1)
to be a fast and accurate##2##6##(2008-10#1)(2008-3#1)
to be a fast and##5##5##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-1#1)
to be a function of the##4##6##(1991-5#1)(2008-2#1)(2008-7#1)(2011-1#1)
to be a function of##7##5##(1991-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-1#1)
to be a fundamental##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
to be a general##3##4##(2008-10#1)(2008-8#2)
to be a good indicator##2##5##(2008-10#1)(2008-3#1)
to be a good predictor of##2##6##(2007-7#1)(2013-7#1)
to be a good tool##2##5##(2008-7#1)(2009-8#1)
to be a good##16##4##(1994-11#2)(1994-12#1)(1994-9#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2013-1#1)(2013-7#1)
to be a high##5##4##(1992-12#1)(1993-9#1)(1994-5#1)(2008-11#1)(2008-8#1)
to be a highly##3##4##(1991-5#1)(2008-10#2)
to be a key factor in##2##6##(2008-11#1)(2010-8#1)
to be a key##6##4##(2008-11#2)(2008-5#1)(2010-8#2)(2013-8#1)
to be a lack of##2##5##(1997-8#1)(2007-2#1)
to be a large##2##4##(1997-6#1)(2007-8#1)
to be a major cause of##2##6##(1991-12#1)(1995-3#1)
to be a major component of##2##6##(2008-10#1)(2008-5#1)
to be a major factor##2##5##(1991-9#1)(1992-1#1)
to be a major##18##4##(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2012-3#1)
to be a marker##2##4##(2010-3#1)(2011-2#1)
to be a member of##2##5##(1992-3#1)(1993-2#1)
to be a metastasis##2##4##(1992-6#1)(1993-12#1)
to be a molecular##2##4##(2008-4#1)(2008-6#1)
to be a more potent##2##5##(1994-11#1)(2008-5#1)
to be a more##10##4##(1994-11#1)(1994-5#1)(2008-10#5)(2008-5#1)(2011-1#1)(2012-1#1)
to be a new##3##4##(2008-10#1)(2008-3#2)
to be a novel##10##4##(2007-11#1)(2008-10#1)(2008-3#7)(2011-2#1)
to be a passive##2##4##(2008-3#1)(2009-7#1)
to be a positive##2##4##(2007-10#1)(2008-11#1)
to be a possible##3##4##(1992-11#1)(1995-11#1)(2011-2#1)
to be a potent inducer of##2##6##(1993-12#1)(2008-10#1)
to be a potent##11##4##(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)
to be a powerful and##2##5##(2008-11#1)(2011-2#1)
to be a powerful means##2##5##(2008-11#1)(2008-3#1)
to be a powerful tool for the##2##7##(2007-12#1)(2008-10#1)
to be a powerful tool for##4##6##(2007-12#2)(2008-10#1)(2008-4#1)
to be a powerful tool in##3##6##(2008-11#1)(2008-3#1)(2009-5#1)
to be a powerful tool##8##5##(1993-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
to be a powerful##17##4##(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-3#3)(2008-4#1)(2009-5#1)(2011-2#1)
to be a practical##3##4##(1997-2#1)(2007-11#1)(2008-3#1)
to be a primary##4##4##(1992-4#1)(1995-1#1)(2008-10#1)(2010-3#1)
to be a priority##2##4##(2007-6#1)(2008-11#1)
to be a promising therapeutic##3##5##(2008-5#1)(2009-8#1)(2011-2#1)
to be a promising##10##4##(1990-11#1)(1991-2#1)(1997-4#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)(2011-7#1)
to be a protective##2##4##(1994-6#1)(2011-1#1)
to be a reasonable##3##4##(1993-1#1)(2006-10#1)(2012-2#1)
to be a reliable technique##2##5##(1996-6#1)(2012-2#1)
to be a reliable##7##4##(1994-2#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
to be a result of##5##5##(1993-12#1)(2007-12#1)(2008-11#1)(2009-2#1)(2012-12#1)
to be a risk factor in##2##6##(1991-4#1)(1992-3#1)
to be a robust##2##4##(2008-10#1)(2012-2#1)
to be a safe and##4##5##(1990-11#1)(1996-9#1)(2007-10#1)(2011-2#1)
to be a safe##7##4##(1990-11#1)(1992-2#1)(1996-9#1)(2007-10#1)(2010-7#1)(2011-2#2)
to be a sensitive and##2##5##(1994-11#1)(2008-10#1)
to be a sensitive##6##4##(1994-11#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
to be a serious##3##4##(2008-12#1)(2009-9#1)(2010-5#1)
to be a significant predictor of##2##6##(1991-3#1)(1996-3#1)
to be a significant source of##2##6##(1995-3#1)(2012-2#1)
to be a significant##13##4##(1991-3#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-7#2)(2011-2#1)(2012-2#1)
to be a simple and##3##5##(1993-5#1)(1995-2#1)(2012-2#1)
to be a simple##5##4##(1993-5#1)(1995-2#1)(2008-10#2)(2012-2#1)
to be a single##4##4##(1990-11#1)(1995-8#1)(2007-7#1)(2011-2#1)
to be a source of##2##5##(2008-10#1)(2010-6#1)
to be a specific##3##4##(1992-11#1)(1992-6#1)(2010-1#1)
to be a strong##4##4##(2007-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
to be a substantial##2##4##(1991-12#1)(2008-3#1)
to be a suitable replacement for##2##6##(2008-11#1)(2008-5#1)
to be a suitable##7##4##(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-1#1)
to be a useful tool for##2##6##(1990-2#1)(1995-11#1)
to be a useful tool in the##3##7##(1994-3#1)(1996-9#1)(2008-2#1)
to be a useful tool in##9##6##(1991-11#1)(1992-1#1)(1994-3#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#1)
to be a useful tool to##2##6##(2008-10#1)(2011-2#1)
to be a useful tool##13##5##(1990-2#1)(1991-11#1)(1992-1#1)(1994-3#1)(1995-11#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
to be a useful##25##4##(1990-2#1)(1991-11#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)
to be a valid##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
to be a valuable##5##4##(1994-6#1)(2008-11#1)(2010-5#1)(2010-7#1)(2013-8#1)
to be a very sensitive##2##5##(1993-12#1)(2008-10#1)
to be a very useful##2##5##(1990-11#1)(1996-12#1)
to be a very##17##4##(1990-11#1)(1990-9#2)(1991-5#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-2#2)
to be a viable alternative to##2##6##(2008-10#2)
to be a viable##6##4##(1994-6#1)(2008-10#3)(2008-11#1)(2013-1#1)
to be a##577##3##(1990-11#6)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#8)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#4)(2006-10#3)(2006-12#2)(2007-10#3)(2007-11#5)(2007-12#10)(2007-2#5)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#4)(2008-10#85)(2008-11#29)(2008-12#4)(2008-2#10)(2008-3#27)(2008-4#7)(2008-5#13)(2008-6#8)(2008-7#14)(2008-8#12)(2008-9#8)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#5)(2010-8#8)(2011-1#7)(2011-2#19)(2011-7#1)(2012-1#4)(2012-12#4)(2012-2#18)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#8)
to be able to bind##2##5##(1994-11#1)(2008-10#1)
to be able to identify##2##5##(2008-11#1)(2013-8#1)
to be able to make##2##5##(1996-3#1)(2008-12#1)
to be able to provide##4##5##(1992-9#1)(1995-3#1)(2008-10#1)(2013-8#1)
to be able to##45##4##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#3)
to be able##47##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#3)
to be abnormal in##2##4##(1991-12#1)(2008-12#1)
to be abnormal##3##3##(1991-12#1)(2008-1#1)(2008-12#1)
to be about##8##3##(1990-6#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#1)
to be absent##2##3##(2008-11#1)(2011-1#1)
to be absorbed##2##3##(2008-10#1)(2008-5#1)
to be acceptable to##2##4##(1993-3#1)(2013-1#1)
to be acceptable##6##3##(1993-3#1)(2007-12#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
to be accepted##2##3##(2007-7#1)(2011-2#1)
to be accessible##2##3##(1995-2#1)(2012-3#1)
to be accommodated##2##3##(1997-3#1)(2008-11#1)
to be accompanied by##2##4##(1992-8#1)(1993-11#1)
to be accurate##13##3##(1995-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-11#1)(2010-8#1)(2012-12#2)(2012-2#1)
to be accurately##2##3##(2008-10#1)(2008-9#1)
to be achievable##3##3##(1996-12#1)(2007-12#1)(2008-2#1)
to be achieved in a single##2##6##(2008-7#1)(2013-1#1)
to be achieved in##3##4##(1992-9#1)(2008-7#1)(2013-1#1)
to be achieved##16##3##(1992-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#2)(2013-1#2)
to be acknowledged and##2##4##(2012-2#1)(2012-3#1)
to be activated by the##2##5##(1995-6#1)(2008-11#1)
to be activated by##6##4##(1993-12#1)(1994-5#1)(1995-6#2)(2008-11#1)(2013-8#1)
to be activated##7##3##(1993-12#1)(1994-5#1)(1995-6#2)(2008-11#1)(2010-7#1)(2013-8#1)
to be active against##4##4##(2007-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
to be active##11##3##(1992-10#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-2#1)(2011-1#2)
to be adapted to##4##4##(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)
to be adapted##6##3##(2008-10#1)(2008-3#1)(2008-7#2)(2009-8#1)(2012-12#1)
to be added to the##2##5##(2008-2#2)
to be added##8##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2012-2#1)
to be addressed are##3##4##(2008-11#1)(2009-3#1)(2011-2#1)
to be addressed for the administrative##4##6##(2013-8#4)
to be addressed for##5##4##(2007-12#1)(2013-8#4)
to be addressed in future##2##5##(2011-2#1)(2012-2#1)
to be addressed in the##5##5##(1992-9#1)(1994-12#1)(1997-5#1)(2008-4#1)(2008-7#1)
to be addressed in##11##4##(1992-9#1)(1994-1#1)(1994-12#1)(1997-2#1)(1997-5#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to be addressed when##2##4##(2008-10#1)(2008-9#1)
to be addressed##56##3##(1991-3#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-1#4)(1994-12#2)(1994-2#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#15)
to be adequate for##2##4##(2008-10#2)
to be adequate##6##3##(1991-12#1)(2008-10#3)(2008-2#1)(2011-2#1)
to be adequately##2##3##(2008-10#1)(2008-6#1)
to be administered##4##3##(1992-8#2)(2008-5#1)(2011-2#1)
to be advantageous##5##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
to be affected by a##2##5##(1990-2#1)(1994-11#1)
to be affected by##12##4##(1990-2#1)(1992-11#1)(1993-6#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
to be affected in##3##4##(1992-3#1)(1997-1#1)(2012-3#1)
to be affected##16##3##(1990-2#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
to be alert##3##3##(2008-12#1)(2008-8#1)(2009-9#1)
to be almost##4##3##(1991-2#1)(1991-8#1)(2007-11#1)(2008-11#1)
to be also useful##2##4##(2008-10#1)(2008-11#1)
to be also##5##3##(1996-2#1)(2008-10#2)(2008-11#1)(2013-8#1)
to be altered in##4##4##(1990-6#1)(1996-12#1)(2008-11#1)(2008-6#1)
to be altered##7##3##(1990-6#1)(1993-12#1)(1996-12#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-2#1)
to be among the most##3##5##(1994-9#1)(2008-11#1)(2008-5#1)
to be among the##4##4##(1994-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
to be amongst the##2##4##(2008-7#1)(2011-2#1)
to be an additional##2##4##(1994-11#1)(1995-3#1)
to be an adrenergic##2##4##(1993-3#1)(1994-8#1)
to be an alternative##2##4##(2008-10#1)(2008-5#1)
to be an appropriate##3##4##(2007-10#1)(2008-9#1)(2013-1#1)
to be an attractive alternative##2##5##(2008-10#1)(2008-11#1)
to be an effective and##2##5##(2007-10#1)(2008-10#1)
to be an effective method of##2##6##(1991-7#1)(2008-10#1)
to be an effective method##4##5##(1991-7#1)(2008-10#2)(2011-2#1)
to be an effective tool##2##5##(2008-10#2)
to be an effective treatment##3##5##(1992-8#1)(1997-6#1)(2008-7#1)
to be an effective##21##4##(1991-4#1)(1991-7#1)(1992-8#1)(1994-11#1)(1997-6#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#2)(2010-8#1)(2011-2#2)
to be an efficient##8##4##(1991-12#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
to be an essential component of the##2##7##(1991-6#1)(1994-11#1)
to be an essential component of##4##6##(1991-6#1)(1992-1#1)(1994-11#1)(2013-8#1)
to be an essential##7##4##(1991-6#1)(1992-1#1)(1993-12#1)(1994-11#1)(1996-2#1)(2007-11#1)(2013-8#1)
to be an excellent##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
to be an extremely##3##4##(1991-5#1)(2008-4#1)(2008-8#1)
to be an ideal##2##4##(2011-1#1)(2012-2#1)
to be an important determinant of##4##6##(1990-12#1)(1990-2#1)(1994-5#1)(2008-7#1)
to be an important factor in##3##6##(1993-9#1)(1996-12#1)(2007-6#1)
to be an important factor##5##5##(1993-9#1)(1996-12#1)(2007-6#1)(2008-6#1)(2009-11#1)
to be an important mechanism##3##5##(1993-2#1)(2008-10#2)
to be an important process##2##5##(1995-3#1)(2008-10#1)
to be an important##24##4##(1990-12#1)(1990-2#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-8#1)(2013-8#1)
to be an independent##2##4##(1995-4#1)(2008-7#1)
to be an integral##4##4##(1990-11#1)(1990-12#1)(1997-2#1)(2008-10#1)
to be an overview##2##4##(2008-12#1)(2008-4#1)
to be an##147##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#4)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#2)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-7#2)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#5)(2013-1#3)(2013-8#4)
to be analysed##4##3##(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
to be analyzed##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
to be anchored##2##3##(1992-3#1)(1997-2#1)
to be answered##8##3##(1993-11#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
to be any##3##3##(2008-2#1)(2010-6#1)(2012-2#1)
to be applicable for##4##4##(2008-10#2)(2008-5#1)(2009-10#1)
to be applicable in##3##4##(2007-12#1)(2008-1#1)(2008-10#1)
to be applicable to a##2##5##(2008-10#2)
to be applicable to the##2##5##(2008-10#1)(2008-5#1)
to be applicable to##5##4##(2008-10#4)(2008-5#1)
to be applicable##13##3##(2007-12#1)(2008-1#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-10#1)
to be applied for##2##4##(2008-8#1)(2012-1#1)
to be applied in##2##4##(2007-6#1)(2008-10#1)
to be applied to the##8##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2010-8#1)
to be applied to##11##4##(1995-1#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2010-8#1)
to be applied##26##3##(1993-6#1)(1994-9#1)(1995-1#1)(1997-8#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#5)(2012-1#1)
to be appreciated##3##3##(1993-11#1)(2010-8#1)(2011-1#1)
to be approached##2##3##(1991-12#1)(2008-10#1)
to be appropriate for##3##4##(2007-12#1)(2010-12#2)
to be appropriate##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#3)
to be approximately 60##2##4##(2007-12#1)(2008-3#1)
to be approximately##22##3##(1995-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2011-2#1)
to be arising from##2##4##(2008-7#1)(2011-2#1)
to be around##3##3##(2008-10#2)(2008-6#1)
to be as close as possible to##2##7##(2008-5#2)
to be as effective as##5##5##(1991-3#1)(1992-12#1)(1996-1#1)(2007-7#1)(2008-10#1)
to be as effective##6##4##(1991-3#1)(1992-12#1)(1996-1#1)(2007-7#1)(2008-10#1)(2011-2#1)
to be as follows##2##4##(1997-2#1)(2008-3#1)
to be as high as##2##5##(2007-10#1)(2008-9#1)
to be as important as##2##5##(2008-11#2)
to be as important##3##4##(1995-6#1)(2008-11#2)
to be as low as##2##5##(2008-2#2)
to be as##22##3##(1991-12#1)(1991-3#1)(1992-12#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#2)
to be ascertained##4##3##(1991-2#1)(1995-12#1)(2008-3#1)(2013-8#1)
to be assessed##6##3##(1995-11#1)(1997-4#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)
to be assigned to##2##4##(1994-2#1)(2008-7#1)
to be assisted##3##3##(1993-9#1)(2011-1#2)
to be associated in##2##4##(1993-12#1)(2012-2#1)
to be associated with a higher##2##6##(2011-2#1)(2013-1#1)
to be associated with a variety of##3##7##(2007-8#1)(2011-2#1)(2012-3#1)
to be associated with a##11##5##(1994-12#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
to be associated with an##2##5##(1992-11#1)(1994-11#1)
to be associated with changes in##2##6##(1990-2#1)(2008-12#1)
to be associated with concurrent##2##5##(1997-5#1)(2007-6#1)
to be associated with increased##2##5##(2008-7#1)(2012-12#1)
to be associated with the##9##5##(1992-12#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-6#1)(1997-4#1)(2007-11#2)(2010-4#1)
to be associated with##85##4##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-6#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
to be associated##90##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-6#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
to be assumed##2##3##(1993-11#1)(2009-8#1)
to be at a##2##4##(2011-2#1)(2012-12#1)
to be at least##4##4##(1997-2#1)(2008-10#1)(2008-2#1)(2010-3#1)
to be at risk for##2##5##(2009-2#1)(2011-2#1)
to be at risk##5##4##(1990-5#1)(1997-3#1)(2009-2#1)(2011-2#1)(2012-12#1)
to be at the##3##4##(1991-5#1)(2008-10#1)(2013-1#1)
to be at##25##3##(1990-5#3)(1991-5#1)(1993-3#2)(1996-11#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#1)
to be attached##3##3##(2008-5#1)(2010-3#1)(2010-8#1)
to be attained##3##3##(1990-5#1)(2008-12#1)(2008-2#1)
to be attenuated by##2##4##(2009-7#1)(2011-2#1)
to be attributable##2##3##(1992-8#1)(2008-5#1)
to be automated##2##3##(2008-10#2)
to be available##11##3##(1993-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-8#1)(2009-1#1)(2011-1#1)(2011-3#1)
to be avoided##8##3##(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)(2013-8#1)
to be aware of the##6##5##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#1)
to be aware of##12##4##(1995-1#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#2)(2012-3#2)
to be aware that##3##4##(1993-12#1)(2012-12#1)(2012-2#1)
to be aware##16##3##(1993-12#1)(1995-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-12#1)(2012-2#3)(2012-3#2)
to be based on a##2##5##(1991-2#2)
to be based on##8##4##(1991-2#2)(1994-12#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
to be based upon##2##4##(1993-2#1)(2008-4#1)
to be based##10##3##(1991-2#2)(1993-2#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
to be because##2##3##(2008-5#1)(2013-8#1)
to be benchmarked##2##3##(1995-12#1)(2013-8#1)
to be beneficial for##2##4##(1992-7#1)(2008-5#1)
to be beneficial in##4##4##(2007-10#1)(2007-11#1)(2008-2#1)(2011-3#1)
to be beneficial##10##3##(1992-7#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-3#1)(2013-8#1)
to be benign##2##3##(2012-3#1)(2013-1#1)
to be best suited##2##4##(1996-5#1)(2007-8#1)
to be best##3##3##(1996-5#1)(2007-7#1)(2007-8#1)
to be better suited for##2##5##(2008-1#1)(2008-10#1)
to be better than##10##4##(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2012-1#1)
to be better##17##3##(1990-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
to be between 0##3##4##(1992-6#1)(2008-10#2)
to be between##15##3##(1991-9#1)(1992-6#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2010-4#1)(2011-2#2)
to be borne##2##3##(1994-9#1)(2008-1#1)
to be both effective and##2##5##(1991-11#1)(2008-10#1)
to be both##6##3##(1991-11#1)(2008-10#3)(2009-5#1)(2011-2#1)
to be calculated##6##3##(2008-10#1)(2008-3#4)(2010-5#1)
to be capable of##15##4##(1991-1#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
to be captured and##2##4##(2008-12#1)(2012-2#1)
to be captured##3##3##(2007-12#1)(2008-12#1)(2012-2#1)
to be cared for##2##4##(2008-3#1)(2008-8#1)
to be carefully considered##2##4##(1995-11#1)(2007-11#1)
to be carefully controlled##2##4##(2008-10#1)(2008-7#1)
to be carefully##9##3##(1990-12#1)(1995-11#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
to be carried out by##2##5##(2008-10#2)
to be carried out in##2##5##(2008-10#1)(2008-2#1)
to be carried out##10##4##(2008-10#6)(2008-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
to be catalysed by##2##4##(1991-2#1)(2008-10#1)
to be catalytically##2##3##(1990-7#1)(1994-8#1)
to be caused by a##4##5##(1995-5#1)(2008-10#1)(2008-11#1)(2009-6#1)
to be caused by the##3##5##(2007-11#1)(2008-10#1)(2010-3#1)
to be caused by##16##4##(1990-11#1)(1994-9#2)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#2)(2009-6#1)(2010-3#1)(2011-2#1)
to be caused##17##3##(1990-11#1)(1994-9#2)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-6#1)(2010-3#1)(2011-2#1)
to be cautious##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
to be central##2##3##(1997-1#1)(2008-9#1)
to be challenging##3##3##(1995-3#1)(2009-12#1)(2013-1#1)
to be changed##5##3##(1991-12#1)(1996-1#1)(2007-7#1)(2008-3#1)(2009-12#1)
to be characteristic of##2##4##(2008-5#1)(2009-4#1)
to be characteristic##4##3##(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)
to be characterized by a##3##5##(1990-4#1)(2008-11#1)(2008-6#1)
to be characterized by##7##4##(1990-3#1)(1990-4#1)(1992-8#1)(2008-11#1)(2008-6#1)(2012-12#1)(2013-8#1)
to be characterized##13##3##(1990-3#1)(1990-4#1)(1992-8#1)(1994-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-12#1)(2013-8#3)
to be chemically##3##3##(1994-5#1)(2008-10#2)
to be chosen##2##3##(2007-8#1)(2013-8#1)
to be clarified##4##3##(2008-1#1)(2009-6#1)(2011-2#1)(2013-8#1)
to be classified as##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
to be classified##7##3##(2008-10#2)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
to be cleaned##2##3##(2008-10#1)(2013-8#1)
to be clearly communicated##2##4##(1996-4#1)(2007-2#1)
to be clearly##7##3##(1996-4#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#2)(2011-2#1)
to be cleaved##2##3##(2008-4#1)(2008-5#1)
to be clinically relevant##3##4##(2006-10#1)(2008-5#1)(2009-11#1)
to be clinically##6##3##(1990-10#1)(1995-5#1)(2006-10#1)(2008-5#1)(2009-11#1)(2011-2#1)
to be clonal lineages##2##4##(2008-10#2)
to be cloned##3##3##(1997-2#1)(2008-4#2)
to be close to the##3##5##(1990-11#1)(1995-3#1)(2008-3#1)
to be close to##11##4##(1990-11#1)(1992-5#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)(2012-12#1)
to be closely related##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
to be closely##8##3##(1992-9#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)
to be collected##3##3##(2008-10#2)(2011-2#1)
to be colonized by##3##4##(1991-3#1)(1997-3#1)(2008-10#1)
to be colonized##4##3##(1991-3#1)(1997-3#1)(2008-10#1)(2008-9#1)
to be combined to##2##4##(2008-8#1)(2009-4#1)
to be combined with##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
to be combined##5##3##(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
to be common##7##3##(1991-7#1)(1994-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2012-3#1)
to be comparable to that##2##5##(2007-11#1)(2008-10#1)
to be comparable to##5##4##(2007-11#1)(2008-10#3)(2008-7#1)
to be comparable with the##2##5##(2008-10#1)(2008-5#1)
to be comparable with##5##4##(2007-12#1)(2008-10#3)(2008-5#1)
to be comparable##12##3##(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)
to be compared##2##3##(1990-10#1)(2008-10#1)
to be compatible with the##4##5##(2008-10#2)(2008-5#1)(2008-7#1)
to be compatible with##6##4##(2008-10#3)(2008-5#1)(2008-7#1)(2010-8#1)
to be compensated by a##2##5##(1995-5#1)(2008-10#1)
to be compensated by##4##4##(1995-5#1)(1997-4#1)(2008-10#1)(2013-1#1)
to be compensated for##2##4##(1990-2#1)(2007-11#1)
to be compensated##8##3##(1990-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2013-1#1)
to be complementary to##3##4##(1994-9#1)(2007-12#1)(2008-10#1)
to be completed##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
to be completely##4##3##(1990-7#1)(1996-5#1)(2006-12#1)(2008-7#1)
to be complex##2##3##(1992-5#1)(2012-3#1)
to be complicated##2##3##(1992-11#1)(2010-3#1)
to be composed of##4##4##(1994-6#1)(2008-10#1)(2008-3#1)(2009-2#1)
to be composed##5##3##(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-2#1)
to be computed##2##3##(2007-11#1)(2008-2#1)
to be concentrated##5##3##(1991-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)
to be concerned##2##3##(1992-1#1)(1994-3#1)
to be conducted on a##2##5##(2011-2#2)
to be conducted on##3##4##(2008-9#1)(2011-2#2)
to be conducted to##3##4##(2010-11#1)(2010-8#1)(2013-8#1)
to be conducted##8##3##(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-8#1)
to be confined##3##3##(1997-6#1)(2007-12#1)(2009-5#1)
to be confirmed by##4##4##(1992-10#1)(2007-12#1)(2008-12#1)(2009-12#1)
to be confirmed##7##3##(1992-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
to be connected to##4##4##(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
to be connected##5##3##(2007-7#1)(2008-10#2)(2008-11#1)(2012-2#1)
to be conserved##3##3##(1990-8#1)(1995-5#1)(2012-1#1)
to be considerable##2##3##(2007-11#1)(2013-1#1)
to be considered as a##3##5##(1992-3#1)(1993-11#1)(2008-10#1)
to be considered as##6##4##(1992-3#1)(1993-11#1)(1994-9#1)(2008-10#1)(2011-2#1)(2011-3#1)
to be considered for the##2##5##(2008-3#2)
to be considered for##5##4##(2008-3#2)(2008-8#1)(2012-3#1)(2013-8#1)
to be considered in any##2##5##(1993-11#1)(2008-11#1)
to be considered in future##2##5##(1992-9#1)(2008-1#1)
to be considered in the##4##5##(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
to be considered in##12##4##(1992-9#1)(1993-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
to be considered when##6##4##(1993-2#2)(2008-10#2)(2008-4#1)(2009-1#1)
to be considered##55##3##(1990-6#3)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-2#2)(1994-9#1)(1996-8#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
to be consistent with a##2##5##(1991-8#1)(2008-10#1)
to be consistent with the##5##5##(1992-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
to be consistent with##13##4##(1991-8#1)(1992-3#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2013-8#1)
to be consistent##16##3##(1991-8#1)(1992-3#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
to be constant##3##3##(1991-5#1)(1992-6#1)(2008-10#1)
to be constrained##2##3##(2008-3#1)(2012-12#1)
to be constructed that##2##4##(1994-3#1)(2009-5#1)
to be constructed##4##3##(1994-3#1)(2007-11#1)(2008-10#1)(2009-5#1)
to be contaminated with##3##4##(1995-11#1)(2008-11#1)(2010-5#1)
to be contaminated##5##3##(1994-3#1)(1995-11#1)(2008-11#1)(2010-5#1)(2011-2#1)
to be controlled by a single##2##6##(2008-10#1)(2008-5#1)
to be controlled by a##3##5##(2008-10#1)(2008-5#1)(2008-9#1)
to be controlled by##6##4##(1994-3#1)(1995-12#1)(2008-10#1)(2008-5#2)(2008-9#1)
to be controlled##15##3##(1994-3#1)(1995-11#1)(1995-12#2)(1997-1#1)(2007-10#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
to be convenient##2##3##(2007-7#1)(2008-4#1)
to be corrected##3##3##(2007-11#1)(2008-3#2)
to be correlated with the##3##5##(1991-6#1)(1992-6#1)(2008-10#1)
to be correlated with##7##4##(1991-6#2)(1992-6#1)(1993-5#1)(1995-12#1)(2008-10#2)
to be correlated##9##3##(1991-6#2)(1992-6#1)(1993-5#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)
to be coupled to##2##4##(1992-3#1)(2008-10#1)
to be coupled##4##3##(1992-3#1)(2008-10#1)(2008-3#2)
to be covalently bound to##2##5##(1990-2#1)(1993-6#1)
to be covalently##5##3##(1990-2#1)(1992-3#1)(1993-6#1)(1997-6#1)(2008-5#1)
to be covered by##2##4##(1990-2#1)(1994-3#1)
to be covered##5##3##(1990-2#1)(1994-3#1)(2007-12#1)(2007-2#1)(2008-11#1)
to be created##2##3##(2010-4#1)(2010-7#1)
to be critical for##4##4##(1997-9#1)(2008-11#1)(2008-8#1)(2010-2#1)
to be critical to##2##4##(2008-10#1)(2012-2#1)
to be critical##9##3##(1990-12#1)(1992-6#1)(1995-6#1)(1997-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2012-2#1)
to be critically##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
to be crucial for##2##4##(2008-5#1)(2009-6#1)
to be crucial##4##3##(1997-3#1)(2008-10#1)(2008-5#1)(2009-6#1)
to be dealt with##2##4##(1996-2#1)(2008-3#1)
to be debated##3##3##(1996-11#1)(2008-11#1)(2008-8#1)
to be declining in##2##4##(2006-10#1)(2008-1#1)
to be decreased by##4##4##(1992-11#2)(1994-6#1)(2012-2#1)
to be decreased in##2##4##(1993-3#1)(2013-1#1)
to be decreased##11##3##(1990-2#1)(1992-11#2)(1993-3#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
to be deduced##2##3##(1996-2#1)(2008-2#1)
to be defective in the##2##5##(1994-2#1)(2009-5#1)
to be defective in##3##4##(1994-2#1)(1995-8#1)(2009-5#1)
to be deficient##2##3##(1995-12#1)(2009-4#1)
to be defined and##2##4##(2012-2#1)(2013-1#1)
to be defined in##2##4##(2007-11#1)(2008-6#1)
to be defined##8##3##(1994-11#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
to be degraded in##2##4##(2007-11#1)(2009-5#1)
to be degraded##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
to be delineated##2##3##(2008-4#1)(2013-8#1)
to be delivered to the##2##5##(2008-3#1)(2008-5#1)
to be delivered to##3##4##(2008-3#1)(2008-5#1)(2013-8#1)
to be delivered##5##3##(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
to be demonstrated##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
to be dependent on the presence of##2##7##(1991-3#1)(2008-11#1)
to be dependent on the##9##5##(1991-3#1)(1991-5#1)(1994-10#1)(1995-6#1)(2008-10#2)(2008-11#2)(2010-5#1)
to be dependent on##18##4##(1990-5#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(2008-10#4)(2008-11#3)(2010-5#1)(2011-2#1)
to be dependent upon the##6##5##(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
to be dependent upon##8##4##(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#1)
to be dependent##27##3##(1990-5#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#2)
to be depleted##3##3##(1992-11#1)(2008-5#1)(2008-7#1)
to be deposited##2##3##(1996-9#1)(2008-11#1)
to be depressed in##2##4##(1996-5#1)(2007-11#1)
to be derived from a##2##5##(1996-2#1)(2008-11#1)
to be derived from the##3##5##(1990-5#1)(1992-6#1)(2008-6#1)
to be derived from##11##4##(1990-5#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)
to be derived##14##3##(1990-5#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
to be designed##2##3##(2008-10#1)(2008-3#1)
to be desired##2##3##(1992-3#1)(2007-10#1)
to be detected and##3##4##(2008-10#2)(2008-8#1)
to be detected with##4##4##(1991-3#1)(2008-2#1)(2008-8#1)(2010-1#1)
to be detected##14##3##(1991-3#1)(1997-2#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-1#1)(2013-8#1)
to be determined and##3##4##(1990-8#1)(2008-10#1)(2008-8#1)
to be determined by##7##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-10#1)
to be determined from##2##4##(2008-10#1)(2011-2#1)
to be determined in##2##4##(2009-5#1)(2010-3#1)
to be determined##62##3##(1990-5#1)(1990-8#1)(1990-9#1)(1994-5#1)(1994-8#2)(1995-2#2)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#2)
to be detrimental to##3##4##(1992-2#1)(2008-11#1)(2008-12#1)
to be developed to##3##4##(2008-11#1)(2008-3#1)(2013-7#1)
to be developed##22##3##(1992-12#1)(1992-8#1)(1994-7#1)(1995-1#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-7#1)
to be diagnosed##4##3##(1990-9#1)(2008-4#1)(2010-9#1)(2013-1#1)
to be different from##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)
to be different in the##2##5##(1993-11#1)(2008-10#1)
to be different##16##3##(1993-11#1)(1993-12#1)(1994-8#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#2)(2010-10#1)(2012-2#1)
to be differentially expressed##2##4##(1991-2#1)(2008-10#1)
to be differentially##6##3##(1991-2#1)(1995-2#1)(2008-10#2)(2009-9#1)(2011-1#1)
to be differentiated##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to be difficult to##2##4##(2008-10#1)(2012-8#1)
to be difficult##5##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-8#1)
to be directed at##3##4##(1997-8#1)(2008-2#1)(2009-5#1)
to be directed##4##3##(1997-8#1)(2008-2#1)(2009-5#1)(2011-2#1)
to be directly##4##3##(2008-10#2)(2008-7#1)(2010-1#1)
to be discovered##5##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
to be discriminated##2##3##(1992-11#1)(2008-3#1)
to be discussed##2##3##(2012-3#1)(2013-8#1)
to be disproportionately represented##2##4##(2007-2#1)(2010-11#1)
to be distinct from the##3##5##(1992-3#1)(1994-12#1)(2008-4#1)
to be distinct##5##3##(1992-3#1)(1994-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
to be distinctly different##2##4##(2008-5#1)(2012-2#1)
to be distinguished from##4##4##(2008-3#1)(2009-3#1)(2012-2#2)
to be distinguished##8##3##(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-2#2)
to be dominated by##4##4##(1990-6#1)(1992-9#1)(2008-3#1)(2011-2#1)
to be done in##3##4##(2008-10#1)(2008-8#1)(2009-7#1)
to be done to##5##4##(1991-1#1)(1995-6#1)(2007-8#1)(2009-1#1)(2011-2#1)
to be done##16##3##(1991-1#1)(1992-3#1)(1994-3#1)(1995-6#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
to be dose dependent##2##4##(1992-5#1)(2008-5#1)
to be dose-dependent##2##3##(1993-3#1)(2008-3#1)
to be dramatically##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
to be due primarily to##4##5##(1997-7#1)(2008-3#1)(2008-8#2)
to be due to a##8##5##(1991-12#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)
to be due to an##2##5##(1991-12#1)(2008-7#1)
to be due to the##8##5##(1990-12#1)(1994-8#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
to be due to##41##4##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
to be due##48##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
to be durable##2##3##(2008-10#2)
to be dynamically##2##3##(1994-8#1)(1996-2#1)
to be easily##6##3##(1994-11#1)(2008-3#2)(2008-5#1)(2009-9#1)(2011-2#1)
to be effective and##4##4##(1990-5#1)(1994-2#1)(2007-8#1)(2012-2#1)
to be effective are##2##4##(2008-6#1)(2010-4#1)
to be effective for the##5##5##(1997-2#1)(2008-11#1)(2008-7#1)(2012-6#1)(2013-1#1)
to be effective for##9##4##(1994-6#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2012-2#1)(2012-6#1)(2013-1#1)
to be effective in reducing the##2##6##(1990-3#1)(2008-8#1)
to be effective in reducing##3##5##(1990-3#1)(2008-8#1)(2012-12#1)
to be effective in terms of##2##6##(1992-12#1)(2008-7#1)
to be effective in##30##4##(1990-3#1)(1992-12#2)(1992-3#1)(1992-9#1)(1994-3#1)(1994-7#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#2)
to be effective not only##2##5##(2008-11#1)(2008-7#1)
to be effective##73##3##(1990-3#1)(1990-5#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
to be efficacious in##3##4##(1994-11#1)(2006-10#1)(2008-10#1)
to be efficacious##5##3##(1994-11#1)(2006-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
to be efficient for##2##4##(2008-10#2)
to be efficient##10##3##(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
to be efficiently analyzed by high-performance liquid chromatography##2##8##(2008-10#2)
to be efficiently##3##3##(2008-10#2)(2008-9#1)
to be either a##2##4##(1996-3#1)(2008-3#1)
to be either##9##3##(1992-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
to be elevated in##3##4##(1993-8#1)(2008-5#1)(2010-11#1)
to be elevated##4##3##(1992-8#1)(1993-8#1)(2008-5#1)(2010-11#1)
to be eliminated##2##3##(2008-10#1)(2010-1#1)
to be elucidated##18##3##(1993-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#2)(2009-8#1)(2009-9#1)(2012-2#2)(2013-1#2)
to be employed as##2##4##(2008-1#1)(2008-10#1)
to be employed for##2##4##(2008-10#1)(2009-7#1)
to be employed##8##3##(1991-4#1)(1996-12#1)(2008-1#1)(2008-10#2)(2009-5#1)(2009-7#1)(2013-1#1)
to be encoded by##2##4##(1991-6#1)(2013-8#1)
to be encoded##3##3##(1991-6#1)(2007-12#1)(2013-8#1)
to be encouraged##2##3##(1991-8#1)(2010-11#1)
to be endemic in##2##4##(2008-1#1)(2011-2#1)
to be endemic##4##3##(2007-12#1)(2008-1#1)(2010-8#1)(2011-2#1)
to be enhanced##5##3##(1994-6#1)(2007-11#2)(2007-12#1)(2010-3#1)
to be enriched##4##3##(1994-11#1)(2008-10#2)(2009-9#1)
to be equal to##6##4##(1991-5#1)(2007-11#1)(2008-10#3)(2010-12#1)
to be equally effective##5##4##(1993-6#1)(1995-3#1)(1996-2#1)(2008-2#1)(2010-7#1)
to be equally##7##3##(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(2007-7#1)(2008-2#1)(2010-7#1)
to be equivalent to##6##4##(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)
to be equivalent##8##3##(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)
to be eradicated##2##3##(1992-5#1)(1993-12#1)
to be especially suitable##2##4##(2008-5#1)(2009-10#1)
to be especially##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
to be essential for growth##2##5##(1990-5#1)(2008-11#1)
to be essential for the activity of##2##7##(1990-5#1)(1994-6#1)
to be essential for the##4##5##(1990-5#1)(1994-6#1)(1995-12#1)(2008-5#1)
to be essential for##21##4##(1990-5#2)(1992-12#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
to be essential##22##3##(1990-5#2)(1992-12#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
to be essentially##3##3##(2007-11#1)(2008-2#2)
to be established for##2##4##(2007-12#1)(2008-11#1)
to be established in##3##4##(1991-2#1)(2008-11#1)(2008-4#1)
to be established##34##3##(1990-12#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
to be estimated##7##3##(1990-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
to be evaluated in##5##4##(1996-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-10#1)
to be evaluated##20##3##(1991-11#1)(1991-6#1)(1994-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
to be even more##5##4##(1990-9#1)(1993-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
to be examined in##2##4##(1995-3#1)(2013-1#1)
to be examined##5##3##(1994-8#1)(1995-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
to be excellent##3##3##(1992-11#1)(1997-2#1)(2008-5#1)
to be excluded##3##3##(1996-8#1)(2008-1#1)(2008-10#1)
to be exerted through##2##4##(1990-12#1)(1994-11#1)
to be expanded##2##3##(2008-11#1)(2011-1#1)
to be expected to##2##4##(1991-3#1)(2008-6#1)
to be expected##11##3##(1990-8#2)(1991-3#1)(1994-3#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-3#1)(2008-6#2)(2010-3#1)
to be explained in terms of##2##6##(2008-8#1)(2012-2#1)
to be explained##3##3##(1995-4#1)(2008-8#1)(2012-2#1)
to be exploited##2##3##(2008-10#1)(2008-7#1)
to be explored##12##3##(1994-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#2)(2013-7#1)
to be exposed to##2##4##(2008-10#1)(2011-2#1)
to be expressed as##2##4##(1997-4#1)(2008-10#1)
to be expressed at##4##4##(1991-6#1)(1996-12#1)(2008-11#1)(2010-11#1)
to be expressed by##2##4##(1990-11#1)(1992-11#1)
to be expressed in a##2##5##(1992-3#1)(2008-2#1)
to be expressed in the##3##5##(1993-6#2)(2010-5#1)
to be expressed in##14##4##(1992-3#1)(1993-6#2)(1994-11#1)(1995-6#1)(2008-10#1)(2008-2#2)(2010-5#2)(2011-1#2)(2012-3#2)
to be expressed##28##3##(1990-11#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#2)(2011-1#2)(2012-3#2)
to be extended to##3##4##(2008-10#1)(2008-3#1)(2009-2#1)
to be extended##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)
to be extremely sensitive##2##4##(1996-2#1)(2008-10#1)
to be extremely##9##3##(1994-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2011-1#1)
to be facilitated##2##3##(2008-11#1)(2008-7#1)
to be familiar with the##4##5##(1992-2#1)(1996-3#1)(2007-8#1)(2008-2#1)
to be familiar with##7##4##(1992-2#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)
to be far more##3##4##(2009-5#1)(2011-2#1)(2013-8#1)
to be far##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
to be fast##3##3##(2008-10#1)(2012-12#2)
to be feasible and##3##4##(2008-11#1)(2010-7#1)(2011-2#1)
to be feasible##6##3##(2008-11#2)(2008-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
to be female##2##3##(1995-3#1)(2008-10#1)
to be filled with##2##4##(2008-10#1)(2008-9#1)
to be filled##4##3##(2008-10#1)(2008-7#2)(2008-9#1)
to be followed by##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
to be followed##8##3##(1993-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2012-2#2)
to be formed in##2##4##(2008-10#1)(2008-11#1)
to be formed##7##3##(1994-9#1)(1995-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
to be found in the##2##5##(1990-12#1)(2008-2#1)
to be found in##4##4##(1990-12#1)(2007-12#1)(2008-12#1)(2008-2#1)
to be found##12##3##(1990-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2011-2#1)
to be free from##3##4##(1992-1#1)(2008-10#2)
to be free of##2##4##(1993-12#1)(1994-3#1)
to be free##5##3##(1992-1#1)(1993-12#1)(1994-3#1)(2008-10#2)
to be frequently##2##3##(2009-8#1)(2013-8#1)
to be from##3##3##(2008-11#2)(2009-7#1)
to be fully elucidated##4##4##(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
to be fully exploited##2##4##(2008-1#1)(2008-9#1)
to be fully##18##3##(1992-1#1)(1994-3#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-1#1)
to be functional##4##3##(1995-9#1)(2008-11#1)(2009-10#2)
to be functionally##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
to be further##7##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
to be gained from##3##4##(1994-3#1)(2010-10#1)(2011-10#1)
to be gained##7##3##(1994-2#1)(1994-3#1)(2009-12#1)(2010-10#1)(2011-10#1)(2011-2#1)(2013-1#1)
to be general##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
to be generally##6##3##(1995-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#2)
to be generated by##3##4##(1990-5#1)(1993-9#1)(1995-2#1)
to be generated in##2##4##(1991-5#1)(2008-10#1)
to be generated##8##3##(1990-5#1)(1991-5#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
to be genetically##4##3##(1991-12#1)(1996-12#1)(2008-10#1)(2008-9#1)
to be geographically##2##3##(2009-9#1)(2010-8#1)
to be given to##5##4##(1992-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
to be given##12##3##(1991-5#1)(1992-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#2)
to be good##11##3##(1990-6#1)(1992-11#1)(1996-3#1)(1997-8#1)(2008-10#5)(2009-5#1)(2011-2#1)
to be greater for##4##4##(1993-6#1)(1994-3#1)(2008-10#1)(2008-2#1)
to be greater in the##2##5##(1997-4#1)(2008-5#1)
to be greater in##6##4##(1996-12#1)(1996-7#1)(1997-4#1)(2008-3#1)(2008-5#1)(2010-3#1)
to be greater than##7##4##(1990-12#2)(2007-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
to be greater##20##3##(1990-12#2)(1993-12#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-7#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2010-3#1)(2013-1#2)
to be guided by##3##4##(2007-10#1)(2007-4#1)(2008-8#1)
to be guided##4##3##(2007-10#1)(2007-12#1)(2007-4#1)(2008-8#1)
to be healthy and##2##4##(2008-10#1)(2013-7#1)
to be held##2##3##(1991-5#1)(2011-4#1)
to be helpful for##2##4##(1997-7#1)(2008-4#1)
to be helpful##3##3##(1997-7#1)(2008-4#1)(2012-2#1)
to be high and##2##4##(1996-12#1)(2008-8#1)
to be high##10##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#1)
to be higher for##2##4##(2010-4#1)(2011-2#1)
to be higher in patients with##2##6##(1993-12#1)(1996-9#1)
to be higher in##10##4##(1990-7#1)(1993-12#1)(1994-5#1)(1995-3#1)(1996-9#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-3#1)(2013-1#1)
to be higher than that of the##2##7##(1993-8#1)(1994-11#1)
to be higher than that##3##5##(1993-8#1)(1994-11#1)(2008-11#1)
to be higher than the##2##5##(2011-2#1)(2013-1#1)
to be higher than##9##4##(1993-8#2)(1994-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2011-2#1)(2013-1#1)
to be higher##26##3##(1990-7#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#2)
to be highest##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
to be highly conserved##2##4##(1990-11#1)(1992-11#1)
to be highly effective in the##2##6##(2007-11#1)(2008-5#1)
to be highly expressed##2##4##(2011-1#1)(2011-2#1)
to be highly relevant to##2##5##(2008-3#1)(2008-5#1)
to be highly resistant to##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
to be highly selective for##2##5##(2008-10#2)
to be highly selective##3##4##(2008-10#3)
to be highly sensitive##3##4##(1992-12#1)(2008-10#1)(2008-7#1)
to be highly significant (P&lt##2##5##(1997-6#1)(2011-1#1)
to be highly significant##3##4##(1997-6#1)(2008-6#1)(2011-1#1)
to be highly unstable##2##4##(1991-4#1)(1995-2#1)
to be highly##52##3##(1990-11#1)(1990-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-8#2)
to be homogeneous##4##3##(1990-5#1)(1992-8#1)(1994-6#1)(2008-3#1)
to be homologous to##2##4##(1995-2#1)(2008-8#1)
to be homologous##4##3##(1991-12#1)(1995-2#1)(1996-12#1)(2008-8#1)
to be hospitalized##3##3##(1995-2#1)(1995-6#1)(2008-3#1)
to be identical to that of##2##6##(1996-12#1)(1997-8#1)
to be identical to that##3##5##(1996-12#1)(1997-8#1)(2008-10#1)
to be identical to the##2##5##(1994-12#1)(1995-6#1)
to be identical to##7##4##(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#2)
to be identical with##2##4##(1991-8#1)(1992-11#1)
to be identical##15##3##(1990-8#1)(1991-8#1)(1992-11#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#2)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)
to be identified and##4##4##(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)
to be identified as##4##4##(2008-10#2)(2013-8#2)
to be identified to##2##4##(2008-5#1)(2010-11#1)
to be identified##31##3##(1990-12#1)(1991-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-7#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#2)
to be ignored##2##3##(2008-3#1)(2013-1#1)
to be imaged##2##3##(2008-12#1)(2008-3#1)
to be immunogenic##2##3##(2007-10#1)(2008-11#1)
to be impacted by##2##4##(2008-5#1)(2011-2#1)
to be impaired in##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
to be impaired##6##3##(1990-11#1)(1995-5#1)(2008-10#1)(2008-7#2)(2012-1#1)
to be implemented##12##3##(1992-1#1)(1992-12#1)(1994-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-3#3)(2011-2#1)(2013-1#1)
to be implicated in##4##4##(2009-4#1)(2009-8#1)(2010-4#1)(2012-2#1)
to be important determinants of##2##5##(2008-8#1)(2009-7#1)
to be important factors##3##4##(2008-10#2)(2008-11#1)
to be important for the##3##5##(1994-8#1)(1996-2#1)(2008-4#1)
to be important for##13##4##(1994-8#1)(1995-6#2)(1996-2#1)(1997-4#2)(1997-6#1)(2008-11#1)(2008-4#3)(2008-7#1)(2009-8#1)
to be important in the##11##5##(1990-2#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)
to be important in##20##4##(1990-2#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
to be important to the##3##5##(2007-2#1)(2010-5#1)(2012-3#1)
to be important##60##3##(1990-11#1)(1990-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-8#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#2)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-3#2)(2013-8#1)
to be improved significantly##2##4##(2009-3#1)(2010-8#1)
to be improved##13##3##(1992-12#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-3#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
to be in a##6##4##(1994-5#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2009-3#1)
to be in agreement##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
to be in excellent agreement with a##2##7##(2007-12#1)(2008-3#1)
to be in excellent agreement with##5##6##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
to be in good agreement with##12##6##(1992-11#1)(2007-11#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#1)
to be in good agreement##14##5##(1992-11#1)(2007-11#2)(2008-10#5)(2008-2#2)(2008-3#3)(2008-8#1)
to be in good##15##4##(1992-11#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#3)(2008-8#1)
to be in place##3##4##(2007-12#1)(2008-12#1)(2011-2#1)
to be in the form of##2##6##(2008-10#1)(2008-2#1)
to be in the range of##7##6##(2008-10#7)
to be in the range##9##5##(2008-10#9)
to be in the##20##4##(1990-12#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-4#1)(2008-10#12)(2008-2#1)(2013-1#2)
to be in##78##3##(1990-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#4)(2008-10#24)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
to be inaccurate##2##3##(2011-2#1)(2013-1#1)
to be inactive##4##3##(1996-5#3)(2008-10#1)
to be inadequate##3##3##(1995-11#1)(2010-11#2)
to be included in the##5##5##(1992-8#1)(2008-1#1)(2008-2#1)(2009-7#1)(2012-3#1)
to be included in##7##4##(1992-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-11#1)(2012-3#1)
to be included##10##3##(1992-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-7#1)(2010-11#2)(2012-3#1)
to be incompatible##2##3##(2008-5#1)(2008-9#1)
to be incomplete and##2##4##(1993-12#1)(2008-11#1)
to be incomplete##4##3##(1993-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
to be incorporated in##3##4##(2008-11#1)(2008-12#1)(2009-7#1)
to be incorporated into the##2##5##(2008-3#1)(2008-9#1)
to be incorporated into##4##4##(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
to be incorporated##9##3##(1991-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
to be increased by a##2##5##(2008-3#1)(2008-7#1)
to be increased by##3##4##(2008-3#1)(2008-7#2)
to be increased in##8##4##(1990-2#1)(1992-8#1)(1994-8#1)(2008-1#1)(2008-10#2)(2012-12#1)(2013-8#1)
to be increased##22##3##(1990-11#1)(1990-2#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#4)(2012-12#1)(2013-8#1)
to be increasing##4##3##(1994-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
to be independent of the##9##5##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
to be independent of##15##4##(1990-2#1)(1991-11#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)
to be independent risk factors for##2##6##(2007-10#1)(2010-8#1)
to be independent##21##3##(1990-12#1)(1990-2#1)(1991-11#1)(1994-7#1)(1997-2#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-2#1)
to be independently associated with##2##5##(1995-8#1)(2012-3#1)
to be independently##4##3##(1992-9#1)(1995-8#1)(2008-2#1)(2012-3#1)
to be indicated##2##3##(1996-9#1)(2013-1#1)
to be induced by##4##4##(1994-2#1)(1996-9#1)(2008-10#1)(2008-2#1)
to be induced in##2##4##(2012-2#1)(2013-8#1)
to be induced##9##3##(1994-11#1)(1994-2#1)(1995-5#1)(1996-9#1)(2008-10#1)(2008-2#2)(2012-2#1)(2013-8#1)
to be ineffective in##4##4##(1994-2#1)(1995-12#1)(2012-12#1)(2013-8#1)
to be ineffective##9##3##(1994-2#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-12#1)(2013-8#1)
to be infected with HIV##2##5##(1993-6#1)(1997-5#1)
to be infected with##3##4##(1993-6#1)(1997-5#1)(2008-10#1)
to be infected##9##3##(1993-6#1)(1997-4#1)(1997-5#1)(2008-10#4)(2008-9#1)(2011-2#1)
to be inferred##2##3##(2008-3#2)
to be influenced by the##8##5##(1990-9#1)(1994-5#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-7#1)(2010-6#1)
to be influenced by##15##4##(1990-9#1)(1993-6#1)(1994-5#2)(1995-5#1)(1996-12#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-2#1)(2010-6#1)
to be influenced##17##3##(1990-9#1)(1993-6#1)(1994-5#2)(1995-5#1)(1996-12#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-1#1)
to be informative for##2##4##(1997-5#1)(2008-12#1)
to be informative##3##3##(1993-8#1)(1997-5#1)(2008-12#1)
to be informed##3##3##(1992-2#1)(1996-1#1)(2012-2#1)
to be inherently##3##3##(2008-3#1)(2010-8#1)(2012-2#1)
to be inhibited by##3##4##(1990-11#1)(1993-8#1)(2008-8#1)
to be inhibited##4##3##(1990-11#1)(1993-8#1)(2008-5#1)(2008-8#1)
to be initiated##6##3##(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-2#1)
to be injected##4##3##(2008-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
to be insensitive to the##2##5##(1990-5#1)(2008-3#1)
to be insensitive to##6##4##(1990-5#1)(2008-10#3)(2008-2#1)(2008-3#1)
to be inserted##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
to be instrumental in the##2##5##(2008-10#1)(2009-11#1)
to be instrumental##3##3##(1993-11#1)(2008-10#1)(2009-11#1)
to be insufficient##2##3##(2008-12#1)(2010-6#1)
to be intact##2##3##(2008-10#1)(2008-11#1)
to be integral membrane proteins##2##5##(1992-8#1)(1995-8#1)
to be integral##3##3##(1992-8#1)(1995-8#1)(2012-3#1)
to be integrated into the##2##5##(1992-5#1)(1995-2#1)
to be integrated##3##3##(1992-5#1)(1995-2#1)(2008-8#1)
to be internalized##2##3##(1994-8#1)(1997-7#1)
to be interrupted##2##3##(1991-8#1)(2007-7#1)
to be interviewed##2##3##(2008-2#1)(2009-6#1)
to be introduced##7##3##(1993-12#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2013-1#1)
to be invaded by##2##4##(2008-5#1)(2008-9#1)
to be invalid##2##3##(1995-2#1)(2013-1#1)
to be invariant to##2##4##(2008-2#1)(2008-3#1)
to be investigated##12##3##(1997-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
to be involved in DNA binding##2##6##(1993-2#1)(2010-10#1)
to be involved in DNA##3##5##(1993-12#1)(1993-2#1)(2010-10#1)
to be involved in binding##2##5##(1994-5#1)(1996-12#1)
to be involved in decisions##2##5##(1993-12#2)
to be involved in signal transduction##2##6##(1995-6#1)(2008-11#1)
to be involved in the pathogenesis of##3##7##(2008-1#1)(2010-10#1)(2013-8#1)
to be involved in the##34##5##(1992-3#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-12#2)(1995-2#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#2)
to be involved in##83##4##(1990-12#1)(1990-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#3)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-8#2)
to be involved with##3##4##(2007-12#1)(2009-10#1)(2009-7#1)
to be involved##93##3##(1990-12#1)(1990-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#3)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-8#2)
to be irreversible##2##3##(1990-2#1)(1992-9#1)
to be isolated from##2##4##(1994-2#1)(2008-6#1)
to be isolated##3##3##(1994-2#1)(2008-5#1)(2008-6#1)
to be justified##2##3##(1992-6#1)(1995-6#1)
to be kept in mind##2##5##(2008-7#1)(2011-3#1)
to be kept##3##3##(2008-11#1)(2008-7#1)(2011-3#1)
to be known##2##3##(1997-8#1)(2008-2#1)
to be laid down##2##4##(2008-10#1)(2008-7#1)
to be largely##5##3##(2007-11#1)(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
to be larger in##2##4##(2008-1#1)(2008-8#1)
to be larger than the##2##5##(2008-10#1)(2008-11#1)
to be larger than##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)
to be larger##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2010-11#1)
to be launched in##2##4##(2008-3#1)(2008-5#1)
to be learned from the##2##5##(1991-11#1)(1992-2#1)
to be learned##8##3##(1991-11#1)(1992-2#1)(1993-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-5#1)
to be less likely to##3##5##(2008-9#2)(2011-2#1)
to be less than one##2##5##(2007-10#1)(2008-10#1)
to be less than those of the##2##7##(2008-11#1)(2008-9#1)
to be less than##19##4##(1990-11#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)(2012-3#1)
to be less##44##3##(1990-11#1)(1990-12#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-5#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#4)(2008-7#2)(2008-9#4)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
to be limited by##3##4##(2008-2#2)(2008-3#1)
to be limited to##4##4##(1995-11#1)(1997-3#1)(2008-10#2)
to be limited##11##3##(1993-8#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-5#1)(2012-2#1)(2012-3#1)
to be linear in the range of##4##7##(2008-10#4)
to be linear over the##4##5##(2008-10#4)
to be linear up to##2##5##(2008-10#2)
to be linear##16##3##(1992-5#1)(2008-10#13)(2008-11#1)(2012-2#1)
to be linearly proportional to the##3##6##(1994-3#1)(2008-10#1)(2008-3#1)
to be linearly proportional##4##4##(1994-3#1)(1995-3#1)(2008-10#1)(2008-3#1)
to be linearly##6##3##(1994-3#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-7#1)
to be linked to##8##4##(2008-10#3)(2008-11#1)(2008-5#2)(2010-3#1)(2012-3#1)
to be linked##9##3##(1993-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-3#1)(2012-3#1)
to be little##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
to be localized in##2##4##(1995-6#1)(2007-12#1)
to be localized##5##3##(1995-2#1)(1995-6#1)(2007-12#1)(2008-5#1)(2009-10#1)
to be located at the##2##5##(2008-10#1)(2008-11#1)
to be located in the##4##5##(1990-5#1)(2008-8#1)(2009-5#1)(2010-8#1)
to be located in##5##4##(1990-5#1)(1994-12#1)(2008-8#1)(2009-5#1)(2010-8#1)
to be located on the##2##5##(2008-11#1)(2010-12#1)
to be located on##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
to be located within##2##4##(1990-11#1)(2007-8#1)
to be located##21##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-8#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
to be longer##2##3##(2010-2#1)(2013-8#1)
to be lost##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
to be low in##4##4##(1991-5#1)(2007-2#1)(2008-12#1)(2008-7#1)
to be low##7##3##(1991-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
to be lower in the##2##5##(2008-10#1)(2008-7#1)
to be lower in##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
to be lower than##5##4##(1993-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
to be lower##12##3##(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2013-8#1)
to be made and##2##4##(1990-6#1)(1992-9#1)
to be made between##2##4##(1990-7#1)(2008-3#1)
to be made in##4##4##(2008-10#1)(2008-3#1)(2010-4#1)(2012-1#1)
to be made on the##3##5##(1993-11#1)(2008-8#1)(2009-10#1)
to be made to##2##4##(1996-3#1)(2008-9#1)
to be made with##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
to be made##29##3##(1990-6#1)(1990-7#1)(1991-5#1)(1992-9#1)(1993-11#1)(1994-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-1#1)(2012-1#1)
to be mainly related to the##2##6##(2008-11#1)(2008-5#1)
to be mainly##7##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#1)
to be maintained in##2##4##(2008-9#1)(2013-8#1)
to be maintained##6##3##(1995-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
to be major##4##3##(1994-11#1)(1994-3#1)(2008-10#1)(2008-5#1)
to be malignant##4##3##(1997-2#1)(2007-8#1)(2008-6#1)(2012-3#1)
to be managed##3##3##(1995-2#1)(1997-3#1)(2012-12#1)
to be manipulated##3##3##(2007-12#1)(2008-10#1)(2009-11#1)
to be marked##2##3##(2008-11#1)(2008-4#1)
to be measured in##2##4##(1990-8#1)(1994-3#1)
to be measured##15##3##(1990-8#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)(2012-2#1)
to be mediated by a##2##5##(2008-11#1)(2009-1#1)
to be mediated by the##2##5##(1997-2#1)(2009-10#1)
to be mediated by##17##4##(1991-5#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2012-1#1)(2013-8#1)
to be mediated through##6##4##(1992-6#2)(1994-11#1)(2008-4#1)(2009-8#1)(2012-12#1)
to be mediated##25##3##(1991-5#1)(1992-3#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
to be medically##2##3##(2008-7#1)(2010-12#1)
to be membrane##2##3##(1990-11#1)(1992-12#1)
to be merely##2##3##(1994-12#1)(1997-8#1)
to be met##7##3##(1995-12#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-9#1)(2013-8#1)
to be mindful of##2##4##(1991-2#1)(2008-11#1)
to be minimal##2##3##(1996-6#1)(2008-3#1)
to be minimized##4##3##(1993-12#1)(1995-5#1)(2008-10#2)
to be minimum##2##3##(2008-2#1)(2008-3#1)
to be missed##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
to be moderately resistant to powdery mildew##2##7##(2008-10#2)
to be moderately##6##3##(2008-10#3)(2012-12#2)(2013-8#1)
to be modified by##2##4##(2007-7#1)(2008-9#1)
to be modified##9##3##(1991-2#1)(1992-3#1)(1993-1#1)(2007-7#1)(2008-3#2)(2008-9#1)(2009-6#1)(2013-1#1)
to be modulated by##2##4##(1992-8#1)(2012-2#1)
to be monitored and controlled##2##5##(2008-2#1)(2013-1#1)
to be monitored##8##3##(1991-12#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
to be more appropriate##2##4##(2008-3#1)(2011-2#1)
to be more complex##2##4##(2010-12#1)(2012-1#1)
to be more effective for##2##5##(2010-4#2)
to be more effective in##4##5##(2007-8#1)(2008-10#2)(2008-11#1)
to be more effective than##3##5##(2008-3#2)(2008-7#1)
to be more effective##14##4##(1992-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#2)(2012-2#2)
to be more efficient than##2##5##(2008-11#1)(2011-1#1)
to be more efficient##7##4##(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
to be more intense##2##4##(2008-8#1)(2012-2#1)
to be more likely##3##4##(1990-3#1)(1993-12#1)(2008-8#1)
to be more prevalent##2##4##(2008-1#1)(2012-12#1)
to be more promising##2##4##(2008-10#1)(2008-3#1)
to be more resistant to##2##5##(1996-5#1)(2007-12#1)
to be more sensitive##10##4##(1990-12#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-1#1)(2012-2#1)
to be more stable than the##3##6##(2008-5#1)(2009-10#1)(2009-8#1)
to be more stable than##4##5##(1992-11#1)(2008-5#1)(2009-10#1)(2009-8#1)
to be more susceptible to##4##5##(1992-3#1)(1997-3#1)(2008-10#1)(2011-2#1)
to be more than##5##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
to be more vulnerable##4##4##(1990-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
to be more##129##3##(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-3#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#7)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#8)(2012-7#1)(2013-1#5)(2013-8#1)
to be most useful##2##4##(2008-11#1)(2012-2#1)
to be most##12##3##(1993-12#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-11#1)(2009-5#1)(2012-2#1)(2013-8#1)
to be mostly##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
to be much lower##4##4##(1995-3#1)(2008-10#2)(2013-1#1)
to be much more##3##4##(1991-9#1)(1993-2#1)(2008-11#1)
to be much##13##3##(1991-9#1)(1993-2#1)(1995-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
to be multifactorial##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
to be named##2##3##(1995-6#1)(2011-1#1)
to be nearly identical to##2##5##(1996-8#1)(2008-10#1)
to be nearly identical##4##4##(1991-12#1)(1995-11#1)(1996-8#1)(2008-10#1)
to be nearly##7##3##(1991-12#1)(1995-11#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-2#2)
to be necessary for a##2##5##(1996-3#1)(2008-9#1)
to be necessary for##10##4##(1990-8#1)(1993-9#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)
to be necessary##15##3##(1990-8#1)(1993-9#1)(1994-6#1)(1996-3#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)
to be negative##5##3##(1993-2#1)(2007-10#1)(2007-11#1)(2013-1#1)(2013-8#1)
to be negatively##2##3##(1991-5#1)(2011-2#1)
to be negligible##10##3##(1990-5#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-3#2)
to be new##13##3##(1997-2#1)(2008-3#12)
to be no##9##3##(1992-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-7#1)(2013-1#1)
to be normal##6##3##(1990-8#1)(1991-6#1)(1992-9#1)(1996-11#1)(2007-11#1)(2008-10#1)
to be not##5##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#1)
to be novel##9##3##(1997-4#1)(2008-10#1)(2008-3#7)
to be observed in##2##4##(2008-2#1)(2008-8#1)
to be observed##5##3##(2007-11#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-8#1)
to be obtained for##2##4##(1994-12#1)(2008-10#1)
to be obtained##17##3##(1994-12#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#2)(2011-2#1)(2012-2#2)
to be of a##2##4##(1990-10#1)(1993-6#1)
to be of great value##2##5##(1991-6#1)(1992-8#1)
to be of greater##3##4##(1994-2#1)(2008-10#1)(2010-4#1)
to be of importance in##2##5##(1994-12#1)(2011-2#1)
to be of importance##5##4##(1994-12#1)(2006-6#1)(2008-3#1)(2011-2#2)
to be of limited##2##4##(1995-12#1)(2008-10#1)
to be of little##2##4##(1991-2#1)(2008-3#1)
to be of minor##2##4##(2008-10#1)(2010-3#1)
to be of particular importance##2##5##(1994-9#1)(2008-9#1)
to be of the order of##2##6##(1992-3#1)(2008-10#1)
to be of the##5##4##(1991-12#1)(1991-5#1)(1992-3#1)(2008-10#2)
to be of value in##3##5##(1992-1#1)(2008-9#2)
to be of##51##3##(1990-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-6#1)(2007-2#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
to be offered to physicians##2##5##(1992-3#1)(1993-3#1)
to be offered##5##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-12#1)(2009-4#1)
to be older##4##3##(1992-3#1)(1994-12#1)(1995-3#1)(2008-10#1)
to be on the##3##4##(1991-12#1)(2009-2#1)(2009-4#1)
to be on##10##3##(1991-12#1)(1993-11#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-4#1)(2013-7#1)
to be one of the major##2##6##(2011-1#1)(2012-1#1)
to be one of the most common##2##7##(2013-1#1)(2013-8#1)
to be one of the most important##2##7##(1990-12#1)(2008-11#1)
to be one of the most##8##6##(1990-12#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to be one of the##16##5##(1990-12#1)(1993-8#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
to be one of##18##4##(1990-12#1)(1993-8#1)(1997-3#1)(2008-11#3)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
to be one##21##3##(1990-12#1)(1993-5#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
to be only about##2##4##(1990-11#1)(2008-10#1)
to be only##9##3##(1990-11#1)(1992-6#1)(1993-6#1)(2007-12#1)(2008-10#3)(2008-8#1)(2012-2#1)
to be optimal for##2##4##(2008-7#1)(2008-8#1)
to be optimal##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
to be optimized##5##3##(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
to be or##2##3##(1993-8#1)(2012-3#1)
to be over##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
to be overcome before##2##4##(1997-6#1)(2008-2#1)
to be overcome##9##3##(1990-6#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-3#1)(2010-6#1)(2010-7#1)(2012-12#1)
to be pH##2##3##(1992-9#1)(2008-10#1)
to be paid to the##3##5##(1997-1#1)(2008-1#1)(2012-12#1)
to be paid to##4##4##(1997-1#1)(2008-1#1)(2008-10#1)(2012-12#1)
to be paid##5##3##(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#1)
to be part of a##3##5##(1992-3#1)(1997-3#1)(2008-11#1)
to be part of the##2##5##(2008-4#1)(2010-11#1)
to be part of##7##4##(1992-3#1)(1992-6#1)(1997-3#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#1)
to be partially##4##3##(1993-9#1)(1995-8#1)(2008-10#1)(2013-1#1)
to be particularly vulnerable##2##4##(1991-1#1)(2013-1#1)
to be particularly##10##3##(1990-2#1)(1991-1#1)(1991-3#1)(1995-12#1)(2007-8#1)(2008-10#3)(2013-1#1)(2013-8#1)
to be partly##4##3##(1991-11#1)(1991-9#1)(1992-3#1)(2008-10#1)
to be pathogenic on##2##4##(2008-10#2)
to be pathogenic##3##3##(2008-10#2)(2011-2#1)
to be perceived by##2##4##(2009-8#1)(2012-3#1)
to be performed by the##2##5##(1993-12#1)(2012-3#1)
to be performed in##2##4##(2007-11#1)(2008-3#1)
to be performed on##3##4##(1995-1#1)(2007-10#1)(2008-3#1)
to be performed##20##3##(1993-11#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-6#1)(2007-10#1)(2007-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
to be phased##3##3##(1992-1#1)(1996-2#1)(2008-3#1)
to be phosphorylated in##2##4##(1993-11#1)(1995-6#1)
to be phosphorylated##3##3##(1993-11#1)(1995-6#1)(2011-2#1)
to be photochemically##2##3##(1996-2#1)(1997-6#1)
to be phylogenetically##2##3##(1997-2#1)(2008-10#1)
to be physiologically##2##3##(2008-8#1)(2010-11#1)
to be placed##3##3##(2008-11#2)(2008-9#1)
to be polygenic##2##3##(2008-10#1)(2011-2#1)
to be polymorphic##2##3##(1992-11#1)(1995-3#1)
to be poorly##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
to be positive for##5##4##(2006-12#1)(2007-7#2)(2013-1#1)(2013-8#1)
to be positive in##2##4##(2010-8#1)(2012-12#1)
to be positive##12##3##(1997-7#1)(2006-12#1)(2007-7#3)(2008-1#1)(2008-8#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
to be positively associated with##3##5##(1993-6#1)(2008-11#1)(2009-11#1)
to be positively correlated with the##2##6##(1991-12#1)(2008-6#1)
to be positively##8##3##(1991-12#1)(1993-6#1)(1995-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)
to be possible##4##3##(1993-12#1)(1995-11#1)(2008-5#1)(2013-8#1)
to be potent##4##3##(1990-2#1)(1991-5#1)(2007-11#1)(2008-10#1)
to be potentially useful for##2##5##(2007-12#1)(2009-7#1)
to be potentially useful##3##4##(1990-8#1)(2007-12#1)(2009-7#1)
to be potentially##6##3##(1990-8#1)(1994-3#1)(2007-12#1)(2009-7#1)(2010-1#1)(2013-8#1)
to be powerful##2##3##(2007-11#1)(2008-10#1)
to be practical##2##3##(1994-12#1)(2008-10#1)
to be preceded by##2##4##(1996-4#1)(2008-11#1)
to be predicted##3##3##(1990-12#1)(2008-10#1)(2010-4#1)
to be predictive of##2##4##(1995-2#1)(2012-12#1)
to be predictive##3##3##(1995-2#1)(2007-2#1)(2012-12#1)
to be predominant in##3##4##(2008-10#2)(2009-10#1)
to be predominant##6##3##(1990-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2009-10#1)
to be preferable for##3##4##(2008-10#3)
to be preferable to##3##4##(1993-3#1)(2008-10#1)(2008-7#1)
to be preferable##8##3##(1993-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)
to be preferred##3##3##(1992-11#1)(1993-11#1)(2008-3#1)
to be prepared##2##3##(2008-11#1)(2009-12#1)
to be prescribed##2##3##(2008-11#1)(2008-8#1)
to be present at the##2##5##(1996-8#1)(2008-7#1)
to be present in a##3##5##(1991-6#1)(2008-10#2)
to be present in the##4##5##(1991-6#1)(1994-12#1)(1995-6#1)(2008-10#1)
to be present in##21##4##(1990-7#1)(1991-6#2)(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-9#1)(2010-3#1)
to be present mainly##2##4##(1991-5#1)(2008-10#1)
to be present on##2##4##(1995-2#1)(2008-4#1)
to be present##36##3##(1990-7#1)(1991-11#1)(1991-5#2)(1991-6#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#1)
to be primarily##2##3##(2008-11#1)(2008-8#1)
to be primary##2##3##(2008-10#1)(2008-5#1)
to be processed to##3##4##(1990-5#1)(1995-2#1)(2008-10#1)
to be processed##4##3##(1990-5#1)(1995-2#1)(2008-10#1)(2010-8#1)
to be produced at##3##4##(1994-9#1)(2008-10#1)(2008-6#1)
to be produced##7##3##(1991-2#1)(1994-9#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
to be progressively##2##3##(2008-3#1)(2011-2#1)
to be promising for##2##4##(2008-11#1)(2013-1#1)
to be promising in##2##4##(2008-11#1)(2012-2#1)
to be promising##7##3##(1996-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#1)
to be properly##4##3##(1997-4#1)(2008-10#2)(2008-12#1)
to be proportional to the##5##5##(1990-3#1)(2007-12#1)(2008-10#2)(2008-3#1)
to be proportional to##7##4##(1990-3#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
to be protected by##2##4##(2008-10#1)(2010-1#1)
to be protected##4##3##(1995-5#1)(2008-10#1)(2009-11#1)(2010-1#1)
to be protective against##3##4##(1993-9#1)(2008-8#1)(2013-1#1)
to be protective##4##3##(1993-9#1)(2008-12#1)(2008-8#1)(2013-1#1)
to be published in the##2##5##(1994-1#1)(1994-2#1)
to be published##4##3##(1994-1#1)(1994-2#1)(2011-2#2)
to be quantified##4##3##(2007-11#1)(2008-3#1)(2008-7#2)
to be quite##11##3##(1990-11#1)(1994-2#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2012-1#1)
to be raised##4##3##(2007-12#1)(2008-12#1)(2009-11#1)(2012-2#1)
to be rapid##3##3##(2008-10#2)(2008-8#1)
to be rare in##2##4##(2007-11#1)(2009-4#1)
to be rather##4##3##(1990-7#1)(2008-10#2)(2008-8#1)
to be re-examined##2##3##(2007-7#1)(2008-10#1)
to be reached##3##3##(1992-3#1)(2008-10#1)(2012-2#1)
to be reactive##2##3##(1990-12#1)(2008-11#1)
to be read##2##3##(2008-3#1)(2009-4#1)
to be readily##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
to be realized##2##3##(1995-12#1)(2012-2#1)
to be recognized##4##3##(1995-11#1)(1995-6#1)(2008-5#1)(2011-2#1)
to be recommended for##2##4##(1990-8#1)(2008-10#1)
to be recommended##5##3##(1990-8#1)(1991-3#1)(1992-11#1)(2008-10#1)(2011-2#1)
to be reconstructed##5##3##(2007-12#1)(2008-3#2)(2008-7#1)(2012-1#1)
to be recorded##2##3##(1996-6#1)(2008-9#1)
to be reduced by##3##4##(1991-9#1)(1992-2#1)(2008-2#1)
to be reduced to##2##4##(2008-2#1)(2008-4#1)
to be reduced##10##3##(1991-9#1)(1992-2#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
to be refined##2##3##(2008-9#1)(2009-12#1)
to be regarded##2##3##(1996-11#1)(2008-7#1)
to be registered##3##3##(1991-11#1)(2008-3#1)(2008-6#1)
to be regulated by a##2##5##(1997-1#1)(2009-8#1)
to be regulated by the##2##5##(1997-2#1)(2008-10#1)
to be regulated by##11##4##(1991-2#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-8#1)
to be regulated##15##3##(1991-2#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-8#1)(2010-3#1)(2011-2#1)
to be related to a##3##5##(1992-6#1)(1994-8#1)(2010-12#1)
to be related to its##2##5##(1997-1#1)(2008-7#1)
to be related to the##20##5##(1990-3#1)(1991-6#1)(1992-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
to be related to##57##4##(1990-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-1#2)(1997-4#1)(2006-10#1)(2006-6#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-2#1)(2009-7#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
to be related with##4##4##(1990-6#1)(1993-11#1)(2007-11#1)(2012-3#1)
to be related##66##3##(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-1#2)(1997-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-2#1)(2009-7#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
to be relatively small##2##4##(2008-2#1)(2008-3#1)
to be relatively##16##3##(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)
to be released by##2##4##(1992-12#1)(2008-5#1)
to be released in##2##4##(1991-2#1)(2009-10#1)
to be released##12##3##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-10#1)
to be relevant##6##3##(1990-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
to be reliable and##3##4##(2007-10#1)(2007-12#1)(2008-10#1)
to be reliable##10##3##(1992-3#2)(1996-3#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
to be remarkably##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
to be remembered as##2##4##(2008-4#1)(2011-2#1)
to be removed by##4##4##(1996-5#1)(2007-12#1)(2008-10#1)(2011-2#1)
to be removed on##2##4##(1990-8#1)(1991-12#1)
to be removed##16##3##(1990-8#2)(1991-12#1)(1991-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-2#5)
to be replaced by##3##4##(1990-10#1)(1995-3#1)(1996-11#1)
to be replaced##6##3##(1990-10#1)(1993-2#1)(1995-3#1)(1996-11#1)(2008-10#1)(2009-7#1)
to be replicated##3##3##(1997-3#1)(2008-7#1)(2008-9#1)
to be reported in##4##4##(1992-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
to be reported##10##3##(1990-5#1)(1992-6#1)(2007-8#1)(2008-10#3)(2008-12#2)(2011-2#1)(2013-1#1)
to be represented##2##3##(2008-3#1)(2009-4#1)
to be required for##7##4##(1993-9#1)(1996-2#1)(1996-8#1)(2008-10#2)(2008-9#1)(2010-3#1)
to be required##10##3##(1993-9#1)(1996-2#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)
to be resistant to##5##4##(1992-9#2)(1993-9#1)(2008-10#2)
to be resistant##6##3##(1992-9#2)(1993-9#1)(2008-10#3)
to be resolved##11##3##(1990-7#1)(1991-2#1)(1992-1#1)(1995-3#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
to be responsible for the##12##5##(1993-8#1)(1994-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-1#1)
to be responsible for##26##4##(1990-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-8#1)(1997-2#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-2#1)(2009-5#2)(2011-1#2)(2011-2#1)
to be restored##3##3##(1996-2#1)(2013-1#2)
to be restricted to the##2##5##(1991-6#1)(2008-7#1)
to be restricted to##4##4##(1991-6#1)(1996-5#1)(2008-7#2)
to be restricted##6##3##(1991-6#1)(1996-5#1)(2008-7#2)(2013-1#2)
to be retained##3##3##(1992-2#1)(2008-10#1)(2008-7#1)
to be reversible and##2##4##(2008-10#1)(2011-2#1)
to be reversible##5##3##(1995-12#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
to be reviewed##2##3##(2008-6#1)(2011-2#1)
to be robust##4##3##(2008-11#1)(2010-3#1)(2010-9#1)(2012-3#1)
to be safe and effective##2##5##(2008-11#1)(2008-8#1)
to be safe and well tolerated##2##6##(1992-8#1)(2013-1#1)
to be safe and##9##4##(1991-12#1)(1992-8#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-2#1)(2013-1#1)
to be safe##16##3##(1991-12#1)(1992-8#1)(1995-5#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#3)
to be sampled##5##3##(2008-10#4)(2008-3#1)
to be satisfactory##4##3##(2007-11#1)(2008-10#3)
to be screened for##2##4##(1992-10#1)(2008-10#1)
to be screened##3##3##(1990-12#1)(1992-10#1)(2008-10#1)
to be secondary to##5##4##(1991-9#1)(1994-6#1)(2007-7#1)(2008-1#1)(2008-6#1)
to be seen##8##3##(1994-3#1)(1994-9#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
to be selected##3##3##(1996-3#1)(2008-10#1)(2012-9#1)
to be selective##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)
to be sensitive to the##5##5##(1995-11#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)
to be sensitive to##19##4##(1990-12#1)(1990-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-4#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
to be sensitive##22##3##(1990-12#1)(1990-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#2)(2009-4#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
to be separated from##4##4##(1990-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
to be sequenced##4##3##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
to be seriously##2##3##(2008-10#1)(2008-5#1)
to be served by##2##4##(1991-11#1)(1997-2#1)
to be set##3##3##(1996-2#1)(2009-10#1)(2013-8#1)
to be severely##2##3##(2008-3#1)(2008-8#1)
to be shown##4##3##(1991-7#1)(2008-10#2)(2013-8#1)
to be significant in##2##4##(1990-12#1)(2008-10#1)
to be significant##11##3##(1990-12#1)(1993-9#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
to be significantly affected by##2##5##(2008-10#1)(2010-4#1)
to be significantly associated with##8##5##(1994-7#1)(2007-12#1)(2008-8#2)(2010-11#1)(2011-1#1)(2012-2#2)
to be significantly associated##9##4##(1994-7#1)(2007-12#1)(2008-8#2)(2010-11#1)(2011-1#1)(2012-2#3)
to be significantly different##4##4##(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
to be significantly elevated##2##4##(2008-3#1)(2008-7#1)
to be significantly higher in the##2##6##(2007-12#1)(2008-10#1)
to be significantly higher in##3##5##(2007-12#1)(2008-10#1)(2011-1#1)
to be significantly higher than##2##5##(1995-12#1)(1996-1#1)
to be significantly higher##7##4##(1994-8#1)(1995-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
to be significantly lower than##2##5##(1993-8#1)(2008-10#1)
to be significantly lower##6##4##(1993-8#1)(2008-10#2)(2008-3#1)(2013-7#1)(2013-8#1)
to be significantly more##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
to be significantly reduced##2##4##(1992-11#1)(2008-3#1)
to be significantly related to##3##5##(1996-1#1)(2007-12#1)(2008-7#1)
to be significantly##59##3##(1990-8#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#2)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-2#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
to be similar in the##2##5##(1993-3#1)(2008-10#1)
to be similar in##4##4##(1991-5#1)(1993-3#1)(1995-5#1)(2008-10#1)
to be similar to that##2##5##(1990-2#1)(2008-5#1)
to be similar to the##2##5##(1993-11#1)(2008-10#1)
to be similar to those of##2##6##(1991-9#1)(2008-9#1)
to be similar to those##6##5##(1991-9#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)
to be similar to##13##4##(1990-2#1)(1991-9#1)(1993-11#1)(1993-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)
to be similar##27##3##(1990-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-5#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
to be simple##5##3##(1994-6#1)(1996-2#1)(2008-10#2)(2010-5#1)
to be slightly higher than##3##5##(1993-2#1)(1995-3#1)(2008-2#1)
to be slightly more effective than##2##6##(1993-12#1)(2008-5#1)
to be slightly more##5##4##(1990-12#1)(1993-12#1)(1995-5#2)(2008-5#1)
to be slightly##9##3##(1990-12#1)(1993-12#1)(1993-2#1)(1995-3#1)(1995-5#2)(2008-2#1)(2008-5#1)(2008-7#1)
to be small##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
to be smaller than##4##4##(2008-3#3)(2010-8#1)
to be smaller##6##3##(2008-3#4)(2010-8#1)(2012-2#1)
to be soluble##2##3##(1992-6#1)(2008-10#1)
to be solved##8##3##(1990-2#1)(1992-9#1)(1994-12#1)(2007-11#1)(2008-3#1)(2010-1#1)(2010-8#1)(2011-1#1)
to be somewhat less##2##4##(2008-2#1)(2010-5#1)
to be somewhat##3##3##(1994-11#1)(2008-2#1)(2010-5#1)
to be specific for##5##4##(1990-7#1)(1992-3#1)(1997-7#1)(2008-10#1)(2008-11#1)
to be specific to the##2##5##(1993-6#1)(2007-12#1)
to be specific to##3##4##(1991-12#1)(1993-6#1)(2007-12#1)
to be specific##9##3##(1990-7#1)(1991-12#1)(1992-3#1)(1993-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)
to be specifically##5##3##(1990-2#1)(1992-8#1)(1993-9#1)(2008-11#1)(2008-7#1)
to be specified##2##3##(2007-7#1)(2008-7#1)
to be stabilized##2##3##(1990-8#1)(2008-3#1)
to be stable and##2##4##(1997-1#1)(2008-3#1)
to be stable for##3##4##(2007-11#1)(2008-11#1)(2008-7#1)
to be stable in the##2##5##(1992-6#1)(2008-10#1)
to be stable in##3##4##(1992-6#1)(2008-10#1)(2013-1#1)
to be stable##17##3##(1990-5#1)(1990-7#1)(1992-6#1)(1996-2#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
to be statistically significant##7##4##(1990-2#2)(1993-12#1)(1997-4#1)(2008-5#2)(2008-8#1)
to be statistically##14##3##(1990-2#2)(1993-12#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
to be still present##2##4##(2008-7#1)(2008-8#1)
to be still##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
to be stimulated by##2##4##(1990-5#1)(1995-6#1)
to be strictly##2##3##(1997-2#1)(2010-5#1)
to be strong##3##3##(1992-8#1)(1994-12#1)(2008-9#1)
to be stronger in subjects with##2##6##(2008-3#1)(2008-5#1)
to be stronger than##2##4##(1997-8#1)(2013-1#1)
to be stronger##4##3##(1997-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
to be strongly dependent on the##2##6##(2008-7#1)(2009-3#1)
to be strongly dependent on##4##5##(2008-2#1)(2008-7#1)(2009-3#1)(2013-1#1)
to be strongly##12##3##(1991-12#2)(1996-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#1)(2013-1#1)
to be structurally##2##3##(1990-8#1)(1994-5#1)
to be studied##7##3##(2007-12#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-11#1)
to be submitted to##2##4##(2008-5#1)(2011-2#1)
to be submitted##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
to be successful even where there was severe overlap of spectra##2##11##(2008-10#2)
to be successful for##2##4##(2008-10#1)(2010-5#1)
to be successful in##9##4##(1991-2#1)(1992-6#1)(1994-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#2)
to be successful##23##3##(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-1#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-5#1)
to be successfully##2##3##(2008-12#1)(2009-6#1)
to be suffering from##2##4##(1990-2#1)(2009-7#1)
to be sufficient for##5##4##(1995-2#1)(1996-3#1)(2007-11#1)(2008-3#1)(2009-12#1)
to be sufficient to##2##4##(1997-4#1)(2011-2#1)
to be sufficient##7##3##(1995-2#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
to be suitable for the##10##5##(1990-12#1)(1993-11#1)(1993-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)(2011-1#1)
to be suitable for##16##4##(1990-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-1#1)
to be suitable##22##3##(1990-12#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-7#1)(2009-7#1)(2011-1#1)
to be superior in terms of##2##6##(2008-10#1)(2010-8#1)
to be superior to the##8##5##(1992-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
to be superior to##12##4##(1992-8#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
to be superior##18##3##(1992-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
to be supplemented##2##3##(1992-12#1)(2009-5#1)
to be supplied##2##3##(1992-9#1)(2008-2#1)
to be supported by##5##4##(1991-11#1)(1992-3#1)(1993-3#1)(2008-11#1)(2008-12#1)
to be suppressed##3##3##(1995-11#1)(2007-12#1)(2008-3#1)
to be sure##3##3##(1993-1#1)(2008-8#1)(2011-2#1)
to be surprisingly##2##3##(1991-5#1)(2008-3#1)
to be susceptible to##3##4##(2008-10#3)
to be susceptible##4##3##(2008-10#4)
to be sustained##3##3##(2008-9#1)(2013-1#2)
to be synonymous##2##3##(2008-10#1)(2010-3#1)
to be synthesized in##2##4##(1991-6#1)(1994-6#1)
to be synthesized##3##3##(1991-6#1)(1994-6#1)(1997-1#1)
to be tailored##2##3##(2008-10#1)(2013-8#1)
to be taken before##2##4##(2010-12#1)(2011-2#1)
to be taken into account in##3##6##(2008-10#1)(2008-5#1)(2012-12#1)
to be taken into account##8##5##(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
to be taken into##9##4##(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#2)(2012-2#1)
to be taken seriously##2##4##(1996-12#1)(2008-10#1)
to be taken to##2##4##(2008-10#1)(2010-8#1)
to be taken##33##3##(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-9#1)(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
to be targeted##3##3##(1997-5#1)(2007-7#1)(2010-5#1)
to be tested as##3##4##(2008-10#2)(2008-5#1)
to be tested for HIV antibodies##2##6##(1995-12#1)(1996-5#1)
to be tested for##3##4##(1995-12#1)(1996-5#1)(2008-4#1)
to be tested in##4##4##(1995-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
to be tested##18##3##(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)
to be that of##2##4##(2008-10#1)(2008-4#1)
to be that##7##3##(1994-6#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
to be the &quot##2##4##(1995-6#1)(2009-7#1)
to be the P2Y(15) receptor activated by##2##7##(2008-4#2)
to be the best therapeutic##2##5##(1994-6#1)(2009-7#1)
to be the best##20##4##(1990-9#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#2)(2011-2#1)(2012-2#1)
to be the case##3##4##(1990-6#1)(1993-6#1)(2008-9#1)
to be the cause of death##2##6##(1990-11#1)(2008-7#1)
to be the cause of##6##5##(1990-11#1)(1991-6#1)(1994-3#1)(2007-7#1)(2008-7#2)
to be the cause##8##4##(1990-11#1)(1991-6#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#2)
to be the dominant##4##4##(1997-1#1)(2008-2#1)(2008-6#1)(2009-3#1)
to be the first demonstration of##2##6##(1992-8#1)(2007-12#1)
to be the first example of##2##6##(1992-12#1)(2007-11#1)
to be the first experimental demonstration of##2##7##(2007-12#2)
to be the first experimental##4##5##(2007-11#1)(2007-12#3)
to be the first reported case of##2##7##(2007-8#1)(2012-2#1)
to be the first time##18##5##(2007-11#12)(2007-12#5)(2008-3#1)
to be the first##57##4##(1992-12#2)(1992-8#1)(1994-8#1)(1996-3#1)(2007-11#19)(2007-12#21)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2009-3#1)(2011-1#1)(2012-2#1)
to be the key##3##4##(2007-11#1)(2008-10#1)(2010-8#1)
to be the main##19##4##(1996-12#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-1#1)(2013-7#1)
to be the major##13##4##(1991-12#1)(1994-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#3)(2010-12#1)(2010-6#1)
to be the mechanism##2##4##(1993-2#1)(2008-3#1)
to be the most common##4##5##(2007-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
to be the most effective##7##5##(1990-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-5#1)
to be the most efficient##2##5##(2008-10#1)(2008-6#1)
to be the most important##5##5##(1992-4#1)(1994-12#1)(1994-6#1)(2009-7#1)(2013-1#1)
to be the most popular##2##5##(1997-6#1)(2008-4#1)
to be the most potent##3##5##(1995-12#1)(2008-8#1)(2013-8#1)
to be the most promising##2##5##(2008-10#1)(2013-1#1)
to be the most sensitive##3##5##(2008-10#2)(2008-12#1)
to be the most significant##3##5##(2008-10#1)(2008-9#1)(2010-3#1)
to be the most successful##2##5##(1994-3#1)(2012-2#1)
to be the most suitable for##3##6##(2008-10#2)(2009-8#1)
to be the most suitable##6##5##(2008-10#4)(2009-8#1)(2012-2#1)
to be the most useful##3##5##(1991-6#1)(1992-1#1)(2009-12#1)
to be the most##58##4##(1990-5#1)(1991-6#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
to be the only##6##4##(1994-9#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
to be the optimal##2##4##(1995-2#1)(2007-8#1)
to be the preferred##2##4##(1996-5#1)(2008-5#1)
to be the primary##3##4##(1997-6#1)(2008-2#1)(2009-5#1)
to be the reason##2##4##(2008-10#1)(2009-11#1)
to be the result of a##2##6##(2008-7#1)(2008-9#1)
to be the result of##10##5##(1992-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
to be the same as that##4##6##(2008-2#1)(2008-3#1)(2008-8#2)
to be the same as the##2##6##(1995-2#1)(2008-9#1)
to be the same as##7##5##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
to be the same##10##4##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)
to be the strongest##2##4##(2011-2#1)(2012-12#1)
to be the sum##2##4##(2008-10#1)(2009-3#1)
to be the##320##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#5)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(2007-10#3)(2007-11#25)(2007-12#25)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#47)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#14)(2008-4#6)(2008-5#4)(2008-6#7)(2008-7#14)(2008-8#7)(2008-9#8)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#3)
to be their##2##3##(1991-3#1)(1993-9#1)
to be those##2##3##(2008-10#1)(2010-4#1)
to be tight##2##3##(1992-11#1)(2008-11#1)
to be tightly##2##3##(1993-8#1)(2009-8#1)
to be time##2##3##(1992-6#1)(2008-10#1)
to be to##3##3##(1992-5#1)(2010-11#1)(2012-2#1)
to be tolerant##3##3##(2008-10#2)(2008-8#1)
to be tolerated##2##3##(2008-11#1)(2012-3#1)
to be too##3##3##(1990-2#1)(1995-6#1)(2012-2#1)
to be toxic and carcinogenic##2##5##(2008-10#2)
to be toxic##3##3##(1992-12#1)(2008-10#2)
to be trained in##2##4##(2008-10#1)(2008-11#1)
to be trained##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
to be transcribed from##2##4##(2008-11#1)(2008-8#1)
to be transcribed##4##3##(1994-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
to be transferred##3##3##(1993-12#1)(1994-5#1)(1997-8#1)
to be transformed into##2##4##(2008-11#1)(2011-1#1)
to be transformed##4##3##(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
to be transient##3##3##(1992-6#1)(2008-8#1)(2010-10#1)
to be transmitted##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
to be transported##3##3##(1996-9#1)(2008-10#1)(2008-7#1)
to be treated as##2##4##(1990-9#1)(2007-10#1)
to be treated surgically##2##4##(1991-6#1)(2012-3#1)
to be treated with##4##4##(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)
to be treated##13##3##(1990-6#1)(1990-9#1)(1991-6#1)(1994-12#1)(2007-10#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to be tuned##2##3##(2008-2#1)(2008-6#1)
to be typical##2##3##(1991-12#1)(1995-8#1)
to be typically##2##3##(1993-11#1)(2008-3#1)
to be unable to synthesize##3##5##(1992-12#2)(2008-11#1)
to be unable to##4##4##(1992-12#2)(1995-5#1)(2008-11#1)
to be unable##5##3##(1992-12#2)(1995-5#1)(1996-9#1)(2008-11#1)
to be unaffected by##4##4##(2007-12#1)(2008-10#1)(2010-4#1)(2012-4#1)
to be under the##2##4##(1992-10#1)(2008-5#1)
to be under##5##3##(1990-11#1)(1992-10#1)(2008-10#2)(2008-5#1)
to be understood##6##3##(1997-6#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)
to be underused in##2##4##(2008-12#1)(2008-3#1)
to be unimportant##2##3##(1997-4#1)(2008-3#1)
to be unique to##2##4##(1991-2#1)(2009-8#1)
to be unique##10##3##(1991-2#1)(1992-12#1)(1992-5#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2013-8#1)
to be uniquely##2##3##(1991-12#1)(2009-8#1)
to be universal##2##3##(1990-12#1)(2008-3#1)
to be unknown##2##3##(2008-3#1)(2012-2#1)
to be unrelated to the##2##5##(1995-12#2)
to be unrelated to##6##4##(1992-3#1)(1995-12#2)(1996-10#1)(1996-12#1)(2007-11#1)
to be unstable##3##3##(1995-3#1)(2008-6#1)(2013-1#1)
to be used as a##9##5##(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
to be used as an##2##5##(1991-9#1)(2008-10#1)
to be used as the##4##5##(1994-3#1)(2008-10#2)(2008-2#1)
to be used as##25##4##(1991-9#1)(1992-5#1)(1993-12#2)(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)
to be used for detection##2##5##(2008-10#1)(2011-1#1)
to be used for the##3##5##(1991-3#1)(2008-11#1)(2011-1#1)
to be used for##21##4##(1991-3#1)(1994-6#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#5)(2008-7#1)(2008-9#1)(2011-1#2)
to be used in a##5##5##(2008-10#3)(2008-2#1)(2008-3#1)
to be used in order to##2##6##(2008-10#1)(2008-6#1)
to be used in the treatment of##2##7##(2008-11#1)(2012-2#1)
to be used in the##9##5##(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2012-2#1)(2013-1#1)
to be used in##38##4##(1990-3#1)(1992-3#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
to be used to##10##4##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-8#1)
to be used with a##2##5##(2010-5#1)(2011-2#1)
to be used with the##2##5##(1997-2#1)(2008-2#1)
to be used with##7##4##(1996-11#1)(1997-2#1)(1997-7#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)
to be used##125##3##(1990-3#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#5)(2008-2#14)(2008-3#8)(2008-4#9)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
to be useful as a##2##5##(1993-1#1)(2008-10#1)
to be useful as##4##4##(1993-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
to be useful for the##2##5##(2008-10#2)
to be useful for##19##4##(1994-3#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#2)(2011-1#1)
to be useful in selecting##2##5##(2008-10#1)(2008-8#1)
to be useful in the area of##2##7##(2008-10#1)(2009-10#1)
to be useful in the prediction of##2##7##(1995-8#1)(2008-9#1)
to be useful in the##6##5##(1995-8#1)(2007-12#2)(2008-10#1)(2008-9#1)(2009-10#1)
to be useful in##21##4##(1990-10#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-6#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2013-1#2)
to be useful##59##3##(1990-10#1)(1990-6#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)
to be utilized for##2##4##(2008-10#1)(2008-5#1)
to be utilized##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
to be vaccinated##5##3##(1996-11#1)(2007-2#2)(2009-12#1)(2009-5#1)
to be valid##3##3##(1993-6#1)(2008-10#2)
to be valuable in##2##4##(1990-11#1)(2011-7#1)
to be valuable##4##3##(1990-11#1)(1991-2#1)(2008-8#1)(2011-7#1)
to be varied##2##3##(2007-11#1)(2007-12#1)
to be verified##3##3##(1993-11#1)(2008-7#1)(2009-12#1)
to be very effective in##4##5##(1991-6#1)(2007-7#1)(2012-2#1)(2013-1#1)
to be very effective##8##4##(1991-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
to be very important for##2##5##(2008-10#1)(2008-5#1)
to be very important##4##4##(2007-11#1)(2008-10#2)(2008-5#1)
to be very powerful##3##4##(1995-12#1)(2008-10#1)(2013-1#1)
to be very sensitive to##3##5##(1990-5#1)(1990-7#1)(2013-8#1)
to be very sensitive##5##4##(1990-5#1)(1990-7#1)(2008-10#1)(2008-7#1)(2013-8#1)
to be very similar##2##4##(1993-9#1)(1995-5#1)
to be very suitable for the##2##6##(2008-10#2)
to be very suitable##3##4##(2008-10#3)
to be very useful in##3##5##(1997-6#1)(1997-8#1)(2008-11#1)
to be very useful##5##4##(1994-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
to be very##60##3##(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to be viable##4##3##(1992-1#1)(1996-8#1)(1997-1#1)(2012-12#1)
to be vigilant##2##3##(1996-8#1)(2010-9#1)
to be visible##2##3##(2007-12#1)(2008-6#1)
to be visualized in##2##4##(2009-11#1)(2012-2#1)
to be warned of##2##4##(2007-2#1)(2008-12#1)
to be weak##2##3##(1997-4#1)(2008-8#1)
to be weighed against##2##4##(2008-11#1)(2010-12#1)
to be weighed##4##3##(1997-8#1)(2008-11#1)(2008-4#1)(2010-12#1)
to be well suited for##3##5##(2008-10#2)(2008-12#1)
to be well tolerated##2##4##(1996-2#1)(2008-5#1)
to be well##14##3##(1993-1#1)(1994-2#1)(1996-2#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)
to be widely used##2##4##(1995-3#1)(1997-3#1)
to be widely##3##3##(1995-3#1)(1997-3#1)(1997-7#1)
to be widespread##2##3##(2008-10#1)(2012-2#1)
to be willing to##3##4##(1991-2#1)(2007-2#1)(2012-3#1)
to be within the##2##4##(1994-8#1)(2008-10#1)
to be within##6##3##(1994-8#1)(2008-10#1)(2008-3#2)(2013-1#1)(2013-7#1)
to be working##2##3##(1992-12#1)(2007-4#1)
to be written##6##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-8#1)
to be young##2##3##(1991-12#1)(2010-11#1)
to be younger##5##3##(1993-1#1)(1996-2#1)(2008-8#1)(2011-2#1)(2012-3#1)
to be zero##2##3##(2008-10#1)(2009-9#1)
to be##7215##2##(1990-10#6)(1990-11#31)(1990-12#35)(1990-2#31)(1990-3#11)(1990-4#1)(1990-5#40)(1990-6#22)(1990-7#25)(1990-8#24)(1990-9#13)(1991-1#4)(1991-10#1)(1991-11#14)(1991-12#46)(1991-2#29)(1991-3#19)(1991-4#7)(1991-5#30)(1991-6#24)(1991-7#10)(1991-8#16)(1991-9#18)(1992-1#19)(1992-10#6)(1992-11#33)(1992-12#37)(1992-2#17)(1992-3#48)(1992-4#3)(1992-5#17)(1992-6#28)(1992-7#1)(1992-8#28)(1992-9#28)(1993-1#11)(1993-11#39)(1993-12#57)(1993-2#17)(1993-3#27)(1993-5#6)(1993-6#20)(1993-8#27)(1993-9#21)(1994-1#10)(1994-10#3)(1994-11#32)(1994-12#41)(1994-2#31)(1994-3#37)(1994-5#29)(1994-6#32)(1994-7#6)(1994-8#33)(1994-9#27)(1995-1#8)(1995-11#35)(1995-12#46)(1995-2#44)(1995-3#42)(1995-4#3)(1995-5#29)(1995-6#44)(1995-8#22)(1995-9#2)(1996-1#16)(1996-10#3)(1996-11#10)(1996-12#34)(1996-2#48)(1996-3#32)(1996-4#2)(1996-5#19)(1996-6#13)(1996-7#3)(1996-8#12)(1996-9#15)(1997-1#28)(1997-2#41)(1997-3#32)(1997-4#38)(1997-5#12)(1997-6#36)(1997-7#27)(1997-8#27)(1997-9#1)(2006-10#14)(2006-12#5)(2006-6#2)(2007-10#38)(2007-11#138)(2007-12#139)(2007-2#23)(2007-4#5)(2007-5#1)(2007-6#9)(2007-7#46)(2007-8#34)(2007-9#2)(2008-1#73)(2008-10#1292)(2008-11#321)(2008-12#90)(2008-2#194)(2008-3#362)(2008-4#111)(2008-5#181)(2008-6#68)(2008-7#227)(2008-8#179)(2008-9#119)(2009-1#6)(2009-10#25)(2009-11#18)(2009-12#29)(2009-2#19)(2009-3#19)(2009-4#21)(2009-5#42)(2009-6#19)(2009-7#44)(2009-8#31)(2009-9#23)(2010-1#10)(2010-10#24)(2010-11#30)(2010-12#32)(2010-2#11)(2010-3#41)(2010-4#26)(2010-5#31)(2010-6#14)(2010-7#20)(2010-8#51)(2010-9#7)(2011-1#87)(2011-10#1)(2011-2#231)(2011-3#7)(2011-4#1)(2011-7#3)(2012-1#31)(2012-12#70)(2012-2#158)(2012-3#85)(2012-4#1)(2012-6#2)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#176)(2013-7#20)(2013-8#120)
to beam##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
to bean##4##2##(2008-10#2)(2008-8#2)
to bear on##4##3##(1992-1#1)(1994-2#1)(2010-1#1)(2010-9#1)
to bear##8##2##(1992-1#1)(1994-2#2)(1996-5#1)(2009-5#1)(2010-1#1)(2010-9#1)(2013-1#1)
to become a reality##2##4##(2008-9#1)(2013-8#1)
to become a##12##3##(1994-1#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-8#1)
to become active##2##3##(2008-4#1)(2013-1#1)
to become an##6##3##(2008-10#1)(2009-9#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-3#1)
to become available##2##3##(1993-11#1)(2008-6#1)
to become capable##2##3##(2008-11#1)(2013-8#1)
to become even##2##3##(2009-3#1)(2009-6#1)
to become familiar with the##2##5##(1991-1#1)(2010-8#1)
to become familiar##4##3##(1991-1#1)(2008-4#1)(2010-8#1)(2011-2#1)
to become infected##2##3##(2008-10#2)
to become involved in##2##4##(1996-1#1)(2008-11#1)
to become involved##3##3##(1994-1#1)(1996-1#1)(2008-11#1)
to become more##9##3##(1993-2#1)(1993-3#1)(1994-2#2)(1997-3#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
to become part of##2##4##(1992-1#1)(2010-9#1)
to become stronger##2##3##(2010-10#1)(2010-5#1)
to become the##6##3##(1994-12#1)(1994-9#1)(1995-3#1)(2007-12#1)(2010-8#1)(2012-12#1)
to become##111##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-12#3)(2007-4#1)(2008-1#5)(2008-10#7)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#3)
to becoming a##3##3##(2008-11#2)(2008-8#1)
to becoming##5##2##(2008-11#2)(2008-8#1)(2012-12#1)(2013-8#1)
to bed and##2##3##(1995-11#1)(2008-9#1)
to bedside##2##2##(2008-8#1)(2009-6#1)
to begin an##3##3##(1990-3#1)(2008-7#1)(2008-9#1)
to begin in the##2##4##(2008-5#2)
to begin investigating the##2##4##(2008-11#1)(2012-2#1)
to begin shortly##2##3##(1996-5#1)(2008-10#1)
to begin to##8##3##(1993-12#1)(1994-6#1)(2008-1#1)(2010-3#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
to begin##28##2##(1990-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-6#1)(1996-5#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
to behave as a##2##4##(1990-11#1)(2008-10#1)
to behave in##2##3##(2008-11#1)(2008-3#1)
to behave##6##2##(1990-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
to behavior##2##2##(2008-3#1)(2009-6#1)
to behavioral##3##2##(2007-8#1)(2008-2#1)(2008-8#1)
to behaviour##2##2##(1992-12#1)(1993-12#1)
to behavioural changes##2##3##(2008-9#1)(2011-1#1)
to behavioural##4##2##(2008-9#3)(2011-1#1)
to being a##3##3##(2010-3#1)(2012-3#2)
to being an##2##3##(1991-11#1)(2012-2#1)
to being##19##2##(1990-11#1)(1991-11#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
to believe in##2##3##(2008-10#1)(2013-1#1)
to believe that they##2##4##(2008-9#1)(2013-7#1)
to believe that##12##3##(1993-12#1)(1994-6#1)(1995-1#1)(1996-4#1)(2008-12#1)(2008-2#1)(2008-9#3)(2009-11#1)(2012-2#1)(2013-7#1)
to believe##15##2##(1993-12#1)(1994-6#1)(1995-1#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#3)(2009-11#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
to belong to a##2##4##(2008-10#1)(2008-3#1)
to belong to the##6##4##(1992-3#1)(2008-10#3)(2008-5#1)(2008-8#1)
to belong to##12##3##(1992-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
to belong##13##2##(1992-3#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
to below##10##2##(1991-6#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-2#1)
to benchmark##4##2##(1995-3#1)(1997-1#1)(2008-12#1)(2008-5#1)
to beneficial##2##2##(2008-10#1)(2011-2#1)
to benefit by the end of therapy##2##7##(2012-2#2)
to benefit from the##2##4##(1997-6#1)(2009-6#1)
to benefit from##18##3##(1993-12#1)(1993-8#1)(1997-6#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
to benefit or##2##3##(1997-3#1)(2012-2#1)
to benefit the##2##3##(1995-2#1)(2008-5#1)
to benefit##29##2##(1993-1#1)(1993-12#1)(1993-8#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-6#2)(2009-8#2)(2011-2#2)(2012-12#1)(2012-2#6)(2013-1#1)(2013-8#1)
to benefits##4##2##(1995-12#1)(1997-1#1)(1997-2#1)(2008-3#1)
to benign##2##2##(2008-11#1)(2012-3#1)
to benomyl at##3##3##(2008-10#3)
to benomyl##5##2##(1990-5#1)(2008-10#4)
to benzene##6##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)
to benzimidazole##2##2##(1997-2#1)(2008-10#1)
to best serve##2##3##(2008-12#1)(2008-8#1)
to best##12##2##(1992-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-8#1)(2012-2#1)
to beta##4##2##(1991-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
to beta-CCE##2##2##(1996-2#2)
to beta-CD##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
to beta-adrenergic##2##2##(2008-9#1)(2010-4#1)
to beta-amyloid##3##2##(1992-12#2)(2010-2#1)
to beta-lactams##4##2##(1996-3#1)(2008-12#2)(2008-7#1)
to better control of##4##4##(1992-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
to better define the##5##4##(1990-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
to better define##6##3##(1990-6#1)(2008-10#3)(2011-2#1)(2013-1#1)
to better describe##2##3##(2008-10#1)(2009-12#1)
to better health##4##3##(1997-1#1)(2008-7#1)(2010-2#2)
to better identify##2##3##(2010-1#1)(2010-9#1)
to better interventions##2##3##(2010-10#1)(2012-3#1)
to better manage##2##3##(1994-2#1)(2008-8#1)
to better meet the needs of patients##2##7##(1996-12#1)(1996-2#1)
to better meet the needs of##3##6##(1996-12#1)(1996-2#1)(2010-7#1)
to better meet##5##3##(1994-2#1)(1996-12#1)(1996-2#2)(2010-7#1)
to better performance##2##3##(2008-12#1)(2008-3#1)
to better quality##2##3##(1990-6#1)(1994-9#1)
to better reflect##2##3##(2008-10#1)(2013-8#1)
to better results##4##3##(2007-11#2)(2008-10#1)(2008-11#1)
to better than 0##2##4##(2008-2#1)(2008-3#1)
to better than##8##3##(1992-11#1)(2008-2#2)(2008-3#5)
to better understand and##3##4##(2007-12#1)(2008-12#1)(2010-10#1)
to better understand how##4##4##(2008-11#1)(2009-7#1)(2010-9#1)(2013-1#1)
to better understand the dynamics and##2##6##(2012-3#2)
to better understand the dynamics of##2##6##(2008-10#1)(2010-9#1)
to better understand the dynamics##4##5##(2008-10#1)(2010-9#1)(2012-3#2)
to better understand the role of##2##6##(2008-11#1)(2008-7#1)
to better understand the##30##4##(1990-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-6#1)(1997-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)
to better understand##48##3##(1990-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-6#1)(1997-9#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#2)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#1)
to better understanding of##3##4##(1994-11#1)(2008-10#1)(2009-11#1)
to better understanding##4##3##(1994-11#1)(2008-10#1)(2009-11#1)(2009-5#1)
to better##138##2##(1990-2#1)(1990-6#2)(1990-8#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-9#1)(2007-11#3)(2007-12#3)(2008-10#16)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-11#3)(2009-12#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#7)(2012-7#1)(2013-1#11)(2013-7#2)(2013-8#2)
to between 0##2##3##(1990-5#1)(2012-12#1)
to between##7##2##(1990-5#2)(1997-5#1)(2008-5#1)(2008-7#1)(2012-12#2)
to bias##5##2##(1997-8#1)(2008-8#1)(2011-2#2)(2012-2#1)
to biases##2##2##(2008-3#1)(2012-2#1)
to bicuculline##3##2##(1993-12#1)(1995-5#1)(1997-2#1)
to bilateral##12##2##(2007-8#1)(2008-10#2)(2008-8#1)(2009-12#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to binary##2##2##(2007-12#1)(2008-10#1)
to bind a##2##3##(1991-12#1)(2011-1#1)
to bind and##5##3##(1991-12#2)(1991-5#1)(1995-6#1)(2010-8#1)
to bind in the##2##4##(1992-5#1)(1997-2#1)
to bind in##4##3##(1992-5#1)(1994-8#1)(1995-3#1)(1997-2#1)
to bind the##11##3##(1992-8#1)(1993-6#1)(1995-2#1)(1995-5#2)(1997-2#2)(2008-10#2)(2008-3#1)(2011-1#1)
to bind their##2##3##(1994-8#1)(2008-9#1)
to bind this##2##3##(1992-12#1)(2008-10#1)
to bind to DNA##2##4##(1995-5#1)(2008-8#1)
to bind to and##2##4##(1995-8#1)(2008-4#1)
to bind to its##2##4##(1995-6#1)(1997-7#1)
to bind to the##7##4##(1992-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(2007-11#1)(2013-1#1)
to bind to##34##3##(1990-12#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#2)
to bind with##4##3##(1995-2#1)(2008-10#2)(2008-4#1)
to bind##105##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1991-12#3)(1991-5#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#2)(1997-2#3)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#11)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
to binding of##3##3##(1990-11#1)(1993-3#1)(2012-2#1)
to binding to the##2##4##(1990-12#1)(2008-9#1)
to binding to##4##3##(1990-12#1)(1992-11#1)(2008-10#1)(2008-9#1)
to binding##11##2##(1990-11#1)(1990-12#1)(1992-11#1)(1993-3#1)(1993-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)
to biochar mass ratio##2##4##(2008-6#2)
to biochemical##2##2##(1991-5#1)(2010-10#1)
to biodiesel##2##2##(2009-3#1)(2013-1#1)
to biological control##2##3##(2008-10#2)
to biological problems##2##3##(1994-9#1)(2009-9#1)
to biological samples##2##3##(1996-12#1)(2008-8#1)
to biological systems##2##3##(1992-3#1)(2008-5#1)
to biological##26##2##(1990-2#1)(1990-7#1)(1992-3#1)(1993-1#1)(1994-9#1)(1995-3#2)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2012-3#2)(2013-8#1)
to biologically##2##2##(2008-12#1)(2013-1#1)
to biomarker##2##2##(2010-5#1)(2010-7#1)
to biomass##5##2##(2008-10#1)(2008-12#1)(2008-7#3)
to biomedical##2##2##(1991-6#1)(2013-1#1)
to biopsy##5##2##(1990-10#1)(2007-8#1)(2008-9#1)(2012-2#2)
to bioreactor##2##2##(2008-11#2)
to biosynthetically##2##2##(2008-1#2)
to biotin and##2##3##(1993-11#1)(1995-2#1)
to biotin##5##2##(1992-6#1)(1993-11#1)(1993-8#1)(1995-2#1)(2008-7#1)
to biotinylated##2##2##(1993-6#2)
to biotype##2##2##(2007-7#1)(2011-2#1)
to bipolar disorder##3##3##(1997-5#3)
to birth##4##2##(1993-6#1)(1997-7#1)(2008-10#1)(2012-12#1)
to black currant reversion associated virus##2##6##(2008-10#2)
to black##6##2##(1994-9#1)(2008-10#4)(2008-3#1)
to bladder##4##2##(1997-4#1)(2008-10#1)(2008-12#1)(2012-1#1)
to blame##2##2##(1994-12#1)(1996-3#1)
to blast in##2##3##(2008-10#2)
to blast##11##2##(2008-10#9)(2008-7#1)(2012-2#1)
to bleed##2##2##(2008-12#1)(2011-1#1)
to blend##3##2##(2009-7#2)(2013-8#1)
to block the##8##3##(1991-1#1)(1992-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1997-1#1)(2009-8#1)
to block##31##2##(1990-4#1)(1991-1#2)(1991-5#2)(1992-8#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-6#2)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#4)(2008-11#3)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
to blockage of the##3##4##(1995-12#1)(1997-2#1)(2011-2#1)
to blood loss##2##3##(1996-12#1)(2013-1#1)
to blood pressure##2##3##(1992-8#1)(2011-2#1)
to blood##17##2##(1990-12#1)(1990-5#1)(1992-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-10#1)(2009-7#1)(2011-2#2)(2013-1#1)
to bloom##3##2##(2008-10#3)
to blue color##2##3##(2008-10#1)(2010-2#1)
to blue##7##2##(2008-10#5)(2008-8#1)(2010-2#1)
to blunt##4##2##(2008-8#1)(2009-2#1)(2012-12#1)(2012-2#1)
to board##2##2##(1993-1#1)(1995-2#1)
to body composition##2##3##(2008-11#1)(2011-2#1)
to body dissatisfaction##2##3##(2007-12#2)
to body image##4##3##(2007-12#4)
to body weight##2##3##(1994-8#1)(2008-7#1)
to body##19##2##(1990-5#1)(1994-12#1)(1994-8#1)(2007-12#8)(2007-7#1)(2008-11#2)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)
to bone and##3##3##(1994-12#1)(2010-3#1)(2011-2#1)
to bone deformity##2##3##(1997-3#2)
to bone marrow transplantation##2##4##(1997-5#1)(2007-4#1)
to bone marrow##3##3##(1997-5#1)(2007-4#1)(2008-7#1)
to bone metastases##8##3##(2007-11#7)(2008-10#1)
to bone##26##2##(1994-12#2)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#8)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-3#1)(2011-2#1)
to bones##2##2##(2007-11#1)(2009-10#1)
to boost its##3##3##(1994-3#3)
to boost##6##2##(1994-3#3)(1994-5#1)(2008-2#1)(2008-3#1)
to border##2##2##(2008-10#1)(2008-9#1)
to bortezomib##2##2##(2010-8#1)(2011-2#1)
to both a##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
to both direct and indirect##2##5##(1990-5#1)(1996-2#1)
to both fungicides##4##3##(2008-10#4)
to both human##2##3##(1992-10#1)(1995-12#1)
to both local##2##3##(1994-2#2)
to both microtubules and##2##4##(1995-2#2)
to both natural##2##3##(2008-10#1)(2008-8#1)
to both of these##2##4##(1992-2#1)(2008-4#1)
to both patient##2##3##(2010-8#1)(2011-2#1)
to both peptides##2##3##(1990-5#2)
to both races##2##3##(2008-10#2)
to both samples##2##3##(2008-10#1)(2008-2#1)
to both sides of the##2##5##(1992-3#1)(2008-10#1)
to both students and##2##4##(1996-1#1)(2008-12#1)
to both the standard##2##4##(1994-9#1)(2008-10#1)
to both the##37##3##(1991-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
to both total##2##3##(1993-12#2)
to both variation in##2##4##(2007-12#1)(2008-9#1)
to both##274##2##(1990-12#1)(1990-2#1)(1990-5#5)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#4)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#6)(1994-6#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#54)(2008-11#6)(2008-12#8)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
to bottom##3##2##(1995-1#1)(2008-10#1)(2013-8#1)
to bound##3##2##(1990-5#1)(2008-2#1)(2010-5#1)
to boundary##2##2##(1997-2#1)(2012-12#1)
to bovine brain membranes##2##4##(1990-8#2)
to bovine lactoferrin##2##3##(1996-12#2)
to bovine serum albumin (BSA)##4##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
to bovine serum albumin##5##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
to bovine##21##2##(1990-12#1)(1990-8#4)(1992-6#2)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
to boys##3##2##(2009-8#1)(2010-7#1)(2012-2#1)
to brain PI##2##3##(1996-2#2)
to brain and##2##3##(2009-6#1)(2011-2#1)
to brain injury##2##3##(1991-11#1)(1997-3#1)
to brain regions##2##3##(1997-2#1)(2009-10#1)
to brain##25##2##(1991-11#1)(1991-5#1)(1993-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-3#1)
to break down##4##3##(1990-11#1)(1997-6#1)(2008-3#1)(2008-5#1)
to break the##6##3##(1992-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2011-1#1)
to break this##2##3##(1994-12#1)(2008-11#1)
to break up##2##3##(2008-11#1)(2008-8#1)
to break##21##2##(1990-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
to breakdown##4##2##(1991-5#1)(2008-12#1)(2008-3#1)(2008-8#1)
to breast cancer##13##3##(1990-8#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-9#1)(1997-1#1)(1997-3#1)(2007-10#2)(2008-4#1)(2009-5#2)(2011-2#1)
to breast##17##2##(1990-2#1)(1990-8#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-9#1)(1997-1#2)(1997-3#1)(1997-7#1)(2007-10#2)(2008-4#1)(2009-5#2)(2011-2#1)(2011-3#1)
to breastfeed##3##2##(2007-2#3)
to breathe##2##2##(1993-3#1)(2011-2#1)
to breathing##2##2##(1992-2#1)(2013-7#1)
to breed##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
to breeding##3##2##(2008-8#3)
to bridge the gap between evidence and##2##7##(1993-12#1)(2008-3#1)
to bridge the gap between##4##5##(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
to bridge the gap##5##4##(1991-1#1)(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
to bridge the##8##3##(1991-1#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)
to bridge##15##2##(1991-1#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2012-2#1)
to briefly##4##2##(1993-1#1)(2008-7#1)(2010-3#1)(2011-3#1)
to bright##2##2##(1997-6#1)(2007-11#1)
to bring about##6##3##(1990-2#1)(1997-3#1)(2008-11#2)(2010-1#1)(2012-12#1)
to bring the system##2##4##(2007-11#1)(2008-3#1)
to bring the##9##3##(1990-8#1)(1992-1#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
to bring this##2##3##(2007-7#1)(2008-9#1)
to bring together##2##3##(1993-3#1)(2011-1#1)
to bring##41##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-1#2)(1992-12#1)(1993-3#1)(1994-9#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#6)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
to broad##3##2##(2008-7#1)(2009-11#1)(2012-12#1)
to broaden our##2##3##(2009-10#1)(2012-2#1)
to broaden the range of##2##5##(1994-9#1)(1995-5#1)
to broaden the##6##3##(1994-9#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-1#1)(2011-2#1)
to broaden##13##2##(1994-9#1)(1995-1#1)(1995-5#2)(1996-2#2)(2007-11#2)(2008-1#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)
to bronchodilator##3##2##(2011-2#3)
to brown stem rot##4##4##(2008-10#4)
to brown##9##2##(2008-10#7)(2008-12#1)(2011-1#1)
to bud##3##2##(2008-10#2)(2012-8#1)
to budding##2##2##(2008-2#1)(2008-5#1)
to buffer##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
to buffered##2##2##(2008-10#1)(2008-11#1)
to build a##22##3##(1993-12#1)(1994-2#2)(1995-12#1)(1996-3#2)(1997-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
to build an##2##3##(2008-11#1)(2008-7#1)
to build and##3##3##(1996-1#1)(2008-4#1)(2011-7#1)
to build the##7##3##(2008-10#3)(2008-12#1)(2009-9#1)(2010-8#1)(2011-2#1)
to build up a##3##4##(2008-10#2)(2008-7#1)
to build##65##2##(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-2#4)(2013-1#2)(2013-8#1)
to building##3##2##(2007-12#1)(2010-12#1)(2011-1#1)
to bulk##5##2##(1992-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
to bundle##2##2##(1992-12#1)(1995-8#1)
to burnout##5##2##(1992-1#1)(2007-4#1)(2008-10#2)(2013-1#1)
to business##2##2##(1991-2#1)(1993-2#1)
to but##4##2##(1991-5#1)(2009-10#1)(2009-7#1)(2009-8#1)
to butyrate##2##2##(1992-3#1)(2008-11#1)
to buy##10##2##(1991-9#1)(1992-12#4)(1992-8#1)(1993-5#1)(1995-2#1)(1996-11#1)(2012-2#1)
to by##2##2##(1994-3#1)(2011-2#1)
to bypass the##2##3##(2008-9#1)(2012-3#1)
to bypass##5##2##(1992-8#1)(1995-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
to c##3##2##(2007-12#2)(2008-11#1)
to cAMP##5##2##(1991-12#1)(1991-2#1)(1992-6#1)(1996-12#1)(1996-2#1)
to cDNA##3##2##(1995-11#1)(2008-4#1)(2008-9#1)
to ca##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
to cadmium and##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
to cadmium##6##2##(1993-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
to cage##4##2##(2007-11#1)(2008-11#3)
to calcium##5##2##(1990-7#1)(1994-3#1)(1995-2#1)(1996-9#1)(2010-11#1)
to calculate a##3##3##(1993-11#1)(2008-10#1)(2009-8#1)
to calculate the corresponding##3##4##(2008-10#2)(2008-2#1)
to calculate the dispersion##2##4##(2007-12#1)(2008-11#1)
to calculate the net##2##4##(2008-11#1)(2011-2#1)
to calculate the relative##2##4##(1996-3#1)(2008-10#1)
to calculate the##96##3##(1990-7#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#19)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)
to calculate##145##2##(1990-7#1)(1991-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#3)(2008-10#32)(2008-11#7)(2008-12#3)(2008-2#15)(2008-3#28)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
to calf thymus DNA##2##4##(1992-2#1)(1995-2#1)
to calibrate a##2##3##(2008-4#1)(2012-2#1)
to calibrate and##2##3##(2008-3#1)(2008-6#1)
to calibrate the##4##3##(2008-3#4)
to calibrate##15##2##(2008-10#1)(2008-3#10)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
to calibration##3##2##(2008-10#1)(2008-3#1)(2010-11#1)
to call the##2##3##(2008-10#1)(2012-12#1)
to call##6##2##(1992-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-12#1)(2013-8#1)
to calls from midwife obstetric units##2##6##(2010-3#2)
to calls from##3##3##(2010-3#3)
to calls##4##2##(1994-3#1)(2010-3#3)
to calorie restriction##2##3##(2008-4#2)
to calreticulin##2##2##(1994-11#2)
to cancel the##2##3##(1992-2#1)(2008-2#1)
to cancel##7##2##(1992-2#1)(1993-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
to cancer cell##2##3##(2008-11#1)(2009-4#1)
to cancer diagnosis##2##3##(1992-10#1)(2010-6#1)
to cancer in##2##3##(1990-9#1)(1997-1#1)
to cancer of the##2##4##(1994-2#1)(2012-12#1)
to cancer of##3##3##(1994-2#1)(2012-12#1)(2012-3#1)
to cancer patients##3##3##(1992-3#1)(1995-2#1)(2011-1#1)
to cancer research##2##3##(2008-11#1)(2008-7#1)
to cancer therapy##2##3##(2008-4#1)(2011-2#1)
to cancer##45##2##(1990-12#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1995-2#1)(1995-9#2)(1996-10#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#2)(2009-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
to cancers of the breast##2##5##(1995-9#1)(2008-11#1)
to cancers##3##2##(1995-9#1)(2008-11#2)
to cannabis##2##2##(2009-7#1)(2012-12#1)
to cannulation##2##2##(1990-8#1)(2007-7#1)
to canopy##3##2##(2008-10#1)(2013-7#2)
to cap##2##2##(1993-8#1)(1994-2#1)
to capillary electrophoresis##2##3##(2008-10#2)
to capillary##3##2##(2008-10#2)(2008-3#1)
to capital##3##2##(1992-2#1)(1997-6#1)(2008-7#1)
to capitalize on the##2##4##(1994-3#1)(1995-2#1)
to capitalize on##4##3##(1994-3#1)(1995-2#1)(2010-9#1)(2011-2#1)
to capitation##3##2##(1995-2#1)(1997-1#1)(1997-2#1)
to capsaicin##4##2##(1990-5#1)(1992-6#1)(2008-11#1)(2012-3#1)
to capture and##2##3##(2008-10#1)(2008-4#1)
to capture the##11##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#1)(2009-8#1)(2013-7#1)
to capture##46##2##(1990-12#1)(1993-12#1)(1995-5#1)(1996-3#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
to capturing##2##2##(2008-11#1)(2013-8#1)
to carbachol##4##2##(1990-5#1)(1996-5#1)(1997-1#1)(2008-3#1)
to carbohydrate##3##2##(1991-5#1)(1992-11#1)(2012-3#1)
to carbon catabolite repression by##2##5##(1993-12#1)(2008-10#1)
to carbon dioxide##3##3##(1993-12#1)(2008-10#1)(2008-2#1)
to carbon##11##2##(1993-12#2)(1997-6#1)(2008-10#5)(2008-2#1)(2008-7#1)(2010-4#1)
to carboxylate##2##2##(1990-12#1)(2008-7#1)
to carcinogenesis##2##2##(2012-1#1)(2013-8#1)
to carcinoma in##2##3##(1997-7#1)(2008-1#1)
to carcinoma##4##2##(1997-7#1)(2008-1#1)(2008-4#1)(2013-8#1)
to cardiac hypertrophy##2##3##(2008-12#2)
to cardiac##16##2##(1992-3#1)(1995-11#1)(1996-9#1)(2007-7#1)(2008-11#3)(2008-12#2)(2009-4#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#3)
to cardiopulmonary bypass##2##3##(2006-10#1)(2007-8#1)
to cardiovascular complications##2##3##(2008-12#1)(2012-3#1)
to cardiovascular disease##9##3##(1990-9#1)(1994-5#1)(2008-3#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)
to cardiovascular diseases##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
to cardiovascular events##2##3##(2010-9#1)(2011-2#1)
to cardiovascular risk factors in##2##5##(2011-1#1)(2012-2#1)
to cardiovascular##25##2##(1990-5#1)(1990-9#1)(1991-2#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to care for bereaved parents##2##5##(2008-11#2)
to care for children##3##4##(2012-2#2)(2013-8#1)
to care for patients##2##4##(1991-2#1)(1995-3#1)
to care for people with mental health problems##2##8##(2008-11#2)
to care for the##7##4##(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-8#2)(2008-9#1)
to care for##33##3##(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-11#6)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
to care of the older person##3##6##(2010-10#3)
to care##75##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#9)(1995-3#3)(1996-1#2)(1996-2#1)(1996-3#5)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-11#6)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#3)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#2)
to careers in##2##3##(1992-7#1)(2012-3#1)
to careers##3##2##(1992-7#1)(2010-10#1)(2012-3#1)
to carefully##4##2##(1992-11#1)(1995-12#1)(2008-8#1)(2013-1#1)
to caregivers##7##2##(1991-1#1)(1994-1#1)(1996-1#1)(2007-12#1)(2008-1#1)(2009-9#1)(2013-8#1)
to caring##5##2##(1994-2#1)(2008-1#1)(2009-5#2)(2011-2#1)
to carotid##2##2##(1990-12#1)(2008-7#1)
to carrier##7##2##(2008-10#1)(2008-11#5)(2008-2#1)
to carry light##2##3##(2008-10#1)(2008-3#1)
to carry out a##3##4##(2007-2#1)(2008-3#1)(2011-1#1)
to carry out activities##2##4##(2008-7#1)(2012-12#1)
to carry out an##2##4##(1991-5#1)(2011-3#1)
to carry out analyses of##2##5##(1996-3#1)(2008-10#1)
to carry out the calibration for the##2##7##(2008-2#2)
to carry out the##16##4##(1992-3#1)(1993-5#1)(1995-12#1)(1997-7#1)(2008-10#5)(2008-2#4)(2008-3#2)(2010-12#1)
to carry out##49##3##(1990-2#1)(1991-5#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-6#2)(1997-7#1)(2007-2#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
to carry the##4##3##(1991-8#1)(1994-6#1)(2008-10#2)
to carry##69##2##(1990-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-6#2)(1997-7#1)(2007-2#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
to case management##2##3##(1992-3#1)(1997-3#1)
to case##6##2##(1992-3#1)(1996-12#1)(1997-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
to cases##4##2##(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
to cast##3##2##(1992-3#1)(2008-5#1)(2013-8#1)
to catabolize##3##2##(1993-3#1)(2008-10#2)
to catalyse the##2##3##(1990-7#1)(2008-5#1)
to catalyst##2##2##(2009-2#1)(2010-6#1)
to catalytic##3##2##(1992-3#1)(1996-5#1)(2008-10#1)
to catalyze the##9##3##(1990-11#2)(1990-12#1)(2008-1#1)(2008-10#2)(2009-12#1)(2009-6#1)(2012-2#1)
to catalyze##14##2##(1990-11#2)(1990-12#1)(1992-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-6#1)(2012-2#1)
to catch up##2##3##(1995-1#1)(2007-3#1)
to catch##5##2##(1992-6#1)(1995-1#1)(1995-3#1)(2007-3#1)(2008-8#1)
to catechol##3##2##(2008-10#3)
to catecholamines##3##2##(1994-6#3)
to categorize the##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
to categorize##7##2##(1995-2#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-11#1)(2012-3#1)(2013-8#1)
to cater##2##2##(2008-7#1)(2010-8#1)
to cation##2##2##(2008-10#1)(2008-8#1)
to cations##4##2##(1990-5#2)(2008-10#1)(2008-7#1)
to cattle##3##2##(1990-6#1)(1997-7#1)(2011-2#1)
to causal##2##2##(1997-3#1)(2009-10#1)
to cause a reduction##2##4##(1991-12#1)(2008-10#1)
to cause a##14##3##(1991-12#1)(1995-12#1)(1995-8#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-8#2)(2009-12#1)(2011-1#1)(2012-12#1)
to cause an##2##3##(2008-7#1)(2011-2#1)
to cause big-vein##2##3##(2008-10#2)
to cause chemical##2##3##(2012-2#2)
to cause disease##3##3##(2008-10#3)
to cause failure##2##3##(2008-10#1)(2013-1#1)
to cause severe damage to##2##5##(2008-10#1)(2008-7#1)
to cause severe##5##3##(1991-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
to cause significant##2##3##(2008-10#1)(2008-8#1)
to cause the##6##3##(1993-2#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-12#1)(2010-10#1)
to cause##128##2##(1991-12#2)(1992-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-10#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#1)
to cavity##3##2##(1991-2#1)(2008-3#2)
to cease##2##2##(1991-11#1)(2007-11#1)
to cefazolin##2##2##(2011-2#2)
to cefotaxime##2##2##(1990-6#1)(2007-7#1)
to celebrate##2##2##(2007-2#1)(2008-10#1)
to cell contact##2##3##(2009-8#1)(2011-1#1)
to cell culture##2##3##(2008-11#2)
to cell cultures##5##3##(1991-12#1)(1997-6#1)(2008-5#3)
to cell cycle##2##3##(1990-11#1)(2011-2#1)
to cell damage##2##3##(2008-7#1)(2011-3#1)
to cell death##13##3##(1991-9#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
to cell destruction##2##3##(2008-2#1)(2011-2#1)
to cell growth and##2##4##(1994-11#1)(2008-11#1)
to cell growth##4##3##(1994-11#1)(2008-11#1)(2008-6#1)(2011-1#1)
to cell membrane##2##3##(2008-8#1)(2012-2#1)
to cell membranes##2##3##(1991-12#1)(2008-12#1)
to cell proliferation##4##3##(1991-2#1)(2008-11#1)(2009-9#1)(2012-8#1)
to cell surface##3##3##(1995-2#1)(1996-2#1)(2008-9#1)
to cell viability##2##3##(1992-11#1)(1994-11#1)
to cell##68##2##(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-6#2)(1994-11#2)(1994-5#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#12)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-2#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-8#1)(2013-7#1)(2013-8#1)
to cell-cycle##3##2##(2008-11#2)(2013-8#1)
to cells and##3##3##(2008-1#1)(2008-10#1)(2009-10#1)
to cells cultured in##3##4##(1992-8#2)(2008-11#1)
to cells in##2##3##(1992-6#1)(2008-5#1)
to cells of the##2##4##(1992-11#1)(1994-5#1)
to cells treated##2##3##(1992-3#1)(1996-12#1)
to cells with##2##3##(2008-9#1)(2012-3#1)
to cells##38##2##(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
to cellular stresses##2##3##(1996-2#2)
to cellular##23##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-4#1)(1995-5#1)(1996-2#3)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
to cellulose##3##2##(1997-4#1)(2008-10#2)
to center layer##2##3##(2013-8#2)
to center##3##2##(2007-12#1)(2013-8#2)
to central##10##2##(1994-11#2)(1994-6#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-3#1)
to cephalosporin##2##2##(2011-1#1)(2011-2#1)
to cerebral infarction##2##3##(2008-7#1)(2012-12#1)
to cerebral##9##2##(1991-2#1)(1996-3#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
to certain other##2##3##(1990-5#1)(2008-5#1)
to certain stimuli##2##3##(2008-4#1)(2008-7#1)
to certain##32##2##(1990-3#1)(1990-5#3)(1990-7#1)(1991-5#1)(1992-2#2)(1993-10#1)(1993-12#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2011-2#3)(2013-1#1)
to certification##2##2##(1991-3#1)(2012-2#1)
to certify the##2##3##(2008-11#1)(2013-1#1)
to cervical cancer screening##2##4##(2007-8#2)
to cervical cancer##5##3##(2007-8#2)(2008-11#1)(2011-2#1)(2012-12#1)
to cervical##9##2##(1994-5#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
to cetuximab##2##2##(2013-8#2)
to challenge the##6##3##(1995-1#1)(1996-5#1)(1997-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
to challenge with##2##3##(1997-3#1)(2008-10#1)
to challenge##19##2##(1990-11#1)(1991-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-3#2)(2007-8#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
to challenging##2##2##(2008-1#1)(2009-3#1)
to change and##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
to change between##2##3##(1991-1#1)(2008-2#1)
to change from##2##3##(2010-6#1)(2011-2#1)
to change in##9##3##(1991-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
to change into##2##3##(2007-12#1)(2013-8#1)
to change the way the##2##5##(2006-10#1)(2008-11#1)
to change the way they##2##5##(1997-2#1)(2007-7#1)
to change the way##4##4##(1997-2#1)(2006-10#1)(2007-7#1)(2008-11#1)
to change the##28##3##(1991-1#3)(1993-11#1)(1994-1#1)(1994-11#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
to change their##3##3##(1992-2#1)(1994-2#1)(2008-11#1)
to change to##2##3##(2008-10#1)(2011-2#1)
to change##115##2##(1991-1#5)(1991-12#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-11#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-1#3)(1997-2#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#8)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#4)
to changes in disease##2##4##(2008-10#1)(2011-1#1)
to changes in environmental##3##4##(1992-12#1)(1995-11#1)(2008-6#1)
to changes in flow##2##4##(1991-9#1)(2008-9#1)
to changes in food##2##4##(2008-11#1)(2008-9#1)
to changes in temperature##5##4##(1990-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-2#1)
to changes in the rate of returning##2##7##(2008-8#2)
to changes in the##24##4##(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#2)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
to changes in their##2##4##(1994-11#1)(2010-3#1)
to changes in variables##2##4##(2008-10#2)
to changes in##81##3##(1990-6#1)(1990-8#3)(1991-10#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-12#4)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#1)
to changes occurring##2##3##(2008-5#1)(2008-6#1)
to changes of##2##3##(1993-9#1)(2008-10#1)
to changes##89##2##(1990-6#1)(1990-8#4)(1991-10#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(2007-12#4)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#1)
to changing environments##2##3##(2008-7#1)(2009-6#1)
to changing##14##2##(1991-1#1)(1992-2#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-3#1)(2012-2#1)(2012-5#1)
to channel##4##2##(1994-2#1)(2007-11#1)(2008-2#1)(2008-8#1)
to chaos##3##2##(1996-2#1)(2007-11#1)(2007-12#1)
to characterise the##10##3##(1991-9#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2013-8#1)
to characterise##20##2##(1991-9#1)(1994-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
to characteristics of the##2##4##(2008-11#1)(2010-10#1)
to characterize a##5##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
to characterize and compare##2##4##(2008-11#1)(2012-3#1)
to characterize and improve##2##4##(1996-12#1)(2007-12#1)
to characterize and to##2##4##(1997-3#1)(2013-1#1)
to characterize and##9##3##(1996-12#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
to characterize biological##2##3##(2008-10#1)(2008-7#1)
to characterize both##2##3##(2009-6#1)(2012-2#1)
to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig##2##15##(1994-8#2)
to characterize pathogenic##2##3##(2008-10#2)
to characterize the baseline##2##4##(2008-10#1)(2008-11#1)
to characterize the effects of##3##5##(1990-7#1)(1994-2#1)(2008-10#1)
to characterize the nonlinear##2##4##(2007-11#1)(2007-12#1)
to characterize the performance of##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
to characterize the population##2##4##(2008-10#1)(2011-2#1)
to characterize the##112##3##(1990-5#1)(1990-7#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-5#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#2)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-8#2)
to characterize their abilities as##2##5##(2008-10#2)
to characterize their##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
to characterize these##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
to characterize this##2##3##(1991-9#1)(2008-7#1)
to characterize ultrashort pulses##2##4##(2007-12#2)
to characterize ultrashort##3##3##(2007-11#1)(2007-12#2)
to characterize##236##2##(1990-5#1)(1990-7#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-8#3)(1995-12#2)(1995-2#3)(1996-1#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2007-11#4)(2007-12#10)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#58)(2008-11#11)(2008-12#3)(2008-2#7)(2008-3#23)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
to characterizing##2##2##(2008-10#1)(2008-8#1)
to charge##6##2##(1990-5#1)(1991-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
to chart a##2##3##(1995-3#1)(2009-10#1)
to chart##4##2##(1995-3#1)(2009-10#1)(2011-1#2)
to cheat##2##2##(2008-9#1)(2010-11#1)
to check its##3##3##(1990-3#1)(1991-3#1)(2008-3#1)
to check the procedures##2##4##(1991-2#1)(2010-8#1)
to check the##15##3##(1991-2#1)(1997-3#1)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)
to check##38##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-5#1)(1995-8#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-7#1)
to checking##2##2##(1996-8#1)(2009-12#1)
to chemical and##3##3##(1997-2#1)(2008-2#1)(2008-3#1)
to chemical or##2##3##(1990-9#1)(2008-10#1)
to chemical##25##2##(1990-9#1)(1993-3#1)(1994-2#1)(1997-2#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
to chemically##6##2##(1993-3#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
to chemicals##2##2##(1992-2#1)(2008-10#1)
to chemometric##2##2##(2008-10#2)
to chemotherapeutic agents##4##3##(1997-7#1)(2008-11#2)(2013-7#1)
to chemotherapeutic drugs##3##3##(1997-7#2)(2008-11#1)
to chemotherapeutic##7##2##(1997-7#3)(2008-11#3)(2013-7#1)
to chemotherapy and##2##3##(2010-3#1)(2012-3#1)
to chemotherapy##31##2##(1990-12#1)(1991-4#2)(1992-10#2)(1994-2#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#2)(2010-3#6)(2011-1#4)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
to chest wall reconstruction##2##4##(2012-2#2)
to chest##3##2##(2008-3#1)(2012-2#2)
to chicken##4##2##(1991-3#2)(1993-6#1)(2008-5#1)
to child survival##2##3##(1997-4#1)(2009-4#1)
to child##4##2##(1994-6#1)(1997-4#1)(2009-4#1)(2013-1#1)
to childhood##4##2##(1997-4#1)(2008-12#2)(2008-9#1)
to children and adolescents##2##4##(2008-8#1)(2008-9#1)
to children and their##2##4##(2008-11#2)
to children and young adults##2##5##(2007-8#1)(2010-3#1)
to children and##7##3##(2007-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)
to children from##2##3##(2008-11#1)(2011-1#1)
to children in##3##3##(1991-6#1)(1994-6#1)(2012-3#1)
to children under##2##3##(2008-12#1)(2013-1#1)
to children who##3##3##(2007-12#1)(2008-11#1)(2008-6#1)
to children with cancer##2##4##(1992-12#1)(2008-11#1)
to children with##5##3##(1991-3#1)(1992-12#1)(1995-8#1)(2008-11#1)(2010-7#1)
to children##38##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to children's perceptions##4##3##(2008-12#3)(2009-4#1)
to children's##9##2##(2008-12#3)(2009-4#1)(2009-7#1)(2010-12#1)(2012-12#2)(2013-1#1)
to chiral##2##2##(1995-6#2)
to chloramphenicol##5##2##(1990-6#1)(1994-12#1)(2007-7#1)(2008-12#1)(2011-2#1)
to chloride##2##2##(1990-8#1)(2008-10#1)
to chlorine##5##2##(1992-5#1)(2008-10#4)
to chlorophyll##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
to chloroplast##2##2##(1990-12#1)(2008-10#1)
to chloroplasts##2##2##(1995-2#1)(2008-1#1)
to chloroquine##3##2##(1992-6#1)(1993-8#1)(1994-12#1)
to choice##5##2##(1995-3#1)(1997-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
to cholesterol and##2##3##(1992-9#1)(2008-8#1)
to cholesterol oxidase##2##3##(1997-7#1)(2008-10#1)
to cholesterol translocation##2##3##(1990-12#1)(1995-12#1)
to cholesterol##11##2##(1990-12#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-8#1)
to cholinergic##4##2##(1992-8#1)(2007-7#1)(2008-11#1)(2008-7#1)
to choose a##2##3##(1993-11#1)(2012-3#1)
to choose an appropriate##2##4##(2008-4#1)(2009-5#1)
to choose an##3##3##(2008-4#1)(2009-5#1)(2011-2#1)
to choose between hospitals in these##2##6##(2008-7#2)
to choose between##3##3##(1992-2#1)(2008-7#2)
to choose from##3##3##(1993-12#1)(2008-3#1)(2011-1#1)
to choose the##7##3##(1993-5#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-3#1)
to choose##34##2##(1990-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#4)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#2)
to chromatographic##6##2##(1991-8#2)(2008-10#4)
to chromatography##2##2##(1992-6#1)(2007-11#1)
to chromium (VI)##3##3##(1996-12#1)(2008-10#2)
to chromium##5##2##(1996-12#1)(2008-10#3)(2009-10#1)
to chromium(VI) by##2##3##(2008-10#2)
to chromosome 16p12##2##3##(1994-11#1)(2007-7#1)
to chromosome 17##2##3##(1995-5#1)(2008-7#1)
to chromosome 2##2##3##(2008-8#1)(2011-1#1)
to chromosome band##3##3##(1994-12#1)(1994-8#1)(1997-7#1)
to chromosome breakage##2##3##(2012-3#2)
to chromosome##36##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-6#2)(1997-4#1)(1997-7#3)(2007-11#1)(2007-7#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2011-1#1)(2012-3#3)
to chromosomes 3##2##3##(2008-10#2)
to chromosomes##7##2##(1993-11#1)(1993-12#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-5#1)
to chronic daily##2##3##(1994-2#2)
to chronic hypoxia##2##3##(2010-4#2)
to chronic infection##2##3##(2008-10#1)(2008-11#1)
to chronic inflammation##3##3##(1997-8#1)(2008-5#1)(2009-8#1)
to chronic renal failure##3##4##(2007-7#1)(2008-1#1)(2008-3#1)
to chronic##42##2##(1991-4#1)(1991-6#1)(1992-11#1)(1994-2#2)(1994-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#2)(2010-4#3)(2011-2#2)(2012-12#1)(2013-1#3)
to chronically##2##2##(1990-8#1)(2012-12#1)
to cigarette smoke##5##3##(1993-8#1)(2008-5#4)
to cigarette##6##2##(1993-8#1)(2007-12#1)(2008-5#4)
to ciprofloxacin##4##2##(2007-7#1)(2008-7#1)(2012-3#2)
to circadian rhythms##2##3##(1996-2#1)(2013-7#1)
to circadian##4##2##(1996-2#1)(2008-5#1)(2008-8#1)(2013-7#1)
to circular dichroism##3##3##(1993-11#1)(1995-2#1)(2008-10#1)
to circular##4##2##(1993-11#1)(1995-2#1)(2008-10#1)(2008-3#1)
to circulate##4##2##(1991-5#1)(1997-2#1)(2008-1#1)(2013-8#1)
to circulating##3##2##(1996-12#1)(2008-8#1)(2010-5#1)
to circumvent the##5##3##(1995-2#1)(2010-1#1)(2010-3#2)(2012-2#1)
to circumvent these##2##3##(1994-11#1)(2007-11#1)
to circumvent this problem##2##4##(2007-12#1)(2008-10#1)
to circumvent this##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
to circumvent##15##2##(1994-1#1)(1994-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2010-1#1)(2010-3#2)(2012-2#2)
to cisplatin##7##2##(1992-2#1)(1993-1#1)(1993-9#1)(2008-4#1)(2008-9#2)(2012-2#1)
to citrus##4##2##(2008-10#3)(2008-5#1)
to claim##2##2##(1990-11#1)(2008-12#1)
to clarify its##2##3##(2008-10#1)(2008-2#1)
to clarify mechanisms##2##3##(1994-9#1)(2008-3#1)
to clarify some##2##3##(2007-12#1)(2008-12#1)
to clarify the definition##2##4##(1993-2#1)(2008-1#1)
to clarify the effect of##2##5##(2008-6#1)(2013-8#1)
to clarify the effects of##3##5##(2010-12#1)(2011-2#1)(2012-3#1)
to clarify the functional##2##4##(1992-3#1)(1994-9#1)
to clarify the mechanism by which##2##6##(1993-3#1)(2008-5#1)
to clarify the mechanism of##3##5##(2007-10#1)(2009-7#1)(2011-2#1)
to clarify the mechanism##5##4##(1993-3#1)(2007-10#1)(2008-5#1)(2009-7#1)(2011-2#1)
to clarify the mechanisms##3##4##(1993-11#1)(2008-11#1)(2011-2#1)
to clarify the relationship between##3##5##(1991-12#1)(2008-9#1)(2009-11#1)
to clarify the relationship##4##4##(1991-12#1)(2008-9#1)(2009-11#1)(2013-8#1)
to clarify the role of the##3##6##(1991-2#1)(2007-8#1)(2008-4#1)
to clarify the role of##6##5##(1991-12#1)(1991-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
to clarify the role##7##4##(1991-12#1)(1991-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
to clarify the situation##2##4##(2008-4#1)(2012-2#1)
to clarify the##57##3##(1991-12#2)(1991-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#5)
to clarify this issue##2##4##(2007-10#1)(2008-9#1)
to clarify this##4##3##(2007-10#2)(2008-9#1)(2009-5#1)
to clarify whether the##2##4##(2007-10#1)(2008-1#1)
to clarify whether##8##3##(1991-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-8#1)
to clarify##88##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-8#1)(2007-10#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-8#5)
to clarithromycin##2##2##(2012-12#2)
to class II MHC##4##4##(1993-3#3)(1993-6#1)
to class II##5##3##(1993-3#3)(1993-6#2)
to class##8##2##(1993-3#3)(1993-6#2)(2007-8#1)(2008-4#1)(2013-7#1)
to classical##14##2##(1993-6#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-9#2)(2010-7#2)(2012-2#1)
to classification##3##2##(2007-8#1)(2008-10#2)
to classify a##2##3##(1993-12#1)(2008-10#1)
to classify and##3##3##(2007-11#1)(2008-10#1)(2009-8#1)
to classify patients##2##3##(1997-3#1)(2013-8#1)
to classify the##7##3##(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2013-8#1)
to classify their##3##3##(1991-12#1)(1995-2#1)(2008-5#1)
to classify these##3##3##(1994-6#1)(1996-9#1)(2008-10#1)
to classify##53##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(2007-11#2)(2008-10#19)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
to clean the##2##3##(2007-8#1)(2012-3#1)
to clean up the##2##4##(1991-5#1)(2009-10#1)
to clean up##4##3##(1991-5#1)(1996-5#1)(2008-10#1)(2009-10#1)
to clean##12##2##(1991-5#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
to clear the##2##3##(2008-10#1)(2013-1#1)
to clear##6##2##(1991-8#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
to clearance of##2##3##(2008-8#1)(2012-12#1)
to clearly##5##2##(2008-10#1)(2008-7#1)(2008-9#2)(2012-3#1)
to cleavage##2##2##(1991-10#1)(2008-4#1)
to cleave the##3##3##(1991-10#1)(1991-9#1)(2008-8#1)
to cleave##7##2##(1991-10#1)(1991-12#1)(1991-9#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
to clients##2##2##(1996-3#1)(2010-5#1)
to climate change##8##3##(2008-8#4)(2008-9#1)(2009-12#1)(2012-12#1)(2012-7#1)
to climate##12##2##(2008-8#5)(2008-9#1)(2009-12#1)(2012-12#2)(2012-7#2)(2012-9#1)
to climatic##4##2##(1992-3#1)(2008-8#3)
to clinical and##2##3##(1994-1#1)(2011-1#1)
to clinical application##4##3##(1991-9#1)(2007-8#1)(2010-5#1)(2012-7#1)
to clinical data##2##3##(2008-5#1)(2011-2#1)
to clinical evaluation##2##3##(1990-2#1)(2008-5#1)
to clinical information##2##3##(1993-3#1)(2008-11#1)
to clinical interview##2##3##(2007-11#1)(2011-2#1)
to clinical laboratories##2##3##(2008-10#1)(2008-7#1)
to clinical outcomes##2##3##(1992-12#1)(2012-12#1)
to clinical practice##23##3##(1993-3#2)(1994-5#1)(1996-3#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-10#9)(2010-11#3)(2013-1#1)
to clinical trials##6##3##(1992-12#1)(1997-3#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-11#1)
to clinical##104##2##(1990-2#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#3)(1993-11#2)(1993-12#1)(1993-3#4)(1994-1#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-7#1)(2010-10#10)(2010-11#5)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
to clinically##5##2##(1997-1#1)(2008-3#1)(2008-4#2)(2008-7#1)
to clinicians##11##2##(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
to clone a##2##3##(1993-3#1)(1997-8#1)
to clone##9##2##(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
to cloning##2##2##(2008-10#1)(2008-8#1)
to clopidogrel##2##2##(2008-4#2)
to close the##7##3##(1992-3#1)(1993-12#1)(1996-3#1)(2008-11#1)(2009-11#1)(2010-10#1)(2010-12#1)
to close##14##2##(1992-3#2)(1993-12#1)(1994-9#1)(1996-3#1)(1997-7#1)(2008-11#3)(2008-5#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-8#1)
to closely##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)
to closure##2##2##(2008-11#1)(2012-12#1)
to clotrimazole##2##2##(2008-5#2)
to clozapine##2##2##(1995-3#1)(2008-9#1)
to cluster the##2##3##(2008-7#1)(2008-8#1)
to cluster##10##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)
to clustering##2##2##(2008-5#1)(2008-7#1)
to coagulase-negative##2##2##(1991-3#1)(2010-12#1)
to coat the##2##3##(2008-10#2)
to coat##3##2##(2008-10#3)
to coax##2##2##(1997-3#1)(2008-10#1)
to cocaine##10##2##(1990-7#1)(1991-1#3)(1991-5#1)(1996-12#1)(2008-11#1)(2010-11#1)(2011-2#2)
to cochlear implant##2##3##(2008-9#2)
to cochlear##7##2##(2008-9#6)(2012-2#1)
to code for##3##3##(1993-6#2)(2008-10#1)
to code the##3##3##(2007-11#1)(2008-3#2)
to code##7##2##(1990-3#1)(1993-6#2)(2007-11#1)(2008-10#1)(2008-3#2)
to coexist##5##2##(1995-5#2)(2008-8#2)(2008-9#1)
to coexistence##3##2##(2008-8#3)
to coffee production in Africa##2##5##(2008-10#2)
to coffee##4##2##(1993-9#1)(2008-10#2)(2008-5#1)
to cognate##2##2##(1991-2#1)(2012-2#1)
to cognitive and##2##3##(2008-5#1)(2009-4#1)
to cognitive##11##2##(1991-11#1)(1992-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-10#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
to cohere##2##2##(1991-7#2)
to coherence##2##2##(1991-7#1)(2008-3#1)
to coherent##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
to coincide with##4##3##(1993-11#1)(2007-12#1)(2008-11#2)
to coincide##5##2##(1993-11#1)(2007-12#1)(2008-11#2)(2009-10#1)
to cold##14##2##(1990-5#1)(1994-11#1)(1997-7#2)(2007-7#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#4)(2013-1#1)(2013-8#1)
to collaborate more##2##3##(2008-6#1)(2010-8#1)
to collaborate with the##2##4##(2008-11#1)(2013-1#1)
to collaborate with##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
to collaborate##7##2##(1995-3#1)(2008-11#1)(2008-6#2)(2010-8#1)(2012-12#1)(2013-1#1)
to collaborative##5##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
to collagen##6##2##(1990-12#1)(2008-11#1)(2008-8#4)
to collagen-coated##2##2##(2008-11#2)
to collagenase IV##3##3##(2008-8#3)
to collapse of the##3##4##(2008-11#1)(2008-8#1)(2009-3#1)
to collapse##7##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-3#1)(2012-12#1)(2012-3#1)
to collate##3##2##(1993-12#1)(2008-7#1)(2008-8#1)
to collect REL data##2##4##(2013-1#2)
to collect and analyze##3##4##(1997-1#1)(1997-3#1)(2011-2#1)
to collect and store##2##4##(2007-11#1)(2010-8#1)
to collect and##6##3##(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
to collect data about##2##4##(2007-11#1)(2011-2#1)
to collect data from##2##4##(1994-2#1)(2008-11#1)
to collect data on##2##4##(1992-11#1)(2007-11#1)
to collect data##14##3##(1992-11#1)(1992-2#1)(1994-2#1)(2007-11#2)(2007-2#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
to collect information##3##3##(1996-2#1)(2008-11#1)(2012-3#1)
to collect outcome information##2##4##(1995-3#1)(2008-6#1)
to collect preliminary data##3##4##(2008-10#1)(2008-8#1)(2010-3#1)
to collect standardized##2##3##(1993-2#1)(2013-1#1)
to collect the##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
to collect##70##2##(1992-11#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#2)(1997-3#2)(1997-5#1)(2007-11#4)(2007-2#1)(2008-10#10)(2008-11#7)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
to colloidal##2##2##(2008-10#1)(2008-7#1)
to colon##2##2##(1992-8#1)(1994-12#1)
to colonic##2##2##(2011-1#1)(2012-3#1)
to colonies##2##2##(1990-7#1)(2008-10#1)
to colonization and##2##3##(2008-10#2)
to colonization by##2##3##(2008-10#2)
to colonization##9##2##(1996-6#1)(2007-6#1)(2008-10#7)
to colonize the intestine##2##4##(2007-6#1)(2011-1#1)
to colonize the##6##3##(2007-6#2)(2008-10#3)(2011-1#1)
to colonize##9##2##(2007-6#2)(2008-10#5)(2008-8#1)(2011-1#1)
to colonoscopy##2##2##(1995-10#1)(2011-2#1)
to colorectal##3##2##(1995-9#1)(2009-12#2)
to colorimetric##2##2##(1992-9#1)(2007-12#1)
to colour##2##2##(2008-10#1)(2010-4#1)
to combat AIDS##2##3##(1990-11#1)(1991-2#1)
to combat the##6##3##(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#2)(2013-8#1)
to combat##32##2##(1990-11#1)(1991-12#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
to combination chemotherapy with##2##4##(1994-3#1)(1997-7#1)
to combination chemotherapy##3##3##(1994-3#1)(1997-7#1)(2008-7#1)
to combination##8##2##(1994-3#1)(1997-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-3#1)
to combine a##2##3##(1995-5#1)(2009-12#1)
to combine results from##2##4##(1996-3#1)(1997-8#1)
to combine the##7##3##(1995-5#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#2)
to combine these approaches##2##4##(2008-7#1)(2008-8#1)
to combine these two##2##4##(2007-12#1)(2009-12#1)
to combine these##4##3##(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)
to combine##30##2##(1992-3#1)(1993-2#1)(1995-5#2)(1996-3#1)(1996-6#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-9#1)(2011-1#1)(2013-1#4)
to combined##2##2##(2013-1#2)
to combustion toxicology##2##3##(1996-12#2)
to combustion##4##2##(1996-12#2)(2008-2#1)(2008-3#1)
to come from##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
to come to##5##3##(1995-2#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
to come together##2##3##(1996-12#1)(2010-11#1)
to come##28##2##(1990-11#1)(1991-8#1)(1993-2#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
to commence a##3##3##(1994-9#1)(2008-5#2)
to commence##4##2##(1992-9#1)(1994-9#1)(2008-5#2)
to comment alcoholaemia##2##3##(2011-2#2)
to comment##5##2##(2007-11#1)(2008-2#2)(2011-2#2)
to comments##2##2##(2007-11#2)
to commercial##14##2##(1996-3#2)(2008-10#10)(2010-3#1)(2011-1#1)
to commercialize##2##2##(2008-5#1)(2008-7#1)
to commercially available##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
to commercially##5##2##(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
to commit##4##2##(1996-9#1)(2008-10#1)(2012-12#2)
to common bean (Phaseolus vulgaris L##2##6##(2008-12#2)
to common bean (Phaseolus##3##4##(2008-10#1)(2008-12#2)
to common bean##4##3##(2008-10#2)(2008-12#2)
to common##27##2##(1990-5#1)(1992-1#1)(1992-9#1)(1994-12#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#2)
to commonly used##5##3##(1996-5#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
to commonly##7##2##(1996-5#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-3#1)
to communicate##20##2##(1992-2#1)(1993-2#1)(1994-3#1)(1995-1#1)(1997-5#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-8#1)
to communication and##4##3##(2008-10#1)(2011-1#2)(2013-1#1)
to community##16##2##(1994-1#3)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)
to community-based##2##2##(1993-12#1)(2010-3#1)
to comorbid##2##2##(2013-1#1)(2013-8#1)
to comparable##5##2##(1994-8#1)(1997-2#1)(2008-8#1)(2010-2#1)(2012-2#1)
to comparative##3##2##(2008-10#2)(2008-7#1)
to comparatively##3##2##(2008-9#1)(2011-1#1)(2012-2#1)
to compare and##4##3##(2008-10#2)(2008-9#1)(2013-7#1)
to compare both##3##3##(1994-5#1)(2007-8#1)(2010-8#1)
to compare clinical##4##3##(1997-8#1)(2008-12#1)(2011-2#1)(2012-12#1)
to compare data##3##3##(2008-10#1)(2013-7#1)(2013-8#1)
to compare differences##3##3##(1995-2#1)(2008-12#1)(2011-2#1)
to compare efficacy##2##3##(1990-9#1)(2008-3#1)
to compare its##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
to compare our##3##3##(1994-3#2)(2008-7#1)
to compare performance of##2##4##(2008-10#1)(2009-5#1)
to compare relative##2##3##(2008-10#1)(2011-2#1)
to compare the accuracy of##3##5##(2007-10#1)(2012-2#1)(2013-8#1)
to compare the cytological##2##4##(2008-10#1)(2013-8#1)
to compare the data##2##4##(1994-3#1)(2008-10#1)
to compare the distribution##2##4##(1992-11#1)(1995-5#1)
to compare the effect of##3##5##(2007-7#1)(2008-1#1)(2010-8#1)
to compare the effectiveness of##3##5##(1994-7#1)(1995-4#1)(2008-10#1)
to compare the effects of two##2##6##(1994-12#1)(2008-11#1)
to compare the effects of##3##5##(1994-12#1)(2008-11#1)(2013-1#1)
to compare the effects##4##4##(1994-12#1)(1994-5#1)(2008-11#1)(2013-1#1)
to compare the efficacy of##3##5##(1997-2#1)(2010-7#1)(2013-1#1)
to compare the efficacy##4##4##(1997-2#1)(2007-8#1)(2010-7#1)(2013-1#1)
to compare the efficiency of##2##5##(2008-5#1)(2012-3#1)
to compare the genetic##3##4##(2008-10#2)(2013-1#1)
to compare the influence##2##4##(2008-2#1)(2008-7#1)
to compare the performance##3##4##(2008-2#1)(2008-6#1)(2008-9#1)
to compare the prevalence of##2##5##(2008-8#1)(2011-2#1)
to compare the quality of##2##5##(1993-12#1)(2008-7#1)
to compare the results obtained##2##5##(2008-10#1)(2013-1#1)
to compare the results##8##4##(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-3#1)(2013-1#1)
to compare the safety and efficacy of##2##7##(1996-3#1)(2007-10#1)
to compare the safety and##3##5##(1996-3#1)(2007-10#1)(2012-2#1)
to compare the sensitivity##2##4##(1997-3#1)(2008-3#1)
to compare the signal intensity##2##5##(1996-2#1)(2008-7#1)
to compare the temporal##3##4##(1996-7#1)(2006-6#1)(2007-10#1)
to compare the use of##3##5##(2008-7#1)(2010-9#1)(2012-3#1)
to compare the##150##3##(1990-7#1)(1991-12#2)(1991-5#2)(1992-10#1)(1992-11#1)(1993-1#1)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-4#1)(1995-5#2)(1996-2#1)(1996-3#4)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#4)
to compare their##8##3##(1994-12#1)(2008-10#2)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#2)
to compare them##5##3##(1991-7#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
to compare these##5##3##(1992-10#1)(1996-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
to compare three##2##3##(2008-10#1)(2008-6#1)
to compare two##6##3##(1994-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
to compare with the##2##4##(2008-1#1)(2012-3#1)
to compare with##4##3##(2008-1#1)(2008-10#1)(2012-3#2)
to compare##295##2##(1990-2#1)(1990-7#2)(1990-9#1)(1991-12#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-3#1)(1993-1#1)(1993-12#5)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-4#1)(1995-5#3)(1996-12#1)(1996-2#2)(1996-3#5)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2006-6#1)(2007-10#5)(2007-11#4)(2007-7#5)(2007-8#7)(2008-1#2)(2008-10#34)(2008-11#4)(2008-12#8)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#14)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#5)(2011-2#17)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#9)(2013-1#19)(2013-7#2)(2013-8#7)
to comparing##4##2##(2008-11#2)(2008-4#2)
to compensate for seasonal##2##4##(2008-5#2)
to compensate for the##19##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to compensate for##38##3##(2007-11#7)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#11)(2008-5#3)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to compensate the##3##3##(1997-7#1)(2008-10#2)
to compensate##52##2##(1990-8#1)(1997-1#1)(1997-7#1)(2007-11#7)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#14)(2008-5#3)(2008-7#2)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to compensation##3##2##(1991-7#1)(1992-11#1)(2007-11#1)
to compete for##3##3##(1993-8#1)(1995-2#1)(2008-8#1)
to compete on##2##3##(1997-1#1)(2008-5#1)
to compete with##9##3##(1993-3#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
to compete##19##2##(1993-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#2)(2012-12#1)(2012-2#1)(2013-7#1)
to competition between##3##3##(1993-8#1)(2007-11#1)(2008-8#1)
to competition##8##2##(1993-8#1)(2007-11#2)(2008-10#1)(2008-8#2)(2008-9#1)(2012-2#1)
to competitive##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
to competitively##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
to compile##6##2##(1990-3#1)(1996-12#1)(1996-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
to complement a##3##3##(1995-5#1)(1996-3#1)(1996-6#1)
to complement the##9##3##(1993-12#1)(1994-12#1)(2008-10#3)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)
to complement this##2##3##(2007-11#1)(2008-7#1)
to complement##26##2##(1990-2#1)(1990-5#2)(1993-12#1)(1993-9#1)(1994-12#1)(1995-5#2)(1996-3#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
to complete a questionnaire in##2##5##(1992-12#1)(2008-7#1)
to complete a questionnaire##4##4##(1992-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
to complete a##9##3##(1990-11#1)(1992-12#1)(1997-2#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-7#1)
to complete loss of##2##4##(1994-3#1)(1995-6#1)
to complete recovery##2##3##(2006-10#1)(2009-7#1)
to complete the##18##3##(1996-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)
to complete##73##2##(1990-11#1)(1991-5#2)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)
to completely block##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
to completely##16##2##(1995-2#1)(1997-3#1)(2007-8#2)(2008-10#6)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#1)(2012-12#1)
to completion of the##2##4##(2008-6#1)(2010-3#1)
to completion of##4##3##(2008-6#1)(2010-3#1)(2010-4#1)(2011-1#1)
to completion##6##2##(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-1#1)
to complex##16##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2012-2#1)
to compliance##3##2##(2007-9#2)(2008-10#1)
to complications such as##2##4##(2009-5#1)(2012-2#1)
to complications##5##2##(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#2)
to comply with a##2##4##(2008-10#1)(2008-11#1)
to comply with the##6##4##(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(2008-1#1)(2013-1#1)
to comply with##10##3##(1993-2#2)(1993-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
to comply##11##2##(1993-2#2)(1993-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
to component##2##2##(2011-1#1)(2012-3#1)
to compose##2##2##(2008-2#1)(2012-3#1)
to composite##2##2##(2009-6#1)(2013-1#1)
to comprehend the##4##3##(2008-12#1)(2008-7#1)(2009-6#1)(2010-10#1)
to comprehend##6##2##(1996-3#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-1#1)
to comprehensive##4##2##(1993-3#1)(1995-1#1)(1997-2#1)(1997-7#1)
to comprehensively assess##2##3##(2008-10#1)(2012-3#1)
to comprehensively##4##2##(2008-10#1)(2008-6#1)(2010-11#1)(2012-3#1)
to compress the##3##3##(2007-12#2)(2013-1#1)
to compress##4##2##(2007-12#2)(2008-10#1)(2013-1#1)
to compression of the##3##4##(1992-9#1)(2007-8#1)(2008-7#1)
to compression of##4##3##(1992-9#1)(2007-8#1)(2008-7#1)(2012-12#1)
to compression##7##2##(1992-9#1)(1993-3#1)(2007-8#1)(2008-5#1)(2008-7#2)(2012-12#1)
to comprise##3##2##(1995-12#1)(2008-2#1)(2008-7#1)
to compromise the##2##3##(1996-12#1)(2010-9#1)
to compromise##5##2##(1990-5#1)(1996-12#1)(1997-5#1)(2009-5#1)(2010-9#1)
to compute a##3##3##(2008-2#1)(2008-6#1)(2009-9#1)
to compute and##2##3##(2008-4#1)(2008-7#1)
to compute the##22##3##(2008-10#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-3#1)
to compute##49##2##(2007-11#1)(2008-10#1)(2008-2#8)(2008-3#12)(2008-4#4)(2008-6#6)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
to computed tomography##2##3##(2008-11#1)(2008-7#1)
to computers##2##2##(1996-1#1)(2008-11#1)
to conceal##3##2##(1996-11#1)(1997-5#1)(2010-4#1)
to conceive of##3##3##(1995-3#1)(2009-9#1)(2010-8#1)
to conceive##7##2##(1994-7#1)(1995-3#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
to concentrate and separate##2##4##(2008-10#2)
to concentrate and##3##3##(2008-10#2)(2008-2#1)
to concentrate in the##2##4##(1990-12#1)(2011-2#1)
to concentrate the##2##3##(1995-2#1)(2007-12#1)
to concentrate##19##2##(1990-12#1)(1995-2#1)(1997-7#2)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)
to concentration of##5##3##(1992-3#1)(2008-10#4)
to concentration##10##2##(1992-3#1)(2008-10#9)
to concentrations of the##2##4##(2008-10#1)(2008-5#1)
to concentrations of##5##3##(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
to concern for##2##3##(1992-4#1)(2013-1#1)
to conclude a##2##3##(2008-10#1)(2010-12#1)
to conclude that the##3##4##(1993-8#1)(1995-3#1)(2008-10#1)
to conclude that##23##3##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-3#2)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#2)
to conclude##31##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-3#2)(1996-3#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#2)
to conclusions##2##2##(2009-9#1)(2012-1#1)
to conclusively document the##2##4##(2007-9#1)(2013-7#1)
to concurrent##3##2##(2008-10#2)(2008-8#1)
to concurrently##2##2##(2008-9#1)(2012-12#1)
to condition##2##2##(2008-10#2)
to conditions##3##2##(1997-2#1)(2008-5#1)(2009-10#1)
to conduct a##10##3##(1994-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#2)
to conduct an##3##3##(1996-12#1)(1997-8#1)(2009-6#1)
to conduct analyses##2##3##(1997-8#1)(2010-3#1)
to conduct research##3##3##(2008-1#1)(2009-6#1)(2010-10#1)
to conduct such##2##3##(1991-2#1)(2012-2#1)
to conduct##44##2##(1991-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#3)(2010-10#1)(2010-3#3)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
to conducting##4##2##(2008-1#1)(2008-10#2)(2009-11#1)
to confer a##2##3##(1993-11#1)(2008-10#1)
to confer resistance to##2##4##(2008-10#2)
to confer resistance##3##3##(2008-10#3)
to confer the##2##3##(2008-7#1)(2010-4#1)
to confer##25##2##(1991-1#1)(1991-2#1)(1992-7#1)(1993-11#1)(1993-8#2)(1994-12#2)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#1)
to confidently##4##2##(2008-10#1)(2008-4#1)(2011-2#1)(2013-7#1)
to configure##2##2##(2008-3#1)(2009-11#1)
to confine##2##2##(1996-2#1)(2007-12#1)
to confirm a##2##3##(1995-12#1)(2013-8#1)
to confirm and##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
to confirm its##5##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
to confirm or exclude##3##4##(1990-2#1)(2008-1#1)(2008-3#1)
to confirm or##7##3##(1990-2#1)(1991-11#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-9#1)
to confirm some##2##3##(2008-5#1)(2008-8#1)
to confirm that the##5##4##(2008-2#1)(2008-3#2)(2010-6#1)(2013-8#1)
to confirm that##12##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
to confirm the diagnosis of##3##5##(2008-11#1)(2008-5#1)(2008-7#1)
to confirm the diagnosis##15##4##(1990-9#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
to confirm the presence of##5##5##(1990-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
to confirm the stability of the##2##6##(1997-6#1)(2012-2#1)
to confirm the stability of##4##5##(1991-5#1)(1997-6#1)(2011-2#1)(2012-2#1)
to confirm the validity of##2##5##(1992-6#1)(2008-2#1)
to confirm the##63##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-7#1)(1996-12#1)(1996-8#1)(1997-6#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#2)
to confirm their##3##3##(2008-10#2)(2012-3#1)
to confirm these findings##5##4##(1994-10#1)(1997-4#1)(2008-4#1)(2009-7#1)(2011-2#1)
to confirm these results##2##4##(2006-8#1)(2011-2#1)
to confirm these##11##3##(1994-10#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#3)
to confirm this hypothesis##3##4##(1991-11#1)(2008-10#1)(2008-12#1)
to confirm this##7##3##(1990-5#1)(1991-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
to confirm whether the##2##4##(2008-10#2)
to confirm whether##3##3##(2008-10#3)
to confirm##141##2##(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2006-8#1)(2007-10#3)(2007-11#2)(2007-8#4)(2008-1#3)(2008-10#28)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
to conflict##2##2##(1994-6#1)(2008-8#1)
to conflicting##2##2##(1997-1#1)(2011-2#1)
to confocal##2##2##(2008-1#1)(2011-1#1)
to conform to the##2##4##(1992-9#1)(2008-11#1)
to conform to##4##3##(1991-12#1)(1992-9#1)(2008-11#1)(2012-2#1)
to conform##5##2##(1991-12#1)(1992-2#1)(1992-9#1)(2008-11#1)(2012-2#1)
to conformational##6##2##(1991-5#1)(1995-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
to confounding##3##2##(1992-3#1)(2008-7#1)(2008-9#1)
to confront##4##2##(1996-2#1)(2008-6#1)(2011-2#1)(2013-7#1)
to confusion##3##2##(1991-2#1)(1995-5#1)(2013-1#1)
to congenital limb deformity in humans##2##6##(2009-3#2)
to congenital##8##2##(1990-5#1)(1994-3#1)(2009-3#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
to conidial germination and##2##4##(2008-10#2)
to conidial germination##3##3##(2008-10#3)
to conidial inoculations##3##3##(2008-10#3)
to conidial##7##2##(2008-10#7)
to conjugal##3##2##(1993-6#1)(2008-2#2)
to conjugate##2##2##(1995-5#1)(2008-10#1)
to connect the##2##3##(2008-7#1)(2013-1#1)
to connect to##2##3##(2008-5#1)(2008-7#1)
to connect##9##2##(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
to conscious##2##2##(1995-12#1)(2007-9#1)
to consciousness##2##2##(1991-11#1)(2008-2#1)
to consent to##3##3##(1992-3#1)(2008-7#1)(2010-11#1)
to consent##4##2##(1992-3#1)(1995-5#1)(2008-7#1)(2010-11#1)
to conservative management##4##3##(1990-9#1)(2007-10#1)(2013-1#2)
to conservative treatment##4##3##(1993-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
to conservative##12##2##(1990-6#1)(1990-9#1)(1993-11#1)(1994-3#1)(2007-10#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#4)
to conserve##3##2##(1992-2#1)(2008-10#1)(2010-4#1)
to conserved##2##2##(1993-2#1)(2008-10#1)
to consider a##2##3##(2008-8#1)(2008-9#1)
to consider before##3##3##(1997-4#1)(2008-10#1)(2013-7#1)
to consider how##5##3##(1996-2#1)(2007-8#1)(2008-10#2)(2013-1#1)
to consider in##9##3##(1993-1#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2012-12#2)(2012-2#1)
to consider some##2##3##(1993-3#1)(2013-1#1)
to consider that##4##3##(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
to consider the role of##2##5##(2008-3#1)(2013-8#1)
to consider the##24##3##(1992-8#1)(1994-5#1)(1997-1#1)(1997-2#1)(2007-2#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#2)
to consider their##3##3##(1994-5#1)(2008-11#1)(2008-8#1)
to consider this##2##3##(2012-12#1)(2012-3#1)
to consider when##7##3##(1991-12#1)(1995-2#1)(2006-10#1)(2008-11#2)(2009-10#1)(2009-8#1)
to consider whether##2##3##(1991-12#1)(2008-12#1)
to considerable##7##2##(1990-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#2)
to considerably##2##2##(2008-11#1)(2009-4#1)
to consist of a##2##4##(1993-6#1)(2008-11#1)
to consist of two##2##4##(1991-10#1)(2008-3#1)
to consist of##11##3##(1991-10#1)(1993-6#1)(2008-10#5)(2008-11#1)(2008-3#3)
to consistent##2##2##(2008-7#1)(2008-9#1)
to consistently##9##2##(1995-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
to consolidate##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
to conspecific##2##2##(1995-12#1)(2010-8#1)
to constant##10##2##(1991-12#1)(1992-3#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)(2012-4#1)
to constantly##3##2##(1993-2#1)(2008-8#1)(2009-8#1)
to constitute a##6##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
to constitute the##4##3##(1995-12#1)(1995-8#1)(2008-1#1)(2008-10#1)
to constitute##12##2##(1990-5#1)(1995-12#1)(1995-8#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
to constitutively##2##2##(1993-12#1)(1995-12#1)
to constrain##5##2##(1991-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
to construct a library##2##4##(2008-4#1)(2011-1#1)
to construct a##45##3##(1990-7#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-3#2)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)
to construct an##10##3##(1991-8#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#1)(2010-1#1)(2010-5#1)
to construct and##4##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-3#1)
to construct molecular##2##3##(2008-10#1)(2008-9#1)
to construct the calibration##2##4##(2008-10#2)
to construct the##10##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)
to construct##113##2##(1990-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#2)(2006-12#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-2#7)(2008-3#9)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#5)(2009-12#2)(2009-2#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#4)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to construction##3##2##(1995-12#1)(2008-3#1)(2008-6#1)
to consult a##2##3##(2010-11#1)(2013-8#1)
to consult##7##2##(1994-11#1)(2008-11#2)(2008-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
to consume##10##2##(2007-12#1)(2008-10#2)(2008-9#1)(2012-2#1)(2013-1#3)(2013-7#2)
to consumer##6##2##(1991-3#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-8#1)(2013-1#1)
to consumers and##3##3##(1992-2#1)(1994-2#1)(1996-2#1)
to consumers##8##2##(1992-1#1)(1992-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-3#2)(2011-1#1)
to consumption##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
to contact with##5##3##(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
to contact##14##2##(1992-3#1)(1995-2#1)(2008-10#5)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
to contain a##6##3##(1990-5#1)(1991-1#1)(1992-12#1)(1993-9#1)(2008-10#1)(2008-11#1)
to contain an open reading frame##2##6##(1994-11#1)(2008-9#1)
to contain an##6##3##(1991-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-9#1)
to contain costs##5##3##(1991-1#1)(1992-12#1)(1994-3#2)(1996-2#1)
to contain detectable##2##3##(1992-11#1)(1992-12#1)
to contain some##2##3##(1997-3#1)(2008-12#1)
to contain the##13##3##(1991-12#1)(1991-5#2)(1991-6#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-2#1)
to contain two##4##3##(1990-5#1)(1993-11#1)(1993-8#1)(1995-6#1)
to contain##98##2##(1990-5#3)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-3#3)(1997-8#1)(2007-2#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
to contaminate##3##2##(1997-4#1)(2008-11#2)
to contaminated##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
to contamination##10##2##(1997-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)
to contemporary##8##2##(1993-3#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)(2013-7#1)
to content##3##2##(2008-12#1)(2008-2#2)
to contextual##2##2##(2008-4#1)(2013-1#1)
to continually##2##2##(2008-4#1)(2012-1#1)
to continue as##2##3##(1991-3#1)(2011-2#1)
to continue attendance##2##3##(2008-6#1)(2012-12#1)
to continue its##3##3##(1993-2#1)(2012-3#2)
to continue the##3##3##(1997-6#1)(2008-10#1)(2008-12#1)
to continue to make##2##4##(1994-2#1)(2010-3#1)
to continue to##16##3##(1992-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-5#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
to continue using##2##3##(1991-3#1)(2008-5#1)
to continue##64##2##(1991-1#1)(1991-12#1)(1991-3#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)
to continued##2##2##(1992-12#1)(2008-7#1)
to continuing##3##2##(1993-3#1)(2007-8#1)(2008-10#1)
to continuous improvement##2##3##(1995-1#1)(1995-3#1)
to continuous quality improvement##7##4##(1993-12#1)(1993-3#2)(1994-2#2)(1994-3#1)(1996-1#1)
to continuous##20##2##(1990-8#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-2#1)(2010-5#1)(2010-6#1)
to continuously generate##2##3##(2009-8#2)
to continuously##7##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#2)(2012-12#1)
to contract with##2##3##(1992-11#1)(1992-3#1)
to contract##7##2##(1992-11#1)(1992-3#1)(1992-4#1)(1995-6#1)(1997-7#1)(2009-1#1)(2011-2#1)
to contrast media##2##3##(1990-3#2)
to contrast##6##2##(1990-3#2)(2009-5#2)(2009-8#1)(2010-11#1)
to contrast-enhanced computed tomography##2##4##(2008-7#1)(2010-12#1)
to contribute significantly to the##2##5##(2008-3#1)(2011-2#1)
to contribute to a better understanding of##2##7##(1990-12#1)(2008-4#1)
to contribute to a##4##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
to contribute to disease##2##4##(2010-4#1)(2012-2#1)
to contribute to the development of##2##6##(2008-4#1)(2008-5#1)
to contribute to the##27##4##(1992-12#1)(1994-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
to contribute to their##2##4##(1991-9#1)(2008-11#1)
to contribute to these##2##4##(2008-5#1)(2012-12#1)
to contribute to##56##3##(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#3)(2008-9#4)(2009-12#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
to contribute##62##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#3)(2008-9#4)(2009-12#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#2)
to control Septoria##2##3##(2008-10#2)
to control a##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
to control access##2##3##(1997-1#1)(2012-2#1)
to control and##4##3##(1996-2#1)(2008-12#1)(2011-3#1)(2012-6#1)
to control because of##2##4##(2007-12#1)(2007-6#1)
to control biofilm formation##2##4##(2011-1#2)
to control bleeding##2##3##(2007-8#1)(2013-1#1)
to control blood##2##3##(1993-2#1)(2010-11#1)
to control blue##2##3##(2008-10#2)
to control cell##3##3##(2008-11#1)(2008-4#1)(2009-10#1)
to control cells##4##3##(1993-6#1)(1994-3#1)(1994-8#1)(2008-11#1)
to control costs##3##3##(1994-12#1)(1995-1#1)(1997-2#1)
to control for the##4##4##(1993-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
to control for##11##3##(1993-2#1)(1994-1#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#2)(2012-2#1)
to control fungal pathogens##2##4##(2008-10#2)
to control groups##3##3##(1995-1#1)(1995-12#1)(2008-7#1)
to control health care costs##2##5##(1994-12#1)(1994-2#1)
to control health care##3##4##(1994-12#1)(1994-2#1)(1997-2#1)
to control late blight##2##4##(2008-10#2)
to control levels after##2##4##(2007-11#1)(2008-7#1)
to control levels##12##3##(1991-5#2)(1994-5#1)(1995-12#2)(1995-3#1)(1996-12#2)(2007-11#1)(2008-6#1)(2008-7#1)(2010-5#1)
to control of##9##3##(1992-3#1)(1996-2#1)(2008-10#5)(2010-8#1)(2012-2#1)
to control or##3##3##(1995-3#1)(1997-7#1)(2007-10#1)
to control pain and improve##2##5##(2008-10#1)(2010-11#1)
to control pain##4##3##(2008-10#2)(2010-11#2)
to control perioperative bleeding##2##4##(2007-8#2)
to control plant diseases##2##4##(2008-10#2)
to control plants##2##3##(1997-6#1)(2008-10#1)
to control rats##2##3##(1993-12#1)(2008-7#1)
to control take-all of wheat##2##5##(2008-10#2)
to control the cost of##2##5##(1995-3#1)(2008-11#1)
to control the direction and##2##5##(2007-12#1)(2008-7#1)
to control the disease##4##4##(2008-10#1)(2011-2#2)(2012-3#1)
to control the effect of##2##5##(2008-10#1)(2008-11#1)
to control the movement of##2##5##(2008-10#1)(2009-2#1)
to control the output##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
to control the pH##2##4##(2008-10#2)
to control the pulmonary##2##4##(2007-8#1)(2008-11#1)
to control the rate##2##4##(2008-10#1)(2008-5#1)
to control the release##2##4##(2008-5#1)(2010-10#1)
to control the size##2##4##(2008-10#1)(2010-12#1)
to control the system and##2##5##(2008-10#2)
to control the##86##3##(1992-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#19)(2008-11#6)(2008-2#4)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
to control their##3##3##(1994-8#1)(2008-5#1)(2011-2#1)
to control this##2##3##(2008-10#1)(2011-1#1)
to control transgene##2##3##(2008-11#1)(2008-2#1)
to control values##6##3##(1991-5#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-8#1)(2013-1#1)
to control##327##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#2)(1995-12#7)(1995-2#1)(1995-3#3)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#6)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#6)(1997-4#1)(1997-6#2)(1997-7#3)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#6)(2008-1#2)(2008-10#64)(2008-11#13)(2008-12#3)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#14)(2011-3#1)(2012-12#4)(2012-2#11)(2012-3#4)(2012-6#1)(2012-8#1)(2013-1#9)(2013-8#3)
to controlled##3##2##(1993-12#1)(2008-4#1)(2008-6#1)
to controlling##3##2##(1994-1#1)(1997-1#1)(2008-11#1)
to controls with##3##3##(2008-11#1)(2008-5#1)(2010-4#1)
to controls##50##2##(1990-11#1)(1990-5#1)(1990-8#2)(1992-12#1)(1993-12#1)(1993-6#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#3)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
to conventional HPLC##2##3##(2008-10#2)
to conventional methods for##2##4##(2008-10#1)(2012-2#1)
to conventional methods##4##3##(2008-10#2)(2010-3#1)(2012-2#1)
to conventional radiography##2##3##(2010-3#1)(2013-1#1)
to conventional therapy##6##3##(1993-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
to conventional treatment##2##3##(2008-12#1)(2011-2#1)
to conventional##87##2##(1990-5#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-3#1)(1996-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-3#4)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
to conventionally##2##2##(1996-5#1)(2008-11#1)
to converge on a##2##4##(2008-9#1)(2009-6#1)
to convergent##2##2##(1997-7#1)(2011-2#1)
to conversion##2##2##(1995-8#1)(2007-11#1)
to convert O6-benzylguanine to guanine##2##5##(1995-5#2)
to convert the##8##3##(1995-11#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2011-2#1)
to convert##36##2##(1990-12#2)(1990-5#1)(1990-8#1)(1993-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-4#1)(2007-12#3)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
to convey##5##2##(1997-3#1)(1997-4#1)(2008-11#1)(2008-12#1)(2012-2#1)
to convince##2##2##(1991-5#1)(1997-7#1)
to cooperate with##4##3##(1990-2#1)(1996-2#1)(2009-10#1)(2011-1#1)
to cooperate##8##2##(1990-2#1)(1993-9#1)(1996-2#2)(2008-1#1)(2009-10#1)(2010-3#1)(2011-1#1)
to cooperative care##2##3##(1995-1#2)
to cooperative##3##2##(1995-1#2)(2008-8#1)
to coordinate the##5##3##(1992-1#1)(1995-5#1)(2009-10#1)(2009-6#1)(2012-2#1)
to coordinate##18##2##(1991-7#1)(1992-1#1)(1992-3#1)(1995-12#2)(1995-5#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#2)(2009-8#1)(2012-2#1)
to coordination of the##2##4##(1994-8#1)(1995-5#1)
to copABCD##2##2##(2008-10#2)
to cope and##2##3##(1995-9#1)(2009-5#1)
to cope in##2##3##(1992-3#1)(2010-10#1)
to cope more##2##3##(1997-8#1)(2013-1#1)
to cope with stress##3##4##(2007-2#1)(2009-12#1)(2010-10#1)
to cope with the##8##4##(1992-6#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)
to cope with##25##3##(1992-6#1)(1993-12#2)(1993-6#1)(1994-12#3)(2007-2#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#1)(2011-2#2)(2013-8#1)
to cope##35##2##(1992-3#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-12#3)(1995-9#1)(1996-1#1)(1996-8#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#2)(2010-10#4)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
to coping##2##2##(1994-2#1)(2010-1#1)
to copper and##2##3##(2008-10#1)(2013-8#1)
to copper##7##2##(1995-11#1)(2008-10#4)(2011-2#1)(2013-8#1)
to corn##5##2##(2008-10#3)(2011-2#2)
to coronary heart disease##2##4##(1991-12#1)(1991-6#1)
to coronary##8##2##(1991-12#1)(1991-6#1)(1997-8#1)(2007-8#1)(2008-11#2)(2010-9#1)(2012-2#1)
to correct for the##8##4##(1991-3#1)(2008-11#1)(2008-2#2)(2008-3#4)
to correct for variations in the##2##6##(2007-11#1)(2008-1#1)
to correct for##18##3##(1991-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2009-8#1)(2011-1#1)
to correct the phase##2##4##(2008-2#1)(2008-3#1)
to correct the##17##3##(1992-8#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2009-10#1)(2012-2#1)
to correct##74##2##(1990-9#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-12#2)(1997-1#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#9)(2008-3#23)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#2)(2012-2#3)(2013-1#1)(2013-8#1)
to correction##2##2##(1997-5#1)(2007-11#1)
to corrective##2##2##(2008-9#1)(2011-1#1)
to correctly identify##2##3##(2010-3#1)(2013-1#1)
to correctly##11##2##(1993-12#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#2)
to correlate the##4##3##(2008-2#1)(2008-6#1)(2012-9#1)(2013-8#1)
to correlate these##3##3##(1992-12#1)(2008-5#1)(2010-8#1)
to correlate this##2##3##(2008-10#2)
to correlate with the risk of##2##6##(2008-9#1)(2009-12#1)
to correlate with the##5##4##(1992-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
to correlate with##23##3##(1992-6#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#3)(2013-1#1)(2013-7#1)
to correlate##53##2##(1990-8#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
to correspond to the##2##4##(2008-10#1)(2008-3#1)
to correspond to those##2##4##(1994-5#1)(2008-10#1)
to correspond to##12##3##(1991-11#2)(1994-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-11#1)
to correspond##13##2##(1991-11#2)(1994-5#1)(2008-10#6)(2008-11#2)(2008-3#1)(2009-11#1)
to corresponding##5##2##(1993-9#1)(2008-3#2)(2008-4#1)(2010-4#1)
to corroborate these results##2##4##(2008-10#1)(2008-2#1)
to corroborate##7##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-7#1)
to corticosteroid##3##2##(2007-7#1)(2008-1#1)(2008-9#1)
to cortisol##3##2##(1997-1#1)(2008-5#1)(2010-2#1)
to cosmetic##3##2##(2008-5#3)
to cosmetics##3##2##(2007-7#2)(2008-5#1)
to cost savings##2##3##(1995-2#1)(2010-8#1)
to cost##11##2##(1991-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-2#1)(2008-7#1)(2010-8#2)
to cost-effective##2##2##(1993-12#1)(2008-10#1)
to costs##2##2##(2009-10#1)(2012-12#1)
to cotton##6##2##(2008-10#4)(2011-2#2)
to counsel##4##2##(1990-6#1)(2008-11#1)(2013-1#2)
to counseling##2##2##(2008-3#1)(2008-7#1)
to count##3##2##(2008-6#1)(2008-9#1)(2011-1#1)
to counter the##2##3##(2008-2#1)(2008-5#1)
to counter##5##2##(1994-6#1)(1996-8#1)(2008-2#1)(2008-5#1)(2008-6#1)
to counteract the##5##3##(1990-9#1)(1994-11#1)(2008-10#2)(2008-4#1)
to counteract##9##2##(1990-9#1)(1994-11#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
to countries with##2##3##(2007-2#1)(2008-1#1)
to countries##3##2##(2007-2#1)(2008-1#1)(2011-2#1)
to country##4##2##(1993-2#1)(1994-1#1)(2008-10#1)(2008-7#1)
to couple light##2##3##(2008-2#1)(2010-5#1)
to couple the##4##3##(2008-10#2)(2008-2#2)
to couple##16##2##(1997-4#1)(2008-10#3)(2008-2#3)(2008-3#2)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#4)
to coupling##2##2##(1992-3#1)(2008-10#1)
to court##2##2##(1994-2#1)(1995-12#1)
to covalent binding of##2##4##(1990-7#1)(2012-12#1)
to covalent##4##2##(1990-7#1)(1993-11#1)(2009-9#1)(2012-12#1)
to covalently##2##2##(1990-2#1)(2008-10#1)
to cover a##3##3##(2008-2#1)(2009-10#1)(2011-2#1)
to cover more than##2##4##(1996-10#2)
to cover the defect##2##4##(2011-2#2)
to cover the whole##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
to cover the##19##3##(1990-2#1)(1992-3#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#2)
to cover##34##2##(1990-2#1)(1991-2#2)(1992-3#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-10#2)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#3)
to cows##2##2##(2012-2#2)
to cranial vault##2##3##(2007-12#2)
to cranial##4##2##(1996-8#1)(2007-12#2)(2008-9#1)
to create a new##5##4##(1991-1#1)(1992-1#1)(1996-3#1)(2008-11#1)(2008-5#1)
to create a set of##2##5##(2008-3#2)
to create a thin##2##4##(2007-12#1)(2008-10#1)
to create a##50##3##(1991-1#1)(1992-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#4)(2011-9#2)(2013-1#2)(2013-8#1)
to create an##8##3##(1991-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-10#1)(2012-2#1)
to create and##8##3##(1991-12#1)(1992-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)
to create awareness among##3##4##(2008-7#1)(2012-3#1)(2013-8#1)
to create awareness##6##3##(1992-12#1)(1997-6#1)(2007-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
to create functional##2##3##(2008-10#1)(2010-4#1)
to create models##2##3##(2010-4#1)(2010-8#1)
to create new##4##3##(1996-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
to create scale##2##3##(2008-8#1)(2009-11#1)
to create social##2##3##(2008-11#1)(2010-12#1)
to create such##2##3##(2008-7#1)(2010-10#1)
to create the##11##3##(1991-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#2)(2009-8#1)(2012-2#1)
to create two##2##3##(2008-1#1)(2008-10#1)
to create##174##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#3)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#18)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-4#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2011-9#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
to creatine##2##2##(1993-11#1)(2008-5#1)
to creating##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
to creatinine ratio##4##3##(2008-5#1)(2012-2#1)(2013-1#2)
to creatinine##5##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#2)
to criminal##2##2##(2008-11#1)(2011-2#1)
to criterion and##2##3##(1993-3#1)(2011-2#1)
to criterion##4##2##(1991-2#1)(1993-3#1)(2011-2#2)
to critical incidents##2##3##(2008-11#1)(2012-1#1)
to critical##12##2##(1992-12#1)(1993-3#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-11#1)(2012-1#2)(2012-12#1)
to critically review the##2##4##(2008-11#1)(2009-7#1)
to critically##10##2##(1992-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#2)
to criticism##2##2##(1991-6#1)(2008-5#1)
to crop productivity##2##3##(2008-10#1)(2011-2#1)
to crop##8##2##(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
to crops##3##2##(2008-10#1)(2012-2#2)
to cross the##5##3##(2007-12#1)(2008-10#1)(2009-8#2)(2011-2#1)
to cross##11##2##(1992-12#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-8#2)(2011-2#1)(2013-1#1)
to cross-link##5##2##(1993-11#3)(1995-12#1)(2008-2#1)
to cross-react with##2##3##(1997-1#1)(2008-7#1)
to cross-resistance##2##2##(2008-10#1)(2011-2#1)
to crosslinking##2##2##(2008-10#1)(2012-2#1)
to crown rust were##2##4##(2008-10#2)
to crown rust##4##3##(2008-10#4)
to crown-7##2##2##(2008-10#2)
to crown-8##2##2##(2008-10#2)
to crystalline silica##2##3##(2009-12#2)
to crystalline##4##2##(2009-12#2)(2010-6#2)
to cucumber##2##2##(2008-10#2)
to cues of##2##3##(2009-9#1)(2010-8#1)
to cues which##2##3##(1993-6#1)(1995-5#1)
to cues##4##2##(1993-6#1)(1995-5#1)(2009-9#1)(2010-8#1)
to cultivar##3##2##(2008-10#2)(2011-10#1)
to cultivars##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
to cultivate##6##2##(2008-11#1)(2008-12#2)(2008-2#1)(2010-4#1)(2013-1#1)
to cultivated##3##2##(2008-10#2)(2008-12#1)
to cultural##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
to culture and##2##3##(1995-12#1)(2008-4#1)
to culture the##3##3##(1992-5#2)(2008-10#1)
to culture##13##2##(1992-11#1)(1992-5#2)(1993-2#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#2)
to cultured endothelial##2##3##(1994-5#1)(2008-1#1)
to cultured mammalian cells##2##4##(2008-9#1)(2012-3#1)
to cultured##12##2##(1990-2#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
to cultures of##2##3##(1993-9#1)(2008-11#1)
to cultures##4##2##(1990-11#1)(1993-9#1)(2008-10#1)(2008-11#1)
to cumulative##6##2##(2008-10#4)(2008-5#1)(2008-6#1)
to curb the##2##3##(1997-5#1)(2010-5#1)
to curb##3##2##(1997-5#1)(2010-5#1)(2013-1#1)
to cure CML##2##3##(2010-4#2)
to cure the##2##3##(1995-8#1)(2012-3#1)
to cure##14##2##(1993-2#1)(1995-8#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-4#2)(2012-12#1)(2012-3#2)(2013-1#1)
to current and future##2##4##(2008-10#1)(2012-1#1)
to current reproduction##3##3##(2008-8#3)
to current therapy##2##3##(2009-5#1)(2010-1#1)
to current work##2##3##(2008-11#1)(2008-12#1)
to current##30##2##(1994-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#4)
to currently available##3##3##(2008-4#1)(2008-5#1)(2010-5#1)
to currently##7##2##(1990-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#1)
to curtail##2##2##(1997-3#1)(2008-10#1)
to customer##3##2##(1994-2#2)(1995-2#1)
to customers##4##2##(1995-12#1)(1995-3#1)(1997-3#1)(2007-5#1)
to customize##2##2##(1993-11#1)(2007-3#1)
to cut costs and##2##4##(1995-1#1)(1996-3#1)
to cut costs##5##3##(1990-4#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-9#1)
to cut##11##2##(1990-4#2)(1991-9#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
to cutaneous##3##2##(2007-7#1)(2008-5#1)(2008-7#1)
to cw##2##2##(2007-12#1)(2008-2#1)
to cyclic##8##2##(1991-9#1)(1994-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-7#2)(2010-4#1)
to cyclists##3##2##(1990-6#3)
to cyclophosphamide##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
to cypermethrin##2##2##(2008-12#2)
to cyromazine##2##2##(2011-2#2)
to cyst##2##2##(1995-2#1)(2006-10#1)
to cystamine to##2##3##(2011-2#2)
to cysteine##6##2##(1991-5#1)(1992-8#2)(1993-11#1)(1994-8#1)(2008-10#1)
to cystic##2##2##(1992-9#1)(2012-2#1)
to cytochrome P450##3##3##(1990-5#1)(1994-8#2)
to cytochrome c##4##3##(1995-2#3)(2008-10#1)
to cytochrome##11##2##(1990-3#2)(1990-5#1)(1994-5#1)(1994-8#2)(1995-2#3)(2008-10#2)
to cytokine##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
to cytokine-induced##2##2##(2010-11#1)(2011-1#1)
to cytokines##3##2##(1990-2#1)(2008-4#1)(2010-11#1)
to cytoplasm##2##2##(1991-2#1)(1997-7#1)
to cytoplasmic##4##2##(1990-7#1)(2008-10#2)(2008-9#1)
to cytosine##2##2##(1991-12#1)(1991-2#1)
to cytotoxic agents##2##3##(2008-11#1)(2010-9#1)
to cytotoxic drugs##2##3##(2008-11#2)
to cytotoxic##7##2##(2008-11#4)(2008-7#1)(2010-9#1)(2013-1#1)
to d-lactic acid##2##3##(2008-11#2)
to dACT##2##2##(2008-9#2)
to daily activities##2##3##(2009-6#1)(2009-8#1)
to daily##8##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#2)
to damage by##2##3##(1994-12#1)(1994-2#1)
to damage in##2##3##(1996-12#1)(2008-10#1)
to damage the##3##3##(1990-5#1)(1996-1#1)(1996-2#1)
to damage to##2##3##(1992-11#1)(1993-6#1)
to damage##19##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
to damaged##2##2##(1994-9#1)(1995-2#1)
to damaging##2##2##(1992-12#1)(2013-1#1)
to dark brown##2##3##(2008-10#2)
to dark skin##2##3##(2008-11#1)(2008-5#1)
to dark##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
to dasatinib##2##2##(2012-2#2)
to data analysis##3##3##(1996-6#1)(2008-12#1)(2008-4#1)
to data describing##2##3##(2008-10#2)
to data from a##2##4##(1997-3#2)
to data from the##3##4##(1997-3#1)(1997-8#1)(2009-7#1)
to data from##10##3##(1997-2#1)(1997-3#3)(1997-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)
to data of##2##3##(1993-1#1)(2012-3#1)
to data on##4##3##(1995-3#1)(1997-7#1)(2008-8#1)(2008-9#1)
to data##50##2##(1991-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-3#4)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#2)
to date a##2##3##(2007-12#1)(2007-8#1)
to date and##5##3##(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)
to date are##4##3##(1995-8#1)(1997-3#1)(2009-3#1)(2012-2#1)
to date for##3##3##(2007-11#1)(2009-12#1)(2010-8#1)
to date from##4##3##(1993-11#1)(1997-5#1)(2008-2#2)
to date have been##3##4##(1995-2#1)(2008-10#1)(2010-8#1)
to date have not##2##4##(2008-12#1)(2011-2#1)
to date have##12##3##(1995-12#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
to date in##7##3##(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
to date is##2##3##(1997-9#1)(2012-1#1)
to date most##2##3##(2008-7#1)(2008-8#1)
to date no##2##3##(2008-5#1)(2009-2#1)
to date of##2##3##(2008-4#1)(2013-1#1)
to date on the##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
to date on##5##3##(2007-11#1)(2008-10#2)(2008-4#1)(2012-2#1)
to date there has been##2##5##(1992-1#1)(2008-8#1)
to date there have been no##2##6##(2008-7#1)(2010-12#1)
to date there##4##3##(1992-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
to date##171##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-7#2)(1997-9#1)(2006-10#1)(2007-11#7)(2007-12#4)(2007-8#1)(2008-1#4)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
to date)##2##2##(1993-9#1)(2013-1#1)
to daughter cells##2##3##(2008-9#1)(2009-3#1)
to day 14##2##3##(2008-8#1)(2011-2#1)
to day 6##3##3##(1995-2#1)(1997-4#1)(2010-7#1)
to day##22##2##(1993-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-7#4)(2011-2#1)(2012-3#1)
to deal with a##3##4##(2006-10#1)(2008-3#2)
to deal with many of the##2##6##(1996-1#1)(2008-10#1)
to deal with students##2##4##(2008-11#1)(2012-3#1)
to deal with the problem##2##5##(2008-4#1)(2012-3#1)
to deal with the##13##4##(1990-4#1)(1994-2#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-5#1)(2012-3#1)
to deal with these problems##2##5##(2008-2#1)(2010-10#1)
to deal with these##5##4##(1996-1#1)(2008-11#2)(2008-2#1)(2010-10#1)
to deal with this problem##2##5##(2007-10#1)(2008-6#1)
to deal with this##4##4##(1993-6#1)(2007-10#1)(2008-6#1)(2012-2#1)
to deal with##60##3##(1990-4#1)(1991-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
to deal##64##2##(1990-4#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
to dealing with##3##3##(1995-2#2)(2008-10#1)
to death due to##2##4##(2009-4#1)(2011-2#1)
to death within##2##3##(1997-3#1)(2012-3#1)
to death##24##2##(1990-11#1)(1991-12#1)(1992-10#1)(1995-1#1)(1995-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#3)(2009-4#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)
to debate##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
to decay##2##2##(2008-10#2)
to decentralize##3##2##(2012-3#2)(2013-1#1)
to decentralized##2##2##(1992-12#1)(1994-2#1)
to decide on the##5##4##(1991-3#1)(1993-6#1)(1995-2#1)(2006-10#1)(2009-8#1)
to decide on##6##3##(1991-3#1)(1993-6#1)(1995-2#1)(2006-10#1)(2007-11#1)(2009-8#1)
to decide the##5##3##(1992-4#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)
to decide whether the##2##4##(1993-2#1)(2008-11#1)
to decide whether##9##3##(1993-2#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-1#1)(2012-2#1)
to decide##28##2##(1991-3#1)(1992-4#1)(1993-2#1)(1993-6#1)(1995-2#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#2)
to decipher the##4##3##(1997-9#1)(2008-10#1)(2008-5#1)(2009-8#1)
to decipher##7##2##(1997-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)
to decision makers##2##3##(1996-1#1)(2008-9#1)
to decision##4##2##(1993-12#1)(1996-1#1)(2007-8#1)(2008-9#1)
to decisions##2##2##(2008-10#1)(2008-11#1)
to decline in the##3##4##(1997-2#1)(2011-2#2)
to decline##12##2##(1990-2#1)(1995-12#1)(1997-2#2)(1997-6#1)(2008-10#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
to declining##2##2##(1992-3#1)(2008-1#1)
to decode a##2##3##(2008-2#1)(2008-3#1)
to decode the##2##3##(2007-12#1)(2008-3#1)
to decode##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
to decompose##7##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
to deconstruct##2##2##(2010-12#1)(2012-3#1)
to decorrelation##2##2##(2007-12#1)(2008-2#1)
to decouple##2##2##(2008-10#1)(2011-1#1)
to decrease as##2##3##(2008-10#1)(2009-5#1)
to decrease cardiovascular##2##3##(2012-2#1)(2012-3#1)
to decrease from##2##3##(2008-6#1)(2008-8#1)
to decrease hot flashes##2##4##(2008-7#2)
to decrease in the##4##4##(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
to decrease in##11##3##(1992-6#1)(1994-12#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-6#1)(2011-2#1)
to decrease morbidity##2##3##(2008-4#1)(2008-7#1)
to decrease the detection limit##3##5##(2008-10#3)
to decrease the incidence of##3##5##(1993-3#1)(2011-2#2)
to decrease the incidence##4##4##(1993-3#1)(2008-10#1)(2011-2#2)
to decrease the number of##3##5##(2011-2#2)(2012-3#1)
to decrease the rate of##3##5##(2010-4#1)(2011-1#1)(2011-2#1)
to decrease the risk of##7##5##(1990-6#1)(1991-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)
to decrease the##48##3##(1990-5#1)(1990-6#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
to decrease their##2##3##(2008-12#1)(2008-2#1)
to decrease with the##2##4##(2008-10#1)(2008-3#1)
to decrease with##7##3##(1996-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)
to decrease##139##2##(1990-2#1)(1990-5#4)(1990-6#1)(1991-2#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#11)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
to decreased availability of##2##4##(2008-6#1)(2013-7#1)
to decreased##16##2##(1991-10#2)(1994-5#1)(1996-12#3)(1997-7#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#2)(2010-1#1)(2011-1#1)(2013-1#1)(2013-7#1)
to decreasing##4##2##(1994-5#1)(2008-1#1)(2009-8#1)(2010-7#1)
to dedifferentiate##2##2##(2008-11#1)(2008-9#1)
to deduce the##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)
to deduce##16##2##(1993-2#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-7#1)
to deep##5##2##(1992-3#1)(1993-12#2)(2012-3#1)(2013-8#1)
to deepen##4##2##(1997-5#1)(2008-10#1)(2009-10#1)(2013-7#1)
to defects##3##2##(2007-10#1)(2008-1#1)(2008-3#1)
to defend against##2##3##(1997-5#1)(2008-2#1)
to defend themselves against##2##4##(1993-3#1)(1997-5#1)
to defend themselves##4##3##(1993-3#1)(1997-5#2)(2008-10#1)
to defend##7##2##(1993-3#1)(1997-5#3)(2008-10#1)(2008-2#1)(2008-5#1)
to defense and##2##3##(2008-8#1)(2009-8#1)
to deficiencies##2##2##(1996-2#1)(2007-10#1)
to define a##10##3##(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
to define and##5##3##(1996-12#1)(1997-3#1)(2008-9#1)(2011-2#2)
to define its role##3##4##(1994-3#1)(1996-12#1)(2008-10#1)
to define its##4##3##(1994-3#1)(1996-12#1)(2008-10#2)
to define more##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
to define specific##2##3##(1990-11#1)(2013-8#1)
to define the best##2##4##(1992-9#1)(2007-12#1)
to define the role of##6##5##(1990-12#1)(1993-11#1)(1993-3#1)(1995-2#1)(2007-11#1)(2009-3#1)
to define the role##7##4##(1990-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1995-2#1)(2007-11#1)(2009-3#1)
to define the severity of##2##5##(2009-5#1)(2013-1#1)
to define the##65##3##(1990-12#2)(1991-1#1)(1991-5#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#2)(1994-6#1)(1995-2#3)(1995-5#1)(1996-2#2)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#4)
to define whether##2##3##(2008-3#1)(2013-7#1)
to define##149##2##(1990-11#1)(1990-12#3)(1991-1#1)(1991-12#2)(1991-5#2)(1992-12#3)(1992-6#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1997-3#2)(1997-8#1)(2007-11#4)(2007-12#3)(2007-7#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#1)
to defined##6##2##(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
to defining##3##2##(1991-6#1)(1997-1#1)(1997-4#1)
to definitely##2##2##(1994-5#1)(2008-4#1)
to deform##3##2##(2009-7#2)(2010-5#1)
to degenerate##2##2##(1992-12#1)(2007-12#1)
to degenerative##2##2##(1997-6#1)(2008-12#1)
to deglycosylated##2##2##(1990-8#1)(1991-12#1)
to degradation by##2##3##(1993-3#1)(1995-8#1)
to degradation##10##2##(1990-5#1)(1993-3#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
to degrade##17##2##(1990-2#1)(1990-8#1)(1992-9#1)(1995-11#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-6#2)(2010-7#1)(2011-2#2)(2012-12#1)
to delay or##5##3##(1994-5#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)
to delay the##6##3##(1990-3#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
to delay##20##2##(1990-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-5#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#2)
to delayed##12##2##(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
to delays##2##2##(2008-5#1)(2009-8#1)
to delete##3##2##(2008-4#1)(2008-8#2)
to delimit the##2##3##(2008-10#1)(2012-12#1)
to delimit##4##2##(2008-10#2)(2010-9#1)(2012-12#1)
to delineate the##5##3##(1990-6#1)(1996-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
to delineate##13##2##(1990-3#1)(1990-6#1)(1996-1#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
to deliver a##9##3##(1996-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-2#2)
to deliver and##3##3##(2008-3#1)(2008-8#1)(2010-10#1)
to deliver genes##2##3##(2008-4#1)(2008-7#1)
to deliver high quality##2##4##(1994-3#1)(1997-1#1)
to deliver high##3##3##(1994-3#1)(1997-1#2)
to deliver the##8##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-12#1)
to deliver therapy##2##3##(2009-10#1)(2011-2#1)
to deliver throughputs in##2##4##(2008-7#2)
to deliver##91##2##(1991-1#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-1#3)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-9#1)(2010-10#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#2)
to delivered##2##2##(2007-12#1)(2008-6#1)
to delivering##2##2##(2008-7#1)(2013-1#1)
to delivery of##2##3##(1994-3#1)(2011-1#1)
to delivery##6##2##(1994-3#1)(1995-8#1)(1996-3#1)(2007-12#1)(2011-1#1)(2012-2#1)
to demand##4##2##(1990-9#1)(1995-12#1)(1997-1#1)(2008-11#1)
to dementia##5##2##(1996-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
to demethylation inhibitor fungicides##2##4##(2008-10#2)
to demodulate##4##2##(2008-3#4)
to demographic variables##2##3##(1996-9#1)(2012-2#1)
to demographic##5##2##(1996-9#1)(1997-5#1)(1997-6#1)(2009-5#1)(2012-2#1)
to demonstrate a##8##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-11#1)(1995-5#1)(2007-11#1)(2008-7#1)(2012-3#1)
to demonstrate an association between##2##5##(2008-3#1)(2012-3#1)
to demonstrate an##7##3##(1994-6#1)(1997-4#1)(2007-12#1)(2008-3#2)(2008-7#1)(2012-3#1)
to demonstrate different##2##3##(1991-2#1)(2008-3#1)
to demonstrate how##7##3##(1991-2#1)(1992-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)
to demonstrate its potential##2##4##(2007-12#1)(2008-3#1)
to demonstrate its##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
to demonstrate statistically##2##3##(1997-5#1)(2008-1#1)
to demonstrate that PptT##2##4##(2013-1#2)
to demonstrate that a##2##4##(1990-5#1)(2008-10#1)
to demonstrate that the##10##4##(1991-3#1)(1997-1#1)(1997-4#1)(2008-10#4)(2010-11#1)(2012-2#1)(2012-3#1)
to demonstrate that##36##3##(1990-5#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-12#1)(1994-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
to demonstrate the antibacterial##2##4##(2008-5#2)
to demonstrate the applicability##2##4##(2008-10#1)(2008-3#1)
to demonstrate the capability of the##2##6##(2008-10#1)(2008-2#1)
to demonstrate the capability##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
to demonstrate the concept##2##4##(2008-2#1)(2008-3#1)
to demonstrate the effect of##2##5##(2008-7#1)(2012-2#1)
to demonstrate the effects of##2##5##(1990-8#1)(1995-5#1)
to demonstrate the efficacy of##2##5##(2008-8#2)
to demonstrate the feasibility of the##4##6##(2008-11#1)(2008-3#2)(2011-2#1)
to demonstrate the feasibility of##11##5##(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
to demonstrate the high##2##4##(2008-10#2)
to demonstrate the performance of the##2##6##(2008-10#2)
to demonstrate the performance of##3##5##(2008-10#2)(2008-3#1)
to demonstrate the potential of##2##5##(2007-12#1)(2008-3#1)
to demonstrate the potential##4##4##(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)
to demonstrate the presence of##2##5##(2007-12#1)(2013-8#1)
to demonstrate the reliability##2##4##(2008-10#1)(2012-3#1)
to demonstrate the use of##3##5##(1995-2#1)(2008-11#1)(2009-8#1)
to demonstrate the usefulness of this##2##6##(2008-10#1)(2011-1#1)
to demonstrate the validity##2##4##(2008-10#1)(2008-3#1)
to demonstrate the##91##3##(1990-5#2)(1990-8#1)(1994-11#2)(1995-2#2)(1995-5#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#13)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to demonstrate their##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
to demonstrate whether##2##3##(2008-10#1)(2008-9#1)
to demonstrate##211##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#2)(1994-6#1)(1995-12#2)(1995-2#3)(1995-5#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#7)(2008-12#4)(2008-2#7)(2008-3#21)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#6)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#2)
to denaturation##3##2##(1990-8#1)(2008-3#1)(2008-4#1)
to density##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
to dental caries##2##3##(2007-7#1)(2008-9#1)
to dental treatment##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
to dental##10##2##(1990-5#1)(1991-6#1)(2007-7#1)(2008-1#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
to dentin##2##2##(1990-2#1)(2013-1#1)
to deny##6##2##(1991-2#1)(1994-12#1)(2006-10#1)(2008-12#1)(2009-11#1)(2012-3#1)
to depend on a##2##4##(2008-10#1)(2008-8#1)
to depend on the##16##4##(1991-1#1)(1992-12#1)(1994-11#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2011-1#1)
to depend on##32##3##(1991-1#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-7#5)(2008-8#4)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
to depend strongly on the##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
to depend strongly on##7##4##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
to depend upon##2##3##(1992-6#1)(1996-6#1)
to depend##46##2##(1991-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#5)(2008-8#4)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
to depict the##5##3##(1991-1#1)(2010-10#1)(2010-12#2)(2012-1#1)
to depict##6##2##(1991-1#1)(2010-10#1)(2010-12#2)(2012-1#1)(2012-12#1)
to deplete the##2##3##(1992-12#1)(2008-9#1)
to deplete##5##2##(1992-12#1)(1993-12#1)(1995-12#1)(1997-6#1)(2008-9#1)
to depletion of##2##3##(2008-7#1)(2012-2#1)
to deploy##4##2##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)
to deployment of##2##3##(2008-10#1)(2011-2#1)
to depolarization##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#2)
to deposit the##2##3##(1994-12#1)(2008-10#1)
to deposit##6##2##(1994-12#1)(2007-11#1)(2008-10#3)(2013-1#1)
to deposition##2##2##(1997-1#1)(2008-10#1)
to depressed##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
to depression##5##2##(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#1)
to depressive##3##2##(2007-7#1)(2009-5#1)(2011-2#1)
to depth##2##2##(2008-2#1)(2011-2#1)
to depths##2##2##(2008-3#2)
to derivatization##2##2##(1990-8#1)(1993-2#1)
to derivatize##2##2##(2008-10#2)
to derive a##13##3##(1992-12#1)(1992-3#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
to derive from the##3##4##(1992-3#1)(1993-12#1)(2012-12#1)
to derive the optical##2##4##(2008-2#2)
to derive the##22##3##(1995-9#1)(1997-2#1)(2008-11#1)(2008-2#7)(2008-3#8)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
to derive##68##2##(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#5)(2008-2#11)(2008-3#15)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
to dermatologists##2##2##(2008-5#1)(2010-8#1)
to describe a##16##3##(1990-9#1)(1994-1#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to describe and compare##2##4##(2008-10#1)(2013-7#1)
to describe and##10##3##(1992-12#2)(2008-10#2)(2008-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
to describe how##5##3##(1992-2#1)(1994-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
to describe in##2##3##(2008-1#1)(2008-3#1)
to describe its##2##3##(2007-12#1)(2011-2#1)
to describe the basic##2##4##(2008-3#1)(2011-2#1)
to describe the characteristics##2##4##(2011-1#1)(2013-1#1)
to describe the clinical##3##4##(2007-12#1)(2007-2#1)(2010-5#1)
to describe the dynamics of##2##5##(2008-10#1)(2012-3#1)
to describe the general##2##4##(2007-11#1)(2008-9#1)
to describe the incidence##2##4##(2012-12#2)
to describe the relationship between##4##5##(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)
to describe the role of##2##5##(1992-1#1)(2012-12#1)
to describe the type##2##4##(2009-3#1)(2011-2#1)
to describe the use of##3##5##(2008-6#1)(2011-2#1)(2012-2#1)
to describe the##146##3##(1990-11#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-2#3)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#15)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#19)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
to describe their##3##3##(1993-1#1)(2008-12#1)(2012-2#1)
to describe this##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
to describe##283##2##(1990-11#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#4)(1993-3#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-8#2)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#6)(2007-2#2)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#31)(2008-11#17)(2008-12#7)(2008-2#13)(2008-3#23)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#10)(2008-8#4)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-11#5)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#6)(2013-1#16)(2013-7#3)(2013-8#2)
to describing the##3##3##(1994-12#1)(2007-11#1)(2008-2#1)
to describing##4##2##(1994-12#1)(2007-11#1)(2008-2#1)(2008-8#1)
to desensitization##2##2##(1992-2#1)(2012-3#1)
to design a##9##3##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)
to design an##4##3##(1994-2#1)(1996-1#1)(2008-10#1)(2008-3#1)
to design and##10##3##(1993-12#1)(1995-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
to design new##3##3##(1997-3#1)(1997-6#1)(2008-5#1)
to design predictive models of##2##5##(2007-11#2)
to design species-specific##2##3##(2008-10#2)
to design the##10##3##(1995-5#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-9#1)(2010-11#1)(2010-8#1)
to design##91##2##(1990-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-2#2)(1995-12#1)(1995-5#1)(1996-1#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#7)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
to designate##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
to designing##3##2##(2008-10#1)(2008-2#1)(2009-9#1)
to desirable##2##2##(1993-2#1)(2009-10#1)
to desire##2##2##(2008-9#1)(2011-2#1)
to desired##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
to desmopressin##2##2##(1992-11#1)(2013-8#1)
to desorb and##3##3##(2008-10#2)(2008-2#1)
to desorb##5##2##(2008-10#4)(2008-2#1)
to destabilize##2##2##(1991-9#1)(2012-2#1)
to destroy the##6##3##(2008-10#2)(2008-11#1)(2010-1#1)(2010-3#1)(2010-4#1)
to destroy##11##2##(1992-1#1)(1994-3#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-3#2)(2010-4#1)
to destruction of the##2##4##(1990-12#1)(2008-10#1)
to destruction of##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
to detached##2##2##(2008-10#2)
to detachment##2##2##(1996-9#1)(2008-11#1)
to detail##7##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-3#1)
to detect DNA damage##2##4##(1996-2#1)(2008-4#1)
to detect DNA of agents of human granulocytic anaplasmosis and monocytic##2##11##(2013-1#2)
to detect DNA##8##3##(1996-2#1)(1997-3#1)(2008-10#1)(2008-4#2)(2013-1#3)
to detect E##2##3##(2008-10#1)(2012-2#1)
to detect H(2)O(2)##2##3##(2008-10#2)
to detect M##4##3##(2008-10#3)(2012-3#1)
to detect OTA in##2##4##(2008-10#2)
to detect P##3##3##(2008-10#2)(2008-12#1)
to detect PLRV##2##3##(2008-10#2)
to detect a given##2##4##(1992-9#1)(2008-7#1)
to detect a##19##3##(1990-3#1)(1992-6#1)(1992-9#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
to detect all##4##3##(1996-12#1)(2008-10#1)(2009-11#1)(2012-2#1)
to detect an##5##3##(1992-6#1)(1992-8#1)(1992-9#1)(2008-1#1)(2010-10#1)
to detect and analyze##2##4##(2008-11#1)(2009-8#1)
to detect and eliminate the##2##5##(1994-3#1)(2007-12#1)
to detect and identify##2##4##(2008-3#1)(2010-5#1)
to detect and image##2##4##(2007-12#1)(2011-2#1)
to detect and monitor the##2##5##(1993-2#1)(2008-4#1)
to detect and quantify the##4##5##(2008-10#3)(2008-3#1)
to detect and quantify##14##4##(2008-10#10)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
to detect and respond to##3##5##(1992-11#1)(2008-8#2)
to detect and treat##2##4##(2012-12#1)(2013-8#1)
to detect and##43##3##(1991-6#1)(1992-11#1)(1993-2#1)(1994-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
to detect any##13##3##(1993-2#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
to detect apoptosis##2##3##(1994-10#2)
to detect as little as 0##2##6##(2008-10#2)
to detect as little as##4##5##(2008-10#3)(2013-1#1)
to detect as##5##3##(2008-10#4)(2013-1#1)
to detect association##2##3##(2012-3#2)
to detect associations##2##3##(2012-3#2)
to detect both##2##3##(2008-10#1)(2008-4#1)
to detect breast cancer##3##4##(2008-10#1)(2008-4#1)(2010-6#1)
to detect cell##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
to detect changes in##2##4##(2008-10#1)(2008-3#1)
to detect changes##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
to detect differences in##2##4##(1992-11#1)(1996-2#1)
to detect early##2##3##(1995-11#1)(2010-6#1)
to detect fungal##2##3##(2008-10#2)
to detect genes with##2##4##(2008-4#1)(2012-3#1)
to detect genes##5##3##(1997-5#1)(2008-4#2)(2012-3#1)(2013-8#1)
to detect genetic variants that##2##5##(2009-5#1)(2012-3#1)
to detect genetic##3##3##(2008-4#1)(2009-5#1)(2012-3#1)
to detect individuals##2##3##(1990-3#1)(1993-8#1)
to detect latent##2##3##(2008-10#1)(2010-6#1)
to detect mRNA##2##3##(1990-12#1)(2008-7#1)
to detect microorganisms##2##3##(2006-10#1)(2008-9#1)
to detect mutations##2##3##(2008-4#2)
to detect nitrite##2##3##(2008-10#2)
to detect occult##2##3##(1990-8#1)(2012-12#1)
to detect of the##2##4##(1997-3#1)(2008-10#1)
to detect or##2##3##(1991-2#1)(2008-4#1)
to detect patients##2##3##(2008-1#1)(2011-2#1)
to detect potential##3##3##(2008-11#1)(2012-1#1)(2013-1#1)
to detect rare##7##3##(1996-12#1)(2011-2#1)(2012-3#5)
to detect significant##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
to detect single##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
to detect small##6##3##(1997-3#1)(2007-11#1)(2008-10#3)(2009-11#1)
to detect smaller##2##3##(1997-3#1)(2008-2#1)
to detect some##2##3##(1992-2#1)(2008-10#1)
to detect specific##5##3##(1990-5#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-1#1)
to detect subtle##2##3##(2009-12#1)(2013-1#1)
to detect the DNA##3##4##(2008-10#2)(2013-1#1)
to detect the effects of##2##5##(2008-3#2)
to detect the hybridization##2##4##(2008-10#2)
to detect the lead content in##2##6##(2008-10#2)
to detect the levels of##2##5##(2011-1#2)
to detect the pathogen##2##4##(2008-10#2)
to detect the presence of a##2##6##(2008-4#1)(2012-3#1)
to detect the presence of##11##5##(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-3#1)
to detect the presence##12##4##(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2011-1#1)(2012-3#1)
to detect the##89##3##(1991-12#2)(1991-5#1)(1992-9#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-4#1)(2007-10#2)(2007-12#4)(2008-10#29)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to detect these##5##3##(1994-6#1)(1995-10#1)(2007-12#1)(2008-10#1)(2010-9#1)
to detect this##2##3##(2008-10#1)(2008-6#1)
to detect two##6##3##(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-11#1)
to detect whether##3##3##(1993-12#1)(1997-4#1)(2007-8#1)
to detect##575##2##(1990-12#2)(1990-3#3)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#4)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1994-10#4)(1994-11#3)(1994-2#4)(1994-3#1)(1994-6#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#7)(1997-4#4)(1997-5#5)(1997-6#2)(1997-7#1)(1997-8#4)(2006-10#2)(2007-10#4)(2007-11#5)(2007-12#11)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#146)(2008-11#15)(2008-12#5)(2008-2#12)(2008-3#27)(2008-4#28)(2008-5#15)(2008-6#4)(2008-7#13)(2008-8#10)(2008-9#18)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#3)(2010-8#5)(2010-9#2)(2011-1#16)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#21)(2013-1#15)(2013-7#2)(2013-8#7)
to detecting##2##2##(2007-11#1)(2008-10#1)
to detection limit##2##3##(2008-10#2)
to detection of##3##3##(2008-10#2)(2013-1#1)
to detection##13##2##(2008-10#6)(2008-3#3)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
to detector##2##2##(2008-10#1)(2008-2#1)
to deter##2##2##(1993-12#1)(2012-2#1)
to deteriorate##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-3#1)
to deterioration##2##2##(1990-6#1)(2007-8#1)
to determination of these##2##4##(2008-10#2)
to determination of trace##2##4##(2008-10#2)
to determination of##23##3##(2008-10#23)
to determination##26##2##(2008-10#26)
to determinations of##3##3##(1994-12#1)(1996-2#1)(2008-10#1)
to determinations##4##2##(1994-12#1)(1996-2#1)(2008-10#2)
to determine Cys##2##3##(2008-10#2)
to determine a##15##3##(1993-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
to determine absolute##3##3##(2007-12#1)(2008-9#1)(2010-11#1)
to determine all the##3##4##(1993-11#1)(2008-10#2)
to determine aluminum##2##3##(2008-10#2)
to determine amounts of##2##4##(2008-10#2)
to determine an effective##2##4##(1992-12#1)(2008-3#1)
to determine an##4##3##(1992-12#1)(2008-10#1)(2008-3#2)
to determine and##4##3##(1993-12#1)(2008-5#1)(2009-8#1)(2010-8#1)
to determine aniline##2##3##(2008-10#2)
to determine any clinical##2##4##(2009-8#1)(2011-2#1)
to determine any##6##3##(1994-10#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-2#1)
to determine arsenic##2##3##(2008-10#1)(2010-5#1)
to determine blood##2##3##(2008-10#1)(2011-2#1)
to determine both the##2##4##(2008-3#2)
to determine both##6##3##(2008-10#4)(2008-3#2)
to determine by##2##3##(1993-9#1)(2008-10#1)
to determine changes in##4##4##(1991-2#1)(1993-12#1)(2008-10#1)(2008-3#1)
to determine chromium##3##3##(2008-10#3)
to determine clinical##2##3##(2007-10#1)(2010-4#1)
to determine compounds##2##3##(2008-10#2)
to determine copper##3##3##(2008-10#3)
to determine diclofenac in##2##4##(2008-10#2)
to determine diclofenac##3##3##(2008-10#3)
to determine differences between##2##4##(2007-7#1)(2009-7#1)
to determine effective##2##3##(1996-2#1)(2008-10#1)
to determine factors associated with##2##5##(2007-10#1)(2013-7#1)
to determine factors##3##3##(2007-10#1)(2013-7#1)(2013-8#1)
to determine furosemide in##2##4##(2008-10#2)
to determine furosemide##3##3##(2008-10#3)
to determine genetic relationships among##2##5##(2008-10#2)
to determine genetic relationships##3##4##(2008-10#3)
to determine genetic##5##3##(2007-10#1)(2008-10#3)(2008-8#1)
to determine how many##4##4##(1996-1#1)(2008-4#2)(2008-9#1)
to determine how the##3##4##(1996-2#1)(2008-11#1)(2008-2#1)
to determine how these factors##2##5##(2008-10#1)(2013-1#1)
to determine how they##2##4##(2008-10#1)(2008-5#1)
to determine how to##2##4##(2008-10#1)(2012-2#1)
to determine how well the##2##5##(2007-12#1)(2008-7#1)
to determine how well##5##4##(1995-5#1)(2007-12#1)(2008-7#1)(2009-11#1)(2010-1#1)
to determine how##38##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-7#1)(1993-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(2007-12#3)(2008-10#7)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
to determine if a##7##4##(1992-3#1)(1997-3#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
to determine if the##25##4##(1990-2#1)(1991-2#2)(1992-2#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
to determine if there is##2##5##(2010-1#1)(2012-3#1)
to determine if there was##2##5##(2008-10#2)
to determine if there##4##4##(2008-10#2)(2010-1#1)(2012-3#1)
to determine if these##3##4##(1997-3#1)(2008-10#2)
to determine if they##3##4##(1996-5#1)(2009-11#1)(2010-8#1)
to determine if this##2##4##(1997-2#1)(2008-10#1)
to determine if treatment##2##4##(1997-5#1)(2007-12#1)
to determine if##100##3##(1990-12#1)(1990-2#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1996-5#3)(1997-2#1)(1997-3#3)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
to determine in##2##3##(2007-5#1)(2011-1#1)
to determine incidence##2##3##(2008-10#1)(2012-2#1)
to determine its effect on##3##5##(1995-3#1)(2008-10#1)(2013-7#1)
to determine its##11##3##(1994-11#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-7#1)
to determine lead##2##3##(2008-10#2)
to determine mercury##3##3##(2008-10#3)
to determine optimal##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
to determine optimum##2##3##(2008-10#1)(2008-3#1)
to determine organic pollutants##2##4##(2008-10#2)
to determine organic##3##3##(2008-10#3)
to determine parameters##2##3##(1997-2#1)(2008-10#1)
to determine perceptions of##2##4##(1993-2#1)(1995-1#1)
to determine possible##2##3##(2008-10#1)(2013-1#1)
to determine potential##3##3##(1997-4#1)(2007-5#1)(2008-10#1)
to determine quantitatively the##2##4##(2008-10#1)(2008-2#1)
to determine relative##2##3##(1991-8#1)(2011-1#1)
to determine sensitivity##2##3##(2011-2#2)
to determine sites of##2##4##(1992-2#1)(2008-10#1)
to determine that the##2##4##(1992-12#1)(2008-3#1)
to determine that##4##3##(1992-12#1)(1993-8#1)(2008-10#1)(2008-3#1)
to determine the ability of##4##5##(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
to determine the absolute##2##4##(2008-9#1)(2009-10#1)
to determine the accuracy of##4##5##(1990-9#1)(1994-3#1)(2012-1#1)(2012-2#1)
to determine the active##2##4##(2008-10#2)
to determine the aerosol##2##4##(2008-2#1)(2008-3#1)
to determine the amino acid##3##5##(1994-9#1)(2008-10#1)(2010-4#1)
to determine the amount of##5##5##(2008-10#5)
to determine the apparent##2##4##(2008-10#2)
to determine the appropriate##6##4##(1993-2#1)(1994-12#1)(2008-10#1)(2008-5#2)(2011-2#1)
to determine the best##8##4##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2010-3#1)(2010-8#1)(2011-1#1)
to determine the cellular##2##4##(1994-10#1)(1995-11#1)
to determine the changes in the##2##6##(2008-3#1)(2011-1#1)
to determine the changes in##3##5##(2008-3#1)(2011-1#1)(2012-2#1)
to determine the changes##4##4##(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
to determine the characteristics of##2##5##(1995-12#1)(1996-9#1)
to determine the characteristics##3##4##(1995-12#1)(1996-9#1)(2011-2#1)
to determine the chromosomal##2##4##(2008-10#1)(2008-4#1)
to determine the composition of the##2##6##(1992-1#1)(2008-10#1)
to determine the composition of##6##5##(1990-9#1)(1992-1#1)(2007-11#1)(2008-10#2)(2008-3#1)
to determine the concentration of##11##5##(1991-12#1)(2008-10#8)(2008-4#1)(2008-9#1)
to determine the concentration##12##4##(1991-12#1)(2008-10#8)(2008-4#1)(2008-9#1)(2010-4#1)
to determine the concentrations of##2##5##(2008-10#1)(2008-3#1)
to determine the content of##4##5##(2008-10#4)
to determine the content##5##4##(1996-1#1)(2008-10#4)
to determine the contents of##2##5##(1992-11#1)(2008-10#1)
to determine the correct##2##4##(2007-8#1)(2008-8#1)
to determine the correlation##2##4##(1992-3#1)(2008-1#1)
to determine the critical##2##4##(2008-10#2)
to determine the current##2##4##(1996-12#1)(2010-8#1)
to determine the degree of##4##5##(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
to determine the degree##5##4##(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
to determine the differences between##2##5##(1997-4#1)(2010-5#1)
to determine the different##3##4##(1990-12#1)(2007-7#1)(2008-10#1)
to determine the effect of different##2##6##(1996-2#1)(2013-1#1)
to determine the effect of the##2##6##(1997-1#1)(2013-1#1)
to determine the effect of##31##5##(1990-5#1)(1991-8#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#2)(1997-1#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)
to determine the effect on##3##5##(1996-7#1)(1997-8#1)(2008-10#1)
to determine the effect##34##4##(1990-5#1)(1991-8#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-12#5)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)
to determine the effective##2##4##(1990-7#1)(2008-11#1)
to determine the effectiveness of##4##5##(1990-10#1)(1990-6#1)(1996-3#1)(2012-3#1)
to determine the effects of a##2##6##(2008-1#1)(2012-3#1)
to determine the effects of the##3##6##(2008-5#1)(2011-2#1)(2013-1#1)
to determine the effects of##28##5##(1990-5#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#3)(2008-7#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
to determine the efficacy of##3##5##(1994-3#1)(2011-2#1)(2012-3#1)
to determine the efficiency of##2##5##(2008-2#1)(2010-7#1)
to determine the exact##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
to determine the extent of##4##5##(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)
to determine the extent to which##3##6##(1992-6#1)(1996-3#1)(2010-8#1)
to determine the extent##8##4##(1992-6#1)(1996-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-12#1)
to determine the factors that##3##5##(1995-3#1)(2008-6#1)(2011-1#1)
to determine the factors##6##4##(1990-6#1)(1995-3#2)(2008-1#1)(2008-6#1)(2011-1#1)
to determine the feasibility and##2##5##(2008-6#1)(2011-2#1)
to determine the feasibility##3##4##(2007-8#1)(2008-6#1)(2011-2#1)
to determine the formation##2##4##(2008-10#1)(2010-9#1)
to determine the frequency of##5##5##(1991-11#1)(1995-1#1)(2007-2#1)(2007-5#1)(2009-5#1)
to determine the function of##3##5##(2008-8#1)(2008-9#1)(2009-10#1)
to determine the genetic##5##4##(2008-10#4)(2011-1#1)
to determine the identity and##2##5##(2008-10#1)(2012-2#1)
to determine the identity##3##4##(1992-9#1)(2008-10#1)(2012-2#1)
to determine the impact of##5##5##(1993-2#1)(1995-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
to determine the impact on##2##5##(1996-7#1)(2012-3#1)
to determine the impact##7##4##(1993-2#1)(1995-1#1)(1996-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
to determine the importance of##3##5##(2007-8#1)(2008-2#1)(2008-7#1)
to determine the in vitro##2##5##(2008-5#1)(2008-8#1)
to determine the in##3##4##(1994-5#1)(2008-5#1)(2008-8#1)
to determine the incidence and##2##5##(2008-7#1)(2013-1#1)
to determine the incidence of##5##5##(1991-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2013-8#1)
to determine the incidence##7##4##(1991-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
to determine the indices of refraction of liquids##2##8##(2008-3#2)
to determine the influence of different##2##6##(2008-10#1)(2011-2#1)
to determine the influence of the##3##6##(1996-5#1)(2008-11#1)(2011-2#1)
to determine the influence of##14##5##(1996-5#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#4)
to determine the interactions##2##4##(2008-10#2)
to determine the kinetic parameters##2##5##(1994-5#1)(2008-10#1)
to determine the kinetics##2##4##(1995-12#1)(2008-9#1)
to determine the level of##7##5##(1990-8#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
to determine the levels of##2##5##(1993-3#1)(2008-12#1)
to determine the likelihood of##2##5##(2008-7#1)(2010-8#1)
to determine the long-term##2##4##(1996-12#1)(2008-8#1)
to determine the magnitude##2##4##(2008-8#1)(2010-8#1)
to determine the major##2##4##(1995-12#1)(2008-10#1)
to determine the maximum##2##4##(2008-6#1)(2012-2#1)
to determine the mechanism by which##2##6##(2008-6#1)(2011-1#1)
to determine the mechanism of##4##5##(1991-9#1)(1994-11#1)(1997-4#1)(2008-10#1)
to determine the mechanism##6##4##(1991-9#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-6#1)(2011-1#1)
to determine the mechanisms underlying##2##5##(2012-2#1)(2013-8#1)
to determine the minimum##2##4##(2008-2#1)(2008-9#1)
to determine the most effective##2##5##(1993-2#1)(2007-12#1)
to determine the most##5##4##(1992-12#1)(1993-2#1)(2007-12#1)(2008-10#2)
to determine the nature of the##4##6##(1991-2#1)(1993-11#1)(2008-10#1)(2008-2#1)
to determine the nature##5##4##(1991-2#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
to determine the number and identity of##2##7##(2008-10#2)
to determine the number and##3##5##(2008-10#3)
to determine the number of##11##5##(1993-3#1)(1994-5#1)(1995-11#1)(2006-10#1)(2008-10#3)(2008-4#2)(2013-1#2)
to determine the number##14##4##(1993-3#1)(1994-5#1)(1995-11#1)(2006-10#1)(2008-10#6)(2008-4#2)(2013-1#2)
to determine the optical properties of##4##6##(2007-12#1)(2008-2#1)(2008-3#2)
to determine the optical##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
to determine the optimal##7##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
to determine the optimum conditions for the##2##7##(2008-10#2)
to determine the optimum conditions for##4##6##(1994-3#1)(2008-10#3)
to determine the optimum##8##4##(1994-3#1)(2008-10#5)(2008-12#1)(2008-3#1)
to determine the overall##4##4##(2008-10#4)
to determine the parameters##2##4##(2008-10#1)(2008-3#1)
to determine the pharmacological##2##4##(1993-3#1)(1994-5#1)
to determine the phase##2##4##(1990-6#1)(2008-3#1)
to determine the position of##2##5##(2008-10#1)(2008-2#1)
to determine the possible role of##2##6##(2008-4#1)(2011-2#1)
to determine the possible##4##4##(1997-4#1)(2008-4#2)(2011-2#1)
to determine the potential##2##4##(2008-7#1)(2013-8#1)
to determine the precise##3##4##(2008-4#1)(2009-4#1)(2012-2#1)
to determine the predictive##2##4##(2010-12#1)(2013-1#1)
to determine the predictors of##2##5##(2007-2#1)(2008-11#1)
to determine the presence of##4##5##(1994-11#1)(2008-10#1)(2008-2#1)(2010-1#1)
to determine the presence##5##4##(1994-11#1)(2008-10#2)(2008-2#1)(2010-1#1)
to determine the prevalence and##2##5##(2011-1#2)
to determine the prevalence of##21##5##(1996-12#1)(2007-7#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
to determine the prevalence##25##4##(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
to determine the proportion of patients with##2##7##(1997-6#1)(2012-12#1)
to determine the proportion of##3##5##(1997-6#1)(2008-4#1)(2012-12#1)
to determine the proportion##4##4##(1997-6#1)(2008-4#1)(2012-12#2)
to determine the rate##4##4##(1996-12#1)(2008-10#2)(2013-1#1)
to determine the refractive index##2##5##(2008-10#1)(2008-3#1)
to determine the relationship between the number of##2##8##(2008-12#1)(2013-1#1)
to determine the relationship between the##4##6##(2008-10#2)(2008-12#1)(2013-1#1)
to determine the relationship between##9##5##(2008-10#3)(2008-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to determine the relationship of##2##5##(2009-5#1)(2011-1#1)
to determine the relationship##11##4##(2008-10#3)(2008-12#2)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
to determine the relationships between##2##5##(1995-2#1)(2010-2#1)
to determine the relative contributions of##2##6##(2008-10#1)(2008-9#1)
to determine the relative##9##4##(1992-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)
to determine the relevance of##3##5##(1990-3#1)(1996-2#1)(2008-10#1)
to determine the requirements##2##4##(2008-10#1)(2013-1#1)
to determine the resistance to##2##5##(2008-5#1)(2008-7#1)
to determine the role of##8##5##(1994-11#1)(1994-8#1)(1995-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2013-1#1)
to determine the role that##2##5##(1993-1#1)(1996-3#1)
to determine the role##12##4##(1993-1#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2013-1#1)
to determine the sensitivity of##2##5##(2008-10#1)(2012-6#1)
to determine the sensitivity##3##4##(1993-3#1)(2008-10#1)(2012-6#1)
to determine the set of##2##5##(2011-1#1)(2012-3#1)
to determine the significance of##2##5##(2006-12#1)(2008-10#1)
to determine the site of##3##5##(1990-11#1)(1993-11#1)(2007-12#1)
to determine the size and##2##5##(1995-2#1)(2008-3#1)
to determine the size##3##4##(1995-2#1)(2008-3#1)(2013-1#1)
to determine the spatial##4##4##(2008-10#3)(2008-2#1)
to determine the specific##2##4##(1995-5#1)(2011-1#1)
to determine the stability constants of the MA and MA(2) complex species formed##2##13##(2008-10#2)
to determine the stability constants of the##3##7##(2008-10#3)
to determine the stability of##2##5##(2008-10#1)(2008-6#1)
to determine the stability##5##4##(2008-10#4)(2008-6#1)
to determine the structural##2##4##(1993-2#1)(2008-9#1)
to determine the structure of##3##5##(1992-9#1)(1995-5#1)(1995-8#1)
to determine the time of##2##5##(1995-6#1)(2008-11#1)
to determine the time##3##4##(1995-6#1)(1997-7#1)(2008-11#1)
to determine the trends##2##4##(2008-10#1)(2012-12#1)
to determine the type##2##4##(2008-10#1)(2010-4#1)
to determine the unknown##2##4##(2008-10#1)(2008-3#1)
to determine the value of##2##5##(2008-1#1)(2008-10#1)
to determine the value##3##4##(1993-2#1)(2008-1#1)(2008-10#1)
to determine the viability##3##4##(1994-1#1)(2008-11#1)(2010-5#1)
to determine the volume##2##4##(2007-12#1)(2008-2#1)
to determine the##775##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-2#6)(1993-3#7)(1993-8#3)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#8)(1996-2#4)(1996-3#3)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#5)(2007-11#4)(2007-12#8)(2007-2#2)(2007-5#2)(2007-7#4)(2007-8#3)(2008-1#9)(2008-10#187)(2008-11#15)(2008-12#22)(2008-2#37)(2008-3#53)(2008-4#20)(2008-5#21)(2008-6#10)(2008-7#15)(2008-8#15)(2008-9#13)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#16)(2011-2#29)(2012-1#3)(2012-12#8)(2012-2#15)(2012-3#13)(2012-6#1)(2013-1#29)(2013-3#1)(2013-7#2)(2013-8#11)
to determine their concentrations##2##4##(2008-10#1)(2012-2#1)
to determine their efficacy in##2##5##(2011-2#1)(2013-7#1)
to determine their functional##2##4##(2007-12#1)(2012-2#1)
to determine their genetic diversity and##2##6##(2008-10#2)
to determine their genetic##3##4##(2008-10#3)
to determine their morphological##2##4##(2008-10#1)(2008-12#1)
to determine their##36##3##(1990-5#1)(1991-2#1)(1992-12#1)(1994-1#1)(1995-10#1)(2007-10#1)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
to determine thermodynamic##2##3##(1993-8#1)(2008-10#1)
to determine these##4##3##(2008-10#3)(2008-7#1)
to determine this##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
to determine to what extent##2##5##(2008-10#1)(2011-1#1)
to determine total##6##3##(1994-2#1)(2007-2#1)(2008-10#3)(2009-4#1)
to determine trace##6##3##(2008-10#6)
to determine traces of##3##4##(2008-10#3)
to determine what factors##3##4##(2008-7#1)(2012-2#1)(2013-8#1)
to determine what##13##3##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-12#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
to determine when##5##3##(1996-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-8#1)
to determine whether B##2##4##(2008-10#1)(2012-2#1)
to determine whether a##8##4##(1996-12#1)(1996-6#1)(2007-11#2)(2008-4#1)(2008-8#1)(2009-12#1)(2012-2#1)
to determine whether any##2##4##(1991-8#1)(2010-3#1)
to determine whether different##2##4##(2010-2#1)(2012-3#1)
to determine whether it is##2##5##(2008-5#1)(2008-6#1)
to determine whether it was likely##2##6##(1994-3#1)(2007-11#1)
to determine whether it##4##4##(1994-3#1)(2007-11#1)(2008-5#1)(2008-6#1)
to determine whether its##2##4##(1992-5#1)(1994-6#1)
to determine whether or not##4##5##(1996-4#1)(2006-10#1)(2012-1#1)(2012-3#1)
to determine whether such##2##4##(2008-10#1)(2013-1#1)
to determine whether the##27##4##(1990-8#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2011-2#1)(2013-8#1)
to determine whether there was##2##5##(1995-12#1)(2007-12#1)
to determine whether there##5##4##(1995-12#1)(2007-12#1)(2008-7#1)(2009-12#1)(2010-7#1)
to determine whether these##6##4##(1997-7#1)(1997-8#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
to determine whether they are##4##5##(2007-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
to determine whether this##6##4##(1991-12#1)(1991-8#1)(1995-11#1)(1995-12#1)(2008-8#1)(2013-1#1)
to determine whether to##2##4##(2008-12#1)(2011-2#1)
to determine whether##168##3##(1990-10#1)(1990-11#1)(1990-5#3)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#2)(2009-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#7)(2013-8#3)
to determine which operational parameters should be included in the optimization##2##11##(2008-10#2)
to determine which##24##3##(1991-6#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
to determine with##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
to determine##1665##2##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#9)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#5)(1991-5#3)(1991-6#1)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#9)(1992-2#4)(1992-3#5)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#8)(1993-12#8)(1993-2#11)(1993-3#8)(1993-5#1)(1993-6#2)(1993-8#8)(1993-9#4)(1994-1#5)(1994-10#3)(1994-11#7)(1994-12#7)(1994-2#8)(1994-3#7)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#9)(1995-12#9)(1995-2#11)(1995-3#8)(1995-5#7)(1995-6#4)(1995-8#2)(1996-1#4)(1996-12#12)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#7)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2006-10#2)(2006-12#1)(2006-4#2)(2007-10#15)(2007-11#15)(2007-12#24)(2007-2#4)(2007-5#10)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#16)(2008-10#485)(2008-11#42)(2008-12#34)(2008-2#51)(2008-3#81)(2008-4#36)(2008-5#42)(2008-6#14)(2008-7#33)(2008-8#27)(2008-9#21)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#9)(2009-5#5)(2009-6#1)(2009-7#8)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#4)(2010-3#8)(2010-4#10)(2010-5#5)(2010-6#8)(2010-7#3)(2010-8#19)(2010-9#2)(2011-1#28)(2011-2#58)(2012-1#4)(2012-12#11)(2012-2#33)(2012-3#20)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#52)(2013-3#1)(2013-7#8)(2013-8#20)
to determining the##7##3##(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
to determining##9##2##(1995-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
to detoxify##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2010-5#1)
to develop a baseline##2##4##(1997-4#1)(2008-12#1)
to develop a better understanding of##2##6##(2008-7#1)(2010-9#1)
to develop a better##4##4##(2007-11#1)(2008-7#1)(2010-9#1)(2012-2#1)
to develop a comprehensive##3##4##(1994-12#1)(2008-3#1)(2013-1#1)
to develop a culture##2##4##(2008-11#1)(2008-5#1)
to develop a detailed##2##4##(2008-8#1)(2009-12#1)
to develop a fully##2##4##(2008-10#1)(2008-9#1)
to develop a method for##2##5##(2009-8#1)(2012-4#1)
to develop a method##3##4##(2008-6#1)(2009-8#1)(2012-4#1)
to develop a model for##2##5##(1996-3#1)(2008-10#1)
to develop a model##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
to develop a new##10##4##(1992-11#1)(1993-3#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
to develop a novel##4##4##(2007-12#1)(2008-10#2)(2010-11#1)
to develop a rapid##3##4##(2008-10#3)
to develop a reliable##3##4##(1990-5#1)(2008-10#1)(2013-1#1)
to develop a simple and##2##5##(2008-10#1)(2008-5#1)
to develop a simple##8##4##(2008-1#1)(2008-10#5)(2008-5#2)
to develop a solid##2##4##(2008-10#2)
to develop a specific##2##4##(2008-10#1)(2010-3#1)
to develop a system##3##4##(2009-8#1)(2010-2#1)(2011-2#1)
to develop a totally##2##4##(2008-10#1)(2009-10#1)
to develop a vaccine against##2##5##(2009-6#1)(2010-1#1)
to develop a##152##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#5)(2008-10#28)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#7)(2013-8#1)
to develop an accurate##2##4##(2008-1#1)(2008-10#1)
to develop an action plan##2##5##(1995-12#1)(2007-4#1)
to develop an assay##2##4##(1990-12#1)(1992-6#1)
to develop an efficient##3##4##(2008-10#1)(2008-11#2)
to develop an in##2##4##(2008-11#1)(2013-1#1)
to develop an##49##3##(1990-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#2)(1995-12#1)(1995-2#1)(1997-1#2)(1997-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2009-9#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
to develop and apply##2##4##(2008-10#1)(2012-12#1)
to develop and evaluate a##2##5##(2008-10#1)(2010-7#1)
to develop and evaluate##7##4##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#1)
to develop and implement a##6##5##(1991-12#1)(1993-1#1)(1995-2#1)(2007-4#1)(2008-9#1)(2013-1#1)
to develop and implement an##2##5##(1992-2#1)(1997-3#1)
to develop and implement##9##4##(1991-12#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-9#1)(2013-1#1)
to develop and test##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
to develop and##39##3##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
to develop better##3##3##(1994-3#1)(2010-2#1)(2010-8#1)
to develop clinical##3##3##(1993-12#1)(2008-12#1)(2010-12#1)
to develop common##2##3##(1996-3#1)(2008-10#1)
to develop comprehensive##2##3##(2010-8#1)(2013-1#1)
to develop critical##2##3##(2008-12#2)
to develop effective interventions##2##4##(2008-12#1)(2013-8#1)
to develop effective##8##3##(1990-10#1)(1992-2#1)(1994-3#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
to develop efficient##4##3##(1997-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
to develop from##2##3##(2007-12#1)(2008-11#1)
to develop fully##2##3##(1997-2#1)(2008-11#1)
to develop in##4##3##(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
to develop methodology##2##3##(2007-7#1)(2012-2#1)
to develop methods##4##3##(1991-12#1)(2008-12#1)(2008-9#1)(2012-12#1)
to develop models of##2##4##(2009-3#1)(2010-3#1)
to develop models##3##3##(2008-10#1)(2009-3#1)(2010-3#1)
to develop molecular##3##3##(1994-5#1)(2008-10#1)(2010-3#1)
to develop more effective##3##4##(2008-12#1)(2010-8#1)(2011-2#1)
to develop more##8##3##(1994-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-2#2)
to develop new agents##2##4##(2008-10#2)
to develop new drugs##2##4##(2009-6#1)(2010-12#1)
to develop new##10##3##(1990-3#1)(1992-3#1)(1994-5#1)(2008-10#2)(2008-3#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#1)
to develop novel##6##3##(1992-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-5#1)
to develop on##2##3##(2008-10#2)
to develop practice##2##3##(1997-7#1)(2008-12#1)
to develop preventive##2##3##(2008-10#1)(2012-2#1)
to develop protocols##2##3##(2006-6#1)(2008-9#1)
to develop rapid##2##3##(2008-5#1)(2008-8#1)
to develop reflective thinking and practice##2##6##(2012-12#2)
to develop reflective##3##3##(1997-4#1)(2012-12#2)
to develop resistance##2##3##(2011-2#2)
to develop simple##2##3##(2008-10#1)(2010-2#1)
to develop skills##3##3##(1993-12#1)(2008-11#2)
to develop specific##3##3##(2008-7#2)(2012-12#1)
to develop strategies for##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
to develop strategies##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
to develop such a##2##4##(2008-10#1)(2013-1#1)
to develop such##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
to develop the concept##2##4##(2008-9#1)(2012-2#1)
to develop the instrument##2##4##(2008-10#2)
to develop the##26##3##(1995-12#1)(1995-6#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
to develop their competencies##2##4##(2008-12#1)(2013-1#1)
to develop their professional##2##4##(2008-1#1)(2008-11#1)
to develop their##6##3##(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)(2013-8#1)
to develop therapeutics##2##3##(2008-5#1)(2013-1#1)
to develop therapies##2##3##(2008-11#1)(2008-7#1)
to develop these##2##3##(1994-2#1)(2013-1#1)
to develop this##2##3##(2008-10#2)
to develop three##2##3##(2008-10#1)(2012-2#1)
to develop tools##2##3##(2008-10#1)(2008-7#1)
to develop training##2##3##(1996-3#1)(2008-12#1)
to develop two##2##3##(2008-10#1)(2008-11#1)
to develop##600##2##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-2#5)(1992-3#2)(1992-6#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#5)(1993-6#3)(1993-7#1)(1994-1#4)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#3)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#8)(1996-3#4)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2006-6#1)(2007-10#4)(2007-11#6)(2007-12#4)(2007-4#2)(2007-7#4)(2007-8#1)(2008-1#13)(2008-10#105)(2008-11#44)(2008-12#20)(2008-2#5)(2008-3#14)(2008-4#5)(2008-5#21)(2008-6#8)(2008-7#20)(2008-8#10)(2008-9#9)(2009-10#4)(2009-11#5)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#8)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#17)(2011-3#1)(2012-1#4)(2012-12#10)(2012-2#18)(2012-3#3)(2012-4#1)(2013-1#21)(2013-7#1)(2013-8#8)
to developed##2##2##(2007-2#1)(2008-10#1)
to developing a##2##3##(1993-2#1)(2008-11#1)
to developing an##2##3##(1996-3#1)(2007-12#1)
to developing and implementing##2##4##(2007-11#1)(2011-1#1)
to developing countries##3##3##(2009-5#1)(2010-12#1)(2011-2#1)
to developing##29##2##(1992-3#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2009-5#1)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#1)
to development of##10##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to development##16##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
to developmental##6##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-9#1)
to developmentally##2##2##(2008-8#1)(2010-4#1)
to device##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
to devise a##5##3##(1994-2#1)(2007-7#1)(2008-10#2)(2013-1#1)
to devise strategies that would minimize incidence of this complication in the future##2##13##(2013-1#2)
to devise strategies##3##3##(2009-4#1)(2013-1#2)
to devise##12##2##(1994-1#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-4#1)(2013-1#4)
to devote##4##2##(1990-4#1)(1994-1#1)(2008-7#1)(2008-8#1)
to dexamethasone##4##2##(1991-12#2)(1993-2#1)(2012-2#1)
to diabetes and##2##3##(2008-11#1)(2013-8#1)
to diabetes##15##2##(1994-12#1)(1994-6#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
to diabetic##3##2##(1995-9#1)(1997-8#1)(2008-1#1)
to diacylglycerol##2##2##(1990-12#1)(1991-12#1)
to diagnose and treat##4##4##(1995-5#1)(2008-4#1)(2011-2#1)(2012-12#1)
to diagnose and##13##3##(1992-5#1)(1995-5#1)(1997-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
to diagnose or##3##3##(2010-5#1)(2011-2#1)(2013-1#1)
to diagnose primary localization of the##2##6##(2007-11#2)
to diagnose the##5##3##(1993-6#1)(1996-3#1)(2009-3#1)(2009-5#1)(2012-3#1)
to diagnose this syndrome##2##4##(1994-12#1)(2011-2#1)
to diagnose this##6##3##(1994-12#1)(2007-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
to diagnose##80##2##(1990-6#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-10#8)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
to diagnosing##3##2##(2008-11#1)(2008-8#1)(2010-12#1)
to diagnosis and treatment##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
to diagnosis and##7##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#2)
to diagnosis of##3##3##(1996-3#1)(2008-10#1)(2008-8#1)
to diagnosis##29##2##(1990-12#1)(1990-6#2)(1992-8#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#6)(2013-1#2)(2013-8#1)
to diagnostic##10##2##(1991-12#1)(1992-5#1)(1993-12#1)(1997-6#1)(2007-11#1)(2008-2#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
to dialysis and##2##3##(2008-1#1)(2010-7#1)
to dialysis##8##2##(1994-8#1)(2008-1#3)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)
to diameter##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
to dibutyltin dichloride##2##3##(2008-10#2)
to dichloroacetic acid##9##3##(2008-9#9)
to dicyclohexylcarbodiimide##2##2##(2008-9#2)
to die as##2##3##(1995-2#1)(2008-10#1)
to die at##2##3##(1993-3#1)(2010-8#1)
to die by##3##3##(1994-8#2)(2008-7#1)
to die in##4##3##(1994-7#1)(2008-11#1)(2011-2#2)
to die of##2##3##(1993-6#1)(2008-7#1)
to die##21##2##(1993-3#1)(1993-6#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-8#1)(2011-2#2)(2012-12#1)
to dietary##13##2##(1991-12#1)(1991-2#1)(1994-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#2)
to diethylstilbestrol (DES) and##2##4##(1990-7#1)(2008-10#1)
to diethylstilbestrol##5##2##(1990-7#2)(2008-10#2)(2010-9#1)
to differ between##2##3##(1991-5#1)(1993-8#1)
to differ from the##2##4##(1992-11#1)(2008-10#1)
to differ from##4##3##(1992-11#1)(2008-10#2)(2011-2#1)
to differ in their##4##4##(1996-12#1)(2007-12#1)(2009-12#1)(2013-1#1)
to differ in##6##3##(1991-12#1)(1996-12#1)(2007-12#1)(2008-8#1)(2009-12#1)(2013-1#1)
to differ##16##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-8#1)(1996-12#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
to difference in##2##3##(2008-12#1)(2008-8#1)
to differences among##2##3##(2008-10#2)
to differences between##3##3##(2008-10#2)(2008-6#1)
to differences in the##10##4##(1991-11#1)(1993-11#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2011-2#1)
to differences in their##2##4##(2008-10#2)
to differences in##38##3##(1991-11#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#3)(2009-12#1)(2009-7#2)(2010-8#1)(2011-2#1)(2012-3#1)
to differences##46##2##(1991-11#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-8#3)(2009-12#1)(2009-7#2)(2010-8#1)(2011-2#1)(2012-3#2)
to different AR##2##3##(2012-2#2)
to different concentrations of##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
to different degrees for##2##4##(1994-5#1)(2008-10#1)
to different degrees##3##3##(1994-5#1)(2008-10#1)(2008-12#1)
to different doses of##2##4##(2007-10#1)(2013-1#1)
to different environmental conditions##2##4##(2010-10#2)
to different environments##3##3##(2008-9#1)(2011-2#2)
to different experimental##2##3##(1991-5#1)(2008-1#1)
to different extent##2##3##(1995-12#1)(2008-9#1)
to different extents##5##3##(1992-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-7#1)
to different groups##2##3##(2008-6#1)(2012-2#1)
to different hosts##3##3##(2008-10#3)
to different kinds of##2##4##(1996-6#1)(2008-10#1)
to different levels of##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
to different levels##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
to different pathogens##3##3##(2006-5#1)(2008-10#2)
to different physiological##2##3##(2008-10#1)(2010-12#1)
to different sample##2##3##(2008-10#1)(2012-12#1)
to different sides of##2##4##(2009-10#2)
to different therapeutic##2##3##(2008-9#1)(2011-2#1)
to different types of##5##4##(1991-1#1)(1993-5#1)(2008-5#1)(2008-9#1)(2009-7#1)
to different##203##2##(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#50)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#4)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#2)
to differential##17##2##(1991-12#1)(1991-5#1)(1992-9#1)(1995-5#1)(2007-11#2)(2008-10#3)(2008-2#5)(2008-7#1)(2008-9#1)(2010-12#1)
to differentials with Pc genes from A##2##7##(2008-10#2)
to differentials with Pc genes from##3##6##(2008-10#3)
to differentiate among##4##3##(1994-1#1)(2008-10#3)
to differentiate and##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
to differentiate between groups of##2##5##(1994-9#1)(2013-7#1)
to differentiate between healthy##2##4##(1997-2#1)(2012-2#1)
to differentiate between these two##2##5##(1996-5#1)(2011-2#1)
to differentiate between##19##3##(1993-6#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
to differentiate by##4##3##(1992-9#1)(1993-3#1)(1994-9#1)(2008-12#1)
to differentiate from##2##3##(2007-12#1)(2011-2#1)
to differentiate in vitro into##2##5##(2008-11#2)
to differentiate in vitro##3##4##(1995-2#1)(2008-11#2)
to differentiate in##4##3##(1995-2#1)(2008-11#2)(2013-1#1)
to differentiate into basophils##2##4##(2008-11#2)
to differentiate into cells##2##4##(2008-8#1)(2008-9#1)
to differentiate into neurons##2##4##(2008-7#1)(2012-12#1)
to differentiate into##15##3##(2008-11#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2012-12#2)(2012-4#1)
to differentiate it from other##2##5##(1994-6#1)(2012-3#1)
to differentiate spontaneously##2##3##(1990-5#2)
to differentiate the##10##3##(2008-10#5)(2008-12#1)(2009-10#1)(2010-4#1)(2012-5#1)(2013-1#1)
to differentiate them##2##3##(1990-8#1)(2008-2#1)
to differentiate these##2##3##(2008-11#1)(2008-9#1)
to differentiate##105##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2012-4#1)(2012-5#2)(2013-1#3)(2013-7#1)
to differentiated##2##2##(2008-5#1)(2012-2#1)
to differentiation##5##2##(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#2)
to differing##3##2##(1992-12#1)(1994-9#1)(2011-2#1)
to difficulties in##4##3##(1992-5#1)(2008-11#1)(2012-2#1)(2013-1#1)
to difficulties with##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
to difficulties##7##2##(1992-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
to difficulty in##2##3##(2007-11#1)(2008-1#1)
to difficulty##3##2##(2007-11#1)(2008-1#1)(2008-5#1)
to diffraction##2##2##(2007-11#1)(2008-3#1)
to diffraction-limited##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
to diffuse##4##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
to diffusion##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
to digestion##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
to digital microscopy##2##3##(2008-3#1)(2011-2#1)
to digital##7##2##(2008-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)
to dihydropyridines##2##2##(1993-11#1)(1993-3#1)
to dihydrotestosterone (DHT)##2##3##(1994-11#1)(2008-2#1)
to dilute##3##2##(2008-7#3)
to dimerize##2##2##(2008-10#1)(2010-12#1)
to dimethylarsinic acid##2##3##(1993-3#2)
to diminish the##3##3##(1991-8#1)(2007-2#1)(2008-3#1)
to diminish##7##2##(1991-8#1)(1995-3#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
to diode##2##2##(2008-10#1)(2008-3#1)
to dioxins##2##2##(2008-10#1)(2008-7#1)
to direct different##2##3##(2008-10#1)(2009-8#1)
to direct patient care##2##4##(1992-1#1)(1995-3#1)
to direct patient##3##3##(1992-1#1)(1995-3#1)(2012-3#1)
to direct stimulation of##2##4##(2008-10#1)(2008-11#1)
to direct sunlight##2##3##(1994-1#1)(2008-10#1)
to direct the synthesis of##2##5##(1991-9#1)(2008-7#1)
to direct the##7##3##(1991-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
to direct transcription of##2##4##(1993-12#1)(1994-2#1)
to direct##53##2##(1990-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-4#1)(1997-7#2)(2007-7#1)(2008-10#8)(2008-11#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)
to directed##2##2##(2008-7#1)(2012-2#1)
to directional##2##2##(2008-11#1)(2008-3#1)
to directly determine##2##3##(2008-10#2)
to directly examine##2##3##(2008-9#1)(2009-11#1)
to directly measure the##2##4##(2008-10#1)(2013-8#1)
to directly measure##4##3##(1992-9#1)(2008-10#1)(2008-4#1)(2013-8#1)
to directly stimulate##4##3##(1996-9#1)(2008-1#1)(2008-11#1)(2010-3#1)
to directly target the##2##4##(1997-1#1)(2010-7#1)
to directly##35##2##(1991-7#1)(1992-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-7#1)(2013-8#1)
to disability##4##2##(1997-6#1)(2008-6#1)(2012-12#2)
to disaggregate##2##2##(1992-12#1)(2008-10#1)
to disappear##6##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-8#1)
to disappearance of##2##3##(1990-8#1)(2009-12#1)
to discern the##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
to discern##10##2##(1996-1#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#2)
to discharge service members##2##4##(1995-6#1)(1996-5#1)
to discharge##14##2##(1994-2#1)(1995-6#1)(1996-5#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#2)(2010-11#1)(2010-4#1)(2012-1#1)
to discipline##2##2##(2009-7#1)(2012-12#1)
to disclose the##4##3##(1990-12#1)(2008-7#3)
to disclose##11##2##(1990-12#1)(1991-12#1)(1995-2#1)(2008-12#1)(2008-7#4)(2010-4#2)(2011-1#1)
to discomfort##2##2##(2008-12#1)(2009-1#1)
to discontinue the##2##3##(1990-2#1)(1992-12#1)
to discontinue treatment##3##3##(1991-3#1)(2011-1#2)
to discontinue##13##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-6#1)(1995-5#1)(2008-7#1)(2009-7#1)(2011-1#2)(2012-2#1)(2013-8#1)
to discount the##2##3##(2009-7#1)(2009-9#1)
to discount##3##2##(1994-3#1)(2009-7#1)(2009-9#1)
to discover new##2##3##(2008-3#1)(2012-3#1)
to discover the##4##3##(1993-1#1)(1995-3#1)(2008-11#1)(2012-3#1)
to discover which##3##3##(1993-10#1)(1995-2#1)(2010-8#1)
to discover##32##2##(1991-7#1)(1993-1#1)(1993-10#1)(1993-11#1)(1994-12#1)(1995-2#2)(1995-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-9#2)(2010-12#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-8#2)
to discovery of##2##3##(2008-7#2)
to discovery##3##2##(2008-7#2)(2010-7#1)
to discrete##7##2##(1994-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-6#1)
to discriminate against##5##3##(1994-2#1)(1994-3#1)(2008-8#2)(2013-1#1)
to discriminate between familiar and unfamiliar##2##6##(2010-2#2)
to discriminate between familiar##3##4##(2010-2#3)
to discriminate between the##2##4##(2008-10#1)(2008-11#1)
to discriminate between##31##3##(1991-12#1)(1991-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#1)(2011-2#1)
to discriminate symmetry##2##3##(2008-8#2)
to discriminate the##4##3##(1993-8#1)(2008-7#2)(2011-1#1)
to discriminate##80##2##(1990-11#1)(1991-12#2)(1991-3#1)(1992-10#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-11#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to discrimination##2##2##(1992-12#1)(2007-12#1)
to discuss and##2##3##(2006-10#1)(2008-10#1)
to discuss current##2##3##(2008-3#1)(2008-7#1)
to discuss how##2##3##(2008-12#1)(2008-4#1)
to discuss recent##2##3##(2009-4#1)(2009-5#1)
to discuss some of these issues##2##6##(2007-7#1)(2008-1#1)
to discuss some of these##3##5##(2007-7#1)(2008-1#2)
to discuss some of##4##4##(2007-7#1)(2008-1#2)(2008-7#1)
to discuss some##5##3##(1991-1#1)(2007-7#1)(2008-1#2)(2008-7#1)
to discuss the possible##2##4##(1994-11#1)(2008-9#1)
to discuss the##34##3##(1991-6#1)(1994-11#1)(1997-4#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
to discuss these##3##3##(1995-1#1)(2007-12#1)(2008-10#1)
to discuss##72##2##(1991-1#1)(1991-6#1)(1994-11#1)(1995-1#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-7#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#2)(2010-11#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
to discussion of##2##3##(2008-10#1)(2013-8#1)
to discussion##4##2##(1994-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
to discussions##2##2##(1996-8#1)(2008-11#1)
to disease and death##2##4##(1997-7#1)(2012-2#1)
to disease and##5##3##(1997-7#1)(2008-10#2)(2008-8#1)(2012-2#1)
to disease development##4##3##(2008-10#4)
to disease incidence##4##3##(2008-10#4)
to disease management programs##2##4##(2008-10#1)(2008-11#1)
to disease management##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
to disease onset##2##3##(2008-10#2)
to disease progression##3##3##(1997-8#1)(2008-10#1)(2008-3#1)
to disease risk assessment##2##4##(2008-10#2)
to disease severity in##2##4##(2008-10#1)(2009-2#1)
to disease severity##7##3##(2008-10#1)(2008-7#1)(2009-2#3)(2011-1#1)(2011-2#1)
to disease suppression##4##3##(2008-10#4)
to disease##66##2##(1994-9#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#31)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
to diseases of##2##3##(2007-5#1)(2010-1#1)
to diseases##6##2##(1992-5#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-1#1)
to disentangle the##4##3##(1991-1#1)(2008-9#1)(2011-2#1)(2012-2#1)
to disentangle##5##2##(1991-1#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
to disk##2##2##(2008-2#1)(2008-3#1)
to dismantle##2##2##(1993-5#1)(1994-12#1)
to dismiss##3##2##(1995-12#1)(1995-6#1)(1996-5#1)
to disordered##4##2##(1996-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
to disorders of##2##3##(2008-11#1)(2008-4#1)
to disorders##3##2##(2007-8#1)(2008-11#1)(2008-4#1)
to disparate##2##2##(1997-9#1)(2008-7#1)
to disparities in##2##3##(1993-12#1)(2013-1#1)
to dispense a##3##3##(1995-1#2)(1996-1#1)
to dispense##4##2##(1995-1#2)(1996-1#1)(1997-7#1)
to dispersal and##2##3##(2008-8#1)(2010-8#1)
to dispersal##6##2##(2008-5#1)(2008-8#4)(2010-8#1)
to disperse##6##2##(1992-6#1)(2008-10#2)(2008-2#1)(2008-8#2)
to dispersion##4##2##(2007-11#3)(2007-12#1)
to displace##7##2##(1992-3#2)(1994-12#1)(2008-10#1)(2008-8#2)(2011-1#1)
to displacement by##2##3##(1994-9#1)(2008-8#1)
to displacement##6##2##(1991-12#1)(1994-9#1)(2007-12#1)(2008-8#2)(2012-2#1)
to display a##4##3##(1990-8#1)(2008-2#1)(2009-11#1)(2012-2#1)
to display the##3##3##(2007-11#1)(2008-3#2)
to display##33##2##(1990-12#2)(1990-7#1)(1990-8#1)(1993-8#1)(1995-1#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#1)
to dispose##2##2##(2008-11#1)(2008-12#1)
to disrupt mitochondrial##2##3##(1990-11#2)
to disrupt the##8##3##(1990-7#1)(1991-3#1)(1994-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
to disrupt##15##2##(1990-11#2)(1990-7#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-9#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
to disruption of##4##3##(2007-2#1)(2007-8#1)(2008-11#1)(2011-2#1)
to disruption##5##2##(2007-2#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
to dissect the##5##3##(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)
to dissect##8##2##(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
to disseminate##6##2##(1991-1#1)(1996-1#1)(2006-9#1)(2008-11#1)(2011-1#1)(2013-1#1)
to dissemination##2##2##(1996-11#1)(2012-12#1)
to dissipate##2##2##(2009-12#1)(2012-12#1)
to dissociate##7##2##(1992-6#1)(1995-2#2)(2008-10#1)(2008-4#2)(2013-8#1)
to dissociation##3##2##(1993-8#1)(1996-7#1)(2012-12#1)
to dissolve both##2##3##(1995-2#2)
to dissolve##6##2##(1994-8#1)(1995-2#3)(2008-7#1)(2008-9#1)
to distal##5##2##(2008-5#1)(2010-1#1)(2010-6#1)(2012-3#1)(2013-3#1)
to distance and##2##3##(2008-10#1)(2011-2#1)
to distance##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
to distant sites##3##3##(1995-4#1)(2009-5#1)(2012-3#1)
to distant##6##2##(1993-3#2)(1995-4#1)(2008-6#1)(2009-5#1)(2012-3#1)
to distinct##14##2##(1991-5#1)(1992-4#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
to distinguish a##4##3##(2008-3#2)(2008-5#2)
to distinguish among different##2##4##(2007-12#1)(2008-10#1)
to distinguish among##7##3##(1993-6#1)(2007-12#1)(2008-10#2)(2008-8#2)(2011-1#1)
to distinguish and##2##3##(2008-4#1)(2010-4#1)
to distinguish between the two##2##5##(1994-2#1)(2012-2#1)
to distinguish between the##6##4##(1994-2#1)(1996-5#1)(2008-10#2)(2009-12#1)(2012-2#1)
to distinguish between##34##3##(1990-3#1)(1990-7#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-4#1)(2008-1#1)(2008-10#12)(2008-6#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
to distinguish patients##2##3##(2012-2#1)(2013-1#1)
to distinguish the two##2##4##(2008-10#1)(2008-11#1)
to distinguish the##13##3##(1993-11#1)(1995-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)
to distinguish them from##2##4##(2008-12#1)(2012-12#1)
to distinguish this##2##3##(2011-1#1)(2012-2#1)
to distinguish whether##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to distinguish##124##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1996-5#1)(1997-3#2)(1997-7#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#3)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#4)
to distinguishing##2##2##(1991-1#1)(2008-10#1)
to distraction##3##2##(2011-2#1)(2012-3#2)
to distress##2##2##(1990-12#1)(2013-7#1)
to distribute##4##2##(2008-3#3)(2008-9#1)
to distributed##4##2##(2007-11#3)(2012-2#1)
to distribution##2##2##(2007-12#1)(2008-10#1)
to disturb the##2##3##(1994-8#1)(2008-5#1)
to disturbance##8##2##(2008-8#7)(2013-7#1)
to diurnal##2##2##(1992-11#1)(2007-12#1)
to divalent cations##2##3##(1990-5#1)(2008-10#1)
to divalent ions##2##3##(2008-10#2)
to divalent##4##2##(1990-5#1)(2008-10#3)
to diverge##4##2##(1992-8#1)(1993-12#1)(2008-9#1)(2010-12#1)
to divergent selection##2##3##(2012-3#1)(2013-1#1)
to divergent##5##2##(1993-12#1)(1997-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
to diverse##15##2##(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
to diversify##2##2##(2008-11#2)
to diversity##3##2##(1994-12#1)(2008-10#2)
to divert##2##2##(1991-1#1)(2012-3#1)
to divide##5##2##(1997-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-10#1)
to divide)##2##2##(2009-12#2)
to divine##2##2##(1992-5#1)(1996-1#1)
to do a##2##3##(2008-8#1)(2013-8#1)
to do it##4##3##(1994-1#1)(1995-1#1)(1995-12#1)(1997-1#1)
to do otherwise##3##3##(2007-12#1)(2010-12#2)
to do research##2##3##(1992-6#1)(2012-3#1)
to do so by##2##4##(2008-11#1)(2008-3#1)
to do so in##2##4##(1997-1#1)(2008-10#1)
to do so##19##3##(1991-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-6#1)
to do the##2##3##(2008-10#1)(2012-2#1)
to do their##3##3##(1997-3#1)(2012-12#1)(2013-8#1)
to do this##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
to do whatever##2##3##(1992-3#1)(1993-1#1)
to do with the##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
to do with##8##3##(1991-1#1)(1994-3#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
to do##88##2##(1990-2#1)(1991-1#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#1)(2007-10#3)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-9#2)(2010-12#4)(2010-3#1)(2010-8#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#3)
to document a##2##3##(2007-9#1)(2008-2#1)
to document and##2##3##(1995-3#1)(2008-10#1)
to document the presence of##2##5##(2010-6#1)(2011-2#1)
to document the##10##3##(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#2)
to document##23##2##(1991-2#1)(1992-3#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#1)
to documented##2##2##(1990-11#1)(1995-6#1)
to dodine##3##2##(2008-10#3)
to domestic##2##2##(2009-11#1)(2011-2#1)
to dominate the##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
to dominate##6##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
to donate a##2##3##(2007-10#1)(2009-3#1)
to donate##6##2##(1991-5#1)(1992-8#1)(1994-3#1)(2007-10#2)(2009-3#1)
to donor##2##2##(1992-3#1)(2011-2#1)
to dopamine##9##2##(1992-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-2#1)(2008-10#1)(2009-12#1)(2010-12#1)
to dopaminergic##3##2##(2008-2#1)(2008-7#1)(2012-12#1)
to doping##2##2##(2008-10#1)(2009-11#1)
to dose##9##2##(1995-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#2)
to double the##2##3##(2007-12#1)(2008-7#1)
to double##6##2##(1996-12#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-3#1)
to double-stranded##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
to down-modulate##2##2##(1995-2#1)(2013-1#1)
to down-regulation of the##2##4##(2007-12#1)(2012-2#1)
to down-regulation of##3##3##(1992-2#1)(2007-12#1)(2012-2#1)
to downregulate##4##2##(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)
to downsizing##2##2##(1993-1#1)(1996-12#1)
to downstream effectors##2##3##(2010-11#1)(2012-12#1)
to downstream##4##2##(1997-4#1)(2008-11#1)(2010-11#1)(2012-12#1)
to downward##2##2##(2008-10#1)(2012-2#1)
to downy mildew##4##3##(2008-10#4)
to dox##2##2##(2008-6#2)
to doxorubicin##4##2##(1990-2#1)(1991-6#1)(1997-4#1)(2008-11#1)
to drain##8##2##(2007-12#2)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
to dramatically reduce##2##3##(2008-10#1)(2008-8#1)
to dramatically##6##2##(1995-12#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-5#1)
to draw a##4##3##(1997-6#1)(2007-12#1)(2012-12#1)(2013-8#1)
to draw attention to an##2##5##(2007-11#1)(2011-2#1)
to draw attention to##6##4##(1990-9#1)(2007-11#1)(2007-8#2)(2011-1#1)(2011-2#1)
to draw conclusions##3##3##(2007-7#1)(2008-6#1)(2010-3#1)
to draw the attention of##3##5##(1991-6#1)(2007-7#1)(2010-3#1)
to draw the##7##3##(1991-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-3#1)
to draw up##3##3##(1997-5#1)(2008-11#1)(2008-9#1)
to draw##37##2##(1990-9#1)(1991-6#1)(1992-11#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
to dream##2##2##(1991-3#1)(2008-3#1)
to drift##2##2##(2008-10#1)(2013-1#1)
to drink##4##2##(1992-3#1)(2008-1#1)(2008-11#1)(2008-5#1)
to drinking water##14##3##(1992-5#1)(1993-8#1)(2007-2#1)(2008-10#1)(2008-9#10)
to drinking##15##2##(1992-5#1)(1993-8#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-9#10)
to drive the##11##3##(1994-6#1)(1994-8#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-8#2)(2009-8#1)(2010-5#1)
to drive##26##2##(1994-6#1)(1994-8#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#4)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)
to drop##5##2##(1992-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
to droplets##2##2##(2008-2#2)
to drought and##2##3##(2012-5#1)(2012-7#1)
to drought stress##2##3##(2008-12#1)(2008-7#1)
to drought##13##2##(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-5#2)(2012-7#3)(2012-8#2)
to drug development##3##3##(1991-3#1)(2008-5#1)(2010-11#1)
to drug therapy##2##3##(2008-4#1)(2008-7#1)
to drug treatment##4##3##(1995-12#1)(1996-9#1)(2008-11#1)(2008-9#1)
to drug use##2##3##(2009-3#1)(2009-7#1)
to drug##24##2##(1991-3#1)(1992-9#1)(1995-12#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-7#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
to drug-induced##2##2##(2007-10#1)(2008-10#1)
to drugs and##3##3##(1993-10#1)(1993-11#1)(2011-1#1)
to drugs with##2##3##(1997-5#1)(2008-7#1)
to drugs##21##2##(1990-12#1)(1991-2#1)(1993-10#1)(1993-11#1)(1994-9#1)(1995-2#1)(1997-5#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#3)(2013-8#1)
to dry and##2##3##(2008-5#2)
to dry out##2##3##(2008-10#1)(2008-9#1)
to dry wines##2##3##(2008-10#2)
to dry##14##2##(2008-10#9)(2008-5#2)(2008-9#1)(2010-4#1)(2013-1#1)
to drying##2##2##(2010-7#1)(2012-2#1)
to dryness on a##2##4##(2008-10#2)
to dryness under##2##3##(2008-10#1)(2013-7#1)
to dryness##13##2##(2008-10#12)(2013-7#1)
to dsDNA##2##2##(2008-1#1)(2008-8#1)
to ducklings##2##2##(1992-9#1)(2008-10#1)
to duplex DNA##2##3##(1991-3#1)(1995-2#1)
to duplex##3##2##(1991-3#1)(1995-2#1)(2008-12#1)
to dural##2##2##(2008-7#1)(2012-3#1)
to duration of##2##3##(1992-2#1)(1996-12#1)
to dye##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
to dye-loaded##2##2##(2008-10#1)(2009-2#1)
to dynamic##7##2##(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
to dynamical##2##2##(2008-8#1)(2010-8#1)
to dysfunction of the##2##4##(1993-12#1)(2009-2#1)
to dysfunction of##3##3##(1993-12#1)(2009-2#1)(2013-1#1)
to dysphagia##2##2##(1993-2#1)(2012-2#1)
to each dimension##2##3##(2010-10#1)(2011-2#1)
to each drug##3##3##(1993-8#1)(2008-10#1)(2008-6#1)
to each electrical##2##3##(1994-2#1)(1997-4#1)
to each individual##2##3##(2008-10#1)(2010-8#1)
to each method##2##3##(1995-11#1)(2012-3#1)
to each nurse##2##3##(1993-12#1)(2008-11#1)
to each of four##2##4##(1990-7#1)(2008-10#1)
to each of the three##3##5##(2007-11#1)(2008-10#2)
to each of the##19##4##(1993-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-9#1)(2007-11#1)(2008-10#6)(2008-3#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
to each of these##5##4##(2008-10#3)(2008-7#1)(2008-9#1)
to each of##26##3##(1990-7#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-9#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
to each other and to the##2##6##(2008-10#1)(2013-1#1)
to each other and##12##4##(1993-11#1)(1993-3#1)(1996-3#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#2)(2013-8#1)
to each other but##3##4##(1995-2#1)(1997-3#1)(2008-10#1)
to each other in##2##4##(1990-12#1)(2008-10#1)
to each other than are##2##5##(1993-6#1)(2008-8#1)
to each other than##4##4##(1993-6#1)(2008-10#2)(2008-8#1)
to each other with##3##4##(2008-1#1)(2008-2#1)(2008-8#1)
to each other##69##3##(1990-12#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#2)(2009-7#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
to each other's##2##3##(1996-7#1)(2010-11#1)
to each participant##3##3##(2007-12#1)(2007-8#1)(2008-11#1)
to each patient##4##3##(1992-6#1)(1994-8#1)(2008-10#1)(2011-2#1)
to each virus##2##3##(2008-10#2)
to each##174##2##(1990-12#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#45)(2008-11#11)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-7#4)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#4)
to ear##4##2##(1993-2#2)(2008-10#2)
to earlier##10##2##(1993-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
to early and##2##3##(2008-4#1)(2008-7#1)
to early detection of##2##4##(1991-4#1)(2009-5#1)
to early recognition##2##3##(2011-2#1)(2012-3#1)
to early stages of##2##4##(1997-8#1)(2008-10#1)
to early##36##2##(1991-4#1)(1992-9#1)(1993-8#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#2)(2012-7#1)(2013-7#1)
to earn##2##2##(1992-12#1)(2008-12#1)
to earthquake prediction##3##3##(1996-4#3)
to earthquake##4##2##(1996-4#4)
to ease##3##2##(2008-5#1)(2008-9#1)(2009-9#1)
to easily##11##2##(1992-9#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2012-12#2)(2012-2#1)
to eat it##3##3##(1993-6#3)
to eat##9##2##(1992-9#1)(1993-6#3)(1997-4#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)
to ecological##5##2##(1996-4#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
to ecology##2##2##(2008-10#1)(2009-8#1)
to economic##5##2##(1994-2#1)(1997-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
to ectopic##2##2##(1990-3#1)(1994-3#1)
to edges##2##2##(2008-9#2)
to editorial##5##2##(1993-12#1)(1993-9#1)(2010-12#3)
to educate and##3##3##(1995-12#1)(1997-6#1)(2011-1#1)
to educate both##2##3##(2008-12#1)(2009-11#1)
to educate patients##3##3##(2007-9#1)(2008-3#1)(2010-4#1)
to educate the public##2##4##(1994-5#1)(2011-2#1)
to educate the##4##3##(1994-1#2)(1994-5#1)(2011-2#1)
to educate##25##2##(1993-12#2)(1994-1#2)(1994-5#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-12#5)(2008-3#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
to education##6##2##(1994-2#1)(1995-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
to educational##2##2##(2008-12#1)(2012-2#1)
to effect a##3##3##(2008-3#1)(2008-4#1)(2008-6#1)
to effect##19##2##(1992-3#1)(1994-1#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-9#1)
to effective therapeutic##2##3##(1994-11#1)(2008-7#1)
to effective##17##2##(1990-9#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
to effectively control the##2##4##(2007-11#1)(2008-7#1)
to effectively increase##2##3##(2008-5#1)(2012-12#1)
to effectively produce##2##3##(2008-10#1)(2008-11#1)
to effectively reduce##2##3##(1996-3#1)(2007-11#1)
to effectively represent the##2##4##(2008-11#1)(2013-1#1)
to effectively treat##2##3##(2008-4#1)(2008-8#1)
to effectively##40##2##(1992-9#1)(1995-1#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-5#1)(2007-11#3)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
to effects of##5##3##(1992-5#1)(2007-12#1)(2008-8#2)(2008-9#1)
to effects on the##2##4##(2008-8#2)
to effects on##4##3##(2008-8#3)(2012-12#1)
to effects##10##2##(1992-5#1)(2007-12#1)(2008-10#1)(2008-8#5)(2008-9#1)(2012-12#1)
to effectuate##2##2##(1990-11#1)(2008-10#1)
to efficacy##4##2##(1995-5#1)(1996-5#1)(2008-5#1)(2011-2#1)
to efficient##6##2##(1996-2#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
to efficiently produce##2##3##(2008-2#1)(2008-6#1)
to efficiently##20##2##(1994-5#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#3)
to efforts##2##2##(2008-11#1)(2011-2#1)
to egg##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
to eggs##4##2##(2007-12#1)(2008-10#1)(2008-8#2)
to eight different##2##3##(2008-10#2)
to eight##22##2##(1990-7#1)(1997-2#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-11#1)(2013-1#1)(2013-7#1)
to eightfold##3##2##(1997-7#1)(2008-10#2)
to either a##7##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)(2013-1#1)
to either an##3##3##(1997-3#1)(2007-11#1)(2009-9#1)
to either enhance or suppress##2##5##(2009-8#1)(2011-2#1)
to either enhance##3##3##(2009-7#1)(2009-8#1)(2011-2#1)
to either of the two##2##5##(1991-12#1)(1994-8#1)
to either the##13##3##(1994-5#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2009-11#1)
to either##103##2##(1990-12#3)(1991-12#3)(1991-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-3#2)(1997-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to ejaculation##5##2##(1991-2#3)(1992-12#1)(1994-2#1)
to elaborate##4##2##(2008-10#1)(2010-1#1)(2010-5#1)(2012-12#1)
to elder abuse##2##3##(1991-2#2)
to elder##3##2##(1991-2#2)(1994-2#1)
to elderly##5##2##(1990-3#1)(1993-12#1)(1997-2#1)(2012-3#2)
to electric##5##2##(1994-5#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-7#1)
to electrical stimulation of the##3##5##(1990-7#1)(1992-8#1)(1993-12#1)
to electrical stimulation of##4##4##(1990-7#1)(1992-8#1)(1993-12#1)(1993-3#1)
to electrical stimulation##6##3##(1990-5#1)(1990-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(2008-7#1)
to electrical##12##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-7#1)
to electroanalytical##2##2##(2008-10#2)
to electrochemical##2##2##(2008-10#2)
to electrode##3##2##(2008-10#3)
to electrodes##2##2##(2008-2#1)(2008-7#1)
to electron beam##2##3##(1992-12#1)(2007-10#1)
to electron##5##2##(1991-5#2)(1992-12#1)(2007-10#1)(2008-3#1)
to electronic##7##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-1#1)
to electrophoretic homogeneity##4##3##(1990-7#1)(1993-8#1)(1994-8#1)(2008-10#1)
to electrophoretic##5##2##(1990-7#1)(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#1)
to electrostatic interactions##2##3##(2008-10#1)(2008-6#1)
to element##2##2##(2008-5#1)(2008-7#1)
to elemental##3##2##(2007-12#1)(2008-10#2)
to elements##2##2##(1995-6#1)(2007-12#1)
to elevate and##2##3##(2007-11#1)(2008-10#1)
to elevate the##4##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-6#1)
to elevate##12##2##(1991-1#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-8#1)
to elevated glucose##3##3##(1992-8#2)(2010-11#1)
to elevated##11##2##(1992-8#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-7#1)(2013-8#1)
to elicit a##5##3##(1993-12#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-4#1)
to elicit an##2##3##(1990-12#1)(2008-10#1)
to elicit the##7##3##(1991-2#1)(1996-3#1)(2008-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
to elicit##46##2##(1990-12#1)(1990-7#1)(1991-2#1)(1992-2#2)(1992-9#2)(1993-12#2)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-1#2)(2013-1#2)(2013-8#1)
to elicitins##2##2##(2008-10#2)
to eliminate malaria##2##3##(2012-12#1)(2012-3#1)
to eliminate or control##2##4##(2007-12#1)(2012-3#1)
to eliminate or##4##3##(2007-12#1)(2010-11#1)(2012-3#1)(2013-8#1)
to eliminate sample matrix interferences##2##5##(2008-10#2)
to eliminate the false##2##4##(1997-4#1)(2008-3#1)
to eliminate the need for##2##5##(2008-10#1)(2008-2#1)
to eliminate the##32##3##(1991-12#1)(1994-3#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#2)(2013-1#1)
to eliminate them##2##3##(1996-3#1)(2013-7#1)
to eliminate undesired fermentation products##2##5##(2008-6#2)
to eliminate##82##2##(1991-12#1)(1991-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#10)(2008-4#2)(2008-6#3)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
to eliminating##2##2##(2008-3#1)(2009-10#1)
to elimination of##3##3##(1996-2#1)(1996-5#1)(2011-1#1)
to elimination##4##2##(1996-2#1)(1996-5#1)(2011-1#1)(2011-2#1)
to elite##2##2##(2008-10#1)(2009-1#1)
to elongate##2##2##(1994-11#2)
to elucidate RNA folding pathways##2##5##(2008-4#2)
to elucidate its##2##3##(2008-10#1)(2013-1#1)
to elucidate potential mechanisms##2##4##(2008-10#1)(2012-1#1)
to elucidate some##3##3##(1993-3#1)(2007-8#1)(2008-10#1)
to elucidate the effect of##2##5##(2008-10#1)(2012-2#1)
to elucidate the functional role of##2##6##(1993-3#1)(1995-6#1)
to elucidate the functional##3##4##(1993-3#1)(1994-3#1)(1995-6#1)
to elucidate the influence of##2##5##(2009-7#1)(2012-6#1)
to elucidate the mechanism by which##3##6##(1990-7#1)(1994-5#1)(2008-11#1)
to elucidate the mechanism of##2##5##(1997-7#1)(2008-10#1)
to elucidate the mechanism underlying##2##5##(2010-8#1)(2012-2#1)
to elucidate the mechanism##7##4##(1990-7#1)(1994-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
to elucidate the mechanisms of##2##5##(2008-10#1)(2012-12#1)
to elucidate the mechanisms##5##4##(1995-8#1)(1997-3#1)(2008-10#2)(2012-12#1)
to elucidate the molecular mechanism##2##5##(2008-10#1)(2008-8#1)
to elucidate the molecular##3##4##(1997-7#1)(2008-10#1)(2008-8#1)
to elucidate the nature of##3##5##(1995-6#1)(2008-10#1)(2008-11#1)
to elucidate the potential##2##4##(2011-2#2)
to elucidate the relationship between the##2##6##(1997-2#1)(1997-8#1)
to elucidate the relationship between##4##5##(1997-2#1)(1997-8#1)(2008-10#1)(2010-4#1)
to elucidate the role of different##2##6##(2008-10#1)(2009-8#1)
to elucidate the role of the##2##6##(1992-3#1)(1992-6#1)
to elucidate the role of these##3##6##(1995-2#1)(2008-10#1)(2009-5#1)
to elucidate the role of##7##5##(1992-3#1)(1992-6#1)(1995-2#1)(2008-10#2)(2009-5#1)(2009-8#1)
to elucidate the structure of the##2##6##(1993-11#1)(2008-10#1)
to elucidate the##87##3##(1990-7#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-6#1)
to elucidate their##2##3##(2008-5#1)(2010-4#1)
to elucidate##126##2##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#2)
to elucidating the mechanisms of##2##5##(2008-8#1)(2012-1#1)
to elute##2##2##(1990-5#1)(2008-10#1)
to elution##2##2##(2008-10#1)(2008-4#1)
to embark on##3##3##(1994-2#1)(1996-2#1)(2008-12#1)
to embrace the##3##3##(1994-12#1)(2008-1#1)(2010-8#1)
to embrace##7##2##(1994-1#1)(1994-12#1)(1997-2#1)(2008-1#2)(2010-7#1)(2010-8#1)
to embryos##2##2##(1991-5#1)(2008-9#1)
to emerge as a##2##4##(2007-11#1)(2007-12#1)
to emerge from##4##3##(2008-11#2)(2009-2#1)(2010-4#1)
to emerge##17##2##(1995-12#1)(1995-9#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-7#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
to emergency##6##2##(1991-12#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-6#2)
to emerging health##2##3##(2008-7#1)(2012-2#1)
to emerging##6##2##(2008-10#2)(2008-7#1)(2010-3#1)(2010-8#1)(2012-2#1)
to emit light##2##3##(2008-2#1)(2008-4#1)
to emit##5##2##(1990-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2012-2#1)
to emotional well-being##2##3##(2012-12#1)(2013-1#1)
to emotional##12##2##(1992-3#1)(1993-5#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
to emphasize that the##2##4##(1997-1#1)(2008-2#1)
to emphasize that##5##3##(1994-11#1)(1997-1#1)(2008-2#1)(2008-4#1)(2012-2#1)
to emphasize the importance of##2##5##(2008-12#1)(2008-8#1)
to emphasize the##10##3##(1992-3#1)(1994-11#1)(1995-4#1)(1996-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-12#1)
to emphasize##19##2##(1992-3#2)(1994-11#2)(1995-4#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#2)
to empirical##2##2##(2008-8#2)
to employ a##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
to employ in the##2##4##(2012-12#1)(2013-8#1)
to employ##20##2##(1990-2#3)(1990-9#1)(1994-12#1)(1994-6#1)(1995-4#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
to employee##5##2##(1993-2#1)(1995-2#1)(1996-5#1)(1997-3#1)(2011-1#1)
to employees##6##2##(1991-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-3#1)(2007-10#1)
to employers and##2##3##(1994-1#1)(2008-3#1)
to empower##3##2##(1992-3#1)(2010-12#1)(2011-2#1)
to emulate##3##2##(2008-3#1)(2010-5#1)(2012-12#1)
to enable a##4##3##(2008-11#1)(2008-2#1)(2012-1#1)(2013-1#1)
to enable informed##2##3##(1994-7#1)(2009-4#1)
to enable older people to remain##2##6##(2013-1#2)
to enable older##3##3##(2013-1#3)
to enable students##2##3##(2008-11#1)(2008-12#1)
to enable the sensitive##2##4##(2008-10#2)
to enable the##17##3##(1994-2#1)(1995-1#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#2)
to enable them to##2##4##(1994-9#1)(2012-1#1)
to enable women##2##3##(2010-12#1)(2011-1#1)
to enable##74##2##(1991-11#1)(1991-5#1)(1993-12#1)(1994-2#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-9#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-3#1)(2011-1#3)(2012-1#2)(2012-2#2)(2013-1#5)
to enact##3##2##(1991-2#1)(1995-12#1)(2008-11#1)
to enantiomerically pure L-amino acids##3##5##(1992-11#1)(1995-3#2)
to encapsulate##2##2##(2008-4#1)(2013-1#1)
to encode a protein of##4##5##(1990-8#1)(1993-12#1)(1996-6#1)(2008-10#1)
to encode a##21##3##(1990-8#1)(1992-4#1)(1993-12#2)(1994-12#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)
to encode an##3##3##(1992-10#1)(2008-2#1)(2008-3#1)
to encode its##2##3##(1990-8#1)(1991-12#1)
to encode proteins##2##3##(1994-9#1)(1995-8#1)
to encode the##5##3##(1994-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
to encode##45##2##(1990-8#2)(1991-12#1)(1992-10#1)(1992-4#1)(1993-12#2)(1993-9#1)(1994-12#3)(1994-9#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
to encompass##6##2##(1991-1#1)(1995-6#1)(1997-2#1)(2008-8#1)(2010-9#1)(2012-2#1)
to encounter##4##2##(1991-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
to encourage new##2##3##(2008-4#1)(2008-6#1)
to encourage nursing##2##3##(2008-11#1)(2010-10#1)
to encourage the##3##3##(1994-3#1)(2008-11#1)(2013-8#1)
to encourage##39##2##(1991-1#1)(1991-2#1)(1991-5#1)(1993-1#1)(1994-1#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-6#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
to end of##2##3##(1997-4#1)(2008-10#1)
to end stage renal disease (ESRD)##2##6##(2007-7#1)(2008-1#1)
to end stage renal disease##3##5##(2007-7#2)(2008-1#1)
to end users##2##3##(1993-3#1)(1995-3#1)
to end##16##2##(1992-6#1)(1993-3#1)(1993-5#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-4#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#2)
to end-stage renal disease##3##4##(2008-1#2)(2010-10#1)
to end-stage renal##5##3##(2008-1#3)(2008-7#1)(2010-10#1)
to end-stage##7##2##(2008-1#3)(2008-7#1)(2010-10#2)(2012-3#1)
to endemic areas##3##3##(2006-10#1)(2007-2#1)(2008-10#1)
to endemic##4##2##(2006-10#1)(2007-2#2)(2008-10#1)
to endocrine cells##2##3##(2008-7#1)(2008-8#1)
to endocrine therapy##2##3##(1993-9#1)(2007-10#1)
to endocrine##10##2##(1993-9#1)(1996-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
to endogenous levels##2##3##(1995-2#1)(2008-10#1)
to endogenous##9##2##(1993-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(2008-10#2)(2009-12#1)(2009-9#1)(2010-11#1)
to endometrial##3##2##(1994-9#1)(2007-10#1)(2011-2#1)
to endophytic sites##2##3##(2008-10#2)
to endoscopic##7##2##(1993-6#1)(1994-9#1)(2007-8#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
to endothelial cells was##2##4##(1991-2#1)(1992-12#1)
to endothelial cells##11##3##(1991-2#2)(1992-12#2)(1994-5#1)(1995-12#2)(1997-1#2)(2008-12#1)(2009-3#1)
to endothelial dysfunction##3##3##(2008-3#1)(2009-10#1)(2010-10#1)
to endothelial##16##2##(1991-2#2)(1992-12#2)(1993-3#1)(1994-5#1)(1995-12#2)(1997-1#2)(1997-8#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-3#1)(2010-10#1)
to endothelin##4##2##(1990-2#2)(1994-11#2)
to endothelin-1##7##2##(1990-8#3)(1995-12#4)
to endothelium##5##2##(1992-12#2)(1995-2#2)(2012-2#1)
to endotoxin##2##2##(1991-9#1)(1996-12#1)
to endurance##2##2##(2008-5#1)(2008-7#1)
to energy intake##2##3##(2009-8#1)(2010-8#1)
to energy##7##2##(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
to energy-matched continuous exercise##2##4##(2013-8#2)
to enforce##7##2##(1992-1#1)(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
to engage consumers##2##3##(2013-1#2)
to engage in health disparities research##2##6##(2012-3#2)
to engage in treatment##2##4##(2013-1#2)
to engage in##22##3##(1990-2#1)(1992-6#1)(1994-3#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2009-7#2)(2011-2#1)(2012-3#4)(2013-1#3)
to engage the##4##3##(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)
to engage youth##2##3##(2008-7#1)(2012-2#1)
to engage##39##2##(1990-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#2)(2009-5#1)(2009-7#2)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#6)(2013-1#5)
to engineer a##2##3##(2008-11#2)
to engineer##12##2##(2007-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-9#1)(2010-10#2)(2011-2#2)(2012-2#1)
to engraft##4##2##(2008-11#1)(2010-11#2)(2012-12#1)
to enhance a##2##3##(1994-3#1)(1997-8#1)
to enhance an##2##3##(2008-10#1)(2008-5#1)
to enhance and##2##3##(2008-4#1)(2010-12#1)
to enhance cell growth and##2##5##(2008-11#2)
to enhance communication##2##3##(1991-12#1)(2012-1#1)
to enhance it##2##3##(1994-5#1)(2010-5#1)
to enhance its##2##3##(1995-3#1)(2008-3#1)
to enhance learning##2##3##(2008-11#1)(2012-2#1)
to enhance medication##2##3##(2011-1#1)(2013-8#1)
to enhance our understanding of##3##5##(2008-7#1)(2009-5#1)(2010-3#1)
to enhance our##4##3##(2008-10#1)(2008-7#1)(2009-5#1)(2010-3#1)
to enhance patient care##2##4##(2008-10#1)(2008-11#1)
to enhance patient##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2010-3#2)
to enhance professional##2##3##(2008-12#1)(2013-8#1)
to enhance quality of##2##4##(1996-12#1)(1996-2#1)
to enhance student learning##2##4##(2008-11#1)(2008-12#1)
to enhance student##3##3##(2008-11#2)(2008-12#1)
to enhance successful##2##3##(1992-3#1)(2008-8#1)
to enhance the CL##2##4##(2008-10#2)
to enhance the accuracy##2##4##(2008-10#2)
to enhance the antiproliferative##2##4##(1990-2#1)(1991-4#1)
to enhance the cell##2##4##(1993-8#1)(2008-11#1)
to enhance the contrast##2##4##(2008-1#1)(2008-3#1)
to enhance the detection of##2##5##(1994-3#2)
to enhance the detection##3##4##(1994-3#2)(2008-3#1)
to enhance the effectiveness of##3##5##(2008-10#1)(2008-12#1)(2008-6#1)
to enhance the efficiency of##2##5##(2008-10#1)(2010-5#1)
to enhance the efficiency##3##4##(2008-10#1)(2008-2#1)(2010-5#1)
to enhance the image##2##4##(2009-10#1)(2011-1#1)
to enhance the learning##2##4##(2011-2#1)(2012-2#1)
to enhance the overall##2##4##(2008-12#1)(2008-7#1)
to enhance the productivity##2##4##(1990-11#1)(2008-11#1)
to enhance the rate##2##4##(1992-8#1)(2008-1#1)
to enhance the sensitivity of##3##5##(2008-10#2)(2009-4#1)
to enhance the sensitivity##4##4##(2008-10#2)(2008-2#1)(2009-4#1)
to enhance the separation of##2##5##(1994-9#1)(2008-10#1)
to enhance the##119##3##(1990-11#1)(1990-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#4)(2008-10#21)(2008-11#12)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)
to enhance their##8##3##(1992-3#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-1#1)(2012-12#1)(2012-3#1)
to enhance understanding of##3##4##(2007-10#1)(2011-2#1)(2013-1#1)
to enhance##273##2##(1990-11#1)(1990-2#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2007-10#2)(2007-11#7)(2007-12#7)(2007-4#1)(2007-7#1)(2008-1#4)(2008-10#41)(2008-11#25)(2008-12#11)(2008-2#4)(2008-3#15)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2012-4#1)(2013-1#6)(2013-8#3)
to enhanced##17##2##(1992-8#1)(1993-9#1)(1994-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-9#1)(2009-4#1)(2012-5#1)
to enhancement of##2##3##(2008-10#1)(2011-2#1)
to enhancing##4##2##(1991-2#1)(2007-10#1)(2007-12#1)(2010-11#1)
to enjoy##3##2##(1991-12#1)(2008-11#1)(2008-9#1)
to enrich the##2##3##(2008-11#1)(2013-1#1)
to enrich##12##2##(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#2)(2013-1#1)
to enrol their children in##2##5##(2009-6#2)
to enrol##3##2##(2009-6#3)
to enroll in##2##3##(1994-3#1)(2008-3#1)
to enroll##3##2##(1994-3#1)(1995-12#1)(2008-3#1)
to ensure a high##2##4##(2012-3#2)
to ensure a##9##3##(1996-3#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#2)
to ensure accuracy##2##3##(2008-3#1)(2008-4#1)
to ensure adequate##5##3##(1990-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
to ensure an##2##3##(2010-3#1)(2012-2#1)
to ensure appropriate##3##3##(1994-3#1)(2008-10#1)(2013-8#1)
to ensure complete##3##3##(2008-10#1)(2008-11#2)
to ensure continuity##2##3##(1993-1#1)(2012-3#1)
to ensure control##2##3##(1993-12#1)(1993-6#1)
to ensure effective##2##3##(1997-3#1)(2013-1#1)
to ensure good##2##3##(1996-12#1)(2010-10#1)
to ensure high quality##2##4##(1995-6#1)(2008-11#1)
to ensure high##3##3##(1995-6#1)(2008-11#1)(2008-3#1)
to ensure it##2##3##(2008-1#1)(2008-11#1)
to ensure its##4##3##(1994-9#1)(2008-10#2)(2008-5#1)
to ensure optimal##2##3##(2008-10#1)(2010-10#1)
to ensure successful##2##3##(2010-3#1)(2011-1#1)
to ensure that a##6##4##(1993-3#1)(1996-3#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-7#1)
to ensure that all##3##4##(1996-12#1)(2012-3#1)(2013-1#1)
to ensure that each##2##4##(1993-2#1)(2012-3#1)
to ensure that the##15##4##(1994-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2010-3#1)(2012-2#1)
to ensure that they are##2##5##(2008-12#1)(2011-2#1)
to ensure that they##3##4##(2008-12#1)(2011-2#2)
to ensure that##69##3##(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#2)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
to ensure the best##2##4##(2008-10#1)(2013-1#1)
to ensure the risk##2##4##(2007-11#1)(2008-10#1)
to ensure the safety of##3##5##(1991-1#1)(2008-9#1)(2011-2#1)
to ensure the##30##3##(1991-1#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-9#1)(2013-1#1)(2013-7#1)
to ensure they##2##3##(1994-2#1)(2013-1#1)
to ensure##213##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#21)(2008-12#6)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#10)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#7)(2012-3#8)(2012-9#1)(2013-1#7)(2013-7#2)(2013-8#2)
to ensuring##8##2##(1992-3#1)(1996-11#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-12#1)
to enter into the##2##4##(1991-2#1)(2008-5#1)
to enter into##5##3##(1991-2#1)(1991-3#1)(1993-3#1)(2006-12#1)(2008-5#1)
to enter the study##2##4##(1990-5#1)(2007-7#1)
to enter the##12##3##(1990-5#1)(1990-7#1)(1991-2#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
to enter##23##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-3#1)(1994-3#1)(1996-12#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
to entering##5##2##(1993-1#1)(1994-12#1)(1994-3#1)(1997-3#1)(2008-11#1)
to entry##2##2##(1995-3#1)(1997-6#1)
to enumerate##2##2##(2008-4#1)(2010-8#1)
to environment##2##2##(2008-10#1)(2008-12#1)
to environmental and##3##3##(2008-12#1)(2008-8#1)(2011-1#1)
to environmental challenges##2##3##(2009-9#1)(2013-8#1)
to environmental changes##5##3##(1994-12#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-8#1)
to environmental conditions##4##3##(1990-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
to environmental cues and##2##4##(2012-1#1)(2012-12#1)
to environmental cues##3##3##(2012-1#2)(2012-12#1)
to environmental factors are##2##4##(2011-2#1)(2012-5#1)
to environmental factors such as##2##5##(2008-10#1)(2013-1#1)
to environmental factors##9##3##(2008-10#3)(2008-5#2)(2011-2#1)(2012-5#1)(2013-1#2)
to environmental features of##2##4##(2008-8#1)(2012-9#1)
to environmental fluctuations##2##3##(2008-8#2)
to environmental samples##4##3##(2008-10#3)(2011-2#1)
to environmental stimuli##2##3##(1992-6#1)(2009-11#1)
to environmental stressors##3##3##(2010-4#3)
to environmental##67##2##(1990-6#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-1#1)(1996-9#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2012-5#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
to envisage##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
to envision##2##2##(1994-2#1)(2012-12#1)
to enzymatic hydrolysis##2##3##(2009-8#1)(2013-1#1)
to enzymatic##6##2##(1993-2#1)(1994-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2013-1#1)
to enzyme##5##2##(1990-11#1)(1993-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
to enzymes##2##2##(1992-3#1)(2011-1#1)
to epidemic##5##2##(1991-12#1)(2007-2#1)(2008-10#2)(2012-12#1)
to epidemiologists##2##2##(2008-10#1)(2008-11#1)
to epidemiology##3##2##(1997-7#1)(2010-12#1)(2011-2#1)
to epidermal growth factor (EGF)##2##5##(1991-2#1)(1993-3#1)
to epidermal growth factor receptor##2##5##(2009-4#1)(2012-1#1)
to epidermal growth factor##5##4##(1991-2#2)(1993-3#1)(2009-4#1)(2012-1#1)
to epidermal##7##2##(1991-2#2)(1993-3#1)(2007-7#1)(2008-10#1)(2009-4#1)(2012-1#1)
to epigenetic##2##2##(2008-7#1)(2012-12#1)
to epiphyseal##2##2##(1990-11#1)(2011-2#1)
to epithelial cells##3##3##(2008-10#1)(2008-5#2)
to epithelial##6##2##(1997-6#1)(2008-10#1)(2008-5#3)(2013-8#1)
to epitopes##2##2##(1993-12#1)(1995-2#1)
to equal##3##2##(1995-1#1)(2008-10#2)
to equilibrium##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
to equip##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
to equipment##4##2##(1994-2#1)(1996-2#1)(2008-12#1)(2011-2#1)
to equivalent##2##2##(1996-1#1)(2008-7#1)
to equivocal##2##2##(1991-3#1)(2009-10#1)
to eradicate polio##3##3##(1994-9#3)
to eradicate the disease##3##4##(1994-9#2)(2011-2#1)
to eradicate##12##2##(1993-12#1)(1994-9#5)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
to erectile dysfunction##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
to erode##2##2##(1991-2#1)(1994-7#1)
to error##3##2##(2008-10#2)(2008-2#1)
to errors in the##3##4##(2008-2#1)(2008-3#2)
to errors in##6##3##(2008-2#1)(2008-3#3)(2009-10#1)(2011-2#1)
to errors##11##2##(2008-12#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
to erythromycin or##2##3##(2010-6#2)
to escalating costs##2##3##(2008-1#1)(2012-12#1)
to escape from the##2##4##(1996-12#1)(2008-8#1)
to escape from##3##3##(1996-12#1)(2008-8#1)(2011-2#1)
to escape the##2##3##(2007-10#1)(2008-9#1)
to escape##8##2##(1996-12#2)(2007-10#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
to essential hypertension##4##3##(2008-9#3)(2010-4#1)
to essential##9##2##(2008-5#1)(2008-9#3)(2009-5#2)(2010-4#1)(2010-6#1)(2012-2#1)
to establish a cell##2##4##(2008-11#1)(2008-7#1)
to establish a classification##2##4##(2008-5#2)
to establish a diagnosis of##2##5##(1994-2#1)(2011-2#1)
to establish a framework##2##4##(1994-3#1)(2008-10#1)
to establish a good##2##4##(1991-1#1)(2008-11#1)
to establish a system##2##4##(1992-3#1)(2008-7#1)
to establish a##52##3##(1990-3#1)(1991-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to establish an##7##3##(1992-5#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)
to establish and maintain##2##4##(2008-2#1)(2012-2#1)
to establish and##5##3##(1991-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#1)
to establish baseline##2##3##(1993-1#1)(2008-11#1)
to establish correlations between##2##4##(2008-10#2)
to establish correlations##3##3##(2008-10#2)(2010-5#1)
to establish different##2##3##(2008-10#1)(2010-5#1)
to establish early##2##3##(1997-1#1)(2008-1#1)
to establish in##2##3##(1996-9#1)(2008-11#1)
to establish its##6##3##(1990-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
to establish new##2##3##(1997-2#1)(2011-2#1)
to establish some##2##3##(1992-3#1)(2011-2#1)
to establish suitable##2##3##(2008-10#1)(2011-2#1)
to establish surgical##2##3##(1997-7#1)(2012-12#1)
to establish systemic infection##2##4##(2008-10#2)
to establish systemic##3##3##(2008-10#3)
to establish that##6##3##(1990-11#1)(1992-3#1)(1995-9#1)(2007-12#1)(2008-3#1)(2013-1#1)
to establish the accuracy##2##4##(1994-2#1)(2008-3#1)
to establish the best##3##4##(2008-10#3)
to establish the extent of##3##5##(1991-6#1)(2007-11#1)(2010-4#1)
to establish the extent##5##4##(1991-6#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-4#1)
to establish the identity##2##4##(2008-10#1)(2011-1#1)
to establish the impact of enquiry based learning##2##8##(2008-11#2)
to establish the most##2##4##(2008-10#1)(2013-8#1)
to establish the new##2##4##(2008-10#1)(2008-9#1)
to establish the optimum##2##4##(1996-9#1)(2008-10#1)
to establish the prevalence of##2##5##(1992-1#1)(2013-8#1)
to establish the role of##2##5##(2008-10#1)(2012-2#1)
to establish the##76##3##(1991-6#1)(1992-1#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
to establish their##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
to establish whether the##2##4##(2009-10#1)(2011-2#1)
to establish whether##7##3##(1995-5#1)(1997-4#1)(2008-11#1)(2009-10#1)(2011-2#2)(2013-7#1)
to establish##274##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#3)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-10#4)(2007-11#4)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#20)(2008-12#4)(2008-2#7)(2008-3#11)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#4)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#15)(2011-7#1)(2012-12#5)(2012-2#11)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#7)
to established##10##2##(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)
to establishing and##2##3##(1992-3#1)(2010-7#1)
to establishing##5##2##(1992-3#1)(1997-3#1)(2008-7#1)(2010-7#1)(2012-12#1)
to estimate DNA##3##3##(1997-4#1)(2008-10#2)
to estimate a##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
to estimate how##2##3##(1995-12#1)(2011-1#1)
to estimate odds ratios##2##4##(2007-10#1)(2011-2#1)
to estimate parameters##2##3##(2008-10#1)(2011-3#1)
to estimate relative##2##3##(2008-10#1)(2008-11#1)
to estimate survival##2##3##(1990-9#1)(2008-10#1)
to estimate the absorption and##2##5##(2008-3#1)(2008-5#1)
to estimate the absorption##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
to estimate the age-specific incidence of an irreversible disease##2##9##(1994-11#2)
to estimate the amount of##4##5##(2008-10#1)(2008-2#1)(2010-8#2)
to estimate the apparent##2##4##(2008-10#2)
to estimate the calibration##2##4##(2008-10#1)(2008-3#1)
to estimate the cell##2##4##(1995-9#1)(2008-11#1)
to estimate the concentration of##3##5##(2007-12#1)(2008-10#2)
to estimate the contribution of##4##5##(1992-12#1)(2008-10#2)(2010-11#1)
to estimate the depth of##2##5##(2008-3#1)(2011-2#1)
to estimate the dynamic##2##4##(2008-12#1)(2009-9#1)
to estimate the impact of##2##5##(1996-3#1)(2008-10#1)
to estimate the importance of##2##5##(1994-3#1)(2008-10#1)
to estimate the levels of##2##5##(2006-10#1)(2012-2#1)
to estimate the maximum##2##4##(2007-11#1)(2008-3#1)
to estimate the mean##2##4##(2008-10#1)(2008-3#1)
to estimate the measurement##2##4##(2008-10#1)(2008-2#1)
to estimate the number of##3##5##(2007-12#1)(2008-10#1)(2008-7#1)
to estimate the number##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
to estimate the parameters##3##4##(2008-10#1)(2008-3#1)(2009-5#1)
to estimate the potential##4##4##(1991-3#1)(2008-10#3)
to estimate the prevalence of##6##5##(1994-9#1)(1995-10#1)(2007-7#1)(2008-12#1)(2009-10#1)(2013-8#1)
to estimate the prevalence##7##4##(1994-9#1)(1995-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2013-8#1)
to estimate the rates##2##4##(2008-11#1)(2013-8#1)
to estimate the relative##2##4##(2008-10#1)(2008-8#1)
to estimate the sensitivity and specificity of##2##7##(1994-11#1)(1996-8#1)
to estimate the sensitivity##3##4##(1994-11#1)(1996-8#1)(2008-7#1)
to estimate the specific growth rate##2##6##(2008-7#2)
to estimate the specific##3##4##(1996-12#1)(2008-7#2)
to estimate the survival##2##4##(1995-12#1)(2008-8#1)
to estimate the total##4##4##(2007-12#1)(2008-10#2)(2008-7#1)
to estimate the vertical##2##4##(2008-3#2)
to estimate the##171##3##(1991-3#1)(1991-5#1)(1992-12#2)(1994-11#5)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#21)(2008-4#3)(2008-5#4)(2008-7#11)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
to estimate these##2##3##(2008-10#1)(2013-1#1)
to estimate zinc##2##3##(2008-10#2)
to estimate##297##2##(1990-9#2)(1991-3#2)(1991-5#1)(1992-12#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#5)(1994-12#1)(1994-3#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#69)(2008-11#11)(2008-12#4)(2008-2#12)(2008-3#36)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#9)(2011-1#4)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#5)
to estimates of##4##3##(1991-2#2)(1992-5#1)(2008-10#1)
to estimates##5##2##(1991-2#2)(1992-5#1)(2008-10#1)(2008-5#1)
to estimation of##3##3##(1997-3#1)(2008-3#1)(2008-9#1)
to estrogen in##3##3##(1992-9#2)(2008-11#1)
to estrogen##9##2##(1991-2#1)(1992-9#3)(1995-4#1)(2008-10#1)(2008-11#2)(2008-7#1)
to estrogens##2##2##(2011-1#2)
to ethanol##21##2##(1992-7#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-6#9)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to ethical##3##2##(1996-12#1)(2008-12#2)
to ethics##3##2##(1995-3#1)(2008-11#2)
to ethnic##3##2##(2008-10#1)(2009-7#2)
to ethnicity##2##2##(2009-7#2)
to ethyl##2##2##(1996-2#1)(2009-12#1)
to ethylene##3##2##(1992-3#1)(2008-10#1)(2009-8#1)
to eucalyptus##3##2##(2008-5#2)(2008-6#1)
to eukaryotic##2##2##(1995-2#1)(2008-9#1)
to evacuate##2##2##(2008-7#2)
to evade##3##2##(2008-10#2)(2010-6#1)
to evaluate a new##2##4##(1991-1#1)(1997-4#1)
to evaluate a##23##3##(1991-1#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
to evaluate additional##2##3##(2008-10#1)(2008-5#1)
to evaluate alternative##2##3##(1992-2#1)(2012-12#1)
to evaluate an##2##3##(2007-11#1)(2011-1#1)
to evaluate and validate##2##4##(2010-7#1)(2013-8#1)
to evaluate and##11##3##(1993-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
to evaluate any##2##3##(1997-2#1)(2008-9#1)
to evaluate both##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
to evaluate changes in##4##4##(1994-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
to evaluate changes##5##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-2#1)
to evaluate clinical##5##3##(1995-2#1)(2007-11#1)(2007-4#1)(2007-8#2)
to evaluate differences in##4##4##(1994-3#1)(2008-10#2)(2009-4#1)
to evaluate disease##2##3##(2008-10#2)
to evaluate each##2##3##(2008-10#2)
to evaluate effects of##4##4##(2008-12#1)(2010-7#1)(2013-1#2)
to evaluate efficacy##2##3##(2008-2#1)(2011-2#1)
to evaluate estrogenic potency of dietary phytoestrogens##2##7##(2008-10#2)
to evaluate estrogenic potency##3##4##(2008-10#3)
to evaluate existing##2##3##(1994-2#1)(2008-10#1)
to evaluate exposure-response##2##3##(2008-7#2)
to evaluate factors##2##3##(2007-7#1)(2008-1#1)
to evaluate for##3##3##(2008-1#1)(2008-10#1)(2009-6#1)
to evaluate how they##2##4##(1993-2#1)(2013-7#1)
to evaluate how##5##3##(1993-2#1)(2008-10#1)(2008-12#1)(2013-7#1)(2013-8#1)
to evaluate if##4##3##(1996-9#1)(2008-4#1)(2011-2#1)(2013-1#1)
to evaluate its clinical##2##4##(2008-10#1)(2010-12#1)
to evaluate its##11##3##(1990-12#1)(1990-2#1)(1994-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-12#2)(2011-1#1)
to evaluate long-term##2##3##(1990-6#1)(2008-10#1)
to evaluate our##2##3##(2007-8#2)
to evaluate oxidative##2##3##(2008-10#1)(2013-1#1)
to evaluate patients with##2##4##(2008-3#1)(2013-8#1)
to evaluate patients##3##3##(2008-3#2)(2013-8#1)
to evaluate platelet##2##3##(2008-9#2)
to evaluate possible##5##3##(1990-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2012-3#1)
to evaluate postoperative##2##3##(1992-3#1)(2011-2#1)
to evaluate potential##4##3##(2008-10#1)(2008-4#2)(2008-6#1)
to evaluate risk##2##3##(2008-8#2)
to evaluate salinity tolerance##2##4##(2008-12#2)
to evaluate the CLB##2##4##(2007-10#2)
to evaluate the ability of this##2##6##(1990-2#1)(1995-5#1)
to evaluate the ability of##5##5##(1990-2#1)(1993-9#1)(1995-5#1)(2008-4#1)(2008-9#1)
to evaluate the association##3##4##(2012-3#1)(2013-1#2)
to evaluate the binding##2##4##(1990-12#1)(2008-10#1)
to evaluate the changes in the##2##6##(1996-6#1)(2008-3#1)
to evaluate the clinical##3##4##(1995-3#1)(2011-2#1)(2013-1#1)
to evaluate the consequences##2##4##(1993-3#1)(2008-9#1)
to evaluate the content of##2##5##(2008-10#2)
to evaluate the contribution of##3##5##(1994-1#1)(2008-9#1)(2009-4#1)
to evaluate the course##2##4##(2008-11#1)(2011-1#1)
to evaluate the degree of##4##5##(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
to evaluate the diagnostic##2##4##(1991-2#1)(2012-12#1)
to evaluate the different##2##4##(1990-9#1)(2008-7#1)
to evaluate the dynamics of##2##5##(2008-10#1)(2010-11#1)
to evaluate the early and##3##5##(2007-8#1)(2008-12#1)(2008-8#1)
to evaluate the early##4##4##(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)
to evaluate the effect of a##4##6##(1995-11#1)(1997-4#1)(2008-2#1)(2012-3#1)
to evaluate the effect of different##2##6##(2008-12#1)(2012-2#1)
to evaluate the effect of the##3##6##(2008-1#1)(2008-10#1)(2008-12#1)
to evaluate the effect of##36##5##(1990-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#2)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
to evaluate the effect##37##4##(1990-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
to evaluate the effectiveness of a##5##6##(1992-1#2)(1996-11#1)(2008-4#1)(2008-9#1)
to evaluate the effectiveness of the##3##6##(2007-11#1)(2008-10#1)(2011-1#1)
to evaluate the effectiveness of##18##5##(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
to evaluate the effectiveness##19##4##(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
to evaluate the effects of different##3##6##(2008-12#1)(2012-2#1)(2013-1#1)
to evaluate the effects of the##2##6##(1993-12#1)(2008-10#1)
to evaluate the effects of##27##5##(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to evaluate the effects##28##4##(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to evaluate the efficacy and safety of##2##7##(2007-10#1)(2008-10#1)
to evaluate the efficacy and##3##5##(1990-2#1)(2007-10#1)(2008-10#1)
to evaluate the efficacy of a##5##6##(1997-8#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
to evaluate the efficacy of##24##5##(1993-1#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
to evaluate the efficacy##27##4##(1990-2#1)(1993-1#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
to evaluate the efficiency of##3##5##(2008-3#1)(2010-8#2)
to evaluate the evidence##2##4##(1993-12#1)(2012-2#1)
to evaluate the extent to which##2##6##(2008-11#1)(2008-3#1)
to evaluate the extent##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
to evaluate the feasibility and##3##5##(1991-3#1)(2013-1#1)(2013-8#1)
to evaluate the feasibility of##3##5##(1992-12#1)(2008-10#1)(2011-2#1)
to evaluate the feasibility##6##4##(1991-3#1)(1992-12#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
to evaluate the frequency of##6##5##(1992-6#1)(1994-12#1)(2007-8#1)(2013-1#2)(2013-8#1)
to evaluate the frequency##8##4##(1992-6#1)(1994-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2013-1#2)(2013-8#1)
to evaluate the impact of a##3##6##(1996-1#1)(2008-3#1)(2012-3#1)
to evaluate the impact of##10##5##(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
to evaluate the incidence and##2##5##(2008-10#1)(2008-2#1)
to evaluate the incidence of##2##5##(2010-2#1)(2013-1#1)
to evaluate the incidence##4##4##(2008-10#1)(2008-2#1)(2010-2#1)(2013-1#1)
to evaluate the individual##2##4##(1995-6#1)(2008-12#1)
to evaluate the influence of the##3##6##(1990-2#1)(2008-12#1)(2009-8#1)
to evaluate the influence of##9##5##(1990-2#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-8#1)(2013-1#1)(2013-7#1)
to evaluate the influence##10##4##(1990-2#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-7#1)
to evaluate the long-term##5##4##(2009-8#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-3#1)
to evaluate the most##2##4##(1995-4#1)(2008-5#1)
to evaluate the overall##3##4##(2008-8#1)(2009-11#1)(2011-1#1)
to evaluate the performance of a##3##6##(2007-8#1)(2008-3#1)(2011-2#1)
to evaluate the performance of the##2##6##(2007-8#1)(2010-8#1)
to evaluate the performance of##9##5##(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-12#1)
to evaluate the physiological##2##4##(2012-2#1)(2013-7#1)
to evaluate the possibility##2##4##(2007-8#1)(2010-12#1)
to evaluate the possible##4##4##(2008-1#1)(2008-5#1)(2012-8#1)(2013-1#1)
to evaluate the potential##6##4##(1992-9#1)(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
to evaluate the prevalence and##2##5##(2007-7#1)(2013-8#1)
to evaluate the prevalence##6##4##(2007-7#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-8#1)
to evaluate the prognostic value##2##5##(1997-8#1)(2007-8#1)
to evaluate the protective effect of##2##6##(2008-5#1)(2013-1#1)
to evaluate the protective##3##4##(2008-5#2)(2013-1#1)
to evaluate the quality of##4##5##(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
to evaluate the rate of##2##5##(1994-6#1)(2010-5#1)
to evaluate the relationship between##3##5##(1995-8#1)(2008-10#1)(2012-2#1)
to evaluate the relationship##5##4##(1995-8#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
to evaluate the reproducibility of##3##5##(2008-10#2)(2008-12#1)
to evaluate the reproducibility##4##4##(2008-10#2)(2008-12#1)(2009-11#1)
to evaluate the results##5##4##(1997-8#1)(2007-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
to evaluate the risk of##5##5##(2007-11#2)(2008-8#1)(2011-2#2)
to evaluate the risk##6##4##(2007-11#2)(2008-10#1)(2008-8#1)(2011-2#2)
to evaluate the role of##11##5##(1994-9#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-10#1)(2011-2#2)(2013-1#1)
to evaluate the roles of##2##5##(2008-10#1)(2008-9#1)
to evaluate the safety and efficacy of the##2##8##(2008-11#2)
to evaluate the safety and efficacy of##4##7##(2008-11#3)(2010-12#1)
to evaluate the safety and##6##5##(2007-10#1)(2008-11#3)(2008-7#1)(2010-12#1)
to evaluate the safety of##2##5##(2008-11#1)(2011-1#1)
to evaluate the safety##9##4##(1992-11#1)(2007-10#1)(2008-11#4)(2008-7#1)(2010-12#1)(2011-1#1)
to evaluate the sampling##2##4##(2008-10#1)(2009-5#1)
to evaluate the significance of##2##5##(1993-12#1)(2011-2#1)
to evaluate the skin##2##4##(2008-5#2)
to evaluate the spatial##2##4##(1994-3#1)(2008-10#1)
to evaluate the stability of##2##5##(1992-2#1)(2010-3#1)
to evaluate the stability##3##4##(1992-2#1)(2008-12#1)(2010-3#1)
to evaluate the suitability of##2##5##(2008-10#2)
to evaluate the therapeutic potential of##2##6##(2009-3#1)(2013-8#1)
to evaluate the therapeutic##4##4##(1990-2#1)(2008-10#1)(2009-3#1)(2013-8#1)
to evaluate the use of##4##5##(1990-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
to evaluate the usefulness of##2##5##(2008-11#1)(2008-6#1)
to evaluate the utility of##2##5##(2008-10#1)(2008-7#1)
to evaluate the whole##2##4##(2008-10#1)(2008-12#1)
to evaluate the wound-healing##2##4##(2008-10#1)(2008-5#1)
to evaluate the##547##3##(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#2)(1991-4#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#8)(2006-10#2)(2007-10#6)(2007-11#11)(2007-12#2)(2007-7#11)(2007-8#12)(2007-9#1)(2008-1#9)(2008-10#84)(2008-11#15)(2008-12#27)(2008-2#7)(2008-3#18)(2008-4#6)(2008-5#30)(2008-6#7)(2008-7#15)(2008-8#7)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#9)(2011-2#31)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#14)(2012-3#14)(2012-8#1)(2013-1#33)(2013-7#5)(2013-8#10)
to evaluate their experiences with##2##5##(2007-7#1)(2008-10#1)
to evaluate their experiences##3##4##(2007-7#1)(2008-10#2)
to evaluate their##18##3##(1994-3#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
to evaluate these##2##3##(2008-1#1)(2011-2#1)
to evaluate this##7##3##(1993-3#1)(1993-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-3#1)
to evaluate three##2##3##(2010-11#1)(2013-1#1)
to evaluate to##2##3##(1994-3#1)(2008-10#1)
to evaluate total##2##3##(2011-1#1)(2011-2#1)
to evaluate treatment response##2##4##(2008-7#1)(2010-9#1)
to evaluate whether the##9##4##(1993-8#2)(1995-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
to evaluate whether##25##3##(1993-8#2)(1994-12#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
to evaluate which##3##3##(1990-6#1)(2008-11#1)(2011-1#1)
to evaluate##922##2##(1990-11#2)(1990-12#5)(1990-2#6)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#2)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#5)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#11)(2006-10#2)(2007-10#8)(2007-11#21)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#15)(2007-8#21)(2007-9#2)(2008-1#14)(2008-10#137)(2008-11#26)(2008-12#36)(2008-2#13)(2008-3#30)(2008-4#15)(2008-5#45)(2008-6#12)(2008-7#30)(2008-8#12)(2008-9#25)(2009-10#3)(2009-11#5)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#9)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#3)(2010-8#11)(2010-9#1)(2011-1#15)(2011-2#49)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#7)(2012-2#21)(2012-3#22)(2012-8#1)(2013-1#54)(2013-7#9)(2013-8#21)
to evaluating##2##2##(1995-12#1)(2007-12#1)
to evaluation of##2##3##(2008-10#1)(2008-9#1)
to evaporate##2##2##(1995-12#1)(2008-11#1)
to even##4##2##(1995-6#1)(2008-10#1)(2008-5#1)(2012-12#1)
to every##9##2##(1991-3#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
to everyday##3##2##(1994-6#1)(2010-4#1)(2012-1#1)
to evidence##3##2##(2008-9#1)(2010-12#1)(2013-1#1)
to evidence-based practice##4##3##(2013-1#4)
to evidence-based##5##2##(2013-1#5)
to evoke##4##2##(1993-12#2)(1993-3#1)(2008-1#1)
to evolution##5##2##(1997-6#1)(2008-8#1)(2012-2#1)(2012-3#2)
to evolutionary##4##2##(2007-12#1)(2008-8#1)(2009-3#1)(2010-3#1)
to evolve and##6##3##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to evolve in##4##3##(1994-12#1)(2008-8#1)(2010-3#1)(2011-2#1)
to evolve rapidly##3##3##(2007-12#1)(2008-6#1)(2010-3#1)
to evolve##36##2##(1994-12#2)(1994-3#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#3)(2010-3#3)(2010-8#2)(2011-2#4)(2012-12#1)(2013-1#2)
to evolving##2##2##(2008-9#2)
to ex vivo##2##3##(2008-11#1)(2011-3#1)
to ex##3##2##(2008-11#1)(2009-8#1)(2011-3#1)
to exactly##3##2##(2007-12#1)(2009-11#1)(2010-8#1)
to examine a##3##3##(1996-12#1)(2007-11#1)(2008-11#1)
to examine and##3##3##(1992-11#1)(1993-12#1)(2010-9#1)
to examine associations between##2##4##(2008-9#1)(2012-1#1)
to examine barriers##2##3##(2008-6#1)(2013-1#1)
to examine both##2##3##(2008-1#2)
to examine developmental changes in the##2##6##(1997-2#1)(2008-11#1)
to examine differences in##2##4##(2008-10#1)(2011-2#1)
to examine factors that contribute to##2##6##(2007-10#1)(2008-7#1)
to examine factors##4##3##(2007-10#1)(2007-7#1)(2008-7#1)(2011-2#1)
to examine how##9##3##(1993-2#1)(1995-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
to examine if##3##3##(1992-11#1)(2008-11#1)(2008-9#1)
to examine in##2##3##(2007-12#1)(2009-7#1)
to examine its##4##3##(1994-9#1)(2007-11#1)(2008-2#1)(2012-2#1)
to examine job satisfaction##2##4##(1994-1#1)(2008-11#1)
to examine molecular##2##3##(2008-7#1)(2008-9#1)
to examine nursing##2##3##(2008-12#1)(2010-10#1)
to examine patterns of##3##4##(1996-4#1)(2008-10#1)(2008-6#1)
to examine possible##3##3##(2008-11#1)(2008-4#1)(2010-7#1)
to examine specific##2##3##(2007-12#1)(2007-6#1)
to examine the association between##5##5##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
to examine the association##6##4##(1995-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#2)
to examine the binding##2##4##(1994-9#1)(1995-12#1)
to examine the changes in##2##5##(2007-8#1)(2013-8#1)
to examine the conditions##2##4##(2008-8#1)(2009-7#1)
to examine the consequences of##3##5##(1995-6#1)(2008-2#1)(2008-8#1)
to examine the crack##2##4##(2009-7#2)
to examine the demographic##2##4##(2008-8#1)(2012-3#1)
to examine the development of##2##5##(2008-11#1)(2008-5#1)
to examine the distribution of##2##5##(2008-5#1)(2008-8#1)
to examine the effect of##18##5##(1991-10#1)(1992-6#1)(1993-12#1)(1994-11#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2010-11#1)(2010-6#1)(2012-2#2)(2013-1#1)
to examine the effects of##16##5##(1991-12#1)(1992-1#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-8#1)(2012-2#1)(2013-8#3)
to examine the experiences of##2##5##(1995-1#1)(2008-12#1)
to examine the expression of##2##5##(1994-6#1)(2008-8#1)
to examine the expression##3##4##(1991-5#1)(1994-6#1)(2008-8#1)
to examine the extent to which##4##6##(2008-1#1)(2008-8#1)(2009-9#1)(2012-2#1)
to examine the feasibility of##2##5##(2008-11#1)(2008-9#1)
to examine the functional##2##4##(1996-5#1)(2008-11#1)
to examine the genetic##2##4##(2008-10#1)(2009-5#1)
to examine the impact of##5##5##(1991-3#1)(1994-2#1)(1997-2#1)(2007-10#1)(2011-2#1)
to examine the influence of##3##5##(1995-3#1)(2008-11#1)(2008-12#1)
to examine the metabolic##2##4##(2008-10#1)(2008-3#1)
to examine the patterns of##2##5##(2008-7#1)(2012-12#1)
to examine the possible role of##2##6##(1994-11#1)(1996-2#1)
to examine the possible##4##4##(1994-11#1)(1996-2#1)(2011-2#1)(2013-1#1)
to examine the prevalence##3##4##(2008-5#1)(2009-5#1)(2010-3#1)
to examine the psychometric properties of the##2##7##(2010-11#1)(2013-1#1)
to examine the reactions of##2##5##(2008-11#1)(2008-7#1)
to examine the regulation of##2##5##(2008-4#1)(2008-9#1)
to examine the relationship between body##2##6##(2009-5#1)(2011-1#1)
to examine the relationship between##13##5##(1992-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to examine the relationship##14##4##(1992-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to examine the relationships between##5##5##(1997-2#1)(2008-10#1)(2009-12#1)(2010-4#1)(2011-2#1)
to examine the relative##2##4##(1996-1#1)(2008-8#1)
to examine the results of##2##5##(2007-10#1)(2009-12#1)
to examine the role of the##2##6##(1993-12#1)(1996-5#1)
to examine the role of##5##5##(1993-12#1)(1994-11#1)(1996-2#1)(1996-5#1)(1997-3#1)
to examine the role##6##4##(1993-12#1)(1994-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-9#1)
to examine the spatial##2##4##(2008-10#2)
to examine the structure of the##2##6##(1995-2#1)(2008-2#1)
to examine the temporal##2##4##(2008-3#2)
to examine the##243##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#4)(1992-6#1)(1992-8#1)(1993-12#5)(1994-11#4)(1994-2#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-5#2)(1997-2#2)(1997-3#1)(1997-6#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#23)(2008-11#18)(2008-12#8)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#10)(2008-7#13)(2008-8#13)(2008-9#6)(2009-10#2)(2009-12#3)(2009-3#1)(2009-5#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#6)
to examine their##5##3##(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)
to examine these##4##3##(1993-12#1)(2008-6#1)(2009-10#1)(2012-2#1)
to examine this##5##3##(2007-12#1)(2009-10#1)(2009-11#1)(2010-2#2)
to examine whether a##2##4##(2008-10#1)(2010-5#1)
to examine whether the##4##4##(1993-12#1)(1996-7#1)(2008-5#1)(2011-1#1)
to examine whether##18##3##(1993-12#1)(1995-9#1)(1996-7#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
to examine##419##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#3)(1992-2#5)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#8)(1993-2#1)(1994-1#2)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-3#1)(1997-6#1)(2007-10#4)(2007-11#6)(2007-12#9)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#35)(2008-11#34)(2008-12#15)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#18)(2008-8#16)(2008-9#11)(2009-10#5)(2009-11#1)(2009-12#5)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#3)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#17)(2012-1#2)(2012-12#5)(2012-2#15)(2012-3#5)(2013-1#14)(2013-8#9)
to examining##4##2##(2008-3#1)(2008-5#1)(2013-1#2)
to exceed a##3##3##(2008-10#2)(2008-7#1)
to exceed that##2##3##(2008-10#1)(2010-2#1)
to exceed the##3##3##(1995-3#1)(2008-3#2)
to exceed##12##2##(1994-12#1)(1995-3#1)(2008-10#3)(2008-3#5)(2008-7#1)(2010-2#1)
to excellent yields##2##3##(2008-9#1)(2010-8#1)
to excellent##8##2##(2007-11#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-7#2)(2010-8#1)(2012-12#1)
to excess##5##2##(1990-7#1)(1993-1#1)(1996-5#1)(2008-10#1)(2008-11#1)
to excessive##13##2##(1992-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-4#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
to exchange the##2##3##(1997-1#1)(2008-10#1)
to exchange##13##2##(1997-1#2)(1997-8#1)(2008-10#3)(2010-8#3)(2011-2#2)(2012-2#2)
to excite fluorescence##2##3##(2008-9#1)(2012-2#1)
to excite the##3##3##(1991-3#1)(2008-2#1)(2008-3#1)
to excite##6##2##(1991-3#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)
to excited##2##2##(2008-10#1)(2010-1#1)
to excited-state absorption##2##3##(2008-3#2)
to exclude a##4##3##(1991-12#1)(2008-12#1)(2008-8#1)(2012-1#1)
to exclude an##3##3##(1993-1#1)(2008-1#1)(2011-2#1)
to exclude other##2##3##(2009-8#1)(2012-3#1)
to exclude the diagnosis##2##4##(1991-12#1)(2008-9#1)
to exclude the##4##3##(1991-12#1)(2008-1#1)(2008-9#1)(2011-2#1)
to exclude##25##2##(1990-12#1)(1990-5#1)(1991-12#2)(1993-1#1)(1995-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
to excrete##2##2##(2008-7#1)(2010-1#1)
to execute the##2##3##(2008-11#1)(2012-3#1)
to execute##10##2##(1990-10#1)(1991-3#1)(1993-2#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
to exempt##2##2##(1996-11#1)(2008-10#1)
to exercise on##2##3##(2009-1#1)(2012-2#1)
to exercise##20##2##(1992-3#1)(1993-2#1)(2007-12#1)(2007-6#2)(2008-11#1)(2008-5#2)(2008-7#2)(2009-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#3)
to exercise-induced##2##2##(1992-9#1)(2010-1#1)
to exert a##6##3##(1990-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)
to exert its##4##3##(1991-8#1)(2011-1#1)(2012-2#2)
to exert##25##2##(1990-12#1)(1990-8#1)(1991-1#2)(1991-8#1)(1992-2#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
to exhaustion##10##2##(2008-5#1)(2011-2#3)(2013-8#6)
to exhibit a##8##3##(1993-12#1)(2008-10#5)(2008-3#1)(2012-2#1)
to exhibit an##2##3##(1996-3#1)(2009-12#1)
to exhibit excellent##2##3##(2008-10#1)(2008-7#1)
to exhibit the##5##3##(1990-12#1)(1994-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
to exhibit##44##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-12#3)(1994-11#2)(1994-3#1)(1995-2#2)(1996-3#2)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#2)(2009-5#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-8#1)
to exist as##3##3##(1990-12#1)(2008-10#1)(2011-3#1)
to exist at the##2##4##(1995-8#1)(2008-10#1)
to exist between##4##3##(1994-5#1)(1995-12#1)(2008-10#2)
to exist in the##5##4##(1990-8#1)(2008-1#1)(2008-10#2)(2008-9#1)
to exist in##11##3##(1990-8#1)(1993-8#1)(1995-11#1)(1996-3#1)(2008-1#2)(2008-10#2)(2008-9#2)(2012-2#1)
to exist##39##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-1#3)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-3#1)(2012-2#2)
to existing methods##2##3##(2008-10#1)(2008-8#1)
to existing##23##2##(1990-7#1)(1992-1#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
to exogenous hormones##2##3##(2008-7#1)(2008-8#1)
to exogenous##14##2##(1994-3#2)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-7#1)
to expand on##2##3##(2008-11#1)(2008-9#1)
to expand our understanding of the##2##6##(2009-9#1)(2010-11#1)
to expand the host range of##2##6##(1997-4#2)
to expand the##15##3##(1994-2#1)(1995-12#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
to expand their##2##3##(2008-8#1)(2009-5#1)
to expand this##2##3##(1994-3#1)(1995-12#1)
to expand##44##2##(1992-1#1)(1992-2#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#2)(1996-3#1)(1997-4#2)(1997-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-9#1)(2010-11#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-7#1)
to expansion of##2##3##(1997-5#1)(2011-2#1)
to expect that##2##3##(1991-5#1)(2010-4#1)
to expect##5##2##(1991-5#1)(1994-3#1)(1996-2#1)(2007-7#1)(2010-4#1)
to expectation##6##2##(1996-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-2#1)
to expectations##6##2##(1993-2#1)(1996-2#1)(2008-10#2)(2008-3#1)(2010-8#1)
to expected##5##2##(1991-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
to expedite##3##2##(1992-2#1)(2008-11#1)(2008-12#1)
to experience a##2##3##(2008-3#1)(2008-6#1)
to experience the##3##3##(1996-9#1)(2008-9#1)(2012-3#1)
to experience##23##2##(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
to experienced##3##2##(1997-1#1)(2008-11#1)(2011-2#1)
to experiment##4##2##(1991-3#1)(1992-9#1)(2008-12#1)(2008-7#1)
to experimental animals##2##3##(1993-3#1)(1996-5#1)
to experimental data##8##3##(2007-11#1)(2008-10#1)(2008-3#3)(2008-7#2)(2013-1#1)
to experimental results##2##3##(1997-2#1)(2008-3#1)
to experimental spectra##2##3##(2008-2#2)
to experimental##25##2##(1993-3#1)(1994-2#1)(1995-9#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-7#2)(2008-8#1)(2010-6#1)(2012-2#2)(2013-1#1)
to experimentally induced##2##3##(1990-11#1)(2007-12#1)
to experimentally test##3##3##(2009-11#1)(2009-2#1)(2013-1#1)
to experimentally verify the##2##4##(2008-10#2)
to experimentally##9##2##(1990-11#1)(2007-12#2)(2008-10#2)(2009-11#1)(2009-2#1)(2010-2#1)(2013-1#1)
to experiments##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)
to expert##2##2##(1994-2#1)(2010-10#1)
to experts##2##2##(1995-6#1)(2008-12#1)
to explain how##8##3##(1993-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-11#1)(2012-12#1)
to explain that##2##3##(1996-5#1)(2012-2#1)
to explain the current##2##4##(2008-10#1)(2008-11#1)
to explain the effect##2##4##(1994-5#1)(2008-3#1)
to explain the experimental results##2##5##(2007-11#1)(2008-9#1)
to explain the maintenance of##2##5##(1997-7#1)(2008-8#1)
to explain the observations##2##4##(2007-11#1)(2008-10#1)
to explain the observed##4##4##(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
to explain the variable##2##4##(2008-4#1)(2012-2#1)
to explain the##89##3##(1990-3#1)(1990-8#2)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-5#1)(1997-7#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#16)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#1)(2010-3#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)
to explain these##4##3##(2008-3#1)(2009-12#1)(2009-2#1)(2012-2#1)
to explain this##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)
to explain why##8##3##(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
to explain##165##2##(1990-3#1)(1990-8#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#1)(1996-5#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#7)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#4)(2012-4#1)(2013-1#2)(2013-8#2)
to explaining the##2##3##(1993-11#1)(2008-8#1)
to explaining##3##2##(1993-11#1)(2008-8#2)
to explicate##3##2##(2008-12#1)(2010-10#1)(2013-7#1)
to exploit the##10##3##(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-10#1)
to exploit this##2##3##(2008-4#1)(2008-7#1)
to exploit##14##2##(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#1)
to exploitation##2##2##(1995-5#1)(2011-2#1)
to exploiting##2##2##(1994-11#1)(2008-3#1)
to explore a##2##3##(2008-11#1)(2013-7#1)
to explore alternative##2##3##(2008-11#1)(2008-12#1)
to explore and##7##3##(2008-10#1)(2008-11#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)
to explore further the##2##4##(1994-12#1)(2008-7#1)
to explore how##5##3##(1995-12#1)(1997-3#1)(2008-11#1)(2012-1#1)(2012-3#1)
to explore in##2##3##(2012-3#1)(2013-1#1)
to explore possible##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
to explore potential##2##3##(2007-8#1)(2012-2#1)
to explore some of the##4##5##(1994-1#1)(2008-7#1)(2010-5#1)(2012-2#1)
to explore the benefits of##2##5##(1994-3#1)(2013-8#1)
to explore the consequences##2##4##(2008-9#1)(2010-10#1)
to explore the effects of##3##5##(2007-12#1)(2008-6#1)(2008-9#1)
to explore the feasibility of##2##5##(2007-2#1)(2010-10#1)
to explore the feasibility##3##4##(2007-2#1)(2008-10#1)(2010-10#1)
to explore the impact of##2##5##(2006-10#1)(2012-3#1)
to explore the possibility of using##2##6##(1993-3#1)(2008-11#1)
to explore the possibility of##3##5##(1993-3#1)(2008-11#1)(2012-3#1)
to explore the potential##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
to explore the relationship between##4##5##(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)
to explore the relationships between##2##5##(2010-8#1)(2012-2#1)
to explore the role of##2##5##(1996-5#1)(2008-1#1)
to explore the use of##3##5##(2008-10#2)(2008-5#1)
to explore the validity of this##2##6##(2008-4#1)(2009-11#1)
to explore the##92##3##(1990-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
to explore their##3##3##(1994-6#1)(2010-8#1)(2011-2#1)
to explore this##4##3##(1993-11#1)(2008-8#2)(2009-10#1)
to explore ways##2##3##(1997-1#1)(2011-2#1)
to explore whether##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
to explore##195##2##(1990-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-6#3)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#11)(2008-11#13)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#3)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#8)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#10)(2013-1#13)(2013-7#3)(2013-8#2)
to exponentially amplify##3##3##(2008-2#2)(2008-9#1)
to exponentially##4##2##(2008-10#1)(2008-2#2)(2008-9#1)
to expose the##7##3##(1994-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
to expose##11##2##(1994-8#1)(1996-12#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
to exposure concentration##2##3##(1990-5#1)(2008-7#1)
to exposure of##2##3##(1991-2#1)(2011-2#1)
to exposure to a##3##4##(1997-8#1)(2008-7#2)
to exposure to##17##3##(1996-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2011-2#2)
to exposure##25##2##(1990-5#1)(1991-2#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-9#1)(2011-2#3)
to express a##2##3##(2007-12#1)(2008-11#1)
to express and purify##2##4##(2008-4#1)(2012-2#1)
to express and##4##3##(1995-1#1)(2008-4#2)(2012-2#1)
to express both the##2##4##(2008-11#1)(2008-5#1)
to express recombinant human##2##4##(2008-11#2)
to express recombinant##3##3##(2008-11#2)(2008-7#1)
to express the##13##3##(1994-11#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)
to express this##2##3##(1994-5#1)(2008-10#1)
to express##63##2##(1991-9#1)(1992-10#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#4)(1996-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
to expression of##3##3##(1995-2#1)(2008-10#2)
to expression##5##2##(1995-2#1)(2008-10#2)(2008-7#1)(2013-7#1)
to extend a##2##3##(1996-2#1)(2008-7#1)
to extend beyond##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
to extend studies##2##3##(2010-2#1)(2012-3#1)
to extend the same##2##4##(2008-10#1)(2008-11#1)
to extend the sensitivity##2##4##(2008-10#1)(2008-7#1)
to extend the##35##3##(1995-3#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#1)
to extend their##4##3##(1993-3#1)(1994-8#1)(2008-11#1)(2010-12#1)
to extend to##3##3##(1995-6#1)(2007-11#1)(2010-4#1)
to extend##66##2##(1993-3#1)(1994-8#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
to extended##4##2##(1994-2#1)(2008-8#1)(2010-12#1)(2011-2#1)
to extensive necrosis##2##3##(1994-5#1)(2012-2#1)
to extensive##7##2##(1990-11#1)(1994-5#1)(1996-1#1)(2008-10#2)(2008-7#1)(2012-2#1)
to external and internal##2##4##(1993-1#1)(2009-10#1)
to external optical##3##3##(2007-11#2)(2008-2#1)
to external pH changes##2##4##(2012-12#2)
to external pressures##2##3##(2008-11#1)(2008-7#1)
to external stimuli##5##3##(1990-9#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-2#1)
to external##36##2##(1990-11#1)(1990-9#1)(1993-1#1)(1993-12#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)
to externally##2##2##(1991-9#1)(2008-4#1)
to extinction##12##2##(2008-8#3)(2008-9#7)(2013-1#1)(2013-7#1)
to extracellular ATP##3##3##(2008-4#3)
to extracellular nucleotides##2##3##(2008-4#2)
to extracellular##15##2##(1993-3#1)(1994-12#1)(1996-2#2)(1996-5#1)(2008-4#7)(2008-7#1)(2009-7#1)(2012-2#1)
to extract accurate##2##3##(2008-2#1)(2008-3#1)
to extract and##6##3##(2008-10#5)(2008-3#1)
to extract certain##2##3##(2008-10#1)(2008-2#1)
to extract from##2##3##(2008-10#1)(2008-3#1)
to extract information about##2##4##(2008-10#1)(2009-8#1)
to extract information##3##3##(2008-10#1)(2008-4#1)(2009-8#1)
to extract kinetic##2##3##(1997-6#1)(2008-9#1)
to extract the velocity##2##4##(2008-3#2)
to extract the##21##3##(2007-11#1)(2007-7#1)(2008-10#8)(2008-3#8)(2009-7#1)(2011-2#1)(2012-3#1)
to extract##87##2##(1990-12#1)(1995-5#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#44)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#1)(2008-6#1)(2008-9#3)(2009-7#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
to extraction of##2##3##(2011-2#2)
to extraction##5##2##(2008-10#3)(2011-2#2)
to extrapolate from##2##3##(2008-11#1)(2010-8#1)
to extrapolate##5##2##(2008-11#2)(2008-7#1)(2010-8#1)(2012-1#1)
to extreme##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
to extremely low frequency electromagnetic fields##2##6##(1992-11#1)(2008-12#1)
to extremely low##3##3##(1992-11#1)(2008-12#1)(2008-6#1)
to extremely##6##2##(1992-11#1)(2008-11#1)(2008-12#2)(2008-6#1)(2012-2#1)
to extrinsic##2##2##(1990-6#1)(2008-9#1)
to extrude##2##2##(2007-11#1)(2008-10#1)
to eye opening##2##3##(2008-7#2)
to eye##3##2##(2008-5#1)(2008-7#2)
to fabricate a##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2009-11#1)(2011-1#1)
to fabricate and##2##3##(2007-12#1)(2008-2#1)
to fabricate artificial heart##2##4##(2008-8#2)
to fabricate the##4##3##(2007-12#1)(2008-12#2)(2008-2#1)
to fabricate##43##2##(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#8)(2008-12#2)(2008-2#6)(2008-3#6)(2008-7#3)(2008-8#3)(2009-11#4)(2010-12#1)(2011-1#1)(2013-1#1)
to fabrication##2##2##(2009-5#1)(2012-12#1)
to face the##3##3##(2007-6#1)(2008-6#1)(2013-1#1)
to face with##2##3##(2008-10#1)(2011-2#1)
to face##23##2##(1994-12#1)(1995-5#1)(1996-11#2)(1996-8#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to facilitate a##3##3##(2007-10#1)(2011-1#1)(2012-2#1)
to facilitate and##2##3##(2008-12#1)(2010-8#1)
to facilitate effective##2##3##(1992-3#1)(2008-11#1)
to facilitate egg##2##3##(2008-5#2)
to facilitate improved##2##3##(2007-12#1)(2008-11#1)
to facilitate its##5##3##(2008-10#1)(2008-4#1)(2008-7#2)(2013-8#1)
to facilitate learning##4##3##(2008-12#3)(2013-8#1)
to facilitate nonlinear calibration##3##4##(2008-10#3)
to facilitate preleptotene spermatocyte migration##2##5##(2009-10#2)
to facilitate purification of##2##4##(1992-6#1)(1994-12#1)
to facilitate simultaneous##2##3##(2010-5#1)(2012-2#1)
to facilitate such##2##3##(2008-3#1)(2008-7#1)
to facilitate surgical##2##3##(1996-3#1)(2008-9#1)
to facilitate the development of new##2##6##(1992-1#1)(2008-11#1)
to facilitate the development of##7##5##(1992-1#1)(2008-11#3)(2008-12#2)(2010-3#1)
to facilitate the dissolution of##2##5##(2008-10#2)
to facilitate the##43##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-8#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to facilitate their##2##3##(2008-10#1)(2009-2#1)
to facilitate understanding##2##3##(2008-3#1)(2008-4#1)
to facilitate use of##2##4##(2008-3#2)
to facilitate##174##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-1#3)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#17)(2008-11#17)(2008-12#10)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#3)
to facilitating the##2##3##(2008-11#1)(2009-7#1)
to facilitation##2##2##(1994-11#1)(2012-1#1)
to factors##4##2##(1991-2#1)(2009-8#1)(2010-3#1)(2012-12#1)
to faculty##2##2##(2008-11#1)(2011-1#1)
to fail##7##2##(1995-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-7#1)(2011-2#1)
to failure in##5##3##(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
to failure of##3##3##(2008-7#1)(2009-8#1)(2012-3#1)
to failure##18##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
to fall asleep##2##3##(1990-5#1)(2007-6#1)
to fall in##2##3##(2008-10#1)(2008-7#1)
to fall into three##2##4##(2008-10#1)(2011-2#1)
to fall into##4##3##(1994-12#1)(1997-1#1)(2008-10#1)(2011-2#1)
to fall##16##2##(1990-2#1)(1990-5#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-1#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
to falls##3##2##(2007-11#2)(2010-10#1)
to familiarize##4##2##(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
to families who##2##3##(1995-1#1)(1997-2#1)
to families##10##2##(1990-12#1)(1991-1#1)(1991-12#4)(1995-1#2)(1997-2#1)(2008-11#1)
to family and##3##3##(2007-4#1)(2013-1#2)
to family members##3##3##(1991-2#1)(2008-9#1)(2009-5#1)
to family##24##2##(1991-12#2)(1991-2#1)(1991-6#1)(1995-12#1)(2007-4#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2013-1#2)(2013-8#2)
to far##3##2##(2008-2#1)(2008-6#1)(2008-7#1)
to farm##2##2##(2008-12#1)(2010-4#1)
to farming##4##2##(2007-8#1)(2008-11#1)(2008-12#2)
to farnesylate##2##2##(1995-2#2)
to fast##5##2##(2008-10#1)(2008-8#1)(2010-5#1)(2013-1#2)
to faster##5##2##(1995-1#1)(2007-8#1)(2008-11#1)(2008-7#2)
to fasting##4##2##(1994-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
to fat##8##2##(1990-2#2)(2007-12#2)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
to fatal##2##2##(2007-8#1)(2012-12#1)
to fatigue##5##2##(2008-10#1)(2008-3#1)(2008-7#2)(2009-7#1)
to favor the##7##3##(1992-3#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-12#1)
to favor##13##2##(1992-3#1)(1996-3#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)(2012-12#2)
to favorable##3##2##(2008-10#2)(2012-3#1)
to favour##2##2##(1994-6#1)(1995-3#1)
to favourable##3##2##(1990-6#1)(2008-11#1)(2009-10#1)
to fear##5##2##(1996-6#1)(2008-11#1)(2010-7#1)(2012-2#1)(2013-8#1)
to febrile neutropenia##2##3##(2008-11#1)(2008-7#1)
to feed on##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
to feed##8##2##(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-8#1)(2013-1#1)
to feedback##2##2##(1990-2#1)(2007-12#1)
to feeding##4##2##(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#1)
to feel##4##2##(1992-3#2)(1997-4#1)(2007-12#1)
to female ratio##2##3##(2008-1#1)(2012-3#1)
to female##26##2##(1990-12#2)(1990-2#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-9#1)(1996-12#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#3)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to females in##2##3##(2007-12#1)(2009-8#1)
to females##15##2##(1990-8#1)(1991-6#1)(1994-11#1)(1995-6#2)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#3)(2011-2#1)(2012-2#1)
to femoral access##2##3##(2007-7#1)(2011-2#1)
to femoral artery##4##3##(2007-8#3)(2011-2#1)
to femoral##7##2##(2007-7#1)(2007-8#3)(2009-3#1)(2011-2#2)
to femtosecond laser##2##3##(2007-12#1)(2011-1#1)
to ferment##6##2##(1993-12#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-3#1)
to ferricenium ions##2##3##(1995-2#2)
to ferricyanide##2##2##(2008-10#2)
to fertile##2##2##(2008-5#1)(2013-7#1)
to fertilization##2##2##(1996-9#1)(2009-2#1)
to fertilize all##2##3##(2008-8#1)(2012-12#1)
to fertilize##4##2##(2008-7#1)(2008-8#2)(2012-12#1)
to fetal bovine serum (FBS)##2##5##(2008-11#2)
to fetal bovine serum##3##4##(2008-11#3)
to fetal##8##2##(1992-12#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#4)
to few##3##2##(2008-10#3)
to fewer##5##2##(1994-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
to fiber##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
to fibers##2##2##(1993-9#1)(2008-3#1)
to fibrinogen##4##2##(1990-5#1)(1997-7#3)
to fibronectin##4##2##(1990-8#1)(1992-10#1)(1992-9#1)(2008-4#1)
to fibrosis##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
to field##6##2##(2008-10#3)(2008-3#1)(2011-2#2)
to fight against##2##3##(1993-6#1)(2012-2#1)
to fight the##3##3##(1994-3#1)(2007-2#1)(2009-7#1)
to fight##20##2##(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-2#2)
to fill a##2##3##(1997-4#1)(2008-10#1)
to fill in##6##3##(2007-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-1#1)
to fill the sampling##2##4##(2008-10#2)
to fill the##7##3##(2008-1#2)(2008-10#3)(2008-3#1)(2013-1#1)
to fill##21##2##(1991-2#1)(1995-2#1)(1997-4#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-9#2)(2012-12#1)(2013-1#2)
to filter the##2##3##(2008-10#1)(2009-12#1)
to filter##7##2##(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)
to filtered##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
to final##5##2##(1992-9#1)(1997-4#1)(2008-10#2)(2011-1#1)
to finally##2##2##(2008-10#1)(2009-8#1)
to finance##6##2##(1991-2#1)(1992-2#1)(1993-8#1)(1994-1#1)(1996-3#1)(2007-4#1)
to financial##7##2##(2007-4#1)(2007-7#1)(2010-10#3)(2010-5#1)(2011-1#1)
to find a common##2##4##(2007-12#1)(2011-2#1)
to find a new##2##4##(1995-2#1)(2008-5#1)
to find a possible##2##4##(2011-2#1)(2012-3#1)
to find a##27##3##(1993-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-3#1)
to find an appropriate##2##4##(1992-6#1)(2008-10#1)
to find an##9##3##(1992-6#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
to find and##3##3##(1994-1#1)(1994-3#1)(1996-8#1)
to find candidate transitions for CO(2) detection##2##7##(2008-2#1)(2008-3#1)
to find its##3##3##(1992-5#1)(1996-1#1)(2008-3#1)
to find more##3##3##(1992-12#1)(2011-2#2)
to find new##2##3##(2008-3#1)(2011-2#1)
to find optimal##2##3##(2008-10#1)(2008-3#1)
to find out if the##2##5##(1993-6#1)(1994-9#1)
to find out the##10##4##(1990-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
to find out whether##3##4##(1991-11#1)(2009-6#1)(2012-2#1)
to find out##26##3##(1990-2#2)(1990-6#1)(1991-11#1)(1991-6#1)(1993-6#1)(1994-9#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#4)
to find specific##2##3##(2011-2#1)(2012-2#1)
to find suitable##2##3##(2008-10#1)(2008-8#1)
to find that##3##3##(2008-3#2)(2012-3#1)
to find the association##2##4##(2012-12#1)(2012-2#1)
to find the best##7##4##(1996-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#1)
to find the conditions##2##4##(2008-3#1)(2008-5#1)
to find the exact##2##4##(2007-11#1)(2008-2#1)
to find the optimal##3##4##(2008-10#1)(2008-3#2)
to find the##45##3##(1990-12#1)(1995-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
to find ways to##3##4##(1992-12#1)(1995-9#1)(2008-9#1)
to find ways##4##3##(1990-9#1)(1992-12#1)(1995-9#1)(2008-9#1)
to find whether##2##3##(1990-5#2)
to find##191##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#4)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-10#28)(2008-11#7)(2008-12#3)(2008-2#9)(2008-3#14)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#5)(2013-7#1)
to finding##6##2##(2008-10#1)(2009-12#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-3#1)
to findings##3##2##(1994-12#1)(2012-3#1)(2013-8#1)
to fine##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
to fine-tune##2##2##(2008-4#1)(2008-5#1)
to fire##4##2##(1996-12#1)(2008-10#2)(2009-8#1)
to firm##2##2##(1990-12#1)(2013-1#1)
to first order##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to first##17##2##(1994-1#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-7#1)
to first-line##4##2##(1992-8#1)(2007-10#1)(2008-8#1)(2013-1#1)
to fishing##2##2##(2009-7#1)(2013-7#1)
to fit a##2##3##(1991-5#1)(1996-5#1)
to fit into a##2##4##(1997-3#1)(2008-2#1)
to fit into the##2##4##(1992-3#1)(2009-6#1)
to fit into##4##3##(1992-3#1)(1997-3#1)(2008-2#1)(2009-6#1)
to fit the##15##3##(1990-8#2)(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
to fit##42##2##(1990-8#2)(1991-5#1)(1992-3#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to fitness##3##2##(2008-1#1)(2010-1#1)(2013-1#1)
to five days##3##3##(1992-5#1)(1996-8#1)(1997-4#1)
to five pathogens##2##3##(2008-10#2)
to five times##3##3##(1993-1#1)(2008-10#2)
to five years##2##3##(1994-9#1)(2008-11#1)
to five##41##2##(1991-2#1)(1992-11#1)(1992-5#1)(1993-1#2)(1993-12#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#18)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
to fivefold higher##2##3##(1993-2#1)(2008-10#1)
to fix the##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
to fix##12##2##(2008-11#2)(2008-4#1)(2008-5#7)(2008-7#1)(2008-9#1)
to fixate##3##2##(2008-10#1)(2008-2#1)(2009-2#1)
to fixation##2##2##(2007-8#1)(2008-9#1)
to flame atomic absorption spectrometry (FAAS)##3##6##(2008-10#3)
to flame atomic absorption##6##4##(2008-10#6)
to flame##8##2##(2008-10#8)
to flat##4##2##(1993-8#1)(2007-11#1)(2008-10#2)
to flex##2##2##(2007-12#1)(2008-9#1)
to flexible##3##2##(2008-1#1)(2008-11#1)(2008-7#1)
to float##2##2##(1993-12#1)(2008-9#1)
to flooding##2##2##(2012-5#2)
to flour##3##2##(1990-3#2)(2008-10#1)
to flow cytometry data##2##4##(2008-8#1)(2008-9#1)
to flow cytometry##6##3##(2008-1#1)(2008-4#2)(2008-8#1)(2008-9#2)
to flow injection (FI)##3##4##(2008-10#3)
to flow injection##6##3##(2008-10#6)
to flow##16##2##(2008-1#1)(2008-10#7)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)
to flower##4##2##(2008-10#2)(2008-5#2)
to flowering##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
to flowers##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
to fluconazole and amphotericin B in##2##6##(2008-5#2)
to fluconazole and amphotericin##3##4##(1996-11#1)(2008-5#2)
to fluconazole and ketoconazole was##2##5##(2008-5#2)
to fluconazole and##6##3##(1996-11#1)(2008-5#5)
to fluconazole##10##2##(1996-11#1)(2008-10#1)(2008-5#8)
to fluctuate##2##2##(2008-3#1)(2009-10#1)
to fluctuating##2##2##(2008-10#1)(2010-7#1)
to fluctuations in the##2##4##(2008-3#1)(2008-7#1)
to fluid##7##2##(1995-3#1)(1997-8#1)(2008-8#1)(2009-5#2)(2010-1#1)(2012-2#1)
to fluorescence##4##2##(2008-10#2)(2008-2#1)(2012-12#1)
to fluorescent##4##2##(1993-11#1)(1995-3#1)(2008-10#2)
to fluoride##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
to fluoroquinolones##3##2##(2007-7#1)(2008-7#2)
to fluorouracil##4##2##(1990-2#4)
to flusilazole##2##2##(2008-10#2)
to fly##2##2##(1994-3#1)(2008-3#1)
to foam##2##2##(1995-3#1)(2013-1#1)
to focal##2##2##(1990-9#1)(2011-2#1)
to focus attention on##2##4##(1992-2#1)(2007-7#1)
to focus more attention##2##4##(1997-1#1)(2007-7#1)
to focus more##3##3##(1997-1#1)(2007-7#1)(2012-2#1)
to focus on the##13##4##(1993-8#1)(1994-1#1)(1994-2#2)(1996-1#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
to focus on##21##3##(1990-11#1)(1991-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-12#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
to focus the##2##3##(2007-12#1)(2008-2#1)
to focus their attention##2##4##(2008-12#1)(2008-7#1)
to focus##43##2##(1990-11#1)(1991-6#1)(1992-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
to focusing##2##2##(2008-3#2)
to folate##4##2##(1992-6#2)(1992-9#1)(2011-1#1)
to fold##2##2##(1993-9#1)(2011-2#1)
to foliar##4##2##(2008-10#3)(2013-8#1)
to follicular growth##2##3##(2008-12#2)
to follicular##4##2##(1995-12#1)(2008-12#2)(2008-8#1)
to follow a##7##3##(1997-2#1)(2007-12#1)(2007-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
to follow in##2##3##(2008-3#1)(2009-11#1)
to follow the development##2##4##(1991-11#1)(2007-8#1)
to follow the distribution of##2##5##(1990-5#1)(1991-12#1)
to follow the evolution of##2##5##(2008-10#2)
to follow the##34##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1994-12#2)(1994-6#1)(1995-9#1)(1997-2#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-3#1)
to follow up the##3##4##(1993-5#1)(2008-10#1)(2009-10#1)
to follow up##7##3##(1993-12#1)(1993-5#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-10#1)
to follow##82##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-6#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)
to follow-up##12##2##(1992-5#1)(1996-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
to following##2##2##(1992-12#1)(2008-9#1)
to food and##2##3##(2008-10#1)(2009-8#1)
to food samples were quantitative##2##5##(2008-10#2)
to food samples##3##3##(2008-10#3)
to food##22##2##(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#3)(2011-2#1)(2012-2#1)(2013-7#1)
to foods##2##2##(1991-11#1)(2008-1#1)
to forage##6##2##(2008-9#5)(2010-8#1)
to force him##2##3##(1996-5#2)
to force##12##2##(1996-5#2)(1997-5#3)(1997-7#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-8#1)
to forced swim##2##3##(2008-11#2)
to forecast##5##2##(1996-6#1)(2008-1#1)(2008-10#1)(2009-8#1)(2013-8#1)
to foreign##5##2##(1990-3#1)(1995-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
to forensic scientists##2##3##(1995-6#1)(2008-10#1)
to forensic##10##2##(1990-7#1)(1995-6#2)(1996-5#1)(1997-2#1)(2008-10#2)(2008-12#2)(2008-6#1)
to foresee##4##2##(1991-2#1)(1997-1#1)(2013-1#2)
to forest trees##2##3##(2008-10#1)(2008-8#1)
to forest##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)
to forge##3##2##(1995-2#1)(2007-2#1)(2008-7#1)
to forget##2##2##(1991-2#1)(2012-12#1)
to form 2##2##3##(1995-6#1)(2008-10#1)
to form DNA##2##3##(1994-8#1)(1995-3#1)
to form a 1##10##4##(1995-11#1)(2008-10#9)
to form a blue complex##2##5##(2008-10#2)
to form a blue##3##4##(1990-2#1)(2008-10#2)
to form a chelate##2##4##(2008-10#2)
to form a colored complex##3##5##(2008-10#3)
to form a colored compound##2##5##(2008-10#2)
to form a colored##8##4##(2008-10#8)
to form a complex##3##4##(2008-10#2)(2008-9#1)
to form a diazonium##2##4##(2008-10#1)(2008-5#1)
to form a highly##2##4##(2007-7#1)(2013-1#1)
to form a precipitate##2##4##(2008-10#2)
to form a primary##2##4##(2008-1#1)(2008-12#1)
to form a specific##2##4##(2008-10#2)
to form a stable##3##4##(1993-11#1)(1994-8#1)(2008-4#1)
to form a ternary complex##2##5##(2008-10#1)(2012-12#1)
to form a violet##2##4##(2008-10#2)
to form a yellow##3##4##(2008-10#3)
to form a##136##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-11#2)(1994-12#4)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-6#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#63)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
to form aggregates##2##3##(1991-2#1)(2008-11#1)
to form an image##2##4##(2008-2#1)(2008-3#1)
to form an intermediate##2##4##(1994-6#1)(1996-2#1)
to form an##25##3##(1990-2#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#1)
to form and##2##3##(2008-5#1)(2008-8#1)
to form association particles##2##4##(2008-10#2)
to form complexes with##5##4##(2008-10#2)(2008-7#1)(2009-8#1)(2010-11#1)
to form glucose##2##3##(1997-7#1)(2008-10#1)
to form highly##2##3##(1997-4#1)(2009-11#1)
to form ion##2##3##(2008-10#2)
to form large##2##3##(2008-10#1)(2008-11#1)
to form many##2##3##(2008-11#1)(2008-3#1)
to form oospores in##2##4##(2008-10#2)
to form particles##3##3##(1994-12#1)(1994-3#1)(1995-5#1)
to form red##2##3##(2008-10#2)
to form site-specific cross-links##2##4##(2008-4#2)
to form small##2##3##(1994-5#1)(2008-10#1)
to form spheroids##2##3##(2008-11#2)
to form stable complexes with##3##5##(1995-5#1)(2008-10#1)(2010-11#1)
to form stable##10##3##(1993-11#1)(1993-6#1)(1995-5#1)(1995-8#1)(2008-10#5)(2010-11#1)
to form the basis of##2##5##(2008-5#1)(2008-9#1)
to form the basis##3##4##(2008-5#1)(2008-9#1)(2013-8#1)
to form the corresponding##5##4##(2008-10#5)
to form the membrane##2##4##(2008-10#1)(2011-2#1)
to form the##39##3##(1991-9#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#14)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
to form this##2##3##(2007-12#1)(2008-5#1)
to form two##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
to form##415##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#4)(1992-2#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#6)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#2)(1995-11#1)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#7)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2007-11#7)(2007-12#13)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#145)(2008-11#16)(2008-12#3)(2008-2#13)(2008-3#11)(2008-4#6)(2008-5#10)(2008-6#6)(2008-7#10)(2008-8#13)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#1)(2013-1#6)(2013-8#2)
to formaldehyde##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
to formally evaluate##2##3##(2013-1#2)
to formally##3##2##(2008-11#1)(2013-1#2)
to formation of##9##3##(1994-8#2)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2009-5#1)(2013-1#1)
to formetanate##2##2##(2011-2#2)
to formulate a##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
to formulate an##3##3##(2007-12#1)(2008-5#1)(2012-7#1)
to formulate and##3##3##(2008-12#1)(2011-1#2)
to formulate the##2##3##(2008-2#1)(2008-5#1)
to formulate##29##2##(1996-4#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#5)(2009-3#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
to forskolin##2##2##(1995-8#1)(1997-2#1)
to fortify##2##2##(2008-10#1)(2008-11#1)
to foster a##3##3##(1990-11#1)(2008-10#1)(2008-4#1)
to foster##18##2##(1990-11#1)(1991-12#1)(1993-1#1)(1995-3#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
to fouling##5##2##(2008-10#2)(2008-6#1)(2013-1#2)
to found##2##2##(1994-12#1)(2011-4#1)
to four cycles of##2##4##(2008-10#1)(2009-8#1)
to four days##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
to four different##6##3##(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#3)
to four the##2##3##(2008-10#1)(2008-2#1)
to four times##5##3##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
to four years##3##3##(1990-11#1)(1991-8#1)(1993-2#1)
to four##81##2##(1990-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-6#1)(1997-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
to fourfold higher##2##3##(1992-11#1)(2008-7#1)
to fourfold##6##2##(1992-11#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-4#1)
to fractionate##4##2##(2008-11#2)(2008-4#1)(2008-7#1)
to fracture##6##2##(2007-11#2)(2008-7#1)(2009-7#1)(2010-10#1)(2013-1#1)
to fragments##2##2##(1995-3#1)(2008-2#1)
to frame##6##2##(1996-3#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#2)
to fraud##2##2##(1993-12#1)(1994-2#1)
to free radical generation##2##4##(1994-11#1)(2009-9#1)
to free radical##5##3##(1991-9#1)(1994-11#1)(2008-10#1)(2008-5#1)(2009-9#1)
to free##18##2##(1991-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(2008-10#6)(2008-11#1)(2008-5#3)(2009-9#1)(2012-12#1)
to freely##2##2##(1997-6#1)(2012-2#1)
to freeze##3##2##(1993-3#1)(2008-1#1)(2008-10#1)
to freezing##2##2##(2009-8#1)(2011-1#1)
to frequency of##2##3##(2007-10#1)(2010-2#1)
to frequency##6##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
to frequency-shifted optical feedback##2##4##(2007-12#1)(2008-3#1)
to frequent##3##2##(1991-4#1)(2008-5#1)(2013-1#1)
to fresh##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2010-8#1)
to freshwater##4##2##(2010-8#3)(2012-2#1)
to frontal##2##2##(1996-12#1)(2012-8#1)
to fruit##11##2##(2008-10#8)(2008-12#2)(2008-5#1)
to fruition##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
to fuel##5##2##(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-4#1)
to fulfil##6##2##(1991-3#1)(1995-8#1)(1997-2#1)(2008-11#1)(2009-12#1)(2012-2#1)
to fulfill##7##2##(1991-12#1)(1995-1#2)(1995-11#1)(2008-6#1)(2009-6#1)(2011-2#1)
to full recovery##3##3##(2007-8#1)(2008-9#1)(2009-7#1)
to full##13##2##(1990-8#1)(2007-8#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-2#1)
to full-length##3##2##(1993-8#1)(1995-2#1)(1997-2#1)
to fully understand##2##3##(1990-12#1)(2012-12#1)
to fully##20##2##(1990-12#1)(1993-8#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-1#2)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to fulminant##2##2##(1992-5#1)(1993-10#1)
to fumigated field##2##3##(2008-10#2)
to fumonisin##4##2##(2008-10#4)
to function as a##8##4##(1992-12#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-6#1)(2010-10#1)
to function as an##3##4##(1995-3#1)(2007-11#1)(2012-2#1)
to function as the##2##4##(1991-12#1)(1993-12#1)
to function as##20##3##(1991-12#1)(1992-11#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2012-2#1)
to function effectively in##2##4##(2008-11#1)(2008-9#1)
to function in a##2##4##(1991-2#1)(1995-1#1)
to function in the##2##4##(1993-9#1)(1997-4#1)
to function in##11##3##(1991-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-4#1)(2007-8#1)(2012-1#1)(2012-2#1)
to function##53##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
to functional changes##2##3##(2012-2#1)(2013-1#1)
to functional##18##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-8#1)(1994-1#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#2)(2011-1#1)(2012-2#1)(2012-7#1)(2013-1#1)
to functionally##4##2##(1993-11#1)(2009-12#1)(2011-2#1)(2012-3#1)
to functions##3##2##(2008-7#1)(2009-6#1)(2012-2#1)
to fund the##2##3##(1991-1#1)(1997-1#1)
to fund##5##2##(1991-1#1)(1991-12#1)(1991-9#1)(1997-1#2)
to fundamental##9##2##(1990-7#1)(1994-12#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
to fungal attack##3##3##(2008-10#3)
to fungal pathogens##2##3##(2008-10#2)
to fungal##13##2##(2008-10#12)(2011-10#1)
to fungicide##2##2##(2008-10#2)
to fungicides##3##2##(2008-10#3)
to furnish a##2##3##(1997-3#1)(2009-11#1)
to furnish##9##2##(1991-1#1)(1992-12#1)(1994-2#1)(1996-5#1)(1997-3#2)(2008-2#1)(2009-11#1)(2010-7#1)
to further characterise##2##3##(1991-12#1)(2008-7#1)
to further characterize the##7##4##(1992-12#1)(1993-12#1)(1993-3#1)(2008-10#2)(2008-11#1)(2009-2#1)
to further characterize##8##3##(1992-12#1)(1993-12#1)(1993-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2009-2#1)
to further clarify the##3##4##(2008-10#2)(2010-12#1)
to further define the##3##4##(1996-5#1)(2008-10#1)(2008-8#1)
to further develop##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2012-2#1)
to further elucidate the##3##4##(1995-12#1)(2008-10#1)(2008-5#1)
to further elucidate##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
to further enhance##4##3##(1995-12#1)(2008-11#2)(2008-3#1)
to further evaluate the##2##4##(2010-8#1)(2011-2#1)
to further evaluate##4##3##(2008-5#1)(2010-8#1)(2011-2#2)
to further expand the##3##4##(2008-11#1)(2009-2#1)(2011-1#1)
to further explore the##3##4##(2008-5#1)(2011-2#2)
to further explore##4##3##(2008-11#1)(2008-5#1)(2011-2#2)
to further improve the##4##4##(1995-6#1)(2007-12#1)(2008-11#1)(2008-5#1)
to further improve##8##3##(1995-3#1)(1995-6#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2012-2#1)
to further investigate the##2##4##(1995-11#1)(2008-10#1)
to further investigate##4##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-8#1)
to further our understanding of##2##5##(2008-7#2)
to further our##3##3##(1994-1#1)(2008-7#2)
to further reduce the##3##4##(1990-8#1)(2008-10#1)(2012-12#1)
to further studies on the##2##5##(1996-12#1)(2008-10#1)
to further study the##4##4##(2008-10#2)(2008-9#2)
to further support##2##3##(2008-12#1)(2010-6#1)
to further test##3##3##(1992-2#1)(2010-6#1)(2012-2#1)
to further the##7##3##(2008-11#1)(2008-12#2)(2008-7#1)(2009-6#1)(2010-8#1)(2012-12#1)
to further understand the##4##4##(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
to further understand this##2##4##(2008-10#1)(2009-9#1)
to further understand##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-9#1)
to further##125##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#3)(2008-10#20)(2008-11#15)(2008-12#6)(2008-3#2)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#4)(2013-8#1)
to fusarium##4##2##(2008-10#4)
to fuse with each other##2##5##(1997-6#1)(2008-2#1)
to fuse with the##2##4##(1992-12#1)(2008-10#1)
to fuse with##4##3##(1992-12#1)(1997-6#1)(2008-10#1)(2008-2#1)
to fuse##5##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
to fusion##4##2##(1995-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
to future development##3##3##(1992-2#2)(2007-8#1)
to future studies##2##3##(2008-10#1)(2008-7#1)
to future##27##2##(1992-2#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#2)(2010-11#1)(2011-2#2)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
to gain a better understanding of##2##6##(2011-1#1)(2012-3#1)
to gain a deeper##2##4##(1993-8#1)(2010-9#1)
to gain a##12##3##(1993-2#1)(1993-8#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to gain access to the##2##5##(2008-10#1)(2008-12#1)
to gain access to##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
to gain an insight##2##4##(2008-11#1)(2010-3#1)
to gain an understanding of##2##5##(2009-10#1)(2009-6#1)
to gain an##5##3##(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)
to gain control of the##3##5##(1994-3#2)(2007-9#1)
to gain deeper##2##3##(2009-8#1)(2013-8#1)
to gain further insight into##2##5##(1995-11#1)(2010-10#1)
to gain information on##2##4##(2007-8#1)(2012-2#1)
to gain insight into the##4##5##(1992-6#1)(2008-10#1)(2009-4#1)(2010-12#1)
to gain insight into##8##4##(1992-6#1)(1993-6#1)(2008-10#3)(2008-7#1)(2009-4#1)(2010-12#1)
to gain insight##9##3##(1992-6#1)(1993-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-4#1)(2010-12#1)
to gain knowledge of##2##4##(1992-2#1)(2012-2#1)
to gain knowledge##4##3##(1992-2#1)(2008-11#1)(2008-9#1)(2012-2#1)
to gain more insight into the##2##6##(2008-10#1)(2008-11#1)
to gain more##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
to gain new##2##3##(2008-6#1)(2008-9#1)
to gain the##5##3##(1994-2#1)(1994-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
to gain valuable##2##3##(1997-8#1)(2008-11#1)
to gain##82##2##(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
to galactose##3##2##(1990-5#1)(1991-9#1)(2008-8#1)
to gamma-cyhalothrin##4##2##(2011-2#4)
to gamma-rays##3##2##(1995-6#1)(2008-7#2)
to gaps##2##2##(1996-3#1)(2008-10#1)
to gas chromatography##2##3##(2008-10#2)
to gas##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
to gasoline##2##2##(1992-3#1)(2008-10#1)
to gastric##8##2##(1990-9#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-12#1)(2007-11#1)(2012-5#1)(2013-8#1)
to gastrin##2##2##(1997-1#2)
to gather data on##2##4##(2008-10#1)(2010-11#1)
to gather data##4##3##(2008-10#1)(2008-11#2)(2010-11#1)
to gather firewood##2##3##(2011-2#2)
to gather information about##2##4##(1991-1#1)(1992-12#1)
to gather information##5##3##(1991-1#1)(1992-12#1)(1992-2#1)(1996-2#1)(2011-2#1)
to gather##26##2##(1990-3#1)(1991-1#1)(1992-12#1)(1992-2#1)(1996-2#2)(1997-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#1)
to gauge the##5##3##(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#2)
to gauge##11##2##(1996-12#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
to gaze shifts##3##3##(2008-11#3)
to gel filtration##3##3##(1990-12#1)(1990-2#1)(1990-7#1)
to gel##7##2##(1990-12#1)(1990-2#1)(1990-7#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
to gender and age of##2##5##(2010-8#1)(2011-1#1)
to gender and##5##3##(1996-6#1)(2010-8#1)(2011-1#3)
to gender differences in##2##4##(2008-6#1)(2009-8#1)
to gender##13##2##(1994-6#1)(1996-6#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)
to gene expression##2##3##(1995-2#1)(2008-9#1)
to gene flow between##2##4##(2008-10#1)(2008-5#1)
to gene flow##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
to gene therapy of##2##4##(2008-8#2)
to gene therapy##3##3##(2008-5#1)(2008-8#2)
to gene##17##2##(1994-5#1)(1995-2#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)
to gene-for-gene##2##2##(2008-10#1)(2008-9#1)
to general medical##2##3##(1995-5#1)(1995-9#1)
to general practice##5##3##(1995-9#2)(1996-8#1)(2011-2#2)
to general practitioners##4##3##(1992-5#1)(2007-2#1)(2008-8#1)(2011-2#1)
to general##27##2##(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-9#3)(1996-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
to generalize the##3##3##(1996-3#1)(2009-7#1)(2012-12#1)
to generalize##6##2##(1995-5#1)(1996-3#1)(2007-8#1)(2008-6#1)(2009-7#1)(2012-12#1)
to generalized##4##2##(2008-11#1)(2008-3#1)(2008-5#2)
to generate CL##2##3##(2008-10#2)
to generate a homogenous irradiance##2##5##(2008-3#2)
to generate a new##2##4##(2008-2#2)
to generate a##46##3##(1991-11#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-8#2)(1995-6#1)(1997-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-5#1)(2010-7#1)(2012-3#1)
to generate an##8##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-6#1)(2009-10#1)
to generate and##5##3##(2008-2#2)(2010-11#1)(2011-1#1)(2011-2#1)
to generate antibody##2##3##(1993-2#1)(2011-2#1)
to generate both the##2##4##(2008-10#1)(2008-3#1)
to generate both##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
to generate complex##2##3##(2008-3#1)(2012-2#1)
to generate different##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
to generate free radicals##2##4##(1990-12#1)(1995-6#1)
to generate high-resolution##2##3##(2007-11#1)(2008-2#1)
to generate human mAbs##2##4##(2008-11#2)
to generate human##3##3##(2008-11#2)(2010-12#1)
to generate hypotheses##2##3##(2008-10#1)(2012-2#1)
to generate more##2##3##(2008-11#1)(2009-11#1)
to generate multiple##2##3##(2008-3#1)(2008-4#1)
to generate mutants##2##3##(2008-10#2)
to generate new##2##3##(2008-11#1)(2008-4#1)
to generate optical##2##3##(2007-11#1)(2008-3#1)
to generate the mature##3##4##(1990-2#1)(1993-8#1)(1997-7#1)
to generate the##29##3##(1990-2#2)(1993-8#1)(1994-2#1)(1995-2#2)(1996-12#2)(1997-7#2)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)
to generate transgenic##3##3##(1994-8#1)(2008-4#1)(2012-3#1)
to generate variants##2##3##(2008-11#1)(2009-6#1)
to generate##269##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1991-11#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-8#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#4)(1995-2#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#3)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#4)(1997-8#2)(2007-11#11)(2007-12#12)(2007-6#1)(2008-1#3)(2008-10#36)(2008-11#17)(2008-12#1)(2008-2#18)(2008-3#23)(2008-4#12)(2008-5#4)(2008-6#6)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#3)(2009-11#2)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#4)(2011-1#3)(2011-2#5)(2011-3#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#2)
to generation of a##3##4##(1997-8#1)(2007-11#1)(2007-12#1)
to generation of##7##3##(1996-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
to generation##8##2##(1996-2#2)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
to generic##2##2##(2010-5#1)(2012-4#1)
to genes and gene##2##4##(2008-9#1)(2012-2#1)
to genes encoding proteins##2##4##(2008-7#1)(2009-6#1)
to genes##13##2##(1993-9#1)(1996-12#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-6#1)(2012-2#1)
to genetic and environmental factors##2##5##(2008-10#1)(2008-11#1)
to genetic and environmental##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
to genetic and##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)
to genetic defects##2##3##(2011-1#1)(2013-8#1)
to genetic factors controlling##2##4##(2008-5#2)
to genetic factors##4##3##(1993-5#1)(2008-10#1)(2008-5#2)
to genetic##29##2##(1993-5#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
to genetically##4##2##(2008-10#2)(2008-11#1)(2012-3#1)
to genome##3##2##(2008-9#1)(2011-1#1)(2013-1#1)
to genomic DNA from various##2##5##(1993-8#1)(1993-9#1)
to genomic DNA from##4##4##(1993-2#1)(1993-8#1)(1993-9#2)
to genomic DNA##5##3##(1993-2#1)(1993-8#1)(1993-9#2)(2011-10#1)
to genomic##9##2##(1993-2#1)(1993-8#1)(1993-9#2)(2008-10#1)(2008-7#1)(2010-2#1)(2011-10#1)(2012-3#1)
to genomics##5##2##(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)
to genomospecies 1##3##3##(2008-10#3)
to genomospecies##4##2##(2008-10#4)
to genotoxic##3##2##(1993-3#1)(2008-5#1)(2011-2#1)
to genotype##12##2##(1995-2#1)(1997-5#1)(2008-10#5)(2008-2#1)(2008-8#2)(2012-12#1)(2013-8#1)
to genus##3##2##(2007-5#1)(2008-5#2)
to geographic##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
to geographical##4##2##(2008-10#3)(2010-6#1)
to germ plasm##2##3##(2008-10#1)(2009-3#1)
to germ##4##2##(2008-10#2)(2009-10#1)(2009-3#1)
to germinate and##3##3##(2008-10#2)(2011-2#1)
to germinate##9##2##(2008-10#7)(2008-12#1)(2011-2#1)
to germination##2##2##(2008-10#2)
to get a better##3##4##(2008-10#1)(2008-3#2)
to get a deeper##2##4##(2008-10#1)(2010-11#1)
to get a##17##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2013-8#4)
to get an insight into this##2##6##(2009-12#1)(2010-12#1)
to get an insight into##4##5##(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)
to get an##8##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
to get better##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
to get cured##2##3##(2007-7#2)
to get information##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
to get into the##2##4##(1996-4#1)(2008-5#1)
to get involved##3##3##(1990-11#1)(1995-1#1)(2008-4#1)
to get rid of##2##4##(2007-8#1)(2009-11#1)
to get the##14##3##(1994-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#2)(2013-8#1)
to get to##2##3##(1992-8#1)(2008-11#1)
to get##91##2##(1990-11#1)(1991-1#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#7)
to giant##2##2##(2011-2#1)(2012-2#1)
to girls in##2##3##(2010-4#1)(2013-1#1)
to girls##4##2##(2010-4#1)(2012-2#1)(2013-1#2)
to give a##32##3##(1991-2#1)(1992-6#1)(1993-1#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#1)(2007-12#1)(2007-6#1)(2008-10#13)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-11#1)(2011-3#1)
to give an intermediate##2##4##(1996-2#1)(2007-11#1)
to give an overview of##2##5##(2008-11#1)(2011-2#1)
to give an##15##3##(1996-2#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
to give and##2##3##(1994-3#1)(2011-2#1)
to give birth##4##3##(2007-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
to give higher##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
to give information about##2##4##(1991-5#1)(2008-4#1)
to give information##4##3##(1991-5#1)(1994-11#1)(2008-11#1)(2008-4#1)
to give its##2##3##(2008-11#1)(2008-2#1)
to give low##2##3##(1996-5#1)(2008-10#1)
to give mature forms of the enzyme##2##7##(1992-12#2)
to give more##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
to give reliable##2##3##(2007-11#1)(2008-2#1)
to give rise to a new##2##6##(2008-3#1)(2009-3#1)
to give rise to the##2##5##(2012-12#1)(2012-2#1)
to give rise to##11##4##(1995-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2012-12#1)(2012-2#1)
to give rise##12##3##(1995-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2012-12#1)(2012-2#1)
to give satisfactory results##3##4##(2007-8#1)(2008-10#2)
to give satisfactory##4##3##(2007-8#1)(2008-10#3)
to give the best##2##4##(1996-12#1)(2008-10#1)
to give the corresponding##2##4##(2007-11#1)(2008-5#1)
to give the highest##3##4##(2008-11#1)(2008-5#2)
to give the##39##3##(1992-2#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#3)(2007-11#4)(2008-10#9)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)
to give their views##2##4##(1992-4#1)(2013-8#1)
to give their##3##3##(1992-1#1)(1992-4#1)(2013-8#1)
to give them a##2##4##(1995-1#1)(2008-1#1)
to give##223##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#4)(1994-8#2)(1995-1#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#1)(1996-12#2)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#9)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#14)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#51)(2008-11#15)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#8)(2008-5#11)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#3)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to gizzard##2##2##(1990-5#1)(1993-8#1)
to glandular##2##2##(2008-11#1)(2008-5#1)
to glass beads##2##3##(2008-10#1)(2008-7#1)
to glass surfaces than the##2##5##(2008-10#2)
to glass##8##2##(2008-10#6)(2008-7#1)(2009-5#1)
to global warming##3##3##(2012-12#1)(2012-5#1)(2012-8#1)
to global##13##2##(1996-9#1)(2007-2#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-5#1)(2012-8#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#1)
to glomerulonephritis##2##2##(2008-1#2)
to glucagon##3##2##(1995-8#1)(1996-2#1)(2008-3#1)
to glucocorticoids##3##2##(1990-11#1)(1996-5#1)(2008-11#1)
to glucose and##5##3##(1995-8#2)(1996-3#1)(2008-10#1)(2008-11#1)
to glucose as##2##3##(2008-5#1)(2008-6#1)
to glucose at##2##3##(2008-10#2)
to glucose by##3##3##(1993-8#1)(2008-6#2)
to glucose intolerance##2##3##(2008-4#1)(2010-11#1)
to glucose##32##2##(1990-12#1)(1990-5#1)(1991-7#1)(1993-8#2)(1995-3#1)(1995-8#3)(1996-3#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#4)(2010-11#2)(2010-12#1)
to glutamate##2##2##(2008-11#1)(2008-4#1)
to glutamic acid##2##3##(1990-10#1)(1995-5#1)
to glutathione within the cell##2##5##(1995-11#2)
to glutathione##4##2##(1991-9#1)(1993-3#1)(1995-11#2)
to glycemic##2##2##(2008-1#1)(2012-2#1)
to glycerol##2##2##(1993-6#1)(1995-8#1)
to glycine##4##2##(1995-5#1)(1997-1#2)(1997-2#1)
to glycogen##4##2##(1995-8#3)(2008-10#1)
to go around the##2##4##(2008-11#1)(2011-2#1)
to go beyond##6##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
to go in##2##3##(1991-12#1)(1994-7#1)
to go into##2##3##(1990-8#1)(2008-7#1)
to go through##2##3##(1995-12#1)(2012-2#1)
to go to##2##3##(2007-2#1)(2012-2#1)
to go##30##2##(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1993-1#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-6#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
to goal##4##2##(2008-11#1)(2009-12#1)(2010-2#1)(2010-6#1)
to goat##2##2##(1990-12#1)(2008-10#1)
to gold##2##2##(2008-10#1)(2008-7#1)
to good yields##3##3##(2007-11#1)(2008-5#1)(2010-6#1)
to good##19##2##(1992-5#2)(1996-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#5)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
to government##3##2##(2008-5#1)(2009-4#1)(2012-2#1)
to grade##3##2##(1991-8#1)(2008-7#1)(2013-8#1)
to graded##3##2##(1992-9#1)(1995-12#1)(2008-8#1)
to graduate##2##2##(2010-3#1)(2011-2#1)
to graft##5##2##(2008-1#1)(2008-8#1)(2009-5#1)(2013-1#2)
to grafting##2##2##(2008-4#1)(2010-3#1)
to grain##3##2##(1991-12#1)(2007-11#1)(2008-3#1)
to gram##2##2##(1996-2#1)(2007-7#1)
to grant##4##2##(1995-6#2)(1996-2#1)(1996-5#1)
to granulocyte##3##2##(1992-3#2)(1994-11#1)
to grasp the##3##3##(1996-2#1)(2008-6#1)(2011-1#1)
to grasp##5##2##(1996-2#2)(2008-6#1)(2008-7#1)(2011-1#1)
to gravity##5##2##(2008-10#1)(2008-11#3)(2008-2#1)
to gray leaf spot##4##4##(2008-10#4)
to gray##7##2##(2008-10#5)(2008-7#1)(2012-3#1)
to grazing##2##2##(1993-8#1)(2008-8#1)
to great##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
to greater than 100##2##4##(2008-2#1)(2008-7#1)
to greater than##6##3##(1990-5#1)(1991-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
to greater##25##2##(1990-5#1)(1991-12#1)(1994-1#1)(1994-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#2)
to greatly##5##2##(1994-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
to ground##3##2##(2008-10#2)(2010-3#1)
to groundwater##2##2##(2008-10#1)(2011-2#1)
to group A##2##3##(2008-10#1)(2011-2#1)
to group I##4##3##(2008-10#2)(2009-3#2)
to group III##2##3##(2008-10#1)(2008-9#1)
to group patients##3##3##(1995-12#1)(2010-12#1)(2010-8#1)
to group the##2##3##(2008-10#1)(2008-5#1)
to group##20##2##(1993-12#1)(1995-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
to group-velocity##2##2##(2007-12#2)
to groups of##4##3##(1996-12#1)(2007-6#1)(2008-5#1)(2009-9#1)
to groups##8##2##(1991-3#1)(1996-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-4#1)
to grow and##8##3##(1993-1#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
to grow at a##2##4##(2008-11#1)(2012-2#1)
to grow at##7##3##(1991-12#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-2#1)
to grow by##2##3##(1991-1#1)(2011-2#1)
to grow faster than##2##4##(1997-1#1)(2010-8#1)
to grow in the presence of##2##6##(2008-11#1)(2010-4#1)
to grow in the##3##4##(2008-11#1)(2008-7#1)(2010-4#1)
to grow in##16##3##(1991-12#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-7#1)(2008-9#1)(2010-4#1)
to grow on##10##3##(1990-5#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-6#1)(2008-8#1)
to grow the##2##3##(2008-7#1)(2008-9#1)
to grow to##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
to grow well##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
to grow##84##2##(1990-5#1)(1991-1#1)(1991-12#2)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#18)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#7)(2009-11#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#2)
to growing##4##2##(1993-3#1)(2010-4#1)(2013-1#2)
to growth and survival##2##4##(2008-7#1)(2011-2#1)
to growth and##4##3##(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
to growth factors##11##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(2006-6#1)(2008-5#1)(2011-2#1)
to growth hormone releasing hormone##2##5##(1992-6#1)(2007-7#1)
to growth hormone##3##3##(1990-12#1)(1992-6#1)(2007-7#1)
to growth hormone-releasing hormone 1-44 NH2##2##6##(1992-9#2)
to growth in##3##3##(1994-5#1)(2008-11#2)
to growth inhibition##2##3##(2008-11#1)(2011-2#1)
to growth of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to growth stimulation##4##3##(1992-12#1)(1992-9#1)(2008-11#2)
to growth##47##2##(1990-12#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#3)(1993-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-6#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-7#1)(2011-2#7)(2012-5#1)(2013-1#1)(2013-7#1)
to guanine##4##2##(1993-9#2)(1995-5#2)
to guanosine##2##2##(1990-8#1)(2008-4#1)
to guarantee the##5##3##(1995-3#1)(2008-10#1)(2008-3#2)(2011-2#1)
to guarantee##14##2##(1995-3#1)(1996-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
to guide a##2##3##(2010-8#1)(2012-2#1)
to guide and##2##3##(1995-12#1)(2008-10#1)
to guide further##2##3##(1994-3#1)(2009-9#1)
to guide future##3##3##(1996-12#2)(2013-1#1)
to guide health##2##3##(1994-3#2)
to guide the choice of##3##5##(2008-10#1)(2008-9#1)(2013-1#1)
to guide the process of##2##5##(2008-11#1)(2008-12#1)
to guide the selection of##2##5##(2008-10#2)
to guide the##26##3##(1994-1#1)(1994-3#2)(1995-3#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-9#1)(2009-9#1)(2010-7#1)(2012-12#2)(2013-1#1)
to guide their##2##3##(1993-12#1)(2007-10#1)
to guide this##2##3##(2007-2#1)(2008-9#1)
to guide##82##2##(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#6)(1995-12#1)(1995-3#2)(1996-12#2)(1996-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#5)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#6)
to guidelines##5##2##(1994-3#1)(1996-11#1)(2007-5#1)(2008-11#1)(2008-8#1)
to guinea-pigs##2##2##(1993-9#1)(1995-12#1)
to hCG##2##2##(1997-1#1)(1997-4#1)
to hVEGF(165)##2##2##(2008-8#2)
to habitat loss##4##3##(2008-9#2)(2009-8#2)
to habitat##10##2##(2008-10#1)(2008-8#3)(2008-9#2)(2009-8#2)(2010-6#1)(2013-7#1)
to haemorrhage##2##2##(1997-3#1)(2011-2#1)
to hair##6##2##(2008-5#5)(2011-2#1)
to half its##2##3##(2008-3#1)(2008-5#1)
to half of##3##3##(1990-9#1)(2013-1#1)(2013-8#1)
to half the##2##3##(2007-7#1)(2008-5#1)
to half##8##2##(1990-9#1)(2007-7#1)(2008-3#1)(2008-5#3)(2013-1#1)(2013-8#1)
to halogen)##2##2##(2008-10#2)
to halt##3##2##(1997-3#1)(2008-3#1)(2008-5#1)
to hand hygiene##2##3##(2008-12#2)
to hand##6##2##(1994-8#1)(1996-1#1)(1997-5#1)(2008-11#1)(2008-12#2)
to handle and##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
to handle multiple##2##3##(2008-4#1)(2008-6#1)
to handle the##2##3##(2008-1#1)(2011-3#1)
to handle this##2##3##(1994-3#1)(2008-2#1)
to handle##38##2##(1990-6#1)(1990-8#1)(1991-1#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#2)(2008-9#1)(2009-12#2)(2011-3#1)(2012-2#2)(2013-8#1)
to happen##6##2##(1992-12#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-3#1)
to harbor##4##2##(2008-10#3)(2012-3#1)
to harmful##4##2##(1990-8#1)(2008-12#1)(2009-12#1)(2011-2#1)
to harness the power of##2##5##(2010-9#1)(2012-3#1)
to harness the##7##3##(2008-10#1)(2008-11#1)(2008-7#2)(2010-9#1)(2011-1#1)(2012-3#1)
to harness##9##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-9#1)(2011-1#2)(2012-3#2)
to harnessing the##2##3##(2008-11#1)(2010-3#1)
to harvest##7##2##(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)
to have 4##2##3##(1990-2#1)(2008-12#1)
to have CP##2##3##(2011-2#1)(2012-2#1)
to have a beneficial effect on##2##6##(1991-11#1)(2012-3#1)
to have a better##3##4##(2008-10#1)(2012-2#1)(2013-7#1)
to have a broad##2##4##(1994-6#1)(2011-2#1)
to have a good prospect of##2##6##(2008-5#1)(2012-3#1)
to have a greater##4##4##(1992-5#1)(2008-3#1)(2008-5#1)(2009-4#1)
to have a high incidence of##2##6##(2007-10#1)(2010-5#1)
to have a high##9##4##(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-5#1)(2011-1#1)(2013-7#1)
to have a higher##3##4##(1991-6#1)(1996-9#1)(2013-8#1)
to have a highly##3##4##(1992-8#1)(2008-10#1)(2008-11#1)
to have a large##4##4##(2008-10#1)(2008-3#3)
to have a larger##2##4##(1994-3#1)(2012-2#1)
to have a low##3##4##(1997-1#1)(2009-7#1)(2012-2#1)
to have a more##4##4##(1990-2#1)(1995-6#1)(2008-11#1)(2013-7#1)
to have a novel##2##4##(1993-3#2)
to have a positive effect on##2##6##(2008-12#1)(2012-2#1)
to have a positive impact on##2##6##(1997-1#1)(2008-11#1)
to have a positive##7##4##(1992-5#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-2#1)(2013-8#1)
to have a relatively##2##4##(1993-12#1)(2008-8#1)
to have a role in##2##5##(1996-2#1)(2013-8#1)
to have a role##3##4##(1996-2#1)(2008-4#1)(2013-8#1)
to have a significant influence on the##2##7##(2007-12#1)(2008-5#1)
to have a significant influence##3##5##(2007-12#1)(2008-5#1)(2011-2#1)
to have a significant##11##4##(2006-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
to have a small##2##4##(1994-5#1)(2008-2#1)
to have a somewhat##2##4##(1996-9#1)(2008-6#1)
to have a specific##2##4##(2008-11#1)(2008-2#1)
to have a strong##3##4##(2008-3#1)(2011-1#1)(2012-3#1)
to have a therapeutic##2##4##(1993-3#1)(1993-5#1)
to have a wide##2##4##(2008-10#1)(2008-7#1)
to have a##183##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#3)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-9#2)(1997-1#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#2)(2007-10#5)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#12)(2008-11#7)(2008-12#5)(2008-2#9)(2008-3#13)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#4)
to have access to##3##4##(1995-3#1)(2007-2#1)(2008-11#1)
to have accumulated##2##3##(2008-10#1)(2011-2#1)
to have active##2##3##(1997-8#1)(2008-10#1)
to have adverse##2##3##(2008-1#1)(2008-10#1)
to have an adverse effect on##2##6##(1997-2#1)(2008-10#1)
to have an effect on##2##5##(1997-4#1)(2008-2#1)
to have an effect##3##4##(1997-4#1)(2008-2#1)(2008-9#1)
to have an impact on##3##5##(1994-2#1)(2007-7#1)(2009-7#1)
to have an important##2##4##(1993-9#1)(2008-3#1)
to have an increased risk##3##5##(2008-12#1)(2009-7#1)(2012-3#1)
to have an increased##4##4##(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)
to have an influence on the##2##6##(2008-10#1)(2008-11#1)
to have an##50##3##(1990-12#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-9#1)(1994-2#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-7#2)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
to have anti-inflammatory##2##3##(2011-3#1)(2013-8#1)
to have any##4##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)
to have applications in##2##4##(2008-9#1)(2011-7#1)
to have arisen##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
to have at least##4##4##(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
to have become##2##3##(2007-7#1)(2008-1#1)
to have been a##2##4##(1996-6#1)(2010-5#1)
to have been plagiarized from##4##5##(2008-10#4)
to have been present##4##4##(1990-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
to have been transmitted##2##4##(1990-3#1)(1990-9#1)
to have been##34##3##(1990-11#1)(1990-3#2)(1990-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#1)(2012-2#2)
to have beneficial##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2010-5#1)
to have better##6##3##(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
to have both##4##3##(1994-12#1)(1996-2#1)(2007-10#1)(2008-4#1)
to have cancer##2##3##(2008-4#1)(2009-11#1)
to have caused##3##3##(1992-6#1)(2008-2#1)(2011-2#1)
to have children##4##3##(1992-2#1)(2009-11#1)(2011-2#1)(2012-12#1)
to have chronic##3##3##(1997-8#1)(2008-4#1)(2013-1#1)
to have considerable impact on##2##5##(1993-6#1)(2008-9#1)
to have considerable##6##3##(1990-3#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
to have different##2##3##(2008-10#1)(2010-8#1)
to have differing##2##3##(1994-6#1)(2008-11#1)
to have effects##2##3##(2007-8#1)(2008-10#1)
to have elevated##3##3##(1997-7#1)(2011-2#1)(2013-1#1)
to have entered##2##3##(1994-11#1)(2012-2#1)
to have evolved##4##3##(2007-6#1)(2009-6#1)(2010-3#2)
to have good##5##3##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
to have great##3##3##(1996-5#1)(2008-10#2)
to have greater##5##3##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
to have had##7##3##(1990-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2012-3#1)
to have high##5##3##(2008-10#2)(2008-7#1)(2013-1#2)
to have higher antioxidant activity than##2##6##(2013-8#2)
to have higher##5##3##(1994-2#1)(2008-2#1)(2013-1#1)(2013-8#2)
to have its##2##3##(2008-5#1)(2011-2#1)
to have little##8##3##(1991-6#1)(1991-7#1)(1993-2#1)(2008-2#1)(2010-6#1)(2011-1#2)(2012-3#1)
to have lost##2##3##(2007-12#1)(2008-10#1)
to have low##3##3##(1995-6#1)(2008-4#1)(2013-1#1)
to have lower##5##3##(2008-10#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)
to have malignant##2##3##(1991-2#1)(2008-5#1)
to have many##2##3##(1991-5#1)(2011-1#1)
to have more##9##3##(1994-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-2#1)
to have much##2##3##(1995-3#1)(2008-2#1)
to have no effect on the##2##6##(1994-8#1)(2008-10#1)
to have no effect on##4##5##(1994-8#1)(2007-10#1)(2008-10#1)(2012-2#1)
to have no effect##5##4##(1994-8#1)(1996-3#1)(2007-10#1)(2008-10#1)(2012-2#1)
to have no##18##3##(1990-11#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#1)
to have normal##2##3##(2006-6#1)(2008-9#1)
to have occurred##3##3##(1994-11#1)(1995-2#1)(2009-8#1)
to have only##2##3##(1994-5#1)(2010-1#1)
to have potential##2##3##(2013-1#2)
to have prognostic##2##3##(1990-5#1)(1997-7#1)
to have proper##2##3##(1994-9#1)(2008-1#1)
to have reached a##2##4##(1994-2#1)(2010-3#1)
to have reached##3##3##(1994-2#1)(1995-6#1)(2010-3#1)
to have received##3##3##(1995-2#1)(2008-9#1)(2009-5#1)
to have recently##2##3##(2008-10#1)(2012-2#1)
to have responded to##2##4##(2008-9#1)(2011-2#1)
to have resulted in##2##4##(1992-1#1)(1992-11#1)
to have resulted##3##3##(1992-1#1)(1992-11#1)(2008-7#1)
to have severe##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
to have significant##11##3##(1991-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(2008-1#1)(2008-10#4)(2011-1#1)(2013-1#1)
to have similar##3##3##(2006-4#1)(2008-10#1)(2012-12#1)
to have small##2##3##(2008-11#1)(2008-3#1)
to have some##2##3##(1993-1#1)(2008-1#1)
to have strong##4##3##(1992-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
to have substantially higher##2##4##(1993-1#1)(1995-2#1)
to have taken##2##3##(1991-9#1)(1995-11#1)
to have the best##2##4##(2008-10#1)(2009-5#1)
to have the greatest##4##4##(2008-10#1)(2011-2#2)(2012-3#1)
to have the lowest##3##4##(1990-5#1)(2008-2#1)(2010-8#1)
to have the most##2##4##(1994-2#1)(2008-9#1)
to have the potential to##2##5##(1997-8#1)(2008-5#1)
to have the potential##3##4##(1997-8#1)(2008-2#1)(2008-5#1)
to have the same##5##4##(1993-6#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
to have the##46##3##(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#3)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)
to have their##3##3##(1990-2#1)(2008-11#2)
to have this##2##3##(1992-4#1)(1994-2#1)
to have three##2##3##(2010-12#1)(2013-1#1)
to have two to##2##4##(2008-10#2)
to have two##7##3##(1990-11#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-9#1)
to having##10##2##(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
to he##2##2##(1992-12#1)(2008-8#1)
to head trauma##2##3##(2012-2#1)(2013-1#1)
to head##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
to heading##3##2##(2008-10#3)
to heal##6##2##(1993-1#1)(1996-1#1)(1997-6#1)(2007-7#1)(2010-6#1)(2012-2#1)
to health and##4##3##(1994-12#1)(2008-12#1)(2008-3#1)(2012-2#1)
to health are##2##3##(1991-2#1)(2012-12#1)
to health behavior##2##3##(2008-4#1)(2011-1#1)
to health care and##2##4##(1996-11#1)(2012-12#1)
to health care facilities##2##4##(1997-3#1)(2007-12#1)
to health care for##3##4##(1991-3#1)(1995-12#1)(1996-2#1)
to health care in##4##4##(1995-12#1)(1995-3#1)(2008-11#1)(2010-4#1)
to health care professionals'##2##4##(2007-11#1)(2007-2#1)
to health care workers in##2##5##(1993-2#1)(1996-12#1)
to health care workers##3##4##(1993-2#1)(1995-2#1)(1996-12#1)
to health care##65##3##(1990-2#1)(1991-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#3)(1994-2#3)(1995-1#4)(1995-12#4)(1995-2#2)(1995-3#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-2#3)(1997-3#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
to health care?##2##3##(1995-2#1)(2012-12#1)
to health insurance##3##3##(1994-3#1)(2012-1#1)(2013-1#1)
to health maintenance organizations (HMOs)##2##5##(1991-1#1)(1993-3#1)
to health maintenance organizations and##2##5##(1991-3#2)
to health maintenance organizations##6##4##(1991-1#2)(1991-3#2)(1993-1#1)(1993-3#1)
to health outcomes##2##3##(2012-2#1)(2013-8#1)
to health problems##2##3##(1995-6#1)(2012-1#1)
to health professionals##2##3##(1995-3#1)(2008-6#1)
to health promotion and##2##4##(1991-1#1)(1993-12#1)
to health promotion##3##3##(1991-1#1)(1993-12#1)(2011-2#1)
to health reform##2##3##(1993-3#1)(1994-1#1)
to health service##2##3##(2008-1#1)(2011-1#1)
to health services##10##3##(1992-2#2)(1994-1#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-8#1)(2011-1#2)(2012-12#1)
to health systems##2##3##(2008-7#1)(2012-2#1)
to health##143##2##(1990-12#1)(1990-2#1)(1991-1#3)(1991-2#1)(1991-3#4)(1992-11#1)(1992-2#2)(1993-1#2)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#1)(1994-1#5)(1994-12#4)(1994-2#4)(1994-3#1)(1995-1#4)(1995-12#5)(1995-2#4)(1995-3#3)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#4)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#6)(2011-2#2)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
to healthcare##10##2##(1991-1#1)(1997-7#1)(2008-4#1)(2008-9#2)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
to healthy control##2##3##(2009-6#1)(2011-2#1)
to healthy controls##6##3##(1993-2#1)(1996-7#1)(2008-1#1)(2009-6#1)(2013-1#2)
to healthy seedlings##2##3##(2008-10#2)
to healthy subjects##4##3##(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to healthy##34##2##(1990-3#1)(1993-2#1)(1995-3#2)(1996-7#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-7#3)(2009-11#2)(2009-6#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
to hearing##2##2##(2007-7#1)(2012-2#1)
to heart failure##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
to heart##10##2##(1990-11#1)(1994-5#1)(1995-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
to heat and acid##2##4##(1994-11#2)
to heat and to##2##4##(2008-10#1)(2008-8#1)
to heat and##4##3##(1994-11#2)(2008-10#1)(2008-8#1)
to heat shock##4##3##(1990-12#1)(1995-11#1)(2008-7#2)
to heat stress##3##3##(1995-5#2)(2008-5#1)
to heat##25##2##(1990-12#1)(1992-3#1)(1994-11#3)(1995-11#1)(1995-5#2)(1995-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)
to heating##3##2##(1993-3#1)(2007-12#1)(2008-3#1)
to heavy metal##2##3##(1997-4#1)(2008-10#1)
to heavy metals##6##3##(2008-10#4)(2013-1#2)
to heavy##11##2##(1993-2#1)(1997-4#1)(2008-10#6)(2008-11#1)(2013-1#2)
to heighten##3##2##(1992-12#1)(1997-4#1)(2008-7#1)
to heir##2##2##(1997-5#1)(2013-7#1)
to helical##2##2##(2008-11#1)(2008-2#1)
to help achieve##2##3##(1996-2#1)(2007-2#1)
to help clarify the##2##4##(2008-5#1)(2011-2#1)
to help clarify##4##3##(2008-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
to help control##2##3##(2008-3#1)(2012-3#1)
to help define the##2##4##(1991-6#1)(2008-7#1)
to help define##3##3##(1991-6#2)(2008-7#1)
to help determine##3##3##(1996-6#1)(2008-1#1)(2009-12#1)
to help ensure##4##3##(1996-9#1)(2008-10#2)(2010-5#1)
to help families assist##2##4##(2011-2#2)
to help guide the##2##4##(2008-10#1)(2010-8#1)
to help guide##4##3##(2008-10#1)(2008-12#1)(2009-4#1)(2010-8#1)
to help health##2##3##(1996-1#1)(2008-12#1)
to help healthcare##2##3##(2011-2#1)(2012-12#1)
to help identify##7##3##(1991-2#1)(1992-8#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-3#1)
to help improve the##3##4##(2008-2#1)(2008-7#1)(2013-7#1)
to help improve##5##3##(1994-12#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-7#1)
to help in##5##3##(1995-2#1)(2008-10#2)(2010-8#2)
to help individuals##3##3##(1995-9#1)(2008-7#2)
to help manage##5##3##(1991-1#1)(1997-2#1)(2008-10#2)(2010-7#1)
to help managers##2##3##(1992-2#1)(2007-10#1)
to help minimize##2##3##(2008-5#1)(2013-1#1)
to help patients##4##3##(2007-6#1)(2008-11#1)(2011-2#2)
to help prevent the##2##4##(2008-12#1)(2012-12#1)
to help prevent##6##3##(1991-7#1)(2007-2#1)(2008-12#1)(2010-1#1)(2010-12#1)(2012-12#1)
to help reduce##3##3##(2008-1#1)(2008-12#1)(2009-5#1)
to help researchers##2##3##(2008-10#1)(2008-4#1)
to help the##15##3##(1991-2#1)(1992-2#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
to help their patients##2##4##(1994-1#1)(2010-9#1)
to help their##4##3##(1994-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
to help them develop##2##4##(1993-2#1)(2010-10#1)
to help them##6##3##(1991-2#1)(1993-2#1)(2008-6#1)(2010-10#1)(2011-1#1)(2012-12#1)
to help understand the##2##4##(2008-5#1)(2008-7#1)
to help understand##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
to help us##2##3##(2008-2#1)(2009-10#1)
to help users##2##3##(2008-9#1)(2011-2#1)
to help with##2##3##(2010-12#1)(2013-8#1)
to help women##2##3##(1994-3#1)(2010-3#1)
to help you##4##3##(1992-3#1)(1994-1#1)(1995-12#1)(1995-2#1)
to help##197##2##(1991-1#1)(1991-2#3)(1991-6#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-5#1)(1997-7#2)(2007-1#1)(2007-10#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#15)(2008-11#9)(2008-12#8)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#4)(2011-2#11)(2012-12#6)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
to help'##2##2##(2012-3#2)
to helping##3##2##(1995-12#1)(2008-8#2)
to hematoma##2##2##(2009-3#1)(2012-3#1)
to heme##5##2##(1992-12#1)(1992-8#1)(1993-8#1)(1997-2#1)(2007-11#1)
to hemodialysis##7##2##(1994-6#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#2)(2013-8#1)
to hemoglobin##3##2##(1990-8#1)(1994-11#1)(2011-1#1)
to hemolytic anemia##2##3##(1997-6#2)
to hemolytic##3##2##(1997-6#2)(2013-1#1)
to heparin##5##2##(1994-3#1)(1997-1#2)(2008-5#1)(2013-1#1)
to hepatic##3##2##(1997-8#1)(2011-1#1)(2012-3#1)
to hepatitis B surface##2##4##(1994-11#1)(2009-12#1)
to hepatitis B##5##3##(1994-11#1)(2009-12#2)(2013-1#2)
to hepatitis C##2##3##(2007-7#1)(2008-6#1)
to hepatitis##8##2##(1994-11#1)(2007-7#1)(2008-6#2)(2009-12#2)(2013-1#2)
to her death##2##3##(1995-12#1)(2011-2#1)
to her##12##2##(1994-6#1)(1995-12#1)(2007-7#1)(2008-12#2)(2008-7#1)(2011-2#4)(2012-12#1)(2013-8#1)
to herbivore##3##2##(2008-8#2)(2008-9#1)
to here as##5##3##(1994-2#1)(2008-3#1)(2008-4#2)(2011-2#1)
to heterogeneity in##2##3##(2008-10#1)(2009-6#1)
to heterogeneity of##2##3##(2006-6#1)(2013-8#1)
to heterogeneity##4##2##(2006-6#1)(2008-10#1)(2009-6#1)(2013-8#1)
to heterosis##2##2##(2012-3#2)
to hexagonal phase##2##3##(1990-12#1)(1994-12#1)
to hexagonal##4##2##(1990-12#1)(1990-2#1)(1994-12#1)(2008-3#1)
to hexaploid##2##2##(2008-10#2)
to hierarchically##2##2##(2008-10#1)(2009-11#1)
to high altitude##3##3##(1992-2#1)(2012-2#2)
to high concentrations of##2##4##(1991-9#1)(2007-12#1)
to high density##2##3##(1995-5#1)(2008-11#1)
to high dose##2##3##(1996-6#1)(2008-1#1)
to high doses of##3##4##(1996-2#1)(2008-7#1)(2010-10#1)
to high doses##5##3##(1996-2#1)(1996-6#1)(2007-11#1)(2008-7#1)(2010-10#1)
to high frequency##2##3##(2008-11#1)(2010-3#1)
to high glucose##2##3##(1992-6#1)(2010-11#1)
to high levels of expression of##2##6##(1997-4#1)(2008-11#1)
to high levels of##4##4##(1997-4#1)(2008-10#1)(2008-11#1)(2009-3#1)
to high levels##5##3##(1997-4#1)(2008-10#2)(2008-11#1)(2009-3#1)
to high molecular weight##2##4##(2008-10#1)(2008-7#1)
to high performance liquid chromatography##2##5##(2008-10#2)
to high performance liquid##3##4##(2008-10#3)
to high risk##5##3##(1993-11#1)(2008-11#1)(2009-3#1)(2009-5#1)(2011-2#1)
to high spatial resolution##2##4##(2008-2#1)(2010-12#1)
to high temperature##3##3##(1995-8#1)(2008-12#2)
to high temperatures##4##3##(2008-10#2)(2008-12#1)(2008-7#1)
to high##110##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#3)(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#24)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#6)(2008-9#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#2)
to high-affinity##3##2##(1993-8#1)(2008-4#1)(2008-9#1)
to high-dose##3##2##(2006-7#1)(2008-8#1)(2011-1#1)
to high-intensity##2##2##(2007-11#1)(2008-4#1)
to high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
to high-performance liquid chromatography##3##4##(1991-7#1)(2008-10#2)
to high-resolution##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
to high-risk##4##2##(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to high-throughput##3##2##(2008-4#1)(2010-12#1)(2010-2#1)
to higher levels of##4##4##(1993-3#1)(2008-7#1)(2009-7#1)(2010-3#1)
to higher levels##5##3##(1993-3#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-3#1)
to higher order##2##3##(2007-12#1)(2012-2#1)
to higher quality##2##3##(1992-11#1)(1992-3#1)
to higher rates##2##3##(2012-12#1)(2012-2#1)
to higher temperatures##2##3##(1995-8#1)(2008-3#1)
to higher than expected##2##4##(1990-5#1)(2008-10#1)
to higher##57##2##(1990-2#1)(1990-4#1)(1990-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#3)(2010-3#1)(2010-5#2)(2010-8#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
to higher-order##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
to highest##2##2##(2008-9#1)(2010-12#1)
to highlight its##2##3##(1995-3#1)(2008-3#1)
to highlight that##2##3##(2012-3#1)(2013-8#1)
to highlight the importance of##3##5##(2007-5#1)(2008-10#1)(2011-1#1)
to highlight the##21##3##(1992-8#1)(1994-12#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)
to highlight##44##2##(1992-8#1)(1994-12#1)(1995-3#2)(1997-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
to highly pleasurable##2##3##(2012-2#2)
to highly resistant##3##3##(2008-10#3)
to highly variable##3##3##(2007-7#1)(2008-8#1)(2013-7#1)
to highly##23##2##(1995-5#1)(1997-1#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to him##2##2##(1990-11#1)(1993-3#1)
to hinder##2##2##(2008-11#1)(2008-4#1)
to hip##2##2##(2008-11#1)(2011-2#1)
to hippocampal##2##2##(1993-5#1)(2008-4#1)
to his or her##2##4##(1994-2#1)(2012-3#1)
to his physician##2##3##(1990-6#1)(2013-1#1)
to his right##2##3##(1996-2#1)(2010-10#1)
to his##29##2##(1990-6#1)(1992-2#1)(1992-6#2)(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
to his/her##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
to histamine##6##2##(1992-9#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-5#2)
to histidine##5##2##(1992-6#1)(1992-9#1)(1995-5#1)(1996-5#1)(1997-3#1)
to histologic##2##2##(1990-3#1)(1991-2#1)
to histological##5##2##(1993-9#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
to historical##2##2##(2007-7#1)(2009-5#1)
to hit##4##2##(1991-3#1)(1994-3#1)(2008-6#1)(2011-2#1)
to hold a##2##3##(2007-11#1)(2010-10#1)
to hold for##2##3##(1995-2#1)(2008-10#1)
to hold the##2##3##(1996-2#1)(2008-12#1)
to hold##16##2##(1990-12#1)(1992-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-1#1)(2013-7#1)
to holographic##3##2##(2008-2#1)(2008-3#2)
to home and##2##3##(1991-12#1)(1993-12#1)
to home care##4##3##(1991-12#1)(1995-3#2)(2006-5#1)
to home##17##2##(1991-12#4)(1991-2#2)(1992-5#1)(1992-9#1)(1993-12#1)(1995-3#2)(2006-5#1)(2007-8#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
to homogeneity as judged by##2##5##(1990-10#1)(1990-11#1)
to homogeneity by a##2##4##(1990-7#1)(1990-8#1)
to homogeneity by##12##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1997-4#2)(2008-8#1)(2009-3#1)(2010-4#1)
to homogeneity##54##2##(1990-10#1)(1990-11#4)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-6#2)(1992-8#3)(1993-11#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#5)(1995-6#1)(1997-2#1)(1997-4#3)(1997-6#2)(2008-10#1)(2008-11#1)(2008-8#4)(2009-3#1)(2010-4#2)
to homogeneous##3##2##(2008-10#1)(2008-3#2)
to homologous##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
to honor##2##2##(1992-12#1)(1996-2#1)
to hormonal##4##2##(1994-3#1)(1994-9#1)(2009-5#1)(2012-3#1)
to hormones##3##2##(1993-8#1)(2008-1#1)(2008-7#1)
to horseradish peroxidase##3##3##(1991-2#1)(1997-3#1)(2008-7#1)
to hospice care##5##3##(1993-12#3)(1995-1#1)(2012-12#1)
to hospice##6##2##(1992-12#1)(1993-12#3)(1995-1#1)(2012-12#1)
to hospital and##4##3##(1991-11#1)(1992-4#1)(1996-1#1)(2007-8#1)
to hospital care##3##3##(1992-2#2)(1996-2#1)
to hospital cost##2##3##(1992-12#1)(1996-12#1)
to hospital discharge##2##3##(2007-9#1)(2008-3#1)
to hospital for##4##3##(1992-5#1)(1993-9#1)(2007-2#2)
to hospital in##2##3##(1990-9#1)(2010-7#1)
to hospital security##2##3##(1993-2#1)(1997-2#1)
to hospital with##8##3##(1992-6#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#2)(2012-12#1)
to hospital##57##2##(1990-2#1)(1990-9#1)(1991-11#2)(1991-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#2)
to hospital-based##2##2##(1991-2#1)(1992-1#1)
to hospitalization for##2##3##(1992-1#1)(2012-2#1)
to hospitalization##9##2##(1991-1#1)(1991-2#2)(1992-1#1)(1995-1#1)(1995-5#1)(2007-11#1)(2009-5#1)(2012-2#1)
to hospitals and##4##3##(1993-6#1)(1995-1#1)(2008-11#1)(2008-4#1)
to hospitals with##3##3##(1993-1#1)(2008-3#1)(2008-8#1)
to hospitals##19##2##(1991-1#2)(1991-3#1)(1992-1#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-5#1)(1997-1#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#1)
to host cells##2##3##(2008-10#2)
to host resistance##3##3##(2008-10#3)
to host size##3##3##(2008-10#1)(2008-9#2)
to host species##2##3##(2008-10#2)
to host##35##2##(1990-8#1)(1994-5#1)(2007-12#2)(2008-10#21)(2008-11#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
to hot wax##2##3##(1992-6#2)
to hot##6##2##(1992-6#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)
to hours##2##2##(2008-4#1)(2010-3#1)
to house dust##2##3##(2012-3#1)(2013-8#1)
to house##4##2##(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to housing##2##2##(1996-5#1)(2013-1#1)
to how it##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
to how they##3##3##(1996-1#1)(2010-9#2)
to how##27##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-9#2)(2011-2#1)
to huge##2##2##(1997-6#1)(2008-3#1)
to human and animal##3##4##(2008-10#2)(2008-9#1)
to human and##7##3##(1995-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
to human antithrombin##2##3##(1992-10#2)
to human brain##3##3##(1990-8#1)(2008-3#1)(2013-1#1)
to human cancer##2##3##(2008-8#1)(2009-4#1)
to human chromosome##8##3##(1994-12#2)(1997-6#1)(1997-7#1)(1997-8#2)(2008-7#1)(2008-9#1)
to human disease##2##3##(2008-4#1)(2013-1#1)
to human erythrocyte##2##3##(1992-1#1)(1994-12#1)
to human health and##2##4##(2009-7#1)(2012-2#1)
to human health##16##3##(1992-2#1)(1994-3#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
to human immunodeficiency##2##3##(1991-9#1)(1992-12#1)
to human plasma##2##3##(1993-6#1)(2008-10#1)
to human serum albumin (HSA) and##2##6##(1994-8#1)(2008-10#1)
to human serum albumin (HSA)##3##5##(1994-8#1)(2008-10#2)
to human serum albumin##5##4##(1990-12#1)(1994-8#1)(2008-10#3)
to human serum##6##3##(1990-12#1)(1994-8#1)(2008-10#3)(2008-12#1)
to human skin##3##3##(2008-5#2)(2012-3#1)
to human##139##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-6#1)(2007-12#1)(2008-10#14)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#7)(2013-8#3)
to humans and##4##3##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
to humans by##2##3##(1997-6#1)(2011-2#1)
to humans##32##2##(1990-5#1)(1991-12#1)(1994-6#1)(1995-11#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
to humic acid##2##3##(2008-10#2)
to humic##3##2##(2008-10#3)
to humidity##2##2##(2008-10#2)
to humoral immunity##2##3##(2008-11#1)(2008-12#1)
to humoral##3##2##(2006-10#1)(2008-11#1)(2008-12#1)
to hundreds of##6##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#2)
to hybrid##4##2##(1995-8#1)(2008-10#1)(2008-3#1)(2012-3#1)
to hybridize to##2##3##(1993-9#1)(2008-8#1)
to hybridize##4##2##(1993-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
to hybridoma##2##2##(2008-11#1)(2008-7#1)
to hydride generation##2##3##(2008-10#2)
to hydrogen ion##3##3##(2008-10#3)
to hydrogen peroxide##3##3##(1995-5#1)(2008-10#2)
to hydrogen##11##2##(1995-3#1)(1995-5#1)(2008-10#9)
to hydrolyse##2##2##(2009-3#1)(2011-1#1)
to hydrolysis and##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
to hydrolysis by##3##3##(1990-2#1)(1991-5#1)(1994-11#1)
to hydrolysis##10##2##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#2)(2008-10#1)(2008-5#2)(2013-1#2)
to hydrolyze##7##2##(1991-12#1)(1992-9#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-4#1)
to hydroxyapatite cement##2##3##(2011-2#2)
to hydroxyapatite##4##2##(2008-11#2)(2011-2#2)
to hydroxylamine##2##2##(1990-11#1)(1997-2#1)
to hydroxylate##2##2##(1991-9#1)(1994-8#1)
to hydroxyurea##2##2##(1994-8#1)(2012-3#1)
to hygiene##3##2##(2008-9#1)(2010-8#1)(2011-2#1)
to hygromycin B##4##3##(1995-2#1)(2008-10#3)
to hygromycin##6##2##(1995-2#1)(2008-10#5)
to hyperglycaemia##2##2##(2008-1#1)(2008-7#1)
to hyperglycemia##2##2##(2009-11#1)(2013-1#1)
to hyperpolarizing##2##2##(1993-8#1)(2009-2#1)
to hypertension##7##2##(1990-2#1)(2007-7#1)(2008-12#1)(2009-7#2)(2010-4#1)(2013-1#1)
to hypertensive##3##2##(2007-7#1)(2008-4#1)(2009-1#1)
to hyperthyroidism##2##2##(1996-5#1)(2011-1#1)
to hyperventilation##3##2##(2008-7#3)
to hypochlorite##2##2##(2007-7#1)(2008-10#1)
to hypotension##2##2##(2008-1#1)(2008-6#1)
to hypotheses##3##2##(2009-5#1)(2009-7#1)(2010-3#1)
to hypothesize that##2##3##(2008-1#1)(2008-4#1)
to hypothesize##3##2##(2008-1#1)(2008-4#1)(2009-7#1)
to hypothetical##3##2##(1993-12#1)(1996-12#2)
to hypoxia in##2##3##(1990-7#1)(2013-1#1)
to hypoxia##19##2##(1990-7#3)(1991-2#1)(1994-2#1)(1994-5#2)(1995-12#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#4)
to hypoxic##2##2##(2008-7#1)(2010-11#1)
to hypoxic-ischemic brain##2##3##(1996-5#2)
to hypoxic-ischemic##3##2##(1996-5#3)
to hysterectomy##4##2##(1991-3#1)(1994-12#1)(1994-9#1)(2008-8#1)
to i##5##2##(1992-3#2)(1992-8#2)(1994-2#1)
to i)##3##2##(2009-12#1)(2009-8#1)(2010-8#1)
to ideal##4##2##(2007-9#1)(2008-12#1)(2008-9#1)(2012-12#1)
to identifiable##2##2##(1991-8#1)(1995-12#1)
to identification of##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
to identification##4##2##(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
to identify &quot##2##3##(1995-1#1)(2008-10#1)
to identify a set of##2##5##(2007-12#1)(2012-3#1)
to identify a specific DNA##2##5##(1990-11#1)(2008-10#1)
to identify a##28##3##(1990-10#1)(1990-11#1)(1990-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
to identify all##4##3##(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
to identify an##3##3##(1991-9#1)(2008-3#1)(2008-7#1)
to identify and characterize the##2##5##(1995-2#1)(2008-12#1)
to identify and characterize##5##4##(1995-2#1)(1997-2#1)(1997-4#1)(2008-12#1)(2009-3#1)
to identify and differentiate##2##4##(2008-10#2)
to identify and isolate##3##4##(1995-1#2)(2008-4#1)
to identify and manage##2##4##(2010-3#1)(2011-2#1)
to identify and purify##2##4##(1993-8#1)(2008-9#1)
to identify and quantify##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
to identify and remove##2##4##(2008-10#1)(2008-3#1)
to identify and to##2##4##(1991-12#1)(1994-8#1)
to identify and understand the##2##5##(2008-12#1)(2010-5#1)
to identify and##64##3##(1991-12#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
to identify any##6##3##(1995-1#1)(1995-12#1)(2008-5#2)(2008-9#1)(2011-1#1)
to identify apoptotic##2##3##(2008-7#1)(2008-9#1)
to identify areas of##2##4##(2007-10#1)(2008-11#1)
to identify areas##4##3##(2007-10#1)(2008-11#2)(2008-12#1)
to identify as bisexual##2##4##(2008-12#2)
to identify as gay##2##4##(2008-12#2)
to identify as##4##3##(2008-12#4)
to identify candidate genes##2##4##(2008-10#2)
to identify candidate##3##3##(2008-10#2)(2008-7#1)
to identify candidates##3##3##(1993-12#2)(2012-12#1)
to identify cases##2##3##(2009-10#1)(2012-12#1)
to identify cells that##2##4##(2008-4#1)(2008-9#1)
to identify cells##3##3##(2008-4#1)(2008-9#1)(2011-1#1)
to identify certain##3##3##(1992-3#1)(1997-4#1)(2008-7#1)
to identify changes in the##2##5##(2008-11#1)(2008-4#1)
to identify changes in##3##4##(2008-1#1)(2008-11#1)(2008-4#1)
to identify changes##6##3##(2008-1#1)(2008-11#1)(2008-4#1)(2010-11#1)(2013-1#2)
to identify common##3##3##(1994-2#1)(2008-11#1)(2011-2#1)
to identify critical##2##3##(2008-11#1)(2008-7#1)
to identify defects##2##3##(2008-12#1)(2008-3#1)
to identify deletion##2##3##(2012-3#2)
to identify determinants of##3##4##(1990-2#1)(1993-6#1)(2009-4#1)
to identify differentially expressed##2##4##(2008-2#1)(2010-12#1)
to identify diseases##2##3##(1997-3#1)(2008-10#1)
to identify dominant##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
to identify environmental##2##3##(1991-1#1)(2008-8#1)
to identify factors associated with##4##5##(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
to identify factors contributing to##2##5##(2008-12#1)(2011-1#1)
to identify factors that influence the##2##6##(2008-9#1)(2013-8#1)
to identify factors that influence##3##5##(2008-9#1)(2013-1#1)(2013-8#1)
to identify factors that##7##4##(2007-10#2)(2008-9#1)(2013-1#2)(2013-8#2)
to identify factors##17##3##(2007-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#4)
to identify family##2##3##(1992-1#1)(2013-8#1)
to identify genes that are##2##5##(2008-7#1)(2009-9#1)
to identify genes that##6##4##(1991-5#1)(1992-9#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
to identify genes##16##3##(1991-5#1)(1992-9#1)(1995-11#1)(2008-10#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-3#2)
to identify genetic##4##3##(2008-10#1)(2010-3#1)(2012-3#2)
to identify high-risk##2##3##(1996-2#1)(2013-1#1)
to identify important##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
to identify in the##2##4##(2008-10#1)(2013-7#1)
to identify individuals with##2##4##(2008-10#1)(2008-3#1)
to identify individuals##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
to identify informative##3##3##(2010-12#1)(2011-3#2)
to identify its##2##3##(1996-7#1)(2008-8#1)
to identify key##2##3##(1993-2#1)(2012-2#1)
to identify molecular markers for##2##5##(2008-10#2)
to identify molecular markers##3##4##(2008-10#3)
to identify molecular##6##3##(2008-10#3)(2008-2#1)(2012-2#1)(2013-8#1)
to identify mutants##2##3##(1995-2#1)(2012-3#1)
to identify new molecular##2##4##(2010-12#1)(2010-3#1)
to identify new##11##3##(2008-8#3)(2009-12#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
to identify novel##7##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2013-1#1)
to identify opportunities for##3##4##(1995-12#1)(1996-3#1)(1997-1#1)
to identify optimal##5##3##(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
to identify other##2##3##(1994-2#1)(2008-10#1)
to identify patients at risk##2##5##(2006-10#1)(2012-2#1)
to identify patients with##6##4##(1992-11#1)(2008-11#1)(2008-8#1)(2011-2#2)(2013-1#1)
to identify patients##12##3##(1992-11#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
to identify patterns##2##3##(1992-2#1)(2011-1#1)
to identify peptides##2##3##(2008-4#1)(2010-2#1)
to identify populations##2##3##(1995-12#1)(2008-9#1)
to identify possible##4##3##(2008-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
to identify potential##13##3##(1990-8#1)(1993-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#3)
to identify predictors of##6##4##(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-3#1)
to identify problems##2##3##(1993-2#1)(2009-5#1)
to identify prognostic##2##3##(2008-6#2)
to identify proteins##2##3##(1992-8#1)(2008-9#1)
to identify published reports##2##4##(2012-12#1)(2013-1#1)
to identify quantitative trait loci (QTL) associated with##2##8##(2008-10#2)
to identify quantitative trait loci (QTL)##4##6##(2008-10#4)
to identify quantitative trait loci##6##5##(2008-10#4)(2012-3#2)
to identify relevant##4##3##(1993-12#1)(2011-8#1)(2013-1#1)(2013-7#1)
to identify research gaps##2##4##(2009-3#2)
to identify resistance##3##3##(2008-10#3)
to identify risk factors for##3##5##(2011-2#1)(2012-12#1)(2013-1#1)
to identify risk factors##7##4##(1996-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
to identify risk##9##3##(1996-12#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
to identify significant##3##3##(2008-8#1)(2010-2#1)(2012-3#1)
to identify similar##2##3##(2008-4#1)(2012-2#1)
to identify solutions to clinical practice problems##3##7##(2010-11#3)
to identify specific##11##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2010-11#1)(2012-12#1)(2012-2#2)
to identify strategies##2##3##(1993-2#1)(2008-11#1)
to identify studies##5##3##(2012-12#3)(2013-1#2)
to identify suitable husbandry conditions for maintaining multi-generation populations##2##9##(2008-11#2)
to identify suitable##3##3##(2008-11#2)(2013-1#1)
to identify targets##2##3##(2008-11#1)(2008-2#1)
to identify the best##2##4##(1993-12#1)(1995-2#1)
to identify the cause of##2##5##(2008-11#1)(2010-4#1)
to identify the extent##2##4##(1997-2#1)(2008-10#1)
to identify the factors that##2##5##(1990-10#1)(2008-1#1)
to identify the factors##7##4##(1990-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-12#1)(2011-2#1)
to identify the functional##2##4##(2008-7#1)(2009-5#1)
to identify the gene##3##4##(1995-6#1)(2008-9#1)(2011-3#1)
to identify the global##2##4##(2008-4#2)
to identify the important##2##4##(2006-8#1)(2008-11#1)
to identify the key##4##4##(2008-3#1)(2008-6#1)(2013-8#2)
to identify the main##5##4##(2008-10#3)(2009-10#1)(2012-3#1)
to identify the major##3##4##(1990-6#1)(1996-1#1)(2008-10#1)
to identify the metabolites##2##4##(1990-11#1)(2008-10#1)
to identify the most appropriate##3##5##(1996-1#1)(2007-11#1)(2011-2#1)
to identify the most##5##4##(1995-12#1)(1996-1#1)(2007-11#1)(2008-10#1)(2011-2#1)
to identify the optimal##4##4##(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)
to identify the precise##2##4##(1993-12#1)(2012-12#1)
to identify the relative##2##4##(1993-12#1)(2008-10#1)
to identify the risk##2##4##(2008-4#1)(2008-7#1)
to identify the species of##2##5##(2007-12#1)(2008-10#1)
to identify the specific##2##4##(1994-8#1)(2008-11#1)
to identify the##192##3##(1990-10#1)(1990-11#4)(1990-2#2)(1990-6#1)(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#28)(2008-11#9)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#6)
to identify their##2##3##(2008-11#1)(2011-1#1)
to identify these##6##3##(1992-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)
to identify this##2##3##(1996-11#1)(2010-11#1)
to identify those patients who##2##5##(2008-1#1)(2012-1#1)
to identify those patients##3##4##(2008-1#1)(2012-1#2)
to identify those##11##3##(1990-7#1)(1993-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-8#1)
to identify two##4##3##(2008-10#3)(2008-9#1)
to identify unknown##2##3##(2008-10#1)(2009-9#1)
to identify variables##3##3##(2007-10#1)(2008-8#1)(2012-2#1)
to identify various##2##3##(2009-1#1)(2012-12#1)
to identify wellbeing with##2##4##(2008-10#2)
to identify whether##3##3##(2008-10#1)(2011-2#2)
to identify which##6##3##(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-12#1)(2009-6#1)
to identify##888##2##(1990-10#3)(1990-11#6)(1990-12#3)(1990-2#4)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#7)(1991-2#3)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#6)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#9)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#3)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#5)(1996-5#2)(1996-7#1)(1997-1#6)(1997-2#4)(1997-3#3)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#7)(2007-11#5)(2007-12#10)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#14)(2008-10#117)(2008-11#45)(2008-12#26)(2008-2#13)(2008-3#17)(2008-4#29)(2008-5#13)(2008-6#11)(2008-7#33)(2008-8#19)(2008-9#32)(2009-1#2)(2009-10#8)(2009-12#7)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#14)(2010-12#6)(2010-2#3)(2010-3#7)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#13)(2011-2#34)(2011-3#4)(2011-8#1)(2012-1#5)(2012-12#22)(2012-2#21)(2012-3#39)(2012-7#1)(2012-8#1)(2013-1#42)(2013-7#7)(2013-8#29)
to identifying an##2##3##(2008-9#1)(2011-1#1)
to identifying##11##2##(1990-5#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
to identity##2##2##(2010-10#1)(2013-8#1)
to ignore the##3##3##(1990-6#1)(2008-10#1)(2008-7#1)
to ignore##6##2##(1990-6#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
to illicit drug use##3##4##(2009-7#2)(2010-4#1)
to illicit##5##2##(2008-10#1)(2008-5#1)(2009-7#2)(2010-4#1)
to illness##5##2##(1992-12#1)(1993-1#1)(1995-2#1)(2009-5#1)(2012-12#1)
to illuminate and##2##3##(2008-3#2)
to illuminate the##4##3##(1997-3#1)(2008-11#1)(2008-9#1)(2012-12#1)
to illuminate##8##2##(1997-3#1)(2008-11#2)(2008-3#3)(2008-9#1)(2012-12#1)
to illumination from below##2##4##(1991-2#2)
to illumination##4##2##(1991-2#2)(1993-3#1)(2008-3#1)
to illusory contours##2##3##(2008-8#2)
to illusory##3##2##(2007-12#1)(2008-8#2)
to illustrate and##4##3##(1992-1#1)(1996-3#1)(2008-7#1)(2010-9#1)
to illustrate how##9##3##(1994-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)
to illustrate its##2##3##(2010-3#1)(2012-3#1)
to illustrate some of##2##4##(2008-4#1)(2012-2#1)
to illustrate the performance of the algorithm##2##7##(2008-2#1)(2008-3#1)
to illustrate the performance of the##3##6##(2008-2#1)(2008-3#2)
to illustrate the performance of##4##5##(2008-2#1)(2008-3#3)
to illustrate the potential##2##4##(1990-8#1)(2008-11#1)
to illustrate the usefulness##2##4##(2008-10#1)(2012-2#1)
to illustrate the##57##3##(1990-8#1)(1991-1#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-2#5)(2013-1#2)(2013-8#1)
to illustrate their##2##3##(2010-1#1)(2010-4#1)
to illustrate this##2##3##(2008-10#1)(2008-3#1)
to illustrate##94##2##(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
to image a##4##3##(1990-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
to image an##2##3##(2007-12#1)(2008-3#1)
to image noise##2##3##(2008-2#2)
to image the##9##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2011-7#1)
to image##42##2##(1990-11#1)(1995-12#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-2#9)(2008-3#13)(2008-5#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-7#1)(2012-2#1)
to images##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
to imaging of##3##3##(1997-8#1)(2007-11#1)(2010-8#1)
to imaging##9##2##(1991-1#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-8#1)(2012-2#1)
to imatinib##3##2##(2012-12#3)
to imipenem##2##2##(2008-12#1)(2012-2#1)
to imitate##2##2##(2008-2#1)(2008-6#1)
to immediate##6##2##(1990-9#1)(2008-11#2)(2008-5#1)(2013-1#2)
to immediately##4##2##(1990-11#1)(2009-8#1)(2010-6#1)(2011-2#1)
to immobilised##2##2##(1990-12#1)(1994-12#1)
to immobilization##2##2##(2008-4#1)(2012-1#1)
to immobilize DNA##2##3##(2008-10#2)
to immobilize a##3##3##(1991-5#2)(2008-10#1)
to immobilize##12##2##(1991-5#2)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)
to immobilized##9##2##(1993-11#1)(1997-2#1)(2008-10#4)(2008-4#2)(2008-7#1)
to immortalize primary##2##3##(2008-11#1)(2008-2#1)
to immortalize##4##2##(2008-11#3)(2008-2#1)
to immune##5##2##(1993-8#1)(2008-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
to immunity##2##2##(1997-3#1)(2008-10#1)
to immunize##6##2##(1993-8#1)(1994-3#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
to immunoassays##2##2##(2008-10#2)
to immunohistochemistry##2##2##(1991-6#1)(2007-8#1)
to immunological##3##2##(1991-5#1)(1996-12#1)(2008-4#1)
to immunoprecipitate##3##2##(1990-11#1)(1992-2#1)(1992-9#1)
to immunosuppression##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
to immunotherapy##2##2##(1994-5#1)(2013-1#1)
to impact on##2##3##(2008-3#1)(2012-3#1)
to impact##7##2##(1997-1#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
to impair the##3##3##(1990-6#1)(1992-10#1)(2008-4#1)
to impair##12##2##(1990-6#1)(1992-10#2)(1993-9#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
to impaired##7##2##(2008-10#1)(2008-3#2)(2009-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
to impairment of##4##3##(1996-12#1)(2008-7#1)(2012-1#1)(2012-12#1)
to impairments in##2##3##(2008-11#1)(2008-7#1)
to impart##2##2##(2009-12#1)(2010-4#1)
to impede##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
to impersonal##2##2##(2008-11#1)(2009-4#1)
to implant and##2##3##(2007-8#1)(2012-3#1)
to implant in##2##3##(2008-9#1)(2012-3#1)
to implant loosening##2##3##(2008-11#2)
to implant##14##2##(1994-9#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-9#4)(2010-6#1)(2012-12#1)(2012-3#2)
to implantation##4##2##(1991-12#1)(2008-9#2)(2012-1#1)
to implement CQI##2##3##(1993-12#1)(1994-12#1)
to implement a new##2##4##(1994-9#1)(2007-11#1)
to implement a##15##3##(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-1#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2013-1#1)
to implement an##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
to implement and##4##3##(1995-2#1)(2008-2#2)(2008-8#1)
to implement continuous quality improvement##2##5##(1994-3#2)
to implement more##2##3##(2008-10#1)(2008-3#1)
to implement some##2##3##(2008-10#1)(2008-4#1)
to implement strategies##2##3##(2008-11#1)(2012-3#1)
to implement such##4##3##(1991-12#1)(1991-2#1)(2012-12#2)
to implement the multicommutation approach##2##5##(2008-10#2)
to implement the##22##3##(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)
to implement these##4##3##(1996-1#1)(2008-11#1)(2009-6#1)(2011-2#1)
to implement total quality management (TQM)##2##6##(1993-12#1)(1994-1#1)
to implement##127##2##(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1997-1#3)(1997-3#1)(1997-7#2)(2007-11#6)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#9)(2008-2#11)(2008-3#15)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
to implementation of the##2##4##(1994-3#1)(1996-2#1)
to implementation of##5##3##(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)(2013-1#1)
to implementation##10##2##(1993-3#3)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-6#1)(2013-1#1)
to implementing##8##2##(1994-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-12#1)
to imply that##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
to imply##4##2##(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)
to import##2##2##(2008-10#1)(2008-4#1)
to important##9##2##(1994-11#1)(1994-5#1)(1997-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
to improve access##2##3##(1994-3#1)(2008-7#1)
to improve accuracy##3##3##(2010-7#1)(2012-12#1)(2012-3#1)
to improve adherence to##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
to improve adherence##5##3##(2008-3#1)(2008-4#1)(2011-1#2)(2013-1#1)
to improve air quality##2##4##(1996-8#1)(2010-5#1)
to improve and##3##3##(1997-2#1)(1997-3#2)
to improve antibiotic##2##3##(1993-11#1)(2010-4#1)
to improve as##2##3##(1994-9#1)(2013-1#1)
to improve blood pressure control##2##5##(2008-8#1)(2013-1#1)
to improve both##2##3##(2009-10#1)(2013-1#1)
to improve care for##4##4##(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
to improve care##15##3##(1994-2#1)(1996-1#1)(1997-3#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
to improve cell##2##3##(2008-11#1)(2008-5#1)
to improve clinical##5##3##(1996-12#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
to improve cognition##2##3##(2009-8#2)
to improve communication##4##3##(1994-11#1)(1996-11#1)(2010-4#1)(2011-1#1)
to improve consumer##2##3##(1995-2#1)(2013-1#1)
to improve crop##2##3##(2010-10#1)(2012-2#1)
to improve decision-making##2##3##(1992-2#1)(2008-8#1)
to improve detection##2##3##(2008-10#1)(2008-7#1)
to improve diagnostic accuracy##2##4##(1991-3#1)(2010-12#1)
to improve diagnostic##3##3##(1991-3#1)(2008-10#1)(2010-12#1)
to improve dyspnea##2##3##(2013-8#2)
to improve efficiency##3##3##(1995-3#1)(2008-2#1)(2008-7#1)
to improve functional recovery##2##4##(2008-8#2)
to improve functional##3##3##(2008-6#1)(2008-8#2)
to improve functioning##2##3##(2012-1#1)(2012-2#1)
to improve growth##2##3##(2008-10#1)(2009-5#1)
to improve health care delivery##2##5##(2007-7#1)(2008-6#1)
to improve health care##8##4##(1993-3#1)(1995-3#1)(1996-3#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
to improve health##14##3##(1993-3#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-7#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#2)
to improve healthcare##2##3##(1997-3#1)(2013-1#1)
to improve hospital##3##3##(1991-1#1)(1997-8#1)(2008-11#1)
to improve image##2##3##(2008-3#1)(2009-10#1)
to improve immunization##2##3##(1996-12#2)
to improve in##3##3##(1994-11#1)(2011-2#1)(2013-1#1)
to improve insulin sensitivity##2##4##(2008-11#1)(2008-3#1)
to improve its##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
to improve many##2##3##(2008-11#1)(2009-9#1)
to improve medical##2##3##(1994-3#1)(1996-3#1)
to improve mental##2##3##(2009-3#1)(2012-2#1)
to improve on##4##3##(1991-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
to improve our understanding of the##2##6##(2008-10#1)(2008-11#1)
to improve our understanding of##4##5##(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
to improve our##7##3##(1992-2#1)(1993-12#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
to improve outcomes in##2##4##(1997-1#1)(2008-6#1)
to improve outcomes##8##3##(1997-1#1)(2008-11#2)(2008-6#1)(2013-1#3)(2013-8#1)
to improve overall##2##3##(2008-3#1)(2010-1#1)
to improve patient care##2##4##(1996-12#1)(2010-3#1)
to improve patient outcomes##2##4##(2008-9#1)(2011-2#1)
to improve patient safety##4##4##(2008-7#1)(2008-8#1)(2011-2#2)
to improve patient##15##3##(1994-2#1)(1996-12#1)(1996-3#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#1)
to improve patients'##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
to improve performance##2##3##(2008-2#1)(2008-7#1)
to improve post-operative##2##3##(2007-8#1)(2008-11#1)
to improve practice##2##3##(2007-10#1)(2008-11#1)
to improve processes##2##3##(1993-3#1)(1995-1#1)
to improve productivity##2##3##(2008-10#1)(2008-11#1)
to improve quality and##3##4##(1994-2#1)(1994-3#1)(2010-8#1)
to improve quality in##2##4##(1992-11#1)(1995-5#1)
to improve quality of care##2##5##(2008-3#2)
to improve quality of##5##4##(1993-12#1)(2008-1#1)(2008-3#2)(2012-2#1)
to improve quality##14##3##(1992-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-1#1)(2008-3#2)(2010-8#1)(2012-2#1)(2013-1#1)
to improve resistance##2##3##(2008-10#1)(2012-5#1)
to improve satisfaction with##2##4##(2008-11#1)(2008-9#1)
to improve selectivity##2##3##(2008-10#1)(2008-11#1)
to improve sensitivity##3##3##(1996-12#1)(2008-10#2)
to improve service##2##3##(1993-12#1)(2012-3#1)
to improve services##2##3##(1991-3#1)(2008-6#1)
to improve survival and##2##4##(1994-6#1)(2011-3#1)
to improve survival##4##3##(1994-6#1)(2011-2#1)(2011-3#1)(2012-3#1)
to improve symptoms and##2##4##(2009-6#1)(2010-6#1)
to improve the QOL##2##4##(1994-12#1)(2012-2#1)
to improve the accuracy of the##3##6##(2008-3#2)(2008-6#1)
to improve the accuracy of##8##5##(2008-10#2)(2008-2#1)(2008-3#4)(2008-6#1)
to improve the accuracy##11##4##(2008-10#3)(2008-2#2)(2008-3#5)(2008-6#1)
to improve the axial##2##4##(2007-11#1)(2008-6#1)
to improve the biocompatibility##2##4##(2008-5#1)(2008-7#1)
to improve the chance that##2##5##(1995-1#1)(2007-2#1)
to improve the delivery##2##4##(1996-2#1)(2008-12#1)
to improve the detection##4##4##(2008-10#2)(2008-3#1)(2013-8#1)
to improve the economics of##2##5##(2008-11#1)(2008-5#1)
to improve the effectiveness of##3##5##(1994-2#1)(1995-2#1)(2008-3#1)
to improve the efficiency of the##2##6##(1996-12#1)(2010-8#1)
to improve the efficiency of##5##5##(1996-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-8#1)
to improve the efficiency##6##4##(1995-3#1)(1996-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-8#1)
to improve the estimation of##2##5##(2008-7#1)(2011-2#1)
to improve the extraction##2##4##(2008-10#2)
to improve the health of the##2##6##(1991-6#1)(2013-1#1)
to improve the health of##4##5##(1991-6#1)(1993-3#1)(1995-1#1)(2013-1#1)
to improve the health status of the##2##7##(1995-2#1)(2008-1#1)
to improve the health##6##4##(1991-6#1)(1993-3#1)(1995-1#1)(1995-2#1)(2008-1#1)(2013-1#1)
to improve the long-term##2##4##(2008-11#1)(2011-2#1)
to improve the method##2##4##(2008-10#1)(2008-11#1)
to improve the nutritional value of##2##6##(2008-6#1)(2010-4#1)
to improve the overall##2##4##(2007-2#1)(2008-3#1)
to improve the performance of a##2##6##(1993-12#1)(2008-3#1)
to improve the performance of the##2##6##(2008-2#1)(2012-1#1)
to improve the performance of##9##5##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-1#1)
to improve the performance##11##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-8#1)(2012-1#1)
to improve the prediction##2##4##(2008-10#1)(2013-1#1)
to improve the process of##3##5##(1993-3#1)(2008-3#1)(2012-12#1)
to improve the production##2##4##(2008-11#2)
to improve the prognosis##2##4##(2010-3#1)(2011-2#1)
to improve the quality and##3##5##(1993-3#1)(1994-2#1)(2008-10#1)
to improve the quality of care provided##2##7##(2008-12#1)(2008-3#1)
to improve the quality of care##4##6##(1996-1#1)(1996-12#1)(2008-12#1)(2008-3#1)
to improve the quality of life##4##6##(1990-2#1)(2007-11#1)(2009-11#1)(2009-5#1)
to improve the quality of patient care##2##7##(1993-3#1)(2009-8#1)
to improve the quality of the##2##6##(2008-10#1)(2008-3#1)
to improve the quality of their##2##6##(1992-2#1)(2008-1#1)
to improve the quality of##23##5##(1990-2#1)(1992-2#2)(1992-3#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#1)
to improve the quality##26##4##(1990-2#1)(1992-2#2)(1992-3#1)(1993-3#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#1)
to improve the resolution of##2##5##(1996-12#1)(2008-3#1)
to improve the sensitivity and##2##5##(2008-10#1)(2008-3#1)
to improve the sensitivity of the##2##6##(2008-10#2)
to improve the sensitivity of##5##5##(2007-12#1)(2008-10#4)
to improve the sensitivity##7##4##(2007-12#1)(2008-10#5)(2008-3#1)
to improve the separation and##2##5##(2008-10#2)
to improve the separation##3##4##(2008-10#3)
to improve the signal-to-noise ratio##4##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
to improve the spectral resolution##2##5##(2007-12#2)
to improve the speed and##2##5##(2008-7#1)(2010-12#1)
to improve the speed##3##4##(2008-7#1)(2008-9#1)(2010-12#1)
to improve the stability of the##2##6##(2008-10#2)
to improve the stability of##4##5##(2008-10#2)(2008-6#1)(2013-1#1)
to improve the survival##2##4##(2008-11#1)(2010-12#1)
to improve the use##2##4##(2012-12#1)(2013-1#1)
to improve the##266##3##(1990-11#1)(1990-2#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-12#3)(1993-3#5)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(2007-11#5)(2007-12#4)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#51)(2008-11#17)(2008-12#5)(2008-2#9)(2008-3#25)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#4)(2012-8#1)(2013-1#14)(2013-8#5)
to improve their ability to##2##5##(2009-3#1)(2012-1#1)
to improve their performance##3##4##(1993-12#1)(2008-10#1)(2010-8#1)
to improve their##24##3##(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#1)(1996-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-3#2)(2010-8#2)(2011-2#4)(2012-1#1)(2012-3#1)
to improve treatment##5##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)
to improve understanding of##2##4##(2008-10#1)(2011-2#1)
to improve understanding##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
to improve with##2##3##(1994-12#1)(2008-3#1)
to improve your##3##3##(1995-2#1)(1996-2#1)(2008-9#1)
to improve##715##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-1#3)(1991-11#1)(1991-12#4)(1991-3#2)(1991-4#1)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#10)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#9)(1994-3#4)(1994-5#2)(1994-6#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#5)(1995-5#1)(1995-6#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#16)(1996-2#8)(1996-3#12)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#8)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#9)(2007-12#5)(2007-2#4)(2007-7#6)(2007-8#7)(2008-1#5)(2008-10#80)(2008-11#47)(2008-12#11)(2008-2#17)(2008-3#46)(2008-4#6)(2008-5#13)(2008-6#16)(2008-7#18)(2008-8#13)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#10)(2010-6#3)(2010-7#2)(2010-8#14)(2010-9#3)(2011-1#14)(2011-2#29)(2011-3#1)(2011-9#1)(2012-1#6)(2012-12#8)(2012-2#17)(2012-3#12)(2012-5#1)(2012-8#1)(2013-1#38)(2013-7#2)(2013-8#15)
to improved outcomes##2##3##(2008-1#1)(2008-12#1)
to improved patient outcomes##2##4##(1996-1#1)(2011-2#1)
to improved##32##2##(1990-9#1)(1991-12#1)(1994-5#1)(1995-1#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#3)
to improvement and##2##3##(2008-5#1)(2008-8#1)
to improvement in##5##3##(1995-3#1)(2007-2#1)(2008-4#1)(2009-7#1)(2010-8#1)
to improvement##10##2##(1993-3#1)(1995-3#1)(1997-8#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)
to improvements in##5##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
to improvements##7##2##(2008-11#2)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)
to improving health##4##3##(1995-2#1)(1996-1#1)(2008-7#1)(2012-2#1)
to improving outcomes for##2##4##(2008-6#1)(2010-3#1)
to improving outcomes##3##3##(2008-6#1)(2008-7#1)(2010-3#1)
to improving patient##4##3##(1993-2#2)(2007-12#1)(2011-2#1)
to improving the efficiency##2##4##(1994-5#1)(2008-2#1)
to improving the##10##3##(1993-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-9#1)(2012-2#1)(2013-8#1)
to improving##35##2##(1991-2#1)(1993-2#2)(1993-3#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
to in situ##4##3##(1991-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
to in vitro##8##3##(1993-1#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-5#1)(2013-1#2)
to in vivo studies##2##4##(2010-7#1)(2011-1#1)
to in vivo##12##3##(1996-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#2)
to in##31##2##(1991-9#1)(1992-11#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#3)(2009-9#2)(2010-5#1)(2010-7#1)(2011-1#3)(2013-1#3)
to in-situ##2##2##(2008-10#1)(2013-8#1)
to inaccurate##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
to inactivate 95% of the sporangia##2##6##(2008-10#2)
to inactivate or##2##3##(2008-6#1)(2013-1#1)
to inactivate the##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
to inactivate##18##2##(1990-8#1)(1991-9#1)(1993-8#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
to inactivation of##2##3##(1990-5#1)(1995-6#1)
to inactivation##3##2##(1990-5#1)(1995-6#1)(2007-12#1)
to inadequate care##2##3##(1992-2#1)(2008-10#1)
to inadequate##10##2##(1992-2#1)(1993-11#1)(1993-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2012-2#1)(2012-3#1)
to inappropriate##4##2##(1994-9#1)(2008-10#1)(2008-3#1)(2010-11#1)
to incarceration##2##2##(2009-11#1)(2010-6#1)
to incidence of##4##3##(1997-3#1)(2008-10#3)
to incidence##8##2##(1991-11#1)(1994-2#1)(1997-3#1)(2008-10#4)(2008-8#1)
to incident##3##2##(2007-2#1)(2008-11#1)(2008-3#1)
to incisional##3##2##(2011-2#2)(2012-12#1)
to include a##13##3##(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2009-7#2)(2010-3#1)(2010-6#1)(2012-2#1)(2013-1#2)
to include additional##2##3##(1995-1#1)(2008-11#1)
to include fungal##2##3##(2007-12#1)(2013-1#1)
to include more##4##3##(1993-12#1)(2007-7#1)(2008-12#1)(2008-3#1)
to include the effect of##2##5##(2008-2#1)(2008-3#1)
to include the##18##3##(1991-1#1)(1991-7#1)(1994-1#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-2#1)
to include three##2##3##(1993-2#1)(2012-2#1)
to include##102##2##(1990-2#1)(1991-1#1)(1991-3#2)(1991-7#1)(1991-9#2)(1992-3#4)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#4)
to incoming##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
to incomplete data##2##3##(2007-2#1)(2008-11#1)
to incomplete##11##2##(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
to inconsistent##5##2##(2008-3#1)(2009-10#1)(2009-4#1)(2012-12#2)
to incorporate a##4##3##(1994-12#1)(1995-5#1)(2008-3#1)(2008-8#1)
to incorporate both##2##3##(1992-3#1)(2012-12#1)
to incorporate new##2##3##(1992-1#1)(2008-10#1)
to incorporate short term event time information##2##7##(2013-1#2)
to incorporate the##4##3##(1995-1#1)(2008-11#1)(2008-3#1)(2008-4#1)
to incorporate##35##2##(1992-1#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(2006-12#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#2)(2008-6#3)(2008-8#1)(2009-11#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#3)
to incorporation##2##2##(1991-5#1)(2008-5#1)
to incorrect##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
to increase (P##2##3##(2008-10#1)(2010-2#1)
to increase D*##2##3##(2008-3#2)
to increase IP3##2##3##(1995-11#2)
to increase after the##2##4##(1995-3#1)(2008-10#1)
to increase after##3##3##(1995-3#1)(2008-10#1)(2008-4#1)
to increase and##3##3##(2007-12#1)(2010-6#1)(2012-3#1)
to increase as the##4##4##(1995-3#1)(2007-12#1)(2008-12#1)(2008-7#1)
to increase as##6##3##(1995-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
to increase awareness of##2##4##(2007-2#1)(2008-1#1)
to increase both##4##3##(1993-6#1)(2008-10#1)(2008-7#1)(2009-3#1)
to increase by##2##3##(1992-12#1)(2013-1#1)
to increase confidence##2##3##(2008-10#1)(2010-11#1)
to increase dramatically##2##3##(1995-3#1)(2008-2#1)
to increase during##3##3##(1994-6#2)(2008-10#1)
to increase efficiency and##2##4##(1994-2#1)(2008-12#1)
to increase efficiency##4##3##(1994-2#1)(2008-11#1)(2008-12#1)(2013-1#1)
to increase for##2##3##(1991-12#1)(2008-10#1)
to increase from##3##3##(1994-9#1)(2007-12#1)(2008-2#1)
to increase in the##6##4##(1994-6#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)
to increase in##17##3##(1994-3#1)(1994-6#1)(1995-3#2)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to increase its##2##3##(2008-10#1)(2008-7#1)
to increase knowledge##3##3##(2010-4#1)(2013-1#2)
to increase our understanding of##3##5##(2008-8#1)(2010-8#1)(2013-1#1)
to increase our understanding##4##4##(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
to increase oxygen delivery##2##4##(1996-3#1)(2010-7#1)
to increase physical##2##3##(1993-2#1)(2008-5#1)
to increase productivity and##3##4##(1993-3#1)(2008-11#1)(2008-7#1)
to increase productivity##4##3##(1993-3#1)(1994-1#1)(2008-11#1)(2008-7#1)
to increase proportionally##2##3##(2008-10#1)(2012-2#1)
to increase recombinant protein production in##2##6##(2008-11#1)(2011-2#1)
to increase risk of##2##4##(1990-8#1)(2008-11#1)
to increase sample##3##3##(2008-10#3)
to increase sensitivity and##2##4##(2008-10#2)
to increase sensitivity##6##3##(2007-11#1)(2008-10#5)
to increase significantly the##2##4##(2008-10#1)(2012-12#1)
to increase significantly##5##3##(1992-11#1)(2008-10#2)(2011-2#1)(2012-12#1)
to increase skill##2##3##(1995-12#1)(2012-1#1)
to increase the awareness##2##4##(2011-2#1)(2012-3#1)
to increase the complexity of##2##5##(2007-11#1)(2011-2#1)
to increase the degree of##2##5##(1995-12#1)(2010-10#1)
to increase the effective##2##4##(2007-12#1)(2008-7#1)
to increase the efficiency of##2##5##(2008-7#1)(2009-9#1)
to increase the efficiency##4##4##(1993-3#1)(2008-7#1)(2009-9#1)(2012-12#1)
to increase the expression##2##4##(1996-2#1)(2009-4#1)
to increase the incidence##3##4##(1992-2#1)(2007-10#1)(2012-3#1)
to increase the intensity of##2##5##(2008-12#1)(2013-8#1)
to increase the knowledge##2##4##(2007-10#1)(2013-1#1)
to increase the level of##3##5##(2008-10#1)(2008-5#1)(2009-6#1)
to increase the likelihood of##2##5##(2008-9#1)(2010-10#1)
to increase the likelihood##3##4##(2008-9#1)(2010-10#2)
to increase the number of##6##5##(1993-2#1)(2008-2#1)(2008-3#3)(2008-4#1)
to increase the number##7##4##(1993-2#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-11#1)
to increase the physical activity of healthcare workers in a public hospital in South Africa##2##15##(2013-1#2)
to increase the precision of##2##5##(2007-8#1)(2008-10#1)
to increase the probability of##4##5##(1995-12#1)(2008-3#1)(2008-7#2)
to increase the resistance##2##4##(1993-3#1)(1994-6#1)
to increase the risk of##2##5##(2008-1#1)(2009-8#1)
to increase the risk##3##4##(2008-1#1)(2009-8#1)(2010-8#1)
to increase the sensitivity and##2##5##(2008-10#2)
to increase the sensitivity of the##2##6##(1995-11#1)(2008-10#1)
to increase the sensitivity of##4##5##(1990-8#1)(1995-11#1)(2008-10#1)(2010-5#1)
to increase the sensitivity##10##4##(1990-8#1)(1995-11#1)(2008-10#6)(2008-2#1)(2010-5#1)
to increase the understanding of the##3##6##(1995-1#1)(1995-5#1)(1997-4#1)
to increase the##156##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#18)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#4)
to increase their##9##3##(1990-12#1)(1992-12#2)(1995-12#1)(1996-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-7#1)
to increase throughout the##2##4##(1996-2#1)(2008-1#1)
to increase to##2##3##(2008-6#1)(2008-7#1)
to increase treatment##2##3##(2008-6#1)(2012-3#1)
to increase understanding of##2##4##(1995-6#1)(2008-12#1)
to increase understanding##3##3##(1995-6#1)(2008-12#2)
to increase with age##2##4##(1995-3#1)(1997-7#1)
to increase with increasing##5##4##(1995-6#1)(1996-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
to increase with the##4##4##(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)
to increase with time##4##4##(1991-2#1)(2008-10#2)(2010-5#1)
to increase with##19##3##(1991-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-5#1)(2012-2#1)
to increase##466##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#11)(1995-5#5)(1995-6#2)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#5)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#3)(2007-11#7)(2007-12#9)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#58)(2008-11#18)(2008-12#11)(2008-2#11)(2008-3#26)(2008-4#7)(2008-5#17)(2008-6#3)(2008-7#19)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#5)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#7)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#10)(2012-2#9)(2012-3#13)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#4)
to increased cell##2##3##(1990-8#1)(2012-5#1)
to increased drug##2##3##(1997-3#1)(2013-1#1)
to increased levels of##2##4##(1994-11#1)(2012-2#1)
to increased metabolic##2##3##(1994-8#1)(2008-9#1)
to increased mortality##2##3##(2008-10#1)(2008-8#1)
to increased risk of##5##4##(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
to increased risk##6##3##(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
to increased##118##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-4#1)(1992-9#2)(1993-12#2)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-12#4)(1995-2#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2012-5#2)(2013-1#9)(2013-7#2)(2013-8#2)
to increases in the##2##4##(1991-2#1)(2008-7#1)
to increases in##7##3##(1991-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)
to increases##10##2##(1991-2#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)
to increasethe##2##2##(2008-11#2)
to increasing concentrations of##2##4##(1990-2#1)(2008-11#1)
to increasing the##2##3##(2008-10#1)(2008-9#1)
to increasing##23##2##(1990-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-6#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-4#1)
to incubate##2##2##(1990-12#1)(2008-8#1)
to incubation##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
to independent living##3##3##(2008-12#1)(2009-10#1)(2013-1#1)
to independent##4##2##(2008-11#1)(2008-12#1)(2009-10#1)(2013-1#1)
to independently##5##2##(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-8#1)
to index##2##2##(2008-3#1)(2008-4#1)
to indicate a##5##3##(1994-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
to indicate how##2##3##(2008-4#1)(2011-2#1)
to indicate that the##3##4##(2008-3#1)(2008-4#1)(2009-12#1)
to indicate that##17##3##(1990-12#1)(1991-6#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-12#1)(2013-1#1)
to indicate the##12##3##(1992-6#1)(1992-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2013-1#1)(2013-8#1)
to indicate whether a##2##4##(2008-11#1)(2008-3#1)
to indicate##50##2##(1990-12#1)(1991-6#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-8#1)(1997-7#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
to indigenous##2##2##(2013-1#2)
to indirect effects##2##3##(2008-11#1)(2012-2#1)
to indirect##3##2##(2008-11#2)(2012-2#1)
to indirectly##3##2##(2007-5#1)(2008-10#1)(2008-4#1)
to individual differences##2##3##(1997-8#1)(2008-7#1)
to individual patients##2##3##(1997-4#1)(2010-12#1)
to individual##37##2##(1991-1#1)(1994-12#1)(1995-2#1)(1995-6#2)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
to individualize the##2##3##(1991-1#1)(1997-4#1)
to individualize##4##2##(1991-1#1)(1992-8#1)(1997-4#1)(2010-10#1)
to individuals with##7##3##(1992-12#1)(1994-2#1)(2007-12#1)(2008-8#1)(2009-4#1)(2010-8#2)
to individuals##12##2##(1992-12#1)(1994-2#1)(2007-12#2)(2008-4#1)(2008-8#1)(2009-4#1)(2010-8#3)(2011-1#1)(2012-2#1)
to indoor##2##2##(1993-6#1)(2008-10#1)
to induce DNA ISC##2##4##(2008-11#2)
to induce DNA damage##2##4##(1993-12#1)(2008-5#1)
to induce DNA single-strand breaks##2##5##(1996-2#1)(2008-3#1)
to induce DNA##8##3##(1993-12#1)(1995-11#1)(1996-2#1)(2008-11#3)(2008-3#1)(2008-5#1)
to induce a delayed##2##4##(1995-12#1)(2008-11#1)
to induce a hypersensitive##2##4##(2008-10#2)
to induce a sensitization response was predicted by##2##8##(2008-10#2)
to induce a##23##3##(1990-12#1)(1992-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)
to induce an##8##3##(1990-2#1)(1992-9#1)(1993-3#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-5#1)
to induce and maintain##2##4##(2007-10#1)(2012-3#1)
to induce and##3##3##(2007-10#1)(2008-8#1)(2012-3#1)
to induce antibody##3##3##(1990-5#1)(1995-5#1)(2008-11#1)
to induce apoptosis in##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
to induce apoptosis##8##3##(1994-9#1)(1996-12#1)(2008-10#2)(2008-8#2)(2009-12#1)(2013-1#1)
to induce both##2##3##(1992-8#1)(2008-10#1)
to induce cell##5##3##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to induce changes in##2##4##(1996-5#1)(2012-2#1)
to induce differentiation of##2##4##(2008-11#1)(2008-9#1)
to induce differentiation##3##3##(1997-3#1)(2008-11#1)(2008-9#1)
to induce ectopic##2##3##(2008-4#1)(2011-2#1)
to induce expression##2##3##(2008-10#1)(2008-11#1)
to induce fluorescence##2##3##(2008-10#2)
to induce formation of the##2##5##(1990-5#1)(2008-10#1)
to induce intrinsic##2##3##(1997-7#1)(2011-2#1)
to induce lysosomal storage of##2##5##(1993-12#2)
to induce lysosomal##3##3##(1993-12#3)
to induce platelet activation##2##4##(2006-6#2)
to induce proliferation##2##3##(1993-6#1)(2008-4#1)
to induce resistance in##3##4##(2008-10#3)
to induce resistance##5##3##(2008-10#5)
to induce reversible##2##3##(1994-11#1)(2009-12#1)
to induce severe symptoms in##2##5##(2008-10#2)
to induce severe##3##3##(2008-10#2)(2011-1#1)
to induce stable##2##3##(1993-11#1)(2008-10#1)
to induce systemic resistance in tobacco##2##6##(2008-10#2)
to induce systemic resistance in##5##5##(2008-10#5)
to induce systemic resistance##7##4##(2008-10#7)
to induce systemic##8##3##(2008-10#8)
to induce the expression of##3##5##(1996-12#1)(2008-10#1)(2008-8#1)
to induce the##19##3##(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2010-7#1)(2013-8#1)
to induce these##3##3##(1990-2#1)(2008-10#1)(2012-12#1)
to induce transdifferentiation##2##3##(2012-12#1)(2012-7#1)
to induce tumors in##2##4##(2008-10#1)(2008-12#1)
to induce##280##2##(1990-12#1)(1990-2#3)(1990-5#3)(1990-7#1)(1991-12#1)(1991-2#3)(1991-5#5)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#3)(1996-12#2)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#1)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#61)(2008-11#16)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#11)(2008-9#6)(2009-10#1)(2009-12#5)(2010-11#3)(2010-12#1)(2010-4#1)(2010-7#3)(2011-1#2)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#1)
to induced##6##2##(1990-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2013-1#1)
to inducing##2##2##(1991-9#1)(2008-10#1)
to induction of apoptosis in##2##5##(2008-11#1)(2008-9#1)
to induction of##6##3##(1993-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
to induction##7##2##(1993-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
to inductively coupled plasma##5##4##(2008-10#5)
to industrial##2##2##(1995-2#1)(2008-10#1)
to ineffective##2##2##(1991-3#1)(2012-12#1)
to inefficient##3##2##(1994-8#1)(2008-2#1)(2009-11#1)
to infant##7##2##(1990-12#1)(1992-6#1)(2009-9#1)(2011-1#4)
to infant's##2##2##(1990-12#2)
to infants##5##2##(1994-2#1)(1995-3#1)(1995-6#1)(2007-8#1)(2008-12#1)
to infect a novel host##2##5##(2013-1#2)
to infect a##4##3##(2008-10#2)(2013-1#2)
to infect different##2##3##(2008-10#2)
to infect its host##2##4##(2008-10#2)
to infect plants of##2##4##(2008-10#2)
to infect sclerotia##2##3##(2008-10#2)
to infect the##6##3##(1991-6#1)(2008-10#3)(2008-8#1)(2013-1#1)
to infect##53##2##(1991-6#1)(1997-1#1)(1997-4#1)(2008-10#39)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#3)
to infected##7##2##(1990-9#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
to infection and##4##3##(1994-2#1)(2008-10#3)
to infection at##2##3##(2008-10#2)
to infection by M##2##4##(2008-10#2)
to infection by##21##3##(2008-10#15)(2009-5#5)(2010-7#1)
to infection control##2##3##(2008-1#1)(2012-3#1)
to infection in the##3##4##(1994-2#2)(2008-10#1)
to infection of##3##3##(2008-10#1)(2008-2#1)(2009-6#1)
to infection was##3##3##(2008-10#3)
to infection with##10##3##(1991-11#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)
to infection##99##2##(1990-6#1)(1991-11#1)(1993-12#1)(1994-2#8)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#59)(2008-12#1)(2008-2#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#6)(2009-6#2)(2010-7#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
to infections in##3##3##(1990-9#1)(2008-10#1)(2008-9#1)
to infections##11##2##(1990-9#1)(1991-9#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to infectious bronchitis##2##3##(1997-3#1)(2007-6#1)
to infectious diseases##5##3##(1990-6#1)(1997-8#1)(2008-10#3)
to infectious##12##2##(1990-6#1)(1997-3#1)(1997-8#2)(2007-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)
to infer climate##2##3##(2008-10#1)(2012-7#1)
to infer that##2##3##(2008-10#1)(2013-1#1)
to infer the##14##3##(1994-3#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-8#2)(2013-1#1)
to infer##34##2##(1994-3#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#3)(2011-1#3)(2012-7#1)(2012-9#1)(2013-1#3)(2013-8#1)
to inferring##2##2##(2008-4#1)(2008-7#1)
to infestation with##3##3##(1996-12#1)(2008-10#2)
to infestation##4##2##(1996-12#1)(2008-10#3)
to infiltrate##2##2##(2008-10#1)(2010-12#1)
to infiltration of##3##3##(2008-10#2)(2009-5#1)
to infiltration##4##2##(2008-10#2)(2008-5#1)(2009-5#1)
to infinity##2##2##(2008-12#1)(2010-12#1)
to inflamed tissues##2##3##(2008-3#2)
to inflamed##3##2##(1997-8#1)(2008-3#2)
to inflammation in##2##3##(1992-6#1)(2012-1#1)
to inflammation##7##2##(1990-5#2)(1992-6#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
to inflammatory##6##2##(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2009-5#1)
to infliximab##5##2##(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
to influence both innate and##2##5##(2006-10#2)
to influence cell##2##3##(1993-6#1)(2008-5#1)
to influence eating habits##2##4##(2010-1#2)
to influence the degree##2##4##(2008-7#1)(2009-7#1)
to influence the##30##3##(1990-9#1)(1991-3#1)(1991-8#1)(1992-10#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
to influence their##2##3##(1997-1#1)(2008-8#1)
to influence them##2##3##(2008-12#1)(2008-2#1)
to influence##91##2##(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-6#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#5)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-5#2)(2010-8#2)(2011-1#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#3)(2013-8#1)
to influenza##9##2##(1992-6#2)(1994-6#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#3)
to inform and##2##3##(1994-1#1)(2012-3#1)
to inform health policy##2##4##(1996-1#1)(2012-12#1)
to inform health##3##3##(1996-1#1)(2012-12#2)
to inform management##2##3##(1996-1#1)(2010-10#1)
to inform practice##2##3##(2007-10#1)(2009-8#1)
to inform the development of appropriate##2##6##(2007-10#1)(2011-2#1)
to inform the public##2##4##(1992-1#1)(1994-3#1)
to inform the##9##3##(1991-9#1)(1992-1#1)(1994-3#1)(2007-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
to inform their patients##2##4##(1991-11#1)(1997-6#1)
to inform them##2##3##(1996-6#1)(2012-3#1)
to inform##57##2##(1991-11#1)(1991-9#1)(1992-1#2)(1992-12#2)(1994-1#1)(1994-3#1)(1996-1#3)(1996-6#1)(1997-3#1)(1997-6#1)(2007-10#2)(2008-11#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#1)
to information##8##2##(1990-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-8#1)(2013-1#1)(2013-8#1)
to infrared (IR)##2##3##(2007-12#1)(2011-2#1)
to infrared##5##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
to infuse##2##2##(1997-3#1)(2009-5#1)
to ingest##4##2##(1990-2#1)(2008-1#1)(2008-5#2)
to inhalation of##3##3##(1990-9#1)(1994-6#1)(1995-11#1)
to inhaled##3##2##(1994-2#1)(2008-3#1)(2009-6#1)
to inherent##3##2##(2008-10#2)(2008-7#1)
to inherit##5##2##(2008-7#1)(2008-8#4)
to inhibit HIV-1##2##3##(1994-6#1)(2011-3#1)
to inhibit a##3##3##(1992-5#1)(2008-11#1)(2013-8#1)
to inhibit elastase##2##3##(2008-5#2)
to inhibit gastric acid secretion##2##5##(1992-6#1)(1997-6#1)
to inhibit growth of##4##4##(1993-1#1)(2008-10#1)(2010-11#1)(2011-2#1)
to inhibit growth##6##3##(1990-2#1)(1993-1#1)(1995-2#1)(2008-10#1)(2010-11#1)(2011-2#1)
to inhibit human##2##3##(1992-8#1)(2008-10#1)
to inhibit its##2##3##(1994-6#1)(1995-2#1)
to inhibit proliferation##2##3##(1997-3#1)(2013-7#1)
to inhibit the binding of 125I-IGF-II to the##2##8##(1990-5#2)
to inhibit the binding of##5##5##(1990-5#2)(1994-8#1)(1995-11#1)(2009-2#1)
to inhibit the expression of##5##5##(1995-11#1)(1997-6#1)(2008-5#1)(2008-9#1)(2010-1#1)
to inhibit the expression##6##4##(1993-6#1)(1995-11#1)(1997-6#1)(2008-5#1)(2008-9#1)(2010-1#1)
to inhibit the formation of##2##5##(1994-5#1)(1996-3#1)
to inhibit the function of##2##5##(1992-8#1)(2008-8#1)
to inhibit the growth of##5##5##(2008-10#5)
to inhibit the##57##3##(1990-11#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#6)(1996-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-4#1)
to inhibit this##2##3##(1995-11#1)(2008-11#1)
to inhibit thrombin formation##2##4##(1994-5#2)
to inhibit thrombin##4##3##(1990-7#1)(1991-9#1)(1994-5#2)
to inhibit tumor##3##3##(2008-11#2)(2008-9#1)
to inhibit##176##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#5)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#2)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-6#6)(1994-8#6)(1994-9#2)(1995-11#10)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-6#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#2)(2010-2#4)(2010-4#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
to inhibition by the##2##4##(1992-3#1)(1994-9#1)
to inhibition by##12##3##(1990-7#1)(1991-12#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#2)(1997-1#1)(1997-2#1)(2013-7#1)
to inhibition of 5-HT##2##4##(2008-7#2)
to inhibition of the##3##4##(1993-6#1)(2008-10#1)(2013-1#1)
to inhibition of vital cellular functions##2##6##(2008-9#2)
to inhibition of##24##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-6#1)(1995-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2011-1#3)(2012-2#1)(2013-1#2)
to inhibition##44##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#3)(1997-1#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2011-1#3)(2012-2#1)(2013-1#2)(2013-7#1)
to inhibitors##4##2##(1992-12#1)(1993-11#1)(2008-10#1)(2013-1#1)
to inhibitory##5##2##(1991-9#1)(1994-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
to initial therapy##2##3##(1993-2#1)(2010-11#1)
to initial##14##2##(1993-2#1)(1996-1#1)(2008-10#6)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)
to initially##3##2##(2008-10#1)(2012-1#1)(2012-12#1)
to initiate a biological weapons program##2##6##(1992-12#2)
to initiate a biological weapons##3##5##(1992-12#3)
to initiate a##7##3##(1992-12#3)(1995-11#1)(2008-10#1)(2009-9#1)(2012-2#1)
to initiate the consent process for##2##6##(2008-8#2)
to initiate the consent process##3##5##(2008-8#3)
to initiate the##14##3##(1993-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2012-12#1)
to initiate transcription##2##3##(1995-2#1)(1996-2#1)
to initiate treatment##3##3##(2008-6#1)(2010-12#1)(2013-8#1)
to initiate##61##2##(1990-11#1)(1990-12#1)(1991-6#1)(1992-12#3)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
to initiating##5##2##(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
to initiation of##5##3##(1991-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)
to initiation##7##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2011-1#1)(2013-8#1)
to inject##4##2##(1990-8#1)(2007-11#1)(2008-10#1)(2013-8#1)
to injection##5##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
to injury##17##2##(1990-7#2)(1992-9#1)(1995-11#2)(2008-1#3)(2008-4#1)(2008-7#2)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#2)
to innate##2##2##(2008-5#1)(2009-6#1)
to inner##4##2##(1995-12#1)(1995-3#1)(2007-8#1)(2008-1#1)
to innovative##2##2##(1994-2#1)(2011-2#1)
to inoculate a##2##3##(2008-10#1)(2008-11#1)
to inoculate##10##2##(2008-10#7)(2008-11#1)(2008-9#2)
to inoculation with##7##3##(2008-10#7)
to inoculation##15##2##(2008-10#14)(2008-8#1)
to inoculum or##2##3##(2008-10#2)
to inoculum##8##2##(2008-10#8)
to inorganic mercury##3##3##(2008-10#3)
to inorganic##7##2##(1990-5#1)(2008-10#4)(2008-3#1)(2008-5#1)
to inositol 1##2##3##(1993-8#2)
to inositol##7##2##(1991-2#1)(1992-11#1)(1993-8#2)(2008-8#3)
to inpatient##2##2##(1996-3#1)(2009-8#1)
to insect feeding##4##3##(2009-8#4)
to insect##6##2##(2009-8#4)(2011-1#1)(2011-2#1)
to insecticides##5##2##(2007-10#1)(2011-2#1)(2012-12#2)(2013-7#1)
to insert in##2##3##(2008-10#1)(2013-1#1)
to insert##6##2##(1990-11#1)(1996-2#1)(2008-10#1)(2010-7#1)(2013-1#2)
to insist on##2##3##(1995-12#1)(2009-7#1)
to inspect the##2##3##(2007-12#1)(2008-7#1)
to inspect##4##2##(1997-5#1)(2007-12#1)(2008-6#1)(2008-7#1)
to instability and##2##3##(2007-11#1)(2012-2#1)
to instability##4##2##(2007-11#1)(2008-6#1)(2009-5#1)(2012-2#1)
to install##2##2##(1996-2#1)(2009-9#1)
to instill##2##2##(2008-12#2)
to institutional care##2##3##(1993-3#1)(1995-3#1)
to institutions##2##2##(1992-3#1)(1995-3#1)
to instrumental##3##2##(1991-6#1)(2007-6#1)(2008-3#1)
to insufficient##10##2##(1990-5#1)(1994-12#1)(2007-7#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to insulate##4##2##(1991-3#2)(1992-2#1)(1994-5#1)
to insulin in##2##3##(1996-2#1)(2010-11#1)
to insulin resistance##3##3##(1990-9#1)(2008-3#1)(2012-5#1)
to insulin##22##2##(1990-9#1)(1991-7#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#2)(1997-8#1)(2008-1#1)(2008-3#4)(2008-9#1)(2010-11#2)(2010-4#1)(2012-5#1)(2013-8#1)
to insurance##4##2##(1992-2#2)(1997-5#1)(2010-4#1)
to insure##5##2##(1993-3#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-9#1)
to intact cells##2##3##(1994-11#1)(1997-1#1)
to intact##11##2##(1990-12#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-5#1)
to integrate a##2##3##(1992-2#1)(2008-3#1)
to integrate and##2##3##(1994-12#1)(1995-1#1)
to integrate public health and medicine##2##6##(1995-2#2)
to integrate public health and##3##5##(1995-2#3)
to integrate research##2##3##(2006-5#2)
to integrate the new##2##4##(1993-2#1)(2009-9#1)
to integrate the##10##3##(1993-2#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2012-3#1)
to integrate their##3##3##(1995-5#1)(1996-2#1)(2008-11#1)
to integrate these##2##3##(2008-7#1)(2012-12#1)
to integrate this##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2010-12#1)
to integrate##66##2##(1991-6#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-5#2)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)
to integrated health##2##3##(1997-2#1)(1997-3#1)
to integrated treatment at 12 months##2##6##(2012-3#2)
to integrated treatment##4##3##(2012-3#4)
to integrated##10##2##(1994-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2012-3#4)
to integrating##5##2##(1994-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2009-6#1)
to integration##6##2##(1992-12#1)(1992-2#1)(1994-3#1)(1997-3#1)(2008-11#1)(2012-2#1)
to integrative##2##2##(2008-12#1)(2008-5#1)
to intense##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2013-7#1)
to intensify the##3##3##(2007-2#1)(2008-1#1)(2008-11#1)
to intensify##6##2##(2007-2#1)(2008-1#1)(2008-11#2)(2010-10#1)(2010-3#1)
to intensity##6##2##(2007-12#2)(2008-3#2)(2008-7#1)(2011-1#1)
to intensive care##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
to intensive##6##2##(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
to interact directly##3##3##(1995-6#2)(2008-4#1)
to interact in##2##3##(1993-6#1)(1994-5#1)
to interact with a##3##4##(1995-2#1)(2009-3#1)(2012-2#1)
to interact with proteins##2##4##(2008-10#1)(2009-8#1)
to interact with the##11##4##(1993-8#1)(1994-5#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-5#2)(2010-5#1)(2012-3#2)
to interact with##47##3##(1992-11#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-6#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
to interact##55##2##(1992-11#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#4)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#3)(1996-6#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
to interaction between##2##3##(1994-11#1)(2008-10#1)
to interaction##6##2##(1994-11#1)(1994-2#1)(2008-10#1)(2008-3#1)(2012-6#2)
to interactions between##2##3##(1996-6#1)(2012-2#1)
to interactions##6##2##(1991-3#1)(1996-6#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-2#1)
to intercalate##4##2##(1991-6#1)(2008-10#2)(2008-6#1)
to intercellular junctions##2##3##(2009-10#2)
to intercellular##3##2##(2008-10#1)(2009-10#2)
to interdisciplinary##2##2##(1992-11#1)(1993-2#1)
to interest##4##2##(1993-1#1)(1994-12#1)(2008-10#1)(2010-3#1)
to interface with##2##3##(2008-10#2)
to interface##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
to interfere with the##2##4##(1993-12#1)(2008-10#1)
to interfere with##15##3##(1993-12#1)(1994-8#1)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
to interfere##19##2##(1993-12#1)(1994-8#1)(1995-2#1)(1997-1#1)(2006-6#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2013-1#1)
to interference from##5##3##(1990-8#1)(2008-10#3)(2008-3#1)
to interference##8##2##(1990-8#1)(1991-9#1)(2008-1#1)(2008-10#4)(2008-3#1)
to interferences##6##2##(1991-7#1)(2008-10#5)
to interindividual##2##2##(1995-11#1)(2007-10#1)
to interleukin-1##2##2##(1990-10#1)(1992-6#1)
to interleukin-2##4##2##(1994-12#4)
to intermediate##5##2##(1990-5#1)(1991-1#1)(1992-3#1)(1993-9#1)(2008-6#1)
to internal membranes##2##3##(1990-5#2)
to internal##12##2##(1990-2#1)(1990-5#2)(1992-12#1)(1993-9#1)(1995-8#1)(2007-12#2)(2008-11#2)(2011-1#1)(2011-2#1)
to international##8##2##(1991-12#1)(1992-12#1)(2007-2#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
to interpret and##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
to interpret results##2##3##(1991-3#1)(2008-10#1)
to interpret the data##4##4##(2008-7#1)(2008-9#2)(2012-3#1)
to interpret the experimental##2##4##(2008-3#1)(2009-7#1)
to interpret the##16##3##(1995-3#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-7#1)(2012-2#1)(2012-3#1)
to interpret##42##2##(1991-11#1)(1991-3#1)(1993-2#1)(1995-12#1)(1995-3#2)(1997-6#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to interpretation##2##2##(2008-12#1)(2012-12#1)
to interrogate multiple##2##3##(2008-10#1)(2008-3#1)
to interrogate##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
to interspecific interactions##2##3##(2008-8#2)
to interspecific##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
to interstitial##2##2##(2008-7#1)(2013-1#1)
to intervene at##2##3##(2006-6#1)(2008-1#1)
to intervene in the##2##4##(1995-6#1)(2013-1#1)
to intervene in##3##3##(1993-3#1)(1995-6#1)(2013-1#1)
to intervene##9##2##(1993-3#1)(1995-6#1)(2006-6#1)(2008-1#1)(2008-12#3)(2008-7#1)(2013-1#1)
to intervention##3##2##(2008-12#1)(2008-3#1)(2008-5#1)
to interventions to##2##3##(2009-9#1)(2011-1#1)
to interventions##6##2##(1992-3#1)(2008-1#1)(2008-6#1)(2009-9#1)(2011-1#1)(2013-1#1)
to interview##2##2##(2008-7#1)(2010-3#1)
to intestinal##5##2##(1990-9#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
to intracavity##2##2##(2007-11#1)(2007-12#1)
to intracellular##5##2##(1995-8#1)(2008-11#1)(2008-4#1)(2009-1#1)(2012-12#1)
to intramolecular##3##2##(1993-8#1)(1994-12#1)(1995-8#1)
to intrathecal##4##2##(1991-4#1)(2011-2#3)
to intravenous##9##2##(1990-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1995-12#1)(1997-2#1)(2006-10#2)(2009-3#1)
to intrinsic##5##2##(1990-6#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
to introduce 20 mul volumes into the##2##7##(2008-10#2)
to introduce a##8##3##(1995-2#1)(1996-7#1)(1997-8#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)(2012-3#1)
to introduce investigators to the types of##2##7##(2008-4#2)
to introduce the concept of##2##5##(2008-11#1)(2012-12#1)
to introduce the##9##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-1#1)(2012-12#1)
to introduce##55##2##(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-2#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to introduction of the##2##4##(2008-10#2)
to introduction of##3##3##(2008-10#2)(2008-3#1)
to introduction##6##2##(2007-7#1)(2008-10#2)(2008-3#1)(2009-2#1)(2011-1#1)
to introgress##2##2##(2008-10#2)
to invade a##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
to invade the##3##3##(2008-10#2)(2009-5#1)
to invade##12##2##(2008-10#4)(2008-5#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
to invasion##6##2##(2007-7#2)(2008-10#3)(2008-8#1)
to invasive ALM over a##2##5##(2010-6#2)
to invasive##9##2##(1995-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2010-6#2)(2010-8#1)(2011-2#1)
to inverse##2##2##(2007-12#1)(2008-3#1)
to invert the##2##3##(2008-3#2)
to invert##4##2##(2008-3#4)
to invest##3##2##(1992-8#1)(1993-12#1)(2008-6#1)
to investigate a##5##3##(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#1)
to investigate and##2##3##(1993-5#1)(2011-2#1)
to investigate any##3##3##(2008-11#1)(2010-5#1)(2010-8#1)
to investigate cellular##2##3##(2008-1#1)(2013-1#1)
to investigate differences##2##3##(2007-12#1)(2010-5#1)
to investigate factors##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
to investigate genetic##2##3##(1996-5#1)(2008-10#1)
to investigate how##13##3##(1994-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
to investigate if the##2##4##(2008-10#1)(2008-6#1)
to investigate if##5##3##(1990-12#1)(2007-10#1)(2008-10#1)(2008-6#1)(2012-2#1)
to investigate its##6##3##(1991-12#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
to investigate key##2##3##(1993-8#1)(2008-11#1)
to investigate new##2##3##(2008-7#1)(2012-2#1)
to investigate possible##5##3##(1997-4#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#1)
to investigate some##2##3##(1993-8#1)(2008-11#1)
to investigate the association between the##2##6##(2008-3#1)(2011-2#1)
to investigate the association between##4##5##(2008-3#1)(2011-2#2)(2013-1#1)
to investigate the behaviour of##2##5##(1991-5#1)(2008-3#1)
to investigate the cellular##4##4##(1993-12#1)(1994-8#1)(2008-4#1)(2011-2#1)
to investigate the changes in##2##5##(2010-4#1)(2012-12#1)
to investigate the characteristics of##3##5##(2008-3#2)(2011-3#1)
to investigate the correlation between##2##5##(2007-10#1)(2008-5#1)
to investigate the distribution of##3##5##(1992-11#1)(2008-10#1)(2008-4#1)
to investigate the dynamics of##2##5##(2008-11#1)(2009-6#1)
to investigate the effect of aging on##2##7##(1994-6#1)(2008-7#1)
to investigate the effect of different##3##6##(2008-12#3)
to investigate the effect of the##4##6##(2007-8#1)(2008-12#1)(2011-2#1)(2013-7#1)
to investigate the effect of##40##5##(1992-8#1)(1993-3#1)(1994-6#1)(1995-3#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
to investigate the effect##41##4##(1992-8#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
to investigate the effectiveness of the##2##6##(2008-2#1)(2013-1#1)
to investigate the effectiveness of##5##5##(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#2)
to investigate the effects and##2##5##(2008-3#1)(2011-3#1)
to investigate the effects of a##2##6##(1990-9#1)(2008-7#1)
to investigate the effects of different##2##6##(2008-8#1)(2013-1#1)
to investigate the effects of##25##5##(1990-3#1)(1990-7#1)(1990-9#1)(1992-2#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
to investigate the effects##27##4##(1990-3#1)(1990-7#1)(1990-9#1)(1992-2#1)(1995-12#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
to investigate the efficacy of##3##5##(2008-10#1)(2009-8#1)(2013-1#1)
to investigate the expression of##3##5##(1991-2#1)(1992-8#1)(2008-10#1)
to investigate the expression##7##4##(1991-2#1)(1992-8#1)(1994-12#1)(2008-10#2)(2008-9#1)(2012-1#1)
to investigate the extent##2##4##(2007-11#1)(2012-3#1)
to investigate the factors##2##4##(1994-12#1)(2008-7#1)
to investigate the feasibility of the##2##6##(2008-2#1)(2008-3#1)
to investigate the feasibility of##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
to investigate the feasibility##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)
to investigate the genetic diversity##2##5##(2008-10#1)(2013-8#1)
to investigate the genetic##3##4##(2007-10#1)(2008-10#1)(2013-8#1)
to investigate the impact of##4##5##(2008-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
to investigate the importance of##2##5##(1995-5#1)(2012-3#1)
to investigate the influence of the##3##6##(2008-10#2)(2011-2#1)
to investigate the influence of##13##5##(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#3)
to investigate the interactions between genetic##2##6##(2008-3#2)
to investigate the kinetics of##2##5##(2008-10#1)(2008-8#1)
to investigate the long-term effects of##2##6##(2008-7#1)(2009-1#1)
to investigate the mechanism of action##2##6##(2008-7#1)(2011-2#1)
to investigate the mechanism of##7##5##(1992-8#1)(1994-8#1)(1995-6#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
to investigate the mechanism##11##4##(1991-11#1)(1992-8#1)(1994-8#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
to investigate the mechanisms underlying##2##5##(2009-5#1)(2012-3#1)
to investigate the mechanisms##5##4##(1992-8#1)(2008-11#1)(2008-6#1)(2009-5#1)(2012-3#1)
to investigate the molecular basis of the##2##7##(1990-8#1)(1995-5#1)
to investigate the molecular basis of##4##6##(1990-8#1)(1995-5#1)(1996-12#1)(1996-2#1)
to investigate the molecular##8##4##(1990-8#1)(1992-3#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-9#1)(2012-1#1)
to investigate the morphological##2##4##(2007-12#1)(2008-10#1)
to investigate the neural##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
to investigate the origin of##2##5##(1997-8#1)(2008-10#1)
to investigate the origin##3##4##(1997-8#1)(2008-10#2)
to investigate the perception##2##4##(2008-1#1)(2008-9#1)
to investigate the possibility of##3##5##(1994-8#1)(2008-11#1)(2012-3#1)
to investigate the possibility that the##2##6##(1994-6#1)(1994-8#1)
to investigate the possibility##5##4##(1994-6#1)(1994-8#2)(2008-11#1)(2012-3#1)
to investigate the possible##4##4##(1992-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
to investigate the potential of##2##5##(1992-9#1)(2008-7#1)
to investigate the potential##5##4##(1992-9#1)(2008-7#2)(2011-2#1)(2012-3#1)
to investigate the presence of##3##5##(1995-12#1)(1995-2#1)(2008-2#1)
to investigate the process##2##4##(2008-10#1)(2008-3#1)
to investigate the production of##2##5##(2012-3#1)(2013-1#1)
to investigate the properties of##2##5##(1990-5#1)(2008-10#1)
to investigate the putative##2##4##(2008-10#1)(2008-11#1)
to investigate the relationship between the##7##6##(1991-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
to investigate the relationship between##18##5##(1991-2#1)(1991-9#1)(1994-3#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to investigate the relationship##20##4##(1991-2#1)(1991-9#1)(1994-3#2)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to investigate the relationships between##5##5##(1992-1#1)(2008-10#1)(2008-9#1)(2010-6#1)(2010-8#1)
to investigate the relationships##6##4##(1992-1#1)(2008-10#2)(2008-9#1)(2010-6#1)(2010-8#1)
to investigate the response##3##4##(1993-11#1)(2008-9#1)(2010-3#1)
to investigate the role of the##2##6##(2008-10#2)
to investigate the role of##16##5##(1993-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)
to investigate the role##17##4##(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)
to investigate the roles of##2##5##(1992-2#1)(2008-12#1)
to investigate the structure##2##4##(2008-4#1)(2008-5#1)
to investigate the suitability of##2##5##(2012-2#1)(2013-1#1)
to investigate the##416##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#6)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#60)(2008-11#14)(2008-12#10)(2008-2#8)(2008-3#14)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#16)(2008-8#11)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#19)(2011-3#4)(2012-1#4)(2012-12#3)(2012-2#11)(2012-3#14)(2013-1#12)(2013-7#3)(2013-8#8)
to investigate their##15##3##(1990-12#1)(1992-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
to investigate these##2##3##(2008-2#1)(2011-1#1)
to investigate this important##2##4##(2006-10#1)(2008-5#1)
to investigate this##5##3##(1996-1#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-5#1)
to investigate whether age is associated with use of osteoporosis drugs in a##2##13##(2010-3#2)
to investigate whether the##8##4##(1991-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)
to investigate whether there is##3##5##(1992-12#1)(2011-1#1)(2011-2#1)
to investigate whether this##3##4##(1994-12#1)(2007-5#1)(2012-2#1)
to investigate whether##35##3##(1991-5#1)(1992-12#1)(1994-12#2)(1995-12#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#2)
to investigate which##3##3##(1995-12#1)(1996-8#1)(2010-3#1)
to investigate##638##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#7)(1994-3#3)(1994-5#2)(1994-6#6)(1994-8#7)(1994-9#1)(1995-1#1)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#5)(2007-11#7)(2007-12#9)(2007-2#2)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#84)(2008-11#38)(2008-12#16)(2008-2#10)(2008-3#20)(2008-4#8)(2008-5#20)(2008-6#8)(2008-7#25)(2008-8#14)(2008-9#18)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#7)(2010-4#1)(2010-5#7)(2010-6#4)(2010-8#7)(2010-9#1)(2011-1#12)(2011-2#31)(2011-3#4)(2012-1#4)(2012-12#5)(2012-2#19)(2012-3#22)(2012-5#1)(2013-1#21)(2013-7#6)(2013-8#10)
to investigated##2##2##(2008-7#1)(2012-3#1)
to investigating##2##2##(1993-2#1)(2013-1#1)
to investigation##8##2##(1993-2#1)(2008-10#1)(2008-11#4)(2008-7#1)(2010-10#1)
to investigators##2##2##(2007-8#1)(2008-4#1)
to investment##2##2##(1994-2#1)(2008-5#1)
to involve a##3##3##(1991-1#1)(1992-9#1)(1994-5#1)
to involve an##2##3##(1996-12#1)(2013-8#1)
to involve both##2##3##(2007-11#1)(2008-2#1)
to involve staff##2##3##(1994-12#2)
to involve the##11##3##(1990-7#1)(1992-11#2)(1995-6#1)(1997-8#1)(2008-10#2)(2009-4#1)(2011-2#2)(2012-12#1)
to involve##45##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-4#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
to involving##2##2##(1994-2#1)(1996-12#1)
to iodate##3##2##(2008-10#3)
to iodine##6##2##(2008-10#5)(2011-1#1)
to ion chromatographic##2##3##(2008-10#2)
to ion chromatography##2##3##(1991-2#1)(2008-10#1)
to ion##8##2##(1991-2#1)(2008-10#5)(2008-7#1)(2012-3#1)
to ion-pair##2##2##(2008-10#2)
to ionizing radiation is##2##4##(1997-4#1)(2008-7#1)
to ionizing radiation##13##3##(1994-8#1)(1995-12#1)(1995-6#2)(1996-6#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-7#3)(2008-9#2)
to ionizing##16##2##(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-6#1)(1997-4#1)(1997-7#2)(2008-11#1)(2008-7#4)(2008-9#2)
to ions##2##2##(1990-5#1)(2008-8#1)
to iprodione##6##2##(2008-10#6)
to iron##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
to iron(II)##2##2##(2008-10#2)
to iron(III) by##2##3##(2008-10#2)
to iron(III)##4##2##(1997-7#1)(2008-10#3)
to irradiate##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#2)
to irradiation##4##2##(1992-10#1)(1994-12#1)(1997-4#1)(2008-7#1)
to irreversible##4##2##(1993-11#1)(2008-8#1)(2010-4#1)(2012-1#1)
to irreversibly##2##2##(1991-4#1)(2011-1#1)
to ischemia##11##2##(1990-6#1)(1996-9#5)(2006-10#1)(2008-10#1)(2008-4#1)(2010-1#1)(2011-2#1)
to ischemia-reperfusion injury##2##3##(1991-9#1)(1996-9#1)
to ischemia-reperfusion##3##2##(1991-9#1)(1996-9#1)(2013-7#1)
to ischemic##7##2##(1996-12#1)(2007-10#1)(2008-10#1)(2013-1#2)(2013-7#1)(2013-8#1)
to islet##3##2##(2007-5#1)(2010-11#2)
to isolate MG2##3##3##(2008-10#3)
to isolate MG96-36##3##3##(2008-10#3)
to isolate a##4##3##(1991-5#2)(1994-12#1)(2008-10#1)
to isolate and characterize##2##4##(1990-2#1)(2008-2#1)
to isolate and quantify##3##4##(1997-2#1)(2008-10#2)
to isolate and##9##3##(1990-2#1)(1993-8#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
to isolate cDNAs encoding##2##4##(1994-11#1)(2008-2#1)
to isolate cDNAs##3##3##(1993-12#1)(1994-11#1)(2008-2#1)
to isolate pure rotational Raman spectra##2##6##(2008-3#2)
to isolate pure##4##3##(1990-12#1)(1990-8#1)(2008-3#2)
to isolate specific##2##3##(2008-4#1)(2008-7#1)
to isolate such##2##3##(1990-5#1)(2008-10#1)
to isolate the active##2##4##(2008-12#2)
to isolate the##20##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-6#1)(1994-12#1)(1997-2#2)(2006-10#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2011-2#1)(2012-2#1)
to isolate##101##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-2#1)(1996-6#1)(1997-2#4)(1997-4#2)(1997-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
to isolated##8##2##(1992-3#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
to isolates from##3##3##(2008-10#3)
to isolates of the##2##4##(2008-10#2)
to isolates of##6##3##(2008-10#6)
to isolates##13##2##(2008-10#13)
to isolating the##2##3##(2008-10#1)(2008-8#1)
to isoprenaline##2##2##(1995-12#1)(1997-2#1)
to issue##3##2##(1992-8#1)(2008-4#1)(2011-2#1)
to issues of##3##3##(1991-12#1)(2008-12#1)(2008-7#1)
to issues that##3##3##(1997-2#1)(2008-11#1)(2013-8#1)
to issues##10##2##(1991-12#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
to it##25##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to items##2##2##(2008-9#1)(2012-2#1)
to iterative##2##2##(2008-10#2)
to iteratively improve##2##3##(2008-10#1)(2009-9#1)
to its ability to##9##4##(1991-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
to its active metabolite##2##4##(1995-5#1)(2008-8#1)
to its advantage of##2##4##(2008-2#1)(2012-2#1)
to its analgesic##2##3##(1990-6#1)(2009-12#1)
to its application##2##3##(1997-6#1)(2013-8#1)
to its central##2##3##(2008-10#1)(2011-2#1)
to its consistency##2##3##(2008-10#1)(2012-2#1)
to its corresponding##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
to its determination by##5##4##(2008-10#5)
to its determination in##2##4##(2008-10#2)
to its determination##7##3##(2008-10#7)
to its detrimental##2##3##(2008-10#1)(2008-7#1)
to its development##5##3##(2010-3#2)(2010-6#1)(2011-1#1)(2012-3#1)
to its effect on the##2##5##(1993-6#1)(1993-8#1)
to its effect on##6##4##(1991-5#1)(1993-6#1)(1993-8#1)(1995-11#1)(2008-10#1)(2010-4#1)
to its effect##7##3##(1991-5#1)(1993-6#1)(1993-8#1)(1995-11#1)(2008-10#2)(2010-4#1)
to its exposure##2##3##(2008-11#1)(2011-1#1)
to its functional##2##3##(2011-2#2)
to its high incidence##2##4##(2008-10#1)(2011-2#1)
to its high porosity##2##4##(2008-11#1)(2009-12#1)
to its high##14##3##(1992-11#1)(1993-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)
to its higher##2##3##(2008-5#1)(2011-2#1)
to its highly##2##3##(2008-10#1)(2008-7#1)
to its implementation##3##3##(1992-1#1)(1995-3#1)(2008-3#1)
to its importance in##2##4##(2008-10#1)(2013-1#1)
to its importance##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
to its incorporation into the##2##5##(1992-6#1)(2008-3#1)
to its inhibition of##2##4##(1992-9#1)(1993-8#1)
to its initial##3##3##(2008-2#1)(2008-9#1)(2011-2#1)
to its large size##2##4##(2009-11#1)(2013-7#1)
to its location##2##3##(2011-2#1)(2013-1#1)
to its low##5##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)
to its maximum##2##3##(2008-12#1)(2008-7#1)
to its measurement##2##3##(2008-10#1)(2012-2#1)
to its molecular##2##3##(1991-2#1)(2008-4#1)
to its more##3##3##(2007-8#1)(2008-5#1)(2009-8#1)
to its most##2##3##(1994-12#1)(2012-3#1)
to its native##4##3##(1992-6#1)(2008-10#2)(2008-9#1)
to its natural##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
to its new##2##3##(1992-12#1)(2008-8#1)
to its own##2##3##(1997-7#1)(2008-5#1)
to its rarity##2##3##(2008-10#1)(2011-2#1)
to its receptor in##2##4##(1995-11#1)(2009-2#1)
to its receptor##11##3##(1990-12#1)(1991-12#1)(1992-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)
to its reliability##2##3##(1990-5#1)(2008-10#1)
to its response##2##3##(1993-6#1)(2008-2#1)
to its role in##3##4##(1997-6#1)(2008-10#1)(2012-1#1)
to its simplicity##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
to its site##2##3##(1990-12#1)(1997-4#1)
to its specific##4##3##(2007-7#1)(2008-5#1)(2011-2#1)(2013-8#1)
to its surface##4##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
to its target##2##3##(2009-2#1)(2011-2#1)
to its tremendous##2##3##(2008-4#1)(2008-7#1)
to its unparalleled##2##3##(2010-7#1)(2013-1#1)
to its use as##2##4##(2008-10#1)(2008-2#1)
to its use##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
to its versatility and##2##4##(2007-12#1)(2009-10#1)
to its versatility##3##3##(2007-12#1)(2009-10#1)(2011-2#1)
to its wide availability and its##2##6##(2009-1#2)
to its wide##3##3##(2008-10#1)(2009-1#2)
to its##427##2##(1990-10#1)(1990-12#4)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#4)(1993-6#4)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2007-10#1)(2007-11#3)(2007-12#8)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#72)(2008-11#15)(2008-12#8)(2008-2#10)(2008-3#8)(2008-4#8)(2008-5#21)(2008-6#1)(2008-7#14)(2008-8#7)(2008-9#6)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#4)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#7)(2011-10#1)(2011-2#24)(2012-1#3)(2012-12#5)(2012-2#13)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#11)
to itself##2##2##(2008-3#1)(2010-4#1)
to jasmonic acid##2##3##(2008-5#1)(2012-2#1)
to jasmonic##3##2##(2008-5#1)(2009-6#1)(2012-2#1)
to job##3##2##(1994-1#1)(1996-2#1)(2009-10#1)
to join the##2##3##(2009-6#1)(2010-3#1)
to join##12##2##(1996-2#1)(1997-1#1)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-3#1)(2012-2#1)
to joint##4##2##(2008-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
to jointly##2##2##(1992-12#1)(2011-1#1)
to journal##3##2##(1991-12#1)(1993-12#1)(2012-3#1)
to judge whether##3##3##(1994-8#1)(1996-2#1)(2008-8#1)
to judge##9##2##(1994-8#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
to just the##2##3##(1992-3#1)(2008-10#1)
to just##5##2##(1992-3#1)(1992-9#1)(2008-10#2)(2010-12#1)
to justify the##7##3##(1995-1#1)(1997-1#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
to justify use of##2##4##(1995-5#1)(2008-7#1)
to justify##15##2##(1995-1#1)(1995-5#1)(1997-1#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2011-2#1)(2012-1#1)
to juvenile##2##2##(2007-5#1)(2008-5#1)
to k##2##2##(1992-9#1)(1995-3#1)
to karyotyping##2##2##(2008-10#1)(2012-12#1)
to keep a##4##3##(1992-11#1)(1992-3#1)(1993-1#1)(2011-1#1)
to keep in mind that##2##5##(1992-3#1)(2009-12#1)
to keep in mind the##2##5##(2009-1#1)(2009-6#1)
to keep in mind##5##4##(1992-3#1)(2007-7#1)(2009-1#1)(2009-12#1)(2009-6#1)
to keep in##9##3##(1991-1#1)(1992-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-1#1)(2009-12#1)(2009-6#1)
to keep pace with##2##4##(1996-2#2)
to keep pace##4##3##(1995-1#1)(1996-2#2)(2009-6#1)
to keep the##20##3##(1991-1#1)(1992-1#1)(1992-3#1)(1994-3#1)(1997-2#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#3)(2012-1#1)
to keep their##4##3##(1993-1#1)(1996-3#1)(2009-10#1)(2010-7#1)
to keep them##2##3##(1993-6#1)(2010-4#1)
to keep##72##2##(1990-3#1)(1991-1#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-2#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-7#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)
to keratinocytes in vitro##3##4##(2008-8#3)
to keratinocytes in##4##3##(2008-8#3)(2012-2#1)
to keratinocytes##9##2##(1996-2#1)(2008-8#6)(2012-2#2)
to kernel##3##2##(2008-10#1)(2008-3#2)
to key##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
to keyhole limpet hemocyanin (KLH)##2##5##(2008-10#2)
to kidney transplantation##3##3##(1995-12#2)(2010-8#1)
to kidney##10##2##(1992-3#1)(1992-5#1)(1995-12#2)(2008-10#1)(2008-8#2)(2010-8#1)(2012-2#1)(2013-1#1)
to kill cells##2##3##(2008-11#1)(2008-4#1)
to kill##17##2##(1995-2#3)(1996-3#1)(1997-5#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
to killing by##4##3##(1991-9#1)(1994-5#1)(1995-8#1)(2012-2#1)
to kinetic data##2##3##(2008-10#1)(2008-4#1)
to kinetic##3##2##(2008-10#2)(2008-4#1)
to knee##3##2##(1997-2#1)(2007-11#1)(2011-2#1)
to knock##2##2##(2008-2#1)(2011-1#1)
to knockout##2##2##(2010-2#2)
to know about the##2##4##(2007-10#1)(2012-2#1)
to know about##4##3##(1995-1#1)(2007-10#1)(2010-5#1)(2012-2#1)
to know and##2##3##(1995-3#1)(2007-7#1)
to know how##3##3##(1992-12#1)(2008-2#1)(2013-8#1)
to know if the##2##4##(1993-3#1)(2008-3#1)
to know if##3##3##(1993-3#1)(2008-11#1)(2008-3#1)
to know more##2##3##(1996-3#1)(2010-8#1)
to know that##2##3##(1995-9#1)(1997-5#1)
to know the fetal sex as part of##3##8##(2013-1#3)
to know the fetal sex##6##5##(2013-1#6)
to know the incidence of##2##5##(2008-11#1)(2013-8#1)
to know the prevalence##2##4##(2007-7#1)(2008-1#1)
to know the##35##3##(1991-9#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#8)(2013-8#3)
to know what##4##3##(2007-7#1)(2008-11#1)(2008-4#1)(2012-1#1)
to know whether or not##3##5##(1993-12#1)(2007-11#1)(2008-11#1)
to know whether##8##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
to know which##2##3##(2007-9#1)(2012-2#1)
to know##85##2##(1990-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#4)
to knowledge in##2##3##(2008-11#1)(2013-8#1)
to knowledge##11##2##(1993-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2013-8#1)
to known genes##7##3##(1995-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-6#1)(1997-8#2)
to known proteins##4##3##(1995-12#1)(1995-9#1)(1996-8#1)(1997-7#1)
to known##39##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
to label the##5##3##(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)
to label##18##2##(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#6)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
to laboratories##2##2##(1995-12#1)(2008-9#1)
to laboratory automation for high throughput screening##2##7##(2008-10#2)
to laboratory automation##3##3##(2008-10#3)
to laboratory##8##2##(1992-11#1)(1996-2#1)(2008-10#4)(2011-2#1)(2012-2#1)
to lack of a##2##4##(1993-12#1)(1993-2#1)
to lack of##26##3##(1992-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-5#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-12#1)(2013-1#2)(2013-8#1)
to lack##30##2##(1991-5#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-5#1)(1996-11#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-12#1)(2013-1#2)(2013-8#1)
to lactic acid##2##3##(1990-12#1)(2013-8#1)
to lag behind##3##3##(2008-12#1)(2008-9#1)(2011-1#1)
to lag##4##2##(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#1)
to lamb##2##2##(2007-10#1)(2008-9#1)
to lambda-cyhalothrin##2##2##(2007-10#2)
to lamin A##2##3##(1990-11#1)(2011-2#1)
to lamin##3##2##(1990-11#1)(2008-8#1)(2011-2#1)
to laminin and fibronectin##2##4##(1993-5#1)(1995-12#1)
to laminin and##3##3##(1992-9#1)(1993-5#1)(1995-12#1)
to land##2##2##(1997-4#1)(2008-10#1)
to language##3##2##(2008-11#1)(2008-2#1)(2012-3#1)
to laparoscopic surgery##2##3##(2009-8#1)(2013-1#1)
to laparoscopic##6##2##(1994-2#1)(2009-8#1)(2011-2#2)(2013-1#2)
to laparotomy##6##2##(1993-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-1#1)(2012-3#1)
to large earthquakes##2##3##(1996-4#2)
to large numbers of##4##4##(1997-8#1)(2008-10#1)(2008-4#1)(2009-6#1)
to large populations##2##3##(1992-2#1)(2013-1#1)
to large scale##3##3##(2008-11#1)(2008-7#2)
to large##48##2##(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-8#1)(1995-12#1)(1996-4#4)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
to large-scale##8##2##(1990-5#1)(1996-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-2#1)
to larger##4##2##(1995-6#1)(2008-10#2)(2008-2#1)
to lase##2##2##(2007-11#1)(2008-3#1)
to laser light##2##3##(2007-12#1)(2012-12#1)
to laser##12##2##(1992-9#1)(1993-3#1)(1994-3#1)(2007-12#2)(2008-2#2)(2008-3#2)(2011-1#1)(2012-12#1)(2013-1#1)
to last##4##2##(2008-7#1)(2009-12#1)(2012-1#1)(2013-1#1)
to late adolescence##2##3##(2009-7#2)
to late blight##3##3##(2008-10#3)
to late##21##2##(1990-11#1)(1991-2#1)(1992-6#1)(2006-6#1)(2008-10#7)(2009-7#2)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
to latent infection##4##3##(2008-10#4)
to latent##6##2##(2008-10#5)(2008-9#1)
to later##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#1)
to lateral##2##2##(1992-11#1)(2007-12#1)
to latex##2##2##(1990-7#1)(1991-12#1)
to launch the##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
to launch##6##2##(1996-2#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
to lay out##2##3##(2008-1#1)(2008-9#1)
to lay the foundation for##3##5##(2008-4#1)(2012-12#1)(2013-8#1)
to lay##11##2##(1993-1#1)(1994-1#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
to layer##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
to layers##2##2##(2008-3#1)(2010-2#1)
to lead a##2##3##(1994-9#1)(2013-8#1)
to lead the##3##3##(2009-6#1)(2009-7#2)
to lead to greater##2##4##(2009-7#1)(2011-2#1)
to lead to more##2##4##(1995-5#1)(1996-12#1)
to lead to the##5##4##(1990-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
to lead to##20##3##(1990-6#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-12#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
to lead##39##2##(1990-6#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#2)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to leadership##2##2##(1995-1#1)(1996-3#1)
to leaf blast##3##3##(2008-10#3)
to leaf rust and##4##4##(2008-10#4)
to leaf rust##12##3##(2008-10#12)
to leaf spot disease##2##4##(2008-10#2)
to leaf spot##3##3##(2008-10#3)
to leaf##31##2##(2008-10#29)(2008-12#1)(2012-9#1)
to lean##2##2##(2008-9#1)(2012-3#1)
to learn about their##3##4##(2007-2#1)(2011-2#1)(2012-2#1)
to learn about##9##3##(1994-1#1)(1994-2#2)(2007-2#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
to learn and##8##3##(1994-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)
to learn from##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
to learn how to##4##4##(1991-3#1)(1994-1#1)(1994-3#1)(1995-9#1)
to learn how##5##3##(1991-3#1)(1994-1#1)(1994-3#1)(1995-9#1)(2012-2#1)
to learn more about the##4##5##(1993-11#1)(2009-11#1)(2009-4#1)(2010-11#1)
to learn more about##5##4##(1993-11#1)(1995-2#1)(2009-11#1)(2009-4#1)(2010-11#1)
to learn more##6##3##(1993-11#1)(1995-2#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-8#1)
to learn of##2##3##(1993-12#1)(1996-5#1)
to learn that##4##3##(1992-12#1)(2007-9#1)(2011-1#1)(2012-3#1)
to learn the fetal sex##2##5##(2013-1#2)
to learn the##10##3##(1993-3#1)(1993-5#1)(1994-12#1)(1996-5#1)(1997-3#1)(2008-4#1)(2008-8#1)(2013-1#3)
to learn to##3##3##(1991-2#1)(1996-12#1)(2008-8#1)
to learn##69##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#3)
to learning and##3##3##(1996-5#1)(2011-1#2)
to learning in a##2##4##(2008-11#1)(2011-1#1)
to learning in##5##3##(2008-11#4)(2011-1#1)
to learning##22##2##(1992-8#1)(1994-2#1)(1996-5#1)(2008-11#9)(2011-1#9)(2011-2#1)
to least##2##2##(2008-5#1)(2008-9#1)
to leave the nest##2##4##(2008-8#2)
to leave the##6##3##(1993-5#1)(1995-6#1)(2008-8#2)(2008-9#2)
to leave their practices##2##4##(2008-9#2)
to leave their##3##3##(2008-9#3)
to leave##16##2##(1993-5#1)(1993-6#1)(1995-6#1)(2008-8#3)(2008-9#6)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
to leaves##7##2##(2008-10#7)
to left ventricular##2##3##(1992-8#1)(2012-2#1)
to left##9##2##(1992-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-10#2)(2009-3#1)(2011-2#1)(2012-2#1)
to lengthen##2##2##(1991-8#1)(2007-11#1)
to lens##2##2##(2007-12#1)(2008-3#1)
to lenticels##2##2##(2008-10#2)
to leprosis##3##2##(2008-10#3)
to lesion##2##2##(1997-6#1)(2008-10#1)
to less positive values##2##4##(2008-10#2)
to less than 0##4##4##(1991-6#1)(2008-10#1)(2008-3#2)
to less than 1##2##4##(1991-10#1)(2008-9#1)
to less than 1%##2##4##(2007-11#2)
to less than 10%##2##4##(2007-7#1)(2008-12#1)
to less than 100##2##4##(1990-5#1)(2008-3#1)
to less than 5%##2##4##(2008-7#1)(2012-2#1)
to less than 50%##2##4##(1994-3#1)(2008-5#1)
to less than half##2##4##(1994-2#1)(2011-1#1)
to less than##31##3##(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1994-2#1)(1994-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
to less##41##2##(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)
to lessen the##2##3##(1991-3#1)(1997-2#1)
to lessen##4##2##(1991-3#1)(1994-2#1)(1997-2#1)(2009-9#1)
to lesser##4##2##(1993-8#2)(1995-6#1)(2007-8#1)
to let the##3##3##(1994-1#1)(1995-6#1)(2008-3#1)
to let##4##2##(1994-1#1)(1994-2#1)(1995-6#1)(2008-3#1)
to lethal##4##2##(1994-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
to lettuce##4##2##(2008-10#4)
to leukemia##2##2##(1991-3#1)(2008-4#1)
to levamisole##3##2##(2007-7#1)(2008-1#2)
to level##2##2##(1992-6#1)(2008-10#1)
to levels comparable to##2##4##(1990-2#1)(1993-12#1)
to levels comparable##3##3##(1990-2#1)(1993-12#1)(2012-2#1)
to levels in##3##3##(1991-2#1)(1992-12#1)(2013-1#1)
to levels of##5##3##(1992-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-10#1)
to levels significantly lower than##2##5##(2008-10#1)(2008-8#1)
to levels##21##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-8#2)(1996-2#1)(2008-10#4)(2008-2#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
to leverage##2##2##(2008-2#1)(2012-3#1)
to levodopa##2##2##(2008-7#2)
to liability##2##2##(1992-12#1)(1994-1#1)
to liberate##4##2##(2008-10#3)(2008-6#1)
to lie in the##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
to lie in##4##3##(1996-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
to lie on##2##3##(1995-6#1)(2007-12#1)
to lie##9##2##(1994-5#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
to life and##6##3##(1993-11#1)(1996-12#1)(2011-2#4)
to life in##3##3##(1990-2#1)(2009-8#1)(2011-2#1)
to life##22##2##(1990-2#1)(1993-11#1)(1993-6#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
to life-threatening##4##2##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to lifestyle changes##3##3##(2008-3#2)(2010-8#1)
to lifestyle##4##2##(2008-1#1)(2008-3#2)(2010-8#1)
to lift##3##2##(1994-2#1)(1997-3#1)(2008-11#1)
to ligand##4##2##(1995-2#1)(2008-10#3)
to ligands##3##2##(2008-10#1)(2008-4#2)
to light is##2##3##(1997-6#1)(2008-12#1)
to light scattering by##2##4##(2007-12#1)(2008-3#1)
to light scattering##3##3##(2007-12#1)(2008-3#2)
to light through##2##3##(2007-12#1)(2008-6#1)
to light##31##2##(1992-6#1)(1994-6#1)(1997-6#2)(2007-12#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-3#1)
to light-induced##2##2##(2007-12#1)(2008-7#1)
to lignin##2##2##(2012-2#1)(2013-1#1)
to limb##3##2##(1992-11#2)(1997-4#1)
to limit family size##2##4##(1996-8#2)
to limit the risk of##2##5##(2008-11#1)(2011-3#1)
to limit the spread of##2##5##(1990-6#1)(2011-2#1)
to limit the##26##3##(1990-6#2)(1991-1#1)(1992-5#1)(1993-3#1)(1994-2#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#2)(2011-2#2)(2011-3#1)(2012-12#1)
to limit##48##2##(1990-6#2)(1991-1#1)(1992-5#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#2)(2009-7#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)
to limitations in##2##3##(2008-12#1)(2012-2#1)
to limitations of##2##3##(2008-11#1)(2010-3#1)
to limitations##6##2##(1997-8#1)(2008-11#1)(2008-12#1)(2010-3#2)(2012-2#1)
to limited##5##2##(1991-7#1)(1995-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
to limits of detection##2##4##(2008-10#1)(2012-1#1)
to linear##6##2##(2007-11#2)(2007-12#1)(2008-3#2)(2008-9#1)
to link population##2##3##(1994-9#1)(2008-10#1)
to link the##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
to link them##2##3##(1993-2#1)(2008-6#1)
to link theory##2##3##(2008-11#1)(2008-12#1)
to link##35##2##(1990-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
to linkage group##2##3##(2008-10#2)
to linkage##4##2##(1990-8#1)(2008-10#2)(2012-3#1)
to linoleate##2##2##(1995-2#2)
to lipase##2##2##(1994-3#1)(1995-2#1)
to lipid peroxidation##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
to lipid##11##2##(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-4#2)(2008-7#1)(2013-1#1)
to lipopolysaccharide##3##2##(1990-5#2)(1997-1#1)
to lipoprotein##3##2##(1991-12#1)(1995-2#1)(2010-10#1)
to liquid chromatography (LC)##2##4##(2008-10#2)
to liquid chromatography##3##3##(1994-9#1)(2008-10#2)
to liquid##10##2##(1994-3#1)(1994-9#1)(1995-11#1)(2008-10#4)(2008-9#1)(2012-2#1)(2013-1#1)
to listen attentively to##2##4##(1990-12#1)(1995-5#1)
to listen##4##2##(1990-12#1)(1995-5#1)(2008-1#1)(2008-5#1)
to literature values##2##3##(2008-10#1)(2008-7#1)
to literature##8##2##(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
to lithium##5##2##(1992-2#1)(2008-10#3)(2009-8#1)
to litigation##2##2##(1992-2#1)(2007-4#1)
to little##2##2##(2008-10#1)(2012-1#1)
to live in##4##3##(1997-2#1)(2011-2#2)(2012-12#1)
to live with##3##3##(1994-2#1)(1995-9#1)(2008-8#1)
to live##20##2##(1993-12#1)(1994-2#1)(1995-9#1)(1997-2#1)(2007-9#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
to liver diseases##2##3##(1991-12#1)(2011-2#1)
to liver##18##2##(1990-5#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2011-2#4)(2012-2#1)(2013-1#2)
to livestock and##2##3##(2008-10#2)
to livestock##5##2##(1997-7#1)(2008-10#3)(2008-12#1)
to living##4##2##(1991-12#1)(1992-8#1)(2010-10#1)(2012-2#1)
to load##3##2##(2007-7#1)(2007-9#1)(2009-7#1)
to loading##2##2##(2009-7#1)(2012-2#1)
to lobby##2##2##(1992-5#1)(2008-10#1)
to local and systemic##2##4##(1990-8#1)(2008-10#1)
to local and##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
to local recurrence##3##3##(2008-6#1)(2010-3#1)(2011-1#1)
to local treatment##2##3##(1990-11#1)(1994-2#1)
to local##41##2##(1990-11#1)(1990-8#1)(1991-2#1)(1992-9#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#2)(1997-3#2)(1997-6#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
to localise##2##2##(2008-11#1)(2012-2#1)
to localised##2##2##(2008-11#1)(2012-2#1)
to localization##2##2##(2007-12#1)(2011-2#1)
to localize a##2##3##(1990-2#1)(1993-11#1)
to localize and##3##3##(1994-9#1)(2008-10#1)(2011-2#1)
to localize the protein##2##4##(1992-3#1)(2008-1#1)
to localize the##10##3##(1990-11#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
to localize##39##2##(1990-11#1)(1990-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to localized##3##2##(1993-3#1)(2008-10#1)(2012-12#1)
to locally##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
to locate the##8##3##(1992-9#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#3)(2011-2#1)
to locate##27##2##(1990-11#2)(1992-3#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-3#4)(2008-4#2)(2008-5#1)(2011-2#2)(2013-7#1)
to location of the##2##4##(2008-10#1)(2008-5#1)
to location##5##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
to loci that##2##3##(1991-12#1)(2008-10#1)
to lock a##2##3##(2007-11#1)(2007-12#1)
to lock##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
to log K(ex)##2##3##(2008-10#2)
to log##5##2##(1996-5#1)(2008-10#3)(2008-5#1)
to long term##2##3##(1990-2#1)(1995-1#1)
to long##7##2##(1990-2#1)(1995-1#1)(2007-10#1)(2007-11#1)(2008-9#1)(2009-8#1)(2010-6#1)
to long-distance##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
to long-lasting##2##2##(1992-3#1)(2012-2#1)
to long-lived##2##2##(2008-11#1)(2009-6#1)
to long-term##17##2##(1991-12#1)(1993-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-1#1)(2010-2#1)(2012-2#1)(2012-3#2)
to longer wavelengths##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
to longer##8##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)
to longitudinal##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
to look at the##3##4##(1996-3#1)(2006-10#1)(2008-7#1)
to look at##9##3##(1993-2#1)(1994-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-7#1)(2010-10#1)(2011-2#1)
to look for a##3##4##(1996-4#1)(2008-10#1)(2011-2#1)
to look for in##2##4##(1992-12#1)(1996-3#1)
to look for the##2##4##(2008-12#1)(2008-5#1)
to look for##21##3##(1991-11#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-3#1)(1996-3#2)(1996-4#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)(2013-8#1)
to look up##2##3##(1992-3#1)(2008-6#1)
to look##39##2##(1991-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-2#2)(1994-3#1)(1996-3#3)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#2)(2013-8#1)
to loose##4##2##(1992-4#1)(1993-12#1)(2012-12#1)(2013-1#1)
to loosen##2##2##(1995-2#1)(2010-1#1)
to lose weight##6##3##(1993-1#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-7#1)(2010-8#1)
to lose##15##2##(1993-1#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)
to loss of a##2##4##(1993-12#1)(1993-9#1)
to loss of##19##3##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
to loss the graft in##2##5##(2011-2#2)
to loss##22##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
to low P##2##3##(2012-3#2)
to low dose##3##3##(2008-7#3)
to low dose-rates of ionizing radiation##2##6##(2013-1#2)
to low doses of ionizing radiation##2##6##(2008-7#1)(2011-1#1)
to low doses of low-LET radiation##2##6##(2008-7#2)
to low doses of radiation##4##5##(2008-7#3)(2010-4#1)
to low doses of##13##4##(2008-10#1)(2008-7#10)(2010-4#1)(2011-1#1)
to low doses##16##3##(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#11)(2010-4#1)(2011-1#1)
to low levels of##3##4##(1992-9#1)(2007-12#1)(2008-7#1)
to low levels##4##3##(1992-9#1)(2007-12#1)(2008-11#1)(2008-7#1)
to low light##2##3##(2009-10#1)(2009-8#1)
to low molecular weight##3##4##(1990-2#1)(2008-10#2)
to low radiation doses##2##4##(1996-6#1)(2013-1#1)
to low temperature##4##3##(2008-11#2)(2011-1#2)
to low values##2##3##(1990-3#1)(2008-5#1)
to low##80##2##(1990-2#2)(1990-3#1)(1990-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-9#1)(1996-12#1)(1996-5#3)(1996-6#3)(1997-4#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#18)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-3#3)(2013-1#4)
to low-dose##3##2##(2008-7#1)(2009-5#1)(2013-1#1)
to low-frequency vibration##2##3##(2008-2#1)(2008-3#1)
to low-frequency##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
to low-molecular weight##2##3##(1991-12#1)(2008-10#1)
to low-molecular##4##2##(1990-5#1)(1991-12#1)(2008-10#2)
to lower levels of##3##4##(2009-5#1)(2009-7#2)
to lower temperature##2##3##(1992-8#1)(2008-10#1)
to lower the##6##3##(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)
to lower##44##2##(1992-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#2)(2010-11#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
to lowest##4##2##(2007-7#1)(2008-10#2)(2008-5#1)
to lumbar##2##2##(1996-2#1)(2010-11#1)
to lunar##2##2##(2008-2#2)
to lung cancer in##2##4##(1996-9#1)(2010-12#1)
to lung cancer##7##3##(1996-3#1)(1996-9#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-1#1)
to lung tissue##2##3##(2011-2#1)(2013-8#1)
to lung transplant##2##3##(2011-3#2)
to lung##21##2##(1991-6#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#3)(2013-1#1)(2013-8#1)
to lungs##2##2##(1994-5#1)(2008-5#1)
to lymph nodes##4##3##(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
to lyse##7##2##(1993-9#1)(1994-3#1)(1994-5#1)(1995-2#1)(2008-4#1)(2009-6#1)(2010-3#1)
to lysis by##3##3##(1992-2#2)(2008-9#1)
to lysis##4##2##(1992-2#2)(2008-9#2)
to lytic##2##2##(1997-3#1)(2013-1#1)
to mRNA##3##2##(1990-7#1)(2010-4#1)(2012-2#1)
to macromolecular##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
to macromolecules##4##2##(1991-9#1)(1995-12#1)(1996-5#1)(2008-7#1)
to macrophage##3##2##(1992-8#1)(1995-6#1)(2013-1#1)
to macrophages##3##2##(1990-12#1)(1995-2#1)(2008-4#1)
to macroporous alginate cryogel##2##4##(2012-1#2)
to macroporous alginate##3##3##(2012-1#3)
to macroscopic##4##2##(2008-10#3)(2008-3#1)
to macular##3##2##(2011-2#1)(2013-1#2)
to made##2##2##(2008-10#1)(2011-2#1)
to magnesium##3##2##(1990-9#1)(2008-10#2)
to magnetic resonance##2##3##(1992-3#1)(1996-5#1)
to main##4##2##(1995-5#1)(2008-10#3)
to mainly##3##2##(1990-6#1)(1994-5#1)(2010-7#1)
to maintain a high##2##4##(1991-6#1)(2011-2#1)
to maintain a relatively##2##4##(1993-11#1)(2012-3#1)
to maintain a##17##3##(1990-4#1)(1991-1#1)(1991-6#1)(1993-11#1)(1993-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
to maintain accurate##2##3##(1992-11#1)(2008-7#1)
to maintain an##4##3##(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
to maintain cell##3##3##(2011-2#2)(2013-1#1)
to maintain control of##2##4##(2008-3#1)(2008-7#1)
to maintain control##3##3##(2008-3#1)(2008-7#1)(2013-7#1)
to maintain damage##2##3##(2008-10#1)(2011-2#1)
to maintain its##2##3##(2008-11#2)
to maintain long-term##3##3##(2007-7#1)(2008-11#1)(2013-1#1)
to maintain normal##3##3##(1990-11#1)(2008-3#2)
to maintain spermatogenesis##3##3##(1992-12#2)(2012-2#1)
to maintain the delicate balance between##2##6##(2008-9#2)
to maintain the highest##2##4##(1994-2#1)(1995-12#1)
to maintain the quality of##2##5##(1994-12#1)(2008-11#1)
to maintain the same##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
to maintain the##46##3##(1990-10#1)(1990-11#1)(1990-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-9#2)(2010-8#1)(2010-9#2)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
to maintain their##4##3##(1991-12#1)(1997-6#1)(2009-6#1)(2013-1#1)
to maintain##165##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#6)(2009-4#2)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#2)
to maintaining a##2##3##(2010-7#1)(2011-2#1)
to maintaining##5##2##(1994-5#1)(2008-3#1)(2010-7#1)(2011-2#2)
to maintenance##2##2##(2007-7#1)(2008-9#1)
to maize leaves##2##3##(2008-10#2)
to maize##8##2##(1991-10#1)(1991-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
to major resistance genes in##2##5##(2008-10#2)
to major resistance genes##3##4##(2008-10#3)
to major##15##2##(1993-1#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-3#1)(2012-3#1)
to make a decision##2##4##(2008-7#1)(2013-1#1)
to make a diagnosis of##3##5##(1997-8#1)(2012-2#1)(2013-8#1)
to make a diagnosis##5##4##(1997-8#1)(2007-11#2)(2012-2#1)(2013-8#1)
to make a difference##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
to make a significant##2##4##(2008-5#1)(2013-8#1)
to make a##52##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-1#4)(1994-11#1)(1994-2#2)(1995-5#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
to make accurate##3##3##(1992-6#1)(2008-3#1)(2012-2#1)
to make an##7##3##(1995-8#1)(2007-11#1)(2007-9#1)(2008-7#2)(2009-10#1)(2011-2#1)
to make appropriate##3##3##(2009-8#1)(2013-1#1)(2013-8#1)
to make better##2##3##(2008-3#1)(2010-9#1)
to make communication##2##3##(1995-12#1)(1996-1#1)
to make comparisons##3##3##(1991-12#1)(2008-10#1)(2011-1#1)
to make decisions##7##3##(1992-2#1)(1993-2#1)(1994-9#1)(2008-1#1)(2009-7#1)(2010-8#1)(2011-8#1)
to make direct##2##3##(2008-7#1)(2008-9#1)
to make in##2##3##(1992-2#1)(2008-3#1)
to make information accessible##2##4##(1995-12#1)(1996-1#1)
to make informed decisions##3##4##(1991-2#1)(2008-1#1)(2008-12#1)
to make it possible to##2##5##(2008-3#1)(2009-11#1)
to make it##11##3##(1993-9#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-3#2)(2009-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
to make judgements##2##3##(2007-10#1)(2008-12#1)
to make medical##2##3##(1995-12#1)(2010-8#1)
to make more##6##3##(1997-3#2)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
to make new##2##3##(2008-5#1)(2011-2#1)
to make our##2##3##(2007-8#1)(2013-8#1)
to make predictions##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
to make progress in##2##4##(2008-5#1)(2010-3#1)
to make progress##3##3##(2008-5#1)(2008-7#1)(2010-3#1)
to make rapid##2##3##(2008-7#1)(2008-9#1)
to make sense##2##3##(1997-7#1)(2009-5#1)
to make smart##2##3##(1996-3#1)(2010-12#1)
to make some##2##3##(1995-2#1)(1996-5#1)
to make substantial##2##3##(1993-12#1)(1994-12#1)
to make such a##2##4##(2007-6#1)(2008-10#1)
to make such##3##3##(1991-1#1)(2007-6#1)(2008-10#1)
to make sure that the##3##5##(1993-1#1)(1995-9#1)(2008-10#1)
to make sure that##5##4##(1993-1#2)(1993-3#1)(1995-9#1)(2008-10#1)
to make sure the##2##4##(1995-6#1)(2008-10#1)
to make sure##7##3##(1993-1#2)(1993-3#1)(1995-6#1)(1995-9#1)(2008-10#2)
to make the best##2##4##(2008-10#1)(2013-1#1)
to make the correct##2##4##(1996-6#1)(2012-2#1)
to make the first##2##4##(2007-8#1)(2010-5#1)
to make the most##2##4##(1993-12#1)(2012-2#1)
to make the system##2##4##(2008-10#2)
to make the##32##3##(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
to make them##3##3##(1991-1#1)(1996-3#1)(2008-11#1)
to make these##3##3##(1993-9#1)(2008-11#1)(2011-1#1)
to make this##4##3##(1990-8#1)(1996-12#1)(1997-8#1)(2008-11#1)
to make those##2##3##(1995-12#1)(2013-7#1)
to make treatment##2##3##(1997-4#1)(2009-4#1)
to make use of##4##4##(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)
to make##313##2##(1990-3#1)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-7#1)(1997-8#4)(2006-10#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#13)(2008-12#6)(2008-2#10)(2008-3#19)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#17)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#14)(2011-3#1)(2011-8#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
to making##6##2##(1993-3#1)(1996-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
to malaria in##2##3##(1995-12#1)(2010-1#1)
to malaria##8##2##(1994-11#1)(1995-12#1)(2007-2#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
to male##20##2##(1990-5#1)(1992-9#1)(1995-3#2)(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#4)(2012-3#2)
to males and approximately##2##4##(2008-9#2)
to males and##14##3##(2008-4#1)(2008-8#3)(2008-9#10)
to males##22##2##(2008-11#1)(2008-4#1)(2008-8#4)(2008-9#12)(2009-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
to malignancy##6##2##(1990-2#1)(1992-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
to malignant progression##2##3##(2008-6#2)
to malignant##13##2##(1990-2#1)(1991-9#2)(1993-2#1)(1993-5#1)(1997-3#1)(1997-8#1)(2008-12#1)(2008-6#2)(2011-2#2)(2013-8#1)
to malnutrition##5##2##(1991-12#1)(1993-12#1)(1996-3#1)(2008-12#1)(2012-2#1)
to mammalian aldo/keto reductases##2##4##(1990-5#2)
to mammalian cells##2##3##(1994-5#1)(2008-9#1)
to mammalian##16##2##(1990-12#1)(1990-5#2)(1991-6#1)(1992-11#1)(1993-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#2)(2008-11#2)(2008-4#1)(2008-9#1)
to mammals##4##2##(1991-9#1)(1996-2#1)(2008-7#1)(2009-6#1)
to mammography##2##2##(1990-10#1)(1995-2#1)
to man##5##2##(1995-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(2010-7#1)
to manage a##2##3##(2007-2#1)(2013-1#1)
to manage the disease##2##4##(2008-10#1)(2008-8#1)
to manage the##18##3##(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#2)
to manage their child's asthma##2##5##(2010-9#2)
to manage their##7##3##(1992-2#1)(1994-1#2)(2010-9#2)(2013-1#1)(2013-7#1)
to manage this##5##3##(1994-3#2)(2008-10#1)(2008-7#1)(2011-2#1)
to manage type##2##3##(2008-7#1)(2009-11#1)
to manage##99##2##(1990-3#1)(1992-2#1)(1993-12#2)(1994-1#2)(1994-2#3)(1994-3#3)(1994-9#1)(1995-12#4)(1995-3#1)(1996-1#1)(1996-2#4)(1996-3#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#1)(2009-11#1)(2010-11#3)(2010-3#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-10#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)
to managed care in##2##4##(1995-12#1)(1996-2#1)
to managed care##11##3##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#2)(1996-2#2)(1997-2#1)
to managed##13##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#2)(1996-2#2)(1997-2#1)(2011-2#1)
to management of##6##3##(2008-1#1)(2008-7#3)(2010-12#1)(2012-12#1)
to management##22##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-6#2)(2008-7#4)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
to managing the##2##3##(2008-12#1)(2008-3#1)
to managing##10##2##(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)
to mandate and##2##3##(1991-12#1)(2008-3#1)
to mandate##5##2##(1991-12#1)(1996-1#1)(1997-3#1)(2008-3#1)(2012-1#1)
to manic-depressive disease##2##3##(1997-5#2)
to manifest##3##2##(2007-7#1)(2009-3#1)(2009-9#1)
to manipulate objects##2##3##(2008-11#1)(2012-2#1)
to manipulate the##8##3##(1990-2#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-12#1)(2009-5#1)(2011-7#1)(2013-8#1)
to manipulate##29##2##(1990-2#1)(1994-8#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-8#2)
to manipulations##2##2##(2008-4#1)(2008-7#1)
to mankind##2##2##(1994-5#1)(2008-10#1)
to manual##5##2##(1994-6#1)(2007-8#1)(2008-10#1)(2010-8#1)(2012-2#1)
to manufacture##6##2##(2008-10#2)(2008-11#1)(2008-3#2)(2010-9#1)
to many biological##2##3##(2009-12#1)(2010-12#1)
to many countries##2##3##(2008-1#1)(2010-7#1)
to many different cell types##2##5##(1994-5#1)(2008-9#1)
to many different##6##3##(1994-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
to many health##2##3##(1995-12#1)(1995-2#1)
to many isolates of##2##4##(2008-10#2)
to many of the##3##4##(1992-2#1)(2008-8#1)(2008-9#1)
to many of##6##3##(1991-3#1)(1992-2#1)(1995-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
to many other##8##3##(1996-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-3#1)(2011-2#1)
to many processes##2##3##(2008-7#2)
to many types of##5##4##(1992-2#1)(1994-3#1)(2008-4#1)(2009-1#1)(2010-1#1)
to many##78##2##(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#3)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
to map genes##2##3##(2008-10#1)(2008-12#1)
to map out##2##3##(1991-8#1)(2008-8#1)
to map the gene##3##4##(1995-2#1)(2008-10#2)
to map the##27##3##(1990-11#1)(1990-2#1)(1990-7#1)(1993-11#2)(1993-12#1)(1995-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#2)(2010-2#1)(2010-8#1)
to map##53##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-8#1)(1993-11#2)(1993-12#1)(1995-2#1)(1996-4#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-2#2)(2010-8#1)(2012-3#1)(2013-1#1)
to marine##3##2##(2007-5#1)(2008-9#1)(2010-5#1)
to mark the##2##3##(2008-4#1)(2012-5#1)
to mark their##2##3##(2009-2#1)(2009-3#1)
to mark##7##2##(2008-10#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-5#1)
to marked##6##2##(2007-12#1)(2008-10#2)(2008-5#1)(2009-3#1)(2012-2#1)
to markedly influence##2##3##(2007-12#1)(2013-8#1)
to markedly##6##2##(1991-5#1)(2007-12#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
to market##13##2##(1990-12#1)(1990-5#1)(1992-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#2)(2009-11#1)(2009-9#1)(2011-2#1)
to markets##2##2##(2011-2#1)(2013-1#1)
to marry##3##2##(1996-11#1)(1996-3#1)(2009-11#1)
to mash##2##2##(1997-4#2)
to mask the##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
to mask##8##2##(1995-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
to mass spectrometry##3##3##(2008-10#2)(2012-3#1)
to mass##9##2##(1990-7#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-3#2)
to mass-produce##2##2##(2008-10#1)(2008-11#1)
to massage##2##2##(2008-10#1)(2008-5#1)
to massive##5##2##(1995-10#1)(1997-4#1)(2006-7#1)(2009-4#1)(2011-2#1)
to mastectomy##2##2##(1990-12#1)(2007-11#1)
to master##2##2##(1992-1#1)(1997-3#1)
to match the##9##3##(1991-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)
to match##23##2##(1991-3#1)(1993-3#1)(1994-1#1)(1995-11#1)(1996-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#2)(2009-2#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-8#2)
to matched##3##2##(1992-6#1)(2009-10#1)(2012-1#1)
to mate and##2##3##(2008-9#1)(2009-9#1)
to mate##6##2##(2008-8#1)(2008-9#1)(2009-9#2)(2011-2#1)(2012-12#1)
to material##4##2##(2008-3#3)(2009-9#1)
to materials##3##2##(1991-12#1)(1997-4#1)(2008-7#1)
to maternal##9##2##(1993-6#1)(1995-8#2)(1996-5#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-11#1)(2011-1#1)
to maternity##2##2##(1992-4#1)(2013-8#1)
to mathematical##2##2##(2007-11#1)(2008-10#1)
to mating pheromone##2##3##(1991-5#1)(1994-12#1)
to mating##3##2##(1991-5#1)(1994-12#1)(2008-10#1)
to matrix interference##2##3##(2008-10#2)
to matrix##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2013-1#1)
to maturation##2##2##(1996-3#1)(2008-10#1)
to mature##11##2##(1990-12#1)(1990-7#1)(1992-12#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-5#2)(2013-8#1)
to maturity##4##2##(1991-12#1)(2008-11#1)(2008-9#1)(2013-7#1)
to maximal##5##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
to maximise the##2##3##(2008-11#1)(2012-2#1)
to maximise##9##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
to maximize the##25##3##(1993-12#1)(1994-3#1)(1995-1#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-8#2)(2012-12#1)(2013-7#1)
to maximize their##3##3##(2008-11#1)(2008-9#2)
to maximize##71##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#10)(2010-10#1)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-7#1)
to maximum##13##2##(1992-11#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
to mean that the##2##4##(2008-10#1)(2010-3#1)
to mean that##3##3##(2008-10#2)(2010-3#1)
to mean the##2##3##(1995-2#1)(1996-5#1)
to mean##8##2##(1990-12#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-3#1)(2010-3#1)(2013-1#1)
to meaningful##2##2##(1997-3#1)(2008-4#1)
to measurable##2##2##(2008-11#1)(2008-8#1)
to measure MT##2##3##(2008-10#2)
to measure a##4##3##(2007-12#1)(2008-3#1)(2010-8#1)(2011-2#1)
to measure absorption##2##3##(2008-3#2)
to measure all##2##3##(2008-10#1)(2008-4#1)
to measure an##3##3##(1993-9#1)(2008-2#1)(2008-3#1)
to measure and##6##3##(1996-3#1)(1997-2#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
to measure atmospheric##3##3##(2008-2#1)(2008-3#2)
to measure blood##6##3##(2007-8#1)(2008-1#1)(2008-10#3)(2010-11#1)
to measure bone##2##3##(1993-11#1)(2009-4#1)
to measure both##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
to measure changes in##5##4##(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#1)
to measure chemotaxis of LGL##2##5##(1990-12#2)
to measure directly##2##3##(2008-2#2)
to measure disease##3##3##(2008-10#2)(2008-7#1)
to measure economic##2##3##(1994-12#1)(1995-9#1)
to measure fluorescence##2##3##(2008-2#1)(2008-4#1)
to measure human##3##3##(1993-6#1)(2008-4#1)(2011-2#1)
to measure in situ the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
to measure in situ##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
to measure in##6##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#1)
to measure intracellular calcium##2##4##(2008-4#2)
to measure optical##3##3##(2007-11#1)(2007-12#1)(2011-7#1)
to measure other##2##3##(1996-12#1)(2012-2#1)
to measure outcomes##3##3##(1996-2#1)(1997-1#1)(2012-12#1)
to measure patient satisfaction##2##4##(1997-1#1)(2011-2#1)
to measure physical morbidity in##2##5##(2012-12#2)
to measure profiles of##2##4##(2008-3#2)
to measure progress##3##3##(1996-1#1)(2008-10#1)(2012-12#1)
to measure protein##2##3##(1990-12#1)(1991-5#1)
to measure quality##3##3##(1997-1#1)(2011-2#2)
to measure satisfaction##2##3##(1996-3#1)(2008-11#1)
to measure sensitivity##2##3##(2008-10#2)
to measure serum##2##3##(1992-11#1)(2008-10#1)
to measure simultaneously and##2##4##(2007-12#1)(2008-11#1)
to measure simultaneously##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
to measure small##4##3##(2008-2#1)(2008-3#3)
to measure spatial variation##2##4##(2008-10#1)(2011-2#1)
to measure temperature##3##3##(2008-3#3)
to measure the absolute##2##4##(2008-2#1)(2008-3#1)
to measure the amplitude of##2##5##(2007-12#1)(2008-3#1)
to measure the changes in##2##5##(2008-12#1)(2008-3#1)
to measure the concentration of##7##5##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
to measure the concentrations of##2##5##(2008-4#1)(2011-1#1)
to measure the effect of##2##5##(2008-11#1)(2008-4#1)
to measure the effect##3##4##(2008-11#1)(2008-4#1)(2008-5#1)
to measure the effectiveness of##3##5##(1991-1#1)(1995-2#1)(2010-10#1)
to measure the extent of##3##5##(1994-5#1)(2008-10#1)(2008-4#1)
to measure the free concentration of##2##6##(2008-10#2)
to measure the impact of these##2##6##(2008-9#1)(2013-1#1)
to measure the impact of##3##5##(1992-12#1)(2008-9#1)(2013-1#1)
to measure the kinetics of##2##5##(2008-3#1)(2008-8#1)
to measure the nonlinear##2##4##(2007-11#1)(2008-2#1)
to measure the optical##3##4##(2008-3#3)
to measure the orientation of##2##5##(2008-3#1)(2010-5#1)
to measure the refractive indices##2##5##(2008-3#2)
to measure the refractive##3##4##(2008-3#3)
to measure the same##2##4##(1997-8#1)(2008-10#1)
to measure the scattering##2##4##(2008-3#2)
to measure the spatial##2##4##(2008-2#1)(2008-3#1)
to measure the spectral##2##4##(2008-2#1)(2008-3#1)
to measure the surface##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
to measure the thermal##3##4##(2008-3#3)
to measure the total##2##4##(2008-10#1)(2008-3#1)
to measure the true##2##4##(2008-3#1)(2009-11#1)
to measure the volume of##2##5##(1996-7#1)(2011-2#1)
to measure the##197##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#2)(1993-11#1)(1993-8#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#7)(2007-12#5)(2007-8#3)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#4)(2008-2#23)(2008-3#47)(2008-4#9)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#7)(2009-11#2)(2009-12#3)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
to measure their##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)
to measure them##2##3##(2008-3#1)(2012-2#1)
to measure these##5##3##(1993-2#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-11#1)
to measure total##4##3##(2008-3#1)(2008-9#2)(2012-12#1)
to measure tropospheric##2##3##(2008-3#2)
to measure two-dimensional##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
to measure##530##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#4)(1994-5#2)(1994-9#2)(1995-1#2)(1995-12#10)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#8)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#13)(2007-12#19)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#52)(2008-11#11)(2008-12#9)(2008-2#42)(2008-3#103)(2008-4#22)(2008-5#16)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#19)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#3)(2009-4#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#13)(2013-7#2)
to measured##3##2##(1991-5#1)(2008-6#1)(2008-7#1)
to measurement and##2##3##(2008-3#1)(2010-1#1)
to measurement errors##2##3##(2008-11#1)(2008-2#1)
to measurement of the##4##4##(1995-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
to measurement of##7##3##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
to measurement##14##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#5)(2010-1#1)
to measurements of##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
to measurements##8##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#4)
to measures of##2##3##(2010-3#1)(2013-8#1)
to measures##3##2##(2008-11#1)(2010-3#1)(2013-8#1)
to measuring an##2##3##(1992-3#1)(2008-2#1)
to measuring the##4##3##(1990-5#1)(2008-3#3)
to measuring##12##2##(1990-5#1)(1992-3#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#5)(2008-4#1)
to mechanical stimulation##3##3##(2008-11#1)(2008-12#1)(2009-12#1)
to mechanical stimuli##2##3##(1993-12#1)(1997-3#1)
to mechanical##22##2##(1990-8#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-3#1)
to mechanically##2##2##(1994-12#1)(2008-8#1)
to mechanisms##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
to media##5##2##(1991-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
to medial##2##2##(1993-12#1)(2013-1#1)
to mediate a variety of##2##5##(2008-4#1)(2010-6#1)
to mediate the relationship between##2##5##(2009-10#1)(2010-3#1)
to mediate the##7##3##(1993-8#1)(1994-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)
to mediate their##2##3##(1990-8#1)(1994-12#1)
to mediate##41##2##(1990-11#1)(1990-8#1)(1992-3#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#3)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
to medical care##5##3##(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-8#1)
to medical education##2##3##(2009-7#1)(2010-11#1)
to medical literature##2##3##(1991-3#1)(2013-1#1)
to medical practice##2##3##(1992-12#1)(2008-3#1)
to medical procedures##2##3##(1996-2#1)(2008-10#1)
to medical staff##2##3##(1992-1#1)(1993-1#1)
to medical students##4##3##(1994-12#1)(2008-3#1)(2008-6#1)(2011-2#1)
to medical therapy##4##3##(1993-3#1)(1994-2#1)(1996-11#1)(2012-12#1)
to medical treatment##8##3##(1991-11#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
to medical##51##2##(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to medication adherence##2##3##(1992-12#1)(2011-1#1)
to medication management##2##3##(2008-11#2)
to medication regimens##2##3##(1992-12#2)
to medication##7##2##(1992-12#3)(2008-11#2)(2011-1#1)(2011-2#1)
to medications##4##2##(2008-1#1)(2008-6#1)(2010-4#1)(2013-1#1)
to medicine##5##2##(1995-6#1)(2007-7#1)(2008-1#1)(2013-1#2)
to medium and##2##3##(1993-8#1)(2008-12#1)
to medium##12##2##(1993-8#1)(1996-2#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)
to medium-sized##2##2##(1990-8#1)(2008-2#1)
to meet a##2##3##(1995-12#1)(2009-11#1)
to meet and##3##3##(1991-6#1)(1994-2#1)(1995-3#1)
to meet changing##2##3##(1995-1#1)(1995-5#1)
to meet current##2##3##(1994-2#1)(2009-3#1)
to meet emerging##2##3##(1997-3#2)
to meet in##2##3##(1992-1#1)(2008-11#1)
to meet its##7##3##(1990-10#1)(1990-5#1)(1993-1#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-3#1)
to meet or exceed##2##4##(1995-1#1)(2010-2#1)
to meet service##2##3##(1995-1#1)(1995-2#1)
to meet the challenges of##2##5##(1994-2#1)(2011-1#1)
to meet the demand##2##4##(2008-11#1)(2008-9#1)
to meet the demands of the##3##6##(1994-2#1)(2008-7#1)(2012-3#1)
to meet the demands of##6##5##(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#2)
to meet the national##2##4##(2008-11#1)(2009-12#1)
to meet the need for##3##5##(1997-7#1)(2008-10#1)(2010-11#1)
to meet the needs of a##2##6##(1991-3#1)(2008-10#1)
to meet the needs of the##4##6##(1994-2#1)(1995-2#2)(1997-1#1)
to meet the needs of their##2##6##(1993-1#1)(2010-3#1)
to meet the needs of##23##5##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
to meet the needs##24##4##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#1)
to meet the new##2##4##(1994-1#1)(2010-7#1)
to meet the requirements of##2##5##(2008-11#1)(2008-2#1)
to meet the specific##2##4##(2010-11#1)(2012-3#1)
to meet the standards##2##4##(1991-8#1)(2011-2#1)
to meet the##77##3##(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#3)(1994-9#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)
to meet their financial##2##4##(2008-11#1)(2008-7#1)
to meet their needs##3##4##(1994-1#1)(2008-11#1)(2008-9#1)
to meet their##6##3##(1994-1#1)(2008-11#3)(2008-7#1)(2008-9#1)
to meet these challenges##3##4##(2008-10#1)(2008-11#1)(2009-12#1)
to meet these requirements##2##4##(1992-12#1)(2008-3#1)
to meet these##8##3##(1992-12#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-4#1)
to meet your##2##3##(1992-1#1)(1995-2#1)
to meet##151##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1994-1#5)(1994-12#2)(1994-2#6)(1994-3#4)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-7#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#12)(2008-11#17)(2008-12#2)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#6)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)
to meeting the##2##3##(1993-1#1)(1995-3#1)
to meeting##3##2##(1993-1#1)(1995-3#1)(2013-1#1)
to mefenoxam##5##2##(2008-10#5)
to melanoma##3##2##(1997-7#1)(2011-2#1)(2012-3#1)
to members of the##6##4##(1994-12#1)(1996-1#1)(1997-8#1)(2008-10#2)(2009-5#1)
to members of##8##3##(1994-12#1)(1995-6#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-5#1)
to membrane depolarization##2##3##(1992-3#1)(2008-8#1)
to membrane fusion##2##3##(2008-8#1)(2012-2#1)
to membrane receptors##2##3##(1991-8#1)(2008-7#1)
to membrane##16##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(1996-5#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-2#1)
to membrane-bound polysomes##2##3##(2008-11#2)
to membrane-bound##4##2##(1994-12#1)(1995-6#1)(2008-11#2)
to membranes and##2##3##(1995-6#1)(2008-7#1)
to membranes##10##2##(1990-7#2)(1991-11#1)(1995-11#2)(1995-6#1)(2008-10#1)(2008-7#2)(2012-2#1)
to memorize##3##2##(2008-6#3)
to memory##5##2##(1991-5#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-12#1)
to men##11##2##(1991-8#1)(1994-6#2)(1996-11#1)(1997-7#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-8#2)
to meningovascular neurosyphilis##2##3##(1997-5#1)(2012-12#1)
to menopausal status##2##3##(1991-12#1)(2010-10#1)
to mental health and well-being##2##5##(2007-6#1)(2011-2#1)
to mental health services##3##4##(1996-3#2)(1997-2#1)
to mental health##10##3##(1996-3#2)(1997-2#1)(2007-6#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to mental##17##2##(1991-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#1)(2007-6#1)(2008-11#2)(2008-12#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
to mentally##2##2##(2009-8#1)(2010-6#1)
to mention new##2##3##(2008-4#1)(2011-2#1)
to mention that##2##3##(2008-10#1)(2008-5#1)
to mention##7##2##(1996-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2011-2#1)
to mentor##2##2##(2008-9#1)(2012-3#1)
to merge in##2##3##(2008-2#1)(2008-3#1)
to merge##6##2##(1992-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)
to mesenteric##3##2##(1996-2#3)
to meta-analysis##2##2##(1994-7#1)(1996-3#1)
to metabolic and##2##3##(2007-10#1)(2008-7#1)
to metabolic syndrome##2##3##(2008-3#2)
to metabolic##7##2##(1990-6#1)(1990-7#1)(2007-10#1)(2008-3#2)(2008-7#1)(2012-3#1)
to metabolically##2##2##(1994-11#1)(2013-1#1)
to metabolise##3##2##(1990-11#2)(2008-7#1)
to metabolism##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
to metabolites##2##2##(2013-8#2)
to metabolize epicatechin showed##2##4##(2008-10#2)
to metabolize##7##2##(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
to metal##15##2##(1991-5#1)(1996-2#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-3#1)(2011-1#1)(2012-12#2)
to metalaxyl##10##2##(2008-10#10)
to metallic##2##2##(2008-10#1)(2008-7#1)
to metals##2##2##(2007-12#1)(2011-1#1)
to metaphase##3##2##(2008-1#1)(2008-4#1)(2013-1#1)
to metastasis##4##2##(1997-3#1)(2007-11#1)(2008-1#2)
to metastasize##4##2##(2009-3#1)(2010-3#2)(2012-3#1)
to metastatic##4##2##(2007-10#1)(2007-11#1)(2009-5#1)(2010-3#1)
to methane##2##2##(2008-10#1)(2008-6#1)
to methanol in whole embryo culture##2##6##(1995-3#2)
to methanol##3##2##(1995-3#3)
to methiocarb##2##2##(2011-2#2)
to methodological##3##2##(2008-10#1)(2008-9#1)(2012-1#1)
to methods##5##2##(1993-9#1)(1994-2#1)(1997-3#1)(2008-3#1)(2010-8#1)
to methotrexate##4##2##(1990-8#1)(1991-4#1)(1994-3#1)(2013-1#1)
to methyl##7##2##(2008-10#5)(2010-12#1)(2013-8#1)
to methylate##2##2##(1992-3#1)(1994-8#1)
to metronidazole##2##2##(2008-12#2)
to mice##12##2##(1990-6#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-5#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2013-1#1)
to micro##3##2##(2009-7#1)(2013-1#2)
to microarray##2##2##(2008-7#1)(2010-10#1)
to microbial##5##2##(2008-10#2)(2008-5#1)(2013-1#2)
to microbiology##2##2##(2008-9#2)
to microencapsulated##2##2##(2010-11#1)(2011-2#1)
to micromolar concentrations##2##3##(2008-10#1)(2008-4#1)
to micromolar##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
to microsatellite##2##2##(2008-10#1)(2008-5#1)
to microsclerotia##3##2##(2008-10#3)
to microsomal##3##2##(1993-8#1)(1994-5#1)(1995-6#1)
to microspheres and##2##3##(2008-9#2)
to microspheres##3##2##(2008-9#3)
to mid##2##2##(1992-9#1)(2008-12#1)
to mid-1994##2##2##(1995-9#1)(2008-2#1)
to midbrain dopaminergic neurons in##2##5##(2008-7#2)
to middle school##2##3##(2009-7#2)
to middle##7##2##(1991-6#1)(1997-2#1)(2008-3#1)(2009-7#4)
to migrate in##2##3##(1994-11#1)(2012-1#1)
to migrate into##2##3##(1997-8#1)(2008-5#1)
to migrate to##2##3##(2011-1#1)(2013-8#1)
to migrate##10##2##(1994-11#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
to migration##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
to mild##10##2##(1991-1#1)(1993-3#1)(1994-11#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
to mildly##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
to military##4##2##(1991-11#1)(1992-3#1)(1995-6#1)(2007-8#1)
to millions of##3##3##(1997-6#1)(2007-12#1)(2008-12#1)
to mimic the##14##3##(1991-9#1)(1992-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-12#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-3#1)(2012-4#1)
to mimic those##3##3##(1990-12#1)(1992-1#1)(1994-5#1)
to mimic##29##2##(1990-12#1)(1991-9#1)(1992-1#1)(1992-4#1)(1994-5#2)(1997-4#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-12#3)(2009-2#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2012-8#1)
to mind##3##2##(2008-9#1)(2009-9#1)(2013-8#1)
to mineral##4##2##(1995-8#1)(2008-10#2)(2008-3#1)
to mineralized##2##2##(2008-10#1)(2013-8#1)
to minimise the high##2##4##(1997-7#1)(2008-10#1)
to minimise the##6##3##(1997-7#1)(2008-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
to minimise their##2##3##(2008-1#1)(2011-2#1)
to minimise##11##2##(1997-7#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
to minimize additional##3##3##(2007-7#1)(2012-2#2)
to minimize diagnostic##2##3##(1996-3#1)(2013-1#1)
to minimize errors##2##3##(2008-2#1)(2012-3#1)
to minimize matrix##2##3##(2008-10#2)
to minimize the bias##2##4##(2007-8#1)(2008-10#1)
to minimize the effect of##3##5##(1995-3#1)(2008-10#1)(2008-3#1)
to minimize the effects of##3##5##(1993-1#1)(2008-3#1)(2008-9#1)
to minimize the interference##2##4##(2008-10#2)
to minimize the risk of##5##5##(1992-3#1)(1993-1#1)(1996-3#1)(2007-8#1)(2010-7#1)
to minimize the risks##3##4##(1997-5#1)(2008-8#1)(2013-1#1)
to minimize the side-effects##2##4##(1997-6#1)(2007-7#1)
to minimize the##51##3##(1992-12#1)(1992-3#1)(1993-1#2)(1993-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#2)
to minimize these##2##3##(2008-11#1)(2008-3#1)
to minimize this##2##3##(1992-3#1)(2009-7#1)
to minimize##110##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-10#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#9)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
to minimizing the##2##3##(2007-11#1)(2008-2#1)
to minimizing##7##2##(1995-12#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-7#1)
to minimum##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
to minor##7##2##(1992-6#1)(1997-5#1)(2008-3#2)(2008-4#1)(2011-2#1)(2013-8#1)
to misalignement##2##2##(2008-3#2)
to misalignment##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
to misalignments##2##2##(2007-11#1)(2008-2#1)
to misidentification##2##2##(2011-2#2)
to misleading##4##2##(1997-2#1)(2008-12#1)(2009-3#1)(2012-2#1)
to misperceptions##2##2##(2008-7#1)(2010-4#1)
to miss##3##2##(1991-1#1)(2012-2#2)
to missing data##2##3##(1994-9#1)(2012-12#1)
to missing##3##2##(1994-9#1)(1997-2#1)(2012-12#1)
to mistakes##2##2##(2008-3#1)(2009-8#1)
to misuse##3##2##(1994-2#1)(2007-11#1)(2012-2#1)
to mitigate the effects of##2##5##(2008-12#1)(2008-2#1)
to mitigate the##7##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)(2013-8#1)
to mitigate##18##2##(1992-1#1)(1994-3#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
to mitochondria##6##2##(1992-9#1)(1994-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
to mitochondrial dysfunction##2##3##(1995-5#1)(2008-1#1)
to mitochondrial##3##2##(1995-5#1)(2008-1#1)(2009-4#1)
to mitogenic##2##2##(1992-6#1)(1996-2#1)
to mitogens##4##2##(1991-12#1)(1992-12#1)(1994-12#1)(2008-4#1)
to mitosis##2##2##(2008-9#1)(2009-10#1)
to mitoxantrone##2##2##(1991-6#2)
to mixed##2##2##(2008-10#1)(2010-10#1)
to mixing##2##2##(2007-10#1)(2008-10#1)
to mixtures of##3##3##(2008-10#2)(2011-2#1)
to mobilise##2##2##(2007-12#1)(2008-11#1)
to mobilize the##3##3##(1996-2#1)(2008-9#1)(2013-8#1)
to mobilize##8##2##(1996-2#1)(1996-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
to mode##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
to model and##5##3##(2008-10#1)(2008-2#2)(2010-4#1)(2010-7#1)
to model predictions##2##3##(2008-10#1)(2008-9#1)
to model relative##2##3##(1992-6#1)(2013-7#1)
to model the system##2##4##(2008-10#1)(2008-2#1)
to model the##36##3##(1994-5#1)(1995-2#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
to model this##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
to model##92##2##(1992-2#1)(1992-6#1)(1994-5#2)(1995-1#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-2#7)(2008-3#19)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#2)(2009-7#1)(2009-9#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-7#2)
to modeling the##2##3##(2008-3#2)
to modeling##13##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-8#1)(2010-9#1)(2013-8#1)
to models that##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
to models##6##2##(1994-12#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-2#1)
to moderate climate##2##3##(2012-5#2)
to moderate levels of##2##4##(2008-10#2)
to moderate the##2##3##(2009-7#2)
to moderate##46##2##(1992-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-1#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-5#3)(2013-1#2)(2013-8#1)
to moderately##3##2##(1994-9#1)(2010-12#1)(2012-1#1)
to modern##9##2##(1990-6#1)(1991-5#1)(1993-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-8#1)(2012-3#2)
to modes of##2##3##(1992-6#1)(2008-2#1)
to modest##2##2##(1995-4#1)(2012-2#1)
to modification##3##2##(1993-3#1)(1997-1#1)(2008-12#1)
to modify a##2##3##(2008-10#1)(2008-11#1)
to modify disease##2##3##(2008-4#1)(2011-2#1)
to modify such##2##3##(1991-3#1)(2008-4#1)
to modify the##24##3##(1990-6#2)(1991-12#1)(1991-6#1)(1992-9#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to modify##56##2##(1990-6#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1997-8#1)(2007-11#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-4#1)(2009-7#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
to modulate cell##2##3##(1995-8#1)(1996-2#1)
to modulate cellular##2##3##(1993-3#1)(2008-8#1)
to modulate neuronal##2##3##(2008-5#1)(2008-7#1)
to modulate the expression of##5##5##(1994-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
to modulate the laser light passing through the ultrasonic beam inside the tissue##2##13##(2007-12#1)(2008-3#1)
to modulate the##27##3##(1990-5#1)(1992-5#1)(1993-8#1)(1994-11#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-7#1)
to modulate this##2##3##(1994-9#1)(1995-6#1)
to modulate##65##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-9#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to modulation of##3##3##(1994-6#1)(1995-8#1)(2009-3#1)
to modulation##4##2##(1994-6#1)(1995-8#1)(2009-3#1)(2011-1#1)
to moisture##4##2##(1996-5#1)(2008-10#3)
to molecular biology##2##3##(1996-6#1)(2013-8#1)
to molecular##20##2##(1992-6#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-6#2)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#4)(2013-8#1)
to monitor and control##3##4##(2008-11#1)(2008-2#1)(2011-1#1)
to monitor and##11##3##(1992-3#1)(1994-1#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-11#1)(2011-1#1)(2012-2#1)
to monitor blending##2##3##(2008-10#2)
to monitor cell##2##3##(2008-3#1)(2012-3#1)
to monitor changes##2##3##(1996-12#1)(2008-7#1)
to monitor for##2##3##(2008-10#1)(2008-4#1)
to monitor growth##2##3##(2008-10#1)(2009-8#1)
to monitor in##2##3##(2008-3#1)(2011-2#1)
to monitor lymphocyte migration##2##4##(2008-4#2)
to monitor patients##3##3##(1990-2#1)(1993-12#1)(2008-10#1)
to monitor the changes in##2##5##(2008-10#2)
to monitor the concentration of l-cysteine##2##6##(2008-10#2)
to monitor the concentration of##3##5##(2008-10#2)(2008-11#1)
to monitor the concentrations of##2##5##(2008-10#2)
to monitor the conformational##2##4##(1992-6#1)(2008-10#1)
to monitor the effect of##3##5##(1992-3#1)(2008-5#1)(2013-8#1)
to monitor the effects of##3##5##(2008-10#1)(2010-5#1)(2013-8#1)
to monitor the efficacy##2##4##(1993-6#1)(2012-12#1)
to monitor the level of##2##5##(1993-3#1)(2008-10#1)
to monitor the success of##2##5##(1994-2#1)(2012-3#1)
to monitor the treatment##2##4##(2008-1#1)(2008-10#1)
to monitor the##78##3##(1991-12#1)(1992-3#1)(1992-6#3)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1997-2#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
to monitor their##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
to monitor these##2##3##(1996-12#1)(2008-3#1)
to monitor##197##2##(1990-2#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-5#1)(1997-2#4)(1997-6#1)(2007-11#2)(2007-12#4)(2007-9#2)(2008-1#1)(2008-10#59)(2008-11#9)(2008-12#1)(2008-2#14)(2008-3#11)(2008-4#8)(2008-5#1)(2008-7#5)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#4)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
to monitoring##7##2##(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-10#1)
to monoamine##2##2##(1994-2#2)
to monolayer cell cultures##3##4##(2008-1#1)(2008-2#1)(2008-5#1)
to monomer##2##2##(1994-6#1)(1996-2#1)
to monomers##3##2##(1991-12#1)(1995-2#1)(2009-12#1)
to monotherapy##2##2##(1997-3#1)(2010-5#1)
to monotone##2##2##(2008-11#2)
to monovalent##6##2##(1990-3#1)(1990-7#1)(2008-10#4)
to monthly##2##2##(1997-3#1)(2013-7#1)
to months##2##2##(1993-2#1)(2008-11#1)
to mood##2##2##(2008-4#1)(2008-7#1)
to more accurately##4##3##(2006-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
to more complex##2##3##(2008-1#1)(2009-7#1)
to more effective##4##3##(1994-3#1)(1997-2#1)(2006-10#1)(2008-10#1)
to more efficient##4##3##(1996-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
to more favorable##2##3##(2008-10#1)(2013-8#1)
to more fully explore##2##4##(2010-3#1)(2010-4#1)
to more fully##3##3##(2010-3#1)(2010-4#1)(2012-2#1)
to more internal##2##3##(1994-11#2)
to more negative##2##3##(2008-10#2)
to more positive values##3##4##(1993-12#1)(2008-10#2)
to more rational##2##3##(2008-11#1)(2011-2#1)
to more severe##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
to more specific##3##3##(1991-12#1)(1996-12#1)(2010-3#1)
to more than 1##2##4##(2008-10#1)(2008-9#1)
to more than 10##2##4##(2007-12#1)(2008-10#1)
to more than 50%##2##4##(1994-11#1)(1995-11#1)
to more than a##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
to more than##26##3##(1990-2#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
to more traditional##2##3##(2008-8#1)(2010-1#1)
to more##135##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1997-2#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#3)
to morphine##7##2##(1991-1#1)(1994-2#1)(1995-12#3)(1996-2#1)(1997-2#1)
to morphological##3##2##(1992-6#1)(1994-8#1)(2008-6#1)
to morphologically##3##2##(2008-11#1)(2008-5#1)(2010-3#1)
to morphology##3##2##(1995-9#1)(2008-5#2)
to mortality##8##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-3#1)
to mosquito##6##2##(1991-5#1)(2011-1#5)
to most effectively##2##3##(1992-3#1)(2008-9#1)
to most of the##5##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
to most of##7##3##(1991-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
to most people##2##3##(1993-2#1)(1996-5#1)
to most##40##2##(1991-3#1)(1992-3#1)(1993-2#1)(1994-6#2)(1995-1#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)(2013-1#2)
to mothers##9##2##(1990-10#1)(1990-2#1)(1992-5#1)(1995-1#1)(2008-2#1)(2008-9#1)(2010-6#1)(2013-1#2)
to mothers'##3##2##(2008-11#1)(2009-10#1)(2010-10#1)
to motion##2##2##(2007-12#1)(2008-11#1)
to motivate patients to##2##4##(1993-11#1)(2008-3#1)
to motivate the##4##3##(1996-3#1)(2008-3#1)(2008-8#1)(2010-5#1)
to motivate##6##2##(1993-11#1)(1996-3#1)(2008-3#2)(2008-8#1)(2010-5#1)
to motor##9##2##(1991-1#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
to mount a##4##3##(1997-6#1)(2006-10#1)(2008-10#1)(2009-12#1)
to mount##6##2##(1997-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)
to mouse##16##2##(1990-11#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-2#2)(1997-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2013-8#1)
to move beyond the##2##4##(1992-2#1)(1993-12#1)
to move beyond##5##3##(1992-2#1)(1993-12#1)(1994-1#1)(2009-8#1)(2013-1#1)
to move forward##2##3##(1996-1#1)(2011-1#1)
to move from##5##3##(1995-1#1)(2008-10#2)(2008-5#1)(2012-3#1)
to move into##3##3##(1994-5#1)(2008-1#1)(2008-8#1)
to move the##3##3##(2008-12#1)(2008-6#1)(2011-1#1)
to move to a##2##4##(2008-7#1)(2010-10#1)
to move toward##3##3##(1994-1#1)(1995-2#1)(2008-10#1)
to move##40##2##(1992-2#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-1#2)(1997-4#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-3#1)(2013-1#1)
to moving##3##2##(2008-8#3)
to much higher##2##3##(1994-3#1)(1995-2#1)
to much##5##2##(1994-3#1)(1995-2#1)(2008-11#1)(2008-7#1)(2010-12#1)
to mucosa##2##2##(1990-9#1)(2008-5#1)
to multilayer##2##2##(2007-11#1)(2008-2#1)
to multiorgan##2##2##(2008-10#1)(2012-12#1)
to multiple sclerosis##2##3##(2008-11#1)(2010-12#1)
to multiple##40##2##(1992-11#1)(1992-3#1)(1995-2#1)(1995-8#1)(1996-2#2)(1997-4#1)(2006-10#1)(2007-11#4)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
to multiplex##3##2##(2008-2#2)(2008-3#1)
to multiplexing##2##2##(2008-4#1)(2012-2#1)
to multiply in##4##3##(1995-2#1)(2008-10#2)(2013-8#1)
to multiply the##2##3##(2008-3#1)(2009-10#1)
to multiply##11##2##(1993-2#1)(1995-2#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2013-8#1)
to multivariate analysis##2##3##(2008-10#1)(2008-7#1)
to multivariate##8##2##(2008-10#6)(2008-7#1)(2009-4#1)
to murine cyclin D3##2##4##(1997-4#2)
to murine##7##2##(1995-2#2)(1997-4#2)(2008-10#1)(2008-11#1)(2008-3#1)
to muscarinic##2##2##(1995-11#1)(1996-2#1)
to muscle fiber##2##3##(2010-4#2)
to muscle##11##2##(1996-5#1)(1997-8#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-4#2)(2010-8#1)(2012-1#1)
to music after implantation##2##4##(2008-9#2)
to music##10##2##(1991-12#1)(2007-6#6)(2008-9#3)
to mutagenic##5##2##(1990-6#2)(1993-11#1)(2008-7#1)(2011-1#1)
to mutant##2##2##(1991-8#1)(2011-2#1)
to mutation##8##2##(1990-8#1)(1994-5#1)(1997-3#3)(2008-9#1)(2012-2#2)
to mutations in the##2##4##(1994-11#1)(2008-11#1)
to mutations in##7##3##(1994-11#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-8#1)(2013-1#1)
to mutations##8##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2013-1#1)
to mutual##3##2##(1992-11#1)(2008-3#1)(2010-4#1)
to my knowledge##3##3##(2008-2#2)(2008-3#1)
to my##8##2##(1997-2#2)(2007-2#1)(2008-2#2)(2008-3#1)(2013-7#1)(2013-8#1)
to myelin##2##2##(1995-12#1)(2012-2#1)
to myocardial ischemia##2##3##(2008-7#1)(2010-5#1)
to myocardial##7##2##(1996-3#1)(1996-9#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
to n-3##2##2##(2013-1#2)
to naive##8##2##(1994-3#1)(1995-12#2)(2008-10#3)(2011-2#2)
to naked##3##2##(1992-12#1)(2010-5#1)(2013-1#1)
to nalidixic acid##2##3##(1995-8#1)(2012-3#1)
to name a few##3##4##(2008-7#1)(2008-9#1)(2009-3#1)
to name a##4##3##(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)
to name the##2##3##(1995-11#1)(2007-12#1)
to name##7##2##(1995-11#1)(2007-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)
to nanomolar concentrations of##2##4##(1990-12#1)(1994-6#1)
to nanoparticles##2##2##(2008-9#1)(2013-1#1)
to naringenin##3##2##(2008-11#3)
to narrow down the##2##4##(2008-8#1)(2011-2#1)
to narrow the##5##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
to narrow##11##2##(1993-12#1)(1997-1#2)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
to nasal##3##2##(1990-7#1)(1990-9#1)(2007-12#1)
to national norms and##2##4##(1996-2#1)(2010-3#1)
to national norms##4##3##(1994-3#2)(1996-2#1)(2010-3#1)
to national##13##2##(1994-3#4)(1996-2#1)(2007-11#1)(2008-10#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#3)
to native uPA##3##3##(2008-11#3)
to native##12##2##(1990-5#1)(1990-7#2)(1992-3#1)(1992-8#1)(1994-6#1)(2008-11#3)(2008-5#1)(2009-8#1)(2009-9#1)
to natural and##4##3##(1993-6#1)(2007-5#1)(2008-10#1)(2012-3#1)
to natural selection##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
to natural stimuli##2##3##(2008-7#2)
to natural water samples##2##4##(2008-10#2)
to natural##30##2##(1990-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#2)(1996-5#1)(1997-4#1)(2007-5#1)(2008-10#10)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
to naturally##2##2##(1991-9#1)(2008-7#1)
to nature##2##2##(2008-8#2)
to navigate##4##2##(1997-3#1)(2007-12#1)(2008-4#1)(2008-9#1)
to near homogeneity##12##3##(1990-5#2)(1990-8#1)(1991-2#2)(1991-5#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-4#1)(2012-2#1)
to near zero##3##3##(2008-10#2)(2008-9#1)
to near##25##2##(1990-5#2)(1990-8#1)(1991-2#3)(1991-5#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#2)
to near-infrared##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
to nearby##3##2##(1991-2#1)(1993-9#1)(2008-8#1)
to nearly 1##2##3##(2007-11#1)(2007-12#1)
to nearly##10##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)
to necrosis##4##2##(1996-5#1)(2008-10#3)
to necrotic##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
to necrotrophic##2##2##(2008-10#2)
to need##3##2##(2007-12#1)(2010-10#1)(2012-2#1)
to negate##2##2##(1994-9#1)(2013-1#1)
to negative##16##2##(1990-11#1)(1990-8#1)(1992-6#1)(1996-2#2)(1996-7#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-4#1)(2012-12#1)(2013-1#1)
to negatively charged##2##3##(1993-3#1)(2008-10#1)
to negatively regulate##2##3##(1995-6#1)(2013-1#1)
to negatively##8##2##(1993-3#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
to negligible##3##2##(1992-8#1)(2008-11#1)(2010-8#1)
to negotiate##2##2##(1994-1#1)(1996-5#1)
to neighboring cells##3##3##(2008-10#2)(2008-4#1)
to neighboring##5##2##(2008-10#3)(2008-4#1)(2008-5#1)
to neighbors##4##2##(2008-8#4)
to neoadjuvant##9##2##(1993-11#1)(2007-8#1)(2010-12#2)(2010-7#1)(2013-8#4)
to neonatal##6##2##(1997-2#1)(2008-11#3)(2011-1#2)
to neoplasia##3##2##(1992-9#1)(1997-3#1)(2011-1#1)
to neoplastic transformation##2##3##(1992-2#1)(2010-3#1)
to nephrology##2##2##(2008-1#2)
to nerve##3##2##(2008-11#2)(2008-6#1)
to nest##3##2##(2008-8#2)(2008-9#1)
to net##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
to neural and##2##3##(2007-8#1)(2013-8#1)
to neural##15##2##(1990-5#1)(1990-9#1)(1993-6#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#2)
to neurite##3##2##(1992-6#1)(1995-11#2)
to neurodegenerative disorders##3##3##(2008-7#1)(2009-8#1)(2010-11#1)
to neurodegenerative##5##2##(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)
to neurofilament##2##2##(1991-1#1)(1996-5#1)
to neurological##3##2##(1997-6#1)(2011-2#1)(2011-7#1)
to neuronal cell death##2##4##(1995-12#1)(2009-12#1)
to neuronal##10##2##(1994-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(2007-12#1)(2008-7#2)(2009-12#1)(2011-2#1)
to neurons and##2##3##(1990-11#1)(2008-11#1)
to neurons##6##2##(1990-11#1)(2008-11#3)(2008-4#1)(2012-12#1)
to neuropathic pain##2##3##(2008-12#1)(2010-4#1)
to neurosurgeons##2##2##(2008-7#1)(2013-1#1)
to neutral##6##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2012-3#1)
to neutralize HF in the microwave-assisted acid dissolution of ceramic glazes for their chemical analysis##2##15##(2008-10#2)
to neutralize the##3##3##(1995-11#1)(2008-5#2)
to neutralize##7##2##(1995-11#1)(2008-10#3)(2008-5#2)(2012-12#1)
to new and##2##3##(2009-12#1)(2011-1#1)
to new applications##2##3##(2008-3#1)(2008-9#1)
to new heterocyclic##2##3##(2007-11#1)(2012-3#1)
to new technologies##2##3##(2008-10#1)(2008-6#1)
to new therapeutic##4##3##(2008-1#1)(2010-5#1)(2011-2#1)(2012-2#1)
to new therapies##3##3##(2008-11#1)(2008-6#2)
to new##63##2##(1990-6#1)(1992-1#1)(1992-6#1)(1993-2#1)(1995-3#1)(1995-9#1)(1996-3#3)(1997-3#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-8#3)
to newborn##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
to ng/mL##2##2##(1993-1#1)(2012-12#1)
to nickel##3##2##(2008-10#3)
to nicotine and##4##3##(1990-7#1)(2008-5#1)(2009-6#1)(2011-2#1)
to nicotine##8##2##(1990-7#1)(1995-12#3)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
to nicotinic receptors##3##3##(1996-12#3)
to nicotinic##4##2##(1996-12#3)(2008-5#1)
to night temperatures##2##3##(2012-5#2)
to nil##2##2##(2008-10#1)(2008-12#1)
to nine##17##2##(1991-5#1)(1996-12#2)(1996-9#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
to nipple feeding##4##3##(2010-5#4)
to nitrate##7##2##(1992-6#2)(2008-10#5)
to nitric acid##2##3##(2008-10#2)
to nitric oxide (NO)##2##4##(2008-10#2)
to nitric oxide##6##3##(1991-9#1)(1993-8#1)(1994-6#1)(2008-10#3)
to nitric##8##2##(1991-9#1)(1993-8#1)(1994-6#1)(2008-10#5)
to nitrite in##2##3##(1993-11#1)(2008-10#1)
to nitrite##13##2##(1993-11#1)(2008-10#12)
to nitrogen dioxide##2##3##(2008-10#2)
to nitrogen##6##2##(1990-2#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-7#1)
to no response##2##3##(1992-6#1)(2007-7#1)
to no##14##2##(1991-6#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
to noise and##4##3##(2007-12#1)(2008-3#3)
to noise ratio of##4##4##(2008-10#2)(2008-7#1)(2011-1#1)
to noise ratio##11##3##(2008-10#7)(2008-7#1)(2008-9#1)(2011-1#2)
to noise##32##2##(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2008-9#3)(2010-8#1)(2011-1#2)(2013-1#1)
to non##2##2##(1996-12#1)(2008-10#1)
to non-availability of##2##3##(2008-7#1)(2010-10#1)
to non-compliance##2##2##(1996-3#1)(2011-2#1)
to non-destructive##2##2##(2008-10#1)(2011-1#1)
to non-hospital sites##2##3##(1996-1#2)
to non-host##2##2##(2007-12#1)(2009-6#1)
to non-invasively image##2##3##(2009-12#1)(2012-3#1)
to non-invasively##4##2##(2008-7#1)(2009-12#1)(2010-12#1)(2012-3#1)
to non-linear##2##2##(2008-10#1)(2008-11#1)
to non-polar##3##2##(2008-10#1)(2009-12#1)(2009-7#1)
to non-pregnant##2##2##(1993-12#1)(2007-2#1)
to non-specific##3##2##(1993-12#1)(1994-2#1)(2008-10#1)
to nonhuman##2##2##(2007-8#1)(2009-2#1)
to noninvasive##2##2##(2008-2#1)(2008-3#1)
to noninvasively##2##2##(2010-8#1)(2012-2#1)
to nonionic##3##2##(2008-10#2)(2008-11#1)
to nonlinear##6##2##(2008-10#1)(2008-3#4)(2008-7#1)
to nonprofit##2##2##(1993-1#1)(1996-2#1)
to nontransgenic##2##2##(1995-2#1)(2008-10#1)
to noradrenaline##2##2##(1990-5#1)(1997-4#1)
to normal after##2##3##(1990-7#1)(2013-1#1)
to normal and##3##3##(1995-12#1)(2008-4#1)(2011-2#1)
to normal breast##2##3##(1990-12#1)(1993-11#1)
to normal cells##2##3##(2009-10#1)(2012-3#1)
to normal controls##3##3##(1995-12#2)(2008-11#1)
to normal fibroblasts##2##3##(1992-8#2)
to normal human##4##3##(1994-8#1)(2008-11#1)(2008-5#1)(2010-3#1)
to normal in##4##3##(1990-11#1)(1991-5#1)(1993-11#1)(1993-3#1)
to normal levels##4##3##(1993-12#1)(1993-6#1)(1994-6#1)(2011-2#1)
to normal skin##3##3##(2008-5#3)
to normal tissue##2##3##(2008-2#1)(2010-3#1)
to normal values##5##3##(1993-6#1)(1994-3#1)(2007-8#1)(2008-12#1)(2013-1#1)
to normal within##4##3##(1992-3#1)(1992-5#1)(1993-12#1)(1996-6#1)
to normal##106##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-7#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#3)(1996-2#2)(1996-6#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
to normalise##2##2##(1991-5#1)(1995-3#1)
to normalization of##2##3##(2012-1#1)(2013-1#1)
to normalization##3##2##(2008-7#1)(2012-1#1)(2013-1#1)
to normalize the results##2##4##(2008-10#1)(2008-3#1)
to normalize the##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
to normalize##11##2##(1991-7#1)(1993-1#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
to normotensives##2##2##(2009-5#1)(2012-2#1)
to normoxia##2##2##(1994-5#1)(1996-12#1)
to northern##2##2##(1996-4#1)(2008-10#1)
to not##5##2##(1990-2#1)(1994-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
to note that the##2##4##(1995-11#1)(2008-4#1)
to note that##7##3##(1995-11#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#1)
to note##12##2##(1992-2#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
to novel methods##2##3##(2007-12#1)(2008-10#1)
to novel##16##2##(1991-9#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
to novelty##4##2##(1993-5#1)(1993-6#3)
to now##16##2##(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#3)
to noxious stimuli##2##3##(1997-2#1)(2008-4#1)
to noxious##5##2##(1997-2#2)(2008-4#1)(2008-7#2)
to nuclear##5##2##(1993-2#1)(1994-9#1)(2007-11#1)(2011-2#2)
to nucleases##2##2##(2008-11#1)(2008-4#1)
to nucleic acid##2##3##(2008-4#1)(2008-9#1)
to nucleic acids##3##3##(1991-8#1)(2008-4#2)
to nucleic##5##2##(1991-8#1)(2008-4#3)(2008-9#1)
to nucleoside##3##2##(1991-5#1)(1994-8#1)(1996-2#1)
to nucleotide##6##2##(1993-11#2)(1996-12#1)(1997-8#1)(2008-10#1)(2008-9#1)
to nucleus##7##2##(1991-2#2)(2007-11#1)(2008-8#1)(2008-9#3)
to null##2##2##(2007-11#1)(2008-3#1)
to number of##3##3##(2008-10#2)(2008-5#1)
to number##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
to numerical##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
to numerous##9##2##(1994-8#1)(1997-1#1)(2007-11#1)(2008-10#2)(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
to nurse education##2##3##(2008-11#1)(2008-12#1)
to nurse##7##2##(1994-2#1)(2008-11#2)(2008-12#1)(2012-3#1)(2013-8#2)
to nurses and##4##3##(2007-10#1)(2008-7#1)(2013-1#2)
to nurses##7##2##(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#2)
to nursing education##3##3##(1996-3#1)(2008-1#1)(2010-3#1)
to nursing home##2##3##(1993-12#1)(2008-11#1)
to nursing homes##5##3##(1990-12#1)(1994-12#2)(1994-2#1)(1995-1#1)
to nursing##27##2##(1990-12#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-9#1)(1996-3#1)(2007-10#3)(2008-1#2)(2008-11#4)(2008-12#4)(2010-3#2)(2011-2#1)(2013-8#1)
to nutrient##6##2##(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#1)
to nutrients##2##2##(2008-10#1)(2008-9#1)
to nutrition##3##2##(2010-5#1)(2010-8#1)(2013-8#1)
to nutritional##2##2##(1993-9#1)(2012-2#1)
to nystatin##2##2##(2008-5#2)
to obese##3##2##(2007-12#2)(2010-10#1)
to obesity##8##2##(2008-1#2)(2008-10#1)(2008-3#1)(2009-11#1)(2010-10#1)(2011-1#2)
to object##3##2##(1992-10#1)(2008-11#1)(2008-3#1)
to objectify##2##2##(1990-9#1)(2010-3#1)
to objectively assess patients'##2##4##(2008-11#1)(2009-1#1)
to objectively quantify##2##3##(2008-11#1)(2010-7#1)
to objectively##7##2##(2007-10#1)(2008-11#2)(2009-1#1)(2010-7#1)(2012-1#1)(2012-3#1)
to objects##2##2##(2008-2#1)(2011-2#1)
to obliterate##2##2##(2007-8#1)(2008-7#1)
to obscure##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
to observation##2##2##(2008-10#1)(2008-8#1)
to observe a##3##3##(1997-4#1)(2008-3#1)(2008-8#1)
to observe and##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)
to observe that##2##3##(1992-6#1)(2008-11#1)
to observe the effect of##2##5##(2008-12#1)(2008-4#1)
to observe the effect##4##4##(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
to observe the effects of##3##5##(2008-9#1)(2011-2#2)
to observe the presence##2##4##(2007-10#1)(2008-10#1)
to observe the##37##3##(1991-8#1)(1994-8#1)(1997-8#1)(2007-10#2)(2008-1#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#1)
to observe their##2##3##(2009-10#1)(2009-4#1)
to observe##76##2##(1991-8#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-3#2)(2013-1#4)
to observed##6##2##(1995-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
to obstruction of the##2##4##(1991-11#1)(2008-1#1)
to obstruction of##3##3##(1991-11#1)(2008-1#1)(2012-12#1)
to obstruction##4##2##(1991-11#1)(2008-1#1)(2008-10#1)(2012-12#1)
to obtain 0##3##3##(1992-11#1)(2008-10#1)(2008-2#1)
to obtain PCR##2##3##(1993-6#1)(2008-10#1)
to obtain a comprehensive##2##4##(1993-1#1)(2008-4#1)
to obtain a direct##2##4##(2008-7#1)(2009-12#1)
to obtain a given##2##4##(1995-9#1)(2008-10#1)
to obtain a good##3##4##(2008-2#1)(2008-9#1)(2013-1#1)
to obtain a high##2##4##(2008-11#1)(2008-3#1)
to obtain a homogeneous##3##4##(2008-10#2)(2009-7#1)
to obtain a quantitative##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
to obtain a reliable##2##4##(2008-10#2)
to obtain a result##3##4##(1991-3#3)
to obtain a stable##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
to obtain a suitable##2##4##(2008-10#2)
to obtain a three-dimensional##2##4##(2008-3#1)(2013-1#1)
to obtain a two-dimensional##2##4##(2007-11#1)(2008-2#1)
to obtain a unique solution##2##5##(1997-8#1)(2008-3#1)
to obtain a##102##3##(1991-2#2)(1991-3#3)(1991-5#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#8)(2008-3#11)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
to obtain accurate and precise##2##5##(2008-10#1)(2008-3#1)
to obtain accurate estimates##2##4##(2008-10#1)(2008-4#1)
to obtain accurate results##3##4##(2008-10#3)
to obtain accurate##11##3##(1990-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
to obtain an appropriate##2##4##(2008-10#1)(2011-2#1)
to obtain an improvement##2##4##(1991-2#1)(2008-10#1)
to obtain an##28##3##(1991-2#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-7#1)(2011-2#3)(2012-2#1)
to obtain and##2##3##(1996-3#1)(2008-5#1)
to obtain approval##2##3##(2008-8#1)(2008-9#1)
to obtain basic##2##3##(1995-1#1)(2011-2#1)
to obtain better##6##3##(1997-7#1)(2008-10#3)(2008-7#1)(2012-3#1)
to obtain both##2##3##(2008-10#1)(2008-2#1)
to obtain by##3##3##(1991-2#1)(2008-10#1)(2008-2#1)
to obtain correct##2##3##(2007-2#1)(2011-2#1)
to obtain definitive##2##3##(1992-12#1)(2011-2#1)
to obtain enough##2##3##(1996-2#1)(2008-11#1)
to obtain extract##3##3##(2008-11#3)
to obtain feedback from##4##4##(2013-1#4)
to obtain free##2##3##(2008-10#1)(2008-4#1)
to obtain full##2##3##(2008-10#1)(2008-6#1)
to obtain good##4##3##(1990-5#1)(2008-10#1)(2008-9#1)(2010-7#1)
to obtain high##8##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
to obtain higher##2##3##(2008-10#1)(2008-2#1)
to obtain human##2##3##(2008-11#1)(2010-12#1)
to obtain information about the##2##5##(2008-3#1)(2008-7#1)
to obtain information about##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
to obtain information on the##4##5##(1997-3#1)(2008-3#1)(2008-4#1)(2011-2#1)
to obtain information on##7##4##(1991-1#1)(1997-3#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
to obtain information##13##3##(1991-1#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2011-2#1)
to obtain insights into the##2##5##(2008-7#1)(2011-2#1)
to obtain its##2##3##(1991-2#1)(2009-3#1)
to obtain maximum sensitivity##2##4##(2008-10#2)
to obtain maximum##6##3##(2008-10#3)(2008-4#2)(2008-9#1)
to obtain milligram amounts of enzymatically active##2##7##(2008-4#2)
to obtain monoclonal##2##3##(2007-10#1)(2008-9#1)
to obtain more accurate##2##4##(1993-12#1)(1996-2#1)
to obtain more information about##2##5##(1995-5#1)(2008-6#1)
to obtain more##7##3##(1993-12#1)(1995-5#1)(1996-2#1)(2007-8#1)(2008-6#1)(2009-4#1)(2010-1#1)
to obtain new##4##3##(2007-11#1)(2008-8#1)(2010-12#1)(2011-3#1)
to obtain optimal##2##3##(1992-12#1)(2009-4#1)
to obtain optimum##2##3##(2008-10#1)(2008-3#1)
to obtain particular##2##3##(2008-10#1)(2008-4#1)
to obtain preliminary##2##3##(2013-7#2)
to obtain pure##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
to obtain qualitative##2##3##(2007-11#1)(2008-10#1)
to obtain quantitative##5##3##(1990-5#1)(2008-10#4)
to obtain relevant##2##3##(1993-3#1)(1997-6#1)
to obtain reliable##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
to obtain some##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
to obtain the Raman##2##4##(2008-2#1)(2008-3#1)
to obtain the absorption##2##4##(2008-3#1)(2012-2#1)
to obtain the analytical##3##4##(2007-11#1)(2008-10#2)
to obtain the average##2##4##(2008-2#1)(2008-7#1)
to obtain the best##3##4##(1990-10#1)(2008-10#2)
to obtain the better##3##4##(2008-10#2)(2010-8#1)
to obtain the calibration##2##4##(2008-10#1)(2008-5#1)
to obtain the corresponding##2##4##(2008-10#1)(2010-7#1)
to obtain the maximum##4##4##(2008-10#4)
to obtain the optimum##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2013-1#1)
to obtain the relevant##2##4##(1995-5#1)(2008-9#1)
to obtain the required##2##4##(1993-12#1)(2008-2#1)
to obtain the##100##3##(1990-10#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-5#1)(2007-10#2)(2007-11#4)(2007-12#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to obtain their##2##3##(1994-1#1)(2008-10#1)
to obtain three-dimensional##2##3##(1996-12#1)(2012-12#1)
to obtain tissue##2##3##(1992-12#1)(2008-3#1)
to obtain total##2##3##(1992-11#1)(2008-10#1)
to obtain valuable information##2##4##(1990-12#1)(2008-10#1)
to obtain valuable##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
to obtain##569##2##(1990-10#1)(1990-12#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#4)(1991-5#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#4)(1995-6#4)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#4)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-12#1)(2006-6#1)(2007-10#5)(2007-11#14)(2007-12#13)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#135)(2008-11#19)(2008-12#8)(2008-2#39)(2008-3#53)(2008-4#19)(2008-5#21)(2008-6#5)(2008-7#12)(2008-8#10)(2008-9#17)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#2)(2011-2#20)(2011-3#1)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#14)(2013-7#2)(2013-8#5)
to obtaining positive samples from the##2##6##(2010-6#2)
to obtaining##5##2##(2007-12#1)(2009-12#1)(2010-6#2)(2012-2#1)
to obviate##2##2##(1991-3#1)(2011-2#1)
to occasional##2##2##(1995-5#1)(2010-9#1)
to occlude##4##2##(1997-3#1)(2006-12#1)(2008-7#1)(2010-5#1)
to occupational##5##2##(1995-3#1)(1997-5#1)(2009-4#1)(2010-9#1)(2013-1#1)
to occupy a##3##3##(1994-2#1)(2006-10#1)(2008-9#1)
to occupy##7##2##(1994-2#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
to occur after##2##3##(1990-7#1)(2009-3#1)
to occur among##2##3##(2009-5#1)(2010-6#1)
to occur and##2##3##(2007-10#1)(2008-10#1)
to occur as##2##3##(2008-11#1)(2008-5#1)
to occur at a##2##4##(1995-3#1)(2008-5#1)
to occur at an##2##4##(1992-12#1)(2007-11#1)
to occur at##5##3##(1990-5#1)(1992-12#1)(1995-3#1)(2007-11#1)(2008-5#1)
to occur by##3##3##(1993-9#1)(1994-2#1)(2008-7#1)
to occur following##2##3##(2008-11#1)(2013-1#1)
to occur for##2##3##(2007-12#1)(2013-8#1)
to occur if##2##3##(2008-10#1)(2008-8#1)
to occur in a##5##4##(1997-7#1)(2007-8#1)(2008-10#2)(2009-8#1)
to occur in the##8##4##(1993-12#1)(1995-10#1)(2008-10#2)(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#1)
to occur in##34##3##(1990-11#1)(1990-6#1)(1991-12#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-7#4)(2008-8#3)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
to occur through##3##3##(1990-7#1)(1994-8#1)(2008-10#1)
to occur throughout the##2##4##(2008-10#2)
to occur when##6##3##(1991-6#1)(1995-3#2)(1996-11#1)(2008-5#1)(2012-12#1)
to occur with##7##3##(1990-11#2)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)
to occur##113##2##(1990-11#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-10#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#2)
to occurrence of##3##3##(1997-4#1)(1997-8#1)(2010-3#1)
to octopamine##2##2##(2008-7#2)
to off-axis##2##2##(2007-12#1)(2008-3#1)
to offer a##8##3##(1991-3#1)(1993-2#1)(1993-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
to offer an##3##3##(1994-12#1)(1994-9#1)(2009-3#1)
to offer some##2##3##(2010-8#1)(2011-3#1)
to offer students##2##3##(1993-12#1)(2008-11#1)
to offer the most##2##4##(1995-3#1)(2011-2#1)
to offer the##4##3##(1995-3#1)(1996-6#1)(2008-2#1)(2011-2#1)
to offer this##2##3##(1992-9#1)(1997-8#1)
to offer to the##2##4##(1991-6#1)(2008-7#1)
to offer to##3##3##(1991-6#1)(2008-7#1)(2009-5#1)
to offer##64##2##(1991-2#1)(1991-3#2)(1991-6#3)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#9)(2008-8#1)(2009-11#1)(2009-3#2)(2009-5#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
to offset a##2##3##(1992-12#1)(1994-3#1)
to offset##4##2##(1992-12#1)(1994-3#1)(2008-10#1)(2008-4#1)
to offspring##4##2##(2007-12#1)(2008-9#2)(2012-2#1)
to ofloxacin##2##2##(2007-7#1)(2008-5#1)
to oil##2##2##(2008-10#2)
to olanzapine##2##2##(2010-2#2)
to older ages##2##3##(2009-7#2)
to older people##5##3##(2008-5#1)(2008-6#1)(2010-10#2)(2013-8#1)
to older##17##2##(1991-12#1)(1992-1#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#2)(2010-10#2)(2011-1#1)(2011-2#1)(2013-8#1)
to oligonucleotides##2##2##(1995-2#1)(2008-4#1)
to olive##2##2##(2008-10#2)
to on##2##2##(2008-11#1)(2008-5#1)
to on-line##6##2##(2008-10#6)
to once weekly##2##3##(2007-12#1)(2008-7#1)
to once-daily##2##2##(1992-8#1)(2010-4#1)
to one another in##2##4##(2007-12#1)(2008-10#1)
to one another##15##3##(1990-11#1)(1992-9#1)(1995-6#1)(1996-2#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)
to one in which they##2##5##(1995-8#1)(2008-8#1)
to one in which##3##4##(1991-9#1)(1995-8#1)(2008-8#1)
to one major##2##3##(2008-5#1)(2008-6#1)
to one molecule##2##3##(1990-9#1)(2008-8#1)
to one month##3##3##(2007-2#1)(2012-2#2)
to one of four groups##3##5##(1992-1#1)(2011-2#2)
to one of four##5##4##(1992-1#1)(2008-9#1)(2011-2#2)(2012-9#1)
to one of the three groups##3##6##(2007-6#1)(2008-12#1)(2013-8#1)
to one of the two##3##5##(2008-12#1)(2008-5#1)(2010-4#1)
to one of the##21##4##(1995-3#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
to one of three##4##4##(1991-1#1)(1994-3#1)(2008-4#1)(2010-11#1)
to one of two##4##4##(2007-12#1)(2008-9#1)(2010-4#1)(2011-1#1)
to one of##41##3##(1991-1#1)(1992-1#1)(1994-3#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-7#2)(2013-8#1)
to one or both##2##4##(2008-10#2)
to one or more of the##3##6##(1992-5#1)(1995-2#1)(2008-10#1)
to one or more##8##4##(1992-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#2)
to one or##11##3##(1992-5#1)(1995-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#2)
to one patient##3##3##(1993-5#1)(2008-5#1)(2010-5#1)
to one side of the##2##5##(2008-10#1)(2008-2#1)
to one side of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
to one third of##3##4##(1993-6#1)(2007-7#1)(2008-12#1)
to one third##4##3##(1993-6#1)(2007-7#1)(2008-10#1)(2008-12#1)
to one week after##2##4##(2008-7#1)(2008-8#1)
to one week##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
to one where##2##3##(2008-7#1)(2010-10#1)
to one year##3##3##(1991-9#1)(1996-1#1)(1997-5#1)
to one##138##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#3)
to one's##2##2##(1994-12#1)(2008-11#1)
to one-fourth of##2##3##(1990-5#1)(2008-6#1)
to one-half of##2##3##(2008-10#1)(2008-4#1)
to onion##3##2##(2008-10#3)
to only a few##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
to only a##5##3##(1992-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
to only one of the##2##5##(2008-10#1)(2008-7#1)
to only one of##3##4##(1991-2#1)(2008-10#1)(2008-7#1)
to only one##7##3##(1990-8#1)(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
to only partially##2##3##(1994-6#1)(2010-3#1)
to only##32##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-10#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
to onset of##6##3##(1992-6#1)(1993-12#2)(1997-2#1)(2008-10#1)(2012-3#1)
to oocyte##2##2##(2012-2#1)(2012-3#1)
to oocytes##2##2##(2008-4#1)(2009-7#1)
to open##18##2##(1994-3#2)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
to operate and##5##3##(1996-2#1)(2008-10#3)(2008-11#1)
to operate at##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-2#1)
to operate in a##2##4##(1997-1#1)(2007-8#1)
to operate in the##2##4##(2008-2#1)(2008-4#1)
to operate in##9##3##(1997-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
to operate the BFNF##2##4##(2008-3#2)
to operate to##2##3##(1994-3#1)(2008-10#1)
to operate under##2##3##(2008-11#1)(2008-3#1)
to operate with##4##3##(1993-9#1)(2007-5#1)(2008-3#2)
to operate##50##2##(1991-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
to operating##2##2##(2007-11#2)
to operation in##2##3##(1990-3#1)(2008-2#1)
to operation##4##2##(1990-3#1)(2008-11#1)(2008-2#1)(2008-7#1)
to operational##2##2##(1991-1#1)(1994-3#1)
to operationalize##3##2##(1991-12#1)(1996-1#1)(2008-1#1)
to operative##2##2##(2007-11#1)(2009-3#1)
to opioid##3##2##(2008-6#1)(2009-7#2)
to opium poppy##3##3##(2008-10#3)
to oppose##3##2##(1997-6#1)(2008-11#1)(2012-3#1)
to opposite##2##2##(1994-11#1)(1997-7#1)
to optic##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)
to optical##17##2##(2007-11#2)(2007-12#3)(2008-2#9)(2008-3#2)(2008-7#1)
to optically##5##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
to optics##2##2##(2007-11#1)(2008-3#1)
to optimal conditions for##2##4##(2008-10#2)
to optimal##8##2##(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
to optimally##4##2##(1993-11#1)(1993-12#1)(2008-4#1)(2008-7#1)
to optimise the reaction conditions##2##5##(2008-10#2)
to optimise the##7##3##(1993-2#1)(1996-12#1)(2008-10#5)
to optimise these##2##3##(2008-10#1)(2008-11#1)
to optimise##18##2##(1990-3#1)(1993-2#1)(1996-12#1)(2007-11#2)(2008-10#9)(2008-11#3)(2008-7#1)
to optimization of##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
to optimization##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)
to optimize a##2##3##(2008-10#1)(2008-7#1)
to optimize and##2##3##(2008-10#1)(2009-1#1)
to optimize conditions for##2##4##(2008-11#1)(2008-4#1)
to optimize conditions##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
to optimize its##2##3##(2007-11#1)(2008-10#1)
to optimize long-term outcomes##2##4##(2009-8#2)
to optimize management##2##3##(2008-10#1)(2013-1#1)
to optimize the care##2##4##(2008-1#1)(2010-8#1)
to optimize the conditions for the##3##6##(2008-10#3)
to optimize the conditions for##10##5##(2008-10#10)
to optimize the conditions##11##4##(2008-10#11)
to optimize the design of##2##5##(2008-8#1)(2011-2#1)
to optimize the design##3##4##(2008-3#1)(2008-8#1)(2011-2#1)
to optimize the detection##2##4##(1996-5#1)(2008-3#1)
to optimize the extraction##3##4##(2008-10#3)
to optimize the system##2##4##(2008-10#1)(2008-9#1)
to optimize the##76##3##(1993-11#1)(1993-5#1)(1996-5#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#32)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2010-10#1)(2010-8#1)(2011-2#5)(2013-7#1)
to optimize their##4##3##(1990-7#1)(1992-10#1)(1993-5#1)(2008-11#1)
to optimize treatment##2##3##(2006-10#1)(2008-5#1)
to optimize##152##2##(1990-7#1)(1992-10#1)(1993-11#1)(1993-5#2)(1995-1#1)(1995-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#46)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#2)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#8)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
to optimizing the##3##3##(2008-3#1)(2012-1#1)(2013-1#1)
to optimizing transfection##2##3##(2008-1#2)
to optimizing##9##2##(1993-3#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#1)(2013-1#1)
to or from##3##3##(1993-12#1)(2008-11#1)(2008-2#1)
to or greater than that##2##5##(1990-12#1)(2008-10#1)
to or greater than##4##4##(1990-12#1)(1991-2#1)(2008-10#1)(2008-8#1)
to or higher than##2##4##(1992-9#1)(2008-11#1)
to or intolerant of##2##4##(2012-1#1)(2012-3#1)
to or larger than##3##4##(1995-9#1)(2007-11#1)(2008-8#1)
to or less than##2##4##(2008-10#1)(2008-2#1)
to or near the##2##4##(2008-10#1)(2008-5#1)
to or smaller##2##3##(2007-11#1)(2013-1#1)
to or##38##2##(1990-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
to oral corticosteroids##2##3##(2006-10#1)(2008-11#1)
to oral hygiene##2##3##(2011-1#2)
to oral##16##2##(1992-11#1)(1993-1#1)(1994-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
to orchestrate##3##2##(2007-12#1)(2008-1#1)(2008-9#1)
to order##4##2##(1995-12#1)(1995-6#1)(2008-11#1)(2008-3#1)
to ordinary##4##2##(1995-3#1)(2008-1#1)(2008-10#2)
to organ##5##2##(1992-1#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
to organ-specific##2##2##(1994-5#1)(2008-4#1)
to organelle##2##2##(2008-2#1)(2011-2#1)
to organic amine##2##3##(2008-10#2)
to organic matter and##2##4##(2008-10#1)(2011-2#1)
to organic matter##4##3##(2008-10#3)(2011-2#1)
to organic solvents##4##3##(1990-8#2)(2008-10#1)(2011-1#1)
to organic##21##2##(1990-8#2)(1993-6#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
to organisms##2##2##(2008-11#1)(2008-8#1)
to organizational and##2##3##(1992-1#1)(1993-2#1)
to organizational##7##2##(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1996-2#1)
to organize the##6##3##(1997-7#1)(2008-1#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
to organize their##2##3##(1991-3#1)(2009-4#1)
to organize##19##2##(1991-3#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
to organizing##3##2##(1997-1#1)(2008-12#1)(2010-8#1)
to organs##2##2##(2012-3#1)(2013-1#1)
to orient the##2##3##(1990-7#1)(1993-3#1)
to orient to##2##3##(2011-2#2)
to orient##4##2##(1990-7#1)(1993-3#1)(2011-2#2)
to originate from##7##3##(2007-10#1)(2007-11#1)(2008-10#3)(2008-7#1)(2011-2#1)
to originate in the##2##4##(1997-4#1)(2008-3#1)
to originate##9##2##(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
to orphan##2##2##(1995-12#1)(2008-4#1)
to orthodontic##2##2##(2010-3#1)(2013-7#1)
to orthopedic##2##2##(2010-3#1)(2012-2#1)
to oscillate##3##2##(1990-2#1)(2007-12#1)(2008-3#1)
to oscillations##2##2##(1990-8#1)(1991-5#1)
to osmotic stress##4##3##(1997-8#1)(2008-7#2)(2009-8#1)
to osmotic##6##2##(1997-8#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)
to osteochondral##2##2##(2007-11#1)(2008-6#1)
to osteomyelitis##2##2##(2010-6#2)
to osteoporosis##6##2##(1993-11#1)(2007-11#2)(2008-12#1)(2008-7#1)(2008-8#1)
to other CARICOMP sites##3##4##(2011-2#3)
to other European countries##2##4##(2007-8#1)(2008-7#1)
to other anions##2##3##(2008-10#2)
to other antigens##2##3##(1995-5#1)(2012-12#1)
to other antihypertensive drugs##2##4##(2008-3#1)(2008-8#1)
to other antioxidants##2##3##(2008-10#1)(2013-8#1)
to other approaches##2##3##(1995-1#1)(2008-3#1)
to other areas##2##3##(2007-5#1)(2008-3#1)
to other causes##2##3##(1993-6#1)(2008-8#1)
to other countries##4##3##(2007-6#1)(2008-12#2)(2010-11#1)
to other databases##2##3##(2008-4#1)(2008-8#1)
to other disciplines##2##3##(1994-12#1)(2008-12#1)
to other diseases##5##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(2012-3#1)
to other eukaryotic##2##3##(1997-6#1)(2008-9#1)
to other forms of##2##4##(2008-11#1)(2012-3#1)
to other groups##3##3##(1992-5#1)(2008-10#1)(2012-2#1)
to other imaging##2##3##(2008-8#1)(2011-2#1)
to other important##2##3##(1992-3#1)(2008-10#1)
to other known proteins##3##4##(1993-6#1)(1995-2#1)(1997-2#1)
to other known##9##3##(1993-11#1)(1993-6#1)(1995-2#2)(1995-8#1)(1996-12#2)(1996-6#1)(1997-2#1)
to other medical##3##3##(1996-1#1)(2008-5#1)(2013-8#1)
to other members of this family##2##6##(1996-12#1)(2010-3#1)
to other members of##3##4##(1996-12#1)(2008-4#1)(2010-3#1)
to other metal cations##2##4##(2008-10#2)
to other methods##2##3##(2007-11#1)(2008-10#1)
to other models##2##3##(2008-10#1)(2009-6#1)
to other organisms##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
to other organs##2##3##(2008-5#1)(2008-7#1)
to other parts of##5##4##(2007-12#1)(2008-12#1)(2010-11#1)(2011-1#2)
to other physical##2##3##(1996-6#1)(2008-10#1)
to other plant##2##3##(2008-10#1)(2008-9#1)
to other plants##3##3##(2013-1#2)(2013-8#1)
to other populations##2##3##(2008-11#1)(2008-8#1)
to other problems##2##3##(2008-2#1)(2008-7#1)
to other proteins##3##3##(1991-4#1)(1994-9#1)(2008-5#1)
to other reported##4##3##(1990-7#1)(1992-8#1)(2007-2#1)(2008-10#1)
to other species##6##3##(1993-6#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-8#1)
to other statins##2##3##(2008-5#2)
to other strains##2##3##(1993-2#1)(2008-10#1)
to other studies##5##3##(1993-11#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
to other techniques for##2##4##(2008-2#1)(2008-9#1)
to other techniques##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
to other treatments##2##3##(2008-10#1)(2012-3#1)
to other types of##11##4##(1990-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-8#2)(2011-2#1)
to other viruses##3##3##(1997-6#1)(2008-10#2)
to other##375##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-4#1)(1991-5#3)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-2#1)(1993-6#5)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#5)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#3)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#3)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#6)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#56)(2008-11#13)(2008-12#9)(2008-2#10)(2008-3#14)(2008-4#9)(2008-5#19)(2008-6#2)(2008-7#12)(2008-8#13)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#11)(2010-9#1)(2011-1#7)(2011-2#15)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#7)
to others##16##2##(1990-2#1)(1991-8#1)(1995-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
to our attention##2##3##(1991-3#1)(2008-10#1)
to our centre##2##3##(2010-10#1)(2011-1#1)
to our criteria##2##3##(2007-8#1)(2008-10#1)
to our department for##2##4##(2012-3#1)(2013-7#1)
to our department##8##3##(1997-8#1)(2008-12#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
to our experience##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
to our facility##5##3##(1992-6#2)(1994-12#1)(2013-8#2)
to our findings##2##3##(1995-12#1)(2007-8#1)
to our hospital because of##3##5##(2008-1#1)(2008-7#1)(2012-2#1)
to our hospital because##4##4##(2008-1#2)(2008-7#1)(2012-2#1)
to our hospital for##8##4##(1991-12#1)(2008-1#2)(2011-2#2)(2013-8#3)
to our hospital with##5##4##(1993-6#1)(2007-10#1)(2008-1#1)(2011-2#1)(2012-12#1)
to our hospital##24##3##(1990-9#1)(1991-12#1)(1993-6#1)(2007-10#1)(2007-8#1)(2008-1#5)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#4)
to our institution##5##3##(2008-12#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
to our knowledge for the first time##3##7##(2008-10#1)(2008-2#1)(2008-3#1)
to our knowledge is##8##4##(2007-12#1)(2008-2#1)(2008-3#6)
to our knowledge of##2##4##(1995-5#1)(2009-8#1)
to our knowledge the first observation##4##6##(2007-11#3)(2007-12#1)
to our knowledge the first##38##5##(2007-11#13)(2007-12#18)(2008-10#1)(2008-2#3)(2008-3#3)
to our knowledge the shortest##2##5##(2007-12#2)
to our knowledge the##46##4##(2007-11#17)(2007-12#21)(2008-10#1)(2008-2#4)(2008-3#3)
to our knowledge this is the first##3##7##(1990-12#1)(1997-8#1)(2008-9#1)
to our knowledge##204##3##(1990-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-8#2)(2007-11#29)(2007-12#39)(2007-6#1)(2008-10#4)(2008-11#3)(2008-2#28)(2008-3#84)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
to our own##2##3##(1990-6#1)(1997-7#1)
to our patients##3##3##(2007-5#1)(2008-3#1)(2008-7#1)
to our previous##2##3##(2008-10#1)(2008-7#1)
to our study##5##3##(2007-11#1)(2008-5#1)(2011-7#2)(2012-12#1)
to our understanding of the##6##5##(2008-1#1)(2008-11#2)(2008-7#2)(2010-5#1)
to our understanding of##12##4##(1996-2#1)(2008-1#1)(2008-11#2)(2008-7#4)(2009-11#1)(2010-5#1)(2012-1#1)(2012-2#1)
to our##348##2##(1990-12#2)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#30)(2007-12#39)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#14)(2008-11#8)(2008-12#2)(2008-2#31)(2008-3#87)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#4)(2011-2#8)(2011-3#1)(2011-7#2)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#8)
to outbreaks##2##2##(2007-7#1)(2011-2#1)
to outcome##3##2##(1995-5#1)(1997-1#1)(2008-11#1)
to outcomes##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
to outdoor##4##2##(1996-3#2)(2008-10#1)(2012-3#1)
to outline the##8##3##(1992-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
to outline##13##2##(1992-12#1)(1994-5#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)
to outpatient##10##2##(1991-1#2)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1996-2#1)(2008-3#1)(2012-2#1)
to outperform##3##2##(1991-8#1)(2008-2#1)(2010-3#1)
to output##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
to outside agencies##2##3##(2007-2#2)
to outside##3##2##(2007-2#2)(2008-8#1)
to outsource##2##2##(1994-2#1)(2009-12#1)
to ovalbumin and##3##3##(1990-5#1)(1995-2#1)(1995-6#1)
to ovarian##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
to over##14##2##(1991-7#1)(1993-12#1)(1994-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2012-3#2)
to overall##10##2##(1991-6#1)(1993-1#1)(1993-12#1)(1995-6#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)
to overcome a##2##3##(2008-7#2)
to overcome current##2##3##(2008-11#1)(2010-5#1)
to overcome many of##2##4##(2008-9#1)(2010-8#1)
to overcome resistance##4##3##(2008-10#2)(2008-11#1)(2012-12#1)
to overcome some of##2##4##(2008-1#1)(2008-5#1)
to overcome the current##3##4##(1991-2#1)(2013-1#1)(2013-7#1)
to overcome the effects##2##4##(2008-10#1)(2008-6#1)
to overcome the limitations of##2##5##(2007-8#1)(2008-10#1)
to overcome the problem of##2##5##(2008-2#1)(2008-3#1)
to overcome the##47##3##(1991-2#2)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#2)
to overcome them##4##3##(2008-1#1)(2009-4#1)(2010-10#1)(2010-12#1)
to overcome these barriers##2##4##(2013-1#2)
to overcome these challenges##2##4##(2011-2#1)(2013-8#1)
to overcome these drawbacks##2##4##(2010-5#1)(2010-6#1)
to overcome these limitations##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)
to overcome these problems##5##4##(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-11#1)
to overcome these##20##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)(2013-1#2)(2013-8#1)
to overcome this limitation##3##4##(2007-11#1)(2008-1#1)(2010-11#1)
to overcome this##11##3##(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#1)
to overcome##135##2##(1990-12#1)(1991-2#2)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#1)
to overcrowding of the##2##4##(2008-8#1)(2008-9#1)
to overestimate disease##2##3##(2008-10#2)
to overestimate the##3##3##(1992-6#1)(1993-2#1)(2008-7#1)
to overestimate##5##2##(1992-6#1)(1993-2#1)(2008-10#2)(2008-7#1)
to overestimation##2##2##(1992-9#1)(2008-10#1)
to overexpress##3##2##(1993-1#1)(1995-2#1)(2008-11#1)
to overhaul the##2##3##(1994-12#1)(1995-3#1)
to overlapping##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
to overloading##2##2##(1990-6#1)(2007-11#1)
to overlying##3##2##(2008-2#1)(2010-3#1)(2011-2#1)
to override##2##2##(2008-5#1)(2012-12#1)
to oversee##2##2##(1994-3#1)(2010-3#1)
to overt##2##2##(2008-1#1)(2008-5#1)
to overturn##2##2##(1992-11#1)(1995-6#1)
to overweight and obesity##7##4##(2011-2#2)(2013-8#5)
to overweight##9##2##(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#5)
to oxalate##2##2##(2008-10#2)
to oxidation of the##2##4##(2008-10#1)(2009-9#1)
to oxidation of##4##3##(2008-10#2)(2009-9#1)(2012-2#1)
to oxidation##12##2##(1991-12#1)(1995-12#2)(1996-3#1)(2008-10#3)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
to oxidative modification##4##3##(1991-2#1)(1991-5#1)(1995-12#2)
to oxidative stress and##3##4##(2008-3#1)(2008-7#1)(2008-9#1)
to oxidative stress in##3##4##(1996-9#1)(2008-7#1)(2012-12#1)
to oxidative stress induced##2##4##(2012-3#1)(2013-1#1)
to oxidative stress##21##3##(1991-2#1)(1996-9#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
to oxidative##32##2##(1991-2#3)(1991-5#1)(1995-12#2)(1996-5#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to oxidise##2##2##(2008-10#1)(2012-3#1)
to oxidize##10##2##(1992-3#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#2)(2013-1#2)
to oxidized LDL##2##3##(1996-2#1)(2013-7#1)
to oxidized##3##2##(1994-5#1)(1996-2#1)(2013-7#1)
to oxygen deficiency##2##3##(1995-11#1)(2007-12#1)
to oxygen radicals##2##3##(1990-5#1)(2010-7#1)
to oxygen##13##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1993-12#2)(1994-8#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-7#1)
to ozone depletion and##2##4##(1991-6#1)(1996-1#1)
to ozone##5##2##(1991-6#1)(1992-3#1)(1996-1#1)(2008-10#1)(2011-2#1)
to p##2##2##(2008-10#1)(2008-11#1)
to p&lt##4##2##(2007-2#2)(2010-6#1)(2010-9#1)
to p-aminophenol##2##2##(2008-10#2)
to p53##2##2##(1994-12#2)
to p75R##5##2##(1994-2#5)
to pH 2##5##3##(1996-5#1)(2008-10#4)
to pH 3##7##3##(1994-8#1)(1996-5#1)(2008-10#4)(2010-3#1)
to pH 4##4##3##(2008-10#2)(2008-5#2)
to pH 5##4##3##(2008-10#3)(2008-11#1)
to pH 6##3##3##(2008-10#2)(2008-7#1)
to pH 8##2##3##(2008-10#2)
to pH 9##2##3##(1994-8#1)(2008-10#1)
to pH##46##2##(1993-12#1)(1994-8#2)(1995-2#1)(1996-5#2)(2008-10#29)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
to package and##2##3##(2008-10#1)(2012-1#1)
to package##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2012-1#1)
to paclitaxel##4##2##(2008-6#1)(2008-8#1)(2010-11#2)
to paediatric##2##2##(2007-9#1)(2008-11#1)
to paid##2##2##(1993-6#1)(2008-7#1)
to pain and##3##3##(2010-3#1)(2012-12#2)
to pain assessment##2##3##(2008-7#1)(2010-7#1)
to pain management among##2##4##(2009-12#1)(2010-11#1)
to pain management##3##3##(2009-12#1)(2010-11#2)
to pain or##3##3##(1996-12#1)(2008-4#1)(2011-2#1)
to pain relief##2##3##(2008-9#1)(2009-12#1)
to pain##22##2##(1996-12#1)(2007-12#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#3)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)
to painful##2##2##(2008-7#1)(2009-11#1)
to paint##2##2##(2008-10#1)(2009-8#1)
to pair##4##2##(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
to palladium##2##2##(2008-10#2)
to palliative##3##2##(1990-12#1)(2007-7#1)(2008-11#1)
to pancreatic lipase##2##3##(1992-3#1)(1995-5#1)
to pancreatic##11##2##(1990-4#1)(1992-3#1)(1995-5#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#2)
to pandemic##3##2##(2011-2#2)(2013-1#1)
to panic##2##2##(2008-11#1)(2013-8#1)
to panicle blast##3##3##(2008-10#3)
to parallel the##3##3##(1992-11#1)(1993-11#1)(1995-2#1)
to parallel##4##2##(1992-11#1)(1993-11#1)(1995-2#1)(1997-7#1)
to parameterize the##2##3##(2008-3#1)(2009-11#1)
to parameterize##3##2##(2008-3#1)(2008-8#1)(2009-11#1)
to parameters##2##2##(2008-2#2)
to parametric##2##2##(1991-12#1)(2007-12#1)
to parasite##2##2##(1997-7#1)(2012-2#1)
to parasites##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)
to parasitism##4##2##(2008-8#4)
to parasitize##6##2##(2008-10#5)(2008-8#1)
to parathyroid hormone##3##3##(1992-3#1)(2010-6#1)(2013-7#1)
to parathyroid##4##2##(1990-9#1)(1992-3#1)(2010-6#1)(2013-7#1)
to parent##7##2##(1990-12#1)(1991-12#1)(1991-4#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#1)
to parental##6##2##(1993-12#1)(1994-11#1)(1994-8#1)(1996-3#1)(2009-7#1)(2010-1#1)
to parenteral and oral aluminum##2##5##(1992-11#2)
to parenteral##4##2##(1992-11#3)(2012-2#1)
to parenthood##3##2##(2007-2#2)(2009-11#1)
to parents who##2##3##(1996-5#1)(2007-7#1)
to parents##9##2##(1992-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-7#1)(2008-8#1)(2011-1#2)
to parietal##2##2##(1990-9#1)(1995-11#1)
to part of##4##3##(1990-5#1)(1992-12#1)(1993-6#1)(2010-8#1)
to partial or##2##3##(2008-8#1)(2009-7#1)
to partial##5##2##(1991-12#1)(1996-9#1)(2008-10#1)(2008-8#1)(2009-7#1)
to partially coherent##2##3##(2007-11#2)
to partially overcome##2##3##(1994-6#1)(2008-11#1)
to partially##17##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
to participants and##2##3##(1995-2#1)(2013-1#1)
to participants in##2##3##(2009-11#2)
to participants##11##2##(1995-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-11#1)(2013-1#1)
to participate and##2##3##(2008-11#1)(2009-6#1)
to participate in a##6##4##(2008-1#2)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#1)
to participate in and##2##4##(1995-1#1)(2013-1#1)
to participate in clinical trials##2##5##(2009-6#1)(2013-1#1)
to participate in research##5##4##(1992-6#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
to participate in the study##5##5##(1994-12#1)(2008-11#1)(2010-1#1)(2010-6#1)(2012-2#1)
to participate in the##15##4##(1992-11#1)(1994-12#1)(1994-2#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-8#1)
to participate in this##4##4##(1991-2#1)(2008-11#1)(2009-7#1)(2010-4#1)
to participate in##64##3##(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#2)(1997-2#1)(2007-10#1)(2008-1#3)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#6)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
to participate##83##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#2)(1997-2#1)(2007-10#3)(2008-1#4)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#8)(2009-7#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#3)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#1)
to participation##5##2##(1994-12#1)(1995-5#1)(2009-4#1)(2011-9#1)(2012-1#1)
to particle size##2##3##(1997-2#1)(2008-3#1)
to particle##8##2##(1997-2#2)(2008-10#1)(2008-3#4)(2008-8#1)
to particles with sharp edges##2##5##(2008-3#2)
to particles##3##2##(1996-12#1)(2008-3#2)
to particular##11##2##(1994-3#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-3#1)
to particulate matter##2##3##(2008-10#1)(2013-8#1)
to particulate##3##2##(1997-4#1)(2008-10#1)(2013-8#1)
to partition##2##2##(1991-7#1)(2008-3#1)
to partner with##2##3##(2010-10#1)(2012-2#1)
to partner##5##2##(2008-6#1)(2009-4#2)(2010-10#1)(2012-2#1)
to partnership##2##2##(2008-11#1)(2009-5#1)
to parts of the##3##4##(1994-12#1)(2009-10#1)(2011-2#1)
to pass through the##2##4##(2007-5#1)(2008-10#1)
to pass through##5##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
to pass##11##2##(1991-11#1)(1994-2#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
to passive##3##2##(1992-12#1)(2011-2#1)(2012-9#1)
to passively##2##2##(2008-3#1)(2012-3#1)
to past##2##2##(2007-2#1)(2012-12#1)
to pasture##2##2##(1994-1#1)(2010-4#1)
to pastures##2##2##(2008-5#1)(2012-12#1)
to patch##2##2##(2008-3#1)(2008-8#1)
to pathogen attack##2##3##(2008-10#2)
to pathogen control##2##3##(2008-10#2)
to pathogen infection##2##3##(2008-10#1)(2009-2#1)
to pathogen##15##2##(2008-10#14)(2009-2#1)
to pathogenesis##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
to pathogenic##6##2##(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
to pathogenicity##2##2##(2008-10#2)
to pathogens by##2##3##(2013-1#2)
to pathogens##7##2##(1997-7#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#2)
to pathology##4##2##(1996-12#1)(2006-12#1)(2008-10#1)(2011-2#1)
to pathotype 1##3##3##(2008-10#3)
to pathotype 2##2##3##(2008-10#2)
to pathotype##6##2##(2008-10#6)
to patient care##10##3##(1993-2#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2012-12#1)
to patient management##2##3##(2011-2#1)(2012-2#1)
to patient satisfaction##3##3##(1993-12#1)(1995-12#1)(2008-9#1)
to patient##47##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-10#2)(2007-3#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
to patient's##6##2##(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
to patients and their##2##4##(1992-3#1)(2010-3#1)
to patients and##5##3##(1990-11#1)(1992-12#1)(1992-3#1)(2007-10#1)(2010-3#1)
to patients in##4##3##(1993-12#1)(1995-12#2)(2012-2#1)
to patients is##3##3##(1995-2#1)(2008-3#1)(2010-2#1)
to patients of##2##3##(1994-3#1)(2012-3#1)
to patients suffering from##2##4##(1997-3#1)(2010-5#1)
to patients the##2##3##(1996-3#1)(2012-2#1)
to patients undergoing##2##3##(1994-3#1)(2008-8#1)
to patients using##2##3##(2008-8#1)(2008-9#1)
to patients who##5##3##(1992-3#1)(2008-11#1)(2010-4#1)(2010-9#1)(2013-1#1)
to patients whose##2##3##(2008-11#1)(2012-12#1)
to patients with left##2##4##(2007-8#1)(2008-7#1)
to patients with severe##2##4##(1997-1#1)(2007-12#1)
to patients with the##2##4##(2008-1#1)(2011-2#1)
to patients with##45##3##(1991-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-1#1)(2007-12#2)(2007-8#4)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-2#1)(2013-1#3)(2013-8#1)
to patients##111##2##(1990-11#1)(1990-2#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#3)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#4)(1995-12#2)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-8#5)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#13)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
to patients'##6##2##(1991-3#1)(1991-8#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-6#1)
to pattern##6##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
to patterns##2##2##(2008-11#1)(2008-9#1)
to pay $1 million to##2##5##(1995-12#2)
to pay $1##3##3##(1995-12#2)(2007-7#1)
to pay and##3##3##(1992-2#1)(2008-1#1)(2012-12#1)
to pay close attention to##2##5##(1995-2#1)(2012-2#1)
to pay for treatment##2##4##(2007-7#1)(2009-10#1)
to pay for##13##3##(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-2#1)(2007-2#1)(2007-7#3)(2008-10#1)(2009-10#1)
to pay in##2##3##(1997-5#1)(2012-12#1)
to pay more attention to##3##5##(1995-1#1)(2008-1#1)(2010-4#1)
to pay##43##2##(1992-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1995-1#3)(1995-12#4)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(2007-2#1)(2007-7#9)(2008-1#2)(2008-10#1)(2008-6#2)(2009-10#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#1)
to peak##12##2##(1990-5#1)(1992-8#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
to peanut##6##2##(1996-11#4)(2008-10#2)
to pear and##2##3##(2008-10#2)
to pear##5##2##(2008-10#5)
to pediatric medical##2##3##(1994-3#1)(2009-6#1)
to pediatric##5##2##(1994-1#1)(1994-3#1)(2008-12#1)(2009-6#1)(2010-5#1)
to pediatricians##2##2##(2007-11#1)(2007-12#1)
to peers##3##2##(2008-12#1)(2010-4#1)(2012-1#1)
to pegylated##2##2##(2011-2#2)
to penetrate into the##3##4##(1994-3#2)(2008-7#1)
to penetrate into##4##3##(1994-3#2)(2008-3#1)(2008-7#1)
to penetrate the cuticle##2##4##(2008-10#2)
to penetrate the##9##3##(1992-12#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-8#2)(2013-1#1)
to penetrate through##2##3##(2008-10#1)(2008-7#1)
to penetrate to the##2##4##(2008-10#1)(2008-6#1)
to penetrate##24##2##(1992-12#1)(1994-3#2)(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2013-1#1)
to penetration##3##2##(2008-10#2)(2012-2#1)
to penicillin G##2##3##(2008-10#1)(2013-8#1)
to penicillin##12##2##(1990-12#1)(1995-3#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2011-1#1)(2011-2#1)(2013-8#1)
to people aged##2##3##(2012-3#1)(2013-1#1)
to people who##3##3##(1995-6#1)(1996-12#1)(2007-8#1)
to people with mental illness##3##5##(2011-1#3)
to people with mental##4##4##(2011-1#3)(2012-12#1)
to people with##14##3##(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-12#1)(2008-9#1)(2009-6#1)(2011-1#4)(2012-12#1)(2013-1#1)
to people##26##2##(1993-1#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#5)(2012-12#1)(2012-3#1)(2013-1#2)
to people's##6##2##(1996-1#1)(2008-1#1)(2010-2#3)(2010-4#1)
to pepper##4##2##(2008-10#4)
to peptide##6##2##(1993-5#2)(1994-6#1)(2008-2#1)(2008-4#2)
to peptides##3##2##(2008-11#1)(2008-4#1)(2010-2#1)
to perceive and##2##3##(2008-7#1)(2011-10#1)
to perceive##9##2##(1996-1#1)(2008-7#2)(2008-8#1)(2009-8#2)(2011-10#1)(2012-3#1)(2013-1#1)
to perceived##6##2##(2007-12#2)(2009-4#1)(2010-10#1)(2011-2#2)
to percent##2##2##(2008-10#2)
to perceptions of##4##3##(1994-3#1)(2010-12#1)(2010-4#1)(2012-3#1)
to perceptions##5##2##(1994-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
to percutaneous##4##2##(1994-11#1)(2007-8#1)(2008-9#1)(2011-2#1)
to perform a biopsy for##2##5##(2012-2#2)
to perform a biopsy##3##4##(2012-2#2)(2013-8#1)
to perform a##29##3##(1993-11#1)(1996-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
to perform accurate##2##3##(2007-12#1)(2013-1#1)
to perform an##8##3##(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-3#1)(2012-3#1)
to perform and##6##3##(1990-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-2#1)
to perform biopsies of##2##4##(2007-8#1)(2011-2#1)
to perform both##2##3##(2008-10#1)(2008-6#1)
to perform complex##2##3##(2008-7#1)(2013-1#1)
to perform electrochemical##2##3##(2008-10#1)(2010-2#1)
to perform fast##2##3##(2011-1#1)(2013-1#1)
to perform in situ##2##4##(2008-10#1)(2008-2#1)
to perform in##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-12#1)
to perform more##3##3##(1993-2#1)(2010-7#1)(2010-8#1)
to perform quantitative analyses##2##4##(1997-2#1)(2013-7#1)
to perform quantitative analysis of##2##5##(2013-1#1)(2013-8#1)
to perform quantitative##8##3##(1997-2#2)(2008-10#2)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
to perform routine living##2##4##(2008-1#2)
to perform simultaneous##2##3##(2008-10#1)(2008-2#1)
to perform tasks##2##3##(2007-9#1)(2008-7#1)
to perform the calculations##3##4##(2008-10#2)(2008-2#1)
to perform the calibration##2##4##(2008-10#2)
to perform the test##2##4##(2010-4#1)(2012-1#1)
to perform the##40##3##(1993-9#1)(1994-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
to perform their##4##3##(1991-3#1)(2007-12#1)(2008-7#1)(2011-2#1)
to perform titration and standard addition in##2##7##(2008-10#2)
to perform two##2##3##(2008-3#2)
to perform well##2##3##(1997-3#1)(2010-8#1)
to perform##256##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-9#2)(1994-3#2)(1995-12#1)(1996-11#1)(1996-12#4)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#56)(2008-11#6)(2008-12#3)(2008-2#14)(2008-3#23)(2008-4#8)(2008-5#5)(2008-6#4)(2008-7#9)(2008-9#6)(2009-10#2)(2009-2#3)(2009-3#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#6)
to performance in##2##3##(1996-3#1)(2007-8#1)
to performance##10##2##(1995-3#1)(1996-2#1)(1996-3#2)(1996-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-10#1)
to performing##4##2##(2007-2#1)(2007-8#1)(2009-8#1)(2011-2#1)
to periodic or##2##3##(2008-2#1)(2008-9#1)
to periodic##5##2##(1990-8#1)(2007-12#2)(2008-2#1)(2008-9#1)
to periodontal##2##2##(1997-4#1)(2012-3#1)
to peripheral blood##2##3##(2010-8#1)(2013-1#1)
to peripheral pulmonary##2##3##(2007-8#1)(2010-8#1)
to peripheral##9##2##(1994-11#1)(1995-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
to peritoneal##2##2##(2011-2#2)
to permanent##5##2##(1997-6#1)(2007-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
to permeabilize##2##2##(1992-9#2)
to permethrin residues##2##3##(2011-2#2)
to permit a##2##3##(1996-12#1)(2007-8#1)
to permit more##2##3##(2008-3#2)
to permit the direct##2##4##(1993-12#1)(2008-3#1)
to permit the rapid##2##4##(1992-8#1)(2007-12#1)
to permit the use of##2##5##(2007-11#1)(2007-12#1)
to permit the##14##3##(1992-8#1)(1993-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#2)(2012-12#1)
to permit##50##2##(1990-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-9#2)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-9#3)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
to peroxidation##2##2##(2009-5#1)(2012-2#1)
to peroxide-induced haemolysis##2##3##(1991-12#2)
to peroxisome##2##2##(1994-8#1)(1995-6#1)
to peroxisomes##2##2##(2009-10#2)
to persist in##5##3##(1990-11#1)(2008-2#1)(2008-7#1)(2008-8#2)
to persist##14##2##(1990-11#1)(1991-2#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2011-3#1)(2013-7#1)
to persistent##6##2##(1991-12#1)(1992-9#1)(2008-8#3)(2011-2#1)
to personal and##2##3##(1993-12#1)(2012-1#1)
to personal##4##2##(1990-8#1)(1993-12#1)(1996-3#1)(2012-1#1)
to personnel##2##2##(1996-2#1)(1997-8#1)
to persons with##4##3##(1996-1#1)(1996-2#1)(2009-7#1)(2013-7#1)
to persons##5##2##(1991-8#1)(1996-1#1)(1996-2#1)(2009-7#1)(2013-7#1)
to persuade##4##2##(1995-6#1)(1996-1#1)(1997-8#1)(2012-12#1)
to perturb the##3##3##(1994-5#1)(1995-9#1)(2008-3#1)
to perturb##4##2##(1990-2#1)(1994-5#1)(1995-9#1)(2008-3#1)
to perturbations in##3##3##(2007-12#1)(2008-3#1)(2010-11#1)
to perturbations##5##2##(2007-12#1)(2008-11#2)(2008-3#1)(2010-11#1)
to pertussis toxin##2##3##(1993-8#1)(1994-11#1)
to pertussis##6##2##(1993-8#1)(1994-11#2)(1995-5#2)(1997-2#1)
to pesticides##2##2##(1990-9#1)(2010-1#1)
to pests##3##2##(2008-10#2)(2011-2#1)
to petroleum##2##2##(1992-10#1)(2013-1#1)
to phage##2##2##(1995-2#1)(2012-2#1)
to pharmaceutical formulations##4##3##(2008-10#4)
to pharmaceutical##9##2##(2008-10#5)(2008-7#1)(2009-5#1)(2010-8#1)(2012-2#1)
to pharmacological##3##2##(2012-1#1)(2012-12#1)(2012-3#1)
to pharmacology##2##2##(1997-2#1)(2008-12#1)
to pharyngeal##2##2##(2011-2#1)(2012-12#1)
to phase matching##2##3##(2007-11#1)(2007-12#1)
to phase modulation##2##3##(2008-2#1)(2008-3#1)
to phase##17##2##(1994-2#1)(1996-1#1)(2007-11#3)(2007-12#2)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
to phenol##2##2##(2008-10#2)
to phenolic##2##2##(2008-10#1)(2011-2#1)
to phenotype R(T)R(V)##2##3##(2008-10#2)
to phenotype##6##2##(2008-10#4)(2008-7#1)(2012-2#1)
to phenotypes##2##2##(2008-10#1)(2011-1#1)
to phenotypic##4##2##(1991-12#1)(2008-8#2)(2012-3#1)
to phenotypically##2##2##(2008-9#2)
to phenylalanine##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
to phenylamide fungicides##2##3##(2008-10#2)
to phenytoin##3##2##(1994-2#2)(2008-8#1)
to phorbol ester##4##3##(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)
to phorbol##5##2##(1993-8#1)(1994-11#2)(1994-8#1)(1995-6#1)
to phosphatase##2##2##(1990-12#1)(1995-3#1)
to phosphate##3##2##(1994-11#1)(1994-6#1)(2008-10#1)
to phosphatidylinositol##4##2##(1995-6#1)(1997-8#1)(2009-10#1)(2009-7#1)
to phosphine##3##2##(1990-8#1)(2008-11#1)(2011-2#1)
to phosphoinositides##2##2##(1994-11#1)(1995-8#1)
to phospholipid##2##2##(1990-11#1)(2008-9#1)
to phospholipids##4##2##(1990-2#1)(1992-8#1)(1992-9#1)(1994-12#1)
to phosphorylate##3##2##(1993-5#1)(1994-5#1)(1995-11#1)
to phosphorylation of##2##3##(1997-1#1)(2008-8#1)
to photo-symbiotic clams##2##3##(2008-5#2)
to photobleaching##3##2##(2008-3#2)(2008-9#1)
to photographic##2##2##(2008-3#2)
to photon##3##2##(2007-12#1)(2008-3#2)
to phylogenetic##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
to physical and mental##2##4##(2008-12#1)(2009-11#1)
to physical and##5##3##(1990-8#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)
to physical therapy##4##3##(1996-1#1)(2008-12#1)(2008-7#1)(2012-2#1)
to physical##26##2##(1990-8#1)(1992-12#1)(1994-9#1)(1996-1#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
to physically##6##2##(1995-11#1)(2008-10#3)(2008-7#1)(2008-8#1)
to physician##6##2##(1993-3#2)(1994-1#1)(1996-12#1)(1996-3#1)(2008-8#1)
to physicians and##6##3##(1992-1#1)(1993-3#1)(1994-12#2)(1994-3#1)(2013-1#1)
to physicians as##2##3##(1993-3#1)(2008-12#1)
to physicians in the##2##4##(1992-6#1)(2010-7#1)
to physicians in##3##3##(1992-6#1)(2010-7#1)(2011-2#1)
to physicians##27##2##(1991-1#1)(1991-3#1)(1992-1#3)(1992-3#1)(1992-6#1)(1993-3#3)(1994-1#1)(1994-12#3)(1994-3#2)(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
to physico-chemical##2##2##(2008-10#2)
to physiologic##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2010-10#1)
to physiological##9##2##(1990-5#1)(2008-4#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
to physiologically##2##2##(2009-12#1)(2009-6#1)
to physiotherapy##3##2##(1992-2#1)(1995-3#1)(2011-2#1)
to pick##2##2##(1992-2#1)(2012-2#1)
to picture##3##2##(1995-2#1)(1997-8#1)(2009-9#1)
to pigs##2##2##(2008-12#1)(2010-4#1)
to pilot##4##2##(1994-3#3)(2008-10#1)
to pin##2##2##(2009-3#1)(2012-3#1)
to pinpoint the##5##3##(1990-12#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-1#1)
to pinpoint##7##2##(1990-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#1)
to pistachio##3##2##(2008-10#3)
to pitch canker##2##3##(2008-10#2)
to pituitary adenomas##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
to place a##2##3##(2007-12#1)(2008-11#1)
to place and##2##3##(2008-2#1)(2012-2#1)
to place the##8##3##(1992-11#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)
to place them in the context of the##2##8##(2008-12#1)(2010-7#1)
to place them in##4##4##(1993-9#1)(1995-1#1)(2008-12#1)(2010-7#1)
to place##37##2##(1991-12#1)(1992-11#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-9#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
to placebo##7##2##(1990-3#1)(1991-11#1)(1992-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
to plan and implement##2##4##(1996-3#1)(2008-11#1)
to plan and##4##3##(1994-2#1)(1996-3#1)(2008-11#1)(2008-6#1)
to plan for the##3##4##(1992-2#1)(1992-4#1)(1993-1#1)
to plan for##6##3##(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(2008-11#1)(2010-3#1)
to plan the##4##3##(2008-10#1)(2008-7#1)(2009-11#1)(2013-8#1)
to plan their##2##3##(1995-12#1)(2013-8#1)
to plan##31##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-2#2)(1995-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-3#2)(2013-1#2)(2013-8#2)
to planning##5##2##(1993-3#1)(1994-2#2)(1995-2#1)(2008-6#1)
to plant cells##2##3##(2008-10#1)(2009-8#1)
to plant disease##4##3##(2008-10#4)
to plant##27##2##(2008-10#14)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
to planting##6##2##(2008-10#6)
to plants##21##2##(1990-11#1)(1992-3#1)(1993-2#1)(1997-3#1)(2008-10#9)(2008-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
to plaque##2##2##(1993-9#1)(2012-2#1)
to plasma TG levels alone##2##5##(2008-3#2)
to plasma membrane##3##3##(1992-11#1)(2008-11#1)(2009-8#1)
to plasma membranes in##2##4##(1992-3#1)(1995-8#1)
to plasma##19##2##(1990-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
to plasminogen and##2##3##(1995-6#1)(1997-2#1)
to plasminogen##3##2##(1995-6#1)(1996-8#1)(1997-2#1)
to plastic##3##2##(2008-11#1)(2009-6#1)(2012-4#1)
to platelet activation##2##3##(1994-6#1)(2008-11#1)
to platelet aggregation##3##3##(1991-8#1)(1991-9#1)(2008-11#1)
to platelet glycoprotein##2##3##(1993-3#1)(2009-12#1)
to platelet##11##2##(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-6#1)(2008-11#2)(2008-6#1)(2009-12#1)
to platelets of##2##3##(2008-3#2)
to platelets##10##2##(1991-8#1)(1992-6#1)(1993-3#1)(2006-6#2)(2008-3#4)(2009-3#1)
to platinum##3##2##(2008-10#1)(2008-4#2)
to platinum-based##2##2##(2008-11#1)(2010-8#1)
to play a central role in##4##6##(1992-9#1)(2008-7#1)(2008-8#1)(2013-8#1)
to play a critical role in##7##6##(1990-11#1)(1994-2#1)(1994-9#1)(1997-4#1)(2011-2#2)(2013-7#1)
to play a critical role##8##5##(1990-11#1)(1994-2#1)(1994-9#1)(1997-4#1)(2008-11#1)(2011-2#2)(2013-7#1)
to play a crucial role in##3##6##(1993-8#1)(2008-6#1)(2010-10#1)
to play a crucial role##4##5##(1992-10#1)(1993-8#1)(2008-6#1)(2010-10#1)
to play a crucial##5##4##(1992-10#1)(1993-8#1)(2008-10#1)(2008-6#1)(2010-10#1)
to play a key role in the##3##7##(1994-9#1)(1995-12#1)(2011-2#1)
to play a key role in##5##6##(1993-6#1)(1994-9#1)(1995-12#1)(2008-9#1)(2011-2#1)
to play a key role##6##5##(1993-6#1)(1994-9#1)(1995-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
to play a major role in the##3##7##(1992-12#1)(1992-8#1)(1994-12#1)
to play a major role in##6##6##(1992-12#1)(1992-8#1)(1994-12#2)(2008-10#1)(2013-1#1)
to play a major role##7##5##(1992-12#1)(1992-8#1)(1994-12#2)(2007-7#1)(2008-10#1)(2013-1#1)
to play a pivotal role in the##2##7##(2008-1#1)(2008-11#1)
to play a pivotal role in##5##6##(2008-1#1)(2008-11#2)(2008-3#1)(2012-2#1)
to play a pivotal role##6##5##(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2012-2#1)
to play a role in the regulation of##2##8##(1992-6#1)(2008-4#1)
to play a role in the##4##6##(1992-6#1)(2008-4#1)(2012-12#1)(2012-2#1)
to play a role in##16##5##(1990-5#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-3#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2010-10#1)(2012-12#1)(2012-2#1)(2012-7#1)
to play a role##17##4##(1990-5#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-3#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-7#1)
to play a significant role in the##2##7##(2008-10#1)(2012-2#1)
to play a significant role in##6##6##(2008-10#3)(2008-7#1)(2012-2#1)(2013-8#1)
to play a##66##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-12#2)(1996-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#3)
to play an important role in the##5##7##(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#2)
to play an important role in this##2##7##(2008-7#1)(2010-8#1)
to play an important role in##30##6##(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-12#3)(1996-2#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2013-1#1)
to play an important role##31##5##(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-12#3)(1996-2#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2013-1#1)
to play an important##32##4##(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-12#3)(1996-2#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2013-1#1)
to play an##34##3##(1991-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-12#3)(1996-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2013-1#1)
to play important roles in##9##5##(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2011-2#1)
to play important##11##3##(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
to play in##12##3##(1992-3#1)(1997-2#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2012-12#1)
to play roles in##2##4##(2008-8#1)(2009-10#1)
to play the role of##2##5##(1990-12#1)(1993-12#1)
to play the##3##3##(1990-12#1)(1993-12#1)(1997-4#1)
to play##145##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-9#2)(1995-12#4)(1995-8#1)(1996-12#3)(1996-2#3)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#11)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#2)(2009-2#2)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#3)
to please##2##2##(1996-3#1)(2008-12#1)
to pneumonia##2##2##(1992-6#1)(2013-8#1)
to point out##3##3##(2007-10#1)(2008-10#1)(2009-7#1)
to point to##2##3##(2010-5#1)(2012-3#1)
to point##8##2##(2007-10#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-5#1)(2012-3#1)(2013-7#2)
to poisoning##2##2##(1997-3#2)
to polarization self-modulation##3##3##(2007-11#3)
to polarization##9##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
to polarized light##2##3##(2007-12#2)
to polarized##5##2##(2007-12#2)(2008-7#1)(2009-8#2)
to policy makers and##2##4##(1997-2#1)(2013-1#1)
to policy makers##6##3##(1994-1#2)(1997-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
to policy##10##2##(1991-2#1)(1993-3#1)(1994-1#2)(1997-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
to pollen tube##2##3##(2009-12#1)(2009-8#1)
to pollen##5##2##(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
to polluted##2##2##(1991-4#1)(2010-5#1)
to poly(dAdT)##2##2##(1995-2#2)
to polychlorinated biphenyls##2##3##(1995-12#1)(2008-11#1)
to polycyclic aromatic hydrocarbons##3##4##(1992-3#2)(1995-11#1)
to polycyclic aromatic##4##3##(1992-3#2)(1995-11#1)(2012-2#1)
to polymer##4##2##(1992-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
to polymerase chain reaction##2##4##(1994-6#1)(2008-10#1)
to polymerase##4##2##(1994-6#1)(1994-8#1)(2008-10#1)(2012-2#1)
to poor health##2##3##(2008-7#1)(2011-2#1)
to poor palatability##2##3##(2008-9#2)
to poor response##2##3##(2010-12#1)(2013-1#1)
to poor##24##2##(1990-6#1)(1991-12#1)(1993-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#4)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to poorly##2##2##(2008-10#1)(2008-7#1)
to popular belief##4##3##(1993-1#1)(1997-3#1)(2008-5#1)(2009-9#1)
to population##13##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#3)(2011-2#1)(2013-1#2)
to populations##6##2##(1992-3#1)(1997-1#1)(2008-10#2)(2010-5#1)(2012-1#1)
to porcine##4##2##(1992-12#1)(1996-12#1)(1997-5#1)(2008-5#1)
to portal hypertension##2##3##(2006-10#1)(2009-8#1)
to portal##5##2##(1993-12#3)(2006-10#1)(2009-8#1)
to portray the##2##3##(1993-2#1)(2009-10#1)
to portray##3##2##(1993-2#1)(1996-3#1)(2009-10#1)
to pose a##5##3##(1994-7#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-9#1)
to pose##10##2##(1994-7#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-9#1)
to position a##2##3##(1994-3#1)(2008-2#1)
to position the##3##3##(1993-8#1)(1995-5#1)(2007-8#1)
to position themselves##2##3##(1994-12#1)(1997-1#1)
to position##16##2##(1992-11#2)(1993-8#1)(1994-12#1)(1994-3#3)(1995-5#2)(1996-1#1)(1997-1#2)(2007-8#1)(2008-2#1)(2010-7#1)(2011-1#1)
to positions##4##2##(1990-7#1)(1997-9#1)(2007-10#1)(2008-3#1)
to positive or negative##2##4##(2008-10#2)
to positive##16##2##(1992-3#1)(1992-5#1)(2008-1#1)(2008-10#4)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#3)
to positively##5##2##(1995-12#1)(2008-10#3)(2008-7#1)
to possess both##2##3##(1990-5#1)(2008-10#1)
to possess the##5##3##(1993-8#1)(2008-10#3)(2008-11#1)
to possess##37##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-1#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-2#1)(2010-3#1)(2012-12#1)(2013-1#2)
to possible##15##2##(1991-12#1)(1994-12#1)(1994-5#1)(1996-6#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-3#1)
to posterior##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
to postmenopausal##2##2##(2008-4#1)(2012-3#1)
to postnatal day##2##3##(1993-3#1)(2008-7#1)
to postoperative##5##2##(2008-7#3)(2009-10#1)(2011-2#1)
to postpartum##2##2##(2008-10#1)(2013-1#1)
to postpone or##2##3##(2011-2#2)
to posttest##2##2##(2008-12#1)(2010-10#1)
to posttranscriptional##3##2##(1994-8#1)(1995-2#1)(1996-12#1)
to posttraumatic stress disorder (PTSD)##2##5##(2008-8#1)(2013-1#1)
to postulate##7##2##(1990-8#2)(1992-6#1)(1995-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
to potassium##2##2##(2008-10#1)(2008-2#1)
to potato and tomato##2##4##(2008-10#2)
to potato and##3##3##(2008-10#3)
to potato late blight of##2##5##(2008-10#2)
to potato##12##2##(2008-10#12)
to potent##2##2##(1992-9#1)(1995-5#1)
to potential mechanisms of##2##4##(2008-11#1)(2008-5#1)
to potential##18##2##(1993-1#1)(1994-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)
to potentially##5##2##(1990-8#1)(1993-1#1)(1994-3#1)(2011-2#1)(2013-1#1)
to potentials more negative than##2##5##(1993-3#1)(1996-5#1)
to potentials more positive than##2##5##(1993-3#1)(1996-5#1)
to potentials more##4##3##(1993-3#2)(1996-5#2)
to potentiate the##4##3##(1990-12#1)(1990-8#2)(1993-6#1)
to potentiate##10##2##(1990-12#1)(1990-8#2)(1993-6#3)(1994-8#1)(2008-1#1)(2008-4#1)(2008-7#1)
to potentiometric##2##2##(2008-10#2)
to powdery mildew in##4##4##(2008-10#4)
to powdery mildew##17##3##(2008-10#17)
to power##4##2##(2008-3#4)
to practical applications of##2##4##(2008-10#1)(2012-2#1)
to practical applications##4##3##(2008-10#1)(2008-2#2)(2012-2#1)
to practical##10##2##(1992-9#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#1)(2012-2#1)
to practically any##2##3##(1993-3#1)(1994-12#1)
to practice and##2##3##(2008-12#1)(2010-10#1)
to practice in##4##3##(2008-11#3)(2008-12#1)
to practice it##2##3##(2008-10#1)(2008-11#1)
to practice the##2##3##(2008-10#1)(2012-3#1)
to practice##47##2##(1993-1#1)(1993-12#2)(1993-3#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#14)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
to practice'##2##2##(2008-11#1)(2008-12#1)
to practise in##2##3##(1997-5#1)(2011-2#1)
to practise##4##2##(1997-5#1)(2011-2#1)(2013-8#2)
to practitioners##2##2##(2008-10#1)(2008-11#1)
to praziquantel##4##2##(2012-3#4)
to pre-existing##2##2##(2007-11#1)(2012-5#1)
to pre-mRNA##2##2##(1991-9#2)
to pre-treat##2##2##(2008-10#2)
to precede the##2##3##(1994-3#1)(2013-8#1)
to precede##3##2##(1994-3#1)(2009-10#1)(2013-8#1)
to precipitate the##4##3##(1993-8#1)(2008-4#1)(2009-2#1)(2013-8#1)
to precipitate##8##2##(1993-8#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-2#1)(2013-8#1)
to precipitation##2##2##(2008-2#1)(2008-8#1)
to precise##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
to precisely##11##2##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
to preconcentrate##8##2##(2008-10#8)
to preconcentration##2##2##(2008-10#2)
to predation risk##2##3##(2008-9#1)(2010-8#1)
to predation##4##2##(2008-9#1)(2010-8#2)(2012-3#1)
to predator##2##2##(2008-4#1)(2008-9#1)
to predators and##2##3##(2008-4#1)(2008-8#1)
to predators##5##2##(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
to predict Fusarium##2##3##(2008-10#2)
to predict a##4##3##(1990-8#2)(2008-10#1)(2009-4#1)
to predict and compare##2##4##(1996-1#1)(2013-1#1)
to predict and##5##3##(1996-1#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
to predict carcinogenicity##2##3##(1995-6#2)
to predict disease severity##2##4##(2008-10#2)
to predict how##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
to predict in vivo##2##4##(2008-11#1)(2008-5#1)
to predict in##4##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)
to predict mortality##2##3##(2008-3#1)(2009-4#1)
to predict risk##3##3##(2010-7#1)(2012-1#1)(2013-1#1)
to predict severity##2##3##(2008-10#2)
to predict that##2##3##(2008-7#1)(2009-5#1)
to predict the accuracy of##2##5##(2008-2#1)(2010-2#1)
to predict the concentration##2##4##(2008-10#1)(2010-4#1)
to predict the consequences of##2##5##(1992-3#1)(2008-7#1)
to predict the distribution and##2##5##(2008-8#2)
to predict the effect of##5##5##(2008-3#2)(2008-7#2)(2012-2#1)
to predict the effects of##2##5##(2008-2#1)(2010-9#1)
to predict the existence of##2##5##(1997-9#1)(2007-12#1)
to predict the flow##2##4##(2008-11#1)(2008-7#1)
to predict the function of##2##5##(2009-5#1)(2010-2#1)
to predict the immune##2##4##(2008-10#2)
to predict the impact of##2##5##(2008-10#1)(2008-8#1)
to predict the impact##3##4##(1997-3#1)(2008-10#1)(2008-8#1)
to predict the incidence of##2##5##(2008-10#1)(2009-3#1)
to predict the intensity##2##4##(2008-2#2)
to predict the likelihood of##2##5##(2009-6#1)(2012-12#1)
to predict the presence of##4##5##(2007-10#1)(2008-10#1)(2012-3#2)
to predict the severity of##2##5##(2008-10#1)(2010-8#1)
to predict the##112##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-3#3)(1997-4#2)(1997-9#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#20)(2008-11#2)(2008-2#7)(2008-3#12)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#9)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
to predict their##2##3##(2007-11#1)(2008-11#1)
to predict this##2##3##(1995-4#1)(2007-11#1)
to predict vaccine equivalence##2##4##(1995-5#2)
to predict whether##3##3##(2008-10#1)(2010-8#2)
to predict who will##2##4##(2008-3#1)(2008-7#1)
to predict##268##2##(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-4#1)(1995-5#2)(1995-6#4)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-8#1)(1997-9#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#47)(2008-11#5)(2008-12#2)(2008-2#12)(2008-3#18)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#15)(2008-8#18)(2008-9#5)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
to predicted##2##2##(1992-3#1)(2008-12#1)
to predicting##3##2##(1995-5#2)(2008-11#1)
to predictions of##2##3##(2008-9#1)(2009-9#1)
to predictions##4##2##(2008-10#1)(2008-9#1)(2009-9#1)(2012-2#1)
to predominantly##3##2##(1992-11#1)(1992-4#1)(2008-8#1)
to predominate in##2##3##(2008-10#2)
to prefer##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
to preferentially##5##2##(1997-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2013-1#1)
to pregnancy and##2##3##(2008-10#1)(2009-1#1)
to pregnancy##9##2##(1992-5#2)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2012-1#1)(2013-1#1)
to pregnant women is##2##4##(1992-11#1)(2013-1#1)
to pregnant women##3##3##(1992-11#1)(2007-2#1)(2013-1#1)
to preliminary##2##2##(1992-11#1)(2008-10#1)
to premature death##3##3##(2012-12#3)
to premature##9##2##(1994-3#1)(1996-1#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#3)
to prenatal care##4##3##(2008-10#1)(2008-11#1)(2009-7#2)
to prenatal##7##2##(1997-3#1)(2008-10#2)(2008-11#1)(2009-7#2)(2011-1#1)
to preoperative##12##2##(1991-2#1)(2007-8#1)(2008-7#3)(2009-10#1)(2009-12#1)(2010-3#3)(2011-2#2)
to preparation##2##2##(2008-10#1)(2008-9#1)
to preparative##2##2##(2008-10#2)
to prepare &quot##2##3##(1990-12#1)(1991-12#1)
to prepare a##10##3##(1990-11#1)(1993-12#1)(2008-10#4)(2008-4#1)(2008-5#2)(2010-7#1)
to prepare an##2##3##(2008-10#2)
to prepare and##7##3##(1993-11#1)(1997-6#1)(2008-10#3)(2008-4#1)(2010-7#1)
to prepare for the##2##4##(2007-12#1)(2012-3#1)
to prepare for##3##3##(1993-2#1)(2007-12#1)(2012-3#1)
to prepare new##3##3##(1997-7#1)(2010-5#1)(2012-3#1)
to prepare nurses##2##3##(2008-11#2)
to prepare the##16##3##(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-4#1)(2012-1#1)(2013-7#1)
to prepare them for the##2##5##(2008-12#1)(2010-3#1)
to prepare them##3##3##(2008-12#1)(2008-4#1)(2010-3#1)
to prepare##97##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#4)(2009-12#1)(2009-5#2)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#4)(2011-1#1)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
to preparing##3##2##(2008-11#1)(2008-12#1)(2008-4#1)
to prescribe antibiotics##2##3##(1997-4#2)
to prescribe##11##2##(1993-2#1)(1996-11#1)(1996-8#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
to prescribers##2##2##(2008-8#1)(2009-3#1)
to prescription##2##2##(2008-8#1)(2010-3#1)
to presence##2##2##(2008-10#2)
to present a case of##4##5##(2011-2#1)(2012-12#2)(2012-2#1)
to present a clinical##2##4##(2008-6#1)(2013-1#1)
to present a major challenge to##2##6##(2008-10#1)(2010-1#1)
to present a##21##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
to present an##4##3##(1997-3#1)(2007-7#1)(2009-6#1)(2010-10#1)
to present and analyse##2##4##(2008-10#1)(2008-11#1)
to present and##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
to present our##2##3##(2007-8#1)(2012-12#1)
to present results##2##3##(2008-12#1)(2011-2#1)
to present the##16##3##(1996-3#1)(1997-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
to present this##2##3##(2007-7#1)(2013-1#1)
to present to##3##3##(1996-6#1)(2010-8#1)(2012-2#1)
to present with##4##3##(2007-12#1)(2008-4#1)(2009-11#1)(2011-2#1)
to present##96##2##(1990-5#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-2#2)(1994-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#7)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#2)(2009-11#2)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
to presentation##4##2##(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
to presenting##2##2##(2008-12#1)(2013-1#1)
to preserve a##2##3##(1996-8#1)(2008-3#1)
to preserve the##15##3##(2007-12#2)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
to preserve their##4##3##(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
to preserve these##2##3##(2008-10#1)(2008-5#1)
to preserve##40##2##(1994-2#1)(1995-12#1)(1996-8#1)(2007-12#4)(2007-7#1)(2008-10#5)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
to preserved##2##2##(2008-10#1)(2013-1#1)
to preserving the##2##3##(1991-3#1)(1997-8#1)
to preserving##3##2##(1991-3#2)(1997-8#1)
to press a##2##3##(1992-11#1)(1993-5#1)
to press##5##2##(1992-11#1)(1992-3#1)(1993-5#1)(2008-10#1)(2008-8#1)
to pressure##8##2##(1997-3#1)(2007-8#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-1#1)(2010-4#1)
to pressures##2##2##(1995-2#1)(2008-2#1)
to preterm##2##2##(2007-2#1)(2008-11#1)
to pretreatment levels##3##3##(1995-12#1)(2007-10#1)(2008-8#1)
to pretreatment##4##2##(1995-12#1)(2007-10#2)(2008-8#1)
to prevent HIV transmission##2##4##(2008-10#1)(2013-8#1)
to prevent HIV##4##3##(1991-12#1)(1997-6#1)(2008-10#1)(2013-8#1)
to prevent a &quot##2##4##(1993-1#1)(1995-2#1)
to prevent a##5##3##(1993-1#1)(1995-2#1)(2008-10#1)(2009-5#1)(2013-8#1)
to prevent abuse##2##3##(1997-7#1)(2012-3#1)
to prevent adhesion##2##3##(2008-7#2)
to prevent and control##6##4##(2007-12#1)(2008-1#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
to prevent and cure##2##4##(2008-10#1)(2008-8#1)
to prevent and relieve##2##4##(2008-11#1)(2012-3#1)
to prevent and treat##8##4##(2008-11#2)(2009-5#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
to prevent and##24##3##(1992-2#1)(1993-3#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
to prevent aspiration##2##3##(1991-11#1)(2010-7#1)
to prevent biofilm formation##2##4##(2008-1#1)(2013-1#1)
to prevent cancer##2##3##(1997-1#1)(2013-7#1)
to prevent childhood##2##3##(2010-8#1)(2012-2#1)
to prevent complications##2##3##(2007-8#1)(2011-1#1)
to prevent contamination by##2##4##(2008-10#1)(2008-2#1)
to prevent contamination##5##3##(1991-6#1)(2008-10#2)(2008-2#1)(2008-8#1)
to prevent damage##2##3##(1992-9#1)(2008-3#1)
to prevent disease##3##3##(2008-7#1)(2013-7#2)
to prevent dissemination##2##3##(2008-10#1)(2012-2#1)
to prevent early##2##3##(2013-1#1)(2013-8#1)
to prevent further##3##3##(1995-12#1)(2007-7#1)(2008-7#1)
to prevent germination##2##3##(2008-7#1)(2011-2#1)
to prevent hemorrhage##2##3##(2008-12#1)(2010-8#1)
to prevent hypertensive##2##3##(1992-8#1)(2008-8#1)
to prevent iatrogenic##2##3##(1996-3#1)(2010-8#1)
to prevent infections##6##3##(2008-5#1)(2011-2#5)
to prevent interference from##2##4##(2008-10#1)(2008-3#1)
to prevent interference##3##3##(2008-10#2)(2008-3#1)
to prevent it##3##3##(1995-5#1)(1996-8#1)(2012-2#1)
to prevent long-term complications##2##4##(2008-1#2)
to prevent long-term##3##3##(2008-1#2)(2013-1#1)
to prevent low##2##3##(1995-12#1)(1997-7#1)
to prevent or delay##3##4##(2008-1#1)(2010-10#2)
to prevent or relieve the##2##5##(2008-9#1)(2010-9#1)
to prevent or reverse the##2##5##(1994-2#1)(2011-1#1)
to prevent or reverse##4##4##(1991-9#1)(1994-2#1)(2008-3#1)(2011-1#1)
to prevent or treat##5##4##(1993-11#1)(2008-10#2)(2008-7#1)(2013-8#1)
to prevent or##21##3##(1991-9#1)(1993-11#1)(1994-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
to prevent possible##3##3##(1990-5#1)(2010-4#1)(2012-12#1)
to prevent postoperative##3##3##(1992-3#1)(2006-10#1)(2010-7#1)
to prevent premature##2##3##(1991-6#1)(2011-3#1)
to prevent psychosocial##2##3##(2010-12#1)(2013-1#1)
to prevent radial artery occlusion and radial artery spasm##2##9##(2011-2#2)
to prevent recurrence of##2##4##(2007-8#1)(2012-2#1)
to prevent recurrence##3##3##(1991-11#1)(2007-8#1)(2012-2#1)
to prevent recurrent##2##3##(1991-11#1)(1991-3#1)
to prevent serious##3##3##(2008-10#1)(2010-1#1)(2010-10#1)
to prevent severe##2##3##(2007-8#1)(2010-1#1)
to prevent skin##2##3##(1991-11#1)(2008-5#1)
to prevent spread of HIV##2##5##(1996-11#1)(2008-8#1)
to prevent such a##2##4##(2008-5#1)(2009-3#1)
to prevent such##4##3##(2007-12#1)(2008-5#1)(2009-3#1)(2013-8#1)
to prevent the binding of##2##5##(1990-11#1)(1990-5#1)
to prevent the development of##6##5##(1991-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)
to prevent the disease##2##4##(1994-9#1)(1996-6#1)
to prevent the onset of##2##5##(2008-7#1)(2013-1#1)
to prevent the onset##3##4##(2008-7#1)(2009-7#1)(2013-1#1)
to prevent the spread of##4##5##(1993-8#1)(1997-6#2)(2008-10#1)
to prevent the##50##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-9#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-12#3)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
to prevent their##3##3##(1991-5#1)(2008-5#1)(2008-6#1)
to prevent them##3##3##(2008-11#1)(2010-11#1)(2013-1#1)
to prevent these##2##3##(2008-5#1)(2008-7#1)
to prevent this##5##3##(1993-11#1)(1995-6#1)(1995-8#1)(2009-10#1)(2013-1#1)
to prevent unnecessary##2##3##(2008-10#1)(2011-2#1)
to prevent##368##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#5)(1993-2#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-7#3)(2007-8#10)(2008-1#14)(2008-10#37)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#5)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#6)(2011-2#24)(2011-3#2)(2012-1#3)(2012-12#6)(2012-2#12)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#10)
to preventing the##2##3##(2008-8#1)(2008-9#1)
to preventing##6##2##(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)
to prevention and treatment##2##4##(1996-3#1)(2012-2#1)
to prevention and##6##3##(1996-3#1)(1997-2#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)
to prevention##8##2##(1996-3#1)(1997-2#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)
to preventive health##3##3##(2008-4#3)
to preventive##4##2##(1990-12#1)(2008-4#3)
to previous findings##3##3##(1993-5#1)(1996-5#1)(1997-1#1)
to previous reports##6##3##(1992-3#1)(1993-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
to previous research##3##3##(1994-2#1)(1994-3#1)(2008-12#1)
to previous results##3##3##(1991-8#1)(2008-6#1)(2011-2#1)
to previous studies##5##3##(2007-12#1)(2007-5#1)(2008-3#1)(2009-6#1)(2012-12#1)
to previous##42##2##(1991-8#1)(1992-10#1)(1992-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)
to previously described##2##3##(1995-9#1)(2008-10#1)
to previously identified##2##3##(1997-8#1)(2008-10#1)
to previously known##2##3##(1992-8#1)(1997-3#1)
to previously published##5##3##(1995-6#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-3#1)
to previously reported##3##3##(1993-1#1)(2008-10#1)(2009-12#1)
to previously##21##2##(1992-8#1)(1993-1#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-10#1)(2009-12#3)(2013-1#1)
to price##2##2##(1993-2#1)(1994-12#1)
to primary open angle glaucoma##2##5##(2011-2#2)
to primary prevention##3##3##(1995-3#1)(1995-5#1)(1997-1#1)
to primary##29##2##(1990-11#1)(1991-8#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
to primate##2##2##(1995-2#2)
to prime##6##2##(1993-9#1)(1994-12#1)(1995-2#2)(2008-11#1)(2008-4#1)
to principal components##2##3##(2008-10#2)
to principal##3##2##(2008-10#2)(2008-11#1)
to prior findings##3##3##(2007-9#1)(2008-9#1)(2009-11#1)
to prior##6##2##(2007-9#1)(2008-1#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)
to prioritize##6##2##(1994-3#1)(2008-10#1)(2010-12#1)(2010-9#2)(2011-2#1)
to private##8##2##(1992-11#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
to proactively##2##2##(1992-1#1)(2010-10#1)
to probe DNA##2##3##(1992-4#1)(2008-10#1)
to probe RNA##2##3##(1991-12#1)(2008-4#1)
to probe a##5##3##(1994-8#1)(1995-8#1)(2007-12#1)(2008-3#2)
to probe the##21##3##(1990-7#1)(1990-8#1)(1991-3#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)(2008-4#1)(2009-10#1)(2009-12#1)(2012-12#1)
to probe their##2##3##(2008-10#1)(2012-2#1)
to probe##55##2##(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-4#1)(1992-6#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#6)(2008-4#2)(2008-8#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-9#1)(2012-12#1)(2012-2#1)
to problem use##3##3##(2013-1#3)
to problem##5##2##(2008-12#1)(2010-11#1)(2013-1#3)
to problems in the##2##4##(1993-6#1)(1997-8#1)
to problems in##3##3##(1993-6#1)(1997-8#1)(2009-3#1)
to problems of##5##3##(1991-6#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-8#1)
to problems##15##2##(1991-6#1)(1993-2#1)(1993-6#1)(1994-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-8#1)(2013-1#1)
to proceed with##6##3##(1990-8#1)(1993-2#1)(1996-5#1)(2008-10#1)(2008-2#1)(2013-1#1)
to proceed##17##2##(1990-8#1)(1991-3#1)(1993-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
to process a##3##3##(2008-9#1)(2009-7#1)(2010-11#1)
to process and##2##3##(1995-3#1)(2008-1#1)
to process monitoring##2##3##(2008-10#2)
to process the##9##3##(2008-10#1)(2008-2#2)(2008-3#5)(2008-8#1)
to process##35##2##(1994-11#1)(1995-3#2)(1996-2#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#10)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
to processes##3##2##(1993-5#1)(2008-8#1)(2009-10#1)
to processing##3##2##(2008-10#2)(2008-3#1)
to produce SA##3##3##(2008-10#3)
to produce a continuous##2##4##(2008-10#1)(2008-5#1)
to produce a high##2##4##(1993-9#1)(2010-4#1)
to produce a large##3##4##(1992-9#1)(2008-10#2)
to produce a larger##2##4##(1994-9#1)(2008-2#1)
to produce a more##2##4##(2008-10#1)(2008-11#1)
to produce a red complex##2##5##(2008-10#2)
to produce a##86##3##(1990-5#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1992-9#2)(1993-12#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1997-6#1)(1997-7#1)(2007-11#5)(2007-12#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
to produce accurate##2##3##(2008-3#1)(2013-1#1)
to produce alcohols from##2##4##(2008-6#2)
to produce an optimal##2##4##(2007-12#1)(2008-11#1)
to produce an##23##3##(1990-8#1)(1992-9#1)(1995-9#1)(1996-5#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)
to produce and secrete##2##4##(1995-2#1)(2008-10#1)
to produce and##4##3##(1995-2#1)(1997-4#1)(2008-1#1)(2008-10#1)
to produce apothecia##2##3##(2008-10#2)
to produce ascites##2##3##(1991-12#2)
to produce both##5##3##(1991-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)
to produce continuous##2##3##(2007-5#1)(2008-7#1)
to produce extracellular##2##3##(2008-10#1)(2008-9#1)
to produce fluorescent##2##3##(2008-10#2)
to produce high levels of##2##5##(1997-4#1)(2007-11#1)
to produce high##3##3##(1997-4#1)(2007-11#1)(2009-5#1)
to produce infectious##2##3##(1990-5#1)(2008-10#1)
to produce inositol phosphates##3##4##(1993-5#3)
to produce large amounts of##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
to produce large quantities of##2##5##(2008-10#1)(2008-11#1)
to produce large##8##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
to produce light emission##2##4##(2008-10#2)
to produce maps of##2##4##(2008-3#1)(2008-8#1)
to produce mature##2##3##(1990-12#1)(2010-8#1)
to produce more##4##3##(1993-11#1)(1994-2#1)(2007-12#1)(2008-8#1)
to produce new##2##3##(2008-11#1)(2012-2#1)
to produce novel##2##3##(2008-7#1)(2009-11#1)
to produce oospores in potato tuber tissue##2##7##(2008-10#2)
to produce oospores in##3##4##(2008-10#3)
to produce oospores##6##3##(2008-10#6)
to produce recombinant##3##3##(1995-5#1)(2008-11#1)(2008-2#1)
to produce results##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
to produce secondary##3##3##(2008-10#3)
to produce similar##3##3##(1992-10#1)(2008-12#2)
to produce sufficient##2##3##(1997-7#1)(2008-11#1)
to produce the desired##3##4##(2007-12#2)(2009-9#1)
to produce the##30##3##(1990-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#2)
to produce these##2##3##(1992-9#1)(2011-1#1)
to produce this##2##3##(2008-10#1)(2008-8#1)
to produce two##2##3##(1997-4#1)(2008-9#1)
to produce valid##2##3##(1991-12#1)(2008-12#1)
to produce##487##2##(1990-12#3)(1990-2#3)(1990-5#3)(1990-8#2)(1991-1#3)(1991-12#4)(1991-2#4)(1991-3#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-5#4)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#4)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#16)(2007-12#14)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#107)(2008-11#26)(2008-12#7)(2008-2#26)(2008-3#27)(2008-4#13)(2008-5#15)(2008-6#10)(2008-7#20)(2008-8#14)(2008-9#8)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-12#2)(2010-3#4)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#1)
to produce)##2##2##(2008-9#2)
to producing##3##2##(1992-5#1)(2008-7#1)(2008-9#1)
to product##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
to production in##2##3##(2008-10#1)(2008-7#1)
to production of sporangia##2##4##(2008-10#2)
to production of##10##3##(1993-6#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-6#1)
to production##15##2##(1992-12#1)(1993-6#1)(1997-4#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)
to products##2##2##(1997-1#1)(2008-10#1)
to professional work##2##3##(2007-11#1)(2011-2#1)
to professional##12##2##(1991-12#1)(1993-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
to profile##4##2##(1995-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
to proflavine##2##2##(1991-12#2)
to profound##3##2##(2008-4#1)(2008-9#2)
to progesterone##4##2##(1991-9#1)(1995-11#1)(2008-7#1)(2012-2#1)
to prognosis##3##2##(1990-8#1)(1993-9#1)(2010-11#1)
to program##6##2##(1995-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
to progress in##4##3##(1996-11#1)(2007-8#1)(2008-11#1)(2011-1#1)
to progress##11##2##(1996-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
to progression of the##2##4##(1992-6#1)(2010-6#1)
to progression of##3##3##(1992-6#1)(2008-1#1)(2010-6#1)
to progression##13##2##(1990-10#1)(1990-2#1)(1991-2#2)(1992-6#1)(1993-1#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-6#1)(2013-1#1)
to progressive loss of##2##4##(2008-7#1)(2012-3#1)
to progressive##9##2##(1991-5#1)(2008-11#1)(2008-7#4)(2011-1#1)(2012-12#1)(2012-3#1)
to project##4##2##(1996-5#1)(2008-2#1)(2009-8#1)(2012-2#1)
to prokaryotic##2##2##(1992-12#1)(2010-10#1)
to prolactin##2##2##(1990-11#1)(2008-4#1)
to proliferate and##6##3##(1997-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)
to proliferate in##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
to proliferate##22##2##(1990-12#2)(1992-2#1)(1992-8#1)(1997-6#1)(2008-10#1)(2008-11#7)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-12#1)(2013-8#1)
to proliferation##2##2##(1991-3#1)(2008-11#1)
to proline##2##2##(1991-12#1)(2008-10#1)
to prolong survival and##2##4##(1990-12#1)(2007-8#1)
to prolong the##3##3##(1991-3#1)(2007-11#1)(2013-8#1)
to prolong##12##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(2007-11#1)(2007-8#1)(2008-5#2)(2008-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
to prolonged##9##2##(1991-4#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#2)
to prominent##3##2##(2006-10#1)(2008-4#1)(2011-1#1)
to promote a##3##3##(2008-10#2)(2008-4#1)
to promote and evaluate critical thinking##2##6##(2008-12#2)
to promote and##7##3##(1996-2#1)(2007-2#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-3#1)
to promote cell growth##2##4##(2008-7#1)(2013-1#1)
to promote cell##4##3##(1995-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
to promote children's##2##3##(2012-2#1)(2013-1#1)
to promote culturally##2##3##(1997-2#1)(2013-8#1)
to promote greater##3##3##(1997-1#1)(2007-10#1)(2010-4#1)
to promote health##5##3##(2007-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-3#1)
to promote more##2##3##(2011-1#1)(2012-2#1)
to promote or##2##3##(2013-1#2)
to promote quality improvement##2##4##(1996-2#1)(1997-1#1)
to promote quality##3##3##(1996-2#1)(1997-1#1)(2008-3#1)
to promote research##2##3##(2008-6#1)(2013-1#1)
to promote smoking cessation##2##4##(1991-12#1)(1994-11#1)
to promote the activation of##2##5##(2008-1#1)(2008-4#1)
to promote the adoption of##2##5##(2008-4#1)(2010-11#1)
to promote the development of##2##5##(2008-11#1)(2011-2#1)
to promote the formation of##3##5##(1995-2#2)(2008-9#1)
to promote the##40##3##(1990-6#1)(1990-8#1)(1991-3#1)(1995-2#3)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
to promote##169##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(2007-10#4)(2007-2#2)(2007-8#1)(2008-1#7)(2008-10#15)(2008-11#6)(2008-12#7)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#3)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#8)(2012-3#8)(2013-1#13)(2013-7#5)(2013-8#3)
to promoters##2##2##(1994-3#1)(2012-3#1)
to promoting##9##2##(1993-12#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
to prompt##5##2##(1995-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
to promptly##3##2##(2006-10#1)(2008-8#1)(2010-6#1)
to pronounced##2##2##(1997-7#1)(2008-3#1)
to propagate##8##2##(1997-7#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)
to proper##3##2##(1993-6#1)(2007-8#1)(2008-7#1)
to properly diagnose##2##3##(2007-5#1)(2008-10#1)
to properly manage##2##3##(1993-2#1)(2012-12#1)
to properly##8##2##(1991-12#1)(1993-2#1)(2007-5#1)(2008-10#2)(2008-7#2)(2012-12#1)
to properties of##4##3##(2007-12#1)(2009-8#2)(2013-1#1)
to propiconazole##5##2##(2008-10#5)
to propose a method for##2##5##(2008-3#1)(2010-3#1)
to propose a new##2##4##(2007-8#1)(2008-3#1)
to propose a##10##3##(1990-7#1)(1993-11#1)(1995-3#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2010-3#1)
to propose an##2##3##(2008-10#1)(2008-11#1)
to propose and##2##3##(1991-3#1)(2010-8#1)
to propose that##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
to propose the##2##3##(2008-1#1)(2008-9#1)
to propose##32##2##(1990-7#1)(1991-3#1)(1992-8#1)(1993-11#2)(1994-2#1)(1995-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-3#1)(2010-8#1)(2013-1#2)
to prospective payment##2##3##(1991-1#1)(1992-1#1)
to prospective##4##2##(1991-1#1)(1992-1#1)(2008-12#2)
to prospectively##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
to prosper##2##2##(1997-2#1)(2008-11#1)
to prostate cancer##5##3##(2007-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)
to prostate-specific antigen##2##3##(2012-12#2)
to prostatic adenoma in##2##4##(1991-6#1)(1994-3#1)
to prostatic##3##2##(1990-12#1)(1991-6#1)(1994-3#1)
to prosthetic##2##2##(2007-11#1)(2011-2#1)
to proteases##3##2##(1992-6#1)(2008-10#2)
to protect against the##2##4##(2008-5#1)(2013-1#1)
to protect against##17##3##(1991-6#3)(1996-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#4)(2010-8#1)(2011-2#2)(2011-9#1)(2013-1#2)
to protect all##3##3##(1995-3#1)(2008-5#1)(2009-12#1)
to protect and##3##3##(1995-6#1)(2010-4#1)(2011-2#1)
to protect assets##2##3##(1992-12#2)
to protect cells##2##3##(1994-11#1)(1997-2#1)
to protect immunodeficient##3##3##(2008-5#3)
to protect public health##2##4##(2008-11#1)(2008-8#1)
to protect squalene##2##3##(2008-5#2)
to protect the artificial##2##4##(2008-5#2)
to protect the cells##2##4##(1992-11#1)(2008-11#1)
to protect the skin from##2##5##(2008-3#1)(2011-2#1)
to protect the skin##3##4##(2008-3#1)(2008-5#1)(2011-2#1)
to protect the##31##3##(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-5#6)(2008-8#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
to protect their##5##3##(1992-3#2)(1994-6#1)(2007-2#1)(2009-10#1)
to protect them against##2##4##(1994-3#1)(2013-1#1)
to protect them##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
to protect themselves and##2##4##(2008-12#1)(2010-3#1)
to protect themselves##3##3##(2007-7#1)(2008-12#1)(2010-3#1)
to protect wheat##2##3##(2008-10#1)(2011-2#1)
to protect women##2##3##(1990-2#2)
to protect##128##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#4)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(2007-11#2)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#17)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#10)(2011-9#1)(2012-12#1)(2012-2#2)(2013-1#4)
to protecting##3##2##(1992-1#1)(1996-2#1)(2013-1#1)
to protection against##2##3##(1992-8#1)(1995-5#1)
to protection##4##2##(1992-8#1)(1995-5#2)(2013-7#1)
to protein kinase C##2##4##(1992-6#1)(1994-11#1)
to protein phosphorylation##2##3##(1994-5#1)(1994-9#1)
to protein##32##2##(1990-5#1)(1991-2#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-4#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)
to protein-free##2##2##(2008-11#2)
to proteinase K##2##3##(1990-5#1)(1996-12#1)
to proteins and##4##3##(1994-12#1)(1995-3#1)(1996-12#1)(2008-10#1)
to proteins from##3##3##(1991-12#1)(1992-8#1)(1995-6#1)
to proteins that##3##3##(1997-3#1)(2010-12#1)(2012-1#1)
to proteins##23##2##(1991-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2012-1#1)
to proteolysis and##2##3##(1995-8#1)(2011-1#1)
to proteolysis##11##2##(1990-5#3)(1991-10#1)(1992-11#2)(1992-3#1)(1995-6#1)(1995-8#1)(2008-1#1)(2011-1#1)
to proteolytic enzymes##2##3##(1994-11#1)(2008-10#1)
to proteolytic##5##2##(1993-8#1)(1994-11#2)(1997-4#1)(2008-10#1)
to protocols##2##2##(1991-8#1)(2012-12#1)
to proton##4##2##(1994-11#1)(1996-12#1)(2008-6#1)(2012-2#1)
to protonated##2##2##(2008-10#1)(2009-11#1)
to prove that##4##3##(1991-7#1)(2007-11#1)(2008-10#1)(2008-6#1)
to prove the##10##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)
to prove##29##2##(1991-7#1)(1993-5#1)(1996-11#1)(1997-4#1)(2007-11#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)
to provide a basis for##2##5##(1991-11#1)(1996-4#1)
to provide a brief##3##4##(1996-2#1)(2010-10#1)(2013-1#1)
to provide a broader##2##4##(2008-11#1)(2008-7#1)
to provide a clearer##2##4##(2012-1#1)(2012-12#1)
to provide a comprehensive##6##4##(1993-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
to provide a description of##2##5##(1991-12#1)(2009-7#1)
to provide a fast##3##4##(2007-12#1)(2008-7#1)(2012-2#1)
to provide a foundation##2##4##(1996-2#1)(2008-12#1)
to provide a framework for the##2##6##(2008-7#1)(2012-12#1)
to provide a framework for##3##5##(1992-6#1)(2008-7#1)(2012-12#1)
to provide a functional##2##4##(1994-8#1)(2008-11#1)
to provide a fundamental##2##4##(2008-11#1)(2008-5#1)
to provide a general##3##4##(1997-3#1)(2008-4#1)(2008-6#1)
to provide a good##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
to provide a more##2##4##(1992-6#1)(1994-12#1)
to provide a profile of##2##5##(1991-12#1)(1995-2#1)
to provide a rational approach to the##2##7##(1996-3#1)(2011-2#1)
to provide a relatively##2##4##(2008-10#1)(2008-7#1)
to provide a reliable##2##4##(2011-7#1)(2012-2#1)
to provide a robust##2##4##(2008-1#1)(2008-3#1)
to provide a safe##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
to provide a specific##3##4##(1997-8#1)(2008-3#1)(2009-9#1)
to provide a##141##3##(1990-3#1)(1991-11#1)(1991-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1997-3#1)(1997-8#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-7#2)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#3)
to provide access to##2##4##(1991-12#1)(2008-11#1)
to provide additional support##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
to provide additional##7##3##(2008-10#2)(2008-12#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
to provide adequate##10##3##(1991-12#1)(1992-4#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
to provide an overview of the##6##6##(2008-10#1)(2008-6#1)(2008-9#1)(2009-6#2)(2011-2#1)
to provide an overview of##14##5##(1995-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
to provide an overview##15##4##(1995-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
to provide an update##2##4##(2008-5#1)(2008-8#1)
to provide an##43##3##(1994-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-4#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
to provide and##3##3##(2009-5#1)(2012-2#2)
to provide any##2##3##(1991-2#1)(1995-11#1)
to provide appropriate##3##3##(1993-3#1)(1995-9#1)(1997-7#1)
to provide better##5##3##(1993-12#1)(2008-3#2)(2008-9#1)(2013-8#1)
to provide care##5##3##(1993-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-3#1)
to provide clues to##2##4##(2008-11#1)(2012-3#1)
to provide clues##4##3##(2008-11#1)(2008-7#2)(2012-3#1)
to provide complete##2##3##(2008-10#1)(2008-8#1)
to provide comprehensive care##2##4##(2008-12#1)(2010-3#1)
to provide comprehensive##3##3##(1993-2#1)(2008-12#1)(2010-3#1)
to provide data for##2##4##(1990-2#1)(2010-7#1)
to provide data##4##3##(1990-2#1)(2008-5#1)(2010-7#1)(2011-2#1)
to provide efficient##2##3##(2007-12#1)(2008-3#1)
to provide estimates of##4##4##(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#1)
to provide evidence of##2##4##(1995-5#1)(2008-12#1)
to provide evidence##6##3##(1995-5#1)(1996-12#1)(2008-11#2)(2008-12#1)(2012-12#1)
to provide for a##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
to provide for##9##3##(1991-3#1)(1992-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#2)
to provide good##2##3##(2008-3#1)(2008-6#1)
to provide greater##2##3##(2008-3#1)(2010-6#1)
to provide guidance for##2##4##(2013-1#1)(2013-8#1)
to provide guidance##5##3##(2007-4#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
to provide guidelines##2##3##(1992-3#1)(2008-10#1)
to provide health care##2##4##(1994-12#1)(1997-3#1)
to provide health##5##3##(1994-12#1)(1997-3#1)(2007-5#1)(2008-11#1)(2010-12#1)
to provide high##5##3##(1991-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
to provide high-quality##3##3##(1991-2#1)(1997-1#1)(2008-1#1)
to provide in the##2##4##(2009-7#1)(2010-10#1)
to provide increased##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
to provide independent##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
to provide information about the##2##5##(1993-12#1)(2008-10#1)
to provide information about##6##4##(1992-2#1)(1993-12#1)(2008-10#2)(2009-5#1)(2011-3#1)
to provide information for##3##4##(1996-12#1)(2008-12#1)(2011-1#1)
to provide information on##2##4##(1995-6#1)(1996-6#1)
to provide information to##3##4##(1996-2#1)(2010-8#1)(2012-1#1)
to provide information##18##3##(1992-2#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2009-5#2)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)
to provide insight into the##2##5##(1994-3#1)(2008-2#1)
to provide insight into##7##4##(1994-3#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-9#1)(2012-3#1)
to provide insight##8##3##(1994-3#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-9#1)(2012-3#1)(2013-1#1)
to provide insights into the##4##5##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
to provide insights into##5##4##(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
to provide insights##6##3##(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
to provide insurance##2##3##(1991-2#2)
to provide integrated##2##3##(2008-7#1)(2010-10#1)
to provide knowledge##2##3##(2009-6#1)(2012-3#1)
to provide medium##2##3##(2007-11#1)(2008-3#1)
to provide mental health##2##4##(1991-1#1)(2013-1#1)
to provide more##6##3##(1990-3#1)(1992-3#1)(1997-1#1)(2008-10#1)(2009-7#1)(2011-2#1)
to provide new information##3##4##(2008-2#1)(2008-3#1)(2012-1#1)
to provide new##8##3##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-8#1)
to provide normal##2##3##(2008-7#1)(2013-3#1)
to provide nutrition##2##3##(1991-12#1)(1991-3#1)
to provide one of the##2##5##(2008-10#1)(2012-2#1)
to provide opportunities for##2##4##(1993-6#1)(2009-11#1)
to provide optimal##4##3##(2007-11#1)(2008-2#1)(2011-3#1)(2012-1#1)
to provide patient##2##3##(2010-5#1)(2013-1#1)
to provide physicians##2##3##(2008-3#2)
to provide protection##2##3##(2008-10#1)(2008-5#1)
to provide quality care##2##4##(2008-11#1)(2011-1#1)
to provide quality health care##2##5##(1994-3#1)(2008-11#1)
to provide quality##5##3##(1994-3#1)(1997-1#1)(2008-11#2)(2011-1#1)
to provide quantitative##3##3##(2008-10#2)(2008-7#1)
to provide rapid##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
to provide recommendations for##2##4##(2008-11#1)(2012-3#1)
to provide reliable##2##3##(2008-10#1)(2012-1#1)
to provide relief##2##3##(2007-11#1)(2008-9#1)
to provide robust##2##3##(2008-2#1)(2013-1#1)
to provide safe##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
to provide services##3##3##(1994-1#2)(2008-11#1)
to provide significant##2##3##(2008-7#1)(2012-3#1)
to provide similar##2##3##(2007-7#1)(2008-4#1)
to provide smoking cessation##3##4##(2011-2#1)(2012-3#2)
to provide some##5##3##(1991-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)
to provide sound##2##3##(2010-5#2)
to provide spatial##2##3##(2008-3#1)(2008-7#1)
to provide specific##2##3##(1991-2#1)(1996-12#1)
to provide students with##2##4##(2008-11#1)(2011-1#1)
to provide students##3##3##(1995-1#1)(2008-11#1)(2011-1#1)
to provide substantial##3##3##(2008-3#1)(2010-12#1)(2011-1#1)
to provide such##2##3##(1996-3#1)(2008-11#1)
to provide sufficient##3##3##(1994-12#1)(2008-11#1)(2008-7#1)
to provide that##2##3##(1996-1#1)(1996-3#1)
to provide the basic information##2##5##(1990-12#1)(2008-7#1)
to provide the best##5##4##(2008-10#3)(2008-4#1)(2010-11#1)
to provide the maximum##2##4##(2008-10#1)(2008-3#1)
to provide the most##2##4##(1997-2#1)(2011-2#1)
to provide the reader with an understanding of the##2##9##(2007-7#1)(2008-10#1)
to provide the reader with##4##5##(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)
to provide the##57##3##(1990-11#1)(1990-12#1)(1991-1#1)(1992-6#1)(1994-2#1)(1995-12#3)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)
to provide their##3##3##(1997-2#1)(2008-9#1)(2010-8#1)
to provide these##3##3##(1997-1#1)(2011-2#1)(2013-8#1)
to provide timely and##2##4##(1992-12#1)(2012-12#1)
to provide timely##3##3##(1992-12#1)(2008-8#1)(2012-12#1)
to provide to##2##3##(2010-8#1)(2013-1#1)
to provide useful information##2##4##(1996-3#1)(2009-5#1)
to provide useful##7##3##(1996-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-2#2)
to provide##690##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-1#2)(1991-11#1)(1991-12#8)(1991-2#5)(1991-3#3)(1991-9#1)(1992-12#1)(1992-2#4)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#8)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#6)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#3)(1996-12#7)(1996-2#7)(1996-3#8)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#10)(2007-12#8)(2007-3#1)(2007-4#4)(2007-5#3)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#67)(2008-11#45)(2008-12#11)(2008-2#15)(2008-3#45)(2008-4#15)(2008-5#14)(2008-6#9)(2008-7#34)(2008-8#8)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#1)(2009-9#6)(2010-10#8)(2010-11#10)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#15)(2011-2#24)(2011-3#3)(2011-7#2)(2012-1#7)(2012-12#16)(2012-2#25)(2012-3#14)(2013-1#14)(2013-3#1)(2013-8#15)
to provider##4##2##(1994-2#1)(1995-2#1)(1996-1#1)(1997-1#1)
to providers##4##2##(1992-12#1)(2008-6#1)(2008-7#2)
to providing##17##2##(1993-3#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#3)(2009-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
to provincial##2##2##(2012-12#2)
to proximal##3##2##(2007-11#2)(2008-11#1)
to psychiatric disorders##2##3##(2009-8#1)(2012-2#1)
to psychiatric##8##2##(1993-12#2)(1997-3#1)(1997-8#1)(2008-4#1)(2009-8#1)(2010-5#1)(2012-2#1)
to psychiatry##2##2##(2009-8#1)(2013-8#1)
to psychological##6##2##(1990-6#1)(1991-12#1)(1995-1#1)(2008-12#1)(2009-10#1)(2010-2#1)
to psychopathology##2##2##(2008-1#1)(2012-1#1)
to psychosocial##3##2##(1995-1#1)(2011-2#2)
to psychotherapy##2##2##(2009-10#1)(2013-1#1)
to psychotic##2##2##(1996-7#1)(2011-1#1)
to public and##2##3##(1994-3#1)(2008-7#1)
to public health practice##4##4##(1996-1#1)(1996-12#1)(1996-3#1)(2012-2#1)
to public health surveillance systems##2##5##(2008-7#2)
to public health surveillance##3##4##(1997-3#1)(2008-7#2)
to public health##25##3##(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#4)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#3)(2013-1#3)
to public health's##2##3##(1996-2#1)(1996-3#1)
to public##38##2##(1992-11#1)(1992-12#1)(1994-3#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1997-3#4)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#3)(2008-7#4)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#3)
to publicize the##2##3##(1992-12#1)(2008-7#1)
to publish##9##2##(1991-12#1)(1991-2#1)(1993-12#1)(2008-7#2)(2009-11#1)(2010-12#3)
to published data##2##3##(1996-1#1)(2008-10#1)
to published##6##2##(1993-12#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
to pull the##2##3##(1994-3#1)(2008-11#1)
to pull##4##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-5#1)
to pulmonary tuberculosis##3##3##(2011-1#2)(2013-1#1)
to pulmonary##14##2##(1994-5#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
to pulse##2##2##(2007-12#1)(2008-10#1)
to pump##2##2##(2008-11#1)(2008-2#1)
to puncture the##2##3##(2010-8#1)(2011-2#1)
to purchase##8##2##(1992-12#1)(1993-12#1)(1994-3#1)(1996-11#1)(1997-3#1)(2008-3#1)(2008-4#1)(2011-2#1)
to pure##9##2##(1990-5#2)(1994-3#1)(2008-10#4)(2008-7#1)(2013-1#1)
to purification##2##2##(2010-5#1)(2011-2#1)
to purified##4##2##(1993-3#1)(2008-1#1)(2008-9#1)(2011-2#1)
to purify the##3##3##(1990-11#1)(1991-7#1)(1994-5#1)
to purify this##2##3##(1994-11#1)(1997-7#1)
to purify##16##2##(1990-11#1)(1991-12#1)(1991-7#1)(1994-11#1)(1994-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)
to purine##2##2##(1993-8#1)(1995-12#1)
to pursue a##3##3##(1992-1#1)(2008-10#1)(2009-5#1)
to pursue the##3##3##(1992-3#1)(2008-11#1)(2008-9#1)
to pursue##17##2##(1991-3#1)(1992-1#1)(1992-3#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
to push##2##2##(2008-4#1)(2010-8#1)
to put more##3##3##(1997-2#1)(2007-7#1)(2008-10#1)
to put the##2##3##(1992-1#1)(1995-6#1)
to put them in##2##4##(1997-6#1)(2011-2#1)
to put##16##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-3#1)(1992-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
to pyrolysis##2##2##(2008-10#2)
to pyruvate were##2##3##(1993-11#1)(1994-9#1)
to pyruvate##3##2##(1993-11#1)(1994-9#1)(2008-7#1)
to quadrat size##2##3##(2008-10#2)
to qualify for##3##3##(1990-4#1)(1993-3#1)(1994-2#1)
to qualitative##2##2##(2008-10#1)(2013-1#1)
to qualitatively##3##2##(2008-10#2)(2008-8#1)
to quality and##2##3##(1997-5#1)(2007-8#1)
to quality care##2##3##(1991-1#1)(1993-12#1)
to quality control##2##3##(1992-9#1)(2008-10#1)
to quality improvement##5##3##(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-8#1)
to quality in##2##3##(1994-1#1)(1996-2#1)
to quality of##2##3##(1995-3#1)(2013-1#1)
to quality##26##2##(1991-1#1)(1991-3#1)(1992-9#1)(1993-12#2)(1994-1#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-12#2)(2013-1#2)
to quantify and stage##2##4##(2012-2#2)
to quantify and##6##3##(2008-10#2)(2008-11#1)(2010-5#1)(2012-2#2)
to quantify changes in##2##4##(2009-7#1)(2011-1#1)
to quantify the degree of##2##5##(2008-10#1)(2010-3#1)
to quantify the effect of##3##5##(2008-10#2)(2008-7#1)
to quantify the effects of##3##5##(2008-10#2)(2008-11#1)
to quantify the extent of##2##5##(1994-11#1)(2013-1#1)
to quantify the hydrolysis##2##4##(2008-10#1)(2013-1#1)
to quantify the size##2##4##(2008-7#1)(2010-10#1)
to quantify the##60##3##(1990-7#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-6#1)(2007-10#1)(2007-12#3)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-3#2)(2010-8#2)(2011-2#2)(2013-1#4)
to quantify total##2##3##(2008-1#1)(2008-12#1)
to quantify##150##2##(1990-7#1)(1991-12#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#50)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
to quantifying##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
to quantitate enantiomeric mixtures##2##4##(2008-10#2)
to quantitate the##10##3##(1991-9#1)(1992-12#1)(1992-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)
to quantitate##38##2##(1990-12#3)(1991-9#2)(1992-12#2)(1992-6#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#6)(2008-6#1)(2008-9#6)(2009-10#1)(2012-2#1)
to quantitation##2##2##(1991-5#1)(2008-10#1)
to quantitative analysis of##2##4##(2008-2#1)(2008-9#1)
to quantitative analysis##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
to quantitative##9##2##(1997-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
to quantitatively analyze the##2##4##(2008-2#1)(2009-7#1)
to quantitatively analyze##3##3##(2008-2#1)(2008-4#1)(2009-7#1)
to quantitatively assess##3##3##(2008-10#2)(2011-1#1)
to quantitatively measure##4##3##(1994-9#1)(2008-10#1)(2008-8#1)(2012-12#1)
to quantitatively##21##2##(1994-9#1)(1995-12#1)(2007-5#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-7#1)(2012-12#1)(2013-8#1)
to quartz surfaces##2##3##(2008-10#2)
to quench##4##2##(1992-9#1)(2008-5#1)(2008-8#1)(2008-9#1)
to quenching##2##2##(1997-7#1)(2013-1#1)
to query##3##2##(2008-10#1)(2008-4#2)
to question the##3##3##(1993-2#1)(2008-12#1)(2010-6#1)
to question##4##2##(1993-2#1)(2008-12#1)(2009-6#1)(2010-6#1)
to questions about##3##3##(1991-2#1)(1992-12#1)(2013-1#1)
to questions of##2##3##(1997-8#1)(2008-10#1)
to questions regarding##2##3##(1994-12#1)(2008-7#1)
to questions that##2##3##(1995-1#1)(2008-11#1)
to questions##11##2##(1991-2#1)(1992-12#1)(1994-12#1)(1995-1#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
to quick##2##2##(2008-10#1)(2011-2#1)
to quickly and##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
to quickly##10##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-7#1)
to quit smoking##4##3##(2013-8#4)
to quit using##2##3##(2008-4#2)
to quit##17##2##(1991-12#1)(1991-5#1)(2008-4#2)(2010-2#3)(2011-2#2)(2013-1#2)(2013-8#6)
to r = 0##2##4##(1991-5#1)(1995-2#1)
to r =##3##3##(1991-3#1)(1991-5#1)(1995-2#1)
to r-hu IFN-gamma##2##3##(1993-9#2)
to rabbit##3##2##(1993-11#1)(1995-2#1)(2010-4#1)
to race 1 isolates##2##4##(2008-10#2)
to race 1##7##3##(2008-10#7)
to race 2##6##3##(2008-10#6)
to race 3##3##3##(2008-10#3)
to race 4##2##3##(2008-10#2)
to race##23##2##(2007-10#1)(2008-10#21)(2011-2#1)
to races 1 and 4 was##2##6##(2008-10#2)
to races 1 and 4##4##5##(2008-10#4)
to races 1 and 8##2##5##(2008-10#2)
to races 1 and##9##4##(2008-10#9)
to races 1##11##3##(2008-10#11)
to races##13##2##(2008-10#13)
to radial##5##2##(1997-3#1)(2007-8#3)(2011-2#1)
to radiation sensitive##2##3##(1993-9#2)
to radiation therapy##2##3##(1994-12#1)(1997-3#1)
to radiation##17##2##(1993-2#1)(1993-9#2)(1994-12#1)(1994-8#1)(1997-3#1)(2008-3#1)(2008-5#1)(2008-7#6)(2008-9#1)(2011-2#1)(2013-7#1)
to radical##2##2##(2008-11#1)(2010-11#1)
to radioactive##2##2##(1993-11#1)(2008-5#1)
to radiolabel##3##2##(1991-3#1)(1996-2#1)(2008-11#1)
to radiological##2##2##(2007-11#1)(2010-9#1)
to radiology##4##2##(1991-2#1)(1992-3#1)(1994-1#1)(1996-2#1)
to radiotherapy##7##2##(1994-8#1)(2008-6#2)(2010-12#1)(2010-3#2)(2011-2#1)
to radon##2##2##(1996-6#1)(2008-7#1)
to raindrop##2##2##(2008-3#2)
to raise the awareness##2##4##(2011-2#1)(2013-1#1)
to raise the##8##3##(1990-8#1)(1991-5#1)(1996-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
to raise##23##2##(1990-8#1)(1991-5#1)(1993-1#1)(1995-11#1)(1996-12#2)(1997-2#1)(1997-9#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
to random##12##2##(1995-12#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#2)(2010-8#2)
to randomly##2##2##(2008-9#1)(2012-2#1)
to range from 0##2##4##(1995-5#1)(2008-10#1)
to range from 1##3##4##(1994-8#1)(2008-10#1)(2013-1#1)
to range from##9##3##(1994-8#1)(1995-5#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
to range##11##2##(1994-8#1)(1995-5#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
to ranges of##2##3##(2008-3#2)
to rank the##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
to rank##9##2##(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
to rapid##14##2##(1990-6#1)(1991-3#1)(1992-9#1)(2008-1#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
to rapidly acquire##2##3##(2011-1#2)
to rapidly detect the##2##4##(2008-10#1)(2008-4#1)
to rapidly detect##4##3##(2008-10#1)(2008-4#1)(2012-2#2)
to rapidly generate##2##3##(2008-11#1)(2008-6#1)
to rapidly screen large##2##4##(2008-10#1)(2008-9#1)
to rapidly screen##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
to rapidly##36##2##(1994-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1997-1#1)(2007-10#2)(2007-12#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#2)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#1)
to rare##4##2##(2006-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
to rarely##2##2##(1996-2#1)(2008-7#1)
to rat liver mitochondria##2##4##(1991-5#1)(1994-12#1)
to rat liver##3##3##(1991-5#1)(1992-6#1)(1994-12#1)
to rat##12##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)
to rate how##2##3##(2009-10#2)
to rate the importance of##2##5##(1993-12#1)(1995-3#1)
to rate the##5##3##(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2013-8#1)
to rate##20##2##(1991-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-2#1)(2013-8#1)
to rates##2##2##(1993-12#1)(2009-8#1)
to rather##2##2##(1991-6#1)(2008-5#1)
to rationalize the##5##3##(1996-5#1)(1997-7#1)(2008-10#2)(2008-7#1)
to rationalize##6##2##(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-7#1)
to rationally design##2##3##(2008-10#1)(2008-4#1)
to rationally##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
to ratios of##2##3##(2008-10#2)
to rats and##2##3##(1995-11#1)(2008-4#1)
to rats produced##2##3##(1996-12#1)(2012-2#1)
to rats##21##2##(1990-5#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2012-2#2)(2013-1#1)
to raw##2##2##(2008-3#1)(2010-4#1)
to re-engineer##2##2##(1996-2#1)(2007-12#1)
to re-evaluate the##2##3##(1995-6#1)(2008-11#1)
to re-evaluate##3##2##(1995-6#1)(2008-11#1)(2008-7#1)
to re-examine the##2##3##(2008-11#1)(2010-12#1)
to re-examine##6##2##(1992-12#1)(1996-3#1)(2008-1#1)(2008-11#2)(2010-12#1)
to re-think##2##2##(1990-2#1)(1991-6#1)
to reach 50% of##2##4##(2008-10#1)(2011-2#1)
to reach a critical##2##4##(2008-7#1)(2008-8#1)
to reach a maximum value##2##5##(2008-5#2)
to reach a##14##3##(1993-3#1)(1993-8#1)(1994-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2012-3#1)
to reach an##2##3##(1996-3#1)(2008-8#1)
to reach clinical##2##3##(2008-11#1)(2008-5#1)
to reach its##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
to reach steady state##2##4##(2008-10#2)
to reach the##27##3##(1990-12#1)(1990-5#1)(1992-5#1)(1995-11#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#1)(2009-12#1)(2009-2#2)(2009-8#1)(2011-2#2)
to reach their##2##3##(2008-6#1)(2010-5#1)
to reach this##4##3##(1997-3#1)(2008-10#1)(2012-12#2)
to reach##99##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-11#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-3#3)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
to react specifically with the##2##5##(1993-6#1)(2008-5#1)
to react with a##2##4##(1991-7#1)(2008-10#1)
to react with o-phthalaldehyde (OPA)##2##5##(2008-10#2)
to react with the##5##4##(1993-11#1)(2008-10#3)(2009-9#1)
to react with##17##3##(1991-7#1)(1993-11#1)(2008-10#13)(2008-8#1)(2009-9#1)
to react##29##2##(1990-11#2)(1990-3#1)(1991-12#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-9#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)
to reaction 2##2##3##(1992-6#2)
to reaction with##2##3##(1992-12#1)(2008-10#1)
to reaction##7##2##(1992-12#1)(1992-6#2)(1996-5#1)(2008-10#2)(2008-7#1)
to reactivate the##2##3##(1990-5#1)(1995-6#1)
to reactivate##4##2##(1990-5#1)(1995-6#1)(1997-7#1)(2008-5#1)
to reactive oxygen species (ROS)##2##5##(2008-10#1)(2011-10#1)
to reactive##9##2##(1991-11#1)(1991-5#1)(1991-9#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-10#1)(2013-7#1)
to read out the##2##4##(2008-3#2)
to read the##3##3##(2008-3#1)(2008-5#1)(2009-11#1)
to read##17##2##(1990-12#1)(1990-3#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-3#3)(2008-5#1)(2009-11#1)(2009-12#1)(2012-2#2)(2013-1#1)
to readily##4##2##(1997-3#1)(2008-1#1)(2009-2#1)(2013-8#1)
to real samples##11##3##(2008-10#11)
to real##30##2##(1996-5#1)(1997-3#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to real-time##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
to realign##2##2##(1995-3#1)(2007-12#1)
to realise the##3##3##(2008-11#2)(2008-12#1)
to realise##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
to reality##2##2##(1991-8#1)(1995-12#1)
to realize a##4##3##(2008-3#1)(2008-5#1)(2010-5#1)(2013-8#1)
to realize that##5##3##(1991-2#1)(1994-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
to realize the##8##3##(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
to realize their##2##3##(2008-10#1)(2010-12#1)
to realize this##3##3##(1995-1#1)(2008-10#1)(2010-8#1)
to realize##36##2##(1991-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-3#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
to realizing##3##2##(2008-3#3)
to reap the##2##3##(1996-1#1)(2008-10#1)
to reap##3##2##(1996-1#1)(2008-10#1)(2008-11#1)
to rearing##2##2##(2008-11#1)(2008-9#1)
to reason about##2##3##(2008-11#1)(2008-9#1)
to reasonably##2##2##(2008-7#1)(2011-2#1)
to reassess##5##2##(1991-3#1)(1996-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
to rebuild##4##2##(1992-2#1)(2007-11#2)(2009-11#1)
to recanalize##2##2##(1991-3#1)(2011-2#1)
to recapitulate##3##2##(2008-2#1)(2008-5#1)(2012-1#1)
to receive a##7##3##(1994-3#1)(1995-12#1)(1996-5#1)(2008-4#1)(2009-4#1)(2010-12#1)(2012-3#1)
to receive an##2##3##(1990-3#1)(2013-1#1)
to receive and##2##3##(2008-7#1)(2013-8#1)
to receive attention##2##3##(2008-1#1)(2012-3#1)
to receive either##6##3##(1990-9#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-7#1)(2013-1#1)
to receive influenza##3##3##(2012-3#3)
to receive information##3##3##(1995-8#1)(1996-1#1)(2009-5#1)
to receive multimodal##2##3##(1991-8#1)(2012-3#1)
to receive the##6##3##(1990-2#1)(1994-9#1)(1997-3#1)(2008-1#1)(2008-5#1)(2011-2#1)
to receive treatment##2##3##(2008-7#1)(2013-1#1)
to receive##88##2##(1990-2#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-10#3)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-7#2)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#1)
to recent findings##3##3##(2008-1#1)(2008-11#2)
to recent##15##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2010-8#1)(2011-2#3)(2013-8#1)
to recently##3##2##(2008-9#1)(2011-2#2)
to receptor##2##2##(1990-4#1)(1994-6#1)
to receptors##3##2##(1993-11#1)(1996-12#1)(1996-2#1)
to recipient##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
to reclaim##2##2##(2008-1#1)(2008-6#1)
to recognise and##2##3##(2008-6#1)(2012-2#1)
to recognise this##2##3##(2007-7#1)(2013-8#1)
to recognise##11##2##(1996-8#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
to recognition##5##2##(1994-9#1)(2008-1#1)(2008-3#1)(2012-2#2)
to recognize a##4##3##(1991-2#1)(1992-8#1)(1997-1#1)(2008-7#1)
to recognize and##13##3##(1993-1#1)(1994-1#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to recognize it##2##3##(1995-5#1)(2008-11#1)
to recognize sexual abuse##2##4##(2009-9#2)
to recognize target##2##3##(1995-8#1)(2008-10#1)
to recognize that##5##3##(1995-11#1)(1996-6#1)(2008-4#1)(2008-9#1)(2009-8#1)
to recognize the most##2##4##(2008-2#1)(2012-3#1)
to recognize the possibility of##2##5##(2008-12#1)(2011-2#1)
to recognize the##19##3##(1990-2#1)(1994-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
to recognize these##2##3##(2008-11#1)(2010-1#1)
to recognize this##3##3##(1991-5#1)(1991-8#1)(2008-9#1)
to recognize##91##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-5#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#8)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
to recognizing##2##2##(2008-12#1)(2008-4#1)
to recombinant##8##2##(1991-12#1)(1992-8#1)(1997-4#2)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
to recombination##2##2##(2008-10#1)(2008-12#1)
to recombine##3##2##(1991-3#1)(1992-12#1)(2008-4#1)
to recommend it##3##3##(1992-12#1)(1996-2#1)(2008-7#1)
to recommend that##2##3##(1997-2#1)(2010-9#1)
to recommend the##7##3##(1993-12#3)(1994-2#1)(2008-10#1)(2010-5#1)(2011-2#1)
to recommend##27##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#3)(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#5)(2009-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to recommended##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
to recommending the##2##3##(2008-10#1)(2009-4#1)
to reconcile the discrepancy between##2##5##(1993-11#1)(2008-11#1)
to reconcile the##7##3##(1992-3#1)(1993-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)
to reconcile these##2##3##(2008-11#1)(2013-8#1)
to reconcile##12##2##(1992-3#1)(1993-11#1)(1995-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-8#1)
to reconsider the##2##3##(1991-1#1)(2008-12#1)
to reconsider##3##2##(1991-1#1)(2008-12#1)(2008-8#1)
to reconstitute the##2##3##(1990-2#1)(1992-3#1)
to reconstitute##4##2##(1990-2#1)(1992-3#1)(1993-6#1)(2012-2#1)
to reconstruct a##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
to reconstruct an##3##3##(2007-12#1)(2008-3#1)(2012-3#1)
to reconstruct large##2##3##(1994-6#1)(2010-6#1)
to reconstruct the##20##3##(2007-12#7)(2008-12#1)(2008-3#6)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to reconstruct##46##2##(1994-6#1)(1995-5#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-12#1)(2008-3#13)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
to reconstruction##4##2##(2008-2#1)(2008-3#3)
to record the##19##3##(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2013-1#2)(2013-8#1)
to record##43##2##(1994-12#1)(1994-3#1)(1996-5#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#14)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
to recover and##2##3##(2013-1#2)
to recover from##2##3##(2007-5#1)(2008-10#1)
to recover the##13##3##(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-5#1)
to recover tocopherols##2##3##(2008-6#2)
to recover##36##2##(1991-12#1)(1995-12#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-10#7)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-5#1)(2012-1#2)(2012-12#1)(2013-1#3)
to recovery##8##2##(2008-6#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
to recreational##2##2##(2009-5#1)(2013-1#1)
to recruit and retain##2##4##(1991-3#1)(2008-5#1)
to recruit the##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
to recruit##17##2##(1991-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1995-2#1)(2007-12#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#1)
to recruitment##4##2##(1990-2#1)(2008-11#1)(2008-8#1)(2010-10#1)
to rectal cancer##2##3##(1993-6#1)(2008-10#1)
to rectal##4##2##(1991-7#1)(1993-6#1)(1996-3#1)(2008-10#1)
to recur##4##2##(1990-8#1)(1993-11#1)(2008-7#1)(2013-1#1)
to recurrence##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
to recurrent##5##2##(1990-6#1)(1992-9#1)(2008-11#1)(2008-8#1)(2013-1#1)
to recycle##2##2##(1995-6#1)(2009-9#1)
to red light##2##3##(1992-6#1)(2008-8#1)
to red##10##2##(1992-6#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2012-2#2)(2012-3#1)
to redefine the##3##3##(1994-3#1)(1996-1#1)(2011-2#1)
to redefine##5##2##(1994-3#1)(1995-2#1)(1996-1#1)(2008-7#1)(2011-2#1)
to redesign##6##2##(1992-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-1#1)
to redirect##2##2##(2008-2#1)(2012-2#1)
to redox##4##2##(2008-10#3)(2011-2#1)
to redress the##2##3##(2008-11#1)(2008-5#1)
to redress##3##2##(2008-11#1)(2008-5#1)(2010-12#1)
to reduce CVD##2##3##(2010-12#1)(2012-12#1)
to reduce a##6##3##(1993-1#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-1#1)
to reduce and##2##3##(1993-8#1)(2012-3#1)
to reduce bacterial##2##3##(2008-10#1)(2013-8#1)
to reduce blood pressure adequately##2##5##(1990-11#1)(1995-2#1)
to reduce blood pressure##3##4##(1990-11#1)(1995-2#1)(2008-8#1)
to reduce cardiovascular risk##2##4##(2008-6#1)(2010-12#1)
to reduce cardiovascular##3##3##(1993-11#1)(2008-6#1)(2010-12#1)
to reduce cost##2##3##(2008-7#1)(2012-2#1)
to reduce costs and##2##4##(1997-1#1)(2010-9#1)
to reduce costs##9##3##(1990-4#1)(1991-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-11#1)(2010-9#1)
to reduce development##3##3##(1994-6#1)(2008-11#1)(2011-2#1)
to reduce disease##2##3##(2008-10#1)(2011-2#1)
to reduce disparities##3##3##(2009-5#1)(2012-3#1)(2013-1#1)
to reduce drastically the##3##4##(2008-10#2)(2008-3#1)
to reduce health##2##3##(1994-12#1)(2010-5#1)
to reduce infection rates##2##4##(2007-8#1)(2012-12#1)
to reduce inflammation and##2##4##(1992-11#1)(2011-2#1)
to reduce its##2##3##(2008-7#1)(2012-12#1)
to reduce length of stay and##2##6##(1993-3#1)(1995-3#1)
to reduce levels##2##3##(2008-1#1)(2008-9#1)
to reduce maternal mortality##2##4##(1994-3#1)(2008-11#1)
to reduce mitochondrial##2##3##(2008-1#1)(2010-3#1)
to reduce morbidity and mortality##2##5##(1990-2#1)(2011-2#1)
to reduce mortality##4##3##(2008-3#1)(2010-5#1)(2010-8#1)(2012-3#1)
to reduce or##7##3##(1992-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-5#1)(2013-1#1)
to reduce pain##2##3##(2012-2#1)(2013-1#1)
to reduce postoperative##2##3##(2008-10#1)(2008-8#1)
to reduce recurrence##2##3##(2007-8#1)(2011-2#1)
to reduce risks##2##3##(1991-3#2)
to reduce significantly the##5##4##(1993-11#1)(2007-12#1)(2008-2#2)(2013-8#1)
to reduce sweating##2##3##(2008-5#2)
to reduce the amount of##3##5##(2008-10#1)(2008-11#2)
to reduce the burden of##3##5##(2007-12#1)(2011-2#1)(2012-3#1)
to reduce the chance##2##4##(1995-6#1)(2008-7#1)
to reduce the clinical##2##4##(2008-8#1)(2013-1#1)
to reduce the computation##2##4##(2008-2#1)(2008-3#1)
to reduce the consequences##2##4##(2008-12#1)(2011-2#1)
to reduce the cost of##2##5##(1997-4#1)(2013-1#1)
to reduce the cost##5##4##(1996-12#1)(1997-4#1)(2008-2#1)(2008-7#1)(2013-1#1)
to reduce the dose##2##4##(2008-7#1)(2013-1#1)
to reduce the effects of##4##5##(1997-6#1)(2008-2#1)(2008-3#2)
to reduce the impact of##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
to reduce the incidence of##13##5##(1991-12#1)(1992-12#2)(1993-3#1)(1996-1#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-3#1)(2011-2#1)
to reduce the incidence##14##4##(1991-12#1)(1992-12#2)(1993-3#1)(1996-1#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-3#1)(2011-2#1)
to reduce the influence of##2##5##(2008-2#2)
to reduce the influence##3##4##(2008-10#1)(2008-2#2)
to reduce the interference##2##4##(2008-10#2)
to reduce the level of##2##5##(1997-6#1)(2008-1#1)
to reduce the morbidity and mortality##3##6##(1996-9#1)(2009-4#1)(2012-12#1)
to reduce the negative consequences of##2##6##(1990-6#1)(2007-8#1)
to reduce the number of##12##5##(1990-11#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-2#1)(2013-8#1)
to reduce the number##13##4##(1990-11#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
to reduce the potential for##2##5##(1993-10#1)(2008-10#1)
to reduce the production of##4##5##(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)
to reduce the rate of##2##5##(1994-12#1)(2010-7#1)
to reduce the required##2##4##(2008-2#1)(2008-3#1)
to reduce the risk of cardiovascular##2##6##(2008-3#1)(2012-2#1)
to reduce the risk of##21##5##(1990-2#1)(1993-11#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#4)
to reduce the risks of##2##5##(2008-12#1)(2008-9#1)
to reduce the risks##3##4##(2008-12#1)(2008-4#1)(2008-9#1)
to reduce the size of the##2##6##(1996-3#1)(2010-10#1)
to reduce the size of##3##5##(1994-11#1)(1996-3#1)(2010-10#1)
to reduce the time##2##4##(2008-10#1)(2008-3#1)
to reduce the variability of##2##5##(2008-10#1)(2008-2#1)
to reduce the##204##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-6#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#25)(2008-11#6)(2008-12#4)(2008-2#16)(2008-3#19)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#8)
to reduce their##5##3##(1991-6#1)(1996-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
to reduce thermal##2##3##(1991-2#1)(2007-12#1)
to reduce these##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
to reduce this risk##2##4##(1994-12#1)(2008-1#1)
to reduce this##8##3##(1994-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
to reduce to##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
to reduce toughness of##2##4##(2013-1#2)
to reduce variation##2##3##(1993-3#1)(1996-1#1)
to reduce violence##3##3##(1994-2#1)(2012-12#1)(2012-3#1)
to reduce##521##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#4)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-2#3)(1993-3#4)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#4)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#14)(2007-12#11)(2007-2#1)(2007-7#1)(2007-8#7)(2008-1#12)(2008-10#60)(2008-11#21)(2008-12#5)(2008-2#28)(2008-3#33)(2008-4#4)(2008-5#13)(2008-6#7)(2008-7#20)(2008-8#13)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-2#21)(2012-1#2)(2012-12#9)(2012-2#12)(2012-3#8)(2013-1#32)(2013-8#14)
to reduced bacterial##2##3##(2008-10#2)
to reduced melanogenesis##2##3##(2008-5#2)
to reduced##33##2##(1990-2#1)(1991-9#1)(1992-9#1)(1995-2#1)(1995-5#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
to reducing the number of##2##5##(1995-5#1)(2008-3#1)
to reducing the##8##3##(1992-12#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-3#1)
to reducing##19##2##(1992-12#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to reduction in##2##3##(2008-1#2)
to reduction of the##2##4##(1994-11#1)(2007-11#1)
to reduction of##6##3##(1994-11#1)(1995-6#1)(2007-11#1)(2008-2#1)(2011-2#2)
to reduction##9##2##(1994-11#1)(1995-6#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2011-2#2)
to reductions in dietary##2##4##(2012-2#2)
to reductions in the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
to reductions in##9##3##(1995-2#1)(2008-10#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
to redundant##2##2##(1994-8#1)(2009-5#1)
to reengineer the##2##3##(1996-1#1)(2011-7#1)
to reestablish##2##2##(2012-2#1)(2013-1#1)
to reexamine##2##2##(1996-12#1)(2008-9#1)
to refer to##4##3##(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
to refer##8##2##(1991-11#1)(1993-3#1)(1995-9#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
to reference##11##2##(1992-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
to referral##3##2##(2006-10#1)(2007-8#1)(2008-6#1)
to referring physicians##2##3##(1993-12#1)(2011-2#1)
to referring##3##2##(1993-12#1)(1996-3#1)(2011-2#1)
to refine the##11##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-8#1)
to refine##17##2##(1994-7#1)(1996-3#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-8#1)
to reflect current##2##3##(1997-2#1)(2011-2#1)
to reflect on##5##3##(1994-9#1)(1995-1#1)(2008-11#1)(2012-3#2)
to reflect that##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
to reflect the impact of##2##5##(2008-2#1)(2011-1#1)
to reflect the presence##2##4##(1997-1#1)(2008-7#1)
to reflect the##19##3##(1993-2#1)(1995-2#1)(1997-1#1)(2007-5#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
to reflect##61##2##(1991-2#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#2)
to reflected##3##2##(2008-3#3)
to reflective##2##2##(1990-5#1)(2013-1#1)
to reform Medicare##2##3##(1997-3#1)(2008-6#1)
to reform the delivery of health care##2##7##(1994-12#1)(1997-1#1)
to reform the##4##3##(1992-5#1)(1994-12#1)(1997-1#1)(2008-4#1)
to reform##9##2##(1992-5#1)(1994-12#1)(1995-2#2)(1997-1#1)(1997-3#1)(2008-4#1)(2008-6#1)(2010-5#1)
to refractive-index##2##2##(2007-11#1)(2008-3#1)
to refuse medication##2##3##(1992-12#2)
to refuse##10##2##(1990-11#1)(1992-12#2)(1994-12#1)(1995-12#2)(1995-2#1)(2008-11#1)(2009-6#2)
to regain their former##2##4##(2012-3#1)(2013-1#1)
to regain##5##2##(1995-8#1)(2008-1#1)(2008-9#1)(2012-3#1)(2013-1#1)
to regard##5##2##(1995-6#1)(1997-7#1)(2008-11#1)(2008-5#1)(2013-8#1)
to regenerate the##4##3##(2008-10#1)(2008-5#2)(2013-1#1)
to regenerate##17##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#6)(2008-8#1)(2009-10#1)(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to region##3##2##(1992-2#1)(2008-10#1)(2008-7#1)
to regional and##2##3##(2009-9#1)(2010-7#1)
to regional##16##2##(1992-12#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#2)(2010-7#1)(2013-7#1)
to regions##2##2##(1996-4#1)(2008-3#1)
to register a##2##3##(2008-11#1)(2008-3#1)
to register##7##2##(1990-11#1)(1991-2#1)(1996-11#1)(1996-7#1)(2007-2#1)(2008-11#1)(2008-3#1)
to registered##3##2##(1995-8#1)(2008-11#1)(2008-12#1)
to regression of##2##3##(1992-12#1)(1996-9#1)
to regular##5##2##(1997-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)
to regularity for##3##3##(2008-10#3)
to regularity##4##2##(2008-10#4)
to regularly##4##2##(1997-7#1)(2007-11#1)(2008-12#1)(2012-12#1)
to regulate a wide##2##4##(2008-11#1)(2008-9#1)
to regulate a##5##3##(1990-8#1)(1995-2#1)(2008-11#1)(2008-9#1)(2009-5#1)
to regulate actin##3##3##(1996-2#1)(2012-2#2)
to regulate and##2##3##(1994-5#1)(2008-2#1)
to regulate both##2##3##(2008-10#1)(2012-2#1)
to regulate cell##2##3##(1994-6#1)(2008-11#1)
to regulate development##2##3##(1993-3#1)(1994-12#1)
to regulate gene expression##2##4##(1993-6#1)(2008-4#1)
to regulate neuronal##2##3##(1995-2#1)(2013-8#1)
to regulate telomere length##2##4##(2012-3#2)
to regulate the activity of##2##5##(1995-5#1)(2009-8#1)
to regulate the cell##2##4##(2008-11#1)(2012-3#1)
to regulate the expression of a number of##2##8##(2010-8#1)(2012-12#1)
to regulate the expression of the##2##6##(1993-12#1)(2008-11#1)
to regulate the expression of##11##5##(1993-12#1)(1994-11#1)(1994-12#1)(1995-9#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#2)(2012-12#2)
to regulate the##24##3##(1993-12#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-9#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)
to regulate transcription##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
to regulate##88##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-9#1)(1996-2#3)(1997-2#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#1)(2013-8#1)
to regulation of##3##3##(2008-8#1)(2009-8#1)(2013-1#1)
to regulation##6##2##(1990-8#1)(1993-8#2)(2008-8#1)(2009-8#1)(2013-1#1)
to regulatory and##2##3##(2012-3#1)(2013-7#1)
to regulatory##5##2##(1995-6#1)(2008-1#1)(2008-11#1)(2012-3#1)(2013-7#1)
to rehabilitation##5##2##(1996-2#1)(2008-6#1)(2008-9#1)(2010-3#1)(2012-2#1)
to reimburse##5##2##(1993-3#1)(1997-2#1)(1997-5#1)(2008-12#2)
to rein in##2##3##(1994-3#1)(2013-7#1)
to reinforce and##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
to reinforce the##7##3##(1992-11#1)(1992-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
to reinforce##17##2##(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#3)(2009-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
to reinforcement##2##2##(2008-10#1)(2008-5#1)
to reintroduce the##2##3##(1990-5#1)(2009-5#1)
to reintroduce##3##2##(1990-5#1)(1995-8#1)(2009-5#1)
to reinvent##2##2##(1994-12#1)(2006-5#1)
to reject the interference##2##4##(2008-10#2)
to reject the##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
to reject##10##2##(1992-1#1)(1995-5#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)
to relapse##4##2##(1994-5#1)(2007-12#1)(2008-8#1)(2010-12#1)
to relate the observed##2##4##(1997-2#1)(2008-10#1)
to relate the##14##3##(1990-3#1)(1997-2#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2012-2#1)
to relate to##5##3##(1994-1#1)(2008-11#1)(2009-8#2)(2012-12#1)
to relate##45##2##(1990-3#1)(1994-1#1)(1994-2#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
to related##2##2##(2007-2#1)(2009-12#1)
to relatedness##2##2##(2008-8#1)(2008-9#1)
to relative##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
to relatively small##4##3##(2008-5#2)(2008-7#1)(2010-8#1)
to relatively##12##2##(1990-12#1)(1996-10#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-8#1)(2013-1#1)
to relax##3##2##(2008-2#1)(2008-7#2)
to release the##6##3##(1994-8#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
to release their##2##3##(2008-4#1)(2011-1#1)
to release##39##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-8#1)
to relevant##2##2##(1990-12#1)(2008-11#1)
to reliably detect##2##3##(2008-10#1)(2008-3#1)
to reliably predict##3##3##(1993-6#1)(2009-4#1)(2012-1#1)
to reliably##17##2##(1993-6#1)(1997-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
to relieve pain##3##3##(2007-11#1)(2008-9#1)(2009-12#1)
to relieve the##2##3##(1995-8#1)(2011-2#1)
to relieve##19##2##(1992-5#1)(1993-3#1)(1995-8#1)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2011-2#2)(2013-1#2)
to religion##3##2##(2008-4#1)(2009-11#1)(2009-7#1)
to religious##3##2##(2008-10#1)(2009-10#1)(2010-2#1)
to relocate the##2##3##(2008-10#1)(2009-4#1)
to rely on##8##3##(1991-9#1)(1993-12#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
to rely##11##2##(1991-9#1)(1993-12#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
to relying on##2##3##(2008-12#1)(2009-5#1)
to remain in their##3##4##(2008-3#1)(2008-9#1)(2010-10#1)
to remain in##7##3##(1991-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-10#1)
to remain intact##2##3##(1996-5#1)(1996-6#1)
to remain living at home##3##5##(2013-1#3)
to remain stable##2##3##(2008-10#1)(2008-7#1)
to remain susceptible to##2##4##(2008-10#2)
to remain the##3##3##(1993-1#1)(1997-6#1)(2008-10#1)
to remain viable##2##3##(1994-12#1)(1997-3#1)
to remain##47##2##(1991-1#2)(1991-3#1)(1991-4#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#2)(1994-5#2)(1996-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#7)(2013-8#1)
to remedy the##2##3##(2008-11#1)(2010-11#1)
to remedy##4##2##(2007-11#1)(2008-11#1)(2010-11#1)(2012-2#1)
to remember that##3##3##(1991-11#1)(2008-5#1)(2013-1#1)
to remember##8##2##(1991-11#1)(1995-3#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
to remind##4##2##(2007-11#2)(2008-1#1)(2008-3#1)
to remote primary##2##3##(1997-4#1)(2008-10#1)
to remote sensing of##2##4##(2008-10#1)(2008-3#1)
to remote sensing##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
to remote##8##2##(1995-1#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#3)
to remotely##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
to removal of##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
to removal##4##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)
to remove a##2##3##(1995-2#1)(2008-6#1)
to remove any##3##3##(1992-6#1)(1994-12#1)(2013-1#1)
to remove barriers##2##3##(1994-2#1)(1997-2#1)
to remove excess##2##3##(2008-10#1)(2011-2#1)
to remove residual##5##3##(2008-10#1)(2008-3#1)(2008-8#3)
to remove silicon##2##3##(2008-10#2)
to remove the most##2##4##(1993-3#1)(2008-10#1)
to remove the##38##3##(1990-11#1)(1992-3#1)(1993-3#1)(1994-8#1)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#18)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#3)(2013-8#1)
to remove traces of##3##4##(2008-10#3)
to remove water##2##3##(2008-10#1)(2009-11#1)
to remove##117##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#36)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#1)(2013-1#7)(2013-7#3)(2013-8#2)
to renal failure##4##3##(2007-6#1)(2008-1#1)(2008-4#2)
to renal##15##2##(1990-11#1)(1991-12#1)(1995-11#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
to render the##4##3##(1990-5#1)(1997-6#1)(2008-10#1)(2010-8#1)
to render##11##2##(1990-5#1)(1994-2#1)(1995-2#1)(1997-5#2)(1997-6#2)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
to renew##3##2##(1992-6#1)(1995-6#1)(2008-3#1)
to reorganize##2##2##(1992-2#1)(2008-2#1)
to repair a##2##3##(1994-5#1)(2007-8#1)
to repair and##3##3##(1994-5#1)(2008-10#1)(2009-3#1)
to repair methylated DNA##2##4##(1995-5#2)
to repair or##2##3##(2008-11#1)(2009-9#1)
to repair the##4##3##(1992-9#1)(2007-12#1)(2009-10#1)(2013-8#1)
to repair##22##2##(1992-9#1)(1994-5#2)(1995-5#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
to repeat##2##2##(1997-5#1)(2008-2#1)
to repeated##13##2##(1997-4#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-12#1)(2012-3#2)(2013-1#1)
to reperfusion##2##2##(2007-10#2)
to repetitive##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
to repetitively##2##2##(2007-12#1)(2008-7#1)
to replace Ca2+ in##2##4##(1995-11#2)
to replace a##3##3##(1991-9#1)(2009-10#1)(2009-5#1)
to replace the conventional##2##4##(2008-11#1)(2013-8#1)
to replace the##18##3##(1990-2#1)(1992-2#1)(1992-3#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-8#2)(2009-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
to replace##55##2##(1990-2#1)(1990-7#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#2)(1995-6#1)(1996-2#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#3)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
to replacement##2##2##(2012-12#1)(2013-1#1)
to replicate in##3##3##(1995-2#1)(1997-3#1)(2008-9#1)
to replicate the##3##3##(1992-11#1)(2008-5#1)(2010-12#1)
to replicate##11##2##(1992-11#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)
to replication##2##2##(2008-5#1)(2012-3#1)
to report a case of##2##5##(2007-12#1)(2011-1#1)
to report a##6##3##(2007-12#1)(2008-11#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-1#1)
to report and discuss the##2##5##(2008-9#1)(2009-10#1)
to report and##5##3##(1993-1#1)(1993-6#1)(1995-2#1)(2008-9#1)(2009-10#1)
to report on the##2##4##(2008-11#1)(2008-12#1)
to report on##5##3##(2008-11#2)(2008-12#1)(2010-3#1)(2013-1#1)
to report outcome##2##3##(2012-1#1)(2012-3#1)
to report the##10##3##(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
to report this##3##3##(2008-7#2)(2013-1#1)
to report##68##2##(1990-11#1)(1991-2#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-12#2)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#6)(2008-12#4)(2008-5#2)(2008-7#4)(2008-9#3)(2009-10#1)(2009-5#3)(2009-7#1)(2010-11#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-3#3)(2013-1#8)(2013-8#3)
to reported genes##2##3##(1995-8#1)(1996-6#1)
to reported##5##2##(1995-8#1)(1996-6#2)(2008-6#1)(2011-1#1)
to reporter##2##2##(2008-10#1)(2008-7#1)
to reporting##3##2##(2010-11#1)(2011-2#2)
to reports##3##2##(1997-6#1)(2007-7#1)(2008-5#1)
to represent a new##2##4##(1991-2#1)(1993-3#1)
to represent a significant##3##4##(1994-5#1)(2008-10#1)(2010-6#1)
to represent a##17##3##(1991-12#1)(1991-2#1)(1993-3#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-6#1)(2011-2#2)(2013-8#1)
to represent an##4##3##(2007-12#1)(2007-8#1)(2008-7#2)
to represent early##2##3##(1991-12#1)(2008-9#1)
to represent the##19##3##(2007-8#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
to represent them##2##3##(2010-5#1)(2013-8#1)
to represent##70##2##(1991-12#3)(1991-2#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-2#1)(2007-12#1)(2007-8#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-6#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
to repress##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
to reproduce a##2##3##(2008-11#1)(2013-8#1)
to reproduce the##10##3##(1997-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2012-1#1)
to reproduce##27##2##(1992-9#2)(1995-8#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-8#2)
to reproducible##2##2##(1996-1#1)(2009-8#1)
to reproducibly##3##2##(2008-11#2)(2009-8#1)
to reproduction##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
to reproduction)##2##2##(2008-8#2)
to reprogram##2##2##(1996-1#1)(2008-9#1)
to reprogramming##2##2##(2008-9#1)(2009-3#1)
to request##3##2##(1992-12#1)(1997-5#1)(2008-1#1)
to require the##5##3##(1995-2#1)(1995-6#2)(2013-1#1)(2013-8#1)
to require##19##2##(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2013-1#1)(2013-8#1)
to reschedule##2##2##(2012-3#2)
to rescue the##6##3##(1993-9#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-8#1)
to rescue##14##2##(1993-9#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#2)(2013-1#1)(2013-8#2)
to research in##2##3##(2007-8#1)(2010-1#1)
to research participants##3##3##(2009-4#2)(2009-6#1)
to research utilisation is##2##4##(2008-11#2)
to research##19##2##(1990-3#1)(1992-11#1)(1992-12#2)(1995-2#1)(1997-3#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-4#3)(2009-6#1)(2010-1#2)(2010-11#1)(2010-9#1)
to research-based##2##2##(2008-11#1)(2008-12#1)
to researchers##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)
to resemble##4##2##(1995-11#1)(2008-12#1)(2008-6#1)(2008-8#1)
to reset##3##2##(2008-5#2)(2009-9#1)
to reshape the##3##3##(1991-1#1)(1995-3#1)(2010-8#1)
to reshape##4##2##(1991-1#1)(1995-3#2)(2010-8#1)
to reside in a##2##4##(1994-5#1)(1994-8#1)
to residential##3##2##(1995-2#1)(2012-12#2)
to residual##12##2##(1996-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-8#1)
to residues##10##2##(1991-12#1)(1992-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-8#1)(2010-5#2)
to resist frosts##2##3##(2009-2#2)
to resist the##3##3##(1991-8#1)(2008-3#1)(2008-8#1)
to resist##12##2##(1991-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-2#2)(2010-4#1)(2013-1#1)
to resistance genes##3##3##(2008-10#3)
to resistance in##3##3##(2008-10#3)
to resistance to##3##3##(2008-10#3)
to resistance##16##2##(2008-10#14)(2013-1#2)
to resistant##2##2##(2008-10#2)
to resolve and##2##3##(2008-10#1)(2008-9#1)
to resolve such##2##3##(2008-3#1)(2009-5#1)
to resolve the##16##3##(1990-8#1)(1994-12#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)
to resolve these##3##3##(1993-12#1)(2008-8#1)(2013-1#1)
to resolve this serious##2##4##(1995-5#1)(2013-1#1)
to resolve this##4##3##(1995-5#1)(2013-1#2)(2013-8#1)
to resolve##63##2##(1990-12#1)(1990-8#2)(1992-3#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-5#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
to resonantly##2##2##(2007-12#2)
to resort to##3##3##(2007-12#1)(2008-8#1)(2009-12#1)
to respective##2##2##(2008-1#1)(2008-11#1)
to respectively##2##2##(1994-5#1)(2007-12#1)
to respiratory##11##2##(1992-4#1)(1993-8#1)(1996-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#3)
to respond more to##2##4##(2008-11#2)
to respond positively##2##3##(1992-3#1)(2012-3#1)
to respond to a##5##4##(1992-8#1)(1993-3#1)(2008-2#1)(2008-7#2)
to respond to new##2##4##(2011-2#1)(2012-12#1)
to respond to stress##2##4##(1994-11#1)(2008-8#1)
to respond to the##15##4##(1991-12#1)(1991-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
to respond to these##6##4##(1991-12#1)(1994-12#1)(1995-1#1)(2008-10#3)
to respond to##78##3##(1990-11#1)(1990-2#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#4)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)
to respond with##2##3##(2008-9#1)(2009-8#1)
to respond without prejudice##2##4##(2008-11#2)
to respond##102##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#4)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#1)
to response##6##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)
to responses##2##2##(1991-5#1)(2008-8#1)
to rest##3##2##(1993-12#1)(2008-9#1)(2013-1#1)
to restore a##2##3##(1993-9#1)(2008-3#1)
to restore and##2##3##(2008-5#1)(2010-12#1)
to restore elbow flexion##3##4##(2008-9#3)
to restore sinus rhythm##2##4##(2007-9#1)(2008-7#1)
to restore the##13##3##(1990-6#1)(1993-3#1)(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
to restore##43##2##(1990-2#1)(1990-6#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
to restrain the##2##3##(2010-8#1)(2013-1#1)
to restrain##4##2##(1996-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
to restraint##2##2##(1993-12#1)(2008-7#1)
to restrict administration of##2##4##(1992-11#2)
to restrict the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
to restrict their##2##3##(1996-5#1)(2010-6#1)
to restrict##11##2##(1991-3#1)(1992-11#2)(1993-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-10#1)(2012-2#1)
to restriction fragment length##2##4##(1994-11#1)(2008-10#1)
to restriction##4##2##(1994-11#1)(2007-7#1)(2008-10#1)(2008-12#1)
to restrictions##2##2##(1992-3#1)(2008-5#1)
to restructure the##2##3##(1994-1#1)(1995-1#1)
to restructure##6##2##(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)
to restructuring##5##2##(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)
to result from a##3##4##(1994-3#1)(1994-8#1)(1995-11#1)
to result from the interaction of##2##6##(1994-3#1)(2008-9#1)
to result from the##11##4##(1990-11#1)(1990-2#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-8#1)
to result from##30##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
to result in a##7##4##(1994-11#1)(1994-3#1)(1997-1#1)(2008-2#2)(2008-3#1)(2009-9#1)
to result in an increase of##2##6##(1994-9#1)(2008-10#1)
to result in an##3##4##(1994-9#1)(1997-8#1)(2008-10#1)
to result in high##2##4##(2008-10#2)
to result in the##6##4##(1990-7#1)(1992-3#1)(1997-7#1)(2007-12#1)(2009-10#1)(2009-2#1)
to result in##35##3##(1990-7#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to result##73##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-9#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-10#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to results from##2##3##(2007-12#1)(2008-1#1)
to results obtained##4##3##(2008-10#3)(2008-6#1)
to results that##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
to results with##3##3##(1992-8#1)(1993-11#1)(2008-10#1)
to results##20##2##(1990-6#1)(1992-8#1)(1993-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#4)(2008-5#1)(2008-6#1)(2009-5#1)(2012-1#1)(2013-8#1)
to resume tobacco use##2##4##(2007-12#2)
to resume tobacco##4##3##(2007-12#4)
to resume##10##2##(1994-8#1)(2007-12#4)(2008-5#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to resuscitate##2##2##(2008-10#1)(2010-7#1)
to retain and##2##3##(1992-12#1)(2008-10#1)
to retain the##6##3##(1994-2#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-8#1)
to retain their##2##3##(1996-1#1)(2008-9#1)
to retain##24##2##(1992-12#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
to retard##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
to retention##2##2##(2008-10#1)(2008-8#1)
to rethink##4##2##(1991-12#1)(2010-3#1)(2011-2#1)(2011-3#1)
to retinal##4##2##(1993-8#1)(2009-6#2)(2011-1#1)
to retinoic acid##6##3##(1992-2#1)(1992-8#1)(1993-12#1)(1994-10#1)(1996-5#1)(2008-9#1)
to retract##2##2##(2010-9#1)(2013-1#1)
to retrieve a##3##3##(1995-6#1)(2008-2#1)(2008-8#1)
to retrieve aerosol properties from lidar backscatter measurements##2##8##(2008-3#2)
to retrieve ozone##2##3##(2008-3#2)
to retrieve the optical##2##4##(2008-2#1)(2008-3#1)
to retrieve the particle##2##4##(2008-3#2)
to retrieve the##16##3##(1993-12#1)(1997-3#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
to retrieve vertical##2##3##(2008-3#2)
to retrieve##48##2##(1993-12#2)(1994-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#20)(2008-4#1)(2008-7#2)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
to retrospectively##2##2##(1992-12#1)(2011-2#1)
to return for##2##3##(1993-6#1)(2008-9#1)
to return the##5##3##(1994-8#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-7#1)
to return their##2##3##(1995-3#1)(2008-6#1)
to return to the##3##4##(2008-10#1)(2008-5#1)(2009-10#1)
to return to their##4##4##(1992-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
to return to work##2##4##(1993-12#1)(2012-12#1)
to return to##15##3##(1992-5#1)(1993-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#3)(2012-12#1)
to return##32##2##(1992-5#1)(1993-1#3)(1993-12#2)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2011-2#5)(2012-12#1)
to revascularize##2##2##(2008-9#2)
to reveal a##4##3##(1997-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
to reveal any##6##3##(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2012-12#1)
to reveal effects##2##3##(2008-10#1)(2008-9#1)
to reveal mechanisms##2##3##(2008-11#1)(2010-7#1)
to reveal optical##2##3##(2007-11#1)(2008-3#1)
to reveal some##2##3##(1993-5#1)(2009-3#1)
to reveal that##2##3##(1995-11#1)(2007-11#1)
to reveal the##11##3##(1994-6#1)(1997-3#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)
to reveal whether##2##3##(2011-2#1)(2012-1#1)
to reveal##62##2##(1990-8#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
to reverse the trend##2##4##(1991-3#1)(1992-8#1)
to reverse the##14##3##(1991-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-5#2)(1996-8#1)(1996-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
to reverse this##2##3##(1991-3#1)(1991-6#1)
to reverse##32##2##(1990-2#1)(1990-9#1)(1991-3#2)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
to reversible##2##2##(1992-6#1)(2008-10#1)
to revert##4##2##(1994-8#2)(2008-10#1)(2012-2#1)
to review a##2##3##(1997-3#1)(2008-11#1)
to review all##5##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
to review and##4##3##(2012-12#1)(2012-2#1)(2013-1#2)
to review current knowledge##2##4##(2008-8#1)(2010-3#1)
to review current##3##3##(2008-8#1)(2010-3#1)(2011-2#1)
to review some of the current##2##6##(2008-11#1)(2009-4#1)
to review some of the##4##5##(1993-12#1)(2008-11#1)(2008-4#1)(2009-4#1)
to review some##5##3##(1990-12#1)(1993-12#1)(2008-11#1)(2008-4#1)(2009-4#1)
to review the evidence##3##4##(1994-11#1)(2008-8#1)(2010-5#1)
to review the literature##3##4##(1993-5#1)(1997-3#1)(2010-3#1)
to review the management of##2##5##(2008-10#1)(2011-2#1)
to review the progress##2##4##(2008-5#1)(2010-10#1)
to review the use##2##4##(2008-10#1)(2013-8#1)
to review the##46##3##(1991-12#1)(1991-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1997-3#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to review##91##2##(1990-12#2)(1991-12#1)(1991-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#2)(1995-6#2)(1996-2#1)(1997-3#2)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
to reviewers##3##2##(2010-11#1)(2010-12#2)
to revise##2##2##(2008-10#1)(2012-3#1)
to revision##4##2##(1993-1#1)(2007-11#1)(2008-8#2)
to revisit##3##2##(1997-8#1)(2008-3#1)(2008-4#1)
to revolutionize the##4##3##(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#1)
to revolutionize##6##2##(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
to reward and##2##3##(1991-3#1)(2007-8#1)
to reward##8##2##(1991-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(2007-8#2)(2011-1#1)
to rheumatoid arthritis##2##3##(2012-3#1)(2013-8#1)
to rhizosphere##2##2##(2008-10#2)
to rhodopsin##2##2##(1990-12#1)(2012-12#1)
to rhythm##2##2##(2008-10#1)(2010-12#1)
to ribosomal proteins##2##3##(1992-8#1)(1993-11#1)
to rice blast in##2##4##(2008-10#1)(2012-2#1)
to rice blast##7##3##(2008-10#6)(2012-2#1)
to rice telomeric##2##3##(2008-8#2)
to rice##14##2##(2008-10#10)(2008-8#2)(2009-10#1)(2012-2#1)
to right coronary##2##3##(2007-8#1)(2012-2#1)
to right heart##2##3##(2010-5#1)(2011-2#1)
to right ventricular##2##3##(2007-8#1)(2011-2#1)
to right##14##2##(1996-2#2)(2007-8#2)(2008-7#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-8#1)
to rigid##2##2##(2008-3#1)(2008-6#1)
to rigorous##4##2##(1992-1#1)(2008-9#1)(2012-3#2)
to rise in##3##3##(1995-3#1)(2012-2#1)(2013-8#1)
to rise with the##2##4##(1993-3#1)(2013-1#1)
to rise##14##2##(1992-2#1)(1993-3#1)(1994-12#2)(1995-3#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to rising##4##2##(1997-2#1)(2010-9#1)(2012-2#1)(2012-6#1)
to risk assessment##4##3##(1996-3#1)(2008-7#1)(2010-12#1)(2010-4#1)
to risk factors##4##3##(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#1)
to risk of##3##3##(1990-6#1)(1994-2#1)(2008-1#1)
to risk##19##2##(1990-6#2)(1992-12#1)(1992-3#1)(1994-2#1)(1996-3#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
to risks in##2##3##(2008-7#1)(2008-9#1)
to risks##4##2##(2008-7#2)(2008-9#1)(2012-2#1)
to road traffic##3##3##(2008-10#1)(2010-11#1)(2013-7#1)
to road##6##2##(2007-2#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-11#1)(2013-7#1)
to robotics##3##2##(2007-12#3)
to roll##2##2##(2008-11#1)(2008-7#1)
to room temperature##2##3##(2007-12#1)(2008-3#1)
to room##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
to root coverage treatment##2##4##(2013-1#2)
to root##8##2##(2008-10#4)(2010-5#1)(2013-1#3)
to root-knot nematodes##2##3##(2008-10#2)
to roots of##3##3##(2008-10#2)(2011-1#1)
to roots##10##2##(1992-12#1)(2008-10#8)(2011-1#1)
to rotate about the##2##4##(2008-3#2)
to rotate about##3##3##(2008-3#3)
to rotate##6##2##(1995-8#1)(2008-2#1)(2008-3#3)(2008-7#1)
to routine analyses##4##3##(1995-2#1)(2008-10#2)(2010-5#1)
to routine analysis##2##3##(2008-10#2)
to routine clinical##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
to routine##17##2##(1990-12#1)(1990-3#1)(1995-2#2)(1996-2#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)
to rubella##2##2##(2007-2#1)(2011-2#1)
to rubisco activase##2##3##(1991-9#2)
to rule out PE##2##4##(2012-2#2)
to rule out the##4##4##(2008-2#1)(2011-2#2)(2012-12#1)
to rule out##19##3##(1995-5#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to rule##21##2##(1995-5#1)(1996-12#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to run##14##2##(1992-8#1)(1993-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
to rupture of##6##3##(1995-5#2)(1996-3#1)(2007-8#1)(2008-10#1)(2012-1#1)
to rupture##9##2##(1995-5#2)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
to ruptured##2##2##(2007-10#1)(2008-7#1)
to rural communities##2##3##(2010-7#1)(2013-1#1)
to rural##10##2##(1991-1#1)(1993-2#2)(1994-1#2)(1994-3#1)(1996-3#1)(2010-10#1)(2010-7#1)(2013-1#1)
to sacrifice##4##2##(1992-11#1)(1996-2#1)(2008-10#1)(2008-12#1)
to safe##7##2##(1996-8#1)(2008-10#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
to safeguard##4##2##(1994-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
to safeguarding##2##2##(1991-12#1)(2009-10#1)
to safely##4##2##(1997-6#1)(2007-8#1)(2008-1#1)(2010-10#1)
to safety##5##2##(1991-3#1)(1996-12#1)(2008-4#1)(2008-8#1)(2010-6#1)
to saikogenin E##2##3##(2008-11#2)
to salary##2##2##(1991-12#1)(1995-3#1)
to salicylic acid##2##3##(2008-5#1)(2008-8#1)
to saline##4##2##(1993-1#1)(1995-12#1)(1995-2#1)(2009-8#1)
to salinity##4##2##(2008-12#2)(2008-5#1)(2013-1#1)
to salivary gland##2##3##(1994-7#1)(2008-8#1)
to salt stress##2##3##(1997-8#1)(2008-8#1)
to salt##5##2##(1993-8#1)(1996-5#1)(1997-8#1)(2008-8#1)(2008-9#1)
to salvage chemotherapy##2##3##(2008-1#1)(2008-6#1)
to salvage##6##2##(2008-1#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
to sample all##2##3##(2008-5#1)(2012-12#1)
to sample size##3##3##(2008-10#2)(2013-1#1)
to sample the##3##3##(2008-10#2)(2008-7#1)
to sample##37##2##(1994-2#1)(1995-2#1)(1995-5#2)(1995-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
to samples from##3##3##(1991-5#1)(1994-2#1)(2008-11#1)
to samples of##3##3##(1995-2#1)(2008-10#2)
to samples prepared in##2##4##(2008-10#2)
to samples##15##2##(1990-2#1)(1991-5#1)(1994-2#1)(1995-2#1)(2008-10#9)(2008-11#1)(2008-5#1)
to sampling##8##2##(1996-12#2)(2008-10#4)(2008-3#1)(2013-7#1)
to sap-sucking insects##2##3##(2006-12#2)
to sap-sucking##3##2##(2006-12#2)(2013-7#1)
to satisfaction with##2##3##(2007-12#2)
to satisfactorily##2##2##(2008-10#2)
to satisfactory##4##2##(1996-8#1)(2008-10#2)(2008-11#1)
to satisfy the##11##3##(1994-2#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
to satisfy##23##2##(1993-1#1)(1994-2#2)(1994-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
to saturate the##2##3##(2008-3#1)(2009-11#1)
to saturate##4##2##(2008-10#1)(2008-3#2)(2009-11#1)
to saturated fatty##2##3##(2008-12#1)(2010-4#1)
to saturated##5##2##(1996-5#1)(2008-12#1)(2010-4#2)(2011-1#1)
to save lives##3##3##(1991-3#1)(2010-11#1)(2010-8#1)
to save the##5##3##(1990-5#1)(1997-7#1)(2007-2#1)(2008-9#1)(2010-8#1)
to save time##2##3##(2008-10#1)(2008-3#1)
to save##24##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-11#1)(1994-2#2)(1996-11#1)(1996-12#2)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-8#2)(2011-2#1)
to say about##2##3##(1992-8#1)(2012-2#1)
to say that##2##3##(1991-3#1)(2008-7#1)
to say the##2##3##(1993-5#1)(2011-2#1)
to say##10##2##(1991-3#1)(1992-8#1)(1993-5#1)(1994-11#1)(2007-12#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
to scab##4##2##(2008-10#4)
to scale the##2##3##(2007-12#1)(2008-3#1)
to scale up##3##3##(2008-11#2)(2008-7#1)
to scale##11##2##(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2010-8#1)
to scale-up the##2##3##(2008-11#2)
to scale-up##3##2##(2008-11#2)(2013-1#1)
to scaling##2##2##(2008-3#1)(2008-8#1)
to scan##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-7#3)(2008-9#1)
to scanning##2##2##(2008-11#1)(2011-7#1)
to scattered light##2##3##(2008-3#1)(2008-4#1)
to scattering##6##2##(2008-2#1)(2008-3#4)(2011-1#1)
to scavenge##2##2##(1992-5#1)(1995-8#1)
to schedule patient##2##3##(1996-1#1)(2013-1#1)
to schedule##6##2##(1995-6#1)(1996-1#2)(2008-5#1)(2013-1#2)
to schistosomiasis##2##2##(1996-12#2)
to schizophrenia##3##2##(1996-7#1)(1997-5#1)(2012-1#1)
to school##6##2##(1996-1#1)(1996-8#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
to schools and##2##3##(2008-9#1)(2010-5#1)
to schools##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
to science##2##2##(1990-8#1)(2011-2#1)
to scientific##6##2##(1992-5#1)(1992-6#1)(1993-1#1)(1997-6#1)(2008-7#1)(2010-5#1)
to scientists##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2013-7#1)
to score##2##2##(1997-3#1)(2008-8#1)
to screen a human##2##4##(1993-11#1)(1994-12#1)
to screen a##5##3##(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(2008-4#1)
to screen an##3##3##(1996-6#1)(2008-8#1)(2013-1#1)
to screen and##2##3##(2008-10#1)(2008-12#1)
to screen cDNA libraries##2##4##(2008-2#2)
to screen for##17##3##(2006-10#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
to screen patients##2##3##(1993-9#1)(1994-8#1)
to screen the##5##3##(1996-9#1)(1997-8#1)(2007-5#1)(2008-8#2)
to screen##62##2##(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#6)(2010-10#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to screening delays among AAW##2##5##(2008-4#2)
to screening delays##3##3##(2008-4#3)
to screening for##2##3##(2008-4#1)(2011-2#1)
to screening is##2##3##(1995-9#1)(2008-10#1)
to screening##17##2##(1995-9#1)(1997-1#2)(2008-10#2)(2008-11#3)(2008-4#5)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
to scrutiny##2##2##(2008-11#2)
to sea water##3##3##(2008-10#2)(2008-5#1)
to seal the##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
to seal##4##2##(2008-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
to search a##3##3##(2008-12#1)(2008-9#2)
to search for new##2##4##(2008-10#1)(2013-1#1)
to search for the##8##4##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-4#1)(2011-1#1)
to search for##27##3##(1992-2#1)(1997-1#1)(1997-6#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
to search the database##3##4##(1991-12#1)(1993-8#1)(2008-4#1)
to search the##8##3##(1991-12#2)(1993-8#1)(1997-6#1)(2008-4#3)(2013-1#1)
to search##53##2##(1991-12#2)(1991-2#1)(1991-8#1)(1992-12#2)(1992-2#1)(1993-8#1)(1994-3#2)(1997-1#1)(1997-6#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)
to seasonal##8##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
to seawater##3##2##(2008-10#2)(2008-3#1)
to second order in##2##4##(2008-3#2)
to second order##4##3##(2007-11#2)(2008-3#2)
to second##6##2##(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#2)
to secondary infection##3##3##(2008-1#1)(2008-10#2)
to secondary##15##2##(1993-12#1)(1997-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
to secrete human##3##3##(2008-11#1)(2008-5#2)
to secrete insulin##3##3##(1990-8#1)(2008-1#1)(2010-10#1)
to secrete##23##2##(1990-8#1)(1992-3#1)(1993-9#1)(1997-4#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
to secretion of##2##3##(1992-3#1)(2013-7#1)
to secretion##3##2##(1992-3#1)(2011-1#1)(2013-7#1)
to section##3##2##(1991-8#2)(2008-3#1)
to secure the wheelchair##2##4##(2013-1#2)
to secure the##5##3##(1996-12#1)(2008-10#1)(2012-3#1)(2013-1#2)
to secure##15##2##(1990-8#1)(1992-1#1)(1994-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
to sediment##3##2##(2007-5#1)(2008-10#2)
to see an increase in##2##5##(1995-12#1)(2008-3#1)
to see an##4##3##(1992-1#1)(1995-12#1)(1997-4#1)(2008-3#1)
to see how##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
to see if the##4##4##(1991-9#1)(1993-3#1)(2007-10#1)(2008-11#1)
to see if there##3##4##(1994-9#1)(1995-12#1)(2008-6#1)
to see if##16##3##(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-12#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-12#1)
to see more##2##3##(1996-2#1)(2008-1#1)
to see that##3##3##(1994-12#1)(1994-9#1)(2012-1#1)
to see the incidence##2##4##(2012-3#2)
to see the##17##3##(1991-12#1)(1992-3#1)(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
to see this##2##3##(1992-3#1)(2009-10#1)
to see whether##5##3##(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-10#1)
to see##69##2##(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#4)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#3)(1995-1#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#2)
to seed the MEF plate##2##5##(2008-8#2)
to seed##9##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-8#4)(2008-9#2)
to seedling##2##2##(2008-10#1)(2008-12#1)
to seedlings of##2##3##(2008-10#2)
to seedlings##5##2##(2008-10#5)
to seek a##4##3##(1992-3#1)(1997-7#1)(2010-4#1)(2010-7#1)
to seek medical##3##3##(2007-2#1)(2012-12#2)
to seek more information##3##4##(1996-1#1)(2008-12#2)
to seek treatment##2##3##(2008-11#1)(2008-9#1)
to seek##36##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-3#2)
to seeking##4##2##(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
to segment and##2##3##(1994-3#1)(2012-3#1)
to segment##6##2##(1994-3#1)(2012-3#5)
to segmental##3##2##(1992-5#1)(1994-2#1)(2008-4#1)
to segregate##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
to seizure generation##2##3##(2009-8#2)
to select a##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-8#1)
to select an appropriate##2##4##(1993-3#1)(1997-2#1)
to select appropriate##2##3##(1991-2#1)(2010-5#1)
to select for##7##3##(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
to select one##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
to select optimum##3##3##(2008-2#3)
to select the appropriate##2##4##(1996-6#1)(2007-10#1)
to select the best##5##4##(2008-10#1)(2008-5#2)(2010-8#1)(2012-3#1)
to select the most appropriate##4##5##(1992-8#1)(2008-10#2)(2008-3#1)
to select the most##7##4##(1990-12#1)(1992-8#1)(1993-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
to select the optimum##3##4##(2008-10#2)(2008-8#1)
to select the##33##3##(1990-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
to select their##2##3##(1997-7#1)(2013-1#1)
to select those##3##3##(2008-10#1)(2009-7#1)(2013-8#1)
to select variables##2##3##(1995-2#2)
to select##102##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#4)(2007-2#1)(2008-10#30)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#4)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
to selected features of the##2##5##(1993-12#1)(2008-10#1)
to selected##11##2##(1993-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#5)
to selection and##2##3##(1994-2#1)(2008-10#1)
to selection for##4##3##(2008-7#1)(2008-8#1)(2008-9#2)
to selection in the##2##4##(2008-8#1)(2012-2#1)
to selection in##3##3##(2008-8#2)(2012-2#1)
to selection of##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
to selection on##2##3##(2008-10#1)(2012-3#1)
to selection was##2##3##(2008-8#1)(2008-9#1)
to selection##29##2##(1994-2#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-8#10)(2008-9#4)(2012-2#1)(2012-3#3)
to selective serotonin reuptake inhibitors##2##5##(2008-6#1)(2012-3#1)
to selective##11##2##(1991-8#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
to selectively detect##2##3##(2008-10#2)
to selectively remove##2##3##(2008-10#2)
to selectively##23##2##(1990-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#10)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
to selectivity##2##2##(1995-3#1)(2008-10#1)
to selenate##2##2##(2008-10#2)
to selenite##2##2##(2008-10#2)
to selenium##2##2##(2008-10#1)(2008-7#1)
to self and##2##3##(2007-7#1)(2008-11#1)
to self##11##2##(1990-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#1)
to self-assemble into##2##3##(1995-5#1)(2008-7#1)
to self-assembly##2##2##(2008-7#1)(2009-11#1)
to self-determination##5##2##(1991-2#2)(1997-8#3)
to self-phase modulation##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
to self-reported##2##2##(2009-11#1)(2013-1#1)
to semi-structured interviews##2##3##(1996-1#1)(2008-1#1)
to send##3##2##(1991-3#1)(1994-12#1)(2008-1#1)
to sense and##2##3##(2010-11#1)(2013-1#1)
to sense the##2##3##(2008-10#1)(2009-11#1)
to sense##11##2##(2008-10#2)(2008-3#3)(2009-11#1)(2009-8#2)(2010-11#1)(2011-1#1)(2013-1#1)
to sensitive##6##2##(2007-12#1)(2008-10#3)(2011-2#1)(2012-2#1)
to sensitivity##2##2##(1994-6#1)(2008-10#1)
to sensitization##2##2##(2008-8#1)(2008-9#1)
to sensor##2##2##(2008-10#1)(2009-11#1)
to sensors##2##2##(2008-10#2)
to sensory##5##2##(1992-5#1)(1997-3#2)(2008-4#1)(2008-7#1)
to sentinel##2##2##(2008-11#1)(2012-2#1)
to separate and identify##3##4##(1996-5#1)(2008-10#2)
to separate and##5##3##(1996-5#1)(2008-10#4)
to separate it##2##3##(2008-4#1)(2008-7#1)
to separate the species##2##4##(2008-10#2)
to separate the##16##3##(1997-2#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
to separate them##2##3##(2008-10#2)
to separate these compounds##2##4##(2008-10#2)
to separate##80##2##(1992-12#1)(1993-11#1)(1994-9#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#48)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to separately##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2011-1#1)
to separation##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2010-5#1)
to sepsis##3##2##(1990-6#1)(2008-4#1)(2013-1#1)
to septoria##4##2##(2008-10#4)
to sequence analysis##2##3##(2008-10#1)(2012-2#1)
to sequence specific##2##3##(1990-11#1)(1991-2#1)
to sequence##7##2##(1990-11#1)(1991-2#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
to sequences##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
to sequencing##3##2##(2008-4#1)(2012-2#2)
to sequentially##3##2##(2007-11#1)(2007-12#1)(2008-4#1)
to sequester the##2##3##(2008-10#1)(2009-12#1)
to sequester##5##2##(1994-8#1)(2008-10#2)(2009-12#1)(2010-6#1)
to serine##7##2##(1992-12#2)(1993-8#1)(2008-10#2)(2008-11#1)(2008-9#1)
to serious##13##2##(1990-3#1)(1993-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#3)
to seroconvert##2##2##(2007-2#1)(2008-5#1)
to serotonin##3##2##(1990-5#1)(1995-12#1)(1997-6#1)
to serotypes 1##2##3##(1996-12#2)
to serum albumin##2##3##(1990-8#1)(2008-7#1)
to serum and##2##3##(1990-12#1)(2008-4#1)
to serum samples was##2##4##(1995-2#1)(2008-10#1)
to serum samples##3##3##(1992-5#1)(1995-2#1)(2008-10#1)
to serum##18##2##(1990-12#1)(1990-8#2)(1991-8#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
to serum-free conditions##2##3##(2008-11#2)
to serum-free medium##2##3##(2008-11#2)
to serum-free##5##2##(2008-11#5)
to serve as a guide for##2##6##(1991-12#1)(2007-2#1)
to serve as a##15##4##(1991-12#1)(1992-3#1)(1995-5#1)(2007-2#1)(2008-10#6)(2008-4#1)(2008-9#1)(2010-11#1)(2010-8#1)(2010-9#1)
to serve as an##3##4##(1995-6#1)(2008-10#1)(2008-5#1)
to serve as##37##3##(1990-11#1)(1991-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-2#2)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)
to serve in##2##3##(2008-2#1)(2008-5#1)
to serve more##2##3##(1993-12#1)(2012-2#1)
to serve the community##2##4##(1997-1#1)(2008-1#1)
to serve the##4##3##(1997-1#1)(1997-3#1)(2008-1#1)(2012-3#1)
to serve##58##2##(1990-11#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#1)(2007-2#2)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#1)
to service##9##2##(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-12#1)(2008-11#2)(2008-12#1)
to services and##5##3##(1991-1#1)(1993-1#1)(1996-1#1)(1997-5#1)(2007-7#1)
to services that##2##3##(2008-5#1)(2013-1#1)
to services##14##2##(1991-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-5#1)(2007-7#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-1#1)(2013-1#1)
to set a##2##3##(2012-2#1)(2013-7#1)
to set the##7##3##(2007-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2012-2#1)(2013-7#1)
to set up a##5##4##(1997-4#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
to set up and##3##4##(1996-1#1)(2008-4#1)(2013-8#1)
to set up##11##3##(1991-3#1)(1996-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-2#1)(2013-8#1)
to set##33##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-6#1)(2010-10#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
to settle##6##2##(1990-6#1)(1995-6#1)(1997-5#2)(2008-5#1)(2013-1#1)
to seven##12##2##(1991-12#1)(1991-6#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-8#1)(2012-3#1)(2013-1#1)
to several biological##2##3##(2008-10#1)(2008-7#1)
to several different##2##3##(1997-2#1)(2008-4#1)
to several diseases##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
to several functions of##2##4##(1992-3#1)(2011-1#1)
to several hours##2##3##(1997-6#1)(2008-10#1)
to several hundred##4##3##(2008-2#2)(2008-4#1)(2009-11#1)
to several meters##2##3##(2008-3#2)
to several other studies##2##4##(2008-5#1)(2008-6#1)
to several other##4##3##(1990-2#1)(2008-5#1)(2008-6#1)(2012-2#1)
to several studies##2##3##(1990-6#1)(2013-1#1)
to several##94##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#4)(2013-1#2)
to severe cognitive impairment##2##4##(2008-2#1)(2010-2#1)
to severe pain##2##3##(2012-1#1)(2013-1#1)
to severe##49##2##(1990-3#1)(1991-11#1)(1991-6#1)(1994-5#2)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#1)
to severely##2##2##(2006-10#1)(2008-10#1)
to severity of##3##3##(1994-2#1)(2008-12#1)(2013-1#1)
to severity##4##2##(1994-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
to sewage##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
to sex and##2##3##(2008-5#1)(2008-7#1)
to sex##8##2##(1994-6#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-5#2)
to sexual changes##3##3##(2008-7#3)
to sexual##13##2##(1996-12#1)(2008-12#3)(2008-7#3)(2008-9#2)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
to sexually transmitted##2##3##(2012-2#1)(2012-3#1)
to shake the##2##3##(1996-12#1)(2008-10#1)
to shake##3##2##(1996-12#1)(2008-10#1)(2013-7#1)
to sham##7##2##(1993-6#1)(1995-11#2)(1996-12#1)(1996-9#1)(2008-7#1)(2012-2#1)
to shape the future of##3##5##(1991-1#1)(2008-1#2)
to shape the##7##3##(1991-1#1)(1995-1#1)(2007-11#1)(2008-1#2)(2008-12#1)(2009-8#1)
to shape##18##2##(1991-1#1)(1991-3#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-3#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
to share information##2##3##(1996-2#1)(2008-11#1)
to share the##4##3##(1992-6#1)(1994-2#1)(1995-1#1)(2009-8#1)
to share their##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
to share##33##2##(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to shared##2##2##(1993-2#1)(1997-7#1)
to shear stress##5##3##(1993-11#1)(2008-11#1)(2010-1#2)(2012-12#1)
to shear##9##2##(1993-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#2)(2012-12#1)(2012-2#1)
to sheath blight##2##3##(2008-10#2)
to shed light on the##3##5##(1997-9#1)(2008-8#1)(2009-5#1)
to shed light on##8##4##(1997-2#1)(1997-9#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-5#2)(2013-1#1)
to shed##12##2##(1997-2#1)(1997-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-5#2)(2012-3#1)(2013-1#1)
to sheep red blood cells##6##5##(1993-12#1)(2008-10#5)
to sheep##9##2##(1993-12#1)(1993-8#1)(1996-12#1)(2008-10#6)
to shift from##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
to shift resources##2##3##(1995-1#1)(1995-2#1)
to shift the##5##3##(1991-8#1)(1997-2#1)(2007-12#1)(2008-3#1)(2013-8#1)
to shift to##2##3##(2008-10#1)(2008-5#1)
to shift##22##2##(1991-8#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
to short duration##2##3##(2011-2#1)(2012-2#1)
to short##14##2##(1992-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
to short-term##3##2##(2008-10#2)(2008-12#1)
to shorten the##6##3##(1992-11#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-8#1)
to shorten##9##2##(1992-1#1)(1992-11#1)(2007-9#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-8#1)
to shorter##6##2##(1992-9#1)(1993-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
to shoulder##5##2##(2007-11#3)(2007-8#2)
to show a relationship between##2##5##(2009-10#1)(2012-3#1)
to show a##16##3##(1994-2#2)(1994-3#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-10#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
to show an effect##2##4##(1994-2#1)(2007-12#1)
to show an interaction##2##4##(2009-8#1)(2013-8#1)
to show an##9##3##(1993-1#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
to show excellent##2##3##(2008-10#1)(2011-2#1)
to show how the##5##4##(2007-10#1)(2007-8#1)(2008-10#2)(2012-2#1)
to show how##12##3##(1993-2#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-2#2)
to show some of##2##4##(2008-11#1)(2009-10#1)
to show that a##3##4##(1994-2#1)(2008-3#1)(2008-8#1)
to show that the##12##4##(1990-8#1)(1991-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
to show that there is##2##5##(2008-3#1)(2012-2#1)
to show that there##3##4##(2008-3#1)(2009-10#1)(2012-2#1)
to show that these##2##4##(1996-5#1)(2008-10#1)
to show that this##2##4##(2007-11#1)(2008-10#1)
to show that##60##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#2)(1994-9#1)(1995-5#1)(1996-2#1)(1996-5#4)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to show the capability of##2##5##(2009-5#1)(2013-1#1)
to show the feasibility of##2##5##(2008-10#1)(2010-5#1)
to show the performance##2##4##(2008-10#1)(2008-2#1)
to show the role of##2##5##(1991-6#1)(2011-1#1)
to show the##40##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-3#1)
to show##183##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-2#5)(1994-3#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#10)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#3)(2009-12#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-3#1)(2013-8#4)
to shrink##4##2##(1994-8#1)(1994-9#1)(2011-2#1)(2012-3#1)
to shuttle##3##2##(1990-2#1)(2008-10#2)
to sick##2##2##(1992-3#1)(2009-7#1)
to sigma sites##2##3##(1992-12#1)(1995-12#1)
to signal transduction##2##3##(1996-10#1)(2012-2#1)
to signal##14##2##(1990-11#1)(1992-12#1)(1994-2#1)(1996-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-8#2)(2009-5#1)(2012-2#1)
to signals##2##2##(1995-5#1)(2009-8#1)
to significant changes in##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
to significant economic losses##2##4##(2008-10#1)(2010-4#1)
to significant improvement in##2##4##(2011-2#1)(2013-8#1)
to significant improvement##3##3##(2008-2#1)(2011-2#1)(2013-8#1)
to significant morbidity including##2##4##(2008-7#1)(2012-2#1)
to significant morbidity##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
to significant##44##2##(1994-1#1)(1995-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#3)(2009-12#1)(2009-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to significantly affect##2##3##(1994-11#1)(2008-8#1)
to significantly alter##2##3##(1997-2#1)(2011-2#1)
to significantly decrease##3##3##(1990-12#1)(1994-12#1)(2008-8#1)
to significantly enhance the##2##4##(2008-10#1)(2008-11#1)
to significantly enhance##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
to significantly higher##4##3##(1992-2#1)(2008-10#2)(2012-5#1)
to significantly improve##2##3##(2008-1#1)(2013-1#1)
to significantly increase##2##3##(1991-12#1)(2008-11#1)
to significantly influence the##2##4##(2008-7#1)(2008-9#1)
to significantly reduce the##5##4##(1992-8#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)
to significantly reduce##11##3##(1992-8#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
to significantly##49##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
to signing##2##2##(1996-1#1)(2008-1#1)
to signs##2##2##(1997-2#1)(2008-7#1)
to silence##4##2##(2008-2#1)(2008-9#1)(2011-1#1)(2012-2#1)
to silica and##2##3##(2008-10#1)(2009-12#1)
to silica gel##3##3##(2008-10#3)
to silica##6##2##(2008-10#5)(2009-12#1)
to silver(I) ion over alkali##2##5##(2008-10#2)
to similar levels##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to similar##17##2##(1990-7#1)(1992-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
to similarly##2##2##(1997-2#1)(2008-10#1)
to simple##12##2##(1991-12#1)(1992-2#1)(1997-3#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-7#2)(2009-6#1)
to simplicity##4##2##(2008-10#3)(2008-11#1)
to simplify the##9##3##(1997-4#1)(2008-10#2)(2008-2#3)(2008-3#2)(2010-8#1)
to simplify##19##2##(1993-12#1)(1996-12#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2010-5#1)(2010-8#1)(2011-2#1)
to simulate a##2##3##(2008-9#1)(2009-7#1)
to simulate radiances##2##3##(2008-3#2)
to simulate the behavior of##3##5##(2008-11#1)(2008-3#2)
to simulate the effects of##2##5##(2008-3#2)
to simulate the##39##3##(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#15)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)
to simulate##76##2##(1990-11#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-2#6)(2008-3#21)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-1#1)
to simulated microgravity##2##3##(2008-9#1)(2009-7#1)
to simulated##15##2##(1994-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2013-7#1)
to simulation##2##2##(2008-11#1)(2008-2#1)
to simultaneous determination of##4##4##(2008-10#4)
to simultaneous determination##5##3##(2008-10#5)
to simultaneous##11##2##(1996-5#1)(2007-11#1)(2007-5#1)(2008-10#7)(2013-8#1)
to simultaneously assess##2##3##(2008-12#1)(2008-9#1)
to simultaneously detect##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
to simultaneously determine the apparent binding constants and thermodynamic parameters##2##10##(2008-10#2)
to simultaneously determine##4##3##(2008-10#3)(2011-1#1)
to simultaneously measure##3##3##(1994-2#1)(2008-9#2)
to simultaneously monitor##2##3##(1996-12#1)(2008-2#1)
to simultaneously##26##2##(1994-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#4)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
to sing##3##2##(1991-8#1)(2008-2#1)(2013-8#1)
to single crystalline##2##3##(2006-4#1)(2009-11#1)
to single out##2##3##(2008-11#1)(2008-3#1)
to single##19##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-6#1)(1994-2#2)(1996-12#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-3#1)(2013-1#2)
to single-mode fiber coupling##2##4##(2008-2#2)
to single-mode fiber with##2##4##(2008-2#1)(2008-3#1)
to single-mode fiber##6##3##(2008-2#5)(2008-3#1)
to single-mode##7##2##(2008-2#5)(2008-3#2)
to single-stranded##2##2##(1991-5#1)(1997-2#1)
to sink##2##2##(1997-2#1)(2008-8#1)
to sinks planted##2##3##(2008-10#2)
to sinus rhythm##4##3##(1990-9#1)(1994-3#1)(2007-9#1)(2013-1#1)
to site and##2##3##(2008-10#1)(2008-6#1)
to site##7##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)
to sites of DNA damage##2##5##(2012-12#1)(2013-1#1)
to sites of##4##3##(1992-12#1)(2009-7#1)(2012-12#1)(2013-1#1)
to sites##6##2##(1992-12#1)(2008-10#2)(2009-7#1)(2012-12#1)(2013-1#1)
to sitting##2##2##(2010-3#1)(2011-2#1)
to situations in which##2##4##(2008-8#1)(2008-9#1)
to situations where##3##3##(1994-11#1)(2008-10#1)(2009-11#1)
to situations##9##2##(1994-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-3#1)
to six different##4##3##(1996-2#1)(2008-10#3)
to six months##3##3##(1993-6#1)(1997-3#1)(2008-10#1)
to six times##3##3##(2008-1#1)(2008-11#1)(2010-12#1)
to six##36##2##(1990-6#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-5#2)(2008-6#1)(2008-8#2)(2009-12#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-7#1)
to size and##2##3##(2007-11#1)(2009-5#1)
to size##11##2##(1993-8#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)
to size-asymmetric competition##2##3##(2008-8#2)
to skeletal muscle in##2##4##(1993-2#1)(2007-6#1)
to skeletal muscle is##2##4##(1990-8#1)(2011-1#1)
to skeletal muscle##6##3##(1990-8#1)(1993-2#1)(2007-6#1)(2008-3#1)(2008-4#1)(2011-1#1)
to skeletal##9##2##(1990-5#1)(1990-8#1)(1993-2#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
to skilled nursing facility##2##4##(1991-1#2)
to skilled nursing##3##3##(1991-1#2)(1991-2#1)
to skin and##2##3##(2008-5#2)
to skin cancer##2##3##(2007-12#2)
to skin##25##2##(1992-8#2)(1993-9#1)(1994-6#1)(1995-1#1)(1997-2#1)(2007-12#2)(2008-5#9)(2008-9#2)(2009-5#1)(2009-9#1)(2010-8#2)(2013-1#2)
to slaughter##2##2##(1997-3#1)(2011-1#1)
to sleep##6##2##(1990-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
to slightly##2##2##(2008-10#1)(2008-11#1)
to slip##2##2##(1996-4#2)
to slow down##2##3##(2008-7#1)(2011-1#1)
to slow the growth##2##4##(1992-2#2)
to slow the progression of myopia##2##6##(2012-12#2)
to slow the##5##3##(1992-2#2)(1997-4#1)(2012-12#2)
to slow##11##2##(1992-2#2)(1995-5#1)(1997-4#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#3)
to slower##2##2##(2008-10#2)
to slowly##2##2##(2008-8#1)(2009-11#1)
to small areas##2##3##(2008-10#1)(2008-3#1)
to small bowel##2##3##(1992-5#1)(2013-1#1)
to small changes in the##3##5##(2008-3#2)(2013-1#1)
to small changes in##4##4##(1996-7#1)(2008-3#2)(2013-1#1)
to small grains##2##3##(2008-10#1)(2008-9#1)
to small organic molecules##2##4##(1997-6#1)(2010-11#1)
to small variations in the##2##5##(1994-12#1)(2008-2#1)
to small variations in##3##4##(1994-12#1)(2008-2#1)(2013-8#1)
to small variations##4##3##(1994-12#1)(2007-12#1)(2008-2#1)(2013-8#1)
to small##40##2##(1992-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
to smaller##7##2##(1990-12#3)(2008-10#2)(2008-3#1)(2009-7#1)
to smoke##5##2##(1991-11#1)(1997-1#1)(2006-10#1)(2010-2#1)(2011-2#1)
to smoking##11##2##(1990-6#1)(1991-9#1)(1994-3#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-2#2)(2012-3#1)(2013-1#2)
to smooth the##2##3##(2008-10#1)(2011-2#1)
to smooth##4##2##(1993-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
to social and##4##3##(1990-3#1)(2008-11#1)(2008-5#1)(2010-12#1)
to social phobia##3##3##(2008-4#3)
to social##23##2##(1990-3#1)(1990-9#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-3#2)
to society of##2##3##(1997-4#1)(2008-2#1)
to society##9##2##(1994-3#1)(1995-11#2)(1995-2#1)(1996-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-7#1)
to socioeconomic status##2##3##(1991-6#1)(1994-6#1)
to socioeconomic##4##2##(1991-6#1)(1994-6#2)(2008-1#1)
to sodium azide##2##3##(1995-8#1)(2008-12#1)
to sodium bromate in##2##4##(2008-9#2)
to sodium bromate##4##3##(2008-9#4)
to sodium dodecyl##2##3##(2008-10#2)
to sodium fluoride##2##3##(2008-12#2)
to sodium##24##2##(1992-11#1)(1992-3#1)(1993-12#2)(1995-8#2)(1996-12#1)(2007-12#1)(2008-10#7)(2008-12#3)(2008-5#1)(2008-9#4)(2010-12#1)
to soft dough##2##3##(2008-10#2)
to soft tissue##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
to soft##8##2##(2007-11#1)(2008-10#4)(2008-6#1)(2009-11#1)(2009-8#1)
to soil at##4##3##(2008-10#4)
to soil drought##3##3##(2012-5#1)(2012-6#1)(2012-8#1)
to soil##25##2##(2008-10#19)(2010-3#1)(2010-5#1)(2012-5#1)(2012-6#1)(2012-8#1)(2013-7#1)
to solar ultraviolet##2##3##(2011-2#2)
to solar##5##2##(1990-9#1)(2008-3#1)(2008-5#1)(2011-2#2)
to solid phase##2##3##(1997-4#1)(2008-10#1)
to solid##5##2##(1997-4#1)(2008-10#3)(2008-4#1)
to solubilize carbon nanotubes##2##4##(2009-10#2)
to solubilize##4##2##(2009-10#2)(2012-2#1)(2013-1#1)
to soluble##4##2##(2008-4#2)(2008-7#1)(2012-4#1)
to solution##2##2##(2008-10#2)
to solutions##4##2##(1990-11#1)(2007-7#1)(2008-10#1)(2009-11#1)
to solve a##5##3##(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)
to solve for##3##3##(2007-12#1)(2008-3#2)
to solve problems##3##3##(2008-3#1)(2008-5#1)(2012-3#1)
to solve the problem that##2##5##(2008-10#1)(2008-3#1)
to solve the problem##5##4##(1997-8#1)(2008-10#2)(2008-3#2)
to solve the radiative transfer equation##2##6##(2008-3#2)
to solve the radiative transfer##3##5##(2008-3#3)
to solve the##27##3##(1992-9#1)(1994-6#1)(1997-8#1)(2008-10#5)(2008-2#2)(2008-3#7)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
to solve these problems##2##4##(2008-10#2)
to solve these##3##3##(2008-10#2)(2009-2#1)
to solve this problem##8##4##(1997-1#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-2#1)(2013-1#1)
to solve##66##2##(1990-12#1)(1992-9#1)(1994-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#14)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
to solvent extraction##4##3##(2008-10#3)(2008-5#1)
to solvent##8##2##(1995-3#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
to solving the##2##3##(2008-12#1)(2008-2#1)
to solving##3##2##(2008-12#1)(2008-2#2)
to somatic##4##2##(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
to somatostatin##2##2##(1994-11#2)
to some authors##2##3##(1992-2#1)(2009-10#1)
to some degree##5##3##(1992-2#1)(1993-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
to some extent on##2##4##(2008-12#1)(2013-1#1)
to some extent the##3##4##(1993-12#1)(1993-9#1)(2008-5#1)
to some extent##26##3##(1990-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
to some form of##2##4##(2009-6#1)(2012-3#1)
to some new##2##3##(2008-10#1)(2008-3#1)
to some of the##9##4##(1992-12#1)(1996-12#1)(2008-10#1)(2008-4#2)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
to some of##10##3##(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
to some other##2##3##(1991-12#1)(2008-5#1)
to some patients##2##3##(2008-9#1)(2010-8#1)
to some strains##2##3##(1991-3#1)(2008-10#1)
to some##111##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#3)(2011-2#4)(2011-3#1)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#1)
to sophisticated##3##2##(1996-1#1)(2008-7#1)(2012-2#1)
to sort##3##2##(1991-12#1)(2008-6#1)(2011-2#1)
to sound##2##2##(1992-3#1)(2009-5#1)
to southern##6##2##(2008-10#6)
to soybean production in the##2##5##(2008-10#2)
to soybean##6##2##(2008-10#6)
to space group##2##3##(1992-11#1)(2008-8#1)
to space##5##2##(1992-11#1)(2008-10#1)(2008-8#2)(2012-3#1)
to span the##3##3##(1991-9#1)(1993-8#1)(2008-4#1)
to spatial heterogeneity##2##3##(2008-8#2)
to spatial##17##2##(1993-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
to spatially variable##2##3##(2008-8#2)
to spatially##11##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-8#2)(2009-8#2)(2010-4#1)(2011-1#1)(2013-8#1)
to speak##8##2##(1991-2#1)(1996-3#1)(2007-7#1)(2008-7#2)(2009-11#1)(2010-4#1)(2011-2#1)
to special##5##2##(1993-2#1)(1993-8#1)(1995-2#1)(2008-3#1)(2012-12#1)
to specialist##4##2##(2008-11#2)(2008-8#1)(2009-8#1)
to specialized##5##2##(1992-6#1)(2008-9#1)(2013-1#3)
to specialty##5##2##(1994-3#1)(1997-2#1)(2006-10#1)(2008-4#1)(2010-12#1)
to speciate##2##2##(2008-10#2)
to speciation##6##2##(1996-6#1)(2008-10#1)(2008-8#2)(2010-6#2)
to species level##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
to species status##2##3##(2008-1#1)(2008-10#1)
to species##17##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
to specific behaviors##2##3##(1997-6#1)(2012-12#1)
to specific cell surface receptors##2##5##(1990-2#1)(2008-7#1)
to specific methodology##2##3##(2008-10#1)(2009-7#1)
to specific regions##2##3##(1993-6#1)(2011-2#1)
to specific sites in##2##4##(1994-12#1)(2009-3#1)
to specific stages##2##3##(2010-5#1)(2012-2#1)
to specific treatment##2##3##(2010-11#1)(2012-2#1)
to specific##82##2##(1990-2#3)(1990-8#2)(1991-11#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#1)(1997-6#1)(1997-7#2)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)
to specifically bind##2##3##(1994-8#1)(2008-10#1)
to specifically detect##3##3##(2008-10#3)
to specifically inhibit the##2##4##(1991-7#1)(1993-3#1)
to specifically measure##2##3##(2008-10#1)(2008-5#1)
to specifically target##3##3##(2008-12#1)(2010-5#1)(2010-8#1)
to specifically##20##2##(1991-7#1)(1991-9#1)(1993-3#1)(1994-8#1)(2008-10#7)(2008-12#1)(2008-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
to specificity##2##2##(1992-3#1)(2012-12#1)
to specified##2##2##(2008-10#1)(2008-5#1)
to specify the##14##3##(1994-12#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
to specify##20##2##(1990-8#1)(1991-5#1)(1994-12#1)(2007-8#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#2)(2010-11#1)(2011-1#2)(2013-1#1)(2013-8#1)
to specimens##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
to spectral analysis##2##3##(2007-12#1)(2008-7#1)
to spectral resolution##2##3##(2007-12#1)(2008-2#1)
to spectral##9##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2012-7#1)
to spectrally##7##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-9#1)
to spectrophotometric determination of##4##4##(2008-10#4)
to spectrophotometric##6##2##(2008-10#6)
to spectroscopic##2##2##(2007-11#1)(2008-2#1)
to spectroscopy##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
to speculate that##5##3##(1990-5#1)(1994-2#1)(2008-11#1)(2008-4#1)(2013-8#1)
to speculate##7##2##(1990-5#1)(1994-2#2)(2008-11#1)(2008-4#1)(2011-3#1)(2013-8#1)
to speech##4##2##(2008-9#2)(2009-2#1)(2012-12#1)
to speed up computations##2##4##(2008-3#2)
to speed up the##4##4##(1997-2#1)(2008-10#2)(2008-3#1)
to speed up##9##3##(1990-11#1)(1997-2#1)(2008-10#3)(2008-3#4)
to speed##15##2##(1990-11#1)(1990-4#1)(1997-1#1)(1997-2#2)(2008-10#5)(2008-3#4)(2012-3#1)
to spend in##2##3##(2008-11#1)(2011-2#1)
to spend more time##2##4##(2008-1#1)(2012-2#1)
to spend time##2##3##(1991-2#1)(2013-8#1)
to spend##11##2##(1991-2#1)(1994-12#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
to sperm##2##2##(2007-12#1)(2008-5#1)
to spherical##2##2##(2008-10#1)(2013-1#1)
to spin##2##2##(1993-3#1)(2008-2#1)
to spinal cord injury##2##4##(1993-12#1)(2007-11#1)
to spinal##7##2##(1990-11#1)(1993-12#2)(1996-2#1)(1997-8#1)(2007-11#1)(2008-7#1)
to spleen##2##2##(2008-11#1)(2008-4#1)
to split##4##2##(1995-12#1)(1996-6#1)(1997-6#1)(2008-10#1)
to spontaneous##5##2##(1990-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)
to spontaneously##2##2##(1990-2#1)(2008-10#1)
to spore germination##2##3##(2008-10#1)(2011-2#1)
to spore##5##2##(2008-10#2)(2010-10#1)(2010-2#1)(2011-2#1)
to sport##2##2##(2008-12#1)(2011-1#1)
to sports##2##2##(2008-9#1)(2010-1#1)
to sporulate##5##2##(1995-9#1)(2008-10#3)(2012-3#1)
to sporulation##3##2##(1997-3#1)(2008-10#2)
to spread and##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
to spread from##2##3##(2008-10#1)(2008-9#1)
to spread in##2##3##(2008-10#2)
to spread into##3##3##(2008-10#2)(2013-1#1)
to spread of scab within##3##5##(2008-10#3)
to spread##23##2##(1995-5#1)(1996-5#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
to spurious##2##2##(2008-3#2)
to stabilise##2##2##(1991-6#1)(2008-10#1)
to stabilization of the##3##4##(1992-3#1)(2008-4#1)(2012-2#1)
to stabilization##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
to stabilize the##13##3##(1992-3#1)(1994-5#1)(1997-2#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
to stabilize##31##2##(1990-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-9#1)(1997-2#2)(1997-6#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
to stable##6##2##(1995-3#2)(1997-3#1)(2008-8#1)(2012-2#1)(2013-7#1)
to stably##2##2##(2008-11#1)(2008-8#1)
to staff and##2##3##(1991-2#1)(1996-3#1)
to staff##12##2##(1991-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-11#2)(2011-1#1)(2013-1#2)
to stage I##3##3##(1991-8#1)(2011-2#2)
to stage of##2##3##(1991-8#1)(2008-11#1)
to stage##11##2##(1991-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#2)(2011-2#2)(2012-3#1)
to stain##5##2##(1991-12#1)(2007-12#1)(2008-8#1)(2008-9#2)
to staining##2##2##(2008-5#1)(2011-2#1)
to stall##2##2##(1991-9#1)(1997-3#1)
to stand for##2##3##(2008-10#1)(2008-5#1)
to stand up and##2##4##(2007-8#1)(2012-12#1)
to stand up##3##3##(2007-8#1)(2010-5#1)(2012-12#1)
to stand##8##2##(1994-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-3#1)
to standard doses of##2##4##(2009-5#1)(2010-3#1)
to standard methods of##2##4##(2008-10#1)(2011-2#1)
to standard methods##5##3##(2008-10#1)(2008-12#1)(2008-3#2)(2011-2#1)
to standard solutions##3##3##(2008-10#3)
to standard therapy##2##3##(2011-2#1)(2013-1#1)
to standard##45##2##(1990-12#1)(1990-8#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
to standardise the##2##3##(2008-1#1)(2008-10#1)
to standardize and##2##3##(2008-9#1)(2013-1#1)
to standardize the##3##3##(2010-4#1)(2011-2#1)(2012-2#1)
to standardize##11##2##(1996-1#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
to standardized##2##2##(2007-10#1)(2008-10#1)
to standards##5##2##(1994-3#1)(2009-2#1)(2011-2#1)(2012-12#2)
to standing##4##2##(2008-10#1)(2008-7#3)
to start a##2##3##(1990-2#1)(1995-12#1)
to start any##2##3##(2007-11#2)
to start at##2##3##(1995-12#1)(2010-9#1)
to start of##2##3##(2008-10#1)(2010-10#1)
to start the##2##3##(2007-11#1)(2008-6#1)
to start with##3##3##(1993-12#1)(1994-12#1)(2010-6#1)
to start##28##2##(1990-2#2)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-6#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
to starting##3##2##(2008-4#1)(2010-8#1)(2013-1#1)
to state that##2##3##(1994-2#1)(2007-12#1)
to state##7##2##(1994-2#1)(1995-11#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-7#1)
to state-of-the-art##2##2##(2009-5#1)(2009-9#1)
to static##4##2##(2008-3#1)(2009-7#1)(2013-8#2)
to stationary##2##2##(2007-12#1)(2009-6#1)
to statistical##4##2##(2008-1#2)(2008-10#1)(2013-7#1)
to statistically##7##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)
to stay healthy##2##3##(1994-12#1)(2011-2#1)
to stay in##2##3##(2007-12#1)(2011-2#1)
to stay open##2##3##(1996-12#1)(2008-3#1)
to stay##16##2##(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#2)
to steady state##2##3##(1994-11#1)(2009-6#1)
to steady##3##2##(1994-11#1)(2008-11#1)(2009-6#1)
to stem cell##3##3##(2009-3#3)
to stem cells##2##3##(2008-11#1)(2012-12#1)
to stem##11##2##(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-3#3)(2012-12#1)
to stenosis##3##2##(2007-8#1)(2008-1#1)(2008-7#1)
to stent occlusion##2##3##(1990-8#1)(2013-1#1)
to stent##4##2##(1990-8#1)(2011-2#2)(2013-1#1)
to stereoselective##2##2##(1994-5#1)(2008-10#1)
to steric hindrance##3##3##(1994-9#1)(2008-10#2)
to steric##6##2##(1994-9#1)(1997-7#1)(2008-10#4)
to steroid therapy##3##3##(1994-6#1)(2008-4#1)(2013-1#1)
to steroid##6##2##(1994-6#1)(1996-2#1)(2008-4#2)(2012-2#1)(2013-1#1)
to steroids##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
to stimulants##2##2##(2008-6#1)(2008-8#1)
to stimulate DNA synthesis##4##4##(1990-11#1)(1992-3#1)(1992-9#1)(1997-7#1)
to stimulate ET release##2##4##(1990-12#2)
to stimulate PI##2##3##(1993-9#1)(1994-9#1)
to stimulate a##2##3##(1993-6#1)(2008-10#1)
to stimulate an##3##3##(2008-12#1)(2009-5#1)(2010-1#1)
to stimulate both##2##3##(1992-3#1)(1997-1#1)
to stimulate glucose##2##3##(1994-8#1)(2008-11#1)
to stimulate insulin##2##3##(1990-8#1)(1995-8#1)
to stimulate or inhibit##2##4##(1994-8#1)(2008-9#1)
to stimulate production of##3##4##(1991-12#2)(2012-2#1)
to stimulate sustained##2##3##(2008-10#1)(2009-12#1)
to stimulate the production of##2##5##(2008-11#1)(2008-6#1)
to stimulate the##21##3##(1990-12#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
to stimulate transcription in##2##4##(1993-8#1)(2011-1#1)
to stimulate transcription##3##3##(1993-8#1)(1994-2#1)(2011-1#1)
to stimulate##110##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-2#4)(1995-8#1)(1996-12#3)(1997-1#4)(1997-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to stimulated##2##2##(1992-8#1)(2007-12#1)
to stimulating sound-pulses##2##3##(2008-8#2)
to stimulating##3##2##(2008-1#1)(2008-8#2)
to stimulation by##2##3##(1992-3#1)(1995-12#1)
to stimulation of##12##3##(1991-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-11#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
to stimulation##28##2##(1991-2#2)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#2)(2007-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#3)
to stimulatory molecules##2##3##(1995-12#2)
to stimuli##9##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(2010-1#1)(2013-1#2)
to stochastic##4##2##(2008-7#1)(2008-8#2)(2009-8#1)
to stop or##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
to stop the##5##3##(1995-6#1)(1996-9#1)(1997-6#1)(2010-2#1)(2012-2#1)
to stop##24##2##(1991-12#1)(1991-6#2)(1992-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-9#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to storage##5##2##(1991-3#1)(1994-3#2)(2008-8#2)
to store and##2##3##(2007-12#1)(2008-7#1)
to store##12##2##(1997-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#4)
to strain##6##2##(1993-9#1)(2008-10#4)(2008-3#1)
to strains##2##2##(2008-10#1)(2010-7#1)
to strategic planning##5##3##(1994-2#2)(1994-3#1)(1995-1#1)(2012-3#1)
to strategic##6##2##(1994-2#2)(1994-3#1)(1995-1#1)(1997-1#1)(2012-3#1)
to strategically##4##2##(1996-1#1)(1996-2#1)(1996-3#2)
to strategies for##2##3##(2008-10#1)(2008-6#1)
to strategies##4##2##(1991-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
to stratify##2##2##(2008-10#1)(2012-2#1)
to stratum##2##2##(2008-5#1)(2012-12#1)
to strawberry fields##3##3##(2008-10#3)
to strawberry##7##2##(2008-10#7)
to stray light##2##3##(2008-2#1)(2008-3#1)
to streamline and##2##3##(1997-3#1)(2008-10#1)
to streamline##6##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-1#1)
to strength##2##2##(1994-8#1)(2008-7#1)
to strengthen and##2##3##(1992-3#1)(2008-7#1)
to strengthen the public health##2##5##(1996-2#1)(1997-2#1)
to strengthen the##14##3##(1992-6#1)(1993-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to strengthen their##3##3##(1992-3#1)(1997-2#1)(2012-12#1)
to strengthen##32##2##(1992-3#2)(1992-6#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to streptomycin##2##2##(2008-10#2)
to stress and##6##3##(1993-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
to stress conditions##3##3##(2008-2#1)(2009-8#1)(2012-12#1)
to stress in##3##3##(2008-10#1)(2008-11#2)
to stress response##2##3##(1996-9#1)(2011-1#1)
to stress the##3##3##(1990-9#1)(2008-3#1)(2008-7#1)
to stress##38##2##(1990-9#1)(1993-12#3)(1994-11#2)(1994-8#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to stressed##2##2##(2008-2#1)(2013-1#1)
to stressors##2##2##(2010-12#1)(2013-1#1)
to stretching##2##2##(2008-10#1)(2009-3#1)
to strict##2##2##(1996-8#1)(2008-4#1)
to striga emergence##2##3##(2008-10#2)
to strike##3##2##(1996-5#2)(2007-12#1)
to stripe rust##10##3##(2008-10#10)
to stroke##6##2##(2007-10#2)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
to strong light##2##3##(1991-12#1)(2008-9#1)
to strong selective##2##3##(2008-7#1)(2013-1#1)
to strong##14##2##(1991-12#1)(1994-8#1)(1997-5#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
to stronger##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
to strongly enhance the##2##4##(2008-10#2)
to strongly influence the##2##4##(2008-10#1)(2008-9#1)
to strongly##13##2##(1990-11#1)(1990-12#1)(1993-11#1)(1995-6#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-4#1)(2012-12#1)
to structural changes##4##3##(1991-5#1)(1993-8#1)(1994-5#1)(1996-3#1)
to structural##17##2##(1991-5#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#2)(2009-9#1)(2011-2#1)(2011-3#1)(2012-1#1)
to structure the##2##3##(2008-8#1)(2010-2#1)
to structure##10##2##(1992-12#1)(1995-2#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#2)
to structures##4##2##(1990-11#1)(1992-11#1)(1995-3#1)(2008-4#1)
to student nurses##2##3##(2008-11#1)(2008-12#1)
to student##8##2##(2008-11#3)(2008-12#3)(2013-1#2)
to students from##2##3##(2008-11#1)(2011-2#1)
to students##11##2##(1996-1#1)(2007-12#1)(2008-11#3)(2008-12#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#2)
to students'##4##2##(2008-12#2)(2013-1#2)
to studies of##6##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
to studies##10##2##(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
to study (1)##2##3##(2008-4#1)(2008-9#1)
to study a##5##3##(1993-11#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-6#1)
to study and compare##2##4##(1992-3#1)(2007-7#1)
to study and##9##3##(1992-3#1)(1995-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#2)(2012-3#1)
to study any##2##3##(1997-6#1)(2007-10#1)
to study basic##3##3##(2008-4#1)(2008-9#1)(2010-7#1)
to study biological##2##3##(2007-12#1)(2008-5#1)
to study both the##4##4##(1993-6#1)(2009-4#1)(2013-1#2)
to study both##6##3##(1993-6#1)(2008-3#1)(2009-4#1)(2010-6#1)(2013-1#2)
to study cancer##2##3##(1995-9#1)(2008-11#1)
to study cell##3##3##(2008-10#1)(2008-4#1)(2009-12#1)
to study clinical##2##3##(2007-8#1)(2012-3#1)
to study competition for nutrients##2##5##(2008-10#2)
to study different##2##3##(2007-10#1)(2008-2#1)
to study effects##2##3##(2006-12#1)(2008-11#1)
to study gene expression##2##4##(2008-10#1)(2008-8#1)
to study how##4##3##(1995-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
to study its effects on##3##5##(1995-2#1)(1995-8#1)(2013-7#1)
to study its##8##3##(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-2#1)(2012-12#1)(2013-7#1)
to study mechanisms of##4##4##(2008-10#1)(2008-4#1)(2013-1#2)
to study of##2##3##(2008-10#2)
to study patterns of##2##4##(2008-7#1)(2009-2#1)
to study photon migration##2##4##(2008-2#1)(2008-3#1)
to study plant##2##3##(2009-10#1)(2013-8#1)
to study prevalence##2##3##(2007-7#1)(2008-12#1)
to study the adsorption of##2##5##(2008-10#2)
to study the adsorption##3##4##(2008-10#3)
to study the antioxidant##2##4##(1993-2#1)(2011-2#1)
to study the binding##3##4##(1991-8#1)(1993-11#1)(2008-11#1)
to study the cellular##3##4##(1994-6#1)(2008-11#1)(2009-12#1)
to study the clinical##2##4##(1993-5#1)(2008-5#1)
to study the distribution of##5##5##(1991-5#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)
to study the dynamics of the##4##6##(2008-1#2)(2008-3#1)(2010-11#1)
to study the dynamics of##6##5##(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
to study the effect of a##2##6##(1991-6#1)(2008-7#1)
to study the effect of the##5##6##(1995-3#1)(2007-12#1)(2008-10#1)(2013-7#2)
to study the effect of##30##5##(1990-11#1)(1990-2#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)
to study the effect##31##4##(1990-11#1)(1990-2#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)
to study the effects of initial##2##6##(2008-10#2)
to study the effects of##22##5##(1992-6#1)(1993-1#1)(1993-11#1)(1997-3#1)(1997-7#2)(2006-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#1)
to study the effects on##2##5##(1993-12#1)(2008-5#1)
to study the effects##24##4##(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1997-3#1)(1997-7#2)(2006-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#1)
to study the efficacy of##2##5##(1991-11#1)(2008-5#1)
to study the expression of##2##5##(1992-3#1)(2008-9#1)
to study the feasibility##2##4##(2008-3#1)(2008-8#1)
to study the formation of##2##5##(2008-4#1)(2008-6#1)
to study the function of##4##5##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
to study the functional##2##4##(1992-11#1)(2008-10#1)
to study the genetic##3##4##(2008-10#1)(2008-7#1)(2010-4#1)
to study the impact of##2##5##(2008-10#1)(2011-1#1)
to study the in##2##4##(2008-1#1)(2011-1#1)
to study the influence of cell shape##2##7##(1994-8#1)(2008-2#1)
to study the influence of the##2##6##(2008-10#1)(2008-2#1)
to study the influence of##11##5##(1992-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2012-2#1)(2013-8#1)
to study the inheritance of##2##5##(2008-10#2)
to study the interaction between##4##5##(1997-6#1)(2008-10#1)(2008-8#1)(2009-6#1)
to study the interaction of##2##5##(2008-5#1)(2008-9#1)
to study the interaction##7##4##(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)
to study the involvement of##2##5##(2008-11#1)(2012-3#1)
to study the kinetic##3##4##(2008-10#2)(2008-11#1)
to study the kinetics of##4##5##(1990-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
to study the mechanism by which##2##6##(1992-3#1)(1994-6#1)
to study the mechanism of##3##5##(2008-1#1)(2008-11#1)(2009-7#1)
to study the mechanism##5##4##(1992-3#1)(1994-6#1)(2008-1#1)(2008-11#1)(2009-7#1)
to study the mechanisms of##2##5##(2008-11#1)(2008-8#1)
to study the mechanisms##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
to study the molecular basis of the##2##7##(1997-2#1)(2008-10#1)
to study the molecular##3##4##(1997-2#1)(2008-10#2)
to study the occurrence of##2##5##(1990-6#1)(2007-10#1)
to study the performance of##2##5##(2009-9#1)(2010-5#1)
to study the population##3##4##(2008-10#2)(2008-8#1)
to study the possible##2##4##(1992-12#1)(2008-10#1)
to study the process of##4##5##(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)
to study the regulation of##3##5##(1992-12#1)(1994-8#1)(2008-4#1)
to study the relationship between the##3##6##(2008-10#1)(2008-5#1)(2011-1#1)
to study the relationship between##5##5##(1991-11#1)(2008-10#2)(2008-5#1)(2011-1#1)
to study the relationship of the SSCT##2##7##(2008-9#2)
to study the relationship of##3##5##(2008-7#1)(2008-9#2)
to study the relationship##8##4##(1991-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)
to study the relative##2##4##(2008-3#1)(2008-4#1)
to study the role of##9##5##(1990-5#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
to study the separation##2##4##(2008-10#2)
to study the spread of##2##5##(2008-10#2)
to study the structure and##2##5##(1997-4#1)(2013-1#1)
to study the structure##4##4##(1993-3#1)(1997-4#1)(2010-5#1)(2013-1#1)
to study the susceptibility##2##4##(1992-9#1)(2008-5#1)
to study the variability##2##4##(2008-10#2)
to study the##347##3##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-5#4)(1994-6#3)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#4)(2006-6#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#6)(2008-10#78)(2008-11#16)(2008-12#6)(2008-2#14)(2008-3#11)(2008-4#11)(2008-5#15)(2008-6#2)(2008-7#12)(2008-8#14)(2008-9#10)(2009-1#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#5)(2011-10#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#4)(2013-8#4)
to study their performance##2##4##(2008-10#1)(2008-8#1)
to study their##7##3##(1994-6#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2013-7#1)
to study these##5##3##(2007-11#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-11#1)
to study this effect##2##4##(1997-4#1)(2008-10#1)
to study this##12##3##(1991-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-4#1)(2008-10#2)(2008-6#1)(2008-9#2)(2012-12#1)(2013-8#1)
to study various aspects of##2##5##(1990-9#1)(2010-10#1)
to study various aspects##3##4##(1990-9#1)(2010-10#1)(2010-6#1)
to study viroid replication##2##4##(2008-9#2)
to study##639##2##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-9#3)(1991-11#2)(1991-12#4)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#3)(1994-5#5)(1994-6#5)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#4)(2006-12#1)(2006-6#1)(2007-10#5)(2007-11#9)(2007-12#11)(2007-7#3)(2007-8#3)(2008-1#10)(2008-10#123)(2008-11#33)(2008-12#12)(2008-2#24)(2008-3#25)(2008-4#25)(2008-5#20)(2008-6#3)(2008-7#27)(2008-8#22)(2008-9#23)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#5)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#11)(2011-10#1)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#10)(2012-9#1)(2013-1#12)(2013-7#8)(2013-8#7)
to studying the##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
to studying##6##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
to sub-Doppler lines of##2##4##(2008-2#2)
to sub-ppb##2##2##(2008-10#2)
to subcellular##2##2##(1993-6#1)(2008-1#1)
to subcortical##2##2##(1993-9#1)(2009-10#1)
to subcutaneous##4##2##(1992-5#1)(2007-7#1)(2008-8#1)(2012-2#1)
to subdivide the##2##3##(2007-11#1)(2012-2#1)
to subgroup I##3##3##(2008-10#3)
to subgroup##7##2##(2008-10#7)
to subgroups##3##2##(1994-9#1)(1996-2#1)(2008-10#1)
to subjective##6##2##(1990-3#1)(1992-5#1)(2008-10#1)(2008-7#2)(2008-9#1)
to subjects##6##2##(1991-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
to sublethal concentrations##2##3##(1991-12#1)(2008-5#1)
to sublethal##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
to submit their##2##3##(2008-11#1)(2008-7#1)
to submit##11##2##(1992-1#1)(1996-5#1)(2007-2#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2012-2#1)
to subsequent##12##2##(1994-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
to subsequently##4##2##(1997-6#1)(2008-1#1)(2008-4#1)(2009-11#1)
to substance abuse##3##3##(1994-2#3)
to substance use##2##3##(2010-10#1)(2010-6#1)
to substance##7##2##(1994-2#3)(2007-8#1)(2010-10#1)(2010-6#1)(2013-8#1)
to substantial##5##2##(1997-8#3)(2008-3#1)(2013-1#1)
to substantially##8##2##(1995-1#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
to substantiate the##4##3##(2008-11#2)(2008-7#1)(2009-9#1)
to substantiate##7##2##(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-12#1)
to substitute for the##3##4##(1993-3#1)(1993-9#1)(1995-2#1)
to substitute for##6##3##(1993-3#1)(1993-9#1)(1995-2#2)(1996-3#1)(2008-10#1)
to substitute the##3##3##(2008-11#1)(2008-8#1)(2010-11#1)
to substitute##12##2##(1993-3#1)(1993-9#1)(1995-2#2)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2013-1#1)
to substituted##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
to substitution##3##2##(1996-2#1)(1996-8#1)(2011-1#1)
to substitutions at position##2##4##(1994-8#2)
to substrate##3##2##(1995-8#1)(2008-6#1)(2008-7#1)
to subtoxic levels of##2##4##(1993-12#1)(2008-10#1)
to subtract##3##2##(2007-12#2)(2008-3#1)
to subunit##2##2##(1991-5#1)(1995-2#1)
to succeed in##2##3##(2008-1#1)(2011-2#1)
to succeed##7##2##(1997-2#1)(1997-3#1)(2008-1#1)(2008-8#2)(2009-12#1)(2011-2#1)
to success in##4##3##(1996-12#1)(1997-1#1)(2008-11#1)(2011-1#1)
to successful##18##2##(1991-12#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-3#1)
to successfully demonstrate the##2##4##(1995-12#1)(2008-10#1)
to successfully manage##2##3##(1994-12#1)(2012-3#1)
to successfully meet the##2##4##(1991-1#1)(1997-1#1)
to successfully treat##3##3##(1991-3#1)(2008-11#1)(2008-7#1)
to successfully##31##2##(1991-1#1)(1991-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-12#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to successive##2##2##(2008-10#1)(2008-2#1)
to such a##5##3##(1993-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-9#1)
to such an##4##3##(1990-11#1)(1993-1#1)(2007-8#1)(2008-2#1)
to such conditions##2##3##(2008-11#1)(2008-7#1)
to such processes##2##3##(2008-7#1)(2013-1#1)
to such##42##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#5)
to sucrose##2##2##(1992-11#1)(2008-8#1)
to sudden cardiac death##3##4##(2007-2#1)(2008-10#1)(2009-5#1)
to sudden##5##2##(2007-12#1)(2007-2#1)(2008-10#1)(2009-2#1)(2009-5#1)
to sue the##2##3##(1995-12#1)(1996-5#1)
to sue##5##2##(1995-12#1)(1996-5#3)(1997-5#1)
to suffer any##2##3##(2009-4#1)(2013-8#1)
to suffer from a##3##4##(2008-3#1)(2008-7#1)(2009-6#1)
to suffer from##6##3##(2008-1#1)(2008-3#2)(2008-7#2)(2009-6#1)
to suffer##13##2##(1991-8#1)(1992-4#1)(2007-10#1)(2008-1#1)(2008-3#2)(2008-7#2)(2009-4#1)(2009-6#1)(2011-2#1)(2013-8#2)
to sufficient##2##2##(1992-6#1)(1995-2#1)
to sugar beet##3##3##(2008-10#3)
to sugarcane mosaic virus##2##4##(2008-10#1)(2008-9#1)
to sugarcane##6##2##(2008-10#3)(2008-9#1)(2013-1#2)
to sugars##2##2##(2011-2#2)
to suggest a##3##3##(2007-12#1)(2008-11#1)(2012-2#1)
to suggest an##2##3##(2007-12#1)(2008-5#1)
to suggest that a##2##4##(2008-7#1)(2013-1#1)
to suggest that the##11##4##(1992-11#1)(1993-3#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
to suggest that their##2##4##(1995-3#1)(2008-10#1)
to suggest that##38##3##(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
to suggest the use of##2##5##(2008-3#1)(2008-8#1)
to suggest the##8##3##(1991-2#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)
to suggest##66##2##(1991-2#1)(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-4#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
to suicidal ideation##2##3##(1992-1#1)(2010-8#1)
to suicidal##4##2##(1992-1#1)(2010-8#1)(2012-12#2)
to suicide##5##2##(1993-3#1)(1996-1#2)(1997-3#1)(2010-6#1)
to suit the##5##3##(1996-6#1)(2010-3#2)(2012-12#1)(2013-1#1)
to suit##9##2##(1993-12#1)(1994-3#1)(1996-6#1)(2008-10#1)(2010-3#2)(2010-4#1)(2012-12#1)(2013-1#1)
to suitable##2##2##(2008-10#2)
to sulfate and##3##3##(2008-10#2)(2011-2#1)
to sulfate##6##2##(2008-10#4)(2008-6#1)(2011-2#1)
to sulfide##5##2##(1993-8#1)(2008-10#3)(2011-2#1)
to sulphide##2##2##(2008-10#2)
to sum up the##2##4##(2007-8#1)(2008-3#1)
to sum##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
to summarise the##5##3##(1996-11#1)(2008-8#2)(2011-1#1)(2012-12#1)
to summarise##7##2##(1996-11#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-12#2)
to summarize our##2##3##(2007-12#1)(2008-11#1)
to summarize some##2##3##(2008-4#1)(2009-10#1)
to summarize the##12##3##(2006-10#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)
to summarize##31##2##(1993-3#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
to sun##5##2##(1991-6#1)(2008-5#1)(2011-2#2)(2013-8#1)
to sunlight##6##2##(2008-5#2)(2011-2#4)
to superficial##2##2##(2008-6#1)(2013-1#1)
to supersede##3##2##(1993-12#1)(2010-12#1)(2013-1#1)
to supplement the clinical##2##4##(1997-2#1)(2008-4#1)
to supplement the##7##3##(1996-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
to supplement their##2##3##(2008-1#1)(2008-5#1)
to supplement##12##2##(1996-3#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#2)(2013-8#1)
to supply the##7##3##(1997-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
to supply##20##2##(1992-3#1)(1995-12#1)(1997-1#1)(2007-12#3)(2008-1#1)(2008-11#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
to support CQI##2##3##(1994-2#1)(1994-3#1)
to support a relationship between##2##5##(1993-11#1)(1996-9#1)
to support a##17##3##(1993-11#1)(1993-12#1)(1994-1#2)(1996-9#1)(2007-12#1)(2008-11#1)(2008-2#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
to support an##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2009-8#1)
to support and##3##3##(1995-1#1)(2008-12#1)(2011-2#1)
to support any##2##3##(2007-8#1)(2008-10#1)
to support appropriate##2##3##(1997-1#1)(2007-8#1)
to support cell growth##3##4##(2008-11#2)(2012-8#1)
to support cell##4##3##(2008-11#2)(2009-7#1)(2012-8#1)
to support children's##2##3##(1992-3#1)(2010-5#1)
to support claims##2##3##(2008-5#2)
to support environmental##2##3##(2008-11#2)
to support future##2##3##(1995-12#1)(1996-2#1)
to support growth##2##3##(1994-2#1)(2011-2#1)
to support its##2##3##(2009-8#1)(2013-8#1)
to support learning in practice##2##5##(2008-11#2)
to support long-term##2##3##(2008-11#1)(2009-6#1)
to support new##2##3##(1996-12#1)(1997-1#1)
to support our##2##3##(2008-10#1)(2012-5#1)
to support patient##2##3##(2008-11#1)(2013-1#1)
to support patients##3##3##(1995-2#1)(2008-1#1)(2011-1#1)
to support such##7##3##(1997-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-1#1)(2013-8#1)
to support teaching##2##3##(2008-11#1)(2012-3#1)
to support that##2##3##(1997-4#1)(2008-10#1)
to support the development and##2##5##(1994-2#1)(2013-1#1)
to support the development##3##4##(1994-2#1)(2012-3#1)(2013-1#1)
to support the growth of##2##5##(2008-11#1)(2008-5#1)
to support the growth##3##4##(2008-11#2)(2008-5#1)
to support the hypothesis that##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
to support the use of##6##5##(2007-12#1)(2007-8#1)(2008-9#1)(2012-12#1)(2013-1#2)
to support the##61##3##(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#2)(1993-12#1)(1994-2#1)(1995-8#1)(1996-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
to support their##5##3##(1993-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
to support this hypothesis##2##4##(2008-7#1)(2008-8#1)
to support this##8##3##(1993-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2013-1#1)
to support##246##2##(1990-5#1)(1991-5#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#4)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#5)(2008-1#2)(2008-10#23)(2008-11#30)(2008-12#5)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#13)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#6)(2011-1#2)(2011-2#10)(2011-9#1)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#7)(2012-5#1)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#4)
to supporting##3##2##(1995-12#1)(2008-11#1)(2012-12#1)
to suppose that##3##3##(1990-5#1)(1994-6#1)(2008-10#1)
to suppress Fusarium wilt##2##4##(2008-10#2)
to suppress disease##3##3##(2008-10#3)
to suppress or##3##3##(1993-6#1)(2006-10#1)(2011-2#1)
to suppress populations##2##3##(2008-10#2)
to suppress the disease##3##4##(2008-10#2)(2008-7#1)
to suppress the interference##2##4##(2008-10#1)(2008-2#1)
to suppress the##24##3##(1990-2#1)(1992-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)
to suppress##81##2##(1990-2#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#2)
to suppression of##4##3##(1994-6#1)(2008-10#2)(2008-11#1)
to supraconducive##3##2##(2008-10#3)
to surface roughness##2##3##(2008-2#1)(2008-3#1)
to surface##20##2##(1990-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#3)(2008-6#1)(2010-4#1)(2010-5#1)(2011-2#1)
to surfaces and##2##3##(1990-2#1)(2008-3#1)
to surfaces##9##2##(1990-2#2)(2008-10#2)(2008-3#2)(2008-6#1)(2013-1#1)(2013-8#1)
to surfactants##2##2##(1996-2#1)(2008-5#1)
to surgeons##2##2##(2008-4#1)(2010-8#1)
to surgery and##6##3##(1991-2#1)(1993-1#1)(1995-9#1)(1997-2#1)(2008-9#1)(2010-7#1)
to surgery for##5##3##(1993-9#1)(1994-9#1)(2008-11#1)(2008-9#1)(2012-3#1)
to surgery or##4##3##(2008-10#1)(2008-7#2)(2008-9#1)
to surgery were##2##3##(2008-7#1)(2012-3#1)
to surgery##44##2##(1990-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#1)
to surgical drainage and##2##4##(2007-7#2)
to surgical excision##2##3##(2009-4#1)(2012-3#1)
to surgical management##3##3##(1991-3#1)(2008-9#1)(2013-1#1)
to surgical procedures##2##3##(1990-3#1)(2007-11#1)
to surgical repair of##2##4##(1993-1#1)(1996-6#1)
to surgical stimuli##2##3##(2011-2#2)
to surgical tracheostomy##2##3##(2008-2#1)(2012-12#1)
to surgical trauma##3##3##(2008-12#1)(2012-12#2)
to surgical treatment##3##3##(1997-8#1)(2007-11#1)(2011-2#1)
to surgical##37##2##(1990-3#2)(1991-3#1)(1993-1#1)(1994-2#1)(1996-6#1)(1997-6#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#6)(2012-12#4)(2012-3#2)(2013-1#1)
to surgically##4##2##(2007-8#1)(2008-7#1)(2009-8#1)(2011-1#1)
to surmount##2##2##(2008-11#1)(2008-3#1)
to surrounding##4##2##(1991-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
to surveillance and##2##3##(1997-1#1)(2013-1#1)
to surveillance##3##2##(1997-1#1)(2011-2#1)(2013-1#1)
to survey for##2##3##(2008-10#2)
to survey the##4##3##(2007-11#1)(2008-10#1)(2009-12#1)(2013-1#1)
to survey##13##2##(1995-12#1)(1996-1#1)(1996-3#2)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2009-12#1)(2011-10#1)(2013-1#1)
to survival##12##2##(1992-9#2)(1994-12#1)(1994-2#1)(2008-10#3)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
to survive and##4##3##(1992-3#1)(2007-12#1)(2008-5#1)(2013-1#1)
to survive for##3##3##(1996-5#1)(2008-7#1)(2008-8#1)
to survive in the##2##4##(2008-10#1)(2011-2#1)
to survive in##5##3##(1993-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
to survive##31##2##(1991-3#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(2007-12#1)(2007-6#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#4)(2012-1#1)(2013-1#1)
to susceptible##4##2##(2008-10#3)(2008-7#1)
to suspect a##2##3##(2008-10#1)(2011-2#1)
to suspect the##2##3##(1991-4#1)(2010-5#1)
to suspect##6##2##(1991-4#1)(2008-10#1)(2010-5#2)(2011-2#1)(2013-8#1)
to suspend##2##2##(1997-2#1)(2008-7#1)
to suspicion of##2##3##(1995-5#1)(2008-1#1)
to sustain the##6##3##(1990-2#1)(2007-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
to sustain##21##2##(1990-2#1)(1993-6#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
to sustained##6##2##(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
to sweeteners##3##2##(2008-2#3)
to swell##3##2##(2008-10#1)(2008-9#1)(2010-2#1)
to swim##2##2##(2008-5#1)(2013-8#1)
to switch from##3##3##(1992-9#1)(1997-6#1)(2008-6#1)
to switch on##2##3##(2009-11#1)(2011-2#1)
to switch##13##2##(1992-9#1)(1996-7#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
to symbiosis##2##2##(2008-5#1)(2010-6#1)
to symmetric##2##2##(2008-11#1)(2008-3#1)
to sympathovagal##2##2##(2009-11#1)(2012-2#1)
to symptom##3##2##(1996-5#1)(2008-10#1)(2010-5#1)
to symptomatic##3##2##(2007-5#1)(2011-2#1)(2012-2#1)
to symptoms from##2##3##(2008-10#1)(2008-3#1)
to symptoms of##2##3##(2008-6#1)(2013-8#1)
to symptoms##11##2##(1991-3#1)(1992-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
to synaptic##3##2##(1994-2#1)(2009-8#2)
to synchronize the##2##3##(2008-11#1)(2008-3#1)
to synchronize##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
to synchronous##2##2##(1996-8#1)(2008-10#1)
to synergize with##2##3##(1993-12#1)(2009-12#1)
to synthesis of##3##3##(1997-4#1)(2007-11#1)(2010-3#1)
to synthesis##5##2##(1995-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2010-3#1)
to synthesise##2##2##(2008-10#1)(2010-12#1)
to synthesize a##4##3##(2008-2#1)(2008-3#1)(2009-3#1)(2010-2#1)
to synthesize and##4##3##(1993-3#1)(2008-10#1)(2008-6#1)(2013-8#1)
to synthesize the##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
to synthesize##49##2##(1990-5#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to synthetic##7##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
to systematic errors##3##3##(2008-2#1)(2008-3#2)
to systematic##5##2##(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)
to systematically evaluate##2##3##(2008-4#1)(2009-4#1)
to systematically##12##2##(1993-2#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-4#1)(2009-9#1)(2013-1#1)
to systematize the##2##3##(2007-7#1)(2008-10#1)
to systemic##13##2##(1990-8#1)(1994-12#2)(1996-3#1)(2008-1#1)(2008-10#4)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
to systemically##3##2##(2008-10#3)
to systems of##2##3##(2007-11#1)(2008-11#1)
to systems##5##2##(1995-1#1)(1997-2#1)(2007-11#1)(2008-11#1)(2012-2#1)
to tackle a##2##3##(2008-1#1)(2009-11#1)
to tackle this##3##3##(1995-5#1)(2009-5#1)(2011-2#1)
to tackle##15##2##(1991-11#1)(1994-3#1)(1995-5#1)(2007-2#1)(2008-1#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
to tag##6##2##(1997-8#1)(2008-10#2)(2008-9#2)(2012-3#1)
to tailor the##4##3##(2007-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
to tailor##11##2##(1993-2#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-7#2)(2009-12#1)(2010-4#1)(2013-1#2)
to take a##7##3##(1990-6#1)(1991-3#1)(1993-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)
to take account of##3##4##(1996-11#1)(2008-3#1)(2010-10#1)
to take account##4##3##(1996-11#1)(2008-3#1)(2010-10#1)(2013-8#1)
to take action##4##3##(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
to take advantage of a##2##5##(2007-11#1)(2008-10#1)
to take advantage of the##3##5##(1994-3#2)(2009-2#1)
to take advantage of this##2##5##(1993-12#1)(2008-7#1)
to take advantage of##13##4##(1990-11#1)(1993-12#1)(1994-3#2)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)
to take full advantage of the##2##6##(1996-4#1)(2008-7#1)
to take full advantage of##3##5##(1994-2#1)(1996-4#1)(2008-7#1)
to take into account the actual three-dimensional geometry##2##8##(2008-3#2)
to take into account the##13##5##(1993-2#1)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#2)
to take into account##16##4##(1990-7#1)(1993-2#1)(1995-12#1)(1995-5#2)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)
to take into##17##3##(1990-7#1)(1993-2#1)(1995-12#2)(1995-5#2)(1997-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)
to take measures##2##3##(2008-12#1)(2010-5#1)
to take more##2##3##(1993-12#1)(2008-11#1)
to take on##2##3##(1990-4#1)(2008-11#1)
to take part in research projects##2##6##(1992-3#1)(2009-6#1)
to take part in research##3##5##(1992-3#1)(2009-6#2)
to take part in the##2##5##(1993-3#1)(1997-6#1)
to take part in##13##4##(1990-11#1)(1992-3#1)(1993-3#1)(1996-11#1)(1997-6#1)(2008-10#1)(2009-6#6)(2013-8#1)
to take part##15##3##(1990-11#1)(1992-3#1)(1993-3#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#2)(2009-6#6)(2013-8#1)
to take place at##2##4##(1996-2#1)(2008-10#1)
to take place in the##3##5##(1992-3#1)(2008-7#2)
to take place in##10##4##(1992-3#1)(2008-10#2)(2008-7#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
to take place via##2##4##(1996-2#1)(2010-4#1)
to take place##21##3##(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1996-2#2)(2008-10#5)(2008-6#1)(2008-7#3)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
to take precautions##2##3##(1996-5#2)
to take steps to##3##4##(1993-1#1)(2007-11#1)(2008-11#1)
to take the lead##3##4##(1995-12#2)(1995-2#1)
to take the##10##3##(1995-12#2)(1995-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#2)
to take them into account##2##5##(2011-1#1)(2012-2#1)
to take up##4##3##(2008-1#1)(2008-2#1)(2008-9#1)(2009-12#1)
to take##150##2##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#3)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#12)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#3)(2008-7#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#6)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
to take-all##3##2##(2008-10#3)
to talk to##3##3##(1997-1#1)(2009-7#1)(2012-3#1)
to talk##7##2##(1997-1#1)(2008-6#1)(2009-11#1)(2009-7#1)(2012-12#2)(2012-3#1)
to tall fescue##2##3##(2008-10#2)
to tall##3##2##(2008-10#2)(2013-1#1)
to tame the##2##3##(1997-1#1)(2008-10#1)
to tamoxifen##8##2##(1990-2#1)(1991-8#2)(1992-8#1)(1993-1#2)(2008-10#2)
to tap water and##3##4##(2008-10#3)
to tap water##5##3##(2008-10#5)
to tap##8##2##(1994-11#1)(2008-10#6)(2012-2#1)
to target cells##5##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
to target human##2##3##(2008-10#1)(2010-1#1)
to target the##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
to target treatment##2##3##(2008-7#1)(2010-3#1)
to target##61##2##(1991-6#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
to targeted##3##2##(1996-11#1)(2008-6#1)(2008-9#1)
to targets defined by proximity##2##5##(2008-9#2)
to targets defined by##3##4##(2008-9#3)
to targets##5##2##(2008-9#3)(2010-5#1)(2011-2#1)
to task##3##2##(1995-11#1)(1995-12#1)(2008-7#1)
to tasks##4##2##(1990-4#1)(2008-11#1)(2009-7#1)(2009-8#1)
to taste stimuli##6##3##(1996-8#1)(2012-12#3)(2013-1#2)
to taste##7##2##(1996-8#2)(2012-12#3)(2013-1#2)
to taxonomic##2##2##(2008-10#1)(2013-7#1)
to teach and##2##3##(2008-11#1)(2008-12#1)
to teach students##2##3##(1995-12#1)(2010-3#1)
to teach the##2##3##(1996-1#1)(2012-1#1)
to teach their##2##3##(1992-4#1)(2012-12#1)
to teach##22##2##(1992-4#1)(1993-12#2)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-7#1)(2009-11#1)(2010-3#1)(2012-1#1)(2012-12#1)
to teachers##2##2##(2007-4#1)(2011-2#1)
to teaching and##2##3##(2008-11#1)(2011-2#1)
to teaching##15##2##(1994-12#1)(1995-1#1)(2007-10#1)(2008-11#5)(2008-12#1)(2009-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
to teams##2##2##(1997-2#2)
to tear##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
to technical##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
to techniques and##2##3##(1991-3#1)(2009-9#1)
to tell the story of##2##5##(2008-3#1)(2011-2#1)
to tell##5##2##(1991-2#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-8#1)
to temperature and hydrostatic pressure##4##5##(2008-2#3)(2008-3#1)
to temperature and pressure##2##4##(2008-3#2)
to temperature and relative humidity##2##5##(2008-10#2)
to temperature and##11##3##(1994-8#1)(2008-10#3)(2008-2#3)(2008-3#4)
to temperature variation##2##3##(2007-11#1)(2011-1#1)
to temperature##37##2##(1990-2#1)(1991-2#1)(1994-12#1)(1994-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-6#2)
to temperatures &gt##2##3##(1995-6#1)(2008-10#1)
to temperatures##8##2##(1995-6#1)(2007-12#1)(2008-10#4)(2008-6#1)(2010-4#1)
to templates##3##2##(2008-6#2)(2008-7#1)
to ten days##2##3##(1991-8#1)(1992-5#1)
to ten times##3##3##(1994-9#2)(2008-10#1)
to ten##13##2##(1990-10#1)(1991-8#1)(1992-1#1)(1992-5#1)(1994-9#2)(1996-2#1)(2008-10#4)(2008-5#1)(2008-8#1)
to tenofovir##2##2##(2013-1#2)
to tens of##3##3##(2007-12#1)(2008-2#2)
to tension##2##2##(2009-1#1)(2011-1#1)
to term##4##2##(1990-5#2)(1992-12#1)(2011-1#1)
to terminal##4##2##(1990-11#1)(1993-8#1)(2008-10#1)(2009-3#1)
to terminate the##5##3##(1991-3#1)(1992-6#1)(1994-11#1)(2007-9#1)(2008-11#1)
to terminate##11##2##(1991-3#1)(1992-2#1)(1992-6#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(2007-9#1)(2008-11#1)(2013-1#2)
to termination##2##2##(2008-1#1)(2009-2#1)
to terms with the##3##4##(1994-1#1)(1995-11#1)(1997-2#1)
to terms with##6##3##(1994-1#1)(1995-1#1)(1995-11#1)(1997-2#1)(2008-11#1)(2012-3#1)
to terror##3##2##(1990-8#1)(2009-7#2)
to tertiary##2##2##(1992-8#1)(2010-8#1)
to test a model##2##4##(2008-12#1)(2012-3#1)
to test a new##2##4##(1996-6#1)(2008-3#1)
to test a##10##3##(1993-12#1)(1996-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#1)(2012-3#1)
to test an##4##3##(1997-3#1)(2008-3#1)(2008-6#1)(2009-3#1)
to test and verify the##2##5##(2007-11#1)(2008-3#1)
to test and verify##3##4##(2007-11#1)(2008-3#2)
to test and##7##3##(2007-11#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)(2013-7#1)
to test associations between##2##4##(1997-5#1)(2012-3#1)
to test different##2##3##(2008-9#1)(2011-2#1)
to test for differences in##2##5##(1994-2#1)(2008-9#1)
to test for the##3##4##(1994-8#1)(2008-11#1)(2010-8#1)
to test for##23##3##(1992-11#1)(1992-2#1)(1994-2#2)(1994-8#1)(1996-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2012-2#2)(2013-1#1)
to test hypotheses about the##2##5##(2008-10#1)(2008-8#1)
to test hypotheses about##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
to test hypotheses##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
to test if the##2##4##(2007-10#1)(2007-12#1)
to test if these##2##4##(2008-10#1)(2012-1#1)
to test if##8##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)
to test its##2##3##(1997-1#1)(2008-12#1)
to test such##2##3##(1992-9#1)(2011-2#1)
to test the accuracy##2##4##(1990-12#1)(2008-3#1)
to test the activity of##2##5##(2008-4#1)(2008-5#1)
to test the effect of##3##5##(1995-2#1)(2008-10#1)(2012-2#1)
to test the effectiveness of##2##5##(2009-3#1)(2010-10#1)
to test the effects of##8##5##(1992-1#1)(1994-12#1)(2008-10#2)(2008-11#2)(2010-11#1)(2012-2#1)
to test the feasibility of##3##5##(1996-2#1)(1997-8#1)(2011-2#1)
to test the feasibility##4##4##(1996-2#1)(1997-8#1)(2008-11#1)(2011-2#1)
to test the function of##2##5##(1995-2#1)(2008-1#1)
to test the hypothesis of##2##5##(1991-2#1)(2008-10#1)
to test the hypothesis that the##4##6##(1994-6#1)(2008-11#1)(2008-7#1)(2009-7#1)
to test the hypothesis that##19##5##(1990-8#1)(1993-12#1)(1994-6#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-5#1)
to test the hypothesis##21##4##(1990-8#1)(1991-2#1)(1993-12#1)(1994-6#1)(1996-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-5#1)
to test the null hypothesis##2##5##(1995-5#1)(2008-10#1)
to test the prediction that##2##5##(2008-5#1)(2008-8#1)
to test the prediction##3##4##(2008-12#1)(2008-5#1)(2008-8#1)
to test the stability of the##2##6##(2008-3#2)
to test the system##2##4##(2007-12#1)(2008-11#1)
to test the validity of the##2##6##(1997-2#1)(2008-10#1)
to test the validity of##4##5##(1997-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
to test the##107##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#7)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-5#2)(2013-1#1)(2013-7#1)(2013-8#1)
to test their##4##3##(1997-5#1)(2008-10#2)(2013-8#1)
to test them##2##3##(2008-10#1)(2010-3#1)
to test these##7##3##(1991-5#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)
to test this hypothesis##4##4##(1995-5#1)(2008-11#1)(2008-7#1)(2008-8#1)
to test this##9##3##(1995-5#1)(1996-3#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
to test two##2##3##(2008-6#1)(2008-9#1)
to test whether a##2##4##(2008-1#1)(2008-7#1)
to test whether the##4##4##(1994-3#1)(2009-2#1)(2009-5#1)(2013-1#1)
to test whether this##3##4##(1997-5#1)(2008-9#1)(2012-3#1)
to test whether##18##3##(1994-3#1)(1995-3#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#2)
to test which##2##3##(2008-8#1)(2009-8#1)
to test##259##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#42)(2008-11#14)(2008-12#4)(2008-2#6)(2008-3#20)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#16)(2008-9#9)(2009-2#2)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#5)(2012-5#2)(2012-6#1)(2013-1#4)(2013-7#2)(2013-8#2)
to testicular##2##2##(2008-10#1)(2008-6#1)
to testify##2##2##(2008-10#1)(2008-11#1)
to testing##8##2##(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2012-12#1)(2012-2#1)
to testosterone##2##2##(1990-11#1)(2012-12#1)
to tests of##2##3##(2011-7#1)(2012-1#1)
to tetanus toxoid##3##3##(2009-5#1)(2011-2#2)
to tetanus##7##2##(1994-8#1)(1995-12#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#2)
to tetracycline##3##2##(2007-10#1)(2008-10#2)
to tetrahydroaminoacridine and##2##3##(1992-8#2)
to thank##2##2##(2011-2#1)(2013-8#1)
to that achieved in##2##4##(1995-12#1)(2008-10#1)
to that achieved with##2##4##(1993-2#1)(2008-7#1)
to that achieved##4##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-7#1)
to that area##2##3##(1996-2#1)(2008-8#1)
to that associated with the##2##5##(1993-12#1)(2008-2#1)
to that associated with##4##4##(1993-12#2)(2008-10#1)(2008-2#1)
to that at the##2##4##(2007-11#1)(2008-3#1)
to that at##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
to that caused by##3##4##(1990-11#1)(1992-8#1)(2010-4#1)
to that described for##3##4##(1990-5#1)(2007-12#1)(2008-10#1)
to that exhibited by##2##4##(1994-12#1)(2008-10#1)
to that expected from##2##4##(1994-12#1)(2008-10#1)
to that for the picrate one##2##6##(2008-10#2)
to that for the##3##4##(2008-10#3)
to that for##11##3##(1993-12#1)(1993-8#1)(1994-5#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-1#1)
to that found in the##3##5##(1995-6#1)(2008-11#1)(2012-12#1)
to that found in##7##4##(1994-8#1)(1995-6#1)(2007-10#1)(2008-11#1)(2008-7#2)(2012-12#1)
to that found with##2##4##(1990-12#1)(1991-3#1)
to that found##12##3##(1990-12#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-8#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#2)(2012-12#1)
to that from##5##3##(1992-12#1)(1995-2#1)(1996-2#1)(2008-6#1)(2009-12#1)
to that habitat##2##3##(2008-8#2)
to that in 2009##2##4##(2012-3#2)
to that in a##2##4##(2008-10#1)(2008-11#1)
to that in control##2##4##(2008-10#1)(2008-7#1)
to that in infected##2##4##(2008-10#2)
to that in normal##2##4##(1996-5#1)(2012-1#1)
to that in the##10##4##(1991-5#1)(1994-11#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)
to that in water##3##4##(2008-10#2)(2008-7#1)
to that in young##2##4##(2008-7#1)(2013-7#1)
to that in##49##3##(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-5#2)(2007-12#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2010-11#1)(2010-3#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
to that induced by##5##4##(1993-3#1)(1995-3#1)(1995-9#1)(2008-10#1)(2009-10#1)
to that known##3##3##(1996-2#1)(1997-4#2)
to that observed for##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
to that observed in the##4##5##(1991-6#1)(1995-12#1)(2008-10#1)(2009-12#1)
to that observed in##23##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#2)
to that observed on##2##4##(1994-10#1)(2007-12#1)
to that observed with##6##4##(1994-8#1)(2008-10#4)(2008-7#1)
to that observed##38##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-7#3)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
to that obtained at##2##4##(2008-10#1)(2008-11#1)
to that obtained by##2##4##(2008-10#1)(2012-2#1)
to that obtained for##2##4##(1992-12#1)(2008-5#1)
to that obtained from##4##4##(1992-6#1)(1993-12#1)(2007-11#1)(2010-4#1)
to that obtained in##6##4##(1990-12#1)(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#2)
to that obtained with a##2##5##(2008-10#1)(2008-3#1)
to that obtained with##6##4##(1995-12#1)(2008-10#4)(2008-3#1)
to that obtained##23##3##(1990-12#1)(1992-12#2)(1992-6#1)(1993-12#1)(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-2#1)
to that of M##2##4##(2008-10#1)(2011-2#1)
to that of a standard##2##5##(2007-11#1)(2011-1#1)
to that of a##22##4##(1992-8#1)(1996-12#1)(1996-4#1)(2007-11#3)(2008-10#6)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
to that of an##3##4##(1991-9#1)(1997-4#1)(2008-2#1)
to that of control##7##4##(1992-10#1)(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#2)
to that of controls##2##4##(1990-11#1)(2008-11#1)
to that of conventional##3##4##(2007-12#1)(2010-12#1)(2012-2#1)
to that of free rhuMAbHER2-Fab'##2##5##(1995-2#2)
to that of free##3##4##(1995-2#2)(1997-7#1)
to that of human##5##4##(1993-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-6#1)
to that of insulin##2##4##(1992-10#1)(2008-8#1)
to that of its##3##4##(1990-5#1)(1997-7#1)(2008-9#1)
to that of mature##2##4##(1990-12#1)(1992-12#1)
to that of native##2##4##(1992-6#1)(1992-8#1)
to that of other##18##4##(1990-11#1)(1990-12#1)(1993-2#1)(1994-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
to that of patients##2##4##(2010-3#1)(2011-2#1)
to that of rat##4##4##(1990-5#1)(1996-12#1)(2008-11#2)
to that of stems##2##4##(2008-12#2)
to that of the control##9##5##(1994-8#1)(2008-8#1)(2008-9#6)(2011-2#1)
to that of the host##2##5##(1994-2#1)(2013-8#1)
to that of the human##4##5##(1990-12#1)(2007-7#1)(2008-4#1)(2011-1#1)
to that of the mature##2##5##(1991-9#1)(1994-9#1)
to that of the native##2##5##(1995-11#1)(2008-11#1)
to that of the rat gene##2##6##(1991-7#1)(1994-11#1)
to that of the rat##3##5##(1991-7#1)(1994-11#1)(2011-2#1)
to that of the reference##2##5##(1995-3#1)(2008-3#1)
to that of the standard##2##5##(1997-3#1)(2008-8#1)
to that of the wild type##3##6##(1990-5#1)(1992-8#1)(1993-3#1)
to that of the wild-type enzyme##2##6##(1992-6#1)(1994-5#1)
to that of the wild-type##4##5##(1992-6#1)(1994-5#1)(1994-6#1)(1995-5#1)
to that of the yeast##3##5##(1991-6#1)(1996-2#1)(1997-8#1)
to that of the##126##4##(1990-12#3)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#3)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#12)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
to that of their##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
to that of##376##3##(1990-11#3)(1990-12#8)(1990-5#5)(1990-8#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#6)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#5)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#5)(1997-3#4)(1997-4#7)(1997-7#5)(1997-8#2)(2007-10#4)(2007-11#7)(2007-12#8)(2007-7#1)(2008-1#2)(2008-10#54)(2008-11#14)(2008-12#6)(2008-2#9)(2008-3#9)(2008-4#2)(2008-5#16)(2008-6#5)(2008-7#8)(2008-8#12)(2008-9#19)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-10#1)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
to that offered##2##3##(1991-2#1)(1995-11#1)
to that on##4##3##(1991-12#1)(1996-2#1)(2008-10#2)
to that point##2##3##(2012-12#1)(2012-2#1)
to that population##2##3##(1995-12#1)(2008-8#1)
to that previously##2##3##(1990-2#1)(2010-8#1)
to that provided by##2##4##(1992-5#1)(2007-10#1)
to that published##2##3##(2008-1#1)(2008-7#1)
to that reported for##5##4##(1991-7#1)(1992-12#1)(2007-12#1)(2008-11#1)(2008-7#1)
to that reported##9##3##(1990-2#1)(1991-7#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
to that seen in##7##4##(1992-12#1)(1994-5#2)(1994-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
to that seen##10##3##(1992-12#1)(1993-8#1)(1994-5#2)(1994-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
to that used##3##3##(2008-10#2)(2010-10#1)
to that which##3##3##(1994-5#1)(2007-11#1)(2009-11#1)
to that with##5##3##(1992-5#1)(1993-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
to that##654##2##(1990-11#4)(1990-12#10)(1990-2#3)(1990-5#6)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#9)(1992-3#5)(1992-5#3)(1992-6#7)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#6)(1993-12#7)(1993-2#4)(1993-3#3)(1993-6#5)(1993-8#8)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#8)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#1)(1995-11#3)(1995-12#6)(1995-2#7)(1995-3#4)(1995-5#6)(1995-6#2)(1995-8#3)(1995-9#2)(1996-12#9)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1997-2#7)(1997-3#6)(1997-4#9)(1997-5#1)(1997-7#6)(1997-8#2)(2007-10#6)(2007-11#11)(2007-12#13)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#108)(2008-11#28)(2008-12#9)(2008-2#10)(2008-3#15)(2008-4#3)(2008-5#18)(2008-6#8)(2008-7#23)(2008-8#21)(2008-9#32)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#5)(2011-10#1)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#6)(2013-1#9)(2013-7#3)(2013-8#5)
to the &quot##27##3##(1990-10#1)(1990-11#1)(1991-8#2)(1992-12#1)(1993-11#1)(1994-9#1)(1995-2#2)(1996-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to the 0##2##3##(1996-8#1)(2008-10#1)
to the 1##5##3##(1992-6#1)(1993-11#1)(2008-10#3)
to the 10##2##3##(1992-11#1)(1997-3#1)
to the 12##3##3##(1996-6#2)(2008-7#1)
to the 16##2##3##(1997-6#1)(2008-2#1)
to the 1985##2##3##(1996-2#1)(2011-2#1)
to the 20##3##3##(1993-1#1)(2008-10#2)
to the 2000s##2##3##(2007-12#1)(2012-3#1)
to the 2001##2##3##(2008-11#1)(2012-12#1)
to the 21##2##3##(1993-6#1)(1996-9#1)
to the 3' end of the##6##6##(1991-7#1)(1992-3#1)(1992-6#1)(1997-2#1)(1997-4#1)(2008-11#1)
to the 3' end of##7##5##(1991-7#1)(1992-3#1)(1992-6#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-8#1)
to the 3' untranslated region##2##5##(2008-7#1)(2009-5#1)
to the 3'##14##3##(1991-7#1)(1992-3#1)(1992-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)
to the 3D##2##3##(1996-2#1)(2008-10#1)
to the 40##4##3##(1996-12#3)(1997-3#1)
to the 5##2##3##(1992-3#1)(2011-2#1)
to the 5' end of##2##5##(1990-12#1)(1994-12#1)
to the 5' terminus of##2##5##(2008-4#2)
to the 5'##10##3##(1990-12#1)(1991-5#1)(1994-12#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-4#2)(2012-2#1)
to the 5'-terminus of##2##4##(2008-4#2)
to the 50%##2##3##(2012-2#1)(2013-1#1)
to the 5S(1/2) ?##2##4##(2007-12#2)
to the 9th##4##3##(1991-9#1)(1993-3#1)(2008-11#1)(2008-7#1)
to the A##3##3##(1990-11#1)(1994-5#1)(2008-10#1)
to the ACL##2##3##(1997-8#1)(2013-1#1)
to the ADHD##2##3##(2006-10#1)(2012-1#1)
to the AGL2 gene family##2##5##(1997-2#2)
to the AGL2##4##3##(1997-2#3)(1997-8#1)
to the AIDS##2##3##(1990-3#1)(1992-12#1)
to the AVM##2##3##(1997-6#1)(2008-7#1)
to the Ag surface##2##4##(2013-1#2)
to the Ag##3##3##(2013-1#3)
to the American##2##3##(2008-3#1)(2010-6#1)
to the Andean##2##3##(2008-10#2)
to the B##3##3##(1991-3#1)(1994-5#1)(2008-10#1)
to the BTB##2##3##(2012-2#2)
to the Bacillus##3##3##(2010-10#1)(2011-2#2)
to the Benes network##2##4##(2008-2#2)
to the British##2##3##(1995-8#1)(2008-10#1)
to the C domain##2##4##(1995-5#2)
to the C terminus of the##2##6##(1994-8#1)(1995-2#1)
to the C##7##3##(1994-8#1)(1995-2#1)(1995-5#2)(2008-10#3)
to the C-terminal##6##3##(1990-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-7#1)(2008-9#1)
to the C-terminus of the##2##5##(1992-3#1)(1995-5#1)
to the C-terminus of##3##4##(1992-3#1)(1995-5#1)(2012-3#1)
to the C10##2##3##(1990-8#1)(1993-11#1)
to the CD4##2##3##(1992-5#1)(1997-4#1)
to the CL intensity##3##4##(2008-10#3)
to the CL##4##3##(2008-10#4)
to the CNS##3##3##(1990-11#1)(2008-2#1)(2010-12#1)
to the COOH-terminal##2##3##(1992-9#1)(1995-6#1)
to the CRE##2##3##(2013-1#2)
to the CSF##2##3##(1993-12#1)(2012-3#1)
to the Ca2+##3##3##(1992-9#1)(1995-12#1)(2008-8#1)
to the Canadian##2##3##(1994-2#1)(1996-1#1)
to the Center##2##3##(1994-3#1)(2013-8#1)
to the Clinic##3##3##(1994-12#1)(1995-9#1)(2011-2#1)
to the Co-4##2##3##(2008-10#2)
to the Convention have##2##4##(1990-2#1)(1992-12#1)
to the Convention##3##3##(1990-2#1)(1992-12#2)
to the Court of##2##4##(1995-12#1)(1997-5#1)
to the D##4##3##(1995-2#1)(2008-10#3)
to the DNA binding##3##4##(1995-6#1)(2008-2#2)
to the DNA##10##3##(1991-5#1)(1992-12#1)(1994-5#1)(1995-6#1)(1997-3#1)(2008-2#2)(2008-9#1)(2010-2#1)(2013-1#1)
to the DNC diet resulted in##2##6##(2010-2#2)
to the Department of##6##4##(1990-10#1)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#1)(2012-12#1)
to the E##2##3##(1990-11#1)(1995-12#1)
to the ED##2##3##(2009-8#1)(2013-1#1)
to the EDP##2##3##(2008-7#2)
to the EGR-1##2##3##(1990-11#1)(1991-10#1)
to the ER##7##3##(1994-12#2)(1997-7#1)(2008-11#3)(2012-2#1)
to the Editor##4##3##(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#1)
to the European##5##3##(1993-5#1)(2008-10#3)(2011-2#1)
to the FI system##2##4##(2008-10#2)
to the Fc portion of##2##5##(1990-12#1)(2008-4#1)
to the Fc region of##2##5##(2008-11#1)(2009-2#1)
to the Fc region##3##4##(2008-11#2)(2009-2#1)
to the Fc##6##3##(1990-12#2)(2008-11#2)(2008-4#1)(2009-2#1)
to the Future##2##3##(2008-10#1)(2013-1#1)
to the G##2##3##(2008-10#1)(2008-6#1)
to the GCN4 motif##2##4##(2008-9#2)
to the Golgi apparatus##2##4##(1990-7#2)
to the Golgi##5##3##(1990-7#2)(1995-2#1)(2009-8#1)(2012-2#1)
to the HBV##2##3##(1997-4#1)(2008-10#1)
to the HIV epidemic##4##4##(1990-6#1)(1993-12#1)(2009-7#1)(2011-2#1)
to the HIV-1##3##3##(1997-3#1)(2008-4#1)(2013-1#1)
to the HLA##2##3##(1991-11#1)(2008-10#1)
to the HPLC##2##3##(2008-10#2)
to the HPV##2##3##(1991-2#2)
to the Health##2##3##(1991-2#1)(1992-2#1)
to the High##3##3##(1992-12#1)(2008-11#1)(2009-6#1)
to the IC##2##3##(2008-10#2)
to the ICP-MS##2##3##(2008-10#2)
to the ICRP##2##3##(1997-8#1)(2013-1#1)
to the ICU##3##3##(2010-5#1)(2012-3#1)(2013-1#1)
to the IgG##2##3##(1994-12#1)(1994-9#1)
to the International##5##3##(1994-9#1)(1997-6#1)(2007-5#1)(2008-10#1)(2012-3#1)
to the Internet##3##3##(1994-12#1)(1994-3#1)(1996-2#1)
to the Israeli-Palestinian##2##3##(2012-12#2)
to the Italian##3##3##(1991-12#1)(1994-2#1)(2008-10#1)
to the LC##2##3##(2008-10#2)
to the LNN##2##3##(2008-2#1)(2008-3#1)
to the Leptosphaeria maculans-Brassica napus##2##5##(2008-10#2)
to the M##4##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-7#1)
to the MHC##2##3##(1995-5#1)(2008-4#1)
to the MMSE##2##3##(2008-7#1)(2013-1#1)
to the MSH##2##3##(1993-5#1)(1995-12#1)
to the Massachusetts##2##3##(2007-10#1)(2008-12#1)
to the Medicare##7##3##(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#1)(1995-2#1)(1996-12#1)
to the Mediterranean##2##3##(2011-2#1)(2013-1#1)
to the Middle Ages##2##4##(2009-10#1)(2013-8#1)
to the Middle##3##3##(2009-10#1)(2009-2#1)(2013-8#1)
to the N domain##2##4##(1995-5#2)
to the N##6##3##(1995-5#3)(2008-10#2)(2011-2#1)
to the N-terminal##5##3##(1990-7#2)(2006-6#1)(2008-11#1)(2011-1#1)
to the N-terminus of##2##4##(1990-7#1)(2008-10#1)
to the NADH##2##3##(1993-6#1)(2008-10#1)
to the NHS##2##3##(2012-12#1)(2013-8#1)
to the NZ##2##3##(2008-11#1)(2008-8#1)
to the National Health##2##4##(1991-2#1)(1994-11#1)
to the National Institute of##3##5##(1992-12#1)(2008-10#1)(2008-3#1)
to the National Institute##4##4##(1992-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
to the National##14##3##(1991-2#1)(1992-12#1)(1992-3#1)(1994-11#1)(1996-5#2)(1997-6#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
to the Netherlands##2##3##(1992-2#1)(2008-10#1)
to the New##3##3##(1990-6#1)(2008-11#1)(2012-1#1)
to the North##3##3##(1992-5#1)(1993-1#1)(1994-12#1)
to the Norwegian##5##3##(1994-9#1)(1995-5#1)(1996-3#1)(1997-8#1)(2011-2#1)
to the Nyquist##2##3##(2007-11#1)(2008-3#1)
to the Ontario##3##3##(1991-2#1)(1994-1#1)(1996-1#1)
to the P##6##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)(2008-10#2)
to the PCR##2##3##(1990-2#1)(2008-10#1)
to the PFC##2##3##(1996-5#1)(1997-2#1)
to the PIHCP##2##3##(2008-1#2)
to the POM##2##3##(2010-6#2)
to the PSD##2##3##(1996-12#1)(2008-3#1)
to the PTV##3##3##(2008-11#1)(2008-2#1)(2008-6#1)
to the Pacific##2##3##(2008-1#2)
to the RNA-dependent RNA polymerase##2##5##(2008-10#2)
to the RRE with##2##4##(1993-8#2)
to the RRE##3##3##(1993-8#3)
to the Royal College of##2##5##(2012-12#1)(2012-3#1)
to the Royal##3##3##(2008-6#1)(2012-12#1)(2012-3#1)
to the S##7##3##(1992-8#1)(1996-6#1)(2008-10#4)(2008-11#1)
to the SH2##2##3##(1995-6#2)
to the SI##4##3##(2008-10#1)(2012-2#3)
to the SL2##2##3##(2007-12#2)
to the SPE##2##3##(2008-10#2)
to the Second##2##3##(1995-4#1)(2011-1#1)
to the Sellmeier dispersion function##2##5##(2008-2#1)(2008-3#1)
to the Senate##2##3##(1995-6#2)
to the Slump Test##2##4##(2008-12#2)
to the South##2##3##(2011-2#2)
to the State##2##3##(1992-1#1)(2011-2#1)
to the T state##2##4##(1990-8#2)
to the T##3##3##(1990-8#3)
to the TATA box##2##4##(1993-6#1)(1993-8#1)
to the TATA##4##3##(1993-6#1)(1993-8#1)(1995-2#1)(1997-2#1)
to the TCRAC##2##3##(1997-9#2)
to the U##8##3##(1993-12#1)(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
to the UK##4##3##(2007-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
to the US Food and Drug Administration##2##7##(1995-8#1)(2012-12#1)
to the US##7##3##(1995-6#1)(1995-8#1)(1997-2#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
to the UV##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
to the United Nations##2##4##(1992-6#1)(1996-1#1)
to the United States##6##4##(1995-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2012-12#1)
to the United##11##3##(1992-6#2)(1995-1#1)(1996-1#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
to the University of##4##4##(1996-1#1)(2008-10#1)(2011-2#2)
to the University##5##3##(1996-1#1)(2008-10#1)(2011-2#3)
to the VLDL receptor##2##4##(1995-6#2)
to the WHO##4##3##(1990-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
to the Western##2##3##(2007-5#1)(2008-10#1)
to the World Health Organization (WHO)##5##6##(1997-6#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-6#1)
to the World Health Organization##8##5##(1990-3#1)(1993-6#1)(1997-6#2)(2008-12#1)(2008-3#1)(2009-8#1)(2010-6#1)
to the World Health##9##4##(1990-3#1)(1993-6#1)(1997-6#2)(2008-12#1)(2008-3#1)(2009-8#1)(2010-5#1)(2010-6#1)
to the World##10##3##(1990-3#1)(1993-6#1)(1997-6#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-5#1)(2010-6#1)
to the X chromosome##3##4##(1994-9#2)(2008-8#1)
to the X##7##3##(1994-9#2)(2007-12#1)(2008-10#2)(2008-8#2)
to the X-chromosome##2##3##(1990-8#1)(2008-12#1)
to the Y chromosome##3##4##(1996-5#2)(2008-8#1)
to the Y##4##3##(1993-9#1)(1996-5#2)(2008-8#1)
to the Z line##3##4##(2008-6#3)
to the Z##4##3##(2008-3#1)(2008-6#3)
to the abdomen##3##3##(1991-5#1)(1997-3#1)(2013-8#1)
to the ability of the##3##5##(1992-12#1)(2008-10#2)
to the ability of##12##4##(1991-12#1)(1992-12#1)(1992-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-3#1)(2013-8#1)
to the ability to##6##4##(1994-3#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
to the ability##18##3##(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-3#1)(2013-8#1)
to the above results##2##4##(1994-3#1)(1994-8#1)
to the above##10##3##(1990-12#1)(1991-1#1)(1994-3#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
to the above-mentioned##3##3##(2008-10#2)(2008-7#1)
to the absence of##14##4##(1990-12#1)(1991-6#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to the absence##15##3##(1990-12#1)(1991-6#1)(1995-5#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to the absolute##4##3##(1991-9#1)(2008-10#2)(2008-8#1)
to the absorbed pump power##3##5##(2007-11#2)(2008-3#1)
to the absorbed##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
to the absorption coefficient of the##2##6##(2008-3#2)
to the absorption coefficient##3##4##(2008-2#1)(2008-3#2)
to the absorption maximum##2##4##(1994-5#1)(2008-10#1)
to the absorption spectra##2##4##(2008-10#1)(2008-2#1)
to the absorption##15##3##(1994-5#1)(2006-4#1)(2008-10#5)(2008-2#2)(2008-3#5)(2013-8#1)
to the abundance of##2##4##(2008-7#1)(2008-9#1)
to the acceptor dye##2##4##(2008-10#1)(2009-2#1)
to the acceptor##4##3##(1990-12#1)(2008-10#2)(2009-2#1)
to the accumulated##2##3##(2008-3#1)(2008-7#1)
to the accumulation of##18##4##(1990-5#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
to the accumulation##19##3##(1990-5#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
to the accuracy of the##2##5##(2008-10#1)(2008-3#1)
to the accuracy##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
to the accurate##2##3##(1991-11#1)(2008-10#1)
to the acid##2##3##(2008-10#2)
to the acquired##2##3##(1990-9#1)(2008-5#1)
to the acquisition##2##3##(1994-8#1)(2009-3#1)
to the actin##2##3##(1994-8#1)(2009-7#1)
to the action of##16##4##(1994-11#2)(1994-8#2)(1995-12#2)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
to the action##17##3##(1992-1#1)(1994-11#2)(1994-8#2)(1995-12#2)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
to the actions of##2##4##(1990-5#1)(2008-4#1)
to the actions##3##3##(1990-5#1)(1992-1#1)(2008-4#1)
to the activated##3##3##(1997-7#1)(2008-10#1)(2009-10#1)
to the activation of##11##4##(1991-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(2008-6#2)(2008-8#1)(2010-11#1)
to the activation##12##3##(1991-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(2008-6#2)(2008-8#1)(2010-11#1)
to the active site of the enzyme##2##7##(1992-11#1)(1994-5#1)
to the active site of##5##5##(1990-5#1)(1992-11#1)(1994-5#2)(1995-11#1)
to the active site##8##4##(1990-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-5#2)(1995-11#1)
to the active##14##3##(1990-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-5#3)(1995-11#2)(2008-10#2)(2008-2#1)(2009-8#1)
to the activity of##3##4##(1992-12#1)(1994-8#1)(2008-10#1)
to the activity##5##3##(1992-12#1)(1994-8#1)(2008-10#2)(2013-1#1)
to the actual##5##3##(1993-12#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-1#1)
to the acute##3##3##(1994-2#1)(1997-2#1)(2008-3#1)
to the acylation##2##3##(1990-8#1)(1997-4#1)
to the addition of##9##4##(1992-8#1)(1993-6#1)(1996-1#1)(2008-10#4)(2008-11#1)(2010-10#1)
to the addition##10##3##(1992-8#1)(1993-6#1)(1996-1#1)(2008-10#4)(2008-11#1)(2009-8#1)(2010-10#1)
to the additional##3##3##(2007-12#1)(2008-7#1)(2009-5#1)
to the adenosine##2##3##(1993-12#1)(1994-5#1)
to the adjacent##3##3##(1994-11#1)(2010-8#1)(2013-1#1)
to the adjustment##2##3##(1992-12#1)(2007-12#1)
to the administration of##8##4##(1994-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-5#2)(2008-9#1)
to the adoption of the##2##5##(2008-1#1)(2008-8#1)
to the adoption of##5##4##(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
to the adsorption##3##3##(2008-10#2)(2008-6#1)
to the adult##6##3##(1997-2#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
to the advancement of##2##4##(2008-10#1)(2010-5#1)
to the advantages##3##3##(1993-12#1)(2008-10#2)
to the adverse##3##3##(1992-3#1)(2009-4#1)(2009-9#1)
to the aerosol##2##3##(1996-3#1)(2008-3#1)
to the aetiology of##6##4##(1996-11#1)(1997-1#1)(2008-5#1)(2008-9#1)(2011-2#2)
to the aetiology##7##3##(1996-11#1)(1997-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#2)
to the affected##4##3##(1993-3#1)(2008-1#1)(2011-1#1)(2011-2#1)
to the aforementioned##2##3##(2008-10#2)
to the age and##2##4##(1994-12#1)(2012-3#1)
to the age of the##3##5##(1994-11#1)(1995-6#1)(2008-10#1)
to the age of##5##4##(1990-6#1)(1994-11#1)(1995-1#1)(1995-6#1)(2008-10#1)
to the age##9##3##(1990-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-12#1)(2012-3#2)
to the agent##3##3##(1991-3#1)(2008-10#1)(2009-8#1)
to the agents##3##3##(1991-12#1)(2008-5#1)(2011-1#1)
to the air##4##3##(2008-10#2)(2008-11#1)(2010-2#1)
to the airway##2##3##(1997-1#1)(2010-7#1)
to the airways##3##3##(1992-3#1)(1994-5#1)(1996-12#1)
to the alfalfa biomass##2##4##(2008-10#2)
to the allergen##2##3##(2008-10#1)(2010-5#1)
to the alpha##13##3##(1990-7#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-2#1)(1993-8#3)(1994-5#1)(1995-2#2)(1995-6#1)
to the already##2##3##(2008-2#1)(2011-2#1)
to the alternative##3##3##(1991-5#1)(1994-9#1)(2008-8#1)
to the amino acid sequence##2##5##(1992-6#1)(1996-12#1)
to the amino acid##3##4##(1992-6#1)(1995-5#1)(1996-12#1)
to the amino terminus of##2##5##(1991-10#1)(1995-2#1)
to the amino##7##3##(1991-10#1)(1992-6#2)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#1)
to the amount of##19##4##(1990-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
to the amount##21##3##(1990-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#2)
to the amounts of##2##4##(2008-10#1)(2013-1#1)
to the amplification of##2##4##(1994-3#1)(2007-11#1)
to the amplification##4##3##(1994-3#1)(2007-11#3)
to the amyloid##2##3##(1992-12#2)
to the analyses of##5##4##(2008-10#5)
to the analyses##6##3##(2008-10#6)
to the analysis of metabolites##2##5##(2008-10#1)(2010-5#1)
to the analysis of natural water##3##6##(2008-10#3)
to the analysis of natural##4##5##(2008-10#4)
to the analysis of pharmaceutical##2##5##(2008-10#2)
to the analysis of phenolic compounds##2##6##(2008-10#2)
to the analysis of real##4##5##(2008-10#3)(2008-2#1)
to the analysis of river##2##5##(2008-10#2)
to the analysis of several##2##5##(2008-10#1)(2009-10#1)
to the analysis of some##4##5##(2008-10#4)
to the analysis of the##11##5##(1992-12#1)(1995-8#1)(2008-10#6)(2008-4#1)(2008-6#1)(2011-2#1)
to the analysis of these herbicides in##2##7##(2008-10#2)
to the analysis of these##4##5##(2008-10#4)
to the analysis of two##2##5##(2008-10#1)(2008-3#1)
to the analysis of##125##4##(1990-3#1)(1992-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#95)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
to the analysis##130##3##(1990-3#1)(1992-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#98)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
to the analyte##4##3##(2008-10#4)
to the analytes##2##3##(2008-10#2)
to the analytical column##2##4##(2008-10#2)
to the analytical##6##3##(2008-10#6)
to the angle of incidence##3##5##(2008-3#3)
to the angle of##5##4##(2008-3#5)
to the angle##7##3##(2008-3#7)
to the animal##2##3##(1993-6#1)(2008-4#1)
to the animals##4##3##(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)
to the annual##3##3##(1995-3#1)(1996-6#2)
to the antagonistic##2##3##(2008-10#1)(2008-12#1)
to the anterior cruciate ligament##5##5##(2007-8#4)(2013-1#1)
to the anterior##12##3##(1991-4#1)(1993-12#1)(2007-8#4)(2008-7#2)(2009-1#1)(2011-2#1)(2011-7#1)(2013-1#1)
to the anti-inflammatory##2##3##(2008-10#1)(2009-1#1)
to the antibiotic##3##3##(1993-2#1)(2008-10#1)(2008-6#1)
to the antibiotics##2##3##(2010-8#1)(2012-3#1)
to the antibody##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
to the anticipated##2##3##(2008-10#1)(2008-3#1)
to the anticoagulant##2##3##(1997-2#1)(2009-11#1)
to the antiestrogen##2##3##(1993-1#1)(2008-11#1)
to the antigens##2##3##(1995-5#1)(2009-5#1)
to the antioxidant activity of##2##5##(2009-6#1)(2013-1#1)
to the aperture##2##3##(2008-2#2)
to the apex##2##3##(2009-2#1)(2013-1#1)
to the apical stem loop##2##5##(2009-7#2)
to the apical surface##2##4##(1991-12#1)(2008-1#1)
to the apical##10##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#1)(2009-7#2)(2012-2#1)
to the apoprotein##2##3##(1990-8#1)(1992-10#1)
to the apoptotic##2##3##(1995-2#1)(2011-2#1)
to the apparent##3##3##(1991-12#1)(1993-2#1)(2008-10#1)
to the appearance of the##4##5##(1991-6#1)(1996-6#1)(2008-5#1)(2012-2#1)
to the appearance of##8##4##(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1996-6#1)(2008-5#1)(2012-2#1)(2012-3#1)
to the appendix##2##3##(2009-7#1)(2011-2#1)
to the application of a##2##5##(1995-5#1)(2008-10#1)
to the application of the##2##5##(2007-8#1)(2008-1#1)
to the application of##13##4##(1992-12#1)(1995-5#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-12#1)(2010-3#1)(2011-1#1)
to the application##16##3##(1992-12#1)(1995-5#1)(1996-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#1)
to the applied##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)
to the approach##3##3##(1993-12#1)(2010-3#1)(2012-2#1)
to the appropriate##6##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-8#1)
to the aqueous phase##6##4##(1990-5#1)(1994-2#1)(2008-10#3)(2008-5#1)
to the aqueous##11##3##(1990-5#1)(1994-2#1)(1995-12#1)(2008-10#7)(2008-5#1)
to the area of##2##4##(1992-8#1)(2012-1#1)
to the area under##3##4##(1997-3#1)(2008-10#2)
to the area##9##3##(1992-2#1)(1992-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)
to the areas of##2##4##(1993-8#1)(2008-4#1)
to the areas##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
to the argument##2##3##(1996-1#1)(2012-12#1)
to the arrangement of##2##4##(2008-7#2)
to the array##3##3##(2008-10#2)(2009-6#1)
to the artificial##2##3##(1990-2#1)(2008-5#1)
to the asialoglycoprotein receptor##2##4##(1993-11#1)(1995-2#1)
to the assay medium##2##4##(1990-12#1)(1996-5#1)
to the assay of##5##4##(1991-5#1)(1992-11#1)(2008-10#3)
to the assay##10##3##(1990-12#1)(1991-5#1)(1992-11#1)(1993-12#1)(1996-5#2)(2008-10#3)(2012-1#1)
to the assembly of##2##4##(2012-12#1)(2012-2#1)
to the assembly##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
to the assessment of##5##4##(1992-3#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-5#1)
to the assessment##7##3##(1992-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-5#1)
to the assignment##2##3##(2008-10#1)(2008-11#1)
to the associated##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
to the assumption that the##2##5##(2009-2#1)(2012-2#1)
to the assumption that##5##4##(1990-5#1)(2008-2#1)(2009-2#1)(2010-2#1)(2012-2#1)
to the assumptions##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
to the asymmetric##2##3##(2008-9#1)(2010-3#1)
to the atmosphere##5##3##(1991-3#1)(1995-3#1)(2008-10#1)(2008-3#2)
to the author##9##3##(1991-1#2)(1991-12#1)(1991-3#2)(1992-1#1)(1993-2#2)(2008-11#1)
to the author's knowledge##3##4##(2007-12#1)(2008-2#2)
to the author's##5##3##(2007-12#1)(2008-2#2)(2011-2#1)(2013-1#1)
to the authors##2##3##(2008-2#1)(2008-7#1)
to the authors' knowledge##15##4##(2007-11#3)(2007-12#6)(2008-2#3)(2008-3#3)
to the authors'##16##3##(1993-3#1)(2007-11#3)(2007-12#6)(2008-2#3)(2008-3#3)
to the availability of more##2##5##(1992-2#1)(2011-2#1)
to the availability of##7##4##(1992-2#1)(1994-3#1)(2008-10#1)(2009-5#1)(2011-2#2)(2012-2#1)
to the available##6##3##(1990-9#1)(1994-3#1)(2006-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
to the average temperature##2##4##(2008-8#2)
to the average##13##3##(1992-6#1)(1993-1#1)(2008-10#4)(2008-6#1)(2008-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to the avirulence gene##3##4##(2008-10#3)
to the avirulence##4##3##(2008-10#4)
to the axial##3##3##(1997-7#1)(2008-10#1)(2011-2#1)
to the axis of the##3##5##(2008-2#2)(2008-3#1)
to the axis##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
to the axon##2##3##(1995-2#1)(1996-2#1)
to the axonal membrane##2##4##(2008-7#1)(2012-2#1)
to the back##7##3##(1997-7#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2013-1#2)
to the background##5##3##(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
to the backscattering##2##3##(2008-3#2)
to the bacteria##2##3##(2008-5#1)(2012-12#1)
to the bacterial##6##3##(1990-11#2)(1990-12#1)(2008-10#1)(2010-10#1)(2012-2#1)
to the balance of##2##4##(1994-11#1)(2008-5#1)
to the bare##2##3##(2008-10#1)(2008-2#1)
to the basal lamina##2##4##(2008-12#1)(2009-10#1)
to the basal##10##3##(1996-5#1)(1997-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)
to the base##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
to the baseline##7##3##(1997-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-1#1)
to the basic##8##3##(1992-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
to the basis##2##3##(1995-1#1)(2007-12#1)
to the basolateral##5##3##(1991-12#1)(1993-6#1)(1994-3#1)(1995-12#1)(2008-1#1)
to the batch##2##3##(2008-10#1)(2008-11#1)
to the beam##3##3##(2008-2#2)(2008-3#1)
to the beet##2##3##(2008-10#1)(2008-12#1)
to the beginning of the##3##5##(1994-5#1)(1997-6#1)(2008-11#1)
to the beginning##4##3##(1994-5#1)(1997-6#1)(2008-11#1)(2010-3#1)
to the behavior observed##2##4##(2008-10#1)(2008-7#1)
to the behavior of##4##4##(2007-12#1)(2008-3#1)(2008-8#1)(2010-2#1)
to the behavior##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)
to the behavioral##2##3##(2008-8#1)(2009-9#1)
to the behaviour of##2##4##(1990-2#1)(2008-5#1)
to the belief that##2##4##(1990-5#1)(1996-2#1)
to the beneficial effects of##2##5##(2008-7#1)(2011-2#1)
to the beneficial##3##3##(2008-7#1)(2010-1#1)(2011-2#1)
to the benefit of##5##4##(2008-1#1)(2008-10#1)(2008-11#2)(2011-1#1)
to the best of our knowledge##14##6##(1995-5#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-6#1)(2010-2#1)(2013-1#1)
to the best of our##15##5##(1995-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-6#1)(2010-2#1)(2013-1#1)
to the best##20##3##(1995-5#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
to the beta##3##3##(1990-7#1)(1993-8#1)(1995-6#1)
to the better##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
to the bifurcation##2##3##(2007-8#1)(2008-3#1)
to the bilayer##2##3##(1990-7#1)(1994-12#1)
to the binary##2##3##(2008-10#1)(2008-2#1)
to the binding##8##3##(1992-12#1)(1993-6#1)(1995-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-2#1)
to the binuclear##2##3##(1995-2#1)(1997-7#1)
to the biological##10##3##(1994-11#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)(2012-3#1)
to the biologically##2##3##(1990-12#1)(2012-3#1)
to the biology##2##3##(1991-6#1)(2011-2#1)
to the biotransformation##2##3##(2008-11#1)(2008-5#1)
to the bladder and##3##4##(1995-12#2)(2011-2#1)
to the bladder##5##3##(1995-12#2)(2008-10#1)(2011-2#1)(2013-1#1)
to the blastocyst stage##2##4##(1995-2#1)(2008-11#1)
to the blood##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
to the bloodstream##2##3##(2008-7#1)(2012-3#1)
to the blue##2##3##(2008-10#1)(2008-2#1)
to the body##10##3##(1992-11#1)(1995-12#1)(1995-5#2)(2008-10#1)(2008-6#1)(2008-9#2)(2011-1#1)(2011-2#1)
to the bone##5##3##(2007-11#1)(2008-7#2)(2008-9#1)(2013-8#1)
to the bones##2##3##(2009-10#1)(2009-3#1)
to the bony##2##3##(2008-7#1)(2008-9#1)
to the both##2##3##(1992-9#1)(2007-8#1)
to the bottom##4##3##(2008-11#1)(2008-4#1)(2008-9#2)
to the boundary##2##3##(2008-2#1)(2010-10#1)
to the brain by##2##4##(2008-5#1)(2010-5#1)
to the brain##17##3##(1992-10#1)(1994-5#1)(1995-12#2)(1995-5#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#2)(2012-1#1)(2013-1#1)
to the breast##4##3##(1993-12#1)(1993-2#1)(2007-5#1)(2011-2#1)
to the broad##4##3##(2006-12#1)(2008-12#1)(2008-7#1)(2012-2#1)
to the broader##2##3##(1993-1#1)(2008-1#1)
to the brush##2##3##(1991-12#1)(1993-6#1)
to the buffer solution##2##4##(1994-3#1)(2008-8#1)
to the buffer##5##3##(1991-5#1)(1994-3#2)(2008-10#1)(2008-8#1)
to the bulk##5##3##(1991-8#1)(2008-10#1)(2008-3#1)(2010-4#1)(2012-2#1)
to the burden of##2##4##(2012-12#1)(2012-2#1)
to the cDNA##4##3##(1991-6#1)(1993-8#2)(2008-7#1)
to the cDNAs##2##3##(1993-2#1)(1994-12#1)
to the calculated##2##3##(1995-12#1)(2008-3#1)
to the calculation of##3##4##(2007-11#1)(2008-3#1)(2009-11#1)
to the calculation##4##3##(2007-11#1)(2008-3#2)(2009-11#1)
to the calibration##2##3##(2008-10#2)
to the cancer##3##3##(1990-5#1)(2008-7#1)(2013-1#1)
to the capability of##2##4##(2008-3#2)
to the capacity of the##2##5##(2013-1#1)(2013-7#1)
to the capacity of##4##4##(1995-3#1)(2008-5#1)(2013-1#1)(2013-7#1)
to the capillary##4##3##(1996-5#1)(2008-10#2)(2008-4#1)
to the carbohydrate##2##3##(1996-5#1)(2008-11#1)
to the carbon paste##2##4##(2008-10#2)
to the carbon##4##3##(1991-3#1)(2008-10#3)
to the carbonyl oxygen of##2##5##(1991-3#1)(1992-6#1)
to the cardiac##3##3##(2007-9#1)(2008-12#1)(2008-7#1)
to the cardiologists##2##3##(2008-11#1)(2011-2#1)
to the care of older people##2##6##(2010-10#2)
to the care of##6##4##(1997-1#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-10#2)
to the care##12##3##(1992-2#1)(1994-12#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-10#2)(2013-1#2)
to the career##2##3##(1997-2#1)(2008-5#1)
to the carotid##3##3##(1996-5#1)(2008-7#1)(2012-3#1)
to the carrier##2##3##(2008-10#2)
to the case of a##2##5##(2008-3#2)
to the case of##8##4##(1992-6#1)(1993-3#1)(2008-2#2)(2008-3#3)(2010-3#1)
to the case##13##3##(1992-6#1)(1993-3#1)(2007-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-8#1)(2010-3#1)
to the catalytic domains of##2##5##(1991-6#1)(1994-8#1)
to the catalytic site of the##2##6##(1994-5#2)
to the catalytic site##3##4##(1994-5#2)(2009-7#1)
to the catalytic##12##3##(1991-6#1)(1992-3#1)(1992-6#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-2#1)
to the category##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
to the caudal##2##3##(1993-3#1)(1996-5#1)
to the cause of##3##4##(2008-3#1)(2008-5#1)(2008-9#1)
to the cavity##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
to the cell body##3##4##(2008-7#3)
to the cell cortex##2##4##(2009-10#2)
to the cell membrane##7##4##(1990-2#1)(1993-12#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-9#1)(2010-8#1)
to the cell periphery##2##4##(2008-11#1)(2009-2#1)
to the cell surface and##2##5##(1990-12#1)(2010-11#1)
to the cell surface of Colo201 cells##2##7##(2008-11#2)
to the cell surface##13##4##(1990-12#1)(1990-5#1)(1991-9#1)(1994-11#1)(1997-1#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-7#1)(2010-11#1)
to the cell##43##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-6#1)(1997-1#2)(1997-4#1)(2008-1#3)(2008-11#5)(2008-2#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#2)(2009-2#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to the cells##14##3##(1991-9#1)(1992-8#2)(1993-3#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-11#3)(2008-6#1)(2010-11#1)(2010-12#1)
to the cellular##5##3##(1992-8#1)(1994-11#1)(1994-2#1)(2007-2#1)(2010-10#1)
to the center of the##3##5##(2007-12#1)(2008-2#2)
to the center##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
to the central nervous system##2##5##(2008-5#1)(2008-9#1)
to the central nucleus##2##4##(1992-6#1)(1993-12#1)
to the central or peripheral nervous system##2##7##(2008-7#1)(2010-7#1)
to the central or##3##4##(1994-12#1)(2008-7#1)(2010-7#1)
to the central##15##3##(1990-3#1)(1991-11#2)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
to the centromeric region of chromosome##2##6##(1996-8#1)(2008-10#1)
to the cerebral cortex##3##4##(1993-12#1)(2008-11#1)(2008-9#1)
to the cerebral##4##3##(1993-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
to the cervical spinal cord##2##5##(2010-5#2)
to the cervical##5##3##(2007-11#1)(2007-8#1)(2010-5#2)(2013-1#1)
to the challenge of##2##4##(2008-10#2)
to the challenge##3##3##(2008-10#2)(2013-1#1)
to the challenges##4##3##(1996-1#1)(1996-2#1)(2009-11#1)(2012-12#1)
to the change in the##2##5##(2008-4#1)(2011-2#1)
to the change in##8##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)
to the change of##3##4##(1992-6#1)(2008-3#1)(2010-8#1)
to the change##12##3##(1990-8#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
to the changes in the##2##5##(2008-10#1)(2008-5#1)
to the changes in##7##4##(1992-3#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)
to the changes of##2##4##(2008-9#1)(2011-1#1)
to the changes that##2##4##(2007-12#1)(2008-12#1)
to the changes##12##3##(1992-3#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
to the changing##2##3##(1994-2#1)(1996-2#1)
to the channel##2##3##(1993-12#1)(2008-8#1)
to the character##2##3##(2007-10#1)(2012-2#1)
to the characteristic##6##3##(1990-11#1)(1997-4#1)(2006-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
to the characteristics of the##3##5##(1996-9#1)(2008-10#1)(2009-7#1)
to the characterization of##6##4##(1991-2#1)(1994-8#1)(2008-10#1)(2008-3#2)(2011-1#1)
to the characterization##7##3##(1991-2#1)(1993-5#1)(1994-8#1)(2008-10#1)(2008-3#2)(2011-1#1)
to the charges##2##3##(1990-7#1)(1991-3#1)
to the chemical##11##3##(1991-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-1#1)(2012-2#1)(2013-8#1)
to the chemotherapy##4##3##(1991-8#1)(2008-11#1)(2008-8#1)(2010-3#1)
to the chest##2##3##(2009-1#1)(2012-2#1)
to the chicken##2##3##(1991-3#1)(2010-3#1)
to the child and##3##4##(2009-10#1)(2012-12#1)(2012-2#1)
to the child##14##3##(1992-4#1)(1993-3#1)(1997-8#1)(2006-5#5)(2008-11#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
to the children##6##3##(1990-11#1)(1995-6#1)(1996-1#1)(2007-11#1)(2008-3#1)(2013-8#1)
to the children's##2##3##(1991-2#1)(2011-2#1)
to the chloramphenicol##4##3##(1990-8#1)(1991-2#1)(1992-12#1)(1995-2#1)
to the choice of##8##4##(1991-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-12#1)(2013-1#1)
to the chromatographic##3##3##(2008-10#3)
to the chronic##2##3##(1992-2#1)(1996-12#1)
to the circular muscle of the guinea-pig##2##7##(1997-4#2)
to the circular muscle of##3##5##(1997-4#3)
to the circular##4##3##(1997-4#3)(2008-3#1)
to the circulation##3##3##(1993-6#1)(2008-7#1)(2009-10#1)
to the citizens##2##3##(2009-3#1)(2012-3#1)
to the class of##5##4##(1995-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
to the class##8##3##(1995-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
to the classic##7##3##(1990-8#1)(2007-12#1)(2008-3#1)(2009-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
to the classical##10##3##(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)
to the classification of##6##4##(1990-3#1)(1994-2#1)(2008-10#1)(2008-7#2)(2010-12#1)
to the classification##8##3##(1990-3#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#1)
to the cleavage furrow##3##4##(2009-8#3)
to the cleavage of##2##4##(1995-6#1)(2008-10#1)
to the cleavage##5##3##(1995-6#1)(2008-10#1)(2009-8#3)
to the client with hypertension##2##5##(2012-3#2)
to the client##3##3##(2010-8#1)(2012-3#2)
to the climate##2##3##(2012-5#1)(2012-9#1)
to the clinic##7##3##(1993-2#1)(1996-6#1)(2007-8#1)(2008-11#2)(2010-8#1)(2011-7#1)
to the clinical practice##2##4##(2007-5#1)(2008-5#1)
to the clinical severity of##2##5##(1997-6#1)(2007-6#1)
to the clinical severity##4##4##(1997-6#1)(2007-6#1)(2009-6#2)
to the clinical situation##2##4##(2008-10#1)(2008-11#1)
to the clinical##28##3##(1990-5#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-10#1)(1994-2#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-6#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
to the clinically##2##3##(1995-3#1)(2012-3#1)
to the clinician##4##3##(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
to the clinicians##2##3##(2008-1#1)(2008-7#1)
to the cluster##2##3##(1997-8#1)(2008-10#1)
to the clustering##2##3##(1990-5#1)(2012-1#1)
to the coating##2##3##(2008-3#1)(2009-11#1)
to the coding##3##3##(1994-5#2)(1994-8#1)
to the cognitive##3##3##(2008-11#1)(2009-10#1)(2010-10#1)
to the coherent##2##3##(2007-11#1)(2008-3#1)
to the cohort##2##3##(2008-6#1)(2008-8#1)
to the collection##3##3##(2008-10#2)(2008-6#1)
to the colon##2##3##(2009-12#1)(2012-1#1)
to the column##3##3##(1992-6#1)(2008-10#2)
to the combination of##6##4##(1990-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)
to the combination##9##3##(1990-2#1)(1991-12#1)(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)
to the combined action of##2##5##(2007-12#1)(2008-11#1)
to the combined effect of##3##5##(1990-2#1)(2007-12#1)(2008-3#1)
to the combined effects of##2##5##(2007-11#1)(2008-10#1)
to the combined##10##3##(1990-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)
to the commercially available##2##4##(1997-3#1)(2010-4#1)
to the common bile duct##2##5##(1990-9#1)(1993-9#1)
to the common##16##3##(1990-9#1)(1991-6#1)(1992-12#1)(1993-9#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-8#2)(2010-11#1)(2012-3#1)
to the community##11##3##(1991-12#1)(1994-1#1)(1995-1#1)(1996-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
to the comparison##2##3##(1996-1#1)(2008-3#1)
to the complete##4##3##(2008-10#2)(2008-7#1)(2009-2#1)
to the completion of the##2##5##(1992-3#1)(2008-11#1)
to the completion of##4##4##(1991-6#1)(1992-3#1)(2008-11#1)(2008-3#1)
to the complex##13##3##(1990-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
to the complexation##3##3##(2008-10#2)(2013-1#1)
to the complexity of the##5##5##(1997-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
to the complexity of##6##4##(1997-3#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#1)
to the complexity##7##3##(1997-3#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#2)
to the compound##4##3##(1996-2#1)(2008-1#1)(2008-10#2)
to the compounds##3##3##(1997-3#1)(1997-4#1)(2008-10#1)
to the compression of##2##4##(2008-2#2)
to the compression##4##3##(1993-3#1)(2008-2#2)(2013-8#1)
to the computer##5##3##(1992-4#1)(2008-10#3)(2009-10#1)
to the concave side of##2##5##(2012-2#2)
to the concentration of formaldehyde##2##5##(2008-10#2)
to the concentration of nucleic acids in the range##2##9##(2008-10#2)
to the concentration of nucleic acids##3##6##(2008-10#3)
to the concentration of the##6##5##(1996-12#1)(2008-10#4)(2010-3#1)
to the concentration of vanadium##2##5##(2008-10#2)
to the concentration of##60##4##(1990-8#1)(1991-12#1)(1991-2#1)(1994-8#1)(1996-12#2)(1997-7#1)(2008-1#1)(2008-10#50)(2008-12#1)(2010-3#1)
to the concentration##66##3##(1990-8#1)(1991-12#1)(1991-2#1)(1994-8#1)(1996-12#2)(1997-7#1)(2008-1#1)(2008-10#55)(2008-12#1)(2008-5#1)(2010-3#1)
to the concentrations of##2##4##(2008-10#2)
to the concentrations##3##3##(2008-10#2)(2008-11#1)
to the concept of##7##4##(1990-2#1)(1990-6#1)(1996-1#1)(2008-2#1)(2008-9#1)(2010-8#1)(2012-12#1)
to the concept that##3##4##(1993-9#1)(1996-5#1)(2008-7#1)
to the concept##10##3##(1990-2#1)(1990-6#1)(1993-9#1)(1996-1#1)(1996-5#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)
to the concepts##3##3##(1992-1#1)(1993-6#1)(1995-1#1)
to the conceptual##2##3##(2008-11#1)(2013-1#1)
to the conclusion that the##5##5##(1992-9#1)(2008-10#2)(2008-3#2)
to the conclusion that##19##4##(1990-6#1)(1992-3#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)
to the conclusion##20##3##(1990-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)
to the conditional##2##3##(1992-6#1)(2008-5#1)
to the conditioned##2##3##(1993-12#1)(1997-7#1)
to the configuration##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
to the conformation##2##3##(1995-11#1)(2008-10#1)
to the consensus##4##3##(1991-11#1)(1991-5#1)(1996-6#1)(2008-10#1)
to the conserved region of##2##5##(1992-11#1)(2008-8#1)
to the conserved region##3##4##(1992-11#1)(1992-6#1)(2008-8#1)
to the conserved##6##3##(1992-11#1)(1992-6#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-8#1)
to the considerable##2##3##(2008-1#1)(2008-10#1)
to the construction of##5##4##(1990-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
to the construction##6##3##(1990-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2013-8#1)
to the consumer##3##3##(1992-12#1)(2008-5#2)
to the consumption of##2##4##(1992-8#1)(2012-2#1)
to the contamination of##3##4##(1994-3#1)(1997-6#1)(2008-10#1)
to the contamination##5##3##(1994-3#1)(1997-6#1)(2008-10#2)(2012-2#1)
to the content of##4##4##(1993-6#1)(2008-10#2)(2008-11#1)
to the continued##3##3##(1993-12#1)(2011-2#1)(2012-1#1)
to the continuous##2##3##(2008-10#1)(2008-2#1)
to the contralateral side##2##4##(2007-12#1)(2007-7#1)
to the contralateral##4##3##(2007-12#1)(2007-7#1)(2008-11#1)(2008-9#1)
to the contrary##6##3##(1991-4#1)(1991-6#1)(1993-6#1)(1995-2#1)(1997-5#1)(2012-2#1)
to the contrast##2##3##(1991-1#1)(2008-3#1)
to the contribution##2##3##(2008-3#1)(2010-4#1)
to the contributions of##2##4##(2008-10#1)(2008-2#1)
to the contributory##2##3##(2011-2#1)(2013-1#1)
to the control group and##2##5##(1991-12#1)(2008-12#1)
to the control group##18##4##(1991-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#1)
to the control level##5##4##(1996-5#1)(2008-11#1)(2008-6#2)(2012-1#1)
to the control of##7##4##(1992-12#1)(1992-8#1)(1997-7#1)(2008-1#1)(2008-10#1)(2010-8#1)(2013-8#1)
to the control values##2##4##(1996-2#1)(2011-2#1)
to the control##62##3##(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#3)(2008-3#1)(2008-6#3)(2008-7#2)(2009-12#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#2)(2013-7#1)(2013-8#2)
to the controlled##3##3##(1994-9#1)(2007-11#1)(2009-8#1)
to the controls##6##3##(1992-12#1)(1994-5#1)(2008-7#2)(2008-8#1)(2010-4#1)
to the controversy##2##3##(1990-12#1)(1991-11#1)
to the conventional technique##2##4##(2011-2#1)(2011-7#1)
to the conventional##30##3##(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2009-2#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to the core matrix##2##4##(2008-4#1)(2009-11#1)
to the core##4##3##(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
to the corneal##2##3##(2008-11#1)(2009-7#1)
to the coronary##6##3##(2008-10#2)(2008-3#1)(2012-3#1)(2013-2#2)
to the correct##6##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
to the corresponding values##3##4##(1990-7#1)(1991-2#1)(2008-10#1)
to the corresponding##42##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#2)(1993-9#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-5#3)(1996-6#1)(1997-7#1)(2007-11#3)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
to the cortex##2##3##(1991-9#1)(2008-11#1)
to the cortical##3##3##(1990-9#2)(2008-7#1)
to the cost of##2##4##(1995-6#1)(2008-10#1)
to the cost##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
to the costs of##2##4##(2008-7#1)(2008-8#1)
to the costs##3##3##(2007-2#1)(2008-7#1)(2008-8#1)
to the coupling##3##3##(1991-12#1)(2008-2#1)(2008-3#1)
to the craniocervical junction##4##4##(2011-2#4)
to the cream##2##3##(2008-5#2)
to the creation of a##2##5##(1991-3#1)(2008-3#1)
to the creation of##11##4##(1991-3#1)(1992-1#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-1#1)
to the creation##12##3##(1991-3#1)(1992-1#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-1#1)
to the criteria##6##3##(1991-11#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
to the critical##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-10#1)
to the cross-linking##2##3##(1995-6#1)(2012-3#1)
to the cross-reactivity##2##3##(1990-12#1)(2008-10#1)
to the crystal##2##3##(2008-2#1)(2008-3#1)
to the culture media##2##4##(2008-11#2)
to the culture medium##21##4##(1990-11#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-11#9)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)
to the culture of##2##4##(2008-11#1)(2008-9#1)
to the culture##36##3##(1990-11#1)(1990-2#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-11#18)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)
to the cultured##2##3##(1993-6#1)(1995-12#1)
to the cultures##2##3##(1997-1#1)(1997-6#1)
to the current nursing##2##4##(1991-2#1)(2008-12#1)
to the current##29##3##(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-6#1)(1996-1#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
to the currently##2##3##(2008-1#1)(2008-7#1)
to the cytoplasm##7##3##(1991-11#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-2#1)(2008-1#1)(2011-2#1)
to the cytoplasmic##4##3##(1992-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
to the cytoskeleton##4##3##(1992-6#1)(2008-11#1)(2012-12#2)
to the cytosol##3##3##(1997-7#1)(2008-1#1)(2011-1#1)
to the cytosolic##3##3##(1996-2#1)(1996-3#1)(2007-12#1)
to the cytotoxic##2##3##(1990-2#1)(2010-12#1)
to the cytotoxicity##2##3##(2008-11#1)(2013-1#1)
to the daily##5##3##(1992-9#1)(1993-3#1)(1996-1#1)(2008-10#1)(2010-5#1)
to the damaged##3##3##(1990-11#1)(2009-6#1)(2012-1#1)
to the data obtained##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
to the data on##3##4##(1990-6#1)(2008-1#1)(2008-10#1)
to the data##21##3##(1990-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
to the database##2##3##(2008-4#1)(2008-7#1)
to the death of##5##4##(1996-6#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-12#1)
to the death##6##3##(1996-6#1)(2007-11#1)(2008-7#2)(2009-10#1)(2009-12#1)
to the debate##3##3##(1993-12#1)(1996-8#1)(2008-6#1)
to the decision of##2##4##(2012-12#1)(2013-1#1)
to the decision to##2##4##(1996-12#1)(2011-2#1)
to the decision##5##3##(1996-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
to the decline of##2##4##(2008-6#1)(2008-7#1)
to the decline##3##3##(2008-6#1)(2008-7#1)(2010-12#1)
to the decrease in the##3##5##(2007-12#1)(2008-3#1)(2008-7#1)
to the decrease in##5##4##(1996-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)
to the decrease of##3##4##(2008-10#2)(2008-3#1)
to the decrease##9##3##(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)
to the defect##2##3##(2008-3#1)(2010-6#1)
to the definition of##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
to the definition##5##3##(1992-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
to the degradation of the##2##5##(2008-2#1)(2008-7#1)
to the degradation##3##3##(1990-2#1)(2008-2#1)(2008-7#1)
to the degree of##23##4##(1990-5#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#2)(2009-5#1)(2010-11#1)
to the delay##2##3##(1991-2#1)(2012-12#1)
to the deleterious effects of##3##5##(2008-1#1)(2008-4#1)(2008-7#1)
to the delivery of##3##4##(1994-1#1)(2008-4#1)(2013-1#1)
to the delivery##4##3##(1994-1#1)(1994-3#1)(2008-4#1)(2013-1#1)
to the demands##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
to the demodulation##2##3##(2008-3#2)
to the density of the##2##5##(2008-10#1)(2008-3#1)
to the density of##3##4##(2008-10#1)(2008-3#1)(2009-11#1)
to the department##4##3##(1990-12#1)(1997-4#1)(2008-11#1)(2013-1#1)
to the dependence of##2##4##(2007-12#1)(2008-1#1)
to the deposition of##3##4##(1990-8#1)(2008-10#1)(2008-7#1)
to the deposition##5##3##(1990-8#1)(2008-10#3)(2008-7#1)
to the depth of##3##4##(1994-9#1)(2008-3#2)
to the depth##4##3##(1994-9#1)(2008-3#3)
to the descending aorta##3##4##(2007-8#2)(2008-11#1)
to the descending##4##3##(2007-8#2)(2008-11#1)(2011-2#1)
to the description of##3##4##(1991-2#1)(1993-9#1)(2008-1#1)
to the design and##3##4##(2008-12#1)(2008-3#1)(2010-9#1)
to the design of the##4##5##(2008-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
to the design of this##2##5##(2008-12#1)(2008-3#1)
to the design of##22##4##(2007-11#3)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
to the design##27##3##(1996-1#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#7)(2008-5#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
to the desired##5##3##(1993-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-4#1)
to the details##2##3##(1994-12#1)(2007-12#1)
to the detected signal##2##4##(2008-3#2)
to the detected##5##3##(2007-11#1)(2008-3#3)(2008-6#1)
to the detection limits of##2##5##(2008-10#2)
to the detection of low##2##5##(2008-10#1)(2008-5#1)
to the detection of##17##4##(1994-2#1)(1994-9#1)(1996-12#1)(2008-10#8)(2008-2#3)(2008-3#1)(2008-5#1)(2013-1#1)
to the detection##25##3##(1994-2#1)(1994-9#1)(1996-12#1)(2008-10#13)(2008-2#4)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
to the detector##10##3##(1996-5#1)(2008-10#5)(2008-2#2)(2008-3#2)
to the determination of Captopril##3##5##(2008-10#3)
to the determination of Cr(III) and Cr(VI) in##2##8##(2008-10#2)
to the determination of Cr(III) and##3##6##(2008-10#3)
to the determination of Fe and##2##6##(2008-10#1)(2013-8#1)
to the determination of Pb and Zn in tapwater and human hair##2##12##(2008-10#2)
to the determination of Se(IV)##2##5##(2008-10#2)
to the determination of ammonia in##2##6##(2008-10#2)
to the determination of ammonium##2##5##(2008-10#2)
to the determination of benzoyl peroxide in wheat flour##2##9##(2008-10#2)
to the determination of chromium in##4##6##(2008-10#4)
to the determination of chromium##5##5##(2008-10#5)
to the determination of dopamine in##2##6##(2008-10#2)
to the determination of glucose in##4##6##(2008-10#3)(2010-5#1)
to the determination of iodate and##2##6##(2008-10#2)
to the determination of iron in##4##6##(2008-10#4)
to the determination of iron##5##5##(2008-10#5)
to the determination of manganese in##2##6##(2008-10#2)
to the determination of nitrite in##4##6##(2008-10#4)
to the determination of palladium in##2##6##(2008-10#2)
to the determination of perchlorate in##2##6##(2008-10#2)
to the determination of protein##2##5##(1991-11#1)(2008-10#1)
to the determination of sodium##2##5##(2008-10#2)
to the determination of sulfide in##3##6##(2008-10#3)
to the determination of the##19##5##(2008-10#18)(2009-8#1)
to the determination of these compounds in##5##7##(2008-10#5)
to the determination of these##16##5##(2008-10#16)
to the determination of trace amount of##4##7##(2008-10#4)
to the determination of trace amounts of##6##7##(2008-10#6)
to the determination of trace##29##5##(2008-10#29)
to the determination of vanadium in##6##6##(2008-10#6)
to the determination of zinc##2##5##(2008-10#2)
to the determination of##379##4##(1990-8#2)(1991-11#1)(1994-8#1)(1994-9#2)(1996-5#2)(1997-2#1)(2008-10#361)(2008-3#4)(2008-5#1)(2009-8#1)(2010-5#1)(2012-4#1)(2013-8#1)
to the determination##387##3##(1990-8#2)(1991-11#1)(1994-8#1)(1994-9#2)(1996-5#2)(1997-2#1)(2008-10#369)(2008-3#4)(2008-5#1)(2009-8#1)(2010-5#1)(2012-4#1)(2013-8#1)
to the detriment of##2##4##(2008-12#1)(2012-12#1)
to the developing##2##3##(1995-6#1)(2008-11#1)
to the development and maintenance of##2##6##(2008-12#1)(2008-4#1)
to the development and progression of##4##6##(2008-10#1)(2011-2#2)(2012-12#1)
to the development and##12##4##(1992-12#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)(2011-2#2)(2012-12#1)
to the development of a##22##5##(1991-9#1)(1992-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(2006-10#1)(2008-10#8)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#3)(2012-12#1)(2012-3#1)
to the development of cardiovascular disease##2##6##(1997-8#1)(2008-1#1)
to the development of diabetic##2##5##(2008-1#1)(2012-2#1)
to the development of hypertension##2##5##(1997-6#2)
to the development of insulin resistance##4##6##(2008-3#1)(2008-9#1)(2012-2#1)(2012-5#1)
to the development of medical##2##5##(1993-2#1)(2010-8#1)
to the development of new strategies##2##6##(2010-5#1)(2011-10#1)
to the development of new##7##5##(2008-2#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-10#1)
to the development of nursing##2##5##(1997-7#1)(2008-12#1)
to the development of resistance##2##5##(1994-8#1)(2011-3#1)
to the development of restrictive lung function##2##7##(1991-12#2)
to the development of specific##2##5##(1994-1#1)(2008-10#1)
to the development of the##8##5##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-4#1)(2011-2#1)(2013-8#1)
to the development of this##5##5##(1995-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)
to the development of##157##4##(1991-12#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#14)(2008-11#9)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#6)(2008-9#4)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#12)(2011-3#2)(2012-12#3)(2012-2#5)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#3)(2013-8#5)
to the development##172##3##(1991-12#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#9)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#5)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#14)(2011-3#2)(2012-12#4)(2012-2#5)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#4)(2013-8#5)
to the developmental stage##2##4##(2008-6#1)(2008-9#1)
to the developmental##3##3##(1995-2#1)(2008-6#1)(2008-9#1)
to the device##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2010-8#1)
to the diagnosis and management of##3##6##(2008-4#1)(2008-7#1)(2011-2#1)
to the diagnosis and treatment of##4##6##(1992-5#1)(2008-1#1)(2012-2#1)(2013-1#1)
to the diagnosis and##9##4##(1992-5#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the diagnosis of the##2##5##(2007-7#1)(2008-2#1)
to the diagnosis of##14##4##(1990-3#1)(1990-6#1)(1991-3#1)(1992-5#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-1#1)
to the diagnosis##27##3##(1990-3#1)(1990-6#1)(1991-3#1)(1992-5#3)(1996-3#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
to the diagnosis-related##2##3##(1991-3#1)(1993-1#1)
to the diagnostic##2##3##(1996-1#1)(2013-1#1)
to the diaphragm and##2##4##(1990-2#1)(2010-9#1)
to the diet##5##3##(1991-2#1)(1991-6#1)(1994-8#1)(1994-9#1)(2008-12#1)
to the difference between the##2##5##(2008-3#1)(2011-1#1)
to the difference in the##4##5##(1990-8#1)(1995-3#1)(2008-10#1)(2008-9#1)
to the difference in##11##4##(1990-8#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)
to the difference##15##3##(1990-8#2)(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-9#2)(2011-1#1)(2012-2#1)(2012-3#1)
to the differences between##2##4##(1995-12#1)(2010-8#1)
to the differences in the##2##5##(2008-10#1)(2009-11#1)
to the differences in##3##4##(2008-10#1)(2009-11#1)(2009-12#1)
to the differences##5##3##(1995-12#1)(2008-10#1)(2009-11#1)(2009-12#1)(2010-8#1)
to the different##22##3##(1992-3#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2012-12#1)(2013-8#1)
to the differential diagnosis of##2##5##(1992-2#1)(2011-2#1)
to the differential diagnosis##4##4##(1992-2#1)(2008-9#1)(2011-2#2)
to the differential##9##3##(1992-2#1)(1992-3#1)(1993-11#1)(1995-5#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)
to the differentiation##3##3##(1996-3#1)(2008-10#2)
to the differing##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
to the difficulties in##2##4##(2007-6#1)(2013-8#1)
to the difficulties##7##3##(1995-1#1)(2007-12#1)(2007-6#1)(2008-11#1)(2009-9#1)(2012-3#1)(2013-8#1)
to the difficulty in obtaining##2##5##(2008-10#1)(2008-9#1)
to the difficulty of##2##4##(2008-11#1)(2008-8#1)
to the difficulty##6##3##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)
to the diffraction limit##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
to the diffuse##2##3##(2008-3#1)(2012-12#1)
to the diffusion of##2##4##(1993-8#1)(2012-2#1)
to the diffusion##6##3##(1993-8#1)(2008-2#1)(2008-3#3)(2012-2#1)
to the digits##2##3##(2008-6#2)
to the dimension##2##3##(1993-5#1)(2009-9#1)
to the dimethyl sulfonium ion##2##5##(1994-8#2)
to the direct##26##3##(1991-12#1)(1991-5#1)(1992-11#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-2#1)(2013-1#1)
to the direction of the##2##5##(1993-12#1)(2008-3#1)
to the direction of##6##4##(1993-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
to the disabled##2##3##(1997-2#1)(2009-6#1)
to the disappearance of##2##4##(1992-6#1)(1995-3#1)
to the disc##2##3##(1996-6#1)(2008-5#1)
to the discovery and##2##4##(1997-4#1)(2010-8#1)
to the discovery of the##4##5##(2008-11#1)(2010-7#1)(2011-3#1)(2013-8#1)
to the discovery of##12##4##(1995-8#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-3#2)(2013-8#1)
to the discovery##15##3##(1995-8#1)(1997-4#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#1)
to the discussion of##2##4##(2008-10#1)(2011-2#1)
to the discussion##3##3##(2008-10#1)(2011-2#2)
to the disease and##3##4##(1996-3#1)(2008-10#1)(2008-6#1)
to the disease##19##3##(1990-6#1)(1991-9#1)(1993-1#1)(1996-3#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-3#1)
to the dish##2##3##(2008-11#2)
to the disorder##6##3##(1991-12#1)(2008-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
to the disruption of the##2##5##(2007-11#1)(2007-12#1)
to the dissociation##2##3##(1993-8#1)(1995-6#1)
to the distal end of the##2##6##(2008-10#1)(2008-5#1)
to the distal end of##3##5##(2008-10#1)(2008-5#1)(2008-8#1)
to the distal end##4##4##(2008-10#1)(2008-5#2)(2008-8#1)
to the distal##10##3##(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
to the distance between##3##4##(2008-10#2)(2008-2#1)
to the distance##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
to the distinct##3##3##(1994-2#1)(1997-4#1)(2008-10#1)
to the distinction between##2##4##(1997-3#1)(2012-12#1)
to the distinction##3##3##(1997-3#1)(1997-5#1)(2012-12#1)
to the distribution of##3##4##(1990-12#1)(1991-6#1)(2010-6#1)
to the distribution##7##3##(1990-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1997-2#1)(2008-5#1)(2010-6#1)
to the diverse range of##2##5##(2010-5#1)(2011-3#1)
to the diverse##5##3##(2008-10#1)(2010-5#2)(2011-3#1)(2012-12#1)
to the diversity of##4##4##(2008-10#3)(2009-5#1)
to the diversity##5##3##(2008-10#4)(2009-5#1)
to the doctor's role##2##4##(1992-6#2)
to the doctors##3##3##(1992-6#1)(1997-4#1)(1997-6#1)
to the donor##6##3##(1992-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
to the dopamine##3##3##(1995-11#1)(1996-12#1)(1996-2#1)
to the dorsal protocerebrum##2##4##(2007-12#2)
to the dorsal##12##3##(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
to the dose of##4##4##(1992-12#1)(1995-12#1)(2013-1#2)
to the dose##9##3##(1992-12#1)(1993-6#1)(1995-12#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-2#1)(2013-1#2)
to the double layer of iridophores in the##2##8##(2008-5#2)
to the double##6##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
to the double-stranded##2##3##(2008-10#2)
to the downstream##3##3##(1994-2#1)(1997-3#1)(2008-9#1)
to the draw direction##2##4##(2010-4#2)
to the drug##7##3##(1990-3#1)(1992-5#1)(1995-12#1)(2008-10#2)(2008-5#2)
to the drugs##2##3##(2008-8#1)(2009-6#1)
to the duration of the##2##5##(2008-10#1)(2011-2#1)
to the duration of##5##4##(2008-10#3)(2008-7#1)(2011-2#1)
to the dye##3##3##(2007-12#1)(2008-10#2)
to the dynamic##2##3##(2008-10#2)
to the dynamics of##4##4##(1996-1#1)(2008-3#1)(2008-8#1)(2008-9#1)
to the ear##4##3##(1996-5#1)(2008-2#1)(2008-9#2)
to the earlier##4##3##(1997-3#1)(2007-8#1)(2008-7#1)(2009-2#1)
to the early detection of##2##5##(1994-12#1)(1994-7#1)
to the early stages of##2##5##(2008-11#1)(2008-7#1)
to the early##17##3##(1991-12#1)(1993-6#1)(1994-12#1)(1994-7#1)(1995-11#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
to the ease of##2##4##(2008-11#1)(2010-12#1)
to the ecological##3##3##(2008-10#2)(2008-8#1)
to the editor##19##3##(1995-8#1)(1996-9#1)(1997-3#1)(2008-11#3)(2008-12#8)(2008-6#1)(2008-9#2)(2010-2#1)(2011-2#1)
to the education of##2##4##(2008-11#1)(2008-12#1)
to the education##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
to the effect of the##5##5##(1993-9#1)(1995-11#1)(2008-2#1)(2008-8#1)(2010-11#1)
to the effect of##16##4##(1993-9#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-1#1)
to the effect##17##3##(1992-11#1)(1993-9#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-1#1)
to the effective##8##3##(1990-2#1)(1991-9#1)(1993-12#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-8#1)
to the effects of a##2##5##(2008-10#1)(2012-3#1)
to the effects of the##2##5##(1992-8#1)(2008-11#1)
to the effects of##22##4##(1990-6#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
to the effects##24##3##(1990-6#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
to the efficacy and##2##4##(2010-3#1)(2011-2#1)
to the efficacy of the##2##5##(2007-2#1)(2013-1#1)
to the efficacy of##3##4##(2007-2#1)(2008-7#1)(2013-1#1)
to the efficacy##5##3##(2007-2#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
to the efficiency of##2##4##(1994-9#1)(2012-3#1)
to the efficiency##4##3##(1994-9#1)(1997-2#1)(2008-10#1)(2012-3#1)
to the efficient##3##3##(2008-10#3)
to the egg##3##3##(1992-8#1)(2008-6#1)(2008-9#1)
to the ejection##2##3##(1990-9#2)
to the elderly and##2##4##(1991-3#1)(1996-1#1)
to the elderly##8##3##(1991-3#1)(1994-1#2)(1996-1#1)(1996-5#1)(2008-2#1)(2008-5#1)(2009-7#1)
to the electrochemical##3##3##(2008-10#3)
to the electrode surface##3##4##(2008-10#3)
to the electrode##6##3##(1995-6#1)(2007-11#1)(2008-10#3)(2008-3#1)
to the electron injection##2##4##(2008-10#2)
to the electron##3##3##(2008-10#3)
to the electrostatic interactions##2##4##(1990-12#1)(2008-10#1)
to the electrostatic##5##3##(1990-12#1)(2008-10#3)(2008-5#1)
to the elements of##2##4##(1994-3#2)
to the elements##3##3##(1994-3#2)(2008-10#1)
to the elevated##2##3##(2007-10#1)(2013-1#1)
to the elevation##2##3##(2008-10#1)(2009-7#1)
to the elimination of##3##4##(1990-11#1)(1993-12#1)(1996-3#1)
to the eluate##2##3##(1991-5#1)(1992-9#1)
to the elucidation of##4##4##(1997-8#1)(2008-2#1)(2008-5#1)(2011-2#1)
to the embryo##2##3##(2008-10#1)(2008-11#1)
to the emergence of drug-resistant##2##5##(2011-3#1)(2013-1#1)
to the emergence of##8##4##(2008-11#1)(2009-12#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
to the emergence or##2##4##(2006-10#1)(2010-4#1)
to the emergence##10##3##(2006-10#1)(2008-11#1)(2009-12#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
to the emergency department (ED)##2##5##(2008-3#1)(2012-2#1)
to the emergency department with a##2##6##(2007-10#1)(2013-1#1)
to the emergency department with##11##5##(2007-10#1)(2007-5#2)(2008-3#4)(2009-9#2)(2011-2#1)(2013-1#1)
to the emergency department##23##4##(2007-10#4)(2007-5#2)(2008-11#1)(2008-3#7)(2009-9#2)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to the emergency room with##4##5##(2008-3#1)(2009-3#1)(2010-12#1)(2013-1#1)
to the emergency room##8##4##(2007-12#2)(2007-8#1)(2008-3#1)(2009-3#1)(2010-12#1)(2013-1#2)
to the emergency service##2##4##(1996-9#1)(2007-8#1)
to the emergency##37##3##(1992-1#1)(1993-2#1)(1996-9#1)(2007-10#4)(2007-12#2)(2007-5#2)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#9)(2009-3#1)(2009-9#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
to the emerging field of##2##5##(2008-4#1)(2009-5#1)
to the emerging##6##3##(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#2)(2010-12#1)
to the emission of##2##4##(2007-12#1)(2008-10#1)
to the emission##6##3##(2007-12#1)(2008-10#4)(2010-7#1)
to the empirical##3##3##(1996-2#1)(2007-12#1)(2013-1#1)
to the end of August##2##5##(2008-2#1)(2008-5#1)
to the end of the study##11##6##(2008-9#11)
to the end of the##20##5##(1993-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#12)(2011-2#1)
to the end of##27##4##(1993-9#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#12)(2009-7#1)(2011-2#1)(2013-1#1)
to the end##28##3##(1993-9#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#12)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
to the endocrine##2##3##(2008-7#1)(2008-9#1)
to the endogenous##3##3##(2008-11#1)(2008-7#1)(2009-12#1)
to the endometrium##2##3##(1991-12#1)(2011-2#1)
to the endoplasmic reticulum (ER)##2##5##(1994-12#1)(2009-2#1)
to the endoplasmic reticulum##10##4##(1994-12#2)(1997-7#1)(2008-11#3)(2009-2#1)(2009-7#1)(2011-1#1)(2012-12#1)
to the endothelial##3##3##(1995-12#2)(2010-10#1)
to the endothelium##2##3##(1996-2#1)(2008-5#1)
to the energy transfer##4##4##(2008-10#2)(2008-8#2)
to the energy##11##3##(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#1)
to the enhanced##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
to the enhancement of##5##4##(1990-6#1)(2008-10#2)(2008-11#1)(2008-9#1)
to the enormous##2##3##(2008-7#1)(2012-3#1)
to the enrichment##3##3##(2008-10#1)(2013-7#2)
to the enthalpy of##2##4##(1992-5#2)
to the entire##9##3##(1991-3#1)(1992-2#1)(1994-6#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-2#2)
to the entry of##2##4##(1993-3#1)(1997-6#1)
to the environment and##2##4##(2008-10#1)(2008-5#1)
to the environment##15##3##(1994-12#1)(1995-2#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#3)(2012-1#2)(2013-1#1)
to the environmental##5##3##(1991-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-7#1)
to the enzyme and##2##4##(1993-11#1)(2008-10#1)
to the enzyme##21##3##(1990-8#1)(1991-3#1)(1992-12#1)(1993-11#3)(1993-2#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-4#1)(2008-10#8)(2008-7#1)(2009-8#1)
to the enzyme-substrate##2##3##(1990-9#1)(1994-5#1)
to the epidemic##3##3##(1995-12#1)(2008-10#1)(2011-1#1)
to the epidemiology of##2##4##(2008-9#1)(2011-2#1)
to the epidemiology##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
to the epidermis and##5##4##(2008-10#4)(2008-5#1)
to the epidermis##7##3##(2007-12#1)(2008-10#4)(2008-5#2)
to the epithelium##2##3##(2011-1#1)(2013-1#1)
to the equilibrium##2##3##(2008-10#2)
to the equivalent##4##3##(1995-3#2)(1997-6#1)(2008-2#1)
to the eradication##2##3##(2008-11#1)(2012-12#1)
to the erosion##2##3##(2008-1#1)(2010-4#1)
to the established##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
to the establishment of a##2##5##(2008-10#1)(2009-10#1)
to the establishment of the##4##5##(1991-6#1)(1994-5#1)(1996-9#1)(1997-2#1)
to the establishment of##13##4##(1991-6#1)(1994-5#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2009-10#1)(2012-12#1)
to the establishment##15##3##(1991-6#1)(1994-12#1)(1994-5#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-12#1)
to the estimated##4##3##(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)
to the estimation##2##3##(1997-3#1)(2008-7#1)
to the estrogen receptor##3##4##(2008-11#3)
to the estrogen##5##3##(1992-6#1)(2008-11#4)
to the ethnic##2##3##(2008-3#1)(2010-8#1)
to the etiology and##2##4##(2008-11#1)(2011-1#1)
to the etiology##4##3##(1990-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
to the evaluation and##2##4##(2006-5#1)(2009-3#1)
to the evaluation of the##2##5##(1996-12#1)(2013-1#1)
to the evaluation of##7##4##(1991-12#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
to the evaluation##10##3##(1991-12#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
to the event##2##3##(2008-2#2)
to the evolution of new traits##2##6##(2010-4#2)
to the evolution of the##3##5##(1993-8#1)(2012-12#1)(2012-3#1)
to the evolution of##19##4##(1993-8#1)(2008-4#1)(2008-8#6)(2009-3#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
to the evolutionary##3##3##(2008-6#1)(2009-6#1)(2013-1#1)
to the evolving##2##3##(1997-2#1)(2010-7#1)
to the exact##6##3##(1990-8#1)(1992-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
to the examiner's##2##3##(2008-12#1)(2008-9#1)
to the excellent##2##3##(2008-10#1)(2008-2#1)
to the exchange of##4##4##(1990-2#1)(2008-10#1)(2008-9#2)
to the exclusion of##4##4##(1995-11#1)(2008-10#1)(2008-9#1)(2009-10#1)
to the executive suite##2##4##(2008-1#2)
to the executive##3##3##(2008-1#2)(2008-8#1)
to the existence of##9##4##(1993-9#1)(1994-6#1)(2007-12#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#1)(2013-1#1)
to the existing##9##3##(1994-1#1)(1994-7#1)(1996-1#2)(1996-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
to the expected##11##3##(1991-12#1)(1991-6#1)(1992-11#1)(1993-8#1)(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
to the experience of##3##4##(1993-6#1)(2008-12#1)(2010-5#1)
to the experiment##2##3##(2006-4#1)(2007-12#1)
to the experimental##10##3##(1995-3#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#2)
to the experts##2##3##(1996-2#1)(1996-3#1)
to the explicit##2##3##(2008-7#1)(2012-12#1)
to the exponential##5##3##(2008-6#2)(2009-11#1)(2010-4#1)(2011-2#1)
to the exposure##3##3##(1991-12#1)(1995-6#1)(2011-2#1)
to the expression of##15##4##(1992-3#1)(1992-6#1)(1994-5#1)(1996-12#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-3#1)
to the expression##19##3##(1992-3#1)(1992-6#2)(1994-5#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-3#1)
to the extension of the##3##5##(2008-10#1)(2010-5#1)(2013-7#1)
to the extension of##4##4##(2007-11#1)(2008-10#1)(2010-5#1)(2013-7#1)
to the extensive##3##3##(2008-8#1)(2012-2#1)(2012-3#1)
to the extent of the##3##5##(2008-10#1)(2008-3#1)(2008-8#1)
to the extent of##8##4##(1992-6#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
to the extent that##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
to the extent##13##3##(1992-3#1)(1992-6#1)(1996-12#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
to the external environment##4##4##(1995-3#2)(1995-5#1)(2008-5#1)
to the external##16##3##(1990-8#1)(1991-5#1)(1994-11#1)(1995-3#2)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
to the extracellular domain##3##4##(1993-8#1)(1995-5#1)(2008-4#1)
to the extracellular matrix##3##4##(1997-3#1)(2011-1#1)(2012-12#1)
to the extracellular##10##3##(1991-6#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-5#1)(1997-3#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-12#1)
to the extraction of##4##4##(2008-10#3)(2012-1#1)
to the extraction##17##3##(2008-10#15)(2012-1#2)
to the eye##5##3##(1995-9#3)(2010-8#1)(2011-1#1)
to the fabrication of##2##4##(2008-3#1)(2009-3#1)
to the fabrication##3##3##(2008-3#2)(2009-3#1)
to the face##5##3##(1996-2#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-5#1)
to the facial##3##3##(1992-4#1)(1996-5#1)(2008-9#1)
to the facilitation of##2##4##(2008-11#2)
to the fact that a##2##5##(1990-11#1)(2008-3#1)
to the fact that it is##2##6##(1994-9#1)(2008-10#1)
to the fact that it##3##5##(1994-9#1)(2008-10#1)(2008-5#1)
to the fact that the##9##5##(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2012-3#1)
to the fact that these##2##5##(1990-2#1)(2009-2#1)
to the fact that they##2##5##(2012-2#1)(2012-3#1)
to the fact that##34##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1994-9#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2012-2#1)(2012-3#2)
to the fact##35##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1994-9#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2012-2#1)(2012-3#2)
to the factors##4##3##(2008-10#2)(2008-4#1)(2011-1#1)
to the facts that##2##4##(2008-10#1)(2010-7#1)
to the failure of the##2##5##(1996-2#1)(2007-11#1)
to the failure of##3##4##(1996-2#1)(2007-11#1)(2011-3#1)
to the families##4##3##(2008-10#2)(2008-5#1)(2013-8#1)
to the family of ubiquitin-protein ligases##2##6##(1995-6#2)
to the family of##10##4##(1991-12#1)(1993-6#1)(1995-6#3)(2007-12#1)(2008-4#1)(2009-7#1)(2012-12#1)(2012-2#1)
to the family##26##3##(1991-12#1)(1993-6#1)(1995-6#3)(2007-12#2)(2008-10#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-7#1)
to the fast##4##3##(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)
to the feature##10##3##(2008-2#4)(2008-3#6)
to the features##4##3##(1992-9#1)(1993-12#1)(2008-3#1)(2008-7#1)
to the female genital##2##4##(2007-12#1)(2008-7#1)
to the female##7##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-10#2)
to the femoral##3##3##(2008-7#1)(2011-2#2)
to the fetus##3##3##(1995-8#3)
to the fiber axis##3##4##(2008-2#1)(2008-3#2)
to the fiber expansion##2##4##(2008-10#2)
to the fiber##10##3##(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)
to the field of##5##4##(1992-3#1)(2007-4#1)(2008-10#1)(2012-1#1)(2012-2#1)
to the field##15##3##(1992-3#1)(1992-6#1)(1996-2#2)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
to the fields##2##3##(2010-5#1)(2012-2#1)
to the fifth##2##3##(2007-12#1)(2008-6#1)
to the fight##2##3##(1993-12#1)(2008-10#1)
to the film##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
to the filter##2##3##(2008-2#1)(2008-3#1)
to the final diagnosis of##2##5##(2008-5#1)(2010-6#1)
to the final diagnosis##3##4##(2008-5#1)(2010-6#1)(2011-2#1)
to the final##12##3##(1993-9#1)(1994-3#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#1)(2013-7#1)
to the financial##2##3##(1995-1#1)(2006-5#1)
to the finding of##2##4##(1996-5#1)(2010-12#1)
to the finding##5##3##(1994-8#1)(1996-5#1)(2010-12#1)(2010-7#1)(2012-2#1)
to the findings of##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
to the findings##5##3##(1991-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
to the fine##3##3##(1993-5#1)(2007-11#1)(2012-1#1)
to the finite##2##3##(2007-12#1)(2009-6#1)
to the fire##3##3##(1996-12#1)(2008-10#1)(2010-3#1)
to the first Stokes##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
to the first coding exon##2##5##(1990-8#2)
to the first order##2##4##(2006-4#1)(2008-3#1)
to the first##36##3##(1990-12#2)(1990-8#2)(1991-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-10#1)(1997-6#2)(1997-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
to the five##2##3##(2008-10#1)(2008-11#1)
to the fixed##2##3##(1997-2#1)(2009-6#1)
to the flexor##2##3##(2008-9#2)
to the floor of the##2##5##(2008-7#1)(2009-9#1)
to the floor##3##3##(1995-6#1)(2008-7#1)(2009-9#1)
to the flow cell##4##4##(2008-10#4)
to the flow of a##2##5##(1991-9#1)(2008-11#1)
to the flow of##4##4##(1991-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
to the flow##13##3##(1991-9#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2011-2#1)
to the flow-injection determination of##2##5##(2008-10#2)
to the flower##2##3##(2008-10#1)(2011-10#1)
to the focal region##2##4##(2007-12#1)(2008-3#1)
to the focal##7##3##(2007-12#1)(2008-3#6)
to the foliage##2##3##(2008-10#2)
to the following conclusions##3##4##(1990-2#1)(2008-10#1)(2012-12#1)
to the following##12##3##(1990-2#1)(1993-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-7#1)
to the food##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
to the foot##2##3##(2009-10#2)
to the foramen##2##3##(2007-8#1)(2008-9#1)
to the force##2##3##(2010-12#1)(2010-2#1)
to the fore##2##3##(2008-2#1)(2008-7#1)
to the forefront##3##3##(1994-1#1)(1997-8#1)(2008-5#1)
to the foreign##2##3##(1990-3#1)(2011-2#1)
to the formal##2##3##(1995-2#1)(2010-7#1)
to the formation and##4##4##(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
to the formation of a##12##5##(1991-9#1)(1994-3#1)(1997-2#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)
to the formation of the##9##5##(1992-12#1)(1996-5#2)(1997-8#1)(2008-10#3)(2008-3#1)(2009-8#1)
to the formation of##74##4##(1990-5#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-5#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#3)
to the formation##79##3##(1990-5#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-5#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#1)
to the former##4##3##(1994-11#1)(1997-4#1)(2008-10#1)(2008-11#1)
to the formulation of##3##4##(2008-5#1)(2010-1#1)(2011-3#1)
to the formulation##4##3##(2008-5#1)(2008-8#1)(2010-1#1)(2011-3#1)
to the four categories of the QOL-ACE##2##7##(1994-12#2)
to the four##7##3##(1992-3#1)(1994-12#2)(2008-10#3)(2008-7#1)
to the fourth##6##3##(2008-10#2)(2008-3#2)(2008-9#1)(2012-2#1)
to the fracture##2##3##(1991-6#1)(2009-3#1)
to the fragment##3##3##(1997-6#1)(2008-2#2)
to the framework of##2##4##(1990-8#1)(1997-6#1)
to the framework##4##3##(1990-8#1)(1997-6#1)(2008-4#2)
to the free energy##2##4##(1990-11#1)(2010-7#1)
to the free##8##3##(1990-11#1)(1992-12#1)(1995-5#2)(2008-10#1)(2008-7#1)(2009-9#1)(2010-7#1)
to the frequency of##4##4##(1991-5#1)(1994-6#1)(2008-10#2)
to the frequency##7##3##(1991-5#1)(1994-6#1)(2007-7#1)(2008-10#3)(2008-3#1)
to the fringe##2##3##(2008-2#1)(2008-3#1)
to the fruit##4##3##(2008-10#4)
to the full##8##3##(1995-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-1#1)
to the full-length##4##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-7#1)
to the function of the##3##5##(2008-4#1)(2008-7#1)(2012-3#1)
to the function of##6##4##(1996-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-3#1)
to the functional role of##2##5##(1994-8#1)(2011-2#1)
to the functional##6##3##(1993-12#1)(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
to the functions of##2##4##(1994-11#1)(2009-8#1)
to the fundamental laser##2##4##(2008-2#1)(2008-3#1)
to the fundamental##13##3##(1992-6#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2010-3#1)(2011-2#1)(2013-8#1)
to the fungal##3##3##(2008-10#3)
to the fungicide metalaxyl##2##4##(2008-10#2)
to the fungicide##5##3##(2008-10#5)
to the fungicides##8##3##(2008-10#8)
to the fungus##5##3##(2008-10#4)(2011-10#1)
to the further##3##3##(2008-9#1)(2010-10#1)(2010-12#1)
to the future development of##2##5##(2008-11#1)(2011-2#1)
to the future##16##3##(1991-1#2)(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
to the gap between##2##4##(1991-1#1)(2013-1#1)
to the gas phase##3##4##(2008-10#2)(2008-7#1)
to the gas##5##3##(1995-11#1)(1996-12#1)(2008-10#2)(2008-7#1)
to the gastric##2##3##(2009-8#1)(2011-2#1)
to the gastrointestinal tract##2##4##(2008-7#1)(2013-1#1)
to the gastrointestinal##3##3##(1997-3#1)(2008-7#1)(2013-1#1)
to the gate##2##3##(2007-11#1)(2009-5#1)
to the gel##4##3##(2008-7#1)(2010-5#2)(2011-1#1)
to the gene encoding##3##4##(1991-12#1)(1991-6#1)(1996-2#1)
to the gene##13##3##(1991-12#1)(1991-6#1)(1992-3#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)
to the genera##9##3##(2008-10#4)(2008-5#1)(2008-7#1)(2013-7#2)(2013-8#1)
to the general population##5##4##(1994-2#1)(1997-3#1)(2008-11#1)(2011-2#1)(2012-12#1)
to the general practitioner##2##4##(1992-5#2)
to the general##14##3##(1992-5#2)(1994-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
to the generalized##2##3##(1990-8#1)(2008-3#1)
to the generally##2##3##(2008-11#1)(2008-2#1)
to the generation of##14##4##(1993-6#1)(1995-9#1)(1997-8#1)(1997-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-9#1)
to the generation##15##3##(1993-6#1)(1995-9#1)(1997-8#1)(1997-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-9#1)
to the genes of##2##4##(1995-12#1)(2008-8#1)
to the genes##5##3##(1995-12#1)(1995-8#1)(1996-6#1)(1997-3#1)(2008-8#1)
to the genetic diversity##3##4##(2008-10#3)
to the genetic regression##2##4##(2008-9#2)
to the genetic risk of##2##5##(2008-1#2)
to the genetic structure of##2##5##(2008-10#2)
to the genetic##15##3##(1990-3#1)(1997-2#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-9#2)(2012-12#1)(2012-3#1)
to the genome##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
to the genus Tospovirus##2##4##(2008-10#2)
to the genus##14##3##(1991-12#1)(1997-4#1)(2008-10#7)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
to the geographic##2##3##(1991-12#1)(2008-10#1)
to the geographical##2##3##(2008-1#1)(2011-2#1)
to the geometric##2##3##(2008-10#1)(2008-3#1)
to the geometry of the##3##5##(1990-12#1)(1990-5#1)(2007-12#1)
to the geometry of##4##4##(1990-12#1)(1990-5#1)(2007-12#1)(2008-10#1)
to the geometry##5##3##(1990-12#1)(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
to the given##2##3##(2008-7#1)(2009-6#1)
to the glandular##2##3##(1997-1#1)(2007-12#1)
to the glass##5##3##(2007-12#1)(2008-10#2)(2008-3#2)
to the glassy carbon electrode##3##5##(2008-10#3)
to the global##8##3##(1991-12#1)(1993-3#1)(1995-5#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#2)
to the glucose##5##3##(2008-10#5)
to the graduate##2##3##(2008-9#1)(2011-2#1)
to the graft##2##3##(1996-2#1)(2010-3#1)
to the grating##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
to the great amount of##3##5##(2008-10#1)(2008-7#1)(2009-8#1)
to the great##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
to the greater##5##3##(1994-5#1)(2008-10#2)(2008-6#1)(2012-2#1)
to the ground##5##3##(2008-10#1)(2008-3#3)(2008-6#1)
to the group of##4##4##(1991-9#1)(2008-10#2)(2012-1#1)
to the group##9##3##(1991-6#1)(1991-9#2)(2008-10#2)(2008-8#1)(2010-3#1)(2012-1#1)(2013-8#1)
to the growing body of##3##5##(1993-1#1)(2009-2#1)(2010-5#1)
to the growing number of##2##5##(1991-1#1)(2009-10#1)
to the growing##14##3##(1991-1#1)(1993-1#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#1)
to the growth inhibitory##3##4##(1992-3#1)(1995-2#1)(2008-11#1)
to the growth of##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)
to the growth##16##3##(1990-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)
to the guidance of the##2##5##(2009-3#1)(2009-8#1)
to the guidelines for##2##4##(2007-8#1)(2008-12#1)
to the guidelines##4##3##(1991-4#1)(2007-8#1)(2008-10#1)(2008-12#1)
to the habit##2##3##(1991-9#1)(2010-12#1)
to the hair##2##3##(2008-5#2)
to the hand and##2##4##(2007-7#1)(2011-2#1)
to the hand##6##3##(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#3)
to the head##4##3##(1995-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
to the headspace##2##3##(2008-10#2)
to the healing##2##3##(2008-9#1)(2009-10#1)
to the health care field##2##5##(1996-3#1)(1997-1#1)
to the health care system##3##5##(1993-3#1)(1997-1#1)(2011-1#1)
to the health care##13##4##(1991-2#1)(1993-12#3)(1993-3#1)(1993-6#1)(1995-1#2)(1996-3#1)(1997-1#2)(2008-11#1)(2011-1#1)
to the health of##3##4##(1991-1#1)(1995-3#1)(2013-8#1)
to the health services##2##4##(1996-11#2)
to the health system##2##4##(2008-1#1)(2009-10#1)
to the health##26##3##(1991-1#1)(1991-2#1)(1991-6#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-5#2)(1995-1#2)(1995-3#1)(1996-11#2)(1996-3#1)(1997-1#2)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-1#1)(2013-8#1)
to the healthcare system##2##4##(2010-2#1)(2013-1#1)
to the healthcare##6##3##(1997-3#1)(2008-11#1)(2010-2#1)(2011-2#2)(2013-1#1)
to the healthy##2##3##(2008-11#1)(2010-12#1)
to the hearing##2##3##(2008-4#1)(2008-9#1)
to the heart and##2##4##(1994-2#1)(2007-8#1)
to the heart##7##3##(1993-1#1)(1994-2#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-2#1)
to the helix##2##3##(1994-5#1)(1995-5#1)
to the heme iron##3##4##(1991-9#1)(1994-5#1)(2008-10#1)
to the heme##8##3##(1990-8#1)(1991-9#1)(1994-5#3)(1994-8#1)(2008-10#1)(2009-9#1)
to the heterologous##4##3##(1993-8#1)(1994-8#1)(2008-10#2)
to the high complexity##2##4##(2008-10#1)(2010-11#1)
to the high number of##2##5##(1993-6#1)(2008-7#1)
to the high prevalence of##2##5##(1992-5#1)(2007-7#1)
to the high prevalence##3##4##(1992-5#1)(2007-7#1)(2008-8#1)
to the high rate of##2##5##(2008-6#1)(2013-8#1)
to the high sensitivity of this##2##6##(2008-10#1)(2013-8#1)
to the high sensitivity of##3##5##(2008-10#2)(2013-8#1)
to the high##47##3##(1990-5#1)(1990-9#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-8#2)(1995-2#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-9#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
to the higher##16##3##(1991-5#1)(1992-8#1)(1994-2#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
to the highest##13##3##(1990-6#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to the highly conserved##2##4##(1994-11#1)(1994-5#1)
to the highly##7##3##(1994-11#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
to the hip##4##3##(2007-11#2)(2008-4#2)
to the hippocampus##4##3##(1993-12#1)(2008-11#1)(2013-8#2)
to the histologic##2##3##(1991-12#1)(1997-7#1)
to the histological##2##3##(1994-9#1)(2010-4#1)
to the histopathological##2##3##(2007-8#1)(2011-2#1)
to the historical##4##3##(1996-3#1)(2008-10#1)(2008-4#1)(2009-10#1)
to the history##3##3##(2009-10#2)(2010-1#1)
to the home##2##3##(1990-11#1)(1991-1#1)
to the homologous##4##3##(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
to the hormone##2##3##(1991-2#1)(1997-1#1)
to the hospital and##2##4##(2011-2#2)
to the hospital due to##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
to the hospital with a##2##5##(2012-12#1)(2013-1#1)
to the hospital with##3##4##(2008-12#1)(2012-12#1)(2013-1#1)
to the hospital##35##3##(1990-9#1)(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-3#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
to the hospital's##2##3##(1996-3#2)
to the hospitals##2##3##(1992-12#1)(2009-5#1)
to the host##12##3##(1991-9#1)(1992-3#1)(1993-6#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#2)(2009-8#1)
to the human hsp27##2##4##(1993-6#2)
to the human##26##3##(1990-12#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-6#2)(1997-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2011-2#2)(2013-1#1)
to the hydrogen##2##3##(1992-6#1)(2008-10#1)
to the hydrophobic##4##3##(1994-6#1)(2008-10#2)(2008-12#1)
to the hydroxyl##4##3##(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#1)
to the hypothesis that the##3##5##(2008-3#1)(2010-2#2)
to the hypothesis that##12##4##(1991-12#1)(1991-6#1)(1993-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to the hypothesis##13##3##(1991-12#1)(1991-6#1)(1993-2#1)(1995-3#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to the hypothetical##2##3##(1996-6#1)(2008-9#1)
to the idea that##4##4##(1992-3#1)(2008-2#1)(2012-12#1)(2012-2#1)
to the ideal##5##3##(1995-6#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-12#1)
to the identification and##2##4##(1991-8#1)(2008-7#1)
to the identification of novel##3##5##(2008-7#2)(2012-1#1)
to the identification of the##3##5##(2008-10#2)(2008-11#1)
to the identification of##25##4##(1990-8#1)(1991-9#1)(1994-9#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
to the identification##27##3##(1990-8#1)(1991-8#1)(1991-9#1)(1994-9#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
to the image of##2##4##(2008-12#2)
to the image##5##3##(2008-12#3)(2008-6#1)(2010-5#1)
to the imaging##3##3##(2008-2#2)(2012-12#1)
to the immediate##3##3##(1992-4#1)(1994-12#1)(2008-11#1)
to the immune##4##3##(2008-10#3)(2009-10#1)
to the impact of##6##4##(2007-12#2)(2008-1#1)(2008-2#1)(2008-8#1)(2013-1#1)
to the impact##8##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-8#1)(2009-11#1)(2013-1#2)
to the implementation of the##2##5##(1994-3#1)(2008-10#1)
to the implementation of this##2##5##(2008-2#1)(2010-10#1)
to the implementation of##8##4##(1994-3#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
to the implications##2##3##(1993-12#1)(2011-1#1)
to the importance of##12##4##(1991-6#1)(1992-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
to the importance##14##3##(1991-6#1)(1991-9#1)(1992-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
to the important##2##3##(2008-10#2)
to the improved##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
to the improvement of##7##4##(1991-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#2)
to the improvement##9##3##(1991-5#1)(1991-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#2)
to the in situ##3##4##(2008-10#1)(2008-3#2)
to the in vitro##2##4##(1992-8#1)(2008-10#1)
to the in vivo##4##4##(1991-1#1)(1997-1#1)(2008-10#1)(2008-5#1)
to the in##9##3##(1991-1#1)(1992-8#1)(1997-1#1)(2008-10#3)(2008-3#2)(2008-5#1)
to the in-vitro##2##3##(1990-12#1)(2008-4#1)
to the inability of##2##4##(2012-3#1)(2013-1#1)
to the inability##4##3##(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
to the inactive##2##3##(1992-6#1)(1993-11#1)
to the inappropriate##3##3##(1993-12#1)(2008-10#2)
to the incentives##2##3##(1992-2#1)(1995-3#1)
to the incidence of##6##4##(1990-8#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
to the incidence##7##3##(1990-8#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
to the incident beam##3##4##(2008-2#1)(2008-3#2)
to the incident radiation##2##4##(2008-3#2)
to the incident##10##3##(2007-12#1)(2008-2#2)(2008-3#7)
to the inclusion##4##3##(2008-10#2)(2009-8#1)(2011-1#1)
to the incoming##2##3##(2008-10#1)(2008-3#1)
to the incorporation##2##3##(2008-11#1)(2008-2#1)
to the increase in the##2##5##(1997-2#1)(2008-10#1)
to the increase in##11##4##(1992-6#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-2#1)
to the increase of##5##4##(2008-10#3)(2009-3#1)(2010-12#1)
to the increase##18##3##(1992-6#1)(1997-2#1)(2006-10#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
to the increased number##5##4##(1991-12#1)(1991-2#1)(1991-3#1)(1994-6#1)(2008-1#1)
to the increased risk of##2##5##(1991-8#1)(2011-2#1)
to the increased##26##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#2)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to the increasing##12##3##(1996-6#1)(1997-3#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
to the incubation##5##3##(1993-11#1)(1993-6#1)(1995-11#1)(2008-5#1)(2011-2#1)
to the index##2##3##(2008-3#1)(2008-9#1)
to the individual patient##3##4##(1996-8#1)(2008-7#1)(2010-6#1)
to the individual##15##3##(1994-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#3)(2007-2#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-6#1)(2012-2#1)(2013-8#1)
to the induction of DNA##2##5##(1997-4#1)(2008-7#1)
to the induction of##10##4##(1990-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-7#1)
to the inductively coupled plasma-mass##2##5##(2008-10#2)
to the infant##3##3##(1995-3#1)(1995-6#1)(2006-5#1)
to the infection##7##3##(1992-8#1)(1993-6#1)(2008-1#1)(2008-10#3)(2008-12#1)
to the inferior##6##3##(1994-3#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
to the inflammatory##4##3##(1994-2#1)(2008-1#1)(2008-9#1)(2012-12#1)
to the influence of a##2##5##(1993-12#1)(2008-7#1)
to the influence of the##3##5##(2008-10#1)(2008-9#1)(2010-3#1)
to the influence of##11##4##(1990-2#1)(1991-12#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-9#1)
to the influence##12##3##(1990-2#1)(1991-12#1)(1993-12#1)(2006-10#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-9#1)
to the information##4##3##(1996-3#1)(2007-5#1)(2008-5#1)(2012-12#1)
to the inherent##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
to the inheritance of##2##4##(1994-9#1)(2007-1#1)
to the inhibition of the##5##5##(1992-9#1)(1993-8#1)(1997-4#1)(2008-8#1)(2008-9#1)
to the inhibition of ubiquitin-proteasome pathway##3##6##(2008-9#3)
to the inhibition of##22##4##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#4)(2010-3#1)(2012-2#1)
to the inhibition##23##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#5)(2010-3#1)(2012-2#1)
to the inhibitor##2##3##(1992-12#1)(1995-11#1)
to the inhibitory effect of##3##5##(1992-5#1)(2008-10#1)(2008-7#1)
to the inhibitory##7##3##(1992-5#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-7#1)
to the initial clinical##2##4##(2008-7#1)(2010-12#1)
to the initial##20##3##(1990-11#1)(1990-7#1)(1992-2#1)(1992-9#1)(1995-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)
to the initiation and development of##3##6##(1997-4#1)(2008-10#1)(2012-3#1)
to the initiation and##5##4##(1993-3#1)(1997-4#1)(2008-10#1)(2008-7#1)(2012-3#1)
to the initiation##7##3##(1993-3#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)
to the injected##2##3##(1995-12#2)
to the injection site##2##4##(1996-7#1)(1997-3#1)
to the injection##4##3##(1996-7#1)(1997-3#1)(2008-1#1)(2011-2#1)
to the inner membrane##2##4##(1991-10#1)(1992-7#1)
to the inner mitochondrial membrane##3##5##(1993-6#1)(1996-2#1)(2012-2#1)
to the inner##11##3##(1991-10#2)(1992-7#1)(1993-6#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
to the inoculated##2##3##(2008-10#2)
to the inoculation##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
to the input variables##2##4##(2008-10#2)
to the input##12##3##(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-6#1)
to the insect##2##3##(2008-10#1)(2008-9#1)
to the insensitivity##2##3##(2008-10#1)(2008-7#1)
to the inside##2##3##(2008-12#1)(2009-8#1)
to the insoluble##2##3##(2008-10#1)(2009-7#1)
to the instability##2##3##(2008-8#1)(2011-2#1)
to the institution##2##3##(1993-2#1)(1994-1#1)
to the instrument##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
to the insulin##3##3##(1996-10#1)(2008-6#1)(2010-11#1)
to the intact##2##3##(1997-8#1)(2008-10#1)
to the integrated##3##3##(1997-7#1)(2008-6#1)(2012-3#1)
to the intensity of the##4##5##(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)
to the intensity of##6##4##(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)
to the intensity##9##3##(1991-12#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
to the intensive care##2##4##(1993-12#1)(2013-1#1)
to the intensive##3##3##(1993-12#1)(2007-7#1)(2013-1#1)
to the intent of the##2##5##(2007-4#1)(2009-4#1)
to the interaction between the##2##5##(2008-10#1)(2012-2#1)
to the interaction between##4##4##(2008-10#2)(2008-8#1)(2012-2#1)
to the interaction of the##2##5##(1994-2#1)(2008-10#1)
to the interaction of##8##4##(1994-11#1)(1994-2#1)(2008-10#4)(2008-4#1)(2009-7#1)
to the interaction with##2##4##(1994-5#1)(2008-3#1)
to the interaction##15##3##(1994-11#1)(1994-2#1)(1994-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2012-2#1)
to the intercellular##2##3##(2008-10#2)
to the interface##2##3##(1995-5#1)(2008-3#1)
to the interference##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
to the interferences##2##3##(2008-10#2)
to the interior of the##2##5##(2007-11#1)(2009-7#1)
to the internal##12##3##(1990-8#1)(1991-3#1)(1991-9#2)(1996-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#2)(2013-1#1)
to the international##3##3##(2008-11#1)(2011-1#1)(2012-3#1)
to the interpretation of##2##4##(2008-10#2)
to the intervention group##3##4##(2007-5#1)(2008-12#1)(2008-9#1)
to the intervention##9##3##(2007-5#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
to the intracellular##5##3##(1990-7#1)(1992-8#1)(1994-12#1)(1995-5#1)(2008-8#1)
to the intrinsic##6##3##(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-11#1)
to the introduction of##9##4##(1991-12#1)(2007-11#1)(2007-7#2)(2008-12#1)(2009-11#1)(2010-3#1)(2010-4#1)(2012-2#1)
to the introduction##10##3##(1991-12#1)(2007-11#1)(2007-7#2)(2008-12#2)(2009-11#1)(2010-3#1)(2010-4#1)(2012-2#1)
to the inverse##5##3##(1997-8#1)(2008-2#2)(2008-5#1)(2008-8#1)
to the inversion of##2##4##(2008-3#2)
to the inversion##3##3##(2008-3#2)(2013-1#1)
to the investigation of##6##4##(1991-12#1)(1991-2#1)(2008-10#3)(2010-3#1)
to the investigation##7##3##(1991-12#1)(1991-2#1)(2008-10#4)(2010-3#1)
to the investigations##2##3##(1997-7#1)(2008-10#1)
to the involvement of a##2##5##(2008-10#1)(2008-4#1)
to the involvement of##6##4##(2008-10#1)(2008-11#2)(2008-4#1)(2010-10#1)(2013-8#1)
to the ion##2##3##(2008-10#2)
to the ionic strength##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
to the ionic##5##3##(1995-2#1)(1997-7#1)(2008-10#2)(2008-5#1)
to the ionization##2##3##(2008-10#2)
to the ionophore##2##3##(2008-10#2)
to the ipsilateral##3##3##(1994-12#1)(2012-12#2)
to the iris##2##3##(1996-5#2)
to the iron##3##3##(1990-3#1)(1994-8#1)(2008-5#1)
to the irreversible##2##3##(1993-12#1)(1994-12#1)
to the ischemic##3##3##(1996-12#1)(1997-2#1)(2008-8#1)
to the isolate##4##3##(2008-10#4)
to the isolates##2##3##(2008-10#2)
to the isolation of a##2##5##(2009-10#1)(2011-1#1)
to the isolation of##6##4##(1992-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-2#1)(2011-1#1)
to the isolation##7##3##(1992-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-2#1)(2011-1#1)
to the issue of the##2##5##(2007-11#1)(2008-3#1)
to the issue of##3##4##(1995-3#1)(2007-11#1)(2008-3#1)
to the issue##4##3##(1995-3#1)(2007-11#1)(2008-3#1)(2009-7#1)
to the iterative Fourier transform algorithm##2##6##(2008-2#1)(2008-3#1)
to the iterative##3##3##(2008-2#1)(2008-3#2)
to the joint##3##3##(2008-7#1)(2008-9#1)(2009-11#1)
to the journal##2##3##(1996-9#1)(2008-11#1)
to the junctional##2##3##(1990-2#1)(1996-12#1)
to the key##3##3##(1995-6#1)(2008-9#1)(2011-1#1)
to the kidney##5##3##(1993-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
to the kinetics of##2##4##(2008-10#2)
to the knee##3##3##(2007-11#2)(2008-12#1)
to the knowledge of the##2##5##(1993-11#1)(2013-8#1)
to the knowledge of##3##4##(1990-5#1)(1993-11#1)(2013-8#1)
to the known##8##3##(1992-3#1)(1995-12#1)(1996-10#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#1)
to the lab##3##3##(2008-9#1)(2012-2#2)
to the laboratory##8##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
to the labyrinth##2##3##(2012-2#2)
to the lac##2##3##(1995-3#1)(1997-6#1)
to the lack of a##2##5##(1991-10#1)(2008-10#1)
to the lack of adequate##3##5##(2008-10#1)(2008-9#1)(2010-5#1)
to the lack of proper##2##5##(2008-10#1)(2011-2#1)
to the lack of the##2##5##(2010-5#1)(2011-2#1)
to the lack of##32##4##(1990-9#1)(1991-10#1)(1995-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#2)(2011-2#5)(2012-12#1)(2013-1#2)
to the lamina##2##3##(2007-8#1)(2008-7#1)
to the large difference##2##4##(1994-6#1)(2008-11#1)
to the large##20##3##(1992-3#2)(1994-12#1)(1994-6#1)(1995-5#1)(1996-2#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#1)
to the larger##4##3##(1996-5#1)(2007-12#1)(2008-9#1)(2012-5#1)
to the largest##2##3##(2009-7#1)(2013-8#1)
to the laser beam##2##4##(2007-12#1)(2008-9#1)
to the laser##9##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-11#1)
to the last##3##3##(1991-8#1)(1992-12#1)(1992-6#1)
to the late##3##3##(1996-9#1)(1997-8#1)(2008-8#1)
to the late-onset##2##3##(1990-5#1)(1991-3#1)
to the lateral##4##3##(1993-12#1)(2007-12#1)(2008-3#1)(2012-3#1)
to the latest##4##3##(1990-2#1)(1991-6#1)(1997-8#1)(2008-9#1)
to the latter##7##3##(1994-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-8#1)
to the launched##2##3##(2007-12#1)(2008-3#1)
to the law##4##3##(1996-5#1)(1997-8#1)(2011-2#2)
to the lead##2##3##(1995-3#1)(2008-3#1)
to the leaf surface##3##4##(1994-11#1)(2008-10#2)
to the leaf##6##3##(1994-11#1)(2008-10#5)
to the learning##2##3##(2008-11#1)(2011-2#1)
to the least##4##3##(2010-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
to the left or to the right##2##7##(2007-4#1)(2013-1#1)
to the left or##3##4##(2007-4#2)(2013-1#1)
to the left##29##3##(1993-12#1)(1993-6#1)(1993-9#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#4)(2010-9#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#2)
to the length and##2##4##(2008-9#1)(2010-7#1)
to the length of the##2##5##(2008-10#1)(2008-9#1)
to the length of##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
to the length##7##3##(1990-8#1)(2008-10#3)(2008-9#2)(2010-7#1)
to the lens##4##3##(1993-9#1)(2008-3#3)
to the lesion##11##3##(1993-3#1)(1996-2#2)(1996-5#4)(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)
to the less##4##3##(1995-11#1)(2008-10#1)(2008-4#1)(2009-12#1)
to the letter to the##2##5##(2008-4#1)(2010-2#1)
to the level and##2##4##(1992-6#1)(2008-11#1)
to the level observed in##2##5##(1993-8#1)(2011-2#1)
to the level of expression of##2##6##(1995-2#1)(2008-11#1)
to the level of the##2##5##(1990-7#1)(2008-10#1)
to the level of##18##4##(1990-7#1)(1993-6#1)(1995-2#2)(1996-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
to the level##29##3##(1990-7#1)(1990-8#1)(1992-6#1)(1993-6#1)(1993-8#2)(1995-2#2)(1996-2#1)(1996-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-2#1)
to the levels of##4##4##(1991-5#1)(1997-8#1)(2008-10#1)(2011-2#1)
to the levels##7##3##(1991-5#1)(1997-8#1)(2008-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
to the ligament##2##3##(2013-1#2)
to the light##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
to the likelihood##2##3##(1992-2#1)(2008-8#1)
to the limited##9##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
to the line##3##3##(2008-3#2)(2008-6#1)
to the linear##8##3##(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-7#1)
to the lines of the grating##3##6##(2008-3#3)
to the lines##4##3##(2008-3#4)
to the link between##2##4##(2012-2#1)(2013-1#1)
to the link##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
to the lipid monolayers##2##4##(1990-5#1)(1995-5#1)
to the lipid##7##3##(1990-2#1)(1990-5#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-5#1)(2008-5#1)
to the lipophilic##2##3##(1992-9#1)(2008-10#1)
to the liposomal surface##2##4##(2008-10#2)
to the liposomal##3##3##(2008-10#3)
to the liquid##5##3##(1992-9#1)(2008-10#3)(2008-2#1)
to the list of##6##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
to the list##7##3##(1991-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
to the literature values##2##4##(2008-10#2)
to the literature##17##3##(1990-6#1)(1991-12#1)(1996-3#2)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)
to the liver##15##3##(1990-2#2)(1990-8#1)(1991-4#1)(1993-3#1)(1994-2#1)(1994-7#1)(1997-4#1)(2008-6#1)(2009-3#1)(2010-5#1)(2012-2#2)(2013-1#2)
to the living##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
to the loaded##2##3##(2008-10#1)(2009-4#1)
to the local##21##3##(1993-11#1)(1995-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#2)
to the location of the##4##5##(1991-6#1)(2007-8#1)(2008-10#1)(2008-11#1)
to the location of##9##4##(1991-6#1)(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)
to the location##12##3##(1991-6#1)(1995-11#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)
to the locomotor##2##3##(1993-3#1)(2007-11#1)
to the locus##2##3##(1996-5#1)(2008-10#1)
to the logarithm of the##2##5##(2008-10#2)
to the logarithm of##4##4##(2008-10#3)(2009-7#1)
to the long##6##3##(1991-3#1)(1992-1#1)(1995-2#1)(2008-9#1)(2009-10#1)(2012-2#1)
to the long-term##5##3##(1994-6#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
to the longitudinal##2##3##(1992-12#1)(2007-12#1)
to the loss of the##3##5##(1995-11#1)(1997-4#1)(2008-2#1)
to the loss of##9##4##(1990-11#1)(1992-11#1)(1993-3#1)(1995-11#1)(1997-4#1)(1997-7#1)(2008-2#1)(2008-5#1)(2011-2#1)
to the low density lipoprotein receptor##2##6##(1990-11#1)(1995-2#1)
to the low density##3##4##(1990-11#1)(1995-2#1)(2012-2#1)
to the low oral##2##4##(2008-8#2)
to the low##22##3##(1990-11#1)(1991-9#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the lower lobe##2##4##(2007-8#2)
to the lower##16##3##(1991-3#1)(1992-3#1)(1992-6#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-9#1)(2010-5#1)(2012-12#1)
to the lowest level##2##4##(2008-10#1)(2008-8#1)
to the lowest##5##3##(2008-10#4)(2008-8#1)
to the lumbar##3##3##(1990-5#2)(2012-2#1)
to the lumen##2##3##(2007-12#1)(2008-10#1)
to the lung##10##3##(1992-2#2)(1992-9#1)(1996-3#1)(1997-1#1)(2008-10#3)(2010-3#1)(2013-8#1)
to the lungfish and caiman calcitonins##2##6##(2008-5#2)
to the lungs and##4##4##(1994-5#1)(1997-1#1)(2007-11#1)(2008-5#1)
to the lungs##9##3##(1990-10#1)(1994-5#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-5#2)(2008-6#1)
to the lysis##2##3##(1997-4#1)(2008-2#1)
to the lytic##2##3##(2008-10#1)(2008-11#1)
to the mRNA##3##3##(1996-12#2)(2011-2#1)
to the mRNAs##2##3##(1993-11#1)(2008-4#1)
to the magnitude of the##4##5##(1990-5#1)(2007-12#1)(2008-10#1)(2013-8#1)
to the magnitude of##9##4##(1990-11#1)(1990-5#1)(1990-8#1)(1993-12#1)(2007-12#1)(2008-10#2)(2010-5#1)(2013-8#1)
to the magnitude##10##3##(1990-11#1)(1990-5#1)(1990-8#1)(1993-12#1)(2007-12#1)(2008-10#2)(2010-5#1)(2012-12#1)(2013-8#1)
to the main##9##3##(1991-9#1)(1994-6#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)
to the maintenance of##8##4##(1995-12#1)(2008-10#1)(2008-5#2)(2009-6#2)(2012-2#1)(2013-8#1)
to the maintenance##10##3##(1990-9#1)(1995-12#1)(2008-10#1)(2008-5#2)(2009-6#2)(2011-1#1)(2012-2#1)(2013-8#1)
to the major##10##3##(1990-12#1)(1992-4#1)(1994-12#1)(1995-8#1)(1997-9#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
to the majority##2##3##(2008-10#1)(2013-8#1)
to the mammalian##5##3##(1994-5#1)(1997-3#1)(2008-4#1)(2010-12#1)(2010-3#1)
to the managed care##2##4##(1994-3#1)(1995-3#1)
to the management of this##2##5##(2008-8#1)(2013-1#1)
to the management of##26##4##(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
to the management##28##3##(1992-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
to the mannose##2##3##(1995-6#1)(2008-10#1)
to the manual##2##3##(2008-10#2)
to the many##5##3##(1993-3#1)(2007-7#1)(2008-7#1)(2008-9#1)(2010-7#1)
to the markers##3##3##(1997-5#2)(2010-11#1)
to the market##4##3##(1991-12#1)(1997-1#1)(2008-10#1)(2008-7#1)
to the marketplace##2##3##(1994-1#1)(2008-11#1)
to the mask##2##3##(2008-3#1)(2010-5#1)
to the mass of##2##4##(1990-8#1)(1996-3#1)
to the mass##5##3##(1990-8#1)(1992-6#1)(1996-3#1)(2008-6#1)(2009-5#1)
to the material##2##3##(2008-10#1)(2010-8#1)
to the mathematical##2##3##(2008-10#1)(2008-6#1)
to the matrix effect##2##4##(2008-10#2)
to the matrix##7##3##(2008-10#6)(2013-7#1)
to the mature##4##3##(1990-11#1)(1995-2#1)(1997-1#1)(2007-12#1)
to the maximal##2##3##(1994-11#1)(2008-6#1)
to the maximum of##2##4##(1996-5#1)(2008-10#1)
to the maximum##10##3##(1994-5#1)(1996-5#1)(2008-10#6)(2008-2#1)(2011-2#1)
to the mean##7##3##(2008-10#4)(2009-10#1)(2011-2#1)(2013-8#1)
to the measured##8##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)
to the measurement of##15##4##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#4)(2009-7#1)
to the measurement##19##3##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#6)(2009-7#1)(2010-3#1)(2012-3#1)
to the measurements##3##3##(2008-2#1)(2008-3#2)
to the mechanical##4##3##(2007-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
to the mechanism of##4##4##(1990-3#1)(1991-5#1)(2008-7#1)(2012-2#1)
to the mechanism##5##3##(1990-3#1)(1991-5#1)(1992-6#1)(2008-7#1)(2012-2#1)
to the media noise in##2##5##(2008-2#1)(2008-3#1)
to the media##6##3##(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#1)
to the medial##8##3##(1997-3#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2011-2#1)
to the median##4##3##(1997-5#1)(2008-10#1)(2008-5#2)
to the mediastinum##4##3##(2008-11#1)(2008-6#2)(2012-2#1)
to the medical care system##2##5##(1995-12#2)
to the medical staff##2##4##(1994-2#1)(2007-11#1)
to the medical##13##3##(1990-6#1)(1992-3#1)(1992-5#1)(1994-2#1)(1995-12#2)(2007-11#1)(2007-7#1)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
to the medication##4##3##(1995-2#1)(2008-11#2)(2012-12#1)
to the medium containing##2##4##(1997-8#1)(2008-5#1)
to the medium was##3##4##(1991-12#1)(1993-12#1)(1993-3#1)
to the medium with##2##4##(1993-12#1)(2008-7#1)
to the medium##21##3##(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#3)(1993-3#2)(1993-6#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
to the membrane and##3##4##(1992-3#1)(2008-2#1)(2008-7#1)
to the membrane fraction##2##4##(1993-8#1)(1995-11#1)
to the membrane of##2##4##(2008-8#1)(2009-2#1)
to the membrane plane##2##4##(1993-8#1)(2008-10#1)
to the membrane support##2##4##(1991-5#2)
to the membrane##22##3##(1990-5#1)(1990-7#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-8#5)(1995-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2013-8#1)
to the membranes##2##3##(1992-3#1)(2008-10#1)
to the meningococcal##2##3##(2010-10#2)
to the mental health##4##4##(2008-11#3)(2012-12#1)
to the mental##5##3##(2008-11#3)(2011-1#1)(2012-12#1)
to the mentioned##2##3##(2008-11#1)(2008-5#1)
to the metal cations##2##4##(2008-10#2)
to the metal##7##3##(2008-10#7)
to the metastatic##3##3##(1990-8#1)(1991-3#1)(2010-3#1)
to the method of##6##4##(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#2)
to the method##11##3##(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2013-1#1)
to the methodology##2##3##(2008-10#1)(2008-11#1)
to the methods of##2##4##(1994-3#1)(2012-12#1)
to the microchip##2##3##(2008-10#2)
to the microstructure##2##3##(2008-3#1)(2009-7#1)
to the middle cerebral artery (MCA)##2##6##(1996-5#1)(2008-7#1)
to the middle##7##3##(1991-4#1)(1995-5#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-7#1)
to the mild##2##3##(1993-12#1)(2008-10#1)
to the miniature##2##3##(2008-10#1)(2009-10#1)
to the minimal##2##3##(1997-7#1)(2009-4#1)
to the minimum##2##3##(1992-3#1)(2008-7#1)
to the missing##2##3##(1993-3#1)(2008-2#1)
to the mitochondria and##2##4##(2008-11#1)(2011-2#1)
to the mitochondria##5##3##(1994-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
to the mitochondrial##4##3##(1995-2#1)(1995-6#1)(1997-2#1)(2009-8#1)
to the mitogenic##2##3##(1991-1#1)(1992-9#1)
to the mixture of##2##4##(2008-10#1)(2008-6#1)
to the mixture##3##3##(1995-8#1)(2008-10#1)(2008-6#1)
to the mobile phase##3##4##(1995-6#1)(2008-10#2)
to the model##13##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-5#1)(2012-3#2)
to the modified##6##3##(1990-8#1)(1995-11#1)(2008-10#2)(2008-2#1)(2010-10#1)
to the modulation##2##3##(2008-3#1)(2010-2#1)
to the modulator##2##3##(2007-12#1)(2008-2#1)
to the moisture##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
to the molecular basis of##2##5##(1993-3#1)(2011-1#1)
to the molecular structure of##2##5##(2008-10#1)(2012-2#1)
to the molecular##9##3##(1992-2#1)(1993-3#1)(2008-10#3)(2011-1#1)(2012-2#3)
to the monitoring of##8##4##(1992-3#1)(2008-10#5)(2008-2#1)(2010-5#1)
to the monoclonal antibody##3##4##(1990-12#1)(1995-12#1)(2008-10#1)
to the monomer##2##3##(2008-10#1)(2008-11#1)
to the morbidity and mortality##2##5##(2007-7#2)
to the morbidity and##3##4##(1997-8#1)(2007-7#2)
to the more##16##3##(1990-5#1)(1994-3#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
to the morphological and##2##4##(1992-6#1)(2012-9#1)
to the morphological##5##3##(1992-6#1)(2008-10#1)(2008-6#1)(2009-8#1)(2012-9#1)
to the mortality##2##3##(2008-8#1)(2008-9#1)
to the most common##2##4##(2008-10#1)(2010-8#1)
to the most potent##2##4##(1995-5#1)(2013-1#1)
to the most recent data##2##5##(2008-4#1)(2011-3#1)
to the most recent##4##4##(2008-4#1)(2010-7#1)(2011-3#1)(2012-2#1)
to the most suitable##2##4##(1994-2#1)(1996-12#1)
to the most##30##3##(1992-12#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
to the mother##2##3##(2008-9#1)(2013-1#1)
to the motion##2##3##(2008-2#1)(2008-6#1)
to the mouse##5##3##(1991-8#1)(1994-5#1)(1997-9#1)(2008-4#1)(2012-3#1)
to the much##4##3##(1994-1#1)(2008-10#2)(2013-7#1)
to the mucosa##2##3##(2011-2#1)(2012-2#1)
to the multiple##2##3##(2008-7#1)(2011-1#1)
to the muscle##5##3##(1991-6#1)(1994-8#1)(2008-2#1)(2010-4#1)(2012-3#1)
to the mutant##3##3##(2008-10#1)(2008-8#2)
to the mutation##2##3##(1990-12#1)(2008-10#1)
to the mutual##2##3##(2007-12#1)(2008-10#1)
to the naked##2##3##(2007-12#1)(2008-8#1)
to the nasal##3##3##(1997-1#1)(2007-4#1)(2007-5#1)
to the national##5##3##(1995-12#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#1)
to the native##15##3##(1990-11#1)(1990-2#1)(1993-3#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-2#2)(1997-4#2)(2008-10#2)(2008-7#1)(2010-5#1)
to the natural product##2##4##(2009-5#2)
to the natural##7##3##(1994-11#1)(1996-3#1)(2008-2#2)(2009-5#2)(2012-3#1)
to the nature and extent of##2##6##(2011-1#1)(2012-2#1)
to the nature and##3##4##(1994-3#1)(2011-1#1)(2012-2#1)
to the nature of the##7##5##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
to the nature of##12##4##(1996-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
to the nature##15##3##(1994-3#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
to the near infrared##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
to the near##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
to the nearby##2##3##(1990-11#1)(1991-8#1)
to the nearest##7##3##(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
to the nebulizer##2##3##(2008-10#2)
to the necessity of##4##4##(1997-4#1)(2007-12#1)(2009-5#1)(2010-4#1)
to the neck##2##3##(1992-6#1)(2008-10#1)
to the need for a better##2##6##(1991-6#1)(2011-2#1)
to the need for a##4##5##(1991-6#1)(2008-12#1)(2008-2#1)(2011-2#1)
to the need for##17##4##(1991-3#1)(1991-6#1)(1994-2#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
to the need to##7##4##(1997-2#1)(2006-10#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-4#1)(2013-1#1)
to the need##26##3##(1991-3#1)(1991-6#1)(1994-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
to the needs and##2##4##(2007-8#1)(2008-7#1)
to the needs of the##5##5##(1995-1#1)(1996-3#1)(2009-12#1)(2009-6#1)(2013-8#1)
to the needs of##12##4##(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-8#1)(2009-12#1)(2009-6#1)(2013-8#1)
to the needs##15##3##(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2013-8#1)
to the negative element##2##4##(2008-11#2)
to the negative##12##3##(1990-6#1)(1992-6#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-4#1)(2009-12#1)(2009-8#1)
to the nematode##2##3##(2008-10#2)
to the nematodes##2##3##(2008-10#1)(2008-12#1)
to the nervous system##2##4##(1991-6#1)(2008-4#1)
to the nest of a##2##5##(2008-9#2)
to the network##2##3##(2008-11#1)(2008-3#1)
to the neural##3##3##(2007-12#2)(2011-2#1)
to the neurological##3##3##(2007-8#1)(2007-9#1)(2013-8#1)
to the neuronal##3##3##(1991-12#2)(1996-12#1)
to the neutral##2##3##(2008-10#1)(2008-4#1)
to the new##19##3##(1991-1#1)(1991-3#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-9#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-2#1)
to the newer##2##3##(1996-1#1)(2007-11#1)
to the newly##2##3##(1991-5#1)(1996-2#1)
to the next generation##3##4##(1997-8#1)(2008-8#1)(2010-10#1)
to the next level##2##4##(2009-4#1)(2013-8#1)
to the next stage##2##4##(1997-4#1)(2008-3#1)
to the next##22##3##(1990-5#1)(1993-6#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-10#1)(2012-2#1)(2013-8#1)
to the niche##3##3##(2008-1#1)(2009-3#2)
to the nitrite##2##3##(2008-10#2)
to the noise##2##3##(2008-3#1)(2009-8#1)
to the nonlinear##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
to the norm##2##3##(2008-11#2)
to the normal level##2##4##(2008-11#1)(2008-6#1)
to the normal##21##3##(1990-7#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-11#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-3#1)
to the normotensive state##2##4##(2013-8#2)
to the north##2##3##(2008-10#1)(2009-10#1)
to the nose and##2##4##(2007-4#1)(2010-5#1)
to the nose##3##3##(2007-4#2)(2010-5#1)
to the notion that##2##4##(2008-3#1)(2008-5#1)
to the novel##4##3##(2008-5#1)(2008-7#1)(2008-8#2)
to the nuclear envelope and##2##5##(2008-9#1)(2011-2#1)
to the nuclear envelope##3##4##(2008-9#1)(2011-2#2)
to the nuclear##5##3##(1995-6#1)(2008-7#1)(2008-9#1)(2011-2#2)
to the nucleolus##2##3##(1994-9#2)
to the nucleotide##4##3##(1990-12#1)(2008-10#2)(2013-8#1)
to the nucleus and##4##4##(1994-9#1)(1995-8#1)(2008-7#2)
to the nucleus by##2##4##(2008-1#1)(2008-10#1)
to the nucleus of##2##4##(1996-5#1)(2009-10#1)
to the nucleus##19##3##(1990-11#1)(1990-12#1)(1991-5#1)(1993-12#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-2#1)
to the number of maxima in the ACE strategy##2##9##(2008-9#2)
to the number of##41##4##(1990-5#1)(1990-8#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-8#2)(2011-2#2)
to the number##44##3##(1990-5#1)(1990-8#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-8#2)(2011-2#2)(2013-8#1)
to the numbers##2##3##(2012-2#1)(2013-1#1)
to the nursing home##2##4##(1992-1#1)(2010-10#1)
to the nursing##3##3##(1992-1#1)(2008-11#1)(2010-10#1)
to the nutritional##4##3##(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
to the observation of##2##4##(2008-10#1)(2011-1#1)
to the observation##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
to the observed data##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
to the observed##16##3##(1993-11#1)(1994-6#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-2#1)
to the observer##2##3##(2007-12#1)(2012-2#1)
to the obstruction##2##3##(2008-3#1)(2010-6#1)
to the obtained##2##3##(2011-2#2)
to the occipital##2##3##(1996-9#1)(2008-7#1)
to the occurrence of the##2##5##(2008-10#1)(2011-2#1)
to the occurrence of##12##4##(1996-7#1)(2008-10#4)(2008-2#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
to the odor of##2##4##(1994-8#1)(2009-8#1)
to the official##3##3##(1991-9#1)(2008-10#2)
to the old##2##3##(2008-8#1)(2012-3#1)
to the on-axis##2##3##(2007-11#1)(2008-2#1)
to the oncologist##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
to the one used##2##4##(1992-1#1)(2010-2#1)
to the one##9##3##(1992-1#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-2#1)(2010-7#1)
to the ones##4##3##(1994-6#1)(2008-11#2)(2008-4#1)
to the ongoing##4##3##(2007-7#1)(2008-1#1)(2009-10#1)(2012-6#1)
to the onset and progression of##2##6##(1993-9#1)(2011-2#1)
to the onset of##13##4##(1991-1#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#1)(2012-2#1)
to the onset##15##3##(1991-1#1)(1993-9#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
to the oocyte##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
to the open##2##3##(1991-5#1)(2012-12#1)
to the operating room##2##4##(2010-12#1)(2012-3#1)
to the operating##4##3##(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
to the operation of the##2##5##(1995-12#1)(2007-12#1)
to the operation of##3##4##(1995-12#1)(2007-12#1)(2008-3#1)
to the operation##5##3##(1995-12#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)
to the operative##3##3##(1996-1#1)(1997-8#1)(2008-10#1)
to the opinion##3##3##(1995-5#1)(1995-6#1)(1997-3#1)
to the opposite##5##3##(1990-8#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-2#1)
to the optical axis of the##2##6##(2008-3#2)
to the optical axis##4##4##(2008-2#1)(2008-3#3)
to the optical##23##3##(1990-8#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#11)(2008-9#1)(2010-1#1)(2012-2#1)
to the optically pure##2##4##(1995-3#2)
to the optimal##4##3##(2007-12#1)(2008-3#1)(2012-12#1)(2012-2#1)
to the optimization of the##2##5##(2008-10#1)(2008-3#1)
to the optimization of##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
to the optimization##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)
to the optimum##6##3##(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
to the oral##5##3##(1990-12#1)(1994-11#1)(2007-12#2)(2012-2#1)
to the orbital##2##3##(2006-12#1)(2009-2#1)
to the order##6##3##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
to the ordinary##3##3##(1991-6#1)(2008-6#1)(2008-7#1)
to the organic##5##3##(2008-10#4)(2008-5#1)
to the organism##4##3##(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
to the organization of##3##4##(1993-9#1)(1994-2#1)(2009-7#1)
to the organization##9##3##(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-2#1)(2009-7#1)(2011-1#2)
to the orientation of the##3##5##(1992-6#1)(2007-11#1)(2007-12#1)
to the origin of the##3##5##(1993-3#1)(2007-12#1)(2007-7#1)
to the origin of##4##4##(1993-3#1)(1994-12#1)(2007-12#1)(2007-7#1)
to the original location##2##4##(2008-10#1)(2009-4#1)
to the original##26##3##(1990-2#2)(1990-9#1)(1991-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2013-1#2)
to the orthopedic##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
to the orthorhombic##3##3##(1992-12#1)(1992-8#1)(2013-8#1)
to the other drugs##2##4##(2008-10#1)(2008-8#1)
to the other in##2##4##(2008-10#1)(2008-3#1)
to the other three##4##4##(2008-10#2)(2008-7#1)(2009-11#1)
to the other two##7##4##(1993-2#1)(1996-12#1)(2006-12#1)(2007-10#1)(2008-10#2)(2010-2#1)
to the other##66##3##(1990-12#2)(1990-8#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-2#1)(1996-12#2)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-2#2)(2010-3#1)(2012-2#1)
to the others##3##3##(2008-10#2)(2008-7#1)
to the outcome of##4##4##(1997-4#1)(2008-10#1)(2011-2#1)(2013-8#1)
to the outcome##6##3##(1997-4#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
to the outcomes##3##3##(2007-12#1)(2008-4#2)
to the outer nuclear membrane##2##5##(2008-9#2)
to the outer surface##2##4##(1994-5#1)(2008-7#1)
to the outer##9##3##(1990-11#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)
to the outpatient setting##2##4##(1993-12#2)
to the outpatient##6##3##(1993-12#2)(1995-12#1)(2006-10#1)(2008-1#1)(2011-2#1)
to the output##3##3##(1997-7#1)(2008-3#2)
to the outside of the##2##5##(2008-10#1)(2008-8#1)
to the outside##6##3##(2007-12#2)(2008-10#2)(2008-12#1)(2008-8#1)
to the ovary##5##3##(1996-2#1)(1997-3#1)(2008-1#1)(2008-12#1)(2013-8#1)
to the overall##31##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#1)(1994-12#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
to the overlying##2##3##(2008-10#1)(2009-1#1)
to the oxidation of##2##4##(2008-10#2)
to the oxidative##5##3##(1995-6#1)(1997-8#1)(2007-11#1)(2009-8#1)(2011-1#1)
to the oxidized##2##3##(1994-5#1)(2008-11#1)
to the oxygen##3##3##(2007-11#1)(2008-10#1)(2009-12#1)
to the p##2##3##(2008-3#1)(2010-3#1)
to the paediatric##4##3##(1996-9#1)(2008-11#1)(2010-7#1)(2013-1#1)
to the pancreas##2##3##(2008-1#1)(2013-1#1)
to the pancreatic##2##3##(1994-12#1)(2008-11#1)
to the parameter##2##3##(2008-10#1)(2008-6#1)
to the parameters of##2##4##(2008-2#1)(2008-3#1)
to the parameters##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
to the parasite##2##3##(2008-10#1)(2011-2#1)
to the paraxial##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to the parent##6##3##(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
to the parental##4##3##(1991-12#1)(1993-3#1)(2008-10#1)(2011-1#1)
to the particle##2##3##(2008-3#2)
to the particular##7##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)
to the particulate##3##3##(1992-11#1)(1995-3#1)(1996-12#1)
to the passive##2##3##(1995-8#1)(2007-11#1)
to the patellar##2##3##(1995-8#1)(2008-9#1)
to the pathogen##12##3##(2008-10#10)(2008-8#1)(2012-3#1)
to the pathogenesis of##10##4##(2007-12#1)(2008-1#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#2)
to the pathogenesis##12##3##(1997-3#1)(2007-12#1)(2008-1#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
to the pathogenetic##2##3##(1997-8#1)(2008-3#1)
to the pathogenic##2##3##(1996-2#1)(2010-6#1)
to the pathological##2##3##(2008-1#1)(2008-6#1)
to the pathology##2##3##(1992-12#1)(2008-4#1)
to the pathophysiology of##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
to the pathophysiology##5##3##(1992-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
to the patient and##8##4##(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
to the patient population##2##4##(1992-3#1)(2010-11#1)
to the patient with##4##4##(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
to the patient##49##3##(1990-10#1)(1990-2#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
to the patient's##20##3##(1990-5#1)(1991-2#1)(1992-12#1)(1994-5#1)(1994-6#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the patients and##2##4##(1993-2#1)(2007-11#1)
to the patients in##2##4##(2007-11#1)(2009-12#1)
to the patients who##2##4##(1992-3#1)(2008-10#1)
to the patients with##5##4##(1995-8#1)(1997-3#1)(2007-7#1)(2008-10#2)
to the patients##20##3##(1990-2#1)(1992-3#1)(1993-2#1)(1994-5#1)(1995-8#1)(1997-3#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-3#1)(2010-8#2)(2011-1#1)
to the patients'##5##3##(1990-2#1)(1996-3#1)(2008-1#1)(2010-8#1)(2013-1#1)
to the pattern of##2##4##(2008-9#1)(2009-10#1)
to the pattern##5##3##(1996-6#1)(2007-12#1)(2007-5#1)(2008-9#1)(2009-10#1)
to the peak of##3##4##(1994-5#1)(2008-2#1)(2008-6#1)
to the peak##6##3##(1994-5#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)
to the pelvis##3##3##(1991-2#1)(2008-8#2)
to the penetration##2##3##(2007-12#1)(2008-10#1)
to the people##2##3##(1991-1#1)(2012-12#1)
to the peptide##9##3##(1990-8#2)(1992-5#1)(1995-2#1)(1996-5#1)(2008-4#3)(2010-11#1)
to the perception of##3##4##(2007-8#1)(2013-8#2)
to the perception##4##3##(2007-8#1)(2008-4#1)(2013-8#2)
to the performance of##5##4##(1990-11#1)(1992-10#1)(2008-10#1)(2008-6#1)(2013-1#1)
to the period of the##2##5##(2007-11#1)(2008-3#1)
to the period##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
to the periodic##2##3##(1993-6#1)(2007-12#1)
to the perioperative##2##3##(2008-8#2)
to the peripheral parts of the##2##6##(1994-12#1)(1996-3#1)
to the peripheral##6##3##(1994-12#1)(1996-3#1)(2008-3#1)(2012-3#1)(2013-1#2)
to the periphery of the##3##5##(1997-8#1)(2007-12#1)(2008-7#1)
to the periphery of##5##4##(1990-8#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-8#1)
to the periphery##6##3##(1990-8#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-2#1)
to the peritoneal cavity##3##4##(1990-2#1)(2007-12#2)
to the persistence of the##3##5##(2008-5#1)(2010-6#1)(2013-8#1)
to the persistence of##5##4##(2008-5#1)(2008-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
to the persistence##6##3##(2008-5#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
to the persistent##2##3##(2008-11#2)
to the pesticide##2##3##(2008-10#1)(2008-7#1)
to the phage##4##3##(1994-12#1)(2008-10#1)(2009-5#1)(2012-2#1)
to the pharmaceutical business##2##4##(2008-10#2)
to the pharmaceutical##5##3##(2008-10#3)(2011-2#1)(2012-2#1)
to the pharmacokinetics study##2##4##(2011-2#2)
to the phase##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
to the phenomenon##4##3##(2007-11#1)(2008-10#1)(2009-10#1)(2012-2#1)
to the phenotype##2##3##(2008-12#1)(2011-1#1)
to the pheromone##2##3##(2008-6#2)
to the photoaging process##2##4##(2008-5#2)
to the physical and chemical##2##5##(2011-1#1)(2011-2#1)
to the physical and##4##4##(2008-3#1)(2011-1#1)(2011-2#2)
to the physical##7##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#2)(2011-2#2)
to the physician##8##3##(1991-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1997-4#1)(2010-3#1)(2010-6#1)(2011-1#1)
to the physiological##3##3##(1990-11#1)(1997-2#1)(2010-10#1)
to the pig##2##3##(1990-9#1)(2011-1#1)
to the pineal##2##3##(1994-5#1)(1995-3#1)
to the pituitary gland##2##4##(1993-9#1)(2012-3#1)
to the pituitary##4##3##(1993-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
to the place of##2##4##(2008-12#1)(2012-12#1)
to the placebo##3##3##(2008-5#3)
to the placement##2##3##(2008-11#1)(2008-12#1)
to the plane of the bilayer##2##6##(1991-5#1)(1994-12#1)
to the plane of the##5##5##(1991-5#1)(1994-12#1)(1995-5#1)(2008-2#1)(2008-3#1)
to the plane of##10##4##(1991-5#1)(1994-12#1)(1995-5#1)(2008-2#1)(2008-3#6)
to the plane##11##3##(1991-5#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#6)
to the planned##2##3##(1992-9#2)
to the plant##7##3##(1992-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-10#1)
to the plants##3##3##(2008-10#2)(2011-2#1)
to the plasma membrane and##2##5##(1994-11#1)(1995-6#1)
to the plasma membrane by##5##5##(1992-3#1)(1995-6#1)(2008-4#1)(2010-11#2)
to the plasma membrane through##2##5##(1996-3#1)(2009-7#1)
to the plasma membrane##18##4##(1990-12#1)(1990-7#1)(1992-3#1)(1994-11#2)(1994-8#1)(1995-6#2)(1996-3#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#2)
to the plasma##24##3##(1990-12#1)(1990-7#1)(1992-3#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-6#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#2)
to the point of##6##4##(1991-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-8#1)
to the point where##2##4##(1992-3#1)(1995-8#1)
to the point##11##3##(1991-3#1)(1992-3#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-8#1)(2013-1#1)
to the polar##2##3##(1990-2#1)(1991-5#1)
to the polarization##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
to the polymer matrix##2##4##(2008-10#1)(2008-3#1)
to the polymerization##3##3##(1990-7#1)(2008-3#1)(2010-10#1)
to the poor##4##3##(1994-7#1)(1996-1#1)(2008-10#2)
to the population in##2##4##(2011-1#1)(2011-2#1)
to the population##8##3##(1992-2#1)(1992-6#1)(1993-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
to the porphyrin core##2##4##(2008-10#1)(2010-6#1)
to the porphyrin##3##3##(2008-10#2)(2010-6#1)
to the portion of the##2##5##(1997-9#1)(2009-1#1)
to the portion of##3##4##(1997-9#2)(2009-1#1)
to the position of the##2##5##(2008-3#2)
to the position of##3##4##(2008-3#3)
to the position##4##3##(2008-3#3)(2009-10#1)
to the positions and##2##4##(1997-2#1)(2008-3#1)
to the positive##5##3##(1990-9#1)(1992-6#1)(1997-7#1)(2008-11#1)(2009-12#1)
to the possibility of##8##4##(1993-12#1)(1996-12#1)(2007-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2012-3#1)
to the possibility that##7##4##(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-2#1)
to the possibility##16##3##(1993-12#1)(1996-12#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-2#1)(2012-3#1)
to the possible complications##2##4##(1993-9#1)(2008-7#1)
to the possible role of##2##5##(2008-10#1)(2008-4#1)
to the possible##9##3##(1990-2#1)(1993-9#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
to the possibly##2##3##(1994-12#1)(2008-3#1)
to the posterior##5##3##(2007-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
to the potent##2##3##(2008-10#1)(2008-5#1)
to the potential for##2##4##(2008-3#1)(2012-3#1)
to the potential of##3##4##(2008-10#2)(2012-12#1)
to the potential##14##3##(1992-6#1)(1995-12#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-3#1)(2012-12#1)(2012-3#1)
to the potting##2##3##(2008-10#2)
to the power##4##3##(2008-10#2)(2009-10#1)(2011-2#1)
to the practical##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
to the practice of##6##4##(1992-1#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-1#1)(2012-3#1)
to the practicing##3##3##(1996-3#1)(2011-2#1)(2013-1#1)
to the preceding##2##3##(2008-10#1)(2008-7#1)
to the precipitation##2##3##(2008-10#1)(2012-2#1)
to the precise##2##3##(1994-1#1)(2008-11#1)
to the precision of##2##4##(2008-10#1)(2008-7#1)
to the preconcentration of##4##4##(2008-10#4)
to the preconcentration##7##3##(2008-10#7)
to the predicted##5##3##(1992-12#1)(1992-3#1)(1996-4#1)(2008-10#1)(2009-8#1)
to the prediction of##2##4##(2008-2#1)(2009-7#1)
to the prediction##3##3##(1995-3#1)(2008-2#1)(2009-7#1)
to the predictions of##3##4##(1995-3#1)(2008-2#1)(2008-8#1)
to the predominance of##3##4##(1992-6#1)(2008-1#1)(2008-6#1)
to the prefrontal##2##3##(2011-2#1)(2012-1#1)
to the preparation of##6##4##(1996-5#2)(2008-10#1)(2008-2#1)(2010-12#1)(2012-2#1)
to the preparation##7##3##(1996-5#2)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-2#1)
to the prescribing##2##3##(1993-12#1)(2008-11#1)
to the presence of a##6##5##(1993-8#1)(1997-6#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
to the presence of an##5##5##(1990-12#1)(1997-3#1)(2008-10#1)(2009-9#1)(2010-10#1)
to the presence of endogenous##2##5##(1996-12#1)(2010-11#1)
to the presence of other##2##5##(2008-10#2)
to the presence of the##5##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
to the presence of##79##4##(1990-12#3)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-8#2)(1995-12#1)(1995-4#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
to the presence##82##3##(1990-12#3)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-8#2)(1995-12#1)(1995-4#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
to the present day##4##4##(2007-5#1)(2008-10#1)(2008-4#1)(2012-3#1)
to the present time##3##4##(1994-2#1)(1997-8#1)(2008-12#1)
to the present##21##3##(1990-5#1)(1990-6#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
to the preservation of##2##4##(2008-10#1)(2011-2#1)
to the preservation##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
to the presumed##2##3##(1994-8#1)(2008-10#1)
to the prevailing##4##3##(1992-3#2)(1996-9#1)(2011-9#1)
to the prevalence of##7##4##(1996-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2011-1#2)(2013-8#1)
to the prevalence##9##3##(1996-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
to the prevention of##6##4##(1991-1#1)(1991-2#1)(1991-5#1)(2008-7#1)(2009-10#1)(2009-4#1)
to the prevention##7##3##(1991-1#1)(1991-2#1)(1991-5#2)(2008-7#1)(2009-10#1)(2009-4#1)
to the previous##7##3##(1997-7#1)(2008-11#1)(2008-5#3)(2008-6#1)(2012-12#1)
to the previously characterized##2##4##(1990-5#1)(1997-4#1)
to the previously described##4##4##(2008-10#4)
to the previously identified##4##4##(1996-12#1)(1996-3#1)(2008-10#1)(2009-4#1)
to the previously reported##4##4##(1992-10#1)(1993-12#1)(2008-10#1)(2011-2#1)
to the previously##20##3##(1990-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-10#8)(2009-4#1)(2011-2#1)
to the primary tumor##2##4##(1991-4#1)(2008-6#1)
to the primary tumour##2##4##(1997-3#1)(2011-2#1)
to the primary##19##3##(1990-4#1)(1991-4#1)(1992-6#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#2)
to the principal##4##3##(2008-2#1)(2008-3#3)
to the principles of##3##4##(1992-6#1)(1994-2#1)(2008-9#1)
to the private##2##3##(2008-10#1)(2012-2#1)
to the probability of##3##4##(2008-3#1)(2008-4#1)(2009-10#1)
to the probability that##2##4##(2008-8#1)(2008-9#1)
to the probability##6##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)
to the probable##2##3##(1991-11#1)(2010-5#1)
to the probe##5##3##(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)
to the probing##2##3##(2007-11#1)(2008-2#1)
to the problem of##13##4##(1991-6#2)(1991-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2009-11#1)(2010-1#1)
to the problem##25##3##(1991-6#2)(1991-9#1)(1994-9#1)(1995-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#3)(2008-9#1)(2009-11#1)(2010-1#1)
to the problems##5##3##(1990-11#1)(1991-3#1)(2008-12#1)(2008-6#1)(2011-2#1)
to the procedure##5##3##(2007-8#2)(2008-7#1)(2012-2#1)(2013-1#1)
to the process of##6##4##(1993-12#1)(1994-11#1)(1995-12#1)(1996-2#1)(2008-11#2)
to the process##17##3##(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
to the processes##3##3##(2008-10#2)(2010-5#1)
to the processing of##6##4##(1990-12#1)(1992-12#1)(1993-6#1)(2008-1#1)(2008-3#1)(2009-8#1)
to the processing##7##3##(1990-12#1)(1992-12#1)(1993-6#1)(1994-11#1)(2008-1#1)(2008-3#1)(2009-8#1)
to the procurement of vascular stents in interventional radiology##2##9##(2012-2#2)
to the producer##2##3##(1992-2#1)(2008-10#1)
to the product of##3##4##(1996-8#1)(2008-3#2)
to the product##4##3##(1994-8#1)(1996-8#1)(2008-3#2)
to the production of an##2##5##(1991-6#1)(2007-11#1)
to the production of the##4##5##(2008-10#3)(2009-2#1)
to the production of##17##4##(1990-7#1)(1991-6#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2013-8#1)
to the production##19##3##(1990-7#1)(1991-6#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2012-3#1)(2013-8#1)
to the profession##2##3##(1992-12#1)(2008-12#1)
to the profiles of the##2##5##(2008-2#1)(2008-7#1)
to the program in##2##4##(1992-3#1)(1995-1#1)
to the program##3##3##(1992-3#1)(1995-1#1)(2007-8#1)
to the progress of##4##4##(1996-4#1)(2009-7#1)(2010-8#1)(2012-2#1)
to the progress##5##3##(1996-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
to the progression of##6##4##(1993-12#1)(1994-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)
to the project##2##3##(2008-11#1)(2008-7#1)
to the proliferation of##2##4##(2008-8#1)(2008-9#1)
to the proliferation##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
to the promoter region of##3##5##(1991-6#1)(1992-11#1)(1992-12#1)
to the promoter##6##3##(1990-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1997-4#1)
to the propagation of##2##4##(2007-11#1)(2008-3#1)
to the propagation##3##3##(2007-11#1)(2008-3#2)
to the proper##2##3##(1996-12#1)(2009-8#1)
to the properties of a##2##5##(2008-11#1)(2008-2#1)
to the properties of the##5##5##(1991-12#1)(1992-3#1)(2008-2#1)(2008-5#1)(2009-5#1)
to the properties of##8##4##(1991-12#1)(1992-3#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-5#1)
to the proportion of##4##4##(2008-7#2)(2008-8#1)(2009-7#1)
to the proposed##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
to the prostate##2##3##(1990-9#1)(1993-8#1)
to the protease##3##3##(1992-11#1)(1992-6#1)(1993-8#1)
to the protection of##2##4##(2008-10#2)
to the protective##5##3##(1991-1#1)(1995-5#1)(1996-2#1)(2007-12#1)(2012-2#1)
to the protein therapeutic##2##4##(2008-10#1)(2008-11#1)
to the protein##18##3##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-6#1)(2009-8#1)(2012-2#1)
to the proteins##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
to the protocol##2##3##(2010-3#1)(2011-2#1)
to the protonation of##2##4##(1991-8#1)(2008-10#1)
to the provincial##2##3##(1991-1#1)(1997-5#1)
to the provision of health care##2##6##(1992-3#1)(1996-3#1)
to the provision of##4##4##(1992-3#1)(1996-3#1)(2008-1#1)(2012-2#1)
to the proximal##7##3##(1993-2#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-9#1)
to the psoas muscle##2##4##(2008-10#1)(2009-2#1)
to the psychological##3##3##(1994-12#1)(1994-9#1)(1996-1#1)
to the public##13##3##(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-3#1)
to the public's##2##3##(1995-12#1)(2010-7#1)
to the published##3##3##(1990-7#1)(2008-3#1)(2008-9#1)
to the pulmonary##3##3##(1992-3#1)(1997-1#1)(2011-2#1)
to the pulse width##3##4##(2008-3#3)
to the pulse##4##3##(2007-12#1)(2008-3#3)
to the pump##4##3##(2007-11#2)(2008-10#1)(2008-2#1)
to the pure##2##3##(1992-5#1)(2008-10#1)
to the pursuit of##2##4##(2008-7#1)(2009-5#1)
to the putative##8##3##(1990-11#1)(1991-9#1)(1993-2#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
to the pyrimidine##2##3##(1992-8#1)(1996-5#1)
to the quadratic##2##3##(2008-10#1)(2008-3#1)
to the quadrature##2##3##(2008-2#1)(2008-3#1)
to the qualitative##2##3##(2007-11#1)(2013-7#1)
to the quality assurance##3##4##(2008-10#2)(2008-11#1)
to the quality control of##2##5##(2008-10#2)
to the quality of the##2##5##(1995-11#1)(2008-3#1)
to the quality of##5##4##(1995-11#1)(1996-2#2)(2008-3#1)(2009-11#1)
to the quality##10##3##(1995-11#1)(1996-2#2)(2008-10#4)(2008-11#1)(2008-3#1)(2009-11#1)
to the quantitation##3##3##(2008-10#3)
to the quantitative##3##3##(2008-10#2)(2009-10#1)
to the quantity of##2##4##(1997-2#1)(2008-10#1)
to the quartz##3##3##(2008-10#2)(2013-8#1)
to the question of the##2##5##(1996-3#1)(2008-9#1)
to the question of##8##4##(1993-2#1)(1996-3#1)(2007-2#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#1)
to the question##9##3##(1993-2#1)(1995-3#1)(1996-3#1)(2007-2#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#1)
to the questions##3##3##(2008-3#1)(2010-4#1)(2013-8#1)
to the radiation##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-10#1)
to the radiative##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to the radiology##2##3##(1995-2#1)(1996-3#1)
to the random##4##3##(1990-7#1)(1996-6#1)(2007-12#1)(2008-10#1)
to the range of##5##4##(1993-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
to the range##6##3##(1991-5#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
to the rank of species##4##5##(2008-10#4)
to the rank##5##3##(2008-10#5)
to the rapid##14##3##(1993-9#1)(1995-6#1)(1996-2#1)(2007-6#1)(2008-10#6)(2008-8#2)(2009-3#1)(2009-4#1)
to the rarity of this##3##5##(2010-12#1)(2010-5#1)(2011-2#1)
to the rarity of##6##4##(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
to the rat and##2##4##(1993-12#1)(1994-11#1)
to the rat##7##3##(1993-12#2)(1994-11#2)(1994-3#1)(1995-12#1)(1995-3#1)
to the rate of##4##4##(1990-12#1)(1991-12#1)(2008-10#1)(2008-8#1)
to the rates of##2##4##(1992-12#1)(1994-11#1)
to the rates##3##3##(1992-12#2)(1994-11#1)
to the rather##2##3##(1991-5#1)(2008-11#1)
to the ratio of##2##4##(2008-10#2)
to the ratio##3##3##(2008-10#2)(2008-5#1)
to the rats in the##2##5##(2011-2#2)
to the rats##3##3##(2011-2#2)(2012-2#1)
to the reaction medium##2##4##(2008-10#1)(2008-7#1)
to the reaction##10##3##(1990-7#1)(1992-2#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-12#1)
to the reactive##5##3##(1995-6#1)(2008-10#1)(2012-2#2)(2013-1#1)
to the reactor##2##3##(2008-11#1)(2009-2#1)
to the reagent##2##3##(2008-10#2)
to the reagents##2##3##(2008-10#2)
to the real##8##3##(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2013-1#1)
to the realization of##4##4##(2007-11#1)(2008-11#1)(2008-7#1)(2009-11#1)
to the realization##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
to the receiver##3##3##(2008-10#1)(2008-2#2)
to the receiving phase##2##4##(2008-10#2)
to the recent##7##3##(1990-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-7#1)
to the recently described##3##4##(1992-8#1)(2012-2#1)(2013-7#1)
to the recently reported##2##4##(1993-12#1)(2008-10#1)
to the recently##10##3##(1992-8#1)(1993-12#1)(1993-9#1)(2008-10#3)(2008-6#1)(2010-9#1)(2012-2#1)(2013-7#1)
to the receptor##12##3##(1990-5#3)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(2008-3#1)(2013-8#1)
to the recipient##2##3##(2011-2#1)(2013-8#1)
to the recognition of##5##4##(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
to the recognition##6##3##(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)
to the recombinant##2##3##(1994-6#1)(1995-5#1)
to the recommendations of the##3##5##(2008-1#1)(2009-11#1)(2012-3#1)
to the recording and##2##4##(1993-12#1)(2008-2#1)
to the recording of##2##4##(2007-11#2)
to the recording##4##3##(1993-12#1)(2007-11#2)(2008-2#1)
to the recovery of##3##4##(2008-10#3)
to the recovery##7##3##(2008-10#6)(2012-12#1)
to the recruitment##3##3##(1996-2#1)(2008-5#1)(2012-2#1)
to the rectum##4##3##(1993-9#1)(2007-12#1)(2008-7#1)(2011-2#1)
to the redox##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
to the reduced##3##3##(1990-12#1)(2008-10#1)(2012-2#1)
to the reduction in##4##4##(1992-9#1)(2007-11#2)(2008-10#1)
to the reduction of the##5##5##(1995-12#1)(2008-10#4)
to the reduction of##20##4##(1990-5#1)(1995-12#1)(2008-10#11)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#3)
to the reduction##24##3##(1990-5#1)(1992-9#1)(1995-12#1)(2007-11#2)(2008-10#12)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#3)
to the reference method##3##4##(2008-10#3)
to the reference spectrophotometer##2##4##(2008-3#2)
to the reference##16##3##(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
to the reflecting##2##3##(2008-3#1)(2009-8#1)
to the refractive index##3##4##(2008-3#3)
to the region of the##3##5##(1992-12#1)(1993-11#1)(1994-8#1)
to the region of##5##4##(1992-12#1)(1993-11#1)(1994-8#1)(2008-5#1)(2008-6#1)
to the region##9##3##(1992-12#1)(1993-11#2)(1994-8#2)(1996-6#1)(2008-5#1)(2008-6#1)(2013-1#1)
to the regional##2##3##(2008-6#1)(2012-12#1)
to the regular##4##3##(1997-6#2)(2007-12#1)(2008-10#1)
to the regulated secretory pathway##2##5##(1990-5#1)(1994-11#1)
to the regulated##5##3##(1990-5#2)(1994-11#1)(1995-2#1)(2008-4#1)
to the regulation of the##2##5##(1995-5#1)(2011-2#1)
to the regulation of##9##4##(1990-2#1)(1995-5#1)(2008-4#1)(2008-5#1)(2010-8#1)(2010-9#1)(2011-2#3)
to the regulation##12##3##(1990-2#1)(1994-11#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)(2010-9#1)(2011-2#3)
to the regulatory##2##3##(2008-11#1)(2013-8#1)
to the rehabilitation##3##3##(1995-5#1)(2007-8#2)
to the relationship between##5##4##(1992-3#1)(1995-2#1)(2007-11#1)(2008-3#1)(2008-8#1)
to the relationship##8##3##(1992-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)
to the relationships##2##3##(2008-11#1)(2011-2#1)
to the relative##14##3##(1990-7#1)(1992-3#1)(1996-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)
to the relatively high##3##4##(1990-12#1)(1994-12#1)(2008-3#1)
to the relatively##7##3##(1990-12#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#2)
to the release of##7##4##(1990-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)
to the release##9##3##(1990-2#1)(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)
to the relevant##5##3##(1995-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2013-8#1)
to the remaining eye##2##4##(1992-10#2)
to the remaining##8##3##(1992-10#2)(1996-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2013-1#1)(2013-8#1)
to the remission##2##3##(1991-2#1)(2008-5#1)
to the renal##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
to the replacement of##2##4##(1990-5#1)(1993-8#1)
to the replication of##2##4##(2008-10#1)(2010-2#1)
to the reported##2##3##(2012-3#1)(2013-8#1)
to the repression of##2##4##(1995-12#1)(2008-10#1)
to the required##3##3##(2008-3#1)(2008-8#1)(2012-12#1)
to the requirements of the##2##5##(2008-4#1)(2013-1#1)
to the requirements of##5##4##(1991-3#1)(2008-2#1)(2008-4#1)(2013-1#2)
to the requirements##6##3##(1991-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#2)
to the rescue##2##3##(1992-3#1)(1995-2#1)
to the research##7##3##(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
to the reservoir##3##3##(1996-2#1)(2008-10#2)
to the residual##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
to the resilience of##2##4##(2009-7#2)
to the resistance gene##2##4##(2008-10#2)
to the resistance of##2##4##(2008-10#1)(2008-5#1)
to the resistance##6##3##(2008-10#5)(2008-5#1)
to the resistant##2##3##(2008-10#2)
to the resolution of##5##4##(2008-10#2)(2008-3#2)(2008-8#1)
to the resolution##6##3##(2008-10#2)(2008-3#3)(2008-8#1)
to the resonance##2##3##(2008-10#1)(2008-2#1)
to the resonant##2##3##(2007-11#1)(2008-3#1)
to the respective##6##3##(2008-10#2)(2008-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
to the respiratory tract##3##4##(1994-12#1)(1996-1#1)(1996-3#1)
to the respiratory##7##3##(1994-11#1)(1994-12#1)(1996-1#1)(1996-3#2)(2010-12#1)(2012-12#1)
to the response##4##3##(1992-6#1)(1994-2#1)(2008-10#2)
to the responses##2##3##(2008-7#1)(2012-12#1)
to the rest of the body##2##6##(1992-3#1)(2013-1#1)
to the rest of the##7##5##(1992-10#1)(1992-3#1)(1993-5#1)(1994-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
to the rest of##10##4##(1992-10#1)(1992-3#1)(1993-5#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-3#1)(2011-2#2)(2013-1#1)
to the rest##11##3##(1992-10#1)(1992-3#1)(1993-5#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
to the resulting##5##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2013-8#1)
to the results from##2##4##(2006-10#1)(2012-3#1)
to the results obtained##2##4##(2008-10#1)(2008-11#1)
to the results of the##5##5##(1995-6#1)(1996-6#1)(2007-11#1)(2008-2#1)(2012-2#1)
to the results of##13##4##(1990-6#1)(1992-11#1)(1994-2#1)(1995-6#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2010-2#1)(2012-2#1)
to the results##36##3##(1990-6#2)(1990-9#1)(1992-11#1)(1993-11#1)(1994-2#1)(1995-6#1)(1996-6#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to the retina##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
to the retrieval##2##3##(2008-3#1)(2010-8#1)
to the reverse##2##3##(1994-12#1)(1997-6#1)
to the rhythm of##2##4##(2012-2#2)
to the right adrenal gland##2##5##(2008-5#2)
to the right and##2##4##(1995-12#1)(2008-3#1)
to the right arm of chromosome##3##6##(1995-6#3)
to the right in##2##4##(1995-12#1)(1995-3#1)
to the right side##2##4##(2007-8#1)(2011-2#1)
to the right##44##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-11#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#3)(1996-2#1)(1996-5#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2009-10#1)(2009-12#1)(2009-2#2)(2011-1#1)(2011-2#1)(2013-1#3)
to the rise in##2##4##(2008-11#2)
to the rise##3##3##(2008-11#3)
to the rising##2##3##(2007-12#1)(2008-3#1)
to the risk group##2##4##(2011-2#2)
to the risk of##10##4##(1991-4#1)(1994-3#1)(1995-11#1)(1996-6#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#2)(2013-1#1)
to the risk##19##3##(1991-4#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#1)
to the robustness of##2##4##(1997-3#1)(2008-10#1)
to the rock##2##3##(1996-4#1)(2008-10#1)
to the role of##14##4##(1993-8#1)(1994-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)
to the role played by##2##5##(2008-1#1)(2008-10#1)
to the role##16##3##(1993-8#1)(1994-2#1)(1997-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)
to the root##4##3##(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)
to the roots of##2##4##(1991-1#1)(2008-10#1)
to the roots##5##3##(1991-1#1)(2008-10#3)(2011-2#1)
to the routine##5##3##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
to the rural##3##3##(1991-1#1)(2008-3#1)(2012-12#1)
to the sacrum##2##3##(2008-8#1)(2013-8#1)
to the sagittal sinus##2##4##(2013-8#2)
to the saline##2##3##(1995-12#1)(2013-1#1)
to the salivary glands##2##4##(2008-10#2)
to the salivary##3##3##(2008-10#2)(2009-1#1)
to the same DNA##2##4##(1991-10#1)(1994-12#1)
to the same degree##3##4##(1993-6#1)(1995-5#1)(2008-10#1)
to the same extent as##8##5##(1992-11#2)(1993-6#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-8#1)
to the same extent in##4##5##(1996-5#1)(2008-10#2)(2008-2#1)
to the same extent##17##4##(1991-5#1)(1991-8#1)(1992-11#2)(1993-6#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
to the same gene##2##4##(1995-8#1)(2008-10#1)
to the same hospital##2##4##(1991-2#1)(1991-3#1)
to the same protein##2##4##(1997-6#1)(2011-1#1)
to the same region of the##2##6##(1990-12#1)(1994-8#1)
to the same region##6##4##(1990-12#1)(1993-8#2)(1994-11#1)(1994-8#1)(2008-10#1)
to the same selective##2##4##(2008-8#2)
to the same species##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
to the same vision##2##4##(1996-1#2)
to the same##105##3##(1990-12#2)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#4)(1991-8#1)(1992-11#4)(1992-2#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#4)(1995-5#2)(1995-8#3)(1996-1#2)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
to the sample in##2##4##(1991-2#1)(2008-10#1)
to the sample solution##4##4##(2008-10#4)
to the sample surface##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
to the sample##24##3##(1991-2#1)(1992-12#1)(1995-2#1)(1996-12#1)(2007-12#2)(2007-9#2)(2008-10#13)(2008-2#1)(2012-2#2)
to the sampled##2##3##(2008-10#1)(2008-2#1)
to the samples##6##3##(1995-2#1)(2008-10#5)
to the sandbar opening and##3##5##(2013-7#3)
to the sandbar opening##4##4##(2013-7#4)
to the satellite##2##3##(2008-2#1)(2008-3#1)
to the scale##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
to the scalp##5##3##(2008-5#2)(2010-6#2)(2013-8#1)
to the scattered##3##3##(2008-3#3)
to the scattering##6##3##(2008-2#2)(2008-3#4)
to the scene##2##3##(2008-1#1)(2012-12#1)
to the scheduled##2##3##(1996-1#1)(2007-8#1)
to the screening of##2##4##(2007-12#1)(2008-10#1)
to the search for##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
to the search of##2##4##(2008-10#1)(2011-2#1)
to the search##7##3##(2008-10#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
to the second##17##3##(1990-8#1)(1991-12#1)(1991-6#2)(1994-12#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-3#1)
to the secondary##5##3##(1993-6#1)(2008-10#1)(2008-4#3)
to the secretion of##3##4##(2008-4#1)(2008-6#1)(2008-8#1)
to the security##2##3##(1993-2#1)(1997-2#1)
to the seed##4##3##(2008-10#3)(2008-8#1)
to the selection of##5##4##(1997-1#1)(2007-12#1)(2008-10#2)(2008-9#1)
to the selective##11##3##(1990-2#1)(1994-8#1)(1995-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2013-1#2)
to the sella##2##3##(1991-6#1)(2011-2#1)
to the sensing interface##2##4##(2008-10#2)
to the sensing##6##3##(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#1)
to the sensitive##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
to the sensitivity of##3##4##(1990-5#1)(1990-6#1)(2008-10#1)
to the sensitivity##8##3##(1990-12#1)(1990-5#1)(1990-6#1)(1995-11#1)(2007-7#1)(2008-10#3)
to the sensor##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
to the sensory##3##3##(1993-12#1)(2008-7#1)(2008-8#1)
to the separately##2##3##(1995-5#2)
to the separation and preconcentration of##2##6##(2008-10#2)
to the separation and##3##4##(2008-10#3)
to the separation of the##2##5##(1991-9#1)(2008-10#1)
to the separation of##10##4##(1991-9#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-7#2)
to the separation##14##3##(1991-9#1)(1996-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#2)
to the septum##2##3##(1991-5#1)(2008-2#1)
to the sequence of a##3##5##(1990-2#1)(1993-6#1)(1994-6#1)
to the sequence of the##2##5##(2008-10#1)(2012-12#1)
to the sequence of##7##4##(1990-11#1)(1990-2#1)(1993-6#1)(1994-6#1)(2008-10#2)(2012-12#1)
to the sequence##12##3##(1990-11#2)(1990-2#1)(1993-6#1)(1994-6#1)(1996-8#1)(2006-6#1)(2008-10#2)(2008-12#1)(2012-12#1)(2013-1#1)
to the sequences of the##2##5##(1994-9#1)(2010-5#1)
to the sequences##3##3##(1990-7#1)(1994-9#1)(2010-5#1)
to the series##2##3##(1995-5#1)(1995-8#1)
to the serious##4##3##(1995-8#1)(2007-11#1)(2007-5#1)(2013-1#1)
to the serum##5##3##(1991-3#1)(1991-6#1)(1995-12#1)(2007-7#1)(2013-8#1)
to the services##2##3##(1993-3#1)(1995-3#1)
to the set of##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
to the set##5##3##(2008-11#1)(2008-3#3)(2013-1#1)
to the severity of the##3##5##(2008-5#1)(2008-6#1)(2008-7#1)
to the severity of their##2##5##(2007-6#1)(2008-11#1)
to the severity of##12##4##(1992-3#1)(1997-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
to the severity##14##3##(1990-12#1)(1992-3#1)(1997-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
to the sexual##3##3##(1991-6#1)(2009-9#1)(2012-12#1)
to the shape of the##2##5##(2008-3#1)(2009-2#1)
to the shape of##3##4##(2008-3#2)(2009-2#1)
to the shape##4##3##(2007-11#1)(2008-3#2)(2009-2#1)
to the shoot##2##3##(2008-10#1)(2012-2#1)
to the short arm of##4##5##(2008-10#4)
to the short##9##3##(1995-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
to the shot##3##3##(1997-8#1)(2007-12#1)(2008-3#1)
to the side effects##3##4##(1992-12#1)(1997-3#1)(2008-4#1)
to the side of the##2##5##(2008-6#1)(2008-7#1)
to the side of##3##4##(2007-12#1)(2008-6#1)(2008-7#1)
to the side##10##3##(1992-12#1)(1992-4#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#2)
to the sight of objects##2##5##(1993-6#2)
to the sigma##2##3##(1995-2#1)(1995-6#1)
to the signal of##2##4##(2008-10#1)(2008-2#1)
to the signal##12##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-9#1)(2010-7#1)
to the significance of##2##4##(1997-8#1)(2011-2#1)
to the significant##7##3##(1994-2#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
to the silica##2##3##(2008-10#2)
to the siloxy bilayer##2##4##(2008-10#2)
to the similar##4##3##(1994-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
to the simple##5##3##(2007-8#3)(2008-10#2)
to the simultaneous analysis of##2##5##(2008-10#2)
to the simultaneous determination of##25##5##(2008-10#25)
to the simultaneous##37##3##(2008-1#1)(2008-10#34)(2008-5#1)(2013-1#1)
to the single##5##3##(2008-10#2)(2008-2#1)(2012-6#1)(2013-1#1)
to the site of infection##2##5##(1997-1#1)(2012-12#1)
to the site of the primary##2##6##(2008-6#1)(2013-1#1)
to the site of the##3##5##(2008-6#1)(2013-1#2)
to the site of##12##4##(1991-9#1)(1994-9#1)(1996-5#2)(1997-1#1)(1997-7#1)(2008-5#1)(2008-6#1)(2012-12#2)(2013-1#2)
to the site##15##3##(1991-9#1)(1994-9#1)(1996-5#2)(1997-1#1)(1997-7#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#2)(2012-2#1)(2013-1#2)
to the situation in pterygote insects##2##6##(2007-12#2)
to the situation in##5##4##(1990-6#1)(1997-4#1)(2007-12#2)(2008-7#1)
to the situation of##2##4##(2007-11#1)(2013-1#1)
to the situation##11##3##(1990-6#1)(1991-5#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#1)
to the six##2##3##(1997-2#1)(2008-1#1)
to the sixth##2##3##(1990-12#1)(2008-2#1)
to the size and the##2##5##(2008-10#1)(2008-3#1)
to the size and##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
to the size of the##5##5##(1990-7#1)(1991-11#1)(1996-12#1)(2008-10#1)(2011-2#1)
to the size of##15##4##(1990-7#1)(1991-11#1)(1992-5#1)(1993-10#1)(1993-2#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
to the size##20##3##(1990-7#1)(1991-11#1)(1992-5#1)(1993-10#1)(1993-2#2)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
to the skeletal muscle##3##4##(1992-5#1)(1993-12#1)(2008-8#1)
to the skeletal##4##3##(1992-5#1)(1993-12#1)(2007-11#1)(2008-8#1)
to the skin but##2##4##(1991-6#1)(2012-3#1)
to the skin in##2##4##(2008-5#2)
to the skin surface##4##4##(2008-10#1)(2008-5#3)
to the skin##28##3##(1991-11#1)(1991-6#1)(1996-1#1)(2008-10#2)(2008-5#14)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to the skull base##2##4##(2006-12#1)(2008-1#1)
to the slide##2##3##(2008-11#1)(2008-8#1)
to the slow##5##3##(1997-2#1)(2008-10#2)(2008-5#2)
to the small intestine##2##4##(2008-3#1)(2011-2#1)
to the small number of##3##5##(1991-5#1)(2008-10#1)(2010-5#1)
to the small##20##3##(1991-12#1)(1991-5#1)(1992-3#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-2#2)
to the so-called##2##3##(2008-10#1)(2009-7#1)
to the social and##2##4##(2008-11#1)(2008-9#1)
to the social##7##3##(1997-5#1)(2008-11#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
to the soil##5##3##(2008-10#3)(2008-11#1)(2008-6#1)
to the soils##2##3##(2008-10#2)
to the solid phase##3##4##(1994-8#1)(2008-10#1)(2008-4#1)
to the solid##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
to the solution of the##4##5##(2007-12#1)(2008-2#3)
to the solution of##5##4##(2007-12#1)(2008-2#3)(2009-10#1)
to the solution##17##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#3)(2009-10#1)(2011-2#1)(2011-3#1)
to the solutions##2##3##(2008-10#2)
to the solvent##4##3##(2008-10#1)(2008-4#1)(2010-2#1)(2013-1#1)
to the sound##2##3##(2008-10#1)(2008-2#1)
to the source of##2##4##(1993-3#1)(1994-9#1)
to the source##7##3##(1993-3#1)(1994-9#1)(2008-10#1)(2008-3#3)(2011-1#1)
to the south##3##3##(2008-10#2)(2008-11#1)
to the spatial##10##3##(1994-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
to the special##7##3##(1997-8#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to the specialist##2##3##(2008-3#1)(2013-1#1)
to the speciation analysis##2##4##(2008-10#2)
to the speciation of##8##4##(2008-10#8)
to the speciation##11##3##(2008-10#11)
to the species##6##3##(1994-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
to the specific energy dissipation rate##4##6##(2008-7#4)
to the specific##25##3##(1991-2#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
to the specificity##3##3##(1997-2#1)(2008-10#2)
to the spectra##3##3##(2008-10#2)(2008-2#1)
to the spectral##10##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#6)(2013-8#1)
to the spectrophotometric determination of##4##5##(2008-10#4)
to the spectrophotometric method##2##4##(2008-10#1)(2008-5#1)
to the spectrophotometric##7##3##(2008-10#6)(2008-5#1)
to the spectrum of##2##4##(2008-10#1)(2011-2#1)
to the sphere##2##3##(1991-6#1)(2008-3#1)
to the spherical##2##3##(2007-12#1)(2012-2#1)
to the spinal cord##7##4##(1994-8#2)(1996-5#2)(2008-4#1)(2008-7#1)(2012-1#1)
to the spinal##8##3##(1994-8#2)(1996-5#2)(2008-4#1)(2008-7#2)(2012-1#1)
to the spine##2##3##(2007-11#1)(2008-3#1)
to the spontaneous##3##3##(1994-2#1)(2008-1#1)(2008-11#1)
to the spread of take-all##2##5##(2008-10#2)
to the spread of##4##4##(2008-10#2)(2008-12#1)(2011-2#1)
to the square root of the##2##6##(2008-10#1)(2008-3#1)
to the square root of##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
to the square##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#6)
to the stability of the##4##5##(1992-6#3)(2008-10#1)
to the stability of##5##4##(1992-6#4)(2008-10#1)
to the stability##6##3##(1992-6#4)(1994-8#1)(2008-10#1)
to the stabilization of##3##4##(1994-12#1)(2007-12#1)(2009-9#1)
to the stabilization##6##3##(1990-8#1)(1994-11#1)(1994-12#1)(1997-2#1)(2007-12#1)(2009-9#1)
to the stage of##5##4##(1992-2#1)(1995-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
to the stages of##2##4##(2008-12#1)(2009-2#1)
to the standard##26##3##(1992-5#1)(1993-2#1)(1993-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#2)(2008-8#2)(2009-2#1)(2010-5#1)(2011-1#2)(2011-7#1)(2012-3#1)
to the standards of##2##4##(1991-3#1)(2011-2#1)
to the standards##3##3##(1991-3#1)(2008-5#1)(2011-2#1)
to the start of##3##4##(2008-10#1)(2008-3#1)(2010-11#1)
to the start site of##2##5##(1992-3#1)(1992-8#1)
to the start##6##3##(1992-3#1)(1992-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)
to the state##7##3##(1992-1#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-6#1)(2011-2#2)
to the states##2##3##(1997-3#1)(1997-8#1)
to the stationary phase##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
to the stationary##5##3##(1996-5#1)(2008-10#1)(2008-7#2)(2011-2#1)
to the statistic##2##3##(1997-3#2)
to the stem##3##3##(2008-10#2)(2009-3#1)
to the step##2##3##(1991-9#1)(2008-3#1)
to the sterol##2##3##(2008-10#2)
to the stimulation of##3##4##(1992-12#1)(1994-11#1)(1994-8#1)
to the stimulation##6##3##(1992-11#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-5#1)
to the stimuli##2##3##(1993-12#1)(1997-2#1)
to the stimulus flicker at each electrode##2##7##(2007-9#2)
to the stomach##3##3##(1990-3#1)(1992-6#1)(2008-5#1)
to the storage##3##3##(2007-8#1)(2008-3#2)
to the strain##3##3##(2008-10#2)(2008-2#1)
to the stratospheric aerosol##2##4##(2008-2#2)
to the stratum corneum##3##4##(2008-5#3)
to the strength of the##2##5##(2007-12#1)(2010-10#1)
to the strength of##6##4##(2007-12#1)(2008-3#1)(2008-8#3)(2010-10#1)
to the strength##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#3)(2010-10#1)
to the stress regimen##2##4##(2008-11#2)
to the stress##5##3##(1996-4#1)(2008-11#3)(2008-6#1)
to the strong##10##3##(1993-8#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2009-5#1)(2009-6#1)(2011-2#1)
to the structural organization of##2##5##(2009-8#1)(2010-8#1)
to the structural##8##3##(1990-12#1)(1995-8#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-8#1)(2013-1#1)
to the structure and##2##4##(2008-1#1)(2008-11#1)
to the structure of the##2##5##(1990-7#1)(2008-10#1)
to the structure of##4##4##(1990-5#1)(1990-7#1)(2008-10#2)
to the structure##9##3##(1990-5#1)(1990-7#1)(1992-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
to the structuring of##2##4##(1993-12#1)(2008-10#1)
to the students##2##3##(2008-11#1)(2013-8#1)
to the students'##2##3##(2012-3#2)
to the studied##2##3##(2008-12#1)(2010-3#1)
to the study of the optical##2##6##(2008-3#2)
to the study of the##9##5##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-9#1)
to the study of these##2##5##(2008-8#1)(2009-8#1)
to the study of two##2##5##(1990-3#1)(2011-1#1)
to the study of##47##4##(1990-12#1)(1990-3#1)(1991-5#2)(1994-8#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-8#2)
to the study##55##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-5#2)(1994-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#2)
to the sub##2##3##(2008-10#1)(2008-12#1)
to the subjects##2##3##(1992-3#1)(1995-5#1)
to the subsequent##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
to the subset##2##3##(2007-12#1)(2008-8#1)
to the substantia##2##3##(1997-2#1)(1997-3#1)
to the substitution##3##3##(2008-10#2)(2011-1#1)
to the substrate and##5##4##(1994-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
to the substrate surface##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
to the substrate##19##3##(1991-5#1)(1992-12#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-7#2)(2010-4#1)(2012-2#1)
to the substratum##2##3##(2007-5#1)(2008-11#1)
to the subtle##2##3##(2010-10#1)(2010-11#1)
to the success of any##2##5##(2008-11#2)
to the success of this##3##5##(2007-12#1)(2008-1#1)(2013-8#1)
to the success of##26##4##(1991-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-3#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
to the success##27##3##(1991-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-3#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
to the successful##9##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#1)
to the sum of the##3##5##(2008-10#2)(2008-2#1)
to the sum of##5##4##(2008-10#3)(2008-2#1)(2008-3#1)
to the superior##3##3##(1996-12#1)(2007-7#1)(2013-1#1)
to the support##3##3##(1990-7#2)(2009-5#1)
to the supportive##2##3##(2013-1#2)
to the suppression of##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
to the suppression##5##3##(1993-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)
to the suppressive effects of##2##5##(1994-10#1)(2008-10#1)
to the suprascapular nerve and##2##5##(2008-9#2)
to the surface and##3##4##(2008-3#1)(2008-5#1)(2008-9#1)
to the surface of a##4##5##(2008-10#2)(2008-2#1)(2010-4#1)
to the surface of the##8##5##(1994-11#2)(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)
to the surface of##18##4##(1994-11#2)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-4#1)
to the surface##42##3##(1991-3#1)(1994-11#2)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#1)
to the surfaces##3##3##(2007-11#1)(2013-8#2)
to the surfactant-rich phase##3##4##(2008-10#3)
to the surgeon##5##3##(1993-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
to the surgery##3##3##(2008-5#1)(2008-7#1)(2011-3#1)
to the surgical procedure##2##4##(2007-8#1)(2008-7#1)
to the surgical##10##3##(1993-6#1)(1995-8#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-3#1)(2011-2#1)
to the surrounding structures##2##4##(1993-6#1)(2012-2#1)
to the surrounding tissues##2##4##(1990-6#1)(2007-12#1)
to the surrounding##7##3##(1990-6#1)(1993-6#1)(1997-4#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
to the survey##8##3##(1995-1#1)(1995-12#1)(1995-3#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
to the survival and##2##4##(2008-10#1)(2012-12#1)
to the survival of##2##4##(2008-10#1)(2008-8#1)
to the survival##4##3##(2008-10#2)(2008-8#1)(2012-12#1)
to the susceptibility of##3##4##(1995-12#1)(2008-10#1)(2012-3#1)
to the susceptibility##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
to the susceptible##3##3##(2008-10#2)(2008-5#1)
to the symptoms##2##3##(2008-2#1)(2011-1#1)
to the synaptic##2##3##(2008-5#1)(2009-8#1)
to the synthesis of##13##4##(1990-8#1)(1992-9#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)
to the synthesis##14##3##(1990-8#1)(1992-9#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
to the synthetic##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
to the system using a multisyringe burette coupled with##2##9##(2008-10#2)
to the system##18##3##(1990-5#1)(1995-3#1)(1997-8#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
to the systemic##2##3##(2008-3#1)(2012-2#1)
to the systems##2##3##(2008-10#1)(2008-5#1)
to the table##3##3##(2008-1#1)(2010-12#1)(2013-1#1)
to the tails##2##3##(1994-3#1)(1997-4#1)
to the talo-crural joint##2##4##(2007-11#2)
to the target DNA##2##4##(2008-4#2)
to the target sequence##3##4##(2008-4#2)(2008-9#1)
to the target##22##3##(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#2)
to the task of##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
to the task##5##3##(1994-3#1)(2008-10#1)(2008-3#1)(2010-5#1)(2013-1#1)
to the taste panel test##2##5##(2008-10#2)
to the taste##4##3##(1991-3#1)(2008-10#2)(2010-5#1)
to the team##2##3##(1993-3#1)(2008-10#1)
to the technique##4##3##(1997-3#2)(2007-11#1)(2008-11#1)
to the telencephalon##2##3##(1996-5#2)
to the temperature##3##3##(2008-2#1)(2008-3#2)
to the temporal##4##3##(2008-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
to the terminal##2##3##(1990-12#1)(2012-12#1)
to the test##8##3##(1992-9#1)(2008-10#5)(2008-5#1)(2009-12#1)
to the testing##2##3##(2007-5#1)(2008-7#1)
to the testis##2##3##(2008-11#1)(2009-10#1)
to the theoretical value##2##4##(2007-12#1)(2008-3#1)
to the theoretical##8##3##(2007-12#2)(2008-10#3)(2008-3#1)(2010-1#1)(2013-1#1)
to the theory of##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2013-7#1)
to the theory that##2##4##(2008-1#1)(2009-8#1)
to the theory##6##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-7#1)
to the therapeutic##5##3##(1993-2#1)(1994-8#1)(1996-11#1)(2008-7#1)(2013-8#1)
to the therapy##3##3##(1994-2#1)(2009-8#1)(2011-1#1)
to the thermal##2##3##(1993-6#1)(2008-3#1)
to the thickness##2##3##(2008-3#1)(2012-2#1)
to the thigh##3##3##(2007-6#1)(2008-6#1)(2009-3#1)
to the third##10##3##(1991-6#1)(1995-5#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-8#2)
to the thoracic spine##2##4##(2008-12#1)(2008-8#1)
to the thoracic##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
to the three major##2##4##(1994-2#1)(2008-10#1)
to the three##25##3##(1991-2#1)(1992-8#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
to the three-dimensional##4##3##(2007-12#2)(2008-3#1)(2008-6#1)
to the thyroid##3##3##(1990-5#1)(2007-8#1)(2008-12#1)
to the tibia##2##3##(2007-8#1)(2008-6#1)
to the tiles##2##3##(2007-5#2)
to the tilt##2##3##(2008-2#1)(2008-3#1)
to the time of##7##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-5#1)
to the time when the##2##5##(2008-10#2)
to the time when##4##4##(2008-10#3)(2008-9#1)
to the time##15##3##(1992-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-5#1)
to the timing of##2##4##(2008-6#1)(2008-7#1)
to the timing##3##3##(2007-12#1)(2008-6#1)(2008-7#1)
to the tip of the##4##5##(1991-12#1)(1996-7#1)(2008-10#1)(2010-6#1)
to the tip of##5##4##(1991-12#1)(1996-7#1)(2008-10#2)(2010-6#1)
to the tissue##5##3##(2008-3#3)(2008-6#1)(2010-4#1)
to the tissues##3##3##(1996-3#1)(2008-10#1)(2010-7#1)
to the titanium##2##3##(2008-5#1)(2009-11#1)
to the top of the##2##5##(1996-4#1)(2008-2#1)
to the top of##4##4##(1996-4#1)(2008-2#1)(2008-3#1)(2008-4#1)
to the top##7##3##(1996-4#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)
to the topic##2##3##(2008-5#1)(2013-8#1)
to the topoisomerase II##2##4##(1994-6#1)(1994-8#1)
to the total amount of food in the sets##2##9##(2009-5#2)
to the total amount of##3##5##(2008-10#1)(2009-5#2)
to the total number of##4##5##(1993-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
to the total of##3##4##(2008-10#1)(2010-8#1)(2011-1#1)
to the total##41##3##(1990-5#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(2006-6#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
to the toxic##3##3##(1992-6#1)(2008-10#2)
to the toxicity of##2##4##(2008-12#1)(2008-9#1)
to the toxicity##3##3##(2007-11#1)(2008-12#1)(2008-9#1)
to the toxin##11##3##(2008-10#11)
to the trace analysis of##2##5##(2008-10#1)(2008-3#1)
to the trace##3##3##(2008-10#2)(2008-3#1)
to the track##2##3##(2008-3#2)
to the traditional risk factors##2##5##(2008-4#1)(2011-2#1)
to the traditional##22##3##(1992-1#1)(1996-1#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#2)
to the traits##2##3##(2008-8#1)(2008-9#1)
to the trajectory##2##3##(1996-6#1)(2008-3#1)
to the transcribed##2##3##(1993-6#1)(1994-8#1)
to the transcription start point##2##5##(1993-12#1)(1997-6#1)
to the transcription start site##2##5##(1995-2#2)
to the transcription start##4##4##(1993-12#1)(1995-2#2)(1997-6#1)
to the transcription##6##3##(1991-12#1)(1993-12#1)(1995-2#2)(1995-6#1)(1997-6#1)
to the transcriptional start##2##4##(1991-2#1)(1996-12#1)
to the transcriptional##3##3##(1991-2#1)(1996-12#1)(2011-1#1)
to the transfer of##3##4##(1992-10#1)(2008-10#1)(2012-3#1)
to the transfer##5##3##(1992-10#1)(1997-6#1)(2008-10#2)(2012-3#1)
to the transformation##2##3##(2008-2#1)(2011-1#1)
to the transformed##2##3##(1995-6#1)(2008-7#1)
to the transient##2##3##(2008-10#1)(2008-2#1)
to the translation start##2##4##(1997-8#1)(2012-2#1)
to the translation##3##3##(1996-5#1)(1997-8#1)(2012-2#1)
to the transmembrane domain##3##4##(1995-2#1)(2008-11#1)(2009-10#1)
to the transmission of##4##4##(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)
to the transmission##6##3##(2008-10#1)(2008-11#1)(2008-2#2)(2010-1#1)(2011-1#1)
to the transport##2##3##(2007-12#1)(2008-2#1)
to the treating physician##2##4##(1996-3#1)(2008-7#1)
to the treating surgeon##3##4##(2009-10#1)(2010-3#1)(2013-1#1)
to the treating##6##3##(1996-3#1)(2008-7#1)(2009-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
to the treatment of##29##4##(1990-9#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1996-3#2)(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#1)(2010-3#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
to the treatment regimen##2##4##(1991-2#1)(1994-12#1)
to the treatment with##3##4##(1991-6#1)(2008-10#1)(2008-5#1)
to the treatment##48##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-3#2)(1996-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#6)(2008-9#2)(2009-7#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)
to the treatments##4##3##(1995-8#1)(2008-10#1)(2010-2#1)(2012-9#1)
to the triggering of##2##4##(2013-1#2)
to the triggering##3##3##(2007-11#1)(2013-1#2)
to the trivalent state##4##4##(2008-10#4)
to the tropics##3##3##(1995-12#1)(2010-6#1)(2011-2#1)
to the true##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
to the tumor##5##3##(1997-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)
to the tumorigenic process##2##4##(1990-11#1)(1994-12#1)
to the two Mn ions##2##5##(2008-8#2)
to the two##32##3##(1991-5#1)(1992-2#1)(1993-3#1)(1994-11#2)(1995-11#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#11)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)
to the two-dimensional##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
to the two-photon##2##3##(2008-3#1)(2009-11#1)
to the type of operation##2##5##(1990-3#2)
to the type of treatment##2##5##(1993-11#1)(1993-6#1)
to the type of##17##4##(1990-3#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to the type##22##3##(1990-3#2)(1991-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1997-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to the types of##3##4##(2007-12#1)(2008-4#2)
to the typical##4##3##(1996-4#1)(2010-10#1)(2010-6#1)(2011-2#1)
to the tyrosine##2##3##(1995-6#1)(1995-8#1)
to the ultrastructural##2##3##(2008-7#1)(2011-2#1)
to the uncertainty##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
to the underlying##8##3##(1991-2#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
to the understanding of gene##3##5##(2008-7#1)(2010-10#1)(2012-3#1)
to the understanding of the##11##5##(1993-11#1)(1994-11#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-6#1)(2009-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
to the understanding of##25##4##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#2)
to the understanding##26##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#2)
to the unexposed##2##3##(2008-3#1)(2008-9#1)
to the unique##9##3##(1991-5#1)(1991-9#1)(1993-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-11#1)(2013-8#1)
to the uniqueness of##2##4##(2008-11#1)(2008-9#1)
to the universal##2##3##(1997-8#1)(2008-8#1)
to the unproteolyzed##2##3##(1995-11#2)
to the untreated##3##3##(1995-12#1)(2008-5#2)
to the unusual##2##3##(1997-6#1)(2011-2#1)
to the upper##10##3##(1992-12#1)(1992-6#1)(1996-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)
to the upper-half of the face##2##6##(2010-1#2)
to the upregulation of##3##4##(2009-8#1)(2010-11#1)(2012-12#1)
to the ureter##2##3##(1997-3#1)(2007-10#1)
to the urgency##2##3##(1996-1#1)(2008-10#1)
to the urinary##3##3##(1996-12#1)(2007-12#1)(2009-7#1)
to the use of a##3##5##(2007-7#1)(2008-10#1)(2008-5#1)
to the use of geospatial data##2##6##(2008-8#2)
to the use of the##3##5##(2008-10#1)(2008-12#1)(2008-2#1)
to the use of##54##4##(1990-2#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)
to the use##55##3##(1990-2#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)
to the user##3##3##(2008-10#1)(2008-4#1)(2010-5#1)
to the usual##10##3##(1990-8#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-9#1)
to the vaccine##3##3##(1990-3#1)(2011-2#1)(2013-8#1)
to the vacuole##3##3##(2009-10#3)
to the validity of the##2##5##(2008-7#2)
to the validity of##3##4##(2008-11#1)(2008-7#2)
to the value of##7##4##(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(2008-3#1)(2008-8#2)
to the value##11##3##(1990-8#1)(1992-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(2008-3#1)(2008-8#2)(2011-1#1)
to the values obtained from##2##5##(1992-2#1)(2008-10#1)
to the values of the##2##5##(2008-10#2)
to the values of##3##4##(2008-10#2)(2010-3#1)
to the values##8##3##(1992-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)
to the valve##2##3##(1997-5#1)(2012-12#1)
to the var##2##3##(2008-5#2)
to the variance##2##3##(2008-8#1)(2008-9#1)
to the variant##2##3##(1991-12#1)(1991-3#1)
to the variation of the##2##5##(2008-2#2)
to the variation of##3##4##(2008-2#2)(2012-3#1)
to the variation##5##3##(2008-10#1)(2008-2#2)(2009-12#1)(2012-3#1)
to the variations##2##3##(1992-3#1)(2008-3#1)
to the variety##2##3##(1990-6#1)(1994-8#1)
to the various##9##3##(1990-5#1)(1994-8#1)(2006-10#1)(2008-10#3)(2009-7#1)(2012-2#1)(2013-1#1)
to the varying##2##3##(1993-8#1)(2008-10#1)
to the vascular tissues##2##4##(2008-10#2)
to the vascular##11##3##(1991-6#2)(1992-6#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-3#1)
to the vector##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
to the vehicle controls##2##4##(2008-9#2)
to the vehicle##3##3##(2008-5#1)(2008-9#2)
to the ventilated##2##3##(1992-6#1)(2006-10#1)
to the ventral striatum##2##4##(1993-6#2)
to the ventral##4##3##(1993-6#2)(1997-7#1)(2007-12#1)
to the ventrolateral##2##3##(1992-11#1)(1993-3#1)
to the very##6##3##(1995-6#1)(2007-11#1)(2008-7#1)(2008-9#2)(2012-2#1)
to the vessel##3##3##(1993-9#1)(2008-10#1)(2008-7#1)
to the view of##2##4##(2012-3#1)(2013-8#1)
to the view##3##3##(2012-3#1)(2013-8#2)
to the vinyl##2##3##(2008-10#2)
to the viral replication##2##4##(1994-8#1)(2008-10#1)
to the viral##6##3##(1990-8#1)(1992-6#1)(1994-8#1)(2008-10#2)(2008-9#1)
to the virus is##2##4##(2011-1#1)(2012-2#1)
to the virus##14##3##(1993-8#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-2#2)(2013-1#1)
to the visible##4##3##(2007-11#1)(2008-3#2)(2013-1#1)
to the visual##3##3##(1992-12#1)(2007-5#1)(2009-12#1)
to the visualization##2##3##(2008-2#1)(2012-3#1)
to the voltammetric##2##3##(2008-10#2)
to the volume of##5##4##(1997-8#1)(2008-10#4)
to the wall##4##3##(1990-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
to the water##7##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
to the wave fronts##2##4##(2007-11#1)(2008-2#1)
to the waveguide##2##3##(2008-10#1)(2008-3#1)
to the wavelength of##2##4##(2008-10#1)(2008-2#1)
to the wavelength##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
to the way##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
to the weak##2##3##(2008-3#1)(2008-8#1)
to the weight of the##2##5##(1991-12#1)(2009-1#1)
to the weight of##3##4##(1991-12#1)(2008-10#1)(2009-1#1)
to the weight##4##3##(1991-12#1)(1996-3#1)(2008-10#1)(2009-1#1)
to the well##2##3##(1995-12#1)(2008-5#1)
to the well-known##6##3##(1995-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
to the wheat stripe rust##2##5##(2008-10#2)
to the whole##6##3##(1993-12#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-9#1)
to the wide variation in##2##5##(1996-12#1)(2012-3#1)
to the wide##7##3##(1991-2#1)(1991-3#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
to the widely##4##3##(1990-6#1)(1992-8#1)(2010-11#1)(2012-2#1)
to the widespread use of##3##5##(1993-12#1)(2008-7#1)(2012-2#1)
to the width of the##2##5##(1993-9#1)(2007-11#1)
to the width of##3##4##(1993-9#1)(2007-11#1)(2013-1#1)
to the wild type##2##4##(2008-10#1)(2008-11#1)
to the wild-type enzyme##3##4##(1990-10#1)(1993-6#1)(1995-2#1)
to the wild-type##10##3##(1990-10#1)(1993-6#1)(1994-12#1)(1995-2#2)(1996-12#1)(1997-2#1)(2008-10#2)(2009-6#1)
to the wind direction##2##4##(2008-10#1)(2008-5#1)
to the wind##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
to the word##2##3##(1994-1#1)(2009-11#1)
to the work of##4##4##(2008-11#1)(2008-12#1)(2010-5#1)(2010-9#1)
to the work piece##2##4##(2008-3#2)
to the work##9##3##(1992-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-5#1)(2010-9#1)(2012-3#1)
to the working##2##3##(2008-10#1)(2008-3#1)
to the workshop##2##3##(1992-5#1)(2008-10#1)
to the world of##4##4##(1995-3#1)(1995-5#1)(1996-12#1)(2006-10#1)
to the world##5##3##(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-10#1)
to the wound##2##3##(1991-6#1)(2008-10#1)
to the writing-beam polarization##2##4##(2007-11#2)
to the year 2018##2##4##(2008-11#2)
to the year##3##3##(2008-11#2)(2009-7#1)
to the yeast##5##3##(1991-6#1)(1994-8#1)(2008-10#1)(2009-12#1)(2010-1#1)
to the young##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
to the younger##2##3##(2008-7#1)(2008-9#1)
to the z axis##2##4##(2008-3#2)
to the zero##4##3##(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
to the zinc##2##3##(1991-10#1)(1991-5#1)
to the zwitterionic##2##3##(2007-11#1)(2008-10#1)
to the##14941##2##(1990-10#7)(1990-11#58)(1990-12#77)(1990-2#54)(1990-3#28)(1990-4#2)(1990-5#74)(1990-6#30)(1990-7#43)(1990-8#75)(1990-9#22)(1991-1#32)(1991-10#9)(1991-11#24)(1991-12#85)(1991-2#57)(1991-3#55)(1991-4#12)(1991-5#60)(1991-6#63)(1991-7#5)(1991-8#27)(1991-9#42)(1992-1#31)(1992-10#20)(1992-11#32)(1992-12#77)(1992-2#38)(1992-3#106)(1992-4#9)(1992-5#29)(1992-6#87)(1992-7#4)(1992-8#51)(1992-9#32)(1993-1#21)(1993-10#3)(1993-11#37)(1993-12#114)(1993-2#45)(1993-3#60)(1993-5#9)(1993-6#75)(1993-8#60)(1993-9#34)(1994-1#24)(1994-10#3)(1994-11#75)(1994-12#97)(1994-2#51)(1994-3#60)(1994-5#67)(1994-6#40)(1994-7#4)(1994-8#84)(1994-9#46)(1995-1#21)(1995-11#53)(1995-12#108)(1995-2#115)(1995-3#74)(1995-4#2)(1995-5#70)(1995-6#87)(1995-8#60)(1995-9#13)(1996-1#50)(1996-10#6)(1996-11#12)(1996-12#94)(1996-2#86)(1996-3#76)(1996-4#19)(1996-5#104)(1996-6#42)(1996-7#10)(1996-8#15)(1996-9#21)(1997-1#42)(1997-2#87)(1997-3#88)(1997-4#82)(1997-5#18)(1997-6#71)(1997-7#75)(1997-8#57)(1997-9#9)(2006-10#24)(2006-12#14)(2006-4#4)(2006-5#9)(2006-6#11)(2006-8#2)(2007-1#4)(2007-10#38)(2007-11#230)(2007-12#314)(2007-2#19)(2007-4#14)(2007-5#31)(2007-6#11)(2007-7#55)(2007-8#109)(2007-9#14)(2008-1#140)(2008-10#2971)(2008-11#542)(2008-12#199)(2008-2#391)(2008-3#785)(2008-4#193)(2008-5#395)(2008-6#170)(2008-7#461)(2008-8#304)(2008-9#327)(2009-1#15)(2009-10#95)(2009-11#43)(2009-12#49)(2009-2#38)(2009-3#32)(2009-4#31)(2009-5#58)(2009-6#42)(2009-7#73)(2009-8#91)(2009-9#35)(2010-1#25)(2010-10#47)(2010-11#37)(2010-12#56)(2010-2#41)(2010-3#69)(2010-4#47)(2010-5#79)(2010-6#36)(2010-7#33)(2010-8#85)(2010-9#14)(2011-1#176)(2011-10#5)(2011-2#449)(2011-3#23)(2011-7#4)(2011-9#2)(2012-1#44)(2012-12#157)(2012-2#254)(2012-3#188)(2012-4#2)(2012-5#5)(2012-6#5)(2012-7#2)(2012-9#4)(2013-1#317)(2013-2#2)(2013-7#44)(2013-8#173)
to their ability to##7##4##(1994-11#2)(2008-10#1)(2008-11#1)(2009-8#1)(2012-2#1)(2013-7#1)
to their adult##2##3##(1995-1#1)(2008-9#1)
to their age##4##3##(1990-8#1)(1994-2#1)(1994-3#1)(2011-2#1)
to their behavior##2##3##(1991-2#2)
to their child##2##3##(1993-12#1)(2012-2#1)
to their children and##2##4##(2010-10#1)(2012-12#1)
to their children##6##3##(1990-2#1)(1995-1#1)(2010-10#2)(2012-12#2)
to their children's##3##3##(1994-3#1)(1995-1#2)
to their clients##2##3##(2008-5#1)(2011-2#1)
to their clinical##4##3##(1993-9#1)(2008-10#1)(2010-11#1)(2011-2#1)
to their complexity##2##3##(2008-10#1)(2011-2#1)
to their corresponding##3##3##(1993-11#1)(2008-9#1)(2009-7#1)
to their counterparts##2##3##(2008-7#1)(2009-6#1)
to their current##2##3##(2008-12#1)(2009-1#1)
to their death##2##3##(2008-10#2)
to their deaths##2##3##(1995-1#1)(2007-2#1)
to their destinations##2##3##(1995-2#1)(1996-5#1)
to their determination##14##3##(2008-10#14)
to their different##2##3##(2008-10#1)(2008-8#1)
to their disease##2##3##(2008-10#1)(2010-3#1)
to their effect on##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
to their effectiveness##3##3##(2008-5#1)(2008-7#1)(2010-1#1)
to their effects on##2##4##(1993-6#2)
to their effects##3##3##(1993-6#2)(2008-10#1)
to their environment##3##3##(1996-12#2)(2009-6#1)
to their excellent##2##3##(1997-8#1)(2009-7#1)
to their financial##2##3##(2010-10#2)
to their free##2##3##(2008-11#1)(2013-7#1)
to their high##9##3##(1995-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
to their home##2##3##(2008-8#1)(2010-8#1)
to their homes for terminal care##2##6##(1993-3#2)
to their homes##4##3##(1990-12#1)(1993-3#2)(2011-2#1)
to their host plants##2##4##(2008-10#1)(2008-9#1)
to their host##3##3##(2008-10#2)(2008-9#1)
to their illness##2##3##(1992-12#1)(2007-7#1)
to their incorporation##2##3##(2008-10#2)
to their increased##2##3##(2012-12#1)(2012-2#1)
to their inherent##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
to their jobs##3##3##(1995-3#1)(1996-1#1)(1997-3#1)
to their learning##2##3##(2008-11#2)
to their length##2##3##(2008-9#2)
to their low##2##3##(2008-11#1)(2008-2#1)
to their malignancy##2##3##(2011-2#1)(2013-8#1)
to their molecular##2##3##(2008-5#1)(2008-7#1)
to their natural##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)
to their nature##2##3##(1990-7#1)(2012-2#1)
to their need##2##3##(1992-3#1)(2010-2#1)
to their normal##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
to their nursing practice##2##4##(2008-12#1)(2013-8#1)
to their offspring##2##3##(2008-2#1)(2008-7#1)
to their optimum##2##3##(2008-10#1)(2009-11#1)
to their original##5##3##(1992-5#1)(2007-12#1)(2008-10#2)(2008-4#1)
to their own##7##3##(1993-1#1)(1993-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#2)
to their patients##9##3##(1990-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-1#2)(1997-1#1)(2008-11#1)(2012-3#1)
to their perceptions of##2##4##(2012-2#1)(2012-3#1)
to their performance##2##3##(2008-10#1)(2012-2#1)
to their potential##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
to their previous##2##3##(2008-7#1)(2008-9#1)
to their primary##2##3##(1995-2#1)(2013-1#1)
to their rapid##2##3##(1992-2#1)(1996-6#1)
to their reduced##2##3##(2008-10#1)(2012-2#1)
to their reduction##2##3##(2007-11#1)(2008-10#1)
to their relationship with##2##4##(1994-8#1)(2008-10#1)
to their respective##14##3##(1992-1#1)(1994-2#1)(1996-9#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-3#1)
to their response##2##3##(2008-10#1)(2013-1#1)
to their role in##5##4##(2008-10#1)(2008-7#2)(2010-3#1)(2012-3#1)
to their roles##2##3##(2011-1#1)(2012-12#1)
to their species##2##3##(2008-10#1)(2008-5#1)
to their specific##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
to their structural##2##3##(1991-9#1)(2009-12#1)
to their success##3##3##(1992-1#1)(2008-10#1)(2012-3#1)
to their survival##2##3##(2008-10#1)(2008-7#1)
to their unique##5##3##(1992-1#1)(1993-3#1)(2010-10#1)(2010-5#1)(2012-2#1)
to their use##5##3##(2007-7#1)(2008-11#2)(2008-8#1)(2011-1#1)
to their##626##2##(1990-12#2)(1990-2#4)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#4)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#9)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#7)(1995-5#2)(1996-1#2)(1996-12#3)(1996-2#4)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#3)(1997-7#2)(1997-8#1)(2006-5#1)(2007-11#5)(2007-12#7)(2007-2#2)(2007-7#3)(2008-1#2)(2008-10#123)(2008-11#30)(2008-12#15)(2008-2#8)(2008-3#10)(2008-4#11)(2008-5#26)(2008-6#3)(2008-7#20)(2008-8#13)(2008-9#19)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#7)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#8)(2010-11#2)(2010-2#1)(2010-3#5)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#7)(2011-2#23)(2011-9#1)(2012-12#8)(2012-2#19)(2012-3#16)(2012-5#1)(2013-1#20)(2013-7#3)(2013-8#5)
to them and##2##3##(2008-12#1)(2008-8#1)
to them of##2##3##(2008-10#1)(2012-3#1)
to them##48##2##(1990-12#1)(1991-4#1)(1992-12#2)(1992-3#3)(1993-11#1)(1994-12#1)(1995-1#1)(1995-9#1)(1997-3#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
to themselves##4##2##(1990-6#1)(1991-12#1)(2008-11#1)(2010-10#1)
to theoretical predictions##2##3##(2008-3#1)(2008-9#1)
to theoretical##9##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#1)
to theoretically##2##2##(2008-3#1)(2010-8#1)
to theory development##2##3##(2008-8#1)(2009-8#1)
to theory##3##2##(2008-5#1)(2008-8#1)(2009-8#1)
to therapeutic##10##2##(1992-3#1)(1993-1#1)(1993-11#1)(2007-9#1)(2008-11#2)(2009-3#1)(2011-1#2)(2012-2#1)
to therapies##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
to therapists##2##2##(2012-2#2)
to therapy in##5##3##(1993-11#3)(2007-7#1)(2011-2#1)
to therapy is##2##3##(1995-2#1)(2008-8#1)
to therapy##43##2##(1991-2#2)(1992-8#1)(1993-11#3)(1994-7#2)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-11#4)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to there##2##2##(1996-7#1)(2007-7#1)
to thermal and##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
to thermal##13##2##(1994-5#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
to thermally##2##2##(2008-2#1)(2009-12#1)
to thermodynamic##2##2##(1992-5#1)(2008-10#1)
to thermographic results##3##3##(1993-11#3)
to these agents##5##3##(1990-2#2)(2008-11#2)(2011-1#1)
to these and other##4##4##(1992-12#1)(2008-12#1)(2008-3#1)(2013-1#1)
to these cells##2##3##(1993-8#1)(1995-2#1)
to these challenges by##2##4##(1995-1#1)(2008-6#1)
to these challenges##3##3##(1994-12#1)(1995-1#1)(2008-6#1)
to these compounds##6##3##(1990-7#1)(1991-6#1)(1992-8#1)(2008-10#2)(2008-8#1)
to these concerns##4##3##(1994-12#1)(2007-12#1)(2012-3#1)(2013-1#1)
to these data##2##3##(1997-8#1)(2008-4#1)
to these diseases##2##3##(2008-8#1)(2009-4#1)
to these disorders##2##3##(1991-4#1)(2006-10#1)
to these drugs##4##3##(1995-11#1)(1997-4#1)(2012-3#1)(2013-8#1)
to these effects##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
to these factors##2##3##(2008-2#1)(2011-2#1)
to these findings##5##3##(1993-9#1)(2008-5#1)(2008-7#1)(2009-1#1)(2013-1#1)
to these functions##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
to these guidelines##2##3##(1992-12#1)(2010-8#1)
to these methods##3##3##(2008-2#1)(2009-3#1)(2010-12#1)
to these parameters##2##3##(1995-11#1)(2008-10#1)
to these patients##5##3##(1994-3#1)(1994-6#1)(2008-1#1)(2010-7#1)(2010-8#1)
to these problems##4##3##(1991-11#1)(2008-8#1)(2008-9#1)(2009-6#1)
to these procedures##2##3##(1993-3#1)(2008-3#1)
to these processes##2##3##(2008-10#1)(2008-3#1)
to these receptors##2##3##(1991-12#1)(2009-12#1)
to these results##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
to these risk factors##2##4##(2007-10#1)(2011-1#1)
to these services##2##3##(1995-2#1)(2013-1#1)
to these signals##2##3##(1995-12#1)(2008-9#1)
to these sources##2##3##(1992-6#1)(2007-2#1)
to these species##2##3##(2008-10#1)(2008-8#1)
to these stimuli##2##3##(1990-12#1)(2012-7#1)
to these studies##2##3##(2007-8#1)(2008-8#1)
to these tests##2##3##(2008-10#1)(2008-12#1)
to these two##10##3##(1993-12#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)
to these variables##2##3##(2008-8#1)(2013-8#1)
to these##257##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#34)(2008-11#11)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#7)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#6)
to thickening##2##2##(2012-1#2)
to thin##3##2##(1995-2#1)(1997-6#1)(2007-12#1)
to think about their##2##4##(2008-6#1)(2013-8#1)
to think about##6##3##(2008-6#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2013-8#1)
to think of##2##3##(1991-1#1)(1996-11#1)
to think##12##2##(1991-1#1)(1995-3#1)(1996-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
to thinking##3##2##(1995-2#1)(2008-6#2)
to thiocyanate##2##2##(2008-10#2)
to thiophanate-methy1 and##3##3##(2008-10#3)
to thiophanate-methy1##4##2##(2008-10#4)
to thiophanate-methyl but##2##3##(2008-10#2)
to thiophanate-methyl##4##2##(2008-10#4)
to third##5##2##(1991-1#1)(1992-1#1)(2008-10#2)(2012-2#1)
to this approach##2##3##(1994-2#1)(2008-10#1)
to this area##2##3##(1990-12#1)(1990-5#1)
to this challenge##3##3##(1993-12#1)(1994-12#1)(2009-9#1)
to this class of##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
to this client group##2##4##(1997-7#1)(2008-11#1)
to this condition##2##3##(2007-11#1)(2008-11#1)
to this disease##5##3##(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#1)(2013-1#1)
to this effect##5##3##(1991-1#1)(1991-3#1)(1995-12#1)(2008-3#1)(2008-7#1)
to this end##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
to this enzyme##3##3##(1990-12#1)(1992-9#1)(1995-3#1)
to this experiment##2##3##(1992-1#1)(2008-12#1)
to this group##3##3##(1992-11#1)(1995-6#1)(2008-6#1)
to this hypothesis##2##3##(1990-3#1)(2008-9#1)
to this is the##2##4##(2008-11#1)(2008-2#1)
to this kind of treatment##2##5##(2008-12#1)(2008-4#1)
to this method##2##3##(2008-11#1)(2013-1#1)
to this model##4##3##(1991-8#1)(1995-2#1)(2008-3#1)(2008-5#1)
to this new##6##3##(1996-12#1)(2008-10#2)(2011-2#1)(2012-1#1)(2013-1#1)
to this pathogen##3##3##(2007-7#1)(2008-10#2)
to this phenomenon##2##3##(1995-11#1)(2008-8#1)
to this population##2##3##(2008-9#1)(2009-5#1)
to this problem##11##3##(1990-11#1)(1994-9#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
to this procedure##3##3##(1994-3#1)(2008-10#1)(2010-6#1)
to this process##3##3##(1995-1#1)(2011-2#1)(2012-12#1)
to this protein##2##3##(1993-12#1)(1997-6#1)
to this question##3##3##(1994-3#1)(2013-1#2)
to this region##6##3##(1994-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
to this response##2##3##(1993-6#1)(2008-7#1)
to this site##2##3##(1990-5#2)
to this special##2##3##(1991-4#1)(2010-7#1)
to this study##7##3##(1991-12#1)(1994-12#1)(2007-7#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)
to this success##2##3##(2008-10#1)(2009-5#1)
to this system##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
to this technique##2##3##(2008-10#1)(2008-3#1)
to this theory##2##3##(2008-10#1)(2008-6#1)
to this topic##2##3##(2008-12#1)(2009-8#1)
to this toxin##2##3##(2008-10#2)
to this trend##2##3##(2011-2#1)(2012-2#1)
to this type of##4##4##(1996-3#1)(2008-10#2)(2008-8#1)
to this variation##2##3##(1995-3#1)(2008-10#1)
to this##327##2##(1990-11#4)(1990-12#3)(1990-3#2)(1990-5#4)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#3)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#5)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2006-12#1)(2006-6#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#45)(2008-11#16)(2008-12#7)(2008-2#7)(2008-3#15)(2008-4#4)(2008-5#6)(2008-6#6)(2008-7#8)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#2)(2010-2#3)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
to thoracic##2##2##(2012-3#2)
to those achieved by the##2##5##(1993-6#1)(2008-12#1)
to those achieved by##3##4##(1993-6#1)(2008-10#1)(2008-12#1)
to those achieved using##2##4##(1991-3#1)(2008-10#1)
to those achieved with##2##4##(2008-10#2)
to those achieved##8##3##(1991-3#1)(1993-6#1)(2008-10#4)(2008-12#1)(2008-8#1)
to those associated with##2##4##(2008-2#1)(2011-2#1)
to those at the##2##4##(1994-12#1)(2008-9#1)
to those at##5##3##(1992-11#1)(1994-12#1)(1995-9#1)(2008-11#1)(2008-9#1)
to those calculated##4##3##(2008-5#1)(2008-8#1)(2012-12#2)
to those caused by##3##4##(2008-10#2)(2008-3#1)
to those cells##2##3##(1996-5#1)(1996-9#1)
to those described in##2##4##(2006-10#1)(2008-10#1)
to those described##5##3##(1994-11#1)(1994-3#1)(2006-10#1)(2008-10#2)
to those determined using##2##4##(2008-10#2)
to those determined##4##3##(1994-8#1)(2008-10#3)
to those employed##2##3##(1993-3#1)(2008-2#1)
to those estimated##2##3##(2008-10#2)
to those for the##3##4##(1995-6#1)(1997-8#1)(2008-10#1)
to those for##7##3##(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-1#1)
to those found in the##3##5##(1991-9#1)(1993-12#1)(2008-7#1)
to those found in##10##4##(1990-2#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
to those found on##2##4##(2008-10#2)
to those found##15##3##(1990-2#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
to those from conventional##2##4##(2008-10#2)
to those from##11##3##(1994-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-5#1)(2010-6#1)
to those grown in##2##4##(2008-10#2)
to those grown##3##3##(1993-6#1)(2008-10#2)
to those identified##3##3##(1994-2#1)(2008-10#1)(2010-4#1)
to those in Group##3##4##(1992-11#1)(2011-1#1)(2011-2#1)
to those in other##2##4##(1990-5#1)(2008-10#1)
to those in the##17##4##(1990-2#1)(1990-8#1)(1993-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-8#1)
to those in##46##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-8#1)
to those induced by##6##4##(1991-6#1)(2008-10#3)(2008-12#1)(2011-2#1)
to those observed for##3##4##(2008-5#1)(2009-11#1)(2009-2#1)
to those observed in the field##4##6##(2008-10#4)
to those observed in the##7##5##(1996-2#1)(1997-8#1)(2008-10#4)(2008-2#1)
to those observed in##21##4##(1990-5#1)(1993-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-8#2)(2008-10#9)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)
to those observed with##3##4##(1992-12#1)(2008-10#1)(2012-3#1)
to those observed##30##3##(1990-5#1)(1992-12#2)(1993-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#2)(2008-10#10)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-3#1)
to those obtained at##3##4##(2007-11#1)(2008-10#2)
to those obtained by a##2##5##(2008-5#2)
to those obtained by the##6##5##(2008-10#5)(2012-2#1)
to those obtained by using##3##5##(2008-10#2)(2010-4#1)
to those obtained by##20##4##(1994-12#1)(2008-10#15)(2008-5#2)(2010-4#1)(2012-2#1)
to those obtained for##3##4##(1993-8#1)(1995-5#1)(2008-10#1)
to those obtained from##2##4##(2008-10#1)(2013-1#1)
to those obtained in the##2##5##(2008-10#2)
to those obtained in##11##4##(1990-5#2)(1990-8#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#5)
to those obtained previously##2##4##(1992-3#1)(1993-11#1)
to those obtained using the##3##5##(2008-10#2)(2008-5#1)
to those obtained using##5##4##(2008-10#4)(2008-5#1)
to those obtained with conventional##2##5##(1996-8#1)(2008-10#1)
to those obtained with the##4##5##(2008-10#3)(2008-11#1)
to those obtained with##16##4##(1992-6#1)(1994-9#1)(1996-8#1)(2008-10#12)(2008-11#1)
to those obtained##63##3##(1990-5#2)(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#40)(2008-11#1)(2008-5#3)(2009-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
to those of a##3##4##(2008-10#3)
to those of acute##2##4##(2008-7#1)(2009-8#1)
to those of an##2##4##(2008-10#2)
to those of bovine##2##4##(1993-11#1)(1994-8#1)
to those of control##2##4##(1993-1#1)(1994-8#1)
to those of conventional##4##4##(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#1)
to those of human##2##4##(1992-6#1)(1993-5#1)
to those of normal##2##4##(1994-12#1)(1996-12#1)
to those of other fungal##2##5##(1997-2#2)
to those of other##8##4##(1994-5#1)(1996-1#1)(1997-2#2)(2008-10#3)(2008-5#1)
to those of previously##2##4##(1996-7#1)(2007-11#1)
to those of the CYP3A probe drug midazolam##2##8##(2011-2#2)
to those of the control##3##5##(2008-9#1)(2012-2#1)(2013-8#1)
to those of the controls##2##5##(1992-9#1)(2008-8#1)
to those of the human##2##5##(1997-7#1)(2008-3#1)
to those of the respective##3##5##(1995-5#2)(2007-11#1)
to those of the wild-type enzyme##2##6##(1990-10#1)(1995-2#1)
to those of the wild-type##4##5##(1990-10#1)(1993-8#1)(1995-2#2)
to those of the##64##4##(1990-10#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#3)(1995-5#3)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#12)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#3)
to those of wild-type##3##4##(1993-11#1)(1995-2#1)(2008-10#1)
to those of##200##3##(1990-10#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#7)(2007-12#4)(2007-5#1)(2007-8#4)(2008-10#35)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#12)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#16)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#4)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-8#4)
to those on##2##3##(1997-3#1)(2008-11#1)
to those prepared##2##3##(2008-10#2)
to those previously##9##3##(1991-12#1)(1991-6#1)(1995-6#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-3#1)
to those produced by##2##4##(1997-7#1)(2008-11#1)
to those produced##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
to those provided by the##3##5##(2008-10#1)(2008-4#2)
to those registered##2##3##(2008-6#1)(2010-4#1)
to those reported for##2##4##(2008-10#1)(2008-3#1)
to those reported in the literature##2##6##(2007-12#1)(2008-10#1)
to those reported in##7##4##(1995-12#1)(1997-2#2)(2007-12#1)(2008-10#3)
to those reported##13##3##(1995-12#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-6#1)(2013-1#1)
to those seen in##4##4##(1995-12#1)(1996-12#1)(2008-2#1)(2012-3#1)
to those seen##9##3##(1991-6#1)(1995-12#1)(1996-12#1)(2006-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#2)
to those that are##3##4##(1994-8#1)(2007-11#1)(2007-12#1)
to those that were##2##4##(2008-10#1)(2008-9#1)
to those that##10##3##(1994-2#1)(1994-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-2#1)
to those treated with##2##4##(1991-3#1)(2008-11#1)
to those used in##2##4##(2008-6#1)(2008-7#1)
to those used##5##3##(1990-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
to those who are##2##4##(1995-12#1)(2011-1#1)
to those who need##2##4##(1993-2#1)(1995-1#1)
to those who##11##3##(1991-5#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-12#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-6#1)(2011-1#1)
to those with strong physician examiner systems##2##7##(1993-12#2)
to those with##12##3##(1990-9#1)(1991-5#1)(1993-12#2)(1997-6#1)(2008-11#1)(2008-7#3)(2010-3#1)(2011-2#1)(2012-2#1)
to those without##10##3##(2008-9#2)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to those##610##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#6)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#4)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#6)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#6)(1993-12#6)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#6)(1995-3#4)(1995-5#6)(1995-6#5)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#5)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#4)(1997-6#2)(1997-7#5)(1997-8#3)(2006-10#2)(2007-10#1)(2007-11#10)(2007-12#8)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#6)(2008-10#155)(2008-11#10)(2008-12#5)(2008-2#12)(2008-3#22)(2008-4#8)(2008-5#19)(2008-6#4)(2008-7#18)(2008-8#8)(2008-9#26)(2009-11#3)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#10)(2011-2#18)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#11)(2012-5#1)(2013-1#6)(2013-8#8)
to thousands of##4##3##(1991-2#1)(2008-10#1)(2008-4#2)
to three consecutive##2##3##(2008-10#1)(2011-2#1)
to three copies of##2##4##(2008-10#1)(2009-7#1)
to three different##11##3##(1991-6#1)(1997-2#1)(2008-10#5)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
to three dimensions##2##3##(2008-3#1)(2012-12#1)
to three distinct##2##3##(2008-10#1)(2010-10#1)
to three groups of##2##4##(1993-1#1)(2008-10#1)
to three groups##6##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#1)
to three of##2##3##(1991-12#1)(2008-11#1)
to three regions of##2##4##(1994-12#1)(2011-2#1)
to three regions##3##3##(1994-12#1)(2008-9#1)(2011-2#1)
to three target##2##3##(1994-8#1)(2008-12#1)
to three times the standard deviation of the blank##6##9##(2008-10#6)
to three times the standard deviation of the##7##8##(2008-10#7)
to three times the standard deviation of##8##7##(2008-10#8)
to three times the##10##4##(1992-3#1)(2008-1#1)(2008-10#8)
to three times##16##3##(1992-3#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#1)(2010-5#1)(2012-2#1)
to three weeks##2##3##(1991-3#1)(1995-2#1)
to three years##2##3##(1992-1#1)(2008-1#1)
to three##115##2##(1990-2#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-1#2)(1994-12#1)(1994-8#1)(1995-2#2)(1996-8#1)(1997-2#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#42)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
to three-dimensional##8##2##(1996-2#1)(2007-11#1)(2008-3#4)(2008-7#1)(2009-3#1)
to threefold##3##2##(1992-11#1)(2008-10#1)(2010-4#1)
to thrips feeding##2##3##(2009-8#2)
to thrips##3##2##(2008-10#1)(2009-8#2)
to thrive and##3##3##(2007-2#1)(2008-1#1)(2012-3#1)
to thrive##11##2##(1992-3#1)(1993-1#1)(1994-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-3#1)
to thrombin##2##2##(2007-10#1)(2013-8#1)
to thrombosis and##3##3##(1997-8#1)(2009-11#1)(2011-3#1)
to thrombosis##4##2##(1997-8#1)(2008-7#1)(2009-11#1)(2011-3#1)
to thrombotic##3##2##(2008-1#1)(2008-10#1)(2009-7#1)
to throw light on##2##4##(2008-1#1)(2010-3#1)
to throw##4##2##(2008-1#1)(2008-11#1)(2010-3#1)(2013-8#1)
to thyroid hormone##5##3##(1991-9#1)(1992-11#1)(1995-8#3)
to thyroid##8##2##(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1995-8#3)(2008-1#1)
to thyrotropin##2##2##(1994-11#1)(1994-6#1)
to ticks##2##2##(1991-11#1)(2008-8#1)
to tie##3##2##(1995-1#1)(1996-2#1)(2012-12#1)
to tight##4##2##(1997-3#1)(2009-11#1)(2011-2#1)(2013-8#1)
to tilt##4##2##(2008-2#2)(2008-3#2)
to time and##2##3##(1992-11#1)(2008-10#1)
to time of##2##3##(1994-11#1)(2008-10#1)
to time##19##2##(1992-11#1)(1994-11#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-2#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
to time-consuming##4##2##(1994-12#1)(2007-12#1)(2008-10#2)
to time-domain##2##2##(2007-12#1)(2011-7#1)
to tissue##16##2##(1990-11#1)(1992-2#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to tissues##3##2##(2010-10#1)(2012-2#1)(2013-1#1)
to titrate##2##2##(2008-10#1)(2009-11#1)
to to##2##2##(1993-6#1)(1995-2#1)
to tobacco and##3##3##(1996-1#1)(1997-1#1)(2009-6#1)
to tobacco smoke##7##3##(1991-12#2)(1991-4#1)(1994-2#2)(2008-11#1)(2013-1#1)
to tobacco use##3##3##(1997-1#2)(2008-6#1)
to tobacco##29##2##(1990-8#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1992-2#1)(1992-6#2)(1993-6#1)(1994-2#2)(1996-1#1)(1997-1#3)(2008-10#5)(2008-11#1)(2008-6#1)(2009-6#1)(2013-1#3)
to tobamoviruses##2##2##(1997-6#1)(2008-10#1)
to today's##3##2##(1991-3#1)(2007-5#1)(2012-12#1)
to tolerance##4##2##(1995-12#1)(1995-3#1)(2008-5#1)(2009-10#1)
to tolerate a##3##3##(1993-2#1)(2008-11#2)
to tolerate##10##2##(1993-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2013-1#1)
to toluene##2##2##(2008-10#1)(2008-7#1)
to tomato plants##4##3##(2008-10#4)
to tomato spotted wilt virus##2##5##(2008-10#2)
to tomato##20##2##(2008-10#16)(2008-8#4)
to tone##2##2##(2008-8#1)(2008-9#1)
to topical application of##2##4##(2007-8#1)(2013-1#1)
to topical application##4##3##(2007-8#1)(2008-12#2)(2013-1#1)
to topical##10##2##(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)
to total quality management##2##4##(1994-2#1)(1994-3#1)
to total##31##2##(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-2#1)(1994-3#2)(1995-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to touch##2##2##(1996-2#1)(2008-11#1)
to toughness##2##2##(2010-2#2)
to town##2##2##(2007-12#1)(2009-10#1)
to toxic##5##2##(1991-9#1)(1992-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
to toxicants##2##2##(2008-9#1)(2012-2#1)
to toxicity##4##2##(2007-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
to toxin##3##2##(1994-5#1)(2008-10#1)(2008-7#1)
to toxins##2##2##(2008-9#1)(2013-8#1)
to trace the##4##3##(1997-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
to trace##9##2##(1997-3#1)(2008-10#5)(2008-3#2)(2012-2#1)
to track a moving target##3##5##(2008-11#3)
to track the##9##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-11#1)(2011-1#1)
to track##27##2##(1995-12#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)
to tracking##2##2##(1995-12#1)(2010-6#1)
to trade off##2##3##(2008-2#1)(2008-3#1)
to trade##6##2##(2008-2#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-2#1)
to traditional health##2##3##(1992-1#1)(1996-12#1)
to traditional masculine norms##2##4##(2009-5#2)
to traditional methods##3##3##(1990-9#1)(2008-10#1)(2009-9#1)
to traditional##43##2##(1990-10#1)(1990-5#1)(1990-9#1)(1992-1#2)(1992-5#1)(1993-12#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
to traffic##3##2##(2008-3#1)(2008-9#1)(2010-11#1)
to train the##2##3##(2008-10#1)(2008-3#1)
to train##17##2##(1992-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#2)(2011-2#1)
to training##6##2##(1991-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
to trans-replicate##2##2##(2008-10#2)
to transcription factors##2##3##(2008-10#1)(2010-11#1)
to transcription##3##2##(1995-6#1)(2008-10#1)(2010-11#1)
to transcriptional activation##2##3##(1992-12#1)(2013-1#1)
to transcriptional##5##2##(1992-12#1)(1996-10#1)(1996-12#1)(2008-4#1)(2013-1#1)
to transduce signals##2##3##(2009-8#1)(2012-2#1)
to transduce##9##2##(1992-12#1)(1994-5#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2012-2#1)
to transfect##3##2##(1993-8#1)(2008-11#2)
to transfer from the BPP calibration set to the RPP calibration set##2##12##(2007-12#2)
to transfer genes into cells from##2##6##(1990-5#2)
to transfer genes to##3##4##(1994-11#1)(1994-5#1)(2008-10#1)
to transfer genes##5##3##(1990-5#2)(1994-11#1)(1994-5#1)(2008-10#1)
to transfer the##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
to transfer##29##2##(1990-5#3)(1992-6#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-5#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
to transform the##12##3##(1992-12#1)(1995-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)
to transform##27##2##(1990-5#2)(1992-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)
to transformation by##3##3##(1993-11#1)(2008-10#1)(2008-6#1)
to transformation##8##2##(1993-11#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-3#1)(2012-12#1)(2013-8#1)
to transforming growth factor-beta##4##4##(1992-2#1)(1992-3#2)(1996-5#1)
to transforming##5##2##(1992-2#1)(1992-3#2)(1996-5#1)(2007-9#1)
to transgenic plants##3##3##(1995-6#1)(2008-11#1)(2013-8#1)
to transient##6##2##(1995-3#1)(1997-4#1)(2008-7#1)(2011-1#1)(2012-2#2)
to transition##2##2##(1995-3#1)(2011-2#1)
to translate and##2##3##(2006-10#1)(2010-1#1)
to translate##13##2##(1993-2#1)(2006-10#1)(2008-3#2)(2008-9#1)(2009-3#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-3#1)
to translational##2##2##(2008-1#1)(2008-8#1)
to translocate##5##2##(1994-5#1)(2007-12#2)(2008-11#1)(2009-10#1)
to transmit TSWV##3##3##(2008-10#3)
to transmit Tomato##2##3##(2008-10#2)
to transmit a##2##3##(2008-3#2)
to transmit both##2##3##(2008-10#2)
to transmit the virus##2##4##(2008-10#2)
to transmit the##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
to transmit virus##2##3##(2008-10#2)
to transmit##33##2##(1990-5#1)(2007-11#2)(2007-12#3)(2008-10#20)(2008-3#5)(2008-8#1)(2012-12#1)
to transplant##4##2##(1995-12#1)(2007-5#1)(2010-6#1)(2011-2#1)
to transplantation##7##2##(1995-12#2)(2010-6#1)(2011-2#4)
to transport##11##2##(1990-2#1)(1991-10#1)(1995-11#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-12#1)(2013-1#1)
to transportation##2##2##(2013-1#2)
to transposon##2##2##(2008-10#1)(2010-5#1)
to transurethral resection##2##3##(1991-9#1)(2008-1#1)
to trap##8##2##(1993-6#1)(1995-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2011-2#1)
to trapping##2##2##(2007-12#1)(2009-12#1)
to trastuzumab and##2##3##(2012-3#1)(2013-1#1)
to trastuzumab##5##2##(2012-3#3)(2013-1#2)
to trauma is##2##3##(1992-4#1)(2012-3#1)
to trauma or##3##3##(2008-5#1)(2008-7#2)
to trauma##14##2##(1992-3#1)(1992-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#3)(2012-3#1)(2013-1#3)
to traumatic##5##2##(2007-8#1)(2008-6#1)(2009-3#2)(2012-3#1)
to travel clinics##2##3##(2007-2#2)
to travel##10##2##(1992-11#1)(1996-1#1)(2007-2#6)(2008-8#1)(2008-9#1)
to travellers##5##2##(2007-2#5)
to traverse the##2##3##(1990-5#1)(2008-10#1)
to treat a wide##3##4##(2008-10#1)(2008-8#1)(2010-2#1)
to treat a##10##3##(1992-1#1)(1993-1#1)(1993-2#2)(2008-10#2)(2008-8#2)(2010-2#1)(2013-1#1)
to treat acute##3##3##(1997-8#1)(2007-8#1)(2008-11#1)
to treat an##2##3##(2008-3#1)(2008-6#1)
to treat and##4##3##(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#1)
to treat anxiety disorders##2##4##(2008-7#1)(2013-8#1)
to treat bipolar disorder##2##4##(2008-8#2)
to treat cancer##3##3##(1994-5#1)(2008-9#1)(2011-2#1)
to treat chronic##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
to treat diabetes##2##3##(2009-3#2)
to treat disease##2##3##(2008-5#1)(2013-8#1)
to treat gastric varices##2##4##(2013-1#2)
to treat hypertension##5##3##(1996-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
to treat inflammatory##2##3##(2008-11#1)(2008-3#1)
to treat or not to##2##5##(1995-5#1)(2008-8#1)
to treat or##4##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
to treat patients with##4##4##(2007-9#1)(2008-3#1)(2009-8#1)(2013-1#1)
to treat patients##7##3##(1994-1#1)(1994-11#1)(1997-1#1)(2007-9#1)(2008-3#1)(2009-8#1)(2013-1#1)
to treat people with HIV##2##5##(1995-6#2)
to treat people with##3##4##(1995-6#2)(1996-1#1)
to treat schizophrenia##2##3##(2008-4#1)(2012-2#1)
to treat the##24##3##(1993-12#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-1#1)
to treat these disorders##2##4##(2008-8#1)(2010-5#1)
to treat these##9##3##(1991-11#1)(2007-7#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)
to treat this condition##2##4##(2006-10#1)(2013-8#1)
to treat this##7##3##(2006-10#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
to treat various##2##3##(2008-7#1)(2010-5#1)
to treat with##2##3##(1997-4#1)(2013-1#1)
to treat##233##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#3)(1994-1#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#15)(2008-8#10)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#18)(2013-8#6)
to treating##2##2##(2007-8#1)(2008-11#1)
to treatment allocation##2##3##(2007-11#1)(2008-10#1)
to treatment and##7##3##(1991-3#1)(1997-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to treatment are##3##3##(1996-8#1)(2008-6#1)(2013-8#1)
to treatment by##3##3##(1993-3#1)(2008-10#1)(2010-12#1)
to treatment for##2##3##(2008-7#1)(2012-2#1)
to treatment is##2##3##(2008-1#1)(2008-5#1)
to treatment of##9##3##(1993-8#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-7#1)(2012-1#1)(2013-8#1)
to treatment or##2##3##(2007-11#1)(2012-2#1)
to treatment was##8##3##(1991-8#1)(1996-6#1)(2007-7#1)(2008-6#2)(2008-7#1)(2013-1#2)
to treatment with antibiotic##2##4##(2008-7#1)(2008-9#1)
to treatment with drugs##2##4##(1994-6#1)(1994-9#1)
to treatment with either##2##4##(1992-8#1)(2010-12#1)
to treatment with the##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
to treatment with##23##3##(1990-2#1)(1990-3#1)(1992-2#1)(1992-6#2)(1992-8#2)(1993-3#1)(1994-6#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)
to treatment##132##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#2)(1993-2#1)(1993-3#2)(1993-8#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-11#4)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#7)
to treatments##3##2##(2008-10#1)(2008-7#2)
to trees##5##2##(2008-10#4)(2010-4#1)
to tremolite##2##2##(1991-12#2)
to trends in##2##3##(1995-1#1)(2008-4#1)
to triage##3##2##(2008-7#1)(2008-9#1)(2010-8#1)
to trial##2##2##(1995-12#1)(1995-6#1)
to trifluoperizine##2##2##(1995-11#2)
to trigger and##2##3##(1994-8#1)(2007-11#1)
to trigger the##3##3##(1993-3#1)(2008-10#1)(2013-8#1)
to trigger##17##2##(1993-3#1)(1994-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
to triggering of the##2##4##(2008-8#2)
to triggering##3##2##(2008-8#2)(2009-8#1)
to trim##3##2##(1992-8#1)(1993-5#1)(2007-12#1)
to triple##2##2##(2008-9#1)(2011-1#1)
to tritiated##2##2##(1994-5#1)(2008-11#1)
to trolox##2##2##(2008-10#2)
to tropical##2##2##(2008-5#1)(2012-2#1)
to true biological##2##3##(2008-10#1)(2010-7#1)
to true##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2010-7#1)
to truncated##2##2##(1993-11#1)(1997-2#1)
to try and##2##3##(2008-1#1)(2008-3#1)
to try to##8##3##(1994-8#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
to try##13##2##(1992-1#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
to trypsin##5##2##(1990-11#1)(1990-3#1)(1991-12#1)(1992-3#1)(1993-3#1)
to tryptophan##2##2##(1993-11#1)(2012-1#1)
to tuberculin##3##2##(1990-6#2)(2010-4#1)
to tuberculosis##8##2##(1991-11#1)(2008-12#1)(2008-7#1)(2011-1#3)(2013-1#2)
to tubing##2##2##(1991-3#1)(2013-8#1)
to tumor cells##5##3##(1990-5#1)(1997-2#2)(2008-9#2)
to tumor formation##2##3##(2008-10#1)(2013-1#1)
to tumor growth##2##3##(1993-11#1)(2008-7#1)
to tumor tissue##2##3##(1993-11#1)(2009-4#1)
to tumor##32##2##(1990-5#1)(1991-12#1)(1993-11#2)(1994-9#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#2)(2009-9#3)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#2)
to tumorigenesis##4##2##(1994-12#1)(2008-6#1)(2011-2#2)
to tumors##8##2##(1993-11#2)(1995-2#1)(2008-6#1)(2011-1#2)(2011-2#1)(2013-8#1)
to tumour##7##2##(1997-4#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2013-1#1)
to tune the##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)
to tune##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-12#1)
to turbulent##2##2##(2008-3#1)(2013-1#1)
to turn##10##2##(1992-6#1)(1994-3#3)(1996-8#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-7#1)
to twelve##2##2##(1996-11#1)(2008-7#1)
to twice the##5##3##(1994-2#1)(1996-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
to twice##7##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
to twins##2##2##(1997-7#1)(2011-2#1)
to two cases##2##3##(1996-2#1)(2008-10#1)
to two decades##2##3##(2008-10#1)(2012-2#1)
to two different##10##3##(1993-2#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-4#1)
to two distinct##2##3##(1993-3#1)(2008-10#1)
to two groups##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
to two major##4##3##(1990-5#1)(1995-5#1)(1997-1#1)(2008-10#1)
to two methods for##2##4##(2008-10#2)
to two or more##2##4##(2008-10#1)(2008-4#1)
to two other##2##3##(2008-4#1)(2010-10#1)
to two possible##2##3##(1992-4#1)(2008-10#1)
to two sets of##2##4##(2008-10#1)(2008-3#1)
to two years##4##3##(1992-11#1)(1997-5#2)(2008-11#1)
to two##133##2##(1990-5#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#3)(1997-7#1)(1997-9#1)(2007-11#2)(2007-12#4)(2008-10#44)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#14)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
to two-dimensional##7##2##(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
to type 1##3##3##(1993-6#1)(2006-10#1)(2008-1#1)
to type 2 diabetes##2##4##(2008-1#1)(2011-1#1)
to type I##4##3##(2007-7#1)(2008-11#2)(2010-5#1)
to type of##5##3##(1991-3#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-1#1)
to type##22##2##(1990-8#1)(1991-3#1)(1991-8#1)(1993-6#1)(1993-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)
to types of##3##3##(1993-12#1)(2007-6#1)(2008-2#1)
to typical##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
to tyrosine kinase##2##3##(2010-4#1)(2013-1#1)
to tyrosine##3##2##(2008-1#1)(2010-4#1)(2013-1#1)
to ubiquitin##3##2##(1991-1#1)(1993-8#1)(2009-7#1)
to ultrafast##2##2##(2008-3#1)(2012-8#1)
to ultrasound##8##2##(1993-8#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
to ultraviolet irradiation##2##3##(1993-3#1)(2010-8#1)
to ultraviolet light##3##3##(1997-4#1)(2011-2#1)(2013-8#1)
to ultraviolet##8##2##(1990-9#1)(1993-3#1)(1997-4#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-8#1)
to unacceptable##2##2##(1990-2#1)(2013-1#1)
to unambiguously##2##2##(2008-10#1)(2010-12#1)
to unbalanced##2##2##(2008-11#1)(2008-3#1)
to uncertainties in the##2##4##(2008-3#2)
to uncover the##7##3##(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-12#1)(2013-1#1)
to uncover##12##2##(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-9#1)(2012-12#2)(2013-1#1)
to under##3##2##(1994-9#1)(2008-10#2)
to underestimate##2##2##(1991-3#1)(1992-6#1)
to undergo HIV-antibody testing##2##4##(1996-5#2)
to undergo a##6##3##(1992-12#1)(1993-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
to undergo an##2##3##(1992-9#1)(2007-12#1)
to undergo apoptosis in##2##4##(1995-2#1)(2008-10#1)
to undergo apoptosis##7##3##(1995-2#3)(2008-10#1)(2008-9#1)(2009-8#1)(2010-6#1)
to undergo rapid##2##3##(2009-9#1)(2010-5#1)
to undergo the##3##3##(2011-2#1)(2012-3#2)
to undergo this##2##3##(1994-12#1)(2008-7#1)
to undergo##61##2##(1990-2#1)(1991-6#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-12#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#4)
to undergraduate##4##2##(1993-3#1)(2008-11#2)(2009-2#1)
to underlie the##3##3##(1995-8#1)(1996-2#1)(2013-1#1)
to underlie##7##2##(1994-5#1)(1995-8#1)(1996-2#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
to underlying##4##2##(2007-8#2)(2010-5#2)
to undermine##2##2##(2009-11#1)(2012-2#1)
to underpin##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
to underscore the##2##3##(2008-10#1)(2011-2#1)
to underserved##2##2##(2008-4#1)(2010-11#1)
to understand and control##3##4##(2008-5#1)(2010-7#1)(2011-1#1)
to understand and##17##3##(1991-9#1)(1994-2#1)(1994-3#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#2)
to understand better the##2##4##(2007-12#1)(2009-12#1)
to understand how the##8##4##(1992-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
to understand how these##2##4##(1993-5#1)(2009-7#1)
to understand how##20##3##(1992-3#1)(1993-5#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
to understand its##2##3##(2008-5#2)
to understand more about##2##4##(2008-11#2)
to understand that##6##3##(1991-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-8#1)
to understand the complex##3##4##(2008-11#1)(2013-1#1)(2013-8#1)
to understand the consequences of##3##5##(1994-2#1)(2008-4#2)
to understand the evolution##2##4##(2008-10#1)(2009-2#1)
to understand the evolutionary##2##4##(2008-11#1)(2013-7#1)
to understand the factors##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
to understand the function of##2##5##(1997-8#1)(2008-9#1)
to understand the functional##2##4##(2007-12#1)(2009-9#1)
to understand the genetic##3##4##(2008-10#1)(2008-8#1)(2012-1#1)
to understand the impact of##2##5##(2007-12#1)(2008-10#1)
to understand the mechanism##2##4##(1994-11#1)(2008-8#1)
to understand the mechanisms##3##4##(1995-2#1)(2008-10#2)
to understand the molecular basis of##3##6##(2008-4#1)(2011-1#1)(2012-2#1)
to understand the molecular basis##4##5##(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
to understand the molecular mechanisms##2##5##(2008-10#1)(2008-4#1)
to understand the molecular##7##4##(1995-5#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)
to understand the nature and##2##5##(2008-10#1)(2008-5#1)
to understand the nature##3##4##(2008-10#2)(2008-5#1)
to understand the pathophysiology of##2##5##(1996-12#1)(2008-7#1)
to understand the physical##2##4##(2008-1#1)(2008-7#1)
to understand the potential##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
to understand the role of##5##5##(1997-2#1)(2008-6#1)(2009-7#2)(2012-3#1)
to understand the##125##3##(1990-5#1)(1990-7#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#4)(2009-9#2)(2010-3#2)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
to understand their biological##2##4##(2008-7#1)(2009-2#1)
to understand their##13##3##(1993-1#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
to understand these##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
to understand this phenomenon##3##4##(2009-9#1)(2013-1#1)(2013-8#1)
to understand this##6##3##(1994-2#1)(1996-12#1)(2009-9#1)(2013-1#1)(2013-8#2)
to understand what##4##3##(1996-6#1)(2009-10#1)(2012-1#1)(2013-8#1)
to understand whether##2##3##(2008-5#1)(2013-1#1)
to understand why##5##3##(1997-6#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
to understand##269##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#3)(1996-4#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#23)(2008-11#14)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#7)(2011-10#1)(2011-2#7)(2012-1#5)(2012-12#4)(2012-2#6)(2012-3#9)(2013-1#11)(2013-7#1)(2013-8#8)
to understanding of##2##3##(1992-12#1)(2008-9#1)
to understanding the##14##3##(1993-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2012-1#1)(2012-2#1)
to understanding##43##2##(1990-5#1)(1992-12#1)(1992-2#1)(1993-12#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-5#1)(2009-8#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#1)
to undertake a##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
to undertake further##2##3##(2008-11#1)(2008-12#1)
to undertake the##2##3##(2008-11#1)(2012-3#1)
to undertake this##2##3##(2007-10#1)(2008-11#1)
to undertake##17##2##(1991-3#1)(1992-1#1)(1992-9#1)(1994-1#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#4)(2008-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
to undetectable levels##4##3##(2008-10#3)(2008-5#1)
to undetectable##5##2##(2008-10#4)(2008-5#1)
to undifferentiated##2##2##(1992-9#1)(2009-6#1)
to unequal##3##2##(1991-12#1)(2008-10#2)
to uneven##2##2##(2008-10#1)(2013-1#1)
to unexpected##2##2##(1994-11#1)(2012-2#1)
to unexposed##2##2##(2008-10#1)(2008-3#1)
to unfamiliar##2##2##(2008-11#1)(2008-12#1)
to unfractionated##2##2##(1997-2#1)(2010-6#1)
to unhealthy##2##2##(1993-2#1)(2012-1#1)
to unify the##2##3##(2008-1#1)(2008-7#1)
to unify##8##2##(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
to unilateral##2##2##(1991-2#1)(1994-3#1)
to uninfected##6##2##(1991-5#1)(1994-9#1)(1995-2#1)(2008-4#1)(2008-8#1)(2012-3#1)
to uninsured##2##2##(1995-1#1)(1995-12#1)
to unintended##2##2##(2007-11#1)(2008-12#1)
to unipolar##2##2##(1996-3#1)(2007-8#1)
to uniquely##2##2##(2008-10#1)(2008-9#1)
to unitary##2##2##(2007-11#1)(2008-9#1)
to unite the##2##3##(2008-10#1)(2010-12#1)
to units of##2##3##(1997-3#1)(2008-2#1)
to universal precautions##2##3##(2010-3#2)
to universal##6##2##(1994-2#1)(2008-10#1)(2008-11#2)(2010-3#2)
to universities##3##2##(1994-12#1)(1997-5#1)(2008-11#1)
to university##2##2##(1990-9#1)(2011-2#1)
to unknown##5##2##(1995-12#1)(1997-8#1)(2007-12#1)(2008-7#2)
to unlinked##2##2##(1995-6#1)(1996-3#1)
to unnecessary##3##2##(1991-11#1)(2007-5#1)(2008-10#1)
to unravel the##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
to unravel##10##2##(1995-11#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-2#1)(2009-6#1)
to unrelated##2##2##(2011-2#1)(2013-1#1)
to unroof the##2##3##(2008-7#2)
to unsafe##3##2##(2008-11#2)(2012-12#1)
to unsuccessful##2##2##(2008-11#1)(2008-4#1)
to untreated control##2##3##(1997-4#1)(2008-11#1)
to untreated##9##2##(1992-5#1)(1995-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
to unwanted##3##2##(1997-5#1)(2008-10#1)(2008-2#1)
to unwind##2##2##(2012-1#2)
to up to##7##3##(1995-2#1)(2008-10#3)(2009-7#1)(2010-8#1)(2011-1#1)
to update and##2##3##(2007-12#1)(2011-1#1)
to update the##6##3##(1994-1#1)(1995-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2012-12#1)
to update their##2##3##(2008-10#1)(2010-5#1)
to update##17##2##(1991-3#1)(1994-1#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
to upper##3##2##(2008-10#2)(2009-9#1)
to upregulate##2##2##(2010-3#1)(2013-1#1)
to upstream##2##2##(2008-11#1)(2008-9#1)
to uptake##4##2##(1993-9#1)(2008-10#1)(2008-7#1)(2012-2#1)
to upward##2##2##(2007-10#1)(2008-10#1)
to uranium##2##2##(2008-10#1)(2013-1#1)
to urban##4##2##(1996-3#1)(2012-12#1)(2013-1#2)
to urea##4##2##(1995-2#2)(2008-10#2)
to uric acid was##2##4##(2008-10#2)
to uric acid##4##3##(1993-12#1)(2008-10#3)
to urinary catheters##2##3##(1996-12#2)
to urinary##6##2##(1993-8#1)(1996-12#2)(2008-1#1)(2008-7#1)(2010-5#1)
to urine samples##2##3##(2008-10#2)
to us for##2##3##(2008-11#1)(2008-8#1)
to us with##4##3##(2012-3#1)(2013-1#2)(2013-8#1)
to us##21##2##(1995-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#2)(2009-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to use HI##2##3##(1997-3#1)(2008-3#1)
to use a##22##3##(1990-3#1)(1995-1#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#4)(2008-6#1)(2008-7#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)
to use all##2##3##(2012-3#1)(2013-7#1)
to use an##5##3##(1994-3#1)(2008-2#1)(2008-3#2)(2012-3#1)
to use and##7##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)
to use as a##2##4##(2007-11#1)(2008-12#1)
to use as an##2##4##(1996-2#1)(2008-2#1)
to use as##6##3##(1996-2#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2010-12#1)
to use by##2##3##(1997-1#1)(2010-8#1)
to use chemotherapy##2##3##(1994-6#1)(2008-6#1)
to use condoms##4##3##(1990-6#1)(2008-4#3)
to use drugs##2##3##(1990-3#1)(2009-9#1)
to use for##2##3##(2008-10#2)
to use in##9##3##(1990-12#1)(1991-1#2)(1993-12#1)(2008-10#2)(2008-6#1)(2012-3#2)
to use it for the##2##5##(1997-3#1)(2008-11#1)
to use it##5##3##(1992-11#1)(1992-4#1)(1997-3#1)(2008-11#1)(2009-7#1)
to use less##2##3##(2008-10#1)(2008-11#1)
to use multiple##2##3##(2008-10#1)(2010-11#1)
to use of a##3##4##(1994-11#1)(2008-3#1)(2012-3#1)
to use of##11##3##(1993-9#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
to use only##2##3##(1991-3#1)(2008-6#1)
to use outcomes##2##3##(1994-1#1)(1996-1#1)
to use positive##2##3##(2008-7#1)(2012-12#1)
to use research in##2##4##(2008-11#1)(2009-3#1)
to use such##4##3##(1997-4#1)(2008-3#1)(2009-9#1)(2013-1#1)
to use than##3##3##(1992-3#1)(2008-7#1)(2012-2#1)
to use the same##3##4##(2008-11#1)(2008-2#1)(2008-8#1)
to use the##54##3##(1990-11#1)(1990-2#2)(1990-3#1)(1991-1#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#7)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2010-5#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to use their own ventilators or##2##6##(2011-1#2)
to use their##4##3##(1994-12#1)(2011-1#2)(2012-2#1)
to use them to##3##4##(1993-12#1)(2008-10#1)(2013-7#1)
to use them##5##3##(1993-12#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-7#1)
to use these##6##3##(1991-1#1)(1994-2#1)(1994-8#1)(2008-10#2)(2010-3#1)
to use thin##2##3##(2007-11#1)(2008-3#1)
to use this##9##3##(1993-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2010-5#1)(2012-3#1)
to use to##4##3##(2007-4#1)(2009-10#1)(2012-12#1)(2013-8#1)
to use when##3##3##(1997-3#1)(2008-9#1)(2010-10#1)
to use##362##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#1)(1990-9#1)(1991-1#4)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#1)(1993-5#1)(1993-9#2)(1994-1#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#3)(1997-3#7)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#35)(2008-11#17)(2008-12#10)(2008-2#6)(2008-3#28)(2008-4#25)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#13)(2009-10#3)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#6)(2010-7#1)(2010-8#7)(2011-1#3)(2011-2#10)(2011-3#1)(2012-12#6)(2012-2#7)(2012-3#10)(2013-1#6)(2013-7#3)(2013-8#5)
to useful##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
to user##3##2##(2008-10#1)(2011-2#2)
to users##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
to using a##2##3##(2012-1#1)(2013-1#1)
to using mice##2##3##(2008-6#2)
to using##11##2##(1992-5#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
to usual##2##2##(2008-4#1)(2008-5#1)
to utilise##2##2##(2006-6#1)(2008-10#1)
to utilization of##2##3##(1991-12#1)(2008-8#1)
to utilization##3##2##(1991-12#1)(1995-12#1)(2008-8#1)
to utilize a##3##3##(1994-2#1)(1995-5#1)(2011-2#1)
to utilize the##8##3##(1995-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
to utilize this##4##3##(1994-3#1)(2008-1#1)(2008-4#1)(2008-5#1)
to utilize xylose##2##3##(2008-6#1)(2012-3#1)
to utilize##36##2##(1991-3#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to vaccinate their daughters##4##4##(2011-1#4)
to vaccination against hepatitis B##2##5##(1993-6#1)(2013-1#1)
to vaccination in##2##3##(2010-4#1)(2011-2#1)
to vaccination##11##2##(1990-11#1)(1993-6#1)(1997-3#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#2)
to vaccine##4##2##(1995-5#1)(2011-2#2)(2012-12#1)
to vaccines##3##2##(2007-11#1)(2009-4#1)(2013-1#1)
to validate a##8##3##(1996-2#1)(2008-10#3)(2008-7#1)(2013-1#2)(2013-8#1)
to validate and##2##3##(2008-3#1)(2009-11#1)
to validate our##2##3##(2008-1#1)(2012-3#1)
to validate the developed##2##4##(2008-10#1)(2011-2#1)
to validate the impact of##2##5##(2011-2#1)(2013-1#1)
to validate the model##6##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)
to validate the proposed##2##4##(2008-2#1)(2008-7#1)
to validate the technique##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
to validate the##46##3##(1991-5#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-7#3)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#1)
to validate this##5##3##(1994-2#1)(1995-3#1)(1995-5#1)(2008-1#1)(2013-1#1)
to validate##75##2##(1991-5#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#1)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#10)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
to validation##2##2##(2008-10#1)(2010-11#1)
to valine##2##2##(1992-9#1)(1993-11#1)
to value##2##2##(1994-12#1)(1995-12#1)
to values below##2##3##(2008-10#1)(2012-3#1)
to values greater than##2##4##(1990-5#1)(2008-3#1)
to values##14##2##(1990-12#2)(1990-5#2)(1992-2#1)(1994-6#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-3#1)
to vancomycin##11##2##(1995-2#1)(2007-12#2)(2007-7#3)(2010-8#2)(2011-2#2)(2012-12#1)
to vanish##2##2##(1990-5#1)(2009-2#1)
to vapor##2##2##(2008-10#2)
to vaporize##2##2##(2008-3#1)(2010-8#1)
to variable##3##2##(1990-12#1)(2008-8#1)(2011-2#1)
to variances in##2##3##(2008-11#1)(2008-9#1)
to variation in##11##3##(1996-2#1)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#1)(2009-10#1)(2011-2#1)
to variation##14##2##(1996-2#1)(2008-1#1)(2008-10#4)(2008-8#3)(2008-9#2)(2009-10#1)(2011-2#1)(2012-3#1)
to variations in the##9##4##(1992-3#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)
to variations in##14##3##(1990-2#2)(1992-3#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
to variations##15##2##(1990-2#2)(1992-3#1)(1993-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
to various antibiotics##2##3##(2008-12#1)(2011-1#1)
to various aspects of##2##4##(1994-5#1)(2012-3#1)
to various degrees##3##3##(1991-12#1)(1993-3#1)(1995-6#1)
to various drugs##3##3##(1991-12#1)(1994-8#1)(2008-10#1)
to various extents##2##3##(1990-5#1)(1992-9#1)
to various forms of##2##4##(1993-9#1)(2008-3#1)
to various groups of##2##4##(2007-7#1)(2008-8#1)
to various optical##2##3##(2008-2#1)(2008-3#1)
to various stimuli##7##3##(1991-2#1)(1995-8#1)(2008-4#3)(2009-3#1)(2010-12#1)
to various water samples##3##4##(2008-10#3)
to various##110##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2009-12#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
to vary according to##3##4##(1992-11#1)(2007-10#1)(2010-2#1)
to vary from##3##3##(1992-11#1)(1992-3#1)(2008-2#1)
to vary in##3##3##(2008-10#3)
to vary little##2##3##(2008-10#2)
to vary significantly##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
to vary the##2##3##(2008-2#1)(2008-3#1)
to vary with##3##3##(1997-3#2)(2008-8#1)
to vary##31##2##(1992-11#2)(1992-12#1)(1992-3#1)(1995-2#1)(1995-3#1)(1997-3#2)(2007-10#1)(2008-10#8)(2008-2#4)(2008-3#4)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2013-1#2)
to varying concentrations of##2##4##(2008-10#1)(2009-11#1)
to varying degrees##2##3##(1993-1#1)(2008-9#1)
to varying extents##3##3##(1992-11#1)(1994-11#1)(2008-10#1)
to varying##12##2##(1992-11#1)(1993-1#1)(1994-11#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-3#1)
to vascular endothelial cells##2##4##(1992-12#1)(1997-1#1)
to vascular endothelial growth factor##3##5##(2008-8#2)(2010-1#1)
to vascular endothelial##6##3##(1992-12#1)(1997-1#1)(2008-8#2)(2010-1#1)(2013-8#1)
to vascular muscle##3##3##(1991-6#3)
to vascular smooth muscle cells##2##5##(1994-6#1)(2008-5#1)
to vascular##19##2##(1991-6#3)(1992-12#2)(1994-6#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-3#1)(2013-8#1)
to vasopressin##3##2##(1990-12#1)(2007-9#1)(2013-1#1)
to vector##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
to vectors##2##2##(2008-10#1)(2011-2#1)
to vegetative##4##2##(2008-10#1)(2008-8#1)(2011-2#2)
to vehicle control##3##3##(1994-9#1)(2008-10#1)(2010-5#1)
to vehicle##6##2##(1991-10#1)(1993-3#1)(1994-9#1)(1996-12#1)(2008-10#1)(2010-5#1)
to vehicle-injected##2##2##(1993-9#1)(1997-2#1)
to velocity##2##2##(2008-2#1)(2008-3#1)
to venous thromboembolism##2##3##(2007-10#1)(2008-3#1)
to venous##6##2##(1996-9#1)(1997-1#1)(2007-10#1)(2008-3#1)(2011-2#1)(2012-1#1)
to ventricular##2##2##(2008-8#1)(2009-10#1)
to ventromedial##2##2##(1991-5#1)(2008-11#1)
to verbs##2##2##(1991-2#1)(2008-11#1)
to verify a##3##3##(1996-3#1)(2006-10#1)(2008-12#1)
to verify and##3##3##(1997-3#1)(2008-10#1)(2010-3#1)
to verify if the##3##4##(2007-7#1)(2008-10#1)(2010-3#1)
to verify if##5##3##(2007-7#1)(2008-10#3)(2010-3#1)
to verify its feasibility##2##4##(2008-10#2)
to verify its##3##3##(2007-7#1)(2008-10#2)
to verify that the##2##4##(1997-3#1)(2008-3#1)
to verify that##5##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
to verify the effect of##2##5##(1997-2#1)(2008-7#1)
to verify the effectiveness of##2##5##(1991-6#1)(2008-2#1)
to verify the effectiveness##3##4##(1991-6#1)(2008-2#1)(2008-5#1)
to verify the influence of##2##5##(2008-7#1)(2013-7#1)
to verify the##45##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#3)(2007-8#2)(2008-10#9)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#6)(2008-9#2)(2009-2#1)(2009-7#1)(2010-5#2)(2010-6#1)(2011-2#1)(2013-7#1)
to verify their##2##3##(2008-10#1)(2013-7#1)
to verify whether##3##3##(2008-11#1)(2010-9#1)(2011-2#1)
to verify##87##2##(1990-5#1)(1990-6#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-5#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-9#3)(2009-2#1)(2009-7#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#3)(2012-2#1)(2013-7#2)
to vertebral##3##2##(1993-11#1)(2008-7#1)(2009-3#1)
to vertebrate##3##2##(1995-2#1)(2008-7#1)(2008-9#1)
to vertebrates##2##2##(2008-12#1)(2012-3#1)
to very good##4##3##(1990-9#1)(1991-3#1)(2008-4#2)
to very high##3##3##(1997-6#1)(2007-6#1)(2010-6#1)
to very low##3##3##(1993-3#1)(2007-12#1)(2012-2#1)
to very stable##2##3##(2008-10#2)
to very##21##2##(1990-9#1)(1991-3#1)(1993-3#2)(1997-3#1)(1997-6#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-4#2)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
to vesicle##4##2##(1992-6#2)(1997-1#1)(2008-11#1)
to vesicles##2##2##(1990-11#1)(2008-10#1)
to vessels and##2##3##(1997-4#1)(2008-2#1)
to vessels##3##2##(1997-4#1)(2006-6#1)(2008-2#1)
to viability##2##2##(2008-11#1)(2008-9#1)
to viable##4##2##(2007-7#1)(2008-11#3)
to vibrations##2##2##(2008-2#2)
to victims of##2##3##(1995-12#1)(2012-12#1)
to video##2##2##(2008-11#1)(2008-3#1)
to view the##8##3##(1993-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-8#1)
to view##22##2##(1992-3#1)(1993-1#2)(1994-8#1)(1995-1#1)(1996-2#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
to vinclozolin (S(T)R(V))##4##3##(2008-10#4)
to vinclozolin##10##2##(2008-10#10)
to vincristine and##2##3##(1993-8#2)
to vincristine plus##2##3##(1993-8#2)
to vincristine##4##2##(1993-8#4)
to vinyl carbamate##2##3##(1994-2#2)
to vinyl##3##2##(1994-2#2)(2012-2#1)
to violate the##2##3##(1995-8#1)(2012-2#1)
to violations of the##2##4##(1994-9#1)(2010-2#1)
to violations of##4##3##(1994-9#2)(2008-8#1)(2010-2#1)
to violence and##3##3##(1995-8#1)(2008-11#1)(2009-9#1)
to violence##8##2##(1995-8#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-9#4)
to violent##2##2##(2007-10#1)(2010-6#1)
to viral RNA##2##3##(2008-10#2)
to viral infection##5##3##(1991-2#1)(2007-10#2)(2007-11#1)(2007-8#1)
to viral infections##3##3##(2008-1#1)(2008-7#1)(2013-1#1)
to viral##18##2##(1991-2#1)(1995-2#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
to virtually any##3##3##(1996-12#1)(2008-3#1)(2010-4#1)
to virulence to##2##3##(2008-10#2)
to virulence##4##2##(2008-10#4)
to virulent##2##2##(2008-10#2)
to virus infection##3##3##(2008-10#2)(2008-11#1)
to virus transmission##2##3##(2008-10#2)
to virus##10##2##(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#1)
to viruses in##2##3##(2007-11#1)(2008-10#1)
to viruses##4##2##(2006-5#1)(2007-11#1)(2008-10#2)
to visceral leishmaniasis##2##3##(2008-7#2)
to visceral##3##2##(2008-7#2)(2009-2#1)
to visible##2##2##(2007-12#1)(2008-3#1)
to vision##2##2##(1993-3#1)(2008-4#1)
to visit a##2##3##(1993-8#1)(1996-8#1)
to visit##8##2##(1992-12#1)(1993-8#1)(1995-6#1)(1996-8#1)(2008-11#1)(2008-7#1)(2008-8#2)
to visual##8##2##(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-7#1)
to visualise the##2##3##(1996-5#1)(2012-2#1)
to visualise##5##2##(1996-5#1)(2008-11#1)(2008-8#1)(2012-2#2)
to visualize and##2##3##(2008-11#1)(2012-2#1)
to visualize the##14##3##(1990-5#1)(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
to visualize##32##2##(1990-10#1)(1990-5#1)(1994-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-8#2)
to visually perceived##2##3##(1995-5#2)
to vitamin A##3##3##(1991-8#1)(1992-8#1)(2008-11#1)
to vitamin C##2##3##(2008-5#1)(2012-2#1)
to vitamin D response elements##2##5##(1995-8#1)(2008-1#1)
to vitamin D##4##3##(1995-8#1)(2008-1#2)(2011-2#1)
to vitamin E##2##3##(1994-5#1)(1996-3#1)
to vitamin##13##2##(1991-8#1)(1992-8#1)(1994-5#1)(1995-8#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
to vocal##2##2##(2007-6#2)
to voice##2##2##(1993-1#1)(1996-11#1)
to volatile##4##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-8#1)
to voltammetric##2##2##(2008-10#2)
to volume##6##2##(1991-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-1#1)
to volunteer##4##2##(1994-2#2)(1994-3#1)(1995-2#1)
to von Frey##2##3##(1997-2#1)(2009-12#1)
to von##3##2##(1993-3#1)(1997-2#1)(2009-12#1)
to vulnerable##2##2##(1993-2#1)(2012-12#1)
to wait for##2##3##(1994-1#1)(2007-7#1)
to wait##5##2##(1994-1#1)(1995-12#1)(2007-7#1)(2012-3#1)(2013-7#1)
to waiting##3##2##(1997-1#1)(2008-12#1)(2008-5#1)
to walk##12##2##(1991-9#1)(1996-9#3)(2007-10#1)(2007-11#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to war##2##2##(1993-9#1)(1994-9#1)
to warfarin##3##2##(2011-1#1)(2012-12#2)
to warm##2##2##(1993-3#1)(2008-10#1)
to warn##2##2##(1997-1#1)(2008-7#1)
to warrant##4##2##(2007-7#1)(2008-10#2)(2011-2#1)
to waste##5##2##(1993-1#1)(2008-10#3)(2011-2#1)
to wastewater##2##2##(2008-10#2)
to watch##5##2##(1995-12#1)(1997-2#1)(2008-10#1)(2009-12#1)(2011-2#1)
to water analysis##4##3##(2008-10#4)
to water and##7##3##(1995-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-3#1)
to water deficit##2##3##(2009-8#2)
to water samples and##2##4##(2008-10#2)
to water samples##9##3##(2008-10#9)
to water stress##4##3##(2009-8#2)(2012-7#2)
to water vapor##3##3##(1997-1#1)(2008-10#2)
to water##50##2##(1990-2#1)(1991-5#1)(1993-11#1)(1995-2#1)(1997-1#1)(2008-10#22)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#4)(2009-9#1)(2010-3#2)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-7#2)(2013-1#1)
to water-leaving##2##2##(2008-3#2)
to water-soluble chromium##2##3##(1994-5#2)
to water-soluble##3##2##(1992-3#1)(1994-5#2)
to waveguide##2##2##(2007-12#2)
to weak##3##2##(1992-12#1)(1993-11#1)(1995-5#1)
to weaken##2##2##(1995-2#1)(2008-9#1)
to wean from##2##3##(2010-8#1)(2013-1#1)
to wear a##2##3##(2008-12#1)(2012-12#1)
to wear##5##2##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
to weather variables##2##3##(2008-10#2)
to weather##5##2##(2008-10#4)(2013-8#1)
to web##2##2##(2010-4#1)(2011-2#1)
to week##2##2##(2008-7#2)
to weeks##3##2##(1997-1#1)(2008-9#1)(2009-12#1)
to weigh##3##2##(1991-9#1)(2008-10#1)(2012-12#1)
to weight loss##3##3##(1995-12#1)(2008-3#1)(2012-2#1)
to weight##4##2##(1995-12#1)(2008-3#1)(2012-2#2)
to well##2##2##(2008-10#1)(2008-11#1)
to well-being##2##2##(2010-2#1)(2010-4#1)
to well-established##2##2##(2008-7#1)(2010-10#1)
to western##2##2##(2008-10#1)(2011-2#1)
to wet digestion##2##3##(2008-10#2)
to wet heat at##2##4##(2008-5#1)(2011-2#1)
to wet##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
to what can be##2##4##(2008-11#1)(2012-3#1)
to what degree##3##3##(1991-12#1)(2007-5#1)(2008-2#1)
to what extent the intended##2##5##(1995-6#2)
to what extent the##11##4##(1995-6#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
to what extent##26##3##(1992-1#1)(1992-12#1)(1995-6#2)(1996-12#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-7#1)
to what has been##5##4##(2007-11#1)(2008-10#2)(2008-3#1)(2010-4#1)
to what has##6##3##(2007-11#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-4#1)
to what is expected##2##4##(2008-8#1)(2008-9#1)
to what is generally##2##4##(1990-2#1)(2008-5#1)
to what is observed in##2##5##(1995-12#1)(1995-3#1)
to what is##13##3##(1990-2#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)(2013-1#1)
to what was observed##2##4##(2008-11#1)(2012-3#1)
to what was##3##3##(2007-2#1)(2008-11#1)(2012-3#1)
to what##73##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
to wheat (Triticum aestivum)##2##4##(2008-10#2)
to wheat chromosomes 7A and 7D##2##6##(2008-5#2)
to wheat leaf rust##2##4##(2008-10#2)
to wheat or##2##3##(2008-10#2)
to wheat stripe rust##2##4##(2008-10#2)
to wheat##19##2##(1990-3#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)
to when the##2##3##(1997-8#1)(2011-2#1)
to when##4##2##(1997-8#1)(2008-8#1)(2011-1#1)(2011-2#1)
to where##3##2##(1996-1#1)(2008-3#1)(2012-2#1)
to whether it is##2##4##(1996-12#1)(2008-10#1)
to whether the##6##3##(1990-6#1)(1991-1#1)(1994-12#1)(2008-11#1)(2008-12#1)(2008-2#1)
to whether this##2##3##(1992-12#1)(1994-2#1)
to whether##25##2##(1990-11#1)(1990-6#2)(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
to which a different toxicity and therefore##2##7##(2008-10#2)
to which a##8##3##(1990-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2012-2#1)
to which it is##5##4##(1990-5#1)(1992-3#1)(1994-12#1)(2008-10#1)(2009-12#1)
to which it##7##3##(1990-5#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-12#1)
to which other##2##3##(1995-2#1)(2009-9#1)
to which the maximum##2##4##(2007-10#1)(2008-2#1)
to which the test product is##2##6##(2008-5#2)
to which the##49##3##(1991-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#5)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#1)
to which their##2##3##(2008-9#1)(2009-7#1)
to which these##5##3##(1990-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-9#1)
to which they are##2##4##(1994-3#1)(1996-1#1)
to which they belong##3##4##(2008-9#1)(2009-5#1)(2011-2#1)
to which they had##2##4##(2008-8#1)(2010-4#1)
to which they have been##2##5##(1991-12#1)(2011-2#1)
to which they have##3##4##(1991-12#1)(2008-8#1)(2011-2#1)
to which they##19##3##(1991-12#1)(1994-3#1)(1996-1#1)(1996-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
to which this##3##3##(1995-2#1)(1997-3#1)(2008-6#1)
to which we##2##3##(2007-12#1)(2008-5#1)
to which##207##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-9#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#8)(2009-11#2)(2009-12#1)(2009-5#5)(2009-7#2)(2009-8#1)(2009-9#5)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
to whispering-gallery modes##3##3##(2007-12#3)
to white##11##2##(1993-5#1)(1995-8#1)(2008-10#8)(2010-11#1)
to whole tissue##2##3##(2010-9#2)
to whole##7##2##(1995-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#2)
to whom the##2##3##(1994-3#1)(2007-8#1)
to whom##6##2##(1994-3#1)(1996-2#1)(2007-8#1)(2010-4#1)(2011-3#1)(2012-12#1)
to wide local excision##2##4##(2008-6#1)(2010-8#1)
to wide##4##2##(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)
to widen the##4##3##(2008-10#1)(2008-12#1)(2010-12#1)(2010-4#1)
to widespread##3##2##(1997-6#1)(2008-10#1)(2011-3#1)
to wild type##6##3##(1995-2#1)(1997-7#1)(2009-8#1)(2011-1#1)(2012-2#2)
to wild##10##2##(1991-9#1)(1995-2#1)(1997-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
to wild-type Mb##2##3##(1994-5#2)
to wild-type hIK1##2##3##(2008-8#2)
to wild-type##19##2##(1990-8#1)(1993-8#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#3)
to win##4##2##(1992-2#1)(1996-1#1)(2008-8#1)(2009-10#1)
to wind##2##2##(2008-3#1)(2008-8#1)
to wine##3##2##(2008-10#3)
to winter##3##2##(2008-10#3)
to withdraw##6##2##(1994-2#1)(1995-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#1)
to withdrawal of the##2##4##(1990-6#1)(1997-1#1)
to withdrawal of##4##3##(1990-6#1)(1994-11#1)(1997-1#1)(2007-7#1)
to withdrawal##5##2##(1990-6#1)(1994-11#1)(1997-1#1)(2007-7#1)(2008-2#1)
to within +/-0##4##3##(2008-3#4)
to within +/-5%##2##3##(2008-2#1)(2008-3#1)
to within 0##4##3##(2008-2#1)(2008-3#3)
to within 1%##3##3##(2008-1#1)(2008-3#2)
to within 10%##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
to within 3##2##3##(2008-3#2)
to within 4##2##3##(1995-3#1)(2013-1#1)
to within 4%##2##3##(2008-2#1)(2008-3#1)
to within a few##3##4##(2008-3#3)
to within a##8##3##(2008-2#1)(2008-3#7)
to within the##3##3##(1991-2#1)(2008-10#1)(2008-3#1)
to within##59##2##(1991-2#1)(1991-5#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#8)(2008-3#35)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
to withstand##10##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-2#1)(2010-8#1)(2012-3#2)
to women in##2##3##(1991-3#1)(1993-6#1)
to women postpartum##2##3##(2007-11#2)
to women who are##2##4##(1997-1#1)(2012-3#1)
to women with##2##3##(2007-12#1)(2008-3#1)
to women##19##2##(1991-12#1)(1991-3#1)(1991-8#1)(1993-6#1)(1996-9#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to women's health##3##3##(1994-9#1)(1996-11#1)(2008-11#1)
to women's##7##2##(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(2007-2#1)(2008-11#1)(2011-2#1)
to wood##5##2##(1990-6#1)(1992-10#1)(2008-10#1)(2008-5#1)(2010-4#1)
to work and##6##3##(1993-2#1)(1994-3#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
to work as a##3##4##(2008-10#2)(2008-11#1)
to work as##4##3##(2008-10#3)(2008-11#1)
to work collaboratively with##2##4##(2008-12#1)(2011-1#1)
to work collaboratively##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
to work differently##2##3##(1991-1#1)(1995-1#1)
to work effectively with##2##4##(2007-12#1)(2008-12#1)
to work for##2##3##(1996-1#1)(2012-1#1)
to work in partnership to##2##5##(1996-2#1)(2008-11#1)
to work in partnership with##3##5##(2008-11#1)(2008-12#2)
to work in partnership##5##4##(1996-2#1)(2008-11#2)(2008-12#2)
to work in##9##3##(1996-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2011-2#1)
to work on the##2##4##(1992-12#1)(2008-10#1)
to work on##7##3##(1992-12#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-6#1)(2013-7#1)
to work rates and##2##4##(2007-11#1)(2012-12#1)
to work rates##3##3##(2007-11#2)(2012-12#1)
to work to##2##3##(2007-2#1)(2008-7#1)
to work together to##2##4##(1991-3#1)(2012-2#1)
to work together##4##3##(1991-12#1)(1991-3#1)(1996-12#1)(2012-2#1)
to work well##4##3##(1994-2#1)(2008-10#2)(2008-3#1)
to work with the##2##4##(1997-2#1)(2009-10#1)
to work with##14##3##(1991-2#1)(1992-12#1)(1994-1#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2013-8#1)
to work within##2##3##(1992-5#1)(2007-10#1)
to work##109##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-5#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-5#2)(1997-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#10)(2008-11#8)(2008-12#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-9#3)(2010-6#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
to workers in the##3##4##(1995-1#1)(2008-7#1)(2011-2#1)
to workplace##2##2##(2008-7#1)(2011-2#1)
to worsening##3##2##(2008-10#1)(2008-3#1)(2009-3#1)
to wound healing in##2##4##(2009-12#1)(2011-2#1)
to wound healing##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
to wound##6##2##(2008-7#3)(2009-12#1)(2011-2#1)(2013-1#1)
to write a##2##3##(2008-3#1)(2010-7#1)
to write the##2##3##(2008-3#1)(2008-6#1)
to write##11##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-4#1)(2010-7#1)(2013-1#1)
to writing##2##2##(1995-11#1)(1996-6#1)
to x-ray##2##2##(1992-6#1)(1996-6#1)
to xanthine##3##2##(1991-9#2)(1993-12#1)
to xylem##2##2##(2008-10#1)(2008-11#1)
to year and##4##3##(2008-10#3)(2013-1#1)
to year##13##2##(1993-2#1)(2008-10#5)(2008-12#1)(2008-8#3)(2011-2#2)(2013-1#1)
to years##4##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
to yeast cells##2##3##(1990-2#1)(2008-10#1)
to yeast##16##2##(1990-2#1)(1990-5#2)(1990-8#1)(1994-6#2)(1995-9#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-8#1)(2008-9#1)
to yellow rust##2##3##(2008-10#2)
to yellow##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
to yield a detection limit of##2##6##(2008-10#2)
to yield a high##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
to yield a variety of##2##5##(1994-11#1)(2007-11#1)
to yield a##33##3##(1994-11#1)(1995-2#1)(1995-8#2)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)
to yield an accurate##2##4##(2007-11#1)(2012-1#1)
to yield an##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
to yield deconvolution##3##3##(2008-10#3)
to yield new##2##3##(2009-5#1)(2012-2#1)
to yield similar##2##3##(1990-8#1)(1991-3#1)
to yield the##24##3##(1990-8#1)(1991-9#1)(1993-11#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)
to yield##144##2##(1990-7#3)(1990-8#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#3)(1994-11#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#11)(2008-3#20)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#3)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
to young##13##2##(1991-12#2)(1992-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#1)(2013-1#1)(2013-7#1)
to younger patients##2##3##(1991-12#1)(2008-7#1)
to younger##3##2##(1991-12#1)(1996-2#1)(2008-7#1)
to your clinical##2##3##(1997-2#1)(2011-2#1)
to your##10##2##(1992-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-4#1)(2011-2#1)
to youth's time in##2##4##(2009-7#2)
to zearalenone##3##2##(2008-10#1)(2013-1#2)
to zero at an##2##4##(1991-11#1)(2008-10#1)
to zero for##2##3##(2008-3#2)
to zero in##2##3##(2008-1#1)(2008-11#1)
to zero or##2##3##(1990-8#1)(1997-7#1)
to zero##32##2##(1990-8#1)(1991-11#1)(1993-12#1)(1994-11#1)(1996-9#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-9#2)(2010-5#1)(2012-2#1)(2013-8#2)
to zidovudine) from replicating with EC50##2##6##(2011-3#2)
to zinc##5##2##(1992-6#2)(2008-1#1)(2008-12#1)(2010-11#1)
to ~0##2##2##(2008-2#1)(2012-12#1)
to ~1##2##2##(2007-11#1)(2008-3#1)
to ~2%##2##2##(2007-11#1)(2008-2#1)
to β-cell##3##2##(2010-11#3)
to##114429##1##(1990-10#67)(1990-11#395)(1990-12#463)(1990-2#411)(1990-3#187)(1990-4#28)(1990-5#504)(1990-6#207)(1990-7#248)(1990-8#371)(1990-9#145)(1991-1#211)(1991-10#28)(1991-11#170)(1991-12#650)(1991-2#433)(1991-3#354)(1991-4#62)(1991-5#369)(1991-6#312)(1991-7#61)(1991-8#212)(1991-9#284)(1992-1#219)(1992-10#106)(1992-11#317)(1992-12#564)(1992-2#327)(1992-3#641)(1992-4#65)(1992-5#200)(1992-6#467)(1992-7#25)(1992-8#361)(1992-9#317)(1993-1#250)(1993-10#14)(1993-11#381)(1993-12#810)(1993-2#347)(1993-3#507)(1993-5#93)(1993-6#426)(1993-7#3)(1993-8#409)(1993-9#267)(1994-1#237)(1994-10#23)(1994-11#429)(1994-12#646)(1994-2#652)(1994-3#641)(1994-5#439)(1994-6#381)(1994-7#43)(1994-8#470)(1994-9#334)(1995-1#285)(1995-10#12)(1995-11#365)(1995-12#812)(1995-2#879)(1995-3#598)(1995-4#19)(1995-5#507)(1995-6#539)(1995-8#313)(1995-9#109)(1996-1#382)(1996-10#28)(1996-11#136)(1996-12#703)(1996-2#683)(1996-3#531)(1996-4#83)(1996-5#487)(1996-6#211)(1996-7#67)(1996-8#115)(1996-9#154)(1997-1#418)(1997-2#684)(1997-3#649)(1997-4#506)(1997-5#193)(1997-6#407)(1997-7#481)(1997-8#390)(1997-9#24)(2006-10#174)(2006-11#1)(2006-12#52)(2006-4#10)(2006-5#19)(2006-6#40)(2006-7#4)(2006-8#21)(2006-9#1)(2007-1#11)(2007-10#462)(2007-11#1694)(2007-12#2099)(2007-2#295)(2007-3#13)(2007-4#77)(2007-5#184)(2007-6#123)(2007-7#567)(2007-8#737)(2007-9#81)(2008-1#1313)(2008-10#20339)(2008-11#4853)(2008-12#1805)(2008-2#2648)(2008-3#5019)(2008-4#1942)(2008-5#2901)(2008-6#1249)(2008-7#3728)(2008-8#2648)(2008-9#2600)(2009-1#74)(2009-10#539)(2009-11#408)(2009-12#447)(2009-2#223)(2009-3#309)(2009-4#312)(2009-5#568)(2009-6#357)(2009-7#565)(2009-8#611)(2009-9#393)(2010-1#214)(2010-10#440)(2010-11#466)(2010-12#529)(2010-2#267)(2010-3#561)(2010-4#517)(2010-5#589)(2010-6#333)(2010-7#310)(2010-8#841)(2010-9#180)(2011-1#1473)(2011-10#41)(2011-2#3923)(2011-3#146)(2011-4#2)(2011-6#1)(2011-7#42)(2011-8#3)(2011-9#18)(2012-1#450)(2012-12#1442)(2012-2#2373)(2012-3#1781)(2012-4#16)(2012-5#49)(2012-6#30)(2012-7#38)(2012-8#29)(2012-9#22)(2013-1#3346)(2013-2#2)(2013-3#5)(2013-7#468)(2013-8#1613)
to)##3##1##(2008-8#1)(2009-7#1)(2013-1#1)
toad##10##1##(1993-5#2)(2008-12#2)(2008-5#4)(2008-6#1)(2013-1#1)
toads (Bufo##2##2##(2008-6#1)(2013-1#1)
toads##7##1##(2008-5#1)(2008-6#4)(2013-1#2)
tobacco (Nicotiana tabacum)##3##3##(2008-10#2)(2008-9#1)
tobacco (Nicotiana##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
tobacco addiction##2##2##(2011-2#1)(2012-12#1)
tobacco and alcohol##5##3##(1996-1#1)(2008-1#1)(2008-10#1)(2009-6#1)(2013-1#1)
tobacco and tomato##2##3##(2008-10#2)
tobacco and##22##2##(1993-11#1)(1994-8#1)(1996-1#2)(1997-1#1)(2008-1#1)(2008-10#11)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
tobacco as##2##2##(1990-8#1)(1991-4#1)
tobacco blue mold##2##3##(2008-10#2)
tobacco can##2##2##(1992-6#1)(2008-9#1)
tobacco cells exhibited##2##3##(2009-6#2)
tobacco cells##7##2##(1997-4#1)(2008-10#1)(2009-6#5)
tobacco cessation intervention##2##3##(2008-4#2)
tobacco cessation##9##2##(2007-12#3)(2008-4#3)(2009-9#1)(2012-2#1)(2013-1#1)
tobacco chewing##3##2##(2008-10#1)(2013-1#2)
tobacco consumption##2##2##(1994-6#2)
tobacco control##3##2##(1996-1#1)(2010-2#1)(2012-12#1)
tobacco dependence##4##2##(1997-3#1)(2010-11#2)(2013-7#1)
tobacco exhibiting##2##2##(2008-10#2)
tobacco exposed##2##2##(2013-1#2)
tobacco exposure##4##2##(1991-12#2)(2012-12#1)(2013-1#1)
tobacco habit in##2##3##(1991-6#1)(1993-9#1)
tobacco hornworm##3##2##(1991-12#1)(2008-7#2)
tobacco in the most recent previous growing season##2##8##(2011-2#2)
tobacco in the##3##3##(2008-1#1)(2011-2#2)
tobacco in##8##2##(1992-6#1)(2008-1#2)(2008-10#2)(2011-2#2)(2012-2#1)
tobacco industry##2##2##(2009-7#2)
tobacco ingredients##2##2##(2009-7#2)
tobacco leaf##2##2##(2008-10#2)
tobacco leaves##5##2##(2008-10#4)(2008-7#1)
tobacco markets and##2##3##(2009-7#2)
tobacco mosaic virus isolated from##2##5##(2008-8#1)(2008-9#1)
tobacco mosaic virus##13##3##(1997-3#1)(1997-6#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#4)
tobacco mosaic##14##2##(1997-3#1)(1997-6#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#4)
tobacco plant##4##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-9#1)
tobacco plants and##2##3##(1997-6#1)(2011-10#1)
tobacco plants in##2##3##(2008-10#2)
tobacco plants were##2##3##(2008-10#2)
tobacco plants with##2##3##(2008-10#2)
tobacco plants##37##2##(1991-7#1)(1997-2#3)(1997-6#4)(2008-10#22)(2008-8#2)(2008-9#2)(2009-8#2)(2011-10#1)
tobacco product##2##2##(1991-5#1)(2009-7#1)
tobacco products##2##2##(1991-5#1)(2009-7#1)
tobacco protoplasts##9##2##(2008-10#4)(2008-11#1)(2008-8#4)
tobacco samples##2##2##(2008-10#2)
tobacco shows##2##2##(2008-10#1)(2008-9#1)
tobacco smoke and##3##3##(1994-2#1)(1996-3#1)(2008-10#1)
tobacco smoke components##2##3##(2013-1#2)
tobacco smoke##18##2##(1991-12#2)(1991-3#1)(1991-4#2)(1992-9#1)(1993-11#1)(1994-2#2)(1995-6#1)(1996-3#2)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#3)
tobacco smoking and##2##3##(2009-5#1)(2013-1#1)
tobacco smoking##5##2##(2008-12#1)(2009-5#1)(2011-1#1)(2013-1#2)
tobacco suspension cell##2##3##(2008-10#2)
tobacco suspension##3##2##(2008-10#2)(2008-8#1)
tobacco to##2##2##(1991-5#1)(1996-1#1)
tobacco use and##2##3##(1997-1#1)(2008-4#1)
tobacco use control##2##3##(1997-1#2)
tobacco use##17##2##(1991-5#2)(1994-3#1)(1997-1#6)(2007-12#2)(2008-11#1)(2008-4#2)(2008-6#2)(2008-9#1)
tobacco users##3##2##(2007-12#2)(2008-4#1)
tobacco was##2##2##(1994-12#1)(2008-9#1)
tobacco were##2##2##(2008-10#2)
tobacco with##4##2##(2007-12#1)(2008-10#2)(2012-2#1)
tobacco##369##1##(1990-2#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-3#1)(1991-4#4)(1991-5#6)(1991-6#1)(1991-7#1)(1992-2#2)(1992-6#8)(1992-8#3)(1992-9#2)(1993-11#2)(1993-6#2)(1993-9#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#6)(1996-3#2)(1996-8#2)(1997-1#8)(1997-2#9)(1997-3#2)(1997-4#3)(1997-6#5)(1997-8#1)(2007-12#10)(2007-7#2)(2008-1#5)(2008-10#132)(2008-11#6)(2008-12#1)(2008-4#9)(2008-6#3)(2008-7#6)(2008-8#13)(2008-9#22)(2009-10#1)(2009-5#1)(2009-6#6)(2009-7#10)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-10#2)(2011-2#7)(2012-12#3)(2012-2#4)(2013-1#21)(2013-7#2)
tobacco-free##5##1##(2008-6#5)
tobacco-related morbidity and mortality##2##4##(1997-1#1)(2008-6#1)
tobacco-related##3##1##(1997-1#2)(2008-6#1)
tobacco-specific##2##1##(1993-11#1)(2013-8#1)
tobaccos##5##1##(2008-8#2)(2008-9#2)(2013-1#1)
tobamovirus##9##1##(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#6)
tobamoviruses##4##1##(1997-3#1)(1997-6#1)(2008-10#2)
tobe##5##1##(2008-11#3)(2008-2#2)
toborinone##5##1##(2008-5#5)
tobramycin and##2##2##(1991-3#1)(2007-7#1)
tobramycin##4##1##(1991-3#1)(2007-7#1)(2008-7#1)(2011-2#1)
tocochromanol##2##1##(2008-11#2)
tocopherol acetate into SLN##3##4##(2008-5#3)
tocopherol acetate##5##2##(2008-5#5)
tocopherol concentration##2##2##(2008-6#1)(2009-8#1)
tocopherol##18##1##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#11)(2008-6#1)(2009-8#1)(2011-1#1)
tocopherols from##2##2##(2008-10#1)(2008-6#1)
tocopherols in##2##2##(2008-10#1)(2008-5#1)
tocopherols##12##1##(1990-2#2)(1992-9#1)(2008-10#3)(2008-5#2)(2008-6#4)
tocopheroxyl##2##1##(1992-9#2)
tocopheryl O-glycosides##2##2##(2009-8#2)
tocopheryl##3##1##(2008-12#1)(2009-8#2)
tocotrienols##3##1##(1992-9#2)(2008-11#1)
todF##2##1##(1991-7#2)
today and in the future##2##5##(2008-12#1)(2008-4#1)
today and to##2##3##(1994-5#1)(2013-8#1)
today and##12##2##(1992-7#1)(1994-5#1)(1995-12#2)(1996-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2011-3#1)(2012-9#1)(2013-8#1)
today are##7##2##(1992-3#1)(1995-1#1)(2007-2#1)(2008-12#1)(2010-10#1)(2010-3#1)(2011-2#1)
today as##3##2##(1997-3#1)(2008-7#1)(2011-1#1)
today has##2##2##(2008-11#1)(2009-12#1)
today in the##3##3##(1992-6#1)(2008-1#1)(2010-6#1)
today in##6##2##(1992-6#1)(1995-3#1)(2008-1#1)(2010-6#1)(2011-2#2)
today is##7##2##(1991-1#1)(1991-2#2)(1993-6#1)(1994-1#1)(2010-8#1)(2011-2#1)
today it##2##2##(2008-1#1)(2009-8#1)
today of##2##2##(1994-2#1)(2008-9#1)
today one##2##2##(2007-8#1)(2008-10#1)
today than##2##2##(2008-11#1)(2008-5#1)
today that##3##2##(1990-8#1)(1993-6#1)(1997-2#1)
today the##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
today to##3##2##(1994-1#1)(2007-12#1)(2008-5#1)
today##168##1##(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#2)(1992-2#1)(1992-3#4)(1992-6#2)(1992-7#1)(1993-11#2)(1993-2#4)(1993-3#2)(1993-6#2)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#4)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#15)(2008-11#10)(2008-12#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#3)(2012-1#1)(2012-2#5)(2012-3#2)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#1)
today's &quot##2##2##(1997-1#1)(2010-3#1)
today's changing##2##2##(1994-3#1)(1997-1#1)
today's competitive##4##2##(1991-2#1)(1991-3#1)(1994-12#1)(2008-12#1)
today's environment##2##2##(1991-3#1)(1995-12#1)
today's health care##9##3##(1991-12#1)(1991-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-11#1)
today's health##10##2##(1991-12#1)(1991-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-11#1)
today's healthcare##3##2##(1993-2#1)(1997-1#1)(2008-10#1)
today's hospitals##2##2##(1994-2#1)(2007-9#1)
today's market##2##2##(1991-3#1)(2008-12#1)
today's practice##2##2##(2008-7#1)(2011-2#1)
today's##72##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#5)(1992-12#1)(1992-2#5)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#4)(1997-2#1)(1997-3#2)(2006-6#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
today?]##2##1##(1997-3#1)(1997-4#1)
toddler##5##1##(2008-11#1)(2012-2#4)
toddlers and##2##2##(2011-1#1)(2012-12#1)
toddlers##14##1##(1992-12#2)(1995-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#6)
toddlers' fear##2##2##(2012-12#2)
toe deformity##2##2##(2010-11#1)(2010-3#1)
toe nails##4##2##(2008-5#2)(2009-2#2)
toe##25##1##(1993-12#1)(1996-8#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-11#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2012-3#1)(2013-1#1)
toenails##4##1##(2008-5#3)(2008-9#1)
toes##9##1##(1997-3#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
toffee##2##1##(2008-10#2)
together a number of##2##4##(1994-12#1)(2008-4#1)
together a##4##2##(1994-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
together all##2##2##(2007-12#1)(2008-3#1)
together along##2##2##(2007-12#1)(2008-9#1)
together and are##2##3##(1996-3#1)(2008-12#1)
together and form a##2##4##(2007-12#1)(2008-10#1)
together and that##2##3##(2008-10#1)(2008-7#1)
together and were##2##3##(2008-10#2)
together and##14##2##(1993-1#1)(1996-1#2)(1996-3#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-7#1)(2012-2#1)
together are##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
together as##5##2##(1997-4#1)(2008-11#2)(2009-10#1)(2010-3#1)
together at##3##2##(2008-10#2)(2008-7#1)
together by a##2##3##(2008-4#1)(2008-8#1)
together by an##2##3##(2008-3#1)(2008-4#1)
together by##7##2##(1996-6#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)
together can##2##2##(1995-3#1)(2012-2#1)
together different##2##2##(2008-11#1)(2010-3#1)
together explained##2##2##(2011-2#1)(2012-3#1)
together for##9##2##(1996-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2013-1#1)
together form a##2##3##(2008-3#1)(2010-5#1)
together health##2##2##(2008-1#1)(2011-9#1)
together in a##9##3##(1991-3#1)(1993-12#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#2)(2013-1#1)
together in the##3##3##(1992-6#1)(2008-10#1)(2012-7#1)
together in##27##2##(1991-3#1)(1992-6#1)(1993-12#1)(1996-12#2)(1997-4#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-7#1)(2013-1#2)
together into a##3##3##(2008-10#2)(2008-5#1)
together into##6##2##(1996-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
together make up##2##3##(2008-9#1)(2009-10#1)
together make##3##2##(2008-9#1)(2009-10#1)(2011-2#1)
together many##2##2##(2008-5#1)(2008-9#1)
together over##2##2##(2009-9#1)(2013-1#1)
together some of##2##3##(2010-5#1)(2012-12#1)
together some##4##2##(2007-5#1)(2008-8#1)(2010-5#1)(2012-12#1)
together the##10##2##(1991-5#1)(1996-1#1)(1996-4#1)(1997-3#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
together these##6##2##(1990-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-7#1)(2008-7#1)
together to address##2##3##(1991-3#1)(1994-2#1)
together to develop a##2##4##(1997-2#1)(2010-7#1)
together to form a##2##4##(1992-6#1)(2008-2#1)
together to form##4##3##(1992-6#1)(1995-2#1)(2008-11#1)(2008-2#1)
together to make##2##3##(2008-11#1)(2008-3#1)
together to produce##2##3##(2010-4#1)(2011-1#1)
together to##29##2##(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#4)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-12#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
together via##2##2##(1990-8#1)(2008-7#1)
together were##2##2##(1997-3#1)(2007-8#1)
together with a 3##2##4##(1990-11#1)(1992-3#1)
together with a discussion on##2##5##(2008-11#1)(2008-8#1)
together with a discussion##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
together with a highly##2##4##(1993-2#1)(1994-12#1)
together with a new##2##4##(1993-6#1)(2009-7#1)
together with a reduction of##2##5##(1993-12#1)(2008-10#1)
together with a review of the literature##3##7##(1996-3#1)(2011-2#1)(2012-2#1)
together with a review of the##4##6##(1991-2#1)(1996-3#1)(2011-2#1)(2012-2#1)
together with a review of##5##5##(1991-2#1)(1996-3#1)(2008-2#1)(2011-2#1)(2012-2#1)
together with a series of##2##5##(2007-11#1)(2009-12#1)
together with a unique##2##4##(1997-8#1)(2008-5#1)
together with a##64##3##(1990-11#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
together with an excellent discussion of the##2##7##(2008-9#2)
together with an##14##3##(1991-9#1)(1994-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
together with analysis of##2##4##(1994-12#1)(2010-12#1)
together with computer##2##3##(2008-3#2)
together with examples that##2##4##(2009-12#1)(2010-10#1)
together with experimental results##2##4##(2007-11#1)(2008-2#1)
together with experimental##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
together with genetic##2##3##(2008-5#1)(2013-8#1)
together with improved##2##3##(1997-1#1)(2008-7#1)
together with its##10##3##(1993-8#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2011-1#1)(2013-1#1)
together with lack of##2##4##(2008-3#1)(2008-9#1)
together with low##2##3##(2008-10#1)(2008-7#1)
together with maternal##2##3##(1995-8#1)(2008-1#1)
together with other##13##3##(1990-11#1)(1991-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
together with our observation##2##4##(1992-3#1)(1996-6#1)
together with oxygen##2##3##(2008-10#2)
together with potassium##2##3##(1997-7#1)(2008-10#1)
together with previous findings##2##4##(1994-12#1)(2008-8#1)
together with previous observations##2##4##(1991-9#1)(1993-12#1)
together with previous##6##3##(1991-9#1)(1993-12#1)(1994-12#1)(2008-11#1)(2008-8#1)(2012-3#1)
together with published data##2##4##(1990-3#1)(1992-7#1)
together with recent##2##3##(1996-6#1)(2013-7#1)
together with serum##2##3##(1991-12#1)(1995-3#1)
together with several##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
together with some##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
together with the appearance of##2##5##(1995-3#1)(2008-7#1)
together with the application of##2##5##(2008-10#1)(2010-11#1)
together with the complete genome sequence and annotation##14##8##(2011-2#14)
together with the complete genome sequence##23##6##(2011-2#23)
together with the complete##24##4##(2011-2#24)
together with the previous##2##4##(1992-2#1)(2012-2#1)
together with the results of##2##5##(1996-11#1)(2008-3#1)
together with the results##3##4##(1996-11#1)(2008-3#1)(2008-9#1)
together with the use##2##4##(1996-5#1)(2008-8#1)
together with the##139##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#2)(1993-12#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#34)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
together with their##14##3##(1990-6#1)(1991-9#1)(1992-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2012-4#1)(2013-1#1)(2013-8#1)
together with theoretical##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
together with those of the##2##5##(1997-7#1)(2008-4#1)
together with those##6##3##(1994-11#1)(1997-7#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
together with two##4##3##(1994-11#1)(2009-5#1)(2011-3#1)(2012-2#1)
together with##483##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-12#5)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#6)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#3)(1997-8#3)(2006-12#1)(2006-6#2)(2007-11#9)(2007-12#8)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#90)(2008-11#18)(2008-12#3)(2008-2#14)(2008-3#25)(2008-4#9)(2008-5#16)(2008-6#7)(2008-7#15)(2008-8#8)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#43)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#6)(2012-4#1)(2012-9#1)(2013-1#6)(2013-7#5)(2013-8#7)
together##885##1##(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#3)(1990-6#2)(1990-7#4)(1990-8#4)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#1)(1993-12#10)(1993-2#4)(1993-3#8)(1993-5#1)(1993-6#6)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#1)(1994-3#4)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#10)(1995-3#5)(1995-5#3)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#8)(1997-6#3)(1997-7#6)(1997-8#4)(2006-12#1)(2006-4#2)(2006-6#3)(2007-11#12)(2007-12#16)(2007-5#3)(2007-7#2)(2007-8#5)(2008-1#7)(2008-10#151)(2008-11#37)(2008-12#8)(2008-2#22)(2008-3#35)(2008-4#17)(2008-5#30)(2008-6#13)(2008-7#29)(2008-8#16)(2008-9#23)(2009-10#6)(2009-11#1)(2009-12#8)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#7)(2010-12#4)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#12)(2011-10#1)(2011-2#56)(2011-3#2)(2011-9#1)(2012-1#3)(2012-12#5)(2012-2#21)(2012-3#11)(2012-4#1)(2012-7#2)(2012-9#1)(2013-1#18)(2013-7#5)(2013-8#13)
toilet##4##1##(2007-12#1)(2008-10#1)(2010-10#1)(2010-11#1)
toileting##3##1##(1991-8#3)
toiletry##2##1##(2008-5#2)
tokamak##5##1##(1990-4#1)(1992-8#1)(1993-5#1)(1994-2#1)(2013-8#1)
tokarensis##2##1##(2008-6#2)
token##3##1##(1991-2#1)(2007-8#1)(2013-1#1)
tolbutamide##6##1##(1991-12#6)
tolcapone##3##1##(1995-5#3)
told about the##2##3##(2008-10#1)(2013-1#1)
told by##2##2##(1993-12#1)(2009-10#1)
told me##2##2##(2009-10#1)(2013-7#1)
told that##3##2##(1995-6#1)(2010-4#1)(2010-9#1)
told to be##2##3##(2012-12#2)
told to##5##2##(1991-8#1)(1992-8#1)(2008-11#1)(2012-12#2)
told you##2##2##(2008-10#1)(2011-2#1)
told##25##1##(1990-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-1#1)(1995-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
tolerability and efficacy of##2##4##(2008-10#1)(2010-12#1)
tolerability and immunogenicity of##2##4##(2007-11#1)(2013-1#1)
tolerability and##14##2##(1990-2#1)(1991-3#1)(1992-11#1)(1996-1#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
tolerability are##2##2##(1990-3#1)(2008-5#1)
tolerability of an##3##3##(1991-2#1)(1992-11#1)(2008-3#1)
tolerability of exenatide in##2##4##(2012-3#2)
tolerability of the##4##3##(1990-2#1)(1991-2#1)(1996-1#1)(2008-3#1)
tolerability of##28##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#3)(1992-11#1)(1994-12#1)(1994-6#1)(1996-1#1)(1997-8#3)(2007-7#2)(2008-3#6)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)
tolerability profile##2##2##(2007-11#1)(2008-3#1)
tolerability##68##1##(1990-10#1)(1990-2#2)(1990-3#2)(1990-6#1)(1991-2#4)(1991-3#1)(1992-11#3)(1994-12#1)(1994-6#2)(1996-1#3)(1997-3#1)(1997-8#5)(2007-10#1)(2007-11#3)(2007-7#2)(2008-10#4)(2008-11#1)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#1)
tolerable in the##2##3##(2008-10#1)(2008-6#1)
tolerable##23##1##(1992-12#1)(1992-2#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
tolerance analysis##3##2##(2008-3#3)
tolerance and adaptation##2##3##(2013-1#2)
tolerance and its##2##3##(2008-10#2)
tolerance and quality of life##2##5##(2008-7#1)(2010-8#1)
tolerance and resistance##2##3##(1996-2#1)(2008-5#1)
tolerance and the##3##3##(1991-3#1)(2008-2#1)(2008-5#1)
tolerance and##33##2##(1991-1#1)(1991-3#1)(1995-2#2)(1996-12#1)(1996-2#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
tolerance at##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
tolerance between##2##2##(2008-10#1)(2008-2#1)
tolerance breaking##2##2##(2008-10#2)
tolerance by##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
tolerance compared##2##2##(1997-4#1)(2008-10#1)
tolerance during##2##2##(1990-8#1)(2012-3#1)
tolerance for most##2##3##(2008-10#2)
tolerance for the##2##3##(2008-2#2)
tolerance for##12##2##(1995-12#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)
tolerance has been##2##3##(1991-9#1)(2008-1#1)
tolerance have##2##2##(2008-11#1)(2008-7#1)
tolerance in plants##3##3##(2008-9#1)(2011-2#2)
tolerance in seeds of##2##4##(2013-7#2)
tolerance in the##3##3##(1991-1#1)(2008-10#1)(2008-5#1)
tolerance in##29##2##(1991-1#1)(1995-11#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#2)(2011-2#4)(2013-1#2)(2013-7#4)(2013-8#2)
tolerance induction##3##2##(2008-11#2)(2011-3#1)
tolerance interval##2##2##(2008-10#2)
tolerance is the##2##3##(2008-11#1)(2013-8#1)
tolerance is##9##2##(1991-9#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
tolerance level##2##2##(2008-10#1)(2008-2#1)
tolerance levels##2##2##(2008-10#1)(2009-2#1)
tolerance limit of##2##3##(2008-10#2)
tolerance limit##4##2##(2008-10#3)(2008-12#1)
tolerance limits for##3##3##(2008-10#3)
tolerance limits of##6##3##(2008-10#6)
tolerance limits##11##2##(2008-10#11)
tolerance of L##2##3##(2010-4#1)(2011-1#1)
tolerance of the##9##3##(1990-11#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)
tolerance of##43##2##(1990-11#1)(1990-6#1)(1993-11#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-8#1)(2010-3#1)(2010-4#3)(2011-1#4)(2011-2#4)(2013-7#1)
tolerance or##2##2##(1994-12#1)(2011-2#1)
tolerance response##2##2##(2008-10#1)(2011-2#1)
tolerance target##2##2##(2009-7#2)
tolerance test##18##2##(1990-8#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2012-7#3)
tolerance tests##2##2##(2007-11#1)(2010-11#1)
tolerance than##2##2##(2008-7#1)(2012-5#1)
tolerance to BYDV##2##3##(2008-10#2)
tolerance to a##3##3##(1991-9#1)(2008-2#1)(2009-8#1)
tolerance to barley yellow dwarf virus##2##6##(2008-10#2)
tolerance to drought##2##3##(2012-5#1)(2012-7#1)
tolerance to the##8##3##(1990-3#1)(1992-3#1)(1995-2#2)(1997-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
tolerance to##63##2##(1990-3#1)(1990-9#1)(1991-1#2)(1991-9#1)(1992-3#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#2)(2011-1#2)(2011-10#2)(2011-2#3)(2012-12#2)(2012-5#3)(2012-7#2)(2013-1#2)
tolerance toward##2##2##(1995-12#1)(2008-4#1)
tolerance was##6##2##(1992-3#1)(1995-5#1)(2008-11#1)(2009-2#1)(2012-5#1)(2013-7#1)
tolerance were##2##2##(2008-3#1)(2012-7#1)
tolerance while##2##2##(2008-10#2)
tolerance with##3##2##(1994-3#1)(1996-2#1)(2008-1#1)
tolerance##421##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#6)(1991-11#1)(1991-3#4)(1991-5#1)(1991-9#6)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#4)(1994-3#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#9)(2008-10#95)(2008-11#14)(2008-12#12)(2008-2#12)(2008-3#29)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#8)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#6)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#16)(2011-10#7)(2011-2#27)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#9)(2012-5#6)(2012-7#8)(2012-9#1)(2013-1#13)(2013-7#6)(2013-8#8)
tolerance)##6##1##(1990-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)
tolerance]##2##1##(1990-3#1)(2008-7#1)
tolerances are##5##2##(2008-2#2)(2008-3#3)
tolerances for phase plates##2##4##(2008-3#2)
tolerances for##4##2##(2008-2#1)(2008-3#3)
tolerances of approximately##2##3##(2008-3#2)
tolerances of##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
tolerances on##2##2##(2008-3#2)
tolerances##29##1##(2007-11#1)(2007-12#2)(2008-2#8)(2008-3#17)(2008-7#1)
tolerancing of##2##2##(2008-3#2)
tolerancing##6##1##(2008-2#1)(2008-3#5)
tolerant CD4 T cells##2##4##(2008-11#2)
tolerant cultivar##2##2##(2008-12#1)(2011-10#1)
tolerant cv##2##2##(2008-10#2)
tolerant host##2##2##(2008-10#2)
tolerant of UVB radiation##2##4##(2008-11#2)
tolerant of##9##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)
tolerant rats##4##2##(1996-2#3)(1997-2#1)
tolerant stage##2##2##(2011-2#2)
tolerant to the##2##3##(2008-10#1)(2012-9#1)
tolerant to##14##2##(1994-5#1)(1996-5#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-8#1)(2011-2#1)(2012-9#1)(2013-1#1)(2013-7#1)
tolerant zucchini##2##2##(2008-10#2)
tolerant##67##1##(1994-5#1)(1996-2#3)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#10)(2008-2#2)(2008-3#1)(2008-8#2)(2011-10#2)(2011-2#6)(2012-9#1)(2013-1#3)(2013-7#1)
tolerate the##6##2##(1992-3#1)(1996-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)
tolerate##28##1##(1991-6#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-4#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
tolerated all##2##2##(2010-7#2)
tolerated and the##2##3##(2007-7#1)(2011-2#1)
tolerated and##12##2##(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#3)(2010-1#1)(2011-2#2)(2013-1#1)
tolerated at##8##2##(1990-11#1)(1997-3#1)(2006-10#1)(2008-10#4)(2008-12#1)
tolerated by the##7##3##(1992-8#1)(2007-8#1)(2008-5#4)(2012-5#1)
tolerated by this##2##3##(1992-11#1)(2008-7#1)
tolerated by##17##2##(1992-11#1)(1992-12#1)(1992-8#1)(1993-5#1)(2007-8#2)(2008-2#1)(2008-5#5)(2008-7#1)(2009-4#1)(2010-6#1)(2012-3#1)(2012-5#1)
tolerated dose##2##2##(1994-9#1)(2008-6#1)
tolerated in a##2##3##(1992-3#1)(2008-10#1)
tolerated in considerable amounts##3##4##(2008-10#3)
tolerated in the##6##3##(1993-11#1)(2007-11#2)(2008-10#1)(2008-11#2)
tolerated in##19##2##(1992-3#1)(1993-11#1)(1996-1#1)(2007-11#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
tolerated the##2##2##(2007-8#1)(2013-1#1)
tolerated##143##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-11#1)(1993-5#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-9#2)(1997-3#2)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#7)(2008-6#6)(2008-7#12)(2008-8#7)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#6)(2013-7#1)
tolerates##3##1##(2008-10#3)
tolerating##3##1##(1997-1#1)(2007-8#1)(2008-2#1)
tolerization##3##1##(1995-2#1)(2008-8#2)
tolerized##3##1##(1995-2#1)(2008-11#2)
tolerogenic##2##1##(2011-1#1)(2011-2#1)
toll on the##3##3##(2008-7#1)(2013-1#2)
toll on##6##2##(1994-9#1)(1996-3#1)(2008-3#1)(2008-7#1)(2013-1#2)
toll##10##1##(1994-9#1)(1996-3#1)(1997-6#2)(2008-3#1)(2008-7#1)(2010-3#1)(2013-1#3)
toll-like receptor##5##2##(2008-3#1)(2009-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
toll-like##6##1##(2008-3#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
tolmetin and furosemide##2##3##(1992-9#2)
tolmetin##5##1##(1992-9#5)
tolnaftate##4##1##(2008-10#4)
toluene and methyl methacrylate##2##4##(1994-8#2)
toluene and p-xylene were obtained##2##5##(2008-10#2)
toluene and p-xylene##3##3##(2008-10#3)
toluene and xylene##2##3##(2008-10#2)
toluene and##13##2##(1994-8#2)(2008-10#9)(2008-5#1)(2013-8#1)
toluene at##2##2##(2008-10#1)(2009-9#1)
toluene depletion##2##2##(2008-7#2)
toluene in##3##2##(2008-10#1)(2008-7#2)
toluene or xylene##3##3##(2008-10#3)
toluene solubility##2##2##(2008-10#2)
toluene to##2##2##(2008-7#1)(2009-9#1)
toluene##90##1##(1991-7#1)(1994-8#3)(2007-12#3)(2008-10#57)(2008-5#1)(2008-6#1)(2008-7#15)(2009-9#6)(2010-11#1)(2012-2#1)(2013-8#1)
toluene)##2##1##(2008-10#1)(2008-7#1)
toluidine blue O##5##3##(2008-10#5)
toluidine blue and##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
toluidine blue o##2##3##(2008-10#2)
toluidine blue staining##2##3##(2008-4#1)(2012-3#1)
toluidine blue##13##2##(1992-12#1)(2008-10#8)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)
toluidine##15##1##(1992-12#1)(2008-10#9)(2008-4#1)(2008-5#2)(2011-2#1)(2012-3#1)
tomatine##2##1##(2008-8#2)
tomato (Lycopersicon esculentum) and##2##4##(2008-10#2)
tomato (Lycopersicon esculentum)##6##3##(2008-10#6)
tomato (Lycopersicon##7##2##(2008-10#7)
tomato DC3000 hrp mutants##2##4##(2008-10#2)
tomato DC3000##6##2##(2008-10#5)(2009-6#1)
tomato and potato crops##2##4##(2008-10#2)
tomato and potato##11##3##(2008-10#11)
tomato and##27##2##(2008-10#26)(2008-12#1)
tomato as a host##2##4##(2008-8#1)(2011-2#1)
tomato by##4##2##(2008-10#4)
tomato caused by Fusarium oxysporum f##2##6##(2008-10#2)
tomato caused by##3##3##(2008-10#3)
tomato chromosome##4##2##(2008-10#1)(2008-5#3)
tomato chromosomes##3##2##(2008-5#3)
tomato crops##5##2##(2008-10#5)
tomato cultivars##7##2##(2008-10#7)
tomato fields and##2##3##(2008-10#2)
tomato fields##4##2##(2008-10#4)
tomato fruits##4##2##(2008-10#2)(2011-2#2)
tomato genotypes that exhibit different levels of##2##7##(2008-10#2)
tomato genotypes##4##2##(2008-10#4)
tomato in the##2##3##(2008-10#2)
tomato in##12##2##(2008-10#12)
tomato isolate##2##2##(2008-10#2)
tomato isolates##5##2##(2008-10#5)
tomato juice agar##2##3##(2008-10#1)(2008-8#1)
tomato late blight##3##3##(2008-10#3)
tomato leaf curl virus##2##4##(2008-10#2)
tomato leaf tissue##2##3##(2008-10#2)
tomato leaf##7##2##(2008-10#7)
tomato leaves##8##2##(2008-10#8)
tomato lines##3##2##(2008-10#3)
tomato mottle##3##2##(2008-10#3)
tomato or##2##2##(2008-10#2)
tomato pathogens##4##2##(2008-10#4)
tomato plant##2##2##(2008-10#2)
tomato plants and##2##3##(2008-10#2)
tomato plants carrying##2##3##(2009-8#1)(2010-9#1)
tomato plants from##2##3##(2008-10#2)
tomato plants grown in##3##4##(2008-10#3)
tomato plants in the##2##4##(2008-10#2)
tomato plants in##5##3##(2008-10#5)
tomato plants treated with##2##4##(2008-10#2)
tomato plants##52##2##(2008-10#49)(2008-9#1)(2009-8#1)(2010-9#1)
tomato population##2##2##(2008-8#2)
tomato production areas##2##3##(2008-10#2)
tomato production##7##2##(2008-10#7)
tomato race 1 (T1)##2##4##(2008-10#2)
tomato race##5##2##(2008-10#5)
tomato resistance##2##2##(2008-10#2)
tomato root##2##2##(2008-10#1)(2008-11#1)
tomato roots was##2##3##(2008-10#2)
tomato roots##10##2##(2008-10#10)
tomato seedlings were##2##3##(2008-10#2)
tomato seedlings##4##2##(2008-10#4)
tomato seeds##2##2##(2008-10#2)
tomato spotted wilt virus (TSWV)##2##5##(2008-10#2)
tomato spotted wilt virus##4##4##(2008-10#4)
tomato spotted wilt##5##3##(2008-10#5)
tomato stem##2##2##(2008-10#2)
tomato than##3##2##(2008-10#1)(2008-8#2)
tomato transplants##2##2##(2008-10#2)
tomato was##3##2##(2008-10#3)
tomato were tested for##2##4##(2008-10#2)
tomato were##7##2##(2008-10#7)
tomato yellow leaf curl virus##3##5##(2008-10#2)(2008-8#1)
tomato yellow leaf curl##4##4##(2008-10#3)(2008-8#1)
tomato##400##1##(1992-8#1)(1993-12#1)(1995-2#2)(1997-2#1)(1997-6#1)(2008-10#352)(2008-11#1)(2008-12#2)(2008-5#12)(2008-7#1)(2008-8#13)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#3)(2010-9#1)(2011-2#5)
tomato-growing areas##2##2##(2008-10#2)
tomato-growing##4##1##(2008-10#4)
tomato-infecting##3##1##(2008-10#3)
tomatoes and##3##2##(1997-4#1)(2008-10#2)
tomatoes are grown##3##3##(2008-10#3)
tomatoes##17##1##(1997-4#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-3#1)
tombusvirus species and##2##3##(2008-10#2)
tombusvirus##5##1##(2008-10#5)
tomentosa##3##1##(2008-5#1)(2012-2#2)
tomogram##3##1##(2007-8#1)(2008-2#2)
tomograms##2##1##(2008-1#1)(2008-2#1)
tomograph##3##1##(1991-9#1)(2008-3#2)
tomographic (CT) scans##4##3##(2008-1#4)
tomographic (CT)##14##2##(2007-5#1)(2008-1#7)(2008-7#5)(2012-3#1)
tomographic and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
tomographic angiography##5##2##(2008-2#1)(2010-9#1)(2011-2#1)(2013-1#2)
tomographic image reconstruction##2##3##(2008-3#1)(2009-5#1)
tomographic images##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
tomographic imaging of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
tomographic imaging##7##2##(2007-12#2)(2008-2#1)(2008-3#2)(2012-1#1)(2013-1#1)
tomographic inversion##2##2##(2008-3#2)
tomographic procedure##2##2##(2007-11#1)(2008-3#1)
tomographic scans have##2##3##(1993-6#1)(2008-9#1)
tomographic scans##4##2##(1992-2#1)(1993-6#1)(2008-9#1)(2011-2#1)
tomographic severity##2##2##(1990-3#1)(2009-8#1)
tomographic##79##1##(1990-3#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-5#2)(1997-5#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-5#1)(2008-1#8)(2008-10#1)(2008-2#5)(2008-3#10)(2008-7#8)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
tomography (CT) and magnetic resonance##3##5##(2010-9#1)(2011-2#2)
tomography (CT) and##10##3##(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
tomography (CT) are##2##3##(2008-2#1)(2012-2#1)
tomography (CT) is##5##3##(2007-10#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
tomography (CT) scan##15##3##(1996-9#1)(2007-10#2)(2008-12#1)(2008-7#6)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
tomography (CT) scans were##2##4##(2007-10#1)(2008-5#1)
tomography (CT) scans##6##3##(2007-10#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-8#1)
tomography (CT)##84##2##(1991-3#1)(1995-2#1)(1996-9#1)(2007-10#7)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#11)(2008-8#5)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#11)(2012-3#2)(2013-1#5)(2013-8#3)
tomography (HRCT)##6##2##(1991-12#2)(2007-8#1)(2008-7#1)(2011-2#2)
tomography (OCT)##27##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#4)(2008-5#2)(2010-12#1)(2011-2#1)(2011-7#8)(2012-2#1)(2013-1#2)
tomography (PET)##18##2##(1990-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#4)(1996-7#1)(2008-1#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
tomography (PET/CT)##2##2##(2009-2#1)(2012-12#1)
tomography after##2##2##(1990-3#1)(2012-12#1)
tomography allows##3##2##(1990-9#1)(2007-11#1)(2008-4#1)
tomography and intravascular ultrasound##2##4##(2009-5#2)
tomography and magnetic resonance imaging scans##2##6##(2008-9#1)(2011-2#1)
tomography and magnetic resonance imaging##11##5##(1990-12#1)(1996-8#1)(1997-8#1)(2007-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#3)
tomography and##38##2##(1990-12#1)(1990-9#1)(1991-11#1)(1993-5#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-7#3)(2008-9#2)(2009-5#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-2#1)
tomography are##5##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
tomography as a##2##3##(2007-12#1)(2009-5#1)
tomography based on##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
tomography coronary angiography##2##3##(2008-11#1)(2009-4#1)
tomography demonstrated a##2##3##(2011-2#1)(2013-8#1)
tomography demonstrated##4##2##(1995-3#1)(2009-3#1)(2011-2#1)(2013-8#1)
tomography diagnostic of the intervertebral disc degeneration and degenerative changes of the lumbo-sacral spine##2##14##(2007-11#2)
tomography examination##3##2##(2007-8#1)(2008-1#1)(2010-3#1)
tomography for##13##2##(1995-11#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#1)(2009-3#1)(2011-7#1)(2012-2#1)
tomography has been##2##3##(2008-3#2)
tomography has##5##2##(2008-3#3)(2008-7#2)
tomography images##3##2##(2007-11#1)(2008-3#1)(2012-3#1)
tomography imaging##4##2##(2008-12#1)(2008-3#2)(2012-1#1)
tomography in patients##3##3##(1991-3#1)(2008-12#1)(2012-2#1)
tomography in the diagnosis##3##4##(2011-7#2)(2012-2#1)
tomography in the##6##3##(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#2)(2012-2#1)
tomography in##27##2##(1990-11#1)(1991-3#1)(1994-1#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-12#3)(2008-3#3)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#2)(2011-7#3)(2012-2#2)(2013-2#1)
tomography is##8##2##(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#3)(2011-2#1)
tomography of the chest##3##4##(2007-8#2)(2008-6#1)
tomography of the##6##3##(1997-8#1)(2007-12#1)(2007-8#2)(2008-6#1)(2008-8#1)
tomography of##12##2##(1993-11#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-1#1)
tomography pattern##2##2##(2007-11#1)(2008-2#1)
tomography provides##2##2##(2007-12#1)(2012-3#1)
tomography revealed a##2##3##(2013-1#2)
tomography revealed##4##2##(2008-7#1)(2010-10#1)(2013-1#2)
tomography scan showed##2##3##(2010-10#1)(2011-1#1)
tomography scan##18##2##(1993-9#1)(2007-12#1)(2008-6#1)(2008-7#3)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)
tomography scans were##2##3##(2008-7#2)
tomography scans##10##2##(2007-10#1)(2008-11#3)(2008-7#4)(2009-7#1)(2009-8#1)
tomography should be##2##3##(1990-11#1)(2007-11#1)
tomography showed a##4##3##(2007-5#1)(2008-12#1)(2013-1#1)(2013-8#1)
tomography showed bilateral##2##3##(1990-3#1)(1997-3#1)
tomography showed##11##2##(1990-3#1)(1993-3#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
tomography study##2##2##(2007-10#1)(2009-9#1)
tomography system##7##2##(2007-11#5)(2008-3#2)
tomography to##5##2##(2007-11#1)(2008-10#1)(2009-10#1)(2011-1#1)(2013-8#1)
tomography using##2##2##(2007-12#1)(2008-3#1)
tomography was used to##3##4##(2007-11#1)(2008-2#1)(2009-4#1)
tomography was##5##2##(2007-11#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
tomography were##2##2##(2012-2#1)(2013-1#1)
tomography with##12##2##(1993-9#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#3)(2008-7#1)(2009-3#1)
tomography##621##1##(1990-11#2)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-3#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-9#2)(1996-12#1)(1996-2#4)(1996-5#8)(1996-7#3)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#4)(2006-10#1)(2006-12#1)(2006-4#3)(2007-10#13)(2007-11#63)(2007-12#34)(2007-5#2)(2007-7#3)(2007-8#16)(2007-9#1)(2008-1#7)(2008-10#3)(2008-11#9)(2008-12#21)(2008-2#22)(2008-3#55)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#43)(2008-8#10)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#6)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#5)(2010-12#11)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#18)(2011-2#42)(2011-3#1)(2011-7#19)(2012-1#8)(2012-12#8)(2012-2#36)(2012-3#7)(2013-1#24)(2013-2#1)(2013-7#1)(2013-8#10)
tomography)##2##1##(1996-11#1)(2012-2#1)
tomography-guided##4##1##(2008-6#1)(2008-8#1)(2009-3#2)
tomography]##3##1##(1990-3#1)(1994-2#1)(2007-8#1)
tomorrow##9##1##(1990-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-12#1)(2009-9#1)(2011-3#1)
tomorrow's health##2##2##(1994-1#1)(1997-3#1)
tomorrow's##6##1##(1993-3#2)(1994-1#1)(1995-3#1)(1996-1#1)(1997-3#1)
tomotherapy##2##1##(2008-11#2)
toms##3##1##(2013-1#3)
ton/ha##2##1##(2008-10#2)
tonal targets##3##2##(2013-8#3)
tonal##5##1##(1991-12#1)(2013-8#4)
tone and##8##2##(1995-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(2010-10#1)(2013-1#1)(2013-8#2)
tone during##2##2##(1991-10#1)(2008-3#1)
tone elicited by noradrenaline##2##4##(1995-12#1)(1997-4#1)
tone if the F0 peak is##2##6##(2013-8#2)
tone in##3##2##(1991-5#1)(2008-2#1)(2008-8#1)
tone of the##3##3##(2008-5#2)(2013-8#1)
tone of##7##2##(1991-9#1)(1995-2#2)(2008-11#1)(2008-5#2)(2013-8#1)
tone or##3##2##(1997-4#2)(2008-7#1)
tone patterns##2##2##(1995-12#2)
tone perception##2##2##(2008-9#2)
tone under##2##2##(1995-2#1)(2007-12#1)
tone was##4##2##(1995-12#1)(1995-2#1)(1996-5#1)(2007-10#1)
tone##99##1##(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-9#1)(1994-6#1)(1995-12#8)(1995-2#12)(1995-5#2)(1996-5#7)(1997-4#4)(2006-6#1)(2007-10#3)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#8)
tone)##2##1##(2008-3#1)(2008-5#1)
toned##2##1##(2008-6#2)
toner##2##1##(1996-11#1)(2008-10#1)
tones and##5##2##(2008-11#1)(2008-9#3)(2011-1#1)
tones of##2##2##(2008-2#1)(2012-1#1)
tones##18##1##(1995-12#2)(1995-5#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-1#1)(2012-1#1)(2013-8#3)
tongue and##5##2##(1993-1#2)(1997-6#1)(2008-5#1)(2013-1#1)
tongue based on##3##3##(2008-10#3)
tongue enlargement##4##2##(2012-12#4)
tongue has##2##2##(2008-1#1)(2008-10#1)
tongue is##4##2##(2007-8#2)(2008-2#1)(2013-1#1)
tongue##62##1##(1992-11#1)(1993-1#3)(1993-12#2)(1993-9#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#3)(2007-12#2)(2007-8#4)(2008-1#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#9)(2013-8#2)
tonic and##3##2##(2008-5#2)(2010-3#1)
tonic clonic##2##2##(2008-12#1)(2012-12#1)
tonic immobility##2##2##(1991-12#2)
tonic##23##1##(1991-12#2)(1994-2#1)(1994-6#2)(1995-12#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
tonically##4##1##(1994-2#1)(1997-2#1)(2008-5#1)(2008-6#1)
tonometric##2##1##(1996-3#1)(2008-7#1)
tonometry##8##1##(1996-9#1)(2008-7#1)(2012-3#4)(2013-1#1)(2013-3#1)
tonoplast##6##1##(2008-10#2)(2008-11#3)(2010-9#1)
tonotopic##2##1##(2008-11#1)(2008-2#1)
tons of##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
tons##6##1##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)
tonsil##5##1##(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
tonsillar##7##1##(1990-6#2)(1995-12#1)(1997-3#1)(2008-4#2)(2013-1#1)
tonsillectomy##8##1##(1995-1#1)(1995-11#1)(2013-1#6)
tonsillitis##6##1##(1993-8#1)(1997-4#1)(2011-2#4)
tonsils##4##1##(1991-8#1)(2008-4#2)(2008-5#1)
tonsurans was##2##2##(2008-5#2)
tonsurans##7##1##(2008-5#6)(2012-3#1)
too are##2##2##(1996-1#1)(2008-5#1)
too close to##2##3##(2008-10#2)
too complicated##3##2##(1995-6#1)(2007-2#1)(2012-3#1)
too costly to be##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
too costly to##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)
too different##4##2##(2008-10#1)(2008-3#1)(2013-1#2)
too early to##5##3##(1993-11#1)(1995-6#1)(2008-1#1)(2008-5#1)(2011-3#1)
too expensive for the##2##4##(1996-5#1)(2007-7#1)
too expensive##8##2##(1995-12#1)(1996-5#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-11#1)(2013-1#1)
too far away##2##3##(1996-4#1)(2011-2#1)
too far##4##2##(1993-3#1)(1995-12#1)(1996-4#1)(2011-2#1)
too few##3##2##(1997-5#1)(2008-4#1)(2011-2#1)
too good to be##2##4##(1995-2#1)(2013-8#1)
too good##3##2##(1990-6#1)(1995-2#1)(2013-8#1)
too great##3##2##(2008-8#2)(2008-9#1)
too have##4##2##(1994-8#1)(1996-1#1)(2008-7#1)(2009-7#1)
too high##10##2##(1991-6#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
too large to be##2##4##(1992-5#1)(2008-12#1)
too large to##6##3##(1992-5#1)(1993-12#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
too large##11##2##(1992-5#1)(1993-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
too late to##2##3##(1993-11#1)(2008-10#1)
too late##7##2##(1993-11#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)
too limited##2##2##(1991-6#1)(1994-3#1)
too little##3##2##(1995-12#1)(2009-3#1)(2010-10#1)
too long##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
too low to allow##2##4##(2008-8#1)(2012-3#1)
too low to##7##3##(1992-6#1)(2008-10#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
too low##16##2##(1990-2#1)(1992-12#1)(1992-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
too many choices##2##3##(2008-11#1)(2013-8#1)
too many##15##2##(1991-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(2007-11#2)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
too much to the##2##4##(2008-2#1)(2009-4#1)
too much##15##2##(1992-2#1)(1993-1#1)(1995-12#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#2)(2009-4#1)(2011-2#2)(2013-1#2)
too often##7##2##(1991-12#1)(1991-3#1)(1993-12#1)(1996-12#1)(1996-2#1)(1997-5#1)(2008-8#1)
too short for##2##3##(1995-6#1)(2008-10#1)
too short##3##2##(1992-6#1)(1995-6#1)(2008-10#1)
too simple##3##2##(2008-2#1)(2010-2#1)(2010-8#1)
too slow##2##2##(2008-3#1)(2008-9#1)
too small and##2##3##(1992-10#1)(2008-8#1)
too small to be##4##4##(1990-8#1)(1991-3#2)(2008-3#1)
too small to##8##3##(1990-8#1)(1991-3#2)(1993-3#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-3#1)
too small##14##2##(1990-8#1)(1991-3#2)(1992-10#1)(1993-3#1)(1994-12#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-3#3)(2008-8#1)(2008-9#1)
too time-consuming##2##2##(2008-8#1)(2011-2#1)
too variable##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
too wide##2##2##(2008-8#2)
too young##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
too##260##1##(1990-2#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#3)(1994-11#1)(1994-12#2)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-8#2)(2007-10#1)(2007-11#5)(2007-2#2)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#16)(2008-9#8)(2009-10#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#12)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#8)(2013-8#6)
took 1##2##2##(1995-11#1)(2008-11#1)
took a##4##2##(2008-10#3)(2013-1#1)
took advantage of the##3##4##(1994-2#1)(2008-12#1)(2008-7#1)
took advantage of##8##3##(1994-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)
took into account##5##3##(1992-9#1)(1997-5#1)(2008-10#2)(2008-4#1)
took longer to##4##3##(1992-11#1)(2008-10#1)(2008-2#1)(2012-1#1)
took longer##5##2##(1992-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
took more##2##2##(2008-10#1)(2013-1#1)
took no##2##2##(1991-6#1)(2008-3#1)
took on##2##2##(1996-1#1)(2008-2#1)
took over##2##2##(2008-10#1)(2008-5#1)
took part in a##2##4##(1997-6#1)(2013-1#1)
took part in an##2##4##(1995-6#1)(2008-10#1)
took part in the study##5##5##(1991-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-1#1)
took part in the##8##4##(1991-8#1)(1995-11#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
took part in this study##2##5##(2008-10#1)(2008-7#1)
took part in this##4##4##(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
took part in##18##3##(1991-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
took part##20##2##(1991-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
took place at the##2##4##(2007-12#1)(2008-5#1)
took place at##5##3##(2007-12#1)(2008-11#1)(2008-5#2)(2008-6#1)
took place between##3##3##(1997-3#1)(2008-9#1)(2010-3#1)
took place during##2##3##(1994-3#1)(2008-10#1)
took place in a##3##4##(1991-6#1)(2008-10#1)(2012-12#1)
took place in the##7##4##(1992-1#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(2008-11#1)(2010-10#1)
took place in##24##3##(1990-10#1)(1991-3#1)(1991-6#1)(1992-1#2)(1993-3#2)(1995-12#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
took place under##3##3##(2008-10#1)(2011-2#2)
took place##61##2##(1990-10#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-6#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#2)(1996-3#1)(1997-3#1)(1997-5#1)(2007-12#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
took samples##2##2##(2008-5#1)(2008-6#1)
took the##4##2##(1992-9#1)(1995-12#1)(2008-10#1)(2012-3#1)
took this##2##2##(2008-7#1)(2011-2#1)
took two##2##2##(1991-3#1)(2008-7#1)
took up the##2##3##(2007-5#1)(2009-7#1)
took up##6##2##(1992-6#1)(1995-11#1)(2007-5#1)(2008-10#1)(2009-7#2)
took##168##1##(1990-10#2)(1990-3#1)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-3#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#3)(1995-12#3)(1995-3#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#3)(1996-6#1)(1996-7#2)(1997-3#1)(1997-5#2)(1997-6#1)(2007-12#4)(2007-5#1)(2007-7#2)(2008-10#24)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
tool among##4##2##(2009-5#3)(2012-1#1)
tool and as a##2##4##(1996-1#1)(1997-4#1)
tool and new##2##3##(2008-7#1)(2011-1#1)
tool and##12##2##(1996-1#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
tool are##2##2##(1997-1#1)(2008-10#1)
tool as a##2##3##(2008-11#2)
tool as##6##2##(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
tool available##2##2##(2008-1#1)(2013-1#1)
tool between##2##2##(1996-1#1)(2008-11#1)
tool can be used##2##4##(2008-1#1)(2008-3#1)
tool can be##3##3##(2008-1#1)(2008-3#1)(2008-9#1)
tool can##5##2##(2008-1#1)(2008-3#2)(2008-4#1)(2008-9#1)
tool commonly used##2##3##(2011-3#1)(2012-1#1)
tool developed to##2##3##(2008-12#1)(2013-1#1)
tool for a##4##3##(1994-6#1)(1997-6#1)(2008-7#1)(2012-12#1)
tool for accelerating##2##3##(2010-11#1)(2013-8#1)
tool for accurate##2##3##(2008-10#1)(2008-7#1)
tool for analysis of##2##4##(2008-1#1)(2011-3#1)
tool for analyzing##3##3##(1997-3#1)(2007-11#1)(2008-3#1)
tool for assessing the##3##4##(2008-4#1)(2008-5#1)(2010-2#1)
tool for better##2##3##(1994-11#1)(2013-7#1)
tool for biomedical research##2##4##(2008-9#1)(2010-12#1)
tool for both##2##3##(1992-4#1)(2008-10#1)
tool for cancer##3##3##(2008-7#1)(2009-12#1)(2009-5#1)
tool for characterizing##2##3##(2008-10#1)(2008-5#1)
tool for clinical##2##3##(1997-3#1)(2012-3#1)
tool for continuous monitoring of##2##5##(2011-1#1)(2013-8#1)
tool for detecting##3##3##(1994-11#1)(1997-3#1)(2007-10#1)
tool for diagnosis##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
tool for early##2##3##(2008-10#1)(2010-9#1)
tool for epidemiological##2##3##(2008-10#1)(2012-3#1)
tool for estimating the##2##4##(1994-7#1)(2008-10#1)
tool for evaluating##3##3##(1990-8#1)(2011-2#1)(2012-2#1)
tool for examining##2##3##(1995-11#1)(2008-9#1)
tool for health care##2##4##(1993-3#1)(2009-8#1)
tool for health##3##3##(1993-3#1)(1997-1#1)(2009-8#1)
tool for identifying##7##3##(1996-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-3#1)
tool for imaging##2##3##(2007-12#1)(2008-4#1)
tool for implementing##2##3##(2008-2#1)(2008-6#1)
tool for improving##3##3##(1994-8#1)(2007-11#1)(2010-2#1)
tool for in##2##3##(2008-10#2)
tool for investigating##2##3##(2008-4#1)(2008-7#1)
tool for leaders##2##3##(1996-1#1)(1997-1#1)
tool for malaria##2##3##(2007-2#1)(2008-8#1)
tool for many##2##3##(2008-1#1)(2008-3#1)
tool for mapping##2##3##(2008-3#1)(2008-8#1)
tool for measurement of##2##4##(2007-11#2)
tool for measuring##2##3##(2008-11#1)(2010-10#1)
tool for modeling##2##3##(2007-11#2)
tool for molecular##4##3##(1995-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
tool for monitoring##5##3##(1997-6#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)
tool for processing the##2##4##(2008-5#1)(2010-8#1)
tool for professional development##2##4##(2008-11#1)(2008-6#1)
tool for quality assurance##2##4##(1992-11#1)(2008-3#1)
tool for quality##3##3##(1992-11#1)(2008-3#1)(2008-9#1)
tool for reducing##2##3##(2008-11#1)(2008-6#1)
tool for risk-selection in##2##4##(2008-7#2)
tool for routine##2##3##(2008-10#1)(2009-11#1)
tool for structural##2##3##(2008-4#1)(2008-9#1)
tool for studies of##2##4##(2008-10#1)(2008-11#1)
tool for studies##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
tool for studying the##3##4##(1991-5#1)(1991-6#1)(2007-12#1)
tool for studying##12##3##(1991-5#1)(1991-6#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)
tool for the analysis of##4##5##(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
tool for the assessment of##2##5##(2011-2#1)(2012-12#1)
tool for the detection of##5##5##(2008-10#3)(2008-11#1)(2008-3#1)
tool for the detection##6##4##(2008-10#4)(2008-11#1)(2008-3#1)
tool for the determination of##2##5##(2008-10#1)(2010-11#1)
tool for the development of##2##5##(2008-8#2)
tool for the diagnosis of##2##5##(2008-1#1)(2011-2#1)
tool for the evaluation of##3##5##(1996-12#1)(2008-10#1)(2009-1#1)
tool for the identification##2##4##(2008-10#1)(2011-1#1)
tool for the rapid##2##4##(2008-10#2)
tool for the study of##8##5##(1993-9#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
tool for the##62##3##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
tool for understanding##2##3##(1996-1#1)(2008-8#1)
tool for##344##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-4#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-3#2)(1996-4#1)(1997-1#3)(1997-3#5)(1997-4#2)(1997-6#3)(2007-10#1)(2007-11#9)(2007-12#5)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#7)(2008-10#62)(2008-11#20)(2008-12#4)(2008-2#14)(2008-3#21)(2008-4#21)(2008-5#5)(2008-6#4)(2008-7#16)(2008-8#10)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
tool has been##3##3##(2008-5#1)(2008-7#1)(2009-2#1)
tool has not been##2##4##(1994-1#1)(2008-11#1)
tool has##5##2##(1994-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)
tool in a##2##3##(2008-7#2)
tool in clinical##3##3##(1992-3#1)(2008-12#1)(2008-9#1)
tool in our##2##3##(2007-7#1)(2008-2#1)
tool in skin##2##3##(2008-5#2)
tool in the clinical##2##4##(1993-11#1)(2008-9#1)
tool in the control of##2##5##(2007-10#1)(2009-5#1)
tool in the diagnosis and##2##5##(1992-2#1)(2008-3#1)
tool in the diagnosis of##3##5##(1991-12#1)(2008-12#1)(2013-1#1)
tool in the diagnosis##6##4##(1991-12#1)(1992-2#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
tool in the evaluation of##5##5##(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)
tool in the evaluation##6##4##(2008-10#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)
tool in the future##2##4##(2008-10#1)(2009-5#1)
tool in the management of##4##5##(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
tool in the study of##2##5##(1994-3#1)(2008-3#1)
tool in the treatment of##4##5##(1990-11#1)(1991-1#1)(1996-9#1)(2008-9#1)
tool in the##59##3##(1990-11#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-12#3)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
tool in this##3##3##(2008-2#1)(2009-7#1)(2010-5#1)
tool in##134##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#3)(2008-1#3)(2008-10#18)(2008-11#7)(2008-12#7)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
tool is##9##2##(1990-12#1)(1993-12#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)
tool may##2##2##(1993-12#1)(2008-10#1)
tool of##8##2##(1991-3#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-8#1)
tool than##2##2##(2008-10#1)(2013-8#1)
tool that can be##2##4##(2008-3#1)(2010-10#1)
tool that can##5##3##(1996-2#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)
tool that may be##2##4##(2008-12#1)(2013-8#1)
tool that will##2##3##(2008-2#1)(2011-2#1)
tool that##19##2##(1992-1#1)(1992-12#1)(1993-3#1)(1995-2#2)(1996-2#1)(1997-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
tool to achieve##2##3##(1996-1#1)(2011-1#1)
tool to aid in##2##4##(2010-8#1)(2012-2#1)
tool to aid##3##3##(2010-8#1)(2011-2#1)(2012-2#1)
tool to assess the##2##4##(2008-12#1)(2013-1#1)
tool to assess##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#2)
tool to be used##2##4##(2009-2#1)(2013-8#1)
tool to capture##2##3##(1996-3#1)(2013-1#1)
tool to characterize##2##3##(1990-7#1)(2010-1#1)
tool to detect##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2009-5#1)
tool to determine the##2##4##(2008-3#1)(2008-4#1)
tool to determine##3##3##(1997-1#1)(2008-3#1)(2008-4#1)
tool to develop##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
tool to differentiate##2##3##(2008-10#1)(2008-4#1)
tool to elucidate##2##3##(2008-10#1)(2008-11#1)
tool to evaluate##5##3##(2008-11#2)(2008-7#1)(2011-1#1)(2012-3#1)
tool to gain##2##3##(2008-7#1)(2012-2#1)
tool to guide##4##3##(2008-3#1)(2008-9#1)(2009-10#1)(2012-1#1)
tool to help improve the##2##5##(2008-2#1)(2013-7#1)
tool to help##6##3##(1992-12#1)(1995-12#1)(2007-10#1)(2008-2#1)(2011-1#1)(2013-7#1)
tool to identify##8##3##(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
tool to improve##2##3##(1996-12#1)(2013-1#1)
tool to investigate the##5##4##(1997-2#1)(2008-11#1)(2010-4#1)(2012-3#1)(2013-8#1)
tool to investigate##9##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-8#1)
tool to measure the##2##4##(2008-3#1)(2010-12#1)
tool to measure##7##3##(1996-3#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)
tool to monitor##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
tool to perform##2##3##(2008-10#1)(2008-3#1)
tool to predict the##2##4##(2008-5#1)(2008-8#1)
tool to predict##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
tool to quantify##3##3##(2008-10#2)(2012-2#1)
tool to study##5##3##(1993-3#1)(1995-12#1)(1996-6#1)(2010-6#1)(2010-8#1)
tool to understand##2##3##(2008-1#1)(2011-2#1)
tool to##155##2##(1990-7#1)(1992-12#2)(1992-2#1)(1993-3#1)(1994-3#1)(1995-12#2)(1996-1#1)(1996-12#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#18)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#5)(2008-7#11)(2008-8#2)(2008-9#6)(2009-10#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#2)(2012-7#2)(2013-1#5)(2013-7#1)(2013-8#3)
tool use##4##2##(2009-2#4)
tool used to##4##3##(1994-2#1)(1997-3#1)(2008-10#1)(2008-9#1)
tool was##7##2##(2008-11#3)(2008-12#2)(2012-12#1)(2013-8#1)
tool which##3##2##(1996-1#1)(1997-3#1)(2007-7#1)
tool with which to##2##4##(2008-3#2)
tool with##11##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
tool within a##2##3##(2008-12#1)(2008-9#1)
tool##896##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#6)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#3)(1995-6#1)(1996-1#9)(1996-10#2)(1996-12#8)(1996-2#2)(1996-3#5)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#8)(1997-2#1)(1997-3#8)(1997-4#7)(1997-6#3)(1997-7#1)(2006-10#2)(2006-4#1)(2007-10#4)(2007-11#15)(2007-12#10)(2007-2#3)(2007-5#1)(2007-7#8)(2007-8#3)(2008-1#19)(2008-10#124)(2008-11#58)(2008-12#25)(2008-2#30)(2008-3#54)(2008-4#33)(2008-5#16)(2008-6#5)(2008-7#41)(2008-8#17)(2008-9#38)(2009-1#1)(2009-10#7)(2009-11#4)(2009-12#6)(2009-2#8)(2009-3#3)(2009-4#4)(2009-5#9)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#7)(2010-12#6)(2010-2#3)(2010-3#7)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#14)(2010-9#2)(2011-1#17)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#7)(2012-12#11)(2012-2#14)(2012-3#13)(2012-7#2)(2013-1#17)(2013-7#3)(2013-8#21)
tool?##2##1##(1995-12#1)(2007-11#1)
toolbox##2##1##(2009-6#1)(2012-2#1)
toolkit of##2##2##(2008-12#1)(2009-5#1)
toolkit##7##1##(2008-10#1)(2008-12#1)(2009-12#3)(2009-5#1)(2013-8#1)
toolkits##2##1##(2008-12#1)(2012-2#1)
tools and a##2##3##(1996-1#1)(2008-10#1)
tools and analyses##2##3##(1994-3#1)(2010-10#1)
tools and methods##3##3##(1993-2#1)(2008-12#1)(2010-12#1)
tools and perceived improvement##2##4##(1996-3#2)
tools and processes##2##3##(2008-8#1)(2010-7#1)
tools and the##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)
tools and##43##2##(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-10#3)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2013-1#1)
tools applied##2##2##(2008-10#1)(2009-10#1)
tools are available##4##3##(2008-2#2)(2008-4#1)(2008-6#1)
tools are the##2##3##(1991-3#1)(1994-2#1)
tools are##18##2##(1991-3#1)(1994-1#1)(1994-2#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
tools as##2##2##(1996-1#1)(2008-10#1)
tools available for the##2##4##(2007-8#1)(2011-2#1)
tools available to##2##3##(2008-7#1)(2012-2#1)
tools available##5##2##(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
tools based on the##2##4##(2008-10#1)(2008-8#1)
tools based on##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
tools can assist the##2##4##(1993-12#1)(2008-12#1)
tools can be##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
tools can##9##2##(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2010-8#1)(2012-12#1)(2012-2#1)
tools designed##2##2##(2008-3#1)(2008-7#1)
tools developed##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
tools for assessing##2##3##(2009-11#1)(2011-2#1)
tools for data##2##3##(2010-11#1)(2011-1#1)
tools for detection and quantification of##2##6##(2008-10#2)
tools for future##2##3##(2010-11#1)(2012-3#1)
tools for identifying##2##3##(2008-8#1)(2008-9#1)
tools for monitoring##3##3##(2008-10#1)(2008-11#2)
tools for pain##2##3##(2007-11#1)(2008-7#1)
tools for studying the##3##4##(2008-4#2)(2010-11#1)
tools for studying##4##3##(2008-4#2)(2008-8#1)(2010-11#1)
tools for the##18##3##(1991-9#1)(1993-12#1)(1993-6#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-7#2)(2010-11#1)(2011-2#1)(2012-2#1)
tools for this##2##3##(2008-5#1)(2010-10#1)
tools for understanding and##2##4##(1994-12#1)(2007-12#1)
tools for understanding##3##3##(1994-12#1)(2007-12#1)(2008-11#1)
tools for##114##2##(1990-9#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-3#3)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#11)(2008-4#11)(2008-5#3)(2008-7#9)(2008-8#5)(2008-9#2)(2009-11#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#5)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
tools from the##2##3##(2008-7#1)(2011-2#1)
tools from##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
tools have been developed##3##4##(2008-11#1)(2008-7#1)(2009-5#1)
tools have been##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)
tools have##11##2##(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)
tools in a##2##3##(2008-10#1)(2008-7#1)
tools in cell##2##3##(2008-11#1)(2008-4#1)
tools in studying##2##3##(2008-5#1)(2010-8#1)
tools in the##7##3##(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
tools in##48##2##(1990-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1997-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-4#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
tools into their##2##3##(1997-2#1)(2010-8#1)
tools into##3##2##(1995-2#1)(1997-2#1)(2010-8#1)
tools is##4##2##(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
tools like##2##2##(1994-1#1)(1996-12#1)
tools may be##3##3##(1993-12#1)(2008-3#1)(2013-8#1)
tools may##4##2##(1993-12#1)(2008-3#1)(2012-3#1)(2013-8#1)
tools of TQM##2##3##(1993-12#1)(1994-1#1)
tools of##8##2##(1993-12#1)(1994-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2010-5#1)
tools or##2##2##(2008-10#1)(2010-12#1)
tools provided by##3##3##(2007-6#1)(2008-3#1)(2012-2#1)
tools such as a##2##4##(2008-10#2)
tools such as the##2##4##(2008-6#1)(2013-7#1)
tools such as##8##3##(1990-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2013-7#1)
tools that are##13##3##(1994-12#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-11#1)(2010-2#1)(2011-3#1)(2012-3#1)
tools that can be used to##2##6##(1996-2#1)(2008-4#1)
tools that can be##3##4##(1996-2#1)(2008-4#1)(2013-1#1)
tools that can greatly##2##4##(2006-10#1)(2008-10#1)
tools that can##8##3##(1996-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
tools that may be##2##4##(1993-12#1)(2008-7#1)
tools that may##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
tools that will##2##3##(1996-12#1)(2008-10#1)
tools that##33##2##(1992-12#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#2)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
tools to assess##3##3##(2008-10#2)(2012-3#1)
tools to create##3##3##(1996-1#1)(2008-11#1)(2010-7#1)
tools to evaluate##2##3##(2008-10#1)(2011-2#1)
tools to further##2##3##(2008-11#1)(2008-6#1)
tools to help the##2##4##(1991-2#1)(2008-10#1)
tools to help##4##3##(1991-2#2)(2008-10#1)(2012-12#1)
tools to identify##3##3##(2008-1#1)(2008-7#1)(2012-1#1)
tools to measure##2##3##(1992-12#1)(2008-9#1)
tools to probe##2##3##(2008-4#1)(2008-8#1)
tools to study the##2##4##(1994-6#1)(2008-10#1)
tools to study##3##3##(1994-6#1)(2008-10#1)(2008-2#1)
tools to##68##2##(1991-2#2)(1992-12#1)(1993-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
tools used by##2##3##(1990-12#1)(2008-12#1)
tools used in##3##3##(1990-10#1)(1995-12#1)(2008-2#1)
tools used##10##2##(1990-10#1)(1990-12#1)(1992-2#1)(1995-12#1)(1996-3#1)(2007-2#1)(2008-12#1)(2008-2#2)(2008-7#1)
tools were##3##2##(2008-10#3)
tools which##3##2##(1992-3#1)(2008-12#1)(2012-3#1)
tools with##2##2##(2008-10#1)(2008-3#1)
tools##587##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-2#3)(1991-3#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#1)(1994-1#5)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#5)(1995-6#1)(1996-1#10)(1996-12#4)(1996-2#3)(1996-3#10)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#3)(2007-4#3)(2007-5#2)(2007-6#3)(2007-8#4)(2008-1#8)(2008-10#80)(2008-11#35)(2008-12#15)(2008-2#10)(2008-3#13)(2008-4#32)(2008-5#9)(2008-6#4)(2008-7#40)(2008-8#20)(2008-9#14)(2009-10#5)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#1)(2010-10#8)(2010-11#12)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#4)(2010-8#8)(2010-9#5)(2011-1#11)(2011-2#24)(2011-3#3)(2012-1#2)(2012-12#9)(2012-2#14)(2012-3#11)(2013-1#20)(2013-7#2)(2013-8#7)
toosendanin##3##1##(2008-11#3)
tooth agenesis in##2##3##(2013-1#2)
tooth agenesis##3##2##(2010-3#1)(2013-1#2)
tooth and##4##2##(1991-5#1)(1996-3#1)(2008-1#1)(2012-2#1)
tooth avulsion##3##2##(2008-12#3)
tooth brushing frequency and##2##4##(2012-2#2)
tooth brushing##3##2##(2012-2#3)
tooth decay##3##2##(1997-8#1)(2007-10#1)(2008-5#1)
tooth developmental##2##2##(2013-1#2)
tooth enamel##4##2##(2008-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
tooth erosion around orthodontic brackets##2##5##(2013-1#2)
tooth extraction##6##2##(2006-12#1)(2007-12#5)
tooth germs##3##2##(2009-3#2)(2013-1#1)
tooth in##2##2##(2008-12#1)(2012-3#1)
tooth is##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
tooth loss in diabetic##2##4##(2012-12#2)
tooth loss in##4##3##(2008-12#2)(2012-12#2)
tooth loss##7##2##(2008-12#2)(2012-12#4)(2013-1#1)
tooth movement##3##2##(2008-11#1)(2013-1#2)
tooth preparation##2##2##(1991-2#1)(2013-1#1)
tooth replacement##3##2##(2009-8#2)(2013-1#1)
tooth separation was##3##3##(2008-12#3)
tooth separation##5##2##(2008-12#5)
tooth stains##5##2##(2013-1#5)
tooth structure##8##2##(1991-2#2)(1997-4#1)(2008-7#3)(2008-9#1)(2010-10#1)
tooth supported##2##2##(2013-1#2)
tooth was##5##2##(2008-7#1)(2010-3#2)(2011-2#1)(2013-1#1)
tooth whitening##2##2##(2009-8#1)(2012-8#1)
tooth with a##2##3##(2009-8#1)(2011-2#1)
tooth with##4##2##(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
tooth##137##1##(1990-5#1)(1991-2#5)(1991-5#1)(1996-2#1)(1996-3#1)(1997-4#3)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#10)(2008-1#1)(2008-11#2)(2008-12#15)(2008-3#1)(2008-5#3)(2008-7#13)(2008-9#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#5)(2010-10#3)(2010-3#6)(2011-2#6)(2012-12#4)(2012-2#6)(2012-3#1)(2012-8#1)(2013-1#37)(2013-8#2)
tooth-row##2##1##(2008-8#2)
toothless##3##1##(1996-3#1)(2013-1#2)
toothpaste##12##1##(2008-10#1)(2008-5#4)(2011-1#1)(2011-2#6)
toothpastes containing##2##2##(2008-5#1)(2011-2#1)
toothpastes##10##1##(2008-5#8)(2011-2#2)
toothpick causing pseudotumor of the first metatarsal##2##7##(2008-12#2)
toothpick##6##1##(2008-10#1)(2008-12#5)
toothpicks##2##1##(2008-10#1)(2008-2#1)
top 10##3##2##(2008-7#2)(2013-8#1)
top component of##2##3##(1992-8#1)(2008-9#1)
top component##3##2##(1992-8#2)(2008-9#1)
top down##2##2##(1996-12#1)(2013-1#1)
top in##2##2##(1993-3#1)(2010-12#1)
top layer of the##2##4##(2007-12#1)(2010-5#1)
top layer of##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
top layer##5##2##(1990-12#1)(2007-12#1)(2008-3#2)(2010-5#1)
top of a##3##3##(2008-3#3)
top of an##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
top of the##18##3##(1990-7#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2010-6#1)
top of##39##2##(1990-7#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
top surface##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
top ten##3##2##(2007-5#1)(2012-3#2)
top trophic levels##2##3##(2008-5#1)(2008-9#1)
top trophic##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
top##173##1##(1990-12#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-8#3)(1993-12#3)(1993-3#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#3)(1997-7#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-5#1)(2008-1#2)(2008-10#38)(2008-11#3)(2008-12#4)(2008-2#14)(2008-3#19)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#4)
top-down modulation of##3##3##(2008-11#1)(2013-8#2)
top-down##12##1##(1995-2#1)(2007-8#1)(2008-11#3)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
top-hat beam##7##2##(2007-12#2)(2008-3#5)
top-hat##10##1##(2007-12#2)(2008-2#1)(2008-3#7)
top-layer optical properties##3##3##(2008-2#1)(2008-3#2)
top-layer##4##1##(2008-2#1)(2008-3#3)
top-managers and##2##2##(1990-12#2)
top-of-the-atmosphere##5##1##(2008-2#2)(2008-3#3)
top1 cleavage##2##2##(1995-5#2)
top1##4##1##(1995-5#4)
top3 slow growth phenotype##3##4##(2010-2#3)
top3##8##1##(2010-2#8)
topic and##4##2##(2008-10#1)(2008-4#1)(2009-12#1)(2013-1#1)
topic for##2##2##(1992-2#1)(1994-8#1)
topic has##2##2##(1990-11#1)(1996-12#1)
topic in the##3##3##(1993-5#1)(2008-3#1)(2009-5#1)
topic in##22##2##(1993-5#1)(2007-8#13)(2008-10#3)(2008-3#1)(2009-5#2)(2009-9#1)(2012-12#1)
topic is##5##2##(1994-2#1)(2008-7#1)(2011-2#2)(2012-2#1)
topic of discussion##2##3##(1996-12#1)(2008-1#1)
topic of interest##2##3##(2009-10#1)(2009-5#1)
topic of the##3##3##(2008-12#2)(2011-2#1)
topic of this article##2##4##(2008-11#1)(2008-5#1)
topic of##26##2##(1991-1#1)(1992-1#2)(1995-3#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
topic with##3##2##(1996-8#1)(2008-12#1)(2013-8#1)
topic##123##1##(1990-11#1)(1990-9#1)(1991-1#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#4)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-12#2)(1996-6#1)(1996-8#1)(2007-10#1)(2007-11#2)(2007-5#2)(2007-8#15)(2008-1#4)(2008-10#9)(2008-11#9)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
topical ALA##2##2##(1992-8#2)
topical acne##2##2##(2010-8#2)
topical administration of##2##3##(2008-5#1)(2011-2#1)
topical administration##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
topical agent##2##2##(1994-2#1)(2008-5#1)
topical agents##2##2##(2008-5#1)(2011-2#1)
topical and systemic##2##3##(2008-5#2)
topical and##6##2##(2007-12#1)(2008-12#1)(2008-5#3)(2009-4#1)
topical antibiotics##2##2##(2007-7#1)(2013-8#1)
topical antifungal therapy##2##3##(2012-3#2)
topical antifungal##3##2##(2011-2#1)(2012-3#2)
topical antifungals##2##2##(2008-5#1)(2011-2#1)
topical application of ALA##2##4##(1992-9#2)
topical application of a##2##4##(2008-5#2)
topical application of##21##3##(1990-11#1)(1991-8#1)(1992-8#3)(1992-9#3)(1996-10#1)(1996-5#1)(2007-8#1)(2008-5#7)(2009-6#1)(2011-2#1)(2013-1#1)
topical application##33##2##(1990-11#1)(1991-8#1)(1992-8#3)(1992-9#3)(1996-10#1)(1996-5#1)(2007-8#1)(2008-12#4)(2008-5#11)(2008-6#1)(2009-6#2)(2011-2#3)(2013-1#1)
topical applications##2##2##(1993-11#1)(2008-8#1)
topical combination##2##2##(2008-5#1)(2012-3#1)
topical corticosteroid##2##2##(2011-1#1)(2012-3#1)
topical corticosteroids##2##2##(2007-11#1)(2012-3#1)
topical exposure##2##2##(1992-2#2)
topical formulation##2##2##(2008-3#1)(2008-5#1)
topical formulations##2##2##(2008-5#2)
topical preparations##2##2##(2008-5#2)
topical products##3##2##(2008-5#3)
topical steroids and##2##3##(2007-7#1)(2011-2#1)
topical therapy##4##2##(1991-8#1)(2008-5#1)(2010-12#1)(2010-8#1)
topical treatment for##2##3##(1993-11#1)(2008-10#1)
topical treatment of##6##3##(1990-6#2)(1992-8#1)(1997-8#1)(2008-5#1)(2010-8#1)
topical treatment##10##2##(1990-6#3)(1992-8#1)(1993-11#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)
topical use##2##2##(2007-11#1)(2008-5#1)
topical##147##1##(1990-11#2)(1990-6#3)(1991-3#1)(1991-8#2)(1992-2#3)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#2)(1993-2#1)(1994-2#3)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#3)(2007-11#4)(2007-12#1)(2007-7#7)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#43)(2008-6#2)(2008-8#3)(2009-4#1)(2009-6#4)(2009-8#1)(2010-12#3)(2010-3#1)(2010-8#5)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
topical/transdermal drug delivery##2##3##(2008-5#2)
topically active##2##2##(1993-1#1)(2008-5#1)
topically administered##2##2##(1994-6#1)(2008-5#1)
topically and##2##2##(2007-8#1)(2008-5#1)
topically applied cosmetic products##2##4##(2008-5#2)
topically applied##14##2##(1992-1#1)(2008-5#13)
topically##30##1##(1992-1#1)(1992-2#1)(1993-1#2)(1994-6#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#20)
topics about the##2##3##(2008-7#1)(2013-1#1)
topics addressed##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
topics and##2##2##(1995-3#1)(2008-11#1)
topics are considered##2##3##(1995-12#1)(2008-10#1)
topics are##9##2##(1995-12#1)(1996-2#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
topics as the##2##3##(2008-11#1)(2008-9#1)
topics as##4##2##(1994-1#1)(2008-11#1)(2008-9#2)
topics discussed##2##2##(1993-12#1)(1994-3#1)
topics for##4##2##(2007-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
topics from##2##2##(2008-2#1)(2008-5#1)
topics in the field of##2##5##(1992-3#1)(2008-5#1)
topics in the##3##3##(1992-3#1)(1994-2#1)(2008-5#1)
topics in##11##2##(1992-3#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#3)(2009-9#1)(2011-1#1)(2013-1#1)
topics of interest to##2##4##(2008-12#1)(2008-5#1)
topics of interest##3##3##(2008-12#1)(2008-5#1)(2010-5#1)
topics of the##4##3##(2008-10#1)(2008-7#1)(2010-11#1)(2012-3#1)
topics of##18##2##(1993-1#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
topics on##2##2##(1994-2#1)(2011-3#1)
topics ranging from##2##3##(2008-7#1)(2008-8#1)
topics such as##4##3##(1994-12#1)(2008-9#1)(2010-12#1)(2011-2#1)
topics that are##2##3##(1997-2#1)(2008-3#1)
topics that##6##2##(1994-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
topics to##2##2##(2010-4#1)(2012-3#1)
topics were##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
topics will##2##2##(1992-9#1)(2008-10#1)
topics##118##1##(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#8)(2008-7#9)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#1)
topiramate##4##1##(2008-7#3)(2013-1#1)
topographic and##3##2##(2007-11#1)(2012-1#1)(2013-1#1)
topographic map##2##2##(1993-9#2)
topographic##28##1##(1991-1#1)(1992-10#1)(1993-9#2)(1995-3#1)(1996-2#1)(1997-5#2)(2007-11#4)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2012-1#1)(2013-1#1)(2013-7#1)
topographical features##3##2##(1995-8#1)(2008-2#2)
topographical organization##3##2##(1994-2#1)(2008-11#2)
topographical##20##1##(1992-5#1)(1994-2#2)(1995-8#1)(2007-11#1)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#1)
topographically##4##1##(2007-12#1)(2008-3#2)(2012-1#1)
topography analysis##2##2##(1991-12#1)(2008-5#1)
topography and##7##2##(1994-5#1)(2006-4#1)(2007-10#1)(2007-5#1)(2008-2#2)(2012-1#1)
topography changes##3##2##(2008-2#1)(2008-3#2)
topography of the##5##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
topography of##15##2##(1990-11#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
topography on##4##2##(2008-3#2)(2013-7#2)
topography was##2##2##(1997-3#1)(2012-1#1)
topography with##2##2##(2008-3#2)
topography##68##1##(1990-11#1)(1991-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1997-3#1)(2006-4#2)(2006-6#1)(2007-10#2)(2007-11#3)(2007-5#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#21)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#4)(2013-8#1)
topoisomerase I and##2##3##(1993-8#1)(1995-3#1)
topoisomerase I cleavable##2##3##(1995-3#1)(1995-5#1)
topoisomerase I inhibitor##2##3##(1993-8#1)(1995-3#1)
topoisomerase I inhibitors##2##3##(2008-11#1)(2008-5#1)
topoisomerase I##24##2##(1990-7#2)(1993-8#7)(1994-8#2)(1995-3#5)(1995-5#2)(2008-11#4)(2008-5#1)(2008-8#1)
topoisomerase II beta##5##3##(1995-6#5)
topoisomerase II in##2##3##(1993-8#2)
topoisomerase II inhibitor##2##3##(1994-6#1)(2008-11#1)
topoisomerase II##22##2##(1993-8#6)(1994-6#2)(1994-8#1)(1995-6#9)(2008-11#3)(2008-8#1)
topoisomerase##54##1##(1990-7#2)(1993-8#13)(1994-6#2)(1994-8#3)(1995-3#6)(1995-5#2)(1995-6#10)(2008-11#7)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-2#1)(2012-3#1)
topoisomerases##3##1##(2012-12#1)(2012-3#2)
topological and##3##2##(2007-11#1)(2008-6#1)(2012-2#1)
topological charge##3##2##(2007-11#2)(2007-12#1)
topological charges##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
topological defects##5##2##(2008-7#4)(2009-11#1)
topological distance indices##5##3##(2007-11#5)
topological distance matrix##2##3##(2007-11#2)
topological distance##7##2##(2007-11#7)
topological index##2##2##(2008-10#2)
topological indices for the##3##4##(2007-11#1)(2008-10#2)
topological indices##11##2##(2007-11#6)(2008-10#5)
topological map##2##2##(2008-3#2)
topological ordering##2##2##(2012-2#2)
topological phase##2##2##(1993-5#1)(2008-2#1)
topological##61##1##(1991-8#1)(1993-5#1)(1994-5#1)(1995-3#1)(2007-11#23)(2007-12#3)(2008-10#8)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#6)(2009-11#1)(2009-3#1)(2010-6#1)(2010-9#1)(2012-2#4)
topologically##6##1##(1994-12#1)(2007-12#2)(2008-6#1)(2010-2#1)(2013-1#1)
topologies and##2##2##(2008-3#1)(2012-3#1)
topologies include##2##2##(2007-12#1)(2008-3#1)
topologies##15##1##(1995-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2010-10#1)(2010-6#1)(2012-2#1)(2012-3#2)
topology and##9##2##(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)
topology by##2##2##(2008-11#1)(2008-6#1)
topology for##2##2##(2008-2#1)(2008-6#1)
topology is##3##2##(1992-4#1)(1997-7#1)(2007-12#1)
topology of the##8##3##(1990-11#1)(1993-6#1)(1994-5#1)(1995-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
topology of##14##2##(1990-11#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-6#1)(1997-7#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
topology on the##2##3##(2008-10#1)(2012-2#1)
topology##57##1##(1990-11#1)(1992-4#3)(1992-7#1)(1993-11#2)(1993-6#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-6#1)(1997-7#8)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#4)(2008-2#6)(2008-3#2)(2008-4#1)(2008-6#5)(2008-7#3)(2008-9#1)(2009-5#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
topometry##2##1##(2008-3#2)
topotecan##5##1##(1995-3#1)(1995-5#2)(2007-7#1)(2008-5#1)
tops##3##1##(1991-5#1)(1992-7#1)(2007-10#1)
topsoil##3##1##(2008-10#3)
tora##2##1##(2008-11#2)
torch with##2##2##(2008-10#2)
torch##13##1##(2007-7#1)(2008-10#12)
torn##5##1##(1992-4#1)(2007-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
tornado##2##1##(1996-2#2)
toroidal uniform##2##2##(2008-3#1)(2013-8#1)
toroidal##12##1##(1993-6#1)(2008-3#8)(2008-7#1)(2013-8#2)
torpid##3##1##(1993-2#1)(1995-12#2)
torquatus##3##1##(2008-7#3)
torque between##3##2##(2013-1#3)
torque in##3##2##(1993-12#1)(2008-12#1)(2010-3#1)
torque levels ranging from##2##4##(1993-12#2)
torque present on##2##3##(2008-2#1)(2008-3#1)
torque was increasing##3##3##(1993-12#3)
torque was##6##2##(1993-12#5)(2008-12#1)
torque were##2##2##(2009-7#1)(2011-1#1)
torque##43##1##(1993-12#11)(1995-12#1)(2007-12#1)(2008-12#5)(2008-2#1)(2008-3#5)(2009-7#4)(2010-3#2)(2010-7#3)(2011-1#1)(2012-2#1)(2013-1#7)(2013-8#1)
torquens##2##1##(2012-2#2)
torques##4##1##(1995-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
torsade de pointes##3##3##(2008-7#2)(2009-8#1)
torsion in##4##2##(2008-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
torsion is##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
torsion of the##3##3##(1990-6#1)(1997-3#2)
torsion of##5##2##(1990-6#1)(1997-3#2)(2011-2#1)(2012-2#1)
torsion##35##1##(1990-6#1)(1997-3#3)(2007-8#1)(2008-10#18)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#4)(2012-2#2)
torsional angles##5##2##(1992-12#3)(1992-4#1)(1993-11#1)
torsional strain in##3##3##(1995-2#1)(2008-7#2)
torsional strain##4##2##(1995-2#1)(2008-7#3)
torsional##20##1##(1992-12#3)(1992-4#1)(1992-9#1)(1993-11#3)(1994-5#1)(1995-2#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2013-7#1)
torso##6##1##(2008-7#3)(2010-8#1)(2011-2#1)(2013-1#1)
tort law##2##2##(1992-1#1)(1994-1#1)
tort liability##2##2##(1993-12#2)
tort reform##5##2##(1991-1#3)(1993-12#1)(2008-4#1)
tort##12##1##(1991-1#3)(1992-1#1)(1993-12#3)(1994-1#3)(1997-5#1)(2008-4#1)
torted##2##1##(2008-10#2)
tortuosity##4##1##(2007-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
tortuous##6##1##(1996-9#1)(1997-3#2)(2012-3#1)(2013-1#2)
torture##15##1##(1990-6#1)(1995-11#4)(1996-11#1)(1996-3#5)(2013-1#4)
tortured refugees##2##2##(2013-1#2)
tortured##4##1##(1995-11#1)(2013-1#3)
torturing##2##1##(2008-4#1)(2013-1#1)
tospoviral##3##1##(2008-10#3)
tospovirus infections##2##2##(2008-10#2)
tospovirus species##9##2##(2008-10#9)
tospovirus##20##1##(2008-10#20)
tospoviruses from##2##2##(2008-10#2)
tospoviruses in##2##2##(2008-10#2)
tospoviruses##27##1##(2008-10#27)
toss##3##1##(2011-2#3)
tosylate (DAST)##4##2##(2007-12#4)
tosylate##6##1##(1992-11#1)(2007-12#4)(2008-4#1)
total (sum of free and sulphate conjugated)##2##7##(1997-7#2)
total APP##4##2##(1996-12#4)
total Al##2##2##(2008-10#1)(2010-5#1)
total As and Sb##2##4##(2008-10#2)
total As##7##2##(2008-10#7)
total BTs##2##2##(2008-11#2)
total CSF##2##2##(1991-2#1)(2008-7#1)
total Cr##4##2##(2008-10#4)
total DNA extracted from##3##4##(2008-10#2)(2008-4#1)
total DNA from##2##3##(1990-5#1)(2008-10#1)
total DNA of##2##3##(2008-10#1)(2008-9#1)
total DNA##14##2##(1990-5#1)(1994-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
total EI score##2##3##(2013-1#2)
total FA content##4##3##(2012-1#4)
total Fe##2##2##(2008-10#2)
total Hg##2##2##(2008-10#2)
total IGF-II##2##2##(1992-9#2)
total Ig##2##2##(1990-12#2)
total IgA##2##2##(1996-11#1)(2008-11#1)
total IgE##4##2##(1990-12#1)(1992-9#1)(2007-11#1)(2009-5#1)
total Ins 1##5##3##(1997-1#5)
total Mallet score##2##3##(2013-1#2)
total Medicaid spending##2##3##(1994-1#2)
total Medicaid##5##2##(1991-3#1)(1992-3#2)(1994-1#2)
total Medicare##2##2##(1991-3#1)(1995-3#1)
total N##4##2##(2008-10#1)(2008-5#3)
total P##2##2##(2008-10#1)(2008-9#1)
total Pb##2##2##(2008-10#2)
total RNA extracted from the##2##5##(1992-3#1)(2008-10#1)
total RNA extracted from##4##4##(1992-3#1)(2008-10#2)(2008-4#1)
total RNA was##3##3##(2008-9#1)(2011-2#2)
total RNA##32##2##(1991-9#1)(1992-3#2)(1993-2#1)(1994-11#1)(1994-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#4)(2008-7#2)(2008-9#3)(2009-12#3)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
total RNAs##2##2##(1992-6#1)(2008-10#1)
total SA concentration##2##3##(2008-12#2)
total SA##3##2##(2008-12#3)
total Se determination##2##3##(2008-10#2)
total Se##4##2##(2008-10#4)
total T##2##2##(1991-6#1)(2007-5#1)
total T4##2##2##(1995-3#1)(2008-7#1)
total WMSA##2##2##(2009-10#2)
total abdominal hysterectomy and vaginal hysterectomy##2##6##(1993-12#2)
total abdominal hysterectomy with bilateral##2##5##(2011-2#1)(2013-1#1)
total abdominal hysterectomy##7##3##(1993-12#2)(1994-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
total abdominal##10##2##(1993-12#5)(1994-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
total absence of##2##3##(1996-12#1)(2008-10#1)
total absence##3##2##(1996-12#1)(1997-7#1)(2008-10#1)
total absorptance##2##2##(2008-3#2)
total absorption coefficients##2##3##(2008-3#2)
total absorption##6##2##(2008-3#6)
total abundance##2##2##(2008-9#1)(2013-7#1)
total acidity in soft drinks##2##5##(2008-10#2)
total acidity##6##2##(2008-10#5)(2012-2#1)
total activity of##2##3##(1992-3#1)(2009-8#1)
total activity##4##2##(1992-3#1)(1997-4#1)(2008-8#1)(2009-8#1)
total adenylate##2##2##(1995-12#1)(2008-11#1)
total aerobic energy##2##3##(2013-8#2)
total alpha##2##2##(1993-12#2)
total amino acids for 1##2##5##(1990-12#2)
total amino acids##7##3##(1990-12#3)(2008-5#3)(2010-4#1)
total amino##8##2##(1990-12#3)(2008-5#3)(2010-4#2)
total amount of food##3##4##(2009-5#3)
total amount of##34##3##(1990-7#1)(1991-6#1)(1991-9#1)(1993-1#1)(1995-6#1)(1996-12#3)(1997-3#1)(2008-10#13)(2008-11#3)(2008-8#4)(2009-5#3)(2010-2#1)(2010-4#1)
total amount##38##2##(1990-7#1)(1991-6#1)(1991-9#1)(1993-1#1)(1995-6#1)(1996-12#3)(1996-5#1)(1997-3#1)(2008-10#14)(2008-11#4)(2008-8#4)(2009-5#3)(2010-2#1)(2010-4#1)(2011-1#1)
total amounts of##3##3##(1994-2#1)(2008-10#2)
total analysis systems (muTAS)##2##4##(2008-10#2)
total analysis systems##3##3##(2008-10#2)(2010-11#1)
total analysis time##10##3##(1991-5#1)(2008-10#8)(2012-1#1)
total analysis##14##2##(1991-5#1)(2008-10#11)(2010-11#1)(2012-1#1)
total analyte##3##2##(2008-10#3)
total and LDL cholesterol as##2##5##(1992-11#1)(2012-2#1)
total and differential##2##3##(1997-6#1)(2008-10#1)
total and free testosterone levels##2##5##(2011-2#2)
total and mercury species determination in##2##6##(2008-10#2)
total and protein-bound homocysteine##4##4##(2008-10#4)
total and##36##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
total anionic##3##2##(2008-10#3)
total ankle replacement##3##3##(2009-10#2)(2009-7#1)
total ankle replacements##2##3##(2009-7#2)
total ankle##5##2##(2009-10#2)(2009-7#3)
total annual##2##2##(2008-11#1)(2011-1#1)
total anomalous pulmonary venous connection##2##5##(2008-11#2)
total antimony##2##2##(2008-10#2)
total antioxidant activity of##2##4##(2008-10#2)
total antioxidant activity##4##3##(2008-10#3)(2011-2#1)
total antioxidant capacity (TAC)##2##4##(2008-10#2)
total antioxidant capacity##9##3##(2008-10#7)(2009-6#1)(2010-5#1)
total antioxidant##14##2##(2008-10#10)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)
total apo B##2##3##(1990-8#2)
total architecture##2##2##(2008-5#2)
total area under the##2##4##(2008-10#1)(2008-8#1)
total area##8##2##(1995-12#4)(2008-10#1)(2008-6#1)(2008-8#1)(2012-1#1)
total arsenic content##2##3##(2008-10#2)
total arsenic in##5##3##(2008-10#5)
total arsenic##20##2##(1995-11#1)(2008-10#19)
total arsenic) were##2##3##(2008-10#2)
total arsenic)##3##2##(2008-10#3)
total atmospheric##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
total backscattering coefficient##2##3##(2008-2#1)(2008-3#1)
total backscattering##4##2##(2008-2#1)(2008-3#3)
total bacteria##4##2##(1997-4#1)(2008-10#2)(2009-4#1)
total bacterial concentrations##2##3##(2009-4#2)
total bacterial count##3##3##(1992-2#3)
total bacterial populations on##2##4##(2008-10#2)
total bacterial proteins##2##3##(2008-4#1)(2008-8#1)
total bacterial##13##2##(1992-12#1)(1992-2#3)(2007-7#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-4#2)(2010-4#1)
total bilirubin in##2##3##(2008-10#1)(2012-3#1)
total bilirubin##11##2##(2007-12#1)(2008-10#3)(2011-2#1)(2012-3#2)(2013-1#4)
total binding##4##2##(1993-6#3)(1996-2#1)
total biomass##4##2##(2008-10#1)(2008-7#3)
total body irradiation##5##3##(1993-9#2)(1996-6#1)(2007-4#1)(2008-1#1)
total body water and##3##4##(1997-8#2)(2008-7#1)
total body water##5##3##(1997-8#2)(2008-7#2)(2009-11#1)
total body##28##2##(1992-1#1)(1992-2#1)(1993-9#2)(1995-5#1)(1996-6#1)(1997-1#1)(1997-8#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#3)(2009-11#1)(2010-1#1)(2010-3#1)(2012-3#1)(2013-1#2)(2013-7#1)
total calcium content##2##3##(1997-4#1)(2008-10#1)
total calcium##3##2##(1997-4#1)(2008-10#2)
total carbohydrates##2##2##(1993-9#1)(2012-12#1)
total carbon and##2##3##(2008-12#1)(2008-5#1)
total carbon##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
total cardiovascular##3##2##(1993-12#2)(2013-1#1)
total care of##2##3##(1992-2#1)(2010-3#1)
total carnitine##3##2##(1991-2#2)(2011-2#1)
total carotenoids and total antioxidants in##2##6##(2011-2#2)
total carotenoids##3##2##(2011-2#2)(2012-2#1)
total cases##2##2##(2008-4#1)(2011-2#1)
total cationic and total anionic arsenic##2##6##(2008-10#2)
total cationic##3##2##(2008-10#3)
total cavity loss##2##3##(2007-11#1)(2008-3#1)
total cavopulmonary connection##2##3##(2007-8#2)
total cell count##2##3##(1995-11#1)(2008-1#1)
total cell densities##2##3##(2008-11#1)(2008-7#1)
total cell number and##2##4##(2008-11#1)(2012-12#1)
total cell number##4##3##(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
total cell protein content##3##4##(1990-5#1)(1992-8#1)(2008-11#1)
total cell protein##7##3##(1990-5#1)(1992-8#2)(1994-12#1)(2008-11#3)
total cell##23##2##(1990-5#1)(1992-8#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)(2012-12#1)(2013-1#1)
total cells##6##2##(2008-10#3)(2008-7#3)
total cellular RNA##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
total cellular protein##4##3##(1990-5#2)(1993-3#1)(2008-9#1)
total cellular##11##2##(1990-5#2)(1990-8#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
total change##2##2##(2008-10#1)(2008-2#1)
total charge and##2##3##(1993-11#2)
total charge##3##2##(1993-11#2)(1994-9#1)
total chlorophyll##4##2##(2008-10#1)(2008-12#2)(2008-9#1)
total cholesterol (TC) levels##2##4##(1990-2#1)(2008-7#1)
total cholesterol (TC)##4##3##(1990-2#1)(2007-11#1)(2008-7#1)(2013-1#1)
total cholesterol (p&lt##2##3##(2008-10#2)
total cholesterol and LDL cholesterol##2##5##(1993-12#1)(2011-2#1)
total cholesterol and triglycerides##2##4##(1990-8#2)
total cholesterol and##7##3##(1990-8#2)(1991-11#1)(1993-12#1)(2008-12#1)(2008-7#1)(2011-2#1)
total cholesterol level##2##3##(1991-8#1)(2008-1#1)
total cholesterol levels##3##3##(1990-2#1)(1994-3#1)(1996-11#1)
total cholesterol values##2##3##(1992-11#1)(1993-11#1)
total cholesterol was##5##3##(1991-6#1)(2007-7#2)(2012-2#1)(2013-1#1)
total cholesterol were##2##3##(1991-8#1)(2011-1#1)
total cholesterol##57##2##(1990-2#2)(1990-8#3)(1991-11#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-11#4)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-11#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
total cholesterolemia and##3##3##(1991-12#3)
total cholesterolemia##4##2##(1991-12#4)
total chromium in##5##3##(2008-10#5)
total chromium##8##2##(2008-10#8)
total circulating##2##2##(1991-6#1)(2006-6#1)
total colectomy##2##2##(2009-5#2)
total collagen##2##2##(2008-5#1)(2010-4#1)
total concentration of the##3##4##(2008-10#3)
total concentration of##12##3##(2008-10#10)(2012-1#1)(2012-2#1)
total concentration##17##2##(2008-10#13)(2008-11#1)(2011-10#1)(2012-1#1)(2012-2#1)
total concentrations of##4##3##(2008-10#3)(2008-7#1)
total constituent backscattering##2##3##(2008-2#1)(2008-3#1)
total content of##5##3##(1992-6#1)(2008-10#4)
total content##7##2##(1992-6#1)(2008-10#6)
total coronary heart disease risk level##2##6##(1991-6#2)
total cost of##5##3##(1990-12#1)(1993-12#1)(1996-11#1)(2009-12#1)(2011-2#1)
total cost##8##2##(1990-12#1)(1992-12#2)(1993-12#1)(1996-11#1)(2009-12#1)(2011-2#2)
total costs##4##2##(1992-12#2)(2008-12#1)(2011-1#1)
total counts##2##2##(1997-4#1)(2008-10#1)
total current##2##2##(2008-10#1)(2008-8#1)
total cystectomy for cancer infiltrating##2##5##(2011-2#2)
total cystectomy##4##2##(1992-11#1)(2011-2#3)
total daily##2##2##(1990-12#1)(2008-9#1)
total darkness##3##2##(2008-10#2)(2008-4#1)
total death rate##2##3##(1990-6#2)
total decomposition of soil##2##4##(2008-10#2)
total decomposition##4##2##(2008-10#4)
total density dependence in##2##4##(2008-8#2)
total density##3##2##(2008-10#1)(2008-8#2)
total determination##2##2##(2008-10#2)
total diet and##2##3##(1994-3#1)(2008-10#1)
total dietary##3##2##(1990-8#1)(2012-2#2)
total digestion##2##2##(2008-10#1)(2008-5#1)
total discharge##2##2##(1990-12#1)(1991-6#1)
total disease incidence##2##3##(2008-10#2)
total disease##6##2##(2008-10#5)(2011-2#1)
total dissolution of##3##3##(2008-10#3)
total dissolved##10##2##(2008-10#10)
total distance from the aperture to the focal point##3##9##(2008-3#3)
total dose in##2##3##(2007-10#1)(2011-2#1)
total dose of##13##3##(1991-11#1)(1991-2#2)(1992-11#1)(1995-3#1)(1995-9#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#3)(2013-1#1)
total dose##29##2##(1991-11#1)(1991-2#2)(1992-10#2)(1992-11#1)(1992-8#1)(1995-3#1)(1995-9#1)(2007-10#2)(2007-4#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#5)(2008-7#2)(2011-2#2)(2013-1#3)
total drug concentrations##2##3##(2008-8#2)
total dry matter and grain yield##2##6##(2008-12#2)
total dry weight ha(-1)##2##4##(2008-12#2)
total dry##4##2##(2008-12#4)
total edentulous patient##2##3##(2013-1#2)
total effect##2##2##(2008-1#1)(2008-10#1)
total energy intake##5##3##(1990-2#1)(1993-9#1)(2008-4#1)(2008-5#1)(2012-2#1)
total energy##13##2##(1990-2#1)(1993-9#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
total episode##2##2##(1994-2#2)
total episodes of##2##3##(1994-2#1)(2013-1#1)
total error##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
total evaporation technique##2##3##(2008-10#2)
total evaporation##5##2##(2008-10#3)(2008-5#2)
total excision of the cerebellar##2##5##(2012-3#1)(2013-1#1)
total extinction altitude profiles##2##4##(2008-2#1)(2008-3#1)
total extraction##2##2##(2008-10#2)
total family##2##2##(1993-12#1)(2008-8#1)
total fat and##2##3##(1990-8#1)(2008-7#1)
total fatty acid##2##3##(2008-12#1)(2008-7#1)
total fatty acids in the##2##5##(2010-4#2)
total fatty##4##2##(2008-12#1)(2008-7#1)(2010-4#2)
total fears##2##2##(2011-2#2)
total fecundity##2##2##(2008-12#1)(2008-9#1)
total flora##3##2##(2011-2#3)
total flow rate##2##3##(2007-12#1)(2008-10#1)
total flow##6##2##(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)
total fluorine##4##2##(2008-10#4)
total free##3##2##(1991-12#1)(2008-12#1)(2010-2#1)
total fungal spore##2##3##(2008-5#2)
total gastrectomy##3##2##(1990-9#1)(1992-9#1)(2013-1#1)
total gene diversity##2##3##(2008-10#1)(2012-5#1)
total gene##3##2##(2008-10#1)(2010-1#1)(2012-5#1)
total genetic variability##2##3##(2008-10#1)(2008-8#1)
total genetic##7##2##(2008-10#6)(2008-8#1)
total genomic DNA##5##3##(2008-1#1)(2008-10#4)
total global##2##2##(2010-12#1)(2010-6#1)
total glutathione##5##2##(1995-12#1)(2008-11#2)(2008-4#1)(2013-1#1)
total glycoalkaloids##5##2##(2008-10#5)
total hPRL and##2##3##(2008-11#2)
total health care##4##3##(1993-12#1)(1994-2#1)(1995-2#1)(1997-2#1)
total health##6##2##(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-2#1)
total healthcare expenditures##2##3##(2013-1#2)
total hemoglobin##3##2##(1996-12#1)(2007-10#1)(2008-3#1)
total hip and total knee##2##5##(1994-3#1)(2009-3#1)
total hip arthroplasties##2##3##(1996-9#2)
total hip arthroplasty (THA)##8##4##(1994-3#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
total hip arthroplasty and total knee arthroplasty##3##7##(2011-2#3)
total hip arthroplasty and##5##4##(2007-8#1)(2008-6#1)(2011-2#3)
total hip arthroplasty in##2##4##(2007-8#1)(2013-1#1)
total hip arthroplasty is##2##4##(1997-6#1)(2007-11#1)
total hip arthroplasty##39##3##(1994-3#1)(1996-9#1)(1997-6#1)(2007-11#2)(2007-8#2)(2008-11#1)(2008-6#1)(2008-8#11)(2009-3#2)(2009-4#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#5)
total hip or knee##2##4##(2013-1#2)
total hip or##3##3##(2007-10#1)(2013-1#2)
total hip plasty##2##3##(2007-11#2)
total hip replacement (THR)##2##4##(2007-11#1)(2009-3#1)
total hip replacement and##2##4##(1996-1#1)(2010-10#1)
total hip replacement##25##3##(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-11#1)(2007-11#3)(2007-8#2)(2008-8#1)(2009-3#3)(2010-10#8)(2013-1#2)
total hip##83##2##(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-9#3)(1997-6#1)(2007-10#1)(2007-11#8)(2007-8#4)(2008-11#1)(2008-6#1)(2008-8#14)(2009-3#7)(2009-4#2)(2010-1#1)(2010-10#8)(2010-3#2)(2011-2#7)(2012-12#1)(2012-2#4)(2013-1#9)
total homocysteine##6##2##(1992-9#1)(1996-11#1)(2008-8#4)
total hospital costs##2##3##(1992-2#1)(2012-3#1)
total hospital##6##2##(1991-12#1)(1992-2#1)(1993-1#2)(1995-1#1)(2012-3#1)
total hours of##3##3##(1994-3#1)(2008-10#2)
total hours##4##2##(1994-3#1)(2008-10#3)
total human DNA##3##3##(2008-12#3)
total human##4##2##(1994-9#1)(2008-12#3)
total hydrocarbon contents and##2##4##(2008-10#2)
total hydrocarbon##3##2##(2008-10#3)
total hydroxyproline in##2##3##(1995-2#2)
total hysterectomy##3##2##(2011-2#3)
total incidence of##2##3##(1991-11#1)(1992-2#1)
total incidence##3##2##(1991-11#1)(1992-2#1)(2011-2#1)
total increase##2##2##(1990-5#1)(1996-12#1)
total infection##2##2##(2008-10#2)
total inorganic As##2##3##(2008-10#2)
total inorganic Se##2##3##(2008-10#2)
total inorganic arsenic##5##3##(2008-10#5)
total inorganic iron##3##3##(2008-10#3)
total inorganic phosphates##5##3##(2008-10#5)
total inorganic##23##2##(2008-10#23)
total insect survival##2##3##(2008-6#2)
total integrated scattering (TIS)##2##4##(2008-2#1)(2008-3#1)
total integrated scattering##4##3##(2008-2#1)(2008-3#3)
total integrated##5##2##(2008-2#1)(2008-3#4)
total intensity##3##2##(2007-11#1)(2008-3#2)
total internal reflection microscopy##7##4##(2007-12#4)(2008-3#3)
total internal reflection##28##3##(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#11)
total internal reflections##2##3##(2007-12#1)(2008-2#1)
total internal##31##2##(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#11)(2011-2#1)
total intracellular##6##2##(1990-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(2008-10#1)
total intravenous anesthesia##3##3##(2011-2#3)
total intravenous##4##2##(2011-2#4)
total ionic concentration##2##3##(2008-10#2)
total ionic##4##2##(2008-10#4)
total iron and vanadium##2##4##(2008-10#2)
total iron in##4##3##(2008-10#4)
total iron##14##2##(2008-10#14)
total isolates recovered)##2##3##(2008-10#2)
total isolates##4##2##(1991-3#1)(2008-10#3)
total joint arthroplasty##5##3##(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#2)
total joint replacement##4##3##(1997-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
total joint##13##2##(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#4)(2009-3#1)(2011-2#1)(2012-12#2)(2012-3#2)
total knee arthroplasty (TKA) with##2##5##(2009-3#2)
total knee arthroplasty (TKA)##11##4##(1994-3#1)(2008-8#2)(2009-3#2)(2011-2#2)(2013-1#4)
total knee arthroplasty##39##3##(1994-3#2)(2007-11#2)(2007-8#1)(2008-8#11)(2009-3#3)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#9)
total knee replacement (TKR)##4##4##(2007-8#1)(2008-8#2)(2013-1#1)
total knee replacement##13##3##(1994-12#1)(1995-2#1)(1996-3#1)(2007-10#1)(2007-8#4)(2008-7#1)(2008-8#2)(2009-3#1)(2013-1#1)
total knee##56##2##(1994-12#1)(1994-3#2)(1995-2#1)(1996-3#1)(1996-9#1)(2007-10#2)(2007-11#2)(2007-8#5)(2008-7#1)(2008-8#15)(2009-3#4)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#10)
total laparoscopic hysterectomy##3##3##(1996-2#1)(2010-3#1)(2011-2#1)
total laparoscopic##4##2##(1996-2#1)(2010-3#1)(2011-2#2)
total length and##2##3##(2007-12#1)(2009-4#1)
total length of the##6##4##(1996-6#1)(1997-6#1)(1997-8#2)(2008-5#1)(2012-12#1)
total length of##10##3##(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2008-5#1)(2012-12#1)(2013-8#2)
total length##19##2##(1996-10#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2007-12#1)(2007-5#1)(2008-5#2)(2009-4#1)(2010-8#3)(2012-12#1)(2013-7#1)(2013-8#2)
total leukocyte count##2##3##(2009-7#1)(2010-5#1)
total leukocyte##3##2##(1996-12#1)(2009-7#1)(2010-5#1)
total levels of##2##3##(1997-7#1)(2008-10#1)
total life##2##2##(1995-12#1)(2008-7#1)
total lifespan##3##2##(2009-12#3)
total linear indices##3##3##(2007-11#3)
total linear##4##2##(1996-1#1)(2007-11#3)
total lipid##5##2##(1995-12#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)
total lipids and serum##3##4##(2008-12#3)
total lipids and##5##3##(2008-12#5)
total lipids in##3##3##(2008-12#2)(2010-11#1)
total lipids##13##2##(2008-11#1)(2008-12#11)(2010-11#1)
total load of##2##3##(2008-10#2)
total loss of##3##3##(1995-8#1)(1996-9#1)(2010-3#1)
total loss##6##2##(1995-8#1)(1996-9#1)(2008-3#2)(2008-6#1)(2010-3#1)
total lung capacity##2##3##(1996-2#2)
total lung##3##2##(1996-2#2)(1996-3#1)
total mRNA rather than polysomal mRNA and##2##7##(2012-2#2)
total mRNA##3##2##(2012-2#3)
total matrix##2##2##(1990-2#1)(2011-2#1)
total mean##3##2##(1991-6#1)(2008-2#1)(2013-1#1)
total measurement time)##2##3##(2008-3#2)
total measurement##3##2##(2008-3#3)
total memory##2##2##(2008-12#1)(2008-3#1)
total mercury##15##2##(2008-10#15)
total mesna##6##2##(2008-10#6)
total metal concentrations##2##3##(2008-10#1)(2011-2#1)
total metal contents##2##3##(2010-5#2)
total metal##5##2##(2008-10#2)(2010-5#2)(2011-2#1)
total metals##4##2##(2008-10#3)(2010-5#1)
total midface deficiency##2##3##(2007-12#2)
total mitochondrial##2##2##(1990-2#1)(1991-5#1)
total molecular##2##2##(2008-10#1)(2008-3#1)
total mortality##4##2##(1990-2#1)(2008-1#1)(2008-5#2)
total muscle##2##2##(1996-12#1)(2008-5#1)
total nitrogen and##2##3##(2008-5#1)(2013-1#1)
total nitrogen determination in animal feed##2##6##(2008-10#2)
total nitrogen##8##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
total nuclear##2##2##(1990-7#1)(2008-5#1)
total nucleated cells##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
total nucleated##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
total nucleic acid extracts##2##4##(1996-12#1)(2008-10#1)
total nucleic##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
total number in the##2##4##(1994-3#1)(2008-10#1)
total number of eggs##2##4##(2007-12#1)(2008-3#1)
total number of protein##2##4##(2008-12#1)(2008-4#1)
total number of subjects##2##4##(2008-12#1)(2008-6#1)
total number of##90##3##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#3)
total number##93##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#3)
total numbers##3##2##(1994-9#1)(2007-5#1)(2011-2#1)
total nutrient uptake##2##3##(2008-12#2)
total nutrient##3##2##(2008-12#2)(2013-7#1)
total obliteration##3##2##(1997-6#1)(2008-7#2)
total occlusion of the left##2##5##(2008-1#1)(2010-3#1)
total occlusion of the##5##4##(2008-1#1)(2008-7#1)(2010-3#1)(2010-4#1)(2013-8#1)
total occlusion of##6##3##(2008-1#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-4#1)(2013-8#1)
total occlusion##11##2##(1997-3#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#1)(2010-3#1)(2010-4#1)(2013-8#1)
total occlusion)##2##2##(2008-7#2)
total of 1##19##3##(1990-11#1)(1990-9#2)(1991-6#1)(1994-11#1)(1996-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
total of 10##13##3##(1993-12#1)(1993-9#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
total of 100##4##3##(1995-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
total of 101##4##3##(2007-8#1)(2008-12#1)(2008-5#1)(2013-8#1)
total of 104##4##3##(1994-2#1)(1997-3#1)(2011-2#1)(2013-7#1)
total of 106##2##3##(2008-10#1)(2008-6#1)
total of 11##11##3##(1993-8#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
total of 111##3##3##(2007-7#1)(2012-2#1)(2013-1#1)
total of 12##8##3##(1992-2#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-12#1)(2013-1#1)
total of 13##3##3##(1997-8#1)(2007-10#1)(2008-11#1)
total of 14##7##3##(1992-11#1)(1993-12#1)(1994-12#1)(1997-6#1)(2008-10#1)(2013-1#1)(2013-7#1)
total of 15##7##3##(2008-10#2)(2008-11#2)(2012-2#1)(2013-7#2)
total of 155##3##3##(1994-3#1)(2008-10#1)(2013-7#1)
total of 156##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
total of 16##5##3##(1996-6#1)(2008-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
total of 179##2##3##(1992-9#1)(2011-1#1)
total of 185##2##3##(2010-4#1)(2011-2#1)
total of 186##3##3##(2007-7#2)(2010-1#1)
total of 189##2##3##(2008-10#1)(2008-3#1)
total of 19 patients##2##4##(1996-6#1)(2011-2#1)
total of 19##11##3##(1991-11#1)(1996-6#1)(1997-8#1)(2008-5#2)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
total of 2##8##3##(1992-6#1)(1996-3#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-7#1)
total of 20##9##3##(1990-8#1)(1992-6#1)(1995-6#1)(1997-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)
total of 200##4##3##(1994-12#1)(2007-10#1)(2007-8#1)(2013-8#1)
total of 21 patients##2##4##(2007-11#1)(2008-5#1)
total of 21##7##3##(1990-3#1)(1990-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-5#1)
total of 225##2##3##(1997-8#1)(2008-10#1)
total of 234##2##3##(2008-10#1)(2011-1#1)
total of 236##2##3##(2011-1#1)(2011-2#1)
total of 24##8##3##(1990-12#1)(1993-1#1)(1997-8#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-7#1)(2013-8#1)
total of 240##3##3##(2007-7#1)(2008-5#1)(2012-2#1)
total of 25##5##3##(1990-11#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
total of 27##4##3##(1990-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
total of 270##2##3##(2007-11#1)(2011-1#1)
total of 28##5##3##(1991-12#1)(1996-9#1)(1997-4#1)(2008-1#1)(2012-3#1)
total of 285##2##3##(2010-12#1)(2011-1#1)
total of 291##2##3##(1991-8#1)(2010-4#1)
total of 3##8##3##(1991-9#1)(1993-1#1)(1996-6#1)(2008-10#1)(2012-2#2)(2012-6#1)(2013-1#1)
total of 30##8##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
total of 31##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
total of 33##5##3##(2007-7#1)(2008-10#2)(2008-9#1)(2010-3#1)
total of 34##5##3##(1993-3#1)(1995-4#1)(2008-4#1)(2008-7#1)(2010-5#1)
total of 350##2##3##(2008-1#1)(2008-12#1)
total of 36##2##3##(1993-2#1)(2011-2#1)
total of 4##4##3##(1994-2#1)(2008-12#1)(2011-1#1)(2013-1#1)
total of 40 patients##2##4##(2008-5#1)(2013-1#1)
total of 40##7##3##(2008-10#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#3)
total of 43##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
total of 44##3##3##(1995-3#1)(1997-6#1)(2007-7#1)
total of 5##5##3##(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
total of 50##3##3##(1994-12#1)(2008-11#1)(2008-8#1)
total of 51##2##3##(1996-12#1)(2008-10#1)
total of 58##2##3##(1994-7#1)(2008-12#1)
total of 6##6##3##(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2011-1#1)
total of 60##6##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
total of 600##2##3##(1992-5#1)(2012-3#1)
total of 605##2##3##(1991-11#1)(2008-10#1)
total of 62##2##3##(2007-4#1)(2012-1#1)
total of 7##4##3##(1997-3#1)(2007-7#1)(2008-6#1)(2008-7#1)
total of 72##3##3##(1996-8#1)(2008-10#1)(2013-1#1)
total of 8##4##3##(1990-2#1)(1993-6#1)(2008-6#1)(2013-7#1)
total of 82##3##3##(1995-6#1)(1996-12#1)(2008-6#1)
total of 87##2##3##(1991-6#1)(2013-7#1)
total of 9##5##3##(1993-3#1)(1997-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
total of 91##2##3##(1997-6#1)(2008-10#1)
total of 96##5##3##(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#1)(2013-7#1)
total of five##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
total of four##3##3##(2007-12#1)(2008-10#2)
total of the##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
total of##661##2##(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-11#2)(1991-12#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#8)(1997-7#1)(1997-8#6)(2006-12#1)(2007-10#7)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#22)(2007-8#7)(2008-1#14)(2008-10#90)(2008-11#15)(2008-12#20)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#30)(2008-6#9)(2008-7#23)(2008-8#9)(2008-9#7)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#5)(2010-4#10)(2010-5#5)(2010-6#2)(2010-8#6)(2010-9#1)(2011-1#22)(2011-2#44)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#17)(2012-3#18)(2012-6#1)(2013-1#37)(2013-3#1)(2013-7#20)(2013-8#20)
total optical properties calculated##2##4##(2008-3#2)
total optical##5##2##(2008-2#1)(2008-3#3)(2010-12#1)
total or partial##3##3##(2007-11#1)(2008-10#1)(2010-9#1)
total or##9##2##(1993-12#1)(1994-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-7#1)(2010-9#1)
total organic carbon##2##3##(2008-10#2)
total organic##5##2##(2008-10#5)
total output power##2##3##(2007-12#2)
total output##5##2##(1994-8#1)(2007-12#2)(2008-3#2)
total ozone abundances from##2##4##(2008-2#2)
total ozone##9##2##(2008-2#9)
total parenteral nutrition (TPN)##3##4##(1992-9#2)(2008-10#1)
total parenteral nutrition##8##3##(1991-6#1)(1992-9#2)(2007-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)
total parenteral##9##2##(1991-6#1)(1992-9#2)(2007-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2009-9#1)(2011-2#1)
total parotidectomy##3##2##(2007-5#1)(2011-2#1)(2013-8#1)
total patient##2##2##(2007-12#1)(2012-3#1)
total percentage##2##2##(2008-6#1)(2010-8#1)
total peripheral##2##2##(1991-12#1)(2008-3#1)
total phenol##2##2##(2008-10#1)(2013-1#1)
total phenolic content of the##2##5##(2008-10#1)(2008-11#1)
total phenolic content of##3##4##(2008-10#2)(2008-11#1)
total phenolic content##6##3##(2008-10#4)(2008-11#1)(2009-6#1)
total phenolic contents##3##3##(2012-2#1)(2013-8#2)
total phenolic##9##2##(2008-10#4)(2008-11#1)(2009-6#1)(2012-2#1)(2013-8#2)
total phenotypic variation for resistance##3##5##(2008-10#3)
total phenotypic variation##4##3##(2008-10#4)
total phenotypic##7##2##(2008-10#6)(2012-3#1)
total phosphorus in##4##3##(2008-10#4)
total phosphorus##8##2##(2008-10#8)
total phosphorylation 0##2##3##(2010-12#2)
total plaque area##2##3##(2008-8#2)
total plaque##3##2##(2008-7#1)(2008-8#2)
total plasma cholesterol levels##2##4##(1990-3#1)(1994-8#1)
total plasma cholesterol##4##3##(1990-3#2)(1994-8#1)(2008-5#1)
total plasma proteins##2##3##(2008-4#1)(2008-5#1)
total plasma volume##2##3##(2011-2#2)
total plasma##12##2##(1990-3#2)(1992-11#1)(1993-11#1)(1994-8#1)(1995-8#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)
total plastic strain##3##3##(2009-7#3)
total pollen##2##2##(2008-5#2)
total polycyclic aromatic hydrocarbons##2##4##(2008-10#2)
total polyphenol index##2##3##(2008-10#2)
total polyphenol##3##2##(2008-10#3)
total population of##11##3##(1991-12#1)(1992-6#1)(1993-6#1)(1995-3#2)(1996-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-12#2)
total population##27##2##(1991-12#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#2)(2013-8#3)
total power of##2##3##(2008-10#1)(2010-8#1)
total power##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)
total precipitation##2##2##(2008-10#2)
total preconcentration time##4##3##(2008-10#4)
total pressure##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
total proctectomy with##2##3##(2007-8#2)
total production of##3##3##(1992-3#1)(2007-12#1)(2011-1#1)
total protein (r =##2##4##(1993-2#1)(2011-2#1)
total protein amount##2##3##(2008-11#2)
total protein and##5##3##(1992-6#1)(1997-8#1)(2008-4#1)(2008-9#1)(2012-2#1)
total protein assay##2##3##(2008-10#2)
total protein content##2##3##(1991-12#1)(2008-10#1)
total protein in human serum##5##5##(2008-10#5)
total protein in##6##3##(2008-1#1)(2008-10#5)
total protein levels##2##3##(2008-10#1)(2008-6#1)
total protein of##3##3##(2007-2#1)(2008-12#2)
total protein##60##2##(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-5#1)(1997-6#1)(1997-8#2)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#5)(2013-1#1)(2013-8#1)
total protein)##2##2##(2008-4#1)(2008-7#1)
total proteins and##2##3##(1994-8#1)(2012-2#1)
total proteins in##5##3##(2008-10#1)(2008-12#1)(2008-8#3)
total proteins of##2##3##(2008-12#1)(2008-9#1)
total proteins##17##2##(1993-6#1)(1994-8#1)(1996-8#1)(2008-10#4)(2008-12#4)(2008-8#3)(2008-9#1)(2010-4#1)(2012-2#1)
total proteolysis##2##2##(1991-5#1)(2013-1#1)
total pulse width##2##3##(2008-10#2)
total quality management (TQM)##15##4##(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#3)(1995-1#1)(1995-3#4)(1996-2#1)
total quality management process##3##4##(1994-1#1)(1994-2#2)
total quality management##42##3##(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#7)(1994-2#10)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#8)(1996-12#1)(1996-2#3)(2008-12#1)
total quality##52##2##(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#4)(1994-1#8)(1994-2#11)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#9)(1996-12#1)(1996-2#3)(2007-8#4)(2008-12#1)
total radiation##2##2##(2008-11#1)(2008-2#1)
total radioactivity##3##2##(1992-2#1)(1993-11#1)(1994-8#1)
total reaction time variance##2##4##(2008-8#2)
total reaction time##3##3##(2008-10#1)(2008-8#2)
total recovery of##2##3##(2008-10#2)
total recovery##4##2##(2008-10#3)(2008-5#1)
total reduction of##2##3##(2008-3#1)(2013-1#1)
total reflectance infrared##3##3##(2008-10#3)
total reflectance##13##2##(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#3)
total reflection Fourier transform infrared##3##5##(2007-12#1)(2008-10#2)
total reflection Fourier transform##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
total reflection Fourier##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
total reflection geometry for##2##4##(2008-3#2)
total reflection##24##2##(1990-2#1)(2007-12#3)(2008-10#11)(2008-2#1)(2008-3#6)(2008-5#2)
total refraction##2##2##(2007-11#2)
total relative standard error##2##4##(2008-10#2)
total removal of the tumour##2##5##(2007-11#1)(2008-7#1)
total removal of the##5##4##(2007-11#1)(2007-5#1)(2008-12#1)(2008-7#2)
total removal of##7##3##(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#3)
total removal##11##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#5)(2012-3#2)
total reproductive success##2##3##(2008-8#2)
total reproductive##4##2##(2008-8#3)(2012-3#1)
total resection of the##2##4##(2008-12#1)(2012-3#1)
total resection of##5##3##(2007-8#1)(2008-12#1)(2008-7#2)(2012-3#1)
total resection##8##2##(2007-8#1)(2008-12#1)(2008-7#5)(2012-3#1)
total respiration##2##2##(2008-7#1)(2008-9#1)
total retrieval##2##2##(2008-3#2)
total root tip##2##3##(2008-10#2)
total root##3##2##(2008-10#2)(2011-2#1)
total sample comprised##2##3##(2008-11#1)(2013-1#1)
total sample##8##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2012-12#1)(2013-1#1)
total scale##3##2##(2007-12#1)(2007-2#1)(2010-11#1)
total scattering##3##2##(2008-2#1)(2008-3#2)
total score and subscale scores were##2##6##(2007-12#2)
total score##10##2##(1991-9#1)(2007-12#2)(2008-4#1)(2010-10#1)(2010-2#1)(2012-3#2)(2013-1#2)
total scores##2##2##(2008-10#1)(2008-11#1)
total screen##2##2##(1991-6#1)(2008-11#1)
total seed##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
total selenium##6##2##(2008-10#5)(2010-11#1)
total serum cholesterol##3##3##(1991-6#1)(1993-12#1)(2008-3#1)
total serum##8##2##(1991-6#1)(1993-12#1)(1993-2#1)(2006-6#1)(2008-10#1)(2008-3#2)(2011-2#1)
total sialic acid##3##3##(1995-12#1)(2008-12#2)
total sialic acids##3##3##(2008-11#3)
total sialic##6##2##(1995-12#1)(2008-11#3)(2008-12#2)
total skin##3##2##(1995-9#2)(2007-7#1)
total sleep time##3##3##(1994-8#1)(2010-7#1)(2012-12#1)
total soluble phenolic compounds##3##4##(2008-10#3)
total soluble protein in the##2##5##(1994-5#1)(2013-1#1)
total soluble protein in##3##4##(1993-9#1)(1994-5#1)(2013-1#1)
total soluble protein##4##3##(1993-9#1)(1994-5#1)(2008-9#1)(2013-1#1)
total soluble##14##2##(1993-9#1)(1994-12#1)(1994-5#1)(2008-10#4)(2008-12#3)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
total spectral##2##2##(2008-10#1)(2008-3#1)
total sugar##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
total sugar)##2##2##(2008-10#2)
total sulfide##2##2##(2008-10#2)
total sulfur##7##2##(2008-10#7)
total sulphur dioxide##5##3##(2008-10#5)
total sulphur##10##2##(2008-10#10)
total surface##4##2##(1997-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
total surgical excision##2##3##(2007-8#1)(2010-11#1)
total surgical##5##2##(1992-12#1)(1994-5#1)(2007-8#1)(2008-8#1)(2010-11#1)
total survival time##2##3##(1995-12#1)(2013-8#1)
total suspended solids##2##3##(2008-10#1)(2013-1#1)
total suspended##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
total syntheses of##2##3##(2009-12#1)(2013-1#1)
total synthesis and##2##3##(1995-3#1)(2013-1#1)
total synthesis of the##2##4##(2009-11#1)(2010-2#1)
total synthesis of##5##3##(2008-7#1)(2009-11#2)(2009-5#1)(2010-2#1)
total synthesis##9##2##(1995-3#2)(2008-7#1)(2009-11#3)(2009-5#1)(2010-2#1)(2013-1#1)
total system##5##2##(2008-5#1)(2011-1#3)(2012-2#1)
total tRNA##3##2##(2008-4#3)
total testosterone##4##2##(2008-5#1)(2012-12#2)(2013-1#1)
total thyroidectomy is the##2##4##(1990-9#1)(1993-6#1)
total thyroidectomy##13##2##(1990-9#2)(1992-5#1)(1993-6#1)(2009-3#1)(2011-2#5)(2013-1#2)(2013-7#1)
total time for##2##3##(2008-10#2)
total time interval##2##3##(1994-3#2)
total time of##4##3##(2008-10#4)
total time##14##2##(1994-3#3)(2008-10#9)(2008-5#1)(2011-1#1)
total trace##3##2##(2007-5#1)(2008-10#1)(2010-5#1)
total tract digestibility##2##3##(2009-4#1)(2010-2#1)
total treatment duration##4##3##(1996-11#1)(2011-2#3)
total treatment##9##2##(1991-12#1)(1993-9#2)(1996-11#1)(2007-7#1)(2009-9#1)(2011-2#3)
total trivalent arsenic##2##3##(2008-10#2)
total understanding of##2##3##(1992-1#1)(1995-11#1)
total uptake of##2##3##(1990-11#1)(1994-6#1)
total uptake##3##2##(1990-11#1)(1992-3#1)(1994-6#1)
total urogenital sinus mobilization##2##4##(2008-10#2)
total value##3##2##(2007-5#1)(2008-10#2)
total vanadium##5##2##(1994-11#1)(2008-10#4)
total variance##19##2##(1993-8#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
total variation##5##2##(2008-10#4)(2008-8#1)
total version##2##2##(2011-2#2)
total viable counts##3##3##(1997-4#1)(1997-5#2)
total vitamin E (P=0##2##4##(2008-10#2)
total volume of##4##3##(1990-5#1)(1992-12#1)(2008-10#1)(2012-12#1)
total volume##6##2##(1990-5#1)(1992-12#1)(2008-10#3)(2012-12#1)
total water##4##2##(2008-10#1)(2008-5#3)
total weight##4##2##(2008-7#2)(2013-1#1)(2013-7#1)
total work##2##2##(2008-11#1)(2011-2#1)
total worm burden##2##3##(1996-12#2)
total worm##3##2##(1996-12#3)
total x-ray absorption coefficient##2##4##(2012-2#2)
total yield##2##2##(2008-10#1)(2008-6#1)
total zirconia##2##2##(2008-10#2)
total##3395##1##(1990-10#1)(1990-11#7)(1990-12#16)(1990-2#12)(1990-3#5)(1990-4#1)(1990-5#8)(1990-6#7)(1990-7#11)(1990-8#14)(1990-9#10)(1991-1#1)(1991-11#8)(1991-12#17)(1991-2#9)(1991-3#6)(1991-5#7)(1991-6#19)(1991-8#9)(1991-9#5)(1992-1#3)(1992-10#5)(1992-11#15)(1992-12#14)(1992-2#12)(1992-3#22)(1992-5#3)(1992-6#12)(1992-8#6)(1992-9#10)(1993-1#8)(1993-11#5)(1993-12#28)(1993-2#12)(1993-3#8)(1993-5#1)(1993-6#11)(1993-8#6)(1993-9#13)(1994-1#13)(1994-11#12)(1994-12#18)(1994-2#25)(1994-3#22)(1994-5#9)(1994-6#8)(1994-7#2)(1994-8#15)(1994-9#4)(1995-1#3)(1995-11#11)(1995-12#17)(1995-2#8)(1995-3#24)(1995-4#2)(1995-5#2)(1995-6#7)(1995-8#5)(1995-9#4)(1996-1#5)(1996-10#3)(1996-11#10)(1996-12#26)(1996-2#13)(1996-3#11)(1996-4#1)(1996-5#5)(1996-6#8)(1996-7#3)(1996-8#3)(1996-9#7)(1997-1#9)(1997-2#11)(1997-3#8)(1997-4#9)(1997-5#4)(1997-6#15)(1997-7#9)(1997-8#14)(2006-12#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#17)(2007-11#43)(2007-12#52)(2007-2#5)(2007-4#5)(2007-5#10)(2007-6#1)(2007-7#36)(2007-8#36)(2007-9#2)(2008-1#36)(2008-10#767)(2008-11#89)(2008-12#99)(2008-2#55)(2008-3#131)(2008-4#36)(2008-5#97)(2008-6#42)(2008-7#98)(2008-8#101)(2008-9#49)(2009-1#2)(2009-10#6)(2009-11#7)(2009-12#10)(2009-2#2)(2009-3#15)(2009-4#11)(2009-5#11)(2009-6#6)(2009-7#14)(2009-8#5)(2009-9#7)(2010-1#5)(2010-10#13)(2010-11#11)(2010-12#14)(2010-2#15)(2010-3#14)(2010-4#21)(2010-5#15)(2010-6#3)(2010-7#6)(2010-8#17)(2010-9#2)(2011-1#48)(2011-10#3)(2011-2#161)(2011-3#5)(2012-1#12)(2012-12#31)(2012-2#59)(2012-3#47)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#147)(2013-3#1)(2013-7#35)(2013-8#46)
total) were##3##2##(2008-10#3)
total)##18##1##(1991-12#1)(1992-12#1)(1994-6#1)(1995-11#1)(2007-12#1)(2008-10#11)(2008-8#1)(2012-3#1)
total- and LDL-cholesterol##2##3##(2008-10#2)
total-Fe##3##1##(2008-10#3)
total-body##2##1##(2008-7#1)(2010-11#1)
total-variation##2##1##(2012-1#2)
total/HDL cholesterol ratio##2##3##(2013-1#2)
total/HDL cholesterol##3##2##(2013-1#3)
totale##3##1##(2008-5#3)
totaled##4##1##(1993-8#1)(2008-10#1)(2008-11#2)
totaling##5##1##(1993-11#1)(2011-2#1)(2013-8#3)
totality##4##1##(1993-8#1)(1996-6#1)(2009-8#1)(2011-2#1)
totalled##2##1##(1997-4#1)(2007-12#1)
totalling##5##1##(1990-3#1)(1993-2#1)(1994-6#1)(2008-10#1)(2010-10#1)
totally abolished##2##2##(1996-5#1)(2008-1#1)
totally blocked by##2##3##(1996-9#1)(2008-10#1)
totally blocked##3##2##(1994-2#1)(1996-9#1)(2008-10#1)
totally deaf##2##2##(2008-2#2)
totally dependent##2##2##(2009-10#1)(2012-1#1)
totally different##4##2##(1997-6#1)(2008-10#1)(2008-3#1)(2008-9#1)
totally endoscopic single vessel##2##4##(2007-8#2)
totally endoscopic single##3##3##(2007-8#3)
totally endoscopic##6##2##(2007-8#6)
totally in##2##2##(2008-12#1)(2008-4#1)
totally independent##2##2##(1991-9#1)(2008-10#1)
totally inhibited##2##2##(1992-12#1)(2008-7#1)
totally new##2##2##(2008-10#1)(2012-1#1)
totally removed and the##2##4##(2008-7#2)
totally removed and##3##3##(2008-7#3)
totally removed##9##2##(2006-12#1)(2008-10#1)(2008-7#6)(2012-3#1)
totally##91##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#2)(1993-6#2)(1994-2#1)(1996-1#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#15)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#3)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#2)
totals##4##1##(1995-3#1)(2008-12#2)(2013-1#1)
tothe##4##1##(2008-11#3)(2008-2#1)
totipotent cells##2##2##(2008-11#1)(2008-12#1)
toucan##2##1##(2008-5#2)
touch and vestibular##2##3##(1995-8#2)
touch and##5##2##(1995-8#2)(2008-7#1)(2010-9#1)(2012-2#1)
touch by##2##2##(2008-12#1)(2008-9#1)
touch the##2##2##(2008-2#1)(2013-1#1)
touch therapy##3##2##(2008-1#1)(2013-1#2)
touch##36##1##(1991-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-1#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#3)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
touched##4##1##(1993-6#1)(1997-3#1)(2008-5#1)(2012-2#1)
touches##3##1##(1993-11#1)(1995-2#1)(2007-11#1)
touching##8##1##(1995-12#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#2)(2011-1#1)
touchscreen##2##1##(2011-2#2)
tough decisions##2##2##(1994-12#1)(1995-2#1)
tough##14##1##(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)
toughening##2##1##(2007-12#1)(2009-6#1)
toughness and defect-tolerance##3##3##(2012-2#3)
toughness and##4##2##(2012-2#3)(2013-1#1)
toughness by##2##2##(2008-8#1)(2009-7#1)
toughness in##3##2##(2008-8#1)(2010-2#1)(2010-4#1)
toughness of raw pork##2##4##(2010-2#2)
toughness of semitendinosus##3##3##(2013-1#3)
toughness of the##3##3##(2008-8#2)(2013-1#1)
toughness of##13##2##(1997-4#1)(2008-8#5)(2010-2#3)(2013-1#4)
toughness##31##1##(1997-4#2)(2008-8#7)(2009-6#3)(2009-7#3)(2010-2#4)(2010-4#1)(2012-2#5)(2013-1#6)
tour##4##1##(1992-6#1)(2007-2#1)(2008-1#1)(2010-9#1)
tourism##7##1##(2007-12#1)(2007-2#2)(2008-11#3)(2013-1#1)
tourist##6##1##(1996-9#1)(2007-2#3)(2008-5#1)(2011-2#1)
tourists##12##1##(1997-6#1)(2007-2#9)(2008-1#1)(2009-10#1)
tourniquet ischemia##5##2##(2006-12#5)
tourniquet##14##1##(1992-6#2)(2006-12#6)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
tourniquets was##2##2##(1992-6#2)
tourniquets##3##1##(1992-6#3)
tours##5##1##(1992-12#4)(2009-6#1)
touted##2##1##(2007-9#1)(2008-3#1)
toward B##2##2##(2008-10#2)
toward H(2)O(2)##3##2##(2008-10#1)(2013-1#2)
toward a global##2##3##(2008-9#1)(2010-7#1)
toward a more##7##3##(1993-1#2)(1995-3#1)(1997-1#1)(2008-9#1)(2011-2#1)(2013-7#1)
toward a target##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
toward a##44##2##(1991-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#2)(2007-12#2)(2008-10#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#4)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
toward advertising##3##2##(2008-12#3)
toward an##8##2##(1994-3#1)(1996-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
toward and##3##2##(2009-5#1)(2010-12#1)(2013-1#1)
toward basal levels##2##3##(1990-7#1)(1995-2#1)
toward better##5##2##(1990-6#1)(1995-11#1)(2006-10#1)(2008-11#1)(2009-3#1)
toward both##2##2##(2008-10#1)(2008-11#1)
toward breast cancer screening##2##4##(2013-1#2)
toward cancer##2##2##(2009-5#1)(2012-2#1)
toward competency##2##2##(1994-12#2)
toward control##3##2##(1993-8#1)(2013-1#1)(2013-8#1)
toward developing a##2##3##(2008-10#1)(2008-6#1)
toward developing##7##2##(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
toward either##2##2##(2008-10#2)
toward extinction##2##2##(2008-8#2)
toward fibrinogen##2##2##(1994-6#1)(1997-2#1)
toward fluoride##4##2##(2008-10#4)
toward greater##6##2##(1991-3#1)(1994-1#1)(1996-2#1)(1997-2#1)(2008-10#2)
toward health care##4##3##(1993-1#1)(1993-12#1)(1996-1#1)(2007-10#1)
toward health##5##2##(1993-1#1)(1993-12#1)(1996-1#1)(2007-10#1)(2009-5#1)
toward higher##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
toward homosexuals##4##2##(1993-1#3)(1995-12#1)
toward human##2##2##(1990-7#1)(2008-11#1)
toward identifying the##2##3##(1995-2#1)(1997-2#1)
toward identifying##3##2##(1995-2#1)(1997-2#1)(2008-11#1)
toward improving##4##2##(1995-6#1)(2013-1#2)(2013-8#1)
toward increased##2##2##(1996-3#1)(2008-10#1)
toward its##5##2##(1990-5#1)(1992-12#1)(1993-6#1)(2007-4#1)(2010-5#1)
toward less positive##2##3##(2008-10#2)
toward less##3##2##(1993-12#1)(2008-10#2)
toward lower##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
toward making##3##2##(1994-2#1)(1995-2#1)(1997-3#1)
toward managed care##2##3##(1995-1#1)(1997-3#1)
toward managed##3##2##(1995-1#1)(1996-1#1)(1997-3#1)
toward more##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
toward nanotechnology##3##2##(2010-12#3)
toward new##2##2##(1991-3#1)(1992-6#1)
toward one##2##2##(1991-3#1)(2008-10#1)
toward other##2##2##(2008-11#1)(2013-1#1)
toward parent participation##2##3##(1994-3#2)
toward partners##2##2##(2009-7#1)(2010-11#1)
toward potassium##2##2##(2008-10#2)
toward providing care##2##3##(1996-2#1)(2011-1#1)
toward providing##6##2##(1996-2#1)(2010-3#1)(2011-1#4)
toward real-time##2##2##(2011-7#2)
toward resistance##3##2##(2008-10#3)
toward shorter##2##2##(1995-6#1)(2012-3#1)
toward specific##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
toward that##2##2##(1993-2#1)(1995-6#1)
toward the HCO and its services##2##6##(2011-2#2)
toward the center of##2##4##(1996-2#1)(2013-7#1)
toward the development of##3##4##(2008-3#1)(2009-1#1)(2009-4#1)
toward the elderly##2##3##(1994-1#1)(2008-11#1)
toward the end of the##2##5##(1992-12#1)(2008-8#1)
toward the focus##2##3##(2007-12#1)(2008-3#1)
toward the internal##2##3##(2007-12#1)(2011-2#1)
toward the oxidation of##2##4##(2008-10#2)
toward the synthesis of##2##4##(2008-4#1)(2008-6#1)
toward the##121##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-2#1)(1994-1#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-8#2)(2006-12#1)(2007-11#3)(2007-12#3)(2008-10#17)(2008-11#4)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
toward their##10##2##(1992-12#1)(1994-3#1)(1996-2#2)(2007-12#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)
toward these##2##2##(1991-12#1)(1992-8#1)
toward this##5##2##(1994-1#1)(1996-1#1)(2008-3#1)(2008-6#1)(2008-9#1)
toward treatment##2##2##(1992-1#1)(2011-1#1)
toward understanding the##3##3##(1991-12#1)(2009-7#1)(2011-2#1)
toward understanding##4##2##(1991-12#1)(2009-10#1)(2009-7#1)(2011-2#1)
toward##626##1##(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#7)(1991-4#1)(1991-5#5)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#5)(1992-3#3)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#7)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#4)(1993-6#1)(1993-8#2)(1994-1#6)(1994-11#5)(1994-12#4)(1994-2#7)(1994-3#9)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#8)(1995-5#5)(1995-6#7)(1996-1#9)(1996-11#2)(1996-12#1)(1996-2#11)(1996-3#4)(1996-5#2)(1996-8#1)(1997-1#7)(1997-2#6)(1997-3#7)(1997-5#3)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#18)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#106)(2008-11#22)(2008-12#7)(2008-2#8)(2008-3#18)(2008-4#7)(2008-5#4)(2008-6#7)(2008-7#16)(2008-8#16)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#1)(2009-7#8)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#5)(2011-1#12)(2011-2#18)(2011-3#1)(2011-7#2)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#22)(2013-7#4)(2013-8#6)
towards 2##2##2##(1997-7#1)(2008-10#1)
towards Cu(II)##3##2##(2008-10#3)
towards H(2)O(2)##2##2##(2008-10#2)
towards HIV infection##2##3##(1994-5#1)(1997-5#1)
towards HIV##3##2##(1994-5#1)(1997-5#1)(2008-1#1)
towards Hg(2+)##2##2##(2008-10#2)
towards Hg(II)##3##2##(2008-10#3)
towards a more##2##3##(2013-1#2)
towards a positive##2##3##(2008-7#1)(2011-1#1)
towards a##30##2##(1990-12#1)(1992-8#1)(1992-9#2)(1994-10#1)(1994-12#1)(1996-1#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#2)(2009-12#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
towards achieving##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
towards acupuncture##2##2##(1993-3#1)(1997-6#1)
towards an increased##2##3##(1997-2#1)(2008-10#1)
towards an##11##2##(1993-1#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-5#1)
towards and##3##2##(1993-12#1)(1997-6#1)(2013-1#1)
towards another##2##2##(1992-9#1)(2008-11#1)
towards clinical##3##2##(2008-5#3)
towards copper(II)##2##2##(2008-10#2)
towards critical##2##2##(2008-1#1)(2008-11#1)
towards developing a##3##3##(1994-12#1)(2009-7#1)(2012-2#1)
towards developing##6##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-2#1)
towards development of##2##3##(2008-11#1)(2008-2#1)
towards different##5##2##(1990-5#1)(2008-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
towards equilibrium##2##2##(2008-1#1)(2008-7#1)
towards family planning##2##3##(1991-1#1)(2008-7#1)
towards high##2##2##(2008-10#1)(2008-12#1)
towards higher##3##2##(1990-2#1)(2011-2#2)
towards human##2##2##(2008-11#1)(2013-1#1)
towards identification##2##2##(2007-7#1)(2010-12#1)
towards improvement in##2##3##(2009-3#1)(2011-2#1)
towards improvement##3##2##(2009-3#2)(2011-2#1)
towards improving##2##2##(2008-4#1)(2012-12#1)
towards in situ##2##3##(2008-10#2)
towards increase##2##2##(2008-1#1)(2012-12#1)
towards increased##2##2##(2008-10#1)(2012-6#1)
towards insulin##2##2##(1993-12#2)
towards iron supplementation in hemodialysis patients treated##2##7##(2008-1#2)
towards less##3##2##(2007-8#1)(2008-10#2)
towards lower##2##2##(2007-8#1)(2008-7#1)
towards many##2##2##(2008-10#1)(2008-11#1)
towards meeting the##2##3##(2008-12#1)(2008-5#1)
towards more##5##2##(1992-6#1)(1996-12#1)(2009-4#1)(2009-7#1)(2010-3#1)
towards other##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)
towards papain##2##2##(1990-2#1)(1994-12#1)
towards people with##2##3##(2009-11#1)(2011-2#1)
towards people##3##2##(2008-11#1)(2009-11#1)(2011-2#1)
towards practice##2##2##(2008-11#2)
towards psychiatry##2##2##(1992-6#1)(2009-7#1)
towards scientific##2##2##(1995-6#1)(2010-2#1)
towards screening##3##2##(1992-2#2)(1994-11#1)
towards some##2##2##(2008-10#2)
towards the detection of##3##4##(2008-10#2)(2008-11#1)
towards the development of a##2##5##(2008-10#1)(2008-7#1)
towards the development of##7##4##(1992-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)
towards the end of##5##4##(1996-3#1)(2008-12#1)(2009-2#1)(2013-1#2)
towards the goal of##3##4##(2008-10#1)(2009-9#1)(2012-2#1)
towards the identification of##2##4##(2011-2#1)(2013-1#1)
towards the most##2##3##(1995-5#1)(2008-5#1)
towards the negative##2##3##(2008-10#1)(2009-12#1)
towards the next##2##3##(2009-10#1)(2012-2#1)
towards the oxidation of NO##2##5##(2008-10#2)
towards the oxidation of##5##4##(2008-10#5)
towards the oxidation##6##3##(2008-10#6)
towards the provision of##2##4##(1992-2#1)(2008-1#1)
towards the two##2##3##(2008-10#1)(2008-5#1)
towards the##142##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#4)(2013-1#7)(2013-8#2)
towards their##6##2##(1990-6#1)(1993-12#2)(2010-3#2)(2012-1#1)
towards this##6##2##(1991-5#1)(2007-7#1)(2008-11#1)(2012-12#1)(2012-2#2)
towards understanding##4##2##(1997-6#1)(2008-10#1)(2009-5#1)(2012-2#1)
towards##603##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#4)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#6)(1993-3#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#4)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#4)(1996-3#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-7#7)(2007-8#7)(2008-1#10)(2008-10#117)(2008-11#34)(2008-12#9)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#14)(2008-6#5)(2008-7#34)(2008-8#8)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#2)(2010-10#6)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#9)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#13)(2011-2#29)(2011-3#3)(2012-1#2)(2012-12#13)(2012-2#17)(2012-3#5)(2012-6#1)(2013-1#29)(2013-8#7)
tower##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
town of Cabar##6##3##(2011-2#6)
town of##14##2##(1995-1#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#6)(2012-12#1)
town##26##1##(1990-2#1)(1990-6#1)(1991-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2011-2#6)(2012-12#2)
towns and##2##2##(2008-11#1)(2008-5#1)
towns##10##1##(1993-2#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
township in##3##2##(2009-4#1)(2013-8#2)
township##8##1##(2007-2#1)(2007-7#1)(2009-4#3)(2013-8#3)
townships##3##1##(1997-4#1)(2011-1#2)
tows##2##1##(2011-2#2)
tox(-)##3##1##(2008-10#3)
toxic action##2##2##(2007-11#1)(2008-10#1)
toxic activities##2##2##(2008-10#1)(2008-5#1)
toxic activity of##2##3##(1994-2#1)(2008-12#1)
toxic activity##4##2##(1992-3#1)(1994-2#1)(2008-10#1)(2008-12#1)
toxic agents##3##2##(1991-9#1)(1994-5#1)(2008-11#1)
toxic and##12##2##(1990-12#1)(1991-6#1)(1994-11#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)
toxic arsenic##3##2##(2008-10#3)
toxic chemicals##5##2##(1994-8#1)(2008-11#3)(2011-1#1)
toxic compounds having##2##3##(2008-11#2)
toxic compounds in##2##3##(2007-11#1)(2008-10#1)
toxic compounds##9##2##(2007-11#1)(2008-10#4)(2008-11#3)(2008-8#1)
toxic effect of##6##3##(1991-8#1)(1992-6#1)(1993-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
toxic effect##9##2##(1991-8#1)(1992-6#1)(1993-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
toxic effects caused by##2##4##(2008-7#1)(2010-4#1)
toxic effects in##2##3##(1991-6#1)(1992-3#1)
toxic effects of##19##3##(1990-5#2)(1991-9#2)(1993-9#2)(1994-5#2)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-1#1)
toxic effects on##5##3##(1992-2#1)(1996-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
toxic effects##43##2##(1990-5#2)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#3)(1993-11#1)(1993-9#2)(1994-5#2)(1994-8#1)(1995-11#1)(1996-3#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-6#1)(2013-1#3)
toxic elements##3##2##(2008-10#2)(2008-5#1)
toxic epidermal necrolysis##2##3##(1992-2#1)(2007-7#1)
toxic equivalent##2##2##(2008-10#2)
toxic equivalents (TEQ)##2##3##(2008-10#2)
toxic equivalents##3##2##(2008-10#3)
toxic for##3##2##(1991-9#1)(1992-12#1)(2008-4#1)
toxic form of##3##3##(2008-10#2)(2012-3#1)
toxic fraction##3##2##(2008-10#3)
toxic free##2##2##(2008-10#1)(2009-10#1)
toxic gas##3##2##(1996-12#3)
toxic gases##6##2##(1996-12#6)
toxic gene##2##2##(1990-5#1)(2008-6#1)
toxic goitre##2##2##(1990-9#2)
toxic levels##2##2##(2008-11#1)(2008-3#1)
toxic metabolite##4##2##(2008-10#4)
toxic metal##5##2##(2007-8#1)(2008-10#3)(2009-7#1)
toxic metals##6##2##(1997-4#1)(2008-10#4)(2010-11#1)
toxic neuropathy##2##2##(2008-2#1)(2011-1#1)
toxic of##2##2##(2007-11#1)(2008-10#1)
toxic oil##2##2##(1995-5#1)(2008-10#1)
toxic only##3##2##(1992-12#1)(2008-10#1)(2009-2#1)
toxic or##6##2##(1992-1#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#2)
toxic organic##2##2##(2008-7#1)(2011-1#1)
toxic oxygen##2##2##(1991-9#2)
toxic phytoplankton##2##2##(1992-8#1)(2009-8#1)
toxic potency##5##2##(1996-12#5)
toxic products##2##2##(1995-3#1)(2008-10#1)
toxic protein isolated from##2##4##(1992-3#1)(1995-11#1)
toxic protein##4##2##(1992-3#2)(1995-11#1)(1995-12#1)
toxic shock syndrome toxin-1##2##4##(1997-2#2)
toxic shock syndrome##6##3##(1993-6#1)(1997-2#2)(2007-12#1)(2011-2#2)
toxic shock##7##2##(1993-3#1)(1993-6#1)(1997-2#2)(2007-12#1)(2011-2#2)
toxic side effects##2##3##(1994-6#1)(2012-2#1)
toxic side##3##2##(1990-10#1)(1994-6#1)(2012-2#1)
toxic species of##2##3##(2008-10#1)(2011-2#1)
toxic species##5##2##(1996-12#1)(2008-10#2)(2010-8#1)(2011-2#1)
toxic substances##13##2##(2008-10#4)(2008-11#7)(2010-7#1)(2013-8#1)
toxic than##10##2##(1990-5#1)(1990-6#1)(1994-5#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
toxic thyroid##2##2##(2008-4#2)
toxic to cultured##2##3##(1997-2#1)(2012-3#1)
toxic to microsclerotia##2##3##(2008-10#2)
toxic to the##5##3##(1991-9#1)(1996-12#1)(2008-10#1)(2008-7#2)
toxic to##33##2##(1990-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#3)(2012-3#1)(2013-1#1)
toxic##388##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#8)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#8)(1992-6#2)(1992-8#3)(1993-11#3)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#22)(1996-3#4)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-7#1)(2006-12#1)(2007-11#5)(2007-12#2)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#101)(2008-11#26)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#19)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#6)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#3)
toxicant exposure##2##2##(2008-10#1)(2008-9#1)
toxicant suppressants##3##2##(1996-12#3)
toxicant##12##1##(1996-12#3)(2008-10#5)(2008-9#4)
toxicants are##3##2##(1996-12#2)(2008-11#1)
toxicants in##4##2##(2008-10#3)(2008-8#1)
toxicants##21##1##(1994-5#1)(1995-11#1)(1996-12#4)(2008-10#5)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#2)
toxicities and##5##2##(1993-12#1)(1994-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
toxicities associated with##2##3##(2011-2#1)(2013-1#1)
toxicities of##6##2##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)
toxicities recorded during##2##3##(2008-10#2)
toxicities were##8##2##(1990-12#1)(1991-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)
toxicities##45##1##(1990-12#1)(1990-5#1)(1991-4#1)(1993-12#1)(1994-5#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-6#4)(2008-7#10)(2008-8#5)(2010-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
toxicity against dopaminergic##3##3##(2008-7#3)
toxicity against##7##2##(1995-5#1)(2008-11#1)(2008-7#4)(2012-12#1)
toxicity and Ca depletion##2##4##(2009-6#2)
toxicity and benthic community condition##2##5##(2012-1#2)
toxicity and carcinogenicity##3##3##(2008-8#1)(2008-9#2)
toxicity and repellency##2##3##(2011-2#2)
toxicity and the##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
toxicity and##51##2##(1991-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#4)(2008-11#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-6#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
toxicity and/or##3##2##(1997-1#1)(2008-8#1)(2011-2#1)
toxicity are##4##2##(1990-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
toxicity assessment##10##2##(1996-12#2)(2008-10#5)(2008-12#1)(2008-5#1)(2013-8#1)
toxicity associated with##3##3##(1990-5#1)(2008-9#2)
toxicity at low##3##3##(2008-12#2)(2008-7#1)
toxicity at the##2##3##(1993-1#1)(2008-10#1)
toxicity at##7##2##(1993-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-10#1)(2013-1#1)
toxicity but##3##2##(1990-11#1)(2008-8#1)(2009-12#1)
toxicity by##3##2##(1995-9#1)(2008-7#2)
toxicity concerns##3##2##(2008-5#2)(2008-7#1)
toxicity could##4##2##(1995-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
toxicity data##2##2##(2007-5#1)(2008-12#1)
toxicity due to##2##3##(1992-2#1)(2012-7#1)
toxicity during induction##2##3##(2008-10#2)
toxicity during##5##2##(1993-6#1)(2008-10#4)
toxicity endpoints##2##2##(2008-10#2)
toxicity for##3##2##(1995-3#2)(2010-11#1)
toxicity has been##2##3##(1991-12#1)(2010-1#1)
toxicity in a##3##3##(1992-11#1)(2007-12#1)(2013-1#1)
toxicity in cultured human##2##4##(1992-11#1)(2008-11#1)
toxicity in male##2##3##(1993-12#1)(2011-2#1)
toxicity in patients with##3##4##(1991-12#1)(2013-1#2)
toxicity in patients##4##3##(1991-12#1)(2008-10#1)(2013-1#2)
toxicity in rats##4##3##(1993-12#1)(1995-3#2)(2008-10#1)
toxicity in the##5##3##(1993-12#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
toxicity in vitro##2##3##(2008-5#1)(2013-1#1)
toxicity in##40##2##(1991-12#1)(1992-11#2)(1993-12#3)(1995-3#2)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#3)(2012-1#2)(2013-1#9)
toxicity induced by##4##3##(1994-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
toxicity induced##5##2##(1994-5#1)(2008-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
toxicity is##12##2##(1994-11#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
toxicity level##4##2##(2008-10#4)
toxicity makes##2##2##(1997-1#1)(2008-7#1)
toxicity may##3##2##(1990-5#1)(1994-11#1)(1995-8#1)
toxicity of MTBE##2##3##(2008-12#2)
toxicity of a weathered oil##2##5##(2008-11#2)
toxicity of a##9##3##(1990-2#1)(1991-8#1)(1992-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
toxicity of aromatic nitrocompounds##2##4##(1995-8#2)
toxicity of cadmium##2##3##(1993-12#1)(2008-7#1)
toxicity of certain##2##3##(2008-10#1)(2008-9#1)
toxicity of docetaxel##2##3##(2008-10#1)(2008-6#1)
toxicity of the pesticide methomyl on the topmouth gudgeon (Pseudorasbora parva)##2##11##(2008-7#2)
toxicity of the##20##3##(1990-6#1)(1995-3#1)(1996-12#2)(1997-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
toxicity of these compounds##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
toxicity of these##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)
toxicity of this##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2011-1#1)
toxicity of##109##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-3#1)(1992-9#1)(1993-12#3)(1994-5#6)(1994-8#1)(1995-3#3)(1995-8#3)(1996-12#5)(1996-3#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#7)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#5)(2012-2#2)(2013-1#3)(2013-8#3)
toxicity on##3##2##(1995-5#1)(2008-11#1)(2013-8#1)
toxicity or##2##2##(1992-10#1)(2008-7#1)
toxicity outcomes##3##2##(2008-8#1)(2012-3#1)(2013-7#1)
toxicity probabilities##3##2##(2012-3#3)
toxicity profile##3##2##(1995-3#1)(2008-11#1)(2010-11#1)
toxicity resulting from##2##3##(1995-3#1)(2008-10#1)
toxicity secondary to##3##3##(1990-10#1)(2013-1#2)
toxicity studies##6##2##(2009-11#1)(2010-2#1)(2011-2#3)(2012-1#1)
toxicity study in##2##3##(1994-11#1)(2008-10#1)
toxicity study of##2##3##(2007-11#1)(2013-1#1)
toxicity study with##2##3##(1994-11#1)(2010-1#1)
toxicity study##6##2##(1994-11#2)(2007-11#1)(2008-10#1)(2010-1#1)(2013-1#1)
toxicity test##5##2##(1996-12#1)(2008-10#3)(2008-9#1)
toxicity testing of##2##3##(1992-3#1)(2008-11#1)
toxicity testing##10##2##(1992-3#1)(1996-12#2)(2008-10#2)(2008-11#2)(2011-1#3)
toxicity tests based on##2##4##(2008-10#2)
toxicity tests##11##2##(1996-12#1)(2008-10#10)
toxicity than the##2##3##(1994-5#1)(1994-7#1)
toxicity than##6##2##(1994-5#1)(1994-7#1)(1995-4#1)(1996-12#1)(2008-3#2)
toxicity to##14##2##(1993-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#4)(2011-2#1)(2012-3#1)(2013-1#1)
toxicity towards##2##2##(1996-12#1)(2011-1#1)
toxicity using##2##2##(2008-10#1)(2008-8#1)
toxicity was observed##4##3##(1992-5#1)(2007-11#1)(2008-12#2)
toxicity was##29##2##(1990-2#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#2)(1992-5#1)(1992-8#2)(1994-8#1)(1995-5#1)(1996-1#1)(1996-3#1)(2007-11#1)(2008-12#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-9#1)
toxicity were##8##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)(2011-2#2)
toxicity with##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
toxicity##656##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#5)(1990-5#3)(1990-6#1)(1991-1#3)(1991-12#4)(1991-2#5)(1991-3#4)(1991-8#4)(1991-9#4)(1992-10#3)(1992-11#7)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#3)(1992-8#6)(1992-9#1)(1993-1#2)(1993-12#9)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#5)(1994-12#2)(1994-5#10)(1994-7#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-3#12)(1995-4#1)(1995-5#5)(1995-8#7)(1995-9#1)(1996-1#2)(1996-12#18)(1996-3#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#5)(2006-10#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#104)(2008-11#29)(2008-12#18)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#23)(2008-6#18)(2008-7#49)(2008-8#27)(2008-9#17)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#13)(2011-2#33)(2011-3#1)(2012-1#8)(2012-12#6)(2012-2#11)(2012-3#11)(2012-7#2)(2013-1#48)(2013-7#1)(2013-8#8)
toxicity-based SQG approaches##2##3##(2012-1#2)
toxicity-based SQG##3##2##(2012-1#3)
toxicokinetics##6##1##(1993-12#1)(1995-3#4)(2011-2#1)
toxicologic and##2##2##(2008-9#1)(2009-12#1)
toxicologic control rats##2##3##(2010-5#2)
toxicologic##9##1##(2008-10#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#3)(2012-1#1)
toxicological analysis##2##2##(1997-2#1)(2011-2#1)
toxicological and##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
toxicological characteristics##3##2##(2008-5#2)(2011-1#1)
toxicological effect of##2##3##(2008-10#1)(2013-1#1)
toxicological effects##2##2##(1992-2#1)(2012-1#1)
toxicological properties##2##2##(2008-12#1)(2008-5#1)
toxicological studies of##2##3##(2008-12#1)(2011-1#1)
toxicological studies##3##2##(2008-11#1)(2008-12#1)(2011-1#1)
toxicological study##2##2##(2008-10#2)
toxicological##48##1##(1990-8#1)(1991-5#1)(1992-2#1)(1994-5#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-5#4)(2008-7#2)(2008-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#4)
toxicologically##4##1##(2008-10#4)
toxicology and##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
toxicology into cosmetic ingredient##2##4##(2008-5#2)
toxicology into##3##2##(2008-5#2)(2010-7#1)
toxicology is##2##2##(1991-9#1)(1996-12#1)
toxicology studies of##4##3##(2008-8#1)(2008-9#3)
toxicology studies##13##2##(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#9)
toxicology study##2##2##(2008-10#2)
toxicology##59##1##(1990-5#1)(1991-6#1)(1991-9#2)(1994-12#1)(1995-11#2)(1996-1#1)(1996-12#13)(1996-5#2)(1997-2#1)(2008-10#6)(2008-11#2)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#11)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
toxicus##5##1##(2008-10#4)(2008-5#1)
toxigenic fungi##2##2##(2010-7#2)
toxigenic in the duckling tests##3##5##(2008-10#3)
toxigenic##10##1##(1996-11#1)(2008-10#6)(2010-7#2)(2011-2#1)
toxigenicity##2##1##(2008-10#1)(2011-2#1)
toxin (CT)##2##2##(1991-12#1)(1994-2#1)
toxin 2##2##2##(2008-7#1)(2013-1#1)
toxin A##7##2##(2007-11#2)(2007-12#5)
toxin A-III##3##2##(1994-2#3)
toxin B from##2##3##(2007-12#1)(2009-2#1)
toxin B subunit##6##3##(2008-11#3)(2008-8#1)(2008-9#1)(2009-2#1)
toxin B##18##2##(1996-5#1)(2007-12#5)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#6)
toxin also##3##2##(1994-2#1)(2008-10#2)
toxin and##12##2##(1990-8#1)(1992-2#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)
toxin assay##2##2##(2008-10#2)
toxin can##3##2##(1991-12#1)(1995-2#1)(2011-2#1)
toxin concentrations##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
toxin did not alter##2##4##(1991-12#1)(1992-3#1)
toxin did not##4##3##(1991-12#2)(1992-3#1)(2008-10#1)
toxin family##2##2##(1994-2#1)(2008-10#1)
toxin from##4##2##(2008-10#2)(2008-8#1)(2012-12#1)
toxin genes##3##2##(2008-10#1)(2010-3#2)
toxin has been used##2##4##(2008-8#1)(2011-2#1)
toxin has been##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
toxin has##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
toxin in##7##2##(1997-8#1)(2008-10#3)(2008-5#1)(2009-3#1)(2009-5#1)
toxin infusion##2##2##(1995-5#1)(2008-5#1)
toxin inhibits##2##2##(1991-12#1)(2010-1#1)
toxin injections##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
toxin insensitivity##2##2##(2008-10#2)
toxin is##9##2##(1991-12#1)(1991-5#1)(1995-8#1)(2008-10#4)(2008-5#1)(2012-3#1)
toxin levels##2##2##(2011-2#2)
toxin of##2##2##(1991-5#1)(2008-5#1)
toxin production##11##2##(1992-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-2#4)
toxin reaction##4##2##(2008-10#4)
toxin sensitivity##4##2##(2008-10#4)
toxin substrate##2##2##(1991-9#1)(1992-9#1)
toxin synthesis##4##2##(2008-10#2)(2011-2#2)
toxin that is##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
toxin that##5##2##(1990-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
toxin therapy##2##2##(2007-11#1)(2011-2#1)
toxin type##7##2##(2008-10#4)(2008-2#1)(2008-8#1)(2010-8#1)
toxin was found to##2##4##(1992-3#1)(2008-10#1)
toxin was##6##2##(1992-3#1)(2008-10#4)(2009-4#1)
toxin were##2##2##(1997-6#1)(2008-8#1)
toxin with##2##2##(1991-9#1)(1997-6#1)
toxin##317##1##(1990-12#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#9)(1991-3#1)(1991-5#3)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#4)(1994-11#1)(1994-2#11)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#5)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#5)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#13)(2008-10#99)(2008-11#4)(2008-2#3)(2008-4#6)(2008-5#13)(2008-7#4)(2008-8#12)(2008-9#2)(2009-10#2)(2009-2#7)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#2)(2010-10#2)(2010-3#2)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#24)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
toxin)##2##1##(2008-7#1)(2008-9#1)
toxin-catalyzed ADP-ribosylation of##3##3##(1992-9#3)
toxin-catalyzed ADP-ribosylation##5##2##(1992-9#4)(1993-8#1)
toxin-induced##3##1##(1994-2#1)(2008-10#1)(2011-2#1)
toxin-insensitive##4##1##(2008-10#3)(2008-4#1)
toxin-producing##2##1##(2008-10#1)(2009-8#1)
toxin-resistant##2##1##(1993-3#1)(2008-8#1)
toxin-sensitive##8##1##(1990-12#1)(1995-11#1)(1997-1#2)(1997-2#1)(2008-10#2)(2011-1#1)
toxin/g of##2##2##(1997-4#2)
toxins A and B##2##4##(2007-12#2)
toxins A##3##2##(2007-12#3)
toxins act##2##2##(2011-1#1)(2011-2#1)
toxins and their##2##3##(1994-12#1)(2008-10#1)
toxins and##8##2##(1994-12#1)(1994-2#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
toxins are##9##2##(1990-5#1)(1994-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)
toxins by##2##2##(1990-9#1)(1994-12#1)
toxins have##5##2##(1994-2#1)(2008-10#1)(2008-5#2)(2011-1#1)
toxins in##6##2##(1997-4#1)(1997-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
toxins of##3##2##(1993-12#1)(1993-6#1)(1994-5#1)
toxins or##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
toxins produced by##3##3##(1997-4#1)(2008-10#1)(2011-1#1)
toxins produced##4##2##(1997-4#2)(2008-10#1)(2011-1#1)
toxins that##2##2##(2008-5#1)(2008-7#1)
toxins to##3##2##(2008-11#1)(2008-5#1)(2009-2#1)
toxins was##2##2##(2008-10#2)
toxins were##4##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
toxins##123##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1993-12#5)(1993-6#3)(1994-12#5)(1994-2#5)(1994-5#3)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-4#3)(1997-6#3)(2006-10#1)(2007-12#5)(2008-10#24)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#15)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2011-1#7)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
toxins)##2##1##(2008-10#1)(2010-3#1)
toxoid##6##1##(1992-2#1)(1995-5#1)(2009-5#1)(2011-2#3)
toxoids##3##1##(1994-8#1)(1995-3#1)(1995-5#1)
toxoplasma##3##1##(1990-9#2)(1993-2#1)
toxoplasmosis and##3##2##(1990-9#1)(2007-10#2)
toxoplasmosis in patients with##2##4##(1991-2#1)(1996-3#1)
toxoplasmosis in##8##2##(1991-2#1)(1992-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-7#2)(2011-2#1)
toxoplasmosis##30##1##(1990-3#1)(1990-9#10)(1991-2#1)(1991-6#1)(1992-2#2)(1995-9#1)(1996-11#3)(1996-3#1)(1997-3#1)(2007-10#3)(2007-12#3)(2007-7#2)(2011-2#1)
toy##4##1##(1997-6#1)(2007-8#1)(2013-8#2)
toys##5##1##(2009-5#1)(2011-1#4)
traC##3##1##(1990-11#3)
traI##4##1##(1991-7#4)
traX##5##1##(1991-7#5)
trabeculae in##2##2##(2009-7#1)(2011-2#1)
trabeculae were##2##2##(2009-7#1)(2013-1#1)
trabeculae##7##1##(2009-7#3)(2011-2#3)(2013-1#1)
trabecular adenoma##2##2##(1992-8#2)
trabecular bone loss##3##3##(1993-11#3)
trabecular bone##12##2##(1993-11#3)(2007-8#1)(2008-7#2)(2009-7#4)(2010-9#2)
trabecular pattern##2##2##(1994-12#1)(2007-11#1)
trabecular##26##1##(1991-11#2)(1992-8#2)(1993-11#4)(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#6)(2010-9#2)(2012-3#1)
trabeculectomy##2##1##(2008-7#1)(2011-1#1)
trace Au(III)##2##2##(2008-10#2)
trace CS##4##2##(2008-5#4)
trace Cu(2+)##2##2##(2008-10#2)
trace DNA analysis##3##3##(2008-12#3)
trace amount of##33##3##(1991-5#1)(2008-10#27)(2008-5#2)(2008-8#1)(2013-1#1)(2013-8#1)
trace amount##34##2##(1991-5#1)(2008-10#28)(2008-5#2)(2008-8#1)(2013-1#1)(2013-8#1)
trace amounts in##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
trace amounts of copper##6##4##(2008-10#6)
trace amounts of copper(II)##3##4##(2008-10#3)
trace amounts of lead##4##4##(2008-10#4)
trace amounts of zinc##3##4##(2008-10#3)
trace amounts of##109##3##(2008-10#108)(2008-11#1)
trace amounts##116##2##(1993-6#1)(2008-10#111)(2008-11#2)(2008-3#1)(2008-5#1)
trace analysis of##8##3##(2008-10#7)(2008-3#1)
trace analysis##15##2##(2008-10#13)(2008-3#2)
trace analytes##2##2##(2008-10#2)
trace and rare earth elements in##2##6##(2008-10#2)
trace and ultra trace##2##4##(2008-10#2)
trace and##12##2##(1994-9#1)(1996-9#1)(2006-4#1)(2008-10#8)(2008-5#1)
trace back to##2##3##(2010-4#1)(2011-1#1)
trace concentration of##2##3##(2008-10#1)(2008-3#1)
trace concentration##5##2##(2008-10#4)(2008-3#1)
trace concentrations of##3##3##(2008-10#3)
trace concentrations##5##2##(2008-10#5)
trace constituents##4##2##(2008-10#3)(2008-2#1)
trace copper in river##2##4##(2008-10#2)
trace copper##5##2##(2008-10#5)
trace criterion##2##2##(2007-12#2)
trace determination of##12##3##(2008-10#12)
trace determination##14##2##(2008-10#14)
trace element analysis##2##3##(2008-10#2)
trace element concentrations##2##3##(1993-2#1)(2008-10#1)
trace element determination##4##3##(2008-10#4)
trace element partitioning##2##3##(2008-10#2)
trace element##26##2##(1993-2#2)(1997-5#1)(2008-10#17)(2008-12#1)(2011-2#3)(2012-2#2)
trace elemental##2##2##(2008-10#2)
trace elements (As##3##3##(2008-10#3)
trace elements and##4##3##(1990-2#1)(2008-1#1)(2008-10#1)(2010-5#1)
trace elements are##2##3##(2008-10#2)
trace elements bound to##2##4##(2008-10#1)(2010-5#1)
trace elements content##2##3##(2008-10#2)
trace elements determination in##2##4##(2008-10#2)
trace elements in water##2##4##(2008-10#2)
trace elements in##25##3##(2008-10#23)(2011-2#1)(2013-8#1)
trace elements of##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
trace elements was##2##3##(2008-10#2)
trace elements were##4##3##(2008-10#4)
trace elements##78##2##(1990-2#1)(2008-1#1)(2008-10#65)(2008-12#2)(2008-5#1)(2010-11#1)(2010-5#2)(2011-2#1)(2013-8#4)
trace elements)##2##2##(2008-10#1)(2008-11#1)
trace enrichment of##5##3##(2008-10#5)
trace enrichment##8##2##(2008-10#8)
trace evidence##3##2##(2008-10#2)(2012-2#1)
trace fossil##3##2##(2013-1#3)
trace gas detection##3##3##(2008-2#1)(2013-8#2)
trace gas##8##2##(2008-10#2)(2008-2#2)(2008-3#2)(2013-8#2)
trace gases##15##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#8)
trace heavy metals##6##3##(2008-10#6)
trace iron##3##2##(2008-10#3)
trace lead in water##6##4##(2008-10#5)(2013-8#1)
trace lead##12##2##(2008-10#9)(2013-8#3)
trace level determination of##3##4##(2008-10#3)
trace level in##2##3##(2008-1#1)(2008-10#1)
trace level##13##2##(2008-1#1)(2008-10#12)
trace levels in##6##3##(2008-10#6)
trace levels of dissolved##2##4##(2008-10#1)(2008-7#1)
trace levels of lead##2##4##(2008-10#2)
trace levels of##29##3##(1990-8#1)(2008-10#27)(2008-7#1)
trace levels##56##2##(1990-8#1)(2008-10#54)(2008-7#1)
trace measurement of##2##3##(2008-10#2)
trace mercury##14##2##(2008-10#14)
trace metal analysis##2##3##(2008-10#2)
trace metal concentrations of##2##4##(2007-5#1)(2008-10#1)
trace metal in##2##3##(2008-10#1)(2008-5#1)
trace metal ion##2##3##(2008-10#2)
trace metal ions##7##3##(2008-10#7)
trace metal##27##2##(2007-5#3)(2008-10#22)(2008-5#2)
trace metals analysis##2##3##(2008-10#2)
trace metals in seawater##2##4##(2008-10#2)
trace metals in water by##2##5##(2008-10#2)
trace metals in water##3##4##(2008-10#3)
trace metals in##22##3##(2007-5#1)(2008-10#21)
trace metals##53##2##(1994-8#1)(2007-5#1)(2008-10#44)(2008-11#3)(2008-5#2)(2010-11#1)(2012-2#1)
trace molybdenum##4##2##(2008-10#4)
trace of##8##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)
trace or##4##2##(2008-10#3)(2008-5#1)
trace quantities##3##2##(2008-10#2)(2010-7#1)
trace rare earth elements##2##4##(2008-10#2)
trace species retrievals##2##3##(2008-2#2)
trace species##4##2##(2008-2#3)(2008-3#1)
trace stimulus##2##2##(2008-5#2)
trace the development of##2##4##(1997-2#1)(2008-2#1)
trace the##9##2##(1995-4#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
trace water##4##2##(2008-10#4)
trace##754##1##(1990-2#1)(1990-8#1)(1991-5#1)(1993-2#2)(1993-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-11#4)(2007-12#4)(2007-5#4)(2008-1#3)(2008-10#599)(2008-11#10)(2008-12#6)(2008-2#12)(2008-3#32)(2008-5#18)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#2)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#8)(2013-1#7)(2013-8#11)
trace-back##3##1##(1993-2#1)(2008-3#2)
trace-gas analysis##2##2##(2008-2#1)(2008-3#1)
trace-gas monitoring##2##2##(2007-12#1)(2008-3#1)
trace-gas##7##1##(2007-12#1)(2008-2#2)(2008-3#4)
traceability of##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
traceability##13##1##(2008-10#3)(2008-3#1)(2010-4#5)(2012-2#4)
traceable to##2##2##(2008-3#1)(2008-8#1)
traceable##6##1##(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)
traced by##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
traced from##2##2##(2007-10#1)(2008-10#1)
traced in##2##2##(2007-5#1)(2009-6#1)
traced over the##2##3##(2008-10#1)(2008-8#1)
traced to the##4##3##(1995-2#1)(2008-10#2)(2012-2#1)
traced to##11##2##(1993-6#2)(1994-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-9#1)(2012-2#1)
traced##32##1##(1993-6#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#13)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
tracer aerosols##2##2##(1994-12#2)
tracer and##4##2##(1996-12#2)(2008-2#1)(2010-5#1)
tracer distribution##2##2##(1990-12#1)(1993-11#1)
tracer elements##2##2##(1997-5#1)(2008-7#1)
tracer imaging##2##2##(2009-12#1)(2013-1#1)
tracer in the##2##3##(1990-5#1)(2008-7#1)
tracer in##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
tracer into the##2##3##(2008-11#1)(2008-7#1)
tracer molecules##2##2##(1990-5#1)(1996-5#1)
tracer##55##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#3)(1991-12#2)(1992-12#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-12#2)(1994-2#2)(1995-12#2)(1996-12#4)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
tracers for##6##2##(1994-8#1)(2008-1#1)(2008-11#2)(2010-6#2)
tracers through a##2##3##(2008-10#2)
tracers##28##1##(1990-5#1)(1992-3#1)(1993-8#1)(1994-8#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-6#3)(2010-7#1)(2012-2#1)
traces and##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
traces are##2##2##(2007-12#1)(2008-3#1)
traces can be##2##3##(2007-12#1)(2008-10#1)
traces in##4##2##(2008-10#3)(2008-5#1)
traces of aluminium##2##3##(2008-10#2)
traces of nickel(II)##3##3##(2008-10#3)
traces of silver ions##3##4##(2008-10#3)
traces of the##2##3##(1990-5#1)(2007-11#1)
traces of##51##2##(1990-11#1)(1990-5#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#42)(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
traces the##6##2##(1997-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)
traces##89##1##(1990-11#1)(1990-5#1)(1995-2#1)(1996-3#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#59)(2008-11#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-8#2)(2012-2#1)(2013-1#2)
trachea and lungs##2##3##(1993-8#1)(2011-1#1)
trachea and##9##2##(1993-8#1)(2007-6#1)(2008-9#2)(2010-10#1)(2010-8#1)(2011-1#3)
trachea were##2##2##(2008-9#1)(2013-1#1)
trachea##44##1##(1990-7#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-12#2)(1996-12#2)(1996-3#1)(1997-1#3)(1997-3#1)(1997-6#2)(2007-6#1)(2007-8#3)(2008-10#1)(2008-5#2)(2008-8#3)(2008-9#7)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#3)(2013-1#4)
tracheae are of no importance for##2##6##(2007-12#2)
tracheae are##3##2##(2007-12#3)
tracheae##15##1##(1993-8#1)(2007-12#14)
tracheal bronchial vasculature##2##3##(1997-1#2)
tracheal bronchial##3##2##(1997-1#3)
tracheal compression and##2##3##(2007-8#1)(2010-7#1)
tracheal epithelium##5##2##(1991-9#1)(1994-6#1)(1995-11#2)(2008-1#1)
tracheal injury##2##2##(2007-8#1)(2010-7#1)
tracheal intubation##3##2##(1991-11#1)(1996-6#1)(2012-12#1)
tracheal mucosa##2##2##(1991-5#1)(2008-8#1)
tracheal mucous velocity##4##3##(1991-9#4)
tracheal obstruction##8##2##(2007-8#1)(2013-1#7)
tracheal smooth##2##2##(1997-7#2)
tracheal stenosis##2##2##(2013-1#2)
tracheal system of harvestmen##2##4##(2007-12#2)
tracheal system of##3##3##(2007-12#3)
tracheal system##5##2##(2007-12#5)
tracheal walls##4##2##(2007-12#4)
tracheal##85##1##(1990-3#1)(1990-7#2)(1991-11#5)(1991-5#1)(1991-9#6)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-11#2)(1996-3#2)(1996-6#1)(1997-1#4)(1997-6#1)(1997-7#2)(2007-12#10)(2007-8#5)(2008-1#3)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#2)(2010-7#3)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#16)
trachealess##2##1##(2010-4#2)
tracheas##2##1##(1997-3#2)
tracheobronchial##7##1##(1992-5#2)(1996-1#1)(1997-1#1)(2007-8#1)(2010-12#1)(2010-8#1)
tracheoesophageal fistula##5##2##(1997-3#2)(2008-11#1)(2008-8#1)(2012-12#1)
tracheoesophageal##6##1##(1997-3#2)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
tracheomalacia##2##1##(2011-1#1)(2013-1#1)
tracheomycosis of##2##2##(2008-10#2)
tracheostomy and ventilator##2##3##(2012-2#2)
tracheostomy and##3##2##(1995-2#1)(2012-2#2)
tracheostomy in##2##2##(2008-2#1)(2013-1#1)
tracheostomy wound##2##2##(2008-2#2)
tracheostomy##26##1##(1995-2#1)(1996-9#1)(2007-12#1)(2008-2#5)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#6)(2012-2#6)(2013-1#2)
tracheosyringeal##2##1##(2008-8#2)
tracheotomy##7##1##(1990-7#2)(2008-10#1)(2008-2#2)(2011-2#1)(2013-1#1)
trachoma in##2##2##(2010-8#2)
trachoma##8##1##(1991-9#1)(2010-8#7)
trachomatis in##5##2##(1990-6#1)(1995-6#1)(2007-7#1)(2008-9#1)(2010-8#1)
trachomatis infection##3##2##(1997-3#1)(2012-3#1)(2013-1#1)
trachomatis serovars##3##2##(1993-9#3)
trachomatis was##2##2##(2008-12#1)(2012-3#1)
trachomatis##44##1##(1990-2#2)(1990-5#2)(1990-6#2)(1991-9#2)(1993-9#5)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#2)(2007-7#6)(2008-12#5)(2008-9#4)(2009-8#1)(2010-8#3)(2012-3#4)(2013-1#1)(2013-8#1)
trachomatis)##2##1##(1997-3#1)(2012-3#1)
tracing and##4##2##(1997-3#1)(2008-2#1)(2008-3#1)(2008-7#1)
tracing method##4##2##(1990-5#2)(2008-3#2)
tracing the##2##2##(2008-10#1)(2012-3#1)
tracing was##2##2##(1994-3#1)(2008-2#1)
tracing##42##1##(1990-5#2)(1994-3#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#16)(2008-3#12)(2008-4#3)(2008-7#1)(2011-3#1)(2012-3#1)(2013-1#1)
track and##2##2##(2008-3#1)(2011-2#1)
track cell##2##2##(2008-9#1)(2012-2#1)
track for##3##2##(1995-12#1)(1997-2#1)(2008-10#1)
track in##2##2##(1992-6#1)(2008-10#1)
track of##3##2##(2008-12#2)(2008-8#1)
track offset##5##2##(2008-2#5)
track patients with diabetes and other##2##6##(2013-8#2)
track patients with diabetes##4##4##(2013-8#4)
track pitch and##2##3##(2008-2#1)(2008-3#1)
track pitch of##2##3##(2007-12#1)(2008-2#1)
track pitch##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
track provides##2##2##(1992-3#2)
track record of##2##3##(2008-1#1)(2012-3#1)
track the change##2##3##(2007-12#1)(2008-10#1)
track the##16##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
track##98##1##(1992-1#1)(1992-3#2)(1992-6#1)(1993-12#1)(1995-12#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
trackball##2##1##(2010-4#2)
tracked by##4##2##(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
tracked from##2##2##(2008-2#1)(2011-1#1)
tracked points in##2##3##(2008-6#2)
tracked the##5##2##(1997-3#1)(2008-11#1)(2008-3#1)(2009-11#1)(2013-8#1)
tracked##27##1##(1992-11#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-4#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
tracker and##2##2##(2008-2#1)(2008-3#1)
tracker##5##1##(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2013-1#1)
trackers##4##1##(2009-12#3)(2012-2#1)
tracking and##5##2##(1995-12#1)(2008-2#2)(2009-4#1)(2010-5#1)
tracking correlations##5##2##(1992-6#5)
tracking devices##3##2##(2009-12#3)
tracking error signal##3##3##(2008-2#3)
tracking in##3##2##(2007-9#1)(2008-9#1)(2013-1#1)
tracking noise##2##2##(2008-2#1)(2008-3#1)
tracking of the number and content of physician performance reports##2##10##(2013-1#2)
tracking of the##8##3##(1995-9#1)(2008-2#2)(2011-1#1)(2012-2#1)(2013-1#3)
tracking of##18##2##(1991-12#1)(1994-12#1)(1995-9#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-6#1)(2009-10#1)(2011-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
tracking software##2##2##(2009-12#1)(2013-1#1)
tracking system##5##2##(2008-2#3)(2009-4#1)(2011-2#1)
tracking systems##4##2##(1995-12#1)(1996-12#1)(2008-1#1)(2008-3#1)
tracking technique##3##2##(2008-11#1)(2008-7#1)(2012-1#1)
tracking the position##2##3##(2008-2#1)(2010-8#1)
tracking the##8##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-8#1)(2011-2#1)
tracking was##2##2##(2012-2#1)(2013-1#1)
tracking##124##1##(1990-11#1)(1991-12#3)(1992-6#6)(1994-12#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-5#1)(2007-11#2)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#7)(2008-2#21)(2008-3#13)(2008-6#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#7)(2009-4#2)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#11)(2013-8#1)
tracking)##2##1##(2007-12#1)(2008-2#1)
tracking-error signal (TES)##2##3##(2008-2#1)(2008-3#1)
tracking-error signal##4##2##(2008-2#2)(2008-3#2)
tracks for##2##2##(1992-3#1)(2008-11#1)
tracks the##3##2##(1996-12#1)(2008-5#1)(2009-4#1)
tracks to##2##2##(1994-9#1)(2010-12#1)
tracks##21##1##(1990-5#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)
tract after##2##2##(2007-8#1)(2008-10#1)
tract and a##2##3##(1995-8#1)(2008-11#1)
tract and the##7##3##(1994-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
tract and##29##2##(1991-2#1)(1993-2#1)(1994-5#1)(1995-8#1)(1996-12#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
tract are##8##2##(1990-6#1)(1992-3#1)(1994-12#1)(2007-12#1)(2008-7#1)(2011-2#2)(2012-2#1)
tract associated##2##2##(1991-2#1)(1992-9#1)
tract by a##3##3##(1992-9#1)(1994-12#1)(2011-1#1)
tract can be##3##3##(1991-9#1)(2013-1#1)(2013-8#1)
tract can##4##2##(1991-9#1)(1996-12#1)(2013-1#1)(2013-8#1)
tract cancers##2##2##(1991-12#1)(2012-3#1)
tract disease in##2##3##(2011-2#2)
tract disease##6##2##(2006-10#1)(2009-3#1)(2011-2#4)
tract diseases##3##2##(1992-6#1)(2008-10#1)(2012-12#1)
tract for##2##2##(2010-5#1)(2011-2#1)
tract from##2##2##(1990-11#1)(2012-12#1)
tract have been##2##3##(1990-8#1)(1997-8#1)
tract in a##3##3##(2007-10#1)(2012-1#1)(2013-8#1)
tract in##9##2##(1990-11#1)(1992-9#2)(1994-12#1)(2007-10#1)(2008-10#1)(2012-1#2)(2013-8#1)
tract infection (UTI)##8##3##(2007-7#2)(2008-1#1)(2008-7#1)(2009-5#2)(2011-2#2)
tract infection in##5##3##(2007-12#1)(2008-1#1)(2008-7#1)(2010-10#1)(2011-2#1)
tract infection##42##2##(1990-11#1)(1991-4#1)(1994-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#3)(2007-7#3)(2008-1#3)(2008-10#3)(2008-4#4)(2008-7#5)(2009-5#4)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
tract infections in infants##2##4##(2007-12#1)(2008-11#1)
tract infections in##12##3##(1991-11#1)(1993-2#1)(1997-2#2)(2007-10#2)(2007-12#1)(2008-11#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#1)
tract infections##52##2##(1991-11#1)(1993-2#3)(1994-11#1)(1997-2#2)(1997-4#2)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-2#2)(2009-3#2)(2009-5#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
tract infections]##3##2##(1993-11#1)(1995-6#1)(2013-8#1)
tract is a##3##3##(1996-1#1)(2008-4#1)(2009-1#1)
tract is rare##2##3##(1990-8#2)
tract is the##3##3##(1996-12#1)(2009-8#1)(2012-12#1)
tract is##14##2##(1990-11#2)(1990-8#2)(1996-1#1)(1996-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-8#1)(2012-12#2)
tract obstruction##4##2##(2007-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
tract of the##7##3##(1990-9#1)(1996-3#1)(1996-5#2)(2008-5#1)(2011-2#1)(2013-1#1)
tract of##24##2##(1990-9#1)(1992-2#1)(1996-12#1)(1996-3#1)(1996-5#3)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#3)(2012-2#2)(2013-1#6)
tract or##2##2##(2008-11#1)(2012-1#1)
tract pathogens##2##2##(2010-3#1)(2013-8#1)
tract reconstruction##2##2##(2007-8#1)(2008-10#1)
tract surgery##2##2##(2009-8#1)(2011-2#1)
tract symptoms##4##2##(1995-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
tract to the##2##3##(2007-12#1)(2008-9#1)
tract tracing##3##2##(2008-4#3)
tract transection in neonatal rats##2##5##(2013-1#2)
tract transection##4##2##(2013-1#4)
tract was##5##2##(1990-6#1)(1996-3#1)(1996-5#1)(2011-1#1)(2013-1#1)
tract were##2##2##(1991-6#1)(2008-1#1)
tract with##2##2##(1991-5#1)(2008-10#1)
tract##499##1##(1990-11#8)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#4)(1990-8#10)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#10)(1993-11#1)(1993-12#3)(1993-2#5)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#3)(1996-12#14)(1996-3#4)(1996-5#11)(1996-7#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#2)(2006-10#2)(2007-10#6)(2007-12#12)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#37)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#13)(2008-5#11)(2008-6#2)(2008-7#17)(2008-9#5)(2009-1#2)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#12)(2009-8#2)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#20)(2011-2#37)(2012-1#11)(2012-12#10)(2012-2#17)(2012-3#9)(2013-1#33)(2013-2#1)(2013-7#1)(2013-8#18)
tract]##3##1##(1995-6#1)(1995-8#1)(2013-7#1)
tractable in##2##2##(2008-11#1)(2012-3#1)
tractable##9##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
traction and##2##2##(2007-11#1)(2007-12#1)
traction before closed reduction##2##4##(2007-8#2)
traction before##3##2##(2007-8#3)
traction mobilizations##3##2##(2008-10#3)
traction##26##1##(2007-11#2)(2007-12#1)(2007-8#9)(2008-10#6)(2008-7#1)(2008-9#4)(2009-4#1)(2013-1#2)
tractional##2##1##(2008-1#1)(2013-1#1)
tractography##4##1##(2008-11#1)(2008-9#2)(2012-2#1)
tractors and##2##2##(2008-11#1)(2008-12#1)
tractors##3##1##(2008-11#1)(2008-12#2)
tracts and##4##2##(2008-1#2)(2008-7#1)(2009-4#1)
tracts in##4##2##(2009-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
tracts of##7##2##(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
tracts##43##1##(1991-11#2)(1992-11#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-5#2)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#3)(2008-4#2)(2008-5#4)(2008-7#8)(2009-4#3)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
tractus solitarius##6##2##(1991-3#1)(1994-2#1)(1997-2#2)(2007-10#2)
tractus##8##1##(1991-3#1)(1992-3#2)(1994-2#1)(1997-2#2)(2007-10#2)
trade agreements##3##2##(1996-12#1)(2008-1#2)
trade and##2##2##(2008-7#1)(2011-2#1)
trade associations##2##2##(1992-8#1)(1995-12#1)
trade in health services will##2##5##(2008-7#2)
trade in health services##3##4##(2008-7#3)
trade in medications##2##3##(2008-9#2)
trade in##11##2##(1994-3#1)(1997-7#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-7#3)(2008-9#2)
trade off between##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
trade off##7##2##(1993-2#1)(2008-2#1)(2008-3#2)(2008-6#2)(2012-12#1)
trade or movement of##2##4##(2007-6#1)(2011-2#1)
trade publications##2##2##(1995-12#1)(2008-12#1)
trade routes##3##2##(2011-2#3)
trade##60##1##(1992-8#1)(1993-2#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-5#6)(2007-6#2)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#9)(2008-9#2)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#1)
trade-off among##2##2##(1994-3#2)
trade-off between competitive ability and##2##5##(2008-8#2)
trade-off between competitive##3##3##(2008-8#3)
trade-off between the##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
trade-off between these##2##3##(2008-2#1)(2008-9#1)
trade-off between##36##2##(1991-5#1)(1995-2#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#9)(2008-8#9)(2008-9#6)(2012-2#1)(2012-3#1)(2013-1#1)
trade-off can##2##2##(2008-8#2)
trade-off for##2##2##(2008-3#1)(2008-8#1)
trade-off in##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
trade-off is##2##2##(2007-11#1)(2008-8#1)
trade-off to##2##2##(2008-8#2)
trade-off##69##1##(1991-5#1)(1994-3#2)(1995-2#2)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#11)(2008-8#29)(2008-9#8)(2010-10#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
trade-off)##2##1##(2008-9#2)
trade-offs between the##2##3##(1996-1#1)(2008-9#1)
trade-offs between##8##2##(1996-1#1)(2008-3#1)(2008-8#3)(2008-9#2)(2012-3#1)
trade-offs for##2##2##(2008-2#1)(2008-9#1)
trade-offs in##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
trade-offs that##3##2##(2008-3#1)(2008-8#1)(2010-3#1)
trade-offs##38##1##(1992-2#1)(1994-2#1)(1994-3#2)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#15)(2008-9#9)(2010-3#3)(2012-3#2)
trademark##2##1##(1995-3#1)(2008-10#1)
tradeoff and##2##2##(2010-2#1)(2010-5#1)
tradeoff between##2##2##(2011-1#1)(2012-1#1)
tradeoff##8##1##(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#2)(2013-8#1)
trades##4##1##(2007-4#1)(2008-10#1)(2008-12#1)(2009-8#1)
trading##5##1##(1990-2#1)(1992-5#1)(2007-12#1)(2008-4#1)(2009-12#1)
tradition and##3##2##(1995-12#1)(2007-8#1)(2011-2#1)
tradition of##7##2##(1991-2#1)(1994-3#1)(1995-1#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-8#1)
tradition##20##1##(1991-2#1)(1992-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-12#3)(2008-2#1)(2008-4#1)(2011-2#2)(2012-3#2)(2013-8#1)
traditional &quot##5##2##(1991-3#1)(1995-8#1)(1996-3#1)(2007-5#2)
traditional 2D##2##2##(2011-7#1)(2013-1#1)
traditional Chinese medicine for##2##4##(1992-2#1)(2008-10#1)
traditional Chinese medicine##17##3##(1992-2#1)(2008-10#4)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)
traditional Chinese medicine)##2##3##(2010-10#2)
traditional Chinese medicines##5##3##(2008-10#1)(2011-2#1)(2011-3#3)
traditional Chinese##35##2##(1992-2#1)(1997-2#2)(2008-10#9)(2008-9#1)(2010-10#2)(2011-2#5)(2011-3#5)(2012-2#2)(2012-3#3)(2013-1#5)
traditional IIP##2##2##(2009-11#2)
traditional RP-LC##2##2##(2008-10#2)
traditional RRFF flap##2##3##(2008-9#2)
traditional air##2##2##(2008-11#2)
traditional and##5##2##(1994-6#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
traditional approach##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
traditional approaches to##3##3##(1997-3#1)(2008-5#1)(2013-1#1)
traditional approaches##6##2##(1997-3#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
traditional areas of##2##3##(2010-7#1)(2011-2#1)
traditional assessment##3##2##(2008-11#1)(2011-2#2)
traditional biological##2##2##(2008-8#1)(2012-2#1)
traditional blood##2##2##(2007-7#2)
traditional cardiovascular risk factors##4##4##(2008-3#1)(2008-9#1)(2011-1#2)
traditional cardiovascular##5##2##(1990-6#1)(2008-3#1)(2008-9#1)(2011-1#2)
traditional clinical##6##2##(1994-1#1)(1996-1#2)(2008-1#1)(2012-3#1)(2013-8#1)
traditional concepts##2##2##(1992-1#1)(1993-3#1)
traditional design##2##2##(1996-12#1)(2006-10#1)
traditional epidemiological##2##2##(2008-7#2)
traditional evaluation##2##2##(1992-6#1)(2010-8#1)
traditional fee-for-service##2##2##(1995-1#1)(1997-2#1)
traditional fermented##5##2##(2009-11#2)(2010-2#2)(2010-4#1)
traditional flow##2##2##(2008-9#2)
traditional futon mattress##2##3##(2008-6#2)
traditional healers##2##2##(2008-10#1)(2012-12#1)
traditional health care##4##3##(1991-1#1)(1992-12#1)(1995-1#1)(1996-12#1)
traditional health##8##2##(1990-11#1)(1991-1#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#2)(1996-12#1)
traditional institutions##2##2##(1991-1#1)(1993-12#1)
traditional jazz##3##2##(1992-3#3)
traditional linear##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
traditional liquid-liquid##3##2##(2008-10#3)
traditional masculine##3##2##(2009-5#2)(2010-8#1)
traditional means##2##2##(2007-12#1)(2008-9#1)
traditional measures##2##2##(1997-1#1)(2007-8#1)
traditional medical##3##2##(1994-1#1)(1997-3#1)(2012-3#1)
traditional medicinal##2##2##(1991-6#1)(2013-1#1)
traditional medicine##10##2##(1992-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
traditional method based on##3##4##(2007-8#1)(2008-10#1)(2012-1#1)
traditional method##8##2##(2007-8#2)(2008-10#2)(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
traditional methods for##2##3##(2008-10#2)
traditional methods of evaluating##2##4##(1991-12#1)(2008-6#1)
traditional methods of##8##3##(1990-9#1)(1991-12#1)(1992-8#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-11#1)
traditional methods##24##2##(1990-9#1)(1991-12#1)(1992-8#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-6#1)
traditional models##4##2##(2008-11#2)(2008-8#2)
traditional off-line live cell counting##2##5##(2008-11#2)
traditional optical##2##2##(2008-3#1)(2008-6#1)
traditional outcome##2##2##(1994-11#1)(2009-5#1)
traditional paradigms##2##2##(1994-2#1)(1996-12#1)
traditional positional enrichment analyses##2##4##(2009-5#2)
traditional practices##4##2##(1992-1#1)(1997-7#3)
traditional process##2##2##(1994-3#1)(2008-11#1)
traditional quality##2##2##(1995-1#1)(1996-12#1)
traditional rehabilitation##2##2##(2008-2#1)(2013-1#1)
traditional risk factors such as##2##5##(2010-12#1)(2013-1#1)
traditional risk factors##8##3##(1993-12#2)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
traditional role##2##2##(1991-2#1)(1996-1#1)
traditional sensory assessment##3##3##(2008-5#3)
traditional stereotype##2##2##(1993-2#1)(2012-3#1)
traditional stroke risk factors for homocysteine testing##2##7##(2007-10#2)
traditional stroke risk factors##3##4##(2007-10#3)
traditional surgical##2##2##(1993-3#1)(2010-6#1)
traditional survey##2##2##(2010-1#1)(2010-8#1)
traditional technique##5##2##(2008-3#1)(2011-2#3)(2013-1#1)
traditional techniques##10##2##(1993-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-8#1)
traditional tests##2##2##(2008-10#1)(2012-3#1)
traditional therapy##4##2##(1990-10#2)(1997-2#2)
traditional total abdominal and vaginal hysterectomies##2##6##(1993-12#2)
traditional total abdominal and##3##4##(1993-12#3)
traditional treatment##3##2##(1994-9#1)(2007-11#1)(2007-8#1)
traditional treatments##3##2##(1991-2#1)(2008-10#1)(2010-6#1)
traditional use##2##2##(2008-6#1)(2013-7#1)
traditional vaginal hysterectomy##2##3##(1993-12#1)(1993-2#1)
traditional varieties##3##2##(2008-12#3)
traditional way##3##2##(1991-12#1)(2008-3#1)(2012-2#1)
traditional##613##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#3)(1992-1#9)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#1)(1992-8#1)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#4)(1994-6#1)(1994-9#2)(1995-1#5)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#5)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#9)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#5)(1997-8#1)(2006-10#3)(2007-10#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#9)(2008-1#14)(2008-10#88)(2008-11#22)(2008-12#9)(2008-2#10)(2008-3#34)(2008-4#13)(2008-5#9)(2008-6#12)(2008-7#13)(2008-8#11)(2008-9#22)(2009-10#2)(2009-11#9)(2009-12#3)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#7)(2010-7#3)(2010-8#10)(2011-1#10)(2011-2#26)(2011-3#6)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#17)(2012-3#15)(2013-1#23)(2013-7#4)(2013-8#7)
traditionally associated with##3##3##(2008-5#1)(2008-9#1)(2012-1#1)
traditionally been##22##2##(1991-2#1)(1991-3#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
traditionally considered to##2##3##(2008-11#1)(2012-8#1)
traditionally considered##6##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-8#1)(2013-1#1)
traditionally has been##2##3##(1994-12#1)(2008-11#1)
traditionally have##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
traditionally performed by##2##3##(1991-6#1)(2008-10#1)
traditionally reported##2##2##(2010-2#1)(2012-12#1)
traditionally used for##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
traditionally used##6##2##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
traditionally##102##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-9#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#1)(2009-4#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#3)
traditions of##3##2##(2008-2#1)(2009-10#1)(2009-6#1)
traditions##17##1##(1991-3#1)(1991-8#1)(1993-3#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#3)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
traffic accident##7##2##(1992-6#1)(1995-3#2)(1997-3#1)(2008-8#1)(2009-3#1)(2012-2#1)
traffic accidents##11##2##(1990-9#1)(1991-6#1)(1992-6#2)(1995-8#1)(1996-8#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-7#1)(2013-8#1)
traffic and##5##2##(2008-11#2)(2010-11#2)(2010-3#1)
traffic as well##2##3##(2008-3#1)(2010-11#1)
traffic between##3##2##(1995-12#1)(2011-2#1)(2012-2#1)
traffic control is##2##3##(2008-3#1)(2011-2#1)
traffic in the##2##3##(2008-10#1)(2008-11#1)
traffic in##4##2##(1991-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
traffic injuries in##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
traffic injuries##6##2##(1990-6#1)(1992-6#1)(2008-10#2)(2009-7#1)(2011-2#1)
traffic intensity##2##2##(2008-5#1)(2013-8#1)
traffic is##4##2##(1992-3#1)(2008-8#3)
traffic lights##3##2##(2011-2#3)
traffic of##2##2##(2008-7#1)(2008-8#1)
traffic safety##2##2##(2010-11#2)
traffic##115##1##(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#5)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#11)(2008-3#7)(2008-5#3)(2008-7#2)(2008-8#16)(2008-9#2)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#12)(2010-3#4)(2010-8#1)(2011-2#12)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
traffic-related injuries##3##2##(2011-2#3)
traffic-related##6##1##(2008-5#1)(2011-2#5)
trafficking and##12##2##(1994-8#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2013-1#1)
trafficking from the##2##3##(2009-7#1)(2012-2#1)
trafficking from##3##2##(2009-10#1)(2009-7#1)(2012-2#1)
trafficking is##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
trafficking of the##3##3##(1997-1#1)(2008-4#1)(2012-3#1)
trafficking of##13##2##(1990-2#1)(1997-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2011-3#1)(2012-2#2)(2012-3#2)
trafficking patterns of liposomal##2##4##(1995-5#2)
trafficking patterns of##3##3##(1995-5#2)(2008-1#1)
trafficking route##2##2##(2009-8#1)(2012-2#1)
trafficking through the##2##3##(2009-2#1)(2009-8#1)
trafficking through##3##2##(2008-1#1)(2009-2#1)(2009-8#1)
trafficking to the##2##3##(2008-8#1)(2009-10#1)
trafficking##64##1##(1990-2#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(1996-5#2)(1997-1#2)(2008-1#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#6)(2009-12#1)(2009-2#1)(2009-7#3)(2009-8#6)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)
tragedy of##2##2##(2009-4#1)(2010-1#1)
tragedy##7##1##(1991-11#1)(1991-12#1)(1992-2#2)(2008-11#1)(2009-4#1)(2010-1#1)
tragus##2##1##(2008-7#1)(2012-2#1)
trail in two hatches##2##4##(2008-12#2)
trail of##5##2##(1991-1#1)(1992-2#1)(1992-8#1)(2011-2#1)(2013-8#1)
trail##12##1##(1991-1#1)(1992-2#1)(1992-8#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2011-2#1)(2013-8#1)
trailer of##2##2##(2008-8#2)
trailer##6##1##(2008-8#6)
trailing edge of the##2##4##(2007-12#1)(2011-2#1)
trailing edge##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
trailing##13##1##(1994-1#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#5)(2011-2#1)
trails##7##1##(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#2)
train and##7##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#1)
train at##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
train in##2##2##(2007-11#2)
train of##9##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)
train physicians##2##2##(1992-12#1)(1997-3#1)
train the##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
train their##2##2##(1994-6#1)(2010-5#1)
train##82##1##(1990-12#1)(1991-2#1)(1992-12#2)(1993-1#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-5#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-11#15)(2007-12#12)(2008-1#2)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-8#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
trained a##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
trained and##9##2##(1994-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#1)(2013-1#2)
trained by back-propagation##3##3##(2008-10#3)
trained by##11##2##(2008-10#8)(2008-6#2)(2010-8#1)
trained for##4##2##(2007-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
trained health##2##2##(1994-3#2)
trained in##18##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#1)
trained males##2##2##(2008-5#1)(2013-1#1)
trained medical##2##2##(2007-4#1)(2012-12#1)
trained microscopists##2##2##(2007-2#1)(2012-2#1)
trained nurses for##2##3##(2007-12#1)(2009-4#1)
trained nurses##4##2##(2007-12#1)(2009-4#2)(2011-2#1)
trained on the##4##3##(1993-12#1)(1997-2#1)(2010-8#2)
trained on##11##2##(1993-12#3)(1993-3#2)(1993-5#1)(1994-3#1)(1997-2#1)(2010-8#2)(2011-2#1)
trained personnel##5##2##(1994-1#1)(2007-7#1)(2008-4#1)(2012-2#2)
trained physicians##2##2##(1993-11#1)(1994-3#1)
trained teachers##2##2##(1993-6#1)(2011-2#1)
trained to detect##2##3##(1992-11#1)(2008-2#1)
trained to discriminate##6##3##(1991-12#1)(1992-10#1)(1993-12#1)(1997-7#2)(2008-8#1)
trained to use##2##3##(2012-3#1)(2013-1#1)
trained to##25##2##(1991-12#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-12#2)(1993-6#2)(1997-7#3)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
trained using##2##2##(2008-10#1)(2010-11#1)
trained violinists##2##2##(2013-8#2)
trained with the##5##3##(2008-10#2)(2010-8#1)(2012-3#2)
trained with##8##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)(2012-3#2)
trained##179##1##(1990-11#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#2)(1993-11#2)(1993-12#7)(1993-3#2)(1993-5#2)(1993-6#3)(1994-1#1)(1994-12#1)(1994-3#7)(1994-8#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#3)(1997-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#4)(2010-8#8)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#12)(2013-8#3)
trainee##6##1##(1992-1#1)(1992-12#1)(1992-6#1)(1994-12#1)(2008-12#1)(2010-2#1)
trainees##21##1##(1992-12#1)(1992-6#5)(1993-11#1)(1994-12#2)(1996-8#1)(2007-10#3)(2008-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
trainer##4##1##(2010-3#3)(2012-3#1)
trainers##4##1##(1992-12#1)(1994-2#1)(1994-3#1)(2013-1#1)
training (i##2##2##(2011-2#1)(2013-1#1)
training (n = 30)##3##4##(2013-8#3)
training (n =##4##3##(2009-11#1)(2013-8#3)
training a##2##2##(1994-2#1)(2008-4#1)
training accuracy##4##2##(2008-8#4)
training adaptations in##2##3##(2008-5#2)
training adaptations##6##2##(2008-5#6)
training aids##2##2##(1997-1#1)(2008-10#1)
training alone##2##2##(2013-1#1)(2013-8#1)
training also##2##2##(1991-5#1)(2008-8#1)
training and at##2##3##(2012-2#1)(2013-8#1)
training and development##6##3##(1993-3#1)(1997-3#1)(2008-12#2)(2011-1#2)
training and education in##2##4##(1995-3#1)(2008-11#1)
training and education of##2##4##(1995-5#1)(2008-11#1)
training and education##6##3##(1995-3#1)(1995-5#1)(1997-6#1)(2008-11#2)(2008-12#1)
training and practice##2##3##(1996-1#1)(2007-5#1)
training and prediction##2##3##(2008-10#2)
training and research##4##3##(1993-1#1)(1993-11#1)(2007-12#1)(2013-1#1)
training and testing##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
training and the##4##3##(2007-11#1)(2008-10#1)(2009-3#1)(2010-8#1)
training and tools##2##3##(2008-8#1)(2009-3#1)
training and##99##2##(1990-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
training are##7##2##(1993-1#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-5#1)(2007-12#1)(2012-3#1)
training as well as##3##4##(1993-6#1)(1994-12#1)(2008-10#1)
training as##8##2##(1991-3#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-1#1)(2013-8#1)
training at##4##2##(1990-11#1)(1993-12#1)(1997-2#1)(2008-11#1)
training available##2##2##(1991-1#1)(2008-9#1)
training by##5##2##(1996-1#1)(1996-3#2)(2007-11#1)(2008-11#1)
training can##2##2##(1993-2#1)(2008-11#1)
training center for##2##3##(2008-11#1)(2008-8#1)
training content##3##2##(2007-12#1)(2008-9#1)(2010-10#1)
training course in##3##3##(2008-11#3)
training course on##2##3##(2008-11#1)(2012-12#1)
training course##6##2##(2008-11#5)(2012-12#1)
training courses##5##2##(2008-10#1)(2008-12#2)(2010-3#1)(2011-2#1)
training currently##2##2##(1992-12#1)(1995-1#1)
training data set##3##3##(2008-10#3)
training data##8##2##(2008-10#5)(2008-3#1)(2010-9#1)(2013-8#1)
training effort##2##2##(1993-2#1)(2011-2#1)
training for nurses##2##3##(2008-11#1)(2008-9#1)
training for patients##2##3##(2008-8#1)(2010-3#1)
training for physicians##2##3##(1991-2#1)(1991-3#1)
training for the##3##3##(1991-3#1)(1994-2#1)(2008-7#1)
training for##36##2##(1990-3#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#2)(1993-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#3)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
training given##2##2##(1991-5#1)(1993-2#1)
training group (n= 10)##3##4##(2013-1#3)
training group (β=##3##3##(2013-1#3)
training group##8##2##(2013-1#8)
training has been##2##3##(1991-3#1)(1993-1#1)
training has##3##2##(1991-3#1)(1993-1#1)(1995-12#1)
training images##3##2##(2008-2#1)(2008-3#2)
training in blood pressure monitoring##2##5##(2008-1#2)
training in family##2##3##(1996-11#1)(1997-6#1)
training in general##2##3##(1991-8#1)(1993-12#1)
training in public health##2##4##(1996-3#1)(2012-12#1)
training in the use of##2##5##(1993-3#1)(2008-11#1)
training in the##7##3##(1993-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
training in##70##2##(1990-12#2)(1991-1#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#7)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
training inputs##2##2##(1992-1#1)(2012-12#1)
training intensity##3##2##(2010-1#2)(2013-1#1)
training is a##2##3##(2008-3#1)(2008-5#1)
training is##15##2##(1991-5#1)(1992-11#1)(1993-1#1)(1994-12#2)(1994-6#1)(1996-2#1)(1997-2#1)(2008-3#1)(2008-5#2)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
training issues##2##2##(1993-2#1)(2013-1#1)
training load##2##2##(2008-5#1)(2012-3#1)
training may##2##2##(2013-1#2)
training method##4##2##(1994-2#1)(2010-8#1)(2013-1#2)
training methods##3##2##(2008-12#3)
training modality##2##2##(2013-8#2)
training must##2##2##(1994-12#1)(2013-1#1)
training needs of##2##3##(2008-1#1)(2008-11#1)
training needs##5##2##(1996-1#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)
training of clinical biochemists##2##4##(1994-12#2)
training of clinical##3##3##(1994-12#3)
training of community health agents##2##5##(2011-2#2)
training of health care##3##4##(1991-3#1)(2008-11#1)(2013-1#1)
training of hospital security##2##4##(1991-12#1)(1996-12#1)
training of medical##9##3##(1992-1#2)(1994-12#3)(1994-6#1)(2007-8#1)(2009-10#1)(2012-3#1)
training of the neural##3##4##(2007-8#1)(2008-3#1)(2010-8#1)
training of the##9##3##(1994-12#2)(1995-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)
training of##66##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#9)(1994-3#3)(1994-6#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-10#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
training on gait performance##2##4##(2013-1#2)
training on the##6##3##(1992-12#1)(1997-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-3#1)
training on##27##2##(1992-12#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-3#2)(2009-6#2)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
training or##5##2##(1994-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
training parameters##2##2##(2008-10#1)(2008-11#1)
training period##3##2##(2008-11#1)(2008-5#2)
training procedure##2##2##(2008-4#1)(2010-7#1)
training procedures##4##2##(1990-11#1)(1994-3#1)(2008-7#1)(2011-2#1)
training processes##2##2##(1993-3#1)(2013-1#1)
training program for##3##3##(1991-12#1)(1993-12#1)(2008-7#1)
training program has##2##3##(2007-12#1)(2008-7#1)
training program in##2##3##(1992-2#1)(2008-7#1)
training program over the##2##4##(1992-1#1)(2011-2#1)
training program##37##2##(1991-12#3)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1993-12#1)(1996-2#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2010-3#3)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)
training programme for##2##3##(2008-12#1)(2013-8#1)
training programme##12##2##(1991-5#1)(1994-12#1)(2008-12#3)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
training programmes for##3##3##(1991-12#1)(1994-12#1)(2011-2#1)
training programmes##8##2##(1991-12#1)(1992-6#1)(1994-12#1)(2007-6#1)(2008-12#1)(2011-2#2)(2013-1#1)
training programs and##2##3##(1996-4#1)(2008-12#1)
training programs are##2##3##(1992-1#1)(2007-12#1)
training programs for clinical##2##4##(1994-12#1)(2008-12#1)
training programs for##4##3##(1992-12#1)(1993-1#1)(1994-12#1)(2008-12#1)
training programs that##2##3##(1996-3#1)(2008-11#1)
training programs to##2##3##(1997-2#1)(1997-6#1)
training programs##25##2##(1992-1#4)(1992-12#3)(1993-1#2)(1994-12#2)(1996-3#3)(1996-4#1)(1997-2#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-12#2)(2011-1#1)(2012-3#2)
training reduces metformin##2##3##(2012-3#2)
training regimen##2##2##(2008-5#1)(2013-1#1)
training required to##2##3##(1992-11#1)(2008-11#1)
training required##3##2##(1992-11#1)(1996-3#1)(2008-11#1)
training requirements##7##2##(1991-12#1)(1992-9#1)(1994-12#2)(1996-2#2)(2007-12#1)
training session##3##2##(1994-8#1)(2009-1#1)(2010-7#1)
training sessions##3##2##(1991-3#1)(2010-3#1)(2012-2#1)
training set and##2##3##(2008-10#2)
training set of##6##3##(1995-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-3#1)
training set##18##2##(1995-6#2)(1995-9#1)(2008-10#11)(2008-3#1)(2008-6#1)(2008-9#1)(2009-3#1)
training should be##3##3##(1996-3#1)(2012-3#1)(2013-1#1)
training study##2##2##(1991-8#1)(2013-1#1)
training subject##2##2##(2010-9#2)
training system##2##2##(2010-12#1)(2010-8#1)
training systems##2##2##(2010-12#1)(2010-8#1)
training that##3##2##(2009-1#1)(2010-5#1)(2011-2#1)
training the##8##2##(1990-7#1)(1993-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-1#1)
training through a##2##3##(1994-12#2)
training time##3##2##(2013-8#3)
training to provide##2##3##(1994-3#1)(2008-4#1)
training to##16##2##(1994-3#1)(1995-1#1)(2007-5#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#4)
training trials##5##2##(1993-6#4)(2008-5#1)
training under##2##2##(1991-3#1)(2009-8#1)
training using##3##2##(2007-10#1)(2007-11#1)(2008-9#1)
training videos##2##2##(1997-1#1)(2011-2#1)
training was##8##2##(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-1#1)(2011-2#1)
training with a##2##3##(1993-5#1)(2007-10#1)
training with metformin##2##3##(2012-3#2)
training with the##2##3##(2008-4#2)
training with##12##2##(1991-9#1)(1993-5#1)(2007-10#2)(2007-11#1)(2008-11#1)(2008-4#2)(2010-10#1)(2012-1#1)(2012-3#2)
training workshop##3##2##(1995-3#1)(2008-8#1)(2013-1#1)
training##994##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-7#1)(1991-1#5)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#13)(1991-5#8)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#9)(1992-10#1)(1992-11#2)(1992-12#13)(1992-2#8)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#16)(1993-11#2)(1993-12#12)(1993-2#10)(1993-3#10)(1993-5#4)(1993-6#6)(1994-1#5)(1994-12#33)(1994-2#6)(1994-3#21)(1994-6#2)(1994-8#2)(1995-1#7)(1995-12#3)(1995-2#9)(1995-3#4)(1995-5#3)(1995-6#7)(1995-8#1)(1995-9#2)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#15)(1996-3#15)(1996-4#1)(1996-6#1)(1996-8#4)(1996-9#4)(1997-1#3)(1997-2#10)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-9#1)(2007-10#6)(2007-11#7)(2007-12#21)(2007-2#6)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#12)(2008-10#46)(2008-11#54)(2008-12#36)(2008-2#3)(2008-3#14)(2008-4#11)(2008-5#35)(2008-6#14)(2008-7#22)(2008-8#11)(2008-9#16)(2009-1#10)(2009-10#4)(2009-11#7)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#9)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#8)(2010-4#1)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#13)(2010-9#5)(2011-1#7)(2011-2#48)(2012-1#9)(2012-12#11)(2012-2#19)(2012-3#33)(2013-1#63)(2013-8#34)
training)##2##1##(2012-3#1)(2013-1#1)
trainings##3##1##(2010-8#1)(2011-1#1)(2013-8#1)
trains and##2##2##(2007-11#1)(2007-12#1)
trains by##2##2##(2007-11#1)(2007-12#1)
trains in##2##2##(2007-11#1)(2007-12#1)
trains of##9##2##(1992-11#1)(1995-2#1)(2007-12#2)(2008-2#3)(2008-3#1)(2009-2#1)
trains was##2##2##(2007-11#2)
trains with##2##2##(2008-3#1)(2013-8#1)
trains##51##1##(1990-5#2)(1991-2#4)(1992-11#1)(1995-2#1)(1996-5#1)(2007-11#10)(2007-12#8)(2008-11#5)(2008-2#5)(2008-3#5)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#3)(2011-1#1)(2013-8#2)
trait Loci mapping##3##3##(2008-10#3)
trait Loci##9##2##(2008-10#9)
trait Q1##2##2##(2012-3#2)
trait affects##2##2##(2008-8#2)
trait and the##3##3##(2008-9#1)(2009-4#1)(2012-3#1)
trait and##13##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2012-3#2)(2013-1#2)
trait anxiety##6##2##(1994-12#2)(1994-2#1)(2008-2#2)(2010-6#1)
trait associations##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
trait evolution##2##2##(2012-3#2)
trait expression##4##2##(2008-8#1)(2012-3#3)
trait in the##2##3##(2008-9#1)(2012-3#1)
trait in##7##2##(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#2)
trait inferences##4##2##(2008-11#4)
trait is##4##2##(1997-7#1)(2008-4#1)(2008-9#2)
trait loci (QTL)##33##3##(2008-10#26)(2008-7#1)(2008-8#3)(2011-1#1)(2012-3#2)
trait loci (QTLs) were identified##2##5##(2008-10#1)(2008-4#1)
trait loci (QTLs) were##3##4##(2008-10#2)(2008-4#1)
trait loci (QTLs)##8##3##(2008-10#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)
trait loci##50##2##(2008-10#31)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2011-1#1)(2012-3#5)
trait locus##22##2##(2008-10#16)(2008-5#1)(2008-8#2)(2010-4#1)(2012-3#1)(2013-8#1)
trait of##8##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
trait ratings##2##2##(2009-8#1)(2012-3#1)
trait resilience##3##2##(2009-8#3)
trait that is##2##3##(2012-2#1)(2012-3#1)
trait that##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
trait variance##3##2##(2008-12#1)(2009-4#2)
trait was##2##2##(1993-12#1)(2012-12#1)
trait with##3##2##(2007-2#1)(2007-7#1)(2008-4#1)
trait##253##1##(1993-12#1)(1994-12#2)(1994-2#3)(1994-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#66)(2008-11#13)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#36)(2008-9#23)(2009-10#2)(2009-4#3)(2009-7#1)(2009-8#5)(2010-1#1)(2010-4#1)(2010-6#4)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#39)(2013-1#6)(2013-7#1)(2013-8#1)
trait-mediated##3##1##(2008-9#3)
trait-specific##2##1##(2008-11#1)(2012-3#1)
traitement médical##2##2##(2011-2#2)
traitement par ľaciclovir injectable##2##4##(2013-1#2)
traitement##10##1##(2011-2#5)(2013-1#5)
traits affecting##3##2##(2008-8#2)(2008-9#1)
traits and growth##2##3##(2012-3#2)
traits and the##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
traits and##27##2##(1995-6#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#3)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#5)
traits are##14##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-4#2)(2012-3#2)(2013-7#1)
traits as##3##2##(1997-4#1)(2008-12#1)(2008-4#1)
traits associated with##2##3##(2008-10#1)(2008-8#1)
traits at##2##2##(2008-8#1)(2009-2#1)
traits can also be##3##4##(2010-4#2)(2012-2#1)
traits can be##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
traits can##10##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#2)(2012-2#2)(2012-3#2)(2013-1#1)
traits could##2##2##(2010-10#1)(2010-4#1)
traits do not##2##3##(2008-10#1)(2011-1#1)
traits do##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
traits for which##2##3##(2008-9#2)
traits for##8##2##(1995-6#1)(2008-10#1)(2008-8#2)(2008-9#3)(2012-2#1)
traits in a##3##3##(2008-1#1)(2008-8#1)(2012-2#1)
traits in an##3##3##(2008-1#1)(2008-8#1)(2008-9#1)
traits in response to##2##4##(2008-8#2)
traits in the##4##3##(2008-8#2)(2008-9#1)(2010-4#1)
traits in##40##2##(2008-1#3)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#15)(2008-9#4)(2009-8#1)(2010-4#2)(2011-1#1)(2011-4#1)(2012-2#1)(2012-3#3)(2013-7#1)
traits including##3##2##(1997-4#1)(2009-8#1)(2010-10#1)
traits involved in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
traits is##8##2##(1997-4#1)(2008-8#3)(2010-3#1)(2012-3#3)
traits may##3##2##(2008-8#1)(2008-9#2)
traits of C24 and##2##4##(2012-3#2)
traits of interest##3##3##(1997-4#1)(2008-8#1)(2012-2#1)
traits of the##9##3##(1990-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-9#1)
traits of##36##2##(1990-5#1)(1993-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2012-7#1)(2012-9#1)(2013-7#2)(2013-8#1)
traits on the##4##3##(1996-2#1)(2008-8#2)(2008-9#1)
traits on##11##2##(1996-2#1)(2007-12#1)(2008-8#3)(2008-9#3)(2009-2#1)(2012-3#2)
traits previously##2##2##(1997-3#1)(2009-8#1)
traits remains##2##2##(2008-8#2)
traits such as##4##3##(2008-10#1)(2008-8#3)
traits that are##7##3##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#2)(2012-5#1)
traits that were##2##3##(2008-5#1)(2008-8#1)
traits that##18##2##(1991-12#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#5)(2008-9#1)(2012-3#4)(2012-5#1)
traits to##7##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
traits using##2##2##(2012-3#2)
traits was##3##2##(2008-10#1)(2008-8#2)
traits were determined##2##3##(2008-10#1)(2010-4#1)
traits were significantly##2##3##(2008-10#1)(2008-8#1)
traits were##17##2##(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#5)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)
traits when##2##2##(2008-5#1)(2008-9#1)
traits which##2##2##(2007-11#1)(2009-8#1)
traits whose##2##2##(2008-8#1)(2008-9#1)
traits will##2##2##(2008-8#1)(2010-3#1)
traits with##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
traits within##2##2##(2007-12#1)(2009-8#1)
traits##441##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-5#1)(1994-2#2)(1994-3#1)(1994-9#3)(1995-2#1)(1995-6#4)(1996-2#1)(1997-3#1)(1997-4#9)(2007-11#2)(2007-12#2)(2008-1#5)(2008-10#42)(2008-11#8)(2008-12#10)(2008-3#3)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#103)(2008-9#51)(2009-10#2)(2009-11#1)(2009-2#3)(2009-5#2)(2009-7#4)(2009-8#10)(2009-9#1)(2010-10#5)(2010-12#3)(2010-2#4)(2010-3#5)(2010-4#18)(2010-5#3)(2010-7#2)(2011-1#7)(2011-2#5)(2011-4#1)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#49)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#8)(2013-7#9)(2013-8#3)
traits?##2##1##(1995-6#1)(2012-3#1)
trajectories and##5##2##(2008-11#2)(2008-12#1)(2009-7#1)(2012-2#1)
trajectories for##4##2##(2008-7#1)(2009-8#2)(2012-12#1)
trajectories in the##2##3##(1996-12#1)(2008-3#1)
trajectories in##4##2##(1992-8#1)(1996-12#1)(2007-12#1)(2008-3#1)
trajectories of a##2##3##(2008-12#1)(2012-2#1)
trajectories of substance use##2##4##(2009-7#2)
trajectories of the##5##3##(1993-12#1)(1994-3#1)(2007-11#1)(2008-11#1)(2008-6#1)
trajectories of##22##2##(1993-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-7#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
trajectories that##4##2##(2007-11#1)(2008-11#2)(2008-8#1)
trajectories to##2##2##(2008-11#1)(2008-8#1)
trajectories were##2##2##(1992-11#1)(2008-8#1)
trajectories with##2##2##(2008-2#1)(2008-9#1)
trajectories##89##1##(1992-11#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-8#4)(1996-12#2)(1997-3#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-9#2)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#7)(2008-8#8)(2008-9#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
trajectory and##3##2##(1994-8#1)(2009-6#1)(2011-2#1)
trajectory errors##2##2##(2008-3#2)
trajectory estimation##3##2##(2008-3#3)
trajectory group##2##2##(2009-8#1)(2010-4#1)
trajectory groups##3##2##(2008-12#1)(2010-4#2)
trajectory in##3##2##(2007-11#1)(2008-7#1)(2009-9#1)
trajectory is##3##2##(1995-12#1)(2008-3#1)(2009-8#1)
trajectory of the##4##3##(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
trajectory of##14##2##(1992-9#1)(1994-2#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
trajectory patterns##2##2##(2013-1#2)
trajectory to##3##2##(1995-12#1)(1996-6#1)(2011-2#1)
trajectory##67##1##(1992-6#1)(1992-9#1)(1994-2#1)(1994-8#3)(1995-12#2)(1996-12#1)(1996-6#3)(1997-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#10)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-12#1)(2010-4#3)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#4)
trajectory-specific##3##1##(1994-8#3)
tramadol and##2##2##(1997-8#1)(2008-10#1)
tramadol##12##1##(1996-5#3)(1997-8#1)(2007-8#1)(2008-10#6)(2008-9#1)
trance##5##1##(2009-10#5)
tranilast##8##1##(1995-11#3)(2008-5#5)
tranquilizers##4##1##(1993-9#1)(2008-9#1)(2011-2#1)(2013-8#1)
tranquillisers##3##1##(2008-7#3)
trans conformation##2##2##(2008-8#2)
trans isomers##7##2##(1990-9#1)(1995-6#1)(2010-2#4)(2013-1#1)
trans to##3##2##(1996-2#2)(2008-10#1)
trans##50##1##(1990-9#3)(1991-12#1)(1991-5#7)(1992-12#2)(1993-12#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-2#3)(1996-5#1)(1996-6#1)(1997-4#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-2#6)(2011-2#4)(2012-2#2)(2013-1#1)
trans)##2##1##(1990-2#2)
trans- and cis-resveratrol##2##3##(2008-10#2)
trans- and##3##2##(2008-10#2)(2009-9#1)
trans-##4##1##(1996-5#1)(2008-10#2)(2009-9#1)
trans-1##3##1##(1996-5#1)(2007-11#2)
trans-2-hydroxycinnamic##2##1##(2013-1#2)
trans-BPIC##2##1##(2008-10#2)
trans-Golgi network##5##2##(1992-12#1)(2007-12#1)(2008-1#2)(2009-10#1)
trans-Golgi##6##1##(1992-12#1)(1997-2#1)(2007-12#1)(2008-1#2)(2009-10#1)
trans-acting elements in##3##3##(1995-2#1)(1996-5#2)
trans-acting factor##2##2##(1993-12#2)
trans-acting factors##5##2##(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-8#1)
trans-acting regulation system was##2##4##(2008-9#2)
trans-acting regulation system##3##3##(2008-9#3)
trans-acting replication specificity##2##3##(2008-10#2)
trans-acting##17##1##(1992-5#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#2)(2008-10#2)(2008-9#3)(2010-5#1)
trans-activating factors##3##2##(2008-9#3)
trans-activating##6##1##(1994-5#1)(2008-9#4)(2010-10#1)
trans-activation of##2##2##(1994-8#1)(1996-12#1)
trans-activation##4##1##(1994-8#3)(1996-12#1)
trans-columella access##2##2##(1990-9#2)
trans-dominant##2##1##(1990-12#1)(2008-10#1)
trans-facet##2##1##(2012-3#2)
trans-farnesyl diphosphate##2##2##(1995-2#2)
trans-flupenthixol##4##1##(1993-6#4)
trans-lucens##2##1##(2008-10#2)
trans-membrane##3##1##(1991-10#1)(2008-11#1)(2008-8#1)
trans-radial##2##1##(2008-11#1)(2011-2#1)
trans-replicate##4##1##(2008-10#4)
trans-sinusal frontal approach##5##3##(2006-12#5)
trans-spliced##3##1##(2007-12#3)
trans-splicing##6##1##(2007-12#4)(2011-3#1)(2012-2#1)
trans-tamoxifen##6##1##(2008-11#6)
trans-thoracic##2##1##(2007-8#1)(2008-10#1)
transabdominal pre-peritoneal##2##2##(2012-12#2)
transabdominal preperitoneal##2##2##(1996-9#1)(2011-2#1)
transabdominal##11##1##(1995-1#1)(1996-1#2)(1996-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
transacting factor##2##2##(1990-5#1)(2008-9#1)
transacting##3##1##(1990-5#1)(2008-9#2)
transaction##7##1##(1992-12#1)(1993-1#1)(1993-3#1)(2008-10#1)(2008-11#3)
transactional sex##2##2##(2011-2#2)
transactions##11##1##(1993-1#2)(1994-12#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-3#1)
transactivate##4##1##(1994-12#1)(1995-8#2)(2008-8#1)
transactivated by##2##2##(1994-11#1)(2008-11#1)
transactivates##3##1##(1993-8#2)(2013-1#1)
transactivating factors##2##2##(2008-11#1)(2008-9#1)
transactivating##5##1##(1990-5#1)(1994-5#1)(2008-11#1)(2008-9#1)(2009-6#1)
transactivation assays##2##2##(2008-10#1)(2013-1#1)
transactivation axis##2##2##(2008-11#2)
transactivation domain##3##2##(1993-8#1)(1995-2#2)
transactivation in##2##2##(1995-2#1)(2012-12#1)
transactivation of##7##2##(1991-9#1)(1993-8#1)(1994-11#1)(2008-10#2)(2008-9#1)(2011-2#1)
transactivation##30##1##(1991-9#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#1)(1995-2#4)(1995-6#4)(2008-10#3)(2008-11#3)(2008-9#2)(2011-2#1)(2012-12#3)(2013-1#1)
transactivator##8##1##(1991-8#1)(1994-11#1)(2008-2#3)(2008-8#1)(2012-12#1)(2013-1#1)
transactivators##5##1##(1995-8#1)(1997-3#1)(2008-11#3)
transaminase and##3##2##(1995-6#1)(2013-1#2)
transaminase levels##3##2##(1992-5#1)(1995-2#1)(1997-3#1)
transaminase or ALP levels##2##4##(2013-1#2)
transaminase##22##1##(1992-5#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-3#1)(2008-11#3)(2008-7#2)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#6)
transaminases##8##1##(1992-5#2)(1994-5#1)(1996-11#1)(2008-1#1)(2012-12#1)(2013-1#2)
transaminases)##2##1##(1995-12#1)(2011-2#1)
transamination of##3##2##(1992-8#1)(1995-12#1)(1997-1#1)
transanal##2##1##(1992-6#1)(2009-12#1)
transannular##3##1##(2009-10#3)
transarterial chemoembolization##3##2##(2010-12#1)(2012-12#1)(2013-7#1)
transarterial##9##1##(1996-3#1)(1996-9#1)(1997-3#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
transaxial##2##1##(1995-5#1)(1997-8#1)
transbilayer##2##1##(1990-11#1)(1992-6#1)
transbronchial biopsy or##2##3##(1996-9#1)(2011-2#1)
transbronchial biopsy##4##2##(1996-9#1)(2011-2#3)
transbronchial lung biopsy (TBLB)##2##4##(2008-1#1)(2012-12#1)
transbronchial lung biopsy##5##3##(2008-1#3)(2010-8#1)(2012-12#1)
transbronchial##10##1##(1996-9#1)(2008-1#3)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)
transcaltachia##4##1##(1992-12#4)
transcarbamoylase##4##1##(1990-8#2)(1995-6#2)
transcarbamylase##5##1##(1990-8#2)(1997-2#1)(2009-8#2)
transcatheter closure of a##2##4##(1996-6#1)(2007-8#1)
transcatheter closure of##4##3##(1996-6#1)(2007-8#1)(2008-11#1)(2013-1#1)
transcatheter closure##6##2##(1996-6#2)(2007-8#2)(2008-11#1)(2013-1#1)
transcatheter##12##1##(1996-6#2)(1997-8#1)(2006-10#1)(2007-8#3)(2008-10#1)(2008-11#2)(2010-8#1)(2013-1#1)
transceiver##4##1##(2008-2#4)
transceivers##3##1##(2007-12#1)(2008-3#2)
transcellular##3##1##(1992-3#1)(2007-12#1)(2008-10#1)
transcend##2##1##(2009-10#1)(2012-2#1)
transcendence##2##1##(2010-8#1)(2013-8#1)
transcendent##2##1##(2008-12#1)(2012-2#1)
transcervical osteotomy##2##2##(2012-2#2)
transcervical##8##1##(1991-2#1)(1991-8#1)(2007-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
transcobalamin II##2##2##(1991-12#2)
transconjugant##4##1##(2008-10#4)
transconjugants##2##1##(2008-10#2)
transcortin##2##1##(1990-12#2)
transcortin-bound##2##1##(1990-12#2)
transcranial Doppler (TCD)##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
transcranial Doppler ultrasonography##3##3##(1996-2#1)(2007-8#1)(2008-7#1)
transcranial Doppler##15##2##(1996-2#1)(1996-6#1)(2007-10#7)(2007-8#2)(2008-7#2)(2008-8#1)(2012-3#1)
transcranial blood-flow##2##2##(2012-1#2)
transcranial color-coded duplex sonography##2##4##(2007-10#2)
transcranial direct current stimulation (tDCS)##2##5##(2010-7#1)(2012-2#1)
transcranial direct current stimulation##7##4##(2010-7#3)(2011-1#2)(2012-2#2)
transcranial direct current##8##3##(2010-7#4)(2011-1#2)(2012-2#2)
transcranial magnetic stimulation (rTMS)##6##4##(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
transcranial magnetic stimulation in##2##4##(2012-2#2)
transcranial magnetic stimulation##21##3##(2008-10#1)(2010-5#2)(2010-7#4)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#3)
transcranial magnetic##22##2##(1996-6#1)(2008-10#1)(2010-5#2)(2010-7#4)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#3)
transcranial resection of pituitary##2##4##(2011-2#2)
transcranial resection##3##2##(2011-2#3)
transcranial stimulation##3##2##(1996-2#3)
transcranial##70##1##(1996-2#5)(1996-3#2)(1996-6#2)(2007-10#9)(2007-12#2)(2007-8#2)(2008-10#1)(2008-7#2)(2008-8#1)(2010-5#8)(2010-7#8)(2010-8#1)(2011-1#6)(2011-2#8)(2012-1#4)(2012-2#5)(2012-3#1)(2013-1#3)
transcranially##2##1##(2010-5#2)
transcribe##3##1##(1993-3#1)(1996-6#1)(2008-7#1)
transcribed RNA##2##2##(1993-3#1)(2008-11#1)
transcribed and analysed##2##3##(2010-3#1)(2011-1#1)
transcribed and translated in##2##4##(1990-12#1)(1993-2#1)
transcribed and translated##3##3##(1990-12#1)(1993-2#1)(2009-10#1)
transcribed and##12##2##(1990-12#1)(1991-11#1)(1992-9#1)(1993-2#1)(1995-1#1)(1997-7#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-12#1)
transcribed as polycistronic##2##3##(2008-8#1)(2012-2#1)
transcribed as##3##2##(1994-12#1)(2008-8#1)(2012-2#1)
transcribed at##3##2##(1993-2#1)(1993-3#1)(1993-9#1)
transcribed by RNA polymerase##2##4##(1993-12#1)(2009-5#1)
transcribed by##4##2##(1992-3#1)(1993-12#1)(1997-2#1)(2009-5#1)
transcribed from a##3##3##(1995-6#1)(1996-2#1)(2007-12#1)
transcribed from the##4##3##(1997-4#1)(1997-8#1)(2008-7#1)(2008-8#1)
transcribed from##13##2##(1990-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
transcribed genes##2##2##(1993-12#1)(2009-10#1)
transcribed in vitro with##2##4##(1993-8#1)(2008-8#1)
transcribed in##13##2##(1990-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-3#2)(2008-8#3)(2012-2#1)(2012-3#1)
transcribed into##3##2##(1993-2#1)(2008-11#1)(2010-4#1)
transcribed open reading frames##2##4##(1996-6#2)
transcribed or not##2##3##(2008-11#2)
transcribed region of the##2##4##(1994-12#1)(1994-8#1)
transcribed sequence##2##2##(1994-12#1)(1996-2#1)
transcribed spacer (ITS) region##17##4##(2008-10#16)(2008-5#1)
transcribed spacer (ITS) sequences##3##4##(2008-10#2)(2008-9#1)
transcribed spacer (ITS)##41##3##(2008-10#38)(2008-5#1)(2008-9#1)(2010-10#1)
transcribed spacer region##15##3##(2008-10#14)(2008-9#1)
transcribed spacer regions of##4##4##(2008-10#4)
transcribed spacer regions##5##3##(2008-10#5)
transcribed spacer sequences##2##3##(2008-10#2)
transcribed spacer##87##2##(2008-10#80)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#2)
transcribed to##3##2##(1992-11#1)(1992-8#1)(1997-7#1)
transcribed verbatim and analysed##2##4##(2008-11#1)(2012-3#1)
transcribed verbatim and analyzed##2##4##(2008-11#1)(2011-1#1)
transcribed verbatim and##5##3##(2008-11#2)(2011-1#1)(2012-12#1)(2012-3#1)
transcribed verbatim##6##2##(2008-11#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
transcribed##196##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#4)(1994-6#2)(1994-8#4)(1995-1#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-6#4)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#84)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#3)(2009-2#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#2)
transcript (1##2##2##(1994-11#1)(2008-5#1)
transcript abundance##5##2##(2008-11#1)(2008-7#2)(2012-2#1)(2012-3#1)
transcript accumulation##2##2##(2008-10#1)(2008-9#1)
transcript and##6##2##(1993-11#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-8#1)(2013-8#1)
transcript expression##5##2##(1995-8#1)(2011-2#4)
transcript from a##2##3##(2008-10#2)
transcript from the##2##3##(1994-12#1)(2008-10#1)
transcript from##4##2##(1994-12#1)(2008-10#3)
transcript in rat##2##3##(1993-6#1)(1995-2#1)
transcript in the##3##3##(1995-12#1)(1996-12#1)(2008-9#1)
transcript in##8##2##(1990-11#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-9#1)
transcript is present in L1 larvae and at the##2##9##(1993-12#2)
transcript is##8##2##(1991-5#1)(1991-9#1)(1993-12#3)(2008-8#1)(2009-10#1)(2013-1#1)
transcript level##5##2##(1990-5#1)(1991-6#1)(1992-9#1)(1997-7#1)(2010-8#1)
transcript levels in##3##3##(1992-9#1)(1996-10#1)(2008-7#1)
transcript levels of##4##3##(1997-7#1)(2008-10#2)(2011-1#1)
transcript levels##13##2##(1992-9#1)(1993-9#1)(1996-10#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-7#3)(2008-9#1)(2011-1#1)
transcript of 1##3##3##(1996-6#3)
transcript of##19##2##(1991-5#1)(1991-6#2)(1992-8#2)(1993-2#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-6#3)(2008-10#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-7#1)
transcript profiles##2##2##(2008-2#1)(2008-7#1)
transcript profiling##2##2##(2008-2#1)(2008-7#1)
transcript that##2##2##(1990-12#1)(1991-5#1)
transcript was detected by##3##4##(2008-10#3)
transcript was detected##5##3##(1996-6#1)(1997-7#1)(2008-10#3)
transcript was expressed##2##3##(1995-6#1)(2008-9#1)
transcript was##11##2##(1993-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#3)(2008-9#1)(2011-2#1)
transcript were##2##2##(1994-11#1)(2008-10#1)
transcript which could##2##3##(1991-9#1)(1992-8#1)
transcript which##4##2##(1991-9#2)(1992-8#1)(1993-11#1)
transcript##186##1##(1990-11#1)(1990-12#2)(1990-5#2)(1991-5#4)(1991-6#3)(1991-9#5)(1992-11#1)(1992-3#1)(1992-8#10)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#7)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#2)(1995-2#4)(1995-6#3)(1995-8#5)(1996-10#4)(1996-12#2)(1996-6#5)(1996-8#1)(1997-2#4)(1997-6#1)(1997-7#8)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#3)
transcriptase (RT)##4##2##(1991-9#1)(1997-6#1)(2008-11#1)(2013-1#1)
transcriptase polymerase chain reaction (RT-PCR)##4##5##(1996-12#1)(1997-4#1)(2008-7#1)(2012-2#1)
transcriptase polymerase chain reaction##10##4##(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-4#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
transcriptase##62##1##(1991-9#1)(1992-3#2)(1992-6#1)(1993-3#3)(1993-6#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#8)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#2)(2011-2#8)(2011-3#9)(2012-2#1)(2013-1#1)
transcriptase-PCR##2##1##(2009-6#1)(2009-7#1)
transcriptase-polymerase chain reaction (RT-PCR) using##2##5##(1997-6#2)
transcriptase-polymerase chain reaction (RT-PCR)##9##4##(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#2)(2007-8#1)(2008-5#1)(2008-8#1)
transcriptase-polymerase chain reaction##17##3##(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#3)(1997-2#1)(1997-6#2)(1997-9#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
transcription (RT)-PCR##2##2##(1994-12#1)(2012-12#1)
transcription activator##6##2##(1991-5#1)(1993-9#1)(1995-6#1)(1997-4#1)(2008-7#1)(2008-9#1)
transcription activators##2##2##(1990-12#1)(2008-9#1)
transcription activity##2##2##(1996-10#1)(2010-5#1)
transcription and analysis of the##2##5##(1993-9#1)(1996-3#1)
transcription and protein##2##3##(1995-12#1)(2008-8#1)
transcription and replication##2##3##(1994-8#1)(1997-2#1)
transcription and to##2##3##(1993-3#1)(1993-6#1)
transcription and translation of##3##4##(1990-11#1)(1990-12#1)(2008-11#1)
transcription and##36##2##(1990-11#1)(1990-12#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#2)(1995-12#3)(1995-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#2)
transcription assays##2##2##(1992-12#1)(1994-8#1)
transcription at or near##2##4##(1994-11#2)
transcription at##3##2##(1994-11#2)(1995-2#1)
transcription bubble&quot##2##2##(1995-2#2)
transcription but##2##2##(1994-8#1)(1995-2#1)
transcription by##20##2##(1990-5#2)(1992-8#3)(1993-6#1)(1994-11#1)(1995-3#1)(1995-6#3)(1996-2#2)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2011-2#1)(2013-1#1)
transcription complex##3##2##(1993-2#1)(1995-2#2)
transcription elongation##2##2##(2012-12#2)
transcription factor 1##2##3##(2009-3#1)(2010-5#1)
transcription factor FOXO1a and##2##4##(2010-11#2)
transcription factor NF-kappa B##3##4##(1995-2#1)(1995-6#1)(2008-9#1)
transcription factor binding sites##2##4##(1994-11#1)(2008-4#1)
transcription factor binding##4##3##(1992-9#1)(1994-11#1)(2008-4#1)(2008-9#1)
transcription factor controlling##2##3##(2012-2#2)
transcription factor genes##2##3##(2008-10#1)(2009-10#1)
transcription factor in##2##3##(1990-5#1)(2009-10#1)
transcription factor is##3##3##(1993-6#1)(2010-11#1)(2011-2#1)
transcription factor of the##2##4##(2006-8#1)(2010-8#1)
transcription factor that##3##3##(1994-11#1)(1996-12#1)(2013-1#1)
transcription factor##153##2##(1990-5#1)(1991-2#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#6)(1994-12#2)(1994-8#5)(1995-11#1)(1995-2#5)(1995-6#6)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-6#1)(1997-7#1)(2006-8#2)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#9)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#8)(2010-11#7)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
transcription factor)##2##2##(1995-2#1)(2011-2#1)
transcription factor-binding##2##2##(1993-6#1)(1994-12#1)
transcription factors (TFs)##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
transcription factors Myf5 and##2##4##(1996-2#1)(2009-3#1)
transcription factors and##11##3##(1993-12#1)(1995-2#1)(1997-3#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
transcription factors are##3##3##(2007-12#1)(2009-5#1)(2012-3#1)
transcription factors as##2##3##(1994-8#1)(2012-1#1)
transcription factors binding##4##3##(1990-5#1)(2008-7#1)(2008-9#2)
transcription factors by##2##3##(2008-11#1)(2009-8#1)
transcription factors can##2##3##(1994-3#1)(2011-1#1)
transcription factors from##2##3##(2008-7#2)
transcription factors in##3##3##(1991-1#1)(1993-2#1)(2008-9#1)
transcription factors is##4##3##(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
transcription factors may##2##3##(1995-12#1)(1995-2#1)
transcription factors of##3##3##(1994-12#1)(2008-1#1)(2013-8#1)
transcription factors regulating##2##3##(2011-1#1)(2013-7#1)
transcription factors such as##2##4##(1994-8#1)(2012-3#1)
transcription factors that regulate##3##4##(1995-8#1)(2008-3#1)(2011-2#1)
transcription factors that##11##3##(1994-9#1)(1995-8#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)
transcription factors to##3##3##(1994-3#1)(1994-9#1)(2011-2#1)
transcription factors were##2##3##(2008-11#2)
transcription factors which##3##3##(1993-9#1)(1997-7#1)(2008-7#1)
transcription factors with##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
transcription factors##152##2##(1990-5#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-12#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#4)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-8#2)(1996-12#3)(1996-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(2007-12#2)(2008-1#4)(2008-10#4)(2008-11#8)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#8)(2009-10#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#6)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#11)(2013-1#1)(2013-7#1)(2013-8#1)
transcription following##2##2##(1993-6#1)(2008-11#1)
transcription from a##3##3##(1990-11#1)(1993-6#1)(2008-9#1)
transcription from##9##2##(1990-11#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-4#2)(2008-9#1)(2012-3#1)
transcription in the##4##3##(1990-11#1)(1994-12#1)(2008-7#1)(2009-3#1)
transcription in vitro##2##3##(1990-12#1)(2008-5#1)
transcription in##24##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#1)(1997-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
transcription incentive##2##2##(1992-2#2)
transcription initiation and##2##3##(2008-2#1)(2008-4#1)
transcription initiation by##2##3##(1995-6#1)(1997-7#1)
transcription initiation site##6##3##(1990-12#1)(1991-9#1)(1993-3#1)(1994-11#1)(1995-2#1)(1997-7#1)
transcription initiation site)##2##3##(1995-6#1)(1997-3#1)
transcription initiation sites##2##3##(1996-5#2)
transcription initiation##20##2##(1990-12#1)(1991-9#2)(1992-6#1)(1993-3#1)(1994-11#1)(1995-2#3)(1995-6#2)(1996-5#2)(1997-3#2)(1997-7#2)(1997-8#1)(2008-2#1)(2008-4#1)
transcription is##18##2##(1991-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
transcription level##5##2##(1993-11#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-8#1)
transcription levels of##3##3##(1996-2#1)(1997-7#1)(2008-10#1)
transcription levels##8##2##(1996-2#1)(1997-7#2)(2008-10#3)(2009-12#1)(2012-12#1)
transcription machinery##3##2##(1995-6#1)(2009-3#1)(2013-1#1)
transcription may##2##2##(1993-12#1)(2011-2#1)
transcription observed##2##2##(1992-8#1)(1995-6#1)
transcription occurred##2##2##(1990-12#1)(2009-6#1)
transcription occurs in the##2##4##(1992-8#1)(2008-2#1)
transcription of XBP1##2##3##(2011-2#2)
transcription of a number of##2##5##(2011-1#2)
transcription of a##4##3##(1996-6#1)(2008-10#1)(2011-1#2)
transcription of an##3##3##(1995-8#1)(1997-7#1)(2008-5#1)
transcription of genes##5##3##(1991-9#1)(1995-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
transcription of several##2##3##(1996-2#1)(2008-10#1)
transcription of the PEPCK gene##2##5##(1995-6#1)(1996-2#1)
transcription of the Rex-1 gene##2##5##(1994-9#2)
transcription of the ada gene##3##5##(1991-9#3)
transcription of the gene encoding##2##5##(1994-8#1)(1995-6#1)
transcription of the human##2##4##(1992-8#1)(1997-7#1)
transcription of the##48##3##(1990-11#1)(1991-12#3)(1991-9#3)(1992-1#1)(1992-12#2)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-2#4)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-7#2)(1997-8#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-8#1)
transcription of##113##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#2)(1992-8#2)(1993-12#2)(1993-3#1)(1993-6#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-8#4)(1994-9#4)(1995-11#2)(1995-2#6)(1995-6#6)(1995-8#4)(1996-12#3)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#2)(2008-1#1)(2008-10#7)(2008-11#6)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#8)(2010-10#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)
transcription or##5##2##(1992-12#1)(1992-3#1)(1994-8#1)(2010-10#1)(2012-3#1)
transcription polymerase chain reaction (RT-PCR)##9##5##(1993-8#1)(1995-11#1)(1996-12#1)(2007-10#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
transcription polymerase chain reaction and##2##5##(2008-10#2)
transcription polymerase chain reaction##15##4##(1993-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-10#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
transcription products##2##2##(1994-6#1)(2008-4#1)
transcription rates of##2##3##(2008-10#2)
transcription rates##3##2##(1991-12#1)(2008-10#2)
transcription regulation##3##2##(1994-8#1)(2008-7#1)(2008-9#1)
transcription regulator##2##2##(2010-10#1)(2011-1#1)
transcription sites of rRNA genes##2##5##(2008-8#2)
transcription sites##3##2##(2008-8#3)
transcription start point (tsp) of##2##5##(1993-12#1)(1993-6#1)
transcription start point (tsp)##10##4##(1991-6#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#3)
transcription start point of##2##4##(1993-9#1)(1997-4#1)
transcription start point##20##3##(1990-11#1)(1990-5#1)(1991-6#3)(1991-9#2)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#2)(1994-12#3)(1997-4#1)(1997-6#1)
transcription start points##4##3##(1990-11#1)(1991-9#1)(1993-2#1)(1993-6#1)
transcription start site was located##2##5##(1997-6#1)(2008-9#1)
transcription start site was##4##4##(1991-7#2)(1997-6#1)(2008-9#1)
transcription start site##12##3##(1991-11#1)(1991-7#2)(1994-8#2)(1995-11#1)(1995-2#2)(1997-2#1)(1997-6#1)(2008-9#2)
transcription start sites##3##3##(1993-8#1)(1994-11#1)(2008-4#1)
transcription start##41##2##(1990-11#3)(1990-5#1)(1991-11#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-9#3)(1993-12#3)(1993-2#3)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-8#2)(1995-11#1)(1995-2#2)(1997-2#1)(1997-4#1)(1997-6#2)(2008-4#1)(2008-9#2)
transcription termination at T1##2##4##(1997-2#2)
transcription termination##5##2##(1990-5#1)(1997-2#3)(2008-11#1)
transcription terminators##4##2##(1990-5#1)(1994-12#1)(1994-5#1)(2008-7#1)
transcription through##2##2##(1995-2#1)(1995-6#1)
transcription to the same extent##2##5##(1995-8#1)(2012-12#1)
transcription to##6##2##(1995-8#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
transcription under##2##2##(1992-12#1)(1994-12#1)
transcription units##2##2##(1993-6#2)
transcription was not##3##3##(1995-8#1)(2008-7#1)(2011-2#1)
transcription was##11##2##(1993-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#2)
transcription were##2##2##(1990-7#1)(1995-2#1)
transcription when##3##2##(1991-10#1)(1993-12#1)(1994-2#1)
transcription with##3##2##(1992-9#1)(1993-11#1)(2008-10#1)
transcription##918##1##(1990-11#7)(1990-12#7)(1990-5#12)(1990-7#2)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#2)(1991-5#6)(1991-6#3)(1991-7#2)(1991-9#13)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#15)(1992-2#2)(1992-3#6)(1992-6#5)(1992-8#11)(1992-9#4)(1993-11#2)(1993-12#14)(1993-2#8)(1993-3#4)(1993-6#21)(1993-8#6)(1993-9#12)(1994-10#2)(1994-11#22)(1994-12#22)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#26)(1994-9#9)(1995-11#7)(1995-12#4)(1995-2#45)(1995-3#4)(1995-5#2)(1995-6#26)(1995-8#12)(1995-9#1)(1996-10#1)(1996-12#10)(1996-2#14)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#12)(1997-3#5)(1997-4#7)(1997-6#6)(1997-7#15)(1997-8#4)(1997-9#1)(2006-8#2)(2007-10#2)(2007-12#6)(2007-6#1)(2007-8#1)(2007-9#4)(2008-1#7)(2008-10#30)(2008-11#41)(2008-2#6)(2008-3#2)(2008-4#23)(2008-5#6)(2008-6#10)(2008-7#28)(2008-8#25)(2008-9#44)(2009-10#5)(2009-12#1)(2009-3#6)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#18)(2010-1#2)(2010-10#7)(2010-11#13)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#16)(2011-2#42)(2012-1#4)(2012-12#18)(2012-2#19)(2012-3#20)(2013-1#13)(2013-7#1)(2013-8#3)
transcription)##5##1##(1992-3#1)(1996-2#1)(2008-1#1)(2009-3#1)(2012-2#1)
transcription-PCR##9##1##(1993-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-9#3)(2010-11#1)(2013-8#1)
transcription-coupled repair##3##2##(1994-8#1)(2008-11#2)
transcription-coupled##4##1##(1994-8#2)(2008-11#2)
transcription-polymerase chain reaction (RT-PCR) with##2##5##(1997-7#1)(2008-10#1)
transcription-polymerase chain reaction (RT-PCR)##25##4##(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-9#1)(2010-1#1)
transcription-polymerase chain reaction and##4##4##(1995-12#1)(2008-10#3)
transcription-polymerase chain reaction using##4##4##(1997-7#1)(2008-10#2)(2008-7#1)
transcription-polymerase chain reaction##59##3##(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#32)(2008-11#2)(2008-7#1)(2008-9#2)(2010-1#1)(2011-2#2)(2013-1#2)
transcription-polymerase chain reactions##2##3##(2008-10#2)
transcription-polymerase chain##63##2##(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#34)(2008-11#2)(2008-7#1)(2008-9#3)(2010-1#1)(2011-2#2)(2013-1#2)
transcription-polymerase##64##1##(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#2)(2008-10#34)(2008-11#3)(2008-7#1)(2008-9#3)(2010-1#1)(2011-2#2)(2013-1#2)
transcription-translation##3##1##(1991-12#1)(1991-9#1)(1995-6#1)
transcription/translation system##2##2##(1994-12#1)(1997-2#1)
transcription/translation##4##1##(1994-12#1)(1996-12#1)(1997-2#1)(2008-1#1)
transcriptional activation and##2##3##(2011-2#2)
transcriptional activation by##4##3##(1993-8#2)(1993-9#1)(1994-9#1)
transcriptional activation in##2##3##(1994-11#1)(1997-2#1)
transcriptional activation is##2##3##(1994-11#2)
transcriptional activation of a##2##4##(1993-3#1)(1995-11#1)
transcriptional activation of ori lambda##2##5##(1994-11#2)
transcriptional activation of the##2##4##(1992-12#1)(1995-8#1)
transcriptional activation of##14##3##(1990-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-11#2)(1995-11#2)(1995-8#1)(1996-12#2)(2008-10#1)(2009-8#2)
transcriptional activation##34##2##(1990-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#6)(1994-8#1)(1994-9#1)(1995-11#2)(1995-8#3)(1996-12#2)(1997-2#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
transcriptional activator (TAT)##2##3##(2009-6#1)(2010-10#1)
transcriptional activator of##2##3##(1990-11#1)(2008-11#1)
transcriptional activator##15##2##(1990-11#1)(1991-5#2)(1992-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#1)
transcriptional activators of##2##3##(1991-12#1)(2008-7#1)
transcriptional activators##5##2##(1991-12#1)(1994-12#1)(1996-2#2)(2008-7#1)
transcriptional activity in##4##3##(1992-12#1)(1994-11#1)(1995-2#1)(2012-3#1)
transcriptional activity of the##2##4##(1992-8#1)(2012-12#1)
transcriptional activity of##11##3##(1992-8#1)(1995-6#1)(1995-8#2)(1996-5#1)(2008-11#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-7#1)
transcriptional activity was##2##3##(1993-12#1)(2011-2#1)
transcriptional activity##33##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-9#1)(1997-4#1)(2008-11#2)(2008-5#2)(2008-8#2)(2009-10#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#6)(2013-7#1)
transcriptional and post-transcriptional levels##3##4##(1991-6#1)(2008-4#1)(2009-8#1)
transcriptional and post-transcriptional##4##3##(1991-6#1)(1995-6#1)(2008-4#1)(2009-8#1)
transcriptional and translational##5##3##(1990-5#1)(1993-2#1)(1993-8#1)(1997-4#1)(2008-5#1)
transcriptional and##14##2##(1990-5#1)(1991-6#1)(1993-2#1)(1993-8#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
transcriptional changes##6##2##(1996-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-2#2)
transcriptional co-activator##3##2##(2011-2#1)(2013-1#2)
transcriptional control elements##2##3##(1993-12#1)(1993-2#1)
transcriptional control of a##2##4##(1995-2#1)(2008-7#1)
transcriptional control of the##4##4##(1993-8#1)(1994-12#1)(1997-3#1)(2010-10#1)
transcriptional control of##10##3##(1992-9#1)(1993-8#1)(1994-12#2)(1995-2#1)(1997-3#1)(2008-7#2)(2010-10#1)(2011-2#1)
transcriptional control##18##2##(1990-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#3)(1995-2#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-2#1)
transcriptional enhancer##2##2##(1992-12#1)(1993-11#1)
transcriptional enhancers##2##2##(2008-8#2)
transcriptional events##3##2##(1995-11#1)(2009-8#1)(2010-1#1)
transcriptional expression##2##2##(2008-8#1)(2010-10#1)
transcriptional factor and##2##3##(2008-9#2)
transcriptional factor that##2##3##(2008-6#1)(2013-1#1)
transcriptional factor##11##2##(1993-2#1)(1993-3#2)(1997-8#1)(2008-6#1)(2008-9#4)(2012-2#1)(2013-1#1)
transcriptional factors##8##2##(1994-6#1)(1996-10#1)(2008-5#2)(2008-9#3)(2012-2#1)
transcriptional fusion##4##2##(1993-12#1)(1994-12#1)(2008-10#2)
transcriptional induction of the##4##4##(1994-8#1)(1994-9#1)(2008-11#1)(2011-1#1)
transcriptional induction of##7##3##(1994-8#1)(1994-9#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
transcriptional inhibition##2##2##(1991-2#1)(1992-12#1)
transcriptional initiation sites##2##3##(1993-3#1)(1993-8#1)
transcriptional initiation##8##2##(1992-12#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#2)(2008-4#1)(2008-9#1)
transcriptional interference##2##2##(1994-11#1)(2011-2#1)
transcriptional level and##2##3##(2008-9#1)(2012-12#1)
transcriptional level in##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
transcriptional level of##3##3##(1997-4#2)(2012-12#1)
transcriptional level##21##2##(1991-12#1)(1994-9#1)(1995-8#1)(1997-4#2)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
transcriptional machinery##4##2##(2008-6#1)(2010-11#2)(2013-1#1)
transcriptional network##2##2##(2009-8#2)
transcriptional networks##4##2##(2008-3#1)(2009-8#2)(2012-12#1)
transcriptional orientation##4##2##(1991-9#1)(1996-3#1)(1997-6#1)(2008-8#1)
transcriptional process##2##2##(1996-12#1)(2011-3#1)
transcriptional profiles##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
transcriptional regulation and##4##3##(1995-2#1)(1996-10#1)(2008-10#1)(2008-7#1)
transcriptional regulation by##2##3##(1992-12#1)(2012-2#1)
transcriptional regulation of human##2##4##(1991-12#1)(1993-8#1)
transcriptional regulation of the##5##4##(1993-6#1)(1997-1#1)(2008-11#2)(2008-7#1)
transcriptional regulation of##16##3##(1991-12#1)(1993-6#1)(1993-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
transcriptional regulation##38##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2010-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
transcriptional regulator##5##2##(1990-5#1)(1994-10#1)(2008-11#1)(2009-8#1)(2012-2#1)
transcriptional regulators##5##2##(1991-5#1)(1997-4#2)(2008-7#1)(2010-10#1)
transcriptional regulatory elements##3##3##(1993-12#2)(1993-6#1)
transcriptional regulatory##8##2##(1991-10#1)(1992-3#1)(1993-12#2)(1993-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
transcriptional reporter gene assay for##2##5##(2010-2#2)
transcriptional repression##2##2##(1996-2#1)(2012-3#1)
transcriptional repressor##4##2##(1991-10#1)(1995-6#1)(2008-7#1)(2009-6#1)
transcriptional repressors##2##2##(1991-5#1)(2009-8#1)
transcriptional response to##2##3##(1994-8#1)(2010-7#1)
transcriptional response##4##2##(1994-8#2)(2010-7#1)(2011-2#1)
transcriptional responses to##2##3##(1991-7#1)(2012-12#1)
transcriptional responses##3##2##(1991-7#1)(2012-12#1)(2012-2#1)
transcriptional silencing of##2##3##(2009-3#1)(2012-12#1)
transcriptional silencing##7##2##(2008-4#1)(2009-3#3)(2010-3#1)(2012-12#2)
transcriptional start site##5##3##(1994-11#1)(1995-11#1)(1995-6#2)(1996-12#1)
transcriptional start sites##5##3##(1990-11#1)(1993-3#1)(1994-11#2)(2008-4#1)
transcriptional start##11##2##(1990-11#1)(1991-2#1)(1993-3#1)(1994-11#3)(1995-11#1)(1995-6#2)(1996-12#1)(2008-4#1)
transcriptional trans-activating factors##2##3##(2008-9#2)
transcriptional trans-activating##3##2##(2008-9#3)
transcriptional unit##3##2##(1993-2#1)(2008-10#2)
transcriptional units##2##2##(2008-7#2)
transcriptional variant originates##2##3##(1993-11#2)
transcriptional##369##1##(1990-11#5)(1990-5#4)(1991-10#2)(1991-12#3)(1991-2#3)(1991-5#5)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#8)(1992-3#2)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#5)(1993-6#2)(1993-8#8)(1993-9#1)(1994-10#1)(1994-11#11)(1994-12#6)(1994-2#1)(1994-6#1)(1994-8#6)(1994-9#4)(1995-11#4)(1995-2#6)(1995-6#9)(1995-8#11)(1996-10#2)(1996-12#7)(1996-2#4)(1996-3#3)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#8)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#18)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#16)(2008-8#9)(2008-9#19)(2009-10#3)(2009-3#3)(2009-5#1)(2009-6#3)(2009-8#13)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#11)(2012-2#13)(2012-3#13)(2013-1#12)(2013-7#1)
transcriptionally activated##3##2##(1990-11#1)(1996-3#1)(2009-8#1)
transcriptionally active##10##2##(1990-7#3)(1994-12#2)(1995-6#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
transcriptionally##25##1##(1990-11#1)(1990-7#3)(1993-2#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-6#1)(1996-3#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
transcriptions##2##1##(2008-1#1)(2008-4#1)
transcriptome analysis of##2##3##(2009-12#1)(2013-1#1)
transcriptome analysis##8##2##(2008-7#1)(2009-12#2)(2009-8#2)(2011-2#1)(2013-1#2)
transcriptome and##2##2##(2008-10#1)(2008-7#1)
transcriptome level##3##2##(2011-2#2)(2012-2#1)
transcriptome meta-analysis##2##2##(2009-10#2)
transcriptome of##2##2##(2009-10#1)(2010-7#1)
transcriptome studies##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
transcriptome##34##1##(2008-10#1)(2008-7#5)(2009-10#4)(2009-12#4)(2009-8#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#4)(2013-8#4)
transcriptomes in##2##2##(2008-7#1)(2012-2#1)
transcriptomes of##2##2##(2008-7#2)
transcriptomes##6##1##(2008-7#4)(2009-10#1)(2012-2#1)
transcriptomic##6##1##(2008-7#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
transcriptomics##2##1##(2008-7#1)(2011-2#1)
transcripts (7##2##2##(1993-3#1)(1994-11#1)
transcripts accumulated##2##2##(2008-8#1)(2008-9#1)
transcripts and##11##2##(1992-12#1)(1997-2#1)(1997-6#4)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
transcripts are##9##2##(1993-6#1)(1994-11#2)(1994-12#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
transcripts derived from##3##3##(1997-2#1)(2008-10#2)
transcripts encoding##2##2##(2008-10#2)
transcripts expressed in##2##3##(1997-1#1)(2008-10#1)
transcripts for##7##2##(1991-12#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
transcripts from the##2##3##(1994-11#1)(2011-1#1)
transcripts from##8##2##(1992-11#1)(1992-6#1)(1994-11#1)(2007-4#1)(2008-10#2)(2011-1#1)(2012-2#1)
transcripts have also been##2##4##(1995-11#1)(2010-4#1)
transcripts in human##2##3##(1992-9#1)(2008-7#1)
transcripts in the##3##3##(1996-8#1)(2008-9#2)
transcripts in wild-type##2##3##(1990-5#1)(2012-3#1)
transcripts in##24##2##(1990-5#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-9#2)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
transcripts may be##2##3##(1997-7#1)(2008-10#1)
transcripts observed in the##2##4##(1992-9#1)(2008-10#1)
transcripts of mrr##2##3##(2008-11#2)
transcripts of the##9##3##(1990-8#1)(1992-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-6#1)(2008-8#2)
transcripts of##27##2##(1990-8#1)(1991-12#2)(1991-2#2)(1992-5#1)(1993-3#1)(1993-9#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-10#5)(2008-11#5)(2008-6#1)(2008-8#3)(2012-2#1)
transcripts revealed##2##2##(2008-9#1)(2009-5#1)
transcripts that##3##2##(1996-10#1)(2007-4#1)(2008-7#1)
transcripts to##3##2##(1993-3#1)(2008-10#1)(2008-11#1)
transcripts was##6##2##(1990-12#2)(1991-9#1)(2008-10#2)(2008-8#1)
transcripts were analyzed##2##3##(1993-2#1)(2008-10#1)
transcripts were detectable##2##3##(1997-8#1)(2008-5#1)
transcripts were detected in##3##4##(1992-9#1)(2008-11#1)(2011-2#1)
transcripts were detected##5##3##(1992-9#1)(1994-11#1)(2008-11#1)(2009-7#1)(2011-2#1)
transcripts were expressed in##2##4##(1991-11#1)(1997-7#1)
transcripts were first detected##2##4##(1993-3#1)(1995-11#1)
transcripts were localized##2##3##(1992-9#1)(1997-4#1)
transcripts were##31##2##(1991-11#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#3)(1994-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
transcripts with the##3##3##(1997-2#1)(2008-11#1)(2008-8#1)
transcripts with##9##2##(1997-2#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)
transcripts within##2##2##(1992-8#1)(2008-4#1)
transcripts##259##1##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#9)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#11)(1994-12#3)(1994-2#3)(1994-8#1)(1994-9#4)(1995-11#3)(1995-12#4)(1995-6#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#2)(1997-4#1)(1997-6#7)(1997-7#10)(1997-8#2)(2007-11#1)(2007-4#6)(2008-1#1)(2008-10#35)(2008-11#11)(2008-12#1)(2008-2#3)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#7)(2009-10#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#5)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-2#11)(2012-3#7)(2013-1#5)(2013-8#1)
transcritical##2##1##(2008-8#2)
transcultural encounters##2##2##(2008-11#1)(2010-8#1)
transcultural##3##1##(2008-11#2)(2010-8#1)
transcutaneous electrical nerve##2##3##(1995-12#1)(2010-1#1)
transcutaneous electrical##3##2##(1995-12#1)(2010-1#1)(2012-3#1)
transcutaneous oxygen pressure##2##3##(2013-1#2)
transcutaneous##12##1##(1992-8#1)(1995-12#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
transcytosis##8##1##(1995-2#2)(2008-1#1)(2009-10#3)(2009-12#1)(2012-2#1)
transdermal administration of nicotine##3##4##(2008-3#3)
transdermal delivery##2##2##(2008-5#1)(2010-12#1)
transdermal granisetron##5##2##(2010-12#5)
transdermal patch##2##2##(2011-2#2)
transdermal##24##1##(1992-8#2)(1994-9#1)(2007-10#2)(2008-3#4)(2008-5#1)(2008-8#1)(2010-12#10)(2011-2#2)(2013-8#1)
transdiaphragmatic##2##1##(2008-10#1)(2012-3#1)
transdifferentiation of##3##2##(2009-3#1)(2012-7#1)(2013-8#1)
transdifferentiation##5##1##(2008-10#1)(2009-3#1)(2012-12#1)(2012-7#1)(2013-8#1)
transdisciplinary##2##1##(2008-1#1)(2008-11#1)
transduce a##3##2##(2008-11#2)(2008-5#1)
transduce exogenous genepCEP-p21 ( WAF-1 ) into##2##7##(2008-8#2)
transduce signals##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
transduce the##2##2##(1993-3#1)(1993-9#1)
transduce##17##1##(1992-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#1)
transduced cells##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
transduced to##2##2##(2008-11#1)(2011-2#1)
transduced with##5##2##(1994-5#3)(2008-9#2)
transduced##24##1##(1993-11#1)(1993-6#1)(1994-5#4)(1997-4#3)(1997-8#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2011-2#1)(2012-12#1)
transducer (LSST) for##2##3##(2008-10#2)
transducer and activator of transcription##3##5##(2008-8#1)(2012-3#1)(2013-1#1)
transducer and activator of##4##4##(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#1)
transducer and the##2##3##(2008-10#2)
transducer and##11##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-3#1)(2013-1#1)
transducer array##2##2##(2007-12#1)(2008-3#1)
transducer for##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
transducer in##2##2##(2008-3#1)(2009-8#1)
transducer of the##3##3##(1995-2#1)(2008-9#1)(2009-5#1)
transducer of##7##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-5#1)
transducer was##3##2##(2008-10#2)(2009-5#1)
transducer were used##2##3##(2007-5#1)(2011-2#1)
transducer##63##1##(1990-9#1)(1995-2#1)(1996-2#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#11)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-2#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
transducers and activators of transcription (STAT)##3##6##(2011-2#2)(2012-3#1)
transducers and activators of transcription##6##5##(1996-2#1)(2009-3#1)(2011-2#3)(2012-3#1)
transducers and activators of##8##4##(1996-2#1)(2008-1#1)(2009-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
transducers and##9##2##(1996-2#1)(2008-1#1)(2009-1#1)(2009-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
transducers for##2##2##(2008-10#1)(2009-5#1)
transducers of cold stimuli##2##4##(2008-8#2)
transducers of##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
transducers that##3##2##(1993-12#1)(2008-7#1)(2010-4#1)
transducers were##2##2##(2007-5#1)(2008-10#1)
transducers##46##1##(1990-8#1)(1993-12#1)(1996-12#3)(1996-2#1)(2007-5#1)(2008-1#1)(2008-10#12)(2008-3#3)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#6)(2010-4#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
transduces##2##1##(2012-2#1)(2013-1#1)
transducible##3##1##(2008-1#2)(2008-11#1)
transducin##3##1##(1992-9#1)(1993-3#1)(2008-10#1)
transducing material for##2##3##(2008-10#2)
transducing##13##1##(1991-6#1)(1993-8#2)(1994-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)
transduction and##13##2##(1991-9#1)(1992-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-9#2)(2010-11#1)(2010-4#1)(2012-1#1)
transduction by##5##2##(1992-12#1)(1994-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
transduction chain for##2##3##(2008-3#1)(2008-4#1)
transduction chain##3##2##(2008-3#1)(2008-4#2)
transduction component##2##2##(1992-3#1)(2008-9#1)
transduction during##2##2##(2008-8#1)(2008-9#1)
transduction efficiency##2##2##(2008-11#1)(2011-3#1)
transduction has been##2##3##(1991-2#2)
transduction has##3##2##(1991-2#2)(2008-4#1)
transduction in##20##2##(1991-2#2)(1991-9#1)(1993-6#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-4#2)(2008-10#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-3#1)(2013-1#1)
transduction of a##3##3##(2008-1#1)(2008-4#1)(2008-8#1)
transduction of insulin##2##3##(1991-12#1)(1994-11#1)
transduction of signals##3##3##(1992-3#1)(1995-2#1)(2008-8#1)
transduction of the##5##3##(1990-12#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-8#1)
transduction of##31##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#3)(2008-9#1)(2010-10#2)(2010-5#1)(2013-1#1)
transduction pathway##23##2##(1991-12#1)(1992-8#1)(1993-6#1)(1994-11#3)(1994-3#1)(1995-8#2)(1997-2#1)(1997-7#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2009-4#1)(2011-3#1)
transduction pathways leading to##3##4##(1992-12#1)(2008-4#1)(2009-6#1)
transduction pathways that##2##3##(1992-2#1)(1994-8#1)
transduction pathways##38##2##(1992-12#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
transduction system in##2##3##(1992-8#1)(1995-8#1)
transduction system##4##2##(1992-12#1)(1992-8#1)(1994-6#1)(1995-8#1)
transduction was##2##2##(1997-2#1)(2008-9#1)
transduction with a reverse fragment to a cDNA encoding human 6A8 alpha-mannosidase##2##12##(2008-8#2)
transduction with##4##2##(1990-11#2)(2008-8#2)
transduction##257##1##(1990-11#3)(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#4)(1991-9#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-8#4)(1993-11#1)(1993-3#1)(1993-6#5)(1993-8#3)(1994-11#7)(1994-12#2)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#2)(1995-2#7)(1995-5#1)(1995-6#2)(1995-8#6)(1996-10#1)(1996-12#1)(1996-2#5)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-7#3)(1997-8#1)(2007-12#3)(2008-1#3)(2008-10#16)(2008-11#15)(2008-2#2)(2008-3#3)(2008-4#19)(2008-5#4)(2008-7#7)(2008-8#17)(2008-9#11)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#4)(2010-11#3)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#5)
transductional##2##1##(2008-11#1)(2008-6#1)
transect from##2##2##(2008-10#1)(2008-2#1)
transect##11##1##(2008-10#5)(2008-2#2)(2008-5#2)(2013-7#2)
transected##5##1##(1990-5#1)(2008-7#1)(2008-9#1)(2013-1#2)
transection of the fornix##2##4##(1991-5#1)(1992-11#1)
transection of the##5##3##(1991-5#1)(1992-11#1)(2008-11#1)(2009-3#1)(2012-3#1)
transection of##6##2##(1991-5#1)(1992-11#1)(1993-3#1)(2008-11#1)(2009-3#1)(2012-3#1)
transection##23##1##(1991-5#2)(1992-11#1)(1993-3#2)(1996-12#5)(2008-10#2)(2008-11#1)(2008-9#2)(2009-2#1)(2009-3#1)(2012-3#1)(2013-1#5)
transections##6##1##(1991-5#2)(1996-12#1)(2008-3#2)(2008-7#1)
transects from the##2##3##(2008-5#1)(2013-7#1)
transects in##2##2##(2008-11#1)(2008-9#1)
transects were##2##2##(2008-10#1)(2013-7#1)
transects##14##1##(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-9#1)(2013-7#5)
transendothelial migration by##2##3##(1995-2#1)(2008-5#1)
transendothelial migration##9##2##(1995-2#4)(2008-5#1)(2009-10#1)(2012-1#3)
transendothelial##10##1##(1995-2#4)(2008-5#1)(2009-10#1)(2012-1#3)(2013-8#1)
transepidermal water loss (TEWL) and##2##5##(2008-5#2)
transepidermal water loss (TEWL) were##2##5##(2008-5#1)(2012-2#1)
transepidermal water loss (TEWL)##9##4##(2008-5#8)(2012-2#1)
transepidermal water loss##13##3##(2008-5#12)(2012-2#1)
transepidermal##14##1##(2008-5#13)(2012-2#1)
transepithelial electrical resistance (TER)##2##4##(2008-11#2)
transepithelial electrical resistance##4##3##(1994-6#1)(2008-11#2)(2008-12#1)
transepithelial electrical##5##2##(1994-6#1)(2008-11#2)(2008-12#2)
transepithelial potential difference##3##3##(2008-12#1)(2008-5#1)(2008-6#1)
transepithelial potential##4##2##(1991-5#1)(2008-12#1)(2008-5#1)(2008-6#1)
transepithelial##12##1##(1991-5#1)(1994-6#1)(2007-12#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#2)(2011-2#1)
transesophageal echocardiogram##4##2##(2009-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
transesophageal echocardiography (TEE)##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
transesophageal echocardiography in##2##3##(1996-6#1)(2013-7#1)
transesophageal echocardiography##18##2##(1996-6#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#3)(2009-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
transesophageal##26##1##(1996-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
transesterification and##2##2##(2008-7#2)
transesterification of vegetable oils in excess methanol##3##7##(2013-1#3)
transesterification of##6##2##(2008-10#1)(2008-6#1)(2010-4#1)(2013-1#3)
transesterification reaction##3##2##(2008-10#2)(2013-1#1)
transesterification reactions##2##2##(2009-9#1)(2013-1#1)
transesterification##17##1##(2008-10#3)(2008-6#3)(2008-7#4)(2009-9#1)(2010-4#1)(2013-1#5)
transexuality##2##1##(2013-1#2)
transfectable##2##1##(1994-5#1)(2008-11#1)
transfectant (p&lt##2##2##(2008-9#2)
transfectant##16##1##(1991-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-3#2)(2008-9#7)
transfectants of##2##2##(1997-9#1)(2008-11#1)
transfectants were##2##2##(1992-9#1)(1993-8#1)
transfectants##27##1##(1992-9#2)(1993-1#5)(1993-11#1)(1993-8#3)(1994-10#1)(1994-3#1)(1997-9#1)(2008-11#10)(2008-2#1)(2008-6#1)(2010-2#1)
transfected CHO cells##3##3##(1995-3#1)(2008-11#2)
transfected CHO##4##2##(1995-3#1)(2008-11#3)
transfected COS cells##2##3##(1994-6#1)(2008-2#1)
transfected COS-7 cells##2##3##(1992-9#1)(1993-3#1)
transfected COS-7##3##2##(1992-9#1)(1993-3#1)(1995-11#1)
transfected Chinese hamster ovary cells##2##5##(1995-12#1)(1995-2#1)
transfected Chinese hamster ovary##3##4##(1992-12#1)(1995-12#1)(1995-2#1)
transfected Chinese hamster##4##3##(1992-12#1)(1995-12#1)(1995-2#1)(2008-11#1)
transfected DNA##3##2##(1995-2#1)(2008-2#2)
transfected Drosophila S2 cells##2##4##(2008-11#2)
transfected Drosophila##3##2##(1994-8#1)(2008-11#2)
transfected PC12 cells##3##3##(1990-5#2)(1992-9#1)
transfected PC12##4##2##(1990-5#2)(1992-9#1)(1995-2#1)
transfected PG##2##2##(2008-8#2)
transfected by##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
transfected cell lines##5##3##(1994-2#1)(2008-11#2)(2008-2#2)
transfected cell##6##2##(1994-2#1)(2008-11#3)(2008-2#2)
transfected cells in##2##3##(1992-9#1)(2008-11#1)
transfected cells was##3##3##(1993-9#2)(2008-11#1)
transfected cells##36##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-5#1)(2008-11#8)(2008-2#2)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#2)
transfected human##6##2##(1991-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-12#1)(2008-8#1)
transfected into Chinese hamster ovary (CHO) cells##2##7##(2008-11#1)(2008-4#1)
transfected into a##3##3##(1991-2#1)(1991-6#1)(1994-6#1)
transfected into##24##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-3#2)(1994-6#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#2)(2011-2#1)
transfected mammalian cells##2##3##(2008-11#1)(2008-2#1)
transfected to##2##2##(1995-2#1)(2008-9#1)
transfected with PD-L1##2##3##(2012-3#2)
transfected with a vector##2##4##(2008-11#1)(2008-7#1)
transfected with a##9##3##(1992-9#1)(1994-2#1)(1995-12#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)
transfected with full-length##2##3##(1992-9#1)(1993-1#1)
transfected with sense construct##2##4##(2008-8#2)
transfected with the gene##2##4##(1995-11#1)(2008-5#1)
transfected with the human##5##4##(1993-11#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-4#1)
transfected with the##24##3##(1993-11#1)(1993-3#1)(1994-11#3)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2008-8#2)(2013-1#1)
transfected with troutCYP1A-CAT##2##3##(2008-11#2)
transfected with##97##2##(1990-12#1)(1992-12#4)(1992-9#3)(1993-1#2)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#6)(1994-2#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-2#1)(1996-5#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-11#19)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#3)
transfected##265##1##(1990-11#1)(1990-12#1)(1990-5#5)(1990-8#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#6)(1992-3#1)(1992-8#1)(1992-9#7)(1993-1#3)(1993-11#1)(1993-3#7)(1993-6#2)(1993-8#1)(1993-9#4)(1994-11#6)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#5)(1994-8#9)(1994-9#3)(1995-11#4)(1995-12#3)(1995-2#13)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#4)(1997-4#1)(1997-7#2)(1997-9#1)(2008-1#1)(2008-10#4)(2008-11#51)(2008-2#10)(2008-3#3)(2008-4#10)(2008-5#7)(2008-7#3)(2008-8#19)(2008-9#11)(2009-8#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#4)
transfecting##10##1##(1997-7#2)(2008-11#6)(2008-8#1)(2008-9#1)
transfection activity of the lipopolylysine##3##5##(1991-5#3)
transfection activity##4##2##(1991-5#4)
transfection and##6##2##(2008-11#4)(2008-2#1)(2008-9#1)
transfection assays with##2##3##(1992-8#1)(1993-6#1)
transfection assays##9##2##(1991-10#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-7#1)
transfection by##2##2##(1994-9#1)(2008-9#1)
transfection can be##2##3##(2008-1#1)(2008-11#1)
transfection can##3##2##(1996-12#1)(2008-1#1)(2008-11#1)
transfection complexes were##2##3##(2008-11#2)
transfection conditions##2##2##(2008-1#1)(2008-2#1)
transfection efficiencies of##2##3##(2008-11#2)
transfection efficiencies##4##2##(2008-11#4)
transfection efficiency and##2##3##(2008-11#2)
transfection efficiency in##2##3##(2008-11#2)
transfection efficiency of the##2##4##(2008-11#1)(2011-1#1)
transfection efficiency of##6##3##(2008-11#4)(2008-9#1)(2011-1#1)
transfection efficiency##19##2##(2008-1#3)(2008-11#12)(2008-2#1)(2008-9#2)(2011-1#1)
transfection experiments##7##2##(1992-9#1)(1993-3#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-6#2)
transfection fate##2##2##(2008-11#2)
transfection has been##2##3##(1996-2#1)(2011-1#1)
transfection has##3##2##(1996-2#1)(2008-9#1)(2011-1#1)
transfection in##6##2##(1991-5#2)(1991-9#1)(1996-12#1)(1996-2#1)(2008-11#1)
transfection into##5##2##(1990-12#1)(1991-11#1)(1995-2#1)(1997-3#1)(2008-11#1)
transfection is##5##2##(2008-1#1)(2008-11#2)(2008-2#1)(2011-1#1)
transfection method##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
transfection methods##3##2##(2008-1#1)(2008-11#1)(2011-1#1)
transfection microarrays##2##2##(2008-7#2)
transfection of NIH 3T3##2##4##(1992-7#1)(1995-2#1)
transfection of a##3##3##(1997-1#1)(2008-11#1)(2008-2#1)
transfection of adherent##2##3##(2008-1#1)(2008-2#1)
transfection of the##4##3##(1990-5#1)(1993-11#1)(1995-6#1)(2008-11#1)
transfection of##32##2##(1990-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#3)(1995-6#1)(1996-12#1)(1997-1#1)(2008-1#3)(2008-11#8)(2008-2#3)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#3)
transfection reagent##3##2##(2008-11#2)(2008-7#1)
transfection reagents##3##2##(2008-11#3)
transfection studies##3##2##(1992-6#1)(1996-5#1)(1996-9#1)
transfection system based on##2##4##(1995-2#1)(2008-11#1)
transfection system##10##2##(1995-2#1)(2008-11#5)(2011-1#4)
transfection techniques##3##2##(2008-11#3)
transfection using the##2##3##(2008-1#1)(2008-11#1)
transfection was##3##2##(2008-11#3)
transfection with##6##2##(1994-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)
transfection##228##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#8)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#13)(1995-4#1)(1995-6#2)(1995-8#2)(1996-12#7)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#3)(2008-1#18)(2008-11#83)(2008-2#13)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#11)(2010-2#1)(2010-8#1)(2011-1#13)(2011-2#2)(2012-2#4)(2012-3#1)
transfections and##2##2##(1994-6#1)(2008-9#1)
transfections##11##1##(1993-6#1)(1994-6#1)(1995-2#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-9#2)(2013-1#1)
transfemoral approach##4##2##(2011-2#4)
transfemoral##6##1##(2011-2#4)(2013-1#2)
transfer RNA##3##2##(1993-1#1)(1993-8#1)(2008-9#1)
transfer a##3##2##(1993-1#1)(1993-2#1)(2013-8#1)
transfer across the##3##3##(1991-5#1)(2008-10#1)(2009-4#1)
transfer across##4##2##(1991-5#1)(2008-10#1)(2008-7#1)(2009-4#1)
transfer activity##4##2##(1995-2#1)(1995-5#3)
transfer agent##4##2##(2008-10#1)(2008-12#2)(2009-11#1)
transfer among##2##2##(2008-1#1)(2013-1#1)
transfer and expression of##3##4##(2008-5#1)(2008-8#1)(2008-9#1)
transfer and expression##5##3##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)
transfer and the##4##3##(1994-5#1)(2008-10#2)(2009-11#1)
transfer and##42##2##(1992-6#1)(1994-11#1)(1994-5#2)(1995-2#2)(1995-8#2)(1996-5#2)(2007-12#4)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#3)(2009-9#1)(2011-1#1)(2012-2#1)
transfer are##6##2##(1994-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
transfer as##2##2##(1994-8#1)(2008-10#1)
transfer at##4##2##(1990-8#1)(1992-6#1)(1995-5#1)(2007-12#1)
transfer between the##7##3##(1995-2#1)(1995-5#1)(2008-10#2)(2008-3#1)(2009-11#1)(2013-1#1)
transfer between two##3##3##(1991-5#1)(2007-11#1)(2012-2#1)
transfer between##37##2##(1990-7#1)(1991-5#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-12#2)(2007-11#3)(2008-10#9)(2008-3#1)(2008-7#2)(2008-8#3)(2009-11#2)(2009-6#1)(2010-10#1)(2010-5#1)(2012-2#5)(2013-1#2)
transfer by the##2##3##(1993-8#1)(2008-10#1)
transfer by##5##2##(1993-8#1)(1997-4#1)(2008-10#2)(2011-2#1)
transfer can be##3##3##(2008-12#1)(2012-12#1)(2012-3#1)
transfer can##8##2##(1992-6#1)(1995-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-3#1)
transfer cells##2##2##(2008-11#2)
transfer coefficient and##3##3##(2008-3#1)(2008-7#2)
transfer coefficient were##2##3##(2008-10#1)(2008-11#1)
transfer coefficient##18##2##(1991-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#8)
transfer coefficients##3##2##(1997-2#1)(1997-6#1)(2008-7#1)
transfer complexes##3##2##(2008-10#2)(2008-9#1)
transfer depends##2##2##(2008-10#1)(2013-8#1)
transfer efficiency and##2##3##(1997-8#1)(2008-9#1)
transfer efficiency of##2##3##(2008-10#1)(2010-10#1)
transfer efficiency##7##2##(1997-8#1)(2008-10#1)(2008-9#2)(2010-10#3)
transfer electrons##2##2##(2008-10#1)(2008-11#1)
transfer episodes##3##2##(1993-12#3)
transfer equation##18##2##(2007-12#2)(2008-2#10)(2008-3#5)(2008-7#1)
transfer excitor##2##2##(2008-5#2)
transfer experiments##5##2##(1996-6#1)(2008-11#2)(2008-4#1)(2008-8#1)
transfer for##8##2##(1994-5#2)(2008-10#2)(2008-11#1)(2008-6#2)(2008-9#1)
transfer from a##5##3##(2007-12#3)(2008-10#2)
transfer from melanocytes to keratinocytes##2##5##(2008-8#2)
transfer from one##3##3##(1994-6#1)(2010-5#1)(2012-2#1)
transfer from the##15##3##(1990-11#1)(1993-11#1)(1995-2#2)(2007-12#4)(2008-10#2)(2008-7#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
transfer from##45##2##(1990-11#2)(1991-12#2)(1992-8#2)(1993-11#3)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#2)(1997-7#1)(2007-11#1)(2007-12#7)(2008-10#8)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
transfer function for##5##3##(2008-10#1)(2008-3#4)
transfer function in##2##3##(2007-12#1)(2008-10#1)
transfer function is##2##3##(2008-3#2)
transfer function measurements of##2##4##(2008-3#2)
transfer function of a##2##4##(2008-2#2)
transfer function of the##2##4##(2008-2#1)(2008-3#1)
transfer function of##8##3##(2008-2#4)(2008-3#4)
transfer function that##2##3##(2008-2#1)(2008-3#1)
transfer function##49##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#17)(2008-3#22)(2008-8#1)(2008-9#1)(2011-2#2)
transfer function)##3##2##(2008-10#2)(2011-2#1)
transfer functions were used in the hidden and output layers##3##10##(2008-10#3)
transfer functions##13##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#5)(2011-2#1)
transfer groups##2##2##(1994-8#1)(1996-5#1)
transfer hydrogenation##2##2##(2010-7#2)
transfer in a##5##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
transfer in an##2##3##(2008-11#1)(2008-2#1)
transfer in rat##2##3##(1991-9#1)(1997-2#1)
transfer in the##18##3##(1991-5#4)(1992-6#1)(1993-11#2)(1996-2#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-8#2)(2009-3#1)
transfer in##61##2##(1991-5#4)(1991-9#3)(1992-6#2)(1992-8#1)(1993-11#2)(1994-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-2#2)(1997-2#2)(1997-4#1)(2008-10#9)(2008-11#3)(2008-2#7)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
transfer inhibitor##2##2##(2008-8#1)(2009-11#1)
transfer inhibitors effectively##2##3##(2009-11#2)
transfer into hematopoietic##2##3##(1994-5#1)(2008-5#1)
transfer into mammalian cells##2##4##(2008-8#1)(2009-3#1)
transfer into mammalian##3##3##(1991-9#1)(2008-8#1)(2009-3#1)
transfer into primary rat hepatocytes##3##5##(2008-9#3)
transfer into##21##2##(1991-9#1)(1994-5#3)(1994-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2010-11#1)
transfer is a##2##3##(2008-4#1)(2012-2#1)
transfer is##15##2##(1991-11#1)(1995-12#1)(1995-5#1)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
transfer kinetics of##2##3##(1990-5#1)(2008-8#1)
transfer matrices##3##2##(2008-2#1)(2008-3#2)
transfer matrix##3##2##(2007-12#1)(2008-2#1)(2009-11#1)
transfer mechanism##2##2##(1991-5#1)(2008-5#1)
transfer method##5##2##(2007-12#3)(2008-11#1)(2008-9#1)
transfer model in##2##3##(1993-11#1)(2009-11#1)
transfer model##20##2##(1993-11#1)(2008-2#7)(2008-3#11)(2009-11#1)
transfer models##4##2##(2008-2#1)(2008-3#3)
transfer occurred##5##2##(1992-3#1)(1995-11#1)(2008-10#2)(2008-3#1)
transfer occurs##3##2##(1993-11#1)(2008-10#2)
transfer of PGCs##4##3##(2008-11#4)
transfer of a##8##3##(1992-10#1)(1994-12#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
transfer of an##5##3##(1994-5#1)(2008-10#3)(2008-11#1)
transfer of bilirubin##2##3##(1992-3#2)
transfer of embryos##2##3##(1991-3#1)(2008-4#1)
transfer of knowledge##2##3##(2008-11#1)(2010-10#1)
transfer of the##33##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#3)(1996-5#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2013-1#1)
transfer of these##3##3##(1992-6#1)(1996-11#1)(2008-9#1)
transfer of this##2##3##(2008-10#1)(2009-10#1)
transfer of transposable elements##2##4##(2009-6#2)
transfer of##158##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#4)(1992-5#2)(1992-6#2)(1992-8#4)(1993-11#2)(1994-12#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#31)(2008-11#14)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#4)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#7)
transfer on the##2##3##(2008-10#1)(2008-2#1)
transfer on##3##2##(2008-10#2)(2008-2#1)
transfer pathway##2##2##(2008-10#2)
transfer patients##2##2##(1992-6#1)(1993-12#1)
transfer problem##3##2##(2008-2#1)(2008-3#2)
transfer procedures##2##2##(2008-10#1)(2008-9#1)
transfer process##9##2##(1992-3#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#2)
transfer processes##9##2##(1990-8#1)(2008-10#4)(2008-2#1)(2008-8#2)(2012-2#1)
transfer programmes##2##2##(1996-6#1)(1996-8#1)
transfer protein##12##2##(1992-7#1)(1995-5#3)(1995-8#1)(2008-12#6)(2008-4#1)
transfer proteins##2##2##(2008-3#1)(2008-6#1)
transfer protocols##2##2##(1996-2#1)(2008-11#1)
transfer radiometer##2##2##(2008-3#2)
transfer rate constant (k(s))##2##4##(2008-10#2)
transfer rate constant##6##3##(2008-10#6)
transfer rate constants##3##3##(1991-5#1)(2008-10#2)
transfer rate##17##2##(1991-5#1)(1991-8#1)(1993-11#1)(1994-11#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)
transfer reaction##5##2##(2008-10#4)(2009-6#1)
transfer reactions of##2##3##(1990-5#2)
transfer reactions##6##2##(1990-5#2)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)
transfer region##2##2##(1990-8#1)(1991-7#1)
transfer resistance##3##2##(2008-10#1)(2012-2#2)
transfer set##4##2##(2007-12#3)(2008-10#1)
transfer studies##2##2##(1992-3#1)(2008-4#1)
transfer substrate##2##2##(2007-11#2)
transfer system##4##2##(1994-5#1)(2007-11#1)(2008-11#1)(2008-3#1)
transfer technique##5##2##(1995-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)
transfer the##9##2##(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
transfer this##2##2##(1997-7#1)(2008-10#1)
transfer through a scattering##2##4##(2008-2#1)(2008-3#1)
transfer through a##3##3##(2008-2#2)(2008-3#1)
transfer through cirrus clouds##2##4##(2008-3#2)
transfer through the##2##3##(1992-3#1)(2008-10#1)
transfer through##10##2##(1992-3#1)(2008-10#3)(2008-2#3)(2008-3#3)
transfer to a##2##3##(2011-2#1)(2012-4#1)
transfer to our facility##2##4##(1992-6#1)(2013-8#1)
transfer to the##13##3##(1992-1#1)(1992-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#1)
transfer to##48##2##(1990-12#1)(1990-2#2)(1992-1#1)(1992-4#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-5#3)(1995-6#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-12#3)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-4#1)(2013-8#1)
transfer treatment##2##2##(2008-10#2)
transfer vector##5##2##(1997-3#2)(1997-4#1)(2008-2#1)(2008-8#1)
transfer vectors for##2##3##(2008-11#1)(2008-4#1)
transfer vectors##8##2##(1997-4#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)
transfer was achieved##2##3##(1990-5#1)(2008-11#1)
transfer was##13##2##(1990-5#1)(1991-5#1)(1992-3#1)(1995-2#2)(2008-10#3)(2008-11#2)(2008-8#2)(2009-10#1)
transfer were##5##2##(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#2)
transfer with##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)
transfer##1182##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#4)(1990-5#10)(1990-7#1)(1990-8#5)(1991-11#3)(1991-12#3)(1991-3#1)(1991-5#12)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#13)(1992-4#1)(1992-5#3)(1992-6#13)(1992-7#1)(1992-8#9)(1993-1#2)(1993-11#12)(1993-12#5)(1993-2#1)(1993-8#3)(1993-9#1)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#28)(1994-6#1)(1994-8#6)(1994-9#3)(1995-11#2)(1995-12#7)(1995-2#20)(1995-3#1)(1995-5#17)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-5#9)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#8)(1997-3#3)(1997-4#10)(1997-6#4)(1997-7#6)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#17)(2007-12#42)(2008-1#4)(2008-10#193)(2008-11#59)(2008-12#16)(2008-2#79)(2008-3#114)(2008-4#24)(2008-5#17)(2008-6#13)(2008-7#30)(2008-8#55)(2008-9#36)(2009-10#7)(2009-11#17)(2009-2#5)(2009-3#6)(2009-4#4)(2009-5#6)(2009-6#4)(2009-8#6)(2009-9#9)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#26)(2011-3#2)(2012-12#8)(2012-2#25)(2012-3#5)(2012-4#1)(2013-1#15)(2013-7#1)(2013-8#6)
transfer)##5##1##(1990-8#1)(2008-8#1)(2008-9#3)
transfer-matrix method##2##2##(2008-3#2)
transfer-matrix##3##1##(2008-3#3)
transfer-proof formulae##2##2##(2008-5#2)
transfer-to-orbit experiment##2##2##(2008-3#2)
transferability of##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
transferability##6##1##(2008-10#2)(2008-11#1)(2008-5#2)(2012-2#1)
transferable to other##2##3##(1991-12#1)(2010-8#1)
transferable to##5##2##(1991-12#1)(1994-6#1)(1996-3#1)(2008-10#1)(2010-8#1)
transferable##11##1##(1991-12#1)(1992-1#1)(1992-12#1)(1994-6#1)(1996-3#1)(2008-10#3)(2008-2#1)(2010-8#1)(2011-2#1)
transferase activity and##2##3##(1995-5#1)(2006-6#1)
transferase activity##5##2##(1992-8#1)(1994-11#1)(1994-8#1)(1995-5#1)(2006-6#1)
transferase and##3##2##(1992-10#1)(2008-4#1)(2013-1#1)
transferase cDNA##3##2##(1992-8#1)(2008-11#2)
transferase inhibitor##2##2##(1991-5#1)(2010-12#1)
transferase##58##1##(1990-12#2)(1991-2#2)(1991-5#2)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#4)(1993-3#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#3)(1996-12#1)(1997-3#2)(1997-7#3)(1997-9#2)(2006-6#2)(2007-11#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#1)(2013-1#1)
transferase-mediated##2##1##(2008-10#1)(2008-8#1)
transferases##7##1##(1992-3#1)(2008-11#3)(2008-8#1)(2011-1#1)(2013-1#1)
transfered##2##1##(2007-10#1)(2007-11#1)
transference of theoretical knowledge of holistic care into##2##8##(2008-11#2)
transference of##3##2##(2008-10#1)(2008-11#2)
transference##8##1##(1994-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)
transferrable##2##1##(1991-2#1)(2008-9#1)
transferred across##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
transferred and##3##2##(2008-11#1)(2008-9#2)
transferred directly into##2##3##(2008-11#1)(2008-2#1)
transferred directly##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
transferred from the##9##3##(1991-5#1)(1993-3#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
transferred from##24##2##(1991-5#1)(1991-9#1)(1993-3#3)(1994-6#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#3)(2011-2#1)(2013-1#1)
transferred in the##2##3##(2008-10#2)
transferred in##5##2##(2007-11#1)(2008-10#2)(2008-12#1)(2012-3#1)
transferred into a##2##3##(2008-10#2)
transferred into papaya##2##3##(2008-10#2)
transferred into the##5##3##(1993-8#1)(1996-5#1)(2008-10#2)(2008-11#1)
transferred into wheat##2##3##(2008-8#2)
transferred into##35##2##(1992-3#1)(1993-8#1)(1994-5#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#2)(2008-8#9)(2008-9#2)(2010-6#1)
transferred nuclear Overhauser effect spectroscopy (TRNOESY)##2##6##(1993-11#2)
transferred nuclear Overhauser##3##3##(1993-11#3)
transferred the##7##2##(1994-11#1)(1994-5#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)
transferred to a##15##3##(1990-10#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
transferred to other hexasaccharides##2##4##(1994-5#2)
transferred to our##2##3##(1990-9#1)(2007-8#1)
transferred to the##24##3##(1992-4#1)(1995-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
transferred to##84##2##(1990-10#1)(1990-9#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-8#1)(1997-2#1)(1997-3#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
transferred##215##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#4)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#5)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-5#4)(1996-8#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-11#3)(2007-12#6)(2007-5#3)(2007-8#2)(2007-9#1)(2008-10#52)(2008-11#13)(2008-12#6)(2008-2#5)(2008-3#2)(2008-4#8)(2008-5#2)(2008-7#3)(2008-8#17)(2008-9#13)(2009-1#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#2)
transferrin (Tf)##3##2##(1990-8#1)(2010-11#1)(2013-7#1)
transferrin and##5##2##(1992-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2013-7#1)
transferrin in##6##2##(1993-12#2)(2008-11#4)
transferrin into##2##2##(1994-5#1)(2008-11#1)
transferrin is##2##2##(1992-6#1)(1992-9#1)
transferrin receptor##14##2##(1990-11#1)(1990-8#5)(1991-6#4)(1993-11#2)(1994-5#1)(1997-4#1)
transferrin receptors##3##2##(1990-8#2)(1993-11#1)
transferrin reduction##2##2##(1994-3#2)
transferrin saturation##5##2##(1992-5#1)(2007-7#2)(2008-1#2)
transferrin##87##1##(1990-11#2)(1990-3#1)(1990-8#9)(1991-6#4)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#6)(1993-12#2)(1993-8#8)(1994-3#4)(1994-5#3)(1995-11#4)(1996-5#1)(1997-2#1)(1997-4#1)(2007-7#2)(2008-1#2)(2008-10#9)(2008-11#15)(2008-5#3)(2008-7#1)(2010-11#1)(2013-7#2)
transferrin-bound##2##1##(1995-11#1)(2008-5#1)
transferring flavoenzymes##2##2##(2008-11#2)
transferring on##2##2##(2008-10#1)(2008-3#1)
transferring the adductor hallucis tendon##2##5##(2009-10#2)
transferring the##4##2##(2008-9#1)(2009-10#3)
transferring##30##1##(1990-8#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-10#3)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
transfers and##2##2##(1991-2#1)(1997-6#1)
transfers are##6##2##(1993-12#1)(1996-2#1)(2008-7#1)(2008-9#2)(2009-6#1)
transfers between##2##2##(1995-2#1)(1996-2#1)
transfers from##2##2##(1995-2#1)(1995-5#1)
transfers have##2##2##(2008-9#2)
transfers in the##2##3##(2008-9#1)(2009-10#1)
transfers in##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
transfers of##6##2##(1996-8#1)(2008-10#1)(2009-6#1)(2012-2#2)(2013-1#1)
transfers the##2##2##(1995-6#1)(2008-7#1)
transfers to##2##2##(1993-12#1)(2013-1#1)
transfers##56##1##(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-2#2)(1996-8#1)(1997-6#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#7)(2009-10#1)(2009-6#3)(2010-8#3)(2012-2#3)(2013-1#4)
transfilter experiments##2##2##(2008-6#2)
transform IR spectrometers##2##3##(2008-3#2)
transform IR##6##2##(2008-2#3)(2008-3#2)(2010-4#1)
transform a##2##2##(1997-7#1)(2009-8#1)
transform algorithm and##2##3##(2008-10#1)(2008-3#1)
transform algorithm##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
transform and the##3##3##(2008-3#3)
transform and##9##2##(2008-1#2)(2008-2#2)(2008-3#5)
transform are##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
transform can be used to##2##5##(2008-3#1)(2010-4#1)
transform can be##5##3##(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)
transform correlator (JTC)##4##3##(2008-2#2)(2008-3#2)
transform correlator for optical##2##4##(2008-3#2)
transform correlator for##5##3##(2008-2#1)(2008-3#4)
transform correlator##41##2##(2008-2#23)(2008-3#18)
transform correlators##3##2##(2008-2#1)(2008-3#2)
transform domain##3##2##(2008-2#3)
transform for##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
transform from##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
transform in##3##2##(2008-2#2)(2012-1#1)
transform infrared spectrometric determination of##2##5##(2008-10#2)
transform infrared spectrometric##4##3##(2008-10#4)
transform infrared spectrometry and##2##4##(1997-2#1)(2008-5#1)
transform infrared spectrometry##13##3##(1992-8#1)(1997-2#2)(2008-10#9)(2008-5#1)
transform infrared spectroscopy##26##3##(2007-12#2)(2008-10#17)(2008-5#2)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
transform infrared##89##2##(1991-5#3)(1992-8#1)(1994-11#1)(1995-5#1)(1997-2#2)(2007-11#1)(2007-12#9)(2008-10#52)(2008-3#3)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
transform into##4##2##(2008-2#1)(2008-5#1)(2010-11#1)(2013-1#1)
transform is a##2##3##(2008-10#1)(2008-3#1)
transform is##11##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
transform limited##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
transform of a##2##3##(2007-12#1)(2009-12#1)
transform of an image##2##4##(2008-3#1)(2012-1#1)
transform of an##3##3##(2008-3#2)(2012-1#1)
transform of the##10##3##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#2)
transform of##16##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#5)(2009-12#1)(2012-1#1)
transform optical correlator##2##3##(2008-3#2)
transform optical##3##2##(2008-3#3)
transform plane##2##2##(2008-3#2)
transform power spectrum##2##3##(2008-3#2)
transform power##3##2##(2008-2#1)(2008-3#2)
transform profilometry##3##2##(2008-2#1)(2008-3#2)
transform spectrometer##9##2##(2008-2#2)(2008-3#7)
transform spectrometers##3##2##(2008-2#1)(2008-3#2)
transform spectroscopy##12##2##(2008-10#2)(2008-2#8)(2008-3#1)(2011-1#1)
transform spectrum##2##2##(2013-8#2)
transform to##5##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
transform was##3##2##(2008-2#2)(2012-2#1)
transform with##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
transform##415##1##(1990-5#3)(1991-2#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-11#7)(2007-12#31)(2007-7#1)(2008-1#5)(2008-10#81)(2008-11#3)(2008-12#1)(2008-2#88)(2008-3#116)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#3)(2010-5#1)(2011-1#2)(2012-1#3)(2012-2#4)(2013-1#5)(2013-8#7)
transform-based Fourier deconvolution##2##3##(2008-10#2)
transform-based##3##1##(2008-10#2)(2008-3#1)
transform-limited pedestal-free##2##2##(2007-11#2)
transform-limited##11##1##(2007-11#5)(2007-12#3)(2008-2#1)(2008-3#2)
transformant Inu-66##2##2##(2011-1#2)
transformant cells##4##2##(1995-12#4)
transformant induced by retTPC##2##4##(1991-9#2)
transformant##19##1##(1991-9#4)(1995-12#5)(2008-10#6)(2008-8#1)(2011-1#3)
transformants and the##3##3##(2008-10#3)
transformants and##4##2##(2008-10#4)
transformants containing##2##2##(2008-10#1)(2008-5#1)
transformants for##2##2##(1990-8#1)(1997-6#1)
transformants in##2##2##(1991-9#1)(2008-10#1)
transformants obtained with##2##3##(2008-10#2)
transformants of##4##2##(2008-10#4)
transformants per##2##2##(2008-10#2)
transformants showed##3##2##(2008-10#3)
transformants that##2##2##(2008-10#2)
transformants were##9##2##(1990-5#2)(1991-9#1)(1993-12#1)(2008-10#4)(2008-4#1)
transformants with##6##2##(1997-2#1)(1997-6#1)(2008-10#2)(2008-8#1)(2011-1#1)
transformants##80##1##(1990-5#4)(1990-8#1)(1991-9#2)(1993-12#3)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#2)(2008-1#1)(2008-10#45)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2011-1#1)(2013-1#1)
transformation (DRIFT) spectroscopy##2##3##(2008-10#2)
transformation and the##5##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
transformation and##28##2##(1991-12#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2011-2#1)(2012-12#3)(2012-2#1)
transformation are##2##2##(1994-8#1)(2008-10#1)
transformation as##2##2##(1994-9#1)(2009-12#1)
transformation between##2##2##(2008-6#1)(2009-11#1)
transformation by the##2##3##(2008-10#2)
transformation by##13##2##(1990-8#2)(1991-9#1)(1993-11#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2009-11#1)(2009-5#1)
transformation event##2##2##(2008-10#2)
transformation for##2##2##(2008-1#1)(2012-3#1)
transformation frequencies##3##2##(1990-7#1)(2008-10#2)
transformation frequency##5##2##(2008-10#2)(2008-7#3)
transformation from##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
transformation has been reported##2##4##(2008-10#1)(2012-12#1)
transformation has been##6##3##(1994-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
transformation has##8##2##(1994-10#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)
transformation in a##2##3##(2007-7#1)(2013-8#1)
transformation in the##3##3##(1990-5#1)(2006-10#1)(2008-7#1)
transformation in vitro##8##3##(2008-7#8)
transformation in##35##2##(1990-5#2)(1992-5#2)(1995-9#1)(1996-2#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#12)(2010-3#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
transformation incidence##2##2##(1994-2#2)
transformation induced by##2##3##(1991-12#1)(1996-2#1)
transformation into##5##2##(1992-12#1)(2008-5#1)(2009-8#1)(2010-4#1)(2013-1#1)
transformation is##14##2##(1994-10#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)
transformation matrix##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
transformation method##2##2##(1994-12#1)(2008-8#1)
transformation occurs in the anolyte##2##5##(2013-1#2)
transformation occurs##3##2##(2012-12#1)(2013-1#2)
transformation of a##7##3##(1992-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-1#1)
transformation of cells##4##3##(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
transformation of human##2##3##(1992-8#1)(2008-4#1)
transformation of incidence##3##3##(2008-10#3)
transformation of mouse##2##3##(1994-2#1)(1997-7#1)
transformation of oral lichen##3##4##(2008-4#3)
transformation of the fluorescent pseudomonad##2##5##(2008-10#2)
transformation of the health##2##4##(1995-2#1)(2008-2#1)
transformation of the##19##3##(1993-12#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-6#1)(2010-12#1)
transformation of##101##2##(1990-11#1)(1990-5#2)(1990-7#2)(1991-12#3)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
transformation procedure##2##2##(2008-10#1)(2008-8#1)
transformation products##3##2##(2008-10#3)
transformation properties##2##2##(1991-8#1)(2008-3#1)
transformation rates are##2##3##(2008-7#1)(2013-1#1)
transformation rates##6##2##(1990-9#1)(2008-7#1)(2012-12#2)(2013-1#2)
transformation system for##2##3##(2008-10#1)(2008-8#1)
transformation system##6##2##(1990-5#1)(1990-7#1)(1997-2#1)(2008-10#1)(2008-8#1)(2012-3#1)
transformation that##2##2##(2007-12#1)(2009-10#1)
transformation to a##3##3##(2008-2#1)(2008-6#1)(2008-7#1)
transformation to colorectal carcinoma##2##4##(2009-12#2)
transformation to##15##2##(1992-1#1)(1992-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#2)(2010-7#1)(2012-12#1)
transformation under##2##2##(2008-2#1)(2008-3#1)
transformation using##2##2##(1990-11#1)(1997-7#1)
transformation vector##2##2##(2008-10#1)(2013-1#1)
transformation was##6##2##(1993-2#1)(1993-9#1)(2008-10#2)(2008-7#1)(2010-5#1)
transformation with a##2##3##(1997-3#1)(2008-3#1)
transformation with##11##2##(1993-2#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)
transformation zone in patients with##2##5##(1990-6#1)(2011-2#1)
transformation zone##8##2##(1990-6#1)(1991-2#1)(1994-12#1)(1994-2#2)(2011-2#1)(2012-3#2)
transformation##464##1##(1990-11#3)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#7)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#7)(1994-8#6)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-7#3)(2006-10#2)(2006-12#2)(2007-10#4)(2007-11#15)(2007-12#10)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#52)(2008-11#19)(2008-12#4)(2008-2#23)(2008-3#17)(2008-4#7)(2008-5#7)(2008-6#13)(2008-7#31)(2008-8#15)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-5#4)(2009-8#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#11)(2012-1#4)(2012-12#21)(2012-2#6)(2012-3#7)(2013-1#14)(2013-8#2)
transformational##3##1##(1992-1#1)(2008-11#2)
transformations and##2##2##(2008-11#1)(2010-5#1)
transformations are##5##2##(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
transformations for##2##2##(2008-2#1)(2010-4#1)
transformations have been##2##3##(2008-10#2)
transformations have##3##2##(2008-10#3)
transformations in soil##2##3##(1990-9#1)(2008-10#1)
transformations in the##2##3##(2008-8#1)(2013-1#1)
transformations in##9##2##(1990-9#1)(1991-9#1)(2008-10#2)(2008-12#2)(2008-8#1)(2013-1#2)
transformations of the##5##3##(1995-11#1)(2008-10#1)(2010-1#1)(2010-4#1)(2013-1#1)
transformations of##9##2##(1995-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2010-1#1)(2010-4#1)(2013-1#1)
transformations that##2##2##(2010-1#1)(2010-12#1)
transformations were##2##2##(1996-5#1)(2010-4#1)
transformations##74##1##(1990-9#1)(1991-9#1)(1992-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-3#2)(2007-1#1)(2007-11#2)(2008-10#16)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#2)(2008-8#3)(2009-10#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
transformative leadership##3##2##(1996-1#1)(2008-1#2)
transformative##10##1##(1996-1#1)(2008-1#2)(2008-12#2)(2010-8#4)(2013-1#1)
transformed and untransformed cells##2##4##(1993-2#1)(2011-2#1)
transformed and##4##2##(1993-2#1)(1993-6#1)(2008-7#1)(2011-2#1)
transformed at##3##2##(1993-12#1)(2008-12#1)(2013-7#1)
transformed by human##2##3##(1992-9#1)(2008-10#1)
transformed by the##6##3##(1991-5#1)(1991-8#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
transformed by##16##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-8#1)
transformed cell lines##4##3##(1993-6#1)(1995-12#1)(1995-2#1)(2008-11#1)
transformed cell##13##2##(1993-6#1)(1994-11#3)(1995-12#1)(1995-2#1)(1997-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
transformed cells did not##2##4##(1993-2#1)(1994-8#1)
transformed cells in##2##3##(1993-8#1)(2008-7#1)
transformed cells##29##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#5)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#1)
transformed data##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
transformed from a##2##3##(1994-12#1)(2008-3#1)
transformed human##7##2##(1992-3#2)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(2008-10#1)
transformed infrared##5##2##(2008-10#4)(2013-8#1)
transformed into a##10##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-1#1)(2012-2#1)
transformed into an##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
transformed into the gaseous##2##4##(2008-10#2)
transformed into the##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
transformed into##38##2##(1994-12#2)(1995-8#1)(1996-3#1)(1996-5#3)(1997-1#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
transformed kidney##2##2##(1993-8#1)(2008-11#1)
transformed migraine##2##2##(2008-9#2)
transformed neonatal rat##2##3##(1996-5#2)
transformed over##2##2##(1993-8#1)(2008-6#1)
transformed phenotype in##2##3##(1995-6#1)(2011-2#1)
transformed phenotype of##2##3##(1995-6#1)(2008-11#1)
transformed phenotype##9##2##(1995-6#2)(1995-9#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2011-2#1)
transformed rat-liver epithelial-cell line##2##4##(1992-9#2)
transformed rat-liver##4##2##(1992-9#4)
transformed respiratory epithelial cells##2##4##(2008-10#2)
transformed the##2##2##(2008-3#1)(2008-8#1)
transformed to the##3##3##(1997-7#1)(2008-6#1)(2010-5#1)
transformed to##16##2##(1997-7#2)(2008-10#2)(2008-11#5)(2008-3#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-5#1)(2013-1#2)
transformed with a##11##3##(1990-12#1)(1993-2#1)(1995-11#1)(1995-6#1)(2008-10#6)(2010-6#1)
transformed with the coat protein (CP)##2##6##(2008-10#2)
transformed with the##7##3##(2008-10#7)
transformed with two##2##3##(1997-7#1)(2008-10#1)
transformed with##33##2##(1990-12#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#2)
transformed yeast##3##2##(1990-12#1)(1990-8#1)(1995-2#1)
transformed##280##1##(1990-11#2)(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-9#6)(1993-11#5)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#9)(1994-12#4)(1994-3#3)(1994-5#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#10)(1995-6#3)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#5)(1997-1#4)(1997-2#1)(1997-6#1)(1997-7#5)(2007-12#3)(2008-1#2)(2008-10#54)(2008-11#24)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#11)(2008-8#11)(2008-9#6)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
transformed)##2##1##(1995-12#1)(2008-9#1)
transformer and##2##2##(2007-12#1)(2008-2#1)
transformer oil##5##2##(2008-10#5)
transformer##16##1##(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#2)(2008-3#3)
transformer-2##5##1##(2007-12#5)
transforming a##5##2##(1991-7#1)(2007-11#2)(2008-10#1)(2008-3#1)
transforming activity##3##2##(1993-11#1)(1994-8#1)(2008-5#1)
transforming an##2##2##(2008-11#1)(2008-2#1)
transforming data##2##2##(2008-4#1)(2012-12#1)
transforming growth factor (TGF)-beta##3##4##(1992-9#1)(2008-11#2)
transforming growth factor alpha (TGF##2##5##(1992-8#1)(1997-1#1)
transforming growth factor alpha##7##4##(1992-8#2)(1992-9#1)(1993-3#1)(1997-1#1)(2008-7#1)(2011-2#1)
transforming growth factor beta (TGF beta)##2##6##(1991-12#1)(1992-9#1)
transforming growth factor beta (TGF-beta)##4##5##(2008-1#1)(2008-11#2)(2008-12#1)
transforming growth factor beta 1##3##5##(1990-8#2)(1993-9#1)
transforming growth factor beta##15##4##(1990-5#1)(1990-8#2)(1991-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-2#1)(2008-1#1)(2008-11#3)(2008-12#1)(2011-2#1)(2012-2#1)
transforming growth factor##37##3##(1990-5#1)(1990-8#3)(1991-12#1)(1991-2#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#1)(1993-9#1)(1995-2#3)(1997-1#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)
transforming growth factor-alpha##2##3##(1992-8#1)(1993-9#1)
transforming growth factor-beta (TGF-beta)##6##4##(1990-2#1)(1993-3#1)(1996-5#1)(2008-11#2)(2009-3#1)
transforming growth factor-beta 1 (TGF-beta 1)##3##6##(1991-12#1)(1992-3#1)(1994-11#1)
transforming growth factor-beta 1##7##4##(1990-2#2)(1991-12#1)(1992-3#2)(1994-11#2)
transforming growth factor-beta##21##3##(1990-2#3)(1991-12#1)(1992-2#1)(1992-3#2)(1993-3#2)(1993-6#1)(1994-11#2)(1995-11#1)(1996-5#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-3#1)(2013-1#1)
transforming growth factor-β##3##3##(2012-1#1)(2012-12#2)
transforming growth##65##2##(1990-2#3)(1990-5#1)(1990-8#3)(1991-12#2)(1991-2#1)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#3)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#2)(1995-11#1)(1995-2#3)(1996-5#1)(1997-1#1)(2008-1#1)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
transforming properties##2##2##(1992-9#1)(2008-2#1)
transforming the##7##2##(1994-3#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
transforming vectors##2##2##(2008-10#2)
transforming##114##1##(1990-2#3)(1990-5#3)(1990-8#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#5)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#5)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#1)
transforms a##3##2##(1992-8#1)(2008-3#1)(2008-9#1)
transforms and##2##2##(2008-3#1)(2008-7#1)
transforms in##2##2##(2008-3#1)(2012-1#1)
transforms into##2##2##(2007-12#1)(2008-8#1)
transforms on##2##2##(2007-11#1)(2008-3#1)
transforms the##3##2##(1997-2#1)(2008-3#2)
transforms##35##1##(1992-8#1)(1993-12#1)(1993-8#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#13)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-1#1)
transfused in the##4##3##(1994-9#1)(2007-9#2)(2011-2#1)
transfused patients##2##2##(1994-3#1)(2011-2#1)
transfused with##6##2##(1994-12#3)(1994-6#2)(1994-9#1)
transfused##26##1##(1991-8#2)(1992-3#1)(1992-6#3)(1994-12#4)(1994-3#1)(1994-6#2)(1994-9#5)(1996-3#1)(1996-9#1)(1997-5#1)(2007-7#1)(2007-9#2)(2011-2#2)
transfusion and##6##2##(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
transfusion associated##3##2##(1995-9#1)(2008-10#2)
transfusion in##13##2##(1990-2#1)(1990-8#1)(1994-9#1)(1995-12#1)(1996-9#2)(1997-5#1)(1997-8#1)(2008-1#1)(2009-3#1)(2011-2#1)(2013-1#2)
transfusion is##2##2##(1996-9#1)(2013-1#1)
transfusion medicine]##2##2##(2008-10#2)
transfusion of##8##2##(1990-2#1)(1994-12#1)(1996-9#1)(2007-7#1)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
transfusion practice##3##2##(2008-12#2)(2009-4#1)
transfusion reactions##5##2##(1994-12#2)(1994-3#1)(1997-1#1)(2012-12#1)
transfusion requirements##4##2##(1996-9#1)(2008-7#2)(2013-8#1)
transfusion response##2##2##(2011-2#2)
transfusion therapy and##2##3##(1990-11#1)(2012-3#1)
transfusion therapy##4##2##(1990-11#3)(2012-3#1)
transfusion volume &gt##2##3##(2011-2#2)
transfusion were##3##2##(1994-12#2)(2013-1#1)
transfusion##131##1##(1990-11#4)(1990-2#2)(1990-3#3)(1990-8#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-9#1)(1994-12#10)(1994-3#1)(1994-9#4)(1995-12#3)(1995-6#1)(1995-9#1)(1996-3#2)(1996-9#11)(1997-1#1)(1997-5#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#6)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2010-11#2)(2011-2#14)(2011-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#3)
transfusion)##2##1##(1994-12#1)(2008-7#1)
transfusion-associated##2##1##(1992-12#1)(2012-12#1)
transfusion-transmitted##3##1##(2009-3#1)(2012-12#2)
transfusional##2##1##(1993-6#1)(2013-8#1)
transfusions and##6##2##(1990-5#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-8#1)
transfusions at##2##2##(1994-12#1)(2009-4#1)
transfusions during##3##2##(2008-1#1)(2008-7#2)
transfusions has##2##2##(1990-11#1)(1990-2#1)
transfusions in patients with##2##4##(2010-9#1)(2011-2#1)
transfusions in##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
transfusions of##3##2##(1990-2#1)(2013-1#1)(2013-8#1)
transfusions on##2##2##(1995-6#1)(2009-4#1)
transfusions to##2##2##(1995-12#1)(2009-4#1)
transfusions were##4##2##(1992-12#1)(1994-9#1)(1996-3#1)(2011-2#1)
transfusions##56##1##(1990-11#2)(1990-2#3)(1990-5#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#4)(1997-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#3)(2010-11#1)(2010-9#1)(2011-2#7)(2013-1#2)(2013-8#1)
transgastric peritoneoscopy##2##2##(2009-8#2)
transgender adults and their##2##4##(2008-12#2)
transgender##7##1##(2008-12#6)(2009-7#1)
transgene and##2##2##(2008-10#1)(2008-2#1)
transgene expression##14##2##(1994-3#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#1)(2011-1#1)
transgene flow##2##2##(2008-10#1)(2011-2#1)
transgene frequency##2##2##(2008-8#2)
transgene in##6##2##(1991-5#1)(1995-2#1)(2008-10#3)(2008-8#1)
transgene integration##4##2##(1995-2#1)(2008-11#3)
transgene is##2##2##(1996-12#1)(2008-10#1)
transgene transcript##2##2##(2008-10#2)
transgene transmission##2##2##(2008-12#2)
transgene was##5##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
transgene##91##1##(1990-12#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-6#2)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#5)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#26)(2008-11#10)(2008-12#3)(2008-2#5)(2008-4#2)(2008-5#1)(2008-8#8)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)
transgene-mediated##2##1##(2008-10#2)
transgene-transgene junctions##2##2##(1993-6#2)
transgenerational marking##2##2##(2010-8#2)
transgenerational##3##1##(2010-8#2)(2011-1#1)
transgenes and##4##2##(1994-5#1)(2008-11#1)(2008-9#2)
transgenes can##4##2##(1995-8#2)(2008-10#1)(2011-1#1)
transgenes could##2##2##(2008-8#1)(2008-9#1)
transgenes in##4##2##(1993-6#2)(1994-5#1)(2008-2#1)
transgenes##29##1##(1993-6#2)(1994-3#1)(1994-5#2)(1995-2#2)(1995-8#2)(2006-12#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-4#1)(2008-8#2)(2008-9#4)(2011-1#1)(2012-3#1)(2013-1#1)
transgenesis##8##1##(1995-8#1)(2008-11#1)(2008-4#3)(2012-3#3)
transgenic Arabidopsis##2##2##(1996-12#1)(2008-10#1)
transgenic Drosophila##3##2##(1993-12#1)(1995-8#1)(2013-1#1)
transgenic N##2##2##(2008-10#1)(2012-3#1)
transgenic and##7##2##(1994-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)
transgenic animals by##2##3##(1992-8#1)(1994-5#1)
transgenic animals##18##2##(1992-11#1)(1992-8#3)(1993-12#2)(1993-6#1)(1994-5#4)(1995-2#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#3)
transgenic approach##3##2##(2008-4#2)(2009-8#1)
transgenic expression of##2##3##(2008-10#1)(2008-8#1)
transgenic expression##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
transgenic females##3##2##(1993-12#2)(1995-2#1)
transgenic flies##3##2##(1993-9#1)(1995-6#1)(2008-8#1)
transgenic hybrids##2##2##(2008-10#2)
transgenic hypovirulent strain##2##3##(2008-10#2)
transgenic hypovirulent strains##4##3##(2008-10#4)
transgenic hypovirulent##6##2##(2008-10#6)
transgenic line##5##2##(1990-11#1)(2008-10#4)
transgenic lines in##2##3##(1994-8#1)(2008-10#1)
transgenic lines were obtained##2##4##(2008-10#1)(2008-8#1)
transgenic lines were##7##3##(2008-10#5)(2008-8#1)(2009-10#1)
transgenic lines with##2##3##(2008-10#1)(2008-8#1)
transgenic lines##31##2##(1994-8#1)(1995-8#1)(1996-6#2)(2008-10#18)(2008-12#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2012-3#1)
transgenic livestock##4##2##(1995-2#1)(2008-11#3)
transgenic maize plants##3##3##(2008-8#3)
transgenic maize##6##2##(1995-6#1)(2008-10#1)(2008-8#3)(2011-2#1)
transgenic mice and##4##3##(1990-8#1)(1992-11#1)(2008-11#1)(2008-4#1)
transgenic mice by##2##3##(1991-5#1)(2008-2#1)
transgenic mice carrying##2##3##(1990-8#1)(1993-12#1)
transgenic mice expressing a##2##4##(1995-2#1)(2008-4#1)
transgenic mice expressing constitutively##2##4##(1996-2#1)(1997-7#1)
transgenic mice expressing##7##3##(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-4#1)(2013-8#1)
transgenic mice for##3##3##(2008-11#1)(2008-4#1)(2009-8#1)
transgenic mice revealed##2##3##(1995-6#1)(2012-2#1)
transgenic mice that##4##3##(1992-11#1)(1994-5#1)(1995-2#1)(1995-6#1)
transgenic mice using##3##3##(1994-8#1)(1996-6#1)(2008-4#1)
transgenic mice were##3##3##(1996-12#1)(2008-9#2)
transgenic mice##88##2##(1990-11#2)(1990-8#2)(1991-5#4)(1992-11#4)(1992-8#2)(1993-12#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#9)(1995-6#5)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#2)(1997-7#2)(2008-10#1)(2008-11#6)(2008-2#2)(2008-4#12)(2008-9#6)(2009-8#2)(2009-9#1)(2010-11#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
transgenic model##2##2##(1990-11#1)(1995-2#1)
transgenic models##2##2##(2008-4#1)(2008-7#1)
transgenic mouse embryos##3##3##(1992-5#1)(1997-6#2)
transgenic mouse model for##2##4##(1995-2#1)(1995-6#1)
transgenic mouse model of##2##4##(1996-5#1)(2008-10#1)
transgenic mouse model##6##3##(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-8#1)
transgenic mouse##16##2##(1992-5#1)(1994-3#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)
transgenic or##3##2##(2008-4#2)(2011-2#1)
transgenic plant##9##2##(2008-10#4)(2008-7#2)(2008-9#3)
transgenic plantlets##3##2##(2008-9#3)
transgenic plants are##2##3##(2008-10#1)(2013-8#1)
transgenic plants could be##2##4##(2008-10#1)(2008-8#1)
transgenic plants expressing a##2##4##(2008-10#2)
transgenic plants expressing the##3##4##(1997-6#1)(2008-10#2)
transgenic plants expressing##8##3##(1997-6#1)(2008-10#5)(2009-8#1)(2011-10#1)
transgenic plants was##3##3##(2008-10#2)(2008-8#1)
transgenic plants##46##2##(1991-7#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-8#1)(2011-10#1)(2011-2#2)(2013-8#2)
transgenic potato plants##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
transgenic potato##6##2##(1997-4#2)(2008-10#1)(2008-8#3)
transgenic rabbits was##2##3##(1994-8#1)(2008-11#1)
transgenic rabbits##7##2##(1994-8#2)(2008-11#2)(2008-12#3)
transgenic rats##4##2##(1990-11#1)(1996-5#1)(1997-7#1)(2008-11#1)
transgenic release##2##2##(2008-8#2)
transgenic resistance to##2##3##(2008-10#2)
transgenic resistance##3##2##(2008-10#3)
transgenic rice plants##2##3##(2008-10#1)(2008-9#1)
transgenic rice variety Zhong 8215##2##5##(2008-9#2)
transgenic rice##11##2##(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#7)
transgenic soybean plants##2##3##(2008-10#2)
transgenic tobacco plants expressing##3##4##(1997-6#1)(2008-10#1)(2008-8#1)
transgenic tobacco plants##10##3##(1991-7#1)(1997-6#2)(2008-10#3)(2008-8#2)(2008-9#1)(2011-10#1)
transgenic tobacco protoplasts was##2##4##(2008-8#2)
transgenic tobacco protoplasts##3##3##(2008-8#3)
transgenic tobacco without##2##3##(2008-9#2)
transgenic tobacco##22##2##(1991-7#1)(1997-6#2)(2008-10#5)(2008-8#6)(2008-9#6)(2011-10#2)
transgenic tobaccos##3##2##(2008-8#1)(2008-9#2)
transgenic tomato##5##2##(2008-10#4)(2010-9#1)
transgenic##411##1##(1990-11#5)(1990-8#2)(1991-5#4)(1991-7#2)(1992-11#5)(1992-5#1)(1992-8#5)(1993-12#9)(1993-6#1)(1993-9#1)(1994-3#2)(1994-5#5)(1994-8#8)(1994-9#1)(1995-11#3)(1995-2#16)(1995-6#10)(1995-8#2)(1996-12#5)(1996-2#2)(1996-5#7)(1996-6#4)(1997-4#3)(1997-6#5)(1997-7#4)(2006-12#3)(2008-10#97)(2008-11#18)(2008-12#8)(2008-2#5)(2008-4#24)(2008-5#2)(2008-7#11)(2008-8#36)(2008-9#40)(2009-10#2)(2009-3#1)(2009-8#6)(2009-9#1)(2010-11#2)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-10#4)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#6)
transgenically##2##1##(2008-10#1)(2010-11#1)
transgenics##5##1##(1995-2#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-2#1)
transglutaminase (TGase)##2##2##(2008-1#1)(2008-5#1)
transglutaminase activity##3##2##(1992-8#2)(2008-5#1)
transglutaminase in##2##2##(1994-9#1)(2008-5#1)
transglutaminase##20##1##(1992-8#7)(1994-11#3)(1994-9#2)(2008-1#1)(2008-10#1)(2008-5#5)(2008-9#1)
transglutaminase-mediated##2##1##(2008-5#2)
transgressive segregation##5##2##(2008-10#5)
transgressive##6##1##(2008-10#6)
transhepatic cholecystoscopic lithotomy##2##3##(2008-5#2)
transhepatic##5##1##(2008-5#4)(2010-12#1)
transient Horner's##2##2##(2008-8#1)(2013-1#1)
transient absorption spectra of the##2##5##(2008-10#1)(2008-9#1)
transient absorption spectra of##3##4##(2008-10#1)(2008-9#2)
transient absorption spectroscopy##2##3##(2007-12#1)(2008-10#1)
transient absorption##16##2##(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#3)(2008-8#1)(2008-9#2)(2011-1#2)
transient activation of##3##3##(1991-2#1)(1995-2#1)(2008-4#1)
transient and##13##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-4#1)(1996-4#1)(2007-11#2)(2008-1#2)(2008-2#1)(2008-3#1)(2008-8#1)(2013-1#1)
transient assay in##2##3##(1992-11#1)(2008-10#1)
transient cerebral ischemia in##2##4##(1990-7#1)(2008-11#1)
transient cerebral##3##2##(1990-7#1)(2008-11#1)(2008-7#1)
transient cotransfection##2##2##(1994-8#1)(2008-9#1)
transient electric##2##2##(1990-7#1)(2008-6#1)
transient elevation of##3##3##(1991-12#1)(1991-5#1)(2008-7#1)
transient exposure##2##2##(1992-8#1)(2012-3#1)
transient expression assay##5##3##(1992-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(2008-11#1)
transient expression in##2##3##(1992-9#1)(2008-2#1)
transient expression level##2##3##(2008-11#1)(2008-9#1)
transient expression of the##3##4##(1994-11#1)(2008-11#1)(2008-4#1)
transient expression of##8##3##(1993-9#1)(1994-11#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-11#1)
transient expression system##4##3##(1994-11#1)(2008-11#1)(2011-2#2)
transient expression##33##2##(1992-12#1)(1992-9#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-11#6)(2008-2#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2010-11#1)(2011-2#2)(2011-3#1)
transient focal ischemia##2##3##(2007-10#2)
transient focal##3##2##(2007-10#2)(2011-2#1)
transient forebrain ischemia##4##3##(1990-5#1)(1996-12#3)
transient formation of##3##3##(1990-12#1)(2008-10#2)
transient gene expression in##3##4##(2008-11#3)
transient gene expression##7##3##(2008-1#1)(2008-11#5)(2008-2#1)
transient gene##9##2##(2008-1#1)(2008-11#6)(2008-2#1)(2008-9#1)
transient global amnesia##2##3##(1996-9#1)(2009-6#1)
transient global##3##2##(1996-9#1)(2009-12#1)(2009-6#1)
transient in##3##2##(1992-3#1)(2007-12#1)(2008-8#1)
transient increase in##13##3##(1990-12#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
transient increase of##3##3##(1992-6#1)(1992-9#1)(2007-11#1)
transient increase##17##2##(1990-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
transient increases in##4##3##(1990-10#1)(1994-6#1)(1994-9#1)(2008-9#1)
transient increases of##2##3##(1990-12#1)(1995-11#1)
transient increases##6##2##(1990-10#1)(1990-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(2008-9#1)
transient inflammatory reaction##2##3##(1997-1#1)(2007-8#1)
transient interactions##2##2##(2008-8#1)(2012-2#1)
transient inward current##2##3##(1990-7#1)(1992-11#1)
transient inward##5##2##(1990-7#1)(1992-11#1)(1995-12#1)(1995-2#1)(2008-4#1)
transient ischaemic attack (TIA) or minor stroke##2##7##(1991-11#1)(2008-8#1)
transient ischaemic attack (TIA)##3##4##(1991-11#1)(2008-8#1)(2011-2#1)
transient ischaemic attack##5##3##(1991-11#1)(2008-8#3)(2011-2#1)
transient ischemia##2##2##(1990-7#1)(2007-10#1)
transient ischemic attack##7##3##(2007-10#4)(2008-8#2)(2013-8#1)
transient ischemic attacks##6##3##(1991-3#1)(1994-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2012-3#1)
transient ischemic##14##2##(1991-3#1)(1994-6#1)(2007-10#5)(2007-7#1)(2007-8#1)(2008-8#3)(2012-3#1)(2013-8#1)
transient manner##2##2##(1992-3#1)(2008-10#1)
transient micelle fusions##2##3##(1993-11#2)
transient nature##3##2##(1995-8#1)(1996-2#1)(2008-10#1)
transient of##2##2##(1996-4#1)(2008-8#1)
transient or##2##2##(2011-1#2)
transient outward##2##2##(2009-12#1)(2010-12#1)
transient paralysis was found in three##2##6##(2008-7#2)
transient paralysis##3##2##(2008-7#2)(2012-1#1)
transient phase##3##2##(1991-5#1)(1994-2#1)(2008-1#1)
transient photoelectromotive force effects##2##4##(2008-3#2)
transient potential change##4##3##(2008-10#4)
transient radiative transfer##2##3##(2008-3#2)
transient receptor potential vanilloid##2##4##(2009-12#1)(2011-2#1)
transient receptor potential##5##3##(2008-8#1)(2009-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
transient regime##2##2##(2007-12#2)
transient replication##2##2##(2008-10#1)(2008-9#1)
transient response of##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
transient response##8##2##(1996-5#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2012-2#1)
transient responses##2##2##(2008-10#1)(2008-9#1)
transient seropositivity##2##2##(2008-5#2)
transient short-pulse##2##2##(2008-3#2)
transient signal##3##2##(1996-2#1)(2007-12#1)(2008-10#1)
transient signals##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
transient silencing##2##2##(2008-10#1)(2009-8#1)
transient species##2##2##(2008-10#1)(2012-1#1)
transient state##2##2##(1996-4#1)(2008-2#1)
transient states##2##2##(1995-9#1)(2008-3#1)
transient stimulated Raman scattering in##2##5##(2007-12#2)
transient stimulated Raman scattering##3##4##(2007-12#3)
transient temperature##2##2##(2008-11#1)(2009-7#1)
transient transfection assays##3##3##(1991-10#1)(1992-8#1)(1997-7#1)
transient transfection experiments##2##3##(1992-9#1)(1993-3#1)
transient transfection system##2##3##(2008-11#2)
transient transfection##14##2##(1991-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1997-7#1)(2008-11#7)(2008-2#1)(2012-2#1)
transient transfections##4##2##(1993-6#1)(1994-6#1)(2008-1#2)
transient type K channel##2##4##(1992-11#2)
transient up-regulation##2##2##(1997-7#1)(2010-10#1)
transient##473##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#4)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#2)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#5)(1996-5#7)(1996-6#1)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#8)(2007-10#12)(2007-11#14)(2007-12#17)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#9)(2008-10#35)(2008-11#35)(2008-12#1)(2008-2#20)(2008-3#24)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#16)(2008-8#18)(2008-9#17)(2009-10#1)(2009-11#3)(2009-12#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#7)(2013-8#2)
transient-grating##2##1##(2007-12#1)(2008-3#1)
transiently and##2##2##(2008-3#1)(2010-11#1)
transiently expressed in##4##3##(1993-3#1)(2008-4#1)(2008-8#2)
transiently expressed##9##2##(1993-3#1)(1993-9#1)(1994-11#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)
transiently expresses##2##2##(1991-9#1)(2008-11#1)
transiently in the##2##3##(1990-7#1)(1992-12#1)
transiently in##3##2##(1990-7#1)(1992-12#1)(1992-9#1)
transiently increased##2##2##(1992-9#1)(1995-8#1)
transiently reduced##2##2##(1995-12#1)(2008-1#1)
transiently suppressed##2##2##(1990-5#1)(2008-11#1)
transiently transfected with the##3##4##(1994-11#2)(1996-5#1)
transiently transfected with##5##3##(1994-11#2)(1994-8#1)(1994-9#1)(1996-5#1)
transiently transfected##11##2##(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#1)(1996-5#2)(2008-11#1)(2008-2#1)(2008-7#1)
transiently##61##1##(1990-5#1)(1990-7#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#2)(1995-8#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2010-11#1)(2010-6#1)(2011-1#1)(2013-1#2)
transients and##2##2##(2008-3#1)(2008-8#1)
transients by##2##2##(2007-12#1)(2008-2#1)
transients during##2##2##(2007-12#1)(2010-8#1)
transients in the##2##3##(1992-9#1)(2008-8#1)
transients in##4##2##(1992-9#2)(2008-3#1)(2008-8#1)
transients of##3##2##(2008-10#1)(2008-3#2)
transients to##2##2##(2007-12#1)(2008-3#1)
transients##24##1##(1991-12#1)(1992-9#2)(1995-12#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#9)(2008-8#2)(2009-12#1)(2009-5#1)(2010-8#2)
transillumination measurements##3##2##(2008-2#1)(2008-3#2)
transillumination##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
transin##2##1##(1992-6#2)
transistor (ISFET)##3##2##(2008-10#3)
transistor##26##1##(1991-5#2)(1995-8#1)(2007-11#2)(2008-10#8)(2008-7#3)(2009-11#3)(2009-5#5)(2009-6#1)(2010-8#1)
transistors and##2##2##(2008-10#1)(2008-7#1)
transistors for##2##2##(2008-10#1)(2008-7#1)
transistors##22##1##(2008-10#8)(2008-7#11)(2009-6#3)
transit in##3##2##(2012-2#1)(2013-1#2)
transit of##5##2##(1992-3#1)(1997-6#1)(1997-7#1)(2008-7#1)(2012-2#1)
transit peptide##3##2##(1996-10#3)
transit through the##2##3##(1995-12#1)(2008-4#1)
transit through##3##2##(1995-12#1)(2008-4#1)(2008-7#1)
transit time##12##2##(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2013-8#2)
transit times##3##2##(2007-11#3)
transit were##2##2##(2013-1#1)(2013-8#1)
transit##49##1##(1992-3#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-10#3)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#4)(2009-4#1)(2009-5#1)(2012-2#3)(2013-1#9)(2013-8#4)
transiting##2##1##(2007-11#1)(2012-2#1)
transition and heavy metal ions##9##5##(2008-10#9)
transition and the##5##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
transition and##23##2##(1991-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
transition as##3##2##(1995-2#1)(2008-10#2)
transition at 1##2##3##(2008-3#2)
transition at nucleotide position##3##4##(1993-3#1)(1994-11#1)(2008-10#1)
transition at nucleotide##4##3##(1993-3#1)(1994-11#2)(2008-10#1)
transition at##23##2##(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#2)(2007-12#7)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#8)
transition between the two##2##4##(1991-6#1)(1996-6#1)
transition between the##4##3##(1991-6#1)(1996-6#1)(2007-12#1)(2008-10#1)
transition between##14##2##(1991-6#1)(1994-12#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
transition by##4##2##(1993-8#1)(1994-2#1)(2007-11#1)(2008-3#1)
transition can be##2##3##(1992-6#1)(2008-10#1)
transition element##2##2##(2008-10#1)(2008-3#1)
transition exhibited##2##2##(1990-8#1)(1992-10#1)
transition for##7##2##(1990-7#1)(1992-1#1)(1993-6#1)(2007-11#2)(2008-11#1)(2011-1#1)
transition frequencies##2##2##(2007-11#1)(2008-10#1)
transition frequency##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
transition from a##5##3##(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-12#1)
transition from coalescent to speciation##2##5##(2010-6#2)
transition from hospital to home##2##5##(1991-12#1)(2011-2#1)
transition from hospital to residential care##2##6##(2012-12#2)
transition from hospital to##4##4##(1991-12#1)(2011-2#1)(2012-12#2)
transition from single##2##3##(1996-12#1)(2008-3#1)
transition from the##7##3##(1990-12#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
transition from##59##2##(1990-12#1)(1991-1#1)(1991-12#2)(1992-10#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
transition has##2##2##(1995-2#1)(2008-3#1)
transition in a##2##3##(1990-12#1)(2007-12#1)
transition in the##9##3##(1990-8#1)(1994-11#1)(1994-3#1)(1997-7#1)(2007-12#2)(2008-3#1)(2009-8#1)(2010-12#1)
transition in##32##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-6#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-3#2)(1997-7#1)(2007-12#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
transition into##2##2##(2008-1#1)(2013-1#1)
transition is##6##2##(1990-11#1)(1990-7#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
transition line##2##2##(2008-2#1)(2008-3#1)
transition losses##4##2##(2008-3#4)
transition matrix##3##2##(2008-3#3)
transition metal and##3##3##(2008-10#1)(2010-11#1)(2010-12#1)
transition metal cations##3##3##(2008-10#3)
transition metal complexes##6##3##(1997-7#2)(2007-11#1)(2008-10#2)(2010-7#1)
transition metal ions and##3##4##(2008-10#3)
transition metal ions##17##3##(2008-10#14)(2008-12#1)(2010-11#1)(2011-1#1)
transition metal##38##2##(1991-9#1)(1996-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#23)(2008-12#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)
transition metals and##3##3##(2008-10#3)
transition metals in##5##3##(2008-10#2)(2008-5#1)(2010-11#2)
transition metals##25##2##(2008-10#17)(2008-5#3)(2009-10#1)(2010-11#2)(2011-1#2)
transition model##3##2##(1992-10#1)(2008-3#1)(2012-12#1)
transition networks##4##2##(2008-7#2)(2010-6#2)
transition occurs##3##2##(1990-7#1)(1996-2#1)(2011-2#1)
transition of a##5##3##(1993-11#1)(2008-11#1)(2008-2#2)(2010-7#1)
transition of atomic##3##3##(2008-2#2)(2008-3#1)
transition of lambda-DNA induced by cationic surfactant##2##7##(2008-8#2)
transition of the DLPE/POPC mixtures##2##5##(1994-3#2)
transition of the##14##3##(1994-3#4)(1995-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-10#1)(2012-12#1)
transition of##49##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-3#4)(1995-5#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#8)(2008-8#4)(2009-11#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
transition or##2##2##(1995-6#1)(2008-3#1)
transition peak at##2##3##(1992-10#2)
transition period##5##2##(1992-3#1)(1996-3#1)(2007-11#1)(2011-2#2)
transition point##2##2##(1991-6#1)(2008-2#1)
transition points and transition intervals of##3##6##(2008-10#3)
transition points##5##2##(1995-5#1)(2008-10#3)(2008-4#1)
transition probability matrices##2##3##(2011-2#2)
transition probability##3##2##(1994-12#1)(2011-2#2)
transition rates##3##2##(2008-2#2)(2008-7#1)
transition region##3##2##(1992-6#1)(1993-11#1)(1996-12#1)
transition shape##2##2##(2008-3#2)
transition state analogue##2##3##(1990-5#1)(1992-8#1)
transition state analogue&quot##2##3##(2009-9#2)
transition state##19##2##(1990-5#4)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-2#2)(1996-5#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-4#1)
transition states for##2##3##(1992-6#1)(1996-5#1)
transition states##7##2##(1991-6#1)(1992-6#1)(1996-5#3)(2012-12#1)(2012-3#1)
transition temperature of the##5##4##(2008-10#1)(2008-3#3)(2010-5#1)
transition temperature of##6##3##(1994-12#1)(2008-10#1)(2008-3#3)(2010-5#1)
transition temperature##18##2##(1990-2#1)(1994-12#1)(1994-3#1)(1995-3#2)(1997-7#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-9#1)(2010-4#1)(2010-5#1)
transition temperatures of##3##3##(2008-10#2)(2010-4#1)
transition temperatures##8##2##(1994-12#1)(1995-3#1)(2008-10#3)(2008-9#1)(2009-7#1)(2010-4#1)
transition test##3##2##(2008-8#3)
transition that results in##2##4##(1991-7#1)(1992-8#1)
transition that##4##2##(1991-12#1)(1991-7#1)(1992-8#1)(2007-12#1)
transition time##3##2##(2007-2#1)(2008-11#1)(2010-5#1)
transition to a##2##3##(1997-7#1)(2008-11#1)
transition to the##2##3##(1991-12#1)(2008-3#1)
transition to##35##2##(1990-8#1)(1991-12#2)(1996-12#1)(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#2)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#2)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
transition type##2##2##(2012-12#2)
transition types##5##2##(2012-12#5)
transition was monitored##2##3##(1990-2#1)(2008-2#1)
transition was##5##2##(1990-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
transition were##2##2##(1992-6#1)(2007-12#1)
transition when##2##2##(2008-6#1)(2008-7#1)
transition with a##6##3##(1992-6#1)(1995-6#1)(2007-12#3)(2008-1#1)
transition with##9##2##(1992-6#1)(1995-6#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-8#1)
transition zone##6##2##(1990-7#2)(1991-5#1)(2008-3#1)(2013-7#2)
transition##657##1##(1990-11#2)(1990-12#3)(1990-2#6)(1990-5#4)(1990-7#7)(1990-8#6)(1991-1#1)(1991-12#6)(1991-5#5)(1991-6#4)(1991-7#1)(1991-9#5)(1992-1#1)(1992-10#5)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#13)(1992-8#5)(1993-11#3)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#9)(1994-8#3)(1995-1#2)(1995-12#1)(1995-2#6)(1995-3#9)(1995-5#4)(1995-6#4)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#6)(1996-3#4)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#9)(2007-10#1)(2007-11#19)(2007-12#44)(2007-2#4)(2007-7#1)(2008-1#9)(2008-10#101)(2008-11#21)(2008-12#5)(2008-2#24)(2008-3#66)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#14)(2008-8#11)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#6)(2010-12#3)(2010-3#1)(2010-4#4)(2010-5#5)(2010-6#8)(2010-7#2)(2010-8#4)(2011-1#5)(2011-10#1)(2011-2#17)(2012-1#1)(2012-12#15)(2012-2#8)(2012-3#8)(2013-1#4)(2013-7#4)(2013-8#3)
transition-metal-ion-doped waveguide##2##2##(2007-11#2)
transition-state analog##4##2##(1991-5#2)(1995-2#2)
transition-state stabilization##3##2##(1992-3#2)(1994-5#1)
transition-state##15##1##(1991-5#2)(1992-3#2)(1993-11#1)(1994-5#2)(1995-2#2)(1995-5#3)(2008-5#2)(2012-12#1)
transitional ER##2##2##(2012-2#2)
transitional and##2##2##(2008-10#1)(2008-4#1)
transitional cell carcinoma of the bladder##2##6##(1997-4#1)(2007-10#1)
transitional cell carcinoma of the##3##5##(1997-4#1)(2007-10#1)(2008-1#1)
transitional cell carcinoma of##5##4##(1997-4#1)(2007-10#1)(2008-1#1)(2012-1#2)
transitional cell carcinoma##16##3##(1990-6#1)(1997-4#3)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#2)(2011-2#1)(2012-1#4)(2012-3#1)
transitional cell##18##2##(1990-6#1)(1997-4#3)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#2)(2011-2#2)(2012-1#4)(2012-3#1)
transitional day hospital##2##3##(1993-2#2)
transitional funding##4##2##(1991-12#2)(1993-1#1)(1994-1#1)
transitional stage##2##2##(2009-10#1)(2009-7#1)
transitional##54##1##(1990-12#1)(1990-6#1)(1991-12#2)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-6#1)(1996-3#1)(1997-4#3)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#4)(2012-2#3)(2012-3#2)
transitioned to##2##2##(2008-1#1)(2010-12#1)
transitioned##3##1##(2008-1#1)(2010-12#1)(2011-2#1)
transitioning from##4##2##(1991-12#1)(2008-10#1)(2009-8#1)(2009-9#1)
transitioning out##2##2##(2009-11#1)(2011-2#1)
transitioning to##2##2##(2008-11#1)(2010-6#1)
transitioning##10##1##(1991-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#2)
transitions and##6##2##(1997-4#1)(2008-10#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-1#1)
transitions are##13##2##(1990-7#2)(1991-8#1)(1992-6#1)(1997-7#2)(2007-11#1)(2008-2#1)(2008-3#2)(2011-2#3)
transitions at##5##2##(1990-7#1)(1997-7#1)(2008-2#2)(2012-2#1)
transitions between##7##2##(1994-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)
transitions for##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2010-10#1)
transitions from##2##2##(2008-1#1)(2008-9#1)
transitions have##2##2##(2008-11#1)(2008-3#1)
transitions in a##2##3##(2007-11#1)(2007-12#1)
transitions in the##10##3##(2007-11#2)(2008-2#3)(2008-3#4)(2013-7#1)
transitions in##26##2##(1990-8#1)(1991-8#1)(1991-9#2)(1992-8#1)(1993-5#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
transitions increases##2##2##(1990-7#1)(2008-10#1)
transitions is##5##2##(1990-11#1)(1995-3#1)(2008-3#2)(2009-10#1)
transitions near##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
transitions of iodine##2##3##(2007-11#1)(2008-3#1)
transitions of the##7##3##(1994-3#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-11#1)
transitions of##21##2##(1990-2#1)(1990-4#1)(1994-3#1)(1995-5#1)(1997-4#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-11#1)(2010-11#1)
transitions or##2##2##(1995-3#1)(2007-12#1)
transitions to##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
transitions were also##2##3##(1994-3#1)(2008-11#1)
transitions were##6##2##(1994-3#2)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
transitions##179##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#4)(1990-8#2)(1991-8#2)(1991-9#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-5#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-3#2)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#7)(2007-11#12)(2007-12#16)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#13)(2008-3#31)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-7#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-7#1)
transitive inference and##2##3##(2009-8#2)
transitive inference##4##2##(2009-8#4)
transitive reasoning##2##2##(2009-8#2)
transitive##8##1##(2008-2#1)(2009-8#7)
transitory increase##2##2##(2008-11#1)(2013-1#1)
transitory ischemic##2##2##(1997-2#1)(2013-7#1)
transitory##12##1##(1990-9#1)(1991-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-6#1)(2013-1#1)(2013-7#1)
transjugular##2##1##(1991-11#1)(2009-9#1)
transketolase##5##1##(1992-3#4)(2008-7#1)
transketolase-catalyzed condensation##2##2##(2008-7#2)
transketolase-catalyzed##3##1##(2008-7#3)
translabyrinthine##3##1##(2008-9#1)(2011-2#2)
translatability##2##1##(1997-3#1)(2012-2#1)
translatable and##2##2##(1997-3#1)(2008-10#1)
translatable to##2##2##(2007-11#1)(2008-2#1)
translatable##6##1##(1991-12#1)(1997-3#2)(2007-11#1)(2008-10#1)(2008-2#1)
translate into a##2##3##(2007-11#1)(2009-5#1)
translate into##11##2##(1991-12#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
translate the##4##2##(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)
translate##30##1##(1991-12#1)(1991-5#1)(1993-2#1)(1995-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
translated and##2##2##(1992-1#1)(2008-12#1)
translated as##2##2##(1992-6#1)(2012-2#1)
translated from##4##2##(1991-6#1)(2006-10#1)(2008-11#1)(2012-12#1)
translated in vitro##3##3##(1990-11#1)(1990-12#1)(1994-8#1)
translated in##10##2##(1990-11#1)(1990-12#1)(1993-2#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-2#1)
translated into a protein##2##4##(1990-11#1)(1995-12#1)
translated into a##7##3##(1990-11#1)(1994-7#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)
translated into clinical practice##2##4##(2008-3#1)(2012-12#1)
translated into clinical##3##3##(2008-3#1)(2012-12#1)(2012-2#1)
translated into##32##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-7#1)(1995-12#2)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-12#3)(2012-2#2)
translated protein##5##2##(1993-6#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
translated sequence of##2##3##(1994-6#1)(1997-3#1)
translated##78##1##(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2012-12#4)(2012-2#6)(2013-1#1)
translates in the##3##3##(2012-12#1)(2012-2#2)
translates into##3##2##(2008-7#2)(2009-4#1)
translates the##2##2##(1994-1#1)(2007-11#1)
translates to##2##2##(2010-4#1)(2010-8#1)
translates##16##1##(1991-12#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#5)
translating evidence into policy##2##4##(2008-7#2)
translating evidence into##3##3##(2008-3#1)(2008-7#2)
translating research##3##2##(2008-11#1)(2013-1#2)
translating the##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)
translating##27##1##(1991-3#1)(1992-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-6#1)(2013-1#3)
translation and expression##2##3##(2008-1#2)
translation and##10##2##(1991-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
translation apparatus##2##2##(2008-7#1)(2013-8#1)
translation as well as##2##4##(2008-9#1)(2010-4#1)
translation coefficients##3##2##(2008-2#3)
translation during##2##2##(1994-8#1)(2009-3#1)
translation elongation factor 1-alpha##2##4##(2008-10#2)
translation elongation factor 1alpha##4##4##(2008-10#4)
translation elongation factor##8##3##(2008-10#7)(2008-8#1)
translation elongation##9##2##(2008-10#8)(2008-8#1)
translation function##3##2##(1992-9#1)(1995-3#1)(2008-8#1)
translation has##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
translation in the##2##3##(2007-12#1)(2008-12#1)
translation in##6##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
translation initiation factor##4##3##(1994-6#1)(1997-1#1)(2010-12#1)(2013-7#1)
translation initiation site##6##3##(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#1)
translation initiation sites of##5##4##(1996-8#1)(1997-2#1)(1997-6#3)
translation initiation sites on the genome of Synechocystis sp##3##9##(1996-8#1)(1997-2#1)(1997-6#1)
translation initiation sites on##4##4##(1996-8#1)(1997-2#2)(1997-6#1)
translation initiation sites##15##3##(1996-8#4)(1997-2#5)(1997-6#6)
translation initiation##37##2##(1991-9#1)(1992-11#2)(1993-3#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-8#4)(1997-1#1)(1997-2#8)(1997-6#9)(1997-7#3)(2008-11#2)(2008-9#1)(2010-12#1)(2013-7#1)
translation into##2##2##(2008-9#1)(2011-2#1)
translation is##5##2##(2008-11#2)(2008-4#1)(2008-9#1)(2013-1#1)
translation matrices are##2##3##(2008-3#2)
translation of an##2##3##(2007-11#1)(2008-3#1)
translation of mRNA##2##3##(1992-12#1)(1995-12#1)
translation of such##2##3##(2012-12#2)
translation of the##20##3##(1990-11#1)(1990-12#1)(1992-12#1)(1992-3#1)(1993-6#1)(1995-6#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-2#2)
translation of these##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
translation of##63##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#2)(1992-12#2)(1992-3#1)(1992-8#1)(1993-6#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-1#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#3)(2013-8#1)
translation or##2##2##(2008-11#1)(2010-8#1)
translation product was##2##3##(1997-8#1)(2008-10#1)
translation product##10##2##(1991-5#1)(1994-8#2)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#1)
translation regulation##3##2##(2008-9#2)(2010-12#1)
translation stage##2##2##(2007-12#1)(2008-2#1)
translation strategies##2##2##(2011-2#1)(2012-3#1)
translation system##2##2##(1991-10#1)(1995-2#1)
translation termination##2##2##(2008-9#2)
translation to##3##2##(1991-12#1)(2009-10#1)(2011-1#1)
translation##279##1##(1990-11#2)(1990-12#1)(1990-5#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-5#1)(1991-9#2)(1992-11#3)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#2)(1994-8#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#6)(1996-1#1)(1996-2#1)(1996-5#3)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#5)(1997-6#10)(1997-7#4)(1997-8#3)(2007-11#5)(2007-12#8)(2007-8#4)(2008-1#4)(2008-10#23)(2008-11#18)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#8)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#21)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#8)(2012-12#5)(2012-2#9)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#6)
translational and##3##2##(1995-11#1)(2008-3#1)(2013-1#1)
translational capacity##2##2##(1994-8#1)(2008-11#1)
translational control during##2##3##(1993-12#1)(1994-8#1)
translational control##9##2##(1993-12#1)(1994-8#1)(2007-12#1)(2008-9#1)(2009-3#1)(2013-8#4)
translational diffusion##2##2##(1993-11#1)(1997-6#1)
translational efficiency##4##2##(2008-11#1)(2008-7#2)(2008-9#1)
translational fusions##4##2##(1990-11#1)(1990-5#1)(1994-12#2)
translational initiation codon##2##3##(1993-3#1)(1994-11#1)
translational initiation##6##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(2008-8#2)
translational level##6##2##(1991-12#2)(1992-8#1)(2008-8#3)
translational machinery is##2##3##(1994-8#1)(2013-8#1)
translational machinery##5##2##(1992-12#1)(1994-8#1)(2008-9#2)(2013-8#1)
translational negative feedback##2##3##(2010-10#2)
translational product was##2##3##(1990-11#1)(1991-12#1)
translational regulation of##2##3##(1992-8#1)(2008-10#1)
translational regulation##6##2##(1992-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#2)
translational research in##3##3##(2008-7#1)(2010-10#2)
translational research##11##2##(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#2)(2010-6#1)(2011-1#1)(2012-12#1)
translational shifts##2##2##(2008-2#2)
translational start codon##3##3##(1992-3#1)(1997-4#1)(2008-9#1)
translational start##7##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-3#1)(1997-4#1)(2008-4#1)(2008-9#1)
translational studies##2##2##(2008-6#1)(2010-5#1)
translational systems biology##2##3##(2010-9#2)
translational temperature and##2##3##(2008-2#1)(2008-3#1)
translational temperature##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
translational termination##2##2##(2008-10#1)(2008-4#1)
translational##123##1##(1990-11#3)(1990-5#3)(1990-7#1)(1991-1#1)(1991-12#4)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#4)(1995-11#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#8)(2009-3#4)(2010-10#4)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#5)
translationally regulated##2##2##(1992-11#1)(2009-3#1)
translationally##6##1##(1992-11#1)(1993-9#1)(2008-11#1)(2009-3#1)(2010-12#2)
translations are##3##2##(1994-3#1)(2008-2#1)(2008-3#1)
translations of the##3##3##(1994-3#1)(2008-3#1)(2012-2#1)
translations##9##1##(1994-3#2)(2008-2#1)(2008-3#2)(2009-6#1)(2010-1#2)(2012-2#1)
translations)##2##1##(2013-1#2)
translator##2##1##(2008-2#1)(2012-2#1)
translocase##3##1##(1995-2#1)(2011-2#1)(2012-2#1)
translocate across##2##2##(1997-1#1)(2007-12#1)
translocate##10##1##(1990-2#1)(1994-5#1)(1997-1#1)(2007-12#2)(2008-11#1)(2009-10#2)(2011-2#1)(2011-3#1)
translocated across the cytoplasmic membrane and##2##6##(1991-10#2)
translocated across the##3##3##(1991-10#3)
translocated from the##3##3##(1991-12#1)(1992-6#1)(2011-2#1)
translocated into the nucleus##2##4##(1996-12#1)(2009-8#1)
translocated into the##3##3##(1990-12#1)(1996-12#1)(2009-8#1)
translocated onto##2##2##(1992-6#1)(2009-10#1)
translocated to the nucleus##2##4##(1994-6#1)(1994-9#1)
translocated to the##8##3##(1990-11#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
translocated##28##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#3)(1991-12#1)(1992-6#2)(1992-8#1)(1993-2#3)(1993-8#1)(1994-6#1)(1994-9#1)(1996-12#1)(2008-10#4)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#4)
translocates##7##1##(1992-12#1)(1993-11#1)(1995-2#1)(2008-10#1)(2011-2#1)(2012-1#2)
translocating##3##1##(1990-5#1)(1996-9#1)(2012-2#1)
translocation across the##3##3##(1994-2#1)(1994-8#1)(2012-2#1)
translocation activity of F(0)##3##4##(2008-8#3)
translocation activity of##5##3##(1997-8#1)(2008-8#4)
translocation activity##6##2##(1997-8#1)(2008-8#5)
translocation and translocation-addition lines##2##4##(2008-8#2)
translocation and##8##2##(1994-6#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-8#2)(2009-8#1)(2012-3#1)
translocation between chromosomes##2##3##(2009-2#1)(2012-12#1)
translocation between##5##2##(1995-12#1)(1997-3#1)(2008-8#1)(2009-2#1)(2012-12#1)
translocation by##4##2##(1992-6#1)(1994-11#1)(2008-10#1)(2008-8#1)
translocation events##2##2##(2008-6#1)(2008-7#1)
translocation from the##2##3##(1992-8#1)(2008-10#1)
translocation from##10##2##(1990-12#1)(1991-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-9#1)
translocation in##8##2##(1993-2#1)(1994-11#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)
translocation into the endoplasmic reticulum##2##5##(1991-2#2)
translocation into the##3##3##(1991-2#3)
translocation into##6##2##(1991-2#3)(1995-12#1)(1997-8#1)(2013-1#1)
translocation is##6##2##(1993-6#1)(1994-11#2)(2008-1#1)(2008-6#1)(2012-1#1)
translocation line##4##2##(2008-5#1)(2008-8#3)
translocation of PKC-sigma and PKC-epsilon##2##5##(1995-11#2)
translocation of PKCalpha from both mitochondria and cytosol to nucleus##2##10##(2008-9#2)
translocation of PKCalpha##3##3##(2008-9#3)
translocation of a##4##3##(1997-8#2)(2008-10#1)(2011-2#1)
translocation of glucose transporter 4##2##5##(2008-11#2)
translocation of rac p21s##4##4##(1993-8#4)
translocation of the cytosolic##2##4##(1990-7#1)(2009-12#1)
translocation of the##9##3##(1990-7#1)(1992-3#2)(1995-6#1)(2008-10#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)
translocation of##63##2##(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#4)(1992-8#1)(1993-8#6)(1994-11#3)(1994-12#1)(1994-8#2)(1995-11#5)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-8#2)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2010-10#2)(2010-11#2)(2011-2#2)(2012-2#2)
translocation points##2##2##(1996-6#2)
translocation through##3##2##(1991-5#1)(2008-4#1)(2009-7#1)
translocation to the##5##3##(1992-11#1)(1993-8#1)(2008-1#1)(2008-11#2)
translocation to##8##2##(1992-11#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#2)
translocation was##6##2##(1990-5#1)(1994-6#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-3#1)
translocation were##2##2##(2007-12#1)(2012-2#1)
translocation with##3##2##(2007-11#1)(2008-10#1)(2010-10#1)
translocation##214##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-5#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#4)(1992-6#3)(1992-8#3)(1993-2#3)(1993-6#3)(1993-8#8)(1994-10#1)(1994-11#11)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-10#1)(1995-11#7)(1995-12#6)(1995-3#1)(1995-6#3)(1996-12#1)(1996-3#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#5)(2007-11#6)(2007-12#5)(2008-1#3)(2008-10#17)(2008-11#7)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#18)(2008-9#6)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#7)(2010-11#3)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#5)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#1)
translocation-addition lines##3##2##(2008-8#3)
translocation-addition##4##1##(2008-8#4)
translocations and##2##2##(2007-11#1)(2008-1#1)
translocations are##3##2##(2008-6#1)(2009-8#1)(2012-3#1)
translocations associated with##2##3##(1997-7#1)(2008-7#1)
translocations in T-cell acute##2##4##(1994-8#2)
translocations in##3##2##(1994-8#2)(1996-2#1)
translocations is##2##2##(2008-5#1)(2008-6#1)
translocations##27##1##(1994-12#1)(1994-8#2)(1995-8#1)(1996-2#1)(1997-7#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#4)(2011-2#1)(2012-3#1)(2013-8#1)
translocator protein (TSPO)##5##3##(2012-2#5)
translocator protein##6##2##(1995-2#1)(2012-2#5)
translocator##11##1##(1994-9#1)(1995-2#5)(2012-2#5)
translucency of##3##2##(2012-2#3)
translucency##12##1##(1991-11#1)(1995-8#2)(2008-11#2)(2012-2#5)(2013-1#2)
translucens and##3##2##(2008-10#3)
translucens population size##2##3##(2008-10#2)
translucens population##3##2##(2008-10#3)
translucens pv##15##2##(2008-10#15)
translucens strains##3##2##(2008-10#3)
translucens##39##1##(2008-10#39)
translucent##7##1##(2007-12#1)(2008-10#1)(2008-3#2)(2009-8#1)(2012-2#2)
transluminal angioplasty (PTA) was##2##4##(2008-1#1)(2011-2#1)
transluminal angioplasty (PTA)##4##3##(2008-1#1)(2008-7#1)(2011-2#2)
transluminal angioplasty##12##2##(1991-3#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-7#2)(2011-2#2)
transluminal coronary angioplasty (PTCA)##11##4##(1992-4#1)(1992-9#1)(1994-11#2)(2006-8#1)(2007-10#1)(2007-8#1)(2008-5#2)(2008-7#1)(2013-8#1)
transluminal coronary angioplasty##20##3##(1992-4#1)(1992-9#1)(1994-11#3)(1995-2#1)(1995-8#1)(2006-8#1)(2007-10#2)(2007-8#4)(2008-11#2)(2008-5#2)(2008-7#1)(2013-8#1)
transluminal coronary##21##2##(1991-3#1)(1992-4#1)(1992-9#1)(1994-11#3)(1995-2#1)(1995-8#1)(2006-8#1)(2007-10#2)(2007-8#4)(2008-11#2)(2008-5#2)(2008-7#1)(2013-8#1)
transluminal##37##1##(1991-3#2)(1992-4#1)(1992-9#1)(1993-8#1)(1994-11#3)(1994-9#1)(1995-2#1)(1995-8#1)(1997-3#1)(2006-8#1)(2007-10#2)(2007-8#5)(2008-1#3)(2008-11#3)(2008-5#2)(2008-7#4)(2009-2#1)(2011-2#2)(2013-1#1)(2013-8#1)
transmastoid approach##2##2##(2011-2#2)
transmastoid##4##1##(2011-2#4)
transmembrane H+##3##2##(1994-6#3)
transmembrane and cytoplasmic##2##3##(1992-12#1)(1997-4#1)
transmembrane and##3##2##(1992-12#1)(1993-12#1)(1997-4#1)
transmembrane conductance regulator (CFTR)##2##4##(1990-8#1)(2011-3#1)
transmembrane conductance regulator##3##3##(1990-8#1)(1994-5#1)(2011-3#1)
transmembrane domain (TMD)##2##3##(2012-2#1)(2013-1#1)
transmembrane domain and an##2##4##(1993-3#1)(2008-11#1)
transmembrane domain and##5##3##(1992-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(2008-11#1)
transmembrane domain of the##5##4##(1992-12#2)(1993-11#1)(1994-6#1)(1994-8#1)
transmembrane domain of##7##3##(1992-12#2)(1993-11#1)(1994-6#2)(1994-8#1)(2008-11#1)
transmembrane domain##24##2##(1990-7#1)(1991-9#1)(1992-12#3)(1993-11#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-2#1)(1997-4#1)(2008-11#2)(2008-4#2)(2009-10#2)(2012-2#2)(2013-1#1)
transmembrane domains and##2##3##(2008-11#1)(2011-1#1)
transmembrane domains##16##2##(1992-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(2008-11#1)(2008-4#7)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
transmembrane electron##2##2##(1994-3#1)(2009-9#1)
transmembrane glycoprotein##3##2##(1992-12#1)(1995-2#1)(1996-12#1)
transmembrane helices##6##2##(1990-5#1)(1993-11#1)(1993-3#2)(2008-4#2)
transmembrane helix of##2##3##(1994-12#1)(2008-8#1)
transmembrane helix##6##2##(1993-11#1)(1994-12#1)(1995-2#1)(2008-8#3)
transmembrane potential##8##2##(1994-12#6)(2008-1#1)(2008-8#1)
transmembrane protein##6##2##(1993-12#1)(2007-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
transmembrane proteins that##2##3##(2008-9#1)(2012-3#1)
transmembrane proteins with##2##3##(2009-1#1)(2009-8#1)
transmembrane proteins##12##2##(1994-12#1)(1995-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#3)(2012-3#1)(2013-1#1)
transmembrane region##6##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-2#1)(2009-8#1)
transmembrane regions of##2##3##(1993-3#1)(2012-2#1)
transmembrane regions##5##2##(1993-3#2)(1994-8#1)(1996-6#1)(2012-2#1)
transmembrane segment of##2##3##(1990-12#1)(1993-8#1)
transmembrane segment##4##2##(1990-12#1)(1993-8#1)(1993-9#1)(2008-8#1)
transmembrane segments##5##2##(1990-5#1)(1995-2#1)(1996-12#1)(1996-3#1)(2012-2#1)
transmembrane segments)##2##2##(1996-2#2)
transmembrane signaling in##2##3##(2008-9#1)(2011-1#1)
transmembrane signaling##12##2##(1991-12#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-5#1)(2008-9#2)(2011-1#3)(2012-2#1)
transmembrane transfer of##2##3##(1990-12#1)(1995-2#1)
transmembrane transport##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
transmembrane##167##1##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#7)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#8)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#9)(1994-3#1)(1994-5#2)(1994-6#5)(1994-8#2)(1995-12#1)(1995-2#6)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#15)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-2#1)(2009-8#4)(2009-9#3)(2010-10#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#1)
transmigration of##2##2##(2008-10#2)
transmigration##3##1##(2008-10#3)
transmissibility of##3##2##(1996-12#1)(2008-10#2)
transmissibility##8##1##(1996-12#1)(2008-10#6)(2011-3#1)
transmissible and nontransmissible##2##3##(2008-10#2)
transmissible by the whitefly vector##2##5##(2008-10#2)
transmissible by the##3##3##(2008-10#3)
transmissible from##3##2##(2007-12#1)(2008-10#2)
transmissible spongiform##2##2##(1996-5#1)(2008-5#1)
transmissible##18##1##(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#10)(2008-5#1)(2010-5#1)(2011-2#2)(2013-8#1)
transmission activity##2##2##(1996-2#2)
transmission among##5##2##(1991-1#1)(2007-12#1)(2012-2#1)(2013-8#2)
transmission and prevention##5##3##(1992-2#1)(2011-2#2)(2012-12#2)
transmission and reflection##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
transmission and solar aureole measurements##2##5##(2008-3#2)
transmission and the##5##3##(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)
transmission and to##2##3##(2009-8#1)(2013-1#1)
transmission and##74##2##(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#16)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2013-1#1)
transmission are not##2##3##(2007-7#1)(2008-10#1)
transmission are##5##2##(2007-11#1)(2007-7#1)(2008-10#1)(2012-3#1)(2013-1#1)
transmission as a function of the##2##6##(2007-11#1)(2007-12#1)
transmission as a function of##3##5##(2007-11#1)(2007-12#1)(2012-2#1)
transmission at a maximum age-specific penetrance##2##6##(1997-5#2)
transmission at the##2##3##(2008-3#1)(2008-9#1)
transmission at##14##2##(1996-2#1)(1997-2#1)(1997-5#2)(2007-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)
transmission bandwidth##2##2##(2007-12#1)(2008-3#1)
transmission based on##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
transmission between##5##2##(2007-11#1)(2007-12#1)(2008-7#2)(2011-2#1)
transmission but##4##2##(2006-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
transmission by the##3##3##(2008-10#2)(2008-3#1)
transmission by##22##2##(1993-3#1)(1995-6#1)(2007-11#1)(2008-10#16)(2008-3#1)(2010-1#1)(2012-3#1)
transmission can be##3##3##(2008-10#1)(2008-3#2)
transmission changes##2##2##(2008-2#1)(2008-9#1)
transmission characteristics of##5##3##(2008-10#1)(2008-3#4)
transmission characteristics##6##2##(2008-10#1)(2008-3#5)
transmission classes##2##2##(2008-10#2)
transmission coefficient for##2##3##(2007-12#1)(2008-3#1)
transmission coefficient##3##2##(2007-12#1)(2008-3#2)
transmission cycle##3##2##(2008-9#1)(2010-6#2)
transmission data##4##2##(2008-2#4)
transmission due to##2##3##(2008-3#1)(2013-1#1)
transmission during##2##2##(1996-5#1)(2007-7#1)
transmission dynamics##3##2##(1991-9#1)(1992-9#2)
transmission efficiency for##2##3##(2008-10#2)
transmission efficiency of the##2##4##(2008-10#2)
transmission efficiency of##5##3##(2008-10#4)(2008-3#1)
transmission efficiency was##2##3##(2008-10#1)(2008-3#1)
transmission efficiency##12##2##(2008-10#9)(2008-2#1)(2008-3#2)
transmission electron microscope (TEM)##3##4##(2008-8#1)(2009-11#1)(2009-7#1)
transmission electron microscope##8##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)
transmission electron microscopic##3##3##(2006-10#1)(2008-5#1)(2009-11#1)
transmission electron microscopy (TEM)##13##4##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
transmission electron microscopy and##5##4##(2008-10#4)(2009-11#1)
transmission electron microscopy showed##3##4##(2007-7#1)(2008-7#1)(2008-8#1)
transmission electron microscopy to##6##4##(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
transmission electron microscopy were##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
transmission electron microscopy##76##3##(1992-11#1)(1997-3#1)(1997-6#1)(2007-12#10)(2007-7#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#7)(2008-7#10)(2008-8#2)(2009-11#2)(2009-2#3)(2009-7#3)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
transmission electron##90##2##(1991-12#1)(1992-11#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-12#11)(2007-7#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#8)(2008-7#13)(2008-8#3)(2009-11#5)(2009-2#3)(2009-7#4)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
transmission enhancement##2##2##(2007-12#2)
transmission experiments##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
transmission for the##2##3##(2008-3#1)(2008-7#1)
transmission for##9##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)
transmission from the##2##3##(1992-8#1)(2013-1#1)
transmission from##10##2##(1992-8#2)(1995-6#1)(1996-5#1)(1997-6#1)(2008-10#2)(2012-12#2)(2013-1#1)
transmission function##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
transmission functions for##2##3##(2008-2#2)
transmission functions##3##2##(2008-2#3)
transmission grating##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
transmission gratings##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
transmission has been##2##3##(1997-7#1)(2008-8#1)
transmission holograms##2##2##(2008-2#1)(2008-3#1)
transmission imaging of##2##3##(2007-12#1)(2008-3#1)
transmission in a##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
transmission in dispersion-managed##2##3##(2007-12#2)
transmission in hippocampal##2##3##(1996-5#1)(2013-8#1)
transmission in the laboratory##2##4##(2008-10#2)
transmission in the##21##3##(1990-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#2)(1997-2#2)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2011-3#1)(2012-3#1)(2013-8#1)
transmission in##55##2##(1990-5#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-5#1)(1997-2#3)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2010-8#1)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#4)
transmission is favored##2##3##(2008-9#2)
transmission is not##3##3##(2008-8#1)(2011-3#1)(2012-3#1)
transmission is the##2##3##(2007-7#1)(2008-10#1)
transmission is##23##2##(1991-11#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#4)(2011-3#1)(2012-3#1)
transmission laser micro-joining of thin##2##5##(2009-7#2)
transmission laser##3##2##(2009-7#3)
transmission line with##2##3##(2007-11#1)(2007-9#1)
transmission line##6##2##(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)
transmission lines is##2##3##(2007-11#1)(2008-3#1)
transmission lines##7##2##(2007-11#4)(2008-3#2)(2012-2#1)
transmission loss##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
transmission matrix##2##2##(2008-3#1)(2013-8#1)
transmission measurement##3##2##(2007-12#1)(2008-2#1)(2008-5#1)
transmission measurements in##2##3##(2008-2#1)(2008-3#1)
transmission measurements with##2##3##(2008-3#1)(2008-5#1)
transmission measurements##16##2##(2007-11#1)(2008-2#4)(2008-3#9)(2008-5#2)
transmission mechanism##2##2##(2008-10#2)
transmission mode##5##2##(2008-2#2)(2008-3#1)(2008-9#2)
transmission model##4##2##(2008-10#3)(2008-3#1)
transmission network##2##2##(2013-1#2)
transmission occurred##2##2##(2008-10#2)
transmission of HCV infection in##2##5##(2007-7#2)
transmission of HIV in##2##4##(2009-4#1)(2013-1#1)
transmission of HIV##11##3##(1991-3#1)(1993-3#1)(1996-5#1)(2009-4#3)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
transmission of HIV-1##2##3##(1992-8#1)(2009-4#1)
transmission of SIVs##2##3##(2013-1#1)(2013-8#1)
transmission of TSWV##2##3##(2008-10#2)
transmission of TYMV in##2##4##(2008-10#2)
transmission of a##6##3##(2007-11#1)(2008-10#1)(2008-3#4)
transmission of both##4##3##(1994-11#1)(1997-7#1)(2008-10#1)(2009-4#1)
transmission of hepatitis C virus##2##5##(2007-7#2)
transmission of hepatitis C##3##4##(2007-7#2)(2008-1#1)
transmission of hepatitis##4##3##(1996-3#1)(2007-7#2)(2008-1#1)
transmission of infection##4##3##(2009-5#1)(2010-5#2)(2013-8#1)
transmission of information##3##3##(1990-11#1)(2008-5#1)(2010-8#1)
transmission of laser##2##3##(2008-3#2)
transmission of light through##2##4##(2008-3#2)
transmission of light##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
transmission of schistosomiasis##3##3##(2008-8#2)(2012-3#1)
transmission of the virus##2##4##(1996-11#1)(2008-10#1)
transmission of the##17##3##(1993-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-9#1)(2011-1#1)(2011-3#1)
transmission of this##2##3##(2008-10#2)
transmission of two##2##3##(2008-3#1)(2008-9#1)
transmission of virus##2##3##(2008-10#2)
transmission of x rays##2##4##(2007-11#1)(2008-3#1)
transmission of##178##2##(1990-11#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-7#6)(2008-1#1)(2008-10#36)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#19)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#3)(2009-2#1)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#6)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
transmission on##4##2##(2007-12#1)(2008-3#2)(2008-8#1)
transmission or##6##2##(1995-12#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
transmission over##5##2##(2007-12#4)(2008-9#1)
transmission patterns##2##2##(2008-3#1)(2013-1#1)
transmission per##2##2##(2008-3#1)(2011-3#1)
transmission performance##3##2##(2007-11#2)(2008-3#1)
transmission profile##2##2##(2008-2#1)(2008-5#1)
transmission properties of##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
transmission properties##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
transmission quality##2##2##(2007-12#2)
transmission rate by##2##3##(2008-10#1)(2008-3#1)
transmission rate of the##2##4##(2008-8#1)(2008-9#1)
transmission rate of##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
transmission rate##12##2##(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)
transmission rates##7##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
transmission regions##2##2##(2012-12#1)(2012-3#1)
transmission risk##2##2##(2008-8#1)(2012-12#1)
transmission spectra and##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
transmission spectra of the##3##4##(2007-11#2)(2008-3#1)
transmission spectra of##7##3##(2007-11#3)(2008-3#4)
transmission spectra##21##2##(2007-11#7)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#7)(2013-8#1)
transmission spectrometry using excised human epidermis as the substrate##2##9##(2008-5#2)
transmission spectrophotometer##2##2##(2010-8#1)(2011-2#1)
transmission spectroscopy##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
transmission spectrum of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
transmission spectrum##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
transmission still##2##2##(1994-8#1)(2007-11#1)
transmission such##2##2##(1994-11#1)(2011-2#1)
transmission system##12##2##(2007-11#3)(2007-12#6)(2008-3#2)(2013-1#1)
transmission systems with##2##3##(2007-11#1)(2007-12#1)
transmission systems##7##2##(2007-11#5)(2007-12#2)
transmission that##4##2##(1993-12#1)(2007-12#1)(2008-3#2)
transmission through a##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
transmission through an optical##2##4##(2007-12#1)(2008-3#1)
transmission through an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
transmission through seed was##2##4##(2008-10#2)
transmission through the##6##3##(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#2)(2011-2#1)
transmission through##28##2##(2007-11#4)(2007-12#6)(2007-9#1)(2008-10#4)(2008-2#4)(2008-3#6)(2008-9#1)(2010-1#1)(2011-2#1)
transmission to patients##2##3##(1992-12#1)(2008-3#1)
transmission to the##6##3##(1990-11#1)(1995-6#1)(1997-4#1)(2010-10#1)(2011-2#2)
transmission to uninfected##2##3##(2008-4#1)(2012-3#1)
transmission to##25##2##(1990-11#1)(1992-12#1)(1995-6#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
transmission was not##2##3##(2008-10#1)(2008-8#1)
transmission was##16##2##(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
transmission were##2##2##(1996-5#1)(2009-10#1)
transmission with##3##2##(2007-11#1)(2008-3#2)
transmission within the##3##3##(2011-3#2)(2013-8#1)
transmission within##4##2##(2008-8#1)(2011-3#2)(2013-8#1)
transmission##1160##1##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#2)(1993-12#6)(1993-3#2)(1993-6#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#5)(1995-11#2)(1995-12#7)(1995-2#2)(1995-5#1)(1995-6#6)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#1)(1996-5#8)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#4)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#66)(2007-12#94)(2007-2#2)(2007-7#15)(2007-8#1)(2007-9#3)(2008-1#6)(2008-10#206)(2008-11#10)(2008-12#8)(2008-2#78)(2008-3#175)(2008-4#11)(2008-5#28)(2008-7#35)(2008-8#47)(2008-9#34)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#9)(2009-5#3)(2009-7#12)(2009-8#6)(2009-9#4)(2010-1#8)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-8#7)(2011-1#10)(2011-2#20)(2011-3#10)(2011-7#1)(2012-1#1)(2012-12#15)(2012-2#16)(2012-3#14)(2013-1#22)(2013-8#24)
transmission)##3##1##(1990-9#1)(2008-10#2)
transmission-blocking antibodies##3##2##(1991-5#3)
transmission-blocking##4##1##(1991-5#4)
transmission-type holographic##3##2##(2008-2#3)
transmission-type##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
transmissions by##4##2##(2007-11#2)(2008-10#2)
transmissions##18##1##(1994-3#2)(1996-2#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#2)
transmissive tilted##3##2##(2008-3#3)
transmissive##12##1##(2007-12#2)(2008-3#10)
transmissivity of##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
transmissivity##4##1##(2007-11#1)(2007-12#1)(2008-3#1)(2013-8#1)
transmissometer for##2##2##(2008-2#2)
transmit TSWV##4##2##(2008-10#4)
transmit and##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
transmit signals##2##2##(2009-8#1)(2010-9#1)
transmit the virus##4##3##(2008-10#4)
transmit the##8##2##(2008-10#6)(2008-3#1)(2008-8#1)
transmit this##2##2##(1991-9#1)(2012-12#1)
transmit##53##1##(1990-5#1)(1991-9#1)(1996-11#1)(1996-5#1)(1996-9#1)(2007-11#2)(2007-12#3)(2008-10#27)(2008-12#1)(2008-2#1)(2008-3#6)(2008-8#1)(2009-8#1)(2010-1#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
transmits the##2##2##(2008-3#1)(2010-2#1)
transmits##7##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-5#1)
transmittable##5##1##(2008-10#4)(2008-3#1)
transmittance and reflectance##2##3##(2008-2#1)(2008-3#1)
transmittance and the##3##3##(2007-11#1)(2008-3#2)
transmittance and##10##2##(2007-11#2)(2008-2#1)(2008-3#7)
transmittance are##2##2##(2008-2#1)(2008-3#1)
transmittance data##2##2##(2007-11#1)(2008-3#1)
transmittance in##2##2##(2008-2#1)(2008-3#1)
transmittance is##3##2##(2008-2#2)(2008-3#1)
transmittance measurements of##2##3##(2008-2#1)(2008-3#1)
transmittance measurements##10##2##(2007-11#1)(2008-2#4)(2008-3#5)
transmittance model##2##2##(2008-2#1)(2008-3#1)
transmittance of a##4##3##(2008-2#1)(2008-3#3)
transmittance of the##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
transmittance of##17##2##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#9)
transmittance spectra of##3##3##(2008-3#3)
transmittance spectra##5##2##(2008-3#5)
transmittance##94##1##(2007-11#8)(2007-12#2)(2008-10#3)(2008-2#26)(2008-3#52)(2008-5#3)
transmittances##3##1##(2008-2#1)(2008-3#2)
transmitted PPV to##2##3##(2008-10#2)
transmitted PPV##3##2##(2008-10#3)
transmitted and##10##2##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#5)
transmitted beam##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
transmitted between##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
transmitted by a##2##3##(2008-2#1)(2008-3#1)
transmitted by aphids##2##3##(2008-10#2)
transmitted by the fiber##2##4##(2008-2#1)(2008-3#1)
transmitted by the##17##3##(1994-8#2)(2008-10#10)(2008-2#1)(2008-3#2)(2010-1#1)(2011-2#1)
transmitted by whiteflies##2##3##(2008-10#2)
transmitted by##51##2##(1992-6#1)(1994-8#2)(1996-11#1)(1996-2#1)(2007-2#1)(2008-10#29)(2008-2#2)(2008-3#4)(2008-4#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
transmitted disease and##2##3##(2008-4#1)(2011-2#1)
transmitted disease##7##2##(1996-12#2)(2008-4#2)(2011-2#1)(2012-1#1)(2012-3#1)
transmitted diseases##25##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1992-4#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-7#2)(2009-12#1)(2011-1#1)(2012-12#1)
transmitted field##5##2##(2007-11#1)(2008-3#4)
transmitted from one##2##3##(2008-10#1)(2008-3#1)
transmitted from the##5##3##(2008-11#1)(2008-2#1)(2008-7#3)
transmitted from##17##2##(1990-3#1)(1990-9#1)(1997-6#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)
transmitted in the##2##3##(2008-10#1)(2008-7#1)
transmitted in##7##2##(1994-8#1)(2007-2#1)(2008-10#4)(2008-7#1)
transmitted infection##2##2##(2008-11#1)(2008-12#1)
transmitted infections (STIs)##3##3##(2007-7#1)(2008-12#1)(2011-2#1)
transmitted infections##22##2##(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#2)(2009-5#2)(2010-11#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
transmitted laser beam##2##3##(2008-3#1)(2009-11#1)
transmitted laser light##3##3##(2007-12#2)(2008-3#1)
transmitted laser##5##2##(2007-12#2)(2008-3#2)(2009-11#1)
transmitted light intensity##2##3##(2008-2#1)(2008-3#1)
transmitted light##12##2##(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)
transmitted only##2##2##(2008-10#2)
transmitted over##3##2##(1992-3#1)(2007-12#1)(2009-9#1)
transmitted pump##2##2##(2007-12#2)
transmitted sexually##2##2##(1996-8#1)(2011-2#1)
transmitted signal##2##2##(2008-3#2)
transmitted the##5##2##(1992-6#1)(2008-10#4)
transmitted through a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
transmitted through the##9##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)
transmitted through##25##2##(1996-5#3)(1997-8#1)(2007-11#2)(2007-12#7)(2008-10#3)(2008-2#2)(2008-3#7)
transmitted to and##2##3##(1990-5#1)(2010-9#1)
transmitted to humans##2##3##(2011-2#1)(2013-8#1)
transmitted to the##5##3##(1992-6#1)(1994-5#2)(1995-5#1)(2012-2#1)
transmitted to##15##2##(1990-5#1)(1992-6#1)(1994-5#2)(1995-5#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
transmitted vertically##2##2##(1995-9#1)(2007-12#1)
transmitted via##4##2##(1990-6#1)(2007-11#1)(2007-2#1)(2008-10#1)
transmitted with##3##2##(1997-6#1)(2008-10#1)(2009-10#1)
transmitted##327##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1993-1#3)(1993-2#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#4)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#1)(2007-11#9)(2007-12#20)(2007-2#5)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#81)(2008-11#5)(2008-12#5)(2008-2#22)(2008-3#42)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-9#1)(2011-1#4)(2011-2#16)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#2)
transmitter and a##2##3##(2008-3#2)
transmitter and receiver##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
transmitter and##11##2##(2007-11#3)(2008-2#1)(2008-3#7)
transmitter for##2##2##(2008-2#1)(2009-10#1)
transmitter in the##2##3##(1993-3#1)(2008-7#1)
transmitter in##3##2##(1993-3#1)(2008-7#2)
transmitter is##2##2##(2007-11#1)(2008-3#1)
transmitter or##2##2##(2007-12#1)(2008-7#1)
transmitter power##2##2##(2007-12#1)(2008-3#1)
transmitter release##2##2##(1995-11#2)
transmitter##44##1##(1992-6#1)(1993-3#2)(1995-11#3)(1996-12#2)(1996-5#1)(2007-11#6)(2007-12#6)(2008-11#1)(2008-2#4)(2008-3#13)(2008-5#1)(2008-7#3)(2009-10#1)
transmitter-receiver##3##1##(2007-12#1)(2008-2#2)
transmitters (up to##2##3##(2008-10#2)
transmitters and##3##2##(2008-2#2)(2008-8#1)
transmitters##17##1##(1992-6#1)(1995-11#2)(1997-2#1)(1997-4#1)(2008-10#3)(2008-2#3)(2008-4#2)(2008-7#2)(2008-8#1)(2009-12#1)
transmitting the virus##2##3##(2008-10#2)
transmitting the##6##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
transmitting##32##1##(1992-9#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#5)(2008-8#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-2#3)
transmittive filters##2##2##(2008-2#2)
transmittive##3##1##(2008-2#3)
transmural and##3##2##(2008-10#1)(2010-8#1)(2013-7#1)
transmural dispersion of repolarization and##2##5##(2009-8#1)(2010-8#1)
transmural##17##1##(1990-5#1)(1991-3#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-8#3)(2012-2#1)(2013-1#1)(2013-7#3)
transmyocardial laser revascularization##2##3##(2007-8#2)
transnasal approach to the##2##4##(2011-2#2)
transnasal approach##3##2##(2011-2#3)
transnasal endoscopic##2##2##(2011-2#2)
transnasal##13##1##(1991-1#1)(2007-2#1)(2008-8#1)(2011-2#8)(2012-1#1)(2013-1#1)
transnitrosation reaction##3##2##(1995-5#3)
transoesophageal echocardiography##3##2##(1994-11#1)(2007-9#1)(2012-3#1)
transoesophageal##4##1##(1994-11#1)(2007-9#1)(2008-8#1)(2012-3#1)
transoral##7##1##(1991-4#1)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#3)
transovarial transmission##3##2##(2008-10#3)
transovarial##4##1##(2008-10#4)
transpalpebral##3##1##(2011-2#3)
transpapillary##5##1##(1990-3#2)(1991-3#1)(2013-1#2)
transparencies##4##1##(2007-12#1)(2008-10#1)(2008-3#2)
transparency and##7##2##(1993-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
transparency in##4##2##(2008-11#1)(2008-2#1)(2011-2#2)
transparency of the##6##3##(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)
transparency of##8##2##(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)(2013-7#1)
transparency##48##1##(1993-5#1)(2007-11#3)(2007-12#9)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
transparent and turbid##2##3##(1994-3#1)(2007-11#1)
transparent and##11##2##(1994-3#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-7#2)(2011-2#1)(2013-7#1)
transparent ceramic##3##2##(2013-8#3)
transparent ceramics were##2##3##(2013-8#2)
transparent elastomeric##2##2##(2008-3#2)
transparent electrodes##2##2##(2008-3#1)(2008-7#1)
transparent film##2##2##(2007-11#1)(2008-11#1)
transparent glass ceramic##2##3##(2008-3#2)
transparent glass##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
transparent in the##3##3##(2007-12#2)(2013-1#1)
transparent in##4##2##(2007-12#2)(2008-4#1)(2013-1#1)
transparent liquid##2##2##(2008-3#1)(2013-8#1)
transparent materials##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
transparent media##3##2##(2007-11#3)
transparent or##5##2##(2008-2#1)(2008-3#4)
transparent particles##2##2##(2008-2#1)(2008-3#1)
transparent samples##2##2##(2008-3#2)
transparent substrate##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
transparent thin##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
transparent to the##2##3##(2008-3#2)
transparent to##3##2##(2008-3#3)
transparent##131##1##(1994-3#1)(1995-5#1)(1997-6#1)(2007-11#8)(2007-12#11)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#20)(2008-3#32)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#7)
transpedicular screws##4##2##(2007-11#4)
transpedicular##11##1##(2007-11#10)(2007-8#1)
transpeptidase##4##1##(1990-3#1)(1995-11#2)(2007-12#1)
transperitoneal##4##1##(1996-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
transpetrosal approach##3##2##(2008-7#3)
transpetrosal##4##1##(2008-7#4)
transphosphorylation of##2##2##(1995-2#2)
transpiration##8##1##(2008-10#7)(2012-7#1)
transpiring##2##1##(2008-11#1)(2008-7#1)
transplacental##3##1##(1990-7#1)(1991-3#1)(1992-4#1)
transplant after##2##2##(1994-6#1)(2012-1#1)
transplant and##2##2##(2006-10#1)(2008-1#1)
transplant are not##2##3##(2011-2#1)(2012-12#1)
transplant are##3##2##(2011-2#2)(2012-12#1)
transplant centers##6##2##(2008-1#1)(2008-4#1)(2010-6#1)(2010-8#2)(2011-3#1)
transplant experiment##3##2##(2008-8#1)(2008-9#2)
transplant for##2##2##(1992-3#1)(1994-5#1)
transplant has##2##2##(2007-7#1)(2008-1#1)
transplant in##2##2##(2007-7#1)(2008-1#1)
transplant is the best##2##4##(2011-2#2)
transplant is##4##2##(2010-6#1)(2011-2#3)
transplant outcome##2##2##(1997-8#1)(2010-5#1)
transplant patient##6##2##(1991-3#1)(2007-2#1)(2007-7#2)(2008-1#1)(2013-1#1)
transplant patients at##2##3##(2008-1#2)
transplant patients is##2##3##(1994-5#1)(2008-1#1)
transplant patients to##2##3##(2006-6#1)(2008-4#1)
transplant patients##28##2##(1990-3#1)(1994-5#3)(1996-8#1)(2006-6#1)(2008-1#13)(2008-10#3)(2008-3#1)(2008-4#1)(2009-10#2)(2010-7#1)(2013-1#1)
transplant population in Saudi Arabia##2##5##(2008-1#2)
transplant population##4##2##(2007-7#1)(2008-1#3)
transplant program##3##2##(2009-3#1)(2011-2#1)(2013-8#1)
transplant programs##2##2##(2008-4#1)(2011-2#1)
transplant recipient##8##2##(2007-7#2)(2008-1#2)(2008-6#1)(2009-2#2)(2011-3#1)
transplant recipients and##2##3##(2008-4#1)(2010-12#1)
transplant recipients in##2##3##(2007-7#2)
transplant recipients##38##2##(1991-11#1)(1996-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-7#2)(2008-1#3)(2008-10#2)(2008-3#8)(2008-4#6)(2008-6#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
transplant rejection##3##2##(1995-8#1)(2008-10#1)(2012-3#1)
transplant renal artery##2##3##(2008-1#2)
transplant was##3##2##(1993-9#1)(1997-3#1)(2010-11#1)
transplant##230##1##(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#2)(1992-3#1)(1993-9#1)(1994-3#1)(1994-5#4)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-5#1)(2007-7#11)(2008-1#40)(2008-10#10)(2008-11#1)(2008-3#9)(2008-4#11)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#3)(2009-2#3)(2009-3#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#3)(2011-2#26)(2011-3#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
transplant-related##2##1##(2008-9#1)(2009-10#1)
transplantable organs##2##2##(1991-3#1)(1994-1#1)
transplantable##9##1##(1990-7#1)(1991-3#2)(1991-6#1)(1992-1#2)(1992-8#1)(1994-1#1)(1995-5#1)
transplantation (n = 1)##2##4##(1994-3#2)
transplantation and its##4##3##(2007-10#1)(2011-2#1)(2012-2#2)
transplantation and##15##2##(2007-10#1)(2008-10#1)(2008-4#2)(2010-10#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
transplantation are##3##2##(1994-6#1)(1997-5#1)(2011-2#1)
transplantation as immunotherapy for##2##4##(2008-11#2)
transplantation as##3##2##(2007-7#1)(2008-11#2)
transplantation at##2##2##(2008-1#1)(2011-2#1)
transplantation but##2##2##(2008-11#1)(2011-2#1)
transplantation can be##2##3##(2011-3#1)(2012-12#1)
transplantation can##5##2##(1997-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
transplantation carries##2##2##(2008-1#1)(2010-12#1)
transplantation due to##2##3##(2008-1#1)(2011-1#1)
transplantation for patients with##2##4##(1991-11#1)(2010-5#1)
transplantation for the treatment of##3##5##(2009-3#1)(2010-12#1)(2013-1#1)
transplantation for the##4##3##(2009-3#1)(2010-12#1)(2010-6#1)(2013-1#1)
transplantation for##24##2##(1990-5#1)(1991-11#3)(1994-8#1)(1995-8#1)(2006-10#1)(2007-8#2)(2008-7#1)(2009-3#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
transplantation from##4##2##(1992-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
transplantation has been shown##2##4##(2010-11#2)
transplantation has been##5##3##(2008-11#2)(2010-11#2)(2013-8#1)
transplantation has##11##2##(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#2)(2010-11#2)(2011-3#1)(2012-7#1)(2013-8#1)
transplantation in a patient with##3##5##(1992-12#1)(2006-10#1)(2011-2#1)
transplantation in a patient##4##4##(1992-12#1)(2006-10#1)(2011-2#1)(2012-12#1)
transplantation in a##7##3##(1991-11#1)(1992-12#1)(2006-10#1)(2011-2#3)(2012-12#1)
transplantation in the type##2##4##(2008-1#2)
transplantation in the##8##3##(2008-1#2)(2008-4#4)(2011-2#2)
transplantation in##43##2##(1991-11#2)(1992-12#1)(1992-6#2)(1994-3#1)(1996-6#1)(1997-5#2)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-4#4)(2008-7#3)(2010-11#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2013-1#1)(2013-8#2)
transplantation into##8##2##(1991-11#2)(1997-4#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-12#1)
transplantation is a##4##3##(1997-4#1)(2007-8#1)(2011-3#1)(2012-12#1)
transplantation is an##3##3##(1997-8#1)(2010-10#1)(2010-6#1)
transplantation is limited by##2##4##(2007-8#1)(2012-12#1)
transplantation is##33##2##(1993-2#1)(1994-6#1)(1995-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-6#2)(2011-2#5)(2011-3#4)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)
transplantation may##2##2##(1991-5#1)(2007-8#1)
transplantation model##2##2##(2006-10#1)(2008-7#1)
transplantation of human##2##3##(2012-12#2)
transplantation of mesenchymal stem cells##5##5##(2012-1#4)(2012-7#1)
transplantation of mononuclear bone marrow cells##2##6##(2012-1#2)
transplantation of mononuclear##3##3##(2012-1#3)
transplantation of##30##2##(1992-12#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-1#9)(2012-10#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)
transplantation on##2##2##(2008-4#1)(2009-10#1)
transplantation or##6##2##(1993-2#1)(2007-7#1)(2008-11#2)(2012-1#2)
transplantation remains the##3##3##(1997-5#1)(2007-8#1)(2010-10#1)
transplantation showed a##2##3##(2011-2#1)(2012-7#1)
transplantation therapy##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
transplantation to##4##2##(1994-3#2)(2007-7#1)(2008-12#1)
transplantation using##2##2##(1995-12#1)(2010-10#1)
transplantation was estimated##2##3##(1991-9#1)(2008-4#1)
transplantation was##13##2##(1991-5#1)(1991-9#2)(1995-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-4#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
transplantation were##3##2##(1991-8#1)(2012-2#1)(2013-1#1)
transplantation with a##2##3##(1994-3#1)(2008-1#1)
transplantation with##9##2##(1994-3#1)(1995-9#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
transplantation##534##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#8)(1991-2#1)(1991-3#1)(1991-5#4)(1991-8#2)(1991-9#3)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#5)(1992-9#1)(1993-12#1)(1993-2#5)(1994-1#1)(1994-3#8)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#6)(1995-2#4)(1995-8#2)(1995-9#3)(1996-11#2)(1996-2#1)(1996-6#2)(1996-9#1)(1997-3#9)(1997-4#3)(1997-5#6)(1997-7#3)(1997-8#4)(2006-10#14)(2007-10#3)(2007-11#5)(2007-12#1)(2007-4#2)(2007-7#16)(2007-8#13)(2008-1#31)(2008-10#10)(2008-11#17)(2008-12#2)(2008-4#13)(2008-5#7)(2008-6#2)(2008-7#14)(2008-8#5)(2008-9#2)(2009-10#7)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#12)(2010-11#18)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#7)(2011-1#3)(2011-2#66)(2011-3#19)(2012-1#15)(2012-10#1)(2012-12#21)(2012-2#15)(2012-3#8)(2012-7#9)(2013-1#21)(2013-7#2)(2013-8#13)
transplantation&quot##3##1##(2009-10#3)
transplantation]##19##1##(1990-3#1)(1991-5#1)(1993-3#1)(1994-5#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2011-2#8)(2012-2#1)(2012-3#1)(2013-8#1)
transplantations have been performed##2##4##(1995-2#1)(1997-5#1)
transplantations performed in##2##3##(1993-9#1)(1996-6#1)
transplantations were performed##2##3##(2008-1#1)(2012-12#1)
transplantations##16##1##(1993-9#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-5#2)(2008-1#2)(2011-2#2)(2011-3#3)(2012-12#1)(2012-3#1)
transplanted F344##2##2##(2011-2#2)
transplanted and##2##2##(1995-2#1)(2011-2#1)
transplanted bone##3##2##(1995-8#1)(2010-11#2)
transplanted cells##3##2##(2010-11#1)(2012-12#2)
transplanted hearts##2##2##(1991-3#1)(2009-3#1)
transplanted in##4##2##(1994-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
transplanted into the##2##3##(2008-10#1)(2010-11#1)
transplanted into##17##2##(1994-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-11#2)(2011-2#3)(2012-12#1)(2013-1#2)
transplanted islet##2##2##(2008-10#1)(2010-11#1)
transplanted islets##2##2##(2008-10#1)(2011-2#1)
transplanted kidney##3##2##(1992-2#2)(2012-12#1)
transplanted organ##2##2##(1990-12#1)(2011-3#1)
transplanted patients##6##2##(2007-4#1)(2007-9#1)(2008-10#1)(2010-8#1)(2013-1#2)
transplanted to##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
transplanted tumor of##2##3##(2008-9#1)(2011-2#1)
transplanted tumor##5##2##(1992-9#1)(2008-9#3)(2011-2#1)
transplanted with##4##2##(2008-11#1)(2008-4#1)(2011-3#1)(2012-2#1)
transplanted##99##1##(1990-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-2#2)(1992-3#1)(1992-9#2)(1993-12#1)(1994-5#2)(1995-2#1)(1995-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#5)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-11#7)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#3)(2012-12#5)(2012-2#1)(2012-7#2)(2013-1#7)(2013-7#1)(2013-8#1)
transplanting##7##1##(1992-12#1)(2008-10#4)(2008-8#1)(2008-9#1)
transplantion##2##1##(2008-1#1)(2011-3#1)
transplants in the field##2##4##(2008-10#2)
transplants in the##4##3##(2008-1#1)(2008-10#2)(2010-6#1)
transplants in##5##2##(2008-1#1)(2008-10#2)(2010-6#1)(2013-8#1)
transplants of##3##2##(1990-5#1)(1993-12#2)
transplants performed##2##2##(2008-1#1)(2009-3#1)
transplants were##4##2##(1991-11#1)(2007-7#1)(2007-8#1)(2008-1#1)
transplants with##2##2##(2008-10#1)(2011-2#1)
transplants##47##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#2)(1993-12#2)(1994-5#1)(1995-2#1)(1996-1#2)(1996-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#6)(2008-5#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#5)(2013-1#1)(2013-8#2)
transplasma membrane electron transfer##2##4##(2009-9#2)
transplasma membrane electron##3##3##(1992-11#1)(2009-9#2)
transplasma membrane##4##2##(1992-11#1)(2009-9#3)
transport a##2##2##(2008-7#1)(2011-2#1)
transport across the##2##3##(1991-12#1)(1997-2#1)
transport across##7##2##(1991-12#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#1)
transport activities##2##2##(1991-12#1)(2008-11#1)
transport activity of##2##3##(2008-11#1)(2008-8#1)
transport activity was##2##3##(1994-8#1)(1996-4#1)
transport activity##16##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-9#2)(1994-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(2008-11#1)(2008-8#2)(2011-2#2)
transport and the##7##3##(1990-11#1)(1990-12#1)(1992-6#1)(2007-8#1)(2008-7#1)(2009-9#1)(2013-1#1)
transport and##53##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-6#3)(1997-1#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-2#1)(2010-4#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
transport between##3##2##(1990-7#1)(1992-12#1)(1995-11#1)
transport by arachidonic acid##2##4##(1995-11#2)
transport by##14##2##(1990-11#1)(1992-11#2)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
transport can be##3##3##(1997-6#1)(2008-10#1)(2008-6#1)
transport can##4##2##(1994-3#1)(1997-6#1)(2008-10#1)(2008-6#1)
transport capacity##2##2##(1995-6#1)(2008-10#1)
transport characteristics of##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
transport characteristics##8##2##(1990-2#1)(1991-5#1)(2007-12#1)(2008-7#1)(2011-2#4)
transport competent##2##2##(1994-11#2)
transport equation is applied to##2##5##(2008-2#1)(2008-3#1)
transport equation is##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
transport equation##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
transport experiments##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
transport flux##2##2##(2008-7#2)
transport for##2##2##(2008-8#1)(2012-2#1)
transport from blood##2##3##(1993-12#1)(1994-9#1)
transport from the##7##3##(1996-2#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-8#1)
transport from##12##2##(1991-2#1)(1992-6#1)(1993-12#1)(1994-9#1)(1996-2#1)(2008-11#3)(2008-3#1)(2008-7#2)(2009-8#1)
transport glycoproteins##3##2##(1990-11#3)
transport has been##2##3##(1996-4#1)(2008-10#1)
transport in a##2##3##(2008-3#1)(2008-7#1)
transport in rabbit##2##3##(1996-2#1)(2008-1#1)
transport in the##11##3##(1995-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)
transport in##43##2##(1990-11#1)(1990-2#1)(1991-12#2)(1994-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#5)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#1)
transport inhibitor##4##2##(1991-8#1)(1994-12#1)(2008-7#2)
transport inhibitors##5##2##(1990-11#1)(1991-5#1)(1994-12#1)(1994-6#1)(2011-1#1)
transport inside##2##2##(2008-3#1)(2011-2#1)
transport into the myotubes##2##4##(1994-11#2)
transport into the nucleus##2##4##(1994-11#1)(2012-2#1)
transport into the##5##3##(1994-11#3)(1994-5#1)(2012-2#1)
transport into##13##2##(1992-12#1)(1994-11#6)(1994-5#1)(2008-1#2)(2008-3#1)(2012-2#2)
transport is a##2##3##(1994-3#1)(2012-2#1)
transport is critical##2##3##(2009-8#1)(2010-7#1)
transport is##20##2##(1991-3#1)(1991-5#1)(1994-3#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#4)(2010-4#1)(2010-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
transport machinery is##3##3##(2009-10#1)(2011-2#2)
transport machinery##5##2##(2008-11#1)(2009-10#1)(2011-2#2)(2012-2#1)
transport may##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
transport mean free path##6##4##(2008-2#2)(2008-3#4)
transport mechanism##4##2##(2008-10#4)
transport medium##2##2##(2009-4#2)
transport model with##2##3##(2008-10#2)
transport model##4##2##(2008-10#2)(2008-2#1)(2013-1#1)
transport of 5-methyltetrahydrofolate##3##3##(1994-6#3)
transport of a##2##3##(1994-11#1)(2008-4#1)
transport of amino acids##2##4##(1990-12#1)(2013-1#1)
transport of cystine##2##3##(2007-7#1)(2008-11#1)
transport of lithium##2##3##(2008-10#2)
transport of small solutes and proteins##2##6##(2011-2#2)
transport of the Eu(III)##2##4##(2008-10#2)
transport of the##15##3##(1990-7#1)(1992-3#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2010-8#1)
transport of uric acid##2##4##(2011-2#2)
transport of β-actin mRNA##3##4##(2012-2#3)
transport of##124##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-3#4)(1993-11#1)(1993-5#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#4)(1994-8#1)(1995-11#2)(1995-12#1)(1995-6#2)(1996-2#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#5)(2012-2#6)(2013-1#3)(2013-8#2)
transport or##2##2##(1994-8#2)
transport parameters##2##2##(2011-2#1)(2011-3#1)
transport pathways##5##2##(1995-6#1)(2008-11#2)(2012-8#2)
transport play a##2##3##(2010-2#1)(2011-2#1)
transport process##4##2##(1991-5#1)(1992-6#2)(2008-7#1)
transport processes##5##2##(1992-3#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#1)
transport properties##9##2##(1992-8#1)(1997-1#1)(2008-10#1)(2008-7#2)(2009-12#3)(2012-1#1)
transport protein##5##2##(1993-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2010-11#1)
transport proteins##13##2##(1990-11#1)(1990-12#1)(1990-8#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#4)(2012-2#1)
transport rate of##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
transport rate##8##2##(1994-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
transport scattering and##2##3##(2008-2#1)(2008-3#1)
transport scattering coefficient##2##3##(2008-2#1)(2008-3#1)
transport scattering coefficients from##2##4##(2008-2#1)(2008-3#1)
transport scattering coefficients##3##3##(2008-2#2)(2008-3#1)
transport scattering##8##2##(2008-2#4)(2008-3#4)
transport site with##2##3##(1995-5#2)
transport site##4##2##(1995-5#4)
transport solution##2##2##(2008-2#2)
transport system and##2##3##(1990-2#1)(2013-1#1)
transport system for the##2##4##(1992-3#1)(1994-12#1)
transport system for##4##3##(1990-2#1)(1992-3#1)(1994-12#1)(1995-12#1)
transport system in##2##3##(1990-5#1)(2008-11#1)
transport system is##3##3##(1991-5#1)(1992-6#1)(1995-8#1)
transport system of##3##3##(1990-11#1)(1992-6#1)(1995-12#1)
transport system##25##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#2)(1994-12#1)(1994-8#1)(1995-12#2)(1995-8#2)(2008-10#1)(2008-11#2)(2010-5#1)(2013-1#1)
transport system)##2##2##(1996-12#2)
transport systems##6##2##(1990-8#4)(1995-8#1)(2011-2#1)
transport through the##8##3##(1994-11#2)(1994-12#1)(1995-2#1)(2006-12#2)(2008-10#2)
transport through##18##2##(1990-12#1)(1992-6#2)(1994-11#2)(1994-12#1)(1995-2#1)(2006-12#2)(2007-11#1)(2008-10#3)(2008-3#2)(2008-7#2)(2011-2#1)
transport to the hospital##2##4##(1994-3#1)(2013-1#1)
transport to the##10##3##(1992-11#2)(1994-3#1)(2008-10#3)(2008-7#1)(2009-11#1)(2012-5#1)(2013-1#1)
transport to##23##2##(1992-11#2)(1994-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#4)(2009-11#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
transport via##4##2##(1994-12#1)(1995-5#1)(2010-11#1)(2013-8#1)
transport was inhibited by##2##4##(1994-11#1)(1995-8#1)
transport was observed with##2##4##(2008-10#2)
transport was observed##4##3##(1996-4#1)(2008-10#2)(2011-2#1)
transport was##18##2##(1990-2#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-4#1)(1997-6#1)(2007-5#1)(2008-10#3)(2011-2#2)
transport were##4##2##(1992-11#1)(2008-10#2)(2013-1#1)
transport with##2##2##(2008-7#1)(2012-2#1)
transport##797##1##(1990-11#13)(1990-12#8)(1990-2#11)(1990-5#6)(1990-7#2)(1990-8#7)(1990-9#2)(1991-10#1)(1991-12#6)(1991-2#5)(1991-3#2)(1991-5#10)(1991-8#1)(1991-9#5)(1992-11#11)(1992-12#2)(1992-3#10)(1992-5#1)(1992-6#20)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#16)(1994-12#14)(1994-3#9)(1994-5#1)(1994-6#11)(1994-7#1)(1994-8#12)(1994-9#1)(1995-10#2)(1995-11#9)(1995-12#4)(1995-2#12)(1995-3#2)(1995-5#8)(1995-6#10)(1995-8#9)(1996-1#3)(1996-12#9)(1996-2#7)(1996-4#4)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#11)(1997-2#7)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#4)(2006-12#2)(2007-11#8)(2007-12#13)(2007-5#5)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#11)(2008-10#80)(2008-11#40)(2008-12#3)(2008-2#14)(2008-3#23)(2008-4#9)(2008-5#3)(2008-6#8)(2008-7#42)(2008-8#16)(2008-9#10)(2009-10#8)(2009-11#2)(2009-12#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#7)(2010-10#1)(2010-11#5)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#2)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#53)(2011-3#8)(2012-1#4)(2012-12#4)(2012-2#21)(2012-3#1)(2012-5#1)(2012-8#2)(2013-1#19)(2013-7#1)(2013-8#5)
transport)##7##1##(1990-11#1)(1992-12#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2012-5#1)
transport-dependent##2##1##(2009-6#2)
transportable system##2##2##(2008-2#1)(2008-3#1)
transportable##6##1##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
transportation and##8##2##(2008-10#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#3)
transportation by##3##2##(2013-1#3)
transportation is##2##2##(2013-1#2)
transportation of##5##2##(1994-9#1)(2008-10#1)(2009-10#2)(2013-1#1)
transportation system##2##2##(1994-1#1)(1996-3#1)
transportation##45##1##(1992-5#1)(1994-1#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-3#1)(2007-2#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#4)(2009-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#16)(2013-8#1)
transported across##2##2##(2008-11#1)(2008-8#1)
transported by a##3##3##(1994-8#1)(2008-7#1)(2010-4#1)
transported by means of a##2##5##(2008-10#2)
transported by##9##2##(1993-8#1)(1994-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)(2012-2#1)
transported from the##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)
transported from##8##2##(1995-12#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
transported in##4##2##(1994-12#1)(1994-8#1)(1996-2#1)(2011-1#1)
transported into##6##2##(1993-12#1)(1993-8#2)(1994-11#1)(2008-10#1)(2012-2#1)
transported over##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
transported through the##2##3##(1997-6#1)(2008-7#1)
transported to an##2##3##(2008-10#2)
transported to the##10##3##(1990-5#1)(1991-12#2)(1994-11#1)(1995-6#1)(2008-10#5)
transported to##16##2##(1990-5#1)(1991-12#2)(1994-11#1)(1995-4#1)(1995-6#1)(1996-9#1)(1997-7#1)(2008-10#7)(2008-11#1)
transported with##2##2##(1994-12#1)(2008-10#1)
transported##74##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#2)(1992-12#1)(1993-12#2)(1993-3#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-8#3)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#23)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-2#2)
transporter (5-HTT)##2##2##(1995-5#1)(1996-12#1)
transporter (DAT)##2##2##(1996-12#2)
transporter (SERT)##2##2##(1996-12#2)
transporter 1##4##2##(1993-8#2)(2009-8#1)(2013-1#1)
transporter 2 (GLUT 2)##2##4##(1994-2#2)
transporter and##3##2##(1994-6#1)(1995-11#1)(2008-7#1)
transporter as##2##2##(2008-6#1)(2008-7#1)
transporter by##2##2##(1995-11#1)(1995-8#1)
transporter could##2##2##(1996-12#2)
transporter expression##4##2##(1993-6#1)(1996-5#3)
transporter family##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
transporter for##3##2##(1996-12#2)(2011-2#1)
transporter gene##4##2##(1991-12#1)(1993-8#1)(2008-10#1)(2010-7#1)
transporter in the##3##3##(1994-2#1)(1994-8#1)(1997-7#1)
transporter in##11##2##(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-12#1)(1997-7#1)(2010-2#1)(2012-3#1)
transporter is encoded by##2##4##(1994-8#1)(1995-6#1)
transporter is more##2##3##(1996-5#2)
transporter is##12##2##(1990-11#3)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)
transporter isoform##2##2##(1993-6#2)
transporter mRNA in the##3##4##(1994-2#2)(2012-2#1)
transporter mRNA##5##2##(1993-3#1)(1994-2#2)(2012-2#2)
transporter mRNAs##2##2##(1996-2#2)
transporter of##6##2##(1992-6#1)(1993-6#1)(1995-6#1)(1995-8#1)(2010-2#1)(2011-1#1)
transporter protein##5##2##(1990-8#1)(1993-6#1)(1995-6#2)(2012-3#1)
transporter proteins may##2##3##(1990-8#1)(1993-3#1)
transporter proteins##5##2##(1990-8#1)(1993-3#2)(1996-12#1)(2008-11#1)
transporter sites##2##2##(1995-5#1)(1996-12#1)
transporter that##2##2##(1995-2#1)(2011-2#1)
transporter were##2##2##(1996-5#1)(2008-10#1)
transporter##181##1##(1990-11#4)(1990-8#3)(1991-12#7)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#4)(1993-6#8)(1993-8#4)(1994-11#2)(1994-12#3)(1994-2#5)(1994-6#5)(1994-8#6)(1995-11#3)(1995-12#7)(1995-2#8)(1995-5#2)(1995-6#7)(1995-8#6)(1996-12#20)(1996-2#9)(1996-5#7)(1996-7#1)(1997-7#2)(2008-10#3)(2008-11#11)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#5)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#3)(2013-1#1)
transporter-1##2##1##(2009-12#1)(2011-1#1)
transporters and##2##2##(1995-6#1)(2013-8#1)
transporters are##3##2##(1993-3#1)(2008-7#1)(2013-1#1)
transporters for##4##2##(1993-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
transporters have##2##2##(2008-8#1)(2010-2#1)
transporters in the##4##3##(2008-11#1)(2008-7#2)(2008-8#1)
transporters in##12##2##(1990-11#1)(1994-12#2)(2008-11#1)(2008-7#4)(2008-8#2)(2009-12#1)(2012-12#1)
transporters of the##2##3##(2008-10#1)(2011-1#1)
transporters of##5##2##(1995-2#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-1#1)
transporters or##2##2##(2008-5#1)(2008-7#1)
transporters to##2##2##(1993-3#1)(2008-4#1)
transporters##82##1##(1990-11#2)(1992-3#1)(1993-3#4)(1993-6#1)(1994-1#1)(1994-12#5)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#18)(2008-8#11)(2009-12#2)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
transporting the##2##2##(2010-12#1)(2012-2#1)
transporting##16##1##(1994-12#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#2)(2013-1#3)
transports to##2##2##(1995-5#1)(2008-1#1)
transports##7##1##(1990-5#1)(1995-2#1)(1995-5#2)(2008-1#1)(2008-11#1)(2010-12#1)
transposa and vacuma##4##3##(2008-10#4)
transposa and##5##2##(2008-10#5)
transposa isolates##3##2##(2008-10#3)
transposa##9##1##(2008-10#9)
transposable element in##2##3##(2008-10#1)(2012-3#1)
transposable element##11##2##(1995-8#1)(2008-10#5)(2008-9#1)(2012-3#3)(2013-1#1)
transposable elements and##3##3##(2009-10#1)(2009-6#2)
transposable elements##18##2##(2008-10#6)(2009-10#3)(2009-3#1)(2009-6#5)(2010-5#1)(2010-8#1)(2012-3#1)
transposable##35##1##(1994-12#1)(1995-12#2)(1995-8#2)(2008-10#12)(2008-9#1)(2009-10#3)(2009-3#1)(2009-6#5)(2010-5#1)(2010-8#2)(2012-3#4)(2013-1#1)
transposase##8##1##(1990-5#1)(1995-8#1)(1996-12#2)(1996-6#1)(2008-10#1)(2012-3#2)
transpose##4##1##(1995-8#2)(2008-3#2)
transposed##7##1##(1992-9#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#2)
transposing##4##1##(1993-1#1)(1995-8#2)(2008-10#1)
transposition and##2##2##(2008-10#1)(2008-9#1)
transposition frequency##4##2##(2012-3#4)
transposition in##3##2##(1997-7#1)(2008-10#1)(2009-10#1)
transposition of a##2##3##(1994-12#1)(1995-2#1)
transposition of the great arteries##2##5##(2009-10#1)(2010-6#1)
transposition of the great##3##4##(1996-11#1)(2009-10#1)(2010-6#1)
transposition of the##7##3##(1990-9#1)(1996-11#1)(2007-8#1)(2008-3#1)(2009-10#1)(2010-6#1)(2011-2#1)
transposition of##13##2##(1990-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
transposition rates##2##2##(2012-3#2)
transposition##45##1##(1990-9#1)(1994-12#2)(1994-6#1)(1995-2#3)(1995-8#3)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-3#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#8)
transposon in##2##2##(2008-10#2)
transposon insertion##3##2##(1993-9#1)(2008-10#1)(2009-10#1)
transposon mutagenesis##4##2##(2008-10#2)(2008-9#2)
transposon##29##1##(1993-12#1)(1993-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#2)(2008-10#11)(2008-9#3)(2009-10#2)(2009-3#2)(2010-4#1)(2010-5#3)
transposons##5##1##(1994-12#1)(1995-8#1)(2008-10#1)(2009-3#1)(2010-5#1)
transracial adoption##2##2##(2008-5#2)
transracial##4##1##(2008-5#4)
transradial access##3##2##(2011-2#3)
transradial approach for coronary##2##4##(2011-2#2)
transradial approach for percutaneous coronary##2##5##(2011-2#2)
transradial approach for##6##3##(2011-2#6)
transradial approach##16##2##(2008-11#3)(2011-2#13)
transradial coronary angiography##2##3##(2011-2#2)
transradial coronary##4##2##(2011-2#4)
transradial interventions##2##2##(2011-2#2)
transradial procedure##2##2##(2011-2#2)
transradial##36##1##(2008-11#3)(2011-2#33)
transrectal ultrasonography##2##2##(1990-9#1)(1997-8#1)
transrectal##7##1##(1990-9#1)(1997-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
transsexuals have##2##2##(2013-1#2)
transsexuals##7##1##(2007-10#1)(2009-10#1)(2013-1#5)
transsphenoidal approach to##2##3##(2011-2#2)
transsphenoidal approach##6##2##(2011-2#6)
transsphenoidal##11##1##(1991-6#1)(2008-7#2)(2011-2#8)
transsynaptic##2##1##(1993-3#1)(1997-2#1)
transtheoretical model (TTM)##2##3##(2008-12#1)(2013-1#1)
transtheoretical model##4##2##(2008-12#1)(2008-3#1)(2013-1#2)
transtheoretical##5##1##(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)
transthoracic and transesophageal##2##3##(2007-7#1)(2011-2#1)
transthoracic echocardiography##2##2##(2007-8#1)(2008-11#1)
transthoracic##10##1##(1993-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2009-10#1)(2009-3#1)(2011-2#2)(2013-1#1)
transthyretin (TTR)##3##2##(1992-8#2)(1993-12#1)
transthyretin (prealbumin) in human cerebrospinal fluid##2##6##(1991-2#2)
transthyretin gene##4##2##(1990-11#1)(1990-5#1)(1992-8#2)
transthyretin##19##1##(1990-11#2)(1990-5#2)(1991-2#7)(1992-8#5)(1993-12#1)(1994-8#2)
transtibial prostheses##3##2##(2013-1#3)
transtibial##6##1##(2007-7#1)(2011-2#1)(2013-1#4)
transtrapezium approach##3##2##(2008-9#3)
transtympanic##5##1##(2008-4#4)(2008-9#1)
transumbilical thoracic##2##2##(2013-1#2)
transumbilical##4##1##(2013-1#4)
transurethral prostate##2##2##(1990-11#2)
transurethral resection of the##2##4##(2012-12#1)(2012-3#1)
transurethral resection of##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
transurethral resection##7##2##(1991-9#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-12#2)(2012-3#1)
transurethral##10##1##(1990-11#2)(1991-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-12#2)(2012-3#1)
transvaginal color Doppler##4##3##(1995-3#4)
transvaginal sonography##2##2##(1990-10#1)(2011-1#1)
transvaginal##14##1##(1990-10#1)(1991-11#2)(1995-3#5)(1996-1#2)(2011-1#1)(2011-2#2)(2012-12#1)
transvenous##8##1##(1996-9#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2013-1#2)
transversal and##2##2##(2007-11#1)(2011-2#1)
transversal study##2##2##(1992-5#1)(2012-3#1)
transversal##11##1##(1992-5#1)(1994-6#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
transversally heated##2##2##(2008-10#2)
transversally into##2##2##(2008-12#1)(2013-1#1)
transversally##6##1##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2013-1#1)
transverse and##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
transverse beam profile##2##3##(2007-12#1)(2008-2#1)
transverse beam##3##2##(2007-12#1)(2008-2#2)
transverse carpal ligament##3##3##(2008-9#3)
transverse coherence##3##2##(2007-12#1)(2008-3#2)
transverse colon##4##2##(1991-6#1)(1993-9#2)(2008-11#1)
transverse diameter of the aberrant pancreatic tissue##2##7##(2012-2#2)
transverse diameter of the##3##4##(2008-4#1)(2012-2#2)
transverse electro-optic effect in##2##4##(2008-3#2)
transverse flow velocity##2##3##(2007-11#1)(2008-3#1)
transverse laser##2##2##(2008-2#1)(2008-3#1)
transverse load##4##2##(2007-12#4)
transverse mode##6##2##(2007-12#1)(2008-3#5)
transverse modes##3##2##(2008-2#3)
transverse myelitis and neuromyelitis optica##2##5##(2012-3#2)
transverse myelitis and##3##3##(2012-3#3)
transverse myelitis##7##2##(2007-7#1)(2012-3#6)
transverse plane##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
transverse planes##2##2##(2007-11#1)(2008-3#1)
transverse profile##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
transverse relaxation##3##2##(2011-1#2)(2012-2#1)
transverse resolution of##3##3##(2007-12#3)
transverse resolution##6##2##(2007-12#5)(2008-3#1)
transverse scanning##2##2##(2007-12#1)(2008-3#1)
transverse sections##6##2##(1995-6#1)(2008-5#2)(2008-7#1)(2011-2#2)
transverse sinus##8##2##(1996-6#2)(1996-9#2)(2006-12#1)(2008-7#3)
transverse spatial##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
transverse to the optical##2##4##(2007-11#1)(2007-12#1)
transverse to the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
transverse##172##1##(1990-5#1)(1991-2#1)(1991-6#1)(1992-2#2)(1993-3#2)(1993-9#2)(1995-2#1)(1995-6#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#22)(2007-12#32)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#16)(2008-3#36)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#4)(2009-3#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#4)(2013-7#1)
transverse-electric fundamental##2##2##(2007-12#2)
transverse-electric##3##1##(2007-12#2)(2008-3#1)
transverse-mode##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
transverse-sigmoid sinus DAVM##2##3##(2006-12#2)
transverse-sigmoid sinus dural arteriovenous malformations##3##5##(2006-12#1)(2008-7#2)
transverse-sigmoid sinus##6##2##(2006-12#4)(2008-7#2)
transversely heated graphite atomizer (THGA)##2##5##(2008-10#2)
transversely heated graphite atomizer##4##4##(2008-10#4)
transversely heated graphite##7##3##(2008-10#7)
transversely varying saturable gain##3##4##(2007-12#3)
transversely##16##1##(2007-11#1)(2007-12#5)(2008-10#9)(2008-3#1)
transversion at##2##2##(1994-11#1)(2008-10#1)
transversion##11##1##(1990-12#1)(1990-5#2)(1991-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(2008-10#4)
transversions##2##1##(1992-2#1)(2008-4#1)
transversus abdominis##3##2##(2008-8#1)(2012-12#2)
transvesical##2##1##(2011-2#1)(2013-1#1)
transwell##2##1##(1992-9#1)(2007-12#1)
trap and##7##2##(2007-11#1)(2008-10#4)(2008-3#1)(2009-8#1)
trap door##2##2##(2008-10#1)(2012-12#1)
trap for##5##2##(2007-12#2)(2008-10#2)(2008-2#1)
trap groups##2##2##(2013-7#2)
trap in##2##2##(2008-5#1)(2013-8#1)
trap mass spectrometer##4##3##(2008-10#4)
trap mass spectrometry##10##3##(2008-10#7)(2008-8#2)(2010-11#1)
trap mass##15##2##(2008-10#12)(2008-8#2)(2010-11#1)
trap plants##5##2##(2008-10#5)
trap plots##2##2##(2008-10#2)
trap system##4##2##(2008-10#3)(2008-9#1)
trap trees for##2##3##(2011-2#2)
trap trees##8##2##(2011-2#8)
trap##119##1##(1990-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(2007-11#7)(2007-12#3)(2008-10#49)(2008-11#1)(2008-2#13)(2008-3#6)(2008-5#3)(2008-8#4)(2008-9#3)(2009-5#3)(2009-8#2)(2010-11#2)(2010-7#2)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
trap/two-hybrid system##3##2##(2008-2#2)(2008-9#1)
trapezium##4##1##(2008-9#2)(2010-6#1)(2010-9#1)
trapezius and##2##2##(2010-9#2)
trapezius muscle##3##2##(2010-9#3)
trapezius##14##1##(2007-5#2)(2010-9#11)(2012-2#1)
trapezoidal apertures of##2##3##(2008-3#2)
trapezoidal##9##1##(2008-10#1)(2008-2#1)(2008-3#6)(2010-8#1)
trapped and##4##2##(2008-10#1)(2008-2#2)(2009-12#1)
trapped by a##2##3##(2007-11#1)(2008-10#1)
trapped by##7##2##(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#4)
trapped flow analysis system (ByT-FAS)##3##5##(2008-10#3)
trapped flow##4##2##(2008-10#4)
trapped in a##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
trapped in the##12##3##(1996-4#1)(2007-11#1)(2008-10#9)(2008-2#1)
trapped in##25##2##(1996-4#1)(2007-11#2)(2007-12#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
trapped pulse##3##2##(2007-11#3)
trapped with##2##2##(1991-9#1)(2008-10#1)
trapped within##4##2##(1990-11#1)(2007-11#1)(2008-3#1)(2012-2#1)
trapped##87##1##(1990-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#1)(1994-11#2)(1994-8#1)(1995-5#1)(1996-4#1)(2007-11#11)(2007-12#9)(2008-10#38)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2009-12#2)(2009-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#2)
trapped-flow analysis##3##2##(2008-10#3)
trapper##2##1##(1997-2#2)
trapping agent##2##2##(1992-9#1)(1995-8#1)
trapping and atomisation efficiency##2##4##(2008-10#2)
trapping and atomisation temperatures##2##4##(2008-10#2)
trapping and atomisation##5##3##(2008-10#5)
trapping and release of the magnetic beads in the flow cell were controlled by##2##14##(2008-10#2)
trapping and##17##2##(2007-11#3)(2008-10#10)(2008-3#2)(2008-8#1)(2009-12#1)
trapping by the##3##3##(2007-11#1)(2008-10#1)(2010-7#1)
trapping by##4##2##(2007-11#2)(2008-10#1)(2010-7#1)
trapping experiments##2##2##(1996-5#1)(2007-12#1)
trapping in##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
trapping of the##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
trapping of##18##2##(1991-6#1)(1992-3#1)(1995-5#1)(1996-5#2)(2007-11#1)(2007-12#4)(2008-10#5)(2008-3#2)(2008-7#1)
trapping properties of a##2##4##(2008-3#2)
trapping solution##2##2##(2008-10#2)
trapping system##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
trapping technique##2##2##(1996-2#1)(2008-10#1)
trapping using##2##2##(1996-2#1)(2008-3#1)
trapping with##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
trapping##118##1##(1990-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#3)(1997-2#1)(2007-11#16)(2007-12#11)(2008-10#44)(2008-11#2)(2008-2#4)(2008-3#10)(2008-5#2)(2008-7#5)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
traps and pitfalls##3##3##(1992-1#2)(1994-3#1)
traps and##6##2##(1992-1#2)(1994-3#1)(2008-10#1)(2010-4#1)(2013-7#1)
traps in##5##2##(1991-3#1)(2008-10#2)(2011-2#1)(2013-7#1)
traps to##2##2##(2013-7#2)
traps were##2##2##(2008-10#1)(2010-8#1)
traps##53##1##(1991-3#1)(1992-1#2)(1993-1#1)(1994-3#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-2#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#9)(2012-2#1)(2013-7#10)
trasnsthoracic##2##1##(2007-8#2)
trastuzumab (Herceptin)##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
trastuzumab and##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
trastuzumab##24##1##(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#4)(2012-3#6)(2013-1#8)
trastuzumab-resistant##2##1##(2012-3#2)
trastuzumab-sensitive##2##1##(2012-3#1)(2013-1#1)
trastuzumab-unresponsive##2##1##(2013-1#2)
trategies##2##1##(2008-11#2)
tratment##2##1##(2007-11#1)(2008-7#1)
trauma and allows##2##3##(2008-9#1)(2012-12#1)
trauma and##31##2##(1990-2#1)(1990-9#1)(1991-2#1)(1992-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-3#1)(2009-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
trauma are##3##2##(2007-11#1)(2012-2#2)
trauma assessment##2##2##(2008-6#2)
trauma can##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
trauma care##3##2##(1991-12#1)(2007-11#1)(2012-2#1)
trauma center##2##2##(2007-9#1)(2012-3#1)
trauma centers##4##2##(2008-11#2)(2008-6#1)(2011-2#1)
trauma due to##2##3##(2008-7#1)(2011-2#1)
trauma exposure##3##2##(2009-4#2)(2012-12#1)
trauma followed by##2##3##(1996-6#1)(2007-5#1)
trauma following##3##2##(1993-5#1)(2012-2#1)(2013-1#1)
trauma has##2##2##(1992-2#1)(2012-2#1)
trauma history##2##2##(2008-9#1)(2013-8#1)
trauma in a##2##3##(2007-10#1)(2011-1#1)
trauma in children##3##3##(2007-11#2)(2011-1#1)
trauma in the##4##3##(2007-10#1)(2009-3#1)(2012-12#1)(2013-8#1)
trauma in##17##2##(1990-2#1)(1994-2#1)(1997-6#1)(2007-10#2)(2007-11#3)(2007-9#1)(2009-3#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
trauma is a major cause of##2##6##(2011-1#1)(2012-3#1)
trauma is a##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
trauma is##11##2##(1992-4#1)(2007-12#1)(2007-8#2)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
trauma life support##3##3##(1992-5#2)(2009-3#1)
trauma of the##2##3##(1990-9#1)(2007-8#1)
trauma of##8##2##(1990-9#1)(1994-2#2)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-1#1)
trauma on##2##2##(2007-10#2)
trauma or##10##2##(1990-9#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
trauma patients##2##2##(2008-11#1)(2012-2#1)
trauma research##2##2##(2009-4#2)
trauma surgery##5##2##(1990-11#1)(2008-8#1)(2010-9#2)(2011-2#1)
trauma to a##2##3##(2007-5#1)(2010-6#1)
trauma to the primary predecessors##2##5##(2013-1#2)
trauma to the##19##3##(1991-11#1)(1991-2#1)(1992-2#1)(1993-1#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-9#2)(2010-7#1)(2010-9#1)(2012-2#3)(2012-7#1)(2013-1#2)
trauma to##24##2##(1991-11#1)(1991-2#1)(1992-2#1)(1993-1#1)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-6#1)(2010-7#1)(2010-9#1)(2012-2#3)(2012-7#1)(2013-1#3)
trauma was##5##2##(1991-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2013-8#1)
trauma with##6##2##(1991-6#1)(2008-12#1)(2010-1#1)(2011-1#2)(2013-8#1)
trauma##348##1##(1990-11#1)(1990-2#4)(1990-6#1)(1990-9#5)(1991-11#4)(1991-12#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#3)(1994-5#3)(1994-7#1)(1995-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#9)(2007-11#20)(2007-12#7)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#18)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#9)(2008-2#1)(2008-4#2)(2008-5#7)(2008-6#7)(2008-7#14)(2008-8#5)(2008-9#13)(2009-11#2)(2009-2#1)(2009-3#7)(2009-4#7)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#4)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#6)(2011-1#8)(2011-2#21)(2012-1#2)(2012-12#11)(2012-2#23)(2012-3#6)(2012-7#3)(2012-8#1)(2013-1#17)(2013-7#1)(2013-8#19)
trauma-focused research with##2##3##(2009-4#2)
trauma-focused research##6##2##(2009-4#6)
trauma-focused##7##1##(2009-4#7)
trauma-hemorrhage##4##1##(2013-1#4)
trauma-related##8##1##(2008-8#1)(2009-11#1)(2009-4#4)(2012-2#2)
trauma]##7##1##(1990-2#1)(1990-9#3)(1991-6#1)(1992-6#1)(1997-6#1)
traumas and##2##2##(1991-6#1)(2012-1#1)
traumas##7##1##(1991-3#1)(1991-6#1)(1996-3#1)(2007-10#1)(2009-3#1)(2009-4#1)(2012-1#1)
traumatic amputations after injuries##2##4##(1992-6#2)
traumatic amputations##3##2##(1992-6#3)
traumatic brachial plexus##2##3##(2008-8#2)
traumatic brain injuries##3##3##(1996-1#1)(2012-2#1)(2013-1#1)
traumatic brain injury (TBI)##7##4##(1993-12#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
traumatic brain injury and##2##4##(2008-8#1)(2013-1#1)
traumatic brain injury in rats##2##5##(1993-12#1)(2008-7#1)
traumatic brain injury in##3##4##(1993-12#1)(2008-7#1)(2012-2#1)
traumatic brain injury##47##3##(1990-12#3)(1991-12#3)(1993-12#2)(1994-12#2)(1997-2#3)(2007-11#2)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2010-1#2)(2010-5#2)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#2)(2013-8#3)
traumatic brain##52##2##(1990-12#4)(1991-12#3)(1993-12#2)(1994-12#3)(1996-1#1)(1997-2#3)(2007-11#2)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2010-1#2)(2010-5#2)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#3)(2013-8#3)
traumatic event##5##2##(2006-12#1)(2008-10#1)(2008-6#2)(2009-3#1)
traumatic events##2##2##(1996-3#1)(2009-4#1)
traumatic injuries##3##2##(2007-12#1)(2008-9#1)(2012-2#1)
traumatic injury##5##2##(2012-12#1)(2012-2#3)(2012-3#1)
traumatic leptomeningeal##2##2##(2013-8#2)
traumatic lesions##2##2##(2007-11#2)
traumatic lung pseudocyst is##3##4##(2013-1#3)
traumatic lung pseudocyst##4##3##(2013-1#4)
traumatic middle cerebral artery occlusion##2##5##(2008-7#2)
traumatic neuronal injury##3##3##(1995-12#3)
traumatic or##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
traumatic pseudoaneurysm of the##2##4##(2008-12#2)
traumatic rupture of the##2##4##(2008-11#1)(2010-8#1)
traumatic rupture of##3##3##(2008-11#1)(2008-12#1)(2010-8#1)
traumatic rupture##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
traumatic stress disorder##3##3##(1991-2#1)(2008-11#1)(2013-8#1)
traumatic stress##5##2##(1991-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
traumatic subarachnoid haemorrhage##2##3##(2008-7#2)
traumatic##161##1##(1990-12#4)(1990-3#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#3)(1993-12#2)(1994-12#3)(1995-12#3)(1996-1#1)(1996-3#1)(1997-2#3)(2006-12#1)(2007-11#9)(2007-12#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#7)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#16)(2008-8#4)(2008-9#8)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-12#3)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#7)(2012-1#5)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#10)(2013-8#6)
traumatica##2##1##(1990-12#2)
traumatically##2##1##(1995-3#1)(1996-1#1)
traumatization##3##1##(1991-6#1)(1994-11#1)(2013-1#1)
traumatized##4##1##(2007-12#1)(2009-4#1)(2012-7#1)(2013-1#1)
traumatology and##2##2##(2007-11#1)(2011-2#1)
traumatology##7##1##(2007-11#1)(2007-8#2)(2011-2#1)(2013-1#2)(2013-8#1)
travail##3##1##(2011-2#1)(2013-1#2)
travel abroad##2##2##(2007-2#1)(2008-1#1)
travel advice##2##2##(2007-2#2)
travel along##2##2##(1993-3#1)(2007-2#1)
travel among##2##2##(2008-9#2)
travel and children##3##3##(2008-11#3)
travel and##14##2##(1992-11#1)(1993-2#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2013-8#1)
travel health advice and##4##4##(2007-2#4)
travel health advice##12##3##(2007-2#12)
travel health associations##2##3##(2007-2#2)
travel health##19##2##(2007-2#19)
travel healthcare professionals##2##3##(2007-2#2)
travel history to##2##3##(2007-12#1)(2011-2#1)
travel history##4##2##(2007-12#1)(2011-2#3)
travel in##2##2##(2011-2#1)(2012-12#1)
travel insurance##2##2##(2007-2#2)
travel is##3##2##(2011-2#1)(2013-8#2)
travel medicine and##3##3##(2007-2#3)
travel medicine##13##2##(1995-9#1)(2007-2#11)(2011-2#1)
travel time##4##2##(1995-3#1)(2008-8#2)(2008-9#1)
travel times##4##2##(2008-1#2)(2008-8#2)
travel to##5##2##(2007-2#3)(2008-8#1)(2009-5#1)
travel was##2##2##(1997-6#1)(2007-2#1)
travel##136##1##(1990-6#1)(1991-8#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1997-6#1)(2007-12#5)(2007-2#59)(2008-1#5)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#8)(2008-9#3)(2009-2#1)(2009-5#2)(2010-3#2)(2010-5#4)(2010-8#1)(2011-2#10)(2012-12#1)(2012-2#2)(2013-8#6)
travel-related##3##1##(2007-2#2)(2011-2#1)
travel]##2##1##(1993-8#1)(2007-3#1)
traveled by##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
traveled to##6##2##(1993-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-12#2)
traveled##16##1##(1993-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
traveler is##2##2##(2007-2#1)(2010-12#1)
traveler##6##1##(1996-8#1)(2007-2#1)(2010-12#2)(2011-2#2)
travelers after##2##2##(2007-2#1)(2011-2#1)
travelers and##2##2##(2011-2#2)
travelers to##3##2##(2007-2#1)(2008-1#1)(2011-2#1)
travelers with##2##2##(2007-2#1)(2011-2#1)
travelers##35##1##(1996-8#2)(2007-2#8)(2008-1#2)(2008-10#2)(2010-12#2)(2011-2#17)(2012-2#2)
travelers]##2##1##(2011-2#2)
traveling to##5##2##(1995-2#1)(2006-10#1)(2011-2#2)(2012-2#1)
traveling wave##2##2##(2008-10#1)(2009-5#1)
traveling waves##5##2##(2007-11#2)(2008-3#1)(2009-5#2)
traveling##26##1##(1991-8#1)(1992-12#1)(1995-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#6)(2008-6#1)(2008-9#1)(2009-5#4)(2010-12#1)(2011-2#4)(2012-2#1)
traveling-wave electro-optic##2##2##(2007-11#1)(2007-12#1)
traveling-wave modulators##2##2##(2007-12#2)
traveling-wave optical parametric##4##3##(2007-12#3)(2008-3#1)
traveling-wave##13##1##(2007-11#3)(2007-12#9)(2008-3#1)
travelled to the##2##3##(1997-7#1)(2008-7#1)
travelled to##3##2##(1997-7#1)(2007-12#1)(2008-7#1)
travelled##7##1##(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-1#1)
traveller##14##1##(1993-8#2)(2007-2#8)(2008-10#2)(2008-11#1)(2009-7#1)
traveller's diarrhea##2##2##(1993-3#1)(1997-3#1)
traveller's##3##1##(1993-3#1)(1997-3#1)(2007-2#1)
travellers due to##2##3##(2007-2#1)(2009-5#1)
travellers for##2##2##(2007-2#2)
travellers from Australia##3##3##(2007-2#3)
travellers from##5##2##(2007-2#5)
travellers in##2##2##(2007-2#2)
travellers is##2##2##(2007-2#2)
travellers should##2##2##(2007-2#2)
travellers to distant##2##3##(1993-3#2)
travellers to endemic areas##2##4##(2007-2#1)(2008-10#1)
travellers to endemic##3##3##(2007-2#2)(2008-10#1)
travellers to##13##2##(1993-3#2)(1997-4#1)(2007-2#8)(2008-10#1)(2009-5#1)
travellers undertaking##2##2##(2007-2#2)
travellers##76##1##(1993-3#2)(1995-2#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-2#60)(2008-10#1)(2009-5#4)(2010-5#3)(2011-2#1)
travelling to Africa##2##3##(2007-2#2)
travelling to##6##2##(2007-2#5)(2008-10#1)
travelling wave##2##2##(1997-3#1)(2008-9#1)
travelling##17##1##(1991-12#1)(1997-3#1)(2007-12#1)(2007-2#5)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
travels##6##1##(1995-1#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-1#1)
traversal##4##1##(2008-6#1)(2008-8#3)
traverse the##5##2##(1990-5#1)(1997-6#1)(2008-10#2)(2009-10#1)
traverse##7##1##(1990-5#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-8#1)(2009-10#1)
traversed##5##1##(2007-11#1)(2007-8#1)(2008-3#2)(2011-2#1)
traverses##2##1##(2008-2#1)(2011-2#1)
traversing the##4##2##(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
traversing##7##1##(2007-8#1)(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
trawl net##2##2##(2008-12#1)(2013-7#1)
trawl##4##1##(2008-12#1)(2013-7#3)
tray##4##1##(1997-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
trays and##2##2##(2008-12#1)(2013-1#1)
trays##7##1##(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
trazodone##12##1##(1995-2#5)(2008-10#2)(2008-3#4)(2008-9#1)
treadmill exercise##5##2##(2008-3#2)(2010-12#2)(2013-1#1)
treadmill running on##3##3##(2008-12#2)(2012-1#1)
treadmill running##8##2##(2008-12#3)(2012-1#3)(2013-1#2)
treadmill test##2##2##(2008-5#1)(2012-2#1)
treadmill tests##2##2##(1991-3#1)(2008-3#1)
treadmill##34##1##(1991-2#1)(1991-3#2)(1994-8#1)(2007-10#2)(2008-10#1)(2008-12#3)(2008-3#3)(2008-5#2)(2008-9#1)(2009-5#1)(2010-12#2)(2012-1#3)(2012-2#2)(2013-1#7)(2013-8#3)
treament##3##1##(1996-9#1)(2008-5#1)(2012-2#1)
treasure##4##1##(1993-1#1)(2008-6#1)(2009-7#1)(2012-12#1)
treat acute##4##2##(1997-8#1)(2007-8#1)(2008-11#1)(2010-3#1)
treat alcohol##2##2##(2008-2#1)(2008-4#1)
treat all##2##2##(2011-2#1)(2013-1#1)
treat and##6##2##(1994-3#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#1)
treat both##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
treat chronic##4##2##(2007-8#1)(2008-8#1)(2008-9#1)(2012-12#1)
treat high-risk##2##2##(2008-11#1)(2012-3#1)
treat illness##2##2##(2008-10#1)(2010-12#1)
treat infants with##2##3##(1992-11#1)(1992-3#1)
treat infants##3##2##(1992-11#1)(1992-3#1)(1997-1#1)
treat invasive##2##2##(2008-7#1)(2011-2#1)
treat it##4##2##(1992-5#1)(1995-5#1)(2007-7#1)(2012-3#1)
treat major##2##2##(1994-11#1)(2008-6#1)
treat most##2##2##(1997-8#1)(2010-3#1)
treat multidrug-resistant##2##2##(2011-2#1)(2013-1#1)
treat osteoporosis##3##2##(1993-11#2)(2007-11#1)
treat patients with##7##3##(1993-2#1)(1995-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-1#1)
treat patients##12##2##(1993-2#1)(1994-1#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
treat stress and##2##3##(2008-10#2)
treat the disease##2##3##(2008-7#1)(2010-5#1)
treat the##33##2##(1993-12#1)(1995-11#1)(1996-3#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
treat them##4##2##(2007-12#2)(2013-1#2)
treat these patients##2##3##(1991-11#1)(2013-8#1)
treat these##13##2##(1991-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-8#1)
treat this infection##2##3##(2006-10#1)(2010-12#1)
treat this##10##2##(1995-5#1)(2006-10#2)(2008-3#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
treat two##2##2##(1995-6#1)(2010-6#1)
treat##319##1##(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#4)(1994-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#4)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#11)(2008-12#6)(2008-2#5)(2008-3#7)(2008-4#9)(2008-5#10)(2008-6#6)(2008-7#20)(2008-8#13)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#4)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#8)(2012-3#8)(2013-1#24)(2013-8#10)
treatable by##2##2##(1995-8#1)(2008-11#1)
treatable disease of##2##3##(1997-2#1)(2013-8#1)
treatable disease##6##2##(1991-8#1)(1997-2#1)(2008-1#2)(2010-6#1)(2013-8#1)
treatable with##3##2##(2009-11#1)(2011-1#1)(2011-3#1)
treatable##25##1##(1991-8#1)(1992-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#2)(2007-10#1)(2008-1#3)(2008-11#2)(2008-7#2)(2009-11#1)(2010-1#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
treated 14 patients##2##3##(2007-11#2)
treated 32##2##2##(1997-4#1)(2013-1#1)
treated HCC##4##2##(2008-10#4)
treated KU812 cells##5##3##(2008-11#5)
treated according to the##3##4##(2008-9#1)(2010-3#1)(2011-2#1)
treated according to##7##3##(1993-11#1)(2008-9#1)(2010-3#1)(2011-2#4)
treated after##4##2##(1996-6#1)(2007-8#3)
treated and control##5##3##(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-10#1)
treated and untreated##6##3##(1990-2#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-3#1)
treated and##27##2##(1990-2#1)(1991-11#1)(1992-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
treated animals##7##2##(1993-12#1)(1994-6#1)(1996-12#1)(2006-6#1)(2008-8#1)(2011-2#2)
treated are##2##2##(1991-9#1)(1993-9#1)
treated as a##10##3##(1992-5#1)(1993-11#1)(2007-10#1)(2008-2#1)(2008-3#3)(2008-9#2)(2013-1#1)
treated as two##2##3##(2008-2#1)(2008-3#1)
treated as##33##2##(1990-9#2)(1991-6#1)(1992-5#1)(1993-11#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-1#1)
treated at our institution##2##4##(2011-2#1)(2013-1#1)
treated at our##10##3##(1990-6#1)(1990-9#1)(1997-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#3)(2013-1#1)
treated at the National##2##4##(2007-8#1)(2012-12#1)
treated at the##17##3##(1990-6#1)(1991-6#2)(1993-12#1)(1993-6#1)(1995-11#1)(1995-5#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)
treated at##40##2##(1990-6#2)(1990-9#1)(1991-6#2)(1993-12#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-5#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)
treated between 1994 and##2##4##(2008-1#1)(2011-2#1)
treated between January##2##3##(2007-8#1)(2011-2#1)
treated between##10##2##(1992-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
treated by Molndal technique##2##4##(2011-2#2)
treated by a combination of##2##5##(1990-12#1)(2007-10#1)
treated by a##10##3##(1990-12#1)(1996-11#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-2#1)
treated by bisphosphonates##2##3##(2007-11#2)
treated by both##2##3##(2008-10#1)(2008-9#1)
treated by chemotherapy##2##3##(1990-8#1)(1994-7#1)
treated by combined##2##3##(2007-11#1)(2011-2#1)
treated by conservative##3##3##(2007-11#1)(2008-2#1)(2013-7#1)
treated by either##2##3##(1994-12#1)(2008-9#1)
treated by embolization##2##3##(1992-9#1)(2008-7#1)
treated by endoscopic##3##3##(1997-8#1)(2008-12#1)(2008-5#1)
treated by external##3##3##(1990-6#1)(1993-11#1)(2007-8#1)
treated by extra-anatomic##2##3##(2007-8#2)
treated by gavage##2##3##(2008-9#1)(2013-8#1)
treated by general##3##3##(1993-2#1)(1994-11#1)(2013-1#1)
treated by internal##2##3##(1990-3#1)(2011-2#1)
treated by means of##2##4##(1994-12#1)(2008-3#1)
treated by monotherapy##2##3##(1990-2#1)(2008-10#1)
treated by open##3##3##(1997-8#1)(2009-4#1)(2012-12#1)
treated by percutaneous##2##3##(1991-8#1)(1993-8#1)
treated by radical exeresis##2##4##(1994-6#2)
treated by radical##4##3##(1994-6#2)(1995-11#1)(2008-6#1)
treated by radiosurgery##3##3##(2008-7#2)(2011-2#1)
treated by radiotherapy and##2##4##(1991-8#1)(2007-11#1)
treated by radiotherapy##3##3##(1990-12#1)(1991-8#1)(2007-11#1)
treated by surgery##3##3##(1992-5#1)(2008-7#1)(2008-8#1)
treated by surgical resection##2##4##(2007-8#1)(2008-6#1)
treated by surgical##4##3##(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)
treated by the##9##3##(1995-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
treated by##187##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#4)(1992-11#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#4)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-6#2)(1994-7#1)(1995-11#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#11)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#17)(2008-8#1)(2008-9#7)(2009-10#1)(2009-4#1)(2009-5#3)(2010-6#1)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#3)
treated case##2##2##(2007-12#1)(2007-7#1)
treated cases##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
treated cell##2##2##(2009-2#2)
treated cells##11##2##(1991-12#1)(1991-5#3)(1992-6#1)(1993-3#1)(1994-6#1)(2007-11#1)(2008-11#2)(2008-9#1)
treated children##2##2##(1993-2#1)(2011-1#1)
treated chronically with##3##3##(1990-5#1)(1997-2#1)(2008-1#1)
treated conservatively and##2##3##(2013-1#2)
treated conservatively with##2##3##(2010-5#1)(2012-12#1)
treated conservatively##17##2##(1992-5#1)(1992-9#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#2)
treated controls##4##2##(1992-8#1)(1996-12#1)(1997-2#1)(1997-4#1)
treated daily with##3##3##(2008-10#2)(2010-6#1)
treated due to##4##3##(2007-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
treated during##6##2##(1991-9#1)(1992-9#1)(2007-8#1)(2008-7#1)(2012-3#2)
treated early##3##2##(2007-12#1)(2010-8#1)(2012-3#1)
treated effectively##2##2##(1992-5#1)(2007-8#1)
treated embryos##4##2##(1991-2#1)(2008-11#2)(2008-12#1)
treated empirically##2##2##(2011-2#1)(2011-3#1)
treated first##2##2##(1996-5#1)(2008-10#1)
treated for breast cancer##2##4##(2011-2#1)(2013-7#1)
treated for breast##3##3##(1996-9#1)(2011-2#1)(2013-7#1)
treated for bronchial asthma##2##4##(2010-2#2)
treated for hypertension##2##3##(1994-6#1)(2008-10#1)
treated for prostate cancer##2##4##(1995-8#1)(2008-7#1)
treated for recurrent##2##3##(1992-9#1)(2008-9#1)
treated for renal##2##3##(1997-8#1)(2009-5#1)
treated for seizures##2##3##(2011-1#2)
treated for spinal##2##3##(2007-11#1)(2009-3#1)
treated for tuberculosis##2##3##(1996-3#1)(2010-12#1)
treated for##78##2##(1990-2#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
treated from##4##2##(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)
treated group##10##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-5#1)(1997-6#1)(2007-8#1)(2008-9#1)(2012-12#1)(2013-1#2)
treated groups##6##2##(1994-8#2)(2008-12#1)(2009-7#1)(2012-12#1)(2012-2#1)
treated hair##2##2##(2008-5#2)
treated here##2##2##(2010-3#1)(2013-7#1)
treated human##2##2##(1991-9#1)(2008-10#1)
treated hypertensives##3##2##(2008-10#3)
treated in Orthopaedic##2##3##(2007-11#2)
treated in a single##3##4##(1997-5#1)(2010-10#1)(2013-8#1)
treated in a##15##3##(1991-5#1)(1991-6#1)(1995-3#1)(1996-3#1)(1997-5#1)(2006-10#2)(2008-12#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
treated in general practice##2##4##(1993-2#1)(2008-3#1)
treated in our department##4##4##(1993-6#1)(2008-1#1)(2012-2#1)(2013-1#1)
treated in our hospital##2##4##(1991-2#1)(2007-8#1)
treated in our##11##3##(1991-2#1)(1992-6#1)(1993-5#1)(1993-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
treated in the Department of##2##5##(1995-11#1)(2008-7#1)
treated in the first##2##4##(1993-3#1)(2008-7#1)
treated in the public system##2##5##(2006-10#2)
treated in the same way as##2##6##(1993-3#1)(2008-10#1)
treated in the same##5##4##(1992-6#1)(1993-3#1)(2008-10#1)(2008-6#2)
treated in the##25##3##(1990-5#3)(1992-6#1)(1992-9#1)(1993-3#2)(1995-11#1)(2006-10#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
treated in their##2##3##(2008-10#1)(2008-9#1)
treated in##94##2##(1990-5#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#4)(2007-11#7)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
treated it##2##2##(2009-1#1)(2012-2#1)
treated leaf##2##2##(2008-10#2)
treated locally##3##2##(2007-10#1)(2007-11#1)(2008-3#1)
treated long##2##2##(1990-6#1)(2007-11#1)
treated male rats##4##3##(1993-6#2)(2008-11#2)
treated mice were##2##3##(2008-9#1)(2012-2#1)
treated mice##11##2##(1995-12#1)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
treated multiple##3##2##(1992-5#1)(1996-8#1)(2011-2#1)
treated muscle##2##2##(1990-11#2)
treated of##2##2##(2008-9#1)(2013-1#1)
treated on the basis of##2##5##(1993-9#1)(2008-10#1)
treated on##4##2##(1993-9#1)(1995-2#1)(2008-10#1)(2010-3#1)
treated only with##4##3##(1991-8#1)(1992-5#1)(1996-12#1)(2008-6#1)
treated only##5##2##(1991-8#1)(1992-5#1)(1996-12#1)(2007-11#1)(2008-6#1)
treated operatively##5##2##(2007-11#4)(2008-3#1)
treated or not treated with##2##5##(2008-10#1)(2011-2#1)
treated or not##4##3##(1990-7#1)(1990-8#1)(2008-10#1)(2011-2#1)
treated or untreated##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
treated or##9##2##(1990-7#1)(1990-8#1)(1992-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)
treated orally with##3##3##(1993-12#1)(1996-6#1)(2007-2#1)
treated over a##3##3##(1990-10#1)(1990-8#1)(2012-2#1)
treated over the##2##3##(2008-6#1)(2008-7#1)
treated over##6##2##(1990-10#1)(1990-3#1)(1990-8#1)(2008-6#1)(2008-7#1)(2012-2#1)
treated palliatively##2##2##(2007-11#1)(2008-6#1)
treated patients and##2##3##(2012-3#1)(2013-8#1)
treated patients was##3##3##(2007-11#1)(2008-7#1)(2011-1#1)
treated patients were##3##3##(1994-2#1)(2011-2#1)(2012-1#1)
treated patients with##6##3##(1993-6#1)(1994-12#1)(1996-9#1)(2008-7#1)(2010-10#1)(2011-2#1)
treated patients##31##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#4)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
treated plants##9##2##(2008-10#5)(2008-11#2)(2008-12#2)
treated prophylactically with##4##3##(1994-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
treated rats##13##2##(1991-12#2)(1993-12#1)(1994-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
treated samples##3##2##(1994-3#1)(1994-9#1)(2008-10#1)
treated sewage##2##2##(2008-10#1)(2013-1#1)
treated simultaneously with##4##3##(1992-3#1)(1992-9#1)(2008-10#1)(2008-7#1)
treated simultaneously##6##2##(1992-3#1)(1992-9#1)(2008-10#3)(2008-7#1)
treated soil##2##2##(2008-10#1)(2012-12#1)
treated successfully by##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
treated successfully with##8##3##(1995-11#1)(1995-2#1)(2007-7#1)(2007-8#1)(2009-11#1)(2009-4#1)(2010-5#1)(2013-1#1)
treated successfully##17##2##(1990-9#1)(1995-11#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
treated surgically at##4##3##(1997-6#1)(2008-7#1)(2009-1#1)(2010-1#1)
treated surgically by##2##3##(2008-8#1)(2013-1#1)
treated surgically due to##3##4##(2007-11#2)(2007-8#1)
treated surgically using##3##3##(2007-7#1)(2008-9#1)(2011-2#1)
treated surgically##31##2##(1990-12#2)(1991-6#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-7#1)(2007-8#4)(2008-12#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
treated than##3##2##(1995-3#1)(2008-2#1)(2009-8#1)
treated throughout##2##2##(2011-2#1)(2013-1#1)
treated to remove##3##3##(2007-12#1)(2008-4#1)(2009-11#1)
treated to##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)
treated two##2##2##(1994-1#1)(2010-12#1)
treated under##3##2##(1991-9#1)(2008-12#1)(2013-1#1)
treated up to##2##3##(1993-8#1)(1996-6#1)
treated using the##5##3##(2006-12#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-8#1)
treated using this##2##3##(1990-3#1)(2008-8#1)
treated using##18##2##(1990-3#1)(1991-2#1)(1991-3#1)(1996-3#1)(2006-12#1)(2007-8#3)(2008-10#2)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
treated waste water##2##3##(2008-10#2)
treated wastewater from a##2##4##(2008-10#1)(2012-12#1)
treated wastewater samples##2##3##(2008-10#1)(2012-12#1)
treated wastewater##5##2##(2008-10#3)(2012-12#2)
treated water and##2##3##(1997-4#1)(2008-1#1)
treated water##4##2##(1997-4#2)(2008-1#1)(2008-5#1)
treated wheat##2##2##(2008-12#2)
treated with 0##8##3##(1994-11#1)(1994-12#1)(1996-12#1)(2008-10#3)(2008-4#1)(2011-2#1)
treated with 1##9##3##(1990-12#1)(1992-9#1)(1993-8#1)(1996-12#1)(2008-10#4)(2012-12#1)
treated with 1- and 2-methoxynaphthalene##3##5##(2011-2#3)
treated with 10##3##3##(1992-11#1)(2008-10#1)(2008-7#1)
treated with 17-MT and##4##4##(2013-7#4)
treated with 17-MT##5##3##(2013-7#5)
treated with 2##2##3##(1996-12#1)(2008-10#1)
treated with 300##2##3##(1990-2#1)(2011-1#1)
treated with 4##3##3##(2008-10#2)(2013-1#1)
treated with 500##2##3##(1995-3#1)(2008-6#1)
treated with 6##2##3##(1991-6#1)(1992-10#1)
treated with Ad-HGF##3##3##(2008-9#3)
treated with BNR##2##3##(2008-10#2)
treated with CO2 laser##3##4##(1995-2#1)(1996-1#1)(2008-4#1)
treated with COC##2##3##(1996-12#2)
treated with CT##4##3##(2011-2#4)
treated with Co60 and##2##4##(2007-10#2)
treated with Co60##6##3##(2007-10#6)
treated with Ender##2##3##(2007-11#1)(2007-8#1)
treated with GM1##2##3##(1993-3#1)(2008-10#1)
treated with H2O2##2##3##(1995-8#2)
treated with LPS##2##3##(1993-3#1)(2008-11#1)
treated with Lyprinol(R)##2##3##(2008-10#2)
treated with MH##2##3##(2008-9#2)
treated with Microsphaeropsis sp##3##4##(2008-10#3)
treated with NJE##2##3##(2013-8#2)
treated with a combination of##6##5##(1991-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
treated with a combination##7##4##(1990-2#1)(1991-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
treated with a new##2##4##(1992-3#1)(1993-2#1)
treated with a variety of##2##5##(1991-3#1)(2008-7#1)
treated with a##48##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#2)(2013-1#4)
treated with acamprosate##2##3##(2008-2#2)
treated with adjuvant##3##3##(1991-4#1)(2008-7#1)(2013-1#1)
treated with alcohol##2##3##(1997-8#1)(2012-2#1)
treated with an oral##2##4##(1990-8#1)(1994-6#1)
treated with an##13##3##(1990-8#2)(1992-11#2)(1994-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
treated with androgen deprivation therapy##2##5##(2008-7#1)(2012-3#1)
treated with androgen##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
treated with anti-tumor necrosis factor##2##5##(2011-2#2)
treated with antibiotic##2##3##(2011-2#1)(2012-12#1)
treated with antibiotics and##2##4##(1996-11#1)(2007-12#1)
treated with antibiotics##5##3##(1996-11#1)(2007-12#1)(2007-7#2)(2013-1#1)
treated with anticoagulation##2##3##(1997-2#1)(2010-6#1)
treated with antifungal##2##3##(2007-12#1)(2011-2#1)
treated with aspirin##2##3##(1996-11#1)(2008-3#1)
treated with atrazine##2##3##(2013-1#2)
treated with band ligation and sclerotherapy##2##6##(2013-1#2)
treated with band ligation##3##4##(2013-1#3)
treated with both##8##3##(1992-2#2)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)
treated with calcium##2##3##(1990-3#1)(1995-11#1)
treated with chemotherapy and##2##4##(1992-8#1)(2011-2#1)
treated with chemotherapy##9##3##(1991-6#1)(1992-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#4)
treated with cisplatin##2##3##(1992-12#1)(2012-2#1)
treated with clotrimazole##2##3##(2007-7#2)
treated with co-artemether##2##3##(2007-2#2)
treated with combination##3##3##(1990-6#1)(2007-10#1)(2007-7#1)
treated with conventional##2##3##(2008-1#1)(2011-1#1)
treated with curative##2##3##(1991-2#1)(2008-6#1)
treated with cyclophosphamide##5##3##(1991-8#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)
treated with cyclosporine##2##3##(2006-10#1)(2008-5#1)
treated with definitive##2##3##(1991-4#1)(2011-2#1)
treated with different##5##3##(2008-4#1)(2008-5#1)(2013-1#3)
treated with drugs##4##3##(1992-9#1)(1993-2#1)(1994-6#1)(2008-10#1)
treated with each##2##3##(1995-2#1)(2008-10#1)
treated with either##8##3##(1994-11#1)(1994-2#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
treated with epoetin beta##2##4##(2008-7#2)
treated with ethanol extract##2##4##(2008-10#1)(2012-2#1)
treated with ethanol##5##3##(1996-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
treated with five##2##3##(2008-6#1)(2012-1#1)
treated with folic acid##2##4##(2008-3#1)(2008-7#1)
treated with fungicides##3##3##(2008-10#3)
treated with granulocyte colony-stimulating factor (G-CSF)##2##6##(2006-10#1)(2008-7#1)
treated with heparin##2##3##(2010-3#1)(2013-8#1)
treated with high doses of##3##5##(1994-3#1)(2006-10#1)(2012-2#1)
treated with high##9##3##(1990-6#2)(1994-3#1)(1994-6#1)(2006-10#1)(2007-7#1)(2012-2#1)(2013-1#2)
treated with home mechanical ventilation##2##5##(1995-2#2)
treated with inhaled insulin compared to##2##6##(2008-8#2)
treated with inhaled##7##3##(1990-9#1)(2007-11#3)(2008-8#2)(2010-2#1)
treated with intensive##2##3##(1990-3#1)(2011-1#1)
treated with intravenous antibiotics##3##4##(2006-10#1)(2011-1#1)(2013-1#1)
treated with intravenous##9##3##(2006-10#1)(2007-7#1)(2008-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
treated with itraconazole##4##3##(2007-7#1)(2008-1#1)(2008-5#2)
treated with laminectomy followed by radiotherapy##2##6##(1991-9#1)(1996-9#1)
treated with local##3##3##(2007-10#2)(2008-7#1)
treated with low##6##3##(1997-7#1)(1997-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
treated with narrow-band ultraviolet B##2##5##(2011-1#2)
treated with neoadjuvant chemotherapy##2##4##(1994-2#1)(2009-4#1)
treated with neoadjuvant##4##3##(1994-2#1)(2009-4#3)
treated with no##2##3##(1997-3#1)(1997-6#1)
treated with one of##2##4##(2008-10#1)(2012-2#1)
treated with one##3##3##(2008-10#2)(2012-2#1)
treated with oral##9##3##(1990-11#1)(1990-3#1)(1991-4#1)(1996-6#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-8#2)
treated with palliative radiation therapy##2##5##(2008-7#1)(2012-12#1)
treated with palliative##3##3##(2007-4#1)(2008-7#1)(2012-12#1)
treated with percutaneous##2##3##(2008-9#1)(2013-8#1)
treated with peritoneal dialysis##2##4##(2008-7#1)(2011-2#1)
treated with peritoneal##3##3##(2008-7#1)(2011-2#2)
treated with phorbol 12-myristate 13-acetate (PMA)##2##6##(1994-3#1)(2008-5#1)
treated with phrenic-musculocutaneous nerve transfer##3##5##(2008-9#3)
treated with placebo##3##3##(1990-6#1)(2008-1#1)(2008-2#1)
treated with platinum-based##2##3##(1990-6#1)(2010-8#1)
treated with potassium##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
treated with potent topical##2##4##(2012-3#2)
treated with praziquantel##2##3##(1996-12#1)(2010-12#1)
treated with primary##3##3##(1992-6#1)(2008-3#2)
treated with radiation##2##3##(1991-12#1)(2012-2#1)
treated with radical##4##3##(2007-11#1)(2011-2#3)
treated with radiotherapy and##3##4##(1997-7#1)(2008-11#1)(2008-7#1)
treated with radiotherapy##6##3##(1991-5#1)(1997-7#1)(2008-11#2)(2008-7#1)(2013-1#1)
treated with recombinant##3##3##(1991-8#1)(2011-2#1)(2012-2#1)
treated with regular##2##3##(2008-12#1)(2013-8#1)
treated with resveratrol##2##3##(2008-10#1)(2012-4#1)
treated with retrograde##2##3##(2006-12#1)(2013-1#1)
treated with rt-PA##2##3##(2007-10#2)
treated with sclerotherapy and##2##4##(2013-1#2)
treated with simple##2##3##(1990-6#1)(2008-5#1)
treated with sodium##6##3##(1990-7#1)(1991-11#1)(1992-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
treated with spinal##2##3##(2007-11#1)(2012-12#1)
treated with standard##2##3##(1996-11#1)(2008-7#1)
treated with steroids##2##3##(1992-5#1)(2009-3#1)
treated with sub-cutaneous insulin##2##4##(2008-8#2)
treated with surgery alone##4##4##(1991-8#1)(1995-5#1)(2012-3#2)
treated with surgery and##2##4##(2011-2#1)(2012-3#1)
treated with surgery##9##3##(1991-8#1)(1995-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-8#1)
treated with surgical excision##4##4##(2008-10#1)(2010-5#1)(2012-1#2)
treated with surgical##7##3##(2008-10#1)(2010-5#1)(2011-2#1)(2012-1#3)(2013-8#1)
treated with systemic antibiotics alone##2##5##(1994-12#1)(2013-8#1)
treated with systemic##4##3##(1994-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
treated with tamoxifen##2##3##(1993-12#1)(1993-6#1)
treated with the combination of##3##5##(1997-7#1)(2008-10#1)(2008-12#1)
treated with the combination##5##4##(1993-9#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#1)
treated with the##38##3##(1990-6#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-9#2)(1994-9#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
treated with these agents##2##4##(2008-10#1)(2008-11#1)
treated with these drugs##2##4##(1994-5#1)(2008-11#1)
treated with these##6##3##(1992-3#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#2)
treated with this##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
treated with three different modalities##2##5##(2007-7#2)
treated with three different##4##4##(2007-7#2)(2010-5#1)(2013-1#1)
treated with two##5##3##(1990-12#1)(1997-7#2)(2008-8#1)(2012-12#1)
treated with vancomycin##2##3##(2007-12#1)(2011-2#1)
treated with various##3##3##(1992-9#1)(1996-12#1)(2008-8#1)
treated with varying##2##3##(1994-11#1)(2008-11#1)
treated with wedge filters##3##4##(2007-10#3)
treated with wide##4##3##(2008-5#2)(2009-5#1)(2013-7#1)
treated with##1029##2##(1990-11#5)(1990-12#10)(1990-2#5)(1990-3#3)(1990-5#3)(1990-6#11)(1990-7#2)(1990-8#3)(1990-9#5)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#5)(1991-4#3)(1991-5#5)(1991-6#5)(1991-8#6)(1991-9#3)(1992-10#4)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#6)(1992-8#4)(1992-9#7)(1993-1#2)(1993-12#2)(1993-2#10)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#7)(1994-8#3)(1994-9#1)(1995-11#8)(1995-12#4)(1995-2#5)(1995-3#5)(1995-5#3)(1995-8#9)(1996-1#4)(1996-11#5)(1996-12#10)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-9#5)(1997-1#4)(1997-2#4)(1997-3#6)(1997-4#6)(1997-6#5)(1997-7#5)(1997-8#7)(2006-10#13)(2006-12#1)(2007-10#18)(2007-11#17)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#25)(2007-8#14)(2008-1#15)(2008-10#123)(2008-11#32)(2008-12#11)(2008-2#6)(2008-3#14)(2008-4#7)(2008-5#34)(2008-6#21)(2008-7#49)(2008-8#27)(2008-9#24)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#5)(2009-5#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#7)(2010-5#6)(2010-6#5)(2010-7#1)(2010-8#7)(2011-1#16)(2011-2#60)(2012-1#4)(2012-12#12)(2012-2#12)(2012-3#15)(2012-4#2)(2013-1#57)(2013-7#9)(2013-8#19)
treated within##3##2##(2007-10#1)(2008-3#1)(2008-7#1)
treated without##2##2##(1992-9#1)(2011-2#1)
treated women##4##2##(1994-12#2)(1994-5#1)(2008-7#1)
treated##2163##1##(1990-10#3)(1990-11#10)(1990-12#16)(1990-2#12)(1990-3#8)(1990-5#8)(1990-6#16)(1990-7#4)(1990-8#6)(1990-9#15)(1991-1#1)(1991-11#6)(1991-12#7)(1991-2#17)(1991-3#10)(1991-4#4)(1991-5#11)(1991-6#16)(1991-8#14)(1991-9#9)(1992-1#1)(1992-10#4)(1992-11#6)(1992-12#7)(1992-2#8)(1992-3#11)(1992-4#2)(1992-5#14)(1992-6#11)(1992-8#7)(1992-9#22)(1993-1#3)(1993-11#4)(1993-12#7)(1993-2#15)(1993-3#9)(1993-5#2)(1993-6#11)(1993-8#5)(1993-9#8)(1994-1#2)(1994-10#1)(1994-11#9)(1994-12#13)(1994-2#6)(1994-3#6)(1994-5#4)(1994-6#13)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#15)(1995-12#6)(1995-2#8)(1995-3#7)(1995-5#6)(1995-6#1)(1995-8#13)(1995-9#1)(1996-1#4)(1996-11#11)(1996-12#14)(1996-2#3)(1996-3#8)(1996-5#6)(1996-6#10)(1996-7#1)(1996-8#1)(1996-9#9)(1997-1#4)(1997-2#9)(1997-3#11)(1997-4#18)(1997-5#2)(1997-6#9)(1997-7#6)(1997-8#14)(2006-10#21)(2006-12#3)(2006-6#2)(2007-10#26)(2007-11#64)(2007-12#8)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#33)(2007-8#60)(2008-1#29)(2008-10#242)(2008-11#60)(2008-12#37)(2008-2#24)(2008-3#42)(2008-4#17)(2008-5#51)(2008-6#49)(2008-7#112)(2008-8#47)(2008-9#54)(2009-1#3)(2009-10#2)(2009-11#8)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#8)(2009-5#10)(2009-6#1)(2009-7#6)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#7)(2010-11#6)(2010-12#11)(2010-2#5)(2010-3#18)(2010-4#3)(2010-5#11)(2010-6#9)(2010-7#2)(2010-8#9)(2011-1#30)(2011-10#1)(2011-2#132)(2011-3#1)(2012-1#10)(2012-12#27)(2012-2#36)(2012-3#35)(2012-4#2)(2012-7#1)(2013-1#102)(2013-7#12)(2013-8#35)
treated-Pennisetum##3##1##(2008-10#3)
treatedwith##2##1##(2008-11#2)
treatement of##2##2##(2007-11#1)(2013-1#1)
treatement##4##1##(2007-11#1)(2007-8#1)(2008-2#1)(2013-1#1)
treating HIV##2##2##(1995-6#1)(2008-6#1)
treating a variety of##2##4##(2011-2#1)(2013-1#1)
treating a##8##2##(1995-6#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
treating acute ischemic stroke##2##4##(2007-10#1)(2012-12#1)
treating acute##3##2##(2007-10#1)(2012-12#1)(2013-1#1)
treating alcohol##2##2##(2008-2#2)
treating chronic##3##2##(1995-2#1)(2009-10#1)(2009-8#1)
treating concomitant##2##2##(2012-12#2)
treating disease##3##2##(2008-11#1)(2010-11#1)(2013-1#1)
treating diseases##3##2##(2008-10#1)(2009-6#1)(2010-5#1)
treating each##2##2##(1994-3#1)(2011-1#1)
treating hepatoma##2##2##(2012-12#2)
treating hypertension in##2##3##(1992-6#1)(1994-12#1)
treating hypertension##4##2##(1992-6#1)(1994-12#1)(2008-11#1)(2009-9#1)
treating patients with##15##3##(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-3#1)(2013-1#1)
treating patients##20##2##(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#2)(2010-3#1)(2012-3#1)(2013-1#1)
treating physician##9##2##(1993-12#1)(1993-6#1)(1996-3#1)(2006-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
treating prostate cancer##2##3##(2008-4#1)(2008-7#1)
treating prostate##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
treating severe##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
treating the symptoms##4##3##(1994-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
treating the##21##2##(1991-12#1)(1992-5#1)(1994-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
treating them##2##2##(1994-11#1)(2007-10#1)
treating these##6##2##(1991-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
treating this##2##2##(2008-7#1)(2011-2#1)
treating uncomplicated##2##2##(2007-2#1)(2008-11#1)
treating women##2##2##(2008-6#1)(2011-2#1)
treating##268##1##(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#8)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#18)(2012-12#12)(2012-2#6)(2012-3#6)(2013-1#24)(2013-7#1)(2013-8#5)
treatise of##2##2##(2007-5#1)(2010-6#1)
treatise##3##1##(2007-5#2)(2010-6#1)
treatment (0##2##2##(2011-2#1)(2012-12#1)
treatment (10##2##2##(1996-2#1)(2012-3#1)
treatment (200##2##2##(1990-8#1)(1994-9#1)
treatment (5##2##2##(1997-4#1)(2008-7#1)
treatment (50##3##2##(1994-2#1)(1994-8#1)(1997-2#1)
treatment (8 x##2##3##(1997-7#2)
treatment (P = 0##3##4##(2012-3#1)(2013-1#2)
treatment (P##4##2##(2011-3#1)(2012-3#1)(2013-1#2)
treatment (from##2##2##(2008-12#1)(2012-3#1)
treatment (including##2##2##(2008-6#1)(2008-9#1)
treatment (p##2##2##(2007-11#1)(2009-12#1)
treatment -##4##2##(2007-11#1)(2007-8#1)(2008-6#1)(2010-5#1)
treatment A##2##2##(1996-6#1)(2011-2#1)
treatment a##3##2##(2007-11#1)(2007-8#1)(2008-8#1)
treatment adequacy of major depressive episodes in France]##2##8##(2010-6#2)
treatment adherence##11##2##(2008-11#1)(2008-7#1)(2010-11#5)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
treatment administration##2##2##(1996-6#1)(2008-7#1)
treatment after##11##2##(1993-8#1)(1997-8#3)(2007-12#1)(2007-8#1)(2008-12#1)(2009-1#1)(2009-11#1)(2009-9#1)(2010-12#1)
treatment against##3##2##(1991-2#1)(2007-2#1)(2010-4#1)
treatment agents for##2##3##(1991-1#1)(2013-1#1)
treatment aimed at##3##3##(2009-12#1)(2010-1#1)(2010-9#1)
treatment algorithm and##2##3##(2008-8#1)(2012-2#1)
treatment algorithm##6##2##(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
treatment algorithms##3##2##(1997-2#1)(2009-11#2)
treatment alone in##2##3##(2008-10#1)(2010-12#1)
treatment alone##17##2##(1991-3#1)(1992-6#1)(1993-12#1)(1995-9#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
treatment along with##2##3##(2008-10#1)(2011-1#1)
treatment also induced a##2##4##(1992-11#1)(2008-7#1)
treatment also induced##3##3##(1992-11#1)(2008-10#1)(2008-7#1)
treatment also showed##2##3##(2009-12#1)(2013-1#1)
treatment also##15##2##(1992-11#1)(1993-9#1)(1994-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
treatment alternatives to##2##3##(1994-2#1)(2009-3#1)
treatment alternatives##5##2##(1994-2#1)(2007-7#1)(2009-3#1)(2009-6#1)(2011-2#1)
treatment among##5##2##(1993-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)
treatment and 1##2##3##(2008-10#1)(2011-2#1)
treatment and 2##2##3##(1991-6#1)(2013-1#1)
treatment and a##3##3##(2006-10#1)(2007-2#1)(2008-10#1)
treatment and after##7##3##(1995-11#1)(1997-4#1)(2008-10#1)(2008-7#2)(2013-8#2)
treatment and as##2##3##(2011-1#1)(2011-2#1)
treatment and at##3##3##(1991-3#1)(2008-7#1)(2009-9#1)
treatment and care##5##3##(2007-12#1)(2009-7#2)(2010-5#1)(2013-1#1)
treatment and control groups##2##4##(2008-10#1)(2012-3#1)
treatment and control##5##3##(2008-1#2)(2008-10#1)(2008-9#1)(2012-3#1)
treatment and criminal justice##2##4##(2008-6#1)(2009-9#1)
treatment and disposal##2##3##(1997-4#1)(2008-10#1)
treatment and follow-up of##2##4##(2011-1#1)(2011-2#1)
treatment and follow-up##4##3##(2007-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
treatment and following##2##3##(1996-9#1)(2011-2#1)
treatment and in##2##3##(2008-10#1)(2009-8#1)
treatment and intervention##2##3##(2012-2#2)
treatment and its##4##3##(1992-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
treatment and may##2##3##(2006-7#1)(2008-7#1)
treatment and monitoring of##2##4##(2013-1#2)
treatment and outcome of##3##4##(2008-6#1)(2008-7#1)(2013-7#1)
treatment and outcome##8##3##(1993-3#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-3#1)(2010-8#1)(2013-7#1)
treatment and outcomes##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
treatment and pharmacotherapy##2##3##(1991-2#1)(2013-1#1)
treatment and prevention of depression##2##5##(2008-12#1)(2011-2#1)
treatment and prevention of##13##4##(1993-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
treatment and prevention##22##3##(1993-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)
treatment and prognosis of##3##4##(2006-8#1)(2010-8#1)(2011-2#1)
treatment and prognosis##11##3##(1991-8#1)(2006-8#2)(2007-12#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#3)
treatment and prophylaxis##3##3##(1994-6#1)(2010-6#2)
treatment and proved##2##3##(1992-8#1)(2008-10#1)
treatment and rehabilitation##5##3##(1995-5#1)(2007-11#3)(2012-12#1)
treatment and research##3##3##(2008-6#1)(2010-11#1)(2012-3#1)
treatment and support##2##3##(1997-3#1)(2009-5#1)
treatment and supportive##2##3##(2008-7#1)(2012-3#1)
treatment and surgical##3##3##(2010-3#1)(2011-2#1)(2012-2#1)
treatment and the results##2##4##(2008-10#1)(2011-2#1)
treatment and the##24##3##(1990-3#1)(1991-2#1)(1991-6#1)(1992-6#1)(1996-12#1)(1997-3#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#2)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
treatment and therapy##2##3##(2010-5#1)(2012-12#1)
treatment and to##4##3##(2007-5#1)(2007-8#1)(2008-5#1)(2013-8#1)
treatment and was##2##3##(2008-10#2)
treatment and were##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
treatment and withdrawal##2##3##(1996-12#1)(2008-10#1)
treatment and##311##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#2)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-3#2)(1996-8#1)(1996-9#1)(1997-3#4)(1997-4#3)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#36)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#10)(2008-6#7)(2008-7#14)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#11)
treatment and/or##2##2##(2008-10#1)(2008-4#1)
treatment appeared to be##2##4##(1990-2#1)(2008-10#1)
treatment approach is##3##3##(2009-6#1)(2012-12#1)(2013-8#1)
treatment approach that##2##3##(2008-12#1)(2013-8#1)
treatment approach to##3##3##(2008-7#2)(2013-8#1)
treatment approach##20##2##(1992-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2009-6#2)(2010-1#2)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
treatment approaches and##2##3##(1996-4#1)(2013-1#1)
treatment approaches##15##2##(1996-4#1)(1997-1#2)(2007-8#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-3#3)(2011-2#2)(2012-3#1)(2013-1#1)
treatment are critical##2##3##(2007-12#1)(2011-2#1)
treatment are described##4##3##(1993-6#1)(1996-8#1)(2008-2#1)(2013-1#1)
treatment are discussed##6##3##(1993-9#1)(1994-9#1)(2006-12#1)(2007-8#1)(2008-11#1)(2013-1#1)
treatment are important##2##3##(2007-8#1)(2013-1#1)
treatment are necessary##2##3##(2009-6#1)(2012-1#1)
treatment are reviewed##2##3##(1990-9#1)(2011-2#1)
treatment are the##3##3##(1992-4#1)(1997-4#1)(2008-9#1)
treatment are##54##2##(1990-12#1)(1990-9#1)(1991-1#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-12#2)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
treatment as a##3##3##(1992-2#1)(1995-1#1)(2007-11#1)
treatment as an##3##3##(1997-8#1)(2012-12#1)(2012-2#1)
treatment as recommended by the##2##5##(1990-6#1)(2011-2#1)
treatment as well as##6##4##(1990-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
treatment as##23##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1995-1#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
treatment assignment##2##2##(1997-3#1)(2008-7#1)
treatment associated##2##2##(2007-8#1)(2010-11#1)
treatment at 50##2##3##(1991-12#1)(1993-11#1)
treatment at a##6##3##(1995-12#1)(1995-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
treatment at all##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
treatment at the##11##3##(1990-8#1)(1996-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
treatment at##44##2##(1990-8#1)(1991-12#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#3)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
treatment based on the##2##4##(2007-12#1)(2007-8#1)
treatment based on##7##3##(1995-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
treatment be##2##2##(1990-11#1)(1991-2#1)
treatment because of the##2##4##(2008-11#1)(2012-1#1)
treatment because of##3##3##(1994-9#1)(2008-11#1)(2012-1#1)
treatment because##4##2##(1994-6#1)(1994-9#1)(2008-11#1)(2012-1#1)
treatment before##3##2##(1991-9#1)(1995-5#1)(2013-1#1)
treatment began##3##2##(1990-10#1)(1992-8#1)(2008-5#1)
treatment benefit##3##2##(2008-6#1)(2010-12#2)
treatment blocked##2##2##(1992-12#1)(1994-2#1)
treatment but the##2##3##(2008-10#1)(2008-3#1)
treatment but##10##2##(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
treatment by electrical stimulation of the auditory cortex##2##8##(2010-7#2)
treatment by reducing##2##3##(2008-7#1)(2013-8#1)
treatment by the##3##3##(1993-3#1)(2007-7#1)(2012-2#1)
treatment by##39##2##(1990-5#1)(1991-2#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-5#2)(1996-6#1)(1996-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#3)(2011-1#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
treatment can be used##2##4##(1997-6#1)(2013-8#1)
treatment can be##13##3##(1993-6#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
treatment can##27##2##(1990-6#1)(1993-6#1)(1995-6#1)(1996-11#2)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
treatment cannot be##2##3##(1991-11#1)(2012-3#1)
treatment cannot##5##2##(1991-11#1)(1993-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
treatment capacity##2##2##(1991-11#2)
treatment carries##2##2##(2011-2#1)(2013-1#1)
treatment caused a##3##3##(1997-7#1)(2008-10#1)(2013-7#1)
treatment caused significant##2##3##(1993-12#1)(2008-10#1)
treatment caused##8##2##(1993-12#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2013-7#1)
treatment causes##2##2##(1992-6#1)(1995-12#1)
treatment center##3##2##(1991-8#1)(2007-9#1)(2008-8#1)
treatment centers##4##2##(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
treatment centres##3##2##(1996-11#1)(2008-11#1)(2008-2#1)
treatment challenges##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
treatment characteristics##2##2##(2006-10#1)(2012-2#1)
treatment choice for##2##3##(1991-6#1)(2013-8#1)
treatment choice##5##2##(1991-6#1)(1995-11#1)(2007-7#1)(2012-2#1)(2013-8#1)
treatment choices and##2##3##(1997-1#1)(2010-11#1)
treatment classes##3##2##(2008-10#3)
treatment combined with##3##3##(1991-2#1)(1996-2#1)(2007-8#1)
treatment compared to##3##3##(2010-6#1)(2012-2#1)(2012-6#1)
treatment compared with##2##3##(1997-5#1)(2008-2#1)
treatment compared##5##2##(1997-5#1)(2008-2#1)(2010-6#1)(2012-2#1)(2012-6#1)
treatment comparisons##2##2##(1997-4#1)(2008-10#1)
treatment completion##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
treatment compliance##2##2##(1997-4#1)(2012-3#1)
treatment comprises##2##2##(1994-3#1)(2008-6#1)
treatment condition##3##2##(2007-6#1)(2011-1#2)
treatment conditions##3##2##(1995-11#1)(2007-6#1)(2008-4#1)
treatment considerations##2##2##(2008-1#1)(2013-1#1)
treatment consisted of##4##3##(1990-3#1)(1991-6#1)(1997-5#1)(2013-1#1)
treatment consisted##5##2##(1990-3#1)(1991-6#1)(1997-5#1)(2007-8#1)(2013-1#1)
treatment consisting of##2##3##(2010-3#1)(2010-9#1)
treatment consists of##3##3##(1991-6#1)(2008-7#1)(2012-12#1)
treatment consists##5##2##(1990-6#1)(1991-6#1)(2008-7#1)(2012-12#2)
treatment continued##2##2##(2008-10#1)(2011-2#1)
treatment cost##3##2##(2007-8#1)(2008-1#1)(2012-12#1)
treatment costs##3##2##(2007-7#1)(2008-10#1)(2009-12#1)
treatment could be##2##3##(1993-12#1)(2013-8#1)
treatment could not##2##3##(2008-10#1)(2012-12#1)
treatment could##6##2##(1993-12#1)(1994-6#1)(1995-12#1)(2008-10#1)(2012-12#1)(2013-8#1)
treatment course##3##2##(2008-10#2)(2011-2#1)
treatment courses##3##2##(1992-10#1)(1993-9#1)(2008-5#1)
treatment cycle##3##2##(2007-4#2)(2010-12#1)
treatment cycles##3##2##(1991-6#1)(1991-8#1)(2010-6#1)
treatment decision##2##2##(1994-1#1)(2010-8#1)
treatment decision-making##2##2##(2008-9#1)(2011-2#1)
treatment decisions##6##2##(2008-10#1)(2008-4#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
treatment decreased##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)
treatment delay for##2##3##(2008-3#1)(2010-11#1)
treatment delay##5##2##(2008-3#1)(2008-4#1)(2010-11#3)
treatment delivery##5##2##(1995-2#1)(2008-2#1)(2009-11#1)(2013-1#2)
treatment demonstrated##3##2##(1991-6#1)(1993-1#1)(2008-6#1)
treatment depends on##5##3##(1993-6#1)(2007-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
treatment design was##2##3##(2008-10#1)(2011-1#1)
treatment did not affect##4##4##(1996-3#1)(1996-5#1)(2007-8#1)(2008-10#1)
treatment did not##10##3##(1992-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-5#1)(2007-8#1)(2008-10#3)(2013-1#1)
treatment difference##2##2##(1994-9#1)(1997-7#1)
treatment differences were##2##3##(2006-11#1)(2008-3#1)
treatment differences##4##2##(1995-12#1)(2006-11#1)(2008-10#1)(2008-3#1)
treatment different##2##2##(2008-10#1)(2013-8#1)
treatment discontinuation##3##2##(2008-11#2)(2013-1#1)
treatment do not##2##3##(1992-9#1)(2008-7#1)
treatment do##3##2##(1990-9#1)(1992-9#1)(2008-7#1)
treatment does not##5##3##(1994-2#1)(1994-6#1)(1996-12#1)(1997-1#1)(2008-8#1)
treatment due to##2##3##(2009-8#1)(2013-1#1)
treatment duration was##3##3##(1996-11#1)(2007-8#2)
treatment duration##12##2##(1996-11#2)(2007-8#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#4)
treatment duration&quot##2##2##(2009-9#2)
treatment during pregnancy##2##3##(1995-12#2)
treatment during the##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
treatment during##15##2##(1990-2#1)(1995-12#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
treatment early##2##2##(2011-2#1)(2013-8#1)
treatment effect is##2##3##(1994-11#1)(2013-1#1)
treatment effect of##2##3##(1992-11#1)(1997-4#1)
treatment effect on##3##3##(1996-6#1)(2008-8#2)
treatment effect##23##2##(1992-11#1)(1992-6#1)(1994-11#1)(1996-3#2)(1996-6#2)(1997-3#3)(1997-4#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#4)(2012-1#1)(2012-2#1)(2013-1#2)
treatment effectiveness##6##2##(1991-1#1)(1993-12#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)
treatment effects associated with manual therapy##2##6##(2012-2#2)
treatment effects in##5##3##(1992-9#1)(2008-11#1)(2008-6#1)(2009-8#1)(2009-9#1)
treatment effects of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
treatment effects##30##2##(1991-6#1)(1992-9#1)(1994-11#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#3)(2009-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#1)
treatment efficacy##13##2##(1992-9#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2011-1#1)
treatment evaluation##2##2##(1990-2#1)(2012-2#1)
treatment even##3##2##(1996-9#1)(2008-7#1)(2012-3#1)
treatment exerted##2##2##(1995-12#1)(2008-7#1)
treatment facilities##7##2##(1995-6#1)(1996-11#1)(1997-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
treatment facility##2##2##(2008-6#1)(2009-5#1)
treatment failed##2##2##(1994-5#1)(2007-8#1)
treatment failure##13##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-8#2)
treatment failures##5##2##(1996-11#3)(2007-10#1)(2010-12#1)
treatment field##3##2##(2007-10#1)(2008-6#2)
treatment fields##3##2##(1993-9#1)(2007-10#2)
treatment five##2##2##(1991-6#1)(2009-5#1)
treatment followed by##3##3##(1997-3#1)(2008-11#2)
treatment followed##4##2##(1997-3#1)(2008-11#2)(2013-8#1)
treatment following##5##2##(1994-8#1)(2008-1#1)(2008-4#1)(2010-12#1)(2011-3#1)
treatment for AVMs##2##3##(1997-3#1)(1997-6#1)
treatment for Alzheimer's disease##2##4##(2008-10#1)(2008-5#1)
treatment for PDA##3##3##(2012-2#3)
treatment for a breast##2##4##(2008-7#1)(2012-3#1)
treatment for a long time##2##5##(2011-1#2)
treatment for a##11##3##(1993-2#1)(1994-6#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
treatment for actinic keratosis##2##4##(2010-8#2)
treatment for acute ischemic stroke##2##5##(2007-10#2)
treatment for acute myocardial infarction##2##5##(1990-3#1)(2013-1#1)
treatment for acute##6##3##(1990-3#1)(2007-10#2)(2007-7#1)(2008-3#1)(2013-1#1)
treatment for advanced##3##3##(2007-8#2)(2011-2#1)
treatment for alcohol##3##3##(1990-2#1)(1993-3#1)(2008-2#1)
treatment for allergic rhinitis##3##4##(2007-11#1)(2008-5#1)(2013-1#1)
treatment for breast cancer##3##4##(1990-12#1)(1992-7#1)(2010-7#1)
treatment for breast##4##3##(1990-11#1)(1990-12#1)(1992-7#1)(2010-7#1)
treatment for cancer##4##3##(2008-10#1)(2008-7#3)
treatment for cerebral##3##3##(1991-11#1)(1993-1#1)(1996-3#1)
treatment for children with##2##4##(2009-4#1)(2013-1#1)
treatment for children##6##3##(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
treatment for chronic##6##3##(1993-8#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment for depression##3##3##(1991-10#1)(2013-8#2)
treatment for diabetes##2##3##(2008-5#1)(2010-11#1)
treatment for each##4##3##(2012-3#1)(2013-1#2)(2013-8#1)
treatment for end-stage renal##2##4##(2008-1#1)(2011-2#1)
treatment for end-stage##4##3##(2008-1#1)(2008-2#1)(2011-2#1)(2011-3#1)
treatment for individuals##2##3##(2012-12#1)(2013-8#1)
treatment for insomnia##3##3##(2013-1#3)
treatment for local##2##3##(1994-8#1)(2008-7#1)
treatment for lower##3##3##(2008-6#1)(2011-2#2)
treatment for massive##2##3##(1992-9#1)(2012-3#1)
treatment for most##2##3##(2008-10#1)(2008-11#1)
treatment for patients with##13##4##(1992-8#1)(1995-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
treatment for patients##16##3##(1992-8#1)(1995-4#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
treatment for primary##3##3##(2008-9#1)(2010-12#1)(2011-2#1)
treatment for prostate cancer##2##4##(2008-7#1)(2013-1#1)
treatment for recurrent##2##3##(1991-3#1)(2010-5#1)
treatment for skeletal metastases from soft tissue sarcomas##2##8##(2008-6#2)
treatment for some##2##3##(2007-9#1)(2010-1#1)
treatment for stable##2##3##(2007-8#2)
treatment for symptomatic##3##3##(1993-3#1)(2012-2#1)(2012-3#1)
treatment for the condition##2##4##(1996-11#1)(1997-8#1)
treatment for the##20##3##(1990-12#1)(1994-9#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
treatment for these##2##3##(1994-6#1)(2008-1#1)
treatment for this population##2##4##(2009-11#2)
treatment for this##8##3##(2008-7#1)(2009-11#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment for unruptured AVMs in##2##5##(2008-7#2)
treatment for use in##2##4##(1991-3#1)(2008-12#1)
treatment for##327##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#3)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-4#1)(1995-6#1)(1996-11#2)(1996-3#3)(1996-8#1)(1997-3#2)(1997-6#2)(1997-8#2)(2007-10#6)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#10)(2008-7#20)(2008-8#3)(2008-9#6)(2009-11#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#4)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2011-1#7)(2011-2#20)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#13)(2012-3#11)(2013-1#25)(2013-8#16)
treatment forms##2##2##(1990-6#1)(2011-2#1)
treatment from a##2##3##(2007-11#1)(2013-1#1)
treatment from the##4##3##(1997-8#1)(2008-5#1)(2011-1#1)(2013-8#1)
treatment from##12##2##(1997-8#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
treatment gave##2##2##(1990-9#1)(1996-5#1)
treatment give##2##2##(1992-9#1)(1994-2#1)
treatment goal##2##2##(2011-7#1)(2013-1#1)
treatment goals are##2##3##(2011-2#1)(2013-8#1)
treatment goals##7##2##(2007-8#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
treatment group and##2##3##(2009-4#1)(2012-3#1)
treatment group receiving##3##3##(1991-1#2)(1991-2#1)
treatment group##35##2##(1990-2#1)(1991-1#2)(1991-2#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-5#2)(1994-9#2)(1996-11#1)(1997-3#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#5)
treatment groups in##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
treatment groups were##5##3##(1991-1#1)(1991-8#1)(2007-8#1)(2008-10#1)(2012-3#1)
treatment groups##48##2##(1991-1#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-12#3)(1994-5#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-3#1)(1997-7#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
treatment guidelines##8##2##(1990-9#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-10#1)(2011-2#1)
treatment had a##2##3##(2007-8#1)(2009-7#1)
treatment had failed##3##3##(1997-8#1)(2007-11#1)(2008-4#1)
treatment had included##2##3##(2008-6#1)(2010-3#1)
treatment had no effect on##2##5##(1997-4#1)(2011-2#1)
treatment had##17##2##(1993-6#1)(1994-6#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#2)(2013-1#1)
treatment has become##2##3##(1997-4#1)(2008-6#1)
treatment has been shown to##2##5##(2008-7#1)(2008-9#1)
treatment has been used##2##4##(2009-5#1)(2011-3#1)
treatment has been##10##3##(1990-12#1)(1993-1#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-3#1)
treatment has focused on##2##4##(1994-2#1)(2009-12#1)
treatment has not been##3##4##(1996-3#1)(2010-5#1)(2011-1#1)
treatment has not##4##3##(1992-5#1)(1996-3#1)(2010-5#1)(2011-1#1)
treatment has to be##2##4##(1997-4#1)(2008-8#1)
treatment has##29##2##(1990-12#1)(1992-5#1)(1993-1#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-4#3)(2007-8#3)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)
treatment have been##3##3##(2007-11#1)(2008-10#1)(2008-12#1)
treatment have##10##2##(1991-8#2)(1996-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
treatment if##2##2##(2008-10#1)(2008-4#1)
treatment implications##3##2##(1993-12#1)(2008-2#2)
treatment improved##2##2##(2011-2#1)(2013-1#1)
treatment improves##2##2##(2012-3#1)(2013-8#1)
treatment in a##15##3##(1990-11#1)(1990-5#1)(1993-1#1)(1993-12#1)(1996-3#1)(2007-7#1)(2008-6#1)(2009-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
treatment in adults with##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
treatment in adults##5##3##(1992-11#1)(1996-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
treatment in all##3##3##(1991-10#1)(2008-4#1)(2011-2#1)
treatment in an##5##3##(1992-5#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
treatment in hospital##2##3##(1991-11#1)(1992-5#1)
treatment in order to##3##4##(1993-11#1)(2008-1#1)(2008-12#1)
treatment in patients with breast cancer##2##6##(1992-10#1)(1993-11#1)
treatment in patients with chronic thromboembolic pulmonary hypertension]##2##8##(2010-6#2)
treatment in patients with chronic##3##5##(1993-11#1)(2010-6#2)
treatment in patients with##18##4##(1990-3#1)(1991-5#1)(1992-10#1)(1993-11#2)(1993-6#1)(1994-12#2)(2007-10#1)(2007-11#4)(2008-10#1)(2008-7#1)(2009-7#1)(2010-6#2)
treatment in patients##20##3##(1990-3#1)(1991-5#1)(1992-10#1)(1993-11#2)(1993-6#1)(1994-12#2)(1996-8#1)(2007-10#1)(2007-11#4)(2008-10#1)(2008-7#1)(2009-7#1)(2010-6#2)(2011-2#1)
treatment in specialized##2##3##(1995-11#2)
treatment in the context of##2##5##(2012-12#1)(2012-3#1)
treatment in the##26##3##(1990-11#1)(1990-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
treatment in this##5##3##(1997-6#1)(2008-11#1)(2008-7#2)(2010-6#1)
treatment in those with##2##4##(2008-7#1)(2011-2#1)
treatment in##210##2##(1990-11#4)(1990-2#3)(1990-3#2)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2007-10#2)(2007-11#15)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#1)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#5)(2010-8#1)(2011-1#6)(2011-2#15)(2012-12#7)(2012-2#3)(2012-3#6)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#2)
treatment included##4##2##(1990-12#1)(2007-6#1)(2008-6#1)(2009-3#1)
treatment includes the##2##3##(2008-10#1)(2008-6#1)
treatment includes##5##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
treatment including##5##2##(1992-5#1)(1996-3#1)(2007-8#1)(2010-12#1)(2013-8#1)
treatment increased the##2##3##(1997-7#1)(2011-1#1)
treatment increased##5##2##(1994-2#1)(1996-5#1)(1997-7#1)(2011-1#1)(2011-2#1)
treatment increases##2##2##(1992-8#1)(1994-6#1)
treatment indicates that##2##3##(1996-5#1)(2008-10#1)
treatment induced a##2##3##(1990-11#1)(2007-10#1)
treatment induced##7##2##(1990-11#1)(1992-11#1)(2007-10#1)(2008-7#1)(2010-6#1)(2011-10#1)(2012-3#1)
treatment induces##2##2##(2008-12#1)(2010-7#1)
treatment initiation##2##2##(2008-8#1)(2010-4#1)
treatment intensity##2##2##(2010-4#1)(2011-2#1)
treatment interruption##5##2##(1990-2#1)(2008-7#1)(2009-4#3)
treatment interval##3##2##(1991-6#1)(2008-12#2)
treatment intervention##5##2##(1995-12#1)(2007-11#1)(2010-1#1)(2012-3#2)
treatment interventions##3##2##(1996-6#1)(2008-6#1)(2013-8#1)
treatment into##2##2##(2008-7#1)(2010-4#1)
treatment involved##3##2##(1990-2#1)(1991-2#1)(2007-8#1)
treatment is a##7##3##(1990-12#1)(2007-11#1)(2008-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)
treatment is aimed at##2##4##(1997-3#1)(2008-10#1)
treatment is also##4##3##(1990-7#1)(2007-7#1)(2008-1#1)(2009-10#1)
treatment is always##2##3##(2008-7#1)(2011-2#1)
treatment is an##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
treatment is associated with##4##4##(1993-9#1)(2008-6#1)(2008-7#1)(2010-6#1)
treatment is based on##3##4##(2007-12#1)(2011-1#1)(2011-2#1)
treatment is crucial to##2##4##(2010-2#1)(2012-3#1)
treatment is crucial##4##3##(1996-12#1)(1996-9#1)(2010-2#1)(2012-3#1)
treatment is difficult##2##3##(2011-1#1)(2013-1#1)
treatment is discussed##5##3##(1992-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
treatment is effective##3##3##(1990-3#1)(2007-11#1)(2008-5#1)
treatment is essential##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
treatment is given##2##3##(2008-2#2)
treatment is indicated##5##3##(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
treatment is likely to##2##4##(2008-5#1)(2008-8#1)
treatment is necessary##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
treatment is not##6##3##(1991-2#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
treatment is of##2##3##(1993-6#1)(2011-2#1)
treatment is often##4##3##(2007-8#1)(2008-2#1)(2013-1#1)(2013-7#1)
treatment is one of the##2##5##(2007-11#1)(2008-10#1)
treatment is only##2##3##(1990-12#1)(2009-8#1)
treatment is recommended for##2##4##(1990-12#1)(2013-1#1)
treatment is recommended##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
treatment is required##2##3##(2008-12#1)(2008-9#1)
treatment is revealed##2##3##(1992-11#1)(2013-1#1)
treatment is similar to that##2##5##(2008-10#1)(2013-1#1)
treatment is still##3##3##(2007-7#1)(2007-8#1)(2008-7#1)
treatment is technically##2##3##(1997-5#1)(2013-1#1)
treatment is the##4##3##(1997-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
treatment is to##4##3##(1993-3#1)(2007-11#1)(2008-7#1)(2011-2#1)
treatment is used##3##3##(1990-11#1)(1994-12#1)(2010-12#1)
treatment is##183##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-2#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-5#2)(1995-9#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#2)(1997-8#2)(2007-10#1)(2007-11#8)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#2)
treatment it##2##2##(2006-10#1)(2013-8#1)
treatment lead##2##2##(2008-5#1)(2012-3#1)
treatment leads to##4##3##(2008-10#2)(2008-6#1)(2013-1#1)
treatment led to##3##3##(1996-6#1)(2008-10#1)(2013-7#1)
treatment may be##8##3##(1990-6#1)(1991-11#1)(1992-6#1)(1993-6#1)(2007-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
treatment may have##2##3##(1997-8#1)(2008-6#1)
treatment may improve##2##3##(1992-4#1)(2010-6#1)
treatment may##26##2##(1990-6#1)(1991-11#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-6#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#4)(2013-1#3)
treatment measures##2##2##(1997-7#1)(2008-4#1)
treatment method should##2##3##(2007-11#1)(2011-2#1)
treatment method##11##2##(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#3)(2012-3#1)
treatment methods##17##2##(1992-9#1)(1995-5#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-8#3)(2008-10#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
treatment might##2##2##(1992-8#1)(2008-10#1)
treatment modalities and##4##3##(1995-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
treatment modalities are##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
treatment modalities for##2##3##(2008-2#1)(2012-2#1)
treatment modalities have been used##2##5##(1995-1#1)(2010-8#1)
treatment modalities have been##3##4##(1995-1#1)(1997-8#1)(2010-8#1)
treatment modalities have##4##3##(1995-1#1)(1997-8#1)(2008-9#1)(2010-8#1)
treatment modalities of##7##3##(1992-9#1)(1993-8#1)(1994-2#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
treatment modalities were##2##3##(1996-9#1)(2011-1#1)
treatment modalities##48##2##(1990-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#4)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
treatment modality for##6##3##(1990-11#1)(1997-1#1)(2007-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
treatment modality##23##2##(1990-11#1)(1991-9#1)(1994-3#2)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#3)(2013-1#1)
treatment model##2##2##(2008-10#1)(2012-12#1)
treatment models##4##2##(2008-10#1)(2008-6#1)(2009-10#1)(2012-12#1)
treatment monitoring##2##2##(2010-8#1)(2011-2#1)
treatment most##2##2##(1996-11#1)(2008-5#1)
treatment must be##4##3##(1991-11#1)(1991-2#1)(2010-12#1)(2012-3#1)
treatment must##6##2##(1991-11#1)(1991-2#1)(1994-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
treatment near##2##2##(1992-9#1)(2008-7#1)
treatment need##4##2##(2008-1#1)(2008-5#1)(2013-7#1)(2013-8#1)
treatment needs to be##2##4##(1995-2#1)(2008-7#1)
treatment needs##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
treatment nonadherence##2##2##(2009-9#2)
treatment nor##2##2##(1995-12#1)(2009-4#1)
treatment of &quot##3##3##(1990-6#1)(2007-11#1)(2010-4#1)
treatment of 11 patients##2##4##(1996-9#1)(2007-11#1)
treatment of 28##2##3##(1994-2#1)(1997-2#1)
treatment of 4##2##3##(1996-2#1)(2007-11#1)
treatment of AD##2##3##(2008-7#1)(2010-2#1)
treatment of ADHD##2##3##(2008-2#2)
treatment of AIDS##2##3##(1994-8#1)(2011-3#1)
treatment of ALL##2##3##(2011-2#2)
treatment of Alzheimer's disease##3##4##(2008-11#1)(2008-5#2)
treatment of Alzheimer's##4##3##(1991-8#1)(2008-11#1)(2008-5#2)
treatment of BA##2##3##(2008-7#2)
treatment of BII phobia##2##4##(2012-2#2)
treatment of CML##3##3##(1997-3#1)(2010-4#1)(2012-12#1)
treatment of DDH##6##3##(2007-11#1)(2007-8#5)
treatment of DME##2##3##(2011-7#2)
treatment of ESRD##2##3##(2007-12#1)(2007-7#1)
treatment of GHF##2##3##(2011-2#2)
treatment of HCV##3##3##(2008-10#2)(2012-1#1)
treatment of HIV##6##3##(1995-12#1)(1995-3#1)(1995-6#1)(2006-10#1)(2008-5#2)
treatment of HL-60##2##3##(1991-9#1)(1994-11#1)
treatment of Hodgkin's##3##3##(1990-9#1)(2008-4#2)
treatment of IL-1 beta##2##4##(1994-11#2)
treatment of PC12 cells with##2##5##(2008-11#2)
treatment of PC12 cells##3##4##(1992-9#1)(2008-11#2)
treatment of Parkinson's disease##7##4##(1992-3#1)(1995-12#1)(1996-3#2)(2008-10#2)(2008-7#1)
treatment of RE##3##3##(2008-8#3)
treatment of T1##2##3##(1991-4#1)(2011-2#1)
treatment of TBI##2##3##(2008-10#1)(2008-9#1)
treatment of a congenital splenic cyst with##2##7##(1997-8#2)
treatment of a patient with##2##5##(2007-11#1)(2008-10#1)
treatment of a variety of##4##5##(2008-11#1)(2008-5#2)(2013-8#1)
treatment of a wide##2##4##(2010-12#1)(2011-2#1)
treatment of a##33##3##(1991-1#1)(1991-2#1)(1992-6#2)(1993-8#1)(1994-2#1)(1994-6#1)(1996-6#1)(1997-8#3)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#4)(2013-1#3)(2013-8#1)
treatment of achalasia##2##3##(2011-1#2)
treatment of acne vulgaris##8##4##(1997-8#1)(2007-7#2)(2008-5#2)(2010-8#3)
treatment of acute myocardial infarction##2##5##(2008-3#1)(2012-2#1)
treatment of acute myocardial##3##4##(1991-6#1)(2008-3#1)(2012-2#1)
treatment of acute##33##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-6#1)(1997-7#1)(2007-10#3)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-7#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
treatment of adult##4##3##(1996-1#1)(2008-4#1)(2008-5#1)(2008-6#1)
treatment of adults with##2##4##(1997-8#1)(2008-11#1)
treatment of adults##3##3##(1996-11#1)(1997-8#1)(2008-11#1)
treatment of advanced stages of##2##5##(2008-4#1)(2011-2#1)
treatment of advanced##16##3##(1990-12#3)(1991-4#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-7#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-1#1)
treatment of airway##2##3##(1995-12#1)(2009-1#1)
treatment of alcohol dependence##5##4##(1991-12#3)(2008-2#2)
treatment of alcohol##6##3##(1990-2#1)(1991-12#3)(2008-2#2)
treatment of alcoholic chronic pancreatitis##3##5##(2009-7#3)
treatment of alcoholic##4##3##(1995-11#1)(2009-7#3)
treatment of all##2##3##(1996-11#1)(2012-2#1)
treatment of allergic rhinitis##5##4##(2007-11#3)(2011-2#1)(2013-8#1)
treatment of allergic##6##3##(2007-11#3)(2011-2#1)(2013-1#1)(2013-8#1)
treatment of amblyopia##2##3##(2012-12#2)
treatment of an abdominal aortic aneurysm##2##6##(2011-2#2)
treatment of an##10##3##(1992-6#1)(1997-5#1)(2007-7#1)(2008-10#1)(2010-11#1)(2011-2#3)(2011-3#1)(2012-3#1)
treatment of anemia##2##3##(1996-2#1)(2008-1#1)
treatment of angina pectoris##2##4##(2010-8#1)(2013-1#1)
treatment of aorta##2##3##(2008-10#1)(2013-8#1)
treatment of arterial hypertension]##3##4##(1993-11#1)(1993-2#1)(1996-3#1)
treatment of arterial##4##3##(1993-11#1)(1993-2#1)(1996-3#1)(2011-2#1)
treatment of arteriovenous##2##3##(1996-9#1)(2008-7#1)
treatment of arthritis##2##3##(1991-8#1)(2008-5#1)
treatment of asthma##7##3##(1992-2#1)(1992-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)
treatment of atrial fibrillation##4##4##(2007-8#2)(2008-7#1)(2012-3#1)
treatment of autism##2##3##(2010-7#1)(2012-2#1)
treatment of autoimmune##3##3##(2007-11#1)(2012-2#1)(2012-3#1)
treatment of axillary##2##3##(1991-8#1)(2008-5#1)
treatment of back##2##3##(1997-2#1)(1997-6#1)
treatment of bacterial meningitis##2##4##(2008-11#1)(2010-12#1)
treatment of bacterial##4##3##(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
treatment of benign##5##3##(1990-5#1)(1990-6#1)(1994-11#1)(2008-5#1)(2011-2#1)
treatment of bone metastases to proximal femur##2##7##(2007-11#2)
treatment of bone metastases to the##3##6##(2007-11#3)
treatment of bone metastases to##5##5##(2007-11#5)
treatment of bone metastases##12##4##(2007-11#11)(2008-7#1)
treatment of bone##14##3##(2007-11#11)(2007-8#1)(2008-7#1)(2011-2#1)
treatment of both##4##3##(1991-3#1)(2010-1#1)(2011-1#1)(2013-1#1)
treatment of brachial plexus##2##4##(2008-9#2)
treatment of breast cancer in##2##5##(1993-1#1)(2010-8#1)
treatment of breast cancer##14##4##(1990-11#2)(1992-5#1)(1993-1#1)(1993-11#3)(1993-8#1)(1995-11#1)(1996-11#1)(1997-3#1)(2009-5#1)(2010-8#1)(2011-1#1)
treatment of breast##19##3##(1990-11#2)(1990-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-6#1)(1993-8#1)(1995-11#1)(1996-11#1)(1997-3#1)(1997-7#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-1#1)
treatment of cancer during pregnancy##2##5##(2013-1#2)
treatment of cancer##25##3##(1990-3#1)(1990-9#1)(1992-3#1)(1993-3#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
treatment of carcinoma##2##3##(1991-3#1)(1991-9#1)
treatment of carotid##2##3##(1990-5#1)(2008-8#1)
treatment of carpal tunnel syndrome##2##5##(2007-8#1)(2008-5#1)
treatment of cat-scratch disease with ciprofloxacin##2##6##(1991-4#2)
treatment of cells expressing##2##4##(1992-8#2)
treatment of cells with the##2##5##(1991-12#1)(2008-11#1)
treatment of cells with##7##4##(1991-12#1)(1995-6#2)(2008-11#3)(2008-8#1)
treatment of cells##11##3##(1991-12#1)(1992-8#2)(1994-9#1)(1995-6#3)(2008-11#3)(2008-8#1)
treatment of central##2##3##(2008-7#1)(2011-2#1)
treatment of cerebral##3##3##(1997-4#1)(2008-8#1)(2008-9#1)
treatment of certain spinal##3##4##(2007-11#1)(2007-8#1)(2008-8#1)
treatment of certain##5##3##(2006-12#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#1)
treatment of cervical intraepithelial neoplasia##4##5##(1991-2#2)(1994-12#1)(2012-3#1)
treatment of cervical##9##3##(1991-1#1)(1991-2#2)(1992-2#1)(1994-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2012-3#1)
treatment of chest##2##3##(1991-2#1)(2007-8#1)
treatment of childhood##7##3##(1991-8#1)(2008-11#2)(2008-3#1)(2011-2#2)(2012-2#1)
treatment of children and adolescents##3##5##(1991-2#1)(1993-1#1)(2008-4#1)
treatment of children with##6##4##(1992-11#1)(1994-6#1)(2006-10#1)(2007-12#1)(2009-3#1)(2011-2#1)
treatment of children##9##3##(1991-2#1)(1992-11#1)(1993-1#1)(1994-6#1)(2006-10#1)(2007-12#1)(2008-4#1)(2009-3#1)(2011-2#1)
treatment of choice for patients with##2##6##(2007-7#1)(2010-10#1)
treatment of choice for##19##4##(1991-9#1)(1994-12#1)(1994-7#1)(1995-8#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#1)(2013-1#2)
treatment of choice in##10##4##(1990-9#1)(1991-6#1)(1992-12#1)(1994-3#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
treatment of choice is##4##4##(1990-2#1)(1994-5#1)(1996-9#1)(2013-1#1)
treatment of choice##54##3##(1990-2#2)(1990-6#2)(1990-9#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-6#4)(2010-8#1)(2011-2#3)(2013-1#5)(2013-8#2)
treatment of chronic heart failure (CHF)##2##6##(2009-10#1)(2012-3#1)
treatment of chronic heart failure##3##5##(2008-7#1)(2009-10#1)(2012-3#1)
treatment of chronic hepatitis B##2##5##(2009-8#2)
treatment of chronic hepatitis C##3##5##(2007-12#1)(2009-5#1)(2012-12#1)
treatment of chronic hepatitis##5##4##(2007-12#1)(2009-5#1)(2009-8#2)(2012-12#1)
treatment of chronic lymphocytic##2##4##(2008-7#1)(2009-12#1)
treatment of chronic obstructive##2##4##(1995-2#1)(2010-5#1)
treatment of chronic##36##3##(1990-6#1)(1991-11#1)(1991-6#1)(1993-5#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
treatment of cocaine abuse##2##4##(1991-1#2)
treatment of cocaine##3##3##(1991-1#3)
treatment of cognitive and##2##4##(1991-6#1)(1996-11#1)
treatment of cognitive##3##3##(1991-6#1)(1996-11#1)(2008-7#1)
treatment of colon and rectal cancer##2##6##(1992-8#1)(2011-2#1)
treatment of colon##3##3##(1992-8#1)(2008-3#1)(2011-2#1)
treatment of colorectal cancer##2##4##(1994-2#1)(2008-5#1)
treatment of colorectal##4##3##(1994-2#1)(2008-5#1)(2012-3#2)
treatment of community-acquired pneumonia##2##4##(2007-12#1)(2008-3#1)
treatment of congenital adrenal hyperplasia##4##5##(2008-4#4)
treatment of congenital heart defects##2##5##(1997-8#2)
treatment of congenital heart##3##4##(1997-8#2)(2006-10#1)
treatment of congenital##11##3##(1990-3#1)(1990-9#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-4#4)(2008-7#1)
treatment of congestive##2##3##(1992-6#1)(1996-3#1)
treatment of control##2##3##(1994-6#2)
treatment of coronary artery##2##4##(2007-8#1)(2011-2#1)
treatment of coronary heart##2##4##(2008-4#2)
treatment of coronary##6##3##(1992-4#1)(2007-8#1)(2008-11#1)(2008-4#2)(2011-2#1)
treatment of cryptococcal meningitis in the##2##6##(1991-2#1)(2011-2#1)
treatment of cultured##2##3##(1990-5#1)(1994-11#1)
treatment of data##2##3##(2008-10#2)
treatment of deep##3##3##(2008-7#1)(2010-5#1)(2012-3#1)
treatment of defects##2##3##(2011-2#1)(2012-2#1)
treatment of dementia##2##3##(1996-9#1)(2008-11#1)
treatment of depression##11##3##(1995-5#1)(2008-4#4)(2008-6#3)(2008-8#1)(2012-12#1)(2012-2#1)
treatment of developmental dislocation of the hip##2##7##(2007-11#1)(2007-8#1)
treatment of developmental dislocation##4##4##(2007-11#2)(2007-8#2)
treatment of developmental dysplasia of the hip##5##7##(2007-8#5)
treatment of developmental hip dislocation##2##5##(2007-8#2)
treatment of developmental##13##3##(2007-11#2)(2007-8#11)
treatment of diabetes##6##3##(1993-9#1)(2008-1#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-3#1)
treatment of diabetic complications##2##4##(2008-1#2)
treatment of diabetic nephropathy##2##4##(2008-1#1)(2013-1#1)
treatment of diabetic##5##3##(2007-7#1)(2008-1#3)(2013-1#1)
treatment of different##5##3##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
treatment of diffuse##2##3##(2007-12#1)(2008-10#1)
treatment of direct inguinal##2##4##(1990-6#2)
treatment of direct##3##3##(1990-6#2)(1996-1#1)
treatment of disease##5##3##(1997-3#1)(2008-11#1)(2009-3#1)(2009-7#1)(2011-2#1)
treatment of diseases##5##3##(1994-9#1)(2007-8#1)(2010-4#1)(2011-2#2)
treatment of diverticulitis##2##3##(2010-8#2)
treatment of drug##3##3##(2008-4#1)(2009-8#1)(2012-3#1)
treatment of dyslipidemia in##2##4##(2008-1#1)(2011-2#1)
treatment of dysphagia in patients with##2##6##(1993-6#1)(2007-8#1)
treatment of early##8##3##(1995-11#1)(1995-8#1)(2007-8#1)(2008-7#2)(2010-7#1)(2010-8#1)(2011-2#1)
treatment of ectopic##2##3##(1997-2#2)
treatment of end-stage##3##3##(2006-10#1)(2010-6#1)(2011-2#1)
treatment of endometriosis##5##3##(1992-2#2)(1994-9#2)(2011-1#1)
treatment of epilepsy##7##3##(1996-3#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)
treatment of essential hypertension##3##4##(1992-8#1)(1993-2#1)(2008-7#1)
treatment of essential##4##3##(1990-9#1)(1992-8#1)(1993-2#1)(2008-7#1)
treatment of fatigue##2##3##(1992-2#1)(2006-10#1)
treatment of female##4##3##(1994-5#1)(2007-9#1)(2008-9#1)(2010-11#1)
treatment of femoral neck fractures##2##5##(1991-9#1)(2007-8#1)
treatment of femoral##4##3##(1991-9#1)(2007-11#1)(2007-8#1)(2008-7#1)
treatment of fungal infections##2##4##(2008-7#1)(2011-2#1)
treatment of fungal##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
treatment of gastroesophageal reflux##3##4##(1992-11#1)(1992-3#1)(2008-3#1)
treatment of giant cell##2##4##(2006-12#2)
treatment of giant##4##3##(2006-12#2)(2008-7#1)(2008-9#1)
treatment of glioblastoma##3##3##(1995-9#1)(2011-2#1)(2011-3#1)
treatment of glioma##2##3##(1993-3#1)(2013-1#1)
treatment of gout##3##3##(1990-11#1)(1991-8#1)(2006-10#1)
treatment of head and neck cancer##2##6##(2007-11#1)(2007-12#1)
treatment of head and neck##4##5##(2007-11#1)(2007-12#1)(2011-2#1)(2013-8#1)
treatment of heart failure##10##4##(1990-3#2)(1996-6#1)(2008-5#2)(2009-10#2)(2010-6#1)(2012-3#2)
treatment of hematological malignancies##2##4##(2008-10#1)(2013-1#1)
treatment of hematological##3##3##(2007-4#1)(2008-10#1)(2013-1#1)
treatment of hepatic hydatid##2##4##(2008-10#1)(2013-1#1)
treatment of hepatic##4##3##(1991-8#1)(1993-9#1)(2008-10#1)(2013-1#1)
treatment of hepatitis C##2##4##(2008-10#1)(2009-7#1)
treatment of hepatitis##4##3##(2007-12#1)(2008-10#1)(2009-7#1)(2010-6#1)
treatment of high blood pressure##2##5##(1992-6#1)(1993-2#1)
treatment of high##4##3##(1992-1#2)(1992-6#1)(1993-2#1)
treatment of hip##2##3##(2007-8#1)(2011-2#1)
treatment of hot flashes in##2##5##(2008-7#2)
treatment of hot flashes##4##4##(2008-7#4)
treatment of human disease##3##4##(1994-5#1)(2010-2#1)(2010-3#1)
treatment of human##9##3##(1994-5#1)(1997-4#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
treatment of hypercholesterolemia##3##3##(1991-6#1)(2008-1#1)(2008-8#1)
treatment of hyperhomocysteinemia##6##3##(2007-10#2)(2008-3#4)
treatment of hypertension in the elderly##2##6##(2008-7#1)(2009-9#1)
treatment of hypertension in the##4##5##(1993-3#1)(1997-5#1)(2008-7#1)(2009-9#1)
treatment of hypertension in##6##4##(1992-6#1)(1993-3#1)(1997-5#1)(2008-1#1)(2008-7#1)(2009-9#1)
treatment of hypertension##28##3##(1990-6#1)(1991-5#1)(1992-6#1)(1992-8#4)(1993-11#1)(1993-2#2)(1993-3#2)(1994-6#1)(1995-11#1)(1997-5#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-9#2)(2011-2#1)(2012-12#1)
treatment of hypertension]##2##3##(1992-4#1)(1993-2#1)
treatment of hypertrophic##2##3##(1992-9#1)(2009-4#1)
treatment of hyperuricemia##2##3##(2008-7#2)
treatment of idiopathic scoliosis##2##4##(2007-11#1)(2007-8#1)
treatment of idiopathic##3##3##(1990-9#1)(2007-11#1)(2007-8#1)
treatment of infected##3##3##(1990-7#1)(1992-12#1)(2011-2#1)
treatment of infection in##2##4##(2007-12#1)(2008-5#1)
treatment of infection##6##3##(1994-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
treatment of infectious diseases##2##4##(1996-11#1)(2008-11#1)
treatment of infectious##3##3##(1990-2#1)(1996-11#1)(2008-11#1)
treatment of inflammatory diseases##4##4##(1995-12#1)(2008-10#1)(2011-1#2)
treatment of inflammatory##9##3##(1995-12#1)(2008-10#1)(2008-3#1)(2009-1#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#1)
treatment of inguinal##2##3##(1996-9#1)(2011-2#1)
treatment of inoperable##2##3##(2009-5#1)(2013-1#1)
treatment of intracranial aneurysms##2##4##(1997-3#1)(2008-7#1)
treatment of intracranial##3##3##(1995-9#1)(1997-3#1)(2008-7#1)
treatment of invasive##5##3##(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
treatment of irritable bowel##2##4##(2010-6#1)(2013-1#1)
treatment of ischemic##4##3##(2008-12#1)(2010-6#2)(2013-1#1)
treatment of kidney##2##3##(2008-12#1)(2012-12#1)
treatment of latent##2##3##(2007-12#1)(2008-8#1)
treatment of left##2##3##(2008-10#1)(2008-3#1)
treatment of leishmaniasis##2##3##(2008-10#1)(2010-5#1)
treatment of lithiasis##2##3##(1990-5#1)(1991-3#1)
treatment of localized##4##3##(1995-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
treatment of locally advanced##4##4##(1992-3#1)(1994-2#1)(1995-9#1)(2009-5#1)
treatment of long bone##2##4##(2007-11#1)(2010-6#1)
treatment of lung cancer##2##4##(2007-8#1)(2010-8#1)
treatment of lung##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)
treatment of malaria##7##3##(1993-8#2)(2008-10#1)(2009-6#1)(2011-2#2)(2012-12#1)
treatment of malignant glioma##2##4##(1993-9#1)(2008-5#1)
treatment of malignant##11##3##(1991-2#1)(1991-6#1)(1992-12#2)(1992-2#1)(1993-6#1)(1993-9#1)(1997-5#1)(2007-5#1)(2008-5#1)(2011-2#1)
treatment of many##8##3##(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-3#1)(2013-1#1)
treatment of membrane##2##3##(1997-8#1)(2008-6#1)
treatment of meningitis##2##3##(1992-11#1)(2009-3#1)
treatment of metabolic syndrome##2##4##(2008-3#2)
treatment of metabolic##3##3##(1997-4#1)(2008-3#2)
treatment of metastatic bone tumors##3##5##(2007-11#3)
treatment of metastatic bone##4##4##(2007-11#3)(2012-3#1)
treatment of metastatic##10##3##(1990-2#1)(1994-5#1)(2007-11#4)(2008-3#1)(2008-6#1)(2010-3#1)(2012-3#1)
treatment of methicillin-resistant Staphylococcus aureus##2##5##(2007-12#1)(2010-6#1)
treatment of mice##3##3##(1992-3#1)(2008-7#2)
treatment of migraine##3##3##(1994-11#1)(2008-6#1)(2008-9#1)
treatment of mild##2##3##(1992-6#1)(1997-8#1)
treatment of moderate to severe##2##5##(2008-7#1)(2012-3#1)
treatment of mood disorders##3##4##(2008-7#2)(2013-8#1)
treatment of morbid obesity##2##4##(1993-3#1)(2013-1#1)
treatment of mouse##2##3##(1990-2#1)(1996-5#1)
treatment of mucormycosis##3##3##(2011-2#3)
treatment of multiple myeloma##2##4##(2008-3#1)(2012-12#1)
treatment of multiple##4##3##(1994-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
treatment of nasopharyngeal cancer##2##4##(2008-8#2)
treatment of nasopharyngeal##3##3##(1993-9#1)(2008-8#2)
treatment of neoplastic##2##3##(1990-12#1)(2007-11#1)
treatment of nephrolithiasis##2##3##(2008-10#1)(2012-12#1)
treatment of nerve##2##3##(2012-2#2)
treatment of neurodegenerative##2##3##(2008-11#2)
treatment of neuroendocrine tumors##2##4##(1993-12#1)(2011-2#1)
treatment of neuropathic pain with##2##5##(1997-3#1)(2008-9#1)
treatment of neuropathic pain##8##4##(1996-5#1)(1997-3#1)(2006-12#1)(2008-9#4)(2010-7#1)
treatment of neuropathic##9##3##(1996-5#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-9#4)(2010-7#1)
treatment of non-metastatic##2##3##(1992-6#1)(2008-10#1)
treatment of non-toxic multinodular goitre##2##5##(1993-6#2)
treatment of nonmetastatic##2##3##(2010-3#2)
treatment of normal##3##3##(1990-2#1)(2008-4#1)(2008-5#1)
treatment of obesity##6##3##(2008-3#2)(2008-4#1)(2008-5#2)(2012-3#1)
treatment of ocular melanoma##3##4##(2010-9#3)
treatment of one##2##3##(2010-12#1)(2012-3#1)
treatment of onychomycosis##2##3##(2008-3#2)
treatment of open##3##3##(1991-6#1)(2007-8#1)(2013-8#1)
treatment of opportunistic##2##3##(2008-5#1)(2011-2#1)
treatment of orofacial##2##3##(2009-10#1)(2013-1#1)
treatment of osteoporosis in##2##4##(2008-7#2)
treatment of osteoporosis##21##3##(1990-11#1)(1991-11#1)(1993-11#6)(1997-6#3)(1997-7#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-12#1)
treatment of osteosarcoma##5##3##(2010-3#5)
treatment of other##4##3##(2008-2#1)(2008-5#1)(2008-7#2)
treatment of pain associated with##2##5##(2007-11#1)(2010-1#1)
treatment of pain##6##3##(2007-11#3)(2008-11#1)(2010-1#1)(2012-3#1)
treatment of painful##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
treatment of pancreatic##4##3##(1990-9#1)(1991-8#1)(1993-6#1)(2011-2#1)
treatment of panic##2##3##(1990-11#1)(1992-2#1)
treatment of pathological fractures##3##4##(2007-11#3)
treatment of pathological##6##3##(2007-11#5)(2013-1#1)
treatment of patients after##2##4##(2006-8#2)
treatment of patients with acute##3##5##(2008-3#1)(2008-5#1)(2012-12#1)
treatment of patients with cardiovascular##2##5##(2010-4#1)(2011-2#1)
treatment of patients with chronic##2##5##(2012-3#2)
treatment of patients with multiple##2##5##(2011-1#2)
treatment of patients with severe##3##5##(1992-1#1)(1993-1#1)(2012-3#1)
treatment of patients with##41##4##(1990-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1993-1#1)(1993-12#1)(1995-9#1)(1996-11#1)(1996-7#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-7#1)(2012-12#2)(2012-3#3)
treatment of patients##54##3##(1990-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-9#1)(1996-11#1)(1996-7#1)(2006-10#1)(2006-8#2)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#6)(2011-2#4)(2011-7#1)(2012-12#2)(2012-3#3)
treatment of pediatric##4##3##(2010-12#1)(2010-6#1)(2013-1#2)
treatment of pelvic endometriosis##3##4##(1992-1#1)(1995-2#1)(2011-1#1)
treatment of pelvic##4##3##(1992-1#1)(1992-3#1)(1995-2#1)(2011-1#1)
treatment of perennial##2##3##(2008-3#1)(2013-1#1)
treatment of perforated##2##3##(1993-6#1)(1993-9#1)
treatment of persistent##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
treatment of plaque psoriasis##2##4##(2008-5#1)(2008-6#1)
treatment of pneumonia##2##3##(2007-12#1)(2008-5#1)
treatment of postmenopausal osteoporosis##4##4##(1993-11#1)(1995-11#1)(2012-2#2)
treatment of primary##14##3##(1990-3#1)(1991-6#1)(1992-11#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-4#1)(2009-8#1)(2010-3#2)(2011-2#1)(2013-1#3)
treatment of prostate cancer##6##4##(2008-4#2)(2011-2#1)(2013-1#1)(2013-8#2)
treatment of proximal humerus fractures##2##5##(2007-8#2)
treatment of proximal humerus##3##4##(2007-8#2)(2009-4#1)
treatment of proximal##4##3##(2007-11#1)(2007-8#2)(2009-4#1)
treatment of psoriasis##7##3##(1993-11#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-6#2)(2011-1#1)
treatment of pulmonary and##2##4##(1997-1#1)(2010-3#1)
treatment of pulmonary##7##3##(1991-11#1)(1997-1#1)(2008-1#1)(2008-10#1)(2010-3#2)(2010-6#1)
treatment of rat##2##3##(1991-5#1)(2008-8#1)
treatment of rats with##5##4##(1990-12#1)(1995-12#1)(1997-1#1)(1997-7#1)(2012-2#1)
treatment of rats##7##3##(1990-12#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-7#1)(2008-10#1)(2012-2#1)
treatment of rectal##3##3##(2009-12#2)(2011-2#1)
treatment of recurrent##7##3##(1996-9#1)(2006-10#1)(2007-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
treatment of refractory##9##3##(1991-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-8#2)
treatment of renal oncocytoma##2##4##(1992-5#2)
treatment of renal##7##3##(1992-5#2)(1994-9#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
treatment of resistant##4##3##(2007-7#1)(2009-12#1)(2010-6#1)(2011-2#1)
treatment of respiratory##3##3##(1996-3#1)(2007-11#1)(2007-12#1)
treatment of rheumatoid arthritis##10##4##(1990-6#2)(1991-8#1)(2006-10#2)(2007-11#2)(2008-5#2)(2008-8#1)
treatment of rheumatoid##11##3##(1990-6#2)(1991-11#1)(1991-8#1)(2006-10#2)(2007-11#2)(2008-5#2)(2008-8#1)
treatment of schizophrenia##15##3##(1995-8#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#3)(2011-2#2)(2012-12#1)
treatment of several##7##3##(2007-4#1)(2008-11#2)(2008-5#1)(2009-1#1)(2010-11#1)(2011-1#1)
treatment of severe##14##3##(1990-8#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-9#1)(2013-1#3)
treatment of short##2##3##(1993-5#1)(2013-1#1)
treatment of shoulder instability##2##4##(2007-11#2)
treatment of shoulder##3##3##(2007-11#3)
treatment of skeletal##2##3##(2007-11#1)(2013-1#1)
treatment of skin##2##3##(1990-6#1)(2012-3#1)
treatment of small##3##3##(1990-6#1)(1995-12#1)(2010-12#1)
treatment of soft tissue sarcomas##2##5##(2008-6#2)
treatment of soft tissue##3##4##(2008-6#3)
treatment of spinal metastases##3##4##(2007-11#2)(2008-7#1)
treatment of spinal metastatic##2##4##(2007-11#2)
treatment of spinal##11##3##(2007-11#6)(2007-8#1)(2008-7#3)(2013-8#1)
treatment of spontaneous##2##3##(2008-11#1)(2008-7#1)
treatment of stress urinary incontinence##2##5##(1994-5#1)(2008-3#1)
treatment of stroke##3##3##(2007-9#1)(2008-2#1)(2011-2#1)
treatment of such##7##3##(1990-9#1)(2007-7#1)(2008-5#1)(2009-3#1)(2011-1#1)(2013-1#2)
treatment of superficial##4##3##(2008-5#2)(2011-1#1)(2012-3#1)
treatment of suppression##2##3##(2012-12#2)
treatment of surgical##3##3##(1990-2#1)(2007-8#1)(2008-5#1)
treatment of symptomatic##3##3##(2007-11#1)(2008-8#1)(2013-7#1)
treatment of testicular##2##3##(1995-5#1)(2008-10#1)
treatment of the breast##2##4##(1990-11#1)(1993-8#1)
treatment of the cells with##4##5##(1995-11#1)(1995-12#1)(2008-11#1)(2008-4#1)
treatment of the chronic##3##4##(1997-3#1)(2007-8#1)(2008-5#1)
treatment of the data##3##4##(2008-10#3)
treatment of the disease##2##4##(2008-1#1)(2011-1#1)
treatment of the idiopathic scoliosis##2##5##(2007-8#2)
treatment of the most##4##4##(1993-2#1)(1996-2#1)(1997-3#1)(2007-11#1)
treatment of the patients##2##4##(1994-5#1)(2008-10#1)
treatment of the primary tumor##2##5##(2008-10#1)(2010-3#1)
treatment of the primary##3##4##(1991-6#1)(2008-10#1)(2010-3#1)
treatment of the sample##3##4##(2008-10#3)
treatment of the urine sample##2##5##(2008-10#2)
treatment of the##132##3##(1990-11#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#4)(2007-11#7)(2007-12#3)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
treatment of these conditions##3##4##(1993-6#1)(2008-3#1)(2010-5#1)
treatment of these diseases##3##4##(2010-2#1)(2010-3#1)(2012-3#1)
treatment of these##21##3##(1991-1#1)(1993-6#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
treatment of this condition##6##4##(1992-5#1)(2008-5#1)(2008-6#1)(2009-10#1)(2013-1#1)(2013-8#1)
treatment of this disease##10##4##(1993-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-7#1)
treatment of this disorder##2##4##(2008-12#1)(2008-2#1)
treatment of this rare##2##4##(2012-12#1)(2012-2#1)
treatment of this##36##3##(1991-9#1)(1992-5#2)(1993-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
treatment of those##3##3##(2008-3#2)(2011-2#1)
treatment of thyroid##2##3##(2008-6#1)(2013-1#1)
treatment of tomato plants with##2##5##(2008-10#2)
treatment of toxic##2##3##(2007-5#1)(2010-7#1)
treatment of traumatic shoulder instability##2##5##(2007-11#2)
treatment of traumatic##4##3##(2007-11#3)(2012-2#1)
treatment of tubal##2##3##(1994-12#1)(1994-3#1)
treatment of tuberculosis##5##3##(1990-6#1)(1996-3#1)(2008-10#1)(2008-8#2)
treatment of tumor##2##3##(2008-2#1)(2008-7#1)
treatment of type 2 diabetes##2##5##(1996-11#1)(2013-1#1)
treatment of type 2##3##4##(1996-11#1)(2008-1#1)(2013-1#1)
treatment of type##5##3##(1996-11#1)(2008-1#1)(2008-9#1)(2011-3#1)(2013-1#1)
treatment of unresectable##3##3##(2008-6#2)(2010-3#1)
treatment of unstable##3##3##(2007-8#2)(2012-2#1)
treatment of ureteral##3##3##(1991-11#1)(2009-1#1)(2013-1#1)
treatment of urinary incontinence in##2##5##(2008-10#1)(2012-3#1)
treatment of urinary tract infections##2##5##(1997-4#1)(2010-3#1)
treatment of urinary tract##3##4##(1997-4#1)(2009-5#1)(2010-3#1)
treatment of urinary##6##3##(1996-3#1)(1997-4#1)(2008-10#1)(2009-5#1)(2010-3#1)(2012-3#1)
treatment of various diseases##3##4##(1997-2#1)(2008-10#2)
treatment of various##10##3##(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
treatment of venous##2##3##(1990-3#1)(1990-6#1)
treatment of vertebral##4##3##(2007-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
treatment of viral infections##2##4##(2007-12#1)(2008-5#1)
treatment of viral##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
treatment of women##2##3##(2008-11#1)(2009-9#1)
treatment of##2245##2##(1990-10#1)(1990-11#12)(1990-12#7)(1990-2#13)(1990-3#10)(1990-5#7)(1990-6#24)(1990-7#2)(1990-8#1)(1990-9#14)(1991-1#7)(1991-10#1)(1991-11#11)(1991-12#10)(1991-2#13)(1991-3#8)(1991-4#4)(1991-5#4)(1991-6#12)(1991-8#13)(1991-9#12)(1992-1#9)(1992-11#7)(1992-12#8)(1992-2#10)(1992-3#12)(1992-4#2)(1992-5#7)(1992-6#15)(1992-7#2)(1992-8#14)(1992-9#9)(1993-1#3)(1993-11#15)(1993-12#3)(1993-2#13)(1993-3#8)(1993-5#5)(1993-6#11)(1993-8#8)(1993-9#11)(1994-1#2)(1994-11#12)(1994-12#8)(1994-2#7)(1994-3#7)(1994-5#8)(1994-6#10)(1994-7#2)(1994-8#7)(1994-9#9)(1995-11#10)(1995-12#11)(1995-2#9)(1995-3#5)(1995-4#1)(1995-5#8)(1995-6#8)(1995-8#6)(1995-9#6)(1996-1#5)(1996-10#1)(1996-11#9)(1996-12#3)(1996-2#5)(1996-3#16)(1996-5#3)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#8)(1997-1#5)(1997-2#10)(1997-3#16)(1997-4#6)(1997-5#6)(1997-6#8)(1997-7#9)(1997-8#15)(2006-10#17)(2006-12#7)(2006-8#2)(2007-10#12)(2007-11#101)(2007-12#40)(2007-2#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#20)(2007-8#84)(2007-9#6)(2008-1#31)(2008-10#104)(2008-11#54)(2008-12#11)(2008-2#20)(2008-3#46)(2008-4#38)(2008-5#83)(2008-6#46)(2008-7#86)(2008-8#40)(2008-9#29)(2009-1#7)(2009-10#12)(2009-11#3)(2009-12#7)(2009-3#12)(2009-4#5)(2009-5#11)(2009-6#4)(2009-7#9)(2009-8#9)(2009-9#12)(2010-1#3)(2010-10#10)(2010-11#12)(2010-12#15)(2010-2#3)(2010-3#32)(2010-4#6)(2010-5#11)(2010-6#24)(2010-7#8)(2010-8#22)(2010-9#10)(2011-1#39)(2011-10#1)(2011-2#137)(2011-3#8)(2011-7#6)(2012-1#8)(2012-12#35)(2012-2#40)(2012-3#52)(2013-1#116)(2013-7#5)(2013-8#38)
treatment offers##2##2##(1992-9#1)(2008-10#1)
treatment often##2##2##(2006-10#1)(2009-12#1)
treatment on the central##2##4##(1992-8#1)(1996-12#1)
treatment on the##21##3##(1990-12#1)(1992-8#2)(1992-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#2)
treatment on this##2##3##(1994-2#1)(2013-1#1)
treatment on##54##2##(1990-12#1)(1990-7#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-8#1)(2013-1#4)(2013-8#1)
treatment once##2##2##(2007-9#1)(2013-1#1)
treatment only##5##2##(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2010-3#1)
treatment option and##2##3##(2007-8#1)(2008-6#1)
treatment option for the##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
treatment option for##13##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
treatment option in##4##3##(2007-11#2)(2008-3#1)(2012-2#1)
treatment option is##2##3##(2007-8#1)(2008-7#1)
treatment option##31##2##(1994-3#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
treatment options and##4##3##(1996-9#1)(2008-3#1)(2008-6#1)(2011-2#1)
treatment options are available##2##4##(2008-1#1)(2010-6#1)
treatment options are discussed##2##4##(2007-12#1)(2008-12#1)
treatment options are##6##3##(2007-12#1)(2008-1#1)(2008-12#1)(2010-4#1)(2010-6#1)(2013-1#1)
treatment options for patients##3##4##(2011-2#2)(2012-12#1)
treatment options for the##2##4##(2012-2#1)(2013-1#1)
treatment options for##16##3##(2007-2#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)
treatment options have##2##3##(2012-2#1)(2013-1#1)
treatment options in##2##3##(2008-7#1)(2012-3#1)
treatment options include##2##3##(2010-12#1)(2013-1#1)
treatment options of##2##3##(2012-2#1)(2013-8#1)
treatment options that##2##3##(2008-11#1)(2008-8#1)
treatment options to##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
treatment options##77##2##(1992-8#1)(1993-1#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#3)
treatment or by##3##3##(1992-1#1)(1996-5#1)(2007-12#1)
treatment or in##2##3##(1995-12#1)(2008-4#1)
treatment or prevention of##2##4##(2008-3#1)(2011-2#1)
treatment or the##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
treatment or##36##2##(1990-6#1)(1992-1#1)(1992-5#2)(1995-12#2)(1996-5#1)(1997-4#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
treatment outcome and continuous quality improvement##2##6##(1993-12#2)
treatment outcome in##4##3##(1994-8#1)(2007-8#1)(2010-1#1)(2013-1#1)
treatment outcome##27##2##(1991-12#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-12#1)(2007-8#5)(2008-11#2)(2008-2#1)(2008-6#2)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
treatment outcomes of##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
treatment outcomes##20##2##(1992-12#1)(1994-3#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-3#2)(2013-8#2)
treatment over the##2##3##(2008-7#2)
treatment over##8##2##(1992-3#1)(1996-6#1)(2008-7#2)(2009-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
treatment paradigm for##2##3##(2010-4#1)(2013-1#1)
treatment paradigms##5##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#2)
treatment parameters and##2##3##(2007-4#1)(2008-10#1)
treatment parameters##7##2##(2007-4#1)(2008-1#1)(2008-10#5)
treatment patients##2##2##(2007-11#1)(2013-1#1)
treatment performed##3##2##(2007-8#1)(2008-12#1)(2013-8#1)
treatment period##20##2##(1990-11#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-12#3)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
treatment phase##4##2##(2008-4#3)(2010-8#1)
treatment plan for##2##3##(2011-2#2)
treatment plan##10##2##(1992-10#1)(1993-3#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
treatment planning and##2##3##(1992-8#1)(2013-8#1)
treatment planning for##4##3##(2008-7#1)(2009-11#2)(2011-1#1)
treatment planning is##3##3##(2008-7#1)(2009-11#1)(2009-2#1)
treatment planning of##4##3##(1994-12#1)(2007-11#1)(2009-11#1)(2009-2#1)
treatment planning systems##2##3##(1994-8#1)(2009-11#1)
treatment planning using##2##3##(1995-9#1)(1997-3#1)
treatment planning##46##2##(1991-12#2)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-8#1)(1995-9#1)(1997-3#2)(2007-11#3)(2008-11#2)(2008-7#7)(2009-11#5)(2009-2#3)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
treatment plans##6##2##(1992-12#2)(1993-1#1)(2008-3#1)(2013-1#2)
treatment plant (WWTP)##4##3##(2008-10#3)(2013-1#1)
treatment plant##9##2##(2008-10#5)(2008-12#3)(2013-1#1)
treatment plants##7##2##(2008-1#1)(2008-10#5)(2008-6#1)
treatment policy##3##2##(1997-3#1)(2007-7#1)(2008-5#1)
treatment portals##2##2##(2009-2#2)
treatment possibilities in##2##3##(1997-7#1)(2008-3#1)
treatment possibilities##3##2##(1993-11#1)(1997-7#1)(2008-3#1)
treatment practices##5##2##(1997-3#1)(2007-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
treatment preferences##4##2##(2009-11#2)(2010-4#2)
treatment prescribed by##2##3##(1997-6#1)(2011-1#1)
treatment prescribed##3##2##(1997-6#1)(2011-1#2)
treatment prevented##5##2##(1994-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
treatment prior to##3##3##(1996-12#1)(2008-10#1)(2011-1#1)
treatment procedure##3##2##(1990-8#1)(2009-10#1)(2012-2#1)
treatment procedures##7##2##(1992-1#1)(1997-8#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-2#1)
treatment process##7##2##(1992-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-1#1)
treatment processes to##2##3##(2013-1#2)
treatment processes##5##2##(2008-10#1)(2008-7#1)(2013-1#3)
treatment program##16##2##(1991-2#2)(1993-1#1)(1994-6#1)(1996-11#1)(1996-3#2)(1997-2#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-4#1)(2011-1#1)
treatment programme##3##2##(1990-11#1)(1991-2#1)(1995-5#1)
treatment programs and##2##3##(2012-2#1)(2013-8#1)
treatment programs can##2##3##(2008-6#2)
treatment programs to##3##3##(1993-2#1)(2008-1#1)(2010-9#1)
treatment programs##27##2##(1993-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#9)(2009-9#1)(2010-3#1)(2010-9#1)(2012-2#5)(2013-8#2)
treatment protocol for##2##3##(1992-5#1)(2008-7#1)
treatment protocol in##2##3##(2008-6#1)(2012-3#1)
treatment protocol##14##2##(1992-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
treatment protocols for##6##3##(2007-8#1)(2011-2#1)(2012-12#3)(2012-3#1)
treatment protocols##18##2##(1992-12#1)(1995-8#1)(1997-8#1)(2007-8#1)(2008-11#1)(2009-7#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
treatment provided to elderly##2##4##(2012-3#2)
treatment provided##4##2##(1992-5#1)(2007-8#1)(2012-3#2)
treatment providers##4##2##(1993-12#1)(2008-6#2)(2009-9#1)
treatment rate##2##2##(1991-12#1)(2012-3#1)
treatment rates and##2##3##(2008-3#2)
treatment rates##6##2##(2008-3#5)(2008-8#1)
treatment received##2##2##(1991-2#1)(1996-1#1)
treatment recommendations##8##2##(1992-12#1)(1996-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
treatment recommended by the##2##4##(1996-11#1)(2008-12#1)
treatment recommended##3##2##(1996-11#1)(2008-10#1)(2008-12#1)
treatment reduced medical##2##3##(1995-1#2)
treatment reduced the##2##3##(2009-1#1)(2011-2#1)
treatment reduced##9##2##(1995-1#2)(1995-8#1)(2007-11#1)(2008-10#1)(2009-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
treatment reduces##4##2##(1992-2#1)(1994-2#1)(1996-5#1)(2012-2#1)
treatment refractory##2##2##(2008-11#1)(2009-9#1)
treatment regime and##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
treatment regime for##2##3##(2008-3#1)(2012-12#1)
treatment regime##8##2##(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#3)(2011-2#1)(2012-12#1)
treatment regimen for##3##3##(1997-1#1)(2008-10#1)(2010-12#1)
treatment regimen with##2##3##(1993-2#1)(2007-10#1)
treatment regimen##18##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
treatment regimens in##2##3##(2007-7#1)(2008-6#1)
treatment regimens##20##2##(1991-2#1)(1992-12#1)(1995-12#1)(1995-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-6#2)(2012-3#1)(2013-1#1)
treatment regimes##4##2##(2008-3#1)(2010-12#1)(2012-12#1)(2012-3#1)
treatment remains##5##2##(1993-11#1)(2008-6#1)(2008-7#2)(2012-3#1)
treatment required##3##2##(1991-2#1)(1993-11#1)(2011-10#1)
treatment requires##4##2##(1997-4#1)(2007-11#1)(2011-2#1)(2013-1#1)
treatment response and##3##3##(1997-8#1)(2009-11#2)
treatment response in##4##3##(2007-2#2)(2008-11#1)(2008-9#1)
treatment response##28##2##(1991-8#1)(1995-2#1)(1997-8#1)(2007-2#2)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
treatment restored the##2##3##(1991-5#1)(2008-5#1)
treatment resulted in a##5##4##(1993-6#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
treatment resulted in##10##3##(1993-6#1)(1993-9#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#2)
treatment resulted##11##2##(1993-6#1)(1993-9#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#2)
treatment results in a##2##4##(1990-11#1)(1996-12#1)
treatment results in children with ALL and##3##7##(2011-2#3)
treatment results in##11##3##(1990-11#1)(1993-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(2009-8#1)(2011-2#5)
treatment results of##12##3##(1996-9#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-6#1)(2008-7#2)(2011-2#3)(2013-1#1)
treatment results##36##2##(1990-11#1)(1990-2#1)(1993-11#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-3#1)(2007-11#4)(2007-8#1)(2008-6#1)(2008-7#3)(2009-8#1)(2011-2#14)(2011-3#1)(2013-1#1)
treatment results]##2##2##(1996-3#1)(2011-2#1)
treatment retention##3##2##(2008-6#1)(2013-8#2)
treatment satisfaction##3##2##(1993-2#1)(1995-2#1)(2009-12#1)
treatment schedule##3##2##(1991-8#2)(1993-11#1)
treatment seems to be##2##4##(2008-5#1)(2012-12#1)
treatment seems##3##2##(1995-5#1)(2008-5#1)(2012-12#1)
treatment selection and##2##3##(2008-7#1)(2009-9#1)
treatment selection##7##2##(2008-7#2)(2009-9#1)(2012-2#4)
treatment sequence##2##2##(1995-10#1)(2008-6#1)
treatment service##2##2##(1991-1#2)
treatment services##11##2##(1991-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-8#3)(2012-1#1)
treatment session##2##2##(2008-12#1)(2010-8#1)
treatment sessions##2##2##(1996-11#1)(2013-1#1)
treatment setting##5##2##(1992-1#1)(2008-12#1)(2008-2#1)(2009-9#1)(2013-1#1)
treatment should be continued for##2##5##(1990-9#1)(1992-11#1)
treatment should be performed##2##4##(2008-4#1)(2012-3#1)
treatment should be##24##3##(1990-9#1)(1991-9#1)(1992-11#1)(1995-1#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
treatment should##31##2##(1990-11#1)(1990-9#1)(1991-9#1)(1992-11#1)(1995-1#1)(1997-3#1)(1997-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
treatment showed significant##2##3##(1991-5#1)(2012-2#1)
treatment showed that##2##3##(1991-12#1)(2010-8#1)
treatment showed##8##2##(1991-12#1)(1991-5#1)(2007-7#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
treatment side effects##2##3##(2008-2#1)(2008-7#1)
treatment significantly increased##2##3##(1990-3#1)(1997-6#1)
treatment significantly reduced##2##3##(1995-12#1)(2013-1#1)
treatment significantly##14##2##(1990-3#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-7#2)(2010-1#1)(2011-10#1)(2011-2#1)(2013-1#2)
treatment skills##3##2##(1997-3#1)(2012-1#2)
treatment so that##3##3##(1992-11#1)(2008-3#1)(2008-8#1)
treatment so##4##2##(1992-11#1)(2008-1#1)(2008-3#1)(2008-8#1)
treatment started##2##2##(2008-10#2)
treatment status##2##2##(2008-11#2)
treatment strategies and options##2##4##(2008-11#1)(2011-2#1)
treatment strategies and##4##3##(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
treatment strategies are##2##3##(1996-11#1)(2008-8#1)
treatment strategies for##7##3##(1994-5#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-3#2)
treatment strategies in##2##3##(1994-1#1)(2011-2#1)
treatment strategies that can##2##4##(2008-9#1)(2011-2#1)
treatment strategies that##4##3##(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
treatment strategies##52##2##(1991-6#1)(1993-11#1)(1994-1#1)(1994-5#1)(1996-11#1)(1996-6#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#4)
treatment strategy for##2##3##(1996-3#1)(2012-12#1)
treatment strategy##18##2##(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-6#4)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
treatment stratification##2##2##(2008-6#1)(2012-2#1)
treatment studies##4##2##(2008-2#1)(2008-5#2)(2008-9#1)
treatment study##3##2##(2010-1#1)(2012-3#2)
treatment success##4##2##(2008-7#1)(2010-6#1)(2012-1#1)(2013-8#1)
treatment suggests that##2##3##(2007-11#1)(2008-10#1)
treatment suggests##3##2##(2007-11#1)(2008-10#2)
treatment suppressed##2##2##(1992-3#1)(2008-10#1)
treatment systems##2##2##(1991-3#1)(2008-3#1)
treatment targets##2##2##(2010-1#1)(2012-2#1)
treatment team##3##2##(1992-3#1)(2008-1#1)(2008-11#1)
treatment technique##2##2##(2007-4#1)(2008-12#1)
treatment techniques##2##2##(2007-4#1)(2008-10#1)
treatment technologies##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
treatment teens##2##2##(2013-1#2)
treatment than##6##2##(1990-9#1)(1993-8#1)(1994-6#1)(2008-4#1)(2009-10#1)(2013-1#1)
treatment that is##3##3##(1994-3#1)(1996-2#1)(2008-7#1)
treatment that was##2##3##(2008-10#1)(2013-1#1)
treatment that##14##2##(1994-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
treatment the##11##2##(1990-2#2)(1990-9#1)(1994-3#3)(1995-3#1)(1996-3#1)(2008-5#2)(2008-7#1)
treatment through##4##2##(1991-6#1)(1996-3#1)(2008-11#1)(2013-1#1)
treatment time##9##2##(1992-10#2)(1994-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#1)
treatment times##2##2##(1994-12#1)(2010-3#1)
treatment to improve##2##3##(1995-11#1)(2008-6#1)
treatment to patients##3##3##(1994-2#1)(1995-12#1)(2010-9#1)
treatment to the##4##3##(1992-12#1)(2007-12#1)(2007-8#1)(2010-3#1)
treatment to##47##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
treatment tools##3##2##(2008-6#2)(2010-5#1)
treatment toward##2##2##(2008-6#1)(2008-7#1)
treatment trial##5##2##(1996-11#1)(2008-8#1)(2009-12#1)(2011-10#1)(2013-1#1)
treatment under##2##2##(1992-11#1)(2010-3#1)
treatment until the##2##3##(2007-8#1)(2011-1#1)
treatment until##3##2##(2007-8#1)(2008-1#1)(2011-1#1)
treatment used##3##2##(1991-4#1)(1992-9#1)(2010-11#1)
treatment using the##2##3##(1996-3#1)(1997-3#1)
treatment using##22##2##(1994-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment utilization##3##2##(1991-1#1)(2008-3#2)
treatment versus##4##2##(2009-4#1)(2009-9#1)(2010-10#1)(2013-1#1)
treatment via##2##2##(2011-1#1)(2012-12#1)
treatment ward##2##2##(2007-11#1)(2013-8#1)
treatment was 2##2##3##(1993-6#1)(2008-12#1)
treatment was 42##2##3##(1994-12#1)(1995-5#1)
treatment was administered for##2##4##(1993-2#1)(2012-12#1)
treatment was administered##5##3##(1993-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
treatment was also##2##3##(1996-5#1)(2013-7#1)
treatment was applied##2##3##(2007-8#1)(2009-7#1)
treatment was associated with##3##4##(2010-5#1)(2011-2#1)(2013-8#1)
treatment was based on##2##4##(1990-8#1)(2011-2#1)
treatment was conservative##2##3##(1993-6#1)(2013-1#1)
treatment was continued with##2##4##(2008-10#1)(2011-1#1)
treatment was continued##3##3##(1991-3#1)(2008-10#1)(2011-1#1)
treatment was correlated with##2##4##(2008-10#1)(2013-1#1)
treatment was delayed##2##3##(1990-6#1)(2011-2#1)
treatment was effective in##2##4##(2008-7#1)(2011-2#1)
treatment was effective##3##3##(2008-7#1)(2011-2#2)
treatment was evaluated##2##3##(1990-3#1)(1997-3#1)
treatment was found##4##3##(2007-11#1)(2008-3#1)(2009-7#1)(2009-8#1)
treatment was given##4##3##(1990-11#1)(1994-11#1)(2011-1#1)(2012-3#1)
treatment was higher##2##3##(2012-3#1)(2012-6#1)
treatment was ineffective##2##3##(2008-10#1)(2013-8#1)
treatment was not##10##3##(1992-8#1)(1993-11#1)(1993-5#1)(1994-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
treatment was performed in##2##4##(1990-6#1)(2009-8#1)
treatment was performed##8##3##(1990-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(2007-11#1)(2008-12#1)(2009-8#1)(2013-8#1)
treatment was started##2##3##(2009-4#1)(2010-2#1)
treatment was stopped##3##3##(1993-1#1)(2010-1#2)
treatment was studied##2##3##(1994-6#1)(1995-12#1)
treatment was successful and##3##4##(1990-9#1)(2008-10#1)(2013-8#1)
treatment was the##2##3##(1993-12#1)(2007-12#1)
treatment was to##3##3##(1991-6#1)(2007-11#1)(2008-10#1)
treatment was unsuccessful##3##3##(1995-11#1)(2007-8#1)(2012-3#1)
treatment was used##2##3##(1990-12#1)(2007-11#1)
treatment was well tolerated##3##4##(1992-12#1)(2007-11#1)(2012-3#1)
treatment was well##4##3##(1992-12#1)(1994-8#1)(2007-11#1)(2012-3#1)
treatment was##155##2##(1990-11#2)(1990-12#2)(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(2007-11#6)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#5)(2008-7#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-3#7)(2012-6#1)(2013-1#11)(2013-7#1)(2013-8#5)
treatment way##2##2##(2007-11#2)
treatment we##3##2##(1995-12#1)(2008-7#1)(2009-6#1)
treatment well##2##2##(2007-8#1)(2008-5#1)
treatment were also##2##3##(2007-11#1)(2011-2#1)
treatment were developed##2##3##(2010-12#1)(2012-3#1)
treatment were examined##2##3##(1995-12#1)(2008-7#1)
treatment were observed##2##3##(1990-6#1)(1996-12#1)
treatment were recorded##2##3##(2011-1#1)(2012-2#1)
treatment were##42##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#3)(1996-5#1)(2007-11#4)(2007-8#2)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)
treatment when##2##2##(1992-6#1)(2010-3#1)
treatment which is##2##3##(1990-2#1)(1991-12#1)
treatment which##7##2##(1990-2#1)(1991-12#1)(1992-5#1)(1997-6#1)(2008-2#1)(2013-1#1)(2013-8#1)
treatment while##4##2##(1991-12#1)(1996-3#1)(2007-11#1)(2008-7#1)
treatment will be discussed##2##4##(2008-12#1)(2008-8#1)
treatment will be##5##3##(2008-12#1)(2008-3#1)(2008-8#2)(2009-7#1)
treatment will##11##2##(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-7#1)(2010-5#1)(2011-2#1)
treatment with 0##4##3##(1994-8#1)(1995-8#1)(2008-10#1)(2008-5#1)
treatment with 1##4##3##(1990-3#1)(2007-11#1)(2008-10#1)(2008-5#1)
treatment with 10##3##3##(1991-6#1)(1995-12#1)(2011-1#1)
treatment with 100 nM alpha-MSH##2##5##(1995-2#2)
treatment with 3##4##3##(1992-12#1)(1993-8#1)(2008-10#1)(2011-1#1)
treatment with 4##2##3##(1992-11#1)(2008-4#1)
treatment with 50##3##3##(1995-8#2)(2008-10#1)
treatment with CO2 laser##2##4##(1991-6#1)(1995-2#1)
treatment with CoQ10##2##3##(1991-5#2)
treatment with IL-1##2##3##(1990-12#1)(1995-12#1)
treatment with L-arginine##2##3##(1997-2#2)
treatment with L-deprenyl##2##3##(1994-6#2)
treatment with Metalaxyl##2##3##(2008-10#2)
treatment with R-PIA##2##3##(1997-1#2)
treatment with RA##2##3##(1993-9#1)(1994-9#1)
treatment with T##2##3##(2008-10#2)
treatment with TPA##2##3##(1990-12#1)(1994-6#1)
treatment with VPA##4##3##(2011-2#4)
treatment with a combination of##2##5##(1994-8#1)(2013-8#1)
treatment with a##18##3##(1990-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#4)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
treatment with alcohol##2##3##(1997-8#1)(2008-9#1)
treatment with ampicillin##2##3##(2009-12#2)
treatment with an##12##3##(1991-11#1)(1991-12#1)(1992-3#1)(1997-6#1)(2008-10#3)(2008-4#2)(2008-5#1)(2011-2#2)
treatment with antibiotic##3##3##(1991-3#1)(2008-7#1)(2008-9#1)
treatment with antibiotics##3##3##(1991-4#1)(2007-7#1)(2011-2#1)
treatment with beclomethasone dipropionate##2##4##(1990-9#1)(2008-1#1)
treatment with both##2##3##(1996-12#1)(2008-9#1)
treatment with calcium##2##3##(1995-12#1)(1996-6#1)
treatment with cetuximab and##2##4##(2011-2#2)
treatment with chloroquine##2##3##(1994-3#1)(2011-2#1)
treatment with clozapine##2##3##(2008-12#2)
treatment with curative##2##3##(2008-1#1)(2010-5#1)
treatment with cyclosporin##2##3##(2008-1#1)(2012-1#1)
treatment with diclofenac sodium 3%##2##5##(2010-8#2)
treatment with different##2##3##(2008-3#1)(2012-3#1)
treatment with either praziquantel or oxamniquine##2##6##(2010-12#2)
treatment with either##12##3##(1990-5#1)(1990-6#1)(1992-5#1)(1992-8#1)(1994-2#1)(1996-6#1)(1997-1#1)(2008-1#1)(2008-6#1)(2010-12#3)
treatment with epoetin##2##3##(2008-7#2)
treatment with furosemide##4##3##(1992-8#4)
treatment with inhaled##2##3##(2008-8#1)(2011-2#1)
treatment with insulin##2##3##(1993-12#1)(2013-8#1)
treatment with interferon alpha is##2##5##(1997-3#2)
treatment with interferon##3##3##(1996-6#1)(1997-3#2)
treatment with intravenous##2##3##(2010-12#1)(2010-8#1)
treatment with liposomal##2##3##(2008-5#1)(2010-3#1)
treatment with low doses of aminoglutethimide##2##6##(1990-10#2)
treatment with low##3##3##(1990-10#2)(2008-11#1)
treatment with mianserin##4##3##(2008-6#4)
treatment with mitoxantrone##2##3##(1991-6#1)(1994-12#1)
treatment with one##2##3##(2008-1#1)(2012-3#1)
treatment with other##2##3##(1995-11#1)(1995-12#1)
treatment with pegylated##2##3##(2009-7#1)(2011-2#1)
treatment with prednisone##4##3##(1990-11#2)(1992-2#1)(2008-7#1)
treatment with quinapril##2##3##(1995-3#2)
treatment with sodium##4##3##(1991-11#1)(1991-12#1)(1994-11#1)(2008-10#1)
treatment with steroids##2##3##(2007-7#1)(2008-1#1)
treatment with surgical##2##3##(2008-6#1)(2012-3#1)
treatment with tamoxifen and progestin##2##5##(1992-2#2)
treatment with the antiwrinkle agent##2##5##(2008-5#2)
treatment with the dopamine##2##4##(1993-3#1)(1996-5#1)
treatment with the drug##2##4##(1990-2#1)(2008-10#1)
treatment with the##40##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-4#1)(1993-11#1)(1993-3#2)(1994-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
treatment with these drugs##3##4##(2010-5#2)(2012-2#1)
treatment with this##3##3##(1991-11#1)(1991-12#1)(2008-1#1)
treatment with thymostimulin##3##3##(1990-2#2)(1992-5#1)
treatment with vancomycin##2##3##(2007-12#2)
treatment with various##3##3##(1992-5#1)(2008-1#1)(2008-3#1)
treatment with##558##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#9)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-11#7)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#4)(1991-8#2)(1991-9#3)(1992-11#6)(1992-12#2)(1992-2#7)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#5)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#14)(1995-2#9)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#5)(1996-5#5)(1996-6#6)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#2)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#11)(2008-10#57)(2008-11#11)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#21)(2008-6#12)(2008-7#16)(2008-8#7)(2008-9#7)(2009-12#4)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#4)(2009-8#6)(2010-1#1)(2010-12#5)(2010-3#2)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#4)(2011-1#6)(2011-10#1)(2011-2#22)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#14)(2013-1#18)(2013-7#1)(2013-8#12)
treatment within the##2##3##(2007-7#1)(2011-3#1)
treatment within##6##2##(1992-9#1)(1994-9#1)(2007-11#1)(2007-7#1)(2011-3#1)(2012-3#1)
treatment without##9##2##(1992-10#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-8#1)(2007-8#1)(2008-8#1)(2011-2#1)(2013-1#1)
treatment would be##2##3##(2007-8#1)(2013-7#1)
treatment would##4##2##(1991-6#1)(2007-8#1)(2008-3#1)(2013-7#1)
treatment##8330##1##(1990-10#9)(1990-11#37)(1990-12#33)(1990-2#44)(1990-3#31)(1990-4#1)(1990-5#16)(1990-6#46)(1990-7#7)(1990-8#10)(1990-9#37)(1991-1#30)(1991-10#3)(1991-11#42)(1991-12#35)(1991-2#59)(1991-3#28)(1991-4#7)(1991-5#15)(1991-6#50)(1991-8#40)(1991-9#24)(1992-1#21)(1992-10#10)(1992-11#27)(1992-12#37)(1992-2#28)(1992-3#45)(1992-4#10)(1992-5#33)(1992-6#35)(1992-7#3)(1992-8#41)(1992-9#38)(1993-1#20)(1993-10#1)(1993-11#48)(1993-12#22)(1993-2#49)(1993-3#27)(1993-5#10)(1993-6#30)(1993-8#28)(1993-9#35)(1994-1#6)(1994-10#1)(1994-11#28)(1994-12#33)(1994-2#35)(1994-3#39)(1994-5#26)(1994-6#53)(1994-7#7)(1994-8#23)(1994-9#30)(1995-1#13)(1995-10#3)(1995-11#40)(1995-12#66)(1995-2#36)(1995-3#22)(1995-4#6)(1995-5#34)(1995-6#17)(1995-8#20)(1995-9#15)(1996-1#15)(1996-10#1)(1996-11#51)(1996-12#32)(1996-2#19)(1996-3#65)(1996-4#1)(1996-5#31)(1996-6#37)(1996-7#11)(1996-8#13)(1996-9#27)(1997-1#22)(1997-2#34)(1997-3#75)(1997-4#34)(1997-5#18)(1997-6#26)(1997-7#28)(1997-8#51)(2006-10#29)(2006-11#1)(2006-12#11)(2006-7#1)(2006-8#4)(2007-1#3)(2007-10#53)(2007-11#285)(2007-12#107)(2007-2#19)(2007-4#13)(2007-5#9)(2007-6#10)(2007-7#67)(2007-8#216)(2007-9#15)(2008-1#112)(2008-10#581)(2008-11#196)(2008-12#109)(2008-2#65)(2008-3#140)(2008-4#102)(2008-5#211)(2008-6#205)(2008-7#339)(2008-8#139)(2008-9#102)(2009-1#12)(2009-10#33)(2009-11#33)(2009-12#33)(2009-2#10)(2009-3#27)(2009-4#30)(2009-5#26)(2009-6#28)(2009-7#36)(2009-8#49)(2009-9#44)(2010-1#23)(2010-10#22)(2010-11#55)(2010-12#97)(2010-2#8)(2010-3#77)(2010-4#44)(2010-5#52)(2010-6#67)(2010-7#22)(2010-8#75)(2010-9#22)(2011-1#169)(2011-10#8)(2011-2#451)(2011-3#25)(2011-7#10)(2012-1#32)(2012-12#150)(2012-2#158)(2012-3#232)(2012-5#2)(2012-6#4)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#455)(2013-7#30)(2013-8#186)
treatment&quot##2##1##(1996-11#1)(2008-10#1)
treatment(s)##3##1##(2012-2#3)
treatment) and the##2##3##(1991-2#1)(2010-5#1)
treatment) and##4##2##(1991-2#1)(2008-12#1)(2008-7#1)(2010-5#1)
treatment)##33##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-11#2)(1992-3#1)(1994-3#1)(1994-8#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
treatment- and##2##2##(2008-12#1)(2009-5#1)
treatment--a##2##1##(2010-3#1)(2012-12#1)
treatment-based classification##2##2##(2008-12#2)
treatment-effectiveness##2##1##(1992-1#2)
treatment-induced##8##1##(1990-2#1)(1997-2#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
treatment-naïve##3##1##(2009-4#1)(2012-2#1)(2013-1#1)
treatment-refractory##4##1##(1992-3#1)(2008-1#1)(2008-11#1)(2008-3#1)
treatment-related attitudes and behaviors##2##4##(2011-1#2)
treatment-related death occurred##3##3##(1991-4#1)(1991-6#1)(1992-2#1)
treatment-related inflammatory leukogram and minimal decreased erythron of chronic inflammation that would be consistent with necrosis and chronic active inflammation of the skin##2##23##(2008-9#2)
treatment-related neoplasms##3##2##(2008-9#3)
treatment-related##22##1##(1991-4#1)(1991-6#1)(1992-2#1)(1997-1#1)(2008-7#4)(2008-9#11)(2011-1#2)(2011-2#1)
treatment-resistant depression##6##2##(2008-6#1)(2011-1#2)(2012-12#3)
treatment-resistant schizophrenic patients##6##3##(2008-12#5)(2008-6#1)
treatment-resistant##16##1##(2006-10#1)(2008-12#5)(2008-6#3)(2011-1#2)(2012-12#5)
treatment-seeking##4##1##(2007-12#1)(2008-2#1)(2008-8#1)(2009-9#1)
treatment?##7##1##(1991-8#1)(1994-1#2)(1994-9#1)(1995-1#1)(2007-2#1)(2008-11#1)
treatment]##35##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#3)(1992-5#2)(1993-2#2)(1993-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-5#2)(1996-11#1)(1996-3#1)(1996-6#2)(1997-4#1)(1997-5#2)(2008-10#1)(2008-12#1)(2008-4#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
treatments (control##2##2##(2012-9#1)(2013-7#1)
treatments affected##2##2##(1990-5#1)(2008-10#1)
treatments also##4##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)
treatments and the##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
treatments and##38##2##(1991-2#1)(1993-7#1)(1994-2#1)(1995-2#1)(1997-7#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#3)(2012-5#2)(2013-1#3)(2013-7#1)
treatments applied##3##2##(2008-10#2)(2008-5#1)
treatments are available##3##3##(2008-11#1)(2010-10#1)(2011-10#1)
treatments are discussed##2##3##(2008-4#1)(2008-6#1)
treatments are not##4##3##(1997-4#1)(2008-11#1)(2008-4#1)(2011-2#1)
treatments are required##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
treatments are##31##2##(1993-2#2)(1997-3#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-10#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)
treatments as##4##2##(2007-11#1)(2008-10#1)(2010-4#1)(2012-12#1)
treatments at##6##2##(1992-9#1)(1995-11#1)(2008-10#2)(2008-8#1)(2009-5#1)
treatments available##3##2##(2008-2#1)(2008-8#1)(2010-7#1)
treatments can##3##2##(2008-3#1)(2013-1#2)
treatments compared with##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
treatments containing##3##2##(2008-10#1)(2008-5#2)
treatments could be##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
treatments during the##3##3##(2008-10#2)(2013-7#1)
treatments during##5##2##(2008-10#2)(2008-5#1)(2013-1#1)(2013-7#1)
treatments for adolescent##2##3##(2009-7#1)(2013-1#1)
treatments for the##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
treatments for these##2##3##(2006-12#1)(2008-2#1)
treatments for##55##2##(1991-1#1)(1993-3#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
treatments given##4##2##(1997-4#1)(2008-10#1)(2011-2#1)(2012-12#1)
treatments had##3##2##(1993-2#1)(2007-3#1)(2008-10#1)
treatments has##4##2##(1992-9#1)(2007-8#1)(2010-8#1)(2012-12#1)
treatments have been##5##3##(1993-1#1)(2007-8#1)(2009-7#1)(2010-7#1)(2013-8#1)
treatments have##15##2##(1993-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#2)(2013-8#1)
treatments in a##2##3##(2010-4#1)(2012-3#1)
treatments in the##4##3##(1993-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
treatments in##30##2##(1990-2#1)(1990-6#1)(1993-1#1)(1996-6#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#2)(2010-1#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
treatments including##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
treatments increased the##2##3##(2008-10#1)(2009-8#1)
treatments increased##4##2##(2008-10#2)(2009-8#1)(2013-7#1)
treatments involving##2##2##(1995-2#1)(2008-10#1)
treatments is##4##2##(1992-9#1)(1995-9#1)(1997-4#1)(2013-1#1)
treatments may##2##2##(1997-4#1)(2008-10#1)
treatments might##2##2##(1994-5#1)(2010-5#1)
treatments of experiment##2##3##(2008-10#2)
treatments of the##5##3##(1994-8#1)(2008-10#2)(2008-3#2)
treatments of these##2##3##(1994-11#1)(2008-9#1)
treatments of##26##2##(1990-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-2#1)
treatments on the##7##3##(1995-12#1)(2008-10#1)(2008-12#3)(2008-5#1)(2013-8#1)
treatments on these##2##3##(2008-3#1)(2011-2#1)
treatments on##15##2##(1995-12#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-8#1)
treatments or##2##2##(2010-8#1)(2011-1#1)
treatments provided##2##2##(2007-11#1)(2013-8#1)
treatments remains##2##2##(1997-5#1)(2008-11#1)
treatments resulted in##6##3##(1991-3#1)(2008-10#2)(2008-5#1)(2010-9#1)(2013-1#1)
treatments should##2##2##(2011-2#2)
treatments showed##2##2##(1997-6#1)(2008-10#1)
treatments significantly reduced##2##3##(2008-10#2)
treatments significantly##3##2##(1995-12#1)(2008-10#2)
treatments such as##8##3##(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
treatments tested##2##2##(2008-10#1)(2008-6#1)
treatments than##2##2##(2008-10#1)(2012-9#1)
treatments that induce##2##3##(2008-7#2)
treatments that prevent##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
treatments that##17##2##(1994-2#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-7#2)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
treatments to##10##2##(1991-2#1)(1995-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)
treatments used##3##2##(2008-7#1)(2009-7#1)(2011-2#1)
treatments was##10##2##(2007-8#1)(2008-10#7)(2008-12#1)(2008-7#1)
treatments were applied##3##3##(2008-10#1)(2008-5#1)(2012-8#1)
treatments were not##2##3##(2008-10#2)
treatments were##31##2##(1994-6#1)(1995-5#1)(1996-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-8#1)
treatments when##2##2##(2008-10#2)
treatments which##6##2##(1994-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-3#1)
treatments with different##2##3##(2008-10#1)(2012-3#1)
treatments with##31##2##(1994-2#1)(1994-6#2)(1996-11#1)(2008-10#18)(2008-12#1)(2008-9#1)(2011-2#3)(2012-2#2)(2012-3#2)
treatments##735##1##(1990-12#1)(1990-2#3)(1990-5#2)(1990-6#2)(1991-1#1)(1991-2#2)(1991-3#4)(1991-6#3)(1992-12#1)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#4)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#3)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-12#1)(2007-10#3)(2007-11#5)(2007-12#9)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#176)(2008-11#16)(2008-12#29)(2008-2#11)(2008-3#13)(2008-4#17)(2008-5#31)(2008-6#13)(2008-7#26)(2008-8#13)(2008-9#16)(2009-10#4)(2009-11#6)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#7)(2009-8#4)(2009-9#4)(2010-1#5)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#7)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#46)(2011-3#2)(2012-1#1)(2012-12#15)(2012-2#16)(2012-3#16)(2012-4#1)(2012-5#2)(2012-6#1)(2012-8#1)(2012-9#3)(2013-1#29)(2013-7#7)(2013-8#10)
treatments) and##2##2##(1990-12#1)(2008-2#1)
treatments)##3##1##(1990-12#2)(2008-2#1)
treatments?##2##1##(2012-3#1)(2013-7#1)
treats the##3##2##(2008-2#1)(2008-7#1)(2010-7#1)
treats##12##1##(1991-2#1)(1993-1#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-7#1)(2012-3#1)
treaty##3##1##(1996-1#1)(2008-1#1)(2009-5#1)
tredecaurelia##2##1##(2008-12#2)
tree Peltogyne##2##2##(2008-5#2)
tree analysis showed that the##2##5##(2009-5#1)(2013-8#1)
tree analysis##3##2##(2009-10#1)(2009-5#1)(2013-8#1)
tree and##11##2##(1994-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
tree based on##5##3##(2008-10#3)(2010-8#1)(2013-1#1)
tree by##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
tree canopies##3##2##(2008-10#3)
tree canopy##8##2##(2008-10#8)
tree constructed##2##2##(2008-10#1)(2008-8#1)
tree crowns##3##2##(2013-7#3)
tree density##2##2##(2009-10#2)
tree diseases##2##2##(2008-10#2)
tree during##2##2##(2007-8#1)(2008-10#1)
tree for the##3##3##(2008-10#1)(2008-3#2)
tree for##5##2##(2008-10#1)(2008-3#2)(2008-7#1)(2009-9#1)
tree growth##3##2##(1990-8#1)(2008-10#1)(2010-4#1)
tree holes##5##2##(2008-9#5)
tree in##6##2##(2008-10#2)(2008-3#1)(2012-12#2)(2013-7#1)
tree of life##3##3##(2009-5#1)(2011-2#1)(2012-3#1)
tree of the##3##3##(1991-6#1)(1997-2#1)(1997-7#1)
tree of##10##2##(1991-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#3)(2009-5#1)(2011-2#1)(2012-3#1)
tree or##3##2##(2007-1#1)(2008-10#1)(2009-8#1)
tree pathogens##2##2##(2008-10#2)
tree pollen##2##2##(2011-2#1)(2013-8#1)
tree seedlings##4##2##(2008-10#1)(2008-5#3)
tree sparrows##2##2##(2008-5#2)
tree species that##2##3##(2008-5#2)
tree species to##2##3##(2008-10#1)(2009-8#1)
tree species##24##2##(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#6)(2008-8#3)(2008-9#1)(2009-8#3)(2012-6#2)(2012-9#1)(2013-7#3)
tree susceptibility##3##2##(2008-10#3)
tree topologies##3##2##(2010-6#1)(2012-3#2)
tree topology##2##2##(2008-7#1)(2012-3#1)
tree trunks and##2##3##(2008-10#1)(2013-7#1)
tree using##2##2##(2008-10#1)(2009-4#1)
tree was constructed##2##3##(2008-12#1)(2013-8#1)
tree was##9##2##(1995-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-7#1)(2011-1#1)(2013-8#2)
tree were##2##2##(2008-3#1)(2012-3#1)
tree##287##1##(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-9#2)(1995-12#2)(1995-3#2)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#100)(2008-11#5)(2008-12#2)(2008-3#6)(2008-4#5)(2008-5#25)(2008-6#1)(2008-7#2)(2008-8#16)(2008-9#12)(2009-10#6)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#5)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#11)(2012-6#2)(2012-9#1)(2013-1#3)(2013-7#10)(2013-8#7)
tree)##4##1##(2008-10#2)(2012-3#2)
tree-based decision model to##2##4##(2010-8#2)
tree-based##5##1##(1994-3#1)(2008-2#1)(2010-8#2)(2012-3#1)
treefrog##3##1##(2009-9#3)
treefrogs##4##1##(2009-5#2)(2009-9#2)
trees affected##2##2##(2008-10#1)(2013-1#1)
trees and shrubs##2##3##(2008-10#2)
trees and##23##2##(2008-10#15)(2008-3#1)(2008-5#2)(2008-7#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
trees are##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2013-7#1)
trees at##4##2##(2008-10#3)(2008-9#1)
trees based##2##2##(2007-6#1)(2013-8#1)
trees by##5##2##(2008-10#5)
trees derived from##2##3##(2008-10#2)
trees during the##2##3##(2008-10#1)(2008-12#1)
trees during##4##2##(2008-10#3)(2008-12#1)
trees for all##2##3##(2008-10#2)
trees for the##2##3##(2008-1#1)(2008-10#1)
trees for##10##2##(2008-1#1)(2008-10#6)(2008-2#1)(2011-2#2)
trees from 15##2##3##(2008-10#2)
trees from##6##2##(2008-10#5)(2011-10#1)
trees generated##3##2##(2008-10#2)(2008-9#1)
trees grafted on trifoliate orange##2##5##(2008-10#2)
trees grew##2##2##(1996-2#1)(2008-8#1)
trees had##2##2##(2008-10#2)
trees have##4##2##(2008-10#2)(2011-2#2)
trees in a##4##3##(2008-10#3)(2008-9#1)
trees in all directions##2##4##(2008-10#2)
trees in the field##3##4##(2008-10#3)
trees in the##10##3##(2008-10#10)
trees in three##2##3##(2008-10#1)(2008-6#1)
trees in##39##2##(2008-10#31)(2008-5#3)(2008-6#2)(2008-9#1)(2012-2#1)(2013-1#1)
trees infected with##7##3##(2008-10#7)
trees infected##8##2##(2008-10#8)
trees inoculated with##2##3##(2008-10#2)
trees is##3##2##(2008-10#2)(2008-8#1)
trees located##2##2##(2008-10#2)
trees occurred##2##2##(2008-10#2)
trees of the##2##3##(2008-10#1)(2008-5#1)
trees of##8##2##(1994-3#1)(2008-10#2)(2008-5#3)(2010-3#1)(2012-2#1)
trees on the##4##3##(2008-10#3)(2008-5#1)
trees on##7##2##(2008-10#5)(2008-5#2)
trees or##3##2##(2008-10#2)(2011-2#1)
trees produced##2##2##(2008-10#1)(2008-9#1)
trees showed##2##2##(2008-10#2)
trees that##3##2##(2008-10#1)(2008-8#1)(2012-7#1)
trees to a##2##3##(2008-10#1)(2013-7#1)
trees to##6##2##(2008-10#4)(2012-8#1)(2013-7#1)
trees treated with##2##3##(2008-10#1)(2011-2#1)
trees treated##3##2##(2008-10#2)(2011-2#1)
trees using##2##2##(2008-4#1)(2008-9#1)
trees was##8##2##(2008-10#5)(2008-12#1)(2008-5#1)(2012-9#1)
trees were constructed##2##3##(2008-8#2)
trees were not significantly##2##4##(2008-10#2)
trees were removed##2##3##(2008-10#2)
trees were treated##2##3##(2008-10#2)
trees were##26##2##(1995-3#1)(2008-10#19)(2008-8#2)(2011-2#3)(2012-6#1)
trees with##11##2##(1994-3#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2012-3#2)
trees within##5##2##(2008-10#5)
trees##406##1##(1994-3#2)(1995-11#1)(1995-3#1)(1996-2#1)(2007-6#1)(2008-1#3)(2008-10#268)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#20)(2008-6#8)(2008-7#6)(2008-8#14)(2008-9#11)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#1)(2011-10#1)(2011-2#17)(2012-2#5)(2012-3#5)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#2)(2013-1#3)(2013-7#6)(2013-8#4)
trees)##5##1##(2008-10#3)(2008-5#1)(2012-6#1)
trehalase##2##1##(2008-6#1)(2013-1#1)
trehalose and##2##2##(1993-8#2)
trehalose supplementation##2##2##(2013-1#2)
trehalose to##2##2##(2013-1#2)
trehalose##29##1##(1993-8#3)(1997-2#5)(2008-10#8)(2008-11#3)(2008-6#1)(2012-3#2)(2013-1#7)
trehalose-supplemented diet##4##2##(2013-1#4)
trematode species##5##2##(2007-6#1)(2008-5#1)(2013-1#3)
trematode##9##1##(1997-6#1)(2007-6#2)(2008-12#1)(2008-5#2)(2013-1#3)
trematodes##2##1##(2010-8#1)(2013-1#1)
tremendous application in##2##3##(2008-7#1)(2013-1#1)
tremendous impact on##3##3##(2007-10#1)(2008-1#1)(2008-10#1)
tremendous potential in##2##3##(2008-12#1)(2008-2#1)
tremendous potential##3##2##(2008-12#1)(2008-2#1)(2011-2#1)
tremendous progress has been made in the##2##7##(2008-11#1)(2008-7#1)
tremendous progress##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
tremendous variation in##2##3##(2008-10#1)(2008-11#1)
tremendous variation##3##2##(2008-10#2)(2008-11#1)
tremendous##43##1##(1991-3#1)(1992-1#1)(2007-10#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
tremendously##2##1##(2008-8#1)(2010-12#1)
tremolite &quot##2##2##(1991-12#2)
tremolite##22##1##(1991-12#22)
tremor (ET)##4##2##(2008-7#3)(2013-1#1)
tremor amplitude##2##2##(2008-7#2)
tremor and##5##2##(2008-7#5)
tremor at rest##6##3##(2008-7#6)
tremor in patients##2##3##(2008-7#2)
tremor in##4##2##(2008-7#3)(2012-3#1)
tremor was##4##2##(2008-7#3)(2012-3#1)
tremor##68##1##(1994-3#1)(1997-2#1)(1997-6#5)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#51)(2010-12#1)(2010-5#1)(2012-3#4)(2013-1#1)
tremorine and cold tremor activity in unanesthetized rats##2##8##(1997-6#2)
tremorine and cold tremor activity in unanesthetized##3##7##(1997-6#3)
tremorine##4##1##(1997-6#4)
tremors were##2##2##(2008-7#2)
tremors##5##1##(2008-2#1)(2008-7#3)(2012-2#1)
trench##7##1##(1991-2#2)(2008-10#1)(2008-3#3)(2009-9#1)
trenches##4##1##(1991-3#1)(1993-12#1)(2008-10#1)(2008-3#1)
trend analysis##2##2##(2008-11#1)(2008-8#1)
trend and##3##2##(1990-11#1)(1993-12#1)(1996-2#1)
trend between##2##2##(2008-7#1)(2012-2#1)
trend by##3##2##(1993-6#1)(2011-2#1)(2012-2#1)
trend during##2##2##(2008-1#1)(2012-3#1)
trend emerged##2##2##(1990-12#1)(2008-12#1)
trend for the discriminative accuracy to be decreased by PCPA##2##10##(1992-11#2)
trend for the##5##3##(1992-11#2)(2007-11#1)(2008-10#1)(2009-6#1)
trend for##14##2##(1990-2#1)(1991-2#1)(1992-11#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
trend has##2##2##(1993-12#1)(2008-3#1)
trend in life expectancy in Norway##2##6##(1996-3#2)
trend in the number of##2##5##(1990-11#1)(1996-11#1)
trend in the##6##3##(1990-11#1)(1990-6#1)(1994-2#1)(1995-12#1)(1996-11#1)(2012-12#1)
trend in##37##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-8#1)(1993-2#1)(1994-2#2)(1995-12#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-3#3)(1997-5#1)(1997-7#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2011-2#3)(2012-12#2)(2013-1#1)
trend is##8##2##(1991-3#1)(1992-3#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-9#1)(2013-1#1)
trend may##2##2##(2012-12#1)(2013-7#1)
trend observed##3##2##(2009-12#1)(2010-4#1)(2012-2#1)
trend of the##7##3##(1990-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)(2012-7#1)(2013-1#1)
trend of##31##2##(1990-12#1)(1990-2#1)(1990-3#1)(1995-3#1)(1995-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
trend over##2##2##(2010-8#1)(2011-2#1)
trend to increase in##2##4##(2006-8#1)(2008-7#1)
trend to##9##2##(1994-1#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-1#1)(2013-8#1)
trend toward greater##2##3##(1997-2#1)(2008-10#1)
trend toward##19##2##(1990-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-2#2)(2013-1#1)
trend towards more##2##3##(2009-4#1)(2010-3#1)
trend towards##21##2##(1990-12#1)(1990-6#1)(1995-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#3)(2009-3#2)(2009-4#1)(2010-11#1)(2010-3#2)(2011-2#1)
trend was not##2##3##(2012-12#1)(2012-2#1)
trend was observed in##2##4##(2007-7#1)(2008-10#1)
trend was observed##4##3##(2007-7#1)(2008-10#2)(2012-12#1)
trend was##16##2##(1990-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
trend will##2##2##(1991-6#1)(2007-7#1)
trend with##3##2##(1993-9#1)(2008-7#1)(2009-5#1)
trend within##2##2##(1991-3#1)(1996-6#1)
trend##249##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#4)(1996-3#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#13)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#8)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#8)(2012-2#6)(2012-3#5)(2012-7#1)(2012-9#1)(2013-1#6)(2013-7#2)(2013-8#4)
trended##4##1##(1996-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
trending##2##1##(2008-12#1)(2010-9#1)
trends among women in##2##4##(2007-4#2)
trends among##3##2##(1993-1#1)(2007-4#2)
trends and correlates##2##3##(1993-3#1)(2013-1#1)
trends and current##2##3##(1996-3#1)(2008-10#1)
trends and directions##2##3##(2008-7#1)(2009-11#1)
trends and issues in##2##4##(1994-2#1)(2008-1#1)
trends and##29##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(1996-1#1)(1996-2#2)(1996-3#2)(1997-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
trends are##11##2##(1991-3#1)(1992-1#1)(1993-5#1)(1994-5#2)(1997-2#1)(2007-12#1)(2008-1#3)(2008-7#1)
trends between##2##2##(1993-12#2)
trends continued##2##2##(1991-2#1)(2007-8#1)
trends for##11##2##(1991-1#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1996-2#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-12#1)
trends from the##2##3##(1994-3#1)(2012-1#1)
trends from##7##2##(1994-3#1)(1996-3#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)
trends in Medicare##2##3##(1991-1#1)(1997-1#1)
trends in cancer##2##3##(1990-9#1)(2012-3#1)
trends in diaphyseal##2##3##(2009-10#2)
trends in females##2##3##(1994-6#1)(1996-3#1)
trends in health care facility construction##2##6##(1991-2#2)
trends in hospital##2##3##(1993-12#1)(1996-1#1)
trends in incidence##2##3##(1994-9#1)(1995-5#1)
trends in managed care##2##4##(1992-2#1)(2009-6#1)
trends in medical##2##3##(1991-1#1)(1994-1#1)
trends in the evolution of##2##5##(2010-3#2)
trends in the management of##2##5##(1995-3#1)(2008-5#1)
trends in the use of##2##5##(1991-3#1)(1993-12#1)
trends in the##26##3##(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-3#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#2)(2011-2#1)
trends in##119##2##(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#4)(1996-3#7)(1997-1#1)(1997-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
trends observed in##2##3##(2008-10#1)(2011-9#1)
trends observed##3##2##(2008-10#1)(2008-6#1)(2011-9#1)
trends of the##3##3##(2007-11#1)(2007-7#1)(2012-12#1)
trends of##18##2##(1994-12#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
trends on##2##2##(2008-10#1)(2011-1#1)
trends over time##4##3##(2008-10#1)(2009-7#1)(2012-12#2)
trends promoting##2##2##(1997-3#1)(2008-11#1)
trends that are##2##3##(1991-1#1)(1996-2#1)
trends that##5##2##(1991-1#1)(1995-2#1)(1996-2#1)(2008-1#1)(2011-2#1)
trends toward##4##2##(1995-3#1)(2007-12#1)(2008-2#1)(2012-3#1)
trends towards##2##2##(2007-7#1)(2008-7#1)
trends were found##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
trends were##10##2##(1993-1#1)(1994-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)(2012-1#1)(2013-1#1)
trends within the##2##3##(1991-3#1)(2010-3#1)
trends within##4##2##(1991-3#1)(1995-12#1)(1997-2#1)(2010-3#1)
trends##319##1##(1990-9#1)(1991-1#7)(1991-12#2)(1991-2#7)(1991-3#8)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-6#1)(1992-9#2)(1993-1#5)(1993-12#6)(1993-2#3)(1993-3#5)(1993-5#1)(1993-9#2)(1994-1#5)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#6)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#1)(1996-1#7)(1996-2#5)(1996-3#11)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#13)(2008-10#25)(2008-11#9)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#5)(2009-10#4)(2009-11#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#10)(2011-9#1)(2012-1#2)(2012-12#10)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#1)
trends)##2##1##(1994-12#1)(2008-8#1)
trends]##3##1##(1990-2#1)(1990-9#1)(2013-1#1)
trephination##2##1##(2012-12#2)
tri- and pentavalent##2##3##(2008-10#1)(2009-6#1)
tri- and##4##2##(2008-10#3)(2009-6#1)
tri- or##2##2##(2008-10#1)(2013-7#1)
tri-##9##1##(1993-11#1)(2008-10#5)(2008-7#1)(2009-6#1)(2013-7#1)
tri-Calciphor##4##1##(1994-6#4)
tri-allelic##2##1##(2008-12#2)
tri-colour light emitting diode##2##4##(2008-10#2)
tri-colour##4##1##(2008-10#4)
tri-iodide##3##1##(2008-10#3)
tri-iodothyronine##2##1##(1991-2#1)(1996-5#1)
tri-methylation##4##1##(2009-10#3)(2013-1#1)
tri-n-butyl phosphate (TBP) and##2##4##(2008-10#2)
tri-n-butylphosphate (TBP)##3##2##(2008-10#3)
tri-n-butylphosphine in order to##2##4##(2008-10#2)
tri-snRNP##2##1##(1995-6#2)
triacetal oxa cages##2##3##(1996-5#2)
triacetate##9##1##(1990-9#2)(2007-11#1)(2007-12#1)(2008-10#4)(2013-1#1)
triacrylate (it is reactive and therefore not available as pure##2##10##(2008-9#2)
triacrylate (technical grade) (CAS No##2##5##(2008-9#2)
triacrylate as a potential contact sensitizer##2##6##(2008-9#2)
triacrylate by skin painting for 3 months##2##7##(2008-9#2)
triacrylate by skin painting for##3##5##(2008-9#3)
triacrylate for 6 months had significantly increased incidences##2##8##(2008-9#2)
triacrylate induced a neutrophil count increase##2##6##(2008-9#2)
triacrylate is##2##2##(2008-9#2)
triacrylate to induce contact hypersensitization##2##5##(2008-9#2)
triacrylate was nominated by the National Cancer Institute for testing##2##10##(2008-9#2)
triacrylate was##3##2##(2008-9#3)
triacrylate##32##1##(2008-9#32)
triacrylate) in acetone dermally for 2 weeks or 3 months##2##10##(2008-9#2)
triacrylate/kg body weight in acetone 5 days per week for 14 weeks##4##12##(2008-9#4)
triacrylate/kg body weight in acetone 5 days per week for##9##10##(2008-9#9)
triacylglycerol and##2##2##(2008-7#1)(2011-2#1)
triacylglycerol##6##1##(1990-5#1)(1993-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
triacylglycerols in##4##2##(1990-8#2)(1996-6#1)(2008-5#1)
triacylglycerols##9##1##(1990-8#2)(1993-6#1)(1996-6#2)(2008-10#1)(2008-11#1)(2008-5#2)
triacyloglycerides##2##1##(2008-12#2)
triad in##2##2##(2010-1#2)
triad of chymotrypsin##2##3##(1995-5#2)
triad of fever##2##3##(2008-8#1)(2009-11#1)
triad of##16##2##(1992-3#1)(1995-2#1)(1995-5#3)(2006-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
triad##32##1##(1992-12#1)(1992-3#2)(1995-2#1)(1995-3#1)(1995-5#4)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-9#1)(2010-1#4)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
triadic vesicles##2##2##(1992-3#1)(1995-6#1)
triadic##3##1##(1992-3#1)(1994-3#1)(1995-6#1)
triadimenol##3##1##(2008-10#2)(2011-2#1)
triads##3##1##(1993-2#1)(2008-10#1)(2009-8#1)
triage of patients with##2##4##(2008-3#2)
triage of suspected scaphoid fractures##2##5##(2008-9#2)
triage of suspected scaphoid##3##4##(2008-9#3)
triage of##5##2##(2008-3#2)(2008-9#3)
triage##19##1##(1997-1#1)(2007-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#5)(2009-5#1)(2010-8#2)(2012-12#1)(2013-1#2)
trial (RCT)##3##2##(2008-10#1)(2013-1#2)
trial (p &lt##2##3##(2008-5#1)(2011-1#1)
trial and error##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
trial and were randomized to##2##5##(2012-2#2)
trial and##21##2##(1995-1#1)(1995-11#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
trial are##4##2##(1991-9#1)(1994-9#1)(1996-3#1)(2011-3#1)
trial as well as##2##4##(2009-12#1)(2010-6#1)
trial assessing##2##2##(2007-10#1)(2010-12#1)
trial by##2##2##(1996-11#2)
trial compared##5##2##(2008-5#1)(2009-4#2)(2013-8#2)
trial comparing the##2##3##(2008-4#1)(2009-5#1)
trial comparing##11##2##(1991-11#1)(1993-1#2)(1993-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(2007-7#1)(2008-4#1)(2009-5#1)
trial conducted in a##2##4##(1990-11#1)(2008-10#1)
trial conducted in##4##3##(1990-11#1)(2008-10#2)(2010-11#1)
trial conducted##5##2##(1990-11#1)(2008-10#2)(2010-11#1)(2012-12#1)
trial consisted of##2##3##(1993-6#1)(2008-7#1)
trial data##5##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
trial demonstrated that##2##3##(1997-2#1)(2009-4#1)
trial demonstrated##3##2##(1997-2#1)(2008-5#1)(2009-4#1)
trial design##6##2##(1997-4#1)(2007-9#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
trial designed to evaluate the##2##5##(2008-4#1)(2011-2#1)
trial designed to##3##3##(2008-4#1)(2010-10#1)(2011-2#1)
trial designs##3##2##(1994-9#1)(1997-8#1)(2011-2#1)
trial evaluating##3##2##(2008-5#1)(2008-7#1)(2010-12#1)
trial for counterbalance order##3##4##(2013-8#3)
trial for the same indication##2##5##(2008-5#2)
trial for the treatment of##2##5##(2008-5#2)
trial for the##5##3##(1997-4#1)(2008-5#4)
trial for##21##2##(1994-5#1)(1995-9#1)(1997-4#1)(2008-10#2)(2008-5#10)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#3)
trial from##2##2##(2008-7#1)(2011-1#1)
trial has##4##2##(1990-2#1)(1996-12#1)(2007-12#1)(2013-1#1)
trial in 10##2##3##(2008-5#2)
trial in a##3##3##(1990-5#1)(1997-5#1)(2008-10#1)
trial in the##2##3##(1995-9#1)(2010-11#1)
trial in which##5##3##(1990-6#1)(2007-8#1)(2008-10#1)(2013-1#1)(2013-7#1)
trial in##34##2##(1990-5#1)(1990-6#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#8)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
trial involving##2##2##(1992-9#1)(2010-2#1)
trial is the##3##3##(1993-12#1)(1996-6#1)(2011-2#1)
trial is##14##2##(1991-11#1)(1993-12#1)(1996-6#2)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#2)(2013-8#1)
trial judge##3##2##(1995-12#1)(1996-5#1)(1997-5#1)
trial of a##7##3##(1990-5#1)(1994-9#1)(1995-5#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
trial of acyclovir for##2##4##(1991-12#1)(1994-3#1)
trial of efavirenz in combination with##2##6##(2008-5#2)
trial of the##4##3##(1990-2#1)(2007-7#1)(2008-10#1)(2012-2#1)
trial of##82##2##(1990-10#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#2)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#2)(2013-1#4)
trial on the##3##3##(1993-5#1)(1997-4#1)(2012-3#1)
trial on##11##2##(1993-11#1)(1993-5#1)(1994-6#1)(1995-12#1)(1997-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
trial one-dimensional##2##2##(2008-3#2)
trial or##2##2##(1995-2#1)(1996-6#1)
trial participants##4##2##(2007-7#1)(2009-6#2)(2012-3#1)
trial participation##3##2##(2007-7#1)(2008-11#1)(2012-3#1)
trial phase##2##2##(2008-3#1)(2008-5#1)
trial recruitment##2##2##(2010-11#2)
trial results##3##2##(2008-5#1)(2008-8#1)(2010-8#1)
trial should##2##2##(1996-6#2)
trial showed a##2##3##(2008-5#1)(2010-12#1)
trial showed that##4##3##(2008-5#1)(2008-6#1)(2008-8#1)(2013-8#1)
trial showed##7##2##(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
trial site##3##2##(2008-10#2)(2010-3#1)
trial study##2##2##(2009-12#1)(2013-7#1)
trial system##2##2##(2008-10#1)(2008-3#1)
trial that##8##2##(1995-2#1)(1995-9#1)(1997-4#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
trial to compare##2##3##(1991-8#1)(2008-9#1)
trial to determine##2##3##(1990-6#1)(2010-6#1)
trial to establish##2##3##(1995-9#1)(2007-12#1)
trial to evaluate the##2##4##(2008-7#1)(2010-3#1)
trial to evaluate##6##3##(1994-12#1)(1997-4#1)(2008-5#2)(2008-7#1)(2010-3#1)
trial to test the##3##4##(1995-5#1)(1997-3#1)(2010-10#1)
trial to##23##2##(1990-6#1)(1991-8#1)(1994-12#1)(1995-5#2)(1995-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)
trial using##3##2##(2009-5#1)(2011-2#1)(2012-12#1)
trial was carried out##2##4##(2008-6#1)(2010-12#1)
trial was conducted in##3##4##(1991-2#1)(2007-7#1)(2008-3#1)
trial was conducted on##2##4##(2013-1#2)
trial was conducted to compare the##3##6##(1994-7#1)(1995-4#1)(1997-2#1)
trial was conducted to compare##4##5##(1994-7#1)(1995-4#1)(1997-2#1)(2010-8#1)
trial was conducted to determine the##2##6##(2008-10#1)(2011-2#1)
trial was conducted to##7##4##(1994-7#1)(1995-4#1)(1997-2#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
trial was conducted##13##3##(1991-2#1)(1994-7#1)(1995-4#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-8#2)(2011-2#1)(2013-1#2)
trial was designed to evaluate the##2##6##(2008-6#1)(2013-1#1)
trial was made##2##3##(1996-1#1)(2008-3#1)
trial was performed##5##3##(1991-3#1)(1992-12#1)(1994-6#1)(1996-9#1)(2008-3#1)
trial was to##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
trial was##34##2##(1991-1#1)(1991-2#2)(1991-3#1)(1992-12#1)(1994-6#1)(1994-7#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
trial wavefunction##2##2##(2012-2#2)
trial were##3##2##(1991-12#1)(1993-12#1)(2012-2#1)
trial will be##3##3##(2008-5#3)
trial will##6##2##(2008-5#6)
trial with two parallel##2##4##(2008-10#1)(2008-3#1)
trial with##19##2##(1992-8#1)(1994-6#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#4)(2010-2#1)(2010-8#1)(2013-1#3)
trial##725##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#3)(1990-6#5)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#5)(1991-8#3)(1991-9#2)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#5)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#1)(1995-4#3)(1995-5#8)(1995-6#1)(1995-8#1)(1995-9#6)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#15)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#10)(1997-5#7)(1997-7#6)(1997-8#4)(2007-10#9)(2007-11#8)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#17)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#45)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#20)(2008-4#6)(2008-5#64)(2008-6#10)(2008-7#25)(2008-8#37)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#6)(2009-2#1)(2009-4#10)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#12)(2010-11#5)(2010-12#10)(2010-2#5)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#6)(2010-7#2)(2010-8#9)(2011-1#5)(2011-10#1)(2011-2#25)(2011-3#1)(2012-1#1)(2012-12#13)(2012-2#24)(2012-3#17)(2013-1#39)(2013-7#3)(2013-8#14)
trial)##6##1##(2008-10#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-12#1)
trial-based##2##1##(2009-6#1)(2013-1#1)
trial]##3##1##(1991-2#1)(1991-3#1)(2013-1#1)
trialists##3##1##(1993-12#1)(1994-9#1)(2008-10#1)
trialkyl##3##1##(1996-5#1)(2008-10#2)
trials (RCT)##3##2##(2009-4#1)(2010-9#1)(2011-2#1)
trials (RCTs)##11##2##(1993-12#1)(2007-7#1)(2008-10#3)(2009-11#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
trials (n =##2##3##(1993-12#2)
trials (p##2##2##(2013-8#2)
trials (phase##2##2##(2008-11#1)(2010-12#1)
trials across##2##2##(2008-10#1)(2008-12#1)
trials against##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
trials aimed at##2##3##(1996-8#1)(2008-5#1)
trials also##2##2##(2010-3#1)(2013-1#1)
trials and discuss##2##3##(1995-2#1)(2008-5#1)
trials and meta-analyses##4##3##(1991-3#1)(1993-12#1)(1996-6#2)
trials and other##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
trials and registries##2##3##(2009-10#1)(2011-2#1)
trials and##44##2##(1990-9#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-12#2)(1995-2#2)(1995-9#1)(1996-3#1)(1996-6#2)(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#5)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-12#4)(2012-2#1)
trials are available##3##3##(2007-9#1)(2008-3#1)(2008-8#1)
trials are currently##2##3##(2007-11#1)(2010-12#1)
trials are discussed##2##3##(2008-12#1)(2008-7#1)
trials are needed to##5##4##(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
trials are needed##6##3##(2008-7#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
trials are required##2##3##(2013-1#1)(2013-8#1)
trials are underway##2##3##(2008-5#1)(2012-2#1)
trials are##41##2##(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#2)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
trials as##9##2##(2008-5#5)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
trials at the##2##3##(2009-6#1)(2009-9#1)
trials at##4##2##(1996-11#1)(2008-10#1)(2009-6#1)(2009-9#1)
trials by##3##2##(1996-9#1)(2008-11#1)(2008-5#1)
trials compared with##2##3##(2008-10#2)
trials compared##4##2##(2008-10#3)(2008-7#1)
trials comparing##5##2##(2008-1#1)(2008-10#1)(2008-6#2)(2010-5#1)
trials conducted in##4##3##(2008-10#3)(2008-8#1)
trials conducted##6##2##(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)
trials confirm the##2##3##(1994-2#1)(2009-5#1)
trials could##2##2##(2008-10#1)(2010-1#1)
trials dealing with##4##3##(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)
trials designed to##3##3##(1994-9#1)(1997-4#1)(2008-11#1)
trials during##2##2##(2010-8#1)(2013-1#1)
trials evaluating##2##2##(2008-2#1)(2011-2#1)
trials focused on##2##3##(2010-6#1)(2011-2#1)
trials for the##3##3##(2008-5#2)(2008-7#1)
trials for##17##2##(1995-5#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
trials had several##2##3##(2008-10#1)(2008-8#1)
trials had##3##2##(2008-10#2)(2008-8#1)
trials has##2##2##(1993-12#1)(1996-6#1)
trials have been conducted##3##4##(1992-10#1)(2008-11#1)(2013-1#1)
trials have been performed##2##4##(2006-10#1)(2008-10#1)
trials have been##8##3##(1992-10#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)(2013-1#1)
trials have demonstrated that##6##4##(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
trials have demonstrated the efficacy of##2##6##(2007-11#1)(2008-8#1)
trials have demonstrated the##4##4##(1991-6#1)(2007-11#1)(2008-8#1)(2012-12#1)
trials have demonstrated##13##3##(1991-6#1)(1996-8#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#1)(2012-12#1)(2013-1#1)
trials have suggested that##2##4##(1996-3#1)(2012-12#1)
trials have##39##2##(1991-6#1)(1991-8#1)(1992-10#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#4)(2010-12#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
trials in MDD##2##3##(2009-9#1)(2012-3#1)
trials in both##3##3##(2008-11#1)(2008-5#1)(2010-6#1)
trials in humans##3##3##(2006-6#1)(2010-5#1)(2011-2#1)
trials in oncology##3##3##(2008-8#1)(2009-12#1)(2010-1#1)
trials in patients with##2##4##(2007-7#1)(2008-7#1)
trials in the US for##3##5##(2008-5#3)
trials in the##7##3##(1990-11#1)(2008-11#1)(2008-5#4)(2012-3#1)
trials in which the##2##4##(2009-4#1)(2011-1#1)
trials in which##4##3##(2009-4#1)(2009-9#2)(2011-1#1)
trials in##75##2##(1990-11#1)(1991-6#1)(1991-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#4)(1994-8#1)(1997-4#1)(2006-6#1)(2007-7#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#14)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#3)(2010-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)
trials include##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
trials including##3##2##(2008-6#1)(2009-11#1)(2010-1#1)
trials involve##2##2##(1997-4#1)(2008-5#1)
trials involving##6##2##(1996-6#1)(2007-10#1)(2008-6#1)(2010-11#1)(2012-2#2)
trials is essential##2##3##(1993-12#1)(2008-3#1)
trials is##14##2##(1993-12#1)(1993-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2013-7#1)
trials may be##2##3##(2008-7#1)(2008-8#1)
trials of a##4##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-5#1)
trials of combination##2##3##(1995-5#1)(2010-10#1)
trials of hypothermia for##2##4##(2008-8#2)
trials of medication##2##3##(1997-3#1)(2008-6#1)
trials of new##2##3##(2008-4#1)(2011-2#1)
trials of patients##2##3##(2008-7#1)(2010-11#1)
trials of the##7##3##(1992-10#1)(1993-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
trials of treatment##2##3##(1991-10#1)(2009-9#1)
trials of##77##2##(1990-11#1)(1991-10#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-10#2)(1993-2#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-5#3)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#1)(2009-11#3)(2009-12#1)(2009-7#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#4)(2013-1#2)
trials on a##2##3##(1994-8#1)(2008-12#1)
trials on##24##2##(1991-5#1)(1991-6#1)(1992-10#1)(1994-2#1)(1994-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
trials or##2##2##(1996-3#1)(2008-3#1)
trials over##2##2##(2008-10#2)
trials per day##2##3##(1993-12#1)(1994-3#1)
trials per##4##2##(1990-11#1)(1992-12#1)(1993-12#1)(1994-3#1)
trials performed##2##2##(1991-3#1)(2008-2#1)
trials reported##2##2##(1997-1#1)(2008-7#1)
trials revealed that##2##3##(2008-10#1)(2011-1#1)
trials should be##3##3##(1996-6#1)(2010-4#1)(2010-8#1)
trials should##5##2##(1993-12#1)(1996-6#1)(2008-6#1)(2010-4#1)(2010-8#1)
trials show that##3##3##(1991-12#1)(2010-5#1)(2012-12#1)
trials showed##3##2##(2008-10#2)(2008-7#1)
trials testing##4##2##(2008-11#1)(2010-12#1)(2012-12#2)
trials than##2##2##(2008-5#1)(2013-8#1)
trials that have##2##3##(1993-12#1)(2008-6#1)
trials that##11##2##(1993-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-3#1)
trials the##3##2##(1992-9#1)(1997-3#1)(2008-8#1)
trials to criterion##2##3##(1993-3#1)(2011-2#1)
trials to determine##2##3##(2007-10#1)(2010-8#1)
trials to study##2##3##(1995-5#1)(2008-8#1)
trials to##23##2##(1992-12#1)(1993-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-8#1)(2007-10#2)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#2)(2010-8#2)(2011-2#4)(2012-2#3)(2013-1#1)
trials using##14##2##(1994-11#1)(1994-9#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2012-3#2)(2013-8#1)
trials was##7##2##(1992-12#1)(1993-3#1)(2008-10#3)(2008-12#1)(2008-5#1)
trials were conducted##4##3##(2008-10#3)(2011-2#1)
trials were##13##2##(2008-10#4)(2008-5#2)(2008-7#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
trials where##2##2##(1995-2#1)(1997-3#1)
trials which##4##2##(1996-6#2)(2012-12#1)(2012-3#1)
trials will##4##2##(1994-9#1)(1995-12#1)(2011-2#1)(2013-7#1)
trials with an##3##3##(2007-6#1)(2008-11#1)(2011-2#1)
trials with two##2##3##(1992-9#1)(2008-10#1)
trials with##28##2##(1990-10#1)(1991-2#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-9#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
trials without##2##2##(2008-10#1)(2009-6#1)
trials##975##1##(1990-10#1)(1990-11#3)(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-5#1)(1991-6#6)(1991-8#3)(1991-9#2)(1992-10#5)(1992-12#6)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#7)(1993-11#2)(1993-12#22)(1993-2#3)(1993-3#6)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#10)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#12)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#11)(1995-5#8)(1995-9#7)(1996-11#2)(1996-3#8)(1996-6#19)(1996-8#4)(1996-9#2)(1997-1#4)(1997-3#8)(1997-4#10)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#5)(2006-6#1)(2007-10#9)(2007-11#11)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#115)(2008-11#42)(2008-12#12)(2008-2#14)(2008-3#18)(2008-4#11)(2008-5#74)(2008-6#11)(2008-7#39)(2008-8#41)(2008-9#7)(2009-10#5)(2009-11#8)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#3)(2009-9#12)(2010-1#3)(2010-10#4)(2010-11#12)(2010-12#13)(2010-2#6)(2010-3#9)(2010-4#1)(2010-5#11)(2010-6#7)(2010-8#10)(2010-9#2)(2011-1#7)(2011-2#42)(2011-3#2)(2011-7#1)(2012-1#4)(2012-12#26)(2012-2#21)(2012-3#36)(2013-1#31)(2013-7#2)(2013-8#15)
trials) and##2##2##(2008-10#2)
trials)##13##1##(1994-2#1)(2008-10#4)(2008-2#3)(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-8#1)
trials?##2##1##(1993-12#1)(2009-6#1)
triamcinolone acetonide##8##2##(1990-11#2)(1991-9#1)(2007-7#2)(2010-12#2)(2011-2#1)
triamcinolone in##2##2##(1991-2#1)(2011-2#1)
triamcinolone##17##1##(1990-11#2)(1991-2#1)(1991-9#1)(1992-5#1)(1996-3#1)(1997-7#2)(2007-7#2)(2008-10#1)(2010-12#2)(2011-2#4)
triamterene##6##1##(2008-10#6)
triangle and##4##2##(2008-6#3)(2011-2#1)
triangle formed by the##2##4##(2010-8#1)(2011-2#1)
triangle mesh##6##2##(2008-6#4)(2012-3#2)
triangle programmed coulometric flow titration##2##5##(2008-10#2)
triangle##36##1##(1992-12#1)(1996-2#1)(2008-10#3)(2008-3#2)(2008-6#20)(2010-8#2)(2011-2#5)(2012-3#2)
triangle)##2##1##(2008-6#1)(2010-8#1)
triangles##4##1##(2008-2#1)(2008-6#2)(2009-12#1)
triangula##2##1##(2008-5#1)(2010-2#1)
triangular design##2##2##(2008-10#2)
triangular lattice of air##2##4##(2007-11#1)(2007-12#1)
triangular lattice##3##2##(2007-11#1)(2007-12#2)
triangular profilometry##3##2##(2008-3#3)
triangular shape##2##2##(2007-12#1)(2008-10#1)
triangular surfaces##2##2##(2008-3#2)
triangular waves##3##2##(2008-10#3)
triangular##44##1##(2007-11#2)(2007-12#6)(2008-10#8)(2008-2#2)(2008-3#16)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-6#2)(2010-8#1)(2012-12#2)
triangular-shaped##2##1##(2008-3#2)
triangulated irregular##2##2##(2008-6#2)
triangulated##5##1##(2008-6#3)(2010-10#1)(2013-1#1)
triangulation configuration##2##2##(2008-3#2)
triangulation##14##1##(2008-2#3)(2008-3#6)(2008-6#1)(2009-11#1)(2012-12#1)(2013-1#2)
triangulation-based##2##1##(2010-7#2)
triantennary complex-type##4##2##(1993-11#2)(1994-5#2)
triantennary##7##1##(1993-11#3)(1994-5#2)(1995-2#1)(2008-8#1)
triatomic##2##1##(2009-2#1)(2012-2#1)
triaxial antenna for microwave##2##4##(2007-12#2)
triaxial dielectric##3##2##(2008-2#3)
triaxial##6##1##(2007-12#3)(2008-2#3)
triazine dendrimers##2##2##(2010-8#2)
triazine derivative##2##2##(2008-2#2)
triazine##12##1##(1997-2#1)(2008-10#5)(2008-2#2)(2010-8#4)
triazines##10##1##(2008-10#10)
triazolam##3##1##(1991-12#1)(1996-12#2)
triazole##5##1##(2007-11#1)(2008-10#2)(2008-5#2)
triazoles for##2##2##(2011-2#2)
triazoles##6##1##(2007-11#1)(2010-3#1)(2011-2#4)
tribal##4##1##(1994-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
tribasic sequence##2##2##(1991-9#2)
tribe of##2##2##(1994-9#1)(1996-6#1)
tribe##4##1##(1994-9#1)(1996-6#1)(2007-12#1)(2008-5#1)
tribes have##2##2##(1991-12#2)
tribes##5##1##(1991-12#2)(2008-12#1)(2008-8#2)
triblock copolymers##3##2##(2008-10#1)(2009-11#2)
tribromoarsenazo-cetylpyridinium##2##1##(2008-10#2)
tributaries##6##1##(2009-9#1)(2010-8#5)
tributary##2##1##(1991-6#1)(2010-8#1)
tribute to##5##2##(2008-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
tributyl phosphate (TBP)##2##3##(2008-10#2)
tributyl phosphate##3##2##(2008-10#3)
tributyl##4##1##(2008-10#4)
tributyltin chloride##3##2##(1996-12#2)(2008-10#1)
tributyltin hydride##2##2##(2008-4#1)(2009-12#1)
tributyltin##8##1##(1996-12#2)(2008-10#2)(2008-11#1)(2008-4#2)(2009-12#1)
tributyrin##4##1##(1990-6#3)(1992-3#1)
tricalcium phosphate##4##2##(2008-5#3)(2012-3#1)
tricarboxylic acid (TCA)##3##3##(1993-6#1)(2008-10#1)(2012-1#1)
tricarboxylic acid cycle##5##3##(2008-7#4)(2008-8#1)
tricarboxylic acid##8##2##(1993-6#1)(2008-10#1)(2008-7#4)(2008-8#1)(2012-1#1)
triceps brachii##3##2##(2008-5#1)(2012-3#2)
triceps##11##1##(1990-7#1)(2007-11#3)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-2#1)(2012-3#2)
trichinosis##3##1##(2008-10#3)
trichlorfon and##3##2##(2008-10#3)
trichlorfon##10##1##(2008-10#8)(2008-6#1)(2013-1#1)
trichloroacetaldehyde hydrate (TCAH)##2##3##(2008-10#2)
trichloroacetate##3##1##(1995-3#1)(2008-10#1)(2008-4#1)
trichloroacetic acid (TCA) and##2##4##(2008-10#2)
trichloroacetic acid (TCA)##4##3##(1995-3#1)(2008-10#3)
trichloroacetic acid##11##2##(1990-8#1)(1995-12#1)(1995-3#1)(2008-10#7)(2008-5#1)
trichloroacetic##12##1##(1990-8#1)(1995-12#1)(1995-3#1)(2008-10#8)(2008-5#1)
trichloroethanol##2##1##(2012-2#2)
trichloroethene##2##1##(2008-10#2)
trichloroethylene (TCE)##5##2##(2008-10#3)(2010-4#1)(2012-12#1)
trichloroethylene##17##1##(2008-10#13)(2008-7#2)(2010-4#1)(2012-12#1)
trichloroisocyanuric acid##2##2##(2008-10#2)
trichloromethane##4##1##(2007-11#1)(2008-10#3)
trichocarpa F(1) progeny##2##3##(2008-10#2)
trichocarpa and##2##2##(2008-10#2)
trichocarpa x P##3##3##(2008-10#3)
trichocarpa##12##1##(2008-10#12)
trichodiene synthase with##2##3##(1995-2#2)
trichodiene synthase##8##2##(1995-2#7)(2008-10#1)
trichodiene##9##1##(1995-2#8)(2008-10#1)
trichomes of##3##2##(1997-6#2)(2008-5#1)
trichomes##9##1##(1997-6#2)(2008-10#1)(2008-5#5)(2008-8#1)
trichomoniasis and##2##2##(1992-2#1)(2011-1#1)
trichomoniasis in##2##2##(2008-10#1)(2008-5#1)
trichomoniasis##8##1##(1992-2#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)
trichosanthin##3##1##(2008-10#2)(2008-8#1)
trichosporium OB3b##2##2##(2008-6#2)
trichothecene toxin##2##2##(2008-10#2)
trichothecene##8##1##(2008-10#5)(2008-11#3)
trichothecenes##7##1##(2008-10#5)(2008-8#1)(2010-7#1)
trichotillomania##3##1##(2007-12#2)(2011-2#1)
trichovirus##2##1##(2008-10#2)
trichrome stain##2##2##(2008-11#1)(2010-12#1)
trichrome##6##1##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#1)
tricks##5##1##(1990-5#1)(1995-12#1)(1996-3#1)(2008-1#1)(2011-2#1)
tricky##2##1##(1992-12#1)(1992-5#1)
triclinic##7##1##(1996-2#3)(1997-7#2)(2007-11#2)
triclosan##6##1##(2008-5#6)
tricortical##3##1##(2008-7#1)(2009-10#2)
tricuspid annular plane systolic excursion##2##5##(2010-10#1)(2011-2#1)
tricuspid annulus##2##2##(2007-8#1)(2008-11#1)
tricuspid valve##8##2##(1997-2#1)(2007-12#3)(2007-7#1)(2007-8#2)(2012-12#1)
tricuspid##15##1##(1997-2#1)(2007-12#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
tricyclic antidepressant drugs##2##3##(1990-8#1)(2008-10#1)
tricyclic antidepressant##3##2##(1990-8#1)(2008-10#1)(2010-1#1)
tricyclic antidepressants##13##2##(1991-11#2)(1991-8#1)(1996-7#1)(1997-8#4)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
tricyclic##25##1##(1990-11#1)(1990-8#1)(1991-11#3)(1991-8#1)(1995-3#2)(1996-5#3)(1996-7#1)(1997-8#4)(2006-10#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2012-2#1)
tricyclics##3##1##(2008-11#2)(2012-2#1)
tridentate##4##1##(1997-7#4)
tried as##3##2##(2007-7#1)(2008-5#2)
tried for##3##2##(1990-5#1)(1995-12#1)(2008-10#1)
tried in##2##2##(1993-3#1)(2008-7#1)
tried on##2##2##(1994-2#1)(2008-10#1)
tried smoking##2##2##(1991-9#1)(2013-1#1)
tried to develop##2##3##(1990-9#1)(2008-10#1)
tried to find out##2##4##(2007-10#1)(2011-1#1)
tried to make##2##3##(2007-8#1)(2010-8#1)
tried to turn##3##3##(1994-3#2)(2009-7#1)
tried to##40##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-5#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-5#2)(1997-5#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-8#3)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
tried##64##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-5#1)(1991-9#2)(1992-4#1)(1993-3#2)(1994-2#1)(1994-3#2)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-5#1)(1997-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
trienzymatic##2##1##(2008-10#2)
trienzyme##4##1##(2008-10#3)(2009-8#1)
triepoxides##2##1##(1996-5#2)
tries to##10##2##(1993-3#1)(1994-12#1)(1995-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
tries##11##1##(1990-6#1)(1993-3#1)(1994-12#1)(1995-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
triethanolamine (TEA) as##3##3##(2008-10#3)
triethanolamine (TEA)##5##2##(2008-10#5)
triethanolamine##8##1##(2008-10#7)(2008-4#1)
triethylamine (TEA) and##2##3##(2008-10#2)
triethylamine and##4##2##(1996-5#1)(2008-10#3)
triethylamine##22##1##(1996-5#3)(2007-11#1)(2008-10#14)(2008-7#3)(2010-5#1)
triethylene glycol##2##2##(2008-10#1)(2013-1#1)
triethylenetetramine##4##1##(2008-10#4)
triflate to##3##2##(1995-11#1)(1996-5#1)(1997-7#1)
triflate##6##1##(1995-11#1)(1996-5#1)(1997-7#2)(2007-11#1)(2012-3#1)
trifloxystrobin##4##1##(2008-10#3)(2011-2#1)
triflumuron##2##1##(2008-10#1)(2011-2#1)
trifluoperazine and##2##2##(2008-10#2)
trifluoperazine##3##1##(1996-2#1)(2008-10#2)
trifluoroacetic acid (TFA)##2##3##(2008-10#2)
trifluoroacetic acid##6##2##(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#3)
trifluoroacetic##9##1##(1990-8#1)(1991-12#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)
trifluoroacetylated##4##1##(1991-2#1)(1995-3#3)
trifluoroethanol and##2##2##(1991-5#1)(2009-8#1)
trifluoroethanol##8##1##(1991-5#1)(1994-11#1)(1994-8#1)(1995-2#2)(2009-8#2)(2010-7#1)
trifluoromethyl ketone inhibitor##2##3##(1993-11#2)
trifluoromethyl ketone##3##2##(1993-11#3)
trifluoromethyl##6##1##(1993-11#3)(2007-12#1)(2008-10#1)(2008-5#1)
triflupromazine##3##1##(2008-10#3)
trifluralin##2##1##(2008-10#1)(2008-5#1)
triflusal##2##1##(2007-8#2)
trifoliata##4##1##(2008-10#1)(2008-5#1)(2010-3#2)
trifoliata)##2##1##(2008-10#2)
trifoliate orange (Poncirus##2##3##(2008-10#2)
trifoliate orange adjacent to P##2##5##(2008-10#2)
trifoliate orange##11##2##(2008-10#11)
trifolii from##2##2##(2008-10#2)
trifolii strain##2##2##(2011-2#2)
trifolii##14##1##(2008-10#6)(2010-3#2)(2011-2#6)
trifunctional protein##2##2##(1993-12#2)
trifunctional silane##2##2##(2008-10#2)
trifunctional##8##1##(1992-10#1)(1993-12#5)(2008-10#2)
trigeminal artery##5##2##(1991-6#2)(2008-12#1)(2008-7#2)
trigeminal cistern##2##2##(1993-1#2)
trigeminal ganglion and##2##3##(1996-2#1)(2008-6#1)
trigeminal ganglion neurons##3##3##(1996-12#3)
trigeminal ganglion##12##2##(1996-12#3)(1996-2#1)(1997-3#3)(2008-6#2)(2008-7#1)(2009-12#1)(2011-2#1)
trigeminal motor nucleus##2##3##(1990-9#1)(1997-2#1)
trigeminal nerve##12##2##(1990-12#1)(1993-12#1)(1996-5#3)(2007-12#1)(2011-2#6)
trigeminal neuralgia##12##2##(2008-5#1)(2008-7#2)(2011-2#8)(2013-1#1)
trigeminal##58##1##(1990-12#1)(1990-9#3)(1991-6#2)(1992-2#1)(1992-5#1)(1993-1#3)(1993-12#1)(1996-12#3)(1996-2#1)(1996-5#4)(1997-2#4)(1997-3#3)(1997-6#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#2)(2009-12#1)(2011-2#15)(2013-1#2)
trigeminally induced apnoea##3##3##(1996-5#3)
trigger a##4##2##(1995-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
trigger and##3##2##(1994-8#1)(2007-11#1)(2009-6#1)
trigger apoptosis##4##2##(2008-4#1)(2009-4#1)(2013-1#1)(2013-8#1)
trigger factor for##2##3##(2012-12#1)(2012-3#1)
trigger finger in##2##3##(2008-9#2)
trigger finger##4##2##(2008-9#4)
trigger for##11##2##(1992-11#1)(1994-5#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-9#2)(2009-9#1)(2012-2#1)(2012-3#1)
trigger germination##2##2##(2008-10#1)(2011-2#1)
trigger of##5##2##(1995-2#1)(2008-1#2)(2011-2#1)(2012-2#1)
trigger point therapy##2##3##(2009-3#1)(2010-3#1)
trigger point##3##2##(2009-3#1)(2010-3#1)(2013-1#1)
trigger points##9##2##(2008-12#3)(2009-7#1)(2010-12#2)(2010-9#2)(2012-3#1)
trigger the activation##2##3##(2008-8#1)(2013-8#1)
trigger the disease##2##3##(1991-2#1)(2006-10#1)
trigger the##11##2##(1991-2#1)(1993-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-2#2)(2013-8#1)
trigger##110##1##(1990-11#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-2#2)(1997-3#2)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#3)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#10)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-3#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#3)
triggered a##4##2##(1995-6#1)(1996-3#2)(1996-5#1)
triggered an##2##2##(1997-2#1)(2008-10#1)
triggered by a##5##3##(1990-8#1)(1991-9#1)(1994-12#1)(2009-10#1)(2012-2#1)
triggered by activation of##2##4##(2009-8#1)(2012-1#1)
triggered by fire##4##3##(2009-10#4)
triggered by the##7##3##(1990-7#1)(1995-12#2)(1997-3#1)(2008-7#1)(2009-8#1)(2010-7#1)
triggered by##58##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
triggered during##2##2##(1994-11#1)(2008-7#1)
triggered release of##3##3##(2008-10#2)(2009-11#1)
triggered release##4##2##(1995-11#1)(2008-10#2)(2009-11#1)
triggered the##5##2##(1993-8#1)(2008-10#2)(2008-7#1)(2012-3#1)
triggered when##2##2##(2008-10#1)(2008-8#1)
triggered##105##1##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#7)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#5)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
triggerfish##2##1##(2007-5#2)
triggering a##3##2##(1992-6#2)(2011-1#1)
triggering agents##2##2##(1990-6#1)(2011-2#1)
triggering in the##2##3##(2011-1#2)
triggering in##3##2##(1991-5#1)(2011-1#2)
triggering level##2##2##(2008-3#2)
triggering mechanism of##2##3##(2008-8#1)(2009-8#1)
triggering of the##3##3##(2008-10#1)(2008-8#2)
triggering of##13##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#6)(2009-8#1)(2010-6#1)(2013-1#2)
triggering the##7##2##(1992-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
triggering##69##1##(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#2)(1994-11#1)(1995-11#1)(1995-8#1)(1996-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#8)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#7)(2012-2#1)(2012-7#1)(2013-1#4)
triggers a##8##2##(1993-11#1)(1995-12#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-3#2)
triggers for##2##2##(2008-12#1)(2008-6#1)
triggers of##3##2##(1990-6#1)(2008-11#1)(2010-5#1)
triggers resistance##2##2##(2008-10#1)(2009-8#1)
triggers sprouting of##2##3##(1993-12#2)
triggers the##4##2##(1993-12#1)(1994-11#1)(2009-12#1)(2013-7#1)
triggers##52##1##(1990-6#1)(1993-11#1)(1993-12#3)(1994-11#2)(1994-3#1)(1994-6#1)(1995-12#2)(1996-4#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#5)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-7#1)(2013-8#2)
triglyceride (TG)##4##2##(2008-7#1)(2010-8#2)(2013-1#1)
triglyceride accumulation##3##2##(2008-1#2)(2008-11#1)
triglyceride and cholesterol##3##3##(1990-8#1)(1993-3#1)(1994-11#1)
triglyceride and##9##2##(1990-8#1)(1992-6#1)(1993-3#1)(1994-11#1)(1997-8#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-6#1)
triglyceride concentrations in##2##3##(1993-12#1)(2007-11#1)
triglyceride concentrations##3##2##(1993-12#1)(2007-11#1)(2008-12#1)
triglyceride contents##3##2##(1993-12#2)(2007-11#1)
triglyceride in##2##2##(1991-12#1)(2011-1#1)
triglyceride level##4##2##(2007-7#1)(2008-3#2)(2013-8#1)
triglyceride levels in##2##3##(1997-7#1)(2008-10#1)
triglyceride levels##10##2##(1997-7#3)(2008-1#1)(2008-10#3)(2008-11#1)(2013-1#2)
triglyceride may##2##2##(2008-1#1)(2012-6#1)
triglyceride was##2##2##(1991-12#1)(2008-12#1)
triglyceride##71##1##(1990-8#1)(1991-12#5)(1991-2#1)(1991-4#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-11#1)(1997-7#3)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#3)(2008-3#7)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-6#3)(2013-1#3)(2013-8#1)
triglyceride-rich lipoproteins in##2##3##(1990-8#1)(1995-6#1)
triglyceride-rich lipoproteins##8##2##(1990-8#1)(1993-12#1)(1995-6#5)(2008-1#1)
triglyceride-rich##11##1##(1990-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#5)(2008-1#1)(2008-6#1)
triglyceride/total##2##1##(1991-12#2)
triglyceridemia##2##1##(1991-12#2)
triglycerides (p =##2##3##(2008-3#2)
triglycerides and##6##2##(1994-11#2)(2008-3#2)(2008-7#1)(2008-8#1)
triglycerides decreased##2##2##(1991-6#1)(2008-3#1)
triglycerides in##7##2##(1991-12#2)(1992-11#1)(1992-12#2)(2012-2#1)(2013-1#1)
triglycerides were##5##2##(1990-8#2)(1991-12#1)(2011-1#1)(2013-8#1)
triglycerides with##2##2##(2008-6#1)(2010-5#1)
triglycerides##90##1##(1990-8#3)(1991-12#4)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-6#4)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#2)(1995-11#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#11)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#5)(2010-5#2)(2011-1#2)(2011-2#4)(2012-2#6)(2012-3#1)(2013-1#11)(2013-8#1)
trigonal bipyramidal##2##2##(1997-7#1)(2008-10#1)
trigonal##7##1##(1993-11#1)(1996-2#3)(1997-7#1)(2008-10#2)
trigonelline##3##1##(2008-10#3)
trihalomethanes (THMs)##3##2##(2008-10#3)
trihalomethanes##13##1##(2008-10#12)(2008-9#1)
trihedral junctions##2##2##(2008-6#2)
triiodide ion##2##2##(2008-10#2)
triiodide##9##1##(2008-10#9)
triiodothyronine (T3)##4##2##(1991-12#1)(1994-11#1)(2008-6#1)(2008-7#1)
triiodothyronine##11##1##(1991-12#1)(1991-5#1)(1994-11#1)(1995-11#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#2)
triiron cluster##2##2##(2010-5#2)
triisooctylamine##2##1##(2008-10#2)
trilineage##2##1##(2008-9#1)(2012-12#1)
trilinear##4##1##(2008-10#4)
trillion by##2##2##(1993-3#1)(2008-10#1)
trillion for##2##2##(1992-3#1)(2008-10#1)
trillion##10##1##(1992-3#1)(1993-3#2)(2008-10#6)(2008-12#1)
trimellitic anhydride (TMA)##3##3##(1995-11#1)(2008-10#2)
trimellitic anhydride##4##2##(1995-11#1)(2008-10#3)
trimellitic##6##1##(1995-11#1)(2008-10#5)
trimeperidine and##3##2##(2012-3#3)
trimeperidine##5##1##(2012-3#5)
trimer and##2##2##(1994-6#1)(2008-10#1)
trimer of##2##2##(1994-6#1)(1997-2#1)
trimer##13##1##(1990-2#1)(1994-2#1)(1994-5#1)(1994-6#3)(1997-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
trimeric G##2##2##(1992-11#2)
trimeric##11##1##(1991-12#1)(1992-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-8#3)
trimers##5##1##(1994-6#1)(1997-2#2)(2008-11#1)(2008-8#1)
trimester and##3##2##(1995-8#1)(2008-1#1)(2012-3#1)
trimester for##3##2##(1993-3#3)
trimester of gestation##2##3##(2008-5#1)(2010-6#1)
trimester of pregnancy##13##3##(1990-12#1)(1992-10#1)(1992-2#2)(1994-9#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-12#2)(2008-2#1)(2011-2#1)(2012-2#1)
trimester of##18##2##(1990-12#1)(1990-6#1)(1992-10#1)(1992-2#2)(1994-9#1)(1996-12#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
trimester ultrasound##3##2##(1996-12#2)(2008-7#1)
trimester with##2##2##(2007-7#1)(2012-3#1)
trimester##73##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#3)(1993-12#1)(1993-3#4)(1994-3#1)(1994-9#2)(1995-8#2)(1996-12#5)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-12#1)(2010-6#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#7)
trimester)##2##1##(2008-1#1)(2010-8#1)
trimesters of gestation##2##3##(1993-12#2)
trimesters##5##1##(1993-12#3)(2010-12#2)
trimestre##5##1##(2011-2#1)(2013-1#4)
trimethoprim in##2##2##(2008-11#2)
trimethoprim##8##1##(2007-7#1)(2008-10#3)(2008-11#3)(2008-7#1)
trimethoprim-sulfamethoxazole##4##1##(1996-3#1)(1997-3#1)(2009-8#1)(2010-8#1)
trimethoprim/sulfamethoxazole##2##1##(2006-10#1)(2009-5#1)
trimethyl##5##1##(1994-8#1)(1996-5#2)(2008-10#2)
trimethylamine (TMA)##3##2##(2008-10#3)
trimethylamine dehydrogenase##4##2##(1995-2#4)
trimethylamine microcarriers##5##2##(2008-11#5)
trimethylamine##19##1##(1995-2#5)(2008-10#8)(2008-11#6)
trimethylammonium##3##1##(2008-10#2)(2008-6#1)
trimethylarsine oxide##3##2##(2008-10#3)
trimethylarsine##4##1##(2008-10#3)(2009-6#1)
trimethylolpropane triacrylate##12##2##(2008-9#12)
trimethylolpropane##20##1##(1996-12#1)(2008-9#19)
trimethylselenonium ion##2##2##(2008-10#2)
trimethylselenonium##3##1##(2008-10#3)
trimethylsilyl derivatives##4##2##(1990-8#1)(2008-10#3)
trimethylsilyl##7##1##(1990-8#1)(1996-5#1)(2008-10#5)
trimetoquinol hydrochloride##2##2##(1990-8#2)
trimetoquinol##3##1##(1990-8#3)
trimipramine##5##1##(1995-2#5)
trimmed##5##1##(1993-11#1)(2007-8#1)(2008-10#2)(2008-8#1)
trimming##5##1##(1995-2#1)(2007-12#1)(2008-2#2)(2008-9#1)
trimodal##2##1##(1990-5#1)(2013-8#1)
trims##2##1##(1992-8#1)(2012-2#1)
trinitrate##8##1##(1995-11#1)(2007-10#2)(2007-8#2)(2008-8#2)(2009-5#1)
trinitrotoluene by##2##2##(2008-10#1)(2008-12#1)
trinitrotoluene##5##1##(2008-10#4)(2008-12#1)
trinuclear complex##2##2##(1997-7#2)
trinuclear units##2##2##(1997-7#2)
trinuclear##7##1##(1997-7#4)(2008-10#3)
trinucleotide repeat##3##2##(1994-12#1)(2008-7#2)
trinucleotide repeats##6##2##(1994-11#3)(1994-12#1)(1997-5#1)(2010-7#1)
trinucleotide##11##1##(1991-9#1)(1994-11#3)(1994-12#2)(1997-5#1)(2008-11#1)(2008-7#2)(2010-7#1)
trio##2##1##(2008-12#1)(2008-7#1)
trioctylamine##2##1##(2008-10#1)(2009-11#1)
trioctylphosphine oxide##3##2##(2008-10#3)
triode and diode##2##3##(2008-2#2)
triode##3##1##(2008-2#3)
triolein and##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
triolein##4##1##(1992-3#1)(1994-3#1)(2008-10#1)(2008-7#1)
triose##2##1##(1993-8#1)(2008-6#1)
triosephosphates##3##1##(2008-1#3)
trioxide##14##1##(1994-11#2)(2008-10#1)(2008-8#2)(2010-8#1)(2011-2#3)(2012-12#2)(2013-1#3)
trip by##2##2##(2008-2#1)(2008-3#1)
trip##7##1##(2007-11#2)(2007-5#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)
tripalmitat##2##1##(2013-1#2)
tripartite leader##2##2##(1997-3#1)(1997-8#1)
tripartite regulation of##2##3##(1996-12#1)(1997-2#1)
tripartite synapse##2##2##(2009-8#1)(2013-1#1)
tripartite##13##1##(1991-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-8#1)(2013-1#1)
tripeptide amide##2##2##(1992-3#1)(2013-7#1)
tripeptide##28##1##(1990-12#1)(1990-2#4)(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#2)(1993-9#2)(2008-10#1)(2008-4#1)(2008-5#3)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-7#1)
tripeptides##6##1##(1990-8#1)(1994-5#4)(1995-6#1)
tripeptidyl##2##1##(1993-5#1)(1995-6#1)
triphasic##3##1##(1990-9#1)(1992-12#1)(2008-5#1)
triphosphatase##4##1##(1994-8#1)(2008-9#1)(2013-1#2)
triphosphate (GTP)##2##2##(1991-9#1)(1992-6#1)
triphosphate diphosphohydrolases##4##2##(2008-4#4)
triphosphate in##2##2##(1990-12#1)(1997-8#1)
triphosphate to##2##2##(1995-11#1)(2008-9#1)
triphosphate was##2##2##(1995-2#2)
triphosphate##57##1##(1990-12#2)(1991-9#3)(1992-6#2)(1992-8#1)(1993-11#1)(1995-11#2)(1995-12#1)(1995-2#11)(1995-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#10)(2008-7#2)(2008-9#2)(2009-12#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#3)(2013-1#1)
triphosphates and##3##2##(2008-4#2)(2008-7#1)
triphosphates##17##1##(1993-8#1)(1996-5#4)(1997-7#1)(2008-2#2)(2008-4#6)(2008-7#1)(2008-9#1)(2010-8#1)
triple antibiotic##2##2##(2011-1#1)(2013-1#1)
triple combination therapy##5##3##(2008-5#1)(2013-1#4)
triple combination##9##2##(2008-5#4)(2011-2#1)(2013-1#4)
triple combinations##2##2##(2008-3#1)(2008-5#1)
triple helix formation##4##3##(1992-12#1)(1995-5#3)
triple helix in##2##3##(1997-4#1)(2013-1#1)
triple helix##18##2##(1992-12#1)(1995-5#6)(1997-4#1)(2009-7#2)(2013-1#8)
triple quadrupole MS##2##3##(2008-10#1)(2013-8#1)
triple quadrupole##3##2##(2008-10#2)(2013-8#1)
triple test##4##2##(1990-10#2)(1996-12#1)(2012-3#1)
triple therapy##3##2##(2007-7#1)(2008-1#2)
triple vessel coronary artery disease##2##5##(2007-9#2)
triple##94##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#7)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#10)(2008-3#2)(2008-5#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-7#3)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#19)(2013-8#1)
triple&quot##2##1##(2011-2#2)
triple-antibody sandwich##3##2##(2008-10#3)
triple-antibody##4##1##(2008-10#4)
triple-decker##2##1##(2008-12#2)
triple-resonance ionization spectroscopy##2##3##(2008-3#2)
triple-resonance##6##1##(2008-3#2)(2009-7#4)
triple-stage##2##1##(2008-10#2)
tripled##6##1##(1990-11#1)(1992-4#1)(2007-11#2)(2008-8#1)(2010-12#1)
triplet state of##2##3##(1997-7#1)(2008-8#1)
triplet state##3##2##(1997-7#1)(2007-11#1)(2008-8#1)
triplet states##2##2##(1992-8#1)(2012-2#1)
triplet##31##1##(1990-10#1)(1992-8#2)(1993-11#1)(1993-3#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#2)(2010-4#2)(2012-2#1)
triplet-state properties##2##2##(1993-11#2)
triplet-triplet##2##1##(1992-8#1)(2010-4#1)
triplets##9##1##(1993-9#1)(1995-5#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-12#2)(2008-6#1)(2012-3#1)
triplex DNA##2##2##(1995-5#1)(2008-8#1)
triplex formation##16##2##(1992-12#1)(1993-8#8)(1995-5#6)(2008-9#1)
triplex##29##1##(1992-12#2)(1993-8#9)(1993-9#1)(1995-5#11)(2008-4#2)(2008-8#1)(2008-9#3)
triplexes have##2##2##(2008-8#2)
triplexes##8##1##(1993-8#1)(1995-5#2)(2008-4#1)(2008-8#4)
triplicate measurements##3##2##(2008-10#3)
triplicate##11##1##(1994-11#1)(1995-2#1)(2008-10#6)(2008-12#1)(2010-11#1)(2013-7#1)
triplicated##3##1##(1996-3#1)(2008-7#2)
triplication of##2##2##(1997-2#1)(2012-3#1)
tripling the##2##2##(2008-2#1)(2012-3#1)
tripling##9##1##(2007-12#2)(2008-2#1)(2008-3#3)(2011-2#2)(2012-3#1)
triploid crucian carp##4##3##(2010-5#4)
triploid ginbuna##2##2##(2008-5#2)
triploid##12##1##(2008-5#4)(2009-12#2)(2010-3#2)(2010-5#4)
triploid-tetraploid mosaics##2##2##(2010-3#2)
triploids of L##2##3##(2008-5#2)
triploids##5##1##(2008-5#3)(2010-3#2)
triploidy##2##1##(1995-8#1)(1996-12#1)
triply resonant##2##2##(2007-11#1)(2007-12#1)
triply##4##1##(1990-8#1)(2007-11#1)(2007-12#1)(2008-8#1)
tripod##4##1##(1994-12#2)(2008-10#2)
tripodal compound##2##2##(2008-10#2)
tripodal##4##1##(1997-7#1)(2008-10#3)
tripolyphosphate##4##1##(1994-3#1)(1997-4#1)(2008-10#2)
tripropylamine##5##1##(2008-10#4)(2010-7#1)
trips##9##1##(1996-1#1)(2008-12#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#3)(2013-7#1)
triptan##4##1##(2008-9#4)
triptolide##2##1##(2008-11#1)(2013-8#1)
tris (2##2##2##(2008-10#2)
tris##4##1##(2008-10#4)
tris(2##21##1##(1996-2#2)(2008-10#19)
tris(2-ethylhexyl) phosphate##3##2##(2008-10#3)
tris(2-ethylhexyl)phosphate (TEHP)##3##2##(2008-10#3)
tris(3##4##1##(1997-7#1)(2008-10#3)
tris(trimethylsilyl)silanes##2##1##(2009-5#2)
tris- and##2##2##(1990-7#1)(1994-9#1)
tris-(2##3##1##(2008-10#3)
tris-(3##4##1##(2008-10#4)
trisaccharide##3##1##(1994-5#3)
trisaccharides##3##1##(1992-12#2)(1994-5#1)
triseriatus##4##1##(2008-12#4)
trisodium##2##1##(2007-3#1)(2008-10#1)
trisomic mice##2##2##(2012-2#2)
trisomic##4##1##(1997-2#1)(2009-12#1)(2012-2#2)
trisomics were##2##2##(2009-12#2)
trisomics##6##1##(2009-12#6)
trisomies were##2##2##(1997-4#1)(2010-1#1)
trisomies##5##1##(1996-12#1)(1997-4#1)(2008-7#2)(2010-1#1)
trisomy 13##3##2##(1995-8#2)(1996-12#1)
trisomy 18##4##2##(1995-8#2)(1997-4#1)(2012-3#1)
trisomy 21##9##2##(1991-12#1)(1995-8#1)(1996-2#1)(1997-4#3)(2008-7#1)(2009-10#1)(2012-3#1)
trisomy of mouse chromosome 17##2##5##(2008-7#2)
trisomy of##3##2##(2008-7#2)(2010-1#1)
trisomy##26##1##(1991-12#1)(1995-8#5)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#4)(1997-5#1)(2008-7#4)(2009-10#1)(2010-1#1)(2012-3#5)
trisphosphate##19##1##(1990-8#5)(1991-12#4)(1992-12#1)(1993-3#3)(1993-6#3)(1994-11#1)(1994-9#1)(1995-2#1)
trisphosphates##3##1##(1991-8#1)(1997-1#2)
tristable##2##1##(2010-12#2)
tristeza virus (CTV) and##2##4##(2008-10#2)
tristeza virus (CTV) isolates T3##2##5##(2008-10#2)
tristeza virus (CTV)##11##3##(2008-10#10)(2008-5#1)
tristeza virus##22##2##(2008-10#20)(2008-5#2)
tristeza##23##1##(2008-10#21)(2008-5#2)
tristimulus colorimetry##5##2##(2008-10#4)(2008-5#1)
trisubstituted##2##1##(2007-11#1)(2008-4#1)
triterpene components##2##2##(2011-3#2)
triterpene##4##1##(2008-11#1)(2011-3#2)(2012-2#1)
triterpenes##5##1##(2008-11#5)
triterpenic derivatives##3##2##(2008-5#3)
triterpenic##4##1##(2008-5#4)
triterpenoid glycosides##2##2##(2010-6#2)
triterpenoid saponins##3##2##(2013-1#3)
triterpenoid##8##1##(2008-8#1)(2010-2#1)(2010-6#2)(2012-2#1)(2013-1#3)
triterpenoids##4##1##(2012-2#3)(2012-3#1)
trithorax##4##1##(1995-11#1)(1997-7#3)
tritiated thymidine##2##2##(2008-4#1)(2008-9#1)
tritiated water##3##2##(2008-11#3)
tritiated##15##1##(1991-12#1)(1991-9#1)(1992-8#1)(1993-5#1)(1993-8#2)(1994-5#1)(1996-2#1)(1996-5#1)(2008-11#3)(2008-4#1)(2008-9#2)
triticale##3##1##(2008-10#2)(2013-1#1)
tritici and P##4##3##(2008-10#4)
tritici and##6##2##(2008-10#6)
tritici attack##2##2##(2008-10#2)
tritici blotch of wheat##2##4##(2008-10#2)
tritici blotch of##3##3##(2008-10#3)
tritici blotch##11##2##(2008-10#11)
tritici on winter wheat##2##4##(2008-10#2)
tritici races##4##2##(2008-10#4)
tritici was##2##2##(2008-10#2)
tritici##71##1##(2008-10#71)
tritici)##7##1##(2008-10#7)
tritici-repentis in##3##2##(2008-10#3)
tritici-repentis isolates##2##2##(2008-10#2)
tritici-repentis race##3##2##(2008-10#3)
tritici-repentis were##2##2##(2008-10#2)
tritici-repentis##46##1##(2008-10#46)
triticina from Ethiopia##2##3##(2008-10#2)
triticina from durum wheat from South America##2##7##(2008-10#2)
triticina from durum wheat from##3##5##(2008-10#3)
triticina from durum wheat##4##4##(2008-10#4)
triticina from##10##2##(2008-10#10)
triticina isolates from##2##3##(2008-10#2)
triticina isolates##3##2##(2008-10#3)
triticina on##3##2##(2008-10#3)
triticina##48##1##(2008-10#48)
triticirepentis##2##1##(2008-10#2)
tritimovirus##3##1##(2008-10#3)
tritium##7##1##(1991-5#3)(1993-8#1)(1994-5#2)(2008-11#1)
tritocerebral commissure##3##2##(2007-12#3)
tritocerebral##6##1##(2007-12#6)
tritocerebrum##3##1##(2007-12#2)(2008-9#1)
triton X-100##3##2##(1991-5#1)(1994-6#1)(2008-10#1)
tritrophic food##3##2##(2008-9#3)
tritrophic##5##1##(2008-9#4)(2009-8#1)
trityl##3##1##(1992-12#2)(2010-4#1)
triumvirate of##2##2##(1994-2#1)(2011-2#1)
trivalent and##2##2##(2008-10#1)(2008-12#1)
trivalent arsenic##3##2##(2008-10#3)
trivalent cations##6##2##(2008-10#6)
trivalent form##2##2##(2008-10#1)(2008-12#1)
trivalent lanthanides##2##2##(2008-10#2)
trivalent metal ions##3##3##(1993-6#1)(2008-10#2)
trivalent metal##5##2##(1990-2#1)(1993-6#1)(2008-10#3)
trivalent state##5##2##(2008-10#5)
trivalent##51##1##(1990-2#1)(1993-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-11#1)(2007-2#1)(2008-10#35)(2008-12#2)(2008-9#2)(2011-2#3)
trivial##10##1##(1994-1#1)(1994-2#1)(1995-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
trizma-chloranilate##2##1##(2008-10#2)
trk receptors##3##2##(1996-12#3)
trk##5##1##(1996-12#5)
trkA##6##1##(1996-12#4)(1997-2#2)
trkA-##2##1##(1995-8#2)
trkB##11##1##(1996-12#11)
trkB-##2##1##(1995-8#2)
trkC##3##1##(1996-12#3)
trkC-like proteins IR##2##3##(1995-8#2)
trkC-like proteins##3##2##(1995-8#3)
trkC-like##4##1##(1995-8#4)
trks##2##1##(1996-12#2)
trnL intron##2##2##(2008-12#2)
trocar and sleeve is inserted##2##5##(1991-12#2)
trocar##8##1##(1990-8#1)(1991-12#2)(1995-3#1)(2007-7#1)(2008-12#1)(2009-3#2)
trochanter of the##2##3##(2007-12#2)
trochanter##5##1##(2007-11#1)(2007-12#2)(2008-5#1)(2008-9#1)
trochanteric fractures##2##2##(2007-8#1)(2013-1#1)
trochanteric##3##1##(2007-11#1)(2007-8#1)(2013-1#1)
trochlear nerve##2##2##(2011-2#2)
troglitazone##4##1##(2008-3#1)(2008-5#1)(2010-11#2)
trolox equivalent antioxidant capacity##2##4##(2008-5#1)(2012-2#1)
trolox##7##1##(2008-10#4)(2008-5#2)(2012-2#1)
tropane-2 beta-carboxylic acid methyl ester##2##5##(1991-12#2)
tropeolin##2##1##(2008-10#2)
tropes##2##1##(2009-10#2)
tropharium##3##1##(2007-12#2)(2008-12#1)
trophectoderm determinant genes##2##3##(2012-12#2)
trophectoderm fate##2##2##(2012-12#2)
trophectoderm##9##1##(1991-12#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#4)
trophectodermal cell##3##2##(2012-12#3)
trophectodermal##4##1##(1991-12#1)(2012-12#3)
trophic action##2##2##(1992-6#1)(1993-3#1)
trophic cascades in terrestrial##2##4##(2008-8#2)
trophic cascades##6##2##(2008-8#6)
trophic complexity##2##2##(2008-8#2)
trophic conditions##3##2##(1991-12#2)(1996-5#1)
trophic effect on##3##3##(1993-5#1)(1993-6#2)
trophic effect##4##2##(1993-5#1)(1993-6#2)(1997-1#1)
trophic effects##2##2##(1997-6#1)(2008-8#1)
trophic factor##3##2##(1996-12#1)(1997-6#1)(2008-1#1)
trophic factors##5##2##(1996-2#1)(2008-1#2)(2008-8#1)(2012-1#1)
trophic groups##2##2##(2008-5#1)(2008-9#1)
trophic guilds##3##2##(2010-8#3)
trophic level##8##2##(2008-5#1)(2008-8#3)(2008-9#4)
trophic levels and##3##3##(2008-5#1)(2008-8#1)(2009-2#1)
trophic levels##17##2##(2008-5#1)(2008-8#6)(2008-9#8)(2009-2#1)(2013-1#1)
trophic spectrum##2##2##(2008-5#2)
trophic structure##2##2##(2008-9#2)
trophic transition networks##2##3##(2010-6#2)
trophic transition##3##2##(2010-6#3)
trophic##92##1##(1990-3#1)(1991-12#3)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#2)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#19)(2008-9#17)(2009-2#1)(2009-8#1)(2010-6#3)(2010-8#7)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
trophic-level##2##1##(2008-8#1)(2009-2#1)
trophoblast and##2##2##(1994-9#1)(2012-1#1)
trophoblast cells##3##2##(1995-11#1)(2011-2#1)(2013-1#1)
trophoblast invasion##5##2##(1994-9#5)
trophoblast##15##1##(1994-9#7)(1995-11#1)(1995-8#1)(1996-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
trophoblastic disease##3##2##(1994-3#2)(1994-5#1)
trophoblastic##6##1##(1994-3#2)(1994-5#1)(1995-8#2)(2008-9#1)
trophoblasts##8##1##(1992-3#1)(1992-8#2)(1994-9#2)(1996-12#3)
trophocytes##2##1##(2007-12#2)
trophozoites of B##2##3##(2007-12#1)(2013-1#1)
trophozoites##3##1##(2007-12#1)(2011-2#1)(2013-1#1)
tropic##4##1##(1992-6#1)(2008-10#1)(2008-9#1)(2009-8#1)
tropica in a##2##3##(2012-2#2)
tropica##3##1##(2012-2#3)
tropical America##2##2##(2008-10#1)(2008-5#1)
tropical Eastern##2##2##(2013-7#2)
tropical and sub-tropical regions##3##4##(1991-11#1)(1994-9#1)(2011-2#1)
tropical and sub-tropical##4##3##(1991-11#1)(1994-9#1)(2011-2#1)(2013-7#1)
tropical and subtropical areas##2##4##(2008-10#2)
tropical and subtropical##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)
tropical and##14##2##(1991-11#1)(1994-9#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-7#1)
tropical areas##3##2##(1996-11#1)(2008-5#1)(2013-7#1)
tropical countries##3##2##(1995-9#1)(2010-4#2)
tropical disease##2##2##(2006-5#1)(2013-8#1)
tropical diseases in##3##3##(2007-2#1)(2011-2#2)
tropical diseases##8##2##(2007-2#1)(2008-8#1)(2011-2#3)(2012-2#3)
tropical dry forest##4##3##(2008-5#2)(2013-7#2)
tropical dry##6##2##(2008-5#2)(2013-7#4)
tropical environment##6##2##(1995-6#1)(1996-12#2)(2008-10#2)(2008-5#1)
tropical environments##2##2##(1996-12#1)(2008-10#1)
tropical fish##2##2##(2008-10#1)(2008-5#1)
tropical forest##4##2##(2008-5#2)(2011-2#1)(2013-7#1)
tropical forests##7##2##(1991-12#1)(1992-5#1)(2008-10#1)(2008-5#1)(2013-7#3)
tropical isolates grouped together##2##4##(2008-10#2)
tropical isolates than##2##3##(2008-10#2)
tropical isolates##14##2##(2008-10#14)
tropical maize##2##2##(2008-10#1)(2012-3#1)
tropical medicine and##2##3##(2010-1#2)
tropical medicine##7##2##(1995-9#3)(2010-1#4)
tropical rain##2##2##(2008-8#1)(2008-9#1)
tropical rainforest##2##2##(1992-8#1)(2013-7#1)
tropical regions##4##2##(1996-12#2)(2008-5#1)(2012-12#1)
tropical river humic substances##3##4##(2008-10#3)
tropical rural populations##2##3##(1996-11#2)
tropical skin##2##2##(2007-12#1)(2011-2#1)
tropical understory plants##2##3##(2008-8#2)
tropical upwelling ecosystem in##2##4##(2008-5#2)
tropical##170##1##(1990-8#1)(1991-11#2)(1991-12#1)(1992-11#2)(1992-5#1)(1992-7#2)(1992-8#1)(1994-9#1)(1995-6#1)(1995-9#4)(1996-11#5)(1996-12#5)(1996-2#2)(2006-5#1)(2007-12#1)(2007-2#4)(2007-5#3)(2008-1#1)(2008-10#48)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#19)(2008-8#10)(2008-9#4)(2009-8#2)(2010-1#4)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#18)(2013-8#1)
tropicalis and##2##2##(2008-5#2)
tropicalis##17##1##(1990-5#2)(1991-9#4)(1995-3#1)(2008-10#2)(2008-5#5)(2010-5#1)(2012-3#2)
tropicamide eye drop test##2##4##(2008-7#2)
tropicamide##7##1##(2008-7#7)
tropics##22##1##(1995-12#2)(1996-12#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-9#1)(2010-6#1)(2010-7#3)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
tropisetron##2##1##(1994-12#1)(2008-7#1)
tropism and##2##2##(2008-5#1)(2013-1#1)
tropism for##2##2##(1992-9#1)(2008-9#1)
tropism##10##1##(1991-9#1)(1992-9#1)(1995-2#1)(2007-10#1)(2008-5#2)(2008-9#1)(2012-12#1)(2013-1#2)
tropisms##6##1##(2008-10#1)(2008-5#2)(2009-8#2)(2011-1#1)
tropocollagen molecule##2##2##(2009-7#2)
tropocollagen molecules##2##2##(2009-7#2)
tropocollagen##4##1##(2009-7#4)
tropomyosin##7##1##(1992-9#4)(1994-5#1)(1996-8#1)(2010-12#1)
troponin C (TnC)##2##3##(1995-5#1)(1995-6#1)
troponin C##5##2##(1991-12#2)(1995-5#2)(1995-6#1)
troponin I (TnI)##3##3##(2007-8#1)(2008-7#1)(2010-12#1)
troponin I##21##2##(1995-5#2)(2007-8#1)(2008-10#8)(2008-7#3)(2010-12#3)(2010-6#1)(2011-2#2)(2013-1#1)
troponin T and##2##3##(1991-12#1)(2008-3#1)
troponin T##11##2##(1991-12#2)(1996-8#1)(2007-8#1)(2008-3#1)(2008-7#3)(2009-6#2)(2011-2#1)
troponin components##2##2##(1991-12#2)
troponin##54##1##(1991-12#7)(1995-5#4)(1995-6#5)(1996-8#1)(1997-7#3)(2007-8#2)(2008-10#9)(2008-3#1)(2008-6#1)(2008-7#6)(2009-6#2)(2010-12#3)(2010-6#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-7#2)
troponins##2##1##(1991-12#1)(2011-2#1)
tropopause##3##1##(2008-3#3)
troposphere and lower stratosphere##4##4##(2008-2#1)(2008-3#3)
troposphere and##6##2##(2008-2#2)(2008-3#4)
troposphere or##2##2##(1992-3#1)(2008-3#1)
troposphere##23##1##(1992-3#1)(2007-11#1)(2008-2#12)(2008-3#8)(2008-5#1)
tropospheric aerosols##5##2##(2008-2#2)(2008-3#3)
tropospheric and stratospheric##3##3##(2008-11#1)(2008-3#2)
tropospheric and total ozone##2##4##(2008-2#2)
tropospheric and##5##2##(2008-11#1)(2008-2#2)(2008-3#2)
tropospheric ozone measurements##3##3##(2008-2#2)(2008-3#1)
tropospheric ozone##11##2##(1992-3#1)(2008-2#6)(2008-3#4)
tropospheric photolysis##2##2##(2008-3#2)
tropospheric water-vapor mixing##2##3##(2008-3#2)
tropospheric water-vapor##4##2##(2008-2#2)(2008-3#2)
tropospheric##42##1##(1992-3#1)(2008-11#2)(2008-2#14)(2008-3#24)(2012-2#1)
trospium chloride was##2##3##(2008-3#2)
trospium chloride##4##2##(2008-3#4)
trouble in##2##2##(1990-3#1)(2008-10#1)
trouble##15##1##(1990-3#1)(1993-2#1)(1994-9#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#2)
trouble-shooting##2##1##(2008-6#1)(2008-9#1)
troubled children##2##2##(2007-9#1)(2008-11#1)
troubled times##2##2##(2008-7#1)(2008-8#1)
troubled##8##1##(1990-8#1)(1993-5#1)(1995-1#1)(1996-3#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)
troubles de##2##2##(2008-11#1)(2013-1#1)
troubles over##2##2##(2008-11#1)(2011-1#1)
troubles##5##1##(2008-11#2)(2011-1#2)(2013-1#1)
troubleshoot##2##1##(1994-2#1)(2008-11#1)
troubleshooting##5##1##(2008-4#3)(2008-9#1)(2011-2#1)
troublesome belching##7##2##(2013-8#7)
troublesome##17##1##(1994-3#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-7#1)(2010-6#1)(2013-8#8)
trough the##2##2##(2008-9#1)(2012-2#1)
trough##11##1##(1992-8#3)(1993-12#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#2)
troughs##3##1##(2008-10#2)(2010-10#1)
trout (Oncorhynchus mykiss)##6##3##(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)
trout Onchorhynchus##2##2##(2010-8#2)
trout Oncorhynchus##3##2##(2010-8#3)
trout fisheries##2##2##(2009-5#2)
trout liver##3##2##(1990-12#2)(1992-6#1)
trout##43##1##(1990-12#2)(1990-5#1)(1992-6#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-5#3)(1997-9#4)(2008-11#3)(2008-5#5)(2008-6#2)(2008-7#3)(2009-5#6)(2009-6#2)(2010-8#6)
troutCYP1A-CAT construct##2##2##(2008-11#2)
troutCYP1A-CAT##5##1##(2008-11#5)
trouve##2##1##(2013-1#2)
trp operator##4##2##(1992-6#2)(1994-3#2)
trp##19##1##(1990-7#2)(1992-6#5)(1992-8#4)(1993-12#1)(1994-3#3)(1994-6#2)(1996-12#1)(2008-10#1)
trpC promoter##2##2##(2008-10#2)
trpC##3##1##(2008-10#2)(2011-1#1)
truck##2##1##(2007-8#1)(2011-2#1)
truckloads exceeding 20 ng/g##2##4##(2008-10#2)
truckloads##3##1##(2008-10#3)
true absorption and endogenous fecal excretion of##3##7##(2010-2#3)
true absorption of Zn##2##4##(2010-2#2)
true absorption##5##2##(2010-2#5)
true airspeed sensor##2##3##(2007-11#2)
true and##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
true aneurysms##2##2##(2010-8#1)(2011-2#1)
true at##2##2##(2008-10#1)(2008-7#1)
true breathing-zone sampling##3##3##(2010-5#3)
true causal##2##2##(2012-3#2)
true cut biopsy##2##3##(2011-2#2)
true difference##2##2##(1992-2#1)(1995-5#1)
true even##2##2##(1995-5#1)(2012-2#1)
true exposures##2##2##(2008-7#2)
true for patients with##2##4##(1997-8#1)(2010-12#1)
true for the##6##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
true for##24##2##(1990-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#2)
true fungi##2##2##(2008-10#2)
true health care##2##3##(1997-1#1)(2009-12#1)
true image##2##2##(2008-2#1)(2008-3#1)
true in the##4##3##(1992-1#1)(1994-12#1)(2010-10#1)(2013-1#1)
true in##13##2##(1992-1#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
true incidence and prevalence of##2##5##(2010-6#1)(2011-1#1)
true incidence of##3##3##(2007-2#1)(2008-8#1)(2011-2#1)
true incidence##7##2##(1994-9#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
true leaf##3##2##(2008-9#3)
true leaves##6##2##(2008-10#6)
true lumen##7##2##(2007-8#3)(2008-11#4)
true of##3##2##(1992-10#1)(2008-9#1)(2013-7#1)
true only##2##2##(2006-4#1)(2009-8#1)
true phase##3##2##(2008-2#2)(2008-3#1)
true positive##4##2##(1990-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
true positives##3##2##(2008-10#1)(2008-12#1)(2009-3#1)
true prevalence of##2##3##(2008-12#1)(2012-3#1)
true profiles##2##2##(2008-2#2)
true refusers##2##2##(1991-6#2)
true scene##2##2##(2008-3#2)
true that##2##2##(2007-11#1)(2008-10#1)
true value of##2##3##(2008-10#1)(2008-9#1)
true value##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
true when the##2##3##(2008-10#1)(2011-3#1)
true##327##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#5)(1991-5#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#3)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-8#4)(2006-4#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#44)(2008-11#10)(2008-12#5)(2008-2#10)(2008-3#25)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#15)(2008-8#10)(2008-9#11)(2009-11#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-12#2)(2012-2#10)(2012-3#10)(2012-7#1)(2013-1#8)(2013-7#3)
true&quot##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
true-time delay##2##2##(2007-12#1)(2008-2#1)
true-time delays that##2##3##(2007-11#1)(2007-12#1)
true-time delays##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
true-time##7##1##(2007-11#1)(2007-12#3)(2008-2#3)
true-time-delay (TTD)##2##2##(2008-3#2)
true-time-delay##7##1##(2007-11#1)(2008-2#1)(2008-3#5)
trueness##2##1##(2008-10#2)
truly##35##1##(1991-3#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
truncal obesity##2##2##(2009-4#1)(2011-2#1)
truncal##4##1##(1990-6#1)(2007-11#1)(2009-4#1)(2011-2#1)
truncate##2##1##(2008-3#1)(2008-5#1)
truncated Poisson##2##2##(1997-8#2)
truncated alpha##2##2##(1994-8#1)(1995-6#1)
truncated and##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
truncated derivatives##2##2##(1994-5#2)
truncated forms of##3##3##(1994-11#1)(1995-6#1)(1997-4#1)
truncated forms##4##2##(1994-11#1)(1995-6#1)(1997-4#1)(2008-4#1)
truncated mutant##3##2##(2008-9#3)
truncated mutants##2##2##(1992-9#1)(2008-9#1)
truncated peptides##3##2##(1995-2#2)(1997-4#1)
truncated product##2##2##(1997-8#1)(2008-1#1)
truncated protein##2##2##(1990-7#1)(1993-9#1)
truncated singular-value decomposition##2##3##(2008-3#2)
truncated the##2##2##(1997-3#1)(2008-2#1)
truncated##77##1##(1990-7#2)(1991-10#1)(1991-12#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-2#7)(1995-6#2)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#5)(2008-9#5)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
truncating the##2##2##(2008-10#1)(2008-3#1)
truncation of the##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
truncation of##6##2##(1995-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
truncation##16##1##(1990-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)
truncations##2##1##(1994-1#1)(2009-6#1)
truncatula##16##1##(2008-10#11)(2008-7#1)(2009-10#1)(2009-8#2)(2011-2#1)
truncatum##3##1##(2008-10#3)
trunk and breast##2##3##(1994-6#2)
trunk and extremities##3##3##(2007-7#1)(2010-6#1)(2013-8#1)
trunk and limbs##2##3##(2007-7#1)(2008-5#1)
trunk and##12##2##(1994-6#2)(1996-3#1)(2007-7#3)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#2)(2013-8#1)
trunk in the##2##3##(2007-12#1)(2008-10#1)
trunk in##5##2##(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)
trunk muscle activity##2##3##(2012-12#2)
trunk of the subdiaphragmatic vagus were##2##6##(1993-12#2)
trunk of the##7##3##(1993-12#2)(1997-3#1)(2006-12#1)(2008-12#2)(2008-7#1)
trunk of##10##2##(1993-12#2)(1997-3#1)(2006-12#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)
trunk on the##2##3##(1996-3#1)(2007-8#1)
trunk rotation##2##2##(1995-8#1)(2008-12#1)
trunk strength and stability on##2##5##(2008-12#2)
trunk strength and stability##3##4##(2008-12#3)
trunk##78##1##(1991-12#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-6#2)(1995-8#6)(1996-3#2)(1997-3#4)(1997-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#5)(2008-10#5)(2008-12#6)(2008-5#3)(2008-6#8)(2008-7#5)(2008-9#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
trunks and##4##2##(1996-2#1)(2008-10#2)(2013-7#1)
trunks of##2##2##(2007-12#1)(2008-10#1)
trunks##8##1##(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2013-7#1)
trust and##5##2##(1995-12#1)(2008-1#2)(2012-12#1)(2013-8#1)
trust between##2##2##(1994-12#1)(1996-1#1)
trust in doctors##2##3##(2011-1#1)(2012-3#1)
trust in##10##2##(2007-11#1)(2008-12#1)(2008-3#1)(2009-6#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
trust##57##1##(1991-1#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-1#3)(1997-3#2)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#4)(2009-6#2)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#6)
trusted##7##1##(1992-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
trustee##5##1##(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-12#1)
trustees and CEOs##2##3##(1995-3#2)
trustees##13##1##(1993-2#4)(1993-3#2)(1994-2#3)(1995-3#3)(2012-2#1)
trusteeship##2##1##(1993-2#2)
trusting##3##1##(1994-12#1)(2008-12#1)(2012-3#1)
trusts##5##1##(1997-5#1)(2008-11#2)(2009-7#1)(2013-8#1)
trustworthiness##2##1##(1994-2#1)(2009-11#1)
trustworthy##6##1##(1992-3#1)(2008-10#2)(2008-7#1)(2010-10#1)(2012-3#1)
truth about##4##2##(1995-1#1)(2008-11#1)(2008-6#1)(2008-8#1)
truth telling in##2##3##(2013-1#2)
truth##13##1##(1992-6#1)(1994-2#1)(1995-1#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
truths about##2##2##(1991-1#1)(2011-2#1)
try to address##2##3##(2008-11#1)(2011-2#1)
try to explain the##2##4##(2008-10#1)(2009-11#1)
try to explain##3##3##(2008-10#1)(2009-11#2)
try to give##2##3##(2009-10#1)(2010-5#1)
try to understand how the##2##5##(1992-3#1)(2009-10#1)
try to understand how##3##4##(1992-3#1)(2009-10#1)(2009-7#1)
try to##37##2##(1991-12#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#3)(2009-11#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
try##46##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2009-10#3)(2009-11#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
trying to develop##2##3##(1994-3#1)(2008-12#1)
trying to meet##2##3##(2007-10#1)(2008-3#1)
trying to prevent##2##3##(2009-12#1)(2010-9#1)
trying to understand##2##3##(1995-1#1)(2009-10#1)
trying to##39##2##(1990-4#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#4)
trying##43##1##(1990-4#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#4)
trypan blue dye exclusion assay##2##5##(2008-11#2)
trypan blue dye exclusion##3##4##(1992-9#1)(2008-11#2)
trypan blue exclusion##5##3##(2008-1#1)(2008-11#2)(2008-9#1)(2013-1#1)
trypan blue test and##2##4##(2007-11#1)(2013-1#1)
trypan blue##16##2##(1992-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-9#1)(2010-7#1)(2013-1#2)
trypan##17##1##(1992-9#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-9#1)(2010-7#1)(2013-1#2)
trypanosomatid parasites of plants##3##4##(2008-10#3)
trypanosomatid parasites##4##2##(2008-10#4)
trypanosomatid##6##1##(1995-11#2)(2008-10#4)
trypanosome cells##2##2##(1993-9#2)
trypanosome##4##1##(1993-9#3)(1997-4#1)
trypanosomes##4##1##(2010-2#2)(2013-1#2)
trypanosomiasis##4##1##(2012-2#1)(2013-1#3)
trypanosomosis##2##1##(1997-7#2)
trypsin S214K##2##2##(1992-3#2)
trypsin and chymotrypsin##4##3##(1990-5#1)(1991-9#2)(1992-9#1)
trypsin and the##2##3##(1996-12#1)(2008-4#1)
trypsin and##11##2##(1990-11#1)(1990-5#2)(1991-9#2)(1992-9#1)(1993-3#1)(1994-11#1)(1996-12#1)(1997-2#1)(2008-4#1)
trypsin by##2##2##(1990-12#1)(2008-7#1)
trypsin cleaved##3##2##(1993-11#3)
trypsin digestion##5##2##(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)(2008-9#1)
trypsin inhibitor and##2##3##(1990-3#1)(1992-8#1)
trypsin inhibitor##19##2##(1990-12#3)(1990-3#1)(1990-5#2)(1990-8#1)(1991-11#1)(1992-8#1)(1994-3#2)(1994-6#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-7#1)
trypsin is##3##2##(1990-12#1)(1992-3#1)(2008-9#1)
trypsin or##2##2##(1995-6#1)(2008-10#1)
trypsin treatment##8##2##(1990-5#2)(1991-11#1)(1992-3#1)(1993-3#1)(1996-5#2)(2008-7#1)
trypsin was used to##2##4##(1990-2#1)(1990-8#1)
trypsin was##4##2##(1990-2#1)(1990-8#1)(2008-7#2)
trypsin##121##1##(1990-11#1)(1990-12#10)(1990-2#4)(1990-3#1)(1990-5#11)(1990-7#2)(1990-8#5)(1991-11#2)(1991-12#1)(1991-5#3)(1991-9#2)(1992-3#9)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-3#3)(1993-8#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#5)(1997-1#1)(1997-2#5)(1997-4#1)(2008-10#11)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#3)(2010-2#1)
trypsin)##3##1##(2008-10#3)
trypsin-like serine##3##2##(1995-5#1)(1995-6#2)
trypsin-like##6##1##(1995-5#1)(1995-6#2)(2008-5#3)
trypsin-resistant##2##1##(1990-7#1)(1993-8#1)
trypsin-treated##2##1##(1992-6#1)(1993-11#1)
trypsinization of##2##2##(1990-2#1)(2008-11#1)
trypsinization##4##1##(1990-2#1)(1992-9#1)(2008-11#2)
trypsinized##2##1##(2008-11#1)(2008-4#1)
trypsinogen##2##1##(1990-8#2)
trypsins##3##1##(1990-12#2)(1992-3#1)
tryptase##4##1##(1993-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
tryptic digest of##4##3##(1990-8#1)(1997-2#1)(2008-8#1)(2013-1#1)
tryptic digestion##5##2##(1991-12#1)(1993-6#1)(1993-8#2)(1994-8#1)
tryptic fragments##2##2##(1993-8#1)(2008-10#1)
tryptic peptide##3##2##(1990-11#1)(1993-6#1)(2008-10#1)
tryptic peptides##8##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-2#1)(2008-7#1)
tryptic phosphopeptide##4##2##(1990-11#1)(1992-10#1)(1993-11#1)(1995-2#1)
tryptic##40##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-6#3)(1993-8#3)(1994-8#2)(1995-2#2)(1995-6#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2013-1#1)
tryptophan (Trp)##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
tryptophan 201##2##2##(1993-11#2)
tryptophan and##7##2##(1992-6#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
tryptophan column##3##2##(2011-2#3)
tryptophan fluorescence##4##2##(1995-2#2)(1995-5#2)
tryptophan hydroxylase##5##2##(1991-5#1)(1992-3#2)(1996-12#1)(2012-2#1)
tryptophan in##4##2##(1991-11#1)(1995-3#1)(2008-10#1)(2009-8#1)
tryptophan levels##2##2##(1995-3#2)
tryptophan metabolism##3##2##(2008-7#1)(2009-10#1)(2012-1#1)
tryptophan methyl ester hydrochloride##3##4##(2008-10#3)
tryptophan methyl##4##2##(2008-10#4)
tryptophan or tyrosine##2##3##(2008-4#2)
tryptophan or##3##2##(2008-4#2)(2008-7#1)
tryptophan residue##3##2##(1992-6#2)(2008-10#1)
tryptophan residues in##4##3##(1991-12#1)(1991-5#1)(1992-6#1)(1995-6#1)
tryptophan residues##12##2##(1991-12#1)(1991-5#1)(1992-6#3)(1993-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(2008-10#1)
tryptophan was##2##2##(1992-6#1)(2009-8#1)
tryptophan##92##1##(1991-11#1)(1991-12#1)(1991-5#3)(1992-3#2)(1992-6#8)(1992-8#1)(1993-11#6)(1994-6#1)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#1)(1996-12#1)(2008-10#20)(2008-11#5)(2008-3#5)(2008-4#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#4)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-2#3)
tryptophan-hyperproducing strain##2##2##(1994-6#2)
tryptophan-rich##2##1##(1992-8#1)(1993-12#1)
tryptophane and tyrosine##2##3##(2008-10#2)
tryptophane and##3##2##(2008-10#3)
tryptophane##4##1##(2008-10#3)(2008-9#1)
tryptophans in##4##2##(1991-12#1)(1995-5#3)
tryptophans##11##1##(1991-12#1)(1992-12#2)(1993-11#1)(1995-2#4)(1995-5#3)
très##4##1##(2009-10#1)(2013-1#3)
ts mutants of##2##3##(2008-10#2)
ts mutants##7##2##(1995-9#1)(2008-10#6)
ts phenotypes##2##2##(1994-12#1)(2008-10#1)
ts##14##1##(1990-5#2)(1994-12#1)(1995-9#1)(1997-3#1)(2008-10#8)(2008-8#1)
ts85 cells##3##2##(1995-11#3)
tsetse flies##4##2##(2010-1#1)(2010-4#1)(2013-8#2)
tsetse##6##1##(1997-7#1)(2010-1#1)(2010-4#2)(2013-8#2)
tsp at##2##2##(1993-12#1)(1993-2#1)
tsp mapping##2##2##(1991-6#1)(1993-9#1)
tsp##6##1##(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-11#1)
tst##2##1##(1997-2#2)
tsunami##6##1##(1990-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#2)
tsx gene##4##2##(1990-11#4)
tsx##6##1##(1990-11#6)
tuatara##7##1##(2010-3#7)
tub2##2##1##(2008-10#2)
tubal anastomosis##2##2##(1991-3#2)
tubal disease##6##2##(1990-2#3)(1991-12#1)(1993-1#1)(1994-9#1)
tubal ectopic pregnancy##3##3##(1993-3#1)(2009-5#1)(2013-7#1)
tubal heterotopic pregnancy##3##3##(2011-1#3)
tubal infertility##4##2##(1990-10#2)(1990-2#1)(1994-9#1)
tubal ligation may be##2##4##(1996-8#2)
tubal ligation##6##2##(1993-12#1)(1996-8#3)(2007-7#1)(2008-7#1)
tubal obstruction##2##2##(1993-1#2)
tubal occlusion##4##2##(1991-11#1)(1991-12#2)(1993-1#1)
tubal patency##3##2##(1991-11#1)(1994-12#1)(1996-2#1)
tubal pregnancy##3##2##(1994-3#2)(2011-1#1)
tubal sterilization##3##2##(1993-3#2)(1995-1#1)
tubal##58##1##(1990-10#2)(1990-2#5)(1991-11#3)(1991-12#3)(1991-3#4)(1992-1#1)(1993-1#5)(1993-12#3)(1993-3#3)(1994-12#5)(1994-3#2)(1994-9#2)(1995-1#2)(1995-12#1)(1996-2#1)(1996-3#3)(1996-8#3)(2007-7#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2013-7#1)
tube (PMT)##2##2##(2008-10#2)
tube agglutination##2##2##(1990-12#1)(2012-2#1)
tube and ovary##2##3##(2011-1#2)
tube and the##3##3##(2008-10#2)(2010-5#1)
tube and##15##2##(1991-11#1)(1991-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-1#3)(2012-12#1)
tube as a##2##3##(2007-12#1)(2008-4#1)
tube as##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
tube at##5##2##(2008-10#4)(2008-2#1)
tube atomizer is##2##3##(2008-10#2)
tube atomizer##7##2##(2008-10#7)
tube cells##2##2##(2009-8#2)
tube containing##2##2##(2008-8#1)(2010-5#1)
tube displacement and##2##3##(2007-11#2)
tube feeding##2##2##(1992-5#1)(2011-1#1)
tube filled with##2##3##(2008-10#2)
tube for##9##2##(1993-3#1)(2007-8#2)(2008-10#5)(2008-3#1)
tube formation##7##2##(2008-10#5)(2010-6#1)(2013-8#1)
tube furnace##3##2##(2008-2#1)(2008-3#2)
tube growth##13##2##(2008-10#9)(2008-11#1)(2009-10#1)(2009-12#2)
tube has##2##2##(1992-1#1)(2008-10#1)
tube insertion##2##2##(2006-10#1)(2007-8#1)
tube into the##2##3##(2008-5#1)(2009-8#1)
tube is##9##2##(1990-8#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)
tube length##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
tube lifetime##5##2##(2008-10#5)
tube of a##2##3##(2008-8#1)(2011-1#1)
tube of##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)
tube on##4##2##(1993-6#3)(2008-3#1)
tube or##2##2##(1996-9#1)(2008-2#1)
tube packed with##3##3##(2008-10#3)
tube placement##5##2##(2009-5#1)(2010-7#3)(2011-2#1)
tube removal##2##2##(1991-3#1)(2007-10#1)
tube robots##3##2##(2012-1#2)(2012-2#1)
tube test##9##2##(1994-3#1)(2011-1#8)
tube that##2##2##(2008-10#1)(2008-4#1)
tube thoracostomy##4##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)
tube type##2##2##(2008-7#1)(2010-5#1)
tube voltage##3##2##(1997-8#2)(2013-8#1)
tube wall##2##2##(1994-9#1)(2009-6#1)
tube was inserted to##2##4##(2010-12#1)(2011-2#1)
tube was##10##2##(1991-3#1)(1991-5#2)(2008-10#4)(2010-12#1)(2011-2#1)(2013-8#1)
tube were##2##2##(2008-10#2)
tube with a##2##3##(2008-10#2)
tube with an##2##3##(1994-9#1)(2008-10#1)
tube with##7##2##(1994-9#1)(2008-10#4)(2008-3#1)(2011-1#1)
tube##343##1##(1990-12#2)(1990-8#2)(1991-11#1)(1991-3#3)(1991-5#2)(1991-6#1)(1992-1#3)(1992-12#2)(1992-3#1)(1992-5#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#118)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#16)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#2)(2009-10#4)(2009-11#2)(2009-12#3)(2009-5#2)(2009-6#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#4)(2010-5#9)(2010-6#1)(2010-7#5)(2011-1#17)(2011-2#5)(2012-1#6)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#3)
tube)##2##1##(2008-10#1)(2013-8#1)
tube-like##3##1##(1997-6#1)(2008-7#1)(2010-2#1)
tubed##3##1##(1990-6#2)(2011-2#1)
tuber tissue was##2##3##(2008-10#2)
tuber tissue##3##2##(2008-10#3)
tuber yield##3##2##(2008-10#3)
tuber##26##1##(1991-5#1)(1992-12#1)(2008-10#22)(2008-9#2)
tubercle##15##1##(1991-2#2)(1991-5#1)(1993-6#1)(1996-12#1)(1997-3#2)(2008-10#1)(2008-9#3)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
tubercles##3##1##(2007-12#1)(2008-5#2)
tubercular infection##2##2##(2012-12#2)
tubercular##11##1##(1995-10#1)(1997-8#2)(2006-10#1)(2007-7#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#2)
tuberculin skin test was##2##4##(1997-4#1)(2013-1#1)
tuberculin skin test##5##3##(1990-6#1)(1997-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
tuberculin skin##6##2##(1990-6#1)(1997-4#1)(2007-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
tuberculin test and risk of##2##5##(2013-1#2)
tuberculin test and##4##3##(2011-2#1)(2013-1#3)
tuberculin test##9##2##(1990-6#1)(1997-8#2)(2011-2#2)(2013-1#4)
tuberculin##21##1##(1990-6#7)(1997-4#1)(1997-8#2)(2007-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2013-1#5)
tuberculoid granuloma##2##2##(2007-7#2)
tuberculoid##4##1##(2007-7#4)
tuberculoma##2##1##(1990-6#1)(2012-3#1)
tuberculosis (TB) and##2##3##(2009-4#1)(2010-4#1)
tuberculosis (TB) is##4##3##(2006-10#1)(2008-1#1)(2010-5#1)(2012-12#1)
tuberculosis (TB)##20##2##(1996-3#4)(2006-10#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
tuberculosis H37Rv##3##2##(2008-7#2)(2012-3#1)
tuberculosis among##6##2##(2011-1#5)(2013-7#1)
tuberculosis and HIV-1/AIDS##2##3##(2009-4#2)
tuberculosis and##26##2##(1993-3#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#3)(2009-4#3)(2009-5#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#4)(2013-1#1)
tuberculosis and/or M##2##3##(2012-3#2)
tuberculosis are##2##2##(1995-2#1)(2008-12#1)
tuberculosis at Biosafety Level 3 containment are also discussed##3##9##(2008-9#3)
tuberculosis at##6##2##(1990-9#1)(2008-9#3)(2009-7#1)(2011-2#1)
tuberculosis by##3##2##(2007-7#1)(2008-5#1)(2010-8#1)
tuberculosis case##2##2##(1996-3#1)(2013-8#1)
tuberculosis cases##5##2##(1995-9#1)(2007-12#1)(2011-1#1)(2013-8#2)
tuberculosis centers of##2##3##(2008-12#2)
tuberculosis clinically##2##2##(1991-11#1)(2007-12#1)
tuberculosis complex##2##2##(1996-11#1)(2007-7#1)
tuberculosis control programme##3##3##(1995-9#2)(2013-8#1)
tuberculosis control##7##2##(1995-9#2)(1997-8#1)(2010-5#1)(2013-7#1)(2013-8#2)
tuberculosis directly observed therapy##2##4##(1996-3#2)
tuberculosis from##2##2##(2011-2#1)(2013-8#1)
tuberculosis genome##2##2##(2008-7#1)(2012-2#1)
tuberculosis in a##6##3##(1990-6#1)(2009-7#2)(2013-1#3)
tuberculosis in children##4##3##(2011-2#3)(2012-3#1)
tuberculosis in patients##2##3##(1996-3#1)(2008-10#1)
tuberculosis in the##4##3##(1995-2#1)(1996-3#1)(2008-7#1)(2009-7#1)
tuberculosis in##30##2##(1990-6#1)(1995-2#1)(1995-3#1)(1996-3#2)(1996-6#1)(1997-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-7#3)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#5)
tuberculosis infection among healthcare professionals##2##5##(2013-1#2)
tuberculosis infection among##3##3##(2011-1#1)(2013-1#2)
tuberculosis infection is##2##3##(1990-6#2)
tuberculosis infection##12##2##(1990-6#3)(2007-12#1)(2008-1#1)(2008-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
tuberculosis is a rare##3##4##(1993-3#1)(2007-8#1)(2008-12#1)
tuberculosis is a##5##3##(1993-3#1)(2007-8#1)(2008-12#1)(2009-5#1)(2010-8#1)
tuberculosis is still##2##3##(1997-8#1)(2007-8#1)
tuberculosis is##10##2##(1993-3#1)(1995-10#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-3#1)
tuberculosis isolates in##2##3##(2007-7#1)(2008-12#1)
tuberculosis isolates##4##2##(2007-7#1)(2008-12#2)(2011-2#1)
tuberculosis mycolic acids##2##3##(2008-9#2)
tuberculosis of##4##2##(2007-10#1)(2007-8#2)(2010-8#1)
tuberculosis patients at##2##3##(1996-3#1)(2013-1#1)
tuberculosis patients in##2##3##(2011-2#1)(2013-8#1)
tuberculosis patients##10##2##(1993-11#1)(1995-9#1)(1996-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
tuberculosis presenting with##2##3##(2007-12#1)(2008-7#1)
tuberculosis surveillance##2##2##(2011-2#1)(2013-8#1)
tuberculosis testing and treatment program##2##5##(1997-2#2)
tuberculosis testing and treatment##3##4##(1997-2#3)
tuberculosis the##2##2##(1996-11#1)(2011-2#1)
tuberculosis treatment##3##2##(1996-11#1)(2007-12#1)(2008-7#1)
tuberculosis was##5##2##(1990-9#1)(1993-3#1)(2008-10#1)(2012-3#2)
tuberculosis were##4##2##(1995-10#2)(2007-8#1)(2011-1#1)
tuberculosis with atlantoaxial dislocation##2##4##(2008-12#2)
tuberculosis with##5##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-12#2)
tuberculosis##389##1##(1990-12#1)(1990-6#6)(1990-9#4)(1991-11#4)(1991-12#1)(1991-3#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#4)(1994-3#1)(1995-10#6)(1995-2#10)(1995-3#2)(1995-5#1)(1995-9#6)(1996-11#7)(1996-3#18)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-12#7)(2007-6#1)(2007-7#13)(2007-8#10)(2008-1#6)(2008-10#15)(2008-11#2)(2008-12#12)(2008-4#2)(2008-5#7)(2008-7#32)(2008-8#3)(2008-9#17)(2009-4#5)(2009-5#5)(2009-6#5)(2009-7#11)(2010-11#2)(2010-12#1)(2010-4#3)(2010-5#4)(2010-8#7)(2011-1#16)(2011-2#32)(2012-12#5)(2012-2#7)(2012-3#21)(2013-1#30)(2013-7#2)(2013-8#13)
tuberculosis]##9##1##(1990-6#1)(1990-9#1)(1992-2#1)(1993-3#1)(1996-11#1)(1996-3#1)(2009-5#2)(2013-1#1)
tuberculous aortitis##2##2##(2007-8#2)
tuberculous epididymo-orchitis##3##2##(2007-7#1)(2011-2#2)
tuberculous infection##3##2##(1990-12#1)(1990-6#1)(2008-4#1)
tuberculous##28##1##(1990-12#1)(1990-6#2)(1997-3#1)(1997-8#3)(2007-7#1)(2007-8#7)(2008-1#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-1#1)(2011-2#5)(2013-7#2)
tuberis##2##1##(2008-6#2)
tuberoinfundibular##2##1##(1992-8#2)
tuberosity##3##1##(1990-6#1)(2008-12#1)(2008-8#1)
tuberosum##9##1##(1992-12#2)(1993-12#1)(2008-10#5)(2008-7#1)
tuberous roots##2##2##(2008-11#1)(2008-9#1)
tuberous sclerosis and the##2##4##(2008-1#2)
tuberous sclerosis##8##2##(1993-12#1)(1997-8#1)(2008-1#3)(2010-6#1)(2011-2#2)
tuberous##10##1##(1993-12#1)(1997-8#1)(2008-1#3)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#2)
tubers and##3##2##(2008-10#2)(2013-8#1)
tubers collected##2##2##(2008-10#2)
tubers examined##2##2##(2008-10#2)
tubers grown in##3##3##(2008-10#2)(2008-12#1)
tubers of##3##2##(2008-10#3)
tubers was##3##2##(2008-10#3)
tubers were##6##2##(2008-10#6)
tubers##52##1##(1992-12#2)(2008-10#46)(2008-12#2)(2010-5#1)(2013-8#1)
tubes and##7##2##(1991-1#1)(2008-10#2)(2008-3#1)(2008-7#3)
tubes at##2##2##(2008-10#1)(2011-1#1)
tubes for##2##2##(2008-9#1)(2010-5#1)
tubes from##2##2##(1990-11#1)(2008-10#1)
tubes in##2##2##(1991-3#1)(2008-10#1)
tubes is##2##2##(2008-12#1)(2013-1#1)
tubes of##6##2##(2008-10#4)(2008-8#2)
tubes on##2##2##(2008-10#2)
tubes that##3##2##(1992-6#1)(2007-12#1)(2008-10#1)
tubes to##4##2##(2008-10#3)(2012-1#1)
tubes were##5##2##(2008-10#3)(2008-9#1)(2013-1#1)
tubes with##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
tubes##129##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#2)(1992-6#1)(1995-5#1)(1996-2#2)(1996-8#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#55)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#4)(2009-12#2)(2010-5#2)(2010-8#1)(2011-1#4)(2012-1#1)(2012-2#5)(2013-1#5)(2013-8#2)
tubing##33##1##(1991-3#1)(1992-1#1)(1995-6#1)(1997-3#3)(2007-7#1)(2008-10#17)(2008-5#1)(2009-7#1)(2009-9#1)(2011-1#4)(2013-8#2)
tubular acidosis##3##2##(2007-7#1)(2008-1#2)
tubular adenomas##3##2##(2009-1#2)(2011-2#1)
tubular and##3##2##(1993-2#1)(1995-11#1)(2007-12#1)
tubular atrophy##3##2##(1993-3#1)(2012-12#1)(2013-8#1)
tubular carcinoma##3##2##(1995-4#3)
tubular cells##7##2##(1992-3#1)(1993-11#1)(1995-11#1)(1996-12#1)(2008-6#1)(2008-8#1)(2011-2#1)
tubular electrode##4##2##(2008-10#4)
tubular epithelial cells##3##3##(1992-3#1)(1994-5#1)(2013-1#1)
tubular epithelial##4##2##(1990-5#1)(1992-3#1)(1994-5#1)(2013-1#1)
tubular fluid##2##2##(1995-6#2)
tubular interstitial changes##2##3##(1993-2#2)
tubular interstitial##3##2##(1993-2#3)
tubular necrosis in the##2##4##(1994-5#1)(1996-12#1)
tubular necrosis##8##2##(1994-5#1)(1996-12#1)(2008-1#1)(2008-4#1)(2012-12#3)(2012-2#1)
tubular or##2##2##(1993-2#1)(2008-6#1)
tubular proteinuria##2##2##(1990-12#1)(2008-1#1)
tubular structures##2##2##(2008-7#2)
tubular toxicity##2##2##(2008-8#2)
tubular##120##1##(1990-12#1)(1990-5#1)(1990-9#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#2)(1994-5#4)(1995-11#4)(1995-4#6)(1995-6#2)(1996-12#2)(1996-2#1)(1996-6#2)(2007-12#6)(2007-7#4)(2008-1#5)(2008-10#19)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#4)(2009-12#2)(2010-5#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
tubularized incised plate##3##3##(2008-10#1)(2009-5#2)
tubule cells##7##2##(1991-5#1)(1992-8#3)(1994-9#1)(2008-11#1)(2008-7#1)
tubule degeneration##8##2##(2008-9#8)
tubule diameter of##2##3##(2008-5#2)
tubule diameter##4##2##(2008-12#1)(2008-5#3)
tubule##44##1##(1991-2#1)(1991-5#1)(1992-8#3)(1994-5#1)(1994-9#1)(1997-1#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-9#15)(2009-10#2)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
tubules and##6##2##(1994-8#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2013-8#1)
tubules from##2##2##(1995-6#1)(2008-7#1)
tubules in the##2##3##(1992-8#1)(1993-3#1)
tubules in##4##2##(1992-8#1)(1993-3#1)(2008-10#1)(2009-10#1)
tubules of##3##2##(1996-5#1)(2007-12#2)
tubules with##5##2##(1997-1#1)(2007-12#2)(2008-7#1)(2011-2#1)
tubules##48##1##(1990-9#1)(1991-5#1)(1992-8#2)(1993-3#1)(1994-8#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-1#5)(2007-12#7)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#9)(2008-9#2)(2009-10#2)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
tubulin and actin##3##3##(1993-6#2)(1995-3#1)
tubulin and##5##2##(1992-6#1)(1993-6#2)(1995-3#1)(2010-11#1)
tubulin carboxypeptidase##2##2##(1992-6#2)
tubulin dimer##4##2##(1993-8#2)(1995-5#1)(2008-6#1)
tubulin from the budding yeast Saccharomyces cerevisiae##2##7##(1993-8#2)
tubulin polymerization and##2##3##(1992-9#1)(1993-8#1)
tubulin polymerization##4##2##(1992-9#1)(1993-8#1)(2008-8#1)(2009-9#1)
tubulin self-assembly##2##2##(1990-7#2)
tubulin with##2##2##(1992-5#1)(1992-9#1)
tubulin##62##1##(1990-7#2)(1991-5#1)(1992-5#1)(1992-6#5)(1992-9#6)(1993-6#3)(1993-8#13)(1994-5#4)(1995-3#1)(1995-5#11)(2008-11#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-7#2)
tubulin-colchicine##2##1##(1995-5#2)
tubulo-interstitial kidney disease##3##3##(2008-1#3)
tubulo-interstitial##6##1##(2008-1#4)(2008-4#2)
tubulointerstitial nephritis##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
tubulointerstitial##5##1##(2007-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
tubulopapillary carcinomas##2##2##(2013-8#2)
tubulovesicles##2##1##(1997-1#2)
tuf gene##2##2##(2008-10#2)
tuf##5##1##(2008-10#5)
tuft##2##1##(2007-12#1)(2010-6#1)
tularemia##2##1##(2011-1#1)(2012-2#1)
tulip##2##1##(2009-12#1)(2013-1#1)
tumbling##2##1##(2008-5#1)(2013-1#1)
tumefaciens cells present during##2##4##(2008-10#2)
tumefaciens cells##5##2##(2008-10#5)
tumefaciens##22##1##(1990-5#3)(1997-2#1)(2008-10#14)(2008-9#2)(2011-2#2)
tumor 14##2##2##(2011-2#2)
tumor ablation##2##2##(2007-12#1)(2013-1#1)
tumor after##2##2##(2009-3#1)(2010-8#1)
tumor and a##2##3##(2007-12#1)(2008-10#1)
tumor and embryonic##2##3##(2009-3#2)
tumor and normal##2##3##(1993-9#1)(1994-8#1)
tumor and severe##2##3##(1993-6#1)(2007-10#1)
tumor and the##6##3##(1993-1#1)(1993-11#2)(1996-11#1)(2006-12#1)(2008-11#1)
tumor and##53##2##(1990-2#3)(1990-9#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#3)(2009-4#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
tumor angiogenesis##8##2##(1994-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
tumor angiogenic##2##2##(2008-11#1)(2008-8#1)
tumor antigen were##2##3##(1995-2#1)(2008-4#1)
tumor antigen##8##2##(1991-12#1)(1993-11#1)(1995-2#2)(1997-4#1)(2008-4#1)(2008-8#1)(2013-1#1)
tumor antigens##8##2##(1991-12#2)(1994-8#1)(2008-4#4)(2008-5#1)
tumor are##3##2##(1990-10#1)(1994-12#1)(2013-1#1)
tumor arising from##3##3##(1992-12#1)(1993-9#1)(2012-12#1)
tumor arising in the##2##4##(1990-2#1)(2009-1#1)
tumor arising in##4##3##(1990-2#1)(1991-2#1)(1994-12#1)(2009-1#1)
tumor arising##7##2##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(2009-1#1)(2012-12#1)
tumor as##2##2##(2008-4#1)(2008-6#1)
tumor associated with a##2##4##(2008-6#1)(2013-1#1)
tumor associated##3##2##(2008-6#1)(2008-8#1)(2013-1#1)
tumor at##4##2##(1992-1#1)(1992-6#1)(2008-6#1)(2013-1#1)
tumor bearing##2##2##(2011-2#1)(2012-2#1)
tumor before##2##2##(2008-5#1)(2010-3#1)
tumor biology##7##2##(2008-10#1)(2009-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2012-3#1)
tumor boron concentrations of approximately##2##5##(1995-2#2)
tumor burden##4##2##(1990-12#1)(1991-4#1)(2011-2#1)(2013-1#1)
tumor by##2##2##(2008-3#1)(2013-1#1)
tumor cell adhesion to##2##4##(2009-3#2)
tumor cell apoptosis##4##3##(2010-1#3)(2012-1#1)
tumor cell growth and##2##4##(2008-9#1)(2012-12#1)
tumor cell growth in##2##4##(2012-3#1)(2013-1#1)
tumor cell growth##9##3##(2007-5#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
tumor cell invasion##4##3##(1994-9#1)(2008-11#2)(2012-1#1)
tumor cell line##12##3##(1990-12#3)(1993-3#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1997-7#1)(2008-11#2)
tumor cell lines and##3##4##(1990-11#1)(1994-5#1)(2008-8#1)
tumor cell lines by##2##4##(1992-9#1)(2010-2#1)
tumor cell lines in vitro and in vivo##2##8##(1991-6#1)(1995-6#1)
tumor cell lines in##3##4##(1991-6#1)(1994-5#1)(1995-6#1)
tumor cell lines was##3##4##(1990-12#1)(1992-2#1)(2010-2#1)
tumor cell lines were##3##4##(1991-2#1)(1992-2#2)
tumor cell lines##38##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#2)(1992-2#9)(1992-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#3)(1995-12#1)(1995-6#1)(1997-7#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#2)(2011-2#1)(2012-12#3)
tumor cell migration##5##3##(2008-11#1)(2011-2#4)
tumor cell population##2##3##(2009-3#1)(2013-8#1)
tumor cell survival##2##3##(1991-12#1)(2011-1#1)
tumor cell##102##2##(1990-11#1)(1990-12#5)(1990-5#2)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-2#9)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1997-7#3)(2007-5#1)(2008-10#1)(2008-11#10)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#6)(2009-12#1)(2009-3#5)(2010-1#3)(2010-2#2)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#1)
tumor cell-derived##2##2##(1994-6#2)
tumor cells after##2##3##(1991-2#1)(2008-9#1)
tumor cells and on##2##4##(1990-5#1)(1993-9#1)
tumor cells and the##2##4##(1992-3#1)(2010-11#1)
tumor cells and##12##3##(1990-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-3#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
tumor cells are##2##3##(2008-1#2)
tumor cells as the targets for##2##6##(2008-4#2)
tumor cells as##6##3##(1991-12#1)(1997-4#1)(2008-11#1)(2008-4#2)(2010-5#1)
tumor cells by##4##3##(1992-12#1)(2008-11#1)(2008-9#2)
tumor cells from##4##3##(2008-4#2)(2008-5#1)(2010-3#1)
tumor cells has##2##3##(1993-6#1)(1993-9#1)
tumor cells in a##2##4##(1993-9#1)(2008-4#1)
tumor cells in bone marrow##2##5##(2010-3#1)(2011-2#1)
tumor cells in the##4##4##(1993-9#1)(1994-7#1)(2008-11#1)(2012-1#1)
tumor cells in vitro##3##4##(1995-2#1)(2009-3#1)(2009-4#1)
tumor cells in##16##3##(1990-12#1)(1990-5#1)(1991-6#1)(1993-9#2)(1994-5#1)(1994-7#1)(1995-2#1)(2008-11#2)(2008-4#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#1)
tumor cells is##2##3##(1991-9#1)(2010-3#1)
tumor cells of##2##3##(2008-11#1)(2009-2#1)
tumor cells or##3##3##(1995-2#1)(2008-6#1)(2008-9#1)
tumor cells than##2##3##(2008-11#1)(2008-4#1)
tumor cells to##9##3##(1991-2#1)(1994-12#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-9#1)
tumor cells was##3##3##(1992-9#2)(2012-1#1)
tumor cells were##11##3##(1990-2#1)(1990-8#1)(1993-9#1)(1994-12#1)(1994-5#2)(2008-11#2)(2009-8#1)(2010-6#1)(2012-1#1)
tumor cells with##2##3##(1994-6#1)(2012-1#1)
tumor cells##219##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#12)(1994-12#2)(1994-5#12)(1994-6#3)(1994-7#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-5#2)(1997-1#2)(1997-2#3)(1997-4#3)(1997-7#1)(2007-12#1)(2008-1#6)(2008-10#1)(2008-11#26)(2008-4#15)(2008-5#6)(2008-6#2)(2008-8#4)(2008-9#13)(2009-2#1)(2009-3#7)(2009-4#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#8)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#7)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
tumor cells)##2##2##(1994-7#1)(2013-8#1)
tumor characteristics##5##2##(2008-10#1)(2008-6#2)(2010-8#1)(2011-2#1)
tumor classification##3##2##(1994-12#1)(2008-6#1)(2013-1#1)
tumor control##3##2##(1995-9#1)(2007-5#1)(2007-8#1)
tumor could be##3##3##(2008-12#1)(2008-2#1)(2008-7#1)
tumor could##4##2##(2007-5#1)(2008-12#1)(2008-2#1)(2008-7#1)
tumor delineation##3##2##(2007-8#1)(2009-11#2)
tumor derived##2##2##(2007-5#1)(2013-1#1)
tumor destruction##2##2##(2010-8#1)(2011-2#1)
tumor detection and##2##3##(2008-3#1)(2013-1#1)
tumor detection##6##2##(1993-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#2)
tumor development and##4##3##(1991-12#1)(1993-8#1)(1994-12#1)(2009-4#1)
tumor development in##2##3##(2007-4#1)(2008-11#1)
tumor development##18##2##(1991-12#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-3#1)(2013-1#3)(2013-8#1)
tumor diagnosis and##2##3##(2008-8#1)(2011-2#1)
tumor diagnosis##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
tumor diameter and number of involved structures/organs##2##7##(2007-8#2)
tumor diameter##5##2##(2007-8#3)(2013-8#2)
tumor dose##2##2##(1992-10#1)(1993-9#1)
tumor during##2##2##(1990-6#1)(2011-1#1)
tumor dynamics##2##2##(2008-8#2)
tumor emboli##4##2##(2011-2#4)
tumor engraftment##2##2##(2013-1#2)
tumor extension##3##2##(2007-10#1)(2011-1#1)(2013-1#1)
tumor foci##2##2##(2010-11#2)
tumor for##2##2##(2010-3#1)(2011-2#1)
tumor formation and##3##3##(2009-3#1)(2011-1#1)(2013-8#1)
tumor formation in##4##3##(2008-11#1)(2011-2#1)(2013-1#2)
tumor formation##15##2##(1991-12#1)(1992-2#1)(2007-10#1)(2008-10#1)(2008-11#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
tumor free##2##2##(1992-5#1)(1993-2#1)
tumor gene##2##2##(1991-10#1)(2007-12#1)
tumor grade##4##2##(1993-9#1)(1994-9#1)(2010-5#1)(2011-2#1)
tumor grading##2##2##(1997-8#1)(2011-2#1)
tumor growing in##2##3##(1991-6#1)(2013-8#1)
tumor growth and metastasis##8##4##(1994-12#2)(2008-8#1)(2009-3#3)(2012-2#1)(2013-8#1)
tumor growth and##15##3##(1991-9#1)(1994-12#2)(1994-6#1)(2008-8#1)(2008-9#1)(2009-3#4)(2010-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
tumor growth in##6##3##(1990-11#1)(1992-2#1)(1994-6#1)(2008-7#1)(2011-1#1)(2013-7#1)
tumor growth may##2##3##(1991-6#1)(2009-2#1)
tumor growth of##2##3##(1990-7#1)(2013-7#1)
tumor growth rate##2##3##(1993-11#2)
tumor growth##70##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-6#2)(1991-9#2)(1992-2#1)(1993-1#3)(1993-11#3)(1994-12#3)(1994-5#1)(1994-6#6)(1994-9#1)(1995-3#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-2#1)(2009-3#5)(2010-1#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#5)
tumor growth?##2##2##(1994-5#1)(1994-6#1)
tumor had a##2##3##(1991-4#1)(1993-6#1)
tumor had##6##2##(1991-4#1)(1993-6#1)(1994-12#1)(1995-4#1)(2007-11#1)(2008-12#1)
tumor has##2##2##(1990-8#1)(2010-11#1)
tumor heterogeneity##2##2##(1994-12#1)(2010-7#1)
tumor immunotherapy##7##2##(1994-5#1)(2008-8#1)(2009-3#2)(2011-2#2)(2012-2#1)
tumor in 66##2##3##(2008-3#1)(2010-3#1)
tumor in a##2##3##(1994-2#1)(2009-11#1)
tumor in all##2##3##(2007-8#1)(2013-1#1)
tumor in the left##2##4##(2008-10#1)(2013-1#1)
tumor in the right##2##4##(1995-4#1)(2012-3#1)
tumor in the##12##3##(1995-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-2#3)(2012-3#1)(2013-1#2)
tumor in##32##2##(1992-3#1)(1994-2#1)(1995-4#1)(1996-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#2)(2009-11#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
tumor incidence in##2##3##(1992-5#1)(2013-1#1)
tumor incidence##6##2##(1990-6#1)(1992-5#1)(1993-11#1)(1994-2#1)(2013-1#2)
tumor initiating##2##2##(1990-7#1)(2013-1#1)
tumor initiation and##3##3##(2008-7#1)(2009-9#1)(2011-2#1)
tumor initiation##4##2##(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
tumor initiator##2##2##(1990-7#2)
tumor invasion and metastasis##4##4##(1993-9#1)(2008-5#1)(2008-8#1)(2012-12#1)
tumor invasion and##6##3##(1993-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#1)
tumor invasion##12##2##(1993-9#1)(1994-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
tumor involution##2##2##(1990-12#2)
tumor is a##2##3##(1990-12#1)(2007-8#1)
tumor is rare##2##3##(1997-1#1)(2007-8#1)
tumor is suspected##2##3##(2008-6#1)(2009-3#1)
tumor is##17##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#1)(1997-1#3)(2007-5#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)
tumor lesions##2##2##(2007-11#1)(2009-12#1)
tumor located in the left##2##5##(2009-8#1)(2012-3#1)
tumor location##4##2##(2008-11#1)(2010-3#2)(2012-3#1)
tumor lysis syndrome##6##3##(2008-7#6)
tumor malignancy##6##2##(1993-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
tumor marker for##3##3##(1992-3#1)(1993-1#1)(2008-4#1)
tumor marker in##2##3##(1990-8#1)(1993-6#1)
tumor marker##17##2##(1990-8#2)(1991-4#1)(1991-8#1)(1992-3#1)(1993-1#2)(1993-6#1)(1997-7#1)(2008-4#4)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)
tumor markers and##2##3##(1990-8#1)(1994-7#1)
tumor markers##12##2##(1990-8#1)(1991-4#1)(1991-8#1)(1994-7#2)(1996-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)
tumor mass##7##2##(1990-6#1)(1993-11#1)(2008-1#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
tumor masses in the##2##4##(2008-1#1)(2011-2#1)
tumor masses##3##2##(2008-1#1)(2010-7#1)(2011-2#1)
tumor may be##2##3##(1997-1#1)(2012-3#1)
tumor measuring##2##2##(1994-7#1)(2013-8#1)
tumor metastasis##6##2##(1994-8#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#1)
tumor microenvironment in##4##3##(2011-1#2)(2013-1#2)
tumor microenvironment is##2##3##(2011-1#2)
tumor microenvironment##20##2##(2009-3#3)(2010-11#1)(2010-3#1)(2011-1#7)(2012-2#1)(2013-1#6)(2013-8#1)
tumor microenvironments##3##2##(2011-1#3)
tumor model##6##2##(1992-2#1)(1992-9#2)(1993-1#1)(1996-5#1)(2008-8#1)
tumor models##3##2##(1994-12#1)(2012-3#1)(2013-1#1)
tumor multiplicity##3##2##(1994-5#2)(2011-2#1)
tumor necrosis factor (TNF)##9##4##(1990-12#1)(1992-12#1)(1994-2#2)(1994-8#1)(1997-4#1)(2008-4#1)(2012-3#2)
tumor necrosis factor (TNF)-alpha##4##4##(1994-12#1)(1996-12#1)(1996-5#1)(2008-5#1)
tumor necrosis factor alpha (TNF alpha)##2##6##(1991-9#1)(1993-6#1)
tumor necrosis factor alpha (TNF)##2##5##(1990-5#1)(1992-7#1)
tumor necrosis factor alpha (TNF-alpha)##2##5##(1993-12#1)(2008-11#1)
tumor necrosis factor alpha and##3##5##(1994-8#1)(2008-11#1)(2011-2#1)
tumor necrosis factor alpha##12##4##(1990-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(2008-11#2)(2008-8#2)(2011-2#1)(2013-8#1)
tumor necrosis factor in##2##4##(1990-12#1)(1991-12#1)
tumor necrosis factor##53##3##(1990-12#3)(1990-5#1)(1990-7#2)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-8#2)(1995-12#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-8#1)
tumor necrosis factor-alpha (TNF-alpha)##15##4##(1992-12#1)(1992-3#1)(1992-8#1)(1995-12#1)(1995-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-7#1)(2012-2#1)
tumor necrosis factor-alpha and##3##4##(1995-10#1)(2008-5#1)(2008-7#1)
tumor necrosis factor-alpha in human##2##5##(1992-8#1)(1994-6#1)
tumor necrosis factor-alpha production in mice##2##6##(1997-7#2)
tumor necrosis factor-alpha production in##3##5##(1997-7#2)(2009-9#1)
tumor necrosis factor-alpha##34##3##(1992-12#2)(1992-3#1)(1992-8#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-7#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
tumor necrosis factor-α inhibitors##2##4##(2013-1#2)
tumor necrosis factor-α##7##3##(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#4)
tumor necrosis##104##2##(1990-12#3)(1990-5#1)(1990-7#2)(1991-12#2)(1991-6#2)(1991-9#1)(1992-12#3)(1992-3#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#2)
tumor necrosis) in##2##3##(1990-12#1)(1992-6#1)
tumor occurring at a##2##4##(1997-3#1)(2010-3#1)
tumor occurring##3##2##(1997-3#2)(2010-3#1)
tumor of a patient##2##4##(1990-11#1)(2013-1#1)
tumor of infancy was##2##4##(2008-10#2)
tumor of infancy##5##3##(2007-12#1)(2008-10#4)
tumor of the breast##5##4##(1994-12#1)(1994-6#1)(1995-4#3)
tumor of the kidney##2##4##(2008-10#2)
tumor of the larynx##2##4##(1993-6#2)
tumor of the pancreas##2##4##(1992-5#1)(2007-10#1)
tumor of the temporal bone##2##5##(2006-12#1)(2011-2#1)
tumor of the##36##3##(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-4#3)(2006-12#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-6#1)(2009-3#3)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
tumor of##57##2##(1990-11#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-4#3)(2006-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#3)(2009-5#1)(2010-3#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
tumor often##2##2##(2008-12#1)(2012-3#1)
tumor on##2##2##(1995-4#1)(2010-8#1)
tumor operation##2##2##(2007-8#2)
tumor or a##2##3##(2009-1#1)(2010-12#1)
tumor or tissue##2##3##(2008-8#2)
tumor or##6##2##(2007-7#1)(2007-8#1)(2008-8#2)(2009-1#1)(2010-12#1)
tumor originating from##3##3##(1993-6#1)(2007-8#1)(2010-12#1)
tumor over##2##2##(2009-8#1)(2010-3#1)
tumor oxygenation##3##2##(1995-9#1)(2008-11#1)(2008-3#1)
tumor patients##2##2##(1995-9#1)(2009-5#1)
tumor population##2##2##(2008-11#1)(2008-9#1)
tumor position##5##2##(2009-11#5)
tumor presence##2##2##(2012-3#2)
tumor presenting as##2##3##(2007-2#1)(2009-4#1)
tumor progression and##5##3##(1991-4#1)(1997-4#1)(2009-3#2)(2012-1#1)
tumor progression in##3##3##(1993-9#1)(1994-5#1)(1994-8#1)
tumor progression##28##2##(1991-2#1)(1991-4#1)(1991-5#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-8#1)(1997-4#1)(2008-1#1)(2008-11#1)(2009-3#4)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
tumor promoter##7##2##(1991-5#1)(1992-2#1)(1993-8#1)(2007-12#2)(2012-3#2)
tumor promoters##6##2##(1992-2#1)(1992-9#4)(1994-9#1)
tumor promoting activity##2##3##(1992-3#1)(1994-11#1)
tumor promoting##5##2##(1991-9#1)(1992-3#1)(1994-11#3)
tumor promotion in##3##3##(1992-8#2)(1993-8#1)
tumor promotion##4##2##(1992-8#2)(1993-8#2)
tumor protein##2##2##(2010-12#2)
tumor recurrence##13##2##(1991-4#1)(1994-8#1)(2008-2#1)(2009-1#1)(2009-5#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-8#1)
tumor regression in##4##3##(1992-12#1)(2009-4#1)(2010-3#1)(2011-2#1)
tumor regression##11##2##(1991-8#2)(1992-12#2)(1994-5#1)(1995-9#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#1)
tumor remained##2##2##(2007-11#1)(2011-1#1)
tumor remission##2##2##(1991-8#1)(2013-8#1)
tumor resection and##4##3##(2007-11#3)(2011-2#1)
tumor resection with##2##3##(2007-11#1)(2012-3#1)
tumor resection##16##2##(1997-7#1)(2007-11#5)(2009-4#1)(2010-3#1)(2011-2#5)(2012-3#2)(2013-1#1)
tumor response and##2##3##(1993-9#1)(2013-1#1)
tumor response was##2##3##(1991-2#1)(1991-6#1)
tumor response##9##2##(1991-2#1)(1991-6#1)(1992-2#1)(1993-9#1)(1995-9#1)(2008-5#1)(2009-4#1)(2010-3#1)(2013-1#1)
tumor samples were##2##3##(1990-12#2)
tumor samples##9##2##(1990-12#2)(1993-9#1)(2008-1#1)(2008-6#2)(2008-9#1)(2010-7#1)(2012-12#1)
tumor sensitivity##2##2##(2008-8#1)(2011-1#1)
tumor should be##3##3##(2008-10#1)(2008-5#2)
tumor showed##4##2##(2007-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
tumor sites##4##2##(2008-11#2)(2011-1#2)
tumor situated in##2##3##(2007-11#1)(2013-1#1)
tumor size and##2##3##(1991-8#1)(1994-12#1)
tumor size##17##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-4#2)(1997-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
tumor specific##3##2##(1994-3#1)(2008-8#1)(2011-2#1)
tumor specimens##7##2##(1994-12#1)(2008-1#1)(2008-4#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
tumor spheroid##4##2##(2008-11#3)(2013-1#1)
tumor spheroids##3##2##(2008-11#3)
tumor spread##3##2##(2008-1#1)(2010-3#1)(2011-1#1)
tumor stage##9##2##(1990-12#2)(1991-6#1)(1991-8#1)(2008-1#1)(2008-2#1)(2008-6#3)
tumor suppression##3##2##(2011-2#2)(2013-1#1)
tumor suppressor activity##3##3##(1995-2#1)(1995-6#1)(2009-5#1)
tumor suppressor and##2##3##(1994-5#1)(2008-9#1)
tumor suppressor function##2##3##(2008-6#1)(2009-4#1)
tumor suppressor gene##25##3##(1990-12#1)(1991-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-6#1)(2007-5#1)(2008-10#1)(2008-9#3)(2009-5#1)(2009-9#2)(2011-2#6)(2012-2#1)(2013-1#2)
tumor suppressor genes in##2##4##(1990-12#1)(2008-7#1)
tumor suppressor genes##13##3##(1990-12#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-2#5)
tumor suppressor p53##3##3##(2007-8#1)(2009-7#1)(2011-2#1)
tumor suppressor protein##3##3##(1994-12#1)(2009-9#1)(2011-1#1)
tumor suppressor proteins##2##3##(1995-6#1)(2008-11#1)
tumor suppressor##68##2##(1990-12#2)(1991-10#1)(1993-12#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-6#4)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#5)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#4)(2010-3#1)(2011-1#1)(2011-2#14)(2012-2#2)(2013-1#5)(2013-8#1)
tumor surface##2##2##(2007-8#1)(2011-2#1)
tumor take##2##2##(2008-6#2)
tumor targeting##4##2##(1993-11#2)(2010-6#1)(2012-2#1)
tumor that usually##2##3##(2009-1#1)(2010-3#1)
tumor that##4##2##(1992-9#1)(2009-1#1)(2010-3#1)(2013-8#1)
tumor therapy##4##2##(1991-2#1)(1992-9#1)(2010-3#1)(2013-8#1)
tumor thrombus in the##2##4##(2011-2#2)
tumor thrombus in##3##3##(2011-2#3)
tumor thrombus##4##2##(2011-2#4)
tumor tissue by##2##3##(1990-12#1)(1990-2#1)
tumor tissue##19##2##(1990-12#1)(1990-2#1)(1991-4#1)(1992-3#1)(1992-9#3)(1993-11#1)(1994-2#1)(1997-8#1)(2007-11#1)(2008-4#2)(2008-9#1)(2009-4#2)(2010-12#2)(2012-2#1)
tumor tissues##7##2##(1994-2#2)(2008-11#1)(2008-8#1)(2008-9#2)(2010-7#1)
tumor to##4##2##(1990-6#1)(2008-1#1)(2012-12#1)(2012-3#1)
tumor type##5##2##(1997-7#1)(2008-7#2)(2011-2#1)(2012-12#1)
tumor types##9##2##(1991-8#1)(1993-9#1)(1997-8#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
tumor uptake##4##2##(2010-6#2)(2013-1#2)
tumor vaccines##2##2##(2008-4#1)(2011-1#1)
tumor variants##2##2##(1992-9#2)
tumor vascular##2##2##(2008-3#2)
tumor vascularization##4##2##(2008-11#3)(2012-1#1)
tumor vasculature##4##2##(1993-9#2)(1994-5#1)(2008-3#1)
tumor virus##5##2##(1994-11#2)(1994-12#1)(1994-7#1)(2008-10#1)
tumor volume##6##2##(1995-9#2)(2007-4#1)(2009-2#2)(2010-11#1)
tumor volumes##3##2##(1992-9#1)(1994-12#1)(2013-1#1)
tumor was achieved##2##3##(2008-6#1)(2011-2#1)
tumor was composed of##6##4##(1991-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
tumor was composed##7##3##(1991-8#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
tumor was diagnosed as a##2##5##(1995-4#1)(2012-1#1)
tumor was diagnosed as##6##4##(1994-7#1)(1995-4#1)(2010-2#1)(2012-1#2)(2013-8#1)
tumor was diagnosed##7##3##(1994-7#1)(1995-4#1)(2010-11#1)(2010-2#1)(2012-1#2)(2013-8#1)
tumor was found##3##3##(1995-4#1)(2007-11#1)(2008-10#1)
tumor was not##2##3##(1994-7#1)(2008-12#1)
tumor was observed in##2##4##(1991-8#1)(1992-6#1)
tumor was observed##3##3##(1991-8#1)(1992-10#1)(1992-6#1)
tumor was performed##2##3##(2008-6#1)(2013-1#1)
tumor was##70##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-6#3)(1992-8#1)(1993-11#1)(1994-7#5)(1995-4#2)(2006-12#3)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#5)(2008-6#4)(2008-7#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#1)(2013-1#4)(2013-8#4)
tumor weight##2##2##(2008-8#1)(2011-2#1)
tumor were##5##2##(1991-8#1)(1992-2#1)(2008-10#2)(2012-3#1)
tumor which##3##2##(1990-6#1)(2012-12#1)(2013-8#1)
tumor with a##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)
tumor with the##2##3##(1994-12#1)(2013-1#1)
tumor with##33##2##(1991-4#1)(1992-10#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-7#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
tumor xenografts in##3##3##(2008-6#2)(2013-7#1)
tumor xenografts##6##2##(1994-3#1)(1995-3#1)(2008-6#2)(2013-7#1)(2013-8#1)
tumor##1959##1##(1990-10#2)(1990-11#9)(1990-12#26)(1990-2#13)(1990-3#1)(1990-5#7)(1990-6#13)(1990-7#7)(1990-8#11)(1990-9#4)(1991-10#3)(1991-12#17)(1991-2#11)(1991-3#1)(1991-4#10)(1991-5#2)(1991-6#18)(1991-8#15)(1991-9#5)(1992-1#3)(1992-10#5)(1992-11#1)(1992-12#12)(1992-2#25)(1992-3#12)(1992-5#6)(1992-6#8)(1992-7#2)(1992-8#17)(1992-9#32)(1993-1#9)(1993-11#23)(1993-12#4)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#10)(1993-8#8)(1993-9#31)(1994-11#9)(1994-12#35)(1994-2#12)(1994-3#4)(1994-5#28)(1994-6#19)(1994-7#17)(1994-8#14)(1994-9#6)(1995-1#1)(1995-10#2)(1995-12#6)(1995-2#16)(1995-3#4)(1995-4#13)(1995-6#7)(1995-8#1)(1995-9#8)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#5)(1996-6#1)(1997-1#9)(1997-2#5)(1997-3#2)(1997-4#7)(1997-7#10)(1997-8#6)(2006-10#1)(2006-12#11)(2007-10#13)(2007-11#30)(2007-12#15)(2007-2#1)(2007-4#7)(2007-5#12)(2007-7#6)(2007-8#45)(2008-1#23)(2008-10#54)(2008-11#84)(2008-12#27)(2008-2#6)(2008-3#13)(2008-4#45)(2008-5#28)(2008-6#48)(2008-7#29)(2008-8#40)(2008-9#48)(2009-1#10)(2009-10#4)(2009-11#10)(2009-12#5)(2009-2#5)(2009-3#51)(2009-4#15)(2009-5#9)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#9)(2010-1#8)(2010-11#11)(2010-12#15)(2010-2#8)(2010-3#48)(2010-4#1)(2010-5#4)(2010-6#13)(2010-7#8)(2010-8#11)(2010-9#4)(2011-1#44)(2011-2#140)(2012-1#17)(2012-12#25)(2012-2#25)(2012-3#38)(2013-1#114)(2013-7#7)(2013-8#60)
tumor's##2##1##(2009-8#1)(2012-2#1)
tumor)##2##1##(2008-4#1)(2010-3#1)
tumor-associated antigen##3##2##(1995-9#1)(2008-11#2)
tumor-associated antigens##7##2##(1993-11#1)(1993-9#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)
tumor-associated##18##1##(1993-11#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-9#2)(2008-11#5)(2008-6#2)(2009-3#1)(2011-1#1)(2011-2#1)
tumor-bearing mice##13##2##(1990-7#4)(1992-9#1)(1994-3#1)(2008-11#1)(2008-8#2)(2008-9#2)(2013-1#1)(2013-8#1)
tumor-bearing mouse##2##2##(1992-5#1)(2013-8#1)
tumor-bearing##18##1##(1990-2#1)(1990-7#4)(1991-12#1)(1992-5#1)(1992-9#1)(1994-3#1)(2008-11#1)(2008-8#2)(2008-9#2)(2010-1#1)(2013-1#1)(2013-8#2)
tumor-cell heterogeneity##2##2##(1992-9#2)
tumor-cell lysis##3##2##(1993-9#3)
tumor-cell##5##1##(1992-9#2)(1993-9#3)
tumor-derived##4##1##(1991-2#1)(1995-12#1)(2012-2#1)(2013-8#1)
tumor-free##3##1##(1993-9#1)(2007-12#2)
tumor-induced angiogenesis##2##2##(2008-11#2)
tumor-induced##4##1##(1995-3#1)(2008-11#2)(2008-7#1)
tumor-infiltrating T cells##2##3##(2011-1#2)
tumor-infiltrating lymphocytes##2##2##(1994-5#1)(2012-2#1)
tumor-infiltrating##5##1##(1994-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
tumor-initiating##2##1##(1990-7#2)
tumor-like lesions##2##2##(2013-1#2)
tumor-like##5##1##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
tumor-promoting##3##1##(1993-8#1)(2010-4#1)(2013-1#1)
tumor-related##4##1##(1990-12#1)(2008-6#1)(2008-7#1)(2010-12#1)
tumor-secreted##2##1##(1991-9#1)(2009-10#1)
tumor-selective##3##1##(1994-5#1)(2008-5#1)(2010-7#1)
tumor-specific##14##1##(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1997-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#2)(2013-1#2)
tumor-suppressor gene##2##2##(1993-8#1)(1993-9#1)
tumor-suppressor genes##2##2##(1993-8#1)(2008-9#1)
tumor-suppressor##5##1##(1993-8#2)(1993-9#1)(2008-9#1)(2012-2#1)
tumor/blood##3##1##(1993-11#1)(1995-2#2)
tumor/nontumor##2##1##(1993-11#2)
tumor?##2##1##(1995-12#1)(1995-9#1)
tumor]##4##1##(1990-2#1)(1994-5#1)(1996-3#1)(2012-3#1)
tumoral disease##2##2##(2007-11#2)
tumoral spheroids##2##2##(2011-2#2)
tumoral##19##1##(1990-3#1)(1991-6#2)(1994-11#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-4#4)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)
tumoricidal##3##1##(1993-9#2)(2013-1#1)
tumorigenesis and##2##2##(2012-12#2)
tumorigenesis by##2##2##(2008-11#1)(2008-8#1)
tumorigenesis in mice##2##3##(1992-8#2)
tumorigenesis in vivo##2##3##(1995-9#1)(1996-5#1)
tumorigenesis in##6##2##(1992-8#2)(1992-9#1)(1995-9#1)(1996-5#1)(2012-12#1)
tumorigenesis induced by PEUs##2##4##(2008-11#2)
tumorigenesis induced by biomaterials##2##4##(2008-11#2)
tumorigenesis induced by##4##3##(2008-11#4)
tumorigenesis of##4##2##(1992-9#1)(1995-10#1)(2010-3#1)(2011-2#1)
tumorigenesis was observed##2##3##(1992-9#1)(1996-5#1)
tumorigenesis##57##1##(1990-6#2)(1991-5#1)(1992-2#1)(1992-8#4)(1992-9#4)(1993-8#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-9#4)(1996-5#2)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#4)(2012-12#7)(2013-1#3)
tumorigenic cell lines##2##3##(1997-1#2)
tumorigenic cell##3##2##(1997-1#3)
tumorigenic clones##2##2##(1992-9#2)
tumorigenic in##2##2##(1992-9#2)
tumorigenic potential##4##2##(1992-9#1)(2008-11#1)(2009-3#1)(2012-12#1)
tumorigenic##24##1##(1990-11#1)(1990-8#1)(1992-9#9)(1993-1#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-9#1)(1997-1#3)(2008-10#1)(2008-11#1)(2009-3#2)(2012-12#1)
tumorigenicity in##2##2##(1992-2#1)(1992-9#1)
tumorigenicity of##3##2##(1990-12#1)(1993-1#1)(2012-12#1)
tumorigenicity##7##1##(1990-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
tumorous lesions##2##2##(1994-5#1)(2009-10#1)
tumorous lymphoblasts##2##2##(2008-5#2)
tumorous##6##1##(1994-5#1)(2008-11#1)(2008-5#2)(2009-10#1)(2013-8#1)
tumors (NETs) are a##2##4##(2011-2#2)
tumors (NETs)##3##2##(2011-2#3)
tumors (P = 0##4##4##(2008-3#2)(2008-7#1)(2012-3#1)
tumors (n =##3##3##(1990-7#1)(2008-3#1)(2008-7#1)
tumors after##4##2##(1992-9#1)(2008-11#1)(2011-1#1)(2012-12#1)
tumors and in##4##3##(1992-5#1)(1994-7#1)(1995-12#1)(2008-3#1)
tumors and its##2##3##(2008-11#1)(2012-12#1)
tumors and the##6##3##(1990-10#1)(1992-12#1)(2007-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
tumors and to##2##3##(1990-12#1)(2007-10#1)
tumors and##64##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-7#1)(1995-12#1)(1997-3#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#5)(2008-9#3)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
tumors are also##2##3##(2008-4#1)(2008-7#1)
tumors are generally##2##3##(2008-6#1)(2010-3#1)
tumors are mostly##2##3##(1997-8#1)(2008-5#1)
tumors are not##2##3##(2008-8#1)(2012-3#1)
tumors are rare##4##3##(1992-9#1)(2007-10#1)(2013-1#2)
tumors are##35##2##(1992-9#3)(1994-2#1)(1996-11#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
tumors arising from##2##3##(2006-12#1)(2011-2#1)
tumors as well as##3##4##(1994-7#1)(2009-11#1)(2011-2#1)
tumors as well##4##3##(1994-7#1)(2009-11#1)(2011-2#2)
tumors as##8##2##(1991-6#1)(1994-7#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
tumors at##4##2##(1990-5#1)(1992-8#1)(2008-3#1)(2012-3#1)
tumors by endoscopic ultrasonography##2##4##(1992-7#1)(2013-1#1)
tumors by##10##2##(1992-7#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-2#1)(2008-1#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
tumors can be##3##3##(2008-11#1)(2010-11#1)(2010-9#1)
tumors can##7##2##(2007-8#1)(2008-11#2)(2010-11#1)(2010-9#1)(2011-2#2)
tumors composed of##2##3##(2011-2#1)(2013-1#1)
tumors could##2##2##(2008-5#1)(2013-8#1)
tumors detected##2##2##(2008-1#1)(2008-4#1)
tumors developed in##3##3##(2006-12#1)(2008-10#1)(2011-1#1)
tumors developed##4##2##(2006-12#2)(2008-10#1)(2011-1#1)
tumors developing in##2##3##(2011-2#1)(2013-1#1)
tumors diagnosed as##2##3##(1995-4#1)(2008-11#1)
tumors did not##3##3##(1993-11#1)(2008-10#1)(2012-12#1)
tumors express##2##2##(1997-4#1)(2013-8#1)
tumors for##2##2##(1990-6#1)(2011-1#1)
tumors found in##2##3##(1990-2#1)(1994-6#1)
tumors from patients with##2##4##(1993-11#2)
tumors from##11##2##(1990-7#1)(1992-2#1)(1993-11#3)(1993-9#2)(2008-6#2)(2010-1#1)(2013-1#1)
tumors had a##2##3##(2012-3#1)(2013-1#1)
tumors had##8##2##(1991-2#1)(1993-1#1)(1993-9#1)(1995-4#2)(2007-4#1)(2012-3#1)(2013-1#1)
tumors has been##2##3##(1997-7#1)(2013-1#1)
tumors has##4##2##(1997-7#1)(2008-7#1)(2012-12#1)(2013-1#1)
tumors have##7##2##(1993-11#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#2)(2013-1#1)
tumors in Syrian hamsters##2##4##(1992-5#2)
tumors in a##3##3##(1995-2#1)(2012-2#1)(2012-3#1)
tumors in adults##2##3##(2008-2#1)(2013-8#1)
tumors in children##3##3##(1990-2#1)(1993-9#1)(2008-10#1)
tumors in humans##2##3##(2008-12#1)(2012-1#1)
tumors in nude mice##4##4##(1993-1#1)(1993-9#2)(2008-8#1)
tumors in rats##2##3##(1993-9#1)(1994-5#1)
tumors in the##17##3##(1990-6#1)(1990-9#1)(1992-2#1)(1993-11#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-3#3)(2010-7#2)(2011-2#2)(2012-3#1)
tumors in these##2##3##(1990-9#1)(1992-5#1)
tumors in this##2##3##(1997-4#1)(2008-4#1)
tumors in vivo##3##3##(1992-8#1)(1994-5#1)(1994-8#1)
tumors in which##2##3##(1994-7#1)(2007-12#1)
tumors in##70##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#1)(1992-2#2)(1992-5#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-9#4)(1994-2#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-4#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#3)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
tumors induced by##2##3##(2008-7#1)(2013-7#1)
tumors induced##3##2##(1990-10#1)(2008-7#1)(2013-7#1)
tumors involving the##2##3##(2009-3#1)(2010-7#1)
tumors is a##4##3##(1997-7#1)(2007-11#1)(2011-2#1)(2012-3#1)
tumors is##17##2##(1991-12#1)(1991-2#1)(1991-9#1)(1993-9#1)(1997-7#2)(1997-8#2)(2007-11#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
tumors may##5##2##(1990-6#1)(1994-2#1)(1997-7#1)(1997-8#1)(2009-5#1)
tumors occurred in##2##3##(1991-8#1)(2008-4#1)
tumors of a##2##3##(1994-12#1)(2008-10#1)
tumors of mesenchymal origin##2##4##(2007-8#1)(2011-2#1)
tumors of other##2##3##(1990-2#1)(1992-12#1)
tumors of the ovary##5##4##(1993-9#3)(2007-8#2)
tumors of the pancreas##2##4##(1990-9#1)(2008-3#1)
tumors of the pelvic##3##4##(1990-5#2)(1993-8#1)
tumors of the small intestine##3##5##(1991-5#2)(1997-3#1)
tumors of the##38##3##(1990-5#2)(1990-9#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-5#1)(1993-5#1)(1993-8#1)(1993-9#5)(1994-6#1)(1995-11#1)(1997-3#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-3#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
tumors of##63##2##(1990-2#3)(1990-5#2)(1990-9#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-8#1)(1993-9#6)(1994-12#1)(1994-6#2)(1995-11#1)(1997-3#2)(1997-7#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#5)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#5)(2012-12#3)(2013-1#3)(2013-8#1)
tumors on##2##2##(1997-8#1)(2011-2#1)
tumors or##8##2##(1991-9#1)(1997-3#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-5#1)
tumors per mouse at a total initiator dose of 1##2##10##(1990-7#2)
tumors per mouse##4##3##(1990-7#4)
tumors presented with##2##3##(2008-3#2)
tumors requires##3##2##(2010-9#1)(2012-2#1)(2012-3#1)
tumors tend to be##2##4##(2008-6#1)(2010-3#1)
tumors than##5##2##(1992-9#1)(1993-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
tumors that are##3##3##(1993-11#1)(2011-2#2)
tumors that occur##2##3##(1990-12#1)(2012-3#1)
tumors that##16##2##(1990-12#1)(1993-11#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2010-6#1)(2011-2#7)(2012-3#1)
tumors to be##2##3##(2006-12#1)(2011-2#1)
tumors to the##2##3##(1992-10#1)(2011-2#1)
tumors to##7##2##(1992-10#1)(2006-12#1)(2007-11#1)(2011-2#2)(2013-7#2)
tumors treated with##2##3##(1992-2#1)(2012-12#1)
tumors using##6##2##(1992-5#1)(1994-2#1)(2007-8#1)(2008-5#2)(2013-1#1)
tumors was investigated##2##3##(1990-7#1)(2008-2#1)
tumors was##10##2##(1990-6#1)(1990-7#1)(1993-11#1)(1994-2#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2013-1#1)
tumors were found##2##3##(1994-7#1)(2013-1#1)
tumors were identified##2##3##(1993-5#1)(2011-1#1)
tumors were observed in the##2##5##(1992-9#1)(1994-5#1)
tumors were observed in##3##4##(1992-9#1)(1994-5#1)(2008-10#1)
tumors were observed##4##3##(1992-5#1)(1992-9#1)(1994-5#1)(2008-10#1)
tumors were studied##2##3##(1990-6#1)(2009-11#1)
tumors were##38##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-6#1)(1992-5#1)(1992-9#2)(1993-1#3)(1993-5#1)(1994-12#1)(1994-5#2)(1994-7#1)(1996-5#1)(1997-1#1)(2006-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-1#5)(2013-8#3)
tumors which##3##2##(2010-3#1)(2010-9#1)(2011-2#1)
tumors will##2##2##(2008-5#1)(2009-8#1)
tumors with a##3##3##(1991-4#1)(1997-2#1)(2010-12#1)
tumors with high##2##3##(1993-11#1)(2010-6#1)
tumors with respect to##2##4##(2009-4#1)(2011-1#1)
tumors with the##2##3##(1992-1#1)(1993-6#1)
tumors with##35##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-4#1)(1992-1#1)(1993-11#2)(1993-6#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)
tumors##951##1##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#14)(1990-3#1)(1990-5#3)(1990-6#10)(1990-7#9)(1990-8#2)(1990-9#6)(1991-12#5)(1991-2#8)(1991-3#2)(1991-4#4)(1991-5#5)(1991-6#4)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#4)(1992-12#3)(1992-2#11)(1992-3#1)(1992-5#15)(1992-7#1)(1992-8#9)(1992-9#24)(1993-1#11)(1993-11#15)(1993-12#1)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#21)(1994-12#11)(1994-2#7)(1994-3#2)(1994-5#10)(1994-6#4)(1994-7#8)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#8)(1995-4#8)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#2)(1997-7#6)(1997-8#9)(2006-12#14)(2007-10#8)(2007-11#20)(2007-12#6)(2007-4#2)(2007-5#6)(2007-7#5)(2007-8#22)(2008-1#6)(2008-10#22)(2008-11#24)(2008-12#9)(2008-2#8)(2008-3#21)(2008-4#16)(2008-5#11)(2008-6#25)(2008-7#41)(2008-8#7)(2008-9#11)(2009-11#3)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#24)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#2)(2010-9#11)(2011-1#16)(2011-2#93)(2012-1#5)(2012-12#21)(2012-2#17)(2012-3#26)(2013-1#62)(2013-7#4)(2013-8#20)
tumors)##7##1##(1992-5#4)(1992-9#1)(1993-9#1)(2008-1#1)
tumors]##15##1##(1990-9#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-3#1)(2010-9#4)(2011-1#1)(2012-3#1)(2013-1#1)
tumour (n =##2##3##(1994-3#2)
tumour ablation##2##2##(2008-2#1)(2008-7#1)
tumour and target volumes for radiotherapy##2##6##(2008-2#2)
tumour and the##4##3##(1991-11#1)(2007-8#1)(2008-7#2)
tumour and##22##2##(1991-11#1)(1992-8#2)(1997-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-7#1)
tumour as##2##2##(2008-7#1)(2013-7#1)
tumour at##2##2##(2007-8#1)(2012-2#1)
tumour bed##4##2##(2008-7#2)(2011-2#2)
tumour biopsy##2##2##(1996-12#2)
tumour cell line##6##3##(1990-6#2)(2008-11#3)(2008-2#1)
tumour cell lines in##2##4##(1993-9#1)(1995-12#1)
tumour cell lines##4##3##(1992-9#1)(1993-9#1)(1995-12#1)(1997-7#1)
tumour cell##17##2##(1990-6#2)(1992-9#3)(1993-9#1)(1994-3#1)(1995-12#2)(1997-7#1)(2008-11#4)(2008-2#1)(2008-6#1)(2009-4#1)
tumour cells and##4##3##(1995-12#1)(1997-4#1)(2011-2#1)(2013-7#1)
tumour cells by##2##3##(1993-9#1)(2008-11#1)
tumour cells in##2##3##(2008-7#1)(2008-9#1)
tumour cells to##4##3##(1992-9#2)(2008-6#1)(2013-8#1)
tumour cells##30##2##(1990-6#2)(1991-6#1)(1992-9#5)(1993-9#2)(1995-12#1)(1997-3#2)(1997-4#1)(2007-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-3#2)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
tumour development##2##2##(1992-3#1)(2009-4#1)
tumour embolism##2##2##(2008-6#2)
tumour excision##4##2##(1995-5#1)(2008-6#2)(2008-7#1)
tumour formation##3##2##(2009-4#1)(2009-5#1)(2011-3#1)
tumour grade or##2##3##(2006-8#1)(2011-2#1)
tumour grade##5##2##(2006-8#1)(2011-2#4)
tumour growth##7##2##(1993-8#1)(1993-9#1)(1995-12#1)(1997-3#1)(2007-10#1)(2008-7#2)
tumour in the##8##3##(2007-8#1)(2008-12#1)(2008-7#4)(2008-8#1)(2013-7#1)
tumour in##19##2##(1994-3#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#2)(2013-8#1)
tumour induced by##2##3##(1995-11#1)(2008-5#1)
tumour initiating##2##2##(1992-2#2)
tumour invasion##2##2##(2008-6#1)(2008-7#1)
tumour is a##4##3##(1993-3#1)(2008-7#1)(2012-2#1)(2012-8#1)
tumour is##11##2##(1993-3#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-7#1)
tumour kill##4##2##(2008-7#4)
tumour location##2##2##(2006-8#2)
tumour marker##4##2##(1990-11#1)(1992-9#1)(1995-12#1)(2008-10#1)
tumour mass##3##2##(1993-8#1)(2008-7#2)
tumour mimics##2##2##(2012-2#2)
tumour models##2##2##(1995-12#1)(2008-4#1)
tumour necrosis factor (TNF)##3##4##(1990-2#1)(1996-2#2)
tumour necrosis factor (TNF)-alpha##2##4##(1995-5#1)(2011-2#1)
tumour necrosis factor##6##3##(1990-2#1)(1995-5#1)(1996-2#2)(2008-7#1)(2011-2#1)
tumour necrosis factor-alpha (TNF-alpha)##2##4##(1992-8#1)(1996-12#1)
tumour necrosis factor-alpha##6##3##(1992-8#2)(1996-12#1)(2007-11#2)(2008-7#1)
tumour necrosis factor-α##2##3##(2012-1#1)(2013-8#1)
tumour necrosis##17##2##(1990-2#1)(1992-8#2)(1995-5#1)(1996-12#1)(1996-2#2)(2007-11#2)(2008-10#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
tumour of the cystic duct##2##5##(2008-12#2)
tumour of the lung##3##4##(2008-7#2)(2013-7#1)
tumour of the urinary##2##4##(1993-9#1)(2008-10#1)
tumour of the##24##3##(1992-6#1)(1993-9#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-6#4)(2008-7#4)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
tumour of##31##2##(1992-6#1)(1993-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-6#5)(2008-7#5)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
tumour perfusion##3##2##(2008-7#3)
tumour progression##10##2##(1991-3#1)(2009-4#3)(2011-2#2)(2013-1#4)
tumour promoter##2##2##(2008-2#1)(2012-2#1)
tumour promoting##3##2##(1992-2#3)
tumour recurrence##5##2##(2008-1#2)(2008-7#2)(2013-1#1)
tumour removal##4##2##(2007-11#1)(2008-7#2)(2008-9#1)
tumour resection##3##2##(2007-11#1)(2008-6#1)(2012-8#1)
tumour response##4##2##(2007-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
tumour showed##2##2##(2008-6#1)(2013-7#1)
tumour size##7##2##(1992-5#1)(1993-9#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-6#1)(2011-2#1)
tumour so##2##2##(1993-3#1)(2007-11#1)
tumour spread##4##2##(2008-1#1)(2012-2#3)
tumour suppressor gene##4##3##(1992-3#1)(1997-7#1)(2008-6#1)(2009-5#1)
tumour suppressor genes##5##3##(1997-3#1)(2008-7#2)(2009-4#1)(2011-2#1)
tumour suppressor##10##2##(1991-11#1)(1992-3#1)(1997-3#1)(1997-7#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2011-2#1)
tumour tissues##2##2##(1991-5#1)(1992-2#1)
tumour to##4##2##(1997-1#1)(2008-6#1)(2008-9#1)(2009-4#1)
tumour types##5##2##(1995-2#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
tumour volume##7##2##(1992-8#1)(1997-4#2)(2008-2#3)(2011-3#1)
tumour was diagnosed as##2##4##(2012-2#1)(2013-7#1)
tumour was diagnosed##3##3##(2007-8#1)(2012-2#1)(2013-7#1)
tumour was##22##2##(1991-6#1)(1995-8#1)(2007-8#1)(2008-6#4)(2008-7#8)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
tumour with##5##2##(1991-11#1)(2007-11#1)(2008-10#1)(2012-8#1)(2013-1#1)
tumour##491##1##(1990-11#5)(1990-2#1)(1990-5#4)(1990-6#6)(1990-9#1)(1991-11#3)(1991-3#1)(1991-5#1)(1991-6#5)(1991-9#1)(1992-2#8)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#6)(1992-9#11)(1993-3#4)(1993-8#2)(1993-9#6)(1994-3#4)(1995-11#1)(1995-12#6)(1995-2#2)(1995-5#3)(1995-8#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#10)(1997-4#6)(1997-6#2)(1997-7#2)(1997-8#1)(2006-8#4)(2007-10#4)(2007-11#16)(2007-5#1)(2007-8#9)(2008-1#9)(2008-10#15)(2008-11#8)(2008-12#4)(2008-2#13)(2008-4#4)(2008-5#4)(2008-6#55)(2008-7#83)(2008-8#2)(2008-9#5)(2009-4#14)(2009-5#3)(2009-7#1)(2010-10#1)(2010-3#4)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#31)(2011-3#5)(2012-1#2)(2012-12#7)(2012-2#18)(2012-8#4)(2013-1#17)(2013-7#11)(2013-8#8)
tumour-associated##3##1##(1993-2#2)(1994-12#1)
tumoural progression amongst##2##3##(2013-1#2)
tumoural progression##5##2##(2013-1#5)
tumoural##6##1##(2013-1#6)
tumourigenesis##4##1##(1994-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
tumourigenic##2##1##(2008-6#2)
tumourous##2##1##(2008-5#1)(2008-7#1)
tumours (n=4)##3##2##(2008-12#3)
tumours and in##2##3##(1997-3#1)(2009-4#1)
tumours and the##4##3##(1997-3#1)(2008-1#1)(2008-8#1)(2012-2#1)
tumours and##20##2##(1991-6#1)(1992-11#2)(1994-10#1)(1994-11#1)(1997-2#1)(1997-3#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-8#1)(2009-4#2)(2011-2#1)(2012-2#3)
tumours are##10##2##(1990-2#1)(1991-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-4#1)
tumours arising##2##2##(2008-6#1)(2011-2#1)
tumours at##4##2##(2008-6#3)(2008-7#1)
tumours display##2##2##(2008-11#2)
tumours expressed##2##2##(1995-12#1)(2013-1#1)
tumours following##2##2##(2008-6#1)(2012-2#1)
tumours from##4##2##(1992-2#1)(2008-1#1)(2008-7#1)(2011-2#1)
tumours had raised##2##3##(1992-11#2)
tumours have been##2##3##(1995-2#1)(2008-7#1)
tumours in a##2##3##(1990-12#1)(2012-3#1)
tumours in adults##2##3##(2013-1#2)
tumours in the##7##3##(1991-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-11#1)(2012-2#1)(2013-1#1)
tumours in##23##2##(1990-12#1)(1991-11#1)(1991-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-11#2)(2007-8#1)(2008-6#2)(2008-7#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
tumours is##5##2##(1990-2#1)(1991-11#1)(1991-6#1)(2008-2#1)(2011-3#1)
tumours may be##2##3##(1990-11#1)(2007-8#1)
tumours of the##16##3##(1991-11#1)(1993-5#1)(1993-9#2)(1994-9#1)(2007-11#1)(2007-8#1)(2008-6#6)(2008-7#1)(2011-2#1)(2012-2#1)
tumours of##20##2##(1991-11#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#7)(2008-7#1)(2011-2#1)(2012-2#1)
tumours on the##2##3##(1991-6#1)(2011-3#1)
tumours that are##2##3##(2011-2#1)(2012-2#1)
tumours that##5##2##(1996-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
tumours to##2##2##(2007-11#1)(2011-2#1)
tumours was found##2##3##(1991-6#1)(1992-11#1)
tumours was##8##2##(1991-6#2)(1992-11#1)(1996-5#1)(2006-8#1)(2008-6#1)(2008-7#2)
tumours were##11##2##(1990-12#2)(1997-4#1)(2006-8#3)(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
tumours when##2##2##(2008-7#1)(2011-2#1)
tumours who##2##2##(2007-8#1)(2013-7#1)
tumours with##9##2##(1992-9#1)(1993-9#1)(1994-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-3#1)(2013-7#1)
tumours without##2##2##(1993-9#1)(2013-1#1)
tumours##340##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#6)(1991-6#9)(1991-8#2)(1991-9#3)(1992-11#10)(1992-2#1)(1992-9#3)(1993-5#4)(1993-8#1)(1993-9#6)(1994-10#9)(1994-11#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-2#3)(1997-3#3)(1997-4#5)(1997-6#2)(1997-8#1)(2006-8#12)(2007-10#1)(2007-11#10)(2007-5#1)(2007-8#8)(2008-1#8)(2008-10#4)(2008-11#5)(2008-12#6)(2008-2#6)(2008-4#2)(2008-5#5)(2008-6#38)(2008-7#37)(2008-8#4)(2009-11#1)(2009-4#8)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-9#2)(2011-1#6)(2011-2#22)(2011-3#3)(2012-12#3)(2012-2#24)(2012-3#2)(2013-1#12)(2013-7#7)(2013-8#3)
tumours)##3##1##(1991-6#1)(2007-8#2)
tuna fish##2##2##(2011-2#2)
tuna##5##1##(1994-5#2)(2008-6#1)(2011-2#2)
tunability in##2##2##(2007-11#1)(2008-3#1)
tunability is achieved by##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
tunability is achieved##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
tunability of the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
tunability of##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
tunability over##2##2##(2007-11#1)(2008-3#1)
tunability##23##1##(2007-11#9)(2007-12#7)(2008-10#1)(2008-2#3)(2008-3#3)
tunable ArF excimer laser##2##4##(2007-12#1)(2008-2#1)
tunable CO(2) laser##2##3##(2008-10#1)(2008-3#1)
tunable CO(2)##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
tunable Fabry-Perot etalon##2##3##(2008-3#2)
tunable KrF excimer laser##2##4##(2008-3#2)
tunable Ti##2##2##(2008-2#1)(2008-3#1)
tunable Tm##2##2##(2007-12#2)
tunable across the##2##3##(2007-12#1)(2008-2#1)
tunable and##4##2##(2007-11#2)(2007-12#1)(2009-8#1)
tunable coherent##2##2##(2007-12#1)(2008-3#1)
tunable continuous-wave##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
tunable control over the##3##4##(2008-12#3)
tunable control over##4##3##(2008-12#4)
tunable control##5##2##(2007-12#1)(2008-12#4)
tunable cw##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
tunable diode laser absorption spectrometer##3##5##(2008-3#3)
tunable diode laser absorption##4##4##(2008-2#1)(2008-3#3)
tunable diode laser spectrometer##2##4##(2008-3#2)
tunable diode laser##10##3##(2007-12#1)(2008-2#1)(2008-3#8)
tunable diode lasers##4##3##(2007-12#1)(2008-3#3)
tunable diode##14##2##(2007-12#2)(2008-2#1)(2008-3#11)
tunable dye laser##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
tunable external-cavity##3##2##(2007-11#1)(2007-12#2)
tunable far-infrared radiation##3##3##(2007-11#2)(2007-12#1)
tunable far-infrared##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
tunable fiber ring##3##3##(2007-11#1)(2008-3#2)
tunable fiber##5##2##(2007-11#2)(2008-3#3)
tunable fiber-film coupler##2##3##(2008-2#2)
tunable fiber-film##3##2##(2008-2#2)(2008-3#1)
tunable filter##13##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#2)
tunable frequency##2##2##(2007-11#1)(2008-2#1)
tunable from 1##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
tunable from##11##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#2)
tunable in a##2##3##(2007-11#2)
tunable in the##7##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
tunable in##9##2##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#1)
tunable laser diode##2##3##(2008-2#1)(2008-3#1)
tunable laser##11##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#7)
tunable lasers##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
tunable narrow-band##3##2##(2007-11#2)(2008-2#1)
tunable narrow-bandwidth##2##2##(2007-11#1)(2008-2#1)
tunable operation of a diode-pumped##2##5##(2007-12#1)(2008-2#1)
tunable operation of a##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
tunable operation##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
tunable optical##6##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
tunable output power##2##3##(2008-2#2)
tunable output##5##2##(2008-2#3)(2008-3#1)(2013-8#1)
tunable over a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
tunable over##12##2##(2007-11#7)(2007-12#2)(2008-2#3)
tunable phase##2##2##(2007-11#1)(2007-12#1)
tunable pulsed##2##2##(2008-3#2)
tunable second-harmonic##2##2##(2008-3#1)(2011-1#1)
tunable single-frequency##3##2##(2007-11#1)(2008-3#2)
tunable to##2##2##(2008-2#1)(2008-5#1)
tunable ultraviolet##4##2##(2007-11#1)(2008-2#3)
tunable wavelength conversion of##2##4##(2007-12#2)
tunable wavelength##4##2##(2007-12#2)(2008-3#2)
tunable##275##1##(1992-6#1)(2006-4#1)(2007-11#50)(2007-12#61)(2008-10#8)(2008-12#4)(2008-2#61)(2008-3#72)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#4)(2013-1#1)(2013-8#3)
tundra##2##1##(2008-9#1)(2011-2#1)
tune the##12##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2010-2#1)
tune##17##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#1)
tuneable##2##1##(2008-7#2)
tuned at##2##2##(2007-12#2)
tuned by adjustment of the##2##5##(2007-12#2)
tuned by use of##2##4##(2007-11#2)
tuned by##13##2##(1996-2#1)(2007-11#4)(2007-12#3)(2008-2#2)(2008-6#1)(2011-1#1)(2012-2#1)
tuned for##3##2##(2008-2#1)(2008-4#1)(2011-1#1)
tuned from 2##2##3##(2007-12#2)
tuned from##8##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-7#1)
tuned in##2##2##(2007-12#2)
tuned over a##2##3##(2007-11#1)(2008-3#1)
tuned over##11##2##(2007-11#5)(2007-12#4)(2008-3#2)
tuned the##4##2##(2007-11#2)(2008-3#2)
tuned to the##2##3##(2006-10#1)(2008-3#1)
tuned to##9##2##(2006-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
tuned with a##2##3##(2008-2#1)(2008-7#1)
tuned with##4##2##(2007-11#1)(2008-2#2)(2008-7#1)
tuned##85##1##(1992-12#2)(1994-12#2)(1995-5#1)(1996-2#1)(2006-10#1)(2007-11#19)(2007-12#22)(2008-11#2)(2008-2#10)(2008-3#12)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
tunes##2##1##(2008-10#1)(2010-12#1)
tungiasis##3##1##(2007-2#3)
tungro disease##2##2##(2008-10#2)
tungro##5##1##(2008-10#5)
tungstate##6##1##(2007-12#1)(2008-10#3)(2013-8#2)
tungstates##2##1##(2008-3#2)
tungsten (VI)##2##2##(2008-10#1)(2009-11#1)
tungsten based##3##2##(2008-10#2)(2009-11#1)
tungsten carbide##2##2##(2007-12#1)(2008-10#1)
tungsten coil atomizer##5##3##(2008-10#5)
tungsten coil electrothermal atomic absorption spectrometry##6##6##(2008-10#6)
tungsten coil electrothermal atomic absorption##7##5##(2008-10#7)
tungsten coil##15##2##(2008-10#15)
tungsten electrode##2##2##(2008-10#2)
tungsten in##10##2##(2008-10#10)
tungsten nanoparticles##2##2##(2008-10#2)
tungsten oxide##4##2##(2008-10#3)(2008-2#1)
tungsten oxide-based##2##2##(2008-10#2)
tungsten plus noble metal##2##4##(2008-10#2)
tungsten tip##2##2##(2007-12#2)
tungsten was##2##2##(2008-10#2)
tungsten wire preconcentration##2##3##(2008-10#2)
tungsten wire##10##2##(2008-10#9)(2009-5#1)
tungsten with##2##2##(2008-10#2)
tungsten##84##1##(2007-11#1)(2007-12#3)(2008-10#74)(2008-2#2)(2009-11#2)(2009-5#1)(2010-4#1)
tungsten(VI)##5##1##(2008-10#5)
tungsten-halogen##2##1##(2008-10#1)(2008-3#1)
tunic granulocytes##3##2##(2008-7#3)
tunic##10##1##(2008-5#2)(2008-7#8)
tunica vaginalis##2##2##(2008-10#2)
tunica##7##1##(2008-10#2)(2008-11#1)(2009-10#3)(2012-3#1)
tunicamycin##8##1##(1991-9#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-11#1)(2012-2#1)(2013-1#2)
tunicate##2##1##(2008-5#2)
tuning and spectral properties of distributed feedback##2##7##(2008-3#2)
tuning and##6##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-9#1)
tuning at##2##2##(1993-12#1)(2008-3#1)
tuning by use of##2##4##(2007-12#2)
tuning by##4##2##(2007-12#2)(2008-3#2)
tuning curve for##2##3##(1996-2#1)(2008-2#1)
tuning curve##3##2##(1996-2#1)(2008-11#1)(2008-2#1)
tuning curves##2##2##(2008-11#1)(2008-8#1)
tuning element##3##2##(2008-2#2)(2008-3#1)
tuning fork##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
tuning from##3##2##(2007-11#1)(2007-12#2)
tuning in a##4##3##(2007-12#4)
tuning in the##2##3##(2007-11#1)(2008-3#1)
tuning in##8##2##(2007-11#1)(2007-12#5)(2008-11#1)(2008-3#1)
tuning is##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
tuning of a single-mode##3##4##(2007-11#2)(2007-12#1)
tuning of a##6##3##(2007-11#3)(2007-12#2)(2008-3#1)
tuning of an##3##3##(2007-11#1)(2007-12#2)
tuning of the crystal##2##4##(2008-3#2)
tuning of the output##2##4##(2007-12#1)(2008-3#1)
tuning of the pump laser##3##5##(2007-11#2)(2007-12#1)
tuning of the pump##4##4##(2007-11#3)(2007-12#1)
tuning of the spectrum shape##2##5##(2008-2#2)
tuning of the##24##3##(2007-11#6)(2007-12#8)(2008-2#4)(2008-3#5)(2008-8#1)
tuning of##45##2##(2007-11#11)(2007-12#15)(2008-11#1)(2008-2#6)(2008-3#9)(2008-8#2)(2011-2#1)
tuning or##3##2##(2008-3#2)(2011-1#1)
tuning over a range##2##4##(2008-2#1)(2008-3#1)
tuning over a##4##3##(2008-2#3)(2008-3#1)
tuning over##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
tuning properties##2##2##(2008-11#2)
tuning range and##2##3##(2007-11#1)(2008-2#1)
tuning range is##2##3##(2007-11#2)
tuning range of from 800 to##2##6##(2008-2#2)
tuning range of the##2##4##(2007-12#1)(2008-2#1)
tuning range of##18##3##(2007-11#2)(2007-12#4)(2008-2#7)(2008-3#4)(2011-1#1)
tuning range was##2##3##(2007-12#1)(2008-2#1)
tuning range##38##2##(2007-11#9)(2007-12#7)(2008-2#14)(2008-3#7)(2011-1#1)
tuning ranges##2##2##(2008-2#1)(2008-3#1)
tuning speeds##2##2##(2007-11#2)
tuning the wavelength of the##4##5##(2006-4#1)(2007-11#2)(2007-12#1)
tuning the##16##2##(1996-5#1)(2006-4#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#1)(2010-12#1)
tuning to##3##2##(2007-12#1)(2008-3#2)
tuning was##2##2##(2007-11#1)(2008-2#1)
tuning width##2##2##(2008-11#1)(2008-2#1)
tuning with##4##2##(2007-12#3)(2008-2#1)
tuning##208##1##(1993-12#2)(1996-2#2)(1996-5#1)(2006-4#1)(2007-11#41)(2007-12#48)(2008-10#5)(2008-11#9)(2008-2#44)(2008-3#39)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-12#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-8#1)
tunnel by##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
tunnel diode##5##2##(2008-3#5)
tunnel infection##3##2##(2011-2#2)(2011-3#1)
tunnel length from 2##2##4##(2013-1#2)
tunnel length##3##2##(2013-1#3)
tunnel surface area##2##3##(2013-1#2)
tunnel surface##3##2##(2013-1#3)
tunnel syndrome in##2##3##(1996-2#1)(2007-8#1)
tunnel syndrome##31##2##(1994-11#1)(1996-2#1)(2007-8#3)(2008-12#6)(2008-5#2)(2008-9#15)(2010-8#2)(2013-1#1)
tunnel##104##1##(1991-12#1)(1994-11#3)(1995-1#1)(1996-2#2)(1997-2#1)(2007-11#1)(2007-12#4)(2007-8#5)(2008-10#2)(2008-11#2)(2008-12#7)(2008-3#8)(2008-5#3)(2008-9#35)(2009-10#2)(2009-6#1)(2010-5#3)(2010-8#2)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#13)
tunneled and cuffed hemodialysis catheters##2##5##(2007-7#2)
tunneled##3##1##(2007-7#2)(2011-2#1)
tunneling barrier##2##2##(2007-12#2)
tunneling cantilevers##2##2##(2008-3#2)
tunneling effect##2##2##(2008-3#2)
tunneling is##2##2##(2007-12#1)(2007-7#1)
tunneling microscope (STM)##2##3##(2008-8#1)(2010-7#1)
tunneling microscope##11##2##(1990-11#1)(1991-5#1)(2007-11#1)(2007-12#4)(2008-3#1)(2008-8#2)(2010-7#1)
tunneling microscopy##2##2##(1990-12#1)(2008-2#1)
tunneling of##2##2##(2007-12#1)(2012-1#1)
tunneling pathway##2##2##(1995-2#2)
tunneling spectroscopy##2##2##(2010-7#2)
tunneling through##2##2##(1992-11#1)(2008-3#1)
tunneling##55##1##(1990-11#1)(1990-12#1)(1991-5#1)(1992-11#3)(1995-2#3)(2007-11#3)(2007-12#13)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#12)(2008-8#2)(2009-9#3)(2010-4#3)(2010-7#4)(2011-2#1)(2012-1#1)
tunnelling##4##1##(2007-7#1)(2008-7#2)(2012-2#1)
tunnels per stalk in the gelatin capsule technique##2##8##(2011-2#2)
tunnels per stalk##5##3##(2011-2#5)
tunnels##19##1##(2008-3#1)(2008-9#1)(2009-10#7)(2011-2#7)(2013-1#3)
tuple-loading##2##1##(2009-9#2)
turanose##2##1##(1992-12#2)
turbid biological tissues##2##3##(2008-2#1)(2008-3#1)
turbid biological##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
turbid coastal and inland waters##2##5##(2008-3#2)
turbid coastal waters##3##3##(2008-3#3)
turbid coastal##5##2##(2008-3#5)
turbid material##2##2##(2008-2#1)(2008-3#1)
turbid media by use of a##2##6##(2007-12#1)(2008-3#1)
turbid media by use of##5##5##(2007-12#1)(2008-3#4)
turbid media by##8##3##(2007-11#1)(2007-12#2)(2008-3#5)
turbid media in a##2##4##(2007-12#1)(2008-3#1)
turbid media on a microscopic level##2##6##(2008-3#2)
turbid media over a##2##4##(2007-12#1)(2008-3#1)
turbid media that##2##3##(2007-12#1)(2008-3#1)
turbid media were##2##3##(2008-3#2)
turbid media with a##2##4##(2008-3#2)
turbid media with##5##3##(2007-12#1)(2008-3#4)
turbid media##72##2##(1994-2#1)(2007-11#7)(2007-12#10)(2008-2#8)(2008-3#41)(2009-10#1)(2011-1#3)(2011-2#1)
turbid medium are##2##3##(2008-2#1)(2008-3#1)
turbid medium such as##3##4##(2008-3#3)
turbid medium with##3##3##(2008-2#2)(2008-3#1)
turbid medium##36##2##(2007-11#3)(2007-12#6)(2008-2#10)(2008-3#17)
turbid samples##6##2##(2008-2#1)(2008-3#5)
turbid suspensions with##2##3##(2008-3#1)(2011-2#1)
turbid suspensions##4##2##(2008-2#1)(2008-3#2)(2011-2#1)
turbid water##3##2##(2008-2#3)
turbid waters##2##2##(2008-3#2)
turbid##149##1##(1994-2#1)(1994-3#1)(1995-2#1)(2007-11#12)(2007-12#18)(2008-10#1)(2008-2#29)(2008-3#80)(2009-10#1)(2011-1#3)(2011-2#2)
turbidimetric determination of##2##3##(2008-10#2)
turbidimetric##5##1##(1993-12#1)(2008-10#3)(2008-12#1)
turbidity and emulsifying##2##3##(2013-8#2)
turbidity and##6##2##(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#2)
turbidity changes##2##2##(1990-2#1)(2009-9#1)
turbidity of the##4##3##(1990-12#1)(2008-10#3)
turbidity of##5##2##(1990-12#1)(2008-10#3)(2009-9#1)
turbidity##35##1##(1990-12#1)(1990-2#1)(1997-4#1)(2007-5#1)(2008-10#10)(2008-2#5)(2008-3#2)(2008-6#1)(2008-8#1)(2009-6#2)(2009-9#4)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#2)
turbimetric##2##1##(2009-9#2)
turbinate region##2##2##(2008-11#1)(2013-1#1)
turbinate##8##1##(2008-11#1)(2008-4#1)(2008-5#4)(2012-1#1)(2013-1#1)
turbo##3##1##(2007-5#1)(2011-2#2)
turbot (Scophthalmus maximus)##3##3##(2010-5#1)(2012-2#2)
turbot Psetta maxima red blood cells##2##6##(2010-8#2)
turbot##9##1##(2010-5#5)(2010-8#2)(2012-2#2)
turbulence and##8##2##(2008-2#1)(2008-3#6)(2012-2#1)
turbulence are##2##2##(2008-3#2)
turbulence by##3##2##(2007-12#1)(2008-3#2)
turbulence can be##2##3##(2008-3#1)(2008-8#1)
turbulence effects##2##2##(2007-11#1)(2008-3#1)
turbulence in the##3##3##(2008-3#3)
turbulence is##3##2##(2007-12#1)(2008-3#2)
turbulence of##2##2##(1993-3#1)(2008-3#1)
turbulence on##6##2##(2008-3#6)
turbulence outer scale##3##3##(2008-2#1)(2008-3#2)
turbulence parameters##2##2##(2008-3#2)
turbulence promoter##2##2##(2008-7#2)
turbulence was##2##2##(2008-3#2)
turbulence with##3##2##(2007-12#1)(2008-3#2)
turbulence##99##1##(1992-11#1)(1992-8#1)(1993-3#1)(1993-5#1)(2007-11#4)(2007-12#5)(2008-12#1)(2008-2#10)(2008-3#67)(2008-5#1)(2008-7#2)(2008-8#2)(2012-2#2)(2013-1#1)
turbulence-induced index of refraction fluctuations##2##5##(2008-3#2)
turbulence-induced##8##1##(2008-2#1)(2008-3#7)
turbulent diffusion is too##2##4##(2008-8#2)
turbulent diffusion##3##2##(2008-8#3)
turbulent flow##4##2##(2008-2#2)(2008-3#1)(2008-9#1)
turbulent flows##4##2##(2008-3#3)(2008-9#1)
turbulent patterns##3##2##(2008-3#3)
turbulent##39##1##(1993-12#1)(1994-12#1)(1997-6#1)(2007-12#2)(2008-2#4)(2008-3#21)(2008-7#1)(2008-8#4)(2008-9#3)(2013-1#1)
turcica##8##1##(1991-6#1)(2008-10#6)(2013-1#1)
turcicum##2##1##(2008-10#2)
turcicum)##2##1##(2008-10#2)
turf battles##2##2##(1993-5#1)(1995-1#1)
turf grass##2##2##(2008-10#2)
turf on##2##2##(2008-10#1)(2013-1#1)
turf##20##1##(1993-5#1)(1995-1#1)(2008-10#13)(2008-11#2)(2013-1#3)
turfgrass##6##1##(2008-10#6)
turfgrasses##4##1##(2008-10#4)
turgidiscabies##5##1##(2008-10#5)
turgidum no##2##2##(2008-10#2)
turgidum sp##3##2##(2008-10#3)
turgidum subsp##4##2##(2012-3#4)
turgidum##13##1##(2008-10#5)(2008-5#2)(2008-8#1)(2012-3#5)
turgidum)##2##1##(2008-10#2)
turgor##3##1##(2009-6#1)(2013-1#2)
turkestani##3##1##(2008-12#3)
turkey GH cDNA##2##3##(1990-12#2)
turkey GH##6##2##(1990-12#6)
turkey adrenocortical cell##2##3##(1993-3#2)
turkey embryos##4##2##(2008-5#4)
turkey growth hormone##2##3##(1990-12#2)
turkey hens##2##2##(2013-1#2)
turkey poults##7##2##(1997-6#3)(2008-5#4)
turkey toms##2##2##(2013-1#2)
turkey##30##1##(1990-12#8)(1992-6#1)(1993-3#2)(1997-6#5)(2007-8#1)(2008-5#9)(2013-1#4)
turkeys in##3##2##(1997-6#2)(2013-1#1)
turkeys##17##1##(1997-6#3)(2007-6#1)(2007-8#3)(2013-1#10)
turkmenica##3##1##(2011-2#3)
turmeric and##2##2##(1992-9#1)(2012-3#1)
turmeric feeding on brain##2##4##(1994-8#2)
turmeric##11##1##(1992-9#2)(1994-8#7)(2008-11#1)(2012-3#1)
turn a##2##2##(2009-12#1)(2011-1#1)
turn back##2##2##(2008-3#1)(2008-8#1)
turn containing Cys-34##2##3##(1994-5#2)
turn in##3##2##(1995-5#1)(2008-1#1)(2013-1#1)
turn is##10##2##(1990-12#1)(1994-12#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
turn malignant##2##2##(2007-4#1)(2007-7#1)
turn of the##7##3##(1990-12#1)(1997-3#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
turn of##10##2##(1990-12#1)(1997-3#3)(2008-1#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
turn off##2##2##(1995-2#1)(1995-6#1)
turn on the##2##3##(1992-6#1)(2008-5#1)
turn on##4##2##(1992-6#1)(2008-5#1)(2012-12#1)(2012-2#1)
turn out to be##3##4##(2009-5#1)(2013-1#2)
turn over##2##2##(2008-8#1)(2011-2#1)
turn the##2##2##(2008-8#1)(2009-7#1)
turn this##2##2##(1994-3#1)(2011-2#1)
turn to##6##2##(1992-12#1)(1992-3#1)(1992-8#1)(2008-10#1)(2010-2#1)(2011-1#1)
turn your##2##2##(1994-12#1)(1995-2#1)
turn##264##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#4)(1993-3#1)(1994-1#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#4)(1994-9#2)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-6#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#23)(2008-11#11)(2008-12#7)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#15)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#6)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#1)
turnaroud time##2##2##(2013-1#2)
turnaround time (TAT)##2##3##(2010-6#1)(2011-2#1)
turnaround time##7##2##(1992-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-6#1)(2011-2#1)
turnaround##9##1##(1992-2#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
turned down##3##2##(1994-7#1)(1996-5#1)(2008-7#1)
turned into##3##2##(1992-12#1)(2008-4#1)(2008-5#1)
turned on##4##2##(1994-12#1)(2008-10#2)(2008-7#1)
turned out to be a very##2##6##(1991-5#1)(2008-11#1)
turned out to be a##6##5##(1991-5#1)(1992-4#1)(1997-6#1)(2007-7#1)(2008-11#1)(2011-1#1)
turned out to be##28##4##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-4#1)(1993-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
turned out to##29##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-4#1)(1993-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
turned out##32##2##(1990-3#2)(1990-5#1)(1991-12#1)(1991-5#2)(1992-4#1)(1993-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
turned over##2##2##(2008-11#1)(2010-3#1)
turned to##9##2##(1991-8#1)(1995-12#1)(1996-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2010-1#1)
turned##63##1##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-5#2)(1991-8#2)(1992-12#1)(1992-4#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-7#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
turner##3##1##(2008-6#1)(2009-12#2)
turning behaviour##3##2##(1995-12#2)(1997-2#1)
turning into##5##2##(2007-12#2)(2008-9#3)
turning movement##2##2##(1993-3#2)
turning point in##2##3##(2009-10#1)(2012-1#1)
turning point##8##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2009-10#1)(2009-7#1)(2012-1#1)
turning the##2##2##(2007-11#1)(2011-1#1)
turning to##5##2##(1993-3#1)(1996-1#1)(2008-11#1)(2009-11#1)(2009-9#1)
turning##40##1##(1990-4#1)(1993-3#3)(1995-1#1)(1995-12#3)(1996-1#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-7#2)(2009-9#1)(2011-1#1)(2012-1#1)(2013-7#1)
turnings##4##1##(2008-10#4)
turnip mosaic potyvirus##2##3##(2008-10#2)
turnip mosaic##5##2##(2008-10#5)
turnip yellow mosaic virus##2##4##(1997-3#2)
turnip##14##1##(1997-3#3)(2008-10#10)(2009-8#1)
turnkey##2##1##(2007-9#1)(2008-10#1)
turnover and regional attrition among physiotherapists in##2##7##(1994-3#2)
turnover and regional attrition##4##4##(1994-3#4)
turnover and##16##2##(1991-12#1)(1993-3#1)(1994-3#5)(1995-12#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-5#1)(2009-9#1)(2011-2#2)
turnover during##2##2##(1993-11#1)(1995-6#1)
turnover for##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
turnover in the olfactory organ of##2##6##(2007-12#2)
turnover in the##8##3##(1990-12#2)(1992-10#2)(1993-9#1)(2007-12#2)(2008-10#1)
turnover in##22##2##(1990-12#3)(1991-11#1)(1991-2#1)(1992-10#2)(1992-9#1)(1993-9#2)(1994-8#1)(1997-6#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#3)
turnover is##4##2##(1996-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
turnover markers##3##2##(2010-10#1)(2011-2#1)(2013-8#1)
turnover of the LDL receptor##2##5##(1990-7#2)
turnover of the##6##3##(1990-7#2)(1992-1#1)(1993-8#1)(2008-10#1)(2008-4#1)
turnover of##28##2##(1990-2#1)(1990-7#3)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1997-2#3)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2009-11#1)(2012-2#1)(2013-1#1)
turnover rate##10##2##(1991-2#1)(1995-11#1)(2008-12#1)(2008-5#5)(2008-9#1)(2009-5#1)
turnover rates were##2##3##(2007-5#2)
turnover rates##6##2##(1991-2#1)(2007-5#4)(2008-10#1)
turnover##158##1##(1990-12#5)(1990-2#3)(1990-7#3)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#6)(1993-2#3)(1993-3#2)(1993-8#2)(1993-9#4)(1994-3#6)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#7)(1997-6#2)(1997-7#4)(2007-11#1)(2007-12#5)(2007-5#4)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
turnover)##2##1##(1997-5#1)(2008-8#1)
turns and##5##2##(1995-12#3)(2008-10#2)
turns out that the##2##4##(2008-11#1)(2013-8#1)
turns out that##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
turns out to be a##3##5##(2008-3#1)(2012-2#2)
turns out to be##12##4##(2007-12#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#3)
turns out to##15##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#3)
turns out##18##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#3)(2013-8#1)
turns to##4##2##(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)
turns##43##1##(1990-11#1)(1993-11#1)(1993-2#1)(1995-12#5)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-8#1)
turpentine-induced##2##1##(1990-2#1)(1992-12#1)
turtle nesting##2##2##(2007-5#2)
turtle##15##1##(1995-3#4)(2007-5#4)(2008-8#2)(2010-3#2)(2013-1#3)
turtles and##3##2##(2013-1#3)
turtles##5##1##(2013-1#5)
tussilaginis##2##1##(2008-10#2)
tutor role##3##2##(2008-11#3)
tutor##9##1##(1994-12#1)(2008-11#6)(2008-12#2)
tutor-less##2##1##(2012-1#2)
tutorial support##7##2##(2008-11#7)
tutorial##19##1##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#7)(2008-12#1)(2009-10#1)(2009-2#1)(2012-12#1)(2013-8#1)
tutorials in##2##2##(2010-3#2)
tutorials##6##1##(1991-3#1)(2008-11#1)(2008-7#1)(2010-3#2)(2013-8#1)
tutors to##2##2##(2008-12#2)
tutors##7##1##(2008-10#1)(2008-11#2)(2008-12#4)
tweezer##3##1##(2007-11#1)(2009-12#2)
tweezer-type dithiocarbamoyl##2##2##(2008-10#2)
tweezer-type##5##1##(2008-10#5)
tweezers to##3##2##(2007-11#1)(2009-12#1)(2012-2#1)
tweezers##24##1##(2007-11#11)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-12#4)(2009-5#2)(2012-2#1)
twelfth week##2##2##(2007-11#2)
twelfth##7##1##(1991-6#1)(2007-11#2)(2008-10#1)(2008-6#1)(2011-2#2)
twelve and##2##2##(1992-3#1)(2008-9#1)
twelve months##4##2##(2007-11#1)(2011-1#1)(2012-3#2)
twelve patients##5##2##(1991-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
twelve species of##2##3##(2008-8#2)
twelve weeks##2##2##(2008-1#1)(2013-1#1)
twelve##53##1##(1990-2#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-6#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)
twentieth anniversary##3##2##(1995-1#2)(2013-1#1)
twentieth century##14##2##(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-7#2)(2010-1#3)(2011-2#3)(2012-12#1)
twentieth##24##1##(1995-1#2)(2008-10#4)(2008-12#1)(2008-8#1)(2009-10#1)(2009-7#2)(2010-1#6)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
twenty blind duplicates##2##3##(2009-8#2)
twenty four##2##2##(1993-3#1)(2013-8#1)
twenty of##2##2##(1991-2#1)(2009-10#1)
twenty years ago##2##3##(1993-12#1)(2011-2#1)
twenty years of##2##3##(1997-6#1)(2012-12#1)
twenty years##13##2##(1991-3#1)(1992-1#1)(1992-4#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
twenty##47##1##(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
twenty-eight##2##1##(2009-8#2)
twenty-first century##10##2##(1994-2#1)(1995-2#1)(1996-12#2)(1997-1#3)(1997-3#1)(2008-12#1)(2013-1#1)
twenty-five years##2##2##(1990-3#1)(2008-1#1)
twenty-five##7##1##(1990-3#1)(1993-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
twenty-four hours##2##2##(1990-5#1)(2008-9#1)
twenty-four##5##1##(1990-3#1)(1990-5#1)(2008-8#1)(2008-9#2)
twenty-nine##3##1##(1993-12#1)(1995-12#1)(2011-1#1)
twenty-one women##2##2##(1996-1#1)(1996-12#1)
twenty-one##7##1##(1991-2#1)(1991-5#1)(1993-12#1)(1996-1#1)(1996-12#1)(2007-12#1)(2010-4#1)
twenty-seven##3##1##(1996-8#1)(2008-10#1)(2012-2#1)
twenty-six##5##1##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
twenty-three##3##1##(1990-9#1)(1991-12#1)(2010-8#1)
twenty-two##5##1##(1996-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
twice a day for eight##2##5##(1996-12#1)(2013-1#1)
twice a day for##3##4##(1996-12#1)(2008-5#1)(2013-1#1)
twice a day##8##3##(1990-8#1)(1993-1#1)(1996-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
twice a multiple of the laser's effective cavity length##2##9##(2008-2#2)
twice a week for##8##4##(1990-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-12#1)
twice a week##14##3##(1990-11#1)(1990-3#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#2)
twice a year##2##3##(1994-9#1)(2013-8#1)
twice a##28##2##(1990-11#1)(1990-3#1)(1990-8#1)(1993-1#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
twice and##5##2##(1994-1#1)(1995-11#1)(2008-12#2)(2010-3#1)
twice as effective as##2##4##(2008-5#1)(2008-6#1)
twice as great as##2##4##(1995-12#1)(2012-2#1)
twice as great##3##3##(1995-12#1)(2008-4#1)(2012-2#1)
twice as high as in the##2##6##(2008-11#2)
twice as high as##5##4##(2007-12#1)(2008-10#1)(2008-11#3)
twice as high##8##3##(2007-12#1)(2008-10#2)(2008-11#4)(2013-1#1)
twice as large as the##2##5##(1992-3#1)(1993-1#1)
twice as large##3##3##(1992-3#1)(1993-1#1)(2008-6#1)
twice as likely to have##2##5##(2008-1#1)(2011-2#1)
twice as likely to##3##4##(2008-1#1)(2011-2#2)
twice as likely##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
twice as long##2##3##(2008-11#1)(2009-3#1)
twice as many##7##3##(1993-1#1)(1994-6#1)(2008-10#2)(2008-12#1)(2009-11#1)(2013-1#1)
twice as much##2##3##(1997-6#1)(2008-12#1)
twice as##39##2##(1992-3#1)(1993-1#2)(1994-6#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#3)(2012-2#1)(2013-1#2)
twice daily and##3##3##(1997-4#2)(2007-10#1)
twice daily for 3 months##2##5##(2008-5#2)
twice daily for 3##3##4##(2008-10#1)(2008-5#2)
twice daily for##10##3##(1993-11#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-5#3)(2009-5#1)(2010-8#1)
twice daily in##2##3##(1996-1#1)(2008-3#1)
twice daily##36##2##(1990-8#1)(1991-4#1)(1993-11#1)(1995-12#1)(1996-1#2)(1996-11#3)(1996-2#2)(1997-4#3)(2007-10#2)(2007-11#3)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)
twice daily)##3##2##(1992-8#1)(1993-12#1)(1996-2#1)
twice during##2##2##(2009-9#1)(2011-2#1)
twice that in##4##3##(1991-5#1)(1995-12#1)(2008-10#1)(2008-9#1)
twice that of##6##3##(1995-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2012-2#1)
twice that##11##2##(1990-3#1)(1991-5#1)(1995-12#1)(1995-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
twice the amount of##2##4##(1993-6#1)(2012-2#1)
twice the efficiency##2##3##(2008-2#1)(2008-3#1)
twice the frequency##2##3##(2008-3#1)(2012-2#1)
twice the magnitude of##2##4##(2007-11#1)(2008-2#1)
twice the value##2##3##(2008-10#1)(2008-7#1)
twice the##40##2##(1990-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#2)
twice using##2##2##(2008-11#1)(2011-1#1)
twice weekly from##2##3##(2008-12#1)(2012-6#1)
twice weekly##6##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-6#1)
twice##219##1##(1990-11#2)(1990-3#2)(1990-8#2)(1991-4#1)(1991-5#1)(1992-3#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1996-1#2)(1996-11#4)(1996-12#3)(1996-2#3)(1996-6#1)(1997-4#4)(1997-6#2)(1997-8#3)(2007-10#3)(2007-11#8)(2007-12#5)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#12)(2008-12#7)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#14)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#8)(2013-8#2)
twice-daily##5##1##(1997-2#1)(2008-5#2)(2011-2#2)
twice-weekly##3##1##(1992-8#1)(1997-6#1)(2008-10#1)
twig lesions##4##2##(2008-10#4)
twig##13##1##(2008-10#9)(2008-9#2)(2012-5#2)
twigs formed during the experimental period##2##6##(2012-5#2)
twigs##5##1##(2008-10#1)(2012-5#4)
twilight polarization##2##2##(2008-2#2)
twilight##5##1##(2008-10#1)(2008-2#4)
twill##2##1##(2007-11#1)(2008-3#1)
twin beams##3##2##(2007-11#3)
twin births##4##2##(1990-6#3)(1995-6#1)
twin gestation##4##2##(1995-6#1)(2009-6#2)(2013-1#1)
twin pairs##4##2##(1994-2#1)(1997-5#1)(2008-12#1)(2008-7#1)
twin pregnancies##3##2##(2007-11#2)(2010-8#1)
twin pregnancy##6##2##(2007-11#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
twin studies##3##2##(2008-1#1)(2008-7#1)(2010-12#1)
twin study##2##2##(2008-12#1)(2009-12#1)
twin##74##1##(1990-6#4)(1991-3#1)(1994-2#3)(1995-1#1)(1995-6#2)(1996-12#2)(1997-1#1)(1997-5#1)(2007-11#9)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-7#2)(2008-9#5)(2009-12#1)(2009-5#1)(2009-6#3)(2010-1#1)(2010-12#3)(2010-8#3)(2011-1#6)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)
twin-hole fiber##2##2##(2007-11#1)(2007-12#1)
twin-image##3##1##(2007-12#2)(2008-3#1)
twin-photon##3##1##(2007-11#3)
twin-ridge laterally coupled diode##2##4##(2007-11#2)
twin-ridge##3##1##(2007-11#3)
twinned aragonite##2##2##(2008-7#2)
twinned##3##1##(2008-7#2)(2010-8#1)
twinning##8##1##(2008-11#1)(2008-7#3)(2012-2#1)(2013-1#3)
twins and##6##2##(1997-7#2)(1997-8#1)(2007-11#1)(2010-1#1)(2011-2#1)
twins in##4##2##(2008-10#1)(2008-12#3)
twins who##2##2##(2008-12#1)(2011-1#1)
twins##50##1##(1990-6#1)(1993-8#1)(1995-6#3)(1997-7#5)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#5)(2008-12#6)(2008-7#5)(2008-8#1)(2009-5#1)(2009-7#2)(2010-1#5)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#2)(2012-3#1)
twins'##2##1##(2008-9#1)(2010-7#1)
twist in##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
twist rate##2##2##(2008-2#2)
twist##19##1##(1990-8#1)(1991-2#1)(2007-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#1)(2011-2#2)(2012-2#2)(2013-7#2)
twisted nematic##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
twisted##20##1##(1990-9#2)(1992-4#1)(1993-11#2)(1997-7#1)(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2010-9#1)
twisted-nematic liquid-crystal##4##2##(2007-12#2)(2008-2#2)
twisting cytometry##2##2##(2008-7#2)
twisting##6##1##(2008-10#1)(2008-12#1)(2008-7#2)(2012-2#2)
twists##12##1##(2007-8#10)(2008-10#1)(2008-3#1)
twitch contraction##3##2##(1990-2#1)(2013-8#2)
twitch forces to##2##3##(2012-7#2)
twitch##12##1##(1990-2#1)(1990-5#2)(1994-9#1)(1997-4#1)(2008-12#1)(2008-3#1)(2012-7#2)(2013-8#3)
twitchin##3##1##(1994-8#3)
twitching##2##1##(1990-5#1)(2009-9#1)
two &quot##5##2##(1995-3#1)(1997-6#1)(2008-10#2)(2008-5#1)
two (0##2##2##(2007-8#1)(2008-9#1)
two (1##2##2##(2007-8#2)
two (3##3##2##(2008-3#1)(2012-3#2)
two 500 mg/kg##2##3##(2008-9#2)
two 6##2##2##(1991-9#1)(2009-3#1)
two ATP-binding motifs##3##3##(1996-2#3)
two ATP-binding##4##2##(1995-9#1)(1996-2#3)
two BDNF##2##2##(1997-2#1)(2013-1#1)
two CO(2)##3##2##(2008-10#2)(2008-3#1)
two DNA##2##2##(1993-8#1)(2008-10#1)
two Dutch##2##2##(2008-10#2)
two European##2##2##(2008-10#1)(2008-7#1)
two FDA##2##2##(2012-12#2)
two G##2##2##(1993-6#1)(1994-12#1)
two G-protein coupled##2##3##(2009-3#1)(2012-2#1)
two Gaussian##2##2##(2008-10#1)(2008-2#1)
two H(2)O molecules##2##3##(2008-8#2)
two His##2##2##(1993-11#1)(2008-8#1)
two Italian##4##2##(2008-10#2)(2012-5#2)
two LEDs##2##2##(2008-10#2)
two MP##2##2##(1991-8#1)(2013-1#1)
two N-linked glycosylation sites##2##4##(1992-12#1)(1992-9#1)
two N-linked##3##2##(1992-12#1)(1992-9#1)(2008-11#1)
two N-terminally##2##2##(1994-8#2)
two NIST##2##2##(2008-10#2)
two North##2##2##(2010-10#1)(2010-4#1)
two ORFs##3##2##(1991-9#1)(1994-12#1)(1997-3#1)
two P##2##2##(2008-10#2)
two PCR##2##2##(2008-10#1)(2008-5#1)
two QTL##3##2##(2008-10#2)(2012-3#1)
two QTLs for##2##3##(2008-8#2)
two QTLs##3##2##(2008-10#1)(2008-8#2)
two Quercus species##2##3##(2012-5#2)
two RNA##4##2##(2008-10#1)(2008-4#2)(2013-1#1)
two RYR##2##2##(1994-9#2)
two S##4##2##(2008-10#4)
two SNPs##2##2##(2012-3#2)
two Ssh7##2##2##(2008-9#2)
two States##4##2##(1992-3#3)(1996-1#1)
two T##4##2##(1990-7#1)(1991-6#1)(2008-10#1)(2008-11#1)
two Ti##2##2##(2008-3#2)
two X##2##2##(2008-10#1)(2008-4#1)
two Zn2+-native##2##2##(1997-4#2)
two absorbers##2##2##(2007-12#1)(2008-3#1)
two absorption##2##2##(2008-10#1)(2008-3#1)
two accessory bodies##2##3##(2007-12#2)
two actin monomers##3##3##(1991-5#3)
two active site##2##3##(1995-5#1)(1996-12#1)
two active##10##2##(1991-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#4)(2008-5#1)
two activities##4##2##(1991-9#1)(1994-8#1)(1995-3#1)(1996-2#1)
two acute##2##2##(1993-2#1)(2011-1#1)
two additional##27##2##(1990-5#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-3#2)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-7#1)(2011-2#1)
two adducts##2##2##(1994-8#2)
two adjacent##14##2##(1990-5#1)(1994-2#1)(1994-5#1)(1997-4#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
two adsorbents##2##2##(2008-10#2)
two adult##3##2##(1994-2#1)(2008-5#1)(2010-7#1)
two adults##2##2##(2011-2#1)(2012-2#1)
two age-matched subgroups of##2##4##(2008-7#1)(2013-1#1)
two age-matched##4##2##(1997-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
two agencies##2##2##(1994-2#1)(1997-2#1)
two agents in##2##3##(2008-10#1)(2008-8#1)
two agents##5##2##(2008-10#1)(2008-8#2)(2009-6#2)
two aims##2##2##(2008-10#1)(2008-7#1)
two algorithms##3##2##(2007-11#1)(2008-3#2)
two alleles##7##2##(1991-11#1)(1993-3#1)(1993-6#2)(1995-5#1)(2008-10#1)(2008-12#1)
two almond cultivars##2##3##(2008-10#2)
two alpha##2##2##(1991-12#1)(2008-5#1)
two also##2##2##(2008-6#1)(2008-7#1)
two alternate protocols are##2##4##(2008-2#1)(2008-4#1)
two alternate protocols##5##3##(2008-2#1)(2008-4#2)(2008-9#2)
two alternate##6##2##(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#2)
two alternating##2##2##(1995-5#1)(2008-3#1)
two alternative methods##2##3##(1997-4#1)(2008-3#1)
two alternative strategies##2##3##(2007-11#1)(2008-7#1)
two alternative##17##2##(1992-9#1)(1995-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#1)
two alternatively spliced##3##3##(1991-9#1)(1995-2#1)(1997-7#1)
two alternatives##3##2##(1996-1#1)(2012-12#1)(2013-1#1)
two amino acid substitutions##3##4##(1992-9#1)(2008-10#1)(2010-4#1)
two amino acid##7##3##(1992-9#1)(1997-9#1)(2008-10#4)(2010-4#1)
two amino acids##7##3##(1990-11#1)(1993-11#2)(1995-8#1)(1996-5#1)(2008-10#2)
two amino##14##2##(1990-11#1)(1992-9#1)(1993-11#2)(1995-8#1)(1996-5#1)(1997-9#1)(2008-10#6)(2010-4#1)
two analogs##3##2##(1993-8#1)(1994-11#1)(1995-12#1)
two analyses##2##2##(1995-6#1)(2008-9#1)
two analytes##5##2##(2008-10#5)
two analytical##5##2##(2008-10#4)(2010-5#1)
two and a half##3##4##(1990-5#1)(2007-7#1)(2008-5#1)
two and a##4##3##(1990-5#1)(1997-3#1)(2007-7#1)(2008-5#1)
two and four##3##3##(1991-6#1)(1992-4#1)(2008-10#1)
two and three##11##3##(1992-9#1)(1993-3#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#1)(2009-5#1)
two and##31##2##(1990-5#1)(1991-11#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-3#1)(1995-9#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
two animals##4##2##(1997-8#1)(2007-8#1)(2008-12#1)(2008-5#1)
two anionic##2##2##(1992-9#1)(2008-10#1)
two annual##3##2##(2008-5#2)(2012-3#1)
two antibodies##4##2##(1991-2#1)(1995-6#1)(2008-7#2)
two antigenically##2##2##(1991-3#1)(2008-4#1)
two antigens##4##2##(1990-12#1)(1992-8#1)(2008-10#1)(2008-4#1)
two antioxidants##2##2##(2008-10#1)(2008-5#1)
two apparent##2##2##(2008-3#1)(2011-1#1)
two applications##2##2##(2008-10#1)(2008-3#1)
two approaches are##2##3##(2008-9#1)(2010-11#1)
two approaches to##7##3##(1994-2#1)(1995-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
two approaches##21##2##(1994-2#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
two appropriate oligonucleotide primers##2##4##(2008-2#1)(2008-9#1)
two approximate methods##2##3##(2008-3#1)(2008-7#1)
two architectural frameworks##2##3##(2007-12#2)
two are##7##2##(1990-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2012-3#1)
two areas##15##2##(1990-8#1)(1994-2#1)(1995-2#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-8#1)(2013-1#3)
two arginine##2##2##(1995-2#1)(1996-7#1)
two aromatic##2##2##(2007-11#1)(2011-10#1)
two articles##2##2##(1994-12#1)(1997-6#1)
two artificial##2##2##(1992-3#1)(2008-7#1)
two as##2##2##(1995-2#1)(2008-5#1)
two asparagine-linked##2##2##(2008-1#1)(2008-8#1)
two aspects of program evaluation##2##5##(1993-12#2)
two aspects of##7##3##(1993-12#2)(2007-12#1)(2008-10#2)(2012-12#1)(2012-3#1)
two aspects##10##2##(1993-12#2)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
two assays##5##2##(1993-11#1)(1994-12#1)(2008-10#2)(2012-2#1)
two assumptions##3##2##(2008-2#1)(2008-9#1)(2012-2#1)
two asymmetric divisions##2##3##(2007-12#1)(2009-5#1)
two asymmetrically##2##2##(2008-2#1)(2009-2#1)
two at the##2##3##(2013-7#2)
two atomic detectors##2##3##(2008-10#2)
two atomic##3##2##(2008-10#3)
two atypical isolates##2##3##(2008-10#2)
two atypical##4##2##(1993-9#1)(2007-8#1)(2008-10#2)
two authors##2##2##(2010-2#1)(2013-1#1)
two autoimmune diseases##2##3##(2007-5#1)(2007-7#1)
two automatic##2##2##(2008-10#2)
two auxiliary##2##2##(2008-3#2)
two axes of##2##3##(2008-10#1)(2008-3#1)
two axes##5##2##(2008-10#1)(2008-3#3)(2010-6#1)
two bacteria##3##2##(2008-10#2)(2008-8#1)
two bacterial##4##2##(1994-3#1)(1995-5#2)(2008-10#1)
two bands of##4##3##(1991-8#1)(1991-9#1)(1993-12#1)(2008-10#1)
two bands##8##2##(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
two base##2##2##(1993-9#1)(2008-10#1)
two basic and##2##3##(1990-11#1)(2008-9#1)
two basic##9##2##(1990-11#1)(1994-6#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-9#1)
two batches##2##2##(2008-11#1)(2013-7#1)
two beams is##2##3##(2008-3#2)
two beams with a##2##4##(2007-12#2)
two beams##9##2##(2007-12#4)(2008-3#5)
two beta polypeptides##2##3##(1994-5#2)
two binary##3##2##(2007-11#1)(2008-3#2)
two binding sites##3##3##(1994-6#1)(1995-5#1)(2008-10#1)
two binding##4##2##(1994-6#1)(1995-5#1)(2008-10#1)(2008-9#1)
two biochemically##2##2##(1994-8#1)(2008-9#1)
two biological##2##2##(2008-10#1)(2008-4#1)
two biotypes##2##2##(2008-10#2)
two birds##2##2##(2011-2#1)(2012-3#1)
two bivariate##2##2##(1995-9#1)(2012-1#1)
two bladder##4##2##(2008-10#3)(2008-4#1)
two blocks##2##2##(1996-3#1)(2007-12#1)
two broad##6##2##(1991-8#1)(1994-2#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-5#1)
two brothers##2##2##(2009-5#1)(2011-2#1)
two by##3##2##(1995-3#1)(1997-7#1)(2008-10#1)
two cDNA clones##3##3##(1990-8#1)(1993-2#1)(2008-11#1)
two cDNAs##4##2##(1993-2#1)(1993-8#1)(2008-7#2)
two calibrated##2##2##(2008-6#1)(2013-1#1)
two calibration##4##2##(2008-10#3)(2008-2#1)
two can be##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
two carbon##2##2##(1992-6#1)(2008-7#1)
two carboxyl##2##2##(1990-5#1)(1990-7#1)
two carriers##4##2##(1992-3#1)(2008-10#1)(2008-11#2)
two case reports of##2##4##(1996-3#1)(2008-6#1)
two case reports##9##3##(1990-12#1)(1996-3#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-6#2)(2013-1#1)(2013-7#1)
two case studies presented##2##4##(1995-2#1)(2008-4#1)
two case studies##6##3##(1995-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-6#1)
two case##16##2##(1990-12#1)(1993-12#1)(1995-2#1)(1996-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-6#1)(2013-1#1)(2013-7#1)
two cases and a##3##4##(2007-7#1)(2007-8#1)(2008-7#1)
two cases and##15##3##(1992-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-7#4)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)
two cases are presented##2##4##(1990-5#1)(2008-5#1)
two cases are##3##3##(1990-5#1)(2007-8#1)(2008-5#1)
two cases had##2##3##(2008-7#1)(2013-1#1)
two cases in which##3##4##(1996-5#1)(2008-10#1)(2011-2#1)
two cases in##4##3##(1995-5#1)(1996-5#1)(2008-10#1)(2011-2#1)
two cases of acute##2##4##(2008-4#1)(2009-4#1)
two cases of malignant##2##4##(1991-12#1)(1993-6#1)
two cases of this##2##4##(1990-10#1)(1996-9#1)
two cases of##73##3##(1990-10#2)(1990-2#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#7)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
two cases that##3##3##(1995-8#1)(2009-1#1)(2013-1#1)
two cases was##3##3##(1993-2#1)(1995-6#1)(1997-3#1)
two cases were##4##3##(1997-8#1)(2008-10#1)(2010-2#1)(2010-3#1)
two cases with##9##3##(1996-2#1)(2007-10#1)(2007-11#1)(2008-6#2)(2010-12#1)(2011-2#1)(2013-1#2)
two cases##175##2##(1990-10#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-5#1)(1992-8#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#3)(2006-10#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#13)(2008-1#5)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#16)(2008-8#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#3)
two cases]##6##2##(2007-8#1)(2009-5#1)(2013-1#4)
two catalytic##4##2##(1990-8#1)(1991-9#1)(1995-5#2)
two categories of##4##3##(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
two categories##10##2##(2007-9#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
two cationic##3##2##(1990-7#1)(1994-12#1)(1996-5#1)
two cations##3##2##(2008-10#3)
two cell lines##16##3##(1993-3#1)(1995-2#1)(2008-11#7)(2008-7#1)(2008-9#4)(2011-2#1)(2012-12#1)
two cell types##6##3##(1992-9#1)(1993-3#1)(2008-11#2)(2008-7#1)(2012-12#1)
two cell##28##2##(1990-11#1)(1992-9#2)(1993-3#2)(1995-11#1)(1995-2#2)(2008-11#9)(2008-7#2)(2008-9#5)(2011-2#1)(2012-12#3)
two cells##2##2##(1994-12#1)(2008-12#1)
two cellular##2##2##(1992-11#1)(1995-2#1)
two central##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
two certified materials##3##3##(2008-10#3)
two certified reference materials##6##4##(2008-10#6)
two certified reference##7##3##(2008-10#7)
two certified##10##2##(2008-10#10)
two channel flow cells##2##4##(2008-10#2)
two channel##3##2##(2007-11#1)(2008-10#2)
two channels##3##2##(2008-10#1)(2008-3#2)
two characteristic##2##2##(2008-10#1)(2008-2#1)
two characteristics##2##2##(2008-10#1)(2008-5#1)
two chemical##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
two chemically##2##2##(1992-9#1)(2007-12#1)
two chemometric##2##2##(2008-10#1)(2008-3#1)
two children with##3##3##(1990-12#1)(2008-9#1)(2011-1#1)
two children##8##2##(1990-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
two chimeric##2##2##(1994-6#1)(2008-1#1)
two chloride##2##2##(1997-7#1)(2008-10#1)
two chromatographic##3##2##(1992-6#1)(2008-10#2)
two chromosomal##2##2##(1997-3#1)(2008-12#1)
two clades##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
two class-II restriction endonucleases from##2##5##(1993-9#2)
two classes of human##2##4##(1994-6#2)
two classes of##20##3##(1990-5#2)(1991-2#1)(1992-5#1)(1993-1#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-2#1)
two classes##26##2##(1990-5#2)(1991-2#1)(1991-8#1)(1992-5#1)(1993-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-2#1)(2010-8#1)(2011-2#1)
two clinical cases##2##3##(1992-6#1)(1993-3#1)
two clinical##12##2##(1992-6#1)(1992-9#1)(1993-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
two cloned##5##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-9#2)
two clones##12##2##(1990-5#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-10#1)(1997-7#1)(2008-10#3)(2008-11#3)
two closely related##10##3##(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-3#1)
two closely spaced##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
two closely##15##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-3#1)
two clusters are##2##3##(1994-2#1)(1997-8#1)
two clusters of##5##3##(1994-5#1)(1995-12#1)(1996-6#1)(2008-10#2)
two clusters##10##2##(1994-2#2)(1994-5#1)(1995-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#3)
two coherent##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
two cohorts of##6##3##(1997-3#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
two cohorts##8##2##(1997-3#1)(2008-11#2)(2011-2#1)(2012-2#2)(2013-1#2)
two collections##2##2##(2008-10#2)
two collimated##2##2##(2007-11#1)(2008-2#1)
two colorectal##2##2##(1991-3#1)(2008-4#1)
two colors##2##2##(2007-12#1)(2008-1#1)
two columns##3##2##(1997-2#1)(2008-10#1)(2012-1#1)
two commercial##9##2##(2008-10#7)(2008-3#1)(2011-1#1)
two common bean##2##3##(2008-10#1)(2008-12#1)
two common haplotypes##2##3##(2008-10#1)(2008-2#1)
two common##15##2##(1990-5#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)(2012-2#1)
two commonly used methods##2##4##(2008-10#1)(2008-9#1)
two commonly used##9##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)
two commonly##10##2##(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)
two communities##3##2##(2010-3#1)(2010-4#1)(2012-2#1)
two compared##2##2##(1996-6#1)(2008-10#1)
two compartments##3##2##(1992-10#1)(1995-2#1)(2008-5#1)
two competing effects##2##3##(2008-10#1)(2008-3#1)
two competing species in##2##4##(2008-8#2)
two competing##7##2##(1994-3#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)
two complementary##11##2##(1992-6#2)(1993-6#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-3#1)
two complete##2##2##(1994-3#1)(2008-10#1)
two complex##3##2##(2008-2#1)(2010-1#1)(2010-3#1)
two complexes##7##2##(1992-4#1)(1996-2#1)(1997-7#1)(2008-10#3)(2012-12#1)
two component##11##2##(1991-12#1)(1994-2#1)(2007-8#1)(2008-10#4)(2008-8#1)(2010-10#1)(2012-1#1)(2012-3#1)
two components are##2##3##(2008-10#1)(2008-3#1)
two components is##2##3##(1995-3#1)(2007-12#1)
two components of##4##3##(2008-8#2)(2008-9#1)(2012-12#1)
two components on the##2##4##(1991-2#1)(2008-3#1)
two components##30##2##(1990-12#1)(1990-8#1)(1991-2#1)(1994-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-9#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-7#1)(2012-12#1)
two compounds in##3##3##(2008-10#2)(2011-3#1)
two compounds##14##2##(1991-9#1)(1992-6#1)(1994-11#1)(1996-5#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-5#1)(2009-2#1)(2011-3#1)
two concentrations of tetrol I-1##2##5##(2008-10#2)
two concentrations of##7##3##(2008-10#4)(2008-3#2)(2008-5#1)
two concentrations##8##2##(2008-10#5)(2008-3#2)(2008-5#1)
two concentric##3##2##(2007-11#1)(2007-12#2)
two conclusions##2##2##(1990-6#1)(1992-3#1)
two conditions##15##2##(1990-2#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2009-11#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
two conflicting##2##2##(2008-10#1)(2009-6#1)
two conformations##2##2##(1992-3#1)(2010-7#1)
two consecutive years##5##3##(2008-10#1)(2008-5#2)(2013-1#1)(2013-7#1)
two consecutive##27##2##(1990-7#1)(1994-12#1)(1996-12#2)(1996-2#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-7#1)
two conserved regions##3##3##(1991-12#1)(1993-6#1)(1997-4#1)
two conserved##7##2##(1991-12#1)(1993-6#1)(1995-5#1)(1997-4#2)(2008-10#1)(2008-8#1)
two constants##2##2##(2008-10#2)
two constructs##4##2##(1995-1#1)(2008-10#1)(2009-12#1)(2012-12#1)
two contexts##2##2##(1993-1#1)(2009-10#1)
two control groups##3##3##(1992-8#1)(1993-12#1)(2009-5#1)
two control measures##3##3##(2008-10#3)
two control##8##2##(1992-8#1)(1993-12#1)(1996-1#2)(2008-10#3)(2009-5#1)
two controls##2##2##(1992-8#1)(2008-11#1)
two conventional hybrids##2##3##(2011-2#2)
two conventional##5##2##(2008-2#1)(2008-3#2)(2011-2#2)
two copies each##2##3##(1994-5#1)(2011-2#1)
two copies of the##2##4##(2008-10#1)(2013-1#1)
two copies of##7##3##(1990-12#1)(1993-6#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
two copies##11##2##(1990-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
two correlations##2##2##(1997-4#1)(2008-3#1)
two counterpropagating##2##2##(2007-11#1)(2007-12#1)
two counties##2##2##(2008-10#1)(2010-5#1)
two countries##4##2##(1991-4#1)(1993-3#1)(1997-8#1)(2008-7#1)
two coupled##6##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-8#1)(2013-8#1)
two couples of##2##3##(2008-10#2)
two courses of##2##3##(2007-8#1)(2008-6#1)
two courses##3##2##(2007-8#1)(2008-6#2)
two critical##4##2##(1993-2#1)(2008-2#1)(2009-11#1)(2011-2#1)
two crossed##2##2##(2008-2#1)(2008-3#1)
two crystal forms##2##3##(2008-8#2)
two crystallographically##2##2##(1996-2#1)(2006-4#1)
two cultivars of##3##3##(2008-10#2)(2008-12#1)
two cultivars##10##2##(2008-10#8)(2008-12#2)
two culture##3##2##(2008-11#2)(2008-7#1)
two cutaneous##2##2##(2008-5#1)(2011-2#1)
two cw##2##2##(2007-12#1)(2008-2#1)
two cyanine##4##2##(2008-10#2)(2008-3#2)
two cycles of##6##3##(1990-6#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-8#1)
two cycles##8##2##(1990-6#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)
two cyclic##3##2##(1993-5#1)(2008-10#2)
two cylindrical lenses##2##3##(2008-10#1)(2008-3#1)
two cylindrical##3##2##(2008-10#1)(2008-3#2)
two cysteine residues##4##3##(1992-8#2)(1994-11#1)(1995-2#1)
two cysteine##5##2##(1992-8#3)(1994-11#1)(1995-2#1)
two cytologists##3##2##(2008-6#3)
two cytoplasmic##2##2##(2008-8#2)
two data sets##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
two data##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)
two datasets##2##2##(2008-6#1)(2013-8#1)
two day old##2##3##(2008-12#1)(2008-8#1)
two day##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
two days after##3##3##(2007-11#1)(2008-11#1)(2008-5#1)
two days of##3##3##(1994-7#1)(2008-11#1)(2008-6#1)
two days##23##2##(1991-3#1)(1991-9#1)(1993-12#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
two deaths##3##2##(2007-8#1)(2008-11#1)(2008-6#1)
two decades ago##3##3##(2008-1#1)(2010-3#1)(2010-5#1)
two decades and##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
two decades by##2##3##(1994-3#1)(2007-2#1)
two decades in##2##3##(2008-5#1)(2011-3#1)
two decades of research##2##4##(2008-6#1)(2012-2#1)
two decades of the##2##4##(2010-12#1)(2013-7#1)
two decades of##10##3##(2008-12#1)(2008-6#1)(2008-8#2)(2010-12#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
two decades##68##2##(1990-6#1)(1991-5#2)(1992-11#1)(1992-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
two deformable##2##2##(2007-11#2)
two degradation products##2##3##(2008-10#2)
two degrees##2##2##(2007-12#1)(2008-10#1)
two departments##2##2##(1995-12#2)
two design##2##2##(2008-3#1)(2008-5#1)
two detection##2##2##(2007-12#1)(2008-3#1)
two developmental##3##2##(1993-9#1)(2009-7#1)(2009-8#1)
two diagnostic##3##2##(1997-8#1)(2009-3#1)(2011-2#1)
two dicots##2##2##(1991-6#1)(2008-10#1)
two died##2##2##(2007-8#1)(2008-7#1)
two dietary##4##2##(1991-12#1)(2008-12#1)(2008-3#1)(2010-6#1)
two diets##2##2##(2008-3#1)(2009-9#1)
two different LHC-II complexes##2##4##(2008-4#2)
two different approaches for##2##4##(2008-10#1)(2012-3#1)
two different approaches to##2##4##(2008-12#1)(2008-9#1)
two different approaches##6##3##(1995-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)
two different configurations##2##3##(2007-11#1)(2008-10#1)
two different experimental##3##3##(2007-12#1)(2007-8#1)(2008-4#1)
two different forms of##3##4##(1994-8#1)(2010-5#1)(2012-12#1)
two different forms##4##3##(1990-6#1)(1994-8#1)(2010-5#1)(2012-12#1)
two different groups##2##3##(2008-10#1)(2008-12#1)
two different instruments##3##3##(2008-2#1)(2008-3#1)(2010-3#1)
two different kind of##2##4##(1993-11#1)(2008-10#1)
two different levels of##3##4##(1990-2#1)(2008-10#1)(2008-7#1)
two different levels##4##3##(1990-2#1)(1991-6#1)(2008-10#1)(2008-7#1)
two different manners##2##3##(2008-10#1)(2008-2#1)
two different methods##8##3##(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)
two different models and##2##4##(2008-10#1)(2008-5#1)
two different models of##2##4##(2007-10#2)
two different models##4##3##(2007-10#2)(2008-10#1)(2008-5#1)
two different operators##2##3##(2008-10#1)(2010-7#1)
two different populations of##3##4##(2008-10#1)(2008-3#1)(2009-2#1)
two different populations##4##3##(2008-10#1)(2008-3#1)(2009-2#2)
two different preparations##2##3##(1993-12#1)(2011-1#1)
two different procedures##2##3##(2008-10#2)
two different processes##3##3##(2008-10#2)(2008-3#1)
two different proteins##2##3##(1995-8#1)(2008-2#1)
two different sample##3##3##(2008-12#1)(2008-2#1)(2008-4#1)
two different sets of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
two different sizes##2##3##(1995-8#1)(2008-10#1)
two different soils##2##3##(2008-10#1)(2008-6#1)
two different stages##2##3##(2008-12#1)(2008-4#1)
two different techniques for##2##4##(2007-12#1)(2008-4#1)
two different techniques##4##3##(2007-12#1)(2007-8#1)(2008-4#1)(2011-1#1)
two different timescales##2##3##(2008-9#2)
two different treatments##2##3##(1992-9#1)(2008-6#1)
two different types of##9##4##(1993-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)
two different ways##3##3##(1992-11#1)(2011-2#1)(2012-2#1)
two different##326##2##(1990-11#3)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-2#2)(1997-4#2)(1997-7#3)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#83)(2008-11#10)(2008-12#9)(2008-2#14)(2008-3#20)(2008-4#14)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#2)
two diffraction##3##2##(2008-2#1)(2008-3#2)
two digital holograms##2##3##(2008-3#2)
two dimensional NMR##2##3##(1991-8#1)(2008-11#1)
two dimensional##7##2##(1991-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)
two dimensions##18##2##(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-8#1)(2012-3#1)(2013-8#1)
two diode##2##2##(2007-11#1)(2009-11#1)
two direct detection methods##2##4##(2008-3#2)
two direct##4##2##(1995-6#1)(2008-10#1)(2008-3#2)
two directions##3##2##(1991-9#1)(2008-3#1)(2008-7#1)
two disciplines##3##2##(1996-1#1)(2008-11#1)(2009-7#1)
two discrete##4##2##(1992-10#1)(1993-3#1)(1993-8#1)(1997-4#1)
two diseases##15##2##(1994-8#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2012-12#1)(2012-3#2)
two disorders##6##2##(1997-5#2)(2007-2#1)(2008-10#1)(2009-7#1)(2012-3#1)
two distant##2##2##(2008-10#1)(2008-5#1)
two distantly related##2##3##(2008-10#1)(2008-7#1)
two distinct clusters of##2##4##(2008-10#2)
two distinct clusters that##2##4##(2008-10#2)
two distinct clusters##6##3##(2008-10#6)
two distinct genetic groups##2##4##(2008-10#1)(2010-10#1)
two distinct genetic##3##3##(1994-6#1)(2008-10#1)(2010-10#1)
two distinct groups of##3##4##(2008-10#1)(2008-7#1)(2010-10#1)
two distinct groups##9##3##(2008-10#6)(2008-7#1)(2010-10#1)(2013-1#1)
two distinct heteromeric DNA-binding forms##2##5##(1993-11#2)
two distinct mechanisms##3##3##(1996-2#2)(2008-10#1)
two distinct modes##2##3##(1992-6#1)(2007-11#1)
two distinct pathways##2##3##(1990-5#1)(1991-2#1)
two distinct phases##2##3##(2008-5#1)(2008-7#1)
two distinct populations##2##3##(1991-8#1)(2008-10#1)
two distinct regions##2##3##(2007-12#1)(2008-10#1)
two distinct subgroups##2##3##(2008-10#2)
two distinct types of##2##4##(2010-1#1)(2012-12#1)
two distinct types##3##3##(2008-10#1)(2010-1#1)(2012-12#1)
two distinct##109##2##(1990-11#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-8#2)(1992-3#1)(1992-6#2)(1993-11#3)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-12#1)(1996-2#3)(1997-7#2)(2007-11#3)(2007-12#2)(2008-10#35)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
two distinctive##4##2##(1990-5#1)(2008-1#1)(2008-10#1)(2008-11#1)
two districts of##2##3##(1994-6#1)(2008-10#1)
two districts##4##2##(1994-6#1)(2008-10#2)(2010-3#1)
two disulfide bonds##2##3##(1993-8#2)
two divergent##6##2##(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#2)
two domains##7##2##(1991-9#2)(1995-6#1)(1997-3#1)(2007-11#1)(2008-9#1)(2012-2#1)
two dominant##3##2##(2008-10#2)(2008-3#1)
two dose##2##2##(1991-3#1)(2008-9#1)
two doses of##2##3##(1995-5#1)(2012-12#1)
two doses##3##2##(1995-5#1)(2010-5#1)(2012-12#1)
two dozen##2##2##(2008-1#1)(2008-10#1)
two drinks##3##2##(1994-2#3)
two droplets##3##2##(2008-3#3)
two drug##3##2##(1990-2#1)(2010-3#2)
two drugs are##2##3##(1995-3#1)(1995-9#1)
two drugs simultaneously##2##3##(1993-8#1)(2012-2#1)
two drugs##20##2##(1990-5#3)(1990-9#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(2007-11#1)(2008-10#2)(2008-11#4)(2010-3#2)(2012-2#1)
two dyes##3##2##(2008-10#1)(2008-2#2)
two each##2##2##(2008-9#1)(2012-2#1)
two earlier studies##2##3##(1994-2#1)(2008-11#1)
two earlier##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
two early##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
two earthquakes##2##2##(1990-11#1)(2012-2#1)
two effects##6##2##(1990-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2012-12#1)
two elderly##2##2##(1994-2#1)(2007-7#1)
two electrochemical##2##2##(2008-10#1)(2008-4#1)
two electrode##4##2##(1993-12#1)(2007-12#1)(2008-10#2)
two electrodes##7##2##(2007-12#1)(2008-10#5)(2008-2#1)
two electrons##2##2##(2008-10#2)
two elemental##2##2##(2008-10#1)(2008-11#1)
two elements of##2##3##(1994-8#1)(2007-11#1)
two elements##6##2##(1990-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(2007-11#1)(2008-11#1)
two enantiomers of##2##3##(1995-3#1)(2008-10#1)
two enantiomers##4##2##(1992-8#1)(1995-3#1)(2008-10#2)
two environments##7##2##(2008-10#3)(2008-5#1)(2008-8#2)(2010-5#1)
two enzyme##2##2##(1993-11#1)(2008-10#1)
two enzymes##10##2##(1990-5#1)(1990-7#1)(1994-8#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)
two epidermal##2##2##(1995-6#1)(2008-10#1)
two episodes of##2##3##(2008-11#1)(2008-12#1)
two equal##7##2##(2007-7#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2012-2#1)
two equations##2##2##(2008-10#2)
two equivalent##3##2##(2007-12#1)(2008-3#1)(2009-6#1)
two equivalents of##2##3##(2008-11#1)(2010-5#1)
two essential##2##2##(2008-3#1)(2013-7#1)
two estrogen##2##2##(1994-12#1)(2008-4#1)
two etalons##2##2##(2008-2#1)(2008-3#1)
two events##3##2##(1991-8#1)(1995-6#1)(2011-2#1)
two examinations##4##2##(1996-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
two example##4##2##(2008-3#4)
two examples of##2##3##(1995-1#1)(2008-3#1)
two examples##6##2##(1992-9#1)(1995-1#1)(1997-7#1)(2008-1#1)(2008-3#1)(2010-5#1)
two excitation windows##2##3##(2011-1#2)
two excitation##6##2##(2008-10#1)(2008-3#3)(2011-1#2)
two exhibited##2##2##(2008-10#2)
two existing##3##2##(1991-3#1)(2008-3#1)(2012-2#1)
two exons##5##2##(1991-6#1)(1993-2#1)(1993-8#1)(1994-12#1)(2008-9#1)
two experimental and##2##3##(1996-1#1)(2013-1#1)
two experimental groups##4##3##(1993-12#1)(2009-12#1)(2010-2#1)(2013-8#1)
two experimental##16##2##(1993-12#1)(1994-8#1)(1994-9#1)(1996-1#1)(2008-10#4)(2008-7#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
two experiments##23##2##(1993-12#1)(1994-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2009-5#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
two expression systems##2##3##(1995-5#1)(1997-4#1)
two expression vectors##2##3##(1994-3#1)(2008-10#1)
two expression##4##2##(1994-3#1)(1995-5#1)(1997-4#1)(2008-10#1)
two extinction##2##2##(2008-2#1)(2008-3#1)
two extreme##4##2##(1995-12#1)(2008-10#1)(2008-11#2)
two extremes##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)
two eyes##2##2##(1994-8#1)(2011-2#1)
two factor##2##2##(2008-5#1)(2012-3#1)
two factors were##2##3##(2008-10#2)
two factors##28##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#2)(1995-5#1)(1997-4#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#1)
two families of##6##3##(1993-12#1)(1994-5#1)(2008-7#2)(2009-11#1)(2009-2#1)
two families##9##2##(1990-3#1)(1991-12#2)(1993-12#1)(1994-5#1)(2008-7#2)(2009-11#1)(2009-2#1)
two family##2##2##(2007-12#1)(2011-2#1)
two farms##2##2##(1994-7#1)(2013-1#1)
two features##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
two female patients##4##3##(1996-8#1)(2007-8#1)(2008-7#1)(2009-8#1)
two females##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
two ferredoxins##2##2##(1995-5#2)
two fetuses##3##2##(1990-2#1)(1992-6#2)
two fiber##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
two fibers##2##2##(2008-10#1)(2013-1#1)
two field experiments##4##3##(2008-10#4)
two field locations##3##3##(2008-10#2)(2008-11#1)
two field sites##2##3##(2008-10#2)
two field trials##3##3##(2008-10#3)
two field##15##2##(2007-11#1)(2008-10#12)(2008-11#1)(2008-3#1)
two fields in##2##3##(2008-10#2)
two fields##9##2##(1991-2#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-3#1)
two fingers##2##2##(1991-12#1)(1996-8#1)
two first##2##2##(2007-12#1)(2013-1#1)
two fish species##3##3##(1991-9#1)(2008-12#1)(2010-8#1)
two fixed##3##2##(2008-3#3)
two flagellins##2##2##(1990-2#2)
two flocks##2##2##(1997-3#2)
two flow##3##2##(1997-2#1)(2008-10#2)
two fluorescent##5##2##(1991-5#1)(1993-8#1)(2008-10#3)
two fluorophores##3##2##(2008-1#2)(2008-2#1)
two fold##7##2##(1993-6#1)(1993-8#1)(2008-11#3)(2008-7#1)(2008-8#1)
two folds##3##2##(2008-11#1)(2008-12#1)(2008-6#1)
two for##12##2##(1990-2#1)(1991-2#1)(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-7#1)(2013-8#1)
two force plate variables##2##4##(2008-10#2)
two force##3##2##(2008-10#2)(2008-7#1)
two forces##2##2##(2008-8#1)(2012-2#1)
two formae speciales##2##3##(2008-10#2)
two forms in##2##3##(1993-8#1)(2012-1#1)
two forms of the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
two forms of##28##3##(1990-5#1)(1991-12#2)(1991-8#1)(1992-12#2)(1992-6#1)(1994-11#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-5#4)(2011-2#1)(2012-3#1)
two forms##41##2##(1990-5#1)(1991-12#3)(1991-5#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-8#1)(1994-11#3)(1995-3#1)(1995-5#2)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#4)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
two formulations of##3##3##(1996-1#2)(2012-12#1)
two formulations##5##2##(1996-1#2)(2008-10#1)(2009-5#1)(2012-12#1)
two fractions##4##2##(1990-12#1)(1991-2#1)(1992-11#1)(1994-3#1)
two fragments of##2##3##(2008-4#1)(2010-4#1)
two fragments##9##2##(1990-12#1)(1990-5#1)(1992-12#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-4#1)
two free##2##2##(1990-3#1)(2008-6#1)
two frequencies##4##2##(1990-5#1)(2008-3#2)(2010-7#1)
two from groups of##2##4##(1996-12#2)
two from##8##2##(1995-6#1)(1996-12#2)(2008-10#3)(2008-5#1)(2008-9#1)
two functional##3##2##(1993-12#1)(1997-6#1)(2010-11#1)
two functions##8##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
two fundamental##4##2##(1991-2#1)(2008-2#1)(2008-7#1)(2008-9#1)
two fungal##2##2##(2008-10#1)(2012-3#1)
two fungi##6##2##(2008-10#6)
two fungicide##2##2##(2008-10#2)
two fungicides (carbendazim and chlorothalonil)##2##5##(1997-4#2)
two further##5##2##(1990-5#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
two genera of##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
two genera##7##2##(2008-10#5)(2008-9#1)(2012-12#1)
two general##6##2##(1991-2#1)(1992-11#1)(1995-5#1)(2008-5#1)(2008-7#1)(2012-3#1)
two generations##5##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-5#1)
two genes encoding##3##3##(1995-8#1)(2008-9#1)(2009-10#1)
two genes for##2##3##(2008-10#2)
two genes have##2##3##(2008-5#1)(2009-8#1)
two genes of the##2##4##(2008-10#2)
two genes were##2##3##(1993-3#1)(2008-10#1)
two genes with additive effects##2##5##(2008-10#2)
two genes##43##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-8#2)(1997-7#2)(1997-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-9#4)(2009-10#2)(2009-8#1)(2012-3#1)
two genetic lines of##2##4##(1997-6#2)
two genetic##6##2##(1997-6#2)(2006-10#1)(2008-10#2)(2012-1#1)
two genetically distinct##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
two genetically##7##2##(1995-6#1)(2008-10#2)(2008-6#3)(2011-2#1)
two genomic##3##2##(1990-12#1)(1997-2#1)(2008-10#1)
two genotypes of##3##3##(2008-10#3)
two genotypes##9##2##(2008-10#7)(2008-4#1)(2011-1#1)
two geographically##2##2##(2008-10#2)
two glass##3##2##(1991-5#1)(1996-12#1)(2008-3#1)
two government##2##2##(2008-8#1)(2011-1#1)
two graft##2##2##(2007-7#1)(2012-12#1)
two grating##6##2##(2007-12#1)(2008-3#5)
two gratings##6##2##(2007-12#1)(2008-3#5)
two greenhouse##2##2##(2008-10#1)(2011-2#1)
two groups (p = 0##2##5##(2010-8#1)(2011-2#1)
two groups according to the##4##5##(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#1)
two groups according to##6##4##(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#2)
two groups and##5##3##(1993-2#1)(1994-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
two groups are##2##3##(1992-6#1)(2008-1#1)
two groups by##3##3##(1992-12#1)(1995-12#1)(2008-10#1)
two groups depending on##2##4##(1991-9#1)(2013-1#1)
two groups did not differ##4##5##(1991-3#1)(2007-8#1)(2010-4#1)(2011-1#1)
two groups in##7##3##(1990-2#1)(1990-6#1)(1995-4#1)(2007-11#2)(2008-10#1)(2008-7#1)
two groups of patients were##2##5##(1991-3#1)(1995-6#1)
two groups of patients##8##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1992-6#1)(1995-6#1)(2008-10#1)(2013-1#1)
two groups of rats##2##4##(2008-7#1)(2009-11#1)
two groups of students##2##4##(1997-2#1)(2008-11#1)
two groups of##55##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#2)(1992-11#1)(1992-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#9)(2008-7#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#3)
two groups on the##2##4##(2008-3#1)(2011-2#1)
two groups on##3##3##(1992-11#1)(2008-3#1)(2011-2#1)
two groups that##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
two groups using##3##3##(1996-2#1)(2012-2#2)
two groups were also##2##4##(2008-10#1)(2008-6#1)
two groups were comparable##5##4##(1992-5#1)(2007-7#1)(2008-6#1)(2009-11#1)(2011-2#1)
two groups were compared##4##4##(2009-12#1)(2011-1#1)(2011-2#2)
two groups were##22##3##(1990-2#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-7#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#2)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
two groups with##7##3##(1994-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
two groups##294##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#3)(1994-7#3)(1995-11#2)(1995-12#6)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#3)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#2)(2007-8#14)(2007-9#3)(2008-1#4)(2008-10#38)(2008-11#5)(2008-12#9)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#22)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#16)(2013-8#2)
two growing seasons##5##3##(2008-10#5)
two guided##2##2##(2007-12#1)(2008-3#1)
two habitat##2##2##(2008-8#2)
two had##5##2##(1992-6#1)(1996-6#1)(2008-1#1)(2008-8#1)(2009-8#1)
two hairpin##2##2##(1994-8#2)
two halves of the##2##4##(1990-11#1)(2008-11#1)
two halves of##3##3##(1990-11#1)(2008-11#1)(2011-3#1)
two halves##5##2##(1990-11#1)(1997-7#1)(2007-12#1)(2008-11#1)(2011-3#1)
two haplotypes##2##2##(2008-10#2)
two have##2##2##(2008-10#1)(2013-8#1)
two health##4##2##(1992-1#1)(1997-4#1)(2009-11#1)(2011-2#1)
two helices##5##2##(1991-5#1)(1992-6#1)(1993-1#3)
two heme##2##2##(1990-8#1)(2008-8#1)
two herds##2##2##(1990-6#1)(1992-2#1)
two high##6##2##(1995-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
two high-affinity##2##2##(1995-6#1)(2008-9#1)
two higher##3##2##(1992-11#1)(2008-3#1)(2010-5#1)
two highly conserved##3##3##(1990-11#1)(1992-6#1)(2008-4#1)
two highly##11##2##(1990-11#1)(1992-2#1)(1992-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
two histidine residues##2##3##(1991-12#1)(1995-5#1)
two histidine##3##2##(1991-12#1)(1992-8#1)(1995-5#1)
two holograms with a short time separation##2##7##(2008-3#2)
two holograms##5##2##(2007-12#1)(2008-3#4)
two homologous##3##2##(1994-5#1)(1997-2#1)(1997-7#1)
two hormones##4##2##(2008-11#2)(2008-6#1)(2011-2#1)
two horses##3##2##(1990-3#2)(1991-6#1)
two hospitals in##4##3##(1993-6#1)(2008-11#1)(2008-7#1)(2012-12#1)
two hospitals##9##2##(1990-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)
two host species##3##3##(2008-8#1)(2008-9#1)(2010-2#1)
two host##4##2##(2008-8#1)(2008-9#2)(2010-2#1)
two hours of##4##3##(1990-9#1)(1994-3#1)(1997-6#1)(2010-7#1)
two hours per##2##3##(1992-6#1)(2008-12#1)
two hours##17##2##(1990-9#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)
two human cDNA##2##3##(1991-6#1)(1993-6#1)
two human cell lines##2##4##(1993-11#1)(2008-8#1)
two human##19##2##(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2012-4#1)
two hundred##2##2##(1990-6#1)(2013-1#1)
two hybridizable##2##2##(2008-9#2)
two hybrids##2##2##(2008-10#2)
two hydride##2##2##(1997-7#2)
two hydrogen bonds##3##3##(1994-5#1)(1995-5#1)(1997-7#1)
two hydrophobic##2##2##(1990-8#1)(1995-6#1)
two hypotheses##7##2##(1996-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-8#1)
two hypothetical##2##2##(1993-12#1)(2008-7#1)
two identical##16##2##(1990-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#4)(2013-1#1)
two images are##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
two images##8##2##(2007-11#1)(2008-2#1)(2008-3#5)(2008-6#1)
two immiscible phases##2##3##(2008-10#2)
two immiscible##6##2##(1993-8#1)(2008-10#4)(2008-8#1)
two important aspects##3##3##(2008-11#1)(2009-6#1)(2013-1#1)
two important##20##2##(1991-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
two in the##9##3##(1994-12#1)(1995-3#1)(1996-12#1)(2008-10#2)(2010-8#1)(2011-3#1)(2013-7#2)
two in vitro models##2##4##(1992-12#1)(2008-5#1)
two in vitro##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
two in##22##2##(1990-5#1)(1992-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(2008-10#7)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-7#2)
two inappropriate rust species##2##4##(2008-10#2)
two incident##2##2##(2007-12#1)(2008-3#1)
two independent conformations##2##3##(1991-3#2)
two independent samples of##2##4##(2011-1#1)(2013-1#1)
two independent techniques##2##3##(2008-3#2)
two independent##34##2##(1991-3#2)(1994-11#1)(1994-8#1)(1997-8#1)(2007-11#5)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
two independently tunable##2##3##(2008-3#2)
two independently##5##2##(1995-12#1)(2008-3#2)(2009-7#1)(2011-2#1)
two indexes##2##2##(2008-10#1)(2011-2#1)
two indicators##2##2##(2008-10#1)(2008-9#1)
two individual##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
two individuals##5##2##(1995-6#1)(2008-10#2)(2008-5#1)(2012-3#1)
two infectious##2##2##(2008-10#1)(2013-1#1)
two initial##2##2##(2008-2#1)(2008-9#1)
two initially##2##2##(2007-12#1)(2008-3#1)
two input##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
two institutions##2##2##(2007-10#1)(2008-11#1)
two instruments##8##2##(2008-10#2)(2008-3#5)(2012-2#1)
two insulin##3##2##(1991-8#1)(1992-10#1)(1994-6#1)
two intensities##3##2##(1993-12#1)(2008-2#2)
two interacting##3##2##(2009-8#2)(2011-2#1)
two interfaces##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
two interfering##3##2##(2007-11#2)(2008-3#1)
two interferometry images##2##3##(2008-3#2)
two intermediate regions##3##3##(1990-3#3)
two intermediate##4##2##(1990-3#3)(1996-2#1)
two internal##2##2##(2007-12#1)(2008-9#1)
two interspecific hybrid##2##3##(2008-10#2)
two interspecific##3##2##(2008-10#3)
two interventions##2##2##(2008-4#1)(2013-1#1)
two intracavity##2##2##(2007-11#1)(2007-12#1)
two intrapartum##2##2##(2011-2#2)
two introns##12##2##(1990-5#1)(1991-2#1)(1991-9#1)(1993-2#2)(1993-6#1)(1993-8#2)(1995-9#1)(2008-10#1)(2008-6#1)(2010-5#1)
two inverted repeat sequences##2##4##(2008-8#2)
two inverted##3##2##(1997-2#1)(2008-8#2)
two is##4##2##(1991-3#1)(2007-8#1)(2011-2#2)
two islands##2##2##(1991-4#1)(2008-8#1)
two isoforms have##2##3##(1992-8#1)(1995-2#1)
two isoforms of pIGFBP-4##2##4##(1991-12#2)
two isoforms of rat kidney prostaglandin##2##6##(1994-9#2)
two isoforms of##10##3##(1991-12#2)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-2#2)(2012-2#1)
two isoforms##15##2##(1991-12#2)(1992-8#1)(1993-12#2)(1994-11#1)(1994-8#1)(1994-9#2)(1995-2#3)(1995-8#1)(2012-2#2)
two isolates of R##3##4##(2008-10#3)
two isolates of##15##3##(1991-8#2)(2008-10#12)(2008-5#1)
two isolates that##2##3##(2008-10#2)
two isolates were##3##3##(2008-10#3)
two isolates##39##2##(1991-8#2)(1997-8#1)(2008-10#32)(2008-5#2)(2009-6#1)(2012-2#1)
two isomers of##2##3##(1993-12#1)(2008-10#1)
two isomers##4##2##(1993-12#1)(1996-2#1)(2008-10#2)
two issues##3##2##(1992-3#1)(2008-10#1)(2013-8#1)
two joint##2##2##(1992-3#1)(2008-8#1)
two key factors##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
two key##17##2##(1997-2#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)
two kinases##2##2##(1994-8#1)(1995-11#1)
two kinds of perturbations##2##4##(2008-10#2)
two kinds of##27##3##(1993-3#1)(1994-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#4)(2011-3#1)(2013-8#1)
two kinds##29##2##(1993-3#1)(1994-2#1)(1997-2#1)(1997-6#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#4)(2008-9#1)(2011-3#1)(2013-8#1)
two known##5##2##(1991-12#1)(1995-6#1)(1997-2#1)(2007-1#1)(2008-2#1)
two labeled##2##2##(2008-10#1)(2008-4#1)
two laboratories##2##2##(1995-11#1)(2008-10#1)
two laboratory##2##2##(2008-10#1)(2008-8#1)
two large##12##2##(1992-2#1)(1994-12#1)(1997-1#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
two largest lineages##3##3##(2008-10#3)
two largest##6##2##(2008-10#6)
two laser##6##2##(2007-11#2)(2008-2#1)(2008-3#2)(2013-7#1)
two lasers##4##2##(2007-12#1)(2008-3#2)(2011-1#1)
two lasing##2##2##(2007-11#1)(2007-12#1)
two last##2##2##(2007-11#1)(2008-10#1)
two lateral##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
two latter##4##2##(1990-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
two layers of##3##3##(2008-10#2)(2008-3#1)
two layers##10##2##(1994-6#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#3)
two leading##2##2##(2008-12#1)(2011-2#1)
two leaf##2##2##(2008-10#2)
two learning##2##2##(1996-3#1)(2008-12#1)
two lesions##7##2##(2007-2#1)(2007-8#1)(2008-6#2)(2012-12#1)(2012-3#1)(2013-1#1)
two level factorial##2##3##(2008-10#2)
two level##4##2##(2008-10#3)(2008-7#1)
two levels for##2##3##(1994-12#1)(2008-11#1)
two levels of##3##3##(2008-10#1)(2009-4#1)(2012-3#1)
two levels##12##2##(1992-9#1)(1994-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2012-3#1)
two ligands##6##2##(1996-2#1)(1997-2#2)(2008-10#3)
two ligated species##2##3##(1990-8#2)
two light##3##2##(1997-6#1)(2008-10#2)
two limiting cases##2##3##(2008-10#1)(2008-7#1)
two lineages##4##2##(2008-8#2)(2010-6#1)(2011-2#1)
two linear##6##2##(1995-2#1)(2008-10#3)(2008-2#1)(2011-2#1)
two lines##6##2##(1994-12#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-3#1)
two lipophilic##2##2##(1994-5#1)(2008-10#1)
two liquid-crystal##2##2##(2008-2#1)(2008-3#1)
two lithium##2##2##(1997-7#1)(2007-11#1)
two loading##2##2##(2008-10#1)(2012-2#1)
two local recurrences##2##3##(1991-4#1)(2013-8#1)
two local##3##2##(1991-4#1)(2007-12#1)(2013-8#1)
two locations in##7##3##(2007-5#1)(2008-1#1)(2008-10#5)
two locations##19##2##(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-5#1)(2012-12#1)
two loci##7##2##(1993-6#1)(2008-10#3)(2008-4#1)(2008-9#1)(2012-3#1)
two long##7##2##(1991-12#1)(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
two long-term##2##2##(1997-3#1)(2008-5#1)
two longitudinal##2##2##(2009-9#1)(2011-2#1)
two low##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
two lower##2##2##(1993-9#1)(2008-10#1)
two mRNA species##2##3##(1990-2#2)
two mRNA##4##2##(1990-2#3)(2008-8#1)
two mRNAs##2##2##(1992-6#1)(1994-6#1)
two main approaches##3##3##(2008-4#2)(2008-9#1)
two main categories##3##3##(1993-11#1)(2008-8#1)(2011-2#1)
two main clusters##3##3##(2008-10#2)(2008-5#1)
two main groups##4##3##(1997-3#1)(2008-10#2)(2008-5#1)
two main reasons for##2##4##(1996-6#1)(2011-2#1)
two main reasons##3##3##(1996-1#1)(1996-6#1)(2011-2#1)
two main##60##2##(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
two maize##3##2##(2008-12#3)
two major NORs##2##3##(1993-12#2)
two major areas##2##3##(1990-12#1)(2008-10#1)
two major challenges##2##3##(2008-10#1)(2012-2#1)
two major groups of##3##4##(1990-5#1)(2008-10#2)
two major groups##5##3##(1990-5#1)(2008-10#4)
two major pathways##2##3##(2008-9#1)(2011-2#1)
two major peaks of##3##4##(1990-7#1)(1993-6#1)(1995-3#1)
two major polypeptides##2##3##(1995-2#1)(1995-5#1)
two major problems##2##3##(1990-2#1)(1994-11#1)
two major protein##2##3##(2008-7#1)(2008-8#1)
two major proteins##2##3##(1990-8#1)(2008-10#1)
two major sources##2##3##(2008-11#1)(2008-5#1)
two major##96##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#4)(1993-6#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#3)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-6#2)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#4)(2012-2#4)
two male##3##2##(1991-2#1)(1992-3#1)(2008-11#1)
two males##5##2##(2007-7#1)(2008-5#1)(2008-8#2)(2008-9#1)
two marine##2##2##(2008-10#1)(2013-7#1)
two marker##2##2##(1992-3#1)(2008-5#1)
two markers##4##2##(2007-7#1)(2008-10#2)(2012-2#1)
two matched##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
two materials in##2##3##(2007-12#1)(2008-5#1)
two materials##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
two maternal##2##2##(1997-7#1)(2009-9#1)
two mathematical##2##2##(2008-10#2)
two mating types##2##3##(2008-10#2)
two mating##3##2##(2008-10#2)(2013-1#1)
two measurements of##2##3##(2007-12#1)(2008-3#1)
two measurements##5##2##(2007-12#1)(2008-3#3)(2008-5#1)
two measures of##4##3##(1994-8#1)(1997-7#1)(2008-11#1)(2009-5#1)
two measures##9##2##(1994-8#1)(1997-7#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-5#1)(2010-3#1)
two mechanisms by which##2##4##(1995-2#1)(2010-4#1)
two mechanisms for##3##3##(1995-2#1)(2008-10#2)
two mechanisms of##2##3##(2008-3#1)(2008-7#1)
two mechanisms that##2##3##(2008-8#1)(2010-4#1)
two mechanisms##18##2##(1995-2#2)(1995-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)
two mechanistically distinct##2##3##(2009-9#1)(2012-2#1)
two medical##5##2##(1995-11#1)(1996-1#1)(1996-6#1)(2011-1#1)(2013-1#1)
two meetings##2##2##(2012-12#2)
two meiotic##2##2##(2008-10#1)(2012-2#1)
two members of the##3##4##(1991-6#1)(2008-3#1)(2008-7#1)
two members of##4##3##(1991-6#1)(2008-3#1)(2008-7#1)(2009-9#1)
two membrane##2##2##(1993-11#1)(2008-10#1)
two membranes##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2009-6#1)
two men##3##2##(1994-11#1)(1996-3#1)(2008-10#1)
two mentioned##3##2##(2008-10#1)(2008-12#2)
two mesocosms##2##2##(2010-8#2)
two messengers##2##2##(1990-7#1)(1993-9#1)
two metabolic##2##2##(1997-6#1)(2008-7#1)
two metabolites##3##2##(1991-5#1)(1995-3#1)(2008-10#1)
two metal ions##4##3##(1995-2#1)(1997-6#1)(2008-10#2)
two metal##6##2##(1995-2#1)(1997-6#1)(2008-10#3)(2008-3#1)
two metals##8##2##(1991-12#1)(1991-5#1)(2008-10#6)
two methodologies for##2##3##(1992-3#1)(2008-10#1)
two methods are equivalent##2##4##(2008-3#2)
two methods are##9##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)
two methods for the##2##4##(2008-10#1)(2008-3#1)
two methods for##9##3##(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)
two methods in##2##3##(1992-12#1)(2013-7#1)
two methods of##13##3##(1997-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-7#1)(2013-1#1)
two methods to##4##3##(2008-3#1)(2008-9#1)(2010-5#1)(2012-3#1)
two methods were##7##3##(2008-10#5)(2008-7#1)(2013-7#1)
two methods##96##2##(1992-12#1)(1992-6#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-5#2)(1997-2#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#2)
two minor##8##2##(1993-12#1)(1994-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
two minutes##3##2##(1990-5#1)(1991-3#1)(1992-11#1)
two mirrors##3##2##(2007-12#1)(2008-3#2)
two miscible##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
two mitochondrial derivatives##5##3##(2007-12#4)(2008-7#1)
two mitochondrial##6##2##(2007-12#4)(2008-7#1)(2013-7#1)
two model parameters##2##3##(2008-7#2)
two model##3##2##(2008-7#2)(2008-9#1)
two models are##2##3##(1995-8#1)(2008-10#1)
two models of##5##3##(1992-8#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
two models##22##2##(1991-1#1)(1991-2#1)(1992-8#1)(1995-8#2)(2007-10#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-8#3)
two modes of##9##3##(1995-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#1)
two modes##13##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#1)
two modified##2##2##(1993-11#1)(1997-2#1)
two modules##2##2##(2008-11#1)(2008-3#1)
two molecular##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
two molecules in the##2##4##(1992-9#1)(2008-8#1)
two molecules of##10##3##(1990-11#1)(1990-9#1)(1992-2#3)(1992-3#1)(1993-12#1)(1994-5#1)(1994-9#1)(2009-2#1)
two molecules##16##2##(1990-11#1)(1990-9#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)
two monoclonal antibodies (MAbs)##2##4##(1990-12#1)(2008-10#1)
two monoclonal antibodies directed against the##2##6##(1992-12#1)(1992-2#1)
two monoclonal antibodies##8##3##(1990-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-8#1)
two monoclonal##9##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-8#1)
two monomers##3##2##(1992-4#1)(2012-12#1)(2012-2#1)
two monthly##2##2##(2008-5#2)
two months after the##4##4##(1994-12#1)(1995-9#1)(2008-8#1)(2010-10#1)
two months after##9##3##(1991-3#1)(1994-12#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-8#2)(2010-10#1)(2013-1#1)
two months and##2##3##(2008-4#1)(2008-5#1)
two months duration##2##3##(2009-2#1)(2012-12#1)
two months later##2##3##(2013-1#2)
two months of therapy##2##4##(2013-1#2)
two months of treatment##2##4##(2008-8#1)(2013-1#1)
two months of##8##3##(2007-7#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#4)
two months without##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
two months##40##2##(1991-2#1)(1991-3#1)(1994-12#1)(1994-6#1)(1995-11#2)(1995-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2009-11#1)(2009-2#1)(2010-10#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#7)
two more##7##2##(1996-2#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#2)
two morphological##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
two morphologically##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
two most common##6##3##(1991-8#1)(2007-12#2)(2007-6#1)(2008-10#1)(2012-2#1)
two most important##5##3##(1991-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(2008-5#1)
two most widely used##2##4##(1992-6#1)(2008-9#1)
two most##24##2##(1991-2#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
two motifs##2##2##(1997-7#1)(2012-3#1)
two mouse##2##2##(2008-4#1)(2008-8#1)
two movements at##2##3##(1994-3#2)
two multigenic families##2##3##(1997-9#2)
two murine##3##2##(1994-3#1)(2008-4#1)(2008-6#1)
two mutant##5##2##(1992-6#1)(1993-12#1)(1995-5#1)(1997-4#1)(2008-8#1)
two mutants##6##2##(1990-5#1)(1995-2#1)(1995-5#1)(1997-7#1)(2008-12#1)(2008-9#1)
two mutations were##2##3##(1993-11#1)(1995-6#1)
two mutations##6##2##(1993-11#1)(1994-12#1)(1995-6#1)(2008-12#1)(2010-4#1)(2012-12#1)
two mutually##4##2##(2007-11#2)(2008-11#1)(2008-8#1)
two nationally representative##2##3##(1993-1#1)(2008-11#1)
two native##2##2##(1994-8#1)(2008-5#1)
two natural##6##2##(1995-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-6#1)(2013-7#1)
two naturally occurring##3##3##(1991-12#1)(1994-9#1)(2008-11#1)
two naturally##4##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-11#1)
two near-infrared wavelengths##2##3##(2008-2#2)
two near-infrared##3##2##(2008-2#2)(2008-3#1)
two nebulizers##2##2##(1996-12#1)(2008-10#1)
two negative##2##2##(1990-5#1)(2009-8#1)
two neighboring##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
two nematode##2##2##(2008-10#2)
two neurons##2##2##(1993-12#1)(2009-5#1)
two new algorithms##2##3##(2008-3#2)
two new cases and##2##4##(2008-10#1)(2008-6#1)
two new cases of##2##4##(2006-12#1)(2008-10#1)
two new cases##4##3##(2006-12#1)(2008-10#2)(2008-6#1)
two new features##2##3##(2008-10#1)(2008-2#1)
two new genotypes##2##3##(2008-10#2)
two new species##5##3##(2008-5#3)(2011-2#1)(2013-8#1)
two new tospovirus species##2##4##(2008-10#2)
two new##61##2##(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#21)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2013-8#1)
two newly described##2##3##(2008-10#2)
two newspapers##2##2##(1992-9#1)(1997-5#1)
two nonidentical subunits##3##3##(1992-9#1)(1997-6#1)(2008-8#1)
two nonlinear##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
two normal##3##2##(1992-3#1)(2012-2#1)(2012-3#1)
two novel genes##2##3##(1993-8#1)(1997-2#1)
two novel##18##2##(1991-12#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-2#1)(1997-2#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)(2011-2#1)
two nuclear##2##2##(1991-2#1)(1995-2#1)
two nuclei##2##2##(2008-10#2)
two nucleoli##2##2##(2008-5#1)(2008-7#1)
two nucleotide##2##2##(1996-12#1)(2008-11#1)
two nucleotides##2##2##(2008-10#1)(2008-5#1)
two nutritional##2##2##(2008-11#1)(2013-7#1)
two object##3##2##(2007-12#1)(2008-2#2)
two objective##3##2##(1990-10#1)(2008-3#1)(2008-9#1)
two objects##2##2##(1992-11#1)(2008-2#1)
two observations##2##2##(1995-9#1)(2008-11#1)
two observers##2##2##(2011-2#1)(2012-12#1)
two occasions##5##2##(1991-8#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-9#1)
two of four##6##3##(1992-2#1)(1996-12#1)(2008-10#4)
two of his##2##3##(1993-2#1)(2007-12#1)
two of the four##9##4##(1992-11#1)(1992-3#1)(1994-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)
two of the most common##2##5##(2012-2#2)
two of the three##8##4##(1991-3#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)
two of the##63##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(2007-11#1)(2007-2#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
two of them were##2##4##(2008-10#1)(2008-9#1)
two of them##12##3##(1991-5#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-5#2)(2008-9#2)(2012-3#1)
two of these patients##2##4##(2008-2#1)(2011-1#1)
two of these were##2##4##(1996-3#1)(1997-8#1)
two of these##22##3##(1990-12#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-1#1)(2013-1#1)
two of three experiments##2##4##(2008-10#2)
two of three##7##3##(1992-2#1)(2008-10#4)(2008-11#1)(2008-5#1)
two of which##10##3##(1994-11#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-8#1)
two of##142##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#32)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)
two on the##2##3##(2008-12#1)(2008-2#1)
two on##3##2##(1997-5#1)(2008-12#1)(2008-2#1)
two one-dimensional##2##2##(2007-12#1)(2008-2#1)
two open reading frames (ORFs)##2##5##(1996-6#1)(2008-10#1)
two open reading frames##7##4##(1990-11#1)(1991-7#1)(1991-9#1)(1996-6#1)(2008-10#3)
two open##8##2##(1990-11#2)(1991-7#1)(1991-9#1)(1996-6#1)(2008-10#3)
two open-ended##2##2##(1992-12#1)(2013-1#1)
two opposing##2##2##(2007-11#1)(2008-9#1)
two opposite sides##2##3##(2008-11#1)(2008-8#1)
two opposite##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
two optical##8##2##(1990-8#1)(2007-12#3)(2008-10#1)(2008-3#3)
two options##2##2##(2008-8#1)(2011-2#1)
two or four##2##3##(1996-12#1)(2008-3#1)
two or more groups##3##4##(1994-9#1)(2008-10#1)(2008-9#1)
two or more pathogens##2##4##(2008-10#2)
two or more##53##3##(1990-8#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-2#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#2)(1997-2#2)(1997-4#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-3#2)(2008-4#2)(2008-9#5)(2009-5#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
two or three times##3##4##(1994-1#1)(2007-7#1)(2008-5#1)
two or three##14##3##(1990-6#1)(1990-8#1)(1994-1#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#3)(2009-10#1)(2012-2#1)
two or##76##2##(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-2#2)(1994-1#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#3)(1996-4#2)(1997-2#2)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#6)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#2)
two orchid##4##2##(2008-10#4)
two orders of magnitude lower than##3##6##(1995-8#1)(2008-10#1)(2008-7#1)
two orders of magnitude##24##4##(1990-11#1)(1990-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#13)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)
two organic##4##2##(1996-5#1)(2008-10#1)(2009-10#2)
two orthogonal polarization modes##2##4##(2007-11#1)(2008-3#1)
two orthogonal polarization##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
two orthogonal##11##2##(2007-11#2)(2008-2#2)(2008-3#7)
two orthogonal-polarized components##2##3##(2008-3#2)
two orthogonally polarized components##2##4##(2007-11#1)(2008-3#1)
two other groups##3##3##(1992-1#1)(2008-12#1)(2008-5#1)
two other methods##2##3##(2008-3#1)(2008-6#1)
two other patients##3##3##(1994-3#1)(1997-3#1)(2007-7#1)
two other species##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
two other##71##2##(1990-11#1)(1990-5#2)(1990-7#3)(1991-2#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)
two others##4##2##(1993-1#1)(2008-10#2)(2008-8#1)
two out of the##2##4##(2008-2#1)(2011-2#1)
two out of three##3##4##(1991-12#1)(2008-1#1)(2008-5#1)
two out of##6##3##(1991-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
two outer ring electrodes##2##4##(2008-10#2)
two output##2##2##(2007-11#1)(2008-2#1)
two overlaid##2##2##(2008-3#2)
two overlapping##4##2##(1992-6#1)(1996-6#1)(1997-8#1)(2012-3#1)
two paediatric##2##2##(2008-9#1)(2010-7#1)
two pairs of IR receptors##2##5##(2007-12#2)
two pairs of degenerate primers##2##5##(2008-10#2)
two pairs of##15##3##(1994-5#2)(1994-9#1)(1995-3#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-5#1)(2010-11#1)(2013-7#1)
two pairs##16##2##(1993-12#1)(1994-5#2)(1994-9#1)(1995-3#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-5#1)(2010-11#1)(2013-7#1)
two palatal roots##2##3##(2013-1#2)
two palatal##4##2##(2013-1#4)
two papers##2##2##(2008-3#1)(2008-4#1)
two parallel##8##2##(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#1)(2011-1#1)
two parameters that##2##3##(2008-2#1)(2008-9#1)
two parameters##26##2##(1992-6#1)(1994-3#1)(1994-5#1)(1995-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#2)(2008-9#1)(2010-8#1)
two partial##4##2##(1990-8#1)(1991-5#1)(1995-12#1)(1997-7#1)
two partially##4##2##(2008-10#1)(2008-8#1)(2009-6#1)(2010-10#1)
two particles##2##2##(2008-3#2)
two particular##2##2##(1990-7#1)(2013-8#1)
two parts##11##2##(1993-1#1)(1994-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
two pathogenic fungi##2##3##(2008-10#1)(2011-1#1)
two pathogenic species##2##3##(2008-10#2)
two pathogenic##4##2##(2008-10#3)(2011-1#1)
two pathogenicity groups##2##3##(2008-10#2)
two pathogenicity##3##2##(2008-10#3)
two pathogens##8##2##(2008-10#6)(2008-9#1)(2010-4#1)
two pathotypes##2##2##(2008-10#2)
two paths##2##2##(1996-1#1)(2008-3#1)
two pathways##6##2##(1994-11#1)(1996-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-3#1)
two patient##4##2##(1993-12#1)(1996-5#1)(2008-10#1)(2008-3#1)
two patients a##2##3##(2008-7#1)(2008-9#1)
two patients and##2##3##(2010-5#1)(2012-12#1)
two patients complained of##2##4##(1990-6#1)(2008-8#1)
two patients had##2##3##(1991-4#1)(2008-10#1)
two patients suffering from##2##4##(1997-6#1)(2013-1#1)
two patients treated##2##3##(1992-4#1)(2008-6#1)
two patients we##2##3##(1996-9#1)(2007-8#1)
two patients were included in##2##5##(2007-9#1)(2012-3#1)
two patients were##7##3##(1994-11#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
two patients who developed##2##4##(2008-1#1)(2012-2#1)
two patients who had##2##4##(1995-11#1)(1997-8#1)
two patients who##8##3##(1993-1#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
two patients with##31##3##(1990-3#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-9#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#4)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
two patients##112##2##(1990-3#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-1#2)(1993-2#2)(1993-5#1)(1994-11#2)(1994-2#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-5#1)(1996-9#5)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#13)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2010-5#3)(2010-7#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)
two patients)##2##2##(2008-6#1)(2011-2#1)
two pattern recognition methods##2##4##(2008-10#2)
two patterns of##3##3##(1992-5#1)(2008-2#1)(2012-2#1)
two patterns##5##2##(1992-5#1)(2008-2#1)(2008-5#1)(2012-1#1)(2012-2#1)
two pea##2##2##(2008-10#2)
two peaks of##3##3##(1990-2#1)(1995-6#1)(2013-1#1)
two peaks were identified##2##4##(2008-10#1)(2008-11#1)
two peaks were##3##3##(2008-10#2)(2008-11#1)
two peaks##14##2##(1990-2#2)(1990-8#2)(1991-12#1)(1993-11#1)(1995-6#1)(2008-10#5)(2008-11#1)(2013-1#1)
two peanut genotypes##2##3##(2008-10#2)
two peptides are##2##3##(1992-6#1)(2011-2#1)
two peptides were##2##3##(1990-5#1)(2008-7#1)
two peptides##12##2##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1995-12#1)(1995-6#1)(2008-10#2)(2008-7#1)(2010-2#1)(2011-2#1)
two per cent##3##3##(1995-12#3)
two percent##2##2##(2013-1#1)(2013-8#1)
two periods##8##2##(1996-3#1)(2007-12#1)(2011-2#4)(2012-3#1)(2013-1#1)
two peripheral##2##2##(2011-1#1)(2013-1#1)
two perpendicular##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
two pertussis##2##2##(1991-9#1)(1992-2#1)
two phase differences##2##3##(2008-3#2)
two phase##9##2##(1994-9#1)(2007-12#1)(2008-3#5)(2008-5#2)
two phase-only##2##2##(2008-3#2)
two phase-systems##2##2##(2008-10#2)
two phases in##2##3##(2008-10#1)(2008-5#1)
two phases of the##4##4##(1994-12#1)(1996-1#1)(1996-2#1)(2008-3#1)
two phases of##5##3##(1994-12#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-3#1)
two phases##29##2##(1991-6#1)(1991-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-4#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
two phenol sulphotransferase genes##2##4##(1994-11#2)
two phenomena that##2##3##(2007-12#1)(2008-7#1)
two phenomena##6##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)
two phenotypic##2##2##(2010-3#1)(2013-8#1)
two phosphonic acids##2##3##(2008-10#2)
two phosphorylated##2##2##(1991-2#1)(2008-8#1)
two photons##2##2##(1992-4#1)(2007-11#1)
two pixels##2##2##(2007-11#2)
two planes##2##2##(2007-11#1)(2007-12#1)
two plant species##3##3##(2008-10#2)(2009-3#1)
two plant##5##2##(2008-10#3)(2008-9#1)(2009-3#1)
two plants were##2##3##(2008-10#1)(2008-8#1)
two plants##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
two plasmids##3##2##(1991-5#1)(1997-3#1)(2011-2#1)
two plates of##2##3##(2008-9#1)(2010-10#1)
two plots were treated##2##4##(2008-10#2)
two point mutations##4##3##(1991-8#1)(1993-11#1)(1993-8#1)(1997-7#1)
two point##5##2##(1991-8#1)(1993-11#1)(1993-8#1)(1997-7#1)(2008-3#1)
two points in four images##2##5##(2008-6#2)
two points in##4##3##(1990-11#1)(2007-12#1)(2008-6#2)
two points##5##2##(1990-11#1)(2007-1#1)(2007-12#1)(2008-6#2)
two polar nuclei##2##3##(2009-12#2)
two polar##4##2##(1996-12#1)(2008-10#1)(2009-12#2)
two polarized##2##2##(2008-10#1)(2008-3#1)
two polyclonal##2##2##(1991-7#1)(1994-11#1)
two polymerase chain##2##3##(2008-10#2)
two polymorphic##2##2##(2008-10#2)
two polypeptides##2##2##(1991-8#1)(1994-5#1)
two populations of I##2##4##(2008-6#1)(2013-8#1)
two populations of an##2##4##(2008-5#1)(2013-1#1)
two populations of cells##2##4##(1992-8#1)(2008-4#1)
two populations of##13##3##(1990-5#1)(1992-8#1)(1993-5#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#2)(2013-8#2)
two populations##34##2##(1990-5#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-5#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2012-2#1)(2013-1#2)(2013-8#2)
two portions##2##2##(2008-10#2)
two positions of##2##3##(2008-10#1)(2013-1#1)
two positions##5##2##(1994-5#1)(1994-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
two possible configurations##2##3##(2008-10#1)(2008-3#1)
two possible scenarios##2##3##(1996-3#1)(2008-10#1)
two possible##13##2##(1990-11#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-9#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-11#1)
two potential##7##2##(1991-9#1)(1992-12#1)(1993-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-1#1)
two potentially##2##2##(2008-2#1)(2010-2#1)
two previous##5##2##(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#1)
two previously##7##2##(1991-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)
two prey species##2##3##(2008-8#2)
two prey##3##2##(2008-8#3)
two primary##8##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#2)(2011-2#1)(2013-1#2)
two primer pairs##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
two primer sets##2##3##(2008-10#2)
two primer##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
two primers##2##2##(2008-5#1)(2008-8#1)
two principal components##4##3##(2008-10#2)(2012-1#1)(2013-7#1)
two probes##4##2##(1990-5#1)(2008-10#2)(2008-5#1)
two problems##5##2##(2008-3#3)(2008-5#2)
two procedures##11##2##(1996-2#1)(2007-11#1)(2008-10#5)(2009-2#1)(2012-12#2)(2012-2#1)
two processes are##4##3##(1990-12#1)(1995-2#2)(2013-1#1)
two processes##12##2##(1990-12#1)(1992-5#1)(1995-2#2)(1996-6#1)(2008-10#2)(2008-7#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
two products##6##2##(1994-8#1)(1995-6#1)(2008-10#3)(2008-5#1)
two progenitors of the##2##4##(2007-12#2)
two progenitors##3##2##(2007-12#2)(2008-12#1)
two projection##2##2##(1995-12#1)(2008-6#1)
two proliferation assays##2##3##(2007-2#1)(2008-4#1)
two prominent##3##2##(1990-7#1)(1994-9#1)(2008-10#1)
two promoters##2##2##(1994-8#1)(2008-9#1)
two properties##2##2##(1994-8#1)(2008-2#1)
two proposed##2##2##(1994-1#1)(2008-10#1)
two prospective##2##2##(2008-11#1)(2008-7#1)
two protein bands##2##3##(1993-3#1)(2008-10#1)
two protein##7##2##(1993-3#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-12#1)
two proteins are##4##3##(1990-8#1)(1991-9#1)(1993-11#1)(2008-4#1)
two proteins of##5##3##(1991-12#1)(1992-9#1)(1993-6#1)(1994-6#1)(2008-10#1)
two proteins that##3##3##(1993-6#1)(2008-12#1)(2010-12#1)
two proteins##38##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
two protocols are##2##3##(2008-2#1)(2008-4#1)
two protocols for##6##3##(2008-2#1)(2008-4#1)(2008-9#3)(2013-7#1)
two protocols##17##2##(2008-2#2)(2008-4#10)(2008-9#4)(2013-7#1)
two pseudogenes##2##2##(1990-8#1)(1991-6#1)
two pulmonary##2##2##(1993-5#1)(2012-3#1)
two pulses##2##2##(2007-11#1)(2013-7#1)
two putative##15##2##(1990-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)
two pyridine##2##2##(1997-7#1)(2012-12#1)
two pyridines##2##2##(1997-7#2)
two quail strains and their reciprocal crosses##2##7##(2008-12#2)
two quantitative models##2##3##(1991-5#1)(2007-11#1)
two quantitative##4##2##(1991-5#1)(2007-11#1)(2008-10#2)
two questions##5##2##(1997-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
two rabbit GRO##2##3##(1994-12#2)
two races of##4##3##(2008-10#3)(2008-8#1)
two races##5##2##(2008-10#4)(2008-8#1)
two random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#2)
two random phase codes##3##4##(2007-12#1)(2008-3#2)
two random phase##4##3##(2007-12#1)(2008-3#3)
two random##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
two randomized##3##2##(1994-9#1)(2008-5#1)(2013-1#1)
two ranges##3##2##(1993-3#1)(1996-5#1)(2008-10#1)
two rare variants##3##3##(1990-8#1)(1991-8#1)(2012-3#1)
two rare##6##2##(1990-8#2)(1991-8#1)(1993-3#1)(2012-3#2)
two ratios##2##2##(2008-3#1)(2008-9#1)
two rays##2##2##(2008-3#2)
two reaction##2##2##(2008-10#1)(2008-3#1)
two reactions##4##2##(1993-12#1)(2008-10#3)
two reactors##3##2##(2008-10#3)
two reagent##2##2##(2008-10#2)
two reagents##2##2##(2008-10#1)(2008-11#1)
two real##3##2##(2008-10#1)(2009-11#1)(2010-1#1)
two reasons##3##2##(1991-1#1)(1994-6#1)(2008-3#1)
two recent studies##3##3##(1993-1#1)(1995-6#1)(2008-2#1)
two recent##4##2##(1993-1#1)(1995-6#1)(2007-8#1)(2008-2#1)
two recently##6##2##(1995-3#1)(1997-4#1)(2008-11#1)(2008-3#1)(2013-1#2)
two receptor##7##2##(1990-11#1)(1991-12#1)(1993-6#2)(1994-11#1)(2008-11#1)(2008-7#1)
two receptors##3##2##(1993-3#1)(1994-11#1)(2008-9#1)
two recessive genes were detected in##3##6##(2008-10#3)
two recessive genes##5##3##(2008-10#5)
two recombinant##4##2##(1995-12#1)(1997-2#1)(2008-1#1)(2008-7#1)
two reconstruction##2##2##(2008-2#1)(2012-1#1)
two redox##3##2##(1995-2#1)(2008-10#2)
two reduction peaks##2##3##(2008-10#2)
two reference##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#2)
two regimens##2##2##(1990-12#1)(1992-2#1)
two regimes##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
two regions are##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
two regions of the##3##4##(1992-9#1)(1993-11#1)(2007-8#1)
two regions of##6##3##(1992-9#1)(1993-11#1)(1996-2#1)(2007-8#2)(2008-7#1)
two regions##22##2##(1991-2#1)(1992-12#1)(1992-9#2)(1993-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-7#3)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
two related##8##2##(1992-1#1)(1992-12#1)(1993-12#1)(1994-11#1)(2007-2#1)(2008-10#2)(2008-7#1)
two relatively##3##2##(2007-8#1)(2008-8#1)(2008-9#1)
two remaining##4##2##(1994-2#1)(2008-10#2)(2008-8#1)
two repeat##2##2##(2008-12#1)(2008-7#1)
two replicas##2##2##(1992-12#1)(2007-11#1)
two replications##3##2##(1993-2#1)(2008-10#2)
two reports##2##2##(2008-9#1)(2013-1#1)
two representative##6##2##(2008-10#3)(2008-9#1)(2009-12#1)(2010-10#1)
two reproductive##2##2##(2008-8#2)
two residues##4##2##(1991-2#1)(1993-11#1)(1993-8#1)(2008-8#1)
two resin##2##2##(1997-2#1)(2009-8#1)
two resins##4##2##(2008-10#4)
two resistant##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
two response##2##2##(1997-7#1)(2010-4#1)
two responses##2##2##(1991-6#1)(2008-10#1)
two restriction##2##2##(2008-10#1)(2008-2#1)
two reversible##2##2##(2008-4#1)(2009-9#1)
two rival##2##2##(2008-11#1)(2008-12#1)
two roots of the##2##4##(2008-3#1)(2008-7#1)
two roots##4##2##(2008-3#1)(2008-7#2)(2011-2#1)
two rounds of##2##3##(2008-11#1)(2008-12#1)
two rounds##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
two routes##2##2##(2009-10#1)(2011-2#1)
two sample portions##2##3##(2008-10#2)
two sample##8##2##(1992-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)
two samples of##4##3##(1993-1#1)(2008-10#2)(2009-4#1)
two samples ranged from##3##4##(2008-10#3)
two samples##22##2##(1993-1#1)(1994-9#1)(2008-10#11)(2008-2#1)(2008-4#1)(2009-4#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
two sampling##4##2##(2008-10#4)
two scales##4##2##(1993-2#1)(2008-10#1)(2010-3#1)(2013-1#1)
two scenarios##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
two schemes##2##2##(1997-1#1)(2008-3#1)
two schools##3##2##(1994-2#1)(2008-9#1)(2010-3#1)
two screening##3##2##(2008-10#2)(2013-1#1)
two seasons##12##2##(2008-10#9)(2008-5#2)(2012-8#1)
two secondary##2##2##(2007-12#1)(2008-3#1)
two sections##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2013-1#1)
two segments##2##2##(2008-10#1)(2008-5#1)
two selected##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
two selective##2##2##(2011-2#1)(2013-1#1)
two semiconductor##2##2##(2007-12#1)(2008-3#1)
two sensing##2##2##(2008-10#1)(2008-3#1)
two separate clusters##2##3##(1996-5#1)(2008-10#1)
two separate experiments##2##3##(2008-10#1)(2008-11#1)
two separate genes##2##3##(1992-6#1)(1993-9#1)
two separate sites##2##3##(1994-2#1)(2008-7#1)
two separate studies##2##3##(1991-11#1)(2009-11#1)
two separate##56##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
two sequences##7##2##(1992-4#1)(1993-3#1)(1996-12#1)(2008-10#1)(2008-4#3)
two sequential##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
two sera##2##2##(1995-2#1)(2012-12#1)
two serially##2##2##(2008-10#1)(2008-3#1)
two series of peptides##2##4##(1995-3#2)
two series of##9##3##(1995-11#1)(1995-3#2)(1997-7#1)(2008-10#4)(2008-5#1)
two series##11##2##(1995-11#1)(1995-3#2)(1997-7#2)(2008-10#4)(2008-4#1)(2008-5#1)
two serious##2##2##(2008-2#1)(2010-3#1)
two serotypes##2##2##(2008-10#2)
two sets of modified##2##4##(2008-10#1)(2008-3#1)
two sets of##31##3##(1992-3#1)(1993-12#2)(1993-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
two sets##33##2##(1992-3#1)(1993-12#2)(1993-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
two settings##2##2##(2007-8#1)(2008-2#1)
two shampoos##2##2##(2008-10#1)(2008-5#1)
two shearing interferograms##2##3##(2008-3#2)
two sibling yeast species##2##4##(1996-6#2)
two sibling##4##2##(1990-5#1)(1996-6#2)(2008-9#1)
two sides of the##2##4##(2008-10#1)(2011-2#1)
two sides##5##2##(1995-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
two signal##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
two signals##6##2##(2008-3#5)(2008-7#1)
two similar##6##2##(1990-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-6#1)(2013-8#1)
two simple##4##2##(1994-8#1)(2007-11#1)(2008-3#1)(2009-10#1)
two simultaneously##2##2##(2007-12#1)(2008-10#1)
two single##9##2##(1995-6#2)(1997-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-3#1)(2013-1#1)
two single-mode##3##2##(2007-11#1)(2008-3#2)
two single-point mutants##2##3##(1993-11#1)(2008-9#1)
two sites in the##2##4##(1997-3#1)(2008-10#1)
two sites in##5##3##(1997-3#1)(1997-7#1)(2008-10#2)(2008-5#1)
two sites on the##2##4##(1992-8#1)(1994-5#1)
two sites##24##2##(1990-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#1)(1995-11#1)(1997-3#1)(1997-7#1)(2007-6#1)(2008-10#7)(2008-5#3)(2008-8#1)(2013-7#3)
two situations##2##2##(2008-10#1)(2010-6#1)
two sizes##2##2##(2007-12#1)(2008-2#1)
two slightly##2##2##(1996-3#1)(2008-2#1)
two small##10##2##(1994-11#2)(1995-3#2)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
two smaller##5##2##(1990-5#1)(1995-8#1)(1997-6#1)(2007-12#1)(2012-3#1)
two sodium##2##2##(1996-2#1)(2008-10#1)
two soil##3##2##(2008-10#1)(2008-11#1)(2012-5#1)
two soils##8##2##(1993-8#1)(2008-10#5)(2008-11#1)(2008-6#1)
two solid##2##2##(2008-10#1)(2008-7#1)
two solitudes##2##2##(1995-1#1)(1996-1#1)
two solutions##2##2##(2008-2#1)(2013-1#1)
two sources##7##2##(1991-12#2)(2008-3#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
two soybean##2##2##(2008-10#1)(2008-12#1)
two spatial scales##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
two spatial##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2010-8#1)
two spatially separated##2##3##(2007-12#1)(2008-7#1)
two spatially##4##2##(2007-12#2)(2008-10#1)(2008-7#1)
two special##2##2##(2008-9#1)(2011-2#1)
two specialists##2##2##(2008-5#1)(2008-8#1)
two species and##3##3##(1991-6#1)(2008-10#2)
two species are##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
two species have##2##3##(1993-6#1)(2008-9#1)
two species in the##2##4##(1991-6#1)(2007-12#1)
two species in##5##3##(1991-6#1)(2007-12#1)(2008-8#2)(2011-2#1)
two species of Papilio butterfly##2##5##(2008-3#2)
two species of halacarid mites##2##5##(2007-12#2)
two species of##29##3##(1993-6#1)(1994-3#1)(1997-4#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-8#1)(2011-2#1)(2013-1#2)
two species that##3##3##(1992-10#1)(2008-8#1)(2010-3#1)
two species##106##2##(1990-7#1)(1991-6#2)(1992-10#1)(1993-12#2)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2007-12#5)(2008-10#27)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#11)(2009-8#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#2)(2013-7#2)
two species-specific##2##2##(1995-12#1)(2008-12#1)
two specific##12##2##(1990-8#1)(1994-11#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)
two specified##2##2##(2008-1#1)(2008-2#1)
two spectral##3##2##(2007-12#1)(2007-5#1)(2008-3#1)
two spectrometer positions##2##3##(2007-12#2)
two spectrometer##3##2##(2007-12#2)(2008-10#1)
two split##2##2##(2008-11#1)(2008-3#1)
two spots##2##2##(2007-12#1)(2010-12#1)
two stacked##2##2##(1994-5#1)(2008-3#1)
two stage##6##2##(1990-12#1)(1992-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
two stages of##3##3##(2008-12#1)(2008-2#2)
two stages##9##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2010-8#2)
two standard reference materials##4##4##(2008-10#4)
two standard##6##2##(1992-1#1)(2008-10#5)
two states##4##2##(1991-3#2)(2007-11#1)(2009-7#1)
two stem##2##2##(2007-12#1)(2009-8#1)
two step AFB##2##3##(2007-8#2)
two step##5##2##(1991-5#1)(2007-8#3)(2008-10#1)
two steps of##5##3##(1993-2#1)(1993-8#1)(2008-10#1)(2010-2#1)(2011-1#1)
two steps##27##2##(1990-7#1)(1991-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-3#3)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)
two stocks of##3##3##(2010-8#3)
two strains and##2##3##(2012-2#1)(2013-1#1)
two strains of##13##3##(1990-3#1)(1991-5#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-6#1)(2013-8#2)
two strains that##3##3##(2008-10#3)
two strains were##3##3##(1993-11#1)(2008-10#1)(2011-1#1)
two strains##36##2##(1990-3#1)(1991-5#1)(1993-11#2)(1996-12#1)(1996-5#1)(1997-3#2)(2007-6#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
two strands of##2##3##(2008-1#1)(2008-9#1)
two strategies##6##2##(1996-1#1)(1997-4#1)(2008-10#2)(2008-8#1)(2010-7#1)
two streams of##3##3##(1996-1#1)(2008-10#1)(2008-8#1)
two streams##5##2##(1995-5#1)(1996-1#1)(2008-10#2)(2008-8#1)
two strikingly different##2##3##(2008-11#1)(2008-9#1)
two strikingly##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
two strongest##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
two strongly##2##2##(2008-5#1)(2008-8#1)
two structural##3##2##(1993-6#1)(1996-2#2)
two structurally##5##2##(1992-12#1)(1994-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
two structures##4##2##(1993-6#1)(1994-3#1)(2008-10#1)(2008-7#1)
two students##2##2##(1992-2#1)(2008-11#1)
two studies were##2##3##(1994-2#1)(2010-8#1)
two studies##20##2##(1991-11#1)(1993-9#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-9#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
two study##4##2##(1991-11#1)(2010-4#1)(2011-2#1)(2013-7#1)
two subfamilies##5##2##(1995-3#1)(2008-4#1)(2008-5#1)(2008-8#2)
two subgroup##2##2##(2008-10#2)
two subgroups according to the##2##5##(2008-10#1)(2011-2#1)
two subgroups of##5##3##(1994-3#1)(2008-10#1)(2008-7#3)
two subgroups##21##2##(1990-8#1)(1994-3#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#2)
two subplots (furrow and##2##4##(2008-10#2)
two subpopulations of##2##3##(2008-10#1)(2008-11#1)
two subpopulations##5##2##(2008-10#3)(2008-11#2)
two subsequent##3##2##(2008-10#2)(2009-6#1)
two subsets##2##2##(2008-4#1)(2010-8#1)
two substances##4##2##(1990-12#1)(1993-11#1)(2008-10#1)(2008-11#1)
two substrates in a##2##4##(1994-5#2)
two substrates##10##2##(1992-10#1)(1994-5#4)(1997-2#1)(2008-10#1)(2008-7#3)
two subtypes of##2##3##(1994-12#1)(2008-8#1)
two subtypes##5##2##(1991-11#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-8#1)
two subunits of##3##3##(1992-9#1)(1993-8#1)(1995-6#1)
two subunits##17##2##(1990-8#1)(1991-10#2)(1991-12#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(1995-2#1)(1995-6#1)(2008-9#2)(2010-5#3)
two successful##2##2##(1996-8#1)(2008-11#1)
two successive injections##2##3##(2008-10#1)(2012-12#1)
two successive##12##2##(1992-6#1)(1993-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)
two such cases##2##3##(2007-7#1)(2012-3#1)
two such##6##2##(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
two sulfonylureas##2##2##(1992-3#2)
two surface integration approaches##2##4##(2008-3#2)
two surface##8##2##(2007-12#1)(2008-3#5)(2008-6#1)(2008-9#1)
two surfaces##4##2##(2008-12#1)(2008-2#1)(2010-10#2)
two surgical techniques##2##3##(2011-2#2)
two survived##2##2##(1994-9#2)
two susceptible##2##2##(2008-10#2)
two sympatric##3##2##(2008-10#1)(2012-3#2)
two synthetic##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#2)
two systems for##2##3##(2007-8#1)(2008-2#1)
two systems##16##2##(1990-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#1)
two tandem##4##2##(1991-9#1)(1994-12#1)(2008-8#1)(2008-9#1)
two tasks were##2##3##(2008-11#1)(2008-9#1)
two tasks##5##2##(1991-2#1)(1994-8#1)(2008-11#2)(2008-9#1)
two teachers##2##2##(1991-12#1)(2008-11#1)
two techniques for the##2##4##(1994-12#1)(2008-10#1)
two techniques have##2##3##(2008-12#1)(2010-7#1)
two techniques is##2##3##(2008-10#1)(2010-5#1)
two techniques##25##2##(1994-12#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)
two teleost##2##2##(2008-1#1)(2008-7#1)
two telomeres##2##2##(1991-7#1)(2008-5#1)
two temperature conditions##2##3##(2008-12#1)(2012-12#1)
two temperatures##3##2##(2007-12#1)(2008-11#1)(2012-1#1)
two terms##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
two test##6##2##(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-8#1)
two tests##7##2##(1991-6#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-4#1)(2008-10#2)
two that##2##2##(1993-11#1)(2008-8#1)
two thin##2##2##(2007-11#1)(2008-3#1)
two thirds of the##4##4##(1992-3#1)(1995-11#1)(2007-2#1)(2009-4#1)
two thirds of##7##3##(1991-11#1)(1992-3#1)(1995-11#1)(2007-2#1)(2008-2#1)(2009-4#1)(2011-2#1)
two thirds##9##2##(1991-11#1)(1992-3#1)(1995-11#1)(2007-2#1)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
two tier##3##2##(1990-3#3)
two tightly linked loci##2##4##(2008-10#2)
two tightly##4##2##(1997-4#1)(2007-11#1)(2008-10#2)
two time constants##2##3##(2008-10#1)(2008-3#1)
two time periods##5##3##(1996-11#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
two time##12##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-1#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
two times as##2##3##(1995-2#1)(2012-2#1)
two times faster##2##3##(2008-10#1)(2008-5#1)
two times the##4##3##(1993-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
two times##20##2##(1993-6#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)
two tissues##2##2##(2008-10#1)(2008-3#1)
two to five##5##3##(1992-11#1)(1996-8#1)(2008-10#2)(2012-2#1)
two to four times##2##4##(1992-8#1)(2008-2#1)
two to four##12##3##(1990-11#1)(1992-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-8#2)(2013-8#1)
two to nine weeks after##2##5##(1996-12#2)
two to seven##3##3##(1997-5#1)(2008-11#1)(2008-5#1)
two to six##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
two to three times##5##4##(1992-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-2#1)
two to three##13##3##(1992-1#1)(1992-3#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
two to##47##2##(1990-11#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-8#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-8#2)(2012-2#2)(2013-8#1)
two tomato##2##2##(1997-2#1)(2008-10#1)
two tones##4##2##(1995-12#2)(2008-4#1)(2013-8#1)
two tools for##2##3##(1994-12#1)(2008-4#1)
two traits##3##2##(2008-8#1)(2008-9#2)
two transcripts##4##2##(1991-9#1)(1997-3#1)(1997-6#1)(2008-8#1)
two transformants##2##2##(2008-4#1)(2008-8#1)
two transgene##2##2##(1993-6#1)(2011-2#1)
two transmembrane domains##3##3##(2008-4#2)(2008-8#1)
two transmembrane##4##2##(2008-4#3)(2008-8#1)
two treatment groups##8##3##(1992-6#1)(1993-1#1)(1995-4#1)(1997-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2012-1#1)
two treatment methods##2##3##(1992-9#1)(2012-2#1)
two treatment studies##2##3##(2008-5#2)
two treatment##17##2##(1992-6#1)(1992-9#1)(1993-1#1)(1995-4#2)(1997-7#2)(2007-8#2)(2008-5#3)(2008-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)
two treatments is##2##3##(1995-9#1)(1997-4#1)
two treatments with##2##3##(2008-12#1)(2008-9#1)
two treatments##15##2##(1992-9#1)(1993-11#1)(1995-2#1)(1995-9#3)(1996-12#1)(1997-4#1)(2008-12#2)(2008-9#2)(2009-6#1)(2013-7#2)
two trends##2##2##(2008-12#1)(2008-6#1)
two trials##6##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-5#1)
two tributaries of the##2##4##(2010-8#2)
two tropical##3##2##(2008-10#3)
two tryptophan residues##5##3##(1991-5#1)(1992-6#2)(1993-11#2)
two tryptophans##2##2##(1995-2#2)
two type I##2##3##(2008-10#2)
two types of NF1-GRD##2##4##(1992-8#2)
two types of PD##2##4##(2008-7#2)
two types of binding sites##3##5##(1990-12#1)(1992-3#1)(2008-10#1)
two types of cells##4##4##(1993-1#1)(1997-1#1)(2008-11#1)(2012-1#1)
two types of distortion##2##4##(2008-2#2)
two types of homologous DNA pairing activity in mouse##2##9##(1992-6#2)
two types of optical##2##4##(2008-10#1)(2008-3#1)
two types of study##2##4##(2008-11#1)(2012-2#1)
two types of##118##3##(1990-11#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#4)(1993-1#2)(1993-11#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
two types##134##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#4)(1993-1#2)(1993-11#2)(1993-12#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
two typical##4##2##(1997-7#1)(2008-3#2)(2008-9#1)
two unbranched neurons##2##3##(2007-12#2)
two underwent##2##2##(2011-2#1)(2013-8#1)
two unique##5##2##(1992-3#1)(2008-10#2)(2008-11#1)(2012-2#1)
two units of##3##3##(1993-2#1)(1994-6#1)(1994-9#1)
two units##4##2##(1993-2#1)(1994-6#1)(1994-9#1)(2008-10#1)
two universal##2##2##(1990-11#1)(2008-10#1)
two university hospitals in##2##4##(2006-8#2)
two unknown##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
two unrelated##6##2##(1993-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
two upstream##2##2##(1990-8#1)(2008-10#1)
two urban##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
two used##2##2##(2008-10#2)
two valleys##2##2##(2008-10#2)
two values##4##2##(1990-12#1)(2008-11#1)(2008-3#2)
two variables##9##2##(1995-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2013-7#1)(2013-8#1)
two variant isoforms##2##3##(1991-12#2)
two variants of##3##3##(1990-7#1)(1992-1#1)(2012-1#1)
two variants##8##2##(1990-6#3)(1990-7#1)(1992-1#1)(1995-5#1)(2008-3#1)(2012-1#1)
two variations##2##2##(2008-12#1)(2011-2#1)
two varieties##4##2##(2008-10#3)(2008-5#1)
two vectors##3##2##(2007-12#1)(2008-8#1)(2011-3#1)
two vein##2##2##(2007-8#1)(2012-2#1)
two versions of##2##3##(2007-12#1)(2010-1#1)
two versions##4##2##(2007-12#1)(2010-1#1)(2011-1#1)(2012-12#1)
two very##5##2##(1993-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2011-2#1)
two views##3##2##(1995-5#1)(2008-6#2)
two villages##2##2##(1992-12#1)(1994-9#1)
two vineyards##2##2##(2008-10#2)
two viral##2##2##(2008-10#1)(2009-11#1)
two viruses##14##2##(1995-2#1)(2007-6#2)(2008-10#10)(2008-9#1)
two visible wavelengths##2##3##(2008-3#1)(2010-5#1)
two volumetric##2##2##(1990-8#1)(2010-5#1)
two water##3##2##(1995-5#1)(2008-8#1)(2010-8#1)
two wave fronts##3##3##(2008-2#2)(2008-3#1)
two wave##4##2##(1993-12#1)(2008-2#2)(2008-3#1)
two waveguides##4##2##(2007-11#3)(2008-3#1)
two wavelength windows##2##3##(2008-3#2)
two wavelength##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
two wavelengths simultaneously##2##3##(2008-2#1)(2008-9#1)
two wavelengths was##2##3##(2008-2#1)(2008-3#1)
two wavelengths##24##2##(2008-10#4)(2008-2#6)(2008-3#13)(2008-9#1)
two waves##2##2##(2007-12#1)(2008-3#1)
two ways of##3##3##(2008-2#2)(2008-8#1)
two ways##17##2##(1992-11#1)(1992-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-4#1)(2011-2#3)
two week##2##2##(1997-3#1)(2008-11#1)
two weeks after##4##3##(1995-12#1)(1995-2#1)(2011-2#1)(2013-8#1)
two weeks and##7##3##(1990-3#1)(1991-9#1)(1996-9#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-5#1)
two weeks during the##2##4##(1990-6#1)(2013-1#1)
two weeks later##4##3##(1991-6#1)(1992-3#2)(2007-8#1)
two weeks of##12##3##(1990-11#1)(1993-3#1)(1994-6#2)(1996-3#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#1)
two weeks to##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
two weeks##69##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-9#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-2#5)(2012-2#2)(2013-1#3)(2013-8#1)
two well resolved##2##3##(2009-9#2)
two well##3##2##(2009-9#2)(2013-1#1)
two well-characterized##2##2##(2008-1#1)(2012-3#1)
two well-separated##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
two were treated by##2##4##(2008-7#2)
two were##21##2##(1990-9#1)(1993-2#1)(1996-5#1)(1997-3#2)(2007-8#2)(2008-10#3)(2008-7#3)(2008-8#3)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
two wheat DH##2##3##(2008-8#2)
two wheat##5##2##(2008-12#3)(2008-8#2)
two widely used##2##3##(2008-3#1)(2008-8#1)
two widely##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
two wild-type##2##2##(2008-10#1)(2012-3#1)
two willows##2##2##(2012-3#2)
two with##9##2##(1992-7#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-12#1)
two within isolates of C##2##5##(2008-10#2)
two women##5##2##(1990-10#1)(1993-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
two writing beams##2##3##(2007-11#1)(2008-2#1)
two year##4##2##(1991-9#1)(2008-12#1)(2008-5#1)(2010-8#1)
two years (2007 and##2##4##(2013-1#1)(2013-8#1)
two years (OR =##2##4##(2011-2#2)
two years after the##2##4##(2008-2#1)(2011-2#1)
two years after##6##3##(1994-3#1)(1996-3#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
two years ago##2##3##(2008-10#1)(2011-2#1)
two years and##4##3##(1992-5#1)(1997-8#1)(2012-2#1)(2013-8#1)
two years in##5##3##(1994-1#1)(1997-2#1)(1997-5#1)(2008-10#2)
two years later##2##3##(1994-3#1)(2013-1#1)
two years of age or older##2##6##(2010-10#2)
two years of age##6##4##(1994-9#1)(1996-1#1)(2010-10#3)(2012-12#1)
two years of operation##2##4##(1994-2#1)(2011-2#1)
two years of the study##2##5##(1997-8#1)(2008-10#1)
two years of the##3##4##(1997-8#1)(2008-10#1)(2012-3#1)
two years of treatment##3##4##(1994-6#1)(2007-8#1)(2012-3#1)
two years of##23##3##(1993-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
two years old##2##3##(2011-2#1)(2012-12#1)
two years since the##2##4##(2007-12#1)(2008-7#1)
two years was##2##3##(1992-5#1)(2008-10#1)
two years were##3##3##(2008-1#2)(2013-1#1)
two years without##2##3##(1997-5#1)(2011-2#1)
two years##114##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-8#2)(1997-2#1)(1997-5#2)(1997-8#4)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#5)(2010-11#2)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
two yeast##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
two yeasts##2##2##(2008-10#1)(2013-1#1)
two young##2##2##(1992-5#1)(1996-3#1)
two zinc##3##2##(1991-6#1)(2008-3#1)(2008-7#1)
two##9130##1##(1990-10#5)(1990-11#37)(1990-12#42)(1990-2#25)(1990-3#22)(1990-5#49)(1990-6#16)(1990-7#34)(1990-8#41)(1990-9#11)(1991-1#8)(1991-10#4)(1991-11#16)(1991-12#57)(1991-2#34)(1991-3#20)(1991-4#4)(1991-5#30)(1991-6#33)(1991-7#4)(1991-8#25)(1991-9#40)(1992-1#10)(1992-10#14)(1992-11#22)(1992-12#34)(1992-2#28)(1992-3#54)(1992-4#14)(1992-5#19)(1992-6#45)(1992-7#1)(1992-8#34)(1992-9#36)(1993-1#25)(1993-11#47)(1993-12#77)(1993-2#35)(1993-3#29)(1993-5#6)(1993-6#45)(1993-8#38)(1993-9#19)(1994-1#8)(1994-11#54)(1994-12#57)(1994-2#47)(1994-3#27)(1994-5#45)(1994-6#31)(1994-7#5)(1994-8#45)(1994-9#33)(1995-1#10)(1995-10#1)(1995-11#30)(1995-12#47)(1995-2#64)(1995-3#32)(1995-4#4)(1995-5#51)(1995-6#47)(1995-8#34)(1995-9#14)(1996-1#26)(1996-10#7)(1996-11#4)(1996-12#44)(1996-2#69)(1996-3#32)(1996-4#9)(1996-5#36)(1996-6#21)(1996-7#3)(1996-8#8)(1996-9#19)(1997-1#7)(1997-2#46)(1997-3#43)(1997-4#37)(1997-5#11)(1997-6#33)(1997-7#69)(1997-8#32)(1997-9#4)(2006-10#4)(2006-11#2)(2006-12#7)(2006-4#3)(2006-6#4)(2006-8#2)(2007-1#2)(2007-10#10)(2007-11#163)(2007-12#255)(2007-2#16)(2007-4#3)(2007-5#13)(2007-6#10)(2007-7#35)(2007-8#90)(2007-9#8)(2008-1#82)(2008-10#1849)(2008-11#275)(2008-12#136)(2008-2#236)(2008-3#548)(2008-4#154)(2008-5#293)(2008-6#118)(2008-7#254)(2008-8#260)(2008-9#239)(2009-1#5)(2009-10#38)(2009-11#23)(2009-12#21)(2009-2#23)(2009-3#17)(2009-4#15)(2009-5#23)(2009-6#26)(2009-7#15)(2009-8#48)(2009-9#28)(2010-1#13)(2010-10#29)(2010-11#16)(2010-12#26)(2010-2#26)(2010-3#25)(2010-4#29)(2010-5#41)(2010-6#16)(2010-7#20)(2010-8#63)(2010-9#6)(2011-1#78)(2011-10#3)(2011-2#257)(2011-3#15)(2012-1#28)(2012-12#79)(2012-2#138)(2012-3#98)(2012-4#1)(2012-5#10)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#201)(2013-7#42)(2013-8#76)
two)##2##1##(2008-5#1)(2008-8#1)
two- and one-dimensional##2##3##(2008-3#2)
two- and three-dimensional##7##3##(2008-2#1)(2008-3#4)(2008-7#1)(2013-1#1)
two- and##15##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#7)(2008-7#1)(2009-2#1)(2013-1#1)
two- or three-dimensional##2##3##(2007-11#1)(2008-3#1)
two- or##5##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
two- to##5##2##(1992-11#1)(1994-5#1)(1996-3#1)(2008-10#2)
two-##29##1##(1992-11#1)(1994-5#1)(1996-3#1)(2007-11#3)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#10)(2008-7#2)(2008-9#1)(2009-2#1)(2013-1#1)
two-alternative##2##1##(2011-2#1)(2012-1#1)
two-band##3##1##(2008-2#1)(2008-3#2)
two-beam coupling##11##2##(2007-11#1)(2007-12#6)(2008-3#4)
two-beam interference method##2##3##(2008-3#2)
two-beam interference##4##2##(2008-3#4)
two-beam interferometer##3##2##(2007-12#1)(2008-3#2)
two-beam##25##1##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#13)
two-bounce##3##1##(2008-2#3)
two-cascade microaperture-per-channel##2##2##(2008-3#2)
two-celled##2##1##(2008-10#1)(2009-12#1)
two-chain form by##2##3##(1992-12#2)
two-chain##3##1##(1992-12#3)
two-channel manifold##2##2##(2008-10#2)
two-channel##14##1##(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#5)(2008-7#1)(2009-2#1)
two-class##5##1##(2008-6#3)(2009-9#1)(2010-4#1)
two-coil CASL##2##2##(2009-10#2)
two-coil##3##1##(2009-10#3)
two-color analysis##2##2##(2008-4#2)
two-color excitation##2##2##(2008-3#2)
two-color light##2##2##(2008-3#2)
two-color measurement##2##2##(2008-3#2)
two-color pyrometry##2##2##(2008-2#1)(2008-3#1)
two-color recording##3##2##(2008-2#1)(2008-3#2)
two-color##31##1##(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#6)(2008-2#4)(2008-3#14)(2008-4#4)
two-color-change##2##1##(2008-10#2)
two-colour##2##1##(2008-5#2)
two-column##2##1##(1992-12#1)(2008-4#1)
two-compartment model##2##2##(1996-5#1)(2008-1#1)
two-compartment##5##1##(1996-5#1)(2008-1#2)(2008-11#1)(2010-11#1)
two-component regulatory##2##2##(1994-12#1)(1996-12#1)
two-component signal transducers in##2##4##(1996-12#2)
two-component signal transducers##3##3##(1996-12#3)
two-component signal##4##2##(1996-12#4)
two-component system##5##2##(1997-7#1)(2009-6#4)
two-component systems##4##2##(1996-12#1)(1997-7#1)(2008-10#1)(2008-2#1)
two-component##28##1##(1994-12#1)(1995-5#2)(1996-12#6)(1997-7#2)(2007-11#2)(2008-10#3)(2008-2#4)(2008-3#3)(2009-6#4)(2011-1#1)
two-compound mixtures##2##2##(2008-10#1)(2008-11#1)
two-cycle##4##1##(2007-11#1)(2008-12#1)(2008-3#2)
two-day##4##1##(2008-10#1)(2008-5#3)
two-dimension##2##1##(2008-10#1)(2011-3#1)
two-dimensional (2-D)##9##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#6)
two-dimensional (2D) photonic crystal##2##4##(2007-11#1)(2007-12#1)
two-dimensional (2D)##23##2##(2007-11#3)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#1)(2012-4#1)(2013-1#1)
two-dimensional 1H NMR##3##3##(1990-9#1)(1994-5#1)(1995-2#1)
two-dimensional 1H##4##2##(1990-9#1)(1994-5#1)(1995-11#1)(1995-2#1)
two-dimensional Gabor##2##2##(2011-1#2)
two-dimensional Gaussian##4##2##(2008-10#4)
two-dimensional NMR techniques##3##3##(1990-9#1)(2008-8#1)(2008-9#1)
two-dimensional NMR##4##2##(1990-9#1)(2008-8#1)(2008-9#1)(2012-8#1)
two-dimensional analysis##4##2##(2008-3#2)(2008-4#1)(2008-5#1)
two-dimensional and axisymmetric##2##3##(2008-3#2)
two-dimensional and three-dimensional##2##3##(1994-9#1)(2008-2#1)
two-dimensional and##4##2##(1994-9#1)(2008-2#1)(2008-3#2)
two-dimensional array of##7##3##(2007-11#1)(2008-2#3)(2008-3#3)
two-dimensional array##10##2##(2007-11#1)(2008-2#4)(2008-3#5)
two-dimensional arrays of##2##3##(2008-3#2)
two-dimensional arrays##3##2##(2008-3#2)(2008-4#1)
two-dimensional beam from the##2##4##(2007-12#2)
two-dimensional beam##5##2##(2007-12#3)(2008-2#2)
two-dimensional data##8##2##(2007-11#2)(2007-12#1)(2008-3#5)
two-dimensional densities of deposited##2##4##(2008-10#2)
two-dimensional difference equations##2##3##(2008-3#2)
two-dimensional difference##3##2##(2008-3#2)(2008-4#1)
two-dimensional diffusion##2##2##(2008-2#1)(2008-3#1)
two-dimensional digital micromirror##2##3##(2008-2#2)
two-dimensional digital##4##2##(2008-2#2)(2008-3#1)(2008-4#1)
two-dimensional discrete soliton networks##2##4##(2007-11#1)(2007-12#1)
two-dimensional echocardiography##5##2##(1991-11#2)(2007-8#1)(2011-2#1)(2012-3#1)
two-dimensional electrophoresis and##2##3##(1997-2#1)(2008-4#1)
two-dimensional electrophoresis##4##2##(1996-8#1)(1997-2#1)(2008-4#2)
two-dimensional fast Fourier transform##2##4##(2008-3#2)
two-dimensional gas chromatography with time-of-flight mass spectrometry##2##7##(2008-10#2)
two-dimensional gas chromatography with##3##4##(2008-10#3)
two-dimensional gas chromatography##4##3##(2008-10#4)
two-dimensional gas##5##2##(2008-10#5)
two-dimensional gel electrophoresis##13##3##(1993-11#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-12#1)
two-dimensional gel##16##2##(1990-7#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#2)(2010-12#1)
two-dimensional homonuclear##2##2##(1990-5#1)(1993-11#1)
two-dimensional image##2##2##(2007-12#1)(2008-3#1)
two-dimensional images of##2##3##(2008-3#1)(2009-12#1)
two-dimensional images were##2##3##(2007-12#2)
two-dimensional images##7##2##(2007-12#3)(2008-2#1)(2008-3#2)(2009-12#1)
two-dimensional imaging of##2##3##(2007-12#1)(2008-7#1)
two-dimensional imaging through##2##3##(2007-12#2)
two-dimensional imaging##8##2##(2007-11#1)(2007-12#4)(2008-3#2)(2008-7#1)
two-dimensional instantaneous##2##2##(2008-3#2)
two-dimensional interleaving##2##2##(2008-2#2)
two-dimensional measurement principle##3##3##(2008-3#3)
two-dimensional measurement##5##2##(2008-3#5)
two-dimensional measurements of##2##3##(2008-2#1)(2008-3#1)
two-dimensional nonlinear photonic##2##3##(2007-11#2)
two-dimensional numerical##3##2##(2008-2#1)(2008-3#1)(2009-6#1)
two-dimensional objects##2##2##(2007-12#1)(2008-2#1)
two-dimensional optical##3##2##(2008-2#1)(2008-3#2)
two-dimensional periodic##4##2##(2008-3#3)(2008-7#1)
two-dimensional phase unwrapping##2##3##(2008-3#2)
two-dimensional phase##3##2##(2008-3#3)
two-dimensional photonic crystal##8##3##(2007-11#6)(2007-12#2)
two-dimensional photonic##9##2##(2007-11#6)(2007-12#2)(2008-3#1)
two-dimensional photonic-crystal##4##2##(2007-11#2)(2007-12#2)
two-dimensional polyacrylamide gel electrophoresis##2##4##(1995-12#1)(1997-2#1)
two-dimensional polyacrylamide##4##2##(1990-11#1)(1995-12#1)(1997-2#2)
two-dimensional profiles of##3##3##(2008-2#2)(2008-3#1)
two-dimensional random##2##2##(2008-2#1)(2008-3#1)
two-dimensional reconstruction##2##2##(2008-3#2)
two-dimensional scan##2##2##(2008-3#2)
two-dimensional signal##2##2##(2007-11#1)(2008-2#1)
two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis##2##7##(2008-10#1)(2008-2#1)
two-dimensional sodium dodecyl##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
two-dimensional solid-state imagers##2##3##(2008-3#2)
two-dimensional space##5##2##(2007-12#1)(2008-11#3)(2013-8#1)
two-dimensional spatial##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
two-dimensional surfaces##2##2##(2008-3#2)
two-dimensional system##4##2##(1992-5#1)(2007-12#1)(2008-3#2)
two-dimensional wave##2##2##(2008-2#1)(2008-3#1)
two-dimensional waveguide##2##2##(2007-11#1)(2008-3#1)
two-dimensional##436##1##(1990-11#4)(1990-5#1)(1990-7#1)(1990-9#3)(1991-11#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-5#1)(1993-11#7)(1993-8#2)(1993-9#4)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#3)(1997-7#2)(2007-11#38)(2007-12#48)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#13)(2008-2#57)(2008-3#138)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#5)(2011-7#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#1)(2013-8#2)
two-dimensionally##2##1##(2008-10#1)(2008-7#1)
two-directional##2##1##(2007-11#2)
two-domain structure##2##2##(1991-6#1)(2008-4#1)
two-domain##5##1##(1991-6#1)(1991-9#1)(2008-4#1)(2010-10#2)
two-drug##2##1##(1995-3#2)
two-electrode##3##1##(2008-10#1)(2008-2#1)(2008-8#1)
two-electron irreversible cathodic peak##2##4##(2008-10#2)
two-electron irreversible##3##2##(2008-10#3)
two-electron##9##1##(1992-1#1)(1993-8#1)(2008-10#6)(2008-11#1)
two-element cavity##2##2##(2007-12#2)
two-element##3##1##(2007-12#2)(2008-3#1)
two-factor##2##1##(1993-6#1)(2008-5#1)
two-flux model##2##2##(2008-2#2)
two-fold after##2##2##(1992-8#1)(1995-9#1)
two-fold greater##2##2##(1993-6#1)(2009-9#1)
two-fold##19##1##(1991-12#1)(1992-12#1)(1992-8#1)(1993-6#1)(1995-9#1)(1996-2#1)(1997-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2012-12#1)(2013-1#1)
two-frequency lidar inversion##3##3##(2008-3#3)
two-frequency##7##1##(2007-11#1)(2008-3#6)
two-generation##3##1##(2008-10#2)(2010-1#1)
two-grating##3##1##(2007-12#2)(2008-3#1)
two-hybrid assay##2##2##(2008-4#1)(2008-9#1)
two-hybrid system to##2##3##(2008-8#1)(2008-9#1)
two-hybrid system##17##2##(1997-7#1)(2008-2#1)(2008-8#9)(2008-9#6)
two-hybrid##29##1##(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#10)(2008-9#8)(2009-10#1)
two-input##4##1##(2008-3#4)
two-laser##5##1##(1996-5#1)(2008-2#2)(2008-3#2)
two-layer diffusion##2##2##(2008-3#2)
two-layer media##2##2##(2008-3#2)
two-layer model##2##2##(2008-2#1)(2008-3#1)
two-layer turbid##3##2##(2008-2#1)(2008-3#2)
two-layer##26##1##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#15)(2010-2#1)(2011-1#1)
two-layered turbid media##2##3##(2008-2#2)
two-layered##3##1##(2008-2#3)
two-lens objective##3##2##(2008-2#3)
two-lens##4##1##(2008-2#4)
two-level full factorial##2##3##(2008-10#2)
two-level##11##1##(2007-11#2)(2008-10#6)(2008-2#1)(2008-7#1)(2012-3#1)
two-lever##2##1##(1992-12#1)(1997-7#1)
two-line##3##1##(2007-12#1)(2008-10#1)(2008-3#1)
two-locus##6##1##(2008-10#2)(2008-4#2)(2008-8#1)(2011-2#1)
two-mirror##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
two-mode##6##1##(2007-11#2)(2007-12#3)(2013-1#1)
two-modulator generalized ellipsometer##2##3##(2008-2#1)(2008-3#1)
two-month##7##1##(1994-3#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-1#1)
two-node model##3##2##(1992-3#3)
two-parameter##4##1##(2007-12#1)(2008-10#1)(2008-2#1)(2009-7#1)
two-part article##7##2##(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(2007-2#1)
two-part series##5##2##(1993-2#1)(1996-2#2)(2007-5#1)(2008-10#1)
two-part##15##1##(1992-12#1)(1992-3#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#2)(2012-3#1)
two-patch##2##1##(2008-8#2)
two-phase extraction of##2##3##(2008-10#1)(2012-1#1)
two-phase extraction##7##2##(2008-10#1)(2008-6#4)(2012-1#2)
two-phase process##2##2##(2008-10#1)(2008-12#1)
two-phase solvent system composed of##3##5##(2008-10#1)(2011-1#2)
two-phase system is##2##3##(2008-10#2)
two-phase system of tetrabutylammonium bromide##3##5##(2008-10#3)
two-phase system of##5##3##(2008-10#5)
two-phase system##16##2##(2008-10#12)(2008-6#1)(2011-2#2)(2012-1#1)
two-phase systems##9##2##(2008-10#4)(2008-6#1)(2008-7#3)(2010-4#1)
two-phase##45##1##(1992-12#1)(1996-5#1)(2007-5#1)(2008-10#21)(2008-12#1)(2008-6#6)(2008-7#3)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-3#1)
two-photon LIF##3##2##(2008-2#2)(2008-3#1)
two-photon absorption (TPA)##3##3##(2007-11#1)(2007-12#2)
two-photon absorption can##2##3##(2007-12#2)
two-photon absorption coefficient##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
two-photon absorption cross##2##3##(2007-11#1)(2007-12#1)
two-photon absorption in a##4##4##(2007-11#4)
two-photon absorption in semiconductors##2##4##(2007-11#2)
two-photon absorption in##7##3##(2007-11#6)(2008-2#1)
two-photon absorption##36##2##(2007-11#17)(2007-12#8)(2008-2#2)(2008-3#6)(2009-11#1)(2010-7#2)
two-photon coherent excitation##2##3##(2007-12#2)
two-photon conductivity##2##2##(2007-12#2)
two-photon dye-doped SiNPs##2##3##(2011-1#2)
two-photon excitation and##2##3##(2008-1#1)(2008-3#1)
two-photon excitation fluorescence imaging##2##4##(2008-3#2)
two-photon excitation fluorescence##3##3##(2008-2#1)(2008-3#2)
two-photon excitation##28##2##(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#15)(2009-2#1)(2011-1#2)
two-photon excited emission##2##3##(2007-11#2)
two-photon excited fluorescence (TPF) is##2##5##(2007-11#1)(2008-10#1)
two-photon excited fluorescence (TPF)##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
two-photon excited fluorescence##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
two-photon excited##7##2##(2007-11#4)(2008-10#1)(2008-3#1)(2009-6#1)
two-photon fluorescence detection##2##3##(2007-11#2)
two-photon fluorescence imaging##5##3##(2008-2#3)(2008-3#2)
two-photon fluorescence microscope based on a##2##6##(2007-11#2)
two-photon fluorescence microscope##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
two-photon fluorescence microscopy##4##3##(2008-2#1)(2008-3#1)(2011-1#2)
two-photon fluorescence spectroscopy##3##3##(2007-11#1)(2008-3#2)
two-photon fluorescence##28##2##(2007-11#8)(2007-12#2)(2008-2#5)(2008-3#9)(2011-1#4)
two-photon imaging##2##2##(2007-11#1)(2008-4#1)
two-photon laser scanning microscopy and confocal laser scanning microscopy##2##9##(2008-10#1)(2008-8#1)
two-photon laser-induced fluorescence (LIF)##2##4##(2008-2#2)
two-photon laser-induced fluorescence##4##3##(2008-2#3)(2008-3#1)
two-photon microscope##2##2##(2008-3#2)
two-photon microscopy##8##2##(2007-12#2)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)
two-photon photorefractive effect##2##3##(2008-3#2)
two-photon process##3##2##(2007-11#1)(2008-3#2)
two-photon transition##2##2##(2008-3#2)
two-photon transitions##2##2##(2007-12#2)
two-photon##164##1##(1992-8#1)(2007-11#39)(2007-12#24)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#19)(2008-3#52)(2008-4#2)(2008-8#2)(2009-11#1)(2009-2#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-7#3)(2011-1#9)
two-photon-excited fluorescence##3##2##(2007-12#1)(2008-3#2)
two-photon-excited##5##1##(2007-12#2)(2008-3#3)
two-piece##2##1##(2008-2#1)(2011-2#1)
two-point affected sibpair linkage analysis##2##5##(2008-9#2)
two-point affected##3##2##(1997-5#1)(2008-9#2)
two-point discrimination##4##2##(2008-9#4)
two-point##17##1##(1996-2#1)(1996-7#1)(1997-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#6)
two-pore domain##2##2##(2012-2#1)(2013-8#1)
two-process##2##1##(2009-8#2)
two-pulse and stimulated photon echoes##2##5##(2007-12#2)
two-pulse##3##1##(2007-12#2)(2008-2#1)
two-row##2##1##(2008-10#2)
two-sample##3##1##(1996-3#1)(1997-4#1)(2009-9#1)
two-sided##2##1##(2008-3#1)(2008-5#1)
two-site binding##2##2##(1995-5#1)(2009-7#1)
two-site##6##1##(1992-9#1)(1994-3#1)(1995-5#1)(2008-10#1)(2009-7#1)(2013-8#1)
two-species##2##1##(2008-8#1)(2008-9#1)
two-stage approach##4##2##(2008-1#1)(2009-10#1)(2009-5#2)
two-stage papain technique##2##3##(1994-12#2)
two-stage procedure##4##2##(1991-12#1)(1991-6#1)(2008-10#1)(2013-1#1)
two-stage process##5##2##(2007-2#1)(2008-11#2)(2008-3#1)(2008-6#1)
two-stage randomized trials with##2##4##(2012-3#2)
two-stage repair##4##2##(2008-10#1)(2009-5#3)
two-stage revision has##2##3##(2008-8#1)(2012-12#1)
two-stage##72##1##(1990-11#1)(1991-12#2)(1991-6#1)(1992-2#1)(1994-12#2)(2007-11#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#7)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)
two-staged##4##1##(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
two-state model##9##2##(1990-7#2)(1991-8#2)(1995-5#1)(1995-6#1)(1997-2#3)
two-state unfolding##2##2##(1993-11#1)(1997-2#1)
two-state##20##1##(1990-7#2)(1990-8#1)(1991-8#2)(1992-10#1)(1993-11#3)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-2#5)(2008-7#1)(2009-10#1)
two-step PCR##3##2##(2008-10#2)(2011-1#1)
two-step leaching method##2##3##(2008-10#2)
two-step learning method##2##3##(2008-3#2)
two-step method##3##2##(1990-7#1)(2008-10#1)(2008-6#1)
two-step model for##2##3##(1995-6#2)
two-step physical algorithm##2##3##(2008-3#2)
two-step procedure##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
two-step process##8##2##(1994-2#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-6#2)(2009-4#1)(2012-3#1)
two-step reaction##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
two-step sequential leaching procedure##3##4##(2008-10#3)
two-step sol-gel##3##2##(2008-10#3)
two-step##72##1##(1990-2#1)(1990-7#3)(1991-8#1)(1991-9#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-5#2)(1997-7#1)(2007-12#3)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#13)(2008-6#4)(2008-9#3)(2009-4#1)(2009-5#2)(2010-8#1)(2011-1#2)(2012-3#1)
two-story##2##1##(2008-2#2)
two-stranded##3##1##(1992-6#2)(2011-2#1)
two-third of##2##2##(2008-1#1)(2008-12#1)
two-thirds of the##15##3##(1990-7#1)(1991-8#1)(1994-12#1)(1997-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-12#1)(2012-3#1)
two-thirds of##25##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1994-12#1)(1994-9#1)(1995-6#2)(1997-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
two-thirds the##2##2##(1995-6#1)(2008-10#1)
two-thirds##32##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-3#1)(1994-12#1)(1994-9#2)(1995-6#3)(1997-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
two-tone method##2##2##(2008-3#2)
two-tone##7##1##(1992-12#1)(2008-11#1)(2008-3#5)
two-wave coupling##3##2##(2008-3#3)
two-wave mixing in a##3##4##(2007-12#1)(2008-3#2)
two-wave mixing in photorefractive crystals##2##5##(2008-3#2)
two-wave mixing in##10##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
two-wave mixing##18##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#11)
two-wave##22##1##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#14)(2009-7#1)
two-wavelength interferogram##2##2##(2008-2#2)
two-wavelength lidar inversion techniques##2##4##(2008-3#2)
two-wavelength lidar##4##2##(2008-2#1)(2008-3#3)
two-wavelength method##2##2##(2008-3#2)
two-wavelength passive quadrature##2##3##(2008-2#2)
two-wavelength##23##1##(2008-2#10)(2008-3#13)
two-way ANOVA and##2##3##(2008-12#2)
two-way active avoidance##2##3##(1991-2#1)(2008-4#1)
two-way factorial##2##2##(2008-10#1)(2008-9#1)
two-way sexters##3##2##(2013-1#3)
two-way text pagers##3##3##(2010-8#3)
two-way text paging systems##2##4##(2010-8#2)
two-way text paging##3##3##(2010-8#3)
two-way text##8##2##(2010-8#8)
two-way##33##1##(1991-2#1)(1993-1#1)(1994-2#1)(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-8#8)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)
two-week period##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
two-week##11##1##(1990-11#1)(1994-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#3)(2010-4#1)(2011-3#1)(2012-2#1)
two-year period##2##2##(1996-2#1)(1996-3#1)
two-year##13##1##(1991-1#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
two?##3##1##(1993-9#1)(2008-12#1)(2013-8#1)
twofold and##3##2##(1996-5#1)(2008-10#2)
twofold axis in the##2##4##(1991-12#2)
twofold increase in##7##3##(1994-2#1)(2008-2#2)(2008-4#1)(2008-7#2)(2009-8#1)
twofold increase##9##2##(1994-2#1)(1996-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)
twofold or##2##2##(2008-10#2)
twofold##48##1##(1991-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-5#2)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-8#2)(2012-3#1)(2013-1#1)
tying##6##1##(1995-1#2)(1996-2#1)(2007-7#1)(2010-12#1)(2010-3#1)
tyloses##2##1##(2008-10#2)
tymovirus##3##1##(1997-3#1)(2008-10#2)
tymoviruses##3##1##(2008-10#3)
tympanic membrane keratinocytes##3##3##(2012-8#3)
tympanic membrane##10##2##(1991-3#2)(2007-10#1)(2009-7#3)(2012-8#4)
tympanic temperature##2##2##(2007-10#2)
tympanic thermometer##2##2##(2008-2#2)
tympanic##16##1##(1991-3#2)(2007-10#3)(2008-2#3)(2008-4#1)(2009-7#3)(2012-8#4)
tympanoplasty##2##1##(2008-9#1)(2010-7#1)
tympanotomy##3##1##(2008-9#3)
typ##2##1##(1992-5#1)(2007-11#1)
type (DAT)##2##2##(1996-11#1)(2008-6#1)
type (P##2##2##(2008-10#2)
type (i##2##2##(1994-2#2)
type (n =##2##3##(2010-8#2)
type 1 (HIV-1) infection##5##4##(2008-2#5)
type 1 (HIV-1)##14##3##(1990-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-2#8)(2011-2#1)
type 1 (NF1)##6##3##(1991-5#1)(1992-8#1)(1994-12#1)(1997-3#1)(2008-7#1)(2012-3#1)
type 1 5' long terminal repeat##2##6##(1993-8#2)
type 1 and 2 diabetes##2##5##(2012-12#2)
type 1 and 2##4##4##(2007-12#1)(2008-1#1)(2012-12#2)
type 1 and type 2 diabetes mellitus##3##7##(2008-1#1)(2010-11#1)(2013-1#1)
type 1 and type 2 diabetes##11##6##(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-4#2)(2013-1#3)
type 1 and type 2 immune responses##2##7##(2008-10#2)
type 1 and type 2##18##5##(1992-8#1)(1993-2#2)(1997-3#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-4#2)(2013-1#3)
type 1 and type##19##4##(1990-12#1)(1992-8#1)(1993-2#2)(1997-3#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-4#2)(2013-1#3)
type 1 and##31##3##(1990-12#1)(1991-2#1)(1992-8#1)(1993-2#2)(1994-11#1)(1997-3#1)(2007-12#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-4#2)(2013-1#5)
type 1 angiotensin II receptor##2##5##(1992-3#2)
type 1 angiotensin II##3##4##(1992-3#3)
type 1 by##2##3##(1991-2#1)(2007-12#1)
type 1 cells##2##3##(1995-12#2)
type 1 delta protein phosphatase##2##5##(1993-6#2)
type 1 diabetes (T1D)##2##4##(2007-5#1)(2013-8#1)
type 1 diabetes and##5##4##(2008-1#1)(2009-3#1)(2009-9#2)(2012-2#1)
type 1 diabetes mellitus##14##4##(1990-6#1)(1991-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)(2011-1#2)(2012-1#1)(2013-1#2)
type 1 diabetes patients##5##4##(2008-1#1)(2013-1#4)
type 1 diabetes##54##3##(1990-6#1)(1991-12#1)(1992-9#1)(2007-5#2)(2008-1#6)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-11#3)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-4#2)(2013-1#9)(2013-8#2)
type 1 diabetic patient##2##4##(2008-1#1)(2013-1#1)
type 1 diabetic patients##4##4##(2010-12#1)(2012-1#1)(2012-4#2)
type 1 diabetic##7##3##(2008-1#2)(2010-12#1)(2012-1#1)(2012-4#2)(2013-1#1)
type 1 is##2##3##(2012-3#1)(2013-1#1)
type 1 protein##2##3##(1993-6#1)(2013-1#1)
type 1 receptor##4##3##(1992-3#2)(2012-2#1)(2013-1#1)
type 1 was##2##3##(2008-12#1)(2011-1#1)
type 1##214##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#5)(1992-6#3)(1992-8#3)(1992-9#1)(1993-2#3)(1993-6#5)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#4)(1995-2#2)(1995-6#1)(1997-3#3)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#16)(2008-10#6)(2008-11#6)(2008-12#4)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#2)(2009-11#3)(2009-3#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#4)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#9)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#5)(2012-4#6)(2013-1#23)(2013-8#2)
type 1)##2##2##(1991-9#1)(2008-10#1)
type 1-diabetes##3##2##(2008-11#1)(2010-11#2)
type 16 was##2##3##(1990-5#1)(1994-1#1)
type 16##6##2##(1990-5#2)(1994-1#2)(1995-2#2)
type 1A##5##2##(1992-3#1)(1997-3#1)(2008-1#1)(2008-7#2)
type 2 (NF2)##2##3##(1997-3#2)
type 2 (non-insulin dependent)##2##4##(1991-5#1)(1994-12#1)
type 2 DM##4##3##(2008-3#2)(2012-2#2)
type 2 and##2##3##(2008-1#1)(2008-10#1)
type 2 angiotensin II receptor##2##5##(1994-9#2)
type 2 diabetes (T2D)##5##4##(2008-1#1)(2009-3#1)(2012-6#1)(2013-7#1)(2013-8#1)
type 2 diabetes and metabolic syndrome##2##6##(2013-1#2)
type 2 diabetes and##12##4##(2008-1#3)(2008-11#1)(2008-7#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#2)
type 2 diabetes has##4##4##(2008-3#3)(2008-4#1)
type 2 diabetes in the##2##5##(2008-12#1)(2009-12#1)
type 2 diabetes in##17##4##(1994-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2009-12#1)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
type 2 diabetes is##2##4##(2008-3#1)(2010-12#1)
type 2 diabetes mellitus (DM)##3##5##(2008-3#2)(2011-1#1)
type 2 diabetes mellitus (T2D)##2##5##(2011-2#1)(2012-2#1)
type 2 diabetes mellitus (T2DM)##7##5##(2008-1#1)(2008-3#1)(2009-11#2)(2009-9#1)(2011-1#1)(2013-1#1)
type 2 diabetes mellitus and##7##5##(2008-1#1)(2008-3#3)(2012-2#2)(2013-1#1)
type 2 diabetes mellitus in##3##5##(2008-3#1)(2010-10#1)(2013-1#1)
type 2 diabetes mellitus model##2##5##(2012-1#2)
type 2 diabetes mellitus##51##4##(1990-2#1)(2007-5#1)(2008-1#6)(2008-10#1)(2008-3#16)(2008-6#1)(2008-7#1)(2009-11#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#4)(2012-5#1)(2013-1#4)(2013-8#2)
type 2 diabetes patients##8##4##(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#2)(2011-1#1)(2011-2#2)
type 2 diabetes should##2##4##(1996-11#2)
type 2 diabetes treated##2##4##(2011-2#1)(2012-4#1)
type 2 diabetes##197##3##(1990-2#1)(1994-12#1)(1996-11#3)(2007-5#2)(2008-1#29)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#37)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#3)(2009-1#1)(2009-11#7)(2009-12#2)(2009-3#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#8)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#9)(2012-4#4)(2012-5#3)(2012-6#2)(2013-1#10)(2013-7#1)(2013-8#4)
type 2 diabetic patients##9##4##(1991-5#1)(1993-2#3)(2008-1#1)(2011-2#4)
type 2 diabetic##16##3##(1991-5#1)(1993-2#3)(2008-1#3)(2011-2#4)(2012-12#2)(2012-3#1)(2012-5#1)(2013-8#1)
type 2 diabetics##2##3##(1990-2#1)(2013-8#1)
type 2 immunity##2##3##(2012-12#2)
type 2 lepra reaction##4##4##(2009-5#4)
type 2 receptor##5##3##(1994-11#2)(1994-8#2)(2012-1#1)
type 2##285##2##(1990-12#1)(1990-2#2)(1991-5#2)(1991-8#4)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#5)(1993-6#1)(1994-11#2)(1994-12#2)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1996-11#3)(1997-1#1)(1997-3#3)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2008-1#35)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#40)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#7)(2009-12#2)(2009-3#3)(2009-5#5)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#2)(2010-8#3)(2011-1#12)(2011-2#17)(2012-1#3)(2012-12#9)(2012-2#14)(2012-3#10)(2012-4#4)(2012-5#5)(2012-6#2)(2013-1#13)(2013-7#1)(2013-8#6)
type 2)##3##2##(1992-7#1)(1993-2#1)(2008-1#1)
type 2A protein phosphatase##2##4##(1995-5#2)
type 2A##3##2##(1990-12#1)(1995-5#2)
type 2b##2##2##(2007-12#1)(2013-1#1)
type 3 MT##2##3##(2008-10#2)
type 3 repeats##2##3##(1994-5#2)
type 3##20##2##(1994-5#2)(1994-6#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#2)(2011-1#2)(2012-12#1)(2013-1#2)
type 5 receptor##2##3##(1994-11#2)
type 5##8##2##(1994-11#2)(1994-5#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-9#1)(2010-12#1)
type 6##3##2##(1991-2#1)(2013-1#2)
type 9##4##2##(1992-9#2)(2013-1#2)
type A NT##2##3##(1990-5#2)
type A acute aortic dissection##2##5##(2007-8#2)
type A and B##2##4##(1997-6#2)
type A and##3##3##(1997-6#2)(2008-5#1)
type A aortic dissection##2##4##(2007-8#2)
type A aortic##4##3##(2007-8#4)
type A dissection##3##3##(2007-8#2)(2013-1#1)
type A heavy chain##2##4##(1990-5#2)
type A or##2##3##(1994-2#1)(1997-6#1)
type A receptor blocker##2##4##(1994-2#2)
type A##45##2##(1990-12#2)(1990-2#1)(1990-5#5)(1993-6#1)(1994-2#3)(1995-2#1)(1997-6#5)(2007-12#1)(2007-6#1)(2007-8#8)(2008-10#6)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
type B and##2##3##(2008-11#1)(2010-4#1)
type B receptor blocker##2##4##(1994-2#2)
type B receptors##2##3##(1994-2#2)
type B vaccine##2##3##(1991-8#2)
type B virus##2##3##(1997-6#2)
type B##35##2##(1991-8#2)(1993-6#1)(1994-2#5)(1994-9#1)(1997-4#2)(1997-6#6)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2013-1#1)
type C##10##2##(1992-3#3)(1992-6#2)(1997-6#1)(2008-10#1)(2008-4#1)(2009-5#1)(2012-2#1)
type D##2##2##(1997-6#1)(1997-8#1)
type E##3##2##(1990-5#1)(1997-6#1)(2007-12#1)
type I AOD with gross instability##2##6##(2012-3#2)
type I AOD##3##3##(2012-3#3)
type I IFNs##4##3##(1995-12#3)(2007-11#1)
type I Myosin##2##3##(2008-10#2)
type I SHG##2##3##(2008-2#2)
type I alpha regulatory subunit##3##5##(1990-2#3)
type I and II##2##4##(2007-11#1)(2008-1#1)
type I and type II##7##5##(1994-2#1)(1995-2#1)(1997-3#1)(2008-3#1)(2008-5#2)(2010-11#1)
type I and type##8##4##(1994-2#1)(1995-2#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-11#1)
type I and##12##3##(1991-11#1)(1994-2#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-2#1)
type I cells##2##3##(2007-12#2)
type I chitinases##2##3##(1992-8#2)
type I collagen fibrils##2##4##(2008-1#1)(2010-8#1)
type I collagen in##2##4##(2008-11#1)(2008-9#1)
type I collagen##15##3##(1994-5#1)(1995-5#1)(1997-1#2)(1997-7#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-8#1)(2013-8#1)
type I copper##2##3##(1993-11#2)
type I diabetes mellitus##3##4##(1993-12#1)(2011-2#1)(2013-1#1)
type I diabetes##5##3##(1990-5#1)(1993-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
type I diabetic patients##2##4##(1993-12#2)
type I endoleaks##3##3##(2007-8#3)
type I error rate##3##4##(2012-1#1)(2012-3#2)
type I error rates##4##4##(2011-2#1)(2013-1#3)
type I error##14##3##(1994-9#1)(1995-2#1)(2008-10#3)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#3)
type I errors##2##3##(2008-7#1)(2011-2#1)
type I hypersensitivity reactions##2##4##(2008-8#1)(2010-5#1)
type I hypersensitivity##3##3##(2008-8#2)(2010-5#1)
type I iodothyronine 5'-deiodinase##3##4##(1990-12#3)
type I iodothyronine##4##3##(1990-12#3)(1992-12#1)
type I keratin##2##3##(1996-2#2)
type I malformation##2##3##(1992-2#1)(2008-7#1)
type I quasi phase matching##2##5##(2007-11#1)(2007-12#1)
type I second-harmonic generation##3##4##(2007-11#1)(2008-2#2)
type I##208##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-8#4)(1992-9#1)(1993-11#5)(1993-12#3)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#8)(1995-2#8)(1995-3#4)(1995-5#3)(1996-12#1)(1996-2#4)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#4)(1997-8#2)(2007-11#10)(2007-12#8)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#9)(2008-11#10)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-3#11)(2013-1#8)(2013-8#3)
type IA##2##2##(2007-11#2)
type II and type##2##4##(1995-12#1)(2008-11#1)
type II and##6##3##(1995-12#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)
type II cells##3##3##(1990-7#1)(1995-8#1)(2007-12#1)
type II collagen##3##3##(1991-5#1)(2008-11#2)
type II diabetes mellitus##6##4##(1991-7#1)(1993-12#2)(1996-11#1)(2008-7#2)
type II diabetes##13##3##(1990-5#1)(1991-7#1)(1993-12#2)(1994-2#1)(1995-8#1)(1996-11#2)(2008-4#1)(2008-7#3)(2010-11#1)
type II diabetic patients##2##4##(1993-12#1)(2008-5#1)
type II hair keratins##2##4##(2008-5#2)
type II inosine 5'-monophosphate dehydrogenase##2##5##(1994-11#2)
type II is##2##3##(1994-9#1)(1995-3#1)
type II phase-matched KTP##2##4##(2007-11#1)(2008-2#1)
type II pneumocytes##6##3##(1990-7#2)(1994-5#3)(1996-9#1)
type II receptor##7##3##(1993-3#4)(1997-2#2)(2008-9#1)
type II sIL-1R##2##3##(1995-2#2)
type II topology##3##3##(1997-7#3)
type II##142##2##(1990-5#1)(1990-7#3)(1991-10#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-12#3)(1993-3#7)(1993-9#2)(1994-11#3)(1994-2#2)(1994-5#5)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#8)(1995-3#6)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#7)(2007-12#6)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-4#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
type II)##3##2##(1995-11#1)(2011-2#1)(2013-8#1)
type IIA##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
type III and IV collagen##2##5##(2013-8#2)
type III and##3##3##(2006-10#1)(2013-8#2)
type III fractures##2##3##(2007-11#1)(2012-2#1)
type III secretion system##4##4##(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
type III secretion##8##3##(2008-10#1)(2008-9#3)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
type III sub-populations##2##3##(2008-8#2)
type III##35##2##(1991-5#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-6#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#4)
type IIIa##3##2##(1997-7#1)(2007-11#1)(2011-3#1)
type IIa##4##2##(1990-3#1)(2007-11#1)(2013-8#2)
type IIb##2##2##(2007-12#1)(2009-1#1)
type IV and##3##3##(1990-2#1)(1992-6#1)(2011-3#1)
type IV collagen and##2##4##(1993-12#1)(1994-7#1)
type IV collagen##7##3##(1993-12#1)(1994-7#4)(1997-3#1)(2010-11#1)
type IV collagenase##7##3##(1992-2#2)(2008-11#1)(2008-8#4)
type IV##27##2##(1990-12#1)(1990-2#2)(1991-8#1)(1992-2#2)(1992-6#2)(1993-12#1)(1994-7#4)(1997-3#1)(2007-11#2)(2008-11#3)(2008-8#5)(2010-11#1)(2011-3#1)(2012-12#1)
type IV) and##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
type IV)##5##2##(2006-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-1#1)
type P##3##2##(1996-12#1)(2008-10#2)
type Q##2##2##(1993-11#2)
type STMV##4##2##(2008-10#4)
type V##2##2##(1992-12#1)(2007-11#1)
type V1 vasopressin##2##3##(1994-9#2)
type VI collagen##7##3##(1993-3#7)
type VIII collagen##4##3##(1990-8#4)
type W##3##2##(2008-10#3)
type X collagen##2##3##(1992-8#1)(2008-11#1)
type X##3##2##(1992-8#1)(2008-11#2)
type affected the##2##3##(2008-10#1)(2008-5#1)
type among##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
type and concentration of##4##4##(2008-10#4)
type and duration of##2##4##(1997-3#1)(2008-7#1)
type and duration##3##3##(1997-3#1)(2008-1#1)(2008-7#1)
type and extent of##3##4##(1995-12#1)(2007-11#1)(2008-4#1)
type and frequency of##2##4##(2007-11#1)(2009-6#1)
type and its##4##3##(2007-11#1)(2008-10#2)(2010-8#1)
type and least amount of eluent for elution of##2##9##(2008-10#2)
type and least amount of eluent for##3##7##(2008-10#3)
type and least amount of##5##5##(2008-10#5)
type and location##2##3##(2008-1#1)(2011-2#1)
type and proportion of##2##4##(2013-7#2)
type and stage##3##3##(2008-8#1)(2011-2#2)
type and the##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
type and volume of##2##4##(2008-10#2)
type and volume##3##3##(2008-10#3)
type and##117##2##(1993-8#1)(1995-12#1)(1997-3#3)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#4)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#38)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
type are the##2##3##(2008-8#1)(2009-5#1)
type are##10##2##(1994-5#1)(1996-2#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-5#1)(2012-12#1)(2013-1#1)
type as well as##2##4##(2008-11#1)(2008-4#1)
type as##3##2##(1997-6#1)(2008-11#1)(2008-4#1)
type b (Hib)##3##3##(1997-3#1)(2008-1#1)(2009-5#1)
type b##17##2##(1990-12#2)(1995-3#1)(1995-5#6)(1997-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2009-5#2)(2012-12#1)
type by##2##2##(2008-10#1)(2008-11#1)
type can be##2##3##(2008-10#1)(2008-8#1)
type can##5##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)
type classification##3##2##(2008-5#1)(2008-6#1)(2012-12#1)
type contained##3##2##(1997-3#3)
type cystomas##2##2##(1990-2#2)
type data##3##2##(2008-10#3)
type de##2##2##(2011-2#1)(2013-1#1)
type did not affect##2##4##(2008-10#2)
type distribution##2##2##(1990-12#1)(2011-2#1)
type epithelium##2##2##(1990-2#1)(2008-7#1)
type for the##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
type for##9##2##(1992-8#1)(2007-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)
type from##2##2##(1993-9#1)(2008-7#1)
type genotype##2##2##(2013-1#2)
type glutamate receptor antagonist##2##4##(2008-11#2)
type glutamate receptor##4##3##(1995-5#2)(2008-11#2)
type glutamate##5##2##(1995-5#3)(2008-11#2)
type had##2##2##(2008-10#1)(2008-11#1)
type has a##2##3##(1991-11#1)(2008-1#1)
type has##3##2##(1991-11#1)(2008-1#1)(2008-10#1)
type hypersensitivity##4##2##(2008-10#4)
type in the same##2##4##(2012-12#2)
type in the##6##3##(2008-10#1)(2008-4#1)(2010-8#1)(2012-12#3)
type in##29##2##(1990-6#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-8#2)(2007-10#1)(2008-1#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#3)(2013-8#1)
type indicated##2##2##(1993-9#1)(2008-10#1)
type into##2##2##(2008-8#1)(2009-9#1)
type is more likely to be##2##6##(2011-2#1)(2013-1#1)
type is the##5##3##(1994-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
type is##22##2##(1990-5#1)(1994-5#1)(1996-4#1)(1997-3#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-8#3)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
type isolates of##2##3##(2008-10#2)
type isolates##3##2##(2008-10#3)
type may##2##2##(1994-2#1)(2008-8#1)
type occurred##2##2##(2008-10#1)(2008-5#1)
type of CP and##2##4##(2011-2#2)
type of SAR##2##3##(1991-1#1)(1995-6#1)
type of abuse##2##3##(2012-12#2)
type of acid##2##3##(2012-2#1)(2013-1#1)
type of activity##5##3##(1991-1#1)(1994-2#1)(2007-6#1)(2008-11#1)(2008-8#1)
type of amyloidosis##2##3##(2011-2#2)
type of analysis##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
type of anesthesia##3##3##(2007-11#3)
type of assay##2##3##(2008-4#1)(2008-9#1)
type of bacteria##2##3##(2011-2#1)(2012-1#1)
type of bone##3##3##(2007-12#1)(2008-4#1)(2011-1#1)
type of cancer##3##3##(1997-6#1)(2013-1#1)(2013-8#1)
type of cell death##2##4##(1992-9#1)(2008-8#1)
type of cell holder##2##4##(2008-2#2)
type of cell in##2##4##(2008-12#2)
type of cell##7##3##(1992-9#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-8#1)
type of cells##3##3##(1992-9#1)(2007-12#1)(2008-12#1)
type of data##3##3##(1996-2#1)(2012-1#1)(2012-12#1)
type of defect##2##3##(2007-11#1)(2007-12#1)
type of defense##2##3##(2008-10#1)(2009-6#1)
type of delivery##3##3##(1994-7#1)(2011-1#1)(2012-3#1)
type of developmental##2##3##(2008-12#1)(2013-1#1)
type of device##2##3##(2008-10#1)(2013-1#1)
type of diabetes##4##3##(1993-2#2)(2011-1#1)(2012-12#1)
type of diagnostic##2##3##(1996-3#1)(2008-10#1)
type of dislocation##2##3##(2010-3#1)(2012-12#1)
type of donor##2##3##(2008-1#1)(2013-1#1)
type of dural arteriovenous shunts##2##5##(1996-9#2)
type of dysplasia##2##3##(2007-11#2)
type of education and##2##4##(1994-2#1)(2008-1#1)
type of education##4##3##(1994-2#1)(2008-1#1)(2008-11#1)(2008-12#1)
type of effect##3##3##(1991-1#3)
type of endometrial carcinoma##2##4##(2011-2#1)(2012-1#1)
type of endometrial##3##3##(1994-9#1)(2011-2#1)(2012-1#1)
type of enzyme##2##3##(1992-3#1)(1995-2#1)
type of event##4##3##(1993-3#1)(1997-4#1)(2008-9#1)(2012-2#1)
type of exercise##2##3##(2008-10#1)(2013-1#1)
type of filter##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
type of food##2##3##(2008-4#1)(2012-2#1)
type of fracture##5##3##(2007-8#3)(2011-2#2)
type of genetic##3##3##(2008-7#1)(2008-9#1)(2012-3#1)
type of health##3##3##(1994-1#2)(2008-7#1)
type of hemocyte was##2##4##(2008-5#2)
type of infection##2##3##(2007-7#1)(2009-3#1)
type of information##6##3##(1994-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-12#1)
type of injury##4##3##(1992-4#1)(2007-11#1)(2013-1#2)
type of insurance##2##3##(1992-1#1)(1996-3#1)
type of interaction##4##3##(1995-11#1)(1997-2#1)(2008-10#1)(2012-1#1)
type of intervention##5##3##(1994-1#1)(2008-7#2)(2008-9#1)(2012-2#1)
type of irrational beliefs##2##4##(2010-5#2)
type of laser##4##3##(1994-2#1)(2007-12#1)(2010-1#1)(2010-8#1)
type of latex##2##3##(1990-12#1)(2008-10#1)
type of leadership style##2##4##(1992-2#2)
type of lesions##2##3##(2008-11#1)(2008-8#1)
type of linker##2##3##(1991-12#1)(1997-4#1)
type of lymphoma##2##3##(2009-1#1)(2011-2#1)
type of malignancy##3##3##(2008-10#2)(2008-7#1)
type of matrix##2##3##(2008-10#2)
type of measurement##2##3##(2008-3#2)
type of methodology##2##3##(2008-10#1)(2011-1#1)
type of mineralization##2##3##(2008-10#2)
type of model##3##3##(1997-2#1)(2007-12#1)(2008-5#1)
type of mutation##3##3##(1990-8#1)(1992-2#1)(2013-1#1)
type of operation##4##3##(1990-3#2)(1991-11#1)(2007-8#1)
type of optical##3##3##(2008-2#1)(2008-3#2)
type of pain##2##3##(2008-4#1)(2010-3#1)
type of patient##2##3##(1991-5#1)(2008-9#1)
type of primary##5##3##(2007-11#2)(2008-1#2)(2010-11#1)
type of procedure##2##3##(2007-11#1)(2013-1#1)
type of program##3##3##(1993-12#1)(1993-2#1)(1997-1#1)
type of protein##2##3##(1990-5#1)(2010-12#1)
type of radiation##3##3##(2008-12#2)(2008-7#1)
type of recording##2##3##(2008-3#1)(2011-1#1)
type of research##5##3##(1993-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
type of residential area##2##4##(2010-3#2)
type of response##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
type of sample##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2011-1#1)
type of samples##3##3##(2008-10#3)
type of service##4##3##(1992-3#1)(1996-2#1)(1997-1#1)(2011-2#1)
type of services##2##3##(1993-2#1)(2011-1#1)
type of skin##2##3##(2007-12#1)(2008-5#1)
type of stationary phase##2##4##(2008-10#1)(2008-11#1)
type of sterilization##2##3##(1991-3#2)
type of structural change##2##4##(2007-12#1)(2008-7#1)
type of structural##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
type of study##7##3##(1992-9#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
type of surgery##7##3##(1993-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-6#2)(2011-2#1)
type of surgical intervention##2##4##(2009-12#1)(2013-1#1)
type of surgical##7##3##(1990-12#1)(1997-2#1)(2008-2#1)(2009-12#1)(2012-2#2)(2013-1#1)
type of the disease##3##4##(1991-11#1)(1996-3#1)(2008-1#1)
type of the##27##3##(1991-11#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2012-12#1)
type of therapy##2##3##(1994-6#1)(2007-12#1)
type of transplant##2##3##(2011-2#2)
type of treatment##10##3##(1991-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(2007-11#1)(2008-10#1)(2011-2#2)
type of tumor##3##3##(1990-2#1)(1993-11#1)(2011-2#1)
type of tumour##4##3##(1993-3#1)(1993-9#1)(2008-6#2)
type of vaccine##2##3##(1993-3#1)(2011-2#1)
type of valve##2##3##(2008-3#1)(2013-1#1)
type of vector##2##3##(2008-10#1)(2008-11#1)
type of visual##3##3##(1991-12#1)(2011-2#2)
type of work##2##3##(2008-4#1)(2013-1#1)
type of##789##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#6)(1991-11#5)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#5)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#6)(1993-12#8)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#6)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#5)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#4)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#2)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2007-10#3)(2007-11#24)(2007-12#24)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#7)(2008-1#11)(2008-10#121)(2008-11#33)(2008-12#16)(2008-2#10)(2008-3#32)(2008-4#17)(2008-5#26)(2008-6#5)(2008-7#20)(2008-8#12)(2008-9#17)(2009-1#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#5)(2010-12#4)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#6)(2010-8#10)(2010-9#1)(2011-1#16)(2011-2#35)(2011-3#3)(2012-1#6)(2012-12#12)(2012-2#15)(2012-3#11)(2013-1#35)(2013-8#12)
type on the##4##3##(1997-3#1)(2008-2#1)(2008-7#1)(2011-2#1)
type on##10##2##(1997-3#1)(2008-10#3)(2008-2#3)(2008-5#1)(2008-7#1)(2011-2#1)
type one##2##2##(1992-6#1)(2007-6#1)
type or##11##2##(1995-6#1)(1996-6#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-7#1)(2012-2#1)(2012-3#1)
type plasminogen activator##2##3##(1990-8#1)(2008-11#1)
type plasminogen##3##2##(1990-8#1)(1995-6#1)(2008-11#1)
type species of the genus##27##5##(1997-2#1)(2008-10#1)(2011-2#25)
type species of the##31##4##(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#27)
type species##39##2##(1997-2#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-2#33)
type specific##6##2##(1997-7#1)(2008-11#2)(2008-12#2)(2009-8#1)
type specificity##2##2##(2008-10#1)(2012-12#1)
type strain (SEBR##3##3##(2011-2#3)
type strain genome from the##2##5##(2011-2#2)
type strain genome from##3##4##(2011-2#3)
type strain of a##2##4##(2011-2#2)
type strain of the species##2##5##(2011-2#2)
type strain of the##4##4##(2011-2#4)
type strain of##8##3##(1997-3#1)(2008-10#1)(2011-2#6)
type strain was##2##3##(2008-12#1)(2012-2#1)
type strain##78##2##(1991-2#1)(1994-6#1)(1997-3#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#2)(2011-2#57)(2012-2#1)(2012-3#2)
type strains of##2##3##(2008-10#2)
type strains##4##2##(1990-5#1)(1997-8#1)(2008-10#2)
type that##8##2##(1995-12#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#1)
type three secretion system##2##4##(2008-11#2)
type to the##2##3##(1990-2#1)(2008-2#1)
type to##4##2##(1990-12#1)(1990-2#1)(2008-12#1)(2008-2#1)
type under##4##2##(2008-10#1)(2008-8#1)(2010-10#1)(2013-1#1)
type used##5##2##(1997-3#1)(2008-2#2)(2008-7#1)(2012-12#1)
type using##2##2##(2008-10#1)(2008-7#1)
type was the##3##3##(2008-3#1)(2012-12#1)(2013-8#1)
type was##19##2##(1990-5#1)(1991-5#1)(1997-3#1)(2007-7#1)(2008-10#9)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
type were##18##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-8#1)(1995-2#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#2)
type when##2##2##(2008-10#2)
type which##2##2##(1991-9#1)(2008-12#1)
type will##2##2##(1994-5#1)(2008-8#1)
type with##7##2##(1997-7#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
type within##3##2##(1994-3#1)(2008-3#1)(2008-9#1)
type##3062##1##(1990-10#1)(1990-11#6)(1990-12#23)(1990-2#22)(1990-3#3)(1990-5#20)(1990-6#3)(1990-7#7)(1990-8#12)(1990-9#1)(1991-1#6)(1991-10#2)(1991-11#9)(1991-12#15)(1991-2#9)(1991-3#7)(1991-5#13)(1991-7#3)(1991-8#13)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#8)(1992-3#22)(1992-4#1)(1992-5#3)(1992-6#21)(1992-7#1)(1992-8#16)(1992-9#12)(1993-1#2)(1993-11#20)(1993-12#16)(1993-2#20)(1993-3#27)(1993-5#3)(1993-6#12)(1993-8#9)(1993-9#8)(1994-1#9)(1994-11#12)(1994-12#10)(1994-2#21)(1994-3#6)(1994-5#15)(1994-6#11)(1994-7#5)(1994-8#9)(1994-9#13)(1995-1#2)(1995-10#1)(1995-11#15)(1995-12#22)(1995-2#28)(1995-3#11)(1995-4#4)(1995-5#20)(1995-6#11)(1995-8#6)(1995-9#1)(1996-1#5)(1996-11#6)(1996-12#5)(1996-2#11)(1996-3#7)(1996-4#3)(1996-5#3)(1996-6#5)(1996-9#4)(1997-1#9)(1997-2#14)(1997-3#32)(1997-4#14)(1997-5#6)(1997-6#26)(1997-7#22)(1997-8#18)(2006-10#5)(2006-8#2)(2007-10#11)(2007-11#71)(2007-12#62)(2007-2#2)(2007-4#1)(2007-5#9)(2007-6#5)(2007-7#14)(2007-8#39)(2008-1#81)(2008-10#448)(2008-11#113)(2008-12#35)(2008-2#55)(2008-3#106)(2008-4#41)(2008-5#71)(2008-6#21)(2008-7#86)(2008-8#70)(2008-9#50)(2009-1#7)(2009-10#2)(2009-11#18)(2009-12#8)(2009-2#1)(2009-3#14)(2009-4#3)(2009-5#16)(2009-6#5)(2009-7#6)(2009-8#19)(2009-9#11)(2010-1#2)(2010-10#5)(2010-11#16)(2010-12#12)(2010-2#4)(2010-3#12)(2010-4#16)(2010-5#15)(2010-6#8)(2010-8#25)(2010-9#3)(2011-1#50)(2011-2#211)(2011-3#9)(2012-1#15)(2012-12#42)(2012-2#47)(2012-3#48)(2012-4#10)(2012-5#5)(2012-6#3)(2012-9#4)(2013-1#116)(2013-7#5)(2013-8#49)
type&quot##2##1##(1997-8#1)(2008-9#1)
type) and##3##2##(2008-10#1)(2008-5#2)
type) were##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
type)##22##1##(1990-12#1)(1990-8#1)(1993-9#1)(1995-2#1)(1997-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-3#2)(2011-2#1)(2013-8#1)
type-1##23##1##(1990-2#1)(1990-8#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-6#3)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-11#1)(2009-7#1)(2012-12#1)(2012-3#2)(2013-7#1)
type-2 diabetes##9##2##(2008-7#4)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
type-2 diabetics##2##2##(2012-3#2)
type-2 plasmids##2##2##(1996-6#2)
type-2##20##1##(1994-6#1)(1996-6#4)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#6)
type-A##2##1##(1993-3#1)(2008-8#1)
type-I collagen##2##2##(1990-12#1)(2008-11#1)
type-I polyketide synthases##2##3##(2013-1#2)
type-I##8##1##(1990-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2013-1#3)(2013-8#1)
type-II cells##7##2##(1994-3#7)
type-II##10##1##(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#7)
type-IV collagenase##2##2##(1992-9#1)(2008-11#1)
type-IV##5##1##(1992-9#3)(2008-11#1)(2011-2#1)
type-specific gene##2##2##(2008-7#1)(2013-8#1)
type-specific serology##3##2##(2008-10#3)
type-specific##17##1##(1992-9#2)(1993-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#2)(2008-10#3)(2008-7#1)(2009-9#1)(2012-3#1)(2013-8#2)
typeI##2##1##(2007-11#2)
typeII##2##1##(2007-11#2)
type]##2##1##(2009-5#1)(2011-1#1)
typed as B##2##3##(1994-12#1)(2007-12#1)
typed as##10##2##(1992-6#1)(1994-12#5)(2007-12#3)(2008-5#1)
typed for##2##2##(1994-12#1)(2012-3#1)
typed##15##1##(1992-6#1)(1994-12#6)(1997-5#1)(1997-8#1)(2007-12#3)(2008-5#1)(2011-2#1)(2012-3#1)
types 1 and 2##2##4##(1992-8#1)(2008-7#1)
types 1##3##2##(1992-8#1)(2007-12#1)(2008-7#1)
types I and II##2##4##(1991-12#1)(2011-2#1)
types I and III##3##4##(2008-11#1)(2008-7#2)
types I and IV##2##4##(1990-12#1)(1994-12#1)
types I and##7##3##(1990-12#1)(1991-12#1)(1994-12#1)(2008-11#1)(2008-7#2)(2011-2#1)
types I##8##2##(1990-12#1)(1991-12#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)
types IIA##2##2##(2012-2#2)
types IV and VII collagens##2##5##(2008-5#2)
types after##2##2##(2008-11#1)(2008-5#1)
types among##2##2##(2007-2#1)(2008-10#1)
types and amounts of##3##4##(1992-3#2)(2008-5#1)
types and can##2##3##(2008-3#1)(2008-4#1)
types and different##2##3##(2008-3#1)(2010-7#1)
types and least amount of eluent##2##6##(2008-10#2)
types and levels of##2##4##(1997-3#1)(2008-10#1)
types and six VCGs##3##4##(2008-10#3)
types and sizes of##2##4##(2009-1#1)(2010-8#1)
types and sizes##3##3##(2009-1#1)(2010-8#2)
types and##58##2##(1990-5#1)(1992-3#3)(1992-8#1)(1994-12#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
types are considered##2##3##(2008-2#1)(2008-3#1)
types are the##2##3##(2010-8#1)(2013-1#1)
types are##21##2##(1992-3#1)(1994-1#1)(1995-9#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
types at##2##2##(1995-12#1)(2008-12#1)
types based on##4##3##(2007-10#2)(2008-10#2)
types but##3##2##(2008-4#1)(2008-5#1)(2008-6#1)
types by##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
types can be##3##3##(1996-9#1)(2008-10#1)(2010-12#1)
types can##5##2##(1996-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-3#1)
types containing##2##2##(2008-10#1)(2008-9#1)
types detected##2##2##(2008-10#1)(2008-2#1)
types did not##3##3##(2008-10#2)(2011-2#1)
types for##7##2##(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-3#1)
types found in the##2##4##(2008-1#1)(2008-10#1)
types found in##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
types from##5##2##(2008-10#2)(2008-4#1)(2009-3#2)
types have been##6##3##(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
types have##11##2##(1992-11#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
types in a##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
types in populations of C##2##5##(2008-10#2)
types in the##9##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-11#1)
types in##38##2##(1992-11#1)(1993-11#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-5#1)
types including##8##2##(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)
types involved in##2##3##(2008-10#1)(2008-5#1)
types is##7##2##(2008-11#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
types may##3##2##(2007-11#1)(2008-7#1)(2012-9#1)
types occurred##3##2##(2008-10#2)(2009-5#1)
types of CWP##3##3##(2008-10#3)
types of DNA damage##2##4##(1994-5#1)(2010-2#1)
types of Haemophilus influenzae##2##4##(2009-5#2)
types of K(+)##2##3##(2008-8#1)(2009-12#1)
types of NF1-GRD##3##3##(1992-8#3)
types of RNA##2##3##(1994-11#1)(1997-2#1)
types of SPME fiber##2##4##(2008-10#1)(2009-8#1)
types of accidents and##2##4##(1990-6#1)(2011-2#1)
types of actions##2##3##(1991-1#1)(2012-2#1)
types of activities##2##3##(1991-1#1)(2007-6#1)
types of alcoholic beverages##3##4##(2008-10#2)(2013-1#1)
types of behavioral##4##3##(1991-1#1)(2007-12#1)(2010-6#1)(2011-2#1)
types of binding sites##4##4##(1990-12#1)(1992-3#2)(2008-10#1)
types of bone##2##3##(2008-4#1)(2009-4#1)
types of cancer in##2##4##(2008-1#1)(2010-10#1)
types of cancer##17##3##(1990-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#1)(2013-1#1)(2013-8#1)
types of cancers##5##3##(1994-3#1)(2009-10#1)(2011-1#1)(2011-2#2)
types of carbon##2##3##(2008-10#1)(2008-3#1)
types of cell##2##3##(1993-8#1)(1994-8#1)
types of cells are##2##4##(2007-12#1)(2008-2#1)
types of cells##21##3##(1993-1#2)(1993-3#1)(1993-8#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-9#1)(2012-1#1)
types of commercial##4##3##(2008-10#3)(2008-3#1)
types of complex##2##3##(2008-10#1)(2008-5#1)
types of coping strategies##3##4##(1994-12#2)(2008-1#1)
types of correlation filter##2##4##(2007-12#1)(2008-3#1)
types of damage##4##3##(1990-8#1)(2007-12#2)(2008-3#1)
types of data##10##3##(1997-8#1)(2008-1#2)(2008-11#2)(2008-4#2)(2008-7#1)(2009-9#1)(2011-2#1)
types of defect##2##3##(2007-12#1)(2008-3#1)
types of diabetes##3##3##(1995-5#1)(2008-1#1)(2013-1#1)
types of disease##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
types of drugs##2##3##(1990-6#1)(1996-3#1)
types of electrode##2##3##(2008-10#2)
types of electrodes##2##3##(2008-10#2)
types of environmental##2##3##(2008-10#1)(2011-1#1)
types of error##2##3##(2008-3#2)
types of evidence##2##3##(2008-10#1)(2008-7#1)
types of experimental##2##3##(1993-3#1)(2012-2#1)
types of exposure to terror##2##5##(2009-7#2)
types of exposure to##3##4##(2009-7#3)
types of exposure##4##3##(2009-7#4)
types of fluorescence##2##3##(1994-5#2)
types of food##2##3##(2008-11#1)(2008-6#1)
types of friends were##2##4##(2009-7#2)
types of friends##3##3##(2009-7#3)
types of gas media##2##4##(2008-10#2)
types of genetic##2##3##(2008-10#1)(2011-3#1)
types of glands##2##3##(2007-12#2)
types of grating##2##3##(2007-11#1)(2008-2#1)
types of grey cast iron##2##5##(2008-10#2)
types of headache##2##3##(1994-9#1)(2008-5#1)
types of health##3##3##(1994-12#1)(1996-1#1)(1996-2#1)
types of hemocytes##2##3##(2008-5#2)
types of honey##2##3##(2008-10#2)
types of hospitals##2##3##(1990-6#1)(1992-12#1)
types of human adenovirus have been##2##6##(2013-8#2)
types of human adenovirus##4##4##(2013-8#4)
types of human##8##3##(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#5)
types of in vitro##2##4##(2008-10#1)(2008-5#1)
types of infection##2##3##(2007-12#1)(2013-1#1)
types of information##4##3##(1991-5#1)(1997-1#1)(2008-4#2)
types of injuries##2##3##(1997-2#1)(2013-1#1)
types of injury##2##3##(2012-2#2)
types of insults##2##3##(2008-9#2)
types of interactions##3##3##(2008-4#2)(2008-8#1)
types of internal modulation##2##4##(2008-1#2)
types of isoflavones##2##3##(2010-3#2)
types of junctions##2##3##(2008-7#1)(2009-10#1)
types of kenkey##3##3##(1997-4#3)
types of lesion##3##3##(1996-9#2)(2008-6#1)
types of managed care plans##2##5##(1994-1#1)(1995-12#1)
types of managed care##3##4##(1994-1#1)(1995-12#1)(1997-2#1)
types of matrices##3##3##(2008-10#1)(2008-11#2)
types of measurement##2##3##(2008-2#1)(2008-3#1)
types of measurements##4##3##(1995-3#1)(2008-10#2)(2008-5#1)
types of medical##5##3##(1993-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-1#1)
types of microbes##3##3##(2011-2#1)(2012-2#2)
types of models##2##3##(2008-10#1)(2010-1#1)
types of molecular##3##3##(2008-5#1)(2008-9#1)(2013-7#1)
types of molecules##2##3##(1996-4#1)(2008-10#1)
types of monitoring##2##3##(2008-10#1)(2010-8#1)
types of motion##2##3##(2008-9#2)
types of motivation##3##3##(1993-6#1)(2013-1#2)
types of multiple##2##3##(1991-12#1)(2012-3#1)
types of muscle##2##3##(2008-6#1)(2013-1#1)
types of music##2##3##(2007-6#1)(2008-9#1)
types of natural##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
types of neurons##5##3##(1997-2#1)(2008-11#2)(2009-8#2)
types of objectives##2##3##(2008-9#2)
types of optical##5##3##(2007-12#1)(2008-10#1)(2008-3#3)
types of organelles##2##3##(2008-4#1)(2009-10#1)
types of organisms##2##3##(2008-7#2)
types of pain##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
types of particle##2##3##(2008-10#1)(2008-3#1)
types of play##2##3##(1993-12#2)
types of plywood##2##3##(2008-7#2)
types of porouscarriers##2##3##(2008-11#2)
types of potassium##2##3##(2008-8#1)(2010-12#1)
types of procedures##2##3##(1995-2#1)(2008-4#1)
types of progenitor cells##2##4##(2008-9#2)
types of projects##2##3##(1995-6#1)(2012-3#1)
types of raw materials##2##4##(2008-10#2)
types of reactions##2##3##(2008-10#2)
types of reactors##2##3##(2008-10#2)
types of receptors##4##3##(1990-11#1)(1993-6#1)(1995-11#1)(1997-1#1)
types of recommendations##2##3##(2010-9#1)(2012-3#1)
types of regression##2##3##(1992-9#1)(2008-10#1)
types of relationships##2##3##(1993-1#1)(2008-8#1)
types of resistance##3##3##(2008-10#3)
types of samples##4##3##(2008-10#3)(2012-2#1)
types of sarcomas##2##3##(2008-6#2)
types of sensilla##2##3##(2007-12#2)
types of services##2##3##(1994-2#1)(1996-3#1)
types of silicon photodiode at oblique incidence##2##7##(2008-3#2)
types of skin##2##3##(2007-8#1)(2008-5#1)
types of soils##2##3##(2008-10#2)
types of solid##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
types of sounds##2##3##(2010-8#1)(2011-1#1)
types of spores##2##3##(2008-10#1)(2008-8#1)
types of stimuli##2##3##(2012-2#1)(2013-8#1)
types of stress##3##3##(1995-3#1)(2008-3#1)(2008-7#1)
types of studies##2##3##(2008-4#1)(2012-3#1)
types of surgery##2##3##(1991-3#1)(1994-12#1)
types of surgical##2##3##(1991-3#1)(2008-4#1)
types of synaptic##2##3##(1997-3#1)(2008-11#1)
types of technical change##2##4##(1992-1#2)
types of the##11##3##(1991-2#1)(1991-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2012-12#1)
types of these##2##3##(2008-10#1)(2010-10#1)
types of treatment##2##3##(2008-8#1)(2008-9#1)
types of treatments##2##3##(2008-5#1)(2009-6#1)
types of tumors##5##3##(2008-11#3)(2008-7#1)(2011-2#1)
types of vascular access##2##4##(2007-7#2)
types of vascular##3##3##(2007-7#3)
types of vibration##2##3##(2008-3#2)
types of water##3##3##(2008-10#2)(2008-2#1)
types of wrinkles##4##3##(2008-5#4)
types of##1015##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#3)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1992-1#3)(1992-12#7)(1992-2#3)(1992-3#7)(1992-6#2)(1992-8#8)(1992-9#2)(1993-1#6)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#8)(1994-1#1)(1994-11#2)(1994-12#8)(1994-2#6)(1994-3#6)(1994-5#3)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#8)(1996-3#3)(1996-4#2)(1996-6#1)(1996-9#4)(1997-1#7)(1997-2#10)(1997-3#6)(1997-4#6)(1997-5#1)(1997-7#4)(1997-8#2)(2006-10#1)(2006-6#2)(2007-10#2)(2007-11#14)(2007-12#27)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#7)(2008-1#15)(2008-10#152)(2008-11#44)(2008-12#10)(2008-2#29)(2008-3#51)(2008-4#40)(2008-5#37)(2008-6#10)(2008-7#36)(2008-8#27)(2008-9#30)(2009-1#2)(2009-10#8)(2009-12#4)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#14)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#12)(2010-9#6)(2011-1#9)(2011-2#31)(2011-3#2)(2011-7#1)(2012-1#5)(2012-12#10)(2012-2#19)(2012-3#18)(2012-8#1)(2012-9#1)(2013-1#32)(2013-7#4)(2013-8#16)
types show##2##2##(2007-10#1)(2008-10#1)
types showed##3##2##(1990-12#1)(2008-10#1)(2012-3#1)
types such as the##2##4##(2008-1#1)(2008-10#1)
types such as##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2012-3#1)
types tested##3##2##(1991-5#1)(1997-1#1)(2009-2#1)
types than##2##2##(2006-12#1)(2008-10#1)
types that are##4##3##(1993-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
types that were##2##3##(2008-10#2)
types that##11##2##(1993-11#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2011-1#1)(2011-2#1)
types to the##2##3##(1997-8#1)(2008-10#1)
types to##6##2##(1995-3#1)(1997-8#1)(2008-10#3)(2008-11#1)
types used##3##2##(2008-11#2)(2008-9#1)
types using##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
types was##8##2##(1990-2#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
types were detected##2##3##(2008-10#2)
types were determined##2##3##(2008-5#2)
types were observed##2##3##(1992-6#1)(2011-2#1)
types were obtained##2##3##(1997-3#1)(2008-6#1)
types were present in##2##4##(2008-10#2)
types were used##2##3##(1993-8#1)(2012-2#1)
types were##32##2##(1991-8#1)(1992-6#1)(1993-8#1)(1994-5#1)(1997-3#1)(2008-10#14)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
types with high##2##3##(2008-10#1)(2008-8#1)
types with the##2##3##(1994-1#1)(2013-8#1)
types with##11##2##(1992-9#1)(1994-1#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
types##1669##1##(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#6)(1990-6#6)(1990-7#2)(1990-8#4)(1991-1#6)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#6)(1991-3#2)(1991-5#3)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#3)(1992-3#12)(1992-6#7)(1992-8#10)(1992-9#4)(1993-1#6)(1993-11#6)(1993-12#8)(1993-2#5)(1993-3#8)(1993-5#2)(1993-6#6)(1993-8#10)(1993-9#5)(1994-1#4)(1994-11#4)(1994-12#12)(1994-2#8)(1994-3#8)(1994-5#6)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#8)(1995-5#5)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#11)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#3)(1996-9#5)(1997-1#9)(1997-2#14)(1997-3#8)(1997-4#10)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#6)(2006-10#1)(2006-12#3)(2006-6#3)(2007-10#7)(2007-11#19)(2007-12#35)(2007-2#3)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#11)(2007-8#8)(2008-1#23)(2008-10#268)(2008-11#83)(2008-12#16)(2008-2#43)(2008-3#71)(2008-4#59)(2008-5#74)(2008-6#18)(2008-7#65)(2008-8#45)(2008-9#49)(2009-1#3)(2009-10#9)(2009-12#8)(2009-2#5)(2009-3#5)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#15)(2009-8#13)(2009-9#10)(2010-1#5)(2010-10#6)(2010-11#5)(2010-12#6)(2010-2#7)(2010-3#6)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#17)(2010-9#7)(2011-1#16)(2011-2#53)(2011-3#3)(2011-7#1)(2012-1#5)(2012-12#24)(2012-2#36)(2012-3#29)(2012-4#1)(2012-5#2)(2012-8#1)(2012-9#2)(2013-1#49)(2013-7#8)(2013-8#21)
types) and##2##2##(1991-2#1)(2008-12#1)
types)##4##1##(1991-2#1)(2008-10#1)(2008-12#1)(2013-1#1)
typhi in##2##2##(1997-6#1)(2007-7#1)
typhi is##2##2##(1990-6#1)(2007-7#1)
typhi##16##1##(1990-12#2)(1990-6#3)(1997-6#2)(2007-7#6)(2008-8#2)(2010-4#1)
typhimurium and##3##2##(1990-6#1)(1997-3#1)(2008-9#1)
typhimurium strain##2##2##(2008-10#1)(2008-9#1)
typhimurium##35##1##(1990-11#2)(1990-6#1)(1991-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-8#2)(1996-2#2)(1996-3#1)(1996-6#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#3)(2008-9#8)(2009-5#3)(2010-4#2)(2011-1#1)
typhoid fever##5##2##(1992-2#1)(1997-6#1)(2007-2#3)
typhoid##7##1##(1990-9#1)(1992-2#1)(1997-6#1)(2007-2#3)(2011-2#1)
typhus imported##2##2##(1997-6#2)
typhus##6##1##(1997-6#4)(2007-2#1)(2007-7#1)
typical CpG##2##2##(2007-11#2)
typical EOG##2##2##(2008-5#2)
typical Michaelis-Menten kinetics##2##3##(1997-2#1)(2008-10#1)
typical Michaelis-Menten##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
typical TATA box##2##3##(1996-10#1)(1997-6#1)
typical adult##2##2##(2008-10#1)(2008-11#1)
typical and##6##2##(1993-3#1)(1994-9#1)(2008-10#1)(2009-12#1)(2010-10#1)(2011-2#1)
typical applications##3##2##(2008-10#2)(2008-2#1)
typical biological##2##2##(2008-2#1)(2008-3#1)
typical case##7##2##(1991-9#1)(1994-12#1)(2008-1#2)(2008-3#1)(2010-9#1)(2012-3#1)
typical clinical presentation##2##3##(2008-1#1)(2008-10#1)
typical clinical symptoms##2##3##(1995-2#1)(2013-1#1)
typical clinical##11##2##(1990-3#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
typical concentrations##2##2##(2008-10#2)
typical data##2##2##(2008-2#1)(2008-9#1)
typical environmental##2##2##(2008-10#1)(2013-1#1)
typical error##2##2##(2008-12#2)
typical examples##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
typical experimental##2##2##(2008-1#1)(2008-3#1)
typical exponential##2##2##(2007-11#1)(2008-10#1)
typical feature##4##2##(1990-8#1)(1997-6#1)(2008-10#1)(2008-8#1)
typical features of##7##3##(1991-3#1)(1993-2#1)(1995-2#1)(2007-12#1)(2008-8#1)(2012-2#1)(2013-7#1)
typical findings##2##2##(2008-5#1)(2010-6#1)
typical for a##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
typical for the##4##3##(1991-6#1)(2007-12#1)(2008-12#1)(2008-2#1)
typical for##33##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#4)
typical form of##4##3##(1997-8#1)(2008-4#1)(2008-7#1)(2010-6#1)
typical head##2##2##(2007-12#1)(2008-7#1)
typical hypersensitive reaction##2##3##(2008-10#2)
typical imaging##4##2##(2008-6#1)(2008-9#1)(2012-3#1)(2013-8#1)
typical language development##2##3##(2009-8#1)(2011-1#1)
typical laser##2##2##(2008-3#1)(2008-9#1)
typical leaf##2##2##(2008-10#2)
typical location##3##2##(1991-4#1)(1991-6#1)(2007-11#1)
typical of a##4##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
typical of apoptosis##3##3##(1992-3#2)(2008-6#1)
typical of free-living##2##3##(2011-2#2)
typical of strains##2##3##(2008-10#1)(2008-5#1)
typical of the##6##3##(1994-11#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
typical of##98##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1997-2#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-4#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
typical operating##3##2##(1995-12#1)(2007-11#1)(2008-2#1)
typical parameters##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
typical pharmaceutical##2##2##(1994-9#1)(2008-10#1)
typical problems##2##2##(2008-10#2)
typical product##2##2##(2008-10#1)(2013-1#1)
typical root##2##2##(2008-10#2)
typical samples##2##2##(2008-10#2)
typical sampling##2##2##(2008-10#1)(2008-3#1)
typical sequence##2##2##(1992-3#1)(2010-9#1)
typical skin##2##2##(1997-8#1)(2012-2#1)
typical symptoms and##2##3##(1995-2#1)(2008-10#1)
typical symptoms of##4##3##(2008-10#2)(2012-12#1)(2013-8#1)
typical symptoms##9##2##(1991-4#1)(1995-2#1)(2008-10#5)(2012-12#1)(2013-8#1)
typical values##2##2##(1994-9#1)(2008-3#1)
typical##591##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#8)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#5)(2006-10#2)(2007-1#1)(2007-10#2)(2007-11#20)(2007-12#16)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#8)(2008-10#118)(2008-11#19)(2008-12#13)(2008-2#19)(2008-3#46)(2008-4#7)(2008-5#17)(2008-6#10)(2008-7#16)(2008-8#16)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#4)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#4)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#6)(2010-9#2)(2011-1#7)(2011-2#22)(2011-3#1)(2012-12#3)(2012-2#14)(2012-3#9)(2013-1#11)(2013-7#3)(2013-8#5)
typical&quot##2##1##(1993-12#1)(2009-11#1)
typically a##3##2##(1995-12#1)(2008-3#1)(2011-2#1)
typically accompanied by##2##3##(1991-3#1)(2012-12#1)
typically affects the##2##3##(2011-2#1)(2012-3#1)
typically affects##3##2##(1991-12#1)(2011-2#1)(2012-3#1)
typically are##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
typically associated with##7##3##(1994-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#2)
typically based on##3##3##(1996-6#1)(2008-3#1)(2009-11#1)
typically be##2##2##(2008-10#1)(2010-12#1)
typically carried##2##2##(2008-11#1)(2012-3#1)
typically characterized by##2##3##(1994-8#1)(2008-4#1)
typically characterized##3##2##(1994-8#1)(2008-4#1)(2009-7#1)
typically collected in##2##3##(2012-12#1)(2013-1#1)
typically consist of##2##3##(2008-7#1)(2008-9#1)
typically contained##2##2##(2008-10#1)(2009-7#1)
typically developing##6##2##(2008-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#2)
typically develops##2##2##(1991-12#1)(2011-2#1)
typically encountered in##2##3##(2008-3#1)(2009-11#1)
typically encountered##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
typically exhibit##3##2##(1993-9#1)(1996-3#1)(2008-10#1)
typically found in##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
typically has##2##2##(2008-10#1)(2008-3#1)
typically have##9##2##(1994-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)
typically in the##3##3##(2007-12#1)(2008-10#1)(2009-1#1)
typically in##4##2##(2007-12#1)(2008-10#1)(2009-1#1)(2012-3#1)
typically increase##2##2##(1995-12#1)(2011-2#1)
typically involved##2##2##(2012-12#1)(2013-1#1)
typically involves##2##2##(2011-2#1)(2012-1#1)
typically is##2##2##(2008-10#1)(2008-2#1)
typically low##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
typically observed in##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
typically occurs in##2##3##(2006-10#1)(2013-7#1)
typically on##2##2##(2008-5#1)(2009-11#1)
typically performed##3##2##(1994-3#1)(2008-10#1)(2012-3#1)
typically present##2##2##(2009-8#1)(2012-2#1)
typically reported for##2##3##(2008-8#2)
typically reported##3##2##(1994-2#1)(2008-8#2)
typically require##2##2##(1995-9#1)(2012-3#1)
typically result in##2##3##(1993-2#1)(2011-2#1)
typically results in##2##3##(2008-8#2)
typically slow##2##2##(2007-11#1)(2008-10#1)
typically stronger##2##2##(2008-10#1)(2010-4#1)
typically the##3##2##(2008-10#2)(2012-3#1)
typically used for##3##3##(2007-12#1)(2007-7#1)(2008-4#1)
typically used in##3##3##(2008-9#1)(2010-12#1)(2010-9#1)
typically used##7##2##(1993-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-9#1)
typically within##2##2##(2008-3#2)
typically yield##2##2##(2008-3#1)(2008-7#1)
typically##274##1##(1991-1#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#43)(2008-11#10)(2008-12#6)(2008-2#9)(2008-3#17)(2008-4#11)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#13)(2008-9#7)(2009-1#1)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-6#2)(2010-9#2)(2011-2#17)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#11)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#2)
typified by##2##2##(2008-10#1)(2009-7#1)
typify##3##1##(1992-3#1)(2008-10#1)(2008-6#1)
typing a##2##2##(1993-9#1)(2008-9#1)
typing and##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
typing assays##2##2##(2008-10#1)(2008-12#1)
typing by##2##2##(2008-9#1)(2011-2#1)
typing in samples##2##3##(2008-12#2)
typing in##5##2##(1997-8#1)(2008-12#3)(2011-2#1)
typing methods##2##2##(2007-8#1)(2011-2#1)
typing of##9##2##(1992-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
typing showed that##2##3##(1997-3#1)(2007-12#1)
typing system##3##2##(1995-11#1)(1997-8#1)(2008-12#1)
typing to##3##2##(2008-10#2)(2008-12#1)
typing was##2##2##(1997-8#1)(2013-8#1)
typing with the##2##3##(2012-3#1)(2013-8#1)
typing##76##1##(1991-6#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-9#2)(1994-3#1)(1995-11#1)(1995-3#2)(1997-3#1)(1997-8#8)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#13)(2008-4#2)(2008-5#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-2#10)(2012-2#2)(2012-3#1)(2013-8#5)
typings were##2##2##(1992-9#1)(2013-8#1)
typologies of##2##2##(1994-2#1)(2008-10#1)
typologies##6##1##(1994-2#3)(1996-2#1)(2008-10#1)(2008-8#1)
typology of##6##2##(1991-6#1)(2008-12#2)(2008-8#1)(2012-12#1)(2013-8#1)
typology##26##1##(1991-6#1)(1992-1#1)(1994-2#5)(1996-12#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#2)(2010-12#1)(2012-12#6)(2013-1#1)(2013-8#2)
tyrR+##2##1##(1991-12#2)
tyramide##2##1##(2008-10#1)(2008-4#1)
tyramine oxidase##3##2##(2009-9#3)
tyramine##9##1##(1991-5#1)(1995-6#1)(2008-10#2)(2008-7#2)(2009-9#3)
tyrosinase activity and melanin##2##4##(1991-5#2)
tyrosinase activity and##4##3##(1991-5#2)(1992-3#1)(2013-1#1)
tyrosinase activity##11##2##(1991-5#2)(1992-3#3)(1995-2#1)(2008-5#2)(2013-1#3)
tyrosinase and horse-radish peroxidase##4##4##(2008-10#4)
tyrosinase and##9##2##(1995-2#1)(2008-10#5)(2008-5#3)
tyrosinase biosensor##3##2##(2008-10#3)
tyrosinase electrode##2##2##(2008-10#2)
tyrosinase enzyme##5##2##(2008-10#5)
tyrosinase expression##2##2##(2007-10#2)
tyrosinase inhibition##2##2##(2008-10#1)(2008-5#1)
tyrosinase inhibitor##2##2##(2013-1#2)
tyrosinase mRNA##3##2##(2007-10#1)(2008-5#2)
tyrosinase was##3##2##(2008-10#2)(2008-5#1)
tyrosinase##75##1##(1991-5#2)(1992-3#4)(1994-12#2)(1995-2#2)(1996-9#1)(1997-4#2)(2007-10#3)(2008-10#32)(2008-5#21)(2013-1#6)
tyrosinase-based carbon paste electrode##2##4##(2008-10#2)
tyrosinase-related##2##1##(1995-2#1)(2008-5#1)
tyrosinate fluorescence##4##2##(1991-5#4)
tyrosinate##5##1##(1991-5#5)
tyrosine and##4##2##(1993-9#1)(1995-2#1)(1996-2#1)(2008-10#1)
tyrosine at##4##2##(1994-11#1)(1997-3#1)(2008-10#2)
tyrosine autophosphorylation##2##2##(1991-11#1)(1992-12#1)
tyrosine hydroxylase (TH) activity##2##4##(1992-12#1)(2008-11#1)
tyrosine hydroxylase (TH) in the##2##5##(2008-10#1)(2011-2#1)
tyrosine hydroxylase (TH) mRNA##2##4##(1993-8#1)(1996-12#1)
tyrosine hydroxylase (TH)##14##3##(1990-7#1)(1992-12#1)(1993-8#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
tyrosine hydroxylase and##2##3##(1993-5#1)(1996-12#1)
tyrosine hydroxylase##21##2##(1990-7#1)(1991-5#1)(1992-12#2)(1993-5#1)(1993-8#2)(1996-12#3)(1996-5#3)(1997-3#1)(1997-5#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
tyrosine in##2##2##(1991-9#1)(2012-12#1)
tyrosine into##2##2##(2008-11#1)(2008-5#1)
tyrosine kinase PYK2##2##3##(1995-8#2)
tyrosine kinase activation and##2##4##(1994-8#1)(2009-6#1)
tyrosine kinase activation##3##3##(1994-8#1)(2008-8#1)(2009-6#1)
tyrosine kinase activities##2##3##(1993-8#2)
tyrosine kinase activity in##3##4##(1991-12#1)(1992-7#1)(2008-3#1)
tyrosine kinase activity of the##2##5##(1992-8#2)
tyrosine kinase activity of##4##4##(1992-8#2)(2009-7#1)(2011-2#1)
tyrosine kinase activity##22##3##(1990-12#3)(1991-12#1)(1992-12#1)(1992-7#3)(1992-8#2)(1993-8#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-3#2)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
tyrosine kinase and##5##3##(1992-7#1)(1996-2#1)(2012-12#2)(2013-1#1)
tyrosine kinase as##2##3##(1991-12#1)(1992-9#1)
tyrosine kinase domain##3##3##(1992-12#2)(2009-8#1)
tyrosine kinase in the##2##4##(1993-8#1)(1995-8#1)
tyrosine kinase inhibitor genistein##2##4##(1993-8#1)(2008-3#1)
tyrosine kinase inhibitor imatinib##2##4##(2008-6#1)(2010-11#1)
tyrosine kinase inhibitor methyl 2##2##5##(1996-12#2)
tyrosine kinase inhibitor##19##3##(1990-11#2)(1993-8#3)(1993-9#1)(1994-6#1)(1994-8#1)(1996-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)
tyrosine kinase inhibitors (TKIs)##3##4##(2012-1#1)(2012-12#2)
tyrosine kinase inhibitors##12##3##(1993-3#1)(1993-8#1)(2010-4#2)(2010-5#2)(2011-3#1)(2012-1#2)(2012-12#2)(2013-1#1)
tyrosine kinase of##2##3##(1990-11#1)(1992-3#1)
tyrosine kinase pathway##2##3##(1991-12#1)(2008-3#1)
tyrosine kinase receptor##3##3##(1993-3#1)(2009-2#1)(2013-1#1)
tyrosine kinase receptors##3##3##(1995-2#1)(2008-8#1)(2012-3#1)
tyrosine kinase signaling##2##3##(1994-8#1)(1996-12#1)
tyrosine kinase that is##2##4##(1995-8#1)(1997-7#1)
tyrosine kinase that plays##2##4##(2008-7#1)(2012-12#1)
tyrosine kinase that##4##3##(1995-8#1)(1997-7#1)(2008-7#1)(2012-12#1)
tyrosine kinase##131##2##(1990-11#3)(1990-12#3)(1991-12#5)(1991-6#1)(1992-12#6)(1992-3#3)(1992-7#9)(1992-8#2)(1992-9#3)(1993-3#3)(1993-8#10)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#7)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#6)(1996-12#3)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#4)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#8)(2012-3#2)(2013-1#4)
tyrosine kinases (PTKs)##3##3##(1993-3#2)(1995-11#1)
tyrosine kinases and##4##3##(1996-2#1)(2011-2#1)(2012-12#2)
tyrosine kinases are##2##3##(1995-6#1)(2012-12#1)
tyrosine kinases as##2##3##(1991-12#1)(2013-1#1)
tyrosine kinases that##2##3##(1992-3#1)(2010-8#1)
tyrosine kinases##33##2##(1991-12#1)(1992-12#4)(1992-3#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#1)
tyrosine phosphatase (PTPase)##3##3##(1993-3#1)(1997-7#1)(2008-8#1)
tyrosine phosphatase activity##4##3##(1992-12#2)(1993-3#1)(1995-2#1)
tyrosine phosphatase epsilon##2##3##(2009-6#2)
tyrosine phosphatase##18##2##(1992-12#3)(1993-11#1)(1993-3#2)(1994-11#1)(1994-6#1)(1995-2#3)(1995-9#1)(1997-7#2)(2008-8#1)(2009-6#2)(2009-7#1)
tyrosine phosphatases##3##2##(1995-8#1)(2008-2#1)(2008-4#1)
tyrosine phosphorylated##5##2##(1993-3#1)(1996-2#2)(2008-6#1)(2012-3#1)
tyrosine phosphorylation and respiratory-burst activity triggered by PMA##2##8##(1994-6#2)
tyrosine phosphorylation and respiratory-burst activity##4##5##(1994-6#4)
tyrosine phosphorylation and##15##3##(1992-8#1)(1993-9#1)(1994-6#8)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2012-3#1)
tyrosine phosphorylation in##7##3##(1992-3#1)(1993-3#1)(1994-6#1)(1996-5#1)(2008-4#1)(2012-3#2)
tyrosine phosphorylation is##3##3##(1996-5#2)(2011-1#1)
tyrosine phosphorylation may be##2##4##(1992-3#1)(1997-1#1)
tyrosine phosphorylation of IRS-I##2##4##(1997-1#2)
tyrosine phosphorylation of NR2B##4##4##(1996-5#1)(1997-2#3)
tyrosine phosphorylation of Shc##3##4##(1995-8#1)(1997-7#2)
tyrosine phosphorylation of a##2##4##(1991-12#1)(1992-3#1)
tyrosine phosphorylation of cellular proteins##2##5##(1992-10#1)(1992-12#1)
tyrosine phosphorylation of the##2##4##(1992-9#1)(1994-8#1)
tyrosine phosphorylation of##25##3##(1991-12#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#4)(1997-7#2)(2008-8#1)(2012-3#1)
tyrosine phosphorylation on##2##3##(1993-3#1)(1993-9#1)
tyrosine phosphorylation was##3##3##(1991-12#1)(1994-6#1)(1997-1#1)
tyrosine phosphorylation##75##2##(1991-12#2)(1992-10#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-8#3)(1992-9#1)(1993-3#4)(1993-8#2)(1993-9#2)(1994-6#11)(1994-8#1)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#4)(1996-5#6)(1997-1#6)(1997-2#4)(1997-6#2)(1997-7#2)(2008-4#1)(2008-8#1)(2011-1#2)(2012-3#5)
tyrosine phosphorylations of##2##3##(1990-12#1)(2012-12#1)
tyrosine protein kinase activity##4##4##(1991-11#1)(1992-3#3)
tyrosine protein kinase p56lck##2##4##(1991-11#2)
tyrosine protein kinase##9##3##(1990-8#1)(1991-11#4)(1992-3#4)
tyrosine protein##10##2##(1990-8#1)(1991-11#4)(1991-12#1)(1992-3#4)
tyrosine residue##7##2##(1992-1#1)(1992-6#1)(1993-11#1)(1994-6#1)(2008-4#2)(2011-1#1)
tyrosine residues in##3##3##(1993-6#1)(1995-8#1)(2008-8#1)
tyrosine residues located in##2##4##(1995-6#1)(2008-4#1)
tyrosine residues##27##2##(1990-11#1)(1990-12#2)(1991-2#2)(1992-3#1)(1993-6#1)(1994-11#3)(1995-6#1)(1995-8#1)(1996-2#1)(1997-9#1)(2008-1#1)(2008-4#6)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#1)
tyrosine##397##1##(1990-11#4)(1990-12#6)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#5)(1991-12#10)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-12#20)(1992-3#15)(1992-4#1)(1992-6#2)(1992-7#9)(1992-8#7)(1992-9#5)(1993-11#2)(1993-3#13)(1993-5#1)(1993-6#1)(1993-8#16)(1993-9#4)(1994-11#6)(1994-12#1)(1994-6#16)(1994-8#11)(1995-11#4)(1995-2#7)(1995-3#1)(1995-6#7)(1995-8#10)(1995-9#1)(1996-12#9)(1996-2#12)(1996-5#10)(1997-1#7)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#7)(1997-9#1)(2007-12#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#15)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#2)(2009-2#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#16)(2012-2#3)(2012-3#10)(2013-1#7)
tyrosine-114##2##1##(1995-5#2)
tyrosine-phosphorylated peptides##4##2##(2008-1#2)(2008-4#2)
tyrosine-phosphorylated##8##1##(1995-6#1)(1995-8#1)(2008-1#2)(2008-4#2)(2008-8#1)(2012-12#1)
tyrosinemia type I##2##3##(1992-8#1)(1992-9#1)
tyrosinemia##5##1##(1992-8#4)(1992-9#1)
tyrosines##5##1##(1992-12#3)(1994-6#1)(2011-1#1)
tyrosol galactoside##2##2##(2011-2#2)
tyrosyl phosphorylation##2##2##(1993-3#1)(1997-7#1)
tyrosyl protein sulfotransferase##2##3##(1991-12#2)
tyrosyl residues##2##2##(1991-12#1)(2008-1#1)
tyrosyl##16##1##(1990-2#2)(1991-12#4)(1992-12#3)(1993-11#2)(1993-3#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-8#1)
tyrphostin 23##2##2##(1992-12#2)
tyrphostin##4##1##(1992-12#4)
u##20##1##(1991-5#6)(1994-12#1)(1994-9#2)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2012-2#1)(2013-1#2)
u-PA and##2##2##(1993-12#1)(2008-4#1)
u-PA antigen##2##2##(1993-12#2)
u-PA##11##1##(1993-12#4)(1994-3#3)(2008-11#3)(2008-4#1)
u-shaped##2##1##(2008-7#1)(2012-12#1)
uM)##2##1##(2008-11#2)
uPA and the##2##3##(1990-12#1)(2008-11#1)
uPA by##2##2##(1990-12#1)(2008-11#1)
uPA that##2##2##(2008-11#2)
uPA##22##1##(1990-12#5)(1997-4#2)(2008-11#15)
uPA-IgG##5##1##(1997-4#5)
uPAR##2##1##(1997-4#2)
u])##3##1##(2012-12#3)
uberis##3##1##(1993-2#1)(1996-8#2)
ubidiai##3##1##(2008-5#3)
ubiquinone oxidoreductase##2##2##(1993-12#1)(2008-10#1)
ubiquinone##7##1##(1993-12#1)(1994-11#1)(1995-3#3)(1995-8#1)(2008-10#1)
ubiquitin ligase in the##2##4##(2009-10#1)(2013-1#1)
ubiquitin ligase##5##2##(2009-10#2)(2011-3#2)(2013-1#1)
ubiquitin ligases##5##2##(2009-10#1)(2012-12#1)(2013-1#3)
ubiquitin promoter##2##2##(2008-9#2)
ubiquitin protein##2##2##(1993-8#1)(1997-3#1)
ubiquitin##35##1##(1991-1#1)(1993-6#1)(1993-8#2)(1994-9#3)(1995-12#1)(1995-3#3)(1995-5#1)(1997-2#2)(1997-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#3)(2009-7#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#5)
ubiquitin-dependent proteasomal degradation##2##3##(2009-7#1)(2013-1#1)
ubiquitin-dependent##5##1##(1994-9#1)(1995-6#1)(2009-7#2)(2013-1#1)
ubiquitin-extension protein gene in##2##4##(1997-2#2)
ubiquitin-extension protein##3##2##(1997-2#3)
ubiquitin-like domain##2##2##(2009-7#2)
ubiquitin-like##5##1##(1993-6#1)(1993-8#1)(2008-4#1)(2009-7#2)
ubiquitin-mediated degradation##2##2##(1994-9#2)
ubiquitin-proteasome##7##1##(2008-9#5)(2011-2#1)(2012-3#1)
ubiquitin-protein conjugates##2##2##(1994-11#1)(2008-4#1)
ubiquitin-protein##4##1##(1994-11#1)(1995-6#2)(2008-4#1)
ubiquitination is##2##2##(2008-8#1)(2013-1#1)
ubiquitination##12##1##(2008-4#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2011-1#1)(2013-1#2)
ubiquitous and##3##2##(1993-8#1)(2008-10#1)(2008-8#1)
ubiquitous in the##4##3##(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)
ubiquitous in##14##2##(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
ubiquitous nature of the##2##4##(2008-10#1)(2008-7#1)
ubiquitous presence of##3##3##(1997-4#1)(2008-2#1)(2013-1#1)
ubiquitous presence##4##2##(1997-4#1)(2008-2#1)(2011-2#1)(2013-1#1)
ubiquitous protein##2##2##(2008-7#1)(2013-1#1)
ubiquitous##75##1##(1990-12#1)(1990-8#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1996-2#1)(1996-8#1)(1997-4#2)(2007-2#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
ubiquitously expressed and##2##3##(2008-4#1)(2013-8#1)
ubiquitously expressed##11##2##(1992-6#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
ubiquitously##19##1##(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-7#2)(1997-8#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-8#2)
ubiquity##2##1##(1993-3#1)(2008-9#1)
ubiquitylates Aurora-A##2##2##(2012-12#2)
ubiquitylation of##2##2##(2012-12#1)(2013-8#1)
ubiquitylation##3##1##(2012-12#2)(2013-8#1)
uda##3##1##(1991-9#3)
udder##2##1##(1990-6#1)(2011-2#1)
ug ml(-1)##3##2##(2008-11#3)
ugly##7##1##(1994-12#1)(2007-8#1)(2008-7#4)(2011-2#1)
uidA##4##1##(2008-10#2)(2008-5#1)(2008-8#1)
uk/##2##1##(2008-7#2)
ulcer =##3##2##(2008-5#3)
ulcer and##10##2##(1992-11#2)(2008-1#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
ulcer bleeding##3##2##(2012-2#2)(2013-1#1)
ulcer bleedings##2##2##(1992-5#2)
ulcer disease##16##2##(1992-9#2)(1993-2#1)(1996-11#1)(1997-1#3)(1997-3#1)(2007-7#1)(2008-5#4)(2009-8#1)(2010-12#1)(2011-2#1)
ulcer healing in the colon##2##5##(2008-12#2)
ulcer healing##6##2##(2008-12#2)(2012-2#4)
ulcer in a##3##3##(2010-4#1)(2011-2#1)(2012-2#1)
ulcer in##4##2##(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
ulcer is a##5##3##(1990-3#1)(1990-9#1)(1996-11#1)(2008-9#1)(2010-8#1)
ulcer is##10##2##(1990-3#1)(1990-9#1)(1992-11#1)(1993-6#1)(1996-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2010-8#1)(2013-1#1)
ulcer may be##2##3##(2008-12#1)(2011-2#1)
ulcer may##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
ulcer model##3##2##(2012-2#3)
ulcer of the##3##3##(1990-3#1)(2008-11#1)(2011-2#1)
ulcer of##4##2##(1990-11#1)(1990-3#1)(2008-11#1)(2011-2#1)
ulcer patients##5##2##(1992-9#1)(1997-1#2)(1997-3#1)(2008-5#1)
ulcer recurrence##2##2##(1991-8#1)(2012-1#1)
ulcer to##2##2##(2008-12#1)(2008-5#1)
ulcer was##5##2##(1992-6#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
ulcer wound##2##2##(2013-1#2)
ulcer##151##1##(1990-11#1)(1990-3#4)(1990-6#5)(1990-9#2)(1991-2#1)(1991-8#1)(1992-11#4)(1992-5#3)(1992-6#4)(1992-9#3)(1993-2#1)(1993-6#1)(1995-10#2)(1996-11#4)(1996-7#2)(1997-1#5)(1997-3#2)(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#13)(2008-5#13)(2008-7#1)(2008-8#2)(2008-9#7)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#6)(2010-8#2)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#7)(2013-1#7)
ulcer]##4##1##(1993-6#1)(1994-3#1)(1997-3#1)(2012-3#1)
ulcerated psoriatic plaques##2##3##(2012-2#2)
ulcerated##9##1##(1990-6#1)(2007-7#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-1#3)
ulceration in##3##2##(1991-8#1)(2012-2#1)(2013-1#1)
ulceration of the mouth in##2##5##(2008-5#1)(2012-2#1)
ulceration of##4##2##(1996-8#2)(2008-5#1)(2012-2#1)
ulceration##25##1##(1990-9#1)(1991-2#1)(1991-8#1)(1996-8#2)(1997-1#1)(2007-7#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-1#8)(2012-2#2)(2013-1#3)(2013-8#1)
ulcerations and##2##2##(2007-10#1)(2008-5#1)
ulcerations##5##1##(1992-2#1)(2007-10#2)(2007-12#1)(2008-5#1)
ulcerative colitis (UC)##4##3##(2010-12#2)(2011-2#1)(2013-8#1)
ulcerative colitis and##2##3##(1995-8#1)(2013-8#1)
ulcerative colitis are##2##3##(1996-2#1)(2012-12#1)
ulcerative colitis is##2##3##(1992-9#1)(2007-10#1)
ulcerative colitis on##2##3##(1995-10#1)(2012-12#1)
ulcerative colitis patients##2##3##(1992-9#1)(1994-2#1)
ulcerative colitis were##3##3##(1992-9#1)(1994-2#1)(1995-10#1)
ulcerative colitis##58##2##(1991-6#1)(1992-9#4)(1994-2#3)(1994-6#2)(1995-10#3)(1995-8#1)(1996-2#1)(1996-8#2)(1997-8#1)(2007-10#4)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#6)(2009-5#3)(2010-11#2)(2010-12#11)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
ulcerative colitis]##3##2##(1990-6#1)(1993-2#1)(2008-12#1)
ulcerative pancolitis##2##2##(2010-12#2)
ulcerative rectocolitis##3##2##(1990-3#1)(1992-3#2)
ulcerative##71##1##(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-3#3)(1992-9#4)(1993-2#1)(1994-2#3)(1994-6#2)(1995-10#3)(1995-8#1)(1996-2#1)(1996-8#2)(1997-8#1)(2007-10#4)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#6)(2009-5#3)(2010-11#2)(2010-12#15)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
ulcerogenic##2##1##(2011-1#2)
ulcers and##6##2##(1995-2#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
ulcers are##4##2##(1990-5#1)(2007-8#1)(2013-1#2)
ulcers at##2##2##(1995-3#1)(2012-2#1)
ulcers in the##2##3##(1990-11#1)(2010-12#1)
ulcers in##6##2##(1990-11#1)(2006-10#1)(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
ulcers of the##3##3##(1990-3#1)(1992-5#1)(2008-5#1)
ulcers of##4##2##(1990-3#1)(1992-5#1)(2008-5#1)(2012-2#1)
ulcers often##2##2##(1997-3#1)(2013-1#1)
ulcers that##2##2##(1991-11#1)(2013-1#1)
ulcers were##2##2##(1996-11#1)(2012-3#1)
ulcers##91##1##(1990-11#1)(1990-3#5)(1990-5#2)(1990-6#1)(1991-11#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-2#2)(1993-8#2)(1995-2#1)(1995-3#1)(1996-11#2)(1996-7#1)(1997-1#1)(1997-3#3)(2006-10#4)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#3)(2008-1#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#6)(2010-10#3)(2010-12#6)(2010-6#1)(2012-2#10)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#1)
ulcers]##3##1##(1990-5#1)(1993-8#2)
ulcus##2##1##(1992-5#2)
ulna in##4##2##(2007-8#1)(2011-2#2)(2013-8#1)
ulna was##2##2##(2007-8#2)
ulna##12##1##(1995-6#2)(2007-8#4)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
ulnar digits##2##2##(2008-9#2)
ulnar nerve compression##3##3##(2008-9#3)
ulnar nerve##15##2##(1992-6#2)(2008-12#1)(2008-9#11)(2011-2#1)
ulnar##32##1##(1992-6#2)(1997-3#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#18)(2010-11#1)(2011-2#2)(2013-8#1)
ulnar-positive##2##1##(2008-9#2)
ultimate carcinogen##2##2##(1990-11#1)(1995-5#1)
ultimate function##2##2##(2009-10#1)(2012-3#1)
ultimate goal is to##3##4##(1992-2#1)(2008-11#1)(2012-3#1)
ultimate goal is##4##3##(1992-1#1)(1992-2#1)(2008-11#1)(2012-3#1)
ultimate goal of##5##3##(2008-7#1)(2009-6#1)(2010-12#1)(2010-9#1)(2012-2#1)
ultimate goal##11##2##(1992-1#1)(1992-2#1)(2008-11#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
ultimate goals in##3##3##(2008-10#2)(2008-7#1)
ultimate goals##4##2##(2008-10#2)(2008-7#2)
ultimate outcome##3##2##(1991-12#1)(1997-3#1)(2008-11#1)
ultimate success of##2##3##(1996-12#1)(1997-1#1)
ultimate tensile strength##2##3##(2012-2#2)
ultimate##77##1##(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#1)(1997-1#2)(1997-3#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)
ultimately a##2##2##(2008-7#1)(2009-10#1)
ultimately be used##2##3##(1992-12#1)(2011-2#1)
ultimately be##5##2##(1992-12#1)(1993-2#1)(1994-5#1)(2010-8#1)(2011-2#1)
ultimately help to##2##3##(2008-4#1)(2009-5#1)
ultimately lead to##4##3##(1997-1#1)(2009-10#1)(2011-2#1)(2013-1#1)
ultimately leading to##4##3##(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
ultimately leading##5##2##(2007-2#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
ultimately leads to##4##3##(1993-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
ultimately progress to##2##3##(2009-8#1)(2011-2#1)
ultimately require##2##2##(1994-7#1)(2009-3#1)
ultimately result in##2##3##(1991-12#1)(2011-2#1)
ultimately resulting in##2##3##(2010-11#1)(2011-2#1)
ultimately results in##2##3##(2008-8#1)(2010-3#1)
ultimately results##3##2##(2008-7#1)(2008-8#1)(2010-3#1)
ultimately to the##2##3##(2008-11#1)(2009-8#1)
ultimately to##6##2##(1994-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
ultimately will##2##2##(1992-12#1)(2012-2#1)
ultimately##144##1##(1990-3#1)(1991-12#1)(1992-10#1)(1992-12#2)(1993-1#2)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#7)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
ultimobranchial##2##1##(1990-12#1)(2008-5#1)
ultimum and##5##2##(2008-10#5)
ultimum on##3##2##(2008-10#3)
ultimum var##6##2##(2008-10#6)
ultimum##40##1##(2008-10#40)
ultra high##5##2##(1992-3#2)(2008-10#1)(2009-3#1)(2010-4#1)
ultra performance liquid chromatography-electrospray##2##4##(2011-1#1)(2012-3#1)
ultra performance liquid##8##3##(2011-1#6)(2012-3#2)
ultra trace amounts of##9##4##(2008-10#9)
ultra trace analysis##3##3##(2008-10#3)
ultra trace##22##2##(2008-10#22)
ultra violet radiation##2##3##(2008-1#1)(2008-9#1)
ultra violet##5##2##(2008-1#2)(2008-10#1)(2008-9#1)(2010-5#1)
ultra##50##1##(1992-3#3)(1992-6#1)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#6)(2012-3#2)
ultra-dilute solutions##2##2##(2008-10#2)
ultra-high resolution##2##2##(2011-7#2)
ultra-high##10##1##(1994-3#1)(2008-10#2)(2008-11#1)(2011-7#2)(2012-1#1)(2012-2#1)(2013-1#2)
ultra-low doses of##2##3##(2012-1#1)(2013-1#1)
ultra-low protein##2##2##(2008-11#2)
ultra-low##4##1##(2008-11#2)(2012-1#1)(2013-1#1)
ultra-pure water and##2##3##(2008-10#2)
ultra-pure water##3##2##(2008-10#3)
ultra-pure##5##1##(2008-10#5)
ultra-sensitive##5##1##(2008-10#4)(2009-12#1)
ultra-slow##3##1##(2011-2#3)
ultra-thin layer of##2##3##(1991-5#2)
ultra-thin layer##3##2##(1991-5#3)
ultra-trace amounts of Cr(VI)##2##4##(2008-10#2)
ultra-trace levels of##3##3##(2008-10#3)
ultra-trace##18##1##(2008-10#18)
ultra-violet absorption##2##2##(2007-2#1)(2008-10#1)
ultra-violet##4##1##(2007-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
ultrabrief bilateral ECT##2##3##(2012-12#2)
ultrabrief pulse##4##2##(2012-12#4)
ultrabrief##7##1##(2012-12#7)
ultrabroadband##7##1##(2007-11#3)(2007-12#3)(2008-3#1)
ultracentrifugation and##2##2##(2008-11#1)(2011-2#1)
ultracentrifugation##17##1##(1990-8#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
ultracold atoms##3##2##(2007-11#2)(2007-12#1)
ultracold##4##1##(2007-11#2)(2007-12#1)(2012-2#1)
ultracompact##2##1##(2007-12#2)
ultraendurance runners##4##2##(2013-8#4)
ultraendurance##5##1##(2013-8#5)
ultrafast all-optical##5##2##(2007-12#4)(2008-3#1)
ultrafast infrared##2##2##(2007-11#1)(2008-8#1)
ultrafast laser pulses and##2##4##(2007-11#2)
ultrafast laser##9##2##(2007-11#6)(2007-12#1)(2008-3#2)
ultrafast optical data##2##3##(2007-12#1)(2008-3#1)
ultrafast optical##11##2##(2007-11#1)(2007-12#8)(2008-3#2)
ultrafast phase##2##2##(2007-11#1)(2007-12#1)
ultrafast pulse##2##2##(2007-11#1)(2007-12#1)
ultrafast pulsed##2##2##(2007-12#1)(2008-2#1)
ultrafast signal##2##2##(2007-11#1)(2008-2#1)
ultrafast spectroscopy##2##2##(2007-11#1)(2008-3#1)
ultrafast walk-off-free##2##2##(2007-11#2)
ultrafast##89##1##(1997-8#1)(2007-11#26)(2007-12#32)(2008-10#1)(2008-2#5)(2008-3#17)(2008-7#1)(2008-8#1)(2009-6#1)(2012-8#4)
ultrafiltered urines##2##2##(2008-12#2)
ultrafiltered##3##1##(2008-12#2)(2008-2#1)
ultrafiltrate##9##1##(1994-2#2)(2008-1#2)(2008-11#2)(2010-5#1)(2011-1#1)(2011-2#1)
ultrafiltration and##5##2##(1992-3#1)(2008-10#3)(2008-6#1)
ultrafiltration in##2##2##(2008-1#1)(2008-10#1)
ultrafiltration is##2##2##(2008-10#2)
ultrafiltration membrane##3##2##(2008-10#3)
ultrafiltration membranes##2##2##(1992-3#1)(2011-2#1)
ultrafiltration method##2##2##(1993-12#1)(1995-12#1)
ultrafiltration methods##2##2##(1993-12#1)(2008-10#1)
ultrafiltration of##2##2##(2007-12#1)(2011-2#1)
ultrafiltration or##2##2##(1996-5#1)(2008-7#1)
ultrafiltration process##2##2##(2008-10#2)
ultrafiltration rate##2##2##(2008-1#1)(2011-1#1)
ultrafiltration rates up to 200%##2##5##(2008-1#2)
ultrafiltration rates##3##2##(2008-1#3)
ultrafiltration was##3##2##(2008-1#2)(2013-8#1)
ultrafiltration##82##1##(1990-8#2)(1992-3#3)(1993-12#5)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2007-12#5)(2007-9#1)(2008-1#9)(2008-10#33)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
ultrafine##2##1##(2008-11#1)(2013-8#1)
ultrahigh vacuum##4##2##(1990-11#1)(2008-7#1)(2012-1#1)(2013-8#1)
ultrahigh##10##1##(1990-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
ultrahigh-numerical-aperture fiber##2##2##(2007-11#2)
ultrahigh-numerical-aperture##3##1##(2007-11#2)(2008-3#1)
ultrahigh-resolution##2##1##(2008-3#1)(2011-1#1)
ultralow frequency##2##2##(2008-9#2)
ultralow##7##1##(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-4#1)
ultralow-noise##2##1##(2007-11#2)
ultramarathon##6##1##(2013-8#6)
ultramarine##2##1##(2008-10#2)
ultramicroelectrode was##2##2##(2008-10#2)
ultramicroelectrode##5##1##(1995-6#1)(2008-10#4)
ultramicrosensors based on electropolymerized films of##2##6##(2008-10#2)
ultramicrosensors##4##1##(2008-10#4)
ultraprecision##2##1##(2008-3#2)
ultrapure dialysate##2##2##(2008-1#2)
ultrapure water##4##2##(2008-1#1)(2008-10#3)
ultrapure##6##1##(2008-1#3)(2008-10#3)
ultrapurified water##2##2##(2008-10#2)
ultrarapid metabolizers##2##2##(2008-10#2)
ultrarapid##4##1##(2008-10#4)
ultrasensitive##11##1##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2009-5#1)(2010-5#1)(2012-2#1)
ultrashort laser pulses by##2##4##(2007-11#1)(2008-2#1)
ultrashort laser pulses from##2##4##(2007-11#1)(2007-12#1)
ultrashort laser pulses in##2##4##(2007-11#1)(2008-3#1)
ultrashort laser pulses##12##3##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#4)(2012-2#1)
ultrashort laser##14##2##(2007-11#5)(2007-12#2)(2008-2#2)(2008-3#4)(2012-2#1)
ultrashort light pulses##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
ultrashort optical pulses##10##3##(2007-11#4)(2007-12#5)(2008-2#1)
ultrashort optical##14##2##(2007-11#6)(2007-12#5)(2008-2#1)(2008-3#2)
ultrashort pulse##8##2##(2007-11#2)(2007-12#2)(2008-3#4)
ultrashort pulsed##2##2##(2007-12#1)(2008-3#1)
ultrashort pulses from a##2##4##(2007-12#1)(2008-3#1)
ultrashort pulses##18##2##(2007-11#4)(2007-12#11)(2008-3#2)(2012-2#1)
ultrashort soliton##3##2##(2007-11#2)(2007-12#1)
ultrashort##79##1##(2007-11#28)(2007-12#30)(2008-2#4)(2008-3#15)(2012-2#2)
ultrashort-pulse##7##1##(2007-11#4)(2007-12#1)(2008-2#2)
ultrasmall pores##2##2##(2007-12#2)
ultrasmall##6##1##(1995-3#1)(2007-11#2)(2007-12#2)(2010-4#1)
ultrasonic agitation and vortex mixing##2##5##(2008-10#2)
ultrasonic agitation##4##2##(2008-10#4)
ultrasonic amplitude##2##2##(2007-11#1)(2008-10#1)
ultrasonic and##7##2##(1991-1#1)(1993-2#1)(2008-5#1)(2012-1#2)(2013-1#2)
ultrasonic assisted##2##2##(2008-10#2)
ultrasonic bath and##3##3##(2008-10#3)
ultrasonic bath##12##2##(2008-10#12)
ultrasonic beam was focused into##2##5##(2007-12#1)(2008-3#1)
ultrasonic beam##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
ultrasonic cavitation##2##2##(2013-8#2)
ultrasonic echo##2##2##(2010-8#1)(2012-3#1)
ultrasonic extraction and##3##3##(2008-10#2)(2013-8#1)
ultrasonic extraction##4##2##(2008-10#3)(2013-8#1)
ultrasonic field to the##2##4##(2007-12#1)(2008-2#1)
ultrasonic field##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
ultrasonic inhaler##3##2##(1993-2#3)
ultrasonic irradiation##2##2##(2008-10#1)(2008-5#1)
ultrasonic method##4##2##(1997-6#2)(2008-10#1)(2008-5#1)
ultrasonic nebulization##8##2##(1991-1#1)(2008-10#7)
ultrasonic nebulizer##6##2##(1991-1#3)(1993-2#2)(2008-10#1)
ultrasonic nebulizers##3##2##(1991-1#1)(1993-2#1)(1996-2#1)
ultrasonic power of 50W and the cavitation time of 15##2##10##(2013-8#2)
ultrasonic power##4##2##(2008-10#1)(2013-8#3)
ultrasonic scalpel##4##2##(2007-8#1)(2010-8#3)
ultrasonic slurry sampling electrothermal##2##4##(2008-10#2)
ultrasonic slurry sampling##4##3##(2008-10#4)
ultrasonic slurry##5##2##(2008-10#5)
ultrasonic surface displacements##3##3##(2007-11#3)
ultrasonic transducer##2##2##(1990-9#1)(2008-3#1)
ultrasonic treatment##3##2##(1993-2#2)(2009-12#1)
ultrasonic vocalization##4##2##(1994-8#3)(2008-4#1)
ultrasonic##146##1##(1990-12#1)(1990-2#3)(1990-9#2)(1991-1#6)(1992-11#1)(1993-2#10)(1994-8#3)(1994-9#1)(1996-2#1)(1997-6#3)(2007-11#8)(2007-12#7)(2007-8#2)(2008-10#55)(2008-11#6)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#4)(2009-12#1)(2009-5#1)(2010-8#5)(2011-2#1)(2012-1#2)(2012-3#5)(2013-1#2)(2013-8#6)
ultrasonic-assisted extraction of##2##3##(2008-10#2)
ultrasonic-assisted extraction##5##2##(2008-10#4)(2011-1#1)
ultrasonic-assisted##6##1##(2008-10#5)(2011-1#1)
ultrasonic-based sample treatment##2##3##(2008-10#2)
ultrasonically guided percutaneous##2##3##(1991-2#1)(2007-8#1)
ultrasonically##4##1##(1991-2#1)(2007-8#1)(2008-11#1)(2012-3#1)
ultrasonication##7##1##(1997-2#1)(2008-10#5)(2010-4#1)
ultrasonogram##2##1##(2007-10#1)(2008-5#1)
ultrasonographic findings##2##2##(1997-7#1)(2008-12#1)
ultrasonographic images##3##2##(2007-10#2)(2008-10#1)
ultrasonographic##17##1##(1990-9#2)(1991-12#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
ultrasonographically##2##1##(2007-11#1)(2007-8#1)
ultrasonography (EUS)##4##2##(1990-9#1)(2008-2#2)(2013-1#1)
ultrasonography (US)##3##2##(2008-1#1)(2010-12#1)(2012-2#1)
ultrasonography and##10##2##(1990-5#1)(1993-9#1)(2007-5#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
ultrasonography as##2##2##(1991-6#1)(1996-11#1)
ultrasonography at##3##2##(1995-6#1)(2010-4#1)(2011-1#1)
ultrasonography for##2##2##(2010-11#1)(2012-3#1)
ultrasonography in the##2##3##(1990-9#1)(2007-8#1)
ultrasonography in##11##2##(1990-9#1)(1992-5#1)(1992-9#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
ultrasonography is##3##2##(1990-9#1)(1994-6#1)(2011-2#1)
ultrasonography of the##2##3##(2008-12#1)(2008-7#1)
ultrasonography of##4##2##(1994-5#2)(2008-12#1)(2008-7#1)
ultrasonography or##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
ultrasonography revealed##3##2##(1996-3#1)(2007-5#1)(2008-5#1)
ultrasonography showed##2##2##(1996-11#1)(2007-8#1)
ultrasonography studies##2##2##(2011-2#1)(2012-12#1)
ultrasonography was##2##2##(1996-11#1)(2011-1#1)
ultrasonography##91##1##(1990-2#1)(1990-5#2)(1990-9#4)(1991-11#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#2)(1995-6#1)(1996-11#3)(1996-2#1)(1996-3#3)(1997-8#2)(2007-10#1)(2007-11#2)(2007-5#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)
ultrasonography]##2##1##(1992-6#1)(2013-8#1)
ultrasound (CEUS) in##2##3##(2008-7#1)(2012-2#1)
ultrasound (CEUS)##6##2##(2008-7#1)(2010-12#2)(2012-2#3)
ultrasound (EUS)##3##2##(2008-2#1)(2010-12#1)(2013-1#1)
ultrasound (US) and##2##3##(2010-12#1)(2013-1#1)
ultrasound (US)##6##2##(2008-9#1)(2010-12#3)(2011-2#1)(2013-1#1)
ultrasound amplitude##3##2##(2008-10#3)
ultrasound and magnetic resonance##2##4##(1994-2#1)(2010-5#1)
ultrasound and##18##2##(1992-2#1)(1994-2#1)(1994-5#1)(1995-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
ultrasound array##2##2##(2008-3#2)
ultrasound assisted pseudo-digestion##3##3##(2008-10#3)
ultrasound assisted##5##2##(2008-10#5)
ultrasound bath##2##2##(2008-10#2)
ultrasound can##3##2##(2008-7#1)(2011-2#2)
ultrasound contrast##3##2##(2008-8#1)(2012-2#2)
ultrasound detection##3##2##(2007-11#1)(2009-5#2)
ultrasound device##2##2##(2008-5#1)(2008-8#1)
ultrasound energy##4##2##(2008-10#4)
ultrasound examination of the##3##4##(1990-9#1)(2007-11#2)
ultrasound examination##17##2##(1990-9#2)(1991-6#1)(1993-5#1)(1994-6#1)(1995-8#1)(1996-11#3)(1997-8#1)(2007-11#3)(2011-2#1)(2012-3#2)(2013-1#1)
ultrasound examinations were performed##2##4##(2007-7#1)(2008-4#1)
ultrasound examinations##4##2##(2007-11#1)(2007-4#1)(2007-7#1)(2008-4#1)
ultrasound field##2##2##(2008-10#1)(2008-3#1)
ultrasound finding##2##2##(2013-1#2)
ultrasound findings##4##2##(1996-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
ultrasound for##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2009-5#1)
ultrasound frequency##4##2##(2008-10#4)
ultrasound guidance for##2##3##(1992-12#1)(2008-1#1)
ultrasound guidance##6##2##(1992-12#1)(2008-1#3)(2008-11#1)(2012-2#1)
ultrasound guided##5##2##(1993-3#1)(1996-3#1)(2007-9#1)(2008-11#1)(2009-7#1)
ultrasound has##5##2##(1991-6#1)(2007-7#1)(2008-7#2)(2012-2#1)
ultrasound images##2##2##(1996-1#1)(2007-11#1)
ultrasound imaging in##3##3##(2008-5#1)(2010-12#2)
ultrasound imaging##4##2##(2008-3#1)(2008-5#1)(2010-12#2)
ultrasound in a##2##3##(2012-3#1)(2013-1#1)
ultrasound in the evaluation of##3##5##(2009-6#1)(2013-1#2)
ultrasound in the presence of the photosensitizing drug Photofrin II##2##10##(1993-8#2)
ultrasound in the##10##3##(1990-2#1)(1993-8#2)(2008-2#1)(2009-6#3)(2010-12#1)(2013-1#2)
ultrasound in##29##2##(1990-2#1)(1992-6#1)(1993-8#3)(1994-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#3)(2009-6#3)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-5#1)(2012-2#2)(2012-3#2)(2013-1#4)
ultrasound is##6##2##(2007-8#1)(2008-10#1)(2008-7#2)(2012-2#1)(2012-3#1)
ultrasound markers for fetal##2##4##(1996-12#2)
ultrasound markers##3##2##(1996-12#3)
ultrasound of the##3##3##(1997-8#1)(2012-2#1)(2013-8#1)
ultrasound of##4##2##(1997-8#1)(2008-7#1)(2012-2#1)(2013-8#1)
ultrasound on the##2##3##(2008-10#1)(2011-2#1)
ultrasound on##5##2##(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
ultrasound or##7##2##(1994-9#1)(2007-8#2)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
ultrasound probes##2##2##(1992-12#1)(2009-12#1)
ultrasound pulses##2##2##(2008-3#2)
ultrasound scan##9##2##(1990-2#1)(1995-10#1)(1997-3#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
ultrasound scanning was##2##3##(2008-4#1)(2008-7#1)
ultrasound scanning##6##2##(1992-11#1)(1994-7#1)(1996-1#1)(2007-2#1)(2008-4#1)(2008-7#1)
ultrasound scans##3##2##(1994-7#1)(2011-2#1)(2013-7#1)
ultrasound screening##5##2##(1994-6#1)(2007-7#1)(2008-11#1)(2010-4#1)(2012-3#1)
ultrasound shear##3##2##(2008-5#3)
ultrasound showed##3##2##(2007-7#1)(2007-8#1)(2009-6#1)
ultrasound studies##2##2##(1990-5#1)(1996-8#1)
ultrasound to##7##2##(1992-12#1)(1992-5#1)(1993-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2011-2#1)
ultrasound transducers##4##2##(2008-3#1)(2010-8#3)
ultrasound was##5##2##(2008-1#1)(2009-3#1)(2010-12#1)(2013-1#2)
ultrasound while##2##2##(2008-3#1)(2013-8#1)
ultrasound with##4##2##(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
ultrasound##385##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-5#2)(1990-9#3)(1991-3#1)(1991-6#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-8#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#6)(1994-7#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#2)(1996-8#1)(1997-3#2)(1997-8#4)(2007-10#1)(2007-11#8)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#15)(2007-9#1)(2008-1#10)(2008-10#48)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#16)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#27)(2008-8#12)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#9)(2009-6#6)(2009-7#3)(2009-8#1)(2010-12#14)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#1)(2011-2#20)(2011-5#1)(2012-1#1)(2012-12#3)(2012-2#18)(2012-3#13)(2013-1#26)(2013-7#1)(2013-8#5)
ultrasound-assisted acid leaching##3##3##(2008-10#3)
ultrasound-assisted extraction and microwave-assisted digestion##2##5##(2008-10#2)
ultrasound-assisted extraction and##3##3##(2008-10#3)
ultrasound-assisted extraction procedure##2##3##(2008-10#2)
ultrasound-assisted extraction##11##2##(2008-10#9)(2013-1#2)
ultrasound-assisted pseudo-digestion##2##2##(2008-10#2)
ultrasound-assisted##19##1##(2008-10#17)(2013-1#2)
ultrasound-guided hookwire##2##2##(2007-8#2)
ultrasound-guided percutaneous##2##2##(1993-11#1)(2008-1#1)
ultrasound-guided regional anesthesia##3##3##(2012-2#3)
ultrasound-guided##19##1##(1991-2#1)(1993-11#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-8#1)(2009-4#1)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#2)
ultrasound-modulated optical tomography in biological tissue##2##6##(2007-12#1)(2008-3#1)
ultrasound-modulated optical tomography##3##3##(2007-12#1)(2008-3#2)
ultrasound-modulated##5##1##(2007-12#2)(2008-3#3)
ultrasound]##4##1##(1996-3#1)(1996-6#1)(2012-2#1)(2013-1#1)
ultrasounds##5##1##(1994-7#1)(1994-8#1)(2008-10#2)(2008-5#1)
ultrastructural alterations##2##2##(2008-10#1)(2008-5#1)
ultrastructural analysis##4##2##(1990-12#1)(1996-9#1)(2008-7#1)(2008-9#1)
ultrastructural and biochemical##2##3##(2008-10#1)(2008-7#1)
ultrastructural and##6##2##(1992-3#1)(1992-8#1)(2007-12#1)(2008-10#2)(2008-7#1)
ultrastructural changes in the##2##4##(2008-12#1)(2011-1#1)
ultrastructural changes in##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
ultrastructural changes##11##2##(1994-5#2)(1995-6#1)(2008-10#6)(2008-12#1)(2011-1#1)
ultrastructural characteristics##2##2##(2008-5#1)(2010-8#1)
ultrastructural evidence##2##2##(1997-2#1)(2009-7#1)
ultrastructural examination##4##2##(1992-2#1)(1992-9#1)(2007-12#1)(2008-11#1)
ultrastructural features consistent with##2##4##(2010-11#2)
ultrastructural features of the##6##4##(1991-8#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-4#1)
ultrastructural features of##8##3##(1991-8#1)(1992-8#1)(2007-12#2)(2008-5#2)(2008-7#1)(2010-4#1)
ultrastructural features##12##2##(1991-8#1)(1992-12#1)(1992-8#1)(2007-12#2)(2008-5#2)(2008-7#2)(2010-11#2)(2010-4#1)
ultrastructural investigation on four species##2##5##(2007-12#2)
ultrastructural investigation##4##2##(2007-12#2)(2008-10#1)(2008-7#1)
ultrastructural level##5##2##(1995-6#1)(2008-10#1)(2008-7#2)(2011-2#1)
ultrastructural localization of##3##3##(1992-3#1)(2008-5#1)(2011-2#1)
ultrastructural morphology of the##2##4##(2007-12#1)(2008-7#1)
ultrastructural morphology##3##2##(2007-12#1)(2008-7#2)
ultrastructural observations##2##2##(2008-5#1)(2011-2#1)
ultrastructural organization##2##2##(2008-7#1)(2009-11#1)
ultrastructural studies on##2##3##(2008-5#1)(2008-7#1)
ultrastructural studies##10##2##(1992-2#1)(1992-8#1)(1993-11#1)(1994-8#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#2)
ultrastructural study of the##2##4##(2008-7#2)
ultrastructural study of##4##3##(1994-6#1)(2008-5#1)(2008-7#2)
ultrastructural study##9##2##(1993-11#1)(1994-6#1)(2008-10#1)(2008-5#2)(2008-7#3)(2009-7#1)
ultrastructural##101##1##(1990-12#1)(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#3)(1992-9#1)(1993-11#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#9)(2007-5#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#11)(2008-6#1)(2008-7#20)(2008-9#2)(2009-11#1)(2009-7#2)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)
ultrastructurally investigated##2##2##(2008-10#2)
ultrastructurally##10##1##(1991-6#1)(1991-8#1)(1994-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
ultrastructure and##6##2##(1995-6#1)(2007-12#4)(2008-10#1)
ultrastructure of spermatozoa##2##3##(2007-12#1)(2008-7#1)
ultrastructure of the##7##3##(1994-9#1)(2007-12#4)(2008-12#1)(2008-5#1)
ultrastructure of##30##2##(1994-9#1)(2007-12#8)(2008-10#2)(2008-12#1)(2008-5#4)(2008-7#10)(2008-8#1)(2009-10#2)(2010-12#1)
ultrastructure##47##1##(1994-9#1)(1995-6#1)(2007-12#14)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2010-12#2)(2012-2#1)
ultrathin films##3##2##(2006-4#1)(2008-10#1)(2008-12#1)
ultrathin polymer films##2##3##(2008-10#2)
ultrathin polymer##3##2##(2008-10#3)
ultrathin sections of##2##3##(2008-10#1)(2008-7#1)
ultrathin sections##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
ultrathin##22##1##(1990-4#1)(1997-2#2)(2006-4#2)(2007-2#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-4#1)
ultratrace amounts of Hg(II)##2##4##(2008-10#2)
ultratrace amounts of##8##3##(2008-10#8)
ultratrace analysis##2##2##(2008-10#2)
ultratrace##17##1##(2008-10#16)(2008-3#1)
ultraviolet (UV) laser##2##3##(2008-3#1)(2008-5#1)
ultraviolet (UV) light##2##3##(1991-6#1)(1997-4#1)
ultraviolet (UV) radiation##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
ultraviolet (UV)##15##2##(1991-6#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#6)(2011-2#1)
ultraviolet (UV)-induced##2##2##(2008-10#1)(2008-5#1)
ultraviolet A##2##2##(1990-9#1)(2008-5#1)
ultraviolet B##4##2##(2008-5#2)(2011-1#2)
ultraviolet absorbance##4##2##(2008-10#3)(2008-7#1)
ultraviolet absorption##2##2##(1990-8#1)(2008-10#1)
ultraviolet and visible light##2##4##(2008-10#2)
ultraviolet and##6##2##(1992-3#1)(2007-11#1)(2008-10#3)(2011-2#1)
ultraviolet circular##2##2##(1992-8#1)(2008-10#1)
ultraviolet detection at##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
ultraviolet detection##15##2##(1996-5#1)(1997-2#1)(2008-10#11)(2008-5#1)(2011-2#1)
ultraviolet dielectric coatings##2##3##(2007-12#2)
ultraviolet dielectric##3##2##(2007-12#2)(2008-3#1)
ultraviolet for##2##2##(2008-3#2)
ultraviolet generation##2##2##(2008-2#1)(2008-3#1)
ultraviolet irradiation##9##2##(1992-6#1)(1993-3#1)(1995-11#1)(2008-10#2)(2008-3#2)(2010-8#1)(2013-1#1)
ultraviolet labelling##2##2##(2008-10#2)
ultraviolet laser radiation##2##3##(2007-11#1)(2008-10#1)
ultraviolet laser##8##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
ultraviolet light is##2##3##(2008-5#1)(2011-2#1)
ultraviolet light##22##2##(1991-8#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-9#2)(2010-8#1)(2011-2#1)(2013-8#1)
ultraviolet lithography##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
ultraviolet measurements##2##2##(2008-2#1)(2008-7#1)
ultraviolet or visible##2##3##(2008-10#2)
ultraviolet pulses##3##2##(2008-2#1)(2008-3#2)
ultraviolet radiation##17##2##(1994-8#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2011-2#3)
ultraviolet region##13##2##(1990-5#1)(2007-11#2)(2008-10#4)(2008-2#5)(2008-3#1)
ultraviolet solar spectra##2##3##(2008-3#2)
ultraviolet spectra##3##2##(2008-2#2)(2008-3#1)
ultraviolet spectrophotometry##2##2##(2008-10#2)
ultraviolet to the near infrared##2##5##(2007-11#1)(2008-3#1)
ultraviolet to the##4##3##(2007-11#1)(2008-3#3)
ultraviolet##220##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-8#1)(2007-11#18)(2007-12#19)(2008-10#46)(2008-11#3)(2008-2#30)(2008-3#42)(2008-5#20)(2008-7#2)(2008-9#2)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#8)(2013-1#1)(2013-8#1)
ultraviolet-B (UVB)##2##2##(2008-11#2)
ultraviolet-B##4##1##(2008-11#3)(2008-7#1)
ultraviolet-visible (UV-vis)##3##2##(2008-10#2)(2009-11#1)
ultraviolet-visible##14##1##(2007-12#1)(2008-10#8)(2008-2#4)(2009-11#1)
ultravoilet A (UVA)##2##3##(2008-5#2)
ultravoilet##3##1##(2008-5#3)
ultrawideband##3##1##(2007-12#3)
um in##2##2##(2010-11#2)
um##4##1##(1996-2#2)(2010-11#2)
umbilical arterial##2##2##(1990-11#1)(1994-5#1)
umbilical artery Doppler##2##3##(1994-3#1)(2011-2#1)
umbilical artery##6##2##(1990-8#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-11#1)(2011-2#1)
umbilical catheter##4##2##(2011-2#4)
umbilical cord arteries##4##3##(2009-8#4)
umbilical cord blood##7##3##(2008-11#2)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
umbilical cord vein##2##3##(2008-11#1)(2011-8#1)
umbilical cord##28##2##(1990-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-11#5)(2008-8#2)(2008-9#1)(2009-8#6)(2010-5#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
umbilical evagination of the bladder##2##5##(2008-10#2)
umbilical vein endothelial cells##28##4##(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
umbilical vein endothelial##31##3##(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)(2013-8#1)
umbilical vein##36##2##(1990-8#2)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1996-3#1)(1997-1#2)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)(2013-8#2)
umbilical veins##5##2##(1992-2#1)(1993-3#1)(1994-6#1)(2008-8#1)(2008-9#1)
umbilical venous##2##2##(1994-5#1)(2010-10#1)
umbilical##105##1##(1990-11#2)(1990-12#1)(1990-8#3)(1991-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2008-10#10)(2008-11#11)(2008-7#1)(2008-8#5)(2008-9#5)(2009-8#6)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#9)(2011-8#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
umbilicus##4##1##(2010-6#2)(2011-1#1)(2011-2#1)
umblical##2##1##(2011-2#2)
umbrella##17##1##(1992-6#2)(1994-9#2)(1997-8#3)(2008-1#1)(2008-12#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
umol/L##2##1##(2008-4#2)
un effet##2##2##(2008-5#2)
un syndrome##5##2##(2013-1#5)
un##27##1##(2008-10#1)(2008-11#3)(2008-5#3)(2009-4#1)(2011-2#2)(2013-1#17)
un- or underphosphorylated##2##3##(1996-2#2)
un- or##3##2##(1996-2#2)(2008-11#1)
un-treated##3##1##(2008-12#3)
unabated##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
unable to afford##3##3##(1994-12#1)(1997-6#1)(2008-11#1)
unable to demonstrate##6##3##(1991-2#1)(1995-12#1)(1996-12#1)(1997-3#1)(2008-8#1)(2009-9#1)
unable to detect any##2##4##(1996-2#1)(2008-5#1)
unable to establish##2##3##(2008-10#1)(2008-9#1)
unable to form##3##3##(1990-5#1)(1993-11#1)(2008-10#1)
unable to grow in##2##4##(1995-2#1)(2008-11#1)
unable to grow##3##3##(1995-2#1)(2008-11#1)(2008-6#1)
unable to identify##2##3##(2008-11#1)(2008-12#1)
unable to induce##2##3##(1992-9#1)(2008-10#1)
unable to infect##6##3##(2008-10#5)(2013-1#1)
unable to inhibit##3##3##(1991-8#1)(1995-6#1)(2008-6#1)
unable to penetrate the##2##4##(1996-9#1)(2008-10#1)
unable to penetrate##3##3##(1996-9#1)(2008-10#1)(2008-3#1)
unable to predict##2##3##(2008-2#1)(2012-2#1)
unable to prevent##2##3##(1995-5#1)(1997-7#1)
unable to provide##4##3##(1990-11#1)(2011-1#1)(2012-2#2)
unable to recognize##2##3##(1997-6#1)(2008-10#1)
unable to return##2##3##(2008-7#1)(2008-9#1)
unable to secrete##3##3##(1993-9#1)(2008-10#1)(2012-2#1)
unable to support##2##3##(2008-5#1)(2008-9#1)
unable to sustain the##2##4##(1990-2#1)(2012-2#1)
unable to synthesize##4##3##(1992-12#2)(2008-11#1)(2008-5#1)
unable to##138##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#3)(1997-7#2)(2007-12#3)(2008-1#4)(2008-10#21)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)
unable##141##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-6#3)(1997-7#2)(2007-12#3)(2008-1#4)(2008-10#21)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)
unacceptable and##2##2##(1992-2#1)(2008-7#1)
unacceptable cosmetic##2##2##(2007-8#1)(2008-5#1)
unacceptable for##2##2##(2007-12#1)(2008-10#1)
unacceptable in##3##2##(1996-8#1)(2008-6#1)(2013-1#1)
unacceptable##31##1##(1990-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#3)
unacceptably high##6##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#2)
unacceptably##7##1##(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#2)
unaccompanied by##2##2##(1993-6#1)(2012-2#1)
unaccounted for##2##2##(1994-5#1)(1997-3#1)
unaccounted##3##1##(1994-5#1)(1996-4#1)(1997-3#1)
unaccustomed to##2##2##(1991-2#1)(1994-3#1)
unaccustomed##3##1##(1991-2#1)(1994-3#1)(2008-5#1)
unacknowledged##3##1##(2008-11#1)(2009-9#1)(2010-10#1)
unaddressed##2##1##(2008-11#1)(2010-1#1)
unaffected by in vitro##2##4##(1993-12#1)(1997-4#1)
unaffected by the presence of##3##5##(1994-3#1)(2008-10#2)
unaffected by the presence##5##4##(1994-3#1)(2008-10#4)
unaffected by the##16##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-10#4)(2010-4#1)
unaffected by treatment with##2##4##(1991-12#1)(1995-12#1)
unaffected by##71##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#3)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-4#2)(1997-5#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-4#1)(2011-2#2)(2012-4#1)(2013-1#1)
unaffected children##2##2##(2007-2#2)
unaffected controls##2##2##(2013-1#2)
unaffected in##4##2##(1994-12#1)(1996-5#1)(2008-7#2)
unaffected individuals##2##2##(1997-5#1)(2008-9#1)
unaffected or##3##2##(1990-5#1)(1993-11#1)(2008-10#1)
unaffected##133##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#4)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#5)(1995-11#2)(1995-12#5)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-5#3)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-9#3)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#4)
unaltered after##2##2##(1994-2#1)(2012-2#1)
unaltered by##6##2##(1991-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-2#1)
unaltered##40##1##(1991-1#1)(1991-12#3)(1992-9#2)(1993-12#3)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-7#2)(2008-10#5)(2008-11#7)(2008-3#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
unambiguous determination of##3##3##(2008-10#1)(2008-3#2)
unambiguous##24##1##(1991-2#1)(1995-9#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
unambiguously identified##3##2##(1995-2#1)(2008-10#2)
unambiguously identifying##2##2##(2008-9#1)(2013-8#1)
unambiguously that the##2##3##(1991-3#1)(1997-7#1)
unambiguously that##3##2##(1991-3#1)(1997-7#1)(2008-10#1)
unambiguously the##2##2##(1995-12#1)(2006-4#1)
unambiguously##28##1##(1991-3#1)(1993-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2006-4#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2013-8#1)
unamended soil##2##2##(2008-10#2)
unamended##3##1##(2008-10#3)
unamplified##3##1##(2007-11#1)(2008-10#1)(2008-2#1)
unanesthetized rats##5##2##(1992-3#1)(1997-2#2)(1997-6#2)
unanesthetized##11##1##(1992-3#1)(1993-12#1)(1997-2#3)(1997-6#3)(2007-10#2)(2008-4#1)
unanimously##4##1##(1993-3#1)(1993-8#1)(1995-6#1)(2008-11#1)
unanswered questions are##2##3##(1995-12#1)(2012-2#1)
unanswered questions regarding the##2##4##(2008-1#1)(2011-2#1)
unanswered questions##11##2##(1993-8#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
unanswered##22##1##(1992-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
unanticipated##8##1##(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-2#1)
unapertured##2##1##(2008-3#2)
unapodized##3##1##(2008-2#2)(2008-3#1)
unappreciated##3##1##(1991-2#1)(2008-11#1)(2013-1#1)
unassisted##4##1##(1995-1#1)(2007-10#1)(2008-6#1)(2008-8#1)
unassociated with##3##2##(1994-6#1)(2007-10#1)(2008-7#1)
unattached##2##1##(2008-8#1)(2010-3#1)
unattainable##3##1##(2007-11#1)(2009-6#1)(2010-2#1)
unattended for##2##2##(2008-11#2)
unattended operation##3##2##(2008-10#2)(2008-2#1)
unattended stimulus##4##2##(2010-5#4)
unattended##18##1##(1995-3#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-8#1)(2008-9#1)(2010-5#5)
unattractive##3##1##(2007-12#2)(2008-9#1)
unauthorized##3##1##(1994-2#1)(1995-12#1)(1996-12#1)
unavailability of##6##2##(1991-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#2)
unavailability##9##1##(1991-9#1)(2008-1#1)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
unavailable to##2##2##(2008-11#1)(2012-12#1)
unavailable##15##1##(1995-1#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
unavoidable if##2##2##(2008-10#1)(2008-4#1)
unavoidable##14##1##(1997-4#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-5#1)(2012-3#1)
unavoidably##2##1##(2008-2#1)(2008-3#1)
unaware of the##3##3##(2008-6#1)(2010-5#1)(2011-2#1)
unaware of##6##2##(1995-12#1)(1997-2#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#1)
unaware##8##1##(1995-12#1)(1996-9#1)(1997-2#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
unbalanced Mach-Zehnder##2##2##(2007-12#1)(2008-2#1)
unbalanced translocations##2##2##(2010-1#2)
unbalanced##22##1##(1994-9#1)(1995-12#1)(1995-8#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
unbearable##2##1##(1993-9#1)(1996-3#1)
unbelievable##2##1##(1997-6#1)(2008-4#1)
unbiased estimates of##2##3##(1997-1#1)(2010-3#1)
unbiased estimates##3##2##(1997-1#1)(2008-3#1)(2010-3#1)
unbiased##26##1##(1990-11#1)(1991-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)
unbleached##3##1##(2008-1#2)(2008-6#1)
unblinded##2##1##(1994-2#1)(1996-12#1)
unborn child##3##2##(2008-2#2)(2013-1#1)
unborn##4##1##(2008-11#1)(2008-2#2)(2013-1#1)
unbound##20##1##(1990-12#2)(1990-3#1)(1991-2#1)(1993-12#1)(1994-8#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)
unbounded##3##1##(2008-8#2)(2009-5#1)
unbranched neurons##3##2##(2007-12#3)
unbranched##9##1##(1994-5#1)(2007-12#5)(2008-5#1)(2010-10#1)(2010-11#1)
unbuffered##3##1##(2008-10#2)(2009-12#1)
unc-104 and unc-116##2##3##(1995-3#2)
unc-86 protein is##3##3##(1990-11#3)
unc-86 protein##5##2##(1990-11#5)
unc-86##10##1##(1990-11#10)
uncalibrated phase##2##2##(2008-3#2)
uncalibrated##7##1##(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)
uncapped RNAs##3##2##(2008-10#2)(2008-9#1)
uncapped viral RNAs##2##3##(2008-10#2)
uncapped##9##1##(2008-10#6)(2008-9#1)(2009-6#1)(2010-2#1)
uncemented##7##1##(2007-11#2)(2008-8#1)(2009-3#1)(2009-4#1)(2012-12#1)(2013-1#1)
uncensored data##3##2##(1995-9#3)
uncertain about the##2##3##(2008-8#1)(2012-2#1)
uncertain and##3##2##(1992-1#1)(2008-5#1)(2008-8#1)
uncertain in the##2##3##(2010-12#1)(2012-2#1)
uncertain##76##1##(1990-3#1)(1990-9#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)
uncertainties are##2##2##(2008-10#1)(2008-3#1)
uncertainties associated with this##2##4##(2008-2#2)
uncertainties associated with##4##3##(2008-2#3)(2008-3#1)
uncertainties associated##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
uncertainties concerning##2##2##(1994-5#1)(2013-8#1)
uncertainties for##2##2##(2008-10#1)(2008-3#1)
uncertainties in speciation##2##3##(2008-10#2)
uncertainties in the##12##3##(1995-6#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#8)
uncertainties in##22##2##(1995-6#1)(1997-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#11)(2008-5#1)
uncertainties involved in the##2##4##(2008-2#1)(2008-3#1)
uncertainties involved in##4##3##(2008-2#2)(2008-3#1)(2009-11#1)
uncertainties of the##2##3##(2007-12#1)(2008-3#1)
uncertainties of##3##2##(2007-12#1)(2008-3#2)
uncertainties on the##2##3##(1993-9#1)(2008-10#1)
uncertainties on##3##2##(1993-9#1)(2008-10#2)
uncertainties still##2##2##(2008-11#1)(2008-7#1)
uncertainties that are due to##2##5##(2008-3#2)
uncertainties##79##1##(1991-12#1)(1992-12#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-4#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#9)(2008-3#37)(2008-5#1)(2008-7#1)(2009-11#3)(2011-2#1)(2013-8#1)
uncertainty U##2##2##(2008-10#2)
uncertainty about the##7##3##(1992-9#1)(1994-1#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
uncertainty about##12##2##(1992-9#1)(1994-1#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#2)(2013-8#1)
uncertainty analysis of##2##3##(2008-2#1)(2008-3#1)
uncertainty and##10##2##(1995-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
uncertainty are##3##2##(2008-10#3)
uncertainty as to##3##3##(1990-6#1)(2008-8#1)(2009-8#1)
uncertainty as##4##2##(1990-6#1)(2008-11#1)(2008-8#1)(2009-8#1)
uncertainty associated with the##6##4##(2008-10#4)(2008-3#1)(2009-11#1)
uncertainty associated with##7##3##(2008-10#5)(2008-3#1)(2009-11#1)
uncertainty associated##8##2##(2008-10#6)(2008-3#1)(2009-11#1)
uncertainty budget##4##2##(2008-10#4)
uncertainty for the##2##3##(2008-10#1)(2008-3#1)
uncertainty for##5##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
uncertainty in parameter##2##3##(2008-10#2)
uncertainty in the##13##3##(2008-10#2)(2008-2#2)(2008-3#5)(2008-7#2)(2009-11#1)(2013-1#1)
uncertainty in volumetric operations##2##4##(2008-10#2)
uncertainty in##40##2##(1992-5#1)(1996-12#1)(1996-3#1)(2008-10#12)(2008-2#3)(2008-3#8)(2008-7#4)(2009-11#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
uncertainty intervals##6##2##(2008-10#6)
uncertainty introduced by the##2##4##(1992-6#1)(2008-3#1)
uncertainty is##9##2##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#1)
uncertainty of 0##5##3##(2006-4#1)(2008-2#1)(2008-3#3)
uncertainty of 1##2##3##(2008-2#1)(2008-3#1)
uncertainty of analytical assays##3##4##(2008-10#3)
uncertainty of less than 0##2##5##(2008-10#1)(2008-3#1)
uncertainty of less than##3##4##(2008-10#1)(2008-3#2)
uncertainty of the analytical##2##4##(2008-10#2)
uncertainty of the##16##3##(1992-5#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#5)(2012-12#3)
uncertainty of##49##2##(1992-5#1)(1992-9#1)(1994-1#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#12)(2008-2#7)(2008-3#18)(2012-12#3)
uncertainty on the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
uncertainty on##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
uncertainty regarding##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
uncertainty remains##2##2##(1992-1#1)(2008-8#1)
uncertainty score threshold##2##3##(2009-8#2)
uncertainty score##4##2##(2009-8#4)
uncertainty source##2##2##(2008-10#1)(2008-3#1)
uncertainty to##2##2##(1996-3#1)(2008-2#1)
uncertainty tolerance in##2##3##(2008-5#2)
uncertainty was##2##2##(2008-2#2)
uncertainty when##3##2##(2008-8#1)(2009-12#1)(2009-7#1)
uncertainty with##3##2##(2008-12#1)(2009-8#1)(2010-10#1)
uncertainty##274##1##(1990-6#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#2)(1992-6#3)(1992-9#3)(1993-12#2)(1993-3#4)(1994-1#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#6)(2007-12#4)(2007-9#1)(2008-10#74)(2008-11#7)(2008-12#5)(2008-2#23)(2008-3#50)(2008-5#2)(2008-7#12)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#10)(2012-1#2)(2012-12#8)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
uncertified home care agencies##2##4##(1995-3#2)
uncertified seeds##3##2##(2008-12#3)
uncertified##6##1##(1995-3#2)(2008-12#3)(2013-8#1)
unchallenged##2##1##(1995-3#1)(2008-7#1)
unchanged after##2##2##(1990-6#1)(1995-12#1)
unchanged as##2##2##(2008-10#1)(2012-3#1)
unchanged at##3##2##(1996-12#1)(2007-8#1)(2008-7#1)
unchanged by the##2##3##(1991-12#1)(2008-10#1)
unchanged by##6##2##(1991-12#1)(1991-2#1)(1996-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
unchanged during the##3##3##(1992-12#1)(2008-5#1)(2008-7#1)
unchanged during##5##2##(1992-12#1)(1992-6#1)(1995-2#1)(2008-5#1)(2008-7#1)
unchanged for##7##2##(1991-11#1)(1992-6#1)(1995-8#1)(1996-12#1)(2008-5#1)(2008-8#1)(2009-12#1)
unchanged from##5##2##(1993-3#1)(1997-1#1)(2008-3#1)(2009-2#1)(2013-1#1)
unchanged in the three##2##4##(1991-6#1)(1995-12#1)
unchanged in the##7##3##(1990-12#1)(1991-5#1)(1991-6#1)(1995-12#1)(1996-12#1)(2011-2#1)(2012-6#1)
unchanged in##16##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-10#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-6#1)(2013-1#1)
unchanged on day 3##2##4##(1994-2#2)
unchanged or decreased##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
unchanged or##5##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
unchanged over the##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
unchanged throughout the##3##3##(2008-7#2)(2008-9#1)
unchanged when##3##2##(1993-6#1)(1993-8#1)(2008-8#1)
unchanged with##4##2##(1992-2#1)(2008-7#1)(2010-4#1)(2012-2#1)
unchanged##171##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#5)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#21)(2008-11#7)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#7)(2012-6#1)(2013-1#4)(2013-8#2)
uncharacterized proteins##2##2##(2008-4#1)(2009-8#1)
uncharacterized virus was isolated from##2##5##(2008-10#2)
uncharacterized##21##1##(1995-8#1)(1996-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
uncharged amino acids to the stability of##2##7##(1992-6#2)
uncharged##9##1##(1990-8#1)(1992-6#3)(1995-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
uncinate##3##1##(2008-3#1)(2008-7#2)
uncini and##2##2##(2008-5#2)
uncinulatum##5##1##(2008-10#5)
unclarified##2##1##(2008-1#1)(2008-4#1)
unclassified isolates##2##2##(2008-10#2)
unclassified##5##1##(1993-9#1)(2008-1#1)(2008-10#2)(2009-8#1)
unclear and##8##2##(1993-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2010-3#1)(2010-4#1)(2013-1#1)
unclear as##2##2##(2010-12#1)(2013-1#1)
unclear how the##2##3##(2008-8#1)(2011-2#1)
unclear how##9##2##(2008-8#1)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
unclear if patients##2##3##(2010-5#1)(2012-12#1)
unclear if##8##2##(2008-10#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#2)(2013-8#1)
unclear in##2##2##(2007-7#1)(2008-10#1)
unclear terms are##2##3##(1993-2#2)
unclear terms##3##2##(1993-2#3)
unclear to what extent the##2##5##(2007-10#1)(2012-2#1)
unclear to##4##2##(1993-2#1)(2007-10#1)(2008-11#1)(2012-2#1)
unclear what##5##2##(1994-12#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
unclear whether the##6##3##(2008-10#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-8#1)
unclear whether these##5##3##(1993-6#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-2#1)
unclear whether this##3##3##(1996-1#1)(2008-11#1)(2013-1#1)
unclear whether##24##2##(1991-2#1)(1993-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
unclear why##2##2##(2008-10#1)(2009-8#1)
unclear##210##1##(1990-5#2)(1991-11#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#14)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#13)(2008-9#6)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#9)(2012-1#5)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#17)(2013-7#1)(2013-8#7)
uncleavable TaqI sites##2##3##(1994-12#2)
uncleavable##3##1##(1994-12#2)(1997-8#1)
uncleaved##5##1##(1990-5#1)(1991-10#1)(2007-11#2)(2008-4#1)
uncloned##2##1##(1992-9#1)(2008-10#1)
unclosed##2##1##(1992-2#1)(2011-1#1)
uncoated and coated##2##3##(2008-10#1)(2008-2#1)
uncoated fiber##2##2##(2007-12#1)(2008-2#1)
uncoated fused-silica capillary##3##3##(2008-10#3)
uncoated probes##2##2##(2008-2#2)
uncoated##28##1##(1994-6#1)(2007-12#3)(2008-10#11)(2008-2#6)(2008-3#7)
uncoils##2##1##(2009-7#2)
uncollapsed##2##1##(2012-3#2)
uncomfortable##5##1##(2007-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
uncommon among##2##2##(2008-9#1)(2009-7#1)
uncommon and usually##2##3##(2007-8#1)(2013-1#1)
uncommon and##8##2##(1990-6#1)(1990-8#1)(1992-5#1)(1994-11#1)(2007-8#1)(2012-12#1)(2013-1#2)
uncommon but##7##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
uncommon case of##5##3##(1992-9#1)(1993-6#1)(2007-10#1)(2011-2#2)
uncommon cause of acute##2##4##(2008-1#1)(2013-8#1)
uncommon cause of##11##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
uncommon cause##12##2##(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
uncommon clinical entities##2##3##(2013-1#2)
uncommon clinical##8##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
uncommon complication of##2##3##(1993-9#1)(2008-7#1)
uncommon complication##5##2##(1993-9#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
uncommon condition##7##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-7#1)
uncommon disease in##2##3##(2008-7#1)(2009-5#1)
uncommon disease which occurs##2##4##(2008-1#2)
uncommon disease##8##2##(1993-5#1)(2007-2#1)(2008-1#3)(2008-12#1)(2008-7#1)(2009-5#1)
uncommon for##2##2##(1992-4#1)(2007-12#1)
uncommon in##15##2##(1992-5#1)(1996-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#2)
uncommon location##2##2##(2012-12#1)(2013-1#1)
uncommon manifestation of##3##3##(2007-10#1)(2007-7#1)(2010-5#1)
uncommon to##3##2##(2006-10#1)(2008-4#1)(2013-8#1)
uncommon tumor##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
uncommon vascular##3##2##(2006-12#1)(2009-5#1)(2012-3#1)
uncommon##207##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#1)(1995-5#1)(1996-11#2)(1996-3#1)(1996-9#1)(2006-10#2)(2006-12#1)(2007-10#3)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#9)(2007-8#9)(2008-1#7)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#18)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#7)(2013-1#19)(2013-7#2)(2013-8#7)
uncommonly##5##1##(2007-7#1)(2008-10#1)(2009-12#1)(2010-4#1)(2012-2#1)
uncompensated care##5##2##(1992-1#1)(1996-1#3)(2008-11#1)
uncompensated##9##1##(1992-1#1)(1992-11#1)(1996-1#3)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
uncompetitive##7##1##(1990-11#1)(1991-12#1)(1992-12#1)(1994-5#1)(1996-8#1)(1997-2#1)(1997-7#1)
uncomplexed tetrol I-1##3##3##(2008-10#3)
uncomplexed tetrol##4##2##(2008-10#4)
uncomplexed##9##1##(1994-2#1)(2008-10#6)(2010-12#2)
uncomplicated cases##2##2##(1992-5#1)(2011-3#1)
uncomplicated disease##2##2##(1992-2#1)(2010-12#1)
uncomplicated malaria##2##2##(2007-2#2)
uncomplicated procedure##2##2##(1992-12#1)(1996-9#1)
uncomplicated urinary tract##3##3##(2008-11#1)(2009-5#1)(2011-2#1)
uncomplicated##45##1##(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-9#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2013-1#2)
unconditional calculation##3##2##(1992-6#3)
unconditional expression##2##2##(1992-6#2)
unconditional logistic regression analysis##2##4##(2008-11#1)(2011-1#1)
unconditional##11##1##(1992-6#7)(1993-1#1)(2008-11#2)(2011-1#1)
unconditioned stimulus##4##2##(1993-12#1)(1995-12#1)(1997-7#1)(2008-5#1)
unconditioned##7##1##(1993-12#1)(1995-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)
unconfirmed##2##1##(2008-10#1)(2008-12#1)
unconjugated Fib75##3##2##(1990-12#3)
unconjugated bile##2##2##(1992-3#1)(2008-11#1)
unconjugated##15##1##(1990-11#2)(1990-12#3)(1992-3#3)(2008-10#1)(2008-11#2)(2008-9#2)(2009-5#1)(2013-1#1)
unconscious##15##1##(1991-12#1)(1992-12#1)(2007-7#1)(2008-11#2)(2008-12#3)(2009-9#1)(2010-1#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
unconsciousness and##2##2##(1995-3#1)(2010-1#1)
unconsciousness##7##1##(1995-3#1)(2010-1#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
unconstitutional##2##1##(1994-2#1)(1997-7#1)
unconstrained handwritten texts##2##3##(2008-6#2)
unconstrained##11##1##(1994-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-10#1)(2012-12#1)
unconstructive##2##1##(2009-7#2)
uncontaminated##5##1##(1992-12#1)(1997-4#1)(2008-10#2)(2008-11#1)
uncontrollable bleeding from the nidus and##2##6##(2008-7#1)(2008-9#1)
uncontrollable bleeding##3##2##(2007-12#1)(2008-7#1)(2008-9#1)
uncontrollable##8##1##(1995-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-3#1)(2012-12#1)
uncontrolled acute and procedural pain##2##5##(2011-2#2)
uncontrolled diabetes##2##2##(2008-12#1)(2013-8#1)
uncontrolled hypertension in high-risk##2##4##(2010-4#2)
uncontrolled hypertension##4##2##(2008-8#1)(2010-4#2)(2011-1#1)
uncontrolled proliferation##2##2##(2011-2#2)
uncontrolled study##2##2##(2008-10#1)(2012-3#1)
uncontrolled##36##1##(1990-9#1)(1991-2#1)(1992-5#1)(1992-6#1)(1995-3#2)(1997-1#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
unconventional splicing of bZIP60 mRNA to produce the active transcription factor##2##11##(2012-2#2)
unconventional##10##1##(1990-11#1)(1991-6#1)(1992-10#1)(1992-8#1)(1994-6#1)(2010-3#1)(2012-2#4)
uncooled##2##1##(2008-10#1)(2008-3#1)
uncoordinated and##2##2##(2008-4#1)(2010-3#1)
uncoordinated##3##1##(2007-10#1)(2008-4#1)(2010-3#1)
uncorrected bias##2##2##(2008-10#2)
uncorrected##13##1##(1990-3#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
uncorrelated with the##2##3##(1992-6#1)(2008-10#1)
uncorrelated##10##1##(1992-6#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-2#1)(2011-1#1)
uncouple##3##1##(1996-4#1)(2008-11#1)(2009-8#1)
uncoupled##6##1##(1991-11#1)(1991-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
uncoupler##3##1##(1991-12#1)(1995-2#1)(1996-4#1)
uncouplers##2##1##(1994-12#2)
uncoupling of##4##2##(1993-11#1)(1994-8#1)(2008-9#2)
uncoupling protein 2##2##3##(2008-10#1)(2012-1#1)
uncoupling protein##3##2##(2008-10#2)(2012-1#1)
uncoupling##12##1##(1991-12#1)(1992-3#1)(1993-11#1)(1994-8#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-8#1)(2010-5#1)(2012-1#1)
uncover the##11##2##(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
uncover##22##1##(1996-6#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
uncovered a##5##2##(2007-11#1)(2008-11#1)(2008-8#3)
uncovered by##3##2##(1995-2#1)(2008-1#1)(2010-8#1)
uncovered##35##1##(1991-11#1)(1991-2#1)(1991-8#1)(1994-2#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
uncovering the##2##2##(2006-10#1)(2007-12#1)
uncovering##7##1##(1995-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)
uncovers##2##1##(2010-8#1)(2012-2#1)
uncrossed tectopontine pathway##2##3##(1993-3#2)
uncrosslinked##2##1##(1995-2#2)
uncultivable bacteria##2##2##(2007-7#2)
uncultivated##3##1##(2008-10#1)(2012-3#1)(2013-1#1)
unculturable##2##1##(1996-8#1)(2008-9#1)
uncultured##3##1##(2008-10#2)(2011-1#1)
uncut##3##1##(1992-11#1)(1993-3#1)(2008-10#1)
und##5##1##(1997-4#1)(2008-10#2)(2008-11#1)(2011-1#1)
undamaged 19-mer##2##2##(1995-2#2)
undamaged plants##4##2##(2008-8#4)
undamaged##17##1##(1995-12#1)(1995-2#6)(2008-8#6)(2009-4#2)(2011-2#1)(2013-1#1)
undec-7-ene##2##1##(2007-11#1)(2008-10#1)
undecimpunctata subsp##2##2##(2008-10#2)
undecose##2##1##(1997-4#2)
undefined in##2##2##(2008-3#1)(2008-5#1)
undefined##20##1##(1990-12#1)(1990-6#1)(1993-12#1)(2007-7#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
undeformed##3##1##(1993-11#1)(2008-2#2)
undegraded 125IUdR##2##2##(1993-11#2)
undeniable##2##1##(2008-8#1)(2009-10#1)
undepleted ground-state population density##3##4##(2008-3#3)
under &quot##3##2##(1991-12#1)(1993-6#1)(2008-5#1)
under 0##2##2##(2008-11#2)
under 1##3##2##(1997-7#1)(2008-11#2)
under 12 months##2##3##(1993-12#1)(2007-8#1)
under 15 years##2##3##(2007-7#1)(2011-1#1)
under 15##5##2##(1990-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
under 18 months of age##2##5##(2008-9#2)
under 2 years##2##3##(2008-9#1)(2010-12#1)
under 2##3##2##(2008-9#1)(2010-12#1)(2011-1#1)
under 3##3##2##(1997-4#1)(2008-10#1)(2008-12#1)
under 30##2##2##(1994-2#1)(1997-3#1)
under 30) and##2##3##(2008-10#1)(2008-3#1)
under 35 years of age##2##5##(2007-5#2)
under 45##2##2##(1992-2#1)(2011-1#1)
under 49 years of age##2##5##(1991-3#2)
under 5##5##2##(1996-12#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
under 5% CO(2)##4##3##(2008-11#4)
under 5%##5##2##(2008-10#1)(2008-11#4)
under 50##2##2##(1992-8#1)(2011-2#1)
under 6##2##2##(2012-12#1)(2013-1#1)
under 60##2##2##(2008-7#1)(2013-8#1)
under 65##2##2##(1991-12#1)(1995-12#1)
under 70 years##2##3##(1990-12#1)(2008-7#1)
under 70##4##2##(1990-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
under E##2##2##(1995-11#2)
under HIPAA##2##2##(2007-12#1)(2008-4#1)
under Medicaid##4##2##(1991-1#1)(1992-2#2)(1997-2#1)
under Medicare##12##2##(1991-1#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#2)(1994-1#2)(1995-12#1)(1996-2#1)
under PPS##4##2##(1992-2#3)(1993-3#1)
under UV irradiation##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
under UV##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-7#1)
under a confocal laser##2##4##(1992-9#1)(2008-8#1)
under a fully##2##3##(1996-3#1)(2008-2#1)
under a high##3##3##(1991-5#1)(2008-2#2)
under a light microscope##2##4##(2010-8#1)(2013-8#1)
under a managed care##2##4##(1994-12#2)
under a range of##2##4##(2007-12#1)(2008-10#1)
under a single##2##3##(1992-1#1)(1997-5#1)
under a variety of conditions##2##5##(1990-2#1)(2008-9#1)
under a variety of experimental conditions##2##6##(2008-7#1)(2011-1#1)
under a variety of##9##4##(1990-2#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
under a wide range of##5##5##(2008-10#2)(2008-11#1)(2008-8#2)
under a wide variety of##2##5##(2008-2#1)(2008-3#1)
under a wide##7##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)
under a##101##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-5#3)(2007-10#2)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-2#9)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-9#1)(2013-1#4)(2013-8#2)
under acidic and basic##2##4##(2008-10#1)(2008-5#1)
under acidic conditions was##2##4##(1990-8#1)(2008-10#1)
under acidic conditions##9##3##(1990-8#1)(1991-12#1)(1996-5#1)(2008-10#6)
under acidic##14##2##(1990-8#1)(1991-12#1)(1996-5#1)(2008-10#9)(2008-5#1)(2011-1#1)
under activation of##2##3##(2008-9#2)
under active##2##2##(1995-5#1)(2008-10#1)
under actual use conditions##2##4##(2008-10#1)(2008-5#1)
under actual##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
under acute condition##2##3##(1992-12#2)
under acute##3##2##(1992-12#2)(1995-12#1)
under adverse conditions##2##3##(2008-10#1)(2008-11#1)
under aerobic and anaerobic conditions##2##5##(1991-2#1)(2008-5#1)
under aerobic conditions and##2##4##(1991-2#1)(2008-7#1)
under aerobic conditions##6##3##(1991-2#2)(2008-10#2)(2008-7#2)
under aerobic##8##2##(1991-2#3)(2008-10#2)(2008-5#1)(2008-7#2)
under age##3##2##(1994-9#1)(1997-3#2)
under alkaline conditions##5##3##(1991-7#1)(1995-3#1)(1996-5#1)(2008-10#2)
under alkaline##6##2##(1991-7#1)(1995-3#1)(1996-5#1)(2008-10#3)
under all conditions##6##3##(1990-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
under all three##2##3##(1995-5#1)(1997-1#1)
under all weather conditions##2##4##(2008-10#1)(2008-3#1)
under all##14##2##(1990-8#1)(1991-2#1)(1992-8#1)(1993-12#1)(1995-5#1)(1997-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2013-8#1)
under alternative##3##2##(1995-2#1)(2008-7#1)(2012-12#1)
under ambient CO(2)##2##3##(2008-10#2)
under ambient conditions##7##3##(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)
under ambient##11##2##(1992-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)
under an applied##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
under an optical microscope##2##4##(2008-5#1)(2009-10#1)
under an##17##2##(1992-6#1)(1994-12#1)(1994-9#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
under anaerobic conditions##6##3##(1991-2#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
under anaerobic##9##2##(1991-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#2)
under anaerobiosis and##2##3##(2008-10#1)(2008-12#1)
under anaerobiosis##4##2##(2008-10#1)(2008-12#1)(2008-6#2)
under anaesthesia##2##2##(1995-5#1)(2010-7#1)
under analysis##4##2##(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#1)
under anesthesia##5##2##(1994-2#1)(2007-8#1)(2009-3#1)(2011-7#1)(2012-2#1)
under anhydrous conditions##2##3##(2010-2#2)
under any##5##2##(1990-7#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-3#1)
under appropriate##4##2##(2007-12#2)(2008-1#1)(2008-10#1)
under aqueous##3##2##(1995-3#1)(2010-7#1)(2012-3#1)
under artificial inoculation##2##3##(2008-10#2)
under artificial##3##2##(2008-10#2)(2013-7#1)
under atmospheric##2##2##(2008-11#2)
under attention condition##2##3##(2008-8#2)
under background##2##2##(2008-2#2)
under basal conditions and##2##4##(1997-2#1)(2013-1#1)
under basal conditions##9##3##(1990-12#1)(1994-2#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#2)(2013-1#2)
under basal##12##2##(1990-12#1)(1991-5#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#3)(2013-1#2)
under base##2##2##(2007-11#1)(2012-12#1)
under batch equilibrium binding conditions##2##5##(1997-2#2)
under batch equilibrium##3##3##(1997-2#3)
under batch##4##2##(1997-2#3)(2008-10#1)
under biologically reasonable##2##3##(2008-9#1)(2010-6#1)
under both anchorage-dependent and anchorage-independent conditions##2##6##(1997-1#2)
under both conditions##2##3##(1994-2#1)(1997-4#1)
under both normal and##2##4##(1995-11#1)(2011-2#1)
under both pH conditions##2##4##(1991-5#1)(1994-8#1)
under both##26##2##(1991-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-1#3)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
under capitated##2##2##(1995-3#1)(1996-2#1)
under cardiopulmonary bypass and##2##4##(2007-8#1)(2013-1#1)
under cardiopulmonary bypass##6##3##(2007-8#3)(2008-7#1)(2013-1#2)
under certain circumstances##7##3##(1990-3#1)(1994-3#1)(1995-8#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
under certain conditions##13##3##(1992-3#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
under certain environmental conditions##3##4##(1993-2#1)(2008-10#1)(2012-3#1)
under certain physiological conditions##2##4##(1990-11#1)(1990-12#1)
under certain##33##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
under circumstances where##2##3##(1991-12#1)(1993-12#1)
under circumstances##3##2##(1991-12#1)(1993-12#1)(2008-11#1)
under clear skies##2##3##(2008-3#2)
under clear##3##2##(2007-12#1)(2008-3#2)
under clinical##3##2##(1990-11#1)(2010-6#1)(2010-8#1)
under coherent illumination##2##3##(2008-3#2)
under combined spinal##2##3##(2008-7#2)
under combined##5##2##(1993-8#1)(2008-7#2)(2010-7#1)(2012-12#1)
under commercial conditions##2##3##(2008-10#2)
under commercial##4##2##(2008-10#4)
under compression##3##2##(2009-3#1)(2009-7#1)(2011-2#1)
under conditions in which##5##4##(1993-1#1)(1993-11#1)(1997-2#1)(2008-10#1)(2012-12#1)
under conditions of partial##2##4##(1996-2#1)(2008-4#1)
under conditions of poor chromatographic resolution##3##6##(2008-10#3)
under conditions of reduced##2##4##(1991-9#1)(2008-11#1)
under conditions of##44##3##(1991-9#1)(1992-3#2)(1992-6#2)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
under conditions similar to##2##4##(2007-11#1)(2008-12#1)
under conditions that##13##3##(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)
under conditions where the##2##4##(1991-8#1)(1992-11#1)
under conditions where##8##3##(1990-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-6#1)(2008-10#1)(2008-4#1)
under conditions which##5##3##(1992-8#1)(1993-3#1)(1994-11#1)(1995-2#1)(2008-10#1)
under conditions##93##2##(1990-12#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
under conservative##2##2##(2009-11#1)(2013-1#1)
under consideration as##2##3##(1992-3#1)(2012-2#1)
under consideration by the##2##4##(1994-12#1)(1995-12#1)
under consideration##12##2##(1992-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
under constant##12##2##(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-3#1)(2012-3#2)(2013-7#1)
under constraints##3##2##(2008-11#2)(2010-3#1)
under construction##6##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-12#1)(2012-2#1)
under continuous flow##3##3##(2008-10#2)(2008-11#1)
under continuous##9##2##(2007-12#1)(2008-10#5)(2008-11#1)(2009-11#1)(2013-8#1)
under control in##2##3##(1997-8#1)(2008-8#1)
under control of an##2##4##(1992-3#1)(1994-11#1)
under control of the##10##4##(1990-11#2)(1991-5#1)(1996-3#1)(1997-7#2)(2008-10#1)(2008-5#1)(2011-10#1)(2012-2#1)
under control of##16##3##(1990-11#2)(1991-5#1)(1992-3#1)(1994-11#1)(1994-5#1)(1996-3#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-10#1)(2012-2#1)
under control##30##2##(1990-11#2)(1991-5#2)(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-7#3)(1997-8#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-12#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
under controlled and field conditions##2##5##(2008-10#2)
under controlled and##3##3##(2008-10#3)
under controlled conditions and a##2##5##(2008-10#1)(2012-2#1)
under controlled conditions and##5##4##(2008-10#4)(2012-2#1)
under controlled conditions for##2##4##(2008-10#1)(2012-12#1)
under controlled conditions##23##3##(1993-8#1)(2008-10#17)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
under controlled environmental conditions##5##4##(2008-10#5)
under controlled laboratory##2##3##(2007-5#1)(2008-10#1)
under controlled##38##2##(1993-8#1)(2007-5#1)(2008-10#30)(2008-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
under conventional##2##2##(2008-10#2)
under current##2##2##(1993-6#1)(2013-7#1)
under curve##3##2##(2008-7#1)(2012-1#1)(2013-7#1)
under cyclic loading##2##3##(2008-5#1)(2009-3#1)
under daylight conditions##2##3##(2007-11#1)(2008-10#1)
under debate##3##2##(2007-8#1)(2008-7#1)(2010-8#1)
under decoherence##2##2##(2012-2#2)
under defined conditions##2##3##(2008-4#1)(2008-7#1)
under defined##3##2##(2008-4#1)(2008-7#2)
under denaturing conditions##6##3##(1990-11#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
under development and##3##3##(2008-10#2)(2011-2#1)
under development as a##2##4##(2008-11#1)(2009-9#1)
under development by SmithKline Beecham##2##5##(2008-5#2)
under development by##13##3##(2008-5#13)
under development for the##2##4##(1991-5#1)(2008-5#1)
under development for##4##3##(1991-5#1)(1994-9#1)(2008-5#1)(2013-1#1)
under development##42##2##(1991-12#1)(1991-5#1)(1994-9#1)(1996-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#14)(2008-7#1)(2008-8#2)(2009-9#1)(2010-10#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
under diagnosis##2##2##(1990-12#1)(1997-8#1)
under different conditions of##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
under different conditions##14##3##(1992-8#1)(1993-12#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#3)(2012-1#1)
under different dietary conditions##2##4##(2008-10#2)
under different environmental conditions##5##4##(2008-10#3)(2008-8#1)(2011-2#1)
under different experimental conditions##3##4##(1991-6#1)(1997-2#1)(2008-10#1)
under different illumination##2##3##(2008-10#1)(2008-3#1)
under different moisture##2##3##(2008-10#1)(2008-12#1)
under different pH##3##3##(2008-10#2)(2010-12#1)
under different stresses##2##3##(2008-7#1)(2012-1#1)
under different temperature and##2##4##(2008-7#1)(2011-2#1)
under different temperature##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
under different##88##2##(1990-8#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-9#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#5)(2008-7#7)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-1#3)(2012-12#1)(2013-1#3)(2013-7#1)
under differential##2##2##(2008-7#1)(2010-12#1)
under difficult conditions##2##3##(2008-2#1)(2008-6#1)
under direct vision##3##3##(1991-12#1)(2007-8#2)
under direct##6##2##(1991-12#1)(2007-11#1)(2007-8#2)(2010-6#1)(2011-2#1)
under discussion##3##2##(1992-11#1)(1992-5#1)(2008-11#1)
under disease progress curve##3##4##(2008-10#3)
under distinct genetic control##2##4##(2011-2#2)
under double##2##2##(2008-11#1)(2011-2#1)
under drip irrigation than under furrow irrigation##2##7##(2008-10#2)
under drought##2##2##(2008-12#1)(2012-6#1)
under dry conditions##2##3##(2008-10#2)
under dry##4##2##(2008-10#3)(2008-5#1)
under dynamic conditions##2##3##(2008-10#1)(2012-4#1)
under dynamic##4##2##(2008-10#2)(2008-7#1)(2012-4#1)
under each of##2##3##(1994-9#2)
under each##3##2##(1994-9#2)(2013-1#1)
under either##4##2##(1992-12#1)(1995-6#1)(2008-5#1)(2013-8#1)
under elevated CO(2) concentrations##3##4##(2008-10#3)
under elevated CO(2)##5##3##(2008-10#5)
under elevated##7##2##(2008-10#6)(2010-10#1)
under environmental##3##2##(2007-11#1)(2008-8#1)(2010-4#1)
under epidural##2##2##(2008-7#1)(2013-1#1)
under equilibrium conditions##2##3##(1997-2#1)(2008-5#1)
under evaluation in the##2##4##(2008-2#1)(2011-2#1)
under evaluation in##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
under evaluation##8##2##(1997-2#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
under examination##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
under experimental conditions##11##3##(1992-12#1)(1993-3#1)(1996-2#1)(1997-3#1)(2008-10#3)(2008-7#2)(2009-8#1)(2010-5#1)
under extreme conditions##2##3##(2007-8#1)(2008-10#1)
under extreme##4##2##(1991-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
under fasting##2##2##(1994-8#1)(2011-1#1)
under favorable##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
under federal and state##2##4##(1994-3#1)(1996-3#1)
under field conditions and##2##4##(2008-10#2)
under field conditions at##3##4##(2008-10#3)
under field conditions##27##3##(2008-10#22)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#2)
under field##28##2##(2008-10#22)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#2)
under fire##2##2##(1995-6#1)(1996-12#1)
under five years##4##3##(1990-12#1)(2008-1#3)
under five##8##2##(1990-12#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-5#1)
under flow conditions##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
under flow##8##2##(2008-1#2)(2008-10#3)(2008-11#1)(2009-10#1)(2010-5#1)
under four##3##2##(1990-12#1)(1991-2#1)(2012-6#1)
under furrow and##2##3##(2008-10#2)
under furrow irrigation##7##3##(2008-10#7)
under furrow##9##2##(2008-10#9)
under general anaesthesia##6##3##(1997-6#1)(2008-7#1)(2010-7#3)(2013-1#1)
under general anesthesia##13##3##(1991-2#1)(1992-12#2)(1993-1#1)(1994-12#1)(1995-3#1)(2007-8#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
under general##20##2##(1991-2#1)(1992-12#2)(1993-1#1)(1994-12#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
under genetic drift##2##3##(2013-1#2)
under genetic##4##2##(1994-11#1)(2008-10#1)(2013-1#2)
under glucose##2##2##(2010-10#1)(2012-2#1)
under good##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
under greenhouse conditions were##2##4##(2008-10#2)
under greenhouse conditions##12##3##(2008-10#12)
under greenhouse##13##2##(2008-10#13)
under growth chamber##2##3##(2008-10#2)
under growth##3##2##(2008-10#3)
under health care reform##2##4##(1994-2#1)(1995-12#1)
under health care##3##3##(1993-3#1)(1994-2#1)(1995-12#1)
under health reform##2##3##(1995-1#1)(1995-12#1)
under health##5##2##(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#2)
under heat stress##3##3##(2008-12#1)(2012-2#2)
under heat##4##2##(2008-12#1)(2008-7#1)(2012-2#2)
under high concentration conditions##2##4##(2008-9#2)
under high glucose##2##3##(1992-8#1)(2011-2#1)
under high pressure##5##3##(1992-11#1)(1996-1#1)(2007-11#1)(2008-10#2)
under high shear stress##2##4##(1992-12#1)(2009-7#1)
under high shear##3##3##(1992-12#1)(2008-11#1)(2009-7#1)
under high temperature##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
under high##30##2##(1992-11#1)(1992-12#1)(1992-8#1)(1994-3#1)(1996-1#1)(2007-11#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#2)
under highly##2##2##(2008-3#1)(2008-5#1)
under hydrodynamic##2##2##(2008-10#1)(2008-4#1)
under hypoxic##4##2##(2008-11#1)(2010-7#1)(2011-2#1)(2013-8#1)
under ideal conditions##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
under ideal##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
under identical conditions##6##3##(1990-5#1)(1991-12#1)(1993-8#1)(2007-11#1)(2008-10#1)(2011-1#1)
under identical experimental conditions##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
under identical##10##2##(1990-5#1)(1991-12#1)(1993-8#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-1#1)
under illumination##4##2##(1992-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
under in vivo conditions##2##4##(1992-3#1)(2009-3#1)
under in vivo##3##3##(1992-3#1)(2009-3#1)(2011-1#1)
under in##4##2##(1992-3#1)(1993-2#1)(2009-3#1)(2011-1#1)
under inattention condition##2##3##(2008-8#2)
under increased##4##2##(2008-11#1)(2009-8#1)(2012-1#1)(2012-2#1)
under increasing##3##2##(1995-3#1)(2007-8#1)(2008-12#1)
under induced##2##2##(2011-1#2)
under influence of##2##3##(2008-10#1)(2011-1#1)
under initial##2##2##(2011-2#2)
under initiative of##2##3##(2008-5#2)
under intense##3##2##(2008-10#2)(2008-7#1)
under intensive##2##2##(2011-3#1)(2012-3#1)
under inverse sampling##3##3##(1995-9#1)(1996-3#2)
under investigation are##2##3##(1997-4#1)(2008-2#1)
under investigation for##2##3##(2008-8#1)(2012-2#1)
under investigation include##2##3##(2008-3#1)(2008-9#1)
under investigation##33##2##(1991-9#1)(1994-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
under isocratic condition##2##3##(2008-10#1)(2008-5#1)
under isocratic##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
under isothermal##4##2##(2008-10#2)(2009-7#2)
under its##2##2##(1996-12#1)(2008-5#1)
under lab conditions##2##3##(2008-10#2)
under laboratory conditions##11##3##(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-10#1)(2011-2#3)
under laboratory##12##2##(1994-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-10#1)(2011-2#3)
under large deformation##2##3##(2009-7#2)
under large##4##2##(2008-6#2)(2009-7#2)
under laser##2##2##(2007-11#1)(2012-2#1)
under light##7##2##(1996-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-1#1)(2012-3#1)(2013-7#1)
under limiting##2##2##(2008-6#1)(2011-10#1)
under load##2##2##(2007-8#1)(2013-1#1)
under local anaesthesia##6##3##(1991-9#1)(1994-2#1)(2008-12#1)(2008-7#1)(2011-1#2)
under local anesthesia and##2##4##(1992-12#1)(1993-1#1)
under local anesthesia##11##3##(1992-12#5)(1993-1#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-3#1)
under local##17##2##(1991-9#1)(1992-12#5)(1993-1#1)(1994-2#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-3#1)
under long daylengths##2##3##(2012-3#2)
under low concentration conditions##2##4##(2008-9#2)
under low##10##2##(1996-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2013-1#2)
under lower temperatures##2##3##(2008-10#2)
under lower##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
under managed care##5##3##(1995-2#2)(1997-2#2)(1997-3#1)
under managed competition##2##3##(1994-3#1)(1995-1#1)
under managed##9##2##(1994-3#1)(1995-1#2)(1995-2#2)(1997-1#1)(1997-2#2)(1997-3#1)
under many##2##2##(2008-10#1)(2008-8#1)
under medical##3##2##(1991-3#1)(1995-3#1)(1996-3#1)
under microwave irradiation##5##3##(2007-11#3)(2008-10#1)(2013-1#1)
under microwave##6##2##(2007-11#3)(2008-10#1)(2008-5#1)(2013-1#1)
under mild conditions##9##3##(1990-11#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)
under mild##14##2##(1990-11#1)(1996-5#2)(2007-11#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)
under more##5##2##(1995-5#1)(2008-11#2)(2008-2#1)(2008-5#1)
under most conditions##2##3##(2008-8#1)(2008-9#1)
under most##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
under mouth conditions##2##3##(2008-10#2)
under multiple reaction monitoring##2##4##(2008-10#1)(2011-1#1)
under multiple##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
under native conditions##2##3##(2008-7#1)(2011-2#1)
under natural conditions and##3##4##(2008-10#2)(2013-7#1)
under natural conditions were##2##4##(1997-6#1)(2008-10#1)
under natural conditions##12##3##(1997-6#1)(2008-10#7)(2008-9#1)(2013-1#2)(2013-7#1)
under natural field conditions##3##4##(2008-10#3)
under natural inoculum pressure##2##4##(2008-10#2)
under natural##23##2##(1997-6#1)(2008-10#15)(2008-5#1)(2008-8#2)(2008-9#1)(2013-1#2)(2013-7#1)
under neutral conditions##4##3##(1990-8#1)(2007-11#1)(2008-4#1)(2010-11#1)
under neutral##5##2##(1990-8#1)(2007-11#1)(2008-4#1)(2010-11#1)(2010-3#1)
under no CO(2) supply was##3##5##(2008-11#3)
under no CO(2) supply##4##4##(2008-11#4)
under no##5##2##(2008-11#4)(2012-2#1)
under non-isothermal conditions##2##3##(2011-2#2)
under non-reducing conditions##2##3##(1990-12#1)(1995-8#1)
under nondenaturing##2##2##(2008-4#1)(2010-11#1)
under nonshock conditions##2##3##(1990-11#2)
under normal and##3##3##(1996-12#1)(2008-5#1)(2012-12#1)
under normal condition##2##3##(2008-11#1)(2008-12#1)
under normal conditions and##2##4##(2008-8#1)(2010-9#1)
under normal conditions##6##3##(1994-11#1)(1994-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)
under normal incidence##2##3##(2007-12#1)(2008-7#1)
under normal laboratory##2##3##(2008-5#1)(2013-1#1)
under normal physiological##2##3##(2007-7#1)(2011-2#1)
under normal##23##2##(1992-11#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
under normoxic conditions##3##3##(1992-10#1)(1994-5#1)(2011-1#1)
under occlusion##2##2##(2007-11#1)(2008-5#1)
under one##3##2##(1992-6#1)(2010-4#1)(2013-8#1)
under optimal conditions for##2##4##(2008-10#2)
under optimal conditions##11##3##(1991-5#1)(2008-10#7)(2008-2#1)(2009-7#1)(2013-1#1)
under optimal reaction conditions##2##4##(2008-10#1)(2008-8#1)
under optimal##18##2##(1991-5#1)(1996-7#1)(2008-10#10)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2013-1#1)
under optimized conditions##4##3##(2008-10#2)(2009-6#1)(2012-1#1)
under optimized##6##2##(2008-10#4)(2009-6#1)(2012-1#1)
under optimum conditions##9##3##(2008-10#6)(2008-11#1)(2008-3#1)(2013-1#1)
under optimum##11##2##(2008-10#8)(2008-11#1)(2008-3#1)(2013-1#1)
under orchard conditions##2##3##(2008-10#2)
under osmotic stress##4##3##(2008-9#3)(2013-7#1)
under other##2##2##(1994-8#1)(2008-5#1)
under otherwise##3##2##(1995-2#1)(2007-12#1)(2008-8#1)
under our experimental conditions##3##4##(1991-12#1)(1994-6#1)(2008-8#1)
under our##5##2##(1991-12#1)(1994-6#1)(2007-8#1)(2008-8#1)(2011-2#1)
under outpatient##2##2##(1990-11#1)(2013-8#1)
under oxidative stress##2##3##(1994-6#1)(2012-1#1)
under oxidative##3##2##(1994-6#1)(2008-11#1)(2012-1#1)
under oxygen##2##2##(2008-11#1)(2008-4#1)
under pH##2##2##(2008-11#1)(2008-6#1)
under paraxial approximation##2##3##(2008-2#2)
under particular conditions##3##3##(1992-12#2)(2008-4#1)
under particular##4##2##(1990-9#1)(1992-12#2)(2008-4#1)
under phase##3##2##(2007-2#1)(2008-5#1)(2013-1#1)
under photopic##2##2##(2011-2#2)
under physiologic and##2##3##(1993-12#1)(1995-2#1)
under physiological and pathophysiological conditions##2##5##(2010-11#1)(2011-1#1)
under physiological and##3##3##(2008-4#1)(2010-11#1)(2011-1#1)
under physiological conditions##18##3##(1990-12#2)(1991-12#1)(1992-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-5#1)(2008-7#3)(2008-8#1)(2012-2#1)
under physiological##25##2##(1990-12#2)(1991-12#1)(1992-12#1)(1995-12#1)(1995-2#2)(1996-6#1)(1997-3#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
under pre- and post-maximal clenching effort conditions##2##7##(2010-9#2)
under predation##2##2##(2007-12#1)(2008-8#1)
under pressure and##2##3##(2008-11#1)(2010-5#1)
under pressure##13##2##(1992-12#2)(1994-3#1)(1995-2#3)(2007-8#1)(2008-11#2)(2009-5#1)(2010-2#1)(2010-5#1)(2012-12#1)
under prolonged##2##2##(1994-5#1)(2008-5#1)
under proper##2##2##(2008-10#1)(2008-11#1)
under prospective##2##2##(1993-1#1)(2012-12#1)
under real##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
under reduced pressure and##2##4##(2008-10#1)(2008-11#1)
under reduced pressure##4##3##(2008-10#1)(2008-11#2)(2013-7#1)
under reduced##9##2##(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2013-1#1)(2013-7#1)
under reducing conditions##8##3##(1990-5#1)(1993-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#1)
under refrigeration##3##2##(2011-2#1)(2012-12#2)
under resting and##2##3##(1996-7#1)(2009-12#1)
under resting conditions##2##3##(2008-4#1)(2008-8#1)
under resting##4##2##(1996-7#1)(2008-4#1)(2008-8#1)(2009-12#1)
under restricted##2##2##(2008-10#1)(2008-5#1)
under review##3##2##(1991-11#1)(1993-12#1)(2010-3#1)
under rice-wheat system##2##3##(2008-12#2)
under routine##2##2##(1997-2#1)(2008-10#1)
under salt stress##2##3##(2008-11#1)(2008-12#1)
under selection for##2##3##(2008-8#2)
under selection##6##2##(2008-10#1)(2008-6#1)(2008-8#3)(2010-4#1)
under selective##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
under septic##2##2##(1994-11#1)(2008-11#1)
under serum free conditions##2##4##(1990-5#1)(2008-11#1)
under serum-free conditions##6##3##(1992-12#1)(1993-3#1)(2008-11#3)(2008-7#1)
under serum-free##8##2##(1992-12#1)(1993-3#1)(1995-11#1)(2008-11#4)(2008-7#1)
under several different##4##3##(1994-12#1)(2008-10#1)(2008-11#2)
under several##12##2##(1994-12#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
under similar conditions##10##3##(1990-9#1)(1995-2#1)(2007-11#1)(2008-10#6)(2009-7#1)
under similar experimental conditions##2##4##(2008-11#1)(2008-4#1)
under similar##15##2##(1990-9#1)(1991-2#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)
under simulated##2##2##(2008-10#1)(2008-9#1)
under six##4##2##(2008-10#1)(2010-11#1)(2011-1#1)(2013-1#1)
under snow cover##2##3##(2008-10#2)
under solvent-free conditions##2##3##(2007-11#1)(2008-5#1)
under some conditions##3##3##(1992-3#1)(2008-9#1)(2010-5#1)
under some##5##2##(1992-3#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-5#1)
under specific conditions##4##3##(2007-11#1)(2008-11#1)(2008-6#1)(2011-3#1)
under specific##9##2##(1996-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)
under sperm-limited conditions##3##3##(2008-8#3)
under spherical illumination##2##3##(2008-2#2)
under spinal anesthesia##2##3##(1996-12#1)(2012-12#1)
under stable##2##2##(1995-11#1)(1997-8#1)
under standard conditions##4##3##(1993-12#1)(1995-8#1)(2008-11#1)(2008-7#1)
under standard##12##2##(1990-7#1)(1990-8#1)(1993-12#1)(1994-11#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
under standardized##2##2##(1991-12#2)
under static##2##2##(1992-12#1)(2008-4#1)
under stationary conditions##2##3##(2008-10#1)(2008-7#1)
under stationary##3##2##(2008-10#2)(2008-7#1)
under steady state##2##3##(1994-5#1)(2008-10#1)
under sterile conditions##2##3##(1990-12#1)(2008-8#1)
under steroid##2##2##(1994-12#1)(2009-4#1)
under stress##4##2##(1992-3#1)(1995-2#1)(2008-6#1)(2013-7#1)
under stressful conditions##2##3##(2012-3#2)
under strict##4##2##(1990-11#1)(2008-6#1)(2008-8#1)(2012-3#1)
under strictly controlled conditions##2##4##(2008-12#1)(2010-1#1)
under strictly##3##2##(1995-11#1)(2008-12#1)(2010-1#1)
under stringent##2##2##(1991-12#1)(2009-7#1)
under strong##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
under study are##2##3##(2009-9#1)(2011-2#1)
under study in##2##3##(2008-10#2)
under study is##3##3##(2007-10#1)(2008-3#2)
under study was comprised of##2##5##(2008-10#2)
under study were##2##3##(2008-10#2)
under study##41##2##(1990-8#1)(1992-3#1)(1997-2#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#19)(2008-2#1)(2008-3#5)(2008-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-3#1)
under subsurface drip irrigation##6##4##(2008-10#6)
under subsurface-drip irrigation##2##3##(2008-10#2)
under suitable conditions##2##3##(2007-11#1)(2008-10#1)
under suitable##3##2##(2007-11#1)(2008-10#2)
under symmetrical##2##2##(1994-11#1)(2007-12#1)
under tension##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
under test and##2##3##(2008-3#2)
under test##12##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#8)
under that##2##2##(1991-2#1)(2013-7#1)
under the ADA##3##3##(1995-6#1)(1996-5#1)(1997-5#1)
under the Americans with Disabilities Act (ADA)##5##7##(1995-12#3)(1997-5#2)
under the Americans with Disabilities Act##6##6##(1995-12#4)(1997-5#2)
under the Boren Amendment##2##4##(1993-12#2)
under the DNL condition##2##4##(2008-3#2)
under the European##2##3##(2008-10#1)(2008-12#1)
under the Health Care Quality Improvement Act##3##7##(1991-1#1)(1991-3#1)(1994-1#1)
under the Medicare fee schedule##2##5##(1994-1#2)
under the Medicare program##4##4##(1991-1#1)(1994-3#1)(1995-1#1)(1997-3#1)
under the Medicare##8##3##(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1997-3#1)
under the Mental Health Act##2##5##(2010-1#1)(2013-1#1)
under the National##3##3##(1994-2#1)(2008-7#1)(2009-4#1)
under the Portuguese Empire##2##4##(2009-10#2)
under the ROC curve##6##4##(2007-8#1)(2008-10#1)(2010-8#1)(2010-9#1)(2012-1#2)
under the ROC##7##3##(2007-8#2)(2008-10#1)(2010-8#1)(2010-9#1)(2012-1#2)
under the SNL condition##3##4##(2008-3#3)
under the Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982 (Public Law 97-248)##2##14##(1993-12#1)(1994-3#1)
under the United##2##3##(2009-11#1)(2012-2#1)
under the action of a##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
under the action of##5##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
under the age of 3##2##5##(2009-5#1)(2011-2#1)
under the age of 5##2##5##(2010-6#1)(2011-2#1)
under the age of##9##4##(1991-12#1)(1995-12#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
under the agro-climatic##2##3##(2008-12#2)
under the alternative##2##3##(1992-6#1)(2013-1#1)
under the assay conditions##2##4##(1993-11#1)(2008-9#1)
under the assumption of##4##4##(1997-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
under the assumption that the##4##5##(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
under the assumption that##6##4##(1993-12#1)(1995-9#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
under the assumption##10##3##(1993-12#1)(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#2)
under the assumptions##2##3##(1993-9#1)(2008-2#1)
under the auspices of the Better Beginnings##2##7##(1995-3#2)
under the auspices of the##6##5##(1994-12#1)(1994-2#1)(1995-3#2)(2008-10#1)(2008-11#1)
under the auspices of##7##4##(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(2008-10#1)(2008-11#1)
under the auspices##8##3##(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(2008-10#1)(2008-11#1)(2013-7#1)
under the concentration-time curve##2##4##(2008-7#1)(2011-1#1)
under the condition of##3##4##(1996-6#1)(2008-10#1)(2008-3#1)
under the condition##4##3##(1996-6#1)(2008-1#1)(2008-10#1)(2008-3#1)
under the conditions employed##3##4##(1994-9#1)(2008-10#2)
under the conditions of nitric oxide synthesis##2##7##(2013-1#2)
under the conditions of##10##4##(1990-6#1)(1995-3#1)(2008-10#4)(2008-3#1)(2010-7#1)(2013-1#2)
under the conditions used##3##4##(1991-2#1)(1996-2#1)(1997-1#1)
under the conditions##21##3##(1990-6#1)(1991-2#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#1)(2013-1#2)
under the control of a##5##5##(1991-9#1)(1992-10#1)(1995-12#1)(1995-6#1)(2008-10#1)
under the control of either the##2##6##(1994-11#1)(1997-4#1)
under the control of either##3##5##(1994-11#1)(1997-4#1)(2010-12#1)
under the control of its own promoter##2##7##(1995-2#1)(2008-10#1)
under the control of the cauliflower mosaic virus 35S promoter##2##10##(1997-4#1)(2008-10#1)
under the control of the cauliflower mosaic virus##3##8##(1997-4#1)(2008-10#2)
under the control of the lac promoter##3##7##(1992-3#1)(1995-2#1)(2008-10#1)
under the control of the polyhedrin promoter of##2##8##(1994-11#1)(1997-4#1)
under the control of the##28##5##(1991-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1997-4#2)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-7#1)
under the control of various##2##5##(1994-2#1)(1996-5#1)
under the control of##69##4##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#7)(2007-11#1)(2008-10#10)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2010-12#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
under the control##71##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#7)(2007-11#1)(2008-10#10)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2010-12#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
under the current##2##3##(1997-1#1)(2009-7#1)
under the curve (AUC)##6##4##(1994-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
under the curve of 0##2##5##(2012-3#1)(2013-1#1)
under the curve of##4##4##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
under the curve##18##3##(1992-9#1)(1994-12#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
under the different##2##3##(2008-10#2)
under the direction of##2##4##(1991-3#1)(2007-8#1)
under the disease progress curve (AUDPC)##10##6##(2008-10#10)
under the disease progress curve and##3##6##(2008-10#3)
under the disease progress curve##21##5##(2008-10#21)
under the disease progress##23##4##(2008-10#23)
under the effect of cocaine##2##5##(2013-8#2)
under the effect of##5##4##(1994-11#1)(2012-2#1)(2013-8#3)
under the excitation##2##3##(2008-10#1)(2013-8#1)
under the experimental conditions##3##4##(2008-10#3)
under the first##2##3##(1992-6#1)(2012-2#1)
under the following conditions##3##4##(1995-2#1)(1996-5#1)(2008-6#1)
under the following##7##3##(1995-2#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-6#1)(2010-12#1)
under the guidance of##3##4##(2008-11#1)(2008-12#1)(2011-2#1)
under the heading##2##3##(2007-7#1)(2008-11#1)
under the headings##3##3##(1991-12#1)(1996-3#1)(2008-11#1)
under the influence of alcohol##4##5##(1995-8#1)(2008-7#1)(2013-1#1)(2013-8#1)
under the influence of moisture##2##5##(2008-10#2)
under the influence of psilocybin##3##5##(2013-8#3)
under the influence of the##3##5##(1990-12#1)(1996-4#1)(2008-10#1)
under the influence of##24##4##(1990-12#2)(1995-8#1)(1996-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
under the influence##25##3##(1990-12#2)(1995-8#1)(1996-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
under the name of##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
under the name##5##3##(2007-5#1)(2008-10#2)(2011-2#1)(2013-8#1)
under the new##2##3##(1992-12#1)(1992-2#1)
under the optimal conditions##4##4##(2008-10#4)
under the optimized conditions##5##4##(2008-10#3)(2011-1#1)(2013-1#1)
under the optimized##6##3##(2008-10#4)(2011-1#1)(2013-1#1)
under the optimum conditions##4##4##(2008-10#4)
under the optimum##7##3##(2008-10#7)
under the present experimental##2##4##(2008-10#1)(2008-5#1)
under the present##3##3##(1990-8#1)(2008-10#1)(2008-5#1)
under the proposed##2##3##(1995-2#1)(2008-10#1)
under the prospective payment system##2##5##(1992-12#1)(1993-1#1)
under the receiver operating curve##3##5##(2008-3#1)(2012-3#1)(2013-1#1)
under the responsibility of##2##4##(2008-11#1)(2011-1#1)
under the same chromatographic conditions##2##5##(2008-10#2)
under the same condition##2##4##(1991-5#1)(1994-9#1)
under the same conditions as##2##5##(1996-2#1)(2008-5#1)
under the same conditions used##2##5##(1992-2#1)(2008-10#1)
under the same conditions##21##4##(1990-2#1)(1992-2#1)(1992-3#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(2008-10#7)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
under the same experimental conditions##6##5##(1990-8#1)(1997-2#1)(2007-12#1)(2008-10#3)
under the same experimental##8##4##(1990-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
under the same##40##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
under the skin##3##3##(2008-3#1)(2008-8#1)(2010-7#1)
under the statute##2##3##(1993-1#2)
under the term##2##3##(2011-2#1)(2013-7#1)
under the transcriptional control of##2##5##(1995-2#1)(2011-2#1)
under the two##3##3##(1997-1#1)(2008-10#1)(2008-8#1)
under the umbrella of##7##4##(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
under the##564##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#5)(1991-1#4)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#7)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#10)(1995-2#6)(1995-3#7)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#11)(1997-5#4)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#123)(2008-11#26)(2008-12#7)(2008-2#6)(2008-3#22)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#18)(2008-8#9)(2008-9#8)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#9)(2011-2#18)(2012-1#4)(2012-12#8)(2012-2#7)(2012-3#7)(2012-9#1)(2013-1#12)(2013-7#5)(2013-8#16)
under their##2##2##(1997-6#1)(2011-1#1)
under these circumstances##4##3##(1992-2#1)(1993-3#1)(2008-7#1)(2011-1#1)
under these conditions##33##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-9#2)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2012-12#1)(2013-7#1)
under these experimental conditions##4##4##(1991-1#1)(1991-12#1)(1996-5#1)(2008-10#1)
under these##55##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-9#2)(1996-5#3)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
under this condition##5##3##(1996-9#1)(2008-10#2)(2008-6#1)(2011-2#1)
under this##15##2##(1991-9#1)(1992-12#1)(1996-9#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
under three different sets of conditions##2##6##(2008-10#1)(2008-4#1)
under three different##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
under three##5##2##(1997-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
under tight control##2##3##(2006-10#1)(2009-8#1)
under total##2##2##(2008-3#1)(2011-2#1)
under transcriptional control of the##3##5##(1994-12#1)(1997-3#1)(2010-10#1)
under transcriptional control of##4##4##(1994-12#1)(1997-3#1)(2008-7#1)(2010-10#1)
under transcriptional control##5##3##(1990-11#1)(1994-12#1)(1997-3#1)(2008-7#1)(2010-10#1)
under treatment with##2##3##(1991-11#1)(2010-12#1)
under treatment##10##2##(1991-11#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2012-3#1)
under trial##3##2##(1990-7#1)(1997-3#1)(2008-10#1)
under two different##2##3##(2008-11#1)(2008-7#1)
under two##11##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
under two-photon excitation##4##3##(2008-2#2)(2008-3#2)
under typical operating conditions##2##4##(1995-12#1)(2007-11#1)
under ultrahigh vacuum conditions##2##4##(2012-1#1)(2013-8#1)
under ultrahigh vacuum##3##3##(2008-7#1)(2012-1#1)(2013-8#1)
under ultrasonic##3##2##(2008-10#2)(2008-5#1)
under ultrasound##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
under ultraviolet light##2##3##(2008-5#1)(2008-9#1)
under ultraviolet##4##2##(2006-8#1)(2008-3#1)(2008-5#1)(2008-9#1)
under universal##2##2##(1995-1#1)(2008-4#1)
under vacuum packaging##2##3##(2011-2#2)
under vacuum##4##2##(2010-1#1)(2011-2#3)
under variable##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
under various conditions of##3##4##(2008-10#3)
under various conditions##8##3##(1990-8#1)(1993-9#1)(1994-12#1)(2008-10#4)(2008-4#1)
under various environmental conditions##2##4##(2008-10#1)(2008-3#1)
under various growth conditions##2##4##(1996-6#1)(1997-1#1)
under various##26##2##(1990-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#9)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)
under varying conditions of##2##4##(2008-10#1)(2008-9#1)
under varying conditions##5##3##(1995-3#1)(2008-10#2)(2008-3#1)(2008-9#1)
under varying##13##2##(1992-12#1)(1995-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#2)(2013-1#1)
under very mild conditions##2##4##(2007-11#1)(2009-11#1)
under very##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2009-11#1)
under visible light##2##3##(2008-8#1)(2013-8#1)
under water stress##3##3##(2008-12#1)(2008-8#2)
under water##5##2##(2008-10#1)(2008-12#2)(2008-8#2)
under way in##2##3##(1995-12#1)(2008-4#1)
under way##8##2##(1995-12#1)(2007-11#1)(2007-9#1)(2008-2#2)(2008-4#1)(2008-7#2)
under well defined##2##3##(2008-11#1)(2008-2#1)
under well-watered and drought##2##4##(2008-12#2)
under wet conditions##2##3##(2008-10#2)
under what conditions##4##3##(1994-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
under what##7##2##(1994-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#2)
under which a##3##3##(2007-11#1)(2007-12#1)(2010-10#1)
under which the##7##3##(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#2)(2013-8#1)
under which##43##2##(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#7)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-2#2)(2013-8#1)
under working conditions##2##3##(2008-10#2)
under##3056##1##(1990-11#11)(1990-12#19)(1990-2#5)(1990-3#3)(1990-5#7)(1990-6#3)(1990-7#6)(1990-8#15)(1990-9#2)(1991-1#8)(1991-11#3)(1991-12#24)(1991-2#25)(1991-3#7)(1991-5#11)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#4)(1992-10#3)(1992-11#6)(1992-12#30)(1992-2#15)(1992-3#17)(1992-5#4)(1992-6#9)(1992-7#1)(1992-8#10)(1992-9#5)(1993-1#9)(1993-11#2)(1993-12#17)(1993-2#5)(1993-3#14)(1993-5#1)(1993-6#10)(1993-8#7)(1993-9#4)(1994-1#7)(1994-10#1)(1994-11#13)(1994-12#21)(1994-2#15)(1994-3#14)(1994-5#10)(1994-6#9)(1994-8#5)(1994-9#14)(1995-1#10)(1995-11#9)(1995-12#29)(1995-2#30)(1995-3#17)(1995-5#11)(1995-6#12)(1995-8#8)(1995-9#5)(1996-1#4)(1996-11#3)(1996-12#15)(1996-2#17)(1996-3#11)(1996-4#2)(1996-5#21)(1996-6#6)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#12)(1997-2#26)(1997-3#16)(1997-4#17)(1997-5#8)(1997-6#4)(1997-7#9)(1997-8#6)(1997-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#8)(2007-11#55)(2007-12#44)(2007-2#4)(2007-4#2)(2007-5#5)(2007-7#7)(2007-8#30)(2007-9#2)(2008-1#22)(2008-10#649)(2008-11#143)(2008-12#38)(2008-2#74)(2008-3#126)(2008-4#34)(2008-5#103)(2008-6#37)(2008-7#110)(2008-8#82)(2008-9#53)(2009-1#1)(2009-10#19)(2009-11#9)(2009-12#8)(2009-2#2)(2009-3#7)(2009-4#4)(2009-5#7)(2009-6#7)(2009-7#13)(2009-8#15)(2009-9#15)(2010-1#7)(2010-10#16)(2010-11#9)(2010-12#14)(2010-2#5)(2010-3#9)(2010-4#8)(2010-5#7)(2010-6#6)(2010-7#14)(2010-8#18)(2010-9#4)(2011-1#47)(2011-10#3)(2011-2#88)(2011-3#6)(2011-7#1)(2012-1#20)(2012-12#37)(2012-2#49)(2012-3#34)(2012-4#1)(2012-6#3)(2012-7#1)(2012-9#2)(2013-1#86)(2013-7#19)(2013-8#44)
under- and##2##2##(2008-10#1)(2012-2#1)
under- or##3##2##(2008-6#1)(2008-7#1)(2008-9#1)
under-##5##1##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
under-2-years mortality##2##2##(2011-1#2)
under-2-years##4##1##(2011-1#4)
under-appreciated##2##1##(2008-9#1)(2009-8#1)
under-diagnosed##2##1##(2011-2#2)
under-diagnosis##2##1##(2010-12#1)(2011-2#1)
under-explored##3##1##(2009-5#1)(2010-8#1)(2012-9#1)
under-five mortality##7##2##(2009-6#5)(2009-7#2)
under-five##12##1##(2008-2#4)(2009-6#5)(2009-7#3)
under-recognised and##2##2##(1996-8#1)(2010-10#1)
under-recognised##3##1##(1996-8#1)(2010-10#1)(2010-12#1)
under-recognized##4##1##(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)
under-reported##2##1##(1993-6#1)(1996-8#1)
under-reporting of##2##2##(1996-11#1)(2010-8#1)
under-studied##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
under-treatment##3##1##(1990-12#1)(2010-12#1)(2011-2#1)
underage drinking##3##2##(2010-7#3)
underappreciated##5##1##(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
underarm##8##1##(2008-5#8)
underarms##2##1##(2008-5#2)
undercare##2##1##(1994-2#1)(1994-3#1)
undercompensation##2##1##(2008-8#2)
underdetermined##2##1##(2008-3#1)(2008-7#1)
underdeveloped and##2##2##(1997-2#1)(2013-1#1)
underdeveloped countries##3##2##(1990-2#2)(1996-2#1)
underdeveloped##9##1##(1990-2#2)(1996-2#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-11#1)(2010-5#1)(2013-1#1)
underdevelopment##2##1##(2009-7#1)(2011-1#1)
underdiagnosed and undertreated##3##3##(2008-8#1)(2013-8#2)
underdiagnosed and##4##2##(2008-6#1)(2008-8#1)(2013-8#2)
underdiagnosed##10##1##(1995-11#2)(1997-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2013-8#2)
underdiagnosis##3##1##(2008-11#1)(2012-3#1)(2013-7#1)
underdominance##3##1##(2008-10#3)
underestimate the true##2##3##(1990-3#1)(2008-7#1)
underestimate the##11##2##(1990-3#1)(1991-12#1)(1991-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2013-8#1)
underestimate##18##1##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-6#1)(1994-3#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
underestimated and##4##2##(1992-9#1)(1995-2#1)(2012-12#1)(2012-3#1)
underestimated at##2##2##(1996-5#1)(2008-10#1)
underestimated in##2##2##(2008-10#1)(2009-7#1)
underestimated the##3##2##(2007-6#1)(2008-3#1)(2008-5#1)
underestimated##37##1##(1992-9#1)(1995-2#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#2)(2010-1#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
underestimates the##4##2##(1994-2#1)(1997-3#1)(2008-1#1)(2008-10#1)
underestimates##6##1##(1994-2#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-6#1)
underestimating##3##1##(2008-3#1)(2008-5#1)(2008-9#1)
underestimation of the##5##3##(2007-2#1)(2008-2#1)(2008-3#2)(2012-3#1)
underestimation of##11##2##(1990-2#1)(1995-5#1)(2007-2#1)(2008-2#1)(2008-3#2)(2009-10#1)(2011-2#2)(2012-3#2)
underestimation##15##1##(1990-2#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
underexpanded##2##1##(2008-3#2)
underexplored##4##1##(2008-10#1)(2010-1#1)(2013-1#2)
undergo HIV-antibody testing##3##3##(1996-5#3)
undergo a two-state##2##3##(1993-8#1)(1997-2#1)
undergo a##28##2##(1991-1#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-1#1)(2010-4#1)(2010-7#2)(2012-2#2)(2013-1#1)
undergo an AIDS test##2##4##(1992-9#2)
undergo an apparent##2##3##(1994-5#1)(1996-2#1)
undergo an##13##2##(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-5#1)(1996-2#3)(2007-11#1)(2007-12#1)(2009-3#1)(2011-1#1)
undergo apoptosis##12##2##(1993-9#1)(1994-10#1)(1995-2#3)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)
undergo closed##2##2##(2007-12#1)(2011-2#1)
undergo differentiation##2##2##(2008-7#1)(2009-6#1)
undergo elective resection after##2##4##(2010-8#2)
undergo elective##3##2##(2010-8#2)(2012-12#1)
undergo further##4##2##(2008-10#1)(2009-4#1)(2011-8#1)(2013-1#1)
undergo major##2##2##(2009-5#1)(2012-2#1)
undergo proliferation##2##2##(1991-5#1)(2008-4#1)
undergo proteolytic processing##2##3##(1993-6#1)(2008-11#1)
undergo proteolytic##3##2##(1993-6#1)(2008-11#1)(2008-4#1)
undergo radical##2##2##(1993-9#1)(2008-10#1)
undergo rapid##5##2##(1990-6#1)(1996-2#1)(2008-8#1)(2009-9#1)(2010-5#1)
undergo resection##2##2##(2010-8#1)(2013-1#1)
undergo significant##2##2##(2008-8#1)(2011-2#1)
undergo similar##2##2##(1990-2#1)(1992-6#1)
undergo spontaneous##3##2##(1995-12#1)(1995-3#1)(2008-7#1)
undergo surgical##2##2##(2008-8#2)
undergo the##12##2##(1992-8#1)(1995-6#2)(2008-10#1)(2008-11#1)(2009-5#2)(2009-6#1)(2009-9#1)(2011-2#1)(2012-3#2)
undergo this##3##2##(1994-12#1)(2008-7#2)
undergo training##2##2##(1994-3#1)(1995-6#1)
undergo two##2##2##(2008-10#1)(2010-11#1)
undergo##235##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#4)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#5)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#6)(2008-9#1)(2009-10#3)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#11)(2011-8#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#7)
undergoes a##17##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-12#1)(1995-5#1)(1996-5#2)(1997-7#1)(2007-11#3)(2008-10#3)(2008-3#1)(2008-9#1)(2013-1#1)
undergoes autophosphorylation##2##2##(1993-6#1)(1994-11#1)
undergoes hydrolysis##2##2##(2008-10#1)(2009-8#1)
undergoes rapid##3##2##(1995-2#1)(2008-5#1)(2009-8#1)
undergoes regular cycles of sexual recombination##2##6##(2008-10#2)
undergoes the##2##2##(2008-8#1)(2011-3#1)
undergoes##78##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-10#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-5#4)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-5#2)(2009-7#2)(2009-8#4)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#1)
undergoing a dramatic##2##3##(1996-12#1)(2007-12#1)
undergoing a major##4##3##(1992-1#1)(1992-12#1)(1994-3#1)(2010-6#1)
undergoing a##16##2##(1991-4#1)(1992-1#1)(1992-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
undergoing active##4##2##(2008-7#1)(2009-5#1)(2010-10#2)
undergoing an operation##2##3##(2011-2#1)(2013-7#1)
undergoing an##5##2##(1996-5#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-7#1)
undergoing angioplasty##2##2##(2008-11#1)(2008-5#1)
undergoing apoptosis##3##2##(1994-12#1)(2008-11#1)(2008-8#1)
undergoing bilateral##4##2##(2007-8#2)(2009-3#2)
undergoing caesarean section##2##3##(2008-7#1)(2011-2#1)
undergoing cardiac##7##2##(2007-8#4)(2007-9#1)(2008-12#1)(2011-2#1)
undergoing cardiopulmonary##2##2##(2008-5#1)(2013-8#1)
undergoing chemotherapy##6##2##(1990-9#1)(2007-7#2)(2008-7#2)(2012-2#1)
undergoing chronic##2##2##(1996-12#1)(2007-7#1)
undergoing cleft lip##2##3##(2011-2#1)(2012-12#1)
undergoing clinical evaluation##3##3##(1995-3#1)(2008-7#2)
undergoing clinical trials##3##3##(1991-3#1)(1994-8#1)(2012-12#1)
undergoing clinical##8##2##(1991-3#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-9#1)(2008-7#2)(2012-12#1)
undergoing coronary artery bypass##4##4##(2007-7#1)(2007-8#2)(2008-12#1)
undergoing coronary artery##6##3##(1997-3#1)(2007-7#1)(2007-8#2)(2008-12#2)
undergoing coronary##13##2##(1991-9#1)(1996-9#1)(1997-3#1)(2007-7#1)(2007-8#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)
undergoing diagnostic##2##2##(2006-10#1)(2008-4#1)
undergoing dialysis##3##2##(2007-12#1)(2008-1#1)(2011-2#1)
undergoing elective##7##2##(1991-5#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
undergoing hemodialysis##6##2##(1993-9#1)(1994-12#1)(2008-7#3)(2010-5#1)
undergoing intensive##2##2##(1994-5#1)(2008-7#1)
undergoing knee joint arthroscopy##2##4##(2007-11#2)
undergoing laparoscopic##5##2##(1991-3#1)(1994-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
undergoing major##2##2##(1996-12#1)(2007-8#1)
undergoing orthopedic surgery##2##3##(2011-2#2)
undergoing orthopedic##3##2##(2008-5#1)(2011-2#2)
undergoing radiotherapy##2##2##(2007-11#1)(2008-7#1)
undergoing rehabilitation##2##2##(2007-11#1)(2012-3#1)
undergoing surgery for##2##3##(2007-8#1)(2008-7#1)
undergoing surgery##8##2##(1993-5#1)(2007-8#2)(2008-7#3)(2008-8#1)(2013-1#1)
undergoing the##6##2##(1994-7#2)(2008-10#1)(2008-12#1)(2009-12#1)(2009-9#1)
undergoing therapy for##2##3##(1993-12#1)(2009-4#1)
undergoing therapy##3##2##(1993-12#1)(2009-4#1)(2011-2#1)
undergoing thoracic surgery##4##3##(1991-2#1)(2006-10#1)(2012-12#2)
undergoing thoracic/thoracolumbar level fusion##2##4##(2012-3#2)
undergoing total joint arthroplasty##2##4##(2012-12#2)
undergoing total knee##3##3##(1996-3#1)(2007-10#1)(2009-3#1)
undergoing total##8##2##(1996-3#1)(2007-10#2)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#2)
undergoing treatment for##3##3##(2008-10#2)(2013-1#1)
undergoing treatment of##2##3##(2010-7#1)(2011-1#1)
undergoing treatment##8##2##(1990-8#1)(2008-10#3)(2008-5#1)(2010-7#1)(2011-1#1)(2013-1#1)
undergoing valve replacement##2##3##(2007-8#1)(2011-2#1)
undergoing##340##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#4)(1993-11#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#3)(1995-3#3)(1995-5#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#2)(1996-9#4)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-5#1)(2007-7#5)(2007-8#26)(2007-9#3)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#6)(2008-3#7)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#31)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#20)(2012-1#1)(2012-12#13)(2012-2#8)(2012-3#15)(2013-1#14)(2013-7#1)(2013-8#8)
undergone RP##2##2##(2010-10#2)
undergone a##18##2##(1990-11#1)(1992-2#1)(1994-7#2)(1996-12#1)(1996-3#2)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#3)(2013-8#1)
undergone an##2##2##(1992-6#1)(1992-8#1)
undergone by##2##2##(2008-10#2)
undergone considerable##2##2##(2008-9#1)(2009-2#1)
undergone coronary##2##2##(1995-3#1)(1996-6#1)
undergone major##2##2##(2008-12#1)(2010-6#1)
undergone more than##2##3##(1992-9#1)(2008-9#1)
undergone rapid##2##2##(1996-3#1)(2010-12#1)
undergone splenectomy##2##2##(1990-9#1)(1994-9#1)
undergone substantial##4##2##(1993-3#1)(2007-6#1)(2008-11#1)(2009-9#1)
undergone surgery##3##2##(1990-9#1)(1992-10#1)(1997-2#1)
undergone the##3##2##(1995-3#1)(2008-7#1)(2013-1#1)
undergone##125##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#3)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#5)(2009-11#2)(2009-2#2)(2009-9#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
undergraduate and postgraduate##4##3##(1994-12#1)(2007-10#1)(2008-11#1)(2012-1#1)
undergraduate and##7##2##(1994-12#1)(2007-10#1)(2008-11#2)(2008-12#2)(2012-1#1)
undergraduate course##2##2##(2008-11#1)(2012-3#1)
undergraduate courses in##2##3##(2008-1#1)(2008-11#1)
undergraduate courses##3##2##(2008-1#1)(2008-11#1)(2010-9#1)
undergraduate curriculum of##4##3##(2011-2#4)
undergraduate curriculum##7##2##(1996-11#1)(2008-12#1)(2011-2#4)(2013-1#1)
undergraduate dental curriculum##4##3##(2012-1#3)(2013-1#1)
undergraduate dental##7##2##(2009-2#2)(2012-1#3)(2013-1#2)
undergraduate education##12##2##(1991-1#1)(1993-3#6)(1994-2#1)(1996-1#1)(2010-3#2)(2013-1#1)
undergraduate health administration##3##3##(1991-1#1)(1992-12#1)(1993-2#1)
undergraduate health##4##2##(1991-1#1)(1992-12#1)(1993-2#1)(2008-12#1)
undergraduate medical students##2##3##(2010-2#1)(2012-2#1)
undergraduate medical##3##2##(2010-2#2)(2012-2#1)
undergraduate nurse education##2##3##(2008-12#2)
undergraduate nurse##4##2##(2008-11#1)(2008-12#3)
undergraduate nurses to provide smoking cessation advice and help##2##9##(2012-3#2)
undergraduate nurses to##3##3##(2008-12#1)(2012-3#2)
undergraduate nurses##7##2##(2008-12#5)(2012-3#2)
undergraduate nursing curriculum##2##3##(2008-11#1)(2008-12#1)
undergraduate nursing education##2##3##(2008-11#2)
undergraduate nursing students and##2##4##(2008-12#2)
undergraduate nursing students##13##3##(2008-11#8)(2008-12#4)(2011-1#1)
undergraduate nursing##22##2##(2008-11#12)(2008-12#8)(2011-1#1)(2012-3#1)
undergraduate participants##2##2##(2010-7#1)(2012-1#1)
undergraduate programs##4##2##(1991-1#4)
undergraduate students of nursing##2##4##(2008-12#2)
undergraduate students were##2##3##(2009-11#1)(2012-2#1)
undergraduate students##9##2##(1995-3#1)(2008-11#1)(2008-12#3)(2009-11#1)(2010-7#1)(2012-2#2)
undergraduate students'##2##2##(2008-11#2)
undergraduate##121##1##(1991-1#8)(1991-6#1)(1992-12#1)(1993-2#1)(1993-3#6)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#29)(2008-12#28)(2009-11#1)(2009-2#2)(2009-4#1)(2010-2#2)(2010-3#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#5)(2012-2#4)(2012-3#7)(2013-1#6)(2013-8#1)
undergraduates##11##1##(1996-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2012-2#1)
underground is##2##2##(2008-1#2)
underground shovelers##2##2##(2008-6#2)
underground##12##1##(1997-6#1)(2008-1#3)(2008-10#5)(2008-6#2)(2010-4#1)
underinsurance##2##1##(1994-2#1)(2011-1#1)
underinsured patients##3##2##(2008-11#3)
underinsured##7##1##(1992-3#1)(2008-11#5)(2011-1#1)
underivatized amino acids##7##3##(2008-10#7)
underivatized##10##1##(1995-5#1)(1996-5#1)(2008-10#8)
underlie the##22##2##(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
underlie these##3##2##(1990-8#1)(2008-11#1)(2009-3#1)
underlie this##3##2##(2008-11#1)(2009-8#1)(2012-12#1)
underlie##60##1##(1990-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#3)(1996-5#3)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#3)(2011-2#1)(2012-12#4)(2013-1#4)(2013-8#1)
underlies both##2##2##(2013-1#2)
underlies the##7##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
underlies##21##1##(1990-5#1)(1992-11#1)(1994-8#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
underline that##3##2##(1991-5#1)(1993-6#1)(1996-3#1)
underline the importance of##8##4##(1990-11#1)(1990-9#1)(1991-6#1)(1992-6#1)(2008-11#1)(2008-12#1)(2008-7#2)
underline the potential of##2##4##(2008-10#1)(2008-11#1)
underline the##20##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#1)(1992-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)
underline##26##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-6#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
underlined and##2##2##(1990-5#1)(1991-6#1)
underlined in##2##2##(2008-10#1)(2008-2#1)
underlined the##2##2##(1991-6#1)(2013-1#1)
underlined##21##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#2)(1992-1#1)(1992-9#1)(1993-5#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#4)(2013-1#1)
underlines the difficulties##2##3##(1990-6#1)(1996-12#1)
underlines the importance of##2##4##(1991-3#1)(1992-6#1)
underlines the##13##2##(1990-6#1)(1991-3#1)(1992-5#1)(1992-6#1)(1996-12#1)(2007-12#2)(2008-11#1)(2008-2#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#1)
underlining the importance of##3##4##(1990-8#1)(1992-6#1)(1994-8#1)
underlining the##9##2##(1990-5#1)(1990-8#1)(1992-6#1)(1994-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
underlining##11##1##(1990-5#1)(1990-8#1)(1992-6#1)(1994-11#1)(1994-8#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
underlying aging##2##2##(2009-5#1)(2012-3#1)
underlying assumptions and##2##3##(1995-1#1)(2008-7#1)
underlying assumptions of##2##3##(2008-8#1)(2012-2#1)
underlying assumptions##8##2##(1992-3#1)(1995-1#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-2#1)
underlying biological##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
underlying brain##3##2##(2007-12#1)(2011-1#1)(2013-8#1)
underlying cause for##3##3##(2007-10#1)(2008-1#1)(2013-8#1)
underlying cause of##4##3##(2008-1#1)(2008-3#1)(2009-3#1)(2010-10#1)
underlying cause##10##2##(1996-12#1)(2007-10#1)(2008-1#3)(2008-3#1)(2009-3#1)(2010-10#2)(2013-8#1)
underlying causes##3##2##(1991-12#1)(2008-7#1)(2011-1#1)
underlying chronic liver disease##2##4##(2013-8#2)
underlying chronic##3##2##(2012-12#1)(2013-8#2)
underlying cognitive##2##2##(2008-11#1)(2012-2#1)
underlying condition##5##2##(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#2)
underlying conditions##4##2##(1994-3#1)(2008-5#1)(2008-8#1)(2010-12#1)
underlying constructs##2##2##(1992-1#1)(2010-3#1)
underlying disease and##3##3##(1994-9#1)(2008-1#1)(2011-3#1)
underlying disease##20##2##(1994-9#1)(1995-9#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
underlying diseases##7##2##(1991-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)
underlying etiology##2##2##(2008-12#1)(2013-7#1)
underlying factors##2##2##(2008-12#1)(2010-11#1)
underlying genetic##5##2##(1991-3#1)(2007-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
underlying health##2##2##(1993-6#1)(1995-2#1)
underlying heart##2##2##(2008-7#1)(2010-10#1)
underlying hypothalamic temperature##2##3##(1993-12#2)
underlying linear##2##2##(2008-8#1)(2009-8#1)
underlying mechanism for the##3##4##(1995-2#1)(2008-7#1)(2011-1#1)
underlying mechanism is##2##3##(2007-11#1)(2012-2#1)
underlying mechanism of##5##3##(1995-12#1)(2008-1#1)(2009-12#1)(2009-8#1)(2010-7#1)
underlying mechanism##20##2##(1995-12#1)(1995-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-8#2)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#3)(2013-1#1)
underlying mechanisms are##2##3##(2008-3#1)(2010-11#1)
underlying mechanisms for##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
underlying mechanisms of##11##3##(1995-12#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
underlying mechanisms##28##2##(1990-2#1)(1992-11#1)(1993-1#1)(1994-8#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#3)
underlying molecular mechanism##3##3##(1995-11#1)(1997-5#1)(2012-2#1)
underlying molecular mechanisms##2##3##(2008-7#1)(2012-2#1)
underlying molecular##7##2##(1995-11#1)(1997-5#1)(2007-7#2)(2008-7#1)(2012-2#2)
underlying mutations##2##2##(2008-8#1)(2008-9#1)
underlying natural##2##2##(2008-11#2)
underlying pathology##3##2##(1992-6#1)(1996-1#1)(2008-12#1)
underlying pathophysiological mechanism##2##3##(2008-3#1)(2011-2#1)
underlying pathophysiological mechanisms##2##3##(2008-3#1)(2009-11#1)
underlying pathophysiological##5##2##(1990-2#1)(2008-3#2)(2009-11#1)(2011-2#1)
underlying pathophysiology##5##2##(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
underlying physical##2##2##(1997-2#1)(2008-3#1)
underlying population##2##2##(2008-10#1)(2011-2#1)
underlying principles of##2##3##(1997-4#1)(2008-9#1)
underlying principles##4##2##(1997-4#1)(2008-9#3)
underlying processes of language##2##4##(2011-1#2)
underlying processes of##3##3##(2008-10#1)(2011-1#2)
underlying processes##5##2##(2008-10#1)(2009-11#1)(2010-6#1)(2011-1#2)
underlying psychiatric##2##2##(1991-12#1)(2008-12#1)
underlying reasons##3##2##(1990-3#1)(1996-2#1)(2007-8#1)
underlying regulatory mechanisms##2##3##(1994-8#1)(2008-11#1)
underlying regulatory##3##2##(1994-8#1)(2008-11#1)(2010-3#1)
underlying risk##2##2##(1994-2#1)(2007-10#1)
underlying sex change##2##3##(2010-5#2)
underlying sexual##2##2##(2008-11#1)(2010-3#1)
underlying social##4##2##(1994-1#1)(2008-4#1)(2008-8#1)(2013-8#1)
underlying stimulation-induced feeding in the sulcal prefrontal cortex##2##8##(1994-3#2)
underlying stimulation-induced feeding##3##3##(1994-3#3)
underlying structure##3##2##(2007-12#1)(2008-1#1)(2012-3#1)
underlying structures##3##2##(2007-8#2)(2011-2#1)
underlying such##2##2##(2008-11#1)(2012-12#1)
underlying synaptic##2##2##(2008-11#1)(2009-9#1)
underlying the HR##2##3##(2008-10#2)
underlying the association between##2##4##(1991-8#1)(2009-6#1)
underlying the pathophysiology of##2##4##(1992-3#1)(2013-8#1)
underlying the regulation of##2##4##(2008-11#1)(2011-2#1)
underlying the##80##2##(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
underlying their##5##2##(2008-3#1)(2009-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
underlying theory##2##2##(2007-11#1)(2013-1#1)
underlying these##12##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
underlying this effect##2##3##(2008-10#1)(2010-12#1)
underlying this phenomenon##2##3##(2008-1#1)(2008-10#1)
underlying this##15##2##(1990-7#1)(1993-2#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#1)
underlying tissue##3##2##(1991-2#1)(1991-5#1)(2010-6#1)
underlying tissues##2##2##(2008-10#1)(2008-4#1)
underlying wave##3##2##(2008-3#2)(2008-9#1)
underlying##598##1##(1990-11#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#3)(1992-9#2)(1993-1#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#3)(1994-2#4)(1994-3#6)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-8#3)(2006-10#1)(2006-6#1)(2007-10#5)(2007-11#7)(2007-12#10)(2007-2#1)(2007-7#9)(2007-8#8)(2008-1#18)(2008-10#23)(2008-11#30)(2008-12#10)(2008-2#7)(2008-3#21)(2008-4#15)(2008-5#11)(2008-6#5)(2008-7#33)(2008-8#20)(2008-9#17)(2009-10#10)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#9)(2009-9#7)(2010-1#2)(2010-10#8)(2010-11#8)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#12)(2011-2#28)(2011-3#3)(2012-1#3)(2012-12#16)(2012-2#31)(2012-3#8)(2013-1#21)(2013-7#3)(2013-8#12)
undermethylated##2##1##(1990-8#1)(1993-6#1)
undermine the goals##2##3##(1995-1#1)(2008-11#1)
undermine the##8##2##(1993-12#1)(1994-3#1)(1995-1#1)(2008-11#2)(2008-8#1)(2009-9#1)(2012-2#1)
undermine##15##1##(1993-12#2)(1994-3#1)(1995-1#2)(2008-11#2)(2008-8#2)(2009-11#2)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
undermined the##2##2##(1996-11#1)(2008-12#1)
undermined##4##1##(1996-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
undermines##6##1##(1992-2#1)(1997-1#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
undermining##2##1##(2008-10#1)(2009-10#1)
underneath a##2##2##(2008-2#2)
underneath the surface##2##3##(2008-5#2)
underneath the##6##2##(2008-11#2)(2008-2#1)(2008-5#2)(2010-2#1)
underneath##13##1##(1994-9#1)(2007-8#1)(2008-11#2)(2008-2#4)(2008-5#3)(2009-6#1)(2010-2#1)
undernourished##3##1##(1990-2#1)(1991-12#1)(2008-7#1)
undernourishment##2##1##(1990-6#1)(1991-6#1)
undernutrition##3##1##(1997-4#1)(2008-7#2)
underphosphorylated##3##1##(1993-8#1)(1996-2#2)
underpin##6##1##(2008-10#1)(2008-11#2)(2008-5#1)(2010-9#1)(2012-3#1)
underpinned by##3##2##(2008-10#1)(2008-12#2)
underpinned##4##1##(2008-10#1)(2008-12#3)
underpinning the##2##2##(2010-4#1)(2013-1#1)
underpinning##9##1##(2007-12#1)(2008-11#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
underpinnings of the##4##3##(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#1)
underpinnings of##12##2##(1991-12#1)(1991-2#1)(1993-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
underpinnings##17##1##(1991-12#1)(1991-2#1)(1993-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(2008-11#3)(2008-2#1)(2008-4#1)(2009-1#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
underpins the##5##2##(2008-1#1)(2008-9#2)(2009-9#1)(2010-12#1)
underpins##7##1##(2008-1#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2012-2#1)
underpowered##2##1##(2007-7#1)(2012-3#1)
underrecognized##2##1##(2008-6#1)(2008-8#1)
underreported##3##1##(2007-7#1)(2011-1#2)
underreporting of Lyme disease##2##4##(1997-3#2)
underreporting of##4##2##(1997-3#2)(2009-10#1)(2012-12#1)
underreporting##12##1##(1991-6#1)(1994-6#1)(1997-3#3)(2007-2#1)(2009-10#2)(2012-12#4)
underrepresented in##3##2##(2007-4#1)(2008-5#1)(2010-8#1)
underrepresented minority##2##2##(2012-3#2)
underrepresented##7##1##(2007-4#1)(2008-10#1)(2008-5#2)(2010-8#1)(2012-3#2)
undersampled##4##1##(2008-3#4)
undersampling##2##1##(2008-2#1)(2012-1#1)
underscore the importance of##8##4##(1990-6#1)(1991-2#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
underscore the need for##2##4##(1995-1#1)(2010-1#1)
underscore the need##3##3##(1991-6#1)(1995-1#1)(2010-1#1)
underscore the potential of##2##4##(2009-9#1)(2013-1#1)
underscore the potential##3##3##(2008-7#1)(2009-9#1)(2013-1#1)
underscore the usefulness of##2##4##(1997-7#1)(2011-2#1)
underscore the##26##2##(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
underscore##28##1##(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
underscored the##2##2##(2008-1#1)(2008-9#1)
underscored##4##1##(2008-1#1)(2008-9#1)(2012-12#2)
underscores the critical##2##3##(1995-3#1)(2008-7#1)
underscores the importance of##5##4##(1990-8#1)(2008-10#2)(2012-2#1)(2013-1#1)
underscores the need to##4##4##(1997-3#1)(2008-3#1)(2008-9#1)(2013-1#1)
underscores the need##5##3##(1997-3#1)(2008-3#1)(2008-9#2)(2013-1#1)
underscores the##18##2##(1990-8#1)(1995-2#1)(1995-3#1)(1997-3#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-7#1)(2012-2#2)(2013-1#2)
underscores##19##1##(1990-8#1)(1995-2#1)(1995-3#1)(1997-3#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
underscoring the##4##2##(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
underscoring##6##1##(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
underserved areas##2##2##(2008-1#1)(2010-11#1)
underserved populations##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
underserved women##3##2##(1996-2#1)(2011-2#2)
underserved##18##1##(1996-2#1)(1997-1#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#2)(2011-2#2)(2012-2#2)(2012-3#1)
understand about##2##2##(2008-7#2)
understand and be##2##3##(1997-4#1)(2013-8#1)
understand and##24##2##(1991-9#1)(1992-1#1)(1994-2#1)(1994-3#1)(1997-4#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
understand both##2##2##(2010-10#1)(2013-1#1)
understand how best to##2##4##(2011-2#1)(2012-3#1)
understand how the##9##3##(1992-3#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
understand how they##2##3##(2008-8#1)(2011-1#1)
understand how##36##2##(1992-3#1)(1993-5#1)(1995-5#1)(1997-6#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#3)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)
understand if##4##2##(2010-2#2)(2012-2#1)(2013-7#1)
understand individual##2##2##(2008-7#1)(2012-3#1)
understand its##5##2##(2008-2#1)(2008-5#2)(2010-2#1)(2010-7#1)
understand mechanisms##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
understand more about##4##3##(2008-1#1)(2008-11#2)(2008-7#1)
understand some##3##2##(2008-12#1)(2008-9#2)
understand that in the##2##4##(1993-3#1)(2008-1#1)
understand that##11##2##(1991-1#1)(1992-3#1)(1993-3#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#2)(2009-10#1)(2009-9#1)(2010-8#1)
understand the basis##2##3##(1997-7#1)(2008-10#1)
understand the behavior of##2##4##(2008-3#1)(2011-2#1)
understand the biochemical##2##3##(1990-8#1)(2008-7#1)
understand the biological##3##3##(1993-8#1)(2010-12#1)(2011-1#1)
understand the concept of##3##4##(1997-7#1)(2009-7#1)(2012-3#1)
understand the consequences##4##3##(1994-2#1)(2008-4#2)(2009-5#1)
understand the contribution of##2##4##(1994-3#1)(2010-5#1)
understand the development of##2##4##(2008-10#1)(2012-3#1)
understand the development##4##3##(2008-10#1)(2008-12#2)(2012-3#1)
understand the dynamics of##4##4##(1994-2#1)(2008-10#1)(2008-2#1)(2010-9#1)
understand the dynamics##6##3##(1994-2#1)(2008-10#1)(2008-2#1)(2010-9#1)(2012-3#2)
understand the epidemiology of##2##4##(2008-10#1)(2008-11#1)
understand the evolution and##2##4##(2008-10#1)(2010-3#1)
understand the evolution of##2##4##(2008-11#1)(2009-2#1)
understand the evolution##4##3##(2008-10#1)(2008-11#1)(2009-2#1)(2010-3#1)
understand the factors that##2##4##(2008-7#1)(2012-2#1)
understand the factors##4##3##(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
understand the formation##2##3##(1992-6#1)(2012-2#1)
understand the function of##5##4##(1996-12#1)(1997-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
understand the genetic##6##3##(1994-9#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-8#1)
understand the impact of##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
understand the importance of##2##4##(1994-12#1)(2008-1#1)
understand the importance##3##3##(1994-12#1)(2008-1#1)(2009-8#1)
understand the indications for##2##4##(2008-7#1)(2012-3#1)
understand the mechanism of##4##4##(1992-6#1)(1994-11#1)(2008-10#1)(2008-11#1)
understand the mechanism##7##3##(1992-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
understand the mechanisms that##2##4##(2008-10#1)(2010-8#1)
understand the mechanisms##7##3##(1992-4#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-8#1)
understand the microbial##2##3##(2008-5#1)(2012-2#1)
understand the molecular basis of##4##5##(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
understand the molecular basis##5##4##(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
understand the molecular mechanism##4##4##(1992-8#1)(1993-8#1)(1995-2#1)(2012-2#1)
understand the molecular mechanisms of##2##5##(2008-10#1)(2008-4#1)
understand the molecular mechanisms##3##4##(2008-10#2)(2008-4#1)
understand the molecular##13##3##(1992-8#1)(1993-8#1)(1995-2#1)(1995-5#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#2)
understand the nature of##3##4##(2008-10#3)
understand the nature##5##3##(2008-10#4)(2008-5#1)
understand the origin of##2##4##(1996-4#1)(2012-12#1)
understand the origin##3##3##(1996-4#1)(2008-5#1)(2012-12#1)
understand the pathophysiology of##4##4##(1996-12#1)(2008-1#2)(2008-7#1)
understand the pathophysiology##5##3##(1996-12#1)(2008-1#2)(2008-7#1)(2008-9#1)
understand the physiological significance of the##2##6##(1994-6#1)(2010-3#1)
understand the physiological##3##3##(1994-6#1)(1997-2#1)(2010-3#1)
understand the potential##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
understand the prevalence of##2##4##(2011-1#2)
understand the process##2##3##(2008-5#1)(2012-3#1)
understand the relationship between##2##4##(1995-2#1)(2008-10#1)
understand the relationship of##2##4##(1993-2#1)(2007-4#1)
understand the relationship##4##3##(1993-2#1)(1995-2#1)(2007-4#1)(2008-10#1)
understand the response##2##3##(2008-10#1)(2012-2#1)
understand the role of the##2##5##(2008-7#1)(2012-3#1)
understand the role of##9##4##(1997-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-7#2)(2012-3#1)
understand the social##2##3##(2011-2#1)(2013-1#1)
understand the structural basis##2##4##(1993-8#1)(1997-9#1)
understand the structural##3##3##(1993-8#1)(1997-9#1)(2008-8#1)
understand the##266##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#5)(2008-10#35)(2008-11#16)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#5)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#2)(2012-12#7)(2012-2#12)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#4)
understand their role and##2##4##(1990-12#1)(2008-3#1)
understand their##22##2##(1990-12#1)(1993-1#1)(1993-2#2)(1994-3#1)(1997-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
understand these##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
understand this phenomenon##4##3##(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
understand this process##2##3##(1994-2#1)(2008-7#1)
understand this##14##2##(1994-2#2)(1996-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-9#2)(2012-2#1)(2013-1#1)(2013-8#2)
understand what it##2##3##(2009-10#1)(2012-1#1)
understand what##8##2##(1996-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-1#2)(2013-8#1)
understand whether##4##2##(1997-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
understand which##2##2##(1991-3#1)(2008-11#1)
understand why##6##2##(1997-6#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
understand##523##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#7)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#3)(1996-1#3)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-4#2)(2007-8#1)(2008-1#9)(2008-10#47)(2008-11#32)(2008-12#14)(2008-2#8)(2008-3#13)(2008-4#8)(2008-5#13)(2008-6#5)(2008-7#24)(2008-8#12)(2008-9#14)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#10)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#7)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#13)(2012-1#7)(2012-12#9)(2012-2#17)(2012-3#15)(2013-1#23)(2013-7#2)(2013-8#10)
understandable##10##1##(1992-12#1)(1995-12#1)(1996-11#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
understanding a##2##2##(2008-7#1)(2010-3#1)
understanding about the##2##3##(1992-8#1)(2011-2#1)
understanding about##5##2##(1992-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
understanding among##2##2##(1995-3#1)(1997-2#1)
understanding and appreciation of##2##4##(2008-1#1)(2009-8#1)
understanding and interpretation of##2##4##(2008-7#1)(2009-12#1)
understanding and the##2##3##(2008-6#1)(2009-4#1)
understanding and treating##3##3##(1995-2#1)(2010-11#1)(2012-12#1)
understanding and treatment of##3##4##(1994-5#1)(2008-4#1)(2008-7#1)
understanding and##41##2##(1991-12#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-5#2)(1995-2#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#2)(2010-11#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
understanding as##2##2##(1993-1#1)(2008-12#1)
understanding biological systems##2##3##(2009-12#1)(2012-2#1)
understanding biological##3##2##(2008-5#1)(2009-12#1)(2012-2#1)
understanding both##2##2##(2008-11#1)(2010-6#1)
understanding customer##2##2##(1996-2#1)(1996-3#1)
understanding development##4##2##(2012-1#3)(2013-8#1)
understanding evolution##2##2##(1997-8#1)(2012-3#1)
understanding evolutionary##2##2##(2008-10#1)(2012-3#1)
understanding fasciolosis transmission in the Andes##2##6##(2008-8#2)
understanding how##10##2##(1991-12#1)(1997-1#1)(2008-7#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-2#3)
understanding in the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
understanding in this##2##3##(1992-9#1)(1997-1#1)
understanding in##6##2##(1992-9#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
understanding is a##2##3##(2008-9#1)(2010-3#1)
understanding is##5##2##(1997-3#1)(2008-12#1)(2008-9#1)(2010-3#1)(2013-1#1)
understanding its##2##2##(2011-1#1)(2013-1#1)
understanding long-term##2##2##(2009-9#1)(2010-2#1)
understanding mechanisms of##4##3##(2007-12#1)(2008-8#1)(2012-2#2)
understanding mechanisms##5##2##(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#2)
understanding of a##3##3##(2008-12#1)(2008-7#2)
understanding of all##2##3##(1995-12#1)(2010-7#1)
understanding of bacterial##2##3##(2008-10#2)
understanding of biological##2##3##(1991-5#1)(2008-10#1)
understanding of both##2##3##(2008-10#1)(2010-3#1)
understanding of cancer##3##3##(2007-11#1)(2009-6#1)(2012-12#1)
understanding of cell##2##3##(2008-7#2)
understanding of cellular##3##3##(1994-11#1)(2008-7#2)
understanding of community##2##3##(1993-1#1)(2008-12#1)
understanding of disease##4##3##(1997-7#1)(2006-10#1)(2008-10#1)(2011-7#1)
understanding of function##2##3##(2008-12#1)(2009-12#1)
understanding of fundamental##2##3##(2008-11#1)(2009-8#1)
understanding of gene##5##3##(2008-4#1)(2008-7#1)(2009-2#1)(2010-10#1)(2012-3#1)
understanding of how parents##2##4##(1993-12#1)(2010-9#1)
understanding of how these##4##4##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
understanding of how##35##3##(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2010-3#1)(2010-9#3)(2011-2#3)(2012-12#2)
understanding of human##2##3##(2008-11#1)(2008-4#1)
understanding of individual##2##3##(2008-10#1)(2012-1#1)
understanding of interactions between##2##4##(2008-11#1)(2011-1#1)
understanding of its role in##2##5##(2011-2#1)(2013-1#1)
understanding of its##6##3##(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#1)
understanding of mechanisms##5##3##(1997-3#1)(1997-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
understanding of mental##2##3##(2008-12#2)
understanding of molecular##3##3##(2007-10#1)(2008-11#1)(2011-2#1)
understanding of neurogenesis##2##3##(2007-12#1)(2008-9#1)
understanding of pathophysiology##3##3##(2006-10#1)(2008-9#1)(2013-1#1)
understanding of pediatric##2##3##(2010-5#1)(2011-2#1)
understanding of physiological##2##3##(2008-10#1)(2011-2#1)
understanding of plant##2##3##(2008-7#1)(2012-1#1)
understanding of risk factors##2##4##(2008-8#1)(2012-3#1)
understanding of skin##2##3##(2008-5#2)
understanding of some of the##2##5##(2008-4#1)(2009-12#1)
understanding of some##3##3##(1993-12#1)(2008-4#1)(2009-12#1)
understanding of such##3##3##(2008-7#1)(2008-8#1)(2009-5#1)
understanding of the action of##2##5##(1995-6#1)(1997-2#1)
understanding of the aetiology##3##4##(1997-1#1)(2009-4#2)
understanding of the anatomy and##2##5##(2007-8#1)(2008-8#1)
understanding of the animal##2##4##(2007-12#1)(2010-4#1)
understanding of the basic mechanisms##3##5##(2010-10#1)(2013-1#2)
understanding of the biological##4##4##(2008-7#1)(2009-11#1)(2012-2#1)(2013-8#1)
understanding of the biology and##2##5##(2008-10#1)(2013-1#1)
understanding of the biology of##6##5##(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
understanding of the biology##8##4##(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
understanding of the brain##2##4##(1990-6#1)(2009-9#1)
understanding of the clinical##2##4##(2008-11#2)
understanding of the complex##4##4##(1995-6#1)(2008-4#1)(2008-8#1)(2011-2#1)
understanding of the complexity of##2##5##(1996-3#1)(2007-12#1)
understanding of the current##2##4##(2008-10#1)(2011-1#1)
understanding of the data##3##4##(2008-7#2)(2008-9#1)
understanding of the development##2##4##(2008-7#2)
understanding of the disease##2##4##(1995-5#1)(2007-12#1)
understanding of the dynamics of the##3##6##(2008-10#2)(2008-11#1)
understanding of the dynamics of##5##5##(1997-3#1)(2008-10#2)(2008-11#1)(2010-3#1)
understanding of the ecology of SNC##2##6##(2008-10#2)
understanding of the ecology of##3##5##(2008-10#3)
understanding of the ecology##4##4##(2008-10#3)(2008-9#1)
understanding of the effect##2##4##(2008-8#1)(2013-1#1)
understanding of the effects of##4##5##(2008-3#2)(2009-7#1)(2011-2#1)
understanding of the epidemiology of##2##5##(2008-10#1)(2009-10#1)
understanding of the epidemiology##3##4##(2008-10#1)(2009-10#1)(2010-6#1)
understanding of the etiology of##2##5##(2007-11#1)(2007-12#1)
understanding of the evolution of##4##5##(1994-5#1)(2008-10#1)(2008-7#1)(2010-5#1)
understanding of the evolution##5##4##(1994-5#1)(2008-10#1)(2008-7#2)(2010-5#1)
understanding of the factors##3##4##(1997-4#1)(2008-9#1)(2012-1#1)
understanding of the genetic##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
understanding of the genetics##2##4##(2008-4#1)(2009-3#1)
understanding of the history of##2##5##(1997-1#1)(2009-10#1)
understanding of the human##2##4##(2008-11#1)(2009-11#1)
understanding of the impact of##3##5##(1994-2#1)(2007-5#1)(2011-2#1)
understanding of the importance of##4##5##(1991-12#1)(2007-12#2)(2010-12#1)
understanding of the influence of##2##5##(2008-11#1)(2011-1#1)
understanding of the interrelationships##2##4##(2008-10#1)(2008-12#1)
understanding of the mechanism of##2##5##(1994-8#1)(2007-11#1)
understanding of the mechanism##3##4##(1990-8#1)(1994-8#1)(2007-11#1)
understanding of the mechanisms by which##2##6##(2008-1#1)(2013-1#1)
understanding of the mechanisms involved in##2##6##(1997-3#1)(2008-4#1)
understanding of the mechanisms of##8##5##(1995-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#2)
understanding of the mechanisms that##3##5##(2008-7#1)(2012-2#1)(2012-3#1)
understanding of the mechanisms##20##4##(1995-11#1)(1997-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
understanding of the metabolism##2##4##(2008-3#1)(2008-7#1)
understanding of the molecular basis of##3##6##(2008-1#1)(2008-11#1)(2011-2#1)
understanding of the molecular##8##4##(1991-12#1)(1996-4#1)(2008-1#1)(2008-11#2)(2009-3#1)(2011-2#2)
understanding of the nature of##5##5##(1992-3#1)(1994-11#1)(1995-1#1)(2008-11#1)(2008-6#1)
understanding of the nature##6##4##(1992-3#1)(1994-11#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
understanding of the neural mechanisms underlying##3##6##(2008-7#1)(2012-12#1)(2012-2#1)
understanding of the neural##5##4##(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#2)
understanding of the pathogenesis of##9##5##(1990-9#1)(1994-3#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
understanding of the pathogenesis##10##4##(1990-9#1)(1994-3#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#2)(2013-1#1)
understanding of the pathology##2##4##(2008-10#1)(2010-3#1)
understanding of the pathophysiology##4##4##(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
understanding of the physical##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
understanding of the physiological##6##4##(1997-3#1)(1997-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-2#1)
understanding of the physiology##2##4##(2010-3#1)(2012-12#1)
understanding of the principles##2##4##(1995-3#1)(2012-12#1)
understanding of the process of##2##5##(2007-8#1)(2012-3#1)
understanding of the process##5##4##(1994-12#1)(1995-1#1)(1996-8#1)(2007-8#1)(2012-3#1)
understanding of the processes##2##4##(1996-12#1)(2010-9#1)
understanding of the relationship between structure and##2##7##(2009-5#1)(2010-4#1)
understanding of the relationship between the##2##6##(2008-7#1)(2012-5#1)
understanding of the relationship between##4##5##(2008-7#1)(2009-5#1)(2010-4#1)(2012-5#1)
understanding of the relationship##5##4##(2008-7#1)(2009-5#1)(2010-10#1)(2010-4#1)(2012-5#1)
understanding of the role of##17##5##(1992-2#1)(1993-3#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
understanding of the role##19##4##(1992-2#1)(1993-3#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
understanding of the significance of##2##5##(1990-2#1)(2012-3#1)
understanding of the underlying##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
understanding of the various##2##4##(2007-12#1)(2013-1#1)
understanding of the##364##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#4)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#11)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#35)(2008-11#21)(2008-12#7)(2008-2#3)(2008-3#12)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#26)(2008-8#11)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#19)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#10)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#7)
understanding of their##9##3##(1995-5#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
understanding of these factors##2##4##(2010-8#1)(2011-2#1)
understanding of these molecular##2##4##(2008-2#1)(2013-1#1)
understanding of these##15##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
understanding of this complex##3##4##(1996-12#1)(2008-5#1)(2008-7#1)
understanding of this##14##3##(1991-6#1)(1993-1#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
understanding of tree##2##3##(2008-10#1)(2010-4#1)
understanding of viral##2##3##(2006-10#1)(2013-1#1)
understanding of ways to##2##4##(2009-4#1)(2012-3#1)
understanding of what##5##3##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
understanding of##734##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#5)(1997-2#2)(1997-3#8)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-10#4)(2007-11#6)(2007-12#20)(2007-5#2)(2007-7#5)(2007-8#6)(2008-1#9)(2008-10#65)(2008-11#41)(2008-12#28)(2008-2#5)(2008-3#15)(2008-4#15)(2008-5#19)(2008-6#4)(2008-7#50)(2008-8#19)(2008-9#33)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#10)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#8)(2009-9#6)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#7)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#6)(2011-1#13)(2011-10#1)(2011-2#37)(2011-7#2)(2012-1#9)(2012-12#16)(2012-2#26)(2012-3#20)(2012-5#1)(2013-1#30)(2013-7#1)(2013-8#12)
understanding on how##2##3##(2009-10#1)(2009-12#1)
understanding on the##6##3##(2008-5#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
understanding on##8##2##(2008-5#1)(2009-10#1)(2009-12#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
understanding or##2##2##(2013-1#2)
understanding regarding the##2##3##(2008-8#1)(2013-1#1)
understanding regarding##4##2##(2008-4#1)(2008-8#1)(2010-3#1)(2013-1#1)
understanding that##4##2##(1996-3#1)(2006-12#1)(2007-2#1)(2008-9#1)
understanding the benefits and##2##4##(1996-12#1)(2009-12#1)
understanding the biological##2##3##(2009-5#1)(2010-3#1)
understanding the differences in##2##4##(2008-8#1)(2010-12#1)
understanding the disease##3##3##(1993-11#1)(2007-7#1)(2008-6#1)
understanding the evolution of##6##4##(2008-11#1)(2008-6#1)(2008-8#2)(2012-2#1)(2013-1#1)
understanding the factors that##2##4##(1992-1#1)(2008-10#1)
understanding the function of##4##4##(2007-12#1)(2008-9#2)(2009-6#1)
understanding the impact of##3##4##(1994-1#1)(2009-12#1)(2010-1#1)
understanding the mechanism##2##3##(2008-10#1)(2008-9#1)
understanding the mechanisms of##3##4##(1991-12#1)(1994-8#1)(2009-8#1)
understanding the mechanisms underlying##4##4##(1990-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
understanding the mechanisms##9##3##(1990-5#1)(1991-12#1)(1994-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#2)(2013-1#1)
understanding the molecular basis of##3##5##(2008-11#2)(2008-9#1)
understanding the molecular##8##3##(1994-11#1)(2008-11#3)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
understanding the nature and##2##4##(2008-4#1)(2012-2#1)
understanding the nature##4##3##(1993-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
understanding the pathogenesis of##2##4##(1993-11#1)(2010-12#1)
understanding the process of##2##4##(2008-12#1)(2009-12#1)
understanding the relationship between##3##4##(1992-2#1)(2011-2#1)(2012-1#1)
understanding the role of##7##4##(1991-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
understanding the role##8##3##(1991-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
understanding the social##2##3##(2008-11#1)(2008-6#1)
understanding the spread of##2##4##(2008-1#1)(2008-10#1)
understanding the structure##2##3##(2008-5#1)(2011-2#1)
understanding the##160##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#3)(1993-12#2)(1993-2#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#13)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#6)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#6)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#4)
understanding their##4##2##(1990-5#1)(2008-1#1)(2008-10#1)(2012-2#1)
understanding these##2##2##(2011-2#1)(2012-2#1)
understanding this##5##2##(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
understanding to##2##2##(2009-12#1)(2011-1#1)
understanding was##4##2##(2008-7#3)(2012-2#1)
understanding what##3##2##(1992-9#1)(2008-4#1)(2012-2#1)
understanding why##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
understanding##1163##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#7)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#6)(1993-11#4)(1993-12#7)(1993-2#4)(1993-3#3)(1993-8#1)(1994-1#2)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#4)(1996-1#2)(1996-11#3)(1996-12#6)(1996-2#5)(1996-3#4)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#7)(1997-2#3)(1997-3#12)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2006-10#5)(2006-12#1)(2007-10#5)(2007-11#8)(2007-12#28)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#7)(2007-8#9)(2008-1#15)(2008-10#95)(2008-11#63)(2008-12#43)(2008-2#7)(2008-3#23)(2008-4#24)(2008-5#29)(2008-6#12)(2008-7#66)(2008-8#32)(2008-9#48)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#16)(2009-2#4)(2009-3#7)(2009-4#12)(2009-5#8)(2009-6#7)(2009-7#9)(2009-8#13)(2009-9#10)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#9)(2010-2#3)(2010-3#15)(2010-4#8)(2010-5#8)(2010-6#5)(2010-7#4)(2010-8#7)(2010-9#7)(2011-1#23)(2011-10#1)(2011-2#56)(2011-7#3)(2012-1#15)(2012-12#29)(2012-2#52)(2012-3#27)(2012-5#2)(2012-9#1)(2013-1#49)(2013-7#2)(2013-8#20)
understandings of the##4##3##(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
understandings of##5##2##(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#2)
understandings on##2##2##(1990-12#1)(2009-2#1)
understandings##11##1##(1990-12#1)(1994-12#1)(2008-11#1)(2008-7#1)(2009-2#2)(2010-1#1)(2010-10#1)(2010-5#1)(2013-1#2)
understands the##3##2##(1994-1#1)(1994-2#1)(2008-11#1)
understood about the##2##3##(1997-3#1)(2007-12#1)
understood and supported##2##3##(1993-2#1)(2008-1#1)
understood and##22##2##(1990-5#1)(1993-2#2)(1994-2#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#3)
understood as a##3##3##(2008-10#2)(2008-6#1)
understood as an##4##3##(1996-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
understood as the##2##3##(2011-2#1)(2012-2#1)
understood as##11##2##(1995-2#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
understood at the molecular level##2##5##(1995-2#1)(2008-10#1)
understood by##8##2##(1992-3#1)(1993-2#1)(1994-1#1)(2008-10#1)(2008-4#2)(2010-2#1)(2010-9#1)
understood from##3##2##(1990-7#1)(2008-8#1)(2009-10#1)
understood how##2##2##(2008-4#1)(2013-1#1)
understood in terms of##2##4##(1996-4#1)(2013-7#1)
understood in##8##2##(1996-4#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
understood on the##2##3##(1990-5#1)(2008-7#1)
understood that the##3##3##(1991-1#1)(1991-12#1)(2012-3#1)
understood that##7##2##(1991-1#1)(1991-12#1)(1993-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
understood the##6##2##(1992-12#1)(1994-2#1)(1996-9#2)(2008-11#1)(2013-1#1)
understood their##2##2##(1996-1#1)(2008-11#1)
understood to##3##2##(2009-1#1)(2010-8#1)(2012-3#1)
understood with##2##2##(2009-4#1)(2011-2#1)
understood##290##1##(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-9#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#22)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#12)(2008-5#8)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#2)(2009-3#5)(2009-4#1)(2009-5#4)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#4)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#11)(2013-1#12)(2013-7#3)(2013-8#9)
understory plants##3##2##(2008-5#1)(2008-8#2)
understory shrub Jacquinia nervosa##2##4##(2008-5#2)
understory##18##1##(2008-10#1)(2008-5#6)(2008-8#5)(2008-9#6)
understudied##4##1##(2008-10#1)(2012-2#1)(2013-1#2)
undersupplied##2##1##(2008-9#2)
undertake a##7##2##(2008-10#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-2#1)
undertake its##2##2##(1994-1#1)(2011-1#1)
undertake this##3##2##(2007-10#1)(2008-11#2)
undertake##28##1##(1991-3#2)(1992-1#1)(1992-9#1)(1993-12#1)(1994-1#2)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#8)(2008-12#3)(2008-3#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
undertaken and##2##2##(2008-10#2)
undertaken as##2##2##(2007-5#1)(2012-3#1)
undertaken at a##3##3##(1993-11#1)(1993-12#1)(2013-1#1)
undertaken at the##2##3##(2008-11#1)(2008-5#1)
undertaken at##10##2##(1993-11#1)(1993-12#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#2)
undertaken by alliances##2##3##(2013-1#2)
undertaken by an##2##3##(1991-3#1)(1993-9#1)
undertaken by the##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
undertaken by##17##2##(1991-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#2)(2011-2#1)(2013-1#2)
undertaken for##6##2##(2008-10#1)(2012-12#5)
undertaken from##4##2##(1995-12#1)(2007-7#1)(2013-1#2)
undertaken in support of the##2##5##(1994-12#1)(2008-10#1)
undertaken in the last decade##2##5##(2008-7#1)(2012-12#1)
undertaken in the##8##3##(1996-5#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
undertaken in##34##2##(1992-2#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#2)(1996-2#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
undertaken on##6##2##(1990-12#1)(1993-11#1)(2007-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
undertaken that##2##2##(1992-12#1)(2008-10#1)
undertaken to characterize the##3##4##(1994-2#1)(2007-7#1)(2008-10#1)
undertaken to control##2##3##(2008-11#1)(2011-2#1)
undertaken to determine if##3##4##(1993-11#1)(2008-7#1)(2012-3#1)
undertaken to determine the##12##4##(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-3#1)(2010-4#1)(2012-12#1)
undertaken to determine##20##3##(1993-11#1)(1993-6#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)
undertaken to elucidate##2##3##(1997-7#1)(2008-10#1)
undertaken to examine how##2##4##(1993-2#1)(2011-2#1)
undertaken to examine the##3##4##(1994-6#1)(2008-7#1)(2009-12#1)
undertaken to examine##7##3##(1993-2#1)(1994-6#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#2)
undertaken to get##2##3##(2010-11#1)(2013-1#1)
undertaken to identify##3##3##(1993-3#1)(1993-6#1)(2012-12#1)
undertaken to investigate the##7##4##(1991-2#1)(1994-12#1)(1995-6#1)(2008-7#1)(2010-3#1)(2012-2#2)
undertaken to investigate##8##3##(1991-2#1)(1994-12#1)(1995-6#1)(2008-7#1)(2010-3#1)(2012-2#2)(2013-1#1)
undertaken to##105##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#12)(2008-11#8)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#8)(2009-12#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)
undertaken using a##3##3##(2008-5#1)(2008-7#1)(2010-3#1)
undertaken using##10##2##(1992-9#1)(1997-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#2)
undertaken with##8##2##(1990-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)
undertaken within##3##2##(2008-11#3)
undertaken##286##1##(1990-12#3)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#6)(2007-8#6)(2008-1#2)(2008-10#33)(2008-11#24)(2008-12#7)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#10)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#1)
undertakes##3##1##(1992-12#1)(2008-11#1)(2008-12#1)
undertaking a##9##2##(1993-12#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-12#1)
undertaking the##5##2##(1996-7#1)(2008-11#1)(2008-12#2)(2013-8#1)
undertaking##36##1##(1991-12#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-11#13)(2008-12#4)(2008-9#1)(2013-8#1)
undertook a study##2##3##(1990-5#1)(2009-6#1)
undertook a##7##2##(1990-5#1)(1991-11#1)(1992-3#1)(2007-12#1)(2008-8#1)(2009-6#1)(2013-1#1)
undertook an##2##2##(1995-2#1)(2008-10#1)
undertook the##3##2##(1990-5#1)(1997-2#1)(2008-1#1)
undertook##20##1##(1990-5#2)(1991-11#1)(1992-3#1)(1994-11#1)(1995-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
undertreated##6##1##(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#2)
undertreatment of##3##2##(2008-4#1)(2010-3#2)
underuse##3##1##(1990-8#1)(2007-10#1)(2008-3#1)
underused in##4##2##(2008-12#1)(2008-3#2)(2010-8#1)
underused##7##1##(2007-10#1)(2008-12#1)(2008-3#3)(2009-3#1)(2010-8#1)
underutilization of##4##2##(1996-1#1)(2008-3#1)(2010-4#1)(2011-2#1)
underutilization##5##1##(1996-1#1)(1997-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
underutilized in##2##2##(2008-11#1)(2012-3#1)
underutilized##8##1##(1992-1#1)(1992-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
underwater##13##1##(2008-10#3)(2008-2#3)(2008-3#6)(2010-2#1)
underway in the##3##3##(1995-3#1)(1996-4#1)(1997-3#1)
underway in##5##2##(1992-1#1)(1995-3#1)(1996-4#1)(1997-3#1)(2008-2#1)
underway to##8##2##(1993-11#1)(1994-10#1)(1994-5#1)(2008-4#2)(2008-8#1)(2009-1#1)(2012-2#1)
underway##28##1##(1992-1#1)(1992-12#1)(1993-11#1)(1994-1#1)(1994-10#1)(1994-5#1)(1995-3#1)(1996-4#1)(1997-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-8#2)(2009-1#1)(2009-10#1)(2010-12#1)(2012-2#2)
underweight and overweight##2##3##(1991-12#2)
underweight##15##1##(1991-12#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2010-6#2)(2010-7#1)(2011-1#3)(2013-1#2)
underwent CABG##2##2##(2007-8#2)
underwent GVBD##2##2##(1995-2#2)
underwent RRT##2##2##(2012-3#2)
underwent TMS in##2##3##(2011-2#2)
underwent a combined##2##3##(2008-11#1)(2008-9#1)
underwent a comprehensive##2##3##(2009-10#1)(2012-12#1)
underwent a laparoscopic##2##3##(2010-3#1)(2012-12#1)
underwent a modified radical##2##4##(1994-12#1)(2008-9#1)
underwent a new##3##3##(1991-9#1)(2007-8#1)(2012-3#1)
underwent a standard##2##3##(2007-9#1)(2011-2#1)
underwent a total##5##3##(2007-8#1)(2008-1#1)(2009-3#1)(2012-12#1)(2013-1#1)
underwent a##77##2##(1990-9#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-10#4)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#2)(2008-7#5)(2008-9#9)(2009-10#2)(2009-3#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#8)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#2)
underwent acute##2##2##(2011-2#1)(2013-1#1)
underwent adjuvant##2##2##(2010-6#1)(2011-2#1)
underwent ambulatory##2##2##(1992-8#1)(2008-3#1)
underwent an emergency##2##3##(2011-2#1)(2013-1#1)
underwent an oral glucose tolerance test##2##6##(1994-12#1)(2008-3#1)
underwent an##27##2##(1990-5#1)(1990-6#1)(1994-12#1)(1995-1#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#4)
underwent aortic##2##2##(2007-8#2)
underwent apoptosis##2##2##(2008-11#2)
underwent appendectomy##2##2##(1997-8#1)(2008-10#1)
underwent arthrodesis##2##2##(2008-6#2)
underwent arthroscopic##2##2##(2007-11#1)(2013-1#1)
underwent biopsy##5##2##(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-7#1)
underwent bone##2##2##(1991-11#1)(2011-2#1)
underwent cervicotomy##2##2##(2013-1#2)
underwent combined##2##2##(2007-8#1)(2008-8#1)
underwent complete resection##2##3##(1990-8#1)(2013-8#1)
underwent complete##5##2##(1990-6#1)(1990-8#1)(1997-8#1)(2007-8#1)(2013-8#1)
underwent computed tomography##2##3##(2010-10#1)(2012-2#1)
underwent conventional##2##2##(2007-8#1)(2008-11#1)
underwent coronary angiography##2##3##(2008-3#1)(2008-7#1)
underwent coronary##3##2##(2007-8#1)(2008-3#1)(2008-7#1)
underwent correction of##2##3##(2008-9#1)(2009-10#1)
underwent curative##2##2##(1991-6#1)(2011-2#1)
underwent diffusion##2##2##(2009-11#1)(2010-7#1)
underwent elective##3##2##(2007-8#1)(2008-11#1)(2012-12#1)
underwent embolization##2##2##(1991-2#1)(2008-7#1)
underwent emergency surgery##2##3##(2008-11#1)(2010-12#1)
underwent emergency##4##2##(1992-5#1)(2008-1#1)(2008-11#1)(2010-12#1)
underwent endoscopic therapy##2##3##(2012-2#2)
underwent endoscopic##4##2##(2007-8#1)(2011-2#1)(2012-2#2)
underwent examination##2##2##(1991-12#1)(2007-11#1)
underwent excision##2##2##(2008-6#1)(2008-9#1)
underwent full-text review##2##3##(2012-12#2)
underwent further##3##2##(2008-6#2)(2008-7#1)
underwent implantation of##2##3##(2007-10#2)
underwent incisional biopsy##2##3##(1997-6#1)(2010-11#1)
underwent laparoscopic##6##2##(1993-12#1)(1994-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#1)
underwent left Lateral##2##3##(2008-1#2)
underwent left##3##2##(2008-1#2)(2008-6#1)
underwent lung transplantation##2##3##(1994-3#1)(2010-10#1)
underwent magnetic resonance imaging##2##4##(2010-3#1)(2011-2#1)
underwent mitotic##2##2##(1995-8#1)(2013-1#1)
underwent multielemental##2##2##(2008-10#2)
underwent myocardial##2##2##(2007-8#1)(2007-9#1)
underwent open reduction and internal fixation##2##6##(2008-12#1)(2009-3#1)
underwent open reduction##3##3##(2008-12#1)(2009-3#1)(2013-1#1)
underwent open##5##2##(2008-10#1)(2008-12#1)(2009-3#1)(2013-1#2)
underwent orthotopic liver transplantation from##2##5##(1992-12#1)(2013-8#1)
underwent orthotopic liver transplantation##3##4##(1991-11#1)(1992-12#1)(2013-8#1)
underwent partial##3##2##(2011-2#1)(2012-3#1)(2013-7#1)
underwent posterior##2##2##(2008-11#1)(2008-8#1)
underwent preoperative##2##2##(1996-8#1)(2008-7#1)
underwent primary##3##2##(1996-9#1)(2007-11#1)(2008-6#1)
underwent radical surgery##5##3##(1990-6#1)(1990-9#1)(1992-10#2)(1997-7#1)
underwent radical surgical treatment##2##4##(2011-2#2)
underwent radical##9##2##(1990-3#1)(1990-6#1)(1990-9#1)(1992-10#2)(1994-7#1)(1997-7#1)(2011-2#2)
underwent radiotherapy##2##2##(2007-8#1)(2011-2#1)
underwent reimplantation with the Nucleus Freedom or Nucleus 5 device##2##10##(2012-2#2)
underwent reimplantation##3##2##(2008-1#1)(2012-2#2)
underwent renal biopsy##2##3##(2008-1#1)(2013-1#1)
underwent renal##3##2##(2008-1#2)(2013-1#1)
underwent repeated surgical##2##3##(2006-12#1)(2012-12#1)
underwent repeated##4##2##(2006-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
underwent resection of the##2##4##(2007-11#1)(2008-6#1)
underwent resection of##4##3##(2007-11#1)(2007-8#1)(2008-6#1)(2012-12#1)
underwent resections##2##2##(1991-4#1)(1992-6#1)
underwent right##2##2##(2008-1#1)(2012-1#1)
underwent salvage##2##2##(1990-6#1)(2010-3#1)
underwent spinal##2##2##(2008-7#1)(2012-3#1)
underwent successful##4##2##(2007-8#1)(2008-12#1)(2009-5#1)(2013-1#1)
underwent surgery after##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
underwent surgery and##2##3##(1992-12#1)(2011-1#1)
underwent surgery at##3##3##(2008-6#1)(2011-1#1)(2011-2#1)
underwent surgery for##4##3##(1994-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
underwent surgery##25##2##(1991-6#1)(1992-12#1)(1994-2#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2011-1#3)(2011-2#3)(2012-3#2)(2013-1#3)
underwent surgical repair##2##3##(2007-8#1)(2008-12#1)
underwent surgical resection##2##3##(2007-8#1)(2012-1#1)
underwent surgical##13##2##(1992-10#1)(1993-6#1)(1996-3#1)(2007-8#3)(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
underwent the##10##2##(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
underwent this procedure##3##3##(1990-2#1)(2008-11#1)(2012-3#1)
underwent this##4##2##(1990-2#1)(2008-11#2)(2012-3#1)
underwent thoracotomy and##2##3##(2007-8#1)(2011-2#1)
underwent total##9##2##(1992-12#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)
underwent transcatheter closure of##2##4##(1996-6#1)(2008-11#1)
underwent transient##2##2##(2008-10#1)(2010-10#1)
underwent treatment at##2##3##(2007-11#1)(2008-7#1)
underwent tumor##2##2##(2007-10#1)(2010-3#1)
underwent two##5##2##(1997-6#1)(2007-12#2)(2008-5#1)(2009-6#1)
underwent upper##2##2##(2008-11#1)(2011-2#1)
underwent##600##1##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#4)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#2)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#3)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#7)(2006-12#2)(2006-6#1)(2007-10#14)(2007-11#21)(2007-12#2)(2007-5#1)(2007-7#5)(2007-8#44)(2007-9#3)(2008-1#16)(2008-10#18)(2008-11#22)(2008-12#11)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#19)(2008-7#28)(2008-8#8)(2008-9#20)(2009-1#1)(2009-10#5)(2009-11#2)(2009-3#9)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#8)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#69)(2011-3#2)(2012-1#2)(2012-12#15)(2012-2#17)(2012-3#22)(2013-1#43)(2013-7#3)(2013-8#10)
underwriters##8##1##(1992-3#1)(1993-12#2)(1993-3#2)(1995-3#1)(1996-12#1)(1997-2#1)
underwriting factors##5##2##(1993-3#5)
underwriting##14##1##(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#6)(1994-2#1)(1995-1#2)(1996-2#1)
undescended testis##3##2##(2008-10#2)(2012-12#1)
undescended##5##1##(2008-10#4)(2012-12#1)
undescribed species of the##2##4##(2008-10#1)(2008-5#1)
undescribed species of##4##3##(2008-10#3)(2008-5#1)
undescribed species##8##2##(2008-10#5)(2008-5#2)(2008-6#1)
undescribed##29##1##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-5#2)(2008-6#1)(2010-3#1)(2011-1#3)(2012-3#2)
undesirable and##3##2##(2008-5#1)(2008-9#1)(2012-2#1)
undesirable effects##2##2##(2007-11#1)(2009-6#1)
undesirable side effects##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
undesirable side##4##2##(1993-11#1)(1993-12#1)(1995-12#1)(2008-7#1)
undesirable##31##1##(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
undesired##15##1##(1993-2#1)(1994-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)
undetectable by##3##2##(1994-8#1)(1994-9#1)(1995-6#1)
undetectable in the##4##3##(1991-12#1)(1994-11#1)(1996-12#1)(1997-6#1)
undetectable in##13##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(2012-2#1)(2013-1#2)
undetectable level##2##2##(1990-9#1)(1994-3#1)
undetectable levels##10##2##(1997-2#2)(2007-11#1)(2008-10#5)(2008-5#1)(2012-1#1)
undetectable on##4##2##(1991-12#1)(1995-6#1)(2008-7#1)(2008-8#1)
undetectable viral##2##2##(2008-10#1)(2013-1#1)
undetectable##57##1##(1990-11#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-5#1)(1992-3#1)(1994-11#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
undetected and##3##2##(1995-12#1)(2008-10#1)(2009-6#1)
undetected in##3##2##(1997-6#2)(2009-8#1)
undetected##22##1##(1990-2#1)(1992-8#1)(1995-12#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
undetermined##14##1##(1991-3#1)(1992-2#1)(1993-1#1)(1993-5#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-8#1)
undeveloped##2##1##(2010-9#1)(2011-2#1)
undiagnosed and##2##2##(2007-10#1)(2012-12#1)
undiagnosed##29##1##(1991-11#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#3)
undifferentiated F9 cells##2##3##(1992-9#2)
undifferentiated P19 cells##2##3##(1990-11#1)(1992-12#1)
undifferentiated PC12 cell deaths at##2##5##(2013-8#2)
undifferentiated PC12 cells##2##3##(2008-4#1)(2013-8#1)
undifferentiated PC12##4##2##(2008-4#1)(2013-8#3)
undifferentiated carcinoma##8##2##(1991-8#2)(1995-10#1)(2007-5#1)(2008-3#4)
undifferentiated cell mass##2##3##(2007-12#1)(2009-6#1)
undifferentiated cells##9##2##(1992-12#1)(1992-3#2)(1992-9#1)(2007-12#1)(2008-11#1)(2008-4#2)(2009-8#1)
undifferentiated embryonic stem cells##2##4##(2008-11#2)
undifferentiated hESC##2##2##(2008-11#1)(2008-9#1)
undifferentiated spondarthritides##2##2##(1990-6#2)
undifferentiated state##3##2##(2008-11#1)(2012-1#1)(2013-1#1)
undifferentiated thyroid##2##2##(1990-3#1)(1992-8#1)
undifferentiated##58##1##(1990-11#1)(1990-3#1)(1990-6#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#4)(1995-10#1)(1997-2#1)(2007-12#2)(2007-5#2)(2008-10#1)(2008-11#8)(2008-3#4)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2011-2#6)(2012-1#1)(2013-1#1)(2013-8#4)
undigested##7##1##(1992-12#2)(1993-11#1)(1994-12#1)(2008-10#2)(2008-12#1)
undiluted samples##3##2##(2008-10#3)
undiluted serum##4##2##(1993-12#4)
undiluted##16##1##(1991-12#1)(1993-12#4)(2008-10#9)(2013-1#2)
undirected##2##1##(2011-2#1)(2012-3#1)
undiscovered##5##1##(1994-2#1)(1996-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
undisputed##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
undissociated##2##1##(2008-6#1)(2011-2#1)
undissolved##2##1##(2008-10#2)
undistorted##6##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
undisturbed##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
undivided##2##1##(2010-2#1)(2011-2#1)
undoped PbO(2)##2##2##(2008-10#2)
undoped YAG##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
undoped and##2##2##(2007-12#1)(2008-10#1)
undoped nematic liquid crystals##2##4##(2007-11#1)(2007-12#1)
undoped##21##1##(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#6)(2008-3#5)(2008-7#1)
undoubtedly have##2##2##(1991-12#1)(1994-3#1)
undoubtedly##19##1##(1991-12#2)(1991-8#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-11#1)(2007-12#1)(2008-12#2)(2008-7#3)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2012-12#1)
undrugged behavior##5##2##(1993-3#5)
undrugged##9##1##(1992-7#1)(1993-12#1)(1993-3#7)
undue burden##2##2##(1995-9#1)(1997-7#1)
undue inducement##2##2##(2009-6#2)
undue##15##1##(1992-2#1)(1992-3#1)(1994-12#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#3)(2010-8#1)
undulate (vs##3##2##(2008-5#3)
undulate##4##1##(2008-5#3)(2011-2#1)
undulated##2##1##(2007-12#1)(2010-10#1)
undulation##3##1##(2009-7#3)
undulosa##6##1##(2008-10#6)
une complication##2##2##(2011-2#2)
une pathologie##3##2##(2011-2#1)(2013-1#2)
une prise en charge##2##4##(2011-2#1)(2013-1#1)
une##43##1##(2008-11#3)(2008-5#10)(2011-2#8)(2013-1#22)
unedited##4##1##(1990-11#2)(1993-12#2)
uneducated##2##1##(1994-7#1)(2012-2#1)
unembalmed##2##1##(2009-1#1)(2012-2#1)
unemployed and underemployed##2##3##(2013-1#2)
unemployed workers##5##2##(2013-1#5)
unemployed##15##1##(1995-12#1)(1997-2#2)(2008-12#1)(2010-11#1)(2011-1#1)(2013-1#9)
unemployment or economic inactivity##3##4##(2013-1#3)
unemployment##22##1##(1991-11#2)(1992-11#1)(1993-3#1)(1997-2#2)(2008-1#1)(2008-11#2)(2008-12#2)(2010-6#1)(2011-1#2)(2011-2#1)(2013-1#7)
unenhanced MRA##2##2##(2008-7#2)
unenhanced transcription##2##2##(1995-6#2)
unenhanced##7##1##(1995-6#3)(2008-7#2)(2010-12#1)(2012-2#1)
unequal access to##2##3##(1991-3#1)(2013-1#1)
unequal access##3##2##(1991-3#1)(2012-2#1)(2013-1#1)
unequal competitors##2##2##(2008-8#2)
unequal mirrors##3##2##(2008-3#3)
unequal sample sizes##3##3##(1991-12#1)(1996-3#1)(2012-1#1)
unequal sister chromatid##2##3##(1993-12#2)
unequal thicknesses##2##2##(2008-3#2)
unequal variances using a generalized least-squares method##2##7##(2012-1#2)
unequal variances##3##2##(1995-12#1)(2012-1#2)
unequal##41##1##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#2)(1993-6#1)(1994-2#1)(1995-12#1)(1996-3#2)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-1#7)(2012-2#1)(2013-1#1)
unequally##3##1##(2008-5#1)(2008-7#2)
unequivocal diagnosis##2##2##(1990-8#1)(1997-3#1)
unequivocal evidence##2##2##(2008-10#1)(2012-3#1)
unequivocal##17##1##(1990-6#1)(1990-8#1)(1991-9#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
unequivocally demonstrate##2##2##(1993-6#1)(2007-8#1)
unequivocally##17##1##(1990-7#1)(1990-8#1)(1992-9#1)(1993-6#1)(1994-1#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#3)(2011-2#1)
unessential##2##1##(1990-8#1)(2008-10#1)
unesterified##2##1##(1990-8#2)
unethical trade practices##2##3##(2008-7#2)
unethical##6##1##(1992-12#1)(2008-12#3)(2008-7#2)
uneven and##2##2##(2007-7#1)(2008-11#1)
uneven distribution of the##2##4##(1994-6#1)(2008-10#1)
uneven distribution of##5##3##(1993-6#1)(1994-6#1)(2008-10#2)(2013-1#1)
uneven distribution##6##2##(1993-6#1)(1994-6#1)(2008-1#1)(2008-10#2)(2013-1#1)
uneven##22##1##(1992-5#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
unevenly distributed across##2##3##(1995-2#1)(2008-10#1)
unevenly distributed##3##2##(1995-2#1)(2008-10#2)
unevenly##8##1##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2009-5#1)
unevenness##2##1##(2008-5#1)(2008-8#1)
uneventful postoperative course##2##3##(2007-8#1)(2011-2#1)
uneventful##43##1##(1991-11#1)(1993-2#1)(1993-9#1)(1994-2#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-12#2)(2008-9#2)(2009-5#1)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)
uneventfully##8##1##(1994-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
unexpected and##6##2##(1994-3#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-6#1)(2011-1#1)
unexpected because##2##2##(2007-11#1)(2011-2#1)
unexpected complication##2##2##(1990-3#1)(2010-12#1)
unexpected death in##2##3##(1991-11#1)(2008-8#1)
unexpected death##5##2##(1991-11#1)(1992-6#1)(2008-12#1)(2008-7#1)(2008-8#1)
unexpected effects##2##2##(2008-3#1)(2013-1#1)
unexpected finding##4##2##(1990-12#1)(1990-2#1)(1991-12#1)(2008-12#1)
unexpected findings##2##2##(2008-10#1)(2012-2#1)
unexpected red cell antibodies##2##4##(1994-9#2)
unexpected role##2##2##(2009-6#1)(2012-12#1)
unexpected##104##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-3#1)(1996-1#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#2)
unexpectedly high##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
unexpectedly large##3##2##(1994-9#1)(2012-12#1)(2013-1#1)
unexpectedly to##2##2##(2007-12#1)(2008-11#1)
unexpectedly##30##1##(1991-1#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
unexplained and##3##2##(1995-6#1)(1996-8#1)(2010-12#1)
unexplained infant death##2##3##(1992-11#2)
unexplained infant##4##2##(1992-11#4)
unexplained recurrent##3##2##(2012-3#2)(2013-1#1)
unexplained##44##1##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-11#6)(1992-8#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
unexploited##4##1##(2008-5#2)(2009-3#2)
unexplored##13##1##(1992-12#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-2#3)(2013-7#1)
unexposed cells##2##2##(1990-7#1)(1994-11#1)
unexposed controls##2##2##(2008-10#2)
unexposed zones is##2##3##(2008-3#2)
unexposed##13##1##(1990-7#2)(1991-2#1)(1992-6#1)(1994-11#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-9#1)
unfair##4##1##(1992-12#1)(1992-3#1)(1995-6#1)(2011-1#1)
unfairly##4##1##(1994-3#1)(1996-11#1)(2012-2#1)(2012-3#1)
unfamiliar animals##2##2##(2010-2#2)
unfamiliar faces##3##2##(2007-8#1)(2008-1#2)
unfamiliar group##3##2##(2010-2#3)
unfamiliar individuals##2##2##(2010-2#2)
unfamiliar##29##1##(1992-2#1)(1994-2#1)(1994-8#1)(1996-5#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-12#2)(2008-4#4)(2010-2#11)(2012-12#1)(2013-7#1)
unfamiliarity##2##1##(1990-12#1)(1990-3#1)
unfavorable conditions##2##2##(1993-3#1)(2013-8#1)
unfavorable decision making##2##3##(2013-7#2)
unfavorable environments##2##2##(2009-7#1)(2012-1#1)
unfavorable outcome##7##2##(2008-11#1)(2009-8#1)(2012-12#1)(2012-3#4)
unfavorable##47##1##(1990-8#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-5#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#2)
unfavourable to##2##2##(1995-2#1)(2013-1#1)
unfavourable##20##1##(1991-12#1)(1992-2#1)(1995-2#1)(1996-3#1)(1997-3#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#3)
unfeasible##4##1##(1993-12#1)(1997-2#1)(2008-10#1)(2012-1#1)
unfertilized eggs##4##2##(1993-6#3)(1997-6#1)
unfertilized human oocytes and##3##4##(1994-11#2)(2011-2#1)
unfertilized##9##1##(1993-6#3)(1994-11#3)(1997-6#1)(2008-8#1)(2011-2#1)
unfilled##3##1##(1991-2#1)(1993-6#1)(2007-4#1)
unfiltered##3##1##(2007-12#1)(2008-10#2)
unfinished##3##1##(2008-11#1)(2008-4#1)(2008-7#1)
unfit for##2##2##(2008-11#1)(2008-3#1)
unfit##4##1##(2008-11#1)(2008-3#1)(2010-5#1)(2013-8#1)
unfixed cells##2##2##(2008-4#2)
unfixed##5##1##(1991-8#1)(2008-4#4)
unfocused##2##1##(2008-2#1)(2008-3#1)
unfold##3##1##(1993-12#1)(1993-9#1)(2008-10#1)
unfolded and##2##2##(2008-10#1)(2008-3#1)
unfolded form##2##2##(1990-7#1)(1995-3#1)
unfolded forms##2##2##(1993-11#1)(1995-5#1)
unfolded protein response##3##3##(2009-8#1)(2011-2#1)(2012-3#1)
unfolded protein##7##2##(1993-11#1)(1997-2#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
unfolded state and##2##3##(1997-2#2)
unfolded state##6##2##(1993-11#2)(1995-5#1)(1997-2#3)
unfolded states of ubiquitin##2##4##(1995-3#2)
unfolded states of##3##3##(1995-3#2)(2009-9#1)
unfolded states##6##2##(1995-3#3)(1995-5#1)(2009-5#1)(2009-9#1)
unfolded##33##1##(1990-7#2)(1992-9#1)(1993-11#4)(1995-2#1)(1995-3#5)(1995-5#3)(1997-2#7)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
unfolding and##3##2##(1994-8#1)(1995-3#1)(2008-10#1)
unfolding experiments##2##2##(1994-6#1)(2008-9#1)
unfolding free energies##2##3##(1997-2#2)
unfolding free##3##2##(1997-2#3)
unfolding in##2##2##(1990-7#1)(1995-5#1)
unfolding is##3##2##(1990-7#1)(1995-5#1)(1997-2#1)
unfolding model##2##2##(1993-11#1)(1997-2#1)
unfolding of RNA##2##3##(2008-4#2)
unfolding of bovine beta-lactoglobulin##2##4##(1995-5#2)
unfolding of local segments##2##4##(1995-5#2)
unfolding of the protein##2##4##(1991-6#1)(1997-2#1)
unfolding of the##11##3##(1990-5#1)(1991-6#1)(1992-6#1)(1995-2#1)(1995-5#3)(1997-2#3)(2008-4#1)
unfolding of##24##2##(1990-5#1)(1990-7#1)(1991-6#2)(1992-6#1)(1993-11#1)(1995-2#1)(1995-5#7)(1997-2#5)(2007-12#1)(2008-4#4)
unfolding pattern of the##2##4##(1995-5#2)
unfolding reaction##2##2##(1995-5#1)(1997-2#1)
unfolding transition##4##2##(1990-7#1)(1992-10#1)(1995-2#1)(1995-5#1)
unfolding was##2##2##(1995-5#2)
unfolding##82##1##(1990-5#1)(1990-7#5)(1991-6#2)(1992-10#1)(1992-6#1)(1993-11#5)(1994-6#1)(1994-8#1)(1995-2#4)(1995-3#3)(1995-5#25)(1997-2#17)(2007-12#2)(2008-1#1)(2008-10#2)(2008-4#5)(2008-9#2)(2009-7#1)(2009-9#1)(2011-1#1)(2012-6#1)
unfolds##5##1##(1994-3#1)(1995-5#1)(1996-9#1)(2009-12#1)(2009-7#1)
unfortunate##5##1##(1993-3#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-6#1)
unfortunately##15##1##(1990-6#1)(1992-5#1)(1994-3#1)(1996-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#2)(2013-7#1)
unfounded and##2##2##(1990-2#1)(2011-2#1)
unfractionated RNA is immobilized by slot or dot blotting##2##9##(2008-4#2)
unfractionated bone cells##3##3##(2008-11#3)
unfractionated bone##4##2##(2008-11#3)(2010-6#1)
unfractionated heparin (UFH)##2##3##(2007-7#1)(2013-8#1)
unfractionated heparin for##2##3##(2007-10#1)(2008-7#1)
unfractionated heparin##11##2##(1997-2#1)(2007-10#4)(2007-7#1)(2008-3#2)(2008-7#1)(2013-8#2)
unfractionated##20##1##(1991-2#1)(1997-2#2)(2007-10#4)(2007-7#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-7#1)(2010-3#1)(2010-6#1)(2013-8#2)
unfragmented##4##1##(1995-3#1)(2008-8#2)(2008-9#1)
unfused##2##1##(1993-6#1)(1994-2#1)
unglycosylated##2##1##(1992-3#1)(2008-11#1)
unguarded seedlings##2##2##(2008-10#2)
unguiculata)##3##1##(2008-10#3)
ungulate and bird introductions to New Zealand##2##7##(2008-8#2)
ungulate##5##1##(1995-2#1)(2008-8#3)(2008-9#1)
ungulates##4##1##(1991-3#1)(2008-5#1)(2008-8#2)
unhealthy assimilation&quot##2##2##(2010-12#2)
unhealthy diet##4##2##(2010-6#4)
unhealthy prepregnancy weight##2##3##(2013-1#2)
unhealthy weight control##4##3##(2012-2#4)
unhealthy weight##6##2##(2008-11#2)(2012-2#4)
unhealthy##29##1##(1991-6#1)(1993-2#1)(1994-8#1)(1997-6#1)(2008-11#4)(2008-3#1)(2010-12#2)(2010-6#5)(2011-2#3)(2012-1#3)(2012-2#4)(2013-1#3)
unheated##5##1##(1990-12#2)(1990-2#1)(2008-2#1)(2008-3#1)
unhelpful in##2##2##(1997-8#1)(2008-9#1)
unhelpful##6##1##(1995-9#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-11#1)(2012-3#1)
unhindered##4##1##(2008-3#2)(2008-4#1)(2012-2#1)
unhomogenized tissue##2##2##(2008-2#2)
uni-##3##1##(1997-7#1)(2007-10#1)(2008-10#1)
uniaxial centered##2##2##(2008-3#2)
uniaxial crystal##3##2##(2008-3#3)
uniaxial crystals##4##2##(2006-4#1)(2008-2#2)(2008-3#1)
uniaxial orientation##2##2##(2010-4#2)
uniaxial##29##1##(2006-4#2)(2008-2#3)(2008-3#17)(2010-4#2)(2011-2#3)(2012-2#1)(2012-7#1)
uniaxially oriented##2##2##(2008-3#1)(2010-4#1)
unicellular##12##1##(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
unicolor laccase-modified##2##2##(2008-10#2)
unicolor##3##1##(2008-10#3)
unicompartmental knee##4##2##(2012-12#2)(2013-1#2)
unicompartmental##5##1##(2012-12#2)(2013-1#3)
unidentified species of##2##3##(2008-10#1)(2008-5#1)
unidentified species##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
unidentified##60##1##(1990-11#1)(1990-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-8#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#14)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
unidimensional##4##1##(1996-2#1)(2010-2#1)(2011-2#1)(2012-2#1)
unidimensionality##4##1##(2007-12#2)(2011-2#1)(2012-2#1)
unidirectional flow##2##2##(2011-2#2)
unidirectional growth##2##2##(2008-7#1)(2008-8#1)
unidirectional ring##2##2##(2007-12#1)(2008-2#1)
unidirectional##19##1##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
unidirectionally##2##1##(1995-8#1)(2008-7#1)
unification of the##2##3##(1997-5#1)(2009-10#1)
unification##6##1##(1994-12#1)(1997-5#1)(2007-11#1)(2008-12#1)(2009-10#1)(2010-12#1)
unified analysis##2##2##(2008-3#1)(2010-11#1)
unified method for##2##3##(1993-12#1)(1994-9#1)
unified theory of##2##3##(1997-5#1)(2007-11#1)
unified treatment##2##2##(2011-2#2)
unified##45##1##(1990-12#1)(1992-1#1)(1993-12#1)(1994-9#1)(1995-1#1)(1996-4#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#2)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
unifies##4##1##(2008-3#1)(2011-2#2)(2012-3#1)
unifocal##2##1##(1991-11#1)(2013-1#1)
uniform TE(0) wave##2##3##(2007-12#2)
uniform and##9##2##(2008-10#3)(2008-2#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-5#1)
uniform beam##4##2##(2007-12#3)(2008-2#1)
uniform beams##2##2##(2008-2#2)
uniform circular##3##2##(2008-3#3)
uniform claims##2##2##(1992-2#1)(1997-3#1)
uniform connectedness##2##2##(2008-9#2)
uniform data##2##2##(1996-2#1)(1997-3#1)
uniform distribution of cells##2##4##(2008-11#1)(2012-1#1)
uniform distribution of##5##3##(2008-10#1)(2008-11#1)(2009-11#1)(2010-4#1)(2012-1#1)
uniform distribution##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-4#1)(2012-1#1)
uniform drug##2##2##(1992-8#1)(2008-12#1)
uniform grating##2##2##(2008-3#1)(2013-8#1)
uniform growth##2##2##(2008-10#1)(2013-1#1)
uniform guidelines##2##2##(2007-2#1)(2009-4#1)
uniform illumination##3##2##(2007-11#1)(2008-3#2)
uniform in size##2##3##(2008-1#1)(2008-10#1)
uniform in##7##2##(2008-1#1)(2008-10#5)(2013-8#1)
uniform irradiance and phase##2##4##(2008-2#2)
uniform irradiance##4##2##(2008-2#3)(2008-3#1)
uniform over##2##2##(2008-10#1)(2008-5#1)
uniform pattern##2##2##(1993-8#1)(2012-3#1)
uniform shell designs##2##3##(2008-10#2)
uniform size##3##2##(1995-2#1)(2008-10#1)(2008-2#1)
uniform spatial##2##2##(2008-8#2)
uniform structure##2##2##(2007-12#1)(2008-5#1)
uniform thickness##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
uniform##221##1##(1990-8#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#2)(1997-3#3)(1997-4#2)(2007-11#11)(2007-12#11)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#1)(2008-2#27)(2008-3#35)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#6)(2009-11#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
uniformed##3##1##(1995-6#2)(2007-11#1)
uniformis and B##2##3##(1997-2#2)
uniformis##3##1##(1997-2#3)
uniformity and##11##2##(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#2)
uniformity in a##2##3##(2008-10#1)(2008-3#1)
uniformity in##5##2##(1996-8#1)(2008-10#1)(2008-3#2)(2008-9#1)
uniformity is##3##2##(2007-11#1)(2008-3#2)
uniformity of better than Deltaf/f##2##5##(2008-3#2)
uniformity of the##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
uniformity of##13##2##(1996-12#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#8)
uniformity over##2##2##(2007-11#1)(2008-3#1)
uniformity was##2##2##(2008-3#2)
uniformity##76##1##(1995-3#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-11#5)(2007-12#2)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#37)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#2)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
uniformly across##2##2##(2007-12#1)(2010-8#1)
uniformly and##3##2##(2008-10#2)(2008-4#1)
uniformly available##3##2##(1995-1#2)(2012-2#1)
uniformly distributed##8##2##(1990-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)
uniformly expressed##2##2##(2008-6#1)(2009-8#1)
uniformly fatal##3##2##(2008-11#1)(2010-12#1)(2012-1#1)
uniformly high##3##2##(2007-7#1)(2008-10#2)
uniformly in##2##2##(2008-10#1)(2008-3#1)
uniformly labeled##3##2##(1992-3#1)(2008-2#1)(2009-7#1)
uniformly the best##2##3##(1991-2#1)(2009-8#1)
uniformly the##3##2##(1990-8#1)(1991-2#1)(2009-8#1)
uniformly throughout the##2##3##(1994-8#1)(2008-10#1)
uniformly within##2##2##(2008-10#1)(2008-3#1)
uniformly##83##1##(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-8#2)(1995-1#2)(1995-12#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-7#3)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#4)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-2#3)
unify the##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
unify##10##1##(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
unifying##13##1##(1992-8#1)(1993-12#1)(1994-6#1)(2007-7#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)
unigenes##2##1##(2008-10#1)(2010-5#1)
unilamellar egg##3##2##(1990-11#1)(1990-2#1)(1992-3#1)
unilamellar liposomes##3##2##(1993-8#1)(1994-12#1)(1995-2#1)
unilamellar vesicles (LUVs)##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
unilamellar vesicles of##2##3##(1994-5#1)(2009-12#1)
unilamellar vesicles##18##2##(1992-6#1)(1994-2#1)(1994-5#2)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-12#1)(2012-2#2)(2013-7#3)
unilamellar##26##1##(1990-11#2)(1990-2#1)(1992-3#2)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-2#2)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-12#1)(2012-2#2)(2013-7#3)
unilateral 6-hydroxydopamine##3##2##(1995-12#1)(1997-2#1)(2012-2#1)
unilateral STN DBS##2##3##(2012-2#2)
unilateral and bilateral##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
unilateral and##4##2##(2008-7#1)(2008-8#2)(2011-2#1)
unilateral approach##2##2##(2007-8#2)
unilateral chyluria##2##2##(2008-10#2)
unilateral cleft##3##2##(2009-7#1)(2011-2#1)(2013-1#1)
unilateral cochlear##2##2##(2008-9#2)
unilateral generalized hypertrichosis##2##3##(2007-7#2)
unilateral illumination##2##2##(1991-2#2)
unilateral in##2##2##(2008-1#1)(2008-12#1)
unilateral lesions##2##2##(1990-5#1)(1993-12#1)
unilateral movements##2##2##(2013-1#2)
unilateral neglect##6##2##(1995-12#1)(1996-2#1)(1996-5#1)(2009-10#1)(2009-2#2)
unilateral or bilateral##5##3##(1990-5#1)(1992-11#1)(2008-10#1)(2008-12#1)(2012-12#1)
unilateral pulmonary##2##2##(2008-11#1)(2010-3#1)
unilateral rubella retinopathy in##2##4##(2011-2#2)
unilateral statolith removal in crayfish##2##5##(2008-5#2)
unilateral statolith removal##3##3##(2008-5#3)
unilateral tinnitus##2##2##(2006-12#2)
unilateral visual##2##2##(2008-11#1)(2011-1#1)
unilateral vs bilateral fusion##2##4##(2008-8#2)
unilateral##154##1##(1990-5#2)(1991-2#4)(1991-5#2)(1992-11#1)(1992-5#2)(1993-12#3)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-8#1)(1994-9#1)(1995-12#6)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#4)(1996-2#4)(1996-5#2)(1997-2#1)(1997-3#2)(1997-7#2)(2006-10#1)(2006-12#3)(2007-10#5)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#12)(2008-8#10)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#1)(2009-7#2)(2010-3#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#8)(2013-8#4)
unilaterally in##4##2##(1992-10#1)(1996-12#3)
unilaterally nominated##2##2##(2009-7#2)
unilaterally##13##1##(1990-6#1)(1992-10#1)(1995-1#1)(1995-12#2)(1996-12#3)(2008-7#1)(2008-9#1)(2009-7#2)(2011-2#1)
unimanual##3##1##(1994-3#2)(2013-1#1)
unimodal function of##2##3##(2008-8#2)
unimodal##8##1##(2008-10#2)(2008-2#1)(2008-8#3)(2012-2#1)(2013-8#1)
unimodality##2##1##(2008-10#2)
unimodally##2##1##(2008-8#2)
unimolecular##6##1##(1991-5#2)(1996-2#3)(2008-2#1)
unimpacted##2##1##(2009-7#2)
unimpaired##3##1##(1991-2#1)(1996-2#1)(2009-10#1)
unimpeded##2##1##(2008-10#1)(2012-2#1)
unimportant for##3##2##(1997-4#1)(2008-9#1)(2012-3#1)
unimportant##9##1##(1995-5#1)(1997-3#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
uninduced##3##1##(1994-8#1)(1997-4#1)(2011-1#1)
uninephrectomy and##2##2##(2011-2#1)(2013-8#1)
uninfected cell##2##2##(1991-12#1)(2008-7#1)
uninfected control##3##2##(1993-6#1)(2011-1#1)(2011-2#1)
uninfected controls##2##2##(1995-2#1)(2010-7#1)
uninfected females##3##2##(2012-3#3)
uninfected plants##2##2##(2008-10#2)
uninfected tissue##2##2##(1994-11#1)(2008-10#1)
uninfected women##2##2##(1994-9#2)
uninfected##55##1##(1990-12#1)(1991-12#1)(1991-5#1)(1993-6#3)(1994-11#3)(1994-5#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-3#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)
uninformative##4##1##(2008-10#2)(2011-2#1)(2012-2#1)
uninformed##3##1##(1992-12#1)(1996-1#1)(2008-11#1)
uninitiated##4##1##(1996-2#1)(2008-9#1)(2010-2#1)(2011-1#1)
uninjected##3##1##(1995-3#1)(1997-7#1)(2008-10#1)
uninjured##8##1##(1993-12#1)(1997-6#5)(2012-3#1)(2013-1#1)
uninoculated controls##2##2##(2008-10#2)
uninoculated leaves of##2##3##(2008-10#2)
uninoculated leaves##9##2##(2008-10#9)
uninoculated upper leaves##2##3##(2008-10#2)
uninoculated##18##1##(2008-10#17)(2008-5#1)
uninsured and underinsured##3##3##(2008-11#3)
uninsured and##6##2##(1994-2#1)(1995-12#1)(2008-11#3)(2011-2#1)
uninsured patients##5##2##(1995-1#3)(1997-2#1)(2008-11#1)
uninsured persons##2##2##(1991-2#1)(1997-2#1)
uninsured##45##1##(1991-2#1)(1992-2#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#6)(1995-12#3)(1996-1#1)(1997-2#2)(1997-3#4)(2008-10#1)(2008-11#12)(2011-1#1)(2011-2#4)(2013-1#2)
unintelligible##2##1##(2008-11#1)(2009-2#1)
unintended consequences##3##2##(1995-1#1)(2007-11#1)(2012-1#1)
unintended pregnancies##3##2##(2008-11#1)(2013-1#2)
unintended pregnancy##2##2##(2008-7#1)(2013-1#1)
unintended##17##1##(1992-12#1)(1992-2#1)(1993-12#1)(1995-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-1#1)(2013-1#3)
unintentional injury##5##2##(2008-11#1)(2013-1#4)
unintentional##17##1##(1991-12#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#6)(2013-8#2)
unintentionally##2##1##(1996-9#1)(2008-10#1)
uninterrupted##11##1##(1994-11#1)(1994-12#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-1#1)
uninvolved##4##1##(1994-2#1)(2007-10#1)(2008-4#1)(2010-3#1)
union and non-union staff in##2##5##(1994-3#2)
union and##7##2##(1994-3#2)(2007-8#2)(2011-2#1)(2012-2#2)
union at##2##2##(2007-8#1)(2012-2#1)
union in##4##2##(1994-8#1)(2007-8#2)(2012-2#1)
union involvement##2##2##(1996-3#2)
union occurred in##2##3##(2008-8#1)(2013-8#1)
union of##7##2##(1995-3#1)(2007-11#2)(2008-6#1)(2011-2#2)(2013-8#1)
union rate##2##2##(2009-10#1)(2012-2#1)
union was achieved##3##3##(2007-11#1)(2007-8#1)(2008-9#1)
union was observed after##2##4##(2013-1#2)
union was observed in##2##4##(2013-1#1)(2013-8#1)
union was observed##4##3##(2013-1#3)(2013-8#1)
union was##10##2##(2007-11#1)(2007-8#1)(2008-9#1)(2009-10#1)(2013-1#3)(2013-8#3)
union with##2##2##(1997-6#1)(2012-2#1)
union##68##1##(1991-2#1)(1992-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#4)(1995-3#1)(1996-3#2)(1997-2#1)(1997-6#1)(2007-11#5)(2007-8#11)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#4)(2010-12#1)(2011-2#4)(2012-2#10)(2013-1#5)(2013-8#5)
unionized##3##1##(1996-3#2)(2012-2#1)
unions##4##1##(1996-3#1)(2013-1#2)(2013-8#1)
uniparental##4##1##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
unipolar and bipolar##3##3##(2007-8#2)(2008-7#1)
unipolar and##5##2##(2007-8#4)(2008-7#1)
unipolar depression##3##2##(1996-7#1)(2009-9#2)
unipolar stimulation##2##2##(2013-8#2)
unipolar##21##1##(1993-12#1)(1996-3#1)(1996-7#3)(1997-5#3)(2007-12#1)(2007-8#5)(2008-7#1)(2009-9#2)(2010-2#1)(2013-7#1)(2013-8#2)
uniporter##2##1##(2008-8#2)
unique AFLP profiles##2##3##(2008-10#2)
unique AFLP##5##2##(2008-10#5)
unique DNA fingerprints##2##3##(2008-10#2)
unique DNA##5##2##(1997-9#1)(2008-10#3)(2008-2#1)
unique ability to##6##3##(2008-11#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
unique ability##10##2##(1997-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
unique advantage of this approach##2##5##(2008-10#1)(2008-4#1)
unique advantage##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2009-6#1)
unique advantages##4##2##(2007-12#1)(2008-3#1)(2011-3#1)(2013-1#1)
unique alleles in##2##3##(2011-2#2)
unique alleles##3##2##(2008-10#1)(2011-2#2)
unique among##9##2##(1992-10#1)(1993-5#1)(1995-8#1)(2008-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
unique anatomy##2##2##(2011-2#1)(2013-1#1)
unique and trustable##2##3##(2012-3#2)
unique and useful##2##3##(2008-8#1)(2008-9#1)
unique and##22##2##(1992-1#1)(1992-2#1)(1993-12#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-9#1)(2011-3#1)(2012-2#1)(2012-3#3)
unique approach to##5##3##(1994-3#1)(1995-2#1)(1996-3#1)(2008-9#1)(2009-8#1)
unique approach##6##2##(1994-3#1)(1995-2#1)(1996-3#1)(2008-7#1)(2008-9#1)(2009-8#1)
unique approaches##2##2##(2008-10#1)(2013-1#1)
unique as##2##2##(1990-5#1)(2013-7#1)
unique aspects of##3##3##(2007-6#1)(2008-10#1)(2010-8#1)
unique case of##7##3##(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
unique case##10##2##(2007-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-1#1)
unique cell##2##2##(2010-11#1)(2012-2#1)
unique cellular##2##2##(1991-2#1)(2012-2#1)
unique challenges##8##2##(1991-3#1)(1997-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
unique characteristics and##4##3##(1992-1#2)(2008-10#1)(2012-12#1)
unique characteristics of##8##3##(1990-11#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
unique characteristics such as##2##4##(1991-5#1)(2010-4#1)
unique characteristics##18##2##(1990-11#1)(1991-5#1)(1992-1#2)(1996-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
unique chemical and physical properties##2##5##(2008-10#1)(2010-7#1)
unique chemical##4##2##(2008-10#3)(2010-7#1)
unique clinical##4##2##(1993-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
unique cloning sites##2##3##(1990-5#1)(1991-9#1)
unique combination of##7##3##(1996-1#1)(2006-12#1)(2008-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
unique combination##8##2##(1996-1#1)(2006-12#1)(2008-3#1)(2008-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
unique contribution##4##2##(1994-2#2)(2011-2#1)(2012-3#1)
unique data##3##2##(1995-6#1)(2008-10#1)(2012-12#1)
unique distribution patterns##2##3##(2008-6#2)
unique educational##3##2##(1993-1#1)(2007-2#1)(2008-10#1)
unique effects of##2##3##(2010-1#1)(2011-1#1)
unique electronic##2##2##(2008-10#1)(2008-7#1)
unique environments##2##2##(1994-2#1)(2008-11#1)
unique enzyme##3##2##(1996-2#1)(1997-9#1)(2011-2#1)
unique family##3##2##(1995-3#1)(2008-4#1)(2008-7#1)
unique feature of the##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
unique feature of this##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
unique feature of##10##3##(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2012-2#1)
unique feature##11##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2012-2#1)
unique features of such##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
unique features of this##2##4##(2008-10#1)(2009-6#1)
unique features of##9##3##(1994-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
unique features that##3##3##(1991-12#1)(2008-10#1)(2010-8#1)
unique features##18##2##(1991-12#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
unique for the##2##3##(1994-12#1)(2008-10#1)
unique for##7##2##(1993-11#1)(1994-12#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-12#1)
unique form of##4##3##(1993-11#1)(1993-2#1)(2012-2#1)(2013-7#1)
unique function##2##2##(2008-11#1)(2009-7#1)
unique functional properties##2##3##(1990-8#1)(2008-8#1)
unique functions##2##2##(2010-10#1)(2010-5#1)
unique genes##3##2##(1997-6#2)(2008-10#1)
unique genetic##2##2##(2008-6#1)(2008-9#1)
unique genomic##2##2##(2012-2#1)(2013-8#1)
unique genotypes##5##2##(2008-10#5)
unique group of##2##3##(1996-3#1)(2008-10#1)
unique group##3##2##(1996-3#1)(2008-10#2)
unique in that it##4##4##(1993-6#1)(1995-9#1)(2009-8#1)(2013-8#1)
unique in that they##2##4##(2007-12#1)(2008-11#1)
unique in that##8##3##(1993-6#1)(1994-5#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-8#1)
unique in the##2##3##(1990-5#1)(1996-12#1)
unique in##22##2##(1990-4#1)(1990-5#1)(1992-5#1)(1992-6#2)(1993-6#1)(1994-5#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-8#2)
unique information##4##2##(1994-8#1)(2008-1#1)(2009-9#1)(2010-8#1)
unique interaction between##2##3##(1994-9#1)(2008-10#1)
unique localization##2##2##(2010-12#1)(2011-2#1)
unique macronutrient composition##3##3##(2008-3#3)
unique macronutrient##4##2##(2008-3#4)
unique management issues##2##3##(2010-6#1)(2012-3#1)
unique management##3##2##(2010-6#1)(2012-3#1)(2013-8#1)
unique marker##3##2##(1993-8#1)(2008-10#1)(2012-12#1)
unique mechanism for##2##3##(1995-8#1)(2008-11#1)
unique mechanism##5##2##(1994-2#1)(1995-8#1)(2008-11#1)(2009-11#1)(2009-8#1)
unique mechanisms##2##2##(1995-2#1)(2012-12#1)
unique molecular##5##2##(1995-2#1)(1995-6#1)(1997-7#1)(2008-3#1)(2009-4#1)
unique natural##2##2##(2008-12#1)(2010-7#1)
unique needs##4##2##(1994-3#3)(2010-8#1)
unique nucleotide##2##2##(1993-8#1)(2010-10#1)
unique opportunities for##3##3##(1995-1#1)(2008-7#1)(2009-9#1)
unique opportunities##5##2##(1995-1#1)(2007-11#1)(2008-7#1)(2009-9#1)(2012-12#1)
unique opportunity to##13##3##(1991-8#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
unique opportunity##15##2##(1991-2#1)(1991-8#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
unique optical##2##2##(2009-11#1)(2010-6#1)
unique or##2##2##(2008-10#2)
unique pair of##2##3##(2008-10#1)(2008-6#1)
unique patterns##2##2##(2007-12#1)(2008-12#1)
unique phenomenon##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
unique physical and chemical##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
unique physical##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
unique points##2##2##(2008-3#2)
unique population##3##2##(2012-2#1)(2013-1#2)
unique position##10##2##(1995-3#1)(1996-1#2)(1997-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)
unique potential for##2##3##(2007-11#1)(2008-11#1)
unique potential##3##2##(2007-11#1)(2008-11#1)(2012-2#1)
unique predictor##3##2##(2010-1#2)(2012-3#1)
unique problems##2##2##(2008-10#1)(2009-10#1)
unique properties of##10##3##(2007-11#3)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
unique properties##20##2##(1993-3#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
unique property of the##2##4##(1996-2#1)(2008-10#1)
unique property of##4##3##(1995-2#1)(1996-2#1)(2008-10#1)(2012-2#1)
unique property##5##2##(1995-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
unique protein##2##2##(1994-8#1)(2008-9#1)
unique regulatory##2##2##(2011-2#1)(2012-3#1)
unique requirements for##2##3##(2008-3#1)(2010-8#1)
unique requirements##4##2##(2008-11#1)(2008-3#1)(2010-7#1)(2010-8#1)
unique restriction##3##2##(1990-7#1)(2008-10#2)
unique risk##2##2##(2010-6#1)(2011-2#1)
unique roles in##2##3##(1992-10#1)(2013-1#1)
unique scheme##2##2##(2008-3#2)
unique sequence##4##2##(1993-12#1)(1993-6#1)(2012-2#1)(2013-1#1)
unique sequences of##2##3##(2008-10#1)(2008-7#1)
unique sequences##7##2##(1995-8#2)(1996-10#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
unique short##2##2##(1992-12#1)(1994-1#1)
unique situation##2##2##(1994-12#1)(2008-12#1)
unique skills##2##2##(2008-1#1)(2011-1#1)
unique species##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
unique specificity##2##2##(2008-10#1)(2008-11#1)
unique spectra##2##2##(2007-12#2)
unique spectral##2##2##(2008-10#1)(2010-5#1)
unique structural##4##2##(1993-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
unique structure##5##2##(1991-2#1)(1993-11#1)(1997-3#1)(2009-3#1)(2010-4#1)
unique substrate specificity##2##3##(1992-3#1)(1995-2#1)
unique substrate##3##2##(1992-3#1)(1995-2#1)(2011-1#1)
unique system##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
unique tissue distribution##2##3##(1993-9#1)(2008-4#1)
unique tissue##4##2##(1993-9#1)(2008-4#1)(2008-5#1)(2010-11#1)
unique to a##3##3##(2008-10#1)(2008-9#2)
unique to the##17##3##(1991-9#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)
unique to this##4##3##(1992-6#1)(1995-6#1)(2008-11#1)(2008-7#1)
unique to##58##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#2)(2010-5#1)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
unique treatment##2##2##(2008-8#1)(2010-3#1)
unique value##2##2##(1996-3#1)(2008-7#1)
unique variance in##2##3##(2007-12#1)(2009-4#1)
unique variance##4##2##(2007-12#1)(2009-4#1)(2009-9#1)(2010-6#1)
unique virulence##2##2##(2008-10#2)
unique##900##1##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#4)(1993-12#5)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#8)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#7)(1994-5#7)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#11)(1995-3#2)(1995-5#1)(1995-6#7)(1995-8#5)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#5)(1996-2#6)(1996-3#8)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#5)(1997-6#4)(1997-7#2)(1997-8#4)(1997-9#2)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#4)(2007-11#17)(2007-12#25)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#126)(2008-11#36)(2008-12#7)(2008-2#21)(2008-3#43)(2008-4#20)(2008-5#13)(2008-6#12)(2008-7#29)(2008-8#19)(2008-9#23)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#4)(2010-11#5)(2010-12#3)(2010-2#3)(2010-3#6)(2010-4#6)(2010-5#6)(2010-6#5)(2010-7#7)(2010-8#10)(2010-9#3)(2011-1#9)(2011-2#26)(2011-3#3)(2011-7#2)(2012-1#6)(2012-12#10)(2012-2#37)(2012-3#22)(2012-5#1)(2013-1#26)(2013-7#3)(2013-8#16)
uniquely expressed##2##2##(1996-12#1)(2011-2#1)
uniquely human##2##2##(2007-12#1)(2008-5#1)
uniquely positioned to##3##3##(1992-1#1)(2007-5#1)(2010-4#1)
uniquely positioned##5##2##(1992-1#1)(1992-4#1)(2007-12#1)(2007-5#1)(2010-4#1)
uniquely sensitive to##2##3##(1993-11#1)(2012-2#1)
uniquely shared by##2##3##(2013-8#2)
uniquely##59##1##(1990-5#1)(1991-12#1)(1992-1#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-8#3)(1994-10#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-7#2)(2009-8#2)(2010-4#3)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#4)
uniqueness and##3##2##(2007-11#1)(2012-12#1)(2013-8#1)
uniqueness is##2##2##(2008-3#2)
uniqueness of the##4##3##(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
uniqueness of##10##2##(2008-1#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#1)
uniqueness##29##1##(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-9#5)(2009-10#1)(2010-10#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#5)
unirradiated cells to##2##3##(1995-2#1)(1995-6#1)
unirradiated##4##1##(1995-2#1)(1995-6#1)(2008-10#1)(2008-2#1)
unisexual species##2##2##(2010-3#2)
unisexual##7##1##(2008-9#4)(2010-3#3)
unisexual-bisexual complex##2##2##(2010-3#2)
unit (Sanki##2##2##(1994-12#2)
unit activity in the##2##4##(1993-12#1)(1993-6#1)
unit activity##6##2##(1990-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(2008-4#2)
unit addresses some##2##3##(2008-4#1)(2008-9#1)
unit addresses##7##2##(2008-2#2)(2008-4#3)(2008-9#2)
unit also contains##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
unit also includes##4##3##(2008-1#1)(2008-4#3)
unit also provides##2##3##(2008-1#1)(2008-4#1)
unit also##17##2##(2008-1#4)(2008-4#10)(2008-9#3)
unit and the##3##3##(1992-9#1)(2007-10#1)(2008-10#1)
unit and##19##2##(1992-4#1)(1992-9#1)(1995-1#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2012-3#1)
unit are##15##2##(1992-4#1)(2008-10#1)(2008-4#7)(2008-9#4)(2010-7#1)(2012-3#1)
unit area of##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
unit area##10##2##(1992-3#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)
unit as##2##2##(1991-3#1)(2008-4#1)
unit assumes##2##2##(2008-4#2)
unit at a##2##3##(1992-3#1)(2012-3#1)
unit at the##2##3##(1992-4#1)(2011-2#1)
unit at##8##2##(1990-9#1)(1992-3#1)(1992-4#1)(1994-3#1)(1996-2#1)(1997-2#1)(2011-2#1)(2012-3#1)
unit attached##2##2##(1992-6#1)(2008-10#1)
unit by##2##2##(2008-9#1)(2012-3#1)
unit can be##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)
unit can##8##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-9#1)
unit cell constants##2##3##(1996-2#1)(2008-8#1)
unit cell##12##2##(1992-9#1)(1996-2#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-7#1)
unit cells##2##2##(2008-7#2)
unit characteristics##2##2##(2008-1#1)(2013-1#1)
unit consists of a##3##4##(1995-6#1)(2010-2#1)(2011-2#1)
unit consists of##5##3##(1995-6#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
unit containing##3##2##(1993-2#1)(1994-5#1)(2008-7#1)
unit contains##11##2##(1992-4#1)(2008-1#3)(2008-4#5)(2008-9#2)
unit costs##2##2##(1992-12#1)(1995-3#1)
unit covers##12##2##(2008-2#1)(2008-4#7)(2008-9#4)
unit deals with##2##3##(2008-4#1)(2008-9#1)
unit deals##3##2##(2008-4#1)(2008-9#2)
unit describes a basic##2##4##(2008-4#2)
unit describes a##51##3##(2008-1#6)(2008-2#1)(2008-4#24)(2008-9#20)
unit describes an assay##3##4##(2008-4#3)
unit describes an##9##3##(2008-1#1)(2008-4#6)(2008-9#2)
unit describes how##7##3##(2008-2#3)(2008-4#4)
unit describes preparation##3##3##(2008-4#2)(2008-9#1)
unit describes the basic##4##4##(2008-4#2)(2008-9#2)
unit describes the##89##3##(2008-1#8)(2008-2#9)(2008-4#49)(2008-9#23)
unit describes two##10##3##(2008-1#1)(2008-2#1)(2008-4#6)(2008-9#2)
unit describes##268##2##(2008-1#25)(2008-2#21)(2008-4#148)(2008-9#74)
unit details##8##2##(2008-2#2)(2008-4#3)(2008-9#3)
unit discusses how##2##3##(2008-4#2)
unit discusses many of the##2##5##(2008-4#1)(2008-9#1)
unit discusses the##18##3##(2008-1#1)(2008-4#7)(2008-9#10)
unit discusses##41##2##(2008-1#2)(2008-4#15)(2008-9#24)
unit focuses on the##3##4##(2008-4#3)
unit focuses on##12##3##(2008-1#1)(2008-4#7)(2008-9#4)
unit for the##3##3##(1996-2#1)(1997-8#1)(2008-10#1)
unit for##18##2##(1991-11#1)(1993-6#1)(1995-6#2)(1996-2#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-7#1)(2010-12#1)(2010-2#1)
unit from##4##2##(2008-10#1)(2008-4#1)(2009-9#1)(2010-2#1)
unit gives##4##2##(2008-2#2)(2008-9#2)
unit has##2##2##(2008-4#1)(2011-7#1)
unit illustrates how to##2##4##(2008-4#1)(2008-9#1)
unit illustrates##3##2##(2008-4#2)(2008-9#1)
unit in a public##2##4##(1991-3#1)(1993-1#1)
unit in a##6##3##(1990-5#1)(1991-3#1)(1993-1#1)(2008-3#2)(2008-7#1)
unit in an##3##3##(1992-2#1)(2010-11#1)(2012-3#1)
unit in the##6##3##(1992-12#1)(1997-6#1)(2007-11#1)(2008-8#2)(2012-2#1)
unit in##19##2##(1990-5#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
unit includes a##2##3##(2008-9#2)
unit includes##9##2##(2008-4#4)(2008-9#5)
unit is a##4##3##(2008-10#1)(2008-2#1)(2008-9#2)
unit is the##2##3##(2008-4#2)
unit is to##9##3##(2008-11#1)(2008-4#4)(2008-9#4)
unit is##53##2##(1990-8#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#20)(2008-7#1)(2008-9#14)(2010-8#1)(2011-2#2)(2013-8#1)
unit length of##3##3##(2006-10#1)(2008-2#1)(2008-5#1)
unit length##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
unit lenses##2##2##(2007-11#2)
unit level##2##2##(2008-10#1)(2012-3#1)
unit management##4##2##(1996-2#1)(2008-3#2)(2012-2#1)
unit mass of the gel##2##5##(2008-10#2)
unit mass##4##2##(2008-10#3)(2008-7#1)
unit membrane##3##2##(1996-9#1)(2007-12#1)(2008-7#1)
unit of a##2##3##(2007-7#1)(2010-8#1)
unit of analysis##4##3##(1996-3#1)(1997-1#1)(2012-12#1)(2012-2#1)
unit of meaning##2##3##(2008-7#1)(2012-3#1)
unit of the##15##3##(1991-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-2#1)
unit of time##3##3##(1996-3#1)(2007-6#1)(2008-9#1)
unit of##64##2##(1991-2#1)(1991-8#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#4)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
unit offers a##4##3##(2008-4#3)(2008-9#1)
unit offers##6##2##(2008-4#5)(2008-9#1)
unit on the##2##3##(1990-5#1)(2008-10#1)
unit on##10##2##(1990-5#1)(1996-2#2)(2008-1#1)(2008-10#1)(2008-9#4)(2012-2#1)
unit operations##2##2##(2008-11#1)(2012-2#1)
unit outlines a##2##3##(2008-9#2)
unit outlines##7##2##(2008-4#5)(2008-9#2)
unit patients##5##2##(2007-7#1)(2009-11#2)(2010-10#1)(2011-2#1)
unit per##2##2##(2009-6#1)(2010-11#1)
unit presents a##24##3##(2008-1#1)(2008-2#2)(2008-4#11)(2008-9#10)
unit presents an alternative to differential display that allows the quantification of transcripts##3##13##(2008-2#3)
unit presents an overview of##5##5##(2008-4#3)(2008-9#2)
unit presents an##8##3##(2008-2#3)(2008-4#3)(2008-9#2)
unit presents protocols for##16##4##(2008-2#1)(2008-4#5)(2008-9#10)
unit presents protocols##19##3##(2008-2#2)(2008-4#6)(2008-9#11)
unit presents the##7##3##(2008-4#3)(2008-9#4)
unit presents##89##2##(2008-1#2)(2008-2#12)(2008-4#32)(2008-9#43)
unit provides a##24##3##(2008-1#2)(2008-2#1)(2008-4#14)(2008-9#7)
unit provides an excellent##4##4##(2008-9#4)
unit provides an overview of##12##5##(2008-2#1)(2008-4#10)(2008-9#1)
unit provides an##20##3##(2008-1#1)(2008-2#1)(2008-4#13)(2008-9#5)
unit provides basic##2##3##(2008-4#2)
unit provides detailed protocols##2##4##(2008-4#1)(2008-9#1)
unit provides detailed##5##3##(2008-4#2)(2008-9#3)
unit provides information on##2##4##(2008-2#1)(2008-9#1)
unit provides information##3##3##(2008-2#2)(2008-9#1)
unit provides##81##2##(2008-1#5)(2008-2#6)(2008-4#42)(2008-8#1)(2008-9#27)
unit reviews##7##2##(2008-4#5)(2008-9#2)
unit should be##5##3##(1996-12#1)(2008-1#1)(2008-9#3)
unit should##6##2##(1996-12#1)(2008-1#1)(2008-2#1)(2008-9#3)
unit takes##2##2##(2008-4#1)(2008-9#1)
unit that##5##2##(1995-6#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-2#1)
unit the##2##2##(1997-6#1)(2008-9#1)
unit time##3##2##(1996-4#1)(2008-3#1)(2008-7#1)
unit to##5##2##(1990-7#1)(2008-10#2)(2008-4#1)(2008-9#1)
unit uses##2##2##(2007-12#1)(2008-9#1)
unit was##15##2##(1990-9#1)(1993-12#1)(1994-3#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#2)(2011-3#1)
unit were##5##2##(1992-12#1)(1995-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
unit which##2##2##(1994-2#1)(2010-1#1)
unit will##9##2##(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#3)(2011-2#1)
unit with##5##2##(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#2)
unit##1397##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#7)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-8#1)(1992-1#2)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#7)(1995-8#2)(1996-12#3)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#2)(2006-10#2)(2007-10#4)(2007-11#12)(2007-12#14)(2007-2#3)(2007-6#2)(2007-7#9)(2007-8#6)(2007-9#2)(2008-1#54)(2008-10#84)(2008-11#23)(2008-12#3)(2008-2#76)(2008-3#34)(2008-4#448)(2008-5#4)(2008-7#26)(2008-8#16)(2008-9#292)(2009-10#1)(2009-11#4)(2009-3#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#7)(2010-11#12)(2010-12#6)(2010-2#6)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#18)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#10)(2012-3#14)(2013-1#14)(2013-7#1)(2013-8#2)
unit's##2##1##(1992-2#1)(2008-10#1)
unit) for water in##2##4##(2008-10#2)
unit)##7##1##(1991-8#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-2#1)
unit-specific##2##1##(2011-1#1)(2013-1#1)
unit/ml##2##1##(1992-8#1)(1993-8#1)
unit]##6##1##(1990-6#1)(1991-3#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
unitary##10##1##(1994-11#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-4#2)
unite!##2##1##(2009-12#2)
unite##7##1##(1992-5#1)(1994-1#1)(1995-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
united the##2##2##(1996-3#1)(2008-11#1)
united##16##1##(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
unites##2##1##(2008-8#1)(2011-2#1)
units (CFU) of##2##3##(1996-12#1)(2013-7#1)
units (CFU)##3##2##(1996-12#1)(2008-10#1)(2013-7#1)
units (the##2##2##(2008-10#2)
units and the##6##3##(1991-2#1)(1992-3#1)(2008-10#2)(2010-7#1)(2013-8#1)
units and##35##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1996-5#1)(1997-7#3)(2006-10#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
units are not##2##3##(1992-11#1)(1995-12#1)
units are proposed##2##3##(2008-3#1)(2010-8#1)
units are##16##2##(1992-11#1)(1995-12#1)(1995-5#2)(1996-5#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#2)(2010-5#1)(2010-8#1)(2012-2#1)
units at##7##2##(1997-8#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)
units belonging to##2##3##(1993-6#1)(2008-10#1)
units by##6##2##(1990-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
units can be##2##3##(1992-9#1)(1995-6#1)
units can##5##2##(1992-9#1)(1995-6#1)(1996-12#1)(2008-8#1)(2009-11#1)
units during##2##2##(2007-12#1)(2013-1#1)
units every##2##2##(2008-7#1)(2012-12#1)
units exhibited##2##2##(1996-2#1)(2011-1#1)
units for##5##2##(1993-6#1)(1994-1#1)(2008-3#2)(2008-9#1)
units from##3##2##(1992-3#1)(1995-3#1)(1996-2#1)
units had been##2##3##(1995-9#1)(2011-2#1)
units had##8##2##(1992-4#1)(1995-6#1)(1995-9#1)(2008-12#1)(2011-1#1)(2011-2#3)
units has##2##2##(1996-2#1)(2006-10#1)
units have##2##2##(1995-6#1)(2011-1#1)
units higher than that##3##4##(1995-5#2)(2008-10#1)
units higher##4##2##(1995-5#2)(2008-10#2)
units in addition to##2##4##(1994-5#1)(1997-7#1)
units in the case of##3##5##(2008-10#3)
units in the##16##3##(1991-2#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-10#2)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
units in this chapter##2##4##(2008-9#2)
units in which##2##3##(1991-7#1)(2008-7#1)
units in##51##2##(1991-2#1)(1991-7#1)(1993-1#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-5#1)(1995-6#2)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
units is##8##2##(1996-2#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-7#2)(2009-10#1)(2010-8#1)
units may##2##2##(2011-1#1)(2013-8#1)
units must##2##2##(1994-2#1)(2007-12#1)
units need to##2##3##(1994-6#1)(2011-1#1)
units of a##2##3##(1993-12#1)(1993-2#1)
units of fresh frozen plasma##2##5##(1990-2#1)(1994-9#1)
units of red blood cells (RBCs)##2##6##(1994-12#1)(1994-9#1)
units of the##8##3##(1990-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
units of this##2##3##(1992-12#1)(2008-4#1)
units of time(-1))##2##3##(2008-10#2)
units of##65##2##(1990-2#1)(1990-6#1)(1990-7#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#7)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
units on the##2##3##(2006-10#1)(2008-12#1)
units on##11##2##(1996-2#2)(1996-7#1)(2006-10#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
units or##2##2##(2008-10#1)(2012-1#1)
units per##7##2##(1991-12#1)(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
units such as##2##3##(2008-11#1)(2008-12#1)
units than the##2##3##(1993-3#1)(2013-1#1)
units than##3##2##(1993-3#1)(2008-2#1)(2013-1#1)
units that##5##2##(1994-9#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-8#1)
units there##3##2##(2008-10#2)(2010-5#1)
units to the##2##3##(1990-8#1)(2008-10#1)
units to##8##2##(1990-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-7#1)
units was##9##2##(1990-7#1)(1994-9#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
units weekly##2##2##(1992-6#1)(2008-7#1)
units were activated by##2##4##(2008-4#2)
units were caring for a total of##2##7##(2011-2#2)
units were caring for##3##4##(2011-2#3)
units were##21##2##(1992-6#1)(1993-12#2)(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-4#2)(2009-9#1)(2011-2#6)(2013-8#1)
units when##2##2##(1995-3#1)(2011-1#1)
units which##2##2##(1993-6#1)(1994-9#1)
units with 25 patients or more##2##6##(2011-2#2)
units with fewer than 25 patients##2##6##(2011-2#2)
units with##17##2##(1990-11#1)(1993-12#1)(1994-3#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-10#1)(2011-2#4)(2012-2#2)(2013-1#1)
units within the ODN-chains##3##4##(2008-10#3)
units within the##7##3##(1992-4#1)(1994-12#1)(2008-10#4)(2010-10#1)
units##624##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#7)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#6)(1991-7#1)(1991-8#3)(1992-1#2)(1992-11#2)(1992-12#4)(1992-3#4)(1992-4#2)(1992-6#4)(1992-9#1)(1993-1#2)(1993-12#8)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#4)(1994-9#14)(1995-1#1)(1995-11#4)(1995-12#6)(1995-3#6)(1995-5#5)(1995-6#13)(1995-9#3)(1996-11#1)(1996-12#2)(1996-2#11)(1996-3#3)(1996-5#6)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#1)(2006-10#4)(2007-10#2)(2007-11#11)(2007-12#14)(2007-2#1)(2007-6#1)(2007-7#9)(2007-8#3)(2008-1#14)(2008-10#93)(2008-11#17)(2008-12#15)(2008-2#8)(2008-3#13)(2008-4#16)(2008-5#11)(2008-6#1)(2008-7#17)(2008-8#12)(2008-9#11)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#5)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#7)(2010-7#2)(2010-8#5)(2011-1#9)(2011-2#36)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#25)(2013-7#3)(2013-8#8)
units&quot##2##1##(2008-8#1)(2011-2#1)
units'##2##1##(2008-11#1)(2011-2#1)
units)##18##1##(1991-6#1)(1992-12#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#3)(2013-1#1)
units/kg##2##1##(2007-7#1)(2007-9#1)
units/kg/week##2##1##(2007-7#2)
units/mg##2##1##(1992-3#2)
units/mg)##2##1##(1993-11#2)
units/ml concentration##2##2##(1994-11#2)
units/ml##6##1##(1990-12#1)(1994-11#2)(2008-10#3)
units/ml)##2##1##(1991-12#2)
units]##4##1##(1993-8#1)(1994-6#1)(1996-9#1)(2011-2#1)
unity among##2##2##(1990-11#1)(1990-6#1)
unity in##3##2##(2008-12#1)(2008-3#1)(2008-4#1)
unity of##5##2##(1994-3#1)(2008-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
unity##37##1##(1990-11#1)(1990-6#1)(1990-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#2)(1996-12#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
univalent metal##4##2##(2008-10#4)
univalent##7##1##(2008-10#6)(2009-12#1)
univariate analyses##6##2##(1990-6#1)(1994-12#1)(1997-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
univariate analysis and##3##3##(2008-6#1)(2012-12#1)(2012-2#1)
univariate analysis##13##2##(1990-8#1)(1991-2#1)(1994-7#1)(1995-4#1)(2006-10#1)(2007-8#1)(2008-6#3)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
univariate and bivariate analysis##2##4##(2008-5#1)(2013-1#1)
univariate and multivariate analyses##5##4##(2008-6#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-8#1)
univariate and multivariate##8##3##(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2013-8#1)
univariate and##11##2##(2007-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
univariate calibration##7##2##(2008-10#7)
univariate method##5##2##(2008-10#5)
univariate##62##1##(1990-6#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-4#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-5#1)(2008-6#5)(2008-7#1)(2009-10#2)(2009-4#2)(2009-8#4)(2010-3#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
univariately##2##1##(1997-3#1)(2012-1#1)
universal access to health##2##4##(1996-1#1)(2008-6#1)
universal access to##5##3##(1996-1#1)(2008-6#1)(2009-7#2)(2012-12#1)
universal access##6##2##(1994-2#1)(1996-1#1)(2008-6#1)(2009-7#2)(2012-12#1)
universal and##7##2##(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
universal approach##2##2##(1994-12#1)(2012-12#1)
universal coverage##5##2##(1994-2#1)(1995-12#1)(1996-1#1)(1997-6#1)(2010-12#1)
universal detection##3##2##(2008-10#2)(2011-2#1)
universal guidelines for precautions##2##4##(2010-3#2)
universal guidelines##3##2##(2010-11#1)(2010-3#2)
universal health care##3##3##(1994-2#1)(1995-1#1)(2007-12#1)
universal health insurance##4##3##(1991-2#4)
universal health##8##2##(1991-2#4)(1994-2#1)(1995-1#1)(1996-2#1)(2007-12#1)
universal human##2##2##(2008-11#1)(2009-10#1)
universal infection control precautions##2##4##(2007-7#2)
universal insurance coverage##2##3##(1994-1#1)(1995-12#1)
universal liposomal nanovesicles for immunoassays##2##5##(2008-10#2)
universal personal##2##2##(2008-1#2)
universal precautions##7##2##(1991-12#2)(1996-1#1)(2010-3#4)
universal primer##3##2##(2008-10#3)
universal primers##4##2##(1996-8#1)(2008-10#2)(2008-8#1)
universal protein G-liposomal nanovesicles##3##4##(2008-10#3)
universal reagent for##3##3##(2008-10#3)
universal reagents for##2##3##(2008-10#2)
universal screening##2##2##(2009-3#1)(2013-1#1)
universal tendencies##2##2##(2012-12#2)
universal testing machine##6##3##(2008-11#1)(2008-12#2)(2009-7#1)(2009-8#1)(2013-1#1)
universal use of##2##3##(2008-8#1)(2011-1#1)
universal##175##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#4)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#3)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#3)(2008-1#4)(2008-10#29)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#4)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#6)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#5)(2012-2#9)(2012-3#2)(2013-1#6)(2013-8#3)
universalist##4##1##(2008-12#2)(2011-2#2)
universality##2##1##(2008-4#1)(2012-2#1)
universally applicable##2##2##(2008-1#1)(2008-8#1)
universally available##3##2##(1991-11#1)(1994-9#1)(2011-2#1)
universally##31##1##(1991-11#1)(1992-10#1)(1992-2#1)(1994-9#1)(1996-1#1)(2007-11#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
universe and##2##2##(1995-6#1)(2008-12#1)
universe##16##1##(1994-2#1)(1995-6#1)(1996-12#1)(2008-12#4)(2008-4#2)(2009-10#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#3)
universities and##6##2##(1997-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)
universities were##2##2##(1997-5#1)(2008-11#1)
universities##32##1##(1990-12#2)(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
university and##10##2##(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#1)(2008-11#1)(2008-12#2)(2010-10#1)(2011-1#1)(2013-1#1)
university authorities##4##2##(2008-10#3)(2010-3#1)
university campus##3##2##(1996-12#1)(2013-1#2)
university center##2##2##(2011-2#1)(2013-8#1)
university departments##2##2##(1990-10#1)(2008-7#1)
university education##4##2##(1994-12#2)(2009-7#1)(2012-3#1)
university funding##2##2##(1997-8#1)(2012-2#1)
university health center##2##3##(2011-2#2)
university health##3##2##(2010-5#1)(2011-2#2)
university hospital in##5##3##(1990-12#1)(1993-1#1)(2011-2#1)(2013-1#2)
university hospital who##2##3##(2006-10#1)(2012-1#1)
university hospital##21##2##(1990-12#1)(1992-5#1)(1993-1#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-11#1)(2009-1#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
university hospitals in##3##3##(1990-12#1)(2006-8#2)
university hospitals##8##2##(1990-12#2)(1991-2#1)(1992-9#1)(1993-6#1)(1997-8#1)(2006-8#2)
university in##4##2##(1997-3#1)(2008-11#1)(2008-12#1)(2012-3#1)
university of##5##2##(2008-11#2)(2008-12#1)(2013-1#2)
university programs##3##2##(1994-1#1)(1995-1#1)(1996-3#1)
university researchers##2##2##(1996-8#1)(2011-2#1)
university staff##3##2##(2007-10#1)(2008-12#2)
university students at##2##3##(2012-12#2)
university students in##2##3##(2011-1#1)(2012-12#1)
university students##7##2##(2007-12#2)(2007-6#1)(2011-1#1)(2012-12#3)
university teaching hospital##2##3##(2007-12#1)(2013-1#1)
university teaching##8##2##(1990-12#1)(1990-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
university to##2##2##(1992-1#1)(2007-12#1)
university training##2##2##(1992-3#1)(2008-11#1)
university##159##1##(1990-10#1)(1990-12#4)(1990-3#1)(1990-9#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-1#4)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#2)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#4)(2008-10#6)(2008-11#20)(2008-12#12)(2008-5#1)(2008-7#2)(2009-1#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#4)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#15)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#8)(2013-8#3)
university-affiliated##2##1##(1994-12#1)(2011-1#1)
univocal##2##1##(1990-6#1)(2008-2#1)
unjust##3##1##(1994-1#1)(2011-2#1)(2012-12#1)
unjustified##2##1##(1996-8#1)(2013-1#1)
unknowingly##2##1##(2008-10#1)(2008-7#1)
unknown analytical##2##2##(2008-10#2)
unknown and##7##2##(1995-12#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
unknown arsenic species##2##3##(2008-10#2)
unknown aspects of##2##3##(1994-2#1)(2008-7#1)
unknown at present##2##3##(1992-9#1)(2010-4#1)
unknown at##3##2##(1992-9#1)(2008-11#1)(2010-4#1)
unknown but##7##2##(1990-12#1)(1990-3#1)(1993-11#1)(1996-3#1)(2008-3#1)(2012-3#1)(2013-8#1)
unknown cause##7##2##(1990-6#1)(1992-8#1)(1994-9#1)(2008-5#1)(2008-7#2)(2012-12#1)
unknown causes##2##2##(1990-6#1)(1995-12#1)
unknown chemical##2##2##(2008-11#1)(2008-5#1)
unknown class##2##2##(2009-10#1)(2012-3#1)
unknown compounds were##2##3##(2008-10#2)
unknown compounds##3##2##(1991-12#1)(2008-10#2)
unknown concentration##2##2##(2008-10#2)
unknown etiology##19##2##(1991-2#1)(1995-6#1)(1997-8#1)(2007-7#2)(2008-1#2)(2008-10#5)(2010-11#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
unknown factors##4##2##(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
unknown function and##2##3##(2008-7#1)(2009-9#1)
unknown function##24##2##(1992-9#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-7#4)(2008-9#3)(2009-10#1)(2009-9#1)(2010-10#3)(2012-12#1)
unknown functions##2##2##(2009-2#1)(2012-2#1)
unknown genes##4##2##(1993-6#1)(1997-6#1)(2008-9#1)(2012-3#1)
unknown how##4##2##(1990-9#1)(2008-10#1)(2011-2#1)(2012-3#1)
unknown in##6##2##(1994-11#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
unknown material##2##2##(2012-1#1)(2012-3#1)
unknown mechanism##3##2##(1994-6#1)(1995-8#1)(2010-10#1)
unknown number of##3##3##(1994-12#1)(2008-9#1)(2010-10#1)
unknown or##5##2##(2008-10#3)(2008-11#1)(2009-9#1)
unknown origin##12##2##(1990-2#1)(1996-11#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
unknown parameters##4##2##(2008-10#2)(2008-3#1)(2009-11#1)
unknown peaks##2##2##(2008-10#2)
unknown primary site##3##3##(1992-2#1)(2007-11#2)
unknown primary##9##2##(1992-11#1)(1992-12#1)(1992-2#1)(2007-11#2)(2008-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
unknown protein##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
unknown proteins##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
unknown reasons##2##2##(1990-5#1)(1997-1#1)
unknown refractive index##2##3##(2008-3#2)
unknown risk##2##2##(1993-3#1)(1994-9#1)
unknown samples##3##2##(2007-11#1)(2008-10#2)
unknown skull##2##2##(1995-6#2)
unknown structures##2##2##(1992-11#1)(2011-2#1)
unknown to what extent these##2##5##(1992-12#1)(2008-3#1)
unknown to##3##2##(1992-12#1)(2008-10#1)(2008-3#1)
unknown until##2##2##(1995-2#1)(2012-2#1)
unknown viruses##2##2##(1994-6#1)(2008-10#1)
unknown whether the##3##3##(1995-5#1)(2010-3#1)(2013-8#1)
unknown whether there is##2##4##(2008-11#1)(2009-11#1)
unknown whether##11##2##(1995-5#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
unknown why##2##2##(2012-2#1)(2013-8#1)
unknown##562##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#4)(1995-12#4)(1995-2#7)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#1)(1996-6#4)(1996-9#1)(1997-1#1)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(2006-10#2)(2007-10#2)(2007-11#7)(2007-12#11)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#7)(2008-10#94)(2008-11#22)(2008-12#4)(2008-2#6)(2008-3#27)(2008-4#6)(2008-5#9)(2008-6#7)(2008-7#27)(2008-8#6)(2008-9#12)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#4)(2010-10#8)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#9)(2011-2#19)(2011-7#1)(2012-1#5)(2012-12#9)(2012-2#22)(2012-3#22)(2013-1#14)(2013-8#12)
unknown)##2##1##(2007-12#1)(2008-3#1)
unknowns about##2##2##(1993-11#1)(2012-3#1)
unknowns##8##1##(1993-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2012-3#1)
unlabeled IGF-II or IGF-I##2##4##(1992-3#2)
unlabeled##31##1##(1990-11#1)(1990-12#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-3#4)(1993-1#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-11#3)(1995-5#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2012-2#1)
unlabelled cells##3##2##(1991-5#3)
unlabelled##13##1##(1990-12#1)(1990-8#2)(1991-5#3)(1992-9#1)(1994-8#1)(1995-12#1)(1997-1#2)(2008-11#1)(2012-12#1)
unladen##4##1##(2008-8#1)(2008-9#3)
unlawful##5##1##(1993-9#1)(1997-5#2)(2008-9#1)(2012-1#1)
unlesioned##2##1##(2012-2#2)
unless a##5##2##(1991-3#1)(1991-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
unless an##2##2##(1997-2#1)(2007-7#1)
unless it is##2##3##(2010-8#1)(2012-12#1)
unless other##2##2##(1994-1#1)(2007-7#1)
unless the##16##2##(1994-3#1)(1995-11#1)(2007-11#1)(2008-10#4)(2008-3#4)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
unless there is##3##3##(2011-1#1)(2011-3#1)(2013-1#1)
unless there##5##2##(2008-11#1)(2008-7#1)(2011-1#1)(2011-3#1)(2013-1#1)
unless they are##2##3##(1991-12#1)(1996-12#1)
unless they have##2##3##(2008-1#1)(2008-9#1)
unless they##5##2##(1991-12#1)(1996-12#1)(2008-1#1)(2008-4#1)(2008-9#1)
unless we assume##2##3##(2012-3#2)
unless we##4##2##(1996-3#1)(1996-4#1)(2012-3#2)
unless##67##1##(1990-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-8#2)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#2)
unlicensed##2##1##(2007-2#1)(2008-9#1)
unliganded##5##1##(1990-8#2)(1995-5#3)
unlike in##6##2##(1995-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)
unlike most##2##2##(2008-10#1)(2011-1#1)
unlike other##5##2##(1992-7#1)(2008-10#1)(2008-4#1)(2009-7#1)(2011-2#1)
unlike our##2##2##(1994-3#1)(2008-12#1)
unlike that of the##2##4##(1990-11#1)(2010-2#1)
unlike the wild-type##2##3##(2008-10#1)(2008-4#1)
unlike the##18##2##(1990-5#1)(1992-11#1)(1992-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-8#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)
unlike those##3##2##(1991-1#1)(1993-12#1)(2013-1#1)
unlike##71##1##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
unlikely that a##2##3##(1993-9#1)(1996-12#1)
unlikely that the##3##3##(2007-12#1)(2007-5#1)(2008-11#1)
unlikely that##25##2##(1990-2#1)(1990-7#1)(1990-8#1)(1993-9#1)(1995-12#2)(1995-5#2)(1996-12#2)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#1)
unlikely to account for##2##4##(1993-12#1)(1996-12#1)
unlikely to be a##4##4##(1996-5#1)(2007-2#1)(2009-7#1)(2010-1#1)
unlikely to be effective##2##4##(2010-10#1)(2013-8#1)
unlikely to be the##2##4##(1997-2#1)(2008-2#1)
unlikely to be##28##3##(1992-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
unlikely to benefit from##2##4##(2009-8#1)(2012-2#1)
unlikely to increase##2##3##(1997-6#1)(2008-8#1)
unlikely to##59##2##(1990-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
unlikely##121##1##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
unlimited calorie diet##2##3##(2008-3#2)
unlimited life time##2##3##(2008-10#2)
unlimited opportunities##2##2##(1992-3#1)(2007-9#1)
unlimited##19##1##(1992-2#1)(1992-3#1)(1993-2#1)(1996-3#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#2)(2009-9#1)
unlinked to##4##2##(1994-9#1)(2008-10#2)(2012-3#1)
unlinked##17##1##(1992-8#1)(1994-9#1)(1995-6#1)(1996-3#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-8#2)(2010-6#1)(2012-3#2)
unloaded by the##2##3##(2013-1#2)
unloaded##13##1##(1990-11#3)(1991-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2013-1#4)
unloading##9##1##(1995-2#1)(2007-7#1)(2008-10#3)(2008-3#1)(2010-3#2)(2010-6#1)
unlock the##2##2##(1996-2#1)(2008-7#1)
unlock##3##1##(1996-2#1)(2008-7#1)(2013-8#1)
unlocked##2##1##(1996-4#2)
unlucky##2##1##(2009-6#1)(2012-3#1)
unmanaged##3##1##(1994-12#1)(1995-2#1)(2008-10#1)
unmarried and##3##2##(2011-2#2)(2012-3#1)
unmarried women##2##2##(1991-6#1)(2012-2#1)
unmarried##9##1##(1990-12#1)(1991-6#1)(2007-7#1)(2009-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
unmask##3##1##(2008-4#1)(2008-7#1)(2009-2#1)
unmasked by##4##2##(1996-9#1)(2008-12#1)(2008-7#1)(2010-12#1)
unmasked##10##1##(1990-2#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
unmasking of##3##2##(1994-11#1)(1996-5#1)(2008-8#1)
unmasks##3##1##(1990-2#1)(2009-2#1)(2010-3#1)
unmatched features##2##2##(2008-9#2)
unmatched information##2##2##(2008-9#2)
unmatched##10##1##(1992-9#1)(2008-9#4)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
unmeasured##2##1##(1997-6#1)(2012-12#1)
unmedicated##3##1##(1995-11#1)(1995-12#1)(2012-1#1)
unmet health##2##2##(2008-7#1)(2010-8#1)
unmet healthcare needs in##2##4##(2010-8#2)
unmet need##7##2##(1995-12#1)(2008-7#1)(2010-8#4)(2012-2#1)
unmet needs in##2##3##(2010-6#1)(2013-1#1)
unmet needs##4##2##(1992-1#1)(1995-1#1)(2010-6#1)(2013-1#1)
unmet##23##1##(1992-1#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-3#2)(2008-5#1)(2008-7#2)(2010-6#1)(2010-8#7)(2012-12#2)(2012-2#2)(2013-1#2)
unmethylated##5##1##(1990-11#1)(1990-8#2)(2008-4#1)(2009-10#1)
unmodeled##2##1##(2008-3#2)
unmodified 5'-OH and 5'-phosphate DNA##2##5##(2008-4#2)
unmodified ODNs##2##2##(2008-4#2)
unmodified and##4##2##(1992-5#1)(1995-2#1)(2008-10#2)
unmodified carbon##3##2##(2008-10#3)
unmodified##42##1##(1990-7#1)(1991-9#1)(1992-5#1)(1993-11#2)(1993-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#17)(2008-3#1)(2008-4#7)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
unmodulated##3##1##(2007-12#2)(2008-3#1)
unmulched##2##1##(2008-10#2)
unmutated IgV(H)##3##2##(2008-9#3)
unmutated##4##1##(2008-9#3)(2012-2#1)
unmyelinated fibers in the contralateral L5 ventral root##2##8##(1993-12#2)
unmyelinated fibers in the##5##4##(1993-12#5)
unmyelinated##8##1##(1993-12#6)(1997-3#1)(2006-12#1)
unnamed Trichoderma anamorphs##2##3##(2008-10#2)
unnamed##6##1##(2008-10#4)(2008-2#1)(2010-10#1)
unnatural amino##2##2##(1992-11#1)(1992-3#1)
unnatural base##2##2##(2008-4#2)
unnatural bases##2##2##(2008-4#2)
unnatural##11##1##(1992-11#1)(1992-12#1)(1992-3#1)(1994-6#1)(2008-4#6)(2008-7#1)
unneccessary and##2##2##(2012-12#2)
unnecessarily##4##1##(1995-3#1)(2008-11#1)(2009-6#1)(2012-3#1)
unnecessary and##2##2##(1996-11#1)(2008-10#1)
unnecessary for##3##2##(1995-2#1)(2010-1#1)(2010-3#1)
unnecessary hospital##2##2##(2009-6#2)
unnecessary services##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
unnecessary surgical intervention##2##3##(1992-9#1)(2007-5#1)
unnecessary surgical##4##2##(1992-9#1)(2007-5#1)(2011-2#2)
unnecessary to##3##2##(1991-5#1)(2009-10#1)(2012-3#1)
unnecessary##62##1##(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)
unneeded##2##1##(2008-4#1)(2013-1#1)
unnoticed##6##1##(1991-3#1)(1992-8#1)(1997-3#1)(2008-7#2)(2012-3#1)
unobservable##5##1##(1997-8#1)(2006-12#1)(2008-3#1)(2008-7#1)(2009-9#1)
unobserved##14##1##(1991-1#1)(1992-6#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#2)
unobstructed##5##1##(1994-8#1)(2007-12#1)(2008-1#1)(2008-3#2)
unobtainable##2##1##(2008-3#1)(2009-3#1)
unoccupied##7##1##(1991-7#1)(1993-9#1)(1996-2#2)(2008-8#2)(2013-1#1)
unoperated control##2##2##(1993-12#1)(1994-3#1)
unoperated controls##2##2##(1992-11#1)(1993-12#1)
unoperated##5##1##(1992-11#1)(1992-9#1)(1993-12#2)(1994-3#1)
unopposed estrogen##3##2##(1994-9#2)(2011-2#1)
unopposed##5##1##(1992-8#1)(1994-9#2)(2008-1#1)(2011-2#1)
unordered##2##1##(2008-10#1)(2008-4#1)
unoriented##4##1##(1991-9#1)(2008-4#1)(2010-4#2)
unorthodox##4##1##(1990-12#1)(1994-8#1)(2010-2#1)(2010-8#1)
unpackaged ssDNA contains##2##3##(1991-5#2)
unpackaged ssDNA##3##2##(1991-5#3)
unpackaged##7##1##(1991-5#5)(1992-8#2)
unpaid caregivers##2##2##(2007-10#2)
unpaid##4##1##(1995-3#2)(2007-10#2)
unpaired anterior aorta##2##3##(2007-12#2)
unpaired electron-spin density##2##3##(1994-5#2)
unpaired##15##1##(1993-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-5#1)(2012-3#1)
unpalatable##3##1##(2008-12#1)(2012-3#1)(2013-1#1)
unparallel grating planes in Talbot interferometry##2##6##(2008-3#2)
unparallel grating planes in##3##4##(2008-3#3)
unparalleled##4##1##(1996-3#1)(2010-5#1)(2010-7#1)(2013-1#1)
unparasitized penultimate##2##2##(1992-6#2)
unparasitized##3##1##(1990-2#1)(1992-6#2)
unperturbed##5##1##(2007-11#3)(2008-10#1)(2008-3#1)
unphosphorylated##3##1##(2008-4#1)(2010-12#2)
unplanned and##2##2##(1993-3#1)(2010-10#1)
unplanned or accidental extubations##2##4##(2007-11#2)
unplanned readmission##2##2##(2007-12#1)(2011-1#1)
unplanned##18##1##(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(2007-11#3)(2007-12#1)(2007-7#1)(2010-10#3)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
unpleasant for##3##2##(2008-5#2)(2012-3#1)
unpleasant##14##1##(1992-2#2)(1992-5#1)(1994-5#1)(2008-1#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-6#1)(2010-5#1)(2012-3#1)
unpleasantness of##4##2##(2008-10#3)(2008-5#1)
unpleasantness##8##1##(2008-10#5)(2008-5#1)(2010-4#1)(2013-8#1)
unpolarized fluorescence##3##2##(2007-11#3)
unpolarized incident light##3##3##(2007-12#1)(2008-3#2)
unpolarized light##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
unpolarized##14##1##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)
unpolluted##3##1##(2008-10#2)(2008-7#1)
unpopular##3##1##(2008-11#2)(2013-8#1)
unpracticed##2##1##(1990-11#1)(2010-7#1)
unprecedented levels of##3##3##(1995-1#1)(1995-2#1)(1996-2#1)
unprecedented##33##1##(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
unpredictability##2##1##(2008-12#1)(2008-8#1)
unpredictable and##3##2##(1996-2#1)(2008-11#1)(2011-1#1)
unpredictable clinical##2##2##(2008-8#1)(2009-5#1)
unpredictable results##2##2##(1993-12#1)(2008-12#1)
unpredictable##39##1##(1992-11#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1996-2#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#4)(2013-1#1)(2013-7#1)
unpredictably##3##1##(1994-3#1)(2007-4#1)(2008-9#1)
unpretreated##2##1##(2008-10#2)
unprimed##2##1##(1994-6#1)(1995-2#1)
unprocessed##11##1##(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-12#4)(2012-12#1)
unproductive##3##1##(1990-2#1)(2008-9#1)(2010-8#1)
unprofessional##2##1##(2008-6#1)(2013-8#1)
unprotected exposure to##2##3##(1992-6#1)(2011-2#1)
unprotected intercourse##2##2##(2009-12#1)(2011-1#1)
unprotected left main##4##3##(2008-3#1)(2009-12#2)(2011-2#1)
unprotected receptive##2##2##(2008-12#1)(2011-2#1)
unprotected sex##4##2##(1996-5#1)(2010-9#1)(2013-1#2)
unprotected sexual intercourse##2##3##(1992-6#1)(2012-2#1)
unprotected sexual##3##2##(1992-6#1)(2008-1#1)(2012-2#1)
unprotected##34##1##(1991-7#1)(1992-6#2)(1996-5#1)(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#4)(2008-5#1)(2009-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-7#5)
unproteolyzed##4##1##(1995-11#4)
unprotonated##5##1##(1991-9#2)(2008-10#3)
unproven safety##2##2##(2008-4#1)(2008-7#1)
unproven##7##1##(1991-3#1)(1995-6#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)
unpublished data##3##2##(2007-5#1)(2008-9#1)(2013-1#1)
unpublished##11##1##(1992-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2013-1#1)
unpurified##3##1##(1994-8#1)(2008-10#2)
unquantified##4##1##(2008-11#1)(2008-4#3)
unquestionable##2##1##(2008-11#1)(2010-6#1)
unquestionably##2##1##(2008-10#1)(2008-6#1)
unravel the##8##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2013-1#1)
unravel##15##1##(1995-11#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-5#1)(2013-1#1)(2013-8#1)
unraveled##2##1##(1996-2#1)(2008-1#1)
unraveling of the##4##3##(2008-7#1)(2009-2#1)(2013-7#1)(2013-8#1)
unraveling of##7##2##(1994-3#2)(2008-10#1)(2008-7#1)(2009-2#1)(2013-7#1)(2013-8#1)
unraveling##13##1##(1994-3#2)(1995-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2013-7#1)(2013-8#1)
unravelled##3##1##(1994-5#1)(1996-11#1)(2007-12#1)
unravelling##2##1##(1996-6#1)(2006-10#1)
unreacted##3##1##(2008-10#3)
unreactive##2##1##(2008-10#2)
unrealistic and##2##2##(1994-12#1)(2008-7#1)
unrealistic##11##1##(1994-12#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2013-1#1)
unrealistically high##2##2##(1992-5#1)(2008-10#1)
unrealized##2##1##(2008-3#1)(2008-9#1)
unreamed tibial nail##2##3##(2009-3#2)
unreamed##3##1##(2009-3#2)(2013-8#1)
unreasonable##5##1##(1990-12#1)(1991-1#1)(1992-3#1)(1994-12#1)(2008-7#1)
unreasonably high##2##2##(1992-3#1)(2008-10#1)
unrecognised in##2##2##(2008-7#1)(2010-12#1)
unrecognised##14##1##(1990-3#1)(1992-9#1)(1994-3#1)(1996-6#1)(2007-2#1)(2007-6#1)(2008-7#1)(2008-8#4)(2010-12#1)(2010-5#1)(2012-12#1)
unrecognized role##2##2##(1995-5#1)(2008-8#1)
unrecognized##39##1##(1993-2#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
unreduced mature##2##2##(2008-9#2)
unreduced##6##1##(2007-8#1)(2008-7#1)(2008-9#4)
unregulated##4##1##(1990-11#1)(2007-5#1)(2008-12#1)(2008-8#1)
unreinforced##3##1##(2008-11#3)
unrelated MLD alleles##2##3##(1997-3#2)
unrelated causes##3##2##(1994-12#1)(2013-1#1)(2013-7#1)
unrelated control##2##2##(1997-7#1)(2008-12#1)
unrelated cord blood##2##3##(2010-11#1)(2013-1#1)
unrelated cord##3##2##(2010-11#2)(2013-1#1)
unrelated drugs##2##2##(2010-8#1)(2012-2#1)
unrelated females##2##2##(1993-6#1)(2008-8#1)
unrelated individuals from the##4##4##(2008-12#4)
unrelated individuals from##7##3##(2008-12#7)
unrelated individuals originating from three different continents (Africa##2##8##(2008-12#1)(2009-5#1)
unrelated individuals##17##2##(2008-12#10)(2008-8#1)(2009-5#1)(2012-3#5)
unrelated isolates##2##2##(2012-3#2)
unrelated patients##3##2##(1991-12#2)(2008-7#1)
unrelated plant viruses##2##3##(2008-10#2)
unrelated to any##5##3##(1993-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)
unrelated to either##2##3##(1992-6#1)(2008-12#1)
unrelated to the##14##3##(1991-8#1)(1995-12#2)(1997-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
unrelated to##52##2##(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)
unrelated##147##1##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#18)(2008-11#3)(2008-12#14)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#8)(2013-7#1)
unreliability##2##1##(1996-3#1)(2008-2#1)
unreliable data##2##2##(1993-9#1)(2008-7#1)
unreliable##18##1##(1990-2#1)(1990-8#1)(1991-11#1)(1993-9#1)(1994-12#1)(1997-3#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#2)(2010-10#1)
unrelieved pain##2##2##(2008-7#2)
unrelieved##4##1##(1990-3#1)(2008-7#2)(2010-8#1)
unremarkable##8##1##(1995-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2012-3#1)(2013-1#2)
unremitting##2##1##(2008-5#1)(2008-6#1)
unreplicated##2##1##(2008-8#1)(2010-2#1)
unreported##21##1##(1990-9#1)(1994-12#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-2#1)(2013-8#1)
unresectable disease##3##2##(1992-3#1)(2008-6#2)
unresectable or metastatic##4##3##(1994-2#1)(2008-6#3)
unresectable or##6##2##(1994-2#1)(2008-6#4)(2012-2#1)
unresectable pancreatic##2##2##(1991-2#1)(2013-1#1)
unresectable tumors##2##2##(2010-3#1)(2013-8#1)
unresectable##26##1##(1991-2#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-4#1)(2007-10#1)(2008-6#10)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#5)(2013-8#1)
unresected choledochal##2##2##(2009-9#2)
unresected##3##1##(2009-9#3)
unresolved cases##2##2##(2010-3#1)(2011-2#1)
unresolved issues##3##2##(1994-12#1)(1995-12#1)(1996-1#1)
unresolved problems##2##2##(2010-11#1)(2011-3#1)
unresolved##39##1##(1992-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)
unresponsive patients##2##2##(1992-8#1)(2008-6#1)
unresponsive to##18##2##(1990-7#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-8#2)(2008-11#1)(2008-7#1)(2011-2#4)
unresponsive##25##1##(1990-7#1)(1991-4#1)(1992-10#1)(1992-8#2)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#2)(2010-11#1)(2011-2#6)
unresponsiveness##5##1##(1993-6#1)(2008-11#4)
unrest and##2##2##(1993-2#1)(2010-4#1)
unrest##4##1##(1991-3#1)(1993-2#1)(1994-2#1)(2010-4#1)
unrestrained rats##3##2##(1995-12#1)(1995-2#1)(2008-4#1)
unrestrained##11##1##(1991-3#1)(1993-12#1)(1995-12#1)(1995-2#4)(1997-1#1)(2007-12#2)(2008-4#1)
unrestricted access to##2##3##(1992-2#1)(2008-7#1)
unrestricted##14##1##(1991-8#2)(1992-2#1)(1992-4#1)(1994-2#2)(2007-12#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2011-2#1)
unretained##4##1##(2008-10#4)
unruptured aneurysm##2##2##(1995-11#1)(2013-8#1)
unruptured arteriovenous malformations##2##3##(2008-7#2)
unruptured##10##1##(1995-11#2)(1995-8#1)(2008-7#5)(2009-7#1)(2013-8#1)
unsafe abortion##5##2##(2008-11#1)(2011-1#3)(2012-12#1)
unsafe abortions##3##2##(2008-11#3)
unsafe sex##2##2##(1996-4#1)(2007-2#1)
unsafe##19##1##(1994-9#1)(1995-12#1)(1996-4#1)(2007-2#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-5#1)(2011-1#3)(2012-12#3)
unsalvageable##2##1##(2008-10#1)(2011-2#1)
unsanitary conditions##2##2##(2008-8#1)(2011-2#1)
unsaponifiable##3##1##(2007-11#1)(2008-5#1)(2008-6#1)
unsatisfactory in##2##2##(2008-7#2)
unsatisfactory results##4##2##(1992-8#1)(2007-11#1)(2008-10#1)(2008-12#1)
unsatisfactory##33##1##(1990-10#1)(1992-11#1)(1992-8#1)(1994-11#1)(1995-12#1)(1996-6#2)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-5#1)(2011-2#3)(2012-1#1)(2012-5#1)(2013-1#1)
unsatisfactory&quot##2##1##(2008-1#2)
unsatisfied##3##1##(2010-2#1)(2010-8#1)(2011-7#1)
unsaturated FA##2##2##(2009-3#2)
unsaturated fatty acid##3##3##(1993-6#1)(1993-8#1)(2010-2#1)
unsaturated fatty acids and##2##4##(1990-8#1)(2008-5#1)
unsaturated fatty acids##16##3##(1990-12#1)(1990-2#2)(1990-8#1)(1991-6#1)(1993-3#1)(1993-6#2)(1994-8#1)(1995-11#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-5#2)
unsaturated fatty##19##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-6#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-8#1)(1995-11#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)
unsaturated ketones##2##2##(1996-5#2)
unsaturated systems##4##2##(1992-6#1)(2008-7#3)
unsaturated to saturated##2##3##(2010-4#1)(2011-1#1)
unsaturated to##3##2##(1994-3#1)(2010-4#1)(2011-1#1)
unsaturated##50##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#2)(1996-5#2)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#6)(2009-3#2)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)
unsaturation in the##2##3##(1992-6#2)
unsaturation on##2##2##(1990-2#1)(1992-6#1)
unsaturation percentage##2##2##(2008-10#2)
unsaturation##18##1##(1990-2#1)(1990-5#1)(1992-6#5)(1993-11#1)(1995-11#2)(1995-5#1)(2008-10#5)(2008-9#1)(2010-4#1)
unscattered##2##1##(2008-3#2)
unscheduled asthma visits##3##3##(2012-1#3)
unscheduled##7##1##(1991-2#1)(2008-11#1)(2009-6#1)(2012-1#3)(2012-2#1)
unscientific##3##1##(1990-2#1)(2008-7#1)(2012-2#1)
unscorable##2##1##(2012-12#2)
unscreened##5##1##(1993-12#1)(1997-5#3)(2007-12#1)
unseeded##4##1##(2007-11#1)(2008-3#3)
unseen##3##1##(2008-6#1)(2010-4#1)(2010-8#1)
unsegmented##2##1##(2008-10#2)
unselected controls##2##2##(1993-5#1)(2008-8#1)
unselected##12##1##(1992-9#1)(1993-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-3#3)
unsensed and uncorrectable##2##3##(2008-3#2)
unsensitized##2##1##(2008-10#2)
unseparated##3##1##(2008-4#3)
unsettled##6##1##(1990-11#1)(1992-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
unsettling##2##1##(1997-3#1)(2009-10#1)
unshaved##2##1##(2008-5#2)
unshielded##2##1##(2008-7#1)(2013-1#1)
unshifted photorefractive##2##2##(2007-11#2)
unshifted##4##1##(1993-12#1)(2007-11#2)(2008-3#1)
unsightly##3##1##(2008-5#1)(2012-3#2)
unskilled##2##1##(1995-5#1)(2012-2#1)
unsolved problems##2##2##(2010-9#1)(2011-1#1)
unsolved##12##1##(1990-12#1)(2007-8#1)(2008-12#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
unspecific##11##1##(1990-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#2)
unspecified##4##1##(1996-12#1)(1996-5#1)(2008-11#1)(2012-3#1)
unspiked samples##2##2##(1990-12#1)(2008-10#1)
unspiked##4##1##(1990-12#1)(2008-10#3)
unspliced##3##1##(1993-12#1)(1993-8#1)(2011-3#1)
unsprayed areas##2##2##(2008-10#2)
unsprayed##7##1##(2008-10#6)(2011-2#1)
unstabile##2##1##(2007-11#2)
unstable aberrations##2##2##(2013-8#2)
unstable alleles##2##2##(2009-5#2)
unstable and##8##2##(1991-4#1)(1992-12#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
unstable angina and non-ST elevation myocardial infarction in##2##8##(2008-3#2)
unstable angina and non-ST elevation myocardial infarction##5##7##(2008-3#5)
unstable angina and##7##3##(2007-8#1)(2008-3#5)(2008-5#1)
unstable angina pectoris and##5##4##(1990-12#1)(1991-9#4)
unstable angina pectoris##9##3##(1990-12#3)(1991-9#5)(2011-2#1)
unstable angina##31##2##(1990-12#3)(1991-9#6)(1992-9#1)(2007-8#3)(2008-10#1)(2008-3#9)(2008-5#3)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
unstable angina/non-ST elevation myocardial infarction##2##5##(2008-3#2)
unstable domains##3##2##(2007-12#2)(2012-2#1)
unstable during##2##2##(1990-5#1)(1996-3#1)
unstable fractures##2##2##(2007-8#2)
unstable in the##2##3##(2007-11#1)(2008-10#1)
unstable in##6##2##(1992-2#1)(2007-11#1)(2008-10#3)(2008-11#1)
unstable malaria##2##2##(2011-2#1)(2012-12#1)
unstable or##2##2##(1997-6#1)(2013-1#1)
unstable resonator with##3##3##(2008-3#3)
unstable resonator##15##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#9)
unstable resonators with a##2##4##(2008-3#2)
unstable resonators##11##2##(2007-11#1)(2008-2#3)(2008-3#7)
unstable to##3##2##(1990-7#1)(1994-11#1)(1996-5#1)
unstable type##2##2##(2007-11#1)(2007-8#1)
unstable##188##1##(1990-12#4)(1990-5#1)(1990-7#4)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-3#2)(1996-4#2)(1996-5#1)(1997-6#1)(2007-11#6)(2007-12#8)(2007-6#1)(2007-8#8)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#34)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-10#1)(2009-4#5)(2009-5#3)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#7)
unstable-cavity lasers with##2##3##(2008-3#2)
unstable-resonator solid-state laser##2##3##(2007-12#2)
unstained cells##2##2##(2007-12#1)(2008-11#1)
unstained##4##1##(2007-12#1)(2008-11#1)(2008-4#1)(2011-1#1)
unsteady##10##1##(1994-3#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
unsteamed##2##1##(2008-10#2)
unsterilized##2##1##(2008-10#2)
unstimulated and##2##2##(1997-8#1)(2012-2#1)
unstimulated##9##1##(1991-2#1)(1992-12#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-9#1)(2012-2#1)(2013-8#2)
unstirred##10##1##(1991-5#7)(2008-10#1)(2008-11#1)(2008-8#1)
unstratified##3##1##(1994-9#1)(1995-9#1)(2008-3#1)
unstressed##5##1##(1995-5#1)(1997-2#1)(2008-11#1)(2008-2#1)(2013-8#1)
unstructured absorption spectra##3##3##(2008-3#3)
unstructured interviews were##2##3##(2008-11#1)(2010-3#1)
unstructured interviews##4##2##(2008-11#2)(2010-10#1)(2010-3#1)
unstructured##28##1##(1991-12#1)(1991-3#1)(1995-2#1)(1995-3#1)(1997-6#1)(2008-11#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#2)(2013-1#5)
unsubstituted##5##1##(1990-7#1)(2008-10#3)(2012-2#1)
unsuccessful attempts##2##2##(1995-6#1)(2010-12#1)
unsuccessful in the##2##3##(1992-9#1)(2007-12#1)
unsuccessful in##3##2##(1992-9#1)(2007-12#1)(2008-11#1)
unsuccessful##43##1##(1991-1#1)(1992-11#1)(1992-9#1)(1993-5#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
unsuccessfully treated with##2##3##(2010-2#1)(2013-1#1)
unsuccessfully treated##3##2##(2010-2#2)(2013-1#1)
unsuccessfully##4##1##(2008-10#1)(2010-2#2)(2013-1#1)
unsuitable as##2##2##(2008-10#2)
unsuitable for further##2##3##(2008-7#1)(2011-2#1)
unsuitable for use in##2##4##(2008-10#1)(2008-9#1)
unsuitable for##16##2##(1991-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-9#3)(2010-6#2)(2011-2#1)
unsuitable##32##1##(1990-11#1)(1991-6#1)(1996-5#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2010-12#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
unsuited##2##1##(2008-4#1)(2008-9#1)
unsupervised learning##2##2##(2008-3#1)(2008-7#1)
unsupervised pattern recognition##3##3##(2008-10#2)(2010-5#1)
unsupervised##12##1##(2007-5#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-7#1)
unsupplemented##4##1##(1992-9#1)(1994-5#1)(2011-2#2)
unsupported##5##1##(1995-8#3)(2008-7#1)(2008-9#1)
unsupportive##4##1##(2010-11#1)(2011-1#2)(2012-12#1)
unsure##3##1##(2008-11#3)
unsurprising##2##1##(2010-10#1)(2012-2#1)
unsuspected##10##1##(1992-3#1)(1994-2#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#1)
unsustainable##3##1##(2007-5#1)(2008-7#1)(2011-7#1)
unsustained##2##1##(2009-10#2)
unsymmetrical##5##1##(2007-11#1)(2008-10#4)
untagged##2##1##(1994-8#1)(2009-10#1)
untapped##7##1##(1992-1#1)(1995-12#1)(1996-12#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-3#1)
untargeted##2##1##(2008-7#1)(2010-5#1)
untestable assumptions##2##2##(2011-2#2)
untested##5##1##(1993-12#1)(1993-3#1)(1994-3#1)(2008-5#1)(2009-8#1)
until 12##2##2##(1995-11#1)(1997-3#1)
until 1991##2##2##(2008-10#1)(2008-7#1)
until 1993##2##2##(1995-12#1)(1997-5#1)
until 2##3##2##(2007-10#1)(2008-10#2)
until 3 to 5 weeks##2##5##(2008-10#2)
until 3 to##3##3##(2008-10#2)(2009-3#1)
until 31 December##2##3##(2008-6#1)(2008-7#1)
until 4 weeks##2##3##(2008-10#1)(2013-8#1)
until 4##4##2##(1996-12#1)(2008-10#2)(2013-8#1)
until 5##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
until 6 to##2##3##(1997-3#1)(2008-10#1)
until 8##2##2##(1996-12#1)(2008-10#1)
until April##3##2##(1990-6#1)(1992-6#1)(2008-10#1)
until August##2##2##(2007-5#1)(2011-2#1)
until December 2008##2##3##(2011-2#1)(2013-1#1)
until December##4##2##(2008-8#1)(2011-2#1)(2013-1#2)
until July##3##2##(1996-5#1)(1997-2#1)(2008-10#1)
until June##5##2##(1996-5#1)(2008-10#2)(2011-2#1)(2013-8#1)
until May##2##2##(1995-6#1)(2008-10#1)
until November##2##2##(2007-8#1)(2011-2#1)
until a##5##2##(1995-3#1)(2008-10#3)(2013-1#1)
until about##2##2##(1996-3#2)
until adulthood##3##2##(1993-12#1)(2008-10#2)
until after##3##2##(2008-10#2)(2008-9#1)
until an##2##2##(2008-4#1)(2011-2#1)
until complete##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
until confluent##2##2##(2008-7#1)(2013-1#1)
until day##6##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
until failure##2##2##(2008-6#1)(2009-7#1)
until first cannulation##2##3##(2007-7#2)
until first##3##2##(2007-7#2)(2008-10#1)
until full##2##2##(2008-12#1)(2008-7#1)
until harvest##8##2##(2008-10#8)
until his death##2##3##(1995-3#1)(2008-7#1)
until his##5##2##(1995-3#1)(1997-5#1)(2008-7#2)(2010-3#1)
until it is##2##3##(1995-5#1)(2008-8#1)
until it reaches##2##3##(1997-2#1)(2008-11#1)
until it##8##2##(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2013-1#1)
until late in##3##3##(2008-10#3)
until late##5##2##(2008-10#5)
until later in##2##3##(1995-2#1)(1997-5#1)
until maximum##2##2##(1990-8#1)(2008-10#1)
until more##2##2##(2008-10#1)(2008-9#1)
until now been##4##3##(1992-12#1)(2008-2#1)(2010-7#1)(2012-2#1)
until now has##2##3##(1992-11#1)(2008-7#1)
until now##21##2##(1992-11#1)(1992-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-7#1)
until one##2##2##(1996-3#1)(2009-12#1)
until puberty and##2##3##(1995-12#1)(2008-5#1)
until puberty##3##2##(1995-12#1)(2008-1#1)(2008-5#1)
until reaching##2##2##(2008-11#1)(2008-5#1)
until recently##20##2##(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
until resolution##2##2##(1991-8#1)(2010-1#1)
until some time##2##3##(1997-3#1)(2008-9#1)
until stage##2##2##(2008-10#1)(2012-2#1)
until the advent of##2##4##(2008-7#1)(2010-3#1)
until the end of the experiment##3##6##(1992-9#1)(2008-4#1)(2008-9#1)
until the end of the##5##5##(1992-8#1)(1992-9#1)(2008-4#1)(2008-8#1)(2008-9#1)
until the end of##11##4##(1992-3#1)(1992-8#1)(1992-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
until the final##3##3##(2007-10#1)(2007-8#1)(2009-8#1)
until the first##2##3##(1992-9#1)(2008-7#1)
until the last##3##3##(1994-3#1)(2008-7#1)(2008-8#1)
until the##92##2##(1990-6#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-7#1)(1995-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
until their##3##2##(2008-1#1)(2009-12#1)(2011-2#1)
until there are##2##3##(1996-3#1)(2008-3#1)
until there is##4##3##(1993-3#2)(1996-3#1)(2009-5#1)
until there was##3##3##(1990-11#1)(1994-8#1)(2008-10#1)
until there##10##2##(1990-11#1)(1993-3#2)(1994-8#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)
until they##7##2##(1990-2#1)(1992-11#1)(1996-12#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
until very recently##2##3##(1995-2#1)(2008-11#1)
until##452##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#4)(1993-6#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-7#2)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#5)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#7)(1997-3#6)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(2007-10#3)(2007-11#2)(2007-12#6)(2007-5#2)(2007-7#4)(2007-8#7)(2008-1#5)(2008-10#95)(2008-11#9)(2008-12#6)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#13)(2008-6#8)(2008-7#20)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#6)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#2)(2010-7#1)(2010-8#7)(2011-1#2)(2011-2#29)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#4)(2012-6#1)(2012-7#2)(2013-1#15)(2013-7#3)(2013-8#6)
untilted##2##1##(2008-3#1)(2013-1#1)
untouched##2##1##(2010-5#1)(2012-3#1)
untoward effects##2##2##(1990-2#1)(2007-7#1)
untoward side-effects##2##2##(2008-2#1)(2008-4#1)
untoward##8##1##(1990-2#1)(1994-12#1)(1994-2#1)(1997-7#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-8#1)
untrained female rats##3##3##(2013-1#3)
untrained limb##2##2##(2013-8#2)
untrained rats##2##2##(1992-8#1)(2013-1#1)
untrained##18##1##(1992-8#2)(1995-12#1)(1996-12#1)(1997-5#1)(2007-2#1)(2007-4#1)(2010-7#1)(2013-1#7)(2013-8#3)
untransfected control##2##2##(2008-11#1)(2008-8#1)
untransfected##4##1##(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)
untransformed cells##4##2##(1993-2#2)(1995-8#1)(2011-2#1)
untransformed##10##1##(1991-9#1)(1993-2#2)(1994-8#1)(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#2)(2011-2#1)
untranslatable##2##1##(2008-10#1)(2012-2#1)
untranslated region (UTR)##3##3##(1992-8#1)(2008-10#2)
untranslated region and##2##3##(1992-3#1)(2008-8#1)
untranslated region is##2##3##(1991-9#1)(2008-8#1)
untranslated region of the##3##4##(1991-9#1)(1995-2#1)(1997-6#1)
untranslated region of##12##3##(1991-9#1)(1992-11#1)(1994-11#2)(1995-2#1)(1995-8#1)(1997-6#2)(1997-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
untranslated region that##2##3##(1996-12#1)(2008-10#1)
untranslated region##35##2##(1991-9#2)(1992-11#3)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#4)(1994-8#1)(1995-2#2)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#3)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#2)(2012-2#1)
untranslated regions of the##3##4##(1990-5#1)(1993-2#1)(2011-2#1)
untranslated regions of##4##3##(1990-5#1)(1993-2#1)(2010-9#1)(2011-2#1)
untranslated regions##9##2##(1990-5#1)(1993-12#2)(1993-2#1)(1994-11#1)(1997-8#1)(2008-10#1)(2010-9#1)(2011-2#1)
untranslated sequence##5##2##(1992-11#2)(1992-3#2)(1993-8#1)
untranslated##55##1##(1990-5#1)(1991-2#1)(1991-9#2)(1992-11#5)(1992-12#1)(1992-3#3)(1992-8#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-8#2)(1995-2#2)(1995-8#2)(1996-12#1)(1997-4#1)(1997-6#3)(1997-8#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#2)(2010-9#1)(2011-2#1)(2012-2#1)
untreatable##5##1##(2008-1#1)(2008-10#2)(2010-5#1)(2012-3#1)
untreated J774##2##2##(1996-12#2)
untreated L-TGF-beta 1##2##3##(1990-2#2)
untreated and##8##2##(1990-6#1)(1994-6#1)(1995-11#1)(1995-8#3)(2008-10#1)(2010-11#1)
untreated area##2##2##(2008-5#2)
untreated cells##5##2##(1992-3#1)(1992-5#1)(1993-6#1)(1993-8#1)(2008-9#1)
untreated control plots##3##3##(2008-10#3)
untreated control##19##2##(1992-12#1)(1993-9#1)(1997-4#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2011-2#1)(2013-7#1)
untreated control)##2##2##(2008-10#1)(2008-11#1)
untreated controls##9##2##(1995-12#2)(1995-2#1)(1995-3#1)(1997-4#3)(2008-10#1)(2008-11#1)
untreated culture##2##2##(1994-9#1)(2010-11#1)
untreated disease##2##2##(2009-12#1)(2011-2#1)
untreated dwarf rats##2##3##(1995-12#2)
untreated dwarf##4##2##(1995-12#4)
untreated fields##2##2##(1995-6#2)
untreated hair##3##2##(2008-5#3)
untreated in##2##2##(1992-2#1)(2007-10#1)
untreated islets##2##2##(2010-11#2)
untreated mice##5##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2013-7#1)
untreated or treated##3##3##(1990-11#1)(2008-11#1)(2008-9#1)
untreated or##6##2##(1990-11#1)(1992-9#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
untreated patients with##5##3##(1990-12#2)(1990-9#1)(1991-4#1)(2008-7#1)
untreated patients##13##2##(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-4#1)(1995-12#1)(2007-7#2)(2008-7#1)(2010-6#1)(2013-8#1)
untreated plants##3##2##(2008-10#2)(2008-11#1)
untreated soil##3##2##(2008-10#3)
untreated water##3##2##(1997-4#2)(2008-10#1)
untreated wheat##2##2##(2008-10#1)(2008-12#1)
untreated wool fibre##2##3##(2008-5#2)
untreated##211##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#9)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#3)(1996-12#5)(1996-7#1)(1997-4#7)(1997-6#2)(1997-7#2)(2006-10#1)(2007-10#4)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#40)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-11#5)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#5)
untwisting rate peak##2##3##(2011-2#2)
untwisting rate##4##2##(2011-2#4)
untwisting##5##1##(2011-2#5)
untypical##2##1##(2011-2#1)(2012-12#1)
ununited ossicle was##2##3##(2008-9#2)
ununited ossicle##3##2##(2008-9#3)
ununited##4##1##(1991-3#1)(2008-9#3)
unusable##2##1##(2008-1#2)
unused##2##1##(1994-6#1)(2008-10#1)
unusual DNA##3##2##(1992-8#1)(1993-11#1)(2008-4#1)
unusual X chromosome-linked dominant##2##4##(1994-8#2)
unusual ability to##2##3##(1994-8#1)(2008-10#1)
unusual aetiologies##2##2##(2012-2#2)
unusual and##9##2##(1990-6#1)(1995-12#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-6#1)(2008-9#1)(2013-1#2)
unusual arrangement##3##2##(1990-11#1)(1997-7#1)(2009-8#1)
unusual capacity##2##2##(1994-8#1)(2008-5#1)
unusual case of a##8##4##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
unusual case of penetrating ocular trauma with##2##7##(2011-1#2)
unusual case of##31##3##(1993-8#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)
unusual case##39##2##(1993-8#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
unusual cases of##2##3##(2008-7#1)(2008-8#1)
unusual cases##4##2##(2008-1#1)(2008-7#1)(2008-8#2)
unusual cause of acute##2##4##(1993-6#1)(2008-10#1)
unusual cause of##10##3##(1993-6#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-8#1)(2010-12#1)(2013-1#3)(2013-8#1)
unusual cause##12##2##(1993-6#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-12#1)(2013-1#3)(2013-8#1)
unusual clinical presentation##3##3##(2007-8#1)(2008-11#2)
unusual clinical##9##2##(1990-3#1)(1990-9#1)(1995-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-4#1)
unusual combination##2##2##(1996-4#1)(2012-3#1)
unusual complication of##4##3##(2006-10#1)(2009-9#1)(2011-2#1)(2013-8#1)
unusual complication##7##2##(2006-10#1)(2007-7#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-8#1)
unusual disease outburst##2##3##(2008-10#2)
unusual disease##3##2##(1997-3#1)(2008-10#2)
unusual diseases##2##2##(1992-2#2)
unusual features##4##2##(2006-10#1)(2008-1#1)(2009-8#1)(2010-3#1)
unusual finding##3##2##(2007-7#1)(2008-12#1)(2011-1#1)
unusual for##3##2##(1990-8#1)(1990-9#1)(1995-3#1)
unusual form of##6##3##(1991-11#1)(1991-3#1)(2006-10#1)(2007-10#1)(2009-6#1)(2012-2#1)
unusual histological##2##2##(1991-8#1)(2012-12#1)
unusual in that##2##3##(1993-9#1)(1996-2#1)
unusual in##5##2##(1993-9#1)(1996-2#1)(2008-7#1)(2009-7#1)(2012-1#1)
unusual injury##2##2##(2008-10#1)(2008-9#1)
unusual location##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
unusual locations##3##2##(1991-4#1)(2007-11#1)(2009-1#1)
unusual mode of suicide##2##4##(2009-10#2)
unusual mode of##3##3##(2009-10#3)
unusual neoplasm##3##2##(1994-6#1)(2008-10#1)(2009-3#1)
unusual observation of##2##3##(2010-4#1)(2013-1#1)
unusual or##2##2##(2007-10#1)(2008-5#1)
unusual organisms##2##2##(2007-12#1)(2007-7#1)
unusual pattern of##3##3##(1992-12#1)(2007-2#1)(2008-7#1)
unusual presentation in a##2##4##(2010-11#1)(2012-3#1)
unusual presentation of##8##3##(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#2)(2010-11#1)(2013-1#1)(2013-7#1)
unusual presentation with##2##3##(2008-7#1)(2009-1#1)
unusual presentation##21##2##(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-7#5)(2009-1#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
unusual properties##2##2##(2008-11#1)(2012-2#1)
unusual radiological##2##2##(2008-7#1)(2012-12#1)
unusual shaped##2##2##(2012-2#2)
unusual structures##2##2##(1992-6#1)(2013-1#1)
unusual thermal##2##2##(1996-5#1)(2008-3#1)
unusual to##2##2##(2008-7#1)(2012-2#1)
unusual tumor and##2##3##(1991-8#1)(2006-12#1)
unusual tumor##4##2##(1991-8#2)(2006-12#1)(2012-2#1)
unusual##368##1##(1990-11#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#4)(1991-11#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#4)(1993-9#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#8)(2006-12#1)(2007-10#7)(2007-11#3)(2007-12#8)(2007-2#2)(2007-5#2)(2007-7#9)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#5)(2008-12#8)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#24)(2008-8#8)(2008-9#9)(2009-1#2)(2009-10#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#11)(2012-1#1)(2012-12#7)(2012-2#21)(2012-3#5)(2013-1#20)(2013-7#4)(2013-8#7)
unusually high##4##2##(1993-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
unusually large##7##2##(1991-2#1)(1992-12#1)(2007-11#1)(2008-10#1)(2009-7#1)(2011-1#1)(2013-7#1)
unusually long##5##2##(1990-12#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
unusually low##2##2##(1996-5#1)(2011-2#1)
unusually##40##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#2)(1994-8#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
unvaccinated##10##1##(1994-2#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-3#1)(2007-2#1)(2008-12#2)(2009-5#1)
unvarnished women##3##2##(2008-5#3)
unveil##2##1##(2012-2#1)(2013-1#1)
unveiled##9##1##(2008-9#1)(2009-3#1)(2010-1#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-7#2)
unveiling the##2##2##(2008-7#1)(2010-2#1)
unveiling##3##1##(2008-4#1)(2008-7#1)(2010-2#1)
unveils##2##1##(1991-9#1)(1995-6#1)
unwanted cells##3##2##(2008-9#2)(2009-10#1)
unwanted diffraction orders##2##3##(2008-2#1)(2008-3#1)
unwanted effects##5##2##(1996-3#1)(2008-10#1)(2008-4#1)(2008-9#2)
unwanted interference##2##2##(2008-2#1)(2008-3#1)
unwanted newborns##2##2##(2007-2#2)
unwanted pregnancies and##2##3##(1993-3#1)(2008-1#1)
unwanted pregnancies##5##2##(1993-3#1)(2008-1#1)(2008-11#2)(2012-2#1)
unwanted pregnancy##3##2##(1997-5#1)(2012-12#1)(2013-1#1)
unwanted side effects##4##3##(1991-3#1)(2008-1#1)(2008-9#1)(2009-12#1)
unwanted##64##1##(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-2#3)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#4)(2008-9#7)(2009-10#2)(2009-12#2)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
unwarranted##3##1##(1996-12#1)(2008-5#1)(2012-2#1)
unwary##2##1##(1993-1#1)(2008-3#1)
unweighted pair group method with arithmetic##3##6##(2008-10#3)
unweighted pair group method##4##4##(2008-10#4)
unweighted pair-group method with arithmetic average cluster analysis##2##8##(2008-10#2)
unweighted pair-group method with arithmetic average##3##6##(2008-10#3)
unweighted pair-group method with arithmetic##4##5##(2008-10#4)
unweighted pair-group method##5##3##(2008-10#5)
unweighted##14##1##(1991-12#1)(1992-12#1)(2008-10#10)(2008-4#1)(2012-2#1)
unwell##5##1##(1993-12#1)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
unwilling to undergo##2##3##(1992-6#1)(2011-2#1)
unwilling to##8##2##(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-9#1)(2010-5#1)(2011-2#1)
unwilling##10##1##(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-9#1)(2008-12#1)(2010-5#1)(2011-2#2)
unwillingness to##2##2##(2008-2#1)(2013-8#1)
unwillingness##4##1##(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
unwind##4##1##(1994-6#1)(1997-4#1)(2012-1#2)
unwinding and##2##2##(1995-3#1)(2012-1#1)
unwinding angle##2##2##(1990-11#2)
unwinding of##3##2##(1994-5#1)(1995-2#1)(1995-3#1)
unwinding##17##1##(1990-11#5)(1994-5#1)(1995-2#1)(1995-3#6)(1997-4#3)(2012-1#1)
unwooded Chardonnay##2##2##(2008-10#2)
unwounded##2##1##(2008-10#2)
unwrapped area##2##2##(2008-2#2)
unwrapped phase##3##2##(2008-2#1)(2008-3#2)
unwrapped##10##1##(2008-2#4)(2008-3#6)
unwrapping algorithm is##2##3##(2008-2#2)
unwrapping algorithm##3##2##(2008-2#2)(2008-3#1)
unwrapping algorithms##2##2##(2008-3#2)
unwrapping and##2##2##(2008-3#2)
unwrapping is##4##2##(2008-2#1)(2008-3#3)
unwrapping of##3##2##(2008-2#1)(2008-3#2)
unwrapping problem##2##2##(2008-2#1)(2008-3#1)
unwrapping process##3##2##(2008-2#1)(2008-3#2)
unwrapping through##3##2##(2008-2#1)(2008-3#2)
unwrapping##49##1##(2007-11#1)(2008-2#13)(2008-3#35)
up a large##2##3##(2008-5#1)(2011-2#1)
up a major##2##3##(2008-11#1)(2009-4#1)
up a new##2##3##(1995-12#1)(2012-2#1)
up a##38##2##(1992-1#1)(1994-1#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
up about##2##2##(1992-3#1)(1996-8#1)
up across the##2##3##(1991-3#1)(2008-2#1)
up after the##2##3##(1997-2#1)(2013-8#1)
up after##8##2##(1990-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-5#2)(2013-1#1)(2013-8#1)
up again##2##2##(1990-2#1)(1996-4#1)
up an##5##2##(1995-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
up and down states##2##4##(2008-11#2)
up and down##6##3##(2008-11#3)(2010-12#1)(2010-8#1)(2011-2#1)
up and##37##2##(1993-6#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#2)(2013-8#1)
up as a##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
up as##8##2##(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
up at 6##2##3##(1995-3#1)(2013-1#1)
up at the intersection of##2##5##(2009-5#2)
up at the##4##3##(2008-2#1)(2008-8#1)(2009-5#2)
up at##14##2##(1995-3#1)(1995-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#1)(2009-5#2)(2010-6#1)(2011-2#1)(2013-1#1)
up based on##4##3##(2008-10#2)(2010-8#1)(2013-1#1)
up by a##7##3##(1990-2#1)(1990-8#1)(1995-11#1)(2008-10#3)(2008-5#1)
up by the##8##3##(1991-11#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-5#1)
up by##37##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#2)(2007-12#1)(2008-10#8)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
up can##2##2##(2008-5#1)(2008-7#1)
up during##3##2##(2008-1#1)(2010-5#1)(2013-1#1)
up for a##4##3##(2007-8#1)(2008-8#1)(2010-5#1)(2013-8#1)
up for the##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
up for##41##2##(1991-9#1)(1992-1#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-9#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#3)
up from##8##2##(1992-12#1)(1992-3#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
up front&quot##2##2##(1994-1#2)
up in the##7##3##(1992-3#1)(1995-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
up in##21##2##(1992-3#1)(1992-5#1)(1992-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-2#1)
up into the##3##3##(1997-3#2)(2007-10#1)
up into##7##2##(1990-11#1)(1992-3#1)(1997-3#2)(2007-10#1)(2008-4#1)(2009-8#1)
up many##2##2##(2008-7#1)(2009-12#1)
up more##3##2##(1990-10#1)(2008-9#1)(2009-5#1)
up new perspectives##2##3##(2008-10#1)(2011-3#1)
up new##12##2##(1993-2#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2011-3#1)(2012-2#1)
up of a##5##3##(1993-6#1)(1996-2#1)(2008-12#1)(2008-4#1)(2008-9#1)
up of the##2##3##(1992-12#1)(2008-10#1)
up of this##2##3##(2008-11#1)(2013-1#1)
up of##68##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-12#2)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
up on a##2##3##(2008-10#1)(2010-11#1)
up on##7##2##(2008-10#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2012-1#2)
up only##2##2##(2007-10#1)(2008-7#1)
up opportunities##2##2##(1996-3#1)(2008-3#1)
up or##4##2##(1996-3#1)(2008-11#1)(2008-2#1)(2008-5#1)
up over the##2##3##(1995-6#1)(2008-11#1)
up protection##2##2##(1997-2#1)(2010-5#1)
up study##3##2##(2007-10#1)(2007-7#1)(2013-1#1)
up the possibility of##5##4##(1990-5#1)(2008-11#1)(2008-7#3)
up the possibility##6##3##(1990-5#1)(2008-11#1)(2008-7#3)(2009-5#1)
up the release of##2##4##(1997-2#2)
up the sample##2##3##(1991-5#1)(2010-9#1)
up the way for##2##4##(1995-4#1)(2008-8#1)
up the##71##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
up their##3##2##(1992-2#1)(2007-12#1)(2008-2#1)
up this##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
up to 0##26##3##(1990-5#1)(1990-7#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-8#1)(2009-4#1)(2012-2#1)
up to 1 MHz##2##4##(2007-12#1)(2008-3#1)
up to 1 m##2##4##(2007-10#1)(2008-10#1)
up to 1 microM##2##4##(1992-3#1)(1993-8#1)
up to 1 month##2##4##(2008-10#1)(2008-7#1)
up to 1##42##3##(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-3#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
up to 1%##2##3##(2008-10#2)
up to 10 days##3##4##(1992-12#1)(1996-12#1)(2009-7#1)
up to 10 mg l(-1)##2##5##(2008-10#2)
up to 10 mg##4##4##(2008-10#2)(2008-2#1)(2008-5#1)
up to 10##26##3##(1990-2#2)(1991-5#1)(1992-11#2)(1992-12#1)(1995-3#1)(1996-12#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
up to 10% of##3##4##(1991-9#1)(2008-4#1)(2008-6#1)
up to 10%##6##3##(1991-9#1)(2008-3#2)(2008-4#1)(2008-6#1)(2010-8#1)
up to 10(3)##2##3##(2008-11#1)(2013-8#1)
up to 10(5)##3##3##(2008-10#2)(2008-11#1)
up to 100 kHz##2##4##(2007-11#1)(2008-3#1)
up to 100 mg##2##4##(2008-10#1)(2008-12#1)
up to 100 microM##2##4##(1995-5#1)(2008-10#1)
up to 100 muM##2##4##(2008-10#2)
up to 100##21##3##(1990-12#1)(1991-2#1)(1993-11#1)(1995-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)
up to 100%##4##3##(1990-5#1)(1993-2#1)(2008-10#2)
up to 1000##3##3##(1994-8#1)(1997-5#1)(2008-10#1)
up to 11##4##3##(2008-10#3)(2008-3#1)
up to 12 months##2##4##(2007-10#1)(2009-10#1)
up to 12##13##3##(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)
up to 120##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
up to 14 days##2##4##(1992-5#1)(2009-12#1)
up to 14##8##3##(1992-5#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-5#1)
up to 140##2##3##(2008-8#1)(2010-8#1)
up to 15 days##4##4##(2007-6#1)(2008-5#3)
up to 15##15##3##(1994-6#1)(1997-1#1)(1997-4#1)(2007-6#1)(2008-10#6)(2008-5#3)(2008-7#1)(2008-8#1)
up to 15%##2##3##(2008-10#1)(2011-2#1)
up to 150##6##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-1#1)
up to 16##4##3##(1997-3#1)(2007-11#1)(2008-11#1)(2013-8#1)
up to 160##2##3##(2008-2#1)(2011-1#1)
up to 175##2##3##(1994-2#1)(2008-10#1)
up to 18##8##3##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-2#1)
up to 19##3##3##(2008-8#2)(2013-1#1)
up to 19%##2##3##(2008-11#1)(2013-1#1)
up to 2 weeks##3##4##(1990-12#1)(2008-10#2)
up to 2 years after##2##5##(2007-11#1)(2008-7#1)
up to 2 years##5##4##(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)
up to 2##29##3##(1990-12#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#1)(1996-12#2)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
up to 2%##2##3##(1995-2#1)(2008-10#1)
up to 2-fold##2##3##(1991-8#1)(1992-3#1)
up to 20 mole percent##2##5##(1990-2#2)
up to 20##14##3##(1990-2#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
up to 20% of the##3##5##(2008-6#1)(2008-7#1)(2011-1#1)
up to 20% of##5##4##(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)
up to 20%##11##3##(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)
up to 200##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
up to 200%##3##3##(1996-2#1)(2008-1#2)
up to 200-fold##3##3##(1994-8#1)(1997-8#1)(2008-10#1)
up to 24 h##4##4##(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
up to 24##7##3##(1995-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)
up to 240##2##3##(2008-10#1)(2008-7#1)
up to 24h##2##3##(2008-10#1)(2008-12#1)
up to 25##6##3##(1991-5#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-2#1)
up to 27##2##3##(2008-8#1)(2008-9#1)
up to 270##2##3##(2008-10#1)(2008-5#1)
up to 28##2##3##(2010-11#1)(2011-2#1)
up to 3 days##5##4##(2008-10#2)(2008-11#1)(2008-7#2)
up to 3##19##3##(1992-8#1)(1997-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2012-3#1)
up to 3%##2##3##(2008-3#1)(2010-3#1)
up to 30 days##4##4##(1997-4#1)(2008-10#1)(2008-5#1)(2010-8#1)
up to 30 min##3##4##(1996-12#1)(1997-8#1)(2008-10#1)
up to 30##19##3##(1991-2#1)(1991-5#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#7)(2008-5#2)(2008-7#1)(2010-8#1)
up to 30% of the##3##5##(2008-10#1)(2011-2#1)(2012-12#1)
up to 30% of##4##4##(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
up to 30%##9##3##(1996-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)
up to 300 degrees C and##2##6##(2008-10#1)(2011-1#1)
up to 31##2##3##(1996-12#1)(1997-6#1)
up to 32##3##3##(1993-3#1)(2007-9#1)(2008-10#1)
up to 35##2##3##(1994-12#1)(1997-6#1)
up to 35%##3##3##(2008-10#2)(2009-7#1)
up to 350##2##3##(2007-12#1)(2008-3#1)
up to 36##2##3##(2007-12#1)(2011-2#1)
up to 4 months after treatment##2##6##(2013-1#2)
up to 4 months after##3##5##(2010-5#1)(2013-1#2)
up to 4 months##5##4##(2008-11#2)(2010-5#1)(2013-1#2)
up to 4##17##3##(1990-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(2008-10#2)(2008-11#4)(2008-7#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
up to 4%##2##3##(1996-12#1)(2008-3#1)
up to 40##2##3##(2008-10#1)(2008-11#1)
up to 40% in##2##4##(2008-10#1)(2008-2#1)
up to 40% of##2##4##(2008-7#1)(2008-8#1)
up to 40%##10##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)
up to 400##3##3##(1992-8#1)(1995-6#1)(2008-11#1)
up to 41##2##3##(1997-1#1)(2008-10#1)
up to 45 days postinoculation##2##5##(2008-10#2)
up to 45##4##3##(2008-10#2)(2008-6#1)(2011-2#1)
up to 47%##2##3##(2008-10#1)(2012-3#1)
up to 48 h##2##4##(2008-10#2)
up to 48 hours##2##4##(1992-4#1)(1994-6#1)
up to 48##7##3##(1992-4#1)(1994-6#1)(1996-5#2)(2008-10#2)(2008-5#1)
up to 5 days##2##4##(1991-5#1)(2008-10#1)
up to 5 years##2##4##(2007-5#1)(2013-1#1)
up to 5##18##3##(1991-5#1)(1994-2#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
up to 5%##4##3##(1996-1#1)(2008-10#2)(2008-4#1)
up to 50##18##3##(1990-2#2)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#2)
up to 50% of##3##4##(2008-1#3)
up to 50%##7##3##(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
up to 500##3##3##(2008-10#3)
up to 56##2##3##(2008-10#2)
up to 6 h##3##4##(2008-5#1)(2008-8#1)(2010-5#1)
up to 6 months of##2##5##(2008-10#1)(2010-6#1)
up to 6 months##5##4##(2007-11#1)(2007-8#1)(2008-10#2)(2010-6#1)
up to 6 weeks##4##4##(1996-6#1)(2008-10#3)
up to 6##22##3##(1990-10#1)(1993-11#1)(1994-5#1)(1995-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)
up to 60 degrees C##2##5##(2008-6#2)
up to 60##12##3##(1992-12#1)(1995-3#1)(1997-1#1)(2007-10#1)(2008-10#4)(2008-6#2)(2008-8#1)(2013-1#1)
up to 60% of the##2##5##(1996-6#1)(2008-10#1)
up to 60% of##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
up to 60%##4##3##(1996-6#1)(2008-10#1)(2008-11#2)
up to 600##3##3##(1996-7#1)(2007-12#1)(2008-10#1)
up to 60min##2##3##(2008-10#2)
up to 610##2##3##(1997-4#1)(2008-11#1)
up to 63##3##3##(1995-5#1)(2008-10#2)
up to 7 days##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
up to 7##6##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-5#1)
up to 70##2##3##(2008-10#1)(2008-8#1)
up to 70% of##2##4##(2008-1#1)(2008-7#1)
up to 70%##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
up to 72 hours##2##4##(1993-11#1)(1994-11#1)
up to 72##5##3##(1993-11#1)(1994-11#1)(1995-1#1)(1996-12#1)(2008-10#1)
up to 73%##2##3##(2008-10#2)
up to 75##3##3##(1994-7#1)(2007-12#1)(2008-10#1)
up to 8 h##2##4##(1992-10#1)(1995-11#1)
up to 8##11##3##(1991-11#1)(1992-10#1)(1993-11#1)(1994-11#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-6#1)
up to 8%##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
up to 80##3##3##(1997-1#1)(2008-10#2)
up to 80% of the##2##5##(1994-3#1)(2013-1#1)
up to 80% of##4##4##(1994-11#1)(1994-3#1)(2008-6#1)(2013-1#1)
up to 80%##6##3##(1994-11#1)(1994-3#2)(2008-10#1)(2008-6#1)(2013-1#1)
up to 85%##2##3##(2008-1#1)(2008-10#1)
up to 9##4##3##(1995-11#1)(1995-2#1)(2008-3#1)(2008-4#1)
up to 90 degrees##2##4##(1990-2#1)(2008-2#1)
up to 90##8##3##(1990-2#1)(1994-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
up to 90% of the##2##5##(2008-10#2)
up to 90% of##3##4##(2008-10#2)(2012-2#1)
up to 90%##5##3##(1991-5#1)(2008-10#3)(2012-2#1)
up to 900 degrees C for Cd##2##7##(2008-10#2)
up to 900##4##3##(1997-2#1)(2008-10#3)
up to 95##2##3##(1992-12#1)(2008-7#1)
up to a certain##2##4##(2007-12#1)(2010-9#1)
up to a concentration of 3##2##6##(1990-5#1)(2008-11#1)
up to a concentration of##8##5##(1990-5#1)(1991-5#1)(2008-10#5)(2008-11#1)
up to a concentration##9##4##(1990-5#1)(1991-5#1)(2008-10#6)(2008-11#1)
up to a factor of##5##5##(1990-11#1)(1992-3#1)(1995-12#1)(2008-3#1)(2008-7#1)
up to a size parameter of 20 at 0##2##9##(2008-3#2)
up to a total##3##4##(1991-2#1)(1992-10#1)(2012-2#1)
up to a##50##3##(1990-11#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)
up to about 10##2##4##(1993-11#1)(2008-10#1)
up to about##8##3##(1992-8#1)(1993-11#1)(1997-6#1)(2008-10#5)
up to an arbitrary constant##2##5##(2008-3#2)
up to an##8##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-8#1)
up to and including##2##4##(2008-3#1)(2012-3#1)
up to approximately##8##3##(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)
up to at least 100##3##5##(2008-10#3)
up to at least##7##4##(2008-10#6)(2008-7#1)
up to date##5##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)
up to eight##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
up to five##4##3##(1991-2#1)(2008-10#2)(2008-8#1)
up to four##13##3##(1991-5#1)(1992-3#1)(1992-9#1)(1993-2#1)(1995-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
up to fourfold##2##3##(2007-12#1)(2008-7#1)
up to half##3##3##(2008-5#2)(2013-8#1)
up to middle age##2##4##(1991-6#1)(2008-3#1)
up to nearly##2##3##(2008-3#1)(2011-1#1)
up to nine##2##3##(2008-10#1)(2009-12#1)
up to now##7##3##(2008-10#2)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#2)
up to one third of##2##5##(2007-7#1)(2008-12#1)
up to one year##2##4##(1996-1#1)(1997-5#1)
up to one##8##3##(1996-1#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
up to or##2##3##(2007-3#1)(2008-7#1)
up to several##6##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-12#1)
up to six times##2##4##(2008-11#1)(2010-12#1)
up to six##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#2)
up to temperatures##2##3##(1995-6#1)(2007-12#1)
up to that##2##3##(2008-3#1)(2012-12#1)
up to the 20th##3##4##(1993-12#1)(2008-11#1)(2008-5#1)
up to the dose of##2##5##(1995-12#1)(2013-1#1)
up to the fourth order##2##5##(2008-3#2)
up to the fourth##4##4##(2008-10#1)(2008-3#2)(2008-9#1)
up to the stage of##2##5##(1992-2#1)(2008-11#1)
up to the surface##3##4##(2008-5#3)
up to the year##2##4##(2008-11#1)(2009-7#1)
up to the##58##3##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-6#1)(1992-2#2)(1993-12#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
up to three##8##3##(1991-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2013-1#1)
up to two##2##3##(1991-11#1)(2008-11#1)
up to##1067##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#7)(1990-3#3)(1990-5#5)(1990-6#4)(1990-7#1)(1990-8#5)(1990-9#1)(1991-11#3)(1991-2#7)(1991-3#3)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#1)(1992-8#7)(1992-9#1)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#7)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#12)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#3)(1996-7#1)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#10)(1997-7#1)(1997-8#4)(2007-10#3)(2007-11#22)(2007-12#35)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#12)(2008-10#312)(2008-11#58)(2008-12#13)(2008-2#31)(2008-3#60)(2008-4#9)(2008-5#32)(2008-6#16)(2008-7#40)(2008-8#20)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#2)(2010-8#9)(2010-9#2)(2011-1#10)(2011-2#27)(2011-7#1)(2012-1#1)(2012-12#10)(2012-2#14)(2012-3#7)(2012-7#1)(2013-1#18)(2013-7#2)(2013-8#7)
up until##2##2##(2009-3#1)(2011-2#1)
up via##2##2##(1994-12#1)(2011-2#1)
up was##9##2##(1990-10#1)(2007-8#1)(2008-10#2)(2009-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
up with a##2##3##(1994-12#1)(2009-6#1)
up with the##6##3##(1996-3#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-7#1)
up with##28##2##(1992-3#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-5#1)(2010-7#1)(2013-8#1)
up within##2##2##(1990-11#1)(2008-2#1)
up##1812##1##(1990-10#4)(1990-11#5)(1990-12#2)(1990-2#11)(1990-3#5)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#8)(1990-9#3)(1991-11#4)(1991-12#2)(1991-2#8)(1991-3#7)(1991-5#8)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#10)(1992-2#4)(1992-3#16)(1992-4#1)(1992-5#6)(1992-6#3)(1992-8#9)(1992-9#1)(1993-11#6)(1993-12#4)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#6)(1993-8#5)(1993-9#4)(1994-1#4)(1994-11#8)(1994-12#5)(1994-2#5)(1994-3#8)(1994-5#3)(1994-6#6)(1994-7#2)(1994-8#7)(1994-9#3)(1995-1#2)(1995-11#9)(1995-12#8)(1995-2#6)(1995-3#10)(1995-4#4)(1995-5#5)(1995-6#9)(1995-8#2)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#12)(1996-2#8)(1996-3#7)(1996-4#2)(1996-5#8)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#12)(1997-3#7)(1997-4#7)(1997-5#5)(1997-6#13)(1997-7#2)(1997-8#7)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#6)(2007-11#31)(2007-12#50)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#5)(2008-1#26)(2008-10#399)(2008-11#107)(2008-12#20)(2008-2#46)(2008-3#81)(2008-4#31)(2008-5#59)(2008-6#25)(2008-7#82)(2008-8#33)(2008-9#31)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#8)(2009-6#4)(2009-7#14)(2009-8#4)(2009-9#2)(2010-1#2)(2010-11#4)(2010-12#8)(2010-2#3)(2010-3#10)(2010-4#8)(2010-5#12)(2010-6#3)(2010-7#4)(2010-8#18)(2010-9#4)(2011-1#17)(2011-2#56)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#20)(2012-2#28)(2012-3#15)(2012-7#1)(2013-1#45)(2013-7#5)(2013-8#27)
up&quot##3##1##(1995-12#1)(1996-4#1)(2013-1#1)
up- or down-regulated##4##3##(2008-4#1)(2009-5#1)(2010-4#2)
up- or##7##2##(1996-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#2)(2012-12#1)
up-##8##1##(1996-12#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#2)(2012-12#1)
up-front##3##1##(1994-2#1)(1997-1#1)(2010-3#1)
up-regulate##4##1##(1994-11#1)(2008-7#2)(2008-9#1)
up-regulated and##4##2##(2008-10#1)(2008-9#1)(2010-4#1)(2010-6#1)
up-regulated by##6##2##(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)
up-regulated during##2##2##(1995-8#1)(2011-2#1)
up-regulated genes##2##2##(2008-10#2)
up-regulated in resistant##2##3##(2008-10#2)
up-regulated in the##3##3##(1995-8#1)(2010-4#1)(2011-2#1)
up-regulated in##18##2##(1995-11#2)(1995-8#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#1)(2010-4#2)(2011-2#2)(2011-3#1)
up-regulated osteopontin gene##2##3##(2008-7#2)
up-regulated the##2##2##(1994-11#1)(2008-11#1)
up-regulated whereas##2##2##(2008-10#1)(2012-3#1)
up-regulated##53##1##(1994-11#1)(1995-11#2)(1995-8#2)(1997-7#1)(2008-10#11)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-4#7)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
up-regulates the##2##2##(1994-6#1)(2008-11#1)
up-regulates##3##1##(1994-6#1)(2008-11#1)(2009-8#1)
up-regulating##2##1##(2008-11#1)(2013-7#1)
up-regulation by##2##2##(1990-5#1)(2010-11#1)
up-regulation in the##4##3##(1997-7#3)(2013-1#1)
up-regulation in##7##2##(1990-2#1)(1996-12#2)(1997-7#3)(2013-1#1)
up-regulation of the##3##3##(1994-6#1)(1995-2#1)(2008-4#1)
up-regulation of##30##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#4)
up-regulation##48##1##(1990-12#1)(1990-2#1)(1990-5#2)(1991-5#1)(1992-11#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#5)(1996-2#1)(1997-7#3)(2008-10#4)(2008-11#2)(2008-4#5)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#3)(2013-1#6)
up-to-date information##5##2##(1991-1#1)(1993-2#1)(2008-7#1)(2012-12#1)(2013-8#1)
up-to-date##21##1##(1991-1#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-5#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
upcoming##13##1##(1993-1#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-1#1)
upconversion and##2##2##(2007-11#1)(2008-3#1)
upconversion in##5##2##(2007-12#3)(2008-3#2)
upconversion of##3##2##(2007-12#2)(2008-3#1)
upconversion##26##1##(2007-11#4)(2007-12#9)(2008-2#2)(2008-3#11)
upconverted##3##1##(2007-11#1)(2008-3#2)
update of an##3##3##(1994-3#1)(2008-8#1)(2012-2#1)
update of the##5##3##(1990-6#1)(2008-10#1)(2008-9#1)(2009-6#1)(2012-1#1)
update of##12##2##(1990-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
update on current##2##3##(2006-7#1)(2008-6#1)
update on recent##2##3##(1991-3#1)(2008-11#1)
update on the##8##3##(2008-1#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
update on##21##2##(1991-3#1)(1994-1#1)(1995-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
update the internal representation of##2##5##(1995-5#2)
update the##9##2##(1994-1#1)(1995-5#2)(1995-6#1)(2007-12#1)(2008-6#1)(2009-6#1)(2009-8#1)(2012-12#1)
update their##3##2##(2008-10#1)(2010-5#1)(2012-3#1)
update to##3##2##(1996-2#1)(2008-5#1)(2012-3#1)
update##118##1##(1990-6#1)(1991-1#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-1#3)(1994-12#1)(1994-3#3)(1995-1#1)(1995-5#2)(1995-6#2)(1996-2#1)(1996-3#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-6#4)(2009-8#3)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#8)(2012-2#3)(2012-3#6)(2013-1#6)
updated for##2##2##(1995-9#1)(2008-10#1)
updated guidelines for##2##3##(2008-7#1)(2010-3#1)
updated in the##2##3##(2008-10#1)(2008-5#1)
updated in##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
updated information##2##2##(1996-6#1)(2011-2#1)
updated overview of the##2##4##(2011-1#1)(2011-2#1)
updated overview##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
updated to include##2##3##(1991-9#1)(2008-4#1)
updated to##4##2##(1991-9#1)(2008-4#1)(2008-7#1)(2013-1#1)
updated version of##2##3##(2008-10#1)(2008-4#1)
updated##56##1##(1991-9#1)(1993-1#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#1)(1995-9#1)(1996-6#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
updates and##2##2##(1991-1#1)(2008-3#1)
updates on##2##2##(2010-5#1)(2012-1#1)
updates the##2##2##(2010-8#1)(2011-1#1)
updates##14##1##(1991-1#2)(1992-12#1)(1994-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
updating and##2##2##(1992-12#1)(2012-12#1)
updating of##4##2##(1995-9#2)(2008-7#1)(2011-2#1)
updating##24##1##(1992-12#3)(1994-2#2)(1995-12#1)(1995-9#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
upfield##3##1##(1992-3#1)(1993-8#1)(2008-10#1)
upfront##3##1##(2008-12#1)(2009-6#1)(2011-2#1)
upgrade the##2##2##(1996-3#1)(2013-1#1)
upgrade##9##1##(1996-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
upgraded to##2##2##(2011-1#1)(2013-8#1)
upgraded##5##1##(1992-11#1)(1996-3#1)(2008-3#1)(2011-1#1)(2013-8#1)
upgrades or##2##2##(1993-2#1)(2008-10#1)
upgrades##6##1##(1993-2#1)(1993-3#1)(2008-10#2)(2008-3#1)(2012-2#1)
upgrading of the##2##3##(1993-1#1)(1993-12#1)
upgrading of##3##2##(1993-1#1)(1993-12#1)(2008-10#1)
upgrading##6##1##(1993-1#1)(1993-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-8#1)
upheld a##4##2##(1994-2#1)(1995-12#1)(1996-5#1)(1997-5#1)
upheld the##2##2##(1995-12#1)(2007-12#1)
upheld##13##1##(1991-1#1)(1994-2#1)(1995-12#4)(1996-5#1)(1997-5#1)(2007-12#1)(2008-8#2)(2009-6#1)(2011-1#1)
uphold##2##1##(1993-3#1)(1995-3#1)
upholds##5##1##(1990-2#1)(1992-11#1)(1995-6#3)
upland rice##3##2##(2008-10#3)
upland##10##1##(2008-10#8)(2008-9#2)
uplift of##2##2##(2008-9#2)
uplift##4##1##(2008-9#4)
uplifted##2##1##(2008-5#2)
uplifting##2##1##(2008-11#1)(2008-5#1)
uploaded##4##1##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
uploading##2##1##(2008-7#1)(2010-8#1)
upon DNA damage##2##3##(2011-2#2)
upon HBV##2##2##(2012-3#2)
upon UV-illumination##2##2##(1991-2#2)
upon a GaAs##2##3##(2007-11#1)(2008-2#1)
upon a close##2##3##(2008-8#1)(2009-6#1)
upon a glass##2##3##(2007-12#2)
upon a three-year project##2##4##(1996-9#1)(2008-11#1)
upon a##54##2##(1990-5#1)(1993-6#1)(1993-8#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-11#5)(2007-12#10)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
upon acquisition##2##2##(1991-2#1)(2008-10#1)
upon activation##2##2##(1992-12#1)(2012-12#1)
upon adding##2##2##(1994-3#1)(2008-10#1)
upon addition of the##2##4##(1991-5#1)(2008-10#1)
upon addition of##9##3##(1990-12#1)(1991-5#1)(1992-8#1)(1995-2#1)(1995-3#1)(2008-10#4)
upon addition##10##2##(1990-12#1)(1991-5#1)(1992-8#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-2#1)
upon admission##3##2##(1991-2#1)(2008-3#1)(2008-7#1)
upon adsorption##2##2##(2008-10#2)
upon amino acid##2##3##(2008-10#1)(2008-12#1)
upon an##8##2##(1991-11#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)
upon annealing##2##2##(2008-3#1)(2009-5#1)
upon binding PALA##2##3##(1990-8#2)
upon binding of##5##3##(1991-12#2)(1995-6#1)(2008-1#1)(2008-11#1)
upon binding to##5##3##(1992-11#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-9#1)
upon binding##17##2##(1990-8#3)(1991-12#2)(1992-11#1)(1992-12#1)(1995-5#2)(1995-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)
upon both##3##2##(1995-11#1)(1997-6#1)(2006-10#1)
upon by##6##2##(1990-11#1)(1990-5#1)(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)
upon cell##3##2##(1992-6#1)(1995-3#1)(2008-10#1)
upon cessation of##2##3##(1995-12#1)(2013-8#1)
upon chromosome##2##2##(2008-11#1)(2012-3#1)
upon clinical##5##2##(1990-3#1)(2007-11#2)(2007-2#1)(2008-12#1)
upon completion of##3##3##(1991-11#1)(1992-3#1)(2013-8#1)
upon complex formation##2##3##(2008-10#1)(2009-7#1)
upon depletion of##2##3##(2008-8#1)(2013-1#1)
upon differentiation##3##2##(1997-2#1)(2008-11#1)(2010-11#1)
upon discharge##2##2##(1994-9#1)(2007-8#1)
upon each##2##2##(2008-11#1)(2009-5#1)
upon encountering##3##2##(1993-12#1)(1995-5#1)(2012-1#1)
upon excitation at##2##3##(2008-10#2)
upon excitation##3##2##(2008-10#3)
upon existing##4##2##(1990-2#1)(2008-3#1)(2009-9#1)(2010-1#1)
upon exposure to##9##3##(1990-5#1)(1992-1#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
upon exposure##10##2##(1990-5#1)(1992-1#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#2)
upon extensive##2##2##(1992-5#1)(2008-10#1)
upon fertilization##2##2##(2012-2#2)
upon findings from##2##3##(1990-11#1)(1991-11#1)
upon findings##3##2##(1990-11#1)(1991-11#1)(1992-4#1)
upon for##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
upon formation of##3##3##(1992-6#2)(1993-11#1)
upon further##2##2##(1994-6#1)(1995-3#1)
upon glucose##2##2##(1993-11#1)(2008-7#1)
upon heat shock##2##3##(1994-8#1)(1997-2#1)
upon heat##3##2##(1994-8#1)(1997-2#1)(2008-7#1)
upon heating##3##2##(1996-5#1)(2008-10#1)(2010-4#1)
upon hybridization to##2##3##(2008-4#2)
upon hybridization##3##2##(2008-4#2)(2012-3#1)
upon illumination##2##2##(1996-10#1)(2012-2#1)
upon in vivo##2##3##(2008-10#1)(2010-11#1)
upon in##4##2##(1991-6#1)(2008-10#1)(2010-11#1)(2010-3#1)
upon increasing the##3##3##(1993-6#1)(1997-2#1)(2008-10#1)
upon increasing##4##2##(1993-6#1)(1997-2#1)(2008-10#2)
upon incubation##3##2##(1990-5#1)(1996-12#1)(2008-10#1)
upon induction##3##2##(1993-3#1)(1997-7#1)(2008-3#1)
upon infection##3##2##(2008-10#3)
upon initiation of##2##3##(2008-7#1)(2009-3#1)
upon insertion##3##2##(1994-2#1)(1995-8#1)(2012-3#1)
upon interaction with##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
upon interaction##4##2##(1991-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
upon interactions##2##2##(1996-12#1)(2008-7#1)
upon irradiation with UV light##2##5##(2008-10#1)(2008-5#1)
upon irradiation##3##2##(2008-10#2)(2008-5#1)
upon it##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
upon its##7##2##(1992-6#2)(1994-12#1)(2008-10#4)
upon learning##2##2##(1991-2#1)(2008-11#1)
upon lowering the pH##2##4##(1991-8#2)
upon modification of the##2##4##(1995-6#1)(2008-1#1)
upon modification of##4##3##(1995-6#3)(2008-1#1)
upon one of the##2##4##(2007-12#1)(2008-3#1)
upon one of##3##3##(2007-12#1)(2008-3#2)
upon one##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
upon other##2##2##(2008-11#1)(2010-3#1)
upon our##4##2##(1995-12#1)(1997-1#1)(2008-1#1)(2011-2#1)
upon oxidation of##2##3##(2008-10#2)
upon pH##2##2##(1990-5#1)(1995-2#1)
upon passage##3##2##(2008-11#3)
upon pattern##2##2##(1991-5#1)(2007-11#1)
upon performance of a spatial location recognition task##2##8##(1994-3#2)
upon performance##4##2##(1992-1#1)(1994-3#2)(2008-12#1)
upon platelet##2##2##(1991-2#1)(2008-9#1)
upon pretreatment##2##2##(1990-11#1)(1991-2#1)
upon previous##3##2##(1992-3#1)(2008-12#1)(2010-11#1)
upon prolonged##2##2##(1993-6#1)(1997-1#1)
upon reduction with##3##3##(1993-11#2)(2008-10#1)
upon reduction##4##2##(1991-8#1)(1993-11#2)(2008-10#1)
upon seed##2##2##(2008-10#1)(2008-7#1)
upon silicon##2##2##(2007-11#1)(2007-12#1)
upon stimulation of the##2##4##(1994-11#1)(1996-2#1)
upon stimulation with##8##3##(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-6#1)(2008-11#1)(2008-3#1)
upon stimulation##10##2##(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-3#1)
upon the action of##2##4##(2008-5#1)(2009-4#1)
upon the addition of##3##4##(1992-11#1)(1993-3#1)(2008-10#1)
upon the apparent##2##3##(1990-5#1)(2008-10#1)
upon the application of##2##4##(2008-11#1)(2008-6#1)
upon the binding of##3##4##(1992-12#1)(1995-6#1)(2008-11#1)
upon the concentration of the##2##5##(1990-5#1)(2008-10#1)
upon the concentration of##3##4##(1990-2#1)(1990-5#1)(2008-10#1)
upon the development of a##2##5##(1993-1#1)(1996-3#1)
upon the development of##3##4##(1993-1#1)(1996-3#1)(1997-2#1)
upon the extent##2##3##(1994-3#1)(2010-8#1)
upon the inside of##2##4##(2008-2#1)(2008-3#1)
upon the length of the##2##5##(1995-3#1)(1996-5#1)
upon the most##2##3##(2008-10#1)(2008-12#1)
upon the nature of the##4##5##(1991-3#1)(2008-10#2)(2011-1#1)
upon the nature##5##3##(1991-3#1)(2008-10#2)(2008-11#1)(2011-1#1)
upon the presence of##8##4##(1992-12#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
upon the presence##9##3##(1992-12#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
upon the reaction##2##3##(2008-10#2)
upon the results of##2##4##(2007-11#1)(2012-3#1)
upon the severity##2##3##(1991-2#1)(2010-7#1)
upon the surface##2##3##(1991-12#1)(2008-3#1)
upon the surrounding##3##3##(2009-6#1)(2013-1#2)
upon the type of##2##4##(1992-3#1)(2008-7#1)
upon the##250##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1991-12#2)(1991-2#1)(1991-3#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#5)(1992-6#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#5)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-6#1)(2008-10#36)(2008-11#18)(2008-12#6)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#15)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
upon their interactions with##2##4##(2008-4#1)(2010-5#1)
upon their##15##2##(1990-3#1)(1991-7#1)(1992-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)
upon them##2##2##(1995-12#1)(2012-12#1)
upon these##4##2##(1991-12#1)(1994-12#1)(2008-11#1)(2008-4#1)
upon this##8##2##(1992-3#1)(1992-6#1)(1994-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
upon tissue##2##2##(2008-9#1)(2013-1#1)
upon to develop##3##3##(1996-2#1)(2008-11#1)(2008-12#1)
upon to##17##2##(1991-1#1)(1992-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-8#1)(2012-12#1)(2013-1#1)
upon treatment with TGF-beta##2##4##(2008-11#2)
upon treatment with##6##3##(1993-9#1)(1995-11#1)(2007-11#1)(2008-11#3)
upon treatment##7##2##(1993-9#1)(1995-11#1)(2007-11#1)(2008-11#3)(2011-2#1)
upon tumor##2##2##(1995-9#1)(2008-11#1)
upon unfolding##2##2##(1992-6#1)(1997-2#1)
upon upshift to 37 degrees C##2##6##(1993-9#2)
upon which##15##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
upon withdrawal##2##2##(1992-11#1)(2008-5#1)
upon##1023##1##(1990-11#10)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#11)(1990-6#1)(1990-7#3)(1990-8#6)(1991-1#3)(1991-11#4)(1991-12#12)(1991-2#12)(1991-3#6)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#10)(1992-2#3)(1992-3#15)(1992-4#1)(1992-5#4)(1992-6#16)(1992-8#6)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#7)(1993-2#2)(1993-3#6)(1993-5#2)(1993-6#10)(1993-8#3)(1993-9#5)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#3)(1994-7#4)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#12)(1995-2#10)(1995-3#8)(1995-5#9)(1995-6#9)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#6)(1996-2#8)(1996-3#4)(1996-5#6)(1996-6#1)(1996-9#1)(1997-1#7)(1997-2#12)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#9)(1997-8#2)(2006-10#1)(2007-10#2)(2007-11#26)(2007-12#28)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#10)(2008-10#151)(2008-11#61)(2008-12#19)(2008-2#15)(2008-3#31)(2008-4#18)(2008-5#32)(2008-6#9)(2008-7#38)(2008-8#16)(2008-9#15)(2009-10#5)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-11#8)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#12)(2011-2#19)(2012-1#5)(2012-12#10)(2012-2#14)(2012-3#13)(2013-1#19)(2013-7#3)(2013-8#10)
upper GI bleeding##3##3##(1991-2#1)(2012-3#2)
upper GI##5##2##(1991-2#1)(2008-11#1)(2011-2#1)(2012-3#2)
upper abdomen and##4##3##(1990-9#1)(1991-6#1)(1995-10#1)(2009-8#1)
upper abdomen##6##2##(1990-9#1)(1991-6#1)(1995-10#1)(2009-8#1)(2010-12#1)(2013-1#1)
upper abdominal##4##2##(1991-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
upper aerodigestive tract##4##3##(2008-1#1)(2009-5#1)(2013-1#2)
upper airway obstruction##4##3##(1995-8#1)(2008-11#1)(2013-1#1)(2013-8#1)
upper airway##8##2##(1990-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
upper airways##4##2##(1991-6#1)(1996-6#1)(1997-4#1)(2012-12#1)
upper and lower detection limits##2##5##(2008-10#2)
upper and lower extremities##3##4##(2009-5#1)(2011-2#1)(2012-2#1)
upper and lower extremity##4##4##(2007-11#2)(2010-3#1)(2012-3#1)
upper and lower##29##3##(1990-11#1)(1992-11#2)(1992-12#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-7#2)(2009-5#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
upper and##33##2##(1990-11#1)(1992-11#2)(1992-12#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-12#2)(2008-3#3)(2008-7#2)(2009-5#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
upper arm##6##2##(2007-7#1)(2008-5#2)(2011-2#1)(2013-8#2)
upper asymptote##2##2##(1990-8#1)(2008-10#1)
upper back##3##2##(2008-7#1)(2012-2#2)
upper body##3##2##(2008-4#1)(2010-1#1)(2010-6#1)
upper bound of##4##3##(2007-12#2)(2009-5#1)(2010-2#1)
upper bound##6##2##(2007-12#3)(2008-6#1)(2009-5#1)(2010-2#1)
upper brachial plexus##2##3##(2008-9#2)
upper canopy##2##2##(2008-8#1)(2011-2#1)
upper cervical##4##2##(2007-11#1)(2008-12#2)(2008-7#1)
upper chest##2##2##(2008-1#1)(2012-12#1)
upper digestive tract##4##3##(1993-9#1)(2008-10#2)(2011-2#1)
upper digestive##5##2##(1991-11#1)(1993-9#1)(2008-10#2)(2011-2#1)
upper end of##2##3##(1994-9#1)(2013-1#1)
upper endoscopic examination##2##3##(1997-8#1)(2008-11#1)
upper endoscopy##3##2##(2009-8#1)(2010-12#1)(2013-8#1)
upper extremities##7##2##(1991-4#1)(1997-4#1)(2007-7#1)(2007-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
upper extremity function##2##3##(2008-8#1)(2012-2#1)
upper extremity##31##2##(1991-11#1)(2007-10#3)(2007-11#1)(2007-7#2)(2008-12#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#9)(2012-2#1)
upper eyelid##5##2##(2010-8#3)(2011-1#2)
upper femur##3##2##(2008-6#3)
upper first##3##2##(2011-2#1)(2013-8#2)
upper gastro-intestinal##2##2##(1994-2#1)(2010-12#1)
upper gastrointestinal (GI)##2##3##(1994-12#1)(2008-11#1)
upper gastrointestinal bleeding##5##3##(2006-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
upper gastrointestinal endoscopy##7##3##(1995-10#2)(1996-3#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
upper gastrointestinal haemorrhage##4##3##(1990-9#2)(1991-8#1)(1997-8#1)
upper gastrointestinal tract##5##3##(2007-5#1)(2008-10#1)(2012-1#2)(2013-1#1)
upper gastrointestinal##31##2##(1990-9#2)(1991-3#1)(1991-8#1)(1994-12#1)(1995-10#2)(1996-3#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-4#1)(2011-2#4)(2012-1#2)(2012-2#3)(2013-1#1)(2013-8#1)
upper genital##2##2##(1996-12#2)
upper healthy##2##2##(2008-10#2)
upper intertidal zone##2##3##(2007-5#1)(2008-9#1)
upper laser##2##2##(2008-3#2)
upper lasing level##4##3##(2008-3#4)
upper leaves##9##2##(2008-10#9)
upper limb##14##2##(1991-4#1)(2007-11#3)(2007-8#3)(2008-7#1)(2008-9#2)(2009-1#2)(2011-2#1)(2013-1#1)
upper limbs##2##2##(2013-1#2)
upper limit is found to##2##5##(2007-12#2)
upper limit of the##5##4##(1993-2#1)(2008-10#1)(2008-2#2)(2013-1#1)
upper limit of##12##3##(1991-5#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
upper limit##25##2##(1991-5#1)(1993-2#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2012-3#1)(2013-1#2)
upper limits of##2##3##(1993-2#1)(2008-10#1)
upper limits##4##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
upper lip##4##2##(1995-12#1)(2007-12#2)(2011-2#1)
upper lobe was##2##3##(1991-9#1)(2007-8#1)
upper lobe##14##2##(1991-9#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-4#1)(2011-2#1)(2012-1#1)(2013-1#3)
upper lung##2##2##(2008-1#1)(2013-1#1)
upper management##2##2##(1994-12#1)(2008-11#1)
upper oesophageal sphincter##3##3##(2011-1#1)(2012-3#2)
upper or lower##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)
upper part of the##6##4##(1991-9#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-4#1)
upper part of##7##3##(1991-9#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
upper part##8##2##(1991-9#1)(1993-9#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
upper phase##11##2##(2008-10#9)(2011-1#2)
upper pole of the kidney##2##5##(2008-7#1)(2011-2#1)
upper pole##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
upper portion##2##2##(2009-9#1)(2012-3#1)
upper quadrant##3##2##(1991-12#1)(2012-3#1)(2013-1#1)
upper rectum##2##2##(1991-5#1)(2008-10#1)
upper respiratory disease##2##3##(2013-8#2)
upper respiratory symptoms##3##3##(2009-4#1)(2013-8#2)
upper respiratory tract##8##3##(1990-8#1)(1995-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
upper respiratory##16##2##(1990-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#6)
upper spinal cord##2##3##(2010-12#2)
upper spinal##3##2##(2007-10#1)(2010-12#2)
upper surface##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
upper third of the##2##4##(2008-10#1)(2012-12#1)
upper third##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
upper thoracic##2##2##(2008-5#1)(2012-3#1)
upper tract##3##2##(2008-10#1)(2009-5#2)
upper trapezius##6##2##(2010-9#6)
upper uninoculated leaves##3##3##(2008-10#3)
upper urinary tract##3##3##(1991-9#1)(2007-10#1)(2011-2#1)
upper##512##1##(1990-11#1)(1990-6#2)(1990-8#2)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1993-2#3)(1993-5#1)(1993-9#4)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#3)(1994-9#2)(1995-10#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#4)(1996-3#2)(1996-4#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#3)(1997-8#2)(2006-10#2)(2007-10#7)(2007-11#13)(2007-12#18)(2007-2#1)(2007-5#7)(2007-7#5)(2007-8#13)(2008-1#9)(2008-10#79)(2008-11#9)(2008-12#11)(2008-2#8)(2008-3#30)(2008-4#3)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#6)(2008-9#12)(2009-1#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#9)(2009-8#3)(2009-9#2)(2010-1#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#5)(2010-9#9)(2011-1#6)(2011-2#33)(2012-1#4)(2012-12#7)(2012-2#10)(2012-3#11)(2013-1#23)(2013-3#1)(2013-7#3)(2013-8#16)
upper- and##3##2##(2011-2#2)(2012-3#1)
upper-##4##1##(2007-10#1)(2011-2#2)(2012-3#1)
upper-atmosphere##2##1##(2008-2#2)
upper-atmospheric wind##2##2##(2008-2#1)(2008-3#1)
upper-extremity##4##1##(2008-7#1)(2011-2#3)
upper-half of the face##6##4##(2010-1#6)
upper-layer thickness (l)##2##3##(2008-3#2)
upper-level ontology##2##2##(2008-7#2)
upper-middle##2##1##(2013-8#2)
upper-state lifetime##2##2##(2008-2#1)(2008-3#1)
upper-stream-limitation##2##1##(2008-8#2)
uppercase##5##1##(2008-11#1)(2008-6#4)
uppermost##7##1##(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#2)
upregulate##3##1##(2010-3#1)(2011-2#1)(2013-1#1)
upregulated by##9##2##(1993-6#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
upregulated during##3##2##(2008-11#1)(2009-8#2)
upregulated in adenoma tissues when compared with##2##7##(2010-12#2)
upregulated in response to##2##4##(2008-6#1)(2013-7#1)
upregulated in the##8##3##(1996-12#1)(2008-10#1)(2008-7#2)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
upregulated in##27##2##(1995-5#1)(1996-12#1)(2008-10#3)(2008-6#1)(2008-7#3)(2009-4#2)(2009-7#1)(2010-12#5)(2012-1#1)(2013-1#5)(2013-7#2)(2013-8#2)
upregulated##57##1##(1993-6#2)(1995-12#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-4#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#5)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#8)(2013-7#3)(2013-8#2)
upregulates the##3##2##(2010-10#1)(2010-5#1)(2013-1#1)
upregulates##5##1##(1993-6#1)(2008-4#1)(2010-10#1)(2010-5#1)(2013-1#1)
upregulating##6##1##(1997-3#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
upregulation and##4##2##(2008-4#1)(2009-9#1)(2011-2#1)(2012-2#1)
upregulation of ADK##3##3##(2009-8#3)
upregulation of OPN promoter activity##2##5##(2010-11#2)
upregulation of OPN##3##3##(2010-11#3)
upregulation of contractile proteins##2##4##(2009-9#2)
upregulation of the##3##3##(2008-5#1)(2012-12#2)
upregulation of##44##2##(1992-8#2)(1994-11#1)(1994-6#1)(1995-2#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#5)(2010-5#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
upregulation##50##1##(1992-8#2)(1994-11#1)(1994-6#2)(1995-2#1)(1995-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#5)(2010-5#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#1)
upright and##2##2##(2007-11#1)(2007-8#1)
upright##10##1##(1994-8#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#2)
ups##4##1##(1995-3#1)(1996-3#1)(2008-6#1)(2013-1#1)
upset##2##1##(1993-1#1)(2008-12#1)
upsets the##2##2##(1996-8#1)(2008-8#1)
upshift##3##1##(1993-9#2)(2008-7#1)
upshifted##2##1##(2007-11#2)
upside down##5##2##(1994-12#2)(2007-8#2)(2010-9#1)
upside-down taper lens end##2##4##(2008-2#2)
upside-down##5##1##(2008-2#2)(2008-3#2)(2010-9#1)
upstaged##5##1##(2008-10#1)(2011-2#1)(2012-12#3)
upstate New York##2##3##(1996-3#1)(2013-1#1)
upstate##3##1##(1992-1#1)(1996-3#1)(2013-1#1)
upstream activating sequence##3##3##(1991-9#1)(1993-9#1)(1996-3#1)
upstream and downstream of the##3##5##(1992-11#1)(2008-7#1)(2009-11#1)
upstream and downstream of##5##4##(1992-11#2)(2008-7#1)(2008-8#1)(2009-11#1)
upstream and downstream##9##3##(1990-11#1)(1992-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-2#1)
upstream and##10##2##(1990-11#1)(1992-11#2)(1997-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-2#1)
upstream ethical engagement##2##3##(2008-11#2)
upstream ethics and##2##3##(2008-11#2)
upstream ethics##3##2##(2008-11#3)
upstream exons##2##2##(1990-8#2)
upstream factor##2##2##(1990-5#1)(1995-2#1)
upstream from a##2##3##(1990-11#1)(1994-11#1)
upstream from the start codon##3##5##(1991-6#2)(2008-10#1)
upstream from the translation initiation codon##3##6##(1992-11#1)(1993-3#1)(1997-6#1)
upstream from the translation initiation##4##5##(1992-11#1)(1993-3#1)(1997-2#1)(1997-6#1)
upstream from the##23##3##(1990-11#1)(1991-11#1)(1991-6#4)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#1)
upstream from##33##2##(1990-11#2)(1991-11#1)(1991-6#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#2)
upstream genes##2##2##(1990-11#1)(1996-12#1)
upstream in##2##2##(1995-8#1)(1996-2#1)
upstream kinases##2##2##(1995-2#1)(2012-12#1)
upstream migration##2##2##(2010-8#2)
upstream molecules##2##2##(2008-11#1)(2013-1#1)
upstream of a##2##3##(1997-4#1)(1997-7#1)
upstream of the K##2##4##(1997-7#2)
upstream of the exon##2##4##(1993-8#1)(1995-6#1)
upstream of the transcription start##2##5##(1993-2#1)(1994-8#1)
upstream of the translation initiation##2##5##(1992-11#1)(1997-2#1)
upstream of the translation##3##4##(1992-11#1)(1997-2#1)(2008-9#1)
upstream of the##36##3##(1990-8#1)(1991-7#1)(1992-11#2)(1992-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#3)(1995-8#2)(1997-2#2)(1997-7#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#3)(2010-8#1)(2011-1#1)(2012-2#1)
upstream of these##2##3##(1992-9#1)(2012-2#1)
upstream of##66##2##(1990-8#1)(1991-7#2)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#4)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#4)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#5)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#2)
upstream or downstream##3##3##(1992-3#1)(2008-8#1)(2012-2#1)
upstream promoter##2##2##(1991-2#1)(2008-4#1)
upstream region linked to the##2##5##(1991-2#1)(1995-2#1)
upstream region of the##2##4##(1992-12#1)(1992-3#1)
upstream region of##7##3##(1992-12#1)(1992-3#1)(1994-6#1)(1996-3#1)(2008-8#2)(2008-9#1)
upstream region was##2##3##(1993-12#1)(1994-2#1)
upstream region##18##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-2#2)(1996-3#1)(1997-2#2)(1997-7#1)(2008-8#2)(2008-9#1)
upstream regions of##4##3##(1993-6#1)(2008-10#1)(2008-9#2)
upstream regulation##2##2##(1990-5#1)(2008-11#1)
upstream regulators##3##2##(2012-1#1)(2012-2#1)(2013-1#1)
upstream sequence##2##2##(1992-3#1)(1997-7#1)
upstream sequences##4##2##(1990-8#1)(1991-6#1)(1992-3#1)(2008-9#1)
upstream##213##1##(1990-11#5)(1990-12#1)(1990-5#4)(1990-8#4)(1991-1#2)(1991-11#1)(1991-2#2)(1991-6#7)(1991-7#2)(1991-9#6)(1992-10#1)(1992-11#5)(1992-12#3)(1992-3#5)(1992-6#1)(1992-9#1)(1993-12#5)(1993-2#5)(1993-3#4)(1993-6#3)(1993-8#3)(1993-9#4)(1994-11#2)(1994-12#5)(1994-2#3)(1994-6#2)(1994-8#1)(1995-2#5)(1995-6#5)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1997-2#7)(1997-3#1)(1997-4#9)(1997-6#3)(1997-7#8)(2008-1#1)(2008-10#8)(2008-11#13)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#12)(2009-11#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)
uptake after##4##2##(1991-5#1)(1993-11#1)(1995-5#1)(2008-10#1)
uptake and a##2##3##(1995-11#1)(2008-1#1)
uptake and binding sites in the##2##6##(2008-7#2)
uptake and biolocalization##2##3##(1992-9#2)
uptake and its##2##3##(1995-11#1)(2008-11#1)
uptake and metabolism of 4-n-nonylphenol##2##5##(2008-11#2)
uptake and metabolism##4##3##(1991-12#1)(2008-11#2)(2013-8#1)
uptake and processing##2##3##(1991-5#1)(1997-4#1)
uptake and release of##2##4##(2008-10#1)(2008-8#1)
uptake and release##7##3##(1991-1#1)(1991-8#1)(2008-10#4)(2008-8#1)
uptake and stripping of these metal ions##2##7##(2008-10#2)
uptake and the##2##3##(1992-8#1)(2008-10#1)
uptake and##67##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#6)(1995-3#2)(1996-2#2)(1996-3#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#10)(2008-11#15)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#2)(2013-8#2)
uptake are##2##2##(1992-3#1)(2008-8#1)
uptake as##4##2##(1991-5#1)(2008-12#1)(2010-10#2)
uptake assay##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
uptake at##3##2##(1992-6#2)(2011-2#1)
uptake between##4##2##(1992-3#1)(1992-8#1)(2013-8#2)
uptake but##3##2##(1995-11#1)(2010-11#1)(2010-6#1)
uptake by human##2##3##(1994-3#1)(2009-9#1)
uptake by the##7##3##(1990-2#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-9#1)(1996-5#1)(2010-1#1)
uptake by yeast cells##3##4##(1990-2#1)(2008-10#2)
uptake by##42##2##(1990-2#2)(1990-5#2)(1990-8#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-3#1)(1995-11#2)(1996-2#3)(1996-5#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
uptake capacity##2##2##(2008-6#2)
uptake during##2##2##(2008-10#1)(2008-5#1)
uptake efficiency##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
uptake for the##2##3##(2008-12#1)(2008-7#1)
uptake for##4##2##(1992-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
uptake from a##2##3##(1996-2#1)(2008-6#1)
uptake from the##3##3##(1997-1#1)(2007-12#1)(2008-11#1)
uptake from##7##2##(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-6#1)
uptake has##2##2##(2009-8#1)(2010-10#1)
uptake in a##5##3##(1991-10#1)(1995-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
uptake in most##2##3##(1991-10#1)(1996-7#1)
uptake in rat##2##3##(1997-1#1)(2008-8#1)
uptake in the midgut##2##4##(2008-10#2)
uptake in the septum##2##4##(1991-5#2)
uptake in the##13##3##(1991-5#3)(1993-11#1)(1993-12#1)(1994-5#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
uptake in##48##2##(1990-7#2)(1990-8#1)(1991-10#2)(1991-5#3)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-1#3)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
uptake increased##2##2##(2008-7#2)
uptake into the##3##3##(1991-8#1)(1994-12#1)(2008-5#1)
uptake into##10##2##(1990-7#2)(1991-8#1)(1994-12#1)(1996-2#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)
uptake is##7##2##(1992-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-8#1)
uptake mechanisms of##2##3##(1994-5#1)(1995-3#1)
uptake of 131I-MIBG##2##3##(1990-10#2)
uptake of 14C-5HT##2##3##(1995-11#2)
uptake of 2##2##3##(1994-5#2)
uptake of 45Ca##2##3##(1993-3#2)
uptake of 45Ca2+##2##3##(1997-2#2)
uptake of [3H]##2##3##(1991-9#1)(1992-11#1)
uptake of a##3##3##(1994-8#1)(2007-11#1)(2008-6#1)
uptake of bile acids##3##4##(1992-3#1)(1994-12#1)(2008-11#1)
uptake of both##2##3##(1994-3#1)(1994-6#1)
uptake of cadmium##2##3##(1995-3#1)(1996-7#1)
uptake of insulin##2##3##(1990-11#1)(2009-11#1)
uptake of iron##2##3##(2008-10#1)(2009-9#1)
uptake of leucine##2##3##(1995-11#2)
uptake of mature aspartate aminotransferase by isolated mitochondria##2##8##(1990-7#2)
uptake of mercury from amalgam fillings##3##6##(1995-6#3)
uptake of mercury##4##3##(1995-6#4)
uptake of sodium##2##3##(1994-6#1)(2008-9#1)
uptake of the##13##3##(1991-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1997-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2011-1#2)(2013-1#2)
uptake of##128##2##(1990-10#2)(1990-11#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#8)(1992-6#2)(1993-11#3)(1993-12#1)(1993-3#4)(1993-6#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1995-11#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#5)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#5)(1997-2#2)(1997-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#2)
uptake on the##3##3##(1996-5#1)(2008-10#1)(2013-1#1)
uptake process##3##2##(1990-11#1)(2008-10#1)(2008-7#1)
uptake processes##2##2##(1992-3#1)(1994-3#1)
uptake properties##2##2##(2008-10#1)(2008-5#1)
uptake rate and the##2##4##(1994-5#1)(2008-7#1)
uptake rate and##4##3##(1994-5#1)(2008-11#2)(2008-7#1)
uptake rate of a##2##4##(1994-5#1)(2008-11#1)
uptake rate was##2##3##(1994-5#1)(2008-11#1)
uptake rate##18##2##(1994-5#5)(2008-10#2)(2008-11#7)(2008-7#4)
uptake rates are##2##3##(2008-10#1)(2008-7#1)
uptake rates in##2##3##(1994-5#1)(2008-8#1)
uptake rates##13##2##(1994-5#1)(2008-10#6)(2008-11#3)(2008-7#2)(2008-8#1)
uptake sites##2##2##(2008-7#2)
uptake stimulated by##2##3##(1994-8#1)(2008-11#1)
uptake system##11##2##(1992-8#1)(1995-11#4)(1996-8#1)(1997-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
uptake systems##4##2##(1992-8#1)(2008-7#2)(2012-2#1)
uptake than##4##2##(1995-6#1)(1997-1#1)(2010-6#2)
uptake to##3##2##(1991-8#1)(2008-6#1)(2013-8#1)
uptake via##4##2##(1995-5#1)(1997-1#1)(2012-2#1)(2013-1#1)
uptake was found##2##3##(1992-3#2)
uptake was inhibited by##2##4##(1990-2#2)
uptake was linear##2##3##(1992-3#2)
uptake was observed for##2##4##(1995-11#1)(2013-1#1)
uptake was observed##6##3##(1991-5#1)(1995-11#1)(1995-5#1)(1997-1#1)(2008-11#1)(2013-1#1)
uptake was obtained##2##3##(2008-11#1)(2008-12#1)
uptake was##41##2##(1990-2#4)(1990-7#1)(1991-5#2)(1992-3#10)(1992-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-5#1)(1997-1#2)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
uptake were##5##2##(1992-11#1)(1993-3#1)(1996-5#1)(2008-12#1)(2013-8#1)
uptake##617##1##(1990-10#2)(1990-11#4)(1990-2#7)(1990-5#2)(1990-7#8)(1990-8#6)(1991-1#2)(1991-10#3)(1991-12#3)(1991-5#9)(1991-7#1)(1991-8#3)(1991-9#3)(1992-11#5)(1992-3#35)(1992-6#5)(1992-8#8)(1992-9#3)(1993-11#6)(1993-12#3)(1993-3#12)(1993-5#1)(1993-6#3)(1993-8#9)(1993-9#3)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#15)(1994-6#3)(1994-8#3)(1995-11#32)(1995-2#2)(1995-3#5)(1995-5#6)(1995-6#9)(1996-12#4)(1996-2#11)(1996-3#1)(1996-5#7)(1996-7#5)(1996-8#2)(1997-1#15)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#5)(2006-10#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#70)(2008-11#60)(2008-12#12)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#9)(2008-7#31)(2008-8#10)(2008-9#6)(2009-11#2)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#2)(2010-2#4)(2010-4#3)(2010-5#1)(2010-6#4)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#1)(2012-5#1)(2013-1#18)(2013-8#22)
uptake)##3##1##(1990-12#1)(1995-8#1)(2008-8#1)
uptakes##3##1##(1990-9#1)(1997-7#1)(2008-10#1)
upto 6##2##2##(2007-7#1)(2008-10#1)
upto##10##1##(2007-7#2)(2008-10#4)(2008-7#2)(2010-5#1)(2013-8#1)
upward and downward##5##3##(2007-10#1)(2008-2#1)(2008-3#2)(2009-11#1)
upward and##6##2##(2007-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)
upward flow##2##2##(2008-4#2)
upward gaze##2##2##(2007-10#2)
upward irradiance##2##2##(2008-2#1)(2008-3#1)
upward to##2##2##(2008-10#1)(2009-7#1)
upward trend##2##2##(1990-2#1)(1997-6#1)
upward##38##1##(1990-2#1)(1990-5#1)(1994-6#1)(1997-6#1)(2007-10#3)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#3)(2009-11#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-9#2)(2012-1#1)
upwardly##4##1##(1996-8#1)(2008-11#2)(2013-1#1)
upwards of##2##2##(1994-2#1)(2008-11#1)
upwards##8##1##(1992-6#1)(1994-11#1)(1994-2#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-12#1)
upwelling and##2##2##(2008-2#1)(2013-7#1)
upwelling irradiance##4##2##(2008-2#1)(2008-3#3)
upwelling radiance##7##2##(2008-2#5)(2008-3#2)
upwelling##22##1##(1991-5#1)(2008-2#9)(2008-3#6)(2008-5#4)(2011-2#1)(2013-7#1)
upwind of the##2##3##(2008-10#2)
upwind##4##1##(2008-10#3)(2008-3#1)
urachal cyst associated with pseudomyxoma peritonei##2##6##(2009-5#2)
urachal cyst associated with##4##4##(2009-5#4)
urachal cyst##7##2##(2008-10#3)(2009-5#4)
urachal##13##1##(2008-10#6)(2008-6#3)(2009-5#4)
uracil##15##1##(1991-7#1)(1992-3#3)(1993-11#1)(1994-8#2)(1996-5#1)(2008-10#4)(2011-1#1)(2013-1#2)
uracils##2##1##(1995-6#1)(2013-7#1)
uralensis Fisch was##2##3##(2008-11#2)
uralensis Fisch##3##2##(2008-11#3)
uranium and mixed rare-earth elements##2##5##(2008-10#2)
uranium and##7##2##(2008-10#6)(2013-1#1)
uranium by##5##2##(2008-10#5)
uranium carbide##3##2##(2008-10#3)
uranium from aqueous solution##2##4##(2008-10#2)
uranium from##8##2##(2008-10#8)
uranium in the##2##3##(2008-10#2)
uranium in##10##2##(2008-10#10)
uranium is important##2##3##(2008-10#2)
uranium is##5##2##(2008-10#5)
uranium isotopes in##2##3##(2008-10#2)
uranium isotopes##4##2##(2008-10#4)
uranium mine##2##2##(2008-10#1)(2013-1#1)
uranium ore##3##2##(2008-10#1)(2013-1#2)
uranium removal##3##2##(2013-8#3)
uranium was##3##2##(2008-10#1)(2013-8#2)
uranium with##4##2##(2008-10#4)
uranium##95##1##(2008-10#77)(2008-3#1)(2010-5#2)(2013-1#10)(2013-8#5)
uranium(VI) and thorium(IV) prior to##3##5##(2008-10#3)
uranium(VI) and thorium(IV)##5##3##(2008-10#5)
uranium(VI) and zinc(II)##3##3##(2008-10#3)
uranium(VI) and##8##2##(2008-10#8)
uranium(VI) from##3##2##(2008-10#3)
uranium(VI) on##2##2##(2008-10#2)
uranium(VI) with##3##2##(2008-10#3)
uranium(VI)##31##1##(2008-10#31)
uranyl ion##8##2##(2008-10#8)
uranyl membrane sensor with##2##4##(2008-10#2)
uranyl nitrate##4##2##(2008-10#2)(2008-8#2)
uranyl phosphate##2##2##(1997-7#2)
uranyl##27##1##(1992-4#1)(1997-7#3)(2008-10#21)(2008-8#2)
urate oxidase and##3##3##(2008-10#3)
urate oxidase##8##2##(2008-10#8)
urate##21##1##(1991-8#1)(1993-2#2)(1993-8#2)(2006-10#1)(2008-10#15)
urban Canadian municipalities##2##3##(2013-8#2)
urban Canadian##3##2##(2012-2#1)(2013-8#2)
urban adolescent girls##2##3##(2009-10#1)(2013-1#1)
urban adolescent##3##2##(1991-1#1)(2009-10#1)(2013-1#1)
urban adolescents of color##2##4##(2009-7#2)
urban adolescents##4##2##(2009-7#3)(2013-1#1)
urban air quality##5##3##(2008-11#5)
urban air##6##2##(2008-11#6)
urban and rural areas##5##4##(1991-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(2009-4#1)
urban and rural hospitals##2##4##(1992-12#1)(1992-2#1)
urban and rural##21##3##(1991-3#1)(1992-12#3)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#2)(2009-4#1)(2009-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
urban and suburban##2##3##(2007-7#1)(2008-11#1)
urban and##33##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#4)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
urban area of##9##3##(2008-11#1)(2008-6#2)(2008-7#1)(2009-10#2)(2012-12#3)
urban area##23##2##(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-10#2)(2010-8#1)(2011-1#2)(2012-12#5)(2012-3#1)
urban areas and##4##3##(1994-2#1)(2008-5#1)(2009-4#1)(2011-2#1)
urban areas of the##2##4##(1992-9#1)(2008-6#1)
urban areas of##5##3##(1992-9#1)(1997-4#1)(2008-3#1)(2008-6#1)(2009-6#1)
urban areas##25##2##(1992-12#1)(1992-9#1)(1994-2#2)(1994-3#1)(1995-1#1)(1997-4#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#1)(2009-4#3)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
urban atmosphere##2##2##(2008-11#1)(2008-2#1)
urban based##2##2##(2008-7#1)(2010-3#1)
urban beneficiaries##5##2##(1994-2#2)(1996-3#3)
urban centers##3##2##(2012-12#2)(2013-1#1)
urban clinic##2##2##(2012-12#1)(2013-1#1)
urban community##4##2##(1992-12#1)(1996-3#1)(2010-3#1)(2011-1#1)
urban dust##2##2##(2008-10#2)
urban enrollees##2##2##(1994-2#2)
urban environment##4##2##(1994-1#1)(2007-10#1)(2008-10#1)(2008-5#1)
urban environments##2##2##(2008-11#1)(2010-1#1)
urban health##3##2##(1997-4#1)(2009-10#1)(2013-8#1)
urban hospitals##6##2##(1990-2#1)(1992-1#1)(1992-12#3)(2008-7#1)
urban ozone##2##2##(2008-11#2)
urban participants##2##2##(2007-12#2)
urban particulate matter##4##3##(2008-10#4)
urban patients##2##2##(1996-2#1)(2007-7#1)
urban population of##6##3##(1991-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-10#1)
urban population##10##2##(1990-2#1)(1991-1#1)(1996-3#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-1#1)(2010-10#1)(2011-2#1)
urban populations##2##2##(1995-5#1)(2012-12#1)
urban sample of##3##3##(2007-12#1)(2009-7#1)(2013-1#1)
urban sample##4##2##(2007-12#1)(2007-9#1)(2009-7#1)(2013-1#1)
urban schools##2##2##(2008-12#1)(2010-1#1)
urban setting##3##2##(1996-1#1)(2009-6#1)(2012-12#1)
urban settings##5##2##(2007-12#1)(2012-12#2)(2013-1#2)
urban sites in##2##3##(2008-10#1)(2008-11#1)
urban sites##3##2##(2008-10#1)(2008-11#2)
urban teaching hospital##2##3##(1993-12#1)(2012-3#1)
urban teaching hospitals##2##3##(1993-12#1)(1996-3#1)
urban teaching##4##2##(1993-12#2)(1996-3#1)(2012-3#1)
urban teens##2##2##(2013-1#2)
urban trauma##2##2##(2011-2#1)(2013-8#1)
urban veterans##2##2##(2012-1#2)
urban waste samples##2##3##(2008-10#2)
urban waste##3##2##(1995-11#1)(2008-10#2)
urban wastewater##2##2##(2008-10#2)
urban women##2##2##(2013-1#2)
urban youth##2##2##(2009-7#1)(2010-9#1)
urban##300##1##(1990-2#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#13)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-2#1)(1994-1#2)(1994-2#10)(1994-3#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#9)(1997-1#1)(1997-4#2)(1997-5#2)(2007-10#3)(2007-12#8)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#30)(2008-11#26)(2008-12#5)(2008-2#2)(2008-3#17)(2008-5#4)(2008-6#8)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#6)(2009-4#6)(2009-6#2)(2009-7#9)(2009-8#1)(2010-1#3)(2010-10#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#4)(2011-1#6)(2011-2#5)(2012-1#9)(2012-12#17)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#24)(2013-8#11)
urban-rural##3##1##(1992-12#1)(1994-2#1)(2008-11#1)
urbanization and##2##2##(2008-2#1)(2008-3#1)
urbanization##8##1##(1991-12#1)(1992-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#3)
urbanized and##2##2##(1991-12#1)(2008-2#1)
urbanized##4##1##(1991-12#1)(2008-2#1)(2010-4#1)(2011-1#1)
urbilaterian##2##1##(2007-12#2)
urceolata##3##1##(2008-8#1)(2008-9#2)
urchin##25##1##(1990-5#1)(1991-2#2)(1995-3#3)(1995-6#1)(1996-5#1)(1997-4#2)(2008-11#1)(2008-5#4)(2008-6#2)(2008-8#2)(2009-2#1)(2009-7#1)(2011-2#2)(2012-2#2)
urchins##6##1##(1990-5#1)(1994-11#1)(1997-4#1)(2007-5#1)(2009-2#2)
urea and guanidine-HCl##2##3##(1997-2#2)
urea and guanidinium chloride##2##4##(1990-8#2)
urea and guanidinium##3##3##(1990-8#2)(2009-9#1)
urea and the##2##3##(1995-3#1)(2011-1#1)
urea and thiourea##2##3##(2008-10#2)
urea and##21##2##(1990-8#2)(1994-12#1)(1994-9#1)(1995-3#1)(1997-2#2)(2008-10#9)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
urea at##2##2##(1995-2#1)(2009-3#1)
urea biosensor##4##2##(2008-10#4)
urea biosensors were##2##3##(2008-10#2)
urea biosensors##3##2##(2008-10#3)
urea clearance##2##2##(2008-1#2)
urea concentration and##2##3##(1990-7#1)(2008-1#1)
urea concentration in##4##3##(1990-7#1)(2008-1#2)(2008-4#1)
urea concentration##15##2##(1990-7#2)(1993-11#2)(1995-5#2)(2008-1#4)(2008-10#2)(2008-4#2)(2008-7#1)
urea concentrations##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
urea cycle##6##2##(1991-9#1)(2008-7#3)(2009-8#2)
urea denaturation##2##2##(1994-5#1)(1995-5#1)
urea determination in##2##3##(2008-10#2)
urea determination##4##2##(2008-10#4)
urea enzyme##2##2##(2008-10#2)
urea excretion##2##2##(2008-10#1)(2008-7#1)
urea in the mobile phase##2##5##(2008-10#2)
urea in the##4##3##(2008-10#4)
urea in##8##2##(2008-10#8)
urea kinetics##3##2##(2008-1#3)
urea level##3##2##(2007-12#1)(2007-7#1)(2012-2#1)
urea nitrogen##9##2##(1994-5#2)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-2#1)
urea or##2##2##(1995-5#1)(2008-10#1)
urea production##4##2##(2008-11#3)(2008-7#1)
urea sensor has##2##3##(2008-10#2)
urea sensor##3##2##(2008-10#3)
urea solution##3##2##(2007-11#1)(2008-10#1)(2008-4#1)
urea synthesis##2##2##(1993-11#2)
urea transport##2##2##(1995-6#2)
urea transporter##2##2##(1995-6#2)
urea were##6##2##(1995-3#1)(2008-11#1)(2011-2#3)(2013-8#1)
urea with##3##2##(2008-10#2)(2008-3#1)
urea##207##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-9#3)(1992-11#1)(1992-3#3)(1993-11#5)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#4)(1994-9#1)(1995-11#1)(1995-2#6)(1995-3#7)(1995-5#5)(1995-6#5)(1997-2#3)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#11)(2008-10#66)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#15)(2008-5#2)(2008-7#7)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-2#6)(2013-1#1)(2013-8#7)
urea)##2##1##(1995-12#1)(2008-10#1)
urea-N##2##1##(2012-2#2)
urea-denatured##3##1##(2009-7#2)(2011-1#1)
urea-functionalized##2##1##(2008-10#2)
ureafaciens##2##1##(1994-11#2)
urealyticum and##3##2##(1997-3#2)(2011-2#1)
urealyticum in semen of infertile##2##5##(2008-12#2)
urealyticum in##3##2##(2008-12#2)(2013-1#1)
urealyticum##15##1##(1997-3#3)(2008-12#7)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
ureaplasma##3##1##(2007-12#1)(2011-2#1)(2013-8#1)
ureas##2##1##(2013-1#2)
urease on the##2##3##(2008-10#2)
urease test##2##2##(1992-5#1)(2012-12#1)
urease##33##1##(1990-2#1)(1992-11#1)(1992-5#1)(1994-11#2)(1994-6#1)(1995-3#3)(2008-10#18)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
uredinia##11##1##(2008-10#11)
uredinial density and latent period##2##5##(2008-10#2)
uredinial density and##3##3##(2008-10#3)
uredinial density##4##2##(2008-10#4)
uredinial diameter##3##2##(2008-10#3)
uredinial##8##1##(2008-10#8)
urediniospore germination##4##2##(2008-10#4)
urediniospore##6##1##(2008-10#6)
urediniospores and##3##2##(2008-10#3)
urediniospores of##2##2##(2008-10#2)
urediniospores##12##1##(2008-10#12)
uredinium area##6##2##(2008-10#6)
uredinium size##2##2##(2008-10#2)
uredinium##8##1##(2008-10#8)
urediospore##2##1##(2008-10#2)
uredospore production##4##2##(2008-10#4)
uremia and##2##2##(1993-2#1)(2010-3#1)
uremia##8##1##(1990-5#1)(1993-2#1)(1994-9#1)(1997-4#1)(2007-7#1)(2008-1#1)(2010-3#1)(2011-2#1)
uremic diabetic##2##2##(1991-6#1)(2008-1#1)
uremic environment##2##2##(2008-11#1)(2013-1#1)
uremic oxalosis##2##2##(2011-2#2)
uremic parathyroid hyperplasia##5##3##(2008-5#5)
uremic patients##3##2##(2007-7#1)(2008-1#2)
uremic symptoms and##2##3##(2007-7#1)(2011-2#1)
uremic##27##1##(1991-6#1)(2007-12#1)(2007-7#3)(2008-1#4)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#5)(2011-2#4)(2013-1#3)
ureter and the##2##3##(2008-10#2)
ureter and##6##2##(1997-4#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-3#1)
ureter in##2##2##(2007-10#1)(2013-7#1)
ureter is##5##2##(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-8#1)
ureter##38##1##(1990-12#1)(1996-3#1)(1997-3#5)(1997-4#4)(2007-10#2)(2008-1#1)(2008-10#8)(2008-4#1)(2008-7#1)(2009-5#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#2)
ureteral arteries##2##2##(1997-4#2)
ureteral obstruction secondary to##3##4##(2007-10#2)(2008-10#1)
ureteral obstruction##6##2##(1993-12#1)(2007-10#2)(2008-1#1)(2008-10#1)(2011-1#1)
ureteral reconstruction##2##2##(2013-8#2)
ureteral reimplantation##3##2##(2008-1#2)(2008-10#1)
ureteral strictures##5##2##(2013-1#3)(2013-8#2)
ureteral valves##2##2##(2008-10#2)
ureteral##43##1##(1990-11#1)(1991-11#1)(1991-6#1)(1993-12#1)(1997-4#6)(2007-10#2)(2007-7#1)(2008-1#4)(2008-10#8)(2008-7#2)(2009-1#1)(2010-11#1)(2011-1#1)(2013-1#6)(2013-8#7)
ureteric bud##2##2##(2008-10#2)
ureteric injury##3##2##(2008-8#2)(2010-3#1)
ureteric length##2##2##(2008-10#1)(2008-8#1)
ureteric obstruction##4##2##(2008-1#1)(2008-10#3)
ureteric re-implantation##2##2##(2008-10#1)(2008-4#1)
ureteric stricture##3##2##(2009-5#1)(2013-1#2)
ureteric##30##1##(1991-9#1)(1997-3#2)(2008-1#3)(2008-10#14)(2008-4#1)(2008-8#4)(2009-5#2)(2010-3#1)(2013-1#2)
uretero-neocystostomy##2##1##(2008-1#2)
ureterocystoplasty##2##1##(2007-9#1)(2008-10#1)
ureteropelvic junction obstruction in##2##4##(2007-8#1)(2008-7#1)
ureteropelvic junction obstruction##9##3##(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#2)
ureteropelvic junction##10##2##(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#3)
ureterosigmoidostomy##3##1##(1996-3#2)(2011-2#1)
ureterovesical##2##1##(2008-1#1)(2008-7#1)
ureters were##2##2##(1996-3#1)(2008-1#1)
ureters with##5##2##(2008-10#5)
ureters##18##1##(1996-3#1)(1997-6#5)(2008-1#4)(2008-10#7)(2011-2#1)
urethan##5##1##(1992-5#5)
urethane##8##1##(1993-12#1)(1994-5#2)(1996-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2013-1#1)
urethane-urea copolymers##3##2##(2008-3#3)
urethra and##5##2##(1997-8#1)(2008-10#3)(2013-1#1)
urethra in##4##2##(1994-3#1)(2008-10#2)(2009-5#1)
urethra was##2##2##(2008-10#2)
urethra##41##1##(1990-7#2)(1991-2#2)(1994-3#1)(1996-12#1)(1997-7#3)(1997-8#1)(2008-10#22)(2009-5#1)(2010-11#2)(2012-12#1)(2012-3#2)(2013-1#3)
urethral and##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
urethral cases##3##2##(2008-10#3)
urethral catheter##3##2##(1990-11#2)(2008-10#1)
urethral dissection##2##2##(2008-10#2)
urethral diverticulum in a female##2##5##(2008-10#2)
urethral diverticulum##3##2##(2008-10#3)
urethral duplication##3##2##(2008-10#3)
urethral inflammation##4##2##(1990-7#4)
urethral meatus##3##2##(1992-1#2)(2010-11#1)
urethral plate##7##2##(2008-10#2)(2009-5#5)
urethral realignment##2##2##(2013-8#2)
urethral reconstruction##2##2##(2009-5#1)(2013-8#1)
urethral strictures##2##2##(2007-9#1)(2008-10#1)
urethral valve##8##2##(2008-10#5)(2011-2#3)
urethral valves##8##2##(1991-11#1)(2008-1#1)(2008-10#6)
urethral##91##1##(1990-11#2)(1990-7#5)(1991-11#1)(1992-1#5)(1996-11#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#42)(2008-3#1)(2008-7#1)(2009-11#1)(2009-5#7)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#11)
urethritis and##5##2##(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
urethritis##17##1##(1990-6#1)(2007-7#4)(2007-8#1)(2008-10#3)(2008-12#1)(2011-2#4)(2012-2#2)(2013-1#1)
urethrogenital##2##1##(1994-2#2)
urethroplasty is##6##2##(2009-5#5)(2013-8#1)
urethroplasty or Snodgrass##2##3##(2008-10#1)(2009-5#1)
urethroplasty with##3##2##(2008-10#1)(2009-5#2)
urethroplasty##17##1##(2008-10#2)(2009-5#12)(2013-8#3)
urge urinary incontinence##3##3##(2008-3#2)(2011-1#1)
urge us to##2##3##(1990-2#1)(2008-12#1)
urge##10##1##(1990-2#1)(1992-11#1)(1993-9#2)(1997-6#1)(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
urged to##4##2##(1990-4#1)(1995-2#1)(1996-2#1)(2008-11#1)
urged##8##1##(1990-4#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-8#1)(2010-12#1)
urgency and##2##2##(2011-2#1)(2011-3#1)
urgency in##2##2##(2008-10#1)(2008-11#1)
urgency of##5##2##(1996-1#2)(2008-9#1)(2010-7#1)(2012-2#1)
urgency##15##1##(1990-3#1)(1990-5#1)(1991-6#1)(1996-1#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
urgent and##5##2##(1992-6#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)
urgent attention##2##2##(2008-11#1)(2010-4#1)
urgent clinical##2##2##(2008-3#1)(2012-12#1)
urgent for the##2##3##(1994-12#1)(2007-10#1)
urgent medical transportation by road##2##5##(2013-1#2)
urgent need for new##2##4##(2008-11#1)(2010-12#1)
urgent need for##9##3##(2007-7#1)(2008-10#1)(2008-11#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)
urgent need of##2##3##(2008-11#1)(2008-5#1)
urgent need to##8##3##(1994-2#1)(1996-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#1)
urgent need##21##2##(1994-2#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)
urgent requirement##2##2##(1992-2#1)(2008-11#1)
urgent surgery##3##2##(2007-8#1)(2008-4#1)(2013-1#1)
urgent surgical##2##2##(2008-6#1)(2011-1#1)
urgent##74##1##(1990-2#2)(1992-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-10#4)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#6)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
urgently needed to provide##2##4##(2008-3#1)(2011-2#1)
urgently needed to##4##3##(2007-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
urgently needed##10##2##(1993-11#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
urgently##27##1##(1991-3#1)(1993-11#1)(1995-2#1)(1995-5#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
urges##6##1##(1991-9#1)(1992-1#1)(1994-2#1)(2007-2#1)(2009-10#1)(2012-3#1)
uric acid (UA)##6##3##(2008-10#6)
uric acid and ascorbic acid##3##5##(2008-10#3)
uric acid and creatinine##4##4##(2008-10#3)(2010-4#1)
uric acid and##15##3##(1993-2#1)(2008-10#10)(2009-6#2)(2010-4#1)(2011-1#1)
uric acid biosensor##2##3##(2008-10#2)
uric acid by##4##3##(2008-10#3)(2011-2#1)
uric acid concentration##2##3##(2008-10#2)
uric acid in the presence of##2##6##(1997-2#1)(2008-10#1)
uric acid in##9##3##(1997-2#2)(2008-10#7)
uric acid levels and##2##4##(2011-1#2)
uric acid levels were higher in##2##6##(1995-12#1)(2011-1#1)
uric acid levels##8##3##(1995-12#1)(2008-7#2)(2011-1#5)
uric acid transport##2##3##(2011-2#2)
uric acid were##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
uric acid##101##2##(1990-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1997-2#2)(2008-10#58)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#4)(2009-6#4)(2010-4#3)(2011-1#6)(2011-2#6)(2013-1#2)
uric##106##1##(1990-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1997-2#2)(2008-10#63)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#4)(2009-6#4)(2010-4#3)(2011-1#6)(2011-2#6)(2013-1#2)
uricase##15##1##(1990-11#6)(1992-8#4)(1995-3#1)(1997-2#1)(2008-10#3)
uridine at##2##2##(1990-7#1)(1995-8#1)
uridine diphosphate##3##2##(1995-8#2)(2008-5#1)
uridine transport##7##2##(1995-10#2)(1995-8#5)
uridine with##2##2##(1993-8#1)(2008-4#1)
uridine##30##1##(1990-5#1)(1990-7#1)(1992-11#3)(1993-11#1)(1993-2#1)(1993-8#2)(1995-10#2)(1995-8#8)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-9#2)(2011-1#1)
uridine-5'-monophosphate##2##1##(1996-5#1)(2013-7#1)
urinalysis was##2##2##(2008-10#1)(2010-8#1)
urinalysis##9##1##(1993-2#4)(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
urinary 1-hydroxypyrene##2##2##(1992-3#2)
urinary 8OHdG##3##2##(2008-10#3)
urinary Bence Jones protein (BJP-DIA)##2##5##(1992-3#2)
urinary Cd##3##2##(1997-4#3)
urinary Gla##3##2##(1991-12#3)
urinary Hg expressed as microgram##2##5##(1993-8#2)
urinary Hg level##2##3##(1993-8#2)
urinary Hg##5##2##(1993-8#5)
urinary albumin excretion in clinical##2##5##(2013-1#2)
urinary albumin excretion##5##3##(2008-1#1)(2012-1#1)(2013-1#3)
urinary albumin##6##2##(2008-1#1)(2012-1#1)(2013-1#4)
urinary aluminum excretion with and without DFO treatment) were##2##9##(1992-11#2)
urinary and fecal##3##3##(1994-5#1)(1996-12#1)(2011-2#1)
urinary and##7##2##(1994-5#1)(1996-12#2)(2008-10#1)(2009-12#1)(2011-2#2)
urinary arsenic##3##2##(1995-11#2)(2008-10#1)
urinary bladder and##3##3##(1993-3#1)(2008-7#1)(2011-2#1)
urinary bladder cancer in##2##4##(2007-11#1)(2011-2#1)
urinary bladder cancer##9##3##(1990-12#1)(1992-11#1)(1995-12#2)(2007-11#1)(2011-2#3)(2013-1#1)
urinary bladder tumour##2##3##(2012-12#2)
urinary bladder were##2##3##(1992-12#1)(1993-9#1)
urinary bladder##62##2##(1990-12#2)(1991-6#1)(1992-11#2)(1992-12#3)(1992-3#3)(1993-2#2)(1993-3#1)(1993-9#2)(1994-8#1)(1995-12#2)(1996-12#1)(1997-2#2)(2007-11#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-7#3)(2009-2#2)(2009-5#2)(2009-7#4)(2011-2#9)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#1)
urinary calculi##2##2##(2007-10#1)(2008-10#1)
urinary catheters##4##2##(1996-12#3)(2011-2#1)
urinary creatinine##2##2##(2008-10#1)(2009-6#1)
urinary cytokine levels##3##3##(1996-12#3)
urinary derivation##2##2##(1990-9#2)
urinary diversion##4##2##(1991-11#1)(2008-10#3)
urinary dolichol##3##2##(1991-12#3)
urinary dolichols##6##2##(1991-12#6)
urinary dysfunction##2##2##(2008-7#2)
urinary endotoxin##2##2##(1996-12#2)
urinary excretion of##17##3##(1990-5#1)(1991-12#1)(1994-5#4)(1995-11#7)(1995-3#1)(1995-6#1)(2008-7#1)(2009-6#1)
urinary excretion##21##2##(1990-5#1)(1991-12#1)(1993-12#1)(1994-5#4)(1995-11#7)(1995-3#1)(1995-6#1)(1996-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2013-8#1)
urinary flow##3##2##(2008-10#3)
urinary free##3##2##(1990-8#2)(2011-2#1)
urinary frequency##2##2##(2006-10#1)(2008-3#1)
urinary gamma-carboxyglutamic acid##2##3##(1991-12#2)
urinary incontinence (SUI)##3##3##(2008-3#1)(2011-1#1)(2011-2#1)
urinary incontinence (UI) and##2##4##(2010-10#1)(2011-1#1)
urinary incontinence (UI)##3##3##(1994-5#1)(2010-10#1)(2011-1#1)
urinary incontinence and##2##3##(1992-8#1)(2008-3#1)
urinary incontinence in elderly##2##4##(1994-5#1)(2011-1#1)
urinary incontinence in patients with##2##5##(2008-10#2)
urinary incontinence in##7##3##(1994-5#1)(2008-10#4)(2011-1#1)(2012-3#1)
urinary incontinence##34##2##(1991-3#1)(1992-8#1)(1994-5#5)(1996-2#1)(2008-10#6)(2008-3#5)(2008-4#1)(2008-5#1)(2009-3#3)(2010-10#1)(2011-1#5)(2011-2#1)(2012-3#1)(2013-8#2)
urinary infection##8##2##(1996-3#1)(2007-12#4)(2008-10#1)(2010-4#1)(2011-1#1)
urinary infections##3##2##(1990-3#1)(2008-10#2)
urinary intervention##2##2##(2007-8#2)
urinary isolates##2##2##(2008-10#1)(2008-4#1)
urinary lead##2##2##(2008-10#2)
urinary leak##2##2##(2008-1#1)(2008-10#1)
urinary levels of##2##3##(1993-12#1)(2009-9#1)
urinary mercury##2##2##(1993-8#1)(1995-3#1)
urinary metabolites##4##2##(1990-11#1)(1990-8#1)(1991-5#1)(2010-5#1)
urinary nitrite and citrulline levels##2##5##(2008-7#2)
urinary obstruction##3##2##(1990-3#1)(2008-1#2)
urinary output##2##2##(1994-9#1)(2007-10#1)
urinary protein##2##2##(1997-8#2)
urinary proteins##2##2##(1990-12#1)(2013-8#1)
urinary pseudouridine and 1-methyladenosine##3##4##(1992-3#3)
urinary retention##3##2##(1993-9#1)(2008-10#2)
urinary sample##2##2##(2008-10#2)
urinary schistosomiasis only##2##3##(1996-12#2)
urinary schistosomiasis##7##2##(1996-12#6)(2008-10#1)
urinary sediment##4##2##(1997-7#2)(2008-1#1)(2013-8#1)
urinary sodium##2##2##(2008-4#1)(2011-2#1)
urinary stone##2##2##(1993-6#1)(2008-4#1)
urinary stress incontinence##2##3##(1994-3#1)(2008-1#1)
urinary symptoms##3##2##(2007-12#1)(2012-12#1)(2012-3#1)
urinary thioether##2##2##(2013-1#2)
urinary tract infection (UTI)##5##4##(2007-7#1)(2008-1#1)(2009-5#1)(2011-2#2)
urinary tract infection and##4##4##(2008-10#1)(2008-4#3)
urinary tract infection in##3##4##(2007-12#1)(2008-1#1)(2011-2#1)
urinary tract infection with##2##4##(2008-10#1)(2009-5#1)
urinary tract infection##31##3##(1990-11#1)(1994-2#1)(1996-12#1)(2007-12#3)(2007-7#2)(2008-1#3)(2008-10#3)(2008-4#4)(2008-7#2)(2009-5#3)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-1#1)
urinary tract infections and##5##4##(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
urinary tract infections in##4##4##(1993-2#1)(2007-10#2)(2007-12#1)
urinary tract infections##26##3##(1993-2#2)(1997-4#2)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
urinary tract is##2##3##(2008-10#1)(2012-12#1)
urinary tract##101##2##(1990-11#3)(1990-8#2)(1991-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#2)(1994-2#1)(1996-12#4)(1997-2#1)(1997-4#3)(2007-10#3)(2007-12#5)(2007-5#2)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#16)(2008-11#1)(2008-4#4)(2008-7#3)(2009-5#5)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#8)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#6)
urinary volume of##2##3##(1993-2#1)(2007-7#1)
urinary##484##1##(1990-11#5)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#2)(1990-8#9)(1990-9#3)(1991-11#4)(1991-12#15)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#4)(1992-3#10)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#2)(1993-6#2)(1993-8#8)(1993-9#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#11)(1994-8#2)(1994-9#1)(1995-11#9)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-12#27)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-2#8)(1997-4#7)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#1)(2007-12#11)(2007-5#2)(2007-7#12)(2007-8#4)(2008-1#15)(2008-10#70)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#8)(2008-5#4)(2008-7#16)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-5#9)(2009-6#6)(2009-7#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-8#1)(2011-1#6)(2011-2#27)(2012-1#5)(2012-12#12)(2012-2#8)(2012-3#6)(2013-1#13)(2013-8#13)
urination##2##1##(1990-10#1)(2008-6#1)
urine (MSU)##2##2##(2007-10#1)(2010-8#1)
urine (p = 0##2##4##(2008-7#2)
urine DPD##3##2##(2008-10#3)
urine after##6##2##(1993-2#1)(2008-10#4)(2008-11#1)
urine analysis##3##2##(1991-12#1)(1996-12#1)(2007-7#1)
urine analytes##3##2##(2008-10#3)
urine and detergents##2##3##(2008-10#2)
urine and hair samples##3##4##(2008-10#3)
urine and increase##2##3##(1990-12#2)
urine and pharmaceuticals##3##3##(2008-10#3)
urine and saliva of##2##4##(2008-10#1)(2008-12#1)
urine and saliva##3##3##(2008-10#2)(2008-12#1)
urine and serum by##2##4##(1990-8#1)(2008-10#1)
urine and serum samples##4##4##(2008-10#4)
urine and serum##24##3##(1990-2#2)(1990-8#2)(1992-8#2)(1995-8#1)(2008-10#17)
urine and##64##2##(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#3)(1992-11#1)(1992-8#2)(1993-12#2)(1995-3#1)(1995-8#1)(1996-6#1)(2008-10#44)(2008-12#1)(2012-2#1)(2013-1#2)
urine as##5##2##(1992-3#1)(2008-10#2)(2011-2#1)(2013-8#1)
urine based on the##2##4##(1990-12#1)(2008-10#1)
urine by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
urine by high performance liquid chromatography##2##6##(2008-10#2)
urine by high performance liquid##4##5##(2008-10#3)(2011-1#1)
urine by the##2##3##(2008-10#1)(2008-7#1)
urine by##42##2##(1990-11#1)(1990-12#1)(1990-8#3)(1992-11#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#2)(2006-10#1)(2008-10#23)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#2)
urine chemistry analyser##3##3##(2007-10#3)
urine collections##2##2##(1995-12#1)(2011-2#1)
urine concentrations##2##2##(1991-12#1)(1992-8#1)
urine could be##2##3##(1990-8#1)(2013-8#1)
urine culture and susceptibility##2##4##(2010-8#1)(2011-2#1)
urine culture##8##2##(2007-7#2)(2008-1#3)(2010-8#1)(2011-2#2)
urine cultures##5##2##(2007-10#1)(2007-12#1)(2007-7#2)(2008-5#1)
urine cytology##4##2##(2008-10#1)(2012-2#1)(2013-8#2)
urine derivation##2##2##(2011-2#2)
urine for##3##2##(2008-10#2)(2008-7#1)
urine from patients with##2##4##(1993-9#1)(2008-10#1)
urine from##4##2##(1993-2#1)(1993-9#1)(2008-10#1)(2012-3#1)
urine glucose##2##2##(1991-12#1)(2008-7#1)
urine has been developed##5##4##(2008-10#5)
urine has been##6##3##(2008-10#6)
urine have##2##2##(1994-12#1)(2008-10#1)
urine in the##2##3##(1991-11#1)(2008-12#1)
urine in##11##2##(1990-12#1)(1991-11#1)(1993-2#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-9#1)(2012-12#1)(2012-3#1)
urine is reported##2##3##(1990-8#1)(2008-10#1)
urine is##15##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(2008-10#5)(2009-6#1)(2009-7#1)(2011-2#1)
urine matrix##4##2##(2008-10#4)
urine media##3##2##(2008-10#3)
urine nitrite and citrulline levels##2##5##(2006-10#2)
urine nitrite##3##2##(2006-10#2)(2008-7#1)
urine nonsecretory RNase and##2##4##(1990-7#2)
urine nonsecretory RNase##4##3##(1990-7#4)
urine of cancer patients##2##4##(1993-8#1)(2008-10#1)
urine of healthy##2##3##(1991-12#1)(2008-10#1)
urine of patients under##2##4##(1996-2#1)(2008-10#1)
urine of patients with##4##4##(1997-2#2)(2008-7#2)
urine of patients##6##3##(1996-2#1)(1997-2#2)(2008-10#1)(2008-7#2)
urine of the patients with cancer of the pancreas##2##9##(2008-7#2)
urine of the patients with cancer of the##3##8##(2008-7#3)
urine of the##6##3##(1995-3#2)(2007-7#1)(2008-7#3)
urine of##32##2##(1990-12#1)(1991-12#2)(1992-3#3)(1993-12#1)(1993-8#1)(1994-5#1)(1995-3#2)(1996-12#4)(1996-2#1)(1997-2#2)(2007-7#1)(2008-10#5)(2008-7#6)(2013-8#2)
urine or feces##2##3##(1996-12#1)(2009-6#1)
urine or##4##2##(1994-8#1)(1996-12#1)(2008-11#1)(2009-6#1)
urine osmolality and##2##3##(2009-12#1)(2013-1#1)
urine osmolality##3##2##(2009-12#1)(2013-1#2)
urine output##2##2##(2008-7#1)(2012-2#1)
urine protein##2##2##(1995-8#1)(2011-3#1)
urine sample was##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
urine sample##19##2##(1990-2#1)(1990-8#2)(1996-12#1)(1996-5#1)(2008-10#11)(2012-2#1)(2013-1#2)
urine samples after a##2##4##(2008-10#2)
urine samples and in##2##4##(2008-10#2)
urine samples and##7##3##(2008-10#7)
urine samples are##3##3##(2008-10#3)
urine samples by##5##3##(2008-10#4)(2010-11#1)
urine samples containing##2##3##(2008-10#2)
urine samples from##9##3##(1990-2#1)(1995-12#1)(1995-2#1)(2008-10#6)
urine samples is##4##3##(1995-2#1)(2008-10#3)
urine samples of##4##3##(1993-8#1)(2008-10#3)
urine samples to##2##3##(2008-10#1)(2008-12#1)
urine samples using##2##3##(2008-10#2)
urine samples was##2##3##(2008-10#2)
urine samples were##12##3##(1993-11#1)(1996-2#1)(1997-4#1)(2008-10#8)(2012-1#1)
urine samples with##3##3##(1997-2#1)(2008-10#1)(2010-4#1)
urine samples##106##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#85)(2008-12#2)(2010-11#1)(2010-4#3)(2012-1#1)
urine secretory RNase##2##3##(1990-7#2)
urine specimen##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
urine specimens by##3##3##(2008-10#3)
urine specimens were##2##3##(2007-7#1)(2008-10#1)
urine specimens##9##2##(1992-8#1)(2007-12#1)(2007-7#1)(2008-10#6)
urine using##6##2##(1991-12#1)(2008-10#5)
urine values##2##2##(1995-3#2)
urine volume##7##2##(1993-2#2)(1995-12#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-2#1)
urine was determined##2##3##(1992-3#1)(2013-8#1)
urine was##15##2##(1990-8#1)(1992-3#1)(1993-8#1)(1995-2#1)(2008-10#9)(2008-12#1)(2013-8#1)
urine were##12##2##(1990-8#4)(1992-5#1)(2008-10#6)(2013-1#1)
urine with##9##2##(1990-12#1)(1990-2#1)(2008-10#6)(2011-2#1)
urine##700##1##(1990-11#3)(1990-12#18)(1990-2#11)(1990-7#9)(1990-8#21)(1990-9#1)(1991-11#1)(1991-12#8)(1991-5#2)(1992-11#4)(1992-3#11)(1992-5#1)(1992-6#1)(1992-8#7)(1992-9#4)(1993-11#1)(1993-12#8)(1993-2#8)(1993-8#6)(1993-9#5)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#5)(1995-12#8)(1995-2#4)(1995-3#10)(1995-6#1)(1995-8#2)(1996-12#15)(1996-2#2)(1996-5#6)(1996-6#1)(1997-2#6)(1997-4#2)(2006-10#10)(2007-10#6)(2007-12#3)(2007-7#11)(2007-8#2)(2008-1#6)(2008-10#347)(2008-11#5)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#20)(2009-12#2)(2009-6#3)(2009-7#2)(2009-9#4)(2010-11#3)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#14)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#9)
urine) is##2##2##(2008-10#1)(2011-2#1)
urine)##5##1##(2008-10#4)(2011-2#1)
urines##7##1##(1990-8#2)(2008-10#2)(2008-12#2)(2013-8#1)
urinoma##9##1##(1993-12#2)(2008-10#5)(2011-2#2)
urocanic acid##2##2##(2008-10#1)(2011-2#1)
urodele##2##1##(1996-5#1)(1997-3#1)
urodeles##2##1##(1996-5#1)(2008-7#1)
urodynamic studies##3##2##(2008-10#3)
urodynamic##8##1##(1994-3#1)(2008-10#5)(2008-7#1)(2012-12#1)
urodynamics##3##1##(1991-11#1)(2008-1#1)(2008-10#1)
urogenital infections##3##2##(1990-6#1)(1991-11#1)(2013-7#1)
urogenital ridges##2##2##(1994-11#2)
urogenital sinus##9##2##(2008-10#9)
urogenital tract##7##2##(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
urogenital##31##1##(1990-6#1)(1990-9#1)(1991-11#1)(1992-6#1)(1994-11#3)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-7#1)(2007-9#1)(2008-10#12)(2008-5#1)(2012-3#2)(2013-1#1)(2013-7#1)
urography##4##1##(1990-11#1)(1990-9#1)(2011-2#2)
urokinase plasminogen activator receptor##2##4##(2013-1#2)
urokinase plasminogen activator##3##3##(1997-4#1)(2013-1#2)
urokinase plasminogen##4##2##(1997-4#2)(2013-1#2)
urokinase##17##1##(1990-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2007-10#2)(2007-11#1)(2008-7#2)(2013-1#2)
urokinase-type plasminogen activator (u-PA)##2##4##(1993-12#1)(1994-3#1)
urokinase-type plasminogen activator (uPA)##2##4##(1990-12#1)(2008-11#1)
urokinase-type plasminogen activator##7##3##(1990-12#1)(1993-12#1)(1994-3#2)(1995-6#1)(2008-11#2)
urokinase-type##8##1##(1990-12#1)(1993-12#1)(1994-3#3)(1995-6#1)(2008-11#2)
urolithiasis##7##1##(1991-3#1)(1992-9#2)(2007-7#1)(2008-1#1)(2008-10#1)(2012-2#1)
urologic cancer surgeries##2##3##(2008-7#2)
urologic cancer surgery##2##3##(2008-7#2)
urologic cancer##5##2##(2008-7#5)
urologic diseases##2##2##(1997-7#1)(2008-10#1)
urologic surgery##2##2##(1991-9#1)(2008-10#1)
urologic trauma##2##2##(2013-8#2)
urologic##21##1##(1990-12#1)(1990-6#1)(1991-9#1)(1992-1#1)(1995-8#1)(1997-7#1)(2007-8#3)(2008-10#4)(2008-7#5)(2013-1#1)(2013-8#2)
urological abnormalities##2##2##(1991-11#1)(2007-12#1)
urological and##2##2##(1996-9#1)(2010-12#1)
urological anomalies##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
urological group##2##2##(1991-11#2)
urological problems##2##2##(2008-10#2)
urological##28##1##(1991-11#3)(1991-8#1)(1996-9#1)(2007-12#1)(2008-1#3)(2008-10#11)(2008-4#1)(2008-7#2)(2009-2#2)(2009-7#1)(2010-12#1)(2012-3#1)
urologist with##2##2##(2008-10#1)(2012-12#1)
urologist##7##1##(2007-10#1)(2007-5#1)(2008-10#1)(2011-2#3)(2012-12#1)
urologists##8##1##(1996-3#1)(2008-10#3)(2011-2#3)(2012-12#1)
urology##18##1##(1992-1#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
uropathy in##3##2##(2008-10#2)(2008-4#1)
uropathy##14##1##(1990-8#1)(2007-7#3)(2008-1#2)(2008-10#5)(2008-4#2)(2009-5#1)
uroporphyrinogen III##3##2##(1991-5#3)
uroporphyrinogen##5##1##(1991-5#5)
urosepsis##5##1##(1996-12#2)(2012-2#2)(2013-1#1)
urothelial carcinoma of the bladder##3##5##(2011-2#1)(2013-1#2)
urothelial carcinoma##6##2##(1993-6#1)(2011-2#3)(2013-1#2)
urothelial##8##1##(1993-6#1)(2008-10#1)(2011-2#3)(2013-1#2)(2013-8#1)
urothelium in##2##2##(2008-10#1)(2012-1#1)
urothelium##6##1##(1992-12#1)(2008-10#2)(2012-1#1)(2013-8#2)
ursinus)##2##1##(1996-12#1)(2008-10#1)
ursodeoxycholic acid##2##2##(2008-8#1)(2012-3#1)
ursolic acid##3##2##(2007-1#1)(2008-5#1)(2012-3#1)
urticae##2##1##(2008-8#1)(2011-2#1)
urticaria and pruritus##2##3##(2013-1#2)
urticaria and##7##2##(2007-7#1)(2010-5#1)(2013-1#5)
urticaria syndrome##2##2##(1990-6#2)
urticaria##27##1##(1990-6#3)(1991-11#1)(1996-11#1)(2007-2#2)(2007-7#4)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#7)
urticarial##4##1##(1990-8#1)(2007-7#1)(2010-1#1)(2012-2#1)
us a new##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
us a##9##2##(1997-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-7#1)(2010-10#1)(2012-2#1)
us about the##4##3##(2008-1#1)(2008-4#1)(2008-8#1)(2012-12#1)
us about##13##2##(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
us all##2##2##(1997-1#1)(2008-12#1)
us and##2##2##(2008-1#1)(2008-10#1)
us as##4##2##(1995-6#1)(2008-1#3)
us for the first time##2##5##(1991-12#1)(2009-7#1)
us for the##3##3##(1991-12#1)(2008-10#1)(2009-7#1)
us for##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-3#1)
us from##6##2##(1992-3#1)(1993-3#1)(1996-6#2)(2007-12#1)(2009-8#1)
us in the##2##3##(2008-10#2)
us in##8##2##(2008-10#2)(2008-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2013-8#1)
us into##2##2##(2006-10#1)(2013-1#1)
us is##2##2##(1994-2#1)(2007-7#1)
us of the##2##3##(2008-12#1)(2012-3#1)
us of##5##2##(1995-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
us that##3##2##(1995-1#1)(2008-11#1)(2012-3#1)
us the##4##2##(2008-4#1)(2008-9#1)(2009-12#1)(2012-2#1)
us to achieve##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
us to also##2##3##(2007-12#1)(2008-10#1)
us to analyse##2##3##(1995-12#1)(2008-7#1)
us to analyze the##2##4##(1992-12#1)(2008-8#1)
us to assess the##4##4##(2008-10#1)(2008-8#2)(2013-1#1)
us to assess##5##3##(1994-5#1)(2008-10#1)(2008-8#2)(2013-1#1)
us to avoid##3##3##(1991-6#1)(2008-3#2)
us to be##2##3##(1991-2#1)(1992-1#1)
us to believe##2##3##(2009-3#1)(2013-7#1)
us to better understand the##4##5##(2008-10#1)(2009-5#1)(2010-5#1)(2010-9#1)
us to better understand##5##4##(2008-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2013-1#1)
us to better##6##3##(2008-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
us to calculate the##3##4##(2008-2#1)(2008-7#1)(2008-8#1)
us to calculate##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
us to carry out##2##4##(1991-5#1)(2008-3#1)
us to clone##2##3##(1991-9#1)(1997-8#1)
us to compare the##2##4##(2008-5#1)(2012-12#1)
us to compare##3##3##(1995-5#1)(2008-5#1)(2012-12#1)
us to conclude that the##2##5##(1993-8#1)(2008-10#1)
us to conclude that##10##4##(1991-2#1)(1993-8#1)(1994-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-2#1)
us to conclude##12##3##(1991-2#1)(1993-12#1)(1993-8#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-2#1)
us to conduct##2##3##(2008-12#1)(2008-3#1)
us to confirm##2##3##(2008-8#1)(2011-1#1)
us to consider##3##3##(2008-3#1)(2008-7#2)
us to construct and##2##4##(1995-6#1)(2008-10#1)
us to derive##2##3##(2008-2#1)(2008-8#1)
us to describe the##2##4##(2008-10#1)(2008-3#1)
us to describe##4##3##(1995-5#1)(2008-10#1)(2008-3#2)
us to determine the##7##4##(2008-10#5)(2008-3#1)(2008-7#1)
us to determine whether##2##4##(1996-12#1)(2012-2#1)
us to determine##17##3##(1996-12#1)(2007-11#1)(2008-10#8)(2008-3#2)(2008-7#1)(2009-4#1)(2009-8#2)(2012-2#1)
us to develop an##2##4##(2007-7#1)(2012-3#1)
us to develop##7##3##(1993-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-3#2)
us to differentiate the##2##4##(2008-10#1)(2009-10#1)
us to differentiate##6##3##(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)
us to dissect the##2##4##(2009-3#1)(2011-2#1)
us to distinguish##5##3##(2008-10#1)(2008-3#1)(2011-1#2)(2011-10#1)
us to draw##2##3##(2008-5#1)(2012-12#1)
us to easily##2##3##(2007-11#1)(2008-3#1)
us to establish##4##3##(2008-10#1)(2008-3#2)(2009-10#1)
us to estimate##3##3##(1992-6#1)(2007-12#1)(2013-8#1)
us to evaluate the##3##4##(2008-3#1)(2008-5#2)
us to evaluate##4##3##(1993-8#1)(2008-3#1)(2008-5#2)
us to examine the##2##4##(2008-1#1)(2013-1#1)
us to examine##4##3##(2008-1#1)(2009-10#1)(2010-7#1)(2013-1#1)
us to explore##3##3##(2008-3#1)(2010-4#1)(2012-3#1)
us to extract##2##3##(2008-10#1)(2009-8#1)
us to find##2##3##(1996-2#1)(1996-9#1)
us to follow##2##3##(1992-6#1)(2008-11#1)
us to generate##2##3##(1993-2#1)(2010-7#1)
us to identify##7##3##(1990-11#1)(1991-9#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
us to improve##3##3##(2008-11#1)(2008-3#1)(2009-11#1)
us to interpret##2##3##(2008-10#1)(2010-3#1)
us to investigate the##3##4##(1992-12#1)(1994-8#1)(2008-4#1)
us to investigate##7##3##(1992-12#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
us to isolate and##2##4##(1990-2#1)(1993-8#1)
us to isolate##4##3##(1990-2#1)(1993-8#1)(1997-4#1)(2008-3#1)
us to make##4##3##(2008-10#2)(2008-7#1)(2010-12#1)
us to map the##2##4##(1993-11#1)(2008-5#1)
us to measure the##4##4##(1993-8#1)(2007-11#1)(2008-3#1)(2010-7#1)
us to measure##6##3##(1993-8#1)(2007-11#2)(2008-3#1)(2008-7#1)(2010-7#1)
us to observe##2##3##(2007-11#1)(2008-3#1)
us to obtain a##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
us to obtain##10##3##(1997-8#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#1)(2012-12#1)
us to optimize##2##3##(2007-12#1)(2008-11#1)
us to overcome the##2##4##(1995-6#1)(2008-10#1)
us to overcome##3##3##(1995-6#1)(2007-8#1)(2008-10#1)
us to perform##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)
us to postulate##3##3##(1992-6#1)(1995-3#1)(2013-1#1)
us to predict the##2##4##(2009-11#1)(2011-2#1)
us to present##2##3##(2008-3#1)(2008-5#1)
us to preserve the##2##4##(2008-10#1)(2008-5#1)
us to process##2##3##(2008-10#1)(2008-3#1)
us to propose a##3##4##(1993-11#1)(2008-10#1)(2008-3#1)
us to propose that##3##4##(2008-11#1)(2008-8#1)(2009-8#1)
us to propose##8##3##(1992-8#1)(1993-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)
us to quantify##2##3##(1994-8#1)(2008-10#1)
us to reduce the##2##4##(1994-12#1)(2007-12#1)
us to reduce##3##3##(1994-12#1)(2007-12#1)(2008-10#1)
us to relate the##2##4##(2008-2#1)(2008-5#1)
us to relate##3##3##(2008-2#1)(2008-5#1)(2008-7#1)
us to report this case##2##5##(2008-7#2)
us to report##3##3##(2008-7#2)(2010-6#1)
us to retrieve##3##3##(2008-2#3)
us to reveal##2##3##(2009-3#1)(2011-2#1)
us to separate##2##3##(2008-10#1)(2008-3#1)
us to study the influence of##2##6##(2008-10#1)(2012-2#1)
us to study the##7##4##(1993-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
us to study##10##3##(1993-2#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
us to suggest##2##3##(2008-5#2)
us to suspect##2##3##(1991-4#1)(2011-2#1)
us to test the##4##4##(1997-7#1)(2008-3#1)(2008-8#2)
us to test##6##3##(1997-7#1)(2008-3#1)(2008-8#4)
us to the##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
us to tune##2##3##(2008-2#1)(2008-3#1)
us to understand how##2##4##(1993-5#1)(2010-4#1)
us to understand##7##3##(1993-5#1)(1994-11#1)(1997-6#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-4#1)
us to use##3##3##(1993-12#1)(2008-3#1)(2011-2#1)
us to##370##2##(1990-10#1)(1990-11#1)(1990-2#5)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#5)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#3)(1995-6#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2007-11#9)(2007-12#13)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#59)(2008-11#6)(2008-12#3)(2008-2#18)(2008-3#44)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#16)(2008-8#13)(2008-9#2)(2009-10#3)(2009-11#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#4)
us who##2##2##(1994-2#1)(2008-10#1)
us with a##5##3##(1992-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2013-8#1)
us with an opportunity to##2##5##(1997-3#1)(2008-7#1)
us with an##4##3##(1997-3#1)(2008-7#2)(2012-3#1)
us with##19##2##(1992-1#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#4)(2008-9#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
us##553##1##(1990-10#1)(1990-11#1)(1990-2#6)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#4)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#5)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#2)(1994-8#3)(1995-1#4)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2006-10#2)(2007-11#12)(2007-12#16)(2007-7#4)(2007-8#3)(2008-1#10)(2008-10#72)(2008-11#16)(2008-12#7)(2008-2#21)(2008-3#47)(2008-4#5)(2008-5#19)(2008-6#5)(2008-7#23)(2008-8#21)(2008-9#8)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#6)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#19)(2012-1#1)(2012-12#7)(2012-2#12)(2012-3#14)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#8)
us?##6##1##(1996-3#1)(1997-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-3#1)
usCRP##2##1##(2012-2#2)
usability for##2##2##(2009-11#1)(2013-8#1)
usability of##4##2##(2007-12#1)(2008-12#1)(2010-10#1)(2012-12#1)
usability##16##1##(2007-12#1)(2008-12#2)(2008-6#2)(2008-7#2)(2009-11#2)(2010-10#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
usable for##2##2##(2007-7#1)(2008-11#1)
usable in##2##2##(2008-2#1)(2008-3#1)
usable life of the knee prosthesis##2##6##(2007-8#2)
usable##20##1##(1991-12#1)(1993-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
usage and the##2##3##(2008-5#1)(2008-9#1)
usage and##12##2##(1993-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
usage as##4##2##(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)
usage for##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
usage in the##4##3##(1990-11#1)(1997-4#1)(2008-1#1)(2011-2#1)
usage in##11##2##(1990-11#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#2)(2011-2#1)
usage is##4##2##(1997-1#1)(2008-2#1)(2008-5#1)(2010-3#1)
usage of the##12##3##(1993-6#1)(1993-9#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#2)
usage of traditional##2##3##(1997-2#1)(2008-1#1)
usage of##51##2##(1991-7#1)(1993-6#1)(1993-9#1)(1994-12#2)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#3)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
usage patterns##2##2##(2012-3#1)(2013-8#1)
usage segmentation##2##2##(1997-1#2)
usage to enterprise##2##3##(2008-12#2)
usage to##6##2##(1997-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-5#1)
usage tracking##2##2##(1991-12#2)
usage was##2##2##(1991-4#1)(1995-3#1)
usage##155##1##(1990-11#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-4#2)(1991-7#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#3)(2007-11#1)(2008-1#6)(2008-10#16)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#6)(2009-12#1)(2009-3#3)(2009-5#4)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#3)
usage-based##2##1##(1997-1#1)(2008-2#1)
usagers##2##1##(2013-1#2)
use (P&lt##2##2##(2007-8#2)
use a combination of##4##4##(2008-10#3)(2008-9#1)
use a different##2##3##(2008-8#1)(2008-9#1)
use a fast##2##3##(2008-2#1)(2008-3#1)
use a model##2##3##(2008-10#1)(2008-11#1)
use a simple##5##3##(2008-10#3)(2008-3#2)
use a variety of##3##4##(1993-12#1)(1995-1#1)(2012-2#1)
use a##100##2##(1990-3#1)(1991-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-9#1)(1997-8#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#17)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-11#3)(2009-3#1)(2009-4#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
use across##5##2##(1995-3#1)(2007-12#1)(2008-5#1)(2009-7#1)(2012-2#1)
use against##3##2##(1993-2#1)(2008-10#2)
use alcohol##2##2##(2012-12#2)
use all available##2##3##(1992-9#1)(2012-3#1)
use all##3##2##(1992-9#1)(2012-3#1)(2013-7#1)
use alone##2##2##(2006-10#1)(2007-8#1)
use among peers##3##3##(2013-1#3)
use among young##2##3##(2008-9#1)(2012-1#1)
use among##33##2##(1992-1#1)(1992-12#1)(1996-6#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#3)
use an##20##2##(1992-3#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
use and (ii)##2##3##(2008-10#1)(2008-7#1)
use and abuse##4##3##(1991-1#1)(2008-11#2)(2010-7#1)
use and communication##2##3##(2008-9#1)(2009-5#1)
use and expenditures##4##3##(1991-12#1)(1991-3#1)(1994-2#1)(1995-3#1)
use and for##2##3##(1992-12#1)(2013-7#1)
use and its##3##3##(2008-1#2)(2008-6#1)
use and low##3##3##(2008-9#1)(2009-7#2)
use and misuse##2##3##(1991-12#1)(2008-11#1)
use and offer##2##3##(1991-12#1)(2013-1#1)
use and other##3##3##(1997-6#1)(2008-1#1)(2013-1#1)
use and perceptions of##2##4##(2010-8#1)(2011-2#1)
use and that##2##3##(1992-9#1)(2008-3#1)
use and the risk of##2##5##(2008-11#1)(2008-8#1)
use and the##9##3##(2008-11#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
use and trends##3##3##(2012-12#3)
use and##154##2##(1990-2#1)(1991-1#4)(1991-12#3)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#3)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#13)(2008-12#4)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#6)(2009-10#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#7)
use any##4##2##(1997-2#1)(2008-3#1)(2013-1#2)
use appears to be##2##4##(2008-5#1)(2009-8#1)
use are discussed##2##3##(2007-10#1)(2008-4#1)
use are##24##2##(1990-2#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#2)(2013-1#1)(2013-8#1)
use as a##32##3##(1991-9#1)(1994-6#1)(1994-7#1)(1994-8#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#2)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
use as an##16##3##(1990-8#1)(1993-12#2)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2013-1#1)
use as well as##2##4##(2008-9#1)(2013-1#1)
use as##93##2##(1990-6#1)(1990-8#2)(1991-9#1)(1992-3#1)(1993-12#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#2)
use associated with##2##3##(2008-8#1)(2010-8#1)
use at the##5##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
use at##13##2##(1990-12#2)(1991-2#1)(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
use available##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
use because##3##2##(1992-11#1)(2008-10#1)(2012-12#1)
use behaviors##7##2##(1994-2#2)(1996-1#4)(2013-1#1)
use both##3##2##(2008-3#3)
use but only##3##3##(2009-7#1)(2012-1#2)
use but##7##2##(2008-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2012-1#2)
use by children##2##3##(2007-12#1)(2012-2#1)
use by the##4##3##(2007-10#1)(2008-5#2)(2011-1#1)
use by women##2##3##(1994-5#1)(1996-11#1)
use by##38##2##(1991-1#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
use can##5##2##(1996-11#1)(2008-5#1)(2009-9#1)(2011-1#1)(2013-8#1)
use causes##2##2##(2008-11#1)(2013-1#1)
use cells##2##2##(1996-2#1)(2008-11#1)
use chirped##2##2##(2007-11#2)
use clinical##2##2##(1997-2#1)(2009-4#1)
use clusters##2##2##(2012-3#1)(2013-1#1)
use condom##2##2##(2010-8#2)
use condoms##5##2##(1990-6#1)(1997-5#1)(2008-4#3)
use contraceptives##2##2##(1990-6#1)(2012-12#1)
use could##2##2##(2008-11#1)(2008-6#1)
use data from a##3##4##(1997-7#1)(2012-12#1)(2013-1#1)
use data from the##2##4##(2008-3#1)(2012-3#1)
use data from##7##3##(1997-7#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
use data##8##2##(1997-7#1)(2007-12#1)(2008-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
use decarboxylated##2##2##(2009-8#1)(2013-8#1)
use deterministic##2##2##(1996-3#1)(2008-9#1)
use different models##2##3##(1992-6#1)(2008-3#1)
use different##13##2##(1991-8#1)(1992-6#1)(1993-12#1)(1995-1#1)(1996-2#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
use disorder##10##2##(2008-6#1)(2009-11#2)(2010-6#2)(2012-12#1)(2012-3#1)(2013-8#3)
use disorders in##4##3##(2008-6#1)(2012-12#1)(2012-3#2)
use disorders##18##2##(1997-5#1)(2008-11#1)(2008-6#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-3#4)(2013-8#2)
use drugs##3##2##(1990-3#1)(1994-2#1)(2009-9#1)
use due to the##2##4##(1991-12#1)(2011-1#1)
use due to##3##3##(1991-12#1)(2011-1#1)(2013-1#1)
use during initial##2##3##(2007-10#1)(2008-6#1)
use during pregnancy##2##3##(1991-1#1)(2008-11#1)
use during##19##2##(1991-1#1)(1991-12#1)(1994-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-1#2)(2013-8#1)
use early in##2##3##(2008-11#1)(2009-7#1)
use efficiency##7##2##(2008-10#2)(2008-5#2)(2008-9#2)(2012-1#1)
use either##2##2##(2008-2#1)(2008-3#1)
use electrical##2##2##(2011-2#2)
use fewer animals##2##3##(2008-8#1)(2008-9#1)
use for a##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
use for the##10##3##(1995-3#2)(2008-10#5)(2008-11#1)(2008-5#1)(2010-8#1)
use for treatment of##2##4##(2008-5#1)(2012-12#1)
use for##75##2##(1990-3#1)(1991-1#1)(1992-1#1)(1994-3#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-8#2)(2008-10#20)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
use from##4##2##(1991-9#1)(2008-12#1)(2009-7#2)
use has been associated with##2##5##(2008-6#1)(2008-8#1)
use has been##8##3##(1992-2#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
use has##15##2##(1990-3#1)(1992-2#1)(1994-3#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
use have been##2##3##(2008-10#1)(2009-6#1)
use have##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2009-6#1)
use in MDIs will##2##4##(1992-3#1)(1996-1#1)
use in a##26##3##(1990-2#1)(1991-1#1)(1992-12#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-3#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#1)(2013-8#4)
use in aerosol##2##3##(1994-1#1)(1994-12#1)
use in all##2##3##(1991-9#1)(2008-10#1)
use in an##5##3##(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)
use in animal##2##3##(2008-11#1)(2011-2#1)
use in both##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
use in children##2##3##(2008-11#1)(2011-2#1)
use in clinical practice##5##4##(1997-7#1)(2007-5#1)(2009-12#1)(2011-2#1)(2012-3#1)
use in clinical##6##3##(1997-7#1)(2007-5#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
use in combination with##2##4##(2008-10#2)
use in cosmetic##2##3##(2008-5#2)
use in cosmetics##2##3##(2008-5#2)
use in determining##3##3##(1991-1#1)(2007-11#1)(2008-10#1)
use in different##2##3##(2008-10#1)(2008-12#1)
use in early##2##3##(2007-10#1)(2012-3#1)
use in gene therapy##2##4##(2010-1#2)
use in gene##3##3##(2008-10#1)(2010-1#2)
use in general##2##3##(1990-6#1)(2008-6#1)
use in high##2##3##(1995-8#1)(2008-8#1)
use in high-resolution##2##3##(2008-3#2)
use in human gene therapy##3##5##(1993-2#1)(1994-5#1)(1997-4#1)
use in human##4##3##(1993-2#1)(1994-5#1)(1997-4#1)(2008-5#1)
use in industrial##2##3##(2008-7#1)(2012-2#1)
use in medical##2##3##(2008-11#1)(2009-8#1)
use in older##2##3##(1996-2#1)(2008-3#1)
use in patients with##3##4##(2007-12#1)(2007-7#1)(2010-12#1)
use in patients##4##3##(2007-12#1)(2007-7#1)(2010-12#1)(2012-3#1)
use in pediatric patients##2##4##(2008-10#1)(2011-2#1)
use in pediatric##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
use in practice##2##3##(2008-10#1)(2008-11#1)
use in routine##3##3##(2008-10#2)(2008-3#1)
use in studies##3##3##(1993-12#1)(1993-8#1)(2008-10#1)
use in studying##2##3##(2008-10#1)(2008-9#1)
use in the United States##3##5##(1993-1#1)(2007-12#1)(2009-11#1)
use in the construction of##3##5##(1994-12#1)(2008-10#1)(2008-9#1)
use in the detection of##2##5##(2008-3#1)(2008-5#1)
use in the management of##2##5##(2007-8#1)(2009-12#1)
use in the optimization of##2##5##(2008-10#1)(2008-2#1)
use in the treatment of##6##5##(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
use in the##70##3##(1991-1#2)(1991-12#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
use in these##3##3##(1994-6#1)(2008-10#2)
use in this##7##3##(1996-2#1)(2006-10#1)(2008-1#1)(2008-6#2)(2008-8#1)(2010-6#1)
use in##409##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#6)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#5)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#4)(2007-11#11)(2007-12#14)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#60)(2008-11#20)(2008-12#5)(2008-2#11)(2008-3#33)(2008-4#6)(2008-5#20)(2008-6#6)(2008-7#10)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#8)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#7)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#8)
use include##2##2##(1996-2#1)(2006-10#1)
use information##2##2##(2010-8#1)(2011-2#1)
use interactively in##2##3##(2008-3#2)
use iron##2##2##(2008-1#1)(2008-3#1)
use is associated with##3##4##(2008-2#1)(2010-12#1)(2013-1#1)
use is becoming##2##3##(2008-7#1)(2013-8#1)
use is limited##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
use is not##2##3##(2008-5#1)(2010-2#1)
use is the##2##3##(2008-7#1)(2013-8#1)
use is##55##2##(1990-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
use it for##5##3##(1994-11#1)(1997-3#1)(2008-11#1)(2013-7#2)
use it to##4##3##(2007-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
use it##14##2##(1992-11#1)(1992-4#1)(1994-11#1)(1996-1#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-7#1)(2013-7#2)(2013-8#1)
use its##2##2##(2008-5#1)(2012-2#1)
use may be##3##3##(2011-1#1)(2011-7#1)(2012-12#1)
use may##11##2##(2008-8#1)(2009-3#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
use measurements of##2##3##(2008-2#1)(2008-5#1)
use measurements##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
use methods##2##2##(1994-11#1)(2008-4#1)
use morphological##2##2##(2007-12#1)(2008-8#1)
use multiple##4##2##(2008-10#1)(2008-8#1)(2010-11#1)(2011-1#1)
use new##3##2##(1994-12#1)(1997-2#1)(2012-3#1)
use norms##2##2##(2007-4#1)(2012-3#1)
use numerical##2##2##(2008-2#1)(2008-3#1)
use of &quot##4##3##(1996-3#1)(1997-6#1)(2010-5#1)(2012-12#1)
use of 0##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
use of 123-I MIBG imaging##2##5##(2012-2#2)
use of BPA##2##3##(2010-9#2)
use of Bacillus-based BCAs##2##4##(2008-10#2)
use of CD-ROM##2##3##(1991-3#1)(1995-3#1)
use of CEUS##2##3##(2010-12#2)
use of CT##3##3##(1992-12#1)(2011-2#1)(2013-1#1)
use of DNA microarrays##3##4##(2008-4#1)(2008-7#1)(2012-3#1)
use of DNA##8##3##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-3#2)(2013-8#1)
use of Fourier##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
use of GFP##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
use of HPLC##3##3##(1990-8#1)(1991-5#2)
use of Ligasure##2##3##(2007-8#1)(2009-2#1)
use of MRI##5##3##(1995-1#1)(1996-8#1)(2007-11#1)(2012-12#1)(2013-1#1)
use of Medicare's##2##3##(1994-12#1)(1994-2#1)
use of MgCl2##2##3##(1990-7#2)
use of N-acetylcysteine##2##3##(1991-9#2)
use of NMDA receptor modulators in the treatment of treatment-resistant depression##2##11##(2012-12#2)
use of SPME##3##3##(2008-10#3)
use of TCD##2##3##(2012-1#2)
use of TNF-α antagonists in aphthous ulceration##2##7##(2012-1#2)
use of TNF-α antagonists in##3##5##(2012-1#3)
use of UV##2##3##(2008-10#1)(2008-3#1)
use of VCT services was##2##5##(2013-1#2)
use of X-ray##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
use of a 5x10(-4) M Fe(III)-1x10(-3) M Fe(II) buffer containing 0##2##11##(2008-10#2)
use of a binary##2##4##(2008-2#1)(2008-3#1)
use of a chirped##2##4##(2007-11#1)(2007-12#1)
use of a composite##2##4##(2008-10#1)(2008-2#1)
use of a conceptual##2##4##(2010-8#1)(2012-3#1)
use of a continuous##3##4##(1994-3#1)(2008-2#1)(2008-6#1)
use of a diffraction grating##2##5##(2007-12#1)(2008-3#1)
use of a diffractive##2##4##(2007-12#1)(2008-3#1)
use of a digital##2##4##(1993-2#1)(2007-12#1)
use of a dual-wavelength##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
use of a few##2##4##(2007-12#1)(2008-10#1)
use of a fiber##3##4##(2007-12#1)(2008-2#2)
use of a focused##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
use of a large##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
use of a laser##2##4##(2007-12#1)(2008-2#1)
use of a liquid##2##4##(2007-12#2)
use of a liquid-crystal##4##4##(2007-11#2)(2008-3#2)
use of a local##2##4##(2007-11#1)(2008-3#1)
use of a low##2##4##(2008-3#2)
use of a low-cost##2##4##(2008-10#1)(2008-3#1)
use of a method##2##4##(2008-2#1)(2008-3#1)
use of a modified##6##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
use of a nearly degenerate broadband##2##6##(2008-3#2)
use of a new##5##4##(2007-11#1)(2008-2#1)(2008-3#2)(2009-2#1)
use of a nonlinear##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
use of a novel technique##2##5##(2007-11#1)(2007-12#1)
use of a novel##8##4##(2007-11#2)(2007-12#3)(2008-3#1)(2008-5#1)(2008-9#1)
use of a number of##3##5##(1991-12#1)(2008-2#1)(2008-9#1)
use of a relatively##2##4##(2009-5#1)(2009-8#1)
use of a scanning##4##4##(2007-11#1)(2008-3#3)
use of a second-order##2##4##(2008-2#1)(2008-3#1)
use of a set of##3##5##(1993-9#1)(2008-10#2)
use of a short##2##4##(2007-11#1)(2008-3#1)
use of a simple##8##4##(1992-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)
use of a single Raman signal##2##6##(2007-12#1)(2008-3#1)
use of a single##14##4##(1995-8#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#5)(2008-6#1)(2009-10#1)
use of a slit##2##4##(2008-2#1)(2008-3#1)
use of a small##3##4##(2008-3#2)(2008-9#1)
use of a specially designed##2##5##(2007-12#1)(2008-11#1)
use of a specially##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
use of a spiritually based##2##5##(2010-10#2)
use of a standard##5##4##(1991-12#1)(2008-2#1)(2008-3#3)
use of a structured##2##4##(2008-3#1)(2010-3#1)
use of a suitable##2##4##(2007-12#1)(2008-7#1)
use of a synthetic##2##4##(2007-11#1)(2011-2#1)
use of a three-dimensional##2##4##(2007-12#1)(2008-10#1)
use of a two-step##3##4##(2007-12#1)(2008-3#1)(2008-9#1)
use of a variety of##2##5##(1991-9#1)(2008-3#1)
use of a wide##2##4##(1996-11#1)(1996-3#1)
use of a##630##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-7#1)(2007-10#2)(2007-11#67)(2007-12#81)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#70)(2008-11#8)(2008-12#6)(2008-2#63)(2008-3#178)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#5)
use of adaptive##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
use of additional##3##3##(2007-11#1)(2007-12#1)(2009-5#1)
use of advance directives##2##4##(1992-12#1)(1993-2#1)
use of aerosol##3##3##(1997-1#1)(2008-10#1)(2010-3#1)
use of agricultural##2##3##(2008-11#1)(2008-12#1)
use of alcohol##4##3##(1991-9#2)(2009-5#1)(2013-8#1)
use of all##4##3##(1992-1#1)(2007-12#1)(2010-8#1)(2013-8#1)
use of alternative medicine##2##4##(1997-6#1)(2008-10#1)
use of alternative##7##3##(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-2#1)
use of amiodarone##2##3##(1993-6#1)(2008-11#1)
use of an assistive device##2##5##(2008-12#1)(2012-2#1)
use of an average##2##4##(2007-12#1)(2008-3#1)
use of an effective##2##4##(2008-2#1)(2008-3#1)
use of an electronic##2##4##(1993-10#1)(2009-10#1)
use of an empirical##2##4##(2008-2#1)(2008-7#1)
use of an external cavity##2##5##(2007-11#1)(2008-3#1)
use of an external##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
use of an external-cavity diode laser##2##6##(2008-2#1)(2008-3#1)
use of an external-cavity##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
use of an optical fiber##2##5##(2007-11#2)
use of an optical##6##4##(2007-11#3)(2007-12#1)(2008-3#2)
use of an optimized phase mask##2##6##(2008-3#2)
use of an##122##3##(1990-3#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-11#15)(2007-12#15)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#15)(2008-3#30)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#2)
use of analgesics##3##3##(1993-9#1)(2008-11#1)(2010-11#1)
use of analytical##2##3##(2008-10#2)
use of and##3##3##(1991-2#1)(1991-3#1)(1996-2#1)
use of animal models##2##4##(1993-12#1)(2008-7#1)
use of animal##4##3##(1993-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
use of animals##5##3##(1990-12#1)(1996-12#1)(2007-3#1)(2008-10#2)
use of antibacterial##2##3##(1997-3#1)(2012-3#1)
use of antibiotic##4##3##(1993-11#1)(1996-11#1)(2008-7#1)(2012-2#1)
use of antibiotics in##2##4##(2011-2#1)(2012-1#1)
use of antibiotics##8##3##(2008-1#1)(2009-5#1)(2011-2#2)(2012-1#2)(2012-2#2)
use of anticoagulants##3##3##(2012-12#3)
use of antimicrobial agents##2##4##(1990-6#1)(2013-1#1)
use of antimicrobial##5##3##(1990-6#1)(2007-7#1)(2008-5#1)(2012-3#1)(2013-1#1)
use of antimicrobials in food-producing animals##2##6##(2010-4#2)
use of antimicrobials##3##3##(2007-7#1)(2010-4#2)
use of antioxidants##2##3##(2011-2#1)(2013-8#1)
use of any##2##3##(2008-10#1)(2008-4#1)
use of appropriate##12##3##(1993-2#1)(1994-9#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
use of aprotinin in coronary artery bypass graft surgery##2##9##(2007-8#2)
use of aprotinin##3##3##(1990-3#1)(2007-8#2)
use of artificial neural networks##2##5##(2008-10#1)(2009-3#1)
use of artificial##3##3##(2008-10#2)(2009-3#1)
use of aspirin##2##3##(1990-3#1)(2008-3#1)
use of atomic force microscopy##2##5##(2008-2#2)
use of atomic##3##3##(2008-2#2)(2011-1#1)
use of autocorrelation##2##3##(2008-3#2)
use of available##4##3##(1991-12#1)(1992-2#1)(2008-1#1)(2013-1#1)
use of bacterial##2##3##(1990-2#1)(2012-2#1)
use of bilateral##3##3##(2007-8#1)(2008-1#1)(2010-8#1)
use of biocides##2##3##(2008-3#2)
use of birth##2##3##(1991-12#1)(2008-7#1)
use of bone##8##3##(1994-9#1)(1997-6#1)(2007-4#1)(2008-1#1)(2008-8#1)(2010-6#1)(2012-12#1)(2013-1#1)
use of both##19##3##(1997-2#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-5#1)(2012-2#3)(2013-1#2)
use of calcium##6##3##(1990-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
use of cannabis##3##3##(2009-7#1)(2013-8#2)
use of carbon##2##3##(1992-1#1)(2008-5#1)
use of cardiovascular##3##3##(2008-3#1)(2009-12#1)(2009-4#1)
use of carvedilol with##2##4##(2011-1#2)
use of case studies as##2##5##(2008-11#2)
use of central venous##2##4##(2008-7#2)
use of certain##4##3##(1992-8#1)(1994-12#1)(2008-11#1)(2008-3#1)
use of certificated##3##3##(2008-12#3)
use of certified seeds##2##4##(2008-12#2)
use of chemical##5##3##(1991-12#1)(2008-11#2)(2008-9#1)(2012-2#1)
use of chemicals##2##3##(2007-5#1)(2013-8#1)
use of chemotherapy##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
use of children's##2##3##(1992-1#1)(1992-3#1)
use of chromatographic##2##3##(2008-10#2)
use of cigarettes and alcohol##2##5##(1991-9#2)
use of cimetidine##2##3##(2008-11#2)
use of climate information for malaria##2##6##(2008-8#2)
use of clinical##4##3##(1993-12#2)(1995-2#1)(2012-12#1)
use of cocaine##5##3##(1991-1#1)(1991-5#1)(1996-5#1)(2010-11#1)(2013-8#1)
use of coherent##2##3##(2007-12#1)(2008-3#1)
use of color##2##3##(2007-12#1)(2008-6#1)
use of combination therapy in##2##5##(2008-2#1)(2010-10#1)
use of combination therapy##3##4##(2008-2#1)(2010-10#2)
use of combination##6##3##(2008-2#1)(2008-6#1)(2010-10#2)(2012-3#2)
use of combined##3##3##(2008-10#2)(2013-1#1)
use of communication strategies##4##4##(2012-3#4)
use of community resources##2##4##(2008-1#1)(2008-6#1)
use of community##4##3##(1996-1#1)(2008-1#1)(2008-6#1)(2012-12#1)
use of computed tomography##2##4##(1997-4#1)(2008-9#1)
use of computed##3##3##(1990-3#1)(1997-4#1)(2008-9#1)
use of computer simulation##2##4##(2007-11#1)(2010-8#1)
use of computer software##3##4##(2008-7#1)(2008-9#2)
use of computer##8##3##(1990-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-8#1)
use of computerized##3##3##(1995-3#1)(1996-8#1)(2013-1#1)
use of computers and##2##4##(1996-2#1)(2008-12#1)
use of computers##3##3##(1996-2#1)(2006-10#1)(2008-12#1)
use of condoms##7##3##(1993-2#1)(2009-5#1)(2011-1#1)(2011-2#4)
use of consumer surveys##2##4##(1996-2#1)(1996-3#1)
use of consumer##3##3##(1996-2#2)(1996-3#1)
use of continuous##2##3##(2007-11#1)(2008-3#1)
use of contraceptives was##2##4##(1996-6#2)
use of contraceptives##4##3##(1994-9#1)(1996-6#2)(2012-2#1)
use of conventional##8##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2011-2#1)
use of cost effectiveness##2##4##(1993-2#1)(2008-7#1)
use of cost##3##3##(1992-1#1)(1993-2#1)(2008-7#1)
use of crack cocaine##2##4##(2008-1#1)(2008-10#1)
use of crack##3##3##(2008-1#1)(2008-10#2)
use of critical##3##3##(1995-12#3)
use of crude tissue section lysates##2##6##(1996-12#2)
use of culture##2##3##(1996-6#1)(2008-7#1)
use of data for##2##4##(1996-2#2)
use of data from##2##4##(1996-6#1)(2011-2#1)
use of data##9##3##(1992-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(2008-3#1)(2010-8#1)(2011-2#1)
use of deep##2##3##(2008-1#1)(2009-12#1)
use of diagnostic##4##3##(1994-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
use of different types of##2##5##(2008-6#1)(2011-2#1)
use of different##31##3##(1990-2#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#2)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
use of diffractive##4##3##(2008-2#2)(2008-3#2)
use of digital speckle photography##2##5##(2008-3#2)
use of digital##9##3##(1992-9#1)(2007-12#1)(2008-3#5)(2008-7#1)(2010-8#1)
use of dilute##2##3##(2008-10#1)(2008-3#1)
use of direct##4##3##(2007-12#2)(2008-10#1)(2010-8#1)
use of distilled water##3##4##(2010-3#3)
use of distraction##2##3##(2007-12#1)(2011-1#1)
use of doll therapy in dementia##3##6##(2013-8#3)
use of dried blood spots##2##5##(1991-8#1)(2010-11#1)
use of dried##3##3##(1991-8#1)(1994-6#1)(2010-11#1)
use of drops##2##3##(2008-10#2)
use of drugs##8##3##(1991-12#1)(1995-1#1)(1996-6#2)(1997-2#1)(2008-11#1)(2008-7#1)(2011-1#1)
use of economic##2##3##(1991-12#2)
use of effective##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
use of either##7##3##(1996-2#1)(2008-10#1)(2008-2#3)(2008-6#1)(2009-6#1)
use of electrically##2##3##(1995-3#1)(2008-9#1)
use of electronic##6##3##(2007-12#1)(2008-1#1)(2008-11#1)(2009-10#1)(2010-8#2)
use of embryonic##2##3##(2008-11#1)(2008-9#1)
use of emerging##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
use of epidemiology##2##3##(1993-11#1)(1994-3#1)
use of existing##6##3##(1994-3#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-3#2)
use of experimental##3##3##(2008-8#1)(2010-2#1)(2010-4#1)
use of external##2##3##(2007-11#1)(2009-1#1)
use of fast##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
use of first##3##3##(1991-12#1)(2008-10#1)(2008-6#1)
use of flow cytometry in##2##5##(2008-9#2)
use of flow cytometry##5##4##(2008-9#5)
use of flow##7##3##(2007-8#1)(2008-10#1)(2008-9#5)
use of fluorescent probes##2##4##(2007-11#1)(2008-9#1)
use of fluorescent##5##3##(1995-5#1)(2007-11#2)(2008-4#1)(2008-9#1)
use of functional##4##3##(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)
use of fungicides##2##3##(2008-10#2)
use of gene##3##3##(1991-11#1)(2007-11#1)(2008-7#1)
use of genetic##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
use of genetically##4##3##(1997-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
use of geospatial data for##2##5##(2008-8#2)
use of geospatial data##4##4##(2008-8#4)
use of glycoprotein IIb/IIIa inhibitors##3##5##(2008-3#3)
use of group##2##3##(2007-2#1)(2008-11#1)
use of habitual##2##3##(2008-11#2)
use of hazardous##4##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-9#1)
use of health care resources##2##5##(1996-12#1)(2008-1#1)
use of health care services##2##5##(1993-12#1)(1993-6#1)
use of health care##6##4##(1993-12#1)(1993-6#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-11#1)
use of health##11##3##(1993-12#2)(1993-6#1)(1994-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-11#1)(2012-12#2)
use of heating##3##3##(1990-2#2)(2008-2#1)
use of high temperature##2##4##(2008-10#2)
use of high##11##3##(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)
use of high-voltage electric shocks to introduce DNA into##2##9##(2008-1#1)(2008-2#1)
use of highly active antiretroviral therapy (HAART)##2##7##(2008-3#1)(2009-5#1)
use of highly efficient##2##4##(2007-12#2)
use of highly sensitive##3##4##(2007-5#1)(2008-3#1)(2010-4#1)
use of highly##8##3##(2007-12#2)(2007-5#1)(2008-1#1)(2008-3#2)(2009-5#1)(2010-4#1)
use of holography##2##3##(2008-2#2)
use of homology##2##3##(1996-2#1)(2008-7#1)
use of host##3##3##(1991-9#1)(2008-10#2)
use of human##11##3##(1992-5#2)(1993-2#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
use of imaging##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-4#1)
use of immunomodulatory##2##3##(1991-5#1)(2008-10#1)
use of implants##5##3##(1996-3#1)(2007-11#4)
use of independent##3##3##(1993-9#1)(1994-3#1)(2008-3#1)
use of indium tin oxide##2##5##(2008-2#1)(2008-3#1)
use of information technology##3##4##(2008-10#2)(2011-1#1)
use of information##8##3##(1992-2#1)(1996-12#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
use of inhalational##2##3##(1991-6#1)(2011-2#1)
use of integrated##2##3##(2007-11#1)(2011-1#1)
use of interpreters##2##3##(2013-8#2)
use of intramedullary locking nail##3##5##(2007-11#3)
use of intraoperative##2##3##(2007-8#1)(2012-12#1)
use of intravascular##2##3##(1994-5#1)(2007-8#1)
use of intravenous##4##3##(2007-10#1)(2007-9#1)(2010-3#1)(2012-12#1)
use of intraventricular##2##3##(2007-10#1)(2008-7#1)
use of its##4##3##(1991-2#1)(2008-10#1)(2008-3#2)
use of joint##2##3##(2008-11#1)(2008-2#1)
use of known##2##3##(2007-11#2)
use of laboratory tests##3##4##(1991-2#1)(1994-12#1)(1996-9#1)
use of laboratory##6##3##(1991-2#1)(1993-2#1)(1994-12#1)(1996-9#1)(2008-10#2)
use of laparoscopic##4##3##(1993-2#1)(1993-3#1)(2008-10#1)(2011-2#1)
use of laparoscopy for##2##4##(2010-8#1)(2011-2#1)
use of laparoscopy##3##3##(2010-8#1)(2011-2#2)
use of large##2##3##(2008-12#1)(2013-1#1)
use of large-scale##2##3##(2008-7#1)(2013-1#1)
use of laryngeal mask##2##4##(2008-2#1)(2008-8#1)
use of laser##7##3##(1991-1#1)(1991-9#1)(2008-10#3)(2008-3#2)
use of lasers##2##3##(1993-12#1)(1993-3#1)
use of learning resources##2##4##(2008-11#2)
use of less##4##3##(1993-6#1)(2008-3#1)(2011-1#1)(2011-2#1)
use of levodopa##2##3##(2008-7#2)
use of light##3##3##(2007-11#1)(2008-3#2)
use of linear##3##3##(2008-3#2)(2011-1#1)
use of liposomes as analytical##2##5##(2008-10#2)
use of liquid##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2010-7#1)
use of low##3##3##(2007-11#1)(2008-11#1)(2012-3#1)
use of low-coherence##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
use of low-dose##2##3##(2007-8#1)(2008-3#1)
use of machine##3##3##(2007-11#2)(2008-7#1)
use of magnetic resonance##2##4##(2007-10#1)(2007-7#1)
use of magnetic##3##3##(2007-10#1)(2007-7#1)(2010-11#1)
use of mammography##2##3##(1990-12#1)(1991-8#1)
use of many of##2##4##(2008-12#1)(2011-2#1)
use of marijuana##3##3##(2009-7#1)(2012-1#1)(2013-8#1)
use of maternal##2##3##(1992-9#1)(2009-7#1)
use of mean##2##3##(2008-2#2)
use of medical##11##3##(1992-12#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-6#1)(2007-10#1)(2008-11#3)(2008-4#1)
use of medication##2##3##(2011-1#1)(2011-2#1)
use of medications##2##3##(2008-10#1)(2008-8#1)
use of medicines in a general population sample##2##8##(2008-11#2)
use of medicines in a##3##5##(2008-11#2)(2011-2#1)
use of medicines##10##3##(1992-2#1)(2008-11#5)(2008-8#2)(2009-3#1)(2011-2#1)
use of mefloquine##2##3##(1996-8#1)(2011-2#1)
use of membrane##2##3##(1991-5#1)(2008-10#1)
use of metformin##3##3##(2008-1#2)(2012-3#1)
use of methanol##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
use of microarray technologies##2##4##(2008-7#1)(2009-10#1)
use of microarray##3##3##(2008-7#2)(2009-10#1)
use of microarrays##2##3##(2008-10#1)(2008-7#1)
use of minimally invasive##2##4##(2007-8#1)(2007-9#1)
use of mixed##2##3##(2008-10#2)
use of mixtures##2##3##(2008-10#2)
use of mobile##2##3##(2008-12#1)(2013-8#1)
use of model##3##3##(1991-5#1)(2008-10#1)(2008-6#1)
use of modern##3##3##(1990-6#1)(2008-10#2)
use of modified##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
use of molecular markers##2##4##(1997-7#1)(2008-10#1)
use of molecular##8##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
use of monoclonal antibodies##5##4##(1993-6#1)(1995-3#1)(2008-11#2)(2009-8#1)
use of monoclonal##6##3##(1993-6#1)(1995-3#1)(1997-7#1)(2008-11#2)(2009-8#1)
use of more##9##3##(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2011-2#2)(2013-1#1)
use of multidimensional##4##3##(1995-5#1)(2008-2#1)(2010-11#1)(2012-3#1)
use of multilayer##2##3##(2008-10#1)(2008-2#1)
use of multiple##13##3##(1991-3#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#2)(2010-9#1)
use of multivariate##5##3##(2008-10#4)(2008-3#1)
use of nalbuphine##2##3##(1992-5#2)
use of nanoparticles##2##3##(2008-7#1)(2013-1#1)
use of near infrared spectroscopy##2##5##(2008-10#2)
use of near##3##3##(2008-10#3)
use of nematicides##2##3##(2008-10#2)
use of new##4##3##(1991-12#1)(1996-11#1)(2008-11#1)(2013-8#1)
use of nicotine replacement therapy##2##5##(2008-6#1)(2012-3#1)
use of non-invasive##2##3##(1990-5#1)(2013-1#1)
use of non-steroidal anti-inflammatory drugs##2##5##(2008-12#1)(2010-2#1)
use of nonlinear##3##3##(2007-11#2)(2012-2#1)
use of nonpharmacological##2##3##(2013-1#1)(2013-8#1)
use of novel##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
use of objective##3##3##(2007-11#2)(2008-11#1)
use of off-duty police##2##4##(1994-2#2)
use of one##7##3##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-12#1)
use of only the##2##4##(2008-3#2)
use of only##9##3##(2008-10#1)(2008-2#1)(2008-3#5)(2008-9#1)(2010-6#1)
use of opioids in FMS##2##5##(2011-2#2)
use of opioids in##3##4##(2011-2#3)
use of optical cavities##2##4##(2007-11#1)(2008-3#1)
use of optical coherence tomography##4##5##(2007-12#1)(2008-3#1)(2011-7#2)
use of optical methods##2##4##(2007-5#1)(2008-3#1)
use of optical##16##3##(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#6)(2011-7#2)
use of optically##2##3##(2008-3#1)(2009-10#1)
use of oral contraceptives##5##4##(1991-2#1)(1991-8#1)(1993-9#1)(2008-11#2)
use of oral##12##3##(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1993-9#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-11#2)(2008-3#1)(2010-6#1)
use of organic solvents##4##4##(2008-10#3)(2008-5#1)
use of organic##5##3##(2008-10#4)(2008-5#1)
use of other##7##3##(1992-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
use of our##4##3##(1995-12#1)(2008-10#1)(2008-3#2)
use of outcome measures##2##4##(2008-11#2)
use of paclitaxel##2##3##(1995-8#1)(2008-7#1)
use of partial##3##3##(2008-10#1)(2008-3#2)
use of partially resistant##2##4##(2008-10#2)
use of patient satisfaction##3##4##(1996-1#2)(1996-3#1)
use of patient##4##3##(1996-1#2)(1996-3#1)(2010-5#1)
use of percutaneous##2##3##(1990-8#1)(2012-12#1)
use of personal protective##2##4##(2008-12#1)(2009-12#1)
use of personal##4##3##(1994-3#1)(2008-12#1)(2009-12#1)(2009-5#1)
use of pharmacotherapy##2##3##(2008-4#1)(2013-1#1)
use of phase##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
use of photorefractive##3##3##(2007-12#1)(2008-3#2)
use of physical restraints##2##4##(2010-10#2)
use of physical##3##3##(2010-10#2)(2013-1#1)
use of physician extenders##2##4##(1991-12#1)(1996-12#1)
use of physician##4##3##(1991-12#1)(1995-12#2)(1996-12#1)
use of plain##2##3##(2007-2#1)(2008-5#1)
use of polarization##3##3##(2008-3#3)
use of polarized light##2##4##(2008-3#2)
use of polymerase chain##2##4##(1995-6#1)(2010-6#1)
use of postmenopausal##2##3##(1993-11#1)(2008-3#1)
use of prenatal care##5##4##(1992-2#2)(1993-3#2)(1995-12#1)
use of preventive services##2##4##(1994-2#2)
use of preventive##3##3##(1994-2#3)
use of professional##3##3##(1993-2#1)(1996-1#1)(2008-11#1)
use of prophylactic##8##3##(1990-6#1)(2007-12#1)(2008-3#1)(2008-7#3)(2012-1#1)(2012-3#1)
use of public##2##3##(1995-12#1)(2013-8#1)
use of pulmonary##2##3##(2007-8#1)(2010-6#1)
use of radioisotopes##6##3##(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#2)
use of radiosurgery##2##3##(1995-12#1)(2008-7#1)
use of rapid##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
use of ray##2##3##(2008-2#1)(2008-3#1)
use of readily available##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
use of recombinant##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
use of reference##2##3##(1995-1#1)(2008-10#1)
use of reflection and##2##4##(2008-11#1)(2008-3#1)
use of reflection##5##3##(2008-11#2)(2008-12#1)(2008-3#2)
use of reflective##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
use of regulations##2##3##(2008-11#2)
use of research##3##3##(2008-12#1)(2010-11#1)(2010-4#1)
use of resistant cultivars##3##4##(2008-10#3)
use of resources##9##3##(1991-2#1)(1994-3#1)(1995-12#1)(1997-5#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-1#2)
use of reverse##2##3##(2008-3#1)(2008-9#1)
use of rhBMP##2##3##(2012-12#2)
use of rhodium##2##3##(2008-10#2)
use of satellite##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
use of screening##2##3##(2008-10#1)(2008-11#1)
use of secondary##3##3##(1993-2#1)(2008-3#1)(2009-2#1)
use of selective media##2##4##(2008-10#2)
use of selective##4##3##(2008-10#3)(2008-12#1)
use of sensors##2##3##(2008-10#2)
use of sequential##2##3##(1991-9#1)(2007-5#1)
use of services##5##3##(1991-2#1)(1993-3#1)(1995-3#1)(1997-8#1)(2012-2#1)
use of several##10##3##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)
use of short-term##2##3##(2008-10#1)(2009-11#1)
use of similar##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
use of simple##9##3##(1991-9#1)(1992-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#1)
use of simulated##2##3##(2008-12#1)(2008-2#1)
use of simulation##2##3##(2008-10#1)(2008-7#1)
use of simulations##4##3##(2008-12#2)(2008-3#2)
use of skin##2##3##(2010-6#1)(2010-8#1)
use of social##6##3##(1992-2#1)(1997-3#1)(2009-12#1)(2011-1#1)(2012-2#2)
use of sodium##4##3##(1990-2#1)(1990-8#1)(1994-9#1)(2010-8#1)
use of some##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
use of spatial##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
use of special##2##3##(1991-11#1)(2007-12#1)
use of specific##5##3##(2008-10#1)(2008-4#1)(2009-11#1)(2009-9#1)(2011-1#1)
use of speech##3##3##(2011-1#2)(2012-2#1)
use of stable##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
use of standard##5##3##(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
use of statistics##2##3##(1996-3#1)(2008-3#1)
use of stem cells##2##4##(2008-11#1)(2012-12#1)
use of storytelling##4##3##(1992-3#1)(2008-11#3)
use of strategies to##2##4##(1996-9#1)(2007-12#1)
use of subcutaneous##2##3##(1997-8#1)(2012-3#1)
use of subsequent##2##3##(2008-2#1)(2012-1#1)
use of such a##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
use of such##13##3##(1992-1#1)(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2012-3#1)
use of supercritical##2##3##(2008-10#2)
use of supportive care##2##4##(2008-7#1)(2011-2#1)
use of surface##3##3##(2008-10#1)(2008-2#1)(2010-6#1)
use of synchronous##2##3##(2008-10#2)
use of synthetic##10##3##(2007-12#1)(2007-8#1)(2008-2#2)(2008-4#2)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
use of techniques of##2##4##(2007-11#1)(2007-12#1)
use of techniques##3##3##(2007-11#1)(2007-12#1)(2009-12#1)
use of technology in##3##4##(2008-10#1)(2008-12#2)
use of technology##9##3##(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-12#3)
use of telemedicine##2##3##(1996-3#1)(2013-1#1)
use of testing##2##3##(2012-2#1)(2013-1#1)
use of tests##2##3##(1990-9#1)(2008-7#1)
use of thalidomide in##2##4##(2008-5#2)
use of the CO 2##2##5##(1992-3#2)
use of the algorithm##2##4##(2008-2#1)(2008-3#1)
use of the approximation##2##4##(1996-3#1)(2009-9#1)
use of the argon##2##4##(1994-3#1)(2008-10#1)
use of the automated##4##4##(2007-7#1)(2008-10#3)
use of the available##3##4##(1991-9#1)(1997-4#1)(2008-9#1)
use of the benefit and in##2##6##(1994-2#1)(1995-3#1)
use of the cationic##2##4##(1996-5#1)(2008-10#1)
use of the conventional##3##4##(2008-12#1)(2008-3#2)
use of the couch##2##4##(2011-2#2)
use of the data##2##4##(2008-11#1)(2008-3#1)
use of the device in##2##5##(2008-11#1)(2010-6#1)
use of the estimated##2##4##(2007-10#1)(2008-10#1)
use of the experimental##2##4##(2008-3#2)
use of the fiber##2##4##(1992-1#1)(2008-3#1)
use of the internal##2##4##(2008-2#1)(2008-9#1)
use of the laser##2##4##(1991-3#1)(1993-3#1)
use of the linear##2##4##(2010-5#1)(2013-1#1)
use of the low##2##4##(2008-10#1)(2008-3#1)
use of the method##2##4##(1994-12#1)(2008-12#1)
use of the most##2##4##(2008-8#1)(2011-1#1)
use of the name##2##4##(2008-10#2)
use of the next generation of##2##6##(1996-11#1)(2008-2#1)
use of the oil##2##4##(2008-5#1)(2011-2#1)
use of the phase##2##4##(2008-2#1)(2008-3#1)
use of the prone##2##4##(1992-11#1)(1992-4#1)
use of the proposed##2##4##(2008-10#2)
use of the radial##4##4##(2007-11#1)(2007-8#2)(2011-2#1)
use of the sensor##2##4##(2008-10#1)(2010-2#1)
use of the spatial##2##4##(2007-11#2)
use of the standard##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
use of the system##6##4##(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(2008-10#2)
use of the technique##5##4##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-5#1)
use of the time##2##4##(2008-8#1)(2010-9#1)
use of the##468##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-3#2)(1991-5#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-3#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-10#6)(2007-11#24)(2007-12#26)(2007-7#2)(2007-8#11)(2008-1#2)(2008-10#75)(2008-11#16)(2008-12#7)(2008-2#35)(2008-3#94)(2008-4#11)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#4)
use of thermal##4##3##(1992-7#1)(2008-10#1)(2008-3#2)
use of these agents in##2##5##(2008-2#1)(2008-3#1)
use of these agents##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
use of these devices##2##4##(2010-9#1)(2011-2#1)
use of these drugs in the treatment of##2##8##(2007-11#2)
use of these drugs in the##3##6##(2007-11#2)(2010-6#1)
use of these drugs in##4##5##(2007-11#2)(2010-6#2)
use of these drugs##7##4##(2007-11#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#2)
use of these instruments##3##4##(1991-6#1)(2008-3#1)(2011-2#1)
use of these modified##2##4##(2008-4#1)(2008-7#1)
use of these techniques##4##4##(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
use of these##74##3##(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#1)(1994-9#1)(1995-12#2)(1996-2#1)(1997-3#2)(1997-4#1)(2007-11#4)(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2010-3#1)(2010-6#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
use of thiazolidinediones##2##3##(2008-3#1)(2010-10#1)
use of third-order##2##3##(2007-11#1)(2007-12#1)
use of this approach with##2##5##(2007-11#1)(2010-9#1)
use of this approach##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2010-9#1)
use of this device##2##4##(2008-3#1)(2008-7#1)
use of this drug in the##2##6##(1991-12#1)(2008-6#1)
use of this material##2##4##(1990-9#1)(2008-2#1)
use of this method##3##4##(2007-12#2)(2008-6#1)
use of this plant##2##4##(2008-10#1)(2008-11#1)
use of this protein##2##4##(1992-12#1)(1992-8#1)
use of this system##3##4##(1997-4#1)(2008-3#2)
use of this technique##6##4##(2007-12#1)(2008-2#2)(2008-3#2)(2011-2#1)
use of this tool##2##4##(2008-3#1)(2012-7#1)
use of this##78##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-2#6)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
use of three##4##3##(1991-12#1)(1992-9#1)(2008-10#1)(2013-1#1)
use of time-resolved##4##3##(2007-12#1)(2008-3#3)
use of total reflection##2##4##(2008-2#1)(2008-3#1)
use of total##5##3##(1995-3#1)(2008-1#1)(2008-2#1)(2008-3#2)
use of traditional##4##3##(2008-12#2)(2009-11#1)(2011-2#1)
use of transgenic##2##3##(2008-11#1)(2013-1#1)
use of treated##2##3##(1997-4#1)(2008-9#1)
use of tricyclic##2##3##(1990-11#1)(2012-2#1)
use of tumor necrosis##2##4##(2011-2#1)(2013-1#1)
use of tunable diode lasers##2##5##(2008-3#2)
use of tunable##3##3##(2008-2#1)(2008-3#2)
use of two different##3##4##(2007-11#1)(2008-3#2)
use of two wavelengths##3##4##(2008-2#1)(2008-3#2)
use of two##34##3##(1990-12#1)(1991-3#1)(1991-5#1)(1997-6#1)(2007-11#6)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#11)(2010-5#1)(2013-1#1)
use of two-photon excitation##3##4##(2007-11#3)
use of two-photon##5##3##(2007-11#5)
use of ultrasonography##3##3##(2009-8#1)(2011-2#2)
use of ultrasound##2##3##(1992-12#1)(2008-10#1)
use of urban##3##3##(1992-12#2)(1995-11#1)
use of urinary##2##3##(1991-12#1)(2010-5#1)
use of various kinds of##2##5##(2007-8#1)(2008-4#1)
use of various types of##2##5##(2008-10#1)(2012-2#1)
use of various##9##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
use of video##2##3##(2008-4#1)(2008-8#1)
use of video-assisted thoracic surgery (VATS)##2##6##(2007-8#2)
use of vitamin##6##3##(1992-9#2)(2007-7#2)(2008-1#2)
use of wood##2##3##(1992-10#1)(1997-6#1)
use of##4489##2##(1990-10#1)(1990-11#4)(1990-12#12)(1990-2#7)(1990-3#8)(1990-5#12)(1990-6#8)(1990-7#5)(1990-8#10)(1990-9#9)(1991-1#4)(1991-11#5)(1991-12#26)(1991-2#14)(1991-3#12)(1991-4#1)(1991-5#12)(1991-6#7)(1991-7#1)(1991-8#8)(1991-9#16)(1992-1#13)(1992-10#2)(1992-11#7)(1992-12#12)(1992-2#10)(1992-3#22)(1992-4#4)(1992-5#7)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#13)(1993-1#3)(1993-10#2)(1993-11#7)(1993-12#18)(1993-2#18)(1993-3#13)(1993-6#7)(1993-8#3)(1993-9#7)(1994-1#4)(1994-11#7)(1994-12#19)(1994-2#24)(1994-3#23)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#13)(1995-1#9)(1995-11#6)(1995-12#23)(1995-2#18)(1995-3#20)(1995-4#1)(1995-5#10)(1995-6#6)(1995-8#4)(1995-9#3)(1996-1#13)(1996-10#1)(1996-11#10)(1996-12#12)(1996-2#17)(1996-3#22)(1996-5#9)(1996-6#14)(1996-7#1)(1996-8#5)(1996-9#10)(1997-1#7)(1997-2#15)(1997-3#21)(1997-4#14)(1997-5#2)(1997-6#6)(1997-7#13)(1997-8#9)(2006-10#7)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#27)(2007-11#233)(2007-12#254)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#7)(2007-6#2)(2007-7#21)(2007-8#48)(2007-9#5)(2008-1#44)(2008-10#603)(2008-11#195)(2008-12#72)(2008-2#262)(2008-3#637)(2008-4#74)(2008-5#65)(2008-6#56)(2008-7#135)(2008-8#56)(2008-9#86)(2009-1#3)(2009-10#16)(2009-11#12)(2009-12#10)(2009-2#8)(2009-3#7)(2009-4#6)(2009-5#22)(2009-6#11)(2009-7#10)(2009-8#9)(2009-9#6)(2010-1#2)(2010-10#14)(2010-11#13)(2010-12#11)(2010-2#6)(2010-3#23)(2010-4#14)(2010-5#17)(2010-6#17)(2010-7#6)(2010-8#37)(2010-9#12)(2011-1#44)(2011-10#2)(2011-2#131)(2011-3#6)(2011-7#5)(2012-1#17)(2012-12#48)(2012-2#57)(2012-3#58)(2012-7#1)(2012-8#1)(2013-1#107)(2013-7#4)(2013-8#49)
use on a##4##3##(1997-1#1)(2007-11#1)(2008-3#1)(2008-4#1)
use on the##2##3##(1992-6#1)(2008-5#1)
use on##25##2##(1991-2#1)(1991-5#1)(1992-6#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
use one##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
use only##8##2##(1991-12#1)(1991-3#1)(1991-5#1)(1993-6#1)(2008-3#2)(2008-6#1)(2010-9#1)
use optical correlation##2##3##(2008-3#2)
use optical##3##2##(2008-3#3)
use or##12##2##(1996-2#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-1#2)(2012-12#1)
use other##2##2##(1996-6#1)(2007-12#1)
use over the##2##3##(2008-7#1)(2012-12#1)
use over##5##2##(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-12#1)
use patient##2##2##(1996-12#1)(2010-8#1)
use patterns to##2##3##(2011-1#1)(2012-3#1)
use patterns##8##2##(1991-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
use population##2##2##(1996-12#1)(2010-6#1)
use practices##2##2##(2008-1#1)(2008-12#1)
use prevention and##2##3##(1997-1#1)(2007-12#1)
use rates##3##2##(1994-2#2)(2010-8#1)
use reduces##2##2##(2007-10#1)(2010-5#1)
use remains##4##2##(1997-1#1)(2008-11#1)(2009-9#1)(2011-2#1)
use remote##2##2##(2008-2#1)(2008-3#1)
use research##4##2##(1997-2#1)(2008-11#1)(2008-12#1)(2009-3#1)
use services##2##2##(2010-10#1)(2012-2#1)
use several##2##2##(2008-1#1)(2008-11#1)
use should be##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
use some##6##2##(1996-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2013-1#2)
use such##7##2##(1995-9#1)(1997-4#1)(2007-10#1)(2008-3#2)(2009-9#1)(2013-1#1)
use than is##2##3##(1995-11#1)(2008-11#1)
use than##8##2##(1992-3#1)(1995-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#1)
use that##6##2##(2008-1#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-8#1)
use the Internet to##2##4##(2007-12#2)
use the current##2##3##(2008-3#1)(2008-4#1)
use the detector##2##3##(2007-11#1)(2008-10#1)
use the information##3##3##(1997-8#1)(2008-3#1)(2008-7#1)
use the measurements##2##3##(1997-3#1)(2007-12#1)
use the method##2##3##(2008-3#2)
use the new##2##3##(2008-1#1)(2008-3#1)
use the ratio##2##3##(2008-3#1)(2013-8#1)
use the relative EC50/IC50##3##4##(2012-2#3)
use the same##7##3##(1994-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#1)
use the##150##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#4)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#5)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#10)(2008-11#3)(2008-2#7)(2008-3#20)(2008-4#12)(2008-7#6)(2008-8#3)(2008-9#5)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
use their hand repetitively##3##4##(2008-9#3)
use their##13##2##(1992-2#1)(1994-12#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-9#3)(2011-1#2)(2012-2#1)
use them to##4##3##(1993-12#1)(2008-10#1)(2008-2#1)(2013-7#1)
use them##11##2##(1993-12#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-7#1)
use these data to##2##4##(1994-2#1)(2008-8#1)
use these data##3##3##(1994-2#1)(2007-4#1)(2008-8#1)
use these##17##2##(1991-1#2)(1994-2#1)(1994-8#1)(1996-12#2)(1997-2#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#2)(2009-2#1)(2010-3#1)
use this approach##3##3##(2008-2#1)(2008-4#1)(2010-3#1)
use this data##2##3##(1991-12#1)(2008-6#1)
use this method to##2##4##(2008-3#1)(2008-7#1)
use this method##4##3##(2008-10#1)(2008-3#2)(2008-7#1)
use this property to##2##4##(2007-11#1)(2008-11#1)
use this property##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
use this technique##2##3##(2008-10#1)(2008-3#1)
use this##31##2##(1991-12#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
use through##3##2##(2009-7#1)(2013-1#1)(2013-7#1)
use to analyze##2##3##(1993-3#1)(2008-1#1)
use to make decisions##2##4##(2008-1#1)(2010-8#1)
use to prevent##2##3##(2008-12#1)(2013-8#1)
use to provide##2##3##(2007-4#1)(2008-10#1)
use to treat##2##3##(2008-11#1)(2012-2#1)
use to##42##2##(1990-2#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(2006-5#1)(2007-4#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
use two##8##2##(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
use under##4##2##(1992-3#1)(1995-2#1)(2008-6#1)(2010-6#1)
use various##6##2##(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)
use was not##2##3##(2008-12#1)(2012-12#1)
use was##13##2##(1990-2#1)(1993-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#3)(2010-3#1)(2012-12#1)
use were##12##2##(1996-11#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#1)(2013-1#1)
use when##5##2##(1997-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)
use which##2##2##(1991-3#1)(2013-7#1)
use whole##2##2##(1991-12#1)(2008-11#1)
use will##4##2##(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#1)
use with an##2##3##(2008-10#1)(2008-2#1)
use with the##6##3##(1996-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2012-3#1)
use with##46##2##(1992-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#5)(2008-6#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
use within a##3##3##(2007-10#1)(2008-2#1)(2008-9#1)
use within the##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
use within##12##2##(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-7#1)(2012-2#3)
use without##4##2##(1993-2#1)(2007-11#1)(2008-11#1)(2010-11#1)
use##7262##1##(1990-10#1)(1990-11#5)(1990-12#16)(1990-2#16)(1990-3#14)(1990-5#12)(1990-6#13)(1990-7#7)(1990-8#12)(1990-9#12)(1991-1#29)(1991-11#7)(1991-12#42)(1991-2#19)(1991-3#22)(1991-4#1)(1991-5#18)(1991-6#14)(1991-7#1)(1991-8#9)(1991-9#22)(1992-1#21)(1992-10#2)(1992-11#13)(1992-12#25)(1992-2#17)(1992-3#39)(1992-4#8)(1992-5#10)(1992-6#10)(1992-7#2)(1992-8#5)(1992-9#19)(1993-1#11)(1993-10#2)(1993-11#10)(1993-12#40)(1993-2#29)(1993-3#17)(1993-5#1)(1993-6#9)(1993-8#6)(1993-9#10)(1994-1#12)(1994-11#11)(1994-12#33)(1994-2#47)(1994-3#44)(1994-5#10)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#17)(1995-1#20)(1995-11#9)(1995-12#37)(1995-2#39)(1995-3#34)(1995-4#1)(1995-5#17)(1995-6#6)(1995-8#6)(1995-9#7)(1996-1#32)(1996-10#1)(1996-11#20)(1996-12#23)(1996-2#30)(1996-3#34)(1996-4#1)(1996-5#11)(1996-6#19)(1996-7#1)(1996-8#5)(1996-9#18)(1997-1#26)(1997-2#25)(1997-3#40)(1997-4#20)(1997-5#9)(1997-6#12)(1997-7#18)(1997-8#15)(2006-10#13)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#52)(2007-11#273)(2007-12#312)(2007-2#13)(2007-3#2)(2007-4#9)(2007-5#11)(2007-6#4)(2007-7#32)(2007-8#75)(2007-9#7)(2008-1#91)(2008-10#864)(2008-11#344)(2008-12#113)(2008-2#345)(2008-3#805)(2008-4#143)(2008-5#157)(2008-6#92)(2008-7#202)(2008-8#106)(2008-9#167)(2009-1#4)(2009-10#26)(2009-11#29)(2009-12#19)(2009-2#16)(2009-3#18)(2009-4#10)(2009-5#43)(2009-6#18)(2009-7#64)(2009-8#27)(2009-9#18)(2010-1#10)(2010-10#24)(2010-11#27)(2010-12#20)(2010-2#11)(2010-3#32)(2010-4#24)(2010-5#32)(2010-6#31)(2010-7#17)(2010-8#74)(2010-9#29)(2011-1#91)(2011-10#2)(2011-2#210)(2011-3#10)(2011-7#9)(2012-1#43)(2012-12#111)(2012-2#120)(2012-3#119)(2012-7#1)(2012-8#2)(2013-1#223)(2013-7#20)(2013-8#115)
use)##9##1##(2008-10#2)(2008-4#1)(2009-9#1)(2010-1#2)(2010-9#1)(2011-1#1)(2011-2#1)
use-dependent block of##2##3##(2008-8#2)
use-dependent##4##1##(2008-5#1)(2008-8#2)(2013-1#1)
use/land##2##1##(2007-5#2)
use]##5##1##(1991-6#1)(1992-5#1)(1994-8#1)(1996-9#1)(2013-8#1)
used (5##2##2##(1996-5#1)(2010-12#1)
used 10##2##2##(2007-7#1)(2008-12#1)
used 11##2##2##(2007-8#1)(2008-10#1)
used BAC transgenic##2##3##(2008-4#1)(2013-8#1)
used Beck's##2##2##(1992-2#1)(2007-7#1)
used DNA##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
used UV##2##2##(2008-10#1)(2008-5#1)
used a combination of##6##4##(1994-9#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-10#1)
used a femtosecond##2##3##(2007-12#2)
used a modified version of the##2##6##(2008-2#1)(2009-4#1)
used a novel##4##3##(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
used a simple##2##3##(1995-12#1)(2008-3#1)
used a single##2##3##(2008-9#1)(2013-1#1)
used a visual##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
used a##157##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#6)(2008-10#17)(2008-11#11)(2008-12#3)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#11)(2013-8#2)
used across##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
used after##4##2##(1990-6#1)(1995-9#1)(2008-10#1)(2011-2#1)
used alone as a##2##4##(2008-10#1)(2008-12#1)
used alone or in combination with##2##6##(2009-5#1)(2013-1#1)
used alone or in combination##3##5##(1993-6#1)(2009-5#1)(2013-1#1)
used alone##19##2##(1990-2#1)(1991-1#1)(1993-12#1)(1993-6#1)(1995-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2009-5#1)(2009-9#1)(2011-2#2)(2013-1#1)
used along with##5##3##(1993-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2012-12#1)
used an in##2##3##(1994-6#1)(2008-7#1)
used an##26##2##(1993-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1996-5#3)(1997-2#1)(1997-5#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
used analytical##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
used and a##5##3##(1991-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
used and compared##5##3##(2008-10#3)(2008-2#1)(2013-7#1)
used and evaluated##2##3##(2008-11#1)(2010-4#1)
used and how##2##3##(2006-10#1)(2008-3#1)
used and in##3##3##(1995-6#1)(2007-11#1)(2008-10#1)
used and is##2##3##(2008-3#1)(2013-1#1)
used and the##17##3##(1990-8#1)(1991-2#1)(1994-12#1)(1997-1#1)(2008-10#10)(2008-6#1)(2008-8#1)(2009-10#1)
used and their##2##3##(2008-10#1)(2008-5#1)
used and##78##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-9#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
used animal model for##2##4##(2010-12#1)(2011-2#1)
used animal##3##2##(2008-4#1)(2010-12#1)(2011-2#1)
used antibiotic##2##2##(1991-3#1)(2008-8#1)
used antibiotics##2##2##(1996-3#1)(2008-12#1)
used approach for##2##3##(2008-10#1)(2012-2#1)
used approach##3##2##(2008-10#1)(2012-2#2)
used appropriately##4##2##(1994-12#1)(2008-3#1)(2008-8#1)(2010-11#1)
used are the##2##3##(2008-1#1)(2008-3#1)
used are##18##2##(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
used as a DNA##2##4##(1990-5#1)(1991-5#1)
used as a basis for##8##5##(1991-6#1)(1993-12#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
used as a basis##9##4##(1991-6#1)(1993-12#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
used as a biological##2##4##(2008-10#2)
used as a biomarker##2##4##(2008-10#1)(2012-2#1)
used as a candidate##2##4##(2008-12#1)(2012-3#1)
used as a carrier##3##4##(1993-11#1)(1996-12#1)(2008-10#1)
used as a chiral##2##4##(2008-10#2)
used as a component of##2##5##(2008-10#1)(2013-8#1)
used as a control##8##4##(1993-8#1)(1995-12#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-6#1)(2013-7#1)
used as a detector for##2##5##(2008-10#2)
used as a detector##4##4##(2008-10#4)
used as a diagnostic##2##4##(1997-3#1)(2008-9#1)
used as a fast##2##4##(2008-12#1)(2008-3#1)
used as a functional test##2##5##(1997-7#1)(2008-10#1)
used as a functional##4##4##(1997-7#1)(2008-10#1)(2010-4#1)(2010-6#1)
used as a general##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
used as a guide to##2##5##(2009-10#1)(2011-2#1)
used as a guide##4##4##(1996-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
used as a marker for the##2##6##(2008-7#1)(2009-2#1)
used as a marker for##4##5##(1994-2#1)(2008-11#1)(2008-7#1)(2009-2#1)
used as a marker of##2##5##(2009-12#1)(2012-2#1)
used as a marker##6##4##(1994-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
used as a matrix##2##4##(2008-11#1)(2008-7#1)
used as a measure of the##3##6##(2008-10#1)(2008-2#1)(2008-8#1)
used as a measure of##6##5##(1990-2#1)(1991-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
used as a method##3##4##(2007-11#1)(2008-10#1)(2013-8#1)
used as a model for##4##5##(1992-5#1)(1997-2#1)(2008-9#1)(2011-1#1)
used as a model of##2##5##(1991-5#1)(2010-1#1)
used as a model system for##2##6##(1994-9#1)(2008-10#1)
used as a model system to##2##6##(2008-10#1)(2008-7#1)
used as a model system##5##5##(1994-9#1)(2008-10#2)(2008-7#1)(2008-9#1)
used as a model to##3##5##(1990-7#1)(1993-12#1)(1993-9#1)
used as a model##21##4##(1990-7#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#1)
used as a new##10##4##(2008-10#4)(2008-2#1)(2008-5#3)(2008-9#1)(2011-2#1)
used as a non-invasive##2##4##(2008-7#1)(2009-8#1)
used as a nonlinear##2##4##(2007-12#1)(2008-3#1)
used as a novel##4##4##(2008-10#3)(2008-9#1)
used as a parameter of##2##5##(1991-10#1)(1991-2#1)
used as a positive##3##4##(1992-12#1)(1996-12#1)(2008-3#1)
used as a probe to##5##5##(1991-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-1#1)
used as a probe##11##4##(1991-2#2)(1991-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
used as a pump##3##4##(2007-11#1)(2007-12#2)
used as a reagent for##2##5##(2008-10#1)(2008-9#1)
used as a reference source in##2##6##(2008-2#2)
used as a reference##13##4##(1993-8#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#2)(2012-2#1)(2013-1#1)
used as a reporter gene##2##5##(1991-5#1)(1994-2#1)
used as a reporter##3##4##(1991-5#1)(1994-2#1)(1997-8#1)
used as a screening system to##2##6##(1991-12#1)(2008-10#1)
used as a single##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
used as a solid support##2##5##(2008-10#2)
used as a solid##4##4##(2008-10#4)
used as a source of##4##5##(1993-8#1)(2008-10#2)(2008-4#1)
used as a source##5##4##(1993-8#1)(2008-10#2)(2008-3#1)(2008-4#1)
used as a specific##2##4##(1991-12#1)(1992-9#1)
used as a standard##4##4##(2008-3#1)(2008-6#1)(2009-11#1)(2013-1#1)
used as a substrate##3##4##(1993-6#1)(2008-10#2)
used as a target for##2##5##(1997-7#1)(2008-8#1)
used as a target##3##4##(1997-7#1)(2008-10#1)(2008-8#1)
used as a template for##2##5##(2008-11#1)(2008-7#1)
used as a template##3##4##(1993-12#1)(2008-11#1)(2008-7#1)
used as a tool to##3##5##(2008-7#1)(2010-6#2)
used as a tool##5##4##(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#2)
used as a tunable##2##4##(2007-11#1)(2008-3#1)
used as a weaning##2##4##(1997-4#2)
used as a working electrode in##3##6##(2008-10#3)
used as a working electrode##5##5##(2008-10#5)
used as a working##6##4##(1992-11#1)(2008-10#5)
used as a##381##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-6#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#3)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#6)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#111)(2008-11#16)(2008-12#8)(2008-2#16)(2008-3#19)(2008-4#6)(2008-5#11)(2008-6#5)(2008-7#13)(2008-8#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-6#3)(2010-8#4)(2011-1#4)(2011-2#9)(2011-3#1)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#9)(2013-7#2)(2013-8#4)
used as additional##2##3##(2008-10#1)(2008-6#1)
used as additives##4##3##(2008-10#3)(2012-2#1)
used as adjuvant therapy##2##4##(2008-7#1)(2011-2#1)
used as alternative##2##3##(2008-10#1)(2012-2#1)
used as an &quot##2##4##(1992-2#1)(2009-5#1)
used as an activator##2##4##(2008-10#1)(2008-5#1)
used as an active##2##4##(1992-3#1)(2008-10#1)
used as an additional##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
used as an adjunct to##3##5##(2010-3#1)(2012-2#1)(2013-1#1)
used as an adjunct##4##4##(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
used as an adjuvant in##2##5##(1990-2#1)(2007-7#1)
used as an aid##3##4##(1991-11#1)(2008-10#1)(2010-4#1)
used as an alternative method to##2##6##(2008-10#2)
used as an alternative method##3##5##(2007-5#1)(2008-10#2)
used as an alternative##8##4##(1992-5#1)(2007-5#1)(2008-10#6)
used as an amperometric sensor for##2##6##(2008-10#2)
used as an amperometric##4##4##(2008-10#4)
used as an analytical##2##4##(2008-10#1)(2008-9#1)
used as an antigen to##2##5##(1993-3#1)(2008-10#1)
used as an antigen##4##4##(1993-3#1)(2008-10#2)(2010-6#1)
used as an enzymatic##2##4##(2008-10#2)
used as an example##5##4##(1992-11#1)(1994-2#1)(2007-11#1)(2008-1#1)(2008-11#1)
used as an excellent##2##4##(2008-10#2)
used as an experimental model to##2##6##(2008-10#1)(2008-8#1)
used as an index##2##4##(2008-11#2)
used as an indicator electrode in potentiometric titration of##6##9##(2008-10#6)
used as an indicator electrode in the potentiometric titration of##3##10##(2008-10#3)
used as an indicator electrode in the potentiometric##4##8##(2008-10#4)
used as an indicator electrode in##10##6##(2008-10#10)
used as an indicator electrode##11##5##(2008-10#11)
used as an indicator for##2##5##(2008-11#1)(2008-7#1)
used as an indicator of the##4##6##(2008-10#3)(2012-12#1)
used as an indicator of##8##5##(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-12#1)
used as an indicator##22##4##(2007-10#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
used as an indirect##2##4##(1997-1#1)(2008-11#1)
used as an internal##11##4##(1993-3#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-2#1)
used as an optical##2##4##(2008-2#1)(2008-3#1)
used as an##136##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#3)(1993-9#1)(1994-2#2)(1994-6#1)(1996-12#1)(1996-8#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#61)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#2)
used as analytical##2##3##(2008-10#2)
used as antigens##2##3##(1990-5#1)(2012-12#1)
used as biological##2##3##(2008-11#1)(2010-8#1)
used as carrier##2##3##(2008-10#2)
used as chemical modifier##5##4##(2008-10#5)
used as chemical##8##3##(2008-10#8)
used as chiral##3##3##(1995-6#1)(1996-5#1)(2008-10#1)
used as coating##2##3##(2008-2#1)(2011-1#1)
used as complementary##2##3##(1990-12#1)(2008-9#1)
used as components of##2##4##(1994-9#1)(2008-10#1)
used as components##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
used as control##6##3##(1993-11#1)(1994-6#1)(2008-12#1)(2008-5#1)(2009-8#1)(2013-7#1)
used as criteria to##2##4##(2008-10#1)(2013-1#1)
used as criteria##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
used as discriminating factors##2##4##(2010-5#2)
used as drugs in##2##4##(2007-11#1)(2013-8#1)
used as drugs##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
used as endpoints##2##3##(1992-9#1)(2007-11#1)
used as excitation##2##3##(2008-10#2)
used as experimental##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
used as external##2##3##(2008-10#1)(2013-8#1)
used as first-line##3##3##(1993-2#1)(1997-3#1)(2013-8#1)
used as fluorescent##2##3##(2008-10#1)(2010-3#1)
used as fuel##2##3##(2008-10#1)(2009-8#1)
used as independent variables##2##4##(2008-3#1)(2008-8#1)
used as independent##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
used as indicator##2##3##(2008-10#2)
used as indicators of##4##4##(1992-3#1)(2008-8#1)(2010-11#1)(2010-4#1)
used as indices##2##3##(1992-3#1)(2008-10#1)
used as inoculum##2##3##(2008-10#2)
used as input for##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
used as input##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
used as internal standard##7##4##(2008-10#7)
used as internal standards##3##4##(2008-10#3)
used as internal##12##3##(2008-10#11)(2008-8#1)
used as ionophores##2##3##(2008-10#2)
used as matrix modifiers##3##4##(2008-10#3)
used as mobile phase##2##4##(2008-10#2)
used as model##6##3##(1990-12#1)(1997-6#1)(2008-10#4)
used as monotherapy##2##3##(2010-5#1)(2012-12#1)
used as novel##2##3##(2008-10#1)(2010-2#1)
used as one of the##3##5##(2008-10#1)(2008-2#1)(2008-9#1)
used as outgroups in##2##4##(1995-11#2)
used as outgroups##3##3##(1995-11#2)(2008-10#1)
used as part of a##3##5##(2008-3#1)(2010-5#1)(2010-6#1)
used as part of##5##4##(2008-10#1)(2008-3#1)(2010-5#1)(2010-6#1)(2012-12#1)
used as primary##5##3##(1990-11#1)(2008-1#1)(2010-1#1)(2010-8#1)(2012-3#1)
used as reference##10##3##(2008-1#1)(2008-10#5)(2008-11#1)(2010-10#1)(2012-3#1)(2013-1#1)
used as screening##3##3##(2008-10#2)(2011-3#1)
used as selective##3##3##(2008-10#2)(2008-12#1)
used as sensing##2##3##(2008-10#2)
used as solid phase##3##4##(1992-9#1)(2008-10#2)
used as sorbent##3##3##(2008-10#3)
used as sources of##2##4##(1993-12#1)(2008-4#1)
used as stabilizer##2##3##(1994-8#1)(2013-8#1)
used as standard##3##3##(2008-10#2)(2010-3#1)
used as standards##3##3##(2008-10#3)
used as starting##3##3##(2008-10#1)(2008-11#2)
used as substrates##8##3##(1991-5#1)(1992-8#1)(1994-5#2)(1994-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
used as supporting##2##3##(2008-10#2)
used as template##4##3##(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
used as templates##2##3##(2008-10#1)(2009-11#1)
used as test##4##3##(1995-8#1)(2008-10#2)(2008-11#1)
used as the analytical##3##4##(2008-10#3)
used as the basic##2##4##(2007-12#1)(2008-2#1)
used as the basis for a##2##6##(2008-10#1)(2008-2#1)
used as the basis for##10##5##(1992-6#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-3#1)(2013-8#1)
used as the basis of a##2##6##(1994-3#1)(2011-1#1)
used as the basis##12##4##(1992-6#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
used as the detector##3##4##(2008-10#3)
used as the light source and the##2##7##(2008-10#2)
used as the light source##5##5##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
used as the mobile phase##6##5##(1990-8#2)(2008-10#2)(2011-1#2)
used as the model##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
used as the only##2##4##(1992-4#1)(2007-11#1)
used as the probe##2##4##(2007-11#1)(2008-2#1)
used as the reference##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
used as the response variable##2##5##(2008-10#2)
used as the sample##2##4##(1992-11#1)(2008-10#1)
used as the solvent##2##4##(2008-10#1)(2008-2#1)
used as the source##2##4##(2008-10#2)
used as the standard##2##4##(2008-10#1)(2011-1#1)
used as the stationary phase##3##5##(2008-10#1)(2011-1#2)
used as the working electrode##2##5##(2008-10#2)
used as the##149##3##(1990-12#1)(1990-8#4)(1991-12#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#66)(2008-11#4)(2008-2#15)(2008-3#9)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#7)(2011-2#1)(2012-9#1)(2013-8#2)
used as therapeutic agents##3##4##(1990-9#1)(1992-12#1)(2010-5#1)
used as therapeutics##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
used as tracer##2##3##(1991-12#1)(2008-10#1)
used as well as##2##4##(1991-6#1)(2011-1#1)
used as well##3##3##(1991-6#1)(2008-3#1)(2011-1#1)
used as##1130##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#7)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-4#2)(1991-5#5)(1991-6#3)(1991-9#2)(1992-11#5)(1992-12#6)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#6)(1993-6#1)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#4)(1997-6#4)(1997-7#3)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#15)(2007-12#20)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#9)(2008-10#415)(2008-11#45)(2008-12#19)(2008-2#46)(2008-3#47)(2008-4#12)(2008-5#30)(2008-6#19)(2008-7#27)(2008-8#21)(2008-9#18)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#3)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#6)(2010-4#7)(2010-5#12)(2010-6#6)(2010-7#2)(2010-8#8)(2011-1#15)(2011-2#20)(2011-3#4)(2012-12#8)(2012-2#16)(2012-3#9)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#20)(2013-7#3)(2013-8#13)
used at a##2##3##(2008-10#2)
used at all##2##3##(2008-10#1)(2008-3#1)
used at least##2##3##(2008-10#2)
used at the##6##3##(1991-2#1)(1993-3#1)(2008-10#1)(2009-10#1)(2013-1#2)
used at##30##2##(1991-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-2#1)(2013-1#2)
used because it##2##3##(1997-2#1)(2008-10#1)
used because of its##2##4##(2008-5#1)(2013-1#1)
used because of##4##3##(1997-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
used because##9##2##(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
used before##3##2##(2007-4#1)(2008-10#1)(2008-7#1)
used behavioral##2##2##(2008-4#1)(2010-6#1)
used both for##2##3##(2008-4#1)(2009-8#1)
used both##9##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#2)(2013-7#1)
used but##2##2##(1990-12#1)(1995-11#1)
used by Medicare and##3##4##(1993-3#1)(1997-3#2)
used by a number of##2##5##(1995-2#1)(2008-1#1)
used by a##4##3##(1995-2#1)(2008-1#1)(2008-7#1)(2012-12#1)
used by all##2##3##(2010-3#1)(2013-8#1)
used by an##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
used by both##2##3##(1995-12#1)(2008-12#1)
used by clinicians to##2##4##(1991-1#1)(2013-1#1)
used by clinicians##3##3##(1991-1#1)(2008-4#1)(2013-1#1)
used by general practitioners##2##4##(1997-4#2)
used by health care organizations##2##5##(1994-2#1)(2008-11#1)
used by health##3##3##(1994-2#1)(2008-11#1)(2008-8#1)
used by individuals##2##3##(2007-7#1)(2008-12#1)
used by many##3##3##(2008-11#2)(2012-2#1)
used by medical##3##3##(2008-10#1)(2009-6#2)
used by most##2##3##(1997-9#1)(2011-2#1)
used by nurses##3##3##(2010-10#1)(2013-1#2)
used by one##2##3##(1992-2#1)(2008-11#1)
used by people##2##3##(2008-10#1)(2012-3#1)
used by the elderly##2##4##(1993-3#2)
used by the##31##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-3#2)(1995-1#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-7#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
used by them##2##3##(1990-9#1)(2008-3#1)
used by these##3##3##(1995-12#1)(2008-7#1)(2013-1#1)
used by this##3##3##(1990-12#1)(2010-8#1)(2011-2#1)
used by##175##2##(1990-11#1)(1990-12#4)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-10#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#3)(1997-9#1)(2006-10#1)(2007-10#2)(2007-12#4)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#5)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#4)
used can##2##2##(2008-10#1)(2008-3#1)
used classifications##3##2##(2007-11#1)(2007-8#2)
used clinically to##2##3##(2008-8#1)(2010-7#1)
used clinically##5##2##(2008-5#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-2#1)
used commercially##5##2##(1992-11#1)(2008-10#3)(2008-12#1)
used compared##2##2##(1996-5#1)(2012-2#1)
used computer##2##2##(1993-2#1)(2009-10#1)
used computers##3##2##(2013-8#3)
used condoms##2##2##(2012-12#1)(2013-1#1)
used consisted of##2##3##(2008-3#1)(2008-8#1)
used conventional pesticide##2##3##(2008-10#2)
used conventional##3##2##(2007-7#1)(2008-10#2)
used correctly##3##2##(1991-9#1)(1995-12#1)(2013-8#1)
used could##2##2##(1996-2#1)(2013-7#1)
used crop##2##2##(2008-12#2)
used data from the##3##4##(1995-12#1)(1996-3#1)(2009-7#1)
used data from##6##3##(1995-12#1)(1996-3#1)(2008-11#1)(2008-8#1)(2009-7#1)(2013-1#1)
used data##9##2##(1995-12#1)(1996-3#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
used detection technique##2##3##(2008-10#2)
used detection##3##2##(2008-10#2)(2008-9#1)
used direct##2##2##(2008-5#1)(2008-9#1)
used directly to##2##3##(2008-10#1)(2008-3#1)
used directly##7##2##(1995-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
used doses##2##2##(1996-3#1)(2012-2#1)
used drugs in##2##3##(1994-6#1)(2006-10#1)
used drugs##9##2##(1994-12#1)(1994-6#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
used during the##3##3##(1994-1#1)(2007-8#1)(2008-10#1)
used during##21##2##(1993-12#1)(1994-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#1)
used early##2##2##(2008-9#1)(2011-2#1)
used easily##2##2##(1991-2#1)(2008-3#1)
used effectively##6##2##(2008-2#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
used either##5##2##(1994-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)
used emotion-focused coping##2##3##(2011-2#2)
used evaluation##2##2##(1996-7#1)(2013-7#1)
used experimental##2##2##(2008-11#1)(2012-12#1)
used experimentally##2##2##(2007-8#1)(2008-3#1)
used expression##2##2##(2008-7#1)(2011-1#1)
used extensively for##3##3##(1994-3#1)(2008-6#1)(2008-8#1)
used extensively in the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
used extensively in##9##3##(1995-12#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)
used extensively to##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
used extensively##18##2##(1992-3#1)(1994-3#1)(1995-12#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-9#1)
used extraction##2##2##(2008-10#2)
used fewer##2##2##(1991-12#1)(1995-3#1)
used flow cytometry##2##3##(2006-6#1)(2008-9#1)
used fluorophores##2##2##(1995-5#1)(2008-9#1)
used focus##2##2##(1994-12#1)(2011-2#1)
used for DNA##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
used for MRI##2##3##(2008-6#1)(2013-1#1)
used for MT##2##3##(2008-10#2)
used for RAPD##2##3##(2008-10#1)(2008-5#1)
used for a long time##3##5##(2008-1#1)(2008-10#1)(2008-5#1)
used for a period of##4##5##(2008-10#4)
used for a##30##3##(1990-2#1)(1991-7#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#10)(2008-3#3)(2008-5#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#1)
used for ab initio##2##4##(2006-4#1)(2008-7#1)
used for absorbance##2##3##(2008-10#1)(2008-3#1)
used for all##4##3##(1990-8#1)(1996-1#1)(2008-10#1)(2008-3#1)
used for analysing##3##3##(1994-3#1)(2011-2#1)(2012-12#1)
used for analysis of##5##4##(2008-10#4)(2010-1#1)
used for analysis##9##3##(2007-12#1)(2008-10#5)(2010-1#1)(2010-6#1)(2012-12#1)
used for analytical##3##3##(2008-10#1)(2008-2#1)(2010-3#1)
used for animal##2##3##(2008-10#1)(2010-1#1)
used for assessment of##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
used for assessment##4##3##(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
used for at least##15##4##(2008-10#15)
used for biological##2##3##(2008-10#1)(2008-7#1)
used for both the##2##4##(2008-2#1)(2008-3#1)
used for both##21##3##(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)(2010-8#1)
used for building##2##3##(2008-10#2)
used for calculating##3##3##(2007-12#1)(2007-7#1)(2008-2#1)
used for calibration##7##3##(2008-10#6)(2008-9#1)
used for carrying out##2##4##(2008-10#1)(2008-9#1)
used for cell##4##3##(1994-5#2)(2008-11#1)(2011-2#1)
used for challenge##3##3##(1997-6#1)(2008-10#2)
used for characterization of##2##4##(1992-8#1)(2008-10#1)
used for characterizing##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
used for chest wall reconstruction##2##5##(2012-2#2)
used for clinical##5##3##(2008-7#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-8#1)
used for collecting##2##3##(2011-2#1)(2013-1#1)
used for column##2##3##(2008-10#2)
used for comparison##10##3##(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-4#1)(2010-8#2)
used for constructing##5##3##(1993-9#1)(2008-10#3)(2009-10#1)
used for creating##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
used for data collection##4##4##(1993-2#1)(2008-8#1)(2009-11#1)(2013-8#1)
used for data##10##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
used for designing a##2##4##(2008-4#1)(2012-12#1)
used for designing and##2##4##(2008-2#1)(2008-3#1)
used for designing##5##3##(2008-2#1)(2008-3#2)(2008-4#1)(2012-12#1)
used for detecting##2##3##(2008-10#1)(2008-9#1)
used for detection of##3##4##(2008-10#1)(2008-12#1)(2008-2#1)
used for detection##7##3##(2008-10#4)(2008-12#1)(2008-2#1)(2011-1#1)
used for determination of the##2##5##(2008-3#2)
used for determination of##22##4##(2008-10#19)(2008-3#2)(2008-7#1)
used for determining DNA##2##4##(1995-2#1)(2008-10#1)
used for determining the##8##4##(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)
used for determining##15##3##(1995-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)
used for diagnosis and treatment##2##5##(1990-3#1)(2011-2#1)
used for diagnosis and##4##4##(1990-3#1)(1991-6#1)(2007-8#1)(2011-2#1)
used for diagnosis##8##3##(1990-3#1)(1991-6#1)(1992-6#1)(1997-2#1)(2007-8#1)(2010-8#1)(2011-2#2)
used for diagnostic##3##3##(1990-10#1)(1996-12#1)(2011-2#1)
used for digestion##2##3##(1994-12#1)(1997-3#1)
used for direct determination of##2##5##(2008-10#2)
used for direct##6##3##(2008-10#4)(2008-4#1)(2010-8#1)
used for drug##4##3##(2008-10#1)(2010-11#2)(2010-5#1)
used for each##5##3##(1990-5#1)(2008-10#3)(2008-8#1)
used for effective##2##3##(2008-10#1)(2008-3#1)
used for efficient##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
used for elution##2##3##(2008-10#1)(2008-4#1)
used for enhancing##2##3##(2008-10#2)
used for enrichment##2##3##(2008-10#2)
used for estimating##2##3##(2008-10#1)(2009-9#1)
used for estimation of##2##4##(2008-3#1)(2013-1#1)
used for evaluating##3##3##(2008-10#2)(2011-2#1)
used for evaluation of##5##4##(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
used for evaluation##12##3##(1996-9#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-9#1)(2011-2#2)
used for examining##2##3##(2008-10#1)(2008-11#1)
used for extraction##3##3##(2008-10#3)
used for fabrication of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
used for fixation##3##3##(2008-10#2)(2009-3#1)
used for further##3##3##(2008-10#2)(2008-9#1)
used for genetic studies##2##4##(2008-10#1)(2008-12#1)
used for genetic##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
used for hemodialysis##3##3##(2007-7#3)
used for identification of##3##4##(2008-1#1)(2008-10#1)(2008-12#1)
used for identification##5##3##(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)
used for image##6##3##(2008-10#1)(2008-3#2)(2008-4#1)(2010-4#1)(2011-1#1)
used for imaging##4##3##(2007-11#1)(2007-12#2)(2009-7#1)
used for in vitro##6##4##(2008-11#1)(2008-4#1)(2008-5#3)(2010-5#1)
used for in##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2010-5#1)
used for initial##2##3##(2010-3#1)(2011-2#1)
used for investigation of the##2##5##(1990-5#1)(2008-10#1)
used for investigation of##3##4##(1990-5#1)(2008-10#1)(2008-2#1)
used for isolation of##2##4##(2008-9#1)(2011-2#1)
used for its determination##4##4##(1997-2#2)(2008-10#2)
used for its##7##3##(1997-2#2)(2008-10#2)(2011-1#1)(2011-2#2)
used for mammalian##2##3##(2008-11#1)(2008-9#1)
used for many##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-8#1)
used for material ablation##2##4##(2008-2#2)
used for measurement of##2##4##(2008-3#1)(2013-8#1)
used for measurement##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
used for measuring the##7##4##(1996-6#1)(2008-10#1)(2008-3#3)(2008-8#1)(2013-1#1)
used for measuring##13##3##(1990-11#1)(1992-1#1)(1996-6#1)(2008-10#2)(2008-3#5)(2008-8#1)(2011-2#1)(2013-1#1)
used for medical purposes##2##4##(1996-9#1)(2013-8#1)
used for metal##2##3##(2008-10#1)(2008-8#1)
used for microbial##2##3##(2008-11#2)
used for modeling the##2##4##(2008-10#1)(2013-1#1)
used for modeling##3##3##(2008-10#1)(2013-1#2)
used for molecular##2##3##(1990-11#1)(2008-7#1)
used for monitoring##5##3##(2008-10#4)(2013-1#1)
used for more than 100##2##5##(2008-10#1)(2008-7#1)
used for more than##12##4##(2008-10#10)(2008-7#1)(2011-2#1)
used for more##14##3##(1997-2#1)(2008-10#11)(2008-7#1)(2011-2#1)
used for numerical##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
used for off-line##2##3##(2008-10#1)(2009-6#1)
used for on-line##2##3##(2008-10#2)
used for optical##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
used for other##3##3##(1996-3#1)(2008-2#1)(2009-8#1)
used for patients##4##3##(1992-3#1)(1995-3#1)(2007-8#1)(2009-7#1)
used for personal##2##3##(1992-3#1)(2008-8#1)
used for preconcentration of##4##4##(2008-10#4)
used for preparation of##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
used for preparation##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
used for prevention of##2##4##(2007-8#1)(2012-3#1)
used for prevention##4##3##(1996-11#1)(1997-2#1)(2007-8#1)(2012-3#1)
used for propagating##2##3##(2008-3#1)(2008-4#1)
used for providing##2##3##(1997-3#1)(2012-12#1)
used for quantification and##2##4##(2008-11#1)(2008-7#1)
used for quantification of##3##4##(2008-10#3)
used for quantification##7##3##(2008-10#5)(2008-11#1)(2008-7#1)
used for quantitative analysis##4##4##(2008-10#3)(2008-5#1)
used for quantitative measurement##2##4##(2008-10#1)(2008-3#1)
used for quantitative##8##3##(2008-10#6)(2008-3#1)(2008-5#1)
used for rapid##7##3##(2008-10#3)(2008-4#1)(2008-5#2)(2010-6#1)
used for real-time monitoring of##2##5##(2008-10#1)(2010-5#1)
used for recording##2##3##(2008-12#1)(2008-3#1)
used for relaxation purposes##2##4##(2007-6#2)
used for reliable##3##3##(1993-12#1)(1993-2#1)(2008-10#1)
used for root##2##3##(2008-11#1)(2013-1#1)
used for routine##4##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-12#1)
used for sample##3##3##(2008-10#3)
used for sampling##3##3##(2007-6#1)(2008-10#1)(2008-2#1)
used for screening##4##3##(2007-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
used for selecting##3##3##(1992-2#1)(2008-10#1)(2008-9#1)
used for selection of##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
used for selection##5##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
used for sensing##2##3##(2008-10#1)(2008-3#1)
used for sensitive and selective##2##5##(2008-10#1)(2009-3#1)
used for sensitive##4##3##(2008-10#2)(2008-3#1)(2009-3#1)
used for sensor##3##3##(2007-11#1)(2008-10#2)
used for several##3##3##(2008-4#1)(2010-10#1)(2013-8#1)
used for simultaneous determination##2##4##(2008-10#2)
used for simultaneous##6##3##(2007-12#1)(2008-10#3)(2008-9#1)(2011-3#1)
used for spatial##2##3##(1993-3#1)(2008-10#1)
used for statistical analysis##3##4##(1994-9#1)(1996-12#1)(2012-3#1)
used for statistical##6##3##(1994-9#1)(1996-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-3#1)
used for studying##7##3##(1994-11#1)(1996-2#1)(2008-10#4)(2008-8#1)
used for such##3##3##(2008-2#1)(2008-8#1)(2012-2#1)
used for surface##2##3##(2008-10#2)
used for synthesis of##2##4##(2008-4#2)
used for testing the##2##4##(2013-1#1)(2013-8#1)
used for testing##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
used for the amplification of##2##5##(1993-2#1)(2008-10#1)
used for the analysis of##5##5##(2008-10#3)(2008-2#1)(2008-4#1)
used for the analysis##7##4##(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)
used for the assay of##6##5##(2008-10#6)
used for the assay##8##4##(1993-9#1)(1996-12#1)(2008-10#6)
used for the assessment of##3##5##(2008-10#2)(2008-8#1)
used for the biological##2##4##(2007-10#1)(2008-10#1)
used for the calculation of##2##5##(2008-10#1)(2008-2#1)
used for the calculations##2##4##(2008-10#2)
used for the characterization of##3##5##(1996-5#1)(2008-3#1)(2010-12#1)
used for the construction of##3##5##(2008-10#2)(2008-7#1)
used for the control of##4##5##(1997-6#1)(2008-10#3)
used for the design of##4##5##(2007-12#1)(2008-11#1)(2009-3#1)(2011-2#1)
used for the detection of##10##5##(2008-10#8)(2008-3#1)(2012-3#1)
used for the determination of Cu(II)##2##6##(2008-10#2)
used for the determination of Se##2##6##(2008-10#2)
used for the determination of the##7##6##(1996-5#1)(2008-10#5)(2008-5#1)
used for the determination of these##2##6##(2008-10#2)
used for the determination of trace##6##6##(2008-10#6)
used for the determination of##75##5##(1990-2#1)(1991-5#1)(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#67)(2008-5#1)(2008-7#1)(2013-1#1)
used for the determination##76##4##(1990-2#1)(1991-5#1)(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#68)(2008-5#1)(2008-7#1)(2013-1#1)
used for the development of##6##5##(2008-10#3)(2008-3#1)(2008-9#1)(2013-1#1)
used for the diagnosis and##2##5##(2008-4#1)(2010-12#1)
used for the diagnosis##3##4##(1997-8#1)(2008-4#1)(2010-12#1)
used for the estimation of the##2##6##(2008-10#1)(2013-1#1)
used for the estimation of##4##5##(2008-10#2)(2008-4#1)(2013-1#1)
used for the evaluation of the##4##6##(1997-3#1)(2008-10#1)(2012-1#1)(2012-2#1)
used for the evaluation of##10##5##(1990-11#1)(1996-5#1)(1997-3#1)(2008-10#4)(2010-3#1)(2012-1#1)(2012-2#1)
used for the experiments##2##4##(2008-2#1)(2008-5#1)
used for the extraction of##3##5##(2008-10#3)
used for the extraction##4##4##(2008-10#4)
used for the fabrication of a##2##6##(2008-10#1)(2008-3#1)
used for the fabrication of##4##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
used for the final##2##4##(2008-10#1)(2008-3#1)
used for the first time to study##2##7##(2008-10#2)
used for the first time to##4##6##(2008-10#3)(2013-8#1)
used for the first time##6##5##(2008-10#4)(2008-2#1)(2013-8#1)
used for the formulation of##2##5##(2008-10#1)(2010-5#1)
used for the identification of##4##5##(2008-10#3)(2008-9#1)
used for the identification##6##4##(2008-10#4)(2008-9#1)(2013-1#1)
used for the investigation of the##2##6##(2008-10#1)(2010-12#1)
used for the investigation of##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
used for the isolation of##2##5##(2008-11#1)(2011-1#1)
used for the measurement of##2##5##(2008-10#1)(2008-2#1)
used for the measurements##2##4##(2008-3#2)
used for the optimization of##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
used for the preconcentration and separation of##2##7##(2008-10#2)
used for the preconcentration and##3##5##(2008-10#3)
used for the preconcentration of##3##5##(2008-10#3)
used for the preconcentration##6##4##(2008-10#6)
used for the preparation of##3##5##(2008-3#1)(2008-8#1)(2012-3#1)
used for the production of recombinant proteins##3##7##(2008-11#3)
used for the production of##9##5##(2008-11#5)(2008-6#2)(2008-8#1)(2012-2#1)
used for the purification##2##4##(2008-10#2)
used for the purpose##2##4##(1993-11#1)(2008-8#1)
used for the quantification of##3##5##(1990-12#1)(2008-10#2)
used for the quantitative determination of##4##6##(2008-10#4)
used for the quantitative##6##4##(2008-10#5)(2008-3#1)
used for the rapid##3##4##(2007-7#1)(2008-10#1)(2010-9#1)
used for the same purpose##2##5##(2007-7#1)(2008-10#1)
used for the same##4##4##(2007-7#2)(2008-10#2)
used for the selective##4##4##(2008-10#4)
used for the sensitive determination of##2##6##(2008-10#2)
used for the separation and##3##5##(2008-10#2)(2008-2#1)
used for the separation of##3##5##(2008-10#2)(2008-11#1)
used for the separation##8##4##(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)
used for the simultaneous determination of the##2##7##(2008-10#2)
used for the simultaneous determination of##5##6##(2008-10#5)
used for the simultaneous##8##4##(2008-1#1)(2008-10#7)
used for the spectrophotometric determination of##2##6##(2008-10#2)
used for the study of##3##5##(2008-10#3)
used for the study##4##4##(2008-10#3)(2011-2#1)
used for the synthesis of##4##5##(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)
used for the treatment of breast##2##6##(1992-9#1)(1993-1#1)
used for the treatment of##10##5##(1992-9#1)(1993-1#1)(1994-11#1)(2007-11#1)(2007-8#3)(2008-7#1)(2011-2#1)(2013-8#1)
used for the vanadium##2##4##(2008-10#2)
used for the##404##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-3#1)(1996-12#2)(1996-5#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#235)(2008-11#17)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#5)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
used for their separation and##2##5##(2008-10#2)
used for their##6##3##(2007-8#1)(2008-10#3)(2008-12#1)(2008-9#1)
used for these studies##2##4##(1991-12#1)(2008-10#1)
used for these##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
used for this purpose##14##4##(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2012-2#1)
used for this##28##3##(1990-5#1)(1993-3#1)(1995-5#1)(1996-12#1)(2007-11#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2012-2#1)(2012-3#1)
used for traditional##2##3##(1997-2#1)(2009-5#1)
used for training##4##3##(2008-10#1)(2008-11#1)(2010-8#2)
used for transformation##2##3##(2008-10#1)(2008-11#1)
used for treating##6##3##(1992-3#1)(2008-10#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
used for treatment of##10##4##(1992-1#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)
used for treatment##12##3##(1992-1#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-8#1)
used for viral##2##3##(2008-8#1)(2011-3#1)
used for wave-front##2##3##(2008-3#2)
used for##1505##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#6)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#2)(1996-5#7)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#9)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#2)(2006-4#1)(2007-10#5)(2007-11#28)(2007-12#36)(2007-2#1)(2007-6#4)(2007-7#13)(2007-8#17)(2008-1#16)(2008-10#583)(2008-11#58)(2008-12#18)(2008-2#55)(2008-3#105)(2008-4#41)(2008-5#29)(2008-6#13)(2008-7#31)(2008-8#25)(2008-9#31)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#7)(2010-12#6)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#11)(2010-6#5)(2010-7#2)(2010-8#16)(2010-9#1)(2011-1#17)(2011-2#40)(2011-3#2)(2012-1#3)(2012-12#13)(2012-2#13)(2012-3#12)(2013-1#33)(2013-7#1)(2013-8#16)
used four##5##2##(2008-10#2)(2010-6#1)(2013-1#1)(2013-8#1)
used from a##2##3##(2009-12#1)(2009-7#1)
used from##5##2##(2008-10#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-6#1)
used functional magnetic resonance imaging (fMRI)##2##6##(2008-11#1)(2010-2#1)
used functional magnetic##3##3##(2008-11#2)(2010-2#1)
used gave##2##2##(1993-9#1)(2008-10#1)
used had##3##2##(2008-10#1)(2009-7#1)(2012-3#1)
used has been##2##3##(2008-2#1)(2008-3#1)
used has##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
used have##2##2##(2008-10#1)(2011-2#1)
used herbs##2##2##(2006-12#1)(2008-10#1)
used here are##2##3##(2008-10#1)(2010-2#1)
used here to##4##3##(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
used here was##2##3##(1993-1#1)(2012-3#1)
used here##21##2##(1990-2#1)(1993-1#1)(1994-8#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
used immunocytochemistry##2##2##(1995-11#1)(2008-7#1)
used implant##2##2##(2011-2#2)
used implants##2##2##(2011-2#2)
used in 7##2##3##(2008-7#1)(2012-2#1)
used in Ayurvedic##2##3##(2008-10#1)(2010-5#1)
used in India##2##3##(2007-7#1)(2011-1#1)
used in Japan##4##3##(2008-10#2)(2008-11#1)(2010-6#1)
used in New Zealand##2##4##(2011-1#1)(2013-8#1)
used in PVC pipe production##2##5##(2008-10#2)
used in a model for##2##5##(1996-3#1)(2008-7#1)
used in a model##3##4##(1996-3#1)(2008-3#1)(2008-7#1)
used in a multiplex##2##4##(2008-10#2)
used in a new##3##4##(2008-10#2)(2008-2#1)
used in a simple##2##4##(1996-11#1)(2008-10#1)
used in a standard##2##4##(1996-12#1)(2007-12#1)
used in a variety of##5##5##(1996-1#1)(1997-3#1)(2008-2#1)(2010-1#1)(2010-4#1)
used in a##77##3##(1993-6#1)(1994-5#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-11#3)(2007-12#3)(2008-10#29)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
used in addition to##2##4##(2007-7#1)(2008-2#1)
used in advanced##2##3##(2007-10#1)(2008-7#1)
used in agriculture##2##3##(1995-11#1)(2009-3#1)
used in all##12##3##(2007-7#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#2)(2011-7#1)
used in an attempt to##2##5##(1994-5#1)(2011-1#1)
used in an##13##3##(1994-5#1)(1996-9#1)(2007-10#1)(2008-10#6)(2008-3#3)(2011-1#1)
used in analysis##2##3##(1997-1#1)(2013-1#1)
used in apple breeding programs##2##5##(2008-10#2)
used in association##3##3##(2008-10#2)(2013-8#1)
used in biological##2##3##(1995-12#1)(2008-9#1)
used in both##7##3##(1992-12#1)(1993-1#1)(1995-6#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
used in cases##2##3##(1990-11#1)(2008-2#1)
used in clinical practice##7##4##(2007-11#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)
used in clinical##15##3##(1992-3#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)
used in combination to##2##4##(2007-11#1)(2010-11#1)
used in combination with a##5##5##(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)
used in combination with##24##4##(1992-1#1)(1993-3#1)(1996-12#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
used in combination##33##3##(1992-1#1)(1993-12#2)(1993-3#1)(1994-11#2)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#2)(2008-8#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
used in conducting##2##3##(2010-3#1)(2013-8#1)
used in conjunction with a##6##5##(1992-9#1)(2008-10#2)(2008-3#2)(2012-1#1)
used in conjunction with an##3##5##(1996-2#1)(2008-3#1)(2008-4#1)
used in conjunction with other##2##5##(2008-8#1)(2010-12#1)
used in conjunction with the##4##5##(2008-10#2)(2008-3#1)(2008-4#1)
used in conjunction with##38##4##(1991-11#1)(1992-9#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#4)(2009-12#1)(2010-12#1)(2012-1#1)
used in connection with##3##4##(2008-10#3)
used in conventional##2##3##(2008-10#1)(2008-3#1)
used in cosmetics##3##3##(2008-5#3)
used in current##2##3##(2008-2#1)(2011-2#1)
used in dentistry##2##3##(2009-12#1)(2009-8#1)
used in designing##2##3##(2008-3#2)
used in determination of nickel and##2##6##(2008-10#2)
used in determination of##3##4##(2008-10#3)
used in developing and##2##4##(1997-3#1)(1997-7#1)
used in developing##5##3##(1994-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-5#1)
used in diabetes##2##3##(2010-7#2)
used in different studies##2##4##(2012-2#2)
used in different##7##3##(2007-8#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#2)
used in differential##2##3##(2008-2#1)(2012-3#1)
used in digital##2##3##(2008-2#1)(2008-9#1)
used in diverse##2##3##(1992-11#1)(2008-9#1)
used in each##6##3##(1994-3#1)(2008-10#4)(2008-2#1)
used in estimating the##2##4##(2008-2#1)(2012-2#1)
used in everyday##2##3##(1997-3#2)
used in fermentation##3##3##(2008-6#2)(2008-8#1)
used in flow##3##3##(2008-10#1)(2008-9#2)
used in food##5##3##(1994-3#1)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
used in general##2##3##(2007-8#1)(2008-9#1)
used in health care##2##4##(1996-12#1)(2008-11#1)
used in health##3##3##(1996-12#1)(2008-11#1)(2011-1#1)
used in hemodialysis##2##3##(2007-7#1)(2008-10#1)
used in high##3##3##(2008-12#1)(2012-12#1)(2013-7#1)
used in immunoassays##2##3##(2008-10#1)(2008-5#1)
used in in##2##3##(2008-3#1)(2008-4#1)
used in industrial##2##3##(2008-1#1)(2008-6#1)
used in industry##3##3##(1994-12#1)(2008-11#1)(2008-9#1)
used in integrated##2##3##(2008-3#2)
used in isolation##5##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)
used in its##3##3##(1991-4#1)(2008-12#1)(2008-5#1)
used in many##7##3##(1997-4#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-7#1)
used in mate##2##3##(2008-8#1)(2008-9#1)
used in measuring##3##3##(1997-1#1)(2008-10#1)(2008-7#1)
used in modern##2##3##(1996-2#1)(2008-3#1)
used in molecular##2##3##(2008-2#1)(2012-3#1)
used in most##3##3##(2007-8#1)(2010-3#1)(2012-3#1)
used in nuclear##2##3##(2008-7#1)(2008-9#1)
used in one##2##3##(2012-12#1)(2013-8#1)
used in optical##8##3##(2008-10#1)(2008-2#4)(2008-3#2)(2010-12#1)
used in order to##23##4##(1991-6#1)(1994-6#2)(1995-1#1)(2007-10#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)
used in other industries##2##4##(1995-12#2)
used in other##5##3##(1992-8#1)(1995-12#2)(2007-12#1)(2010-8#1)
used in our hospital##2##4##(1992-5#1)(2010-6#1)
used in our##9##3##(1992-5#1)(1995-1#1)(2007-11#1)(2008-3#3)(2008-7#1)(2010-6#1)(2013-8#1)
used in part to##2##4##(1992-1#1)(2009-11#1)
used in patients with##4##4##(1993-2#1)(1996-11#1)(2007-11#2)
used in patients##5##3##(1993-2#1)(1996-11#1)(2007-11#2)(2008-11#1)
used in pictorial works of art prior to conservation or restoration##2##11##(2008-10#2)
used in pictorial works of art##3##6##(2008-10#3)
used in place of the##2##5##(2008-10#1)(2012-2#1)
used in practice##2##3##(1994-9#1)(2013-8#1)
used in prevention of##2##4##(2011-3#1)(2012-3#1)
used in previous studies##2##4##(1994-12#1)(2012-2#1)
used in previous##3##3##(1994-12#1)(2008-9#1)(2012-2#1)
used in primary##3##3##(1996-9#1)(2012-12#1)(2013-8#1)
used in programs##2##3##(1996-12#1)(2008-11#1)
used in protein##2##3##(1997-6#1)(2008-4#1)
used in public health##2##4##(1995-6#1)(2012-12#1)
used in research##2##3##(1997-3#1)(2010-8#1)
used in rice##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
used in scientific##2##3##(2007-11#1)(2008-5#1)
used in several##4##3##(2008-7#2)(2011-2#1)(2013-1#1)
used in skin##2##3##(2009-6#1)(2012-3#1)
used in solid##2##3##(2008-10#1)(2008-7#1)
used in some##3##3##(2008-10#1)(2011-2#2)
used in studies of the##2##5##(2007-11#1)(2008-4#1)
used in studies of##7##4##(1993-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2012-2#1)
used in such##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
used in survey##2##3##(1994-2#1)(2008-10#1)
used in the United States##2##5##(2011-2#1)(2012-3#1)
used in the analysis of##5##5##(1990-2#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
used in the analysis##12##4##(1990-2#1)(1992-3#1)(1994-2#2)(1995-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2012-6#1)
used in the assay##2##4##(2008-10#1)(2008-4#1)
used in the calibration of##2##5##(2008-3#2)
used in the calibration##6##4##(2008-10#4)(2008-3#2)
used in the case of##2##5##(2009-4#1)(2013-8#1)
used in the clinic##2##4##(1992-3#1)(2008-7#1)
used in the clinical practice##2##5##(2010-3#1)(2013-1#1)
used in the community##2##4##(2008-11#1)(2009-3#1)
used in the construction of##3##5##(1995-2#1)(1997-4#1)(2007-11#1)
used in the context of##2##5##(2009-6#1)(2010-11#1)
used in the data analysis##2##5##(1990-3#1)(2008-10#1)
used in the design of##4##5##(2008-3#3)(2010-12#1)
used in the design##5##4##(2008-3#4)(2010-12#1)
used in the determination of##7##5##(2008-10#7)
used in the development of##2##5##(2008-10#2)
used in the diagnosis and##2##5##(2007-8#1)(2012-2#1)
used in the diagnosis of##5##5##(1994-2#1)(1995-12#1)(1997-8#1)(2007-7#1)(2011-2#1)
used in the diagnosis##7##4##(1994-2#1)(1995-12#1)(1997-8#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)
used in the evaluation of##2##5##(1990-5#1)(2010-10#1)
used in the experiment##3##4##(2007-11#1)(2008-5#1)(2008-6#1)
used in the experiments##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
used in the fabrication##2##4##(2008-10#1)(2008-2#1)
used in the field of##5##5##(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
used in the field##6##4##(1995-12#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
used in the hidden##6##4##(2008-10#4)(2010-8#2)
used in the identification of##3##5##(1995-11#1)(2011-2#1)(2012-2#1)
used in the identification##4##4##(1995-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
used in the management of##4##5##(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
used in the manufacture of##3##5##(1996-9#1)(2007-12#1)(2008-11#1)
used in the measurement##3##4##(2008-2#1)(2008-3#1)(2012-3#1)
used in the model##3##4##(2008-10#2)(2008-2#1)
used in the optimization##2##4##(2008-10#1)(2008-3#1)
used in the past##5##4##(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-3#1)
used in the potentiometric titration of Cu(2+) with EDTA##2##9##(2008-10#2)
used in the potentiometric titration of##4##6##(2008-10#4)
used in the preparation of##3##5##(2008-10#2)(2008-12#1)
used in the present##3##4##(2008-10#2)(2013-8#1)
used in the production of##3##5##(2008-5#1)(2008-9#2)
used in the recording##4##4##(2007-12#1)(2008-1#1)(2008-3#2)
used in the same sample treatment)##2##6##(2008-10#2)
used in the same##4##4##(2008-1#1)(2008-10#2)(2009-12#1)
used in the separation##2##4##(2008-10#2)
used in the statistical##2##4##(1990-8#1)(2011-2#1)
used in the study of##5##5##(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#2)
used in the study##16##4##(1990-6#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2013-1#1)
used in the synthesis of##2##5##(1990-8#1)(2007-11#1)
used in the traditional medicine in##2##6##(2008-10#2)
used in the traditional##3##4##(2008-10#3)
used in the treatment of Parkinson's disease##4##7##(1992-3#1)(1995-12#1)(1996-3#1)(2008-10#1)
used in the treatment of##29##5##(1990-3#2)(1992-3#1)(1992-6#1)(1994-5#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
used in the##359##3##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#4)(1992-6#3)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#4)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#100)(2008-11#12)(2008-12#3)(2008-2#10)(2008-3#31)(2008-4#7)(2008-5#10)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#6)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#9)(2011-2#14)(2012-12#2)(2012-2#4)(2012-3#8)(2012-6#2)(2013-1#8)(2013-8#4)
used in therapy##2##3##(1994-12#1)(2011-2#1)
used in these experiments##3##4##(2008-10#2)(2008-3#1)
used in these studies##4##4##(1992-11#1)(1992-5#1)(2008-11#1)(2008-9#1)
used in these##16##3##(1992-11#1)(1992-5#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
used in this experiment##2##4##(2008-10#1)(2008-2#1)
used in this field##4##4##(2008-10#2)(2010-11#1)(2012-12#1)
used in this investigation##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
used in this manual##4##4##(2008-4#1)(2008-9#3)
used in this method##3##4##(2008-10#2)(2008-4#1)
used in this research##3##4##(2008-3#1)(2009-7#1)(2010-4#1)
used in this study is##2##5##(2008-5#1)(2009-12#1)
used in this study was##2##5##(2008-12#1)(2010-9#1)
used in this study were##3##5##(1990-10#1)(1995-11#1)(1997-8#1)
used in this study##47##4##(1990-10#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-8#2)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#2)
used in this work##6##4##(2008-10#6)
used in this##82##3##(1990-10#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-8#2)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#2)
used in traditional Chinese medicine##2##5##(1992-2#1)(2008-10#1)
used in traditional##3##3##(1992-2#1)(2008-10#1)(2013-1#1)
used in transmission##2##3##(2008-2#1)(2008-3#1)
used in treatment of##3##4##(2007-11#1)(2011-2#1)(2012-3#1)
used in treatment##5##3##(2007-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
used in various##4##3##(2008-3#1)(2008-5#1)(2008-9#2)
used in vitro##2##3##(1990-12#1)(2011-3#1)
used in vivo##4##3##(1995-2#1)(2008-6#1)(2012-2#2)
used in which##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
used in##1364##2##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#5)(1990-5#1)(1990-6#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#1)(1992-1#3)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-5#4)(1992-6#6)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#8)(1994-2#6)(1994-3#4)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#5)(1995-12#10)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#8)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#6)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#5)(1997-1#6)(1997-2#3)(1997-3#8)(1997-4#6)(1997-6#1)(1997-7#2)(1997-8#3)(1997-9#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-10#10)(2007-11#23)(2007-12#21)(2007-2#1)(2007-6#1)(2007-7#11)(2007-8#13)(2008-1#11)(2008-10#314)(2008-11#45)(2008-12#20)(2008-2#52)(2008-3#104)(2008-4#33)(2008-5#38)(2008-6#20)(2008-7#39)(2008-8#29)(2008-9#38)(2009-10#3)(2009-11#2)(2009-12#7)(2009-2#2)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#7)(2009-8#4)(2010-1#4)(2010-10#3)(2010-11#12)(2010-12#8)(2010-2#1)(2010-3#9)(2010-4#6)(2010-5#5)(2010-6#5)(2010-7#6)(2010-8#18)(2010-9#2)(2011-1#12)(2011-2#41)(2011-3#3)(2011-7#1)(2012-1#5)(2012-12#10)(2012-2#33)(2012-3#24)(2012-6#2)(2013-1#27)(2013-7#7)(2013-8#17)
used include##2##2##(1997-1#1)(2011-2#1)
used included##3##2##(1996-8#1)(2008-12#2)
used increasingly in##2##3##(2006-10#1)(2008-10#1)
used increasingly##6##2##(1992-3#1)(1992-5#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#1)
used individually or##2##3##(1996-1#1)(2008-10#1)
used individually##4##2##(1996-1#1)(2008-10#2)(2008-8#1)
used instead of a##2##4##(2008-3#2)
used instead of the##3##4##(1990-11#1)(2008-3#1)(2011-2#1)
used instead of##16##3##(1990-11#1)(1995-12#1)(2007-11#2)(2008-10#2)(2008-3#4)(2008-4#2)(2008-7#1)(2011-2#3)
used instead##18##2##(1990-11#1)(1995-12#1)(2007-11#2)(2008-10#4)(2008-3#4)(2008-4#2)(2008-7#1)(2011-2#3)
used is a##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
used is the##3##3##(1994-3#1)(2007-11#1)(2008-3#1)
used is##19##2##(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#6)(2008-7#1)
used it to##6##3##(1991-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
used it##9##2##(1991-12#1)(1993-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
used laser##2##2##(2008-2#1)(2008-9#1)
used low##2##2##(2007-7#1)(2008-10#1)
used lubricating oil##2##3##(2008-10#2)
used lubricating oils by##3##4##(2008-10#3)
used lubricating oils##5##3##(2008-10#5)
used lubricating##7##2##(2008-10#7)
used mainly##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
used many##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
used may##2##2##(2008-1#1)(2008-3#1)
used measures of##2##3##(2008-10#1)(2010-11#1)
used measures##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
used medicines classified##2##3##(2008-11#2)
used method##5##2##(1995-2#1)(2008-4#2)(2008-9#1)(2013-8#1)
used methods and##3##3##(1997-8#1)(2008-10#2)
used methods for##3##3##(1992-6#1)(2008-1#1)(2008-3#1)
used methods of##3##3##(2008-10#1)(2008-2#1)(2010-11#1)
used methods that##2##3##(2008-10#1)(2008-2#1)
used methods to##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
used methods##18##2##(1992-6#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
used misoprostol##2##2##(2008-11#2)
used modality##2##2##(2012-12#1)(2012-3#1)
used models##2##2##(1993-12#1)(2008-8#1)
used molecular##3##2##(1992-9#1)(2008-10#2)
used more frequently##3##3##(2008-4#1)(2009-6#1)(2010-6#1)
used more often##3##3##(2007-8#1)(2008-11#1)(2009-12#1)
used more##15##2##(1994-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-6#2)(2011-2#1)(2012-12#1)
used most often##2##3##(1994-11#1)(1996-1#1)
used most##3##2##(1994-11#1)(1995-3#1)(1996-1#1)
used multiple##2##2##(2008-10#1)(2010-11#1)
used new##2##2##(2008-10#1)(2011-2#1)
used no##3##2##(1992-2#1)(2013-1#2)
used not only as##2##4##(2008-10#1)(2008-2#1)
used not only for##2##4##(2011-1#1)(2011-2#1)
used not only to##4##4##(1991-5#1)(1995-1#1)(2008-10#1)(2008-4#1)
used not only##9##3##(1990-5#1)(1991-5#1)(1995-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
used nuclear##2##2##(1993-11#1)(2008-7#1)
used on a##8##3##(1994-12#1)(1997-3#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-12#1)(2013-7#1)
used on each##2##3##(1996-12#1)(2013-1#1)
used on the##5##3##(1992-12#1)(1994-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
used on##33##2##(1990-3#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-5#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
used once##2##2##(2008-11#1)(2008-5#1)
used one##4##2##(2008-10#2)(2010-1#1)(2011-2#1)
used only as##2##3##(1994-12#1)(2008-5#1)
used only in##2##3##(1993-2#1)(2007-11#1)
used only##11##2##(1992-12#1)(1993-2#1)(1994-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#2)
used or##7##2##(2006-10#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-12#2)
used organic##2##2##(2008-10#1)(2008-5#1)
used our##2##2##(2007-8#1)(2011-2#1)
used over a period of 4 months with good reproducibility##2##10##(2008-10#2)
used over a period of##4##5##(2008-10#4)
used over a##8##3##(2007-11#1)(2008-10#6)(2008-3#1)
used over##10##2##(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)
used pesticides##2##2##(2008-10#2)
used preoperatively##2##2##(1990-5#1)(1992-6#1)
used previously for##2##3##(2007-12#1)(2008-10#1)
used previously##7##2##(1992-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2011-3#1)
used primarily for##2##3##(2008-10#1)(2008-3#1)
used primarily to##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
used primarily##9##2##(1991-6#1)(1994-2#1)(1995-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2013-1#1)
used prior to##6##3##(1992-2#1)(2007-8#1)(2008-10#3)(2010-8#1)
used productively##2##2##(1994-2#1)(1996-6#1)
used protocols##2##2##(2008-4#1)(2008-9#1)
used psilocybin##2##2##(2013-8#2)
used qualitative methods to##2##4##(2008-6#1)(2012-3#1)
used qualitative##6##2##(2008-4#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
used quality##3##2##(1994-3#1)(1996-3#2)
used quantitative##3##2##(1995-11#1)(2008-12#1)(2012-3#1)
used repeatedly for the##2##4##(2008-10#1)(2008-6#1)
used repeatedly for##3##3##(2008-10#2)(2008-6#1)
used reverse transcription##2##3##(1994-6#1)(2010-5#1)
used reverse##3##2##(1994-11#1)(1994-6#1)(2010-5#1)
used rockwool##6##2##(2008-10#6)
used rodent##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
used routinely##4##2##(1995-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
used safely and##2##3##(2007-8#1)(2010-6#1)
used safely##4##2##(1995-8#1)(2007-8#1)(2010-6#1)(2012-12#1)
used several##3##2##(1995-6#1)(1997-8#1)(2009-9#1)
used significantly##2##2##(2008-10#1)(2008-7#1)
used similar##2##2##(1990-10#1)(2008-5#1)
used simple##2##2##(2008-9#1)(2010-4#1)
used simulation##2##2##(2008-2#1)(2008-9#1)
used since##7##2##(1995-2#1)(2007-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
used site-directed mutagenesis##2##3##(1991-5#1)(1995-5#1)
used so that##2##3##(2008-10#1)(2008-4#1)
used so##4##2##(2007-11#1)(2008-10#2)(2008-4#1)
used solely##3##2##(2008-9#1)(2011-2#1)(2011-3#1)
used solid##2##2##(2008-10#2)
used spectral##2##2##(2007-11#1)(2008-3#1)
used statistical##2##2##(2007-11#1)(2008-4#1)
used stereological morphometric methods to investigate##2##6##(2007-12#2)
used successfully for the##5##4##(1997-2#1)(2008-10#3)(2008-7#1)
used successfully for##10##3##(1997-2#1)(2008-10#5)(2008-2#2)(2008-7#1)(2009-3#1)
used successfully in the##6##4##(2008-10#3)(2008-4#1)(2009-10#1)(2009-4#1)
used successfully in##10##3##(2008-10#5)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-11#1)
used successfully to##9##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
used successfully##32##2##(1992-12#1)(1997-2#1)(2007-12#1)(2008-10#11)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-8#1)(2012-2#1)
used technique for##4##3##(2008-3#2)(2010-5#1)(2013-1#1)
used technique##6##2##(1996-8#1)(2008-3#2)(2010-5#1)(2012-12#1)(2013-1#1)
used techniques##6##2##(1990-12#1)(2008-10#1)(2008-4#3)(2013-1#1)
used test##3##2##(2008-5#2)(2012-12#1)
used tests to##2##3##(2008-10#1)(2008-8#1)
used the comet assay##2##4##(1997-4#2)
used the in##2##3##(1994-8#1)(1996-2#1)
used the model system##2##4##(2008-11#1)(2008-9#1)
used the model##3##3##(2008-11#1)(2008-9#1)(2010-6#1)
used the same##8##3##(1994-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)
used the system##3##3##(1996-5#1)(2007-8#1)(2008-2#1)
used the##117##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-2#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#3)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#5)
used their##3##2##(2010-8#1)(2010-9#1)(2013-8#1)
used them##4##2##(1991-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
used these data to##2##4##(1995-3#1)(2008-8#1)
used these results to##3##4##(1990-7#1)(1994-3#1)(2008-3#1)
used these##7##2##(1990-7#1)(1994-3#1)(1995-3#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-8#1)
used this information to##2##4##(2007-12#1)(2008-3#1)
used this method##3##3##(1997-3#1)(2007-8#1)(2008-3#1)
used this technique to##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
used this technique##5##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
used this##30##2##(1990-12#1)(1991-12#1)(1991-5#1)(1997-3#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-12#1)(2009-2#1)(2012-2#4)(2013-1#1)
used three##4##2##(1992-12#1)(1995-1#1)(2008-10#1)(2013-8#1)
used throughout the##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
used throughout##10##2##(1996-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)
used to ablate##2##3##(1991-2#1)(2013-1#1)
used to account for##3##4##(1990-8#1)(2008-3#1)(2012-2#1)
used to achieve a##2##4##(1997-2#1)(2008-3#1)
used to achieve high##2##4##(2008-10#1)(2008-3#1)
used to achieve the##4##4##(2008-11#1)(2010-3#1)(2013-8#2)
used to achieve##19##3##(1995-3#1)(1997-2#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-3#3)(2009-3#1)(2010-3#1)(2012-3#1)(2013-8#2)
used to adapt##2##3##(2008-2#1)(2008-5#1)
used to address##6##3##(1994-2#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
used to adjust for##2##4##(2008-2#1)(2008-3#1)
used to adjust##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
used to aid##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
used to allow the##2##4##(2008-10#1)(2008-3#1)
used to allow##4##3##(2007-10#1)(2008-10#1)(2008-3#2)
used to ameliorate the##2##4##(2008-5#1)(2010-7#1)
used to amplify a##4##4##(1992-8#1)(1993-8#1)(2008-10#2)
used to amplify the##8##4##(1991-7#1)(1996-5#1)(2008-10#3)(2008-8#1)(2009-4#1)(2012-12#1)
used to amplify##19##3##(1991-7#1)(1992-6#1)(1992-8#1)(1993-8#1)(1996-5#1)(2007-6#1)(2008-10#8)(2008-4#1)(2008-8#2)(2009-4#1)(2012-12#1)
used to analyse the##4##4##(1993-2#1)(1997-4#1)(2008-12#1)(2010-11#1)
used to analyse##11##3##(1993-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-11#1)(2010-3#1)(2010-5#1)
used to analyze 24##2##4##(2008-10#2)
used to analyze the data##2##5##(2008-10#1)(2011-2#1)
used to analyze the##26##4##(1992-1#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#4)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
used to analyze this##2##4##(2007-11#1)(2009-10#1)
used to analyze##58##3##(1990-11#1)(1992-1#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
used to apply##2##3##(2007-8#1)(2008-10#1)
used to ascertain##2##3##(2008-10#2)
used to assay##5##3##(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)
used to assess a##3##4##(2008-10#1)(2008-11#1)(2009-10#1)
used to assess differences in##2##5##(2008-10#1)(2013-1#1)
used to assess its##2##4##(2008-11#2)
used to assess the ability of##2##6##(1991-12#1)(2008-11#1)
used to assess the effect of##3##6##(2008-10#1)(2008-3#1)(2011-2#1)
used to assess the impact of##3##6##(1992-2#1)(2008-10#1)(2008-11#1)
used to assess the##41##4##(1991-12#1)(1992-2#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
used to assess whether the##2##5##(2008-10#1)(2013-1#1)
used to assess##95##3##(1990-7#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#7)(2008-3#3)(2008-4#2)(2008-5#9)(2008-7#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#1)
used to assign the##2##4##(1996-2#2)
used to assign##5##3##(1996-2#2)(1996-5#1)(2008-10#1)(2010-4#1)
used to assist in##2##4##(1996-2#1)(2008-10#1)
used to attenuate##2##3##(2008-9#1)(2013-1#1)
used to be considered##2##4##(2008-4#1)(2011-2#1)
used to be##6##3##(1996-11#1)(1996-3#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
used to better##3##3##(1994-2#1)(2009-7#1)(2013-1#1)
used to bind##2##3##(1992-6#1)(2008-10#1)
used to both##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
used to build##4##3##(2008-10#3)(2010-5#1)
used to calculate the forces and##2##6##(2008-2#1)(2008-3#1)
used to calculate the##41##4##(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#2)(2008-7#1)(2010-7#1)(2011-1#1)
used to calculate transition##2##4##(2008-2#1)(2008-3#1)
used to calculate##64##3##(1992-5#1)(1993-11#1)(1994-12#1)(1995-5#1)(1995-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#16)(2008-5#2)(2008-7#1)(2009-8#2)(2010-7#1)(2011-1#1)(2013-8#1)
used to calibrate the##3##4##(2008-3#3)
used to calibrate##8##3##(2008-10#1)(2008-3#5)(2008-9#1)(2012-2#1)
used to capture##2##3##(2008-10#1)(2008-3#1)
used to carry out the##2##5##(2008-10#2)
used to carry out##4##4##(2008-10#2)(2008-4#1)(2012-2#1)
used to carry##5##3##(2008-10#3)(2008-4#1)(2012-2#1)
used to change the##2##4##(2008-3#1)(2010-5#1)
used to characterise the##3##4##(2008-10#2)(2010-4#1)
used to characterise##5##3##(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
used to characterize and##2##4##(2008-3#1)(2012-3#1)
used to characterize the expression##2##5##(1993-8#1)(2008-1#1)
used to characterize the##27##4##(1993-11#1)(1993-8#1)(1994-5#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
used to characterize ultrashort##2##4##(2007-11#1)(2007-12#1)
used to characterize##54##3##(1991-9#2)(1992-12#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(2007-11#2)(2007-12#4)(2008-1#3)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
used to check the##5##4##(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
used to check##7##3##(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)
used to classify subjects##2##4##(1994-2#1)(2012-12#1)
used to classify##7##3##(1993-12#1)(1994-2#1)(1995-2#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-12#1)
used to clean##3##3##(2008-10#2)(2012-3#1)
used to cleave##2##3##(2008-11#1)(2008-8#1)
used to close##2##3##(1992-3#1)(2012-8#1)
used to collect data##8##4##(1992-2#1)(2007-2#1)(2008-11#2)(2010-10#1)(2012-12#1)(2012-3#2)
used to collect the##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
used to collect##23##3##(1992-2#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-8#1)
used to compare the performance of##2##6##(2008-2#1)(2008-6#1)
used to compare the##23##4##(1990-7#1)(1991-5#1)(1993-12#1)(1995-5#2)(1996-7#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#2)
used to compare two##2##4##(2008-4#1)(2012-1#1)
used to compare##37##3##(1990-7#1)(1991-5#1)(1993-12#1)(1994-5#1)(1995-5#2)(1996-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-6#2)(2010-9#2)(2011-1#2)(2012-1#2)
used to compensate##4##3##(2008-3#3)(2013-8#1)
used to complete##2##3##(2008-10#1)(2008-8#1)
used to compute the##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
used to compute##19##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-3#1)
used to concentrate and##2##4##(2008-10#1)(2008-2#1)
used to concentrate##6##3##(2008-10#5)(2008-2#1)
used to confirm QTL associations detected in the##2##8##(2008-10#2)
used to confirm the diagnosis##2##5##(2008-7#1)(2012-2#1)
used to confirm the presence of##2##6##(2008-10#1)(2011-2#1)
used to confirm the##6##4##(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
used to confirm##13##3##(1997-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
used to construct a simple##2##5##(2008-10#1)(2008-2#1)
used to construct a##16##4##(1990-7#1)(1992-3#1)(1992-6#1)(1996-6#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
used to construct an##3##4##(1997-2#1)(2007-11#1)(2008-2#1)
used to construct the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
used to construct##33##3##(1990-7#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)
used to control for the##2##5##(2008-9#1)(2012-2#1)
used to control the##7##4##(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)
used to control##22##3##(1994-12#1)(1996-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
used to convert##5##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
used to correct for##3##4##(2007-11#1)(2008-3#2)
used to correct the##3##4##(2008-3#2)(2009-10#1)
used to correct##10##3##(2007-11#1)(2008-3#5)(2008-9#1)(2009-10#1)(2009-7#1)(2012-2#1)
used to create a##4##4##(1996-4#1)(2008-2#1)(2009-11#1)(2011-2#1)
used to create the##3##4##(2008-10#1)(2009-7#1)(2012-2#1)
used to create##23##3##(1990-8#1)(1991-9#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-7#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
used to cultivate##2##3##(2008-11#1)(2008-12#1)
used to decide##2##3##(2008-10#1)(2009-9#1)
used to deduce the##2##4##(2008-2#1)(2008-8#1)
used to deduce##4##3##(1997-6#1)(2008-2#1)(2008-7#1)(2008-8#1)
used to define the##8##4##(1994-2#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)
used to define##16##3##(1990-11#1)(1994-2#1)(1996-1#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)
used to delineate##2##3##(1997-7#1)(2008-2#1)
used to deliver##6##3##(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#1)
used to demonstrate that##5##4##(1991-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
used to demonstrate the feasibility of##3##6##(2008-10#2)(2008-11#1)
used to demonstrate the##14##4##(1994-11#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)
used to demonstrate##24##3##(1990-11#1)(1991-2#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
used to derive a##4##4##(1992-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
used to derive the##6##4##(2008-11#1)(2008-2#2)(2008-3#3)
used to derive##22##3##(1992-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#6)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)
used to describe a##2##4##(1990-9#1)(2008-9#1)
used to describe and##2##4##(2008-10#1)(2010-3#1)
used to describe the distribution##2##5##(1996-5#1)(2011-2#1)
used to describe the##18##4##(1994-2#1)(1996-5#1)(1997-2#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-12#1)(2011-2#1)
used to describe this##2##4##(2007-11#1)(2008-11#1)
used to describe##37##3##(1990-11#1)(1990-9#1)(1991-2#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-9#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
used to design and##2##4##(1993-12#1)(2007-11#1)
used to design primers for##2##5##(2008-10#1)(2008-11#1)
used to design primers##3##4##(2008-10#2)(2008-11#1)
used to design the##3##4##(1996-1#1)(2008-10#1)(2008-3#1)
used to design##19##3##(1993-12#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-5#1)
used to detect DNA##2##4##(2008-4#2)
used to detect P##2##4##(2008-10#2)
used to detect a##2##4##(2007-11#1)(2008-9#1)
used to detect and##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
used to detect genes##2##4##(2008-4#1)(2013-8#1)
used to detect microbial##2##4##(2008-11#2)
used to detect the##20##4##(1995-3#1)(1996-5#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-8#1)
used to detect two##2##4##(2008-4#1)(2008-9#1)
used to detect##92##3##(1990-12#1)(1990-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#1)(2008-7#2)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
used to determination of##2##4##(2008-10#2)
used to determine a##3##4##(1993-12#1)(2007-11#1)(2008-3#1)
used to determine absolute##2##4##(2007-12#1)(2010-11#1)
used to determine antibody##2##4##(2007-2#1)(2008-10#1)
used to determine both metals in##2##6##(2008-10#2)
used to determine both##3##4##(2008-10#2)(2008-3#1)
used to determine concentrations of##2##5##(2008-10#1)(2013-1#1)
used to determine how##3##4##(2007-12#1)(2009-11#2)
used to determine levels of##2##5##(1997-4#1)(2008-10#1)
used to determine that##3##4##(1993-8#1)(2008-10#1)(2008-3#1)
used to determine the composition of##3##6##(1990-9#1)(1992-1#1)(2007-11#1)
used to determine the concentration of##6##6##(1991-12#1)(2008-10#3)(2008-4#1)(2008-9#1)
used to determine the effect of##2##6##(2008-10#1)(2012-2#1)
used to determine the effects of##2##6##(2008-1#1)(2011-2#1)
used to determine the extent##2##5##(1992-6#1)(2008-7#1)
used to determine the influence of##2##6##(2008-10#1)(2008-6#1)
used to determine the low##2##5##(2008-10#2)
used to determine the nature of the##3##7##(1991-2#1)(1993-11#1)(2008-10#1)
used to determine the number of##4##6##(1995-11#1)(2006-10#1)(2008-10#2)
used to determine the optimum##2##5##(2008-10#1)(2008-3#1)
used to determine the prevalence##2##5##(2011-1#1)(2012-3#1)
used to determine the relative##2##5##(2008-11#1)(2008-5#1)
used to determine the##109##4##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-11#2)(1995-2#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)
used to determine trace##2##4##(2008-10#2)
used to determine whether the##3##5##(1993-8#1)(2008-2#1)(2008-3#1)
used to determine whether##9##4##(1993-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-8#1)
used to determine which##2##4##(1993-12#1)(2008-10#1)
used to determine##226##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-11#2)(1995-2#3)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#102)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#2)(2009-4#1)(2010-11#2)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
used to develop a simple##2##5##(2008-10#2)
used to develop a##13##4##(1990-12#1)(1991-6#1)(1994-5#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-6#1)(2012-12#1)
used to develop an##8##4##(1993-3#1)(1997-1#1)(2008-10#4)(2008-12#1)(2013-1#1)
used to develop and##2##4##(1994-1#1)(2008-11#1)
used to develop the##8##4##(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2013-8#1)
used to develop##54##3##(1990-12#1)(1991-6#1)(1993-3#2)(1994-1#1)(1994-5#2)(1995-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
used to devise##2##3##(2008-10#1)(2008-2#1)
used to diagnose##9##3##(1997-2#1)(1997-3#2)(2007-10#1)(2008-10#2)(2009-3#2)(2013-1#1)
used to differentiate##5##3##(2008-10#1)(2008-5#1)(2008-7#2)(2012-5#1)
used to digest##2##3##(1994-12#1)(2008-10#1)
used to direct the##2##4##(2008-7#2)
used to directly##5##3##(1995-3#1)(2008-10#3)(2008-7#1)
used to discover##2##3##(2008-10#1)(2008-9#1)
used to discriminate between##5##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-6#1)
used to discriminate##11##3##(1994-12#1)(2007-11#1)(2008-10#3)(2008-7#4)(2010-6#1)(2013-8#1)
used to display##3##3##(2008-2#2)(2010-2#1)
used to distinguish among##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
used to distinguish##10##3##(1993-6#1)(2006-4#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2013-8#1)
used to draw##4##3##(1990-9#1)(2007-12#1)(2008-9#1)(2010-3#1)
used to drive the##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
used to effectively##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
used to efficiently##2##3##(2007-12#1)(2008-6#1)
used to eliminate the##4##4##(2007-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
used to eliminate##7##3##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)
used to elucidate the##6##4##(2008-10#2)(2008-4#1)(2009-7#1)(2010-9#1)(2012-1#1)
used to elucidate##9##3##(1993-3#1)(1994-8#1)(2008-10#3)(2008-4#1)(2009-7#1)(2010-9#1)(2012-1#1)
used to enhance the##15##4##(1990-11#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)
used to enhance##19##3##(1990-11#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)
used to ensure##3##3##(1995-12#1)(2008-10#1)(2008-2#1)
used to establish a##4##4##(2008-11#2)(2008-2#1)(2008-4#1)
used to establish the calibration##2##5##(2008-10#2)
used to establish the##6##4##(2008-10#3)(2010-6#1)(2011-1#1)(2013-1#1)
used to establish##19##3##(1990-12#1)(1991-1#1)(1995-11#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
used to estimate the potential##3##5##(1991-3#1)(2008-10#2)
used to estimate the probability##2##5##(1994-11#1)(2008-10#1)
used to estimate the##44##4##(1991-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-7#3)(2009-10#1)(2010-6#1)(2011-1#2)(2011-2#1)
used to estimate##67##3##(1990-9#1)(1991-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
used to evaluate a##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
used to evaluate the association between##2##6##(2013-1#2)
used to evaluate the effects of##5##6##(1996-2#1)(1997-2#1)(2008-11#1)(2009-11#1)(2012-2#1)
used to evaluate the purity of##2##6##(2008-4#1)(2008-8#1)
used to evaluate the relative##2##5##(2008-10#1)(2011-2#1)
used to evaluate the##53##4##(1991-1#1)(1993-1#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
used to evaluate##88##3##(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#1)(1993-1#1)(1994-12#1)(1994-3#3)(1994-5#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
used to examine the effect of##3##6##(1991-10#1)(1996-12#1)(2007-5#1)
used to examine the relationships between##2##6##(2008-10#1)(2009-12#1)
used to examine the##26##4##(1991-10#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-3#1)(1996-12#1)(2007-5#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
used to examine whether##3##4##(1996-7#1)(2008-10#1)(2008-12#1)
used to examine##48##3##(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-11#1)(1995-3#1)(1996-12#2)(1996-7#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
used to excite the##2##4##(1991-3#1)(2008-3#1)
used to expand##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
used to explain the##10##4##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2011-1#1)(2013-1#1)
used to explain##12##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
used to explore the##10##4##(1990-3#1)(2008-1#2)(2008-6#1)(2009-12#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
used to explore##18##3##(1990-3#1)(1994-6#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
used to express##9##3##(1993-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)
used to extend the##4##4##(2008-10#2)(2008-8#1)(2009-3#1)
used to extend##5##3##(2007-11#1)(2008-10#2)(2008-8#1)(2009-3#1)
used to extract the##4##4##(2008-10#2)(2008-3#1)(2012-3#1)
used to extract##19##3##(1990-12#1)(1995-5#1)(2008-10#13)(2008-3#2)(2008-9#1)(2012-3#1)
used to fabricate the##2##4##(2008-12#2)
used to fabricate##13##3##(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2013-1#1)
used to facilitate##5##3##(2008-12#1)(2008-4#2)(2008-6#1)(2012-2#1)
used to find the##10##4##(2007-12#1)(2008-10#4)(2008-2#3)(2008-6#1)(2012-12#1)
used to find##20##3##(2007-12#1)(2008-10#9)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
used to fit the experimental data##2##6##(2008-10#1)(2008-3#1)
used to fit the models##2##5##(2008-9#2)
used to fit the##6##4##(1990-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#2)
used to fit##9##3##(1990-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#2)
used to follow the##5##4##(1991-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
used to follow##11##3##(1990-11#1)(1991-12#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-2#1)
used to form a##5##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
used to form an##2##4##(2007-12#1)(2008-10#1)
used to form the##2##4##(2008-10#1)(2008-3#1)
used to form##11##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-9#1)
used to formulate##2##3##(2008-10#1)(2008-2#1)
used to further##7##3##(2008-10#3)(2008-3#1)(2008-7#1)(2010-5#1)(2012-12#1)
used to gain##3##3##(1995-11#1)(2007-8#1)(2009-5#1)
used to gather##2##3##(1996-2#1)(2008-3#1)
used to generate a##6##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)
used to generate genomic fingerprints of##2##6##(2008-10#2)
used to generate the##10##4##(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)(2010-5#1)
used to generate##49##3##(1990-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-3#2)(2007-11#4)(2007-12#5)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-3#1)(2012-2#1)
used to give a##2##4##(2008-3#1)(2008-7#1)
used to give##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
used to grow##3##3##(2008-10#1)(2008-7#2)
used to guide the choice of##2##6##(2008-10#1)(2013-1#1)
used to guide the##3##4##(1995-3#1)(2008-10#1)(2013-1#1)
used to guide##8##3##(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2013-1#3)
used to help##9##3##(1992-8#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
used to highlight##2##3##(2007-11#1)(2010-12#1)
used to identify a##7##4##(1990-11#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
used to identify and##4##4##(1993-3#1)(1994-8#1)(2008-10#1)(2011-2#1)
used to identify candidate##2##4##(2008-10#1)(2008-7#1)
used to identify factors##2##4##(2011-1#1)(2013-1#1)
used to identify genes##2##4##(2008-10#1)(2012-1#1)
used to identify molecular markers##2##5##(2008-10#2)
used to identify specific##4##4##(2008-4#3)(2010-11#1)
used to identify the##30##4##(1990-11#1)(1991-5#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
used to identify##124##3##(1990-11#3)(1990-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#4)(2009-12#2)(2009-5#2)(2009-7#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
used to illustrate the##9##4##(1992-9#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-4#2)
used to illustrate##12##3##(1992-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-4#3)
used to image a##2##4##(1990-11#1)(2011-1#1)
used to image the##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
used to image##11##3##(1990-11#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)(2011-1#1)(2012-2#1)
used to immunize##2##3##(1993-8#1)(2011-2#1)
used to immunoprecipitate the##2##4##(1990-11#1)(1992-9#1)
used to implement a##2##4##(2007-11#2)
used to implement the##2##4##(1995-2#1)(2008-3#1)
used to implement##10##3##(1995-2#1)(2007-11#2)(2008-10#1)(2008-3#5)(2009-6#1)
used to improve the accuracy##2##5##(2008-10#1)(2008-3#1)
used to improve the sensitivity of##2##6##(2007-12#1)(2008-10#1)
used to improve the##20##4##(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-6#1)(2010-12#1)(2013-1#1)
used to improve##40##3##(1994-2#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#2)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
used to increase the##6##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
used to increase##11##3##(1994-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
used to indicate the##3##4##(1992-6#1)(1992-8#1)(2008-12#1)
used to indicate##5##3##(1991-6#1)(1992-6#1)(1992-8#1)(2008-12#1)(2008-4#1)
used to induce##10##3##(2007-11#2)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)
used to infect##5##3##(1991-6#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)
used to infer the##3##4##(1994-3#1)(1997-2#1)(2010-8#1)
used to infer##8##3##(1994-3#1)(1997-2#1)(2008-1#1)(2008-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
used to inform##4##3##(1996-1#1)(2008-7#1)(2012-12#1)(2013-8#1)
used to inhibit the##3##4##(1997-6#1)(2008-3#1)(2008-8#1)
used to initiate the##2##4##(2008-10#1)(2008-2#1)
used to initiate##3##3##(2008-10#2)(2008-2#1)
used to inoculate##5##3##(2008-10#5)
used to interpret##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
used to interrogate##2##3##(2007-12#1)(2010-5#1)
used to introduce##7##3##(1994-5#2)(2008-10#2)(2008-3#1)(2008-6#1)(2009-11#1)
used to investigate the abuse potential of new compounds and to study the effects of candidate medications for the treatment of drug addiction##2##23##(2008-4#1)(2012-3#1)
used to investigate the cellular##2##5##(1993-12#1)(2008-4#1)
used to investigate the effect##4##5##(1993-3#1)(1995-2#1)(2008-10#1)(2013-1#1)
used to investigate the effects of##4##6##(1995-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
used to investigate the feasibility of##2##6##(2008-10#1)(2008-3#1)
used to investigate the molecular basis of##2##7##(1990-8#1)(1996-12#1)
used to investigate the role of##4##6##(1994-6#1)(2008-11#1)(2008-6#1)(2011-2#1)
used to investigate the##63##4##(1990-2#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#2)(1996-12#2)(1996-5#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
used to investigate whether##2##4##(1994-12#1)(2010-8#1)
used to investigate##86##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-5#2)(1994-6#3)(1995-12#1)(1995-2#2)(1996-11#1)(1996-12#2)(1996-5#2)(2007-12#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-5#1)(2009-8#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
used to isolate a##2##4##(1991-5#1)(2008-10#1)
used to isolate the##2##4##(1994-12#1)(2008-4#1)
used to isolate##19##3##(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-5#1)
used to know##2##3##(2008-10#1)(2008-11#1)
used to label##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)(2012-2#1)
used to localize##2##3##(2010-4#1)(2011-1#1)
used to locate the##3##4##(2008-10#1)(2008-3#2)
used to locate##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2013-7#1)
used to look at##2##4##(1997-4#1)(2011-2#1)
used to look##3##3##(1992-3#1)(1997-4#1)(2011-2#1)
used to maintain##4##3##(2008-10#3)(2008-7#1)
used to make##18##3##(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
used to manage##7##3##(2008-10#3)(2008-7#1)(2010-3#1)(2013-1#2)
used to manufacture##2##3##(2008-10#1)(2008-3#1)
used to map quantitative trait loci (QTL)##2##7##(2008-10#2)
used to map the##6##4##(1990-2#1)(1993-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
used to map##14##3##(1990-2#1)(1993-12#1)(1996-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)
used to measure and##2##4##(2008-11#1)(2008-9#1)
used to measure both##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
used to measure relative##2##4##(1992-1#1)(2008-3#1)
used to measure temperature##2##4##(2008-3#2)
used to measure the ability##2##5##(2008-1#1)(2012-3#1)
used to measure the absorption##2##5##(2008-2#2)
used to measure the effects of##2##6##(1995-12#1)(2008-9#1)
used to measure the extent of##2##6##(1994-5#1)(2008-4#1)
used to measure the rate of##3##6##(1993-11#1)(2008-4#1)(2009-12#1)
used to measure the##56##4##(1990-12#1)(1992-12#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
used to measure two-dimensional##2##4##(2008-2#1)(2008-4#1)
used to measure##125##3##(1990-12#2)(1990-2#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#13)(2008-3#29)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)
used to mimic##2##3##(1994-5#1)(2008-10#1)
used to minimize the##5##4##(1992-12#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-2#1)
used to minimize##8##3##(1992-12#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
used to mitigate the##2##4##(2008-2#1)(2013-1#1)
used to model the##13##4##(1994-5#1)(1997-1#1)(2008-10#4)(2008-3#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)
used to model##26##3##(1992-6#1)(1994-5#1)(1997-1#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-7#1)
used to modify the surface##2##5##(2008-10#1)(2009-7#1)
used to modify the##5##4##(1992-9#1)(2007-11#1)(2008-10#1)(2009-7#1)(2013-8#1)
used to modify##8##3##(1992-9#1)(2007-11#1)(2008-10#3)(2009-7#1)(2013-8#2)
used to modulate the##4##4##(2007-11#2)(2008-11#1)(2008-3#1)
used to monitor the growth##2##5##(2008-10#1)(2008-11#1)
used to monitor the hydrolysis of##2##6##(2008-10#1)(2011-2#1)
used to monitor the hydrolysis##3##5##(2008-10#2)(2011-2#1)
used to monitor the reaction##2##5##(1994-5#1)(2008-10#1)
used to monitor the##27##4##(1992-3#1)(1994-5#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2011-2#1)(2012-3#1)
used to monitor##51##3##(1990-2#1)(1991-5#1)(1992-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-3#1)
used to normalize##2##3##(2008-10#1)(2011-2#1)
used to observe and##2##4##(2008-10#1)(2011-1#1)
used to observe the effect##2##5##(2008-10#1)(2008-4#1)
used to observe the##6##4##(2007-10#1)(2008-10#3)(2008-4#1)(2010-8#1)
used to observe##11##3##(1993-3#1)(2007-10#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
used to obtain a##3##4##(2008-2#1)(2008-3#1)(2009-11#1)
used to obtain an##3##4##(1994-5#1)(2008-2#1)(2008-3#1)
used to obtain the analytical##2##5##(2007-11#1)(2008-10#1)
used to obtain the##12##4##(1993-8#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-2#1)(2013-8#1)
used to obtain##52##3##(1991-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-11#4)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
used to optimize the##13##4##(1993-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#1)
used to optimize##16##3##(1993-5#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#3)(2009-11#1)
used to organize##2##3##(1993-12#1)(2009-4#1)
used to overcome the##2##4##(2007-11#1)(2009-11#1)
used to overcome##5##3##(1996-3#1)(2007-11#1)(2008-10#1)(2009-11#1)(2012-2#1)
used to package##2##3##(2008-3#1)(2012-1#1)
used to parameterize##2##3##(2008-8#1)(2009-11#1)
used to perform a##2##4##(2008-2#1)(2012-2#1)
used to perform the##4##4##(1994-3#1)(2008-10#1)(2008-2#1)(2013-8#1)
used to perform##20##3##(1994-3#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#4)(2008-3#3)(2008-6#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
used to place the PVA isolates into##2##7##(2008-10#2)
used to place##4##3##(2008-10#2)(2008-5#1)(2009-11#1)
used to plot calibration curves##2##5##(2008-10#2)
used to position##2##3##(1993-8#1)(1994-3#1)
used to precipitate##2##3##(2008-10#2)
used to preconcentrate##2##3##(2008-10#2)
used to predict the##19##4##(1992-4#1)(1992-6#1)(1995-1#1)(1997-3#1)(1997-4#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2013-8#1)
used to predict whether the##2##5##(2008-10#1)(2010-8#1)
used to predict##43##3##(1992-4#1)(1992-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-10#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-8#2)(2012-3#2)(2013-1#1)(2013-8#1)
used to prepare a##3##4##(1990-11#1)(2008-10#1)(2008-4#1)
used to prepare the##8##4##(2008-10#4)(2008-12#1)(2008-3#1)(2012-1#1)(2013-7#1)
used to prepare##19##3##(1990-11#1)(1991-2#2)(1994-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-2#2)(2013-7#1)
used to present the##3##4##(1996-3#1)(2008-10#2)
used to present##4##3##(1996-3#1)(2007-8#1)(2008-10#2)
used to prevent and treat##2##5##(2010-4#1)(2013-1#1)
used to prevent##10##3##(1990-6#1)(1991-6#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
used to probe a##2##4##(1995-8#1)(2008-3#1)
used to probe the##7##4##(1990-8#1)(1992-6#1)(1995-6#1)(2007-11#1)(2008-10#3)
used to probe##20##3##(1990-8#1)(1991-12#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-12#1)
used to process the##2##4##(2008-2#1)(2008-3#1)
used to process##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
used to produce a##4##4##(1992-9#1)(2008-2#2)(2008-3#1)
used to produce the##6##4##(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2011-3#1)
used to produce##40##3##(1992-9#1)(1994-11#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#5)(2008-3#5)(2008-4#2)(2008-7#2)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#1)
used to promote##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
used to propose##3##3##(1995-3#1)(2008-1#1)(2008-10#1)
used to protect the##3##4##(1993-3#1)(2008-3#1)(2009-5#1)
used to protect##4##3##(1993-3#1)(1994-3#1)(2008-3#1)(2009-5#1)
used to prove##2##3##(2008-10#1)(2008-5#1)
used to provide a##9##4##(1992-6#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-4#1)
used to provide##22##3##(1991-12#1)(1992-6#1)(1996-3#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#2)(2013-1#1)
used to purify the##2##4##(1990-11#1)(1991-7#1)
used to purify##4##3##(1990-11#1)(1991-7#1)(1997-7#1)(2008-1#1)
used to quantify and##2##4##(2010-5#1)(2012-2#1)
used to quantify the##7##4##(1990-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)
used to quantify##28##3##(1990-7#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)
used to quantitate the##2##4##(2008-10#1)(2009-10#1)
used to quantitate##11##3##(1990-12#1)(1991-9#1)(1992-12#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-9#1)(2009-10#1)
used to quantitatively assess##2##4##(2008-10#1)(2011-1#1)
used to quantitatively determine##3##4##(2007-5#1)(2008-10#2)
used to quantitatively##8##3##(2007-5#1)(2008-10#3)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)
used to rapidly##6##3##(1994-6#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#2)
used to read##2##3##(2007-12#1)(2008-3#1)
used to reconstruct the##8##4##(2007-12#1)(2008-3#5)(2008-9#1)(2013-1#1)
used to reconstruct##13##3##(2007-12#2)(2008-3#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2013-1#1)
used to record the##5##4##(2007-10#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-6#1)
used to record##11##3##(1996-5#1)(2007-10#1)(2008-2#1)(2008-3#4)(2009-4#1)(2009-8#1)(2010-6#1)(2012-2#1)
used to recover the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
used to recover##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
used to reduce the##14##4##(1991-12#1)(1995-12#1)(1996-11#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#5)(2008-4#1)(2012-2#1)
used to reduce##21##3##(1991-12#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-4#1)(2012-2#1)
used to refine##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)
used to reflect##2##3##(2008-3#1)(2011-1#1)
used to relate##4##3##(2008-10#4)
used to reliably##5##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)
used to remove the##5##4##(2007-11#1)(2008-10#3)(2008-2#1)
used to remove##14##3##(1990-12#1)(1991-6#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
used to replace enamel in stratified composite restoration techniques##2##9##(2012-2#2)
used to replace the##2##4##(2008-8#1)(2013-8#1)
used to replace##6##3##(1994-12#1)(2008-2#1)(2008-8#1)(2012-2#2)(2013-8#1)
used to represent the##4##4##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)
used to represent##8##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)
used to resolve the##3##4##(1994-12#1)(1996-8#1)(2008-11#1)
used to resolve##6##3##(1990-8#1)(1994-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-11#1)
used to restore##2##3##(1996-3#1)(2008-4#1)
used to retrieve##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
used to reveal##3##3##(1997-2#1)(2008-10#2)
used to sample the##2##4##(2008-10#1)(2008-7#1)
used to sample##5##3##(2008-10#4)(2008-7#1)
used to scale##2##3##(2008-11#1)(2008-2#1)
used to screen for##2##4##(2008-10#1)(2010-6#1)
used to screen the##2##4##(1997-8#1)(2008-8#1)
used to screen##16##3##(1992-8#1)(1994-6#1)(1994-8#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-6#1)(2013-8#1)
used to search for##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
used to search##6##3##(1993-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
used to select##18##3##(1994-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-12#2)
used to selectively##2##3##(2008-10#2)
used to separate##16##3##(1992-12#1)(2007-12#1)(2008-10#11)(2008-2#2)(2009-12#1)
used to set##4##3##(1991-2#1)(1992-2#1)(1997-3#1)(2012-2#1)
used to show that the##3##5##(1990-8#1)(2008-10#1)(2008-11#1)
used to show that##9##4##(1990-8#1)(1991-3#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
used to show##11##3##(1990-8#1)(1991-3#1)(1994-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
used to simplify the heating cycles##2##6##(2008-10#2)
used to simplify the##4##4##(2008-10#2)(2008-2#2)
used to simulate the##8##4##(2007-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)
used to simulate##14##3##(1990-11#1)(2007-11#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)
used to solve for##2##4##(2007-12#1)(2008-3#1)
used to solve the##3##4##(2008-2#1)(2008-9#1)(2011-1#1)
used to solve##9##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)
used to stabilize the##2##4##(2007-12#1)(2008-1#1)
used to stabilize##4##3##(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#1)
used to strengthen##2##3##(1995-5#1)(2008-10#1)
used to study basic##2##4##(2008-9#1)(2010-7#1)
used to study mechanisms of##2##5##(2008-4#1)(2013-1#1)
used to study the association##2##5##(1993-12#1)(2008-10#1)
used to study the binding##2##5##(1991-8#1)(1993-11#1)
used to study the effect of##10##6##(1990-11#1)(1990-2#1)(1992-3#1)(1993-8#1)(2008-7#3)(2008-8#1)(2013-7#2)
used to study the effects of##4##6##(1997-7#1)(2007-11#1)(2008-5#1)(2013-7#1)
used to study the growth##2##5##(2008-3#1)(2013-8#1)
used to study the interaction between a##2##7##(2008-10#1)(2009-6#1)
used to study the interactions of##2##6##(2008-9#2)
used to study the interactions##3##5##(2008-9#2)(2011-2#1)
used to study the kinetic##2##5##(2008-10#2)
used to study the kinetics of##2##6##(1990-12#1)(2008-4#1)
used to study the mechanisms by which##2##7##(2008-10#1)(2008-2#1)
used to study the relationship##3##5##(2008-10#2)(2008-9#1)
used to study the##91##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#3)(1994-5#1)(1995-12#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#26)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#3)(2013-8#1)
used to study this##2##4##(2008-10#1)(2013-8#1)
used to study##142##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#3)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#6)(2008-10#33)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#4)(2008-7#7)(2008-8#5)(2008-9#7)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#2)
used to substitute##2##3##(2008-10#1)(2010-11#1)
used to successfully##3##3##(2008-10#3)
used to support the##2##4##(2008-10#2)
used to support##8##3##(1994-6#1)(1995-1#1)(2008-10#3)(2008-9#1)(2011-2#1)(2011-9#1)
used to suppress##4##3##(2007-11#1)(2008-10#2)(2011-2#1)
used to synthesize##9##3##(1993-8#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
used to tailor##3##3##(2009-12#1)(2010-4#1)(2013-1#1)
used to teach##4##3##(2008-11#1)(2008-12#2)(2009-11#1)
used to test a##4##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
used to test for##6##4##(1992-11#1)(1992-2#1)(1994-2#1)(2008-10#1)(2010-2#1)(2012-2#1)
used to test the prediction##2##5##(2008-12#1)(2008-5#1)
used to test the##16##4##(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#4)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
used to test whether##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
used to test##44##3##(1990-3#1)(1992-11#1)(1992-2#1)(1994-2#1)(1995-6#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
used to the determination of##3##5##(2008-10#3)
used to the##6##3##(2008-10#6)
used to track the##2##4##(2008-10#2)
used to track##5##3##(2007-11#1)(2008-10#3)(2008-6#1)
used to train##5##3##(1995-2#1)(2008-10#2)(2008-4#1)(2011-2#1)
used to transfect##2##3##(1993-8#1)(2008-11#1)
used to transfer##4##3##(1990-5#1)(2007-12#1)(2008-10#2)
used to transform##8##3##(1990-5#2)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
used to treat a myriad of##2##6##(2008-10#1)(2008-8#1)
used to treat a##4##4##(1992-1#1)(1993-2#1)(2008-10#1)(2008-8#1)
used to treat hypertension##2##4##(2008-11#1)(2008-12#1)
used to treat localized##2##4##(2008-7#1)(2012-1#1)
used to treat osteoporosis##2##4##(1993-11#1)(2007-11#1)
used to treat the##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
used to treat this##2##4##(2011-1#1)(2013-8#1)
used to treat##52##3##(1990-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-11#2)(1993-2#1)(1994-11#2)(1994-5#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2009-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
used to understand##5##3##(2008-10#2)(2008-7#1)(2010-4#1)(2010-7#1)
used to validate the model##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
used to validate the##14##4##(2008-10#6)(2008-3#4)(2008-7#1)(2011-2#3)
used to validate##15##3##(1995-3#1)(2008-10#6)(2008-3#4)(2008-7#1)(2011-2#3)
used to verify the##4##4##(1997-4#1)(2008-10#1)(2010-5#2)
used to verify##6##3##(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#2)
used to visualise##2##3##(2008-8#1)(2012-2#1)
used to visualize the##5##4##(2007-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-1#1)
used to visualize##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-1#1)(2013-8#1)
used to##3549##2##(1990-11#20)(1990-12#12)(1990-2#6)(1990-3#4)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#10)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#11)(1991-2#12)(1991-3#6)(1991-5#7)(1991-6#6)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#5)(1992-11#3)(1992-12#10)(1992-2#6)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#11)(1992-7#1)(1992-8#5)(1992-9#4)(1993-1#2)(1993-11#9)(1993-12#13)(1993-2#6)(1993-3#12)(1993-5#1)(1993-6#6)(1993-8#16)(1993-9#2)(1994-1#1)(1994-11#10)(1994-12#18)(1994-2#10)(1994-3#12)(1994-5#20)(1994-6#10)(1994-7#1)(1994-8#9)(1994-9#6)(1995-1#6)(1995-11#7)(1995-12#9)(1995-2#19)(1995-3#9)(1995-5#10)(1995-6#8)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#5)(1996-12#19)(1996-2#17)(1996-3#13)(1996-4#3)(1996-5#15)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#6)(1997-2#15)(1997-3#13)(1997-4#10)(1997-5#1)(1997-6#10)(1997-7#7)(1997-8#6)(1997-9#1)(2006-10#3)(2006-4#2)(2006-8#1)(2007-10#17)(2007-11#78)(2007-12#76)(2007-2#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#17)(2008-1#45)(2008-10#891)(2008-11#126)(2008-12#40)(2008-2#170)(2008-3#327)(2008-4#111)(2008-5#67)(2008-6#33)(2008-7#111)(2008-8#81)(2008-9#88)(2009-10#15)(2009-11#21)(2009-12#14)(2009-2#2)(2009-3#7)(2009-4#7)(2009-5#11)(2009-6#7)(2009-7#19)(2009-8#16)(2009-9#12)(2010-1#3)(2010-10#6)(2010-11#13)(2010-12#7)(2010-2#9)(2010-3#22)(2010-4#16)(2010-5#29)(2010-6#15)(2010-7#10)(2010-8#21)(2010-9#6)(2011-1#47)(2011-2#65)(2011-3#5)(2011-9#1)(2012-1#14)(2012-12#28)(2012-2#61)(2012-3#38)(2012-5#1)(2012-8#1)(2013-1#73)(2013-7#11)(2013-8#46)
used today##6##2##(1991-6#1)(1992-6#1)(1994-5#1)(2007-12#2)(2008-5#1)
used together with the##2##4##(2008-10#1)(2008-3#1)
used together with##5##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
used together##7##2##(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
used tool for the##2##4##(2009-1#1)(2011-1#1)
used tool to##2##3##(2012-2#2)
used tool##6##2##(2006-10#1)(2009-1#1)(2011-1#1)(2012-2#2)(2012-3#1)
used traditional##2##2##(2008-10#1)(2013-7#1)
used traditionally##2##2##(2008-1#1)(2008-5#1)
used two##10##2##(1990-8#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
used type of##3##3##(2010-8#1)(2011-1#2)
used under##5##2##(2007-11#1)(2008-10#3)(2013-1#1)
used was a##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2010-5#1)
used was the##2##3##(1991-4#1)(2012-12#1)
used was##37##2##(1991-4#1)(1991-6#1)(1992-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#2)
used were##25##2##(1990-8#1)(1993-6#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
used when##23##2##(1991-12#1)(2006-10#1)(2007-12#2)(2008-1#2)(2008-10#6)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#2)
used which##3##2##(1994-12#1)(2008-10#1)(2012-12#1)
used widely in##4##3##(1994-11#1)(1996-12#1)(2008-10#1)(2008-3#1)
used widely##8##2##(1993-11#1)(1994-11#1)(1996-12#1)(2008-10#2)(2008-3#1)(2010-10#1)(2013-8#1)
used with a##13##3##(1991-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2010-5#1)(2011-1#1)(2011-2#2)
used with an##2##3##(2008-10#2)
used with caution##4##3##(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
used with good##2##3##(1991-5#1)(2008-1#1)
used with heterodyne detection to measure##2##6##(2007-12#1)(2008-3#1)
used with success for##3##4##(1992-11#1)(2007-11#1)(2009-2#1)
used with the aim##2##4##(2008-10#1)(2011-2#1)
used with the##15##3##(1992-9#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-8#1)(2011-2#3)
used with##109##2##(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#4)(2008-10#18)(2008-11#2)(2008-2#5)(2008-3#15)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#7)(2012-3#1)(2013-1#6)(2013-8#1)
used within a##2##3##(2008-11#1)(2008-2#1)
used within the##2##3##(2007-12#1)(2010-2#1)
used within##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)
used without##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
used worldwide##4##2##(2008-10#1)(2010-3#1)(2010-8#1)(2011-1#1)
used##10625##1##(1990-10#6)(1990-11#39)(1990-12#34)(1990-2#21)(1990-3#14)(1990-5#24)(1990-6#11)(1990-7#10)(1990-8#30)(1990-9#11)(1991-1#6)(1991-10#2)(1991-11#6)(1991-12#36)(1991-2#30)(1991-3#14)(1991-4#7)(1991-5#26)(1991-6#19)(1991-7#4)(1991-8#4)(1991-9#14)(1992-1#17)(1992-10#1)(1992-11#18)(1992-12#34)(1992-2#26)(1992-3#37)(1992-4#6)(1992-5#10)(1992-6#27)(1992-7#1)(1992-8#18)(1992-9#19)(1993-1#9)(1993-10#4)(1993-11#27)(1993-12#40)(1993-2#26)(1993-3#38)(1993-5#3)(1993-6#16)(1993-8#25)(1993-9#17)(1994-1#10)(1994-10#1)(1994-11#29)(1994-12#51)(1994-2#35)(1994-3#32)(1994-5#40)(1994-6#29)(1994-7#2)(1994-8#26)(1994-9#16)(1995-1#17)(1995-11#25)(1995-12#41)(1995-2#48)(1995-3#18)(1995-5#22)(1995-6#28)(1995-8#13)(1995-9#5)(1996-1#20)(1996-11#10)(1996-12#56)(1996-2#41)(1996-3#36)(1996-4#4)(1996-5#43)(1996-6#14)(1996-7#7)(1996-8#9)(1996-9#10)(1997-1#30)(1997-2#46)(1997-3#49)(1997-4#41)(1997-5#12)(1997-6#24)(1997-7#22)(1997-8#19)(1997-9#3)(2006-10#21)(2006-11#1)(2006-12#3)(2006-4#5)(2006-6#4)(2006-8#2)(2007-10#46)(2007-11#202)(2007-12#214)(2007-2#7)(2007-4#5)(2007-5#7)(2007-6#9)(2007-7#50)(2007-8#75)(2007-9#1)(2008-1#121)(2008-10#2777)(2008-11#395)(2008-12#150)(2008-2#416)(2008-3#800)(2008-4#271)(2008-5#236)(2008-6#116)(2008-7#284)(2008-8#215)(2008-9#247)(2009-1#3)(2009-10#34)(2009-11#35)(2009-12#32)(2009-2#14)(2009-3#29)(2009-4#22)(2009-5#29)(2009-6#21)(2009-7#42)(2009-8#44)(2009-9#28)(2010-1#15)(2010-10#22)(2010-11#48)(2010-12#41)(2010-2#19)(2010-3#61)(2010-4#42)(2010-5#76)(2010-6#47)(2010-7#26)(2010-8#89)(2010-9#15)(2011-1#129)(2011-10#3)(2011-2#280)(2011-3#19)(2011-7#1)(2011-9#1)(2012-1#30)(2012-12#105)(2012-2#185)(2012-3#134)(2012-5#1)(2012-6#5)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#265)(2013-7#33)(2013-8#146)
used)##5##1##(2008-10#2)(2008-3#1)(2008-4#1)(2013-1#1)
usedfor##2##1##(2008-11#2)
useful adjunct in##2##3##(1997-8#1)(2007-8#1)
useful adjunct##6##2##(1993-2#1)(1997-8#1)(2007-8#1)(2008-9#1)(2010-11#1)(2012-3#1)
useful agent##2##2##(1993-3#1)(2008-7#1)
useful agents##2##2##(1992-6#1)(2010-1#1)
useful alternative for the##2##4##(2008-10#1)(2012-2#1)
useful alternative for##4##3##(2008-10#3)(2012-2#1)
useful alternative##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
useful analytical tools##3##3##(2008-10#3)
useful analytical##5##2##(2008-10#4)(2008-3#1)
useful and can be##2##4##(1991-3#1)(2012-1#1)
useful and effective##2##3##(1993-12#1)(2008-8#1)
useful and safe##2##3##(1994-11#1)(2011-2#1)
useful and##25##2##(1991-12#1)(1991-3#1)(1993-12#1)(1994-11#1)(1996-12#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
useful applications for##2##3##(2008-3#1)(2012-2#1)
useful applications##5##2##(2008-1#1)(2008-3#3)(2012-2#1)
useful approach to##5##3##(1990-6#1)(1997-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
useful approach##12##2##(1990-6#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#2)
useful as a means of##2##5##(1997-4#1)(2008-11#1)
useful as a model for##2##5##(1995-8#1)(2008-1#1)
useful as a##31##3##(1990-6#2)(1993-1#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#3)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)
useful as an##4##3##(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
useful as diagnostic##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
useful as##61##2##(1990-6#2)(1990-8#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#3)(2007-12#2)(2008-1#1)(2008-10#18)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-1#1)(2013-1#1)
useful because##4##2##(1993-12#1)(1996-9#1)(2008-2#1)(2009-3#1)
useful biological##3##2##(2008-5#1)(2010-11#1)(2011-1#1)
useful biomarkers##2##2##(2010-12#1)(2010-7#1)
useful both to##2##3##(2010-4#1)(2013-1#1)
useful both##3##2##(1992-12#1)(2010-4#1)(2013-1#1)
useful but##2##2##(1992-12#1)(2013-8#1)
useful characteristics##3##2##(2008-10#2)(2008-2#1)
useful clinical tool##3##3##(1993-12#2)(2008-12#1)
useful clinical##6##2##(1993-12#2)(2006-6#1)(2007-11#1)(2008-12#2)
useful compounds##3##2##(1994-11#2)(2009-5#1)
useful criteria for##2##3##(2008-10#1)(2013-1#1)
useful data##4##2##(1994-12#1)(1994-5#1)(2008-10#1)(2008-4#1)
useful diagnostic tool in##3##4##(2007-11#1)(2007-7#1)(2008-12#1)
useful diagnostic tool##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)
useful diagnostic tools##2##3##(2010-7#1)(2012-12#1)
useful diagnostic##10##2##(1997-4#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)
useful drug##3##2##(1990-9#1)(2007-11#1)(2011-2#1)
useful drugs##3##2##(1992-3#1)(2008-5#1)(2012-3#1)
useful even##2##2##(2011-2#1)(2013-1#1)
useful for a variety of##2##5##(1994-5#1)(2008-4#1)
useful for a##5##3##(1990-12#1)(1994-5#1)(1997-2#1)(2008-11#1)(2008-4#1)
useful for analysis of##3##4##(2007-11#1)(2008-10#1)(2008-4#1)
useful for analyzing##3##3##(1997-6#1)(2008-4#2)
useful for application##2##3##(2008-10#1)(2008-5#1)
useful for applications such as##2##5##(2007-11#1)(2008-7#1)
useful for applications##3##3##(2007-11#2)(2008-7#1)
useful for assessing##3##3##(2008-6#1)(2008-9#1)(2010-12#1)
useful for both##3##3##(2007-12#1)(2008-1#1)(2008-9#1)
useful for characterizing the##3##4##(1992-1#1)(1994-11#1)(2008-11#1)
useful for characterizing##4##3##(1992-1#1)(1994-11#1)(2008-10#1)(2008-11#1)
useful for classifying##2##3##(2008-10#1)(2012-12#1)
useful for detecting##4##3##(1994-7#1)(2007-10#1)(2008-12#1)(2009-7#1)
useful for detection of##3##4##(2008-10#2)(2011-2#1)
useful for detection##4##3##(1992-8#1)(2008-10#2)(2011-2#1)
useful for determining the##2##4##(2007-12#1)(2008-10#1)
useful for determining##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
useful for diagnosing##3##3##(2008-9#1)(2011-2#2)
useful for diagnosis##2##3##(1991-2#1)(2012-2#1)
useful for differential##2##3##(2008-4#1)(2012-1#1)
useful for establishing##2##3##(2008-4#1)(2013-1#1)
useful for estimating##4##3##(1994-3#1)(1994-9#1)(2008-10#1)(2009-9#1)
useful for evaluating##3##3##(2008-5#1)(2010-4#1)(2013-1#1)
useful for examining the##2##4##(1995-2#1)(2008-4#1)
useful for examining##5##3##(1995-2#1)(2008-4#3)(2008-7#1)
useful for further##3##3##(2008-10#2)(2011-1#1)
useful for future##2##3##(2007-11#1)(2008-12#1)
useful for grouping##2##3##(2008-10#2)
useful for identification##2##3##(2008-4#1)(2010-8#1)
useful for identifying##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
useful for in vivo##3##4##(1997-4#1)(2008-4#2)
useful for in##6##3##(1996-12#1)(1997-4#1)(2008-3#1)(2008-4#2)(2008-5#1)
useful for investigating the##2##4##(1997-2#1)(2008-4#1)
useful for investigating##3##3##(1997-2#1)(2008-2#1)(2008-4#1)
useful for investigation of##2##4##(1995-12#1)(2008-10#1)
useful for making##2##3##(1997-8#1)(2008-3#1)
useful for marker-assisted selection##2##4##(2008-10#2)
useful for measuring##6##3##(2008-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-7#1)
useful for monitoring##7##3##(2008-10#4)(2008-11#1)(2010-8#1)(2013-8#1)
useful for predicting##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
useful for producing##2##3##(2008-10#1)(2008-2#1)
useful for providing##2##3##(2008-2#1)(2012-3#1)
useful for rapid##2##3##(2008-10#1)(2008-5#1)
useful for screening purposes##2##4##(1997-1#1)(2008-10#1)
useful for screening##4##3##(1997-1#1)(2008-10#3)
useful for studies of##3##4##(2008-1#1)(2008-7#1)(2010-12#1)
useful for studies##5##3##(1995-12#1)(2008-1#2)(2008-7#1)(2010-12#1)
useful for studying the##9##4##(1992-12#1)(1995-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
useful for studying##15##3##(1992-12#1)(1993-9#1)(1995-11#1)(1995-2#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
useful for targeting##2##3##(2008-7#1)(2008-8#1)
useful for the analysis of##3##5##(1994-2#1)(2008-10#1)(2008-2#1)
useful for the determination of##3##5##(2008-10#2)(2008-3#1)
useful for the diagnosis of##3##5##(1990-8#1)(2008-10#1)(2008-5#1)
useful for the diagnosis##4##4##(1990-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
useful for the evaluation of##5##5##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#2)
useful for the measurement of##2##5##(2008-10#1)(2008-7#1)
useful for the measurement##3##4##(2008-10#2)(2008-7#1)
useful for the study of##2##5##(1996-12#1)(2008-4#1)
useful for the treatment of##3##5##(2008-11#1)(2008-3#1)(2011-1#1)
useful for the##51##3##(1990-3#1)(1990-8#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
useful for their##2##3##(2007-11#1)(2010-10#1)
useful for this##2##3##(2008-10#1)(2009-7#1)
useful for treatment##2##3##(2008-1#1)(2011-2#1)
useful for understanding##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
useful for##361##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#3)(1991-1#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-8#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#2)(2007-10#3)(2007-11#12)(2007-12#12)(2007-8#1)(2008-1#6)(2008-10#81)(2008-11#19)(2008-12#5)(2008-2#17)(2008-3#19)(2008-4#25)(2008-5#10)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#8)(2009-10#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#7)(2011-1#5)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#5)
useful frequency##2##2##(2008-2#1)(2008-3#1)
useful functions##2##2##(2008-7#1)(2010-8#1)
useful genes##2##2##(2009-10#1)(2011-1#1)
useful genetic##4##2##(1996-10#1)(2008-10#2)(2008-8#1)
useful in a variety of##3##5##(2008-11#1)(2008-3#1)(2008-5#1)
useful in a##7##3##(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#1)(2012-2#1)
useful in assessing##3##3##(2008-2#1)(2010-10#1)(2011-2#1)
useful in assisting##3##3##(2008-12#1)(2010-5#1)(2012-12#1)
useful in both the##2##4##(1994-2#1)(2008-2#1)
useful in clinical##3##3##(1990-8#1)(2008-5#1)(2013-1#1)
useful in combination with##2##4##(2008-3#2)
useful in creating##2##3##(2008-2#1)(2012-3#1)
useful in designing##2##3##(1994-2#1)(2008-3#1)
useful in detecting##5##3##(1991-4#1)(2007-9#1)(2010-8#1)(2012-2#2)
useful in determining##7##3##(1990-5#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)
useful in developing##8##3##(1994-11#1)(2008-10#3)(2009-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
useful in differentiating##3##3##(2008-5#1)(2012-2#2)
useful in discriminating between##2##4##(2008-5#1)(2008-7#1)
useful in further studies on##2##5##(1993-1#1)(1993-8#1)
useful in further##4##3##(1993-1#1)(1993-8#1)(1994-8#1)(2012-3#1)
useful in future studies of##3##5##(2007-7#1)(2008-10#1)(2013-1#1)
useful in identifying##7##3##(1992-5#1)(1994-6#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
useful in indicating##2##3##(2008-11#1)(2013-1#1)
useful in making##2##3##(1990-2#1)(2008-3#1)
useful in measuring##2##3##(1994-12#1)(2007-11#1)
useful in modeling##2##3##(2008-11#1)(2013-8#1)
useful in monitoring##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
useful in patients with##4##4##(1990-10#1)(1991-8#1)(1992-12#1)(1997-1#1)
useful in predicting the##2##4##(2008-5#2)
useful in predicting##7##3##(1992-3#1)(1996-6#1)(2008-5#2)(2008-7#1)(2009-5#1)(2013-1#1)
useful in preventing and treating##2##5##(2007-11#1)(2013-7#1)
useful in preventing##5##3##(2007-11#1)(2008-11#1)(2010-1#1)(2010-8#1)(2013-7#1)
useful in providing##2##3##(2008-10#1)(2008-11#1)
useful in screening for##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
useful in screening##4##3##(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
useful in selecting a##2##4##(1995-9#1)(2008-10#1)
useful in selecting##3##3##(1995-9#1)(2008-10#1)(2008-8#1)
useful in some patients##2##4##(1997-1#1)(1997-8#1)
useful in some##3##3##(1997-1#1)(1997-8#1)(2008-1#1)
useful in studies##3##3##(1991-12#1)(1992-6#1)(1993-11#1)
useful in studying the##4##4##(1990-5#1)(1993-6#1)(1996-12#1)(2008-4#1)
useful in studying##7##3##(1990-5#1)(1993-6#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
useful in that they##2##4##(2008-4#1)(2011-2#1)
useful in that##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
useful in the analysis of##2##5##(2008-10#1)(2010-3#1)
useful in the design of##2##5##(1995-6#1)(2012-2#1)
useful in the detection of##2##5##(1994-12#1)(2008-7#1)
useful in the detection##3##4##(1994-12#1)(2008-10#1)(2008-7#1)
useful in the development of##4##5##(1994-11#1)(1994-3#1)(1994-6#1)(2008-10#1)
useful in the diagnosis and##2##5##(2008-12#1)(2011-2#1)
useful in the diagnosis of##5##5##(1994-11#1)(1996-11#1)(2007-10#1)(2010-6#1)(2011-2#1)
useful in the diagnosis##7##4##(1994-11#1)(1996-11#1)(2007-10#1)(2008-12#1)(2010-6#1)(2011-2#2)
useful in the early##2##4##(1995-2#1)(2008-8#1)
useful in the fabrication of##2##5##(2007-12#2)
useful in the field##2##4##(2008-10#1)(2013-1#1)
useful in the investigation of##2##5##(2008-2#1)(2012-8#1)
useful in the study of##2##5##(1991-5#1)(2008-3#1)
useful in the treatment of##5##5##(1991-11#1)(2008-10#1)(2008-5#2)(2009-5#1)
useful in the##69##3##(1990-3#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-6#1)(1997-8#2)(2006-11#1)(2007-10#1)(2007-12#4)(2007-9#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#3)(2012-8#1)(2013-1#1)
useful in treating##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
useful in understanding##5##3##(1996-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
useful in##310##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#4)(2006-10#1)(2006-11#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#37)(2008-11#12)(2008-12#5)(2008-2#14)(2008-3#15)(2008-4#8)(2008-5#14)(2008-7#12)(2008-8#6)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#12)(2012-3#4)(2012-8#1)(2013-1#9)(2013-7#2)(2013-8#5)
useful information about the##5##4##(1991-2#1)(1992-8#1)(2007-10#1)(2010-8#1)(2012-3#1)
useful information about##7##3##(1991-2#1)(1992-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-3#1)
useful information and##4##3##(2007-11#1)(2008-4#1)(2008-7#1)(2009-12#1)
useful information for##10##3##(1992-10#1)(1992-5#1)(1996-3#1)(2008-10#4)(2008-2#1)(2009-11#1)(2010-5#1)
useful information on the##2##4##(2008-5#1)(2009-5#1)
useful information on##4##3##(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)
useful information##38##2##(1991-2#1)(1992-10#1)(1992-5#1)(1992-8#1)(1994-12#2)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#1)
useful insight into the##2##4##(2009-5#1)(2012-2#1)
useful insights into##2##3##(2007-12#1)(2009-6#1)
useful insights##4##2##(2007-12#2)(2008-11#1)(2009-6#1)
useful instrument##2##2##(1992-1#1)(1995-2#1)
useful is##2##2##(2008-9#1)(2012-3#1)
useful levels##2##2##(2008-3#1)(2009-5#1)
useful life of##2##3##(1990-8#1)(2008-10#1)
useful life##3##2##(1990-8#1)(2008-10#1)(2008-2#1)
useful lifetime of##4##3##(2008-10#3)(2009-11#1)
useful local##2##2##(2008-3#1)(2008-7#1)
useful marker for##5##3##(2008-4#2)(2008-6#1)(2010-8#1)(2011-2#1)
useful marker##8##2##(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
useful markers for##2##3##(1994-9#1)(2008-11#1)
useful markers to##2##3##(2008-12#1)(2009-8#1)
useful markers##5##2##(1994-9#1)(2008-11#1)(2008-12#1)(2009-6#1)(2009-8#1)
useful material##2##2##(2008-10#1)(2013-1#1)
useful means for##3##3##(2008-10#1)(2008-9#2)
useful means##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#1)
useful measure##2##2##(2007-11#1)(2012-3#1)
useful measurements and data##2##4##(2008-2#2)
useful measurements##3##2##(2008-2#2)(2008-3#1)
useful medium##2##2##(2008-11#1)(2008-5#1)
useful method for##7##3##(1990-12#1)(1996-9#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
useful method of##3##3##(1994-5#1)(2007-9#1)(2008-2#1)
useful method to##2##3##(2008-1#1)(2010-6#1)
useful method##13##2##(1990-12#1)(1994-5#1)(1996-9#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2010-6#1)(2012-3#1)(2013-1#1)
useful methods of##2##3##(1993-2#1)(2007-11#1)
useful methods##5##2##(1993-2#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
useful model for##7##3##(1990-5#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)
useful model##10##2##(1990-5#1)(1990-8#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-9#1)(2011-2#1)
useful models for##2##3##(1991-9#1)(1995-11#1)
useful molecular##3##2##(1992-5#1)(2008-10#1)(2008-9#1)
useful nonnatural amino acids##2##4##(2009-9#2)
useful option##2##2##(2006-12#1)(2012-12#1)
useful or##2##2##(1995-8#1)(2008-12#1)
useful parameter to##3##3##(1992-12#1)(2008-10#1)(2010-7#1)
useful platform for##2##3##(1994-6#1)(2008-4#1)
useful predictive##2##2##(2008-8#1)(2010-8#1)
useful predictor variables##3##3##(2008-10#3)
useful predictor##5##2##(2008-10#3)(2008-3#1)(2013-1#1)
useful predictors of##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
useful procedure##4##2##(1992-5#1)(2008-4#1)(2012-3#1)(2013-1#1)
useful prognostic##3##2##(1994-7#1)(2008-9#1)(2011-2#1)
useful range##3##2##(2008-2#1)(2008-7#2)
useful results##2##2##(1995-3#1)(2008-12#1)
useful screening##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
useful signals##4##2##(1990-8#2)(2008-10#2)
useful spatial##2##2##(2009-8#1)(2012-2#1)
useful strategy##3##2##(2008-10#1)(2009-12#1)(2010-10#1)
useful technique for the##2##4##(2007-11#1)(2008-3#1)
useful technique for##7##3##(1992-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2013-8#1)
useful technique##11##2##(1991-5#1)(1992-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2010-7#1)(2013-8#1)
useful techniques##2##2##(1992-3#1)(2013-1#1)
useful therapy##2##2##(2010-5#1)(2011-2#1)
useful to assess the effect of##2##6##(1996-6#1)(1997-1#1)
useful to assess the##3##4##(1990-2#1)(1996-6#1)(1997-1#1)
useful to assess##6##3##(1990-2#1)(1996-6#2)(1997-1#1)(2008-10#1)(2008-4#1)
useful to classify##2##3##(2008-10#1)(2013-8#1)
useful to control##2##3##(1990-12#1)(2008-10#1)
useful to detect##2##3##(2006-10#1)(2008-11#1)
useful to determine##5##3##(1992-2#1)(2008-10#1)(2008-11#2)(2010-8#1)
useful to develop##2##3##(2012-12#1)(2013-1#1)
useful to diagnose##2##3##(1997-1#1)(2009-5#1)
useful to examine##2##3##(1994-11#1)(2012-12#1)
useful to identify##5##3##(2008-11#1)(2008-3#1)(2008-4#2)(2011-2#1)
useful to increase##2##3##(2008-10#1)(2012-1#1)
useful to policy makers##3##4##(1994-1#2)(2011-2#1)
useful to predict the risk of##2##6##(2011-2#1)(2013-1#1)
useful to predict the##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
useful to study##3##3##(2007-12#1)(2008-11#1)(2011-1#1)
useful to the##4##3##(1992-12#1)(1993-12#1)(1997-3#1)(2008-2#1)
useful to##108##2##(1990-12#1)(1990-2#1)(1991-1#1)(1992-12#1)(1992-2#3)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#1)(1996-1#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-3#5)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
useful tool for the##7##4##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#1)(2008-10#2)(2008-3#1)
useful tool for##27##3##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-9#1)(1995-11#2)(1996-12#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
useful tool in the diagnosis##2##5##(1991-12#1)(2012-12#1)
useful tool in the treatment of##2##6##(1990-11#1)(1996-9#1)
useful tool in the##12##4##(1990-11#1)(1991-12#1)(1994-3#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
useful tool in##26##3##(1990-11#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
useful tool to investigate the##3##5##(2008-11#1)(2010-4#1)(2013-8#1)
useful tool to investigate##4##4##(2008-11#1)(2010-3#1)(2010-4#1)(2013-8#1)
useful tool to##11##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-8#1)
useful tool##65##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-11#2)(1996-12#2)(1996-4#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
useful tools for##3##3##(1995-12#1)(2007-4#1)(2008-5#1)
useful tools in##4##3##(2007-4#1)(2008-10#1)(2010-11#1)(2012-2#1)
useful tools to##4##3##(1994-6#1)(2007-11#1)(2008-7#1)(2008-8#1)
useful tools##11##2##(1994-6#1)(1995-12#1)(2007-11#1)(2007-4#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)
useful way##3##2##(1991-4#1)(2008-9#1)(2011-2#1)
useful when the##2##3##(2008-2#1)(2008-4#1)
useful when there##4##3##(2008-10#1)(2008-4#3)
useful when##12##2##(2008-10#1)(2008-11#1)(2008-2#4)(2008-4#5)(2010-10#1)
useful with##2##2##(1991-12#1)(1995-12#1)
useful##1533##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#2)(1990-5#5)(1990-6#5)(1990-8#11)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#9)(1991-4#2)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#11)(1992-2#6)(1992-3#10)(1992-4#2)(1992-5#4)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#11)(1993-2#6)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-11#11)(1994-12#7)(1994-2#8)(1994-3#7)(1994-5#4)(1994-6#8)(1994-7#3)(1994-8#6)(1994-9#3)(1995-11#6)(1995-12#6)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#11)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#6)(1997-2#7)(1997-3#11)(1997-4#12)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#8)(2006-10#4)(2006-11#1)(2006-12#2)(2006-6#1)(2007-10#8)(2007-11#33)(2007-12#29)(2007-2#4)(2007-4#3)(2007-7#4)(2007-8#6)(2007-9#5)(2008-1#14)(2008-10#239)(2008-11#80)(2008-12#24)(2008-2#69)(2008-3#66)(2008-4#73)(2008-5#41)(2008-6#5)(2008-7#54)(2008-8#25)(2008-9#40)(2009-1#1)(2009-10#4)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#11)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#9)(2010-1#4)(2010-10#6)(2010-11#6)(2010-12#8)(2010-2#3)(2010-3#9)(2010-4#10)(2010-5#6)(2010-6#3)(2010-7#10)(2010-8#23)(2011-1#18)(2011-10#1)(2011-2#50)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#12)(2012-2#37)(2012-3#25)(2012-8#1)(2013-1#31)(2013-7#5)(2013-8#19)
usefully##5##1##(1990-2#1)(1990-8#1)(2007-12#1)(2008-3#1)(2010-5#1)
usefulness and##13##2##(1990-2#2)(1996-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-1#3)
usefulness for##8##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)
usefulness has been limited##2##4##(1996-3#1)(2008-6#1)
usefulness in the##2##3##(1991-6#1)(2008-3#1)
usefulness in##13##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#1)(1994-2#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
usefulness is##2##2##(2008-3#1)(2008-7#1)
usefulness of a##6##3##(1993-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
usefulness of an##2##3##(2008-10#1)(2012-12#1)
usefulness of procalcitonin in the diagnosis of appendicitis##2##8##(2013-1#2)
usefulness of such##2##3##(1992-1#1)(1994-12#1)
usefulness of the proposed##6##4##(2007-11#2)(2008-10#3)(2008-3#1)
usefulness of the system##2##4##(2008-10#2)
usefulness of the##49##3##(1990-5#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-9#1)(1993-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
usefulness of these##4##3##(1992-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
usefulness of this approach##4##4##(1997-6#1)(2008-10#2)(2011-1#1)
usefulness of this drug##2##4##(1997-2#1)(2008-5#1)
usefulness of this method##4##4##(1993-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
usefulness of this##18##3##(1993-12#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
usefulness of##176##2##(1990-3#1)(1990-5#2)(1991-1#1)(1991-3#3)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-6#5)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-10#36)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#4)
usefulness to##4##2##(1995-6#1)(2008-2#1)(2011-1#1)(2012-12#1)
usefulness##236##1##(1990-2#2)(1990-3#2)(1990-5#2)(1991-1#1)(1991-3#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-6#5)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-10#46)(2008-11#12)(2008-12#5)(2008-2#6)(2008-3#13)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#8)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#6)
useless##8##1##(1991-6#1)(1992-2#1)(1995-12#1)(1997-6#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-12#1)
user and non-user controls##2##4##(1996-7#2)
user and##7##2##(1991-3#1)(1996-7#2)(2008-12#2)(2008-6#1)(2009-6#1)
user commands##2##2##(2011-2#2)
user facilities##3##2##(1993-3#2)(1997-3#1)
user friendly##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
user groups##2##2##(1995-1#1)(2008-7#1)
user interface for##2##3##(2008-4#1)(2010-8#1)
user interface##11##2##(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#5)(2011-1#1)
user involvement and##2##3##(2008-12#2)
user involvement in##2##3##(2008-11#1)(2008-12#1)
user involvement##6##2##(2008-11#1)(2008-12#5)
user is##2##2##(1995-11#1)(2011-1#1)
user of##3##2##(1991-9#1)(1995-12#1)(2008-3#1)
user satisfaction##2##2##(1996-2#1)(2011-2#1)
user to##13##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#3)(2008-9#2)(2009-12#1)(2011-2#1)
user##132##1##(1991-1#1)(1991-12#3)(1991-3#2)(1991-9#1)(1992-1#1)(1993-3#5)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-7#4)(1997-1#2)(1997-3#2)(2007-11#2)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#7)(2008-2#4)(2008-3#11)(2008-4#7)(2008-6#6)(2008-7#5)(2008-9#8)(2009-12#1)(2009-6#3)(2010-5#2)(2010-8#6)(2011-1#3)(2011-2#13)(2012-2#1)(2013-1#2)(2013-8#1)
user's##6##1##(1993-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#2)
user-defined##6##1##(2008-10#2)(2008-2#2)(2008-4#1)(2013-1#1)
user-friendly and##2##2##(2007-8#1)(2007-9#1)
user-friendly##16##1##(1991-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#2)(2010-12#1)(2011-1#1)
user-specified##2##1##(2008-4#1)(2009-9#1)
users aged##2##2##(2012-2#1)(2013-8#1)
users and carers##4##3##(2009-6#4)
users and the##5##3##(1995-2#1)(1996-1#1)(1996-2#1)(2010-10#1)(2013-1#1)
users and their##3##3##(1996-4#1)(2008-11#1)(2008-12#1)
users and##35##2##(1992-2#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-6#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-6#4)(2010-10#1)(2010-8#1)(2012-1#2)(2013-1#2)(2013-8#4)
users are##7##2##(1991-3#1)(1992-12#1)(1994-3#1)(1997-6#1)(2008-11#1)(2012-1#1)(2013-1#1)
users as##4##2##(2008-12#2)(2008-4#1)(2012-3#1)
users at##4##2##(1992-12#1)(1993-3#1)(1996-5#1)(2008-10#1)
users can##4##2##(2008-2#2)(2008-9#1)(2013-1#1)
users compared to##2##3##(2013-8#2)
users do##2##2##(1991-3#1)(2008-9#1)
users for##2##2##(1995-1#1)(2008-9#1)
users had##2##2##(1996-9#1)(1997-6#1)
users have##2##2##(2008-5#1)(2008-9#1)
users in##23##2##(1991-1#2)(1991-12#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-12#1)(2007-7#1)(2008-12#6)(2008-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
users may##3##2##(2008-9#1)(2012-12#1)(2013-8#1)
users of NSAIDs##2##3##(2008-8#2)
users of a##3##3##(1992-5#1)(1995-5#1)(2012-12#1)
users of benzodiazepines##2##3##(1991-1#1)(1996-9#1)
users of meloxicam##3##3##(2008-11#3)
users of non-proven therapies##4##4##(1997-6#4)
users of such##2##3##(2008-11#1)(2009-5#1)
users of the##7##3##(1996-1#1)(1997-8#1)(2008-9#3)(2012-1#1)(2012-3#1)
users of##53##2##(1991-1#2)(1991-12#1)(1991-3#1)(1992-11#1)(1992-5#2)(1993-3#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#3)(1997-6#4)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-8#3)
users receive##2##2##(1994-2#1)(2008-9#1)
users through##2##2##(2008-11#1)(2008-4#1)
users to##20##2##(1993-2#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#3)(2008-7#4)(2008-9#3)(2010-8#1)(2011-2#1)(2011-3#1)
users using##3##2##(1995-3#1)(2008-9#1)(2013-8#1)
users was##3##2##(1996-9#1)(2008-11#1)(2013-8#1)
users were more likely to##4##5##(2008-11#2)(2012-12#2)
users were##10##2##(1991-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#2)
users who##8##2##(1995-1#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#3)
users will##3##2##(1991-12#1)(1991-3#1)(1996-3#1)
users with##5##2##(2008-11#1)(2008-9#2)(2010-10#1)(2011-1#1)
users##369##1##(1990-12#1)(1990-8#1)(1991-1#13)(1991-12#7)(1991-3#6)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-5#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#7)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#5)(1995-2#1)(1995-3#7)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#4)(1997-5#1)(1997-6#11)(1997-8#1)(2006-10#1)(2007-1#2)(2007-12#3)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#32)(2008-12#15)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#51)(2009-10#1)(2009-5#2)(2009-6#6)(2009-7#1)(2010-1#2)(2010-10#3)(2010-5#1)(2010-8#3)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#9)(2012-12#8)(2012-2#8)(2012-3#7)(2013-1#7)(2013-8#22)
users' needs##3##2##(1991-9#1)(1996-2#1)(2011-2#1)
users' perspective##3##2##(1996-1#1)(1997-3#1)(2009-3#1)
users'##14##1##(1991-9#1)(1995-12#1)(1996-1#2)(1996-2#1)(1997-3#1)(2008-11#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
users]##4##1##(1995-2#1)(1996-9#1)(2009-10#1)(2013-8#1)
uses Duet Technologies'##2##3##(2008-2#2)
uses a CCD##2##3##(2007-12#1)(2008-10#1)
uses a binary##2##3##(2008-3#2)
uses a combination of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
uses a group##2##3##(1992-1#1)(2012-2#1)
uses a new##2##3##(1994-12#1)(2011-2#1)
uses a phase##2##3##(2007-12#1)(2008-3#1)
uses a simple##4##3##(2007-12#2)(2008-3#1)(2008-9#1)
uses a single##8##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
uses a thin##2##3##(2008-2#1)(2008-3#1)
uses a variety of##2##4##(1991-3#1)(2008-6#1)
uses a##134##2##(1991-3#2)(1992-1#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#9)(2007-12#12)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#12)(2008-3#45)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
uses an##31##2##(1993-12#1)(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#14)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
uses and##4##2##(1993-2#1)(2007-5#1)(2009-9#1)(2010-12#1)
uses both##2##2##(2008-3#2)
uses classical##2##2##(2008-10#1)(2009-10#1)
uses data##3##2##(1996-12#1)(2007-12#1)(2010-8#1)
uses either the##2##3##(2008-3#1)(2009-5#1)
uses for##7##2##(1992-3#1)(1997-3#1)(2007-12#1)(2008-6#1)(2010-3#1)(2011-1#1)(2012-1#1)
uses four##2##2##(1992-3#1)(2008-2#1)
uses in##3##2##(1991-12#1)(2008-8#2)
uses it##2##2##(1997-2#1)(2010-12#1)
uses measurements##2##2##(2008-2#1)(2008-3#1)
uses mechanical##2##2##(2007-12#1)(2008-7#1)
uses nonlinear##2##2##(2007-11#1)(2008-9#1)
uses of a##2##3##(1993-2#1)(2010-12#1)
uses of the Internet##2##4##(1996-2#1)(2009-5#1)
uses of the##7##3##(1991-12#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)
uses of##37##2##(1991-12#2)(1991-2#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#3)(2011-2#1)(2013-1#2)
uses one##2##2##(2007-12#1)(2008-5#1)
uses only a single##2##4##(1990-12#1)(2008-3#1)
uses only a##3##3##(1990-12#1)(1991-12#1)(2008-3#1)
uses only two##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
uses only##10##2##(1990-12#1)(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)
uses second-order##2##2##(2008-10#1)(2008-3#1)
uses the##53##2##(1992-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#9)(2008-3#17)(2008-6#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
uses three##5##2##(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
uses two monoclonal antibodies##2##4##(1992-12#1)(1993-2#1)
uses two##14##2##(1992-12#1)(1993-2#1)(2007-11#2)(2008-2#3)(2008-3#6)(2008-8#1)
uses##550##1##(1990-12#1)(1990-2#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#2)(1992-1#1)(1992-12#3)(1992-3#4)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-6#3)(1996-1#5)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#6)(2007-11#27)(2007-12#33)(2007-5#1)(2008-1#3)(2008-10#45)(2008-11#7)(2008-2#53)(2008-3#147)(2008-4#14)(2008-5#8)(2008-6#11)(2008-7#18)(2008-8#10)(2008-9#16)(2009-10#4)(2009-11#2)(2009-12#2)(2009-5#5)(2009-6#2)(2009-7#3)(2009-9#2)(2010-11#3)(2010-12#3)(2010-3#1)(2010-5#5)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#2)
usher in##4##2##(1991-5#1)(1995-6#1)(2009-5#1)(2011-7#1)
ushered##5##1##(1993-6#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)
using &quot##4##2##(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)
using (1)D at##2##3##(2008-10#2)
using (31)P##2##2##(2008-10#1)(2012-2#1)
using (i)##3##2##(2008-10#2)(2009-12#1)
using 0##19##2##(1990-8#1)(2008-10#14)(2008-11#1)(2008-5#1)(2009-12#1)(2013-1#1)
using 1##20##2##(1991-5#1)(1993-3#2)(2008-10#12)(2008-11#1)(2008-5#3)(2010-3#1)
using 1-(2-pyridylazo)-2-naphthol##2##2##(2008-10#2)
using 1-nitroso-2-naphthol##3##2##(2008-10#3)
using 10##6##2##(1994-11#1)(2008-10#3)(2008-5#1)(2012-2#1)
using 100##2##2##(1994-9#2)
using 11##3##2##(2008-10#2)(2013-8#1)
using 12##5##2##(1994-7#1)(2008-10#2)(2008-12#2)
using 15##2##2##(2008-10#1)(2008-12#1)
using 16##4##2##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
using 16S rRNA gene##2##4##(2011-1#1)(2011-2#1)
using 18##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
using 19F##2##2##(1994-8#1)(1996-2#1)
using 1H##2##2##(1996-5#1)(2008-12#1)
using 1H-NMR spectroscopy##2##3##(1990-5#1)(1991-12#1)
using 2 mM##2##3##(1994-9#1)(2008-10#1)
using 2##14##2##(1990-2#1)(1994-9#1)(2008-10#8)(2008-6#2)(2008-8#1)(2011-2#1)
using 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##2##2##(2008-10#2)
using 2-D##2##2##(2008-2#1)(2008-4#1)
using 20##3##2##(2008-10#2)(2010-8#1)
using 200##2##2##(1996-5#1)(2012-3#1)
using 23Na nuclear magnetic resonance##2##5##(1994-3#2)
using 3##8##2##(1991-2#1)(1992-12#1)(1995-11#1)(1997-4#1)(2008-10#3)(2009-10#1)
using 3D##3##2##(2008-6#1)(2008-7#1)(2010-8#1)
using 4##4##2##(2006-10#1)(2008-10#2)(2010-3#1)
using 40##2##2##(2009-8#1)(2012-12#1)
using 4M aqueous HCl to yield##2##6##(2010-8#2)
using 5 ml##3##3##(2008-10#3)
using 5##9##2##(2008-10#8)(2012-2#1)
using 50##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
using 500##2##2##(2008-11#1)(2008-9#1)
using 8##5##2##(2008-10#3)(2008-8#1)(2009-10#1)
using AAS##2##2##(2008-10#2)
using AFLP##2##2##(2008-10#2)
using AFM##2##2##(2008-10#2)
using Advanced##2##2##(2008-5#1)(2013-8#1)
using Affymetrix##2##2##(2008-8#1)(2009-8#1)
using Akaike's##2##2##(2008-10#1)(2008-9#1)
using Amberlite XAD-16##2##3##(2008-10#2)
using Amberlite XAD-2##2##3##(2008-10#2)
using Amberlite##4##2##(2008-10#4)
using C##4##2##(1993-9#1)(2007-12#1)(2008-10#1)(2008-6#1)
using C(18)##2##2##(2008-10#2)
using C18##2##2##(2008-10#2)
using C8 cartridges##2##3##(2008-10#2)
using CD##2##2##(1995-3#1)(2008-8#1)
using CE##3##2##(1994-12#2)(2008-10#1)
using CEUS##2##2##(2008-7#1)(2012-2#1)
using CHO##2##2##(1996-5#1)(2008-2#1)
using COS-1 cells##2##3##(1994-11#1)(1995-6#1)
using COS-1##3##2##(1994-11#1)(1995-6#1)(2008-11#1)
using COX-2##3##2##(2010-2#1)(2011-2#1)(2013-8#1)
using CT with##2##3##(2008-7#1)(2012-12#1)
using CT##5##2##(2008-7#2)(2008-9#1)(2012-12#2)
using Chinese##2##2##(2008-11#1)(2011-1#1)
using Codessa Pro##2##3##(2009-3#2)
using Coomassie##2##2##(1992-8#1)(2008-10#1)
using Cox##2##2##(2007-10#1)(2011-2#1)
using DNA from##2##3##(2008-10#2)
using DNA##20##2##(1991-9#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-5#2)(2012-2#1)(2012-3#1)(2013-1#1)
using Dega and Salter##2##4##(2007-8#2)
using Doehlert##3##2##(2008-10#3)
using Doppler##3##2##(1990-6#1)(2010-10#1)(2013-1#1)
using Drosophila##2##2##(2008-2#1)(2010-4#1)
using Dsquame(R)##2##2##(2008-5#2)
using Dynalign on##2##3##(2008-4#2)
using Dynalign##3##2##(2008-4#3)
using E##2##2##(1997-6#1)(2011-1#1)
using EDTA as##3##3##(2008-10#3)
using ELISA##5##2##(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
using FAAS##2##2##(2008-10#2)
using FT-IR spectroscopy##3##3##(2008-10#3)
using FT-IR##5##2##(2008-10#3)(2008-7#2)
using FTIR##2##2##(2008-10#2)
using Fisher's exact test##2##4##(1995-12#1)(2008-12#1)
using Fourier transform infrared (FT-IR)##2##5##(2007-12#2)
using Fourier transform infrared##4##4##(2007-12#2)(2008-10#2)
using Fourier##5##2##(1993-11#1)(2007-12#2)(2008-10#2)
using Fourier-transform infrared##2##3##(2008-10#1)(2008-3#1)
using GC-FID##3##2##(2008-10#2)(2012-1#1)
using GC-MS##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
using Gene-Fizz##2##2##(1996-12#2)
using Gibbs sampling##2##3##(1997-7#1)(2011-2#1)
using Giemsa##2##2##(2008-12#2)
using HIC##2##2##(2008-10#2)
using HPLC and##3##3##(2008-10#2)(2008-7#1)
using HPLC separation##2##3##(2008-10#2)
using HPLC with##2##3##(1997-2#1)(2008-10#1)
using HPLC##15##2##(1990-12#1)(1990-8#1)(1992-2#1)(1994-8#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-7#1)
using HeLa##2##2##(1993-6#1)(2008-11#1)
using High##2##2##(2008-7#1)(2012-12#1)
using ICP-AES##2##2##(2008-10#2)
using ICP-MS##3##2##(2008-10#3)
using ISFETs##2##2##(2008-10#2)
using ITS##2##2##(2008-10#2)
using JPEG##2##2##(2008-3#2)
using Jones##2##2##(2008-2#1)(2008-3#1)
using Lactobacillus##2##2##(2008-12#1)(2008-6#1)
using MR##2##2##(2008-10#1)(2011-2#1)
using MRI##5##2##(1996-9#1)(1997-8#1)(2009-4#1)(2012-12#1)(2012-2#1)
using MTT##2##2##(1994-5#1)(1995-8#1)
using Medicare##2##2##(1994-1#1)(1995-3#1)
using Medline##2##2##(2008-10#1)(2008-7#1)
using Microsoft##2##2##(1994-3#1)(1996-2#1)
using MoAbs##2##2##(1993-8#2)
using Monte Carlo simulation##2##4##(2011-2#2)
using Monte Carlo simulations##2##4##(2007-11#1)(2008-2#1)
using Monte Carlo##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)
using N##8##2##(2008-10#8)
using N-methylpyridinium as##2##3##(2008-10#2)
using NMR##4##2##(1994-3#1)(2008-10#1)(2009-6#1)(2009-7#1)
using New Zealand White rabbits##2##5##(1994-3#2)
using P##2##2##(2008-10#1)(2012-12#1)
using PBL in##3##3##(2008-12#3)
using PBMC##4##2##(2011-2#4)
using PCR amplification##2##3##(1993-12#1)(2008-4#1)
using PCR##12##2##(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
using PCR-RFLP##5##2##(2008-10#1)(2008-12#2)(2008-8#1)(2011-2#1)
using PLS##3##2##(2008-10#2)(2008-5#1)
using PLS-1##2##2##(2008-10#2)
using PTFE##2##2##(2008-10#2)
using PUF##2##2##(2008-11#2)
using Pavlik harness and Frejka pillow##2##6##(2007-8#2)
using Pd as a permanent modifier##2##6##(2008-10#2)
using Poisson regression##2##3##(2008-10#1)(2010-1#1)
using Protein##2##2##(1990-11#1)(2008-11#1)
using Pseudomonas##2##2##(2008-10#2)
using PubMed##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
using R##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
using RAPD##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
using RFLP and##2##3##(2008-10#2)
using RFLP##3##2##(1996-12#1)(2008-10#2)
using RNA from##4##3##(1991-9#1)(1993-3#1)(1994-11#1)(1994-12#1)
using RNA##7##2##(1991-9#1)(1993-3#1)(1994-11#1)(1994-12#2)(2008-5#1)(2010-2#1)
using RP HPLC##2##3##(2010-3#1)(2012-2#1)
using RT-PCR##6##2##(1996-12#1)(1997-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
using Raman spectroscopy##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
using Rasch##2##2##(2012-2#2)
using S##2##2##(1996-6#1)(2008-8#1)
using SEM##2##2##(2008-7#1)(2008-8#1)
using SF-CO(2) at##2##3##(2008-10#2)
using SF-CO(2)##3##2##(2008-10#3)
using SPME##3##2##(2008-10#3)
using SPSS##4##2##(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
using SYBR Green I##2##4##(2008-10#1)(2012-3#1)
using Sep Pac##2##3##(1991-12#2)
using Sephadex##2##2##(1997-2#1)(2008-10#1)
using Student's t-test##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
using Student's##7##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
using T-matrix##2##2##(2008-2#1)(2008-3#1)
using TGS##2##2##(2008-10#2)
using TachoComb##2##2##(2007-8#2)
using TaqMan##4##2##(2008-10#3)(2008-12#1)
using Triton##3##2##(1991-8#1)(2008-10#2)
using TurboSEQUEST##2##2##(2008-4#2)
using USP##2##2##(2012-2#2)
using UV detection##2##3##(2008-10#2)
using UV##8##2##(1997-4#1)(2008-10#5)(2008-5#1)(2013-8#1)
using UV-Vis##2##2##(2008-10#1)(2009-9#1)
using W-Rh##2##2##(2008-10#2)
using Web##2##2##(1996-12#1)(2008-11#1)
using X-ray absorption##2##3##(2008-10#2)
using X-ray diffraction##3##3##(2008-10#3)
using X-ray##6##2##(2008-10#6)
using Zeeman effect background correction##2##5##(2008-10#2)
using a &quot##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
using a 0##4##3##(1995-11#1)(2007-12#1)(2008-10#2)
using a 1##4##3##(1997-3#1)(2008-10#2)(2008-11#1)
using a 2##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
using a 20 mM borate buffer (pH##2##7##(2008-10#2)
using a 4##2##3##(1990-12#1)(2008-10#1)
using a 5##5##3##(2008-10#3)(2008-8#1)(2013-1#1)
using a 60 s preconcentration time##2##6##(2008-10#2)
using a 60##4##3##(2008-10#2)(2008-5#1)(2009-11#1)
using a C(18) column##2##4##(2008-10#2)
using a C(18)##3##3##(2008-10#2)(2009-8#1)
using a Neyman-Scott cluster process##2##5##(2008-10#2)
using a PTFE##2##3##(2008-10#2)
using a TEA CO2##2##4##(2007-12#2)
using a UV detector at##2##5##(2008-10#2)
using a UV detector##3##4##(2008-10#3)
using a UV##5##3##(1995-11#1)(2008-10#4)
using a baculovirus expression system##2##5##(1992-10#1)(1993-6#1)
using a battery of##3##4##(2008-2#1)(2009-10#2)
using a beta-cyclodextrin##2##3##(2011-1#2)
using a binary##3##3##(1992-9#1)(2008-10#1)(2008-3#1)
using a broadband##2##3##(2012-2#2)
using a cDNA array##2##4##(2008-10#1)(2008-9#1)
using a cDNA##4##3##(1991-6#1)(1992-8#1)(2008-10#1)(2008-9#1)
using a calculator##2##3##(2008-11#2)
using a canine##3##3##(2009-8#1)(2010-4#1)(2012-3#1)
using a capillary##3##3##(2008-10#3)
using a carbon paste electrode modified with##4##7##(2008-10#4)
using a carbon paste electrode modified##6##6##(2008-10#6)
using a carbon##7##3##(2008-10#7)
using a central composite design##4##5##(2008-10#4)
using a central composite##5##4##(2008-10#4)(2008-11#1)
using a chemical##2##3##(2008-10#1)(2008-7#1)
using a chromatographic##2##3##(2008-10#2)
using a closed##2##3##(2008-10#1)(2008-6#1)
using a closed-loop##2##3##(2007-11#1)(2010-5#1)
using a column##5##3##(2008-10#4)(2008-2#1)
using a combination of##35##4##(1990-8#1)(1992-3#1)(1993-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)
using a combined##4##3##(2008-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
using a commercial##7##3##(1993-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-5#1)
using a commercially available##5##4##(1993-9#1)(1994-2#1)(2008-10#3)
using a common spectrofluorometer##4##4##(2008-10#4)
using a common##10##3##(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
using a comparative##3##3##(2008-10#2)(2012-3#1)
using a competitive##3##3##(1991-9#1)(1997-4#1)(2008-10#1)
using a complete##3##3##(1993-11#1)(2008-12#1)(2012-3#1)
using a complex##3##3##(2008-10#2)(2008-8#1)
using a composite##2##3##(2008-10#1)(2008-2#1)
using a computer##4##3##(1990-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
using a computer-based##3##3##(1992-12#1)(2008-2#1)(2008-9#1)
using a confocal laser##2##4##(1994-9#1)(2008-9#1)
using a conjugate of##2##4##(2008-11#1)(2008-2#1)
using a conjugate##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
using a constant##3##3##(2008-10#2)(2008-11#1)
using a continuous glucose monitoring##2##5##(2008-1#1)(2012-4#1)
using a continuous##9##3##(1992-1#2)(2008-1#1)(2008-10#4)(2012-4#1)(2013-1#1)
using a conventional##10##3##(2008-10#7)(2008-5#1)(2009-10#1)(2009-8#1)
using a critical##2##3##(2008-4#1)(2008-7#1)
using a cross-linked##2##3##(2008-10#1)(2008-5#1)
using a crude##2##3##(1992-12#1)(2008-10#1)
using a cylindrical##2##3##(2008-10#1)(2008-3#1)
using a diffusion##2##3##(2008-10#1)(2008-2#1)
using a digital##4##3##(1993-11#1)(2008-12#1)(2008-7#1)(2012-6#1)
using a direct##4##3##(2008-10#3)(2010-6#1)
using a double##2##3##(1994-12#1)(2008-10#1)
using a dual##3##3##(1997-2#1)(2008-10#1)(2009-8#1)
using a dynamic##4##3##(2007-5#1)(2008-10#2)(2008-12#1)
using a factorial design##2##4##(2008-10#1)(2010-4#1)
using a factorial##3##3##(2008-10#2)(2010-4#1)
using a fast##3##3##(2008-10#2)(2008-6#1)
using a fiber optic##3##4##(2008-10#2)(2010-6#1)
using a fiber##4##3##(2008-10#2)(2008-2#1)(2010-6#1)
using a fibrin-glue coated collagen patch##3##6##(2007-8#3)
using a fixed##5##3##(2007-9#1)(2008-10#2)(2008-3#1)(2012-1#1)
using a flow cytometer##4##4##(1994-2#2)(2008-9#2)
using a flow injection system with##3##6##(2008-10#3)
using a flow injection system##6##5##(2008-10#6)
using a flow injection##10##4##(2008-10#10)
using a flow system##2##4##(2008-10#2)
using a flow##20##3##(1994-2#2)(1997-7#1)(2008-1#1)(2008-10#13)(2008-9#2)(2011-2#1)
using a flow-injection system##2##4##(2008-10#2)
using a flow-injection##3##3##(2008-10#3)
using a flow-through##2##3##(2008-10#2)
using a fluorescence##2##3##(1993-11#1)(2008-1#1)
using a fluoride##2##3##(2008-10#2)
using a fluoride-selective electrode##2##4##(2008-10#2)
using a focalized##3##3##(2008-10#3)
using a focused microwave oven##2##5##(2008-10#2)
using a focused##3##3##(2008-10#2)(2013-1#1)
using a fully automated##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
using a fully##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
using a function##2##3##(2008-10#2)
using a general##2##3##(2008-10#1)(2013-1#1)
using a generalized##3##3##(2008-3#1)(2012-1#2)
using a genome-wide##2##3##(2008-9#1)(2013-1#1)
using a glassy carbon electrode##3##5##(2008-10#3)
using a glassy carbon##4##4##(2008-10#4)
using a global##2##3##(2007-11#1)(2012-7#1)
using a gold binding polypeptide##2##5##(2008-10#2)
using a gold##4##3##(2008-10#3)(2008-12#1)
using a gradient flow##2##4##(2008-10#2)
using a graphite##2##3##(2008-10#2)
using a grounded theory##2##4##(2013-1#1)(2013-8#1)
using a hanging mercury drop electrode##4##6##(2008-10#4)
using a heating##2##3##(2008-10#2)
using a heterologous##2##3##(1994-8#1)(1997-4#1)
using a high frequency dielectric method##2##6##(2008-10#2)
using a high##8##3##(1990-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-12#1)
using a high-temperature##2##3##(1994-9#1)(2009-8#1)
using a high-volume sampler##2##4##(2008-10#2)
using a highly sensitive##2##4##(2011-2#1)(2013-1#1)
using a highly##6##3##(1992-11#1)(1994-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
using a human##3##3##(1993-12#1)(2008-11#1)(2012-3#1)
using a hybrid##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
using a large##2##3##(2008-10#1)(2009-10#1)
using a laser scanning cytometer##2##5##(2008-9#2)
using a laser##5##3##(2008-10#1)(2008-9#2)(2009-7#1)(2013-8#1)
using a lateral##3##3##(2007-11#1)(2008-10#1)(2009-10#1)
using a life##2##3##(2009-9#1)(2011-2#1)
using a light microscope##3##4##(2008-4#1)(2008-9#1)(2011-2#1)
using a limited##2##3##(1990-12#1)(2009-8#1)
using a linear model##3##4##(2008-3#1)(2009-6#1)(2010-2#1)
using a linear##10##3##(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2009-6#1)(2010-2#1)
using a liquid##2##3##(2008-10#2)
using a local##2##3##(1994-2#1)(2008-6#1)
using a locking plate system##3##5##(2010-3#3)
using a logarithmic##2##3##(2007-11#1)(2008-11#1)
using a long##2##3##(2007-12#1)(2008-3#1)
using a long-term##2##3##(2008-10#1)(2008-8#1)
using a low##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
using a lower##2##3##(2006-10#1)(2009-8#1)
using a magnetic##2##3##(2008-10#1)(2008-8#1)
using a mandelic acid dioxolanone as a synthetic equivalent##2##9##(2007-11#2)
using a manual##2##3##(1991-12#1)(2008-10#1)
using a mass spectrometer##2##4##(2008-4#1)(2010-6#1)
using a mass##3##3##(2008-4#1)(2009-10#1)(2010-6#1)
using a mathematical##2##3##(1992-2#1)(2008-10#1)
using a mechanical stapler##2##4##(1992-9#2)
using a metal##4##3##(1993-5#1)(2008-3#1)(2012-1#1)(2013-1#1)
using a method of##2##4##(2008-12#1)(2008-9#1)
using a method##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
using a micro-column packed with##2##5##(2008-10#2)
using a microplate reader##2##4##(1996-12#1)(2008-11#1)
using a mini-column##2##3##(2008-10#2)
using a mixed WO(3)-based##2##4##(2008-10#2)
using a mixture of##17##4##(2008-10#16)(2013-1#1)
using a mobile phase##3##4##(2008-10#3)
using a model in which##2##5##(2008-8#1)(2008-9#1)
using a model that##2##4##(2008-3#2)
using a model##12##3##(1994-8#1)(1995-9#1)(2008-10#3)(2008-3#2)(2008-8#1)(2008-9#2)(2012-1#1)(2012-2#1)
using a modified American Orthopaedic Foot and Ankle Society##2##9##(2009-10#2)
using a modified commercial##2##4##(2007-11#1)(2008-10#1)
using a modified version of the##3##6##(2008-1#1)(2008-10#1)(2008-4#1)
using a modified##23##3##(1994-11#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
using a monoclonal antibody##5##4##(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
using a monoclonal##6##3##(1993-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#2)
using a more##2##3##(1994-12#1)(2008-11#1)
using a moving##2##3##(2008-2#1)(2008-7#1)
using a multifunctional anaesthesia##2##4##(2011-2#2)
using a multimode##2##3##(2008-10#1)(2010-4#1)
using a multisyringe##3##3##(2008-10#3)
using a multivariate##4##3##(1991-3#1)(1993-12#1)(2008-10#1)(2012-12#1)
using a nested##2##3##(2010-6#1)(2011-2#1)
using a new automated##2##4##(1997-2#1)(2010-11#1)
using a new chelating##2##4##(2008-10#2)
using a new method##2##4##(2008-5#1)(2008-8#1)
using a new particle-mediated immunoassay##2##5##(2008-10#2)
using a new##32##3##(1991-5#1)(1994-6#1)(1995-2#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#15)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
using a newly developed##6##4##(1994-11#2)(1994-12#1)(1995-4#1)(2007-11#1)(2012-3#1)
using a newly synthesized##2##4##(2008-10#2)
using a newly##10##3##(1994-11#2)(1994-12#1)(1995-4#1)(2007-11#1)(2008-10#2)(2011-2#2)(2012-3#1)
using a non-detachable balloon catheter to##2##6##(1997-3#2)
using a non-linear##3##3##(1996-5#1)(2008-10#2)
using a nonionic##2##3##(2008-10#2)
using a normal##2##3##(1993-9#1)(2008-10#1)
using a novel fluorescence##2##4##(1997-7#1)(2007-11#1)
using a novel method##2##4##(1997-7#1)(2008-2#1)
using a novel##18##3##(1990-5#1)(1994-1#1)(1997-7#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-2#1)
using a number of##2##4##(2008-10#1)(2008-11#1)
using a one-pot##2##3##(1997-3#1)(2008-10#1)
using a pH 2##2##4##(2008-10#2)
using a pH##3##3##(2008-10#3)
using a pair of##3##4##(2008-3#2)(2008-9#1)
using a panel of##2##4##(1993-1#1)(1997-6#1)
using a partial least##2##4##(2008-10#2)
using a partial least-squares##2##4##(2008-10#2)
using a partial##6##3##(1994-8#1)(2008-10#4)(2008-8#1)
using a peripheral##3##3##(1990-8#2)(2008-4#1)
using a peristaltic pump##2##4##(2008-10#1)(2008-11#1)
using a photodiode array detector##2##5##(2008-10#2)
using a plasmid##2##3##(1991-3#1)(2007-7#1)
using a plastic##3##3##(1990-8#1)(1991-3#1)(2008-2#1)
using a polyurethane foam##2##4##(2008-10#1)(2008-11#1)
using a polyvinyl##2##3##(2008-10#2)
using a portable##4##3##(2008-10#2)(2009-1#1)(2013-1#1)
using a position laser system##2##5##(2008-7#2)
using a potentiometric sensor immobilized in a graphite matrix##2##9##(2008-10#2)
using a potentiometric##5##3##(2008-10#5)
using a preconcentration time of##4##5##(2008-10#4)
using a previous preconcentration step##2##5##(2008-10#2)
using a previously##4##3##(1990-8#1)(1992-1#1)(2008-10#1)(2013-1#1)
using a principal component analysis##2##5##(2008-10#1)(2013-7#1)
using a principal component##3##4##(2008-10#2)(2013-7#1)
using a probe for##2##4##(1990-8#1)(1997-3#1)
using a probe##6##3##(1990-8#1)(1991-6#1)(1993-8#1)(1994-12#1)(1997-3#1)(2008-3#1)
using a program##2##3##(2008-10#2)
using a protein##2##3##(1990-12#1)(1990-8#1)
using a prototype##4##3##(2007-8#1)(2008-2#1)(2008-6#1)(2010-11#1)
using a pulsed laser##2##4##(2008-10#1)(2012-2#1)
using a pulsed##5##3##(1990-2#1)(2008-10#2)(2008-2#1)(2012-2#1)
using a purge-and-trap system##2##4##(2008-10#2)
using a qualitative##2##3##(2008-11#1)(2013-1#1)
using a quantitative descriptive##2##4##(2008-10#1)(2010-4#1)
using a quantitative##4##3##(1992-5#1)(1997-2#1)(2008-10#1)(2010-4#1)
using a quartz crystal microbalance##2##5##(2008-10#2)
using a quartz##3##3##(2008-10#3)
using a questionnaire##11##3##(1992-1#1)(1993-3#1)(1993-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)
using a rabbit##2##3##(1991-10#1)(2008-10#1)
using a radioimmunoassay##2##3##(1990-2#1)(2008-3#1)
using a random##4##3##(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
using a randomized##3##3##(2008-8#1)(2013-1#2)
using a range of##5##4##(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
using a rapid##2##3##(2008-10#2)
using a rat##3##3##(1992-3#1)(1992-8#1)(1994-6#1)
using a ray-tracing##2##3##(2008-2#2)
using a real-time PCR##2##4##(2008-10#1)(2010-6#1)
using a recently developed##3##4##(1991-5#1)(1992-6#1)(2008-10#1)
using a recently##5##3##(1991-5#1)(1992-6#1)(2008-10#3)
using a recombinant inbred line##2##5##(2008-10#2)
using a recombinant##3##3##(2008-10#2)(2010-4#1)
using a relatively small amount of##2##6##(2008-10#1)(2008-7#1)
using a relatively small##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
using a repeated##2##3##(1993-3#1)(2008-11#1)
using a reversed##2##3##(1995-6#1)(2008-10#1)
using a reversed-phase##3##3##(1996-5#1)(2008-10#1)(2013-1#1)
using a sample of##4##4##(1995-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
using a sample volume of##2##5##(2008-10#2)
using a sample##8##3##(1994-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2012-12#1)
using a second##2##3##(2008-10#1)(2008-3#1)
using a secreted##2##3##(1995-2#2)
using a selective##3##3##(1991-5#1)(1992-2#1)(2011-1#1)
using a semi-automated##2##3##(2009-10#1)(2010-12#1)
using a semiconductor##3##3##(2008-2#1)(2008-3#2)
using a semistructured##4##3##(2007-11#1)(2009-5#1)(2010-9#1)(2011-1#1)
using a sensitive##3##3##(1996-5#1)(2008-10#2)
using a sequential injection analysis##2##5##(2008-10#2)
using a sequential injection system##3##5##(2008-10#3)
using a sequential injection##6##4##(2008-10#6)
using a sequential##9##3##(2008-10#9)
using a series of##3##4##(1997-6#1)(2008-10#1)(2008-8#1)
using a serum-free##2##3##(2008-11#1)(2008-7#1)
using a set of##8##4##(1995-8#1)(2008-10#4)(2008-8#1)(2009-10#1)(2011-1#1)
using a similar technique##2##4##(1991-3#1)(2008-3#1)
using a similar##4##3##(1990-2#1)(1991-3#1)(2008-3#1)(2009-10#1)
using a simple and##2##4##(2008-10#2)
using a simple heterogeneous mixture of reagents##2##7##(2008-5#2)
using a simple model##3##4##(1992-4#1)(1992-9#1)(2008-7#1)
using a simple##26##3##(1990-8#1)(1992-4#1)(1992-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2011-2#1)
using a simplified##2##3##(2008-10#1)(2008-8#1)
using a single excitation##2##4##(2008-9#1)(2011-1#1)
using a single extraction##2##4##(2008-10#2)
using a single##20##3##(1991-5#1)(1992-3#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#1)
using a small##2##3##(2008-10#1)(2012-1#1)
using a solid phase##2##4##(2008-10#1)(2013-8#1)
using a solid##5##3##(2008-10#4)(2013-8#1)
using a solid-phase attachment##2##4##(2008-10#2)
using a solid-phase extraction (SPE)##2##5##(2008-10#2)
using a solid-phase##6##3##(2008-1#1)(2008-10#5)
using a solution##2##3##(1991-9#1)(2008-10#1)
using a spatial##2##3##(2007-12#1)(2008-2#1)
using a spatially##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
using a special##4##3##(1994-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
using a specially##3##3##(2007-10#1)(2008-5#1)(2010-3#1)
using a specific antibody##2##4##(1992-12#1)(1997-1#1)
using a specific##9##3##(1990-5#1)(1992-12#2)(1993-8#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2013-1#1)
using a spectrophotometer##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
using a spectrophotometric##2##3##(2008-10#2)
using a square-wave##2##3##(2008-10#2)
using a standard curve##2##4##(1996-12#1)(2008-10#1)
using a standard protocol##2##4##(2008-10#1)(2012-2#1)
using a standard##18##3##(1991-12#1)(1992-10#1)(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
using a standardized##6##3##(2008-10#1)(2008-12#1)(2009-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
using a structured questionnaire##4##4##(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
using a structured##6##3##(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
using a sucrose##2##3##(1995-2#1)(2008-1#1)
using a suitable##2##3##(2008-10#2)
using a surface plasmon resonance (SPR) biosensor##2##7##(2008-10#1)(2008-4#1)
using a surface plasmon resonance##3##5##(2008-10#2)(2008-4#1)
using a surface##5##3##(2008-10#3)(2008-4#1)(2008-5#1)
using a surgical##3##3##(1994-9#1)(2008-9#1)(2012-3#1)
using a survey##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
using a synthetic##8##3##(1990-7#1)(1994-12#2)(1995-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
using a system with##2##4##(2008-2#1)(2011-1#1)
using a system##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
using a target##2##3##(2008-10#1)(2008-3#1)
using a technique##5##3##(2008-10#2)(2008-7#1)(2009-11#1)(2010-3#1)
using a test##2##3##(2009-3#1)(2013-1#1)
using a thermodynamic##2##3##(1993-11#1)(2008-10#1)
using a thin##2##3##(2008-10#2)
using a three##2##3##(2008-10#1)(2008-5#1)
using a threshold##2##3##(2011-1#1)(2013-1#1)
using a total of##3##4##(1990-11#1)(1994-5#1)(2008-7#1)
using a total##4##3##(1990-11#1)(1994-5#1)(2008-3#1)(2008-7#1)
using a traditional##2##3##(2008-10#2)
using a two-color##2##3##(1997-3#1)(2008-2#1)
using a two-stage##2##3##(2008-11#1)(2011-2#1)
using a typical##3##3##(2008-3#1)(2008-7#1)(2009-5#1)
using a unique##2##3##(2008-10#1)(2012-3#1)
using a validated##3##3##(2010-3#1)(2010-7#1)(2012-12#1)
using a variable##2##3##(2007-11#1)(2008-10#1)
using a variety of methods##3##5##(1993-3#1)(2008-10#1)(2008-12#1)
using a variety of##14##4##(1992-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#1)
using a video##2##3##(1993-12#1)(2013-1#1)
using a virtual learning environment (VLE)##2##6##(2008-12#2)
using a visual##3##3##(1996-12#1)(2008-10#1)(2012-1#1)
using a water mobile phase##3##5##(2008-10#3)
using a water-soluble##2##3##(2008-10#2)
using a weakly##2##3##(2008-10#2)
using a well##2##3##(2008-7#1)(2013-1#1)
using a whole##2##3##(2011-1#1)(2011-2#1)
using a yeast##2##3##(1994-12#1)(2008-9#1)
using a##1888##2##(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#5)(1990-7#3)(1990-8#12)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-5#6)(1991-6#3)(1991-9#2)(1992-1#8)(1992-10#2)(1992-11#5)(1992-12#7)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#7)(1992-8#3)(1992-9#13)(1993-1#2)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#5)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#5)(1994-1#1)(1994-11#8)(1994-12#11)(1994-2#8)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#7)(1995-12#2)(1995-2#12)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#6)(1996-3#2)(1996-5#6)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#9)(1997-4#5)(1997-6#4)(1997-7#8)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#5)(2007-11#30)(2007-12#30)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#19)(2007-9#2)(2008-1#12)(2008-10#671)(2008-11#67)(2008-12#21)(2008-2#57)(2008-3#71)(2008-4#19)(2008-5#57)(2008-6#18)(2008-7#51)(2008-8#27)(2008-9#42)(2009-1#2)(2009-10#17)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#7)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#22)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#7)(2010-12#5)(2010-2#5)(2010-3#14)(2010-4#7)(2010-5#2)(2010-6#10)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#23)(2011-2#46)(2011-3#2)(2012-1#12)(2012-12#19)(2012-2#28)(2012-3#24)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#52)(2013-7#7)(2013-8#16)
using absorbable##2##2##(1992-2#1)(2012-12#1)
using absorbance spectroscopy##2##3##(2008-4#1)(2010-11#1)
using absorbance##4##2##(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
using accelerated solvent extraction##2##4##(2008-10#2)
using acellular dermis##2##3##(2008-9#2)
using acetone##2##2##(1992-8#1)(2008-7#1)
using acetonitrile and##2##3##(2008-10#1)(2011-1#1)
using acetonitrile##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
using acid##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
using acidic##2##2##(2008-10#1)(2012-3#1)
using acidified##2##2##(2008-10#2)
using actual##2##2##(2007-12#1)(2009-7#1)
using adaptive##2##2##(2007-12#1)(2012-12#1)
using additional##3##2##(1991-3#1)(2008-4#1)(2008-7#1)
using administrative##2##2##(1996-1#1)(1996-3#1)
using adsorptive stripping voltammetry##2##4##(2008-10#2)
using adsorptive##3##2##(2008-10#3)
using affected sib pair##2##4##(1997-5#2)
using agents that##2##3##(2006-10#1)(2008-3#1)
using air##3##2##(2008-10#1)(2008-6#1)(2009-5#1)
using alkaline##3##2##(2008-10#2)(2008-5#1)
using all the##3##3##(2008-2#1)(2009-2#1)(2013-8#1)
using all three##3##3##(2008-10#2)(2008-11#1)
using all##8##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2013-8#1)
using allograft##3##2##(2009-10#2)(2012-3#1)
using alternative##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
using ammonium##4##2##(1997-4#1)(2008-10#3)
using amniotic membranes##2##3##(1993-1#2)
using amperometric biosensors##2##3##(2008-10#2)
using amperometric##3##2##(2008-10#3)
using amperometry##2##2##(2008-10#2)
using amplified fragment length polymorphism (AFLP) and##3##7##(2008-10#3)
using amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#2)
using amplified fragment length polymorphism (AFLP)##6##6##(2008-10#6)
using amplified fragment length polymorphism##9##5##(2008-10#9)
using amplified fragment length##10##4##(2008-10#10)
using amplified##12##2##(1990-12#1)(2008-10#10)(2008-11#1)
using amylose as a substrate##2##5##(1990-9#2)
using an ELISA##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
using an HPLC system##2##4##(2008-10#2)
using an HPLC##3##3##(2008-10#3)
using an ODS column##2##4##(2008-10#2)
using an XTT##2##3##(2011-2#1)(2013-1#1)
using an acetate buffer as a carrier##2##7##(2008-10#2)
using an acid##3##3##(2008-10#3)
using an affinity##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
using an allele-specific##2##3##(1995-12#1)(2008-4#1)
using an alternative##3##3##(1992-3#1)(2008-12#1)(2009-8#1)
using an amperometric##2##3##(2008-10#2)
using an analysis of##2##4##(2007-10#1)(2008-10#1)
using an analysis##3##3##(2007-10#1)(2008-10#2)
using an analytical##2##3##(1991-12#1)(2008-3#1)
using an anion##2##3##(1996-12#1)(2008-10#1)
using an anion-exchange##3##3##(2008-10#3)
using an antibody##3##3##(1995-5#1)(2008-10#1)(2009-8#1)
using an appropriate##2##3##(2008-10#1)(2008-3#1)
using an aqueous solution##2##4##(2008-10#2)
using an aqueous##4##3##(2008-10#4)
using an array of##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
using an artificial neural network##2##5##(2008-10#1)(2008-8#1)
using an artificial##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
using an assay##3##3##(1990-7#1)(1991-12#1)(1992-12#1)
using an atomic absorption##2##4##(2008-10#2)
using an atomic##3##3##(2008-10#2)(2010-4#1)
using an automated system##2##4##(2008-10#1)(2008-4#1)
using an automated##8##3##(2007-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-7#1)
using an automatic##2##3##(1991-12#1)(2008-10#1)
using an avocado##2##3##(2008-10#2)
using an efficient##2##3##(2008-3#1)(2013-1#1)
using an electrochemical##2##3##(2008-10#2)
using an electron##2##3##(2008-10#2)
using an electronic nose##2##4##(2008-10#1)(2008-11#1)
using an electronic portal imaging device##2##6##(1993-9#1)(2009-2#1)
using an electronic##6##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2013-1#1)
using an empirical##2##3##(2008-7#1)(2012-3#1)
using an endovascular##3##3##(1991-3#1)(2007-10#2)
using an enzymatic##5##3##(1992-11#1)(2008-10#4)
using an enzyme immunoassay##2##4##(1990-5#1)(2008-5#1)
using an enzyme-linked immunosorbent assay##2##5##(2008-10#2)
using an epidural##2##3##(1993-10#1)(2007-2#1)
using an experimental design approach##2##5##(2008-10#2)
using an experimental design##4##4##(2008-10#4)
using an external##2##3##(1990-9#1)(2007-12#1)
using an image##3##3##(1991-6#1)(1995-8#1)(1996-5#1)
using an improved##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
using an in situ##2##4##(1995-3#1)(2008-10#1)
using an in vitro##6##4##(1991-9#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-7#1)
using an in##10##3##(1991-9#1)(1994-11#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#1)
using an indirect##2##3##(2008-10#1)(2008-11#1)
using an infrared##2##3##(2007-12#1)(2008-7#1)
using an innovative##2##3##(2009-3#1)(2010-3#1)
using an integrated##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
using an ion##3##3##(2008-10#3)
using an on-line##5##3##(2008-10#5)
using an online##2##3##(2008-10#1)(2011-2#1)
using an optical##3##3##(1995-12#1)(2008-10#2)
using an oxygen electrode##2##4##(1992-11#1)(2008-10#1)
using an ultrasonic##2##3##(2008-10#1)(2008-11#1)
using an##371##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#2)(1996-12#1)(1996-5#3)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-10#6)(2007-11#5)(2007-12#7)(2007-2#1)(2007-8#5)(2008-1#2)(2008-10#141)(2008-11#16)(2008-12#3)(2008-2#12)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#12)(2012-1#4)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#9)(2013-8#2)
using analytical##2##2##(1992-2#1)(1993-3#1)
using and##4##2##(1991-2#1)(1994-2#1)(2008-4#1)(2009-8#1)
using animal##4##2##(2007-12#1)(2008-6#1)(2008-7#1)(2012-12#1)
using anodic##2##2##(2008-10#2)
using another##3##2##(2008-10#3)
using anthropometric##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
using anti##2##2##(2008-12#1)(2008-5#1)
using anti-inflammatory##3##2##(2008-5#1)(2008-7#1)(2009-12#1)
using antibiotics##2##2##(1993-2#1)(2012-3#1)
using antibodies against##5##3##(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
using antibodies specific for##3##4##(1993-6#1)(1994-8#1)(1995-3#1)
using antibodies##14##2##(1990-11#1)(1992-11#1)(1993-6#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
using antibody##4##2##(1993-12#1)(2008-4#1)(2008-8#1)(2010-11#1)
using antisense##3##2##(1991-9#1)(1993-6#1)(2008-11#1)
using antisera against##2##3##(1991-12#1)(2008-10#1)
using antisera##4##2##(1991-12#1)(1993-9#1)(2008-10#2)
using any##10##2##(1995-2#1)(2008-10#3)(2008-3#2)(2008-9#3)(2011-2#1)
using appropriate##6##2##(1990-12#1)(1992-6#1)(2008-4#1)(2012-2#3)
using aqueous##10##2##(2008-10#8)(2008-5#1)(2011-2#1)
using artificial intelligence techniques##2##4##(2010-8#2)
using artificial neural networks (ANN)##2##5##(2008-10#1)(2010-8#1)
using artificial neural networks##9##4##(1995-5#2)(2008-10#6)(2010-8#1)
using artificial neural##10##3##(1995-5#2)(2008-10#7)(2010-8#1)
using artificial##12##2##(1995-5#2)(2008-10#7)(2010-8#3)
using artificially##2##2##(2011-1#1)(2012-2#1)
using as a##3##3##(1990-2#1)(1990-9#1)(2008-10#1)
using as little as##2##4##(1997-4#1)(2008-11#1)
using as mobile phase##2##4##(2008-10#2)
using as probes##2##3##(1993-2#1)(1994-11#1)
using as##14##2##(1990-2#1)(1990-9#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-2#1)
using ascorbate##2##2##(1992-6#1)(2008-10#1)
using ascorbic acid##2##3##(2008-10#2)
using asymptotic##2##2##(2008-3#2)
using at least##2##3##(2007-12#1)(2008-10#1)
using atomic absorption spectrometry##4##4##(2008-10#3)(2009-6#1)
using atomic absorption##6##3##(2008-10#5)(2009-6#1)
using atomic force microscopy (AFM)##2##5##(2008-10#1)(2008-8#1)
using atomic##8##2##(2008-10#6)(2008-8#1)(2009-6#1)
using attenuated total##2##3##(2007-12#1)(2008-10#1)
using autogenic bone grafts##2##4##(2007-11#2)
using autologous rib##3##3##(2012-3#3)
using autologous##6##2##(2008-11#1)(2011-2#1)(2012-3#3)(2013-1#1)
using automated##5##2##(1991-5#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
using automatic##2##2##(2008-10#2)
using autoradiography##2##2##(1993-9#1)(2008-4#1)
using available##2##2##(2008-7#2)
using bacterial##2##2##(2008-10#1)(2008-4#1)
using balloon angioplasty##2##3##(1994-11#1)(2012-3#1)
using balloon##4##2##(1994-11#1)(2008-1#1)(2008-7#1)(2012-3#1)
using basic##2##2##(2008-3#1)(2012-1#1)
using batch##2##2##(2008-10#2)
using behavioural##2##2##(1993-6#1)(2007-7#1)
using beta-correction##3##2##(2008-10#3)
using binding##2##2##(1995-3#1)(1995-5#1)
using biochemical methods##2##3##(2008-12#1)(2013-7#1)
using biochemical##4##2##(1995-5#1)(2008-10#1)(2008-12#1)(2013-7#1)
using bioinformatics##2##2##(2008-4#1)(2008-7#1)
using biological##2##2##(2007-11#1)(2008-6#1)
using biotinylated estradiol##2##3##(2008-10#2)
using biotinylated##3##2##(1997-3#1)(2008-10#2)
using blood##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
using bone##2##2##(1996-11#1)(2008-7#1)
using borate##2##2##(2008-10#2)
using boron-doped diamond##2##3##(2008-10#2)
using both a##6##3##(2007-12#1)(2008-10#4)(2009-11#1)
using both an##2##3##(2008-2#1)(2010-11#1)
using both methods##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
using both the##10##3##(1994-9#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-6#1)
using both types of##2##4##(2008-10#1)(2013-1#1)
using both virulence##2##3##(2008-10#2)
using both##73##2##(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#2)(2013-1#1)
using bovine##6##2##(1991-5#1)(1992-9#1)(1994-5#1)(1994-9#1)(2008-10#1)(2008-7#1)
using bromate##2##2##(2008-10#2)
using bromocresol##2##2##(2008-10#2)
using bulk##2##2##(2008-10#1)(2008-3#1)
using bulked segregant analysis##4##4##(1995-6#1)(2008-10#2)(2008-5#1)
using cDNA##2##2##(2008-10#1)(2008-4#1)
using calibrated##4##2##(2006-6#1)(2008-3#1)(2008-5#1)(2009-11#1)
using cannabis##2##2##(2008-12#1)(2012-12#1)
using capillary electrophoresis with##3##4##(1994-9#1)(2008-10#2)
using capillary electrophoresis##7##3##(1994-9#2)(1997-2#1)(2008-10#3)(2008-4#1)
using capillary zone electrophoresis (CZE)##4##5##(2008-10#4)
using capillary##12##2##(1994-9#2)(1997-2#1)(2008-10#8)(2008-4#1)
using carbon dioxide##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
using carbon##6##2##(2008-10#4)(2012-2#1)(2012-3#1)
using carrageenan-induced paw edema##2##4##(2011-1#1)(2013-7#1)
using case##2##2##(1995-2#1)(2008-11#1)
using catalytic##3##2##(2008-10#2)(2012-2#1)
using cationic##3##2##(2008-1#2)(2008-10#1)
using cavity ringdown spectroscopy##2##4##(2008-3#2)
using celestial cues##2##3##(1994-3#2)
using cell culture##2##3##(2008-7#1)(2012-2#1)
using cell##6##2##(2008-11#2)(2008-7#3)(2012-2#1)
using cells##5##2##(2008-11#2)(2008-6#1)(2008-7#1)(2010-10#1)
using cellular##4##2##(1992-11#1)(1995-3#1)(2007-2#1)(2008-11#1)
using cellulose##2##2##(1994-3#1)(2008-5#1)
using cellulose-azure##2##2##(2008-10#2)
using central composite##2##3##(2008-10#2)
using certified##3##2##(2008-10#3)
using chelating##2##2##(2008-10#2)
using chemical##7##2##(1992-5#1)(2008-10#5)(2013-7#1)
using chemically modified##2##3##(2008-10#2)
using chemically##3##2##(1995-12#1)(2008-10#2)
using chemometric##2##2##(2008-10#2)
using chemometrics##3##2##(2008-10#3)
using chimeric##2##2##(2008-10#1)(2013-1#1)
using chloroquine##2##2##(1994-3#2)
using chromosome##2##2##(2008-5#1)(2013-1#1)
using claims data##2##3##(1996-1#1)(2009-9#1)
using classical methods##2##3##(2008-10#2)
using classical##5##2##(1990-2#1)(2008-10#4)
using clinical##3##2##(1997-5#1)(2008-3#1)(2011-2#1)
using cloned##4##2##(1995-11#1)(2008-10#2)(2008-9#1)
using closed##2##2##(1992-11#1)(2008-10#1)
using cluster analysis##2##3##(1992-11#1)(2008-11#1)
using co-immobilized##2##2##(2008-10#1)(2008-6#1)
using coalescent-based##2##2##(2009-2#1)(2010-6#1)
using cochlear implants and##2##4##(2008-9#2)
using cochlear implants##9##3##(2008-9#9)
using cold##2##2##(2008-8#1)(2010-5#1)
using colloidal##4##2##(2008-10#4)
using colorimetric##2##2##(2008-10#1)(2009-8#1)
using column##2##2##(1994-11#1)(2008-10#1)
using columns##2##2##(2008-10#1)(2011-2#1)
using combination therapy##2##3##(2010-11#1)(2012-12#1)
using combinations of##2##3##(2010-10#1)(2012-12#1)
using combined##4##2##(2007-11#1)(2008-10#1)(2009-12#1)(2012-2#1)
using commercial##9##2##(1995-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2011-7#1)(2012-2#1)
using commercially available##7##3##(1991-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)
using common##6##2##(1993-2#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)
using competing##2##2##(2008-7#1)(2013-1#1)
using competition##2##2##(2008-4#1)(2012-3#1)
using competitive##2##2##(2008-10#2)
using completely##2##2##(2008-10#1)(2008-5#1)
using composite interval##2##3##(2008-10#2)
using composite##3##2##(2008-10#3)
using computational##2##2##(2012-2#1)(2013-1#1)
using computed tomography (CT)##3##4##(2008-11#1)(2010-1#1)(2013-1#1)
using computed tomography##6##3##(2008-11#2)(2010-1#1)(2011-2#2)(2013-1#1)
using computer technology##2##3##(2008-9#2)
using computer##5##2##(2008-1#1)(2008-3#1)(2008-9#2)(2012-3#1)
using computer-assisted##2##2##(1991-12#1)(2008-10#1)
using computerized##6##2##(1992-9#1)(2008-11#3)(2008-5#1)(2009-12#1)
using computers##3##2##(2008-11#1)(2013-8#2)
using concentrated##2##2##(2008-10#1)(2008-9#1)
using concentrations of##2##3##(1990-11#1)(2008-11#1)
using condoms##8##2##(1993-2#1)(1997-3#1)(1997-6#2)(2010-7#3)(2011-1#1)
using confocal laser##2##3##(1995-5#1)(2010-8#1)
using confocal microscopy##6##3##(1997-1#1)(2008-11#2)(2008-9#2)(2011-2#1)
using confocal##12##2##(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#1)
using connected-component contours##2##3##(2008-6#2)
using conserved##2##2##(2008-10#2)
using constant##3##2##(2006-12#1)(2008-10#1)(2009-9#1)
using contact##2##2##(1997-2#1)(2008-10#1)
using content##2##2##(2008-2#1)(2012-3#1)
using continuous##7##2##(1994-12#2)(1994-3#1)(1995-11#1)(2007-8#1)(2008-10#2)
using contraception##2##2##(1991-6#1)(2012-12#1)
using contrast-enhanced ultrasound##2##3##(2008-7#1)(2010-12#1)
using controlled##2##2##(2008-7#1)(2012-4#1)
using conventional and##2##3##(2008-10#1)(2008-9#1)
using conventional##24##2##(1993-12#1)(1993-8#1)(1995-5#1)(2007-5#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
using copper ions##2##3##(2008-10#2)
using copper##4##2##(2008-10#4)
using copper(II)-neocuproine##2##2##(2008-10#2)
using corona discharge ion mobility spectrometry##2##6##(2008-10#2)
using correlation##2##2##(1992-3#1)(2008-8#1)
using coupled##2##2##(2008-10#2)
using covalent##2##2##(2008-10#2)
using covalently closed circular##2##4##(1990-11#2)
using cromolyn sodium##2##3##(1995-12#1)(2011-1#1)
using crown ethers##2##3##(2008-10#2)
using culture##4##2##(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
using cultured##3##2##(1992-12#1)(1994-5#1)(2008-11#1)
using current##6##2##(1992-2#1)(1993-12#1)(2007-8#1)(2008-10#1)(2010-3#1)(2012-12#1)
using currently##2##2##(2008-10#1)(2010-11#1)
using cyclic and differential pulse voltammetry##2##6##(2008-10#2)
using cyclic and square-wave voltammetry##2##5##(2008-10#2)
using cyclic and##4##3##(2008-10#4)
using cyclic voltammetry (CV) and##3##5##(2008-10#3)
using cyclic voltammetry (CV)##4##4##(2008-10#4)
using cyclic voltammetry and##3##4##(2008-10#3)
using cyclic voltammetry##15##3##(2008-10#13)(2008-6#1)(2009-9#1)
using cyclic##22##2##(2008-10#20)(2008-6#1)(2009-9#1)
using cylindrical##2##2##(1995-12#1)(2012-1#1)
using data collected from##5##4##(2008-10#4)(2008-12#1)
using data collected##7##3##(1994-11#1)(2008-10#4)(2008-12#1)(2008-7#1)
using data from a##5##4##(1992-9#1)(1993-9#1)(2008-8#1)(2008-9#1)(2009-10#1)
using data from the National##2##5##(1995-12#1)(2009-7#1)
using data from the##10##4##(1990-2#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-9#1)(2008-10#1)(2009-7#1)(2011-2#2)(2012-2#1)
using data from##33##3##(1990-12#1)(1990-2#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-1#1)(2006-4#1)(2007-5#1)(2008-10#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-2#1)
using data on##3##3##(1997-1#1)(2008-8#1)(2010-8#1)
using data##52##2##(1990-12#1)(1990-2#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-1#2)(2006-4#1)(2007-5#1)(2008-10#11)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
using deep##2##2##(2007-8#1)(2008-8#1)
using degenerate oligonucleotides designed##2##4##(1996-8#1)(2008-10#1)
using degenerate oligonucleotides##3##3##(1993-8#1)(1996-8#1)(2008-10#1)
using degenerate primers##4##3##(2008-10#4)
using degenerate##9##2##(1993-8#1)(1994-12#1)(1996-8#1)(1997-6#1)(2008-10#5)
using denaturing##2##2##(2008-4#1)(2008-9#1)
using density functional theory##2##4##(1996-2#1)(2013-8#1)
using density##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
using derivative spectrophotometry and##3##4##(2008-10#3)
using derivative spectrophotometry##4##3##(2008-10#4)
using derivative##7##2##(2008-10#7)
using deuterium-labeled##2##2##(1994-8#1)(2008-10#1)
using diagnosis-related groups##2##3##(1991-1#1)(1991-12#1)
using diagnosis-related##3##2##(1991-1#1)(1991-12#1)(1995-2#1)
using diagnostic##3##2##(2010-6#1)(2013-1#2)
using different cell##2##3##(2008-10#1)(2008-11#1)
using different in vitro##3##4##(2008-5#1)(2008-9#1)(2011-1#1)
using different methods##2##3##(1990-5#1)(2008-5#1)
using different models of##2##4##(1996-5#1)(2012-2#1)
using different types of##2##4##(2008-10#1)(2011-2#1)
using different##70##2##(1990-5#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
using differential display##2##3##(2008-8#1)(2010-12#1)
using differential pulse polarography##4##4##(2008-10#4)
using differential pulse##7##3##(1995-5#1)(2008-10#6)
using differential##16##2##(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)
using diffuse reflectance spectroscopy##2##4##(2008-10#2)
using diffuse reflectance##4##3##(2008-10#4)
using digital image analysis of light micrographs and##2##8##(2008-10#2)
using digital signal processing techniques##2##5##(1994-12#1)(2010-8#1)
using digital##5##2##(1994-12#1)(2008-10#2)(2009-12#1)(2010-8#1)
using dilute##2##2##(2008-10#1)(2013-1#1)
using dimethyl-beta-cyclodextrin##2##2##(2008-10#2)
using dimethylsulfoxide##3##2##(2008-10#2)(2008-5#1)
using diode##2##2##(2008-2#1)(2008-3#1)
using direct LA-ICP-MS##2##3##(2008-10#2)
using direct##12##2##(1992-3#1)(2008-10#6)(2008-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#1)
using discrete##2##2##(2008-10#1)(2013-8#1)
using disease##3##2##(1997-5#1)(2008-10#2)
using disposable##2##2##(1992-12#1)(2008-8#1)
using distance##2##2##(2008-11#1)(2012-3#1)
using dithizone##3##2##(2008-10#3)
using dot blot hybridization##2##4##(1994-1#1)(2008-10#1)
using double##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
using drugs that##2##3##(2008-3#1)(2012-1#1)
using drugs##4##2##(1996-3#1)(2007-12#1)(2008-3#1)(2012-1#1)
using dry##2##2##(2008-10#1)(2010-4#1)
using dual##5##2##(1994-11#1)(2008-10#3)(2011-1#1)
using dual-energy X-ray absorptiometry##2##4##(2008-10#1)(2008-7#1)
using duplex oligomers containing##2##4##(2008-11#2)
using duplex##3##2##(2008-11#2)(2013-1#1)
using dynamic##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
using each of the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
using each##7##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
using early##2##2##(1994-6#1)(2009-8#1)
using ecological##2##2##(2010-1#1)(2011-2#1)
using eight primer##2##3##(2008-10#2)
using eight##4##2##(2008-10#3)(2011-2#1)
using either a##5##3##(1992-5#1)(2008-10#2)(2008-9#1)(2011-1#1)
using either the##6##3##(1992-11#1)(1992-3#1)(2008-2#2)(2008-4#1)(2010-8#1)
using either##44##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
using electrical stimulation##2##3##(2008-5#1)(2009-10#1)
using electrical##3##2##(2008-12#1)(2008-5#1)(2009-10#1)
using electrochemical##5##2##(2008-10#3)(2008-5#1)(2009-10#1)
using electrolytic deposition##2##3##(2008-10#2)
using electromagnetic##3##2##(2008-3#1)(2009-12#1)(2012-3#1)
using electron microscopy##3##3##(1997-7#1)(2008-11#2)
using electron paramagnetic resonance##2##4##(2008-10#1)(2008-5#1)
using electron##8##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
using electronic##3##2##(1993-12#1)(1996-1#1)(2013-8#1)
using electrophoresis##2##2##(2008-10#1)(2008-5#1)
using electrospray##2##2##(2008-10#2)
using electrothermal atomic absorption spectrometry (ETAAS)##2##6##(2008-10#2)
using electrothermal atomic absorption spectrometry with slurry##2##7##(2008-10#2)
using electrothermal atomic absorption spectrometry with##3##6##(2008-10#3)
using electrothermal atomic absorption spectrometry##6##5##(2008-10#6)
using electrothermal##7##2##(2008-10#7)
using embryonic##2##2##(1996-5#1)(2008-8#1)
using empirical equations##2##3##(2008-10#2)
using enantioselective##2##2##(2008-10#2)
using endogenous##2##2##(1997-7#1)(2008-4#1)
using endoscopic##4##2##(2008-10#2)(2009-4#1)(2013-1#1)
using environmental##2##2##(1996-3#1)(2008-9#1)
using enzyme##3##2##(1992-8#1)(2008-10#2)
using enzyme-linked##3##2##(2008-10#2)(2008-6#1)
using equipment##3##2##(2008-4#2)(2010-8#1)
using error-prone PCR##2##3##(2008-8#1)(2011-1#1)
using essentially##2##2##(2008-10#1)(2008-4#1)
using established##2##2##(2007-8#1)(2008-7#1)
using ethanol##3##2##(2008-6#2)(2008-8#1)
using ethyl##2##2##(2008-10#1)(2008-4#1)
using europium##2##2##(2008-10#2)
using evidence##3##2##(2008-11#1)(2009-11#1)(2009-3#1)
using evidence-based##2##2##(2007-5#1)(2008-8#1)
using examples from the literature##2##5##(2007-4#1)(2008-10#1)
using examples from the##3##4##(2007-4#1)(2008-10#1)(2008-7#1)
using examples from##4##3##(2007-4#1)(2008-10#2)(2008-7#1)
using examples##5##2##(2007-4#1)(2008-10#2)(2008-7#1)(2012-3#1)
using excised inside-out membrane patches##2##5##(1995-5#1)(2008-8#1)
using excised##4##2##(1995-5#1)(2008-5#2)(2008-8#1)
using excision##2##2##(2008-10#1)(2008-9#1)
using excitation-emission matrix##2##3##(2008-10#2)
using exfoliated graphite##2##3##(2008-10#2)
using existing##3##2##(2011-8#1)(2012-2#1)(2013-8#1)
using experimental design methodology##2##4##(2008-10#2)
using experimental design##5##3##(2008-10#4)(2008-6#1)
using experimental##8##2##(2008-10#5)(2008-3#1)(2008-6#1)(2009-9#1)
using exploratory##2##2##(2008-10#1)(2008-11#1)
using expression##2##2##(1997-7#1)(2008-11#1)
using external calibration##3##3##(2008-10#3)
using external##5##2##(2007-12#1)(2008-10#3)(2008-9#1)
using extracellular recording techniques##2##4##(1995-12#1)(2009-10#1)
using extracellular##3##2##(1995-12#1)(2008-11#1)(2009-10#1)
using extracts##2##2##(2008-10#1)(2009-6#1)
using fMRI##2##2##(2008-1#1)(2008-11#1)
using factor analysis##2##3##(2008-10#1)(2011-2#1)
using factorial design and##2##4##(2008-10#2)
using factorial design for optimization##2##5##(2008-10#2)
using factorial design##6##3##(2008-10#6)
using factorial##9##2##(2008-10#9)
using fast##2##2##(1992-3#1)(2008-5#1)
using femtosecond##3##2##(2007-12#2)(2013-8#1)
using fetal##2##2##(1994-3#1)(2012-2#1)
using fiber-optic##2##2##(2008-10#1)(2008-3#1)
using fibronectin-coated dishes##2##3##(2008-11#2)
using field##3##2##(2007-5#1)(2011-2#2)
using filter##2##2##(2008-12#1)(2008-3#1)
using finite##3##2##(2008-2#1)(2008-7#1)(2009-7#1)
using finite-difference time-domain##2##3##(2007-12#1)(2013-8#1)
using first##2##2##(1993-6#1)(2008-7#1)
using five##7##2##(2008-1#1)(2008-10#4)(2008-11#1)(2013-8#1)
using flame AAS##2##3##(2008-10#2)
using flame atomic absorption spectrometry (FAAS)##3##6##(2008-10#3)
using flame atomic absorption spectrometry##5##5##(2008-10#5)
using flame atomic absorption##8##4##(2008-10#7)(2011-2#1)
using flame##11##2##(2008-10#10)(2011-2#1)
using flow cytometric##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
using flow cytometry and##2##4##(2008-9#1)(2011-2#1)
using flow cytometry##15##3##(1993-8#2)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#5)(2009-6#1)(2011-2#3)
using flow electroporation##2##3##(2008-11#2)
using flow injection (FI)##2##4##(2008-10#2)
using flow injection analysis (FIA)##2##5##(2008-10#2)
using flow injection analysis with tris(2##3##6##(2008-10#3)
using flow injection analysis with##8##5##(2008-10#8)
using flow injection analysis##16##4##(2008-10#16)
using flow injection##34##3##(2008-10#34)
using flow##55##2##(1993-8#2)(1997-4#1)(2008-10#36)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#5)(2009-6#1)(2011-2#3)(2012-12#1)
using flow-injection analysis##3##3##(2008-10#3)
using flow-injection##11##2##(2008-10#10)(2010-4#1)
using flowing##2##2##(2008-10#1)(2010-5#1)
using fluorescein isothiocyanate##2##3##(2008-10#1)(2008-4#1)
using fluorescence detection##3##3##(1992-11#1)(1996-5#1)(2008-10#1)
using fluorescence in situ hybridisation##2##5##(2008-12#2)
using fluorescence in situ hybridization##3##5##(1997-4#1)(2008-11#1)(2008-9#1)
using fluorescence in situ##5##4##(1997-4#1)(2008-11#1)(2008-12#2)(2008-9#1)
using fluorescence microscopy##4##3##(1991-9#1)(1994-5#1)(2008-11#1)(2009-12#1)
using fluorescence resonance energy transfer##2##5##(1994-5#1)(2008-4#1)
using fluorescence spectroscopy##2##3##(1991-3#1)(2008-10#1)
using fluorescence techniques##2##3##(1995-5#1)(2008-7#1)
using fluorescence##27##2##(1991-3#1)(1991-9#1)(1992-11#1)(1994-5#2)(1994-6#1)(1995-5#2)(1996-5#1)(1997-4#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)
using fluorescent##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
using fluorimetric detection##2##3##(2008-10#2)
using focus group discussions##2##4##(2008-11#1)(2008-12#1)
using focus group##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
using focus##5##2##(2008-11#2)(2008-12#2)(2010-10#1)
using focused##2##2##(2007-12#1)(2008-3#1)
using follistatin##2##2##(1992-6#2)
using food##2##2##(1994-12#1)(2013-1#1)
using four different##2##3##(2008-10#1)(2009-11#1)
using four##14##2##(1991-9#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-4#1)(2013-1#1)
using fractional##2##2##(2007-11#1)(2013-1#1)
using free##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
using free-flow electrophoresis##2##3##(2008-1#1)(2008-4#1)
using frequencies##3##2##(2007-11#1)(2012-12#2)
using frequency##2##2##(1991-2#1)(2008-7#1)
using full##4##2##(2008-10#3)(2013-1#1)
using functional##5##2##(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)
using fura-2##2##2##(1992-9#1)(2013-1#1)
using fuzzy##2##2##(2008-5#1)(2013-8#1)
using galvanostatic##2##2##(2008-10#1)(2009-10#1)
using gas chromatography with electron capture detection##2##7##(2008-10#2)
using gas chromatography with##3##4##(2008-10#3)
using gas chromatography##10##3##(2007-12#1)(2008-10#9)
using gas chromatography-mass spectrometry##4##4##(1992-8#1)(1994-2#1)(2008-10#1)(2011-1#1)
using gas chromatography-mass##5##3##(1992-8#1)(1994-2#1)(2008-10#1)(2011-1#2)
using gas##19##2##(1992-8#1)(1994-2#1)(2007-12#1)(2008-10#12)(2008-5#1)(2011-1#3)
using gel filtration##5##3##(1990-2#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
using gel##9##2##(1990-2#1)(1992-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
using gelatin##4##2##(1991-8#1)(2008-10#2)(2009-11#1)
using gene##7##2##(1992-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-10#1)(2010-2#1)
using general##2##2##(2008-10#1)(2008-4#1)
using generalized##2##2##(1990-12#1)(2008-10#1)
using generic##2##2##(2008-5#1)(2013-1#1)
using genetic algorithm##2##3##(2008-8#1)(2008-9#1)
using genetic##11##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
using genetically##4##2##(1994-11#1)(1995-5#1)(2008-9#1)(2012-3#1)
using genomic##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
using glass##2##2##(2008-2#1)(2008-5#1)
using glassy carbon##3##3##(2008-10#3)
using glucose##3##2##(2008-10#2)(2008-6#1)
using glutaraldehyde and fixed on a pretreated##2##7##(2008-10#2)
using glutaraldehyde and fixed on##3##5##(2008-10#3)
using glutaraldehyde##6##2##(1997-2#1)(2008-10#5)
using glycerol as##2##3##(2008-6#1)(2008-7#1)
using gold##4##2##(2008-10#2)(2009-7#1)(2010-1#1)
using gradient elution with##2##4##(2008-10#1)(2011-1#1)
using gradient elution##3##3##(2008-10#2)(2011-1#1)
using gradient##4##2##(2008-10#3)(2011-1#1)
using graphite furnace atomic absorption spectrometry##3##6##(2008-10#3)
using graphite furnace atomic absorption##4##5##(2008-10#4)
using graphite##5##2##(2008-1#1)(2008-10#4)
using grounded theory methodology##2##4##(2011-2#2)
using group##3##2##(2008-10#2)(2011-2#1)
using hanging mercury drop electrode##2##5##(2008-10#2)
using head space##2##3##(2008-5#1)(2012-2#1)
using headspace solvent microextraction##2##4##(2008-10#2)
using headspace##4##2##(2008-10#4)
using heat-inactivated##2##2##(2008-10#1)(2008-5#1)
using helper##2##2##(1997-4#1)(2008-4#1)
using heparin##2##2##(1995-6#1)(2007-11#1)
using heteropolyacid montmorillonite clay-modified##2##4##(2008-10#2)
using hierarchical##2##2##(2008-7#1)(2012-2#1)
using high doses of##2##4##(2007-10#1)(2010-1#1)
using high frequency##2##3##(2011-2#1)(2012-12#1)
using high performance liquid chromatography (HPLC)##2##6##(1991-8#1)(2008-10#1)
using high performance liquid chromatography with##2##6##(1993-2#1)(2008-10#1)
using high performance liquid chromatography##8##5##(1991-8#1)(1993-2#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)
using high performance liquid##11##4##(1990-12#1)(1991-8#1)(1993-2#1)(2008-10#4)(2011-1#2)(2011-2#1)(2012-2#1)
using high pressure liquid chromatography##2##5##(2008-10#1)(2011-1#1)
using high resolution##4##3##(2008-10#2)(2008-8#1)(2010-4#1)
using high##32##2##(1990-12#1)(1991-8#1)(1993-2#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
using high-frequency##2##2##(2012-12#1)(2013-1#1)
using high-molecular-mass polyethyleneimine##2##3##(1996-5#2)
using high-performance liquid chromatography (HPLC)##4##5##(1992-11#1)(2008-10#1)(2008-5#1)(2010-2#1)
using high-performance liquid chromatography with fluorescence detection and##2##8##(2008-10#2)
using high-performance liquid chromatography with##3##5##(1996-5#1)(2008-10#2)
using high-performance liquid chromatography##11##4##(1990-11#1)(1990-7#1)(1992-11#1)(1996-5#1)(2008-10#5)(2008-5#1)(2010-2#1)
using high-performance liquid##12##3##(1990-11#1)(1990-7#1)(1992-11#1)(1996-5#1)(2008-10#6)(2008-5#1)(2010-2#1)
using high-purity##2##2##(2008-10#2)
using high-resolution##4##2##(1992-3#1)(1994-3#1)(2008-10#1)(2011-1#1)
using high-sensitivity##2##2##(1997-6#1)(2010-12#1)
using high-speed counter-current##2##3##(2011-1#2)
using high-throughput methods##2##3##(2008-7#1)(2011-2#1)
using high-throughput technologies##2##3##(2008-8#1)(2012-2#1)
using high-throughput##6##2##(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
using higher##5##2##(1994-12#1)(2008-11#1)(2008-7#2)(2010-12#1)
using highly##4##2##(2006-4#1)(2008-10#2)(2008-5#1)
using historical##2##2##(1994-1#1)(2008-10#1)
using homologous##2##2##(1990-2#1)(2008-4#1)
using horseradish peroxidase and##2##4##(1990-12#1)(2008-9#1)
using horseradish peroxidase##3##3##(1990-12#1)(2008-4#1)(2008-9#1)
using household##2##2##(2010-3#1)(2011-2#1)
using human##17##2##(1990-11#1)(1993-3#2)(1995-8#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-5#1)
using hydride##2##2##(2008-10#2)
using hydrogen##2##2##(2008-10#1)(2008-6#1)
using hydrophilic##2##2##(2012-2#2)
using hyphenated##2##2##(2008-10#2)
using iliac##2##2##(2008-12#2)
using image analysis software##2##4##(1995-12#1)(2008-4#1)
using image analysis##3##3##(1995-12#1)(2008-4#1)(2008-5#1)
using image guidance system##2##4##(2011-2#2)
using image##8##2##(1995-12#1)(2008-4#1)(2008-5#2)(2010-8#1)(2011-2#2)(2013-7#1)
using immobilised##2##2##(2008-10#2)
using immobilized cells##2##3##(2008-7#2)
using immobilized##13##2##(1990-8#1)(1995-2#1)(2008-10#2)(2008-6#2)(2008-7#6)(2008-8#1)
using immobilized-enzyme reactors##2##3##(2008-10#2)
using immunoaffinity##2##2##(2008-10#1)(2012-2#1)
using immunocapture##2##2##(2011-2#2)
using immunocytochemical##2##2##(2007-12#1)(2008-8#1)
using immunocytochemistry and##2##3##(1992-6#1)(2008-9#1)
using immunofluorescence##2##2##(2008-10#1)(2008-5#1)
using immunohistochemical methods##2##3##(1993-6#1)(1994-2#1)
using immunohistochemical##4##2##(1992-3#1)(1993-6#1)(1994-2#1)(2008-4#1)
using immunohistochemistry with##4##3##(1996-5#3)(1997-7#1)
using immunohistochemistry##11##2##(1996-5#3)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
using immunosuppressive drugs##2##3##(1995-2#1)(2013-1#1)
using implicit##2##2##(1993-1#1)(2009-12#1)
using improved##2##2##(1991-8#1)(2009-5#1)
using in situ hybridization and##2##5##(1991-12#1)(2008-10#1)
using in situ hybridization##6##4##(1991-12#1)(1992-8#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-4#1)
using in situ synthesized##2##4##(2008-10#2)
using in situ##12##3##(1991-12#1)(1992-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-3#1)(2008-4#1)
using in the##2##3##(2008-10#1)(2012-3#1)
using in vitro assays##2##4##(2008-10#1)(2010-4#1)
using in vitro##12##3##(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
using in vivo and in vitro##2##6##(2008-10#1)(2008-11#1)
using in vivo and##3##4##(2008-10#1)(2008-11#2)
using in vivo##6##3##(1992-7#1)(1994-2#1)(1997-8#1)(2008-10#1)(2008-11#2)
using in##32##2##(1991-12#1)(1992-7#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
using inbred##2##2##(2012-3#2)
using indirect##4##2##(1997-2#1)(2007-7#1)(2008-10#1)(2008-9#1)
using indium##2##2##(2008-1#1)(2008-10#1)
using individual##7##2##(1992-6#1)(2007-10#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-1#1)
using individual-based##2##2##(2008-8#1)(2008-9#1)
using inductively coupled plasma atomic emission spectrometry (ICP-AES)##4##8##(2008-10#4)
using inductively coupled plasma mass spectrometry (ICP-MS)##2##7##(2008-10#2)
using inductively coupled plasma mass spectrometry##4##6##(2008-10#4)
using inductively coupled plasma##9##4##(2008-10#9)
using inductively coupled plasma-optical emission spectrometry (ICP-OES)##2##7##(2008-10#2)
using inductively coupled##13##3##(2008-10#13)
using information from##4##3##(1997-3#1)(1997-7#1)(2008-4#2)
using information##10##2##(1993-2#1)(1993-3#1)(1997-3#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-4#2)(2008-8#1)
using infrared spectroscopy and##2##4##(2008-10#2)
using infrared spectroscopy##3##3##(2008-10#3)
using infrared##9##2##(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
using innovative##2##2##(1997-1#1)(2008-10#1)
using intact##4##2##(1994-8#1)(2008-10#2)(2009-5#1)
using integrated##3##2##(2008-10#1)(2008-7#2)
using interaction##2##2##(2008-9#1)(2009-10#1)
using interactive##2##2##(2007-5#1)(2009-6#1)
using internal standard##2##3##(2008-10#2)
using internal standardization##2##3##(2008-10#2)
using internal##10##2##(1991-5#1)(1997-2#1)(2008-10#5)(2010-10#1)(2011-2#1)(2012-12#1)
using inverse##2##2##(2008-10#1)(2009-9#1)
using iodide##2##2##(2008-10#2)
using ion chromatography (IC)##2##4##(2008-10#2)
using ion chromatography##5##3##(2008-10#5)
using ion exchange##5##3##(1997-2#1)(2008-10#3)(2013-1#1)
using ion mobility spectrometry (IMS)##2##5##(2008-10#2)
using ion mobility spectrometry##5##4##(2008-10#5)
using ion pairing##2##3##(2008-10#2)
using ion##19##2##(1997-2#1)(2007-11#1)(2008-10#16)(2013-1#1)
using ion-selective electrodes (ISEs)##2##4##(2008-10#2)
using ion-selective electrodes##3##3##(2008-10#3)
using ion-spray mass spectrometry##2##4##(1994-5#2)
using isolated##4##2##(1992-3#1)(2008-11#1)(2012-2#2)
using isolates##2##2##(2008-10#2)
using isotope dilution##2##3##(2008-10#2)
using it as a##2##4##(2008-10#1)(2013-8#1)
using it as##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
using it##7##2##(2008-10#1)(2008-12#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
using its##5##2##(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
using knotted##2##2##(2008-10#2)
using known##2##2##(1990-5#1)(2008-8#1)
using labelled##2##2##(1996-1#1)(2008-7#1)
using laboratory##3##2##(2009-5#1)(2010-6#1)(2011-2#1)
using laccase##2##2##(2008-6#2)
using laminar##2##2##(2008-2#1)(2010-10#1)
using large##2##2##(2008-10#1)(2012-3#1)
using large-scale##2##2##(1991-8#1)(2009-8#1)
using larger##3##2##(2007-11#1)(2008-7#1)(2008-9#1)
using laser ablation inductively coupled plasma##2##6##(2008-10#2)
using laser ablation##3##3##(2008-1#1)(2008-10#2)
using laser##6##2##(2008-1#1)(2008-10#5)
using laser-induced##2##2##(2007-12#1)(2008-10#1)
using layer-by-layer##3##2##(2008-10#2)(2008-7#1)
using lectins##2##2##(1992-6#1)(1994-11#1)
using less##2##2##(2008-10#1)(2010-8#1)
using light and electron microscopy##4##5##(2008-10#3)(2008-7#1)
using light microscopy##7##3##(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)
using light##16##2##(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-7#1)
using limited data sets##2##4##(2008-5#2)
using limited##4##2##(1995-3#1)(2008-5#2)(2012-3#1)
using linear regression##2##3##(2010-8#1)(2013-7#1)
using linear sweep stripping##2##4##(2008-10#2)
using linear sweep##3##3##(2008-10#3)
using linear##12##2##(2008-10#5)(2008-12#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-8#1)(2013-1#1)(2013-7#1)
using linked administrative databases##2##4##(2008-6#1)(2011-1#1)
using lipoprotein subclass analysis##2##4##(2008-3#2)
using liposomes##2##2##(2008-10#2)
using liquid chromatography and mass spectrometry##2##6##(2008-1#1)(2008-10#1)
using liquid chromatography and##3##4##(2008-1#1)(2008-10#2)
using liquid chromatography tandem mass spectrometry (LC-MS/MS)##2##7##(2011-1#2)
using liquid chromatography##7##3##(2008-1#1)(2008-10#4)(2011-1#2)
using liquid##11##2##(2008-1#1)(2008-10#7)(2011-1#3)
using liquid-liquid extraction##2##3##(2008-10#2)
using lithium##3##2##(1992-2#2)(2008-4#1)
using living##6##2##(2008-10#3)(2008-5#1)(2011-2#2)
using local##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
using logistic regression##5##3##(1993-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
using logistic##6##2##(1993-9#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#2)
using long##3##2##(1993-3#1)(2008-10#1)(2008-6#1)
using longitudinal data##2##3##(2012-12#1)(2013-1#1)
using longitudinal##3##2##(2008-2#1)(2012-12#1)(2013-1#1)
using low melt agarose##2##4##(2008-11#2)
using low##7##2##(1990-5#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-4#1)(2013-8#1)
using low-cost##2##2##(2008-6#1)(2008-7#1)
using luminol##2##2##(1995-3#1)(2008-10#1)
using mRNA differential display##2##4##(2008-8#1)(2008-9#1)
using macrocyclic##2##2##(2008-10#2)
using magnetic beads##2##3##(2008-4#2)
using magnetic microbeads##2##3##(2008-10#2)
using magnetic nanoparticles##2##3##(2011-2#1)(2012-2#1)
using magnetic resonance##3##3##(1996-2#1)(2008-11#1)(2008-7#1)
using magnetic##13##2##(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
using manual##2##2##(1991-3#1)(1993-1#1)
using mass spectrometry##3##3##(2008-2#1)(2011-2#2)
using mass##5##2##(1997-4#1)(2008-11#1)(2008-2#1)(2011-2#2)
using material##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
using mathematical##3##2##(1995-6#1)(2008-5#1)(2010-5#1)
using matrix##2##2##(2008-10#2)
using maximum parsimony##2##3##(2007-12#1)(2008-10#1)
using mean##3##2##(1992-9#1)(2008-10#2)
using measured##2##2##(2008-7#1)(2012-12#1)
using measurements of##3##3##(2008-4#1)(2010-8#2)
using measures of##2##3##(1994-2#1)(2008-10#1)
using mechanical##3##2##(2008-10#3)
using medium##2##2##(1992-6#1)(1994-5#1)
using membrane mass spectrometry##2##4##(2008-11#2)
using membrane##8##2##(1995-3#1)(2008-11#3)(2009-10#1)(2010-4#1)(2012-3#2)
using membranes##3##2##(1992-12#1)(2007-12#2)
using mercaptosephadex##2##2##(2008-10#2)
using message-driven parallel quantum and classical dynamics##2##7##(2013-1#2)
using metal##2##2##(2008-10#2)
using metallic##2##2##(2008-10#2)
using methanol as##2##3##(2008-10#2)
using methanol##5##2##(1994-9#1)(2008-10#4)
using methods##3##2##(1997-3#1)(2008-4#1)(2009-8#1)
using methyl##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
using mice as##2##3##(2008-12#1)(2008-6#1)
using mice##8##2##(1994-8#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2009-8#1)
using micellar##4##2##(2008-10#4)
using microarray and##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
using microarray technologies##2##3##(2008-4#1)(2009-12#1)
using microarray##7##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2012-3#1)
using microarrays##3##2##(2009-6#1)(2012-3#1)(2013-1#1)
using microelectrodes##2##2##(2008-10#1)(2008-7#1)
using microgravimetric quartz-crystal-microbalance##2##3##(2008-10#2)
using microinjection##2##2##(1992-6#1)(1996-6#1)
using microsatellite DNA##2##3##(2008-11#1)(2011-2#1)
using microsatellite markers and##2##4##(2008-10#2)
using microsatellite markers##4##3##(2008-10#4)
using microsatellite##7##2##(2008-10#5)(2008-11#1)(2011-2#1)
using microspectrofluorometry##2##2##(1993-6#2)
using microtiter##2##2##(2008-11#1)(2010-11#1)
using microwave heating##2##3##(2008-10#2)
using microwave irradiation##2##3##(2007-11#1)(2008-10#1)
using microwave##8##2##(2007-11#2)(2008-10#5)(2009-7#1)
using microwaves##2##2##(2008-10#2)
using mild##3##2##(1990-2#1)(2008-10#2)
using mineral##2##2##(2013-1#2)
using minimal##3##2##(1992-8#1)(2008-1#1)(2008-6#1)
using mitochondrial##2##2##(2008-10#1)(2010-4#1)
using mixed ion-pairing##2##3##(2008-10#2)
using mixed##4##2##(2008-10#4)
using mixtures of##6##3##(2008-10#5)(2011-1#1)
using mobile phase##2##3##(2008-10#1)(2011-1#1)
using mobile##3##2##(1992-5#1)(2008-10#1)(2011-1#1)
using model##5##2##(2008-10#4)(2012-3#1)
using models of##2##3##(2008-10#1)(2008-2#1)
using models##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
using modern scientific##2##3##(2011-1#1)(2013-1#1)
using modern##5##2##(2008-10#1)(2008-6#1)(2010-7#1)(2011-1#1)(2013-1#1)
using modified##12##2##(1995-3#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#2)(2013-1#1)
using molecular beacons##2##3##(2008-10#1)(2008-9#1)
using molecular##14##2##(1993-11#1)(1994-6#1)(1995-11#1)(2008-10#5)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
using molybdenum containing chemical modifiers##2##5##(2008-10#2)
using molybdenum##4##2##(2008-10#4)
using monoclonal antibodies and##3##4##(1990-11#1)(1995-5#1)(2008-10#1)
using monoclonal antibodies in##2##4##(2008-10#1)(2008-7#1)
using monoclonal antibodies to##2##4##(1992-3#1)(1995-3#1)
using monoclonal antibodies##11##3##(1990-11#1)(1991-5#1)(1992-3#1)(1993-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-7#1)
using monoclonal antibody##3##3##(1990-11#1)(1995-6#1)(1997-4#1)
using monoclonal##18##2##(1990-11#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-7#1)(2012-3#1)
using monodisperse##2##2##(2010-12#1)(2010-8#1)
using monolithic column chromatography##2##4##(2008-10#2)
using monolithic silica##2##3##(2008-10#2)
using monolithic##4##2##(2008-10#4)
using more##6##2##(1993-3#1)(1995-12#1)(1997-3#1)(2008-9#1)(2009-7#1)(2012-7#1)
using morphological criteria##2##3##(2008-10#2)
using morphological##6##2##(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)
using mouse##2##2##(2008-10#1)(2010-1#1)
using multidimensional##2##2##(1995-12#1)(2008-4#1)
using multilocus##2##2##(2008-9#1)(2012-3#1)
using multiple linear regression##3##4##(2008-10#3)
using multiple regression with##2##4##(2008-10#2)
using multiple regression##3##3##(2008-10#3)
using multiple##30##2##(1993-12#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
using multivariate calibration methods##3##4##(2008-10#3)
using multivariate calibration##6##3##(2008-10#6)
using multivariate##14##2##(1991-1#1)(1997-4#1)(2008-10#9)(2008-3#1)(2008-7#2)
using multiwalled carbon nanotubes as##2##5##(2008-10#2)
using native##2##2##(1995-12#1)(2011-2#1)
using natural##6##2##(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)
using naturally##2##2##(2008-10#2)
using near-infrared##5##2##(2007-11#1)(2008-10#3)(2011-1#1)
using negative##2##2##(2008-10#2)
using nested##3##2##(1996-12#1)(1997-4#1)(2008-6#1)
using network##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
using neural network##2##3##(2008-8#1)(2010-8#1)
using neural networks##2##3##(2008-8#1)(2010-8#1)
using neural##4##2##(2008-8#2)(2010-8#2)
using new materials##2##3##(2012-3#1)(2013-1#1)
using new##7##2##(1990-3#1)(1995-9#1)(1996-12#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
using newer##4##2##(2008-3#1)(2011-2#2)(2013-8#1)
using nine##2##2##(2008-10#1)(2013-8#1)
using non##3##2##(2008-10#3)
using non-linear##2##2##(2008-10#1)(2010-3#1)
using non-parametric statistics##2##3##(2012-12#1)(2013-1#1)
using nonlinear regression##2##3##(2008-10#1)(2008-4#1)
using nonlinear##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
using nonparametric##2##2##(1997-5#1)(2008-10#1)
using novel##8##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)
using nuclear##3##2##(1994-5#1)(1995-6#1)(2010-3#1)
using nucleic##2##2##(2008-10#1)(2009-5#1)
using nucleoside phosphorylase##2##3##(1993-12#2)
using nude mice##2##3##(1994-11#1)(2010-1#1)
using numerical##2##2##(1996-4#1)(2008-7#1)
using o-phenylenediamine as##2##3##(2008-10#2)
using objective##2##2##(2008-9#1)(2012-1#1)
using octadecyl silica membrane disks modified by##5##7##(2008-10#5)
using octadecyl##6##2##(2008-10#6)
using octadecylsilica##2##2##(2008-10#2)
using of##6##2##(2008-10#4)(2011-2#1)(2012-3#1)
using oligonucleotide##3##2##(1991-12#1)(1992-6#1)(1993-3#1)
using on-column##2##2##(2008-10#1)(2013-1#1)
using on-line electrogenerated##2##3##(2008-10#2)
using on-line radiochemical detection##2##4##(1991-5#2)
using on-line##10##2##(1991-5#2)(2008-10#8)
using one of the##2##4##(1994-12#1)(2008-10#1)
using one of two##2##4##(2010-8#1)(2011-2#1)
using one of##4##3##(1994-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
using one or##2##3##(2008-5#1)(2011-1#1)
using one##17##2##(1994-12#1)(1995-12#1)(1997-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
using one-way ANOVA and##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
using one-way ANOVA##4##3##(2008-12#2)(2011-2#1)(2013-1#1)
using one-way##5##2##(2008-10#1)(2008-12#2)(2011-2#1)(2013-1#1)
using online##2##2##(2008-10#1)(2008-11#1)
using only a##2##3##(1995-6#1)(2008-3#1)
using only one##4##3##(2008-10#3)(2008-3#1)
using only the##2##3##(2008-10#1)(2008-6#1)
using only##21##2##(1994-2#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-3#1)
using open##2##2##(2007-8#1)(2013-1#1)
using optical##15##2##(1993-5#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#3)(2009-7#1)(2010-8#1)(2013-1#1)
using optically##2##2##(2007-12#1)(2008-9#1)
using optimized##2##2##(2008-10#1)(2010-4#1)
using oral##4##2##(1991-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
using organic solvents##2##3##(2008-10#2)
using organic##3##2##(2008-10#2)(2013-1#1)
using orthopaedic##2##2##(2007-8#2)
using other##15##2##(1991-5#1)(1994-12#1)(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
using our##10##2##(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-8#1)(2012-3#1)
using outpatient##4##2##(1994-2#1)(1995-1#1)(1995-2#2)
using oxygen##2##2##(2008-6#1)(2008-7#1)
using p-aminoacetophenone and its application in environmental and biological samples##2##10##(2008-10#2)
using packed column supercritical fluid chromatography (SFC)##2##7##(2008-10#2)
using packed column supercritical fluid chromatography##3##6##(2008-10#3)
using paired##2##2##(2008-5#1)(2012-1#1)
using palm oil##2##3##(2008-6#2)
using parsimony and Bayesian##2##4##(2010-4#1)(2010-6#1)
using parsimony##4##2##(2008-10#1)(2008-9#1)(2010-4#1)(2010-6#1)
using partial least squares (PLS) regression##2##6##(2008-10#2)
using partial least squares (PLS)##4##5##(2008-10#4)
using partial least squares multivariate calibration##2##6##(2008-10#2)
using partial least squares regression##2##5##(2008-10#2)
using partial least squares##13##4##(2008-10#13)
using partial least-squares (PLS)##2##4##(2008-10#2)
using partial least-squares##6##3##(2008-10#6)
using partial##21##2##(2007-12#1)(2007-8#1)(2008-10#19)
using passive##2##2##(2007-11#1)(2008-2#1)
using patch-clamp recording##2##3##(2008-8#1)(2011-2#1)
using patch-clamp##3##2##(1994-11#1)(2008-8#1)(2011-2#1)
using path##2##2##(1994-2#1)(2012-3#1)
using pathways##2##2##(2008-3#2)
using pattern recognition##2##3##(2008-10#2)
using pea##2##2##(2008-10#2)
using peak##4##2##(2008-10#4)
using penalized regression##2##3##(2009-8#1)(2012-3#1)
using peripheral blood mononuclear cells##2##5##(2008-11#1)(2011-2#1)
using permanent modifiers##3##3##(2008-10#3)
using permanent##4##2##(2007-5#1)(2008-10#3)
using permanganate##2##2##(2008-10#2)
using phase##2##2##(1997-7#1)(2008-10#1)
using phosphate##2##2##(2008-10#1)(2012-2#1)
using phosphoric##2##2##(2008-10#2)
using phosphorothioate##2##2##(1993-3#1)(1995-11#1)
using photo diode array##2##4##(2008-10#2)
using photoactivated##2##2##(2008-10#1)(2012-2#1)
using photothermal OCT##2##3##(2011-1#2)
using phylogenetic##2##2##(2008-10#2)
using physical##2##2##(1995-4#1)(2008-10#1)
using plasmid##2##2##(2008-8#1)(2008-9#1)
using plasmids##2##2##(1995-6#1)(2008-10#1)
using playback##2##2##(2008-8#2)
using polyamine##2##2##(2008-10#1)(2008-12#1)
using polyclonal antisera##2##3##(1990-8#1)(2008-10#1)
using polyclonal##7##2##(1990-8#1)(1993-6#1)(1993-9#1)(1997-4#1)(2008-10#2)(2008-5#1)
using polyethylene glycol##2##3##(2008-10#1)(2008-9#1)
using polyethylenimine##2##2##(2008-10#1)(2008-11#1)
using polymer##3##2##(2008-10#2)(2009-5#1)
using polymerase chain reaction (PCR)##5##5##(1994-3#1)(2008-10#4)
using polymerase chain reaction amplification##2##5##(2008-10#2)
using polymerase chain reaction##15##4##(1990-2#1)(1991-8#1)(1994-3#1)(2006-8#1)(2008-10#8)(2008-12#1)(2010-4#1)(2013-1#1)
using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)##2##8##(1997-8#1)(2008-10#1)
using polymerase chain##20##3##(1990-2#1)(1991-8#1)(1994-3#1)(1997-8#3)(2006-8#1)(2008-10#10)(2008-12#1)(2010-4#1)(2013-1#1)
using polymeric##2##2##(2007-11#1)(2008-10#1)
using polymers##2##2##(2008-7#1)(2010-10#1)
using polystyrene latex particles##2##4##(2010-6#2)
using polystyrene##3##2##(2008-4#1)(2010-6#2)
using polytetrafluoroethylene##3##2##(2008-10#3)
using polyurethane membrane##2##3##(2008-10#2)
using polyurethane##3##2##(2008-10#3)
using pooled##2##2##(2008-10#1)(2008-6#1)
using porcine##2##2##(2008-3#1)(2013-1#1)
using porous graphitic carbon##2##4##(2008-10#2)
using porous##3##2##(2008-10#3)
using positive##4##2##(2008-10#1)(2008-9#1)(2011-1#2)
using post-column##2##2##(1991-5#1)(2008-7#1)
using potassium hydroxide##2##3##(1996-2#1)(2008-6#1)
using potassium##5##2##(1996-2#1)(2008-10#3)(2008-6#1)
using potentiometric and##2##3##(2008-10#2)
using potentiometric titration##3##3##(2008-10#3)
using potentiometric##9##2##(2008-10#9)
using prescription##2##2##(2008-3#1)(2013-1#1)
using primary cultures of##2##4##(1995-12#1)(1996-5#1)
using primary##5##2##(1990-5#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-5#1)
using primer##3##2##(2008-4#1)(2008-9#2)
using primers flanking the##3##4##(2008-11#1)(2008-7#1)(2010-4#1)
using primers specific for##2##4##(2008-10#2)
using primers##13##2##(1992-6#1)(1993-2#1)(1994-12#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)
using principal component analysis (PCA)##3##5##(2008-10#2)(2010-5#1)
using principal component analysis##8##4##(2008-10#6)(2008-11#1)(2010-5#1)
using principal component##9##3##(2008-10#7)(2008-11#1)(2010-5#1)
using principal components analysis (PCA)##2##5##(2008-10#2)
using principal components analysis##4##4##(1992-2#1)(2008-10#3)
using principal components##5##3##(1992-2#1)(2008-10#4)
using principal##14##2##(1992-2#1)(2008-10#11)(2008-11#1)(2010-5#1)
using private##2##2##(1994-2#1)(2008-7#1)
using probe RG57##2##3##(2008-10#2)
using probe##6##2##(1993-3#2)(1995-3#1)(2007-12#1)(2008-10#2)
using probes##2##2##(2008-4#1)(2008-9#1)
using propidium iodide##2##3##(2008-4#1)(2009-6#1)
using propolis##2##2##(2008-10#2)
using protamine##2##2##(2008-10#1)(2008-6#1)
using protein##6##2##(1997-2#1)(2008-10#1)(2008-4#2)(2010-6#1)(2011-1#1)
using proteomics##2##2##(2008-10#2)
using published##4##2##(1994-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
using pulse##4##2##(1992-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
using pulsed amperometric detection##2##4##(1995-2#1)(2008-10#1)
using pulsed laser##3##3##(2008-10#2)(2008-2#1)
using pulsed##7##2##(1995-2#1)(1996-11#1)(2008-10#4)(2008-2#1)
using pure##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
using purified protein##2##3##(1997-4#1)(2008-10#1)
using purified##13##2##(1991-12#1)(1992-8#1)(1993-11#1)(1994-9#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
using pyrene carboxylic acid##3##4##(2008-10#3)
using pyrene##5##2##(1990-11#1)(2008-10#4)
using pyrosequencing##2##2##(2009-8#1)(2012-2#1)
using qualitative and quantitative##2##4##(2008-1#1)(2008-11#1)
using qualitative content analysis##3##4##(2008-12#1)(2010-10#2)
using qualitative##6##2##(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)
using quantitative autoradiography##2##3##(1994-2#1)(1994-3#1)
using quantitative data##2##3##(2008-8#1)(2009-5#1)
using quantitative real-time##2##3##(2010-7#1)(2011-2#1)
using quantitative##16##2##(1994-2#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
using quantum##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
using quartz crystal##2##3##(2008-10#2)
using questionnaires and##2##3##(2008-12#1)(2013-1#1)
using questionnaires##3##2##(2008-12#1)(2012-1#1)(2013-1#1)
using rabbit##4##2##(1990-11#1)(1994-8#1)(1996-5#1)(1997-6#1)
using radiofrequency##2##2##(2007-8#1)(2011-2#1)
using radiolabeled##6##2##(1997-4#1)(2008-1#1)(2008-10#2)(2012-2#1)(2012-3#1)
using radioligand binding assays##2##4##(1994-2#1)(1994-6#1)
using radioligand binding##3##3##(1994-2#1)(1994-6#1)(2008-4#1)
using radiotherapy##2##2##(2010-3#1)(2011-3#1)
using random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#2)
using random amplified polymorphic DNA (RAPD)##3##6##(2008-10#3)
using random amplified##4##3##(2008-10#4)
using random##7##2##(2008-10#6)(2013-8#1)
using randomly##2##2##(2007-5#1)(2008-8#1)
using rapid##3##2##(2008-1#1)(2008-11#1)(2010-8#1)
using rat##4##2##(1991-12#1)(1993-3#1)(1994-8#1)(2008-4#1)
using rats##2##2##(2008-10#2)
using ray##2##2##(2008-2#1)(2008-3#1)
using reaction cell and hydride generation##2##6##(2008-10#2)
using readily available##3##3##(1992-9#1)(1996-2#1)(2008-4#1)
using real data##2##3##(2011-2#1)(2012-1#1)
using real##4##2##(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)
using real-time PCR##3##3##(2008-10#2)(2013-1#1)
using real-time polymerase chain reaction##3##5##(2008-10#2)(2013-1#1)
using real-time quantitative##3##3##(2008-10#2)(2008-4#1)
using real-time##11##2##(2008-10#7)(2008-4#1)(2012-2#1)(2013-1#2)
using realistic##3##2##(1996-4#1)(2008-10#1)(2010-12#1)
using recombinant##6##2##(1991-5#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-4#1)
using red##2##2##(2008-3#1)(2012-2#1)
using reduced##2##2##(2008-11#1)(2008-12#1)
using reference##4##2##(2008-10#3)(2008-2#1)
using reflection##2##2##(2008-12#2)
using regression##3##2##(2008-10#1)(2008-11#1)(2009-9#1)
using relational databases##2##3##(2008-4#2)
using relational##3##2##(2008-12#1)(2008-4#2)
using relative##2##2##(2008-2#1)(2012-6#1)
using repeated measures ANOVA##2##4##(2008-5#1)(2009-3#1)
using repeated##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
using repetitive##2##2##(2008-10#2)
using resistant##2##2##(2008-10#1)(2011-2#1)
using resonance Rayleigh scattering (RRS)##2##5##(2008-10#2)
using resonance light scattering##2##4##(2008-10#2)
using resonance##4##2##(2008-10#4)
using restriction fragment length polymorphism (RFLP)##2##6##(1996-12#1)(2008-10#1)
using restriction fragment length polymorphism markers##3##6##(2008-10#3)
using restriction fragment length polymorphism##7##5##(1996-12#1)(2008-10#6)
using restriction fragment length##8##4##(1996-12#1)(2008-10#7)
using restriction##10##2##(1995-12#1)(1996-12#1)(2008-10#8)
using results##2##2##(2008-1#1)(2008-10#1)
using reverse transcription-polymerase chain reaction (RT-PCR)##2##6##(1997-7#1)(2008-10#1)
using reverse transcription-polymerase chain reaction##4##5##(1994-6#1)(1997-7#1)(2008-10#1)(2011-2#1)
using reverse##9##2##(1993-12#1)(1994-6#1)(1997-7#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-12#1)
using reverse-phase##2##2##(1992-8#1)(2008-5#1)
using reversed phase##3##3##(1990-2#1)(1991-5#1)(2008-5#1)
using reversed##4##2##(1990-2#1)(1991-5#1)(2008-10#1)(2008-5#1)
using reversed-phase high performance liquid##2##5##(2011-1#2)
using reversed-phase high-performance liquid chromatography##5##5##(1992-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(2008-10#1)
using reversed-phase liquid chromatography##2##4##(2008-10#2)
using reversed-phase##12##2##(1992-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(2008-10#6)(2011-1#2)
using rhBMP-2##2##2##(2008-5#1)(2012-12#1)
using rhodamine S##2##3##(2008-10#2)
using rhodamine##4##2##(2008-10#4)
using role-play as##2##3##(2008-11#2)
using routine##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
using routinely obtained blood specimens treated with##2##7##(2008-10#2)
using salicylate##2##2##(2008-10#2)
using salinized##2##2##(2008-12#2)
using sample##3##2##(2008-10#2)(2010-5#1)
using samples of##3##3##(2008-10#2)(2013-8#1)
using samples##5##2##(2008-10#3)(2012-2#1)(2013-8#1)
using satellite##2##2##(2007-5#1)(2008-12#1)
using scanning electron microscopy (SEM)##4##5##(2007-12#1)(2008-10#1)(2009-11#1)(2013-8#1)
using scanning electron microscopy and microradiography##2##6##(1995-6#2)
using scanning electron microscopy##10##4##(1995-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-11#1)(2013-1#1)(2013-8#1)
using scanning electron##11##3##(1995-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-11#1)(2009-3#1)(2013-1#1)(2013-8#1)
using scanning##12##2##(1995-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2013-1#1)(2013-8#1)
using scenario-based design##2##3##(2010-8#2)
using selected##5##2##(2008-10#4)(2008-8#1)
using selective##6##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
using self-assembled##2##2##(2010-12#2)
using semi-quantitative##3##2##(1994-11#1)(1994-2#1)(2011-2#1)
using semi-structured##2##2##(2013-1#2)
using sensitive##3##2##(2008-4#1)(2008-9#1)(2012-12#1)
using sensory##2##2##(2008-10#1)(2008-9#1)
using separate##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
using sequence##3##2##(1995-6#1)(2008-8#1)(2010-4#1)
using sequences of the##2##4##(2008-10#1)(2008-9#1)
using sequential injection analysis##2##4##(2008-10#2)
using sequential injection##4##3##(2008-10#4)
using sequential##9##2##(1992-9#1)(2008-10#7)(2008-11#1)
using serological##2##2##(2008-10#1)(2011-2#1)
using serum##6##2##(1991-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
using serum-free##2##2##(2008-11#1)(2008-7#1)
using seven##3##2##(1996-6#1)(2008-10#1)(2008-5#1)
using several different##4##3##(1994-5#1)(2008-10#1)(2011-2#2)
using several techniques##2##3##(1992-9#1)(2010-8#1)
using several##17##2##(1992-12#1)(1992-9#2)(1994-5#1)(1995-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
using short##6##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
using silica gel loaded with##4##5##(2008-10#4)
using silica gel##7##3##(2008-10#6)(2008-11#1)
using silicone##2##2##(2008-2#1)(2011-2#1)
using silver and##2##3##(2008-10#2)
using silver##5##2##(2008-10#4)(2008-4#1)
using similar##4##2##(2008-11#1)(2008-2#1)(2012-12#1)(2012-2#1)
using simple##17##2##(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-1#1)
using simulated annealing##2##3##(2008-2#1)(2008-3#1)
using simulated##8##2##(1997-7#1)(2008-10#4)(2008-2#1)(2008-3#2)
using simulation##2##2##(2008-11#1)(2012-3#1)
using simulations##3##2##(2008-6#1)(2010-11#1)(2012-1#1)
using simultaneous##2##2##(2010-12#1)(2012-2#1)
using single nucleotide##2##3##(2008-7#1)(2009-8#1)
using single##7##2##(1991-6#1)(1994-8#2)(2008-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
using singular value decomposition##2##4##(1994-11#1)(2008-10#1)
using site-directed mutagenesis##4##3##(1994-5#1)(1995-2#2)(2008-9#1)
using six##4##2##(1997-5#1)(2008-10#1)(2008-12#1)(2010-5#1)
using skin##2##2##(2007-8#1)(2011-2#1)
using slurry sampling##5##3##(2008-10#5)
using small volumes##2##3##(2008-10#2)
using small##7##2##(2008-10#5)(2008-9#1)(2010-11#1)
using sodium 3-(2-pyridyl)-5##2##3##(2008-10#2)
using sodium##12##2##(1994-9#2)(2008-10#9)(2008-12#1)
using soft##2##2##(2008-10#2)
using software##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
using sol-gel##2##2##(2008-10#1)(2009-8#1)
using solid phase extraction##5##4##(2008-10#4)(2008-11#1)
using solid phase##6##3##(2008-10#5)(2008-11#1)
using solid##12##2##(2008-10#10)(2008-11#1)(2013-1#1)
using solid-phase extraction and##3##4##(2008-10#3)
using solid-phase extraction##5##3##(2008-10#4)(2013-8#1)
using solid-phase microextraction##3##3##(2008-10#3)
using solid-phase##9##2##(2008-10#8)(2013-8#1)
using soluble##3##2##(1994-8#1)(2008-10#1)(2009-12#1)
using somatic##2##2##(1997-9#1)(2008-10#1)
using some of these##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
using some of##4##3##(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
using some##8##2##(1995-12#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-1#1)
using sonography##2##2##(1991-11#1)(2008-8#1)
using spatially##2##2##(2007-11#1)(2011-1#1)
using species-specific primers and##2##4##(2008-10#2)
using species-specific##3##2##(2008-10#2)(2011-2#1)
using specific primers##3##3##(1994-11#1)(2008-7#1)(2013-1#1)
using specific##22##2##(1990-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
using spectral##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2009-10#1)
using spectrophotometric##7##2##(2008-10#7)
using speech##2##2##(2008-9#2)
using spiked##2##2##(2008-10#2)
using spiro form rhodamine B hydrazide##2##6##(2008-10#2)
using spontaneous##2##2##(2008-12#1)(2011-1#1)
using spot##2##2##(2008-10#2)
using square wave voltammetry##3##4##(2008-10#3)
using square wave##6##3##(2008-10#6)
using square-wave##3##2##(2008-10#3)
using stabilized##4##2##(1996-12#1)(2008-10#2)(2008-6#1)
using stable##3##2##(1991-5#1)(2008-10#2)
using standard addition method##2##4##(2008-10#2)
using standard addition##3##3##(2008-10#3)
using standard bacteriological##3##3##(2008-12#3)
using standard procedures##5##3##(1990-11#1)(1991-11#1)(2008-10#2)(2010-8#1)
using standard##36##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-3#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#4)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#1)
using standardized##6##2##(1996-2#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
using statistical software##2##3##(2008-10#2)
using statistical##7##2##(1993-2#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
using statistics##2##2##(2008-10#1)(2010-2#1)
using steady-state##3##2##(2008-10#2)(2008-8#1)
using stereotactic##2##2##(2008-7#2)
using stochastic dynamic programming##2##4##(2008-8#1)(2008-9#1)
using stochastic##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
using strain##2##2##(2008-10#1)(2008-12#1)
using strain-specific monoclonal##2##3##(2008-10#2)
using strategy of gene disruption##2##5##(2008-8#2)
using structural##2##2##(2008-7#1)(2012-3#1)
using structured questionnaires##2##3##(2008-8#1)(2010-2#1)
using structured##4##2##(2008-11#1)(2008-8#1)(2010-2#1)(2010-3#1)
using student##2##2##(1997-2#2)
using such a##2##3##(2007-12#1)(2008-7#1)
using such##8##2##(1992-9#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#1)
using supercritical fluid extraction##2##4##(2008-10#2)
using supercritical##4##2##(2008-10#3)(2012-2#1)
using support vector##2##3##(2008-11#1)(2010-8#1)
using surface plasmon resonance (SPR)##2##5##(2008-10#2)
using surface plasmon resonance##3##4##(2008-10#3)
using surface##9##2##(1997-8#1)(2008-10#4)(2008-11#1)(2010-6#1)(2011-2#2)
using sweep##2##2##(2008-10#1)(2011-2#1)
using synchrotron radiation and##2##4##(2008-10#1)(2008-2#1)
using synchrotron radiation##5##3##(2008-10#2)(2008-2#2)(2008-5#1)
using synchrotron##6##2##(2008-10#2)(2008-2#2)(2008-5#2)
using synthetic data##2##3##(2008-2#1)(2008-3#1)
using synthetic peptides##2##3##(1990-4#1)(1995-11#1)
using synthetic##12##2##(1990-4#1)(1992-6#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)
using systematic##2##2##(2008-10#1)(2011-2#1)
using tandem##2##2##(2008-11#1)(2009-11#1)
using target##2##2##(2008-10#1)(2010-5#1)
using techniques##6##2##(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)
using technology to##3##3##(2008-11#1)(2008-7#2)
using technology##7##2##(2008-11#3)(2008-7#2)(2010-3#2)
using temperature modulated SnO(2) gas sensor##2##6##(2008-10#2)
using temperature##4##2##(2008-10#3)(2011-2#1)
using temporal##2##2##(2008-9#1)(2012-1#1)
using ten##2##2##(2008-2#1)(2008-5#1)
using test##2##2##(2008-10#1)(2009-10#1)
using tetra-3##2##2##(2008-10#2)
using tetrazolium##2##2##(2008-10#1)(2008-11#1)
using the &quot##6##3##(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)
using the 2##3##3##(2008-10#2)(2008-5#1)
using the Affymetrix##2##3##(2009-10#1)(2010-11#1)
using the BDD electrode##2##4##(2008-10#2)
using the Beads technique##2##4##(1996-12#2)
using the Bentall and##2##4##(2012-2#2)
using the Brief##2##3##(2008-7#1)(2010-2#1)
using the CE##2##3##(2008-10#2)
using the CO 2 laser##4##5##(1992-1#3)(1992-3#1)
using the CO2 laser##2##4##(1994-12#2)
using the Cavitron##2##3##(1995-12#2)
using the Cox##2##3##(1994-7#1)(1997-3#1)
using the DNA microarray##3##4##(2008-7#1)(2012-3#2)
using the DNA##5##3##(1997-6#1)(2008-7#1)(2010-5#1)(2012-3#2)
using the ELISA technique##2##4##(2008-6#1)(2013-1#1)
using the FOITS technique##2##4##(2008-5#2)
using the Frejka pillow##2##4##(2007-8#2)
using the Functional Assessment of Cancer##2##6##(2008-7#2)
using the GROC and##2##4##(2008-12#2)
using the Genetic Analysis Workshop 17##3##6##(2012-3#3)
using the HITRAN##2##3##(2008-2#1)(2008-3#1)
using the Hoechst 33342##2##4##(1991-6#1)(2008-9#1)
using the Hospital##2##3##(2007-11#1)(2009-3#1)
using the Ilizarov##3##3##(2008-8#1)(2009-3#1)(2009-4#1)
using the Internet to##2##4##(1997-1#1)(2008-10#1)
using the Internet##3##3##(1997-1#1)(2008-10#1)(2009-5#1)
using the Keystone action plan criteria##2##6##(2011-1#2)
using the MTT assay##3##4##(1992-2#1)(2012-3#1)(2013-1#1)
using the Mann-Whitney##2##3##(1997-3#1)(2013-8#1)
using the MeSH##2##3##(2008-1#1)(2013-1#1)
using the Monte Carlo method##2##5##(1994-3#1)(2008-10#1)
using the Morris water maze##2##5##(1994-6#1)(1997-2#1)
using the PCR##3##3##(1997-6#1)(2008-11#1)(2008-4#1)
using the Parafac2 model##2##4##(2013-1#2)
using the SPSS##3##3##(2010-6#1)(2012-3#1)(2013-8#1)
using the Saccharomyces cerevisiae##2##4##(1991-9#1)(2008-10#1)
using the Student's t-test##2##4##(2008-10#1)(2012-12#1)
using the Student's##3##3##(2007-8#1)(2008-10#1)(2012-12#1)
using the T-cell##2##3##(2008-10#2)
using the TaqMan##2##3##(2008-10#1)(2012-2#1)
using the University of##2##4##(1996-3#1)(2008-11#1)
using the Wilcoxon signed rank test##2##6##(1997-8#1)(2010-6#1)
using the World Health Organization##2##5##(2010-3#1)(2010-8#1)
using the Zeeman modulation technique##2##5##(2008-3#2)
using the above##4##3##(1992-8#1)(2007-5#1)(2008-11#1)(2008-2#1)
using the absolute##2##3##(2008-3#1)(2012-2#1)
using the agar dilution##2##4##(1994-11#1)(2012-12#1)
using the alkaline##2##3##(1992-3#1)(1997-4#1)
using the analysis of variance##2##5##(1990-8#1)(2013-1#1)
using the appropriate##3##3##(2008-10#2)(2008-11#1)
using the area under the disease progress curve##2##8##(2008-10#2)
using the area under the##3##5##(2008-10#3)
using the automated##2##3##(2006-12#1)(2008-10#1)
using the available##3##3##(1994-5#1)(2008-10#1)(2010-3#1)
using the bacteriophage##2##3##(1996-2#1)(2008-2#1)
using the baculovirus system##2##4##(2008-11#1)(2008-2#1)
using the baculovirus##3##3##(1992-8#1)(2008-11#1)(2008-2#1)
using the batch injection analysis (BIA) technique##2##7##(2008-10#2)
using the beam propagation method##2##5##(2008-3#2)
using the best##2##3##(2008-11#1)(2010-8#1)
using the biosensor developed##2##4##(2008-10#2)
using the boundary##2##3##(2008-3#1)(2009-11#1)
using the cDNA##2##3##(1994-11#1)(1997-2#1)
using the carbon dioxide laser##2##5##(1991-12#2)
using the catalytic hydrogen wave##2##5##(2008-10#2)
using the cell##4##3##(2007-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
using the chloramphenicol acetyltransferase (CAT) gene as##2##7##(1992-6#1)(1997-8#1)
using the chloramphenicol##3##3##(1992-12#1)(1992-6#1)(1997-8#1)
using the classic##2##3##(1994-3#1)(2006-8#1)
using the classical##2##3##(2008-10#1)(2008-8#1)
using the cloned##2##3##(1994-11#2)
using the combined##2##3##(2011-2#1)(2013-1#1)
using the computer program GenMark##2##5##(1995-12#2)
using the computer program##4##4##(1995-12#2)(1997-2#1)(2008-11#1)
using the computer##7##3##(1995-12#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)
using the concept##2##3##(2008-5#1)(2008-9#1)
using the constant##2##3##(2008-10#1)(2008-11#1)
using the conventional method##2##4##(2008-10#2)
using the conventional##7##3##(1992-3#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-7#1)
using the coordinates##2##3##(1992-4#1)(1995-5#1)
using the correlation coefficient##2##4##(2008-10#1)(2011-3#1)
using the corresponding##3##3##(1993-2#1)(1997-4#1)(2008-10#1)
using the current##3##3##(1993-12#1)(1995-1#1)(2011-2#1)
using the data##2##3##(2008-11#1)(2010-12#1)
using the density##2##3##(1995-6#1)(2013-1#1)
using the described##2##3##(2008-3#1)(2010-8#1)
using the desirability function##2##4##(2008-10#2)
using the developed##6##3##(2008-10#6)
using the different##3##3##(1995-3#1)(2008-10#1)(2008-9#1)
using the differential pulse##2##4##(2008-10#2)
using the direct##3##3##(2008-10#2)(2010-6#1)
using the discrete##2##3##(2008-2#1)(2008-6#1)
using the dual grid##2##4##(2013-1#2)
using the dye##2##3##(1994-6#1)(2012-2#1)
using the dynamic##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
using the electrochemical quartz crystal microbalance##2##6##(2008-10#2)
using the electrode##3##3##(2008-10#2)(2008-9#1)
using the electron##2##3##(2008-6#1)(2009-7#1)
using the embryo-larval stages##2##4##(1996-2#2)
using the equation##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
using the established##2##3##(2008-10#2)
using the experimental##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
using the extraction##2##3##(2008-10#2)
using the finite-difference time-domain##2##4##(2008-3#2)
using the first derivative##2##4##(2008-10#2)
using the first##4##3##(2008-10#2)(2009-9#1)(2013-7#1)
using the fluorescence##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
using the fluorescent##4##3##(1990-2#1)(1992-3#1)(1994-5#1)(1996-6#1)
using the following##12##3##(1993-12#1)(1995-6#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-6#2)(2012-12#1)(2013-8#1)
using the formula##2##3##(2010-4#1)(2011-2#1)
using the full##2##3##(2007-8#1)(2010-8#1)
using the gene##2##3##(1992-3#1)(2008-11#1)
using the general##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
using the headspace##2##3##(2008-10#2)
using the human##5##3##(1995-12#1)(1997-2#1)(2007-12#1)(2008-11#2)
using the in-situ##2##3##(2013-8#2)
using the independent##2##3##(2008-12#1)(2008-3#1)
using the information##2##3##(2010-8#1)(2011-3#1)
using the initial##2##3##(2008-10#2)
using the isolated##2##3##(1996-12#1)(2008-5#1)
using the isotope-coded affinity tag##2##5##(2008-4#2)
using the key words##2##4##(2008-1#1)(2011-1#1)
using the laboratory##2##3##(2008-2#1)(2008-5#1)
using the lactate dehydrogenase##2##4##(2008-11#1)(2008-6#1)
using the least##2##3##(1995-12#1)(2008-5#1)
using the linear##3##3##(2008-10#2)(2013-1#1)
using the luciferase##2##3##(1996-5#1)(2008-11#1)
using the measured##2##3##(1994-12#1)(2008-2#1)
using the medical##2##3##(2008-11#1)(2013-8#1)
using the metal##2##3##(2007-5#1)(2008-10#1)
using the method of constant stimuli##2##6##(1990-11#2)
using the method of standard additions##3##6##(2008-10#3)
using the method of##14##4##(1990-11#3)(1992-9#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-4#1)(2010-12#1)(2013-1#1)
using the method##18##3##(1990-11#3)(1992-9#1)(1995-5#1)(1997-3#1)(2007-11#2)(2008-10#6)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
using the methodology##2##3##(2008-10#1)(2008-5#1)
using the mixture of##2##4##(2008-10#1)(2008-5#1)
using the model##9##3##(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
using the modified##9##3##(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
using the most##2##3##(1992-5#1)(2008-4#1)
using the mouse##2##3##(2008-8#1)(2008-9#1)
using the multiple##2##3##(2008-10#1)(2008-11#1)
using the national##2##3##(2010-12#1)(2012-2#1)
using the neighbor-joining##2##3##(2008-10#1)(2008-6#1)
using the new primers##3##4##(2008-10#2)(2012-12#1)
using the new##11##3##(1991-9#1)(2008-10#5)(2008-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
using the newly##2##3##(2007-8#1)(2008-10#1)
using the nursing process in##2##5##(2008-12#1)(2010-3#1)
using the open##2##3##(1990-5#1)(2010-3#1)
using the optical##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
using the optimized##4##3##(2008-10#4)
using the oxygen radical absorbance capacity (ORAC) assay##2##8##(2008-10#1)(2008-7#1)
using the partial##2##3##(2007-11#1)(2008-10#1)
using the patch-clamp technique##2##4##(1994-9#1)(1995-5#1)
using the patch-clamp##3##3##(1994-9#1)(1995-5#1)(2008-11#1)
using the peak##3##3##(2008-10#2)(2008-7#1)
using the polymerase chain reaction (PCR)##5##6##(1990-2#1)(1991-11#1)(1991-2#1)(1997-7#1)(2008-4#1)
using the polymerase chain reaction to##3##6##(1991-9#1)(2008-11#1)(2011-2#1)
using the polymerase chain reaction##19##5##(1990-11#1)(1990-2#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
using the polymerase chain##20##4##(1990-11#1)(1990-2#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-2#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
using the present##3##3##(2008-10#3)
using the principle##2##3##(2008-10#1)(2008-7#1)
using the program##3##3##(1993-11#1)(1995-5#1)(2008-4#1)
using the proposed biosensor##2##4##(2008-10#2)
using the proposed method##3##4##(2008-10#3)
using the proposed methodology##2##4##(2008-10#2)
using the proposed procedure##3##4##(2008-10#3)
using the proposed##22##3##(2008-10#20)(2008-3#1)(2008-8#1)
using the protein##2##3##(1990-8#1)(2009-12#1)
using the rat##4##3##(1990-5#1)(1990-7#1)(1992-10#1)(1995-2#1)
using the ratio##3##3##(1996-5#2)(2008-10#1)
using the reaction of##3##4##(2008-10#3)
using the reaction##4##3##(2008-10#4)
using the reactors##2##3##(2008-10#2)
using the real-time PCR##2##4##(2008-10#1)(2013-8#1)
using the recently##2##3##(1990-12#1)(2008-7#1)
using the redox##2##3##(2008-10#2)
using the reported search##8##4##(2007-8#8)
using the restriction enzymes##2##4##(2008-10#1)(2009-10#1)
using the restriction##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
using the results##2##3##(2008-6#1)(2008-7#1)
using the reverse transcription polymerase chain reaction (RT-PCR)##2##8##(2007-10#1)(2008-7#1)
using the reverse##4##3##(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
using the same experimental##2##4##(2008-10#1)(2008-7#1)
using the same instrument##2##4##(2008-10#1)(2008-6#1)
using the same spectrometer##2##4##(2008-3#2)
using the same##28##3##(1990-12#1)(1994-12#1)(1995-2#2)(1996-3#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2010-12#1)
using the samples##3##3##(1991-1#1)(2008-10#2)
using the simulated##2##3##(2008-10#1)(2012-3#1)
using the slurry##2##3##(2008-10#2)
using the soft##2##3##(2011-1#1)(2013-8#1)
using the software##2##3##(2010-12#1)(2013-1#1)
using the square wave##2##4##(2008-10#1)(2011-2#1)
using the standard addition method##3##5##(2008-10#3)
using the standard addition##4##4##(2008-10#4)
using the standard##15##3##(1992-12#1)(1994-1#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
using the statistical##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
using the stopped-flow##3##3##(2008-10#3)
using the strategy##3##3##(2010-7#3)
using the supplemental##2##3##(2008-7#1)(2013-7#1)
using the synchronous##2##3##(2008-10#1)(2008-3#1)
using the system##3##3##(1994-12#1)(2008-10#2)
using the tagging reagent 1##2##5##(2008-10#2)
using the technique of##4##4##(2008-10#3)(2008-11#1)
using the technique##5##3##(2008-10#3)(2008-11#1)(2008-4#1)
using the temporal##2##3##(2007-11#1)(2008-10#1)
using the terms##2##3##(2011-2#1)(2013-1#1)
using the theory of##2##4##(2008-2#1)(2008-3#1)
using the three##4##3##(2008-10#3)(2013-1#1)
using the traditional##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
using the two different##2##4##(2008-2#1)(2012-12#1)
using the two##9##3##(1997-4#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-7#1)
using the two-dimensional##2##3##(2008-5#1)(2008-8#1)
using the variable##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
using the white-ivory##2##3##(1996-2#2)
using the whole##2##3##(1993-3#1)(2008-4#1)
using the whole-cell##3##3##(1993-3#1)(1995-12#1)(2009-12#1)
using the yeast##2##3##(2008-7#1)(2008-8#1)
using the zero-crossing approach for determination of##2##7##(2008-10#2)
using the##1623##2##(1990-11#5)(1990-12#4)(1990-2#6)(1990-3#1)(1990-5#4)(1990-7#6)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#6)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#3)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#1)(1993-10#1)(1993-11#6)(1993-12#9)(1993-2#7)(1993-3#4)(1993-6#2)(1993-8#5)(1993-9#1)(1994-1#2)(1994-11#6)(1994-12#6)(1994-2#2)(1994-3#7)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#6)(1995-1#3)(1995-12#16)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#4)(1995-9#1)(1996-1#1)(1996-12#7)(1996-2#16)(1996-3#5)(1996-4#1)(1996-5#7)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#10)(1997-3#6)(1997-4#15)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#5)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#9)(2007-11#20)(2007-12#8)(2007-2#2)(2007-5#6)(2007-6#1)(2007-7#6)(2007-8#36)(2007-9#1)(2008-1#10)(2008-10#479)(2008-11#61)(2008-12#23)(2008-2#28)(2008-3#62)(2008-4#32)(2008-5#48)(2008-6#20)(2008-7#47)(2008-8#34)(2008-9#41)(2009-1#1)(2009-10#8)(2009-11#6)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#8)(2010-4#9)(2010-5#2)(2010-6#7)(2010-7#7)(2010-8#15)(2011-1#18)(2011-2#50)(2011-3#2)(2011-7#1)(2012-1#9)(2012-12#22)(2012-2#28)(2012-3#19)(2012-5#1)(2012-7#1)(2013-1#45)(2013-7#6)(2013-8#26)
using their##6##2##(1993-2#1)(2006-6#1)(2008-10#2)(2013-1#2)
using them to##2##3##(1997-4#1)(2008-6#1)
using them##7##2##(1995-6#1)(1997-4#1)(2008-12#1)(2008-6#1)(2009-12#1)(2011-2#2)
using thematic##3##2##(2008-11#1)(2009-12#1)(2012-12#1)
using thermal##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
using these antigens##2##3##(2008-10#1)(2011-2#1)
using these data##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
using these markers##2##3##(2008-9#1)(2013-8#1)
using these methods##5##3##(2008-10#3)(2008-3#1)(2008-9#1)
using these new techniques##2##4##(2009-3#1)(2012-2#1)
using these new##3##3##(1990-5#1)(2009-3#1)(2012-2#1)
using these primers##2##3##(2008-10#2)
using these techniques##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
using these two##2##3##(2007-12#1)(2007-8#1)
using these##63##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
using thin##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
using thiol-ene chemistry##2##3##(2010-12#2)
using this &quot##2##3##(2008-10#1)(2008-9#1)
using this analytical##2##3##(2008-10#2)
using this approach##11##3##(1992-2#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
using this assay##3##3##(2008-10#2)(2008-7#1)
using this electrode##3##3##(2008-10#3)
using this information and##2##4##(1995-8#1)(2008-7#1)
using this material as##2##4##(2008-10#1)(2008-3#1)
using this method and##2##4##(2008-10#2)
using this method at##2##4##(1990-3#1)(2008-3#1)
using this method for the determination of##2##7##(2008-10#2)
using this method##15##3##(1990-3#1)(1990-8#1)(1992-2#1)(1997-7#1)(2008-10#8)(2008-3#1)(2008-7#1)(2013-8#1)
using this methodology##2##3##(2008-10#2)
using this model##5##3##(1992-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)
using this new##2##3##(2008-10#1)(2008-12#1)
using this novel##2##3##(1997-4#1)(2008-8#1)
using this procedure##3##3##(1994-9#1)(2008-10#2)
using this simple##2##3##(2007-8#2)
using this strategy##3##3##(2008-11#2)(2008-9#1)
using this substrate##2##3##(2008-10#2)
using this system##6##3##(1997-4#1)(1997-8#1)(2008-10#2)(2008-2#1)(2011-1#1)
using this technique to##2##4##(2007-12#1)(2013-8#1)
using this technique##9##3##(2007-12#1)(2008-10#5)(2008-8#1)(2012-1#1)(2013-8#1)
using this test##2##3##(1993-11#1)(2008-8#1)
using this type of##2##4##(1995-6#1)(2011-1#1)
using this voltammetric##2##3##(2008-10#2)
using this##128##2##(1990-12#1)(1990-3#1)(1990-8#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#47)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#8)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-3#2)(2013-8#2)
using those##2##2##(1997-8#1)(2007-12#1)
using three different##11##3##(1990-7#1)(1992-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2010-3#1)
using three##26##2##(1990-7#1)(1992-5#1)(1995-12#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-3#2)(2008-5#1)(2010-3#1)(2010-4#1)(2010-8#1)
using three-dimensional##4##2##(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
using time-frequency methods##2##3##(2010-8#2)
using time-resolved##2##2##(2007-12#1)(2008-10#1)
using tissue engineering##2##3##(2010-8#1)(2012-3#1)
using tissue microarray##2##3##(2008-10#1)(2008-11#1)
using tissue##8##2##(1994-2#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)(2012-3#1)
using titanium trichloride##2##3##(2008-10#2)
using titanium##4##2##(2008-10#3)(2011-2#1)
using tools from##2##3##(2008-11#1)(2011-2#1)
using topical application##2##3##(2008-5#1)(2011-2#1)
using topical##5##2##(1992-8#1)(2008-5#2)(2011-2#2)
using total##6##2##(1992-6#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)
using traditional methods##2##3##(2008-10#1)(2008-5#1)
using traditional##12##2##(1994-3#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
using transcranial Doppler##2##3##(2007-10#2)
using transcranial##4##2##(2007-10#3)(2012-2#1)
using transgenic##3##2##(1996-12#1)(2009-8#1)(2013-8#1)
using transmission electron microscopy##3##4##(2008-10#3)
using transmission##5##2##(2008-10#4)(2011-2#1)
using transparent##2##2##(2008-5#1)(2009-12#1)
using tri-n-octylamine##2##2##(2008-10#2)
using tristimulus colorimetry and a quantitative##2##6##(2008-10#2)
using trypan blue exclusion##2##4##(2008-9#1)(2013-1#1)
using trypan blue##3##3##(2007-11#1)(2008-9#1)(2013-1#1)
using two certified reference materials##2##5##(2008-10#2)
using two different approaches##2##4##(1995-12#1)(2008-10#1)
using two different methods##2##4##(2008-10#1)(2008-4#1)
using two different##16##3##(1995-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2012-12#1)
using two level##2##3##(2008-10#2)
using two techniques##2##3##(2008-10#1)(2008-2#1)
using two types of##3##4##(1994-12#1)(2008-5#1)(2009-2#1)
using two types##4##3##(1994-12#1)(2008-5#1)(2008-8#1)(2009-2#1)
using two##93##2##(1990-8#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-12#2)(1995-12#2)(1995-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)
using two-dimensional##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
using two-photon##2##2##(2008-2#2)
using two-way##2##2##(2008-4#1)(2012-2#1)
using typical##2##2##(2008-10#1)(2010-10#1)
using tyrosinase##2##2##(2008-10#2)
using ultra##3##2##(2008-10#2)(2011-1#1)
using ultrafiltration##3##2##(2008-10#3)
using ultrasonic##3##2##(2008-10#3)
using ultrasonography##3##2##(1990-5#1)(1993-2#1)(2007-11#1)
using ultrasound##4##2##(1992-5#1)(2008-10#2)(2012-3#1)
using ultraviolet (UV)##2##3##(2008-10#1)(2008-5#1)
using ultraviolet##5##2##(2008-10#4)(2008-5#1)
using ultraviolet-visible spectroscopy##2##3##(2008-10#2)
using uncoated##2##2##(2008-10#2)
using univariate##3##2##(2008-10#3)
using universal protein G-liposomal nanovesicles##2##5##(2008-10#2)
using up to##2##3##(1993-11#1)(1995-3#1)
using variable##2##2##(1993-12#1)(2008-3#1)
using variations of##2##3##(1992-9#1)(2011-1#1)
using various##30##2##(1990-11#1)(1997-3#1)(2007-11#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
using vegetative compatibility##3##3##(2008-10#3)
using vertebral vectors##2##3##(2012-2#2)
using very##2##2##(1990-8#1)(2008-9#1)
using virtual##2##2##(2008-11#1)(2013-7#1)
using visual##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
using voltammetric##2##2##(2008-10#2)
using water and##2##3##(2008-10#2)
using water as solvent##2##4##(2008-10#1)(2011-1#1)
using water##12##2##(2008-10#7)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
using water-soluble##2##2##(1997-2#1)(2008-10#1)
using wavelength##3##2##(2008-10#2)(2008-3#1)
using wavelet##4##2##(2008-10#4)
using weather##3##2##(2008-10#3)
using wet##3##2##(2008-10#1)(2011-2#2)
using what##2##2##(2008-3#1)(2013-1#1)
using wheat##2##2##(2008-10#1)(2008-5#1)
using white##2##2##(1991-11#1)(2009-4#1)
using whole blood##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
using whole##7##2##(1990-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
using whole-cell##4##2##(1995-12#1)(1995-2#1)(2008-8#1)(2011-2#1)
using wide-field##2##2##(2008-8#1)(2011-1#1)
using wild-derived mouse stocks##2##4##(2009-5#2)
using winter wheat##2##3##(1992-3#1)(2008-10#1)
using winter##3##2##(1992-3#1)(2008-10#2)
using wireless##3##2##(2007-9#1)(2008-12#1)(2013-1#1)
using x-ray##2##2##(1991-6#1)(2008-3#1)
using yeast one-hybrid system##3##4##(2008-8#1)(2008-9#2)
using yeast two-hybrid system##2##4##(2008-8#1)(2008-9#1)
using yeast two-hybrid##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
using yeast##12##2##(1991-5#1)(1996-10#1)(2008-10#2)(2008-4#2)(2008-8#2)(2008-9#4)
using zero##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
using zymography##2##2##(2008-11#1)(2011-2#1)
using##11030##1##(1990-11#34)(1990-12#35)(1990-2#27)(1990-3#5)(1990-4#1)(1990-5#32)(1990-6#4)(1990-7#18)(1990-8#33)(1990-9#7)(1991-1#7)(1991-10#1)(1991-11#5)(1991-12#34)(1991-2#11)(1991-3#22)(1991-5#31)(1991-6#20)(1991-7#1)(1991-8#9)(1991-9#22)(1992-1#16)(1992-10#6)(1992-11#23)(1992-12#33)(1992-2#22)(1992-3#35)(1992-4#5)(1992-5#12)(1992-6#30)(1992-7#2)(1992-8#31)(1992-9#33)(1993-1#8)(1993-10#2)(1993-11#25)(1993-12#40)(1993-2#27)(1993-3#30)(1993-5#3)(1993-6#19)(1993-8#25)(1993-9#21)(1994-1#6)(1994-11#40)(1994-12#42)(1994-2#33)(1994-3#41)(1994-5#26)(1994-6#20)(1994-7#3)(1994-8#27)(1994-9#32)(1995-1#9)(1995-11#26)(1995-12#60)(1995-2#52)(1995-3#36)(1995-4#5)(1995-5#25)(1995-6#33)(1995-8#21)(1995-9#10)(1996-1#10)(1996-10#5)(1996-11#5)(1996-12#49)(1996-2#50)(1996-3#21)(1996-4#4)(1996-5#45)(1996-6#10)(1996-7#2)(1996-8#4)(1996-9#6)(1997-1#17)(1997-2#46)(1997-3#29)(1997-4#53)(1997-5#11)(1997-6#24)(1997-7#32)(1997-8#19)(1997-9#1)(2006-10#7)(2006-12#4)(2006-4#6)(2006-6#5)(2006-8#3)(2007-10#45)(2007-11#132)(2007-12#142)(2007-2#5)(2007-4#2)(2007-5#23)(2007-6#8)(2007-7#27)(2007-8#117)(2007-9#12)(2008-1#77)(2008-10#3781)(2008-11#443)(2008-12#160)(2008-2#189)(2008-3#305)(2008-4#236)(2008-5#290)(2008-6#148)(2008-7#301)(2008-8#216)(2008-9#289)(2009-1#4)(2009-10#55)(2009-11#33)(2009-12#36)(2009-2#17)(2009-3#32)(2009-4#12)(2009-5#36)(2009-6#21)(2009-7#35)(2009-8#64)(2009-9#27)(2010-1#16)(2010-10#25)(2010-11#31)(2010-12#39)(2010-2#22)(2010-3#55)(2010-4#49)(2010-5#44)(2010-6#42)(2010-7#34)(2010-8#89)(2010-9#4)(2011-1#151)(2011-2#317)(2011-3#16)(2011-7#4)(2011-8#1)(2012-1#54)(2012-12#117)(2012-2#183)(2012-3#149)(2012-4#3)(2012-5#4)(2012-6#3)(2012-7#4)(2013-1#284)(2013-3#2)(2013-7#30)(2013-8#116)
usitata##2##1##(2008-10#2)
usual DBP##2##2##(1990-3#2)
usual and##3##2##(1991-2#1)(2006-10#1)(2007-12#1)
usual care##7##2##(1990-5#1)(2008-4#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)
usual method##3##2##(2007-7#1)(2008-10#1)(2008-12#1)
usual methods##4##2##(2008-10#2)(2008-5#2)
usual source of##5##3##(1995-12#1)(2008-10#3)(2012-3#1)
usual source##6##2##(1995-12#2)(2008-10#3)(2012-3#1)
usual##145##1##(1990-10#1)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#3)(2006-10#2)(2007-11#7)(2007-12#6)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#20)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)
usual&quot##5##1##(1995-1#1)(1997-1#1)(2008-3#3)
usually a combination of##2##4##(1990-9#1)(2011-2#1)
usually a##9##2##(1990-9#1)(1991-3#1)(1991-4#1)(1993-2#1)(1994-2#1)(1997-3#1)(2008-7#1)(2011-2#2)
usually accompanied by##3##3##(1997-8#1)(2008-10#1)(2010-2#1)
usually affects##2##2##(2009-10#1)(2010-3#1)
usually after##2##2##(1992-5#1)(1993-9#1)
usually appears in the##2##4##(2007-8#1)(2008-3#1)
usually appears##3##2##(2007-8#1)(2008-3#1)(2013-1#1)
usually applied##2##2##(2007-12#1)(2009-4#1)
usually are of##3##3##(1992-9#1)(2007-12#1)(2008-5#1)
usually are##10##2##(1992-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
usually assessed##2##2##(1990-11#1)(2008-3#1)
usually associated with a##2##4##(2008-2#1)(2009-8#1)
usually associated with the##3##4##(1997-6#1)(2012-2#1)(2013-1#1)
usually associated with##17##3##(1997-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
usually associated##18##2##(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
usually asymptomatic##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
usually at pH##2##3##(2008-10#2)
usually at##4##2##(2007-7#1)(2008-10#2)(2008-11#1)
usually attributed to##2##3##(2008-11#1)(2008-5#1)
usually based on the##2##4##(1995-12#1)(2008-3#1)
usually based on##5##3##(1995-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
usually based##6##2##(1990-8#1)(1995-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
usually be##8##2##(1990-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#1)
usually believed##2##2##(2008-8#1)(2013-8#1)
usually benign##4##2##(1992-9#1)(2008-11#1)(2013-1#2)
usually between##2##2##(2008-1#1)(2008-10#1)
usually by##2##2##(2007-2#1)(2008-7#1)
usually called##2##2##(1990-2#1)(2008-10#1)
usually causes##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
usually characterised by##2##3##(2008-6#1)(2010-11#1)
usually characterised##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
usually considered as a##2##4##(2008-10#1)(2012-3#1)
usually considered to be##3##4##(2008-4#1)(2008-7#1)(2009-2#1)
usually considered to##4##3##(2008-4#1)(2008-7#1)(2009-2#2)
usually considered##11##2##(2008-10#2)(2008-4#2)(2008-7#2)(2009-2#2)(2009-7#1)(2009-9#1)(2012-3#1)
usually consist##2##2##(1996-12#1)(2007-5#1)
usually consists of##2##3##(2011-2#2)
usually consulted##2##2##(1996-6#1)(1997-4#1)
usually contain##4##2##(1993-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
usually cured##2##2##(2011-2#1)(2013-1#1)
usually described in##2##3##(2007-8#1)(2012-2#1)
usually described##4##2##(2007-8#1)(2008-9#1)(2010-5#1)(2012-2#1)
usually detected in##2##3##(2008-10#1)(2013-8#1)
usually detected##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
usually developed##2##2##(2008-10#1)(2009-11#1)
usually develops in##3##3##(2008-5#1)(2008-7#1)(2013-8#1)
usually develops##6##2##(2008-10#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#1)
usually diagnosed##4##2##(1993-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
usually difficult##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
usually do not##2##3##(1996-3#1)(2010-4#1)
usually dominated by##2##3##(1997-6#1)(2008-3#1)
usually due to##3##3##(2008-1#1)(2008-7#1)(2012-3#1)
usually during##2##2##(2007-2#1)(2012-3#1)
usually employed##4##2##(2007-11#1)(2007-12#1)(2008-7#2)
usually encountered in##5##3##(1990-8#1)(2008-10#2)(2009-4#1)(2012-2#1)
usually exhibit##2##2##(2008-10#1)(2013-8#1)
usually found in the##4##4##(2007-8#1)(2009-3#1)(2010-12#1)(2013-8#1)
usually found in##8##3##(2007-7#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-12#1)(2013-7#1)(2013-8#1)
usually found##11##2##(1991-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-3#1)(2010-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
usually has##2##2##(1997-3#1)(2008-2#1)
usually have##5##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
usually higher##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
usually in the##2##3##(2007-7#1)(2008-10#1)
usually in##6##2##(1992-1#1)(1997-6#1)(2007-7#1)(2008-10#2)(2013-8#1)
usually include##3##2##(2007-9#1)(2008-9#1)(2012-3#1)
usually included##2##2##(2008-10#1)(2008-2#1)
usually increased##2##2##(1992-5#1)(2012-2#1)
usually involves the##2##3##(2006-10#1)(2008-10#1)
usually involves##7##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-1#1)(2013-1#1)
usually is##5##2##(1997-6#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-3#1)
usually leads to##2##3##(1997-6#1)(2013-1#1)
usually less than##2##3##(1992-1#1)(2008-3#1)
usually less##4##2##(1992-1#1)(2007-11#1)(2008-3#1)(2008-9#1)
usually limited##2##2##(2007-8#1)(2008-10#1)
usually located in##2##3##(2010-12#1)(2013-1#1)
usually located##4##2##(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
usually manifests as a##2##4##(2007-12#1)(2010-6#1)
usually mild and##2##3##(2008-6#1)(2010-12#1)
usually mild##5##2##(1997-3#1)(2007-11#1)(2008-1#1)(2008-6#1)(2010-12#1)
usually more##4##2##(1995-5#1)(1996-4#1)(2008-10#2)
usually necessary for##3##3##(2007-8#1)(2008-10#1)(2010-11#1)
usually no##2##2##(2008-3#1)(2012-2#1)
usually normal##4##2##(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
usually not##11##2##(1990-12#1)(1992-3#1)(1993-6#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#1)
usually observed##3##2##(2008-7#1)(2012-12#1)(2012-3#1)
usually occur in##2##3##(2009-5#1)(2013-7#1)
usually occur##3##2##(2009-5#1)(2010-1#1)(2013-7#1)
usually occurs as a##2##4##(2007-8#1)(2008-6#1)
usually occurs as##3##3##(1990-5#1)(2007-8#1)(2008-6#1)
usually occurs in##9##3##(1993-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#3)
usually occurs##18##2##(1990-5#1)(1990-6#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-6#2)(2010-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
usually of##2##2##(2010-8#1)(2012-1#1)
usually on##2##2##(1990-3#1)(2007-2#1)
usually only##3##2##(1996-12#1)(2011-3#1)(2013-1#1)
usually originate from##2##3##(1997-1#1)(2011-2#1)
usually overcome##2##2##(1995-1#1)(2008-10#1)
usually overlooked##2##2##(2010-4#1)(2011-1#1)
usually performed as##2##3##(2008-7#1)(2010-3#1)
usually performed##13##2##(1990-9#1)(1992-9#1)(1993-6#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#1)(2010-3#1)(2011-2#1)
usually present in##3##3##(2008-10#2)(2010-4#1)
usually present with##7##3##(1990-8#1)(2008-1#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-2#2)
usually present##14##2##(1990-8#1)(1995-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)
usually presents with##4##3##(2008-11#1)(2008-7#2)(2012-3#1)
usually presents##6##2##(2008-10#1)(2008-11#1)(2008-7#2)(2012-3#2)
usually provided by the lamp's manufacturer##2##6##(2008-3#2)
usually range##2##2##(1997-8#1)(2008-10#1)
usually recommended##4##2##(2006-10#1)(2008-10#1)(2010-11#1)(2013-7#1)
usually reduces##2##2##(2008-2#1)(2008-8#1)
usually refers to##2##3##(2008-11#1)(2008-5#1)
usually regarded##3##2##(1990-8#1)(1995-11#1)(2010-7#1)
usually related to##2##3##(1991-5#1)(2013-8#1)
usually reported##3##2##(1997-4#1)(2007-12#1)(2008-7#1)
usually require##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
usually required to##3##3##(1995-3#1)(1995-5#1)(2010-9#1)
usually required##5##2##(1995-3#1)(1995-5#1)(2008-10#1)(2010-9#1)(2011-2#1)
usually requires##5##2##(1995-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
usually restricted##2##2##(2008-4#1)(2010-4#1)
usually result from##2##3##(1996-6#1)(2008-2#1)
usually result##3##2##(1996-6#1)(2007-8#1)(2008-2#1)
usually results in##2##3##(2008-10#1)(2013-1#1)
usually secondary to##2##3##(1991-5#1)(2008-10#1)
usually secondary##3##2##(1991-5#1)(2008-10#1)(2013-8#1)
usually seen in##3##3##(2008-10#2)(2011-2#1)
usually seen##7##2##(1997-5#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)(2012-2#1)
usually self-limiting##2##2##(2008-8#1)(2011-1#1)
usually several##2##2##(2008-6#1)(2010-6#1)
usually show##2##2##(1997-6#1)(2010-8#1)
usually starts##2##2##(1995-5#1)(2008-3#1)
usually studied##3##2##(1995-5#1)(2008-10#1)(2012-12#1)
usually sufficient##2##2##(2009-4#1)(2010-11#1)
usually tested##2##2##(1997-5#1)(2011-2#1)
usually the only##2##3##(1991-6#1)(2013-8#1)
usually the result of##2##4##(1995-1#1)(2008-6#1)
usually the##7##2##(1991-6#1)(1995-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
usually transient and##2##3##(2008-3#1)(2013-1#1)
usually treated as##2##3##(2008-2#1)(2008-9#1)
usually treated with##2##3##(1991-8#1)(2010-5#1)
usually treated##4##2##(1991-8#1)(2008-2#1)(2008-9#1)(2010-5#1)
usually used for##2##3##(2008-10#1)(2008-2#1)
usually used in##2##3##(2008-10#2)
usually used to##2##3##(2008-10#1)(2008-3#1)
usually used##8##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
usually very##2##2##(1996-4#1)(2008-10#1)
usually was##2##2##(2008-10#1)(2011-1#1)
usually were##4##2##(2008-10#3)(2008-8#1)
usually with##3##2##(2008-1#1)(2008-4#1)(2008-7#1)
usually##678##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#4)(1994-12#3)(1994-2#4)(1994-6#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-6#6)(1997-1#1)(1997-2#1)(1997-3#9)(1997-4#5)(1997-5#2)(1997-6#7)(1997-7#1)(1997-8#3)(2006-10#4)(2006-5#1)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#1)(2008-1#15)(2008-10#98)(2008-11#16)(2008-12#8)(2008-2#16)(2008-3#34)(2008-4#15)(2008-5#16)(2008-6#10)(2008-7#29)(2008-8#19)(2008-9#9)(2009-1#5)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#5)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#27)(2011-3#4)(2012-1#4)(2012-12#7)(2012-2#20)(2012-3#17)(2013-1#36)(2013-7#3)(2013-8#16)
uteri##6##1##(1993-12#1)(1994-12#1)(1994-5#1)(1996-5#1)(2013-1#1)(2013-7#1)
uterine LMS##4##2##(2012-2#4)
uterine adenocarcinoma##2##2##(2008-1#1)(2013-7#1)
uterine and##3##2##(1990-11#1)(2011-2#1)(2012-12#1)
uterine arteries##3##2##(1994-9#2)(1995-3#1)
uterine artery##3##2##(1994-9#1)(2012-12#1)(2013-1#1)
uterine atony##5##2##(1995-12#2)(2011-2#3)
uterine bleeding (DUB)##2##3##(1994-9#1)(2008-10#1)
uterine bleeding is##2##3##(1994-9#2)
uterine bleeding##13##2##(1991-12#1)(1991-2#2)(1994-12#1)(1994-9#3)(1995-3#1)(2008-10#1)(2009-5#1)(2010-3#1)(2013-7#1)(2013-8#1)
uterine carcinosarcoma##2##2##(2012-1#2)
uterine cavity##6##2##(1993-12#1)(1994-9#1)(1996-1#1)(2010-9#2)(2012-3#1)
uterine cells##4##2##(1994-8#1)(1994-9#2)(2007-12#1)
uterine cervical carcinoma##3##3##(1994-8#1)(2007-4#2)
uterine cervical neoplasms amongst females from##2##6##(2012-12#2)
uterine cervical neoplasms##3##3##(2012-12#3)
uterine cervical##7##2##(1994-8#1)(2007-4#2)(2012-12#3)(2012-2#1)
uterine cervix cancer##3##3##(1990-6#2)(1993-11#1)
uterine cervix##10##2##(1990-6#3)(1993-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#2)(2011-2#1)
uterine compression##2##2##(2011-2#2)
uterine epithelial cells##10##3##(2008-6#10)
uterine fibroids##3##2##(1993-12#2)(1994-9#1)
uterine horn##4##2##(1991-3#1)(1992-1#1)(1992-3#2)
uterine leiomyosarcoma##3##2##(2008-6#1)(2012-2#2)
uterine lipoma##4##2##(2013-7#4)
uterine muscle##3##2##(1993-12#3)
uterine natural killer cells##2##4##(2013-1#2)
uterine prolapse##2##2##(2008-10#2)
uterine prostanoid synthesis##2##3##(1994-3#2)
uterine retention##2##2##(2008-8#2)
uterine rupture##5##2##(1995-12#2)(2011-1#3)
uterine smooth muscle##3##3##(1993-12#1)(1994-9#1)(2010-3#1)
uterine tissue##5##2##(1994-8#1)(1996-12#1)(1997-6#3)
uterine tissues##4##2##(1997-6#2)(2010-3#1)(2012-2#1)
uterine wall##2##2##(1993-1#1)(1994-9#1)
uterine weight##2##2##(1996-2#1)(2011-2#1)
uterine##187##1##(1990-10#2)(1990-11#3)(1990-6#4)(1991-12#4)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#12)(1993-8#2)(1994-12#3)(1994-3#3)(1994-7#1)(1994-8#5)(1994-9#21)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#5)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#12)(2008-8#2)(2008-9#1)(2009-11#2)(2009-5#2)(2010-12#1)(2010-3#6)(2010-9#2)(2011-1#4)(2011-2#15)(2011-8#1)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#4)(2013-1#5)(2013-7#7)(2013-8#1)
uterine-placental adherence##2##2##(1994-9#2)
utero##27##1##(1990-5#1)(1990-7#1)(1991-1#1)(1993-2#1)(1993-6#1)(1994-8#2)(1996-5#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#4)(2012-12#1)(2012-3#2)(2013-8#1)
uteroferrin##2##1##(1991-8#2)
uterus and##5##2##(1993-8#1)(2007-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
uterus epithelial cells and##2##4##(2008-9#2)
uterus in##5##2##(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2012-1#1)
uterus is##4##2##(1993-11#1)(2007-11#1)(2008-8#1)(2011-2#1)
uterus with##3##2##(1994-2#1)(2011-1#1)(2013-1#1)
uterus##66##1##(1990-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-11#3)(1993-8#2)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-11#1)(2007-11#6)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-3#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#3)
utilisation and##2##2##(2008-11#1)(2008-7#1)
utilisation in##2##2##(2008-11#1)(2010-9#1)
utilisation of the##2##3##(1993-8#1)(2008-11#1)
utilisation of##11##2##(1993-8#1)(2008-10#4)(2008-11#2)(2010-8#1)(2012-12#2)(2012-2#1)
utilisation##27##1##(1993-8#1)(1997-2#1)(2008-10#8)(2008-11#9)(2008-5#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-12#3)(2012-2#1)
utilise the##2##2##(2008-11#1)(2008-4#1)
utilise##10##1##(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
utilised a##2##2##(1997-3#1)(2007-11#1)
utilised as##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
utilised for##5##2##(2008-10#4)(2008-11#1)
utilised the##3##2##(2008-10#1)(2008-11#2)
utilised to##8##2##(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)
utilised##33##1##(1991-12#1)(1993-12#1)(1993-6#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#9)(2011-1#1)
utilises a##3##2##(2008-10#1)(2008-12#2)
utilises the##5##2##(2006-6#1)(2008-10#4)
utilises##11##1##(2006-6#1)(2007-11#1)(2008-10#5)(2008-12#2)(2008-5#1)(2011-1#1)
utilising a##5##2##(1997-3#1)(2008-10#1)(2008-7#1)(2013-1#2)
utilising the##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
utilising##17##1##(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2012-12#2)(2013-1#2)(2013-8#2)
utilitarian##3##1##(1997-1#1)(2008-10#1)(2008-11#1)
utilities of##2##2##(2008-10#1)(2012-3#1)
utilities##10##1##(1996-12#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#2)
utility and limitations of##2##4##(1995-1#1)(2008-9#1)
utility and limitations##3##3##(1995-1#1)(2008-9#1)(2010-4#1)
utility and##13##2##(1992-3#1)(1993-1#1)(1994-11#1)(1995-1#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-3#1)
utility as a##3##3##(2008-2#1)(2008-6#1)(2010-8#1)
utility as##6##2##(2007-8#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-8#1)
utility for##14##2##(1993-12#2)(2007-10#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-9#1)
utility in clinical##2##3##(2008-9#1)(2012-1#1)
utility in the##5##3##(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
utility in##22##2##(1992-1#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
utility is illustrated##2##3##(2008-10#1)(2011-1#1)
utility is##5##2##(2008-10#2)(2008-8#1)(2010-6#1)(2011-1#1)
utility of a##7##3##(1996-7#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
utility of information##2##3##(1995-12#1)(2010-3#1)
utility of our##3##3##(2009-12#1)(2009-5#1)(2013-1#1)
utility of such a##2##4##(2008-10#1)(2008-3#1)
utility of such##4##3##(1995-5#1)(2008-10#2)(2008-3#1)
utility of the method##4##4##(1994-9#1)(2008-3#2)(2009-12#1)
utility of the new##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
utility of the proposed method##2##5##(2008-10#1)(2008-3#1)
utility of the proposed##5##4##(2008-10#3)(2008-3#2)
utility of the##51##3##(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#10)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
utility of these##4##3##(2008-10#1)(2008-12#1)(2013-1#2)
utility of this method##2##4##(2008-10#2)
utility of this##13##3##(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-8#1)
utility of##175##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#5)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#31)(2008-11#8)(2008-12#4)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#10)(2013-8#2)
utility scale##2##2##(2008-7#2)
utility to##2##2##(1992-1#1)(2013-1#1)
utility##274##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1996-1#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#47)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#14)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#18)(2008-8#5)(2008-9#11)(2009-10#1)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#15)(2013-1#15)(2013-8#5)
utilization among##5##2##(1992-4#1)(2008-12#1)(2008-7#1)(2012-1#1)(2013-8#1)
utilization and access##3##3##(1994-1#1)(1994-2#1)(1995-12#1)
utilization and cost##3##3##(1995-3#1)(1997-2#2)
utilization and costs##2##3##(2008-11#1)(2009-11#1)
utilization and expenditure##2##3##(1992-1#1)(1994-1#1)
utilization and program##3##3##(1991-3#2)(1992-1#1)
utilization and##41##2##(1991-1#1)(1991-3#2)(1992-1#3)(1993-12#1)(1993-3#2)(1994-1#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#3)(1997-2#2)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
utilization as##6##2##(1997-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
utilization by the##2##3##(1994-12#1)(2011-1#1)
utilization by##11##2##(1990-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-1#1)(2008-6#1)(2008-7#1)(2011-1#1)
utilization data##2##2##(1994-3#2)
utilization for##7##2##(1993-1#1)(1993-2#1)(1994-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
utilization groups##3##2##(1991-2#1)(1993-12#1)(1994-3#1)
utilization in a##2##3##(1991-1#1)(2008-6#1)
utilization in the##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
utilization in##31##2##(1990-11#2)(1990-7#2)(1991-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#3)(2009-11#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
utilization is##5##2##(1994-1#1)(2008-11#2)(2012-12#1)(2012-2#1)
utilization management (UM)##2##3##(1996-1#1)(1997-2#1)
utilization management program##3##3##(1995-1#2)(1996-1#1)
utilization management##18##2##(1991-3#1)(1993-12#3)(1994-12#1)(1995-1#6)(1995-2#1)(1996-1#3)(1996-12#1)(1997-2#2)
utilization of a##6##3##(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#1)(2012-3#1)
utilization of beta-adrenergic##2##3##(2008-3#2)
utilization of certain##2##3##(2008-10#1)(2008-11#1)
utilization of drugs##2##3##(1995-1#1)(1997-2#1)
utilization of glucose##2##3##(2008-6#1)(2008-7#1)
utilization of health care services##4##5##(1993-2#1)(1993-3#1)(1994-1#2)
utilization of health##5##3##(1993-2#1)(1993-3#1)(1994-1#2)(1995-3#1)
utilization of mental health##2##4##(1996-12#1)(1996-3#1)
utilization of occupational therapy services##2##5##(2013-7#2)
utilization of services##3##3##(1991-12#1)(1994-2#1)(1996-1#1)
utilization of the##15##3##(1994-1#3)(1994-5#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2011-2#1)
utilization of two##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
utilization of very##2##3##(2008-10#1)(2008-11#1)
utilization of##135##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-12#3)(1992-12#2)(1992-3#1)(1992-5#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#7)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#2)(1995-3#5)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2010-10#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
utilization on##3##2##(1992-12#1)(2007-10#1)(2008-10#1)
utilization patterns in##2##3##(1994-2#1)(2008-7#1)
utilization patterns##7##2##(1992-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-7#1)
utilization profiles##2##2##(1997-2#1)(2008-10#1)
utilization rate##6##2##(1993-1#1)(2008-11#1)(2008-6#1)(2008-7#3)
utilization rates##9##2##(1993-1#3)(1994-1#1)(2007-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)
utilization review##13##2##(1991-3#2)(1992-1#2)(1992-12#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)
utilization to##2##2##(2008-10#1)(2008-7#1)
utilization was##6##2##(1990-7#1)(1994-8#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
utilization when##2##2##(2008-6#1)(2012-2#1)
utilization##443##1##(1990-11#3)(1990-12#3)(1990-5#3)(1990-7#4)(1990-8#2)(1991-1#5)(1991-12#4)(1991-2#1)(1991-3#5)(1991-7#2)(1992-1#5)(1992-12#8)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#7)(1993-12#6)(1993-2#3)(1993-3#5)(1993-9#1)(1994-1#16)(1994-11#2)(1994-12#5)(1994-2#9)(1994-3#10)(1994-5#2)(1994-8#5)(1995-1#12)(1995-12#6)(1995-2#3)(1995-3#8)(1995-5#2)(1996-1#6)(1996-12#3)(1996-2#7)(1996-3#5)(1996-6#1)(1997-1#5)(1997-2#12)(1997-3#2)(1997-4#2)(2006-10#1)(2007-10#4)(2007-11#3)(2007-4#1)(2008-1#1)(2008-10#37)(2008-11#19)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#17)(2008-7#28)(2008-8#12)(2008-9#5)(2009-10#1)(2009-11#3)(2009-4#1)(2009-5#3)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#6)(2010-9#1)(2011-1#7)(2011-2#12)(2012-1#5)(2012-12#6)(2012-2#11)(2012-3#10)(2013-1#10)(2013-7#2)(2013-8#7)
utilize a##6##2##(1994-2#1)(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
utilize both##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
utilize the##24##2##(1992-3#1)(1995-2#1)(1997-4#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)
utilize this##6##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
utilize##108##1##(1990-7#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(2007-12#4)(2008-1#2)(2008-10#13)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#5)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
utilized a##13##2##(1992-10#1)(1992-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-3#1)(2013-1#1)
utilized an##2##2##(1993-2#1)(1996-2#1)
utilized and##4##2##(1995-8#1)(2008-10#1)(2010-8#1)(2012-2#1)
utilized as a##12##3##(1991-4#1)(1992-3#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2009-11#1)
utilized as an effective##2##4##(2008-11#1)(2012-7#1)
utilized as an##10##3##(1991-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2012-7#1)
utilized as the##3##3##(1996-5#1)(2007-12#1)(2008-6#1)
utilized as##36##2##(1991-4#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1996-5#3)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2012-7#1)(2013-1#1)
utilized by the##3##3##(2008-6#1)(2011-1#1)(2012-1#1)
utilized by##12##2##(1993-1#1)(1996-2#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
utilized during##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
utilized epidemiologists##2##2##(2008-11#2)
utilized for a variety of##2##5##(2009-10#2)
utilized for assessment of##2##4##(2008-9#1)(2012-2#1)
utilized for the analysis of##2##5##(1990-12#1)(2008-10#1)
utilized for the##16##3##(1990-12#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-5#1)(2010-5#1)(2011-1#1)
utilized for##58##2##(1990-11#1)(1990-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-7#1)
utilized in a##5##3##(2008-10#2)(2010-5#1)(2012-2#2)
utilized in developing##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
utilized in routine##2##3##(2008-10#1)(2008-12#1)
utilized in the experiments##2##4##(2008-10#1)(2008-9#1)
utilized in the##11##3##(1991-9#1)(1993-9#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)
utilized in##52##2##(1991-3#1)(1991-9#1)(1992-9#2)(1993-3#2)(1993-9#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-10#12)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)(2013-1#1)(2013-8#1)
utilized the##7##2##(1990-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
utilized these##2##2##(1997-4#1)(2008-8#1)
utilized this##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)
utilized to achieve a##2##4##(2008-3#1)(2012-3#1)
utilized to achieve##3##3##(2008-3#1)(2009-6#1)(2012-3#1)
utilized to assess##5##3##(1992-10#1)(1996-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
utilized to construct##3##3##(1995-5#1)(2008-9#2)
utilized to detect##5##3##(2007-11#1)(2008-10#3)(2013-1#1)
utilized to evaluate##2##3##(1990-2#1)(2008-3#1)
utilized to identify the##2##4##(2007-12#1)(2012-2#1)
utilized to identify##5##3##(1990-12#1)(2007-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
utilized to measure##2##3##(1995-1#1)(2010-8#1)
utilized to prepare##2##3##(1994-5#1)(2008-10#1)
utilized to screen##2##3##(2008-4#1)(2008-9#1)
utilized to study the##2##4##(2008-10#1)(2008-3#1)
utilized to study##3##3##(2008-10#1)(2008-3#2)
utilized to support##2##3##(2013-1#1)(2013-8#1)
utilized to##84##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-1#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-8#1)(2007-11#3)(2007-12#3)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
utilized with##2##2##(2008-2#1)(2011-1#1)
utilized##369##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-5#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#3)(1992-10#2)(1992-12#3)(1992-2#3)(1992-3#4)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-2#2)(1995-3#4)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#8)(1996-3#2)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-5#1)(2008-1#3)(2008-10#88)(2008-11#12)(2008-12#6)(2008-2#13)(2008-3#10)(2008-4#11)(2008-5#7)(2008-6#7)(2008-7#4)(2008-8#4)(2008-9#9)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-8#5)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#3)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#6)
utilizes a##19##2##(1990-12#1)(1992-8#1)(1993-12#2)(1994-6#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-4#1)(2009-10#1)(2011-1#1)
utilizes an##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-1#1)
utilizes its##3##2##(1997-2#1)(1997-8#1)(2011-2#1)
utilizes sophisticated##2##2##(2008-3#1)(2011-1#1)
utilizes the fact that##2##4##(2008-3#1)(2008-5#1)
utilizes the##26##2##(1993-12#1)(1994-5#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-9#1)(2011-1#2)(2012-2#1)
utilizes this##2##2##(1996-3#1)(1997-5#1)
utilizes##101##1##(1990-10#1)(1990-12#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#13)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-6#1)(2010-2#1)(2010-8#2)(2011-1#5)(2011-2#4)(2012-2#1)(2012-3#1)
utilizing 0##2##2##(1991-7#1)(2008-10#1)
utilizing a redox reaction##2##4##(2008-10#2)
utilizing a##40##2##(1990-8#1)(1991-12#1)(1993-9#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-7#2)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
utilizing an##3##2##(1993-2#1)(1995-5#1)(2008-10#1)
utilizing in-line preconcentration/separation##2##3##(2008-10#2)
utilizing initial##2##2##(2008-10#1)(2009-7#1)
utilizing more than##2##3##(1996-3#1)(2008-4#1)
utilizing optical##3##2##(2008-3#1)(2008-5#1)(2009-7#1)
utilizing standard##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
utilizing the beta-catenin##2##3##(2007-12#2)
utilizing the same##2##3##(2008-11#1)(2009-5#1)
utilizing the##29##2##(1992-1#1)(1992-8#1)(1993-6#1)(1996-2#1)(2007-12#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
utilizing these##4##2##(1992-3#1)(1996-2#1)(2013-1#2)
utilizing this##4##2##(1991-5#1)(1992-9#1)(2008-7#1)(2013-8#1)
utilizing volunteers##2##2##(1994-3#1)(1995-12#1)
utilizing##223##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#2)(1992-1#2)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#8)(2007-12#8)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#51)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#9)(2008-8#1)(2008-9#7)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
utmost importance##13##2##(1991-6#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
utmost##16##1##(1991-6#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
utterances##2##1##(2008-6#1)(2013-8#1)
uv##2##1##(1991-6#1)(2008-10#1)
uveal melanoma##3##2##(1991-6#1)(2008-7#2)
uveal##6##1##(1991-6#2)(2008-7#3)(2013-8#1)
uveitis##6##1##(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
uvomorulin with##2##2##(1990-11#1)(1994-6#1)
uvomorulin##5##1##(1990-11#3)(1994-6#2)
uvs112##2##1##(1995-9#2)
uvsC##2##1##(1997-4#2)
uvsC114 mutant##2##2##(1997-4#2)
v 100%##2##2##(2007-10#2)
v##262##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#6)(1990-3#1)(1990-5#2)(1990-7#2)(1991-1#4)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#4)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#7)(1992-2#2)(1992-3#22)(1992-8#5)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#8)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#8)(1994-3#3)(1994-7#2)(1994-8#1)(1995-1#1)(1995-12#16)(1995-2#5)(1995-3#3)(1995-5#4)(1995-6#5)(1996-12#6)(1996-2#6)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#11)(1997-6#1)(1997-7#6)(2006-12#1)(2007-10#8)(2007-2#3)(2007-3#4)(2007-7#9)(2008-1#7)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#7)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#5)
v&quot##2##1##(2008-3#2)
v(-1))##2##1##(2008-10#2)
v(i) and v(j)##3##3##(2008-10#3)
v(i) and##4##2##(2008-10#4)
v)##6##1##(2007-11#1)(2008-10#3)(2008-11#1)(2009-9#1)
v-Mos##2##1##(1995-2#2)
v-Mos-catalyzed phosphorylation sites##2##3##(1995-2#2)
v-Src##4##1##(1994-8#4)
v-jun##2##1##(1991-9#1)(2008-11#1)
v-myc##2##1##(1990-12#1)(2009-7#1)
v-src##2##1##(1995-6#1)(1997-7#1)
v-src-transformed##3##1##(1997-1#3)
v/v in##2##2##(1990-12#1)(2008-10#1)
v/v##28##1##(1990-12#1)(1994-5#1)(1997-1#1)(2008-10#16)(2008-5#8)(2010-5#1)
v/v) and the##2##3##(1997-2#1)(2008-10#1)
v/v) and##12##2##(1990-8#1)(1997-2#1)(2008-10#9)(2008-7#1)
v/v) as mobile phase##2##4##(2008-10#1)(2011-2#1)
v/v) as##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
v/v) at the flow rate##2##5##(2008-10#2)
v/v) at##5##2##(2008-10#4)(2011-1#1)
v/v) by##2##2##(2008-10#1)(2008-5#1)
v/v) containing 0##2##3##(2008-10#1)(2011-2#1)
v/v) containing##8##2##(1996-5#1)(2008-10#6)(2011-2#1)
v/v) eluent containing the##2##4##(2008-10#2)
v/v) eluent containing##3##3##(2008-10#3)
v/v) in##2##2##(2008-10#2)
v/v) solution##2##2##(2008-10#2)
v/v) was##3##2##(1991-5#1)(2008-10#1)(2008-7#1)
v/v) with##2##2##(2008-10#1)(2010-3#1)
v/v)##84##1##(1990-8#2)(1991-5#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#63)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)
v/v)]##2##1##(2008-5#2)
v/v/v) as mobile phase##2##4##(2008-10#2)
v/v/v) with a flow rate of 1##2##7##(2008-10#1)(2008-5#1)
v/v/v)##11##1##(2008-10#9)(2008-5#1)(2010-3#1)
v/v/v/v)##3##1##(2008-10#1)(2011-1#1)(2012-2#1)
v? =##2##2##(2008-2#2)
v?) =##2##2##(2008-3#2)
vAcCMVBar##2##1##(2008-8#2)
vV(nuc) were##2##2##(1996-9#2)
vV(nuc)##3##1##(1996-9#3)
vWA##6##1##(2008-12#5)(2012-12#1)
vWF gene##3##2##(2008-12#3)
vWF in##3##2##(2007-10#1)(2013-8#2)
vWF##18##1##(1993-3#1)(2007-10#4)(2008-11#3)(2008-12#3)(2013-8#7)
va##3##1##(2008-10#2)(2012-2#1)
vacancies in the##2##3##(1992-5#2)
vacancies in##3##2##(1992-5#2)(2011-2#1)
vacancies##8##1##(1992-5#2)(2008-9#4)(2011-2#1)(2012-12#1)
vacancy##11##1##(1991-2#1)(1993-1#1)(2008-8#2)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#2)
vacant##11##1##(1990-6#1)(1991-11#1)(1992-3#3)(1994-3#1)(2008-10#4)(2008-9#1)
vacated##2##1##(1996-12#1)(2008-7#1)
vacations##2##1##(1991-3#1)(2008-10#1)
vaccinal##4##1##(1990-6#1)(1997-6#3)
vaccinate##7##1##(1994-9#1)(1996-12#1)(2011-1#4)(2011-2#1)
vaccinated and non-vaccinated##3##3##(1997-3#1)(1997-6#1)(2008-5#1)
vaccinated and unvaccinated##3##3##(1994-2#1)(1997-3#1)(2007-2#1)
vaccinated and##8##2##(1991-6#1)(1994-2#1)(1997-3#2)(1997-6#1)(2007-2#2)(2008-5#1)
vaccinated animals gave##2##3##(2010-4#2)
vaccinated animals##5##2##(1995-9#2)(2008-9#1)(2010-4#2)
vaccinated at##2##2##(1990-11#1)(2010-4#1)
vaccinated birds##2##2##(1997-3#1)(2008-5#1)
vaccinated broilers##2##2##(1997-3#2)
vaccinated cattle##3##2##(1994-3#1)(2007-2#2)
vaccinated chickens were##2##3##(1997-6#1)(2008-5#1)
vaccinated chickens##5##2##(1996-11#1)(1997-6#1)(2008-5#3)
vaccinated or##2##2##(1996-12#1)(2007-2#1)
vaccinated with##8##2##(1997-3#1)(1997-6#2)(2008-5#1)(2010-4#3)(2012-3#1)
vaccinated##71##1##(1990-11#2)(1991-6#1)(1991-8#1)(1994-2#3)(1994-3#1)(1995-5#2)(1995-9#4)(1996-11#2)(1996-12#1)(1997-3#7)(1997-6#6)(2007-2#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-9#1)(2009-12#1)(2009-5#3)(2010-4#7)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#2)
vaccinating##3##1##(2011-1#1)(2012-2#1)(2013-1#1)
vaccination against##11##2##(1992-9#1)(1993-6#1)(1994-9#1)(2007-2#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
vaccination and prophylactic##2##3##(2007-2#1)(2008-7#1)
vaccination and the##3##3##(1990-9#1)(1993-2#1)(2008-7#1)
vaccination and##12##2##(1990-9#1)(1991-8#1)(1993-2#1)(1997-2#1)(2007-2#2)(2008-7#2)(2009-12#1)(2009-5#1)(2010-12#1)(2012-2#1)
vaccination coverage in##3##3##(1996-12#1)(2011-2#2)
vaccination coverage##10##2##(1994-9#1)(1995-3#2)(1996-12#2)(2008-9#2)(2011-2#3)
vaccination for##5##2##(1995-2#1)(1995-6#1)(1995-8#1)(2006-10#1)(2007-12#1)
vaccination has##4##2##(1996-8#1)(1997-8#1)(2008-7#1)(2013-1#1)
vaccination history of Bacille Calmette Guerin##2##6##(2011-1#2)
vaccination in the##5##3##(1990-6#1)(1996-9#1)(2009-12#1)(2010-4#1)(2012-3#1)
vaccination in##18##2##(1990-3#1)(1990-6#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-12#3)(2009-5#1)(2010-4#3)(2011-2#1)(2012-3#1)
vaccination is not##2##3##(2007-2#1)(2012-12#1)
vaccination is recommended for all##2##5##(2009-12#1)(2011-2#1)
vaccination is##9##2##(1995-5#1)(1996-3#2)(2007-2#2)(2007-6#1)(2009-12#1)(2011-2#1)(2012-12#1)
vaccination of##14##2##(1990-3#1)(1992-5#1)(1994-8#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
vaccination on the##4##3##(1991-6#1)(1996-1#1)(1996-3#1)(2007-12#1)
vaccination on##5##2##(1991-6#1)(1996-1#1)(1996-3#2)(2007-12#1)
vaccination programme##3##2##(1997-3#1)(2008-9#1)(2011-1#1)
vaccination programs##2##2##(2008-4#1)(2009-12#1)
vaccination rates##3##2##(2008-4#2)(2009-5#1)
vaccination recommendations for travelers##2##4##(2011-2#2)
vaccination recommendations for##3##3##(2011-2#3)
vaccination recommendations##4##2##(2010-9#1)(2011-2#3)
vaccination schedules##2##2##(2007-2#1)(2008-4#1)
vaccination should##2##2##(1995-3#1)(2010-8#1)
vaccination started##2##2##(1993-6#1)(2008-9#1)
vaccination status of##2##3##(2007-2#1)(2007-3#1)
vaccination status##4##2##(1994-9#1)(2007-2#1)(2007-3#1)(2008-4#1)
vaccination strategies##5##2##(1997-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
vaccination strategy##2##2##(1997-8#1)(2013-1#1)
vaccination to##2##2##(2007-12#1)(2007-2#1)
vaccination was##4##2##(2010-4#1)(2011-2#2)(2013-1#1)
vaccination with a##4##3##(1995-9#1)(2008-9#1)(2013-1#2)
vaccination with##15##2##(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
vaccination##265##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-6#2)(1991-8#1)(1992-5#3)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#5)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#6)(1995-2#3)(1995-3#6)(1995-5#11)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#4)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#4)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#22)(2007-3#1)(2007-6#5)(2007-7#1)(2008-10#7)(2008-11#8)(2008-3#2)(2008-4#17)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#8)(2009-12#8)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#24)(2012-12#6)(2012-2#7)(2012-3#7)(2013-1#12)(2013-8#1)
vaccination]##3##1##(1994-2#1)(1995-12#1)(2008-8#1)
vaccinations against##2##2##(2011-2#1)(2012-12#1)
vaccinations to##2##2##(2011-2#1)(2012-3#1)
vaccinations##20##1##(1993-3#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#1)
vaccine (OPV)##3##2##(1994-9#1)(1995-3#1)(2008-4#1)
vaccine -##2##2##(2007-7#1)(2013-8#1)
vaccine adjuvant##3##2##(1995-5#1)(1996-9#1)(2013-1#1)
vaccine administration##2##2##(2007-11#1)(2009-4#1)
vaccine against the##2##3##(1997-7#2)
vaccine against tuberculosis##2##3##(1995-2#1)(2008-7#1)
vaccine against##20##2##(1991-3#1)(1995-12#1)(1995-2#2)(1995-5#2)(1997-7#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
vaccine and the##2##3##(2007-10#1)(2011-2#1)
vaccine and##17##2##(1992-2#1)(1995-5#2)(1997-5#1)(2007-10#3)(2008-11#1)(2008-4#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
vaccine antigen##2##2##(2008-7#1)(2012-12#1)
vaccine antigens##6##2##(1995-5#3)(2008-7#3)
vaccine at##2##2##(1994-9#1)(2010-10#1)
vaccine bank##3##2##(2011-2#3)
vaccine banks##3##2##(2007-6#1)(2011-2#2)
vaccine can##2##2##(1996-12#1)(2011-2#1)
vaccine candidate##6##2##(1993-2#1)(1993-3#1)(2008-11#2)(2008-12#1)(2009-6#1)
vaccine candidates##6##2##(1993-3#1)(2008-7#1)(2009-5#2)(2010-12#1)(2011-2#1)
vaccine cold chain##2##3##(1993-2#1)(1997-8#1)
vaccine components##2##2##(1995-5#2)
vaccine containing##2##2##(2008-10#1)(2008-11#1)
vaccine coverage##2##2##(2007-2#1)(2010-4#1)
vaccine delivery##4##2##(1995-5#3)(2010-8#1)
vaccine design##6##2##(1995-5#2)(2007-12#1)(2007-6#2)(2012-12#1)
vaccine development##11##2##(1992-12#1)(1993-3#1)(1994-8#1)(1995-5#1)(1997-7#1)(2009-12#1)(2010-8#2)(2011-2#2)(2012-3#1)
vaccine doses##2##2##(2008-11#1)(2009-12#1)
vaccine effectiveness##5##2##(2010-4#5)
vaccine efficacy and##2##3##(1995-2#1)(2010-5#1)
vaccine efficacy##13##2##(1994-2#2)(1995-2#2)(1995-5#4)(2008-4#1)(2009-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
vaccine for 2 of 3##2##5##(2007-11#2)
vaccine for children##2##3##(2008-11#2)
vaccine for the prevention of##2##5##(1995-2#1)(2011-2#1)
vaccine for##15##2##(1994-8#1)(1995-2#1)(1995-5#1)(2007-10#1)(2007-11#4)(2008-11#2)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#1)
vaccine formulations##4##2##(1995-5#2)(2008-4#1)(2012-2#1)
vaccine from##2##2##(1991-8#1)(2011-1#1)
vaccine given at##2##3##(1992-2#1)(2007-11#1)
vaccine has proved##2##3##(2011-2#1)(2013-8#1)
vaccine has##8##2##(1993-3#1)(1995-5#1)(2007-7#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
vaccine in healthy##2##3##(2009-5#1)(2011-2#1)
vaccine in the##2##3##(1995-5#1)(2013-8#1)
vaccine in##16##2##(1990-6#1)(1990-9#1)(1991-8#1)(1991-9#1)(1994-6#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
vaccine is##10##2##(1993-6#1)(1994-2#1)(1994-9#1)(2007-11#1)(2007-2#3)(2009-12#1)(2011-2#1)(2012-2#1)
vaccine made##2##2##(1997-6#1)(2013-1#1)
vaccine of##2##2##(2011-2#2)
vaccine on##2##2##(1997-6#1)(2011-2#1)
vaccine or##4##2##(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
vaccine production##2##2##(2008-11#1)(2012-3#1)
vaccine research##2##2##(2008-5#1)(2013-1#1)
vaccine response##4##2##(2008-3#1)(2009-4#3)
vaccine responses##4##2##(2007-11#1)(2009-4#1)(2012-12#2)
vaccine safety##3##2##(1995-5#3)
vaccine should be##2##3##(1994-9#1)(2009-4#1)
vaccine strain##8##2##(2007-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-8#4)
vaccine strains##4##2##(1995-5#1)(2008-11#1)(2011-1#2)
vaccine strategy##2##2##(2012-12#1)(2013-1#1)
vaccine technologies##2##2##(2009-12#2)
vaccine that##3##2##(1994-8#1)(2011-1#1)(2011-2#1)
vaccine to protect against##2##4##(2007-2#1)(2007-6#1)
vaccine to##7##2##(1995-12#1)(1996-8#1)(1997-6#1)(2007-2#1)(2007-6#1)(2008-5#1)(2013-1#1)
vaccine trial##2##2##(1993-12#1)(2012-12#1)
vaccine trials##4##2##(1994-9#1)(1995-5#1)(2008-11#1)(2012-12#1)
vaccine vector##2##2##(2008-11#2)
vaccine vehicle##2##2##(1995-5#1)(2011-2#1)
vaccine virus##3##2##(1995-5#1)(1995-9#1)(2013-8#1)
vaccine was##7##2##(1996-12#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-9#1)(2011-2#1)(2011-3#1)
vaccine will be##2##3##(1990-11#1)(2008-11#1)
vaccine##445##1##(1990-11#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#2)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#8)(1993-6#3)(1994-2#5)(1994-6#1)(1994-8#4)(1994-9#13)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#6)(1995-5#51)(1995-9#3)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-8#4)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#9)(1997-7#6)(1997-8#1)(2007-10#7)(2007-11#19)(2007-12#6)(2007-2#10)(2007-6#4)(2007-7#6)(2008-1#2)(2008-10#7)(2008-11#27)(2008-12#1)(2008-3#3)(2008-4#8)(2008-5#10)(2008-7#8)(2008-8#4)(2008-9#11)(2009-12#5)(2009-4#10)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#6)(2010-12#2)(2010-4#7)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#38)(2011-3#1)(2012-12#13)(2012-2#5)(2012-3#7)(2013-1#21)(2013-8#15)
vaccine)##3##1##(1991-8#2)(2008-10#1)
vaccine-associated##2##1##(1995-5#1)(2013-8#1)
vaccine-induced##3##1##(1995-5#1)(1995-9#1)(2009-4#1)
vaccine-preventable diseases##3##2##(1995-3#1)(1996-12#1)(2013-1#1)
vaccine]##3##1##(1994-9#1)(2007-10#1)(2007-6#1)
vaccines administered##2##2##(1991-5#1)(2008-10#1)
vaccines against##11##2##(1994-11#1)(1995-5#2)(1997-7#1)(2007-10#2)(2008-11#2)(2010-8#1)(2012-2#1)(2013-1#1)
vaccines and##11##2##(1995-5#1)(1995-6#1)(1996-6#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
vaccines are##13##2##(1995-5#1)(1996-11#1)(1997-4#1)(1997-7#1)(2007-2#2)(2008-11#1)(2009-12#1)(2010-10#1)(2011-2#3)(2013-1#1)
vaccines at the##2##3##(1992-5#1)(1995-5#1)
vaccines available##2##2##(1997-8#1)(2011-1#1)
vaccines based on##2##3##(2009-8#1)(2012-2#1)
vaccines can##2##2##(1997-4#1)(1997-8#1)
vaccines for##7##2##(1995-5#2)(1997-7#1)(2007-2#1)(2009-4#1)(2011-2#1)(2012-12#1)
vaccines from##2##2##(1991-8#1)(2008-5#1)
vaccines have been##2##3##(2008-5#1)(2008-7#1)
vaccines have##5##2##(1991-5#1)(2008-11#2)(2008-5#1)(2008-7#1)
vaccines in children and adults##3##5##(2011-2#3)
vaccines in the##2##3##(1994-2#1)(2008-11#1)
vaccines in##15##2##(1994-2#2)(1994-9#1)(1995-5#2)(1997-6#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2011-2#3)(2013-1#2)
vaccines is##4##2##(1995-5#1)(2008-4#1)(2009-12#1)(2010-4#1)
vaccines must be##2##3##(1995-5#1)(2007-7#1)
vaccines must##3##2##(1995-5#2)(2007-7#1)
vaccines of##2##2##(1995-5#1)(2011-2#1)
vaccines prepared from##2##3##(1991-5#1)(1991-8#1)
vaccines prepared##3##2##(1991-5#1)(1991-8#1)(2011-2#1)
vaccines produced##2##2##(2008-11#1)(2009-5#1)
vaccines requires##2##2##(1997-4#1)(2008-11#1)
vaccines should##3##2##(1995-5#2)(1997-7#1)
vaccines that##3##2##(1990-12#1)(1995-5#1)(2007-11#1)
vaccines to fight##2##3##(2009-7#1)(2012-2#1)
vaccines to##8##2##(1995-5#1)(1997-4#1)(2008-11#1)(2008-5#2)(2009-7#1)(2011-2#1)(2012-2#1)
vaccines were##4##2##(1991-8#1)(1995-5#2)(1996-3#1)
vaccines will depend on##2##4##(1997-7#2)
vaccines will##4##2##(1995-5#1)(1996-12#1)(1997-7#2)
vaccines with##3##2##(1995-5#2)(1997-8#1)
vaccines##238##1##(1990-12#3)(1990-3#1)(1991-5#4)(1991-8#3)(1992-5#1)(1993-3#1)(1994-11#1)(1994-2#3)(1994-9#4)(1995-5#60)(1995-6#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#10)(1997-6#7)(1997-7#7)(1997-8#5)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#4)(2007-6#3)(2007-7#1)(2008-10#3)(2008-11#19)(2008-4#6)(2008-5#10)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#3)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#17)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
vaccines]##4##1##(1990-2#1)(1992-5#1)(1996-9#1)(2008-8#1)
vaccinia viral vector##2##3##(2008-8#2)
vaccinia virus expression system##2##4##(2008-2#2)
vaccinia virus##14##2##(1991-5#2)(1994-12#1)(1995-6#1)(2008-11#1)(2008-2#4)(2008-8#3)(2013-1#2)
vaccinia##22##1##(1991-5#2)(1994-12#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-2#6)(2008-4#1)(2008-8#6)(2013-1#2)
vaccinii were##2##2##(2008-10#2)
vaccinii##4##1##(2008-10#4)
vaccinii-corymbosi and##2##2##(2008-10#2)
vaccinii-corymbosi##17##1##(2008-10#17)
vaccinology##6##1##(2010-8#6)
vacuma and transposa##2##3##(2008-10#2)
vacuma isolates##2##2##(2008-10#2)
vacuma##10##1##(2008-10#10)
vacuolar ATPase##3##2##(1995-6#3)
vacuolar membrane##2##2##(2008-11#1)(2012-2#1)
vacuolar proton ATPase##2##3##(1993-11#1)(1994-6#1)
vacuolar##17##1##(1992-8#1)(1993-11#2)(1994-6#2)(1994-8#1)(1995-3#3)(1995-6#3)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
vacuolated area##2##2##(2007-10#1)(2007-12#1)
vacuolated##5##1##(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
vacuolation##5##1##(1995-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-2#1)
vacuole of##3##2##(1990-12#2)(2011-2#1)
vacuole##20##1##(1990-12#2)(1993-3#2)(2008-1#1)(2008-11#3)(2008-6#1)(2008-9#2)(2009-10#3)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#2)
vacuoles and##8##2##(2007-12#3)(2008-11#1)(2008-5#1)(2008-7#3)
vacuoles are##3##2##(2007-12#2)(2008-7#1)
vacuoles in chloroquine-induced myopathy-affected muscle##2##5##(1995-12#2)
vacuoles in##4##2##(1995-12#2)(2008-12#1)(2013-1#1)
vacuoles of##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
vacuoles were##2##2##(2008-7#2)
vacuoles##49##1##(1994-8#1)(1995-12#3)(2007-12#13)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#13)(2008-9#1)(2009-10#1)(2012-7#1)(2013-1#1)
vacuolization of##4##2##(2008-12#1)(2008-8#1)(2008-9#2)
vacuolization##15##1##(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#8)
vacuous chewing movements##3##3##(1996-2#3)
vacuum and##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
vacuum aspiration##4##2##(1995-8#1)(1996-8#1)(2011-1#2)
vacuum assisted closure (VAC)##2##4##(2007-8#1)(2008-11#1)
vacuum assisted closure##3##3##(2007-8#1)(2008-11#2)
vacuum disc herniation##3##3##(2012-2#3)
vacuum disc##7##2##(2008-12#2)(2012-2#5)
vacuum heat pump dryer##2##4##(2011-2#2)
vacuum heat pump##3##3##(2011-2#3)
vacuum heating##2##2##(2008-10#2)
vacuum or##2##2##(1990-8#1)(2008-10#1)
vacuum packaging##3##2##(2011-2#3)
vacuum pump##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
vacuum ultraviolet (VUV)##2##3##(2008-2#1)(2010-4#1)
vacuum ultraviolet radiation##3##3##(2007-11#2)(2008-2#1)
vacuum ultraviolet##6##2##(2007-11#2)(2008-2#3)(2010-4#1)
vacuum was##2##2##(2008-10#1)(2011-2#1)
vacuum##75##1##(1990-11#1)(1990-8#1)(1992-8#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-11#5)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#7)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
vacuum-assisted##2##1##(2012-2#1)(2012-3#1)
vacuum-deposited##2##1##(2008-3#1)(2013-8#1)
vacuum-packaged##2##1##(2010-4#2)
vacuum-ultraviolet wavelengths##2##2##(2008-3#2)
vacuum-ultraviolet##7##1##(1990-12#1)(2007-11#2)(2007-12#1)(2008-3#3)
vacuums##2##1##(2008-10#1)(2008-11#1)
vadis##2##1##(1993-2#1)(2011-2#1)
vagal reflex##2##2##(1995-3#2)
vagal tone##3##2##(1991-1#1)(1991-10#1)(2011-2#1)
vagal##13##1##(1991-1#1)(1991-10#1)(1992-6#1)(1995-3#2)(1996-5#2)(2007-10#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-7#1)
vagally##2##1##(1990-5#1)(2009-7#1)
vagile##2##1##(2008-8#2)
vagina and##3##2##(1990-10#1)(1996-12#2)
vagina and/or##2##2##(1996-12#2)
vagina or##2##2##(1992-3#1)(2009-2#1)
vagina syndrome after classical anterior##2##5##(2012-3#2)
vagina syndrome##3##2##(2012-3#3)
vagina##25##1##(1990-10#2)(1990-2#1)(1990-8#1)(1991-12#2)(1992-3#1)(1993-1#1)(1994-1#2)(1996-12#4)(1996-9#1)(2007-12#2)(2008-11#1)(2009-10#1)(2009-2#1)(2010-11#1)(2012-3#3)(2013-1#1)
vaginal HPV##2##2##(1992-3#2)
vaginal agenesis##2##2##(1993-1#2)
vaginal and external anogenital condylomas##3##5##(1996-1#3)
vaginal and##6##2##(1996-1#3)(2007-10#1)(2008-4#1)(2010-11#1)
vaginal approach to##2##3##(1991-3#1)(1996-12#1)
vaginal approach##3##2##(1991-3#1)(1996-12#2)
vaginal bleeding##6##2##(1991-2#1)(2007-10#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
vaginal cylinders##7##2##(2009-2#7)
vaginal delivery##7##2##(1993-6#1)(1995-12#1)(2010-8#1)(2011-1#1)(2011-2#3)
vaginal discharge##4##2##(2007-2#1)(2007-7#2)(2011-2#1)
vaginal fluid##8##2##(1995-11#1)(1996-12#7)
vaginal hysterectomies performed by the senior##2##6##(1993-12#2)
vaginal hysterectomies##10##2##(1993-12#4)(1995-1#6)
vaginal hysterectomy in##3##3##(1993-12#2)(1995-12#1)
vaginal hysterectomy is##3##3##(1993-12#1)(2010-3#1)(2011-2#1)
vaginal hysterectomy was##2##3##(1995-12#1)(1996-2#1)
vaginal hysterectomy with or without##2##5##(1993-2#1)(1994-2#1)
vaginal hysterectomy with##3##3##(1993-2#1)(1994-2#1)(2010-3#1)
vaginal hysterectomy##38##2##(1991-3#2)(1993-12#11)(1993-2#3)(1993-3#1)(1994-2#4)(1995-1#1)(1995-12#2)(1995-3#2)(1996-2#3)(2008-12#1)(2010-3#3)(2011-2#5)
vaginal operations##2##2##(1992-1#2)
vaginal product##2##2##(2007-7#1)(2012-2#1)
vaginal prolapse##2##2##(2011-2#2)
vaginal rings##2##2##(1994-9#2)
vaginal route##3##2##(1994-2#1)(1995-1#1)(1995-12#1)
vaginal sex##4##2##(2010-7#2)(2013-1#2)
vaginal surface##2##2##(2009-11#1)(2009-2#1)
vaginal swabs taken##2##3##(2008-12#2)
vaginal swabs##4##2##(2007-7#2)(2008-12#2)
vaginal ultrasound##2##2##(1992-12#1)(1995-8#1)
vaginal wall##4##2##(1991-12#1)(1996-12#1)(2008-10#1)(2011-2#1)
vaginal##181##1##(1990-2#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1992-1#3)(1992-12#2)(1992-3#3)(1993-1#2)(1993-12#16)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#7)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#8)(1995-11#1)(1995-12#4)(1995-3#2)(1995-8#1)(1996-1#3)(1996-12#14)(1996-2#4)(1996-9#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#5)(2008-10#7)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#4)(2008-8#2)(2009-11#1)(2009-2#11)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#5)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#15)(2012-2#2)(2012-3#3)(2013-1#4)
vaginalis##12##1##(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#5)(2012-2#1)
vaginally##4##1##(1991-2#1)(1994-2#1)(1994-9#1)(2011-2#1)
vaginitis##7##1##(1994-12#1)(2011-1#2)(2011-2#4)
vaginoplasty and##2##2##(2007-7#1)(2013-1#1)
vaginosis##10##1##(2007-12#2)(2007-7#2)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#3)
vagotomy with pyloroplasty##4##3##(1990-6#4)
vagotomy##8##1##(1990-6#5)(1993-2#1)(1995-12#1)(1996-5#1)
vague##14##1##(1990-6#1)(1993-3#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
vagueness of##2##2##(2008-1#1)(2011-2#1)
vagus nerve stimulation##4##3##(1995-12#1)(2008-1#1)(2008-7#1)(2011-1#1)
vagus nerve##11##2##(1993-12#2)(1995-12#2)(2008-1#2)(2008-11#1)(2008-7#2)(2009-7#1)(2011-1#1)
vagus##20##1##(1993-12#7)(1994-2#1)(1995-12#2)(1996-5#1)(2008-1#2)(2008-11#1)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#2)
valaciclovir to acyclovir##2##3##(1995-6#2)
valaciclovir##6##1##(1995-6#6)
valence and##3##2##(2008-5#1)(2008-8#1)(2010-2#1)
valence of the##2##3##(2008-10#1)(2008-2#1)
valence of##6##2##(2008-10#2)(2008-2#3)(2008-5#1)
valence states##2##2##(2006-4#1)(2008-10#1)
valence##31##1##(1991-5#2)(1992-8#2)(1997-7#3)(2006-4#2)(2007-11#1)(2008-10#6)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#3)(2008-8#2)(2009-5#1)(2010-2#1)
valency chlorine species##2##3##(2008-10#2)
valency##4##1##(2008-10#3)(2012-2#1)
valerate##4##1##(1996-12#2)(2007-11#2)
valeric acid was##2##3##(1991-5#1)(2008-6#1)
valeric acid##5##2##(1991-5#2)(2008-10#1)(2008-6#2)
valeric##7##1##(1991-5#3)(2008-10#1)(2008-6#3)
valgus and##2##2##(2007-2#1)(2012-2#1)
valgus angle##2##2##(2007-8#1)(2012-2#1)
valgus extension overload##2##3##(2008-8#2)
valgus malalignment##2##2##(2009-4#1)(2012-2#1)
valgus osteotomy##3##2##(2009-3#2)(2012-2#1)
valgus##27##1##(2007-2#1)(2007-8#2)(2008-8#2)(2009-10#3)(2009-3#2)(2009-4#3)(2010-11#1)(2010-3#1)(2012-2#9)(2013-1#3)
valid and reliable##8##3##(1993-12#1)(1993-2#1)(1996-2#1)(1997-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
valid and useful##2##3##(2010-10#1)(2010-4#1)
valid and##15##2##(1993-12#1)(1993-2#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
valid assessment of##2##3##(1995-11#1)(2008-7#1)
valid evidence##2##2##(2007-8#1)(2008-7#1)
valid for any##2##3##(2008-2#2)
valid for the##6##3##(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
valid for##26##2##(1993-6#1)(1994-5#1)(1995-3#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#8)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)
valid in##3##2##(2007-11#1)(2008-9#2)
valid measures of##2##3##(1994-2#1)(2010-10#1)
valid model##2##2##(1992-12#1)(2010-2#1)
valid procedure##2##2##(2011-2#2)
valid results##2##2##(2009-4#1)(2010-12#1)
valid tool for##3##3##(2008-7#1)(2010-10#1)(2011-1#1)
valid tool##4##2##(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)
valid##167##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-11#4)(2007-12#3)(2007-8#3)(2008-10#19)(2008-11#2)(2008-12#4)(2008-2#13)(2008-3#17)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#5)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
valid?##2##1##(1993-11#1)(2009-11#1)
validate a##14##2##(1996-2#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
validate an##2##2##(1995-12#1)(2008-10#1)
validate our##5##2##(2008-1#1)(2008-3#1)(2009-12#1)(2009-9#1)(2012-3#1)
validate the proposed##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
validate the technique##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
validate the##67##2##(1991-5#1)(1992-6#1)(1993-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#13)(2008-7#3)(2009-12#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-2#1)(2013-1#2)
validate these##3##2##(2009-10#1)(2010-2#1)(2013-1#1)
validate this##7##2##(1994-2#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2013-1#1)
validate##121##1##(1991-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#1)(2006-10#1)(2008-1#3)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#17)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#2)
validated a##4##2##(2008-3#1)(2009-8#1)(2011-2#2)
validated against##7##2##(2008-3#1)(2008-7#2)(2010-9#1)(2012-2#1)(2012-3#1)(2012-7#1)
validated and##15##2##(1996-12#1)(1996-5#1)(2008-10#10)(2010-3#1)(2011-1#1)(2013-1#1)
validated as##5##2##(2008-10#2)(2010-8#1)(2011-1#1)(2012-12#1)
validated automatic##2##2##(2010-7#2)
validated by Western##2##3##(2010-12#2)
validated by a##3##3##(2008-10#1)(2008-12#2)
validated by analysis of##3##4##(2008-10#3)
validated by analysis##4##3##(2008-10#4)
validated by analyzing a certified reference material##2##7##(2008-10#2)
validated by analyzing##4##3##(2008-10#4)
validated by comparing the##3##4##(2008-10#3)
validated by comparing##4##3##(2008-10#4)
validated by comparison with##6##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
validated by comparison##7##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
validated by determining the##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
validated by determining##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
validated by testing##2##3##(2008-10#1)(2013-8#1)
validated by the analysis of##3##5##(2008-10#3)
validated by the##8##3##(2008-10#5)(2008-3#1)(2011-2#1)(2012-1#1)
validated by using two##2##4##(2008-10#2)
validated by using##9##3##(2008-10#7)(2008-5#1)(2010-2#1)
validated by##79##2##(1990-9#1)(1991-11#1)(1996-3#1)(2007-11#2)(2008-1#1)(2008-10#46)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#2)
validated experimentally##5##2##(2008-2#2)(2008-3#2)(2009-10#1)
validated for the determination of##3##5##(2008-10#2)(2011-2#1)
validated for the##9##3##(2008-10#4)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
validated for##19##2##(2008-10#10)(2008-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-7#1)
validated in a##3##3##(2007-10#1)(2008-10#1)(2012-2#1)
validated in terms of##5##4##(2008-10#2)(2010-3#1)(2012-2#1)(2013-1#1)
validated in this##2##3##(2008-10#2)
validated in##20##2##(2007-10#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-3#1)(2012-2#3)(2013-1#2)
validated measures##2##2##(2008-11#1)(2008-6#1)
validated method##2##2##(2008-10#1)(2011-2#1)
validated methods##2##2##(1997-4#1)(2008-10#1)
validated model##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
validated models##2##2##(2008-3#1)(2010-8#1)
validated on a##2##3##(2008-3#1)(2008-8#1)
validated on##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
validated over the concentration range##2##5##(2008-10#1)(2011-3#1)
validated over##3##2##(2008-10#2)(2011-3#1)
validated questionnaire##4##2##(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
validated questionnaires##2##2##(1991-2#1)(2013-1#1)
validated statistically and by recovery studies##3##6##(2010-5#3)
validated the proposed method##2##4##(2008-10#2)
validated the##16##2##(1997-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-12#1)(2013-7#1)
validated through comparison with##2##4##(2008-10#1)(2008-2#1)
validated through the analysis of##2##5##(2008-10#2)
validated through##6##2##(1995-12#1)(2008-10#4)(2008-2#1)
validated using a##4##3##(1990-12#1)(1990-2#1)(2008-10#2)
validated using##18##2##(1990-12#1)(1990-2#1)(1997-2#1)(2008-10#12)(2008-8#1)(2010-7#1)(2011-2#1)
validated with a##6##3##(2008-10#6)
validated with the##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
validated with##21##2##(1994-3#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
validated##343##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#150)(2008-11#10)(2008-12#4)(2008-2#5)(2008-3#20)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#3)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#6)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#1)(2012-7#1)(2013-1#21)(2013-7#1)(2013-8#3)
validates a##3##2##(1996-3#1)(2008-7#1)(2011-2#1)
validates the##8##2##(1990-12#1)(2008-10#5)(2009-4#1)(2011-1#1)
validates##16##1##(1990-12#1)(1996-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
validating the use of##2##4##(2008-10#2)
validating the##9##2##(2008-10#7)(2008-8#1)(2013-1#1)
validating##21##1##(2008-1#1)(2008-10#9)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
validation and updating of a prognostic model for kidney graft survival##2##11##(1995-9#2)
validation and##14##2##(1995-1#1)(1995-9#3)(1996-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#2)
validation cases##2##2##(2008-10#2)
validation data set##2##3##(2008-10#2)
validation data##9##2##(2008-10#8)(2012-12#1)
validation errors of##2##3##(2008-10#2)
validation for##2##2##(2012-2#1)(2013-8#1)
validation in the##3##3##(2008-10#2)(2008-2#1)
validation in##8##2##(1993-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-12#1)(2010-5#1)
validation is provided##2##3##(2008-7#1)(2010-5#1)
validation is##6##2##(2008-11#1)(2008-7#3)(2009-11#1)(2010-5#1)
validation method##3##2##(2008-10#2)(2008-2#1)
validation mixtures##2##2##(2008-10#2)
validation of a scale##2##4##(2008-12#1)(2013-1#1)
validation of a specific##2##4##(2008-10#1)(2011-1#1)
validation of a##25##3##(1992-9#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
validation of an automated##2##4##(1990-2#1)(2008-10#1)
validation of an innovative##2##4##(2012-12#1)(2013-1#1)
validation of an##8##3##(1990-2#1)(1996-12#1)(2008-10#3)(2009-12#1)(2012-12#1)(2013-1#1)
validation of analytical##2##3##(2008-10#2)
validation of molecular##3##3##(2008-5#1)(2009-4#1)(2010-10#1)
validation of new##2##3##(2008-10#1)(2009-7#1)
validation of the method is##2##5##(2007-12#1)(2008-10#1)
validation of the method##3##4##(2007-12#1)(2008-10#2)
validation of the proposed##2##4##(1995-2#1)(2012-3#1)
validation of the##26##3##(1995-2#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
validation of their##2##3##(2008-10#1)(2010-2#1)
validation of this##3##3##(2008-10#2)(2008-5#1)
validation of##103##2##(1990-2#1)(1992-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-1#2)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#6)(2008-7#6)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#3)(2010-10#2)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)
validation or##2##2##(2008-12#1)(2008-4#1)
validation parameters##4##2##(2008-10#4)
validation protocol##2##2##(2008-10#2)
validation protocols##2##2##(2008-10#1)(2009-7#1)
validation results##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
validation samples##2##2##(1997-1#1)(2008-10#1)
validation scheme##3##2##(2008-10#3)
validation set##9##2##(1995-9#2)(2008-10#7)
validation sets##5##2##(2007-11#1)(2008-10#4)
validation studies##10##2##(1990-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)(2012-12#1)(2012-2#1)
validation study##5##2##(1994-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-9#1)
validation using##2##2##(2008-10#1)(2011-1#1)
validation was##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
validation were##2##2##(2008-10#1)(2013-8#1)
validation with##2##2##(2009-11#1)(2011-2#1)
validation##310##1##(1990-2#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#5)(1996-12#2)(1996-2#4)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#130)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#17)(2008-4#2)(2008-5#9)(2008-7#15)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-7#4)(2010-10#2)(2010-11#6)(2010-2#2)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#3)
validation)##2##1##(2007-12#1)(2010-8#1)
validations##5##1##(2008-10#2)(2008-3#2)(2012-2#1)
validity and limitations of##2##4##(1994-12#1)(2011-2#1)
validity and reliability of the##3##5##(1994-2#1)(1994-6#1)(2013-8#1)
validity and reliability of##6##4##(1994-2#1)(1994-6#1)(2007-10#1)(2010-9#1)(2013-8#2)
validity and reliability##10##3##(1994-2#1)(1994-6#1)(1995-2#1)(2007-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
validity and the##2##3##(2008-3#1)(2012-2#1)
validity and##26##2##(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
validity but##2##2##(2008-10#1)(2010-10#1)
validity for##4##2##(1995-5#1)(1996-7#1)(2008-11#1)(2008-2#1)
validity in the##2##3##(2008-11#1)(2011-1#1)
validity in##4##2##(1993-12#1)(1995-6#1)(2008-11#1)(2011-1#1)
validity is##2##2##(2008-7#1)(2013-1#1)
validity of a##4##3##(2008-3#1)(2009-2#1)(2009-9#1)(2010-9#1)
validity of an##2##3##(2013-1#1)(2013-8#1)
validity of both##2##3##(2008-10#1)(2009-12#1)
validity of different##2##3##(1991-12#1)(2008-12#1)
validity of the LPIA##2##4##(2008-3#2)
validity of the instrument##2##4##(1993-3#1)(2009-12#1)
validity of the method is##2##5##(2007-12#1)(2008-10#1)
validity of the method was##2##5##(1990-8#1)(2008-10#1)
validity of the method##7##4##(1990-8#1)(2007-12#1)(2008-10#5)
validity of the model##4##4##(2008-2#1)(2008-3#2)(2008-7#1)
validity of the new##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
validity of the proposed method##4##5##(2008-10#2)(2008-3#2)
validity of the proposed##5##4##(2008-10#2)(2008-3#3)
validity of the##94##3##(1990-10#1)(1990-5#1)(1990-8#3)(1992-6#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#20)(2008-4#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#1)(2013-8#1)
validity of these##8##3##(1993-12#1)(2008-3#2)(2009-11#1)(2010-10#1)(2010-12#2)(2012-2#1)
validity of this approach##4##4##(1992-3#1)(2007-12#1)(2008-2#1)(2008-5#1)
validity of this##14##3##(1992-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-6#1)
validity of##183##2##(1990-10#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-10#29)(2008-11#8)(2008-12#5)(2008-2#14)(2008-3#32)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
validity testing##2##2##(1996-3#1)(2011-1#1)
validity to##2##2##(1996-4#1)(2011-2#1)
validity was##8##2##(2008-10#2)(2008-3#1)(2008-7#1)(2010-11#2)(2012-2#1)(2012-3#1)
validity were##2##2##(2007-10#1)(2012-2#1)
validity with##2##2##(1994-12#1)(2011-1#1)
validity##311##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(2007-10#6)(2007-11#3)(2007-12#13)(2007-8#2)(2008-10#38)(2008-11#16)(2008-12#6)(2008-2#18)(2008-3#36)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#11)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#12)(2011-2#9)(2012-1#2)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#5)
validly published##2##2##(2011-2#2)
validly##4##1##(2010-8#1)(2011-2#3)
valine (branched-chain amino acid) dehydrogenase-encoding gene##2##6##(1995-8#2)
valine and##4##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-11#1)
valine##30##1##(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-3#1)(1995-11#3)(1995-2#1)(1995-8#4)(1996-2#3)(1996-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
valinomycin##12##1##(1990-2#1)(1992-12#3)(1993-11#2)(1994-12#1)(1994-5#1)(2008-10#4)
vallate papillae##3##2##(2011-2#3)
valley from##2##2##(2008-11#1)(2011-2#1)
valley oak (Quercus lobata)##2##4##(2008-10#2)
valley##29##1##(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
valleys of the##2##3##(2008-10#1)(2008-8#1)
valleys of##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
valleys##14##1##(2008-10#4)(2008-8#2)(2009-5#7)(2013-7#1)
valproate doses##3##2##(2008-3#3)
valproate##21##1##(1990-5#3)(1995-12#4)(1996-5#1)(2008-3#7)(2008-6#1)(2008-7#2)(2009-8#2)(2010-7#1)
valproic Acid##2##2##(2011-1#1)(2011-2#1)
valproic acid (VPA) and##2##4##(1996-5#1)(2011-1#1)
valproic acid (VPA)##6##3##(1996-5#2)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
valproic acid##14##2##(1996-5#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#3)(2011-1#1)(2011-2#2)(2013-1#3)
valproic##16##1##(1996-5#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#3)(2011-1#2)(2011-2#3)(2013-1#3)
valsartan in bulk##2##3##(2011-1#2)
valsartan in##3##2##(2010-3#1)(2011-1#2)
valsartan##5##1##(2010-3#1)(2011-1#4)
valuable and##9##2##(1990-3#1)(1991-2#1)(1991-3#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2013-8#1)
valuable baseline##3##2##(2007-10#1)(2008-7#1)(2013-1#1)
valuable because##2##2##(1994-5#1)(2008-11#1)
valuable contribution##3##2##(1992-2#1)(1997-3#1)(2008-11#1)
valuable cultural##2##2##(2008-10#2)
valuable data##4##2##(1992-4#1)(2008-7#2)(2010-2#1)
valuable for the##3##3##(1993-2#1)(2008-9#1)(2011-3#1)
valuable for##21##2##(1993-2#1)(1994-5#1)(1994-7#1)(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-3#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
valuable in determining##2##3##(2008-10#1)(2008-7#1)
valuable in the##8##3##(1992-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-7#1)
valuable in##24##2##(1990-11#1)(1991-1#1)(1992-1#1)(1992-2#1)(1995-11#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#2)(2011-7#1)
valuable information about##7##3##(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#2)
valuable information for##6##3##(1990-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
valuable information in##2##3##(2006-10#1)(2011-2#1)
valuable information on the##4##4##(2008-10#3)(2012-2#1)
valuable information on##6##3##(2008-10#3)(2008-5#1)(2012-2#2)
valuable information to the##2##4##(2008-1#1)(2013-8#1)
valuable information to##5##3##(2008-1#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
valuable information##32##2##(1990-12#1)(1994-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-8#1)
valuable insight into the##2##4##(2008-11#1)(2009-2#1)
valuable insight##3##2##(2008-11#1)(2008-3#1)(2009-2#1)
valuable insights into the##2##4##(1994-10#1)(2012-2#1)
valuable insights into##4##3##(1994-10#1)(2008-8#1)(2010-11#1)(2012-2#1)
valuable insights##6##2##(1994-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-2#1)
valuable new insights in the field of comparative genomics##2##9##(2009-5#1)(2011-2#1)
valuable prognostic##2##2##(1994-7#1)(2008-6#1)
valuable quantitative##2##2##(2010-5#1)(2011-1#1)
valuable resource##5##2##(2008-11#2)(2008-12#1)(2012-2#1)(2012-3#1)
valuable services##2##2##(1992-2#2)
valuable supplement##4##2##(1990-2#1)(2007-11#2)(2007-8#1)
valuable therapeutic##4##2##(1990-5#1)(1993-2#1)(2011-3#1)(2012-2#1)
valuable time##2##2##(1992-3#1)(2008-11#1)
valuable to the##2##3##(1993-2#1)(2008-9#1)
valuable to##11##2##(1993-2#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-9#4)(2010-2#1)(2010-4#1)(2013-1#1)
valuable tool for##22##3##(1991-6#1)(1993-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)
valuable tool##40##2##(1991-6#1)(1993-2#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)
valuable tools for##8##3##(1995-6#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
valuable tools in##2##3##(2008-10#1)(2010-5#1)
valuable tools##13##2##(1991-2#1)(1995-6#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
valuable##308##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-2#5)(1993-3#1)(1994-10#1)(1994-2#2)(1994-5#3)(1994-6#1)(1994-7#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#3)(2006-10#3)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#32)(2008-11#21)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#8)(2008-5#4)(2008-6#5)(2008-7#13)(2008-8#8)(2008-9#16)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#10)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#13)(2012-3#7)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#4)
valuation of GAP##3##3##(2013-1#3)
valuation of the##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
valuation of##8##2##(1990-6#1)(2008-10#1)(2008-9#1)(2009-11#1)(2013-1#4)
valuation##11##1##(1990-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-11#1)(2013-1#5)
value &lt##7##2##(1995-12#1)(2007-7#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-1#1)
value (0##2##2##(1993-6#1)(2006-10#1)
value (p##2##2##(2008-3#2)
value 3##2##2##(1996-9#1)(2008-10#1)
value =##2##2##(2008-10#1)(2013-8#1)
value achieved##2##2##(2007-11#1)(2008-3#1)
value added profile##2##3##(1996-1#1)(1997-1#1)
value added&quot##2##2##(1996-1#2)
value after##2##2##(2008-10#2)
value and its##2##3##(2008-3#1)(2011-1#1)
value and that##2##3##(1995-2#1)(2008-3#1)
value and the##8##3##(1991-5#1)(1992-12#1)(1993-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2010-9#1)
value and##50##2##(1991-5#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
value are##2##2##(2008-11#1)(2013-8#1)
value as a##6##3##(1991-12#1)(2008-11#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
value as the##2##3##(1997-3#1)(2008-5#1)
value as##15##2##(1991-12#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#1)
value at##20##2##(1990-5#1)(1990-7#2)(1992-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-1#1)
value because##3##2##(1995-11#1)(1995-3#1)(2008-5#1)
value below##2##2##(1992-11#1)(1994-3#1)
value between##4##2##(1990-9#1)(1991-8#1)(2008-10#1)(2008-5#1)
value but##2##2##(2008-12#1)(2009-4#1)
value by##3##2##(1996-7#1)(2008-10#1)(2008-11#1)
value can be obtained##2##4##(2008-10#2)
value can be##7##3##(1994-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
value can##9##2##(1994-11#1)(2008-10#4)(2008-2#1)(2008-3#3)
value compared with##2##3##(2007-12#1)(2008-10#1)
value compared##3##2##(2007-12#1)(2008-10#2)
value composite resins##2##3##(2012-2#2)
value corresponding to the##2##4##(1994-3#1)(2008-10#1)
value creation##2##2##(1995-1#1)(2008-10#1)
value detected##2##2##(2013-1#1)(2013-7#1)
value determination##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
value determined for##2##3##(1991-12#1)(2008-3#1)
value determined##4##2##(1991-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
value for [3H]flunitrazepam binding##2##4##(1996-2#2)
value for a##3##3##(1995-9#1)(2007-12#1)(2008-3#1)
value for money##3##3##(1993-2#1)(1994-2#1)(2008-9#1)
value for patients##2##3##(2007-9#1)(2008-7#1)
value for the preconcentration##3##4##(2008-10#3)
value for the##34##3##(1990-8#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-5#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-2#4)(2008-3#4)(2008-5#2)(2011-1#5)(2011-2#1)(2013-1#1)
value for their##3##3##(1993-3#1)(1994-3#1)(1997-1#1)
value for young##2##3##(1994-6#1)(2008-11#1)
value for##126##2##(1990-8#3)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-7#3)(2010-5#1)(2011-1#7)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
value from##4##2##(1991-9#1)(1994-12#1)(2007-12#1)(2008-3#1)
value greater than##2##3##(1990-10#1)(1996-12#1)
value has been##2##3##(2008-10#2)
value higher than##2##3##(1997-3#1)(2008-10#1)
value in a##2##3##(2008-10#1)(2008-3#1)
value in about##2##3##(2008-10#1)(2008-5#1)
value in both##2##3##(2008-11#1)(2013-1#1)
value in comparison to##2##4##(2008-11#1)(2012-3#1)
value in predicting the##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
value in routine administration of outcome questionnaires##2##7##(2012-12#2)
value in routine administration of outcome##3##6##(2012-12#3)
value in the diagnosis##2##4##(2007-2#1)(2012-2#1)
value in the##22##3##(1990-12#1)(1991-2#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)
value in##85##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-1#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
value increased##4##2##(1995-5#1)(2008-10#2)(2008-11#1)
value is about##2##3##(1995-5#1)(2013-8#1)
value is first##2##3##(2008-2#1)(2008-3#1)
value is##24##2##(1992-6#2)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#1)(1996-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
value measured##3##2##(1996-5#1)(1997-2#1)(2008-2#1)
value most##2##2##(2008-10#1)(2010-2#1)
value observed in##3##3##(1996-1#1)(2008-10#2)
value observed##4##2##(1996-1#1)(2008-10#2)(2008-8#1)
value obtained for the##3##4##(1995-11#1)(2008-10#1)(2008-2#1)
value obtained for##4##3##(1995-11#1)(2008-10#2)(2008-2#1)
value obtained from##2##3##(1993-11#1)(2008-10#1)
value obtained was##2##3##(2008-10#2)
value obtained##13##2##(1990-8#1)(1993-11#1)(1995-11#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
value of -0##2##3##(1992-7#1)(2008-10#1)
value of 0##31##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-2#2)(1995-8#1)(1996-7#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#2)(2009-3#2)(2009-8#1)(2011-1#1)(2012-2#1)
value of 1##13##3##(1990-7#1)(1994-2#1)(1995-6#2)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
value of 16##2##3##(1992-5#1)(2007-11#1)
value of 2##4##3##(1991-9#1)(2008-10#2)(2008-6#1)
value of 20 nM##2##4##(1995-3#1)(1996-2#1)
value of 3##4##3##(1991-5#1)(1994-11#1)(1995-11#1)(2009-4#1)
value of 4##6##3##(1990-11#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-3#2)
value of 51##2##3##(2007-11#1)(2008-10#1)
value of 6##7##3##(1992-6#1)(1994-5#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-3#1)
value of 67##2##3##(1991-9#1)(2008-10#1)
value of 7##5##3##(1996-2#2)(2008-10#1)(2008-2#1)(2008-3#1)
value of 8##2##3##(1991-12#1)(1995-3#1)
value of 9##2##3##(1990-2#1)(2008-10#1)
value of AKBR##2##3##(2007-8#2)
value of Bcl-2##2##3##(2009-4#2)
value of CT##2##3##(2007-11#1)(2008-1#1)
value of MRI in the##2##5##(1996-11#1)(2010-12#1)
value of MRI##3##3##(1996-11#1)(2007-11#1)(2010-12#1)
value of N##2##3##(2008-10#2)
value of Q and##3##4##(2007-11#1)(2008-10#2)
value of R##2##3##(2008-10#2)
value of a single##2##4##(1994-7#1)(2008-7#1)
value of a##22##3##(1990-3#1)(1990-7#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-5#2)(1994-2#1)(1994-7#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
value of alternative##2##3##(1993-1#1)(2007-2#1)
value of approximately##3##3##(2008-11#1)(2009-5#1)(2009-7#1)
value of carotid##2##3##(2010-10#1)(2012-3#1)
value of cathepsin D##2##4##(2008-7#2)
value of clinical##4##3##(2008-10#1)(2008-7#1)(2009-3#1)(2012-12#1)
value of computed tomography##2##4##(2008-11#1)(2011-1#1)
value of contrast-enhanced MR mammography in patients with breast cancer##2##10##(1997-8#2)
value of contrast-enhanced##3##3##(1997-8#2)(2012-2#1)
value of correlation coefficient##2##4##(2008-10#2)
value of different##3##3##(1991-6#1)(2011-1#1)(2013-1#1)
value of disease##2##3##(2008-10#2)
value of eta(h)##2##3##(2008-3#2)
value of magnetic resonance imaging##2##5##(2008-7#1)(2010-12#1)
value of magnetic resonance##3##4##(1996-11#1)(2008-7#1)(2010-12#1)
value of monitoring##3##3##(1994-7#1)(1995-3#1)(2013-1#1)
value of n##2##3##(1994-8#1)(2009-12#1)
value of neonatal screening for congenital dysplasia of the hip##2##10##(2007-11#2)
value of neuron-specific enolase##2##4##(1990-6#1)(2011-2#1)
value of non-invasive##2##3##(1996-3#1)(2008-1#1)
value of our##2##3##(2007-11#1)(2010-8#1)
value of procalcitonin in##2##4##(2008-5#1)(2013-1#1)
value of procalcitonin##4##3##(2008-5#1)(2013-1#3)
value of pull-out strength##2##4##(2007-11#2)
value of rho##3##3##(2008-10#1)(2008-3#2)
value of role modelling##3##4##(2008-12#3)
value of screening##2##3##(2007-4#1)(2008-1#1)
value of selected##2##3##(1996-1#1)(2012-3#1)
value of serum##3##3##(1991-8#1)(2007-5#1)(2013-1#1)
value of such##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
value of the applied voltage##2##5##(2013-8#2)
value of the phase##3##4##(2007-11#1)(2008-3#2)
value of the test##4##4##(1990-6#1)(1991-12#2)(2008-7#1)
value of the wall##2##4##(2008-3#1)(2009-6#1)
value of the##126##3##(1990-11#1)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#3)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#19)(2008-11#3)(2008-2#4)(2008-3#25)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
value of their##3##3##(1996-2#1)(2009-10#1)(2010-4#1)
value of these##5##3##(1992-6#1)(1994-3#1)(2008-5#1)(2010-2#1)(2011-2#1)
value of this assay##2##4##(1991-12#1)(2008-10#1)
value of this##11##3##(1990-6#1)(1991-12#1)(1992-12#2)(1995-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
value of tumor##2##3##(1995-9#1)(2011-2#1)
value of using##6##3##(1992-2#1)(1995-12#1)(1995-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
value of v##2##3##(2008-10#1)(2008-5#1)
value of##679##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#4)(1990-5#1)(1990-6#4)(1990-7#6)(1990-8#6)(1990-9#2)(1991-11#1)(1991-12#8)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#8)(1995-3#12)(1995-4#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#4)(1997-8#6)(2007-10#2)(2007-11#21)(2007-12#12)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#6)(2008-1#6)(2008-10#110)(2008-11#26)(2008-12#17)(2008-2#17)(2008-3#56)(2008-4#7)(2008-5#16)(2008-6#7)(2008-7#22)(2008-8#13)(2008-9#8)(2009-10#2)(2009-12#2)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#1)(2010-8#4)(2011-1#11)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#11)(2012-3#10)(2013-1#15)(2013-7#3)(2013-8#7)
value on the##4##3##(1992-5#1)(1996-8#1)(2009-5#1)(2013-8#1)
value on##8##2##(1990-8#1)(1992-5#1)(1992-8#1)(1993-11#1)(1996-8#1)(2008-9#1)(2009-5#1)(2013-8#1)
value or##2##2##(1997-7#1)(2008-12#1)
value over##4##2##(1997-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
value ranges##3##2##(2008-10#3)
value stream##4##2##(2010-8#3)(2012-2#1)
value streams##3##2##(2010-8#3)
value structures and##2##3##(1995-1#2)
value that##8##2##(1993-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
value the##2##2##(1990-6#1)(1994-2#1)
value theorem##3##2##(1995-2#1)(2008-2#2)
value to both##2##3##(1992-8#1)(2008-12#1)
value to predict the presence of##2##6##(2012-3#2)
value to the##10##3##(1990-3#1)(1992-3#1)(1994-1#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2010-3#2)(2011-2#1)
value to##36##2##(1990-3#1)(1990-4#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-3#3)
value under##2##2##(2010-1#2)
value units (RVUs)##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
value units##7##2##(1991-12#2)(1992-3#1)(1994-1#1)(2012-2#1)(2013-1#2)
value was 0##4##3##(1990-12#1)(2008-5#1)(2011-2#2)
value was found##2##3##(2008-10#1)(2008-12#1)
value was higher than##2##4##(1996-6#1)(2008-10#1)
value was higher##3##3##(1996-6#1)(2008-10#1)(2008-4#1)
value was not##2##3##(1996-2#1)(2008-3#1)
value was observed in##2##4##(2008-3#1)(2008-5#1)
value was observed##3##3##(1997-4#1)(2008-3#1)(2008-5#1)
value was obtained for##3##4##(2008-10#2)(2008-3#1)
value was obtained##6##3##(2008-10#4)(2008-3#1)(2012-12#1)
value was only##2##3##(2007-8#1)(2008-10#1)
value was significantly##4##3##(1991-9#1)(2007-8#1)(2011-2#1)(2013-7#1)
value was then##2##3##(2008-10#1)(2008-11#1)
value was##57##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-9#1)(1993-8#1)(1994-5#1)(1994-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#2)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#4)(2012-12#1)(2013-7#1)
value were##3##2##(2008-10#2)(2012-2#1)
value when##3##2##(2008-1#1)(2008-3#1)(2011-2#1)
value with the##3##3##(2008-10#2)(2008-3#1)
value with##5##2##(1992-11#1)(2008-10#2)(2008-3#2)
value within the##2##3##(2008-2#2)
value within##5##2##(1992-6#1)(2008-10#2)(2008-2#2)
value##1645##1##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#6)(1990-3#5)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#10)(1990-8#16)(1990-9#4)(1991-11#1)(1991-12#20)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#5)(1991-8#6)(1991-9#8)(1992-1#5)(1992-10#2)(1992-11#8)(1992-12#6)(1992-2#3)(1992-3#9)(1992-5#6)(1992-6#11)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#4)(1993-11#6)(1993-12#4)(1993-2#9)(1993-3#5)(1993-5#1)(1993-6#4)(1993-8#9)(1993-9#2)(1994-1#4)(1994-11#5)(1994-12#15)(1994-2#6)(1994-3#12)(1994-5#5)(1994-6#2)(1994-7#5)(1994-8#3)(1994-9#2)(1995-1#8)(1995-11#4)(1995-12#17)(1995-2#15)(1995-3#18)(1995-4#1)(1995-5#4)(1995-6#7)(1995-8#2)(1995-9#2)(1996-1#10)(1996-11#3)(1996-12#6)(1996-2#10)(1996-3#4)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#7)(1997-1#5)(1997-2#9)(1997-3#13)(1997-4#9)(1997-5#2)(1997-6#1)(1997-7#8)(1997-8#13)(2006-10#1)(2007-10#6)(2007-11#34)(2007-12#25)(2007-2#3)(2007-4#4)(2007-5#3)(2007-7#3)(2007-8#19)(2007-9#1)(2008-1#20)(2008-10#315)(2008-11#53)(2008-12#31)(2008-2#41)(2008-3#127)(2008-4#14)(2008-5#46)(2008-6#15)(2008-7#36)(2008-8#19)(2008-9#24)(2009-1#2)(2009-10#4)(2009-11#4)(2009-12#3)(2009-3#6)(2009-4#8)(2009-5#3)(2009-6#4)(2009-7#9)(2009-8#11)(2009-9#3)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#7)(2010-3#3)(2010-4#11)(2010-5#7)(2010-8#16)(2010-9#2)(2011-1#26)(2011-2#61)(2011-3#2)(2012-1#7)(2012-12#16)(2012-2#29)(2012-3#21)(2013-1#28)(2013-7#5)(2013-8#17)
value&quot##2##1##(2007-4#1)(2008-1#1)
value) and##2##2##(2008-10#1)(2010-1#1)
value) was##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
value)##14##1##(1993-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-1#1)(2011-2#2)
value-added products##2##2##(2008-6#1)(2013-1#1)
value-added##9##1##(1993-1#1)(1993-2#2)(1996-3#1)(2008-10#1)(2008-6#2)(2010-6#1)(2013-1#1)
value-based##3##1##(2008-6#2)(2012-3#1)
valued highly by the##2##4##(1997-1#2)
valued in##2##2##(2008-11#1)(2012-3#1)
valued##20##1##(1990-5#1)(1991-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1997-1#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
values &gt##3##2##(1994-11#1)(2007-11#1)(2008-10#1)
values &lt##7##2##(1994-11#1)(2008-10#3)(2008-3#2)(2011-2#1)
values (##4##2##(2008-10#3)(2008-11#1)
values (&lt##2##2##(1994-12#1)(2008-10#1)
values (0##5##2##(1995-6#1)(2008-10#3)(2010-11#1)
values (6##2##2##(2008-10#2)
values (P &lt##2##3##(1994-3#1)(2008-10#1)
values (P##3##2##(1991-12#1)(1994-3#1)(2008-10#1)
values (R##2##2##(2008-10#2)
values (mean##2##2##(1994-12#1)(2008-10#1)
values (p##2##2##(2008-3#1)(2013-8#1)
values (the##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
values 0##2##2##(1993-12#1)(2008-10#1)
values a##2##2##(2008-10#1)(2008-9#1)
values above the##2##3##(1996-7#1)(2007-12#1)
values above##5##2##(1994-6#1)(1996-7#1)(2007-12#1)(2008-5#1)(2012-2#1)
values achieved##2##2##(2008-10#1)(2009-4#1)
values against##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
values agree##2##2##(2008-10#1)(2011-1#1)
values agreed##2##2##(2008-10#2)
values among##4##2##(1990-8#1)(2008-10#3)
values and attitudes##2##3##(2009-10#1)(2011-2#1)
values and beliefs##5##3##(1995-1#2)(2008-12#2)(2010-5#1)
values and can##2##3##(2008-10#1)(2008-8#1)
values and have##2##3##(2008-10#1)(2008-3#1)
values and in##2##3##(1993-11#1)(2008-3#1)
values and the##13##3##(1995-12#1)(1995-3#1)(2007-11#2)(2008-10#8)(2011-2#1)
values and those##2##3##(2008-10#2)
values and with##2##3##(2008-10#2)
values and##98##2##(1990-3#1)(1990-7#2)(1993-11#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#2)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(2007-11#2)(2008-1#4)(2008-10#35)(2008-11#1)(2008-12#5)(2008-3#5)(2008-7#4)(2008-8#1)(2009-10#2)(2010-1#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
values are 3##2##3##(1990-5#1)(2008-10#1)
values are always##2##3##(2008-10#1)(2008-2#1)
values are compared with##2##4##(2008-10#1)(2008-11#1)
values are compared##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
values are estimated##2##3##(2008-3#1)(2012-1#1)
values are generally##2##3##(2008-10#1)(2012-12#1)
values are given##2##3##(2008-10#2)
values are in the range##2##5##(2008-10#2)
values are in the##3##4##(2008-10#3)
values are in##6##3##(2008-10#4)(2008-2#1)(2008-3#1)
values are lower than##2##4##(2008-10#1)(2008-3#1)
values are not##2##3##(2008-10#2)
values are the##2##3##(2008-10#1)(2008-2#1)
values are##73##2##(1990-5#1)(1990-8#1)(1991-11#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-12#2)(2008-10#31)(2008-11#1)(2008-2#6)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
values as a function of##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
values as compared to##2##4##(2008-10#2)
values as high as##2##4##(2008-10#1)(2008-2#1)
values as##19##2##(1992-9#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#2)(2011-2#1)
values associated with##4##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
values associated##5##2##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
values at the##2##3##(2008-10#1)(2008-3#1)
values at##29##2##(1990-11#1)(1990-7#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-6#1)(2006-12#1)(2008-10#13)(2008-3#5)(2008-5#1)(2010-4#1)(2011-2#2)
values became##6##2##(1990-6#1)(1991-5#2)(1995-5#1)(1996-2#1)(2013-1#1)
values before##4##2##(1991-2#1)(2007-12#1)(2007-8#1)(2011-2#1)
values being##2##2##(2008-10#1)(2008-5#1)
values below 5##3##3##(1992-11#1)(2008-5#2)
values below the##3##3##(1996-7#1)(2008-10#1)(2008-2#1)
values below##10##2##(1992-11#1)(1995-5#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-5#2)(2012-3#1)
values between 0##5##3##(2008-10#4)(2008-5#1)
values between 4##2##3##(1993-9#1)(2008-5#1)
values between the##2##3##(2008-10#1)(2012-3#1)
values between##25##2##(1993-9#1)(2007-11#1)(2008-10#15)(2008-5#3)(2008-7#1)(2011-2#2)(2012-3#1)(2012-9#1)
values but both##2##3##(1994-12#1)(2008-12#1)
values but##5##2##(1994-12#1)(1994-6#1)(1995-8#1)(2008-10#1)(2008-12#1)
values by +##2##3##(1991-3#2)
values by##10##2##(1991-3#2)(2008-10#7)(2012-3#1)
values calculated from the##2##4##(1995-3#1)(1997-2#1)
values calculated with##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
values calculated##7##2##(1995-3#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-6#1)
values can be##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
values can##5##2##(1992-8#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-4#1)
values characterizing##2##2##(2008-2#1)(2012-2#1)
values correlated well with##2##4##(1991-2#1)(2008-1#1)
values corresponding to##2##3##(2008-5#1)(2013-8#1)
values declined##2##2##(2008-10#1)(2010-8#1)
values decreased##3##2##(1995-8#1)(2008-4#1)(2009-11#1)
values derived from the##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
values derived##5##2##(1997-2#1)(2008-10#1)(2008-3#2)(2008-7#1)
values determined by##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
values determined##8##2##(1991-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-7#1)
values did not##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2010-8#1)
values do##2##2##(1994-8#1)(2008-10#1)
values due to##2##3##(2008-10#1)(2012-12#1)
values during the##3##3##(1994-8#1)(2010-5#1)(2011-1#1)
values during##4##2##(1994-2#1)(1994-8#1)(2010-5#1)(2011-1#1)
values education##2##2##(1992-2#2)
values estimated##2##2##(2008-2#1)(2010-6#1)
values even##3##2##(1993-2#1)(2007-12#1)(2008-10#1)
values far##2##2##(2008-10#2)
values fit##2##2##(1997-2#1)(2008-2#1)
values for K(ijk)##2##3##(2008-10#2)
values for S and##2##4##(2008-2#1)(2008-3#1)
values for a##7##3##(1994-9#1)(2008-10#3)(2008-2#2)(2008-3#1)
values for all##3##3##(1995-5#1)(1997-2#1)(2009-11#1)
values for both##6##3##(1991-2#1)(1993-11#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-5#1)
values for each##4##3##(1990-3#1)(2008-10#2)(2008-2#1)
values for free##3##3##(1997-7#3)
values for human##2##3##(1990-12#1)(2008-3#1)
values for isolated##2##3##(1993-8#1)(1994-8#1)
values for odour perception than those##2##6##(2008-7#2)
values for other##3##3##(1990-7#1)(1990-8#1)(2008-5#1)
values for the first##2##4##(2007-12#1)(2008-10#1)
values for the three##3##4##(1990-9#1)(2008-10#1)(2008-4#1)
values for the two##2##4##(1992-5#1)(2008-10#1)
values for the##75##3##(1990-10#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#4)(1994-11#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#21)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#4)
values for these##5##3##(1996-2#1)(2008-10#2)(2008-6#1)(2013-3#1)
values for this##4##3##(1990-2#1)(1994-5#1)(2008-3#1)(2011-2#1)
values for##273##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-5#2)(1995-6#6)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#7)(1997-4#1)(1997-7#4)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#70)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#18)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2013-1#7)(2013-3#2)(2013-7#1)
values found for##3##3##(2008-10#3)
values found in the##2##4##(2008-10#1)(2008-3#1)
values found##8##2##(1993-2#1)(2008-10#4)(2008-2#1)(2008-3#2)
values from 0##2##3##(1993-12#1)(2008-5#1)
values from data##2##3##(1997-2#1)(2008-10#1)
values from the##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
values from##26##2##(1990-2#1)(1992-6#1)(1993-12#1)(1997-2#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
values generated##2##2##(2008-10#1)(2008-3#1)
values gives the##2##3##(1994-11#1)(2008-3#1)
values greater than##6##3##(1990-5#1)(2007-12#1)(2008-10#2)(2008-3#2)
values have been##2##3##(2008-10#2)
values have##4##2##(2008-10#3)(2008-5#1)
values higher than##4##3##(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)
values in February##2##3##(2008-5#1)(2013-7#1)
values in a##6##3##(1993-2#1)(2008-10#3)(2008-3#1)(2009-12#1)
values in relation to##2##4##(1990-5#1)(2013-1#1)
values in the micromolar##2##4##(1990-2#1)(2008-4#1)
values in the range 0##2##5##(2008-10#2)
values in the range of##2##5##(2008-10#1)(2010-5#1)
values in the range##6##4##(2008-10#5)(2010-5#1)
values in the##41##3##(1990-2#2)(1990-3#1)(1991-4#2)(1992-9#1)(1994-3#1)(2007-10#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
values in this##2##3##(1997-4#1)(2013-7#1)
values in##110##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#2)(1992-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#5)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#3)
values increased##5##2##(1991-6#1)(1993-12#1)(2008-6#1)(2008-9#1)(2010-4#1)
values indicate that##5##3##(1992-12#1)(1993-8#1)(1996-2#1)(2008-10#1)(2013-8#1)
values indicated that##2##3##(1992-1#1)(2008-10#1)
values indicated##3##2##(1992-1#1)(2008-10#2)
values instead of##4##3##(2008-10#3)(2008-8#1)
values is##9##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#2)(2011-1#1)
values larger##2##2##(2007-12#1)(2008-5#1)
values less than 10##2##4##(1990-12#1)(2008-1#1)
values less than##7##3##(1990-12#1)(1991-4#1)(2008-1#1)(2008-10#3)(2008-11#1)
values lower than those##2##4##(1990-8#1)(2008-10#1)
values lower than##5##3##(1990-8#1)(2008-10#4)
values may##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
values measured for##2##3##(1994-8#1)(2008-3#1)
values measured##6##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2011-2#1)
values near##5##2##(1990-5#1)(1992-3#1)(2008-10#2)(2008-3#1)
values observed with##2##3##(1990-2#1)(1992-6#1)
values observed##4##2##(1990-2#1)(1992-6#1)(2008-10#2)
values obtained are in good agreement with the##2##8##(2008-10#1)(2008-2#1)
values obtained by the##2##4##(2008-10#1)(2010-4#1)
values obtained by##16##3##(1990-2#1)(1990-8#1)(2008-10#11)(2008-3#1)(2010-4#1)(2013-1#1)
values obtained for the##3##4##(2008-10#3)
values obtained for##9##3##(2008-10#6)(2012-12#2)(2012-2#1)
values obtained from a##2##4##(2008-10#1)(2013-1#1)
values obtained from the##3##4##(1991-9#1)(1992-2#1)(1996-5#1)
values obtained from##15##3##(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1996-5#1)(2008-10#5)(2008-3#2)(2008-6#1)(2012-1#1)(2013-1#1)
values obtained in the##2##4##(2008-10#2)
values obtained in##6##3##(1997-6#1)(2008-10#3)(2008-12#1)(2012-3#1)
values obtained were##4##3##(1995-6#1)(2008-10#3)
values obtained with##6##3##(2008-10#4)(2008-3#1)(2009-3#1)
values obtained##68##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-6#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#39)(2008-12#1)(2008-2#1)(2008-3#6)(2008-6#1)(2009-3#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
values occurred##2##2##(2008-9#2)
values of % A##4##4##(2008-5#4)
values of &lt##3##3##(2008-10#3)
values of 0##29##3##(1991-8#1)(1992-8#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#4)(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
values of 1##7##3##(1990-8#1)(1992-12#1)(1993-3#1)(1997-7#1)(2008-10#2)(2008-3#1)
values of 13##2##3##(1995-8#1)(2008-10#1)
values of 2##6##3##(1995-12#1)(2008-1#1)(2008-10#3)(2008-7#1)
values of 3##3##3##(1995-8#1)(2008-10#2)
values of 4##4##3##(1995-2#1)(2008-11#2)(2013-1#1)
values of 44##2##3##(1991-8#1)(2008-10#1)
values of 5##2##3##(1995-5#1)(2008-10#1)
values of 6##2##3##(1990-8#1)(2008-3#1)
values of 7##3##3##(1995-11#1)(1995-3#1)(2008-5#1)
values of LDL alpha-tocopherol##2##4##(1991-12#2)
values of P##4##3##(2011-2#2)(2012-2#2)
values of Y##2##3##(2008-7#2)
values of Young's modulus##2##4##(2009-4#1)(2009-7#1)
values of a##2##3##(2008-11#1)(2008-4#1)
values of aPS##2##3##(2008-7#2)
values of about##3##3##(1993-2#1)(1997-2#1)(2008-12#1)
values of absorption##2##3##(2008-2#1)(2008-3#1)
values of all##4##3##(2008-10#2)(2011-1#1)(2013-1#1)
values of creatinine##3##3##(2008-1#2)(2008-4#1)
values of dihydroetorphine for the##2##5##(1995-11#2)
values of disease##2##3##(2008-10#2)
values of each##2##3##(2008-10#2)
values of genetic diversity##2##4##(2008-10#2)
values of genetic##3##3##(2008-10#3)
values of less than##2##4##(1994-7#1)(1995-1#1)
values of parameters##2##3##(2008-3#1)(2012-12#1)
values of raw##2##3##(2010-4#2)
values of recoveries##2##3##(2008-10#2)
values of reflectivity##2##3##(2008-3#2)
values of sensitivity##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
values of stability##2##3##(2008-10#2)
values of t(1)##2##3##(2008-10#2)
values of the F(1) generation were##2##6##(2008-10#2)
values of the FAPP##2##4##(2008-2#2)
values of the samples##2##4##(2008-10#2)
values of the scattering##3##4##(2008-2#2)(2008-3#1)
values of the second-order##2##4##(1993-8#1)(2007-11#1)
values of the significant variables##2##5##(2008-10#2)
values of the spectral##2##4##(2008-3#2)
values of the##136##3##(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1992-6#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-11#7)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#23)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-2#4)(2013-1#3)(2013-8#4)
values of these constants##2##4##(2008-10#2)
values of these##7##3##(2008-10#3)(2008-12#2)(2008-3#1)(2010-3#1)
values of this##2##3##(1991-6#1)(2008-5#1)
values of tilt##2##3##(2008-2#2)
values of total bilirubin##2##4##(2013-1#2)
values of total##3##3##(1991-12#1)(2013-1#2)
values of up to##2##4##(2007-12#1)(2009-11#1)
values of vital##2##3##(1994-7#1)(2012-12#1)
values of volume##2##3##(2008-2#1)(2011-1#1)
values of |beta| for selection##2##5##(2008-8#2)
values of##555##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#5)(1990-8#4)(1991-12#7)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#6)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#5)(1994-1#1)(1994-12#4)(1994-3#4)(1994-5#2)(1994-7#4)(1994-8#2)(1995-1#1)(1995-11#5)(1995-12#6)(1995-2#2)(1995-3#3)(1995-5#7)(1995-6#1)(1995-8#6)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#14)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#140)(2008-11#19)(2008-12#14)(2008-2#29)(2008-3#56)(2008-4#6)(2008-5#17)(2008-6#4)(2008-7#20)(2008-8#13)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#7)(2010-6#1)(2010-8#6)(2011-1#5)(2011-2#12)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#5)
values on the##2##3##(2010-6#1)(2011-3#1)
values on##9##2##(1992-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2010-6#1)(2011-1#1)(2011-3#1)
values or##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
values over##6##2##(2008-10#3)(2008-2#1)(2008-7#1)(2010-11#1)
values predicted by##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
values predicted from##2##3##(2007-11#1)(2011-1#1)
values predicted##6##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
values present##2##2##(1990-7#1)(2008-10#1)
values provided##2##2##(2012-3#1)(2013-1#1)
values range from##3##3##(1991-8#1)(1996-2#2)
values ranged between##3##3##(2008-10#2)(2008-5#1)
values ranged from 0##5##4##(2008-10#4)(2008-5#1)
values ranged from##10##3##(1995-3#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2012-2#1)
values ranged##14##2##(1991-5#1)(1995-3#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-7#1)(2012-2#1)
values ranging between##2##3##(1992-5#1)(2013-1#1)
values ranging from 0##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
values ranging from 1##3##4##(2008-10#3)
values ranging from 6##2##4##(2008-10#1)(2010-4#1)
values ranging from##17##3##(2007-12#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#2)(2009-7#2)(2010-4#1)
values ranging##19##2##(1992-5#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#2)(2009-7#2)(2010-4#1)(2013-1#1)
values remained##2##2##(2008-10#1)(2011-2#1)
values reported for##3##3##(2007-11#1)(2008-3#1)(2012-12#1)
values reported in the literature##3##5##(1991-3#1)(2008-10#1)(2008-6#1)
values reported in##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
values reported##11##2##(1991-3#1)(2007-11#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2012-12#1)
values resulted in a##2##4##(1994-7#1)(2008-3#1)
values show a significant##2##4##(1995-2#1)(2008-5#1)
values show##3##2##(1995-11#1)(1995-2#1)(2008-5#1)
values significantly##4##2##(1997-6#1)(2008-10#1)(2010-2#1)(2011-2#1)
values similar##2##2##(2007-11#1)(2008-11#1)
values suggest that##2##3##(2010-10#1)(2010-6#1)
values suggests##2##2##(1996-5#1)(2008-9#1)
values tend to##2##3##(2008-10#1)(2009-6#1)
values than the##2##3##(2007-10#1)(2007-12#1)
values than those obtained##2##4##(1995-12#1)(1997-7#1)
values than those##4##3##(1995-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
values than##14##2##(1991-5#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-6#1)(2011-2#4)
values that are##6##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#2)
values that were##2##3##(2008-10#1)(2008-5#1)
values that##16##2##(1995-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#2)
values the##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
values through##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
values to characterize the##2##4##(1997-7#1)(2008-3#1)
values to the##4##3##(2007-12#1)(2008-10#1)(2008-12#2)
values to##18##2##(1992-3#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
values using##3##2##(2008-10#3)
values varied between##2##3##(2008-10#1)(2008-5#1)
values versus##2##2##(2008-5#1)(2012-3#1)
values was found##2##3##(1996-5#1)(2008-7#1)
values was good##2##3##(2008-10#2)
values was##19##2##(1992-8#1)(1996-5#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)
values well##2##2##(1992-6#1)(2008-10#1)
values were 0##4##3##(1990-2#1)(2008-10#1)(2008-12#1)(2012-12#1)
values were 1##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
values were 4##4##3##(2008-10#2)(2008-11#1)(2009-4#1)
values were 6##2##3##(2008-10#1)(2008-5#1)
values were also##6##3##(1995-5#1)(1997-4#1)(2007-10#1)(2008-10#2)(2009-6#1)
values were approximately##2##3##(1990-2#1)(2008-10#1)
values were below##2##3##(1995-8#1)(2012-1#1)
values were calculated for##2##4##(2007-11#1)(2008-10#1)
values were calculated##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2011-3#1)(2013-1#1)
values were comparable##2##3##(1997-7#1)(2008-7#1)
values were compared to##2##4##(1990-9#1)(2008-10#1)
values were compared##5##3##(1990-9#1)(2008-10#3)(2013-1#1)
values were determined for##2##4##(1995-8#1)(2007-11#1)
values were determined##8##3##(1995-8#1)(2007-11#1)(2008-10#2)(2008-5#2)(2009-9#1)(2011-2#1)
values were established##2##3##(1996-12#1)(2008-10#1)
values were found in##5##4##(1990-6#1)(2007-8#2)(2008-5#1)(2008-7#1)
values were found to be##3##5##(1991-12#1)(2008-10#2)
values were found to##4##4##(1991-12#1)(2008-10#3)
values were found##14##3##(1990-6#1)(1991-12#1)(2007-8#2)(2008-10#7)(2008-5#1)(2008-7#2)
values were higher in##3##4##(2011-2#3)
values were higher##5##3##(1992-9#1)(2011-2#3)(2012-1#1)
values were identical to those observed##2##6##(1992-12#1)(2009-2#1)
values were in good agreement##2##5##(2008-10#1)(2008-3#1)
values were in the##2##4##(2008-10#1)(2008-8#1)
values were in##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
values were less##2##3##(2008-10#1)(2008-8#1)
values were low##2##3##(1995-3#1)(1995-8#1)
values were lower##2##3##(2008-10#1)(2008-7#1)
values were measured for##2##4##(1995-11#1)(1996-5#1)
values were measured##6##3##(1995-11#1)(1996-5#1)(2008-10#2)(2008-2#1)(2012-2#1)
values were not significantly different##4##5##(1990-9#1)(1996-7#1)(2008-10#2)
values were not##5##3##(1990-9#1)(1992-6#1)(1996-7#1)(2008-10#2)
values were observed for##3##4##(1990-12#1)(1996-5#1)(2008-10#1)
values were observed in##7##4##(1993-8#1)(1996-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2010-4#1)
values were observed##10##3##(1990-12#1)(1993-8#1)(1996-5#1)(1996-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2010-4#1)
values were obtained for##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
values were obtained##9##3##(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-2#1)
values were recorded##2##3##(2011-1#1)(2013-8#1)
values were significantly (P &lt##2##5##(1993-1#1)(2008-5#1)
values were significantly different##2##4##(2008-10#1)(2013-1#1)
values were significantly higher in##2##5##(2008-11#1)(2012-3#1)
values were significantly higher than##2##5##(1990-8#1)(2009-8#1)
values were significantly higher##6##4##(1990-8#1)(2007-10#1)(2008-11#1)(2009-1#1)(2009-8#1)(2012-3#1)
values were significantly##13##3##(1990-8#1)(1993-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2012-3#2)(2013-1#1)
values were similar to##2##4##(1996-12#1)(2008-7#1)
values were similar##4##3##(1996-12#1)(2008-3#1)(2008-7#2)
values were used to##2##4##(1993-11#1)(2008-3#1)
values were used##3##3##(1993-11#1)(2008-3#1)(2011-2#1)
values were##204##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#3)(1990-9#4)(1991-12#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#2)(1994-8#2)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#2)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#3)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#4)(2008-1#2)(2008-10#64)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#2)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
values when##4##2##(1994-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
values which are##2##3##(1990-12#1)(2008-11#1)
values which were##3##3##(2008-10#2)(2008-7#1)
values which##9##2##(1990-12#1)(1993-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)
values will be##2##3##(1992-3#1)(2008-11#1)
values with the##2##3##(1991-5#1)(2008-3#1)
values with##13##2##(1991-5#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)
values within##6##2##(1992-2#1)(1996-7#1)(2008-10#2)(2009-2#1)(2012-2#1)
values##2554##1##(1990-10#2)(1990-11#3)(1990-12#9)(1990-2#13)(1990-3#6)(1990-5#11)(1990-6#4)(1990-7#13)(1990-8#21)(1990-9#6)(1991-11#4)(1991-12#15)(1991-2#9)(1991-3#5)(1991-4#5)(1991-5#10)(1991-6#6)(1991-8#11)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#6)(1992-2#8)(1992-3#15)(1992-4#1)(1992-5#7)(1992-6#10)(1992-7#1)(1992-8#12)(1992-9#7)(1993-1#4)(1993-11#13)(1993-12#8)(1993-2#8)(1993-3#2)(1993-6#2)(1993-8#16)(1993-9#5)(1994-1#4)(1994-11#11)(1994-12#14)(1994-2#5)(1994-3#9)(1994-5#10)(1994-6#5)(1994-7#9)(1994-8#13)(1994-9#6)(1995-1#4)(1995-11#14)(1995-12#24)(1995-2#16)(1995-3#13)(1995-5#14)(1995-6#11)(1995-8#12)(1995-9#1)(1996-12#12)(1996-2#8)(1996-3#6)(1996-4#2)(1996-5#12)(1996-6#1)(1996-7#10)(1996-8#1)(1996-9#1)(1997-2#28)(1997-3#7)(1997-4#12)(1997-6#3)(1997-7#14)(1997-8#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-10#16)(2007-11#37)(2007-12#34)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#14)(2008-1#26)(2008-10#794)(2008-11#50)(2008-12#43)(2008-2#85)(2008-3#191)(2008-4#16)(2008-5#88)(2008-6#25)(2008-7#74)(2008-8#43)(2008-9#15)(2009-1#1)(2009-10#6)(2009-11#8)(2009-12#2)(2009-2#3)(2009-3#7)(2009-4#7)(2009-5#1)(2009-6#5)(2009-7#14)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#10)(2010-11#8)(2010-12#2)(2010-2#5)(2010-3#7)(2010-4#20)(2010-5#3)(2010-6#5)(2010-8#15)(2010-9#3)(2011-1#23)(2011-2#78)(2011-3#3)(2012-1#9)(2012-12#17)(2012-2#15)(2012-3#24)(2012-9#1)(2013-1#53)(2013-3#2)(2013-7#9)(2013-8#17)
values) and##3##2##(1992-8#1)(2008-10#1)(2011-1#1)
values) are##2##2##(1997-7#1)(2008-10#1)
values) had##2##2##(1997-7#1)(2013-1#1)
values) of##3##2##(2008-10#3)
values)##26##1##(1992-11#1)(1992-12#1)(1992-8#2)(1995-8#1)(1997-7#2)(2008-10#16)(2008-12#1)(2011-1#1)(2013-1#1)
values?##2##1##(1991-12#1)(2008-8#1)
values]##3##1##(1996-2#1)(2010-12#1)(2011-2#1)
valuing##3##1##(1991-12#1)(2008-11#1)(2011-2#1)
valvar tissue##2##2##(2007-8#2)
valve and the##2##3##(2008-10#1)(2013-1#1)
valve and##17##2##(1994-5#1)(2007-8#2)(2008-10#8)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
valve as##2##2##(2008-12#1)(2013-1#1)
valve at##2##2##(2007-12#1)(2008-4#1)
valve bladder syndrome##2##3##(2008-10#2)
valve disease##5##2##(1994-3#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
valve dysfunction##4##2##(2008-4#2)(2012-2#1)(2012-3#1)
valve endocarditis##4##2##(2007-12#2)(2011-2#2)
valve function##4##2##(2007-8#3)(2008-10#1)
valve in##6##2##(1991-3#1)(2007-12#1)(2008-10#2)(2010-12#1)(2010-8#1)
valve insufficiency in##2##3##(1997-5#1)(2011-2#1)
valve insufficiency##4##2##(1997-5#1)(2007-8#1)(2011-2#1)(2012-2#1)
valve is the##2##3##(2007-8#1)(2013-1#1)
valve is##6##2##(1996-1#2)(2007-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
valve leaflets##2##2##(2007-8#1)(2013-1#1)
valve lesion##2##2##(2009-4#1)(2013-1#1)
valve of##2##2##(2008-10#2)
valve or##2##2##(2010-8#1)(2011-2#1)
valve prostheses##5##2##(1990-12#2)(2010-8#3)
valve prostheses]##2##2##(1990-12#1)(2010-8#1)
valve prosthesis##4##2##(1994-3#1)(1997-5#1)(2007-8#1)(2009-12#1)
valve repair using##3##3##(2007-8#3)
valve repair##18##2##(2007-8#7)(2008-10#3)(2009-7#1)(2011-2#5)(2013-1#2)
valve replacement in##3##3##(2007-8#1)(2011-2#2)
valve replacement with a bioprosthesis##2##5##(2007-8#2)
valve replacement with a##4##4##(2007-8#3)(2012-2#1)
valve replacement##33##2##(1990-3#1)(1994-3#1)(1996-9#1)(1997-5#2)(2007-8#12)(2008-4#1)(2009-12#1)(2009-5#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
valve replacements##2##2##(2007-8#2)
valve stenosis##4##2##(1992-5#1)(2007-7#1)(2007-8#1)(2009-5#1)
valve surgery##8##2##(1993-12#1)(2007-8#5)(2009-5#1)(2010-8#1)
valve tissue##2##2##(2008-4#1)(2011-2#1)
valve vegetations##2##2##(1990-11#1)(2007-12#1)
valve was used##2##3##(2008-10#2)
valve was##8##2##(1991-3#2)(2008-10#5)(2013-1#1)
valve with##8##2##(1991-2#1)(1992-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
valve##289##1##(1990-11#2)(1990-12#3)(1990-3#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#4)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#5)(1994-5#1)(1994-6#1)(1996-1#2)(1996-9#1)(1997-2#2)(1997-5#6)(2007-11#1)(2007-12#10)(2007-7#2)(2007-8#54)(2008-10#50)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#6)(2008-7#2)(2008-8#5)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#5)(2009-7#1)(2009-9#1)(2010-12#7)(2010-8#10)(2011-1#4)(2011-2#29)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#18)(2013-8#2)
valve-related##2##1##(2007-8#2)
valved catheters##2##2##(2007-7#2)
valved stent implanted##2##3##(2007-8#2)
valved stent was##2##3##(2007-8#2)
valved stent##5##2##(2007-8#5)
valved##12##1##(1996-2#1)(2007-7#4)(2007-8#7)
valves and##5##2##(1996-2#1)(1997-1#1)(2008-10#3)
valves are##5##2##(2008-10#2)(2010-8#1)(2013-1#2)
valves in##2##2##(1996-12#1)(2011-2#1)
valves is##3##2##(1997-2#1)(2010-12#1)(2010-8#1)
valves or##2##2##(1991-11#1)(2008-8#1)
valves were##5##2##(2008-10#3)(2008-3#1)(2010-12#1)
valves##72##1##(1991-11#1)(1991-12#1)(1991-3#3)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(2006-6#1)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#2)(2009-11#1)(2010-12#5)(2010-6#1)(2010-8#5)(2010-9#1)(2011-2#1)(2013-1#2)
valvula cerebelli##3##2##(1993-12#3)
valvula##4##1##(1993-12#4)
valvular disease##3##2##(2011-2#2)(2012-3#1)
valvular heart disease##3##3##(2007-8#1)(2008-5#1)(2012-2#1)
valvular heart##11##2##(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#8)
valvular insufficiency##3##2##(1994-3#2)(1995-8#1)
valvular##33##1##(1990-11#1)(1991-12#1)(1994-3#2)(1995-8#1)(2007-8#6)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#11)
valvuloplasty for mitral##2##3##(1990-3#1)(2011-2#1)
valvuloplasty for##3##2##(1990-3#1)(2011-2#2)
valvuloplasty##10##1##(1990-3#2)(1994-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2011-2#4)
vampire bat##2##2##(2008-5#2)
van Cittert-Zernike##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
van Gogh's case##2##3##(1996-3#2)
van Gogh's##4##2##(1992-2#1)(1996-3#3)
van de zorgbehoefte van##2##4##(2012-12#2)
van de zorgbehoefte##3##3##(2012-12#3)
van de##7##2##(1997-3#1)(1997-5#1)(2008-2#1)(2012-12#4)
van der Waals interactions between##3##5##(1993-8#1)(2008-10#2)
van der Waals interactions##5##4##(1991-3#1)(1993-8#1)(2008-10#2)(2010-2#1)
van der Waals space##2##4##(2007-11#2)
van der Waals##25##3##(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(2007-11#5)(2008-10#4)(2008-3#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#3)
van der##29##2##(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(1997-3#1)(2007-11#5)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#3)
van##60##1##(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-3#5)(1997-3#2)(1997-5#1)(2007-11#5)(2007-12#3)(2008-10#8)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#10)(2013-1#3)
van't Hoff plots##5##3##(1997-2#3)(2008-10#2)
van't Hoff##10##2##(1997-2#7)(2008-10#3)
vanadate increased##2##2##(1997-1#2)
vanadate species##2##2##(1994-11#2)
vanadate##33##1##(1990-2#3)(1990-5#3)(1994-11#6)(1994-12#2)(1994-6#5)(1995-2#1)(1995-6#1)(1997-1#8)(2008-10#4)
vanadium (IV)##2##2##(1990-5#1)(2008-10#1)
vanadium (V)##4##2##(2008-10#3)(2011-2#1)
vanadium adsorption from the NH(4)VO(3) solution##2##6##(2008-10#2)
vanadium adsorption##3##2##(2008-10#3)
vanadium and molybdenum bearing geological##2##5##(2008-10#2)
vanadium and molybdenum##5##3##(2008-10#5)
vanadium and##17##2##(2007-11#1)(2008-10#14)(2008-11#1)(2011-2#1)
vanadium at##3##2##(2008-10#3)
vanadium by##6##2##(2008-10#6)
vanadium can be determined##2##4##(2008-10#2)
vanadium can be##3##3##(2008-10#3)
vanadium content in##2##3##(2008-10#2)
vanadium contents##2##2##(2008-10#2)
vanadium determination##3##2##(2008-10#3)
vanadium from##4##2##(2008-10#3)(2008-6#1)
vanadium in natural waters##3##4##(2008-10#3)
vanadium in the range##3##4##(2008-10#3)
vanadium in the##5##3##(2008-10#5)
vanadium in##32##2##(2008-10#32)
vanadium species in##3##3##(2008-10#3)
vanadium species##5##2##(2008-10#5)
vanadium was##4##2##(1990-5#1)(2008-10#3)
vanadium##139##1##(1990-2#2)(1990-5#5)(1994-11#1)(1996-2#2)(2007-11#3)(2008-10#120)(2008-11#1)(2008-6#1)(2011-2#4)
vanadium(IV) and (V)##2##3##(2008-10#2)
vanadium(IV) and vanadium(V)##3##3##(2008-10#3)
vanadium(IV) and##8##2##(2008-10#8)
vanadium(IV) in##2##2##(2008-10#2)
vanadium(IV)##12##1##(2008-10#12)
vanadium(V) and##3##2##(2008-10#3)
vanadium(V) with##4##2##(2008-10#4)
vanadium(V)##23##1##(2008-10#23)
vanadyl ions##2##2##(1990-2#1)(2008-10#1)
vanadyl sulfate##2##2##(1990-2#1)(1994-6#1)
vanadyl sulphate intoxication in mice##2##5##(1990-5#2)
vanadyl was##2##2##(1990-2#2)
vanadyl##14##1##(1990-2#8)(1990-5#2)(1994-6#1)(2008-10#3)
vancomycin and##8##2##(2007-12#1)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
vancomycin as##2##2##(1996-3#1)(2007-7#1)
vancomycin hydrochloride##2##2##(2008-10#1)(2010-4#1)
vancomycin resistance in##3##3##(1995-2#1)(2007-7#2)
vancomycin resistance##4##2##(1995-2#2)(2007-7#2)
vancomycin were##2##2##(2007-7#1)(2008-12#1)
vancomycin##51##1##(1995-2#2)(1996-3#1)(2007-12#12)(2007-7#8)(2008-10#7)(2008-12#2)(2009-8#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-12#4)(2013-8#1)
vancomycin-resistant enterococci##2##2##(1996-3#1)(2009-5#1)
vancomycin-resistant##4##1##(1996-3#1)(2007-12#1)(2009-5#2)
vandalism##3##1##(1994-2#1)(1995-2#1)(1996-12#1)
vanes##3##1##(2008-3#2)(2008-8#1)
vanilla beans from##2##3##(2008-10#2)
vanilla beans##3##2##(2008-10#3)
vanilla##9##1##(2008-10#9)
vanillic##2##1##(2008-10#1)(2011-2#1)
vanillin and PHB##3##3##(2008-10#3)
vanillin and##6##2##(2008-10#6)
vanillin##10##1##(2008-10#10)
vanilloid receptor##2##2##(2008-11#2)
vanilloid##5##1##(2008-11#2)(2008-4#1)(2009-12#1)(2011-2#1)
vanish##3##1##(1990-5#1)(2008-3#1)(2009-2#1)
vanished##3##1##(2008-5#1)(2009-8#1)(2013-8#1)
vanishes##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
vanishing##4##1##(2008-1#1)(2008-10#1)(2009-8#1)(2010-12#1)
vannamei##3##1##(2008-5#3)
vantage point of##2##3##(1992-12#1)(2008-3#1)
vantage point##4##2##(1992-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
vantage##5##1##(1992-12#1)(2008-2#1)(2008-3#1)(2011-1#2)
vapor and##9##2##(2008-10#2)(2008-2#2)(2008-3#5)
vapor at##4##2##(2007-12#2)(2008-3#2)
vapor atomic##10##2##(2008-10#10)
vapor cell##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
vapor concentrations##2##2##(1991-5#1)(2008-2#1)
vapor deposition##21##2##(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#7)(2009-11#2)(2009-7#1)(2010-4#1)
vapor detection##2##2##(2007-12#1)(2008-10#1)
vapor diffusion techniques##2##3##(2007-5#1)(2008-8#1)
vapor diffusion##3##2##(2007-5#1)(2008-8#1)(2008-9#1)
vapor exposure##2##2##(1995-3#1)(2008-10#1)
vapor from##2##2##(2008-3#2)
vapor generation atomic absorption spectrometry##2##5##(2007-12#1)(2008-10#1)
vapor generation##5##2##(2007-12#1)(2008-10#4)
vapor in##10##2##(2008-10#1)(2008-2#3)(2008-3#6)
vapor is##4##2##(2008-10#1)(2008-3#3)
vapor laser##6##2##(1992-9#2)(2008-2#2)(2008-3#2)
vapor on##2##2##(2008-10#1)(2008-3#1)
vapor phase##7##2##(2007-11#2)(2008-10#3)(2008-7#1)(2008-8#1)
vapor pressure deficit and##2##4##(2008-10#2)
vapor pressure##3##2##(2008-10#3)
vapor pressures##2##2##(1992-3#1)(2008-10#1)
vapor sources are##2##3##(2008-2#1)(2008-3#1)
vapor sources##3##2##(2008-2#2)(2008-3#1)
vapor transmission rate##2##3##(2008-5#2)
vapor was##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
vapor were##2##2##(2007-12#1)(2008-10#1)
vapor with##3##2##(2008-3#3)
vapor##199##1##(1991-1#1)(1991-5#3)(1992-3#1)(1992-9#2)(1995-3#1)(1997-1#1)(2007-11#11)(2007-12#14)(2007-5#1)(2008-10#65)(2008-11#1)(2008-2#22)(2008-3#59)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-7#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
vapor-deposited films##3##2##(2007-12#3)
vapor-deposited##4##1##(2007-12#3)(2008-3#1)
vapor-phase##2##1##(2008-10#2)
vaporization and##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
vaporization behavior of##3##3##(2008-10#3)
vaporization for##2##2##(1991-2#1)(2010-4#1)
vaporization in##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
vaporization inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
vaporization inductively coupled plasma##6##4##(2008-10#6)
vaporization of##7##2##(1992-3#2)(2007-12#2)(2008-10#3)
vaporization temperature of##4##3##(2008-10#4)
vaporization temperature##5##2##(2008-10#5)
vaporization##55##1##(1991-2#3)(1992-3#2)(1996-1#1)(2007-12#4)(2007-8#1)(2008-10#36)(2008-2#2)(2008-3#5)(2010-4#1)
vaporized and##2##2##(1991-2#1)(2008-10#1)
vaporized at##4##2##(1991-2#1)(2008-10#3)
vaporized##12##1##(1991-2#3)(1992-1#2)(1992-3#2)(2008-10#5)
vaporizer##4##1##(2008-10#4)
vaporizing##2##1##(1991-2#1)(2008-2#1)
vapors of##2##2##(2008-10#1)(2008-3#1)
vapors##22##1##(2007-12#1)(2008-10#15)(2008-2#1)(2008-3#5)
vapour and##2##2##(2008-10#1)(2009-11#1)
vapour atomic absorption##9##3##(2008-10#9)
vapour atomic fluorescence spectrometry##3##4##(2008-10#3)
vapour atomic fluorescence##5##3##(2008-10#5)
vapour atomic##14##2##(2008-10#14)
vapour by##2##2##(2008-10#2)
vapour diffusion##2##2##(1992-11#1)(2008-8#1)
vapour generation and atomic##2##4##(2008-10#2)
vapour generation and##3##3##(2008-10#3)
vapour generation atomic fluorescence spectrometry##2##5##(2008-10#2)
vapour generation##7##2##(2008-10#7)
vapour phase decomposition (VPD) of quartz powder##2##7##(2008-10#2)
vapour phase##7##2##(2008-10#7)
vapour pressure of##7##3##(2008-5#6)(2009-11#1)
vapour pressure##11##2##(1990-9#1)(2008-5#7)(2009-11#3)
vapour pressures##2##2##(2008-5#2)
vapour##64##1##(1990-9#1)(1992-11#1)(1995-6#2)(1996-12#1)(2008-10#39)(2008-4#1)(2008-5#10)(2008-7#2)(2008-8#2)(2009-11#4)(2013-8#1)
vapour-phase catalyst delivery##2##3##(2008-7#2)
vapour-phase##3##1##(2008-10#1)(2008-7#2)
vapours were##2##2##(2008-10#2)
vapours##16##1##(1991-6#3)(1996-12#1)(1997-3#1)(2008-10#11)
var genes##3##2##(2012-3#3)
var##170##1##(1991-11#1)(1995-6#1)(2008-10#116)(2008-11#5)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#17)(2008-6#1)(2009-10#1)(2009-2#3)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#6)(2013-1#2)
varanid##2##1##(2013-1#2)
varanids##5##1##(2013-1#5)
varenicline##4##1##(2011-2#3)(2013-1#1)
varenidine##3##1##(2013-8#3)
variabilities of##2##2##(2008-10#1)(2008-8#1)
variabilities##4##1##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
variability among isolates##2##3##(2008-10#2)
variability among the##3##3##(2008-10#3)
variability among##15##2##(1990-2#1)(2008-10#11)(2008-5#2)(2013-7#1)
variability and a##2##3##(2008-10#1)(2010-8#1)
variability and the##2##3##(2008-3#2)
variability and uncertainty##2##3##(1993-3#1)(2008-10#1)
variability and##35##2##(1993-3#1)(1997-3#1)(1997-7#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#2)
variability are##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
variability as a##2##3##(1991-2#1)(2009-11#1)
variability associated with##2##3##(2008-3#1)(2008-8#1)
variability at##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
variability between the##3##3##(1991-12#1)(1993-12#1)(2007-10#1)
variability between##15##2##(1990-7#1)(1991-12#1)(1993-12#1)(1997-3#1)(2007-10#1)(2008-10#7)(2009-2#1)(2009-6#1)(2012-3#1)
variability coefficient for the exercise was nearby to the average value for##2##12##(2008-10#2)
variability coefficient##3##2##(2008-10#3)
variability could be##2##3##(2008-10#1)(2012-3#1)
variability during the##2##3##(2011-2#1)(2012-2#1)
variability for##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
variability found in##2##3##(2008-10#1)(2012-2#1)
variability from##2##2##(2008-8#1)(2012-2#1)
variability has##2##2##(2008-11#1)(2012-4#1)
variability in clinical##3##3##(2007-11#1)(2008-8#1)(2009-11#1)
variability in disease incidence##2##4##(2008-10#2)
variability in disease##4##3##(2008-10#4)
variability in per capita population growth rates##2##7##(2008-8#2)
variability in response to##2##4##(2008-7#1)(2009-5#1)
variability in response##3##3##(2008-7#1)(2009-5#2)
variability in sag##2##3##(2012-2#2)
variability in seed output##2##4##(2008-9#2)
variability in seed production##2##4##(2008-9#2)
variability in seed##4##3##(2008-9#4)
variability in species'##2##3##(2008-8#2)
variability in the##31##3##(1990-8#1)(1991-12#2)(1993-12#1)(1994-2#2)(1997-1#1)(1997-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#1)
variability in tumor delineation##2##4##(2009-11#2)
variability in virulence##2##3##(2008-10#2)
variability in##130##2##(1990-8#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#2)(1995-11#3)(1995-2#1)(1996-6#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#6)(2008-8#12)(2008-9#6)(2009-11#4)(2009-12#1)(2009-2#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
variability indicators##2##2##(2012-4#2)
variability is##6##2##(1991-12#1)(2008-10#2)(2008-5#1)(2009-2#1)(2011-2#1)
variability may##2##2##(1993-12#1)(2008-10#1)
variability of BP##2##3##(2008-11#2)
variability of oceanic phycoerythrin spectral types##2##6##(2008-2#2)
variability of real samples##2##4##(2008-10#2)
variability of the pathogen##3##4##(2008-10#3)
variability of the##25##3##(1990-11#2)(1991-11#1)(1994-11#1)(1994-9#1)(1996-3#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2013-1#1)
variability of this##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
variability of##90##2##(1990-11#2)(1990-8#1)(1991-11#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-4#1)(2007-6#1)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
variability on the##2##3##(1992-9#1)(2011-2#1)
variability on##4##2##(1992-9#1)(2008-10#1)(2011-2#2)
variability over##2##2##(2008-12#1)(2008-9#1)
variability present##2##2##(2008-10#2)
variability than##3##2##(1990-8#1)(2008-10#1)(2010-3#1)
variability was attributable to##2##4##(2008-10#1)(2008-7#1)
variability was##11##2##(1992-5#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#2)(2009-6#1)
variability were##6##2##(1991-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
variability which##3##2##(1993-3#1)(2008-10#1)(2013-7#1)
variability with##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
variability within##6##2##(1994-3#1)(2008-10#3)(2008-5#1)(2008-9#1)
variability##506##1##(1990-11#2)(1990-2#2)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-5#4)(1992-6#4)(1992-9#4)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-11#4)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#2)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#141)(2008-11#17)(2008-12#9)(2008-2#10)(2008-3#18)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#19)(2008-8#28)(2008-9#21)(2009-10#1)(2009-11#12)(2009-12#1)(2009-2#7)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#5)(2011-2#18)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#9)(2012-4#7)(2012-5#4)(2013-1#6)(2013-7#6)(2013-8#8)
variability)##4##1##(2008-11#1)(2008-8#3)
variable DNA##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
variable Zagreb##3##2##(2007-11#3)
variable among##5##2##(1997-8#1)(2008-3#2)(2008-9#1)(2010-8#1)
variable amount of##2##3##(2012-2#1)(2013-1#1)
variable amounts of##4##3##(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#1)
variable amounts##6##2##(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
variable and the##2##3##(2008-10#1)(2012-12#1)
variable and##21##2##(1994-11#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#3)(2013-8#1)
variable angle-of-incidence##2##2##(2008-2#1)(2008-3#1)
variable as a function of##2##5##(2008-10#2)
variable as##3##2##(2008-10#2)(2008-7#1)
variable associated with##2##3##(2008-10#1)(2013-1#1)
variable at##2##2##(2008-10#1)(2008-7#1)
variable between##3##2##(2008-10#2)(2013-8#1)
variable bias##2##2##(1992-6#2)
variable can##2##2##(2008-8#1)(2011-2#1)
variable clinical expression##2##3##(2011-2#1)(2013-8#1)
variable clinical##7##2##(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
variable connectivity index##2##3##(2007-11#2)
variable curvature##2##2##(2012-1#2)
variable degrees of##2##3##(2007-10#1)(2011-1#1)
variable degrees##3##2##(1997-6#1)(2007-10#1)(2011-1#1)
variable deletions##2##2##(1993-11#1)(1997-3#1)
variable depending on the##2##4##(1997-8#1)(2008-5#1)
variable depending on##4##3##(1997-8#1)(2008-12#1)(2008-5#1)(2009-8#1)
variable disease##2##2##(2012-2#1)(2013-1#1)
variable domains##2##2##(1991-9#1)(1992-6#1)
variable effect##2##2##(2008-10#1)(2008-11#1)
variable environments##2##2##(2008-8#2)
variable expression##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
variable for the##2##3##(2008-10#1)(2008-7#1)
variable for##6##2##(1994-3#1)(1996-6#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)
variable fragment##4##2##(2008-10#4)
variable frequency##2##2##(2012-3#1)(2013-1#1)
variable from##5##2##(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
variable growth##2##2##(2008-12#2)
variable in the##3##3##(1997-7#1)(2010-4#1)(2011-2#1)
variable in##14##2##(1993-11#1)(1993-2#1)(1994-2#1)(1996-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)
variable interval##2##2##(1992-12#1)(1993-6#1)
variable is##3##2##(1995-12#1)(2008-8#1)(2011-2#1)
variable length##5##2##(1992-6#1)(1996-2#1)(2008-10#3)
variable levels of##2##3##(2008-8#2)
variable linking##2##2##(2011-2#1)(2012-12#1)
variable measurement variances##2##3##(2008-7#2)
variable number of tandem repeat##2##5##(2008-10#1)(2008-11#1)
variable number of##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
variable number tandem repeat##2##4##(2008-10#1)(2008-7#1)
variable number##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
variable numbers of##2##3##(1990-12#1)(1993-11#1)
variable of##3##2##(1990-11#1)(1990-12#1)(1990-8#1)
variable on the##2##3##(2008-10#2)
variable on##3##2##(2008-10#2)(2010-2#1)
variable part##2##2##(2008-2#1)(2008-5#1)
variable phase##2##2##(2007-11#1)(2008-2#1)
variable phenotype##3##2##(1997-3#1)(2008-4#1)(2009-12#1)
variable proportion of##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
variable radius mirror##2##3##(2008-2#1)(2008-3#1)
variable rates##2##2##(1992-5#1)(2008-12#1)
variable reflectivity##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
variable region of##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
variable region##12##2##(1992-6#1)(1993-11#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-8#2)(2012-12#1)(2012-2#1)
variable regions##4##2##(1994-3#1)(1995-11#1)(2008-10#1)(2008-8#1)
variable resistance##2##2##(1991-5#1)(2011-10#1)
variable response##2##2##(2008-9#1)(2013-8#1)
variable responses##3##2##(1994-2#1)(2008-11#1)(2008-4#1)
variable results##5##2##(2006-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-3#1)
variable retarder##2##2##(2008-3#2)
variable sample volume##2##3##(2008-10#2)
variable selection methods##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
variable selection##14##2##(1995-2#2)(2008-10#4)(2008-7#1)(2010-1#3)(2012-12#2)(2012-3#2)
variable sensitivity##2##2##(2010-8#1)(2011-2#1)
variable severity of##2##3##(2007-12#1)(2007-7#1)
variable severity##4##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)
variable sites##3##2##(2008-10#3)
variable spatial##2##2##(2008-2#1)(2008-3#1)
variable success##3##2##(2010-10#1)(2010-5#1)(2011-1#1)
variable symptoms and##2##3##(2008-10#1)(2010-4#1)
variable symptoms##3##2##(2008-10#1)(2008-4#1)(2010-4#1)
variable temperature (1)H##2##3##(1996-2#1)(1996-5#1)
variable temperature##4##2##(1996-2#1)(1996-5#1)(2008-10#1)(2009-11#1)
variable than those##2##3##(2008-10#1)(2008-9#1)
variable than##4##2##(1993-3#1)(2007-8#1)(2008-10#1)(2008-9#1)
variable that##4##2##(1991-8#1)(2008-9#1)(2013-1#2)
variable thickness##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
variable time##2##2##(2008-11#1)(2008-3#1)
variable to##4##2##(2008-10#3)(2008-8#1)
variable values)##2##2##(2008-10#2)
variable vertex-connectivity index##2##3##(2007-11#2)
variable was##4##2##(1992-1#1)(1993-3#1)(2008-10#1)(2008-11#1)
variable wavelength epi-fluorescence microscope##2##4##(2008-10#2)
variable##575##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#6)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1994-1#1)(1994-11#4)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#10)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-8#1)(2007-10#2)(2007-11#12)(2007-12#7)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#10)(2008-10#117)(2008-11#18)(2008-12#9)(2008-2#19)(2008-3#29)(2008-4#9)(2008-5#11)(2008-6#4)(2008-7#20)(2008-8#39)(2008-9#14)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#4)(2011-10#1)(2011-2#27)(2012-1#2)(2012-12#14)(2012-2#10)(2012-3#9)(2013-1#16)(2013-7#7)(2013-8#10)
variable)##3##1##(2008-3#1)(2008-7#2)
variable-focal-length##2##1##(2007-12#1)(2008-3#1)
variable-line-spaced grating##3##2##(2008-3#3)
variable-line-spaced##4##1##(2008-3#4)
variable-reflectivity signal##2##2##(2007-11#2)
variable-reflectivity##3##1##(2007-11#2)(2008-3#1)
variable-retardance##2##1##(2007-12#1)(2008-3#1)
variable-size##2##1##(2008-3#2)
variable-temperature##2##1##(1995-5#1)(1996-2#1)
variable-term computer leases##2##3##(1993-2#2)
variable-tone long calls##2##3##(2008-8#2)
variables (age##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
variables (e##6##2##(2007-12#2)(2007-7#1)(2008-7#3)
variables (pH##2##2##(2008-10#2)
variables (sample##3##2##(2008-10#3)
variables 1##2##2##(2008-7#2)
variables accounted for##2##3##(2008-10#1)(2008-8#1)
variables affect##2##2##(2008-10#1)(2012-3#1)
variables affecting the fluorescence##4##4##(2008-10#4)
variables affecting the##21##3##(2008-10#20)(2012-12#1)
variables affecting##25##2##(2008-10#23)(2012-12#1)(2012-2#1)
variables also##3##2##(1995-2#1)(1997-4#1)(2008-10#1)
variables and body##2##3##(2008-7#1)(2008-9#1)
variables and surgical management of foot melanoma##2##7##(2012-3#2)
variables and the##7##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)(2013-7#1)
variables and their##4##3##(1994-6#1)(1996-9#1)(2008-10#2)
variables and##48##2##(1992-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-9#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
variables are the##2##3##(2008-10#1)(2008-4#1)
variables are##24##2##(1992-1#1)(1992-3#2)(1992-6#3)(1996-1#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
variables as independent##2##3##(1990-9#1)(2008-10#1)
variables as well as##6##4##(2008-10#5)(2009-8#1)
variables as well##7##3##(2008-10#5)(2008-5#1)(2009-8#1)
variables as##10##2##(1990-9#1)(2008-10#7)(2008-5#1)(2009-8#1)
variables associated with##9##3##(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
variables at the##2##3##(2008-10#1)(2009-7#1)
variables at##5##2##(2008-10#4)(2009-7#1)
variables based on##2##3##(2008-10#2)
variables being##2##2##(2008-10#2)
variables between##2##2##(2012-12#1)(2013-1#1)
variables by the##2##3##(2008-10#1)(2008-3#1)
variables by##4##2##(1992-6#1)(2008-10#1)(2008-3#1)(2013-1#1)
variables can be##3##3##(1992-6#1)(2008-3#1)(2008-8#1)
variables corresponding##2##2##(1997-7#1)(2008-10#1)
variables did not##3##3##(2008-8#1)(2009-7#1)(2011-2#1)
variables during##2##2##(2008-11#1)(2010-9#1)
variables examined##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
variables explained##2##2##(2007-10#1)(2008-7#1)
variables for each##2##3##(2012-3#1)(2013-7#1)
variables for the##5##3##(2008-10#3)(2010-5#1)(2013-1#1)
variables for##17##2##(1991-3#1)(1992-2#1)(1993-12#1)(2008-10#8)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
variables from##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
variables had##3##2##(1991-3#1)(2008-10#2)
variables have been optimized##3##4##(2008-10#3)
variables have been##4##3##(2008-10#4)
variables in both##2##3##(1996-12#1)(2010-8#1)
variables in the model##3##4##(1992-6#1)(2008-10#1)(2008-11#1)
variables in the##10##3##(1991-6#1)(1992-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2013-1#1)
variables in##37##2##(1991-3#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-10#1)(1994-1#1)(1994-7#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
variables including##4##2##(2007-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
variables influence##2##2##(1996-1#1)(2008-12#1)
variables influenced##2##2##(2008-11#1)(2008-9#1)
variables influencing the##2##3##(2008-10#2)
variables influencing##3##2##(1994-2#1)(2008-10#2)
variables is##8##2##(1997-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2011-2#1)
variables like##4##2##(2008-10#3)(2011-1#1)
variables may##4##2##(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
variables measured##3##2##(1996-7#1)(2008-1#1)(2013-1#1)
variables of each##2##3##(2011-2#1)(2013-7#1)
variables of the system##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
variables of the##10##3##(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)
variables of##22##2##(1993-12#1)(1995-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
variables on the determination of##2##5##(2008-10#2)
variables on the##8##3##(1990-8#1)(1992-12#1)(2008-10#5)(2011-2#1)
variables on these##2##3##(2008-10#1)(2008-4#1)
variables on##16##2##(1990-8#1)(1992-12#1)(1992-6#1)(1997-7#1)(2008-10#8)(2008-4#1)(2008-5#1)(2011-2#2)
variables or##4##2##(1995-12#1)(1995-9#1)(2008-4#2)
variables related to##7##3##(1995-1#1)(1995-2#1)(2008-10#3)(2013-1#1)(2013-8#1)
variables related##8##2##(1995-1#1)(1995-2#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-8#1)
variables showed##2##2##(1996-5#1)(2008-10#1)
variables studied##5##2##(1994-3#2)(2008-10#1)(2008-11#1)(2011-2#1)
variables such as age##2##4##(2007-8#1)(2008-12#1)
variables such as nationality##2##4##(2009-8#1)(2011-2#1)
variables such as pH##2##4##(2008-10#2)
variables such as the##6##4##(2008-10#5)(2009-7#1)
variables such as##38##3##(1990-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-2#2)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
variables such##39##2##(1990-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-2#2)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
variables that affect the##2##4##(2008-10#2)
variables that affect##4##3##(2008-10#3)(2008-8#1)
variables that are##4##3##(1995-1#1)(2008-10#1)(2008-8#1)(2009-4#1)
variables that contributed##2##3##(2008-10#1)(2008-8#1)
variables that could affect the performance of this system were investigated as well as the possible interferents##2##17##(2008-10#2)
variables that could##3##3##(1994-7#1)(2008-10#2)
variables that have##2##3##(1992-3#1)(2009-10#1)
variables that influence the##2##4##(2008-10#2)
variables that influence##4##3##(2008-10#3)(2009-8#1)
variables that may##2##3##(2006-10#1)(2008-12#1)
variables that were##3##3##(2008-11#1)(2011-2#1)(2013-7#1)
variables that##35##2##(1991-12#1)(1992-2#1)(1992-3#1)(1994-7#1)(1995-1#1)(1995-5#1)(2006-10#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#4)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
variables the##4##2##(1990-3#1)(1994-2#1)(2008-10#2)
variables to be studied##2##4##(2008-10#2)
variables to be##6##3##(2008-10#4)(2008-11#1)(2008-2#1)
variables to the##2##3##(2008-10#1)(2008-8#1)
variables to##21##2##(1990-7#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#3)(2010-3#1)(2012-2#2)(2013-8#1)
variables used##2##2##(1994-2#1)(2008-5#1)
variables using a##2##3##(2008-10#1)(2008-11#1)
variables was completely studied by factorial design analysis##2##8##(2008-10#2)
variables was studied##2##3##(2008-10#2)
variables was##13##2##(1992-2#1)(1996-5#1)(2008-10#7)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
variables were collected##3##3##(2008-10#1)(2011-1#2)
variables were considered##2##3##(2008-10#1)(2008-11#1)
variables were determined##2##3##(1995-3#1)(1996-3#1)
variables were measured in##3##4##(2008-10#1)(2012-12#1)(2013-7#1)
variables were measured##5##3##(1994-1#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
variables were not##4##3##(1992-3#1)(1994-9#1)(1995-1#1)(2013-1#1)
variables were optimized##2##3##(2008-10#2)
variables were studied and optimized##3##5##(2008-10#3)
variables were studied in order to##2##6##(2008-10#2)
variables were studied in##3##4##(2008-10#2)(2011-2#1)
variables were studied##8##3##(2008-10#6)(2008-8#1)(2011-2#1)
variables were tested##2##3##(2008-10#1)(2011-1#1)
variables were then##2##3##(2008-12#1)(2011-2#1)
variables were used##2##3##(2008-10#2)
variables were##80##2##(1991-12#1)(1992-3#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-8#2)(2008-10#29)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#2)
variables which##8##2##(1991-12#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-7#1)
variables with##11##2##(1990-9#1)(1991-4#1)(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)
variables##881##1##(1990-11#1)(1990-2#1)(1990-3#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#5)(1992-3#6)(1992-6#8)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#3)(1994-1#2)(1994-12#1)(1994-2#8)(1994-3#4)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#5)(1995-12#5)(1995-2#10)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#4)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#4)(1997-7#3)(2006-10#1)(2007-10#3)(2007-11#3)(2007-12#10)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#301)(2008-11#26)(2008-12#17)(2008-2#13)(2008-3#17)(2008-4#8)(2008-5#22)(2008-6#3)(2008-7#36)(2008-8#25)(2008-9#15)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#8)(2009-8#8)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#1)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#14)(2011-2#36)(2012-1#4)(2012-12#17)(2012-2#14)(2012-3#14)(2013-1#34)(2013-7#15)(2013-8#13)
variables)##6##1##(2007-12#1)(2008-7#2)(2010-1#1)(2013-1#1)(2013-7#1)
variably expressed in##2##3##(2007-12#1)(2012-3#1)
variably expressed##3##2##(1996-12#1)(2007-12#1)(2012-3#1)
variably sized##2##2##(2008-12#1)(2009-4#1)
variably##14##1##(1992-6#1)(1993-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-3#2)
variamine blue##3##2##(2008-10#3)
variance (I)##2##2##(2008-8#2)
variance analysis and##2##3##(1996-12#1)(2008-10#1)
variance analysis##6##2##(1992-2#1)(1996-12#1)(2008-10#3)(2008-2#1)
variance and##16##2##(1990-3#1)(1992-9#1)(1993-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#2)
variance associated with##2##3##(2009-9#1)(2013-1#1)
variance between##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
variance can##3##2##(2008-10#1)(2008-8#2)
variance components##2##2##(1994-9#1)(2008-7#1)
variance could be##2##3##(1993-2#1)(2007-12#1)
variance explained##3##2##(2008-12#1)(2011-1#2)
variance for##8##2##(2008-10#6)(2008-3#2)
variance in gain##2##3##(2008-9#2)
variance in perceived learning outcome##2##5##(2011-2#2)
variance in population##2##3##(2008-8#2)
variance in the lognormal##2##4##(2008-8#2)
variance in the##18##3##(1995-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-12#1)(2010-8#1)(2012-3#1)
variance in##73##2##(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-6#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#11)(2008-9#10)(2009-10#1)(2009-12#4)(2009-4#2)(2010-11#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
variance indicated##3##2##(2008-10#3)
variance is due to##2##4##(2008-10#1)(2009-4#1)
variance is##7##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-4#1)(2010-2#1)
variance observed##2##2##(2008-10#1)(2008-7#1)
variance of area estimates##3##4##(1997-3#3)
variance of area##4##3##(1997-3#3)(2008-10#1)
variance of the##17##3##(1992-6#1)(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#4)(2010-3#1)(2012-1#1)(2012-3#1)
variance of##37##2##(1992-6#1)(1992-9#1)(1993-8#1)(1997-3#3)(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#3)(2008-3#5)(2008-8#1)(2009-2#1)(2009-5#2)(2010-3#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-3#2)
variance on the##2##3##(2008-10#1)(2008-3#1)
variance over##2##2##(2008-9#1)(2010-8#1)
variance reduction##2##2##(1993-12#1)(2008-3#1)
variance revealed that##4##3##(2008-10#3)(2013-1#1)
variance revealed##6##2##(2008-10#3)(2009-11#1)(2012-3#1)(2013-1#1)
variance tests##2##2##(2008-10#1)(2011-2#1)
variance to##3##2##(2007-12#1)(2008-10#1)(2009-7#1)
variance was##8##2##(1991-2#1)(2008-10#4)(2008-6#2)(2013-1#1)
variance with the##3##3##(1995-6#1)(2008-10#1)(2009-6#1)
variance with##12##2##(1990-3#1)(1990-8#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-6#1)
variance##344##1##(1990-2#1)(1990-3#3)(1990-8#2)(1991-2#1)(1992-2#2)(1992-6#2)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-3#4)(2007-10#2)(2007-11#5)(2007-12#7)(2007-6#1)(2007-8#2)(2008-10#97)(2008-11#3)(2008-12#6)(2008-2#10)(2008-3#22)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#30)(2008-9#22)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#4)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#5)(2012-2#2)(2012-3#10)(2013-1#13)(2013-8#2)
variance)##4##1##(2008-10#2)(2008-3#1)(2008-8#1)
variance-covariance matrix##2##2##(2013-1#2)
variance-mean relationship##2##2##(2008-10#2)
variance-mean##3##1##(2008-10#3)
variance-to-mean##2##1##(2008-10#2)
variances and##2##2##(2008-8#1)(2013-1#1)
variances are##2##2##(2008-3#1)(2012-1#1)
variances as well as##2##4##(2008-2#1)(2008-7#1)
variances in##3##2##(1994-9#1)(2008-11#1)(2008-9#1)
variances of##8##2##(1995-5#1)(2008-10#2)(2012-1#4)(2012-3#1)
variances using##3##2##(2012-1#3)
variances were##2##2##(2008-10#1)(2010-3#1)
variances##48##1##(1994-2#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#11)(2012-3#4)(2013-1#1)
variant (Met352----Arg)##2##2##(1990-8#2)
variant Na(V) 1##2##3##(2013-1#2)
variant and##3##2##(2012-2#1)(2013-1#2)
variant associated with##2##3##(2007-12#1)(2013-1#1)
variant exhibited##2##2##(1990-8#1)(1994-12#1)
variant form of##2##3##(1991-3#1)(1992-6#1)
variant form##3##2##(1991-3#1)(1992-6#1)(1994-8#1)
variant forms of##2##3##(1994-12#1)(2008-7#1)
variant genes##3##2##(2011-2#3)
variant genotypes##5##2##(2008-8#1)(2012-3#4)
variant has been##3##3##(1991-12#1)(1993-8#1)(2011-2#1)
variant has##4##2##(1991-12#2)(1993-8#1)(2011-2#1)
variant hepatic##2##2##(2012-2#2)
variant hypothesis##3##2##(2012-3#3)
variant in##5##2##(1992-8#1)(1994-12#1)(1994-8#2)(2008-7#1)
variant is##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
variant isolates##3##2##(2008-10#3)
variant lines##2##2##(2008-8#2)
variant number##2##2##(2008-8#1)(2008-9#1)
variant of 3beta-HSD deficiency CAH##2##5##(2008-4#2)
variant of Bartter syndrome##2##4##(2007-7#2)
variant of PPV HC-Pro##2##4##(2008-10#2)
variant of Wegener's granulomatosis##3##4##(2010-11#3)
variant of serous cystadenoma of the pancreas##3##7##(2012-2#3)
variant of serous cystadenoma##4##4##(2012-2#4)
variant of the##13##3##(1994-5#1)(1995-11#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2010-7#1)(2013-1#1)
variant of this##2##3##(1997-1#1)(2011-2#1)
variant of##72##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-12#2)(1992-12#1)(1992-2#1)(1992-4#1)(1994-5#1)(1995-11#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#4)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
variant on##2##2##(2008-9#1)(2012-3#1)
variant was##5##2##(1994-3#1)(1996-3#1)(2010-12#1)(2011-1#1)(2012-3#1)
variant with different##2##3##(1990-8#1)(2008-9#1)
variant with##4##2##(1990-8#2)(1995-6#1)(2008-9#1)
variant##252##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#2)(1990-8#9)(1991-12#12)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-11#3)(1993-3#3)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2008-10#19)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#11)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#20)(2013-1#13)(2013-8#1)
variants and isoforms##2##3##(1997-2#2)
variants and##12##2##(1997-2#2)(2008-10#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#3)
variants are presented##2##3##(1996-9#1)(2012-2#1)
variants are##12##2##(1992-9#1)(1996-9#1)(2007-12#1)(2008-10#1)(2012-2#2)(2012-3#5)(2013-1#1)
variants associated with##2##3##(2012-3#1)(2013-8#1)
variants at##5##2##(1990-7#1)(1993-9#1)(2008-12#1)(2012-2#1)(2012-3#1)
variants by##3##2##(1995-6#1)(2008-9#1)(2012-3#1)
variants can##5##2##(2008-3#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
variants differ##2##2##(1990-6#2)
variants for the##2##3##(1991-12#1)(1991-8#1)
variants for##3##2##(1991-12#1)(1991-8#1)(2012-3#1)
variants have been##6##3##(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
variants have##8##2##(2008-10#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#2)(2013-1#1)
variants in the##5##3##(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
variants in##40##2##(1991-12#3)(1992-9#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#9)(2013-1#6)
variants is##4##2##(1990-2#1)(1991-12#1)(1997-7#1)(2010-1#1)
variants may##2##2##(2008-12#1)(2008-9#1)
variants of cytochrome##2##3##(1990-5#1)(1997-2#1)
variants of human trace amine-associated receptor 5##2##7##(2012-2#2)
variants of human##4##3##(1991-8#1)(1997-9#1)(2012-2#2)
variants of satellite tobacco mosaic virus##2##6##(2008-10#2)
variants of the##12##3##(1990-11#1)(1992-1#1)(1992-4#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-4#1)
variants of##49##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-9#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
variants on##2##2##(2009-7#1)(2012-3#1)
variants or##2##2##(1990-11#1)(2012-3#1)
variants tested##2##2##(2008-11#1)(2011-1#1)
variants that are responsible for##2##5##(2009-5#1)(2012-3#1)
variants that are##3##3##(2009-5#1)(2012-3#2)
variants that contribute to##4##4##(2012-3#4)
variants that##13##2##(1996-2#1)(2008-10#3)(2009-5#1)(2011-1#1)(2012-3#6)(2013-1#1)
variants using##2##2##(2012-3#2)
variants was##4##2##(1990-7#2)(1997-3#1)(2008-11#1)
variants were collapsed##3##3##(2012-3#3)
variants were##14##2##(1991-8#1)(1994-12#1)(1994-8#1)(2008-10#3)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
variants with increased##2##3##(2008-8#1)(2013-1#1)
variants with##15##2##(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-9#1)(2010-12#1)(2011-3#1)(2012-3#3)(2013-1#1)
variants within a##2##3##(2008-10#1)(2012-3#1)
variants within##4##2##(2008-10#1)(2012-3#3)
variants##328##1##(1990-11#2)(1990-2#2)(1990-5#1)(1990-6#6)(1990-7#4)(1990-8#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-8#6)(1991-9#1)(1992-1#1)(1992-4#1)(1992-9#5)(1993-6#3)(1993-9#2)(1994-12#6)(1994-2#1)(1994-8#4)(1995-11#2)(1995-5#1)(1995-6#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#2)(1997-7#2)(1997-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#43)(2008-11#6)(2008-12#3)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#5)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#7)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#17)(2012-3#69)(2013-1#20)(2013-8#2)
variates##3##1##(1992-9#1)(2008-10#2)
variation &lt##3##2##(2008-10#3)
variation Dkappa##2##2##(2008-3#2)
variation across##5##2##(1994-12#1)(1994-3#1)(1995-8#1)(2008-3#1)(2008-9#1)
variation along##3##2##(2008-3#3)
variation among strains was##2##4##(2008-10#2)
variation among strains##3##3##(2008-10#3)
variation among the##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
variation among##29##2##(1991-5#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-9#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)
variation and effect of##2##4##(1997-2#1)(2008-10#1)
variation and the##5##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-8#1)
variation and variation in##2##4##(2008-10#2)
variation and##46##2##(1992-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-6#2)(1997-2#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-5#2)(2009-7#1)(2010-1#1)(2010-3#2)(2010-5#1)(2012-2#2)(2012-3#1)(2012-6#1)(2012-9#1)(2013-8#2)
variation are##5##2##(1991-2#1)(1996-3#1)(2008-10#1)(2009-2#1)(2011-1#1)
variation as a function of##2##5##(2008-5#1)(2012-2#1)
variation as well as##2##4##(2008-11#1)(2009-7#1)
variation as##4##2##(2008-11#1)(2008-5#1)(2009-7#1)(2012-2#1)
variation associated with##5##3##(1995-2#1)(2008-10#2)(2008-11#1)(2010-5#1)
variation at##15##2##(1993-2#1)(1994-3#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#2)
variation between 1##2##3##(2008-10#1)(2012-2#1)
variation between the##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
variation between##21##2##(1994-12#1)(1994-9#1)(2007-1#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#3)(2009-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
variation both within##2##3##(2008-5#1)(2012-3#1)
variation by##5##2##(1994-12#1)(1996-6#1)(2008-10#2)(2008-8#1)
variation can be##3##3##(2008-3#1)(2008-8#2)
variation can##6##2##(1993-3#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-9#1)
variation coefficient of the##2##4##(2008-10#2)
variation coefficient of##4##3##(1993-9#1)(2008-10#3)
variation coefficient were##3##3##(2008-10#3)
variation coefficient##9##2##(1993-9#1)(2008-10#8)
variation coefficients of##2##3##(2008-10#2)
variation coefficients##4##2##(2008-10#3)(2008-7#1)
variation compared##2##2##(2008-10#1)(2008-8#1)
variation continues to##2##3##(1991-12#1)(1996-3#1)
variation depending on##2##3##(2008-10#1)(2010-5#1)
variation detected##2##2##(2008-10#1)(2008-5#1)
variation due to##4##3##(2008-10#2)(2008-2#1)(2009-5#1)
variation during##3##2##(1995-9#1)(2008-3#1)(2012-2#1)
variation exists##3##2##(1996-12#1)(2007-10#1)(2008-10#1)
variation for components of aggressiveness##2##5##(2008-10#2)
variation for resistance in##5##4##(2008-10#5)
variation for resistance to##2##4##(2008-10#2)
variation for resistance##8##3##(2008-10#8)
variation for the##4##3##(2008-10#3)(2008-5#1)
variation for this##2##3##(1994-12#1)(2008-9#1)
variation for##33##2##(1990-2#1)(1993-8#1)(1994-12#1)(2007-11#1)(2008-10#23)(2008-5#2)(2008-9#3)(2012-3#1)
variation from##5##2##(1995-8#1)(1996-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
variation has been##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
variation in Bragg wavelength##3##4##(2013-8#3)
variation in a##4##3##(1991-3#1)(2007-12#1)(2008-12#1)(2008-3#1)
variation in aggressiveness##2##3##(2008-10#2)
variation in an##2##3##(1993-1#1)(2008-3#1)
variation in body size and##4##5##(2008-9#1)(2010-3#1)(2010-8#1)(2013-7#1)
variation in body##5##3##(2008-9#1)(2010-3#1)(2010-8#1)(2013-7#2)
variation in cell size##2##4##(2008-7#1)(2013-1#1)
variation in competitive##2##3##(2008-8#1)(2008-9#1)
variation in condition##2##3##(2010-8#2)
variation in disease severity##3##4##(2008-10#3)
variation in disease##6##3##(2008-10#6)
variation in egg size##4##4##(2008-8#4)
variation in epicuticular##2##3##(2008-8#2)
variation in fitness##4##3##(2008-8#4)
variation in glucose homeostasis##2##4##(2008-1#2)
variation in growth##4##3##(2007-11#1)(2008-8#2)(2010-8#1)
variation in health care utilization and##2##6##(2007-10#2)
variation in health care##3##4##(2007-10#2)(2008-1#1)
variation in health##4##3##(2007-10#2)(2008-1#1)(2008-7#1)
variation in host##2##3##(2008-10#1)(2008-9#1)
variation in individual##2##3##(1996-2#1)(2008-8#1)
variation in larval growth##2##4##(2007-5#2)
variation in larval##4##3##(1995-2#1)(2007-5#2)(2008-9#1)
variation in level##2##3##(1990-5#1)(1996-3#1)
variation in levels of##2##4##(1992-3#1)(1993-11#1)
variation in mammary thermography##2##4##(1990-2#2)
variation in number of Bs##2##5##(2008-5#2)
variation in one##2##3##(2008-12#1)(2008-8#1)
variation in parasitic fitness##2##4##(2008-10#2)
variation in patch density##2##4##(2008-8#2)
variation in patch##4##3##(2008-8#3)(2008-9#1)
variation in pathogenicity##3##3##(2008-10#3)
variation in phenotypic##2##3##(2008-10#1)(2013-1#1)
variation in population density##2##4##(2008-8#2)
variation in population##4##3##(2008-8#3)(2008-9#1)
variation in presentation##2##3##(2009-10#1)(2012-2#1)
variation in rectal and bladder doses##2##6##(2009-11#2)
variation in resistance##2##3##(2008-10#1)(2011-2#1)
variation in selection##2##3##(2010-3#1)(2013-1#1)
variation in sex##2##3##(2008-8#2)
variation in skin surface##2##4##(2008-5#2)
variation in soil##2##3##(2008-10#1)(2013-7#1)
variation in species richness##4##4##(2008-8#4)
variation in the environment##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
variation in the relative##2##4##(2007-12#1)(2008-2#1)
variation in the##71##3##(1991-11#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-11#2)(1995-9#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-2#4)(2012-3#4)(2013-1#2)(2013-7#1)
variation in their##5##3##(1990-9#1)(1994-5#1)(1997-2#1)(2008-9#1)(2013-8#1)
variation in these##2##3##(1992-3#1)(2008-8#1)
variation in thickness of the##2##5##(2008-3#2)
variation in this##2##3##(2008-10#1)(2008-9#1)
variation in time##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
variation in urinary cytokine levels in##2##6##(1996-12#2)
variation in virulence and##2##4##(1991-8#1)(2008-10#1)
variation in virulence##4##3##(1991-8#1)(2008-10#3)
variation in virus titer##2##4##(1994-8#2)
variation in##421##2##(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#2)(1993-1#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-10#4)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#71)(2008-11#8)(2008-12#11)(2008-2#8)(2008-3#14)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#64)(2008-9#20)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#6)(2010-4#2)(2010-8#17)(2011-1#3)(2011-2#12)(2011-3#2)(2012-2#6)(2012-3#17)(2013-1#15)(2013-7#4)(2013-8#4)
variation influences##2##2##(2011-2#1)(2012-3#1)
variation into##2##2##(2008-10#1)(2012-3#1)
variation is essential##2##3##(2008-10#1)(2008-7#1)
variation is found##2##3##(2008-1#1)(2011-2#1)
variation is##24##2##(1990-8#1)(1992-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2011-2#1)(2013-8#1)
variation limits##2##2##(2007-10#1)(2007-12#1)
variation may##3##2##(2008-7#1)(2009-10#1)(2010-5#1)
variation method##2##2##(2008-10#2)
variation not##2##2##(1995-11#1)(2010-5#1)
variation observed##5##2##(2008-10#3)(2009-12#1)(2010-3#1)
variation of a quantitative trait##2##5##(2012-3#2)
variation of a##6##3##(1996-6#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-3#2)
variation of influenza##2##3##(2013-8#2)
variation of leaf##2##3##(2011-10#1)(2012-5#1)
variation of one##2##3##(2008-3#1)(2009-10#1)
variation of rDNA##2##3##(2008-5#2)
variation of results##2##3##(2008-12#1)(2010-8#1)
variation of the light##4##4##(2008-10#1)(2008-3#3)
variation of the mean##2##4##(2008-10#1)(2008-2#1)
variation of the pH##2##4##(2008-10#2)
variation of the source##2##4##(2008-3#2)
variation of the##76##3##(1990-8#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-12#4)(2008-10#19)(2008-2#10)(2008-3#18)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
variation of these##2##3##(2007-12#1)(2008-10#1)
variation of##199##2##(1990-6#1)(1990-8#1)(1991-11#1)(1992-11#3)(1993-1#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2008-10#52)(2008-11#1)(2008-12#2)(2008-2#19)(2008-3#28)(2008-5#9)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#3)(2011-10#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#3)(2012-5#2)(2013-1#4)(2013-7#5)(2013-8#8)
variation on the##2##3##(2012-2#1)(2013-8#1)
variation on##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-2#1)(2013-8#1)
variation or##2##2##(2008-9#1)(2010-5#1)
variation present##2##2##(1993-9#1)(2010-4#1)
variation resulting##2##2##(1997-3#1)(2008-3#1)
variation showed##3##2##(1993-8#2)(2008-10#1)
variation shows##2##2##(2008-10#1)(2008-8#1)
variation than##4##2##(2007-12#1)(2008-5#1)(2008-8#2)
variation that##2##2##(2008-10#1)(2010-4#1)
variation to##6##2##(1990-8#1)(2008-10#2)(2008-3#1)(2010-3#1)(2013-7#1)
variation was detected##3##3##(2010-2#1)(2010-3#1)(2010-8#1)
variation was due to##2##4##(2008-10#2)
variation was found in##3##4##(2007-1#1)(2012-3#1)(2013-8#1)
variation was found##6##3##(2007-1#1)(2008-10#3)(2012-3#1)(2013-8#1)
variation was greatest##2##3##(2008-10#2)
variation was less than##2##4##(2008-3#2)
variation was observed##7##3##(1996-1#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
variation was##47##2##(1991-8#1)(1992-8#1)(1993-11#1)(1996-1#1)(1997-2#1)(2007-1#1)(2008-10#22)(2008-12#1)(2008-3#4)(2008-5#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
variation with a##2##3##(2007-10#1)(2008-10#1)
variation with##7##2##(2007-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-5#1)
variation within a##6##3##(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
variation within and among##2##4##(2008-10#2)
variation within and between##2##4##(2008-10#1)(2009-6#1)
variation within and##6##3##(2008-10#4)(2009-6#1)(2013-1#1)
variation within the population##2##4##(2008-8#1)(2012-3#1)
variation within the##7##3##(2008-10#3)(2008-12#1)(2008-8#1)(2010-3#1)(2012-3#1)
variation within##30##2##(1995-5#1)(2008-10#15)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
variation##1251##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#1)(1992-11#5)(1992-12#3)(1992-3#4)(1992-6#2)(1992-8#2)(1993-1#4)(1993-11#6)(1993-12#3)(1993-2#4)(1993-3#5)(1993-8#4)(1993-9#5)(1994-12#8)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#3)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#7)(1996-5#2)(1996-6#7)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#8)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(1997-9#1)(2006-6#1)(2007-1#2)(2007-10#10)(2007-11#14)(2007-12#20)(2007-2#3)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#332)(2008-11#15)(2008-12#22)(2008-2#38)(2008-3#77)(2008-4#3)(2008-5#52)(2008-6#6)(2008-7#28)(2008-8#96)(2008-9#36)(2009-10#5)(2009-11#3)(2009-12#2)(2009-2#5)(2009-4#1)(2009-5#10)(2009-6#3)(2009-7#9)(2009-8#3)(2009-9#5)(2010-1#5)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#14)(2010-4#7)(2010-5#13)(2010-6#1)(2010-8#25)(2011-1#6)(2011-10#1)(2011-2#30)(2011-3#5)(2012-1#1)(2012-12#3)(2012-2#30)(2012-3#44)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#28)(2013-7#15)(2013-8#20)
variation) was##2##2##(1993-1#1)(1995-2#1)
variation)##6##1##(1991-5#1)(1993-1#1)(1995-2#1)(2007-11#1)(2008-8#1)(2008-9#1)
variational approach##4##2##(1990-12#1)(2007-12#1)(2009-9#2)
variational##16##1##(1990-12#1)(2007-11#2)(2007-12#3)(2008-3#1)(2008-7#1)(2009-9#5)(2010-2#2)(2012-3#1)
variations across##2##2##(1997-1#1)(2008-2#1)
variations after##2##2##(1991-5#1)(1996-5#1)
variations and pathologic##2##3##(1996-6#2)
variations and##20##2##(1992-8#1)(1996-6#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-3#1)
variations are##9##2##(1996-3#1)(1997-2#1)(2007-10#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-7#2)
variations as a function of##2##5##(2008-3#2)
variations as a##3##3##(1991-2#1)(2008-3#2)
variations as##6##2##(1991-2#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-3#2)
variations between the##2##3##(1997-2#1)(2008-7#1)
variations between##9##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-2#1)(1997-2#1)(2008-7#2)(2009-2#1)(2011-2#1)
variations by##2##2##(2008-11#1)(2008-3#1)
variations caused by##2##3##(2008-10#1)(2008-2#1)
variations exist in the##2##4##(2009-7#1)(2010-8#1)
variations for##2##2##(2008-3#1)(2008-5#1)
variations found##2##2##(2008-8#1)(2008-9#1)
variations from##3##2##(2008-3#2)(2011-2#1)
variations have been##2##3##(2007-12#1)(2009-11#1)
variations in a##3##3##(2008-2#1)(2008-3#2)
variations in all##2##3##(1992-8#1)(2008-12#1)
variations in both##2##3##(1995-5#1)(2008-3#1)
variations in disease##2##3##(2008-10#2)
variations in gene##2##3##(2008-10#1)(2012-3#1)
variations in maternal##2##3##(1995-8#1)(2008-8#1)
variations in pH and temperature##2##5##(2008-11#1)(2008-5#1)
variations in shape and##2##4##(2008-5#1)(2009-5#1)
variations in temperature##2##3##(2008-10#1)(2013-8#1)
variations in the amino acid sequence##2##6##(1992-9#1)(2011-2#1)
variations in the cell##2##4##(2008-11#1)(2008-5#1)
variations in the context of##2##5##(2008-8#1)(2011-2#1)
variations in the intensity of##2##5##(2008-10#1)(2008-3#1)
variations in the photosensitizer##2##4##(2009-4#2)
variations in the thickness##2##4##(2008-5#1)(2008-9#1)
variations in the##81##3##(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#2)(2009-6#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-8#3)
variations in this##2##3##(1994-3#1)(2008-10#1)
variations in##199##2##(1990-2#2)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#4)(2008-2#10)(2008-3#21)(2008-4#3)(2008-5#12)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#8)
variations may be##3##3##(2008-3#1)(2008-7#1)(2009-11#1)
variations may##4##2##(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
variations occurred in##2##3##(2007-6#1)(2008-9#1)
variations of a##2##3##(2008-3#1)(2011-2#1)
variations of the absorption coefficient##2##5##(2007-12#1)(2008-3#1)
variations of the##22##3##(1992-8#1)(1992-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2013-1#1)
variations of##71##2##(1990-8#1)(1990-9#1)(1991-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1996-10#1)(1996-2#1)(1996-5#1)(2007-11#3)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
variations on the##6##3##(1990-10#1)(2008-11#1)(2008-3#3)(2013-8#1)
variations on##12##2##(1990-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2011-2#1)(2013-8#2)
variations ranging from##2##3##(2008-10#1)(2009-7#1)
variations that##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
variations were observed among##2##4##(2008-10#2)
variations were observed##3##3##(1990-8#1)(2008-10#2)
variations were##15##2##(1990-8#1)(1994-3#1)(1995-11#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-8#1)
variations with respect to##2##4##(2008-11#1)(2009-5#1)
variations with##4##2##(1997-7#1)(2008-11#1)(2008-5#1)(2009-5#1)
variations within##4##2##(1997-8#1)(2008-10#1)(2008-5#1)(2009-7#1)
variations##471##1##(1990-10#1)(1990-2#2)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#4)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#5)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#10)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#56)(2008-11#12)(2008-12#7)(2008-2#30)(2008-3#52)(2008-4#9)(2008-5#32)(2008-6#7)(2008-7#17)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#5)(2011-1#4)(2011-2#17)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#7)(2012-9#1)(2013-1#10)(2013-7#6)(2013-8#15)
variceal bleeding##2##2##(1995-8#1)(2009-8#1)
variceal hemorrhage##2##2##(2011-2#2)
variceal##11##1##(1995-8#1)(2006-10#1)(2008-8#1)(2009-8#1)(2011-2#6)(2013-1#1)
varicella infection and##2##3##(2008-12#1)(2010-8#1)
varicella infection##4##2##(1992-1#1)(1994-3#1)(2008-12#1)(2010-8#1)
varicella vaccine in##2##3##(2007-12#1)(2009-5#1)
varicella vaccine##4##2##(2007-12#2)(2008-11#1)(2009-5#1)
varicella virus##2##2##(2008-11#2)
varicella zoster infection##5##3##(2008-7#3)(2010-8#2)
varicella zoster virus##3##3##(1994-2#1)(2008-7#1)(2013-1#1)
varicella zoster##8##2##(1994-2#1)(2008-7#4)(2010-8#2)(2013-1#1)
varicella##33##1##(1990-6#1)(1992-1#1)(1994-2#1)(1994-3#1)(1997-5#1)(2007-12#2)(2008-11#8)(2008-12#3)(2008-4#3)(2008-7#4)(2009-5#1)(2010-8#6)(2013-1#1)
varicella-related##3##1##(2008-11#2)(2008-12#1)
varicella-zoster virus (VZV)##2##3##(2008-7#1)(2011-1#1)
varicella-zoster virus##5##2##(2008-12#2)(2008-7#1)(2011-1#2)
varicelle##5##1##(2013-1#5)
varices in##2##2##(2011-2#1)(2013-1#1)
varices were##2##2##(2013-1#2)
varices with##3##2##(2011-2#3)
varices##34##1##(1991-11#1)(1991-5#1)(2006-10#1)(2009-8#7)(2009-9#2)(2011-2#9)(2013-1#12)(2013-8#1)
varicocele in##2##2##(1990-3#2)
varicocele##9##1##(1990-3#8)(1990-9#1)
varicoceles##2##1##(1990-9#1)(2008-1#1)
varicophlebitis of the lower##2##4##(1990-6#2)
varicophlebitis##3##1##(1990-6#3)
varicose nerve##2##2##(1990-5#1)(1997-3#1)
varicose terminals##2##2##(1992-8#1)(1996-5#1)
varicose##7##1##(1990-5#1)(1992-8#1)(1994-6#1)(1996-5#1)(1997-3#1)(2011-3#2)
varicosities##3##1##(1995-5#1)(1996-6#1)(1997-3#1)
varied according to the##5##4##(1993-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
varied according to##8##3##(1993-12#1)(1996-7#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
varied across the##6##3##(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)(2013-8#1)
varied across##8##2##(1994-3#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-1#1)(2011-1#1)(2013-8#1)
varied among experiments##2##3##(2008-10#2)
varied among strains##2##3##(2008-10#1)(2009-5#1)
varied among the##4##3##(1993-3#1)(1996-5#1)(2008-10#1)(2008-9#1)
varied among tissues##2##3##(2008-11#2)
varied among##20##2##(1993-3#1)(1996-5#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-7#1)
varied and were##2##3##(2008-10#1)(2008-12#1)
varied and##8##2##(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
varied as##5##2##(1993-9#1)(1997-3#1)(2007-11#1)(2008-2#1)(2011-2#1)
varied at##3##2##(2007-12#1)(2008-6#1)(2008-8#1)
varied based on##2##3##(2009-7#1)(2013-8#1)
varied between 0 and##2##4##(2008-2#1)(2008-6#1)
varied between 0##10##3##(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)
varied between 1 and##2##4##(2008-10#2)
varied between 1##5##3##(1994-2#1)(2008-10#3)(2008-2#1)
varied between##45##2##(1992-1#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#3)(2008-2#2)(2008-5#2)(2008-6#3)(2009-12#1)(2013-1#1)(2013-7#2)(2013-8#3)
varied by a factor of##2##5##(1994-12#1)(1995-3#1)
varied by age##2##3##(1995-2#1)(2009-7#1)
varied by changing the##2##4##(1992-6#1)(1994-9#1)
varied by the##3##3##(1994-11#1)(2008-3#1)(2010-4#1)
varied by##24##2##(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#2)(2006-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#2)(2009-4#1)(2009-7#2)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
varied clinical##2##2##(2008-8#1)(2009-5#1)
varied considerably between##2##3##(1992-3#1)(1992-6#1)
varied considerably in size and##2##5##(1994-2#1)(2008-5#1)
varied considerably##7##2##(1992-3#1)(1992-6#1)(1994-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
varied depending on the##3##4##(1993-12#1)(1995-5#1)(2008-12#1)
varied depending on##5##3##(1993-12#1)(1994-6#1)(1995-5#1)(2008-12#1)(2011-2#1)
varied during the##2##3##(1997-2#1)(2007-4#1)
varied during##3##2##(1997-2#1)(2007-4#1)(2008-2#1)
varied for the##2##3##(1990-2#1)(2007-12#1)
varied for##3##2##(1990-2#1)(2007-12#1)(2008-10#1)
varied from &lt##2##3##(2008-10#2)
varied from 0 to##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
varied from 0##18##3##(1993-1#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#3)(2012-2#1)
varied from 1##5##3##(2008-10#3)(2011-2#1)(2012-2#1)
varied from 10##2##3##(1993-1#1)(2008-10#1)
varied from 2##7##3##(2008-1#1)(2008-10#4)(2008-5#1)(2009-2#1)
varied from 20 to##2##4##(1997-3#1)(2011-2#1)
varied from 20##4##3##(1997-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
varied from 3##2##3##(2007-2#1)(2008-10#1)
varied from 4 to##2##4##(1997-7#1)(2013-8#1)
varied from 5##2##3##(2008-10#1)(2008-6#1)
varied from 6##3##3##(1995-3#1)(2008-10#1)(2009-3#1)
varied from 85##2##3##(2008-10#2)
varied from 95##2##3##(2008-10#2)
varied from 97##2##3##(2008-10#2)
varied from##93##2##(1993-1#2)(1993-12#1)(1993-3#2)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#42)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-8#1)
varied greatly among##2##3##(2008-10#1)(2010-8#1)
varied greatly over##2##3##(2008-10#1)(2008-8#1)
varied greatly##9##2##(1991-12#1)(1995-5#1)(2008-10#4)(2008-8#1)(2010-8#1)(2012-3#1)
varied in a##7##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
varied in different##2##3##(2008-3#1)(2013-8#1)
varied in size from##2##4##(2008-5#1)(2012-3#1)
varied in size##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
varied in the range##3##4##(2008-10#3)
varied in the##8##3##(1993-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#2)
varied in their ability to##2##5##(1993-12#1)(2008-10#1)
varied in their##7##3##(1993-12#1)(1994-5#1)(2008-10#4)(2008-8#1)
varied in##46##2##(1992-3#2)(1993-12#2)(1994-11#1)(1994-2#1)(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#3)(2008-9#1)(2009-5#2)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
varied independently##2##2##(2007-10#1)(2009-2#1)
varied linearly##2##2##(2008-10#2)
varied more##2##2##(1991-1#1)(2008-10#1)
varied much##2##2##(1992-3#1)(2008-10#1)
varied over a##2##3##(2008-11#1)(2008-2#1)
varied over##6##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-5#1)
varied quantitatively##2##2##(2008-10#2)
varied significantly among##2##3##(2008-10#1)(2011-2#1)
varied significantly between##2##3##(2011-2#1)(2012-3#1)
varied significantly for##2##3##(2007-10#1)(2007-11#1)
varied significantly from##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
varied significantly##15##2##(1991-11#1)(1991-12#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
varied somewhat between##2##3##(2007-12#1)(2013-1#1)
varied somewhat##3##2##(2007-12#1)(2008-9#1)(2013-1#1)
varied spatially and seasonally##2##4##(2007-5#2)
varied substantially##3##2##(1992-5#1)(1995-3#1)(2009-5#1)
varied the##3##2##(1993-8#1)(2007-12#1)(2008-11#1)
varied through##2##2##(1997-7#1)(2007-11#1)
varied to##8##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
varied widely between##2##3##(2008-10#1)(2008-11#1)
varied widely from##2##3##(1990-12#1)(2008-10#1)
varied widely in their##2##4##(1991-2#1)(2008-11#1)
varied widely##12##2##(1990-12#1)(1990-3#1)(1991-2#1)(1994-9#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-12#1)(2013-1#1)
varied with pH##2##3##(2008-10#2)
varied with the##12##3##(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-5#1)(2013-1#1)
varied with##23##2##(1991-6#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
varied within the##2##3##(2008-10#1)(2009-2#1)
varied within##6##2##(2008-10#3)(2008-2#1)(2009-2#2)
varied##479##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#5)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-12#7)(1993-3#4)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#6)(1995-5#4)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#4)(2006-11#1)(2006-6#1)(2007-10#3)(2007-11#6)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#136)(2008-11#19)(2008-12#11)(2008-2#18)(2008-3#18)(2008-5#16)(2008-6#6)(2008-7#6)(2008-8#14)(2008-9#10)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#1)(2009-5#6)(2009-7#6)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#13)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#12)(2013-7#4)(2013-8#12)
variegated##7##1##(2008-10#6)(2011-2#1)
variegatus##7##1##(2008-10#6)(2008-8#1)
varies according to the##4##4##(1994-5#1)(2007-2#1)(2008-10#1)(2013-1#1)
varies according to##7##3##(1994-5#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
varies across the##2##3##(2007-11#1)(2009-10#1)
varies across##4##2##(1995-1#1)(2007-11#1)(2008-7#1)(2009-10#1)
varies along the##2##3##(1992-9#1)(2008-2#1)
varies among##2##2##(1991-10#1)(2012-3#1)
varies and##2##2##(1992-9#1)(2008-5#1)
varies between 0##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
varies between##15##2##(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-2#2)(2013-1#2)
varies by##5##2##(1997-1#1)(2007-11#1)(2009-9#1)(2012-3#1)(2013-8#1)
varies considerably##5##2##(1990-2#1)(1994-12#1)(1994-6#1)(1996-11#1)(2012-12#1)
varies depending on the##7##4##(1993-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-1#1)(2013-1#1)
varies depending on##8##3##(1993-8#1)(1995-1#1)(2006-6#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-1#1)(2013-1#1)
varies from 0##3##3##(1990-9#1)(2008-10#2)
varies from 2##3##3##(1992-11#1)(2007-11#1)(2007-7#1)
varies from 6 to##2##4##(2007-11#1)(2008-10#1)
varies from one##3##3##(1995-1#1)(2007-12#1)(2010-8#1)
varies from##24##2##(1990-9#1)(1992-11#1)(1993-2#1)(1995-1#1)(1995-2#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-8#1)
varies greatly##2##2##(1995-2#1)(2013-1#1)
varies in a density-dependent manner##2##5##(2008-10#1)(2008-9#1)
varies in different##2##3##(1994-12#1)(2008-5#1)
varies in size##2##3##(1990-12#1)(1993-9#1)
varies in##13##2##(1990-12#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
varies inversely with the##2##4##(2008-10#1)(2009-7#1)
varies linearly with the concentration of##2##6##(2008-10#2)
varies linearly with the##4##4##(2008-10#3)(2008-6#1)
varies over##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
varies periodically##2##2##(2008-3#2)
varies significantly##4##2##(1996-2#1)(2008-3#1)(2009-6#1)(2012-3#1)
varies widely in##2##3##(2007-11#1)(2012-3#1)
varies widely##3##2##(2007-11#1)(2008-3#1)(2012-3#1)
varies with the type of##2##5##(1996-3#1)(2008-6#1)
varies with the##13##3##(1990-5#1)(1990-6#2)(1990-8#1)(1995-12#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-9#1)
varies with##33##2##(1990-5#2)(1990-6#2)(1990-8#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
varies within##3##2##(2008-3#1)(2008-5#1)(2009-2#1)
varies##177##1##(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-12#1)(2008-2#9)(2008-3#19)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#1)
varietal##5##1##(2008-10#5)
varieties and##7##2##(2008-10#3)(2008-12#2)(2008-5#1)(2011-2#1)
varieties are##2##2##(2008-12#2)
varieties have been##2##3##(2008-10#1)(2008-9#1)
varieties in farms##3##3##(2008-12#3)
varieties in##6##2##(2008-10#1)(2008-12#4)(2011-1#1)
varieties of D##3##3##(2008-10#3)
varieties of apples##2##3##(2008-10#1)(2008-3#1)
varieties of##26##2##(1991-8#1)(1993-2#1)(1997-3#2)(2008-10#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#4)(2013-8#1)
varieties or##3##2##(2008-10#2)(2008-8#1)
varieties that##3##2##(1995-6#1)(2008-10#2)
varieties were##2##2##(2008-10#2)
varieties which##2##2##(1996-8#1)(2008-12#1)
varieties with##3##2##(2008-12#2)(2008-8#1)
varieties##106##1##(1991-8#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-8#3)(1997-3#2)(2008-10#44)(2008-12#22)(2008-3#1)(2008-5#2)(2008-8#6)(2008-9#3)(2009-10#2)(2009-6#1)(2010-3#1)(2011-1#4)(2011-2#10)(2013-8#1)
variety and##4##2##(1990-6#1)(1996-1#1)(2008-10#1)(2010-8#1)
variety in##5##2##(1993-2#1)(2008-10#1)(2010-6#1)(2011-2#2)
variety of DNA##3##3##(1994-5#1)(2008-3#1)(2008-4#1)
variety of activities##3##3##(1997-3#1)(2007-11#1)(2010-8#1)
variety of adaptive responses##2##4##(1996-12#2)
variety of agents##6##3##(1995-6#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
variety of alternative##3##3##(1996-1#1)(1996-6#1)(2009-12#1)
variety of anatomical##2##3##(2008-5#1)(2013-1#1)
variety of anions##2##3##(2008-10#2)
variety of applications##13##3##(1995-1#1)(1996-1#1)(1997-4#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#1)
variety of approaches to##3##4##(2008-10#1)(2008-9#1)(2010-11#1)
variety of approaches##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)
variety of atmospheric##2##3##(2008-2#1)(2008-3#1)
variety of behavioral##4##3##(1993-12#1)(1994-3#1)(2008-4#1)(2008-8#1)
variety of biological##10##3##(1990-11#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)
variety of cell lines##3##4##(1991-6#1)(2008-11#1)(2008-7#1)
variety of cell types##7##4##(1992-3#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)
variety of cell##14##3##(1991-6#1)(1992-3#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#2)(2012-12#1)
variety of cells##10##3##(1992-7#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-2#1)
variety of cellular##7##3##(1994-12#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)
variety of clinical manifestations##2##4##(2008-1#2)
variety of clinical##11##3##(1992-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2010-5#1)(2011-1#1)
variety of complex##3##3##(1992-11#1)(1997-2#1)(2009-11#1)
variety of compounds##4##3##(1992-11#1)(2008-10#2)(2009-4#1)
variety of conditions##7##3##(1990-2#1)(1990-7#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-8#1)
variety of defects##2##3##(2007-12#1)(2009-8#1)
variety of different##11##3##(1996-11#1)(1997-4#2)(2008-10#2)(2008-5#1)(2008-8#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
variety of disciplines##2##3##(2011-2#1)(2013-8#1)
variety of disease##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
variety of diseases in humans and animals##2##7##(2011-1#1)(2012-3#1)
variety of diseases##9##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#2)
variety of disorders##2##3##(2007-10#1)(2008-11#1)
variety of diverse##2##3##(1996-5#1)(2007-11#1)
variety of drugs##4##3##(1990-11#1)(1992-3#1)(2006-10#1)(2008-11#1)
variety of environmental##4##3##(2008-10#3)(2009-8#1)
variety of environments##2##3##(2008-3#1)(2008-9#1)
variety of eukaryotic##2##3##(1996-3#1)(2008-4#1)
variety of factors##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
variety of features##2##3##(2008-6#1)(2011-2#1)
variety of food products##2##4##(2008-10#1)(2011-2#1)
variety of food##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
variety of functions##5##3##(1997-6#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)
variety of genes##5##3##(1993-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)
variety of genetic##2##3##(2009-3#1)(2011-2#1)
variety of growth##2##3##(1994-8#1)(2011-2#1)
variety of health##2##3##(1995-3#1)(1996-12#1)
variety of human malignancies##2##4##(1994-10#1)(2011-2#1)
variety of human##11##3##(1990-11#1)(1994-10#2)(1994-6#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
variety of interests##2##3##(1992-1#1)(2010-2#1)
variety of kidney diseases##2##4##(2008-1#2)
variety of kidney##3##3##(2008-1#2)(2008-7#1)
variety of materials##5##3##(1995-3#1)(1996-4#1)(2007-11#1)(2010-4#1)(2012-2#1)
variety of methods for##2##4##(2008-4#2)
variety of methods##9##3##(1993-3#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)(2012-2#1)
variety of molecular##3##3##(2008-10#1)(2010-10#2)
variety of new##4##3##(1995-3#1)(2007-9#1)(2010-10#1)(2012-3#1)
variety of normal##3##3##(1994-5#1)(2008-4#1)(2008-6#1)
variety of optical devices##2##4##(2008-3#1)(2008-9#1)
variety of optical##7##3##(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#1)
variety of options for##2##4##(2007-12#1)(2011-2#1)
variety of organisms##7##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2012-3#1)
variety of other anions and##2##5##(2008-10#2)
variety of other anions##4##4##(1990-5#1)(2008-10#3)
variety of other cancers##2##4##(2011-2#1)(2011-3#1)
variety of other##29##3##(1990-5#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-8#1)(2007-4#1)(2008-10#13)(2008-4#1)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
variety of pathologies##3##3##(2006-12#1)(2010-4#1)(2012-2#1)
variety of patient- and##2##4##(2010-8#1)(2011-2#1)
variety of physiological functions##2##4##(2008-5#1)(2008-7#1)
variety of physiological##5##3##(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
variety of possible##2##3##(2008-7#1)(2008-8#1)
variety of potential##7##3##(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
variety of proteins##3##3##(1994-9#1)(1995-12#1)(2008-4#1)
variety of psychiatric##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
variety of purposes##3##3##(1991-7#1)(2010-12#1)(2012-3#1)
variety of recombinant##2##3##(1993-2#1)(2013-8#1)
variety of research##4##3##(2008-10#1)(2008-4#1)(2009-10#1)(2010-10#1)
variety of sample types##2##4##(2008-10#1)(2008-3#1)
variety of sample##3##3##(2008-10#2)(2008-3#1)
variety of samples##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
variety of sensing##2##3##(2008-10#1)(2008-3#1)
variety of signs##2##3##(1993-2#1)(2008-9#1)
variety of skin##2##3##(2008-5#2)
variety of specimens##2##3##(2008-9#1)(2010-1#1)
variety of stakeholders##2##3##(1997-2#1)(2008-11#1)
variety of substrates##4##3##(1994-8#1)(1996-5#1)(2008-2#1)(2010-4#1)
variety of systems##2##3##(1994-8#1)(2008-3#1)
variety of techniques##8##3##(1991-3#1)(1994-1#1)(1995-5#1)(2007-11#1)(2009-5#1)(2010-3#1)(2012-2#2)
variety of the##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
variety of tissues##4##3##(1993-3#1)(1994-11#2)(1997-8#1)
variety of treatment modalities##2##4##(2007-11#1)(2008-7#1)
variety of treatment##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
variety of##903##2##(1990-11#4)(1990-2#2)(1990-5#2)(1990-7#1)(1991-12#3)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#6)(1992-7#1)(1992-9#3)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#3)(1994-10#2)(1994-11#7)(1994-12#9)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#3)(1995-12#6)(1995-2#4)(1995-3#9)(1995-5#4)(1995-6#3)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#8)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#6)(1997-3#6)(1997-4#8)(1997-6#2)(1997-7#7)(1997-8#4)(2006-10#2)(2006-12#2)(2007-10#2)(2007-11#9)(2007-12#14)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#99)(2008-11#47)(2008-12#16)(2008-2#25)(2008-3#30)(2008-4#47)(2008-5#27)(2008-6#17)(2008-7#43)(2008-8#26)(2008-9#34)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#1)(2009-5#6)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#8)(2010-5#1)(2010-6#4)(2010-8#11)(2010-9#3)(2011-1#11)(2011-2#36)(2011-3#2)(2011-8#1)(2012-1#3)(2012-12#12)(2012-2#25)(2012-3#16)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#17)
variety on##2##2##(2008-10#1)(2011-2#1)
variety was##2##2##(2008-12#1)(2008-5#1)
variety were##3##2##(2008-12#2)(2011-2#1)
variety##963##1##(1990-11#4)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#6)(1992-7#1)(1992-9#3)(1993-11#3)(1993-12#4)(1993-2#8)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#3)(1994-10#2)(1994-11#7)(1994-12#9)(1994-2#6)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#9)(1995-5#4)(1995-6#3)(1995-8#1)(1996-1#6)(1996-11#1)(1996-12#8)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#6)(1997-3#6)(1997-4#8)(1997-6#2)(1997-7#7)(1997-8#4)(2006-10#2)(2006-12#2)(2007-10#2)(2007-11#9)(2007-12#14)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#12)(2008-10#106)(2008-11#48)(2008-12#32)(2008-2#25)(2008-3#30)(2008-4#47)(2008-5#33)(2008-6#17)(2008-7#44)(2008-8#26)(2008-9#38)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#1)(2009-5#6)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#8)(2010-5#1)(2010-6#5)(2010-8#12)(2010-9#3)(2011-1#11)(2011-2#44)(2011-3#2)(2011-8#1)(2012-1#3)(2012-12#12)(2012-2#25)(2012-3#17)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#18)
varifocal lens##2##2##(2008-2#2)
varimax rotation##3##2##(1992-1#1)(1996-5#1)(2013-1#1)
various &quot##2##2##(1995-3#1)(2010-12#1)
various activities##3##2##(2009-10#2)(2011-2#1)
various advantages##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
various agents##5##2##(1991-12#1)(2007-2#1)(2008-5#1)(2009-8#2)
various ages##3##2##(1996-1#1)(2008-10#1)(2008-5#1)
various agricultural##2##2##(2008-10#1)(2013-1#1)
various ailments##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
various air##2##2##(1995-3#1)(2008-10#1)
various alcohols##2##2##(1994-9#1)(2007-12#1)
various algorithms##2##2##(2008-3#2)
various alloys and biological samples##2##5##(2008-10#2)
various amino acids##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
various amounts of##10##3##(1990-8#1)(1991-5#1)(1992-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)
various analytes##3##2##(2008-10#3)
various analytical##4##2##(2008-10#3)(2010-11#1)
various animal models##2##3##(2008-4#1)(2008-7#1)
various animal##7##2##(1990-6#1)(1995-6#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-7#1)
various anti-inflammatory##2##2##(1994-11#1)(2009-11#1)
various antibiotics in##2##3##(2008-12#1)(2011-2#1)
various antibiotics##5##2##(1990-5#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
various antigens##2##2##(1995-5#1)(2008-11#1)
various applications##5##2##(1993-3#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-12#1)
various approaches to the##2##4##(1990-9#1)(2008-3#1)
various approaches to##4##3##(1990-9#1)(1993-2#1)(1995-2#1)(2008-3#1)
various approaches##9##2##(1990-9#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-3#1)
various approximations for computing the absorption efficiency and single-scattering albedo of##2##11##(2008-3#2)
various arrangements##2##2##(1996-2#1)(2012-12#1)
various aspects in##2##3##(2007-12#1)(2010-6#1)
various aspects of gene##2##4##(1995-2#1)(2012-3#1)
various aspects of the##8##4##(1990-9#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-2#2)
various aspects of##29##3##(1990-9#1)(1992-6#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-3#2)
various aspects##36##2##(1990-9#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#2)
various attempts##2##2##(1991-3#1)(2011-1#1)
various authors##4##2##(1996-3#1)(2009-10#1)(2010-7#1)(2013-1#1)
various bacterial##2##2##(1993-9#1)(2013-1#1)
various base##3##2##(1995-6#1)(2008-10#2)
various behavioral##2##2##(1991-2#1)(2008-8#1)
various biological and##2##3##(2012-12#1)(2013-8#1)
various biological fluids##3##3##(1995-11#1)(1996-12#1)(1996-2#1)
various biological##13##2##(1990-12#1)(1991-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
various biomedical applications##3##3##(2008-5#2)(2011-1#1)
various biomedical##4##2##(2008-5#2)(2010-4#1)(2011-1#1)
various biomolecules##5##2##(2008-10#1)(2008-9#1)(2010-5#2)(2011-2#1)
various blood##2##2##(1992-3#1)(2008-3#1)
various body##3##2##(1992-3#1)(2009-10#1)(2013-1#1)
various brain##2##2##(1991-12#1)(1996-2#1)
various branches of##2##3##(2008-7#1)(2012-2#1)
various brands of##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
various cancer cell lines##2##4##(2008-11#2)
various cancer##3##2##(1993-8#1)(2008-11#2)
various cancers##3##2##(2010-8#1)(2013-1#1)(2013-7#1)
various carbohydrates##4##2##(2008-10#3)(2008-6#1)
various carbon##3##2##(2008-10#2)(2008-8#1)
various cardiovascular##2##2##(1997-7#1)(2013-1#1)
various cases of##2##3##(2008-2#1)(2008-3#1)
various cationic##7##2##(2008-10#6)(2008-11#1)
various causes of##2##3##(2008-11#1)(2012-2#1)
various causes##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
various cell lines##3##3##(1993-3#1)(2008-11#1)(2008-6#1)
various cell types##7##3##(1994-11#1)(1994-3#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-3#1)
various cell##17##2##(1992-10#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
various cells##3##2##(2007-2#1)(2008-11#1)(2008-9#1)
various cellular and##2##3##(1990-3#1)(2008-11#1)
various cellular##4##2##(1990-3#1)(1995-11#1)(2008-11#1)(2009-8#1)
various cerebral##3##2##(1997-2#2)(1997-3#1)
various challenges##2##2##(2009-9#1)(2011-1#1)
various characteristics of##2##3##(1992-1#1)(1992-5#1)
various chemical elements##2##3##(2008-10#1)(2008-5#1)
various chemical modifiers##4##3##(2008-10#4)
various chemical##13##2##(1990-2#1)(1992-2#1)(1992-4#1)(2008-10#8)(2008-5#1)(2011-2#1)
various chemistries##2##2##(2008-5#1)(2008-7#1)
various chromatographic##2##2##(2008-10#1)(2011-2#1)
various chronic##4##2##(1991-3#1)(2008-3#1)(2008-8#1)(2009-12#1)
various circumstances##2##2##(2008-9#1)(2012-2#1)
various cleavage##2##2##(1993-6#1)(1997-3#1)
various clinical and##2##3##(2008-7#1)(2013-1#1)
various clinical##10##2##(1991-3#1)(1993-2#1)(2007-7#3)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
various combinations of##13##3##(1992-3#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)
various combinations##16##2##(1992-3#1)(1993-11#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)
various complex##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)
various components in##2##3##(2007-12#1)(2009-10#1)
various components of the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
various components of##9##3##(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)
various components##16##2##(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)
various compounds##6##2##(1992-5#1)(1993-12#1)(2008-10#3)(2008-11#1)
various concentration of##2##3##(2008-11#1)(2008-12#1)
various concentration##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
various concentrations (0##3##3##(1995-12#1)(2008-10#1)(2012-2#1)
various concentrations of NaCl##2##4##(1994-12#1)(2012-7#1)
various concentrations of standard##2##4##(2008-10#2)
various concentrations of the##2##4##(1996-12#1)(1996-5#1)
various concentrations of##26##3##(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2012-2#1)(2012-7#1)(2013-8#1)
various concentrations##32##2##(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-8#1)(1996-12#2)(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#1)(2012-2#2)(2012-7#1)(2013-8#1)
various conditions##13##2##(1990-8#1)(1993-9#1)(1994-12#1)(1996-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2011-3#1)
various configurations##3##2##(2008-2#2)(2008-3#1)
various conventional##2##2##(2008-10#1)(2010-5#1)
various cosmetic##3##2##(2008-5#2)(2008-7#1)
various countries##7##2##(1993-3#1)(1994-5#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
various criteria##2##2##(2008-2#1)(2008-6#1)
various crops##4##2##(2008-10#4)
various cultural##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
various culture##2##2##(2008-11#1)(2008-7#1)
various data##3##2##(1995-2#1)(1995-3#1)(2008-7#1)
various days##2##2##(1995-12#1)(2010-10#1)
various definitions of##2##3##(2008-5#1)(2009-7#1)
various degrees of occlusion##2##4##(2010-4#2)
various degrees of##8##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#2)(2012-3#1)
various degrees##13##2##(1991-12#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#2)(2012-2#1)(2012-3#1)
various developmental stages##2##3##(2008-10#1)(2008-11#1)
various dietary##2##2##(2008-5#2)
various different##4##2##(1997-4#1)(2007-8#1)(2008-7#1)(2012-1#1)
various diffraction orders##2##3##(2008-2#1)(2008-3#1)
various diluents having low dielectric constants##2##6##(2008-10#2)
various diluents of low dielectric##2##5##(2008-10#2)
various diluents##6##2##(2008-10#6)
various dimensions of##3##3##(1992-3#1)(1993-1#1)(2008-11#1)
various disciplines##4##2##(1992-2#1)(1994-2#1)(1997-3#1)(2007-11#1)
various diseases in##2##3##(1997-2#1)(2013-8#1)
various diseases##15##2##(1995-12#1)(1996-12#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
various dose##2##2##(1994-3#1)(1994-5#1)
various doses of##4##3##(2008-11#2)(2008-5#1)(2008-7#1)
various doses##5##2##(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)
various drugs##8##2##(1991-12#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-12#1)(2013-8#1)
various effects##2##2##(2007-11#1)(2013-1#1)
various electron##3##2##(1995-3#1)(2009-11#1)(2012-3#1)
various elements of the##2##4##(1993-3#1)(2008-3#1)
various elements##7##2##(1993-3#1)(1994-3#2)(2008-10#2)(2008-3#1)(2011-2#1)
various environmental samples##3##3##(2008-10#3)
various environmental stresses##2##3##(2008-9#1)(2012-1#1)
various environmental##13##2##(1996-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)
various enzymatic##2##2##(2008-10#1)(2010-10#1)
various enzymes involved in##2##4##(1993-5#1)(2011-2#1)
various enzymes##3##2##(1992-6#1)(1993-5#1)(2011-2#1)
various epithelial##2##2##(1993-3#1)(2008-4#1)
various ethnic groups##2##3##(2008-5#1)(2012-2#1)
various experimental parameters##3##3##(2008-10#2)(2010-4#1)
various experimental##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2010-4#1)
various experts##2##2##(1993-12#1)(2008-6#1)
various explanations##2##2##(2008-8#1)(2010-1#1)
various exposure##3##2##(2008-10#2)(2008-7#1)
various expression##3##2##(1997-8#1)(2008-7#1)(2008-9#1)
various facets of##2##3##(1993-5#1)(2007-12#1)
various factors affecting the##2##4##(2008-10#1)(2008-5#1)
various factors affecting##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
various factors##25##2##(1990-3#1)(1990-9#1)(1992-2#1)(1992-8#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
various filamentous fungi##2##3##(1994-5#1)(1997-2#1)
various findings##2##2##(1994-2#1)(2013-1#1)
various fish species##2##3##(2008-10#1)(2009-5#1)
various flow##2##2##(1991-3#1)(2010-8#1)
various food##3##2##(2008-10#2)(2011-2#1)
various foods##2##2##(2008-6#1)(2013-7#1)
various foreign ions have been investigated##2##6##(2008-10#2)
various foreign ions have been##3##5##(2008-10#3)
various foreign ions##4##3##(2008-10#4)
various foreign##8##2##(1997-4#1)(2008-10#7)
various forms of##16##3##(1990-2#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
various forms##20##2##(1990-2#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
various fractions of##2##3##(2008-10#1)(2008-7#1)
various fractions##3##2##(2008-10#2)(2008-7#1)
various freshwaters##2##2##(2008-5#2)
various functional##2##2##(1990-9#1)(2008-11#1)
various functions##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)
various fungi##2##2##(2008-10#2)
various gastrointestinal##2##2##(1991-3#1)(2013-1#1)
various gene##3##2##(2008-11#2)(2011-1#1)
various genes##2##2##(2008-4#1)(2011-2#1)
various geographical##2##2##(2008-10#1)(2013-8#1)
various groups of##5##3##(1991-2#1)(1994-11#1)(2007-7#1)(2008-8#1)(2012-2#1)
various groups##7##2##(1991-2#1)(1994-11#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
various growth##5##2##(1994-9#1)(1996-6#1)(1997-1#1)(2008-4#1)(2008-5#1)
various habitats##2##2##(2009-6#1)(2011-1#1)
various hair##3##2##(2008-5#3)
various health conditions and diseases##2##5##(2013-7#2)
various health problems##2##3##(1992-3#1)(2008-8#1)
various health##7##2##(1992-3#1)(1993-2#1)(1996-1#1)(2008-8#1)(2010-10#1)(2013-7#2)
various histological types of##3##4##(1996-9#2)(2011-2#1)
various histological types##4##3##(1996-9#2)(2008-6#1)(2011-2#1)
various histological##5##2##(1996-9#2)(2008-6#1)(2011-2#1)(2012-1#1)
various histopathological##2##2##(1996-6#1)(2011-1#1)
various host##4##2##(2008-10#3)(2011-2#1)
various hosts and##3##3##(2008-10#3)
various hosts in##2##3##(2008-10#1)(2012-3#1)
various hosts##7##2##(2008-10#5)(2011-1#1)(2012-3#1)
various human tissues##6##3##(1990-12#1)(1991-5#1)(1993-6#1)(1995-6#1)(2008-8#2)
various human##16##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2013-1#1)
various immune##2##2##(2008-10#1)(2008-11#1)
various immunological##3##2##(1990-12#1)(1991-5#1)(2007-5#1)
various indications##5##2##(1990-8#1)(2008-1#1)(2008-11#2)(2008-8#1)
various indicators of##2##3##(2008-11#1)(2013-7#1)
various infections##2##2##(2008-5#1)(2008-7#1)
various inflammatory##7##2##(1990-2#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
various inorganic##4##2##(2008-10#4)
various internal and external##2##4##(1992-12#1)(1996-1#1)
various internal and##3##3##(1992-12#1)(1996-1#1)(2008-5#1)
various internal##4##2##(1992-12#1)(1996-1#1)(2008-5#2)
various intervals##2##2##(2008-5#1)(2013-1#1)
various interventions##3##2##(1994-5#1)(2008-10#1)(2010-10#1)
various intracellular##2##2##(2008-4#1)(2008-5#1)
various ionic strengths##3##3##(1997-7#1)(2008-10#2)
various ions##5##2##(2008-10#5)
various isolates of##2##3##(2008-10#1)(2008-12#1)
various isolates##5##2##(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)
various kinds of##11##3##(1993-9#2)(1995-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-1#1)(2012-2#1)(2013-1#1)
various kinds##12##2##(1993-9#2)(1995-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-6#1)(2010-1#1)(2012-2#1)(2013-1#1)
various known##2##2##(2008-5#1)(2010-12#1)
various laboratories##2##2##(2008-10#2)
various lengths of the##2##4##(1992-12#1)(1996-5#1)
various lengths of##3##3##(1992-12#1)(1996-5#1)(2008-6#1)
various lengths##4##2##(1992-12#1)(1996-5#1)(2008-6#1)(2008-9#1)
various levels of suppressiveness##2##4##(2008-10#2)
various levels of##10##3##(1991-11#1)(1996-3#1)(2008-10#5)(2008-2#1)(2008-5#1)(2012-12#1)
various levels##15##2##(1991-11#1)(1996-3#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)
various ligands##2##2##(2008-10#1)(2008-4#1)
various lineages##2##2##(2010-3#1)(2012-12#1)
various linear##4##2##(1995-3#1)(2008-3#3)
various locations in the##2##4##(2007-12#1)(2008-10#1)
various locations on##2##3##(2008-10#1)(2010-4#1)
various locations##9##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2010-4#1)
various macromolecules##2##2##(2007-12#1)(2009-11#1)
various mammalian##3##2##(1994-11#1)(1995-2#1)(2008-9#1)
various mammals##2##2##(1993-3#1)(2008-7#1)
various management##2##2##(1994-3#1)(2008-8#1)
various materials##3##2##(2008-10#2)(2008-3#1)
various matrices##3##2##(2008-10#2)(2008-2#1)
various matrixes##2##2##(2008-10#1)(2008-5#1)
various matters##3##2##(1995-12#3)
various measures##4##2##(1992-11#1)(2008-12#1)(2008-4#1)(2010-6#1)
various mechanisms##2##2##(2007-11#1)(2008-11#1)
various media##6##2##(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2011-2#1)
various medical and##2##3##(2008-7#1)(2013-8#1)
various medical##4##2##(2008-7#1)(2012-3#1)(2013-8#2)
various membranes##2##2##(2008-10#1)(2008-7#1)
various metabolic##3##2##(2008-1#1)(2011-1#1)(2012-2#1)
various metabolites##2##2##(2008-10#1)(2008-11#1)
various metal ions on the##2##5##(2008-10#2)
various metal ions##3##3##(2008-10#3)
various metal##5##2##(2008-10#5)
various methodologies##5##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-10#1)
various methods for##2##3##(2008-12#1)(2008-4#1)
various methods of##9##3##(1992-9#1)(1995-11#1)(1995-9#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-8#1)(2009-7#1)(2012-1#1)
various methods##21##2##(1992-9#1)(1995-11#1)(1995-9#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2011-2#1)(2012-1#1)
various model##3##2##(1990-2#1)(1997-3#1)(2008-11#1)
various models##4##2##(1996-9#1)(2008-10#1)(2008-11#2)
various modes of##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
various molecular##8##2##(2008-10#5)(2009-1#1)(2010-11#1)(2013-1#1)
various molecules##2##2##(1990-8#1)(2008-7#1)
various mouse tissues##4##3##(1993-8#1)(1994-12#1)(2008-11#2)
various mouse##5##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-11#2)
various multilayer##2##2##(2007-11#1)(2008-2#1)
various mutants##3##2##(1993-2#1)(1994-11#1)(1994-8#1)
various natriuretic##2##2##(1990-12#2)
various natural and##2##3##(1995-2#1)(2008-10#1)
various natural##3##2##(1995-2#1)(1997-4#1)(2008-10#1)
various neurological##3##2##(1993-8#2)(2008-5#1)
various nf harmonics of the background signals##2##7##(2008-3#2)
various nf harmonics of##3##4##(2008-3#3)
various operating conditions##2##3##(2008-3#1)(2012-3#1)
various optical elements##2##3##(2008-3#2)
various optical##7##2##(1992-9#1)(2008-2#1)(2008-3#5)
various options##4##2##(1990-8#1)(1993-9#1)(2008-10#1)(2008-8#1)
various organic acids##2##3##(2008-10#2)
various organic compounds##3##3##(2008-10#2)(2009-8#1)
various organic solvents##4##3##(2008-10#3)(2008-7#1)
various organic##15##2##(2008-10#11)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)
various organisms##3##2##(1995-2#1)(2008-9#1)(2009-8#1)
various organizations##2##2##(1991-12#1)(2012-3#1)
various organs of##4##3##(1991-5#1)(1991-8#1)(1992-9#1)(1996-12#1)
various organs##19##2##(1990-12#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#3)(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-9#2)(2012-12#2)(2012-3#2)
various other##14##2##(1990-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1996-4#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
various pH##5##2##(1991-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
various pHs##3##2##(1992-12#1)(2008-10#2)
various parameter##2##2##(2008-3#1)(2010-9#1)
various parameters that##2##3##(2008-10#1)(2008-5#1)
various parameters##19##2##(1990-6#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
various parts of the world##3##5##(2008-10#1)(2008-6#1)(2011-2#1)
various parts of the##9##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-1#1)
various parts of##14##3##(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-9#1)(2011-2#3)(2012-1#1)
various pathogenic##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
various pathogens and##2##3##(2008-10#1)(2012-2#1)
various pathogens##4##2##(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
various pathological conditions##3##3##(1992-2#1)(2011-2#1)(2012-2#1)
various pathological##6##2##(1992-2#1)(2006-8#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
various pathology##2##2##(1991-3#1)(1993-5#1)
various pathways##2##2##(2009-1#1)(2011-2#1)
various patient groups##2##3##(2008-10#1)(2008-6#1)
various patient##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
various patterns##2##2##(1996-9#1)(2011-2#1)
various peptide##3##2##(1992-6#1)(1994-8#1)(1995-6#1)
various periods of time##4##4##(1990-12#1)(1992-1#1)(1996-2#1)(1997-7#1)
various periods##5##2##(1990-12#1)(1992-1#1)(1996-2#1)(1997-7#1)(2008-10#1)
various pharmacological##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
various pharmacopoeias are responding with monographs or informational chapters addressing excipient functionality##2##12##(2012-2#2)
various phases of##2##3##(1992-9#1)(1996-7#1)
various physical##8##2##(1993-3#1)(1997-2#1)(2007-11#1)(2008-3#1)(2009-11#1)(2013-1#3)
various physiological##2##2##(2008-4#1)(2008-7#1)
various plant##8##2##(1993-11#1)(1995-6#1)(2008-10#5)(2008-12#1)
various plasticizers##3##2##(2008-10#3)
various points##2##2##(1990-11#1)(2008-10#1)
various polymers##2##2##(2008-5#1)(2009-11#1)
various populations##3##2##(1997-8#1)(2008-1#1)(2010-3#1)
various portions of the##3##4##(1992-6#1)(2008-5#1)(2009-8#1)
various portions of##5##3##(1992-6#1)(1993-8#1)(2008-5#2)(2009-8#1)
various positions##2##2##(1995-5#1)(2007-11#1)
various possible##2##2##(1990-3#1)(2013-1#1)
various potential##2##2##(2008-12#1)(2008-5#1)
various practical##3##2##(1991-12#1)(1995-6#1)(2012-2#1)
various primates revealed##2##3##(1993-8#1)(2008-7#1)
various problems##3##2##(2008-3#1)(2008-6#1)(2009-12#1)
various procedures##6##2##(2007-12#2)(2007-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
various processes##3##2##(1994-11#1)(2009-8#1)(2011-2#1)
various professional##2##2##(1991-12#1)(2008-2#1)
various proportions of##2##3##(2008-10#2)
various proportions##5##2##(2007-12#1)(2008-10#4)
various protein##3##2##(1990-8#1)(2008-2#1)(2010-12#1)
various proteins in##2##3##(1991-12#1)(1997-2#1)
various proteins including##2##3##(2008-8#2)
various proteins##13##2##(1991-12#1)(1993-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-2#1)
various proteomic techniques##2##3##(2010-12#2)
various protocols##4##2##(1997-1#1)(2008-4#1)(2008-9#1)(2013-8#1)
various psychiatric disorders##2##3##(1996-6#1)(2012-2#1)
various psychiatric##3##2##(1996-6#1)(2009-10#1)(2012-2#1)
various public##2##2##(1995-6#1)(2011-2#1)
various pump##2##2##(2007-11#1)(2008-2#1)
various rat tissues##3##3##(1991-9#1)(1993-3#1)(1995-11#1)
various ratios of##2##3##(1993-8#1)(2008-2#1)
various ratios##3##2##(1993-8#1)(2008-2#1)(2008-5#1)
various reaction##2##2##(2008-3#1)(2011-1#1)
various reactions##4##2##(2008-5#1)(2009-7#1)(2010-11#1)(2011-2#1)
various reasons##11##2##(1993-3#1)(1994-5#1)(1995-5#1)(2007-10#1)(2008-5#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
various recombinant proteins##2##3##(2008-11#1)(2008-7#1)
various recombinant##3##2##(1994-8#1)(2008-11#1)(2008-7#1)
various reference materials##2##3##(2008-10#2)
various regimes of##3##3##(1997-2#1)(2008-10#2)
various regions in##2##3##(2007-6#1)(2011-1#1)
various regions of the##6##4##(1994-12#1)(1997-2#1)(2008-3#1)(2008-7#2)(2009-8#1)
various regions of##8##3##(1994-12#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-8#1)
various regions##11##2##(1994-12#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-1#1)
various regression diagnostics##2##3##(2008-10#2)
various religious##2##2##(2008-12#1)(2008-9#1)
various renal##2##2##(2007-7#1)(2013-8#1)
various research##4##2##(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
various responses##2##2##(2008-6#1)(2012-2#1)
various retinal##2##2##(2008-3#1)(2011-7#1)
various risk factors associated with##2##5##(1993-11#1)(2012-12#1)
various risk factors##5##3##(1991-6#1)(1993-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
various risk##7##2##(1991-6#1)(1993-11#1)(2007-7#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)
various samples##7##2##(2008-10#7)
various sampling schemes##2##3##(2008-10#2)
various scales##2##2##(2008-3#1)(2008-8#1)
various scattering##4##2##(2008-2#1)(2008-3#3)
various scenarios of##2##3##(2008-8#1)(2010-7#1)
various scenarios##3##2##(2008-2#1)(2008-8#1)(2010-7#1)
various separation##2##2##(2008-10#1)(2013-1#1)
various settings##3##2##(1991-12#1)(2010-5#1)(2010-9#1)
various shapes##4##2##(2008-10#2)(2008-3#1)(2010-6#1)
various side effects##2##3##(2008-11#1)(2008-8#1)
various side##3##2##(1990-11#1)(2008-11#1)(2008-8#1)
various signaling pathways##5##3##(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
various signaling##6##2##(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
various signals##2##2##(2008-10#1)(2008-2#1)
various sites##7##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
various situations of##2##3##(1990-3#1)(2008-1#1)
various size of##2##3##(2013-8#2)
various size##4##2##(1993-9#1)(2008-1#1)(2013-8#2)
various sizes and##3##3##(1997-3#1)(1997-6#1)(2013-1#1)
various sizes of##3##3##(1991-12#1)(2008-11#1)(2008-3#1)
various sizes##13##2##(1991-12#1)(1995-1#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
various social##2##2##(1996-4#1)(2008-9#1)
various soil##2##2##(2008-10#2)
various soilborne##2##2##(2008-10#2)
various solutions##2##2##(2010-10#1)(2013-1#1)
various solvents##6##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)
various sources of##2##3##(2008-10#1)(2008-3#1)
various sources##6##2##(1993-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
various spatial profiles##2##3##(2007-12#2)
various spatial##3##2##(2007-12#2)(2008-10#1)
various species formed##2##3##(2008-10#2)
various species##12##2##(1990-5#1)(1991-12#1)(1991-9#1)(1993-2#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)
various specific##2##2##(1996-5#1)(2008-3#1)
various spectral##3##2##(2008-10#1)(2008-3#2)
various speech and language disturbances##2##5##(2007-8#2)
various stages of cell##2##4##(2008-8#1)(2012-12#1)
various stages of development##3##4##(1991-7#1)(2007-12#1)(2008-5#1)
various stages of the##2##4##(2008-2#1)(2008-7#1)
various stages of##27##3##(1991-7#1)(1993-11#2)(1994-9#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
various stages##34##2##(1991-7#1)(1993-11#2)(1994-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-4#3)(1997-8#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
various stakeholders##4##2##(1993-12#1)(1995-1#1)(1996-3#1)(2010-8#1)
various standard alloys and environmental samples##4##6##(2008-10#4)
various standard alloys and##5##4##(2008-10#5)
various standard##6##2##(2008-10#6)
various statistical##2##2##(2008-10#1)(2008-7#1)
various stent##2##2##(2008-7#1)(2010-8#1)
various steps##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2010-10#1)
various stimuli in##2##3##(1995-12#1)(2010-12#1)
various stimuli##9##2##(1991-2#1)(1993-6#1)(1995-12#1)(1995-8#1)(2008-4#3)(2009-3#1)(2010-12#1)
various stimulus##2##2##(1995-5#1)(2009-5#1)
various strains of##6##3##(1994-2#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-8#1)(2013-7#1)
various strategies for##2##3##(1996-9#1)(2008-10#1)
various strategies##5##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
various stress##2##2##(2008-11#1)(2012-1#1)
various structural##2##2##(1992-6#1)(2008-2#1)
various structures of##2##3##(2008-10#1)(2008-8#1)
various structures##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
various studies##7##2##(1990-6#1)(1994-2#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
various subpopulations##2##2##(2007-7#1)(2008-9#1)
various subsites##2##2##(1991-6#1)(1992-12#1)
various substrates##4##2##(1994-8#1)(2008-10#1)(2008-6#1)(2012-3#1)
various surgical procedures##2##3##(1990-9#1)(2013-1#1)
various surgical##5##2##(1990-9#1)(1991-3#1)(2008-9#1)(2010-8#1)(2013-1#1)
various symptoms##3##2##(1990-6#1)(2008-10#1)(2008-2#1)
various systems##3##2##(2008-10#2)(2008-9#1)
various teaching##2##2##(2008-12#1)(2013-8#1)
various techniques have been##2##4##(1996-3#1)(2008-10#1)
various techniques##23##2##(1990-7#1)(1991-1#1)(1991-2#1)(1994-9#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-9#1)(2009-1#1)(2009-5#3)(2010-9#1)(2012-2#1)(2012-3#2)
various tests##3##2##(1991-5#1)(2008-11#1)(2011-2#1)
various therapeutic options##2##3##(1992-6#1)(2008-3#1)
various therapeutic##5##2##(1992-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
various thicknesses of##2##3##(2008-2#1)(2008-3#1)
various thicknesses##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
various time##11##2##(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2010-2#1)(2013-7#1)
various times after##4##3##(2008-10#2)(2011-2#1)(2012-1#1)
various times##15##2##(1992-1#1)(1992-9#1)(1994-8#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
various tissue##2##2##(2008-4#2)
various tissues and##3##3##(1993-3#1)(2012-1#1)(2013-1#1)
various tissues of the##2##4##(1992-8#1)(1994-5#1)
various tissues of##3##3##(1992-8#1)(1994-5#1)(2008-11#1)
various tissues##23##2##(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
various total##2##2##(2008-10#1)(2009-7#1)
various treatment strategies##2##3##(2008-7#1)(2009-8#1)
various treatment##5##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
various treatments##4##2##(1994-8#1)(2008-5#2)(2012-2#1)
various tumors##2##2##(1990-6#1)(2011-1#1)
various types of cancers##2##4##(2009-10#1)(2011-2#1)
various types of cells##3##4##(1993-3#1)(2008-4#2)
various types of innovative##2##4##(2010-3#2)
various types of sexual##2##4##(2012-2#1)(2012-3#1)
various types of tumors##2##4##(2008-11#2)
various types of vitreous silica at 1064##2##7##(2008-3#2)
various types of##78##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-9#2)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
various types##86##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-9#2)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
various values of##2##3##(2008-2#1)(2008-3#1)
various values##3##2##(2008-2#1)(2008-3#2)
various vertebrate species##2##3##(1993-8#1)(2008-5#1)
various vertebrate##4##2##(1991-6#1)(1993-12#1)(1993-8#1)(2008-5#1)
various visual##2##2##(2008-10#1)(2008-6#1)
various water samples##5##3##(2008-10#5)
various water##6##2##(2008-10#6)
various ways##11##2##(1990-8#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-7#1)
various wheat##2##2##(1991-12#1)(2008-10#1)
various yeast##2##2##(1993-12#1)(1997-4#1)
various##2565##1##(1990-11#7)(1990-12#10)(1990-2#11)(1990-3#7)(1990-5#9)(1990-6#5)(1990-7#6)(1990-8#16)(1990-9#6)(1991-1#2)(1991-11#2)(1991-12#22)(1991-2#11)(1991-3#9)(1991-4#1)(1991-5#9)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#5)(1992-10#1)(1992-11#8)(1992-12#8)(1992-2#8)(1992-3#10)(1992-4#1)(1992-5#4)(1992-6#10)(1992-8#8)(1992-9#12)(1993-1#3)(1993-11#8)(1993-12#18)(1993-2#8)(1993-3#21)(1993-5#5)(1993-6#5)(1993-8#15)(1993-9#9)(1994-1#3)(1994-11#11)(1994-12#12)(1994-2#9)(1994-3#11)(1994-5#9)(1994-6#3)(1994-7#1)(1994-8#15)(1994-9#9)(1995-1#3)(1995-11#5)(1995-12#13)(1995-2#16)(1995-3#11)(1995-4#1)(1995-5#9)(1995-6#12)(1995-8#4)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#18)(1996-2#12)(1996-3#11)(1996-4#3)(1996-5#12)(1996-6#5)(1996-7#2)(1996-9#6)(1997-1#4)(1997-2#19)(1997-3#12)(1997-4#14)(1997-5#1)(1997-6#1)(1997-7#10)(1997-8#12)(2006-10#6)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#6)(2007-11#28)(2007-12#40)(2007-2#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#18)(2007-8#14)(2008-1#16)(2008-10#510)(2008-11#99)(2008-12#31)(2008-2#67)(2008-3#152)(2008-4#56)(2008-5#98)(2008-6#27)(2008-7#85)(2008-8#51)(2008-9#44)(2009-1#5)(2009-10#12)(2009-11#15)(2009-12#9)(2009-2#6)(2009-3#2)(2009-4#8)(2009-5#11)(2009-6#4)(2009-7#7)(2009-8#15)(2009-9#7)(2010-1#3)(2010-10#16)(2010-11#12)(2010-12#15)(2010-2#6)(2010-3#15)(2010-4#8)(2010-5#10)(2010-6#6)(2010-7#6)(2010-8#11)(2010-9#6)(2011-1#28)(2011-2#69)(2011-3#6)(2011-7#3)(2012-1#12)(2012-12#32)(2012-2#63)(2012-3#41)(2012-7#2)(2012-8#1)(2013-1#61)(2013-7#12)(2013-8#34)
variously##6##1##(1992-12#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)
varnish on the##2##3##(1995-2#1)(2010-3#1)
varnish##4##1##(1995-2#1)(2010-3#1)(2011-2#2)
varroa##2##1##(2008-6#2)
varsigma-polarized emission##2##2##(2008-3#2)
varus deformity##2##2##(2009-3#1)(2013-1#1)
varus in##2##2##(2008-7#1)(2010-3#1)
varus##10##1##(2007-8#1)(2008-7#1)(2009-3#1)(2009-4#2)(2010-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
vary according to the type of##2##6##(1993-9#1)(2008-1#1)
vary according to the##8##4##(1993-9#1)(1994-9#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-2#1)(2012-12#1)
vary according to##13##3##(1990-6#1)(1992-11#1)(1993-9#1)(1994-9#1)(1995-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-6#1)(2012-12#1)
vary across the##2##3##(2008-10#1)(2011-2#1)
vary across##10##2##(1994-1#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
vary along##2##2##(2008-2#1)(2008-6#1)
vary among##5##2##(1991-10#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-3#1)
vary and##2##2##(1992-2#1)(2008-11#1)
vary as a function of##3##5##(2008-2#1)(2009-4#1)(2009-7#1)
vary as the##2##3##(2008-3#1)(2008-7#1)
vary as##6##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)
vary between 80 and 100%##2##5##(1992-11#1)(2008-10#1)
vary between different##2##3##(2007-7#1)(2008-7#1)
vary between individuals##2##3##(2007-11#1)(2010-11#1)
vary between##11##2##(1992-11#1)(1996-3#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-7#1)(2010-11#1)
vary by as much as##2##5##(1995-3#1)(2007-11#1)
vary by gender##2##3##(2011-2#2)
vary by##19##2##(1994-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-2#2)(2007-11#1)(2008-1#2)(2008-10#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-12#1)(2013-1#3)
vary considerably among##2##3##(2008-7#1)(2008-9#1)
vary considerably##9##2##(1991-3#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#1)
vary depending on the cell##2##5##(2008-2#1)(2008-9#1)
vary depending on the##5##4##(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
vary for##2##2##(1994-1#1)(2008-10#1)
vary from 1##2##3##(1992-11#1)(2013-1#1)
vary from 20 to##2##4##(2007-12#1)(2008-10#1)
vary from a##2##3##(2008-10#1)(2011-2#1)
vary from one##2##3##(2008-5#1)(2013-1#1)
vary from the##2##3##(1997-3#1)(2010-6#1)
vary from##28##2##(1991-6#1)(1992-11#1)(1992-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#2)
vary greatly##2##2##(2010-8#1)(2013-1#1)
vary in a##3##3##(1995-11#1)(2008-12#1)(2008-3#1)
vary in both##2##3##(1990-8#1)(1994-8#1)
vary in different##3##3##(2008-10#2)(2010-6#1)
vary in size##2##3##(1991-8#1)(2012-3#1)
vary in the order of##2##5##(2008-10#2)
vary in the order##4##4##(2008-10#4)
vary in the##9##3##(1992-3#1)(1997-1#1)(2008-10#6)(2008-8#1)
vary in their##5##3##(1993-9#1)(1994-12#1)(2008-10#1)(2008-8#2)
vary in##41##2##(1990-8#1)(1991-8#2)(1992-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-1#2)(2007-12#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
vary inversely##2##2##(1992-8#1)(1995-2#1)
vary linearly##3##2##(2008-10#2)(2008-3#1)
vary little##3##2##(1996-4#1)(2008-10#2)
vary over##3##2##(1992-8#1)(2007-12#1)(2008-10#1)
vary significantly at##2##3##(2008-8#1)(2011-2#1)
vary significantly##12##2##(1996-1#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-8#3)(2009-7#2)(2011-2#1)(2013-7#1)
vary slightly##2##2##(2008-1#1)(2008-3#1)
vary slowly##2##2##(2008-2#1)(2008-3#1)
vary substantially among##2##3##(2008-9#1)(2013-8#1)
vary substantially between##2##3##(2008-10#1)(2008-11#1)
vary substantially##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
vary the##6##2##(1990-2#1)(2008-2#1)(2008-3#3)(2008-7#1)
vary widely in##4##3##(1993-5#1)(2008-11#1)(2008-6#1)(2012-2#1)
vary widely##13##2##(1991-11#1)(1993-5#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#2)(2012-3#1)
vary with respect to the##2##5##(1997-3#1)(2007-9#1)
vary with the##8##3##(1993-6#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-2#1)
vary with##28##2##(1993-6#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#5)(2009-12#1)(2010-2#1)(2013-1#1)(2013-7#1)
vary within the##2##3##(2008-5#1)(2008-7#1)
vary worldwide##2##2##(2009-3#1)(2012-12#1)
vary##278##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#5)(1997-2#3)(1997-3#3)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#35)(2008-11#8)(2008-12#7)(2008-2#10)(2008-3#12)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#15)(2008-9#13)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#7)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#3)(2010-8#3)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#1)
varying amounts of##5##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
varying amounts##7##2##(1993-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)
varying between##5##2##(1990-8#1)(1991-9#1)(2008-10#2)(2013-8#1)
varying by as much as##2##5##(1992-9#1)(1995-11#1)
varying coefficient##2##2##(2011-1#1)(2013-1#1)
varying composition##4##2##(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)
varying concentrations of##12##3##(2008-10#5)(2008-11#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#2)(2013-1#1)
varying concentrations##14##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#2)(2013-1#1)
varying conditions and##2##3##(2008-3#1)(2009-5#1)
varying conditions##6##2##(1995-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)
varying degree of##4##3##(2008-3#1)(2008-7#1)(2013-1#2)
varying degree##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
varying degrees of resistance##3##4##(2008-10#3)
varying degrees of success##2##4##(2008-11#1)(2008-9#1)
varying degrees of##28##3##(1991-6#1)(1992-11#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
varying degrees##34##2##(1991-6#1)(1992-11#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
varying doses of##4##3##(1994-11#1)(2007-2#1)(2008-11#1)(2008-5#1)
varying environmental##2##2##(1992-12#1)(2008-10#1)
varying ethnic##2##2##(2010-8#2)
varying from 1##3##3##(2008-10#3)
varying from 10##2##3##(2008-10#1)(2010-8#1)
varying from 3 to##2##4##(2008-10#1)(2010-5#1)
varying from##24##2##(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#13)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
varying impacts of factors##2##4##(2010-11#2)
varying in their##2##3##(1991-2#1)(2008-10#1)
varying in##9##2##(1991-2#1)(1993-11#1)(1995-6#1)(2008-10#4)(2008-6#1)(2011-2#1)
varying inbreeding depression##2##3##(2008-8#2)
varying intensity##2##2##(2009-3#1)(2013-8#1)
varying lag times##2##3##(2008-5#2)
varying laser##2##2##(2008-2#1)(2008-3#1)
varying lengths##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
varying levels of##14##3##(1994-2#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
varying levels##16##2##(1994-2#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
varying local##2##2##(2008-12#1)(2008-9#1)
varying molecular##2##2##(1992-12#1)(2009-9#1)
varying pH##3##2##(2008-10#3)
varying period##2##2##(2008-10#1)(2008-3#1)
varying proportions##3##2##(2007-12#1)(2008-10#2)
varying several##2##2##(2008-10#2)
varying stability##2##2##(2008-10#2)
varying stages of##3##3##(2008-4#1)(2008-9#1)(2012-2#1)
varying temperatures##3##2##(1997-4#1)(2008-10#1)(2012-4#1)
varying the amount of##3##4##(2008-10#2)(2009-8#1)
varying the metallic##2##3##(2010-6#2)
varying the thickness of the##2##5##(2008-2#1)(2008-3#1)
varying the thickness of##3##4##(2008-2#1)(2008-3#2)
varying the##62##2##(1991-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#18)(2008-12#1)(2008-2#4)(2008-3#10)(2008-5#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#1)
varying types and##2##3##(1997-3#1)(2009-1#1)
varying with the##3##3##(1997-2#1)(2008-2#1)(2009-5#1)
varying with##4##2##(1997-2#1)(2007-12#1)(2008-2#1)(2009-5#1)
varying##422##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#2)(1996-5#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(2006-10#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#103)(2008-11#17)(2008-12#7)(2008-2#17)(2008-3#34)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#12)(2008-8#9)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-11#3)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#5)(2012-4#2)(2013-1#10)(2013-8#5)
varying-coefficient models##4##2##(1997-7#3)(2010-1#1)
varying-coefficient##5##1##(1997-7#3)(2010-1#1)(2013-1#1)
vas deferens##12##2##(1990-7#1)(1992-3#1)(1994-8#2)(1997-7#1)(1997-8#2)(2008-10#5)
vas##21##1##(1990-7#1)(1992-2#1)(1992-3#1)(1994-8#7)(1997-7#1)(1997-8#2)(2008-10#5)(2010-4#2)(2011-3#1)
vascular abnormalities##2##2##(2012-3#1)(2013-1#1)
vascular access and##2##3##(2007-7#1)(2013-1#1)
vascular access for hemodialysis##3##4##(1991-6#1)(2007-7#1)(2008-1#1)
vascular access for##6##3##(1991-6#1)(2007-7#3)(2008-1#1)(2013-8#1)
vascular access in hemodialysis##2##4##(2007-7#2)
vascular access in##5##3##(2007-7#4)(2011-2#1)
vascular access plays##3##3##(2007-7#3)
vascular access site##3##3##(2007-7#1)(2011-2#2)
vascular access##39##2##(1990-8#1)(1991-6#1)(2007-7#23)(2008-1#6)(2011-2#5)(2013-1#2)(2013-8#1)
vascular accesses##2##2##(2007-7#1)(2008-1#1)
vascular alterations##3##2##(2008-1#1)(2008-7#1)(2013-8#1)
vascular anastomosis##2##2##(2007-7#1)(2008-1#1)
vascular anatomy##3##2##(1993-6#1)(2008-7#1)(2012-2#1)
vascular and neurological complications##3##4##(2013-1#3)
vascular and neurological##4##3##(2008-7#1)(2013-1#3)
vascular and non-vascular##2##3##(1992-12#1)(2012-2#1)
vascular and##19##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(2007-11#2)(2008-1#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#5)
vascular architecture##2##2##(1997-6#1)(2008-1#1)
vascular assess##2##2##(2007-10#2)
vascular assessment##2##2##(1996-7#1)(2013-1#1)
vascular barrier##3##2##(2008-4#3)
vascular basement membrane##2##3##(1992-12#2)
vascular bed##4##2##(1991-8#1)(1997-1#1)(2008-10#1)(2008-3#1)
vascular beds##3##2##(1991-3#1)(2010-9#2)
vascular biology##4##2##(1994-5#1)(2008-1#2)(2008-3#1)
vascular bundle##4##2##(2008-10#1)(2009-3#2)(2013-7#1)
vascular bundles##6##2##(2008-10#6)
vascular calcification##4##2##(2009-1#2)(2012-12#2)
vascular cell adhesion##2##3##(1995-12#1)(2012-2#1)
vascular cell##3##2##(1995-12#1)(1995-2#1)(2012-2#1)
vascular cells##8##2##(1992-3#2)(1993-3#1)(1994-5#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-4#1)
vascular changes##3##2##(1992-6#1)(2008-1#1)(2008-7#1)
vascular colonization by##2##3##(2008-10#2)
vascular complication##7##2##(1993-2#2)(1994-3#1)(2007-8#1)(2008-1#3)
vascular complications and##2##3##(2011-2#2)
vascular complications##14##2##(1992-8#1)(2008-1#6)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#4)
vascular component##2##2##(1996-11#1)(2008-4#1)
vascular compromise##3##2##(2007-12#1)(2008-12#2)
vascular damage##4##2##(2008-3#1)(2008-4#3)
vascular dementia (VD)##3##3##(1996-11#1)(1996-5#1)(2008-7#1)
vascular dementia and##2##3##(2008-3#1)(2008-7#1)
vascular dementia##16##2##(1996-11#2)(1996-5#2)(2007-10#2)(2008-3#1)(2008-7#9)
vascular density##4##2##(2008-11#2)(2009-12#1)(2011-2#1)
vascular deposits##2##2##(1996-5#2)
vascular development##2##2##(2008-3#1)(2009-6#1)
vascular disease and##2##3##(1992-6#1)(1992-9#1)
vascular disease in##6##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-1#1)
vascular disease of##2##3##(1990-5#1)(2008-10#1)
vascular disease or##2##3##(2008-1#1)(2008-3#1)
vascular disease##49##2##(1990-3#1)(1990-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-2#2)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-2#2)
vascular diseases and##2##3##(2008-5#1)(2011-2#1)
vascular diseases##11##2##(1991-11#1)(1991-9#1)(1995-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
vascular diseases]##2##2##(1995-11#1)(1996-11#1)
vascular disorder##3##2##(1992-5#1)(2008-10#1)(2008-9#1)
vascular disruption##3##2##(1997-3#3)
vascular effect##2##2##(1997-6#1)(2008-3#1)
vascular endothelial cell growth factor##2##5##(1991-2#1)(1992-9#1)
vascular endothelial cell##5##3##(1991-2#1)(1991-9#1)(1992-9#1)(1996-12#1)(2009-7#1)
vascular endothelial cells##27##3##(1990-2#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-12#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-6#1)(1995-11#1)(1996-12#3)(1997-1#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-7#2)(2010-1#2)
vascular endothelial growth factor (VEGF)##19##5##(1992-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
vascular endothelial growth factor in##2##5##(2008-7#1)(2008-9#1)
vascular endothelial growth factor receptor##2##5##(2008-8#1)(2012-1#1)
vascular endothelial growth factor##34##4##(1992-3#2)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
vascular endothelial growth##37##3##(1992-3#2)(1994-3#1)(1997-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
vascular endothelial##74##2##(1990-2#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-9#3)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#4)(1997-1#3)(1997-7#2)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-1#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
vascular endothelium and##2##3##(1992-12#1)(2008-3#1)
vascular endothelium##6##2##(1992-12#1)(1994-8#1)(1996-2#1)(2008-3#2)(2013-8#1)
vascular event##3##2##(2008-7#1)(2008-8#1)(2010-3#1)
vascular events##7##2##(2006-6#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-5#1)(2013-1#1)
vascular function and##2##3##(2012-12#1)(2013-8#1)
vascular function##5##2##(1993-6#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
vascular graft materials##2##3##(2009-11#1)(2011-3#1)
vascular graft##7##2##(2007-10#2)(2008-5#1)(2009-11#2)(2011-3#2)
vascular grafts##6##2##(2007-10#1)(2008-5#1)(2010-8#3)(2011-3#1)
vascular growth##2##2##(2008-1#1)(2013-1#1)
vascular imaging##9##2##(2008-8#1)(2009-10#3)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
vascular injury##12##2##(1992-12#2)(1992-9#2)(1994-5#1)(2007-10#4)(2009-3#1)(2011-2#1)(2013-1#1)
vascular insufficiency##5##2##(2008-9#3)(2011-1#1)(2012-3#1)
vascular invasion##4##2##(1990-10#1)(1993-9#1)(2011-2#2)
vascular lesion##4##2##(1997-8#2)(2007-7#1)(2008-7#1)
vascular lesions##10##2##(1996-11#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
vascular malformation of##2##3##(2012-3#2)
vascular malformation##3##2##(2011-2#1)(2012-3#2)
vascular malformations in##2##3##(2008-7#1)(2012-3#1)
vascular malformations##13##2##(1992-5#1)(2008-10#1)(2008-7#3)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)
vascular mapping##3##2##(2007-7#1)(2013-1#2)
vascular muscle alpha##2##3##(1991-6#2)
vascular muscle##4##2##(1991-6#4)
vascular network##9##2##(1996-1#1)(2008-11#4)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
vascular occlusion##4##2##(1992-6#1)(2008-4#1)(2009-1#1)(2011-2#1)
vascular or##4##2##(1992-8#1)(2007-12#1)(2011-3#1)(2012-12#1)
vascular organization##2##2##(1991-6#2)
vascular pathologies##2##2##(2010-3#1)(2013-8#1)
vascular pathology##3##2##(1991-1#1)(2012-1#1)(2013-8#1)
vascular pedicle##3##2##(1991-4#1)(2007-12#1)(2008-6#1)
vascular permeability factor were##3##4##(1991-9#3)
vascular permeability factor##11##3##(1991-2#1)(1991-9#8)(1992-9#1)(2008-9#1)
vascular permeability##20##2##(1990-12#1)(1991-2#1)(1991-8#1)(1991-9#8)(1992-12#1)(1992-6#1)(1992-9#1)(1994-8#1)(2008-1#2)(2008-9#2)(2012-12#1)
vascular plant##7##2##(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)
vascular plants##10##2##(2008-8#4)(2008-9#3)(2009-6#1)(2009-8#2)
vascular plug##3##2##(2010-5#3)
vascular pressure##2##2##(1997-1#1)(2010-7#1)
vascular proliferation##2##2##(2007-8#1)(2008-9#1)
vascular prostacyclin##2##2##(1994-5#2)
vascular prosthesis##2##2##(2008-11#1)(2011-3#1)
vascular prosthetic graft##2##3##(2011-3#2)
vascular reactivity in##2##3##(1995-12#1)(2012-2#1)
vascular reactivity##5##2##(1995-12#2)(2012-2#3)
vascular reconstruction##2##2##(1991-11#1)(2009-3#1)
vascular remodeling##5##2##(1996-6#1)(2008-1#2)(2012-3#1)(2013-1#1)
vascular remodelling of##2##3##(2010-6#2)
vascular remodelling##3##2##(2010-10#1)(2010-6#2)
vascular repair##3##2##(2009-11#1)(2009-3#2)
vascular resistance from##2##3##(2007-9#1)(2008-12#1)
vascular resistance of##3##3##(1997-5#1)(2007-9#1)(2009-5#1)
vascular resistance##20##2##(1990-11#1)(1991-3#1)(1991-9#2)(1995-12#1)(1996-6#1)(1997-5#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-10#2)(2010-6#1)(2010-8#1)(2012-2#1)
vascular response##4##2##(1992-2#1)(2011-1#1)(2013-8#2)
vascular risk factors and##4##4##(2007-10#2)(2008-7#2)
vascular risk factors##7##3##(2007-10#4)(2008-3#1)(2008-7#2)
vascular risk##14##2##(2007-10#10)(2008-3#2)(2008-7#2)
vascular screening##3##2##(2007-7#3)
vascular smooth muscle and##2##4##(1990-8#1)(1992-3#1)
vascular smooth muscle cell##4##4##(1991-9#1)(1993-11#1)(2008-11#1)(2008-9#1)
vascular smooth muscle cells (VSMC)##7##5##(1990-12#1)(1992-9#1)(1993-2#1)(1994-9#1)(2008-1#1)(2008-5#1)(2008-8#1)
vascular smooth muscle cells (VSMCs)##2##5##(1994-6#1)(2012-12#1)
vascular smooth muscle cells and##3##5##(1990-2#2)(1995-2#1)
vascular smooth muscle cells to##2##5##(1990-12#1)(1995-11#1)
vascular smooth muscle cells were##2##5##(1990-8#1)(1992-8#1)
vascular smooth muscle cells##41##4##(1990-12#3)(1990-2#3)(1990-8#3)(1991-12#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-11#3)(1994-6#1)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#3)(1997-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2012-12#1)
vascular smooth muscle##60##3##(1990-12#5)(1990-2#3)(1990-8#6)(1991-12#1)(1991-6#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#4)(1994-6#1)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#3)(1997-1#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
vascular smooth##63##2##(1990-12#5)(1990-2#3)(1990-8#6)(1991-12#1)(1991-6#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#4)(1994-6#1)(1994-9#2)(1995-11#3)(1995-12#5)(1995-2#3)(1997-1#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
vascular stents##4##2##(2011-1#1)(2012-2#3)
vascular stretch##2##2##(1990-12#2)
vascular structure##3##2##(2008-7#1)(2009-5#1)(2012-12#1)
vascular structures##5##2##(1997-8#1)(2007-8#1)(2008-3#1)(2010-6#1)(2011-2#1)
vascular supply to the##2##4##(2007-11#1)(2007-12#1)
vascular supply##4##2##(2007-11#1)(2007-12#2)(2009-8#1)
vascular surgery##5##2##(2006-10#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
vascular surgery]##3##2##(1991-3#1)(2009-5#1)(2011-3#1)
vascular system##11##2##(1990-8#1)(2008-10#5)(2008-7#2)(2009-2#1)(2009-6#1)(2010-8#1)
vascular thrombosis and##2##3##(2008-10#1)(2009-8#1)
vascular thrombosis##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
vascular tissue##9##2##(2008-10#7)(2008-11#1)(2009-11#1)
vascular tissues of##2##3##(2008-10#1)(2008-8#1)
vascular tissues##15##2##(1993-8#1)(1995-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)
vascular tone and##2##3##(2010-10#1)(2013-1#1)
vascular tone##8##2##(1994-6#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-5#1)(2010-10#1)(2012-4#1)(2013-1#1)
vascular tree##4##2##(1994-9#1)(2006-10#1)(2012-12#1)(2012-2#1)
vascular tumor##4##2##(2006-12#1)(2007-8#1)(2009-1#1)(2011-1#1)
vascular tumors##2##2##(2013-1#1)(2013-8#1)
vascular wall##8##2##(1990-12#1)(1990-8#1)(1992-9#1)(2006-6#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#1)
vascular walls##3##2##(1992-9#1)(2012-1#1)(2012-3#1)
vascular wilt##3##2##(2008-10#3)
vascular##900##1##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#9)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#8)(1991-4#1)(1991-5#2)(1991-6#11)(1991-8#2)(1991-9#17)(1992-12#11)(1992-2#1)(1992-3#5)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#15)(1993-11#2)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#2)(1994-9#7)(1995-11#5)(1995-12#14)(1995-2#7)(1996-1#1)(1996-11#6)(1996-12#4)(1996-2#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#7)(1997-2#1)(1997-3#8)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#7)(2006-10#5)(2006-12#2)(2006-6#2)(2007-10#28)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#35)(2007-8#6)(2007-9#2)(2008-1#40)(2008-10#56)(2008-11#22)(2008-12#10)(2008-2#1)(2008-3#29)(2008-4#10)(2008-5#10)(2008-6#3)(2008-7#52)(2008-8#20)(2008-9#23)(2009-1#6)(2009-10#6)(2009-11#6)(2009-12#1)(2009-2#2)(2009-3#9)(2009-4#2)(2009-5#10)(2009-6#4)(2009-7#7)(2009-8#10)(2010-1#6)(2010-10#6)(2010-12#4)(2010-3#5)(2010-4#2)(2010-5#6)(2010-6#10)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#11)(2011-2#41)(2011-3#10)(2012-1#5)(2012-12#16)(2012-2#20)(2012-3#12)(2012-4#2)(2013-1#26)(2013-7#1)(2013-8#18)
vascularity of the##2##3##(1991-8#1)(1996-8#1)
vascularity of##3##2##(1991-8#1)(1996-8#1)(2009-5#1)
vascularity##10##1##(1991-8#1)(1996-8#1)(2008-7#3)(2009-5#1)(2011-2#3)(2013-1#1)
vascularization of the##2##3##(1990-5#1)(2011-1#1)
vascularization of##5##2##(1990-5#1)(1990-6#1)(2010-11#1)(2011-1#1)(2013-7#1)
vascularization##21##1##(1990-5#2)(1990-6#1)(1993-9#1)(2007-8#1)(2008-10#1)(2008-11#6)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-8#1)(2013-7#1)
vascularized flaps##2##2##(2009-5#1)(2012-2#1)
vascularized muscle##2##2##(2007-8#1)(2008-9#1)
vascularized##23##1##(1995-11#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
vascularly perfused##2##2##(1992-12#1)(1997-6#1)
vascularly##3##1##(1992-12#1)(1995-12#1)(1997-6#1)
vasculature and##3##2##(1991-9#1)(1996-2#1)(2008-3#1)
vasculature for##2##2##(1996-5#1)(2008-7#1)
vasculature in##6##2##(1993-9#1)(2008-7#1)(2008-9#3)(2011-2#1)
vasculature to##4##2##(1991-2#1)(1996-2#1)(2007-10#1)(2013-1#1)
vasculature##57##1##(1991-2#1)(1991-9#2)(1993-9#5)(1994-5#1)(1996-2#2)(1996-5#2)(1997-1#6)(1997-3#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#3)(2008-5#1)(2008-7#6)(2008-9#4)(2009-10#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
vasculitic leg ulcers associated with hepatitis C virus infection##2##9##(2013-1#2)
vasculitic##4##1##(1997-2#1)(2010-6#1)(2013-1#2)
vasculitides##2##1##(2012-3#2)
vasculitis and##4##2##(2006-10#1)(2007-7#1)(2010-6#1)(2011-2#1)
vasculitis in a##2##3##(2011-1#2)
vasculitis in the##2##3##(1991-3#1)(1997-5#1)
vasculitis in##10##2##(1991-3#2)(1996-3#1)(1997-5#1)(1997-8#2)(2007-7#1)(2008-1#1)(2011-1#2)
vasculitis is##4##2##(1990-8#1)(2007-7#1)(2011-1#1)(2012-3#1)
vasculitis of##4##2##(1990-8#1)(2006-10#2)(2007-7#1)
vasculitis that##2##2##(2008-1#1)(2008-8#1)
vasculitis##66##1##(1990-8#6)(1991-3#2)(1992-5#1)(1993-2#1)(1995-5#1)(1996-3#3)(1996-8#1)(1997-4#5)(1997-5#1)(1997-8#8)(2006-10#5)(2007-10#2)(2007-7#5)(2008-1#6)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-5#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-3#5)
vasculogenesis and angiogenesis##2##3##(2012-12#2)
vasculogenesis##3##1##(2012-12#3)
vasculogenic##5##1##(2009-3#2)(2009-5#1)(2012-12#1)(2012-3#1)
vasculopathy and##2##2##(2011-2#1)(2013-1#1)
vasculopathy##6##1##(2007-10#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#1)
vase##2##1##(2008-12#1)(2008-3#1)
vasectomies##5##1##(1996-1#5)
vasectomized men##2##2##(1990-9#2)
vasectomized##3##1##(1990-9#2)(2008-12#1)
vasectomy##8##1##(1990-9#4)(1992-5#1)(1996-1#1)(2008-7#1)(2008-8#1)
vasinfectum from##2##2##(2008-10#2)
vasinfectum race 1##2##3##(2008-10#2)
vasinfectum##10##1##(2008-10#10)
vaso-occlusive##2##1##(1991-6#1)(2012-2#1)
vasoactive drugs##4##2##(1990-3#1)(1991-12#1)(1997-1#1)(2013-1#1)
vasoactive intestinal peptide (VIP)##2##4##(1994-11#1)(1994-3#1)
vasoactive intestinal peptide##5##3##(1994-11#1)(1994-3#3)(1995-5#1)
vasoactive intestinal polypeptide (VIP)##5##4##(1990-7#1)(1993-3#1)(1993-9#1)(1995-11#1)(2008-4#1)
vasoactive intestinal polypeptide##7##3##(1990-5#1)(1990-7#1)(1993-3#1)(1993-9#1)(1995-11#1)(1997-1#1)(2008-4#1)
vasoactive intestinal##14##2##(1990-5#1)(1990-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#3)(1995-11#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-4#1)(2012-3#1)
vasoactive mediators and##2##3##(1996-2#1)(2008-1#1)
vasoactive peptide##3##2##(1992-3#1)(1993-3#1)(2011-2#1)
vasoactive peptides##4##2##(1994-9#4)
vasoactive substances##2##2##(1994-9#1)(2011-2#1)
vasoactive##36##1##(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#3)(1994-9#5)(1995-11#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-1#2)(2008-1#2)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
vasoconstricting##2##1##(1994-11#1)(2008-7#1)
vasoconstriction and##2##2##(1993-3#1)(1994-2#1)
vasoconstriction effect##2##2##(2011-2#2)
vasoconstriction in guinea-pig vena cava##2##5##(1995-12#2)
vasoconstriction in##6##2##(1992-3#1)(1995-12#3)(1997-4#1)(2008-7#1)
vasoconstriction of##3##2##(1991-6#1)(1992-2#1)(2007-10#1)
vasoconstriction##35##1##(1990-5#2)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#2)(1993-3#2)(1994-2#1)(1994-9#1)(1995-12#10)(1997-4#1)(1997-6#2)(2006-10#1)(2007-10#2)(2008-1#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#2)
vasoconstrictive##2##1##(1991-5#1)(2011-1#1)
vasoconstrictor and##5##2##(1991-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2009-10#1)
vasoconstrictor effect##2##2##(1991-9#1)(2008-12#1)
vasoconstrictor peptide##3##2##(1991-8#1)(1993-3#1)(1995-11#1)
vasoconstrictor responses##2##2##(1994-6#1)(2010-10#1)
vasoconstrictor##20##1##(1990-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-1#4)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-12#1)(2009-10#1)(2010-10#1)
vasoconstrictors##4##1##(1990-5#1)(1991-3#1)(1994-11#1)(1994-9#1)
vasocontraction##2##1##(1992-5#1)(1995-12#1)
vasodepressor##2##1##(1990-7#1)(1997-2#1)
vasodilatation and the##2##3##(1997-7#1)(2006-10#1)
vasodilatation and##3##2##(1997-7#1)(2006-10#2)
vasodilatation in man##2##3##(1994-11#2)
vasodilatation in##6##2##(1990-7#1)(1994-11#2)(1995-11#3)
vasodilatation##25##1##(1990-12#1)(1990-7#3)(1990-8#1)(1992-6#1)(1994-11#2)(1995-11#3)(1995-12#1)(1997-7#3)(2006-10#3)(2008-10#1)(2008-11#5)(2008-8#1)
vasodilation and##3##2##(1995-12#1)(2008-8#1)(2011-1#1)
vasodilation by##2##2##(1990-7#1)(2009-4#1)
vasodilation in##2##2##(1997-7#1)(2008-7#1)
vasodilation##16##1##(1990-7#1)(1991-9#2)(1992-9#1)(1995-12#2)(1997-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
vasodilator##24##1##(1990-12#1)(1990-3#1)(1991-3#3)(1991-9#1)(1992-5#1)(1993-3#1)(1994-6#2)(1996-6#1)(1997-7#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#3)(2009-5#1)(2009-9#1)(2010-10#1)(2012-3#1)
vasodilators and##2##2##(2008-10#1)(2010-6#1)
vasodilators##12##1##(1994-7#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-3#3)(2009-5#1)(2010-10#1)(2010-6#1)
vasodilatory action##2##2##(1992-5#1)(2008-5#1)
vasodilatory shock after##2##3##(2007-9#2)
vasodilatory##11##1##(1990-7#1)(1992-5#1)(1997-1#1)(2007-9#2)(2008-3#1)(2008-4#3)(2008-5#1)(2013-8#1)
vasogenic edema##3##2##(2007-10#3)
vasogenic##4##1##(1996-6#1)(2007-10#3)
vasography##2##1##(1997-8#2)
vasomotor rhinitis##2##2##(2011-1#2)
vasomotor tone##2##2##(1992-9#1)(2008-3#1)
vasomotor##8##1##(1991-12#1)(1992-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#2)(2013-1#1)
vasopressin (40##2##2##(1997-4#2)
vasopressin (AVP)##3##2##(1992-8#1)(1993-12#1)(2008-4#1)
vasopressin V1 receptor antagonist##3##4##(1995-12#3)
vasopressin V1##4##2##(1995-12#4)
vasopressin and angiotensin II stimulate the phosphorylation of##2##8##(1996-2#2)
vasopressin and angiotensin II##3##4##(1996-2#3)
vasopressin and##9##2##(1991-9#1)(1992-5#2)(1994-9#2)(1995-12#1)(1996-2#3)
vasopressin immunoreactivity in##2##3##(1994-2#2)
vasopressin immunoreactivity##3##2##(1994-2#3)
vasopressin in the##2##3##(2007-9#2)
vasopressin in##5##2##(1990-12#1)(1993-12#1)(1995-12#1)(2007-9#2)
vasopressin on sodium intake##2##4##(1997-4#2)
vasopressin receptors##4##2##(1994-2#3)(1994-9#1)
vasopressin type 2 receptor##2##4##(1994-8#2)
vasopressin##70##1##(1990-12#2)(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#5)(1992-8#2)(1993-12#2)(1993-6#2)(1994-11#2)(1994-2#8)(1994-8#2)(1994-9#7)(1995-12#8)(1996-12#1)(1996-2#4)(1997-3#1)(1997-4#7)(2007-9#4)(2008-4#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-12#1)(2013-1#4)
vasopressin-containing cells##3##2##(1993-12#3)
vasopressor##5##1##(2008-4#1)(2009-8#2)(2010-5#1)(2013-1#1)
vasoreactivity##2##1##(2012-3#2)
vasorelaxant properties##2##2##(2009-5#2)
vasorelaxant##4##1##(1992-9#1)(1994-11#1)(2009-5#2)
vasorelaxation##6##1##(1991-9#1)(1992-9#1)(1993-6#2)(2013-8#2)
vasospasm after AVM rupture##3##4##(2012-3#3)
vasospasm after##4##2##(2007-10#1)(2012-3#3)
vasospasm and diminished coronary blood flow reserve##2##7##(2008-7#2)
vasospasm and##5##2##(2007-10#1)(2008-7#4)
vasospasm in coronary artery bypass grafts##2##6##(2011-2#2)
vasospasm in##4##2##(1991-3#1)(2011-2#2)(2012-3#1)
vasospasm is##2##2##(2007-8#1)(2008-7#1)
vasospasm##37##1##(1991-3#1)(1992-9#1)(1994-11#1)(1995-11#1)(1996-3#1)(1997-3#1)(2007-10#9)(2007-8#1)(2008-3#2)(2008-7#8)(2008-8#1)(2011-2#3)(2012-3#7)
vasospasms##2##1##(1991-3#1)(1995-5#1)
vast amount of##5##3##(1993-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-12#1)
vast amounts of data##3##4##(1995-12#1)(2008-9#1)(2012-3#1)
vast amounts of##4##3##(1995-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
vast areas##2##2##(1992-2#1)(2008-10#1)
vast geographic range##2##3##(2008-5#2)
vast majority of cases##2##4##(2008-12#1)(2009-8#1)
vast majority of patients##4##4##(1997-1#1)(2007-11#1)(2007-7#1)(2012-2#1)
vast majority of the##2##4##(2008-1#1)(2011-2#1)
vast majority of##28##3##(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-9#1)(2011-2#2)(2012-2#1)
vast majority##30##2##(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-9#1)(2011-2#2)(2012-2#1)
vast number of##3##3##(1995-8#1)(2008-7#1)(2012-12#1)
vast##78##1##(1990-3#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#3)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
vastly improved##2##2##(2010-3#1)(2011-2#1)
vastly##8##1##(2008-10#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
vastus lateralis##6##2##(2008-5#2)(2010-4#4)
vaterite##3##1##(2008-10#3)
vault and##2##2##(2007-12#1)(2008-5#1)
vault##24##1##(1991-12#1)(1994-12#2)(2006-7#1)(2007-11#1)(2007-12#7)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#5)(2010-8#1)(2011-2#3)
vcr1##2##1##(2008-10#2)
vcr2##3##1##(2008-10#3)
vdW parameters##3##2##(2008-10#3)
vdW##4##1##(2008-10#4)
vdh##3##1##(1995-8#3)
vector DNA##2##2##(1993-9#1)(1994-12#1)
vector Polymyxa graminis##2##3##(2008-10#2)
vector amplification##3##2##(2008-2#1)(2008-4#1)(2011-2#1)
vector and nonvector whiteflies##2##4##(2008-10#2)
vector and nonvector##3##3##(2008-10#3)
vector and the cDNA##2##4##(1994-11#1)(1994-12#1)
vector and the##12##3##(1990-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)
vector and##34##2##(1990-7#1)(1991-9#1)(1992-8#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#1)(2010-5#1)
vector based on##2##3##(2008-11#1)(2008-3#1)
vector but##2##2##(2008-10#2)
vector by##5##2##(1994-12#1)(1997-8#1)(2008-4#2)(2008-9#1)
vector can be##4##3##(1990-5#1)(1995-2#1)(2008-2#1)(2008-4#1)
vector carrying a##3##3##(1995-8#1)(2010-5#1)(2011-1#1)
vector carrying the human tissue inhibitor of##2##7##(2010-1#2)
vector carrying##9##2##(1995-8#1)(2008-8#1)(2008-9#1)(2010-1#4)(2010-5#1)(2011-1#1)
vector competency##2##2##(2008-10#2)
vector containing the##6##3##(1990-5#1)(1991-9#1)(2008-10#1)(2008-11#2)(2012-3#1)
vector containing##14##2##(1990-5#1)(1991-9#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#4)(2008-9#2)(2012-3#1)
vector control##8##2##(2008-8#2)(2010-1#3)(2011-1#1)(2012-12#1)(2013-1#1)
vector designed##2##2##(1991-12#1)(1993-6#1)
vector diffraction##3##2##(2008-2#1)(2008-3#2)
vector driven##2##2##(2008-11#1)(2010-11#1)
vector during the##2##3##(2008-10#1)(2010-8#1)
vector during##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
vector ecology##2##2##(2008-10#1)(2010-1#1)
vector expressing##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
vector fields##2##2##(2008-6#2)
vector for the##7##3##(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
vector for##20##2##(1990-5#1)(1996-2#1)(1997-4#2)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#2)
vector formalism##2##2##(2007-11#1)(2008-3#1)
vector from##3##2##(2008-10#1)(2008-11#2)
vector has##2##2##(2008-11#1)(2008-9#1)
vector in the##3##3##(1990-12#1)(2008-3#1)(2008-8#1)
vector in##17##2##(1990-12#1)(1990-5#1)(1995-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)
vector inoculation##3##2##(2007-2#1)(2008-10#2)
vector insects##2##2##(2008-10#2)
vector is##7##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
vector may##2##2##(1997-6#1)(1997-8#1)
vector of a##2##3##(2008-8#1)(2010-10#1)
vector of the##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
vector of##19##2##(1992-8#1)(1997-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#3)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)
vector packaging##2##2##(2008-11#1)(2008-8#1)
vector particles##2##2##(2008-2#1)(2008-4#1)
vector population##4##2##(2008-10#2)(2011-2#1)(2011-3#1)
vector populations##4##2##(2008-10#3)(2008-8#1)
vector quantization##3##2##(2008-3#3)
vector quantizer##2##2##(2008-3#2)
vector radiative transfer##2##3##(2008-3#2)
vector radiative##3##2##(2007-11#1)(2008-3#2)
vector relationships are##2##3##(2008-10#2)
vector resistance##3##2##(2008-10#2)(2013-7#1)
vector results in##2##3##(1995-2#1)(2008-3#1)
vector sequences##2##2##(1997-8#1)(2008-11#1)
vector sequential projection##2##3##(2008-10#2)
vector soliton##4##2##(2007-11#3)(2007-12#1)
vector solitons and##2##3##(2007-11#2)
vector solitons##9##2##(2007-11#7)(2007-12#2)
vector spatial solitons##2##3##(2007-12#2)
vector species of##2##3##(2008-10#1)(2013-1#1)
vector species##11##2##(2008-10#9)(2008-8#1)(2013-1#1)
vector specificity##4##2##(2008-10#4)
vector spherical##2##2##(2007-12#1)(2008-2#1)
vector status##2##2##(2008-10#2)
vector suitable for##2##3##(1994-12#1)(1996-2#1)
vector system for efficient##2##4##(2008-11#1)(2011-1#1)
vector system for##3##3##(1991-6#1)(2008-11#1)(2011-1#1)
vector system in##3##3##(1997-4#2)(2008-11#1)
vector system##18##2##(1991-6#2)(1994-12#1)(1996-12#1)(1997-4#4)(1997-7#1)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)
vector systems##6##2##(1993-12#1)(1997-1#1)(1997-4#1)(2008-2#1)(2008-4#1)(2013-1#1)
vector that allows##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
vector that##7##2##(1997-8#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#1)
vector theory to##2##3##(2008-2#1)(2008-3#1)
vector theory##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
vector to##4##2##(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
vector transmission of##2##3##(2008-10#2)
vector transmission##5##2##(2008-10#5)
vector under the control of##2##5##(1995-6#1)(1997-4#1)
vector under the control##3##4##(1995-6#1)(1997-4#1)(2008-11#1)
vector under##4##2##(1995-6#1)(1997-3#1)(1997-4#1)(2008-11#1)
vector via##3##2##(2008-4#1)(2008-8#1)(2010-7#1)
vector was constructed##4##3##(1994-5#1)(1995-8#1)(2008-9#1)(2011-1#1)
vector was##16##2##(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-8#2)(2008-11#1)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)
vector with##7##2##(1994-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
vector##679##1##(1990-11#3)(1990-12#2)(1990-5#20)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-9#7)(1992-12#2)(1992-3#2)(1992-8#4)(1993-12#5)(1993-2#1)(1993-6#3)(1993-8#6)(1993-9#2)(1994-11#1)(1994-12#13)(1994-5#8)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#9)(1995-6#2)(1995-8#4)(1996-10#1)(1996-12#3)(1996-2#4)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#15)(1997-6#4)(1997-7#2)(1997-8#14)(2007-10#2)(2007-11#20)(2007-12#14)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#123)(2008-11#56)(2008-2#31)(2008-3#48)(2008-4#17)(2008-5#15)(2008-6#7)(2008-7#8)(2008-8#56)(2008-9#37)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#12)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#11)(2011-1#5)(2011-2#17)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
vector)##3##1##(2008-2#1)(2008-9#1)(2013-7#1)
vector-based##2##1##(2009-10#1)(2012-12#1)
vector-borne disease##2##2##(2008-8#1)(2012-2#1)
vector-borne diseases##2##2##(2010-1#1)(2011-1#1)
vector-borne##4##1##(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
vector-diffraction effects##2##2##(2008-3#2)
vector-diffraction theory##3##2##(2008-3#3)
vector-diffraction##6##1##(2008-3#6)
vector-encoded##2##1##(1995-2#1)(1995-5#1)
vector-field##3##1##(2008-2#2)(2009-8#1)
vector-matrix multiplier##3##2##(2008-2#1)(2008-3#2)
vector-mediated##2##1##(1994-5#1)(2012-3#1)
vector-phytoplasma-plant##2##1##(2008-10#2)
vector-specific##2##1##(2008-11#1)(2008-4#1)
vectored by the##3##3##(2008-10#2)(2012-3#1)
vectored by##6##2##(2008-10#5)(2012-3#1)
vectored##8##1##(2008-10#7)(2012-3#1)
vectorial effects##2##2##(2007-11#2)
vectorial theory##2##2##(2007-11#1)(2008-3#1)
vectorial##21##1##(1993-6#1)(1997-6#2)(2007-11#10)(2008-11#1)(2008-3#6)(2009-10#1)
vectoring ability##2##2##(2008-10#2)
vectoring##4##1##(2008-10#4)
vectors allow##2##2##(2008-11#1)(2012-2#1)
vectors and a##2##3##(2008-10#2)
vectors and their##3##3##(1997-4#2)(2008-10#1)
vectors and##23##2##(1990-5#1)(1993-3#1)(1994-12#1)(1997-4#4)(2007-11#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-1#2)
vectors are particularly##2##3##(1993-12#1)(2008-4#1)
vectors are##16##2##(1991-7#1)(1993-12#3)(1994-12#3)(1994-5#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-5#1)
vectors can be used##2##4##(1991-7#1)(2008-4#1)
vectors can be##4##3##(1991-7#1)(1993-12#1)(2008-3#1)(2008-4#1)
vectors can##5##2##(1991-7#1)(1993-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
vectors carrying the##2##3##(1994-5#1)(2008-11#1)
vectors carrying##5##2##(1994-12#1)(1994-5#1)(2008-10#1)(2008-11#2)
vectors contain##4##2##(2008-11#2)(2008-4#1)(2008-7#1)
vectors containing the##3##3##(1994-12#1)(2008-11#2)
vectors containing##12##2##(1990-5#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#2)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
vectors described##2##2##(2008-10#1)(2008-2#1)
vectors encoding##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
vectors for constructing##2##3##(1990-5#1)(1993-2#1)
vectors for direct cloning##2##4##(1991-7#1)(1997-4#1)
vectors for gene therapy##6##4##(1994-5#1)(2008-11#3)(2008-4#1)(2008-5#1)
vectors for gene##9##3##(1994-5#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)
vectors for human##2##3##(2008-11#1)(2008-8#1)
vectors for the##3##3##(1990-5#1)(2008-11#1)(2008-3#1)
vectors for use in##3##4##(1993-12#1)(1994-5#1)(2012-2#1)
vectors for##41##2##(1990-5#4)(1991-6#1)(1991-7#1)(1993-12#2)(1993-2#3)(1994-12#3)(1994-3#1)(1994-5#3)(1997-4#3)(2007-11#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2011-3#1)(2012-2#1)
vectors has##2##2##(1990-5#1)(1997-4#1)
vectors have been##6##3##(1990-5#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
vectors have##12##2##(1990-5#2)(1994-5#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)
vectors in combination with##2##4##(2008-11#1)(2008-9#1)
vectors in which##2##3##(1991-7#1)(2008-8#1)
vectors in##17##2##(1991-6#1)(1991-7#1)(1993-12#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-9#1)
vectors into##3##2##(1993-12#1)(1997-4#1)(2008-9#1)
vectors is described##2##3##(1993-9#1)(1994-12#1)
vectors is##6##2##(1993-9#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
vectors may be useful for##2##5##(1994-5#1)(1997-4#1)
vectors may be##4##3##(1994-5#1)(1995-5#1)(1997-4#1)(2008-10#1)
vectors may##6##2##(1993-12#1)(1994-5#1)(1995-5#1)(1997-4#2)(2008-10#1)
vectors of the##3##3##(2007-11#1)(2008-3#2)
vectors of##19##2##(1991-12#1)(1993-6#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-3#3)(2011-2#1)(2012-12#1)(2012-2#1)
vectors or intermediate hosts##2##4##(2008-8#1)(2013-1#1)
vectors or##5##2##(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)
vectors than##2##2##(1991-9#1)(2008-10#1)
vectors that##5##2##(1994-5#1)(1995-5#1)(2008-11#1)(2010-1#1)(2012-12#1)
vectors to##8##2##(1991-7#1)(1994-11#1)(1994-5#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-9#1)
vectors using##3##2##(1994-12#1)(2008-11#2)
vectors was##3##2##(1997-4#1)(2008-11#1)(2011-3#1)
vectors were constructed##5##3##(1993-12#1)(1997-4#1)(2008-8#1)(2008-9#2)
vectors were##15##2##(1990-5#1)(1993-12#2)(1994-12#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2013-8#1)
vectors which##4##2##(1993-6#1)(1996-6#1)(1997-4#1)(2013-8#1)
vectors with##5##2##(1993-12#1)(1993-2#1)(2008-11#2)(2008-9#1)
vectors##392##1##(1990-11#1)(1990-5#12)(1991-12#3)(1991-5#1)(1991-6#2)(1991-7#5)(1991-9#5)(1992-12#1)(1993-12#24)(1993-2#5)(1993-3#2)(1993-6#4)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#24)(1994-3#1)(1994-5#13)(1994-6#2)(1995-12#1)(1995-2#4)(1995-5#5)(1996-12#2)(1996-6#1)(1997-1#2)(1997-4#25)(1997-7#1)(1997-8#3)(2007-11#7)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#51)(2008-11#53)(2008-12#1)(2008-2#14)(2008-3#12)(2008-4#22)(2008-5#9)(2008-7#2)(2008-8#13)(2008-9#13)(2009-10#2)(2009-5#1)(2009-9#1)(2010-1#4)(2010-8#3)(2011-1#1)(2011-2#2)(2011-3#5)(2012-12#3)(2012-2#9)(2013-1#2)(2013-7#1)(2013-8#2)
vecuronium##6##1##(1993-1#2)(2010-7#3)(2012-2#1)
ved##3##1##(2012-12#3)
vegetable consumption##4##2##(1990-8#1)(2008-7#1)(2009-4#1)(2009-5#1)
vegetable crops##5##2##(1997-6#1)(2008-10#3)(2011-2#1)
vegetable dietary guidelines (p &lt##2##5##(2009-5#2)
vegetable intake##3##2##(1992-10#1)(2008-10#1)(2013-1#1)
vegetable matrices##2##2##(2008-10#2)
vegetable oil##5##2##(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
vegetable oils##15##2##(1990-8#1)(1991-12#1)(2008-10#8)(2009-3#1)(2012-2#1)(2013-1#3)
vegetable samples##9##2##(2008-10#9)
vegetable shortening##2##2##(2008-4#2)
vegetable##73##1##(1990-2#1)(1990-8#2)(1991-12#1)(1992-10#1)(1997-4#3)(1997-6#1)(2008-10#34)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#3)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#3)
vegetables and fruits##2##3##(2008-7#1)(2012-2#1)
vegetables and whole grains##3##4##(2012-12#3)
vegetables and##13##2##(1990-8#1)(1994-2#1)(2008-10#4)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
vegetables grown##2##2##(1992-12#1)(2008-10#1)
vegetables in##4##2##(2008-10#1)(2012-2#3)
vegetables is##3##2##(2008-10#2)(2012-2#1)
vegetables may##2##2##(1994-2#2)
vegetables was##2##2##(2011-1#1)(2012-12#1)
vegetables were##2##2##(2008-10#1)(2013-8#1)
vegetables##82##1##(1990-8#3)(1991-2#1)(1992-10#2)(1992-12#2)(1992-8#1)(1994-2#3)(1997-1#1)(2007-12#1)(2008-10#29)(2008-4#3)(2008-7#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#2)(2012-1#1)(2012-12#7)(2012-2#10)(2013-1#3)(2013-8#1)
vegetal extracts##2##2##(2008-5#2)
vegetal##9##1##(1997-6#1)(2008-10#5)(2008-5#2)(2009-12#1)
vegetans##4##1##(2007-8#2)(2011-2#2)
vegetarian##2##1##(1990-9#1)(1992-9#1)
vegetated##5##1##(2008-11#1)(2008-8#4)
vegetation and##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)
vegetation change##2##2##(2008-8#1)(2008-9#1)
vegetation cover data##2##3##(2008-12#2)
vegetation cover##6##2##(2008-12#6)
vegetation coverage##3##2##(2011-1#3)
vegetation dynamics in##2##3##(1990-8#1)(2008-9#1)
vegetation in##2##2##(2008-8#1)(2008-9#1)
vegetation index##4##2##(2008-8#4)
vegetation indices##2##2##(2013-8#2)
vegetation of##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
vegetation on##3##2##(1990-11#1)(2008-5#1)(2008-8#1)
vegetation type##2##2##(2008-5#1)(2008-9#1)
vegetation types##2##2##(2008-5#1)(2008-9#1)
vegetation was##2##2##(2008-8#1)(2011-1#1)
vegetation##89##1##(1990-11#1)(1990-8#1)(2006-6#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#7)(2008-3#6)(2008-5#9)(2008-8#20)(2008-9#11)(2009-8#1)(2010-8#1)(2011-1#4)(2011-2#1)(2013-1#4)(2013-7#3)(2013-8#9)
vegetations were##2##2##(2007-7#1)(2008-4#1)
vegetations##5##1##(1990-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)
vegetative and reproductive##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-8#1)
vegetative and##8##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-9#1)(2012-8#1)(2013-8#1)
vegetative cell##2##2##(1993-3#1)(2008-12#1)
vegetative cells of##2##3##(2008-10#1)(2008-11#1)
vegetative cells##7##2##(1997-3#2)(2008-10#2)(2008-11#2)(2011-2#1)
vegetative compatibility and##2##3##(2008-10#2)
vegetative compatibility group (VCG)##6##4##(2008-10#6)
vegetative compatibility group##8##3##(2008-10#8)
vegetative compatibility grouping (VCG)##2##4##(2008-10#2)
vegetative compatibility groups (VCGs)##11##4##(2008-10#11)
vegetative compatibility groups##18##3##(2008-10#18)
vegetative compatibility##41##2##(2008-10#41)
vegetative forms and B##2##4##(2007-7#2)
vegetative growth and##2##3##(2008-10#1)(2008-5#1)
vegetative growth##4##2##(1996-6#1)(2008-10#2)(2008-5#1)
vegetative hyphae##2##2##(2008-10#1)(2011-1#1)
vegetative incompatibility (vic) genes##2##4##(2008-10#2)
vegetative incompatibility##4##2##(2008-10#4)
vegetative phase##2##2##(2008-8#2)
vegetative shoots##2##2##(2008-10#2)
vegetative state##9##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-12#1)(1997-5#1)(2008-11#2)(2008-2#2)
vegetative##109##1##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-8#2)(1993-3#1)(1996-6#1)(1997-3#2)(1997-5#1)(2007-5#1)(2007-7#2)(2008-10#62)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#3)(2008-8#7)(2009-10#3)(2009-12#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-8#2)(2013-8#2)
vegetatively compatible##4##2##(2008-10#4)
vegetatively incompatible##4##2##(2008-10#4)
vegetatively##13##1##(1993-6#1)(1997-6#1)(2008-10#10)(2008-5#1)
vehicle accident##5##2##(2008-12#1)(2008-7#2)(2009-4#1)(2012-3#1)
vehicle and##4##2##(1996-12#1)(2008-5#1)(2009-11#1)(2012-12#1)
vehicle by##2##2##(2008-2#1)(2009-7#1)
vehicle control groups##9##3##(2008-9#9)
vehicle control##19##2##(1994-9#1)(2008-10#1)(2008-9#14)(2010-1#1)(2010-5#1)(2013-1#1)
vehicle controls##39##2##(1993-3#2)(2008-9#37)
vehicle effects##2##2##(2008-5#2)
vehicle for the##6##3##(1992-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-12#1)(2008-5#1)
vehicle for##23##2##(1991-2#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-2#2)(1995-5#2)(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#1)
vehicle group##5##2##(1993-12#1)(2008-5#1)(2011-2#1)(2013-8#2)
vehicle in which##3##3##(2008-5#3)
vehicle in##5##2##(1994-8#1)(1997-7#1)(2008-5#3)
vehicle injection##2##2##(1994-8#1)(2012-3#1)
vehicle on##4##2##(1996-2#1)(2008-2#1)(2008-5#2)
vehicle or##5##2##(1994-8#1)(1995-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
vehicle that##2##2##(2008-1#1)(2009-11#1)
vehicle to##7##2##(1992-12#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
vehicle were##2##2##(1992-11#1)(1995-12#1)
vehicle##200##1##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#3)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#4)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#29)(2008-7#3)(2008-8#3)(2008-9#53)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
vehicle-treated animals##2##2##(1993-12#1)(1996-12#1)
vehicle-treated##4##1##(1992-3#1)(1993-12#1)(1995-12#1)(1996-12#1)
vehicles and##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
vehicles for##7##2##(1991-3#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
vehicles on the release and##2##5##(2008-3#1)(2008-5#1)
vehicles on the##3##3##(2008-3#1)(2008-5#2)
vehicles were characterized##2##3##(2008-11#1)(2008-5#1)
vehicles were##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
vehicles##46##1##(1990-6#1)(1991-3#1)(1993-1#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-3#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#8)(2008-7#1)(2008-8#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
vehicles)##2##1##(1997-6#1)(2008-5#1)
vehicular##4##1##(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#1)
veiling glare##4##2##(2008-3#4)
veiling##5##1##(2008-3#5)
vein and the##4##3##(1992-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
vein and##12##2##(1992-12#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
vein as##2##2##(2007-8#1)(2011-2#1)
vein at the##3##3##(1996-9#1)(2007-7#1)(2011-2#1)
vein bypass##3##2##(1990-9#1)(1996-2#1)(2007-8#1)
vein endothelial cells##30##3##(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#5)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)
vein endothelial##33##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1997-1#2)(2008-10#4)(2008-11#7)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2012-2#2)(2013-8#1)
vein formation##3##2##(2009-6#3)
vein graft##18##2##(1990-3#1)(1996-2#1)(2006-6#1)(2007-8#10)(2008-10#1)(2008-9#2)(2009-5#1)(2011-3#1)
vein grafts##8##2##(1991-3#1)(2007-8#4)(2007-9#1)(2008-7#1)(2008-9#1)
vein harvest##2##2##(2009-7#1)(2011-3#1)
vein in the##2##3##(1993-5#1)(2013-8#1)
vein in##9##2##(1993-5#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-3#4)(2013-8#1)
vein is a rare##2##4##(2008-11#1)(2010-11#1)
vein is##4##2##(1991-6#1)(1992-12#1)(2008-11#1)(2010-11#1)
vein necrosis##2##2##(2008-10#2)
vein occlusion and##2##3##(1991-5#1)(2011-1#1)
vein occlusion##7##2##(1991-5#1)(2011-1#3)(2011-2#2)(2013-1#1)
vein occlusions##2##2##(2011-1#2)
vein of Galen malformation##4##4##(1996-6#4)
vein of Galen##5##3##(1996-6#4)(1996-9#1)
vein of##16##2##(1995-2#1)(1996-6#5)(1996-9#3)(2006-12#2)(2007-8#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
vein or artery##2##3##(1996-3#1)(2008-4#1)
vein or##4##2##(1991-6#1)(1996-3#1)(2008-1#1)(2008-4#1)
vein stenosis##6##2##(2008-1#6)
vein thrombosis in##3##3##(1992-9#1)(2009-1#1)(2012-2#1)
vein thrombosis##15##2##(1992-9#2)(1997-8#3)(2006-10#1)(2007-10#2)(2007-12#1)(2009-1#1)(2010-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
vein transposition##4##2##(2007-7#2)(2008-1#2)
vein was##3##2##(1993-5#1)(2008-4#1)(2011-2#1)
vein were found in##2##4##(2012-3#2)
vein were##4##2##(1993-6#1)(2008-7#1)(2012-3#2)
vein with##2##2##(2008-1#1)(2008-7#1)
vein yellowing##2##2##(2008-10#2)
vein##299##1##(1990-3#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#1)(1992-12#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#1)(1996-2#4)(1996-3#1)(1996-6#6)(1996-9#5)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#5)(2006-10#2)(2006-12#2)(2006-6#1)(2007-10#3)(2007-12#1)(2007-7#13)(2007-8#22)(2007-9#1)(2008-1#20)(2008-10#30)(2008-11#10)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#3)(2008-9#6)(2009-1#1)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#6)(2009-7#2)(2009-9#2)(2010-1#2)(2010-11#4)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#8)(2011-2#20)(2011-3#7)(2011-8#1)(2012-12#3)(2012-2#8)(2012-3#12)(2013-1#8)(2013-2#2)(2013-8#7)
vein)##2##1##(1994-7#2)
veinal mottle virus##4##3##(2008-10#4)
veinal necrosis##3##2##(2008-10#3)
veinal##7##1##(2008-10#7)
veins and##16##2##(1991-9#1)(1995-11#1)(2007-8#3)(2008-1#1)(2008-7#4)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#2)
veins are##5##2##(1996-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)
veins as##2##2##(2008-10#1)(2008-7#1)
veins in the##2##3##(2009-6#1)(2011-2#1)
veins in##6##2##(1995-12#2)(2009-6#1)(2011-2#1)(2012-3#2)
veins is##2##2##(1993-5#1)(2011-3#1)
veins of##4##2##(1995-12#1)(2007-2#1)(2008-7#1)(2012-3#1)
veins to##2##2##(1997-1#1)(2006-6#1)
veins were##4##2##(1994-6#1)(1995-12#1)(2008-10#1)(2010-8#1)
veins without endothelium##2##3##(1995-12#2)
veins without##3##2##(1995-12#2)(2011-2#1)
veins##111##1##(1991-6#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#12)(1996-2#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#13)(2008-8#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#3)(2012-2#1)(2012-3#9)(2012-9#1)(2013-1#6)(2013-8#1)
velocimeter based on##2##3##(2008-3#2)
velocimeter has been##2##3##(2008-2#1)(2008-3#1)
velocimeter that##2##2##(2008-3#2)
velocimeter##16##1##(2007-11#1)(2008-2#2)(2008-3#13)
velocimetry (PIV)##3##2##(2008-2#2)(2008-3#1)
velocimetry and##6##2##(1994-3#1)(2008-2#1)(2008-3#4)
velocimetry at##2##2##(2008-3#1)(2011-2#1)
velocimetry in##3##2##(2007-11#1)(2008-3#2)
velocimetry with##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
velocimetry##46##1##(1994-11#1)(1994-3#3)(2007-11#2)(2007-12#4)(2008-2#8)(2008-3#24)(2011-2#4)
velocities and##2##2##(1996-6#1)(2008-11#1)
velocities are determined##2##3##(1992-3#1)(2008-3#1)
velocities can##2##2##(1992-3#1)(2008-3#1)
velocities in the range##2##4##(2007-12#1)(2008-2#1)
velocities in the##7##3##(1996-2#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
velocities in##8##2##(1996-2#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
velocities may##2##2##(2008-9#1)(2009-5#1)
velocities of pandemic spread##2##4##(2008-10#2)
velocities of the##2##3##(2007-11#1)(2007-12#1)
velocities of##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)
velocities were##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
velocities##50##1##(1992-3#2)(1993-3#1)(1993-8#1)(1995-2#1)(1996-2#1)(1996-6#3)(1997-3#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-6#3)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
velocity (EDV)##2##2##(2008-1#1)(2013-8#1)
velocity (Vmax)##2##2##(1993-8#1)(1995-11#1)
velocity and length##2##3##(2008-3#2)
velocity and temperature##2##3##(2008-2#2)
velocity and the##12##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-6#1)(2011-2#1)
velocity and##30##2##(1994-12#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#8)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
velocity are##5##2##(2008-2#1)(2008-3#4)
velocity at##3##2##(1996-4#1)(1997-2#1)(2013-1#1)
velocity breakpoint##2##2##(2008-7#2)
velocity by##2##2##(2008-3#1)(2011-2#1)
velocity c##2##2##(2010-8#2)
velocity changes##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
velocity component##2##2##(2007-11#1)(2008-2#1)
velocity components##2##2##(2008-3#2)
velocity did not change##2##4##(1990-3#1)(2008-11#1)
velocity difference##3##2##(1990-8#1)(2008-3#2)
velocity during##2##2##(1991-9#1)(2009-1#1)
velocity estimates##3##2##(2008-2#2)(2008-3#1)
velocity estimators##2##2##(2008-2#2)
velocity field##5##2##(2008-2#1)(2009-5#4)
velocity fields in##2##3##(2007-11#1)(2008-3#1)
velocity flow##2##2##(2008-4#1)(2008-7#1)
velocity for the##3##3##(2008-3#1)(2008-8#1)(2010-8#1)
velocity for##4##2##(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)
velocity gradient##4##2##(2008-3#4)
velocity in heterogenous biofilms##2##4##(2008-7#2)
velocity in the ipsilateral middle cerebral artery##2##7##(2007-10#2)
velocity in the##6##3##(1996-6#1)(2007-10#2)(2007-8#1)(2008-2#1)(2008-3#1)
velocity in##16##2##(1996-3#1)(1996-6#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
velocity increased##3##2##(1997-7#1)(2008-6#1)(2012-1#1)
velocity information##4##2##(2008-3#4)
velocity is##7##2##(2007-11#1)(2008-3#4)(2008-9#1)(2009-6#1)
velocity mapping in turbid media##2##5##(2007-12#2)
velocity may##2##2##(1991-2#1)(2008-7#1)
velocity measurement##6##2##(1996-2#1)(2007-11#1)(2008-2#1)(2008-3#3)
velocity measurements of##2##3##(2008-3#2)
velocity measurements##8##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
velocity mismatch##2##2##(2007-11#1)(2008-2#1)
velocity of a##6##3##(2008-3#3)(2011-1#1)(2011-2#2)
velocity of contraction##2##3##(1997-7#2)
velocity of pandemic spread##2##4##(2008-10#2)
velocity of the red cells##2##5##(2008-3#2)
velocity of the##14##3##(1996-3#1)(1996-6#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-8#1)(2011-2#4)
velocity of##62##2##(1991-11#1)(1991-12#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-7#2)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#14)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#7)(2012-1#2)
velocity or##2##2##(2007-10#1)(2011-2#1)
velocity profile##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
velocity profiles##3##2##(1997-2#1)(2008-7#2)
velocity range##2##2##(2007-11#1)(2007-12#1)
velocity sedimentation##3##2##(1990-12#1)(1993-8#1)(2008-1#1)
velocity still##2##2##(1991-9#1)(2008-8#1)
velocity that##2##2##(1991-9#1)(2008-2#1)
velocity to be##2##3##(2008-3#1)(2008-4#1)
velocity to##7##2##(1993-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)
velocity up##2##2##(1993-12#1)(2008-11#1)
velocity vector##2##2##(2009-4#1)(2011-2#1)
velocity was##6##2##(1995-3#1)(2008-7#3)(2008-8#1)(2010-9#1)
velocity with##3##2##(2007-11#2)(2008-3#1)
velocity##365##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#6)(1992-3#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-5#1)(1995-11#3)(1995-3#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#5)(1997-2#2)(1997-7#4)(2007-10#10)(2007-11#24)(2007-12#17)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#16)(2008-11#13)(2008-12#2)(2008-2#31)(2008-3#85)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#17)(2012-1#4)(2012-3#1)(2013-1#7)(2013-3#1)(2013-7#2)(2013-8#4)
velocity)##4##1##(2008-10#2)(2008-9#1)(2010-8#1)
velogenic##4##1##(1997-3#1)(2007-6#2)(2008-11#1)
velvetleaf leaves##2##2##(2008-10#2)
velvetleaf##3##1##(2008-10#3)
vena cava and##5##3##(1995-12#1)(2007-8#2)(2008-11#1)(2010-4#1)
vena cava disease##2##3##(2008-7#2)
vena cava in##2##3##(1992-9#1)(2007-8#1)
vena cava is a##2##4##(2008-12#1)(2008-7#1)
vena cava syndrome##5##3##(1993-9#1)(1995-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
vena cava was##4##3##(2007-7#1)(2007-8#2)(2010-4#1)
vena cava##62##2##(1991-8#1)(1992-9#3)(1993-5#1)(1993-9#1)(1995-12#4)(1995-8#1)(1997-8#1)(2007-7#1)(2007-8#16)(2008-1#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#7)(2010-11#3)(2010-4#3)(2011-2#5)(2012-2#2)(2013-1#3)
vena caval##2##2##(2007-8#1)(2011-2#1)
vena##66##1##(1991-8#1)(1992-9#3)(1993-5#1)(1993-9#1)(1995-12#4)(1995-8#1)(1997-8#1)(2007-7#1)(2007-8#17)(2008-1#2)(2008-11#5)(2008-12#2)(2008-4#1)(2008-7#7)(2009-5#1)(2010-11#3)(2010-4#3)(2011-2#6)(2011-3#1)(2012-2#2)(2013-1#3)
vending##2##1##(1996-1#1)(2007-12#1)
vendor##12##1##(1991-1#1)(1991-3#1)(1992-12#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#3)(2011-2#1)
vendors and users##2##3##(1991-3#2)
vendors and##3##2##(1991-3#2)(2010-8#1)
vendors##20##1##(1991-3#2)(1993-12#2)(1994-1#2)(1994-2#1)(1994-3#2)(1995-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-7#1)
veneer##6##1##(2009-8#2)(2013-1#4)
veneering##2##1##(2010-12#1)(2011-2#1)
veneers over discolored backgrounds##2##4##(2009-8#2)
veneers##4##1##(2009-8#4)
venepuncture##2##1##(2008-11#1)(2012-2#1)
venereal##3##1##(1991-6#2)(2013-1#1)
venerealis##3##1##(2011-1#3)
venipuncture##4##1##(1994-12#1)(1997-7#1)(2010-11#1)(2011-2#1)
venlafaxine and mirtazapine##2##3##(2010-5#2)
venlafaxine##6##1##(2008-11#1)(2008-9#1)(2010-5#2)(2012-2#2)
veno-occlusive disease##2##2##(2010-10#2)
venographic##3##1##(2008-1#1)(2012-3#2)
venography##11##1##(1993-9#1)(2007-10#1)(2007-7#4)(2007-8#1)(2012-3#3)(2013-1#1)
venom gland##2##2##(2008-7#2)
venom of Agkistrodon halys Pallas##2##5##(2008-8#2)
venom of the##5##3##(1990-5#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-5#1)
venom of##13##2##(1990-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#2)(1995-8#1)(2008-5#2)(2008-8#2)
venom proteins##2##2##(1993-3#2)
venom was##3##2##(1992-8#1)(1994-3#1)(2008-5#1)
venom##45##1##(1990-5#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#4)(1993-6#2)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-5#4)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#7)(2008-7#4)(2008-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
venoms##7##1##(1990-5#3)(1992-8#1)(1993-11#1)(2008-5#1)(2008-8#1)
venosus##2##1##(2008-11#1)(2008-5#1)
venous abnormalities##3##2##(2008-7#1)(2012-3#2)
venous access can##2##3##(2011-2#2)
venous access##9##2##(2007-7#3)(2009-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
venous and##4##2##(2008-10#1)(2010-12#1)(2011-3#1)(2012-12#1)
venous anomalies##3##2##(2008-9#1)(2010-11#1)(2012-3#1)
venous anomaly of##2##3##(2010-11#1)(2012-2#1)
venous anomaly##4##2##(2010-11#2)(2011-2#1)(2012-2#1)
venous blood and##2##3##(1994-7#1)(2011-2#1)
venous blood samples were taken before##2##6##(1990-3#1)(2013-8#1)
venous blood samples were##3##4##(1990-3#1)(1991-6#1)(2013-8#1)
venous blood samples##4##3##(1990-3#1)(1991-6#1)(2008-7#1)(2013-8#1)
venous blood##14##2##(1990-3#1)(1991-1#1)(1991-6#1)(1994-7#2)(1997-1#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
venous cannulation##2##2##(2008-1#1)(2010-11#1)
venous catheter insertion##2##3##(2008-1#1)(2010-6#1)
venous catheter##21##2##(1990-8#1)(1991-5#1)(2007-7#7)(2008-1#1)(2008-7#6)(2010-6#1)(2011-2#3)(2013-1#1)
venous catheterization##2##2##(2008-7#1)(2010-10#1)
venous catheters##7##2##(1990-3#1)(2007-7#1)(2008-1#2)(2008-7#3)
venous channels##2##2##(2008-7#1)(2012-3#1)
venous disorders##4##2##(2008-3#1)(2010-7#3)
venous drainage and##2##3##(1996-9#1)(2008-7#1)
venous drainage is##2##3##(1996-9#1)(2010-8#1)
venous drainage of the##2##4##(1996-9#2)
venous drainage##14##2##(1996-9#4)(2008-7#6)(2010-8#1)(2012-12#1)(2012-3#2)
venous dysfunction##2##2##(2010-7#2)
venous embolization##4##2##(1997-8#2)(2008-7#1)(2012-12#1)
venous flow##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
venous graft##2##2##(2007-8#1)(2011-2#1)
venous hypertension##2##2##(2008-7#2)
venous infarction##2##2##(1996-9#1)(2007-10#1)
venous insufficiency and##2##3##(2008-5#1)(2011-3#1)
venous insufficiency may##2##3##(2013-1#2)
venous insufficiency##22##2##(1990-3#2)(2007-8#1)(2008-5#1)(2011-3#2)(2012-3#8)(2013-1#8)
venous leg ulcer##2##3##(1997-3#2)
venous leg ulcers##3##3##(1990-6#1)(1997-3#2)
venous leg##6##2##(1990-6#1)(1997-3#5)
venous malformations##2##2##(2007-7#1)(2012-1#1)
venous occlusion##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
venous or arterial##2##3##(1996-3#1)(2008-10#1)
venous outflow##2##2##(2008-7#1)(2009-8#1)
venous outlet##2##2##(1996-9#2)
venous phase##2##2##(2008-7#1)(2013-1#1)
venous phases##2##2##(2010-12#1)(2013-1#1)
venous plasma##4##2##(1990-5#3)(1994-3#1)
venous plexus##14##2##(1996-9#2)(2009-6#2)(2011-2#10)
venous plexuses##3##2##(2011-2#3)
venous pressure##6##2##(1990-9#1)(1991-5#1)(2007-8#2)(2008-7#1)(2010-8#1)
venous return and##2##3##(1996-3#1)(2013-7#1)
venous return##4##2##(1996-3#1)(2007-8#2)(2013-7#1)
venous sinus thrombosis##3##3##(1997-6#2)(2007-10#1)
venous sinus##5##2##(1996-9#2)(1997-6#2)(2007-10#1)
venous stenosis##2##2##(1997-8#1)(2008-1#1)
venous stroke##4##2##(2007-10#4)
venous system in##2##3##(2008-9#1)(2013-2#1)
venous system##6##2##(2008-9#1)(2011-2#2)(2011-3#2)(2013-2#1)
venous thromboembolic disease##4##3##(1996-3#1)(1996-9#1)(2007-8#2)
venous thromboembolic##6##2##(1996-3#1)(1996-9#1)(2007-8#2)(2010-6#1)(2013-1#1)
venous thromboembolism (VTE)##3##3##(2007-10#1)(2007-2#1)(2011-2#1)
venous thromboembolism after##3##3##(2007-10#1)(2013-1#2)
venous thromboembolism and##2##3##(2008-3#1)(2008-7#1)
venous thromboembolism in##4##3##(1993-5#2)(2010-11#2)
venous thromboembolism##30##2##(1993-5#4)(1996-11#2)(1997-2#1)(1997-5#4)(2007-10#4)(2007-2#1)(2008-3#3)(2008-7#1)(2010-11#3)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#3)
venous thrombosis after##2##3##(1990-6#1)(2007-10#1)
venous thrombosis and pulmonary embolism##4##5##(1997-2#1)(2008-12#1)(2012-3#1)(2013-1#1)
venous thrombosis in##6##3##(1996-6#1)(2008-7#1)(2008-9#1)(2010-11#2)(2012-3#1)
venous thrombosis with##2##3##(2008-10#1)(2008-8#1)
venous thrombosis##36##2##(1990-6#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-9#1)(1996-6#2)(1997-2#1)(1997-3#2)(2007-10#5)(2007-2#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-11#2)(2011-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
venous thrombus##3##2##(2007-8#1)(2008-9#1)(2013-1#1)
venous vascular##3##2##(2007-7#1)(2013-8#2)
venous vessels##2##2##(1990-3#1)(1997-6#1)
venous wall##3##2##(2007-8#1)(2009-7#2)
venous##357##1##(1990-3#9)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-5#6)(1993-9#1)(1994-3#1)(1994-5#1)(1994-7#3)(1994-9#3)(1995-11#1)(1996-11#2)(1996-3#3)(1996-6#2)(1996-9#17)(1997-1#1)(1997-2#2)(1997-3#7)(1997-5#5)(1997-6#4)(1997-8#3)(2007-10#15)(2007-2#3)(2007-7#20)(2007-8#12)(2008-1#7)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#7)(2008-5#2)(2008-7#39)(2008-8#4)(2008-9#8)(2009-4#1)(2009-6#4)(2009-7#3)(2009-8#3)(2010-10#1)(2010-11#10)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#8)(2010-8#3)(2011-1#1)(2011-2#33)(2011-3#6)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#23)(2013-1#22)(2013-2#1)(2013-7#2)(2013-8#4)
venous-venous anastomoses##2##2##(2008-9#2)
venovenous##3##1##(2007-8#1)(2008-4#1)(2009-7#1)
vent##14##1##(1991-3#6)(2008-10#3)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)
ventilated and##3##2##(2008-3#1)(2008-7#1)(2010-7#1)
ventilated##21##1##(1990-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#2)
ventilation and perfusion##2##3##(1997-1#1)(2008-1#1)
ventilation and the##3##3##(1995-2#1)(1996-9#1)(2007-11#1)
ventilation and##17##2##(1992-12#1)(1992-5#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
ventilation for##4##2##(1996-12#1)(2008-1#1)(2012-2#1)(2013-7#1)
ventilation have been##2##3##(2008-5#1)(2010-5#1)
ventilation in the##2##3##(1995-2#1)(2007-6#1)
ventilation in##9##2##(1994-6#1)(1995-2#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-6#2)(2013-7#1)(2013-8#1)
ventilation is##2##2##(1994-6#1)(2013-7#1)
ventilation of##5##2##(1990-3#1)(1994-6#2)(2007-11#1)(2008-4#1)
ventilation was##3##2##(1990-12#1)(2007-8#1)(2010-7#1)
ventilation while on cardiopulmonary bypass##2##5##(2007-8#2)
ventilation with##2##2##(1991-6#1)(2010-7#1)
ventilation##113##1##(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#10)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1996-12#7)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#2)(2006-10#6)(2007-10#2)(2007-11#4)(2007-6#4)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#1)(2010-5#5)(2010-6#1)(2010-7#5)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#6)(2013-8#1)
ventilation)##2##1##(2009-10#1)(2013-1#1)
ventilation-perfusion##3##1##(2010-6#2)(2013-7#1)
ventilator associated##2##2##(2008-10#1)(2010-7#1)
ventilator##24##1##(1993-3#1)(1995-12#2)(1995-5#1)(2007-8#1)(2008-10#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#7)
ventilator-associated pneumonia##2##2##(2013-1#2)
ventilators##10##1##(1994-6#1)(2010-5#1)(2011-1#4)(2011-2#3)(2013-8#1)
ventilatory support and##2##3##(2007-8#1)(2009-3#1)
ventilatory support##6##2##(1993-10#1)(2006-10#1)(2007-8#2)(2009-3#1)(2012-2#1)
ventilatory##26##1##(1992-2#2)(1993-10#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-2#2)(1997-1#1)(2006-10#1)(2007-8#3)(2008-1#1)(2008-7#2)(2009-3#1)(2012-2#2)(2012-3#1)(2013-7#4)(2013-8#1)
venting##2##1##(1996-12#1)(2008-10#1)
ventral and##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
ventral cochlear##3##2##(1993-12#1)(1996-12#1)(1996-2#1)
ventral eyespots##2##2##(2008-9#2)
ventral ganglia##2##2##(1994-2#1)(2008-5#1)
ventral horn##3##2##(1990-7#1)(1995-5#1)(2010-5#1)
ventral keels##2##2##(2008-5#2)
ventral mesencephalic grafts##3##3##(1996-2#3)
ventral midline##2##2##(1990-5#1)(1994-12#1)
ventral nerve cord in##2##4##(2007-12#2)
ventral nerve cord##8##3##(1997-7#1)(2007-12#5)(2008-5#1)(2008-9#1)
ventral nerve cords##2##3##(2007-12#1)(2008-5#1)
ventral nerve##10##2##(1997-7#1)(2007-12#6)(2008-5#2)(2008-9#1)
ventral pallidum##2##2##(1993-6#1)(1997-2#1)
ventral posteromedial##2##2##(2007-10#2)
ventral prostatic##2##2##(1990-7#2)
ventral receptacle##2##2##(2007-12#2)
ventral root of the##2##4##(1993-12#2)
ventral root of##3##3##(1993-12#3)
ventral root##7##2##(1993-12#7)
ventral roots##3##2##(1992-8#1)(1993-12#2)
ventral somite##2##2##(1994-12#2)
ventral striatal##3##2##(1992-10#1)(2011-1#2)
ventral striatum##12##2##(1993-6#6)(1994-2#3)(1994-8#1)(2011-1#1)(2013-8#1)
ventral subiculum and##2##3##(1993-6#2)
ventral subiculum lesions##2##3##(1993-6#2)
ventral subiculum##5##2##(1993-6#5)
ventral tegmental area (VTA) and##3##5##(1996-12#1)(1996-5#1)(2009-8#1)
ventral tegmental area (VTA)##9##4##(1993-12#3)(1996-12#2)(1996-5#1)(2008-7#2)(2009-8#1)
ventral tegmental area##17##3##(1993-12#4)(1995-12#1)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#3)(2009-8#1)
ventral wing##2##2##(2008-9#2)
ventral##171##1##(1990-11#1)(1990-5#1)(1990-7#4)(1991-2#1)(1991-5#1)(1992-10#2)(1992-8#3)(1993-12#18)(1993-3#1)(1993-6#13)(1994-12#4)(1994-2#5)(1994-8#1)(1995-12#5)(1995-5#2)(1996-12#8)(1996-2#5)(1996-5#2)(1997-2#3)(1997-3#3)(1997-7#2)(2007-10#2)(2007-12#23)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#16)(2008-6#3)(2008-7#4)(2008-9#5)(2009-12#2)(2009-5#6)(2009-7#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
ventralizing##3##1##(1994-12#1)(2008-6#2)
ventrally into##2##2##(2007-12#2)
ventrally##4##1##(1994-12#1)(2007-12#2)(2011-2#1)
ventricle (LV)##2##2##(1991-3#1)(1992-8#1)
ventricle and##7##2##(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#2)(2012-2#1)(2013-8#1)
ventricle anterior##2##2##(2011-2#2)
ventricle are##2##2##(2008-7#1)(2009-12#1)
ventricle assistance##4##2##(2012-3#4)
ventricle ejection fraction##2##3##(2011-2#1)(2013-1#1)
ventricle free##2##2##(2008-7#2)
ventricle in##8##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#2)
ventricle of the##2##3##(1990-7#1)(2007-7#1)
ventricle of##5##2##(1990-7#1)(1994-11#1)(1995-12#1)(2007-7#1)(2010-2#1)
ventricle or##2##2##(1991-12#1)(2007-8#1)
ventricle presenting##2##2##(2008-7#2)
ventricle through##2##2##(1993-12#1)(2008-7#1)
ventricle wall##2##2##(1996-6#1)(2009-12#1)
ventricle was##2##2##(2011-2#1)(2013-1#1)
ventricle with##3##2##(1992-9#1)(2010-10#1)(2010-8#1)
ventricle##114##1##(1990-7#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#2)(1993-12#2)(1994-11#1)(1994-2#1)(1995-12#3)(1995-5#1)(1996-5#1)(1996-6#1)(1996-7#3)(1997-8#1)(2007-12#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#21)(2008-8#1)(2009-10#1)(2009-12#5)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#1)
ventricle]##2##1##(2008-10#1)(2013-1#1)
ventricles and##3##2##(1991-12#1)(1996-5#1)(2010-9#1)
ventricles is##3##2##(2008-7#1)(2009-10#1)(2011-2#1)
ventricles of##4##2##(1992-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
ventricles##27##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1993-12#1)(1995-5#1)(1995-8#1)(1996-5#3)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#2)
ventricular (LV)##5##2##(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
ventricular action potential##2##3##(2008-8#2)
ventricular activation time##3##3##(2008-7#3)
ventricular and##3##2##(1995-12#1)(2008-8#1)(2012-12#1)
ventricular aneurysm##3##2##(2007-8#3)
ventricular apical##3##2##(2009-6#1)(2010-5#1)(2012-2#1)
ventricular arrhythmias##13##2##(1990-6#1)(1991-8#1)(1992-6#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2009-10#3)(2010-6#1)(2011-2#1)(2012-3#1)
ventricular assist device##5##3##(2007-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
ventricular assist devices (VADs)##3##4##(2010-6#2)(2012-3#1)
ventricular assist devices##8##3##(2008-8#1)(2010-6#4)(2011-2#2)(2012-3#1)
ventricular assist##14##2##(2007-8#2)(2008-8#1)(2010-6#4)(2010-8#1)(2011-2#4)(2012-3#2)
ventricular cardiomyocytes in##2##3##(2008-7#1)(2011-1#1)
ventricular cardiomyocytes##3##2##(2008-11#1)(2008-7#1)(2011-1#1)
ventricular cell models##2##3##(2008-11#2)
ventricular cell##4##2##(2008-11#4)
ventricular cells##2##2##(2008-11#2)
ventricular cerebrospinal fluid##2##3##(2006-7#1)(2011-2#1)
ventricular chamber##2##2##(2009-10#1)(2012-12#1)
ventricular contraction and##2##3##(2007-8#1)(2008-10#1)
ventricular contraction##6##2##(1991-2#1)(2007-8#3)(2008-10#2)
ventricular dilatation##4##2##(1995-3#1)(1997-3#1)(2008-12#1)(2012-3#1)
ventricular disorders of the cardiac rhythm##2##6##(2011-1#2)
ventricular disorders of##3##3##(2011-1#3)
ventricular disorders##4##2##(2011-1#4)
ventricular dysfunction##17##2##(1990-12#1)(1992-12#1)(1992-5#1)(1994-7#1)(1996-6#1)(1996-9#1)(2007-8#3)(2008-12#1)(2008-3#2)(2009-1#1)(2010-5#1)(2010-6#1)(2011-2#2)
ventricular ejection fraction##12##3##(1995-3#1)(1997-5#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
ventricular ejection##13##2##(1995-3#1)(1997-5#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-7#1)
ventricular endomyocardial fibrosis##2##3##(2007-8#1)(2009-5#1)
ventricular enlargement##2##2##(1996-7#2)
ventricular extra##2##2##(2011-1#2)
ventricular extrasystoles##4##2##(1992-5#1)(1996-3#2)(2012-1#1)
ventricular failure##5##2##(1990-9#1)(1996-3#1)(2007-8#1)(2010-5#1)(2010-6#1)
ventricular fibrillation during##2##3##(1995-12#1)(2008-12#1)
ventricular fibrillation##12##2##(1990-12#1)(1992-6#1)(1995-12#3)(1996-3#2)(2008-10#1)(2008-12#1)(2009-10#1)(2010-1#2)
ventricular function in##3##3##(2009-10#1)(2010-4#1)(2012-2#1)
ventricular function##19##2##(1990-9#2)(1995-3#1)(1996-6#1)(1997-3#1)(2007-8#3)(2007-9#2)(2008-3#1)(2009-10#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
ventricular hypertrophy and##5##3##(2007-7#1)(2008-1#1)(2010-8#1)(2013-1#1)(2013-8#1)
ventricular hypertrophy is##2##3##(2008-7#1)(2009-1#1)
ventricular hypertrophy##22##2##(1992-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-1#2)(2010-8#4)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
ventricular infarction##2##2##(1993-9#1)(1997-3#1)
ventricular mass##9##2##(1995-3#2)(1997-8#1)(2011-2#1)(2012-12#1)(2012-3#4)
ventricular myocardial##4##2##(1990-11#1)(2008-12#3)
ventricular myocardium##2##2##(1990-11#1)(1992-6#1)
ventricular myocytes##10##2##(1993-3#2)(1994-12#1)(1994-6#1)(1994-8#3)(1995-5#1)(2008-8#1)(2013-1#1)
ventricular or##3##2##(2008-3#1)(2009-6#1)(2012-3#1)
ventricular outflow tract obstruction##3##4##(2007-9#1)(2011-1#1)(2012-2#1)
ventricular outflow tract##10##3##(2007-8#1)(2007-9#2)(2011-1#3)(2012-2#1)(2013-2#1)(2013-8#2)
ventricular penetration##2##2##(2007-8#2)
ventricular performance##2##2##(1994-12#1)(2008-5#1)
ventricular premature depolarizations##2##3##(1995-12#2)
ventricular premature##3##2##(1995-12#2)(1996-3#1)
ventricular pressure (LVP)##2##3##(1993-1#1)(2007-8#1)
ventricular rate##4##2##(1990-9#1)(2010-12#2)(2012-3#1)
ventricular remodeling and##2##3##(2009-10#1)(2012-12#1)
ventricular remodeling##5##2##(2009-10#1)(2011-2#1)(2012-12#2)(2013-8#1)
ventricular septal defect in the##2##5##(1992-2#1)(2012-12#1)
ventricular septal defect in##3##4##(1992-2#1)(2012-1#1)(2012-12#1)
ventricular septal defect##11##3##(1992-2#1)(2007-8#5)(2008-7#1)(2012-1#1)(2012-12#2)(2013-8#1)
ventricular septal defects##2##3##(2007-9#1)(2013-1#1)
ventricular septal##19##2##(1992-2#1)(2007-8#6)(2007-9#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
ventricular shunts##2##2##(1996-11#1)(2010-6#1)
ventricular tachyarrhythmia##2##2##(1992-6#1)(2008-3#1)
ventricular tachyarrhythmias##2##2##(1993-2#1)(2012-2#1)
ventricular tachycardia and fibrillation##3##4##(1995-12#3)
ventricular tachycardia and ventricular fibrillation##2##5##(1995-12#1)(1996-3#1)
ventricular tachycardia and##7##3##(1995-12#4)(1996-3#1)(2008-11#1)(2008-12#1)
ventricular tachycardia induction##2##3##(1990-3#2)
ventricular tachycardia of torsade de pointes type##2##7##(2008-7#2)
ventricular tachycardia was##3##3##(1990-3#1)(1995-12#1)(2007-8#1)
ventricular tachycardia##29##2##(1990-3#6)(1994-11#1)(1995-12#5)(1996-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-10#2)(2009-4#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
ventricular tissue##2##2##(1996-9#1)(2008-8#1)
ventricular volume##7##2##(2011-2#7)
ventricular wall stress##2##3##(2008-7#1)(2009-1#1)
ventricular wall thickness##2##3##(1993-12#1)(2012-2#1)
ventricular wall##8##2##(1991-12#1)(1993-12#2)(1997-3#2)(2008-7#1)(2009-1#1)(2012-2#1)
ventricular zone##3##2##(1996-2#1)(1996-5#1)(2008-11#1)
ventricular##424##1##(1990-11#2)(1990-12#2)(1990-3#7)(1990-6#1)(1990-9#4)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-6#1)(1994-7#1)(1994-8#4)(1995-11#2)(1995-12#14)(1995-3#8)(1995-5#2)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#14)(1996-5#2)(1996-6#2)(1996-7#4)(1996-9#3)(1997-3#6)(1997-5#2)(1997-6#1)(1997-8#3)(2006-10#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#35)(2007-9#5)(2008-1#2)(2008-10#9)(2008-11#18)(2008-12#21)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#21)(2008-8#6)(2009-1#5)(2009-10#11)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#5)(2010-6#9)(2010-8#7)(2011-1#10)(2011-2#32)(2012-1#2)(2012-12#11)(2012-2#19)(2012-3#15)(2013-1#11)(2013-2#1)(2013-7#5)(2013-8#9)
ventriculo-peritoneal##3##1##(2008-7#2)(2012-12#1)
ventriculography##3##1##(1991-2#2)(2011-2#1)
ventriculomegaly##3##1##(1997-3#2)(2012-3#1)
ventriculoperitoneal shunt##6##2##(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)
ventriculoperitoneal##8##1##(2010-11#1)(2011-2#2)(2012-12#4)(2012-2#1)
ventriculostomy##7##1##(2007-10#5)(2008-2#1)(2011-2#1)
ventro-lateral##4##1##(1992-8#2)(2008-5#1)(2008-9#1)
ventrobasal##3##1##(1994-2#2)(2008-1#1)
ventrolateral medulla##8##2##(1993-12#1)(1996-5#1)(1997-2#2)(1997-6#2)(2007-10#2)
ventrolateral pons##2##2##(1993-3#2)
ventrolateral##22##1##(1992-11#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-2#2)(1994-3#2)(1996-5#1)(1997-2#2)(1997-6#4)(2007-10#2)(2007-12#3)
ventrolaterally on the second and third abdominal##2##7##(2007-12#2)
ventromedial and##5##2##(1990-7#2)(1991-2#1)(1991-5#1)(1994-2#1)
ventromedial nucleus##3##2##(1994-2#1)(2008-4#1)(2008-9#1)
ventromedial prefrontal cortex##4##3##(2008-11#3)(2013-1#1)
ventromedial##15##1##(1990-7#2)(1991-2#1)(1991-5#1)(1993-12#1)(1994-2#3)(2008-11#3)(2008-4#2)(2008-9#1)(2013-1#1)
vents##2##1##(2008-7#1)(2011-2#1)
venture of##2##2##(2008-3#1)(2008-5#1)
venture##20##1##(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-3#4)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#1)
ventures##15##1##(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#2)(1993-12#1)(2008-11#8)
venturing##2##1##(1993-1#1)(2008-9#1)
venue##3##1##(2008-5#1)(2009-5#1)(2012-2#1)
venues in##3##2##(2008-1#1)(2008-12#1)(2009-5#1)
venular resistance##4##2##(2008-3#4)
venular##7##1##(1995-12#1)(2008-3#6)
venules and##2##2##(1997-1#1)(2008-7#1)
venules##7##1##(1995-12#1)(1997-1#2)(1997-7#1)(2007-12#1)(2008-7#1)(2011-2#1)
venus##2##1##(1990-8#1)(1991-5#1)
vera##4##1##(1993-9#1)(1996-3#1)(2007-7#1)(2009-7#1)
veracity##3##1##(1997-1#1)(2010-3#1)(2012-3#1)
verapamil and##4##2##(1993-3#1)(1994-8#1)(1995-11#1)(2011-3#1)
verapamil in##2##2##(1991-8#2)
verapamil##28##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#3)(1991-9#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#4)(1996-5#2)(2008-10#1)(2008-7#1)(2011-2#2)(2011-3#1)
veratridine##4##1##(1992-3#2)(1995-11#1)(1995-12#1)
veratryl alcohol##2##2##(1993-3#2)
verb inflection##2##2##(2012-1#2)
verb##10##1##(1991-2#1)(2008-4#3)(2012-1#6)
verbal aggression##4##2##(2008-2#4)
verbal and non-verbal##4##3##(1990-3#1)(1997-6#1)(2007-11#1)(2009-2#1)
verbal and visual##2##3##(2007-6#1)(2009-6#1)
verbal and##11##2##(1990-3#1)(1997-6#1)(2007-11#1)(2007-6#1)(2009-2#2)(2009-6#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
verbal description ability##2##3##(2008-7#2)
verbal memory##2##2##(2007-8#1)(2010-7#1)
verbal or non-verbal##2##3##(1990-11#1)(2008-7#1)
verbal self-monitoring mechanisms##2##3##(2008-9#2)
verbal span##3##2##(2007-8#3)
verbal working memory##3##3##(2009-9#1)(2012-3#2)
verbal##68##1##(1990-11#2)(1990-3#1)(1993-1#1)(1995-8#1)(1996-2#3)(1997-6#1)(2007-11#1)(2007-2#1)(2007-6#3)(2007-8#5)(2008-10#5)(2008-2#4)(2008-7#5)(2008-8#1)(2008-9#6)(2009-11#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-7#5)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
verbalization##2##1##(2008-4#2)
verbascoside##5##1##(2008-8#5)
verbatim##8##1##(2008-1#1)(2008-11#3)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
verbenone##3##1##(2011-2#3)
verbs and##3##2##(1996-2#1)(2008-11#1)(2008-4#1)
verbs in##3##2##(1991-2#2)(2008-11#1)
verbs##9##1##(1991-2#2)(1996-2#1)(2008-11#3)(2008-4#2)(2012-1#1)
verdict##5##1##(1995-12#2)(1997-3#1)(1997-5#2)
veredas&quot##2##1##(2008-6#2)
verifiable##3##1##(1994-6#2)(2008-3#1)
verification and theory##2##3##(2008-2#2)
verification and##5##2##(2008-2#4)(2009-2#1)
verification for the##2##3##(1995-3#1)(2010-9#1)
verification for##3##2##(1995-3#1)(2010-9#1)(2012-3#1)
verification of the##15##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#3)(2009-2#1)
verification of##37##2##(1993-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-9#4)(2009-2#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
verification set##2##2##(1995-6#1)(2008-10#1)
verification##82##1##(1990-12#1)(1991-2#2)(1993-12#1)(1994-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#15)(2008-3#17)(2008-4#1)(2008-7#2)(2008-9#5)(2009-10#1)(2009-2#4)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)
verifications of##2##2##(1995-2#1)(2008-7#1)
verifications##4##1##(1995-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
verified a##2##2##(1991-9#1)(2008-10#1)
verified and##2##2##(2008-10#2)
verified as##2##2##(2008-10#1)(2008-9#1)
verified at##2##2##(2008-3#1)(2013-1#1)
verified by DNA sequencing##2##4##(2008-10#1)(2008-8#1)
verified by a##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
verified by comparison of##2##4##(2008-3#1)(2010-12#1)
verified by direct##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
verified by experiment##2##3##(2008-3#2)
verified by measurement of##2##4##(1991-8#1)(2008-3#1)
verified by the analysis of##3##5##(2008-10#3)
verified by the##17##3##(1990-5#1)(2008-10#9)(2008-2#2)(2008-3#3)(2010-12#1)(2010-4#1)
verified by use of##2##4##(2007-11#1)(2008-3#1)
verified by##77##2##(1990-5#1)(1990-6#1)(1991-5#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#4)(2007-12#5)(2008-10#23)(2008-2#5)(2008-3#13)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#2)(2010-4#1)(2011-1#3)(2012-3#1)(2012-4#1)
verified experimentally for##2##3##(1997-6#1)(2008-7#1)
verified experimentally##9##2##(1997-1#1)(1997-6#1)(2008-2#2)(2008-3#4)(2008-7#1)
verified for both##2##3##(2008-3#1)(2008-4#1)
verified for##6##2##(2007-12#1)(2008-10#1)(2008-3#3)(2008-4#1)
verified histologically##2##2##(1990-12#1)(1990-8#1)
verified in a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
verified in the##4##3##(1990-2#1)(2008-10#3)
verified in##14##2##(1990-2#1)(1994-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)
verified on##4##2##(1992-12#1)(2008-10#2)(2010-8#1)
verified or##2##2##(2008-7#1)(2009-4#1)
verified that the##9##3##(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)
verified that##15##2##(1997-4#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#2)(2009-12#1)(2013-1#1)
verified the diagnosis of##2##4##(1991-11#1)(1997-3#1)
verified the effectiveness of the##2##5##(2008-3#2)
verified the##16##2##(1991-11#1)(1991-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2009-9#1)(2013-7#1)
verified through##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
verified to be##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
verified to##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
verified using##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
verified with##8##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-2#1)(2010-4#1)(2012-3#1)
verified##217##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#10)(2007-12#8)(2008-1#1)(2008-10#62)(2008-11#3)(2008-12#2)(2008-2#11)(2008-3#38)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#6)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#5)(2013-7#1)
verifies that the##2##3##(2008-2#1)(2012-2#1)
verifies that##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
verifies the##4##2##(2008-3#2)(2009-8#1)(2012-2#1)
verifies##7##1##(2008-2#1)(2008-3#3)(2009-8#1)(2012-2#2)
verify if##6##2##(2007-7#1)(2008-10#3)(2010-3#1)(2012-3#1)
verify its##4##2##(2007-7#1)(2008-10#2)(2008-3#1)
verify our##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
verify that the##7##3##(1997-3#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
verify that##15##2##(1992-6#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
verify the accuracy##3##3##(2008-10#3)
verify the existence of##3##4##(1992-12#1)(1992-3#1)(2008-2#1)
verify the feasibility of##2##4##(2008-6#1)(2013-8#1)
verify the numerical##2##3##(2008-3#1)(2008-9#1)
verify the occurrence of##3##4##(1991-9#1)(2008-10#1)(2008-6#1)
verify the theoretical##2##3##(2008-3#1)(2010-5#1)
verify the usefulness of##2##4##(2008-3#2)
verify the validity of##2##4##(2008-2#1)(2008-7#1)
verify the##74##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#14)(2008-12#1)(2008-2#5)(2008-3#12)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
verify these##2##2##(2008-10#2)
verify this##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
verify whether##4##2##(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
verify##141##1##(1990-5#1)(1990-6#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-11#4)(2007-12#5)(2007-7#2)(2007-8#2)(2008-10#28)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#18)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#2)
verifying its##2##2##(2008-10#1)(2008-4#1)
verifying that##4##2##(1994-2#1)(1996-5#1)(2008-3#2)
verifying the##5##2##(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
verifying##14##1##(1991-8#1)(1992-8#1)(1994-2#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#2)
vermicomposting process##2##2##(2008-12#2)
vermicomposting##4##1##(2008-12#4)
vermiculite##4##1##(2008-10#4)
vermiform appendix##3##2##(2008-12#3)
vermilion##2##1##(1995-8#2)
vermis##4##1##(1995-12#2)(2008-7#1)(2010-11#1)
vernalization##4##1##(2009-8#2)(2012-3#2)
vernalized##3##1##(2008-10#1)(2009-8#2)
vernicifera##2##1##(2008-10#2)
vernix is##2##2##(2008-5#2)
vernix##4##1##(2008-5#4)
verrucae seborrhoicae##2##2##(2011-2#2)
verrucae vulgares##2##2##(2011-2#2)
verrucae##4##1##(2011-2#4)
verrucous##5##1##(2007-7#1)(2009-10#1)(2010-6#1)(2010-7#1)(2012-3#1)
vers##3##1##(2009-10#1)(2009-4#1)(2013-1#1)
versatile and##12##2##(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#2)
versatile building##2##2##(1996-5#1)(2007-11#1)
versatile derivatization##2##2##(2008-10#2)
versatile in##2##2##(2008-10#1)(2009-3#1)
versatile method##2##2##(2007-11#1)(2008-10#1)
versatile methods##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
versatile tools##2##2##(2008-7#1)(2010-4#1)
versatile##94##1##(1992-3#1)(1994-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#28)(2008-11#3)(2008-2#2)(2008-3#14)(2008-4#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-1#4)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
versatility and##8##2##(2007-12#1)(2008-10#2)(2009-10#1)(2009-11#2)(2010-6#1)(2013-1#1)
versatility is##2##2##(2008-3#1)(2008-7#1)
versatility of sol-gel##2##3##(2008-10#1)(2010-7#1)
versatility of the##11##3##(1996-5#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-4#2)(2012-6#1)
versatility of##25##2##(1996-5#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-2#1)(2008-4#2)(2008-7#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-6#1)
versatility##48##1##(1996-2#1)(1996-5#1)(2007-12#2)(2007-5#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-7#3)(2009-10#1)(2009-11#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)
versican and##2##2##(2008-9#1)(2012-1#1)
versican##8##1##(2008-11#4)(2008-9#1)(2012-1#3)
versicolor 550##2##2##(1994-3#2)
versicolor and##3##2##(2008-5#2)(2011-2#1)
versicolor is##2##2##(2007-7#1)(2008-5#1)
versicolor##23##1##(1994-3#2)(2007-7#4)(2008-11#3)(2008-5#8)(2008-6#2)(2008-9#2)(2009-9#1)(2011-2#1)
versicolor)##3##1##(2008-7#1)(2009-9#2)
version 1##2##2##(2008-10#1)(2008-11#1)
version 2##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
version 3##2##2##(2008-4#1)(2012-12#1)
version and##2##2##(2007-8#1)(2008-8#1)
version for##2##2##(2008-9#1)(2011-1#1)
version guarantees##2##2##(1995-6#2)
version has##2##2##(1995-6#1)(2012-1#1)
version is##4##2##(1994-3#1)(2008-11#1)(2008-2#1)(2008-9#1)
version of a##4##3##(2008-12#1)(2008-3#1)(2011-1#1)(2013-7#1)
version of the Hydrolight computer program##2##6##(2008-3#2)
version of the Hydrolight##3##4##(2008-3#3)
version of the Morris water maze##4##6##(1993-12#4)
version of the Morris water##5##5##(1993-12#5)
version of the experiment##2##4##(2008-4#2)
version of the model##4##4##(1997-8#1)(2008-10#1)(2008-8#1)(2009-4#1)
version of the protocol##2##4##(1997-2#1)(2008-4#1)
version of the standard##2##4##(1997-3#1)(2008-2#1)
version of the##85##3##(1991-9#1)(1992-12#1)(1993-12#5)(1993-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#6)(2008-3#10)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2010-1#1)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
version of this task##2##4##(1994-3#1)(2009-10#1)
version of this##25##3##(1994-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
version of##141##2##(1991-1#1)(1991-9#1)(1992-12#1)(1993-12#6)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1995-2#2)(1995-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-8#2)(2008-1#4)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#3)(2010-2#1)(2010-9#2)(2011-1#5)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
version was##2##2##(2009-10#1)(2012-1#1)
version with##2##2##(2008-10#1)(2008-2#1)
version##212##1##(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-12#6)(1993-3#1)(1993-8#1)(1994-2#2)(1994-3#4)(1995-2#2)(1995-5#1)(1995-6#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#4)(2007-10#1)(2007-11#2)(2007-8#4)(2008-1#5)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#15)(2008-4#8)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#5)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#9)(2011-2#10)(2012-1#6)(2012-12#8)(2012-2#8)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#6)
version)##2##1##(2011-1#2)
versions of a scene perturbed##2##5##(2008-3#2)
versions of a##3##3##(2008-3#2)(2010-1#1)
versions of the##20##3##(1991-9#1)(1994-3#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#2)
versions of this##2##3##(1997-7#1)(2008-2#1)
versions of##38##2##(1991-10#1)(1991-9#1)(1994-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-1#1)(2010-3#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
versions were##2##2##(2008-10#1)(2010-5#1)
versions##51##1##(1991-10#1)(1991-9#1)(1994-3#1)(1994-8#1)(1995-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#6)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
versus &gt##3##2##(1997-5#3)
versus 0##8##2##(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
versus 1##4##2##(1990-5#1)(2007-7#2)(2007-8#1)
versus 10##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
versus 13##3##2##(1997-5#2)(2007-8#1)
versus 14##3##2##(1997-5#1)(2008-10#1)(2013-1#1)
versus 18##2##2##(1995-6#1)(2008-7#1)
versus 2##2##2##(2007-7#1)(2010-11#1)
versus 20##2##2##(1994-9#1)(1997-6#1)
versus 23##2##2##(1991-11#1)(2013-1#1)
versus 24##2##2##(2008-10#1)(2008-6#1)
versus 29##2##2##(1991-6#1)(2013-1#1)
versus 3##6##2##(1992-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-1#1)
versus 33##2##2##(1995-3#1)(2013-1#1)
versus 36##3##2##(1997-6#1)(2007-8#1)(2011-2#1)
versus 38##2##2##(1990-6#1)(2008-1#1)
versus 4##3##2##(2007-8#1)(2008-7#2)
versus 5##2##2##(2008-4#1)(2013-1#1)
versus 57##2##2##(1997-6#1)(2013-1#1)
versus 6##2##2##(2007-8#1)(2008-12#1)
versus 64##2##2##(2008-7#1)(2013-1#1)
versus 65##2##2##(2008-8#1)(2013-1#1)
versus 7##4##2##(1991-9#1)(1994-11#1)(2008-3#1)(2008-7#1)
versus Ag/AgCl electrode##2##3##(2008-10#2)
versus Ag/AgCl in##4##3##(2008-10#4)
versus Ag/AgCl to##2##3##(2008-10#2)
versus Ag/AgCl using##2##3##(2008-10#2)
versus Ag/AgCl##35##2##(2008-10#35)
versus Ag/AgCl)##6##2##(2007-12#1)(2008-10#5)
versus E(1/2)]##2##2##(2009-11#2)
versus G-CSF##2##2##(2008-7#2)
versus Low Dose##2##3##(1994-7#1)(2012-3#1)
versus SCE in##2##3##(2008-10#2)
versus SCE##9##2##(2008-10#9)
versus a reference##2##3##(2008-10#1)(2008-12#1)
versus a##14##2##(1991-11#1)(1991-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
versus all other##2##3##(1992-8#1)(2008-10#1)
versus an##2##2##(2008-10#1)(2013-1#1)
versus asexual##3##2##(2008-10#1)(2009-5#1)(2010-12#1)
versus concentration of##4##3##(2008-10#4)
versus concentration##11##2##(1992-2#1)(2008-10#10)
versus control in##2##3##(2008-10#1)(2008-5#1)
versus control##5##2##(1991-12#1)(2008-10#2)(2008-5#2)
versus conventional##4##2##(2007-8#1)(2008-3#1)(2010-8#1)(2012-2#1)
versus delayed loading of##2##4##(2013-1#2)
versus delayed##5##2##(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#2)
versus delta plot##2##3##(2008-10#2)
versus female##3##2##(2007-12#1)(2008-8#2)
versus full##2##2##(2008-10#1)(2011-2#1)
versus fusion##4##2##(2008-11#2)(2012-12#2)
versus human##2##2##(2007-7#1)(2009-12#1)
versus individual##2##2##(1991-12#1)(2009-4#1)
versus intensity##2##2##(2007-11#1)(2012-12#1)
versus log##3##2##(2008-10#2)(2008-8#1)
versus low##2##2##(2008-4#2)
versus no##4##2##(1995-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
versus noise##2##2##(2009-5#2)
versus observed##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
versus old##2##2##(2008-7#2)
versus oral##2##2##(1991-8#1)(2007-8#1)
versus ordinary##2##2##(2011-1#2)
versus other##5##2##(2008-10#2)(2008-12#1)(2009-11#1)(2009-12#1)
versus pH##3##2##(2008-10#3)
versus patients with##2##3##(2012-12#1)(2012-3#1)
versus patients##3##2##(1990-6#1)(2012-12#1)(2012-3#1)
versus placebo in a##2##4##(2008-2#1)(2008-5#1)
versus placebo in##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
versus placebo##18##2##(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#6)(2011-2#3)(2012-2#1)
versus postoperative##2##2##(1994-8#2)
versus reality##3##2##(2007-12#1)(2007-8#1)(2008-7#1)
versus sample##3##2##(2008-10#3)
versus saturated calomel##2##3##(2008-10#2)
versus secondary##3##2##(1994-2#1)(2012-12#1)(2012-2#1)
versus slow##2##2##(2008-10#1)(2011-2#1)
versus standardized patient satisfaction surveys##2##5##(1996-3#2)
versus surgery##2##2##(1991-4#1)(2012-3#1)
versus temperature##2##2##(2008-10#1)(2008-3#1)
versus that##2##2##(2007-11#1)(2008-11#1)
versus the concentration of##2##4##(1992-3#1)(2008-4#1)
versus the concentration##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
versus the control group##3##4##(2008-12#1)(2008-7#1)(2011-2#1)
versus the##52##2##(1990-6#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-1#1)(1995-5#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
versus time##8##2##(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#2)
versus total##3##2##(2008-10#2)(2008-4#1)
versus unfractionated heparin##3##3##(2007-10#3)
versus wavelength##3##2##(2008-10#2)(2008-3#1)
versus##863##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#5)(1991-12#4)(1991-2#2)(1991-3#5)(1991-4#1)(1991-6#1)(1991-8#7)(1991-9#1)(1992-1#3)(1992-2#2)(1992-3#7)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#6)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#6)(1996-1#3)(1996-12#7)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#9)(1997-4#2)(1997-5#9)(1997-6#4)(1997-7#1)(1997-8#1)(2006-10#4)(2006-5#1)(2006-8#1)(2007-10#12)(2007-11#7)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#6)(2007-7#8)(2007-8#16)(2007-9#1)(2008-1#5)(2008-10#195)(2008-11#16)(2008-12#10)(2008-2#9)(2008-3#29)(2008-4#19)(2008-5#14)(2008-6#6)(2008-7#37)(2008-8#21)(2008-9#18)(2009-10#5)(2009-11#7)(2009-12#7)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#6)(2010-1#2)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#37)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#14)(2012-2#14)(2012-3#15)(2012-6#1)(2013-1#49)(2013-7#6)(2013-8#8)
vertebra##18##1##(1991-11#1)(1994-7#1)(1996-6#1)(1997-4#1)(2007-10#1)(2007-11#6)(2007-12#1)(2008-10#1)(2008-6#2)(2008-7#1)(2013-1#2)
vertebrae and##5##2##(2007-11#4)(2007-8#1)
vertebrae##37##1##(1991-11#1)(1994-12#1)(1996-6#1)(1997-4#2)(2007-11#15)(2007-8#5)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#2)(2013-1#3)(2013-8#2)
vertebral and##2##2##(2008-7#2)
vertebral arteries##4##2##(1995-3#3)(1997-6#1)
vertebral artery (VA)##2##3##(2008-7#1)(2012-3#1)
vertebral artery dissecting aneurysm##2##4##(2008-7#2)
vertebral artery dissection##8##3##(1991-8#2)(2008-7#4)(2011-2#1)(2013-8#1)
vertebral artery stenosis##2##3##(2007-10#1)(2012-3#1)
vertebral artery##30##2##(1991-8#3)(1992-6#1)(1993-3#2)(1996-9#2)(1997-6#1)(2007-10#1)(2008-12#4)(2008-7#9)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
vertebral bodies and##2##3##(2007-11#1)(2007-8#1)
vertebral bodies in##2##3##(1997-3#1)(2011-2#1)
vertebral bodies##11##2##(1997-3#1)(2007-11#2)(2007-8#3)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
vertebral body and intervertebral discs wedging in##2##7##(2007-8#2)
vertebral body and##4##3##(2007-11#2)(2007-8#2)
vertebral body height##3##3##(2007-8#2)(2012-2#1)
vertebral body metastases##2##3##(2007-11#1)(2008-6#1)
vertebral body or##2##3##(2007-11#2)
vertebral body wedging factor in the##2##6##(2007-8#2)
vertebral body wedging factors##2##4##(2007-8#2)
vertebral body wedging##4##3##(2007-8#4)
vertebral body with##2##3##(2008-6#1)(2009-3#1)
vertebral body##30##2##(1996-8#1)(2007-11#9)(2007-8#12)(2008-6#2)(2008-7#1)(2009-3#2)(2012-1#1)(2012-2#2)
vertebral bone##4##2##(1991-11#1)(2011-2#2)(2012-12#1)
vertebral column resection##3##3##(2008-8#3)
vertebral column##13##2##(1997-2#1)(2007-11#4)(2007-8#2)(2008-8#3)(2011-2#2)(2013-1#1)
vertebral compression fractures secondary to##2##5##(2008-7#2)
vertebral compression fractures##7##3##(2007-8#1)(2008-7#5)(2008-8#1)
vertebral compression##8##2##(2007-8#1)(2008-12#1)(2008-7#5)(2008-8#1)
vertebral crush##2##2##(1991-11#2)
vertebral fracture in##2##3##(1991-11#1)(1993-2#1)
vertebral fracture##7##2##(1991-11#3)(1993-2#1)(2007-11#1)(2011-2#2)
vertebral fractures and##2##3##(1991-11#1)(1993-11#1)
vertebral fractures in##3##3##(1991-11#1)(1993-11#1)(2008-11#1)
vertebral fractures##19##2##(1991-11#3)(1993-11#2)(2007-11#3)(2007-8#3)(2008-11#6)(2008-4#1)(2008-7#1)
vertebral metastases##2##2##(2011-2#1)(2012-2#1)
vertebral rotation in##2##3##(2007-8#2)
vertebral rotation##4##2##(2007-8#3)(2012-2#1)
vertebral tumours##2##2##(2008-7#2)
vertebral vector##2##2##(2012-2#2)
vertebral vein##2##2##(1996-9#1)(2012-3#1)
vertebral venous plexus and##2##4##(2011-2#2)
vertebral venous plexus##10##3##(2011-2#10)
vertebral venous##12##2##(2011-2#12)
vertebral##192##1##(1990-11#1)(1991-11#10)(1991-8#4)(1992-6#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1995-3#3)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2007-10#1)(2007-11#24)(2007-8#28)(2008-11#6)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#27)(2008-8#6)(2009-3#5)(2011-2#25)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#2)(2013-8#2)
vertebrate and invertebrate##5##3##(1990-11#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-9#1)
vertebrate and##6##2##(1990-11#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
vertebrate animal##2##2##(2008-2#1)(2008-9#1)
vertebrate animals##2##2##(1993-3#1)(2011-2#1)
vertebrate brain##2##2##(1994-12#1)(2008-4#1)
vertebrate cells##2##2##(1996-2#1)(2008-9#1)
vertebrate defensive##2##2##(1993-3#1)(1994-5#1)
vertebrate embryos##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
vertebrate evolution##3##2##(1997-9#1)(2008-8#1)(2011-2#1)
vertebrate genome##2##2##(1995-2#1)(2011-2#1)
vertebrate genomes##3##2##(1991-6#1)(2010-3#1)(2011-2#1)
vertebrate hemoglobins##2##2##(1990-8#2)
vertebrate host##2##2##(1991-5#1)(2008-9#1)
vertebrate immune system##2##3##(2008-4#1)(2010-8#1)
vertebrate lineage##3##2##(2008-1#1)(2012-12#1)(2012-2#1)
vertebrate model##3##2##(2007-12#1)(2012-3#2)
vertebrate nervous##2##2##(2008-7#2)
vertebrate populations##2##2##(2008-8#1)(2012-3#1)
vertebrate skeletal muscle##3##3##(1993-9#1)(2008-6#1)(2008-9#1)
vertebrate species for which##2##4##(1993-12#1)(2008-8#1)
vertebrate species##6##2##(1993-12#1)(1993-8#1)(1996-6#1)(2008-5#1)(2008-8#1)(2012-2#1)
vertebrate##129##1##(1990-11#1)(1990-5#2)(1990-8#2)(1991-5#1)(1991-6#3)(1992-12#1)(1992-8#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-2#4)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-7#1)(1997-9#2)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#11)(2009-11#2)(2010-1#1)(2010-3#6)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#3)
vertebrates and##9##2##(1993-6#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-7#3)(2009-7#1)
vertebrates in the##2##3##(2007-10#1)(2011-2#1)
vertebrates is the##2##3##(2010-9#1)(2011-1#1)
vertebrates is##4##2##(1994-11#1)(2010-4#1)(2010-9#1)(2011-1#1)
vertebrates##78##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#1)(1993-2#2)(1993-6#2)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#3)(1995-2#2)(1996-2#1)(1996-5#2)(1997-7#1)(2007-10#1)(2007-12#11)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#11)(2008-8#3)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
vertebrectomy and##2##2##(2008-7#1)(2008-8#1)
vertebrectomy##5##1##(2008-7#3)(2008-8#2)
vertebro- and kyphoplasty in##2##4##(2007-8#2)
vertebro- and kyphoplasty##3##3##(2007-8#3)
vertebrobasilar and##2##2##(1991-3#1)(2008-7#1)
vertebrobasilar artery##5##2##(1997-3#1)(2008-7#1)(2012-3#3)
vertebrobasilar insufficiency##2##2##(1993-3#1)(2008-12#1)
vertebrobasilar stroke##2##2##(2007-10#1)(2007-11#1)
vertebrobasilar system##2##2##(2008-7#1)(2011-2#1)
vertebrobasilar##16##1##(1991-3#1)(1993-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2011-2#1)(2012-3#4)
vertebroplasty and kyphoplasty##2##3##(2008-7#2)
vertebroplasty and##3##2##(2008-7#2)(2011-2#1)
vertebroplasty is##4##2##(2007-11#2)(2007-8#2)
vertebroplasty##17##1##(2007-11#5)(2007-8#6)(2008-7#3)(2008-8#1)(2011-2#2)
vertex of the##2##3##(2008-6#1)(2008-9#1)
vertex of##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
vertex##13##1##(1993-9#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-9#1)(2011-2#1)(2013-8#1)
vertex-connectivity index##3##2##(2007-11#3)
vertical and horizontal##5##3##(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
vertical and##12##2##(1992-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-8#1)
vertical attenuation##2##2##(2008-2#1)(2008-3#1)
vertical axis##2##2##(2007-8#1)(2009-9#1)
vertical cavity surface emitting##2##4##(2007-12#2)
vertical cavity surface-emitting laser##2##4##(2008-3#2)
vertical cavity##4##2##(2007-12#2)(2008-3#2)
vertical cell morphology##2##3##(2009-7#2)
vertical cell##3##2##(2009-7#3)
vertical dimension##5##2##(2008-7#1)(2009-11#1)(2009-8#2)(2010-3#1)
vertical directions##5##2##(2008-2#1)(2008-3#3)(2009-11#1)
vertical distribution of##6##3##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
vertical distribution##8##2##(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)
vertical gap is##2##3##(2008-7#2)
vertical infection##4##2##(2011-3#4)
vertical integration##5##2##(1991-3#2)(1996-2#1)(1997-3#1)(2010-7#1)
vertical mixing##2##2##(2008-11#1)(2008-3#1)
vertical or##3##2##(1991-2#1)(2008-2#1)(2008-7#1)
vertical orientation##2##2##(2008-2#1)(2009-5#1)
vertical profile##2##2##(2008-3#2)
vertical profiles of pressure and temperature##2##6##(2008-3#2)
vertical profiles of the##3##4##(2008-3#3)
vertical profiles of##9##3##(2008-11#1)(2008-2#1)(2008-3#7)
vertical profiles##14##2##(2008-11#1)(2008-2#2)(2008-3#11)
vertical resolution of the##3##4##(2008-3#3)
vertical resolution of##5##3##(2008-3#5)
vertical resolution##14##2##(2007-12#1)(2008-2#1)(2008-3#12)
vertical scanning interferometry##3##3##(2008-3#3)
vertical scanning##4##2##(2008-3#4)
vertical structure of##3##3##(2008-2#2)(2008-3#1)
vertical structure##6##2##(1990-12#1)(2008-2#2)(2008-3#3)
vertical substance and volume loss##2##5##(2011-2#2)
vertical surface##2##2##(2009-11#2)
vertical temperature##2##2##(2008-2#1)(2008-3#1)
vertical transmission in##3##3##(2008-9#1)(2011-3#2)
vertical transmission is not##2##4##(2008-8#1)(2011-3#1)
vertical transmission of HBV from HBsAg-positive father to infant##3##9##(2011-1#3)
vertical transmission of HBV##4##4##(2011-1#4)
vertical transmission of##5##3##(2008-10#1)(2011-1#4)
vertical transmission##18##2##(2008-10#1)(2008-8#1)(2008-9#7)(2011-1#4)(2011-3#4)(2012-3#1)
vertical##220##1##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-2#2)(1992-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-2#21)(2008-3#64)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#9)(2009-11#5)(2009-5#1)(2009-7#7)(2009-8#3)(2009-9#2)(2010-3#3)(2010-7#1)(2011-1#4)(2011-2#4)(2011-3#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
vertical) and##2##2##(2008-2#1)(2008-3#1)
vertical)##4##1##(1991-2#1)(2008-2#1)(2008-3#2)
vertical-cavity surface-emitting laser (VCSEL)##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
vertical-cavity surface-emitting laser arrays##3##4##(2007-11#1)(2008-3#2)
vertical-cavity surface-emitting laser##16##3##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#6)
vertical-cavity surface-emitting lasers (VCSEL's)##3##4##(2008-3#3)
vertical-cavity surface-emitting lasers (VCSELs)##2##4##(2007-11#2)
vertical-cavity surface-emitting lasers and##2##4##(2008-2#1)(2008-3#1)
vertical-cavity surface-emitting lasers for##2##4##(2008-2#2)
vertical-cavity surface-emitting lasers##25##3##(2007-11#8)(2007-12#3)(2008-2#5)(2008-3#9)
vertical-cavity surface-emitting##41##2##(2007-11#10)(2007-12#8)(2008-2#8)(2008-3#15)
vertical-cavity##44##1##(2007-11#11)(2007-12#8)(2008-2#9)(2008-3#16)
vertical-external-cavity surface-emitting semiconductor lasers##2##4##(2007-12#2)
verticalia##3##1##(2008-5#3)
vertically aligned##3##2##(2008-7#2)(2010-4#1)
vertically and horizontally##4##3##(1994-1#1)(2008-1#2)(2008-2#1)
vertically displaced##2##2##(2007-12#1)(2009-5#1)
vertically in##2##2##(2008-12#1)(2008-9#1)
vertically integrated##2##2##(1997-3#1)(2010-7#1)
vertically oriented##2##2##(2008-2#2)
vertically polarized##4##2##(2008-2#1)(2008-3#3)
vertically stratified water##2##3##(2008-2#2)
vertically stratified##3##2##(2008-2#2)(2010-8#1)
vertically to##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
vertically##46##1##(1994-1#1)(1995-9#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#9)(2008-5#2)(2008-7#2)(2008-9#2)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-3#1)(2013-1#1)
vertices##6##1##(1996-2#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
verticillioides and F##2##3##(2008-10#2)
verticillioides and##5##2##(2008-10#4)(2008-12#1)
verticillioides in the##2##3##(2008-10#2)
verticillioides in##5##2##(2008-10#4)(2008-12#1)
verticillioides infection##2##2##(2008-10#2)
verticillioides on##2##2##(2008-10#2)
verticillioides##30##1##(2008-10#28)(2008-12#2)
verticillioides-inoculated rows##2##2##(2008-10#2)
vertiginous symptomatology##2##2##(2008-2#2)
vertiginous syndromes##3##2##(2008-2#3)
vertiginous##8##1##(2008-2#7)(2013-1#1)
vertigo and##4##2##(2008-4#1)(2012-3#2)(2013-7#1)
vertigo is##2##2##(2008-4#1)(2012-3#1)
vertigo##22##1##(1990-5#2)(1994-9#1)(1997-8#1)(2008-2#2)(2008-4#5)(2012-12#1)(2012-2#2)(2012-3#7)(2013-7#1)
very abundant##2##2##(1992-12#1)(1997-4#1)
very accurate##5##2##(2008-10#2)(2008-3#1)(2008-4#2)
very acidic##2##2##(2008-10#1)(2008-4#1)
very active##12##2##(1991-12#1)(1991-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#2)(2009-10#1)(2013-8#2)
very advanced##4##2##(2008-12#1)(2008-9#3)
very aggressive##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
very attractive as##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
very attractive##12##2##(1992-12#1)(1994-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2010-10#1)(2012-2#1)
very basic##4##2##(2007-12#1)(2008-4#1)(2008-9#2)
very beginning##3##2##(2007-11#1)(2010-11#1)(2011-2#1)
very bright##3##2##(1990-2#1)(2008-12#1)(2008-2#1)
very broad##3##2##(2008-11#2)(2011-2#1)
very busy##3##2##(2007-7#1)(2008-7#1)(2013-8#1)
very carefully##2##2##(2007-11#1)(2010-8#1)
very cautiously##2##2##(1994-2#1)(2008-7#1)
very challenging##6##2##(1992-3#1)(2008-10#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
very clear##2##2##(1991-1#1)(2008-10#1)
very close to the##10##4##(1992-1#1)(1993-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2012-3#2)(2013-8#1)
very close to##18##3##(1990-8#1)(1992-1#1)(1993-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#2)(2012-3#2)(2013-8#1)
very close##24##2##(1990-8#1)(1992-1#1)(1993-11#1)(1993-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
very closely related to##3##4##(2007-12#1)(2008-10#2)
very closely related##5##3##(2007-12#1)(2008-10#4)
very closely##8##2##(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#5)
very common among##2##3##(1996-11#1)(2012-12#1)
very common and##2##3##(2008-10#1)(2008-11#1)
very common in this##2##4##(2008-12#1)(2008-5#1)
very common in##8##3##(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2009-8#1)
very common##24##2##(1991-6#1)(1996-11#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
very compact##5##2##(1996-6#1)(2007-11#1)(2007-12#2)(2008-3#1)
very complex and##2##3##(2008-9#1)(2012-2#1)
very complex##26##2##(1992-5#1)(1992-9#2)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
very complicated##6##2##(2006-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-8#2)
very consistent##3##2##(2010-9#1)(2012-12#1)(2012-3#1)
very convenient##4##2##(2008-10#3)(2008-11#1)
very different between##2##3##(1990-5#1)(2008-10#1)
very different from that of##2##5##(2008-10#1)(2008-8#1)
very different from the##2##4##(2008-8#1)(2010-4#1)
very different from those of##2##5##(1992-1#1)(2008-10#1)
very different from##7##3##(1992-1#1)(2008-10#2)(2008-8#2)(2010-4#1)(2012-3#1)
very different##39##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
very differently##2##2##(1996-12#1)(2007-11#1)
very difficult to##17##3##(1994-11#1)(1996-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
very difficult##26##2##(1990-8#1)(1993-1#1)(1994-11#1)(1996-4#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-7#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
very distinct##5##2##(1991-9#1)(2008-10#3)(2008-5#1)
very diverse##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
very dry##2##2##(2008-5#2)
very early in##6##3##(1990-9#1)(2007-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
very early stage of##2##4##(2009-7#1)(2010-6#1)
very early stage##4##3##(2007-11#1)(2009-7#1)(2010-6#1)(2012-3#1)
very early##22##2##(1990-9#2)(1996-12#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
very easy to##2##3##(2008-10#1)(2008-11#1)
very easy##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
very easy/easy&quot##2##2##(2012-3#2)
very effective against##3##3##(2007-7#1)(2008-10#1)(2013-8#1)
very effective and##4##3##(1994-2#1)(1995-5#1)(2007-11#1)(2008-3#1)
very effective for##3##3##(2008-10#1)(2013-1#2)
very effective in reducing##2##4##(1990-12#1)(2007-11#1)
very effective in##11##3##(1990-12#1)(1991-6#1)(1992-3#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
very effective to##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
very effective##38##2##(1990-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#2)(1997-3#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
very effectively##4##2##(1992-9#2)(2007-10#1)(2008-10#1)
very efficient and##2##3##(1997-2#1)(2007-12#1)
very efficient##8##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#1)
very efficiently##3##2##(1994-11#1)(2007-12#1)(2008-5#1)
very elongate##2##2##(2007-12#1)(2008-7#1)
very encouraging with##2##3##(2007-7#1)(2008-10#1)
very encouraging##3##2##(2007-7#1)(2008-10#2)
very expensive##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
very extensive##2##2##(2008-8#1)(2011-2#1)
very fast and##2##3##(2008-10#2)
very fast nonlinear scans##2##4##(2007-12#2)
very fast response##2##3##(2008-10#2)
very fast##20##2##(1990-2#1)(2007-12#8)(2008-10#8)(2008-3#2)(2010-5#1)
very favorable##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
very few cases have been##2##5##(1997-8#1)(2013-1#1)
very few cases have##3##4##(1990-12#1)(1997-8#1)(2013-1#1)
very few complications##2##3##(1990-11#1)(1991-2#1)
very few reported##2##3##(2009-10#1)(2012-3#1)
very few reports##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
very few##48##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
very first##3##2##(1994-1#1)(2008-10#1)(2008-12#1)
very flexible##3##2##(1994-12#1)(2008-10#1)(2008-6#1)
very frequent##6##2##(2008-2#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
very general##7##2##(1994-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
very good agreement between the##2##5##(2008-10#2)
very good agreement between##3##4##(2008-10#3)
very good agreement with the##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
very good agreement##8##3##(2008-10#4)(2008-3#2)(2008-9#1)(2011-2#1)
very good and good results##2##5##(2007-11#2)
very good and good##3##4##(2007-11#3)
very good and good)##2##4##(2007-8#2)
very good and##7##3##(1994-11#1)(1994-8#1)(2007-11#3)(2007-8#2)
very good correlation##2##3##(2008-10#2)
very good effect##3##3##(2008-11#2)(2008-7#1)
very good in##4##3##(1990-6#1)(1995-6#1)(2007-11#2)
very good or good results - no pain##2##8##(2007-11#2)
very good or good##3##4##(1991-3#1)(2007-11#2)
very good quality##2##3##(2008-10#1)(2011-3#1)
very good reproducibility##2##3##(1996-6#1)(2008-10#1)
very good resolution##2##3##(2008-7#1)(2009-8#1)
very good results in##3##4##(2007-11#2)(2011-3#1)
very good results##9##3##(1990-9#1)(1993-3#1)(1996-11#1)(2007-11#3)(2008-11#1)(2011-3#1)(2013-1#1)
very good selectivity for##3##4##(2008-10#3)
very good selectivity##4##3##(2008-10#4)
very good sensitivity##2##3##(2008-10#2)
very good stability##2##3##(2007-11#1)(2008-10#1)
very good##100##2##(1990-6#1)(1990-9#1)(1991-3#3)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-1#1)(2007-11#18)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#2)(2011-3#3)(2013-1#2)(2013-8#1)
very hard##2##2##(2008-10#1)(2008-3#1)
very helpful in differentiating##2##4##(2009-5#1)(2012-12#1)
very helpful in##6##3##(2008-1#1)(2008-12#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
very helpful##8##2##(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
very heterogeneous##4##2##(1990-3#1)(2010-12#1)(2010-4#1)(2011-2#1)
very high affinity##4##3##(1992-11#1)(1993-8#1)(1994-2#1)(1997-4#1)
very high and##3##3##(2008-10#2)(2013-1#1)
very high aspect ratio##2##4##(2007-12#2)
very high concentration##3##3##(1990-12#1)(2008-10#2)
very high concentrations of##2##4##(1990-5#1)(2012-3#1)
very high concentrations##3##3##(1990-5#1)(1996-12#1)(2012-3#1)
very high doses##2##3##(1994-9#1)(2007-2#1)
very high in the##3##4##(1990-5#1)(1992-5#1)(2008-1#1)
very high in##8##3##(1990-5#1)(1992-5#1)(1997-4#1)(2008-1#2)(2008-7#1)(2008-9#1)(2011-1#1)
very high level of##6##4##(1990-2#1)(1991-9#1)(2008-10#2)(2011-1#1)(2013-1#1)
very high levels in##2##4##(1997-4#1)(2008-10#1)
very high levels of##8##4##(1997-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
very high levels##12##3##(1992-8#1)(1997-4#1)(1997-7#3)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
very high molecular weight##3##4##(1991-12#1)(1991-2#1)(2008-5#1)
very high mortality##4##3##(1996-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
very high or##2##3##(2012-3#1)(2013-8#1)
very high prevalence##2##3##(1991-12#1)(2011-2#1)
very high risk##5##3##(2007-8#1)(2008-1#2)(2009-12#1)(2011-2#1)
very high selectivity##3##3##(2008-10#2)(2008-7#1)
very high specific radioactivity##2##4##(1990-12#2)
very high specificity##2##3##(2008-4#1)(2010-8#1)
very high##173##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#2)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-4#3)(1997-6#3)(1997-7#5)(2006-5#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#6)(2008-10#40)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#4)(2013-8#2)
very high-speed##2##2##(2007-11#2)
very highly##2##2##(2008-4#1)(2012-2#1)
very homogeneous##2##2##(2008-10#1)(2013-8#1)
very hydrophilic##2##2##(1997-2#1)(2008-10#1)
very important and##3##3##(1990-5#1)(2012-2#1)(2012-3#1)
very important factors in##3##4##(2007-11#1)(2007-8#1)(2011-2#1)
very important for the correct##2##5##(1993-8#1)(2008-1#1)
very important for the##9##4##(1993-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)
very important for##22##3##(1990-12#1)(1992-12#1)(1993-8#1)(1994-2#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
very important in##7##3##(1990-9#1)(1992-11#1)(1994-5#1)(1997-1#1)(2008-1#1)(2008-10#2)
very important role in##5##4##(1990-9#1)(2007-8#1)(2008-9#1)(2009-2#1)(2010-5#1)
very important role##7##3##(1990-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-5#1)
very important to the##2##4##(2010-7#1)(2013-8#1)
very important to##13##3##(1991-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
very important##95##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-8#1)(1994-2#2)(1994-5#1)(1995-1#1)(1996-11#1)(1997-1#1)(2006-10#2)(2007-11#5)(2007-8#2)(2008-1#5)(2008-10#13)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
very inexpensive##3##2##(2008-10#3)
very infrequent##2##2##(1992-5#1)(2008-8#1)
very intense##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
very interesting##9##2##(1993-9#1)(1994-2#1)(1996-5#1)(2008-10#2)(2008-5#2)(2010-11#1)(2011-2#1)
very isolated##2##2##(2008-9#1)(2011-2#1)
very large and##2##3##(2008-8#1)(2012-2#1)
very large aperture##2##3##(2008-3#2)
very large coalesced LCA consisting##2##5##(1997-6#2)
very large groups##2##3##(1993-12#1)(2008-10#1)
very large##41##2##(1990-8#1)(1992-1#1)(1993-12#1)(1994-12#1)(1996-12#1)(1997-6#2)(2007-11#3)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
very late##7##2##(1997-3#2)(1997-4#3)(2008-11#1)(2012-1#1)
very lightly##2##2##(1990-7#1)(1997-2#1)
very likely that##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
very likely to be##2##4##(2008-1#1)(2008-7#1)
very likely to##4##3##(1994-3#1)(2008-1#1)(2008-11#1)(2008-7#1)
very likely##13##2##(1990-5#1)(1992-5#1)(1992-8#1)(1994-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
very limited and the##2##4##(2008-10#1)(2008-7#1)
very limited and##3##3##(2008-10#2)(2008-7#1)
very limited##27##2##(1990-5#1)(1993-1#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#2)(2012-7#1)
very little data##2##3##(2008-8#1)(2012-12#1)
very little information about##2##4##(2008-11#1)(2009-11#1)
very little information##5##3##(1994-3#1)(2008-1#1)(2008-11#1)(2009-11#1)(2013-1#1)
very little is known about the##4##6##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
very little is known about##6##5##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-7#1)
very little or##2##3##(1994-11#1)(2009-6#1)
very little research has##3##4##(2007-6#1)(2008-11#1)(2008-9#1)
very little research##4##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
very little response##2##3##(2008-10#1)(2008-9#1)
very little sequence identity##2##4##(1995-11#1)(1995-5#1)
very little work has##2##4##(2008-5#1)(2009-7#1)
very little work##3##3##(2008-5#1)(2008-6#1)(2009-7#1)
very little##64##2##(1991-11#1)(1992-12#3)(1992-5#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
very long##11##2##(1992-12#1)(1992-3#1)(1997-7#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)(2011-2#1)
very low (&lt##2##3##(2008-3#2)
very low (0##3##3##(1992-11#1)(2008-10#1)(2008-7#1)
very low activity##2##3##(1991-12#1)(1997-8#1)
very low at##3##3##(1995-9#1)(2008-10#1)(2008-5#1)
very low birth weight infants##2##5##(1995-8#2)
very low birth weight##5##4##(1995-6#1)(1995-8#2)(2011-1#1)(2012-1#1)
very low birth##6##3##(1994-6#1)(1995-6#1)(1995-8#2)(2011-1#1)(2012-1#1)
very low compared with##3##4##(2007-2#1)(2008-11#1)(2013-1#1)
very low compared##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
very low concentration of##2##4##(2008-10#1)(2013-8#1)
very low concentration##6##3##(2008-10#4)(2008-7#1)(2013-8#1)
very low concentrations of##3##4##(1991-12#1)(1994-8#1)(2008-5#1)
very low concentrations##15##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1994-12#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2013-1#1)
very low density lipoprotein (VLDL)##2##5##(1995-6#1)(2008-10#1)
very low density lipoprotein##6##4##(1993-12#1)(1993-8#1)(1993-9#1)(1995-6#2)(2008-10#1)
very low density lipoprotein-cholesterol and triglycerides##2##6##(2010-5#2)
very low density lipoproteins (VLDL)##4##5##(1991-12#1)(1992-12#1)(1993-8#1)(1994-3#1)
very low density lipoproteins##8##4##(1991-12#2)(1992-12#2)(1992-3#1)(1993-8#1)(1994-3#1)(1995-2#1)
very low density##18##3##(1991-12#2)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#2)(2008-10#1)(2010-5#2)(2013-1#1)
very low detection limits##2##4##(2008-10#2)
very low dose##2##3##(2008-10#1)(2008-7#1)
very low frequencies##2##3##(2008-10#1)(2011-2#1)
very low frequency##3##3##(2008-5#1)(2008-8#1)(2010-7#1)
very low in the##5##4##(1995-11#1)(2008-1#1)(2008-10#3)
very low in##9##3##(1995-11#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-8#1)
very low levels and##2##4##(1994-2#1)(2008-9#1)
very low levels of##8##4##(1990-12#1)(1992-10#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)
very low levels##17##3##(1990-12#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-2#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-9#1)(2009-10#1)
very low limit of detection##2##5##(2008-10#2)
very low or undetectable##3##4##(1997-1#1)(2008-10#1)(2012-2#1)
very low or##4##3##(1997-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
very low output##2##3##(1995-3#1)(2010-8#1)
very low risk##2##3##(2008-7#1)(2009-3#1)
very low signal##2##3##(1991-11#1)(2008-10#1)
very low solubility##2##3##(1997-1#1)(2008-7#1)
very low to##4##3##(1995-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
very low##239##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#3)(1991-12#4)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-3#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#61)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#3)
very low-density lipoprotein##4##3##(1994-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
very marked##2##2##(1990-5#1)(2010-8#1)
very mild##5##2##(1991-2#1)(2007-11#2)(2008-10#1)(2009-11#1)
very minor##2##2##(1997-6#1)(2008-10#1)
very modest##6##2##(1994-12#1)(2008-1#2)(2008-11#1)(2009-4#1)(2012-3#1)
very much higher##2##3##(1994-11#1)(2008-8#1)
very much##14##2##(1990-9#1)(1994-11#1)(1996-11#1)(1997-1#1)(2008-1#2)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)
very narrow##2##2##(2008-10#1)(2010-8#1)
very nature##6##2##(2007-11#1)(2007-12#2)(2008-8#1)(2009-4#1)(2010-12#1)
very near##3##2##(1991-12#1)(2008-4#1)(2012-12#1)
very nonpolar compounds##2##3##(2008-10#2)
very often##8##2##(1992-4#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
very old age##4##3##(1990-11#1)(2008-7#3)
very old##7##2##(1990-11#1)(1993-11#1)(1996-8#1)(2008-1#1)(2008-7#3)
very peculiar##2##2##(1997-4#1)(2011-2#1)
very poor prognosis##4##3##(1991-11#1)(2007-10#1)(2010-1#1)(2010-6#1)
very poor##19##2##(1990-4#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
very poorly##3##2##(1992-9#1)(2010-10#1)(2010-3#1)
very popular in##3##3##(2008-10#2)(2011-2#1)
very popular##5##2##(2008-10#2)(2010-7#1)(2011-2#1)(2012-3#1)
very positive##7##2##(1992-12#1)(1993-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
very potent inhibitor of##2##4##(1991-8#1)(2008-11#1)
very potent##6##2##(1991-8#1)(1992-12#1)(1992-3#1)(1995-3#1)(2008-11#1)(2013-8#1)
very powerful##11##2##(1995-12#1)(2008-10#3)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
very precise##5##2##(1991-8#1)(2008-10#3)(2008-9#1)
very precisely##2##2##(2007-11#1)(2008-10#1)
very preliminary in##2##3##(2008-5#1)(2008-6#1)
very preliminary##4##2##(1991-1#1)(2008-1#1)(2008-5#1)(2008-6#1)
very premature infants##2##3##(2007-11#1)(2011-2#1)
very preterm##2##2##(1993-12#1)(1997-5#1)
very prominent##2##2##(2008-10#1)(2008-9#1)
very promising##20##2##(1990-9#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-7#2)(2011-2#1)(2012-2#3)
very pure##2##2##(2008-11#1)(2008-4#1)
very quickly##7##2##(1990-6#1)(1991-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
very rapid and simple##2##4##(2008-10#1)(2008-4#1)
very rapid effectiveness of##2##4##(1990-2#1)(1991-3#1)
very rapid##15##2##(1990-2#2)(1991-3#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-9#1)(1996-12#1)(2008-10#4)(2008-4#1)(2009-12#1)(2009-6#1)
very rapidly##8##2##(1990-8#1)(1996-11#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-2#2)
very rare and##10##3##(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
very rare case of##5##4##(1994-7#1)(2008-7#2)(2011-2#2)
very rare in##4##3##(1991-11#1)(1996-8#1)(2009-8#1)(2013-1#1)
very rare##80##2##(1990-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1994-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2009-11#1)(2009-7#3)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#8)(2012-12#4)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#5)
very rarely##5##2##(1990-12#1)(1992-9#1)(2008-7#1)(2012-2#1)(2013-8#1)
very real##2##2##(1992-2#1)(1994-2#1)
very recent##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
very recently##5##2##(1990-7#1)(1993-6#1)(1995-2#1)(2008-11#1)(2008-6#1)
very reliable and##2##3##(2008-10#1)(2011-2#1)
very reliable##5##2##(2008-10#2)(2011-2#1)(2012-2#2)
very resistant to##3##3##(1994-2#1)(2008-10#1)(2009-5#1)
very restricted##3##2##(1993-12#1)(2008-10#1)(2008-8#1)
very robust##2##2##(2007-12#1)(2008-9#1)
very safe##2##2##(1994-9#1)(2008-7#1)
very satisfactory results##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
very satisfactory##10##2##(1990-5#1)(1991-2#1)(2008-10#5)(2008-9#1)(2009-10#1)(2011-2#1)
very satisfied with the##3##4##(1992-5#1)(1994-1#1)(2008-9#1)
very satisfied with##5##3##(1992-5#1)(1993-3#1)(1994-1#1)(2008-9#1)(2011-2#1)
very selective for##2##3##(2008-10#1)(2010-5#1)
very selective##4##2##(2008-10#3)(2010-5#1)
very sensitive and##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
very sensitive method##3##3##(2008-10#3)
very sensitive to the##4##4##(1992-6#1)(2008-7#1)(2008-8#1)(2009-8#1)
very sensitive to##17##3##(1990-5#1)(1990-7#1)(1992-6#1)(1994-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
very sensitive##45##2##(1990-12#1)(1990-5#1)(1990-7#1)(1992-6#1)(1993-12#1)(1994-8#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
very serious##8##2##(1993-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
very seriously##2##2##(1994-3#1)(2010-8#1)
very severe##9##2##(1990-9#2)(1996-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-6#1)
very short and##2##3##(2008-5#2)
very short response time##2##4##(2008-10#2)
very short##17##2##(1992-6#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)
very sick##2##2##(2008-8#1)(2012-3#1)
very significant##7##2##(1990-8#1)(1997-2#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2013-1#1)
very significantly##3##2##(1990-6#1)(2008-12#2)
very similar for##3##3##(1995-3#1)(2008-10#2)
very similar in##7##3##(1990-11#1)(1994-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
very similar rates##2##3##(2008-11#1)(2013-1#1)
very similar to each other##2##5##(1994-6#1)(2008-10#1)
very similar to other##2##4##(1991-9#1)(2010-11#1)
very similar to that of the##4##6##(1991-7#1)(1997-4#1)(2008-5#1)(2008-8#1)
very similar to that of##11##5##(1991-7#1)(1992-8#1)(1993-2#2)(1993-8#1)(1996-12#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
very similar to that##14##4##(1991-7#1)(1992-8#1)(1993-2#2)(1993-8#1)(1994-5#2)(1996-12#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
very similar to the##8##4##(1993-8#1)(1994-12#1)(2008-10#4)(2009-8#1)(2012-2#1)
very similar to those obtained##2##5##(1993-11#1)(1993-8#1)
very similar to those of##7##5##(1992-11#1)(1992-3#1)(1992-8#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
very similar to those##13##4##(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)
very similar to##50##3##(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#3)(1993-11#1)(1993-2#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)
very similar##108##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#28)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
very simple and fast##3##4##(2008-10#2)(2008-3#1)
very simple and##11##3##(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)
very simple##42##2##(1990-8#1)(1992-8#1)(2006-4#1)(2007-12#2)(2008-10#28)(2008-2#3)(2008-3#3)(2008-4#1)(2009-6#1)(2012-2#1)
very simply##2##2##(1992-9#1)(2008-10#1)
very slight or no##2##4##(2008-10#2)
very slight##4##2##(1995-6#1)(1996-2#1)(2008-10#2)
very slightly##2##2##(2008-10#2)
very slow##6##2##(1994-11#1)(2006-12#1)(2008-1#1)(2008-10#3)
very slowly##7##2##(1991-6#1)(1993-5#2)(1996-2#1)(2008-12#1)(2008-3#1)(2008-9#1)
very small amounts of##3##4##(2008-10#2)(2008-9#1)
very small and##3##3##(2008-10#2)(2013-7#1)
very small fraction of##2##4##(1991-5#1)(2008-11#1)
very small lesions##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
very small number##2##3##(1995-5#1)(1997-2#1)
very small##59##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#20)(2008-11#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#5)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#2)
very soon after##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
very soon##4##2##(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
very sparse##2##2##(2008-7#1)(2012-12#1)
very specific##13##2##(1990-5#1)(1991-5#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
very stable and homogeneous##2##4##(2008-10#2)
very stable and##5##3##(2008-10#4)(2008-11#1)
very stable even##2##3##(2008-10#1)(2013-8#1)
very stable##26##2##(1990-12#2)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
very strong correlation between##2##4##(2007-8#1)(2008-7#1)
very strong##18##2##(1990-7#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2012-3#1)
very strongly##4##2##(1993-6#1)(2006-6#1)(2008-10#1)(2009-7#1)
very successful in##2##3##(2007-8#1)(2008-4#1)
very successful##11##2##(1993-1#1)(1993-8#1)(1994-9#1)(1995-9#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
very successfully##2##2##(2008-10#2)
very suggestive##2##2##(1993-3#1)(1997-8#1)
very suitable for##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
very suitable##10##2##(2007-12#2)(2008-10#5)(2008-5#1)(2009-5#1)(2011-2#1)
very susceptible to##2##3##(2008-10#2)
very susceptible##5##2##(2008-10#5)
very thin##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)
very tight##2##2##(1992-6#1)(2008-3#1)
very tightly##2##2##(1991-5#1)(2008-9#1)
very unbalanced##2##2##(1995-12#1)(1995-8#1)
very uncommon##6##2##(1991-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
very unfavorable##2##2##(1993-2#1)(2012-12#1)
very unstable##2##2##(1992-12#1)(2008-10#1)
very unusual##8##2##(1991-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
very useful and##2##3##(1996-12#1)(2008-11#1)
very useful for##17##3##(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-8#1)
very useful in identifying##2##4##(2008-11#1)(2012-2#1)
very useful in##13##3##(1993-11#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-2#1)(2012-2#2)
very useful to##4##3##(1992-2#1)(1997-3#1)(2008-10#1)(2013-1#1)
very useful##56##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
very valuable##7##2##(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
very versatile##3##2##(2008-3#1)(2008-4#1)(2008-7#1)
very weak##25##2##(1990-8#1)(1994-6#1)(1995-2#1)(1996-2#2)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#8)(2008-4#1)(2008-7#4)(2012-2#2)(2013-8#2)
very weakly##4##2##(1993-1#2)(2007-7#1)(2008-10#1)
very well be##3##3##(1995-5#1)(2008-10#1)(2012-2#1)
very well in##2##3##(2008-3#1)(2013-1#1)
very well to##2##3##(1997-4#1)(2007-7#1)
very well tolerated##2##3##(1992-11#1)(2007-11#1)
very well with the##5##4##(1992-6#1)(1995-2#1)(2008-10#2)(2010-12#1)
very well with those obtained##2##5##(2008-10#2)
very well with##11##3##(1992-6#1)(1993-3#1)(1995-2#1)(2007-12#1)(2008-10#5)(2009-9#1)(2010-12#1)
very well##37##2##(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
very wide##9##2##(1992-12#1)(1995-3#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2010-7#1)
very widespread##2##2##(2007-11#1)(2010-1#1)
very young and##2##3##(1994-9#1)(1995-3#1)
very young children##3##3##(2008-9#2)(2012-12#1)
very young##10##2##(1994-9#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-3#1)(2008-11#1)(2008-9#2)(2012-12#1)
very##2368##1##(1990-10#2)(1990-11#7)(1990-12#14)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#14)(1990-6#5)(1990-7#6)(1990-8#10)(1990-9#10)(1991-1#3)(1991-11#6)(1991-12#13)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#12)(1991-6#9)(1991-7#1)(1991-8#5)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#8)(1992-12#18)(1992-2#6)(1992-3#14)(1992-4#2)(1992-5#7)(1992-6#9)(1992-8#8)(1992-9#12)(1993-1#6)(1993-11#8)(1993-12#13)(1993-2#6)(1993-3#9)(1993-5#2)(1993-6#5)(1993-8#11)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#13)(1994-12#13)(1994-2#15)(1994-3#5)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#2)(1995-11#6)(1995-12#6)(1995-2#9)(1995-3#13)(1995-5#11)(1995-6#9)(1995-8#6)(1995-9#2)(1996-1#3)(1996-11#6)(1996-12#17)(1996-2#7)(1996-3#5)(1996-4#5)(1996-5#3)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#12)(1997-3#10)(1997-4#15)(1997-5#2)(1997-6#11)(1997-7#12)(1997-8#12)(1997-9#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#8)(2007-11#73)(2007-12#54)(2007-2#5)(2007-4#3)(2007-5#5)(2007-6#2)(2007-7#13)(2007-8#23)(2007-9#1)(2008-1#41)(2008-10#526)(2008-11#88)(2008-12#29)(2008-2#27)(2008-3#52)(2008-4#40)(2008-5#72)(2008-6#22)(2008-7#97)(2008-8#46)(2008-9#62)(2009-10#8)(2009-11#8)(2009-12#7)(2009-2#4)(2009-3#2)(2009-4#6)(2009-5#6)(2009-6#6)(2009-7#11)(2009-8#12)(2009-9#2)(2010-1#4)(2010-10#10)(2010-11#13)(2010-12#10)(2010-3#10)(2010-4#10)(2010-5#13)(2010-6#9)(2010-7#11)(2010-8#18)(2010-9#4)(2011-1#12)(2011-2#76)(2011-3#4)(2012-1#6)(2012-12#23)(2012-2#52)(2012-3#30)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#61)(2013-7#10)(2013-8#32)
very-long-chain acyl-CoA##2##2##(1993-3#2)
very-long-chain fatty acid beta-oxidation system##2##5##(1994-6#2)
very-long-chain fatty acid##4##3##(1994-6#2)(1995-2#2)
very-long-chain fatty##5##2##(1994-6#2)(1995-2#3)
very-long-chain##7##1##(1993-3#2)(1994-6#2)(1995-2#3)
very-low-birthweight infants##2##2##(1992-2#2)
very-low-carbohydrate##2##1##(2008-5#2)
very-low-density##2##1##(1990-8#1)(2008-6#1)
vesamicol##2##1##(1993-9#2)
vesical fistula##2##2##(2008-1#1)(2008-10#1)
vesical##9##1##(1991-6#1)(1994-5#1)(1997-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
vesicarium were exposed to##2##4##(2008-10#2)
vesicarium##8##1##(2008-10#8)
vesicatoria be##2##2##(2008-10#2)
vesicatoria group##2##2##(2008-10#2)
vesicatoria in##2##2##(2008-10#2)
vesicatoria race T1##2##3##(2008-10#2)
vesicatoria##22##1##(2008-10#22)
vesicle aggregation##2##2##(1997-2#2)
vesicle are##2##2##(2008-1#1)(2008-11#1)
vesicle coat proteins##2##3##(2009-6#1)(2011-2#1)
vesicle exocytosis##2##2##(2008-4#1)(2011-2#1)
vesicle formation##5##2##(2008-10#1)(2009-8#1)(2012-2#2)(2013-1#1)
vesicle fusion##5##2##(1994-12#2)(1995-2#1)(1997-1#1)(2012-2#1)
vesicle is##4##2##(2007-12#1)(2008-11#1)(2011-2#2)
vesicle membranes##4##2##(1990-2#1)(1993-11#3)
vesicle movement##3##2##(2008-11#3)
vesicle preparation##3##2##(1990-7#2)(2012-2#1)
vesicle release##3##2##(1994-8#1)(2008-8#2)
vesicle trafficking and exocytosis##2##4##(1995-2#1)(2009-8#1)
vesicle trafficking and##3##3##(1995-2#1)(2008-11#1)(2009-8#1)
vesicle trafficking##7##2##(1993-6#1)(1995-2#1)(1997-1#1)(2008-11#1)(2009-10#1)(2009-8#2)
vesicle transport##4##2##(1993-9#1)(1997-1#1)(2008-11#2)
vesicle turnover##2##2##(1997-7#2)
vesicle##107##1##(1990-11#1)(1990-2#3)(1990-7#2)(1991-10#1)(1992-11#1)(1992-3#6)(1992-6#4)(1993-11#3)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#4)(1995-3#1)(1995-6#2)(1996-12#1)(1997-1#4)(1997-2#3)(1997-7#2)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#19)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#3)(2010-6#1)(2011-2#7)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
vesicle-mediated##2##1##(2008-10#2)
vesicles (CCVs)##2##2##(2008-1#1)(2009-6#1)
vesicles (SUV)##2##2##(1992-3#1)(2008-10#1)
vesicles and were in##2##4##(1997-2#2)
vesicles and##20##2##(1992-12#1)(1993-12#1)(1994-8#1)(1995-12#2)(1997-2#2)(2007-12#1)(2008-10#7)(2008-7#3)(2008-8#2)
vesicles are##12##2##(1990-2#1)(1994-12#1)(1997-3#1)(1997-7#1)(2008-1#4)(2008-5#1)(2008-7#2)(2011-1#1)
vesicles as##5##2##(1991-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
vesicles but##4##2##(1991-5#1)(1994-5#1)(2008-7#1)(2011-2#1)
vesicles by a##2##3##(1992-6#1)(2008-10#1)
vesicles by##8##2##(1992-6#1)(1994-12#1)(1995-6#2)(2008-1#1)(2008-10#2)(2013-7#1)
vesicles can##3##2##(1994-5#1)(2008-10#1)(2013-8#1)
vesicles containing##8##2##(1990-2#1)(1992-12#3)(1994-5#1)(1997-6#1)(2007-12#1)(2008-8#1)
vesicles for##2##2##(2008-10#2)
vesicles from##5##2##(1990-11#1)(1992-12#1)(2008-11#2)(2012-3#1)
vesicles has been##2##3##(1990-2#1)(1997-6#1)
vesicles in the##2##3##(1990-11#1)(1997-1#1)
vesicles in##11##2##(1990-11#1)(1990-2#2)(1994-12#1)(1997-1#2)(1997-7#1)(2007-12#2)(2008-10#1)(2009-2#1)
vesicles increased##2##2##(2008-5#1)(2008-8#1)
vesicles is##2##2##(1990-11#1)(2008-11#1)
vesicles isolated from##2##3##(1994-12#1)(2008-11#1)
vesicles isolated##3##2##(1994-12#1)(2008-11#2)
vesicles labeled with##2##3##(1992-3#1)(2008-8#1)
vesicles made##2##2##(2008-8#1)(2012-2#1)
vesicles obtained by##2##3##(1991-5#1)(1993-8#1)
vesicles of defined##2##3##(1990-2#1)(1992-6#1)
vesicles of different##3##3##(1990-2#1)(1994-5#1)(2013-7#1)
vesicles of##10##2##(1990-2#2)(1992-6#1)(1994-12#1)(1994-5#2)(2007-12#1)(2009-10#1)(2009-12#1)(2013-7#1)
vesicles or##4##2##(1991-2#1)(1997-7#1)(2007-7#1)(2008-5#1)
vesicles prepared from##5##3##(1991-5#2)(1994-6#1)(1997-8#1)(2008-11#1)
vesicles prepared##6##2##(1990-7#1)(1991-5#2)(1994-6#1)(1997-8#1)(2008-11#1)
vesicles that##4##2##(1992-12#1)(1994-5#1)(2008-10#1)(2008-11#1)
vesicles to##8##2##(1992-3#1)(1994-5#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-8#1)
vesicles was##5##2##(1991-9#1)(1992-3#2)(2008-10#1)(2008-11#1)
vesicles were solubilized##2##3##(1990-11#1)(1990-2#1)
vesicles were##10##2##(1990-11#1)(1990-2#1)(1992-3#2)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
vesicles which##3##2##(1997-7#1)(2008-10#1)(2008-6#1)
vesicles with a##3##3##(1990-11#1)(1996-5#1)(1997-3#1)
vesicles with the##3##3##(1990-2#1)(1992-6#1)(2009-2#1)
vesicles with##15##2##(1990-11#3)(1990-12#1)(1990-2#2)(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-2#1)
vesicles##306##1##(1990-11#11)(1990-12#3)(1990-2#15)(1990-7#1)(1991-2#3)(1991-5#8)(1991-9#3)(1992-12#6)(1992-3#11)(1992-6#10)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#12)(1994-2#1)(1994-5#10)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#4)(1996-5#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-6#4)(1997-7#8)(1997-8#7)(2007-12#10)(2007-7#1)(2008-1#11)(2008-10#34)(2008-11#20)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#3)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-7#6)(2013-8#7)
vesicles)##3##1##(1991-10#1)(1994-2#1)(2008-9#1)
vesico-ureteral reflux##3##2##(2008-10#2)(2008-4#1)
vesico-ureteric junction##3##2##(2008-10#2)(2012-3#1)
vesico-ureteric reflux##3##2##(2007-7#1)(2008-4#2)
vesico-ureteric##6##1##(2007-7#1)(2008-10#2)(2008-4#2)(2012-3#1)
vesicocutaneous##2##1##(1993-2#1)(2011-2#1)
vesicostomy##2##1##(2008-10#2)
vesicoureteral reflux##13##2##(2007-9#1)(2008-1#1)(2008-10#10)(2008-7#1)
vesicoureteric reflux##5##2##(1990-8#1)(1991-11#1)(2008-1#1)(2008-6#1)(2009-5#1)
vesicoureteric##6##1##(1990-8#1)(1991-11#2)(2008-1#1)(2008-6#1)(2009-5#1)
vesicovaginal##2##1##(1993-2#1)(1996-2#1)
vesicular disease##2##2##(2011-2#2)
vesicular fusion##2##2##(1995-2#1)(2008-5#1)
vesicular glutamate transporter##2##3##(2008-7#1)(2009-8#1)
vesicular membranes##2##2##(1990-11#1)(1991-10#1)
vesicular monoamine transporter is not##2##5##(1995-12#2)
vesicular monoamine transporter##8##3##(1995-12#6)(1996-12#2)
vesicular monoamine##9##2##(1995-12#7)(1996-12#2)
vesicular stomatitis virus glycoprotein##2##4##(1991-2#1)(1997-4#1)
vesicular stomatitis virus##12##3##(1991-2#1)(1992-12#2)(1993-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-4#2)(2007-8#1)(2008-4#1)
vesicular stomatitis##13##2##(1991-2#1)(1992-12#2)(1993-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-4#2)(2007-8#1)(2008-1#1)(2008-4#1)
vesicular trafficking##5##2##(1996-5#1)(2009-10#2)(2009-7#1)(2011-2#1)
vesicular transport##4##2##(1995-2#1)(1995-8#1)(1996-12#1)(2008-11#1)
vesicular transporter##3##2##(1996-12#3)
vesicular##67##1##(1990-11#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-12#2)(1992-7#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#7)(1995-2#3)(1995-8#1)(1996-12#6)(1996-5#2)(1997-4#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
vesiculation##2##1##(1997-3#2)
vespertinus##2##1##(2011-2#2)
vessel and the##2##3##(1993-8#1)(2008-10#1)
vessel and##10##2##(1993-8#1)(1994-11#2)(2008-10#6)(2012-3#1)
vessel avulsion model##2##3##(2007-10#2)
vessel coronary artery disease##3##4##(2007-8#1)(2007-9#2)
vessel diameter##3##2##(2009-12#1)(2011-2#2)
vessel disease and##2##3##(1994-11#1)(2008-8#1)
vessel disease##9##2##(1994-11#2)(2007-10#3)(2008-7#1)(2008-8#2)(2009-10#1)
vessel elements##2##2##(2008-10#2)
vessel failure##2##2##(2008-11#1)(2009-10#1)
vessel in the##2##3##(2008-3#2)
vessel is##3##2##(2008-10#2)(2008-12#1)
vessel of##2##2##(2008-10#1)(2008-7#1)
vessel or##2##2##(1994-11#1)(2013-1#1)
vessel size##2##2##(2009-7#1)(2012-5#1)
vessel surgery##2##2##(1991-12#1)(1994-3#1)
vessel tone##2##2##(1995-2#2)
vessel vasculitis##4##2##(1997-8#2)(2008-10#1)(2012-3#1)
vessel wall##20##2##(1992-9#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
vessel walls##6##2##(1990-8#1)(1991-3#1)(1994-9#1)(2008-11#1)(2008-4#1)(2009-8#1)
vessel was##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)
vessel were##2##2##(1995-3#1)(2007-8#1)
vessel##205##1##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-9#3)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#6)(1994-3#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-8#2)(2007-10#5)(2007-11#1)(2007-12#4)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#42)(2008-11#10)(2008-12#1)(2008-3#14)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#2)(2009-10#8)(2009-12#1)(2009-3#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#6)(2012-5#1)(2013-1#7)(2013-8#2)
vessel)##2##1##(2008-5#1)(2011-2#1)
vessels and the##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
vessels and##29##2##(1991-6#1)(1991-8#1)(1994-9#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
vessels are##5##2##(1993-9#1)(1994-9#1)(2007-7#1)(2008-1#1)(2008-11#1)
vessels around the##2##3##(2006-12#1)(2008-7#1)
vessels by##3##2##(1991-8#1)(2008-3#1)(2008-8#1)
vessels formed##2##2##(2008-7#1)(2011-2#1)
vessels from the##2##3##(2011-2#2)
vessels from##5##2##(1995-12#1)(2010-9#1)(2011-2#2)(2013-8#1)
vessels in a##2##3##(2008-10#1)(2011-2#1)
vessels in the##3##3##(2009-12#1)(2011-2#1)(2012-1#1)
vessels in##13##2##(1991-8#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-2#2)(2012-1#1)(2013-8#2)
vessels is##6##2##(1993-9#1)(1994-9#1)(1997-8#1)(2010-1#1)(2010-11#1)(2011-2#1)
vessels leads to##2##3##(1992-9#1)(2012-2#1)
vessels of the##6##3##(1997-5#1)(2007-12#1)(2008-10#1)(2010-5#1)(2012-1#1)(2013-7#1)
vessels of##15##2##(1992-12#1)(1997-5#1)(2007-12#1)(2008-10#5)(2008-11#3)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#1)
vessels or##3##2##(1990-2#1)(2008-7#1)(2011-2#1)
vessels that##2##2##(1997-8#1)(2008-3#1)
vessels to the##2##3##(2011-2#1)(2012-3#1)
vessels to##3##2##(1996-3#1)(2011-2#1)(2012-3#1)
vessels was##5##2##(2007-7#1)(2008-11#1)(2008-7#2)(2011-2#1)
vessels were##10##2##(1994-11#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#3)
vessels which##3##2##(1995-4#1)(2008-10#1)(2011-2#1)
vessels with##3##2##(1991-6#1)(2006-6#1)(2008-8#1)
vessels##250##1##(1990-11#1)(1990-2#3)(1990-3#2)(1990-8#2)(1991-2#1)(1991-6#2)(1991-8#3)(1992-12#1)(1992-5#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#7)(1995-12#3)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-9#3)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#5)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#6)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#5)(2008-10#21)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#16)(2008-8#4)(2008-9#2)(2009-12#2)(2009-5#2)(2009-7#3)(2009-8#1)(2010-1#3)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#29)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#7)
vested##5##1##(1991-12#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-12#1)
vestibular and##3##2##(1991-2#2)(1996-5#1)
vestibular aqueduct syndrome##2##3##(2008-9#2)
vestibular aqueduct##3##2##(2008-9#3)
vestibular compensation in the goldfish##2##5##(1991-2#2)
vestibular disorders##5##2##(2008-4#3)(2012-3#2)
vestibular function##2##2##(2011-1#1)(2012-3#1)
vestibular hypofunction##2##2##(2012-3#2)
vestibular nerve##2##2##(1993-9#1)(2011-2#1)
vestibular nucleus##2##2##(1993-5#1)(1993-9#1)
vestibular rehabilitation##2##2##(2012-2#2)
vestibular schwannoma and meningioma##2##4##(2010-11#2)
vestibular schwannoma##7##2##(2010-11#2)(2010-4#3)(2011-2#2)
vestibular schwannomas##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
vestibular signals##3##2##(1995-5#2)(1995-8#1)
vestibular stimulation##4##2##(1995-8#1)(1996-5#1)(1997-2#2)
vestibular system##4##2##(1995-8#2)(2008-4#1)(2009-9#1)
vestibular##62##1##(1990-10#1)(1990-6#1)(1991-2#8)(1993-12#1)(1993-5#1)(1993-9#2)(1995-12#1)(1995-5#4)(1995-8#5)(1996-12#1)(1996-5#2)(1997-2#2)(2008-10#1)(2008-12#1)(2008-4#5)(2008-9#3)(2009-9#1)(2010-11#2)(2010-4#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#2)
vestibule##2##1##(1993-9#1)(2013-1#1)
vestibulo-ocular reflex and optokinetic afternystagmus##4##5##(2008-4#4)
vestibulo-ocular reflex and optokinetic##5##4##(2008-4#5)
vestibulo-ocular reflex##8##2##(2008-4#8)
vestimentiferans##2##1##(2009-8#2)
vet##4##1##(1991-8#1)(1997-6#1)(1997-8#1)(2010-8#1)
veteran##3##1##(1996-1#1)(2012-1#1)(2013-1#1)
veterans and##2##2##(2011-2#1)(2012-1#1)
veterans from##3##2##(2012-1#1)(2013-1#2)
veterans in##2##2##(2012-1#1)(2012-3#1)
veterans of##4##2##(2011-1#1)(2012-1#1)(2013-1#2)
veterans with##3##2##(2007-7#1)(2012-2#1)(2013-1#1)
veterans##31##1##(1996-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#4)(2012-1#9)(2012-2#1)(2012-3#2)(2013-1#7)
veterinarians and##4##2##(1997-7#1)(2008-12#1)(2010-4#1)(2013-1#1)
veterinarians##6##1##(1991-8#1)(1997-7#1)(2008-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
veterinary and##5##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
veterinary antibiotics##2##2##(2008-10#2)
veterinary clinic##2##2##(2011-1#2)
veterinary drug residues##2##3##(1994-3#1)(2010-5#1)
veterinary health care settings##2##4##(2010-4#2)
veterinary medicine##3##2##(2009-3#1)(2010-4#1)(2012-3#1)
veterinary parasitologists##2##2##(1997-7#2)
veterinary pharmaceuticals##2##2##(2008-10#2)
veterinary research##2##2##(1990-9#1)(1997-7#1)
veterinary scientists##3##2##(2010-1#3)
veterinary surgeons##2##2##(1990-6#1)(1995-9#1)
veterinary##58##1##(1990-6#2)(1990-9#3)(1992-8#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#6)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-8#4)(2009-3#1)(2009-4#1)(2010-1#4)(2010-11#1)(2010-4#5)(2010-5#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
veterinary-assessed mobility##4##2##(2008-10#4)
veto##3##1##(1992-11#1)(1995-6#1)(1996-5#1)
vetoed##2##1##(1996-5#2)
vexing##5##1##(1996-2#1)(2008-11#1)(2009-12#1)(2010-12#1)(2010-3#1)
via Agrobacterium tumefaciens##2##3##(2008-10#1)(2008-9#1)
via Ca2+##2##2##(1990-5#1)(1993-12#1)
via DNA##2##2##(1991-9#1)(2010-7#1)
via PLSVC##2##2##(2012-2#2)
via RNA##2##2##(2010-5#1)(2012-2#1)
via a Knoevenagel##2##3##(2009-7#2)
via a combination of##2##4##(1995-2#1)(2009-2#1)
via a complex##2##3##(1994-5#1)(2008-11#1)
via a concerted##2##3##(1996-2#2)
via a direct##2##3##(2007-8#1)(2008-5#1)
via a facile##2##3##(2008-10#1)(2012-2#1)
via a limited##2##3##(2008-7#2)
via a mechanism##2##3##(1992-3#1)(2008-5#1)
via a modified##3##3##(2008-10#1)(2008-8#2)
via a pathway##2##3##(1993-8#1)(1995-8#1)
via a series of##2##4##(2008-4#1)(2008-7#1)
via a transient##2##3##(2008-11#1)(2009-11#1)
via a two-step##2##3##(1996-5#1)(2009-5#1)
via a##146##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-7#3)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#4)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)
via activation of the##2##4##(1994-8#2)
via activation of##6##3##(1992-9#1)(1994-8#2)(2008-11#1)(2008-4#1)(2008-9#1)
via an associative##3##3##(1996-2#1)(2013-1#2)
via an intramolecular##3##3##(1995-2#1)(1995-3#1)(2008-6#1)
via an##55##2##(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#4)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
via anion##2##2##(1990-2#1)(2008-4#1)
via anion-exchange##2##2##(2008-4#1)(2010-4#1)
via any##2##2##(2007-11#1)(2008-9#1)
via appropriate##2##2##(2011-1#1)(2011-2#1)
via aqueous Diels-Alder cycloaddition##2##4##(2008-4#2)
via aqueous##3##2##(1992-3#1)(2008-4#2)
via automated##2##2##(1992-4#1)(2008-10#1)
via binding##2##2##(1990-5#1)(1997-8#1)
via biochemical##2##2##(2010-10#1)(2010-4#1)
via both##4##2##(1991-9#1)(1992-12#1)(1995-6#1)(2008-10#1)
via bronchoscopy##3##2##(1994-2#2)(2010-10#1)
via calcium##3##2##(1990-5#1)(2008-4#1)(2008-8#1)
via cellular##2##2##(2008-11#1)(2008-8#1)
via complex formation with modifier##2##5##(2008-10#2)
via complex##4##2##(1995-12#1)(2008-10#2)(2008-8#1)
via conventional##4##2##(1990-7#1)(2008-10#2)(2009-5#1)
via cytochrome P-450##2##3##(1990-2#1)(2008-3#1)
via different mechanisms##2##3##(1993-6#1)(1997-1#1)
via different pathways##2##3##(1994-6#1)(2010-8#1)
via different##8##2##(1993-6#1)(1994-6#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)
via diffusion##4##2##(2008-10#2)(2009-9#1)(2011-1#1)
via direct##8##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)
via distinct##2##2##(1992-3#1)(1994-9#1)
via drinking water##2##3##(1996-12#1)(2008-9#1)
via duplication and##2##3##(1992-3#1)(2008-2#1)
via either##3##2##(2008-10#2)(2012-12#1)
via electron beam##2##3##(2008-10#1)(2009-11#1)
via electron##4##2##(1995-3#1)(2008-10#1)(2008-8#1)(2009-11#1)
via expression##2##2##(2008-4#1)(2012-1#1)
via flow##2##2##(2008-10#1)(2012-3#1)
via fluorescence##2##2##(1990-11#1)(2011-1#1)
via glutaraldehyde##2##2##(2008-10#1)(2009-10#1)
via glycosylation##2##2##(2008-11#2)
via group##2##2##(1996-5#1)(2008-10#1)
via high##2##2##(1993-6#1)(1997-4#1)
via homologous recombination##2##3##(1991-9#1)(2008-4#1)
via human##2##2##(1990-6#1)(1991-12#1)
via hyphal anastomosis##2##3##(2008-10#2)
via immunogold##2##2##(2008-9#2)
via increased##3##2##(2008-3#1)(2012-12#1)(2012-3#1)
via induction of##2##3##(1991-12#1)(2008-10#1)
via ingestion##2##2##(2008-12#1)(2008-7#1)
via inhibition of##4##3##(1994-8#1)(2008-10#1)(2011-3#1)(2012-2#1)
via interactions with##2##3##(1994-12#1)(1994-5#1)
via interactive##2##2##(2008-10#1)(2012-3#1)
via interpolation##2##2##(2008-5#1)(2008-8#1)
via ion##2##2##(2008-10#1)(2008-5#1)
via its##13##2##(1990-7#2)(1992-12#1)(1992-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-10#2)(2010-3#1)(2011-2#2)(2013-7#1)
via laparoscopy in##2##3##(1991-3#1)(1993-9#1)
via laparoscopy##5##2##(1991-3#3)(1993-9#1)(1996-2#1)
via layer-by-layer##2##2##(2008-10#2)
via lysosomal exocytosis##2##3##(2012-12#2)
via median##2##2##(2008-10#2)
via mitochondrial pathways##2##3##(1992-10#1)(2013-1#1)
via mitochondrial##3##2##(1992-10#2)(2013-1#1)
via modulating##2##2##(2009-10#1)(2012-3#1)
via modulation of##3##3##(1997-1#1)(2008-5#1)(2013-1#1)
via monocytes##2##2##(1991-12#2)
via multiple##2##2##(2010-5#1)(2011-2#1)
via muscle metaboreflex##2##3##(2013-8#2)
via muscle##3##2##(2012-2#1)(2013-8#2)
via on-line##3##2##(2008-10#3)
via our##2##2##(1992-2#1)(2008-11#1)
via oxidation##2##2##(1991-5#1)(2012-3#1)
via p53 in##2##3##(2011-2#2)
via p53##3##2##(2007-8#1)(2011-2#2)
via particle bombardment##3##3##(2008-10#3)
via potentiometric titration##2##3##(2008-10#2)
via production of##2##3##(1994-9#1)(2011-2#1)
via promoter##2##2##(2008-7#1)(2008-8#1)
via protein-protein interactions##3##3##(1992-3#1)(1992-8#1)(2009-7#1)
via prunin##2##2##(2008-11#2)
via reaction##2##2##(2009-2#1)(2009-9#1)
via receptor-mediated endocytosis##2##3##(2008-11#2)
via reduction of##2##3##(2008-10#1)(2008-5#1)
via reverse Na-Ca+K exchange##2##4##(1995-5#2)
via reverse##3##2##(1995-5#3)
via several##5##2##(1997-1#1)(2008-4#1)(2008-8#1)(2011-1#2)
via similar##4##2##(1990-5#1)(1991-9#1)(2009-6#2)
via simulation##2##2##(2009-9#1)(2012-3#1)
via simulations##2##2##(2008-6#1)(2012-12#1)
via single##2##2##(2008-10#1)(2009-12#1)
via specific##2##2##(2008-11#1)(2008-8#1)
via sternotomy##4##2##(2007-8#4)
via stimulation of##3##3##(1995-12#2)(1996-2#1)
via suppressing##2##2##(2008-10#1)(2008-11#1)
via text##2##2##(2012-1#1)(2013-1#1)
via the A1##3##3##(1993-6#1)(1994-11#1)(1994-6#1)
via the IL-5 receptor##2##4##(1990-12#2)
via the Internet in##2##4##(2007-12#1)(2008-1#1)
via the Internet##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
via the MT1##2##3##(2013-7#2)
via the action of##2##4##(1994-6#1)(2008-11#1)
via the activation of##2##4##(1995-6#1)(2009-8#1)
via the adenosine##2##3##(2008-10#1)(2008-4#1)
via the cAMP##2##3##(1994-8#1)(1996-5#1)
via the central nervous system##2##5##(1997-7#1)(2013-7#1)
via the complex##2##3##(1993-8#1)(2008-10#1)
via the formation of##2##4##(1990-12#1)(1995-5#1)
via the interaction of##2##4##(2008-10#1)(2012-2#1)
via the media##2##3##(2008-11#1)(2013-1#1)
via the reaction of##2##4##(1993-6#1)(2008-10#1)
via the reaction##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
via the same##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
via the sympathetic innervation##2##4##(1994-5#1)(1995-3#1)
via the telephone##2##3##(2013-1#2)
via the trachea##2##3##(1994-5#1)(2008-10#1)
via the transarterial route##2##4##(1997-3#2)
via the##215##2##(1990-12#3)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-11#3)(2007-12#8)(2007-2#1)(2008-1#4)(2008-10#34)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#16)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#4)(2013-8#2)
via their##6##2##(1996-2#1)(2007-12#1)(2008-4#2)(2010-1#1)(2012-2#1)
via these##3##2##(2008-5#1)(2009-2#2)
via this receptor##2##3##(1995-6#1)(2008-5#1)
via this##6##2##(1993-11#1)(1994-11#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-5#1)
via three##3##2##(1994-2#1)(2007-12#1)(2008-12#1)
via transient##2##2##(1996-5#1)(2011-1#1)
via two##5##2##(1995-6#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)
via use of##3##3##(2008-10#2)(2011-2#1)
via wireless##4##2##(2008-10#2)(2008-9#1)(2010-8#1)
via##1211##1##(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#6)(1991-10#1)(1991-12#8)(1991-2#2)(1991-3#6)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#9)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#13)(1992-4#1)(1992-6#6)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#5)(1993-5#2)(1993-6#8)(1993-8#5)(1993-9#6)(1994-11#3)(1994-12#6)(1994-2#8)(1994-3#2)(1994-5#7)(1994-6#5)(1994-8#9)(1994-9#8)(1995-11#2)(1995-12#14)(1995-2#9)(1995-3#5)(1995-5#7)(1995-6#5)(1995-8#7)(1996-12#4)(1996-2#12)(1996-3#5)(1996-4#1)(1996-5#16)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#10)(1997-2#3)(1997-3#4)(1997-4#7)(1997-6#2)(1997-7#8)(1997-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#12)(2007-12#26)(2007-2#1)(2007-4#1)(2007-8#13)(2007-9#2)(2008-1#12)(2008-10#196)(2008-11#54)(2008-12#12)(2008-2#7)(2008-3#6)(2008-4#48)(2008-5#31)(2008-6#17)(2008-7#46)(2008-8#37)(2008-9#21)(2009-1#1)(2009-10#7)(2009-11#9)(2009-12#9)(2009-2#7)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#8)(2009-7#5)(2009-8#8)(2009-9#9)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#3)(2010-4#9)(2010-5#6)(2010-6#4)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#28)(2011-2#55)(2011-3#3)(2012-1#6)(2012-12#19)(2012-2#27)(2012-3#22)(2013-1#39)(2013-7#11)(2013-8#11)
viabilities##8##1##(2008-10#1)(2008-11#7)
viability after##4##2##(1994-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
viability and body size##2##4##(2013-1#2)
viability and growth of##2##4##(1990-6#1)(2009-9#1)
viability and productivity##2##3##(2008-11#2)
viability and proliferation##4##3##(2008-11#1)(2008-5#2)(2012-6#1)
viability and the##2##3##(2011-2#1)(2013-8#1)
viability and##58##2##(1990-6#1)(1992-2#1)(1994-1#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-8#1)(2008-10#6)(2008-11#12)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#2)(2013-8#1)
viability are##2##2##(1994-5#1)(2011-2#1)
viability as##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
viability assessment##2##2##(2008-9#1)(2012-2#1)
viability costs##2##2##(2008-8#2)
viability during##3##2##(2008-10#1)(2008-11#2)
viability in the##2##3##(1995-3#1)(1996-12#1)
viability in##22##2##(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-11#7)(2011-2#1)(2013-1#2)
viability is##2##2##(1997-4#1)(2008-9#1)
viability of a##2##3##(2008-10#1)(2008-7#1)
viability of cells##3##3##(2008-4#1)(2009-12#1)(2013-1#1)
viability of conidia##2##3##(2008-10#2)
viability of the method##4##4##(2008-10#3)(2008-5#1)
viability of the##18##3##(1992-1#1)(1992-5#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-11#4)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#3)
viability of##76##2##(1990-6#1)(1991-1#1)(1992-1#1)(1992-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#18)(2008-11#13)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
viability or##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
viability remained##2##2##(1992-12#1)(2008-11#1)
viability selection##7##2##(2008-8#1)(2008-9#1)(2013-1#5)
viability test##3##2##(2008-11#1)(2010-5#1)(2012-12#1)
viability than the##2##3##(2008-9#1)(2013-1#1)
viability traits##2##2##(2012-3#2)
viability using##2##2##(2008-11#1)(2008-9#1)
viability was determined##2##3##(2008-11#1)(2012-12#1)
viability was observed##2##3##(2008-10#1)(2008-11#1)
viability was##16##2##(1994-5#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#6)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
viability were##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
viability##352##1##(1990-6#4)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#4)(1994-6#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-7#5)(1996-8#1)(1996-9#2)(1997-3#4)(1997-4#5)(1997-7#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#47)(2008-11#73)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#15)(2008-8#10)(2008-9#29)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#2)(2009-9#4)(2010-10#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2012-12#3)(2012-2#9)(2012-3#9)(2012-6#1)(2013-1#25)(2013-7#4)(2013-8#2)
viability)##2##1##(1992-9#1)(2008-11#1)
viable and total cell##2##4##(2008-11#1)(2008-7#1)
viable and##11##2##(1996-8#1)(2008-10#2)(2008-11#2)(2008-7#3)(2008-9#2)(2013-1#1)
viable animal cells##2##3##(2008-11#2)
viable at##4##2##(1993-3#1)(2008-11#1)(2008-9#2)
viable bacteria##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
viable bacterial counts##2##3##(2008-10#2)
viable biomass##2##2##(2008-11#2)
viable but##2##2##(2008-10#1)(2008-9#1)
viable candidates for##2##3##(2010-10#1)(2012-12#1)
viable cell concentration##9##3##(1994-3#1)(2008-11#3)(2008-7#5)
viable cell concentrations##2##3##(1994-5#1)(2008-11#1)
viable cell density and##2##4##(2008-11#2)
viable cell density in##2##4##(2008-11#2)
viable cell density of##3##4##(2008-11#3)
viable cell density##18##3##(1994-5#1)(2008-11#17)
viable cell number##6##3##(2008-11#6)
viable cell##42##2##(1994-3#1)(1994-5#2)(2008-11#33)(2008-7#5)(2010-4#1)
viable cells for##2##3##(1990-12#1)(2008-9#1)
viable cells in##4##3##(2008-11#4)
viable cells##22##2##(1990-12#1)(1994-2#1)(2007-7#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2010-4#1)(2012-2#1)
viable counts dropped##2##3##(2012-2#2)
viable counts in the##2##4##(2008-10#1)(2013-1#1)
viable counts were##2##3##(1997-5#1)(2008-10#1)
viable counts##13##2##(1997-4#1)(1997-5#2)(2007-7#2)(2008-10#4)(2012-2#3)(2013-1#1)
viable for##5##2##(1994-5#1)(2008-10#2)(2008-7#1)(2011-2#1)
viable hepatocytes##2##2##(2008-11#2)
viable in##3##2##(1994-12#1)(2008-1#1)(2010-11#1)
viable myocardium##6##2##(2007-8#6)
viable option for the##2##4##(2008-10#1)(2009-10#1)
viable option for##6##3##(2008-10#2)(2009-10#1)(2011-2#2)(2012-2#1)
viable option##9##2##(2008-10#3)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
viable populations##3##2##(2007-7#1)(2008-8#1)(2013-7#1)
viable spores##3##2##(2008-10#2)(2011-2#1)
viable technique for##3##3##(2008-10#1)(2008-4#1)(2012-4#1)
viable technique##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-4#1)
viable tissue##3##2##(2007-8#1)(2013-7#2)
viable yeast##2##2##(2007-12#1)(2008-10#1)
viable##289##1##(1990-12#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#6)(2007-8#7)(2008-1#1)(2008-10#54)(2008-11#64)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#15)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-4#4)(2011-1#1)(2011-2#10)(2012-12#6)(2012-2#10)(2012-3#2)(2012-4#1)(2013-1#11)(2013-7#4)(2013-8#1)
vial and##2##2##(2008-10#1)(2008-8#1)
vial of##2##2##(1997-4#1)(2008-8#1)
vial##15##1##(1992-3#1)(1997-4#1)(2008-10#8)(2008-3#3)(2008-8#2)
vials##11##1##(2008-10#5)(2008-3#3)(2008-8#1)(2010-4#1)(2012-2#1)
vibrant Soundbridge middle-ear implant##2##4##(2008-9#2)
vibrant##5##1##(2008-10#1)(2008-12#1)(2008-9#2)(2009-10#1)
vibrate##3##1##(2008-2#1)(2008-3#2)
vibrated image##2##2##(2008-2#2)
vibrated images##2##2##(2008-2#1)(2008-3#1)
vibrated##4##1##(2008-2#3)(2008-3#1)
vibrates##2##1##(2008-2#1)(2008-3#1)
vibrating surfaces##2##2##(2008-2#2)
vibrating##13##1##(1992-8#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#5)(2012-2#1)
vibration amplitude##2##2##(2008-2#1)(2008-3#1)
vibration amplitudes of a##3##4##(2008-3#3)
vibration amplitudes##5##2##(2008-2#1)(2008-3#4)
vibration and##6##2##(1991-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-3#1)
vibration effects##2##2##(2008-3#2)
vibration frequency##2##2##(2008-2#2)
vibration is##2##2##(2008-3#2)
vibration measurement##3##2##(2007-11#1)(2008-2#2)
vibration of a##2##3##(2007-12#1)(2008-2#1)
vibration of the##8##3##(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-8#1)
vibration of##13##2##(1995-5#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2013-8#1)
vibration to##3##2##(2008-3#3)
vibration##81##1##(1990-4#1)(1991-12#1)(1995-5#1)(1996-2#2)(2007-11#5)(2007-12#5)(2008-10#7)(2008-11#5)(2008-2#13)(2008-3#30)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#2)(2012-2#1)(2012-3#2)(2013-8#3)
vibration-blur impulse response##2##3##(2008-3#2)
vibrational Raman##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
vibrational and rotational Raman##2##4##(2007-11#1)(2008-10#1)
vibrational band##4##2##(2008-3#3)(2008-8#1)
vibrational bands of##2##3##(1995-5#2)
vibrational bands##3##2##(1995-5#2)(2008-5#1)
vibrational echo##2##2##(2008-8#2)
vibrational energy##2##2##(2007-1#1)(2008-3#1)
vibrational frequencies##3##2##(1996-2#1)(2013-1#2)
vibrational modes of the##2##4##(1992-6#1)(2008-4#1)
vibrational modes##7##2##(1992-6#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2013-7#1)
vibrational relaxation##2##2##(2007-1#2)
vibrational spectra of Bis(melaminium) terephthalate dihydrate##2##6##(2013-1#2)
vibrational spectra of##4##3##(1993-11#1)(1996-2#1)(2013-1#2)
vibrational spectra##7##2##(1993-11#1)(1996-2#2)(2013-1#3)(2013-8#1)
vibrational spectroscopic##2##2##(2008-10#1)(2013-1#1)
vibrational spectroscopy##2##2##(2007-12#1)(2008-10#1)
vibrational spectrum of##2##3##(1993-11#1)(2010-7#1)
vibrational spectrum##3##2##(1993-11#1)(2007-11#1)(2010-7#1)
vibrational transition of##2##3##(2007-11#1)(2008-2#1)
vibrational transition##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
vibrational##74##1##(1990-8#1)(1991-9#1)(1992-6#1)(1993-11#2)(1994-11#1)(1995-5#3)(1996-2#3)(2007-1#3)(2007-11#9)(2007-12#4)(2008-10#8)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2009-6#1)(2010-7#1)(2011-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
vibrational-rotational Raman##2##2##(2008-3#2)
vibrational-rotational##4##1##(2008-3#4)
vibrationally excited NO##2##3##(2008-3#2)
vibrationally excited##6##2##(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
vibrationally##7##1##(1995-2#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
vibrations and##2##2##(1990-12#1)(2008-3#1)
vibrations are##2##2##(2008-2#2)
vibrations for##2##2##(2007-11#1)(2008-3#1)
vibrations in##2##2##(2008-10#1)(2010-2#1)
vibrations is##2##2##(1994-3#1)(2008-3#1)
vibrations of the##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2012-2#1)
vibrations of##9##2##(1992-6#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2009-9#1)(2012-2#1)
vibrations to improve##2##3##(2008-2#2)
vibrations##48##1##(1990-12#1)(1992-6#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#14)(2008-3#14)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#2)
vibrators##2##1##(2008-7#1)(2012-2#1)
vibratory signaling differences predicted winners##2##5##(2009-9#2)
vibratory signaling##4##2##(2009-9#4)
vibratory##6##1##(1995-5#1)(1997-6#1)(2009-9#4)
vibrissae##4##1##(1994-2#4)
vibrissal FSC##4##2##(2011-2#4)
vibrissal follicle-sinus complex##2##3##(2011-2#2)
vibrissal##11##1##(2011-2#11)
vibrometer##3##1##(2008-3#2)(2013-8#1)
vibrometry##3##1##(2007-11#1)(2008-2#2)
vibron Raman##2##2##(2008-10#2)
vibron##3##1##(2008-10#3)
vic##2##1##(2008-10#2)
vicariance##2##1##(2008-9#2)
vicarious calibration experiments##3##3##(2008-3#3)
vicarious calibration of the##3##4##(2008-3#3)
vicarious calibration##8##2##(2008-3#8)
vicarious liability##3##2##(1991-3#2)(1995-1#1)
vicarious##14##1##(1991-3#2)(1995-1#1)(2008-3#10)(2012-12#1)
vice versa##32##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
vice##37##1##(1990-5#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
viciae-villosae##3##1##(2008-10#3)
vicinal##4##1##(1992-4#1)(1996-11#1)(1996-5#1)(2008-4#1)
vicinities##2##1##(1992-3#1)(2008-12#1)
vicinity of the##33##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-5#1)(1994-8#2)(1995-2#1)(1996-2#1)(2007-11#4)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#2)
vicinity of##64##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#5)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)
vicinity##75##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-2#1)(1997-4#1)(1997-7#1)(2007-11#6)(2007-12#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
vicious cycle##5##2##(1994-2#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
vicious##6##1##(1994-2#1)(2010-3#2)(2010-5#1)(2012-12#1)(2012-2#1)
vicosae##3##1##(2008-6#3)
victim of##5##2##(1991-6#1)(1995-5#1)(2007-1#1)(2008-10#1)(2009-5#1)
victim to##3##2##(1993-9#1)(1994-3#1)(2008-7#1)
victim was##3##2##(1995-3#1)(2008-12#1)(2011-2#1)
victim were##2##2##(1995-6#1)(2008-2#1)
victim##28##1##(1991-6#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#1)
victim's##3##1##(1996-3#1)(2008-10#1)(2008-11#1)
victimization among##3##2##(2009-7#1)(2010-1#1)(2013-1#1)
victimization and##2##2##(2008-12#1)(2013-1#1)
victimization experiences##4##2##(2012-12#4)
victimization in##4##2##(2009-5#1)(2009-7#2)(2010-1#1)
victimization were##2##2##(2012-12#1)(2013-1#1)
victimization##39##1##(2008-10#1)(2008-12#4)(2008-4#1)(2009-5#6)(2009-7#6)(2010-1#3)(2011-2#1)(2012-12#8)(2013-1#7)(2013-8#2)
victimized##3##1##(2009-7#1)(2010-1#1)(2012-12#1)
victims and##5##2##(1996-3#1)(2007-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
victims are##4##2##(1996-3#1)(2008-2#2)(2012-3#1)
victims had##3##2##(1992-6#1)(2009-7#2)
victims of a mass disaster##3##5##(1995-11#3)
victims of domestic##2##3##(1995-12#1)(2011-2#1)
victims of intimate partner violence##2##5##(2012-12#2)
victims of the##2##3##(2006-9#1)(2009-6#1)
victims of violence##3##3##(1991-12#2)(2008-9#1)
victims of##26##2##(1991-12#3)(1992-1#1)(1992-12#1)(1993-6#1)(1995-11#3)(1995-12#1)(1996-11#1)(1997-4#2)(2006-9#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-9#2)(2011-2#1)(2012-12#3)(2013-1#1)
victims than##2##2##(1992-1#1)(1993-8#1)
victims were reported to##2##4##(1993-3#1)(2007-2#1)
victims were##7##2##(1990-12#1)(1993-3#1)(1995-3#1)(1996-11#1)(2007-2#2)(2011-2#1)
victims with##2##2##(1993-3#1)(2008-7#1)
victims##82##1##(1990-12#1)(1991-12#3)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#5)(1993-6#1)(1993-8#1)(1995-11#3)(1995-12#1)(1995-3#1)(1996-11#5)(1996-3#3)(1997-4#4)(2006-9#1)(2007-10#1)(2007-2#2)(2008-11#4)(2008-2#7)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#3)(2009-7#4)(2009-9#2)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#4)(2012-3#2)(2013-1#3)
victims'##6##1##(2009-7#4)(2012-3#1)(2013-1#1)
victoria##3##1##(1996-6#1)(2008-10#1)(2008-8#1)
victoriae##8##1##(2008-10#4)(2013-8#4)
victoriae)##2##1##(2008-10#2)
victoriensis##3##1##(2011-2#3)
victory##2##1##(1997-6#2)
video and confocal##2##3##(2008-3#2)
video and##9##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2012-12#1)
video camera systems##2##3##(2008-3#2)
video camera##7##2##(2007-11#1)(2008-3#4)(2008-5#2)
video cameras##4##2##(1995-12#1)(2008-3#2)(2012-2#1)
video clips##2##2##(2008-12#2)
video fluoroscopy##2##2##(2008-9#1)(2013-1#1)
video frame rates##2##3##(2008-3#2)
video frame##3##2##(2008-3#3)
video game play##4##3##(2013-1#4)
video game##7##2##(2012-12#2)(2013-1#5)
video image##2##2##(2008-2#1)(2008-3#1)
video imagery##2##2##(2008-3#2)
video images##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
video microscope##2##2##(2008-3#1)(2008-9#1)
video microscopy##2##2##(2008-10#1)(2008-3#1)
video monitor##2##2##(1993-12#1)(2008-12#1)
video rate of##2##3##(2007-12#1)(2008-3#1)
video rate##7##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2011-1#1)
video recording##2##2##(1993-3#1)(2008-5#1)
video sequences##5##2##(2008-3#2)(2008-6#2)(2008-9#1)
video surveillance##3##2##(1996-2#1)(2012-2#1)(2013-1#1)
video system##3##2##(1995-11#1)(2008-3#1)(2010-8#1)
video technology##3##2##(1991-6#1)(1995-12#1)(2012-12#1)
video##134##1##(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#3)(1996-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#8)(2008-11#4)(2008-12#7)(2008-2#8)(2008-3#28)(2008-4#2)(2008-5#4)(2008-6#10)(2008-8#4)(2008-9#5)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#13)
video-assisted thoracic surgery (VATS) in##2##5##(2007-8#1)(2008-10#1)
video-assisted thoracic surgery (VATS) were##2##5##(2008-1#1)(2010-8#1)
video-assisted thoracic surgery (VATS)##5##4##(2007-8#2)(2008-1#1)(2008-10#1)(2010-8#1)
video-assisted thoracic surgery##9##3##(2007-8#4)(2008-1#1)(2008-10#1)(2010-8#2)(2012-1#1)
video-assisted thoracoscopic extended thymectomy##2##4##(2007-8#2)
video-assisted thoracoscopic surgery##3##3##(2007-8#1)(2013-1#1)(2013-7#1)
video-assisted thoracoscopic##9##2##(2007-8#6)(2010-8#1)(2013-1#1)(2013-7#1)
video-assisted##23##1##(2007-8#12)(2008-1#1)(2008-10#1)(2010-8#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
video-based##2##1##(2007-11#1)(2008-3#1)
video-rate##5##1##(2007-11#1)(2008-3#2)(2011-1#2)
video-recorded##3##1##(2008-5#1)(2009-5#1)(2012-3#1)
video-teleconferencing##2##1##(2008-6#2)
videoconferencing##6##1##(2008-11#6)
videoendoscopic##3##1##(2007-8#3)
videofluorography##2##1##(1993-2#2)
videos of##2##2##(2008-9#1)(2009-9#1)
videos##11##1##(1993-12#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-9#1)(2011-2#2)
videos)##2##1##(2012-2#2)
videotape##15##1##(1991-1#2)(1993-2#1)(1994-3#1)(1995-12#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)
videotaped##11##1##(1991-6#1)(1992-5#1)(1993-2#2)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
videotapes of##2##2##(1991-6#1)(1996-2#1)
videotapes##9##1##(1991-6#1)(1993-12#1)(1993-2#5)(1994-6#1)(1996-2#1)
videotaping##2##1##(1995-12#2)
vidicon##2##1##(2007-11#1)(2008-2#1)
vie##2##1##(2009-4#2)
view and the##2##3##(2007-11#1)(2008-5#1)
view and##13##2##(1992-6#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
view angle and##2##3##(2008-3#1)(2011-2#1)
view by##2##2##(1991-8#1)(2008-2#1)
view condition-specific performance measures##2##4##(1997-3#2)
view from the##5##3##(1991-1#1)(1993-1#1)(1995-2#1)(2008-11#1)(2008-3#1)
view from##11##2##(1991-1#1)(1993-1#1)(1994-1#1)(1995-2#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-6#1)
view in the##2##3##(2007-7#1)(2008-2#1)
view in##5##2##(1991-1#1)(2007-7#1)(2008-2#2)(2013-1#1)
view into the##4##3##(1994-3#1)(2010-8#1)(2011-7#1)(2012-2#1)
view into##5##2##(1994-3#1)(2008-4#1)(2010-8#1)(2011-7#1)(2012-2#1)
view is##8##2##(1995-6#1)(2007-11#1)(2008-3#4)(2010-4#1)(2013-1#1)
view of a##9##3##(1991-3#1)(1992-3#1)(1994-1#1)(1995-2#2)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
view of an##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
view of both##2##3##(1990-2#1)(2009-12#1)
view of gene##3##3##(1995-6#1)(2010-1#1)(2010-5#1)
view of health care##2##4##(1993-1#1)(1994-6#1)
view of how to##2##4##(1993-2#1)(1997-7#1)
view of how##4##3##(1993-2#1)(1997-7#1)(2008-11#1)(2008-9#1)
view of its##4##3##(1990-12#1)(1990-5#1)(2008-11#1)(2008-7#1)
view of life and death##2##5##(1993-11#2)
view of statistical##2##3##(2008-11#1)(2013-8#1)
view of the fact that##3##5##(1997-1#1)(1997-5#1)(2008-10#1)
view of the future##2##4##(2013-1#2)
view of the high##4##4##(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
view of the history of##2##5##(1993-11#1)(1994-12#1)
view of the impact##2##4##(1995-12#1)(2008-10#1)
view of the importance of this##2##6##(2008-10#2)
view of the other##2##4##(1994-3#1)(1994-8#1)
view of the##95##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-5#2)(1996-4#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-5#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
view of their##7##3##(1994-3#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
view of these##5##3##(1994-3#1)(1995-1#1)(1995-11#1)(2007-12#1)(2008-10#1)
view of this##7##3##(2007-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)
view of##229##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#6)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#4)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#26)(2008-11#8)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#4)
view on the##3##3##(1993-6#1)(1994-5#1)(2011-1#1)
view on##13##2##(1993-6#1)(1994-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#2)(2011-1#1)(2013-1#2)
view point##2##2##(1994-3#1)(2008-7#1)
view that the##12##3##(1990-12#1)(1990-5#1)(1994-11#1)(1995-5#1)(1997-6#1)(1997-9#1)(2007-8#2)(2008-1#1)(2008-12#2)(2009-9#1)
view that##48##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#3)(1994-6#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2012-3#2)(2013-7#1)(2013-8#1)
view the##13##2##(1993-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-8#2)
view their##4##2##(1993-2#1)(1994-3#1)(1996-1#1)(2009-7#1)
view this##2##2##(2008-6#1)(2012-3#1)
view to##28##2##(1991-3#1)(1991-6#1)(1992-12#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#2)(2009-10#1)(2010-2#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
view was##2##2##(2008-3#1)(2009-10#1)
view with##3##2##(1996-3#1)(1997-1#1)(2008-3#1)
view##578##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#7)(1992-6#1)(1992-8#1)(1993-1#6)(1993-11#4)(1993-12#1)(1993-2#7)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#9)(1994-5#2)(1994-6#5)(1994-8#5)(1995-1#3)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#4)(1995-6#2)(1996-1#4)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2007-10#3)(2007-11#11)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#10)(2008-1#6)(2008-10#53)(2008-11#17)(2008-12#10)(2008-2#23)(2008-3#47)(2008-4#7)(2008-5#13)(2008-6#12)(2008-7#27)(2008-8#12)(2008-9#14)(2009-10#6)(2009-11#2)(2009-12#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#5)(2010-12#6)(2010-2#3)(2010-3#7)(2010-4#2)(2010-5#4)(2010-7#4)(2010-8#3)(2011-1#3)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#8)(2013-1#15)(2013-7#1)(2013-8#10)
view)##9##1##(2007-11#2)(2008-10#4)(2008-2#1)(2013-8#2)
view-dependent##4##1##(2008-6#4)
viewed a##3##2##(1994-3#1)(1996-5#1)(2009-11#1)
viewed as a##16##3##(1992-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
viewed as an##6##3##(1992-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
viewed as the##2##3##(2008-11#1)(2010-4#1)
viewed as##50##2##(1991-3#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
viewed at##2##2##(2008-3#2)
viewed by##7##2##(1991-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
viewed from the##4##3##(2007-11#1)(2008-3#2)(2010-12#1)
viewed from##7##2##(2007-11#2)(2008-10#1)(2008-3#2)(2010-12#1)(2011-3#1)
viewed in##3##2##(1996-1#1)(1997-8#1)(2008-2#1)
viewed photographs of##2##3##(2007-4#1)(2008-11#1)
viewed the##2##2##(1996-2#1)(2008-8#1)
viewed through##3##2##(2008-2#2)(2011-7#1)
viewed under##2##2##(2008-3#1)(2008-9#1)
viewed with a##2##3##(2008-10#1)(2008-3#1)
viewed with##5##2##(1991-2#1)(1993-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
viewed##122##1##(1991-2#2)(1991-3#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-3#2)(1997-5#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#12)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-2#3)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)
viewer##3##1##(2008-11#1)(2008-3#1)(2009-3#1)
viewers do not##2##3##(2009-3#2)
viewers##3##1##(2009-3#2)(2010-11#1)
viewing and##4##2##(1996-8#1)(2008-4#1)(2008-6#2)
viewing angle and##2##3##(2008-1#1)(2010-8#1)
viewing angle of the##3##4##(2007-11#1)(2008-2#2)
viewing angle of##5##3##(2007-11#2)(2008-2#3)
viewing angle##12##2##(2007-11#3)(2008-1#1)(2008-2#4)(2008-3#2)(2008-4#1)(2010-8#1)
viewing angles##9##2##(1995-5#1)(2008-2#1)(2008-3#5)(2008-4#1)(2012-1#1)
viewing direction##3##2##(2008-3#3)
viewing directions##2##2##(2008-3#2)
viewing geometry##3##2##(2008-3#3)
viewing of the##2##3##(2007-11#1)(2007-8#1)
viewing of##4##2##(2007-11#1)(2007-8#1)(2010-7#1)(2012-3#1)
viewing resolution##3##2##(2007-11#3)
viewing the##7##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
viewing zenith##2##2##(2008-3#2)
viewing##91##1##(1990-9#1)(1991-12#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1996-8#2)(2007-11#8)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#30)(2008-4#4)(2008-6#5)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
viewing-angle##2##1##(2008-3#2)
viewpoint is##2##2##(1994-12#1)(2012-12#1)
viewpoint of##17##2##(1990-6#1)(1991-3#1)(1993-8#1)(1996-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
viewpoint##47##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-3#1)(2007-11#5)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-9#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
viewpoint]##3##1##(1993-10#1)(1993-6#1)(1994-6#1)
viewpoints are##2##2##(2008-6#1)(2008-9#1)
viewpoints of##5##2##(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
viewpoints within##2##2##(2008-6#2)
viewpoints##13##1##(1991-6#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-6#4)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)
views about the##5##3##(1994-1#1)(2008-6#1)(2009-7#1)(2010-12#1)(2013-8#1)
views about##6##2##(1994-1#1)(2008-6#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
views and##13##2##(1990-5#1)(1992-4#1)(1994-1#1)(1997-8#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-10#1)(2013-1#2)
views are##3##2##(1990-9#1)(2008-12#1)(2010-12#1)
views in##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
views of a##2##3##(2007-12#1)(2008-11#1)
views of an##2##3##(2008-3#1)(2012-3#1)
views of the##18##3##(1991-1#1)(1991-2#1)(1992-2#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
views of their##2##3##(2008-11#1)(2011-1#1)
views of##48##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
views on the##13##3##(1992-5#1)(1992-9#1)(1994-11#1)(1996-3#1)(2007-8#2)(2008-12#2)(2008-6#1)(2010-3#1)(2012-2#2)(2013-8#1)
views on##28##2##(1991-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-8#2)(2008-11#1)(2008-12#2)(2008-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
views that##3##2##(2008-12#1)(2008-5#1)(2009-8#1)
views were##2##2##(2007-10#1)(2008-12#1)
views within the##2##3##(2008-11#1)(2008-2#1)
views##143##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-1#2)(2008-11#10)(2008-12#16)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#8)(2008-7#5)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#4)(2010-3#1)(2010-8#1)(2011-1#9)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#3)
vigabatrin##9##1##(1992-3#5)(1996-8#1)(2013-1#3)
vigilance and##2##2##(1992-3#1)(2013-8#1)
vigilance in##2##2##(2008-10#1)(2008-9#1)
vigilance regarding##2##2##(2008-10#1)(2011-2#1)
vigilance##10##1##(1992-3#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-12#1)(2011-2#1)(2013-8#1)
vigilant##10##1##(1996-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-9#3)(2010-11#1)(2010-9#1)(2012-12#1)
vigintioctopunctata##3##1##(2008-6#3)
vignette##2##1##(1996-2#1)(2007-12#1)
vignettes##4##1##(1993-12#1)(2007-12#1)(2009-4#1)(2010-5#1)
vigor index and seedling dry weight##2##6##(2008-12#2)
vigor of##2##2##(2008-10#1)(2008-8#1)
vigor##17##1##(1996-1#1)(2008-10#9)(2008-12#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)
vigorous physical activity##7##3##(2010-1#1)(2010-11#5)(2013-1#1)
vigorous shaking##2##2##(2008-10#1)(2008-7#1)
vigorous##22##1##(1990-12#1)(1992-3#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-11#5)(2010-4#1)(2012-3#1)(2013-1#1)
vigorously##5##1##(1991-1#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
vigour##4##1##(2008-12#2)(2008-7#1)(2010-1#1)
village in##2##2##(1990-12#1)(2011-2#1)
village level##2##2##(2008-8#1)(2010-8#1)
village to##2##2##(1997-1#1)(2008-10#1)
village##22##1##(1990-12#1)(1992-12#2)(1994-3#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#4)(2010-8#2)(2011-2#1)(2012-12#2)(2013-8#1)
villagers##4##1##(1994-3#2)(2008-10#2)
villages and##3##2##(1994-9#1)(1996-12#2)
villages in the##3##3##(2008-1#1)(2008-8#1)(2012-1#1)
villages in##6##2##(2008-1#1)(2008-10#2)(2008-8#1)(2010-8#1)(2012-1#1)
villages of##2##2##(2008-10#1)(2012-12#1)
villages with no infection##2##4##(2010-8#2)
villages##29##1##(1991-12#3)(1992-12#2)(1994-9#3)(1995-9#2)(1996-12#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-8#1)(2010-8#5)(2012-1#1)(2012-12#1)
villi were##3##2##(1993-6#2)(1995-3#1)
villi##16##1##(1990-12#1)(1992-6#1)(1993-6#3)(1994-9#1)(1995-3#1)(2011-1#8)(2013-1#1)
villosa##5##1##(1990-7#1)(2007-11#2)(2008-8#2)
villous adenoma##2##2##(1990-10#2)
villous atrophy##2##2##(1991-11#1)(2013-1#1)
villous height in##2##3##(2013-1#2)
villous height##7##2##(2013-1#7)
villous##13##1##(1990-10#2)(1991-11#1)(2009-3#1)(2010-3#1)(2013-1#8)
villus sampling##4##2##(1991-11#1)(1991-2#1)(2007-7#1)(2008-4#1)
villus##12##1##(1990-12#3)(1991-11#1)(1991-12#4)(1991-2#1)(2007-2#1)(2007-7#1)(2008-4#1)
vim##2##1##(2008-8#1)(2008-9#1)
vimentin and##5##2##(1991-6#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)
vimentin##19##1##(1991-6#2)(1993-8#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
viminalis##5##1##(2012-3#5)
vinblastine##9##1##(1990-2#2)(1991-6#2)(1993-6#1)(1993-8#1)(2008-5#1)(2011-1#2)
vinca alkaloids##2##2##(1995-5#2)
vinca site agents##5##3##(1995-5#5)
vinca site##6##2##(1995-5#6)
vinca##10##1##(1994-8#1)(1995-5#9)
vinclozolin##21##1##(2008-10#21)
vincristine and##6##2##(1993-8#2)(1994-12#1)(2008-6#1)(2008-7#1)(2013-8#1)
vincristine plus etoposide##2##3##(1993-8#2)
vincristine plus##3##2##(1993-8#3)
vincristine##27##1##(1990-11#1)(1990-12#1)(1991-6#1)(1993-8#6)(1994-12#1)(1995-3#2)(1995-9#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-11#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
vinculin and##2##2##(1991-5#1)(1994-9#1)
vinculin##8##1##(1991-5#2)(1994-9#3)(2009-7#2)(2010-4#1)
vindesine (VDS)##2##2##(1992-12#1)(1993-2#1)
vindesine##5##1##(1990-2#2)(1992-12#2)(1993-2#1)
vine decline##2##2##(2008-10#2)
vine##12##1##(2008-10#10)(2008-6#2)
vinegar and##2##2##(2008-10#2)
vinegar##11##1##(2008-10#9)(2008-5#1)(2008-6#1)
vinegars and##2##2##(2008-10#2)
vinegars##6##1##(2008-10#6)
vinelandii hydrogenase##2##2##(1990-11#1)(1992-3#1)
vinelandii##14##1##(1990-11#4)(1992-3#2)(2008-7#6)(2009-7#2)
vines in##2##2##(2008-10#2)
vines infected with##3##3##(2008-10#3)
vines infected##5##2##(2008-10#5)
vines showing esca symptoms in##2##5##(2008-10#2)
vines that had been inoculated##2##5##(2008-10#2)
vines that##3##2##(2008-10#3)
vines were##3##2##(2008-10#3)
vines##29##1##(2008-10#29)
vineyard soil##3##2##(2008-10#3)
vineyard##11##1##(2008-10#11)
vineyards in##4##2##(2008-10#4)
vineyards##22##1##(2008-10#21)(2011-2#1)
vinifera 'Chardonnay'##3##2##(2008-10#3)
vinifera L##5##2##(2008-10#1)(2008-5#1)(2009-8#2)(2013-1#1)
vinifera cultivars##4##2##(2008-10#4)
vinifera cv##2##2##(2008-10#2)
vinifera##24##1##(2008-10#19)(2008-5#2)(2009-8#2)(2013-1#1)
vinifera) and##2##2##(2008-10#2)
vinifera)##7##1##(2008-10#7)
vinorelbine as a single agent##2##5##(1994-8#2)
vinorelbine as##3##2##(1994-2#1)(1994-8#2)
vinorelbine in##2##2##(1994-12#1)(2010-8#1)
vinorelbine##8##1##(1994-12#1)(1994-2#1)(1994-8#4)(2007-4#1)(2010-8#1)
vintages were##2##2##(2008-10#2)
vintages##3##1##(2008-10#3)
vinyl acetate copolymer (EVA)##2##4##(2008-11#2)
vinyl acetate copolymer##3##3##(1994-6#1)(2008-11#2)
vinyl carbamate##4##2##(1994-2#4)
vinyl chloride##6##2##(1993-11#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)
vinyl ether##3##2##(1996-5#3)
vinyl ethers##2##2##(1996-5#1)(2008-10#1)
vinyl groups##4##2##(2008-10#4)
vinyl pyrrolidone##2##2##(2008-5#2)
vinyl##43##1##(1991-9#1)(1993-11#2)(1994-2#4)(1994-6#1)(1995-11#1)(1996-5#5)(2007-11#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#3)(2009-12#3)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
vinylic##3##1##(1996-5#1)(2009-6#2)
vinylidene##3##1##(1996-12#2)(2007-12#1)
violaceus##4##1##(2008-8#2)(2008-9#2)
violate the##5##2##(1995-8#1)(1996-5#1)(1996-9#1)(2010-3#1)(2012-2#1)
violate##14##1##(1993-1#1)(1993-3#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-2#1)
violated by##3##2##(1995-2#1)(2008-8#1)(2010-10#1)
violated the Americans with Disabilities Act (ADA)##2##7##(1995-6#1)(1997-5#1)
violated the##7##2##(1992-9#1)(1993-6#1)(1995-12#2)(1995-6#1)(1997-5#2)
violated##28##1##(1992-9#1)(1993-6#1)(1994-11#1)(1995-12#4)(1995-2#1)(1995-6#1)(1996-5#1)(1997-5#3)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
violates the##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
violates##5##1##(1995-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
violating the##4##2##(1992-12#1)(1993-6#1)(2008-7#2)
violation of LG inequalities##2##4##(2012-2#2)
violation of the##10##3##(1993-1#1)(1993-3#1)(1994-2#1)(1995-6#1)(2008-3#3)(2008-9#1)(2011-2#1)(2012-2#1)
violation of##17##2##(1993-1#1)(1993-3#1)(1994-2#1)(1995-6#1)(2008-3#4)(2008-9#1)(2011-2#2)(2012-2#4)(2013-8#2)
violation##21##1##(1990-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-3#4)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#4)(2013-8#2)
violations of the##4##3##(1994-9#1)(2008-3#1)(2008-4#1)(2010-2#1)
violations of##11##2##(1990-8#1)(1994-9#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
violations##25##1##(1990-6#1)(1990-8#1)(1991-1#1)(1993-12#2)(1993-3#1)(1994-9#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
violence against##4##2##(1993-2#1)(2008-12#1)(2008-9#1)(2011-2#1)
violence among##4##2##(2008-9#1)(2009-9#1)(2013-1#1)(2013-8#1)
violence and the##3##3##(2008-11#1)(2010-3#1)(2013-8#1)
violence and##20##2##(1991-12#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
violence as well as##2##4##(2008-2#2)
violence as##3##2##(1995-12#1)(2008-2#2)
violence during pregnancy##2##3##(2008-2#2)
violence during##3##2##(2008-2#2)(2008-9#1)
violence exposure##4##2##(2009-12#2)(2009-9#2)
violence has##3##2##(2008-12#1)(2008-7#1)(2010-3#1)
violence in a##2##3##(1994-2#1)(2009-2#1)
violence in the workplace##2##4##(1991-12#1)(1995-2#1)
violence in the##6##3##(1991-12#2)(1995-2#1)(2008-11#1)(2013-1#2)
violence in##15##2##(1991-1#1)(1991-12#2)(1994-2#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-7#1)(2009-9#1)(2013-1#3)
violence involvement##2##2##(2013-1#2)
violence is a##2##3##(2008-2#1)(2011-2#1)
violence is##8##2##(1991-12#1)(1991-3#1)(2008-2#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
violence perpetration and victimization##4##4##(2009-7#3)(2013-1#1)
violence perpetration##6##2##(2009-7#4)(2013-1#2)
violence victimization##8##2##(2009-5#1)(2013-1#6)(2013-8#1)
violence were##2##2##(2008-7#1)(2012-12#1)
violence##182##1##(1990-2#1)(1990-6#2)(1991-1#1)(1991-12#4)(1991-3#1)(1991-6#2)(1992-12#2)(1993-12#4)(1993-2#1)(1994-1#1)(1994-2#1)(1994-9#2)(1995-12#5)(1995-2#6)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#10)(2008-12#7)(2008-2#8)(2008-6#1)(2008-7#6)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#8)(2009-7#7)(2009-9#8)(2010-10#1)(2010-11#2)(2010-3#6)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#9)(2012-3#3)(2013-1#22)(2013-8#7)
violence-related##2##1##(2008-7#1)(2009-9#1)
violent actions##2##2##(1995-2#1)(2013-1#1)
violent acts##2##2##(1991-6#2)
violent and psychopathic individuals is##2##5##(2008-11#2)
violent and##5##2##(1990-6#1)(1995-11#1)(2008-11#2)(2008-7#1)
violent behavior##2##2##(1996-2#1)(2009-5#1)
violent behaviors##2##2##(2009-5#1)(2012-2#1)
violent causes##2##2##(1990-6#1)(2013-1#1)
violent crime##3##2##(1995-2#1)(2008-11#1)(2008-12#1)
violent death##3##2##(1991-6#1)(2009-7#2)
violent incidents##3##2##(1993-12#1)(2007-2#1)(2012-3#1)
violent patients##4##2##(1995-11#1)(1996-2#2)(2008-7#1)
violent situations##3##2##(1991-1#1)(2008-7#2)
violent##44##1##(1990-6#2)(1990-8#1)(1991-1#1)(1991-6#4)(1993-12#1)(1994-12#1)(1995-11#2)(1995-2#4)(1996-2#5)(1996-5#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-7#5)(2009-5#2)(2009-7#2)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
violet (CV)##3##2##(2008-10#3)
violet (PCV)##3##2##(2008-10#3)
violet and##5##2##(2008-10#4)(2008-3#1)
violet as a##2##3##(2008-10#2)
violet by potassium periodate##2##4##(2008-10#2)
violet by##3##2##(2008-10#3)
violet colored##2##2##(2008-10#2)
violet dye##2##2##(2008-10#2)
violet light##3##2##(2008-3#1)(2008-5#1)(2009-4#1)
violet method##2##2##(2008-10#1)(2008-9#1)
violet modified carbon paste electrode##2##5##(2008-10#2)
violet staining##3##2##(1990-12#1)(1996-12#1)(2008-8#1)
violet##62##1##(1990-12#1)(1991-8#1)(1994-5#1)(1996-12#1)(2008-1#2)(2008-10#44)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-5#1)
violinists##5##1##(2013-8#5)
viologen##8##1##(1991-5#1)(1992-8#1)(1995-8#1)(1997-7#1)(2008-10#3)(2010-12#1)
viper##4##1##(1990-5#1)(1994-6#2)(2013-7#1)
virE1##2##1##(2008-10#2)
virVf##2##1##(2008-10#2)
viraemia and##2##2##(1991-3#1)(2009-12#1)
viraemia##5##1##(1991-3#1)(1994-5#1)(2009-12#2)(2013-1#1)
viraemic##2##1##(1991-3#1)(2008-5#1)
viral DNA replication##4##3##(1995-6#1)(1997-3#2)(2008-2#1)
viral DNA##22##2##(1991-5#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-3#3)(1997-4#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-4#1)(2009-11#2)(2011-2#1)(2013-1#1)
viral DNA)##2##2##(2008-10#2)
viral G protein##4##3##(1993-6#4)
viral LTR##2##2##(1992-6#1)(1994-11#1)
viral RNA from##2##3##(2007-6#1)(2008-9#1)
viral RNA genome##2##3##(2008-10#1)(2009-11#1)
viral RNA is##3##3##(2008-10#1)(2008-9#2)
viral RNA was##5##3##(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#2)
viral RNA##39##2##(1995-2#1)(1997-2#2)(1997-3#2)(1997-6#1)(2007-6#1)(2008-10#14)(2008-2#1)(2008-8#1)(2008-9#10)(2009-11#1)(2009-2#1)(2010-5#4)
viral RNAs from plant protoplasts##2##5##(2008-9#2)
viral RNAs in##2##3##(2008-10#1)(2008-9#1)
viral RNAs##12##2##(1997-3#1)(2008-10#5)(2008-9#6)
viral S##3##2##(2008-10#3)
viral accumulation##2##2##(1997-3#1)(2008-10#1)
viral activity##2##2##(2008-10#2)
viral and bacterial##3##3##(1992-11#1)(2009-4#1)(2009-9#1)
viral and cell##2##3##(2008-4#1)(2011-3#1)
viral and cellular##4##3##(2008-10#1)(2008-9#2)(2009-2#1)
viral and viral-like agents##2##4##(2008-11#2)
viral and##19##2##(1992-11#1)(1992-3#1)(1994-12#1)(1995-2#2)(2006-10#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-9#1)(2011-3#2)
viral antigens##4##2##(1990-5#1)(1997-4#2)(2011-2#1)
viral assembly##4##2##(1991-5#2)(2011-3#2)
viral capsid protein##3##3##(2008-10#2)(2009-8#1)
viral capsid##6##2##(1995-2#2)(2007-2#1)(2008-10#2)(2009-8#1)
viral causes##2##2##(2007-5#1)(2010-5#1)
viral coat protein (CP)##2##4##(2008-10#2)
viral coat protein##5##3##(2008-10#4)(2008-8#1)
viral complementary##4##2##(2008-10#4)
viral components##2##2##(2008-10#1)(2008-4#1)
viral contamination##3##2##(1990-2#1)(2008-11#2)
viral contaminations as##2##3##(2008-11#2)
viral contaminations in##3##3##(2008-11#3)
viral contaminations##6##2##(2008-11#6)
viral detection##2##2##(2008-10#1)(2010-5#1)
viral diarrhea virus##3##3##(2008-11#1)(2012-3#2)
viral diarrhoea##4##2##(1993-2#1)(1997-5#2)(2008-1#1)
viral disease of##3##3##(2008-10#3)
viral disease##11##2##(2008-10#6)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
viral diseases##10##2##(1991-9#1)(1992-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2011-2#1)(2011-3#1)(2012-2#1)
viral early##2##2##(1995-2#2)
viral encephalitis##2##2##(2008-7#1)(2011-1#1)
viral envelope##3##2##(1994-8#2)(2008-4#1)
viral etiology of##3##3##(2013-1#3)
viral etiology##4##2##(2013-1#4)
viral factors##3##2##(2008-11#3)
viral fusion##3##2##(1991-5#1)(1994-12#1)(2009-8#1)
viral gene expression and##2##4##(2008-10#1)(2013-1#1)
viral gene expression##7##3##(2008-10#1)(2008-8#2)(2009-2#2)(2012-12#1)(2013-1#1)
viral gene products##3##3##(1995-2#1)(1997-4#1)(2012-2#1)
viral gene##11##2##(1995-2#1)(1997-4#1)(2008-10#2)(2008-8#2)(2009-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
viral genes##7##2##(1995-2#2)(1997-6#1)(2008-8#2)(2008-9#1)(2010-1#1)
viral genetic##2##2##(2011-2#1)(2013-1#1)
viral genome and##2##3##(2008-9#2)
viral genome##17##2##(1990-7#1)(1991-6#1)(1994-11#2)(1994-8#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#3)(2011-1#1)(2013-8#1)
viral genome-associated protein##2##3##(2008-10#2)
viral genomes##9##2##(1994-11#3)(1995-2#1)(1996-2#1)(2008-11#1)(2008-4#2)(2008-9#1)
viral genomic RNA##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
viral genomic##5##2##(1992-6#1)(2008-10#2)(2008-11#2)
viral genotypes##2##2##(2008-10#1)(2013-8#1)
viral hemorrhagic fever (VHF)##2##4##(1995-6#2)
viral hemorrhagic##6##2##(1995-6#4)(2011-1#1)(2013-8#1)
viral hepatitis and##5##3##(2007-7#3)(2008-6#1)(2011-2#1)
viral hepatitis##17##2##(1991-9#1)(2006-10#1)(2007-12#3)(2007-7#5)(2008-6#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
viral inactivation##4##2##(1993-3#1)(2011-3#3)
viral infection and##5##3##(1997-1#1)(2008-11#1)(2008-9#2)(2012-12#1)
viral infection in##2##3##(2007-8#1)(2008-7#1)
viral infection of##2##3##(1997-7#1)(2007-8#1)
viral infection##33##2##(1990-6#1)(1991-2#1)(1992-12#2)(1992-3#1)(1996-11#1)(1997-1#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-9#2)(2009-2#1)(2009-8#3)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
viral infections and##2##3##(1994-12#1)(2013-1#1)
viral infections##27##2##(1990-6#1)(1994-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2010-5#2)(2010-6#2)(2012-3#1)(2013-1#3)
viral inhibitory substance##2##3##(1997-4#2)
viral inhibitory##4##2##(1997-4#4)
viral isolates##3##2##(2008-10#1)(2013-8#2)
viral isolation##3##2##(2011-2#1)(2013-8#2)
viral latency##3##2##(2012-2#3)
viral load and##3##3##(2007-7#1)(2010-12#1)(2013-8#1)
viral load was##2##3##(2008-5#2)
viral load##20##2##(2006-10#1)(2007-1#1)(2007-7#1)(2008-5#4)(2008-6#1)(2010-11#1)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
viral loads##3##2##(2009-5#1)(2012-3#1)(2013-1#1)
viral mRNA##6##2##(1991-2#2)(1992-12#2)(1995-9#1)(2008-9#1)
viral markers##2##2##(2007-7#1)(2008-10#1)
viral miRNAs##5##2##(2013-1#5)
viral movement##2##2##(2008-10#2)
viral myocarditis##3##2##(2010-5#1)(2010-7#2)
viral nucleic acid##2##3##(2008-10#1)(2011-2#1)
viral oncogene##2##2##(1992-9#1)(1995-2#1)
viral or##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-2#1)
viral origin##2##2##(2008-5#1)(2011-1#1)
viral particles##8##2##(1991-2#1)(1997-3#2)(2008-4#1)(2009-4#1)(2011-3#2)(2012-3#1)
viral pathogen##2##2##(1995-5#1)(2007-12#1)
viral pathogens##4##2##(2008-10#2)(2010-12#1)(2013-1#1)
viral peptides##2##2##(2008-4#1)(2012-2#1)
viral population##2##2##(2008-10#2)
viral populations##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
viral processes##2##2##(2008-11#1)(2013-1#1)
viral production##4##2##(2008-11#3)(2011-3#1)
viral promoter##2##2##(2012-12#2)
viral promoters##3##2##(1997-4#1)(1997-8#2)
viral protein and##2##3##(2008-11#1)(2011-2#1)
viral protein##10##2##(1992-12#1)(1994-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)
viral proteins##10##2##(1994-11#2)(1995-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
viral quasispecies##5##2##(2013-8#5)
viral replicase##2##2##(2008-10#2)
viral replication and##3##3##(1992-8#1)(2008-9#1)(2012-12#1)
viral replication in##2##3##(1995-5#1)(1997-3#1)
viral replication##23##2##(1990-5#1)(1992-8#1)(1994-8#2)(1995-5#1)(1997-3#2)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
viral resistance in##2##3##(1991-2#2)
viral resistance##5##2##(1991-2#2)(1997-6#1)(2008-10#1)(2012-2#1)
viral respiratory##2##2##(1990-5#1)(2007-11#1)
viral shedding##4##2##(1994-6#1)(2009-6#2)(2013-8#1)
viral species##3##2##(2008-10#3)
viral strains##2##2##(2008-10#1)(2012-12#1)
viral strand##2##2##(2008-10#2)
viral suppression##2##2##(2008-5#1)(2010-11#1)
viral titers##2##2##(2008-11#2)
viral titre##2##2##(2007-10#1)(2008-11#1)
viral transcription##2##2##(1995-2#1)(2012-12#1)
viral transcripts##4##2##(1994-8#1)(2008-9#2)(2011-3#1)
viral transmission##4##2##(2008-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
viral vaccine##2##2##(2008-11#2)
viral vaccines##5##2##(1995-5#1)(2008-11#3)(2011-2#1)
viral vector containing##2##3##(2008-8#1)(2008-9#1)
viral vector##12##2##(1995-2#2)(1997-4#1)(2008-8#2)(2008-9#3)(2010-5#2)(2011-2#2)
viral vectors to##2##3##(2008-11#1)(2008-9#1)
viral vectors##9##2##(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#1)
viral##703##1##(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#7)(1991-5#6)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#2)(1992-6#5)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-1#3)(1994-11#10)(1994-12#4)(1994-6#1)(1994-7#1)(1994-8#13)(1995-2#24)(1995-3#1)(1995-5#5)(1995-6#5)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#13)(1997-4#13)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#3)(2006-10#6)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#4)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#3)(2008-1#6)(2008-10#127)(2008-11#51)(2008-12#2)(2008-2#4)(2008-4#12)(2008-5#15)(2008-6#2)(2008-7#7)(2008-8#17)(2008-9#45)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#2)(2010-4#3)(2010-5#12)(2010-6#4)(2010-7#2)(2011-1#5)(2011-2#25)(2011-3#15)(2012-12#13)(2012-2#18)(2012-3#8)(2013-1#43)(2013-8#16)
viral-cellular##3##1##(2006-10#1)(2008-9#2)
viral-like##3##1##(2008-11#2)(2010-12#1)
virally transformed##2##2##(1994-3#1)(2008-4#1)
virally##4##1##(1991-9#1)(1994-3#1)(2008-4#2)
virens##10##1##(2008-10#10)
virescens##3##1##(2008-11#1)(2010-2#2)
virga##4##1##(2008-6#4)
virgal##2##1##(2008-6#2)
virgifera##4##1##(2011-2#4)
virgin and##2##2##(1991-12#1)(2008-8#1)
virgin females##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
virgin hair##2##2##(2008-5#2)
virgin olive oil##2##3##(2009-3#1)(2012-2#1)
virgin##18##1##(1991-12#1)(1992-9#1)(1993-8#1)(1997-4#3)(2007-12#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
virginiana##9##1##(1996-5#2)(2008-10#6)(2008-8#1)
virginica##3##1##(2008-7#3)
virgo##3##1##(2008-10#2)(2008-8#1)
virial##2##1##(2008-10#1)(2009-6#1)
viridans group##2##2##(2007-12#2)
viridans streptococcus##2##2##(2007-12#2)
viridans##6##1##(1997-8#1)(2007-12#4)(2008-10#1)
viride S17A##5##2##(2008-10#5)
viride and##2##2##(1992-3#1)(2008-10#1)
viride##9##1##(1992-3#1)(2008-10#8)
viridis##13##1##(1993-11#2)(1993-8#3)(2008-12#4)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
virilization##2##1##(2008-1#1)(2008-4#1)
virion RNA##3##2##(1997-3#3)
virion preparations##3##2##(2008-10#3)
virion structural protein##2##3##(1993-12#2)
virion##25##1##(1991-5#1)(1991-6#1)(1992-8#2)(1993-12#4)(1995-5#1)(1997-3#6)(1997-4#1)(2008-10#6)(2008-9#3)
virions and##2##2##(1995-2#1)(2008-10#1)
virions of##2##2##(2008-10#2)
virions were observed##2##3##(2008-10#2)
virions were##7##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)
virions##36##1##(1990-5#1)(1992-8#2)(1993-12#2)(1993-2#2)(1994-11#1)(1994-7#1)(1994-8#1)(1995-2#2)(1997-3#2)(2007-12#2)(2008-10#16)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
viroid combinations##2##2##(2008-10#2)
viroid mixtures##2##2##(2008-10#2)
viroid replication##4##2##(2008-9#4)
viroid##33##1##(2008-10#28)(2008-9#5)
viroid-like##2##1##(2008-10#2)
viroids in coconut##2##3##(2008-10#2)
viroids in##4##2##(2008-10#4)
viroids were##2##2##(2008-10#2)
viroids##19##1##(2008-10#18)(2008-9#1)
virologic response##4##2##(2009-5#1)(2013-1#3)
virologic##9##1##(1994-6#1)(2007-2#1)(2008-4#1)(2009-5#2)(2009-8#1)(2013-1#3)
virological breakthrough##2##2##(2013-1#2)
virological response (SVR)##2##3##(2012-1#1)(2012-12#1)
virological response in##2##3##(2007-7#1)(2012-1#1)
virological response##7##2##(2007-7#1)(2009-8#2)(2012-1#2)(2012-12#2)
virological##14##1##(1997-3#1)(2007-7#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)
virologists##3##1##(2008-9#2)(2010-10#1)
virology##3##1##(2007-12#1)(2008-10#1)(2008-8#1)
virosomes##3##1##(1990-2#3)
virotherapy##2##1##(2013-1#1)(2013-8#1)
virtual and##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
virtual environments##2##2##(2008-3#1)(2008-6#1)
virtual laboratory for studying RNA secondary structures##2##7##(2009-11#2)
virtual lesion extension##2##3##(2008-10#2)
virtual lesion##4##2##(2008-10#4)
virtual models##2##2##(2008-6#1)(2009-4#1)
virtual point source##2##3##(2008-2#1)(2008-3#1)
virtual reality (VR)##2##3##(2009-11#1)(2010-4#1)
virtual reality package##2##3##(2008-11#2)
virtual reality##18##2##(2008-11#3)(2008-6#1)(2008-7#1)(2009-11#2)(2009-6#1)(2010-1#1)(2010-4#3)(2010-8#1)(2011-7#2)(2012-12#1)(2012-3#1)(2013-1#1)
virtual screening and##2##3##(2011-3#1)(2013-7#1)
virtual screening##6##2##(2008-8#2)(2011-3#1)(2013-7#3)
virtual source##3##2##(2007-11#2)(2008-3#1)
virtual##97##1##(1993-12#1)(1996-1#2)(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#12)(2008-5#1)(2008-6#8)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#4)(2009-3#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#4)(2010-8#5)(2011-2#3)(2011-3#1)(2011-7#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#3)
virtually absent in##4##3##(1990-2#1)(2007-12#1)(2008-10#1)(2008-5#1)
virtually absent##8##2##(1990-2#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)
virtually all the##2##3##(1996-12#1)(2008-10#1)
virtually all##21##2##(1992-1#1)(1992-3#1)(1994-12#1)(1994-9#1)(1996-12#2)(1996-6#1)(1997-2#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-2#1)(2012-2#2)
virtually and##2##2##(2009-4#1)(2013-1#1)
virtually any##6##2##(1994-3#1)(1996-12#1)(1997-7#1)(2008-3#1)(2010-4#1)(2011-2#1)
virtually eliminated##2##2##(1994-9#1)(2011-2#1)
virtually every##6##2##(1996-12#1)(1997-1#1)(2008-10#3)(2008-12#1)
virtually identical##4##2##(1995-3#1)(1996-7#1)(2008-10#2)
virtually impossible##3##2##(1994-1#1)(2008-1#1)(2011-1#1)
virtually inactive##2##2##(1993-11#1)(2008-4#1)
virtually no##8##2##(1990-5#1)(1992-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
virtually specific##2##2##(2008-10#2)
virtually unchanged##4##2##(1993-6#1)(1994-6#1)(2008-10#1)(2009-12#1)
virtually##101##1##(1990-2#1)(1990-5#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
virtue of the##3##3##(1995-2#1)(2008-3#1)(2009-3#1)
virtue of##17##2##(1991-9#1)(1993-11#2)(1993-2#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)
virtue##19##1##(1991-9#1)(1993-11#2)(1993-2#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)
virtues##5##1##(1991-12#2)(2008-3#1)(2008-9#1)(2012-2#1)
virtuous##2##1##(1991-12#1)(2008-12#1)
virulence among##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
virulence and molecular##2##3##(2008-10#2)
virulence and resistance##7##3##(2008-10#4)(2011-10#1)(2012-3#1)(2013-1#1)
virulence and transmission##2##3##(2008-10#1)(2008-8#1)
virulence and##38##2##(1991-8#1)(2007-10#1)(2008-10#23)(2008-7#1)(2008-8#3)(2008-9#4)(2011-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
virulence are##2##2##(2008-8#1)(2008-9#1)
virulence as##2##2##(2008-10#2)
virulence assays##2##2##(2008-10#2)
virulence associations##2##2##(2008-10#2)
virulence at##2##2##(2008-10#2)
virulence by##6##2##(2008-10#4)(2009-8#1)(2011-1#1)
virulence complexity was##2##3##(2008-10#2)
virulence complexity##4##2##(2008-10#4)
virulence determinants##2##2##(1994-12#1)(2011-1#1)
virulence diversity##3##2##(2008-10#3)
virulence factor expression##2##3##(2009-2#1)(2009-8#1)
virulence factor of##3##3##(2008-10#2)(2013-1#1)
virulence factor##12##2##(1996-12#1)(2007-8#1)(2008-10#5)(2009-2#1)(2009-8#1)(2011-2#2)(2013-1#1)
virulence factors and##2##3##(1995-8#1)(2008-10#1)
virulence factors of##4##3##(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
virulence factors##23##2##(1993-12#1)(1995-8#1)(1996-12#2)(2007-10#1)(2007-7#1)(2008-10#6)(2008-5#2)(2008-9#1)(2009-2#3)(2009-8#1)(2011-1#2)(2013-1#2)
virulence for##5##2##(1991-8#1)(1997-6#1)(2008-10#3)
virulence frequency##3##2##(2008-10#3)
virulence gene##5##2##(1995-2#1)(2008-10#3)(2009-8#1)
virulence genes in the##2##4##(1995-2#1)(2008-10#1)
virulence genes##6##2##(1995-2#1)(2008-10#4)(2012-3#1)
virulence genotype frequencies##2##3##(2008-10#2)
virulence genotype##3##2##(2008-10#3)
virulence groups##2##2##(2008-10#2)
virulence in P##2##3##(2008-10#2)
virulence in the pathogen##3##4##(2008-10#3)
virulence in the##4##3##(2008-10#4)
virulence in##17##2##(2008-10#12)(2008-8#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
virulence is##4##2##(2008-10#3)(2008-8#1)
virulence level##2##2##(2008-10#2)
virulence of C##2##3##(2008-10#1)(2009-2#1)
virulence of Pseudomonas syringae##3##4##(2008-10#3)
virulence of isolates##4##3##(2008-10#4)
virulence of pathogens##2##3##(2008-10#1)(2008-8#1)
virulence of the organism##2##4##(2008-7#2)
virulence of the pathogen##2##4##(2008-10#2)
virulence of the##8##3##(2007-6#1)(2008-10#5)(2008-7#2)
virulence of these organisms##2##4##(2008-9#1)(2011-2#1)
virulence of##44##2##(1996-12#2)(2007-6#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#2)(2009-5#1)(2009-6#2)(2011-2#1)(2013-1#1)
virulence on a##2##3##(2008-10#2)
virulence on barley##2##3##(2008-10#2)
virulence on the##2##3##(2008-10#2)
virulence on tomato##2##3##(2008-10#2)
virulence on##28##2##(2008-10#27)(2008-9#1)
virulence or##6##2##(2008-10#5)(2011-2#1)
virulence patterns##2##2##(2008-10#2)
virulence phenotype##4##2##(2008-10#4)
virulence phenotypes and##2##3##(2008-10#2)
virulence phenotypes##10##2##(2008-10#10)
virulence polymorphism##2##2##(2008-10#2)
virulence proteins##2##2##(1993-12#1)(2008-10#1)
virulence spectrum##5##2##(2008-10#5)
virulence than##2##2##(2008-10#2)
virulence to##16##2##(2008-10#15)(2008-9#1)
virulence toward##2##2##(2008-10#2)
virulence under##2##2##(2008-10#1)(2013-1#1)
virulence was##2##2##(2008-10#1)(2008-11#1)
virulence were observed among##2##4##(2008-10#2)
virulence were##8##2##(1991-8#1)(2008-10#7)
virulence##387##1##(1991-8#4)(1992-12#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#3)(1995-8#1)(1996-12#5)(1997-6#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#263)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#22)(2008-9#17)(2009-2#7)(2009-5#1)(2009-6#2)(2009-8#7)(2011-1#6)(2011-10#1)(2011-2#9)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#1)
virulence-attenuated phenotype##2##2##(2012-2#2)
virulence-attenuated##3##1##(2012-2#3)
virulence/avirulence##2##1##(2008-10#2)
virulences were##4##2##(2008-10#4)
virulences##9##1##(2008-10#9)
virulent (causing lesions##2##3##(2008-10#2)
virulent (mean disease severity was##2##5##(2008-10#2)
virulent C##6##2##(1995-12#1)(1996-12#1)(2008-10#4)
virulent and avirulent##4##3##(2008-10#4)
virulent and##16##2##(2008-10#13)(2008-5#3)
virulent genotypes##2##2##(2008-10#2)
virulent isolate##5##2##(2008-10#5)
virulent isolates alone##2##3##(2008-10#2)
virulent isolates of##2##3##(2008-10#2)
virulent isolates produced##2##3##(2008-10#2)
virulent isolates##18##2##(2008-10#18)
virulent on all##2##3##(2008-10#2)
virulent on##16##2##(2008-10#16)
virulent only on##2##3##(2008-10#2)
virulent plant##2##2##(2008-9#2)
virulent populations of##2##3##(2008-10#2)
virulent populations##6##2##(2008-10#6)
virulent strain of##2##3##(2008-10#2)
virulent strain##4##2##(1993-12#1)(2008-10#2)(2008-8#1)
virulent strains of the##3##4##(2008-10#3)
virulent strains##5##2##(1991-3#1)(2008-10#4)
virulent than the##3##3##(2008-10#2)(2008-5#1)
virulent than##12##2##(2008-10#10)(2008-5#1)(2013-1#1)
virulent to all##2##3##(2008-10#2)
virulent to##21##2##(2007-12#1)(2008-10#20)
virulent virus##3##2##(2008-10#3)
virulent wild-type##2##2##(2008-10#2)
virulent##183##1##(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-6#1)(2006-6#2)(2007-12#1)(2007-2#1)(2008-10#145)(2008-12#1)(2008-4#1)(2008-5#11)(2008-8#1)(2008-9#7)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
virulent/avirulent phenotypes##2##2##(2008-10#2)
viruliferous aphids##4##2##(2008-10#4)
viruliferous insects##2##2##(2008-10#2)
viruliferous mites##2##2##(2008-10#2)
viruliferous whiteflies##4##2##(2008-10#4)
viruliferous##20##1##(2008-10#20)
virus (BTV)##3##2##(1997-4#1)(2010-4#1)(2011-2#1)
virus (EBV) is##2##3##(2007-2#1)(2011-2#1)
virus (EBV)##17##2##(1992-12#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2010-6#1)(2011-2#1)
virus (HCV)##33##2##(1990-3#1)(1994-8#1)(2006-10#1)(2007-7#5)(2008-1#3)(2008-10#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
virus (HIV) and##3##3##(2007-2#1)(2008-5#1)(2011-2#1)
virus (HIV)##45##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
virus (HPV)##4##2##(1991-2#2)(1996-12#1)(2008-10#1)
virus (PHV)##4##2##(2008-10#2)(2008-5#2)
virus (RSV)##7##2##(1996-3#1)(1997-8#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#2)
virus (SIV)##5##2##(1992-6#1)(1995-2#2)(1997-3#1)(2011-2#1)
virus (SPMV)##2##2##(2008-10#2)
virus (VSV)##2##2##(2008-11#1)(2008-4#1)
virus (WSMV)##4##2##(2008-10#4)
virus (strain)##4##2##(2008-10#4)
virus -##2##2##(2007-12#1)(2007-5#1)
virus 1 and##2##3##(1994-8#1)(2012-3#1)
virus 1##9##2##(1994-8#3)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)
virus 2##3##2##(1993-2#1)(1997-4#1)(2008-10#1)
virus 40 T##2##3##(1995-6#2)
virus 40 T-antigen##2##3##(1996-5#1)(2008-11#1)
virus 40##13##2##(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-7#1)(1997-8#1)(2008-11#2)(2011-2#1)(2013-1#1)
virus A##7##2##(2008-10#6)(2010-5#1)
virus B##2##2##(2008-10#1)(2013-8#1)
virus D9964 strain##3##3##(2013-8#3)
virus D9964##4##2##(2013-8#4)
virus DNA polymerase##4##3##(1993-8#1)(1995-2#3)
virus DNA##9##2##(1990-8#1)(1993-8#1)(1995-2#3)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)
virus Helper##2##2##(2008-10#2)
virus Infecting##2##2##(2008-10#2)
virus Infection##2##2##(2008-10#2)
virus Is a Distinct##2##4##(2008-10#2)
virus Is##4##2##(2008-10#4)
virus Isolates##3##2##(2008-10#3)
virus RNA##8##2##(1994-8#2)(1997-6#1)(2008-10#3)(2011-2#1)(2013-8#1)
virus Resistance in##3##3##(2008-10#3)
virus Resistance##5##2##(2008-10#5)
virus X (PVX)##7##3##(1997-3#1)(2008-10#6)
virus X##12##2##(1996-8#1)(1997-3#1)(2008-10#8)(2010-9#1)(2012-12#1)
virus Y (PVY)##2##3##(2008-10#2)
virus Y##11##2##(2008-10#10)(2012-3#1)
virus a##3##2##(1994-12#1)(1997-6#1)(2008-10#1)
virus accumulated##2##2##(2008-10#2)
virus accumulation and##2##3##(2008-10#2)
virus accumulation in inoculated##2##4##(2008-10#2)
virus accumulation in##4##3##(2008-10#4)
virus accumulation##19##2##(2008-10#19)
virus acquisition##2##2##(2008-10#2)
virus alone##5##2##(2008-10#5)
virus also##2##2##(1993-11#1)(2008-10#1)
virus among##3##2##(2007-7#1)(2008-7#1)(2011-3#1)
virus and Bean common mosaic##2##5##(2008-10#2)
virus and Pepper##2##3##(2008-10#2)
virus and Tomato##3##3##(2008-10#2)(2011-2#1)
virus and cellular##2##3##(1994-8#1)(1997-3#1)
virus and host##3##3##(1995-3#1)(2008-10#1)(2009-2#1)
virus and is##2##3##(1994-8#1)(2008-10#1)
virus and its##2##3##(2012-2#1)(2013-1#1)
virus and may##2##3##(2008-10#1)(2012-2#1)
virus and of##3##3##(1991-2#1)(2008-10#2)
virus and one##2##3##(1997-5#1)(2013-1#1)
virus and potato virus##2##4##(2008-10#2)
virus and the##6##3##(1990-5#1)(1994-6#1)(1996-11#1)(1997-3#1)(1997-7#1)(2008-8#1)
virus and##93##2##(1990-5#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-3#1)(1996-11#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-2#1)(2007-6#1)(2007-7#3)(2008-10#46)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
virus antibodies in##5##3##(1990-3#1)(1992-8#1)(1994-7#2)(1997-3#1)
virus antibodies##6##2##(1990-3#1)(1992-8#1)(1994-7#3)(1997-3#1)
virus antibody##3##2##(1994-7#1)(2010-12#1)(2010-4#1)
virus antigens##3##2##(2006-10#1)(2008-11#1)(2008-5#1)
virus are##9##2##(1994-2#1)(2007-12#1)(2008-10#3)(2008-9#3)(2013-1#1)
virus as a##5##3##(1990-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
virus as##11##2##(1990-11#1)(1990-2#1)(2008-10#5)(2008-11#2)(2008-8#1)(2011-2#1)
virus associated with##3##3##(1991-8#1)(2008-10#2)
virus associated##4##2##(1991-8#1)(2007-7#1)(2008-10#2)
virus at##7##2##(2008-10#4)(2008-11#2)(2010-4#1)
virus based on##2##3##(2008-10#2)
virus based##3##2##(1990-12#1)(2008-10#2)
virus binding##3##2##(2008-11#3)
virus budding##4##2##(1997-1#3)(1997-3#1)
virus by the##2##3##(2008-10#2)
virus by##13##2##(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#9)(2013-8#1)
virus can##4##2##(1994-11#1)(2007-12#1)(2008-10#1)(2010-4#1)
virus capsid protein##2##3##(2008-10#1)(2009-7#1)
virus caused##2##2##(2008-10#2)
virus clone##3##2##(1995-2#3)
virus coat protein gene##2##4##(2008-10#2)
virus coat protein##3##3##(2008-10#2)(2011-2#1)
virus coat##4##2##(2008-10#3)(2011-2#1)
virus complex##3##2##(1994-8#1)(2008-10#2)
virus complexes##2##2##(2008-10#2)
virus concentration##2##2##(2008-10#2)
virus contamination in##3##3##(1994-7#1)(2008-2#1)(2008-4#1)
virus contamination##5##2##(1990-11#1)(1994-7#2)(2008-2#1)(2008-4#1)
virus content##3##2##(2008-10#3)
virus core##3##2##(1994-7#1)(1996-12#1)(2008-8#1)
virus could be detected##2##4##(2008-10#1)(2013-8#1)
virus could be##5##3##(2008-10#3)(2008-5#1)(2013-8#1)
virus could##8##2##(1991-5#1)(2008-10#5)(2008-5#1)(2013-8#1)
virus density##2##2##(2008-9#2)
virus derived from infectious##2##4##(2008-10#2)
virus derived from##7##3##(2008-10#7)
virus detection##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
virus did not##2##3##(1991-3#1)(2008-10#1)
virus disease##6##2##(1995-2#1)(2008-10#5)
virus diseases##2##2##(2007-11#1)(2007-12#1)
virus does not##3##3##(1992-6#1)(2008-10#1)(2008-8#1)
virus entry##2##2##(1994-6#1)(2011-2#1)
virus envelope protein##2##3##(2009-7#1)(2011-1#1)
virus excretion##2##2##(2008-5#1)(2011-2#1)
virus exit process##3##3##(1997-1#3)
virus expressing##3##2##(2008-10#2)(2008-7#1)
virus expression##3##2##(2008-2#2)(2008-4#1)
virus families have##2##3##(1997-6#1)(2013-1#1)
virus families##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
virus following##2##2##(2008-5#1)(2012-3#1)
virus for##8##2##(2008-10#6)(2008-4#2)
virus from the##3##3##(2008-10#2)(2011-1#1)
virus from##23##2##(1990-11#1)(1992-8#1)(1996-11#1)(2007-6#1)(2008-10#17)(2009-5#1)(2011-1#1)
virus genome##5##2##(1994-8#2)(2008-10#2)(2008-11#1)
virus genomes##4##2##(1997-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
virus genotype##3##2##(2009-3#1)(2009-5#1)(2013-1#1)
virus glycoprotein##5##2##(1991-2#1)(1995-2#2)(1997-4#1)(2011-2#1)
virus had##3##2##(1995-9#1)(2008-10#2)
virus has a##3##3##(2008-10#2)(2008-2#1)
virus has##9##2##(1990-11#1)(1992-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-2#1)
virus illness##2##2##(1993-1#1)(2009-10#1)
virus in Transgenic##2##3##(2008-10#2)
virus in a##6##3##(1993-6#1)(1995-5#1)(2007-7#1)(2008-10#2)(2008-11#1)
virus in chickens##2##3##(1997-6#1)(2008-5#1)
virus in patients##2##3##(1993-2#1)(2008-10#1)
virus in the##10##3##(1990-9#1)(1991-2#1)(1995-5#1)(1997-4#2)(2008-10#1)(2009-5#2)(2012-2#1)(2012-3#1)
virus in##95##2##(1990-9#1)(1991-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-12#2)(1995-5#2)(1997-3#2)(1997-4#2)(1997-6#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#47)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
virus incidence##4##2##(2008-10#3)(2012-1#1)
virus infected##2##2##(2008-11#1)(2008-12#1)
virus infection and##5##3##(1997-6#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
virus infection in##10##3##(1991-2#1)(1991-3#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
virus infection is##4##3##(2008-1#1)(2008-11#1)(2008-6#1)(2012-3#1)
virus infection may##2##3##(2006-10#1)(2008-10#1)
virus infection of##2##3##(1993-2#1)(2008-10#1)
virus infection was##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
virus infection who##3##3##(1997-7#1)(2006-10#1)(2013-1#1)
virus infection##78##2##(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1993-2#2)(1994-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(2006-10#5)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#5)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
virus infection]##5##2##(1991-6#1)(1992-2#1)(1993-2#1)(1993-5#1)(1996-11#1)
virus infections##10##2##(1990-6#1)(1990-9#1)(1992-6#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
virus ingestion##2##2##(2008-10#2)
virus inoculum##3##2##(2008-11#3)
virus into the##3##3##(1993-6#1)(1997-2#1)(2008-4#1)
virus into##4##2##(1993-6#1)(1997-2#1)(2008-10#1)(2008-4#1)
virus is a##2##3##(2007-2#1)(2008-10#1)
virus is highly##2##3##(1992-8#1)(2013-8#1)
virus is most##2##3##(2008-10#2)
virus is not##2##3##(2008-10#1)(2008-2#1)
virus is proposed##4##3##(2008-10#4)
virus is the##2##3##(2008-9#1)(2011-2#1)
virus is transmitted##3##3##(2007-2#2)(2008-10#1)
virus is##37##2##(1992-8#1)(1993-11#1)(1994-8#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-2#5)(2007-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
virus isolate from##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
virus isolate##9##2##(1997-6#1)(2007-6#3)(2008-10#3)(2008-8#1)(2008-9#1)
virus isolated from##4##3##(2008-5#2)(2008-8#1)(2008-9#1)
virus isolates##7##2##(1995-5#1)(2008-10#4)(2008-8#1)(2011-1#1)
virus isolation was##2##3##(2012-3#1)(2013-1#1)
virus isolation##4##2##(2012-3#2)(2013-1#1)(2013-8#1)
virus isolations##2##2##(1992-6#1)(1997-6#1)
virus life##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
virus long terminal repeat##4##4##(1990-12#2)(1995-6#2)
virus may##5##2##(2007-10#1)(2008-10#2)(2008-11#1)(2008-8#1)
virus models##2##2##(1994-11#2)
virus most##2##2##(1991-5#1)(2008-10#1)
virus movement##6##2##(2008-10#6)
virus neutralization test##2##3##(1997-6#1)(2008-12#1)
virus neutralization##3##2##(1997-3#1)(1997-6#1)(2008-12#1)
virus of Central/East African genotype##5##5##(2011-1#5)
virus of##13##2##(1991-6#1)(1995-2#1)(2007-6#1)(2008-10#2)(2008-8#1)(2011-1#7)
virus on mortality during the first##2##6##(2011-2#2)
virus on##4##2##(1994-11#1)(2008-12#1)(2011-2#2)
virus only##2##2##(1997-6#1)(2012-3#1)
virus or##7##2##(1992-2#1)(1995-6#1)(1997-3#1)(2008-10#3)(2011-2#1)
virus particle##4##2##(1997-3#1)(2008-10#1)(2011-2#1)(2011-3#1)
virus particles by##2##3##(1996-3#1)(1997-3#1)
virus particles were##6##3##(1994-8#1)(2008-10#5)
virus particles##24##2##(1990-2#1)(1990-5#1)(1991-5#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-3#3)(1997-4#2)(2008-10#13)
virus per##3##2##(2008-10#2)(2008-12#1)
virus plus##2##2##(1990-5#1)(1991-2#1)
virus population##4##2##(2007-6#1)(2008-10#3)
virus populations##3##2##(2008-10#2)(2011-2#1)
virus preparations##3##2##(1997-3#1)(2008-10#2)
virus previously##2##2##(2008-10#1)(2012-2#1)
virus produced##3##2##(1992-6#1)(1997-3#1)(2006-10#1)
virus produces##2##2##(1994-11#1)(2012-2#1)
virus production in##2##3##(2008-11#2)
virus production##8##2##(2008-11#8)
virus progeny##2##2##(2008-10#1)(2008-4#1)
virus recovered from##2##3##(2008-10#2)
virus related to##2##3##(1990-3#1)(2008-10#1)
virus replication and##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
virus replication by##2##3##(1995-2#1)(1997-4#1)
virus replication in##2##3##(2007-6#1)(2007-8#1)
virus replication was##3##3##(1997-3#1)(2008-10#2)
virus replication##24##2##(1992-12#1)(1994-11#5)(1995-2#3)(1997-3#1)(1997-4#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-9#2)(2012-2#1)(2013-1#1)
virus research##2##2##(2007-6#1)(2008-9#1)
virus resistance genes##3##3##(2008-10#3)
virus resistance in wheat##2##4##(2008-10#2)
virus resistance in##4##3##(2008-10#4)
virus resistance##13##2##(2008-10#11)(2008-2#1)(2008-5#1)
virus serotype##3##2##(2008-10#1)(2008-5#2)
virus shedding##3##2##(1995-5#2)(2013-8#1)
virus source##2##2##(2008-10#2)
virus species in##2##3##(2008-10#2)
virus species##4##2##(2008-10#4)
virus spread##6##2##(1992-9#1)(2008-10#5)
virus stocks##3##2##(2008-4#2)(2008-9#1)
virus strain##11##2##(1997-6#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
virus strains from##2##3##(1993-3#1)(2009-2#1)
virus strains##9##2##(1993-3#1)(2008-10#5)(2009-2#1)(2012-12#1)(2013-1#1)
virus structure##3##2##(2008-10#3)
virus surface##8##2##(1994-11#2)(1997-3#1)(1997-4#1)(1997-6#1)(2008-8#3)
virus system##2##2##(2008-9#2)
virus testing##3##2##(2007-12#1)(2013-1#2)
virus than##3##2##(1990-6#1)(2007-2#1)(2008-9#1)
virus that##9##2##(1991-5#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-3#1)
virus through##2##2##(2008-10#2)
virus throughout##2##2##(2007-12#1)(2009-2#1)
virus titer##7##2##(1994-8#2)(2008-10#2)(2008-11#3)
virus titers by##2##3##(2008-11#2)
virus titers in##2##3##(2008-10#1)(2011-2#1)
virus titers##6##2##(2008-10#1)(2008-11#4)(2011-2#1)
virus to##14##2##(1992-5#1)(1994-6#1)(1996-2#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-5#2)(2011-3#1)
virus transmission in##2##3##(2008-10#1)(2008-9#1)
virus transmission was##2##3##(2008-10#2)
virus transmission##16##2##(1995-6#1)(2008-10#12)(2008-12#1)(2008-9#1)(2012-2#1)
virus type 1 in##4##4##(1992-6#1)(1993-6#1)(2007-6#1)(2008-12#1)
virus type 1##37##3##(1990-2#1)(1990-5#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-3#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#7)(2008-4#1)(2008-9#1)(2011-2#2)
virus type 2##2##3##(1992-6#1)(2013-1#1)
virus type I##5##3##(1991-11#1)(1991-12#2)(2008-11#1)(2012-12#1)
virus type##48##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#2)(1992-11#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-3#1)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#7)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
virus type-1##7##2##(1990-2#1)(1994-11#1)(1997-3#1)(1997-4#1)(2007-7#1)(2009-11#1)(2012-12#1)
virus types##2##2##(1991-12#1)(1995-5#1)
virus using##3##2##(2007-7#1)(2008-10#2)
virus vaccine and##2##3##(2007-10#1)(2008-9#1)
virus vaccine candidate##2##3##(2008-11#2)
virus vaccine for##3##3##(2007-10#1)(2007-11#2)
virus vaccine##14##2##(1992-12#1)(1995-9#2)(1997-6#1)(2007-10#3)(2007-11#2)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
virus vaccines##7##2##(1994-2#1)(1995-5#2)(2007-10#1)(2008-11#2)(2011-2#1)
virus variant##2##2##(1993-8#1)(2007-12#1)
virus vector##4##2##(1992-12#1)(1996-12#1)(2008-8#1)(2008-9#1)
virus vectors##7##2##(1992-12#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)
virus viability##2##2##(1997-3#1)(2008-10#1)
virus was acquired##3##3##(2008-10#3)
virus was also##2##3##(2008-10#2)
virus was detected in##2##4##(2008-10#2)
virus was detected##3##3##(2008-10#3)
virus was evaluated##2##3##(2008-10#1)(2012-3#1)
virus was identified##2##3##(2008-11#1)(2011-2#1)
virus was isolated from##4##4##(2008-10#4)
virus was isolated##5##3##(2008-10#4)(2008-5#1)
virus was readily transmitted##2##4##(2008-10#2)
virus was transmitted##5##3##(2008-10#5)
virus was used##2##3##(1997-1#1)(2008-10#1)
virus was whitefly-transmissible##2##3##(2008-10#2)
virus was##58##2##(1991-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#3)(2007-6#1)(2008-10#40)(2008-11#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
virus were##7##2##(1992-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-3#1)(2013-8#1)
virus which##2##2##(1996-6#1)(2008-8#1)
virus with##11##2##(2006-10#1)(2008-10#7)(2008-11#1)(2008-8#1)(2012-12#1)
virus within##2##2##(2008-5#2)
virus yields##2##2##(2008-11#2)
virus##2475##1##(1990-11#7)(1990-12#3)(1990-2#5)(1990-3#6)(1990-5#12)(1990-6#3)(1990-8#3)(1990-9#4)(1991-11#6)(1991-12#3)(1991-2#13)(1991-3#5)(1991-5#9)(1991-6#5)(1991-8#4)(1991-9#7)(1992-11#1)(1992-12#13)(1992-2#3)(1992-5#1)(1992-6#12)(1992-8#8)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#3)(1993-5#1)(1993-6#6)(1993-8#7)(1993-9#3)(1994-11#21)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#14)(1994-7#8)(1994-8#33)(1994-9#2)(1995-1#1)(1995-12#8)(1995-2#33)(1995-3#2)(1995-5#14)(1995-6#7)(1995-9#3)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#8)(1997-3#42)(1997-4#31)(1997-5#4)(1997-6#39)(1997-7#5)(1997-8#8)(2006-10#15)(2007-10#7)(2007-11#3)(2007-12#27)(2007-2#17)(2007-5#1)(2007-6#24)(2007-7#27)(2007-8#3)(2008-1#9)(2008-10#1090)(2008-11#100)(2008-12#29)(2008-2#17)(2008-3#1)(2008-4#36)(2008-5#51)(2008-6#1)(2008-7#13)(2008-8#67)(2008-9#74)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#9)(2009-6#3)(2009-7#8)(2009-8#17)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#31)(2011-2#59)(2011-3#13)(2012-1#4)(2012-12#26)(2012-2#25)(2012-3#25)(2013-1#55)(2013-7#2)(2013-8#36)
virus)##12##1##(1992-9#1)(1994-8#1)(1995-2#1)(1997-6#1)(2007-6#1)(2008-10#4)(2008-11#1)(2010-3#1)(2011-2#1)
virus-1##14##1##(1991-9#2)(1992-12#1)(1992-8#1)(1994-11#1)(1994-5#1)(2007-6#1)(2008-10#5)(2008-11#1)(2012-1#1)
virus-2##4##1##(2008-10#4)
virus-associated##2##1##(2008-12#1)(2012-12#1)
virus-based##4##1##(1995-2#1)(1997-8#1)(2008-7#1)(2009-3#1)
virus-binding##2##1##(2008-10#2)
virus-derived##2##1##(1995-2#1)(2008-10#1)
virus-encoded proteins##2##2##(2008-8#1)(2009-2#1)
virus-encoded##4##1##(2008-8#1)(2009-2#1)(2009-7#1)(2013-1#1)
virus-free counterparts##2##2##(2008-10#2)
virus-free fungal##2##2##(2008-10#2)
virus-free##14##1##(2008-10#11)(2008-11#2)(2008-4#1)
virus-host interactions##3##2##(2007-6#1)(2010-1#1)(2012-12#1)
virus-induced##8##1##(1990-5#1)(1990-6#1)(1997-6#1)(2008-10#4)(2012-2#1)
virus-infected cells##6##2##(1994-11#1)(1995-2#1)(1997-3#1)(2008-11#2)(2009-11#1)
virus-infected isolates##2##2##(2008-10#2)
virus-infected lettuce##2##2##(2008-10#2)
virus-infected plants##3##2##(2008-10#3)
virus-infected##19##1##(1994-11#1)(1995-2#2)(1997-3#1)(1997-4#1)(2008-10#10)(2008-11#3)(2009-11#1)
virus-like particles (VLP)##2##3##(2008-10#2)
virus-like particles##7##2##(1995-5#1)(1997-4#2)(2008-10#4)
virus-like##10##1##(1995-5#1)(1997-4#2)(2008-10#7)
virus-mediated##2##1##(2008-8#1)(2008-9#1)
virus-related hepatocellular carcinoma##2##3##(2013-8#2)
virus-related##3##1##(2007-12#1)(2013-8#2)
virus-resistant plants##2##2##(2008-10#2)
virus-resistant##6##1##(2008-10#6)
virus-retention region of##2##3##(2008-10#2)
virus-specific##12##1##(2008-10#10)(2010-5#2)
virus-transformed##4##1##(1994-9#1)(1995-8#2)(2008-11#1)
virus-virus interactions##3##2##(1997-3#1)(2008-10#2)
virus]##5##1##(1990-3#1)(1991-6#1)(1996-6#1)(2012-3#1)(2013-8#1)
viruses and a##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
viruses and the##3##3##(2007-10#1)(2008-11#2)
viruses and viral##2##3##(1995-2#1)(2008-11#1)
viruses and##20##2##(1993-3#1)(1995-12#1)(1995-2#3)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#2)(2013-8#1)
viruses are##12##2##(1997-4#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#2)(2013-1#1)(2013-8#1)
viruses as##3##2##(2007-2#1)(2008-10#1)(2008-11#1)
viruses belonging to the##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
viruses but##2##2##(1990-5#1)(2008-10#1)
viruses by multiplex##2##3##(2008-10#2)
viruses by##6##2##(2008-10#5)(2013-1#1)
viruses can##2##2##(2008-10#1)(2010-1#1)
viruses causing##3##2##(1997-6#1)(2008-10#1)(2013-8#1)
viruses depend on##2##3##(2008-10#1)(2008-9#1)
viruses displayed##2##2##(1995-2#1)(2008-10#1)
viruses during##2##2##(1996-6#1)(2006-10#1)
viruses for the##2##3##(1995-2#1)(2013-8#1)
viruses for##5##2##(1995-2#1)(1997-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
viruses from the##2##3##(2008-10#2)
viruses from##11##2##(1997-3#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-9#1)(2011-2#2)(2013-1#1)
viruses had##2##2##(2012-3#1)(2013-8#1)
viruses has been##3##3##(1994-9#1)(1997-6#1)(2008-7#1)
viruses has##4##2##(1994-9#1)(1997-6#1)(2008-7#1)(2013-1#1)
viruses have been##3##3##(1997-6#1)(2008-8#1)(2011-3#1)
viruses have##4##2##(1997-6#1)(2008-8#1)(2008-9#1)(2011-3#1)
viruses in a##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
viruses in both##2##3##(1997-8#1)(2013-1#1)
viruses in humans##3##3##(2011-2#2)(2013-1#1)
viruses in the plant##2##4##(2008-10#2)
viruses in the##14##3##(1997-6#1)(2008-10#11)(2008-5#1)(2013-1#1)
viruses in vivo##2##3##(2007-11#1)(2013-1#1)
viruses in##58##2##(1991-5#1)(1994-8#1)(1997-3#1)(1997-6#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#23)(2008-11#1)(2008-5#1)(2008-9#2)(2009-5#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#9)(2013-8#2)
viruses including##2##2##(2013-1#1)(2013-8#1)
viruses infect##2##2##(2008-10#2)
viruses infecting##2##2##(2008-10#1)(2013-1#1)
viruses is##8##2##(1994-9#1)(1995-2#2)(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)(2013-8#1)
viruses isolated from##4##3##(1997-3#1)(2007-6#1)(2008-10#2)
viruses isolated in##2##3##(1992-6#1)(2009-5#1)
viruses isolated##7##2##(1992-6#1)(1997-3#1)(2007-6#1)(2008-10#2)(2009-5#1)(2011-2#1)
viruses may##3##2##(1991-5#1)(1995-12#1)(2007-7#1)
viruses must##2##2##(1994-6#1)(2008-10#1)
viruses of the##5##3##(1992-9#3)(2008-4#1)(2011-2#1)
viruses of##16##2##(1992-9#3)(1995-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#2)(2011-2#2)(2013-8#2)
viruses or virus strains##3##4##(2008-10#3)
viruses or##6##2##(1995-2#1)(1996-11#1)(2008-10#4)
viruses predominated during##2##3##(1994-9#1)(1996-6#1)
viruses responsible##2##2##(1997-6#1)(2010-4#1)
viruses showed##2##2##(2008-10#2)
viruses simultaneously##2##2##(2008-10#2)
viruses such as##3##3##(1997-4#1)(2011-3#2)
viruses tested##2##2##(2008-5#1)(2013-1#1)
viruses that cause barley yellow dwarf disease##2##7##(2008-10#2)
viruses that cause##7##3##(1995-6#1)(2008-10#5)(2013-8#1)
viruses that##14##2##(1994-8#1)(1995-6#1)(1995-9#1)(1997-6#1)(2008-10#7)(2011-1#1)(2012-12#1)(2013-8#1)
viruses there##2##2##(1997-6#1)(2008-11#1)
viruses to##5##2##(1995-12#1)(2008-10#2)(2010-4#1)(2012-2#1)
viruses transmitted by##2##3##(2008-10#1)(2012-2#1)
viruses was observed##3##3##(1996-6#2)(2008-10#1)
viruses was##12##2##(1996-6#2)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
viruses were isolated from##2##4##(2011-2#1)(2013-8#1)
viruses were isolated##3##3##(2011-2#1)(2013-8#2)
viruses were mechanically##2##3##(2008-10#2)
viruses were most##3##3##(1996-6#1)(2008-10#2)
viruses were##30##2##(1991-6#1)(1996-6#2)(1997-4#1)(2007-12#3)(2008-10#13)(2008-11#3)(2011-2#2)(2013-1#1)(2013-8#4)
viruses with##2##2##(1994-6#1)(2007-6#1)
viruses within the##2##3##(2008-10#2)
viruses within##3##2##(2008-10#3)
viruses##495##1##(1990-5#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#4)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#1)(1994-6#4)(1994-8#8)(1994-9#5)(1995-12#5)(1995-2#14)(1995-5#1)(1995-6#3)(1995-9#4)(1996-11#1)(1996-6#8)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-6#12)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#2)(2007-6#10)(2007-7#4)(2008-10#190)(2008-11#23)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#26)(2009-3#1)(2009-5#3)(2009-8#1)(2010-1#3)(2010-10#1)(2010-4#2)(2010-5#2)(2010-7#3)(2011-1#2)(2011-2#19)(2011-3#4)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#26)(2013-8#30)
viruses)##3##1##(1996-6#1)(2008-4#1)(2008-9#1)
viruses]##4##1##(2010-10#1)(2010-4#1)(2013-8#2)
vis-a-vis##5##1##(1991-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-5#1)
vis-à-vis the##2##2##(1990-5#1)(2008-1#1)
vis-à-vis##6##1##(1990-5#1)(2008-1#1)(2008-10#2)(2010-8#1)(2012-2#1)
viscera##12##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-8#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
visceral adipose tissue in##2##4##(2008-5#2)
visceral adipose tissue##5##3##(2008-3#2)(2008-5#3)
visceral afferents##2##2##(2008-4#2)
visceral and##3##2##(1995-1#1)(1997-4#1)(2007-7#1)
visceral cells##3##2##(2012-1#3)
visceral disease##2##2##(1995-1#1)(2008-7#1)
visceral fat area##2##3##(2008-3#2)
visceral fat##11##2##(2008-11#3)(2008-3#3)(2010-6#1)(2012-2#4)
visceral involvement##3##2##(1997-8#1)(2012-2#1)(2013-1#1)
visceral leishmaniasis in##5##3##(2007-12#2)(2008-7#1)(2008-8#1)(2012-2#1)
visceral leishmaniasis##22##2##(1990-7#2)(1990-9#1)(1996-12#1)(2007-12#5)(2007-7#1)(2008-12#2)(2008-7#6)(2008-8#2)(2012-2#1)(2013-1#1)
visceral lesions##2##2##(1992-6#1)(1997-6#1)
visceral malignancies##3##2##(2008-7#1)(2010-8#2)
visceral metastases##2##2##(1996-6#1)(2012-2#1)
visceral obesity##2##2##(2008-10#1)(2013-1#1)
visceral organs##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
visceral##99##1##(1990-10#1)(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-6#4)(1994-5#1)(1995-1#2)(1995-3#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-12#8)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#10)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-1#4)(2012-2#12)(2013-1#4)(2013-7#1)(2013-8#2)
viscoelastic and##2##2##(2007-12#1)(2009-12#1)
viscoelastic behavior##2##2##(2009-7#2)
viscoelastic properties##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
viscoelastic##21##1##(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#4)(2008-9#1)(2009-12#1)(2009-4#3)(2009-7#3)(2012-2#4)
viscoelasticity##7##1##(1992-11#1)(2008-10#2)(2008-5#2)(2009-11#1)(2009-4#1)
viscometric##2##1##(1991-12#1)(1992-3#1)
viscosa leaves##2##2##(2008-10#2)
viscosa##10##1##(2008-10#9)(2010-2#1)
viscosities and##2##2##(2008-5#1)(2008-7#1)
viscosities##8##1##(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)
viscosity and density of##2##4##(2008-10#2)
viscosity and density##5##3##(2008-10#5)
viscosity and physical stability##2##4##(2008-5#2)
viscosity and the##2##3##(2008-10#1)(2008-5#1)
viscosity and##22##2##(1991-1#1)(1992-12#1)(1995-3#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#6)(2008-7#1)(2011-2#1)(2011-3#1)
viscosity of shampoo##4##3##(2008-5#4)
viscosity of the##12##3##(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-7#1)(2013-1#1)(2013-8#1)
viscosity of##27##2##(1992-3#1)(1994-11#3)(2008-10#7)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#2)
viscosity on the##2##3##(2008-10#1)(2009-10#1)
viscosity reduction##2##2##(2008-10#1)(2013-1#1)
viscosity was##2##2##(1992-12#1)(2008-5#1)
viscosity with##2##2##(2007-11#1)(2008-8#1)
viscosity##109##1##(1991-1#2)(1992-12#2)(1992-3#1)(1994-11#4)(1994-12#1)(1995-3#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#5)(2008-1#1)(2008-10#26)(2008-3#4)(2008-5#26)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#2)(2011-1#3)(2011-2#4)(2011-3#1)(2013-1#3)(2013-8#2)
viscosupplementation##2##1##(2007-11#1)(2013-1#1)
viscous liquid##2##2##(1995-3#1)(2008-12#1)
viscous triangular elements##2##3##(2008-7#2)
viscous##20##1##(1990-4#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#5)(2009-11#1)(2009-6#1)(2011-1#1)
visibilities##2##1##(2008-2#1)(2008-3#1)
visibility and##4##2##(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#1)
visibility decrease##2##2##(2008-2#1)(2012-3#1)
visibility is##3##2##(1994-3#1)(2007-12#1)(2008-2#1)
visibility measurements##2##2##(2008-3#2)
visibility of the##9##3##(1994-3#1)(1995-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2009-11#1)(2009-6#1)
visibility of##17##2##(1994-3#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2009-11#1)(2009-6#1)(2010-7#1)(2012-1#1)(2012-3#1)
visibility##53##1##(1994-2#1)(1994-3#3)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#21)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-7#1)(2012-1#2)(2012-3#2)(2013-1#1)
visible absorbance##2##2##(1995-2#1)(2008-8#1)
visible absorption##4##2##(1992-1#1)(1993-11#1)(2007-12#1)(2008-10#1)
visible and infrared##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
visible and invisible##3##3##(2008-1#3)
visible and near##3##3##(2008-3#1)(2010-4#2)
visible and near-infrared channels##2##4##(2008-2#2)
visible and near-infrared##9##3##(2007-11#1)(2008-2#5)(2008-3#2)(2013-8#1)
visible and##32##2##(1995-4#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#2)(2008-2#7)(2008-3#12)(2010-4#2)(2013-8#2)
visible at the##3##3##(1993-12#1)(2008-7#1)(2010-10#1)
visible at##5##2##(1993-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-2#1)
visible bands##2##2##(2008-3#2)
visible by##7##2##(2007-12#2)(2008-10#3)(2008-5#1)(2008-7#1)
visible changes##2##2##(2007-11#1)(2008-11#1)
visible clinical##2##2##(2008-10#1)(2008-5#1)
visible damage##2##2##(2008-10#1)(2008-11#1)
visible disease##2##2##(2008-10#1)(2013-1#1)
visible in the##11##3##(1990-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
visible in##21##2##(1990-7#3)(1993-12#1)(1994-11#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
visible laser beam##2##3##(2007-12#1)(2008-2#1)
visible laser light##2##3##(2008-3#2)
visible laser##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
visible light irradiation##3##3##(2009-3#2)(2013-8#1)
visible light##19##2##(1992-1#1)(1994-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-8#1)(2009-3#2)(2011-1#2)(2011-2#1)(2013-8#2)
visible necrosis##2##2##(2008-10#2)
visible nucleoli##2##2##(1993-12#2)
visible on##5##2##(2007-10#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
visible or##3##2##(1997-7#1)(2008-2#1)(2011-2#1)
visible quiescent infections##2##3##(2008-10#2)
visible region of the spectrum is presented##2##7##(2007-11#1)(2008-10#1)
visible region of the spectrum##3##5##(2007-11#2)(2008-10#1)
visible region of the##4##4##(2007-11#2)(2008-10#1)(2008-2#1)
visible region##21##2##(2007-11#4)(2007-12#1)(2008-10#7)(2008-2#6)(2008-3#2)(2013-1#1)
visible solid-state##2##2##(2007-12#2)
visible spectral##6##2##(2007-11#1)(2008-3#3)(2009-12#1)(2013-8#1)
visible spectrophotometric##5##2##(2008-10#5)
visible spectrophotometry##2##2##(2008-10#2)
visible spectroscopy##2##2##(2008-10#1)(2013-8#1)
visible spectrum##9##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)
visible symptoms##7##2##(2008-10#6)(2009-9#1)
visible to the##3##3##(2007-12#2)(2008-2#1)
visible to##5##2##(2007-12#2)(2008-2#2)(2010-2#1)
visible wavelength##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
visible wavelengths##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)
visible with##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
visible within the##2##3##(2008-11#1)(2008-7#1)
visible##342##1##(1990-7#3)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#2)(1992-3#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-7#1)(2006-12#1)(2007-10#2)(2007-11#22)(2007-12#30)(2008-1#4)(2008-10#71)(2008-11#8)(2008-2#40)(2008-3#63)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#6)(2013-8#7)
visible)##2##1##(1993-12#1)(2008-2#1)
visible-light##3##1##(2008-2#1)(2008-3#2)
visible-near-IR##2##1##(2007-11#1)(2008-2#1)
visibly##7##1##(1992-6#1)(2008-10#4)(2008-5#1)(2012-3#1)
vision among##5##2##(1995-1#1)(2010-8#4)
vision and##19##2##(1991-3#1)(1993-12#1)(1994-1#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
vision as a##2##3##(2007-11#1)(2008-7#1)
vision as##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
vision at##3##2##(1994-8#1)(2007-5#1)(2011-2#1)
vision by##2##2##(2007-8#2)
vision for the future##2##4##(1997-1#1)(2011-1#1)
vision for the##7##3##(1994-3#1)(1997-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-1#1)
vision for##11##2##(1994-3#1)(1997-1#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-1#2)(2013-1#1)(2013-8#1)
vision in one##2##3##(2008-7#1)(2013-7#1)
vision in##13##2##(1994-8#1)(1995-5#2)(1997-8#1)(2008-7#2)(2010-10#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-7#1)
vision is##3##2##(1997-8#1)(2008-12#1)(2010-8#1)
vision less than##2##3##(2010-8#1)(2012-3#1)
vision loss##6##2##(2007-11#2)(2008-1#1)(2011-1#2)(2011-2#1)
vision of public health##2##4##(1996-3#1)(2013-1#1)
vision of the##6##3##(1995-12#1)(1996-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
vision of##21##2##(1992-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(2007-12#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
vision on##3##2##(1994-1#1)(1995-1#1)(2011-3#1)
vision or##2##2##(1994-12#1)(2011-2#1)
vision system##3##2##(2008-3#2)(2012-1#1)
vision that##3##2##(2008-3#2)(2013-8#1)
vision was##8##2##(2008-12#2)(2010-10#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
vision were##2##2##(2011-2#1)(2012-3#1)
vision with##2##2##(2011-2#2)
vision##208##1##(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#1)(1994-1#4)(1994-12#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2006-12#1)(2007-11#7)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#1)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#14)(2008-4#1)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#3)(2009-12#2)(2009-7#2)(2009-8#1)(2010-10#5)(2010-2#1)(2010-5#1)(2010-8#17)(2010-9#1)(2011-1#12)(2011-2#19)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#3)
visionaries##2##1##(2008-1#1)(2009-11#1)
visionary##5##1##(1996-1#1)(2008-1#1)(2008-7#1)(2010-1#1)(2013-1#1)
visions and##2##2##(1996-1#1)(2009-10#1)
visions##6##1##(1994-1#1)(1995-11#1)(1996-1#1)(2008-1#2)(2009-10#1)
visit all##2##2##(1994-8#1)(2008-7#1)
visit and##5##2##(1995-12#1)(1996-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
visit in##2##2##(1991-3#1)(2010-8#1)
visit the##2##2##(2009-3#1)(2011-1#1)
visit to the##2##3##(1996-2#1)(2009-10#1)
visit to##6##2##(1995-3#1)(1996-2#1)(2008-1#1)(2008-12#1)(2009-10#1)(2013-8#1)
visit was##4##2##(1991-12#1)(1994-12#1)(1995-12#1)(2012-3#1)
visit##84##1##(1990-6#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-3#5)(1995-5#1)(1995-6#2)(1996-1#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#5)
visitation and##3##2##(1994-2#1)(2008-5#1)(2008-8#1)
visitation in the##2##3##(1994-2#2)
visitation program##2##2##(1993-2#1)(2009-11#1)
visitation##12##1##(1993-2#1)(1994-2#3)(2008-5#1)(2008-8#6)(2009-11#1)
visited a##2##2##(2008-1#1)(2012-12#1)
visited in##3##2##(1990-3#1)(1992-12#1)(2009-7#1)
visited on##2##2##(1997-4#1)(2010-12#1)
visited only##2##2##(1992-12#1)(2008-8#1)
visited our department with##2##4##(2008-12#1)(2012-3#1)
visited our department##3##3##(1995-4#1)(2008-12#1)(2012-3#1)
visited our##5##2##(1995-4#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
visited the##6##2##(1996-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2010-8#1)(2013-8#1)
visited##38##1##(1990-3#1)(1992-12#3)(1993-9#1)(1994-2#2)(1994-8#1)(1995-4#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-2#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
visiting a##3##2##(1990-9#1)(1994-2#1)(2012-2#1)
visiting and involvement##2##3##(1990-6#2)
visiting the##5##2##(1992-12#1)(1996-12#1)(2008-12#1)(2008-9#1)(2013-1#1)
visiting##29##1##(1990-6#2)(1990-9#1)(1992-12#2)(1992-2#2)(1993-12#2)(1994-2#1)(1996-12#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-11#3)(2008-12#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
visitor##5##1##(1993-12#1)(1993-9#2)(2008-12#1)(2013-8#1)
visitors to##3##2##(1992-2#1)(1996-1#1)(2011-2#1)
visitors##22##1##(1990-12#1)(1990-6#1)(1991-5#1)(1992-11#1)(1992-2#6)(1993-12#1)(1994-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
visits and##11##2##(1992-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-11#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
visits are##4##2##(1992-6#1)(1994-2#1)(2007-8#1)(2012-3#1)
visits as##2##2##(1992-3#1)(1995-3#1)
visits by a##3##3##(1996-11#1)(2010-3#2)
visits by##5##2##(1996-11#1)(2008-1#1)(2008-3#1)(2010-3#2)
visits can##2##2##(1997-2#1)(2008-10#1)
visits during the##2##3##(1992-3#1)(1996-1#1)
visits during##3##2##(1992-3#2)(1996-1#1)
visits for##5##2##(1996-3#1)(2007-2#1)(2009-12#1)(2011-2#1)(2012-3#1)
visits from##2##2##(1995-1#1)(2008-7#1)
visits in the United States and##2##6##(2011-2#1)(2013-1#1)
visits in##3##2##(1992-6#1)(2011-2#1)(2013-1#1)
visits or##2##2##(2008-11#1)(2008-3#1)
visits per##2##2##(1991-12#1)(2008-10#1)
visits than##2##2##(1992-2#1)(1994-2#1)
visits the##2##2##(1991-6#1)(1994-6#1)
visits to the##4##3##(1992-5#2)(2010-8#1)(2011-1#1)
visits to##13##2##(1990-9#1)(1991-12#1)(1992-5#2)(1993-1#1)(1995-12#1)(1997-2#1)(2007-5#1)(2008-7#1)(2010-8#2)(2011-1#1)(2013-1#1)
visits were made to##2##4##(2008-12#1)(2008-5#1)
visits with##2##2##(1995-2#1)(2012-3#1)
visits##112##1##(1990-9#1)(1991-1#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#4)(1993-1#2)(1994-1#1)(1994-2#5)(1994-6#1)(1995-1#3)(1995-12#4)(1995-2#2)(1995-3#4)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#4)(1997-4#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#4)(2008-12#7)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-3#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2011-9#1)(2012-1#3)(2012-2#2)(2012-3#3)(2013-1#4)
vison##2##1##(2008-6#2)
visors##2##1##(2010-1#2)
vistas##3##1##(1993-2#1)(2008-2#1)(2012-2#1)
visual access to the##2##4##(2007-9#2)
visual acuities##2##2##(2011-2#1)(2013-1#1)
visual acuity (BCVA)##3##3##(2011-2#3)
visual acuity (VA)##2##3##(2011-2#1)(2013-1#1)
visual acuity and##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
visual acuity improvement##2##3##(2010-9#1)(2011-2#1)
visual acuity of the##2##4##(2010-8#1)(2013-8#1)
visual acuity of##6##3##(2010-10#1)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
visual acuity##32##2##(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-10#2)(2010-8#1)(2010-9#2)(2011-2#14)(2013-1#4)(2013-7#1)(2013-8#2)
visual aids##2##2##(1993-11#2)
visual analog scale (VAS)##3##4##(2008-6#1)(2009-3#1)(2012-2#1)
visual analog scale##7##3##(2008-10#1)(2008-6#1)(2009-3#2)(2012-2#2)(2013-1#1)
visual analog scales##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
visual analog##11##2##(1996-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-3#2)(2011-1#1)(2012-2#2)(2013-1#1)
visual analogue scale (VAS)##3##4##(2007-7#1)(2008-7#1)(2012-1#1)
visual analogue scale##8##3##(1995-12#1)(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
visual analogue scales##5##3##(1996-3#1)(2007-11#1)(2007-6#1)(2008-10#2)
visual analogue##14##2##(1995-12#1)(1996-3#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
visual and digital assessments##2##4##(2008-10#2)
visual and quantitative analysis of different tastes##3##7##(2008-10#3)
visual and##24##2##(1990-8#1)(1991-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2013-1#2)(2013-8#2)
visual area##2##2##(1992-11#1)(2008-9#1)
visual assessment of disease##2##4##(2008-10#2)
visual assessment of##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
visual assessment##10##2##(2007-10#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)
visual assessments of##2##3##(2008-10#1)(2008-5#1)
visual association##3##2##(1996-2#2)(2011-2#1)
visual attention with##2##3##(2008-9#2)
visual attention##10##2##(1995-12#1)(2007-4#1)(2008-11#3)(2008-6#1)(2008-9#3)(2010-5#1)
visual autocatalytic##2##2##(2008-10#2)
visual complications##3##2##(2012-3#3)
visual confluency##3##2##(2008-11#3)
visual control##2##2##(2007-12#1)(2013-1#1)
visual cortex activity##2##3##(2012-2#2)
visual cortex and##3##3##(1995-11#1)(1995-12#1)(2008-8#1)
visual cortex in the ferret##2##5##(2008-1#2)
visual cortex is##2##3##(1990-8#1)(1995-11#1)
visual cortex of adult##4##4##(1992-10#1)(1993-12#1)(1995-12#2)
visual cortex of##6##3##(1992-10#1)(1993-12#1)(1995-12#2)(2008-11#1)(2008-8#1)
visual cortex with##2##3##(1993-12#1)(2008-7#1)
visual cortex##61##2##(1990-5#1)(1990-8#3)(1992-10#2)(1993-12#3)(1994-3#1)(1994-8#5)(1995-11#5)(1995-12#6)(1996-2#1)(1997-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#7)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#4)(2012-2#6)(2013-8#1)
visual cortical areas##2##3##(2008-8#1)(2009-10#1)
visual cortical##6##2##(1991-5#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)
visual cue##5##2##(2008-1#1)(2008-8#3)(2010-5#1)
visual cueing for##2##3##(2007-6#2)
visual cues##6##2##(1991-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)
visual culture##2##2##(2012-2#2)
visual deprivation##4##2##(1994-1#1)(2010-9#3)
visual detection##2##2##(1995-12#1)(2009-6#1)
visual direction and orientation disparity##2##5##(2008-9#2)
visual discrimination and##2##3##(1993-6#1)(1996-2#1)
visual discrimination##4##2##(1991-2#1)(1993-6#1)(1995-12#1)(1996-2#1)
visual discriminations##3##2##(1993-12#3)
visual display##5##2##(2008-11#1)(2008-6#2)(2013-1#2)
visual disturbances##8##2##(2008-8#1)(2011-2#5)(2012-3#2)
visual dyslexia##3##2##(2012-1#3)
visual environment##3##2##(1995-5#1)(2008-2#1)(2008-9#1)
visual errors##2##2##(2012-1#2)
visual estimation of##2##3##(2008-10#2)
visual estimation##3##2##(2008-10#3)
visual evaluation##9##2##(1994-11#1)(1996-12#1)(2007-10#5)(2008-2#1)(2008-5#1)
visual evoked potentials##2##3##(1990-3#1)(1996-2#1)
visual evoked##4##2##(1990-3#1)(1995-12#2)(1996-2#1)
visual feedback##2##2##(2008-6#1)(2009-12#1)
visual field and##4##3##(2011-2#4)
visual field damage in children##2##5##(2011-2#2)
visual field defects in##3##4##(1993-2#1)(2008-7#2)
visual field defects##5##3##(1993-2#1)(2007-10#1)(2008-7#2)(2009-2#1)
visual field in##2##3##(1992-6#1)(2011-2#1)
visual field##31##2##(1992-6#2)(1993-2#1)(1996-2#5)(2007-10#2)(2008-1#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-2#1)(2011-2#13)(2012-3#1)
visual fields##2##2##(2011-2#1)(2013-1#1)
visual function##5##2##(2011-2#1)(2011-7#1)(2013-1#3)
visual guidance##4##2##(2007-12#1)(2008-1#2)(2010-12#1)
visual hallucinations##6##2##(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
visual identity##3##2##(2008-12#3)
visual imagery##3##2##(2008-11#3)
visual impairment in childhood##3##4##(2011-2#3)
visual impairment##8##2##(2008-10#1)(2011-2#5)(2012-3#1)(2013-8#1)
visual impression of##2##3##(1995-12#1)(2012-2#1)
visual improvement##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
visual information can##2##3##(1995-11#1)(2008-1#1)
visual information processing##3##3##(1996-2#1)(2007-8#1)(2008-11#1)
visual information##12##2##(1995-11#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-3#1)
visual input and##2##3##(2008-6#1)(2010-10#1)
visual input##12##2##(1991-2#7)(1993-12#1)(2008-6#1)(2010-10#1)(2012-2#1)(2013-8#1)
visual inspection##8##2##(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-8#1)(2012-2#1)
visual latencies##2##2##(1996-2#2)
visual learning##4##2##(2008-11#1)(2008-8#2)(2012-12#1)
visual loss and##2##3##(2013-7#2)
visual loss in##2##3##(2008-7#1)(2012-2#1)
visual loss##13##2##(2007-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
visual memory of##2##3##(2008-6#2)
visual memory performance##2##3##(2010-7#2)
visual memory##7##2##(1993-12#1)(2008-11#1)(2008-6#2)(2009-6#1)(2010-7#2)
visual modality##2##2##(2008-8#2)
visual motion detection##2##3##(2011-2#2)
visual motion##4##2##(2011-2#2)(2012-3#1)(2013-8#1)
visual naming activated##2##3##(1996-2#2)
visual naming##3##2##(1996-2#3)
visual obscurations and headache##2##4##(2008-7#2)
visual observation##2##2##(2008-10#1)(2008-11#1)
visual observations##3##2##(1992-3#1)(2008-11#1)(2008-3#1)
visual optical##2##2##(2008-3#2)
visual or##2##2##(2008-10#1)(2008-6#1)
visual outcome##2##2##(2011-2#2)
visual pattern##2##2##(1991-2#1)(2012-2#1)
visual perception and##2##3##(2007-8#1)(2008-3#1)
visual perception of##2##3##(2008-2#1)(2009-10#1)
visual perception##9##2##(1994-8#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
visual pigment##3##2##(1990-12#1)(1991-9#1)(1997-4#1)
visual pigments##2##2##(1990-12#2)
visual preferences##2##2##(2008-10#1)(2008-8#1)
visual presentation##3##2##(2008-3#1)(2009-4#1)(2010-7#1)
visual processing##5##2##(1995-5#1)(2008-1#1)(2008-11#1)(2012-2#2)
visual projection##2##2##(1993-12#1)(2008-3#1)
visual quality##3##2##(2008-3#2)(2008-6#1)
visual ratings##2##2##(1991-12#1)(2008-10#1)
visual reactions and critical flicker frequency##2##6##(2012-1#2)
visual responses of##2##3##(2008-8#2)
visual responses##3##2##(2008-1#1)(2008-8#2)
visual search##4##2##(2009-10#1)(2009-2#1)(2012-2#1)(2012-3#1)
visual space to##2##3##(1995-11#1)(2008-3#1)
visual stimuli and##2##3##(2008-5#1)(2008-6#1)
visual stimuli may##2##3##(1993-6#1)(1996-5#1)
visual stimuli##13##2##(1992-10#1)(1993-6#5)(1996-5#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)
visual stimulus##8##2##(1991-12#1)(1992-11#2)(1995-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-10#1)
visual symptoms resolved##2##3##(2011-2#1)(2012-3#1)
visual symptoms##8##2##(2008-10#5)(2011-2#1)(2012-3#1)(2013-8#1)
visual system##22##2##(1993-12#1)(1994-8#1)(1995-5#7)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-12#2)(2011-2#1)
visual systems##2##2##(1991-2#1)(2008-3#1)
visual target##4##2##(1994-8#1)(1995-5#2)(2009-8#1)
visual targets##2##2##(1995-5#1)(2009-8#1)
visual task##2##2##(2013-8#2)
visual textures##2##2##(1994-8#2)
visual vertical##2##2##(2013-1#2)
visual##678##1##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#6)(1991-11#1)(1991-12#3)(1991-2#17)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#3)(1992-11#5)(1992-12#2)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#12)(1993-2#2)(1993-6#6)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#11)(1995-1#1)(1995-11#10)(1995-12#14)(1995-2#1)(1995-5#13)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#24)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#9)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#7)(2007-9#5)(2008-1#15)(2008-10#59)(2008-11#34)(2008-12#6)(2008-2#4)(2008-3#22)(2008-4#1)(2008-5#11)(2008-6#18)(2008-7#20)(2008-8#31)(2008-9#18)(2009-10#8)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#3)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#8)(2011-1#9)(2011-2#68)(2011-7#2)(2012-1#9)(2012-12#2)(2012-2#24)(2012-3#16)(2013-1#22)(2013-7#6)(2013-8#22)
visual-vestibular integration##2##2##(1991-2#2)
visualisation and##2##2##(2008-10#1)(2011-3#1)
visualisation of the##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
visualisation of##9##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2011-3#1)(2012-2#1)
visualisation##17##1##(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#2)(2011-3#3)(2012-2#1)
visualise##8##1##(1996-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#3)
visualised in##3##2##(1996-5#1)(2008-11#1)(2012-2#1)
visualised##6##1##(1996-5#1)(2007-8#1)(2008-11#2)(2008-8#1)(2012-2#1)
visualization and analysis##5##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)
visualization and##14##2##(2007-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-5#1)(2010-8#1)(2012-12#1)
visualization as##2##2##(2008-3#1)(2008-9#1)
visualization by##2##2##(1995-6#1)(2007-12#1)
visualization of a##2##3##(2008-2#1)(2011-2#1)
visualization of cardiac##2##3##(2010-6#1)(2010-8#1)
visualization of complex##3##3##(2008-7#1)(2011-2#1)(2011-7#1)
visualization of natural gas leaks##2##5##(2008-2#2)
visualization of protein##2##3##(2008-4#2)
visualization of the data##2##4##(2008-10#1)(2008-6#1)
visualization of the##24##3##(1992-9#1)(1994-3#1)(1995-12#1)(1996-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)
visualization of this##2##3##(2006-12#1)(2008-11#1)
visualization of three-dimensional##2##3##(2008-3#1)(2008-6#1)
visualization of##85##2##(1991-12#1)(1992-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#8)(2008-3#6)(2008-4#9)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-7#2)(2012-2#2)
visualization on the##2##3##(1992-12#1)(2008-6#1)
visualization technique##2##2##(2008-3#1)(2013-8#1)
visualization techniques##3##2##(2008-3#1)(2008-6#2)
visualization tools##2##2##(2008-4#1)(2010-2#1)
visualization##156##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#5)(2008-2#8)(2008-3#10)(2008-4#18)(2008-5#2)(2008-6#14)(2008-7#8)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#7)(2011-7#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
visualizations##4##1##(2008-4#1)(2008-6#2)(2010-12#1)
visualize and quantify##2##3##(2012-2#2)
visualize and##4##2##(2008-11#1)(2008-6#1)(2012-2#2)
visualize the##16##2##(1990-5#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
visualize##46##1##(1990-10#1)(1990-12#1)(1990-5#1)(1994-5#1)(1995-11#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#2)
visualized and##3##2##(1993-11#1)(2007-12#1)(2010-8#1)
visualized as##3##2##(1996-5#1)(2008-10#1)(2010-5#1)
visualized by confocal microscopy##2##4##(2008-10#1)(2008-7#1)
visualized by digital infrared thermography##2##5##(2008-10#2)
visualized by silver staining##2##4##(1992-8#1)(1995-12#1)
visualized by staining##2##3##(2008-8#1)(2013-1#1)
visualized by##26##2##(1992-8#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-3#1)(2011-2#2)(2013-1#1)
visualized from##2##2##(2008-11#1)(2008-3#1)
visualized in##14##2##(1990-7#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-4#1)(2012-2#2)
visualized on the##2##3##(2008-10#1)(2008-7#1)
visualized on##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
visualized the##2##2##(2008-10#1)(2011-1#1)
visualized using##5##2##(1992-8#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-9#1)
visualized with##3##2##(1996-12#1)(2008-1#1)(2008-10#1)
visualized within##2##2##(2007-12#1)(2008-9#1)
visualized##84##1##(1990-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1994-11#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#8)(2009-11#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#3)
visualizes##2##1##(1997-8#1)(2008-3#1)
visualizing the##5##2##(1996-1#1)(2008-10#3)(2008-2#1)
visualizing##23##1##(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#2)
visually and##4##2##(2007-10#1)(2008-10#1)(2008-5#2)
visually evoked potential##2##3##(1992-8#2)
visually for##2##2##(2008-10#2)
visually presented##2##2##(1990-8#1)(1995-2#1)
visually##45##1##(1990-8#1)(1992-8#2)(1993-12#1)(1993-8#1)(1995-2#1)(1995-5#2)(2007-10#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
visuals##2##1##(2009-9#1)(2013-1#1)
visuo-motor coordination##4##2##(2008-7#4)
visuo-motor##5##1##(2008-1#1)(2008-7#4)
visuo-spatial and##2##2##(2008-7#1)(2011-1#1)
visuo-spatial memory##2##2##(1997-2#2)
visuo-spatial##5##1##(1995-12#1)(1997-2#2)(2008-7#1)(2011-1#1)
visuomotor##4##1##(1996-2#1)(2007-8#3)
visuospatial skills##2##2##(2008-6#2)
visuospatial##7##1##(2008-11#1)(2008-6#2)(2008-7#1)(2009-10#2)(2009-6#1)
vital and##2##2##(1993-3#1)(2007-8#1)
vital calves##2##2##(1994-7#2)
vital capacity in supine##2##4##(2012-3#2)
vital capacity##12##2##(1997-3#1)(2007-2#1)(2008-1#2)(2008-7#1)(2012-2#3)(2012-3#4)
vital clinical##2##2##(1996-3#1)(2008-11#1)
vital components##2##2##(1990-5#1)(2012-2#1)
vital dyes##2##2##(2008-11#1)(2008-9#1)
vital events##2##2##(1993-2#1)(2013-1#1)
vital exhaustion##3##2##(2008-11#3)
vital for##11##2##(1994-3#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-5#1)(2013-8#1)
vital if##2##2##(1994-7#1)(2008-12#1)
vital in##2##2##(2012-1#1)(2012-12#1)
vital link##2##2##(1997-3#1)(2008-11#1)
vital organs##3##2##(2010-12#1)(2010-8#1)(2012-2#1)
vital records##4##2##(2012-12#4)
vital registration##2##2##(2008-11#1)(2012-12#1)
vital role##18##2##(1990-11#1)(1990-12#2)(1993-1#1)(1993-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
vital signs##14##2##(1993-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-8#2)(2012-3#1)(2013-8#1)
vital statistics systems##5##3##(2012-12#5)
vital statistics##13##2##(1991-12#1)(1992-6#1)(1997-3#1)(2012-12#9)(2013-1#1)
vital status##2##2##(2008-7#1)(2012-12#1)
vital structures##2##2##(2007-12#1)(2012-2#1)
vital systems##2##2##(1996-12#1)(2007-8#1)
vital that the##2##3##(2008-11#1)(2013-1#1)
vital that##7##2##(1997-1#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#3)
vital to the success of##2##5##(2012-2#1)(2013-8#1)
vital to the##10##3##(1993-9#1)(1995-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-8#1)
vital to their##2##3##(1996-2#1)(2008-5#1)
vital to##27##2##(1991-1#1)(1993-9#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
vital##219##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#4)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#17)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#1)(2008-9#7)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#22)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#8)
vitality##18##1##(1990-3#1)(1990-9#1)(1991-5#2)(1994-7#2)(2007-11#2)(2008-1#1)(2008-11#2)(2011-2#3)(2012-12#1)(2013-1#3)
vitally##3##1##(1991-12#1)(1993-2#1)(2008-4#1)
vitamin A acetate##7##3##(2008-11#7)
vitamin A deficiency among##2##4##(1991-8#2)
vitamin A deficiency and##2##4##(2007-11#2)
vitamin A deficiency##14##3##(1991-8#6)(1992-9#2)(2007-11#2)(2012-1#4)
vitamin A derivatives##2##3##(2008-4#1)(2009-8#1)
vitamin A in##2##3##(1992-9#1)(2012-1#1)
vitamin A intake##3##3##(1996-3#1)(2011-1#2)
vitamin A supplementation##2##3##(2007-11#1)(2010-5#1)
vitamin A##47##2##(1991-8#6)(1992-8#1)(1992-9#3)(1993-3#1)(1993-9#1)(1996-3#1)(1997-8#1)(2007-11#7)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#4)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#8)
vitamin A)##2##2##(2007-11#2)
vitamin A-deficient##2##2##(1992-9#1)(2012-1#1)
vitamin B(12##2##2##(2008-11#2)
vitamin B(12) and##2##3##(2008-10#1)(2008-3#1)
vitamin B(12) deficiency##2##3##(2008-7#2)
vitamin B(12) did not promote##2##5##(2008-11#2)
vitamin B(12)##13##2##(2007-10#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-7#2)(2011-1#3)
vitamin B(6)##4##2##(2007-10#1)(2008-3#2)(2008-8#1)
vitamin B12 and##2##3##(1993-12#1)(2010-1#1)
vitamin B12 concentration##2##3##(1990-3#2)
vitamin B12 deficiency##8##3##(1990-3#5)(1993-12#1)(1995-11#1)(2007-9#1)
vitamin B12 levels##4##3##(1990-3#2)(1993-12#1)(2007-1#1)
vitamin B12 or B-complex##2##4##(2010-1#2)
vitamin B12 or##3##3##(1992-9#1)(2010-1#2)
vitamin B12 routine fortification##2##4##(2010-1#2)
vitamin B12 status##2##3##(1993-12#1)(2012-3#1)
vitamin B12##45##2##(1990-3#13)(1992-9#2)(1993-12#11)(1995-11#3)(2007-1#1)(2007-9#1)(2008-8#1)(2010-1#10)(2012-3#1)(2013-8#2)
vitamin B6##8##2##(1991-2#1)(1991-5#2)(1992-9#2)(2013-1#3)
vitamin C administration##4##3##(1997-3#1)(2011-1#3)
vitamin C and E##2##4##(2008-5#1)(2010-11#1)
vitamin C and##6##3##(1992-9#1)(2008-5#2)(2010-11#1)(2010-6#1)(2010-7#1)
vitamin C as##2##3##(1992-9#1)(2008-5#1)
vitamin C is##2##3##(1992-9#1)(2012-2#1)
vitamin C level##2##3##(1992-9#1)(2011-1#1)
vitamin C levels in different brain areas of##2##8##(2011-1#2)
vitamin C levels in##3##4##(2011-1#3)
vitamin C levels##5##3##(1992-9#1)(2011-1#4)
vitamin C or E##2##4##(1992-9#1)(2008-1#1)
vitamin C supplementation##5##3##(1992-9#1)(1996-12#2)(1997-3#1)(2011-2#1)
vitamin C tablet##4##3##(2008-10#4)
vitamin C tablets##2##3##(2008-10#2)
vitamin C##69##2##(1992-9#12)(1993-9#1)(1996-12#2)(1997-3#4)(1997-4#1)(1997-8#1)(2007-1#1)(2008-1#2)(2008-10#15)(2008-12#1)(2008-5#6)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#13)(2011-2#1)(2012-12#1)(2012-2#4)
vitamin D and thyroid hormone##2##5##(1993-3#2)
vitamin D and##6##3##(1990-11#1)(1993-3#2)(2008-10#1)(2010-10#1)(2012-3#1)
vitamin D deficiency has been##2##5##(2011-2#1)(2013-1#1)
vitamin D deficiency has##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
vitamin D deficiency in##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
vitamin D deficiency rickets##2##4##(2011-1#2)
vitamin D deficiency was##2##4##(2011-2#1)(2012-12#1)
vitamin D deficiency##18##3##(2008-11#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
vitamin D endocrine system##3##4##(2008-4#2)(2008-7#1)
vitamin D in##2##3##(1997-6#1)(2012-2#1)
vitamin D insufficiency and##3##4##(1993-11#1)(2008-7#1)(2012-3#1)
vitamin D levels##13##3##(2008-1#1)(2012-12#5)(2012-3#3)(2013-1#4)
vitamin D receptor (VDR)##4##4##(1995-2#1)(2008-4#1)(2008-7#1)(2012-12#1)
vitamin D receptor##7##3##(1995-2#2)(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
vitamin D response element (VDRE)##2##5##(1992-12#1)(2012-12#1)
vitamin D response##4##3##(1992-12#1)(1995-8#1)(2008-1#1)(2012-12#1)
vitamin D status with##2##4##(2012-2#1)(2013-7#1)
vitamin D status##5##3##(2012-2#2)(2013-7#3)
vitamin D synthesis##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
vitamin D treatment##2##3##(2010-10#1)(2011-1#1)
vitamin D was##2##3##(1991-11#1)(2012-3#1)
vitamin D were##3##3##(1992-1#1)(2013-1#2)
vitamin D##123##2##(1990-11#1)(1991-11#2)(1991-5#1)(1992-1#5)(1992-12#1)(1993-11#4)(1993-3#3)(1994-3#4)(1995-2#3)(1995-8#2)(1997-6#1)(2008-1#8)(2008-10#4)(2008-11#1)(2008-4#7)(2008-7#6)(2008-8#1)(2009-12#1)(2010-10#2)(2010-3#2)(2011-1#8)(2011-2#3)(2012-12#10)(2012-2#11)(2012-3#16)(2013-1#12)(2013-7#3)(2013-8#1)
vitamin D(2) into##3##3##(2008-10#3)
vitamin D(2)##8##2##(2008-10#8)
vitamin D(3)##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
vitamin D-fortified doogh##2##3##(2013-7#2)
vitamin D/250 mL)##3##2##(2013-7#3)
vitamin D3##10##2##(1991-12#1)(1991-5#2)(1993-11#1)(1993-3#1)(1994-3#1)(1996-5#1)(1997-5#1)(1997-7#2)
vitamin E analogue##2##3##(1995-6#1)(2013-1#1)
vitamin E and##2##3##(1994-5#1)(2011-2#1)
vitamin E deficiency##3##3##(1994-5#3)
vitamin E deficient##3##3##(1994-5#3)
vitamin E in the##2##4##(1994-6#1)(1995-6#1)
vitamin E in##10##3##(1992-9#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-5#1)
vitamin E is##2##3##(1992-9#1)(1996-3#1)
vitamin E levels##2##3##(1993-2#1)(2008-7#1)
vitamin E on##4##3##(1990-2#1)(1992-9#1)(1993-6#1)(2011-1#1)
vitamin E sufficient##7##3##(1994-5#7)
vitamin E to##2##3##(1991-12#1)(1993-6#1)
vitamin E was##2##3##(1990-8#2)
vitamin E##79##2##(1990-2#2)(1990-8#3)(1991-12#3)(1991-2#2)(1991-9#1)(1992-9#8)(1993-2#1)(1993-6#4)(1994-5#15)(1994-6#1)(1995-12#1)(1995-6#3)(1996-3#5)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#8)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#7)
vitamin E-modified##8##2##(2007-7#4)(2008-1#4)
vitamin K deficiency in##2##4##(1992-12#1)(1996-6#1)
vitamin K deficiency##3##3##(1992-12#1)(1996-6#1)(1997-7#1)
vitamin K##8##2##(1992-12#1)(1996-6#1)(1997-7#2)(2008-7#1)(2009-11#3)
vitamin K(1)##4##2##(2008-10#4)
vitamin K-dependent##5##2##(1990-5#1)(1992-12#2)(1992-9#1)(2009-11#1)
vitamin K1##2##2##(1992-11#1)(1992-12#1)
vitamin K3##6##2##(1991-12#4)(2008-10#2)
vitamin and mineral supplements##2##4##(2008-11#2)
vitamin and mineral##6##3##(1990-3#2)(1997-3#2)(2008-11#2)
vitamin and##10##2##(1990-3#2)(1997-3#2)(2008-10#3)(2008-11#2)(2011-2#1)
vitamin d##3##2##(2008-4#1)(2011-1#2)
vitamin deficiencies##2##2##(1997-8#1)(2010-12#1)
vitamin pills##4##2##(1996-8#1)(2008-10#3)
vitamin status##2##2##(1992-9#2)
vitamin supplements##4##2##(1992-9#1)(2008-11#1)(2013-1#2)
vitamin tablets##5##2##(2008-10#5)
vitamin##528##1##(1990-11#2)(1990-2#2)(1990-3#16)(1990-5#1)(1990-8#4)(1991-11#2)(1991-12#9)(1991-2#4)(1991-5#6)(1991-8#6)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#5)(1992-8#1)(1992-9#35)(1993-11#5)(1993-12#11)(1993-2#2)(1993-3#5)(1993-6#5)(1993-9#2)(1994-3#5)(1994-5#15)(1994-6#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-6#4)(1995-8#2)(1996-12#2)(1996-3#6)(1996-5#1)(1996-6#2)(1996-8#1)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#3)(2007-1#2)(2007-10#2)(2007-11#9)(2007-7#4)(2007-9#1)(2008-1#17)(2008-10#58)(2008-11#19)(2008-12#4)(2008-3#5)(2008-4#9)(2008-5#25)(2008-7#12)(2008-8#4)(2009-11#5)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#10)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#32)(2011-2#7)(2012-1#10)(2012-12#12)(2012-2#16)(2012-3#18)(2013-1#25)(2013-7#8)(2013-8#3)
vitamins A and E##3##4##(2007-7#2)(2008-10#1)
vitamins A##4##2##(2007-7#2)(2008-10#1)(2008-11#1)
vitamins C and E##3##4##(1992-9#2)(2008-5#1)
vitamins C##4##2##(1992-9#3)(2008-5#1)
vitamins E and##2##3##(1992-9#1)(2008-11#1)
vitamins and minerals##3##3##(2010-6#1)(2011-2#1)(2013-8#1)
vitamins and minerals)##2##3##(2011-1#1)(2013-8#1)
vitamins and##12##2##(1992-9#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#2)
vitamins in pharmaceutical preparations##2##4##(2008-10#2)
vitamins in##5##2##(1992-9#1)(2008-10#3)(2008-5#1)
vitamins on##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
vitamins was##2##2##(2008-10#2)
vitamins were##2##2##(2008-5#1)(2009-8#1)
vitamins##72##1##(1990-8#1)(1992-9#12)(1994-9#1)(1995-6#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-7#2)(2008-10#22)(2008-11#6)(2008-12#2)(2008-3#2)(2008-5#8)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
vitegnus##2##1##(2008-12#2)
vitellarium##2##1##(2007-12#2)
vitellin cleavage products##5##3##(2007-12#5)
vitellin##8##1##(2007-12#6)(2008-6#2)
vitelline coat of##3##3##(1993-6#3)
vitelline coat##5##2##(1993-6#4)(2008-6#1)
vitelline envelope and the chorion##2##5##(2008-12#2)
vitelline envelope and##3##3##(2007-12#1)(2008-12#2)
vitelline envelope##5##2##(1994-5#1)(2007-12#1)(2008-12#3)
vitelline##13##1##(1993-6#4)(1994-5#2)(2007-12#2)(2008-10#1)(2008-12#3)(2008-6#1)
vitellogenesis##11##1##(2007-12#4)(2008-12#1)(2008-6#2)(2008-7#2)(2008-8#2)
vitellogenic stage##2##2##(2008-6#2)
vitellogenic##4##1##(2008-6#3)(2010-5#1)
vitellogenin in##2##2##(2008-6#2)
vitellogenin mRNA levels##2##3##(2008-6#2)
vitellogenin receptor##3##2##(1995-2#3)
vitellogenin using##2##2##(2008-10#2)
vitellogenin was##2##2##(2008-6#1)(2010-4#1)
vitellogenin##21##1##(1992-6#2)(1995-2#3)(2008-10#4)(2008-6#7)(2010-4#3)(2010-5#2)
vitellogenins##3##1##(1990-2#2)(1995-2#1)
vitians strains##6##2##(2008-10#6)
vitians##11##1##(2008-10#11)
viticola DNA in##2##3##(2008-10#2)
viticola DNA##4##2##(2008-10#4)
viticola and##2##2##(2008-10#2)
viticola was##2##2##(2008-10#2)
viticola##30##1##(2008-10#30)
vitiligo and##3##2##(1996-1#1)(2007-7#2)
vitiligo##25##1##(1996-1#1)(1996-3#1)(1997-8#1)(2007-5#2)(2007-7#9)(2007-8#1)(2008-8#1)(2009-1#1)(2011-2#1)(2013-1#7)
vitiligo-like depigmentation##4##2##(2010-6#4)
vitis##12##1##(2008-10#12)
vitrectomy##4##1##(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
vitreomacular##3##1##(2011-7#1)(2013-1#2)
vitreoretinal##2##1##(2011-2#1)(2011-7#1)
vitreous and##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
vitreous carbon (RVC)##2##3##(2008-10#2)
vitreous carbon##5##2##(2008-10#5)
vitreous silica##3##2##(2008-2#1)(2008-3#2)
vitreous##22##1##(2008-1#2)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#3)(2009-3#2)(2011-1#1)(2011-2#2)(2013-1#1)
vitrification##4##1##(2008-10#2)(2012-3#1)(2013-8#1)
vitrified wastes##2##2##(2008-10#2)
vitrified##4##1##(1991-3#1)(2008-10#3)
vitrinus##2##1##(1996-12#2)
vitripennis##3##1##(2008-6#3)
vitro Evaluation of##3##3##(2008-10#1)(2010-5#1)(2012-2#1)
vitro activities of##4##3##(1997-7#1)(2008-7#1)(2008-8#1)(2011-3#1)
vitro activities##5##2##(1997-7#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)
vitro activity of##6##3##(1994-11#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)
vitro activity##17##2##(1990-6#1)(1993-1#2)(1994-11#1)(1995-3#2)(1995-5#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
vitro analysis##6##2##(1995-2#1)(2008-1#3)(2008-10#1)(2010-7#1)
vitro and in vivo data##4##5##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
vitro and in vivo determinations of sun protection factors##2##9##(2008-5#2)
vitro and in vivo determinations##3##5##(2008-5#3)
vitro and in vivo evaluation##3##5##(2008-5#1)(2011-2#1)(2012-2#1)
vitro and in vivo experiments##2##5##(2007-8#1)(2010-2#1)
vitro and in vivo results##3##5##(1991-2#1)(2008-5#1)(2012-12#1)
vitro and in vivo studies##7##5##(1992-11#1)(1993-5#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
vitro and in vivo##139##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#4)(1995-3#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#19)(2008-7#6)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-11#2)(2010-2#4)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
vitro and in##160##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-12#4)(1995-3#2)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-8#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#9)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#20)(2008-7#6)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2010-11#3)(2010-12#1)(2010-2#4)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
vitro and##228##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-12#5)(1995-2#2)(1995-3#5)(1995-6#2)(1996-12#4)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#15)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#23)(2008-7#7)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#4)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
vitro andin vivo##5##3##(2008-11#2)(2008-8#3)
vitro andin##6##2##(2008-11#2)(2008-8#4)
vitro anergized T##2##3##(2008-11#2)
vitro antagonistic activity##2##3##(2008-12#2)
vitro antifungal resistance in##2##4##(2008-5#2)
vitro antifungal susceptibility of clinical isolates##2##6##(2008-5#2)
vitro antifungal susceptibility##5##3##(2008-5#5)
vitro antifungal##12##2##(2008-10#1)(2008-5#9)(2010-5#2)
vitro antimicrobial activity of##4##4##(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
vitro antimicrobial##6##2##(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
vitro antioxidant activity and in vivo photoprotective effect of a##2##10##(2008-5#2)
vitro antioxidant activity and##3##4##(2008-10#1)(2008-5#2)
vitro antioxidant activity of##2##4##(1994-9#1)(2008-10#1)
vitro antioxidant activity##6##3##(1994-9#1)(2008-10#2)(2008-5#2)(2010-5#1)
vitro antioxidant##7##2##(1994-9#1)(2008-10#2)(2008-5#2)(2010-5#1)(2011-1#1)
vitro as well##4##3##(1992-9#1)(2008-11#1)(2009-5#1)(2012-3#1)
vitro as##7##2##(1991-6#1)(1992-9#1)(1995-2#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-3#1)
vitro assay systems##3##3##(2008-11#1)(2008-4#1)(2008-7#1)
vitro assay##12##2##(1990-12#1)(1992-9#1)(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
vitro assays##16##2##(1995-2#1)(1995-3#1)(1997-3#1)(2008-10#8)(2008-4#1)(2008-9#1)(2009-4#1)(2010-4#1)(2013-1#1)
vitro assessment of##2##3##(2008-5#2)
vitro assessment##3##2##(2008-11#1)(2008-5#2)
vitro bioactivity##2##2##(1994-11#1)(2009-7#1)
vitro bioassays##2##2##(1994-9#1)(2008-8#1)
vitro cell culture##2##3##(1992-2#1)(2008-11#1)
vitro cell##5##2##(1992-2#1)(2008-11#2)(2008-7#1)(2008-9#1)
vitro characterization of##2##3##(2008-10#1)(2013-1#1)
vitro comparison of##3##3##(2008-5#2)(2011-3#1)
vitro comparison##5##2##(1991-3#1)(2008-5#2)(2009-4#1)(2011-3#1)
vitro conditions##6##2##(1993-2#1)(1996-5#1)(2008-11#2)(2008-5#1)(2011-1#1)
vitro culture of human##2##4##(2008-11#2)
vitro culture##13##2##(1995-3#2)(2006-6#1)(2008-11#4)(2008-2#1)(2008-9#2)(2009-11#1)(2009-6#1)(2013-1#1)
vitro cultured##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2012-2#1)
vitro cytotoxic##5##2##(1992-3#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
vitro development##6##2##(1996-2#2)(2008-11#2)(2009-12#1)(2012-3#1)
vitro differentiation##6##2##(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)
vitro dilution##2##2##(1993-12#2)
vitro drug interaction of glimepride with atorvastatin and rosuvastatin##2##9##(2011-1#2)
vitro drug##10##2##(2010-3#4)(2010-5#2)(2011-1#3)(2012-2#1)
vitro effect of##3##3##(1991-12#1)(1993-12#1)(1996-11#1)
vitro effects of##8##3##(1993-9#1)(1995-12#2)(1995-9#1)(1997-1#1)(1997-4#1)(2011-1#1)(2013-1#1)
vitro effects##11##2##(1993-9#1)(1995-12#2)(1995-5#2)(1995-9#1)(1997-1#1)(1997-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
vitro efficacy##4##2##(2008-12#1)(2008-5#3)
vitro evidence##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
vitro experiments##16##2##(1991-5#1)(1991-9#1)(1993-12#1)(1994-12#1)(1994-5#1)(1997-4#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2010-11#1)
vitro expression##4##2##(1995-8#1)(2007-7#1)(2008-10#2)
vitro for##13##2##(1991-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#2)
vitro functional assays##2##3##(1993-8#1)(2008-8#1)
vitro gene##2##2##(1995-2#1)(2008-7#1)
vitro glycation##2##2##(1991-12#1)(1992-12#1)
vitro growth##10##2##(1990-3#1)(1992-8#2)(1993-11#1)(1993-8#1)(2008-10#4)(2009-8#1)
vitro immunization (IVI)##2##3##(2008-11#2)
vitro immunization##15##2##(2008-11#15)
vitro in the presence##3##4##(2008-4#1)(2008-8#1)(2012-2#1)
vitro in the##6##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
vitro in##30##2##(1990-5#1)(1991-2#2)(1991-6#1)(1992-3#1)(1994-8#2)(1995-12#2)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-1#1)(2012-2#2)
vitro incubation of##3##3##(1990-2#1)(1991-2#1)(1994-11#1)
vitro incubation##4##2##(1990-2#1)(1991-2#1)(1994-11#1)(2008-10#1)
vitro invasion##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
vitro metabolism of##3##3##(1990-6#2)(1993-11#1)
vitro metabolism##4##2##(1990-11#1)(1990-6#2)(1993-11#1)
vitro models of##3##3##(1992-12#1)(2008-4#2)
vitro models to##2##3##(2008-11#1)(2011-1#1)
vitro models##16##2##(1992-12#1)(1994-9#1)(2008-11#2)(2008-4#3)(2008-5#5)(2008-7#2)(2011-1#1)(2012-1#1)
vitro motility##2##2##(1995-2#1)(1997-7#1)
vitro mycelial growth of##2##4##(2008-10#2)
vitro mycelial growth##3##3##(2008-10#3)
vitro phosphorylation of the##3##4##(1992-3#1)(1995-6#1)(1997-2#1)
vitro phosphorylation of##5##3##(1992-3#1)(1995-6#1)(1997-2#3)
vitro phosphorylation##9##2##(1992-3#1)(1993-3#1)(1993-8#1)(1995-5#1)(1995-6#1)(1997-2#4)
vitro photodynamic##2##2##(2012-3#2)
vitro platelet##2##2##(1994-2#1)(1997-7#1)
vitro production of##5##3##(1994-12#1)(1994-8#1)(2008-10#1)(2008-11#2)
vitro proliferative response of##3##4##(1991-1#1)(2008-7#2)
vitro proliferative response##4##3##(1991-1#1)(2008-7#3)
vitro protein##5##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(2011-2#1)
vitro release##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
vitro results##2##2##(1994-6#1)(2008-6#1)
vitro selection of##2##3##(2008-4#1)(2010-5#1)
vitro selection using modified##2##4##(2008-4#2)
vitro selection using##3##3##(2008-4#3)
vitro selection##14##2##(1990-8#1)(1997-6#1)(2008-11#1)(2008-4#7)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
vitro skin##5##2##(2008-5#5)
vitro splicing##2##2##(1993-12#2)
vitro stimulation##3##2##(2008-5#2)(2011-2#1)
vitro studies demonstrated that##5##4##(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
vitro studies demonstrated##6##3##(1994-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
vitro studies have shown that##4##5##(1992-12#1)(1997-1#1)(2008-5#1)(2009-11#1)
vitro studies have shown##5##4##(1992-12#1)(1997-1#1)(2008-5#2)(2009-11#1)
vitro studies have##7##3##(1992-12#1)(1997-1#1)(2008-5#3)(2009-11#1)(2013-1#1)
vitro studies showed that##2##4##(1992-12#1)(1994-8#1)
vitro studies##46##2##(1991-9#1)(1992-11#1)(1992-12#2)(1992-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#5)(2008-5#5)(2009-1#1)(2009-11#2)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
vitro study##23##2##(1990-5#2)(1992-8#1)(1993-12#1)(1994-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#7)(2013-8#1)
vitro susceptibility of##2##3##(1991-8#1)(2008-5#1)
vitro susceptibility##7##2##(1991-8#1)(2007-7#1)(2008-5#3)(2011-2#2)
vitro system##30##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-9#3)(1992-8#1)(1993-3#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-3#1)(1996-12#2)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
vitro testing##8##2##(1994-2#1)(2008-5#4)(2008-8#1)(2009-7#1)(2011-2#1)
vitro tests##9##2##(1992-9#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-7#1)(2012-3#1)
vitro transcription and##3##3##(1990-11#1)(1990-12#1)(2008-11#1)
vitro transcription##17##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-9#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#3)
vitro translated##3##2##(1991-7#1)(1993-8#1)(1995-2#1)
vitro translation of##5##3##(1995-2#1)(1995-6#1)(1997-3#1)(2008-9#2)
vitro translation##12##2##(1991-11#1)(1995-2#1)(1995-6#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-9#2)
vitro tyrosine##2##2##(1991-11#1)(1993-3#1)
vitro with##22##2##(1991-2#1)(1992-8#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-6#1)(2011-3#1)
vitro##2038##1##(1990-11#16)(1990-12#18)(1990-2#11)(1990-3#8)(1990-4#2)(1990-5#16)(1990-6#6)(1990-7#6)(1990-8#7)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#7)(1991-12#17)(1991-2#11)(1991-3#5)(1991-4#1)(1991-5#8)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#17)(1992-11#7)(1992-12#20)(1992-2#6)(1992-3#12)(1992-5#2)(1992-6#9)(1992-8#14)(1992-9#17)(1993-1#8)(1993-11#10)(1993-12#15)(1993-2#1)(1993-3#16)(1993-5#5)(1993-6#8)(1993-7#1)(1993-8#23)(1993-9#16)(1994-11#17)(1994-12#13)(1994-2#3)(1994-3#3)(1994-5#13)(1994-6#12)(1994-8#32)(1994-9#16)(1995-11#15)(1995-12#30)(1995-2#25)(1995-3#26)(1995-5#7)(1995-6#19)(1995-8#8)(1995-9#4)(1996-11#1)(1996-12#16)(1996-2#20)(1996-3#1)(1996-5#16)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#10)(1997-3#12)(1997-4#19)(1997-6#14)(1997-7#24)(1997-8#6)(2006-6#7)(2007-10#3)(2007-11#9)(2007-12#2)(2007-7#5)(2007-8#2)(2008-1#16)(2008-10#239)(2008-11#178)(2008-12#13)(2008-2#7)(2008-3#11)(2008-4#59)(2008-5#158)(2008-6#14)(2008-7#56)(2008-8#62)(2008-9#57)(2009-1#1)(2009-10#7)(2009-11#7)(2009-12#22)(2009-3#5)(2009-4#6)(2009-5#3)(2009-6#7)(2009-7#11)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#15)(2010-12#3)(2010-2#9)(2010-3#14)(2010-4#1)(2010-5#15)(2010-6#4)(2010-7#1)(2010-8#3)(2011-1#38)(2011-2#35)(2011-3#11)(2012-1#5)(2012-12#19)(2012-2#40)(2012-3#15)(2012-5#1)(2012-6#2)(2013-1#61)(2013-7#1)(2013-8#7)
vitro)##10##1##(1994-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2012-3#1)
vitronectin##4##1##(1995-2#1)(2008-11#3)
vitronectin-bound PAI-1 and latent PAI-1##2##5##(1995-8#2)
vittatus##3##1##(2008-6#3)
vivax infection##2##2##(2012-12#2)
vivax malaria in##3##3##(2012-12#3)
vivax malaria##16##2##(2007-2#3)(2007-7#1)(2011-2#2)(2012-12#9)(2012-2#1)
vivax##30##1##(2007-2#4)(2007-7#4)(2008-4#1)(2010-12#2)(2011-2#5)(2012-12#13)(2012-2#1)
vivax) malaria##2##2##(2007-2#1)(2011-2#1)
vivid##5##1##(2008-5#1)(2011-2#3)(2012-3#1)
viviparae and nymphs##2##3##(2008-9#2)
viviparity##5##1##(2008-8#2)(2010-3#3)
viviparous##5##1##(2007-12#2)(2008-5#1)(2008-7#1)(2008-8#1)
viviparum##3##1##(2009-5#3)
vivo DTI##2##2##(2008-11#2)
vivo activities##3##2##(1990-2#1)(1992-6#2)
vivo administration##3##2##(1990-12#1)(1994-6#1)(2012-2#1)
vivo and in vitro studies##7##5##(1991-9#1)(1992-11#1)(1994-8#1)(1995-9#1)(2009-1#1)(2010-5#1)(2013-1#1)
vivo and in vitro##76##4##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-5#3)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
vivo and in vivo##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
vivo and in##81##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-5#3)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
vivo and##114##2##(1990-11#2)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#3)(1994-8#4)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-3#1)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
vivo antifungal##2##2##(2008-11#2)
vivo approaches##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
vivo assay systems##2##3##(2008-11#1)(2008-4#1)
vivo assay##11##2##(1990-5#1)(1991-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)
vivo assays of##2##3##(2008-10#1)(2008-4#1)
vivo assays##11##2##(1995-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)
vivo biodistribution and##2##3##(2008-7#1)(2012-2#1)
vivo by using##2##3##(2008-8#1)(2008-9#1)
vivo by##18##2##(1990-12#1)(1991-9#1)(1994-6#1)(1994-8#1)(1995-3#2)(1996-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
vivo characterization of##2##3##(2008-5#1)(2011-2#1)
vivo confocal##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
vivo could##2##2##(1995-5#1)(2008-8#1)
vivo data##8##2##(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#1)
vivo delivery##3##2##(1995-2#1)(2008-4#1)(2008-8#1)
vivo effects of##7##3##(1995-12#2)(1995-3#2)(2008-10#2)(2008-11#1)
vivo effects##8##2##(1991-1#1)(1995-12#2)(1995-3#2)(2008-10#2)(2008-11#1)
vivo evaluation of##6##3##(1995-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
vivo evaluation##7##2##(1995-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
vivo experiment##2##2##(2008-8#2)
vivo experiments##10##2##(1993-8#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-5#3)(2010-11#1)(2010-2#1)
vivo expression##4##2##(1990-8#2)(1994-12#1)(2008-7#1)
vivo for##9##2##(1991-2#1)(1993-12#1)(1995-11#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
vivo gene transfer##5##3##(1994-5#3)(1997-4#2)
vivo gene##9##2##(1994-12#1)(1994-5#5)(1997-4#2)(2008-4#1)
vivo hepatic##2##2##(1991-1#1)(1997-4#1)
vivo histological##2##2##(2011-7#1)(2013-1#1)
vivo imaging of##3##3##(1994-11#1)(2007-11#1)(2008-5#1)
vivo imaging##11##2##(1994-11#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-7#1)
vivo in##30##2##(1990-11#1)(1990-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-9#1)(2010-12#1)(2011-1#1)
vivo incubation of the SC resulted in##2##7##(2008-5#2)
vivo insulin##2##2##(1990-12#1)(2011-1#1)
vivo investigations##2##2##(2008-10#1)(2008-8#1)
vivo is##13##2##(1992-10#1)(1994-11#2)(1997-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2012-12#2)
vivo measurements##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
vivo method##3##2##(1991-12#1)(2008-5#2)
vivo microdialysis##11##2##(1992-7#1)(1994-8#1)(1995-12#3)(1995-3#1)(1997-2#2)(1997-6#1)(2008-10#2)
vivo model of##4##3##(1991-5#1)(1996-5#1)(2006-6#1)(2009-12#1)
vivo model##6##2##(1991-5#1)(1996-2#1)(1996-5#1)(2006-6#1)(2008-10#1)(2009-12#1)
vivo models##7##2##(2006-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#1)
vivo monitoring of##4##3##(1991-5#1)(2008-10#3)
vivo or in vitro##6##4##(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
vivo or in##8##3##(1990-8#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
vivo or##10##2##(1990-8#1)(1992-11#1)(1995-2#1)(1996-12#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-11#1)(2011-1#1)
vivo pharmacology of##2##3##(1995-12#2)
vivo platelet##2##2##(1993-6#1)(2006-6#1)
vivo processing##3##2##(1991-12#1)(1997-1#2)
vivo production of##2##3##(1992-3#2)
vivo proton magnetic resonance spectroscopy##2##5##(1991-1#1)(2008-7#1)
vivo regulation of##3##3##(1991-12#1)(1992-8#1)(2011-1#1)
vivo response to##2##3##(1991-9#1)(2008-11#1)
vivo response##3##2##(1991-9#1)(1994-8#1)(2008-11#1)
vivo results suggest##2##3##(1992-11#1)(2008-11#1)
vivo results##5##2##(1991-2#1)(1992-11#1)(2008-11#1)(2008-5#1)(2012-12#1)
vivo studies on the##2##4##(2007-12#1)(2008-11#1)
vivo studies##22##2##(1992-11#2)(1993-5#1)(1995-3#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
vivo study of##2##3##(1993-1#1)(2008-5#1)
vivo study##17##2##(1990-5#1)(1993-1#2)(1995-12#1)(2008-5#5)(2008-8#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#3)
vivo tests##5##2##(1995-12#2)(1996-12#1)(2008-10#1)(2008-3#1)
vivo tissue##2##2##(1992-12#1)(2011-1#1)
vivo transfer##2##2##(2008-4#1)(2008-5#1)
vivo tritium contamination##2##3##(1991-5#2)
vivo under##2##2##(2008-5#1)(2008-7#1)
vivo with##13##2##(1991-1#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(2008-2#3)(2008-5#1)(2008-8#1)
vivo##1350##1##(1990-11#14)(1990-12#6)(1990-2#5)(1990-4#2)(1990-5#11)(1990-6#4)(1990-7#3)(1990-8#9)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#2)(1991-12#10)(1991-2#5)(1991-4#3)(1991-5#14)(1991-6#3)(1991-8#6)(1991-9#16)(1992-10#3)(1992-11#10)(1992-12#10)(1992-2#2)(1992-3#7)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#4)(1992-9#6)(1993-1#5)(1993-11#7)(1993-12#7)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#5)(1993-8#11)(1993-9#8)(1994-10#1)(1994-11#14)(1994-12#10)(1994-2#5)(1994-3#5)(1994-5#21)(1994-6#8)(1994-8#15)(1994-9#5)(1995-10#1)(1995-11#15)(1995-12#31)(1995-2#25)(1995-3#20)(1995-5#11)(1995-6#9)(1995-8#2)(1995-9#3)(1996-12#13)(1996-2#15)(1996-5#12)(1996-8#1)(1997-1#3)(1997-2#9)(1997-3#8)(1997-4#17)(1997-6#5)(1997-7#12)(1997-8#5)(2006-12#2)(2006-6#11)(2007-10#1)(2007-11#18)(2007-12#14)(2007-7#1)(2007-8#3)(2008-1#8)(2008-10#76)(2008-11#83)(2008-12#3)(2008-2#20)(2008-3#30)(2008-4#53)(2008-5#110)(2008-6#8)(2008-7#47)(2008-8#26)(2008-9#37)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#20)(2009-2#3)(2009-3#6)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#1)(2009-9#6)(2010-1#5)(2010-10#3)(2010-11#15)(2010-12#2)(2010-2#8)(2010-3#1)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#25)(2011-2#22)(2011-3#5)(2011-7#2)(2012-12#18)(2012-2#32)(2012-3#10)(2013-1#41)(2013-7#3)(2013-8#3)
vivo) and##2##2##(2007-11#1)(2008-5#1)
viz##62##1##(1990-12#1)(1991-5#1)(1992-8#3)(1993-8#1)(1995-2#1)(1997-4#1)(2006-12#1)(2007-7#1)(2008-10#23)(2008-11#4)(2008-12#7)(2008-5#5)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#2)(2010-4#1)(2012-2#1)(2013-1#5)(2013-8#1)
vm1AchR##2##1##(1997-4#2)
vocabularies are##3##2##(2008-7#2)(2008-9#1)
vocabularies in the##2##3##(2008-7#1)(2008-9#1)
vocabularies in##3##2##(2008-7#2)(2008-9#1)
vocabularies##14##1##(2008-2#1)(2008-7#8)(2008-9#4)(2010-8#1)
vocabulary and##6##2##(2008-12#2)(2008-9#2)(2011-2#2)
vocabulary intervention##4##2##(2011-2#4)
vocabulary words##3##2##(2011-2#3)
vocabulary##28##1##(1993-2#1)(2007-8#1)(2008-12#5)(2008-6#1)(2008-7#6)(2008-9#3)(2010-4#1)(2011-2#10)
vocal center (HVC)##2##3##(1997-2#1)(2008-9#1)
vocal center##5##2##(1997-2#1)(2008-9#4)
vocal cord palsy##2##3##(2008-8#1)(2010-7#1)
vocal cord##5##2##(1991-4#2)(2008-2#1)(2008-8#1)(2010-7#1)
vocal cues##2##2##(2009-10#1)(2013-8#1)
vocal fold vibration##2##3##(2009-11#2)
vocal fold##5##2##(2009-11#3)(2011-2#1)(2012-2#1)
vocal learning##3##2##(2009-2#2)(2012-2#1)
vocal music##2##2##(1991-12#1)(2007-6#1)
vocal versus instrumental##2##3##(2007-6#2)
vocal##48##1##(1991-12#1)(1991-4#3)(1991-5#1)(1997-2#1)(2007-6#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#4)(2008-9#10)(2009-10#2)(2009-11#3)(2009-2#6)(2009-9#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-8#1)
vocalization from##2##2##(1994-8#1)(2009-2#1)
vocalization in##2##2##(1994-8#1)(2008-9#1)
vocalization of##2##2##(2010-2#2)
vocalization was##2##2##(2008-9#1)(2010-2#1)
vocalization##17##1##(1994-8#5)(2008-4#1)(2008-9#2)(2009-2#1)(2010-2#6)(2012-12#2)
vocalizations and##2##2##(2008-9#2)
vocalizations##8##1##(2008-4#1)(2008-9#3)(2009-2#2)(2009-4#1)(2012-2#1)
vocalizing##2##1##(2009-4#1)(2010-2#1)
vocally and morphologically##2##3##(2008-8#2)
vocation##2##1##(2008-1#1)(2010-2#1)
vocational and##2##2##(2008-12#1)(2010-1#1)
vocational education##3##2##(1992-2#1)(2008-11#1)(2011-2#1)
vocational rehabilitation##5##2##(1992-3#2)(1993-3#2)(2009-10#1)
vocational status##2##2##(2007-11#1)(2008-1#1)
vocational training schemes##3##3##(1990-3#1)(1996-8#2)
vocational training##6##2##(1990-3#1)(1995-5#1)(1996-8#2)(2009-7#1)(2011-2#1)
vocational##26##1##(1990-3#1)(1992-2#1)(1992-3#2)(1993-3#2)(1994-12#1)(1995-5#3)(1996-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-9#1)(2011-2#2)
vogue##2##1##(1991-6#1)(2008-7#1)
voice and speech##3##3##(2011-1#3)
voice and##5##2##(1995-2#1)(2009-10#1)(2011-1#3)
voice disorders##2##2##(2013-8#2)
voice in health professional education?##2##5##(2008-12#2)
voice in##5##2##(2008-12#2)(2008-5#1)(2013-1#2)
voice##50##1##(1993-1#1)(1995-2#1)(1996-11#1)(1996-5#2)(2007-8#2)(2008-1#3)(2008-11#3)(2008-12#2)(2008-2#3)(2008-5#1)(2008-7#1)(2008-9#6)(2009-10#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
voice?##2##1##(1996-3#1)(2012-2#1)
voiced##2##1##(1990-12#1)(1995-2#1)
voices##8##1##(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#4)(2013-8#1)
voicing##2##1##(2008-12#1)(2008-9#1)
void volume##3##2##(1990-12#1)(1993-6#1)(2008-10#1)
void##13##1##(1990-12#1)(1992-12#1)(1993-1#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
voiding cystourethrogram##3##2##(2008-10#3)
voiding##14##1##(1990-5#2)(1994-3#1)(2008-10#7)(2008-4#1)(2009-5#1)(2012-3#1)(2013-8#1)
voids formed##2##2##(2007-12#2)
voids in##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
voids##13##1##(1993-11#1)(1995-6#1)(2007-12#5)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
voie##4##1##(2008-11#1)(2011-2#1)(2013-1#2)
vol##20##1##(1990-11#1)(1990-3#1)(2008-11#3)(2008-6#1)(2008-7#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
vol/vol)##3##1##(2008-10#3)
volar and dorsal##3##3##(2008-9#3)
volar fixed-angle##2##2##(2008-9#2)
volar forearm##9##2##(2008-5#9)
volar locking##2##2##(2008-9#2)
volar plate##2##2##(2008-9#2)
volar##34##1##(2008-10#1)(2008-5#9)(2008-9#22)(2011-2#2)
volatile and##7##2##(2008-10#5)(2008-11#1)(2009-8#1)
volatile anesthetics##2##2##(1990-2#2)
volatile chlorination by-products##3##3##(2008-10#3)
volatile components##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
volatile compounds and##2##3##(2008-10#2)
volatile compounds emitted by##2##4##(2009-8#1)(2011-10#1)
volatile compounds from wine##2##4##(2008-10#2)
volatile compounds from##3##3##(2008-10#2)(2009-8#1)
volatile compounds were isolated##3##4##(2008-10#3)
volatile compounds were##4##3##(2008-10#4)
volatile compounds##27##2##(2008-10#23)(2009-8#3)(2011-10#1)
volatile element##2##2##(2008-10#2)
volatile elements##3##2##(2008-10#3)
volatile emissions##3##2##(2009-8#2)(2011-10#1)
volatile fatty acids (VFAs)##2##4##(2008-10#1)(2008-5#1)
volatile fatty acids##5##3##(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
volatile fatty##6##2##(2008-10#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
volatile flavour compounds were##2##4##(2008-10#2)
volatile flavour compounds##3##3##(2008-10#3)
volatile halogenated organic compounds##2##4##(2008-10#2)
volatile halogenated##3##2##(2008-10#2)(2009-8#1)
volatile hydrocarbons##2##2##(2008-10#2)
volatile issue##2##2##(1994-3#1)(1995-12#1)
volatile odor##4##2##(2008-10#2)(2008-5#2)
volatile oil##2##2##(2008-11#1)(2013-8#1)
volatile oils##5##2##(2008-11#4)(2013-1#1)
volatile organic compounds (VOCs) in##2##5##(2008-10#1)(2011-1#1)
volatile organic compounds (VOCs)##6##4##(2008-10#5)(2011-1#1)
volatile organic compounds in air##2##5##(2008-10#1)(2013-1#1)
volatile organic compounds in##5##4##(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
volatile organic compounds##25##3##(1995-6#1)(2008-10#19)(2008-11#1)(2008-3#1)(2011-1#2)(2013-1#1)
volatile organic##29##2##(1995-6#1)(2008-10#22)(2008-11#1)(2008-3#2)(2011-1#2)(2013-1#1)
volatile organochlorine compounds##2##3##(2008-10#2)
volatile products##3##2##(2008-10#2)(2008-5#1)
volatile sesquiterpene##2##2##(2008-11#2)
volatile signals##2##2##(2009-8#2)
volatile solids##2##2##(2008-12#1)(2008-6#1)
volatile species##3##2##(2007-12#2)(2008-10#1)
volatile steroids##3##2##(2008-5#3)
volatile substances##2##2##(2008-10#2)
volatile sulfide##4##2##(2008-10#4)
volatile sulfides##2##2##(2008-10#2)
volatile sulfur##2##2##(2008-10#2)
volatile sulphur-containing compounds##2##3##(1997-4#2)
volatile##193##1##(1990-2#2)(1992-3#1)(1994-3#2)(1995-12#1)(1995-6#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#114)(2008-11#11)(2008-12#1)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#11)(2010-8#1)(2011-1#3)(2011-10#6)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
volatiles and semivolatiles in##2##4##(2008-10#2)
volatiles and##4##2##(2008-10#3)(2011-2#1)
volatiles are##2##2##(2008-10#1)(2009-8#1)
volatiles emitted by##2##3##(2008-10#2)
volatiles from 'Isabella' grapes##2##4##(2008-10#2)
volatiles from##5##2##(2008-10#4)(2013-8#1)
volatiles in##4##2##(1990-11#2)(2007-12#1)(2008-10#1)
volatiles on the growth of##2##5##(2008-10#1)(2009-8#1)
volatiles on the sporulation##2##4##(2008-10#2)
volatiles on the##4##3##(2008-10#3)(2009-8#1)
volatiles on##6##2##(2008-10#5)(2009-8#1)
volatiles or##2##2##(2009-8#2)
volatiles to##2##2##(1990-11#1)(2009-8#1)
volatiles were##2##2##(2007-12#1)(2009-6#1)
volatiles##44##1##(1990-11#4)(2007-12#2)(2008-10#24)(2009-6#1)(2009-8#9)(2011-10#1)(2011-2#2)(2013-8#1)
volatilities##2##1##(2008-10#1)(2012-12#1)
volatility matrix##4##2##(2012-12#4)
volatility of##3##2##(1991-12#1)(2008-10#2)
volatility##22##1##(1991-12#1)(1991-2#1)(1995-1#1)(1997-7#1)(2008-10#7)(2012-12#11)
volatilization from##2##2##(2008-10#2)
volatilization##10##1##(2008-10#10)
volcanic aerosols##2##2##(2008-2#1)(2008-3#1)
volcanic dust##3##2##(2008-2#3)
volcanic eruption##3##2##(2008-2#2)(2008-9#1)
volcanic eruptions##2##2##(1992-3#2)
volcanic##17##1##(1990-6#1)(1992-3#2)(1996-3#1)(1996-4#1)(2008-10#2)(2008-2#8)(2008-3#1)(2008-9#1)
vole##7##1##(1991-8#2)(1994-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
voles (Microtus##3##2##(1991-8#1)(2008-9#2)
voles and##2##2##(2012-1#1)(2013-1#1)
voles born into a##2##4##(1994-8#2)
voles mounted##3##2##(2008-9#3)
voles##27##1##(1991-8#3)(1994-3#3)(1994-8#6)(1996-6#1)(2008-9#9)(2012-1#1)(2012-3#2)(2013-1#2)
volition##3##1##(1991-5#1)(2008-6#1)(2011-2#1)
volitional##2##1##(2010-9#1)(2013-1#1)
voltae##3##1##(1990-2#3)
voltage (&lt##2##2##(2008-10#1)(2010-4#1)
voltage V(c)##2##2##(2008-10#2)
voltage activated##3##2##(2008-11#1)(2008-8#2)
voltage and phase compensation##4##4##(2013-8#4)
voltage and##21##2##(1991-5#1)(1992-11#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#3)(2013-8#4)
voltage applied to the##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
voltage applied to##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
voltage clamp technique##3##3##(1993-12#1)(1995-12#1)(2008-8#1)
voltage clamp##7##2##(1990-7#1)(1991-5#1)(1993-12#1)(1995-12#1)(2008-1#1)(2008-8#1)(2009-12#1)
voltage dependence of activation and##2##5##(1992-11#1)(2008-8#1)
voltage dependence of##3##3##(1992-11#1)(2008-8#2)
voltage dependence##7##2##(1992-11#1)(2007-11#1)(2008-4#1)(2008-8#3)(2009-11#1)
voltage dependent##4##2##(1993-12#1)(1997-4#1)(2008-11#1)(2009-12#1)
voltage dynamic range##2##3##(2009-5#2)
voltage for##2##2##(2008-10#1)(2008-7#1)
voltage is applied to##3##4##(2008-2#1)(2008-3#2)
voltage is applied##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
voltage is##8##2##(2008-10#4)(2008-2#1)(2008-3#2)(2013-8#1)
voltage of 1##2##3##(2007-11#1)(2010-12#1)
voltage of 15##2##3##(2007-11#1)(2008-10#1)
voltage of##23##2##(2007-11#3)(2007-12#2)(2008-10#13)(2008-2#3)(2008-3#1)(2010-12#1)
voltage on the##5##3##(1991-5#1)(2008-10#1)(2008-3#3)
voltage on##6##2##(1991-5#1)(2008-10#2)(2008-3#3)
voltage probe##2##2##(2008-3#2)
voltage sensor based on##2##4##(2008-3#2)
voltage sensor for##2##3##(2008-3#2)
voltage sensor##10##2##(2008-3#4)(2008-8#2)(2010-12#4)
voltage steps##2##2##(1995-12#1)(2008-8#1)
voltage to##2##2##(2008-11#1)(2008-2#1)
voltage tuning##2##2##(2008-3#1)(2011-1#1)
voltage was##2##2##(2008-10#2)
voltage were##3##2##(2008-10#2)(2008-3#1)
voltage##211##1##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#5)(1991-9#1)(1992-11#2)(1992-12#1)(1993-12#2)(1993-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1997-2#3)(1997-4#1)(1997-8#2)(2007-11#16)(2007-12#13)(2008-1#1)(2008-10#67)(2008-11#5)(2008-2#17)(2008-3#19)(2008-4#1)(2008-7#4)(2008-8#11)(2009-11#1)(2009-12#2)(2009-5#4)(2009-6#1)(2010-10#1)(2010-12#5)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#8)
voltage-activated calcium##3##2##(1993-12#2)(2008-8#1)
voltage-activated##8##1##(1993-12#2)(1995-11#2)(2008-8#4)
voltage-controlled##4##1##(2007-11#1)(2008-3#3)
voltage-dependent Ca(2+)##2##2##(2008-8#1)(2009-12#1)
voltage-dependent Ca2+ channels##4##3##(1994-11#1)(1995-12#1)(1996-5#1)(2008-8#1)
voltage-dependent Ca2+##6##2##(1992-7#1)(1994-11#1)(1995-12#2)(1996-5#1)(2008-8#1)
voltage-dependent calcium##3##2##(1990-12#1)(1996-2#1)(2008-8#1)
voltage-dependent inactivation##2##2##(1996-2#1)(2008-8#1)
voltage-dependent inward##2##2##(1993-3#1)(2009-12#1)
voltage-dependent##35##1##(1990-12#1)(1991-9#1)(1992-7#1)(1993-3#5)(1994-11#1)(1995-11#1)(1995-12#5)(1996-2#2)(1996-5#2)(1997-2#3)(2007-11#2)(2008-8#6)(2009-12#2)(2009-2#1)(2009-8#1)(2012-2#1)
voltage-gated Ca2+ channels##3##3##(1994-5#1)(1996-2#1)(2009-7#1)
voltage-gated Ca2+##4##2##(1992-12#1)(1994-5#1)(1996-2#1)(2009-7#1)
voltage-gated Na(+) and##2##3##(2008-7#1)(2009-12#1)
voltage-gated Na(+) channel##2##3##(2008-8#2)
voltage-gated Na(+)##4##2##(2008-7#1)(2008-8#2)(2009-12#1)
voltage-gated and##2##2##(2008-4#1)(2008-8#1)
voltage-gated calcium channel currents##2##4##(1993-12#2)
voltage-gated calcium channels##5##3##(2008-12#1)(2008-8#2)(2008-9#1)(2012-3#1)
voltage-gated calcium##7##2##(1993-12#2)(2008-12#1)(2008-8#2)(2008-9#1)(2012-3#1)
voltage-gated sodium channel##5##3##(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#2)
voltage-gated sodium channels##4##3##(2008-5#1)(2008-8#1)(2012-3#2)
voltage-gated sodium##11##2##(1992-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#1)(2012-12#1)(2012-3#4)
voltage-gated##34##1##(1992-11#1)(1992-12#1)(1993-12#2)(1994-2#1)(1994-5#2)(1996-2#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#5)
voltage-independent##3##1##(1997-7#1)(2008-8#2)
voltage-operated calcium channels##2##3##(1992-12#2)
voltage-operated calcium##3##2##(1992-12#3)
voltage-sensitive dye##3##2##(1996-5#1)(2008-4#2)
voltage-sensitive dyes##2##2##(1994-12#1)(2008-4#1)
voltage-sensitive##7##1##(1993-11#1)(1994-12#1)(1995-3#1)(1996-5#1)(2008-4#3)
voltages and##2##2##(1997-2#1)(2007-11#1)
voltages as low as##2##4##(2007-12#2)
voltages##16##1##(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2010-8#1)(2012-1#1)
voltametric##2##1##(2008-10#2)
voltametry##4##1##(2008-10#2)(2009-5#2)
voltammetric (SWV)##3##2##(2008-10#3)
voltammetric analysis of##5##3##(2008-10#5)
voltammetric analysis##7##2##(2008-10#7)
voltammetric analyzer##2##2##(2008-10#2)
voltammetric approach##2##2##(2008-10#2)
voltammetric behavior of the##2##4##(2008-10#2)
voltammetric behavior of##7##3##(2008-10#7)
voltammetric behavior##9##2##(2008-10#9)
voltammetric behaviour of##7##3##(2008-10#7)
voltammetric behaviour##9##2##(2008-10#9)
voltammetric biosensor##2##2##(2008-10#2)
voltammetric characteristics##2##2##(2008-10#2)
voltammetric conditions##2##2##(2008-10#2)
voltammetric curves##2##2##(2008-10#2)
voltammetric data##3##2##(2008-10#3)
voltammetric detection of##4##3##(2008-10#4)
voltammetric detection##10##2##(2008-10#10)
voltammetric determination at##2##3##(2008-10#2)
voltammetric determination in##2##3##(2008-10#2)
voltammetric determination of copper##2##4##(2008-10#2)
voltammetric determination of the##3##4##(2008-10#3)
voltammetric determination of trace amount##3##5##(2008-10#3)
voltammetric determination of trace##4##4##(2008-10#4)
voltammetric determination of traces of nickel(II)##2##6##(2008-10#2)
voltammetric determination of##33##3##(2008-10#33)
voltammetric determination##38##2##(2008-10#38)
voltammetric enzyme-linked immunoassay system##3##4##(2008-10#3)
voltammetric enzyme-linked immunoassay##4##3##(2008-10#4)
voltammetric experiments##5##2##(2008-10#5)
voltammetric measurement##3##2##(2008-10#3)
voltammetric measurements##8##2##(2008-10#8)
voltammetric method for the determination of##2##6##(2008-10#2)
voltammetric method for the##3##4##(2008-10#3)
voltammetric method for##6##3##(2008-10#6)
voltammetric method is##4##3##(2008-10#4)
voltammetric method was##2##3##(2008-10#2)
voltammetric method##22##2##(2008-10#22)
voltammetric methods##3##2##(2008-10#3)
voltammetric oxidation##2##2##(2008-10#2)
voltammetric peak and##2##3##(2008-10#2)
voltammetric peak at potential of -0##2##6##(2008-10#2)
voltammetric peak at##3##3##(2008-10#3)
voltammetric peak current##2##3##(2008-10#2)
voltammetric peak##11##2##(2008-10#11)
voltammetric peaks##3##2##(2008-10#3)
voltammetric procedure for##3##3##(2008-10#3)
voltammetric procedure##8##2##(2008-10#8)
voltammetric reduction##2##2##(2008-10#2)
voltammetric response in##2##3##(2008-10#2)
voltammetric response of##3##3##(2008-10#3)
voltammetric response was##2##3##(2008-10#2)
voltammetric response##12##2##(2008-10#12)
voltammetric responses of##2##3##(2008-10#2)
voltammetric responses##3##2##(2008-10#3)
voltammetric results##3##2##(2008-10#3)
voltammetric scan##5##2##(2008-10#5)
voltammetric sensor for##2##3##(2008-10#2)
voltammetric sensor##4##2##(2008-10#4)
voltammetric signals##5##2##(2008-10#5)
voltammetric stripping##2##2##(2008-10#2)
voltammetric studies##3##2##(2008-10#1)(2009-9#2)
voltammetric system##2##2##(2008-10#2)
voltammetric systems##2##2##(2008-10#2)
voltammetric technique for the##2##4##(2008-10#2)
voltammetric technique for##4##3##(2008-10#4)
voltammetric technique##5##2##(2008-10#5)
voltammetric techniques##7##2##(2008-10#7)
voltammetric##252##1##(2008-10#249)(2009-9#2)(2010-6#1)
voltammetrically##3##1##(2008-10#3)
voltammetry (CV) and##9##3##(2008-10#9)
voltammetry (CV)##20##2##(2008-10#20)
voltammetry (LSV)##2##2##(2008-10#2)
voltammetry and chronoamperometry##2##3##(2008-10#2)
voltammetry and chronocoulometry##2##3##(2008-10#2)
voltammetry and##26##2##(2008-10#23)(2013-1#3)
voltammetry at a carbon paste electrode##2##6##(2008-10#2)
voltammetry at a##11##3##(2008-10#11)
voltammetry at the##2##3##(2008-10#2)
voltammetry at##20##2##(1995-5#1)(2008-10#19)
voltammetry based on the adsorption collection##2##6##(2008-10#2)
voltammetry determination of##2##3##(2008-10#2)
voltammetry experiments##3##2##(2008-10#3)
voltammetry for##3##2##(2008-10#3)
voltammetry has been##2##3##(2008-10#2)
voltammetry have been##2##3##(2008-10#2)
voltammetry in a flow injection system##2##6##(2008-10#2)
voltammetry in##6##2##(2008-10#6)
voltammetry is##4##2##(2008-10#3)(2010-2#1)
voltammetry methods##2##2##(2008-10#2)
voltammetry of the##5##3##(2008-10#5)
voltammetry of##19##2##(2008-10#18)(2008-12#1)
voltammetry on a##6##3##(2008-10#6)
voltammetry on##8##2##(2008-10#8)
voltammetry technique##2##2##(2008-10#2)
voltammetry to the##2##3##(2008-10#2)
voltammetry using a##2##3##(2008-10#2)
voltammetry using##12##2##(2008-10#12)
voltammetry was used to study the##2##6##(2008-10#1)(2008-8#1)
voltammetry was used to##5##4##(2008-10#4)(2008-8#1)
voltammetry was used##6##3##(2008-10#5)(2008-8#1)
voltammetry was##11##2##(2008-10#10)(2008-8#1)
voltammetry were##4##2##(2008-10#4)
voltammetry with a##6##3##(2008-10#6)
voltammetry with the##2##3##(2008-10#2)
voltammetry with##16##2##(2008-10#14)(2008-4#1)(2009-9#1)
voltammetry##367##1##(1995-5#1)(2008-10#354)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-9#1)(2010-2#1)(2013-1#3)
voltammetry)##4##1##(2008-10#4)
voltammogram of##3##2##(2008-10#2)(2009-9#1)
voltammogram was##2##2##(2008-10#2)
voltammogram##10##1##(2008-10#9)(2009-9#1)
voltammograms in##2##2##(2008-10#1)(2010-6#1)
voltammograms of the##2##3##(2008-10#2)
voltammograms of##8##2##(1996-5#1)(2008-10#7)
voltammograms recorded##3##2##(2008-10#3)
voltammograms##28##1##(1996-5#1)(2008-10#26)(2010-6#1)
volts##2##1##(1995-3#1)(2008-3#1)
volts)##2##1##(1990-11#1)(1995-3#1)
volume (0##3##2##(2008-3#1)(2010-11#1)(2012-12#1)
volume (1##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
volume (100##2##2##(2008-10#2)
volume (GTV)##3##2##(2008-2#2)(2009-2#1)
volume (PTV)##4##2##(2008-11#1)(2008-2#2)(2008-6#1)
volume (ca##2##2##(2008-10#2)
volume 0##2##2##(1990-8#1)(2008-10#1)
volume analysis##3##2##(1991-12#1)(1994-12#1)(2010-11#1)
volume and a##2##3##(2008-10#1)(2013-8#1)
volume and better##2##3##(2008-7#1)(2013-8#1)
volume and cristae##2##3##(2012-3#2)
volume and flow##2##3##(2008-10#1)(2010-5#1)
volume and in##2##3##(2008-10#2)
volume and intensity of##2##4##(1991-2#2)
volume and intensity##3##3##(1991-2#3)
volume and is##4##3##(2007-12#1)(2008-10#1)(2011-2#2)
volume and limit of detection##4##5##(2008-10#4)
volume and surface area##2##4##(1996-5#2)
volume and surface##3##3##(1996-5#2)(2008-2#1)
volume and the##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
volume and##84##2##(1991-2#3)(1992-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#20)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
volume are##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#1)
volume as a##2##3##(1995-2#1)(2013-7#1)
volume as##5##2##(1992-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2013-7#1)
volume at##6##2##(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-4#1)
volume before##3##2##(2007-10#1)(2008-8#1)(2011-3#1)
volume being##2##2##(1996-5#1)(2010-7#1)
volume between##2##2##(1995-3#1)(2007-10#1)
volume but##2##2##(2008-10#1)(2008-3#1)
volume by##2##2##(1993-12#1)(2008-3#1)
volume can be##4##3##(1993-11#1)(1994-9#1)(2008-3#2)
volume changes##5##2##(1990-8#2)(1996-12#1)(2008-8#1)(2009-1#1)
volume column system was##2##4##(2008-10#2)
volume column system##3##3##(2008-10#3)
volume compressibility##2##2##(1991-5#1)(2008-10#1)
volume concentration##2##2##(2007-12#1)(2008-3#1)
volume concentrations##3##2##(2008-2#1)(2008-3#2)
volume consumption for##2##3##(2008-3#2)
volume consumption is##2##3##(2008-3#2)
volume consumption##5##2##(2008-3#5)
volume decrease##4##2##(1990-2#2)(2008-8#1)(2013-8#1)
volume decreased##2##2##(1995-8#1)(2008-6#1)
volume density of syncytiotrophoblast##2##4##(2011-1#2)
volume density of##5##3##(2008-3#1)(2009-11#1)(2011-1#2)(2012-1#1)
volume density##11##2##(1995-8#1)(2008-3#2)(2009-11#2)(2011-1#4)(2012-1#1)(2012-3#1)
volume determination##3##2##(1996-7#1)(2008-10#2)
volume distribution##2##2##(2008-3#2)
volume during##6##2##(2011-2#6)
volume effect##2##2##(2009-7#1)(2011-1#1)
volume efficient than##2##3##(2008-3#2)
volume element of a highly diffusing medium##2##7##(2007-12#2)
volume element##4##2##(2007-12#3)(2009-7#1)
volume estimation of the hippocampus##2##5##(1996-9#2)
volume flow increased##2##3##(2006-10#1)(2008-11#1)
volume flow was##2##3##(2006-10#2)
volume flow##8##2##(2006-10#5)(2008-11#3)
volume for the##2##3##(2008-10#1)(2012-12#1)
volume for##6##2##(1993-9#2)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
volume fraction and##5##3##(2008-2#1)(2008-3#2)(2009-6#1)(2009-7#1)
volume fraction of##7##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
volume fraction##21##2##(1995-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#7)(2009-6#1)(2009-7#2)(2011-1#1)
volume fraction)##2##2##(2008-10#2)
volume fractions of the##3##4##(2008-2#1)(2008-3#2)
volume fractions##9##2##(2008-2#2)(2008-3#3)(2009-7#1)(2013-8#3)
volume from##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
volume grating##4##2##(2008-3#4)
volume gratings written##2##3##(2007-12#1)(2008-3#1)
volume gratings##5##2##(2007-12#2)(2008-3#3)
volume group##2##2##(2009-7#2)
volume hologram##3##2##(2007-12#1)(2008-3#2)
volume holograms recorded##2##3##(2008-2#2)
volume holograms##8##2##(2008-2#3)(2008-3#5)
volume holographic data storage##5##4##(2007-11#1)(2008-3#4)
volume holographic data##6##3##(2007-11#2)(2008-3#4)
volume holographic memories##3##3##(2008-2#2)(2008-3#1)
volume holographic memory##2##3##(2008-2#2)
volume holographic storage##2##3##(2007-12#1)(2008-3#1)
volume holographic system are presented##2##5##(2007-11#2)
volume holographic##25##2##(2007-11#6)(2007-12#4)(2008-2#4)(2008-3#11)
volume immediately##2##2##(2008-3#1)(2013-8#1)
volume in a##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
volume in the##7##3##(2007-10#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
volume in##23##2##(1996-5#1)(1996-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
volume increased##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
volume increases##2##2##(2007-12#1)(2008-10#1)
volume index gratings##2##3##(2007-11#2)
volume injected##3##2##(2008-10#3)
volume integral equation simulations of##2##5##(2008-2#2)
volume integral equation##4##3##(2008-2#2)(2008-3#2)
volume integral##5##2##(2008-2#2)(2008-3#3)
volume is##18##2##(1992-12#1)(1994-3#1)(1994-6#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2013-1#1)
volume measurements##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-8#1)
volume median droplet diameter d(v50)##2##5##(2008-5#2)
volume mixing ratio##4##3##(2008-3#4)
volume mixing ratio) with##2##4##(2008-2#2)
volume mixing##6##2##(2008-2#2)(2008-3#4)
volume of 0##3##3##(2008-10#3)
volume of 1##4##3##(2007-11#1)(2008-10#2)(2013-1#1)
volume of 100 mul##4##4##(2008-10#4)
volume of 100##8##3##(2008-10#8)
volume of 10ml##2##3##(2008-10#2)
volume of 20 mul##2##4##(2008-10#2)
volume of 20##3##3##(2008-10#2)(2008-5#1)
volume of 200##2##3##(2008-10#2)
volume of 25 ml##2##4##(2008-10#2)
volume of 25##3##3##(2008-10#3)
volume of 50 ml##2##4##(2008-10#2)
volume of 50##3##3##(2008-10#3)
volume of CO(2)##2##3##(2008-10#2)
volume of a##4##3##(1990-12#1)(1996-2#1)(2008-10#2)
volume of about##2##3##(1995-6#1)(2007-7#1)
volume of air##2##3##(2008-10#1)(2008-2#1)
volume of an##4##3##(2008-10#3)(2008-3#1)
volume of aqueous phase and interference of a number of metal ions on the determination of##3##16##(2008-10#3)
volume of aqueous phase and interference of a##4##8##(2008-10#4)
volume of aqueous phase and##5##5##(2008-10#5)
volume of aqueous phase##6##4##(2008-10#6)
volume of aqueous##9##3##(2008-10#9)
volume of each##2##3##(2008-10#2)
volume of eluent##4##3##(2008-10#4)
volume of fresh##3##3##(1995-2#1)(2008-11#1)(2008-8#1)
volume of gas##2##3##(1995-3#2)
volume of organic solvent and##3##5##(2008-10#3)
volume of procedures##4##3##(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)
volume of saline##3##3##(1990-7#1)(1991-12#1)(2011-2#1)
volume of sample and##2##4##(2008-10#2)
volume of sample##6##3##(2008-10#6)
volume of samples and##2##4##(2008-10#2)
volume of samples##3##3##(2008-10#3)
volume of services##3##3##(1992-2#3)
volume of syncytiotrophoblast in resorption villi of##3##7##(2011-1#3)
volume of syncytiotrophoblast in resorption villi##4##6##(2011-1#4)
volume of the sample##3##4##(1990-12#1)(2008-10#2)
volume of the water##2##4##(2008-10#2)
volume of the##44##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1995-12#1)(1996-7#1)(1997-8#1)(2007-10#3)(2007-12#2)(2008-10#19)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
volume of tissue##4##3##(1991-2#2)(1996-5#2)
volume of water##2##3##(1997-2#1)(2011-1#1)
volume of##283##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#6)(1995-6#1)(1996-2#3)(1996-5#3)(1996-7#1)(1997-2#2)(1997-8#3)(2006-10#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#139)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-5#1)(2010-8#4)(2011-1#7)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
volume on the##2##3##(2008-10#2)
volume on##9##2##(1996-7#1)(2007-12#1)(2008-10#4)(2008-12#1)(2009-7#1)(2012-3#1)
volume or##4##2##(2007-12#1)(2008-11#1)(2008-9#1)(2012-1#1)
volume overload and##3##3##(1994-9#2)(2010-8#1)
volume overload##4##2##(1994-9#2)(2008-10#1)(2010-8#1)
volume per testis##2##3##(1992-12#2)
volume per##5##2##(1992-12#2)(2008-11#1)(2008-3#1)(2008-6#1)
volume performance##2##2##(1992-2#1)(1993-12#1)
volume ratio of the##2##4##(2008-10#1)(2009-5#1)
volume ratio of##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
volume ratio##10##2##(2008-10#6)(2008-11#1)(2009-5#3)
volume ratios##2##2##(2008-10#1)(2008-4#1)
volume reduction##2##2##(2008-10#1)(2013-1#1)
volume regulation of##3##3##(1990-2#2)(2013-8#1)
volume regulation##6##2##(1990-2#3)(2008-8#2)(2013-8#1)
volume rendering##6##2##(2007-11#3)(2008-6#2)(2012-1#1)
volume samples##2##2##(2008-10#1)(2008-6#1)
volume scattering function is##2##4##(2008-2#1)(2008-3#1)
volume scattering function##4##3##(2008-2#2)(2008-3#2)
volume scattering##5##2##(2008-2#3)(2008-3#2)
volume substitution##2##2##(2008-7#2)
volume than##2##2##(1994-3#1)(2008-12#1)
volume that##4##2##(2008-3#2)(2010-4#1)(2012-3#1)
volume the##2##2##(1991-12#1)(2008-2#1)
volume to the##2##3##(1992-3#1)(2008-2#1)
volume to##9##2##(1992-12#1)(1992-3#1)(1996-2#1)(1996-7#1)(2008-10#3)(2008-2#1)(2008-7#1)
volume up to##3##3##(2008-10#2)(2008-7#1)
volume was 0##2##3##(1997-4#1)(2011-1#1)
volume was increased##2##3##(2009-10#1)(2009-12#1)
volume was reduced##2##3##(1995-3#1)(1995-8#1)
volume was significantly higher##2##4##(2012-12#1)(2012-3#1)
volume was significantly##4##3##(1996-7#1)(2008-7#1)(2012-12#1)(2012-3#1)
volume was##39##2##(1990-2#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)
volume were investigated##2##3##(2008-10#2)
volume were##9##2##(2008-10#8)(2009-2#1)
volume will##2##2##(1997-1#1)(2008-11#1)
volume with a##2##3##(2008-10#1)(2008-2#1)
volume with##7##2##(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
volume##1203##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#6)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#4)(1991-1#2)(1991-11#3)(1991-12#4)(1991-2#8)(1991-3#2)(1991-5#4)(1992-11#4)(1992-12#13)(1992-2#6)(1992-3#2)(1992-6#2)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#7)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#10)(1995-6#2)(1995-8#5)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#7)(1996-3#1)(1996-5#8)(1996-6#2)(1996-7#9)(1996-9#6)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#3)(2006-10#6)(2007-10#22)(2007-11#20)(2007-12#34)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#341)(2008-11#46)(2008-12#8)(2008-2#66)(2008-3#123)(2008-4#8)(2008-5#10)(2008-6#15)(2008-7#51)(2008-8#14)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#9)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#7)(2009-7#16)(2009-9#1)(2010-1#1)(2010-11#4)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#9)(2011-1#20)(2011-2#44)(2011-3#2)(2011-4#1)(2012-1#7)(2012-12#14)(2012-2#8)(2012-3#16)(2012-4#1)(2013-1#21)(2013-7#4)(2013-8#10)
volume) and##2##2##(2008-11#1)(2009-5#1)
volume) of the##2##3##(1993-6#1)(2010-2#1)
volume) was##2##2##(2008-10#1)(2013-7#1)
volume) were##2##2##(2008-10#1)(2013-1#1)
volume)##22##1##(1991-12#1)(1993-6#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-6#2)(2008-9#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-7#1)
volume-equivalent##4##1##(2008-2#2)(2008-3#2)
volume-holographic correlator##2##2##(2008-3#2)
volume-holographic##4##1##(2007-11#2)(2008-3#2)
volume-index grating##2##2##(2007-12#2)
volume-mixing ratio for a 1-m path##2##6##(2008-3#2)
volume-mixing##3##1##(2008-3#3)
volume-type##2##1##(2008-3#2)
volumes and solubility parameters of##3##5##(2008-10#3)
volumes and##12##2##(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#1)(2011-2#1)
volumes are##10##2##(1993-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
volumes as##2##2##(1992-11#1)(1997-2#1)
volumes by##2##2##(1995-12#1)(2012-2#1)
volumes for##5##2##(2008-2#2)(2008-3#1)(2011-2#1)(2012-12#1)
volumes have##2##2##(2008-10#1)(2009-7#1)
volumes in the##2##3##(1997-6#1)(2013-1#1)
volumes in##9##2##(1992-6#1)(1997-6#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
volumes into a##2##3##(2008-10#1)(2008-9#1)
volumes into##4##2##(2008-10#3)(2008-9#1)
volumes is##3##2##(2008-10#1)(2008-2#2)
volumes of sample##6##3##(2008-10#5)(2008-9#1)
volumes of the##6##3##(1991-12#1)(1994-3#1)(2008-10#3)(2008-2#1)
volumes of##51##2##(1990-8#2)(1991-11#1)(1991-12#1)(1994-3#1)(2008-10#29)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-7#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
volumes ranging from##2##3##(2008-10#2)
volumes were measured##2##3##(1995-5#1)(2011-2#1)
volumes were##15##2##(1993-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-9#1)(2007-10#2)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#3)
volumes with##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
volumes##203##1##(1990-8#2)(1991-11#2)(1991-12#2)(1992-11#3)(1992-6#2)(1992-9#1)(1993-2#2)(1993-3#2)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#69)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#15)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#10)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#10)(2012-2#2)(2012-3#1)(2013-1#4)
volumes)##2##1##(2008-10#1)(2012-12#1)
volumetric Karl Fischer titration##2##4##(2008-10#2)
volumetric Karl Fischer##4##3##(2008-10#4)
volumetric and##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
volumetric changes##2##2##(2011-2#2)
volumetric density##2##2##(2007-11#1)(2007-12#1)
volumetric flow rate##3##3##(1995-3#2)(2008-10#1)
volumetric flow##4##2##(1995-3#2)(2008-10#1)(2013-8#1)
volumetric images##2##2##(2011-1#1)(2011-7#1)
volumetric lung depth##2##3##(1996-2#2)
volumetric productivity of##3##3##(2008-11#2)(2008-6#1)
volumetric productivity was##2##3##(2008-11#1)(2008-6#1)
volumetric productivity##6##2##(2008-11#3)(2008-6#3)
volumetric protein productivity##2##3##(2008-11#1)(2008-7#1)
volumetric spore trap##3##3##(2008-10#2)(2008-5#1)
volumetric spore traps##3##3##(2008-10#2)(2010-5#1)
volumetric spore##6##2##(2008-10#4)(2008-5#1)(2010-5#1)
volumetric titers##3##2##(2008-11#3)
volumetric titration##3##2##(2008-10#3)
volumetric##83##1##(1990-8#1)(1995-3#2)(1995-5#1)(1996-2#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#13)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-9#2)(2009-10#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
voluminous##9##1##(1991-6#1)(1993-9#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)
voluntarily##11##1##(1991-2#1)(1994-3#2)(1995-1#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
voluntary abortion##2##2##(2013-1#2)
voluntary alcohol intake in##2##4##(1993-12#1)(2008-2#1)
voluntary alcohol intake##3##3##(1993-12#2)(2008-2#1)
voluntary alcohol##5##2##(1993-12#4)(2008-2#1)
voluntary and##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
voluntary board##2##2##(1994-2#2)
voluntary contraction (MVC)##2##3##(2010-6#1)(2013-8#1)
voluntary contraction##7##2##(2010-6#3)(2010-9#1)(2012-12#1)(2013-8#2)
voluntary contractions##2##2##(1993-9#1)(1996-5#1)
voluntary counselling and testing##2##4##(2009-7#1)(2013-1#1)
voluntary health##3##2##(1996-3#1)(2008-11#1)(2012-1#1)
voluntary isometric contraction##2##3##(1993-12#2)
voluntary movements##2##2##(1994-3#1)(2007-10#1)
voluntary organizations##3##2##(1991-12#1)(1996-2#2)
voluntary##89##1##(1990-12#1)(1990-6#2)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#8)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-9#1)(1995-2#1)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#8)(2013-8#3)
voluntary&quot##2##1##(1996-12#1)(1997-2#1)
volunteer administration##4##2##(1992-1#1)(1994-3#1)(1996-12#1)(1997-2#1)
volunteer administrator##2##2##(1993-1#1)(1994-1#1)
volunteer administrators to##2##3##(1993-1#1)(1995-2#1)
volunteer administrators##5##2##(1991-3#1)(1993-1#1)(1993-2#2)(1995-2#1)
volunteer agency##2##2##(1991-12#1)(1997-2#1)
volunteer and##5##2##(1991-3#1)(1993-2#1)(1994-2#2)(1996-2#1)
volunteer blood donors##2##3##(2008-12#2)
volunteer donors##2##2##(2008-10#2)
volunteer experience##3##2##(1992-3#2)(1994-3#1)
volunteer group##2##2##(1993-2#2)
volunteer input##2##2##(1993-2#1)(2008-12#1)
volunteer management##5##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-3#2)
volunteer organizations##3##2##(1992-12#1)(1993-12#2)
volunteer program##8##2##(1991-1#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-2#1)
volunteer programs##7##2##(1991-3#1)(1994-2#3)(1994-3#1)(1996-12#1)(1997-2#1)
volunteer recruitment##3##2##(1992-3#1)(1993-12#1)(1994-2#1)
volunteer service##2##2##(1996-3#2)
volunteer study##3##2##(2008-10#1)(2008-5#2)
volunteer work##4##2##(1991-12#1)(1994-2#1)(1995-2#2)
volunteer##149##1##(1991-1#3)(1991-12#4)(1991-2#4)(1991-3#3)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#8)(1993-1#6)(1993-12#5)(1993-2#7)(1994-1#1)(1994-12#1)(1994-2#16)(1994-3#16)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#8)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#10)(1997-2#5)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#5)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
volunteer's##2##1##(1991-2#1)(2012-3#1)
volunteered for the study##2##4##(2008-5#1)(2011-2#1)
volunteered for##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
volunteered to##4##2##(2008-11#1)(2008-12#2)(2012-2#1)
volunteered##10##1##(1993-12#1)(2008-11#1)(2008-12#2)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
volunteering##3##1##(1994-1#1)(1994-2#1)(2010-12#1)
volunteerism in##3##2##(1991-3#1)(1996-3#2)
volunteerism##18##1##(1991-2#1)(1991-3#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-2#5)(1996-3#3)(2008-12#1)(2008-4#1)(2008-5#2)
volunteers (mean age##2##3##(1995-11#1)(2008-7#1)
volunteers (n =##2##3##(1996-7#1)(2010-9#1)
volunteers a##2##2##(1994-2#1)(2008-5#1)
volunteers and the##2##3##(1994-3#1)(2013-8#1)
volunteers and their##2##3##(1993-12#1)(1994-3#1)
volunteers and##15##2##(1991-12#1)(1992-3#3)(1993-12#1)(1993-9#1)(1994-3#3)(1995-12#1)(1996-7#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#1)
volunteers are##4##2##(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)
volunteers as##4##2##(1992-2#1)(1994-3#1)(2008-10#1)(2008-5#1)
volunteers at##3##2##(1994-3#1)(1995-11#1)(2008-7#1)
volunteers by##2##2##(1990-3#1)(2008-5#1)
volunteers can##3##2##(1991-3#1)(1994-2#1)(2013-1#1)
volunteers for##6##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-5#1)(2008-10#1)(2008-5#1)
volunteers from##3##2##(1995-11#1)(2007-6#1)(2012-12#1)
volunteers had##2##2##(1995-11#1)(1997-4#1)
volunteers in a##2##3##(2008-12#1)(2008-5#1)
volunteers in##10##2##(1991-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
volunteers is##3##2##(1993-12#1)(1994-3#1)(2008-5#1)
volunteers make##2##2##(1994-3#1)(1997-2#1)
volunteers of##3##2##(2008-5#2)(2013-8#1)
volunteers on the##2##3##(2008-10#1)(2008-5#1)
volunteers performed##2##2##(2008-10#1)(2012-2#1)
volunteers that##2##2##(2007-10#1)(2008-2#1)
volunteers to##7##2##(1992-3#1)(1992-6#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-6#1)(2009-5#1)
volunteers underwent##2##2##(2007-10#1)(2013-8#1)
volunteers using a##2##3##(1996-1#1)(2008-5#1)
volunteers was##2##2##(2008-5#1)(2013-1#1)
volunteers were randomly assigned to##2##5##(2008-3#1)(2010-4#1)
volunteers were reexamined after##2##4##(1996-5#2)
volunteers were##22##2##(1991-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1996-5#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#6)(2010-4#1)(2012-3#1)(2013-1#1)
volunteers while they##2##3##(1996-2#1)(1996-7#1)
volunteers while##3##2##(1996-2#1)(1996-3#1)(1996-7#1)
volunteers who##2##2##(1992-3#1)(1997-4#1)
volunteers with##8##2##(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-5#3)(2013-1#1)
volunteers##288##1##(1990-3#2)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#10)(1992-6#1)(1992-8#1)(1993-12#5)(1993-2#3)(1993-8#1)(1993-9#2)(1994-2#8)(1994-3#20)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#7)(1995-12#5)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#6)(1996-7#7)(1997-1#3)(1997-2#2)(1997-4#6)(1997-7#1)(2006-10#1)(2006-12#2)(2007-10#9)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#7)(2008-5#48)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#8)(2013-8#3)
volunteers'##5##1##(1991-12#1)(2008-10#1)(2008-5#2)(2013-1#1)
volunteers?##2##1##(1994-3#1)(1997-2#1)
volvulus in##2##2##(1991-12#1)(2013-1#1)
volvulus##13##1##(1990-6#2)(1991-12#1)(1991-9#1)(1993-5#2)(2008-10#1)(2010-1#1)(2012-3#4)(2013-1#1)
vomeronasal##7##1##(1992-8#1)(1994-2#2)(2008-6#1)(2012-2#3)
vomifoliol##2##1##(2007-11#2)
vomiting and##16##2##(1992-10#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2010-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
vomiting episodes##2##2##(1990-12#2)
vomiting in##4##2##(1990-12#1)(1990-6#2)(2009-5#1)
vomiting of##2##2##(2007-12#1)(2013-8#1)
vomiting or##3##2##(1991-12#1)(2007-8#1)(2008-8#1)
vomiting was##2##2##(1990-6#1)(2013-7#1)
vomiting##96##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-6#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-5#1)(1993-2#2)(1993-6#1)(1995-9#1)(1996-9#1)(1997-7#1)(1997-8#3)(2007-12#2)(2007-5#2)(2007-8#2)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#16)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#3)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#7)
vomiting)##2##1##(1990-6#1)(2008-1#1)
von Bertalanffy##7##2##(2010-8#4)(2013-7#3)
von Hippel-Lindau disease##2##3##(2008-1#1)(2012-3#1)
von Hippel-Lindau##5##2##(2008-1#1)(2008-7#1)(2011-1#2)(2012-3#1)
von Recklinghausen's disease##3##3##(1991-2#1)(1992-9#1)(2008-10#1)
von Recklinghausen's##5##2##(1991-2#1)(1992-9#1)(2008-10#3)
von Willebrand Factor (vWF)##2##4##(2008-11#1)(2008-12#1)
von Willebrand Factor and##2##4##(1990-5#1)(1994-11#1)
von Willebrand Factor##5##3##(1990-5#1)(1994-11#1)(2008-11#2)(2008-12#1)
von Willebrand factor (vWF)##3##4##(1993-3#1)(2007-10#1)(2013-8#1)
von Willebrand factor##11##3##(1990-5#1)(1992-11#1)(1993-3#2)(1994-11#1)(2007-10#2)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
von Willebrand##18##2##(1990-5#2)(1992-11#1)(1993-3#2)(1994-11#2)(1997-7#1)(2007-10#2)(2008-10#1)(2008-11#2)(2008-12#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
von Willebrand's Disease##2##3##(2008-12#2)
von Willebrand's disease##3##3##(1992-11#2)(2011-1#1)
von Willebrand's##6##2##(1992-11#2)(2008-12#2)(2011-1#2)
von##50##1##(1990-5#2)(1991-2#1)(1992-11#3)(1992-9#2)(1993-3#2)(1994-11#2)(1997-2#1)(1997-7#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-8#4)(2011-1#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#2)
voor##4##1##(1991-6#1)(1995-12#2)(2012-12#1)
voriconazole for##2##2##(2009-5#1)(2012-2#1)
voriconazole##6##1##(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
vortex structure##3##2##(2007-11#1)(2007-12#2)
vortex##29##1##(1991-5#2)(2007-11#7)(2007-12#10)(2007-7#1)(2008-10#3)(2009-5#2)(2012-2#3)(2013-8#1)
vortices in##3##2##(1990-4#1)(2007-11#1)(2007-12#1)
vortices of electromagnetic##2##3##(2007-12#2)
vortices##21##1##(1990-4#1)(2007-11#6)(2007-12#10)(2008-2#4)
vorticity##4##1##(2007-12#1)(2008-3#3)
vote of##2##2##(1996-2#1)(2013-1#1)
vote on May##2##3##(1995-6#1)(1996-5#1)
vote on##4##2##(1991-9#1)(1995-6#1)(1996-5#1)(1997-2#1)
vote##10##1##(1991-9#1)(1993-5#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#1)(2012-3#1)(2013-1#1)
voted##4##1##(1991-12#1)(1995-6#1)(1996-5#1)(1997-5#1)
voters##4##1##(1997-5#1)(2008-11#1)(2008-6#1)(2008-7#1)
votes##3##1##(1991-1#1)(1995-6#1)(1997-5#1)
voting in##2##2##(1993-6#1)(2008-6#1)
voting##9##1##(1993-6#1)(2008-6#6)(2008-7#1)(2009-10#1)
voucher##2##1##(1996-12#1)(2008-6#1)
vouchers##2##1##(2008-4#1)(2008-9#1)
vowel deviants##2##2##(2009-2#2)
vowel inventory##2##2##(2013-8#2)
vowel space##2##2##(2013-8#2)
vowel##15##1##(2009-11#1)(2009-2#5)(2012-12#2)(2013-8#7)
vowel-to-vowel coarticulation##4##2##(2013-8#4)
vowel-to-vowel##5##1##(2013-8#5)
vowels ([i##3##2##(2012-12#3)
vowels ([o##3##2##(2012-12#3)
vowels and consonants by##2##4##(2013-8#2)
vowels##18##1##(2009-11#4)(2012-12#6)(2013-8#8)
voxel##4##1##(2008-11#1)(2008-7#2)(2011-1#1)
voxel-based morphometry##3##2##(2009-9#2)(2013-1#1)
voxels##5##1##(2007-11#3)(2008-11#1)(2008-7#1)
vrn-B1##2##1##(2012-3#2)
vs -0##3##2##(2007-10#3)
vs 0##13##2##(1990-12#1)(2007-10#1)(2009-11#2)(2010-1#2)(2011-2#3)(2013-1#2)(2013-8#2)
vs 1##11##2##(2007-10#1)(2007-7#1)(2008-9#1)(2012-3#1)(2013-1#7)
vs 10##2##2##(1995-8#1)(2011-2#1)
vs 10%)##3##2##(2010-4#3)
vs 13##6##2##(2007-10#1)(2007-7#1)(2010-4#3)(2011-2#1)
vs 15##4##2##(1990-11#1)(1990-3#1)(1992-2#1)(2007-10#1)
vs 16##5##2##(2010-4#4)(2011-2#1)
vs 17##3##2##(1993-2#2)(2007-10#1)
vs 2##7##2##(1990-3#1)(1991-7#1)(1992-2#1)(1994-8#1)(1997-2#1)(2008-7#1)(2011-2#1)
vs 20##2##2##(2010-1#1)(2012-12#1)
vs 23##2##2##(2010-4#2)
vs 25##2##2##(1991-5#1)(1994-2#1)
vs 26##3##2##(2010-4#3)
vs 3##5##2##(1992-5#1)(2008-1#1)(2010-11#1)(2010-4#2)
vs 30##3##2##(1993-8#1)(1997-2#1)(1997-8#1)
vs 33##2##2##(2008-4#1)(2010-4#1)
vs 36##2##2##(2010-4#2)
vs 37##3##2##(1991-8#1)(2008-1#1)(2011-2#1)
vs 38##2##2##(2008-7#1)(2011-2#1)
vs 4##7##2##(1992-2#1)(1994-1#1)(1996-2#2)(1997-2#2)(2012-12#1)
vs 40##2##2##(2012-1#2)
vs 41##2##2##(2011-1#1)(2012-1#1)
vs 42##2##2##(1994-2#1)(1994-6#1)
vs 46##2##2##(1996-2#1)(2008-4#1)
vs 5##4##2##(1990-3#1)(1995-12#1)(2008-8#1)(2008-9#1)
vs 6##5##2##(1991-5#1)(2010-4#3)(2013-1#1)
vs 7##2##2##(2011-2#1)(2012-3#1)
vs 80##2##2##(1996-2#1)(2011-2#1)
vs 92%##2##2##(2007-10#2)
vs A1 receptors##2##3##(1995-3#2)
vs A1##3##2##(1995-3#3)
vs Ag/AgCl##2##2##(2008-10#2)
vs SCE in##2##3##(1997-7#1)(2008-10#1)
vs SCE##3##2##(1996-5#1)(1997-7#1)(2008-10#1)
vs external##2##2##(2008-11#1)(2008-8#1)
vs no##3##2##(2008-10#1)(2010-6#2)
vs pH for##2##3##(1991-9#2)
vs pH##3##2##(1991-9#3)
vs peers##2##2##(2008-12#2)
vs the##4##2##(1996-2#1)(2007-7#1)(2008-4#1)(2008-8#1)
vs##761##1##(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#6)(1991-12#5)(1991-2#1)(1991-4#4)(1991-5#8)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#10)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#9)(1992-3#1)(1992-5#2)(1992-9#4)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#2)(1993-8#6)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#8)(1994-3#4)(1994-5#2)(1994-6#9)(1994-8#3)(1994-9#5)(1995-1#1)(1995-12#15)(1995-2#5)(1995-3#9)(1995-8#2)(1995-9#1)(1996-1#7)(1996-2#15)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#8)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#6)(2006-10#7)(2007-10#25)(2007-11#3)(2007-2#2)(2007-5#1)(2007-7#8)(2007-8#24)(2008-1#9)(2008-10#40)(2008-11#17)(2008-12#7)(2008-3#20)(2008-4#10)(2008-5#13)(2008-6#5)(2008-7#27)(2008-8#16)(2008-9#9)(2009-10#3)(2009-11#9)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#13)(2009-9#3)(2010-1#4)(2010-11#5)(2010-2#2)(2010-3#10)(2010-4#33)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#15)(2011-2#47)(2012-1#6)(2012-12#28)(2012-2#3)(2012-3#32)(2013-1#28)(2013-7#2)(2013-8#20)
vuittenezi##3##1##(2008-10#3)
vulE and vulF##2##3##(2007-12#2)
vulF cells##2##2##(2007-12#2)
vulF##3##1##(2007-12#3)
vulcanization##3##1##(2008-10#3)
vulgare##12##1##(1995-6#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)
vulgare)##4##1##(2008-10#2)(2008-5#1)(2008-8#1)
vulgaris ESP6 could##2##3##(2013-1#2)
vulgaris ESP6##5##2##(2013-1#5)
vulgaris L##11##2##(2008-12#5)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
vulgaris is##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
vulgaris tissue homogenate##2##3##(2008-10#2)
vulgaris to##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
vulgaris##87##1##(1990-8#3)(1991-12#2)(1994-5#1)(1995-12#1)(1997-8#1)(2007-7#9)(2008-10#20)(2008-11#3)(2008-12#7)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#2)(2010-3#1)(2010-4#1)(2010-8#8)(2011-2#1)(2012-3#3)(2013-1#8)(2013-8#4)
vulgaris)##18##1##(2008-10#18)
vulgaris]##2##1##(1997-8#1)(2012-3#1)
vulgatus##3##1##(1997-2#3)
vulnerabilities of##2##2##(1997-3#1)(2011-2#1)
vulnerabilities##15##1##(1990-6#1)(1995-12#1)(1997-3#2)(2007-12#1)(2008-11#2)(2008-12#3)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
vulnerability and##6##2##(1994-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)
vulnerability factors##2##2##(1994-2#1)(2008-11#1)
vulnerability for##4##2##(2007-8#1)(2008-2#1)(2010-7#1)(2013-1#1)
vulnerability in##3##2##(2007-2#1)(2009-5#1)(2013-1#1)
vulnerability locus##2##2##(1997-5#2)
vulnerability of the##8##3##(1995-11#1)(1995-3#1)(1996-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
vulnerability of##13##2##(1990-5#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
vulnerability to alcoholism##5##3##(1994-2#2)(2007-8#2)(2008-6#1)
vulnerability to##23##2##(1994-2#2)(1994-6#1)(1995-11#1)(1996-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
vulnerability##86##1##(1990-5#2)(1991-2#1)(1994-2#4)(1994-6#1)(1995-11#2)(1995-3#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-5#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#2)(2009-4#6)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
vulnerable group##2##2##(2011-1#1)(2012-1#1)
vulnerable groups##2##2##(2008-10#1)(2013-8#1)
vulnerable in##2##2##(2009-5#1)(2012-12#1)
vulnerable infant##2##2##(2013-1#2)
vulnerable patients##2##2##(2012-2#1)(2013-1#1)
vulnerable plaque##5##2##(2008-10#1)(2012-2#4)
vulnerable plaques##6##2##(2008-10#3)(2008-7#1)(2012-2#2)
vulnerable population##7##2##(1993-2#1)(2008-12#1)(2009-4#1)(2009-5#1)(2009-9#3)
vulnerable populations##15##2##(1991-1#1)(1995-12#2)(1995-2#1)(1997-2#1)(2008-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#3)
vulnerable prey##2##2##(2008-8#2)
vulnerable to HIV infection##2##4##(2008-7#1)(2009-5#1)
vulnerable to HIV##3##3##(1996-11#1)(2008-7#1)(2009-5#1)
vulnerable to a##2##3##(2011-9#1)(2013-1#1)
vulnerable to any##3##3##(1991-1#1)(2013-1#2)
vulnerable to extinction##2##3##(2013-1#1)(2013-7#1)
vulnerable to infection##2##3##(2008-10#1)(2013-8#1)
vulnerable to the##6##3##(1995-2#1)(2007-12#1)(2008-8#1)(2012-2#1)(2013-1#2)
vulnerable to##43##2##(1991-1#1)(1993-6#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#4)(2008-8#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
vulnerable##128##1##(1990-2#1)(1991-1#2)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#6)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#5)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-9#2)(2011-1#2)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#16)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#3)
vulva and##3##2##(1993-1#2)(2008-10#1)
vulva##20##1##(1992-3#4)(1993-1#2)(1994-1#2)(1996-12#4)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-7#2)
vulval cells##2##2##(2007-12#2)
vulval development##2##2##(2007-12#2)
vulval fates)##2##2##(1990-11#2)
vulval induction##4##2##(1990-11#4)
vulval##12##1##(1990-11#7)(2007-12#5)
vulvar and vaginal##2##3##(2008-10#1)(2013-1#1)
vulvar cancer##2##2##(1992-3#1)(1993-9#1)
vulvar carcinoma##3##2##(1990-10#1)(1992-3#1)(1993-9#1)
vulvar squamous-cell##2##2##(1993-9#2)
vulvar##20##1##(1990-10#1)(1991-2#1)(1992-3#5)(1993-9#8)(1994-1#1)(1996-12#1)(2008-10#1)(2011-1#1)(2013-1#1)
vulvovaginal candidiasis##7##2##(2008-5#4)(2011-1#2)(2012-3#1)
vulvovaginal##9##1##(2007-10#1)(2008-5#4)(2011-1#2)(2011-2#1)(2012-3#1)
vvCCL19##3##1##(2013-1#3)
vying for##2##2##(2008-10#1)(2010-4#1)
w v(-1)##2##2##(2008-10#2)
w##22##1##(1991-5#3)(1992-12#1)(2007-10#3)(2007-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-3#1)(2010-4#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
w(m##3##1##(2007-11#3)
w(w) decreased##2##2##(2008-12#2)
w-3##5##1##(2008-9#5)
w/o##5##1##(2008-5#5)
w/v##12##1##(2008-10#7)(2008-12#1)(2008-5#2)(2008-6#1)(2012-2#1)
w/v)##14##1##(1996-12#1)(2008-10#5)(2008-12#2)(2008-6#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
w/w (C(4##6##2##(2008-5#6)
w/w carrier in##2##3##(2008-10#2)
w/w for##2##2##(1992-11#1)(2008-10#1)
w/w of##4##2##(2008-10#2)(2010-3#2)
w/w##27##1##(1992-11#1)(2008-10#9)(2008-5#9)(2008-7#1)(2008-8#1)(2010-3#5)(2011-2#1)
w/w% Ag-zeolite could show a sufficient antimicrobial effect against##2##9##(2008-5#2)
w/w% Ag-zeolite##3##2##(2008-5#3)
w/w%##5##1##(2008-5#5)
w/w) and##2##2##(1993-11#2)
w/w) in##3##2##(2008-10#2)(2009-6#1)
w/w)##29##1##(1993-11#6)(1993-6#1)(1996-5#1)(2008-10#12)(2008-5#3)(2008-6#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-4#1)(2013-1#1)
w19##2##1##(1994-12#2)
w5##2##1##(1994-12#2)
wR(2) = 0##4##3##(1996-2#4)
wa##2##1##(2008-8#1)(2009-7#1)
waf1/p21##2##1##(2008-9#2)
wafer and##2##2##(2008-10#1)(2008-3#1)
wafer by##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
wafer that##2##2##(2008-3#2)
wafer with##2##2##(2007-12#2)
wafer##28##1##(1992-6#2)(2007-11#1)(2007-12#6)(2008-10#4)(2008-2#2)(2008-3#11)(2008-7#1)(2009-7#1)
wafers and##3##2##(1992-6#1)(2008-3#1)(2008-7#1)
wafers of##3##2##(2008-3#2)(2008-7#1)
wafers##19##1##(1992-6#2)(2007-11#1)(2008-2#1)(2008-3#11)(2008-4#1)(2008-7#2)(2012-2#1)
wage and price controls##3##4##(1994-12#3)
wage and salary##2##3##(1994-3#1)(2012-12#1)
wage and##5##2##(1994-12#3)(1994-3#1)(2012-12#1)
wage index##2##2##(1992-12#1)(1992-2#1)
wage rates##2##2##(1992-1#2)
wage##15##1##(1992-1#2)(1992-12#3)(1992-2#1)(1993-6#1)(1994-12#3)(1994-3#1)(2011-2#1)(2012-12#2)(2013-8#1)
wages and salaries##2##3##(1992-1#1)(1994-1#1)
wages and##3##2##(1992-1#1)(1994-1#1)(1996-2#1)
wages##9##1##(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1994-1#1)(1996-2#1)(1996-3#1)(2008-11#1)
waist and##3##2##(2007-11#2)(2011-2#1)
waist circumference and##3##3##(2010-8#1)(2011-1#1)(2013-1#1)
waist circumference to##2##3##(1996-8#1)(2008-11#1)
waist circumference##21##2##(1996-8#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#1)(2013-1#1)
waist obesity was independently associated with abnormal ALT levels##2##9##(2013-1#2)
waist obesity##3##2##(2013-1#3)
waist of##3##2##(2008-2#1)(2008-3#2)
waist radius of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
waist##49##1##(1996-8#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-9#5)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-12#1)(2013-1#4)
waist-hip ratio##2##2##(2011-2#2)
waist-hip##3##1##(2008-12#1)(2011-2#2)
waist-to-hip ratio (WHR)##5##3##(2007-12#3)(2008-3#1)(2011-1#1)
waist-to-hip ratio##13##2##(1990-9#6)(2007-12#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
waist-to-hip##15##1##(1990-9#8)(2007-12#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
waist/hip ratio##4##2##(1994-12#2)(1997-7#1)(2008-5#1)
wait and##2##2##(2008-8#1)(2009-5#1)
wait for##6##2##(1994-1#1)(1996-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)
wait listing##2##2##(1995-12#2)
wait times and##2##3##(2009-3#2)
wait times##4##2##(2009-3#3)(2010-8#1)
wait to##2##2##(2008-8#1)(2008-9#1)
wait until##2##2##(1993-3#1)(2013-7#1)
wait while##2##2##(1991-3#1)(1996-3#1)
wait##24##1##(1991-3#1)(1993-3#1)(1994-1#1)(1995-12#3)(1996-11#1)(1996-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#4)(2009-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
wait-list##2##1##(2011-1#1)(2012-2#1)
waited until##2##2##(1994-12#1)(1995-6#1)
waited##4##1##(1992-5#1)(1994-12#1)(1995-6#1)(2008-8#1)
waiting for the##2##3##(1995-5#1)(2008-6#1)
waiting for##15##2##(1992-1#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
waiting in the##2##3##(1991-12#1)(1996-1#1)
waiting list##21##2##(1991-11#6)(1993-2#3)(1996-11#1)(1997-1#6)(2007-8#1)(2008-5#1)(2011-2#1)(2011-3#2)
waiting lists and##2##3##(1991-11#1)(1993-2#1)
waiting lists in##2##3##(1991-11#2)
waiting lists##16##2##(1991-11#7)(1992-12#1)(1993-2#5)(1996-8#1)(2007-12#1)(2011-3#1)
waiting period##3##2##(1994-2#1)(2006-8#1)(2008-5#1)
waiting time and##2##3##(1991-11#1)(2012-2#1)
waiting time for##5##3##(1991-11#3)(1992-12#1)(2008-5#1)
waiting time to see##2##4##(1994-2#1)(2007-8#1)
waiting time##19##2##(1991-11#10)(1992-12#1)(1993-12#1)(1994-2#2)(2007-8#1)(2008-5#3)(2012-2#1)
waiting times##8##2##(1991-11#1)(1995-12#1)(1997-5#1)(2008-11#2)(2008-5#1)(2008-9#2)
waiting##97##1##(1991-11#27)(1991-12#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-2#8)(1994-2#3)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-8#2)(1997-1#6)(1997-2#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#4)(2012-2#2)(2013-1#1)(2013-8#1)
waiting)##2##1##(2010-10#1)(2011-3#1)
waitlist##2##1##(2011-1#1)(2012-2#1)
waiver is##2##2##(1992-2#1)(1997-2#1)
waiver patients and##2##3##(1997-2#2)
waiver program is##3##3##(1991-1#1)(1993-1#1)(1997-2#1)
waiver program##4##2##(1991-1#1)(1993-1#2)(1997-2#1)
waiver programs##2##2##(1994-2#1)(1996-2#1)
waiver##33##1##(1991-1#4)(1992-2#5)(1993-1#4)(1993-9#2)(1994-2#1)(1996-1#2)(1996-12#2)(1996-2#3)(1997-2#9)(2012-3#1)
waivers##9##1##(1991-3#1)(1994-12#1)(1996-1#7)
wake onset time##2##3##(1996-7#2)
wake##11##1##(1990-7#1)(1991-3#1)(1995-1#1)(1996-7#3)(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-12#1)
wake-up##3##1##(1993-2#1)(2011-2#2)
wakefulness##5##1##(1992-8#1)(2007-6#2)(2012-2#2)
waking MW##2##2##(2013-8#2)
waking##12##1##(1991-5#2)(1992-5#1)(1993-12#1)(2007-8#2)(2008-11#1)(2013-1#1)(2013-8#4)
walk distance##4##2##(2010-10#1)(2011-2#1)(2013-1#2)
walk test##2##2##(2008-10#1)(2011-2#1)
walk time##2##2##(2007-10#2)
walk##36##1##(1991-3#1)(1991-9#1)(1996-3#1)(1996-9#3)(2007-10#3)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
walk-off##12##1##(2007-11#9)(2007-12#3)
walk-off-free nonlinear optical loop mirror##2##5##(2007-11#2)
walk-off-free##3##1##(2007-11#3)
walked##7##1##(1992-5#1)(1996-3#1)(2013-1#5)
walker##3##1##(2010-12#1)(2010-5#1)(2013-1#1)
walkeri##11##1##(2008-10#11)
walkers##7##1##(2008-7#1)(2013-1#6)
walking abilities##2##2##(2009-4#1)(2010-12#1)
walking ability##4##2##(1996-9#3)(2010-10#1)
walking aids##2##2##(2008-8#2)
walking and##7##2##(1993-12#1)(2008-4#1)(2008-9#1)(2013-1#4)
walking at similar speeds##2##4##(2007-10#2)
walking at##3##2##(2007-10#3)
walking distance##4##2##(1995-2#1)(2010-12#1)(2010-3#1)(2010-4#1)
walking in##3##2##(1997-2#1)(2007-10#1)(2013-1#1)
walking legs of##3##3##(2007-12#3)
walking legs##5##2##(2007-12#5)
walking on##2##2##(1997-2#1)(2008-6#1)
walking speed##3##2##(1991-3#1)(2007-10#1)(2013-1#1)
walking test##3##2##(2007-8#1)(2013-1#2)
walking up##2##2##(2008-7#2)
walking was##2##2##(1993-12#1)(2008-10#1)
walking with##2##2##(2010-3#1)(2012-12#1)
walking##96##1##(1990-6#2)(1991-3#1)(1993-12#7)(1994-8#1)(1995-2#2)(1996-6#1)(1996-9#3)(1997-2#3)(2007-10#6)(2007-11#2)(2007-12#18)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-4#4)(2010-10#1)(2010-12#2)(2010-3#4)(2010-4#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#16)(2013-8#1)
walks of life##2##3##(1994-9#1)(2008-7#1)
walks##5##1##(1993-1#1)(1994-9#1)(1995-2#1)(2008-7#1)(2010-4#1)
wall after##3##2##(1995-3#1)(2012-1#1)(2012-2#1)
wall and in##2##3##(1996-12#1)(2010-3#1)
wall and the##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
wall and##31##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-9#1)(1996-12#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-8#1)
wall apposition##2##2##(2008-10#2)
wall appositions and##4##3##(2008-10#4)
wall appositions##11##2##(2008-10#11)
wall are##3##2##(2007-12#1)(2007-8#1)(2008-12#1)
wall as##5##2##(1990-9#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-8#1)
wall assembly##2##2##(2009-10#1)(2012-1#1)
wall at the##2##3##(2007-8#1)(2008-10#1)
wall by##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
wall defect##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
wall deposition##2##2##(2008-10#1)(2009-10#1)
wall dissolution around invading hyphae##2##5##(2008-10#2)
wall during##4##2##(2008-5#1)(2008-9#2)(2012-12#1)
wall dynamics in##2##3##(2009-6#2)
wall following##2##2##(1991-5#1)(2009-3#1)
wall formation##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
wall from##2##2##(2008-10#1)(2009-7#1)
wall hydatidosis##2##2##(2007-12#2)
wall imaging##2##2##(2010-9#2)
wall in##7##2##(1990-9#1)(1991-1#2)(1992-9#1)(1997-8#1)(2008-11#1)(2008-7#1)
wall invasion##2##2##(1990-9#2)
wall is a rare##4##4##(1997-8#1)(2007-12#1)(2007-8#2)
wall is##11##2##(1990-5#1)(1991-9#1)(1994-7#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)
wall jet##2##2##(2008-10#2)
wall may##3##2##(1992-9#1)(2008-7#1)(2011-2#1)
wall motion abnormalities##5##3##(2007-8#2)(2011-2#1)(2013-1#2)
wall motion abnormality##4##3##(1997-3#3)(2012-2#1)
wall motion##14##2##(1997-3#3)(1997-8#2)(2007-8#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
wall of both##2##3##(2008-5#1)(2011-2#1)
wall of left##4##3##(2008-7#4)
wall of the right##2##4##(2007-8#2)
wall of the urinary bladder##2##5##(1997-2#1)(2011-2#1)
wall of the##32##3##(1990-11#1)(1993-12#1)(1993-9#1)(1997-2#1)(1997-8#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-8#5)(2008-10#5)(2008-12#2)(2008-7#2)(2008-9#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
wall of##53##2##(1990-11#1)(1993-12#1)(1993-9#1)(1997-2#1)(1997-8#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-8#6)(2008-10#11)(2008-12#2)(2008-5#3)(2008-7#6)(2008-9#1)(2009-2#1)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
wall or##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
wall painting##2##2##(2008-10#2)
wall paintings found in##2##4##(2008-10#2)
wall paintings##5##2##(2008-10#5)
wall permeability##2##2##(2008-9#1)(2010-12#1)
wall pore sensilla##2##3##(2007-12#2)
wall pore##3##2##(2007-12#3)
wall reconstruction##13##2##(2008-9#1)(2012-2#12)
wall reflectivity##2##2##(2008-3#2)
wall region##2##2##(2008-9#2)
wall revealed##2##2##(1991-12#1)(2008-10#1)
wall sarcoma##2##2##(2008-6#2)
wall shear rate##3##3##(2008-9#3)
wall shear stress (WSS)##2##4##(2011-2#1)(2013-1#1)
wall shear stress##8##3##(1992-12#1)(2008-11#1)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
wall shear##12##2##(1992-12#1)(2008-11#2)(2008-9#3)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
wall stress##6##2##(1996-3#1)(2008-7#3)(2009-1#1)(2009-7#1)
wall surface##3##2##(2008-10#2)(2008-7#1)
wall synthesis##2##2##(2008-3#1)(2009-10#1)
wall temperature##2##2##(2008-2#2)
wall that##2##2##(2008-10#1)(2008-3#1)
wall thickening##6##2##(1992-5#1)(1997-8#1)(2008-10#3)(2011-2#1)
wall thickness and##2##3##(2007-8#1)(2011-2#1)
wall thickness##18##2##(1993-12#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#3)(2009-1#1)(2009-11#1)(2011-2#4)(2012-2#1)
wall to##8##2##(1997-6#1)(2008-10#2)(2009-12#1)(2009-7#3)(2011-2#1)
wall tuberculosis is##2##3##(2007-8#2)
wall tuberculosis##4##2##(2007-8#4)
wall tumors##3##2##(2012-2#3)
wall was##12##2##(1992-12#1)(1995-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-12#1)
wall were##2##2##(2007-8#1)(2013-8#1)
wall which##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
wall with##5##2##(1996-3#1)(2007-12#1)(2007-8#1)(2008-9#1)(2009-1#1)
wall##653##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#3)(1991-12#7)(1991-5#1)(1991-9#1)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-9#2)(1994-1#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-3#6)(1995-6#6)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-6#4)(1997-7#1)(1997-8#11)(2006-10#2)(2006-12#3)(2006-6#2)(2007-11#4)(2007-12#15)(2007-7#1)(2007-8#37)(2008-10#122)(2008-11#11)(2008-12#8)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#19)(2008-6#16)(2008-7#33)(2008-8#3)(2008-9#20)(2009-1#5)(2009-10#8)(2009-11#5)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#1)(2009-6#13)(2009-7#14)(2009-8#1)(2009-9#1)(2010-10#5)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#5)(2011-1#4)(2011-10#1)(2011-2#49)(2011-7#1)(2012-1#7)(2012-12#10)(2012-2#53)(2012-3#3)(2013-1#15)(2013-8#5)
wall)##3##1##(1993-3#1)(2007-5#1)(2008-10#1)
wall-bound##2##1##(2008-10#2)
wall-jet (flow-onto)##2##2##(2008-10#2)
wall-jet amperometric detection##3##3##(2008-10#3)
wall-jet cell##3##2##(2008-10#3)
wall-jet configuration##3##2##(2008-10#3)
wall-jet detector##2##2##(2008-10#2)
wall-jet##14##1##(2008-10#14)
wall-less##2##1##(2008-10#2)
wall-pore sensilla##3##2##(2008-7#3)
wall-pore##4##1##(2007-12#1)(2008-7#3)
wall]##3##1##(1990-5#1)(1991-5#1)(2011-2#1)
walled##3##1##(2008-7#1)(2012-12#1)(2012-2#1)
wallengreni n##3##2##(2013-8#3)
walls and##6##2##(1991-9#1)(2008-10#2)(2010-4#1)(2012-3#1)(2013-1#1)
walls are##3##2##(1991-6#1)(2007-12#1)(2011-2#1)
walls by##3##2##(1997-6#1)(2008-11#1)(2013-8#1)
walls during##2##2##(2008-10#1)(2008-11#1)
walls in##4##2##(2008-10#3)(2009-6#1)
walls is##2##2##(2008-3#1)(2009-11#1)
walls of a##4##3##(1997-2#1)(2008-10#3)
walls of the##13##3##(1996-5#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
walls of##40##2##(1996-5#1)(1997-2#1)(2007-12#5)(2008-10#23)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
walls were##5##2##(2008-10#4)(2012-2#1)
walls with##2##2##(2007-8#1)(2008-10#1)
walls##150##1##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#4)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#62)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#4)(2009-10#2)(2009-11#2)(2009-6#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
wan##2##1##(2008-4#2)
wander##2##1##(2008-3#1)(2008-7#1)
wandering behavior##2##2##(1996-5#2)
wandering##8##1##(1995-4#1)(1996-5#3)(2008-9#1)(2013-8#3)
waning##2##1##(2008-2#1)(2009-5#1)
want him to##2##3##(1992-3#2)
want to be##5##3##(1995-12#1)(1997-5#1)(2008-1#1)(2012-2#1)(2013-8#1)
want to emphasize##2##3##(2012-2#2)
want to know whether##2##4##(2009-5#1)(2012-3#1)
want to know##3##3##(2008-11#1)(2009-5#1)(2012-3#1)
want to learn##2##3##(1993-3#1)(1994-1#1)
want to use##2##3##(2008-4#1)(2011-1#1)
want to work##2##3##(1997-2#1)(2011-1#1)
want to##49##2##(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#4)(1994-1#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-12#2)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
want##69##1##(1992-1#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-3#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-7#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-5#1)(2007-12#2)(2008-1#4)(2008-10#2)(2008-11#4)(2008-4#3)(2008-7#3)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#1)(2013-8#1)
want?##3##1##(1994-12#1)(1995-3#1)(2007-9#1)
wanted more##2##2##(1993-3#1)(1997-5#1)
wanted to compare the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
wanted to compare##4##3##(2008-11#1)(2011-2#2)(2013-1#1)
wanted to determine##3##3##(2008-10#1)(2008-4#1)(2013-7#1)
wanted to##25##2##(1990-2#1)(1991-7#1)(1992-11#1)(1995-5#2)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#7)(2013-1#2)(2013-7#1)
wanted##30##1##(1990-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-5#2)(1995-6#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#7)(2013-1#2)(2013-7#1)
wanting to##4##2##(1992-8#1)(2008-12#1)(2008-9#1)(2010-3#1)
wanting##6##1##(1992-8#1)(2007-10#1)(2008-12#1)(2008-9#1)(2010-3#1)(2013-1#1)
wants to##7##2##(1995-5#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-1#1)(2013-7#1)
wants##14##1##(1992-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-8#2)(1997-3#2)(2007-12#1)(2007-7#1)(2008-1#1)(2009-5#1)(2012-12#1)(2013-7#1)
war and##7##2##(1994-9#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2013-1#2)
war in##2##2##(1993-9#1)(2008-11#1)
war##37##1##(1990-6#2)(1991-3#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-9#2)(1996-11#1)(1996-3#1)(1997-5#1)(1997-6#3)(2007-11#1)(2007-7#5)(2008-10#5)(2008-11#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
ward after##2##2##(2007-11#2)
ward and in##2##3##(1992-6#1)(2008-11#1)
ward and the##2##3##(2008-11#1)(2010-3#1)
ward and##7##2##(1992-6#1)(2008-11#2)(2008-7#2)(2010-3#1)(2012-2#1)
ward in##4##2##(1991-8#1)(1993-12#1)(2011-2#1)(2012-3#1)
ward of##3##2##(1993-2#1)(2007-2#1)(2008-2#1)
ward situations##2##2##(2011-1#2)
ward staff##4##2##(2007-10#1)(2011-1#2)(2013-8#1)
ward stock##3##2##(2010-3#3)
ward visits by a pharmacist##2##5##(2010-3#2)
ward##74##1##(1990-3#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1996-2#1)(1997-3#1)(2007-10#2)(2007-11#3)(2007-2#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-7#2)(2010-3#10)(2010-5#1)(2010-6#1)(2010-8#8)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#7)
wards and##4##2##(2010-3#1)(2013-8#3)
wards as##3##2##(1993-9#1)(2013-1#2)
wards of##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
wards that##3##2##(2008-7#1)(2013-1#2)
wards were##3##2##(2013-1#2)(2013-8#1)
wards##53##1##(1992-6#5)(1993-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#9)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#14)(2013-8#5)
ware false##2##2##(2011-2#2)
ware##6##1##(2008-10#3)(2011-2#3)
warehousing##3##1##(2008-4#2)(2008-7#1)
warfare agent##6##2##(2008-10#1)(2008-11#5)
warfare agents##6##2##(2008-10#1)(2008-11#5)
warfare in##2##2##(1993-12#1)(1995-1#1)
warfare##23##1##(1990-2#2)(1991-3#1)(1992-12#5)(1993-12#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-11#10)
warfarin in the##2##3##(2011-1#1)(2012-12#1)
warfarin in##4##2##(1990-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
warfarin therapy##2##2##(2012-1#2)
warfarin was##2##2##(2008-10#1)(2011-1#1)
warfarin##37##1##(1990-12#4)(1990-9#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#2)(2009-11#2)(2010-4#2)(2010-8#1)(2011-1#6)(2012-1#3)(2012-12#9)(2013-8#1)
warm and##6##2##(1991-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-6#1)
warm blood cardioplegia##5##3##(1991-3#2)(1996-9#3)
warm on cold##2##3##(1990-2#2)
warm season##3##2##(2008-10#3)
warm winters##2##2##(2008-10#1)(2012-4#1)
warm##45##1##(1990-12#1)(1990-2#3)(1991-3#2)(1991-8#2)(1993-12#1)(1993-3#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-9#3)(2007-12#2)(2008-10#10)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#3)(2012-4#3)(2012-6#1)(2012-7#1)
warm-blooded##3##1##(1994-12#1)(2008-5#1)(2011-2#1)
warm-up##4##1##(2008-10#1)(2008-2#1)(2009-1#1)(2013-1#1)
warmer and drier##3##3##(2008-10#2)(2012-7#1)
warmer and##5##2##(2008-10#3)(2012-7#2)
warmer locations##3##2##(2008-10#3)
warmer temperatures##3##2##(2008-10#2)(2008-5#1)
warmer##18##1##(2008-10#10)(2008-5#1)(2008-8#1)(2009-11#1)(2012-5#2)(2012-7#2)(2013-1#1)
warming and##7##2##(1996-8#1)(2012-5#3)(2012-6#2)(2012-7#1)
warming##44##1##(1992-1#1)(1992-3#3)(1995-3#1)(1996-1#1)(1996-8#1)(2007-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-5#8)(2012-6#11)(2012-7#2)(2012-8#1)(2012-9#4)(2013-7#1)(2013-8#2)
warmth and competence##2##3##(2009-11#2)
warmth and##5##2##(2008-11#1)(2009-11#4)
warmth in##2##2##(2006-10#1)(2009-9#1)
warmth on##2##2##(2010-1#1)(2012-3#1)
warmth##24##1##(1996-6#1)(2006-10#1)(2007-10#2)(2008-1#1)(2008-11#2)(2009-11#9)(2009-9#1)(2010-1#6)(2012-3#1)
warn of##2##2##(1990-3#1)(2013-1#1)
warn us of##2##3##(2008-7#1)(2008-8#1)
warn##9##1##(1990-3#1)(1993-2#1)(1994-3#1)(1997-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
warned##4##1##(2007-2#1)(2008-11#1)(2008-12#1)(2011-1#1)
warning about##2##2##(2008-10#1)(2013-1#1)
warning signs of##4##3##(1992-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
warning signs##7##2##(1992-1#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2013-1#1)
warning system was##2##3##(2008-10#2)
warning system##7##2##(2008-10#6)(2008-8#1)
warning systems##6##2##(1991-12#1)(2008-10#5)
warning was##2##2##(2013-1#1)(2013-8#1)
warning##43##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
warnings##8##1##(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
warns about##2##2##(1992-8#1)(2013-1#1)
warns##3##1##(1992-2#1)(1992-8#1)(2013-1#1)
warp##2##1##(2008-12#1)(2012-1#1)
warping##2##1##(2008-6#1)(2010-8#1)
warps##2##1##(2008-3#1)(2009-7#1)
warrant extensive##2##2##(1991-4#1)(2007-7#1)
warrant further investigation##2##3##(1992-2#1)(2013-1#1)
warrant further study##2##3##(2008-4#1)(2013-8#1)
warrant further##10##2##(1992-2#1)(1996-2#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
warrant the##2##2##(1995-6#1)(2008-10#1)
warrant##31##1##(1991-4#1)(1992-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
warranted and##4##2##(1991-12#1)(1996-3#1)(2008-11#1)(2011-2#1)
warranted in##5##2##(1990-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
warranted to determine##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
warranted to##15##2##(1992-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-4#1)(2011-2#1)(2013-1#1)
warranted using##2##2##(2007-11#1)(2012-3#1)
warranted##70##1##(1990-10#1)(1990-12#2)(1991-12#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-12#1)(1996-12#1)(1996-3#2)(1997-2#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#1)(2009-4#2)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)
warranting##5##1##(1992-12#1)(2008-7#1)(2009-11#1)(2013-1#2)
warrants a##3##2##(2008-7#1)(2013-1#2)
warrants an examination of##2##4##(1991-12#1)(2008-11#1)
warrants consideration##2##2##(1990-12#1)(2008-7#1)
warrants further investigation##3##3##(2008-5#1)(2009-8#1)(2013-1#1)
warrants further study##2##3##(2008-10#1)(2008-5#1)
warrants further##7##2##(2007-8#1)(2008-10#1)(2008-5#2)(2009-8#1)(2011-2#1)(2013-1#1)
warrants the##2##2##(2011-1#1)(2013-8#1)
warrants##26##1##(1990-12#1)(1990-8#1)(1991-12#1)(1996-12#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
wars##6##1##(1991-3#1)(1992-8#1)(2007-7#4)
warts##18##1##(1996-1#2)(2007-12#5)(2008-4#4)(2011-1#2)(2013-1#5)
was $5##2##2##(1994-9#1)(1995-1#1)
was &gt##27##2##(1993-1#1)(1994-9#1)(1996-2#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#1)(2009-2#2)(2010-11#1)(2011-2#3)(2012-1#1)
was &lt##28##2##(1994-9#2)(2007-11#1)(2008-10#19)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
was &quot##8##2##(1990-2#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-1#1)(2012-3#1)
was (0##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)
was (1)##2##2##(1990-11#1)(1991-3#1)
was +/-0##3##2##(2008-10#3)
was -0##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
was 0##387##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#3)(1992-11#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#4)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-4#2)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#220)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-3#1)(2009-8#3)(2009-9#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#5)
was 0%##5##2##(1990-2#1)(1991-2#1)(2007-8#1)(2008-10#1)(2008-6#1)
was 1 and##3##3##(2008-10#2)(2008-5#1)
was 1 mol of S-1 per##2##6##(1991-5#2)
was 1##199##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-9#2)(1992-10#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#2)(1997-9#1)(2007-11#5)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#91)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-12#1)(2012-3#8)(2013-1#4)(2013-7#1)(2013-8#1)
was 1%##2##2##(1997-8#1)(2011-3#1)
was 1-10##2##2##(2008-10#2)
was 10 mm##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
was 10 months##4##3##(1990-2#1)(1990-8#1)(1991-4#1)(2008-6#1)
was 10##46##2##(1990-2#1)(1990-8#1)(1991-4#1)(1992-3#1)(1995-3#1)(1996-9#2)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
was 10% in##2##3##(1996-9#1)(2011-2#1)
was 10%##3##2##(1996-9#1)(2010-6#1)(2011-2#1)
was 10(4)##2##2##(2007-11#1)(2007-12#1)
was 100##6##2##(1991-8#1)(1994-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
was 100% and##2##3##(2007-8#1)(2010-6#1)
was 100% in##3##3##(1994-12#1)(1997-3#1)(2012-3#1)
was 100% with##2##3##(2007-2#1)(2008-9#1)
was 100%##25##2##(1990-10#1)(1991-2#1)(1994-12#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#4)(2013-1#1)
was 101##2##2##(1992-11#1)(2008-10#1)
was 107##3##2##(1991-12#1)(2007-12#1)(2008-1#1)
was 11 months (range##3##4##(1990-8#1)(1991-6#1)(2008-10#1)
was 11##29##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-6#2)(1992-5#1)(1994-11#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
was 11%##4##2##(1990-6#1)(1996-12#1)(2008-10#1)(2010-3#1)
was 119##2##2##(1997-5#1)(2013-8#1)
was 12 months##2##3##(1990-2#1)(1994-11#1)
was 12 ng##2##3##(2008-10#2)
was 12##22##2##(1990-2#2)(1994-11#1)(1996-8#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
was 12%##5##2##(1994-3#1)(1996-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
was 120##2##2##(2008-10#2)
was 13 months##2##3##(1991-6#1)(2008-10#1)
was 13 ng##2##3##(2008-10#2)
was 13##22##2##(1991-12#1)(1991-6#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
was 13%##4##2##(1990-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
was 14##18##2##(1990-12#2)(1992-3#1)(1995-8#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-4#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was 14%##4##2##(2007-10#2)(2007-12#1)(2011-1#1)
was 15 days##2##3##(1990-12#1)(2013-1#1)
was 15##28##2##(1990-12#1)(1991-1#1)(1992-3#2)(1994-9#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-6#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
was 15%##2##2##(1991-11#1)(2013-1#1)
was 150##3##2##(2007-12#1)(2008-10#2)
was 1500##2##2##(2008-2#1)(2008-3#1)
was 151##3##2##(1997-5#2)(2013-1#1)
was 16##17##2##(1991-1#1)(1994-6#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-6#1)(2009-10#1)(2013-1#1)(2013-8#2)
was 16%##2##2##(2008-8#1)(2008-9#1)
was 160##2##2##(1991-12#1)(1991-8#1)
was 17 months##2##3##(2007-8#1)(2008-10#1)
was 17##19##2##(1990-8#1)(1990-9#1)(1993-9#1)(1995-8#1)(1996-6#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
was 170##2##2##(2008-10#1)(2008-12#1)
was 18 months old##2##4##(2010-6#1)(2011-2#1)
was 18##18##2##(1991-6#1)(2007-8#2)(2008-10#5)(2008-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-8#2)
was 18%##6##2##(1997-6#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
was 185##2##2##(2007-11#1)(2008-11#1)
was 19##12##2##(1990-9#1)(1992-2#1)(1993-10#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2013-1#1)(2013-8#1)
was 19%##2##2##(1991-6#1)(2008-3#1)
was 2 days##2##3##(1993-2#1)(2009-9#1)
was 2##140##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-11#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#65)(2008-11#5)(2008-12#6)(2008-3#3)(2008-5#4)(2008-6#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
was 2%##9##2##(1990-2#1)(1993-9#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-6#1)
was 2-3 times##2##3##(1992-8#1)(1993-12#1)
was 2-fold##3##2##(1995-3#1)(2008-10#1)(2012-2#1)
was 20 months##2##3##(2007-11#1)(2008-9#1)
was 20##29##2##(1991-2#1)(1992-3#1)(1995-12#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was 20% in##2##3##(2008-10#1)(2008-5#1)
was 20%##3##2##(1993-5#1)(2008-10#1)(2008-5#1)
was 200##2##2##(2008-10#1)(2008-9#1)
was 203##2##2##(1995-12#1)(2011-2#1)
was 21 months##3##3##(2008-6#1)(2010-11#1)(2011-1#1)
was 21##10##2##(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
was 210##3##2##(1996-11#1)(2008-10#1)(2008-3#1)
was 213##2##2##(2007-11#1)(2008-3#1)
was 22##8##2##(1992-9#1)(1995-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#2)
was 22%##6##2##(1990-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
was 23##10##2##(1994-9#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2013-1#1)(2013-8#2)
was 23%##2##2##(2008-7#1)(2010-3#1)
was 24##10##2##(1991-11#1)(1992-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)
was 24%##2##2##(2007-7#1)(2008-6#1)
was 240##2##2##(2007-11#1)(2010-7#1)
was 25 degrees C##2##4##(2008-10#1)(2011-1#1)
was 25 min##2##3##(1994-3#1)(2008-10#1)
was 25##14##2##(1992-11#1)(1994-3#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
was 25% higher in##2##4##(2008-10#1)(2008-11#1)
was 25%##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
was 25-fold##2##2##(2008-10#2)
was 26##6##2##(1991-12#1)(1991-6#1)(1993-11#1)(2007-8#2)(2012-12#1)
was 27##12##2##(1991-12#1)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
was 27%##2##2##(2011-2#2)
was 28##16##2##(1990-11#1)(1992-11#1)(1992-12#1)(1995-11#1)(1995-4#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#3)(2013-1#1)(2013-8#2)
was 29##12##2##(1990-9#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#2)(2010-1#1)(2012-3#1)
was 2x10(-6)##2##2##(2008-10#2)
was 3 days##4##3##(1997-3#1)(2008-10#2)(2013-8#1)
was 3 x 10(-7)M for##2##5##(2008-10#2)
was 3##118##2##(1990-2#2)(1991-11#1)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1995-6#2)(1996-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#54)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#2)
was 3%##6##2##(2007-8#1)(2008-10#4)(2013-8#1)
was 3-fold##2##2##(1994-5#1)(1995-2#1)
was 30 degrees C##2##4##(1997-6#1)(2008-10#1)
was 30 degrees##3##3##(1997-6#1)(2008-10#1)(2012-2#1)
was 30##17##2##(1992-10#1)(1992-9#1)(1994-11#1)(1997-6#1)(2008-10#4)(2008-5#2)(2008-6#2)(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
was 30%##7##2##(1991-6#1)(1997-5#1)(2008-10#1)(2008-4#1)(2010-3#1)(2010-9#1)(2011-2#1)
was 300##2##2##(2007-11#1)(2008-10#1)
was 31##9##2##(1994-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#2)
was 32 weeks##2##3##(1991-6#1)(2013-8#1)
was 32##10##2##(1991-11#1)(1991-6#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
was 33 +/-##2##3##(2012-3#1)(2013-1#1)
was 33##15##2##(1990-8#1)(1992-11#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-6#1)(2011-1#2)(2012-3#2)(2013-1#1)
was 33%##5##2##(1990-6#1)(1991-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
was 330##2##2##(1990-10#1)(2008-10#1)
was 34##9##2##(1993-6#1)(1993-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
was 34%##5##2##(1994-6#1)(1997-4#1)(2008-2#1)(2008-8#1)(2010-8#1)
was 35##6##2##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
was 35%##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
was 36 for##2##3##(2008-10#2)
was 36 months (range##2##4##(2008-11#1)(2010-3#1)
was 36##16##2##(1990-10#1)(1996-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
was 36%##5##2##(1990-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
was 37##12##2##(1991-11#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
was 38##6##2##(1995-2#1)(2008-10#2)(2008-8#1)(2009-3#1)(2010-8#1)
was 38%##5##2##(1996-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
was 39##14##2##(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1997-6#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#2)(2010-3#1)(2013-1#1)
was 39%##2##2##(1994-3#1)(1996-12#1)
was 4 months##3##3##(1990-2#1)(2008-7#1)(2012-12#1)
was 4 to##2##3##(1996-8#1)(2008-6#1)
was 4 x##2##3##(1995-2#1)(2010-1#1)
was 4##86##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#4)(2008-10#29)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#3)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#3)
was 4% for##2##3##(2008-10#2)
was 4%##7##2##(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
was 40##13##2##(1990-12#1)(1991-2#1)(1994-6#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#3)
was 40%##4##2##(1992-12#1)(1995-5#1)(2008-3#1)(2012-2#1)
was 41##7##2##(1993-8#1)(1994-7#1)(2007-7#1)(2008-10#2)(2012-2#1)(2012-3#1)
was 41%##4##2##(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
was 42##10##2##(1994-11#1)(1994-12#1)(1995-5#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
was 43##4##2##(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)
was 43%##4##2##(1991-8#1)(1997-6#1)(2008-2#1)(2012-2#1)
was 435##2##2##(1992-12#1)(2008-10#1)
was 44##5##2##(1994-9#1)(2008-10#2)(2009-5#1)(2013-1#1)
was 45 kDa##2##3##(1991-8#1)(1993-1#1)
was 45##11##2##(1991-2#1)(1991-8#1)(1993-1#1)(1995-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
was 45%##2##2##(2008-3#1)(2008-8#1)
was 46##8##2##(1997-2#1)(1997-3#2)(2007-2#2)(2007-7#1)(2008-10#1)(2011-1#1)
was 46%##2##2##(1991-4#1)(2008-12#1)
was 47##5##2##(1996-3#1)(2007-4#1)(2011-2#2)(2012-3#1)
was 47% in##2##3##(1990-2#1)(2008-2#1)
was 47%##5##2##(1990-2#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
was 48##11##2##(1992-5#1)(1996-9#1)(1997-5#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
was 49##10##2##(1993-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#2)
was 49%##2##2##(2008-11#1)(2010-12#1)
was 5 and##2##3##(2007-8#1)(2008-10#1)
was 5 months##2##3##(1994-8#1)(2010-3#1)
was 5 to##2##3##(2008-10#1)(2013-1#1)
was 5 x##3##3##(2007-12#1)(2008-10#1)(2010-11#1)
was 5##79##2##(1990-11#2)(1990-6#1)(1991-5#1)(1991-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
was 5%##8##2##(1990-9#1)(1991-8#1)(1991-9#1)(1995-3#1)(2007-10#1)(2008-10#3)
was 50 min##2##3##(2008-10#1)(2008-11#1)
was 50 times##2##3##(2007-11#1)(2008-10#1)
was 50##17##2##(1990-11#1)(1990-3#1)(1994-2#1)(2007-11#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-3#1)
was 50% of the##2##4##(2007-12#1)(2013-1#1)
was 50% of##4##3##(1993-12#1)(2007-12#1)(2008-4#1)(2013-1#1)
was 50%##12##2##(1990-7#1)(1992-11#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2012-12#1)(2013-1#1)
was 500##3##2##(2007-12#1)(2008-10#2)
was 51##8##2##(1996-12#1)(1997-7#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-3#1)
was 52##7##2##(1991-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2011-2#1)
was 53##6##2##(1991-8#1)(1992-2#1)(1996-5#1)(2011-2#1)(2011-7#1)(2013-1#1)
was 53%##4##2##(1991-3#1)(2008-12#1)(2008-6#1)(2010-8#1)
was 54##6##2##(1992-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-6#1)
was 55##9##2##(1990-7#1)(1991-8#1)(1992-11#1)(1993-2#1)(1997-3#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-1#1)
was 55% after##2##3##(1990-9#1)(2011-2#1)
was 55%##3##2##(1990-2#1)(1990-9#1)(2011-2#1)
was 56 years##3##3##(1995-4#1)(2008-11#1)(2011-2#1)
was 56##9##2##(1991-9#1)(1992-3#1)(1994-3#1)(1995-4#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-11#1)(2011-2#1)
was 57##6##2##(1990-8#1)(1993-8#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)
was 57%##2##2##(2008-6#1)(2008-8#1)
was 58##7##2##(1990-3#1)(1991-8#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-2#1)
was 58%##3##2##(1993-1#1)(2008-10#1)(2008-12#1)
was 59##8##2##(1991-3#1)(1992-3#1)(1992-5#1)(1992-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
was 6 months##4##3##(2007-11#2)(2008-8#1)(2011-2#1)
was 6 x##3##3##(2008-10#1)(2008-2#2)
was 6##65##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-10#1)(1993-6#1)(1994-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#4)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
was 6%##3##2##(2008-10#2)(2008-7#1)
was 60 min##2##3##(1994-2#1)(2008-10#1)
was 60 years##2##3##(1992-8#1)(2008-11#1)
was 60##12##2##(1990-12#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-5#1)(2008-10#4)(2008-11#1)(2009-11#1)(2011-2#1)
was 60%##5##2##(1991-9#1)(1992-2#1)(1994-5#1)(2008-3#1)(2010-8#1)
was 61##7##2##(1990-9#1)(2007-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)
was 61%##4##2##(1992-10#1)(1996-12#1)(2008-10#1)(2009-8#1)
was 62##5##2##(2007-11#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
was 63 years##2##3##(1991-2#1)(2009-3#1)
was 63##11##2##(1991-2#1)(1991-7#1)(1991-8#1)(1993-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#1)
was 63%##3##2##(1990-10#1)(2008-10#2)
was 64##4##2##(1996-12#1)(1997-7#1)(2008-12#1)(2010-3#1)
was 643##2##2##(2007-9#1)(2011-1#1)
was 65##6##2##(1990-2#1)(2008-10#1)(2012-12#1)(2013-1#3)
was 65%##6##2##(1993-1#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-8#1)
was 66 +/-##2##3##(2008-3#1)(2008-4#1)
was 66##11##2##(1990-11#1)(1991-12#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
was 67##5##2##(1994-3#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
was 67%##7##2##(1991-6#1)(1991-8#2)(2008-10#2)(2011-2#1)(2012-12#1)
was 68##10##2##(1990-8#1)(1991-12#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
was 68%##3##2##(1995-8#1)(2007-12#1)(2008-6#1)
was 69##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
was 7 days##2##3##(2008-11#1)(2012-3#1)
was 7 months (range##4##4##(1990-2#1)(1991-2#1)(1992-2#1)(1992-8#1)
was 7 months##5##3##(1990-2#1)(1991-2#1)(1992-2#1)(1992-8#1)(1994-8#1)
was 7##46##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
was 7%##4##2##(1990-3#1)(1993-9#1)(2007-8#1)(2010-12#1)
was 70##9##2##(1991-11#1)(1994-8#1)(1996-12#1)(2008-1#2)(2008-10#4)
was 70%##3##2##(1992-12#1)(1992-6#1)(2008-7#1)
was 71##9##2##(1991-4#1)(1994-12#2)(1997-2#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
was 71%##2##2##(1993-1#1)(2012-3#1)
was 72##6##2##(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)
was 72%##4##2##(1993-5#1)(1994-2#1)(2008-11#1)(2013-1#1)
was 73##4##2##(1991-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
was 73%##3##2##(1992-11#1)(1994-9#1)(2008-8#1)
was 74##5##2##(2008-1#1)(2008-7#2)(2009-12#1)(2013-1#1)
was 75##6##2##(1991-11#1)(1991-4#1)(1996-9#1)(2008-10#2)(2008-5#1)
was 75% and##2##3##(2008-6#1)(2013-8#1)
was 75% for##2##3##(1990-6#1)(2008-8#1)
was 75%##8##2##(1990-6#1)(1992-11#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
was 76##6##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-3#1)
was 76%##5##2##(1990-8#1)(1992-3#1)(1993-1#1)(2008-6#1)(2011-2#1)
was 77##3##2##(1990-8#1)(1997-7#1)(2007-8#1)
was 77%##3##2##(1991-11#1)(1997-6#1)(2008-3#1)
was 78##5##2##(1993-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
was 78%##2##2##(1992-3#1)(2008-7#1)
was 79##3##2##(1990-6#1)(2008-6#1)(2010-8#1)
was 8 months##3##3##(1990-2#1)(2007-11#1)(2008-3#1)
was 8##36##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
was 80 samples per hour##2##5##(2008-10#2)
was 80##11##2##(1991-2#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
was 80%##4##2##(1991-2#1)(1994-6#1)(2007-11#1)(2008-3#1)
was 82##7##2##(1995-6#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
was 82% and##2##3##(2006-10#1)(2013-8#1)
was 82%##4##2##(1990-10#1)(2006-10#1)(2006-12#1)(2013-8#1)
was 83##2##2##(2007-12#1)(2008-7#1)
was 84##3##2##(1991-12#1)(1992-8#1)(2013-1#1)
was 84% and##2##3##(2008-3#1)(2008-7#1)
was 85##9##2##(1990-8#1)(1992-6#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-12#1)
was 85%##5##2##(2007-8#1)(2008-6#2)(2008-8#1)(2013-7#1)
was 850##2##2##(2008-10#1)(2011-1#1)
was 86##7##2##(1990-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-4#1)
was 87##2##2##(1996-12#1)(2008-10#1)
was 87%##2##2##(2008-6#1)(2013-8#1)
was 88##3##2##(1990-10#1)(2011-1#1)(2011-2#1)
was 88%##5##2##(1991-2#1)(1991-6#1)(2008-6#1)(2008-7#1)(2010-5#1)
was 89%##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
was 9 months##2##3##(1990-12#1)(1990-2#1)
was 9##43##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#4)
was 9%##3##2##(1996-3#1)(2008-10#2)
was 90##6##2##(1996-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
was 90% in##2##3##(2007-8#1)(2008-5#1)
was 90%##5##2##(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#2)
was 90s##2##2##(2008-10#2)
was 91##5##2##(1990-8#1)(1997-8#1)(2007-8#1)(2010-8#1)(2011-2#1)
was 91%##7##2##(1990-2#1)(1994-1#1)(1994-3#1)(1997-6#1)(2007-8#1)(2008-3#1)(2008-6#1)
was 92##2##2##(2013-8#2)
was 93##9##2##(1991-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2011-3#1)(2012-12#1)
was 93%##3##2##(2008-11#1)(2008-6#2)
was 94##7##2##(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
was 94%##4##2##(1996-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
was 95##12##2##(1996-12#1)(2006-12#1)(2007-8#3)(2008-10#4)(2008-4#1)(2010-8#1)(2012-3#1)
was 95%##6##2##(1991-8#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#2)
was 96##9##2##(1990-12#1)(1992-3#1)(2007-8#3)(2008-10#2)(2008-11#1)(2013-8#1)
was 96%##7##2##(1990-6#1)(1993-3#1)(2007-11#1)(2008-10#2)(2012-3#1)(2013-1#1)
was 97##5##2##(2007-8#1)(2008-10#1)(2009-3#1)(2009-4#1)(2009-5#1)
was 97%##5##2##(1990-2#1)(1995-11#1)(2007-7#1)(2008-10#2)
was 98##10##2##(1990-12#1)(1990-2#1)(1993-8#1)(1993-9#1)(1996-12#3)(2008-1#1)(2008-12#1)(2011-2#1)
was 98%##3##2##(2007-2#1)(2008-6#1)(2010-5#1)
was 99##9##2##(1992-5#1)(2008-10#5)(2008-12#1)(2008-6#1)(2011-1#1)
was A##3##2##(1994-8#2)(2008-5#1)
was C##3##2##(1997-2#1)(2008-5#1)(2010-4#1)
was D(m) =##2##3##(2010-7#2)
was Gaussian##2##2##(1996-12#1)(2008-10#1)
was HIV##2##2##(1991-7#1)(2008-11#1)
was HIV-positive##4##2##(1991-7#1)(1995-12#1)(1996-5#1)(1997-5#1)
was NOK##3##2##(1995-2#2)(1997-4#1)
was PCR amplified##2##3##(1993-12#1)(1997-4#1)
was R##2##2##(2008-10#1)(2011-1#1)
was S##3##2##(2008-5#1)(2011-1#1)(2013-8#1)
was a better##5##3##(1993-12#1)(2008-10#2)(2010-3#1)(2010-8#1)
was a case of##3##4##(2008-1#1)(2011-1#1)(2013-8#1)
was a case##4##3##(2008-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
was a clear##3##3##(1991-2#1)(2008-10#1)(2012-1#1)
was a common##4##3##(2008-10#1)(2010-12#1)(2010-4#1)(2011-1#1)
was a competitive##2##3##(2008-10#2)
was a complete##2##3##(2008-10#1)(2008-11#1)
was a concordance of##2##4##(2008-7#1)(2013-1#1)
was a consequence of##2##4##(2008-11#1)(2012-5#1)
was a consistent##4##3##(1997-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
was a cross-sectional study##6##4##(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
was a cross-sectional##9##3##(2011-2#3)(2012-12#3)(2013-1#2)(2013-8#1)
was a decrease in##7##4##(1991-12#1)(1991-6#1)(1991-8#1)(1993-12#1)(1995-12#1)(2008-12#1)(2010-9#1)
was a decrease##9##3##(1991-12#1)(1991-6#1)(1991-8#1)(1993-12#1)(1995-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2010-9#1)
was a descriptive##6##3##(2010-10#1)(2011-2#1)(2012-12#3)(2013-1#1)
was a difference##2##3##(1991-4#1)(2011-1#1)
was a dimer of##2##4##(1991-7#1)(1992-3#1)
was a direct##5##3##(1994-5#1)(2008-10#3)(2011-2#1)
was a dose-response relationship between paternal serum HBV-DNA load levels and neonatal cord blood HBV-DNA positive##2##16##(2011-1#2)
was a dramatic##3##3##(1993-3#1)(1996-12#1)(2010-10#1)
was a function of##2##4##(2008-10#1)(2008-11#1)
was a function##3##3##(2008-10#2)(2008-11#1)
was a general trend##2##4##(2008-10#2)
was a general##5##3##(2008-10#3)(2011-1#1)(2012-3#1)
was a good agreement between the##2##6##(2008-10#2)
was a good correlation between the##5##6##(1990-7#2)(1995-12#1)(2007-8#1)(2008-5#1)
was a good predictor of the##2##6##(2008-10#1)(2008-9#1)
was a good predictor of##3##5##(2008-10#1)(2008-8#1)(2008-9#1)
was a good predictor##4##4##(2008-10#2)(2008-8#1)(2008-9#1)
was a good##17##3##(1990-7#2)(1992-11#1)(1994-11#1)(1995-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
was a great##3##3##(1994-2#1)(2008-10#1)(2010-11#1)
was a greater##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
was a group of##2##4##(2007-7#1)(2008-11#1)
was a high incidence of##2##5##(1994-12#1)(2008-12#1)
was a high prevalence of##3##5##(1994-6#1)(2008-12#1)(2013-1#1)
was a high##13##3##(1990-5#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
was a higher incidence of##4##5##(1996-3#1)(2007-8#1)(2008-9#1)(2013-8#1)
was a higher##13##3##(1992-4#1)(1993-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was a highly significant##4##4##(1994-3#1)(2008-5#1)(2008-8#2)
was a key##2##3##(2008-9#1)(2012-12#1)
was a known##2##3##(1997-5#1)(2013-8#1)
was a large##3##3##(1994-2#1)(2008-7#2)
was a linear relationship between the##3##6##(2008-10#2)(2008-11#1)
was a linear relationship between##5##5##(2007-2#1)(2008-10#3)(2008-11#1)
was a linear##8##3##(2007-2#1)(2008-10#5)(2008-11#1)(2008-12#1)
was a little##4##3##(1992-3#1)(2008-11#2)(2013-8#1)
was a low##2##3##(1990-2#1)(1996-8#1)
was a major problem##2##4##(1990-10#1)(2013-8#1)
was a major##10##3##(1990-10#1)(1995-3#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
was a marked##5##3##(1997-4#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-6#1)
was a member of##2##4##(1997-6#1)(2008-10#1)
was a minor##3##3##(1990-5#1)(1992-3#1)(2011-1#1)
was a mixture of##3##4##(2008-10#2)(2010-5#1)
was a moderate##2##3##(1991-2#1)(1991-8#1)
was a modest##2##3##(1990-11#1)(2008-9#1)
was a more effective##2##4##(1997-7#1)(2013-1#1)
was a more##6##3##(1994-12#1)(1995-3#1)(1997-7#1)(2008-10#1)(2013-1#1)(2013-8#1)
was a much##2##3##(1991-8#1)(1995-2#1)
was a negative correlation##3##4##(1991-11#1)(2008-10#1)(2008-8#1)
was a negative##4##3##(1991-11#1)(2008-1#1)(2008-10#1)(2008-8#1)
was a new##7##3##(2008-10#2)(2008-11#1)(2008-8#2)(2009-10#1)(2011-3#1)
was a notable##2##3##(1995-11#1)(2012-3#1)
was a novel##3##3##(1991-12#1)(2008-10#1)(2012-3#1)
was a poor substrate for##2##5##(1994-11#1)(1997-3#1)
was a poor##3##3##(1994-11#1)(1997-3#1)(2011-1#1)
was a positive correlation between the##2##6##(1990-10#1)(2008-10#1)
was a positive correlation between##3##5##(1990-10#1)(2008-10#1)(2013-7#1)
was a positive correlation##4##4##(1990-10#1)(2008-10#2)(2013-7#1)
was a positive##9##3##(1990-10#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2013-7#2)
was a possible solution##2##4##(2007-5#1)(2009-10#1)
was a possible##3##3##(2007-5#1)(2008-9#1)(2009-10#1)
was a potent inhibitor of##2##5##(1994-8#1)(1995-11#1)
was a potent##3##3##(1994-8#2)(1995-11#1)
was a predominance of##2##4##(2008-7#1)(2012-3#1)
was a primary##4##3##(1992-2#1)(2007-2#1)(2008-7#1)(2010-3#1)
was a prospective##4##3##(2007-11#1)(2009-6#1)(2012-12#1)(2013-8#1)
was a qualitative##2##3##(2008-11#1)(2013-1#1)
was a randomized##2##3##(2008-4#1)(2010-8#1)
was a reduction in##5##4##(1990-5#1)(1996-2#1)(1997-1#1)(2010-8#1)(2013-8#1)
was a reduction of##3##4##(2007-7#1)(2008-10#1)(2013-1#1)
was a reduction##8##3##(1990-5#1)(1996-2#1)(1997-1#1)(2007-7#1)(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
was a relatively##3##3##(1991-12#1)(1992-12#1)(2008-10#1)
was a remarkable##4##3##(1990-6#1)(2008-12#1)(2011-2#1)(2012-3#1)
was a result of the##2##5##(2008-10#1)(2008-9#1)
was a result of##3##4##(2008-10#1)(2008-9#1)(2009-5#1)
was a retrospective##6##3##(2007-8#1)(2008-3#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
was a robust##3##3##(2008-3#1)(2010-1#2)
was a selective##4##3##(1993-12#1)(1994-8#2)(2010-8#1)
was a sensitive parameter##2##4##(2008-10#2)
was a sensitive##4##3##(2008-10#3)(2008-7#1)
was a shift of##2##4##(1991-12#1)(2008-10#1)
was a shift##3##3##(1991-12#1)(2008-1#1)(2008-10#1)
was a significant association between##4##5##(2008-10#1)(2011-2#2)(2012-12#1)
was a significant association##5##4##(2008-10#1)(2008-12#1)(2011-2#2)(2012-12#1)
was a significant correlation between##11##5##(1992-11#1)(1992-8#1)(1996-12#1)(2007-10#2)(2007-7#2)(2008-6#2)(2013-1#2)
was a significant correlation of##2##5##(2011-2#1)(2013-1#1)
was a significant correlation##13##4##(1992-11#1)(1992-8#1)(1996-12#1)(2007-10#2)(2007-7#2)(2008-6#2)(2011-2#1)(2013-1#3)
was a significant decrease in the##6##6##(1993-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
was a significant decrease in##9##5##(1993-12#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
was a significant decrease##12##4##(1993-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
was a significant difference between the##2##6##(2008-7#1)(2009-8#1)
was a significant difference between##3##5##(1995-5#1)(2008-7#1)(2009-8#1)
was a significant difference##8##4##(1990-10#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
was a significant effect of##3##5##(1996-12#1)(2008-10#1)(2010-7#1)
was a significant effect##4##4##(1996-12#1)(2008-10#1)(2008-12#1)(2010-7#1)
was a significant fall in##2##5##(2008-3#1)(2008-7#1)
was a significant improvement in##2##5##(2008-10#1)(2012-12#1)
was a significant increase in the##3##6##(2007-9#1)(2013-8#2)
was a significant increase in##9##5##(1993-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#2)(2013-8#2)
was a significant increase of##3##5##(1995-8#1)(2007-7#1)(2012-2#1)
was a significant increase##14##4##(1993-12#1)(1994-7#1)(1995-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#2)
was a significant negative correlation (R = -0##2##8##(1990-12#1)(2008-10#1)
was a significant negative correlation##8##5##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2008-10#2)(2008-7#1)(2012-6#1)
was a significant positive##3##4##(2008-10#1)(2008-8#2)
was a significant predictor of##4##5##(2008-5#1)(2012-3#2)(2013-1#1)
was a significant reduction of##2##5##(1996-12#1)(2012-2#1)
was a significant reduction##7##4##(1993-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
was a significant##106##3##(1990-10#1)(1990-12#1)(1990-5#1)(1992-11#2)(1992-8#1)(1993-1#1)(1993-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#3)(1997-8#1)(2007-10#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#6)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2012-6#1)(2013-1#6)(2013-8#4)
was a significantly greater##2##4##(1996-12#1)(2008-4#1)
was a significantly##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2010-7#1)
was a simple##4##3##(1995-11#1)(2008-10#3)
was a single##5##3##(1996-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2008-9#1)
was a slight##3##3##(1992-6#1)(2008-10#1)(2010-8#1)
was a small##4##3##(1992-2#1)(2008-10#1)(2008-9#1)(2012-1#1)
was a specific##2##3##(1990-5#1)(2008-4#1)
was a statistical difference##2##4##(2006-6#1)(2012-12#1)
was a statistical##5##3##(1990-12#2)(2006-6#1)(2008-3#1)(2012-12#1)
was a statistically significant difference between the##3##7##(2007-6#1)(2009-8#1)(2011-2#1)
was a statistically significant difference between##4##6##(2007-12#1)(2007-6#1)(2009-8#1)(2011-2#1)
was a statistically significant difference##6##5##(2007-12#1)(2007-6#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
was a statistically significant##16##4##(1993-10#1)(1993-9#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-4#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
was a strong correlation between##2##5##(1991-6#1)(2008-10#1)
was a strong correlation##5##4##(1991-6#1)(1994-8#1)(2008-10#3)
was a strong##16##3##(1990-8#1)(1991-6#1)(1994-8#3)(1995-6#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)
was a stronger##2##3##(1994-12#1)(2009-7#1)
was a suitable##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
was a thin##2##3##(1994-11#1)(2008-7#1)
was a trend for the##2##5##(1992-11#1)(2008-10#1)
was a trend for##4##4##(1990-2#1)(1992-11#1)(2008-10#1)(2008-11#1)
was a trend toward better##2##5##(1995-11#1)(2009-3#1)
was a trend toward##5##4##(1995-11#1)(2008-10#2)(2008-7#1)(2009-3#1)
was a trend towards##5##4##(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)
was a trend##16##3##(1990-2#1)(1992-11#1)(1995-11#1)(1996-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#2)
was a unique##2##3##(1995-2#1)(2013-1#1)
was a useful##2##3##(2008-11#1)(2013-1#1)
was a validated##2##3##(2010-4#1)(2012-2#1)
was a very poor##2##4##(1991-8#1)(1992-3#1)
was a very##9##3##(1990-7#1)(1991-8#2)(1992-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)
was a wide range##2##4##(1996-3#1)(2008-10#1)
was a wide##5##3##(1996-3#1)(1997-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
was a##829##2##(1990-10#5)(1990-11#6)(1990-12#7)(1990-2#3)(1990-3#3)(1990-5#10)(1990-6#2)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#8)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#3)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#10)(1995-11#6)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#6)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#8)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#6)(1996-7#1)(1996-8#1)(1997-1#3)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-2#2)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#2)(2008-1#15)(2008-10#133)(2008-11#27)(2008-12#22)(2008-2#5)(2008-3#13)(2008-4#6)(2008-5#14)(2008-6#9)(2008-7#29)(2008-8#23)(2008-9#26)(2009-10#3)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#4)(2010-1#6)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#17)(2011-2#31)(2011-3#2)(2012-1#5)(2012-12#20)(2012-2#15)(2012-3#14)(2012-4#1)(2012-5#1)(2012-6#2)(2013-1#35)(2013-7#4)(2013-8#22)
was abdominal pain##2##3##(1990-9#1)(1991-8#1)
was ablated##4##2##(1991-2#1)(2008-11#2)(2008-3#1)
was able to achieve##2##4##(1996-3#1)(2012-2#1)
was able to be##2##4##(2008-11#2)
was able to bind to##2##5##(1993-8#1)(1995-2#1)
was able to bind##3##4##(1993-8#1)(1994-8#1)(1995-2#1)
was able to detect##6##4##(1994-2#1)(1995-2#1)(2007-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
was able to develop##2##4##(1993-1#1)(2008-1#1)
was able to distinguish##2##4##(2007-5#1)(2008-10#1)
was able to enhance##2##4##(1990-2#1)(1994-5#1)
was able to generate##2##4##(1995-2#1)(2008-10#1)
was able to grow in##2##5##(2008-11#1)(2008-7#1)
was able to grow##6##4##(2008-10#2)(2008-11#2)(2008-7#1)(2012-2#1)
was able to identify the##2##5##(2008-10#1)(2008-4#1)
was able to induce##3##4##(1997-7#1)(2008-10#1)(2008-11#1)
was able to infect##2##4##(2008-10#2)
was able to make##2##4##(1993-2#1)(2008-2#1)
was able to predict##2##4##(2008-10#2)
was able to provide##2##4##(1994-12#1)(2008-7#1)
was able to reduce the##2##5##(1995-3#1)(2008-5#1)
was able to reduce##6##4##(1995-3#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-2#1)
was able to rescue the##2##5##(1995-11#1)(2008-10#1)
was able to reverse the##2##5##(1995-12#1)(2012-3#1)
was able to significantly reduce##2##5##(2007-9#1)(2008-10#1)
was able to significantly##3##4##(1994-11#1)(2007-9#1)(2008-10#1)
was able to stay##2##4##(1996-12#1)(1997-2#1)
was able to stimulate##2##4##(1994-2#1)(2008-11#1)
was able to substitute for##2##5##(1993-3#1)(1995-2#1)
was able to support the##2##5##(2008-10#2)
was able to support##4##4##(2008-10#3)(2008-5#1)
was able to##125##3##(1990-10#1)(1990-2#2)(1990-5#1)(1991-6#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-9#2)(2009-1#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-3#1)(2011-7#1)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#1)
was abnormal##4##2##(1994-8#1)(1997-3#1)(2008-8#1)(2013-1#1)
was abolished by the addition of##3##6##(1992-8#1)(1994-6#1)(2013-1#1)
was abolished by the presence of serosal ouabain##2##8##(2008-6#2)
was abolished by the presence of##3##6##(1995-11#1)(2008-6#2)
was abolished by the##6##4##(1992-8#1)(1994-6#1)(1995-11#1)(2008-6#2)(2013-1#1)
was abolished by##22##3##(1990-2#1)(1992-7#2)(1992-8#1)(1993-6#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1997-2#2)(1997-4#1)(2008-6#2)(2008-9#1)(2011-2#2)(2013-1#1)
was abolished in the presence of##2##6##(1990-5#1)(1991-12#1)
was abolished in the##5##4##(1990-5#1)(1991-12#1)(1992-3#1)(1996-12#1)(2009-10#1)
was abolished in##9##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-3#1)(1995-11#2)(1996-12#1)(2008-10#1)(2009-10#1)
was abolished##40##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#3)(1995-11#4)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-1#1)
was about 0##2##3##(1995-12#1)(2008-10#1)
was about 1##4##3##(1992-6#1)(2008-10#2)(2013-8#1)
was about 2 times##2##4##(2008-11#1)(2008-6#1)
was about 2##10##3##(1990-7#1)(1990-8#1)(1992-8#1)(1993-2#1)(1997-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)
was about 20%##2##3##(1992-12#1)(2008-11#1)
was about 25##3##3##(2008-10#1)(2013-1#2)
was about 3##2##3##(2008-10#1)(2008-11#1)
was about 30 min##2##4##(2008-10#2)
was about 30##5##3##(2008-10#5)
was about 30%##3##3##(1995-6#1)(1996-5#1)(2008-5#1)
was about 4##3##3##(1992-9#1)(1993-9#1)(2008-7#1)
was about 400##2##3##(1990-11#1)(2008-10#1)
was about 5##3##3##(2008-10#3)
was about 50% higher than the##2##6##(2008-10#1)(2013-1#1)
was about 6##2##3##(1990-5#1)(2009-11#1)
was about 9##2##3##(1992-9#1)(2008-10#1)
was about the##2##3##(2008-10#1)(2011-2#1)
was about three##2##3##(1996-2#1)(2008-10#1)
was about twice as high##2##5##(2008-11#2)
was about##100##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#29)(2008-11#13)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-11#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#4)(2013-8#1)
was above the##3##3##(2008-10#1)(2010-4#1)(2013-8#1)
was above##11##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-3#1)(2012-12#1)(2013-8#1)
was abrogated by##2##3##(1992-6#1)(1992-9#1)
was abrogated##4##2##(1992-6#1)(1992-9#1)(1996-12#1)(2008-11#1)
was absent from the##2##4##(1993-9#1)(1994-11#1)
was absent from##4##3##(1993-9#1)(1994-11#1)(2008-10#1)(2012-2#1)
was absent in##12##3##(1990-12#1)(1990-3#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-4#1)
was absent##35##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
was absorbed##7##2##(1990-11#1)(1990-12#1)(1990-6#1)(1992-11#1)(2008-10#3)
was abundant in the##2##4##(1992-8#1)(2008-5#1)
was abundant in##3##3##(1992-8#1)(1996-5#1)(2008-5#1)
was abundant##5##2##(1992-8#1)(1996-5#1)(2008-10#1)(2008-5#1)(2009-7#1)
was accelerated##4##2##(1995-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
was acceptable and##2##3##(2008-1#1)(2013-1#1)
was acceptable##7##2##(1991-8#1)(1992-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
was accepted at##2##3##(2008-5#1)(2010-8#1)
was accepted##5##2##(1990-6#1)(2007-11#1)(2008-5#1)(2010-8#1)(2011-1#1)
was accessed##4##2##(2008-10#1)(2008-7#1)(2009-8#1)(2013-1#1)
was accidentally##3##2##(1991-6#1)(2007-10#1)(2007-8#1)
was accompanied by a decrease in the##2##7##(1990-11#1)(1991-5#1)
was accompanied by a decrease##3##5##(1990-11#1)(1991-5#1)(1992-9#1)
was accompanied by a decreased##2##5##(1992-3#1)(2008-11#1)
was accompanied by a##16##4##(1990-11#2)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-11#3)(2009-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
was accompanied by an increase in the##2##7##(2008-10#1)(2011-2#1)
was accompanied by an increase in##3##6##(1992-8#1)(2008-10#1)(2011-2#1)
was accompanied by an##6##4##(1992-8#1)(2008-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
was accompanied by changes in##2##5##(2009-6#1)(2010-4#1)
was accompanied by enhanced##2##4##(2009-2#1)(2011-1#1)
was accompanied by the##2##4##(2008-10#1)(2010-3#1)
was accompanied by##42##3##(1990-11#2)(1990-5#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#1)(1996-12#2)(2008-10#5)(2008-11#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
was accompanied with##3##3##(1997-1#1)(2010-6#1)(2011-2#1)
was accompanied##46##2##(1990-11#2)(1990-5#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#1)(1996-12#2)(1997-1#1)(2008-10#5)(2008-11#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
was accomplished by using##4##4##(2007-12#1)(2008-10#3)
was accomplished by##23##3##(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-5#1)(2007-12#2)(2008-10#12)(2008-5#2)(2008-6#1)(2011-1#1)
was accomplished in the##2##4##(2010-4#1)(2011-2#1)
was accomplished in##5##3##(2008-10#3)(2010-4#1)(2011-2#1)
was accomplished using a##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
was accomplished using##9##3##(2007-5#1)(2008-10#4)(2008-5#2)(2008-6#1)(2012-2#1)
was accomplished with a##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
was accomplished with##9##3##(1990-8#1)(2008-10#4)(2008-3#2)(2008-8#1)(2012-12#1)
was accomplished without##2##3##(1996-8#1)(2009-8#1)
was accomplished##55##2##(1990-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
was accounted for by##2##4##(1994-3#1)(1997-8#1)
was accounted for##4##3##(1992-8#1)(1994-3#1)(1997-8#1)(2008-10#1)
was accounted##6##2##(1992-8#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
was accumulated by##2##3##(2006-10#1)(2008-10#1)
was accumulated on##2##3##(2008-10#2)
was accumulated##13##2##(1991-7#1)(1994-6#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)
was accurate in##2##3##(2013-8#2)
was accurate##3##2##(2011-1#1)(2013-8#2)
was accurately##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
was acetonitrile##2##2##(2008-10#1)(2008-5#1)
was acetonitrile-water##2##2##(2008-10#1)(2010-4#1)
was achieved after##8##3##(1995-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2012-12#1)(2012-2#1)
was achieved and##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
was achieved as compared with the##2##6##(2008-10#2)
was achieved as compared##3##4##(2008-10#2)(2008-7#1)
was achieved as##5##3##(2008-10#3)(2008-7#1)(2011-2#1)
was achieved at a##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
was achieved at the##3##4##(1990-6#1)(2008-10#1)(2008-6#1)
was achieved at##16##3##(1990-6#1)(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
was achieved between##2##3##(2007-11#1)(2008-1#1)
was achieved by a combination of##2##6##(1991-5#1)(2008-11#1)
was achieved by a##8##4##(1991-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-3#1)
was achieved by applying##2##4##(2008-10#1)(2008-5#1)
was achieved by the##9##4##(2008-10#8)(2008-11#1)
was achieved by this##2##4##(2007-12#1)(2008-10#1)
was achieved by two##3##4##(1996-12#1)(2008-10#2)
was achieved by use of##2##5##(2007-12#2)
was achieved by using a##2##5##(2008-10#2)
was achieved by using the##2##5##(2008-10#1)(2011-2#1)
was achieved by using##10##4##(1994-12#1)(2008-10#7)(2008-12#1)(2011-2#1)
was achieved by##93##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#1)(1996-12#2)(1996-2#1)(1996-5#3)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#3)(2008-10#41)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#2)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
was achieved for a##2##4##(2007-11#1)(2007-12#1)
was achieved for the##2##4##(2008-10#2)
was achieved for##18##3##(1994-1#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#9)(2008-6#1)(2009-3#1)
was achieved from##2##3##(2008-10#1)(2013-1#1)
was achieved in 17##2##4##(2008-6#2)
was achieved in 29##2##4##(1997-4#1)(2008-10#1)
was achieved in a##3##4##(2008-10#1)(2008-3#1)(2009-9#1)
was achieved in about##2##4##(2008-10#2)
was achieved in all cases##2##5##(1995-5#1)(2009-3#1)
was achieved in all##5##4##(1995-5#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
was achieved in less than##3##5##(2008-10#3)
was achieved in the##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
was achieved in##56##3##(1990-6#1)(1991-6#1)(1992-12#1)(1992-4#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#3)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
was achieved on a##4##4##(1990-8#1)(1995-6#1)(2008-10#2)
was achieved on an##2##4##(2008-10#2)
was achieved on the##2##4##(2008-10#1)(2008-11#1)
was achieved on##12##3##(1990-8#1)(1995-6#1)(2008-10#7)(2008-11#1)(2011-1#1)(2013-1#1)
was achieved only##3##3##(2007-2#1)(2008-10#1)(2008-11#1)
was achieved through a##2##4##(2008-5#1)(2010-3#1)
was achieved through the##2##4##(2008-10#2)
was achieved through##6##3##(2007-12#1)(2008-10#2)(2008-5#2)(2010-3#1)
was achieved under##2##3##(2008-10#2)
was achieved using a##5##4##(2008-10#4)(2008-5#1)
was achieved using##16##3##(1990-12#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2011-3#1)(2013-1#1)
was achieved via##2##3##(1996-5#1)(2008-10#1)
was achieved when the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)
was achieved when weather supported severe epidemics##2##7##(2008-10#2)
was achieved when weather supported##3##5##(2008-10#3)
was achieved when##15##3##(1995-6#1)(2006-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-2#1)
was achieved with 0##2##4##(2008-10#2)
was achieved with a##8##4##(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2011-2#1)
was achieved with high##2##4##(2008-10#1)(2008-5#1)
was achieved with no##2##4##(1997-7#1)(2008-7#1)
was achieved with the##9##4##(1991-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2011-2#1)
was achieved with##49##3##(1990-10#1)(1991-9#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#1)
was achieved within##7##3##(2008-10#5)(2008-8#1)(2009-11#1)
was achieved without any##2##4##(2008-10#1)(2011-2#1)
was achieved without##6##3##(1993-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
was achieved##423##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#4)(1990-6#2)(1990-8#3)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1993-1#3)(1993-12#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-3#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#4)(1996-9#1)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#17)(2007-12#21)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#166)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#19)(2008-4#2)(2008-5#11)(2008-6#9)(2008-7#13)(2008-8#6)(2008-9#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2011-1#2)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#4)
was achiewed in##2##3##(2007-11#2)
was acquired and##2##3##(1993-6#1)(2008-10#1)
was acquired by##5##3##(1994-8#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-8#1)
was acquired##14##2##(1993-6#1)(1994-8#1)(1995-2#1)(2008-10#7)(2008-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
was acting##2##2##(1992-1#1)(1993-2#1)
was activated by##11##3##(1990-11#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-3#2)(1995-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-11#1)
was activated to##2##3##(1990-5#1)(1995-11#1)
was activated##22##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-8#1)(1995-11#2)(1995-6#1)(1997-6#1)(2008-10#2)(2008-11#2)(2010-10#1)(2010-11#1)(2010-6#1)(2012-7#1)
was active against##4##3##(1991-9#1)(2007-1#1)(2008-10#1)(2008-11#1)
was active at##3##3##(1990-7#1)(1992-2#1)(1995-2#1)
was active in##4##3##(1990-12#1)(1993-9#1)(1997-6#1)(2008-8#1)
was active##17##2##(1990-12#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-9#1)(1995-2#2)(1995-3#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
was actively##3##2##(1993-2#1)(2007-11#1)(2008-6#1)
was actually##5##2##(1991-7#1)(1995-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
was acute##3##2##(1997-5#1)(2007-11#1)(2008-7#1)
was adapted for the##2##4##(2008-10#1)(2013-1#1)
was adapted for##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
was adapted to a##2##4##(2008-10#1)(2010-12#1)
was adapted to the##3##4##(1995-1#1)(2008-10#1)(2008-2#1)
was adapted to##10##3##(1991-1#1)(1991-5#1)(1995-1#1)(2008-10#3)(2008-2#1)(2009-10#1)(2010-12#1)(2012-3#1)
was adapted##19##2##(1991-1#1)(1991-5#1)(1995-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
was added after##2##3##(2008-10#2)
was added as an##2##4##(2008-10#1)(2010-2#1)
was added as##3##3##(1990-8#1)(2008-10#1)(2010-2#1)
was added at##4##3##(1990-5#1)(2008-10#2)(2008-7#1)
was added for##2##3##(2008-5#1)(2012-3#1)
was added in##5##3##(1994-2#1)(2008-10#2)(2008-5#1)(2008-6#1)
was added into the solution##2##5##(2008-10#2)
was added into the##4##4##(2008-10#3)(2011-1#1)
was added into##6##3##(2008-10#4)(2008-11#1)(2011-1#1)
was added to a##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
was added to an##2##4##(1997-2#1)(2008-10#1)
was added to isolated##2##4##(1994-6#1)(2012-2#1)
was added to prevent the##2##5##(1990-11#1)(2008-10#1)
was added to the apical side of##2##7##(2008-11#2)
was added to the culture##2##5##(2008-11#2)
was added to the patient's##2##5##(1994-6#1)(2008-7#1)
was added to the sample solution##2##6##(2008-10#2)
was added to the sample##4##5##(2008-10#4)
was added to the solution##4##5##(2008-10#4)
was added to the test##2##5##(1992-9#1)(2008-10#1)
was added to the##48##4##(1991-3#1)(1992-9#2)(1994-1#1)(1994-3#1)(1994-6#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#23)(2008-11#6)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)
was added to this##2##4##(2008-10#1)(2011-2#1)
was added to##86##3##(1990-11#1)(1990-2#1)(1991-3#2)(1992-3#2)(1992-9#2)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#36)(2008-11#8)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
was added##147##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#2)(1992-3#2)(1992-9#2)(1993-3#3)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#61)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#7)(2008-7#3)(2008-9#1)(2010-2#4)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
was additionally##7##2##(1993-12#1)(1997-7#1)(2006-6#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
was additive##3##2##(1995-8#1)(2008-10#2)
was addressed by##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
was addressed to the##2##4##(1996-11#1)(2013-7#1)
was addressed##8##2##(1996-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
was adequate for the##2##4##(2008-10#1)(2008-6#1)
was adequate for##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
was adequate to##2##3##(2008-10#1)(2008-6#1)
was adequate##6##2##(1991-8#1)(2008-10#2)(2008-6#2)(2012-2#1)
was adjusted for##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
was adjusted to 3##2##4##(2008-10#2)
was adjusted to 6##3##4##(1990-8#1)(2008-10#2)
was adjusted to pH##3##4##(2008-10#2)(2008-7#1)
was adjusted to the##2##4##(2008-5#1)(2008-7#1)
was adjusted to##13##3##(1990-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)
was adjusted with a##2##4##(2008-10#1)(2008-2#1)
was adjusted##22##2##(1990-8#1)(1991-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
was administered Mao-to from day##2##5##(2010-7#2)
was administered as a##2##4##(2007-9#1)(2011-1#1)
was administered as##3##3##(2007-9#1)(2010-7#1)(2011-1#1)
was administered at a##2##4##(1991-2#1)(1994-2#1)
was administered at the##2##4##(1990-3#1)(2011-2#1)
was administered at##6##3##(1990-3#1)(1991-2#1)(1993-12#1)(1994-2#1)(2011-2#1)(2013-1#1)
was administered by##3##3##(1993-10#1)(2011-1#1)(2012-2#1)
was administered during the##2##4##(1993-12#1)(2008-1#1)
was administered every##2##3##(1992-2#1)(2011-2#1)
was administered for 2##2##4##(1995-11#1)(2012-12#1)
was administered for##7##3##(1990-2#1)(1990-9#1)(1993-2#1)(1995-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
was administered in##5##3##(1990-6#1)(1997-6#1)(2008-12#1)(2010-7#1)(2013-1#1)
was administered intravenously at the##2##5##(2008-11#1)(2013-1#1)
was administered intravenously##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
was administered on##2##3##(2007-10#1)(2008-6#1)
was administered oral##2##3##(2010-7#2)
was administered orally##5##3##(1991-5#1)(1993-8#1)(1995-12#1)(2008-5#1)(2013-1#1)
was administered over##2##3##(1994-1#1)(2011-2#1)
was administered to a##4##4##(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)
was administered to the##2##4##(2008-1#1)(2008-3#1)
was administered to##27##3##(1990-5#1)(1994-2#2)(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
was administered with##3##3##(2008-4#1)(2013-1#1)(2013-8#1)
was administered##110##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#3)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-7#6)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
was administrated##2##2##(2008-12#1)(2012-3#1)
was admitted because of##4##4##(1993-12#1)(2007-8#1)(2008-7#1)(2009-1#1)
was admitted for##11##3##(1992-5#1)(1994-9#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
was admitted in the ICU##2##5##(2013-1#2)
was admitted in the##4##4##(2011-2#1)(2013-1#3)
was admitted in##5##3##(2011-2#1)(2013-1#4)
was admitted to hospital##4##4##(1993-3#1)(2007-2#1)(2008-4#1)(2011-2#1)
was admitted to our department##4##5##(2008-12#1)(2011-2#2)(2012-3#1)
was admitted to our hospital because##2##6##(2008-1#1)(2008-7#1)
was admitted to our hospital for##4##6##(1991-12#1)(2008-1#2)(2013-8#1)
was admitted to our hospital with##4##6##(1993-6#1)(2007-10#1)(2008-1#1)(2011-2#1)
was admitted to our hospital##10##5##(1991-12#1)(1993-6#1)(2007-10#1)(2008-1#4)(2008-7#1)(2011-2#1)(2013-8#1)
was admitted to our##15##4##(1991-12#1)(1993-6#1)(2007-10#1)(2008-1#4)(2008-12#2)(2008-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
was admitted to the hospital because of##2##7##(1993-6#1)(2008-10#1)
was admitted to the hospital because##3##6##(1993-6#1)(2008-10#1)(2012-3#1)
was admitted to the hospital##6##5##(1993-6#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
was admitted to the##9##4##(1993-6#1)(1993-8#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
was admitted to##30##3##(1991-12#1)(1992-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
was admitted with a##2##4##(2007-8#1)(2008-6#1)
was admitted with fever##3##4##(2009-3#1)(2010-12#1)(2011-2#1)
was admitted with##13##3##(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
was admitted##65##2##(1991-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-9#1)(1997-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-3#2)(2013-1#10)(2013-8#3)
was adopted and##3##3##(2008-6#1)(2008-8#2)
was adopted as a##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
was adopted as##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
was adopted for##3##3##(2008-10#2)(2011-2#1)
was adopted in##4##3##(1993-8#1)(2007-6#1)(2013-1#2)
was adopted to##4##3##(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)
was adopted##29##2##(1993-8#1)(1996-3#1)(2007-5#1)(2007-6#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)
was adsorbed on a small column packed with Sephadex G-25 gel##2##11##(2008-10#2)
was adsorbed on the##2##4##(2008-10#1)(2008-2#1)
was adsorbed on##6##3##(1991-5#1)(2008-10#4)(2008-2#1)
was adsorbed##7##2##(1991-5#1)(2008-10#4)(2008-2#1)(2008-7#1)
was adsorption##2##2##(2008-10#1)(2010-5#1)
was advanced##3##2##(1992-8#1)(2007-5#1)(2013-1#1)
was advantageous##5##2##(2008-10#4)(2013-1#1)
was adversely affected##2##3##(2008-10#1)(2008-6#1)
was advised##4##2##(2008-8#1)(2012-2#1)(2013-1#2)
was affected by the##10##4##(1990-8#1)(1992-1#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
was affected by##29##3##(1990-8#1)(1991-12#1)(1992-1#1)(1992-3#1)(1995-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-7#3)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-8#1)
was affected in##4##3##(1995-12#1)(1996-3#1)(2007-2#1)(2008-9#1)
was affected mainly by##4##4##(2008-10#4)
was affected significantly (P &lt##2##5##(1996-6#1)(2008-10#1)
was affected significantly##3##3##(1996-6#1)(2008-10#2)
was affected##51##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-7#1)(2007-2#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-8#1)
was after##3##2##(1992-6#1)(2008-7#1)(2010-6#1)
was afterwards##2##2##(2008-10#2)
was again##4##2##(1992-10#1)(1997-3#1)(2008-3#1)(2008-9#1)
was aggregated##2##2##(1993-6#1)(2008-10#1)
was agreement##2##2##(2008-9#1)(2011-10#1)
was aimed at characterizing##2##4##(1994-2#1)(2008-10#1)
was aimed at##19##3##(1990-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#2)
was aimed to##13##3##(1991-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
was aimed##32##2##(1990-6#1)(1991-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was alive##3##2##(1994-12#1)(1996-12#1)(2013-1#1)
was all##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
was alleviated by##2##3##(1991-12#1)(1996-3#1)
was alleviated##3##2##(1991-12#1)(1996-3#1)(2009-8#1)
was allocated##2##2##(1991-9#1)(2008-8#1)
was allowed to dry##2##4##(2008-10#2)
was allowed to##8##3##(1990-12#2)(2008-10#3)(2009-9#1)(2010-2#1)(2013-7#1)
was allowed##10##2##(1990-12#2)(1996-3#1)(2008-10#3)(2009-1#1)(2009-9#1)(2010-2#1)(2013-7#1)
was almost a##2##3##(1996-12#1)(2008-10#1)
was almost completely##4##3##(1993-8#1)(1994-9#1)(1995-12#1)(2008-6#1)
was almost the same##2##4##(2008-10#1)(2008-5#1)
was almost totally##2##3##(2008-10#1)(2008-6#1)
was almost##36##2##(1990-5#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-2#2)
was already done##2##3##(1990-3#2)
was already in##2##3##(2008-10#1)(2008-11#1)
was already##17##2##(1990-2#1)(1990-3#2)(1991-12#2)(1992-5#1)(1994-11#1)(1994-8#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-8#1)(2013-1#1)
was also a significant##5##4##(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
was also a##18##3##(1992-10#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
was also able to##2##4##(2008-10#1)(2011-1#1)
was also able##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
was also achieved with##3##4##(1994-5#1)(2007-11#1)(2011-1#1)
was also achieved##5##3##(1994-5#1)(2007-11#1)(2008-10#2)(2011-1#1)
was also added to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
was also affected by the##2##5##(2008-10#2)
was also affected by##5##4##(1994-11#1)(1995-6#1)(2008-10#2)(2011-2#1)
was also affected##6##3##(1993-3#1)(1994-11#1)(1995-6#1)(2008-10#2)(2011-2#1)
was also an##4##3##(1993-9#1)(1995-3#1)(2008-10#1)(2008-8#1)
was also analysed##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
was also analyzed##8##3##(1992-2#1)(1995-6#1)(1997-6#1)(2008-10#3)(2008-11#1)(2013-1#1)
was also applied to the##2##5##(2008-10#2)
was also applied to##8##4##(2008-10#7)(2013-8#1)
was also applied##13##3##(2008-10#12)(2013-8#1)
was also assessed by##2##4##(2008-10#1)(2009-12#1)
was also assessed##14##3##(1994-12#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-2#1)
was also associated with a significant increase##2##7##(1990-9#1)(1994-6#1)
was also associated with a##7##5##(1990-9#1)(1994-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
was also associated with an increased likelihood of##2##8##(2013-1#2)
was also associated with an##4##5##(1993-11#1)(1996-5#1)(2013-1#2)
was also associated with increased##2##5##(2012-2#1)(2012-6#1)
was also associated with##21##4##(1990-9#1)(1993-11#1)(1994-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#4)(2013-7#1)
was also associated##22##3##(1990-9#1)(1993-11#1)(1994-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#4)(2013-7#1)
was also attenuated##3##3##(1990-12#1)(1994-9#1)(2008-11#1)
was also blocked by##3##4##(1991-9#1)(1995-12#1)(2008-11#1)
was also bound##2##3##(1993-3#1)(2010-10#1)
was also carried out with##2##5##(2011-1#1)(2013-1#1)
was also carried out##12##4##(1993-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#2)
was also characterized##2##3##(1991-8#1)(2008-10#1)
was also checked by##2##4##(2008-10#1)(2012-1#1)
was also compared##2##3##(2008-10#1)(2008-3#1)
was also conducted to##2##4##(2008-5#1)(2013-8#1)
was also conducted##4##3##(2008-5#1)(2013-1#1)(2013-8#2)
was also confirmed in##2##4##(1990-7#1)(1993-2#1)
was also confirmed##8##3##(1990-7#1)(1993-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)
was also decreased by##2##4##(1994-11#1)(1995-2#1)
was also decreased##5##3##(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(2009-12#1)
was also demonstrated for##2##4##(1994-12#1)(2008-10#1)
was also demonstrated in##2##4##(1991-5#1)(2008-5#1)
was also demonstrated##22##3##(1990-5#1)(1991-5#1)(1993-8#1)(1994-12#2)(1994-3#1)(1997-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)
was also dependent on the##3##5##(2008-10#1)(2008-4#1)(2008-7#1)
was also dependent on##4##4##(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
was also described##5##3##(2008-10#3)(2010-3#1)(2013-1#1)
was also detected in the##4##5##(1993-3#1)(1994-11#1)(1996-12#1)(2008-8#1)
was also detected in##15##4##(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#2)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#1)
was also detected only in##2##5##(1990-11#1)(2012-12#1)
was also detected##26##3##(1990-11#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#2)(1996-12#2)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
was also determined by##5##4##(1990-12#1)(1993-12#1)(2008-10#3)
was also determined in##4##4##(1991-12#1)(2007-10#1)(2008-10#1)(2008-5#1)
was also determined using##2##4##(2008-10#2)
was also determined##24##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1993-12#1)(1997-4#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-5#2)(2009-12#1)(2010-1#1)(2011-2#1)
was also developed for##3##4##(2008-10#3)
was also developed to##3##4##(2008-10#2)(2008-3#1)
was also developed##11##3##(1990-8#1)(1991-2#1)(2008-10#7)(2008-3#2)
was also discussed##17##3##(1993-3#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-8#1)(2011-3#1)
was also documented##2##3##(1996-2#1)(2011-2#1)
was also done with##3##4##(1992-6#1)(1994-12#1)(2007-7#1)
was also done##5##3##(1992-6#1)(1994-12#1)(2007-7#1)(2008-5#1)(2013-8#1)
was also effective in##2##4##(1994-8#1)(2008-11#1)
was also employed##2##3##(1993-8#1)(2008-8#1)
was also enhanced by##2##4##(1997-4#1)(2008-5#1)
was also enhanced in##2##4##(1993-12#1)(2008-11#1)
was also enhanced##4##3##(1993-12#1)(1997-4#1)(2008-11#1)(2008-5#1)
was also evaluated and##2##4##(2008-10#2)
was also evaluated in##4##4##(2008-10#1)(2008-12#2)(2008-5#1)
was also evaluated using##2##4##(2008-10#1)(2008-11#1)
was also evaluated with two##2##5##(1997-3#1)(1997-8#1)
was also evaluated##28##3##(1995-11#1)(1997-3#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-5#1)(2009-2#1)(2012-3#1)
was also evidence for##2##4##(2008-11#1)(2008-9#1)
was also evidence##3##3##(1991-8#1)(2008-11#1)(2008-9#1)
was also evident in the##2##5##(1990-11#1)(2008-10#1)
was also evident##5##3##(1990-11#1)(1990-12#1)(2008-10#3)
was also examined in the##2##5##(1997-8#1)(2008-10#1)
was also examined using##2##4##(1992-3#1)(2008-10#1)
was also examined##19##3##(1991-12#1)(1992-3#1)(1994-11#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-6#1)
was also explored##3##3##(2009-10#1)(2010-1#1)(2013-1#1)
was also expressed in##2##4##(2008-8#1)(2008-9#1)
was also expressed##3##3##(1992-9#1)(2008-8#1)(2008-9#1)
was also followed##2##3##(1994-5#1)(2008-10#1)
was also formed##3##3##(1990-8#1)(1995-5#1)(2008-12#1)
was also found at##2##4##(1994-11#1)(2008-10#1)
was also found for##4##4##(2007-6#1)(2008-10#2)(2008-3#1)
was also found in the##2##5##(2008-11#1)(2009-6#1)
was also found in##14##4##(1990-2#1)(1992-5#1)(1992-9#1)(1995-9#1)(1997-6#1)(2008-10#5)(2008-11#1)(2009-6#1)(2010-3#1)(2012-3#1)
was also found that##17##4##(1990-2#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#3)(2008-7#2)(2008-8#2)
was also found to be a##2##6##(1996-3#1)(2007-12#1)
was also found to be##12##5##(1992-12#1)(1992-6#1)(1993-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-2#1)
was also found to decrease##2##5##(1990-5#1)(2011-2#1)
was also found to##18##4##(1990-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-6#1)(1996-3#2)(1996-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
was also found##68##3##(1990-2#2)(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
was also greater##2##3##(1993-8#1)(2008-5#1)
was also high##2##3##(1990-10#1)(2012-3#1)
was also higher in##5##4##(1991-12#1)(1996-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
was also higher##8##3##(1991-12#1)(1994-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
was also identified in##2##4##(2008-10#2)
was also identified##9##3##(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-7#1)(2008-1#1)(2008-10#3)
was also improved##2##3##(1996-6#1)(2008-10#1)
was also in##2##3##(1990-5#1)(2008-10#1)
was also included in the##4##5##(1994-2#1)(2008-10#2)(2008-5#1)
was also included##5##3##(1992-8#1)(1994-2#1)(2008-10#2)(2008-5#1)
was also incorporated##2##3##(2008-10#1)(2010-12#1)
was also increased by##5##4##(1995-12#1)(1995-3#1)(1997-6#1)(2008-10#1)(2011-2#1)
was also increased##10##3##(1994-11#1)(1995-12#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#2)
was also indicated##3##3##(1996-5#1)(2008-7#1)(2008-9#1)
was also induced by##3##4##(1992-12#1)(1993-8#1)(2008-4#1)
was also induced##7##3##(1991-11#1)(1992-12#1)(1993-8#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
was also inhibited by##9##4##(1990-2#1)(1990-5#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
was also inhibited##11##3##(1990-2#2)(1990-5#1)(1991-8#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
was also investigated by##3##4##(2008-10#3)
was also investigated for##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
was also investigated in order to##2##6##(1994-6#1)(2010-4#1)
was also investigated in##4##4##(1992-6#1)(1992-8#1)(1994-6#1)(2010-4#1)
was also investigated using##2##4##(2007-9#1)(2008-10#1)
was also investigated##39##3##(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-5#3)(2009-10#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
was also isolated from the##2##5##(1992-9#1)(2008-8#1)
was also isolated from##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
was also largely##2##3##(2010-12#1)(2013-1#1)
was also lower than##2##4##(2008-3#1)(2008-9#1)
was also lower##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
was also measured using a##2##5##(1993-2#1)(2008-5#1)
was also measured##9##3##(1991-3#1)(1993-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
was also more##2##3##(2007-8#1)(2008-12#1)
was also negatively associated with##2##5##(2008-11#1)(2010-3#1)
was also not affected##3##4##(1993-5#1)(2008-10#1)(2008-12#1)
was also not##5##3##(1993-5#1)(1995-12#1)(2008-10#2)(2008-12#1)
was also noted in the##3##5##(1994-8#1)(1996-12#1)(2008-10#1)
was also noted##8##3##(1994-8#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-8#1)(2010-7#2)
was also noticed##4##3##(1997-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
was also observed after##2##4##(2008-5#1)(2010-4#1)
was also observed at##2##4##(1996-5#1)(2008-6#1)
was also observed for the##3##5##(1991-1#1)(1992-6#1)(2012-2#1)
was also observed for##4##4##(1991-1#1)(1992-10#1)(1992-6#1)(2012-2#1)
was also observed in the##8##5##(1991-12#1)(1992-9#1)(2008-10#4)(2008-8#1)(2009-6#1)
was also observed in##20##4##(1991-12#1)(1991-2#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-5#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
was also observed on##2##4##(1994-2#1)(2008-10#1)
was also observed that##11##4##(1992-6#1)(1995-11#1)(1995-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-6#1)(2013-8#1)
was also observed when the##2##5##(1991-5#1)(1997-6#1)
was also observed when##5##4##(1991-5#1)(1993-12#1)(1994-5#1)(1997-6#1)(2008-10#1)
was also observed within##3##4##(1991-12#1)(1992-8#1)(2008-10#1)
was also observed##70##3##(1990-11#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
was also obtained by##2##4##(1992-10#1)(2008-5#1)
was also obtained##13##3##(1992-10#1)(1994-11#1)(1995-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)
was also one of the##3##5##(2008-10#2)(2008-3#1)
was also performed in##3##4##(1992-10#1)(2008-10#1)(2008-5#1)
was also performed on##3##4##(1994-8#1)(1995-2#1)(2008-10#1)
was also performed##21##3##(1992-10#1)(1992-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#2)
was also positively##2##3##(1997-2#1)(2008-6#1)
was also possible##2##3##(2008-10#2)
was also posted##2##3##(2008-11#1)(2012-3#1)
was also prepared##3##3##(1992-12#1)(1993-8#1)(2008-2#1)
was also present in other##2##5##(2008-10#1)(2008-7#1)
was also present in the##2##5##(1990-5#1)(2008-10#1)
was also present in##7##4##(1990-5#1)(1993-2#1)(1994-6#1)(2008-10#3)(2008-7#1)
was also present##10##3##(1990-5#1)(1990-7#1)(1991-9#1)(1993-2#1)(1994-6#1)(2008-10#3)(2008-7#1)(2012-2#1)
was also presented##2##3##(1996-2#1)(2012-2#1)
was also prevented##2##3##(1994-2#1)(1997-1#1)
was also produced by##2##4##(1992-6#1)(2008-11#1)
was also produced##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
was also proposed##2##3##(2008-10#1)(2009-11#1)
was also proved to##2##4##(2008-10#1)(2008-11#1)
was also proved##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
was also recently##2##3##(1994-11#1)(2010-3#1)
was also recorded in##2##4##(1995-12#1)(2010-4#1)
was also recorded##7##3##(1993-2#1)(1995-12#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-4#1)(2013-1#1)
was also reduced by##3##4##(1995-12#1)(2008-10#1)(2008-12#1)
was also reduced in##3##4##(1990-12#1)(1993-12#1)(2012-12#1)
was also reduced##8##3##(1990-12#1)(1992-8#1)(1993-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2012-12#1)
was also reported##3##3##(1993-1#1)(2007-8#1)(2008-6#1)
was also seen in##4##4##(1991-11#1)(1995-11#1)(1996-12#1)(2009-4#1)
was also seen##6##3##(1990-5#1)(1991-11#1)(1995-11#1)(1996-12#1)(2008-10#1)(2009-4#1)
was also shown to be expressed in##2##7##(2010-5#2)
was also shown to be##3##5##(1991-5#1)(2010-5#2)
was also shown to##8##4##(1991-10#1)(1991-5#1)(1992-6#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-5#2)
was also shown##12##3##(1991-10#1)(1991-5#1)(1992-6#1)(1996-6#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-3#1)(2010-5#2)
was also significant##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
was also significantly associated with##2##5##(2011-1#2)
was also significantly diminished##2##4##(1991-12#1)(2008-8#1)
was also significantly higher than that in##2##7##(2008-9#1)(2011-1#1)
was also significantly higher than##3##5##(1991-4#1)(2008-9#1)(2011-1#1)
was also significantly higher##4##4##(1991-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
was also significantly##14##3##(1991-12#1)(1991-4#1)(1991-5#1)(1994-8#2)(1996-3#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#3)(2011-2#1)
was also stimulated##2##3##(1994-11#1)(1994-3#1)
was also studied and##2##4##(2008-10#2)
was also studied by##2##4##(1996-2#1)(2008-10#1)
was also studied on##2##4##(2008-10#1)(2009-12#1)
was also studied using##2##4##(2008-10#1)(2009-3#1)
was also studied##41##3##(1990-2#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-10#23)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
was also successfully##2##3##(2008-10#2)
was also supported by##2##4##(1990-5#1)(2008-7#1)
was also supported##3##3##(1990-5#1)(2008-7#1)(2009-2#1)
was also suppressed##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
was also suspected##2##3##(2008-10#1)(2013-1#1)
was also tested in##2##4##(1997-7#1)(2008-11#1)
was also tested##10##3##(1995-2#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-1#1)
was also the most##2##4##(2008-10#1)(2008-11#1)
was also undertaken##2##3##(2008-10#1)(2012-3#1)
was also used as a##3##5##(1996-8#1)(2008-10#1)(2008-12#1)
was also used as##4##4##(1996-8#1)(2008-10#2)(2008-12#1)
was also used for the determination of##2##7##(2008-10#2)
was also used for the##3##5##(2008-10#3)
was also used for##10##4##(1991-12#1)(1996-3#1)(2008-10#8)
was also used in a##2##5##(2008-10#2)
was also used in##5##4##(1994-9#1)(2008-10#4)
was also used to assess the##2##6##(1994-2#1)(2008-10#1)
was also used to calculate##2##5##(2008-10#1)(2008-3#1)
was also used to compare the##2##6##(1995-5#1)(2008-5#1)
was also used to measure the##2##6##(2008-10#1)(2008-2#1)
was also used to screen##2##5##(2008-10#2)
was also used to##20##4##(1994-2#1)(1995-5#1)(2007-11#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2011-2#1)
was also used##41##3##(1991-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-8#1)(2007-11#2)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2011-2#1)
was also utilized##2##3##(1995-8#1)(2012-2#1)
was also validated by##3##4##(2008-1#1)(2008-10#1)(2010-5#1)
was also verified##5##3##(2008-10#3)(2008-9#1)(2011-1#1)
was also very##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
was also##1023##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#6)(1990-5#8)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#7)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#2)(1991-8#3)(1991-9#6)(1992-10#4)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#8)(1992-8#6)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#10)(1993-2#8)(1993-3#5)(1993-5#1)(1993-6#6)(1993-8#9)(1993-9#2)(1994-11#9)(1994-12#5)(1994-2#7)(1994-3#7)(1994-5#6)(1994-6#7)(1994-8#9)(1994-9#3)(1995-11#4)(1995-12#14)(1995-2#10)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#3)(1995-9#1)(1996-12#10)(1996-2#6)(1996-3#4)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#5)(1997-4#5)(1997-6#5)(1997-7#2)(1997-8#5)(2006-10#2)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#303)(2008-11#33)(2008-12#17)(2008-2#12)(2008-3#21)(2008-4#4)(2008-5#42)(2008-6#12)(2008-7#27)(2008-8#22)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#6)(2009-8#5)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#12)(2011-2#22)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#14)(2012-3#8)(2012-6#2)(2013-1#31)(2013-7#3)(2013-8#9)
was altered by site-directed mutagenesis##2##5##(1991-2#1)(1993-11#1)
was altered by##5##3##(1991-2#1)(1993-11#1)(2007-11#1)(2008-10#2)
was altered in##4##3##(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
was altered##15##2##(1991-2#1)(1991-9#1)(1993-11#1)(1993-8#1)(1996-12#1)(1996-5#1)(2007-11#2)(2008-10#4)(2008-8#1)(2011-2#1)(2013-7#1)
was alternated##2##2##(2008-3#1)(2012-3#1)
was always associated with##3##4##(2008-10#3)
was always found to be##2##5##(2008-10#1)(2008-12#1)
was always found##3##3##(2008-10#2)(2008-12#1)
was always higher than##2##4##(1995-3#1)(2008-10#1)
was always higher##3##3##(1995-3#1)(2008-10#1)(2013-8#1)
was always less##2##3##(2008-10#1)(2008-3#1)
was always observed##2##3##(2008-10#1)(2008-11#1)
was always##34##2##(1990-5#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-6#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2012-12#1)(2012-2#1)(2013-8#1)
was ameliorated by##3##3##(2008-6#1)(2012-12#1)(2013-1#1)
was amended with##6##3##(2008-10#6)
was among the first##2##4##(1993-3#1)(2012-2#1)
was among the##4##3##(1993-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
was among those who##2##4##(1993-3#2)
was among##6##2##(1993-3#3)(2008-10#1)(2008-12#1)(2012-2#1)
was amplified and sequenced##2##4##(2008-10#2)
was amplified and##5##3##(2008-10#3)(2008-11#1)(2008-7#1)
was amplified by PCR and cloned##2##6##(1997-8#1)(2008-8#1)
was amplified by PCR and##3##5##(1997-8#1)(2008-10#1)(2008-8#1)
was amplified by PCR##6##4##(1992-3#1)(1997-8#1)(2008-10#1)(2008-8#2)(2011-1#1)
was amplified by polymerase chain reaction (PCR) and##2##8##(2008-10#1)(2010-6#1)
was amplified by polymerase chain reaction##3##6##(2008-10#2)(2010-6#1)
was amplified by reverse transcription-polymerase chain reaction (RT-PCR)##2##8##(1997-6#1)(2008-10#1)
was amplified by the##3##4##(1997-7#1)(2008-10#1)(2008-11#1)
was amplified by##18##3##(1992-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-8#4)(2010-6#1)(2011-1#1)
was amplified from##10##3##(1995-8#1)(1997-3#1)(1997-9#1)(2008-10#6)(2008-4#1)
was amplified through##2##3##(2008-5#1)(2011-1#1)
was amplified using##3##3##(2006-8#1)(2008-12#1)(2009-5#1)
was amplified##43##2##(1992-3#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-8#1)(2007-12#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-5#1)(2010-6#1)(2011-1#2)
was an additional##2##3##(2008-10#1)(2011-2#1)
was an apparent##2##3##(2008-10#1)(2010-11#1)
was an association of##2##4##(2007-10#1)(2008-10#1)
was an association##3##3##(2007-10#1)(2008-10#1)(2013-8#1)
was an attempt##2##3##(1992-3#1)(2010-3#1)
was an early##3##3##(1990-7#1)(2008-1#1)(2008-10#1)
was an effective technique##2##4##(2008-10#2)
was an effective tool to##2##5##(2008-10#1)(2010-10#1)
was an effective##8##3##(1993-12#1)(2008-10#5)(2008-7#1)(2010-10#1)
was an efficient##3##3##(1990-11#1)(1994-8#1)(2008-10#1)
was an excellent correlation between##2##5##(1992-2#1)(2008-10#1)
was an excellent##3##3##(1992-2#1)(2007-10#1)(2008-10#1)
was an extremely##2##3##(2010-1#1)(2013-1#1)
was an important##3##3##(2008-5#1)(2011-3#1)(2013-8#1)
was an improvement in##4##4##(2008-10#1)(2008-5#2)(2008-7#1)
was an improvement##5##3##(2008-10#1)(2008-5#3)(2008-7#1)
was an incidental finding during##2##5##(1992-9#1)(2008-12#1)
was an incidental finding##3##4##(1992-9#1)(1995-11#1)(2008-12#1)
was an increase in the##4##5##(2008-11#1)(2008-9#1)(2009-8#1)(2013-8#1)
was an increase in##11##4##(1992-12#1)(2008-10#3)(2008-11#3)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
was an increase##12##3##(1992-12#1)(2008-10#4)(2008-11#3)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
was an increased##2##3##(2008-11#1)(2011-2#1)
was an independent risk factor##2##5##(1994-12#1)(2007-8#1)
was an independent##6##3##(1994-12#2)(1995-4#1)(2007-8#1)(2011-2#1)(2012-3#1)
was an inverse relationship between##3##5##(1991-5#1)(1996-7#1)(2008-10#1)
was an inverse##6##3##(1991-5#1)(1996-7#1)(2008-10#3)(2012-12#1)
was an isoschizomer of##2##4##(1993-9#2)
was an unexpected finding##2##4##(1990-12#1)(2008-12#1)
was an unusual##2##3##(2008-7#1)(2010-5#1)
was an up-regulation of##2##4##(2010-11#1)(2010-4#1)
was an##149##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#3)(1994-12#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#28)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#7)(2008-7#6)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
was analysed and##2##3##(1996-12#1)(2008-10#1)
was analysed by the##2##4##(1990-5#1)(2008-5#1)
was analysed by##11##3##(1990-5#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-5#4)(2009-10#1)(2012-2#1)
was analysed for##6##3##(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-9#1)
was analysed in##3##3##(1996-5#1)(2008-5#2)
was analysed using##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
was analysed##43##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-5#6)(2008-6#1)(2009-10#1)(2009-7#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-9#1)(2013-8#1)
was analysis of##2##3##(2007-8#1)(2008-7#1)
was analyzed after##2##3##(2008-10#2)
was analyzed and the##2##4##(1997-8#1)(2008-10#1)
was analyzed and##9##3##(1993-12#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-10#2)(2009-9#1)(2011-1#1)(2011-2#1)
was analyzed as a##2##4##(2007-8#1)(2008-10#1)
was analyzed as##3##3##(2007-8#1)(2008-10#1)(2010-8#1)
was analyzed at the##2##4##(1994-3#1)(2008-8#1)
was analyzed at##4##3##(1994-3#1)(1994-5#1)(2008-8#1)(2013-7#1)
was analyzed both##2##3##(2008-10#1)(2011-2#1)
was analyzed by SDS-PAGE##2##4##(2011-1#1)(2013-1#1)
was analyzed by means of##2##5##(2008-5#1)(2013-8#1)
was analyzed by modified##2##4##(1995-12#1)(2008-2#1)
was analyzed by the##5##4##(1990-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2013-7#1)
was analyzed by##53##3##(1990-11#1)(1990-2#1)(1992-11#1)(1992-9#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(2007-11#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#3)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
was analyzed for its##2##4##(2010-5#1)(2011-2#1)
was analyzed for the##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
was analyzed for##20##3##(1992-10#2)(1993-1#1)(1993-9#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-5#2)(2011-2#1)(2012-2#1)
was analyzed in detail##2##4##(2008-10#1)(2008-9#1)
was analyzed in the##4##4##(1995-8#1)(2008-10#2)(2008-5#1)
was analyzed in##23##3##(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#3)(1994-11#1)(1995-8#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
was analyzed on the basis of##3##6##(2007-8#1)(2008-3#1)(2008-6#1)
was analyzed on##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
was analyzed to##2##3##(2008-10#2)
was analyzed using a##2##4##(2008-10#2)
was analyzed using an##2##4##(2007-10#1)(2008-10#1)
was analyzed using the##7##4##(1991-2#1)(1992-8#1)(2008-10#4)(2013-1#1)
was analyzed using##25##3##(1991-2#1)(1992-8#1)(1997-5#1)(2007-10#1)(2008-10#14)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
was analyzed with##6##3##(2008-2#1)(2008-6#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-8#1)
was analyzed##194##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#3)(2008-10#55)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-11#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#12)
was anchored##2##2##(1997-4#1)(2010-3#1)
was annealed at##2##3##(2013-8#2)
was annealed##3##2##(1992-12#1)(2013-8#2)
was another##3##2##(2008-1#1)(2008-5#1)(2010-4#1)
was antagonized by##2##3##(1990-5#1)(1994-8#1)
was apoptosis##2##2##(2008-11#2)
was apparent in the##2##4##(1997-3#1)(2007-5#1)
was apparent in##3##3##(1991-6#1)(1997-3#1)(2007-5#1)
was apparent##13##2##(1991-6#1)(1992-10#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-9#1)
was apparently not##2##3##(1991-10#1)(2013-1#1)
was apparently##7##2##(1991-10#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
was applicable to the analysis of##2##6##(2008-10#2)
was applicable to##5##3##(2008-10#4)(2013-8#1)
was applicable##9##2##(1993-12#1)(2008-10#7)(2013-8#1)
was applied and##6##3##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
was applied as a##6##4##(2008-10#5)(2008-11#1)
was applied as an##3##4##(2008-10#2)(2010-4#1)
was applied as##14##3##(2008-10#11)(2008-11#1)(2008-12#1)(2010-4#1)
was applied at##6##3##(2008-10#3)(2010-4#1)(2011-1#1)(2012-2#1)
was applied before##3##3##(1992-2#1)(2008-10#2)
was applied by##2##3##(2008-5#1)(2008-7#1)
was applied directly##2##3##(1996-5#1)(2008-10#1)
was applied during##4##3##(1991-12#1)(1994-3#1)(2008-10#1)(2009-4#1)
was applied for copper determination in##2##6##(2008-10#2)
was applied for copper determination##3##5##(2008-10#3)
was applied for determination of##3##5##(2008-10#3)
was applied for simultaneous##2##4##(2008-10#1)(2008-2#1)
was applied for the analysis of##3##6##(2008-10#3)
was applied for the determination of drug##2##7##(2008-10#2)
was applied for the determination of the##4##7##(1991-7#1)(2008-10#3)
was applied for the determination of##25##6##(1991-7#1)(2008-10#24)
was applied for the simultaneous##3##5##(2008-10#3)
was applied for the##48##4##(1991-7#1)(2007-11#1)(2008-10#45)(2008-11#1)
was applied for##84##3##(1991-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#73)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2010-4#1)
was applied in a##2##4##(2008-10#2)
was applied in order to determine the##2##7##(2008-10#2)
was applied in order to##3##5##(1996-5#1)(2008-10#2)
was applied in pharmacokinetic##2##4##(2008-10#1)(2011-3#1)
was applied in the##4##4##(2008-10#4)
was applied in##22##3##(1996-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
was applied on the##5##4##(1996-1#1)(2008-10#1)(2009-11#1)(2011-3#1)(2013-1#1)
was applied on##10##3##(1996-1#1)(2008-10#5)(2008-5#1)(2009-11#1)(2011-3#1)(2013-1#1)
was applied over the##2##4##(2008-10#1)(2008-9#1)
was applied over##3##3##(2008-10#2)(2008-9#1)
was applied satisfactorily to the##3##5##(2008-10#3)
was applied satisfactorily to##6##4##(2008-10#6)
was applied successfully for the determination of##2##7##(2008-10#2)
was applied successfully in##2##4##(2008-10#2)
was applied successfully to determine##2##5##(2008-10#2)
was applied successfully to the determination of##13##7##(2008-10#13)
was applied successfully to the##14##5##(2008-10#14)
was applied successfully to##17##4##(1991-5#1)(2008-10#16)
was applied successfully##21##3##(1991-5#1)(2008-10#20)
was applied to 1##3##4##(2008-10#2)(2013-1#1)
was applied to a##19##4##(1990-5#1)(1991-12#1)(1995-2#1)(2007-11#1)(2008-10#11)(2008-3#4)
was applied to analyse##2##4##(2008-10#2)
was applied to assay##2##4##(2008-10#2)
was applied to assess the associations##2##6##(2011-1#1)(2013-1#1)
was applied to characterize##2##4##(1996-2#1)(2008-10#1)
was applied to commercial##2##4##(2008-10#2)
was applied to detect the##2##5##(2008-10#1)(2011-1#1)
was applied to detect##5##4##(2008-10#3)(2011-1#1)(2013-1#1)
was applied to determination of##6##5##(2008-10#6)
was applied to determine the##7##5##(2008-10#5)(2009-12#1)(2011-1#1)
was applied to determine zinc##2##5##(2008-10#2)
was applied to determine##19##4##(2008-10#17)(2009-12#1)(2011-1#1)
was applied to different##4##4##(2008-10#4)
was applied to extract##2##4##(2008-10#2)
was applied to identify##2##4##(2011-3#1)(2013-8#1)
was applied to investigate the##2##5##(2008-9#1)(2011-3#1)
was applied to measure##3##4##(2008-2#1)(2008-6#1)(2012-2#1)
was applied to obtain the##2##5##(2008-10#2)
was applied to obtain##3##4##(2008-10#2)(2008-5#1)
was applied to on-line##2##4##(2008-10#2)
was applied to select the##2##5##(2008-10#1)(2010-8#1)
was applied to several##2##4##(2008-10#2)
was applied to study the##5##5##(1997-7#1)(2008-10#3)(2011-3#1)
was applied to study##6##4##(1997-7#1)(2008-10#4)(2011-3#1)
was applied to tap water##3##5##(2008-10#3)
was applied to the analysis of certified##2##7##(2008-10#2)
was applied to the analysis of##24##6##(2008-10#23)(2010-4#1)
was applied to the detection of##2##6##(2008-10#2)
was applied to the determination of cadmium in##3##8##(2008-10#3)
was applied to the determination of chloramphenicol##2##7##(2008-10#2)
was applied to the determination of copper in##2##8##(2008-10#2)
was applied to the determination of hydrazine in water samples##2##10##(2008-10#2)
was applied to the determination of molybdenum in##2##8##(2008-10#2)
was applied to the determination of silver in##2##8##(2008-10#2)
was applied to the determination of the drug in##2##9##(2008-10#2)
was applied to the determination of the##3##7##(2008-10#3)
was applied to the determination of these compounds in##3##9##(2008-10#3)
was applied to the determination of these##7##7##(2008-10#7)
was applied to the determination of##93##6##(1996-5#1)(1997-2#1)(2008-10#91)
was applied to the direct determination##2##6##(2008-10#2)
was applied to the direct##3##5##(2008-10#3)
was applied to the extraction##2##5##(2008-10#2)
was applied to the measurement of##2##6##(1990-8#1)(2008-10#1)
was applied to the simultaneous determination of##2##7##(2008-10#2)
was applied to the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
was applied to the simultaneous##6##5##(2008-10#6)
was applied to the speciation of##3##6##(2008-10#3)
was applied to the speciation##4##5##(2008-10#4)
was applied to the##191##4##(1990-2#1)(1990-8#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#169)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#2)(2011-2#1)(2013-1#3)(2013-8#1)
was applied to two different##2##5##(2008-10#1)(2008-3#1)
was applied to two##7##4##(2008-10#4)(2008-3#3)
was applied to verify the##2##5##(2008-10#1)(2013-7#1)
was applied to##393##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#2)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#300)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#18)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-6#1)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#3)(2012-2#2)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#4)
was applied using a##2##4##(2008-11#1)(2013-1#1)
was applied using##3##3##(2008-11#1)(2013-1#2)
was applied with##6##3##(2007-8#1)(2008-10#3)(2008-12#1)(2009-7#1)
was applied##654##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#2)(2007-8#9)(2008-1#2)(2008-10#472)(2008-11#11)(2008-12#5)(2008-2#7)(2008-3#21)(2008-5#12)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#6)(2010-8#2)(2011-1#5)(2011-2#5)(2011-3#5)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#4)
was appointed##5##2##(1993-11#1)(1993-3#2)(2010-1#1)(2011-1#1)
was appressed##2##2##(2008-10#2)
was approached by##2##3##(1993-12#1)(1995-11#1)
was approached##4##2##(1991-2#1)(1992-3#1)(1993-12#1)(1995-11#1)
was appropriate for##3##3##(2008-1#1)(2008-10#2)
was appropriate##4##2##(2008-1#1)(2008-10#2)(2010-12#1)
was appropriately##3##2##(2007-11#1)(2008-4#1)(2008-5#1)
was approved by the##3##4##(2008-9#1)(2010-4#1)(2012-12#1)
was approved by##6##3##(1996-7#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
was approved for the treatment of##2##6##(2008-5#1)(2008-7#1)
was approved for##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
was approved in##2##3##(2006-12#1)(2012-3#1)
was approved##12##2##(1996-7#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
was approximately 0##6##3##(2008-10#3)(2008-3#3)
was approximately 1##8##3##(1992-11#1)(1995-2#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
was approximately 10##4##3##(1991-5#1)(1994-11#1)(1995-6#1)(2008-3#1)
was approximately 10-fold##2##3##(1993-3#1)(2008-10#1)
was approximately 13%##2##3##(2008-10#1)(2008-8#1)
was approximately 2##5##3##(1990-8#1)(1992-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
was approximately 20##2##3##(2008-10#1)(2009-9#1)
was approximately 200 times##2##4##(2008-10#1)(2010-5#1)
was approximately 200##3##3##(2008-10#1)(2009-7#1)(2010-5#1)
was approximately 3##2##3##(2008-3#2)
was approximately 4##2##3##(1991-2#1)(2008-10#1)
was approximately 5##3##3##(1992-4#1)(1996-2#1)(2008-3#1)
was approximately 50%##3##3##(1994-11#1)(2008-10#1)(2008-7#1)
was approximately 60%##2##3##(1993-11#1)(2011-2#1)
was approximately equal##2##3##(1994-11#1)(2008-10#1)
was approximately##88##2##(1990-2#1)(1990-8#2)(1991-2#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-3#2)(1994-11#3)(1994-2#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#12)(2008-5#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-7#1)(2009-9#2)(2010-5#1)(2011-2#2)(2012-12#1)
was arbitrarily##2##2##(1993-12#1)(2008-10#1)
was around##15##2##(1990-7#1)(1992-4#1)(2008-10#9)(2008-11#2)(2008-9#1)(2012-3#1)
was arranged##3##2##(2008-12#1)(2010-11#1)(2011-2#1)
was arrested and##2##3##(1995-12#1)(2011-2#1)
was arrested##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
was arrived at##3##3##(1990-3#1)(1995-6#1)(2009-5#1)
was as effective as##3##4##(1993-9#1)(2008-10#1)(2008-8#1)
was as effective##4##3##(1993-9#1)(2008-10#2)(2008-8#1)
was as efficient as##2##4##(1990-12#1)(2008-10#1)
was as follows##12##3##(1990-2#1)(1994-11#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#2)
was as good as##2##4##(2008-9#1)(2011-1#1)
was as high as##7##4##(1997-4#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
was as large as##3##4##(2008-2#1)(2008-3#1)(2009-11#1)
was as low as 0##2##5##(1992-8#1)(2008-10#1)
was as low as 1##2##5##(2008-10#1)(2011-1#1)
was as low as##8##4##(1992-8#1)(2008-10#6)(2011-1#1)
was as much##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
was as potent as##2##4##(1990-2#1)(1995-12#1)
was as##54##2##(1990-12#1)(1990-2#2)(1990-6#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#3)
was ascertained by##6##3##(2008-10#5)(2011-1#1)
was ascertained##10##2##(1993-9#1)(1994-8#1)(1997-3#1)(2008-10#5)(2008-6#1)(2011-1#1)
was asked to##3##3##(1990-11#1)(1991-3#1)(2008-11#1)
was asked##4##2##(1990-11#1)(1991-3#1)(1995-2#1)(2008-11#1)
was aspirated##5##2##(2008-10#3)(2008-7#1)(2010-12#1)
was assayed by##6##3##(1992-5#1)(2008-10#3)(2008-11#1)(2009-9#1)
was assayed in##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
was assayed on##4##3##(2007-11#2)(2008-10#1)(2008-7#1)
was assayed using##3##3##(1995-8#1)(1997-7#1)(2008-8#1)
was assayed##20##2##(1990-12#1)(1990-7#1)(1992-5#1)(1993-3#1)(1995-8#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2009-9#1)
was assembled for##2##3##(2008-10#1)(2012-2#1)
was assembled to##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
was assembled with##3##3##(1997-4#1)(2008-10#2)
was assembled##16##2##(1995-2#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#8)(2008-2#1)(2010-5#1)(2012-2#2)
was assesed##2##2##(2007-11#1)(2008-7#1)
was assessed according to##2##4##(1993-8#1)(2012-3#1)
was assessed after##2##3##(1990-12#1)(1991-5#1)
was assessed and##2##3##(2008-10#1)(2008-3#1)
was assessed as##5##3##(2008-1#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-2#1)
was assessed at##6##3##(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)
was assessed based on##2##4##(2008-10#2)
was assessed by a##2##4##(1996-5#1)(2008-10#1)
was assessed by comparing the##2##5##(1991-6#1)(2008-10#1)
was assessed by comparing##5##4##(1991-6#1)(1994-1#1)(1997-3#1)(2008-10#1)(2010-4#1)
was assessed by comparison with##2##5##(2008-10#1)(2008-5#1)
was assessed by counting colonies formed from spore-bearing splash droplets deposited in sheltered petri plates containing a selective medium##2##19##(2008-10#2)
was assessed by determining##2##4##(2008-10#1)(2008-5#1)
was assessed by enzyme-linked immunosorbent assay##2##6##(2008-10#1)(2011-2#1)
was assessed by evaluating##2##4##(1993-6#1)(2008-10#1)
was assessed by flow cytometry##2##5##(2008-4#1)(2013-7#1)
was assessed by means of##2##5##(2007-11#1)(2008-7#1)
was assessed by measuring serum##2##5##(2008-10#1)(2012-2#1)
was assessed by measuring the##3##5##(1990-5#1)(1995-3#1)(2008-3#1)
was assessed by measuring##6##4##(1990-5#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
was assessed by quantitative##2##4##(2007-8#1)(2008-7#1)
was assessed by the determination of##2##6##(2008-10#2)
was assessed by the##12##4##(1993-3#1)(1993-6#1)(2008-10#4)(2008-5#1)(2009-3#2)(2012-1#1)(2013-1#2)
was assessed by use of##3##5##(1995-11#1)(2008-7#1)(2013-1#1)
was assessed by using##3##4##(1990-7#1)(2008-10#2)
was assessed by##91##3##(1990-5#1)(1990-7#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-5#2)(1994-6#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#30)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
was assessed during##2##3##(2008-10#1)(2013-8#1)
was assessed either by##2##4##(1992-1#1)(1995-6#1)
was assessed for the##2##4##(2008-10#2)
was assessed for##6##3##(2008-10#3)(2008-9#1)(2010-12#1)(2011-2#1)
was assessed from the##2##4##(1997-4#1)(2008-10#1)
was assessed from##3##3##(1997-4#1)(2008-10#2)
was assessed in 20##2##4##(1992-3#1)(2008-10#1)
was assessed in a large##2##5##(1993-3#1)(2008-7#1)
was assessed in a##7##4##(1993-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-7#1)(2013-1#1)
was assessed in all##2##4##(2008-7#1)(2012-2#1)
was assessed in field experiments##2##5##(2008-10#2)
was assessed in terms of##4##5##(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
was assessed in the##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
was assessed in these##2##4##(1994-2#1)(2008-10#1)
was assessed in two##2##4##(2007-8#1)(2008-10#1)
was assessed in##51##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1993-3#1)(1994-2#2)(1994-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#2)
was assessed on the##2##4##(2007-8#1)(2008-10#1)
was assessed on##6##3##(1990-6#1)(1992-8#1)(2007-8#1)(2008-10#3)
was assessed through##7##3##(2008-10#6)(2013-1#1)
was assessed to##2##3##(2007-7#1)(2008-8#1)
was assessed using a##8##4##(1997-7#1)(2008-1#1)(2008-10#3)(2009-3#2)(2012-3#1)
was assessed using the##10##4##(1990-11#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
was assessed using##42##3##(1990-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-7#1)(1997-3#1)(1997-7#1)(2007-10#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
was assessed with a##4##4##(1993-12#1)(2008-5#2)(2010-7#1)
was assessed with the##5##4##(1994-2#1)(2008-10#2)(2008-7#1)(2013-8#1)
was assessed with##15##3##(1993-12#1)(1994-2#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#2)(2010-7#1)(2013-1#1)(2013-8#1)
was assessed##296##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#89)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#17)(2008-6#5)(2008-7#11)(2008-8#2)(2008-9#5)(2009-11#1)(2009-3#4)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#4)(2012-5#2)(2013-1#14)(2013-7#3)(2013-8#6)
was assigned a##2##3##(1993-6#1)(2010-2#1)
was assigned to the##3##4##(1991-8#1)(1994-11#1)(2008-8#1)
was assigned to##10##3##(1991-8#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-8#1)
was assigned using##2##3##(1992-3#1)(2008-10#1)
was assigned##17##2##(1991-8#1)(1992-3#1)(1993-6#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-2#1)
was associated to##2##3##(2008-10#2)
was associated with Buerger's disease##2##5##(1997-8#2)
was associated with a 1##2##5##(2008-11#1)(2013-1#1)
was associated with a better outcome in##2##7##(2008-11#1)(2009-10#1)
was associated with a decrease##2##5##(1996-6#1)(2008-7#1)
was associated with a decreased risk of##2##7##(2011-2#1)(2013-7#1)
was associated with a decreased##4##5##(1992-8#1)(2011-2#2)(2013-7#1)
was associated with a high##3##5##(2008-1#1)(2008-6#1)(2008-7#1)
was associated with a higher proportion of##2##7##(1996-2#1)(2008-9#1)
was associated with a higher##3##5##(1996-2#1)(2008-9#1)(2013-1#1)
was associated with a lower##2##5##(2008-10#1)(2013-8#1)
was associated with a reduction in##3##6##(2008-10#1)(2010-11#1)(2013-1#1)
was associated with a significant increase in##2##7##(1995-12#1)(2012-1#1)
was associated with a significant reduction in##5##7##(2007-10#1)(2007-2#1)(2008-3#1)(2010-5#1)(2010-6#1)
was associated with a significant##9##5##(1995-12#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-8#1)
was associated with a##62##4##(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-8#1)(1992-9#1)(1994-12#1)(1995-12#2)(1996-2#1)(1996-6#1)(1997-4#1)(2006-12#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#4)
was associated with abnormal##2##4##(1990-8#1)(2008-9#1)
was associated with an increase in##7##6##(1990-7#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#2)
was associated with an increased risk of##2##7##(1993-11#1)(2010-6#1)
was associated with an increased##4##5##(1990-12#1)(1993-11#1)(2008-11#1)(2010-6#1)
was associated with an##19##4##(1990-12#1)(1990-7#1)(1993-11#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
was associated with better##2##4##(2011-1#1)(2012-2#1)
was associated with both##3##4##(1990-8#1)(1995-2#1)(2010-7#1)
was associated with decreased##5##4##(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)(2013-8#1)
was associated with elevated##4##4##(2007-10#1)(2008-10#1)(2008-5#1)(2010-7#1)
was associated with enhanced##2##4##(2008-12#1)(2010-11#1)
was associated with fewer##2##4##(2007-7#1)(2011-2#1)
was associated with greater##8##4##(2007-10#1)(2008-4#2)(2009-11#1)(2009-5#1)(2010-4#1)(2010-9#1)(2013-8#1)
was associated with having##2##4##(2008-6#1)(2009-4#1)
was associated with high##4##4##(1994-8#1)(2007-7#1)(2008-10#1)(2009-4#1)
was associated with higher##6##4##(1993-3#1)(1994-12#1)(2008-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
was associated with improved##2##4##(2008-6#1)(2010-4#1)
was associated with increased##18##4##(1991-3#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-6#1)(2013-1#1)
was associated with increases in##2##5##(1993-3#1)(2008-10#1)
was associated with less##4##4##(2009-10#1)(2009-11#1)(2009-12#1)(2010-9#1)
was associated with low##2##4##(2008-10#1)(2008-7#1)
was associated with lower##8##4##(1993-3#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2012-1#1)(2013-1#2)
was associated with marked##2##4##(1991-5#1)(2008-10#1)
was associated with meeting##2##4##(2009-5#2)
was associated with more than one##2##6##(2008-10#2)
was associated with more##8##4##(1995-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#2)
was associated with poorer##3##4##(2008-9#1)(2009-9#1)(2012-1#1)
was associated with significant##4##4##(1996-12#1)(2008-10#1)(2010-12#1)(2010-6#1)
was associated with significantly##3##4##(1993-9#1)(2010-5#1)(2012-2#1)
was associated with the induction of##2##6##(2008-10#1)(2008-11#1)
was associated with the##20##4##(1992-8#1)(1993-3#1)(1993-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
was associated with##321##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-10#2)(1992-12#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-12#1)(2007-10#5)(2007-2#3)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#57)(2008-11#11)(2008-12#8)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#11)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-7#3)(2009-9#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#11)(2012-1#8)(2012-12#7)(2012-2#9)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#22)(2013-7#2)(2013-8#12)
was associated##328##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-10#2)(1992-12#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-12#1)(2007-10#5)(2007-2#3)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#61)(2008-11#11)(2008-12#8)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#11)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-7#3)(2009-9#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#11)(2012-1#8)(2012-12#7)(2012-2#9)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#23)(2013-7#2)(2013-8#12)
was assumed that the##3##4##(2008-11#1)(2008-6#2)
was assumed that##6##3##(2008-10#3)(2008-11#1)(2008-6#2)
was assumed to be a##2##5##(1991-2#1)(2008-7#1)
was assumed to be##6##4##(1990-5#1)(1991-2#1)(2008-10#2)(2008-3#1)(2008-7#1)
was assumed to##8##3##(1990-5#1)(1991-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
was assumed##20##2##(1990-5#1)(1991-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
was asymptomatic##9##2##(1990-8#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#4)
was at a##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
was at all##2##3##(1990-12#1)(2013-7#1)
was at approximately##3##3##(1993-8#1)(2007-11#1)(2008-10#1)
was at least as##2##4##(2008-10#1)(2008-8#1)
was at least partly##3##4##(1994-8#1)(2008-10#2)
was at least##13##3##(1993-6#1)(1994-8#1)(1995-12#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-9#1)(2013-8#1)
was at pH##2##3##(1992-9#1)(2008-10#1)
was at the same##2##4##(2008-5#1)(2008-9#1)
was at the##7##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
was at##51##2##(1990-12#1)(1991-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-8#1)(2007-11#2)(2007-8#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-7#2)(2013-8#1)
was attached to a##2##4##(1993-11#1)(2008-10#1)
was attached to the##6##4##(2008-10#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)
was attached to##10##3##(1993-11#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)
was attached##13##2##(1993-11#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)
was attained by##3##3##(2008-10#2)(2011-1#1)
was attained for##3##3##(1995-6#1)(2007-12#1)(2008-10#1)
was attained in the presence of##2##6##(1990-2#1)(1993-6#1)
was attained in the##3##4##(1990-2#1)(1993-6#1)(2008-11#1)
was attained in##7##3##(1990-2#1)(1991-3#1)(1992-12#1)(1993-6#1)(2008-10#2)(2008-11#1)
was attained with##2##3##(2007-4#1)(2008-3#1)
was attained within a##2##4##(2008-10#2)
was attained within##3##3##(2008-10#2)(2011-1#1)
was attained##28##2##(1990-2#1)(1991-3#1)(1992-12#1)(1993-6#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-6#1)(2010-8#1)(2011-1#2)
was attempted from##2##3##(1997-3#1)(2008-10#1)
was attempted in##2##3##(1991-8#1)(2008-1#1)
was attempted##15##2##(1991-8#1)(1993-5#1)(1996-6#1)(1997-3#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#1)
was attended by approximately##2##4##(2008-5#2)
was attended by over##2##4##(2008-4#1)(2010-5#1)
was attended by##5##3##(2008-4#1)(2008-5#3)(2010-5#1)
was attended##6##2##(2008-4#1)(2008-5#3)(2010-5#1)(2012-3#1)
was attenuated by a##3##4##(1994-2#2)(2009-9#1)
was attenuated by##9##3##(1994-2#2)(1994-5#1)(1995-5#1)(1997-1#1)(1997-6#1)(2009-2#1)(2009-9#2)
was attenuated in##2##3##(1996-5#1)(2008-10#1)
was attenuated##14##2##(1993-3#1)(1994-2#2)(1994-5#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-9#2)
was attributable to##8##3##(1990-11#1)(1992-1#1)(2008-10#5)(2008-7#1)
was attributed to a##6##4##(2008-10#3)(2008-3#1)(2008-7#1)(2010-1#1)
was attributed to the##16##4##(1990-5#1)(1991-12#1)(1994-3#1)(1995-5#2)(1996-5#1)(1997-4#1)(2008-10#6)(2008-5#1)(2008-7#2)
was attributed to##36##3##(1990-5#1)(1991-12#1)(1992-5#1)(1994-3#3)(1995-5#2)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#15)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-1#1)
was attributed##38##2##(1990-5#1)(1991-12#1)(1992-5#1)(1994-3#3)(1995-5#2)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-4#1)
was atypical##3##2##(2006-10#1)(2007-7#1)(2011-2#1)
was augmented by##3##3##(1996-5#1)(1997-8#1)(2007-8#1)
was augmented##5##2##(1996-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-11#1)
was autoclaved##2##2##(2008-10#1)(2008-11#1)
was automated##2##2##(1997-2#1)(2008-10#1)
was available for##5##3##(1991-8#1)(1993-9#1)(2007-7#1)(2008-1#1)(2008-9#1)
was available##17##2##(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#2)(1993-3#1)(1993-9#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
was avirulent to##3##3##(2008-10#3)
was avirulent##4##2##(2008-10#4)
was avoided by the##2##4##(2008-10#2)
was avoided by##3##3##(2008-10#3)
was avoided##7##2##(1990-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-8#1)
was awake##3##2##(2007-12#1)(2012-2#1)(2013-8#1)
was awarded to##2##3##(2008-10#1)(2013-1#1)
was awarded##8##2##(1995-12#1)(1997-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
was aware of##2##3##(1995-12#1)(2013-1#1)
was aware##4##2##(1995-12#1)(1996-1#1)(2013-1#1)(2013-8#1)
was back-flushed with the##2##4##(1990-8#1)(2008-10#1)
was barely inhibited by inaperisone##2##5##(1992-3#2)
was barely##4##2##(1992-3#2)(2008-9#1)(2013-7#1)
was based on a sample of##2##6##(2010-11#1)(2010-5#1)
was based on a##19##4##(1990-9#1)(1993-12#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)
was based on an##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
was based on continuous##2##4##(2008-10#1)(2008-7#1)
was based on the chemiluminescence##2##5##(2008-10#2)
was based on the formation of##3##6##(2008-10#3)
was based on the presence##2##5##(1997-8#1)(2008-10#1)
was based on the reaction##4##5##(2008-10#4)
was based on the reduction of the##2##7##(2008-10#2)
was based on the use of the##2##7##(2008-10#2)
was based on the use of##4##6##(2008-10#4)
was based on the##65##4##(1992-4#1)(1994-8#1)(1997-3#1)(1997-8#1)(2007-11#3)(2008-10#44)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
was based on their##2##4##(2008-10#1)(2013-8#1)
was based on two##2##4##(2008-10#2)
was based on##155##3##(1990-8#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#9)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#76)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
was based upon##5##3##(1993-12#1)(1993-5#1)(2007-8#1)(2008-10#2)
was based##163##2##(1990-8#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#9)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#80)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-9#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
was been##2##2##(2008-10#1)(2011-2#1)
was begun##5##2##(1992-10#1)(2008-11#1)(2010-7#1)(2013-1#1)(2013-8#1)
was being treated with##2##4##(1991-11#1)(2010-10#1)
was being##11##2##(1991-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
was believed to##3##3##(1993-2#1)(1997-2#1)(2007-7#1)
was believed##5##2##(1990-3#1)(1993-2#1)(1997-2#1)(2007-7#1)(2012-3#1)
was below 0##2##3##(2008-10#2)
was below 10%##2##3##(1995-2#1)(2013-1#1)
was below 4##2##3##(1993-8#1)(2008-10#1)
was below 5##2##3##(1994-12#1)(2008-10#1)
was below the level of##2##5##(2008-10#1)(2008-5#1)
was below the##8##3##(1991-11#1)(1992-6#1)(1993-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
was below##24##2##(1991-11#1)(1992-6#1)(1993-8#3)(1994-12#1)(1995-2#1)(2008-10#13)(2008-5#1)(2011-2#2)(2013-1#1)
was beneficial in##2##3##(2008-10#1)(2008-12#1)
was beneficial##3##2##(2008-10#1)(2008-12#2)
was best described by the##2##5##(2008-10#2)
was best described by##3##4##(2008-10#2)(2013-1#1)
was best described##4##3##(2008-10#3)(2013-1#1)
was best##13##2##(1990-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
was beta##2##2##(1993-11#1)(1995-8#1)
was better at##2##3##(2007-5#1)(2008-10#1)
was better for##2##3##(2008-10#1)(2008-5#1)
was better in##5##3##(1991-2#1)(1994-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
was better than that of##2##5##(2008-10#2)
was better than that##3##4##(2008-10#2)(2008-3#1)
was better than##14##3##(1991-2#1)(1993-3#1)(1995-5#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-8#1)
was better with the##2##4##(1995-2#1)(2007-7#1)
was better with##3##3##(1995-2#1)(2007-12#1)(2007-7#1)
was better##39##2##(1991-2#2)(1993-3#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2011-2#3)(2013-1#1)
was between 0##8##3##(1990-2#1)(2008-10#6)(2008-5#1)
was between 1 and##3##4##(2008-10#3)
was between 1##6##3##(2008-10#6)
was between 10 and##2##4##(2008-10#1)(2008-7#1)
was between 45 and##2##4##(1990-5#1)(1993-9#1)
was between 5 and##2##4##(2008-10#2)
was between 5##3##3##(2008-10#3)
was between 80 and##2##4##(2008-10#1)(2010-5#1)
was between 92##2##3##(2008-10#2)
was between 95##2##3##(2008-10#1)(2011-1#1)
was between the##3##3##(1990-7#1)(1990-9#1)(1991-3#1)
was between##55##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-3#1)(1993-9#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#29)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
was biologically inactive##2##3##(1993-8#1)(1995-3#1)
was biologically##3##2##(1993-8#1)(1995-3#1)(2008-11#1)
was biopsied##2##2##(2008-10#2)
was biphasic##3##2##(1990-7#1)(1994-9#1)(1995-8#1)
was bleeding##2##2##(1992-6#1)(2007-10#1)
was blocked by a##3##4##(1992-9#1)(1995-2#1)(1997-7#1)
was blocked by atropine##2##4##(1996-12#1)(2010-4#1)
was blocked by pretreatment##2##4##(1993-6#1)(1995-2#1)
was blocked by the##8##4##(1990-5#1)(1992-12#1)(1995-12#2)(1996-2#2)(2008-11#1)(2008-2#1)
was blocked by##44##3##(1990-5#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#6)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#3)(2009-12#1)(2009-4#1)(2010-4#1)(2012-2#1)
was blocked with##2##3##(1990-11#1)(2008-11#1)
was blocked##58##2##(1990-11#1)(1990-5#1)(1991-12#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-4#1)(2010-4#1)(2012-2#1)
was blunted##3##2##(1995-8#1)(1997-7#1)(2008-4#1)
was born##4##2##(2007-5#1)(2008-9#2)(2012-2#1)
was both##8##2##(1990-2#1)(1992-5#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
was bound by##2##3##(1992-12#1)(1992-6#1)
was bound to the##2##4##(2008-10#2)
was bound to##5##3##(1990-12#1)(1992-6#1)(1992-9#1)(2008-10#2)
was bound##9##2##(1990-12#1)(1991-8#1)(1992-12#1)(1992-6#2)(1992-9#1)(1995-2#1)(2008-10#2)
was broad##4##2##(1997-5#1)(2008-10#2)(2011-10#1)
was broadened##2##2##(2007-12#1)(2008-8#1)
was broadest among##2##3##(2008-10#2)
was broadly##2##2##(2007-12#1)(2008-10#1)
was broken##2##2##(1997-3#1)(2008-9#1)
was brought to the##4##4##(1992-6#1)(1995-4#1)(2009-3#1)(2010-12#1)
was brought to##5##3##(1992-6#1)(1995-4#1)(2008-10#1)(2009-3#1)(2010-12#1)
was brought##8##2##(1992-6#1)(1995-4#1)(2008-10#2)(2008-3#1)(2009-3#1)(2010-12#1)(2012-2#1)
was buffered##2##2##(1996-2#1)(2008-10#1)
was built and tested##2##4##(2008-3#2)
was built and##6##3##(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
was built by##2##3##(2008-10#1)(2013-8#1)
was built for##3##3##(2008-10#1)(2008-3#2)
was built from##2##3##(1994-11#1)(2008-11#1)
was built in##2##3##(1992-2#1)(2009-7#1)
was built up##2##3##(2008-10#2)
was built with##3##3##(2008-10#3)
was built##32##2##(1990-3#1)(1992-2#1)(1994-11#1)(1994-6#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
was by far the##2##4##(2008-5#2)
was by##12##2##(1994-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)
was ca##9##2##(1991-5#1)(1995-3#1)(2008-10#7)
was calculated after##2##3##(2008-8#1)(2012-12#1)
was calculated and compared##2##4##(2008-5#1)(2008-8#1)
was calculated and##8##3##(1995-3#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)
was calculated as 1##2##4##(2008-10#1)(2008-12#1)
was calculated as a##2##4##(2007-11#1)(2008-5#1)
was calculated as the difference##2##5##(2008-10#2)
was calculated as the##5##4##(2008-10#2)(2008-7#1)(2012-3#1)(2013-7#1)
was calculated as##16##3##(2007-11#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2012-7#2)(2013-7#1)(2013-8#1)
was calculated at##6##3##(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
was calculated by##10##3##(2008-10#4)(2008-12#2)(2008-3#2)(2008-9#1)(2011-3#1)
was calculated for each##6##4##(2008-10#4)(2010-3#1)(2012-2#1)
was calculated for the##2##4##(1993-2#1)(2008-1#1)
was calculated for##19##3##(1992-6#1)(1993-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
was calculated from the frequency##2##5##(2008-10#1)(2008-3#1)
was calculated from the##12##4##(1992-6#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-3#2)(2012-2#1)
was calculated from##19##3##(1992-6#1)(1993-11#1)(1995-5#1)(1997-7#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)
was calculated in##2##3##(1991-10#1)(2010-8#1)
was calculated over##2##3##(2008-10#1)(2009-12#1)
was calculated to be 0##3##5##(1990-8#1)(2008-10#1)(2008-2#1)
was calculated to be 4##2##5##(2008-10#2)
was calculated to be 99##2##5##(1996-12#1)(2008-10#1)
was calculated to be approximately##2##5##(1995-6#1)(2008-3#1)
was calculated to be##19##4##(1990-5#1)(1990-8#1)(1991-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#9)(2008-2#1)(2008-3#2)(2009-12#1)
was calculated to evaluate the##2##5##(2008-10#1)(2012-3#1)
was calculated to##24##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#10)(2008-2#2)(2008-3#3)(2009-12#1)(2012-3#1)
was calculated using the##4##4##(1995-5#1)(2008-1#1)(2008-10#1)(2008-2#1)
was calculated using##10##3##(1995-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2012-12#2)(2013-8#1)
was calculated with a##2##4##(2008-3#2)
was calculated##176##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#57)(2008-11#2)(2008-12#6)(2008-2#5)(2008-3#12)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2012-7#2)(2013-1#2)(2013-7#2)(2013-8#4)
was calibrated by##2##3##(2007-11#1)(2008-10#1)
was calibrated using##2##3##(2008-10#2)
was calibrated with a##3##4##(2008-3#3)
was calibrated with##5##3##(1992-7#1)(2007-11#1)(2008-3#3)
was calibrated##16##2##(1992-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2010-9#1)
was called##4##2##(1990-8#1)(1992-9#1)(1997-2#1)(2008-10#1)
was cannulated##2##2##(2008-12#1)(2008-4#1)
was capable of moving##2##4##(2008-10#2)
was capable of protecting##2##4##(1995-12#1)(2008-10#1)
was capable of##16##3##(1995-12#1)(1995-2#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2013-1#1)
was captured in##2##3##(2008-12#1)(2008-6#1)
was captured##4##2##(2008-12#1)(2008-6#2)(2013-7#1)
was carefully##2##2##(2007-12#1)(2008-10#1)
was carried by a##2##4##(2008-1#1)(2008-10#1)
was carried by##4##3##(1996-12#1)(2008-1#1)(2008-10#2)
was carried out after 1##2##5##(2008-5#1)(2013-1#1)
was carried out after##3##4##(1993-12#1)(2008-5#1)(2013-1#1)
was carried out against##2##4##(2008-10#2)
was carried out and##4##4##(2008-10#3)(2008-2#1)
was carried out as a##2##5##(1990-12#1)(1995-5#1)
was carried out as##4##4##(1990-12#1)(1995-5#1)(2008-10#1)(2008-9#1)
was carried out at 25 degrees C and 25 kV##2##10##(2008-10#2)
was carried out at the##3##5##(2008-12#3)
was carried out at##24##4##(2007-7#1)(2008-10#10)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
was carried out by a##3##5##(2008-1#1)(2008-10#2)
was carried out by means of##2##6##(2008-10#1)(2011-2#1)
was carried out by the##8##5##(1991-12#1)(2008-10#5)(2008-7#1)(2012-2#1)
was carried out by using a##3##6##(2008-10#3)
was carried out by using##7##5##(1992-12#1)(2008-10#6)
was carried out by##53##4##(1990-8#1)(1991-12#1)(1992-12#1)(1994-11#1)(1994-5#1)(2008-1#1)(2008-10#39)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
was carried out during the##2##5##(2010-1#1)(2012-2#1)
was carried out during##5##4##(2007-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
was carried out for all patients##2##6##(2008-1#1)(2008-4#1)
was carried out for all##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
was carried out for the##2##5##(1991-2#1)(1994-5#1)
was carried out for##16##4##(1990-12#1)(1991-2#1)(1994-5#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
was carried out in a##9##5##(1990-12#1)(1994-2#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2013-1#1)
was carried out in all##2##5##(1990-11#1)(2011-1#1)
was carried out in order to evaluate the##2##8##(2007-8#1)(2008-10#1)
was carried out in order to##5##6##(1991-9#1)(1995-5#1)(2007-8#1)(2008-10#2)
was carried out in six##2##5##(2008-5#1)(2012-12#1)
was carried out in the absorbance mode at##2##8##(2008-10#2)
was carried out in the##14##5##(1993-6#1)(1994-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2013-1#1)
was carried out in two##4##5##(2007-11#1)(2008-10#2)(2011-1#1)
was carried out in##77##4##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-6#2)(1994-10#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-7#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
was carried out on a##9##5##(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2013-1#1)
was carried out on an##3##5##(2008-6#1)(2011-1#2)
was carried out on the##5##5##(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#2)
was carried out on##35##4##(1990-3#1)(1992-12#1)(1993-6#1)(1994-6#1)(1995-5#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2013-1#2)
was carried out the##2##4##(1991-8#1)(2008-10#1)
was carried out to assess##4##5##(1991-5#1)(1993-8#1)(1996-6#1)(2011-2#1)
was carried out to characterize##2##5##(1990-7#1)(2007-11#1)
was carried out to compare the##2##6##(2007-7#1)(2008-6#1)
was carried out to confirm the##2##6##(2008-10#1)(2011-2#1)
was carried out to determine the prevalence of##3##8##(1996-12#1)(2010-8#1)(2011-2#1)
was carried out to determine the##8##6##(1994-3#1)(1996-12#1)(2008-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
was carried out to determine##10##5##(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
was carried out to evaluate the##7##6##(1990-2#1)(1991-2#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)
was carried out to evaluate##9##5##(1990-11#1)(1990-2#1)(1991-2#1)(1992-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)
was carried out to find the##3##6##(1995-12#1)(2011-3#1)(2013-7#1)
was carried out to investigate the##6##6##(1991-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#1)
was carried out to investigate##8##5##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-8#1)
was carried out to##58##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-10#10)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
was carried out under##2##4##(2008-2#1)(2011-1#1)
was carried out using a##7##5##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)
was carried out using an##3##5##(1994-9#1)(2008-10#2)
was carried out using the##5##5##(1990-11#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
was carried out using two##2##5##(2008-10#1)(2008-5#1)
was carried out using##40##4##(1990-11#1)(1991-5#1)(1991-9#1)(1994-9#1)(1995-3#1)(1996-12#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-5#4)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
was carried out with a##4##5##(2007-11#1)(2008-2#1)(2008-3#1)(2009-11#1)
was carried out with the aim of##4##7##(1994-3#1)(1997-3#1)(2008-8#1)(2010-4#1)
was carried out with the##6##5##(1994-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)
was carried out with##22##4##(1991-12#1)(1994-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
was carried out##432##3##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-1#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#8)(2007-12#1)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#153)(2008-11#9)(2008-12#11)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#20)(2008-6#8)(2008-7#9)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#10)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#6)
was carried to##2##3##(1997-8#1)(2008-12#1)
was carried##443##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-1#1)(1996-12#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#8)(2007-12#1)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#155)(2008-11#9)(2008-12#12)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#20)(2008-6#9)(2008-7#9)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#11)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#7)
was catalytically##2##2##(1994-6#1)(2008-10#1)
was catalyzed by##2##3##(2012-2#1)(2013-1#1)
was catalyzed##3##2##(1997-2#1)(2012-2#1)(2013-1#1)
was categorized as##2##3##(2008-11#1)(2012-1#1)
was categorized into##2##3##(2008-10#1)(2010-3#1)
was categorized##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)(2012-1#1)
was caused by a##7##4##(1992-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-10#3)
was caused by an##2##4##(2008-11#2)
was caused by the##12##4##(1997-4#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-3#1)(2013-8#1)
was caused by##39##3##(1992-1#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
was caused##42##2##(1990-9#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
was centered around##2##3##(1996-2#1)(2008-10#1)
was centered at##2##3##(2008-2#1)(2009-5#1)
was centered##4##2##(1996-2#1)(2008-10#1)(2008-2#1)(2009-5#1)
was centrally##2##2##(2009-11#1)(2010-2#1)
was chaired by Professor##2##4##(2008-5#2)
was challenged##2##2##(2010-4#1)(2010-5#1)
was challenging##2##2##(2008-9#1)(2013-8#1)
was changed from##5##3##(1993-8#1)(2008-10#2)(2008-3#1)(2009-9#1)
was changed to##6##3##(1992-6#1)(1997-8#1)(2010-6#1)(2011-1#1)(2013-8#2)
was changed with##2##3##(2008-5#1)(2012-2#1)
was changed##22##2##(1992-6#1)(1993-8#2)(1995-5#1)(1997-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#2)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
was characterised by##6##3##(1990-3#1)(1991-3#1)(1997-8#1)(2008-10#2)(2011-2#1)
was characterised##9##2##(1990-3#1)(1991-3#1)(1997-8#1)(2008-10#4)(2008-11#1)(2011-2#1)
was characteristic of the##2##4##(2008-10#2)
was characteristic of##6##3##(1990-3#1)(1993-11#1)(1996-10#1)(1997-3#1)(2008-10#2)
was characteristic##7##2##(1990-3#1)(1993-11#2)(1996-10#1)(1997-3#1)(2008-10#2)
was characterized after##2##3##(2007-6#1)(2011-1#1)
was characterized and##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
was characterized as a##2##4##(1993-11#1)(2008-10#1)
was characterized as##4##3##(1993-11#1)(2008-10#3)
was characterized by UV##2##4##(1990-7#2)
was characterized by X-ray##2##4##(1996-2#1)(2008-10#1)
was characterized by a##8##4##(1991-2#1)(1992-12#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
was characterized by an##4##4##(1990-5#1)(1994-5#1)(2008-10#1)(2012-1#1)
was characterized by low##2##4##(2008-10#1)(2012-1#1)
was characterized by means of##2##5##(2008-10#2)
was characterized by mild##2##4##(2006-10#1)(2007-12#1)
was characterized by surface##2##4##(2008-10#1)(2011-2#1)
was characterized by the presence of##2##6##(2008-10#2)
was characterized by the##8##4##(2007-10#1)(2008-10#4)(2008-7#1)(2013-1#2)
was characterized by using##2##4##(2009-9#1)(2011-2#1)
was characterized by##85##3##(1990-11#2)(1990-5#2)(1990-7#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-5#3)(1994-9#2)(1995-12#1)(1995-2#1)(1996-2#3)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#32)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#3)
was characterized in##5##3##(1994-12#1)(2008-10#3)(2008-2#1)
was characterized using a##2##4##(2008-6#1)(2009-12#1)
was characterized using##9##3##(1993-6#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#1)
was characterized with respect to the##2##6##(2008-10#1)(2008-11#1)
was characterized with respect to##4##5##(1996-2#1)(2008-10#2)(2008-11#1)
was characterized with##8##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
was characterized##133##2##(1990-11#2)(1990-5#2)(1990-7#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-9#2)(1995-12#1)(1995-2#1)(1996-2#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-6#1)(2008-10#50)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#4)
was charged with##4##3##(1994-1#2)(1996-5#2)
was charged##8##2##(1992-5#1)(1994-1#2)(1994-9#2)(1996-5#2)(2008-10#1)
was checked by analysing##2##4##(2008-10#2)
was checked by analyzing##2##4##(2008-10#2)
was checked by measuring the##2##5##(2008-10#2)
was checked by performing##2##4##(1994-1#1)(2008-10#1)
was checked by the analysis of##2##6##(2008-10#2)
was checked by the use##2##5##(2008-10#2)
was checked by the##4##4##(2008-10#4)
was checked by##25##3##(1994-1#1)(1995-9#1)(2008-10#22)(2013-1#1)
was checked for##5##3##(1995-2#1)(2008-10#4)
was checked with##5##3##(2008-10#3)(2008-11#1)(2012-2#1)
was checked##48##2##(1994-1#1)(1995-2#1)(1995-9#1)(2007-2#1)(2008-10#39)(2008-11#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
was chemically modified with##2##4##(1993-11#1)(2008-6#1)
was chemically##4##2##(1992-6#1)(1993-11#1)(2008-10#1)(2008-6#1)
was chose as the##2##4##(2007-11#1)(2011-1#1)
was chosen as a##6##4##(2008-10#3)(2008-11#1)(2008-7#1)(2010-2#1)
was chosen as an##2##4##(1992-5#1)(2011-2#1)
was chosen as the##7##4##(2008-10#7)
was chosen as##24##3##(1992-5#1)(1997-6#1)(2008-10#16)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)(2011-3#2)
was chosen because##2##3##(2006-10#1)(2008-10#1)
was chosen due to##2##4##(2008-10#1)(2008-3#1)
was chosen for the##2##4##(2008-10#2)
was chosen for this study##2##5##(2008-10#1)(2008-11#1)
was chosen for##6##3##(1991-12#1)(2008-10#3)(2008-11#1)(2012-12#1)
was chosen to examine##2##4##(2008-11#1)(2008-12#1)
was chosen to provide##2##4##(2008-5#1)(2008-7#1)
was chosen to##13##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
was chosen##60##2##(1990-6#1)(1991-12#1)(1992-5#1)(1993-5#1)(1994-12#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#3)(2011-3#2)(2012-12#1)
was chronic##2##2##(2008-1#1)(2009-10#1)
was cited##2##2##(2008-12#1)(2010-4#1)
was clamped##2##2##(1993-12#1)(1995-12#1)
was clarified##3##2##(2007-12#1)(2008-10#1)(2009-6#1)
was classified according to##2##4##(2008-7#1)(2011-2#1)
was classified as##15##3##(1992-12#1)(1995-6#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-4#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
was classified in##2##3##(1990-2#1)(2008-10#1)
was classified into six##2##4##(2008-5#1)(2008-6#1)
was classified into the##2##4##(1996-2#1)(2007-10#1)
was classified into two##2##4##(2007-12#1)(2010-8#1)
was classified into##9##3##(1990-8#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
was classified##29##2##(1990-2#1)(1990-8#1)(1992-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
was clear for##2##3##(2010-3#1)(2011-2#1)
was clear that##2##3##(1990-7#1)(1993-3#1)
was clear##5##2##(1990-7#1)(1993-3#2)(2010-3#1)(2011-2#1)
was cleared##3##2##(2008-5#1)(2009-3#1)(2013-1#1)
was clearly evident##2##3##(2008-11#1)(2011-1#1)
was clearly observed##2##3##(2008-10#1)(2008-11#1)
was clearly suppressed##2##3##(2008-5#1)(2008-8#1)
was clearly##30##2##(1990-3#1)(1990-7#1)(1992-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-6#1)(2008-10#12)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
was cleaved at##4##3##(1991-2#3)(1995-6#1)
was cleaved by##3##3##(1991-2#1)(1992-3#1)(2008-5#1)
was cleaved##9##2##(1991-2#4)(1992-3#1)(1995-6#1)(2008-5#2)(2009-2#1)
was clinical##5##2##(1994-12#1)(1995-12#1)(2007-7#1)(2008-7#1)(2011-2#1)
was clinically and##2##3##(1995-12#1)(1997-6#1)
was clinically##6##2##(1991-5#1)(1995-12#1)(1997-6#1)(2008-1#1)(2008-6#1)(2012-3#1)
was cloned and characterized##5##4##(1994-12#1)(1995-2#1)(1997-2#1)(2008-10#2)
was cloned and completely sequenced##2##5##(2008-10#2)
was cloned and its nucleotide##2##5##(1994-12#1)(1997-7#1)
was cloned and its##4##4##(1990-11#1)(1994-12#1)(1997-7#1)(2008-10#1)
was cloned and overexpressed in Escherichia coli##2##7##(1992-3#1)(2008-10#1)
was cloned and sequenced from##2##5##(1992-3#1)(2008-10#1)
was cloned and sequenced##14##4##(1992-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)
was cloned and the##2##4##(2008-8#2)
was cloned and##32##3##(1990-11#1)(1992-3#2)(1993-12#1)(1994-12#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-8#3)(2008-9#1)
was cloned based on##2##4##(1993-9#1)(2010-5#1)
was cloned by a##2##4##(1993-2#1)(2009-2#1)
was cloned by##8##3##(1991-9#1)(1993-2#1)(1994-12#1)(1996-8#1)(2008-11#1)(2008-8#2)(2009-2#1)
was cloned downstream from##2##4##(1997-4#2)
was cloned downstream##3##3##(1997-4#2)(2008-8#1)
was cloned from human##2##4##(1994-6#1)(1995-6#1)
was cloned from the##3##4##(1991-5#1)(1993-9#1)(2008-8#1)
was cloned from##11##3##(1991-12#1)(1991-5#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-6#1)(1997-8#1)(2008-11#1)(2008-8#1)
was cloned in a##2##4##(1992-8#1)(1997-3#1)
was cloned in the##2##4##(1995-11#1)(2008-9#1)
was cloned in##10##3##(1990-11#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
was cloned into a##7##4##(1990-5#1)(1993-12#1)(1993-6#2)(1994-12#1)(2008-10#2)
was cloned into the##3##4##(1991-6#1)(1994-9#1)(1995-2#1)
was cloned into##16##3##(1990-5#1)(1991-6#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-8#3)(2008-9#1)
was cloned##101##2##(1990-11#3)(1990-12#3)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-9#3)(1994-11#1)(1994-12#5)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#22)(2008-11#3)(2008-5#2)(2008-8#11)(2008-9#4)(2009-2#1)(2009-3#1)(2010-5#1)
was close agreement between##2##4##(2008-10#1)(2008-5#1)
was close to 1##2##4##(2008-10#1)(2008-8#1)
was close to that##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
was close to the##8##4##(1990-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
was close to##22##3##(1990-12#1)(1990-6#1)(1995-5#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
was close##24##2##(1990-12#1)(1990-6#1)(1995-5#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
was closed and##2##3##(1992-2#1)(2007-8#1)
was closed##13##2##(1990-12#1)(1991-12#1)(1992-2#1)(1996-9#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
was closely related to the##5##5##(1991-11#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
was closely related to##12##4##(1991-11#1)(1994-8#1)(1994-9#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
was closely##20##2##(1991-11#1)(1992-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-7#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
was closer to##2##3##(2008-10#2)
was closer##3##2##(2008-10#2)(2013-1#1)
was closest to##2##3##(2008-10#1)(2008-9#1)
was co-chaired by Dr##2##4##(2008-5#2)
was coated with##3##3##(2008-10#2)(2008-2#1)
was coated##8##2##(2008-10#5)(2008-2#1)(2008-7#1)(2012-1#1)
was coexpressed with##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
was coexpressed##5##2##(1996-12#1)(2008-11#2)(2008-7#1)(2008-8#1)
was coincident with the##2##4##(1992-3#1)(1995-2#1)
was coincident with##3##3##(1992-3#1)(1995-2#1)(2008-8#1)
was coined in##2##3##(2013-8#2)
was collated##2##2##(2008-12#1)(2012-2#1)
was collected and##5##3##(2008-10#1)(2008-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
was collected at##2##3##(2008-10#1)(2012-2#1)
was collected by questionnaire##2##4##(2011-2#2)
was collected by##8##3##(1992-11#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#3)(2012-12#1)
was collected during##2##3##(2008-10#1)(2008-7#1)
was collected for##4##3##(1992-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
was collected from each##2##4##(2008-10#2)
was collected from the##2##4##(2008-10#1)(2013-1#1)
was collected from##20##3##(1991-2#1)(1994-1#1)(2008-10#8)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
was collected in a capillary of a sampling arm assembly##2##10##(2008-10#2)
was collected in a##5##4##(2008-10#3)(2008-11#1)(2011-1#1)
was collected in the##3##4##(2008-10#3)
was collected in##14##3##(1993-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-1#1)
was collected on activated carbon after##2##6##(2008-10#2)
was collected on activated carbon##3##5##(2008-10#3)
was collected on the##2##4##(2008-10#2)
was collected on##9##3##(1995-3#1)(2008-10#6)(2008-9#1)(2010-5#1)
was collected through a##2##4##(2008-12#1)(2008-7#1)
was collected through##3##3##(2007-11#1)(2008-12#1)(2008-7#1)
was collected using##2##3##(2010-3#1)(2011-2#1)
was collected with a##3##4##(2010-9#1)(2011-1#1)(2013-1#1)
was collected with the##2##4##(2007-7#1)(2010-3#1)
was collected with##5##3##(2007-7#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#1)
was collected##88##2##(1990-6#1)(1991-2#1)(1992-11#2)(1993-6#1)(1994-1#1)(1995-3#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#25)(2008-11#2)(2008-12#8)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-4#2)(2009-7#1)(2010-3#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
was combined in##2##3##(1993-2#1)(2008-3#1)
was combined with a##3##4##(2008-6#2)(2011-2#1)
was combined with the##2##4##(2008-10#2)
was combined with##24##3##(1990-10#1)(1994-2#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-6#3)(2010-3#1)(2010-4#1)(2011-2#1)(2012-7#1)(2013-1#1)
was combined##27##2##(1990-10#1)(1993-2#1)(1993-9#1)(1994-2#1)(2007-12#1)(2008-10#12)(2008-3#2)(2008-6#3)(2010-3#1)(2010-4#1)(2011-2#1)(2012-7#1)(2013-1#1)
was common and##2##3##(2011-2#1)(2013-1#1)
was common in##4##3##(1991-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
was common to##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
was common within a local area of influence that extended##2##10##(2008-10#2)
was common##18##2##(1990-8#1)(1991-11#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
was commonly detected##2##3##(1995-12#1)(2010-6#1)
was commonly##9##2##(1990-3#1)(1995-12#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-6#2)(2013-8#1)
was comparable for##2##3##(1997-7#1)(2013-1#1)
was comparable in the two groups##2##6##(1990-11#1)(2012-2#1)
was comparable in the two##3##5##(1990-11#1)(2008-7#1)(2012-2#1)
was comparable in the##4##4##(1990-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
was comparable in##5##3##(1990-11#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
was comparable to that in##5##5##(1990-7#1)(2008-11#2)(2008-12#1)(2008-7#1)
was comparable to that obtained##2##5##(2008-10#1)(2008-11#1)
was comparable to that of the##2##6##(1993-6#1)(2008-10#1)
was comparable to that of##6##5##(1992-9#1)(1993-6#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-11#1)
was comparable to that##13##4##(1990-7#1)(1992-9#1)(1993-6#1)(1995-3#1)(2007-10#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)
was comparable to the##5##4##(1990-12#1)(1991-3#1)(1993-12#1)(2008-1#1)(2008-10#1)
was comparable to those##2##4##(1992-11#1)(2008-10#1)
was comparable to##25##3##(1990-12#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)
was comparable with that of##3##5##(1990-8#2)(1991-3#1)
was comparable with that##4##4##(1990-8#2)(1991-3#1)(1993-1#1)
was comparable with the##2##4##(1992-3#1)(2007-11#1)
was comparable with##9##3##(1990-8#2)(1991-3#1)(1992-3#1)(1993-1#1)(2007-11#1)(2008-10#3)
was comparable##50##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-3#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
was comparatively##6##2##(1992-2#1)(1992-9#1)(1995-12#1)(1995-3#1)(2008-3#1)(2013-1#1)
was compared against##2##3##(2008-7#1)(2009-5#1)
was compared between the##4##4##(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
was compared between##10##3##(1996-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-2#2)(2013-1#1)
was compared by##5##3##(1991-8#1)(1993-3#1)(1994-9#1)(1996-12#1)(2012-12#1)
was compared for##3##3##(1991-2#1)(1997-2#1)(2013-1#1)
was compared in the##2##4##(1994-8#1)(2011-2#1)
was compared in##9##3##(1990-11#1)(1991-12#1)(1991-8#1)(1993-8#1)(1994-8#1)(1997-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
was compared on##2##3##(2008-7#1)(2010-12#1)
was compared to a##6##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-3#1)
was compared to that obtained##2##5##(1992-12#2)
was compared to that of##6##5##(1991-3#1)(1993-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
was compared to that##9##4##(1991-3#1)(1992-12#2)(1993-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#2)
was compared to the##7##4##(1990-10#1)(1991-4#1)(1995-12#1)(2007-10#1)(2008-10#2)(2010-11#1)
was compared to##34##3##(1990-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#2)(1993-12#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#3)(2009-10#2)(2010-11#1)(2012-12#2)(2012-3#1)
was compared using##3##3##(1995-3#1)(2007-12#1)(2008-7#1)
was compared with a##5##4##(1991-2#1)(2008-10#3)(2011-2#1)
was compared with an##4##4##(1990-6#1)(2008-10#2)(2008-3#1)
was compared with its##2##4##(1995-3#1)(2008-5#1)
was compared with other##2##4##(1990-12#1)(2008-10#1)
was compared with that of the##6##6##(1991-12#1)(1991-2#1)(1991-6#1)(2007-12#1)(2008-10#1)(2010-12#1)
was compared with that of##18##5##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-11#1)(1995-2#1)(1995-6#2)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)
was compared with that##25##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-6#1)(1995-2#1)(1995-6#2)(1996-12#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2013-8#1)
was compared with the performance of##2##6##(2008-2#1)(2008-3#1)
was compared with the standard##2##5##(2008-10#1)(2008-3#1)
was compared with the##28##4##(1990-5#1)(1991-2#1)(1992-2#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-7#1)(2008-10#13)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
was compared with those of##3##5##(1997-2#2)(2008-10#1)
was compared with##101##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#3)(1991-6#1)(1992-10#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-2#2)(1997-4#1)(1997-8#2)(2006-6#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#38)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
was compared##185##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#4)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#52)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
was compatible with##5##3##(2008-10#2)(2008-2#1)(2012-3#1)(2013-1#1)
was compensated for##2##3##(2008-10#1)(2008-3#1)
was compensated##4##2##(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
was competing##2##2##(1991-3#1)(2012-12#1)
was competitive with##2##3##(1991-12#1)(1994-12#1)
was competitive##6##2##(1991-12#1)(1992-3#1)(1992-8#1)(1994-12#1)(2008-11#1)(2008-5#1)
was competitively##2##2##(1993-6#1)(2008-10#1)
was compiled to##3##3##(1993-12#1)(1997-5#1)(2012-1#1)
was compiled##7##2##(1993-12#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
was complemented by##2##3##(2008-10#1)(2010-2#1)
was complete in##4##3##(1990-9#1)(1991-8#1)(2008-10#2)
was complete##9##2##(1990-9#1)(1991-8#1)(1993-3#1)(1994-11#1)(2008-10#4)(2008-11#1)
was completed by the##2##4##(2008-10#2)
was completed by##8##3##(1992-12#1)(1994-11#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-4#1)
was completed in less than##3##5##(1996-11#1)(2008-10#2)
was completed in##10##3##(1996-1#1)(1996-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)
was completed to##2##3##(1991-12#1)(2012-12#1)
was completed under##2##3##(1991-12#1)(2008-10#1)
was completed with##3##3##(2007-12#1)(2010-12#1)(2011-2#1)
was completed within##6##3##(1990-7#1)(1992-11#1)(1992-2#1)(2008-10#3)
was completed##43##2##(1990-7#1)(1991-12#2)(1992-11#1)(1992-12#2)(1992-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)
was completely abolished in##2##4##(1996-2#1)(1997-7#1)
was completely abolished##5##3##(1993-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)
was completely blocked by##6##4##(1990-5#1)(1994-8#1)(1995-6#1)(2008-5#1)(2008-9#1)(2012-2#1)
was completely blocked##7##3##(1990-5#1)(1994-8#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
was completely excised##2##3##(2012-12#1)(2013-1#1)
was completely identical to that of##2##6##(1990-12#1)(1993-11#1)
was completely inhibited by##5##4##(1990-2#1)(1992-3#1)(1994-9#1)(1995-2#1)(1995-8#1)
was completely removed##2##3##(2008-5#1)(2008-7#1)
was completely resected##3##3##(2008-7#1)(2009-5#1)(2012-2#1)
was completely resistant##2##3##(1992-12#1)(2008-10#1)
was completely reversed by##2##4##(1993-5#1)(1995-12#1)
was completely reversed##3##3##(1993-5#1)(1995-12#1)(2008-9#1)
was completely reversible##4##3##(1991-3#1)(1992-8#1)(1993-1#1)(1994-11#1)
was completely##70##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-5#1)(1993-8#2)(1994-11#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
was complexed with##5##3##(2007-11#1)(2008-10#4)
was complicated by##9##3##(2007-7#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
was complicated##13##2##(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
was composed by##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
was composed of 30##2##4##(2007-8#1)(2008-2#1)
was composed of a##6##4##(1993-12#1)(1997-6#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
was composed of the head##2##5##(2008-8#2)
was composed of the##4##4##(2008-8#2)(2010-6#1)(2013-1#1)
was composed of##43##3##(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was composed##50##2##(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was compressed by##2##3##(2008-10#1)(2008-5#1)
was compressed##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
was comprised of seven teams##2##5##(2012-2#2)
was comprised of seven##3##4##(2008-10#1)(2012-2#2)
was comprised of##8##3##(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)(2013-1#1)
was comprised##9##2##(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)(2013-1#1)(2013-7#1)
was computed for##2##3##(2008-5#1)(2008-6#1)
was computed from the##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
was computed from##5##3##(1993-12#1)(2008-10#1)(2008-3#1)(2012-5#1)(2013-1#1)
was computed to##2##3##(2008-9#1)(2011-1#1)
was computed using##2##3##(2008-10#1)(2008-7#1)
was computed##20##2##(1990-12#1)(1992-12#1)(1993-12#1)(1993-9#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)
was concealed##2##2##(2011-2#1)(2012-2#1)
was conceived##4##2##(1991-1#1)(2008-10#1)(2010-5#1)(2012-1#1)
was concentrated by##2##3##(2008-10#2)
was concentrated in##3##3##(1990-5#1)(2008-10#2)
was concentrated##7##2##(1990-5#1)(2008-10#6)
was concentration dependent and##3##4##(1990-12#1)(1994-8#1)(2008-7#1)
was concentration##4##2##(1990-12#1)(1994-11#1)(1994-8#1)(2008-7#1)
was concentration- and##2##3##(1992-7#1)(2008-4#1)
was concentration-dependent##2##2##(1990-7#1)(2008-4#1)
was concerned with##4##3##(2008-10#1)(2008-8#1)(2012-1#1)(2012-12#1)
was concerned##7##2##(1991-2#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
was concluded that for##2##4##(2008-10#1)(2008-11#1)
was concluded that one##2##4##(1997-3#1)(2008-10#1)
was concluded that the##28##4##(1990-11#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#4)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
was concluded that##78##3##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
was concluded to##2##3##(2008-10#1)(2012-1#1)
was concluded##83##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
was concomitant##2##2##(2008-10#1)(2008-6#1)
was conditioned##2##2##(1992-12#1)(2008-10#1)
was conducted among##7##3##(1992-6#1)(2008-12#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
was conducted and##2##3##(2007-2#1)(2013-8#1)
was conducted at the##9##4##(1994-1#1)(2007-7#1)(2008-12#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
was conducted at##17##3##(1994-1#1)(2007-7#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
was conducted between##4##3##(1993-2#1)(2011-2#2)(2013-8#1)
was conducted both##2##3##(1991-1#1)(2008-3#1)
was conducted by##13##3##(1990-12#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
was conducted during##4##3##(2007-11#1)(2008-12#1)(2008-5#1)(2013-7#1)
was conducted for##3##3##(1996-12#1)(1996-2#1)(2008-12#1)
was conducted from##4##3##(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
was conducted in 2004##2##4##(2008-1#1)(2013-8#1)
was conducted in a##10##4##(1995-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
was conducted in order to##6##5##(1997-7#1)(1997-8#1)(2008-12#1)(2008-9#2)(2009-11#1)
was conducted in the Federated States of Micronesia##4##8##(2013-8#4)
was conducted in the Republic of Palau##2##7##(2008-1#1)(2013-8#1)
was conducted in the Republic of##3##6##(2008-1#1)(2013-8#2)
was conducted in the##16##4##(1992-2#1)(2007-5#1)(2008-1#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#9)
was conducted in two phases##2##5##(2008-10#1)(2013-1#1)
was conducted in which##3##4##(1993-1#1)(1997-4#1)(2012-7#1)
was conducted in##84##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-9#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#6)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#11)
was conducted of##4##3##(1994-2#1)(2009-10#1)(2009-9#1)(2011-2#1)
was conducted on a##4##4##(1991-7#1)(2008-5#1)(2012-5#1)(2013-1#1)
was conducted on the##3##4##(1994-8#1)(1997-6#1)(2008-10#1)
was conducted on##34##3##(1991-5#1)(1991-7#1)(1994-8#1)(1997-5#1)(1997-6#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#3)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#4)(2013-8#2)
was conducted over a##2##4##(2007-8#1)(2008-10#1)
was conducted over##4##3##(2007-8#1)(2008-1#1)(2008-10#2)
was conducted to assess the##6##5##(2007-7#1)(2008-10#2)(2010-5#1)(2011-1#1)(2012-12#1)
was conducted to assess##7##4##(2007-7#1)(2008-10#3)(2010-5#1)(2011-1#1)(2012-12#1)
was conducted to compare the##6##5##(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2012-12#1)(2012-2#1)
was conducted to compare##7##4##(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
was conducted to determine if##4##5##(1992-3#1)(1995-3#1)(2008-10#2)
was conducted to determine the effect of##3##7##(2008-10#1)(2008-12#2)
was conducted to determine the effects of##2##7##(2008-10#1)(2008-7#1)
was conducted to determine the##19##5##(1992-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-8#1)
was conducted to determine whether##5##5##(1995-8#1)(2008-10#2)(2008-7#1)(2012-1#1)
was conducted to determine##33##4##(1992-12#1)(1992-3#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-4#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
was conducted to establish##2##4##(2008-10#1)(2011-2#1)
was conducted to evaluate the effect of##2##7##(2008-12#1)(2012-2#1)
was conducted to evaluate the effects of##3##7##(2008-12#2)(2010-4#1)
was conducted to evaluate the##13##5##(2008-10#2)(2008-11#1)(2008-12#3)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
was conducted to evaluate##17##4##(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
was conducted to examine the##2##5##(2008-10#1)(2008-12#1)
was conducted to examine whether##2##5##(2008-11#1)(2012-2#1)
was conducted to examine##6##4##(1994-1#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
was conducted to explore the##2##5##(2008-11#1)(2008-12#1)
was conducted to explore##3##4##(2008-11#1)(2008-12#1)(2009-5#1)
was conducted to identify the##5##5##(1995-10#1)(1995-12#1)(2008-10#1)(2009-10#1)(2011-1#1)
was conducted to identify##13##4##(1994-9#1)(1995-10#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#2)(2009-10#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#2)
was conducted to investigate the effect of different##2##8##(2008-12#2)
was conducted to investigate the effect of##3##7##(2008-12#2)(2011-2#1)
was conducted to investigate the effects of##3##7##(1992-2#1)(2010-2#1)(2011-2#1)
was conducted to investigate the##9##5##(1992-2#1)(2008-10#1)(2008-12#2)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
was conducted to investigate##10##4##(1991-3#1)(1992-2#1)(2008-10#1)(2008-12#2)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
was conducted to obtain##3##4##(2008-3#1)(2013-1#2)
was conducted to study the##3##5##(2008-10#1)(2008-3#1)(2010-4#1)
was conducted to study##5##4##(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
was conducted to##130##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1994-1#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#23)(2008-11#5)(2008-12#14)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#3)
was conducted under the##3##4##(2008-10#1)(2008-11#1)(2012-1#1)
was conducted using a##6##4##(1991-12#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)
was conducted using the##4##4##(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
was conducted using##25##3##(1991-12#1)(1993-8#1)(1996-2#2)(1996-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
was conducted via##2##3##(2009-12#1)(2013-1#1)
was conducted with the##2##4##(2012-12#1)(2013-7#1)
was conducted with##12##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
was conducted##410##2##(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#6)(2008-10#56)(2008-11#12)(2008-12#31)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#13)(2008-8#2)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-5#4)(2009-7#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#11)(2011-2#28)(2012-1#2)(2012-12#11)(2012-2#12)(2012-3#13)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#26)(2013-7#4)(2013-8#19)
was conferred by a single##3##5##(2008-10#3)
was conferred by##5##3##(2008-10#5)
was confined to the##5##4##(1993-12#1)(1994-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
was confined to##12##3##(1991-11#1)(1993-12#1)(1994-3#1)(1995-8#1)(2008-10#4)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
was confirmed after##4##3##(1990-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
was confirmed and##5##3##(1993-8#1)(2008-10#3)(2008-9#1)
was confirmed at##3##3##(2008-10#2)(2011-2#1)
was confirmed by PCR##2##4##(1992-8#1)(2011-2#1)
was confirmed by RT-PCR##2##4##(2008-10#1)(2008-8#1)
was confirmed by a##3##4##(1990-12#1)(1994-5#1)(2010-12#1)
was confirmed by an##2##4##(2008-10#1)(2008-7#1)
was confirmed by analysis of##5##5##(2008-10#5)
was confirmed by comparing the##3##5##(1996-12#1)(2008-10#1)(2009-2#1)
was confirmed by computed tomography##2##5##(2008-7#1)(2008-8#1)
was confirmed by culture##2##4##(2009-11#1)(2011-2#1)
was confirmed by experiments##3##4##(2007-11#1)(2008-11#2)
was confirmed by polymerase chain reaction##3##6##(2008-10#3)
was confirmed by restriction##3##4##(1992-8#1)(1992-9#1)(2008-1#1)
was confirmed by the demonstration of##2##6##(1994-8#1)(2007-7#1)
was confirmed by the good concordance between found and certified values in the analysis of certified reference materials##2##18##(2008-10#2)
was confirmed by the##23##4##(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#1)(2011-2#2)(2013-1#1)
was confirmed by western blotting##2##5##(2008-10#1)(2008-11#1)
was confirmed by##148##3##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-5#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#5)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#43)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#3)
was confirmed experimentally##2##3##(1996-2#1)(2008-7#1)
was confirmed for the##3##4##(2008-10#1)(2008-11#1)(2010-3#1)
was confirmed for##6##3##(2008-10#2)(2008-11#1)(2010-3#2)(2012-3#1)
was confirmed in a##3##4##(1994-12#1)(2008-10#1)(2008-5#1)
was confirmed in the##4##4##(1995-11#1)(2008-10#3)
was confirmed in##21##3##(1990-5#1)(1991-5#1)(1994-12#1)(1995-11#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
was confirmed on##3##3##(2012-2#1)(2013-7#1)(2013-8#1)
was confirmed that the##2##4##(1991-9#1)(2008-8#1)
was confirmed that##5##3##(1991-9#1)(1995-12#1)(2008-10#2)(2008-8#1)
was confirmed through##3##3##(1995-12#1)(2008-5#1)(2013-1#1)
was confirmed to be##7##4##(1997-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
was confirmed to##11##3##(1994-2#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
was confirmed using##6##3##(1991-5#1)(1994-6#1)(2008-10#3)(2008-5#1)
was confirmed with the##2##4##(1997-7#1)(2012-12#1)
was confirmed with##6##3##(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2010-5#1)(2012-12#1)
was confirmed##254##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-12#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#5)(1995-8#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-7#2)(1997-8#1)(2007-11#3)(2007-12#1)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#74)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#7)(2008-8#5)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-3#3)(2010-5#2)(2011-1#5)(2011-2#11)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#2)
was confounded##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
was conjugated to##6##3##(1991-2#1)(1993-3#1)(2008-10#3)(2012-2#1)
was conjugated with##3##3##(1992-3#1)(2010-12#1)(2013-1#1)
was conjugated##9##2##(1991-2#1)(1992-3#1)(1993-3#1)(2008-10#3)(2010-12#1)(2012-2#1)(2013-1#1)
was connected to##3##3##(2008-10#2)(2008-12#1)
was consecutively##2##2##(1994-5#1)(2008-10#1)
was consequently##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)
was conserved at the##2##4##(1995-6#1)(2012-2#1)
was conserved##3##2##(1994-11#1)(1995-6#1)(2012-2#1)
was considerable##4##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
was considerably higher in##2##4##(1995-12#1)(2013-1#1)
was considerably higher##4##3##(1993-8#1)(1995-12#1)(2008-11#1)(2013-1#1)
was considerably less##2##3##(1991-12#1)(1992-6#1)
was considerably lower than##3##4##(2007-11#1)(2008-10#1)(2012-12#1)
was considerably lower##7##3##(1990-6#1)(2007-11#1)(2008-10#2)(2012-12#2)(2013-1#1)
was considerably more##2##3##(2008-10#1)(2008-6#1)
was considerably reduced in##2##4##(2008-10#1)(2008-12#1)
was considerably reduced##5##3##(1993-2#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-12#1)
was considerably##30##2##(1990-12#1)(1990-6#1)(1991-12#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#2)
was considered a##9##3##(1993-1#1)(1994-12#1)(2006-10#1)(2008-1#1)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
was considered and##2##3##(2008-10#1)(2012-12#1)
was considered as a##6##4##(1992-3#1)(1993-9#1)(2007-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
was considered as the##2##4##(2008-10#1)(2008-12#1)
was considered as##15##3##(1992-3#1)(1993-9#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
was considered by##4##3##(2007-11#1)(2008-7#2)(2011-2#1)
was considered in##2##3##(2012-12#2)
was considered inoperable##2##3##(2007-10#1)(2010-3#1)
was considered positive##3##3##(1995-4#1)(2008-12#1)(2012-12#1)
was considered that##3##3##(2008-7#1)(2012-1#1)(2013-8#1)
was considered the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
was considered to be a##3##5##(2008-10#2)(2010-12#1)
was considered to be either##2##5##(1992-5#1)(1996-3#1)
was considered to be the##2##5##(1996-12#1)(2009-7#1)
was considered to be##14##4##(1992-5#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)
was considered to##17##3##(1992-5#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)
was considered useful##2##3##(1990-6#1)(2008-5#1)
was considered##93##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#14)(2008-12#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#1)(2009-2#1)(2009-7#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-7#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#6)(2013-8#2)
was consistent among##2##3##(1997-3#1)(2008-10#1)
was consistent with a##7##4##(1990-2#1)(1992-3#1)(2007-12#1)(2008-10#2)(2010-8#1)(2011-2#1)
was consistent with our##2##4##(1995-11#1)(2008-2#1)
was consistent with the##15##4##(1993-1#1)(1993-12#1)(1995-12#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-8#2)(2008-9#1)(2012-1#1)
was consistent with what##2##4##(2007-12#1)(2008-7#1)
was consistent with##47##3##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-5#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
was consistent##51##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
was consistently associated with##2##4##(2008-10#1)(2012-12#1)
was consistently higher##2##3##(1991-12#1)(2011-1#1)
was consistently isolated from##3##4##(1997-6#1)(2008-10#2)
was consistently present in##2##4##(2008-10#2)
was consistently##22##2##(1991-12#1)(1992-10#1)(1992-2#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
was consolidated##2##2##(2009-6#1)(2012-12#1)
was constant at##2##3##(2008-10#1)(2008-7#1)
was constant in##2##3##(2011-2#1)(2012-3#1)
was constant##11##2##(1990-11#1)(1990-12#1)(1993-8#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-3#1)
was constantly##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
was constituted by the##4##4##(2008-10#3)(2010-8#1)
was constituted by##6##3##(1993-11#1)(2008-10#3)(2010-8#1)(2011-1#1)
was constituted##7##2##(1993-11#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-1#1)
was constitutively##2##2##(1992-8#1)(1995-6#1)
was constrained##2##2##(2008-10#1)(2008-3#1)
was constructed and is described##2##5##(2008-3#2)
was constructed and is##3##4##(2008-3#3)
was constructed and tested##3##4##(2008-10#3)
was constructed and used##2##4##(2008-2#1)(2008-8#1)
was constructed and##21##3##(1991-7#1)(1992-3#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#5)(2008-9#1)
was constructed as a##2##4##(2008-10#2)
was constructed based on##2##4##(2008-10#1)(2008-9#1)
was constructed by immobilizing##3##4##(2008-10#3)
was constructed by inserting##2##4##(1995-8#1)(2008-8#1)
was constructed by using##3##4##(2008-11#1)(2008-8#1)(2011-3#1)
was constructed by##23##3##(1995-2#1)(1995-8#1)(1996-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#1)(2009-5#1)(2011-1#1)(2011-3#2)
was constructed for the##3##4##(2008-10#2)(2008-5#1)
was constructed for##7##3##(2008-10#3)(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#1)
was constructed from a##3##4##(2007-11#1)(2008-10#2)
was constructed from##8##3##(1994-12#1)(1994-6#1)(2007-11#2)(2008-10#3)(2010-8#1)
was constructed in order to##2##5##(1995-2#1)(2011-2#1)
was constructed in which##3##4##(1994-5#1)(2008-10#1)(2010-5#1)
was constructed in##9##3##(1990-5#1)(1991-9#1)(1994-5#1)(1995-2#1)(1997-6#1)(2008-10#2)(2010-5#1)(2011-2#1)
was constructed that##2##3##(1990-11#1)(2008-3#1)
was constructed to##10##3##(1991-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#2)
was constructed using a##2##4##(1995-8#1)(2007-8#1)
was constructed using the##6##4##(1993-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
was constructed using##16##3##(1993-8#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#2)
was constructed with a##3##4##(2008-10#2)(2008-2#1)
was constructed with the##2##4##(2008-5#1)(2008-8#1)
was constructed with##11##3##(1990-11#1)(1996-10#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
was constructed##148##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#3)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-8#2)(2008-10#46)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#3)(2008-8#21)(2008-9#12)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#2)(2013-8#1)
was consumed in##2##3##(2008-11#1)(2013-7#1)
was consumed##5##2##(1990-2#1)(1993-9#1)(2008-11#2)(2013-7#1)
was contacted##2##2##(1991-12#1)(2008-7#1)
was contained in##3##3##(1995-8#1)(1997-8#1)(2008-11#1)
was contaminated by##2##3##(2008-11#1)(2013-8#1)
was contingent on##2##3##(2008-9#1)(2009-9#1)
was continued at##2##3##(1990-2#1)(2011-1#1)
was continued for##4##3##(2007-8#1)(2008-5#2)(2008-6#1)
was continued until##3##3##(1991-3#1)(1994-8#1)(2013-8#1)
was continued with##3##3##(1997-2#1)(2008-10#1)(2011-1#1)
was continued##14##2##(1990-2#1)(1991-3#1)(1994-8#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2011-1#2)(2013-8#1)
was continuous##3##2##(1995-10#1)(1997-2#1)(2008-10#1)
was continuously monitored by##2##4##(2008-10#2)
was continuously monitored##3##3##(2008-10#2)(2011-1#1)
was continuously pumped through the##2##5##(2008-10#2)
was continuously##17##2##(1990-12#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-1#1)
was contrasted##2##2##(2008-10#1)(2008-5#1)
was controlled at##3##3##(2006-12#1)(2008-11#1)(2008-6#1)
was controlled by a single dominant locus##3##7##(2008-10#3)
was controlled by a single dominant##4##6##(2008-10#4)
was controlled by a##6##4##(2008-10#6)
was controlled by the##3##4##(2008-10#3)
was controlled by##22##3##(1990-6#1)(1994-3#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-8#1)
was controlled in##4##3##(1990-12#1)(1990-6#1)(1997-8#1)(2008-10#1)
was controlled with##4##3##(1994-2#1)(2007-2#1)(2008-11#1)(2013-1#1)
was controlled##41##2##(1990-12#1)(1990-6#3)(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
was convened to discuss##2##4##(2007-4#1)(2008-3#1)
was convened to##3##3##(2007-4#1)(2008-3#1)(2008-6#1)
was convenient##2##2##(2008-10#2)
was converted in##3##3##(1993-9#1)(1996-5#1)(2007-8#1)
was converted into the corresponding phenylhydrazone which was determined using reversed-phase high-performance liquid chromatography##2##14##(1992-6#1)(1993-9#1)
was converted into the##4##4##(1990-12#1)(1992-6#1)(1993-9#1)(2012-3#1)
was converted into##8##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-8#1)(2011-1#1)(2012-3#1)
was converted to a##3##4##(1993-8#1)(2008-10#2)
was converted to the##2##4##(1990-8#1)(2007-11#1)
was converted to##22##3##(1990-8#1)(1991-5#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-6#2)(2009-9#1)(2010-5#1)(2012-1#1)(2013-8#1)
was converted##38##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-6#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-6#4)(2009-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
was coordinated##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
was correct##2##2##(2008-6#1)(2008-8#1)
was corrected by##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
was corrected for##2##3##(2008-10#2)
was corrected##7##2##(2007-12#1)(2008-10#3)(2008-7#1)(2013-1#1)(2013-8#1)
was correctly##5##2##(1990-9#1)(1992-6#1)(1992-8#1)(2008-11#1)(2012-1#1)
was correlated to a##2##4##(2008-9#1)(2011-2#1)
was correlated to the##4##4##(1992-12#1)(1995-8#1)(2008-7#1)(2009-10#1)
was correlated to##11##3##(1991-12#1)(1992-12#1)(1995-8#1)(2006-10#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
was correlated with an increased##2##5##(2008-10#1)(2008-7#1)
was correlated with the severity of##2##6##(2008-10#1)(2008-7#1)
was correlated with the##22##4##(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
was correlated with their##2##4##(1997-6#1)(2009-5#1)
was correlated with##47##3##(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)
was correlated##66##2##(1991-12#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#30)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)
was corroborated by in vitro##2##5##(1993-9#1)(1995-2#1)
was corroborated by##8##3##(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-8#1)
was corroborated##11##2##(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#5)(2008-6#1)(2008-8#1)
was counted##8##2##(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
was coupled to a##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
was coupled to the##2##4##(1990-12#1)(2008-10#1)
was coupled to##8##3##(1990-12#1)(1991-5#1)(2008-10#4)(2008-11#1)(2009-12#1)
was coupled with a##3##4##(1994-1#1)(1996-12#1)(2009-5#1)
was coupled with the##2##4##(1990-11#1)(1995-11#1)
was coupled with##8##3##(1990-11#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-4#1)
was coupled##16##2##(1990-11#1)(1990-12#1)(1991-5#1)(1994-1#1)(1995-11#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)
was covalently attached to the##2##5##(1995-5#1)(2008-10#1)
was covalently attached to##3##4##(1993-8#1)(1995-5#1)(2008-10#1)
was covalently attached##4##3##(1990-12#1)(1993-8#1)(1995-5#1)(2008-10#1)
was covalently bound to##3##4##(1990-8#1)(2008-10#1)(2009-5#1)
was covalently bound##6##3##(1990-8#1)(1994-5#1)(2008-10#3)(2009-5#1)
was covalently immobilized on##2##4##(1997-2#1)(2008-10#1)
was covalently immobilized onto a##2##5##(2008-10#2)
was covalently immobilized##5##3##(1997-2#1)(2008-10#4)
was covalently linked to##2##4##(2008-10#2)
was covalently##21##2##(1990-12#1)(1990-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#13)(2009-5#1)
was covered with##2##3##(2008-10#1)(2013-1#1)
was covered##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
was created and##2##3##(1991-12#1)(1996-1#1)
was created by##4##3##(2007-8#1)(2010-7#1)(2011-2#2)
was created in##6##3##(1996-1#1)(2007-8#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
was created to##5##3##(1992-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
was created using##2##3##(2008-10#1)(2008-5#1)
was created##31##2##(1990-11#1)(1991-12#1)(1992-2#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(2007-8#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-5#1)(2010-7#1)(2011-2#2)(2011-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
was critical for the##2##4##(2008-11#1)(2010-7#1)
was critical for##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#1)
was critical to##2##3##(1995-3#1)(2010-4#1)
was critical##8##2##(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-3#1)
was critically reviewed##2##3##(2007-10#1)(2012-3#1)
was critically##6##2##(2007-10#1)(2008-10#3)(2012-3#1)(2013-8#1)
was cross-linked##3##2##(1993-11#1)(2008-10#2)
was crossed to##3##3##(2008-10#3)
was crossed with an##2##4##(2008-10#2)
was crossed with##8##3##(2008-10#6)(2008-5#1)(2009-10#1)
was crossed##12##2##(2008-10#10)(2008-5#1)(2009-10#1)
was crosslinked with##2##3##(2008-10#2)
was crosslinked##3##2##(1993-3#1)(2008-10#2)
was crucial for##2##3##(2008-10#1)(2008-3#1)
was crucial in##2##3##(2013-1#2)
was crucial##5##2##(2008-10#1)(2008-3#1)(2010-3#1)(2013-1#2)
was crystallized in a##2##4##(2008-9#1)(2010-10#1)
was crystallized in##3##3##(2008-9#2)(2010-10#1)
was crystallized##4##2##(1991-3#1)(2008-9#2)(2010-10#1)
was cultivated in a##3##4##(2008-11#1)(2008-6#1)(2008-7#1)
was cultivated in##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
was cultivated on the##2##4##(2008-6#2)
was cultivated on##3##3##(2008-6#3)
was cultivated##10##2##(1992-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#4)(2008-7#1)
was cultured from##2##3##(2008-1#1)(2011-2#1)
was cultured##7##2##(2008-1#1)(2008-11#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-3#1)
was cut##8##2##(1992-11#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-3#1)(2012-1#1)
was cytotoxic##4##2##(1993-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
was day 21##2##3##(1996-5#2)
was day##4##2##(1996-5#4)
was decided that the##2##4##(2007-12#1)(2008-11#1)
was decided that##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-4#1)
was decided##10##2##(1991-6#1)(1994-2#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-4#1)(2013-1#2)
was declared##3##2##(1991-1#1)(2008-1#1)(2008-10#1)
was decomposed##2##2##(2008-10#2)
was decreased after##2##3##(1992-12#1)(2008-10#1)
was decreased and the##2##4##(2008-10#1)(2013-8#1)
was decreased and##5##3##(1994-6#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
was decreased by the##2##4##(1994-6#1)(2008-10#1)
was decreased by##20##3##(1990-7#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-3#2)
was decreased for##2##3##(1991-9#1)(2010-5#1)
was decreased from##2##3##(2008-11#1)(2009-5#1)
was decreased in comparison##2##4##(1993-3#1)(2008-8#1)
was decreased in the presence of##2##6##(2008-10#2)
was decreased in the##5##4##(1996-12#1)(2007-8#1)(2008-10#2)(2008-9#1)
was decreased in##16##3##(1991-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(2007-8#2)(2008-10#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2012-12#1)
was decreased significantly in##2##4##(1993-8#1)(2012-2#1)
was decreased to##2##3##(1994-12#1)(2008-10#1)
was decreased with##2##3##(1997-7#1)(2010-6#1)
was decreased##75##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-8#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
was decreasing##3##2##(1993-12#1)(2007-11#1)(2008-10#1)
was deduced from the sequence of##2##6##(1992-8#1)(1993-11#1)
was deduced from the##7##4##(1992-8#1)(1993-11#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
was deduced from##8##3##(1992-8#1)(1993-11#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#1)
was deduced to be##4##4##(1990-7#1)(2008-10#1)(2008-8#1)(2009-2#1)
was deduced to##5##3##(1990-7#1)(1994-5#1)(2008-10#1)(2008-8#1)(2009-2#1)
was deduced##16##2##(1990-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2010-5#1)(2012-2#1)
was deemed to be##2##4##(2007-2#1)(2008-12#1)
was deemed to##3##3##(2007-2#1)(2008-12#1)(2008-3#1)
was deemed##9##2##(1995-11#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-3#1)(2011-1#2)(2012-3#1)
was defined as a##9##4##(1995-8#1)(2008-6#2)(2008-8#1)(2011-2#3)(2013-1#2)
was defined as an##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
was defined as the difference between the##2##7##(2009-11#1)(2011-2#1)
was defined as the ratio of##2##6##(2008-10#1)(2011-2#1)
was defined as the##12##4##(1992-6#1)(1993-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#3)(2012-2#1)(2012-3#1)
was defined as##34##3##(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was defined by##4##3##(2007-8#1)(2008-3#1)(2010-6#1)(2012-3#1)
was defined using##2##3##(2010-11#1)(2013-1#1)
was defined##47##2##(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1995-8#1)(1997-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
was degraded in the##2##4##(2008-10#1)(2012-12#1)
was degraded in##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
was degraded##8##2##(1992-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)
was delayed and##2##3##(2008-5#1)(2012-3#1)
was delayed for##4##3##(1992-12#1)(2008-10#2)(2010-11#1)
was delayed in##6##3##(1991-9#1)(1995-6#1)(2008-10#2)(2008-7#1)(2010-6#1)
was delayed until##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
was delayed##30##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#9)(2008-5#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)
was deleted in##2##3##(1991-2#1)(1997-3#1)
was deleted##6##2##(1991-2#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-9#1)(2009-8#1)
was delimited##2##2##(1993-9#1)(2008-10#1)
was delivered by a##2##4##(1991-2#1)(2008-10#1)
was delivered by##4##3##(1991-2#1)(1997-8#1)(2008-10#1)(2008-4#1)
was delivered in##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
was delivered to the##3##4##(1994-12#1)(2008-6#1)(2011-2#1)
was delivered to##5##3##(1994-12#1)(1997-6#1)(2008-11#1)(2008-6#1)(2011-2#1)
was delivered via##2##3##(2012-3#1)(2013-1#1)
was delivered##27##2##(1990-12#3)(1991-2#1)(1992-10#1)(1992-8#1)(1994-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
was demonstrable##3##2##(1994-9#1)(1997-4#1)(2008-5#1)
was demonstrated after##2##3##(1995-12#1)(2012-3#1)
was demonstrated and##4##3##(1992-12#1)(2008-10#2)(2008-5#1)
was demonstrated as a##2##4##(2008-10#2)
was demonstrated at the##2##4##(1996-12#1)(2012-3#1)
was demonstrated at##4##3##(1993-11#1)(1996-12#1)(2008-10#1)(2012-3#1)
was demonstrated between##4##3##(1994-9#1)(1996-7#1)(2007-11#1)(2009-8#1)
was demonstrated by analyzing##6##4##(2008-10#6)
was demonstrated by detecting##3##4##(2008-11#2)(2013-1#1)
was demonstrated by means of##3##5##(2007-10#1)(2008-3#1)(2008-5#1)
was demonstrated by monitoring##2##4##(2008-10#2)
was demonstrated by the##8##4##(1990-11#1)(2008-10#5)(2012-2#1)(2013-7#1)
was demonstrated by their##2##4##(1994-6#1)(1995-5#1)
was demonstrated by use of##3##5##(2008-3#3)
was demonstrated by##54##3##(1990-11#1)(1990-5#1)(1991-3#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
was demonstrated for the##4##4##(2008-10#4)
was demonstrated for##10##3##(1997-5#1)(2007-12#2)(2008-10#6)(2008-5#1)
was demonstrated in a field##2##5##(2008-10#2)
was demonstrated in a##6##4##(2008-10#4)(2008-2#1)(2009-6#1)
was demonstrated in the##8##4##(1991-5#1)(1993-11#1)(1994-8#1)(2008-10#4)(2013-1#1)
was demonstrated in this##2##4##(2008-10#1)(2008-9#1)
was demonstrated in##34##3##(1990-3#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-8#2)(1997-1#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-8#1)(2013-1#1)
was demonstrated on the##3##4##(1996-3#1)(2008-10#2)
was demonstrated on##6##3##(1993-1#1)(1996-3#1)(2008-10#4)
was demonstrated that the##16##4##(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2013-1#1)(2013-8#1)
was demonstrated that##33##3##(1990-12#1)(1993-8#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2010-11#1)(2013-1#1)(2013-8#2)
was demonstrated the##2##3##(2008-10#2)
was demonstrated to be##6##4##(1995-11#1)(1995-2#1)(1997-7#1)(2008-10#2)(2012-1#1)
was demonstrated to##11##3##(1992-8#1)(1995-11#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-6#1)(2012-1#1)
was demonstrated using##5##3##(1994-9#1)(2008-10#2)(2008-11#1)(2010-11#1)
was demonstrated with a##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
was demonstrated with the##3##4##(1990-8#1)(2008-10#1)(2008-2#1)
was demonstrated with##12##3##(1990-8#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-2#1)
was demonstrated##244##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#5)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-7#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-6#1)(2007-8#1)(2008-10#88)(2008-11#11)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
was denied##2##2##(1995-12#1)(2010-10#1)
was density dependent##2##3##(2008-8#1)(2008-9#1)
was dependant##2##2##(1997-3#1)(2008-12#1)
was dependent on both the##2##5##(1990-11#1)(2008-5#1)
was dependent on both##3##4##(1990-11#1)(1996-12#1)(2008-5#1)
was dependent on plant##2##4##(2008-10#1)(2008-8#1)
was dependent on the concentration of##3##6##(1992-12#1)(2010-3#1)(2013-1#1)
was dependent on the presence of##4##6##(1993-6#1)(1995-2#2)(2008-4#1)
was dependent on the##33##4##(1990-2#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
was dependent on##52##3##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#4)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
was dependent upon the presence of##2##6##(1992-9#1)(2008-6#1)
was dependent upon the##9##4##(1990-5#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-6#1)
was dependent upon##13##3##(1990-5#1)(1992-12#1)(1992-9#2)(1993-6#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#2)(2008-6#1)
was dependent##67##2##(1990-11#2)(1990-2#2)(1990-5#2)(1990-7#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
was depleted##2##2##(2008-10#1)(2008-6#1)
was deployed##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
was deposited at##2##3##(2008-10#2)
was deposited in the##2##4##(1994-12#2)
was deposited on the##3##4##(2008-10#2)(2009-5#1)
was deposited on##5##3##(2008-10#2)(2009-11#2)(2009-5#1)
was deposited onto##2##3##(2007-12#1)(2008-10#1)
was deposited##18##2##(1994-12#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-7#1)(2009-11#2)(2009-5#1)
was depressed##3##2##(1994-5#1)(2008-12#1)(2008-8#1)
was derivatized with##5##3##(1993-9#1)(1997-2#1)(2008-10#3)
was derivatized##6##2##(1993-9#1)(1996-5#1)(1997-2#1)(2008-10#3)
was derived by##3##3##(2008-10#3)
was derived for##2##3##(1993-2#1)(2007-11#1)
was derived from a##2##4##(1991-6#1)(1995-3#1)
was derived from the##9##4##(1992-5#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
was derived from##20##3##(1991-12#1)(1991-6#1)(1992-5#1)(1994-11#1)(1995-3#1)(1996-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
was derived to##2##3##(2008-10#1)(2008-3#1)
was derived##39##2##(1991-12#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
was described and##4##3##(2008-10#3)(2011-7#1)
was described as a##2##4##(1995-12#1)(2011-2#1)
was described as##7##3##(1995-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#2)
was described by a##4##4##(1990-7#1)(1992-3#1)(1995-5#1)(2008-10#1)
was described by the##2##4##(2008-10#2)
was described by##11##3##(1990-5#1)(1990-7#1)(1992-3#1)(1995-5#1)(2008-10#4)(2008-8#1)(2011-1#1)(2013-1#1)
was described for determination of##2##5##(2008-10#2)
was described for the determination of##2##6##(2008-10#2)
was described for the##4##4##(2008-10#3)(2010-4#1)
was described for##6##3##(2008-10#5)(2010-4#1)
was described in this paper##2##5##(2007-11#2)
was described in##10##3##(1997-5#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-3#1)
was described on the##3##4##(2008-12#3)
was described recently##2##3##(2008-3#1)(2008-7#1)
was described##70##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-3#1)(1995-12#1)(1995-5#1)(1997-5#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#3)
was designated as##11##3##(1994-2#1)(1996-2#1)(2008-10#6)(2008-8#2)(2008-9#1)
was designated##18##2##(1990-7#1)(1994-2#1)(1996-2#1)(2008-10#12)(2008-8#2)(2008-9#1)
was designed and built##2##4##(2008-11#1)(2008-2#1)
was designed and constructed##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
was designed and developed##2##4##(2008-10#1)(2009-12#1)
was designed and fabricated##2##4##(2007-12#1)(2010-2#1)
was designed and synthesized##3##4##(2008-8#2)(2008-9#1)
was designed and tested##3##4##(2008-11#1)(2008-3#2)
was designed and##26##3##(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#3)(2008-9#1)(2009-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#1)
was designed as a##6##4##(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
was designed as##7##3##(2008-3#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#2)
was designed based on the##2##5##(1993-8#1)(2008-10#1)
was designed by##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
was designed for evaluating##2##4##(2011-2#1)(2012-12#1)
was designed for operation##2##4##(2007-12#2)
was designed for the##4##4##(2008-10#3)(2010-5#1)
was designed for##15##3##(1993-9#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
was designed in##4##3##(1994-2#1)(2008-10#1)(2010-10#1)(2010-8#1)
was designed that##2##3##(2008-3#2)
was designed to assess the##5##5##(1994-6#1)(2009-4#1)(2010-10#1)(2011-2#2)
was designed to assess##8##4##(1994-3#1)(1994-6#1)(1996-3#1)(2007-10#1)(2009-4#1)(2010-10#1)(2011-2#2)
was designed to be##5##4##(1996-2#1)(1997-4#1)(2007-9#1)(2008-10#2)
was designed to compare##9##4##(1991-12#1)(1994-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
was designed to define the##2##5##(1995-2#1)(2009-3#1)
was designed to detect##2##4##(2008-10#2)
was designed to determine if##3##5##(1994-2#1)(2008-11#1)(2008-7#1)
was designed to determine##8##4##(1990-5#1)(1992-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
was designed to estimate the##3##5##(2008-12#1)(2010-3#1)(2013-1#1)
was designed to evaluate a##2##5##(1996-1#1)(2010-3#1)
was designed to evaluate the##11##5##(1995-8#1)(2007-7#3)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#3)
was designed to evaluate##17##4##(1995-8#1)(1996-1#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#5)
was designed to examine the##8##5##(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
was designed to examine##10##4##(1992-2#1)(1992-8#1)(1993-12#2)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
was designed to facilitate##2##4##(1992-6#1)(2008-4#1)
was designed to help##2##4##(2008-9#1)(2012-12#1)
was designed to investigate the influence of##2##7##(2011-2#2)
was designed to investigate the##12##5##(1993-12#1)(1993-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-12#1)
was designed to investigate##14##4##(1993-12#1)(1993-3#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-5#1)(2011-2#5)(2012-12#1)
was designed to measure##4##4##(1993-9#1)(1995-2#1)(2008-6#1)(2012-3#1)
was designed to study##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
was designed to target##2##4##(2008-10#1)(2010-5#1)
was designed to test the##3##5##(1992-1#1)(1997-8#1)(2008-10#1)
was designed to##146##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#6)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-4#3)(1997-6#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-5#3)(2011-1#2)(2011-2#12)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#6)(2013-8#1)
was designed using##2##3##(2008-10#1)(2008-2#1)
was designed which##2##3##(1990-2#1)(2008-10#1)
was designed with a##2##4##(1992-1#1)(2008-3#1)
was designed with the##4##4##(2008-10#1)(2008-3#2)(2013-1#1)
was designed with##10##3##(1992-1#1)(2008-10#5)(2008-3#3)(2013-1#1)
was designed##242##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#6)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-4#3)(1997-6#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#43)(2008-11#7)(2008-12#4)(2008-2#7)(2008-3#19)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#6)(2009-12#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-8#3)(2011-1#3)(2011-2#15)(2012-12#4)(2012-2#2)(2012-3#9)(2013-1#10)(2013-8#3)
was desorbed##3##2##(2008-10#3)
was destroyed by##2##3##(1992-8#1)(2008-10#1)
was destroyed##5##2##(1991-6#1)(1992-10#1)(1992-8#1)(2007-11#1)(2008-10#1)
was detached from the##2##4##(2008-5#1)(2011-2#1)
was detached##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
was detailed##2##2##(1992-1#1)(2008-10#1)
was detectable by##2##3##(1990-5#1)(1991-5#1)
was detectable in##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
was detectable##15##2##(1990-2#2)(1990-5#1)(1991-5#1)(1993-8#1)(1994-8#1)(2006-6#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)
was detected after##5##3##(1992-11#1)(2007-8#1)(2008-10#2)(2010-11#1)
was detected among all##2##4##(2008-10#2)
was detected among the##2##4##(2008-12#1)(2011-2#1)
was detected among##7##3##(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
was detected and##6##3##(1991-2#1)(1996-12#1)(2008-10#3)(2012-12#1)
was detected as a##2##4##(2007-8#1)(2008-10#1)
was detected as##5##3##(1992-2#1)(2007-8#1)(2008-10#2)(2009-6#1)
was detected at the##5##4##(1991-12#1)(1992-3#2)(1994-12#1)(2008-10#1)
was detected at##15##3##(1991-12#1)(1992-12#1)(1992-3#2)(1994-12#1)(1994-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
was detected between the##3##4##(1996-9#1)(2008-1#1)(2008-10#1)
was detected between##9##3##(1996-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-12#1)
was detected by Southern##2##4##(1992-9#1)(2008-10#1)
was detected by Western blot##2##5##(2008-8#1)(2008-9#1)
was detected by a##3##4##(1992-2#1)(2008-10#1)(2008-7#1)
was detected by direct##2##4##(2012-2#1)(2012-3#1)
was detected by in vitro##2##5##(1997-3#1)(2011-1#1)
was detected by in##3##4##(1995-12#1)(1997-3#1)(2011-1#1)
was detected by polymerase chain reaction (PCR) in##2##8##(2008-10#2)
was detected by polymerase chain reaction##4##6##(2008-10#2)(2008-4#1)(2011-2#1)
was detected by the##6##4##(1991-3#1)(2008-10#3)(2008-12#1)(2008-6#1)
was detected by using##3##4##(2008-9#2)(2011-1#1)
was detected by##66##3##(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#5)(2010-1#1)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-8#2)
was detected even##2##3##(2008-10#1)(2010-3#1)
was detected for##7##3##(1995-5#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
was detected from the##2##4##(2008-10#1)(2008-6#1)
was detected from##8##3##(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-6#1)(2009-5#1)
was detected in 15##2##4##(2008-12#1)(2013-8#1)
was detected in 18##2##4##(1996-6#1)(2008-12#1)
was detected in 20##2##4##(1997-3#1)(2011-2#1)
was detected in 38##2##4##(2011-2#1)(2012-12#1)
was detected in a##6##4##(1992-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
was detected in about##2##4##(2008-11#1)(2010-5#1)
was detected in all##4##4##(1990-2#1)(1991-2#1)(2008-10#1)(2008-11#1)
was detected in an##2##4##(1991-9#1)(1995-11#1)
was detected in both##2##4##(1996-12#1)(2008-10#1)
was detected in cultured##2##4##(1994-11#1)(1994-6#1)
was detected in human##3##4##(1992-12#1)(1993-6#1)(1996-12#1)
was detected in one##2##4##(2007-10#1)(2008-10#1)
was detected in only##3##4##(2008-11#1)(2011-2#2)
was detected in other##2##4##(1994-6#1)(2008-10#1)
was detected in plants##2##4##(2008-10#2)
was detected in the inoculated##2##5##(2008-10#1)(2008-8#1)
was detected in the right##2##5##(2008-1#2)
was detected in the##53##4##(1990-12#1)(1990-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-6#1)(1996-7#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
was detected in these##2##4##(1997-4#1)(2008-5#1)
was detected in turkeys##2##4##(1997-6#1)(2013-1#1)
was detected in various##2##4##(1995-6#1)(1996-2#1)
was detected in##211##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#2)(1994-8#2)(1995-11#5)(1995-12#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#59)(2008-11#6)(2008-12#7)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
was detected on a##2##4##(1991-2#1)(2008-10#1)
was detected on##13##3##(1991-2#1)(1994-11#2)(1997-8#1)(2008-10#6)(2008-6#1)(2011-2#1)(2013-1#1)
was detected only in##3##4##(2008-10#3)
was detected only##7##3##(1990-7#1)(1994-12#1)(2008-10#5)
was detected over##3##3##(1995-11#2)(2008-10#1)
was detected spectrophotometrically##2##3##(2008-10#2)
was detected to##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
was detected using the##2##4##(1993-12#1)(2008-9#1)
was detected using##9##3##(1991-12#1)(1993-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-9#1)
was detected when the##3##4##(1997-6#1)(2007-7#1)(2008-10#1)
was detected when##6##3##(1993-12#1)(1997-6#1)(2007-7#1)(2008-10#2)(2010-5#1)
was detected with a##2##4##(2008-10#1)(2008-11#1)
was detected with an##2##4##(1990-5#1)(1991-5#1)
was detected with the##3##4##(1993-8#1)(2007-11#1)(2008-10#1)
was detected with##20##3##(1990-5#1)(1991-12#1)(1991-5#1)(1993-8#1)(1995-11#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2011-2#1)(2011-3#2)(2012-2#1)
was detected within the##2##4##(2008-10#1)(2008-7#1)
was detected within##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
was detected##518##2##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#4)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#3)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#7)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-11#8)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#5)(1996-2#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#6)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#162)(2008-11#15)(2008-12#14)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#12)(2008-6#7)(2008-7#12)(2008-8#13)(2008-9#10)(2009-1#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#9)(2011-2#15)(2011-3#2)(2012-12#6)(2012-2#9)(2012-3#7)(2012-6#1)(2013-1#14)(2013-7#1)(2013-8#9)
was determinated##2##2##(1997-7#1)(2008-7#1)
was determined according to the##2##5##(2008-10#2)
was determined according to##4##4##(2008-10#2)(2008-7#1)(2013-7#1)
was determined after##7##3##(1990-2#1)(1990-8#1)(1995-6#1)(2008-10#4)
was determined and analyzed##2##4##(2008-3#1)(2008-8#1)
was determined and its##2##4##(1992-8#1)(2008-10#1)
was determined and the##3##4##(1991-7#1)(2008-10#1)(2008-5#1)
was determined and turned out to be identical to##2##9##(1995-6#1)(1997-8#1)
was determined and##20##3##(1991-7#1)(1992-8#2)(1993-9#1)(1994-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#2)
was determined as a function of the##2##7##(1991-9#1)(2008-3#1)
was determined as a function of##4##6##(1991-9#1)(2008-10#2)(2008-3#1)
was determined as a##5##4##(1991-9#1)(1997-2#1)(2008-10#2)(2008-3#1)
was determined as the##3##4##(1992-12#1)(1996-1#1)(2009-8#1)
was determined as##23##3##(1990-11#1)(1991-9#1)(1992-12#1)(1992-9#1)(1996-1#1)(1997-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-7#1)
was determined at 2##4##4##(1997-6#1)(2008-10#2)(2008-8#1)
was determined at##12##3##(1995-8#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#1)
was determined based on the##2##5##(2008-10#1)(2013-8#1)
was determined based on##3##4##(2008-10#1)(2009-3#1)(2013-8#1)
was determined before##3##3##(2008-12#1)(2009-3#1)(2012-12#1)
was determined between##2##3##(2008-12#2)
was determined by GF-AAS##2##4##(2008-10#2)
was determined by HPLC##2##4##(2008-10#1)(2008-7#1)
was determined by a##13##4##(1990-2#1)(1993-12#1)(1993-2#1)(1993-9#1)(2008-10#7)(2008-5#1)(2012-12#1)
was determined by adsorptive##4##4##(2008-10#4)
was determined by an##2##4##(1997-7#1)(2008-5#1)
was determined by atomic absorption spectrometry##4##6##(2008-10#4)
was determined by atomic##5##4##(2008-10#5)
was determined by both##2##4##(1993-11#1)(2008-10#1)
was determined by enzyme-linked immunosorbent assay##2##6##(2008-10#1)(2010-4#1)
was determined by flow##2##4##(2008-10#2)
was determined by gel filtration##2##5##(1990-7#1)(2008-10#1)
was determined by graphite furnace atomic absorption spectrometry##2##8##(1995-6#1)(2008-10#1)
was determined by graphite furnace##3##5##(1992-3#1)(1995-6#1)(2008-10#1)
was determined by inoculating##2##4##(2008-10#2)
was determined by matrix-assisted##3##4##(2008-11#3)
was determined by means of##2##5##(2008-10#1)(2012-2#1)
was determined by measuring the##5##5##(1990-12#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-12#1)
was determined by measuring##8##4##(1990-12#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-6#1)
was determined by the##29##4##(1990-3#1)(1990-5#1)(1992-12#1)(1994-8#1)(1997-4#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
was determined by use of##4##5##(1991-8#1)(2008-3#3)
was determined by using the##2##5##(1991-9#1)(2008-10#1)
was determined by using##4##4##(1991-9#1)(2008-10#2)(2008-9#1)
was determined by##207##3##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#4)(1990-8#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#3)(1997-7#1)(1997-8#2)(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#79)(2008-11#8)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#2)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#2)
was determined directly##2##3##(2008-10#1)(2008-11#1)
was determined every##2##3##(2008-12#1)(2008-5#1)
was determined for both##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
was determined for each##2##4##(1993-12#1)(2008-10#1)
was determined for the##3##4##(1990-5#1)(1993-12#1)(2009-10#1)
was determined for##21##3##(1990-5#1)(1993-12#2)(1994-9#1)(1995-1#1)(2008-10#8)(2008-12#1)(2008-5#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
was determined from the measured##2##5##(2007-11#1)(2008-3#1)
was determined from the##9##4##(2007-11#1)(2008-10#5)(2008-3#3)
was determined from##20##3##(1993-12#1)(1996-6#1)(2007-11#2)(2008-10#12)(2008-2#1)(2008-3#3)
was determined in a##4##4##(1992-5#1)(2007-10#1)(2008-10#1)(2012-12#1)
was determined in order to##4##5##(2008-10#2)(2011-1#1)(2012-1#1)
was determined in plasma##2##4##(1994-2#1)(1997-3#1)
was determined in rat##2##4##(1994-5#1)(2008-8#1)
was determined in samples##2##4##(1992-3#1)(2008-10#1)
was determined in the##13##4##(1995-5#1)(1997-2#1)(2006-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)
was determined in this##2##4##(1997-2#1)(2008-10#1)
was determined in##74##3##(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-3#3)(1992-5#1)(1993-6#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#3)(1997-3#2)(1997-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-4#1)(2013-3#1)
was determined mainly by##2##4##(2008-10#2)
was determined on a##2##4##(1996-5#2)
was determined on the##4##4##(1994-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
was determined on##12##3##(1990-6#1)(1992-10#1)(1994-12#1)(1996-5#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)(2013-7#1)
was determined over a##2##4##(2008-3#1)(2008-8#1)
was determined over##6##3##(2008-10#4)(2008-3#1)(2008-8#1)
was determined spectrophotometrically##2##3##(2008-10#2)
was determined that##8##3##(1991-4#1)(1991-9#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
was determined through##2##3##(2007-9#1)(2008-10#1)
was determined to be (3##2##5##(2008-10#2)
was determined to be 0##7##5##(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)
was determined to be 2##3##5##(2008-10#3)
was determined to be 3##3##5##(1993-8#1)(2008-10#2)
was determined to be 4##2##5##(1997-8#1)(2008-10#1)
was determined to be 9##2##5##(1995-11#1)(2008-10#1)
was determined to be a mean of##2##7##(2010-6#2)
was determined to be a##3##5##(1991-8#1)(2010-6#2)
was determined to be at the##2##6##(1991-5#1)(2008-10#1)
was determined to be at##3##5##(1991-5#1)(2008-10#1)(2008-11#1)
was determined to be##65##4##(1991-5#1)(1991-8#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#3)(2008-10#33)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-2#2)
was determined to have##2##4##(1990-7#1)(2008-10#1)
was determined to##79##3##(1990-7#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1996-2#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#36)(2008-11#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-11#1)(2010-5#2)(2010-6#2)(2011-2#3)(2012-2#1)
was determined using a##4##4##(2007-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
was determined using the##7##4##(1994-11#1)(2008-10#4)(2008-9#1)(2013-7#1)
was determined using##34##3##(1990-8#1)(1992-12#1)(1992-6#1)(1993-9#2)(1994-11#1)(2007-6#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
was determined with a##4##4##(1990-11#1)(2008-10#1)(2008-3#1)(2010-3#1)
was determined with satisfactory results##2##5##(2008-10#2)
was determined with the##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
was determined with##17##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#1)(2008-10#7)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-3#1)
was determined##693##2##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#6)(1990-6#2)(1990-7#7)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#1)(1992-12#5)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#5)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#1)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#2)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#4)(1997-4#8)(1997-6#3)(1997-7#4)(1997-8#5)(2006-4#2)(2007-10#3)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#271)(2008-11#26)(2008-12#12)(2008-2#4)(2008-3#20)(2008-4#2)(2008-5#20)(2008-6#7)(2008-7#13)(2008-8#15)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#6)(2012-4#1)(2012-7#1)(2012-9#1)(2013-1#10)(2013-3#1)(2013-7#5)(2013-8#6)
was developed a##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
was developed and applied to##2##5##(2008-10#2)
was developed and characterized##2##4##(2008-10#1)(2008-11#1)
was developed and evaluated via##2##5##(2007-12#2)
was developed and implemented##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
was developed and optimized##3##4##(2008-10#3)
was developed and tested##8##4##(1997-4#1)(2007-12#1)(2008-10#4)(2008-2#2)
was developed and used for the##2##6##(2008-10#1)(2008-7#1)
was developed and used for##3##5##(2008-10#2)(2008-7#1)
was developed and used in##2##5##(2008-10#2)
was developed and used to study the##2##7##(2008-10#1)(2008-8#1)
was developed and used to##7##5##(1991-5#1)(2008-10#4)(2008-7#1)(2008-8#1)
was developed and used##12##4##(1991-5#1)(2008-10#8)(2008-7#2)(2008-8#1)
was developed and utilized##2##4##(2008-10#2)
was developed and validated by##2##5##(2008-10#2)
was developed and validated in##2##5##(2008-10#2)
was developed and validated##10##4##(1995-12#1)(2008-10#8)(2008-11#1)
was developed and##59##3##(1990-5#1)(1991-5#1)(1992-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-12#4)(2007-9#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#2)(2013-1#1)
was developed as a##9##4##(1994-3#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-1#1)(2012-3#1)
was developed as an alternative to##2##6##(1997-2#1)(2008-2#1)
was developed as an##3##4##(1997-2#1)(2008-2#1)(2011-2#1)
was developed as##14##3##(1994-3#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
was developed at##4##3##(1992-2#1)(2008-1#1)(2008-12#2)
was developed based on a##2##5##(2008-10#2)
was developed based on mitochondrial##2##5##(2008-10#2)
was developed based on the##6##5##(2008-10#4)(2008-8#1)(2011-1#1)
was developed based on##18##4##(2008-10#13)(2008-12#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
was developed by a##4##4##(1995-2#1)(1997-3#1)(2008-10#2)
was developed by coupling##5##4##(2008-10#5)
was developed by immobilizing##2##4##(2008-10#2)
was developed by the##4##4##(1994-3#1)(2008-10#1)(2009-5#1)(2010-11#1)
was developed by use of##2##5##(2008-2#1)(2008-3#1)
was developed by using##3##4##(2008-10#3)
was developed by##36##3##(1990-12#1)(1991-2#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#20)(2008-2#1)(2008-3#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
was developed for a##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
was developed for detecting##2##4##(1995-11#1)(2008-9#1)
was developed for determination of##7##5##(2008-10#7)
was developed for identification and##2##5##(1995-12#1)(2008-10#1)
was developed for measuring##2##4##(2008-5#1)(2008-7#1)
was developed for monitoring##2##4##(2008-10#2)
was developed for quantitative##2##4##(2008-10#2)
was developed for sample##2##4##(2008-10#2)
was developed for simultaneous determination of##5##6##(2008-10#5)
was developed for simultaneous##7##4##(2008-10#7)
was developed for the analysis of organophosphorus pesticides##2##8##(2008-10#2)
was developed for the analysis of##5##6##(2008-10#5)
was developed for the detection of##5##6##(1990-12#1)(2008-10#4)
was developed for the determination of cadmium in##2##8##(2008-10#2)
was developed for the determination of the##2##7##(2008-10#2)
was developed for the determination of trace levels of##2##9##(2008-10#2)
was developed for the determination of trace##3##7##(2008-10#3)
was developed for the determination of##46##6##(1990-8#1)(1996-5#1)(2008-10#38)(2008-11#1)(2011-1#3)(2011-3#1)(2012-1#1)
was developed for the direct##2##5##(2008-10#2)
was developed for the quantitation of##2##6##(2008-10#2)
was developed for the rapid##3##5##(2008-10#3)
was developed for the separation and##3##6##(2008-10#3)
was developed for the separation of##2##6##(2008-10#2)
was developed for the separation##5##5##(2008-10#5)
was developed for the simultaneous determination of##4##7##(2008-10#4)
was developed for the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
was developed for the simultaneous##8##5##(2008-10#8)
was developed for the spectrophotometric determination of##3##7##(2008-10#3)
was developed for the##107##4##(1990-12#1)(1990-8#1)(1992-11#1)(1994-12#1)(1996-5#2)(2007-10#1)(2008-10#86)(2008-11#3)(2008-3#2)(2008-6#1)(2010-4#1)(2011-1#4)(2011-3#1)(2012-1#1)(2013-1#1)
was developed for##179##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1993-12#1)(1994-12#2)(1995-11#1)(1995-12#2)(1996-5#2)(1997-2#1)(2007-10#2)(2008-10#130)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-4#2)(2011-1#4)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
was developed from a cross between##2##6##(2008-10#2)
was developed from a##5##4##(1992-2#1)(2008-10#4)
was developed from##8##3##(1991-2#1)(1992-2#1)(2008-10#5)(2008-6#1)
was developed in a##3##4##(2008-10#2)(2008-7#1)
was developed in conjunction with##3##5##(1996-2#1)(2008-10#2)
was developed in order to##6##5##(1990-2#1)(1991-3#1)(1996-12#1)(2008-10#2)(2008-11#1)
was developed in order##7##4##(1990-2#1)(1991-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
was developed in the##6##4##(1992-11#1)(1994-3#1)(2008-10#3)(2012-7#1)
was developed in this work##3##5##(2008-10#3)
was developed in this##5##4##(2008-10#5)
was developed in which the##2##5##(2008-11#2)
was developed in which##5##4##(1992-3#1)(2008-10#1)(2008-11#2)(2008-3#1)
was developed in##41##3##(1990-2#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-7#1)
was developed on the basis of##2##6##(2008-10#1)(2008-2#1)
was developed on the##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
was developed on##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
was developed over##2##3##(1997-6#1)(2008-7#1)
was developed prior to##2##4##(1993-12#1)(2008-10#1)
was developed recently##2##3##(2008-10#1)(2008-9#1)
was developed that included##2##4##(1997-1#1)(2010-7#1)
was developed that includes a##2##5##(1990-8#1)(2007-11#1)
was developed that##15##3##(1990-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-7#1)(2009-6#1)(2010-7#1)
was developed to address##3##4##(2008-12#1)(2008-3#1)(2008-7#1)
was developed to assess##3##4##(1996-12#1)(2008-11#1)(2010-9#1)
was developed to characterize##2##4##(2008-10#2)
was developed to describe the##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
was developed to detect the##2##5##(1991-12#1)(2013-1#1)
was developed to detect##4##4##(1991-12#1)(1997-4#1)(2008-10#1)(2013-1#1)
was developed to determine the##5##5##(2008-10#4)(2008-5#1)
was developed to determine##15##4##(2008-10#14)(2008-5#1)
was developed to enable##2##4##(2008-10#1)(2010-10#1)
was developed to evaluate##5##4##(1996-7#1)(1997-2#1)(2008-10#2)(2013-1#1)
was developed to examine##2##4##(2008-11#1)(2008-9#1)
was developed to generate##2##4##(2008-11#1)(2008-3#1)
was developed to guide##2##4##(2010-6#1)(2012-2#1)
was developed to measure##2##4##(1993-6#1)(2008-3#1)
was developed to monitor the##3##5##(2008-10#3)
was developed to predict the##2##5##(2008-10#2)
was developed to predict##4##4##(1992-3#1)(2008-10#3)
was developed to provide##4##4##(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
was developed to quantify the##2##5##(2007-12#1)(2008-10#1)
was developed to quantify##4##4##(2007-12#1)(2008-10#3)
was developed to quantitatively measure##2##5##(1994-9#1)(2008-10#1)
was developed to separate##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
was developed to simultaneously##4##4##(2008-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
was developed to study the##4##5##(2008-10#3)(2008-11#1)
was developed to##122##3##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#56)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
was developed using a##2##4##(2008-10#2)
was developed using an##2##4##(2008-10#2)
was developed using##25##3##(1990-2#2)(1992-6#1)(2008-10#18)(2008-11#1)(2011-1#2)(2013-1#1)
was developed which##5##3##(1991-5#1)(1997-3#1)(2008-10#2)(2008-11#1)
was developed with a view to##2##6##(2008-10#1)(2008-11#1)
was developed with a##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
was developed with the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
was developed with##17##3##(2007-11#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-12#1)(2012-3#1)
was developed##732##2##(1990-12#2)(1990-2#5)(1990-5#1)(1990-8#4)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#4)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(1997-6#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#416)(2008-11#30)(2008-12#19)(2008-2#16)(2008-3#34)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#15)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#15)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#5)(2012-7#1)(2013-1#10)(2013-8#1)
was devised for the##2##4##(1990-8#1)(2007-12#1)
was devised for##3##3##(1990-8#1)(2007-12#1)(2008-5#1)
was devised to##2##3##(2008-10#1)(2012-2#1)
was devised##11##2##(1990-8#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-2#1)
was devoid of##6##3##(1991-9#1)(1994-5#1)(1996-1#2)(1997-3#1)(2008-7#1)
was devoted to##2##3##(2008-10#1)(2008-7#1)
was diagnosed after##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
was diagnosed and##5##3##(1996-6#1)(2007-12#1)(2010-10#1)(2011-1#2)
was diagnosed as a##4##4##(1995-4#1)(2008-11#1)(2012-1#1)(2012-2#1)
was diagnosed as having a##2##5##(1996-9#1)(2011-2#1)
was diagnosed as having##8##4##(1991-11#1)(1996-9#1)(2008-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
was diagnosed as##29##3##(1990-6#2)(1991-11#1)(1991-12#1)(1994-7#1)(1995-2#1)(1995-4#1)(1996-9#1)(2007-7#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
was diagnosed at##5##3##(2008-6#1)(2010-11#2)(2012-3#2)
was diagnosed based on##2##4##(2012-2#1)(2013-1#1)
was diagnosed by##8##3##(2007-8#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
was diagnosed during##2##3##(2007-8#1)(2009-1#1)
was diagnosed in a##3##4##(1990-2#1)(1991-5#1)(2007-10#1)
was diagnosed in two##2##4##(1996-3#1)(2008-11#1)
was diagnosed in##26##3##(1990-2#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#2)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
was diagnosed more often##3##4##(2012-3#1)(2013-1#2)
was diagnosed on the basis of##3##6##(1995-12#1)(2008-1#1)(2008-11#1)
was diagnosed on the##4##4##(1990-9#1)(1995-12#1)(2008-1#1)(2008-11#1)
was diagnosed on##6##3##(1990-9#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)
was diagnosed preoperatively##2##3##(1991-5#1)(2013-7#1)
was diagnosed to have##6##4##(1997-8#1)(2007-7#1)(2008-12#1)(2008-6#1)(2012-2#2)
was diagnosed to##7##3##(1997-8#1)(2007-7#2)(2008-12#1)(2008-6#1)(2012-2#2)
was diagnosed using##2##3##(2008-5#1)(2010-8#1)
was diagnosed with a##5##4##(1995-12#1)(2007-8#2)(2008-2#1)(2012-12#1)
was diagnosed with severe##2##4##(2010-10#1)(2012-3#1)
was diagnosed with the##2##4##(2008-10#1)(2013-8#1)
was diagnosed with##33##3##(1994-1#1)(1995-12#1)(1996-5#1)(1997-3#2)(1997-5#1)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
was diagnosed##170##2##(1990-2#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-3#3)(1997-5#4)(1997-8#4)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#6)(2008-1#5)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#2)(2010-11#3)(2010-2#1)(2010-3#1)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#13)(2013-7#3)(2013-8#4)
was diarrhea##3##2##(1992-10#1)(2007-2#1)(2008-7#1)
was different between the##2##4##(2008-10#2)
was different between##4##3##(2008-10#3)(2013-7#1)
was different for##2##3##(2008-10#2)
was different from other##2##4##(2008-10#1)(2008-11#1)
was different from that of the##3##6##(1997-6#1)(2008-10#2)
was different from that of##5##5##(1997-6#1)(1997-7#1)(2008-10#3)
was different from that on##2##5##(2008-10#1)(2008-5#1)
was different from that##9##4##(1993-3#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#1)
was different from the##4##4##(1994-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
was different from##18##3##(1993-3#1)(1993-8#1)(1994-6#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
was different##34##2##(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-7#1)
was differentially##2##2##(1994-6#1)(1995-2#1)
was differentiated##2##2##(2008-5#1)(2013-1#1)
was difficult to detect##2##4##(2008-10#1)(2012-12#1)
was difficult to identify##4##4##(1990-10#2)(2008-10#2)
was difficult to##14##3##(1990-10#2)(1990-2#1)(1990-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
was difficult##16##2##(1990-10#2)(1990-2#1)(1990-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
was diffuse##2##2##(1992-10#1)(1992-11#1)
was digested with trypsin##2##4##(1990-2#1)(1994-11#1)
was digested with##11##3##(1990-2#1)(1990-5#1)(1994-11#2)(1994-12#1)(1996-12#1)(2006-8#1)(2008-10#3)(2008-8#1)
was digested##12##2##(1990-2#1)(1990-5#1)(1992-6#1)(1994-11#2)(1994-12#1)(1996-12#1)(2006-8#1)(2008-10#3)(2008-8#1)
was diluted in##2##3##(2008-10#1)(2013-1#1)
was diluted##7##2##(1992-3#1)(2008-10#4)(2011-2#1)(2013-1#1)
was diminished by##5##3##(1992-12#1)(1993-12#1)(1993-9#1)(1995-8#1)(2008-10#1)
was diminished##11##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-3#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
was directed by##2##3##(2008-9#1)(2010-1#1)
was directed toward##2##3##(1993-1#1)(2008-9#1)
was directed##9##2##(1992-12#1)(1993-1#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#1)
was directly correlated with##2##4##(2008-10#1)(2011-2#1)
was directly dependent on##2##4##(2007-7#1)(2008-8#1)
was directly determined##2##3##(1993-6#1)(2008-10#1)
was directly introduced into##2##4##(2008-10#1)(2008-6#1)
was directly introduced##4##3##(2008-10#2)(2008-6#1)(2008-9#1)
was directly measured##2##3##(2008-10#1)(2008-3#1)
was directly proportional to the##3##5##(2008-10#2)(2008-11#1)
was directly proportional to##4##4##(2008-10#3)(2008-11#1)
was directly related to the##3##5##(1990-5#1)(2008-10#1)(2011-1#1)
was directly related to##6##4##(1990-5#2)(2008-10#2)(2011-1#2)
was directly related##7##3##(1990-5#2)(2008-10#2)(2008-3#1)(2011-1#2)
was directly##48##2##(1990-5#2)(1993-6#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
was discarded##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
was discharged after##3##3##(1995-3#1)(2010-12#1)(2013-8#1)
was discharged from the hospital##4##5##(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
was discharged home##3##3##(2007-8#1)(2008-12#1)(2010-7#1)
was discharged on the##4##4##(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
was discharged on##7##3##(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
was discharged##24##2##(1994-9#1)(1995-3#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#3)
was disclosed##4##2##(1995-3#1)(1997-3#2)(2008-8#1)
was discontinued after##4##3##(2007-5#1)(2008-9#2)(2011-1#1)
was discontinued and##2##3##(2008-1#1)(2013-1#1)
was discontinued in##2##3##(2007-5#1)(2011-2#1)
was discontinued##16##2##(1992-6#1)(1994-6#1)(2006-12#1)(2007-5#2)(2008-1#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
was discovered about##2##3##(2008-10#1)(2008-4#1)
was discovered as a result of##2##6##(1991-11#1)(2008-10#1)
was discovered as a##3##4##(1991-11#1)(2008-10#1)(2011-2#1)
was discovered as##4##3##(1991-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
was discovered by##4##3##(1990-5#1)(2008-1#1)(2008-7#1)(2008-8#1)
was discovered in a##3##4##(1990-8#1)(2008-7#1)(2012-12#1)
was discovered in the##3##4##(1995-1#1)(2008-9#1)(2010-7#1)
was discovered in##11##3##(1990-8#1)(1995-1#1)(1995-8#1)(1996-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#2)
was discovered on##3##3##(2010-7#1)(2013-1#1)(2013-8#1)
was discovered that##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
was discovered to have##2##4##(2008-10#2)
was discovered##46##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1993-9#1)(1994-11#2)(1995-1#1)(1995-8#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-7#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
was discussed and the##2##4##(2008-10#2)
was discussed and##4##3##(2008-10#3)(2009-7#1)
was discussed in##5##3##(1997-8#1)(2008-10#3)(2013-8#1)
was discussed##39##2##(1995-11#1)(1997-1#1)(1997-8#1)(2008-10#27)(2008-5#1)(2008-8#4)(2009-7#1)(2011-7#1)(2013-8#2)
was disease##3##2##(1994-8#1)(2008-10#2)
was dislocated##2##2##(2007-8#1)(2009-4#1)
was dislodged##2##2##(1997-6#1)(2011-2#1)
was disorganized and##2##3##(1996-7#1)(2009-10#1)
was dispersed into##2##3##(1994-12#1)(2008-10#1)
was dispersed##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2010-5#1)
was displaced by##2##3##(1994-3#1)(1994-6#1)
was displaced##4##2##(1993-1#1)(1994-11#1)(1994-3#1)(1994-6#1)
was displayed on##3##3##(1996-2#1)(2013-1#1)(2013-8#1)
was displayed##4##2##(1993-3#1)(1996-2#1)(2013-1#1)(2013-8#1)
was disrupted in##3##3##(1993-3#1)(2008-10#2)
was disrupted##7##2##(1993-3#1)(1997-7#1)(2008-10#4)(2008-7#1)
was dissected##3##2##(1996-5#1)(2006-12#1)(2012-3#1)
was dissociated##3##2##(1991-12#1)(1993-8#1)(2008-11#1)
was dissolved in the##3##4##(1994-11#1)(2008-5#1)(2008-6#1)
was dissolved in##10##3##(1994-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)
was dissolved with##7##3##(2008-10#7)
was dissolved##17##2##(1994-11#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)
was distinct from that of##3##5##(1992-10#1)(2008-10#1)(2008-6#1)
was distinct from##8##3##(1992-10#1)(1995-5#1)(2008-10#4)(2008-12#1)(2008-6#1)
was distinct##10##2##(1992-10#1)(1993-8#1)(1995-5#1)(2008-10#5)(2008-12#1)(2008-6#1)
was distinctly##4##2##(1993-12#1)(1994-12#1)(2008-10#1)(2012-2#1)
was distributed among fields within##2##5##(2008-10#2)
was distributed among fields##3##4##(2008-10#3)
was distributed among##9##3##(2008-10#9)
was distributed in the##2##4##(2008-10#2)
was distributed in##3##3##(2008-10#3)
was distributed throughout##2##3##(1995-11#1)(1996-1#1)
was distributed to##4##3##(1992-6#1)(1993-12#1)(1996-9#1)(2012-12#1)
was distributed within##7##3##(2008-10#7)
was distributed##32##2##(1992-3#1)(1992-6#2)(1993-12#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-9#1)(2008-10#22)(2009-2#1)(2012-12#1)
was divided in##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
was divided into five##2##4##(2008-10#1)(2008-7#1)
was divided into four##2##4##(2008-10#1)(2008-5#1)
was divided into three##6##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-8#2)
was divided into two##2##4##(2009-8#1)(2011-2#1)
was divided into##22##3##(1990-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#2)(2011-2#1)(2013-1#2)
was divided on##2##3##(2008-6#1)(2013-1#1)
was divided##29##2##(1990-12#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#2)(2011-2#2)(2013-1#4)
was documented by##2##3##(2007-12#1)(2012-2#1)
was documented in##11##3##(1991-7#1)(1992-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#2)
was documented##23##2##(1991-12#1)(1991-7#1)(1992-3#2)(1992-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
was dominant in the##4##4##(1992-3#1)(1995-11#1)(2008-10#1)(2010-8#1)
was dominant in##6##3##(1990-6#1)(1992-3#1)(1995-11#1)(2008-10#2)(2010-8#1)
was dominant##8##2##(1990-6#1)(1992-3#1)(1994-12#1)(1995-11#1)(1997-7#1)(2008-10#2)(2010-8#1)
was dominated by##9##3##(1990-2#1)(1990-7#1)(2007-5#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-1#1)(2011-2#1)
was done after##4##3##(2007-7#1)(2008-3#1)(2008-7#1)(2012-12#1)
was done and##9##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was done at##6##3##(1990-3#1)(1995-12#1)(2007-11#1)(2008-10#1)(2010-7#1)(2013-8#1)
was done before and##2##4##(2008-10#1)(2012-2#1)
was done by ELISA##2##4##(1993-11#1)(2013-1#1)
was done by a##3##4##(2008-6#1)(2010-1#1)(2013-1#1)
was done by comparison##2##4##(2008-10#2)
was done by the##3##4##(1994-6#1)(2008-10#1)(2013-8#1)
was done by using the##3##5##(2008-10#1)(2008-11#1)(2013-8#1)
was done by using##6##4##(2008-10#3)(2008-11#1)(2013-8#2)
was done by##39##3##(1991-2#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#5)
was done for the##2##4##(2011-1#1)(2013-1#1)
was done for##6##3##(2007-8#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
was done in a##3##4##(2008-10#1)(2011-2#2)
was done in one##2##4##(1994-8#1)(2007-11#1)
was done in order to##3##5##(1990-10#2)(2008-10#1)
was done in the##3##4##(2008-10#3)
was done in##29##3##(1990-10#2)(1994-12#1)(1994-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-10#5)(2008-12#4)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
was done on the##2##4##(1993-12#1)(2008-5#1)
was done on##7##3##(1993-12#1)(1993-6#1)(1997-7#1)(2008-5#1)(2012-2#1)(2013-8#2)
was done through the##2##4##(2012-12#1)(2012-2#1)
was done to compare the##3##5##(2007-7#1)(2008-10#1)(2010-7#1)
was done to confirm##2##4##(2008-5#1)(2012-12#1)
was done to identify##2##4##(2012-12#1)(2013-8#1)
was done to##21##3##(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#4)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#4)
was done under local##2##4##(1992-12#1)(2011-1#1)
was done using##9##3##(1996-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2010-8#1)
was done with the##4##4##(1990-8#1)(2008-7#2)(2012-12#1)
was done with two##2##4##(2008-10#1)(2011-1#1)
was done with##12##3##(1990-12#1)(1990-8#1)(2007-8#1)(2008-10#1)(2008-7#3)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
was done within##3##3##(2012-3#1)(2013-1#2)
was done##188##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-11#5)(2007-5#1)(2007-7#6)(2007-8#11)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#16)
was dose dependent##3##3##(1993-6#1)(1994-11#1)(1995-5#1)
was dose##5##2##(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-5#1)
was dose-dependent##9##2##(1991-12#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-11#1)
was dose-dependently##2##2##(1995-6#1)(2012-3#1)
was doubled to##2##3##(2008-11#2)
was doubled##3##2##(2008-11#3)
was doubly##2##2##(1991-3#1)(2008-10#1)
was down to##4##3##(1997-4#1)(2008-10#2)(2008-11#1)
was down##6##2##(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
was down-regulated##4##2##(1993-8#1)(1995-11#1)(2008-8#2)
was downregulated in##4##3##(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
was downregulated##7##2##(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
was drafted##2##2##(2007-6#1)(2008-5#1)
was drained##3##2##(1990-5#1)(1993-12#1)(2008-1#1)
was dramatic##2##2##(2007-12#1)(2013-1#1)
was dramatically increased##4##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)
was dramatically reduced##2##3##(1994-2#1)(2012-12#1)
was dramatically##9##2##(1990-7#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
was drastically enhanced by##2##4##(2009-2#2)
was drastically##4##2##(2008-10#2)(2009-2#2)
was drawn from##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
was drawn into the syringe##3##5##(2008-10#3)
was drawn##9##2##(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-7#1)(2011-1#1)
was dried and##3##3##(2008-10#2)(2008-5#1)
was dried##6##2##(2008-10#5)(2008-5#1)
was driven by a##2##4##(1994-12#1)(2008-11#1)
was driven by the##2##4##(1997-6#1)(2013-1#1)
was driven by##8##3##(1994-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-11#1)(2013-1#1)
was driven##9##2##(1994-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2009-11#1)(2010-11#1)(2013-1#1)
was due in part to##2##5##(1990-2#1)(2007-7#1)
was due largely to##2##4##(2007-12#1)(2008-10#1)
was due mainly to##4##4##(1994-8#1)(1996-11#1)(2008-10#1)(2008-7#1)
was due to a##8##4##(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-10#2)
was due to an##3##4##(1990-5#1)(1993-12#1)(1995-12#1)
was due to both##2##4##(1994-6#1)(2008-9#1)
was due to changes in##2##5##(1991-10#1)(1997-2#1)
was due to differences in isolates between groups##2##8##(2008-10#2)
was due to differences in##4##5##(1994-2#1)(1995-3#1)(2008-10#2)
was due to inhibition of the##2##6##(1993-6#1)(2008-10#1)
was due to the##15##4##(1991-9#2)(1994-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
was due to##85##3##(1990-2#1)(1990-5#1)(1991-10#1)(1991-9#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-3#6)(2008-5#1)(2008-7#2)(2008-9#2)(2010-8#3)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was due##98##2##(1990-2#2)(1990-5#1)(1991-10#1)(1991-9#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-3#6)(2008-5#1)(2008-7#3)(2008-9#2)(2010-8#3)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was during the##2##3##(2007-7#1)(2010-10#1)
was during##3##2##(1991-5#1)(2007-7#1)(2010-10#1)
was dynamically##2##2##(2008-10#2)
was earlier##2##2##(2008-10#1)(2013-1#1)
was early##2##2##(1997-8#1)(2008-10#1)
was easier##2##2##(2008-10#2)
was easily##21##2##(1992-12#2)(1993-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-6#1)(2009-3#1)(2013-1#1)
was easy to##2##3##(2007-8#1)(2008-5#1)
was easy##5##2##(1991-3#1)(1992-11#1)(2007-12#1)(2007-8#1)(2008-5#1)
was effected by##2##3##(1993-9#1)(2007-11#1)
was effected with##2##3##(1990-8#1)(2008-10#1)
was effected##6##2##(1990-8#1)(1992-6#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)
was effective against##2##3##(2008-10#2)
was effective and##2##3##(2008-5#1)(2011-2#1)
was effective for##3##3##(2007-8#1)(2008-10#2)
was effective in achieving##2##4##(2008-12#1)(2012-2#1)
was effective in lowering the##2##5##(2007-10#1)(2008-1#1)
was effective in the##2##4##(2007-11#1)(2008-11#1)
was effective in##25##3##(1990-12#1)(1990-6#1)(1992-2#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-12#2)(1997-1#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#2)(2012-2#1)
was effective on##2##3##(1990-5#1)(1993-12#1)
was effective to##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
was effective##51##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1992-2#1)(1993-12#2)(1993-8#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2011-2#5)(2012-2#1)
was effectively inhibited by##2##4##(1996-2#1)(2008-8#1)
was effectively##12##2##(1994-11#1)(1996-2#1)(2008-10#4)(2008-11#3)(2008-8#1)(2011-1#1)(2012-3#1)
was efficient in##2##3##(1997-4#1)(2008-5#1)
was efficient##5##2##(1993-8#1)(1993-9#1)(1997-4#1)(2008-5#1)(2012-2#1)
was efficiently##10##2##(1990-12#1)(1990-7#1)(1991-10#1)(1992-8#1)(1995-8#1)(2008-10#2)(2008-4#1)(2013-1#2)
was either increased or##2##4##(1991-9#1)(2008-10#1)
was either##19##2##(1991-9#1)(1996-12#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#3)(2013-1#1)
was elaborated##2##2##(1990-11#1)(1992-12#1)
was elected as##2##3##(2008-10#1)(2008-7#1)
was elected##6##2##(1995-1#2)(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#1)
was electrochemically##3##2##(2008-10#3)
was electrostatically##2##2##(2008-10#2)
was elevated and##3##3##(2008-5#1)(2009-1#1)(2012-2#1)
was elevated at the##3##4##(1993-6#1)(2008-10#1)(2011-2#1)
was elevated at##4##3##(1990-5#1)(1993-6#1)(2008-10#1)(2011-2#1)
was elevated by DON##2##4##(2008-10#2)
was elevated by##7##3##(1993-6#1)(1993-8#1)(1994-8#1)(2008-10#3)(2012-2#1)
was elevated for##4##3##(2008-12#4)
was elevated from##2##3##(1993-6#1)(1994-7#1)
was elevated in##5##3##(1990-2#1)(1993-6#1)(1994-2#1)(1997-8#1)(2008-7#1)
was elevated significantly##2##3##(1994-8#1)(1995-5#1)
was elevated##37##2##(1990-2#1)(1990-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#4)(1993-8#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
was elicited by##4##3##(1992-8#1)(1993-12#1)(1997-8#1)(2007-7#1)
was elicited using##2##3##(2012-1#1)(2013-8#1)
was elicited##10##2##(1991-9#1)(1992-8#1)(1993-12#1)(1997-8#1)(2007-7#1)(2008-11#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
was eliminated after##2##3##(2008-10#1)(2008-8#1)
was eliminated by##5##3##(1994-11#1)(2008-10#3)(2008-11#1)
was eliminated from the##2##4##(1990-11#1)(2008-7#1)
was eliminated in##3##3##(1995-12#1)(2008-10#1)(2013-8#1)
was eliminated when##2##3##(1994-8#1)(2008-10#1)
was eliminated##20##2##(1990-11#1)(1994-11#1)(1994-8#1)(1995-12#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-8#2)
was eluted at the##2##4##(1990-12#1)(2008-11#1)
was eluted from the column##2##5##(2008-10#2)
was eluted from the##3##4##(2008-10#3)
was eluted from##5##3##(1992-6#1)(2008-10#4)
was eluted with a##2##4##(2008-10#2)
was eluted with##4##3##(1993-6#1)(2008-10#3)
was eluted##14##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-6#1)(1993-3#1)(1993-6#1)(2008-10#7)(2008-11#1)
was embedded in##4##3##(2008-10#3)(2008-8#1)
was emitted##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
was empirically##2##2##(2010-12#1)(2012-2#1)
was employed and the##2##4##(1990-8#1)(2008-10#1)
was employed and##4##3##(1990-8#1)(1996-9#1)(2008-10#2)
was employed as a##2##4##(1990-2#1)(1991-12#1)
was employed as the##6##4##(2008-10#4)(2008-2#1)(2008-3#1)
was employed as##11##3##(1990-2#1)(1991-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
was employed for extraction##2##4##(2008-10#2)
was employed for quantitative determination##3##5##(2008-10#3)
was employed for quantitative measurement##2##5##(2008-10#2)
was employed for quantitative##5##4##(2008-10#5)
was employed for screening##2##4##(2008-10#1)(2008-5#1)
was employed for the determination of##7##6##(2008-10#6)(2011-1#1)
was employed for the##12##4##(2008-10#9)(2008-12#1)(2008-3#1)(2011-1#1)
was employed for##29##3##(2006-12#1)(2008-10#24)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
was employed in order to obtain##2##6##(2008-10#1)(2009-7#1)
was employed in order to##3##5##(2008-10#1)(2008-11#1)(2009-7#1)
was employed in##9##3##(1990-12#1)(1993-1#1)(2008-10#4)(2008-11#1)(2009-7#1)(2013-1#1)
was employed to analyze the##3##5##(2008-10#2)(2008-11#1)
was employed to characterize the##2##5##(2008-10#2)
was employed to detect##2##4##(2008-10#2)
was employed to determine the##2##5##(2008-11#1)(2008-8#1)
was employed to determine##6##4##(1991-2#1)(2008-10#2)(2008-11#2)(2008-8#1)
was employed to evaluate the effects of##2##7##(2008-6#1)(2013-8#1)
was employed to evaluate the##4##5##(2008-10#1)(2008-12#1)(2008-6#1)(2013-8#1)
was employed to generate##3##4##(1995-5#1)(2008-3#2)
was employed to investigate the##3##5##(2008-10#2)(2008-11#1)
was employed to measure the##2##5##(2008-10#1)(2008-3#1)
was employed to monitor##2##4##(2008-10#2)
was employed to obtain the optimum##2##6##(2008-10#1)(2013-1#1)
was employed to produce##2##4##(2008-10#1)(2012-12#1)
was employed to study the##3##5##(2007-12#1)(2008-10#2)
was employed to study##4##4##(2007-12#1)(2008-10#2)(2011-1#1)
was employed to##65##3##(1990-6#1)(1991-2#1)(1991-9#1)(1993-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#33)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-5#2)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
was employed using##2##3##(2008-10#1)(2009-7#1)
was employed with##3##3##(1992-1#1)(2008-10#1)(2010-5#1)
was employed##149##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-5#1)(1995-9#1)(1996-9#2)(1997-2#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#85)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#4)(2010-2#1)(2010-5#3)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
was enabled by the##2##4##(2011-3#1)(2013-8#1)
was enabled by##3##3##(2008-7#1)(2011-3#1)(2013-8#1)
was enacted##4##2##(1995-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
was encapsulated##2##2##(2008-10#1)(2008-12#1)
was encountered in##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-3#1)
was encountered##10##2##(1990-9#1)(1992-8#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-3#1)(2012-2#1)
was enhanced after##2##3##(1992-6#1)(2008-6#1)
was enhanced and##3##3##(1997-4#1)(2008-10#1)(2008-12#1)
was enhanced by a##2##4##(1990-12#1)(2008-10#1)
was enhanced by the addition of##2##6##(1992-9#1)(2008-10#1)
was enhanced by the presence of##2##6##(2008-10#1)(2008-6#1)
was enhanced by the##6##4##(1992-9#2)(1996-5#1)(2008-10#2)(2008-6#1)
was enhanced by##27##3##(1990-11#1)(1990-12#1)(1992-9#2)(1993-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-7#1)(2006-6#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#1)
was enhanced in the##3##4##(1993-12#1)(2008-10#1)(2008-2#1)
was enhanced in##13##3##(1993-11#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-11#1)
was enhanced more##2##3##(1990-11#1)(2008-10#1)
was enhanced only##2##3##(2008-11#1)(2008-7#1)
was enhanced significantly##2##3##(2008-10#1)(2008-5#1)
was enhanced when##2##3##(1993-6#1)(1996-12#1)
was enhanced##81##2##(1990-11#3)(1990-12#1)(1990-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-12#3)(1996-5#1)(1997-4#1)(1997-7#2)(2006-6#2)(2007-11#1)(2008-10#21)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
was enough to##2##3##(2008-10#2)
was enough##3##2##(2008-10#3)
was enriched in##7##3##(1990-2#1)(1992-9#1)(1995-6#1)(1996-5#2)(2008-10#1)(2012-3#1)
was enriched with##2##3##(1996-2#1)(2008-10#1)
was enriched##11##2##(1990-2#1)(1992-9#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-10#2)(2008-7#1)(2012-3#1)
was ensured##3##2##(1990-3#1)(2008-10#2)
was entirely##2##2##(1991-12#1)(1995-8#1)
was entrapped in the##2##4##(2008-10#2)
was entrapped in##3##3##(2008-10#3)
was entrapped##4##2##(2008-10#4)
was envisaged##2##2##(2008-5#1)(2009-3#1)
was enzymatically##4##2##(1990-11#1)(1990-12#1)(2008-10#1)(2008-5#1)
was equal to 0##2##4##(2008-10#1)(2008-5#1)
was equal to 1##3##4##(1993-12#1)(2008-10#1)(2012-3#1)
was equal to or##3##4##(1990-12#1)(2008-10#1)(2013-1#1)
was equal to the##2##4##(2007-11#1)(2008-9#1)
was equal to##15##3##(1990-12#2)(1993-12#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
was equal##18##2##(1990-12#2)(1993-12#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
was equally potent in##2##4##(1992-3#2)
was equally##7##2##(1992-12#1)(1992-3#2)(1997-8#1)(2008-11#2)(2008-8#1)
was equipped with##2##3##(2007-11#1)(2008-11#1)
was equivalent in##3##3##(1990-2#1)(2008-10#1)(2012-12#1)
was equivalent to a##2##4##(2008-10#2)
was equivalent to##6##3##(1992-8#1)(2008-10#4)(2011-2#1)
was equivalent##11##2##(1990-2#1)(1992-8#1)(1995-11#1)(2008-10#5)(2010-9#1)(2011-2#1)(2012-12#1)
was eradicated##2##2##(1990-2#1)(1990-3#1)
was escalated from##2##3##(1990-12#1)(2010-3#1)
was especially##6##2##(1995-5#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
was essential for the##3##4##(1997-2#1)(2008-8#1)(2013-1#1)
was essential for##9##3##(1991-9#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#3)(2013-1#1)
was essential to##2##3##(2008-10#1)(2008-8#1)
was essential##17##2##(1991-9#1)(1992-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#4)(2013-1#1)
was essentially inactive##2##3##(1992-12#1)(1995-2#1)
was essentially##17##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
was established (genes##2##3##(2008-10#2)
was established after##4##3##(1990-10#1)(2008-10#2)(2012-12#1)
was established and##6##3##(1992-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2011-1#1)
was established as an##2##4##(2009-11#2)
was established as the##3##4##(1995-5#1)(2008-10#1)(2010-12#1)
was established as##10##3##(1995-5#1)(2007-1#1)(2008-10#4)(2008-12#1)(2009-11#2)(2010-12#1)
was established based on##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
was established between##5##3##(1992-2#1)(2008-10#3)(2008-5#1)
was established by a##2##4##(1992-8#1)(2008-11#1)
was established by the##2##4##(1995-12#1)(1995-2#1)
was established by##24##3##(1990-5#1)(1990-8#1)(1992-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-8#1)
was established for the##6##4##(2008-10#3)(2011-1#3)
was established for##12##3##(1995-6#1)(2008-10#5)(2008-11#1)(2011-1#4)(2013-1#1)
was established from##3##3##(1994-11#1)(1996-5#1)(2008-11#1)
was established in both##2##4##(2011-1#1)(2011-2#1)
was established in order to##2##5##(2008-6#1)(2010-3#1)
was established in the##4##4##(1995-2#1)(1997-7#1)(2008-10#2)
was established in##27##3##(1992-8#1)(1993-3#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-8#1)
was established on##2##3##(1993-6#1)(2007-8#1)
was established prior to##2##4##(1992-10#1)(2008-10#1)
was established that the##3##4##(1995-9#1)(1996-3#1)(2008-10#1)
was established that##9##3##(1990-10#1)(1995-9#1)(1996-3#1)(2008-10#4)(2008-5#1)(2013-8#1)
was established to determine##2##4##(2008-10#1)(2008-11#1)
was established to study##2##4##(1995-11#1)(2007-12#1)
was established to##12##3##(1994-1#1)(1995-11#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)
was established using##3##3##(2008-10#2)(2008-11#1)
was established when it was used in##2##7##(2008-8#2)
was established when##5##3##(1992-2#1)(2008-8#4)
was established with the##3##4##(2008-10#2)(2013-8#1)
was established with##6##3##(1992-3#1)(2008-10#3)(2011-2#1)(2013-8#1)
was established##196##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#3)(1993-1#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#60)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#4)(2009-11#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#6)(2011-2#8)(2011-3#1)(2012-12#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#7)
was estimated according to##3##4##(1991-6#1)(2007-11#1)(2012-3#1)
was estimated among##2##3##(2008-10#1)(2008-4#1)
was estimated and##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
was estimated as 0##4##4##(2008-10#3)(2008-12#1)
was estimated as##17##3##(1990-11#1)(1990-2#1)(1993-8#1)(1995-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)
was estimated at##13##3##(1992-12#1)(1992-2#1)(2008-1#1)(2008-10#5)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
was estimated by a##2##4##(1993-3#1)(2008-10#1)
was estimated by analysis of##2##5##(2008-10#2)
was estimated by quantitative##2##4##(2008-10#1)(2008-11#1)
was estimated by the##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
was estimated by this##2##4##(2008-2#1)(2008-3#1)
was estimated by##32##3##(1990-11#1)(1990-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
was estimated for##2##3##(2008-10#2)
was estimated from the##3##4##(2008-10#2)(2008-7#1)
was estimated from##9##3##(1990-11#1)(1992-10#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)
was estimated in##6##3##(1996-8#1)(1997-8#1)(2008-10#2)(2012-12#1)(2012-2#1)
was estimated to be 0##4##5##(2008-10#3)(2013-1#1)
was estimated to be 1##4##5##(1995-11#1)(2007-11#1)(2008-10#1)(2012-2#1)
was estimated to be 10##2##5##(1990-12#1)(1992-12#1)
was estimated to be 2##3##5##(2008-10#2)(2008-2#1)
was estimated to be approximately##2##5##(2008-10#1)(2008-3#1)
was estimated to be less than##3##6##(2008-10#1)(2008-3#2)
was estimated to be##47##4##(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1995-11#2)(1997-6#2)(2007-11#2)(2007-12#1)(2008-10#17)(2008-2#3)(2008-3#5)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
was estimated to have##3##4##(1990-5#1)(1991-5#1)(2011-2#1)
was estimated to range##2##4##(2008-10#1)(2010-3#1)
was estimated to##56##3##(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1995-11#2)(1997-6#2)(2007-11#2)(2007-12#1)(2008-10#18)(2008-2#4)(2008-3#6)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
was estimated using the##2##4##(2008-10#1)(2011-1#1)
was estimated using##7##3##(2008-10#5)(2008-7#1)(2011-1#1)
was estimated with the##2##4##(2007-8#1)(2008-6#1)
was estimated with##5##3##(2007-8#1)(2008-10#3)(2008-6#1)
was estimated##180##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-8#1)(1997-6#2)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#72)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
was evaluated according to the##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
was evaluated according to##7##4##(2007-11#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
was evaluated after##2##3##(2008-10#2)
was evaluated against the##2##4##(1994-3#1)(2008-5#1)
was evaluated against##10##3##(1994-3#1)(2008-10#3)(2008-5#1)(2010-5#1)(2012-2#3)(2013-1#1)
was evaluated and compared with##2##5##(2008-10#2)
was evaluated and the##3##4##(2008-10#2)(2012-1#1)
was evaluated and##7##3##(2008-10#6)(2012-1#1)
was evaluated as a function of##4##6##(2008-10#3)(2008-11#1)
was evaluated as a##7##4##(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
was evaluated as the##2##4##(2008-10#1)(2011-2#1)
was evaluated as##14##3##(1994-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-12#1)
was evaluated at the##3##4##(2008-10#3)
was evaluated at three##2##4##(2008-10#1)(2011-2#1)
was evaluated at##11##3##(2008-10#7)(2008-5#2)(2008-7#1)(2011-2#1)
was evaluated based on##2##4##(2007-8#1)(2008-10#1)
was evaluated by MTT##2##4##(2007-2#1)(2011-3#1)
was evaluated by a##5##4##(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
was evaluated by analysis of##2##5##(2008-10#2)
was evaluated by analyzing##6##4##(1997-3#1)(2008-10#5)
was evaluated by applying##2##4##(2008-10#1)(2008-5#1)
was evaluated by assaying##2##4##(2008-10#1)(2010-5#1)
was evaluated by calculating##2##4##(2008-10#1)(2008-5#1)
was evaluated by comparing##3##4##(1991-9#1)(2008-10#2)
was evaluated by comparison with##4##5##(2008-10#3)(2008-2#1)
was evaluated by determining##3##4##(1997-4#1)(2008-10#2)
was evaluated by means of##5##5##(1991-12#1)(1997-3#1)(1997-4#1)(2008-10#2)
was evaluated by measuring the##2##5##(1990-11#1)(1994-8#1)
was evaluated by measuring##5##4##(1990-11#1)(1994-8#1)(1997-2#1)(2008-10#1)(2012-3#1)
was evaluated by performing##2##4##(2008-10#1)(2013-8#1)
was evaluated by standard##2##4##(2008-10#2)
was evaluated by testing##2##4##(2008-10#1)(2013-8#1)
was evaluated by the##14##4##(2008-10#9)(2008-9#1)(2009-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
was evaluated by use of##2##5##(2008-2#1)(2008-3#1)
was evaluated by using the##3##5##(1992-3#1)(2008-10#1)(2012-12#1)
was evaluated by using##7##4##(1992-3#1)(2008-10#4)(2011-1#1)(2012-12#1)
was evaluated by##115##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-9#1)(2007-2#1)(2007-8#2)(2008-10#51)(2008-11#2)(2008-2#5)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#5)
was evaluated during##2##3##(2011-1#1)(2013-8#1)
was evaluated for its ability to##2##6##(2008-10#1)(2008-5#1)
was evaluated for its##8##4##(1993-2#1)(2008-10#5)(2008-5#1)(2009-2#1)
was evaluated for resistance to##2##5##(2008-10#2)
was evaluated for the determination of##4##6##(2008-10#3)(2010-5#1)
was evaluated for the##13##4##(1994-5#1)(1997-2#1)(2008-10#7)(2008-5#1)(2010-5#1)(2012-1#1)(2013-1#1)
was evaluated for their##3##4##(2009-3#1)(2011-2#1)(2012-3#1)
was evaluated for##47##3##(1992-6#1)(1993-2#1)(1994-5#2)(1997-2#1)(2008-10#24)(2008-5#3)(2009-2#1)(2009-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#2)
was evaluated from the##3##4##(1995-6#1)(2008-5#1)(2008-7#1)
was evaluated from##9##3##(1995-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)
was evaluated further##3##3##(1992-3#1)(2008-10#2)
was evaluated in 20##2##4##(1995-12#1)(2008-1#1)
was evaluated in a randomized##2##5##(2008-10#2)
was evaluated in a##10##4##(1991-4#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#2)(2012-12#1)
was evaluated in an##5##4##(1993-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
was evaluated in bioassays##2##4##(2008-10#2)
was evaluated in greenhouse trials##2##5##(2008-10#2)
was evaluated in greenhouse##3##4##(2008-10#3)
was evaluated in mice##2##4##(1995-12#1)(2013-1#1)
was evaluated in rats##2##4##(1996-12#1)(2008-10#1)
was evaluated in terms of the##2##6##(2008-10#2)
was evaluated in terms of##3##5##(2008-10#3)
was evaluated in the greenhouse##2##5##(2008-10#2)
was evaluated in the##10##4##(1991-3#1)(1995-4#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)
was evaluated in vitro##2##4##(2007-8#1)(2008-10#1)
was evaluated in##85##3##(1990-3#2)(1991-2#2)(1991-3#1)(1991-4#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)
was evaluated on the##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
was evaluated on##18##3##(1993-2#1)(1993-3#1)(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#2)(2011-1#1)(2012-2#2)(2013-1#1)
was evaluated over a##2##4##(2008-10#2)
was evaluated over##3##3##(2008-10#2)(2012-3#1)
was evaluated the##2##3##(2008-10#2)
was evaluated through the determination of##2##6##(2008-10#2)
was evaluated through the##4##4##(2008-10#3)(2008-12#1)
was evaluated through##8##3##(1991-1#1)(2008-10#5)(2008-12#1)(2013-1#1)
was evaluated to be 1##2##5##(2008-10#1)(2008-3#1)
was evaluated to##7##3##(2008-10#5)(2008-3#1)(2008-5#1)
was evaluated using a##10##4##(1995-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
was evaluated using different##2##4##(2007-11#1)(2008-10#1)
was evaluated using scanning electron microscopy##2##6##(2008-5#1)(2009-11#1)
was evaluated using the##8##4##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
was evaluated using two##2##4##(2007-9#1)(2008-10#1)
was evaluated using##38##3##(1990-5#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)
was evaluated via##3##3##(2009-2#1)(2010-10#1)(2012-2#1)
was evaluated when##2##3##(2008-6#1)(2013-1#1)
was evaluated with a##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
was evaluated with an##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
was evaluated with reference##2##4##(2008-10#1)(2008-11#1)
was evaluated with respect to the##2##6##(2008-10#2)
was evaluated with respect to##4##5##(1993-1#1)(2008-10#3)
was evaluated with the##6##4##(1990-5#1)(1990-7#1)(2007-8#1)(2008-10#2)(2013-1#1)
was evaluated with##26##3##(1990-5#1)(1990-7#1)(1993-1#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
was evaluated##510##2##(1990-11#2)(1990-3#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-7#2)(1997-8#1)(1997-9#1)(2006-12#1)(2007-10#3)(2007-11#7)(2007-2#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#210)(2008-11#14)(2008-12#7)(2008-2#8)(2008-3#6)(2008-5#27)(2008-6#7)(2008-7#10)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#8)(2011-2#15)(2011-3#2)(2012-1#7)(2012-12#9)(2012-2#9)(2012-3#13)(2013-1#22)(2013-7#1)(2013-8#8)
was evaporated to dryness##5##4##(2008-10#5)
was evaporated##9##2##(2008-10#7)(2008-11#1)(2008-5#1)
was even more##4##3##(2007-12#1)(2008-5#1)(2010-3#1)(2011-1#1)
was even##11##2##(1990-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-2#1)
was eventually diagnosed as##2##4##(2009-3#1)(2013-8#1)
was eventually##6##2##(2008-10#1)(2008-7#1)(2009-3#1)(2013-8#3)
was evidence of##5##3##(1992-5#1)(1995-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
was evidence that##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
was evidence##8##2##(1992-5#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
was evidenced by##6##3##(1996-12#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-4#1)
was evidenced in##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
was evidenced##15##2##(1990-8#1)(1993-3#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)
was evident at##3##3##(1994-3#1)(2008-8#1)(2011-2#1)
was evident by##2##3##(1997-3#1)(2012-1#1)
was evident for##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
was evident from the##3##4##(2008-10#1)(2013-1#2)
was evident from##5##3##(1994-6#1)(2008-10#1)(2008-7#1)(2013-1#2)
was evident in the##4##4##(1993-11#1)(1996-5#1)(2008-8#1)(2011-1#1)
was evident in##13##3##(1993-11#1)(1993-12#1)(1996-5#2)(1997-4#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#1)(2012-5#1)
was evident that the##2##4##(1993-12#1)(2008-10#1)
was evident that##3##3##(1993-12#1)(2007-5#1)(2008-10#1)
was evident##47##2##(1990-12#1)(1991-12#1)(1993-11#1)(1993-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-6#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#2)
was evoked##3##2##(1997-6#1)(2007-10#1)(2008-9#1)
was evolved##2##2##(2008-10#1)(2012-12#1)
was exacerbated by##2##3##(2008-10#1)(2011-10#1)
was examined among##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
was examined and an oral##2##5##(2008-5#2)
was examined and the##3##4##(1992-6#1)(1994-6#1)(2008-10#1)
was examined and##8##3##(1991-1#1)(1992-6#1)(1994-6#1)(2008-10#2)(2008-5#2)(2008-8#1)
was examined as a##5##4##(1994-5#1)(2008-10#2)(2010-1#1)(2012-2#1)
was examined as an##2##4##(2008-10#2)
was examined as##10##3##(1991-12#1)(1994-5#1)(2008-10#5)(2008-5#1)(2010-1#1)(2012-2#1)
was examined at##3##3##(1992-12#1)(2007-12#1)(2008-10#1)
was examined because of##2##4##(2011-2#1)(2012-3#1)
was examined because##3##3##(1994-5#1)(2011-2#1)(2012-3#1)
was examined by a##2##4##(1990-3#1)(1991-2#1)
was examined by immunohistochemistry##2##4##(1994-10#1)(1995-12#1)
was examined by measuring##3##4##(1992-11#1)(2008-10#1)(2008-11#1)
was examined by reverse##2##4##(1995-8#1)(2011-2#1)
was examined by using##4##4##(2008-10#2)(2008-7#1)(2009-12#1)
was examined by##46##3##(1990-3#1)(1991-2#1)(1992-11#1)(1993-3#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-12#2)(2009-7#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
was examined during##2##3##(2008-10#1)(2012-8#1)
was examined following##2##3##(1990-7#1)(1997-6#1)
was examined for its##4##4##(1992-5#1)(1995-2#1)(2007-11#1)(2008-10#1)
was examined for the##4##4##(1997-8#1)(2008-10#3)
was examined for##19##3##(1991-12#2)(1992-5#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
was examined in a sample of##2##6##(2008-11#1)(2011-2#1)
was examined in a##11##4##(1991-8#1)(1993-6#2)(1996-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-3#1)(2011-2#2)(2013-1#1)
was examined in adult##2##4##(1996-12#1)(1997-2#1)
was examined in cultured##2##4##(1990-8#1)(1994-6#1)
was examined in order to##2##5##(2008-10#2)
was examined in rat##2##4##(1993-3#1)(1993-6#1)
was examined in rats##3##4##(1992-11#1)(1994-5#1)(1995-12#1)
was examined in relation to##2##5##(2008-5#1)(2009-11#1)
was examined in the##12##4##(1990-5#1)(1991-5#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#2)(2010-8#1)
was examined in##70##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#3)(2009-11#1)(2009-3#1)(2010-7#1)(2010-8#4)(2011-2#3)(2013-1#1)
was examined on##9##3##(1993-12#1)(1995-3#1)(1997-2#1)(1997-5#1)(2007-5#1)(2008-10#3)(2008-6#1)
was examined to##6##3##(2008-10#3)(2008-5#1)(2010-8#2)
was examined using a##7##4##(1992-6#2)(1995-2#1)(2008-10#3)(2012-2#1)
was examined using an##3##4##(1991-9#1)(1992-3#1)(2011-2#1)
was examined using light##2##4##(2007-12#1)(2008-10#1)
was examined using the##2##4##(1990-2#1)(1992-12#1)
was examined using##34##3##(1990-2#2)(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-5#1)(2011-2#1)(2012-2#1)
was examined with the##3##4##(1995-5#1)(2008-10#1)(2009-10#1)
was examined with##5##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-3#1)(2009-10#1)
was examined##316##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#6)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#90)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#19)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-7#1)(2010-8#7)(2011-2#10)(2012-1#1)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#2)
was excellent in##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
was excellent with##2##3##(2008-10#2)
was excellent##22##2##(1991-8#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-8#1)(1996-9#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
was excised and##2##3##(2009-1#1)(2011-2#1)
was excised through##2##3##(2011-2#1)(2013-1#1)
was excised##10##2##(1992-12#1)(2007-8#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
was excited by##3##3##(1997-3#1)(2008-3#2)
was excited##5##2##(1997-3#1)(1997-7#1)(2008-3#3)
was excluded and##3##3##(1994-12#1)(2008-12#1)(2013-1#1)
was excluded by##2##3##(1991-6#1)(1995-2#1)
was excluded from the##2##4##(1994-7#1)(2008-10#1)
was excluded from##3##3##(1994-7#1)(1997-5#1)(2008-10#1)
was excluded##12##2##(1991-6#1)(1994-12#1)(1994-7#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)(2013-1#1)
was exclusively present in##2##4##(2008-10#1)(2009-8#1)
was exclusively##7##2##(1995-6#1)(2007-8#2)(2008-10#2)(2009-8#1)(2011-1#1)
was excreted##3##2##(1991-12#1)(1995-2#1)(1995-3#1)
was executed to##2##3##(2009-12#1)(2011-2#1)
was executed with##2##3##(1993-9#1)(2008-11#1)
was executed##7##2##(1993-9#1)(2007-8#1)(2008-11#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
was exhibited by##4##3##(2008-10#3)(2012-2#1)
was exhibited in##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
was exhibited##8##2##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
was expanded to include##2##4##(2008-10#1)(2012-2#1)
was expanded to##6##3##(2008-10#3)(2010-3#1)(2011-9#1)(2012-2#1)
was expanded##10##2##(1992-3#1)(1997-7#1)(2008-10#3)(2008-8#2)(2010-3#1)(2011-9#1)(2012-2#1)
was expected that##3##3##(1990-12#1)(2007-12#1)(2008-8#1)
was expected to be &lt##2##5##(2013-1#2)
was expected to be##4##4##(2008-10#1)(2013-1#3)
was expected to##8##3##(1997-4#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#3)
was expected##18##2##(1990-12#1)(1992-3#1)(1993-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)(2013-1#3)
was experienced in##2##3##(2007-9#1)(2012-2#1)
was experimentally demonstrated##3##3##(2008-3#3)
was experimentally determined to be##2##5##(2008-10#2)
was experimentally determined##4##3##(1994-3#1)(2008-10#2)(2011-2#1)
was experimentally investigated##2##3##(2007-11#1)(2008-2#1)
was experimentally##20##2##(1994-3#1)(1995-11#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
was explained by the##4##4##(1992-1#1)(1996-3#1)(2008-10#1)(2008-9#1)
was explained by##13##3##(1992-1#1)(1996-3#1)(2008-10#5)(2008-8#1)(2008-9#2)(2012-12#2)(2013-1#1)
was explained##18##2##(1992-1#1)(1996-3#1)(2008-10#9)(2008-12#1)(2008-8#1)(2008-9#2)(2012-12#2)(2013-1#1)
was explicitly##2##2##(2008-10#1)(2008-2#1)
was exploited for##2##3##(1992-11#1)(2008-10#1)
was exploited to enhance##2##4##(2007-11#1)(2008-7#1)
was exploited to##5##3##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
was exploited##8##2##(1992-11#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)
was explored as a##2##4##(2008-10#1)(2008-8#1)
was explored at the cellular level##2##6##(2008-10#2)
was explored by##3##3##(1995-8#1)(2008-10#2)
was explored in##4##3##(1990-12#1)(1996-6#1)(2008-3#1)(2009-10#1)
was explored using a##2##4##(1993-1#1)(2008-1#1)
was explored##26##2##(1990-12#1)(1993-1#1)(1993-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-5#1)(2013-1#1)
was exponentially##2##2##(1995-6#1)(2008-10#1)
was exposed directly onto##2##4##(2008-2#1)(2008-3#1)
was exposed to a##2##4##(1993-12#1)(2008-11#1)
was exposed to the##3##4##(1990-6#1)(2008-11#1)(2010-4#1)
was exposed to##18##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-12#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-11#2)(2010-4#1)(2010-5#1)(2012-6#1)
was exposed##23##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-12#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2010-4#1)(2010-5#1)(2012-6#1)
was expressed as a##4##4##(1992-6#1)(2008-10#2)(2008-11#1)
was expressed as the percentage of##2##6##(2006-6#1)(2008-10#1)
was expressed as the##4##4##(2006-6#1)(2008-10#2)(2008-5#1)
was expressed as##10##3##(1992-6#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-5#1)
was expressed at high levels##2##5##(1995-2#1)(1996-12#1)
was expressed at##4##3##(1995-2#1)(1996-12#1)(2008-10#1)(2008-8#1)
was expressed by a##2##4##(2008-10#1)(2008-11#1)
was expressed by all##2##4##(1993-3#1)(2008-7#1)
was expressed by the##3##4##(1993-3#1)(1994-12#1)(1996-5#1)
was expressed by##13##3##(1990-12#1)(1992-9#1)(1993-3#3)(1994-12#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#1)
was expressed from##3##3##(2007-7#1)(2012-3#2)
was expressed in E##2##4##(1991-9#1)(2008-9#1)
was expressed in Escherichia coli##6##5##(1990-11#2)(1991-12#1)(1993-8#1)(1995-2#1)(2009-3#1)
was expressed in a##3##4##(1994-8#1)(1995-5#1)(2008-10#1)
was expressed in all##2##4##(2008-6#1)(2010-5#1)
was expressed in the##8##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)
was expressed in transgenic##2##4##(2008-10#1)(2008-9#1)
was expressed in##46##3##(1990-11#2)(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-3#2)(2010-5#1)(2011-2#1)(2013-7#1)
was expressed inE##2##3##(2008-8#1)(2008-9#1)
was expressed on##2##3##(1990-7#1)(1992-8#1)
was expressed only in##2##4##(1992-8#1)(2008-5#1)
was expressed only##4##3##(1992-4#1)(1992-8#1)(1996-12#1)(2008-5#1)
was expressed under the control of##3##6##(1990-8#1)(1992-12#1)(1997-4#1)
was expressed##109##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#4)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#2)(1996-5#1)(1997-2#3)(1997-4#2)(1997-7#1)(2006-6#1)(2007-7#1)(2008-10#19)(2008-11#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#6)(2009-3#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
was extended by##3##3##(1997-4#1)(2008-10#2)
was extended for the##2##4##(2008-10#1)(2008-3#1)
was extended for##3##3##(2008-10#2)(2008-3#1)
was extended from##3##3##(2008-10#1)(2008-11#2)
was extended to##9##3##(1997-4#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#1)
was extended##25##2##(1997-4#2)(1997-8#3)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)
was extensive##3##2##(2008-10#2)(2008-9#1)
was extensively##6##2##(1992-1#1)(2008-10#2)(2008-2#1)(2010-11#1)(2013-1#1)
was extracted and##7##3##(1995-11#1)(1996-9#1)(1997-6#1)(2008-10#3)(2008-12#1)
was extracted by the##2##4##(2010-3#1)(2011-1#1)
was extracted by##6##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2011-1#2)
was extracted from soil##2##4##(2008-10#2)
was extracted from the blood##2##5##(2013-1#1)(2013-8#1)
was extracted from the##9##4##(1994-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#1)(2013-8#1)
was extracted from##36##3##(1991-2#2)(1991-4#1)(1992-9#1)(1994-2#1)(2006-8#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
was extracted in##3##3##(2008-10#3)
was extracted into the##3##4##(2008-10#3)
was extracted into##5##3##(2008-10#5)
was extracted quantitatively with 10 ml of##2##7##(2008-10#2)
was extracted to##3##3##(2008-10#2)(2009-6#1)
was extracted with TTCTOHA into octan-1-ol as##2##7##(2008-10#2)
was extracted with##12##3##(2008-10#7)(2008-11#2)(2008-5#1)(2011-1#1)(2012-2#1)
was extracted##87##2##(1991-2#2)(1991-4#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#45)(2008-11#3)(2008-12#6)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was extremely low##5##3##(1991-12#1)(2008-10#2)(2009-7#1)(2010-6#1)
was extremely##12##2##(1990-12#1)(1991-12#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-6#1)
was fabricated and##4##3##(2007-11#1)(2008-10#3)
was fabricated by a##2##4##(2008-3#2)
was fabricated by coating a##2##5##(2008-10#2)
was fabricated by coating##4##4##(2008-10#3)(2013-1#1)
was fabricated by##20##3##(1992-11#1)(2008-10#9)(2008-2#1)(2008-3#6)(2012-1#1)(2013-1#2)
was fabricated for##3##3##(2008-3#1)(2009-11#2)
was fabricated from a##2##4##(2008-10#1)(2008-2#1)
was fabricated from##3##3##(2008-10#2)(2008-2#1)
was fabricated on##2##3##(2008-10#1)(2008-3#1)
was fabricated to investigate the characteristics of each component##2##9##(2008-3#2)
was fabricated using##2##3##(2008-10#2)
was fabricated##44##2##(1992-11#1)(2007-11#1)(2007-12#2)(2008-10#21)(2008-2#3)(2008-3#11)(2009-11#2)(2012-1#1)(2013-1#2)
was faced with the##2##4##(1997-1#1)(2008-11#1)
was faced with##3##3##(1993-1#1)(1997-1#1)(2008-11#1)
was facilitated by the##2##4##(1990-11#1)(2008-10#1)
was facilitated by##4##3##(1990-11#1)(1991-7#1)(1995-12#1)(2008-10#1)
was facilitated##6##2##(1990-11#1)(1991-7#1)(1995-12#1)(1996-6#1)(2008-10#2)
was fair##4##2##(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#1)
was fairly##2##2##(2008-10#1)(2013-8#1)
was far below##2##3##(1997-4#1)(2008-10#1)
was far##6##2##(1992-5#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2009-10#1)
was fast and##3##3##(2008-10#3)
was fast##4##2##(2008-10#4)
was faster and##3##3##(1996-5#1)(2012-2#1)(2012-3#1)
was faster in the##3##4##(1991-5#1)(2008-11#1)(2008-8#1)
was faster in##6##3##(1991-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
was faster than that##3##4##(2008-10#3)
was faster than##4##3##(1994-1#1)(2008-10#3)
was faster##17##2##(1991-5#1)(1994-1#1)(1996-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#1)
was favorable##5##2##(2009-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
was favored by a high##2##5##(2013-1#2)
was favored by##5##3##(2008-10#3)(2013-1#2)
was favored##6##2##(2008-10#3)(2008-12#1)(2013-1#2)
was favourable with##3##3##(2008-5#1)(2010-12#1)(2011-1#1)
was favourable##5##2##(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)
was favoured##2##2##(1990-5#1)(2010-12#1)
was feasible##4##2##(2008-10#1)(2008-8#1)(2012-1#1)(2012-2#1)
was fed to##2##3##(2008-10#1)(2012-2#1)
was fed with a low-nutrition diet##2##6##(2011-2#2)
was fed with a normal diet##2##6##(2011-2#2)
was fed with a##5##4##(2011-2#5)
was fed##14##2##(1990-3#1)(1992-8#1)(1992-9#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#5)(2012-2#1)
was felt to have##2##4##(2008-1#1)(2008-7#1)
was felt to##3##3##(2008-1#1)(2008-7#1)(2009-5#1)
was felt##5##2##(2008-1#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)
was figured##2##2##(2008-3#1)(2011-3#1)
was filed by##2##3##(1995-12#1)(1996-12#1)
was filled in##2##3##(2008-5#1)(2013-1#1)
was filled with##9##3##(1991-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-3#1)(2013-1#2)
was filled##13##2##(1991-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2013-1#5)
was filtered##3##2##(2008-11#1)(2008-3#1)(2013-7#1)
was finally diagnosed##2##3##(1994-3#1)(2012-12#1)
was finally##14##2##(1994-3#1)(2006-10#1)(2007-8#2)(2008-10#7)(2010-8#1)(2011-2#1)(2012-12#1)
was finished with Amira 4##2##5##(2012-3#2)
was finished##4##2##(1995-3#1)(2008-10#1)(2012-3#2)
was fired##3##2##(1995-12#1)(1997-5#2)
was first applied to##2##4##(2008-10#2)
was first applied##3##3##(2008-10#3)
was first described by##2##4##(2011-1#1)(2011-2#1)
was first described in 1986##2##5##(2008-3#1)(2008-6#1)
was first described in the##2##5##(2008-10#1)(2012-2#1)
was first described in##11##4##(1990-12#1)(1996-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
was first described##18##3##(1990-12#1)(1992-2#1)(1996-3#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
was first detected at##2##4##(2008-10#1)(2009-6#1)
was first detected in the hemolymph##2##6##(2008-10#2)
was first detected in the##3##5##(2008-10#3)
was first detected in##6##4##(1997-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
was first detected##11##3##(1997-2#1)(2008-10#5)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
was first developed##2##3##(2008-10#1)(2008-11#1)
was first estimated##2##3##(2008-10#1)(2008-2#1)
was first found in##2##4##(2008-10#1)(2008-5#1)
was first identified as a##2##5##(1995-2#1)(2008-10#1)
was first identified in##3##4##(1995-6#1)(2008-10#1)(2013-7#1)
was first identified##5##3##(1995-2#1)(1995-6#1)(2008-10#2)(2013-7#1)
was first introduced##5##3##(1991-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
was first isolated##2##3##(1990-12#1)(2011-2#1)
was first noted##2##3##(1990-10#1)(2008-9#1)
was first observed in##3##4##(2008-10#3)
was first observed##5##3##(2008-10#5)
was first performed##2##3##(1994-2#1)(2008-10#1)
was first proposed##3##3##(2008-10#1)(2009-12#1)(2012-1#1)
was first recognized in the##2##5##(2008-10#1)(2012-1#1)
was first recognized##5##3##(1992-9#1)(1997-8#1)(2008-10#1)(2011-1#1)(2012-1#1)
was first reported in##5##4##(2008-10#4)(2008-12#1)
was first reported##7##3##(2008-10#4)(2008-12#1)(2008-9#1)(2013-1#1)
was first seen##3##3##(1996-12#1)(2008-8#1)(2011-2#1)
was first treated with##2##4##(2008-10#1)(2009-8#1)
was first used to##2##4##(2008-11#2)
was first used##4##3##(2008-10#2)(2008-11#2)
was first##119##2##(1990-10#1)(1990-12#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-10#48)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-3#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)
was firstly developed for the##2##5##(2008-10#2)
was firstly developed##3##3##(2008-10#3)
was firstly##13##2##(2007-10#1)(2008-10#9)(2008-9#1)(2011-2#1)(2013-8#1)
was fitted to##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
was fitted with##2##3##(1992-12#1)(2008-10#1)
was fitted##7##2##(1992-12#1)(2008-10#4)(2008-7#1)(2012-3#1)
was five##2##2##(2008-1#1)(2008-10#1)
was fixed at##3##3##(2008-10#2)(2008-5#1)
was fixed in a##2##4##(2008-10#2)
was fixed on##2##3##(2008-10#2)
was fixed##14##2##(2008-10#8)(2008-12#2)(2008-5#1)(2009-8#1)(2010-3#1)(2012-2#1)
was flat##2##2##(1991-2#1)(1997-2#1)
was flexed##4##2##(1995-3#1)(1997-8#3)
was focused##4##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
was followed at##2##3##(1993-1#1)(2008-10#1)
was followed by a reduction##2##5##(1992-4#1)(1993-3#1)
was followed by a significant increase in##2##7##(1994-3#1)(1997-6#1)
was followed by a significant##3##5##(1994-3#1)(1997-6#1)(2008-11#1)
was followed by a##18##4##(1990-11#1)(1990-2#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1997-6#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2013-1#1)
was followed by formation of##2##5##(2008-10#2)
was followed by the##3##4##(1994-11#1)(2008-8#1)(2012-2#1)
was followed by##48##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-7#2)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
was followed for##4##3##(1990-5#1)(2008-10#2)(2008-5#1)
was followed in the##2##4##(1992-5#1)(2008-10#1)
was followed in##5##3##(1992-5#1)(2008-10#3)(2013-1#1)
was followed over##2##3##(2008-10#2)
was followed to##3##3##(2008-10#2)(2008-12#1)
was followed up for##2##4##(2008-8#1)(2011-1#1)
was followed up##6##3##(2008-10#2)(2008-8#1)(2011-1#1)(2013-1#2)
was followed##78##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-7#2)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#5)(2013-8#2)
was for the first time##4##5##(2008-10#4)
was for the##5##3##(2008-10#5)
was for##13##2##(1992-2#1)(1993-11#1)(2008-10#8)(2008-12#1)(2008-7#1)(2012-1#1)
was forced to##2##3##(1992-1#1)(2008-10#1)
was forced##4##2##(1992-1#1)(2007-8#1)(2008-10#1)(2008-2#1)
was formed at the##5##4##(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)
was formed at##6##3##(1997-7#1)(2008-10#3)(2008-11#1)(2008-7#1)
was formed by a##2##4##(2008-10#1)(2011-2#1)
was formed by##13##3##(2007-12#3)(2008-10#5)(2008-12#1)(2008-9#1)(2011-2#2)(2012-1#1)
was formed in##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
was formed on a##2##4##(2008-10#2)
was formed to##6##3##(1994-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2013-1#1)
was formed with##4##3##(1993-11#1)(1995-11#1)(2007-11#1)(2008-7#1)
was formed##53##2##(1990-9#1)(1993-11#1)(1994-1#1)(1994-12#3)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-10#16)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
was formulated and##4##3##(2008-11#1)(2008-2#1)(2008-5#2)
was formulated as##2##3##(1996-8#1)(2008-5#1)
was formulated to##3##3##(1994-12#1)(2008-7#1)(2012-2#1)
was formulated##12##2##(1994-12#1)(1996-8#1)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#2)(2012-2#1)(2012-3#1)
was found after##5##3##(1993-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
was found among the##4##4##(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)
was found among##13##3##(1993-6#1)(1994-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
was found and##6##3##(1994-5#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#2)
was found around##2##3##(2008-10#1)(2008-9#1)
was found as 0##2##4##(2008-10#2)
was found as##8##3##(2008-10#7)(2011-1#1)
was found at all##2##4##(1992-8#1)(1996-12#1)
was found at low##2##4##(1991-9#1)(2008-10#1)
was found at the##7##4##(1995-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-9#1)(2012-12#1)
was found at##24##3##(1990-3#1)(1990-5#1)(1991-9#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
was found between groups##2##4##(2008-12#1)(2009-2#1)
was found between methods##2##4##(2008-10#1)(2008-6#1)
was found between the determined##2##5##(2008-10#2)
was found between the level of##2##6##(1992-2#1)(2012-12#1)
was found between the number of##2##6##(1995-12#1)(2011-2#1)
was found between the presence of##2##6##(1994-7#1)(2008-5#1)
was found between the two groups##2##6##(2010-12#1)(2013-1#1)
was found between the two##5##5##(1994-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#1)
was found between the##61##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
was found between these##2##4##(1990-3#1)(2008-2#1)
was found between##141##3##(1990-12#3)(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#3)(1994-11#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#33)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#10)(2012-12#2)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#2)
was found both in##2##4##(1995-11#1)(2008-9#1)
was found both##3##3##(1993-12#1)(1995-11#1)(2008-9#1)
was found by using##3##4##(2008-10#2)(2008-8#1)
was found by##17##3##(1990-6#1)(1993-12#1)(1997-7#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
was found dead##2##3##(1995-11#1)(1995-3#1)
was found due to##2##4##(1996-2#2)
was found during##5##3##(1990-3#1)(1990-5#1)(1992-6#1)(2008-11#1)(2008-6#1)
was found experimentally to be##2##5##(2008-3#1)(2008-5#1)
was found for complete blood##2##5##(2008-10#2)
was found for professional##2##4##(1992-3#1)(2011-2#1)
was found for the##12##4##(1995-5#1)(1996-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
was found for##43##3##(1990-12#1)(1992-11#1)(1992-3#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-6#5)(2008-10#12)(2008-12#1)(2008-3#1)(2008-7#3)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#2)
was found from the##3##4##(2008-10#3)
was found from##5##3##(2008-10#3)(2008-2#1)(2012-12#1)
was found in &gt##2##4##(2008-10#1)(2008-7#1)
was found in 11##3##4##(2007-11#1)(2008-1#1)(2008-4#1)
was found in 14##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
was found in 20##2##4##(2008-6#1)(2013-1#1)
was found in 3##2##4##(2007-11#1)(2008-9#1)
was found in 4##4##4##(2007-11#1)(2008-4#1)(2011-2#2)
was found in 5 cases##2##5##(1993-2#1)(2007-8#1)
was found in 6##2##4##(2008-1#1)(2011-1#1)
was found in C57BL/10 mice##2##5##(1990-3#2)
was found in a##11##4##(1990-11#2)(1990-3#1)(1991-10#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
was found in all of the##2##6##(2008-11#1)(2008-5#1)
was found in all the##2##5##(1993-2#1)(2008-10#1)
was found in all##16##4##(1990-7#1)(1991-8#1)(1993-2#1)(1997-9#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#2)(2010-11#1)(2012-3#1)(2013-8#1)
was found in an##2##4##(1995-11#1)(2008-10#1)
was found in any of the##3##6##(1991-8#1)(2008-7#1)(2010-8#1)
was found in any##4##4##(1991-8#1)(1996-12#1)(2008-7#1)(2010-8#1)
was found in both##4##4##(1990-12#1)(1993-2#1)(1997-6#1)(2011-2#1)
was found in children##2##4##(2008-10#1)(2008-12#1)
was found in most##2##4##(1991-2#1)(2011-2#1)
was found in only##2##4##(2008-1#1)(2011-2#1)
was found in patients##3##4##(2007-11#2)(2008-7#1)
was found in some##2##4##(2008-10#1)(2013-1#1)
was found in the central##2##5##(1993-11#1)(2007-1#1)
was found in the medial##2##5##(1990-9#1)(1997-4#1)
was found in the number of##2##6##(2008-5#1)(2008-9#1)
was found in the range##3##5##(2008-10#2)(2011-2#1)
was found in the right##2##5##(2006-10#1)(2011-1#1)
was found in the##76##4##(1990-3#1)(1990-9#1)(1991-6#2)(1992-3#2)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-6#1)(1994-7#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was found in this study##2##5##(2008-5#1)(2012-2#1)
was found in this##4##4##(1994-12#1)(2008-5#1)(2008-6#1)(2012-2#1)
was found in three##4##4##(2008-7#2)(2010-4#2)
was found in two##2##4##(2008-10#2)
was found in##293##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#4)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#7)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#6)(1996-2#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-9#1)(2006-10#1)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#7)(2008-10#43)(2008-11#12)(2008-12#9)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#15)(2008-8#2)(2008-9#8)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#15)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#6)
was found mainly in the##2##5##(2008-7#1)(2008-8#1)
was found mainly on Phaeophyta followed by##2##7##(2008-5#2)
was found mainly##4##3##(2008-5#2)(2008-7#1)(2008-8#1)
was found more##3##3##(1993-9#1)(2008-10#1)(2008-5#1)
was found most##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
was found not##2##3##(1993-12#1)(2008-4#1)
was found of##2##3##(1990-2#1)(1994-8#1)
was found on follow-up##2##4##(1996-6#1)(2007-11#1)
was found on the##5##4##(1994-6#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
was found on##17##3##(1990-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
was found only in the##2##5##(1997-3#1)(2008-11#1)
was found only in two##2##5##(1991-2#1)(2008-8#1)
was found only in##12##4##(1990-8#1)(1991-2#1)(1994-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#1)
was found only##14##3##(1990-8#1)(1991-2#1)(1994-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#2)
was found showing##2##3##(1995-11#1)(2013-1#1)
was found significantly higher than##2##5##(2007-8#1)(2008-12#1)
was found significantly##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
was found suitable for##2##4##(2008-11#1)(2008-12#1)
was found that a##5##4##(1992-1#1)(1997-6#1)(2007-11#1)(2008-12#1)(2011-1#1)
was found that all##2##4##(2008-12#1)(2008-7#1)
was found that at the##2##5##(1991-5#1)(1993-11#1)
was found that at##5##4##(1991-5#1)(1993-11#1)(1994-3#1)(2007-12#1)(2008-10#1)
was found that both the##2##5##(2008-10#2)
was found that both##4##4##(2008-10#2)(2008-11#1)(2010-5#1)
was found that exposure to##2##5##(2007-12#1)(2010-5#1)
was found that for##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
was found that in the presence of##3##7##(1993-8#1)(2008-10#2)
was found that in the##5##5##(1993-8#1)(1994-8#1)(2008-10#3)
was found that in##7##4##(1993-1#1)(1993-8#1)(1994-8#1)(2008-10#3)(2011-1#1)
was found that the distribution of##2##6##(2008-8#2)
was found that the lower##2##5##(2007-11#1)(2008-2#1)
was found that the##138##4##(1990-10#1)(1990-8#2)(1991-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#6)(2007-12#1)(2008-10#54)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#8)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#1)(2009-11#1)(2009-6#2)(2009-7#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#3)
was found that their##2##4##(2008-10#2)
was found that there were##3##5##(1993-2#1)(2008-10#1)(2013-1#1)
was found that there##6##4##(1993-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)
was found that this##6##4##(1995-3#1)(2008-10#2)(2008-3#2)(2013-1#1)
was found that three##2##4##(2008-10#1)(2008-11#1)
was found that while##2##4##(2008-5#1)(2009-11#1)
was found that##338##3##(1990-10#1)(1990-12#3)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#10)(2007-12#5)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#106)(2008-11#13)(2008-12#11)(2008-2#10)(2008-3#20)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#17)(2008-9#2)(2009-1#1)(2009-11#3)(2009-12#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-1#2)(2010-2#3)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#9)(2013-8#4)
was found the most##2##4##(2008-12#1)(2008-7#1)
was found the##3##3##(2008-12#1)(2008-7#1)(2013-7#1)
was found through the##2##4##(2008-10#2)
was found to accumulate##2##4##(2008-10#1)(2008-6#1)
was found to affect##2##4##(2008-10#1)(2008-7#1)
was found to afford##2##4##(2007-11#1)(2008-11#1)
was found to be &gt##2##5##(2007-7#1)(2008-10#1)
was found to be 0##17##5##(1990-6#1)(2008-10#14)(2010-3#1)(2011-1#1)
was found to be 1##13##5##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2010-3#1)
was found to be 10##2##5##(1997-4#1)(2008-10#1)
was found to be 2##12##5##(1996-5#1)(2008-10#9)(2008-2#2)
was found to be 3##4##5##(1990-12#1)(2008-10#2)(2008-3#1)
was found to be 4##6##5##(1995-12#1)(2008-10#4)(2012-3#1)
was found to be 5##2##5##(2008-10#2)
was found to be 6##2##5##(1992-2#1)(2008-10#1)
was found to be 7##3##5##(1991-5#1)(2008-10#2)
was found to be a major##2##6##(1990-7#1)(2008-4#1)
was found to be a more##2##6##(2008-10#2)
was found to be a potent##2##6##(1991-5#1)(1997-4#1)
was found to be a safe##2##6##(1990-11#1)(2010-7#1)
was found to be a significant##2##6##(2008-6#1)(2009-7#1)
was found to be a useful##2##6##(2007-11#1)(2008-10#1)
was found to be a viable##2##6##(2008-10#1)(2013-1#1)
was found to be a##43##5##(1990-11#3)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
was found to be about##2##5##(1994-8#1)(2011-2#1)
was found to be acceptable##2##5##(2007-12#1)(2011-2#1)
was found to be active##2##5##(2008-11#1)(2010-2#1)
was found to be an efficient##3##6##(1991-12#1)(2007-12#1)(2012-2#1)
was found to be an##8##5##(1991-12#1)(1992-2#1)(1995-4#1)(2007-12#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
was found to be approximately##5##5##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
was found to be associated with##6##6##(1993-11#1)(1993-3#1)(1997-6#1)(2008-1#1)(2012-12#1)(2013-1#1)
was found to be at##2##5##(2008-2#1)(2008-3#1)
was found to be best##2##5##(1996-5#1)(2007-7#1)
was found to be better than##2##6##(2008-10#1)(2012-1#1)
was found to be better##4##5##(2008-10#3)(2012-1#1)
was found to be between##7##5##(1991-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)
was found to be close to##4##6##(2008-10#2)(2008-9#1)(2012-12#1)
was found to be closely related to##2##7##(2008-10#1)(2008-8#1)
was found to be comparable##2##5##(2008-10#2)
was found to be dependent on the##3##7##(1991-3#1)(2008-10#1)(2010-5#1)
was found to be dependent on##5##6##(1991-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
was found to be dependent##6##5##(1991-3#1)(1993-8#1)(2008-10#2)(2008-11#1)(2010-5#1)
was found to be different##2##5##(1993-11#1)(2012-2#1)
was found to be due to the##2##7##(1990-12#1)(2008-9#1)
was found to be due to##7##6##(1990-12#1)(1993-11#1)(1993-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-2#1)
was found to be effective for##2##6##(2008-7#1)(2012-2#1)
was found to be effective in##2##6##(2007-7#1)(2013-1#1)
was found to be effective##5##5##(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
was found to be essential for##2##6##(1995-2#1)(2007-11#1)
was found to be expressed##3##5##(1991-6#1)(2008-10#1)(2008-11#1)
was found to be followed##2##5##(2008-10#2)
was found to be greater##3##5##(1990-12#1)(1993-12#1)(1993-6#1)
was found to be growth##2##5##(1994-5#1)(2008-11#1)
was found to be higher than##2##6##(2008-11#2)
was found to be higher##4##5##(1990-7#1)(2008-11#3)
was found to be highly##10##5##(1990-11#1)(1992-12#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-6#1)(2011-1#1)
was found to be identical to##2##6##(2008-10#2)
was found to be impaired##2##5##(1990-11#1)(1995-5#1)
was found to be important##2##5##(1993-12#1)(2008-4#1)
was found to be improved##2##5##(2009-3#2)
was found to be in the range of##3##8##(2008-10#3)
was found to be in##6##5##(1992-11#1)(2007-11#1)(2008-10#4)
was found to be independent of the##2##7##(2007-12#1)(2008-10#1)
was found to be independent##3##5##(1990-12#1)(2007-12#1)(2008-10#1)
was found to be independently##2##5##(1992-9#1)(1995-8#1)
was found to be influenced by##2##6##(1994-5#1)(2008-11#1)
was found to be influenced##3##5##(1994-5#1)(2008-11#1)(2011-1#1)
was found to be insensitive to##3##6##(2008-10#2)(2008-3#1)
was found to be involved in##2##6##(2008-10#1)(2010-4#1)
was found to be less than 0##2##7##(2008-10#2)
was found to be less than##3##6##(2008-10#3)
was found to be less##4##5##(2008-10#3)(2008-9#1)
was found to be linear in the range of##2##9##(2008-10#2)
was found to be linear##6##5##(2008-10#5)(2012-2#1)
was found to be linearly##2##5##(2008-10#1)(2008-7#1)
was found to be low##2##5##(2008-7#1)(2010-5#1)
was found to be lower##2##5##(2011-2#2)
was found to be mainly##3##5##(1990-12#1)(2008-4#1)(2008-5#1)
was found to be mediated by##3##6##(2008-10#1)(2008-11#1)(2008-2#1)
was found to be mediated##4##5##(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
was found to be more effective##3##6##(2008-10#1)(2008-7#1)(2012-2#1)
was found to be more sensitive than##2##7##(1990-12#1)(2012-1#1)
was found to be more sensitive##3##6##(1990-12#2)(2012-1#1)
was found to be more##19##5##(1990-12#2)(1990-6#1)(1992-11#1)(1992-8#1)(1995-3#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
was found to be most##2##5##(2008-10#1)(2013-8#1)
was found to be much higher than##2##7##(2008-7#1)(2009-7#1)
was found to be much##6##5##(1991-9#1)(1995-3#1)(2008-10#2)(2008-7#1)(2009-7#1)
was found to be nearly##2##5##(1996-8#1)(2008-2#1)
was found to be necessary##2##5##(1990-8#1)(2008-10#1)
was found to be negligible##2##5##(2008-10#2)
was found to be of##2##5##(1994-2#1)(2008-10#1)
was found to be only##2##5##(2007-12#1)(2008-10#1)
was found to be partially##2##5##(1993-9#1)(2013-1#1)
was found to be positive for##2##6##(2007-7#1)(2013-1#1)
was found to be positive##4##5##(2007-7#2)(2010-8#1)(2013-1#1)
was found to be preferable##3##5##(2008-10#2)(2008-11#1)
was found to be present in##2##6##(2008-1#1)(2008-12#1)
was found to be present##3##5##(2008-1#1)(2008-10#1)(2008-12#1)
was found to be protective##2##5##(2008-12#1)(2013-1#1)
was found to be quite##2##5##(2008-10#2)
was found to be related to##2##6##(1992-9#1)(2008-10#1)
was found to be safe and##2##6##(1992-8#1)(2008-11#1)
was found to be significant##3##5##(1993-9#1)(2008-10#1)(2008-9#1)
was found to be significantly associated with##2##7##(2007-12#1)(2008-8#1)
was found to be significantly correlated with##2##7##(1994-3#1)(2008-5#1)
was found to be significantly higher##2##6##(1994-8#1)(2008-10#1)
was found to be significantly lower in##2##7##(2008-10#1)(2013-7#1)
was found to be significantly lower##3##6##(2008-10#1)(2013-7#1)(2013-8#1)
was found to be significantly##17##5##(1994-3#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
was found to be similar to##2##6##(1990-2#1)(1993-9#1)
was found to be slightly##2##5##(1990-12#1)(1993-2#1)
was found to be specific##2##5##(1992-3#1)(2008-10#1)
was found to be statistically##3##5##(1990-2#2)(2011-2#1)
was found to be strongly##3##5##(2008-10#1)(2008-7#1)(2009-11#1)
was found to be suitable for the determination of##2##9##(2008-10#2)
was found to be suitable for the##4##7##(2008-10#3)(2011-1#1)
was found to be suitable for##5##6##(2008-10#4)(2011-1#1)
was found to be suitable##6##5##(2008-10#5)(2011-1#1)
was found to be superior to the##2##7##(1996-2#1)(2008-10#1)
was found to be superior##4##5##(1996-2#1)(2008-10#2)(2010-8#1)
was found to be the best##4##6##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
was found to be the major##4##6##(2008-10#4)
was found to be the most common##2##7##(2008-9#1)(2011-2#1)
was found to be the most effective##2##7##(2008-10#1)(2009-5#1)
was found to be the most sensitive##2##7##(2008-10#1)(2008-12#1)
was found to be the most significant##2##7##(2008-9#1)(2010-3#1)
was found to be the most suitable##2##7##(2008-10#1)(2012-2#1)
was found to be the most##17##6##(1992-1#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
was found to be the##32##5##(1991-6#1)(1992-1#1)(1996-9#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#1)(2011-2#3)(2012-2#1)(2013-7#1)
was found to be useful##2##5##(2008-10#1)(2008-9#1)
was found to be very sensitive to##2##7##(1990-5#1)(2013-8#1)
was found to be very##11##5##(1990-5#1)(1992-12#1)(1997-4#1)(2008-10#3)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
was found to be within##2##5##(2008-10#1)(2013-1#1)
was found to be##605##4##(1990-11#8)(1990-12#9)(1990-2#6)(1990-5#4)(1990-6#3)(1990-7#6)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#5)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#6)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#8)(1997-6#2)(1997-8#1)(2007-11#6)(2007-12#7)(2007-7#8)(2007-8#3)(2008-1#3)(2008-10#222)(2008-11#24)(2008-12#6)(2008-2#10)(2008-3#9)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#15)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#13)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#4)(2013-1#12)(2013-7#2)(2013-8#4)
was found to bind##2##4##(2008-10#1)(2012-2#1)
was found to consist of##2##5##(1991-10#1)(1993-6#1)
was found to contain##10##4##(1990-5#1)(1990-7#1)(1991-1#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(2008-5#1)(2011-2#1)(2013-1#1)
was found to correlate with the##2##6##(1992-6#1)(2008-3#1)
was found to correlate with##4##5##(1992-6#1)(1994-2#1)(2008-3#1)(2013-7#1)
was found to correlate##5##4##(1992-6#1)(1994-2#1)(2008-3#1)(2008-9#1)(2013-7#1)
was found to cross-link##3##4##(1993-11#3)
was found to decrease the rate of##2##7##(2010-4#1)(2011-1#1)
was found to decrease the##6##5##(1997-2#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
was found to decrease##11##4##(1990-2#1)(1990-5#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
was found to degrade##2##4##(2008-10#1)(2012-12#1)
was found to depend on the##3##6##(2008-10#1)(2008-7#1)(2011-1#1)
was found to depend on##4##5##(2008-10#2)(2008-7#1)(2011-1#1)
was found to depend strongly on##3##6##(2007-11#1)(2008-11#1)(2008-3#1)
was found to depend##8##4##(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
was found to display##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
was found to effectively##2##4##(2008-10#1)(2013-1#1)
was found to enhance the##4##5##(1993-12#1)(2008-10#1)(2008-11#1)(2009-11#1)
was found to exist between peak height and the concentration of the##2##12##(2008-10#2)
was found to exist##4##4##(1992-3#1)(2008-10#3)
was found to follow##2##4##(2008-10#1)(2008-4#1)
was found to form##2##4##(1995-8#1)(2009-11#1)
was found to give satisfactory results##2##6##(2008-10#2)
was found to give the##2##5##(2008-10#1)(2008-11#1)
was found to give##10##4##(2008-10#9)(2008-11#1)
was found to have a high##2##6##(2008-10#1)(2013-7#1)
was found to have a highly##2##6##(2008-10#1)(2008-11#1)
was found to have a significant##2##6##(2007-8#1)(2008-3#1)
was found to have a##28##5##(1992-5#1)(1992-6#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1997-6#1)(1997-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2011-2#1)(2013-7#1)
was found to have an##8##5##(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-7#1)
was found to have no##2##5##(1992-12#1)(2012-2#1)
was found to have significantly##2##5##(2008-2#1)(2008-3#1)
was found to have the following##2##6##(1991-12#1)(1993-3#1)
was found to have the##4##5##(1991-12#1)(1991-8#1)(1993-3#1)(2008-10#1)
was found to have two##2##5##(1997-6#1)(2008-7#1)
was found to have##72##4##(1990-6#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#6)(2009-11#1)(2009-3#3)(2009-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
was found to increase with increasing##2##6##(1995-6#1)(2008-7#1)
was found to increase with the##2##6##(2008-10#1)(2008-8#1)
was found to increase with##4##5##(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
was found to increase##13##4##(1992-8#1)(1994-3#1)(1994-6#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)
was found to induce##9##4##(1990-5#1)(1991-2#2)(1991-9#1)(1993-6#1)(1994-9#1)(2008-10#2)(2012-2#1)
was found to inhibit the##3##5##(1990-7#1)(1994-5#1)(2008-10#1)
was found to inhibit##10##4##(1990-7#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-5#2)(1995-12#1)(2008-10#1)(2008-11#1)
was found to interfere##2##4##(2008-10#2)
was found to mediate##2##4##(1992-3#1)(2009-10#1)
was found to obey##2##4##(2008-10#2)
was found to occur with##2##5##(1990-11#2)
was found to occur##4##4##(1990-11#2)(2007-11#1)(2008-10#1)
was found to produce a##2##5##(2008-10#2)
was found to produce##7##4##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)
was found to provide##4##4##(2008-10#3)(2008-3#1)
was found to range from##2##5##(1994-8#1)(2008-9#1)
was found to reduce the##2##5##(1993-2#1)(2008-10#1)
was found to reduce##3##4##(1993-2#1)(1995-5#1)(2008-10#1)
was found to result from the##2##6##(1990-2#1)(2008-7#1)
was found to result from##3##5##(1990-2#1)(1991-9#1)(2008-7#1)
was found to result##4##4##(1990-2#1)(1991-9#1)(1992-3#1)(2008-7#1)
was found to share##2##4##(1995-6#1)(1997-6#1)
was found to significantly##4##4##(1990-12#1)(1995-3#1)(2008-10#1)(2008-9#1)
was found to strongly##2##4##(1990-11#1)(1995-6#1)
was found to support##3##4##(2008-10#1)(2008-11#2)
was found to take##2##4##(2008-10#1)(2008-7#1)
was found to vary from##2##5##(1992-11#1)(1992-3#1)
was found to vary significantly##2##5##(2008-10#1)(2009-7#1)
was found to vary##4##4##(1992-11#1)(1992-3#1)(2008-10#1)(2009-7#1)
was found to yield##3##4##(1997-3#1)(2008-2#2)
was found to##914##3##(1990-11#12)(1990-12#10)(1990-2#8)(1990-5#8)(1990-6#4)(1990-7#8)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#8)(1992-5#2)(1992-6#5)(1992-8#7)(1992-9#5)(1993-11#7)(1993-12#6)(1993-2#5)(1993-3#3)(1993-6#7)(1993-8#2)(1993-9#6)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#6)(1994-6#5)(1994-8#5)(1994-9#2)(1995-11#4)(1995-12#9)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#8)(1997-6#5)(1997-7#2)(1997-8#2)(2007-11#11)(2007-12#8)(2007-6#1)(2007-7#10)(2007-8#6)(2008-1#6)(2008-10#296)(2008-11#45)(2008-12#11)(2008-2#15)(2008-3#19)(2008-4#6)(2008-5#12)(2008-6#10)(2008-7#29)(2008-8#13)(2008-9#11)(2009-10#3)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#8)(2009-5#1)(2009-6#1)(2009-7#11)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#3)(2011-1#13)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#15)(2012-3#5)(2013-1#15)(2013-7#4)(2013-8#8)
was found using##4##3##(1992-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
was found when the##4##4##(1994-3#2)(2008-10#1)(2008-3#1)
was found when##11##3##(1994-3#2)(1996-2#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#2)
was found which is##2##4##(2008-10#2)
was found which##4##3##(1990-11#1)(1990-12#1)(2008-10#2)
was found with a##3##4##(2007-11#1)(2013-1#2)
was found with an##3##4##(1991-12#1)(1992-3#1)(2008-10#1)
was found with other##2##4##(1990-2#1)(2008-10#1)
was found with the##4##4##(1992-2#1)(1993-9#1)(2008-10#1)(2008-2#1)
was found with##30##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-6#2)(1993-9#1)(1994-5#1)(2007-11#1)(2008-10#5)(2008-12#3)(2008-2#2)(2008-7#4)(2011-2#2)(2012-12#1)(2013-1#2)
was found within a##2##4##(1992-9#1)(2008-10#1)
was found within and##2##4##(2008-10#2)
was found within the##2##4##(2008-10#2)
was found within##7##3##(1992-9#1)(2008-10#6)
was found##2154##2##(1990-10#1)(1990-11#19)(1990-12#20)(1990-2#12)(1990-3#8)(1990-5#14)(1990-6#7)(1990-7#11)(1990-8#8)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#6)(1991-12#9)(1991-2#10)(1991-3#1)(1991-5#7)(1991-6#7)(1991-7#2)(1991-8#6)(1991-9#12)(1992-1#2)(1992-10#1)(1992-11#8)(1992-12#12)(1992-2#6)(1992-3#15)(1992-4#2)(1992-5#3)(1992-6#11)(1992-8#9)(1992-9#11)(1993-1#2)(1993-10#1)(1993-11#11)(1993-12#25)(1993-2#13)(1993-3#5)(1993-6#11)(1993-8#7)(1993-9#12)(1994-1#3)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#5)(1994-3#9)(1994-5#13)(1994-6#10)(1994-7#4)(1994-8#11)(1994-9#4)(1995-11#12)(1995-12#14)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#6)(1995-6#7)(1995-8#9)(1996-11#1)(1996-12#12)(1996-2#10)(1996-3#4)(1996-5#9)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#10)(1997-4#12)(1997-5#3)(1997-6#9)(1997-7#8)(1997-8#4)(1997-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#10)(2007-11#44)(2007-12#22)(2007-5#2)(2007-6#7)(2007-7#17)(2007-8#15)(2008-1#16)(2008-10#600)(2008-11#86)(2008-12#48)(2008-2#35)(2008-3#55)(2008-4#13)(2008-5#51)(2008-6#24)(2008-7#84)(2008-8#42)(2008-9#28)(2009-1#3)(2009-10#4)(2009-11#10)(2009-12#3)(2009-2#2)(2009-3#11)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#18)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#7)(2010-3#7)(2010-4#10)(2010-5#9)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#32)(2011-2#67)(2011-3#3)(2012-1#5)(2012-12#17)(2012-2#29)(2012-3#13)(2012-6#1)(2013-1#51)(2013-7#9)(2013-8#31)
was founded by##2##3##(1993-2#1)(2008-10#1)
was founded in##4##3##(2008-11#1)(2010-3#1)(2011-2#1)(2012-1#1)
was founded##8##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)(2011-4#1)(2012-1#1)
was four##6##2##(1990-9#1)(1992-4#1)(1992-5#1)(2008-10#2)(2011-2#1)
was fractionated on##4##3##(1990-5#1)(1991-5#1)(1992-12#1)(2011-2#1)
was fractionated##7##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-8#1)(2008-12#1)(2011-2#1)
was free from##8##3##(1991-12#1)(1992-6#1)(2008-10#5)(2013-8#1)
was free of##6##3##(1991-8#1)(1992-9#1)(1994-8#1)(2009-1#1)(2011-2#2)
was free##14##2##(1991-12#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-8#1)(2008-10#5)(2009-1#1)(2011-2#2)(2013-8#1)
was freely##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
was frequency##2##2##(2008-10#1)(2008-2#1)
was frequent in##2##3##(2008-10#1)(2008-7#1)
was frequent##3##2##(2008-10#1)(2008-7#2)
was frequently observed##2##3##(1992-6#1)(2013-1#1)
was frequently##9##2##(1992-6#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#2)
was from 0##3##3##(2008-10#3)
was from 1##6##3##(2008-10#6)
was from 3 to##2##4##(2008-10#1)(2008-7#1)
was from 3##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
was from 5##4##3##(2008-10#3)(2011-2#1)
was from the##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
was from##43##2##(1990-2#1)(1992-1#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#25)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
was full##2##2##(1994-3#1)(2008-3#1)
was fully active##2##3##(1993-9#1)(2008-7#1)
was fully automated##2##3##(1993-9#1)(2008-10#1)
was fully##15##2##(1990-5#1)(1990-8#1)(1993-8#1)(1993-9#2)(1995-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-3#1)
was functional##2##2##(2008-10#2)
was functionalized##2##2##(2008-10#2)
was functionally##3##2##(1994-8#1)(1997-4#1)(2008-8#1)
was funded by the##2##4##(2008-10#1)(2012-2#1)
was funded by##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
was funded##5##2##(1993-3#1)(1995-3#1)(2008-1#1)(2008-10#1)(2012-2#1)
was further applied to##2##4##(2008-10#2)
was further characterized##3##3##(1990-5#2)(1994-11#1)
was further confirmed by##4##4##(1990-12#1)(1997-2#1)(2008-8#1)(2011-2#1)
was further converted##2##3##(1992-11#1)(2010-5#1)
was further demonstrated by##2##4##(1995-12#1)(2008-5#1)
was further demonstrated##5##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)
was further enhanced by##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
was further enhanced##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
was further evaluated##2##3##(1995-3#1)(2012-12#1)
was further examined##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
was further improved##2##3##(2007-11#1)(2008-9#1)
was further inhibited by##2##4##(1992-3#1)(1996-5#1)
was further investigated by##2##4##(1990-11#1)(1995-5#1)
was further investigated##3##3##(1990-11#1)(1995-5#1)(2008-1#1)
was further reduced##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
was further studied##2##3##(2008-10#1)(2008-11#1)
was further supported by the##3##5##(1995-6#1)(2008-10#1)(2012-2#1)
was further supported by##4##4##(1995-6#1)(2008-10#2)(2012-2#1)
was further supported##5##3##(1995-6#1)(2008-10#2)(2012-2#1)(2012-3#1)
was further tested##2##3##(2008-10#1)(2011-1#1)
was further treated##2##3##(2007-11#1)(2007-2#1)
was further used##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
was further validated by##4##4##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
was further validated##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
was further##86##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#1)(1992-11#1)(1992-3#2)(1993-11#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#6)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
was fused to##2##3##(1990-11#1)(1991-5#1)
was fused with##3##3##(1995-11#1)(1997-6#1)(2008-10#1)
was fused##9##2##(1990-11#1)(1991-5#1)(1991-7#1)(1995-11#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
was gained##3##2##(1990-12#1)(1991-6#1)(2009-10#1)
was gathered##3##2##(1992-1#1)(2010-6#1)(2011-2#1)
was generalized##2##2##(2008-10#1)(2008-2#1)
was generally good##2##3##(1991-6#1)(2008-7#1)
was generally higher##2##3##(2008-10#1)(2008-12#1)
was generally mild##2##3##(1990-2#1)(2008-6#1)
was generally poor##3##3##(2008-1#1)(2008-10#1)(2009-4#1)
was generally##40##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1994-3#1)(1995-3#1)(1997-4#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#2)(2010-2#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
was generated and##2##3##(1995-12#1)(2008-2#1)
was generated at a##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
was generated by the##2##4##(2008-10#1)(2011-1#1)
was generated by##16##3##(1990-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2013-8#1)
was generated for the##2##4##(2008-10#1)(2013-7#1)
was generated from##9##3##(1992-8#1)(1994-11#1)(2008-10#4)(2008-2#1)(2008-3#2)
was generated in a##2##4##(2007-11#1)(2008-10#1)
was generated in rabbits##2##4##(1997-4#1)(2008-10#1)
was generated in##7##3##(1992-8#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2013-8#1)
was generated using##3##3##(1991-9#1)(1997-4#1)(2008-2#1)
was generated with##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-8#1)
was generated##60##2##(1990-11#1)(1991-9#1)(1992-8#2)(1994-11#1)(1995-12#1)(1997-4#2)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#9)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
was genetic##3##2##(2007-10#1)(2008-10#1)(2008-9#1)
was genetically mapped##2##3##(2008-9#2)
was genetically##5##2##(1997-6#1)(2008-10#1)(2008-9#2)(2010-2#1)
was genotyped##2##2##(1997-5#1)(2008-10#1)
was given an##2##3##(2008-1#1)(2008-10#1)
was given as a##4##4##(1992-9#1)(1995-6#1)(2007-8#1)(2008-6#1)
was given as##7##3##(1991-6#1)(1992-9#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)
was given at##2##3##(1994-8#1)(2013-1#1)
was given by the##5##4##(2007-8#1)(2008-10#3)(2008-6#1)
was given during##2##3##(1992-9#1)(2011-2#1)
was given for the##2##4##(1994-11#1)(2007-8#1)
was given for##4##3##(1994-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
was given i##2##3##(1990-12#1)(2008-7#1)
was given in a##3##4##(1997-7#1)(2007-7#1)(2013-8#1)
was given in##9##3##(1990-10#1)(1991-8#1)(1993-3#1)(1993-6#1)(1995-3#1)(1997-7#1)(2007-7#1)(2011-1#1)(2013-8#1)
was given intravenously##2##3##(1991-6#1)(1996-12#1)
was given orally to##2##4##(2012-2#1)(2013-1#1)
was given orally##4##3##(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
was given to the##5##4##(2007-5#1)(2008-12#1)(2011-2#1)(2013-1#2)
was given to##20##3##(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
was given with##2##3##(1995-3#1)(2007-7#1)
was given##102##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-6#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-5#1)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#5)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
was glycated##2##2##(1991-5#1)(1992-12#1)
was going to##2##3##(1992-3#1)(1996-4#1)
was going##3##2##(1992-3#1)(1996-4#1)(2008-8#1)
was good agreement##3##3##(1996-12#1)(2008-7#1)(2012-3#1)
was good and##7##3##(1995-2#1)(2007-7#1)(2008-10#2)(2012-12#1)(2012-3#1)(2013-8#1)
was good in all##2##4##(1994-9#1)(1996-6#1)
was good in##4##3##(1994-9#1)(1996-6#1)(2013-1#1)(2013-8#1)
was good##35##2##(1990-12#1)(1990-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
was governed by##2##3##(2008-10#2)
was grade##2##2##(2007-11#1)(2013-8#1)
was graded as good##2##4##(1997-3#1)(2010-7#1)
was graded in##2##3##(1990-3#1)(1996-6#1)
was graded using a##2##4##(2011-2#1)(2012-2#1)
was graded using##3##3##(2010-8#1)(2011-2#1)(2012-2#1)
was graded##15##2##(1990-3#1)(1996-6#2)(1997-3#1)(2007-6#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)
was gradual##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
was gradually increased##2##3##(2008-11#1)(2011-2#1)
was gradually##8##2##(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
was granted##2##2##(1995-6#1)(2013-8#1)
was greater (P&lt##3##3##(2009-4#3)
was greater among##2##3##(1995-1#1)(2008-9#1)
was greater at higher##2##4##(2008-2#1)(2008-8#1)
was greater at the##2##4##(2008-10#1)(2011-1#1)
was greater at##8##3##(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
was greater for##9##3##(2008-10#2)(2008-9#4)(2010-7#1)(2011-2#1)(2012-2#1)
was greater in the##8##4##(1992-6#2)(1995-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
was greater in##30##3##(1990-2#1)(1992-12#1)(1992-6#2)(1994-5#1)(1995-12#2)(1995-5#1)(1996-9#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
was greater on##3##3##(1997-6#1)(2008-10#2)
was greater than 1##2##4##(2007-12#1)(2008-10#1)
was greater than 95%##5##4##(2008-10#2)(2008-11#2)(2008-6#1)
was greater than 99%##4##4##(2008-10#3)(2012-3#1)
was greater than or equal to 22##2##7##(1991-8#2)
was greater than or equal to##5##6##(1991-8#3)(2008-10#2)
was greater than that of##9##5##(1990-8#1)(1994-11#2)(1994-3#1)(1995-11#1)(2008-10#2)(2011-2#2)
was greater than that##14##4##(1990-8#1)(1991-12#1)(1991-3#1)(1994-11#2)(1994-3#1)(1995-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#2)
was greater than the##3##4##(2007-10#1)(2008-9#1)(2010-5#1)
was greater than##50##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-6#1)(1994-11#2)(1994-3#1)(1995-11#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#2)
was greater when##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-2#1)
was greater with##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
was greater##130##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-12#1)(1992-6#3)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#46)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#8)(2009-10#1)(2009-4#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#2)
was greatest among##2##3##(1992-6#1)(2008-10#1)
was greatest at##2##3##(2008-10#2)
was greatest between##3##3##(2008-10#3)
was greatest following##2##3##(2008-10#2)
was greatest for 'Spanco'##2##4##(2008-10#2)
was greatest for##6##3##(2008-10#5)(2013-1#1)
was greatest in the##5##4##(1991-12#1)(1993-9#1)(2008-9#1)(2009-7#1)(2012-1#1)
was greatest in##10##3##(1991-12#1)(1993-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
was greatest on##5##3##(2008-10#5)
was greatest when##3##3##(2008-10#3)
was greatest##39##2##(1991-12#2)(1991-2#1)(1992-6#1)(1993-9#1)(1995-2#1)(2008-10#26)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
was greatly enhanced by##2##4##(1997-8#1)(2008-10#1)
was greatly enhanced##6##3##(1991-12#1)(1997-8#1)(2008-10#4)
was greatly improved##3##3##(2008-10#2)(2008-11#1)
was greatly increased##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
was greatly reduced##10##3##(1990-5#2)(1991-5#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
was greatly##31##2##(1990-2#2)(1990-5#2)(1991-12#1)(1991-5#1)(1993-6#1)(1995-2#1)(1997-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2012-12#2)
was grossly##3##2##(1990-8#1)(1994-9#1)(2009-3#1)
was grouped into##2##3##(2008-10#1)(2008-5#1)
was grouped##7##2##(1994-3#1)(1994-6#1)(2008-10#2)(2008-5#2)(2008-6#1)
was grown for##2##3##(2008-10#2)
was grown in##11##3##(1990-5#1)(2008-10#7)(2011-2#1)(2012-2#1)(2012-5#1)
was grown on##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#2)
was grown##22##2##(1990-5#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)
was guided by the##2##4##(2010-3#2)
was guided by##6##3##(2008-9#1)(2009-11#1)(2010-11#1)(2010-3#2)(2010-9#1)
was hampered by##2##3##(1995-6#1)(2008-10#1)
was handled in##2##3##(2008-11#1)(2008-3#1)
was handled##3##2##(2008-11#1)(2008-3#1)(2009-11#1)
was hardly extracted with##2##4##(2008-10#2)
was hardly##4##2##(1990-12#1)(1993-6#1)(2008-10#2)
was harvested##11##2##(2007-7#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-9#1)(2013-1#3)
was heat stable##2##3##(1992-9#1)(2008-10#1)
was heat##3##2##(1992-9#1)(2008-10#2)
was heat-stable##2##2##(2008-10#1)(2008-11#1)
was heated at##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
was heated on a##2##4##(2008-10#2)
was heated##8##2##(1995-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)
was heavily##4##2##(1990-6#1)(1993-6#1)(1994-12#1)(2008-10#1)
was held at##2##3##(2008-10#1)(2008-8#1)
was held constant at##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
was held constant##6##3##(1995-12#1)(2008-10#3)(2008-6#1)(2008-9#1)
was held in##9##3##(1991-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-5#2)(2011-2#1)(2011-4#1)
was held on##2##3##(1991-11#1)(2008-7#1)
was held to##2##3##(2007-11#1)(2008-3#1)
was held##29##2##(1991-11#1)(1991-3#1)(1992-5#2)(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-5#2)(2011-2#1)(2011-4#1)
was helpful in##2##3##(2008-12#2)
was helpful to##3##3##(1994-3#1)(1996-9#1)(2010-8#1)
was helpful##5##2##(1994-3#1)(1996-9#1)(2008-12#2)(2010-8#1)
was heterogeneous##3##2##(1992-9#1)(2008-11#1)(2008-7#1)
was high (&gt##2##3##(2013-1#2)
was high and##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2009-11#1)
was high at##2##3##(2008-10#2)
was high but##3##3##(1996-2#1)(1996-5#1)(2013-1#1)
was high for##5##3##(2008-10#2)(2008-7#1)(2009-3#1)(2009-7#1)
was high in all##3##4##(2008-10#3)
was high in both##2##4##(2008-5#1)(2011-2#1)
was high in##14##3##(1995-8#1)(1997-6#1)(2007-7#2)(2008-10#5)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
was high##75##2##(1990-6#3)(1991-6#2)(1992-7#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-10#26)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
was higher (P &lt##5##4##(2010-2#5)
was higher after##2##3##(1991-12#1)(1995-11#1)
was higher among the##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
was higher among##7##3##(1993-11#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
was higher at##8##3##(2008-10#2)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
was higher for the##5##4##(1993-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
was higher for##11##3##(1993-12#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
was higher in males##2##4##(1995-6#1)(2007-7#1)
was higher in patients with##3##5##(1990-8#1)(1994-12#1)(2008-7#1)
was higher in patients##4##4##(1990-8#1)(1994-12#1)(2008-7#1)(2011-2#1)
was higher in the##20##4##(1990-3#1)(1991-12#2)(1991-9#1)(1995-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-7#2)(2013-8#1)
was higher in women##2##4##(2008-10#1)(2013-3#1)
was higher in younger##2##4##(2011-2#2)
was higher in##62##3##(1990-3#1)(1990-8#3)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-3#1)(2013-7#2)(2013-8#4)
was higher on##2##3##(2008-10#1)(2008-5#1)
was higher than 301 var##2##5##(2008-12#2)
was higher than 301##4##4##(2008-12#4)
was higher than 4##2##4##(2008-10#1)(2010-4#1)
was higher than for##2##4##(2008-8#1)(2008-9#1)
was higher than in##7##4##(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)
was higher than that for##2##5##(1994-5#1)(2008-12#1)
was higher than that in##2##5##(2008-10#2)
was higher than that of the##3##6##(1992-10#1)(2008-5#1)(2009-7#1)
was higher than that of##15##5##(1992-10#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-3#1)(2013-1#1)
was higher than that reported##2##5##(1994-12#1)(2012-12#1)
was higher than that##26##4##(1992-10#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-3#2)(2012-12#1)(2013-1#1)
was higher than the##6##4##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-8#1)
was higher than those##2##4##(1992-3#1)(2010-11#1)
was higher than##76##3##(1990-12#2)(1991-3#1)(1992-10#1)(1992-3#1)(1993-10#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#14)(2008-11#7)(2008-12#10)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#4)(2009-7#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
was higher when##5##3##(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)
was higher with##5##3##(1992-12#1)(1997-8#1)(2008-10#1)(2010-7#1)(2013-8#1)
was higher##203##2##(1990-12#2)(1990-3#1)(1990-8#3)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#3)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#4)(2008-10#35)(2008-11#11)(2008-12#12)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#7)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#16)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#8)(2013-3#1)(2013-7#3)(2013-8#8)
was highest among the##2##4##(2008-10#1)(2008-11#1)
was highest among##4##3##(2008-10#1)(2008-11#1)(2009-6#1)(2013-1#1)
was highest at##5##3##(1993-11#1)(2008-10#4)
was highest during##2##3##(2008-11#1)(2010-8#1)
was highest following corn##2##4##(2011-2#2)
was highest following##3##3##(2011-2#3)
was highest for##3##3##(1992-6#1)(2008-10#1)(2011-2#1)
was highest in the##7##4##(1993-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2013-3#1)
was highest in##27##3##(1990-8#1)(1993-3#1)(1994-5#1)(1994-7#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#3)(2009-7#3)(2011-2#1)(2012-1#1)(2013-1#1)(2013-3#1)
was highest##54##2##(1990-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-7#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-6#1)(2009-7#4)(2010-8#1)(2011-2#5)(2012-1#1)(2013-1#2)(2013-3#1)(2013-8#1)
was highlighted##3##2##(1993-3#1)(2008-11#1)(2010-8#1)
was highly conserved##3##3##(1997-7#1)(2008-10#2)
was highly correlated to##2##4##(1990-2#1)(2008-10#1)
was highly correlated with##2##4##(2008-10#2)
was highly correlated##5##3##(1990-2#1)(2008-10#4)
was highly dependent on the##2##5##(1997-8#1)(2008-11#1)
was highly effective in##3##4##(2008-10#2)(2008-5#1)
was highly expressed in rat##2##5##(1992-11#1)(1994-6#1)
was highly expressed in##5##4##(1992-11#1)(1994-6#1)(1994-8#1)(2008-6#1)(2013-8#1)
was highly expressed##8##3##(1992-11#1)(1994-6#1)(1994-8#1)(2008-6#2)(2008-8#1)(2010-5#1)(2013-8#1)
was highly homologous to##3##4##(1991-9#1)(1994-12#1)(1997-2#1)
was highly homologous##5##3##(1990-5#1)(1991-9#1)(1994-12#1)(1997-2#1)(1997-4#1)
was highly predictive of improvement of##2##6##(2007-8#2)
was highly predictive of##3##4##(2007-8#2)(2008-6#1)
was highly predictive##4##3##(1993-11#1)(2007-8#2)(2008-6#1)
was highly purified from##3##4##(1993-3#1)(2008-9#2)
was highly resistant to##2##4##(2008-10#1)(2011-2#1)
was highly resistant##3##3##(2008-10#2)(2011-2#1)
was highly selective for##2##4##(1991-7#1)(2010-1#1)
was highly selective##3##3##(1991-7#1)(2010-1#1)(2013-8#1)
was highly sensitive to##3##4##(1992-8#2)(2008-10#1)
was highly sensitive##5##3##(1992-8#2)(1994-11#1)(2008-10#2)
was highly significant##9##3##(1990-4#1)(1990-6#1)(1995-6#1)(2007-7#1)(2008-10#4)(2011-2#1)
was highly specific##5##3##(1991-11#1)(1997-4#1)(2008-10#3)
was highly variable##5##3##(2008-10#2)(2008-9#2)(2010-8#1)
was highly##93##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#30)(2008-11#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-4#2)(2010-1#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
was his##2##2##(1995-5#1)(2013-8#1)
was histologically verified##2##3##(2008-10#1)(2008-7#1)
was histologically##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
was historically##2##2##(1997-5#1)(2013-8#1)
was homogenized##2##2##(2008-10#2)
was homologous to##3##3##(1992-9#1)(1997-7#1)(2008-8#1)
was homozygous for resistance to##2##5##(2008-10#2)
was homozygous for##3##3##(1994-11#1)(2008-10#2)
was hospitalised##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
was hospitalized for##3##3##(1990-8#1)(2011-2#1)(2013-8#1)
was hospitalized##6##2##(1990-8#1)(1993-6#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
was however##3##2##(1993-9#1)(1996-12#1)(2008-10#1)
was hybridized to##2##3##(1993-2#1)(2008-10#1)
was hybridized with a##2##4##(1990-2#1)(2008-8#1)
was hybridized with##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
was hybridized##5##2##(1990-2#1)(1993-2#1)(2008-10#2)(2008-8#1)
was hydrolyzed##4##2##(1990-7#1)(1992-3#1)(2008-10#2)
was hyperphosphorylated##2##2##(1994-8#1)(2009-6#1)
was hypertension##2##2##(2007-7#1)(2012-12#1)
was hypophisiary##2##2##(2013-1#2)
was hypothesized that this##2##4##(2008-5#1)(2008-8#1)
was hypothesized that##13##3##(1992-2#1)(1995-1#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
was hypothesized to##2##3##(1993-12#1)(2012-3#1)
was hypothesized##17##2##(1992-2#1)(1993-12#1)(1995-1#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
was identical in all##2##4##(2009-9#1)(2012-12#1)
was identical in##4##3##(1990-5#1)(2008-10#1)(2009-9#1)(2012-12#1)
was identical to that of the##2##6##(1990-5#1)(1990-8#1)
was identical to that of##3##5##(1990-12#1)(1990-5#1)(1990-8#1)
was identical to that##8##4##(1990-12#1)(1990-5#1)(1990-8#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
was identical to the##3##4##(1990-2#1)(2008-5#1)(2009-11#1)
was identical to##13##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1993-12#1)(1997-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)
was identical with that##3##4##(1990-7#1)(1991-2#2)
was identical with##5##3##(1990-7#1)(1991-2#2)(2006-10#1)(2008-10#1)
was identical##29##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-2#2)(1993-12#1)(1997-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
was identifiable##2##2##(2008-7#2)
was identified and quantified##2##4##(2008-10#1)(2013-8#1)
was identified and shown to##2##5##(1991-8#1)(2006-8#1)
was identified and##13##3##(1990-5#1)(1990-8#1)(1991-8#1)(1994-8#1)(1997-2#1)(2006-8#1)(2007-8#2)(2008-10#3)(2009-4#1)(2013-8#1)
was identified as a##19##4##(1990-12#1)(1990-8#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-6#1)(1997-4#1)(2008-10#5)(2008-5#3)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
was identified as an##3##4##(1990-12#1)(2008-10#1)(2008-11#1)
was identified as the major##3##5##(1994-1#1)(1994-9#1)(1997-3#1)
was identified as the most##4##5##(1995-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
was identified as the##16##4##(1991-5#1)(1994-1#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2010-4#1)(2011-2#1)(2012-12#1)
was identified as##58##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#15)(2008-11#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
was identified at##3##3##(1993-3#1)(2008-3#1)(2011-2#1)
was identified between the##3##4##(2007-7#1)(2010-12#1)(2011-1#1)
was identified by Southern hybridization##2##5##(1995-8#1)(2008-8#1)
was identified by a##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
was identified by means of##2##5##(2008-10#1)(2008-11#1)
was identified by##26##3##(1990-8#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-8#1)(2008-10#8)(2008-11#1)(2008-8#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
was identified for##4##3##(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
was identified from##4##3##(1994-12#2)(2008-10#1)(2008-9#1)
was identified in a##3##4##(1993-3#1)(2008-10#2)
was identified in the##11##4##(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-11#1)
was identified in three##2##4##(2008-10#1)(2012-3#1)
was identified in##47##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#3)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
was identified on chromosome##2##4##(2008-10#1)(2008-9#1)
was identified on the##2##4##(2008-10#2)
was identified on##5##3##(1992-3#1)(2008-10#3)(2008-9#1)
was identified that##7##3##(1992-5#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-9#1)
was identified through##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
was identified to be##4##4##(1993-8#2)(2008-9#1)(2012-3#1)
was identified to##5##3##(1993-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
was identified using##2##3##(1997-4#1)(2008-10#1)
was identified whose##2##3##(1995-2#1)(2011-2#1)
was identified with##2##3##(1995-12#1)(2008-8#1)
was identified within the##3##4##(1995-8#1)(1996-3#1)(2013-8#1)
was identified##231##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-12#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#3)(1995-6#3)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#3)(1997-3#2)(1997-4#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#53)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#9)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#5)(2013-8#5)
was illuminated with##2##3##(2007-12#1)(2008-2#1)
was illuminated##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
was illustrated##9##2##(1991-12#1)(1997-6#1)(2008-10#6)(2012-3#1)
was imaged##2##2##(2008-2#2)
was immediate##2##2##(1995-12#1)(2008-5#1)
was immediately##5##2##(2008-10#2)(2010-10#1)(2012-2#1)(2013-1#1)
was immersed##2##2##(2008-10#1)(2010-5#1)
was immobilised on a##2##4##(2008-10#2)
was immobilised on the##3##4##(2008-10#3)
was immobilised on##5##3##(2008-10#5)
was immobilised##8##2##(2007-11#1)(2008-10#7)
was immobilized at##2##3##(2008-10#1)(2009-3#1)
was immobilized by##4##3##(2008-10#4)
was immobilized in##6##3##(2008-10#3)(2008-6#2)(2010-3#1)
was immobilized on a##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
was immobilized on porous silica beads (glass##2##7##(2008-10#2)
was immobilized on the biosensor surface##2##6##(2008-10#2)
was immobilized on the surface of the##2##7##(2008-10#1)(2008-11#1)
was immobilized on the surface of##3##6##(2008-10#2)(2008-11#1)
was immobilized on the##10##4##(2008-10#9)(2008-11#1)
was immobilized on##27##3##(1997-2#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)
was immobilized onto##5##3##(1991-5#1)(2008-10#4)
was immobilized##55##2##(1991-5#1)(1993-12#1)(1997-2#1)(2008-10#41)(2008-11#3)(2008-12#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)
was immune##2##2##(1995-6#1)(2008-10#1)
was immunolocalized##2##2##(1995-12#2)
was immunoprecipitated with##4##3##(1990-11#2)(1991-12#1)(1991-5#1)
was immunoprecipitated##5##2##(1990-11#2)(1991-12#1)(1991-5#1)(1995-6#1)
was impaired by##3##3##(2012-12#2)(2013-1#1)
was impaired in##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
was impaired when##3##3##(1990-11#1)(2008-7#1)(2012-2#1)
was impaired##14##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
was implanted in the##3##4##(1992-4#1)(2011-3#1)(2013-1#1)
was implanted in##6##3##(1991-3#1)(1992-4#1)(2011-3#1)(2012-3#1)(2013-1#2)
was implanted##13##2##(1991-3#2)(1992-4#1)(2007-7#1)(2007-8#2)(2009-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
was implemented and##2##3##(2008-3#1)(2008-6#1)
was implemented by##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
was implemented for##3##3##(1992-4#1)(2008-8#1)(2010-8#1)
was implemented in a##4##4##(2008-10#2)(2008-3#1)(2013-8#1)
was implemented in##8##3##(2008-10#2)(2008-11#1)(2008-3#2)(2013-1#2)(2013-8#1)
was implemented on a##2##4##(1992-3#1)(2008-3#1)
was implemented on##4##3##(1992-3#1)(2008-11#1)(2008-3#1)(2010-2#1)
was implemented to evaluate##2##4##(1997-1#1)(2011-1#1)
was implemented to##6##3##(1997-1#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
was implemented##51##2##(1992-3#1)(1992-4#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#2)(2007-12#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
was implicated in##2##3##(1997-8#1)(2008-10#1)
was implicated##3##2##(1997-8#1)(2008-10#2)
was important for##2##3##(1991-8#1)(2008-8#1)
was important to##2##3##(1992-11#1)(2008-9#1)
was important##9##2##(1991-8#1)(1992-11#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)
was imposed##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
was impossible##4##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
was improved by a factor of##3##6##(1996-12#1)(2008-10#1)(2011-2#1)
was improved by the##3##4##(2008-10#2)(2008-7#1)
was improved by using##3##4##(1990-8#1)(2008-10#2)
was improved by##18##3##(1990-7#1)(1990-8#1)(1992-8#1)(1993-8#1)(1996-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
was improved in the##3##4##(2008-10#2)(2012-3#1)
was improved in##4##3##(2008-10#2)(2008-7#1)(2012-3#1)
was improved significantly##2##3##(2007-11#1)(2008-10#1)
was improved to##4##3##(2008-10#3)(2008-3#1)
was improved using##2##3##(2008-10#2)
was improved when##2##3##(2008-10#1)(2008-11#1)
was improved with##2##3##(1994-12#1)(2013-1#1)
was improved##53##2##(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
was in a persistent vegetative state##2##6##(1990-11#1)(2008-2#1)
was in a##7##3##(1990-11#1)(1996-9#1)(2007-6#1)(2008-10#2)(2008-2#1)(2009-7#1)
was in accordance with the##2##5##(2008-10#1)(2008-5#1)
was in accordance with##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
was in addition##2##3##(2008-10#1)(2008-5#1)
was in agreement with the##2##5##(2008-10#2)
was in agreement with##5##4##(2008-10#4)(2008-4#1)
was in direct correlation to##2##5##(2008-11#2)
was in fact##2##3##(1995-5#1)(1997-4#1)
was in general##2##3##(1997-4#1)(2008-7#1)
was in good agreement with##2##5##(2008-10#1)(2008-11#1)
was in good general##2##4##(2013-8#2)
was in good##6##3##(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#2)
was in inverse proportion to the##2##6##(1990-8#1)(2008-10#1)
was in the order##4##4##(2008-10#4)
was in the range of 0##2##6##(2011-2#1)(2012-1#1)
was in the range of 2##2##6##(2008-10#2)
was in the range of##13##5##(2008-10#10)(2008-6#1)(2011-2#1)(2012-1#1)
was in the range##20##4##(2008-10#17)(2008-6#1)(2011-2#1)(2012-1#1)
was in the##45##3##(1991-12#2)(1991-3#1)(1992-8#1)(1992-9#1)(1995-12#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-6#1)(2009-2#1)(2011-2#2)(2012-1#1)(2013-7#1)
was in##132##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#2)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#48)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#8)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
was inactivated##6##2##(1992-5#1)(1993-2#1)(1995-5#2)(2008-6#1)(2012-2#1)
was inactive##7##2##(1990-5#1)(1991-5#2)(1992-2#1)(1992-3#1)(1993-9#1)(2008-4#1)
was inadequate and that##2##4##(1994-3#1)(1996-12#1)
was inadequate##6##2##(1994-3#1)(1996-12#1)(2008-11#2)(2008-5#1)(2013-7#1)
was inadequately##2##2##(1997-8#1)(2011-10#1)
was inaugurated##2##2##(2009-10#1)(2009-7#1)
was incapable of forming##2##4##(1992-8#1)(1997-3#1)
was incapable of##3##3##(1992-8#1)(1997-3#1)(1997-5#1)
was incidentally##2##2##(2010-4#1)(2013-8#1)
was included as a##3##4##(2008-11#2)(2010-1#1)
was included as an##2##4##(2008-10#2)
was included as##5##3##(2008-10#2)(2008-11#2)(2010-1#1)
was included in the##6##4##(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
was included in##11##3##(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
was included##27##2##(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-6#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
was incompatible with##2##3##(2007-12#1)(2008-10#1)
was incomplete##4##2##(1995-2#1)(1997-6#1)(2008-10#2)
was incompletely occluded##2##3##(1996-9#1)(2013-1#1)
was inconclusive##7##2##(1995-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
was inconsistency##2##2##(2008-11#1)(2011-2#1)
was inconsistent##7##2##(1995-2#1)(1995-3#1)(2008-10#2)(2008-8#2)(2010-4#1)
was incorporated in the##2##4##(2008-10#2)
was incorporated in##8##3##(1990-5#1)(1995-2#1)(2008-10#5)(2008-9#1)
was incorporated into a##2##4##(1994-11#1)(2008-10#1)
was incorporated into the##8##4##(1995-6#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)
was incorporated into##23##3##(1992-10#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#5)(2008-8#3)
was incorporated##38##2##(1990-5#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#2)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#5)(2008-8#4)(2008-9#1)(2009-9#1)
was incorrect##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
was incorrectly##3##2##(1994-3#1)(2007-10#1)(2007-11#1)
was increased about##3##3##(1994-6#1)(1997-4#2)
was increased after##3##3##(1993-6#1)(1993-9#1)(2008-10#1)
was increased and the##2##4##(1995-3#1)(2008-10#1)
was increased and##4##3##(1995-3#1)(2008-10#2)(2008-2#1)
was increased by 0##2##4##(1992-10#1)(1993-1#1)
was increased by a factor of##2##6##(1993-9#1)(2008-10#1)
was increased by a##3##4##(1993-9#1)(1994-9#1)(2008-10#1)
was increased by about##2##4##(2008-10#1)(2008-11#1)
was increased by##40##3##(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-9#2)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
was increased due to the##2##5##(2008-10#1)(2008-5#1)
was increased during##3##3##(1991-12#2)(1997-2#1)
was increased from 0##2##4##(1991-2#1)(1994-3#1)
was increased from##9##3##(1991-2#1)(1993-8#1)(1994-3#1)(1995-5#1)(2008-10#4)(2013-1#1)
was increased gradually##2##3##(2013-8#2)
was increased in M patients compared to##2##7##(2012-3#2)
was increased in a##2##4##(1992-6#1)(1997-7#1)
was increased in patients##2##4##(2008-7#1)(2012-3#1)
was increased in the presence of##2##6##(1990-5#1)(1997-1#1)
was increased in the##9##4##(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1994-11#1)(1997-1#1)(2008-9#2)
was increased in##39##3##(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#3)
was increased linearly##2##3##(2008-10#2)
was increased significantly in##2##4##(2007-10#1)(2011-1#1)
was increased significantly##5##3##(1991-3#1)(1992-3#1)(2007-10#1)(2008-11#1)(2011-1#1)
was increased to 30##2##4##(2006-10#1)(2008-10#1)
was increased to##13##3##(1994-2#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
was increased twofold##2##3##(2008-11#1)(2008-8#1)
was increased under##2##3##(1997-2#2)
was increased upon##2##3##(1992-5#1)(1995-2#1)
was increased when##2##3##(2008-5#2)
was increased with the##2##4##(1994-11#1)(2009-7#1)
was increased with##3##3##(1994-11#1)(2008-9#1)(2009-7#1)
was increased##188##2##(1990-2#1)(1990-5#3)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#4)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#3)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#35)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
was increasing##6##2##(1993-12#3)(2008-12#1)(2008-9#1)(2011-1#1)
was incubated at##2##3##(1992-6#1)(1994-3#1)
was incubated for##3##3##(1992-6#1)(1993-9#1)(2013-1#1)
was incubated in##4##3##(1991-12#1)(2008-10#3)
was incubated on##2##3##(2008-8#1)(2010-3#1)
was incubated with##17##3##(1990-12#3)(1990-2#1)(1991-2#1)(1992-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
was incubated##31##2##(1990-12#3)(1990-2#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#2)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(1997-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-3#1)(2013-1#1)
was indeed a##2##3##(1994-7#1)(2009-8#1)
was indeed##6##2##(1992-6#1)(1994-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#1)
was independent of pH##3##4##(1990-7#1)(1991-5#1)(2008-10#1)
was independent of the##15##4##(1992-8#1)(1995-6#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#2)(2013-8#1)
was independent of##30##3##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-4#1)(2013-8#1)
was independent on the##2##4##(1995-12#1)(2008-10#1)
was independent##33##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-4#1)(2013-8#1)
was independently associated with##7##4##(2007-8#1)(2008-7#1)(2013-1#5)
was independently associated##8##3##(2007-8#2)(2008-7#1)(2013-1#5)
was independently##12##2##(1994-2#1)(2007-8#2)(2008-7#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#5)
was indicated by the##5##4##(1990-2#1)(1994-8#1)(2008-10#2)(2011-1#1)
was indicated by##10##3##(1990-2#1)(1994-8#1)(1997-2#1)(2008-10#4)(2008-7#1)(2008-8#1)(2011-1#1)
was indicated for##2##3##(2007-11#1)(2008-12#1)
was indicated that the##3##4##(2008-10#1)(2008-8#2)
was indicated that##4##3##(2008-10#1)(2008-8#3)
was indicated##23##2##(1990-2#1)(1994-8#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-10#8)(2008-12#2)(2008-7#1)(2008-8#4)(2010-3#1)(2011-1#1)(2013-8#1)
was indirect##2##2##(1991-2#1)(2008-10#1)
was indirectly related to##3##4##(2009-7#2)(2012-3#1)
was indirectly##5##2##(2008-10#2)(2009-7#2)(2012-3#1)
was indistinguishable from that##3##4##(1990-11#1)(1995-12#1)(1995-5#1)
was indistinguishable from##5##3##(1990-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-7#1)
was indistinguishable##6##2##(1990-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-7#1)(2008-10#1)
was individual##2##2##(2008-11#1)(2010-8#1)
was individually##3##2##(1993-11#1)(2008-1#1)(2008-12#1)
was induced by a##4##4##(1990-2#1)(2007-8#1)(2008-10#1)(2008-6#1)
was induced by exposing the##2##5##(1995-12#1)(2013-1#1)
was induced by permanent##2##4##(1997-2#1)(2007-10#1)
was induced by the##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
was induced by##43##3##(1990-12#1)(1990-2#1)(1990-7#2)(1990-9#1)(1992-4#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-8#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#2)
was induced in a wheat cultivar-specific manner##2##7##(2008-10#2)
was induced in a##3##4##(1993-8#1)(2008-10#2)
was induced in the##6##4##(1990-7#1)(1992-5#1)(1994-12#1)(1996-12#1)(2010-5#1)(2013-7#1)
was induced in##29##3##(1990-3#1)(1990-7#2)(1991-2#1)(1991-8#1)(1992-5#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#3)(2008-10#7)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
was induced only by##2##4##(2008-11#1)(2008-8#1)
was induced only##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
was induced to##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
was induced with##4##3##(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#1)
was induced##103##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#4)(1990-9#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#22)(2008-11#6)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#6)(2009-7#1)(2010-5#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
was inducible by##2##3##(1992-6#1)(1993-9#1)
was ineffective against C##2##4##(2008-10#2)
was ineffective against##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
was ineffective in reducing the##2##5##(2008-10#1)(2008-7#1)
was ineffective in##5##3##(1995-3#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-7#1)
was ineffective##23##2##(1990-5#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-8#2)(2008-10#5)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
was infected by##5##3##(1996-5#1)(2008-10#3)(2008-11#1)
was infected with##2##3##(2008-10#1)(2008-11#1)
was infected##9##2##(1996-5#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-12#1)
was infectious in##2##3##(2008-10#2)
was infectious##6##2##(1997-3#1)(2008-10#4)(2008-9#1)
was inferred from##3##3##(1990-5#1)(1995-5#1)(2008-7#1)
was inferred that##3##3##(2008-10#2)(2008-8#1)
was inferred to be##2##4##(1995-3#1)(1995-6#1)
was inferred to##3##3##(1995-3#1)(1995-6#1)(2013-8#1)
was inferred##12##2##(1990-5#1)(1992-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-7#1)(2008-8#2)(2013-8#1)
was infested with##2##3##(2008-10#2)
was infiltrated into##2##3##(2008-10#2)
was infiltrated##3##2##(2008-10#2)(2009-1#1)
was inflated##3##2##(1997-3#1)(1997-6#1)(2013-8#1)
was influenced by the##20##4##(1990-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2009-10#1)(2012-2#1)
was influenced by##30##3##(1990-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)
was influenced primarily by##2##4##(1991-6#1)(2008-10#1)
was influenced##34##2##(1990-11#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2012-2#1)
was informed by##3##3##(2007-10#1)(2011-1#1)(2012-3#1)
was infrequent##2##2##(2008-10#2)
was infused into the##3##4##(1993-12#2)(2011-2#1)
was infused##8##2##(1992-10#1)(1992-3#1)(1993-12#2)(2010-3#2)(2011-2#1)(2012-2#1)
was inherited##2##2##(2008-10#2)
was inhibited (by##4##3##(1994-6#1)(2008-2#3)
was inhibited about##2##3##(1990-5#1)(1997-2#1)
was inhibited and##3##3##(1997-7#1)(2008-7#1)(2008-9#1)
was inhibited at##6##3##(1992-9#1)(2008-10#4)(2008-6#1)
was inhibited by a##2##4##(1990-7#1)(1992-6#1)
was inhibited by actinomycin D##2##5##(1994-9#1)(2008-4#1)
was inhibited by an##2##4##(1990-5#1)(1993-9#1)
was inhibited by indomethacin##3##4##(1991-3#1)(1995-3#1)(1997-1#1)
was inhibited by pretreatment##2##4##(1994-3#1)(2008-11#1)
was inhibited by the addition of##4##6##(1993-8#1)(1994-3#1)(1994-6#1)(2008-8#1)
was inhibited by the same##2##5##(1993-3#1)(1994-8#1)
was inhibited by the##14##4##(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
was inhibited by##104##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-5#3)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#1)(1997-7#1)(2006-6#1)(2008-10#10)(2008-11#7)(2008-3#1)(2008-4#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2012-2#2)(2013-1#3)
was inhibited in a dose-dependent manner##2##6##(1992-6#1)(1993-9#1)
was inhibited in the presence of##2##6##(2008-10#1)(2008-11#1)
was inhibited in the##3##4##(1995-12#1)(2008-10#1)(2008-11#1)
was inhibited in##9##3##(1992-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
was inhibited markedly by##2##4##(1991-8#1)(1995-8#1)
was inhibited to##2##3##(1991-12#1)(2008-8#1)
was inhibited when##2##3##(1990-11#1)(1997-7#1)
was inhibited with##4##3##(1991-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
was inhibited##162##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-5#4)(1990-7#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#5)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#3)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#3)(1997-7#3)(2006-6#1)(2008-10#19)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
was inhibition of##2##3##(2008-11#1)(2008-5#1)
was inhibitory to conidial germination##2##5##(2008-10#2)
was inhibitory##4##2##(1995-2#1)(1997-3#1)(2008-10#2)
was initially demonstrated##2##3##(2008-10#2)
was initially diagnosed as##2##4##(2007-7#1)(2008-7#1)
was initially diagnosed with##2##4##(2012-3#1)(2013-8#1)
was initially diagnosed##5##3##(2007-7#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
was initially identified##2##3##(2008-12#1)(2012-3#1)
was initially low##2##3##(2008-8#1)(2010-10#1)
was initially thought to be##2##5##(2008-10#1)(2013-1#1)
was initially thought##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
was initially treated with##3##4##(2008-7#1)(2013-8#2)
was initially very##2##3##(2008-1#1)(2008-10#1)
was initially##51##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#6)(2008-8#3)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2012-3#4)(2013-1#2)(2013-8#3)
was initiated at the##3##4##(1990-5#1)(1991-3#1)(2007-10#1)
was initiated at##5##3##(1990-5#1)(1991-3#1)(2007-10#1)(2008-7#1)(2011-2#1)
was initiated by##8##3##(1990-11#2)(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#2)(2008-4#1)
was initiated in##12##3##(1990-2#1)(1991-1#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#1)
was initiated on##4##3##(2008-1#1)(2010-12#3)
was initiated to investigate##2##4##(1997-4#1)(2008-10#1)
was initiated to##7##3##(1997-4#1)(2008-10#4)(2008-11#1)(2009-4#1)
was initiated##56##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#3)(2009-4#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
was injected and##3##3##(2008-10#1)(2009-4#1)(2012-1#1)
was injected at##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
was injected directly into##2##4##(1991-12#1)(2008-10#1)
was injected directly##3##3##(1990-8#1)(1991-12#1)(2008-10#1)
was injected in the##3##4##(1993-12#1)(1997-2#1)(2008-10#1)
was injected in##6##3##(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#3)
was injected into a semiconductor tapered##2##6##(2007-12#1)(2008-2#1)
was injected into a water carrier stream##2##7##(2008-10#2)
was injected into a##10##4##(2007-12#1)(2008-10#8)(2008-2#1)
was injected into an##2##4##(2008-10#2)
was injected into the carrier stream##2##6##(2008-10#2)
was injected into the##15##4##(1990-8#1)(1993-12#1)(1995-12#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-7#1)
was injected into##35##3##(1990-8#1)(1993-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-10#1)(2011-2#1)(2013-7#1)
was injected intravenously##3##3##(1993-12#1)(2011-2#1)(2013-1#1)
was injected onto the##2##4##(1992-3#1)(2008-10#1)
was injected onto##3##3##(1992-3#1)(2008-10#2)
was injected to##2##3##(2008-10#2)
was injected with 300 mug kg(-1) body wt of AFB1 once every 3 days for 15 days and##2##18##(2008-10#2)
was injected with a sample##2##5##(2008-10#2)
was injected with##7##3##(1994-5#1)(2008-10#4)(2008-12#1)(2011-2#1)
was injected##85##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#3)(1997-2#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#1)(2010-10#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-7#1)
was injured##2##2##(1991-3#1)(2012-2#1)
was inoculated in##2##3##(2008-10#1)(2008-5#1)
was inoculated onto##2##3##(2008-10#1)(2008-8#1)
was inoculated with 50##2##4##(2008-10#1)(2008-12#1)
was inoculated with##10##3##(2008-10#9)(2008-12#1)
was inoculated##21##2##(2008-10#16)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)
was insensitive to the##2##4##(2006-6#1)(2008-2#1)
was insensitive to##7##3##(1990-2#1)(1992-12#1)(1995-11#1)(2006-6#1)(2008-10#2)(2008-2#1)
was inserted in##3##3##(1994-2#1)(1997-3#1)(2008-10#1)
was inserted into a gene that encodes a##2##8##(2008-10#2)
was inserted into a##3##4##(2008-10#2)(2008-11#1)
was inserted into the vector##2##5##(2008-8#1)(2010-5#1)
was inserted into the##12##4##(1990-5#1)(1991-9#1)(1993-3#1)(1993-9#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-5#1)
was inserted into##21##3##(1990-11#1)(1990-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#2)(2010-5#1)(2011-2#1)
was inserted##38##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#4)(2013-1#1)
was insignificant##3##2##(2008-10#3)
was installed on a##2##4##(2008-3#1)(2011-1#1)
was installed##4##2##(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)
was instilled##2##2##(1996-2#1)(2012-3#1)
was instituted##4##2##(1991-1#1)(1994-12#1)(2008-7#1)(2009-4#1)
was instructed to##2##3##(2010-2#1)(2010-6#1)
was insufficient to##2##3##(1996-1#1)(2008-8#1)
was insufficient##6##2##(1993-8#1)(1996-1#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)
was intact and##2##3##(2011-1#1)(2012-12#1)
was intact##4##2##(1997-2#1)(2009-7#1)(2011-1#1)(2012-12#1)
was integrated into##4##3##(1996-3#1)(1997-4#1)(2008-8#1)(2012-1#1)
was integrated with the##2##4##(2008-11#1)(2008-2#1)
was integrated##12##2##(1996-3#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-8#2)(2008-9#1)(2012-1#1)
was intended to##7##3##(1990-11#1)(1992-1#1)(1992-12#1)(2008-5#2)(2008-7#1)(2011-1#1)
was intended##8##2##(1990-11#1)(1992-1#1)(1992-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
was intensified##2##2##(2008-10#1)(2013-7#1)
was intercalated into the##2##4##(1997-4#1)(2008-10#1)
was intermediate##8##2##(1994-3#1)(1995-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#2)
was internalized##3##2##(1991-12#1)(1994-8#2)
was interpreted as##3##3##(1990-7#1)(2008-3#1)(2012-7#1)
was interpreted to be due to##2##6##(1992-12#1)(2008-10#1)
was interpreted to##3##3##(1992-12#1)(2008-10#2)
was interpreted##9##2##(1990-7#1)(1992-12#1)(2008-10#5)(2008-3#1)(2012-7#1)
was interrupted by an intron##3##5##(1993-8#1)(1995-8#1)(1997-2#1)
was interrupted by##7##3##(1993-12#2)(1993-2#1)(1993-8#1)(1995-8#1)(1997-2#1)(1997-4#1)
was interrupted##9##2##(1991-3#1)(1993-12#2)(1993-2#1)(1993-8#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-4#1)
was interviewed using##2##3##(2009-9#1)(2011-2#1)
was interviewed##5##2##(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
was introduced and##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
was introduced as a tool##2##5##(2008-10#1)(2009-10#1)
was introduced as a##4##4##(2008-10#2)(2009-10#1)(2012-2#1)
was introduced as##5##3##(2008-10#2)(2008-12#1)(2009-10#1)(2012-2#1)
was introduced at the##2##4##(1992-5#1)(2010-9#1)
was introduced at##3##3##(1992-5#1)(2008-12#1)(2010-9#1)
was introduced by##5##3##(2008-10#3)(2008-11#1)(2013-1#1)
was introduced for##4##3##(1991-9#1)(2007-7#1)(2008-10#1)(2012-12#1)
was introduced in a##4##4##(2008-10#2)(2008-5#1)(2012-12#1)
was introduced in the early##2##5##(1996-3#1)(2010-12#1)
was introduced in the##7##4##(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
was introduced in##21##3##(1992-2#1)(1993-11#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
was introduced into a##4##4##(2007-12#2)(2008-10#1)(2008-9#1)
was introduced into the flow##2##5##(2008-10#2)
was introduced into the##18##4##(1992-6#1)(1995-6#1)(1997-3#1)(1997-6#2)(2008-10#8)(2008-11#3)(2008-2#1)(2011-2#1)
was introduced into tobacco plants##2##5##(1997-6#2)
was introduced into tobacco##3##4##(1997-6#2)(2008-9#1)
was introduced into##44##3##(1990-8#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)
was introduced recently##2##3##(2008-2#1)(2008-3#1)
was introduced that##2##3##(2008-2#1)(2008-3#1)
was introduced through##2##3##(1990-2#1)(1996-3#1)
was introduced to##7##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
was introduced using##2##3##(1994-7#1)(2008-10#1)
was introduced##120##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#4)(1997-2#1)(1997-3#1)(1997-6#4)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#32)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
was introgressed from##2##3##(2008-10#2)
was introgressed##3##2##(2008-10#3)
was intubated##2##2##(2009-4#1)(2010-7#1)
was invaded##3##2##(1995-6#1)(2008-10#2)
was invariably##2##2##(1995-8#1)(2007-7#1)
was invasive##3##2##(1997-3#1)(2008-10#1)(2013-1#1)
was inversely associated with##3##4##(2009-3#1)(2009-9#2)
was inversely correlated with##8##4##(1996-6#1)(2008-10#2)(2008-7#1)(2010-3#2)(2010-4#1)(2011-2#1)
was inversely correlated##10##3##(1991-12#1)(1996-6#1)(2008-10#3)(2008-7#1)(2010-3#2)(2010-4#1)(2011-2#1)
was inversely proportional to##3##4##(1990-12#1)(1993-8#1)(2011-1#1)
was inversely related to the##4##5##(1990-2#1)(1990-5#1)(1990-8#1)(1993-6#1)
was inversely related to##6##4##(1990-2#1)(1990-5#1)(1990-8#1)(1993-6#1)(2008-10#1)(2010-8#1)
was inversely##23##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-6#1)(1993-8#1)(1996-6#1)(2008-10#4)(2008-7#1)(2009-3#1)(2009-9#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
was invested in##2##3##(2011-2#2)
was investigated against##3##3##(2010-5#1)(2012-2#1)(2012-3#1)
was investigated along##2##3##(1990-12#1)(2008-12#1)
was investigated and it##2##4##(1990-11#1)(1990-8#1)
was investigated and the results##2##5##(2008-10#2)
was investigated and the##7##4##(2008-10#5)(2008-6#1)(2013-1#1)
was investigated and##17##3##(1990-11#1)(1990-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
was investigated as a##5##4##(2007-7#1)(2008-10#3)(2008-3#1)
was investigated as##8##3##(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)
was investigated at various##3##4##(2008-10#3)
was investigated at##11##3##(2007-12#1)(2008-10#9)(2008-11#1)
was investigated by a##2##4##(1991-6#1)(2008-10#1)
was investigated by analyzing##3##4##(1992-5#1)(2008-10#1)(2008-9#1)
was investigated by cyclic voltammetry##2##5##(2008-10#2)
was investigated by cyclic##5##4##(2008-10#5)
was investigated by immunohistochemical##2##4##(1991-5#1)(1997-3#1)
was investigated by light microscopy##2##5##(2007-12#2)
was investigated by means of##5##5##(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
was investigated by measuring##2##4##(2008-10#1)(2008-11#1)
was investigated by the##2##4##(2008-10#1)(2008-11#1)
was investigated by using a##2##5##(2008-10#1)(2008-7#1)
was investigated by using##11##4##(1990-7#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)
was investigated by##87##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-10#31)(2008-11#5)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was investigated during##2##3##(1996-5#1)(2008-10#1)
was investigated employing##2##3##(1990-8#1)(2008-10#1)
was investigated experimentally##2##3##(2007-12#1)(2008-11#1)
was investigated following##3##3##(1993-5#1)(1995-5#1)(2008-11#1)
was investigated for its ability to##2##6##(2008-10#2)
was investigated for its ability##3##5##(2008-10#2)(2008-11#1)
was investigated for its##4##4##(2008-10#3)(2008-11#1)
was investigated for the##5##4##(2007-11#1)(2008-10#4)
was investigated for various##2##4##(2008-10#1)(2008-2#1)
was investigated for##24##3##(1994-11#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#2)
was investigated from##3##3##(1994-6#1)(2007-12#1)(2008-10#1)
was investigated further##2##3##(2008-10#2)
was investigated in a series of##3##6##(1991-8#1)(2008-10#2)
was investigated in a##8##4##(1991-8#1)(1995-3#1)(2008-10#3)(2008-7#2)(2012-2#1)
was investigated in an##3##4##(2007-10#1)(2007-12#1)(2008-10#1)
was investigated in aqueous##2##4##(2008-10#2)
was investigated in cultured##2##4##(1990-2#1)(1995-8#1)
was investigated in detail##4##4##(2008-10#3)(2013-1#1)
was investigated in different##3##4##(1994-9#1)(2008-10#2)
was investigated in human##6##4##(1991-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-7#1)(2013-1#1)
was investigated in mice##2##4##(1996-2#1)(2013-8#1)
was investigated in normal##2##4##(2008-10#1)(2010-11#1)
was investigated in order to##4##5##(2008-10#2)(2008-11#1)(2008-5#1)
was investigated in order##5##4##(2008-10#2)(2008-11#2)(2008-5#1)
was investigated in terms of##5##5##(1994-8#1)(1996-2#1)(2008-10#3)
was investigated in the##16##4##(1990-12#1)(1990-7#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2012-3#1)
was investigated in two##2##4##(1990-3#1)(2008-10#1)
was investigated in vitro##2##4##(1994-9#1)(2008-10#1)
was investigated in##120##3##(1990-12#4)(1990-2#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#3)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#1)(2008-10#39)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2009-10#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
was investigated on##8##3##(1990-5#1)(1991-2#1)(2008-10#4)(2008-6#1)(2010-4#1)
was investigated over the visible and near-infrared spectral##2##8##(2008-2#2)
was investigated over##3##3##(2008-10#1)(2008-2#2)
was investigated spectrophotometrically##2##3##(2008-10#2)
was investigated through the##2##4##(2007-11#1)(2008-7#1)
was investigated through##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
was investigated to##7##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)
was investigated under controlled##2##4##(2008-10#2)
was investigated under##5##3##(2008-10#3)(2008-11#1)(2008-6#1)
was investigated using a##7##4##(1990-2#1)(2008-10#4)(2008-9#1)(2010-4#1)
was investigated using an assay##2##5##(1990-7#1)(1992-12#1)
was investigated using an##3##4##(1990-7#1)(1992-12#1)(1993-6#1)
was investigated using the##5##4##(1990-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#1)
was investigated using##37##3##(1990-12#1)(1990-2#1)(1990-7#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
was investigated with a##3##4##(1991-2#1)(1997-3#1)(2008-5#1)
was investigated with##13##3##(1990-5#1)(1991-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)
was investigated##617##2##(1990-11#2)(1990-12#7)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#4)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#5)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#3)(1993-3#5)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#2)(1994-11#4)(1994-3#2)(1994-5#1)(1994-6#7)(1994-8#4)(1994-9#6)(1995-11#3)(1995-12#3)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#3)(1996-5#6)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#4)(2007-10#1)(2007-11#5)(2007-12#13)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#265)(2008-11#33)(2008-12#5)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#19)(2008-6#9)(2008-7#17)(2008-8#12)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#4)(2010-5#3)(2010-8#3)(2011-1#7)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#9)(2013-8#5)
was invited to##2##3##(2008-9#1)(2011-1#1)
was involved in a##4##4##(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
was involved in the##8##4##(1993-8#1)(1994-12#1)(1997-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-8#1)(2013-1#1)
was involved in this##2##4##(1995-11#1)(2012-2#1)
was involved in##23##3##(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-3#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
was involved##27##2##(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-3#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
was irradiated##7##2##(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
was irreversible and##4##3##(1993-12#1)(2008-10#3)
was irreversible##6##2##(1993-12#2)(1994-11#1)(2008-10#3)
was isolated after##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
was isolated and characterized##7##4##(1990-7#1)(1993-2#1)(1994-11#1)(1995-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
was isolated and found to##3##5##(1992-8#1)(1993-8#1)(1995-2#1)
was isolated and named##2##4##(1990-7#1)(1997-8#1)
was isolated and purified from##2##5##(1992-8#1)(1995-2#1)
was isolated and sequenced##6##4##(1991-11#1)(1991-2#1)(1991-5#1)(1993-2#1)(1997-1#1)(2008-10#1)
was isolated and##28##3##(1990-11#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#2)(1993-2#2)(1993-8#1)(1994-11#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
was isolated as a##2##4##(1995-8#1)(2011-2#1)
was isolated by culture##2##4##(2008-5#2)
was isolated by screening a human##2##6##(1996-10#1)(2008-8#1)
was isolated by using##2##4##(1994-8#1)(2008-9#1)
was isolated by##18##3##(1990-2#1)(1990-8#2)(1993-3#2)(1994-8#1)(1995-6#1)(1996-10#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-2#1)
was isolated for##2##3##(2008-9#1)(2013-1#1)
was isolated from Candida##2##4##(1995-8#1)(1997-4#1)
was isolated from a cosmid##2##5##(1993-12#2)
was isolated from a genomic library##3##6##(1990-5#1)(1992-8#1)(1993-6#1)
was isolated from a human liver cDNA library##2##8##(1992-8#1)(1994-11#1)
was isolated from a human##6##5##(1992-8#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(2008-9#1)
was isolated from a rat##2##5##(1991-12#1)(1996-12#1)
was isolated from a##34##4##(1990-12#1)(1990-5#3)(1991-12#1)(1991-8#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2011-2#6)
was isolated from an##2##4##(1997-7#1)(2011-2#1)
was isolated from both##3##4##(1995-11#1)(2008-10#2)
was isolated from cerebrospinal fluid##2##5##(1995-3#1)(2009-3#1)
was isolated from human##3##4##(1991-12#1)(1992-3#1)(2011-2#1)
was isolated from the liver of the##2##7##(1992-12#1)(2010-5#1)
was isolated from the liver##3##5##(1992-12#1)(1995-9#1)(2010-5#1)
was isolated from the##18##4##(1990-2#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2010-5#1)
was isolated from##115##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-12#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-8#2)(1993-12#2)(1993-2#3)(1993-6#2)(1993-8#1)(1994-11#3)(1994-5#2)(1994-9#1)(1995-11#2)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-9#1)(2006-10#1)(2007-8#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#13)(2012-2#1)(2013-1#1)
was isolated in a##2##4##(1997-3#1)(2012-2#1)
was isolated in##8##3##(1997-3#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-9#1)(2012-2#1)
was isolated that##2##3##(1990-11#1)(2007-8#1)
was isolated through##2##3##(2008-9#1)(2010-5#1)
was isolated using the##2##4##(1991-6#1)(1995-12#1)
was isolated using##4##3##(1990-2#1)(1991-6#1)(1995-12#2)
was isolated##219##2##(1990-11#3)(1990-12#2)(1990-2#4)(1990-5#3)(1990-7#4)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-12#1)(1992-3#4)(1992-8#5)(1992-9#1)(1993-12#3)(1993-2#5)(1993-3#3)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#5)(1995-9#1)(1996-10#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#3)(1997-8#1)(1997-9#1)(2006-10#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#1)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#7)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-10#1)(2011-2#15)(2012-2#3)(2012-3#1)(2013-1#2)
was issued##3##2##(1993-12#1)(2013-1#1)(2013-8#1)
was it##5##2##(1991-3#1)(1993-11#1)(2007-5#1)(2008-10#1)(2011-2#1)
was its##3##2##(1995-8#1)(2008-10#1)(2008-5#1)
was judged by##2##3##(1997-2#1)(2007-10#1)
was judged to be equivocal##3##5##(2008-8#1)(2008-9#2)
was judged to be##4##4##(2008-10#1)(2008-8#1)(2008-9#2)
was judged##11##2##(1991-3#1)(1992-2#1)(1995-4#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#2)(2012-3#1)
was just as##2##3##(1994-12#1)(2008-9#1)
was just##6##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
was kept as##2##3##(2007-11#1)(2008-5#1)
was kept at##7##3##(1990-8#1)(1992-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-1#1)
was kept under##2##3##(2010-3#1)(2012-3#1)
was kept##17##2##(1990-8#1)(1992-1#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
was killed##3##2##(1992-3#1)(1995-3#1)(2011-1#1)
was kinetically##7##2##(1990-7#1)(1995-2#2)(2008-10#3)(2009-10#1)
was known about##3##3##(1992-10#1)(1993-3#1)(2011-2#1)
was known to be##2##4##(1994-5#1)(2008-5#1)
was known to##6##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-1#1)
was known##14##2##(1990-12#1)(1992-10#1)(1993-3#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
was labeled with##6##3##(1994-11#1)(2008-10#3)(2008-12#1)(2008-9#1)
was labeled##10##2##(1990-11#1)(1994-11#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-12#1)
was labelled by the##2##4##(1994-2#1)(1995-12#1)
was lacking##4##2##(1994-9#1)(2010-8#1)(2011-2#2)
was laid##3##2##(2008-12#2)(2008-7#1)
was large and very##2##4##(2008-10#1)(2008-5#1)
was large and##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
was large enough##2##3##(2008-10#1)(2008-9#1)
was large variation##2##3##(2008-3#1)(2013-1#1)
was large##9##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2010-5#1)(2013-1#1)
was largely restricted to##2##4##(1990-3#1)(1997-3#1)
was largely##19##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-6#1)(1994-12#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#2)(2013-1#2)
was larger in##2##3##(1990-12#1)(2013-7#1)
was larger than that##4##4##(1994-9#1)(1997-7#1)(2008-10#1)(2008-3#1)
was larger than##8##3##(1993-12#1)(1994-9#1)(1997-7#1)(2008-10#3)(2008-3#1)(2012-12#1)
was larger##14##2##(1990-12#1)(1993-12#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)(2013-7#1)
was later confirmed by##2##4##(2008-4#1)(2011-2#1)
was later##7##2##(1995-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
was launched in##4##3##(1996-9#1)(2009-7#1)(2010-5#1)(2010-8#1)
was launched on##3##3##(2008-2#1)(2008-3#2)
was launched##14##2##(1993-6#1)(1996-9#1)(2007-5#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
was least##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
was left in place##2##4##(1994-9#1)(2008-9#1)
was left in##3##3##(1994-9#1)(2008-9#1)(2013-1#1)
was left##8##2##(1991-7#1)(1992-3#1)(1994-9#1)(2008-11#2)(2008-5#1)(2008-9#1)(2013-1#1)
was less at##3##3##(1997-6#1)(2008-10#1)(2008-9#1)
was less clear##2##3##(1992-2#1)(2008-10#1)
was less common##2##3##(1997-6#1)(2013-1#1)
was less consistent##2##3##(1996-7#1)(2008-6#1)
was less diverse##2##3##(2012-3#1)(2013-1#1)
was less effective and##2##4##(1992-12#1)(1995-6#1)
was less effective than##2##4##(2008-10#2)
was less effective##6##3##(1992-12#1)(1993-12#1)(1995-6#1)(2008-10#2)(2008-11#1)
was less frequent in##3##4##(1994-6#1)(2011-2#1)(2013-1#1)
was less in the##2##4##(1997-6#1)(2012-12#1)
was less in##6##3##(1997-6#1)(2008-10#2)(2010-12#1)(2012-12#1)(2012-2#1)
was less pronounced in##3##4##(1994-2#1)(2008-3#1)(2012-6#1)
was less pronounced##7##3##(1990-2#1)(1994-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-6#1)
was less reactive##2##3##(1993-8#1)(2010-4#1)
was less satisfactory##2##3##(2008-10#1)(2008-9#1)
was less sensitive##2##3##(1997-7#1)(2008-10#1)
was less severe in##2##4##(1994-5#1)(1997-2#1)
was less severe##4##3##(1994-5#1)(1997-2#1)(2008-10#1)(2012-1#1)
was less susceptible to##2##4##(1994-6#1)(2011-2#1)
was less than 0##6##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-3#1)
was less than 1##5##4##(1990-2#1)(2008-10#3)(2008-3#1)
was less than 15%##2##4##(2008-10#1)(2011-3#1)
was less than 2##4##4##(1991-8#1)(2008-10#2)(2008-2#1)
was less than 3##3##4##(2007-11#1)(2008-10#2)
was less than 4% for all##2##6##(2008-10#1)(2008-3#1)
was less than 4%##4##4##(2008-10#3)(2008-3#1)
was less than 40##2##4##(1996-6#1)(2008-10#1)
was less than 5##2##4##(2008-10#1)(2012-3#1)
was less than 5%##7##4##(2008-10#5)(2010-12#1)(2013-1#1)
was less than 50%##2##4##(2011-2#2)
was less than 6##2##4##(2008-10#1)(2011-2#1)
was less than 8##3##4##(1995-3#1)(2008-10#2)
was less than one##2##4##(1991-6#1)(2008-1#1)
was less than that by the##2##6##(2008-9#2)
was less than that by##3##5##(2008-9#3)
was less than that of##3##5##(1992-6#1)(1997-4#1)(2008-9#1)
was less than that##8##4##(1992-6#1)(1994-6#1)(1994-8#1)(1997-4#1)(2008-9#4)
was less than the##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
was less than##81##3##(1990-2#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-2#2)(2008-3#7)(2008-7#3)(2008-9#5)(2010-12#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#2)
was less then##2##3##(2008-10#1)(2008-2#1)
was less##159##2##(1990-2#2)(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#55)(2008-11#4)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#8)(2009-3#2)(2010-12#2)(2010-4#1)(2011-10#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#8)(2013-8#2)
was lethal to##2##3##(1992-3#1)(2008-10#1)
was liberated##2##2##(1996-2#1)(2008-11#1)
was ligated##3##2##(1993-11#1)(1997-2#1)(2007-8#1)
was likely a##2##3##(2008-10#2)
was likely that##2##3##(1994-3#1)(2011-2#1)
was likely to be##3##4##(1992-12#1)(1995-6#1)(1997-7#1)
was likely to have##2##4##(1996-2#1)(2008-11#1)
was likely to##9##3##(1992-12#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2012-2#1)
was likely##21##2##(1992-12#1)(1992-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
was limited and##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
was limited by the##10##4##(1997-2#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)
was limited by##17##3##(1995-2#1)(1997-2#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
was limited in all##2##4##(2007-11#1)(2008-10#1)
was limited in##3##3##(2007-11#1)(2008-10#2)
was limited only##2##3##(1994-9#1)(2007-12#1)
was limited to a##3##4##(2008-10#1)(2009-8#1)(2010-8#1)
was limited to the##3##4##(2008-10#2)(2012-2#1)
was limited to##19##3##(1990-2#1)(2008-10#8)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)
was limited##51##2##(1990-2#1)(1992-8#1)(1994-9#1)(1995-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#19)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
was linear between 10##2##4##(2008-10#2)
was linear between##6##3##(1995-2#1)(2008-10#5)
was linear for the range of concentrations between 0##2##9##(2008-10#2)
was linear for##4##3##(1996-12#1)(2008-10#3)
was linear from 0##7##4##(1997-2#1)(2008-10#6)
was linear from 1##2##4##(2008-10#2)
was linear from 20 to##2##5##(2008-10#2)
was linear from##15##3##(1997-2#1)(2008-10#14)
was linear in the concentration range from 5##2##8##(2008-10#2)
was linear in the concentration range of##3##7##(2008-10#3)
was linear in the concentration range##6##6##(2008-10#6)
was linear in the range 0##5##6##(2008-10#5)
was linear in the range 3##2##6##(2008-10#2)
was linear in the range of 0##3##7##(2008-10#3)
was linear in the range of 1##2##7##(2008-10#2)
was linear in the range of##8##6##(2008-10#8)
was linear in the range##24##5##(2008-10#24)
was linear in the##33##4##(2008-10#33)
was linear in##34##3##(2008-10#34)
was linear over a range##2##5##(1993-9#1)(2008-10#1)
was linear over a##7##4##(1993-9#1)(1996-5#1)(2008-10#4)(2011-2#1)
was linear over about##2##4##(2008-10#2)
was linear over the concentration range from##2##7##(2008-10#2)
was linear over the concentration range of##2##7##(2008-10#2)
was linear over the concentration range##7##6##(2008-10#7)
was linear over the range 0##4##6##(2008-10#4)
was linear over the range 1##3##6##(2008-10#3)
was linear over the range of 2##2##7##(2008-10#2)
was linear over the range of##6##6##(2008-10#6)
was linear over the range##16##5##(2008-10#16)
was linear over the##26##4##(2008-10#26)
was linear over##38##3##(1993-9#1)(1996-5#1)(2008-10#35)(2011-2#1)
was linear to##7##3##(2008-10#7)
was linear up to 0##2##5##(2008-10#2)
was linear up to 100##2##5##(2008-10#2)
was linear up to##12##4##(1992-3#1)(2008-10#11)
was linear with a correlation coefficient of 0##5##8##(2008-10#5)
was linear with a##7##4##(2008-10#7)
was linear with the##5##4##(2008-10#5)
was linear with##14##3##(2008-10#14)
was linear##138##2##(1992-3#3)(1993-9#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-2#1)(2008-10#128)(2011-2#1)
was linearly correlated with##3##4##(2008-10#2)(2008-7#1)
was linearly dependent on the##3##5##(1990-11#1)(2008-10#2)
was linearly related to the logarithm of##2##7##(2008-10#2)
was linearly related to the##6##5##(1995-3#1)(2008-10#5)
was linearly related to##7##4##(1995-3#1)(2008-10#6)
was linearly##15##2##(1990-11#1)(1995-3#1)(2008-10#11)(2008-2#1)(2008-7#1)
was linked in##3##3##(2008-10#3)
was linked to the##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
was linked to##9##3##(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
was linked with##4##3##(2008-10#2)(2009-10#1)(2012-1#1)
was linked##16##2##(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
was little difference##2##3##(1991-4#1)(2010-8#1)
was little evidence for##2##4##(2008-5#1)(2010-11#1)
was little##23##2##(1990-11#1)(1991-4#1)(1994-12#1)(1994-3#1)(1996-2#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-8#1)
was loaded in##2##3##(2008-10#1)(2008-9#1)
was loaded on##3##3##(2008-10#3)
was loaded##6##2##(2008-10#5)(2008-9#1)
was localized at##4##3##(1990-11#1)(1994-10#1)(1995-6#1)(2008-11#1)
was localized in a##2##4##(2009-10#1)(2013-1#1)
was localized in the##6##4##(1992-3#1)(1992-6#1)(1996-5#1)(1997-4#1)(2009-8#1)(2011-2#1)
was localized in##15##3##(1992-3#1)(1992-6#1)(1992-9#1)(1996-5#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
was localized on##3##3##(1991-5#1)(1994-12#1)(1995-6#1)
was localized only in##2##4##(2008-10#2)
was localized specifically##2##3##(2008-7#1)(2010-11#1)
was localized to a##3##4##(1993-9#1)(1994-2#1)(1995-6#1)
was localized to the basolateral##2##5##(1993-6#1)(1994-3#1)
was localized to the##8##4##(1991-11#1)(1992-7#1)(1993-6#2)(1994-3#1)(1994-8#1)(2008-11#1)(2009-10#1)
was localized to##13##3##(1991-11#1)(1992-7#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-7#1)(2008-11#1)(2009-10#1)
was localized##50##2##(1990-11#1)(1991-11#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#3)(1996-5#2)(1997-4#2)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-8#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
was located at the##3##4##(1991-9#1)(1996-9#1)(2013-8#1)
was located at##4##3##(1991-9#1)(1996-9#1)(1997-4#1)(2013-8#1)
was located between the##3##4##(1991-7#1)(2008-5#1)(2008-9#1)
was located between##4##3##(1991-7#1)(2008-5#1)(2008-9#1)(2012-2#1)
was located in the##15##4##(1990-5#1)(1991-3#1)(1991-6#1)(1993-9#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#4)
was located in##22##3##(1990-5#1)(1991-3#1)(1991-6#1)(1993-9#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#2)(2013-8#4)
was located near the##2##4##(1992-9#1)(2008-10#1)
was located near##4##3##(1992-9#1)(2008-10#1)(2012-3#2)
was located on a##2##4##(1992-3#1)(2008-5#1)
was located on the##6##4##(1992-4#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)
was located on##13##3##(1992-3#1)(1992-4#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)
was located within the##2##4##(2007-8#1)(2013-1#1)
was located within##3##3##(1997-6#1)(2007-8#1)(2013-1#1)
was located##66##2##(1990-5#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-9#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#5)(1997-8#2)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#5)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#6)
was locked to##3##3##(2007-12#1)(2008-2#2)
was locked##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
was long and##3##3##(2007-12#2)(2008-10#1)
was long##5##2##(2007-12#2)(2008-10#2)(2008-11#1)
was longer in##4##3##(1991-5#1)(1996-1#1)(2013-8#2)
was longer than##3##3##(2008-11#1)(2008-7#1)(2009-4#1)
was longer##10##2##(1990-10#1)(1991-5#1)(1992-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-8#2)
was lost after##4##3##(1991-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
was lost and##2##3##(1990-9#1)(2008-1#1)
was lost by##2##3##(2008-11#1)(2008-6#1)
was lost in all##2##4##(2008-1#1)(2008-7#1)
was lost in##6##3##(1991-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2013-7#1)
was lost##24##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
was low (1##2##3##(2010-11#1)(2013-8#1)
was low and similar##2##4##(2008-8#1)(2013-8#1)
was low and the##2##4##(1996-2#1)(2011-2#1)
was low and##8##3##(1996-12#1)(1996-2#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
was low compared with##2##4##(1993-8#1)(2013-7#1)
was low in all##2##4##(2008-10#1)(2013-1#1)
was low in the##2##4##(1990-5#1)(1993-9#1)
was low in##12##3##(1990-5#1)(1992-10#1)(1993-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
was low throughout the##2##4##(2008-10#1)(2010-8#1)
was low when##2##3##(2008-10#1)(2013-7#1)
was low with##3##3##(1993-1#1)(2008-10#2)
was low##90##2##(1990-3#1)(1990-5#1)(1990-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#2)
was lower (P &lt##2##4##(2010-2#2)
was lower (P##3##3##(2008-5#1)(2010-2#2)
was lower and##2##3##(1992-3#1)(2008-8#1)
was lower at##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
was lower by##2##3##(2008-2#1)(2008-7#1)
was lower for##8##3##(2008-10#6)(2008-9#1)(2012-2#1)
was lower in plants##2##4##(2008-10#1)(2009-2#1)
was lower in the less reproductively##2##6##(2009-12#1)(2012-3#1)
was lower in the##11##4##(1991-11#1)(1993-10#1)(1994-2#2)(2007-10#1)(2008-10#2)(2008-7#1)(2009-12#1)(2012-3#1)(2013-8#1)
was lower in##25##3##(1990-8#1)(1991-11#1)(1991-6#1)(1993-10#1)(1994-2#2)(1995-11#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
was lower than 0##2##4##(2008-10#2)
was lower than 3##3##4##(1990-2#1)(2008-10#1)(2012-12#1)
was lower than in##6##4##(1990-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
was lower than normal in TT##3##6##(2007-7#3)
was lower than normal##4##4##(2007-2#1)(2007-7#3)
was lower than that observed in##2##6##(1994-2#1)(1995-8#1)
was lower than that of##4##5##(1990-3#1)(2008-10#1)(2011-2#2)
was lower than that reported in Caucasian##2##7##(1997-8#1)(2009-5#1)
was lower than that##11##4##(1990-3#1)(1990-6#1)(1992-3#1)(1994-2#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#2)
was lower than the##3##4##(2008-7#2)(2008-8#1)
was lower than those##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
was lower than##51##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-3#1)(1997-8#1)(2007-2#1)(2007-7#3)(2008-10#16)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)
was lower when compared##2##4##(2008-12#1)(2012-3#1)
was lower when##4##3##(1990-5#1)(2007-8#1)(2008-12#1)(2012-3#1)
was lower##122##2##(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-2#3)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#7)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
was lowered by 50%##2##4##(1992-6#1)(1996-12#1)
was lowered by##3##3##(1991-6#1)(1992-6#1)(1996-12#1)
was lowered##5##2##(1991-6#1)(1992-6#1)(1994-3#1)(1996-12#1)(2008-10#1)
was lowest in##6##3##(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)
was lowest##15##2##(1993-9#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-5#2)
was lyophilized##2##2##(2008-5#1)(2013-7#1)
was made a##2##3##(2008-10#1)(2013-1#1)
was made according to##2##4##(2008-1#1)(2013-1#1)
was made among##3##3##(2008-10#2)(2013-1#1)
was made and##6##3##(1997-4#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-7#1)
was made at##4##3##(1990-2#1)(1991-12#1)(1993-12#1)(2008-3#1)
was made based on the##2##5##(1991-6#1)(2011-2#1)
was made based on##4##4##(1991-6#1)(2008-11#1)(2011-2#1)(2012-3#1)
was made between##11##3##(1994-3#2)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-7#1)
was made by the##2##4##(2008-3#1)(2012-3#1)
was made by##26##3##(1990-12#1)(1992-9#1)(1993-9#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-5#3)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
was made for all the##2##5##(2007-8#1)(2008-10#1)
was made for##8##3##(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
was made from##6##3##(2008-10#3)(2010-12#1)(2010-2#1)(2012-3#1)
was made in##19##3##(1990-10#2)(1990-3#1)(1990-6#1)(1994-2#1)(1997-2#1)(2007-11#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
was made of the##8##4##(1991-1#1)(1991-3#1)(1992-6#1)(1994-1#1)(2008-10#2)(2012-12#1)(2013-1#1)
was made of##16##3##(1991-1#1)(1991-3#1)(1992-5#1)(1992-6#1)(1994-1#1)(1996-1#1)(1996-12#1)(2008-10#3)(2009-10#1)(2012-12#3)(2013-1#2)
was made on the basis of##3##6##(1994-11#1)(2008-1#1)(2008-10#1)
was made on the##6##4##(1990-11#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-8#1)
was made on##10##3##(1990-11#1)(1994-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)
was made possible by a##2##5##(2008-12#1)(2008-3#1)
was made possible by##5##4##(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)
was made to find the##2##5##(2008-5#1)(2010-4#1)
was made to find##3##4##(2008-5#1)(2010-4#1)(2012-2#1)
was made to##22##3##(1990-6#1)(1993-12#1)(1995-4#1)(1996-12#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
was made up of##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
was made up##5##3##(1995-11#1)(1996-1#1)(2008-10#2)(2008-8#1)
was made using a##4##4##(2008-10#1)(2008-9#1)(2012-12#2)
was made using##11##3##(2008-10#6)(2008-5#1)(2008-9#1)(2012-12#2)(2013-1#1)
was made with a##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
was made with##8##3##(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2013-1#1)
was made##227##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-8#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#8)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#53)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#8)(2008-5#9)(2008-7#4)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#8)(2012-12#9)(2012-2#3)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#2)
was mailed to a random sample of##2##7##(1991-3#1)(2009-4#1)
was mailed to a##3##4##(1991-3#1)(1995-12#1)(2009-4#1)
was mailed to##9##3##(1991-3#1)(1994-1#1)(1995-12#1)(1996-3#2)(2007-10#1)(2008-4#2)(2009-4#1)
was mainly composed of##2##4##(2008-10#1)(2008-8#1)
was mainly due to a##2##5##(1997-2#1)(2008-10#1)
was mainly due to##10##4##(1991-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)
was mainly found in##2##4##(1991-2#1)(1995-3#1)
was mainly observed##2##3##(2008-10#2)
was mainly specific for##2##4##(2008-7#2)
was mainly##43##2##(1990-12#1)(1991-2#2)(1992-10#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
was maintained after the##2##4##(1991-2#1)(2009-6#1)
was maintained as##2##3##(2008-6#1)(2009-7#1)
was maintained at a##2##4##(1993-12#1)(2008-11#1)
was maintained at##8##3##(1993-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-2#1)(2012-12#1)
was maintained between##4##3##(2008-1#1)(2008-10#2)(2012-2#1)
was maintained by##2##3##(2007-8#1)(2013-7#1)
was maintained for the##2##4##(1993-11#1)(2011-2#1)
was maintained for up to##2##5##(2009-12#1)(2010-9#1)
was maintained for##8##3##(1993-11#1)(1995-12#1)(2008-5#1)(2009-12#1)(2010-9#1)(2011-2#3)
was maintained in a##2##4##(1991-12#1)(2011-2#1)
was maintained in the##3##4##(2009-10#1)(2010-7#1)(2012-12#1)
was maintained in##5##3##(1991-12#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
was maintained on##5##3##(1991-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
was maintained with##2##3##(2008-8#1)(2011-2#1)
was maintained##60##2##(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-12#2)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-4#1)(2008-5#5)(2008-6#3)(2008-8#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
was male##4##2##(1992-11#1)(2007-2#1)(2011-2#1)(2012-12#1)
was managed by##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
was managed conservatively##2##3##(2013-1#1)(2013-8#1)
was managed successfully by##2##4##(2008-7#1)(2012-2#1)
was managed successfully##4##3##(2008-7#1)(2010-10#1)(2010-11#1)(2012-2#1)
was managed with##5##3##(2008-1#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
was managed##18##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
was manifested by a##3##4##(2008-10#1)(2009-8#2)
was manifested by##4##3##(1995-8#1)(2008-10#1)(2009-8#2)
was manifested##7##2##(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2009-8#2)
was manipulated by using##2##4##(1995-2#1)(2008-12#1)
was manipulated by##3##3##(1995-2#1)(2008-12#1)(2009-12#1)
was manipulated in##3##3##(1995-12#1)(2008-8#1)(2009-11#1)
was manipulated##8##2##(1995-12#1)(1995-2#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)
was manufactured##2##2##(2008-3#1)(2008-5#1)
was mapped by##2##3##(1995-6#1)(2007-5#1)
was mapped in the##2##4##(2008-8#1)(2008-9#1)
was mapped in##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
was mapped on chromosome##2##4##(2008-8#1)(2008-9#1)
was mapped on##4##3##(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
was mapped onto##2##3##(2008-9#1)(2012-1#1)
was mapped to a##3##4##(1994-11#1)(1994-6#1)(2008-10#1)
was mapped to chromosome##4##4##(1996-6#1)(1997-7#1)(2008-8#2)
was mapped to the short arm of chromosome##2##8##(2008-10#2)
was mapped to the##9##4##(1990-8#1)(1991-10#1)(1993-2#1)(1994-9#1)(2008-10#5)
was mapped to##19##3##(1990-8#1)(1991-10#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-10#7)(2008-8#2)(2011-2#1)
was mapped##37##2##(1990-8#1)(1991-10#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#2)(1996-6#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-8#6)(2008-9#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
was marginally more resistant to##2##5##(2008-10#2)
was marginally##7##2##(1996-9#1)(1997-8#1)(2007-10#1)(2008-10#3)(2012-1#1)
was marked by##3##3##(2008-10#1)(2008-12#1)(2009-1#1)
was marked##8##2##(1993-12#1)(1996-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-1#1)(2010-11#1)
was markedly better##2##3##(2008-10#1)(2008-9#1)
was markedly enhanced by##3##4##(1992-8#1)(1993-8#1)(1995-2#1)
was markedly enhanced##5##3##(1990-11#1)(1992-8#2)(1993-8#1)(1995-2#1)
was markedly higher than##2##4##(1992-12#1)(2008-9#1)
was markedly higher##4##3##(1992-12#1)(1995-6#1)(1997-2#1)(2008-9#1)
was markedly increased in##3##4##(1994-2#1)(1995-3#1)(2012-2#1)
was markedly increased##4##3##(1992-12#1)(1994-2#1)(1995-3#1)(2012-2#1)
was markedly inhibited by##3##4##(1990-2#1)(1991-2#1)(1993-8#1)
was markedly more##2##3##(2008-10#1)(2008-5#1)
was markedly reduced in##3##4##(2008-10#2)(2013-1#1)
was markedly reduced##9##3##(1991-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1997-2#1)(2008-10#2)(2013-1#1)(2013-7#1)
was markedly suppressed##2##3##(1993-3#1)(1994-11#1)
was markedly##46##2##(1990-11#2)(1990-2#1)(1991-2#1)(1991-5#2)(1992-12#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#1)(2013-7#1)
was massively##3##2##(1991-9#1)(2008-5#1)(2011-2#1)
was maximal at##2##3##(1991-12#1)(2008-10#1)
was maximal in##2##3##(1993-6#1)(1997-1#1)
was maximal when##2##3##(1993-11#1)(1994-2#1)
was maximal##8##2##(1991-12#1)(1991-5#1)(1993-11#1)(1993-6#1)(1994-2#1)(1997-1#1)(1997-5#1)(2008-10#1)
was maximally expressed##2##3##(1990-5#1)(2008-11#1)
was maximally##7##2##(1990-5#1)(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
was maximized at##2##3##(2013-1#2)
was maximized##7##2##(2008-11#2)(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#2)
was maximum in##2##3##(2007-7#1)(2012-1#1)
was maximum when##2##3##(2008-10#2)
was maximum##10##2##(1995-5#1)(1997-6#1)(2007-7#3)(2008-10#3)(2008-5#1)(2012-1#1)
was mean##2##2##(1992-6#1)(2013-1#1)
was measured after 24 h##2##5##(1997-4#1)(2013-1#1)
was measured after staining##2##4##(2008-10#1)(2008-7#1)
was measured after##11##3##(1997-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2013-1#1)
was measured against##2##3##(2008-10#2)
was measured and compared with##2##5##(2008-3#1)(2009-6#1)
was measured and found to be in##2##7##(2007-11#1)(2007-12#1)
was measured and the##2##4##(2008-12#1)(2011-1#1)
was measured and##12##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
was measured as a function of the##5##7##(2008-2#2)(2008-3#3)
was measured as a function of##11##6##(1993-11#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)
was measured as a##12##4##(1993-11#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)
was measured as an##3##4##(2008-10#1)(2008-11#2)
was measured as the##2##4##(2007-11#1)(2008-10#1)
was measured as##22##3##(1993-11#1)(1993-12#1)(1993-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#4)(2008-7#1)
was measured at 1##2##4##(2008-3#2)
was measured at a##2##4##(2007-12#1)(2008-5#1)
was measured at each##2##4##(2008-2#1)(2009-2#1)
was measured at the##3##4##(2007-11#1)(2008-3#1)(2010-12#1)
was measured at two##2##4##(2007-5#1)(2008-9#1)
was measured at##35##3##(1990-2#1)(1991-12#1)(1995-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#14)(2008-2#2)(2008-3#6)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2013-1#1)
was measured based on##2##4##(2008-2#1)(2013-8#1)
was measured before and after##3##5##(1996-2#1)(2007-12#1)(2009-12#1)
was measured before and##4##4##(1996-2#1)(2007-12#1)(2008-5#1)(2009-12#1)
was measured before##5##3##(1996-2#1)(1997-3#1)(2007-12#1)(2008-5#1)(2009-12#1)
was measured by a##9##4##(1990-6#1)(1992-3#1)(1994-2#1)(1994-6#1)(2008-10#3)(2009-7#1)(2010-3#1)
was measured by an##2##4##(1991-5#1)(1995-5#1)
was measured by continuous##2##4##(2008-3#1)(2011-2#1)
was measured by quantitative##2##4##(1992-5#1)(2013-1#1)
was measured by radioimmunoassay##2##4##(1990-5#1)(2011-1#1)
was measured by the##16##4##(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1996-2#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-1#2)
was measured by use of##3##5##(2007-11#1)(2008-2#1)(2009-1#1)
was measured by using##4##4##(1995-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
was measured by##78##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
was measured directly##4##3##(1993-6#1)(2008-10#2)(2008-3#1)
was measured during##7##3##(1993-1#1)(1995-11#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-7#1)
was measured every##2##3##(1995-11#1)(2007-12#1)
was measured following##2##3##(1992-3#1)(2008-3#1)
was measured for a##2##4##(2007-11#2)
was measured for each##2##4##(2008-10#1)(2008-9#1)
was measured for the##3##4##(2007-12#1)(2008-3#1)(2009-4#1)
was measured for##11##3##(1992-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-4#1)
was measured from the date of first##2##7##(1990-8#1)(2008-7#1)
was measured from the##3##4##(1990-8#1)(2008-7#1)(2011-2#1)
was measured from##4##3##(1990-8#1)(2008-12#1)(2008-7#1)(2011-2#1)
was measured in a##3##4##(1993-11#1)(2008-2#1)(2012-2#1)
was measured in both##2##4##(1993-3#1)(2011-1#1)
was measured in four##2##4##(2008-10#1)(2008-5#1)
was measured in situ##2##4##(2008-10#1)(2010-8#1)
was measured in the##13##4##(1993-2#1)(1993-3#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
was measured in vitro in##2##5##(1991-2#1)(2008-10#1)
was measured in vitro##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
was measured in vivo##2##4##(2008-2#1)(2008-3#1)
was measured in##65##3##(1990-2#2)(1990-3#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#2)(2008-10#11)(2008-2#4)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
was measured on a##2##4##(2008-2#1)(2011-2#1)
was measured on the basis of##2##6##(1994-7#1)(2010-11#1)
was measured on the##4##4##(1994-7#1)(2007-11#1)(2009-2#1)(2010-11#1)
was measured on##10##3##(1994-7#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#1)
was measured over a##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
was measured over##6##3##(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#2)
was measured spatially##2##3##(2008-2#2)
was measured through##2##3##(2008-10#1)(2008-3#1)
was measured to be 5##2##5##(2008-3#1)(2009-11#1)
was measured to be approximately##2##5##(2008-2#1)(2008-3#1)
was measured to be##14##4##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#4)(2008-8#1)(2009-11#1)
was measured to determine the##2##5##(2008-10#2)
was measured to determine##3##4##(2007-8#1)(2008-10#2)
was measured to##20##3##(1996-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#5)(2008-8#1)(2009-11#1)
was measured under##2##3##(2007-12#1)(2008-10#1)
was measured using a##4##4##(1994-8#1)(2008-5#1)(2008-7#1)(2009-7#1)
was measured using the##5##4##(1991-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-3#1)
was measured using##26##3##(1991-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#2)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
was measured via##2##3##(2008-10#1)(2008-12#1)
was measured with a##9##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
was measured with an##6##4##(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)
was measured with both##3##4##(1990-12#1)(2008-3#1)(2008-5#1)
was measured with positron emission tomography##2##6##(1996-2#1)(1996-5#1)
was measured with the##4##4##(2008-1#1)(2008-10#2)(2010-7#1)
was measured with##34##3##(1990-12#1)(1996-2#1)(1996-5#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-7#1)(2013-1#1)
was measured##431##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#5)(1991-9#1)(1992-3#3)(1992-5#1)(1992-6#2)(1993-1#3)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#4)(1995-8#3)(1996-12#3)(1996-2#4)(1996-5#4)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#5)(2007-11#18)(2007-12#17)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#88)(2008-11#11)(2008-12#7)(2008-2#28)(2008-3#41)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#5)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#7)(2011-2#10)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#16)(2013-7#3)(2013-8#6)
was mechanically##3##2##(2008-10#2)(2012-1#1)
was mediated by the##2##4##(1993-9#1)(2010-10#1)
was mediated by##10##3##(1991-2#1)(1993-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#1)
was mediated through##2##3##(1995-12#1)(2008-10#1)
was mediated##13##2##(1991-2#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#1)
was merged with an##2##4##(2007-12#1)(2008-10#1)
was merged with##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
was met with##2##3##(1995-12#1)(2007-5#1)
was metabolically##2##2##(1990-11#1)(1994-6#1)
was metabolized by the##2##4##(1990-5#1)(2008-11#1)
was metabolized by##3##3##(1990-5#1)(1993-8#1)(2008-11#1)
was metabolized to##2##3##(1992-11#1)(2008-11#1)
was metabolized##5##2##(1990-5#1)(1992-11#1)(1993-8#1)(2008-11#2)
was microinjected into##2##3##(1995-3#1)(1997-2#1)
was microinjected##3##2##(1990-7#1)(1995-3#1)(1997-2#1)
was mild##4##2##(1992-10#1)(2008-10#1)(2008-7#1)(2012-12#1)
was milder##2##2##(1995-8#1)(2013-1#1)
was mimicked by##2##3##(1994-11#1)(1995-12#1)
was mineralized##2##2##(2008-10#1)(2009-11#1)
was minimal and##3##3##(1990-12#1)(1991-6#1)(2011-2#1)
was minimal in##2##3##(1991-2#1)(2012-3#1)
was minimal##13##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-12#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
was minimally##2##2##(2008-10#2)
was minimized by##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
was minimized##9##2##(1995-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)
was minimum##3##2##(2008-10#1)(2010-5#1)(2012-1#1)
was mirrored##2##2##(1997-7#1)(2008-8#1)
was misdiagnosed as##2##3##(2007-12#1)(2011-2#1)
was misdiagnosed##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
was missed##3##2##(1991-11#1)(2009-4#1)(2012-12#1)
was missing in##2##3##(2008-11#1)(2012-2#1)
was missing##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
was mixed on-line with##2##4##(2008-10#2)
was mixed with a##2##4##(1994-5#1)(2008-10#1)
was mixed with the##7##4##(2008-10#6)(2011-1#1)
was mixed with##19##3##(1992-6#1)(1994-5#1)(1997-6#1)(2008-10#13)(2011-1#1)(2012-12#1)(2012-2#1)
was mixed##25##2##(1992-6#1)(1994-5#1)(1997-6#1)(2008-10#17)(2008-2#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
was mobilized##2##2##(2007-8#1)(2012-3#1)
was mode locked##2##3##(2007-11#2)
was mode##3##2##(2007-11#2)(2013-8#1)
was modeled as a##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
was modeled as##4##3##(2008-10#2)(2010-3#1)(2013-1#1)
was modeled using##5##3##(1992-12#1)(2008-10#2)(2011-2#1)(2013-1#1)
was modeled with##3##3##(2008-10#1)(2008-3#2)
was modeled##16##2##(1992-12#1)(2007-11#1)(2008-10#6)(2008-3#2)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
was modelled##2##2##(2008-10#1)(2009-4#1)
was moderate##7##2##(1990-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)
was moderately##8##2##(1991-6#1)(1992-12#1)(1992-5#1)(2008-10#2)(2008-6#1)(2010-2#1)(2013-1#1)
was modest##2##2##(2008-6#1)(2012-3#1)
was modified and##2##3##(2008-10#2)
was modified by adding##2##4##(2008-5#1)(2010-3#1)
was modified by##7##3##(1991-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-3#1)
was modified so##2##3##(1993-3#1)(2008-10#1)
was modified to include##2##4##(2007-7#1)(2008-6#1)
was modified to##12##3##(1992-8#1)(1996-2#1)(1997-6#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)
was modified with##4##3##(2008-10#3)(2008-3#1)
was modified##37##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(2007-7#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-3#1)(2013-1#1)
was modulated by the##2##4##(2008-11#1)(2010-12#1)
was modulated by##5##3##(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#2)
was modulated##6##2##(2007-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#2)
was molecularly##2##2##(2007-6#1)(2012-12#1)
was monitored at the##2##4##(2008-10#2)
was monitored at##10##3##(2008-10#9)(2008-2#1)
was monitored by a##4##4##(1993-2#1)(2007-10#1)(2008-10#1)(2008-2#1)
was monitored by collection##2##4##(2007-5#2)
was monitored by fluorescence##2##4##(2008-10#1)(2008-11#1)
was monitored by measuring##2##4##(2008-10#2)
was monitored by the##3##4##(1990-2#1)(1990-8#1)(2008-10#1)
was monitored by##32##3##(1990-2#1)(1990-8#2)(1991-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-2#1)(1997-6#1)(2007-10#1)(2007-5#2)(2007-6#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-8#1)
was monitored during the##2##4##(1992-9#1)(2008-10#1)
was monitored during##4##3##(1992-9#1)(2008-10#2)(2008-7#1)
was monitored fluorometrically at 455nm (excitation at 340nm)##2##8##(2008-10#2)
was monitored fluorometrically##3##3##(2008-10#3)
was monitored for##3##3##(2008-10#3)
was monitored in real time##2##5##(2008-10#2)
was monitored in real-time##2##4##(2008-10#2)
was monitored in situ##2##4##(2008-10#1)(2013-8#1)
was monitored in the##2##4##(2008-10#2)
was monitored in##16##3##(2008-10#13)(2008-11#1)(2008-2#1)(2013-8#1)
was monitored simultaneously##2##3##(2008-3#1)(2009-12#1)
was monitored spectrophotometrically at##3##4##(2008-10#3)
was monitored spectrophotometrically by measuring the##5##6##(2008-10#5)
was monitored spectrophotometrically##9##3##(2008-10#9)
was monitored through##4##3##(1997-2#1)(2008-10#1)(2008-6#1)(2012-7#1)
was monitored throughout the##3##4##(2008-10#2)(2008-3#1)
was monitored using the##3##4##(1996-2#1)(2008-10#1)(2010-4#1)
was monitored using##8##3##(1990-8#1)(1995-5#1)(1996-2#1)(2008-10#3)(2010-4#1)(2011-1#1)
was monitored with##8##3##(1990-8#2)(2008-10#3)(2008-2#2)(2008-3#1)
was monitored##122##2##(1990-2#1)(1990-8#5)(1991-3#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-5#2)(2007-6#1)(2008-10#73)(2008-11#2)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#2)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-8#1)
was monomeric and##2##3##(1992-6#1)(1995-6#1)
was more accurate than##2##4##(2008-10#1)(2013-1#1)
was more active##3##3##(1992-10#1)(2008-10#1)(2008-11#1)
was more affected by##2##4##(2011-2#2)
was more affected##3##3##(2010-11#1)(2011-2#2)
was more common in patients##3##5##(2007-7#1)(2010-12#1)(2011-2#1)
was more common in##6##4##(1990-2#1)(2007-10#1)(2007-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
was more common##8##3##(1990-2#1)(1990-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
was more dependent on##3##4##(2008-10#1)(2012-9#1)(2013-1#1)
was more dramatic##2##3##(2008-12#1)(2008-3#1)
was more effective at##4##4##(2008-10#2)(2010-4#1)(2012-3#1)
was more effective in##7##4##(1992-5#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
was more effective than##10##4##(1992-9#1)(1995-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2012-12#1)
was more effective##26##3##(1992-5#1)(1992-9#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#8)(2008-5#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
was more efficacious##2##3##(2008-10#1)(2011-2#1)
was more efficient in##4##4##(2008-10#2)(2009-3#1)(2012-3#1)
was more efficient than##5##4##(1994-12#1)(1994-5#1)(2008-10#2)(2012-3#1)
was more efficient##13##3##(1992-11#1)(1994-12#1)(1994-5#1)(2008-10#5)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#2)
was more evident in##2##4##(1992-12#1)(2008-10#1)
was more evident##3##3##(1992-12#1)(2008-10#1)(2009-7#1)
was more frequent among##3##4##(1997-3#1)(2008-9#1)(2013-8#1)
was more frequent in##7##4##(1994-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
was more frequent than##2##4##(2007-10#1)(2011-1#1)
was more frequent##14##3##(1994-7#1)(1997-3#1)(2007-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
was more frequently observed in##2##5##(2008-10#1)(2011-1#1)
was more frequently##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
was more highly##2##3##(1997-2#1)(2008-10#1)
was more important than##2##4##(2008-10#1)(2008-8#1)
was more important##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
was more in##3##3##(1994-7#1)(2007-7#1)(2013-1#1)
was more informative than##2##4##(2008-10#2)
was more intense##3##3##(1993-11#1)(1994-5#1)(2008-10#1)
was more likely to##2##4##(2008-11#1)(2008-8#1)
was more likely##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
was more marked in##2##4##(1990-11#1)(1991-12#1)
was more marked##3##3##(1990-11#1)(1991-12#1)(2008-11#1)
was more often##2##3##(1993-8#1)(2008-4#1)
was more or less##2##4##(2008-10#1)(2008-11#1)
was more potent in##2##4##(1990-12#1)(1992-3#1)
was more potent than##4##4##(1994-6#1)(1995-12#2)(1996-2#1)
was more potent##6##3##(1990-12#1)(1992-3#1)(1994-6#1)(1995-12#2)(1996-2#1)
was more prevalent in##5##4##(2007-2#1)(2008-10#2)(2010-1#1)(2011-2#1)
was more prevalent##7##3##(2007-2#1)(2008-10#4)(2010-1#1)(2011-2#1)
was more prominent##2##3##(1996-6#1)(2012-3#1)
was more pronounced at##4##4##(1991-2#1)(2008-10#3)
was more pronounced in the##3##5##(1997-1#1)(2008-7#1)(2010-3#1)
was more pronounced in##9##4##(1993-2#1)(1993-5#1)(1994-11#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)
was more pronounced##14##3##(1991-2#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-5#1)(1997-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
was more rapid##2##3##(1993-6#1)(1995-2#1)
was more remarkable in the##2##5##(2007-6#1)(2008-11#1)
was more resistant to##2##4##(2008-10#1)(2008-3#1)
was more robust and##2##4##(2008-11#1)(2008-3#1)
was more robust##3##3##(2008-11#2)(2008-3#1)
was more sensitive than the##2##5##(1994-12#1)(2008-10#1)
was more sensitive than##5##4##(1990-3#1)(1994-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
was more sensitive to##9##4##(1992-7#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)
was more sensitive##17##3##(1990-3#1)(1992-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-2#1)(2007-10#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-6#1)(2009-6#1)
was more serious in##2##4##(1993-12#1)(2008-2#1)
was more severe##3##3##(2008-10#2)(2008-5#1)
was more significant##3##3##(1997-5#1)(2008-10#1)(2011-2#1)
was more specific##2##3##(2008-3#1)(2011-2#1)
was more stable and##2##4##(1993-11#1)(2008-12#1)
was more stable##6##3##(1990-12#1)(1993-11#1)(1994-11#1)(1995-5#1)(2008-10#1)(2008-12#1)
was more strongly correlated with##2##5##(2008-9#1)(2012-3#1)
was more strongly##4##3##(2008-9#1)(2009-7#1)(2010-2#1)(2012-3#1)
was more than 3##2##4##(1991-8#1)(2008-3#1)
was more than in##2##4##(1994-7#1)(2012-3#1)
was more than that of alpha-pinene##2##6##(2010-5#2)
was more than that of##3##5##(2008-7#1)(2010-5#2)
was more than##33##3##(1990-11#1)(1990-5#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-5#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
was more with Group I##2##5##(2010-7#2)
was more with Group##3##4##(2010-7#3)
was more with##4##3##(2010-7#3)(2011-1#1)
was more##288##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-8#1)(2007-10#3)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#63)(2008-11#15)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#23)(2012-12#4)(2012-2#3)(2012-3#7)(2012-9#1)(2013-1#8)(2013-8#5)
was most closely related to##8##5##(1997-8#1)(2008-10#5)(2008-5#1)(2008-9#1)
was most commonly##4##3##(2008-10#2)(2008-9#2)
was most dramatic##2##3##(1995-8#1)(2008-10#1)
was most effective in##3##4##(1992-6#1)(1997-8#1)(2008-4#1)
was most effective when##2##4##(2008-10#1)(2013-1#1)
was most effective##9##3##(1992-6#1)(1993-6#1)(1997-8#1)(2008-10#4)(2008-4#1)(2013-1#1)
was most frequent##2##3##(2008-5#1)(2008-6#1)
was most frequently##3##3##(2008-10#2)(2013-8#1)
was most highly expressed in##2##5##(2013-8#2)
was most important##2##3##(2007-11#1)(2008-10#1)
was most likely due to##2##5##(2007-10#1)(2008-10#1)
was most likely##10##3##(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2010-10#1)(2010-8#1)
was most often##2##3##(1993-3#1)(2008-5#1)
was most prevalent in##2##4##(2008-10#2)
was most prevalent##4##3##(2008-10#3)(2011-1#1)
was most probably##2##3##(2008-10#1)(2011-2#1)
was most prominent##2##3##(2008-2#1)(2008-6#1)
was most pronounced at##2##4##(1994-11#1)(1994-8#1)
was most pronounced in##5##4##(1990-7#1)(1993-8#1)(1995-2#1)(1996-5#1)(2008-8#1)
was most pronounced##9##3##(1990-7#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-8#1)(2013-8#1)
was most rapid##2##3##(2008-10#1)(2008-12#1)
was most similar to##2##4##(1992-9#1)(2008-10#1)
was most##87##2##(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-5#3)(1996-7#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#4)
was mostly due to##2##4##(1990-11#1)(2011-3#1)
was mostly in the##2##4##(2008-10#2)
was mostly##13##2##(1990-11#1)(1991-2#1)(1993-12#1)(2008-10#6)(2008-12#1)(2008-8#1)(2011-3#1)(2012-2#1)
was motivated by##2##3##(1991-12#1)(2008-2#1)
was mounted in##2##3##(2008-10#1)(2008-3#1)
was mounted on a##2##4##(2008-10#1)(2008-5#1)
was mounted##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2012-1#1)
was moved##2##2##(2008-10#1)(2009-4#1)
was much better##2##3##(2007-11#1)(2008-3#1)
was much faster than##3##4##(2007-8#1)(2008-2#1)(2009-10#1)
was much faster##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#2)
was much fewer##2##3##(2008-5#1)(2008-9#1)
was much greater than##2##4##(2008-10#1)(2008-7#1)
was much greater##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
was much higher in##4##4##(1997-2#1)(1997-6#1)(2008-10#2)
was much higher than that##2##5##(2008-10#1)(2010-3#1)
was much higher than##6##4##(2008-10#3)(2008-8#1)(2009-2#1)(2010-3#1)
was much higher##11##3##(1997-2#1)(1997-6#1)(2008-10#6)(2008-8#1)(2009-2#1)(2010-3#1)
was much larger##3##3##(1995-6#1)(1997-2#1)(2008-10#1)
was much less than that##2##5##(1990-12#1)(2010-2#1)
was much less##8##3##(1990-12#2)(1992-11#1)(1994-8#1)(1996-1#1)(1996-2#1)(2008-10#1)(2010-2#1)
was much lower than that in##2##6##(1993-11#1)(2008-7#1)
was much lower than that of##3##6##(1994-2#1)(2008-8#2)
was much lower than that##6##5##(1993-11#1)(1994-2#1)(2008-10#1)(2008-7#1)(2008-8#2)
was much lower than##10##4##(1993-11#1)(1994-2#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#3)(2013-8#1)
was much lower##17##3##(1992-8#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-3#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#3)(2011-3#1)(2013-8#1)
was much more rapid##2##4##(2008-10#1)(2008-11#1)
was much more than##2##4##(2007-2#1)(2008-8#1)
was much more##18##3##(1990-2#1)(1991-5#1)(1993-5#1)(1994-3#1)(1996-4#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#2)(2011-2#2)(2013-1#1)
was much shorter than##2##4##(1991-12#1)(2008-10#1)
was much slower##3##3##(1993-6#1)(1993-8#1)(2008-8#1)
was much##84##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-6#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#2)(2009-2#1)(2010-2#1)(2010-3#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
was mutagenic##2##2##(1993-11#1)(2008-9#1)
was mutated##6##2##(1990-8#1)(1991-2#1)(1995-2#1)(2008-12#1)(2008-4#1)(2013-8#1)
was named as##2##3##(2008-7#1)(2010-8#1)
was named##19##2##(1990-7#1)(1991-9#1)(1993-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
was narrow##2##2##(1997-3#1)(2008-9#1)
was narrowed##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
was near##6##2##(1993-12#1)(1997-2#2)(1997-5#1)(2007-7#1)(2008-3#1)
was nearly identical to##2##4##(1997-2#1)(2008-10#1)
was nearly identical##5##3##(1997-2#1)(2008-10#3)(2011-2#1)
was nearly##20##2##(1992-8#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-2#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
was necessary for the##4##4##(1994-11#1)(1994-9#1)(2010-5#1)(2011-2#1)
was necessary for##13##3##(1990-5#1)(1992-4#1)(1994-11#1)(1994-9#1)(1996-2#1)(2007-10#1)(2008-10#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
was necessary in##7##3##(1994-2#1)(1994-9#1)(2007-8#1)(2007-9#1)(2008-6#1)(2011-2#2)
was necessary to use##2##4##(1992-9#1)(2008-10#1)
was necessary to##19##3##(1990-2#2)(1990-5#1)(1990-9#1)(1992-6#1)(1992-9#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)
was necessary##57##2##(1990-2#2)(1990-5#2)(1990-9#1)(1991-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#6)(2012-2#1)(2013-1#2)
was needed and##3##3##(1996-1#1)(2008-10#1)(2013-1#1)
was needed due to##2##4##(2007-11#1)(2008-10#1)
was needed for##3##3##(1990-5#1)(1992-12#1)(2008-7#1)
was needed in##2##3##(2008-10#1)(2008-11#1)
was needed to##8##3##(1994-3#1)(1997-2#1)(2008-10#4)(2008-9#1)(2011-2#1)
was needed##24##2##(1990-5#1)(1992-12#1)(1994-3#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
was negative and##2##3##(2008-7#1)(2013-1#1)
was negative for##7##3##(1995-4#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
was negative in##3##3##(2007-7#2)(2008-11#1)
was negative##42##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-6#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-4#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
was negatively associated with##3##4##(2008-8#1)(2011-2#1)(2013-8#1)
was negatively correlated to##2##4##(2008-10#1)(2012-2#1)
was negatively correlated with plant tissue nitrogen content and positively correlated with##2##12##(2008-10#2)
was negatively correlated with##14##4##(2008-10#9)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#2)
was negatively correlated##17##3##(2008-10#11)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-2#1)
was negatively related to later-life appraisals##2##6##(2013-1#2)
was negatively##26##2##(2008-10#12)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
was neglected##2##2##(2008-5#1)(2008-8#1)
was negligent##2##2##(1991-7#1)(1995-6#1)
was negligible for##3##3##(1991-5#1)(1991-9#1)(2008-10#1)
was negligible##10##2##(1990-2#1)(1991-5#1)(1991-9#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#4)
was neither##9##2##(1990-2#1)(1992-3#1)(1995-3#1)(1995-6#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
was neurologically##2##2##(2008-7#1)(2011-2#1)
was neutralized##3##2##(1997-1#1)(2008-10#2)
was never observed##4##3##(1993-6#1)(2008-10#2)(2012-3#1)
was never##15##2##(1990-8#1)(1993-6#1)(1996-11#1)(2006-12#1)(2007-5#1)(2008-10#4)(2008-5#1)(2009-10#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
was newly synthesized##2##3##(2008-10#1)(2008-9#1)
was nil##2##2##(1991-6#1)(2008-7#1)
was nine##2##2##(2012-3#1)(2013-8#1)
was no association with##3##4##(2008-1#1)(2008-12#1)(2008-9#1)
was no association##8##3##(1993-1#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
was no change in the##7##5##(1990-5#1)(1991-2#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-3#1)(2008-7#1)
was no change in##10##4##(1990-5#1)(1991-2#1)(1995-2#1)(1996-12#2)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
was no change##11##3##(1990-5#1)(1991-2#1)(1995-2#1)(1996-12#2)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
was no clear##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
was no clinical##2##3##(2008-4#1)(2012-3#1)
was no correlation between##14##4##(1991-11#1)(1991-8#2)(1993-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#2)
was no correlation##18##3##(1991-11#1)(1991-8#2)(1993-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2011-2#3)(2013-1#1)
was no difference between the##6##5##(1990-2#1)(1990-5#1)(1990-7#1)(2007-10#1)(2008-9#1)(2013-1#1)
was no difference between##11##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1994-3#1)(2007-10#2)(2008-10#1)(2008-9#1)(2010-5#1)(2013-1#1)
was no difference in the##12##5##(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
was no difference in##37##4##(1990-11#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#6)
was no difference##53##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-12#2)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-3#2)(2007-10#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
was no effect of##4##4##(1995-11#1)(1996-12#1)(2008-10#1)(2009-3#1)
was no effect on##3##4##(1992-2#1)(1995-2#1)(1997-6#1)
was no effect##9##3##(1990-5#1)(1992-2#1)(1992-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-10#1)(2009-3#1)
was no evidence of a##3##5##(1996-7#1)(2007-12#1)(2013-1#1)
was no evidence of any##2##5##(1990-3#1)(1996-3#1)
was no evidence of##34##4##(1990-3#1)(1991-1#1)(1991-6#1)(1992-5#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#6)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was no evidence that##4##4##(1993-9#1)(1996-3#1)(2008-10#1)(2008-9#1)
was no evidence##41##3##(1990-3#1)(1991-1#1)(1991-6#1)(1992-5#1)(1993-9#1)(1996-1#1)(1996-3#2)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-7#1)(2008-8#1)(2008-9#7)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was no higher than##2##4##(2008-10#1)(2012-2#1)
was no increase in##4##4##(1991-3#1)(1992-6#1)(1995-11#2)
was no interference##6##3##(1993-2#1)(2008-10#4)(2010-5#1)
was no longer##12##3##(1990-5#1)(1990-8#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-2#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-11#2)
was no marked##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
was no mortality##5##3##(1991-6#1)(1997-8#1)(2007-8#1)(2008-5#1)(2008-7#1)
was no need to##2##4##(2007-11#2)
was no other##3##3##(2008-7#2)(2009-9#1)
was no preceding##2##3##(1994-7#1)(2009-4#1)
was no recurrence##5##3##(2007-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
was no relationship between the##5##5##(1990-2#1)(1991-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
was no relationship between##12##4##(1990-2#1)(1991-11#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
was no relationship##13##3##(1990-2#1)(1991-11#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
was no response##2##3##(2008-10#1)(2010-12#1)
was no significant association with##3##5##(1995-8#2)(2008-12#1)
was no significant association##5##4##(1994-7#1)(1995-8#2)(2008-12#1)(2011-1#1)
was no significant change in##5##5##(1990-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
was no significant change##6##4##(1990-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
was no significant correlation between DNA##2##6##(1994-12#1)(2008-10#1)
was no significant correlation between the##5##6##(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#1)(2010-3#1)
was no significant correlation between##12##5##(1994-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-3#1)
was no significant correlation##13##4##(1994-12#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-3#1)
was no significant difference among##3##5##(2008-10#2)(2013-1#1)
was no significant difference between the##11##6##(1993-8#1)(1997-8#1)(1997-9#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)
was no significant difference between##29##5##(1991-11#1)(1991-8#3)(1993-2#1)(1993-8#1)(1997-8#1)(1997-9#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2011-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was no significant difference in latency##2##6##(1992-9#1)(2011-2#1)
was no significant difference in the percentage of isolates in each group##2##12##(1991-8#2)
was no significant difference in the proportion of##2##8##(2011-2#1)(2012-3#1)
was no significant difference in the##19##6##(1990-7#1)(1991-2#1)(1991-8#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-8#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)
was no significant difference in##45##5##(1990-7#1)(1991-2#1)(1991-8#2)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#3)(2012-7#1)(2013-1#2)
was no significant difference##84##4##(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#5)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-4#1)(1997-8#1)(1997-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#1)
was no significant differences##2##4##(2008-7#1)(2013-1#1)
was no significant increase in##3##5##(1997-6#1)(2008-2#1)(2013-1#1)
was no significant increase##5##4##(1997-6#1)(2008-11#1)(2008-2#1)(2013-1#2)
was no significant interaction##3##4##(2008-10#2)(2008-12#1)
was no significant relationship between##3##5##(2007-5#1)(2008-10#1)(2008-6#1)
was no significant relationship##4##4##(2007-5#1)(2008-10#2)(2008-6#1)
was no significant##136##3##(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#5)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#2)(1997-2#1)(1997-6#1)(1997-8#2)(1997-9#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#5)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#7)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#1)
was no statistical difference between##6##5##(1996-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
was no statistical difference in the##2##6##(1991-5#1)(2011-1#1)
was no statistical difference in##3##5##(1990-12#1)(1991-5#1)(2011-1#1)
was no statistical difference##10##4##(1990-12#1)(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
was no statistical##13##3##(1990-12#1)(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#3)
was no statistically significant difference between##2##6##(2007-7#1)(2009-12#1)
was no statistically significant difference in##5##6##(1994-2#1)(2008-11#1)(2008-12#1)(2010-9#1)(2012-2#1)
was no statistically significant difference##10##5##(1994-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
was no statistically significant##12##4##(1994-2#1)(1996-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
was no statistically valid##2##4##(2007-8#1)(2011-2#1)
was no statistically##14##3##(1994-2#1)(1996-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
was no##491##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#6)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#5)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#7)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#5)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-7#3)(1994-8#1)(1995-11#4)(1995-12#2)(1995-2#8)(1995-3#2)(1995-4#1)(1995-8#3)(1996-1#1)(1996-12#8)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#4)(1997-3#4)(1997-6#2)(1997-8#4)(1997-9#1)(2006-6#1)(2006-8#2)(2007-10#8)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#11)(2008-10#74)(2008-11#18)(2008-12#11)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#8)(2008-7#18)(2008-8#8)(2008-9#20)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#14)(2011-2#23)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#10)(2012-7#1)(2012-8#1)(2013-1#25)(2013-7#2)(2013-8#13)
was nominated by##3##3##(2008-9#3)
was nominated for study by##2##5##(2008-9#2)
was nominated for##3##3##(2008-9#3)
was nominated##7##2##(2008-9#7)
was noncompetitive##3##2##(1992-3#3)
was nonetheless##2##2##(1995-12#1)(2011-2#1)
was nonreactive##2##2##(1994-12#2)
was normal at##2##3##(1991-6#1)(2013-1#1)
was normal in##4##3##(1991-3#1)(1994-8#1)(2010-12#1)(2013-1#1)
was normal##33##2##(1990-6#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-6#1)(1994-8#1)(1997-8#2)(2007-12#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#7)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
was normalized to##2##3##(1993-12#1)(2008-10#1)
was normalized##3##2##(1993-12#1)(2008-10#2)
was not a good##2##4##(2008-10#2)
was not a major##3##4##(1994-1#2)(2008-10#1)
was not a significant##3##4##(1996-1#1)(2011-2#2)
was not a##28##3##(1991-9#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-7#1)(1994-8#1)(1995-2#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#2)(2010-1#1)(2011-2#3)(2013-1#2)
was not able to##6##4##(1992-3#1)(1995-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
was not abundant##2##3##(2008-6#1)(2009-7#1)
was not accompanied by an increase in##2##7##(1994-6#1)(1995-12#1)
was not accompanied by##5##4##(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-11#1)
was not accompanied##6##3##(1991-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-11#1)
was not achieved##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
was not active##2##3##(2008-11#1)(2011-3#1)
was not affected at##3##4##(1993-12#1)(1997-4#1)(2013-1#1)
was not affected by the presence of##2##7##(1992-8#1)(2008-10#1)
was not affected by the##8##5##(1992-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)
was not affected by tillage##2##5##(2008-10#2)
was not affected by##42##4##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
was not affected under##2##4##(1997-2#1)(2012-12#1)
was not affected##64##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-12#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was not altered by##4##4##(1994-3#1)(1995-11#1)(1995-3#1)(1997-7#1)
was not altered in##2##4##(2008-12#1)(2011-2#1)
was not altered##11##3##(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
was not always##8##3##(1991-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)
was not an##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
was not anticipated##2##3##(1995-5#1)(2009-10#1)
was not any##3##3##(1995-2#1)(2007-2#1)(2008-7#1)
was not apparent##4##3##(1995-1#1)(1997-2#1)(2008-10#1)(2008-7#1)
was not as common as in##2##6##(2008-1#2)
was not as effective as##5##5##(2007-11#1)(2008-10#3)(2013-1#1)
was not as effective##6##4##(2007-11#1)(2008-10#3)(2013-1#2)
was not as sensitive##2##4##(1991-3#1)(2011-2#1)
was not as##13##3##(1991-3#1)(1995-5#1)(2007-11#1)(2008-1#2)(2008-10#5)(2011-2#1)(2013-1#2)
was not associated with a##3##5##(1992-8#1)(2008-12#1)(2012-2#1)
was not associated with an##2##5##(2009-10#1)(2012-2#1)
was not associated with any##4##5##(2008-10#2)(2008-12#1)(2012-3#1)
was not associated with the##3##5##(2008-10#1)(2012-3#1)(2013-1#1)
was not associated with##36##4##(1992-8#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2009-10#2)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
was not attached to any##2##5##(2013-1#2)
was not available for##2##4##(2008-11#1)(2011-1#1)
was not available##7##3##(2008-11#1)(2008-7#2)(2010-3#3)(2011-1#1)
was not being##2##3##(2010-1#1)(2013-1#1)
was not blocked by##2##4##(1990-5#1)(1993-6#1)
was not changed significantly##2##4##(1993-11#1)(2008-11#1)
was not changed##7##3##(1993-11#1)(1994-6#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
was not clear##4##3##(1993-11#1)(2008-10#1)(2008-11#1)(2009-6#1)
was not closely related to##2##5##(2008-10#2)
was not common##3##3##(1991-6#1)(2008-10#2)
was not completely##2##3##(1990-2#1)(2008-10#1)
was not compromised##2##3##(2008-10#1)(2012-6#1)
was not confirmed in the##2##5##(1992-2#1)(2008-1#1)
was not confirmed in##4##4##(1992-2#1)(2007-8#1)(2008-1#1)(2011-2#1)
was not confirmed##6##3##(1990-6#1)(1992-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
was not considered##5##3##(1992-5#1)(2007-7#1)(2008-10#1)(2010-10#1)(2013-1#1)
was not consistent with the##2##5##(2008-1#1)(2008-10#1)
was not consistent##4##3##(1997-4#1)(2008-1#1)(2008-10#2)
was not consistently##4##3##(1990-3#1)(2008-10#2)(2012-2#1)
was not constant throughout the##2##5##(1993-3#1)(2008-7#1)
was not correlated to##2##4##(1994-6#1)(2008-10#1)
was not correlated with##10##4##(1991-8#1)(1992-9#1)(2008-10#5)(2008-9#1)(2010-6#1)(2011-1#1)
was not correlated##14##3##(1991-8#1)(1992-9#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)
was not cytotoxic##2##3##(1994-8#1)(1997-4#1)
was not dependent on the##2##5##(2012-2#1)(2013-8#1)
was not dependent on##3##4##(1995-12#1)(2012-2#1)(2013-8#1)
was not dependent upon##3##4##(1991-12#1)(2008-10#1)(2008-5#1)
was not dependent##6##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
was not detectable in##3##4##(1991-5#1)(1994-11#1)(2008-10#1)
was not detectable##8##3##(1991-12#1)(1991-5#1)(1993-6#1)(1994-11#1)(1997-4#1)(2008-10#2)(2008-9#1)
was not detected at all in##2##6##(1995-11#1)(2008-10#1)
was not detected at##4##4##(1995-11#1)(2008-10#2)(2008-5#1)
was not detected by##2##4##(1994-11#1)(2008-10#1)
was not detected during the##2##5##(1997-2#1)(2008-10#1)
was not detected in all##2##5##(2008-10#2)
was not detected in any##2##5##(1993-9#1)(2008-12#1)
was not detected in the##9##5##(1990-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
was not detected in##26##4##(1990-9#1)(1991-12#1)(1993-9#1)(1996-2#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
was not detected##49##3##(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#2)(1996-2#1)(1997-2#1)(1997-6#1)(2007-5#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
was not determined##3##3##(1995-9#1)(1997-3#1)(2008-10#1)
was not different between##3##4##(1994-5#1)(2012-3#1)(2013-8#1)
was not different from##2##4##(1994-8#1)(2008-10#1)
was not different in##4##4##(1990-2#1)(1990-8#1)(2007-7#1)(2009-7#1)
was not different##12##3##(1990-2#1)(1990-8#1)(1994-5#1)(1994-8#1)(2007-7#1)(2008-10#3)(2009-7#1)(2012-3#1)(2013-8#2)
was not directly##4##3##(1990-8#1)(1997-6#1)(2008-10#1)(2008-11#1)
was not done##4##3##(1992-2#1)(1994-8#1)(1995-4#1)(2008-7#1)
was not due to a##7##5##(1992-3#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2009-6#1)
was not due to an##3##5##(1990-8#1)(1997-1#1)(1997-7#1)
was not due to lack of##2##6##(1993-6#1)(2007-12#1)
was not due to the##4##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
was not due to##25##4##(1990-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-6#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
was not due##27##3##(1990-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-6#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2009-6#1)(2013-1#1)
was not effective in##5##4##(1993-5#1)(2008-1#1)(2008-10#2)(2010-1#1)
was not effective##8##3##(1992-12#1)(1993-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-1#1)
was not elevated##2##3##(1995-5#1)(2011-2#1)
was not enhanced by##2##4##(2008-10#1)(2008-11#1)
was not enough to##2##4##(1996-2#1)(2008-9#1)
was not enough##3##3##(1996-2#1)(2008-4#1)(2008-9#1)
was not evident##5##3##(2008-10#1)(2008-7#1)(2011-1#2)(2011-2#1)
was not exposed##2##3##(1995-12#1)(2008-8#1)
was not expressed##2##3##(1993-6#1)(2008-8#1)
was not followed by##2##4##(1997-3#1)(2010-12#1)
was not found in any of the##2##7##(1991-8#1)(2006-8#1)
was not found in any##4##5##(1991-4#1)(1991-8#1)(2006-8#1)(2008-10#1)
was not found in##11##4##(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-9#1)(2006-8#1)(2008-10#4)(2008-9#1)
was not found to be##5##5##(1996-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-12#1)
was not found to##12##4##(1991-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1996-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
was not found##32##3##(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1996-2#1)(1996-6#1)(2006-8#1)(2008-10#7)(2008-5#1)(2008-6#2)(2008-9#2)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#1)(2013-1#1)
was not fully##2##3##(2007-8#1)(2008-10#1)
was not generally##2##3##(1994-2#2)
was not given##2##3##(1990-6#1)(1994-6#1)
was not higher##3##3##(2007-10#1)(2008-10#1)(2010-2#1)
was not identified##2##3##(2008-11#1)(2012-3#1)
was not impaired##3##3##(2008-4#1)(2008-7#2)
was not implemented##2##3##(2008-10#1)(2010-10#1)
was not improved##2##3##(2008-10#2)
was not in itself##2##4##(1990-12#1)(2007-6#1)
was not in##7##3##(1990-12#1)(1993-6#1)(1995-6#1)(2007-5#1)(2007-6#1)(2008-10#1)(2011-2#1)
was not increased##3##3##(1997-1#1)(2007-7#1)(2008-1#1)
was not induced by##3##4##(1995-5#1)(2011-2#1)(2012-2#1)
was not induced##6##3##(1994-8#1)(1995-5#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
was not influenced by the##5##5##(1991-9#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
was not influenced by##11##4##(1990-12#1)(1991-12#1)(1991-9#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
was not influenced##12##3##(1990-12#1)(1991-12#1)(1991-9#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
was not inhibited by##9##4##(1990-2#1)(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
was not inhibited in##2##4##(1996-12#1)(2008-10#1)
was not inhibited##15##3##(1990-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
was not initially considered##2##4##(2008-12#1)(2013-1#1)
was not investigated##2##3##(2008-10#1)(2011-2#1)
was not involved in the##3##5##(1995-2#1)(2008-10#2)
was not involved in##5##4##(1995-2#1)(1997-4#1)(2008-10#3)
was not involved##6##3##(1995-2#1)(1997-4#1)(2008-10#3)(2008-11#1)
was not known##6##3##(1990-12#1)(1992-8#1)(2007-10#1)(2008-10#2)(2008-12#1)
was not lethal##2##3##(2008-10#2)
was not likely##2##3##(2008-10#2)
was not lower##2##3##(2008-10#1)(2012-12#1)
was not maintained##3##3##(1994-6#1)(2008-4#1)(2009-12#1)
was not mentioned in##2##4##(2007-12#1)(2008-7#1)
was not mentioned##5##3##(2007-12#1)(2008-7#3)(2012-12#1)
was not mimicked by##2##4##(1993-3#1)(2008-5#1)
was not modified by##4##4##(1994-8#1)(1995-12#1)(2008-10#1)(2009-9#1)
was not modified##7##3##(1994-8#2)(1995-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
was not more effective than##2##5##(2008-8#2)
was not more##4##3##(2007-8#1)(2008-10#1)(2008-8#2)
was not mutagenic in##4##4##(1995-11#1)(2008-9#3)
was not necessary##4##3##(1995-2#1)(2008-10#3)
was not observed for##2##4##(2007-10#1)(2008-10#1)
was not observed in any##3##5##(1995-3#1)(1996-5#1)(2009-5#1)
was not observed in the presence of##2##7##(1994-11#1)(1995-3#1)
was not observed in the##11##5##(1992-2#1)(1993-11#1)(1994-11#2)(1995-11#1)(1995-3#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-1#1)
was not observed in##27##4##(1991-12#1)(1992-2#1)(1993-11#1)(1994-11#2)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-8#1)(2008-10#5)(2008-11#3)(2008-3#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
was not observed on##2##4##(2008-10#1)(2013-8#1)
was not observed when##2##4##(1995-3#1)(2008-6#1)
was not observed##60##3##(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-12#1)(1996-5#3)(1997-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-9#1)(2010-10#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
was not obtained##4##3##(2008-10#2)(2008-12#2)
was not of##3##3##(1993-2#1)(2008-10#2)
was not only the##2##4##(1992-6#1)(2011-2#1)
was not only##9##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-2#2)(2012-12#1)
was not performed##2##3##(1996-3#1)(2007-11#1)
was not possible because of##2##5##(1991-11#1)(2008-10#1)
was not possible to##11##4##(1992-9#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-2#1)
was not possible with the##2##5##(2008-10#1)(2008-3#1)
was not possible##21##3##(1991-11#1)(1992-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#3)(2008-7#1)(2010-2#1)
was not powered to##2##4##(2008-5#1)(2010-10#1)
was not powered##3##3##(2008-5#1)(2010-10#1)(2013-1#1)
was not predictive of##3##4##(2007-2#1)(2008-9#1)(2011-2#1)
was not present in##4##4##(1995-8#1)(2008-11#1)(2011-2#2)
was not present##9##3##(1994-11#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#3)
was not previously##2##3##(1996-2#1)(2008-9#1)
was not produced##2##3##(1997-8#1)(2008-11#1)
was not properly##3##3##(1995-6#2)(2008-11#1)
was not random##2##3##(2008-10#1)(2008-8#1)
was not reached##4##3##(1993-12#1)(1997-7#1)(2008-10#1)(2012-12#1)
was not recognized##2##3##(1993-8#1)(2008-10#1)
was not reduced by##2##4##(1995-2#1)(2008-10#1)
was not reduced in##2##4##(1993-12#1)(2011-2#1)
was not reduced##9##3##(1991-5#1)(1993-12#1)(1995-2#1)(1996-11#1)(2008-10#3)(2011-2#1)(2013-7#1)
was not regulated by##2##4##(1995-8#1)(1997-2#1)
was not related to the##7##5##(1992-2#1)(1993-10#1)(1994-9#1)(1996-1#1)(2008-10#1)(2008-9#1)(2011-1#1)
was not related to##21##4##(1991-12#2)(1992-2#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-1#1)
was not related##22##3##(1991-12#2)(1991-8#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-1#1)
was not reported##4##3##(1994-3#1)(2008-12#1)(2010-12#1)(2012-12#1)
was not required for the##2##5##(1992-10#1)(2008-11#1)
was not required for##6##4##(1992-10#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
was not required##11##3##(1992-10#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
was not resolved##2##3##(1991-3#1)(2008-4#1)
was not restricted to##2##4##(2008-10#1)(2008-11#1)
was not restricted##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
was not retained##2##3##(1992-6#1)(2008-10#1)
was not reversed by##2##4##(1992-3#1)(2013-1#1)
was not seen in##3##4##(1992-7#1)(1994-5#1)(2008-1#1)
was not seen until##2##4##(1997-3#2)
was not seen with##2##4##(2008-6#1)(2008-8#1)
was not seen##10##3##(1990-12#1)(1992-7#1)(1992-9#1)(1994-5#1)(1997-3#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)
was not sensitive to##3##4##(1993-9#1)(2008-11#1)(2012-3#1)
was not shown##3##3##(1992-3#1)(2008-11#1)(2009-10#1)
was not significant (p##2##4##(2008-10#1)(2013-1#1)
was not significant between##2##4##(2007-8#1)(2011-2#1)
was not significant but##2##4##(2008-5#1)(2011-2#1)
was not significant##29##3##(1990-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#2)(1994-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
was not significantly affected by the##2##6##(1996-12#1)(2008-10#1)
was not significantly affected by##9##5##(1990-5#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2010-5#1)
was not significantly affected##14##4##(1990-5#1)(1996-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-6#1)(2010-11#1)(2010-5#1)(2012-2#1)
was not significantly altered by##2##5##(1992-1#1)(1995-12#1)
was not significantly altered in##3##5##(1995-6#1)(2008-10#1)(2008-9#1)
was not significantly altered##5##4##(1992-1#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-9#1)
was not significantly associated with##2##5##(2008-8#1)(2012-2#1)
was not significantly associated##3##4##(2008-8#1)(2012-12#1)(2012-2#1)
was not significantly changed by the##2##6##(2008-10#1)(2011-1#1)
was not significantly changed##3##4##(1992-6#1)(2008-10#1)(2011-1#1)
was not significantly different (P##2##5##(2008-10#2)
was not significantly different among the##2##6##(2008-7#1)(2013-1#1)
was not significantly different among##3##5##(2008-10#1)(2008-7#1)(2013-1#1)
was not significantly different between the two##2##7##(1995-12#1)(2013-1#1)
was not significantly different between the##3##6##(1995-12#1)(2011-2#1)(2013-1#1)
was not significantly different between##6##5##(1991-8#1)(1993-11#1)(1995-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
was not significantly different from that of##2##7##(1990-8#1)(2008-5#1)
was not significantly different from that##4##6##(1990-8#1)(2008-10#2)(2008-5#1)
was not significantly different from the mean##2##7##(2007-7#2)
was not significantly different from the##5##6##(1993-1#1)(1993-6#1)(2007-7#2)(2008-6#1)
was not significantly different from##15##5##(1990-8#1)(1993-1#1)(1993-6#1)(1995-8#1)(1996-12#1)(1997-6#1)(2007-7#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
was not significantly different than##2##5##(2008-10#1)(2009-12#1)
was not significantly different##33##4##(1990-8#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-6#2)(2007-7#2)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
was not significantly reduced##2##4##(2008-10#1)(2008-9#1)
was not significantly related to##2##5##(2007-7#1)(2012-12#1)
was not significantly##73##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-6#2)(1997-8#1)(2007-7#3)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
was not simply##2##3##(2007-11#1)(2008-11#1)
was not so##4##3##(1993-8#1)(2007-10#1)(2007-7#1)(2008-10#1)
was not solubilized##2##3##(1991-10#1)(1991-5#1)
was not specifically##2##3##(1997-4#1)(2008-10#1)
was not statistically different from##3##5##(1992-5#1)(2008-10#1)(2012-3#1)
was not statistically different##5##4##(1990-3#1)(1991-12#1)(1992-5#1)(2008-10#1)(2012-3#1)
was not statistically significant##20##4##(1990-11#1)(1990-6#1)(1991-6#1)(1996-12#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
was not statistically##26##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-5#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was not stimulated by##2##4##(1990-11#1)(1992-3#1)
was not subject to##2##4##(1991-7#1)(2008-10#1)
was not substantially##2##3##(1994-1#1)(2008-10#1)
was not successful##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2013-1#1)
was not sufficient for##2##4##(2008-10#1)(2012-2#1)
was not sufficient to##2##4##(1994-8#1)(1997-7#1)
was not sufficient##5##3##(1994-8#1)(1997-7#1)(2008-10#1)(2010-3#1)(2012-2#1)
was not suitable##2##3##(1996-7#1)(2008-10#1)
was not superior to##2##4##(1997-8#1)(2010-12#1)
was not supported##2##3##(1996-1#1)(1997-5#1)
was not suppressed##5##3##(1993-12#1)(1997-2#1)(2008-10#2)(2011-1#1)
was not suspected##3##3##(2007-12#1)(2007-7#2)
was not taken up by##2##5##(1994-12#1)(2008-11#1)
was not taken##3##3##(1994-12#1)(1995-3#1)(2008-11#1)
was not the case for##2##5##(2008-11#1)(2011-2#1)
was not the case##3##4##(1994-5#1)(2008-11#1)(2011-2#1)
was not the result of##3##5##(1996-2#1)(1997-1#1)(2008-12#1)
was not the same##2##4##(1997-8#1)(2008-10#1)
was not the##14##3##(1993-6#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
was not toxic to##2##4##(2008-10#1)(2008-7#1)
was not transmitted##3##3##(2008-10#3)
was not uniform##2##3##(2008-11#1)(2010-8#1)
was not used to##2##4##(1992-3#1)(1996-12#1)
was not used##10##3##(1992-11#1)(1992-3#1)(1993-10#1)(1994-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2009-7#1)(2012-12#1)(2013-1#1)
was not well##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
was not yet##2##3##(2008-2#1)(2013-1#1)
was not##1163##2##(1990-11#2)(1990-12#7)(1990-2#5)(1990-3#2)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#13)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#5)(1992-3#10)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#8)(1993-1#4)(1993-10#2)(1993-11#5)(1993-12#12)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#12)(1993-8#7)(1993-9#7)(1994-1#3)(1994-11#9)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#7)(1994-7#2)(1994-8#9)(1994-9#3)(1995-1#1)(1995-11#9)(1995-12#9)(1995-2#14)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#8)(1995-8#5)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#13)(1996-2#8)(1996-3#2)(1996-5#5)(1996-6#1)(1996-7#2)(1997-1#6)(1997-2#10)(1997-3#7)(1997-4#7)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#9)(2006-8#1)(2007-10#6)(2007-11#7)(2007-12#6)(2007-2#3)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#11)(2008-1#10)(2008-10#258)(2008-11#54)(2008-12#23)(2008-2#3)(2008-3#10)(2008-4#11)(2008-5#27)(2008-6#11)(2008-7#35)(2008-8#20)(2008-9#24)(2009-10#8)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#5)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#14)(2011-2#38)(2011-3#1)(2012-1#2)(2012-12#23)(2012-2#17)(2012-3#13)(2012-6#1)(2013-1#37)(2013-7#2)(2013-8#11)
was notable##3##2##(1992-8#1)(1995-12#1)(2011-2#1)
was noted among##2##3##(2007-7#1)(2013-8#1)
was noted and##2##3##(2008-7#1)(2012-12#1)
was noted as##2##3##(2008-12#1)(2008-9#1)
was noted at the##3##4##(1990-3#1)(2008-7#1)(2013-1#1)
was noted at##8##3##(1990-3#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-1#1)
was noted between##7##3##(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-7#1)(2013-1#1)
was noted following##2##3##(2008-10#1)(2012-3#1)
was noted for the##3##4##(2008-10#1)(2008-9#1)(2010-3#1)
was noted for##5##3##(1993-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-3#1)
was noted in patients with hypoalbuminemia##2##6##(2013-1#2)
was noted in patients with##3##5##(2012-12#1)(2013-1#2)
was noted in the presence of##2##6##(1992-3#1)(1993-12#1)
was noted in the##12##4##(1991-12#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-7#1)(2010-3#1)(2010-6#1)
was noted in two other##2##5##(2007-7#1)(2007-8#1)
was noted in two##4##4##(2007-7#1)(2007-8#2)(2012-2#1)
was noted in##40##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-9#1)(1997-1#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
was noted that##5##3##(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
was noted to have##3##4##(2008-1#1)(2011-1#1)(2013-1#1)
was noted to##5##3##(2008-1#1)(2011-1#1)(2012-3#1)(2013-1#2)
was noted when##4##3##(1992-3#1)(1996-3#1)(1997-2#1)(2008-10#1)
was noted with##2##3##(1994-8#1)(2008-6#1)
was noted##112##2##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-12#2)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#7)(2009-1#1)(2009-3#2)(2009-5#1)(2009-7#2)(2010-3#2)(2010-6#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#3)(2012-7#1)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#2)
was noticeable in##2##3##(1994-6#1)(2008-5#1)
was noticeable##5##2##(1992-5#1)(1994-6#1)(2008-3#1)(2008-5#2)
was noticed for##2##3##(1990-12#1)(2007-11#1)
was noticed in##4##3##(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
was noticed on the##2##4##(2008-11#1)(2010-12#1)
was noticed that##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
was noticed##19##2##(1990-12#1)(2007-11#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
was now##3##2##(1992-11#1)(1997-3#1)(2008-6#1)
was obeyed over the range 0##2##6##(2008-10#2)
was obeyed over the range of 0##2##7##(2008-10#2)
was obeyed over the range##6##5##(2008-10#6)
was obeyed over the##8##4##(2008-10#8)
was obeyed##15##2##(2008-10#15)
was obscured##2##2##(1995-11#1)(2008-2#1)
was observed 4##2##3##(1995-12#1)(2008-11#1)
was observed a##4##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-11#1)
was observed after 8 h with##2##6##(2008-7#2)
was observed after addition of##2##5##(1993-8#1)(2013-1#1)
was observed after the##2##4##(1995-2#1)(2011-2#1)
was observed after##20##3##(1991-12#1)(1992-10#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
was observed against##2##3##(2008-10#1)(2012-12#1)
was observed along with##2##4##(1995-5#1)(2008-10#1)
was observed along##3##3##(1995-5#1)(2008-10#1)(2010-8#1)
was observed among isolates of##2##5##(2008-10#1)(2012-2#1)
was observed among isolates##4##4##(2008-10#3)(2012-2#1)
was observed among the##2##4##(2008-10#1)(2012-2#1)
was observed among##13##3##(2008-10#8)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#2)
was observed and the detection##2##5##(2008-10#2)
was observed and the##5##4##(1994-3#1)(2008-10#2)(2008-8#1)(2013-8#1)
was observed and##14##3##(1994-3#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2013-8#1)
was observed as the##2##4##(2007-11#1)(2008-5#1)
was observed as##6##3##(1991-2#1)(1994-12#1)(2007-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
was observed at 2##2##4##(2012-2#1)(2013-1#1)
was observed at 20##2##4##(1994-3#1)(2008-10#1)
was observed at 6##2##4##(1994-11#1)(1995-8#1)
was observed at a##2##4##(1992-8#1)(2007-11#1)
was observed at all##2##4##(2007-11#1)(2008-10#1)
was observed at high##4##4##(1994-5#1)(2008-10#1)(2008-12#2)
was observed at higher##2##4##(2008-10#2)
was observed at low##2##4##(2007-12#1)(2008-10#1)
was observed at the##8##4##(1993-6#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
was observed at##65##3##(1990-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#25)(2008-11#3)(2008-12#4)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
was observed because##2##3##(2008-10#1)(2008-12#1)
was observed between the two##3##5##(1990-2#1)(1992-10#1)(2008-10#1)
was observed between the##31##4##(1990-2#1)(1990-7#1)(1992-10#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-2#1)(2010-4#3)(2011-2#2)(2013-1#1)
was observed between##72##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-10#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#4)(2008-7#3)(2009-4#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
was observed both##2##3##(1993-9#1)(2008-5#1)
was observed by the addition of##2##6##(1992-6#1)(1997-2#1)
was observed by the##3##4##(1992-6#1)(1997-2#1)(2007-10#1)
was observed by using##4##4##(2008-10#2)(2008-2#1)(2008-8#1)
was observed by##21##3##(1991-5#1)(1992-6#1)(1993-11#1)(1994-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-3#1)(2012-3#1)
was observed due to##2##4##(2008-10#2)
was observed during the first##2##5##(2009-4#1)(2012-3#1)
was observed during the##10##4##(1994-5#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-3#1)
was observed during##20##3##(1994-5#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-1#2)(2012-3#1)
was observed experimentally##2##3##(2007-11#1)(2008-3#1)
was observed following microinjections of##2##5##(1990-7#1)(1993-12#1)
was observed following##4##3##(1990-7#1)(1993-12#1)(1993-3#1)(2008-5#1)
was observed for all##2##4##(1990-6#1)(1997-4#1)
was observed for both##4##4##(1995-2#1)(2008-10#2)(2011-2#1)
was observed for either##2##4##(2008-10#1)(2009-2#1)
was observed for the first time##3##6##(2008-10#1)(2008-12#1)(2008-9#1)
was observed for the##17##4##(1993-6#1)(1994-5#1)(1995-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-9#1)(2009-1#1)(2011-2#1)
was observed for##77##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#21)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was observed from the##5##4##(1991-9#1)(1992-5#1)(2008-10#2)(2012-3#1)
was observed from##18##3##(1991-9#1)(1992-5#1)(1995-2#1)(2008-10#10)(2008-11#2)(2008-12#2)(2012-3#1)
was observed if the##2##4##(2008-10#1)(2008-6#1)
was observed in 10##3##4##(1990-6#1)(1991-2#1)(1994-7#1)
was observed in 14 patients##2##5##(1991-4#1)(2013-1#1)
was observed in 14##3##4##(1991-4#1)(2007-11#1)(2013-1#1)
was observed in 16##3##4##(1990-2#1)(2007-11#1)(2008-5#1)
was observed in 2##2##4##(1992-12#1)(2008-9#1)
was observed in 3 patients##2##5##(1991-8#1)(1997-7#1)
was observed in 3##3##4##(1991-8#1)(1992-8#1)(1997-7#1)
was observed in EMR-F and EMR-A groups##3##7##(2008-12#3)
was observed in a range##2##5##(1993-9#1)(2010-4#1)
was observed in a##9##4##(1991-8#1)(1993-9#1)(2008-10#3)(2008-3#2)(2010-4#1)(2012-12#1)
was observed in all cases##3##5##(2007-12#1)(2008-5#1)(2013-7#1)
was observed in all three##2##5##(2008-10#2)
was observed in all##16##4##(1995-5#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
was observed in animals##2##4##(1993-6#1)(1994-7#1)
was observed in any##2##4##(1993-12#1)(2008-3#1)
was observed in both cases##2##5##(2008-7#1)(2013-8#1)
was observed in both##11##4##(1992-11#1)(1992-12#1)(1996-12#2)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
was observed in cells##3##4##(1990-8#1)(1995-6#1)(1997-4#1)
was observed in females##2##4##(1994-6#1)(2008-7#1)
was observed in five##2##4##(2008-10#1)(2012-3#1)
was observed in four##2##4##(1994-12#1)(2008-8#1)
was observed in intestinal##3##4##(1993-9#1)(1996-12#1)(2008-10#1)
was observed in most of the##2##6##(2008-6#1)(2011-2#1)
was observed in most##3##4##(2008-6#1)(2011-2#1)(2013-1#1)
was observed in one of##3##5##(2007-11#1)(2008-4#2)
was observed in one##5##4##(2007-11#1)(2008-4#3)(2008-7#1)
was observed in only##2##4##(1992-6#1)(1995-2#1)
was observed in patients with##3##5##(2007-11#1)(2010-12#1)(2011-2#1)
was observed in patients##5##4##(1996-6#1)(1996-7#1)(2007-11#1)(2010-12#1)(2011-2#1)
was observed in plants##2##4##(2008-10#2)
was observed in several##2##4##(2008-10#1)(2008-2#1)
was observed in six##3##4##(1997-3#1)(2008-10#1)(2008-5#1)
was observed in some cases##2##5##(2007-11#1)(2008-10#1)
was observed in some##5##4##(1990-7#1)(1993-12#1)(2007-11#1)(2008-10#1)(2009-4#1)
was observed in the absence of##2##6##(2008-11#2)
was observed in the case of##2##6##(2008-11#1)(2011-1#1)
was observed in the cells##2##5##(1994-9#1)(2008-9#1)
was observed in the cytoplasm of##2##6##(1995-8#1)(2008-11#1)
was observed in the nucleus accumbens##2##6##(1994-8#1)(1995-5#1)
was observed in the presence of##9##6##(1991-2#1)(1991-8#1)(1992-8#1)(1997-2#1)(2008-10#4)(2008-4#1)
was observed in the presence##10##5##(1991-2#1)(1991-8#1)(1992-3#1)(1992-8#1)(1997-2#1)(2008-10#4)(2008-4#1)
was observed in the##103##4##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#4)(1992-9#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
was observed in these##3##4##(1994-3#1)(2008-11#1)(2008-6#1)
was observed in this##2##4##(2008-1#1)(2008-5#1)
was observed in three##2##4##(1990-8#1)(2008-10#1)
was observed in two##2##4##(1997-3#1)(2008-5#1)
was observed in women##2##4##(1995-9#1)(2012-3#1)
was observed in##398##3##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#3)(1991-11#2)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#5)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#9)(1997-4#5)(1997-7#2)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#72)(2008-11#21)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#16)(2008-6#3)(2008-7#14)(2008-8#6)(2008-9#8)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#11)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#6)
was observed on both##2##4##(1990-8#1)(2008-5#1)
was observed on day##2##4##(1992-3#1)(2006-6#1)
was observed on fibronectin and polystyrene##2##6##(2008-11#2)
was observed on the surface##2##5##(2008-10#1)(2008-11#1)
was observed on the##11##4##(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)
was observed on##36##3##(1990-8#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-2#2)(1995-3#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#2)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#2)
was observed only for the##2##5##(2008-10#1)(2008-5#1)
was observed only in the##2##5##(2007-11#1)(2013-1#1)
was observed only in##7##4##(1990-8#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2013-1#1)
was observed only on##2##4##(2008-10#2)
was observed only when##2##4##(1992-9#1)(2008-10#1)
was observed only##19##3##(1990-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2009-2#1)(2009-6#1)(2013-1#1)
was observed over##4##3##(1990-12#1)(2008-10#2)(2008-3#1)
was observed that the##14##4##(1993-9#1)(2008-10#9)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
was observed that these##2##4##(1996-2#1)(2008-10#1)
was observed that##45##3##(1990-5#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-4#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
was observed throughout##2##3##(2009-8#1)(2013-1#1)
was observed to be linear##2##5##(2008-10#2)
was observed to be##8##4##(1992-3#1)(1993-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2013-1#1)
was observed to coincide with##2##5##(2007-12#1)(2008-11#1)
was observed to decrease##3##4##(2008-3#2)(2008-6#1)
was observed to occur##3##4##(1995-3#1)(1997-4#1)(2009-5#1)
was observed to##30##3##(1992-3#1)(1993-8#3)(1995-3#1)(1996-7#1)(1997-4#2)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#2)
was observed under the##2##4##(1993-6#1)(2008-10#1)
was observed under##7##3##(1993-1#1)(1993-6#1)(2008-10#4)(2008-11#1)
was observed up to 0##2##5##(1990-5#1)(2008-10#1)
was observed up to##4##4##(1990-5#1)(2008-10#2)(2013-8#1)
was observed upon##3##3##(1990-11#1)(1992-3#1)(2012-12#1)
was observed using##10##3##(1991-9#1)(1992-5#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)
was observed when HGF was added##2##6##(2008-11#2)
was observed when a##3##4##(1997-4#1)(2008-10#1)(2008-2#1)
was observed when cells##2##4##(2008-11#2)
was observed when compared with##2##5##(2008-10#1)(2011-2#1)
was observed when the##11##4##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(2007-11#1)(2008-10#4)(2008-5#1)(2010-4#1)
was observed when##41##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-11#2)(1994-6#1)(1997-4#1)(2007-11#1)(2008-10#12)(2008-11#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
was observed where##2##3##(2008-10#1)(2008-11#1)
was observed which##2##3##(2008-10#1)(2012-2#1)
was observed with a##6##4##(1990-5#1)(1993-9#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
was observed with an##2##4##(1990-11#1)(1993-12#1)
was observed with increasing##2##4##(2008-10#1)(2008-2#1)
was observed with the##6##4##(2008-10#1)(2008-11#1)(2008-5#3)(2013-1#1)
was observed with##47##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-7#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
was observed within the##4##4##(1991-12#1)(2007-11#1)(2008-10#2)
was observed within##9##3##(1991-12#1)(1994-11#1)(1995-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2012-12#1)
was observed##1343##2##(1990-10#2)(1990-11#4)(1990-12#10)(1990-2#7)(1990-3#1)(1990-5#9)(1990-6#6)(1990-7#9)(1990-8#6)(1991-10#1)(1991-11#3)(1991-12#12)(1991-2#7)(1991-4#2)(1991-5#13)(1991-6#4)(1991-8#7)(1991-9#8)(1992-10#4)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#9)(1992-5#4)(1992-6#7)(1992-8#10)(1992-9#6)(1993-1#2)(1993-11#5)(1993-12#14)(1993-2#2)(1993-3#6)(1993-6#8)(1993-8#7)(1993-9#12)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#4)(1994-3#8)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#5)(1995-11#5)(1995-12#9)(1995-2#13)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#4)(1995-8#7)(1995-9#1)(1996-1#1)(1996-12#11)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#13)(1997-4#12)(1997-6#1)(1997-7#4)(1997-8#2)(2006-6#1)(2006-8#1)(2007-10#5)(2007-11#23)(2007-12#19)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#5)(2008-10#346)(2008-11#77)(2008-12#28)(2008-2#17)(2008-3#27)(2008-4#10)(2008-5#46)(2008-6#18)(2008-7#36)(2008-8#18)(2008-9#17)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#6)(2009-2#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-11#6)(2010-12#6)(2010-2#5)(2010-3#3)(2010-4#11)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#15)(2011-2#30)(2011-3#5)(2012-1#4)(2012-12#10)(2012-2#18)(2012-3#16)(2013-1#38)(2013-7#6)(2013-8#16)
was obtained (r=0##2##3##(2008-10#2)
was obtained after a##2##4##(2008-10#1)(2008-8#1)
was obtained after##9##3##(1990-2#1)(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-8#1)(2012-2#1)
was obtained and the##4##4##(1997-5#1)(2008-10#2)(2009-6#1)
was obtained and##9##3##(1997-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2009-6#1)(2012-2#1)
was obtained around pH 7##2##5##(2008-10#2)
was obtained as##5##3##(1990-12#1)(1994-11#1)(2008-10#2)(2008-9#1)
was obtained at 0##3##4##(1992-9#1)(2008-10#1)(2012-2#1)
was obtained at a##8##4##(1994-3#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-6#1)
was obtained at##26##3##(1991-9#1)(1992-9#1)(1994-3#1)(2007-11#3)(2007-12#3)(2008-10#9)(2008-12#1)(2008-3#1)(2008-6#3)(2012-2#2)(2013-1#1)
was obtained between Vg concentration and##2##6##(2008-10#2)
was obtained between the##13##4##(1990-2#1)(1993-2#1)(2008-10#11)
was obtained between##21##3##(1990-2#1)(1993-2#2)(1995-2#1)(2008-10#16)(2008-2#1)
was obtained by a##6##4##(1991-2#1)(1995-9#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
was obtained by both##2##4##(2008-10#1)(2011-2#1)
was obtained by collecting##2##4##(1996-10#1)(1996-2#1)
was obtained by the##6##4##(1995-12#1)(2008-10#4)(2010-12#1)
was obtained by use of a##2##6##(2007-11#1)(2008-3#1)
was obtained by use of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
was obtained by using a##3##5##(2008-10#3)
was obtained by using an injected volume of##2##8##(2008-10#2)
was obtained by using the##2##5##(2008-10#1)(2010-7#1)
was obtained by using##12##4##(2008-10#8)(2008-8#2)(2008-9#1)(2010-7#1)
was obtained by##79##3##(1991-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
was obtained compared##3##3##(2008-10#2)(2008-8#1)
was obtained experimentally##2##3##(2008-10#1)(2010-4#1)
was obtained for a##6##4##(2007-12#2)(2008-10#4)
was obtained for all##4##4##(1992-10#1)(2008-10#3)
was obtained for arsenic determination between##2##6##(2008-10#2)
was obtained for both##2##4##(2008-10#2)
was obtained for the determination of##2##6##(2008-10#2)
was obtained for the##17##4##(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-12#2)(2008-3#1)(2011-1#1)
was obtained for##69##3##(1991-5#1)(1992-10#1)(1996-12#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#46)(2008-11#2)(2008-12#3)(2008-3#5)(2008-5#1)(2010-11#1)(2011-1#1)
was obtained from 0##4##4##(2008-10#4)
was obtained from a genomic##2##5##(1990-12#1)(1993-2#1)
was obtained from a##13##4##(1990-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)
was obtained from an##2##4##(1993-6#1)(2008-10#1)
was obtained from the##17##4##(1997-4#1)(2006-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-7#1)(2013-1#1)
was obtained from##63##3##(1990-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1997-4#2)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#5)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-7#2)(2013-1#2)(2013-7#1)(2013-8#1)
was obtained in 0##2##4##(2008-10#2)
was obtained in 11##3##4##(1990-6#1)(1992-12#1)(2013-8#1)
was obtained in 40%##2##4##(1991-6#1)(2012-2#1)
was obtained in 44##2##4##(1991-6#1)(1991-8#1)
was obtained in a##8##4##(1992-2#1)(1993-2#1)(2007-12#2)(2008-10#3)(2008-3#1)
was obtained in all cases##2##5##(2008-6#1)(2009-3#1)
was obtained in all##3##4##(2008-6#1)(2008-7#1)(2009-3#1)
was obtained in the concentration range of 0##2##8##(2008-10#2)
was obtained in the concentration range of##4##7##(2008-10#3)(2010-5#1)
was obtained in the concentration range##7##6##(1996-5#1)(2008-10#5)(2010-5#1)
was obtained in the concentration##8##5##(1996-5#1)(2008-10#6)(2010-5#1)
was obtained in the presence of##2##6##(1997-2#1)(2008-10#1)
was obtained in the range of##3##6##(2008-10#2)(2008-12#1)
was obtained in the range##8##5##(2008-10#7)(2008-12#1)
was obtained in the##28##4##(1996-5#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2013-1#1)
was obtained in##81##3##(1990-10#1)(1990-11#1)(1990-6#2)(1991-6#3)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-8#4)(2008-10#28)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
was obtained on a##2##4##(2008-10#2)
was obtained on the##3##4##(2007-10#1)(2008-10#2)
was obtained on##14##3##(1991-9#1)(1997-2#1)(2007-10#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
was obtained only with the##3##5##(1991-6#1)(1992-9#1)(2008-3#1)
was obtained only##4##3##(1991-6#1)(1992-9#1)(2008-3#1)(2008-8#1)
was obtained over the##5##4##(2008-10#5)
was obtained over##6##3##(2008-10#6)
was obtained that##3##3##(1996-8#1)(2008-3#1)(2011-1#1)
was obtained through the##4##4##(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)
was obtained through##12##3##(1990-10#1)(1992-9#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-8#2)
was obtained to##2##3##(2008-3#1)(2013-1#1)
was obtained under the##2##4##(2008-10#1)(2008-3#1)
was obtained under##5##3##(2007-11#1)(2008-10#2)(2008-3#2)
was obtained using##11##3##(1992-6#1)(1997-3#1)(2008-10#5)(2008-11#1)(2010-11#1)(2010-4#1)(2013-1#1)
was obtained when the##9##4##(1995-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#2)
was obtained when##15##3##(1991-2#1)(1995-5#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-6#4)
was obtained which##2##3##(2008-9#1)(2012-12#1)
was obtained with a##23##4##(1991-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)
was obtained with the##12##4##(2007-10#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
was obtained with##67##3##(1990-11#1)(1990-5#1)(1991-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-5#2)(1997-4#1)(2007-10#3)(2007-11#2)(2007-12#3)(2008-10#31)(2008-11#4)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#2)(2011-2#2)
was obtained within a##2##4##(2007-12#1)(2008-10#1)
was obtained within##6##3##(1991-2#1)(2007-12#1)(2008-10#4)
was obtained without##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
was obtained##692##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#4)(1993-3#4)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#8)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#2)(1997-8#2)(2006-8#1)(2007-10#7)(2007-11#22)(2007-12#21)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#297)(2008-11#22)(2008-12#10)(2008-2#20)(2008-3#34)(2008-4#2)(2008-5#14)(2008-6#17)(2008-7#14)(2008-8#10)(2008-9#11)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#14)(2012-12#1)(2012-2#9)(2012-7#2)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#9)
was obvious##5##2##(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
was obviously enhanced##2##3##(2008-11#1)(2013-1#1)
was obviously##6##2##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
was occasionally##2##2##(1991-2#1)(2010-3#1)
was occluded with##2##3##(2006-12#1)(2008-4#1)
was occupied by##3##3##(1990-7#1)(1994-2#1)(2008-7#1)
was of 0##5##3##(2008-10#4)(2013-7#1)
was of 1##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-7#1)
was of 12##2##3##(1993-9#1)(2008-10#1)
was of 4##3##3##(2008-10#2)(2012-2#1)
was of 5##3##3##(2007-8#1)(2008-10#2)
was of 50##2##3##(2007-8#2)
was of a##7##3##(1991-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-8#1)(2013-8#1)
was of borderline statistical significance##2##5##(2008-11#2)
was of moderate##2##3##(1990-12#1)(2008-6#1)
was of significant##2##3##(2008-10#1)(2010-9#1)
was of the order of##2##5##(2008-3#2)
was of the##6##3##(1991-2#1)(1994-6#1)(2008-10#1)(2008-3#2)(2011-2#1)
was of##78##2##(1990-12#1)(1991-12#1)(1991-2#3)(1992-10#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-6#2)(1996-1#1)(1997-4#1)(1997-6#3)(2007-11#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#18)(2008-11#3)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#4)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
was offered to the##2##4##(1995-6#1)(2007-8#1)
was offered to##4##3##(1994-11#1)(1995-6#1)(2007-8#1)(2010-8#1)
was offered##10##2##(1994-11#1)(1995-6#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-8#1)(2012-2#1)
was often observed##2##3##(1996-6#1)(2012-2#1)
was often questionable##2##3##(1993-6#2)
was often##20##2##(1991-3#1)(1992-11#1)(1993-6#2)(1995-12#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
was on chronic steroid therapy##2##5##(2008-7#1)(2013-1#1)
was on the##6##3##(2008-3#1)(2009-4#1)(2011-2#3)(2012-3#1)
was on##27##2##(1991-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
was on-line detected##2##3##(2008-10#2)
was on-line electrogenerated by constant-current electrolysis##2##6##(2008-10#2)
was on-line electrogenerated##3##3##(2008-10#3)
was on-line##6##2##(2008-10#6)
was once##4##2##(1991-11#1)(1992-8#1)(1996-3#1)(2008-5#1)
was one of the highest##2##5##(2008-11#1)(2011-2#1)
was one of the most important##2##6##(2010-7#1)(2013-1#1)
was one of the most##4##5##(2007-7#1)(2009-7#1)(2010-7#1)(2013-1#1)
was one of the##15##4##(1995-2#1)(1996-12#1)(1997-6#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
was one of these##2##4##(2008-11#2)
was one of##18##3##(1995-2#1)(1996-12#1)(1997-6#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#4)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#1)
was one##35##2##(1992-9#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#5)(2008-11#4)(2008-7#3)(2008-8#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#2)
was only 0##7##3##(1991-5#1)(1993-8#1)(1994-6#1)(1994-7#1)(1997-5#1)(2008-10#1)(2008-11#1)
was only 1##2##3##(1991-3#1)(1993-8#1)
was only 11##2##3##(1990-9#1)(1995-5#1)
was only 20%##3##3##(1990-8#1)(1994-5#1)(1995-5#1)
was only 52%##2##3##(1992-3#1)(2011-2#1)
was only 8##2##3##(2008-11#1)(2008-5#1)
was only 9##2##3##(2008-10#2)
was only a minor##2##4##(2008-10#2)
was only a##8##3##(1995-3#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#3)(2011-2#1)
was only about##5##3##(2007-5#1)(2008-10#2)(2008-11#1)(2009-11#1)
was only after##2##3##(1997-5#1)(2011-1#1)
was only associated with##2##4##(2009-8#1)(2013-1#1)
was only detected in##3##4##(1990-11#1)(2008-10#1)(2011-2#1)
was only expressed##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
was only found in##4##4##(1997-6#1)(2007-6#1)(2008-10#1)(2008-7#1)
was only found##5##3##(1997-6#1)(2007-6#1)(2008-10#2)(2008-7#1)
was only marginally##2##3##(1990-5#1)(1995-2#1)
was only observed at##2##4##(2008-10#1)(2008-7#1)
was only observed in##2##4##(1997-1#1)(2012-5#1)
was only observed##8##3##(1990-3#1)(1992-3#1)(1997-1#1)(2008-10#2)(2008-7#1)(2012-5#1)(2013-1#1)
was only one##6##3##(1991-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-8#1)(2011-1#1)
was only partially##5##3##(1990-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)
was only possible##2##3##(2008-1#1)(2008-10#1)
was only present in##2##4##(1991-9#1)(2008-5#1)
was only slightly##4##3##(1994-2#1)(1995-2#1)(1996-2#1)(2008-5#1)
was only the##2##3##(2008-10#1)(2012-2#1)
was only used##2##3##(1997-3#1)(2008-10#1)
was only##146##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-5#1)(2009-8#2)(2010-7#1)(2011-1#5)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)
was open##3##2##(1991-4#1)(1994-12#1)(2009-3#1)
was opened##2##2##(1996-6#1)(2011-2#1)
was operated at##3##3##(2008-10#1)(2013-1#2)
was operated in the##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
was operated in##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2012-3#1)
was operated on##2##3##(1992-6#1)(2013-1#1)
was operated with##2##3##(2008-10#1)(2008-2#1)
was operated##20##2##(1992-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-6#1)(2009-1#1)(2012-3#1)(2013-1#5)(2013-7#1)
was opposite##2##2##(2008-3#1)(2013-7#1)
was optically##3##2##(1994-9#1)(2007-12#1)(2008-3#1)
was optimal at pH##2##4##(2008-10#1)(2008-11#1)
was optimal at##6##3##(1995-11#1)(2008-10#4)(2008-11#1)
was optimal for##3##3##(1995-2#1)(2008-10#2)
was optimal##12##2##(1990-2#1)(1995-11#1)(1995-2#1)(2008-10#7)(2008-11#1)(2008-7#1)
was optimised for##3##3##(2008-10#3)
was optimised##6##2##(2008-10#6)
was optimized and##10##3##(1995-3#1)(2008-10#9)
was optimized as##2##3##(2008-10#2)
was optimized by##9##3##(2007-11#1)(2008-10#6)(2008-7#1)(2009-11#1)
was optimized for an##2##4##(2008-10#1)(2008-11#1)
was optimized for the##2##4##(2008-10#1)(2008-2#1)
was optimized for##10##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-5#1)
was optimized to##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
was optimized using the##2##4##(2008-10#2)
was optimized using##4##3##(2008-10#4)
was optimized with respect to##2##5##(2008-10#2)
was optimized with##3##3##(2008-10#2)(2011-1#1)
was optimized##55##2##(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#36)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2013-1#1)
was optimum at##2##3##(1994-3#1)(2008-10#1)
was optimum##4##2##(1990-12#1)(1994-3#1)(2008-10#2)
was orally administered##2##3##(2008-10#1)(2013-1#1)
was orally##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
was organized as a##2##4##(2008-5#1)(2008-8#1)
was organized by the##2##4##(2008-10#1)(2008-8#1)
was organized by##8##3##(2008-10#1)(2008-5#4)(2008-8#1)(2009-11#1)(2010-5#1)
was organized to##2##3##(2011-2#1)(2013-1#1)
was organized##14##2##(2008-10#1)(2008-5#5)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
was originally derived##2##3##(2008-2#1)(2008-3#1)
was originally described##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
was originally developed##2##3##(2008-3#1)(2008-5#1)
was originally isolated from##4##4##(1996-2#1)(2011-2#3)
was originally presented##2##3##(2008-12#1)(2012-3#1)
was originally##24##2##(1993-6#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
was otherwise##4##2##(1991-6#1)(1991-8#1)(2008-11#1)(2013-1#1)
was outlined##2##2##(2008-10#1)(2009-12#1)
was over 90%##2##3##(2007-11#1)(2008-10#1)
was over##16##2##(1994-2#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)
was over-expressed in##3##3##(1991-8#1)(2008-11#1)(2010-11#1)
was overall survival##2##3##(1992-2#1)(2011-2#1)
was overall##4##2##(1992-1#1)(1992-2#1)(2008-10#1)(2011-2#1)
was overcome by##7##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-6#1)(2011-1#1)
was overcome##8##2##(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-6#1)(2011-1#1)
was overexpressed in##4##3##(1994-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
was overexpressed##6##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
was overweight##2##2##(2009-4#1)(2013-8#1)
was oxidized by##4##3##(1992-6#1)(2008-10#3)
was oxidized to##3##3##(2008-10#3)
was oxidized##11##2##(1990-12#1)(1992-6#1)(2008-10#8)(2010-5#1)
was pH 4##2##3##(2008-10#2)
was pH##7##2##(1991-12#1)(1994-8#1)(2008-10#4)(2013-1#1)
was packed in a##2##4##(2008-10#2)
was packed into##2##3##(2008-10#2)
was packed with##4##3##(2008-10#4)
was packed##9##2##(2008-10#9)
was palpable##3##2##(1994-7#1)(2008-10#1)(2011-1#1)
was palpated in the##2##4##(1994-7#1)(2013-8#1)
was palpated##3##2##(1994-7#1)(2007-8#1)(2013-8#1)
was paralleled by a##3##4##(1993-9#1)(1995-12#1)(2008-7#1)
was paralleled by##6##3##(1991-5#1)(1992-8#1)(1993-9#1)(1995-12#2)(2008-7#1)
was paralleled##8##2##(1991-5#1)(1992-8#1)(1993-9#1)(1994-6#1)(1995-12#2)(2008-11#1)(2008-7#1)
was parameterized##2##2##(2008-10#1)(2008-9#1)
was part of a##6##4##(1990-7#1)(1996-12#1)(2010-10#1)(2010-7#1)(2013-1#2)
was part of the##4##4##(1996-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
was part of##14##3##(1990-7#1)(1995-6#1)(1996-12#2)(1996-3#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
was partially blocked by##2##4##(1994-9#1)(1995-6#1)
was partially dominant##2##3##(2008-10#2)
was partially effective##2##3##(2008-10#2)
was partially inactivated##2##3##(1993-11#1)(1993-2#1)
was partially inhibited by the##2##5##(1990-2#1)(1994-11#1)
was partially inhibited by##3##4##(1990-2#1)(1994-11#1)(1997-4#1)
was partially inhibited##4##3##(1990-2#1)(1994-11#1)(1997-4#1)(2008-11#1)
was partially overcome##2##3##(1994-8#1)(2008-10#1)
was partially purified and##2##4##(1994-11#1)(1997-6#1)
was partially purified by##2##4##(1991-9#1)(2010-2#1)
was partially purified from##4##4##(1993-8#1)(1994-8#1)(2008-10#1)(2008-8#1)
was partially purified##11##3##(1990-5#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1997-6#1)(2008-10#2)(2008-8#1)(2010-2#1)
was partially reactivated##2##3##(1993-11#1)(1993-6#1)
was partially##50##2##(1990-2#2)(1990-5#3)(1991-12#1)(1991-9#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-7#1)(2013-1#2)
was participating in##2##3##(2007-6#1)(2011-2#1)
was particular##3##2##(1992-5#1)(2008-7#1)(2008-9#1)
was particularly high##2##3##(1990-6#1)(1993-2#1)
was particularly strong##3##3##(2008-7#1)(2008-8#2)
was particularly##20##2##(1990-11#1)(1990-6#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#3)(2010-4#1)
was partly due to##2##4##(1997-7#1)(2008-11#1)
was partly##11##2##(1995-3#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)
was passed through a##6##4##(1991-2#1)(1992-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
was passed through the##2##4##(2008-10#2)
was passed through##9##3##(1991-2#1)(1992-12#1)(2008-10#5)(2008-2#1)(2008-5#1)
was passed to##2##3##(1993-1#1)(2007-8#1)
was passed##15##2##(1991-1#1)(1991-2#1)(1992-12#1)(1993-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)
was passing##2##2##(2007-8#1)(2008-7#1)
was perceived as##3##3##(1996-2#2)(2008-11#1)
was perceived to be##3##4##(1991-2#1)(2008-7#1)(2010-3#1)
was perceived to##4##3##(1991-2#1)(2008-11#1)(2008-7#1)(2010-3#1)
was perceived##9##2##(1991-2#1)(1994-3#1)(1996-12#1)(1996-2#2)(2008-11#2)(2008-7#1)(2010-3#1)
was perfectly##2##2##(2008-12#1)(2008-5#1)
was performed 3##2##3##(2010-6#1)(2012-8#1)
was performed according to##2##4##(2008-9#1)(2009-1#1)
was performed after##10##3##(1990-8#1)(1996-3#2)(2007-4#1)(2008-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
was performed and a##2##4##(2008-10#1)(2011-2#1)
was performed and the##12##4##(1990-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#2)
was performed and##31##3##(1990-3#1)(1993-9#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
was performed as a##4##4##(2007-11#1)(2008-10#1)(2012-12#1)(2013-1#1)
was performed as##9##3##(1991-2#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
was performed at 6 and##2##5##(2008-9#1)(2011-2#1)
was performed at a##3##4##(1991-2#1)(2008-10#1)(2008-4#1)
was performed at an##2##4##(1991-1#1)(2008-5#1)
was performed at the##3##4##(1997-8#1)(2007-11#1)(2013-8#1)
was performed at##26##3##(1990-3#1)(1991-1#1)(1991-2#1)(1994-3#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
was performed because of##3##4##(1993-6#1)(2008-7#1)(2011-2#1)
was performed before##3##3##(2007-10#1)(2007-11#1)(2007-8#1)
was performed between##4##3##(1994-11#1)(1996-12#1)(2008-10#2)
was performed by a##7##4##(2008-10#6)(2010-4#1)
was performed by combining##2##4##(2010-12#1)(2012-2#1)
was performed by comparison of##2##5##(2008-10#1)(2008-3#1)
was performed by gas##2##4##(2008-10#2)
was performed by laparoscopy##2##4##(1993-9#1)(1994-9#1)
was performed by means of##3##5##(1994-9#1)(2008-10#2)
was performed by measuring the##2##5##(2008-10#1)(2008-11#1)
was performed by the##9##4##(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
was performed by use of##3##5##(2008-3#1)(2008-9#2)
was performed by using a##2##5##(2008-10#1)(2011-2#1)
was performed by using##6##4##(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
was performed by##97##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1994-9#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-8#3)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#3)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)
was performed due to##4##4##(2008-1#1)(2008-10#2)(2011-2#1)
was performed during the##3##4##(2008-2#1)(2008-5#1)(2012-2#1)
was performed during##4##3##(2008-2#1)(2008-5#2)(2012-2#1)
was performed for each##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
was performed for the##2##4##(2011-2#1)(2012-3#1)
was performed for##18##3##(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
was performed from##5##3##(2007-8#1)(2008-1#1)(2010-3#1)(2013-1#1)(2013-8#1)
was performed immediately##2##3##(2009-9#1)(2013-1#1)
was performed in 1##2##4##(2008-10#1)(2009-10#1)
was performed in 11##2##4##(2008-5#1)(2013-1#1)
was performed in 13##2##4##(2008-6#1)(2008-7#1)
was performed in 15 cases##2##5##(2008-7#1)(2011-2#1)
was performed in 17##2##4##(1994-9#1)(2011-2#1)
was performed in 2##2##4##(2007-8#1)(2009-10#1)
was performed in 20##2##4##(1990-12#1)(1991-3#1)
was performed in 24 patients with##3##6##(1994-11#1)(2007-10#1)(2008-7#1)
was performed in 33 patients##2##5##(2007-11#1)(2007-8#1)
was performed in 4##2##4##(1990-6#1)(2008-10#1)
was performed in a##8##4##(1994-5#1)(1996-6#1)(2008-10#2)(2010-7#1)(2011-2#1)(2013-1#2)
was performed in all patients##3##5##(1990-9#1)(1992-5#1)(1993-3#1)
was performed in all##6##4##(1990-9#1)(1992-5#1)(1993-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
was performed in an##8##4##(1991-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-11#1)(2013-7#1)
was performed in combination with##2##5##(1992-1#1)(2008-10#1)
was performed in five cases##2##5##(1997-3#1)(1997-8#1)
was performed in five##4##4##(1997-3#1)(1997-8#1)(2007-7#2)
was performed in four##2##4##(1991-5#1)(2013-7#1)
was performed in one##2##4##(2008-10#1)(2011-2#1)
was performed in order to##6##5##(2007-12#1)(2008-10#3)(2008-7#1)(2009-7#1)
was performed in patients##2##4##(1996-3#1)(1996-9#1)
was performed in the operating##2##5##(2007-8#1)(2011-2#1)
was performed in the##17##4##(1992-3#1)(1996-11#1)(1996-12#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-8#1)
was performed in two##2##4##(2007-7#1)(2008-5#1)
was performed in which##2##4##(1997-6#1)(2010-3#1)
was performed in##137##3##(1990-12#1)(1990-2#3)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-8#3)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#3)(2007-8#7)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#10)(2012-12#1)(2012-2#1)(2013-1#9)(2013-7#2)(2013-8#2)
was performed of##5##3##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
was performed on a##11##4##(1997-5#1)(2008-10#2)(2008-12#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
was performed on all##2##4##(2007-7#1)(2012-2#1)
was performed on an##2##4##(2011-1#2)
was performed on day##4##4##(2008-1#1)(2008-11#1)(2013-8#2)
was performed on the##10##4##(2008-10#6)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
was performed on##74##3##(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-5#2)(1997-5#2)(1997-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-2#2)(2013-1#4)(2013-8#5)
was performed over##2##3##(2010-4#1)(2013-1#1)
was performed through a##2##4##(2007-8#1)(2009-3#1)
was performed through the##2##4##(2008-9#1)(2013-1#1)
was performed through##7##3##(2007-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
was performed to assess the##4##5##(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
was performed to assess##6##4##(2008-10#1)(2008-5#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
was performed to compare##2##4##(2008-7#1)(2013-1#1)
was performed to detect the##2##5##(2008-8#1)(2013-8#1)
was performed to detect##4##4##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
was performed to determine if##2##5##(2008-10#2)
was performed to determine whether##2##5##(1994-8#1)(2008-7#1)
was performed to determine##9##4##(1994-8#1)(2008-10#4)(2008-3#1)(2008-7#2)(2011-2#1)
was performed to evaluate the feasibility of##2##7##(1992-12#1)(2008-10#1)
was performed to evaluate the##7##5##(1992-12#1)(1992-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2011-2#2)
was performed to evaluate##10##4##(1992-12#1)(1992-3#1)(1992-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2011-2#3)(2013-8#1)
was performed to examine the##2##5##(2008-10#1)(2008-2#1)
was performed to examine##3##4##(1996-4#1)(2008-10#1)(2008-2#1)
was performed to investigate the##4##5##(1992-8#1)(1997-6#1)(2008-2#1)(2008-9#1)
was performed to obtain##3##4##(1994-11#1)(2007-8#1)(2012-3#1)
was performed to optimize the##2##5##(2008-10#1)(2008-5#1)
was performed to prevent##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
was performed to treat##2##4##(2009-3#1)(2012-12#1)
was performed to##80##3##(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#5)
was performed twice##3##3##(2008-12#2)(2008-7#1)
was performed under cardiopulmonary bypass##2##5##(2007-8#1)(2013-1#1)
was performed under##9##3##(1996-5#1)(1997-6#1)(2007-8#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
was performed using a modified##2##5##(2008-10#1)(2013-1#1)
was performed using a##16##4##(1990-3#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#2)(2013-1#2)
was performed using the##17##4##(1992-3#2)(1997-8#1)(2007-11#1)(2008-10#3)(2008-7#3)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
was performed using##76##3##(1990-3#1)(1991-3#1)(1992-3#2)(1992-9#1)(1995-6#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-10#26)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#7)(2013-8#1)
was performed via a##2##4##(2008-10#1)(2011-2#1)
was performed with a##14##4##(1995-3#1)(1996-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-7#1)
was performed with an##2##4##(2006-12#1)(2008-12#1)
was performed with the##5##4##(1991-3#1)(2008-10#2)(2008-7#1)(2013-8#1)
was performed with##54##3##(1990-3#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-3#1)(2012-7#1)(2013-8#1)
was performed within##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
was performed without##2##3##(1994-3#1)(2008-7#1)
was performed##880##2##(1990-10#2)(1990-12#4)(1990-2#4)(1990-3#4)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#4)(1991-6#5)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#5)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#1)(1994-9#6)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#6)(1996-3#5)(1996-4#1)(1996-5#6)(1996-6#2)(1996-9#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#7)(1997-7#1)(1997-8#8)(1997-9#1)(2006-10#1)(2006-12#1)(2007-10#5)(2007-11#22)(2007-12#5)(2007-2#2)(2007-4#2)(2007-7#5)(2007-8#34)(2008-1#12)(2008-10#184)(2008-11#18)(2008-12#27)(2008-2#5)(2008-3#21)(2008-4#4)(2008-5#22)(2008-6#13)(2008-7#38)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2011-1#14)(2011-2#64)(2011-3#2)(2011-7#1)(2012-1#6)(2012-12#13)(2012-2#16)(2012-3#14)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#50)(2013-7#4)(2013-8#25)
was periodically##2##2##(1997-4#1)(2007-12#1)
was permitted##2##2##(2012-2#1)(2013-8#1)
was perpendicular to the##2##4##(2007-11#1)(2008-3#1)
was perpendicular to##3##3##(2007-11#1)(2008-3#2)
was petrolatum##2##2##(2008-5#2)
was phase##2##2##(2008-3#1)(2008-5#1)
was phosphorylated at##2##3##(1990-11#1)(1994-9#1)
was phosphorylated in vitro by##3##5##(1990-11#1)(1993-8#1)(1995-2#1)
was phosphorylated in vitro##4##4##(1990-11#2)(1993-8#1)(1995-2#1)
was phosphorylated##12##2##(1990-11#3)(1992-3#1)(1993-8#2)(1994-9#4)(1995-2#1)(2008-6#1)
was phylogenetically distinct from##2##4##(2008-10#2)
was phylogenetically##3##2##(2008-10#2)(2012-3#1)
was physically##5##2##(1991-8#1)(1995-6#1)(1997-7#1)(2008-10#1)(2013-1#1)
was picked##2##2##(1995-3#1)(1997-3#1)
was pilot tested##2##3##(2010-10#1)(2012-1#1)
was piloted##2##2##(2008-11#1)(2008-12#1)
was pioneered by##2##3##(1994-9#1)(2013-1#1)
was pivotal##2##2##(2008-8#1)(2010-10#1)
was placed between##2##3##(2008-10#1)(2008-5#1)
was placed downstream from the##2##5##(1994-12#1)(1997-4#1)
was placed downstream##3##3##(1994-12#1)(1997-4#1)(2008-8#1)
was placed in a##2##4##(2008-10#1)(2012-3#1)
was placed in an##2##4##(2008-10#1)(2008-6#1)
was placed in the##6##4##(1993-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
was placed in##18##3##(1992-5#1)(1993-11#1)(1995-8#1)(2007-11#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
was placed inside##3##3##(1997-6#1)(2008-10#2)
was placed into a##2##4##(2008-10#2)
was placed on the##2##4##(2008-7#1)(2011-2#1)
was placed on##4##3##(2008-7#2)(2011-2#2)
was placed under the control of##3##6##(1994-11#1)(1997-4#2)
was placed##47##2##(1992-5#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-4#4)(1997-6#1)(2007-11#2)(2008-10#12)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
was planned as a##2##4##(2010-6#1)(2010-7#1)
was planned as##3##3##(1990-6#1)(2010-6#1)(2010-7#1)
was planned to##6##3##(1994-11#1)(2007-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
was planned##19##2##(1990-3#1)(1990-6#1)(1991-5#1)(1993-3#1)(1994-11#1)(2007-10#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
was planted in##2##3##(2008-10#2)
was planted##3##2##(2008-10#2)(2011-2#1)
was plotted against##2##3##(2008-10#1)(2008-8#1)
was plotted##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
was pointed out##3##3##(1991-6#1)(2008-10#2)
was poor in##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
was poor##20##2##(1991-3#1)(1995-12#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
was poorer##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
was poorly##8##2##(1990-12#1)(1991-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-3#1)(2007-12#1)
was posed##2##2##(1995-8#1)(2008-9#1)
was positioned on##2##3##(2008-10#2)
was positioned##6##2##(2008-10#3)(2008-6#1)(2012-1#1)(2013-1#1)
was positive for##13##3##(1990-12#1)(1991-11#1)(1995-4#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
was positive in 1##2##4##(2011-1#2)
was positive in all##2##4##(1995-11#1)(1996-8#1)
was positive in the##3##4##(1994-7#1)(2008-5#1)(2011-2#1)
was positive in##16##3##(1990-2#1)(1994-1#1)(1994-7#1)(1995-11#1)(1996-8#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
was positive with##5##3##(1991-2#1)(1994-12#1)(1995-12#1)(2008-7#1)(2012-2#1)
was positive##47##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
was positively associated with the##2##5##(2008-8#2)
was positively associated with##9##4##(1996-9#1)(2008-12#1)(2008-8#3)(2009-7#1)(2009-9#1)(2013-1#2)
was positively correlated to the##3##5##(2006-10#1)(2008-10#1)(2011-2#1)
was positively correlated to##4##4##(2006-10#1)(2008-10#2)(2011-2#1)
was positively correlated with children's behavior problems##2##7##(2010-11#2)
was positively correlated with percentage of field area affected by FCRR##2##11##(2008-10#2)
was positively correlated with the##8##5##(1990-7#1)(1996-6#1)(2008-10#3)(2009-7#1)(2010-1#1)(2012-12#1)
was positively correlated with##38##4##(1990-7#1)(1991-12#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#16)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
was positively correlated##44##3##(1990-7#1)(1991-12#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#19)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
was positively identified as##2##4##(1995-6#1)(2008-10#1)
was positively related to the number of good##2##8##(2009-8#2)
was positively related to the##4##5##(1996-12#1)(2009-8#2)(2011-2#1)
was positively related to##13##4##(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-12#1)
was positively related##14##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#1)
was positively##72##2##(1990-7#1)(1991-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#23)(2008-12#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#3)
was possible by##3##3##(1996-5#1)(2008-10#2)
was possible for##2##3##(2008-3#1)(2008-9#1)
was possible from##2##3##(2008-11#1)(2013-1#1)
was possible in all##2##4##(2010-7#1)(2011-2#1)
was possible in##8##3##(1990-12#1)(1991-6#1)(1993-3#1)(2007-8#1)(2008-11#1)(2010-7#1)(2011-2#1)(2013-1#1)
was possible thanks to##2##4##(2009-12#1)(2012-12#1)
was possible to identify##2##4##(2008-10#1)(2012-3#1)
was possible to observe##2##4##(1992-6#1)(1997-2#1)
was possible to obtain a##3##5##(2008-10#2)(2013-1#1)
was possible to obtain##6##4##(2008-10#5)(2013-1#1)
was possible to resolve##2##4##(2007-12#1)(2008-10#1)
was possible to##63##3##(1990-3#1)(1990-6#1)(1991-3#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#2)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#28)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#2)
was possible using##3##3##(2008-10#3)
was possible with a##2##4##(2008-10#2)
was possible with the##2##4##(1995-6#1)(2008-3#1)
was possible with##6##3##(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)
was possible##106##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#44)(2008-11#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)
was possibly##5##2##(1994-12#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#1)
was postponed##2##2##(2010-5#1)(2013-1#1)
was postulated that##2##3##(2008-10#1)(2009-8#1)
was postulated to be##2##4##(2008-10#1)(2008-7#1)
was postulated to##4##3##(2008-10#3)(2008-7#1)
was postulated##7##2##(2008-10#5)(2008-7#1)(2009-8#1)
was potentiated##2##2##(1994-11#1)(1996-2#1)
was practically##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
was preceded by a##5##4##(1993-12#1)(1993-9#1)(2008-10#2)(2008-12#1)
was preceded by the##2##4##(1994-5#1)(2008-8#1)
was preceded by##8##3##(1993-12#1)(1993-9#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)
was precipitated and##2##3##(2008-10#1)(2008-6#1)
was precipitated by##3##3##(1990-12#1)(2008-10#1)(2008-9#1)
was precipitated in##2##3##(2008-10#2)
was precipitated with##3##3##(1991-5#1)(2008-10#2)
was precipitated##10##2##(1990-12#1)(1991-5#1)(2008-10#6)(2008-6#1)(2008-9#1)
was precisely##2##2##(2008-10#2)
was precluded##2##2##(2008-10#1)(2009-6#1)
was preconcentrated in a membrane cell##2##6##(2008-10#2)
was preconcentrated in a##3##4##(2008-10#3)
was preconcentrated in##5##3##(2008-10#5)
was preconcentrated on the##2##4##(2008-10#2)
was preconcentrated on##4##3##(2008-10#4)
was preconcentrated onto the##2##4##(2008-10#2)
was preconcentrated##16##2##(2008-10#16)
was predicted by##8##3##(2008-10#4)(2008-12#1)(2008-9#1)(2010-1#1)(2010-2#1)
was predicted for##2##3##(1990-5#1)(1992-2#1)
was predicted from##2##3##(1990-5#1)(2008-10#1)
was predicted to be##2##4##(1990-12#1)(2008-8#1)
was predicted to##3##3##(1990-12#1)(1995-3#1)(2008-8#1)
was predicted##24##2##(1990-12#1)(1990-5#2)(1992-2#1)(1995-3#1)(1996-8#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-2#1)
was predominant in the##2##4##(2007-5#1)(2010-8#1)
was predominant in##8##3##(1994-2#2)(2007-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-8#1)
was predominant##13##2##(1994-2#3)(2007-5#1)(2008-10#3)(2008-5#4)(2008-7#1)(2010-8#1)
was predominantly expressed in the##2##5##(1997-4#1)(1997-6#1)
was predominantly expressed in##3##4##(1992-8#1)(1997-4#1)(1997-6#1)
was predominantly##18##2##(1992-10#1)(1992-12#1)(1992-8#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
was preferential##2##2##(1997-2#1)(2008-5#1)
was preferentially##5##2##(1990-2#1)(1993-6#1)(1997-1#1)(1997-7#1)(2008-11#1)
was preferred over##2##3##(1991-11#1)(2010-8#1)
was preferred##8##2##(1991-11#1)(1991-6#1)(1992-3#1)(1993-2#1)(2008-10#2)(2010-8#1)(2013-1#1)
was preformed##3##2##(2008-5#1)(2009-5#1)(2012-12#1)
was preliminary##2##2##(1995-3#1)(2010-11#1)
was prepared and evaluated##3##4##(1993-9#1)(1995-3#1)(2009-6#1)
was prepared and its##5##4##(2008-10#3)(2008-5#1)(2013-1#1)
was prepared and used to##2##5##(2008-10#1)(2008-11#1)
was prepared and used##5##4##(2008-10#4)(2008-11#1)
was prepared and##26##3##(1993-11#1)(1993-9#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-5#2)(2009-11#1)(2009-6#1)(2013-1#1)(2013-7#1)
was prepared as##2##3##(1994-9#1)(2008-10#1)
was prepared by a##3##4##(2008-10#2)(2013-1#1)
was prepared by dissolving##2##4##(2008-10#2)
was prepared by mixing##2##4##(2008-10#1)(2008-2#1)
was prepared by sol-gel##2##4##(2008-10#2)
was prepared by the##4##4##(1990-7#1)(2008-10#3)
was prepared by using##3##4##(2008-10#3)
was prepared by##42##3##(1990-7#1)(1993-11#1)(1993-9#1)(1994-2#1)(1997-7#2)(2007-12#1)(2008-10#25)(2008-11#1)(2008-2#2)(2008-5#3)(2009-7#1)(2012-2#1)(2013-1#2)
was prepared for##2##3##(1997-3#1)(2008-10#1)
was prepared from the##2##4##(1994-2#1)(2011-2#1)
was prepared from##11##3##(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
was prepared in##5##3##(1996-2#1)(2008-10#4)
was prepared to##3##3##(1994-8#1)(1995-3#1)(2008-10#1)
was prepared using##7##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-8#1)
was prepared with##6##3##(1990-5#1)(1996-6#1)(2008-10#2)(2008-3#1)(2011-3#1)
was prepared##122##2##(1990-12#1)(1990-5#1)(1990-7#1)(1993-11#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#2)(1996-2#3)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#58)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#8)(2008-8#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-7#1)
was prescribed##4##2##(1995-11#1)(1995-3#1)(2008-9#1)(2012-1#1)
was present as##2##3##(2008-10#2)
was present at a##3##4##(1991-12#1)(2008-10#2)
was present at the##2##4##(1996-5#1)(2008-10#1)
was present at##10##3##(1991-12#1)(1993-3#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-8#1)
was present for##2##3##(1997-1#1)(2010-6#1)
was present in 13##2##4##(1997-8#1)(2013-8#1)
was present in 38##2##4##(1991-11#1)(2007-7#1)
was present in a##5##4##(1992-11#1)(1994-2#1)(2008-10#3)
was present in all##8##4##(1991-4#1)(1992-11#1)(1992-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
was present in both the##2##5##(1997-4#1)(2013-7#1)
was present in both##3##4##(1997-4#1)(2006-6#1)(2013-7#1)
was present in patients##2##4##(2007-12#1)(2008-5#1)
was present in the##17##4##(1990-11#1)(1992-12#1)(1993-12#2)(1995-12#1)(1995-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-3#1)
was present in these##2##4##(1992-12#1)(1997-2#1)
was present in##95##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-11#3)(1992-12#3)(1992-8#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#3)(2012-3#7)(2013-7#1)(2013-8#1)
was present mainly in##3##4##(2008-10#2)(2008-4#1)
was present mainly##4##3##(1993-11#1)(2008-10#2)(2008-4#1)
was present on##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
was present only in##2##4##(2008-10#1)(2008-6#1)
was present only##3##3##(2008-10#2)(2008-6#1)
was present within##2##3##(2008-10#2)
was present##163##2##(1990-11#3)(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#5)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#7)(2013-1#1)(2013-7#1)(2013-8#1)
was presented as a new##2##5##(2008-10#1)(2012-2#1)
was presented as a##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
was presented as##5##3##(1997-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
was presented at the##2##4##(1995-2#1)(2008-7#1)
was presented at##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
was presented for##2##3##(2008-10#1)(2013-8#1)
was presented in this paper##2##5##(2011-2#1)(2013-8#1)
was presented in##7##3##(1992-11#1)(1994-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#2)
was presented to##4##3##(1995-5#1)(2008-5#1)(2008-7#1)(2013-1#1)
was presented with##7##3##(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
was presented##44##2##(1990-7#1)(1992-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
was preserved in the##2##4##(2008-11#1)(2009-4#1)
was preserved in##5##3##(1994-12#1)(2008-11#1)(2009-1#1)(2009-4#1)(2012-3#1)
was preserved##10##2##(1990-5#1)(1991-10#1)(1994-11#1)(1994-12#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-4#1)(2012-12#1)(2012-3#1)
was presumed to##3##3##(2008-4#1)(2009-10#1)(2012-1#1)
was prevalent##2##2##(2008-10#2)
was prevented by the##5##4##(1993-5#1)(1993-9#1)(1994-8#1)(1995-5#1)(1997-1#1)
was prevented by##17##3##(1990-2#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-7#1)(2011-1#1)(2013-1#2)
was prevented in##3##3##(1995-2#1)(1997-1#1)(2013-8#1)
was prevented only##2##3##(1994-5#1)(1995-2#1)
was prevented##29##2##(1990-2#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#2)(1996-12#2)(1996-2#1)(1997-1#3)(1997-7#1)(2008-10#3)(2011-1#1)(2013-1#3)(2013-8#1)
was previously characterized##2##3##(1997-3#1)(2008-10#1)
was previously determined##2##3##(1991-11#1)(2008-10#1)
was previously found to be##3##5##(1994-11#1)(1997-6#1)(2008-7#1)
was previously found##5##3##(1994-11#2)(1995-11#1)(1997-6#1)(2008-7#1)
was previously identified as##2##4##(1997-7#1)(2008-10#1)
was previously identified##3##3##(1990-12#1)(1997-7#1)(2008-10#1)
was previously reported to##2##4##(2008-10#1)(2011-2#1)
was previously reported##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
was previously shown to be required for##2##7##(1993-9#1)(2008-9#1)
was previously shown to be##6##5##(1992-3#1)(1993-12#1)(1993-9#1)(2008-10#1)(2008-9#1)(2012-1#1)
was previously shown to##13##4##(1990-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
was previously shown##14##3##(1990-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
was previously suggested##2##3##(1995-5#1)(2008-10#1)
was previously thought##2##3##(1995-6#1)(2007-10#1)
was previously##58##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-11#3)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#18)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
was primarily in##2##3##(1995-5#1)(2010-11#1)
was primarily influenced by##2##4##(2008-10#1)(2010-8#1)
was primarily##16##2##(1993-12#1)(1995-5#1)(1997-6#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
was principally##2##2##(1995-4#1)(1996-12#1)
was printed##2##2##(2007-11#1)(2008-2#1)
was probably a##2##3##(2008-10#1)(2008-7#1)
was probably an##2##3##(1994-8#1)(2008-9#1)
was probably caused by##2##4##(1992-8#1)(2008-10#1)
was probably due to the high##2##6##(2008-10#1)(2010-5#1)
was probably due to the##3##5##(2008-10#1)(2010-5#1)(2010-8#1)
was probably due to##9##4##(1990-8#1)(1996-6#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#1)
was probably the##3##3##(2008-10#2)(2009-5#1)
was probably##28##2##(1990-6#1)(1990-8#1)(1991-11#1)(1992-8#1)(1994-8#1)(1996-4#1)(1996-6#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
was probed by##2##3##(1992-4#1)(1994-8#1)
was probed##5##2##(1990-8#1)(1992-4#1)(1993-8#1)(1994-8#1)(2010-4#1)
was proceeded##2##2##(2008-10#1)(2008-5#1)
was processed by##3##3##(1996-12#1)(2008-10#1)(2010-11#1)
was processed in##2##3##(1991-9#1)(2008-3#1)
was processed to##3##3##(1995-8#1)(1997-1#1)(2008-3#1)
was processed##16##2##(1990-11#1)(1991-9#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-3#2)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
was produced against##5##3##(1996-12#1)(2008-10#4)
was produced and##5##3##(1993-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
was produced as##3##3##(2008-10#1)(2010-5#2)
was produced by a##3##4##(1993-12#1)(2008-10#2)
was produced by fusing##2##4##(2008-11#2)
was produced by the##2##4##(2008-10#1)(2008-6#1)
was produced by using##2##4##(1995-12#1)(2008-5#1)
was produced by##31##3##(1990-7#2)(1991-9#1)(1993-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-12#1)(2010-1#1)(2013-1#1)
was produced for the##2##4##(1990-12#1)(2008-10#1)
was produced for##3##3##(1990-12#1)(2008-10#2)
was produced from##5##3##(1991-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
was produced in Escherichia coli##3##5##(1991-5#1)(1991-9#1)(2010-6#1)
was produced in a##4##4##(1990-5#1)(2008-11#2)(2008-6#1)
was produced in the##2##4##(2008-10#1)(2008-7#1)
was produced in##18##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#2)(1994-12#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-6#1)(2013-1#1)
was produced with##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
was produced##93##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-5#2)(1991-9#2)(1992-3#1)(1993-12#4)(1993-8#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#26)(2008-11#8)(2008-3#2)(2008-5#4)(2008-6#7)(2008-7#1)(2008-8#3)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#2)
was programmed##3##2##(1992-3#1)(2008-10#2)
was progressively##8##2##(1991-12#1)(1992-9#1)(2008-1#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-11#1)(2013-1#1)
was prohibited##2##2##(1995-2#1)(2008-5#1)
was projected##2##2##(2008-10#1)(2011-2#1)
was prolonged for##2##3##(2010-5#1)(2012-2#1)
was prolonged in##2##3##(1994-6#1)(2007-11#1)
was prolonged##14##2##(1993-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-3#1)(2012-2#1)
was promoted by##3##3##(1992-6#1)(1995-6#1)(2009-8#1)
was promoted##4##2##(1992-6#1)(1995-6#1)(2008-11#1)(2009-8#1)
was prompted by##2##3##(1996-12#1)(2008-11#1)
was pronounced in##2##3##(1993-3#1)(2010-6#1)
was pronounced##3##2##(1993-3#1)(1996-2#1)(2010-6#1)
was propagated##2##2##(1993-3#1)(2011-1#1)
was properly##2##2##(1993-6#1)(2008-11#1)
was proportional to the concentration of##6##6##(2008-10#6)
was proportional to the square of the##2##7##(2008-3#2)
was proportional to the##23##4##(1990-5#1)(1991-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-7#1)(2012-2#1)
was proportional to viable cell number##2##6##(2008-11#2)
was proportional to##29##3##(1990-5#1)(1991-2#1)(1991-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#14)(2008-11#4)(2008-3#3)(2008-7#1)(2012-2#1)
was proposed and##6##3##(2008-10#5)(2008-2#1)
was proposed as a##4##4##(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
was proposed as an##2##4##(2011-2#1)(2011-3#1)
was proposed as##7##3##(2008-10#1)(2008-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
was proposed based on##2##4##(2008-10#2)
was proposed by##4##3##(1990-11#1)(2007-11#1)(2008-10#2)
was proposed for the determination of trace##2##7##(2008-10#1)(2013-8#1)
was proposed for the determination of##7##6##(2008-10#6)(2013-8#1)
was proposed for the##11##4##(2008-10#10)(2013-8#1)
was proposed for##20##3##(1992-8#1)(2007-12#1)(2008-10#14)(2008-2#1)(2008-8#1)(2010-4#1)(2013-8#1)
was proposed in the##2##4##(2008-10#1)(2013-8#1)
was proposed in##6##3##(1994-9#1)(2008-10#3)(2008-9#1)(2013-8#1)
was proposed that the##2##4##(2008-9#1)(2011-1#1)
was proposed that##4##3##(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)
was proposed to be##3##4##(2008-10#2)(2012-1#1)
was proposed to explain the##2##5##(2008-10#2)
was proposed to##15##3##(2006-10#1)(2008-10#9)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
was proposed using##2##3##(2008-10#2)
was proposed##108##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#63)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2010-4#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-8#4)
was prospectively studied##2##3##(1994-12#1)(2008-1#1)
was prospectively##4##2##(1994-12#2)(1995-4#1)(2008-1#1)
was protected from##2##3##(1990-11#1)(2012-2#1)
was protected##3##2##(1990-11#1)(1992-4#1)(2012-2#1)
was protective##3##2##(1996-9#1)(2008-7#1)(2011-2#1)
was proved by the##4##4##(2008-10#4)
was proved by##10##3##(1997-3#1)(2007-11#1)(2008-10#6)(2008-8#1)(2008-9#1)
was proved that the##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
was proved that##9##3##(1995-3#1)(2007-10#1)(2008-10#3)(2008-8#1)(2008-9#2)(2013-8#1)
was proved to be an##2##5##(1997-6#1)(2013-1#1)
was proved to be##9##4##(1996-2#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-10#4)(2013-1#1)
was proved##39##2##(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-8#2)(2008-9#3)(2012-3#2)(2013-1#1)(2013-8#1)
was proven by##2##3##(2008-10#1)(2010-7#1)
was proven to be##4##4##(1994-11#1)(1995-12#1)(2008-8#1)(2011-2#1)
was proven to##6##3##(1994-11#1)(1995-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
was proven##11##2##(1994-11#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-7#1)(2011-2#2)
was provided by an##2##4##(2008-2#1)(2008-3#1)
was provided by the##6##4##(1996-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2013-8#1)
was provided by##13##3##(1993-8#1)(1996-12#2)(1997-2#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-8#1)
was provided for##3##3##(1993-1#1)(2007-7#1)(2011-2#1)
was provided with##2##3##(2007-8#1)(2011-2#1)
was provided##25##2##(1991-12#1)(1993-1#1)(1993-8#1)(1996-12#2)(1997-2#1)(1997-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
was published in##4##3##(1993-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
was published##9##2##(1993-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
was pulled##2##2##(2008-6#1)(2013-1#1)
was pumped at a##2##4##(1991-5#1)(2010-3#1)
was pumped at##4##3##(1991-5#1)(2007-11#1)(2008-10#1)(2010-3#1)
was pumped by a##2##4##(2007-11#1)(2007-12#1)
was pumped through the##2##4##(2008-10#1)(2008-11#1)
was pumped with a##2##4##(2007-11#1)(2007-12#1)
was pumped with##3##3##(2007-11#1)(2007-12#2)
was pumped##13##2##(1991-5#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#1)(2010-3#1)
was purely##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
was purified and used to##2##5##(1993-8#1)(2008-10#1)
was purified and used##4##4##(1993-8#1)(1994-2#1)(2008-10#1)(2008-8#1)
was purified and##12##3##(1990-4#1)(1992-12#1)(1993-8#2)(1994-2#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-1#1)
was purified by a##2##4##(1994-3#1)(2008-11#1)
was purified by affinity chromatography##2##5##(1997-2#1)(2010-4#1)
was purified by##17##3##(1990-8#1)(1991-8#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-2#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)
was purified from the##7##4##(1991-5#1)(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)
was purified from##24##3##(1990-11#1)(1990-12#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#3)(1993-11#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)
was purified to an##2##4##(1990-11#1)(1994-5#1)
was purified to electrophoretic homogeneity##2##5##(1990-7#1)(1993-8#1)
was purified to homogeneity by##4##5##(1990-8#1)(1997-4#1)(2009-3#1)(2010-4#1)
was purified to homogeneity from the##3##6##(1990-11#1)(1990-5#1)(1991-12#1)
was purified to homogeneity from##8##5##(1990-11#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
was purified to homogeneity##18##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)
was purified to near homogeneity by##2##6##(1993-6#1)(1994-8#1)
was purified to near homogeneity from##2##6##(1990-8#1)(1993-11#1)
was purified to near homogeneity##4##5##(1990-8#1)(1993-11#1)(1993-6#1)(1994-8#1)
was purified to##28##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-4#1)
was purified with##2##3##(1995-12#1)(2008-10#1)
was purified##100##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#3)(1991-12#1)(1991-5#3)(1991-8#2)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-12#2)(1995-6#3)(1996-2#1)(1997-2#5)(1997-4#3)(1997-6#3)(2008-10#13)(2008-11#5)(2008-12#2)(2008-6#2)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2010-4#2)(2011-1#1)(2011-2#1)
was put on##3##3##(2007-5#1)(2007-8#1)(2011-2#1)
was put##6##2##(2007-5#1)(2007-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
was qualified as##2##3##(1991-6#1)(2012-3#1)
was qualified##5##2##(1991-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
was qualitative##2##2##(2008-10#1)(2011-2#1)
was qualitatively##3##2##(2008-10#2)(2008-5#1)
was quantified as##3##3##(2008-10#2)(2010-4#1)
was quantified by the##3##4##(2006-6#1)(2008-10#1)(2008-11#1)
was quantified by##14##3##(1995-12#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#2)(2012-4#1)
was quantified in##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
was quantified using##4##3##(2008-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
was quantified##35##2##(1995-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-7#2)(2009-5#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
was quantitated by##2##3##(1991-12#1)(1992-6#1)
was quantitated in##3##3##(1994-5#1)(2008-4#1)(2008-6#1)
was quantitated##6##2##(1991-12#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
was quantitative and##2##3##(2008-10#2)
was quantitative##6##2##(1991-12#2)(2008-10#4)
was quantitatively analyzed##3##3##(1996-5#1)(2008-10#2)
was quantitatively extracted with##3##4##(2008-10#3)
was quantitatively extracted##5##3##(2008-10#5)
was quantitatively retained##3##3##(2008-10#3)
was quantitatively##17##2##(1991-10#1)(1992-9#1)(1996-5#1)(2008-10#13)(2010-12#1)
was quenched##3##2##(1992-5#1)(1996-4#1)(2008-3#1)
was quickly##4##2##(1995-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
was quite effective##2##3##(1992-12#1)(2007-11#1)
was quite similar##2##3##(2008-10#1)(2008-7#1)
was quite##11##2##(1992-12#1)(1992-5#1)(1993-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-9#1)
was r=0##2##2##(2008-10#1)(2010-11#1)
was race##2##2##(2008-10#2)
was radical##2##2##(2008-7#1)(2011-1#1)
was radically##2##2##(2007-10#1)(2008-10#1)
was raised against the##2##4##(1994-8#1)(2008-4#1)
was raised against##3##3##(1994-8#1)(2007-12#1)(2008-4#1)
was raised from##2##3##(1993-3#1)(2011-2#1)
was raised in the##2##4##(1991-12#1)(2008-10#1)
was raised in##7##3##(1990-9#1)(1991-12#1)(1995-12#1)(2007-7#1)(2008-10#2)(2008-6#1)
was raised to##3##3##(1990-11#1)(1990-2#1)(1990-9#1)
was raised##28##2##(1990-11#1)(1990-2#1)(1990-9#2)(1991-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
was random##3##2##(2008-10#3)
was randomized##2##2##(1997-2#1)(2008-11#1)
was randomly selected for each##2##5##(1993-12#1)(2012-2#1)
was randomly selected##3##3##(1993-12#1)(2012-2#1)(2013-1#1)
was randomly##11##2##(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
was rapid and##5##3##(1993-6#1)(1994-2#1)(1995-1#1)(2008-10#2)
was rapid##16##2##(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-8#1)
was rapidly##9##2##(1992-3#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
was rare and##2##3##(2008-9#1)(2009-10#1)
was rare##8##2##(2008-1#1)(2008-10#4)(2008-9#1)(2009-10#1)(2011-3#1)
was rated as excellent##2##4##(2012-1#2)
was rated as##5##3##(1993-2#1)(2007-11#1)(2011-2#1)(2012-1#2)
was rated by##2##3##(2010-4#1)(2012-2#1)
was rated highest##2##3##(1993-2#1)(2009-11#1)
was rated##11##2##(1993-2#3)(2007-11#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
was rather##12##2##(1990-5#1)(1992-2#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
was re-evaluated##2##2##(2008-10#1)(2008-12#1)
was reached after 60##2##4##(2008-10#2)
was reached after##3##3##(2008-10#2)(2011-1#1)
was reached and##2##3##(2011-2#1)(2013-1#1)
was reached for##2##3##(2008-10#2)
was reached in##5##3##(2008-10#2)(2011-1#2)(2011-2#1)
was reached with##2##3##(2008-10#1)(2008-2#1)
was reached within##2##3##(1991-12#1)(2010-5#1)
was reached##32##2##(1991-11#1)(1991-12#1)(1992-3#2)(2008-10#11)(2008-11#4)(2008-2#1)(2008-5#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#3)(2013-1#2)
was reacted with##10##3##(1991-5#1)(1996-5#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-12#1)
was reacted##11##2##(1991-5#1)(1996-5#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-12#1)
was reactive with##3##3##(1992-9#1)(1997-7#1)(2008-5#1)
was reactive##4##2##(1992-9#1)(1997-7#1)(2008-12#1)(2008-5#1)
was read by##2##3##(2008-10#2)
was readily detected##2##3##(1991-12#1)(1995-2#1)
was readily observed##2##3##(1996-5#1)(2007-6#1)
was readily purified##4##3##(1993-9#1)(1994-11#1)(1995-2#1)(1997-4#1)
was readily##20##2##(1991-12#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-5#2)(1997-4#1)(2007-6#1)(2008-10#6)(2008-3#1)(2011-2#1)
was realized between##2##3##(2008-10#1)(2008-12#1)
was realized by##3##3##(2007-10#1)(2008-10#1)(2012-3#1)
was realized in##2##3##(2007-11#1)(2009-9#1)
was realized with##2##3##(2008-9#1)(2013-1#1)
was realized##18##2##(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
was reasonable##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
was reassessed##2##2##(2008-10#1)(2008-12#1)
was received by less than##2##5##(2008-1#2)
was received by##3##3##(2008-1#2)(2010-3#1)
was received##6##2##(1996-12#1)(2008-1#2)(2010-3#1)(2011-2#1)(2013-8#1)
was recently determined##2##3##(1997-3#1)(2012-2#1)
was recently developed##2##3##(2008-3#2)
was recently discovered that##2##4##(2009-6#1)(2010-7#1)
was recently found to##3##4##(1994-11#1)(1996-2#1)(2012-12#1)
was recently found##4##3##(1994-11#1)(1996-2#1)(2011-2#1)(2012-12#1)
was recently identified as##2##4##(1994-11#1)(2008-10#1)
was recently identified##3##3##(1994-11#2)(2008-10#1)
was recently introduced##2##3##(1996-3#1)(2008-3#1)
was recently presented##2##3##(2008-3#2)
was recently proposed by##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
was recently proposed##7##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-3#3)
was recently reported##3##3##(2008-2#1)(2008-4#1)(2008-8#1)
was recently shown##2##3##(2009-8#1)(2011-2#1)
was recently##50##2##(1990-8#1)(1992-6#1)(1994-11#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
was recognised##2##2##(1991-3#1)(2010-3#1)
was recognized as a##2##4##(2008-3#1)(2012-2#1)
was recognized as##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
was recognized by antibodies##2##4##(1990-11#1)(1994-11#1)
was recognized by##5##3##(1990-11#1)(1990-5#1)(1994-11#1)(1995-12#1)(2008-10#1)
was recognized in##6##3##(1996-9#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
was recognized that##2##3##(2008-11#1)(2008-7#1)
was recognized##22##2##(1990-11#1)(1990-5#1)(1994-11#1)(1995-12#1)(1996-9#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#3)(2012-2#1)
was recommended for##2##3##(1990-12#1)(2008-7#1)
was recommended that##3##3##(1997-1#1)(2008-10#1)(2010-8#1)
was recommended to##2##3##(2008-6#1)(2008-7#1)
was recommended##11##2##(1990-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
was reconfirmed##2##2##(1993-12#1)(2011-2#1)
was reconstituted in vitro##3##4##(1992-12#1)(1993-8#1)(1994-8#1)
was reconstituted in##4##3##(1992-12#1)(1993-8#1)(1994-8#1)(2008-10#1)
was reconstituted##7##2##(1992-12#1)(1993-8#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
was reconstructed using##2##3##(2008-9#1)(2010-8#1)
was reconstructed with##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
was reconstructed##11##2##(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was recorded after##2##3##(2007-11#1)(2008-11#1)
was recorded and analyzed##2##4##(2008-3#1)(2009-11#1)
was recorded and##5##3##(1993-12#1)(1994-3#1)(2008-3#1)(2008-7#1)(2009-11#1)
was recorded as##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
was recorded at##7##3##(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)
was recorded between##3##3##(2008-12#1)(2010-8#1)(2013-8#1)
was recorded by##4##3##(1993-9#1)(2008-12#1)(2008-5#1)(2008-7#1)
was recorded during##4##3##(1993-6#1)(1996-2#1)(2007-5#1)(2013-1#1)
was recorded for##7##3##(1994-7#1)(2008-10#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-8#2)
was recorded from 64##2##4##(2008-11#1)(2013-8#1)
was recorded from the##2##4##(1995-12#1)(2010-9#1)
was recorded from##10##3##(1992-8#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
was recorded in the##4##4##(1990-3#1)(1991-8#1)(1994-12#1)(2012-1#1)
was recorded in##28##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-8#1)(1994-12#2)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-7#2)(2009-12#1)(2011-2#3)(2012-1#2)(2013-1#2)(2013-7#1)
was recorded on##4##3##(1994-3#1)(2008-10#3)
was recorded using a##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
was recorded weekly##2##3##(1995-3#1)(2008-10#1)
was recorded with##3##3##(1991-3#1)(2008-3#2)
was recorded##112##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#2)(2013-1#6)(2013-7#1)(2013-8#6)
was recovered after##2##3##(1991-2#1)(2013-1#1)
was recovered and##2##3##(1994-9#1)(2011-2#1)
was recovered by##3##3##(1993-12#1)(1997-4#1)(2008-7#1)
was recovered from the##3##4##(2008-10#2)(2008-7#1)
was recovered from##13##3##(1993-12#1)(2007-5#1)(2008-10#10)(2008-7#1)
was recovered only from##2##4##(2007-6#1)(2008-10#1)
was recovered with the dowex resin plus the##2##8##(2008-10#2)
was recovered##39##2##(1991-12#1)(1991-2#1)(1993-12#2)(1994-9#1)(1997-4#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-2#2)(2013-1#1)
was recruited##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
was rediscovered in the##2##4##(2008-6#1)(2012-1#1)
was reduced (P &lt##2##4##(1992-12#1)(2011-3#1)
was reduced after##5##3##(1990-12#1)(1995-12#1)(2008-10#1)(2009-4#1)(2013-1#1)
was reduced and##9##3##(1991-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
was reduced as##4##3##(1992-6#1)(2008-10#1)(2009-7#1)(2010-5#1)
was reduced at a##3##4##(1990-8#1)(2008-10#2)
was reduced at##9##3##(1990-8#1)(1993-9#1)(1995-8#1)(2008-10#6)
was reduced by 0##2##4##(2008-10#1)(2012-2#1)
was reduced by 10%##2##4##(1996-7#1)(2008-2#1)
was reduced by 25 and##2##5##(1991-5#1)(1994-8#1)
was reduced by 40%##2##4##(1995-8#1)(2008-10#1)
was reduced by a factor of##2##6##(2008-10#1)(2008-7#1)
was reduced by a##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
was reduced by about##3##4##(2008-10#2)(2008-6#1)
was reduced by only##2##4##(1995-5#1)(2008-3#1)
was reduced by the##2##4##(1991-9#1)(2008-11#1)
was reduced by##67##3##(1990-3#1)(1991-5#2)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#2)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
was reduced compared with##2##4##(1995-8#1)(2008-10#1)
was reduced during the##2##4##(2008-1#1)(2012-2#1)
was reduced for##2##3##(2008-10#1)(2011-2#1)
was reduced from 10##2##4##(2008-10#2)
was reduced from##12##3##(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#4)(2012-12#1)
was reduced in a##3##4##(1990-5#1)(2008-10#2)
was reduced in the##8##4##(1993-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
was reduced in##26##3##(1990-11#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#3)(2013-1#2)
was reduced sensitive to##2##4##(2007-6#2)
was reduced significantly after##2##4##(1996-5#1)(2008-10#1)
was reduced significantly in##2##4##(2008-7#1)(2011-2#1)
was reduced significantly##7##3##(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
was reduced to Cr(III)##2##4##(2008-10#2)
was reduced to##30##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-9#1)(1994-3#2)(1995-12#2)(1995-6#1)(1996-5#2)(1997-2#1)(1997-6#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
was reduced when##4##3##(2008-10#3)(2008-4#1)
was reduced with##5##3##(1994-2#1)(2007-11#2)(2008-10#1)(2012-2#1)
was reduced##233##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#3)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#4)(1996-12#1)(1996-2#2)(1996-5#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#71)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#3)
was referred because of##4##4##(1995-5#1)(2007-5#1)(2012-3#1)(2013-1#1)
was referred for evaluation##2##4##(1997-3#1)(2013-8#1)
was referred for##12##3##(1992-11#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
was referred to an##2##4##(1993-12#1)(2010-10#1)
was referred to our department##2##5##(2011-2#1)(2013-7#1)
was referred to our hospital for##4##6##(2011-2#2)(2013-8#2)
was referred to our hospital##5##5##(2008-1#1)(2011-2#2)(2013-8#2)
was referred to our##9##4##(2008-1#1)(2008-10#1)(2010-10#1)(2011-2#3)(2013-7#1)(2013-8#2)
was referred to the##3##4##(1994-12#1)(2008-6#1)(2011-1#1)
was referred to us##2##4##(2007-12#1)(2008-1#1)
was referred to##22##3##(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-10#2)(2011-1#2)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
was referred##44##2##(1991-11#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-3#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#2)(2010-12#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
was refined at 2##2##4##(1992-4#1)(1993-8#1)
was refined##5##2##(1992-4#1)(1993-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
was reflected by##4##3##(1992-3#1)(1994-11#1)(1994-12#1)(2008-10#1)
was reflected in the##2##4##(1990-5#1)(1992-6#1)
was reflected in##9##3##(1990-5#1)(1992-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)
was reflected##15##2##(1990-5#1)(1992-3#1)(1992-6#2)(1992-9#1)(1994-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
was refractory to##5##3##(1991-6#1)(1994-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
was regarded as a##3##4##(1990-3#1)(2008-1#1)(2008-3#1)
was regarded as##9##3##(1990-3#1)(1992-6#1)(1993-2#1)(1994-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)
was regenerated by##2##3##(2008-10#2)
was regenerated##3##2##(2008-10#3)
was registered in##2##3##(1993-11#1)(2008-10#1)
was registered on##2##3##(2008-6#1)(2010-5#1)
was registered##10##2##(1991-2#1)(1993-11#1)(2008-10#3)(2008-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
was regular##2##2##(1992-6#1)(1993-3#1)
was regulated by##7##3##(1991-9#1)(1995-11#1)(1996-5#1)(1997-6#1)(2008-10#1)(2009-10#1)(2009-3#1)
was regulated##8##2##(1991-5#1)(1991-9#1)(1995-11#1)(1996-5#1)(1997-6#1)(2008-10#1)(2009-10#1)(2009-3#1)
was reinfused##2##2##(1996-9#1)(2012-12#1)
was reintroduced##2##2##(1990-3#1)(2008-10#1)
was rejected for##2##3##(1991-1#1)(2012-3#1)
was rejected##5##2##(1991-1#1)(1991-6#1)(2008-10#2)(2012-3#1)
was related to a##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
was related to both##2##4##(2008-10#1)(2008-5#1)
was related to increased##2##4##(2008-10#1)(2013-7#1)
was related to its##2##4##(1992-11#1)(2008-10#1)
was related to the concentration of##2##6##(2008-10#2)
was related to the risk of##2##6##(1991-4#1)(2011-1#1)
was related to the##28##4##(1990-7#1)(1991-4#1)(1992-12#1)(1992-8#1)(1994-3#1)(1997-7#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
was related to##76##3##(1990-5#2)(1990-7#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-9#3)(1994-3#2)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#3)(2009-8#3)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was related##83##2##(1990-5#2)(1990-7#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-9#3)(1994-3#3)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#2)(2007-6#1)(2008-10#27)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#3)(2009-8#3)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was relative##2##2##(1995-3#1)(2008-10#1)
was relatively constant##3##3##(1990-11#1)(1995-8#1)(2008-5#1)
was relatively good##2##3##(1992-8#1)(2007-10#1)
was relatively high##6##3##(1997-6#1)(2008-10#4)(2008-9#1)
was relatively insensitive to##2##4##(1993-8#1)(1995-3#1)
was relatively low##2##3##(2011-1#1)(2013-7#1)
was relatively rare##2##3##(2011-2#1)(2013-1#1)
was relatively small##3##3##(2008-10#1)(2009-3#1)(2010-5#1)
was relatively unaffected##2##3##(1995-5#1)(2008-6#1)
was relatively well##2##3##(1994-12#1)(1997-2#1)
was relatively##39##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
was relaxed##2##2##(1997-7#1)(2012-3#1)
was released by##5##3##(1992-6#1)(1994-11#1)(2008-10#1)(2013-8#2)
was released from the##2##4##(1991-5#1)(2011-2#1)
was released from##6##3##(1991-5#1)(1992-3#1)(1993-11#1)(1993-6#1)(2008-10#1)(2011-2#1)
was released into the##2##4##(1990-2#1)(2011-2#1)
was released##20##2##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#1)(2008-10#4)(2008-11#1)(2010-6#1)(2011-2#2)(2013-8#2)
was reliable and##4##3##(1991-3#1)(2008-10#3)
was reliable for##3##3##(2008-10#3)
was reliable##10##2##(1991-3#1)(2007-7#2)(2008-10#7)
was relieved by##2##3##(1991-5#1)(2008-7#1)
was relieved##6##2##(1991-12#1)(1991-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
was remarkable for##2##3##(2008-11#1)(2008-7#1)
was remarkable##3##2##(1991-3#1)(2008-11#1)(2008-7#1)
was remarkably higher##2##3##(1996-2#1)(2008-9#1)
was remarkably inhibited##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
was remarkably##9##2##(1990-6#1)(1992-12#1)(1992-4#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-1#1)
was removed and replaced##3##4##(2008-10#2)(2008-9#1)
was removed and##6##3##(2006-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)
was removed at##2##3##(2010-3#1)(2011-1#1)
was removed by the##2##4##(2008-7#1)(2013-1#1)
was removed by##12##3##(1991-6#1)(1992-8#1)(1992-9#1)(1994-5#1)(1996-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
was removed from the minicolumn with##2##6##(2008-10#2)
was removed from the##7##4##(1992-5#1)(2008-10#5)(2008-11#1)
was removed from##12##3##(1992-5#2)(2008-10#7)(2008-11#2)(2008-3#1)
was removed in##2##3##(1991-6#1)(1997-3#1)
was removed under##2##3##(2007-8#2)
was removed with##2##3##(1990-5#1)(2008-10#1)
was removed##60##2##(1990-5#1)(1991-6#2)(1992-5#2)(1992-8#2)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-3#1)(2006-12#2)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
was rendered##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
was reoperated##5##2##(1992-10#1)(2007-8#2)(2008-10#1)(2008-6#1)
was repaired with a##2##4##(2007-8#1)(2008-12#1)
was repaired with##6##3##(2007-8#4)(2008-10#1)(2008-12#1)
was repaired##10##2##(2007-8#4)(2008-10#1)(2008-12#3)(2008-7#1)(2012-3#1)
was repeatable##2##2##(2008-10#1)(2012-2#1)
was repeated every##3##3##(2007-11#1)(2008-10#1)(2008-12#1)
was repeated in##4##3##(1994-8#1)(2007-11#1)(2010-6#1)(2011-1#1)
was repeated on##2##3##(1990-2#1)(1994-7#1)
was repeated three times##3##4##(1990-8#1)(1994-2#1)(2008-10#1)
was repeated until##2##3##(1997-6#1)(2008-1#1)
was repeated with##3##3##(1992-6#1)(2011-3#1)(2012-12#1)
was repeated##28##2##(1990-2#1)(1990-6#1)(1990-8#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
was repeatedly##2##2##(2008-10#1)(2008-2#1)
was replaced by Ala##2##4##(1992-6#1)(1994-5#1)
was replaced by a single##2##5##(2008-10#2)
was replaced by a##3##4##(2008-10#3)
was replaced by the##3##4##(1990-2#1)(1997-3#1)(2008-8#1)
was replaced by##22##3##(1990-10#1)(1990-2#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-5#2)(1995-12#1)(1995-6#1)(1997-3#2)(2008-10#5)(2008-8#1)(2008-9#3)(2013-1#1)
was replaced with valine##2##4##(1995-2#1)(1996-2#1)
was replaced with##17##3##(1990-5#1)(1991-12#1)(1991-9#1)(1993-8#1)(1995-2#2)(1995-3#1)(1996-2#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
was replaced##42##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#2)(2008-10#6)(2008-11#2)(2008-8#1)(2008-9#4)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
was replicated##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
was reported and##2##3##(2008-11#1)(2011-2#1)
was reported as##3##3##(1997-2#1)(2007-2#1)(2013-8#1)
was reported by##13##3##(1990-12#1)(1991-8#1)(1995-6#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
was reported for the##2##4##(1995-2#1)(2008-6#1)
was reported for##4##3##(1995-2#1)(2008-6#1)(2009-8#1)(2013-8#1)
was reported in the##4##4##(1994-9#1)(1996-5#1)(2008-12#1)(2008-3#1)
was reported in this paper##2##5##(2008-10#1)(2008-9#1)
was reported in this##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
was reported in##21##3##(1990-6#1)(1991-3#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)
was reported on##2##3##(2008-10#2)
was reported that the##2##4##(2008-11#1)(2010-7#1)
was reported that##3##3##(2008-11#2)(2010-7#1)
was reported to be##10##4##(1995-12#1)(1996-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-8#1)
was reported to have##2##4##(2007-11#1)(2008-10#1)
was reported to##13##3##(1995-12#1)(1996-12#1)(1996-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-8#1)
was reported##88##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
was representative of##2##3##(1992-2#1)(2009-11#1)
was represented by a##2##4##(2008-10#2)
was represented by##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
was represented in##2##3##(1992-12#1)(1992-3#1)
was represented##9##2##(1992-12#1)(1992-3#1)(1994-8#1)(2008-10#4)(2008-5#1)(2008-7#1)
was reproduced##5##2##(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
was reproducible and##2##3##(2008-10#2)
was reproducible within##2##3##(2008-10#2)
was reproducible##4##2##(2008-10#4)
was reproducibly induced by##2##4##(2008-11#1)(2011-2#1)
was requested##2##2##(2008-11#1)(2012-12#1)
was required as##2##3##(2008-10#1)(2008-11#1)
was required for growth##2##4##(1997-4#2)
was required for##21##3##(1990-5#2)(1992-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#2)(1997-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#2)(2011-2#1)
was required in the##3##4##(2008-1#1)(2008-10#1)(2009-11#1)
was required in this##2##4##(2007-8#1)(2008-10#1)
was required in##8##3##(1990-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2009-11#1)(2010-7#1)
was required to##16##3##(1990-12#1)(1990-2#1)(1993-2#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
was required##69##2##(1990-12#1)(1990-2#2)(1990-5#2)(1991-1#1)(1992-12#1)(1993-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
was rescued by##3##3##(1995-2#1)(1996-3#1)(2008-3#1)
was researched##3##2##(2012-3#1)(2013-8#2)
was resected and##4##3##(2006-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
was resected##16##2##(1991-9#1)(1992-9#1)(1995-3#1)(2006-12#1)(2007-8#4)(2008-6#1)(2008-7#3)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
was resistant to all##4##4##(2007-6#1)(2008-10#2)(2008-5#1)
was resistant to the##2##4##(1993-12#1)(1995-2#1)
was resistant to##15##3##(1990-11#1)(1992-9#1)(1993-12#1)(1995-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-8#1)
was resistant##18##2##(1990-11#1)(1992-9#1)(1993-12#1)(1995-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-8#1)
was resolved by##3##3##(1991-12#1)(1997-4#1)(2008-10#1)
was resolved##8##2##(1991-12#1)(1994-9#1)(1997-4#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
was respectively##3##2##(1991-8#1)(1995-6#1)(2008-10#1)
was responsible for the##7##4##(1990-6#1)(1994-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
was responsible for##21##3##(1990-6#1)(1991-2#1)(1991-4#1)(1994-6#1)(1997-5#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
was responsive to##2##3##(2008-8#1)(2011-9#1)
was responsive##3##2##(1990-8#1)(2008-8#1)(2011-9#1)
was restored and##2##3##(2007-11#1)(2007-8#1)
was restored by##10##3##(1991-5#2)(1992-3#1)(1993-12#1)(1996-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)
was restored in##5##3##(1997-3#1)(2008-1#1)(2008-11#1)(2012-3#2)
was restored to##3##3##(1992-11#1)(2008-2#1)(2011-2#1)
was restored with a##3##4##(2013-1#3)
was restored with##7##3##(1997-8#1)(2007-11#1)(2012-3#1)(2013-1#4)
was restored##33##2##(1991-5#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1995-3#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#4)
was restricted by the##2##4##(2008-10#1)(2008-11#1)
was restricted to a##2##4##(1997-1#1)(2013-8#1)
was restricted to the##9##4##(1991-12#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-3#1)
was restricted to##18##3##(1991-12#1)(1993-12#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-8#1)(2008-10#6)(2008-11#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
was restricted##26##2##(1991-12#1)(1993-12#1)(1994-7#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-11#3)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
was retained and##3##3##(1995-2#2)(2008-10#1)
was retained by##2##3##(1993-1#1)(2008-10#1)
was retained in the##2##4##(2008-10#2)
was retained in##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
was retained on##2##3##(1990-11#1)(1990-12#1)
was retained##20##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-1#1)(1993-9#1)(1995-2#2)(1996-3#1)(1996-4#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
was retarded##2##2##(2008-10#1)(2008-11#1)
was retrieved by##2##3##(2007-7#1)(2008-3#1)
was retrieved from##2##3##(2008-10#1)(2008-3#1)
was retrieved##4##2##(2007-7#1)(2008-10#1)(2008-3#2)
was retrospective##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
was retrospectively reviewed from##2##4##(2013-1#2)
was retrospectively reviewed##3##3##(2012-3#1)(2013-1#2)
was retrospectively##5##2##(2010-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
was revealed by##8##3##(1993-9#1)(1994-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)
was revealed in three##2##4##(2008-12#1)(2008-4#1)
was revealed in##5##3##(2007-11#2)(2008-12#1)(2008-4#1)(2008-7#1)
was revealed that the##2##4##(2008-10#1)(2008-12#1)
was revealed that##10##3##(1992-8#1)(1993-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2009-4#1)
was revealed##38##2##(1990-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-7#1)(1995-5#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-4#1)(2012-12#1)
was reverse##2##2##(1991-11#1)(2013-1#1)
was reversed by the##2##4##(2008-10#1)(2008-7#1)
was reversed by##9##3##(1990-5#1)(1991-1#1)(1993-12#1)(1994-2#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2012-12#1)
was reversed upon##2##3##(1991-12#1)(1997-7#1)
was reversed when##2##3##(2007-6#1)(2008-10#1)
was reversed##19##2##(1990-5#1)(1991-1#1)(1991-12#1)(1993-12#1)(1994-2#1)(1994-6#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-10#6)(2008-7#1)(2009-11#1)(2012-12#1)(2012-3#1)
was reversible##8##2##(1991-2#1)(1991-8#1)(1992-5#1)(1993-6#1)(1994-8#1)(2008-10#2)(2008-7#1)
was reversibly##3##2##(1990-5#1)(1991-12#1)(2008-10#1)
was reviewed and##3##3##(1992-3#1)(2007-12#1)(2012-3#1)
was reviewed##13##2##(1992-3#1)(1994-2#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
was revised##2##2##(1993-6#1)(2009-8#1)
was robust##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
was rotated##3##2##(1993-6#1)(1997-5#1)(2008-11#1)
was roughly##6##2##(1991-2#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-6#1)
was routinely##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
was ruled out##7##3##(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(2009-3#1)(2010-12#1)(2013-1#1)
was run in##2##3##(1990-3#1)(2008-11#1)
was run to##2##3##(2008-10#1)(2013-7#1)
was run##9##2##(1990-3#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
was sacrificed##2##2##(2008-7#1)(2008-9#1)
was safe and effective##2##4##(2008-12#1)(2012-12#1)
was safe and##5##3##(2008-12#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-3#1)
was safely##2##2##(2012-12#1)(2012-2#1)
was same##2##2##(2011-2#1)(2012-12#1)
was sampled and##2##3##(2008-11#1)(2008-5#1)
was sampled by##2##3##(2007-10#1)(2008-5#1)
was sampled from##2##3##(1990-5#1)(2008-10#1)
was sampled##10##2##(1990-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-5#1)(2013-7#1)
was sandwiched##2##2##(2008-10#1)(2008-2#1)
was satisfactorily applied to the determination of##6##7##(2008-10#6)
was satisfactorily applied to the##7##5##(2008-10#7)
was satisfactorily applied to##8##4##(2008-10#8)
was satisfactorily applied##9##3##(2008-10#9)
was satisfactorily##12##2##(2008-10#11)(2011-1#1)
was satisfactory in both cases##3##5##(2008-10#1)(2011-2#2)
was satisfactory in##6##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)
was satisfactory##17##2##(1991-11#1)(1991-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
was satisfied##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
was saturable and inhibited by##2##5##(1994-6#1)(1994-8#1)
was saturable##4##2##(1991-12#1)(1993-8#1)(1994-6#1)(1994-8#1)
was scaled##2##2##(2008-11#1)(2008-7#1)
was scanned over##2##3##(2008-2#1)(2008-3#1)
was scanned##7##2##(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)
was scarcely##4##2##(1993-12#1)(1995-11#1)(2008-11#1)(2008-5#1)
was scheduled##2##2##(1996-9#1)(2007-8#1)
was scored according to##3##4##(1994-3#1)(2008-10#1)(2008-6#1)
was scored by the##2##4##(2010-5#1)(2013-1#1)
was scored by##4##3##(1995-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
was scored##11##2##(1994-3#1)(1995-3#1)(1997-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
was screened by##2##3##(1992-8#1)(2008-9#1)
was screened for##7##3##(1992-11#1)(1993-6#1)(1994-12#1)(1995-2#1)(2008-10#3)
was screened in##2##3##(2008-8#1)(2008-9#1)
was screened out##2##3##(2008-8#2)
was screened using a##2##4##(1991-1#1)(1992-3#1)
was screened using##9##3##(1991-1#1)(1992-3#1)(1992-6#1)(1996-10#1)(2008-10#2)(2008-8#2)(2013-1#1)
was screened with the##3##4##(1990-12#1)(1990-7#1)(1994-6#1)
was screened with##11##3##(1990-12#2)(1990-7#2)(1990-8#2)(1991-6#1)(1992-3#2)(1994-6#1)(2008-8#1)
was screened##39##2##(1990-12#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-6#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-10#1)(2007-11#1)(2008-10#5)(2008-8#6)(2008-9#2)(2013-1#1)(2013-8#2)
was searched for##3##3##(2009-3#1)(2011-1#1)(2011-2#1)
was searched##5##2##(2009-3#1)(2011-1#2)(2011-2#2)
was secondary to##2##3##(2007-7#1)(2013-1#1)
was secreted and##2##3##(1990-11#1)(1992-10#1)
was secreted by##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
was secreted in##2##3##(1995-8#1)(1997-2#1)
was secreted into the culture medium##4##6##(1993-3#1)(1993-9#1)(1997-4#2)
was secreted into the medium##2##5##(1991-9#2)
was secreted into the##7##4##(1991-9#2)(1993-3#1)(1993-9#2)(1997-4#2)
was secreted##21##2##(1990-11#1)(1990-8#1)(1991-9#3)(1992-10#1)(1992-12#2)(1993-3#2)(1993-9#2)(1994-11#1)(1995-8#1)(1997-2#1)(1997-4#2)(2008-10#2)(2008-7#1)(2008-8#1)
was sectioned in##2##3##(2008-12#1)(2008-9#1)
was sectioned##4##2##(2008-12#1)(2008-9#1)(2009-4#1)(2013-1#1)
was secured##2##2##(2008-9#1)(2009-3#1)
was seedborne##2##2##(2008-10#2)
was seen after##6##3##(1991-8#1)(1994-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2010-11#1)
was seen among##2##3##(1997-3#1)(2008-3#1)
was seen as an##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
was seen as##8##3##(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
was seen at our##2##4##(1994-7#1)(1997-4#1)
was seen at the##3##4##(1996-5#1)(2008-10#1)(2010-3#1)
was seen at##9##3##(1990-5#1)(1991-2#1)(1992-12#1)(1994-7#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-3#1)
was seen between##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
was seen by##2##3##(2008-9#1)(2012-12#1)
was seen during##2##3##(1990-12#1)(2008-7#1)
was seen even##2##3##(1991-12#1)(1993-12#1)
was seen following##2##3##(1991-3#1)(1993-6#1)
was seen for##3##3##(1991-8#1)(1995-5#1)(2008-10#1)
was seen in 100%##2##4##(2012-3#1)(2013-1#1)
was seen in 28##2##4##(2007-8#1)(2011-2#1)
was seen in 34##2##4##(2008-1#2)
was seen in 6##2##4##(2007-7#1)(2012-2#1)
was seen in a##2##4##(2007-7#1)(2010-10#1)
was seen in all##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
was seen in cells##2##4##(1994-8#1)(1995-8#1)
was seen in one patient##2##5##(1994-12#1)(2008-7#1)
was seen in one##3##4##(1994-12#1)(2008-5#1)(2008-7#1)
was seen in only 2##2##5##(1994-7#1)(1997-8#1)
was seen in only##3##4##(1994-7#1)(1997-8#1)(2007-7#1)
was seen in patients with##2##5##(1991-3#1)(2007-10#1)
was seen in the##15##4##(1992-11#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-12#4)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
was seen in##78##3##(1990-12#1)(1990-2#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#5)(1997-2#1)(1997-3#1)(1997-8#2)(2007-10#3)(2007-7#10)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
was seen more##2##3##(2008-12#1)(2011-1#1)
was seen on##4##3##(2006-10#1)(2006-12#1)(2007-4#1)(2008-6#1)
was seen that##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
was seen to be a##2##5##(2008-10#1)(2012-2#1)
was seen to be##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
was seen to have##2##4##(2008-5#1)(2012-3#1)
was seen to##6##3##(1991-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
was seen when##2##3##(1994-11#1)(2008-10#1)
was seen with the##2##4##(1995-11#1)(2008-10#1)
was seen with##8##3##(1990-12#1)(1991-8#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)
was seen##180##2##(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#3)(1992-11#2)(1992-12#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-7#2)(1994-8#2)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#2)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-4#1)(2007-7#11)(2007-8#4)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#4)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2011-1#4)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#1)
was selected and##4##3##(1994-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
was selected as a##4##4##(1996-1#1)(2008-10#2)(2008-5#1)
was selected as the##8##4##(1996-2#1)(2008-10#4)(2008-5#1)(2011-1#2)
was selected as##14##3##(1996-1#1)(1996-2#1)(2008-10#8)(2008-5#2)(2011-1#2)
was selected based on in vitro characteristics and used in vivo radiographic studies by incorporating barium sulphate##2##17##(2012-2#2)
was selected by##7##3##(1991-4#1)(1997-6#1)(2008-10#1)(2008-6#2)(2013-1#2)
was selected for further##2##4##(2008-9#1)(2009-6#1)
was selected for its##2##4##(2008-10#2)
was selected for the determination of##3##6##(2008-10#3)
was selected for the##8##4##(2008-10#8)
was selected for##19##3##(1994-2#1)(1996-12#1)(2008-10#12)(2008-3#1)(2008-9#1)(2009-6#1)(2010-11#1)(2012-12#1)
was selected from a##2##4##(2008-10#1)(2013-8#1)
was selected from the##2##4##(2008-12#1)(2008-2#1)
was selected from##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-8#1)
was selected on the basis of its##2##7##(2008-10#1)(2008-3#1)
was selected on the basis of##3##6##(2008-10#1)(2008-3#1)(2010-3#1)
was selected that##2##3##(1997-7#1)(2008-10#1)
was selected to##4##3##(1991-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
was selected##71##2##(1991-2#1)(1991-4#1)(1992-9#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#30)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
was selective for##2##3##(1994-8#1)(2008-10#1)
was selective##9##2##(1992-9#1)(1994-8#1)(2008-1#1)(2008-10#4)(2011-3#2)
was selectively##8##2##(1990-2#1)(1995-11#1)(1996-5#1)(2008-10#4)(2011-2#1)
was sensed again##3##3##(2008-10#3)
was sensed by the##2##4##(2008-10#2)
was sensed by##3##3##(2008-10#3)
was sensed##7##2##(2008-10#7)
was sensitive and##2##3##(2008-10#1)(2008-5#1)
was sensitive enough to##3##4##(1997-2#1)(1997-4#1)(2013-7#1)
was sensitive to the##2##4##(2007-11#1)(2008-10#1)
was sensitive to##22##3##(1990-11#1)(1990-2#1)(1991-9#1)(1993-3#3)(1993-9#1)(1994-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)
was sensitive##30##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1993-3#3)(1993-9#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-7#1)
was sent to a##6##4##(1991-6#1)(1993-2#1)(1997-3#1)(2008-9#1)(2009-5#1)(2013-1#1)
was sent to all##8##4##(1993-12#1)(1995-6#3)(1996-3#1)(2008-11#1)(2012-2#2)
was sent to general practitioners (GPs)##2##6##(2007-2#1)(2011-2#1)
was sent to the##3##4##(1994-1#1)(2007-12#1)(2013-1#1)
was sent to##33##3##(1990-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1995-6#3)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#4)(2007-7#1)(2008-1#2)(2008-11#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
was sent##35##2##(1990-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1995-6#3)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#2)(2007-2#4)(2007-7#1)(2008-1#2)(2008-11#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
was sentenced to##2##3##(1997-5#2)
was separated and##2##3##(2008-10#1)(2011-1#1)
was separated by centrifugation and##2##5##(2008-10#1)(2008-5#1)
was separated by##10##3##(1993-9#1)(1996-5#1)(1996-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
was separated from sample##2##4##(2008-10#2)
was separated from the sample##2##5##(2008-10#1)(2008-5#1)
was separated from the##7##4##(1992-3#1)(2008-10#4)(2008-5#1)(2008-9#1)
was separated from##13##3##(1992-3#1)(2008-10#10)(2008-5#1)(2008-9#1)
was separated in##2##3##(2008-10#2)
was separated into##5##3##(1990-7#1)(1997-4#1)(2006-8#1)(2008-10#2)
was separated on a##3##4##(2008-10#3)
was separated##42##2##(1990-7#1)(1992-3#1)(1993-9#1)(1996-5#2)(1996-9#1)(1997-4#1)(2006-8#1)(2008-10#25)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#2)
was sequenced and analyzed##3##4##(1992-3#1)(1993-2#1)(2013-1#1)
was sequenced and identified as##2##5##(2008-10#2)
was sequenced and the amino acid sequence##2##7##(1991-9#1)(1994-9#1)
was sequenced and the##3##4##(1991-9#1)(1994-12#1)(1994-9#1)
was sequenced and##14##3##(1990-11#1)(1991-1#1)(1991-9#2)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(2008-10#3)(2008-8#1)(2013-1#1)
was sequenced by##2##3##(1990-12#1)(1995-12#1)
was sequenced for##2##3##(2008-10#2)
was sequenced from##2##3##(2008-10#1)(2008-12#1)
was sequenced##32##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-1#1)(1991-9#3)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-9#1)(1997-9#1)(2008-10#11)(2008-12#1)(2008-8#1)(2013-1#1)
was serially##2##2##(1990-9#1)(2011-2#1)
was served##2##2##(2008-11#1)(2011-1#1)
was set at##8##3##(2007-12#1)(2008-10#2)(2010-1#1)(2011-1#2)(2011-2#1)(2013-1#1)
was set in##2##3##(2008-3#1)(2008-5#1)
was set out##2##3##(2008-11#1)(2011-2#1)
was set to##5##3##(2008-8#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
was set up based on the##2##6##(2008-10#1)(2013-1#1)
was set up for the##2##5##(2008-10#1)(2008-3#1)
was set up to##3##4##(1990-3#1)(1991-11#1)(2008-2#1)
was set up##17##3##(1990-3#1)(1991-11#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was set##35##2##(1990-3#1)(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
was seven##2##2##(1995-3#1)(2008-3#1)
was severe##4##2##(1990-2#1)(2007-11#1)(2008-10#2)
was severely compromised##2##3##(2011-2#1)(2012-2#1)
was severely impaired##2##3##(2008-10#2)
was severely inhibited##3##3##(1993-8#1)(1994-8#1)(2009-6#1)
was severely##14##2##(1992-9#1)(1993-8#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
was shaped by##4##3##(2008-10#1)(2010-11#1)(2012-2#2)
was shaped##5##2##(2007-11#1)(2008-10#1)(2010-11#1)(2012-2#2)
was shared by##2##3##(2008-10#2)
was shared##3##2##(2008-10#2)(2012-12#1)
was shifted by##2##3##(1990-9#1)(1997-7#1)
was shifted from##2##3##(1994-3#1)(2008-11#1)
was shifted to a##2##4##(1991-9#1)(1995-8#1)
was shifted to the left##2##5##(1995-8#1)(2013-1#1)
was shifted to the right##2##5##(1990-12#1)(1990-5#1)
was shifted to the##5##4##(1990-12#1)(1990-5#1)(1995-8#1)(2010-5#1)(2013-1#1)
was shifted to##8##3##(1990-12#1)(1990-5#1)(1991-9#1)(1995-8#2)(2010-5#1)(2012-3#1)(2013-1#1)
was shifted##15##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-8#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
was shortened##2##2##(1991-2#1)(2008-2#1)
was shorter in##3##3##(2011-2#2)(2013-1#1)
was shorter than that of the##2##6##(1993-3#1)(2010-4#1)
was shorter than that of##3##5##(1993-3#1)(2010-4#1)(2010-8#1)
was shorter than##4##3##(1993-3#1)(2010-4#1)(2010-8#1)(2013-8#1)
was shorter##12##2##(1993-3#1)(2007-6#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
was showed##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
was shown after##2##3##(2008-11#1)(2008-7#1)
was shown as##2##3##(2008-7#1)(2008-8#1)
was shown at##2##3##(2008-10#2)
was shown by the##3##4##(1990-12#1)(2008-10#2)
was shown by##23##3##(1990-10#1)(1990-12#2)(1990-7#1)(1992-10#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-12#1)(2013-1#2)
was shown for the first time##3##6##(1996-2#1)(2008-10#2)
was shown for##7##3##(1990-5#1)(1993-12#1)(1996-2#1)(2008-10#3)(2008-4#1)
was shown how the##2##4##(2008-10#1)(2008-3#1)
was shown in##11##3##(1990-10#1)(1991-1#1)(1992-9#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
was shown previously to##3##4##(1993-8#1)(1995-5#1)(2007-6#1)
was shown previously##4##3##(1993-8#1)(1994-11#1)(1995-5#1)(2007-6#1)
was shown that a##2##4##(1990-3#1)(2008-8#1)
was shown that only##2##4##(2008-10#1)(2008-11#1)
was shown that the##25##4##(1990-8#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#1)(2008-8#2)(2013-1#1)
was shown that##89##3##(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-3#2)(2007-6#1)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#7)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
was shown the##2##3##(2007-11#1)(2013-8#1)
was shown to activate##3##4##(1995-2#1)(2008-7#1)(2010-8#1)
was shown to be a##9##5##(1993-12#1)(1994-11#1)(2007-12#1)(2008-10#3)(2011-2#2)(2012-12#1)
was shown to be an##3##5##(1990-5#1)(2008-10#2)
was shown to be dependent on the##2##7##(1991-5#1)(2008-11#1)
was shown to be different##2##5##(2008-10#1)(2009-12#1)
was shown to be highly##3##5##(1993-3#1)(1996-2#1)(1997-6#1)
was shown to be increased##2##5##(1992-8#1)(2008-5#1)
was shown to be more##2##5##(2007-11#1)(2011-2#1)
was shown to be present##2##5##(1996-8#1)(2008-4#1)
was shown to be regulated by##2##6##(1993-8#1)(1997-2#1)
was shown to be stable##2##5##(2007-11#1)(2008-11#1)
was shown to be the major##2##6##(2008-11#1)(2008-7#1)
was shown to be the result of##2##7##(2008-10#1)(2008-3#1)
was shown to be the##5##5##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
was shown to be useful##2##5##(2008-10#1)(2008-2#1)
was shown to be##82##4##(1990-12#2)(1990-5#2)(1990-7#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)
was shown to bind directly to##2##6##(1993-11#1)(1993-6#1)
was shown to bind##5##4##(1990-10#1)(1992-8#1)(1993-11#1)(1993-6#1)(1995-12#1)
was shown to contain an##2##5##(1992-3#1)(1994-11#1)
was shown to contain##4##4##(1992-12#1)(1992-3#1)(1994-11#1)(1995-8#1)
was shown to correlate with##2##5##(2011-1#1)(2013-1#1)
was shown to depend on the##3##6##(1992-12#1)(1994-11#1)(2008-2#1)
was shown to encode a##2##5##(1997-4#1)(2007-7#1)
was shown to exist##2##4##(1995-8#1)(2008-9#1)
was shown to have a##2##5##(1994-5#1)(2008-10#1)
was shown to have##7##4##(1990-12#2)(1990-5#1)(1994-5#1)(1994-6#1)(2008-10#2)
was shown to increase##2##4##(2008-2#1)(2008-7#1)
was shown to induce##2##4##(2008-3#1)(2008-8#1)
was shown to inhibit##2##4##(1990-2#1)(2008-11#1)
was shown to occur##2##4##(2008-10#2)
was shown to produce##5##4##(1993-9#1)(1997-7#1)(2007-12#1)(2008-9#1)(2011-1#1)
was shown to provide##4##4##(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)
was shown to significantly reduce##2##5##(2007-2#1)(2008-3#1)
was shown to##163##3##(1990-10#1)(1990-12#4)(1990-2#1)(1990-5#3)(1990-7#1)(1991-5#4)(1991-7#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-8#5)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#37)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#1)
was shown##332##2##(1990-10#3)(1990-12#7)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#4)(1991-7#1)(1991-9#3)(1992-10#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#6)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#1)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#75)(2008-11#15)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#7)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#8)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#4)
was significant (P &lt##2##4##(2008-10#2)
was significant (P##3##3##(2008-10#3)
was significant and##2##3##(2009-4#1)(2012-3#1)
was significant association between##2##4##(2009-7#1)(2011-1#1)
was significant at##5##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
was significant correlation of##2##4##(2008-10#2)
was significant correlation##3##3##(2008-10#3)
was significant for##4##3##(1995-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
was significant improvement##2##3##(2008-9#2)
was significant in##6##3##(1990-11#1)(2008-10#3)(2008-8#1)(2011-2#1)
was significant##64##2##(1990-11#1)(1990-6#1)(1991-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-7#2)(2008-10#15)(2008-11#1)(2008-12#3)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-4#2)(2009-7#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
was significantly (P &lt##9##4##(1994-2#1)(2008-10#7)(2010-7#1)
was significantly (P = 0##2##5##(1996-8#1)(2008-10#1)
was significantly (P =##3##4##(1996-8#1)(2008-10#1)(2008-8#1)
was significantly (P##12##3##(1994-2#1)(1996-8#1)(2008-10#8)(2008-8#1)(2010-7#1)
was significantly (P&lt##2##3##(2008-10#1)(2012-3#1)
was significantly (p &lt##2##4##(1993-3#1)(2008-11#1)
was significantly (p = 0##2##5##(1991-5#1)(2008-12#1)
was significantly (p##4##3##(1991-5#1)(1993-3#1)(2008-11#1)(2008-12#1)
was significantly (p&lt##3##3##(2008-12#1)(2010-4#1)(2013-1#1)
was significantly affected by##4##4##(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)
was significantly affected##7##3##(2008-10#1)(2008-12#1)(2008-6#1)(2010-11#1)(2010-2#2)(2011-1#1)
was significantly associated with a##2##5##(1997-4#1)(2013-8#1)
was significantly associated with fewer##2##5##(2011-1#1)(2012-2#1)
was significantly associated with the##2##5##(2011-2#1)(2012-12#1)
was significantly associated with##28##4##(1990-9#2)(1995-11#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-12#1)(2009-5#2)(2009-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
was significantly associated##31##3##(1990-9#2)(1991-6#1)(1995-11#1)(1997-4#1)(2007-10#1)(2008-10#4)(2008-12#1)(2009-5#2)(2009-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
was significantly better than the##2##5##(2008-10#1)(2010-3#1)
was significantly better##6##3##(1991-6#1)(1994-2#1)(2008-10#2)(2008-7#1)(2010-3#1)
was significantly correlated with the##9##5##(1996-5#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-5#1)(2013-8#1)
was significantly correlated with##20##4##(1990-8#1)(1991-8#1)(1993-12#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-5#1)(2012-7#1)(2013-8#1)
was significantly decreased in##5##4##(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-7#1)
was significantly decreased on##2##4##(1994-2#1)(2013-1#1)
was significantly decreased##15##3##(1993-1#1)(1994-2#2)(1995-12#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
was significantly delayed##2##3##(1997-3#1)(2011-2#1)
was significantly different (P &lt##2##5##(2008-10#1)(2011-1#1)
was significantly different between the##2##5##(2008-10#2)
was significantly different between##3##4##(2008-10#3)
was significantly different from zero##2##5##(2008-10#2)
was significantly different from##3##4##(2008-10#3)
was significantly different in##3##4##(2008-12#2)(2011-1#1)
was significantly different##21##3##(1994-3#1)(1996-12#1)(2007-12#1)(2008-10#8)(2008-12#3)(2008-5#2)(2010-4#1)(2010-5#1)(2011-1#3)
was significantly down-regulated##2##3##(2008-11#1)(2008-7#1)
was significantly elevated in the##2##5##(1996-12#1)(2008-10#1)
was significantly elevated in##3##4##(1996-12#2)(2008-10#1)
was significantly elevated##7##3##(1993-12#1)(1996-12#2)(2007-10#1)(2008-10#1)(2008-12#1)(2009-6#1)
was significantly enhanced by the##3##5##(1995-12#1)(2007-12#1)(2008-11#1)
was significantly enhanced by##4##4##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
was significantly enhanced in##2##4##(1996-7#1)(2008-10#1)
was significantly enhanced##9##3##(1995-12#1)(1996-7#1)(2007-12#1)(2008-10#5)(2008-11#1)
was significantly greater for##4##4##(1993-9#1)(1995-2#1)(2009-7#1)(2013-1#1)
was significantly greater in the##10##5##(1996-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#2)
was significantly greater in##16##4##(1992-12#1)(1995-5#1)(1996-5#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2011-2#2)
was significantly greater than that in##3##6##(2008-5#1)(2008-9#2)
was significantly greater than that##5##5##(1991-9#1)(2008-10#1)(2008-5#1)(2008-9#2)
was significantly greater than the##2##5##(1995-3#1)(2010-9#1)
was significantly greater than##13##4##(1991-9#1)(1992-5#1)(1995-3#1)(2007-6#1)(2008-10#3)(2008-5#2)(2008-9#2)(2010-9#1)(2013-1#1)
was significantly greater##37##3##(1991-9#1)(1992-12#1)(1992-5#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-6#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#3)(2009-7#1)(2010-9#1)(2011-2#2)(2013-1#3)
was significantly high##3##3##(1995-3#1)(2012-2#1)(2012-3#1)
was significantly higher (P &lt##2##5##(1996-12#1)(2008-10#1)
was significantly higher (p##2##4##(1993-11#1)(2008-6#1)
was significantly higher among patients##2##5##(2011-2#1)(2013-1#1)
was significantly higher among##5##4##(1996-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
was significantly higher at##2##4##(2008-10#2)
was significantly higher for##4##4##(1992-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
was significantly higher in cases##2##5##(1990-12#1)(1997-8#1)
was significantly higher in males than in females##2##8##(2008-11#1)(2009-3#1)
was significantly higher in patients with##5##6##(1992-12#1)(2007-7#1)(2008-5#1)(2010-4#1)(2013-1#1)
was significantly higher in patients##7##5##(1991-6#1)(1992-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
was significantly higher in studies conducted using##2##7##(2008-10#2)
was significantly higher in the second##2##6##(2007-11#1)(2008-6#1)
was significantly higher in the##20##5##(1990-3#1)(1990-7#1)(1992-2#1)(1992-3#1)(1993-1#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
was significantly higher in women##2##5##(1991-3#1)(2008-3#1)
was significantly higher in##71##4##(1990-12#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-3#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-10#12)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-3#2)(2009-4#1)(2010-4#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#4)(2013-1#1)
was significantly higher on the##2##5##(2008-5#1)(2011-2#1)
was significantly higher on##5##4##(1992-5#1)(2008-10#1)(2008-5#2)(2011-2#1)
was significantly higher than in the##3##6##(1991-4#1)(1991-5#1)(1997-8#1)
was significantly higher than in##10##5##(1990-11#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-10#1)(1995-3#1)(1997-8#1)(2007-10#1)(2008-11#1)(2012-1#1)
was significantly higher than that in the control##2##8##(1995-3#1)(2012-2#1)
was significantly higher than that in the##3##7##(1995-3#1)(2007-10#1)(2012-2#1)
was significantly higher than that in##5##6##(1995-3#1)(2007-10#1)(2008-10#1)(2011-1#1)(2012-2#1)
was significantly higher than that of##5##6##(1992-3#1)(2007-7#1)(2008-10#1)(2011-2#1)(2011-3#1)
was significantly higher than that##14##5##(1992-3#1)(1994-11#1)(1995-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
was significantly higher than the##3##5##(2008-10#1)(2009-10#1)(2011-2#1)
was significantly higher than##39##4##(1990-11#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-3#2)(1997-7#1)(1997-8#1)(2007-10#2)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-10#1)(2009-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
was significantly higher##144##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1991-11#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-11#2)(1994-11#1)(1994-3#1)(1995-3#2)(1995-5#1)(1996-12#4)(1996-5#2)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#2)(2011-1#5)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#1)
was significantly impaired##2##3##(1991-2#1)(1992-12#1)
was significantly improved##6##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)
was significantly increased after##5##4##(1995-3#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
was significantly increased at##2##4##(1995-12#1)(2008-10#1)
was significantly increased by##6##4##(1992-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2012-6#1)
was significantly increased in the##4##5##(1991-8#1)(2006-10#1)(2008-7#2)
was significantly increased in##17##4##(1990-2#1)(1991-8#1)(1994-11#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#3)(2011-2#1)
was significantly increased when the##2##5##(1992-12#1)(1993-3#1)
was significantly increased##46##3##(1990-2#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-11#1)(1995-11#2)(1995-12#4)(1995-3#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-6#1)
was significantly influenced by the##4##5##(1992-5#1)(2008-10#1)(2009-8#1)(2010-4#1)
was significantly influenced##5##3##(1992-5#1)(1995-12#1)(2008-10#1)(2009-8#1)(2010-4#1)
was significantly inhibited by##2##4##(1992-3#1)(2008-4#1)
was significantly inhibited##6##3##(1992-3#1)(1993-11#1)(1993-9#1)(1997-4#1)(2008-4#1)(2008-8#1)
was significantly larger in the##2##5##(2008-7#1)(2011-1#1)
was significantly larger in##5##4##(2007-10#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
was significantly larger than##3##4##(1990-7#1)(1991-9#1)(1995-3#1)
was significantly larger##9##3##(1990-7#1)(1991-9#1)(1993-11#1)(1995-3#1)(2007-10#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
was significantly less for##4##4##(2008-10#3)(2012-2#1)
was significantly less frequent##2##4##(2007-8#1)(2011-2#1)
was significantly less in group##2##5##(1996-3#1)(2012-2#1)
was significantly less in##3##4##(1996-3#1)(2008-10#1)(2012-2#1)
was significantly less than in##3##5##(1995-12#1)(2008-10#2)
was significantly less than that##2##5##(1994-12#1)(1997-4#1)
was significantly less than##7##4##(1994-12#1)(1995-12#1)(1997-4#1)(2008-10#3)(2012-2#1)
was significantly less##21##3##(1990-2#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-10#9)(2011-2#1)(2012-2#3)
was significantly longer in the##3##5##(2007-8#1)(2009-4#1)(2011-2#1)
was significantly longer in##5##4##(2007-8#1)(2008-5#1)(2009-4#2)(2011-2#1)
was significantly longer##8##3##(1993-1#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-4#2)(2011-2#1)
was significantly lower (p &lt##2##5##(2013-1#2)
was significantly lower (p less than 0##2##7##(1991-8#1)(1992-3#1)
was significantly lower (p##5##4##(1991-8#1)(1992-3#1)(2008-1#1)(2013-1#2)
was significantly lower for##4##4##(1990-12#1)(1993-11#1)(2008-10#1)(2011-2#1)
was significantly lower in the##3##5##(1990-3#1)(1993-10#1)(2007-8#1)
was significantly lower in##15##4##(1990-3#1)(1992-3#1)(1993-10#1)(1995-5#1)(1997-6#1)(2007-8#2)(2008-10#4)(2008-7#1)(2010-1#1)(2011-1#2)
was significantly lower than in control##3##6##(1991-11#1)(2007-10#1)(2010-1#1)
was significantly lower than in the##5##6##(1995-11#1)(1995-8#1)(2007-5#1)(2008-7#1)(2011-2#1)
was significantly lower than in##13##5##(1990-11#1)(1991-11#1)(1995-11#1)(1995-8#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-7#2)(2010-1#1)(2010-2#1)(2011-2#1)
was significantly lower than that in the##3##7##(1995-4#1)(1995-8#1)(2012-2#1)
was significantly lower than that of##2##6##(1994-8#1)(2008-9#1)
was significantly lower than that##7##5##(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-2#1)(2008-9#1)(2012-2#1)
was significantly lower than the##2##5##(1996-12#1)(2008-7#1)
was significantly lower than##23##4##(1990-11#1)(1991-11#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)
was significantly lower when##2##4##(2008-10#1)(2008-7#1)
was significantly lower##57##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-7#5)(2008-9#1)(2010-1#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
was significantly more abundant##2##4##(2008-10#1)(2008-8#1)
was significantly more common in the##2##6##(2008-7#1)(2011-2#1)
was significantly more common in##4##5##(2008-7#2)(2010-4#1)(2011-2#1)
was significantly more common##5##4##(2008-7#2)(2010-4#1)(2011-2#1)(2012-3#1)
was significantly more effective##4##4##(2008-10#2)(2008-5#1)(2013-1#1)
was significantly more in##2##4##(1992-12#1)(2012-2#1)
was significantly more##25##3##(1992-12#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
was significantly observed##2##3##(2008-10#1)(2008-11#1)
was significantly raised##2##3##(1990-12#1)(2007-10#1)
was significantly reduced by P##2##5##(2008-10#2)
was significantly reduced by##13##4##(1991-2#1)(1995-11#1)(1996-12#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-10#1)(2012-12#1)(2012-3#1)
was significantly reduced compared with##2##5##(2008-10#1)(2008-4#1)
was significantly reduced compared##3##4##(1992-10#1)(2008-10#1)(2008-4#1)
was significantly reduced in all##2##5##(1996-12#1)(2008-3#1)
was significantly reduced in plants##2##5##(2008-10#2)
was significantly reduced in the##2##5##(1990-5#1)(2010-12#1)
was significantly reduced in##22##4##(1990-5#1)(1991-5#1)(1993-11#1)(1995-12#1)(1996-12#4)(1996-5#1)(1997-2#1)(2008-10#6)(2008-3#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
was significantly reduced##55##3##(1990-5#1)(1991-2#1)(1991-5#2)(1992-10#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-12#7)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(2008-10#14)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
was significantly related to##7##4##(2007-12#1)(2008-10#1)(2009-7#2)(2010-1#1)(2011-2#1)(2012-3#1)
was significantly retarded (P##2##4##(2008-10#2)
was significantly shorter in##2##4##(2008-5#1)(2011-2#1)
was significantly shorter than##2##4##(2008-8#2)
was significantly shorter##5##3##(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#1)
was significantly slower##3##3##(2008-10#2)(2011-2#1)
was significantly smaller in##3##4##(1995-12#1)(1996-7#1)(2011-2#1)
was significantly smaller than that##3##5##(2008-10#2)(2012-12#1)
was significantly smaller than##4##4##(1995-12#1)(2008-10#2)(2012-12#1)
was significantly smaller##8##3##(1995-12#2)(1996-7#1)(2008-10#3)(2011-2#1)(2012-12#1)
was significantly superior##2##3##(2008-5#1)(2010-3#1)
was significantly suppressed##3##3##(1994-8#2)(2012-3#1)
was significantly##633##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#4)(1991-8#3)(1991-9#4)(1992-10#2)(1992-12#7)(1992-2#1)(1992-3#5)(1992-5#4)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#3)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#5)(1995-12#11)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#3)(1995-8#2)(1996-12#18)(1996-2#4)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#4)(2006-10#1)(2007-10#8)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#10)(2008-1#4)(2008-10#128)(2008-11#16)(2008-12#15)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#24)(2008-6#9)(2008-7#22)(2008-8#6)(2008-9#14)(2009-10#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#3)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#8)(2010-5#1)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#15)(2011-2#36)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#16)(2012-3#13)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#18)(2013-7#1)(2013-8#9)
was silenced##2##2##(2008-9#1)(2011-2#1)
was similar among##3##3##(1994-11#1)(2008-11#1)(2013-8#1)
was similar and##2##3##(1996-3#1)(2008-10#1)
was similar between men##2##4##(1991-9#1)(2007-7#1)
was similar between the##3##4##(2008-10#2)(2011-2#1)
was similar between##8##3##(1991-9#1)(1995-8#1)(2007-7#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-1#1)
was similar for all the##2##5##(2008-10#1)(2008-3#1)
was similar for all##5##4##(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
was similar for both groups##2##5##(2008-10#1)(2009-11#1)
was similar for both##5##4##(1995-8#1)(1996-1#1)(2008-10#2)(2009-11#1)
was similar for##14##3##(1990-2#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#2)
was similar in both groups##5##5##(1991-5#1)(2007-8#1)(2007-9#1)(2009-10#1)(2011-2#1)
was similar in both##10##4##(1990-3#1)(1991-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-7#1)
was similar in the two groups##3##6##(1992-2#1)(1992-3#1)(2007-8#1)
was similar in the two##5##5##(1991-12#1)(1992-2#1)(1992-3#1)(2007-8#1)(2012-3#1)
was similar in the##8##4##(1991-12#1)(1992-2#1)(1992-3#1)(2007-8#1)(2008-10#2)(2011-3#1)(2012-3#1)
was similar in##35##3##(1990-3#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-3#1)(1995-11#1)(1997-2#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#5)(2008-9#1)(2009-10#1)(2010-4#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
was similar on##2##3##(2008-10#2)
was similar to a##3##4##(1991-7#1)(1995-2#1)(2008-9#1)
was similar to other##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
was similar to that by controls##2##6##(2008-9#2)
was similar to that by##6##5##(2008-8#2)(2008-9#4)
was similar to that from##2##5##(1996-2#1)(2008-6#1)
was similar to that in the##2##6##(1994-11#1)(2008-9#1)
was similar to that in##6##5##(1991-11#1)(1994-11#1)(1996-5#1)(2008-7#1)(2008-9#2)
was similar to that observed for##2##6##(2008-10#1)(2011-2#1)
was similar to that observed in##4##6##(1991-12#1)(1991-2#1)(1993-8#1)(1997-2#1)
was similar to that observed##7##5##(1991-12#1)(1991-2#1)(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#1)(2011-2#1)
was similar to that obtained##2##5##(1995-12#1)(2008-10#1)
was similar to that of control##4##6##(1992-3#1)(1993-8#1)(2008-9#2)
was similar to that of other##2##6##(2008-7#1)(2010-8#1)
was similar to that of the control groups##6##8##(2008-8#1)(2008-9#5)
was similar to that of the vehicle##5##7##(2008-9#5)
was similar to that of the##16##6##(1990-12#1)(1992-6#1)(1993-6#1)(2008-8#3)(2008-9#10)
was similar to that of##28##5##(1990-12#2)(1992-3#2)(1992-6#1)(1993-6#1)(1993-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#13)(2010-8#1)
was similar to that##59##4##(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#19)(2010-8#1)(2011-2#1)(2013-1#1)
was similar to the value obtained##2##6##(1990-8#1)(1995-11#1)
was similar to the##21##4##(1990-8#1)(1993-8#1)(1994-2#1)(1995-11#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#2)(2009-8#1)(2010-4#2)(2010-7#1)(2012-2#1)
was similar to those##2##4##(2008-5#1)(2008-9#1)
was similar to##105##3##(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-6#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#24)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
was similar##193##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#2)(1994-2#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#6)(2008-9#25)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
was similarly inhibited##2##3##(1993-3#1)(1995-8#1)
was similarly##9##2##(1992-1#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2008-10#1)(2010-2#1)(2013-1#2)
was simple and##8##3##(1991-2#1)(1996-3#1)(2008-10#4)(2008-11#1)(2008-7#1)
was simple##16##2##(1991-2#1)(1993-11#1)(1996-3#1)(2008-10#9)(2008-11#1)(2008-7#1)(2013-8#2)
was simply##7##2##(1996-3#1)(2008-10#4)(2008-4#1)(2009-12#1)
was simulated by##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
was simulated using a##3##4##(2008-10#3)
was simulated using##4##3##(2008-10#3)(2008-7#1)
was simulated with##2##3##(2008-3#1)(2011-1#1)
was simulated##16##2##(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#2)
was simultaneously##10##2##(1990-8#1)(1992-11#1)(1994-3#1)(1994-7#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)
was single##2##2##(2007-11#1)(2007-12#1)
was situated in##2##3##(2007-11#1)(2009-3#1)
was situated##5##2##(2007-11#1)(2007-2#1)(2008-7#1)(2009-3#1)(2011-2#1)
was six##2##2##(1991-11#1)(2012-1#1)
was skewed##2##2##(2008-10#1)(2008-7#1)
was sliced##2##2##(1991-1#1)(2008-11#1)
was slight##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
was slightly but significantly##2##4##(2008-10#2)
was slightly but##3##3##(1990-7#1)(2008-10#2)
was slightly different from##2##4##(1996-6#1)(2008-11#1)
was slightly different##4##3##(1991-8#1)(1996-6#1)(2008-10#1)(2008-11#1)
was slightly elevated in##2##4##(1990-9#1)(2012-12#1)
was slightly higher in the##3##5##(2008-11#1)(2011-2#1)(2012-1#1)
was slightly higher in##5##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
was slightly higher than that in##2##6##(1994-12#1)(2008-11#1)
was slightly higher than##5##4##(1994-12#1)(2008-10#2)(2008-11#1)(2010-3#1)
was slightly higher##14##3##(1992-12#1)(1994-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
was slightly improved##2##3##(2008-11#1)(2008-7#1)
was slightly increased in##2##4##(2008-10#1)(2011-1#1)
was slightly increased##4##3##(1990-11#1)(2008-10#1)(2010-10#1)(2011-1#1)
was slightly lower in##2##4##(1990-3#1)(2008-3#1)
was slightly lower than that of##2##6##(2008-11#1)(2010-8#1)
was slightly lower than##3##4##(2006-10#1)(2008-11#1)(2010-8#1)
was slightly lower##5##3##(1990-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
was slightly more effective than##3##5##(1990-12#1)(2008-10#1)(2008-11#1)
was slightly more effective##4##4##(1990-12#1)(1994-3#1)(2008-10#1)(2008-11#1)
was slightly more##7##3##(1990-12#1)(1990-7#1)(1992-5#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
was slightly smaller than##2##4##(1992-3#1)(2008-5#1)
was slightly##64##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#12)(2008-11#9)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
was slow and##2##3##(1990-7#1)(2008-10#1)
was slow##4##2##(1990-7#1)(1990-9#1)(2008-10#2)
was slower in##4##3##(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
was slower than that of##3##5##(1990-5#1)(1990-7#1)(2008-10#1)
was slower than that##4##4##(1990-5#1)(1990-7#1)(2008-10#2)
was slower than##5##3##(1990-5#1)(1990-7#1)(1992-9#1)(2008-10#2)
was slower##12##2##(1990-5#1)(1990-7#1)(1992-9#1)(1995-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)
was slowly##3##2##(1990-6#1)(1992-3#2)
was small but##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
was small in##2##3##(1993-8#1)(2010-8#1)
was small##20##2##(1991-11#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-8#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-10#8)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)
was smaller and##2##3##(1996-2#1)(2008-7#1)
was smaller in##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
was smaller than in##2##4##(2008-5#1)(2008-7#1)
was smaller than that##3##4##(1993-8#1)(1995-11#1)(2011-1#1)
was smaller than##10##3##(1993-8#2)(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
was smaller##22##2##(1993-8#2)(1994-5#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
was so low that##2##4##(2007-12#1)(2008-3#1)
was so##9##2##(1992-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#2)
was solely##3##2##(1990-12#1)(1996-12#1)(2008-6#1)
was solubilized and##2##3##(1994-11#1)(2008-10#1)
was solubilized in##2##3##(1990-2#1)(1995-11#1)
was solubilized##6##2##(1990-2#1)(1994-11#1)(1994-12#1)(1995-11#1)(2008-10#2)
was soluble##4##2##(1992-12#1)(1992-7#1)(1994-11#1)(2011-2#1)
was solved using##2##3##(2008-7#1)(2009-11#1)
was solved with##2##3##(1996-3#1)(2011-3#1)
was solved##9##2##(1992-12#1)(1996-3#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2011-3#1)(2012-2#1)
was some evidence of##3##4##(2008-10#2)(2010-8#1)
was some evidence##6##3##(1994-3#1)(2008-10#3)(2009-6#1)(2010-8#1)
was some##15##2##(1991-12#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-3#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
was sometimes##3##2##(1990-3#1)(2008-10#1)(2013-1#1)
was somewhat less##2##3##(1995-12#1)(2007-8#1)
was somewhat##12##2##(1991-6#1)(1991-8#1)(1995-1#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2012-1#1)(2013-8#1)
was sorbed on##2##3##(2008-10#2)
was sought##3##2##(1992-2#1)(1993-3#1)(2011-1#1)
was specific and##2##3##(2008-10#1)(2008-11#1)
was specific for##9##3##(1990-12#1)(1990-5#1)(1993-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)
was specific to##3##3##(1990-8#1)(2008-10#2)
was specific##18##2##(1990-12#1)(1990-5#1)(1990-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-4#1)
was specifically designed##2##3##(2008-2#1)(2009-11#1)
was specifically expressed in##3##4##(2008-8#2)(2008-9#1)
was specifically##19##2##(1990-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#2)(1994-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)
was specified##2##2##(2008-7#1)(2009-7#1)
was spent##4##2##(1992-4#1)(1997-2#1)(1997-3#1)(2010-8#1)
was splenectomized##2##2##(1994-9#2)
was spliced##2##2##(2007-11#1)(2008-9#1)
was split into two##2##4##(2008-10#1)(2013-8#1)
was split into##3##3##(2008-10#2)(2013-8#1)
was split##5##2##(1992-11#1)(2008-10#3)(2013-8#1)
was spontaneously##2##2##(1994-11#1)(2008-7#1)
was sprayed##2##2##(2008-10#2)
was spreading##2##2##(1990-3#1)(2009-10#1)
was stabilized by##2##3##(1991-12#1)(1997-8#1)
was stabilized##5##2##(1991-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
was stable and##4##3##(1990-9#1)(2008-10#3)
was stable at##2##3##(1991-12#1)(2008-11#1)
was stable for##8##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)
was stable in##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
was stable over##4##3##(1997-2#1)(2008-10#3)
was stable to##3##3##(1991-5#1)(2008-10#1)(2008-6#1)
was stable when##2##3##(1997-1#1)(2010-2#1)
was stable##38##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-1#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-1#1)(2010-2#1)(2012-3#2)
was stably expressed by##2##4##(2008-11#2)
was stably transfected##2##3##(1992-9#1)(2008-8#1)
was stably##10##2##(1992-9#1)(1994-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#2)
was stage##2##2##(1995-4#1)(2008-10#1)
was stained with##2##3##(1995-12#1)(2013-1#1)
was stained##4##2##(1991-12#1)(1995-12#1)(1996-5#1)(2013-1#1)
was standardised as##2##3##(2008-10#2)
was standardized##3##2##(2008-5#1)(2010-3#1)(2012-12#1)
was started at the##3##4##(2007-11#1)(2008-7#1)(2011-2#1)
was started in the##2##4##(2007-11#1)(2013-8#1)
was started in##6##3##(1991-12#1)(1992-11#1)(1996-6#1)(2007-11#1)(2011-2#1)(2013-8#1)
was started on##7##3##(2007-12#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-8#2)
was started with##4##3##(1990-11#1)(1991-6#1)(2011-1#1)(2013-1#1)
was started within##2##3##(1992-2#1)(2011-2#1)
was started##39##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1995-5#1)(1996-6#2)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-2#1)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#6)
was stated##4##2##(2007-11#1)(2007-2#1)(2007-8#2)
was statistically associated with##2##4##(1990-3#1)(2010-3#1)
was statistically evaluated##3##3##(2008-10#3)
was statistically higher##2##3##(2010-8#2)
was statistically not##2##3##(2008-1#1)(2008-7#1)
was statistically significant (P &lt##2##5##(1996-12#1)(2008-5#1)
was statistically significant (P##4##4##(1990-3#1)(1996-12#1)(2008-10#1)(2008-5#1)
was statistically significant (p &lt##3##5##(2008-12#1)(2010-7#1)(2011-2#1)
was statistically significant (p##4##4##(2008-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
was statistically significant in##2##4##(2008-6#1)(2013-8#1)
was statistically significant##32##3##(1990-3#2)(1993-12#1)(1994-11#1)(1995-9#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-3#2)(2009-6#1)(2010-3#2)(2010-7#1)(2011-2#6)(2013-1#4)(2013-8#1)
was statistically##52##2##(1990-3#3)(1993-12#1)(1994-11#1)(1995-9#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#2)(2009-6#1)(2010-3#4)(2010-7#1)(2010-8#2)(2011-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
was sterile##2##2##(2006-10#1)(2011-2#1)
was still able to##3##4##(2008-10#2)(2008-3#1)
was still higher##2##3##(1990-7#1)(2008-8#1)
was still maintained##2##3##(2008-10#1)(2008-11#1)
was still observed##2##3##(2008-9#1)(2009-12#1)
was still significant##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
was still##41##2##(1990-7#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#3)(2012-2#1)(2012-3#1)
was stimulated by spermine##2##4##(1990-3#2)
was stimulated by##12##3##(1990-3#2)(1994-8#1)(1995-12#1)(1995-6#2)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)
was stimulated electrically##2##3##(1993-12#1)(2008-9#1)
was stimulated in the##2##4##(1990-12#1)(2008-6#1)
was stimulated to##2##3##(1990-5#1)(2008-10#1)
was stimulated##22##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)
was stopped and##2##3##(1993-1#1)(2010-12#1)
was stopped because##2##3##(2011-2#1)(2013-1#1)
was stopped##15##2##(1990-8#1)(1993-1#1)(1996-3#1)(1997-1#2)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#2)(2010-12#1)(2011-2#1)(2013-1#1)
was stored##4##2##(1993-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
was stratified by##2##3##(2010-3#1)(2013-1#1)
was stratified##3##2##(2008-10#1)(2010-3#1)(2013-1#1)
was strengthened##3##2##(2009-12#1)(2012-12#1)(2013-8#1)
was stressed##3##2##(1990-5#1)(1994-7#1)(2008-5#1)
was strictly controlled##2##3##(2008-8#1)(2008-9#1)
was strictly##7##2##(1990-7#1)(1994-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
was striking##3##2##(1994-11#1)(2007-12#1)(2008-3#1)
was stripped from the##2##4##(2008-10#2)
was stripped from##3##3##(2008-10#3)
was stripped with##3##3##(2008-10#3)
was stripped##7##2##(2008-10#7)
was strong but that of##2##5##(2008-8#2)
was strong##9##2##(1994-9#1)(1996-12#1)(2008-10#1)(2008-8#2)(2009-7#1)(2012-2#1)(2012-3#1)(2012-9#1)
was stronger for##3##3##(2007-12#1)(2010-1#1)(2013-1#1)
was stronger in##2##3##(2008-9#1)(2011-2#1)
was stronger than that of##3##5##(2008-10#1)(2008-8#1)(2009-8#1)
was stronger than that##4##4##(2008-10#1)(2008-8#2)(2009-8#1)
was stronger than##9##3##(1993-2#1)(2008-10#1)(2008-8#4)(2009-8#1)(2010-9#1)(2011-2#1)
was stronger##18##2##(1993-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2013-1#1)
was strongly affected by##2##4##(2008-10#1)(2008-8#1)
was strongly and##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
was strongly associated with the##3##5##(2008-3#1)(2010-12#1)(2011-2#1)
was strongly associated with##10##4##(2008-10#4)(2008-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
was strongly correlated with##4##4##(1991-8#1)(2008-10#2)(2009-10#1)
was strongly dependent on the presence of##2##7##(1995-6#1)(2008-10#1)
was strongly dependent on the##3##5##(1995-6#1)(2008-10#1)(2008-9#1)
was strongly dependent on##5##4##(1994-9#1)(1995-6#1)(2008-10#2)(2008-9#1)
was strongly dependent##7##3##(1994-9#1)(1995-6#1)(2008-10#4)(2008-9#1)
was strongly enhanced##2##3##(1991-2#1)(1997-7#1)
was strongly inhibited by##4##4##(1990-11#1)(1993-9#1)(1995-6#1)(2008-11#1)
was strongly inhibited##7##3##(1990-11#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#1)
was strongly reactive##2##3##(1994-9#1)(2008-11#1)
was strongly reduced in##2##4##(1995-5#1)(2008-10#1)
was strongly reduced##4##3##(1995-2#1)(1995-5#1)(2008-10#1)(2008-5#1)
was strongly suggested##2##3##(1990-5#1)(2008-10#1)
was strongly##68##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#23)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
was struck##2##2##(2008-2#1)(2008-6#1)
was structured##5##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)
was studied and compared with##2##5##(2008-10#2)
was studied and compared##3##4##(2008-10#3)
was studied and optimized##2##4##(2008-10#2)
was studied and the##3##4##(2008-10#2)(2008-12#1)
was studied and##15##3##(1990-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2010-5#1)
was studied as a function of the##2##7##(2007-11#1)(2008-10#1)
was studied as a##6##4##(2007-11#1)(2008-10#5)
was studied as##9##3##(2007-11#1)(2008-10#7)(2008-8#1)
was studied at 25 degrees C and in##2##8##(2008-10#2)
was studied at pH 3##2##5##(1991-2#1)(2008-10#1)
was studied at the##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
was studied at##16##3##(1991-2#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-7#1)(2008-9#1)(2013-1#1)
was studied both##2##3##(2008-11#1)(2008-3#1)
was studied by comparing##2##4##(2008-10#1)(2010-4#1)
was studied by cyclic voltammetry at a glassy carbon electrode##3##10##(2008-10#3)
was studied by cyclic voltammetry##5##5##(2008-10#5)
was studied by in situ##2##5##(2008-10#1)(2012-1#1)
was studied by investigating the##2##5##(1997-2#1)(2008-10#1)
was studied by means of##2##5##(2008-10#1)(2013-8#1)
was studied by measuring##3##4##(1990-12#1)(2008-8#1)(2008-9#1)
was studied by potentiometric##2##4##(2008-10#2)
was studied by the##5##4##(1994-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
was studied by using a##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
was studied by using##9##4##(1992-7#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2013-1#1)
was studied by##95##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-6#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#3)(2007-12#1)(2007-7#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-5#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
was studied during##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
was studied employing##2##3##(2008-10#1)(2008-6#1)
was studied for the first time##2##6##(2008-10#1)(2010-4#1)
was studied for the##5##4##(1992-3#1)(2008-10#2)(2009-2#1)(2010-4#1)
was studied for##12##3##(1992-3#2)(1994-8#1)(2008-10#6)(2008-7#1)(2009-2#1)(2010-4#1)
was studied from##4##3##(2008-10#3)(2008-5#1)
was studied in a mouse model##2##6##(1994-5#1)(2008-10#1)
was studied in a##23##4##(1990-11#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-7#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2010-2#1)(2010-3#1)
was studied in an##3##4##(1993-12#1)(2008-7#1)(2008-9#1)
was studied in aqueous##4##4##(2008-10#4)
was studied in batch##2##4##(2008-10#1)(2008-11#1)
was studied in crosses##2##4##(2008-10#2)
was studied in cultured##2##4##(1994-6#1)(1995-11#1)
was studied in detail and improved performance was observed at several instances##2##12##(2008-10#2)
was studied in detail##9##4##(1991-12#1)(2008-10#8)
was studied in four##3##4##(2007-8#1)(2008-10#1)(2009-9#1)
was studied in isolated rat##2##5##(1995-8#2)
was studied in one##2##4##(2008-10#1)(2013-1#1)
was studied in order to##3##5##(1994-11#1)(2008-10#2)
was studied in patients##2##4##(1990-12#1)(2008-1#1)
was studied in rats##2##4##(1991-5#1)(1994-5#1)
was studied in the field##2##5##(2008-10#2)
was studied in the presence of##2##6##(2008-10#2)
was studied in the presence##3##5##(2008-10#3)
was studied in the range of##2##6##(1990-5#1)(2008-10#1)
was studied in the rat##3##5##(1996-12#2)(1997-2#1)
was studied in the##21##4##(1990-5#1)(1990-7#1)(1992-3#1)(1995-8#1)(1996-12#3)(1997-2#2)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
was studied in this paper##3##5##(2008-10#3)
was studied in this##4##4##(2008-10#3)(2011-1#1)
was studied in two##2##4##(2008-10#1)(2008-12#1)
was studied in vitro##5##4##(1990-7#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
was studied in vivo##2##4##(1993-12#1)(2008-5#1)
was studied in##166##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-12#3)(1991-2#1)(1991-5#2)(1991-6#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#1)(1995-8#3)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(2007-8#1)(2008-1#2)(2008-10#54)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#3)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
was studied on a##5##4##(2008-10#4)(2010-4#1)
was studied on##13##3##(1990-8#1)(1991-2#1)(1993-9#1)(1995-12#1)(2008-10#7)(2009-8#1)(2010-4#1)
was studied over the##2##4##(1995-2#1)(1995-5#1)
was studied over##4##3##(1991-6#1)(1995-2#1)(1995-5#1)(2008-5#1)
was studied prospectively in##2##4##(1990-9#1)(1991-4#1)
was studied prospectively##3##3##(1990-9#1)(1991-4#1)(2008-10#1)
was studied spectrophotometrically##2##3##(2008-10#2)
was studied through##3##3##(2008-10#2)(2008-9#1)
was studied to assess##2##4##(1991-9#1)(1995-2#1)
was studied to determine the##2##5##(2008-7#1)(2012-3#1)
was studied to##7##3##(1991-9#1)(1992-3#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
was studied under##6##3##(1995-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2012-1#1)
was studied using a##6##4##(2008-10#4)(2008-9#1)(2010-10#1)
was studied using an##3##4##(2008-10#3)
was studied using flow##2##4##(2008-10#2)
was studied using human##2##4##(1990-11#1)(2011-1#1)
was studied using##49##3##(1990-11#1)(1991-12#1)(1991-6#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-5#3)(1996-12#1)(1997-7#1)(1997-8#1)(2008-10#22)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
was studied while##2##3##(2008-11#1)(2008-2#1)
was studied with the##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
was studied with##18##3##(1990-5#1)(1991-3#1)(1993-12#1)(1994-6#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
was studied##608##2##(1990-11#5)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#5)(1991-9#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#6)(1995-8#5)(1996-12#4)(1996-2#5)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#255)(2008-11#9)(2008-12#7)(2008-2#10)(2008-3#14)(2008-4#2)(2008-5#21)(2008-6#10)(2008-7#16)(2008-8#16)(2008-9#11)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#2)(2011-1#4)(2011-2#9)(2011-3#2)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#8)
was subcloned into##4##3##(1991-2#1)(1996-12#1)(2008-11#1)(2008-9#1)
was subcloned##8##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-8#1)(1994-12#1)(1996-12#1)(2008-11#1)(2008-9#1)
was subcultured##2##2##(2008-10#1)(2008-8#1)
was subdivided##2##2##(2008-10#1)(2012-1#1)
was subject to##8##3##(1997-8#1)(2008-10#1)(2008-12#2)(2009-3#1)(2012-12#2)(2013-1#1)
was subjected to a##2##4##(2007-7#1)(2012-12#1)
was subjected to acid and alkali hydrolysis##2##7##(2008-10#2)
was subjected to an electrochemical pretreatment in order to improve the##2##11##(2008-10#2)
was subjected to the##2##4##(2008-10#2)
was subjected to##30##3##(1992-8#1)(1993-11#1)(1994-11#1)(1997-1#1)(2007-12#1)(2007-7#2)(2008-10#12)(2008-11#3)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
was subjectively##2##2##(2007-12#1)(2008-8#1)
was submitted to##7##3##(1996-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-12#1)
was submitted##8##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-12#1)
was subsequently confirmed by##3##4##(1993-11#1)(1994-7#1)(2008-7#1)
was subsequently found to have##2##5##(2008-7#1)(2012-2#1)
was subsequently separated##2##3##(1996-5#2)
was subsequently shown to##3##4##(1990-10#1)(1991-2#1)(2008-7#1)
was subsequently shown##4##3##(1990-10#1)(1991-2#1)(1992-6#1)(2008-7#1)
was subsequently tested##2##3##(1991-7#1)(2008-5#1)
was subsequently used as##2##4##(1993-3#1)(2010-6#1)
was subsequently used##4##3##(1993-3#1)(1996-5#1)(2008-10#1)(2010-6#1)
was subsequently##36##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-1#1)(1996-5#3)(1996-6#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-8#1)
was substantial##4##2##(1995-1#1)(1995-6#1)(2008-10#1)(2008-7#1)
was substantially##9##2##(1993-8#1)(1995-2#2)(1995-6#1)(1997-3#1)(2008-10#2)(2010-3#1)(2012-12#1)
was substantiated by the##2##4##(1994-2#1)(2008-10#1)
was substantiated by##5##3##(1994-2#1)(2008-10#4)
was substantiated##6##2##(1991-10#1)(1994-2#1)(2008-10#4)
was substituted by##6##3##(1990-7#1)(1991-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
was substituted for the##2##4##(1990-12#1)(2008-10#1)
was substituted for##4##3##(1990-12#1)(1990-2#1)(2006-12#1)(2008-10#1)
was substituted with a##2##4##(1993-6#1)(1995-11#1)
was substituted with##4##3##(1993-6#1)(1995-11#1)(1995-5#1)(2008-10#1)
was substituted##18##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-6#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-8#2)
was successful and##4##3##(1990-9#1)(2007-8#1)(2008-10#1)(2013-8#1)
was successful for##2##3##(2008-10#1)(2013-7#1)
was successful in all##3##4##(2007-12#1)(2011-2#1)(2012-2#1)
was successful in##16##3##(1990-8#1)(1993-1#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)
was successful##31##2##(1990-8#1)(1990-9#1)(1991-1#1)(1993-1#1)(1996-2#1)(2007-12#1)(2007-5#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-4#1)(2009-10#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#1)
was successfully achieved##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
was successfully applied for determination of##3##6##(2008-10#3)
was successfully applied for the assay of##2##7##(2008-10#2)
was successfully applied for the determination of##9##7##(2008-10#9)
was successfully applied for the##18##5##(2008-10#16)(2009-11#1)(2009-8#1)
was successfully applied for##26##4##(2008-10#24)(2009-11#1)(2009-8#1)
was successfully applied in the##3##5##(2008-10#3)
was successfully applied in##5##4##(2008-10#4)(2011-3#1)
was successfully applied to a##2##5##(1994-7#1)(2012-2#1)
was successfully applied to determination of##2##6##(2008-10#2)
was successfully applied to the analysis of##13##7##(2008-10#12)(2013-1#1)
was successfully applied to the determination of Cr(III) and##2##9##(2008-10#2)
was successfully applied to the determination of copper in##2##9##(2008-10#2)
was successfully applied to the determination of glucose in##2##9##(2008-10#1)(2010-5#1)
was successfully applied to the determination of trace##4##8##(2008-10#4)
was successfully applied to the determination of##59##7##(1994-9#1)(1996-5#1)(2008-10#56)(2010-5#1)
was successfully applied to the determination##60##6##(1994-9#1)(1996-5#1)(2008-10#57)(2010-5#1)
was successfully applied to the direct determination##2##7##(2008-10#2)
was successfully applied to the extraction and determination of##5##9##(2008-10#5)
was successfully applied to the extraction##6##6##(2008-10#5)(2012-1#1)
was successfully applied to the simultaneous determination of##9##8##(2008-10#9)
was successfully applied to the simultaneous##10##6##(2008-10#10)
was successfully applied to the speciation of##2##7##(2008-10#2)
was successfully applied to the speciation##3##6##(2008-10#3)
was successfully applied to the##102##5##(1994-9#1)(1996-5#1)(2008-10#96)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
was successfully applied to##129##4##(1992-11#1)(1994-7#1)(1994-9#2)(1996-5#1)(2007-12#1)(2008-10#117)(2008-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
was successfully applied##164##3##(1992-11#1)(1994-7#1)(1994-9#2)(1996-5#1)(2007-12#1)(2008-10#148)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
was successfully cloned##2##3##(2008-8#1)(2010-6#1)
was successfully constructed##2##3##(2008-10#1)(2010-1#1)
was successfully demonstrated##2##3##(2008-10#1)(2010-5#1)
was successfully done##2##3##(2008-1#1)(2008-6#1)
was successfully employed for the##2##5##(2008-10#2)
was successfully employed in the##2##5##(2008-10#2)
was successfully employed##6##3##(2008-10#5)(2011-1#1)
was successfully established##2##3##(2008-10#1)(2010-9#1)
was successfully evaluated##2##3##(2008-10#2)
was successfully identified##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
was successfully performed in##2##4##(2007-7#1)(2012-3#1)
was successfully performed on##2##4##(2008-10#1)(2008-5#1)
was successfully performed##6##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
was successfully reduced##2##3##(2007-11#1)(2008-3#1)
was successfully removed##4##3##(2008-7#2)(2011-2#1)(2013-8#1)
was successfully resected##2##3##(2007-8#1)(2013-1#1)
was successfully tested##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
was successfully treated by##4##4##(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
was successfully treated with surgical##2##5##(2008-10#1)(2013-8#1)
was successfully treated with##17##4##(2007-12#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-5#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
was successfully treated##26##3##(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#3)(2013-1#3)(2013-8#2)
was successfully used as##3##4##(2008-10#3)
was successfully used for the determination of##6##7##(2008-10#6)
was successfully used for the##8##5##(2008-10#8)
was successfully used for##10##4##(2008-10#10)
was successfully used in the##2##5##(2007-8#1)(2008-10#1)
was successfully used in##3##4##(2007-8#1)(2008-10#1)(2011-3#1)
was successfully used to##10##4##(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2013-1#1)
was successfully used##26##3##(2007-8#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
was successfully validated##2##3##(2008-10#2)
was successfully##299##2##(1990-8#1)(1991-8#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#192)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#4)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#5)(2011-3#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
was successively##4##2##(1992-5#1)(1993-8#1)(1993-9#1)(2008-10#1)
was such that##2##3##(1997-2#1)(2012-2#1)
was such##3##2##(1997-2#1)(1997-3#1)(2012-2#1)
was suffering from##4##3##(1990-3#1)(2008-12#1)(2011-1#1)(2012-12#1)
was sufficient for##10##3##(1991-2#1)(1995-2#2)(1997-2#1)(1997-7#1)(2008-10#4)(2011-2#1)
was sufficient to cause##2##4##(1995-2#1)(2008-8#1)
was sufficient to##19##3##(1990-8#1)(1992-12#2)(1994-11#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
was sufficient##34##2##(1990-8#1)(1991-2#1)(1992-12#2)(1994-11#1)(1995-2#3)(1997-2#1)(1997-7#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
was sufficiently high##2##3##(2008-10#1)(2008-9#1)
was sufficiently low to##2##4##(2008-10#2)
was sufficiently##10##2##(2008-10#8)(2008-11#1)(2008-9#1)
was suggested and##3##3##(2008-10#1)(2012-12#2)
was suggested as a possible##2##5##(2007-8#1)(2012-12#1)
was suggested as##3##3##(1992-8#1)(2007-8#1)(2012-12#1)
was suggested by##2##3##(2008-10#1)(2008-11#1)
was suggested for##2##3##(1997-3#1)(2012-3#1)
was suggested in##2##3##(2008-2#1)(2008-6#1)
was suggested that the##6##4##(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(2011-1#1)
was suggested that##25##3##(1991-1#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
was suggested to be##2##4##(2008-7#1)(2008-9#1)
was suggested to##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
was suggested##50##2##(1991-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-4#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
was suggestive of##5##3##(2007-8#1)(2008-1#2)(2012-2#1)(2012-3#1)
was suitable for use##2##4##(2008-10#1)(2008-9#1)
was suitable for##11##3##(2008-10#6)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)
was suitable##12##2##(2008-10#7)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)
was suitably##2##2##(2008-10#1)(2008-3#1)
was summarized##2##2##(2008-5#1)(2013-8#1)
was superior in terms of##2##5##(2008-10#1)(2009-2#1)
was superior in##4##3##(2008-10#2)(2009-2#1)(2013-1#1)
was superior to a##2##4##(2008-3#1)(2010-3#1)
was superior to that observed##2##5##(2008-10#2)
was superior to that of##2##5##(1996-2#1)(2008-10#1)
was superior to that##5##4##(1993-2#1)(1996-2#1)(2008-10#3)
was superior to the##5##4##(1992-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
was superior to##20##3##(1992-5#1)(1993-12#1)(1993-2#1)(1996-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-4#1)(2011-2#1)
was superior##27##2##(1992-5#1)(1993-12#1)(1993-2#1)(1996-2#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
was supplemented with 100 nmolml(-1)##2##5##(2013-1#2)
was supplemented with##6##3##(1991-2#1)(2008-10#2)(2008-5#1)(2013-1#2)
was supplemented##8##2##(1991-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#2)
was supplied to the##2##4##(1995-3#1)(2008-10#1)
was supplied##3##2##(1995-3#1)(1996-9#1)(2008-10#1)
was supported by a##2##4##(2009-4#1)(2010-11#1)
was supported by an##2##4##(2008-10#1)(2008-3#1)
was supported by the##3##4##(2008-10#3)
was supported by##21##3##(1990-12#1)(1991-11#1)(1991-12#1)(1993-9#1)(1996-6#1)(2008-10#11)(2008-12#1)(2008-3#1)(2009-4#1)(2010-11#1)(2011-2#1)
was supported further by##2##4##(2008-10#2)
was supported##27##2##(1990-12#1)(1991-11#1)(1991-12#1)(1993-9#1)(1996-6#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#1)
was suppressed after##2##3##(2008-10#1)(2008-11#1)
was suppressed by the##4##4##(1997-1#1)(1997-2#1)(2008-3#1)(2008-7#1)
was suppressed by##18##3##(1990-2#1)(1992-8#3)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
was suppressed in all##2##4##(2008-10#2)
was suppressed in##4##3##(1994-2#1)(2008-10#2)(2011-2#1)
was suppressed when compared##2##4##(2008-10#1)(2008-12#1)
was suppressed when##4##3##(1992-3#1)(2008-10#1)(2008-12#1)(2008-9#1)
was suppressed##41##2##(1990-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
was suppressive##3##2##(2008-10#3)
was surgery##2##2##(2008-6#1)(2013-1#1)
was surgical##3##2##(1993-5#1)(1993-9#1)(2013-1#1)
was surgically excised##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
was surgically##7##2##(1993-2#1)(2007-12#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
was surprisingly##3##2##(1991-12#1)(1992-10#1)(1995-11#1)
was surrounded by a##2##4##(2008-10#2)
was surrounded by##5##3##(2008-10#3)(2008-5#1)(2012-1#1)
was surveyed by##2##3##(1995-1#1)(2007-12#1)
was surveyed in##4##3##(1992-3#1)(1997-3#1)(2008-10#1)(2011-1#1)
was surveyed##10##2##(1992-3#1)(1995-1#1)(1995-9#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-7#1)
was susceptible to both cyromazine and abamectin##2##7##(2011-2#2)
was susceptible to both##3##4##(2008-11#1)(2011-2#2)
was susceptible to infection##2##4##(2007-12#1)(2008-10#1)
was susceptible to##11##3##(2007-12#1)(2008-10#6)(2008-11#1)(2011-2#3)
was susceptible##12##2##(2007-12#1)(2008-10#7)(2008-11#1)(2011-2#3)
was suspected from##2##3##(2008-7#2)
was suspected of##2##3##(1996-9#1)(2009-3#1)
was suspected on the basis of##2##6##(1990-3#1)(2008-7#1)
was suspected on##3##3##(1990-3#1)(2008-7#1)(2012-2#1)
was suspected to be##2##4##(2008-10#1)(2010-6#1)
was suspected##24##2##(1990-2#1)(1990-3#1)(1990-8#1)(1992-4#1)(1994-9#1)(1996-9#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
was suspended##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
was sustained for##4##3##(1990-10#1)(1997-7#1)(2008-7#1)(2010-5#1)
was sustained##10##2##(1990-10#1)(1992-3#1)(1993-8#1)(1994-3#1)(1997-7#1)(2008-1#1)(2008-7#1)(2010-5#2)(2012-1#1)
was swallowed##2##2##(1990-6#1)(2008-10#1)
was swept##2##2##(2008-10#1)(2008-3#1)
was switched off##2##3##(2008-10#1)(2008-4#1)
was switched on##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
was switched to##2##3##(2008-1#1)(2008-7#1)
was switched##8##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
was symmetric##2##2##(2008-8#2)
was symptomatic##2##2##(2008-7#1)(2011-3#1)
was synergistic##2##2##(2007-12#1)(2008-10#1)
was synergistically increased by##2##4##(1997-1#2)
was synthesised##3##2##(2008-10#2)(2008-4#1)
was synthesized and characterized##4##4##(1993-8#1)(1995-3#1)(2008-10#2)
was synthesized and its##2##4##(2008-10#2)
was synthesized and tested##2##4##(1992-8#1)(2008-8#1)
was synthesized and used##2##4##(1990-2#1)(2008-10#1)
was synthesized and##19##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-8#2)(1993-8#1)(1994-11#1)(1995-3#2)(2008-10#7)(2008-12#1)(2008-8#1)(2012-12#1)
was synthesized as a##2##4##(1990-8#1)(2008-10#1)
was synthesized at##2##3##(1993-6#1)(2008-10#1)
was synthesized by a##3##4##(2008-10#3)
was synthesized by reacting##2##4##(1994-2#1)(1995-3#1)
was synthesized by using##2##4##(2008-10#2)
was synthesized by##16##3##(1992-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(2008-10#9)(2008-3#1)(2009-11#1)(2013-8#1)
was synthesized from##3##3##(2008-10#2)(2011-1#1)
was synthesized in##3##3##(1990-11#1)(1994-5#1)(2008-12#1)
was synthesized using##3##3##(2008-10#3)
was synthesized with a##3##4##(1990-5#1)(2013-1#2)
was synthesized with##4##3##(1990-5#1)(1994-5#1)(2013-1#2)
was synthesized##66##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#1)(1992-3#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-3#4)(1995-8#1)(1997-3#1)(2008-10#31)(2008-12#2)(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was systematically examined##2##3##(1992-6#1)(2008-10#1)
was systematically studied##2##3##(1991-12#1)(2008-10#1)
was systematically##8##2##(1991-12#1)(1992-6#2)(1995-5#1)(2007-8#1)(2008-10#2)(2013-8#1)
was tagged with##2##3##(2008-10#2)
was tailored##3##2##(1990-12#1)(2009-9#1)(2012-12#1)
was taken and##2##3##(1995-6#1)(2011-2#1)
was taken as an##2##4##(1996-5#1)(2008-10#1)
was taken as evidence##2##4##(2008-10#1)(2008-8#1)
was taken as the##5##4##(2007-8#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
was taken as##10##3##(1992-11#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
was taken at##2##3##(2007-10#1)(2008-7#1)
was taken for##5##3##(2008-10#2)(2008-8#1)(2010-8#1)(2012-2#1)
was taken from a##2##4##(2010-8#1)(2012-12#1)
was taken from the##2##4##(2008-5#2)
was taken from##6##3##(2008-10#1)(2008-5#2)(2010-8#1)(2012-12#1)(2013-1#1)
was taken into account##4##4##(1994-9#1)(2008-10#2)(2013-1#1)
was taken off##2##3##(1995-12#1)(2008-10#1)
was taken to##6##3##(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)
was taken up by the##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
was taken up by##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
was taken up##6##3##(1991-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)
was taken##58##2##(1991-12#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-8#2)(2008-10#12)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
was taking an##2##3##(1995-6#2)
was taking##5##2##(1994-12#1)(1995-6#3)(2007-12#1)
was targeted##4##2##(1995-11#1)(2008-5#1)(2010-2#1)(2011-2#1)
was taught##2##2##(2010-9#1)(2013-8#1)
was technically##2##2##(2008-12#1)(2012-12#1)
was temperature dependent##2##3##(2008-10#2)
was temperature##5##2##(1993-12#1)(2007-12#2)(2008-10#2)
was ten times higher than##2##5##(1990-12#1)(1991-5#1)
was ten times##3##3##(1990-12#1)(1991-5#1)(2008-9#1)
was ten##4##2##(1990-12#1)(1991-5#1)(1993-1#1)(2008-9#1)
was tentatively identified as##2##4##(1995-5#1)(2008-10#1)
was tentatively##4##2##(1995-5#1)(2008-10#3)
was termed##4##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)
was terminated by##2##3##(1995-12#1)(2008-12#1)
was terminated##8##2##(1990-5#1)(1992-3#1)(1995-12#1)(2008-12#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-4#1)
was tested against##9##3##(1996-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#1)
was tested and##8##3##(1990-5#1)(1994-12#1)(2008-10#3)(2008-3#1)(2009-11#1)(2013-8#1)
was tested as a##2##4##(1994-9#1)(1997-6#1)
was tested as an##2##4##(2008-10#2)
was tested as##6##3##(1994-9#1)(1997-6#1)(2008-10#3)(2008-3#1)
was tested at##2##3##(2008-10#2)
was tested by adding##2##4##(1990-11#1)(1995-3#1)
was tested by analysing a##3##5##(2008-10#3)
was tested by analysing##5##4##(2008-10#5)
was tested by analyzing##4##4##(2008-10#3)(2011-2#1)
was tested by measurement of the##2##6##(2008-10#1)(2008-2#1)
was tested by measuring the##2##5##(1991-12#1)(2008-11#1)
was tested by measuring##4##4##(1991-12#1)(1994-11#1)(2008-11#1)(2008-8#1)
was tested by the##5##4##(2008-10#2)(2008-5#1)(2012-7#1)(2013-8#1)
was tested by##46##3##(1990-11#1)(1991-12#1)(1991-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#24)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#2)(2011-1#2)(2011-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
was tested experimentally by##2##4##(2008-10#1)(2008-7#1)
was tested experimentally##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
was tested for its ability to##2##6##(2008-10#2)
was tested for its##5##4##(1992-2#1)(2008-10#4)
was tested for potential toxicity and carcinogenicity in two relatively well-studied models##2##12##(2008-8#1)(2008-9#1)
was tested for the determination of##3##6##(2008-10#3)
was tested for the##4##4##(2008-10#4)
was tested for##33##3##(1991-3#1)(1991-6#1)(1992-2#1)(1994-8#2)(2008-10#22)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#1)
was tested here##2##3##(2008-6#1)(2012-5#1)
was tested in a sample of##2##6##(2009-8#1)(2010-10#1)
was tested in a##10##4##(1990-8#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)
was tested in an##2##4##(2008-10#1)(2008-7#1)
was tested in the analysis of##2##6##(2008-10#2)
was tested in the determination of##2##6##(2008-10#2)
was tested in the laboratory##2##5##(2008-10#2)
was tested in the presence##2##5##(2008-11#1)(2013-1#1)
was tested in the##13##4##(2008-10#9)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
was tested in vitro##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
was tested in##45##3##(1990-12#1)(1990-8#1)(1995-6#1)(1996-12#1)(2008-10#21)(2008-11#3)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
was tested on a##2##4##(2008-10#1)(2008-2#1)
was tested on the##3##4##(1992-2#1)(1992-8#1)(2008-10#1)
was tested on##21##3##(1990-2#1)(1991-3#1)(1992-2#1)(1992-8#1)(2008-10#10)(2008-12#3)(2008-2#2)(2008-3#2)
was tested through##3##3##(2010-10#1)(2011-2#1)(2013-8#1)
was tested to##3##3##(1995-2#1)(2008-10#2)
was tested under##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
was tested using a##3##4##(2008-10#3)
was tested using the##4##4##(1990-5#1)(2007-10#1)(2008-12#1)(2010-4#1)
was tested using two##2##4##(1995-2#1)(2008-10#1)
was tested using##16##3##(1990-5#1)(1995-2#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
was tested with##10##3##(2008-10#8)(2008-3#1)(2010-8#1)
was tested##252##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#5)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#125)(2008-11#7)(2008-12#6)(2008-2#4)(2008-3#11)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#4)(2013-8#5)
was that of a##3##4##(1995-8#1)(2008-11#1)(2011-2#1)
was that of##13##3##(1992-12#1)(1994-9#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#2)(2012-12#1)
was that the##13##3##(1991-12#1)(1991-6#1)(1992-3#2)(2008-10#4)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)
was that they##2##3##(2007-10#1)(2012-12#1)
was that##58##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-12#2)(2013-1#1)
was the &quot##2##3##(2010-8#1)(2012-2#1)
was the aim of the##2##5##(2008-7#1)(2009-10#1)
was the aim of##3##4##(2008-11#1)(2008-7#1)(2009-10#1)
was the analysis of##4##4##(2007-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
was the basis##2##3##(1992-3#1)(2012-3#1)
was the best choice for##2##5##(2008-10#2)
was the best predictor of##2##5##(1996-7#1)(2013-1#1)
was the best##14##3##(1992-8#1)(1996-7#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#2)
was the case for##3##4##(1991-7#1)(1993-1#1)(2013-1#1)
was the case##6##3##(1991-7#1)(1993-1#1)(1995-6#1)(2008-10#2)(2013-1#1)
was the cause of##4##4##(1992-5#1)(1995-3#1)(2007-8#1)(2008-4#1)
was the cause##5##3##(1992-5#1)(1995-3#1)(2007-8#1)(2008-4#1)(2013-1#1)
was the change in##2##4##(2008-4#1)(2010-5#1)
was the clinical##2##3##(2011-1#1)(2013-1#1)
was the common##2##3##(1990-12#1)(2010-8#1)
was the commonest cause of secondary##2##6##(2007-7#1)(2008-1#1)
was the commonest cause of##4##5##(2007-7#2)(2008-1#1)(2008-4#1)
was the commonest cause##6##4##(2007-7#2)(2008-1#3)(2008-4#1)
was the commonest mode of presentation##3##6##(1997-8#1)(2007-7#1)(2008-1#1)
was the commonest species##3##4##(2007-7#1)(2008-5#2)
was the commonest##20##3##(1997-8#1)(2007-7#9)(2008-1#5)(2008-4#2)(2008-5#2)(2008-8#1)
was the core##2##3##(2008-10#1)(2013-8#1)
was the creation of##2##4##(2012-3#1)(2013-8#1)
was the determination of##3##4##(1994-7#1)(2010-5#1)(2011-2#1)
was the development and##2##4##(2008-5#1)(2013-1#1)
was the development of##4##4##(2008-10#3)(2008-3#1)
was the development##6##3##(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#1)
was the discovery##2##3##(2012-1#1)(2012-12#1)
was the dominant species##2##4##(2008-10#2)
was the dominant##5##3##(2008-10#4)(2008-12#1)
was the evaluation of the##2##5##(2011-1#1)(2011-2#1)
was the finding of##2##4##(1996-12#1)(2011-2#1)
was the finding that##3##4##(1994-8#1)(1996-5#1)(2008-7#1)
was the finding##5##3##(1994-8#1)(1996-12#1)(1996-5#1)(2008-7#1)(2011-2#1)
was the first of##2##4##(2008-5#1)(2012-2#1)
was the first##12##3##(1992-5#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#3)(2013-8#1)
was the highest among##2##4##(1996-3#1)(2008-12#1)
was the highest in the##2##5##(2008-10#2)
was the highest in##4##4##(2007-11#1)(2008-10#2)(2009-7#1)
was the highest##14##3##(1990-10#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#1)
was the implementation##2##3##(1994-1#1)(2008-10#1)
was the increased##2##3##(2008-11#1)(2011-2#1)
was the index##2##3##(2008-7#1)(2010-11#1)
was the initial##2##3##(1990-9#1)(2007-8#1)
was the introduction of##2##4##(1997-3#1)(2008-12#1)
was the lack of##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
was the last##4##3##(1991-3#2)(1993-12#1)(2012-2#1)
was the leading##2##3##(2008-1#2)
was the least##10##3##(2008-10#6)(2008-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
was the limiting##2##3##(2008-10#1)(2011-2#1)
was the lowest among the##2##5##(2008-5#1)(2011-3#1)
was the lowest##5##3##(1994-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-3#1)
was the main reason##2##4##(2011-1#1)(2012-12#1)
was the main##13##3##(1991-12#1)(1996-6#1)(2008-1#2)(2008-10#3)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)
was the major compound##2##4##(2008-5#1)(2013-1#1)
was the major##19##3##(1990-10#1)(1990-6#2)(1992-3#1)(1997-6#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)(2013-1#1)
was the most abundant species##4##5##(2011-2#3)(2013-1#1)
was the most abundant##8##4##(1992-12#1)(2010-5#1)(2011-2#4)(2013-1#1)(2013-7#1)
was the most active against##2##5##(2008-7#2)
was the most active##6##4##(1991-12#1)(2008-4#2)(2008-7#2)(2013-8#1)
was the most appropriate##2##4##(2008-10#2)
was the most common diagnosis##2##5##(2006-8#1)(2011-2#1)
was the most common indication for biopsy##2##7##(2008-1#2)
was the most common mechanism##2##5##(2010-1#1)(2013-8#1)
was the most common toxicity during##2##6##(2008-10#2)
was the most common##31##4##(1990-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
was the most commonly##2##4##(2008-10#1)(2011-2#1)
was the most diverse##2##4##(2008-10#1)(2013-7#1)
was the most effective and##2##5##(2008-10#1)(2012-12#1)
was the most effective in##2##5##(2008-10#2)
was the most effective##17##4##(1990-5#1)(1993-12#1)(1995-2#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
was the most efficient##2##4##(1994-6#1)(2008-10#1)
was the most frequent symptom##2##5##(1991-8#1)(1995-11#1)
was the most frequent##15##4##(1991-8#2)(1995-11#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-3#2)
was the most frequently##5##4##(1991-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2011-2#1)
was the most important##4##4##(1991-2#1)(2007-10#1)(2008-12#1)(2013-7#1)
was the most numerous##2##4##(2007-8#1)(2013-7#1)
was the most potent##5##4##(1990-7#1)(1994-3#1)(1996-2#1)(1997-4#1)(2011-2#1)
was the most prevalent##8##4##(1992-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
was the most resistant##3##4##(2008-10#3)
was the most sensitive of the##2##6##(1995-12#1)(2008-10#1)
was the most sensitive##9##4##(1990-12#1)(1992-11#1)(1995-12#1)(2008-10#4)(2008-6#1)(2008-8#1)
was the most serious##2##4##(1991-12#1)(2012-2#1)
was the most significant##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
was the most suitable##3##4##(1990-8#1)(2008-10#1)(2008-12#1)
was the most variable##2##4##(2008-10#1)(2012-12#1)
was the most##157##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-4#2)(2006-8#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-7#5)(2007-8#2)(2008-1#9)(2008-10#37)(2008-12#8)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#6)(2013-8#3)
was the one that##2##4##(2008-1#1)(2008-10#1)
was the only factor associated with##2##6##(2007-10#1)(2011-1#1)
was the only factor that##3##5##(1991-2#1)(2007-7#1)(2012-12#1)
was the only factor##7##4##(1991-2#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
was the only one##3##4##(1990-12#1)(1997-5#1)(2008-7#1)
was the only race##2##4##(2008-10#2)
was the only significant predictor##3##5##(1993-1#1)(2007-10#1)(2008-9#1)
was the only significant##4##4##(1993-1#1)(2007-10#1)(2008-9#1)(2012-2#1)
was the only treatment##2##4##(2010-8#1)(2011-2#1)
was the only variable##2##4##(1990-8#1)(2013-1#1)
was the only##59##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-10#2)(2007-7#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
was the optimal##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
was the predominant mode##3##4##(2008-10#3)
was the predominant species##3##4##(1994-11#1)(1996-12#1)(2008-10#1)
was the predominant##20##3##(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-12#1)(2007-7#1)(2008-10#10)(2008-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
was the preferred strategy##3##4##(2012-3#3)
was the preferred##4##3##(1993-10#1)(2012-3#3)
was the presence of##4##4##(1992-3#1)(2009-8#1)(2011-1#1)(2012-3#1)
was the presence##7##3##(1990-7#2)(1992-3#1)(2008-2#1)(2009-8#1)(2011-1#1)(2012-3#1)
was the presenting feature##2##4##(2007-7#1)(2008-1#1)
was the primary diagnosis in##2##5##(1992-1#2)
was the primary##10##3##(1992-1#2)(2007-12#3)(2008-10#4)(2013-1#1)
was the production of##2##4##(1996-2#1)(2012-2#1)
was the proportion of patients achieving##2##6##(2010-8#1)(2013-1#1)
was the proportion of##3##4##(2010-8#1)(2012-2#1)(2013-1#1)
was the result of three##2##5##(1996-1#1)(2009-2#1)
was the result of##5##4##(1995-2#1)(1996-1#1)(2007-12#1)(2007-8#1)(2009-2#1)
was the same as that of##3##6##(1990-5#1)(1993-9#1)(2008-10#1)
was the same as that##6##5##(1990-5#1)(1993-9#1)(1995-3#1)(2007-7#1)(2008-10#2)
was the same as##14##4##(1990-5#1)(1991-12#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)
was the same for both##3##5##(1995-11#1)(1996-2#1)(2008-5#1)
was the same for##4##4##(1995-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
was the same in both groups##2##6##(1993-9#1)(1994-3#1)
was the same in both##4##5##(1991-2#1)(1993-9#1)(1994-3#1)(2008-11#1)
was the same in the##2##5##(1992-11#1)(1993-11#1)
was the same in##7##4##(1991-2#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-3#1)(2008-10#1)(2008-11#1)
was the same##29##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-9#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
was the second most##3##4##(2008-1#1)(2008-12#1)(2011-2#1)
was the second##5##3##(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
was the selected##2##3##(2008-10#2)
was the sole##8##3##(1992-11#1)(1994-8#1)(1995-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
was the species##2##3##(2008-12#1)(2008-5#1)
was the standard##2##3##(1993-12#1)(2010-3#1)
was the strongest predictor of##6##5##(1995-5#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2012-3#1)
was the strongest##7##3##(1995-5#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-10#1)(2012-3#1)
was the technique##2##3##(2008-10#1)(2010-6#1)
was the third##3##3##(1992-2#1)(2008-12#1)(2008-5#1)
was the use of##4##4##(2008-10#2)(2011-1#1)(2013-1#1)
was the work of##2##4##(1996-1#1)(2008-10#1)
was the##744##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#5)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#5)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#3)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#5)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2006-10#1)(2006-8#1)(2007-10#7)(2007-11#10)(2007-12#8)(2007-5#1)(2007-7#21)(2007-8#9)(2007-9#1)(2008-1#31)(2008-10#149)(2008-11#14)(2008-12#27)(2008-2#2)(2008-3#11)(2008-4#10)(2008-5#25)(2008-6#11)(2008-7#17)(2008-8#8)(2008-9#11)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#7)(2010-6#1)(2010-8#8)(2011-1#13)(2011-2#30)(2011-3#2)(2012-1#1)(2012-12#14)(2012-2#19)(2012-3#14)(2013-1#26)(2013-7#8)(2013-8#16)
was their##3##2##(1991-12#1)(1992-3#1)(2009-9#1)
was then applied to##5##4##(1991-9#1)(2008-10#2)(2009-2#1)(2012-2#1)
was then applied##9##3##(1991-9#1)(2008-10#4)(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#1)
was then assessed##2##3##(2008-10#1)(2013-1#1)
was then carried##2##3##(1994-3#1)(2008-10#1)
was then compared##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
was then confirmed by##2##4##(2010-12#1)(2012-12#1)
was then confirmed##3##3##(2008-12#1)(2010-12#1)(2012-12#1)
was then converted to##3##4##(1994-12#1)(1994-3#1)(2008-10#1)
was then coupled with##2##4##(2008-10#1)(2008-5#1)
was then demonstrated##2##3##(1990-12#1)(1990-8#1)
was then determined by##3##4##(2008-10#2)(2008-5#1)
was then determined##6##3##(1990-6#1)(2008-10#4)(2008-5#1)
was then eluted with##2##4##(2008-10#2)
was then evaluated in##2##4##(2007-8#1)(2008-11#1)
was then evaluated##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
was then extracted##3##3##(2008-10#2)(2008-5#1)
was then followed##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
was then made##2##3##(2010-3#1)(2011-2#1)
was then mixed with the reagent##2##6##(2008-10#2)
was then performed by##2##4##(2008-10#2)
was then performed##5##3##(2008-10#3)(2008-11#1)(2011-2#1)
was then purified##2##3##(1994-8#1)(2008-5#1)
was then repeated##3##3##(1993-2#1)(2008-10#2)
was then separated##2##3##(2008-10#2)
was then successfully##2##3##(1990-8#1)(2008-7#1)
was then taken##2##3##(2008-3#1)(2012-12#1)
was then tested##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
was then treated with##2##4##(2006-10#1)(2008-10#1)
was then used as a##2##5##(1991-2#1)(2009-12#1)
was then used for a##2##5##(1995-2#1)(2008-10#1)
was then used for##3##4##(1995-2#1)(2008-10#2)
was then used to##10##4##(1991-5#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)
was then used##16##3##(1991-2#1)(1991-5#1)(1995-2#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2012-2#1)
was then##169##2##(1990-12#3)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#3)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#60)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#11)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#7)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#4)
was theoretically and##2##3##(2007-12#2)
was theoretically##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
was there a##2##3##(2008-10#1)(2008-3#1)
was there any##2##3##(1991-4#1)(1996-9#1)
was there##6##2##(1991-4#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-3#1)(2010-11#1)
was therefore designed##2##3##(1994-12#1)(2008-3#1)
was therefore##26##2##(1990-5#2)(1991-8#1)(1992-3#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
was thickened##2##2##(2007-11#1)(2008-10#1)
was this##2##2##(1995-12#1)(2008-12#1)
was thoroughly##2##2##(1990-5#1)(2008-10#1)
was thought to be a##3##5##(2008-10#1)(2008-3#1)(2008-8#1)
was thought to be of##2##5##(2011-2#1)(2013-1#1)
was thought to be the##3##5##(2007-10#1)(2008-7#2)
was thought to be##17##4##(1993-1#1)(1993-3#1)(1996-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
was thought to occur##2##4##(2008-10#1)(2008-7#1)
was thought to##24##3##(1993-1#1)(1993-3#1)(1993-9#1)(1996-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#4)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
was thought##32##2##(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1996-11#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
was three times greater##2##4##(2008-10#2)
was through binding##2##3##(2008-11#2)
was through##5##2##(2008-11#2)(2008-7#1)(2010-12#1)(2011-1#1)
was thus demonstrated##2##3##(2008-10#1)(2008-11#1)
was thus##21##2##(1990-2#1)(1990-6#1)(1990-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
was tightly##4##2##(1992-6#1)(1995-2#1)(1997-6#1)(2008-7#1)
was time- and##2##3##(1994-6#1)(1995-12#1)
was time-dependent##2##2##(1990-8#1)(1992-3#1)
was titrated with##2##3##(1994-5#1)(1995-2#1)
was titrated##4##2##(1994-5#1)(1995-2#1)(2008-10#2)
was to analyse the##9##4##(2007-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-3#1)(2011-1#1)(2013-8#1)
was to analyse##13##3##(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
was to analyze the##13##4##(1995-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-3#2)
was to analyze##24##3##(1995-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)
was to answer the following##2##5##(1994-8#1)(2012-3#1)
was to apply a##2##4##(2008-10#1)(2008-5#1)
was to apply##5##3##(2008-10#2)(2008-5#2)(2013-1#1)
was to ascertain the##3##4##(1991-12#1)(2008-9#1)(2010-3#1)
was to ascertain##5##3##(1991-12#1)(1992-3#1)(1997-4#1)(2008-9#1)(2010-3#1)
was to assess the feasibility of##3##6##(1993-12#1)(1997-8#1)(2007-8#1)
was to assess the feasibility##4##5##(1993-12#1)(1997-8#1)(2007-10#1)(2007-8#1)
was to assess the impact of##2##6##(1992-1#1)(2007-8#1)
was to assess the influence of##4##6##(2008-5#1)(2009-2#1)(2009-8#1)(2013-1#1)
was to assess the possible##2##5##(2012-3#1)(2012-8#1)
was to assess the potential##2##5##(2008-5#1)(2008-7#1)
was to assess the##47##4##(1990-6#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#2)(2009-2#2)(2009-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#2)(2013-8#1)
was to assess whether##4##4##(1991-6#1)(2008-7#1)(2009-7#1)(2012-2#1)
was to assess##65##3##(1990-6#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#2)(1995-1#2)(1996-1#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#3)(2012-8#1)(2013-1#2)(2013-8#1)
was to be##4##3##(1996-9#1)(2010-1#1)(2012-12#2)
was to characterize the##6##4##(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#1)
was to characterize##12##3##(1993-1#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#2)(2010-4#1)(2012-3#1)(2013-8#1)
was to clarify the##4##4##(2007-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
was to collect##2##3##(1995-3#1)(2010-3#1)
was to compare differences in##2##5##(2008-12#1)(2011-2#1)
was to compare laparoscopically assisted vaginal hysterectomy##2##7##(1993-12#1)(1994-2#1)
was to compare the##29##4##(1992-10#1)(1996-2#1)(1997-8#1)(2007-10#2)(2007-8#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#6)(2013-8#2)
was to compare##58##3##(1990-2#1)(1992-10#1)(1993-12#2)(1994-12#1)(1994-2#1)(1996-2#1)(1997-8#2)(2007-10#2)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#6)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#9)(2013-7#1)(2013-8#2)
was to confirm the##2##4##(2012-2#2)
was to confirm##3##3##(2008-10#1)(2012-2#2)
was to create awareness##2##4##(1992-12#1)(2013-8#1)
was to create##3##3##(1992-12#1)(2008-7#1)(2013-8#1)
was to define factors##2##4##(2008-9#1)(2011-2#1)
was to define the##4##4##(1995-2#1)(2007-11#1)(2008-8#1)(2011-2#1)
was to define##8##3##(1991-5#1)(1995-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)
was to delineate the##2##4##(1996-1#1)(2012-12#1)
was to demonstrate the##4##4##(2007-8#1)(2008-10#2)(2011-2#1)
was to describe the##15##4##(1992-3#1)(1993-12#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
was to describe##22##3##(1992-3#1)(1993-12#1)(1995-12#1)(1996-9#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
was to detect##4##3##(1994-8#1)(2008-7#1)(2010-8#1)(2012-3#1)
was to determine how##4##4##(1991-2#1)(1992-7#1)(1996-2#1)(2008-10#1)
was to determine if the##4##5##(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
was to determine if##19##4##(1993-2#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
was to determine the effects of##10##6##(2008-10#1)(2008-12#1)(2008-5#3)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#2)
was to determine the frequency of##2##6##(2007-2#1)(2007-5#1)
was to determine the incidence of##2##6##(1991-11#1)(2013-8#1)
was to determine the prevalence of##5##6##(2008-12#2)(2010-2#1)(2012-2#1)(2013-1#1)
was to determine the##90##4##(1990-11#1)(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-5#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#6)(2013-3#1)(2013-8#6)
was to determine whether a##2##5##(1996-6#1)(2008-8#1)
was to determine whether the##3##5##(1990-8#1)(1995-12#1)(2008-10#1)
was to determine whether##27##4##(1990-10#1)(1990-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-8#1)(2007-10#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#3)(2013-1#2)
was to determine which factors##2##5##(1991-6#1)(2007-8#1)
was to determine which##7##4##(1991-6#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
was to determine##157##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#10)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-5#4)(2009-6#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#4)(2012-6#1)(2013-1#9)(2013-3#1)(2013-8#8)
was to develop a##16##4##(1997-2#1)(1997-4#1)(2007-10#1)(2008-10#4)(2008-5#3)(2008-6#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-4#1)
was to develop an##9##4##(1991-5#1)(1991-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
was to develop and validate a##4##6##(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
was to develop and validate##6##5##(2008-10#2)(2008-5#1)(2012-1#2)(2012-2#1)
was to develop and##10##4##(2008-10#4)(2008-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)
was to develop##46##3##(1991-5#1)(1991-9#1)(1993-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-5#7)(2008-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-4#1)(2013-1#1)
was to discuss the##2##4##(2010-5#1)(2013-1#1)
was to discuss##4##3##(2008-4#1)(2009-4#1)(2010-5#1)(2013-1#1)
was to elucidate the##4##4##(1994-3#1)(1995-6#1)(2008-10#1)(2008-8#1)
was to elucidate##6##3##(1994-3#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-9#1)(2013-1#1)
was to establish a##3##4##(1997-4#1)(2010-6#1)(2013-1#1)
was to establish the##6##4##(1994-2#1)(2007-11#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-7#1)
was to establish whether##2##4##(2008-11#1)(2011-2#1)
was to establish##15##3##(1993-12#1)(1994-2#1)(1997-4#1)(2007-11#2)(2008-11#2)(2008-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
was to estimate the number of##2##6##(2008-10#1)(2008-7#1)
was to estimate the##10##4##(1996-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
was to estimate##12##3##(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
was to evaluate a##6##4##(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
was to evaluate clinical##2##4##(2007-8#2)
was to evaluate the capacity of##2##6##(2013-1#2)
was to evaluate the effect of##7##6##(1992-8#1)(1996-2#1)(2008-1#1)(2008-5#1)(2012-2#2)(2013-1#1)
was to evaluate the effectiveness of##3##6##(2007-8#1)(2008-9#1)(2013-1#1)
was to evaluate the efficacy of##6##6##(2007-7#2)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
was to evaluate the impact of a##2##7##(1996-1#1)(2008-3#1)
was to evaluate the impact of##4##6##(1996-1#1)(2007-11#1)(2008-12#1)(2008-3#1)
was to evaluate the performance of##3##6##(2007-8#1)(2008-11#1)(2012-12#1)
was to evaluate the results of##4##6##(1997-8#1)(2007-8#1)(2008-9#1)(2011-2#1)
was to evaluate the role of##4##6##(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
was to evaluate the stability##2##5##(2008-12#1)(2010-3#1)
was to evaluate the##112##4##(1990-11#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1996-1#1)(1996-2#1)(1997-8#5)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#9)(2008-3#2)(2008-4#1)(2008-5#11)(2008-7#3)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#1)
was to evaluate whether the##2##5##(1995-12#1)(2013-8#1)
was to evaluate whether##7##4##(1995-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
was to evaluate##165##3##(1990-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#7)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#3)(2007-8#12)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#12)(2008-3#2)(2008-4#2)(2008-5#15)(2008-6#1)(2008-7#7)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#6)
was to examine possible##2##4##(2008-11#1)(2008-4#1)
was to examine the effects of a##3##7##(2007-12#1)(2009-3#1)(2013-8#1)
was to examine the effects of##6##6##(1991-12#1)(2007-12#1)(2008-5#1)(2009-3#1)(2013-8#2)
was to examine the extent to which##2##7##(2008-1#1)(2009-9#1)
was to examine the impact of##2##6##(2007-10#1)(2011-2#1)
was to examine the influence of##2##6##(1995-3#1)(2008-12#1)
was to examine the##53##4##(1990-5#1)(1990-6#1)(1991-12#1)(1992-2#1)(1993-12#2)(1995-1#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
was to examine whether##3##4##(1997-2#1)(2007-6#1)(2013-1#1)
was to examine##79##3##(1990-5#1)(1990-6#1)(1991-12#1)(1992-2#1)(1993-12#2)(1995-1#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#2)(2008-1#1)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#3)
was to explain##2##3##(2010-3#1)(2012-2#1)
was to explore the##9##4##(1996-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
was to explore##25##3##(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
was to find a##3##4##(2008-10#1)(2008-6#1)(2012-1#1)
was to find out##3##4##(1990-2#1)(1994-9#1)(2008-5#1)
was to find##10##3##(1990-2#1)(1990-5#1)(1994-9#1)(1995-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#1)
was to formulate##5##3##(2008-3#1)(2008-5#2)(2011-1#1)(2012-7#1)
was to further evaluate##2##4##(2011-2#2)
was to further##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#2)
was to gain##2##3##(2010-9#1)(2012-12#1)
was to get##2##3##(1997-3#1)(2010-2#1)
was to highlight##2##3##(2008-5#1)(2013-1#1)
was to identify genes##2##4##(2008-9#1)(2012-3#1)
was to identify risk factors##2##5##(1996-12#1)(2013-1#1)
was to identify the##17##4##(1992-2#1)(1994-5#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
was to identify##37##3##(1990-2#1)(1990-7#1)(1992-2#1)(1994-5#1)(1996-12#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#4)(2012-3#1)(2013-1#3)
was to improve the##4##4##(2007-11#1)(2008-11#1)(2010-8#1)(2012-3#1)
was to improve##7##3##(2007-11#1)(2008-10#1)(2008-11#2)(2009-4#1)(2010-8#1)(2012-3#1)
was to increase##3##3##(1995-1#1)(1997-1#1)(2008-10#1)
was to investigate the association between##2##6##(2011-2#1)(2013-1#1)
was to investigate the relationships between##2##6##(2008-10#1)(2010-6#1)
was to investigate the utilization of##2##6##(2009-11#1)(2013-7#1)
was to investigate the##90##4##(1990-9#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
was to investigate whether a##2##5##(2008-5#1)(2012-3#1)
was to investigate whether there is##2##6##(1992-12#1)(2011-1#1)
was to investigate whether##16##4##(1992-12#1)(1997-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
was to investigate##132##3##(1990-12#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#4)(2013-8#2)
was to measure the##4##4##(1994-3#1)(2008-5#1)(2010-10#1)(2011-2#1)
was to measure##5##3##(1994-3#1)(2008-11#1)(2008-5#1)(2010-10#1)(2011-2#1)
was to observe##3##3##(2008-10#2)(2013-1#1)
was to obtain##11##3##(1992-12#1)(1993-1#1)(1994-5#1)(1995-6#1)(1997-3#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-7#1)
was to perform a##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
was to perform##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
was to prepare##3##3##(1993-11#1)(2008-5#1)(2010-5#1)
was to present##9##3##(1994-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
was to produce##3##3##(1996-12#1)(1997-4#1)(2008-7#1)
was to propose a##2##4##(2007-8#1)(2010-3#1)
was to prove##2##3##(2008-5#1)(2009-8#1)
was to provide a##4##4##(1995-2#1)(2010-6#1)(2012-1#1)(2012-2#1)
was to provide an##2##4##(2008-5#1)(2010-11#1)
was to provide##10##3##(1995-2#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
was to quantify the##4##4##(2007-10#1)(2008-10#2)(2009-5#1)
was to quantify##5##3##(1996-6#1)(2007-10#1)(2008-10#2)(2009-5#1)
was to relate##2##3##(2007-12#1)(2008-5#1)
was to review the##9##4##(1991-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-7#1)
was to review##14##3##(1991-12#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#2)
was to search##5##3##(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
was to see##4##3##(2007-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
was to study the effect of##2##6##(2012-2#1)(2013-1#1)
was to study the prevalence of##2##6##(1990-9#1)(2007-10#1)
was to study the relationship##2##5##(1991-11#1)(2008-7#1)
was to study the##19##4##(1990-9#1)(1991-11#1)(1993-5#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
was to study##26##3##(1990-9#1)(1991-11#1)(1993-5#1)(1997-7#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#3)
was to summarize##2##3##(2008-10#1)(2013-8#1)
was to systematically##2##3##(1993-2#1)(2013-1#1)
was to test the##7##4##(1990-8#1)(1991-9#1)(1993-12#1)(1996-9#1)(2008-8#1)(2010-3#1)(2012-2#1)
was to test whether##2##4##(1995-3#1)(1997-2#1)
was to test##14##3##(1990-8#1)(1991-9#1)(1993-12#2)(1995-3#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
was to understand the##3##4##(2008-11#1)(2011-1#1)(2012-3#1)
was to use##9##3##(1993-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
was to validate the##3##4##(2008-12#1)(2009-12#1)(2013-1#1)
was to validate##5##3##(2008-12#1)(2008-8#1)(2009-12#1)(2013-1#2)
was to verify if##2##4##(2008-10#2)
was to verify the occurrence of##2##6##(1991-9#1)(2008-6#1)
was to verify the##7##4##(1991-9#1)(1992-3#1)(2008-10#2)(2008-6#1)(2008-7#2)
was to verify##12##3##(1991-9#1)(1992-3#1)(1996-3#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-9#1)
was to##1223##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#5)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#2)(1993-12#13)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#8)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#6)(1996-12#4)(1996-2#4)(1996-3#4)(1996-5#2)(1996-6#3)(1996-9#4)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#13)(2006-10#1)(2006-6#1)(2006-8#2)(2007-10#26)(2007-11#19)(2007-12#12)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#9)(2007-8#39)(2008-1#8)(2008-10#99)(2008-11#44)(2008-12#55)(2008-2#3)(2008-3#11)(2008-4#12)(2008-5#76)(2008-6#21)(2008-7#41)(2008-8#16)(2008-9#30)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#6)(2009-5#13)(2009-6#3)(2009-7#9)(2009-8#10)(2009-9#5)(2010-1#2)(2010-10#9)(2010-11#5)(2010-12#4)(2010-2#8)(2010-3#15)(2010-4#8)(2010-5#11)(2010-6#8)(2010-7#4)(2010-8#7)(2010-9#6)(2011-1#25)(2011-2#80)(2011-7#2)(2012-1#10)(2012-12#17)(2012-2#39)(2012-3#29)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#81)(2013-3#1)(2013-7#15)(2013-8#29)
was tolerant to##2##3##(2008-10#1)(2013-1#1)
was tolerated##2##2##(1991-3#1)(2008-1#1)
was too low##2##3##(2008-10#1)(2008-11#1)
was too small to##3##4##(1991-3#1)(1994-12#1)(2008-10#1)
was too##12##2##(1990-6#1)(1991-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)
was topically##2##2##(2008-5#2)
was total##2##2##(2008-7#1)(2008-9#1)
was totally removed with##2##4##(2006-12#1)(2012-3#1)
was totally removed##4##3##(2006-12#1)(2008-7#2)(2012-3#1)
was totally##12##2##(1992-6#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#4)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
was toxic to##2##3##(2008-10#1)(2008-11#1)
was toxic##6##2##(1992-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)
was traced to the##2##4##(2008-10#1)(2012-2#1)
was traced to##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
was traced##5##2##(2008-10#3)(2009-9#1)(2012-2#1)
was traditionally##2##2##(1991-6#1)(2008-5#1)
was trained as a##2##4##(2010-7#2)
was trained##10##2##(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#2)
was transcribed in##4##3##(1997-3#1)(2008-8#3)
was transcribed##7##2##(1990-12#1)(1993-12#1)(1997-3#2)(2008-8#3)
was transfected into##4##3##(1990-5#2)(1990-8#1)(2008-3#1)
was transfected with##2##3##(1992-9#1)(2008-9#1)
was transfected##9##2##(1990-5#2)(1990-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)
was transferable##2##2##(1996-3#1)(2008-10#1)
was transferred from##3##3##(1991-9#1)(1997-3#1)(2013-1#1)
was transferred into##8##3##(2008-10#3)(2008-11#1)(2008-8#4)
was transferred to a##2##4##(2012-12#1)(2013-8#1)
was transferred to the##5##4##(2011-2#1)(2012-2#1)(2013-1#3)
was transferred to##11##3##(1992-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
was transferred##25##2##(1991-9#1)(1992-3#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-8#4)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
was transformed by##2##3##(2008-8#1)(2010-3#1)
was transformed into a##2##4##(2008-2#1)(2012-1#1)
was transformed into##8##3##(1997-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
was transformed to##2##3##(2008-11#2)
was transformed with a##3##4##(1990-12#1)(1995-11#1)(2008-10#1)
was transformed with##5##3##(1990-12#1)(1995-11#1)(2008-10#2)(2008-8#1)
was transformed##20##2##(1990-12#1)(1992-6#1)(1993-11#1)(1995-11#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#3)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
was transfused in the##2##4##(2007-9#2)
was transfused with##5##3##(1994-12#2)(1994-6#2)(1994-9#1)
was transfused##10##2##(1992-3#1)(1994-12#3)(1994-6#2)(1994-9#1)(1996-3#1)(2007-9#2)
was transient##6##2##(1990-7#1)(1991-12#1)(1994-3#1)(1995-2#1)(2007-6#1)(2008-11#1)
was transiently##5##2##(1995-12#1)(1995-8#1)(1997-2#1)(2008-11#2)
was translated in##2##3##(1994-8#1)(2008-10#1)
was translated into##2##3##(1992-8#1)(2008-10#1)
was translated##6##2##(1992-8#1)(1994-8#1)(2006-10#1)(2008-10#2)(2008-3#1)
was translocated from the cytosol to##2##6##(1992-6#1)(2011-2#1)
was translocated##4##2##(1992-6#1)(1993-2#1)(2008-10#1)(2011-2#1)
was transmissible##2##2##(2008-10#2)
was transmitted by##8##3##(2008-10#7)(2010-1#1)
was transmitted mechanically##2##3##(2008-10#2)
was transmitted##17##2##(1992-6#1)(1996-5#1)(2008-10#13)(2008-12#1)(2010-1#1)
was transplanted into##2##3##(2008-10#1)(2010-11#1)
was transplanted##4##2##(2008-10#1)(2008-5#1)(2010-11#1)(2013-8#1)
was transported by##2##3##(1993-8#1)(2008-10#1)
was transported to the##3##4##(2008-10#3)
was transported to##4##3##(2008-10#4)
was transported##6##2##(1993-8#1)(2008-10#5)
was transposed##2##2##(1992-9#1)(2008-6#1)
was trapped##2##2##(2008-10#1)(2009-2#1)
was treated by surgical##2##4##(2007-8#1)(2011-2#1)
was treated by##14##3##(1990-8#1)(2007-8#2)(2008-10#1)(2008-12#3)(2008-2#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
was treated conservatively##5##3##(2008-12#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
was treated for##3##3##(2009-5#1)(2010-3#1)(2012-2#1)
was treated in##3##3##(1995-3#1)(2011-1#1)(2013-1#1)
was treated medically##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
was treated successfully with##2##4##(2007-8#1)(2009-11#1)
was treated successfully##4##3##(1990-9#1)(2007-8#1)(2008-1#1)(2009-11#1)
was treated surgically using##2##4##(2008-9#1)(2011-2#1)
was treated surgically##6##3##(2008-12#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
was treated using##2##3##(2011-2#1)(2013-1#1)
was treated with 0##2##4##(1996-12#1)(2008-10#1)
was treated with a##2##4##(2008-11#1)(2012-3#1)
was treated with an##2##4##(2008-6#1)(2013-1#1)
was treated with chemotherapy##2##4##(2009-8#1)(2011-2#1)
was treated with ciprofloxacin and##2##5##(2007-7#1)(2011-2#1)
was treated with ciprofloxacin##3##4##(1997-6#1)(2007-7#1)(2011-2#1)
was treated with intravenous antibiotics##2##5##(2006-10#1)(2013-1#1)
was treated with intravenous##4##4##(2006-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
was treated with surgery##2##4##(2010-12#1)(2013-8#1)
was treated with the combination##2##5##(2007-7#1)(2008-12#1)
was treated with the##4##4##(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
was treated with##91##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-6#1)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#2)(1997-6#1)(1997-8#1)(2006-10#6)(2007-10#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#4)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#9)(2013-8#2)
was treated##141##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-3#1)(1996-11#1)(1996-12#3)(1996-5#3)(1996-6#2)(1997-6#1)(1997-8#1)(2006-10#6)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#11)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#2)
was triggered##3##2##(1990-11#1)(2008-10#2)
was true for##2##3##(2008-11#1)(2012-2#1)
was true##6##2##(1996-5#1)(1997-8#1)(2006-4#1)(2008-11#1)(2012-2#2)
was truncated##2##2##(1992-8#1)(1993-8#1)
was tunable##2##2##(2008-2#2)
was tuned from##3##3##(2007-11#2)(2007-12#1)
was tuned##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
was turned##3##2##(1991-8#1)(2008-11#1)(2008-7#1)
was twice as high as##2##5##(2008-10#1)(2008-11#1)
was twice as##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
was twice that in##2##4##(1991-5#1)(2008-10#1)
was twice that of##2##4##(2008-10#1)(2008-11#1)
was twice that##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
was twice##10##2##(1991-5#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)
was two years##2##3##(1993-11#1)(1996-3#1)
was two##7##2##(1993-11#1)(1993-6#2)(1996-3#1)(2008-11#1)(2008-5#1)(2008-7#1)
was two-fold higher in##2##4##(2008-4#2)
was two-fold##3##2##(2007-6#1)(2008-4#2)
was twofold##3##2##(1994-1#1)(1995-2#1)(2010-8#1)
was type##2##2##(1997-6#1)(2007-11#1)
was typical of##4##3##(2008-10#3)(2010-4#1)
was typical##6##2##(2007-11#1)(2008-10#3)(2008-12#1)(2010-4#1)
was typically##8##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-12#1)(2012-12#1)
was ultimately##3##2##(1997-4#1)(2007-7#1)(2009-5#1)
was unable to infect##5##4##(2008-10#5)
was unable to inhibit the##2##5##(1991-8#1)(2008-6#1)
was unable to##22##3##(1991-8#1)(1993-11#1)(1993-3#1)(1995-6#1)(1997-7#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2011-1#1)(2012-2#1)
was unaffected by the##3##4##(1990-7#1)(1991-12#1)(1994-3#1)
was unaffected by##24##3##(1990-2#1)(1990-7#1)(1991-12#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#2)(2008-10#2)(2011-2#2)
was unaffected in##2##3##(1994-12#1)(2008-7#1)
was unaffected##38##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
was unaltered by##2##3##(1991-12#1)(2008-11#1)
was unaltered in##2##3##(1993-12#1)(1996-12#1)
was unaltered##7##2##(1991-12#1)(1993-12#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
was unambiguously##2##2##(2008-10#2)
was unchanged by##2##3##(2008-10#1)(2008-8#1)
was unchanged in##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
was unchanged##21##2##(1990-5#1)(1990-6#1)(1992-6#1)(1994-2#1)(1994-6#2)(1996-5#1)(1996-9#1)(2007-12#1)(2007-8#5)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)
was unclear##6##2##(2007-7#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
was uncommon##5##2##(1993-10#1)(1994-2#1)(2007-7#1)(2008-8#1)(2008-9#1)
was uncomplicated and thus lymphedema##2##5##(2009-3#2)
was uncomplicated##4##2##(1993-9#1)(2009-3#2)(2011-2#1)
was under the##2##3##(1992-8#1)(2008-10#1)
was under##9##2##(1990-5#1)(1992-8#1)(1993-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#2)
was undergoing##3##2##(1992-1#1)(2012-12#1)(2013-7#1)
was understood##2##2##(2007-12#1)(2008-10#1)
was undertaken at a##2##4##(1993-11#1)(2013-1#1)
was undertaken at##3##3##(1993-11#1)(2011-1#1)(2013-1#1)
was undertaken between##3##3##(1994-2#1)(2008-1#1)(2008-10#1)
was undertaken by##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
was undertaken for articles published##5##5##(2012-12#5)
was undertaken in the##4##4##(1996-5#1)(2008-5#1)(2009-6#1)(2012-1#1)
was undertaken in two##2##4##(2008-11#1)(2008-3#1)
was undertaken in##18##3##(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#2)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
was undertaken of##4##3##(1990-12#1)(1994-3#1)(2010-1#1)(2013-1#1)
was undertaken on##3##3##(1990-12#1)(2012-2#1)(2012-3#1)
was undertaken through##2##3##(1991-6#1)(2008-11#1)
was undertaken to analyze##2##4##(2010-8#1)(2012-2#1)
was undertaken to assess whether##2##5##(1993-12#1)(1995-11#1)
was undertaken to assess##6##4##(1991-12#1)(1993-12#1)(1994-6#1)(1995-11#1)(2008-10#1)(2013-7#1)
was undertaken to characterize the##2##5##(2007-7#1)(2008-10#1)
was undertaken to determine the##10##5##(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-12#1)
was undertaken to determine##15##4##(1993-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-6#1)(2012-12#1)
was undertaken to establish the##2##5##(2008-7#1)(2012-2#1)
was undertaken to establish##5##4##(1993-2#1)(2008-10#1)(2008-7#1)(2012-2#2)
was undertaken to estimate##2##4##(2008-10#2)
was undertaken to evaluate the##8##5##(1991-4#1)(1996-1#1)(1996-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
was undertaken to explore the##2##5##(2009-5#1)(2012-3#1)
was undertaken to identify##2##4##(1993-3#1)(2012-12#1)
was undertaken to investigate the##6##5##(1991-2#1)(1994-12#1)(2008-7#1)(2010-3#1)(2012-2#2)
was undertaken to##75##3##(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-4#1)(2007-7#3)(2007-8#1)(2008-10#10)(2008-11#6)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
was undertaken using##4##3##(1997-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
was undertaken with the##2##4##(1990-12#1)(2007-7#1)
was undertaken with##4##3##(1990-12#1)(2007-7#1)(2008-12#1)(2008-5#1)
was undertaken within##2##3##(2008-11#2)
was undertaken##155##2##(1990-12#3)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-5#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#15)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)
was underused##2##2##(2007-10#1)(2008-3#1)
was undetectable in the##2##4##(1994-11#1)(1996-12#1)
was undetectable in##4##3##(1990-5#1)(1991-5#1)(1994-11#1)(1996-12#1)
was undetectable##6##2##(1990-5#1)(1991-5#1)(1994-11#1)(1996-12#1)(2008-10#1)(2012-3#1)
was undetected in##2##3##(1997-6#2)
was undetected##3##2##(1997-6#2)(2008-10#1)
was uneven##3##2##(1992-5#1)(2008-8#1)(2008-9#1)
was unevenly distributed##2##3##(2008-10#2)
was uneventful without##2##3##(2010-12#1)(2012-2#1)
was uneventful##22##2##(1991-11#1)(1996-8#1)(2006-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
was unexpectedly##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
was uniformly##4##2##(1991-8#1)(2008-10#1)(2008-9#1)(2009-7#1)
was unique in that##2##4##(1994-5#1)(2009-8#1)
was unique##5##2##(1991-9#1)(1994-5#1)(2008-10#1)(2009-8#1)(2011-2#1)
was uniquely##3##2##(2008-10#1)(2009-7#1)(2009-8#1)
was unknown##4##2##(1994-11#1)(2008-10#2)(2012-2#1)
was unlikely##5##2##(1992-2#1)(1995-6#1)(2008-10#1)(2009-3#1)(2010-2#1)
was unrelated to the##2##4##(2008-7#1)(2013-1#1)
was unrelated to##8##3##(1994-11#1)(1994-9#1)(2008-10#2)(2008-7#1)(2009-4#1)(2013-1#2)
was unremarkable##2##2##(2007-2#1)(2013-1#1)
was unresponsive to##3##3##(2007-8#1)(2011-2#2)
was unstable in##2##3##(2008-10#1)(2008-11#1)
was unstable##4##2##(1990-7#1)(2008-10#2)(2008-11#1)
was unsuccessful##11##2##(1992-11#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-3#2)(2013-1#2)
was unsuitable##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
was unusual in##2##3##(1993-9#1)(2009-7#1)
was up to##17##3##(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-8#3)(2012-2#1)(2013-8#1)
was up-regulated after##2##3##(2010-4#1)(2013-1#1)
was up-regulated in##3##3##(1995-11#1)(2008-10#1)(2010-4#1)
was up-regulated##6##2##(1995-11#1)(2008-10#1)(2010-4#2)(2012-3#1)(2013-1#1)
was upregulated in##5##3##(1996-12#1)(2009-4#1)(2010-12#2)(2013-7#1)
was upregulated##7##2##(1993-6#1)(1996-12#1)(2008-1#1)(2009-4#1)(2010-12#2)(2013-7#1)
was urgently##3##2##(2008-12#1)(2010-1#1)(2011-3#1)
was used after##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
was used alone##3##3##(1993-12#1)(2008-10#1)(2009-9#1)
was used and a##3##4##(1991-5#1)(2008-10#1)(2013-8#1)
was used and the##11##4##(1990-8#1)(2008-10#9)(2008-8#1)
was used and##20##3##(1990-8#1)(1991-5#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-7#1)(2013-8#1)
was used as a control##3##5##(1995-12#1)(2008-11#1)(2008-5#1)
was used as a fluorescent##2##5##(1991-5#1)(2008-10#1)
was used as a functional##2##5##(1997-7#1)(2010-4#1)
was used as a measure of##2##6##(1990-2#1)(1991-4#1)
was used as a model to##2##6##(1993-12#1)(1993-9#1)
was used as a model##4##5##(1993-12#1)(1993-9#1)(1994-9#1)(2008-10#1)
was used as a positive##2##5##(1992-12#1)(1996-12#1)
was used as a probe##6##5##(1991-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
was used as a pump##2##5##(2007-11#1)(2007-12#1)
was used as a reference##3##5##(1993-8#1)(2008-10#1)(2012-2#1)
was used as a sample##3##5##(2008-10#2)(2010-5#1)
was used as a solid##2##5##(2008-10#2)
was used as a substrate##2##5##(1993-6#1)(2008-10#1)
was used as a support material for##2##7##(2008-10#2)
was used as a target##2##5##(1997-7#1)(2008-10#1)
was used as a working electrode in##2##7##(2008-10#2)
was used as a working electrode##3##6##(2008-10#3)
was used as a##96##4##(1990-2#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1992-12#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-12#3)(2008-10#46)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-7#1)
was used as amperometric##2##4##(2008-10#2)
was used as an affinity##2##5##(2008-7#1)(2010-5#1)
was used as an amperometric##3##5##(2008-10#3)
was used as an indicator electrode##4##6##(2008-10#4)
was used as an indicator of##2##6##(2008-10#1)(2008-5#1)
was used as an indicator##8##5##(2007-10#1)(2008-10#5)(2008-5#1)(2008-7#1)
was used as an internal standard##8##6##(1993-3#1)(2008-10#7)
was used as an internal##9##5##(1993-3#1)(2008-10#7)(2008-2#1)
was used as an##40##4##(1993-3#2)(1994-6#1)(2007-10#1)(2008-10#27)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2012-2#1)
was used as both supporting electrolyte and##2##7##(2008-10#2)
was used as chemical modifier##4##5##(2008-10#4)
was used as control##4##4##(1993-11#1)(2008-12#1)(2008-5#1)(2013-7#1)
was used as internal standard##5##5##(2008-10#5)
was used as internal##6##4##(2008-10#6)
was used as model##3##4##(1990-12#1)(2008-10#2)
was used as primary##2##4##(1990-11#1)(2012-3#1)
was used as reference##2##4##(2008-1#1)(2012-3#1)
was used as template##2##4##(2008-10#1)(2008-9#1)
was used as the analytical##2##5##(2008-10#2)
was used as the chemical modifier##3##6##(2008-10#3)
was used as the indicator##2##5##(2008-10#2)
was used as the internal standard##2##6##(2008-10#2)
was used as the light source##2##6##(2007-12#1)(2008-10#1)
was used as the mobile phase##5##6##(1990-8#2)(2008-10#1)(2011-1#2)
was used as the model##2##5##(2008-10#1)(2008-7#1)
was used as the pump##2##5##(2008-2#1)(2008-3#1)
was used as the reference##2##5##(2008-11#1)(2011-1#1)
was used as the sole##3##5##(1995-6#1)(2008-6#1)(2008-7#1)
was used as the substrate##2##5##(1990-12#1)(2008-6#1)
was used as the##67##4##(1990-12#1)(1990-8#4)(1992-3#1)(1992-6#1)(1993-9#1)(1995-6#1)(2007-12#2)(2008-10#35)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#2)(2011-1#6)
was used as working electrode##2##5##(2008-10#2)
was used as##273##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#6)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#152)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#7)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#2)(2010-4#1)(2010-5#3)(2011-1#6)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#2)(2013-7#2)
was used at pH 7##2##5##(2008-10#2)
was used at##5##3##(2008-10#3)(2008-5#1)(2013-1#1)
was used by##9##3##(1993-10#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
was used for a##5##4##(2008-1#1)(2008-10#2)(2010-10#1)(2012-12#1)
was used for analysis##2##4##(2008-10#2)
was used for both##2##4##(2007-11#1)(2007-12#1)
was used for comparison##2##4##(2008-10#1)(2010-4#1)
was used for data analysis##3##5##(2008-10#1)(2010-11#1)(2011-1#1)
was used for data collection##2##5##(2009-11#1)(2013-8#1)
was used for data##7##4##(2008-10#1)(2008-11#1)(2009-11#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
was used for detection of##2##5##(2008-10#1)(2008-2#1)
was used for detection##3##4##(2008-10#2)(2008-2#1)
was used for determination of##6##5##(2008-10#6)
was used for determining##2##4##(1995-2#1)(2008-7#1)
was used for evaluating##2##4##(2008-10#2)
was used for evaluation of##2##5##(2008-7#2)
was used for fabrication of##2##5##(2008-10#1)(2008-3#1)
was used for genomic##2##4##(1995-12#1)(2008-10#1)
was used for identification##2##4##(2008-10#2)
was used for imaging##2##4##(2007-12#2)
was used for measuring the##2##5##(2008-8#1)(2013-1#1)
was used for numerical##2##4##(2008-10#1)(2008-2#1)
was used for preconcentration of##2##5##(2008-10#2)
was used for quantification##2##4##(2008-10#1)(2008-11#1)
was used for statistical analysis##2##5##(1994-9#1)(2012-3#1)
was used for statistical##3##4##(1994-9#1)(2008-10#1)(2012-3#1)
was used for the analysis##2##5##(2008-10#1)(2008-9#1)
was used for the assay of##2##6##(2008-10#2)
was used for the detection of##2##6##(2008-10#2)
was used for the determination of trace##3##7##(2008-10#3)
was used for the determination of##22##6##(1991-5#1)(1996-5#1)(2007-12#1)(2008-10#19)
was used for the development of a##2##7##(2008-10#1)(2013-1#1)
was used for the electroanalytical determination of##2##7##(2008-10#2)
was used for the evaluation of##3##6##(2008-10#1)(2010-3#1)(2012-2#1)
was used for the first time to##3##7##(2008-10#2)(2013-8#1)
was used for the immobilization of##2##6##(2008-10#2)
was used for the quantitative determination of##3##7##(2008-10#3)
was used for the quantitative##4##5##(2008-10#4)
was used for the simultaneous##3##5##(2008-1#1)(2008-10#2)
was used for the##97##4##(1991-2#1)(1991-5#1)(1993-2#1)(1994-11#1)(1996-5#3)(2007-12#1)(2008-1#1)(2008-10#69)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
was used for this purpose##3##5##(2008-10#3)
was used for this##4##4##(2008-10#3)(2008-2#1)
was used for##265##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-1#2)(1996-5#3)(1997-2#3)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#6)(2007-8#2)(2008-1#4)(2008-10#143)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#5)
was used here as a##3##5##(1990-2#1)(2008-10#1)(2008-7#1)
was used here##4##3##(1990-2#1)(2008-10#2)(2008-7#1)
was used in a##8##4##(1996-11#1)(1996-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)
was used in all##3##4##(2007-7#1)(2008-10#1)(2009-3#1)
was used in combination with a##2##6##(2007-12#2)
was used in combination with##3##5##(2007-12#2)(2008-10#1)
was used in conjunction with a##2##6##(2008-10#1)(2008-3#1)
was used in conjunction with##8##5##(1996-5#1)(2008-10#4)(2008-3#1)(2008-8#2)
was used in determination of##2##5##(2008-10#2)
was used in order to determine##3##6##(2007-10#1)(2008-10#2)
was used in order to##8##5##(2007-10#1)(2008-10#5)(2008-12#1)(2008-7#1)
was used in the study##3##5##(1996-1#1)(2007-7#1)(2008-10#1)
was used in the##27##4##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-7#1)(1996-1#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-8#1)(2012-6#1)
was used in this study##6##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-7#1)
was used in this##7##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-7#1)
was used in##117##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-4#3)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#40)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2009-12#2)(2009-3#3)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-6#1)(2013-7#1)(2013-8#1)
was used instead of##2##4##(1990-11#1)(2008-10#1)
was used not only##2##4##(1995-1#1)(2008-10#1)
was used on##6##3##(1990-3#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
was used prior to##3##4##(1992-2#1)(2008-10#2)
was used successfully for the##2##5##(2008-10#2)
was used successfully for##3##4##(2008-10#2)(2008-2#1)
was used successfully in the##2##5##(2008-10#2)
was used successfully##5##3##(2008-10#4)(2008-2#1)
was used through##2##3##(1992-1#1)(2013-1#1)
was used throughout##2##3##(1996-5#1)(2008-10#1)
was used to achieve the##2##5##(2013-8#2)
was used to achieve##8##4##(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-8#2)
was used to aid##2##4##(2008-11#1)(2008-7#1)
was used to amplify a##3##5##(1992-8#1)(1993-8#1)(2008-10#1)
was used to amplify##7##4##(1991-7#1)(1992-6#1)(1992-8#1)(1993-8#1)(1996-5#1)(2008-10#2)
was used to analyse the##2##5##(1997-4#1)(2008-12#1)
was used to analyse##3##4##(1997-4#1)(2008-12#1)(2010-3#1)
was used to analyze the##6##5##(1992-1#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
was used to analyze##14##4##(1992-1#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
was used to assay##2##4##(1996-12#1)(2008-11#1)
was used to assess the##11##5##(2007-11#1)(2008-10#5)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
was used to assess##24##4##(1993-1#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
was used to calculate the##5##5##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
was used to calculate##9##4##(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2013-8#1)
was used to catalyze##2##4##(2008-7#1)(2009-6#1)
was used to characterise##2##4##(2008-10#1)(2008-5#1)
was used to characterize the interfacial##3##6##(2008-10#3)
was used to characterize the##4##5##(2008-10#4)
was used to characterize##10##4##(1991-9#1)(1993-11#1)(2008-10#6)(2012-2#1)(2012-3#1)
was used to collect the data##2##6##(2008-9#1)(2013-8#1)
was used to collect the##3##5##(2008-10#1)(2008-9#1)(2013-8#1)
was used to collect##9##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
was used to compare the##8##5##(1991-5#1)(1995-5#1)(1996-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-6#1)
was used to compare with##2##5##(2008-1#1)(2008-10#1)
was used to compare##16##4##(1991-5#1)(1994-5#1)(1995-5#1)(1996-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-6#2)(2010-9#2)(2012-1#1)
was used to compress the##2##5##(2007-12#2)
was used to compute##2##4##(2008-3#1)(2009-5#1)
was used to concentrate##3##4##(2008-10#3)
was used to conduct the##2##5##(2010-3#1)(2013-8#1)
was used to confirm the##2##5##(2008-10#2)
was used to confirm##6##4##(1997-3#1)(2008-10#3)(2008-2#1)(2010-11#1)
was used to construct a recombinant##2##6##(1992-3#1)(2008-8#1)
was used to construct a##11##5##(1990-7#1)(1992-3#1)(1996-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
was used to construct the##2##5##(2008-3#1)(2008-8#1)
was used to construct##14##4##(1990-7#1)(1992-3#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-1#1)
was used to control##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
was used to create the##2##5##(2009-7#1)(2012-2#1)
was used to create##6##4##(1995-5#1)(2009-11#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
was used to demonstrate that##4##5##(1991-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
was used to demonstrate the##6##5##(1994-11#1)(2008-10#4)(2008-11#1)
was used to demonstrate##12##4##(1991-2#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-7#1)
was used to derive##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
was used to describe the##2##5##(1996-5#1)(2006-8#1)
was used to describe##4##4##(1996-5#1)(1997-8#1)(2006-8#1)(2007-8#1)
was used to design the##2##5##(2008-10#1)(2008-3#1)
was used to design##3##4##(2008-10#2)(2008-3#1)
was used to detect the##6##5##(1995-3#1)(2008-10#2)(2008-4#1)(2010-3#1)(2010-4#1)
was used to detect##24##4##(1990-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#1)(2009-3#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
was used to determine the amount of##2##7##(2008-10#2)
was used to determine the concentration of##3##7##(1991-12#1)(2008-10#2)
was used to determine the spatial distribution of##2##8##(2008-10#2)
was used to determine the stoichiometry of##2##7##(1993-8#1)(1995-11#1)
was used to determine the##33##5##(1990-8#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-8#1)(1995-11#1)(1996-7#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#2)(2011-2#1)
was used to determine these##2##5##(2008-10#2)
was used to determine whether##3##5##(1993-8#1)(2008-10#1)(2013-8#1)
was used to determine##70##4##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-8#3)(1995-11#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#38)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-8#1)
was used to develop a##6##5##(1990-12#1)(1991-6#1)(1994-5#1)(2008-10#2)(2008-6#1)
was used to develop an##5##5##(1993-3#1)(2008-10#4)
was used to develop the##3##5##(2008-10#3)
was used to develop##17##4##(1990-12#1)(1991-6#1)(1993-3#1)(1994-5#1)(2008-10#12)(2008-6#1)
was used to discriminate##2##4##(2007-11#1)(2013-8#1)
was used to eliminate##2##4##(2008-10#1)(2008-2#1)
was used to enhance the##5##5##(1990-11#1)(2008-10#3)(2008-6#1)
was used to establish the##2##5##(2008-10#1)(2013-1#1)
was used to establish##5##4##(1990-12#1)(1995-11#1)(2008-10#2)(2013-1#1)
was used to estimate the##10##5##(1995-1#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)
was used to estimate##15##4##(1995-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#1)(2011-2#1)
was used to evaluate a model##2##6##(2008-10#1)(2008-6#1)
was used to evaluate the effects of##4##7##(1996-2#1)(1997-2#1)(2008-11#1)(2009-11#1)
was used to evaluate the##21##5##(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
was used to evaluate##37##4##(1990-12#1)(1991-12#2)(1991-3#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-6#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)
was used to examine the##12##5##(1991-10#1)(1991-12#1)(1991-5#1)(1995-3#1)(2008-10#4)(2008-8#1)(2009-7#1)(2012-3#1)(2013-1#1)
was used to examine whether##2##5##(1996-7#1)(2008-10#1)
was used to examine##21##4##(1991-10#1)(1991-12#1)(1991-5#1)(1995-3#1)(1996-12#1)(1996-7#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
was used to explore the##2##5##(2008-1#1)(2008-6#1)
was used to explore##6##4##(1994-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)
was used to extend the##2##5##(2008-10#1)(2009-3#1)
was used to extract##9##4##(2008-10#9)
was used to fabricate##4##4##(2008-10#1)(2008-12#1)(2008-2#1)(2013-1#1)
was used to find the##5##5##(2008-10#3)(2008-6#1)(2012-12#1)
was used to find##9##4##(2008-10#7)(2008-6#1)(2012-12#1)
was used to follow##3##4##(1990-11#1)(1996-12#1)(2008-10#1)
was used to generate an optical##2##6##(2008-10#1)(2008-2#1)
was used to generate##12##4##(1994-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)
was used to identify a##5##5##(1990-11#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
was used to identify the##7##5##(1990-11#1)(1996-5#1)(2008-10#2)(2008-12#1)(2010-6#1)(2013-7#1)
was used to identify##39##4##(1990-11#3)(1990-12#1)(1993-6#1)(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was used to image the##2##5##(2007-11#1)(2008-2#1)
was used to improve the##2##5##(2008-10#2)
was used to indicate the##2##5##(1992-8#1)(2008-12#1)
was used to indicate##3##4##(1991-6#1)(1992-8#1)(2008-12#1)
was used to induce##3##4##(2008-8#1)(2008-9#1)(2010-12#1)
was used to initiate##2##4##(2008-10#2)
was used to introduce##3##4##(1994-5#1)(2008-10#1)(2008-6#1)
was used to investigate the##18##5##(1990-2#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#1)(2013-8#1)
was used to investigate##24##4##(1990-2#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
was used to isolate genomic##2##5##(1990-11#1)(2008-10#1)
was used to isolate##8##4##(1990-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-4#1)(2010-5#1)
was used to locate##2##4##(2008-10#1)(2013-7#1)
was used to manage##2##4##(2010-3#1)(2013-1#1)
was used to map##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
was used to measure both##2##5##(2008-10#1)(2008-3#1)
was used to measure the##17##5##(1992-12#1)(1993-11#1)(1995-12#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2010-9#1)(2011-1#1)(2011-3#1)
was used to measure##41##4##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-12#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2013-1#3)
was used to minimize the##3##5##(1992-12#1)(1995-2#1)(2008-2#1)
was used to minimize##4##4##(1992-12#1)(1994-9#1)(1995-2#1)(2008-2#1)
was used to model the##3##5##(1997-1#1)(2008-10#1)(2008-3#1)
was used to model##5##4##(1997-1#1)(2008-10#1)(2008-3#2)(2010-6#1)
was used to modify##2##4##(1992-9#1)(2008-10#1)
was used to monitor the##9##5##(2008-10#8)(2008-11#1)
was used to monitor##16##4##(1991-5#1)(2008-10#12)(2008-11#1)(2008-7#1)(2010-5#1)
was used to observe the##4##5##(2007-10#1)(2008-10#3)
was used to observe##6##4##(1993-3#1)(2007-10#1)(2008-10#3)(2008-5#1)
was used to obtain an##2##5##(1994-5#1)(2008-2#1)
was used to obtain the##5##5##(1993-8#1)(2008-10#2)(2012-2#1)(2013-8#1)
was used to obtain##16##4##(1993-8#1)(1994-3#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
was used to optimize the##3##5##(2008-10#3)
was used to optimize##4##4##(2008-10#3)(2008-5#1)
was used to perform##7##4##(2008-10#2)(2008-2#2)(2013-1#1)(2013-8#2)
was used to place##2##4##(2008-10#1)(2008-5#1)
was used to predict the##2##5##(2008-3#2)
was used to predict##5##4##(1996-12#1)(2008-10#2)(2008-3#2)
was used to prepare a##2##5##(1990-11#1)(2008-10#1)
was used to prepare the##5##5##(2008-10#3)(2012-1#1)(2013-7#1)
was used to prepare##7##4##(1990-11#1)(2008-10#4)(2012-1#1)(2013-7#1)
was used to produce##4##4##(1997-4#1)(2008-11#2)(2008-2#1)
was used to provide a##2##5##(1996-3#1)(1997-8#1)
was used to provide##5##4##(1996-3#1)(1997-8#1)(2008-3#1)(2008-8#1)(2011-1#1)
was used to quantify the##2##5##(1990-7#1)(2008-11#1)
was used to quantify##6##4##(1990-7#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-12#1)
was used to quantitate##2##4##(1992-12#1)(2008-1#1)
was used to quantitatively determine##2##5##(2007-5#1)(2008-10#1)
was used to quantitatively##4##4##(2007-5#1)(2008-10#1)(2008-9#1)(2009-7#1)
was used to rapidly##2##4##(1994-6#1)(2008-10#1)
was used to record the##2##5##(2007-10#1)(2009-8#1)
was used to record##3##4##(2007-10#1)(2009-8#1)(2012-2#1)
was used to recover##2##4##(2008-10#1)(2013-1#1)
was used to reduce the##2##5##(1995-12#1)(2008-10#1)
was used to reduce##3##4##(1995-12#1)(2007-11#1)(2008-10#1)
was used to relate##2##4##(2008-10#2)
was used to remove the##3##5##(2008-10#2)(2008-2#1)
was used to remove##6##4##(1990-12#1)(1995-2#1)(2008-10#3)(2008-2#1)
was used to scan##3##4##(2008-2#2)(2008-9#1)
was used to screen##5##4##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
was used to seal the##2##5##(2008-10#1)(2013-8#1)
was used to select the number of factors##4##8##(2008-10#4)
was used to select the##8##5##(2008-10#7)(2008-11#1)
was used to select##13##4##(2008-10#9)(2008-11#1)(2009-9#1)(2010-3#1)(2012-12#1)
was used to separate##3##4##(1992-12#1)(2008-10#2)
was used to show that the##2##6##(1990-8#1)(2008-10#1)
was used to show that##4##5##(1990-8#1)(1991-3#1)(2008-10#2)
was used to study the effect of##2##7##(1990-2#1)(1993-8#1)
was used to study the##23##5##(1990-12#1)(1990-2#1)(1993-6#1)(1993-8#2)(1995-12#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-1#1)(2012-1#1)
was used to study##31##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-12#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-1#1)(2012-1#1)
was used to support##2##4##(2008-10#1)(2011-9#1)
was used to test a##2##5##(2008-12#1)(2008-3#1)
was used to test the##7##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2013-1#1)
was used to test##16##4##(1990-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-2#1)(2012-3#1)(2013-1#2)
was used to the determination of##2##6##(2008-10#2)
was used to the##4##4##(2008-10#4)
was used to transduce##2##4##(1992-12#1)(2008-8#1)
was used to transform##4##4##(1990-5#1)(1995-2#1)(1997-7#1)(2008-10#1)
was used to validate the##5##5##(2008-10#1)(2008-3#1)(2011-2#3)
was used to verify the##3##5##(1997-4#1)(2008-10#1)(2010-5#1)
was used to##890##3##(1990-11#9)(1990-12#8)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#7)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#6)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#1)(1996-12#5)(1996-2#6)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#4)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#6)(1997-6#4)(1997-7#3)(1997-8#4)(2006-10#1)(2006-8#1)(2007-10#3)(2007-11#12)(2007-12#14)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#307)(2008-11#33)(2008-12#8)(2008-2#33)(2008-3#40)(2008-4#3)(2008-5#15)(2008-6#8)(2008-7#15)(2008-8#17)(2008-9#11)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#7)(2010-4#3)(2010-5#8)(2010-6#6)(2010-8#2)(2010-9#4)(2011-1#16)(2011-2#12)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#10)(2012-2#9)(2012-3#8)(2013-1#24)(2013-7#4)(2013-8#19)
was used which##2##3##(1994-12#1)(2012-12#1)
was used with a##3##4##(1993-6#1)(2008-11#1)(2011-1#1)
was used with information##2##4##(2007-11#1)(2013-1#1)
was used with the##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
was used with##14##3##(1993-6#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
was used without##2##3##(2008-10#1)(2008-6#1)
was used##1856##2##(1990-10#1)(1990-11#14)(1990-12#12)(1990-2#5)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#13)(1990-9#1)(1991-10#2)(1991-12#7)(1991-2#5)(1991-3#3)(1991-4#4)(1991-5#8)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#4)(1992-12#9)(1992-2#4)(1992-3#4)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#6)(1993-6#5)(1993-8#8)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#1)(1994-5#10)(1994-6#7)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-11#3)(1995-12#10)(1995-2#9)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#7)(1996-3#2)(1996-5#12)(1996-6#4)(1996-7#4)(1997-1#3)(1997-2#10)(1997-3#5)(1997-4#9)(1997-6#6)(1997-7#5)(1997-8#7)(2006-10#1)(2006-6#2)(2006-8#2)(2007-10#8)(2007-11#25)(2007-12#34)(2007-2#1)(2007-5#4)(2007-6#1)(2007-7#8)(2007-8#15)(2008-1#14)(2008-10#728)(2008-11#55)(2008-12#18)(2008-2#54)(2008-3#75)(2008-4#7)(2008-5#38)(2008-6#16)(2008-7#40)(2008-8#36)(2008-9#24)(2009-10#4)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#7)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#8)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#13)(2010-4#5)(2010-5#15)(2010-6#6)(2010-7#1)(2010-8#5)(2010-9#6)(2011-1#27)(2011-2#27)(2011-3#5)(2011-9#1)(2012-1#4)(2012-12#18)(2012-2#19)(2012-3#14)(2012-6#1)(2012-7#1)(2013-1#51)(2013-7#9)(2013-8#31)
was used) was##2##3##(2008-10#1)(2008-3#1)
was useful for##10##3##(2007-10#1)(2008-10#6)(2008-3#1)(2008-9#1)(2010-8#1)
was useful in the##3##4##(1994-12#1)(2008-10#2)
was useful in##9##3##(1990-2#1)(1994-12#1)(2008-10#5)(2008-9#1)(2009-4#1)
was useful to##6##3##(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2011-2#1)
was useful##27##2##(1990-2#1)(1992-12#1)(1994-12#1)(2007-10#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)
was usually##3##2##(1991-6#1)(2008-10#1)(2008-7#1)
was utilised for##2##3##(2008-10#2)
was utilised in##2##3##(2008-10#1)(2008-11#1)
was utilised to##2##3##(2008-11#2)
was utilised##9##2##(1997-2#1)(2007-9#1)(2008-10#4)(2008-11#3)
was utilized as a##4##4##(1991-4#1)(1992-3#1)(2008-10#1)(2008-11#1)
was utilized as##5##3##(1991-4#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
was utilized for sample##2##4##(2008-10#2)
was utilized for the##2##4##(2008-10#1)(2008-2#1)
was utilized for##12##3##(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2012-2#1)
was utilized in the##2##4##(1997-4#1)(2010-10#1)
was utilized in##6##3##(1991-3#1)(1997-4#1)(2008-10#1)(2010-10#1)(2012-2#2)
was utilized to assess##3##4##(1992-10#1)(1996-1#1)(2013-8#1)
was utilized to detect##2##4##(2008-10#1)(2013-1#1)
was utilized to determine the##3##5##(2008-10#1)(2008-12#1)(2010-4#1)
was utilized to estimate the##2##5##(2008-11#1)(2010-3#1)
was utilized to examine the##2##5##(2007-12#1)(2012-12#1)
was utilized to examine##3##4##(2007-12#1)(2008-11#1)(2012-12#1)
was utilized to map the##2##5##(1995-2#1)(2008-10#1)
was utilized to##29##3##(1990-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1995-2#1)(1996-1#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was utilized##61##2##(1990-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-12#3)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
was validated by analysis of the certified reference##2##8##(2008-10#2)
was validated by analysis##3##4##(2008-10#3)
was validated by comparing the##2##5##(2008-10#2)
was validated by the analysis of##2##6##(2008-10#2)
was validated by the##4##4##(2008-10#3)(2012-1#1)
was validated by using##2##4##(2008-10#1)(2010-2#1)
was validated by##25##3##(1996-3#1)(2008-10#18)(2008-7#1)(2009-9#1)(2010-2#1)(2012-1#1)(2013-8#2)
was validated for the##2##4##(2008-10#2)
was validated for##6##3##(2008-10#6)
was validated in##5##3##(2008-10#2)(2010-3#1)(2012-2#2)
was validated using two##2##4##(2008-10#2)
was validated using##10##3##(1997-2#1)(2008-10#9)
was validated with a##3##4##(2008-10#3)
was validated with##9##3##(2008-10#7)(2008-11#1)(2013-1#1)
was validated##72##2##(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#51)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#2)
was vaporized at##2##3##(1991-2#1)(2008-10#1)
was vaporized##3##2##(1991-2#1)(2008-10#2)
was variability in##2##3##(2012-2#1)(2013-1#1)
was variability##4##2##(1990-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
was variable##12##2##(1993-2#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2011-2#1)
was varied between##4##3##(2007-8#1)(2008-12#3)
was varied by the##2##4##(1994-11#1)(2010-4#1)
was varied by##5##3##(1992-6#1)(1994-11#1)(2009-11#2)(2010-4#1)
was varied from 0 to##2##5##(2008-7#1)(2011-2#1)
was varied from##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
was varied in response to##2##5##(2008-10#2)
was varied in##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
was varied##25##2##(1992-6#1)(1993-3#1)(1994-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2011-2#1)
was verified by the##7##4##(1990-5#1)(2008-10#5)(2010-4#1)
was verified by##27##3##(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1997-2#1)(2008-10#15)(2008-3#1)(2008-4#1)(2010-4#1)
was verified in a##2##4##(2008-11#1)(2008-5#1)
was verified in the##3##4##(2008-10#3)
was verified in##6##3##(2008-10#4)(2008-11#1)(2008-5#1)
was verified that the##2##4##(2008-10#1)(2008-11#1)
was verified that##4##3##(2008-10#3)(2008-11#1)
was verified through##2##3##(2008-10#2)
was verified to be##2##4##(2008-10#1)(2008-5#1)
was verified to##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
was verified using##2##3##(2012-2#1)(2013-1#1)
was verified with##2##3##(2010-4#1)(2012-3#1)
was verified##60##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1997-2#1)(2008-10#30)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
was very close to##3##4##(2008-5#1)(2012-2#2)
was very common##2##3##(1997-3#1)(2012-12#1)
was very effective for##2##4##(2008-10#1)(2013-1#1)
was very effective in##2##4##(1992-3#1)(1995-3#1)
was very effective##4##3##(1992-3#1)(1995-3#1)(2008-10#1)(2013-1#1)
was very fast##2##3##(2008-10#1)(2010-5#1)
was very good##8##3##(1994-8#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#3)(2009-11#1)
was very high in both##2##5##(2008-7#1)(2008-9#1)
was very high in##3##4##(2008-1#1)(2008-7#1)(2008-9#1)
was very high##11##3##(1991-12#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-9#1)
was very important##3##3##(1997-1#1)(2008-1#2)
was very low##16##3##(1990-8#1)(1992-11#1)(1992-9#1)(1995-9#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2012-3#1)
was very similar to that of the##2##7##(1991-7#1)(2008-5#1)
was very similar to that of##4##6##(1991-7#1)(1993-2#1)(2008-5#1)(2008-6#1)
was very similar to that##5##5##(1991-7#1)(1993-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
was very similar to the##2##5##(2008-10#2)
was very similar to##8##4##(1991-7#1)(1993-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)
was very similar##10##3##(1991-7#1)(1993-2#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
was very simple##3##3##(2008-10#3)
was very small##2##3##(2008-10#1)(2011-2#1)
was very stable##2##3##(2008-10#2)
was very weak##2##3##(2013-8#2)
was very##112##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
was via##2##2##(2009-6#1)(2011-2#1)
was viable##2##2##(2008-10#1)(2012-12#1)
was viewed##3##2##(2008-11#1)(2008-12#1)(2009-9#1)
was violated by##2##3##(1995-2#1)(2008-8#1)
was violated##3##2##(1995-12#1)(1995-2#1)(2008-8#1)
was virtually identical to that of##2##6##(1996-7#1)(2008-10#1)
was virtually##5##2##(1993-9#1)(1995-12#1)(1996-7#1)(2008-10#1)(2011-1#1)
was virulent##2##2##(2008-10#2)
was visible in the##2##4##(2008-5#1)(2009-8#1)
was visible##8##2##(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-2#1)
was visualised##2##2##(1996-5#1)(2008-8#1)
was visualized as a##2##4##(1996-5#1)(2008-10#1)
was visualized by##2##3##(1992-8#1)(2011-2#1)
was visualized in##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2009-4#1)
was visualized using##2##3##(1996-6#1)(2007-7#1)
was visualized##15##2##(1992-8#1)(1996-5#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-9#3)(2009-4#1)(2011-2#1)
was washed and##2##3##(1991-5#1)(1992-6#1)
was washed with##2##3##(1991-5#1)(2008-10#1)
was washed##4##2##(1991-5#2)(1992-6#1)(2008-10#1)
was weak##7##2##(1993-8#1)(2008-10#3)(2008-3#1)(2008-8#2)
was weakly associated with##2##4##(2007-12#1)(2008-8#1)
was weakly inhibited by##2##4##(1992-3#1)(2009-9#1)
was weakly##9##2##(1992-3#1)(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-9#1)
was weaned from##3##3##(2007-9#1)(2012-2#2)
was well accepted by##2##4##(1994-8#1)(2012-3#1)
was well below##2##3##(1992-12#1)(2010-11#1)
was well described by a##4##5##(1995-8#1)(2008-10#3)
was well described by##5##4##(1995-8#1)(2008-10#4)
was well tolerated and##4##4##(2007-11#1)(2008-7#2)(2011-2#1)
was well tolerated by the skin and provided significant##2##9##(2008-5#2)
was well tolerated by##5##4##(1992-12#1)(1993-5#1)(2007-8#1)(2008-5#2)
was well tolerated in the##2##5##(1993-11#1)(2007-11#1)
was well tolerated in##3##4##(1993-11#1)(2007-11#1)(2008-3#1)
was well tolerated##24##3##(1990-6#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
was well##48##2##(1990-2#1)(1990-6#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
was well-tolerated and##3##3##(2008-1#1)(2008-5#2)
was well-tolerated##7##2##(2008-1#1)(2008-5#6)
was whether##12##2##(1992-8#1)(1996-11#1)(1997-3#1)(2007-8#9)
was white##2##2##(2007-12#1)(2008-11#1)
was widely distributed##2##3##(2008-10#1)(2010-8#1)
was widely##6##2##(1992-2#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-8#1)
was widespread##2##2##(2008-10#2)
was willing to##2##3##(1991-5#1)(2013-1#1)
was with the##3##3##(2008-10#2)(2011-2#1)
was with##8##2##(2007-10#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#1)
was withdrawn##3##2##(1990-7#1)(2007-9#1)(2008-10#1)
was within +/-20%##2##3##(2008-10#2)
was within normal range in##3##5##(2007-7#3)
was within normal##4##3##(1993-2#1)(2007-7#3)
was within the range##2##4##(2008-9#1)(2010-11#1)
was within the##4##3##(2008-3#1)(2008-9#1)(2010-11#1)(2012-12#1)
was within##22##2##(1993-2#1)(1996-5#1)(2007-7#3)(2008-10#10)(2008-3#3)(2008-9#1)(2009-10#1)(2010-11#1)(2012-12#1)
was without effect on##5##4##(1991-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)
was without effect##11##3##(1991-6#1)(1992-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-8#1)
was without##13##2##(1991-6#1)(1992-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-8#1)
was worked out##2##3##(1990-2#1)(2008-11#1)
was wrapped##3##2##(2008-7#1)(2010-3#1)(2011-2#1)
was written in##4##3##(1994-3#2)(2008-10#2)
was written##23##2##(1993-3#1)(1994-3#2)(1996-5#1)(2007-8#12)(2008-10#3)(2008-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
was ~0##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
was ~1##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
was##49196##1##(1990-10#52)(1990-11#205)(1990-12#282)(1990-2#231)(1990-3#108)(1990-4#3)(1990-5#268)(1990-6#124)(1990-7#158)(1990-8#225)(1990-9#68)(1991-1#36)(1991-10#23)(1991-11#85)(1991-12#267)(1991-2#208)(1991-3#114)(1991-4#34)(1991-5#206)(1991-6#139)(1991-7#34)(1991-8#158)(1991-9#156)(1992-1#42)(1992-10#72)(1992-11#126)(1992-12#213)(1992-2#116)(1992-3#286)(1992-4#35)(1992-5#94)(1992-6#192)(1992-7#16)(1992-8#175)(1992-9#159)(1993-1#85)(1993-10#17)(1993-11#151)(1993-12#312)(1993-2#127)(1993-3#203)(1993-5#23)(1993-6#204)(1993-8#214)(1993-9#184)(1994-1#39)(1994-10#7)(1994-11#235)(1994-12#209)(1994-2#170)(1994-3#173)(1994-5#136)(1994-6#173)(1994-7#54)(1994-8#224)(1994-9#147)(1995-1#31)(1995-10#2)(1995-11#194)(1995-12#329)(1995-2#281)(1995-3#207)(1995-4#26)(1995-5#161)(1995-6#235)(1995-8#165)(1995-9#21)(1996-1#67)(1996-10#15)(1996-11#25)(1996-12#313)(1996-2#199)(1996-3#118)(1996-4#11)(1996-5#245)(1996-6#98)(1996-7#37)(1996-8#35)(1996-9#62)(1997-1#104)(1997-2#270)(1997-3#234)(1997-4#221)(1997-5#76)(1997-6#197)(1997-7#170)(1997-8#201)(1997-9#10)(2006-10#56)(2006-12#27)(2006-4#5)(2006-6#20)(2006-8#18)(2007-1#5)(2007-10#249)(2007-11#627)(2007-12#518)(2007-2#74)(2007-4#18)(2007-5#74)(2007-6#55)(2007-7#361)(2007-8#626)(2007-9#26)(2008-1#414)(2008-10#14117)(2008-11#1772)(2008-12#917)(2008-2#538)(2008-3#1080)(2008-4#285)(2008-5#1333)(2008-6#653)(2008-7#1322)(2008-8#939)(2008-9#891)(2009-1#35)(2009-10#128)(2009-11#110)(2009-12#101)(2009-2#70)(2009-3#152)(2009-4#88)(2009-5#108)(2009-6#81)(2009-7#170)(2009-8#134)(2009-9#87)(2010-1#80)(2010-10#97)(2010-11#109)(2010-12#146)(2010-2#106)(2010-3#231)(2010-4#194)(2010-5#221)(2010-6#107)(2010-7#102)(2010-8#233)(2010-9#45)(2011-1#683)(2011-10#7)(2011-2#1627)(2011-3#102)(2011-4#5)(2011-7#7)(2011-9#6)(2012-1#186)(2012-12#533)(2012-2#711)(2012-3#623)(2012-4#4)(2012-5#16)(2012-6#15)(2012-7#21)(2012-8#9)(2012-9#4)(2013-1#1552)(2013-3#4)(2013-7#193)(2013-8#776)
was)##2##1##(2008-10#1)(2008-7#1)
wasenhanced##2##1##(2008-11#2)
wasfound##2##1##(2008-11#1)(2008-2#1)
wash##20##1##(1990-11#1)(1993-12#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#4)(2008-8#2)(2009-3#1)(2010-8#1)(2012-2#1)
wash-out period##2##2##(1990-5#1)(1996-3#1)
wash-out##5##1##(1990-3#1)(1990-5#1)(1995-5#1)(1996-3#1)(2008-8#1)
washed and##8##2##(1991-5#1)(1991-9#1)(1992-6#1)(2008-10#3)(2008-4#2)
washed free of##2##3##(2008-10#2)
washed off##2##2##(2008-10#1)(2008-11#1)
washed platelets##3##2##(1991-12#1)(2008-7#1)(2008-8#1)
washed roots##3##2##(2008-10#3)
washed the##2##2##(1992-6#1)(2011-2#1)
washed their hands##2##3##(2012-12#2)
washed with water##2##3##(2008-10#2)
washed with##6##2##(1990-8#1)(1991-5#1)(2008-10#3)(2008-8#1)
washed##54##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1994-9#2)(1995-11#1)(1996-2#2)(1996-3#1)(2008-10#19)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#6)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#2)
washer##2##1##(2007-8#2)
washes and##3##2##(1990-7#1)(2008-1#1)(2013-1#1)
washes##16##1##(1990-7#2)(1993-6#1)(1994-11#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-9#1)(2013-1#1)
washing and##7##2##(2008-10#4)(2008-5#1)(2008-7#1)(2013-1#1)
washing before##2##2##(1990-3#1)(1997-4#1)
washing for##2##2##(1991-3#1)(2013-8#1)
washing of the##2##3##(2008-10#1)(2008-7#1)
washing of##5##2##(1993-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
washing powders##2##2##(2008-10#2)
washing step##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
washing steps##2##2##(2008-10#1)(2012-2#1)
washing the##8##2##(1994-12#1)(2008-10#5)(2008-4#1)(2008-5#1)
washing with water##2##3##(2008-10#2)
washing with##8##2##(2008-10#6)(2008-4#1)(2008-6#1)
washing##71##1##(1990-11#1)(1990-3#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1997-2#3)(1997-4#2)(2008-10#37)(2008-11#1)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#3)(2012-2#1)(2013-1#1)(2013-8#1)
washing)##3##1##(1994-2#1)(2008-10#1)(2008-3#1)
washings and##3##2##(1994-2#1)(1997-4#1)(2010-12#1)
washings are##2##2##(1991-11#1)(2008-5#1)
washings##10##1##(1990-2#1)(1991-11#1)(1994-2#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-5#1)(2010-12#1)
washington state##2##2##(2008-10#2)
washington##3##1##(2008-10#3)
washout of##2##2##(1996-12#1)(2009-12#1)
washout period##4##2##(1990-11#1)(1994-2#1)(2008-1#1)(2011-1#1)
washout solution##2##2##(2008-11#2)
washout##18##1##(1990-11#1)(1993-6#2)(1994-11#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-12#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
wasn't##5##1##(1990-6#1)(1993-12#1)(1995-12#1)(1997-3#1)(2012-2#1)
wasobtained##2##1##(2008-11#2)
wasp Cotesia##2##2##(1990-11#1)(2008-8#1)
wasp size##2##2##(2008-9#2)
wasp##21##1##(1990-11#1)(1991-2#3)(1992-6#1)(2007-12#3)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#5)(2010-4#1)(2013-8#1)
wasperformed##2##1##(2009-8#1)(2013-8#1)
wasps##26##1##(1990-11#1)(2007-12#8)(2008-10#4)(2008-6#4)(2008-8#2)(2008-9#5)(2010-2#2)
wasshown to be##2##3##(2008-11#2)
wasshown##3##1##(2008-11#3)
wastage of##3##2##(1996-9#1)(2008-10#1)(2010-3#1)
wastage##5##1##(1996-9#3)(2008-10#1)(2010-3#1)
waste and##5##2##(1990-9#1)(2007-7#1)(2008-10#2)(2011-2#1)
waste compost##4##2##(1995-11#2)(2008-10#2)
waste disposal##5##2##(2008-12#3)(2008-6#2)
waste effluent##2##2##(2008-10#2)
waste from##3##2##(1997-2#1)(2008-6#1)(2013-1#1)
waste generation##13##2##(2008-10#13)
waste management practises##2##3##(1996-1#2)
waste management system in Mashad##2##5##(2008-12#2)
waste management##11##2##(1996-1#4)(2007-7#1)(2008-10#1)(2008-12#4)(2009-12#1)
waste materials##2##2##(2008-10#2)
waste of##5##2##(1994-2#1)(2010-8#2)(2012-2#1)(2013-8#1)
waste plastics##3##2##(2008-10#3)
waste polymers##4##2##(2008-10#4)
waste production##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
waste products##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
waste rules##2##2##(1994-2#1)(2007-7#1)
waste samples##3##2##(2008-10#3)
waste solution##2##2##(2008-10#2)
waste stream##2##2##(2008-10#1)(2013-1#1)
waste streams and##2##3##(2008-10#1)(2008-11#1)
waste streams##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
waste treatment##2##2##(2008-10#1)(2008-6#1)
waste using##2##2##(2008-10#1)(2008-6#1)
waste water and##6##3##(2008-10#5)(2008-5#1)
waste water by##2##3##(2008-10#2)
waste water samples##6##3##(2008-10#6)
waste water##34##2##(1994-5#1)(2008-10#30)(2008-5#1)(2008-6#1)(2013-1#1)
waste waters and##2##3##(2008-10#2)
waste waters##14##2##(2008-10#14)
waste##214##1##(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-11#2)(1996-1#6)(1996-12#2)(1996-3#2)(1997-2#2)(1997-3#2)(2007-12#1)(2007-7#3)(2008-10#129)(2008-11#5)(2008-12#13)(2008-5#1)(2008-6#14)(2008-7#1)(2008-9#2)(2009-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#5)(2013-1#5)(2013-8#1)
waste-water##8##1##(2008-10#6)(2008-6#1)(2012-12#1)
wasted##2##1##(2007-12#1)(2008-10#1)
wasteful##2##1##(1997-1#1)(2008-6#1)
wastes and the##2##3##(2008-10#2)
wastes and##7##2##(1991-7#1)(2008-10#5)(2008-7#1)
wastes as the C source##2##5##(2008-6#2)
wastes by##2##2##(2008-10#2)
wastes in the process of endovascular stent procurement in interventional radiology##2##11##(2012-2#2)
wastes to##2##2##(2008-12#1)(2008-6#1)
wastes##47##1##(1991-7#1)(1992-3#1)(1997-4#1)(2008-10#28)(2008-12#2)(2008-6#7)(2008-7#2)(2011-2#1)(2012-2#3)(2013-1#1)
wastewater and##6##2##(2008-10#5)(2012-12#1)
wastewater as##2##2##(2008-10#1)(2008-6#1)
wastewater from a##3##3##(2008-10#2)(2012-12#1)
wastewater from an electroplating plant##2##5##(2008-10#2)
wastewater from an##3##3##(2008-10#3)
wastewater from##7##2##(2008-10#6)(2012-12#1)
wastewater is##2##2##(2008-10#1)(2013-1#1)
wastewater of##2##2##(2008-10#1)(2012-2#1)
wastewater quality##4##2##(2008-10#4)
wastewater samples from##2##3##(2008-10#2)
wastewater samples with##3##3##(2008-10#3)
wastewater samples##24##2##(2008-10#21)(2012-12#3)
wastewater toxicity assessment##3##3##(2008-10#3)
wastewater treatment plant (WWTP)##3##4##(2008-10#3)
wastewater treatment plant##5##3##(2008-10#3)(2008-12#2)
wastewater treatment plants##5##3##(2008-10#5)
wastewater treatment system##2##3##(2012-12#1)(2013-1#1)
wastewater treatment##26##2##(1997-4#2)(2008-10#12)(2008-12#2)(2008-6#2)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#5)
wastewater was##2##2##(2008-10#2)
wastewater##123##1##(1997-4#2)(2008-10#90)(2008-12#5)(2008-6#3)(2008-7#2)(2009-4#1)(2011-2#1)(2012-1#2)(2012-12#6)(2012-2#1)(2013-1#10)
wastewater)##3##1##(2008-10#3)
wastewaters##16##1##(2008-10#14)(2008-6#1)(2008-7#1)
wasting in##3##2##(1994-9#1)(2007-11#1)(2008-12#1)
wasting##14##1##(1994-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-6#1)(2010-8#1)(2012-3#1)
watch##13##1##(1993-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-2#2)(2008-10#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#2)
watched##4##1##(1996-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
watching television##2##2##(2009-7#1)(2010-6#1)
watching##8##1##(2008-11#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)
watchman's wife##2##2##(1992-6#2)
water (0##4##2##(2008-10#4)
water (4##2##2##(2009-6#1)(2012-2#1)
water (80##2##2##(2010-3#1)(2011-3#1)
water (EC =##3##3##(2008-10#3)
water (EC##4##2##(2008-10#3)(2008-12#1)
water (at##2##2##(1995-3#1)(2008-10#1)
water (containing##2##2##(2008-5#1)(2011-1#1)
water (n =##2##3##(1995-12#1)(2010-8#1)
water (or##2##2##(2008-10#1)(2009-12#1)
water (pH##4##2##(2008-10#4)
water absorption capacity##2##3##(2008-5#2)
water absorption##7##2##(2008-3#3)(2008-5#4)
water activities##2##2##(2008-7#2)
water activity (a(w))##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
water activity##9##2##(1994-3#1)(2008-10#2)(2008-5#1)(2008-7#5)
water addition##2##2##(2008-10#2)
water affected the##2##3##(2008-10#1)(2008-12#1)
water after preconcentration of##2##4##(2008-10#2)
water after preconcentration##3##3##(2008-10#3)
water after##8##2##(2008-10#7)(2008-5#1)
water agar##11##2##(2008-10#11)
water alone was##2##3##(2008-10#1)(2008-5#1)
water alone##3##2##(2008-10#2)(2008-5#1)
water among##2##2##(2011-2#1)(2012-1#1)
water analysis and##2##3##(2008-10#2)
water analysis##16##2##(2008-10#15)(2008-2#1)
water and 0##2##3##(1993-2#1)(2008-10#1)
water and a phosphate buffer##2##5##(2008-10#2)
water and a##4##3##(2008-10#4)
water and acetonitrile##3##3##(2008-10#3)
water and acid extracts from coal##2##6##(2008-10#2)
water and alloy samples##2##4##(2008-10#2)
water and also##3##3##(2008-10#3)
water and biological##3##3##(2008-10#3)
water and by##2##3##(2008-10#1)(2013-1#1)
water and chlorophyll##2##3##(2008-3#2)
water and electrolyte##3##3##(1993-12#1)(1994-12#1)(2007-7#1)
water and estimated##2##3##(2008-10#2)
water and from##2##3##(1993-11#1)(2008-10#1)
water and fruit juice##4##4##(2008-10#4)
water and fumonisin-producing fungus added##2##5##(2013-1#2)
water and in##8##3##(1992-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
water and mineral water samples##2##5##(2008-10#2)
water and natural##3##3##(2008-10#2)(2008-11#1)
water and other##3##3##(2008-10#3)
water and river water##4##4##(2008-10#4)
water and river##5##3##(2008-10#5)
water and sea##2##3##(2008-10#1)(2008-3#1)
water and sediment##3##3##(2008-10#3)
water and soil##2##3##(2008-10#2)
water and some##6##3##(2008-10#6)
water and stream sediment##2##4##(2008-10#2)
water and synthetic##2##3##(2008-10#2)
water and tap water##3##4##(2008-10#3)
water and the##12##3##(1990-8#1)(2007-2#1)(2008-10#8)(2010-8#1)(2013-8#1)
water and their##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
water and then##2##3##(2008-10#1)(2008-4#1)
water and two##2##3##(2008-10#2)
water and urine##2##3##(2008-10#2)
water and vegetable samples##4##4##(2008-10#4)
water and very##2##3##(2008-10#1)(2012-12#1)
water and wastewater samples##4##4##(2008-10#4)
water and wastewater##6##3##(2008-10#6)
water and well water##2##4##(2008-10#2)
water and##251##2##(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#166)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
water are##9##2##(2008-10#6)(2008-2#1)(2008-3#1)(2011-2#1)
water as a##10##3##(1990-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
water as an##3##3##(2008-10#2)(2008-7#1)
water as solvent##4##3##(2008-10#1)(2011-1#1)(2012-2#2)
water as the##4##3##(1993-9#1)(1995-3#1)(2008-10#1)(2013-7#1)
water as well as##2##4##(2008-10#1)(2010-12#1)
water as##29##2##(1990-11#1)(1991-6#1)(1993-9#1)(1995-3#1)(2008-10#14)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#1)
water at 25 degrees C##2##5##(2008-10#1)(2013-8#1)
water at a##2##3##(2008-10#1)(2008-2#1)
water at the end of##2##5##(2008-10#1)(2010-3#1)
water at the##4##3##(2008-10#3)(2010-3#1)
water at##27##2##(1992-9#1)(1995-2#1)(1997-2#1)(1997-6#1)(2007-5#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#2)
water availability##5##2##(2008-10#1)(2011-2#1)(2012-5#1)(2012-8#1)(2013-7#1)
water available##2##2##(1990-7#1)(2008-5#1)
water barrier##5##2##(2008-5#5)
water bath at##2##3##(2008-10#1)(2008-3#1)
water bath##9##2##(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
water before##2##2##(2008-11#1)(2011-2#1)
water beginning##2##2##(1996-5#1)(2008-10#1)
water binding capacity##2##3##(2007-11#1)(2013-1#1)
water bodies##8##2##(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)
water body##12##2##(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#3)(2013-1#1)
water buffalo##5##2##(2008-12#4)(2008-5#1)
water but##4##2##(2008-10#3)(2008-2#1)
water by a##2##3##(2008-10#2)
water by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
water by graphite furnace atomic absorption spectrometry##3##7##(2008-10#3)
water by inductively coupled##2##4##(2008-10#2)
water by solid-phase##2##3##(2008-10#2)
water by the##2##3##(2008-10#2)
water by using##3##3##(2008-10#2)(2011-2#1)
water by##59##2##(1995-3#1)(2008-10#52)(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#2)
water can also##2##3##(2007-12#1)(2008-10#1)
water can be##5##3##(2008-10#4)(2010-5#1)
water can##10##2##(2007-12#1)(2008-10#6)(2008-3#2)(2010-5#1)
water channels##2##2##(2007-12#1)(2008-7#1)
water clarity##3##2##(2009-5#3)
water color##2##2##(2008-3#1)(2013-8#1)
water column##13##2##(2007-5#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#2)(2012-2#1)
water compared##2##2##(2008-10#2)
water concentration##4##2##(1993-2#1)(2010-8#3)
water concentrations of##2##3##(2008-10#1)(2010-8#1)
water concentrations##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
water conservation##3##2##(2008-9#3)
water consumption declined with increasing exposure concentration##2##7##(2008-9#2)
water consumption was##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
water consumption##7##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-9#4)
water contained in##2##3##(2007-12#1)(2008-5#1)
water containing 0##13##3##(2008-10#3)(2008-9#10)
water containing bromide##3##3##(2008-9#2)(2010-5#1)
water containing##30##2##(1990-7#1)(1990-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#12)(2010-5#1)(2012-3#1)
water contaminated##2##2##(2007-2#1)(2008-10#1)
water content and##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-7#1)
water content as a##2##4##(1992-8#1)(2008-10#1)
water content determination##3##3##(2008-10#3)
water content in the SC##2##5##(2008-5#2)
water content in the##4##4##(2008-10#2)(2008-5#2)
water content in##7##3##(2008-10#3)(2008-12#2)(2008-5#2)
water content is##3##3##(2008-10#3)
water content of the stratum corneum##3##6##(2008-5#3)
water content of the##6##4##(2008-10#1)(2008-3#1)(2008-5#3)(2009-6#1)
water content of##10##3##(2008-10#2)(2008-3#1)(2008-5#4)(2009-6#1)(2012-8#1)(2013-1#1)
water content was##3##3##(1995-11#1)(2008-10#2)
water content##63##2##(1992-8#1)(1995-11#1)(2008-10#23)(2008-12#2)(2008-3#3)(2008-5#13)(2008-7#3)(2009-12#1)(2009-6#3)(2009-9#2)(2010-8#2)(2012-12#2)(2012-2#1)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#1)(2013-8#1)
water contents in##2##3##(2008-10#1)(2008-5#1)
water contents##3##2##(2008-10#2)(2008-5#1)
water control##4##2##(2008-10#1)(2008-12#3)
water correlated strongly with##2##4##(1993-2#2)
water correlated##3##2##(1993-2#2)(2008-10#1)
water could##2##2##(1996-5#1)(2008-7#1)
water deficit##5##2##(2009-8#4)(2012-5#1)
water deprivation##2##2##(2012-2#1)(2013-1#1)
water depth on##2##3##(2008-10#2)
water depth##6##2##(2008-10#2)(2008-2#1)(2008-6#1)(2009-11#2)
water determination##2##2##(1993-2#2)
water did not result in##2##5##(2008-10#1)(2009-2#1)
water did not##3##3##(1993-8#1)(2008-10#1)(2009-2#1)
water diffusion across the##2##4##(1991-5#2)
water disinfection##4##2##(2008-10#2)(2008-9#2)
water droplet##7##2##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-5#1)
water droplets or ice##2##4##(2008-2#2)
water droplets or##3##3##(2008-10#1)(2008-2#2)
water droplets##12##2##(2007-11#1)(2008-10#2)(2008-2#7)(2008-3#2)
water drops##3##2##(2008-10#1)(2008-2#2)
water during##5##2##(1992-8#1)(1996-6#1)(2008-10#2)(2008-12#1)
water eluent##4##2##(2008-10#4)
water emulsions##2##2##(2008-10#1)(2008-5#1)
water environment##3##2##(2008-10#2)(2008-9#1)
water extract##12##2##(2008-10#9)(2008-5#1)(2009-6#1)(2013-8#1)
water extraction and##3##3##(2008-10#3)
water extraction##12##2##(2008-10#11)(2012-1#1)
water extracts of propolis##3##4##(2008-11#3)
water extracts of##5##3##(2008-10#2)(2008-11#3)
water extracts##8##2##(2008-10#5)(2008-11#3)
water flow##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
water flux##3##2##(1990-2#1)(2008-5#1)(2008-6#1)
water followed by##3##3##(2008-5#1)(2008-9#1)(2011-1#1)
water for 10 min##2##4##(2006-11#1)(2008-10#1)
water for 10##3##3##(2006-11#1)(2008-10#1)(2008-12#1)
water for human consumption##2##4##(2008-11#1)(2008-5#1)
water for the##4##3##(2008-10#3)(2008-7#1)
water for##36##2##(1994-3#1)(1995-12#1)(2006-11#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#8)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
water fraction of##2##3##(2007-5#1)(2008-10#1)
water fraction##7##2##(2007-5#1)(2008-10#5)(2010-2#1)
water from a##2##3##(2008-10#2)
water from the##10##3##(1992-5#1)(1997-2#1)(2007-5#1)(2008-10#5)(2008-3#1)(2011-2#1)
water from##20##2##(1992-5#1)(1997-2#1)(2007-5#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
water has been developed##5##4##(2008-10#5)
water has been##12##3##(2008-10#11)(2008-7#1)
water has##15##2##(2007-12#1)(2008-10#12)(2008-3#1)(2008-7#1)
water have been##8##3##(1992-9#1)(2008-10#5)(2008-3#1)(2012-5#1)
water have##9##2##(1992-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2012-5#1)
water holding capacity##6##3##(2008-5#2)(2010-4#2)(2013-1#1)(2013-7#1)
water ice##4##2##(2008-3#4)
water immersion and##2##3##(2008-5#2)
water immersion##6##2##(2008-3#1)(2008-5#5)
water in a##4##3##(1996-2#1)(2008-3#2)(2008-5#1)
water in the presence of##2##5##(2008-10#2)
water in the##19##3##(1990-7#1)(1996-5#1)(2008-10#10)(2008-2#3)(2008-7#2)(2010-3#1)(2011-1#1)
water in##55##2##(1990-7#1)(1990-9#1)(1992-9#1)(1996-2#1)(1996-5#1)(2008-10#27)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
water increased##2##2##(2008-5#1)(2008-7#1)
water insoluble##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
water intake##5##2##(1993-12#1)(2008-1#1)(2008-2#1)(2011-1#1)(2013-1#1)
water into the##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)
water into##8##2##(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)
water is 0##2##3##(2008-10#1)(2008-2#1)
water is a##3##3##(1994-3#1)(1995-11#1)(2008-10#1)
water is demonstrated##2##3##(2008-10#1)(2008-2#1)
water is described##3##3##(2008-10#3)
water is proposed##2##3##(2008-10#2)
water is reported##3##3##(2008-10#2)(2008-3#1)
water is the##2##3##(1995-5#1)(2008-5#1)
water is thought to##2##4##(2008-5#2)
water is used##2##3##(2008-10#1)(2010-3#1)
water is##46##2##(1994-3#1)(1995-11#1)(1995-5#1)(2008-10#27)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#3)(2009-2#1)(2010-3#1)(2013-1#1)(2013-7#1)
water level##2##2##(2008-5#1)(2012-3#1)
water levels##3##2##(1996-6#1)(2008-5#2)
water limiting conditions in the study area##2##7##(2008-12#2)
water loss (TEWL) and##3##4##(2008-5#3)
water loss (TEWL)##11##3##(2008-5#10)(2012-2#1)
water loss from##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
water loss##24##2##(2007-12#1)(2008-10#2)(2008-5#19)(2010-4#1)(2012-2#1)
water masses##2##2##(2008-2#1)(2010-8#1)
water matrices##2##2##(2008-10#2)
water matrix##3##2##(2008-10#3)
water may be performed##2##4##(2008-10#1)(2008-5#1)
water may be##3##3##(2008-10#1)(2008-5#2)
water may##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
water maze and##2##3##(2008-12#1)(2008-9#1)
water maze task##6##3##(1994-3#3)(1997-2#1)(2008-10#1)(2008-4#1)
water maze test##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
water maze##39##2##(1991-2#1)(1992-8#1)(1993-12#9)(1993-3#3)(1994-3#5)(1994-6#2)(1994-8#2)(1997-2#3)(2008-10#2)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-3#2)
water media##2##2##(1994-3#1)(2008-10#1)
water medium##4##2##(2008-10#3)(2008-3#1)
water membrane permeability##2##3##(2008-7#1)(2013-7#1)
water miscible##3##2##(2008-10#3)
water mist##3##2##(1991-2#3)
water mobile phase was##2##4##(2008-10#2)
water mobile phase##9##3##(2008-10#9)
water molecule in##2##3##(1992-3#1)(1995-5#1)
water molecule##10##2##(1992-12#1)(1992-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1997-7#1)(2008-8#1)(2009-9#1)
water molecules and##3##3##(2008-10#2)(2009-11#1)
water molecules in the##2##4##(1995-5#2)
water molecules in##3##3##(1995-5#2)(2008-10#1)
water molecules near##2##3##(1992-9#1)(2008-2#1)
water molecules##39##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-5#1)(1995-11#1)(1995-5#2)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#15)(2008-2#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)
water movement during##2##3##(2007-12#1)(2008-10#1)
water movement##4##2##(2007-12#2)(2008-10#2)
water near##2##2##(1992-9#1)(2008-3#1)
water of the##2##3##(2008-10#1)(2008-5#1)
water of##13##2##(1991-11#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)
water on##7##2##(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-1#1)
water or in##3##3##(1994-8#1)(2008-10#2)
water or##19##2##(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-1#1)(2013-1#1)
water oxygen##2##2##(1994-8#1)(1997-7#1)
water permeability##5##2##(1990-2#1)(1991-5#1)(1995-6#1)(2008-7#1)(2013-7#1)
water phase was##2##3##(1991-5#1)(2013-8#1)
water phase##8##2##(1991-5#1)(1993-11#1)(2008-10#2)(2008-5#2)(2013-8#2)
water potential##7##2##(2008-10#5)(2008-7#1)(2012-7#1)
water potentials##4##2##(2008-10#2)(2008-12#1)(2008-7#1)
water properties##2##2##(2008-3#2)
water quality and##2##3##(2007-5#1)(2008-5#1)
water quality##18##2##(2007-5#3)(2008-10#11)(2008-5#1)(2013-1#1)(2013-8#2)
water reference##4##2##(1993-2#1)(2008-10#3)
water regain##3##2##(2008-10#3)
water relations and##2##3##(2009-8#2)
water resistance of##3##3##(2008-5#3)
water resistance##5##2##(2008-5#5)
water resources##4##2##(2008-10#2)(2008-12#2)
water sac ducts are##2##4##(2007-12#2)
water sac##5##2##(2007-12#5)
water sacs##2##2##(2007-12#2)
water sample and the##2##4##(2008-10#1)(2008-2#1)
water sample and##4##3##(2008-10#3)(2008-2#1)
water sample by##2##3##(2008-10#2)
water sample containing##2##3##(2008-10#2)
water sample in##3##3##(2008-10#3)
water sample is##3##3##(2008-10#2)(2008-3#1)
water sample with##2##3##(2008-10#2)
water sample##45##2##(2008-10#42)(2008-2#1)(2008-3#1)(2012-2#1)
water sample)##2##2##(2008-10#2)
water samples (0##2##3##(2008-10#2)
water samples (relative standard deviation (R##2##6##(2008-10#2)
water samples (tap##3##3##(2008-10#3)
water samples after preconcentration of##2##5##(2008-10#2)
water samples after##6##3##(2008-10#6)
water samples and the##2##4##(2008-10#2)
water samples and##25##3##(2008-10#24)(2012-1#1)
water samples are##4##3##(2008-10#4)
water samples as well as in##2##6##(2008-10#1)(2008-11#1)
water samples as##3##3##(2008-10#2)(2008-11#1)
water samples at##5##3##(2007-5#1)(2008-10#4)
water samples by electrothermal##2##4##(2008-10#2)
water samples by flame atomic absorption spectrometry##2##7##(2008-10#2)
water samples by flame##3##4##(2008-10#3)
water samples by flow##2##4##(2008-10#2)
water samples by solid phase##2##5##(2008-10#2)
water samples by using##4##4##(2008-10#4)
water samples by##33##3##(2008-10#33)
water samples can be##2##4##(2008-10#2)
water samples collected from##2##4##(2008-10#2)
water samples collected##4##3##(2008-10#4)
water samples containing##5##3##(2008-10#5)
water samples for##2##3##(2008-10#2)
water samples from##8##3##(2008-10#8)
water samples has been developed##3##5##(2008-10#3)
water samples has been##5##4##(2008-10#5)
water samples have been##2##4##(2008-10#2)
water samples in##6##3##(2007-7#1)(2008-10#5)
water samples is described##4##4##(2008-10#4)
water samples is presented##2##4##(2008-10#2)
water samples is successful##2##4##(2008-10#2)
water samples is##14##3##(2008-10#14)
water samples obtained from##2##4##(2008-10#2)
water samples of##3##3##(2008-10#3)
water samples on the##2##4##(2008-10#2)
water samples on##3##3##(2008-10#3)
water samples spiked with##4##4##(2008-10#4)
water samples using a##2##4##(2008-10#2)
water samples using##14##3##(2008-10#14)
water samples was also##3##4##(2008-10#3)
water samples was##16##3##(2008-10#16)
water samples were analyzed##3##4##(2008-10#3)
water samples were collected from##2##5##(2007-5#2)
water samples were demonstrated##2##4##(2008-10#2)
water samples were in##2##4##(2008-10#2)
water samples were##22##3##(2007-5#2)(2008-10#18)(2008-11#1)(2012-12#1)
water samples when##2##3##(2008-10#2)
water samples with a##5##4##(2008-10#5)
water samples with satisfactory results##7##5##(2008-10#7)
water samples with##19##3##(2008-10#19)
water samples##424##2##(2007-5#4)(2007-7#1)(2008-10#412)(2008-11#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
water solubility of##2##3##(1994-8#1)(2008-10#1)
water solubility##5##2##(1994-8#1)(1995-3#1)(2008-10#2)(2008-5#1)
water soluble and##2##3##(2009-7#1)(2010-2#1)
water soluble polymer##3##3##(2008-10#3)
water soluble##16##2##(1990-11#1)(1992-8#1)(1995-6#1)(2008-10#7)(2008-3#1)(2008-5#2)(2009-7#1)(2010-2#1)(2010-4#1)
water solution is##2##3##(2008-10#1)(2008-3#1)
water solution##13##2##(1991-5#1)(1995-2#1)(2008-10#6)(2008-12#2)(2008-3#2)(2013-8#1)
water solutions of##2##3##(2008-10#2)
water solutions##6##2##(1990-2#1)(2008-10#5)
water sorption and solubility##2##4##(2013-1#2)
water sorption and##3##3##(2008-5#1)(2013-1#2)
water sorption##5##2##(2008-5#2)(2010-3#1)(2013-1#2)
water source##3##2##(2008-10#2)(2012-3#1)
water sources##6##2##(2008-10#5)(2008-7#1)
water spiked with##4##3##(2008-10#4)
water spiked##5##2##(2008-10#5)
water standards##2##2##(2008-10#1)(2009-6#1)
water storage##4##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-7#1)
water stream##4##2##(2008-10#4)
water stress in##2##3##(2008-8#1)(2012-7#1)
water stress##20##2##(2008-10#6)(2008-12#3)(2008-8#3)(2009-8#3)(2012-7#5)
water stress-induced ABA accumulation##4##4##(2008-8#4)
water studies)##4##2##(2008-9#4)
water subjected to##2##3##(2010-5#2)
water supplies##6##2##(1996-6#3)(2007-6#1)(2008-10#1)(2008-9#1)
water supply##6##2##(2008-10#1)(2008-11#1)(2011-2#4)
water surface##8##2##(1990-11#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-9#1)
water suspensions##2##2##(2008-10#2)
water system##2##2##(2008-10#1)(2008-9#1)
water systems##5##2##(2008-10#3)(2010-4#1)(2012-2#1)
water tank##2##2##(2011-2#2)
water temperature##10##2##(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-7#3)
water temperatures##3##2##(2010-8#1)(2013-7#2)
water than##4##2##(1993-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
water that must be##2##4##(2008-5#2)
water that##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
water through the##2##3##(2008-10#1)(2008-6#1)
water through##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
water to form a##2##4##(1994-12#1)(2008-5#1)
water to the##8##3##(1992-5#1)(1994-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-3#1)
water to##23##2##(1992-5#1)(1994-12#2)(1997-4#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)
water toxicity##4##2##(2008-10#4)
water transport and##2##3##(2009-8#1)(2013-1#1)
water transport properties##3##3##(2009-12#3)
water transport##8##2##(2007-12#1)(2008-10#2)(2009-12#3)(2009-8#1)(2013-1#1)
water treatment facilities##2##3##(2008-10#1)(2013-1#1)
water treatment plant##2##3##(2008-10#1)(2013-1#1)
water treatment technologies##2##3##(2008-1#1)(2008-3#1)
water treatment##14##2##(1992-5#1)(2008-1#2)(2008-10#6)(2008-3#1)(2013-1#4)
water types##5##2##(2008-10#2)(2008-3#3)
water under##2##2##(1996-5#1)(2008-10#1)
water use and##2##3##(2009-6#1)(2011-2#1)
water use efficiency##2##3##(2008-5#2)
water use##6##2##(2008-12#1)(2008-5#2)(2009-6#1)(2011-2#2)
water used in##2##3##(1994-3#1)(2008-10#1)
water used to##2##3##(2008-10#1)(2012-3#1)
water used##7##2##(1994-3#1)(2008-10#4)(2008-6#1)(2012-3#1)
water using a##2##3##(2008-10#2)
water using##17##2##(2008-10#15)(2008-3#1)(2012-1#1)
water vapor and ammonia##2##4##(2008-3#2)
water vapor and##3##3##(2008-3#3)
water vapor are presented##2##4##(2008-3#2)
water vapor in the##3##4##(2008-2#1)(2008-3#2)
water vapor in##9##3##(2008-2#3)(2008-3#6)
water vapor with##2##3##(2008-3#2)
water vapor##43##2##(1991-5#3)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#8)(2008-3#24)(2008-5#1)(2013-8#1)
water vapour##2##2##(1996-12#1)(2013-8#1)
water varies##2##2##(2008-3#1)(2013-1#1)
water volume##2##2##(1994-5#1)(2011-1#1)
water was detected##2##3##(1990-5#1)(2013-8#1)
water was developed##2##3##(2008-10#2)
water was found to be##2##5##(1993-2#1)(2008-10#1)
water was measured##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
water was studied##2##3##(2008-10#2)
water was used as the##2##5##(2008-5#1)(2008-6#1)
water was used as##4##4##(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)
water was used##5##3##(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
water was##42##2##(1990-5#1)(1991-2#1)(1992-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2009-11#1)(2010-8#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#1)
water were determined##2##3##(2008-10#1)(2008-2#1)
water were prepared##2##3##(2008-3#1)(2008-5#1)
water were##25##2##(1994-3#1)(2007-12#1)(2008-10#16)(2008-2#2)(2008-3#2)(2008-5#2)(2013-1#1)
water when##2##2##(1993-2#1)(2008-5#1)
water with a##5##3##(2008-10#4)(2008-3#1)
water with low##2##3##(2008-10#2)
water with satisfactory results##8##4##(2008-10#8)
water with##39##2##(1995-5#1)(1996-12#2)(2006-11#1)(2008-10#27)(2008-2#1)(2008-3#2)(2008-5#3)(2011-1#1)(2012-2#1)
water would be##2##3##(1996-4#1)(2008-10#1)
water##3070##1##(1990-11#3)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#7)(1990-8#3)(1990-9#3)(1991-11#6)(1991-12#1)(1991-2#7)(1991-3#2)(1991-5#13)(1991-6#3)(1992-1#2)(1992-11#8)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#6)(1992-6#1)(1992-8#5)(1992-9#8)(1993-11#4)(1993-12#13)(1993-2#18)(1993-3#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#19)(1994-5#2)(1994-6#2)(1994-8#10)(1994-9#1)(1995-11#8)(1995-12#3)(1995-2#9)(1995-3#13)(1995-5#9)(1995-6#3)(1996-12#7)(1996-2#4)(1996-4#2)(1996-5#7)(1996-6#5)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#5)(1997-6#4)(1997-7#8)(1997-8#2)(2006-11#2)(2007-10#5)(2007-11#7)(2007-12#27)(2007-2#7)(2007-3#1)(2007-5#11)(2007-6#2)(2007-7#5)(2007-8#2)(2008-1#9)(2008-10#1673)(2008-11#45)(2008-12#48)(2008-2#87)(2008-3#160)(2008-4#5)(2008-5#192)(2008-6#14)(2008-7#40)(2008-8#25)(2008-9#69)(2009-1#1)(2009-10#4)(2009-11#7)(2009-12#6)(2009-2#3)(2009-5#5)(2009-6#9)(2009-7#7)(2009-8#16)(2009-9#4)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#15)(2010-4#10)(2010-5#9)(2010-6#1)(2010-7#1)(2010-8#17)(2011-1#14)(2011-2#41)(2011-3#1)(2012-1#10)(2012-12#11)(2012-2#22)(2012-3#12)(2012-5#7)(2012-6#1)(2012-7#9)(2012-8#3)(2012-9#2)(2013-1#53)(2013-7#16)(2013-8#29)
water&quot##4##1##(2008-10#3)(2008-5#1)
water) and##4##2##(1991-5#1)(2008-10#2)(2011-1#1)
water) by##2##2##(2008-10#1)(2008-5#1)
water) to##2##2##(1995-11#1)(2008-10#1)
water) was##2##2##(2008-10#2)
water)##34##1##(1990-8#1)(1991-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-10#21)(2008-5#3)(2010-3#1)(2011-1#1)(2012-3#1)
water-##3##1##(2008-10#3)
water-accessible surface##2##2##(1992-4#1)(1992-5#1)
water-accessible##3##1##(1991-11#1)(1992-4#1)(1992-5#1)
water-acetonitrile##2##1##(2008-10#1)(2013-1#1)
water-assisted##2##1##(2008-7#2)
water-based##4##1##(2007-11#1)(2008-10#1)(2010-5#1)(2013-1#1)
water-bath##2##1##(2008-12#2)
water-borne##3##1##(2008-10#1)(2011-1#2)
water-contact##3##1##(2008-8#3)
water-contacts##2##1##(2008-8#2)
water-containing##2##1##(2008-10#1)(2013-8#1)
water-cooled##4##1##(2008-10#1)(2008-2#1)(2008-3#2)
water-ethanol##3##1##(2008-10#2)(2008-3#1)
water-filled##3##1##(2008-10#2)(2012-1#1)
water-immersion lenses##2##2##(2008-3#2)
water-immersion objective##2##2##(2008-3#2)
water-immersion##6##1##(2008-3#5)(2008-5#1)
water-immiscible##2##1##(1994-3#1)(2008-10#1)
water-in-oil emulsion##3##2##(2008-10#2)(2012-2#1)
water-in-oil microemulsion##4##2##(2008-10#2)(2008-5#2)
water-in-oil##9##1##(2008-10#5)(2008-5#3)(2012-2#1)
water-insoluble##9##1##(1992-9#1)(1994-3#1)(1996-5#1)(2008-10#5)(2008-6#1)
water-leaving radiance in##3##3##(2008-3#3)
water-leaving radiance##12##2##(2008-2#3)(2008-3#9)
water-leaving radiances##9##2##(2008-3#9)
water-leaving reflectance##8##2##(2008-2#4)(2008-3#4)
water-leaving##30##1##(2008-2#8)(2008-3#22)
water-maze task##3##2##(1994-8#3)
water-maze##6##1##(1993-3#1)(1994-8#4)(2008-7#1)
water-microemulsion-oil systems##2##2##(2008-10#2)
water-only##2##1##(2008-10#2)
water-purification systems##2##2##(1994-3#2)
water-purification##3##1##(1994-3#3)
water-soaked lesions on##2##3##(2008-10#2)
water-soaked##5##1##(2008-10#5)
water-soaking##3##1##(2008-10#2)(2008-12#1)
water-solubility##2##1##(1994-12#1)(2009-12#1)
water-soluble and##2##2##(1992-4#1)(2008-10#1)
water-soluble antioxidant##2##2##(1992-9#1)(2008-10#1)
water-soluble calixarenes##2##2##(2008-10#2)
water-soluble conjugates of BaP 7##2##5##(1992-2#2)
water-soluble conjugates##4##2##(1992-2#3)(1992-3#1)
water-soluble fraction##6##2##(1991-9#1)(2008-11#5)
water-soluble organic compounds##2##3##(2008-10#2)
water-soluble organic##5##2##(2008-10#5)
water-soluble polymer##6##2##(2008-10#3)(2008-7#2)(2012-2#1)
water-soluble polymers##3##2##(2008-10#3)
water-soluble porphyrin##4##2##(2007-11#1)(2008-10#3)
water-soluble tertiary amines##2##3##(2008-10#2)
water-soluble vitamins excreted in human urine##2##6##(2008-10#2)
water-soluble vitamins excreted in##3##4##(2008-10#3)
water-soluble vitamins##9##2##(2008-10#9)
water-soluble##101##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-7#1)(1992-9#1)(1994-3#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#46)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-2#3)(2013-1#1)
water-temperature sensors##2##2##(2008-3#2)
water-treated##3##1##(2008-10#3)
water-vapor and temperature##3##3##(2008-2#3)
water-vapor and##4##2##(2008-2#4)
water-vapor concentration##2##2##(2008-3#2)
water-vapor differential absorption lidar##2##4##(2008-3#2)
water-vapor lidar##3##2##(2008-3#3)
water-vapor measurements by##4##3##(2008-2#1)(2008-3#3)
water-vapor measurements with##2##3##(2008-2#2)
water-vapor measurements##8##2##(2008-2#3)(2008-3#5)
water-vapor mixing ratio##6##3##(2008-3#6)
water-vapor mixing##7##2##(2008-3#7)
water-vapor profiles##4##2##(2008-2#1)(2008-3#3)
water-vapor retrievals##3##2##(2008-2#3)
water-vapor##57##1##(2007-12#1)(2008-2#18)(2008-3#38)
water-window##3##1##(2007-12#2)(2008-3#1)
water/acetonitrile##3##1##(2008-10#3)
water/methanol##2##1##(2008-10#2)
water]##2##1##(1996-2#1)(2013-8#1)
waterbirth##3##1##(2007-2#3)
waterborne##9##1##(1996-6#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-4#2)
watered##3##1##(2008-10#3)
watergrass##2##1##(2008-10#2)
watering##3##1##(2007-7#1)(2008-10#1)(2008-12#1)
watermarking##2##1##(2010-8#2)
watermelon and##3##2##(2008-10#3)
watermelon blossoms##2##2##(2008-10#2)
watermelon cultivars##3##2##(2008-10#3)
watermelon fruit##2##2##(2008-10#2)
watermelon plants##2##2##(2008-10#2)
watermelon silver mottle virus##2##4##(2008-10#2)
watermelon##30##1##(2008-10#30)
waterproofing##3##1##(2009-5#1)(2012-12#1)(2012-3#1)
waters and a##2##3##(2008-2#2)
waters and the##2##3##(2008-10#2)
waters and##38##2##(2008-10#33)(2008-2#2)(2008-3#2)(2013-1#1)
waters are##3##2##(2008-10#2)(2008-9#1)
waters as well as in##2##5##(2008-10#1)(2008-12#1)
waters as well as##3##4##(2008-10#2)(2008-12#1)
waters based on##4##3##(2008-10#3)(2008-3#1)
waters by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
waters by electrothermal##3##3##(2008-10#3)
waters by the##6##3##(2008-10#5)(2013-1#1)
waters by use of##2##4##(2008-10#1)(2008-3#1)
waters by##31##2##(2008-10#27)(2008-3#3)(2013-1#1)
waters can be##2##3##(2008-10#1)(2008-3#1)
waters can##3##2##(2008-10#2)(2008-3#1)
waters containing##3##2##(2008-10#3)
waters dominated by##2##3##(2008-3#2)
waters from the##2##3##(2008-10#1)(2008-3#1)
waters from##4##2##(2008-10#3)(2008-3#1)
waters has been determined##2##4##(2008-10#2)
waters has been developed##2##4##(2008-10#2)
waters has been##4##3##(2008-10#4)
waters in the##2##3##(2008-10#1)(2008-4#1)
waters in##3##2##(2008-10#2)(2008-4#1)
waters is described##4##3##(2008-10#4)
waters is proposed##3##3##(2008-10#2)(2008-3#1)
waters is##12##2##(2008-10#9)(2008-2#2)(2008-3#1)
waters of the##6##3##(2007-5#1)(2008-10#3)(2008-5#1)(2010-5#1)
waters of##12##2##(1990-11#1)(1997-1#1)(2007-5#1)(2008-10#5)(2008-5#2)(2010-5#1)(2012-2#1)
waters samples##4##2##(2008-10#4)
waters to##2##2##(2008-10#2)
waters using a##3##3##(2008-10#3)
waters using##14##2##(2008-10#13)(2010-4#1)
waters was also##2##3##(2008-10#2)
waters were determined##2##3##(2008-10#2)
waters were##7##2##(2008-10#6)(2008-3#1)
waters with arbitrary##2##3##(2008-2#2)
waters with the##2##3##(2008-10#2)
waters with##16##2##(2008-10#11)(2008-2#2)(2008-3#2)(2010-8#1)
waters without##2##2##(2008-10#2)
waters##354##1##(1990-11#1)(1994-11#1)(1994-8#1)(1997-1#1)(2007-10#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#265)(2008-11#1)(2008-12#4)(2008-2#23)(2008-3#34)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#2)(2012-2#1)(2013-1#2)
waters)##7##1##(2008-10#6)(2008-5#1)
watershed management##2##2##(2008-10#2)
watershed##6##1##(2008-10#3)(2008-5#2)(2008-9#1)
watertight dural closure##2##3##(2012-3#1)(2013-8#1)
watertight##4##1##(2012-3#2)(2013-8#2)
waterways##2##1##(2008-10#1)(2013-1#1)
watery diarrhea##2##2##(1993-8#1)(1996-3#1)
watery##8##1##(1993-8#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
wave UV-light##2##2##(1991-6#2)
wave aberration##4##2##(2007-12#3)(2008-2#1)
wave activity##3##2##(1991-2#1)(2008-3#1)(2008-7#1)
wave adsorptive stripping voltammetric##2##4##(2008-10#2)
wave adsorptive stripping##9##3##(2008-10#9)
wave amplitudes##2##2##(1991-9#1)(2008-3#1)
wave analysis##4##2##(2007-11#1)(2008-3#1)(2009-5#1)(2013-8#1)
wave and its##2##3##(2008-10#1)(2009-5#1)
wave and the##6##3##(2007-11#1)(2008-3#5)
wave and##25##2##(1990-8#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#8)(2009-5#1)(2010-1#2)(2011-1#2)
wave at -0##2##3##(2008-10#2)
wave at the##4##3##(2007-12#3)(2008-10#1)
wave at##7##2##(2007-12#3)(2008-10#4)
wave band##3##2##(2008-3#2)(2013-7#1)
wave biosensors##2##2##(2009-3#2)
wave blocking##2##2##(2009-8#2)
wave by a##3##3##(2008-2#1)(2009-10#2)
wave by##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#2)
wave condition##2##2##(2008-3#2)
wave could##2##2##(2011-1#1)(2011-2#1)
wave detector##2##2##(2008-10#1)(2008-3#1)
wave equation##6##2##(2007-12#2)(2008-3#3)(2013-7#1)
wave field##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
wave fields##11##2##(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#1)
wave front and##2##3##(2008-3#2)
wave front at a##2##4##(2008-3#2)
wave front at##4##3##(2008-3#4)
wave front can be##3##4##(2008-2#2)(2008-3#1)
wave front from##3##3##(2007-12#1)(2008-3#2)
wave front is reconstructed from##2##5##(2008-3#2)
wave front is then reconstructed##2##5##(2008-3#2)
wave front is##7##3##(2008-2#1)(2008-3#6)
wave front of the##2##4##(2008-3#2)
wave front under study##2##4##(2008-3#2)
wave front under test##4##4##(2008-3#4)
wave front under##7##3##(2008-3#7)
wave front was##3##3##(2008-2#2)(2008-3#1)
wave front with##2##3##(2008-3#2)
wave front##61##2##(2007-12#3)(2008-2#12)(2008-3#46)
wave fronts are##2##3##(2007-12#1)(2008-2#1)
wave fronts can be##3##4##(2008-2#1)(2008-3#2)
wave fronts of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
wave fronts that##2##3##(2008-3#2)
wave fronts with##3##3##(2008-2#1)(2008-3#2)
wave fronts##36##2##(2007-11#5)(2007-12#2)(2008-2#9)(2008-3#20)
wave function##3##2##(2008-2#1)(2012-12#2)
wave functions##4##2##(1991-5#1)(2008-11#1)(2008-2#1)(2012-2#1)
wave generated##2##2##(2008-3#1)(2009-5#1)
wave generation##3##2##(2007-11#2)(2007-12#1)
wave in a##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
wave in the##5##3##(1996-3#1)(2008-2#1)(2008-3#3)
wave in##11##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#6)
wave interference##2##2##(2008-3#1)(2008-5#1)
wave into##2##2##(2007-11#1)(2008-3#1)
wave is calculated##2##3##(2008-2#1)(2008-3#1)
wave is##20##2##(1995-6#1)(2007-11#5)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#7)
wave lasted for##3##3##(2011-1#3)
wave lasted##4##2##(2011-1#4)
wave length##3##2##(1994-6#1)(1996-11#1)(2007-8#1)
wave mixing##7##2##(2007-11#2)(2007-12#3)(2009-7#2)
wave mode##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
wave modes##4##2##(2007-11#3)(2009-6#1)
wave number##2##2##(2007-12#2)
wave numbers##3##2##(2008-2#1)(2008-3#2)
wave numbers)##2##2##(1995-3#1)(2008-2#1)
wave of a##3##3##(2007-12#1)(2008-7#1)(2010-5#1)
wave of the##5##3##(1992-3#1)(1996-12#1)(1997-3#1)(2008-10#2)
wave of##20##2##(1991-12#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-7#1)(2010-5#1)(2012-2#1)
wave on the##3##3##(2008-3#2)(2011-1#1)
wave on##5##2##(2008-2#1)(2008-3#2)(2011-1#2)
wave over the##2##3##(2007-11#1)(2008-10#1)
wave pattern##4##2##(2008-2#1)(2011-2#3)
wave patterns##3##2##(2008-2#2)(2011-2#1)
wave plate##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
wave polarization##2##2##(2007-11#1)(2008-3#1)
wave power##3##2##(2007-11#2)(2008-3#1)
wave propagating##2##2##(2007-11#2)
wave propagation in##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)
wave propagation through##3##3##(2007-12#2)(2008-2#1)
wave propagation##14##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#3)(2009-8#1)
wave spectroscopy##2##2##(2008-10#1)(2008-3#1)
wave that is##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
wave that##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)
wave theory##6##2##(2008-2#1)(2008-3#5)
wave through a##3##3##(2007-11#1)(2008-3#1)(2009-10#1)
wave to##4##2##(2007-11#1)(2008-3#2)(2008-4#1)
wave transit time##2##3##(2008-3#2)
wave upon##2##2##(2007-12#1)(2008-3#1)
wave vector##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
wave vectors##3##2##(2008-2#1)(2008-3#2)
wave velocity##4##2##(2007-10#2)(2013-3#1)(2013-7#1)
wave voltammetry##30##2##(2008-10#28)(2008-8#2)
wave was##7##2##(1995-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
wave were##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
wave with a##2##3##(2008-3#2)
wave with##6##2##(2008-2#1)(2008-3#5)
wave##683##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#4)(1997-3#2)(1997-6#2)(2006-12#3)(2007-10#3)(2007-11#68)(2007-12#59)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#129)(2008-11#10)(2008-12#1)(2008-2#63)(2008-3#188)(2008-4#2)(2008-5#5)(2008-7#11)(2008-8#7)(2008-9#3)(2009-10#4)(2009-3#5)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#14)(2011-2#15)(2012-12#5)(2012-2#4)(2013-1#1)(2013-3#1)(2013-7#3)(2013-8#4)
wave&quot##2##1##(1995-2#1)(2008-4#1)
wave's##2##1##(2007-11#1)(2008-3#1)
wave-aberration##2##1##(2007-12#1)(2008-3#1)
wave-front aberration##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
wave-front aberrations##11##2##(2007-11#1)(2008-2#6)(2008-3#4)
wave-front coding##2##2##(2008-3#2)
wave-front correction##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
wave-front corrector##2##2##(2007-11#1)(2007-12#1)
wave-front curvature##3##2##(2007-12#1)(2008-3#2)
wave-front distortion##6##2##(2007-11#2)(2007-12#1)(2008-2#3)
wave-front distortions##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
wave-front error##3##2##(2008-2#3)
wave-front generation##3##2##(2008-3#3)
wave-front measurement##2##2##(2008-2#1)(2008-3#1)
wave-front measurements##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
wave-front phase##4##2##(2008-2#1)(2008-3#3)
wave-front reconstruction##7##2##(2008-3#7)
wave-front scanner##2##2##(2008-3#2)
wave-front sensing with##2##3##(2008-3#2)
wave-front sensing##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
wave-front sensor and a##2##4##(2007-12#1)(2008-3#1)
wave-front sensor##17##2##(2007-11#1)(2007-12#7)(2008-3#9)
wave-front sensors##2##2##(2007-11#1)(2008-3#1)
wave-front slopes##2##2##(2007-12#1)(2008-3#1)
wave-front tilt##2##2##(2008-3#2)
wave-front##135##1##(2007-11#17)(2007-12#22)(2008-2#29)(2008-3#67)
wave-front-sensing##2##1##(2008-3#2)
wave-guiding layer##2##2##(2008-10#2)
wave-number##3##1##(2008-2#1)(2008-3#2)
wave-vector separations##2##2##(2008-3#2)
wave-vector##6##1##(2007-11#2)(2008-3#4)
waveband##4##1##(2008-10#1)(2013-8#3)
wavebands##2##1##(2008-10#2)
waveform and##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#1)
waveform generation##3##2##(2007-11#2)(2008-2#1)
waveform of##3##2##(1994-2#1)(2007-11#1)(2008-10#1)
waveform was##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
waveform with a##2##3##(2007-11#1)(2007-12#1)
waveform##44##1##(1992-12#3)(1994-2#1)(1995-5#1)(2006-12#1)(2007-11#8)(2007-12#5)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#3)(2009-10#1)(2010-1#2)(2010-8#1)(2011-2#1)
waveforms are##3##2##(2008-2#2)(2008-3#1)
waveforms of the##2##3##(2007-11#1)(2008-3#1)
waveforms of##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
waveforms to##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
waveforms with##3##2##(2007-11#1)(2007-12#1)(2011-1#1)
waveforms##35##1##(1995-5#1)(2007-11#5)(2007-12#8)(2008-10#1)(2008-2#7)(2008-3#4)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2013-1#4)
wavefront##2##1##(2008-3#1)(2010-8#1)
wavefunction##3##1##(2010-7#1)(2012-2#2)
waveguide (LCW)##5##2##(2008-10#4)(2008-2#1)
waveguide Bragg gratings##2##3##(2007-11#1)(2008-2#1)
waveguide and a##4##3##(2007-11#1)(2008-3#3)
waveguide and the photonic##2##4##(2007-12#1)(2008-3#1)
waveguide and the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
waveguide and##14##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#6)(2008-7#1)
waveguide are##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
waveguide arrays##3##2##(2007-11#2)(2012-2#1)
waveguide as a##3##3##(2007-11#2)(2008-3#1)
waveguide as##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
waveguide autocorrelator##2##2##(2008-2#2)
waveguide based##2##2##(2008-10#1)(2008-2#1)
waveguide bends##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
waveguide birefringence##3##2##(2008-2#3)
waveguide by##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
waveguide can be##4##3##(2007-12#1)(2008-3#2)(2010-8#1)
waveguide can##5##2##(2007-12#2)(2008-3#2)(2010-8#1)
waveguide capillary##3##2##(2008-10#3)
waveguide configurations##2##2##(2008-3#2)
waveguide couplers##2##2##(2008-2#1)(2008-3#1)
waveguide crystal##4##2##(2007-12#4)
waveguide delivery##2##2##(2008-3#1)(2008-7#1)
waveguide device##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
waveguide evolves##2##2##(2007-11#1)(2007-12#1)
waveguide filter##3##2##(2007-11#1)(2007-12#2)
waveguide for##4##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
waveguide formation##2##2##(2007-11#1)(2008-3#1)
waveguide grating mirror##2##3##(2007-11#2)
waveguide grating##5##2##(2007-11#3)(2007-12#2)
waveguide gratings##7##2##(2008-3#7)
waveguide has a##2##3##(2007-11#1)(2008-10#1)
waveguide has##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
waveguide hologram##5##2##(2007-12#1)(2008-3#4)
waveguide in a##2##3##(2007-11#2)
waveguide in##3##2##(2007-11#2)(2008-3#1)
waveguide induced by##2##3##(2007-11#2)
waveguide intersections with##2##3##(2007-11#2)
waveguide is presented##2##3##(2008-3#1)(2010-5#1)
waveguide is##10##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#4)(2010-5#1)
waveguide laser that##2##3##(2007-11#2)
waveguide laser##12##2##(2007-11#6)(2008-2#1)(2008-3#5)
waveguide lasers##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
waveguide loss has##2##3##(2007-12#2)
waveguide made of##2##3##(2008-10#2)
waveguide mode##3##2##(2007-11#1)(2008-10#2)
waveguide model##2##2##(2008-2#2)
waveguide modes##5##2##(1992-8#1)(2007-11#2)(2008-3#2)
waveguide modulator##4##2##(2007-12#1)(2008-2#3)
waveguide of##2##2##(2008-3#2)
waveguide on##2##2##(2007-11#1)(2008-3#1)
waveguide photodetectors##2##2##(2007-11#2)
waveguide structure##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
waveguide structures##4##2##(2007-12#2)(2008-3#2)
waveguide system##2##2##(2007-12#1)(2008-10#1)
waveguide that is##2##3##(2007-12#1)(2010-8#1)
waveguide that##4##2##(2007-12#2)(2008-3#1)(2010-8#1)
waveguide thickness##3##2##(2008-2#2)(2008-3#1)
waveguide to##3##2##(2007-11#1)(2007-9#1)(2008-10#1)
waveguide type##2##2##(2007-11#1)(2008-2#1)
waveguide using##2##2##(2007-12#1)(2008-10#1)
waveguide was formed##2##3##(2007-12#2)
waveguide was##11##2##(2007-11#5)(2007-12#4)(2008-10#2)
waveguide when##2##2##(2007-11#1)(2008-2#1)
waveguide with##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
waveguide##406##1##(1992-3#1)(1992-8#1)(2007-11#96)(2007-12#79)(2007-9#5)(2008-10#45)(2008-2#58)(2008-3#110)(2008-7#2)(2010-5#2)(2010-8#4)(2012-2#1)(2013-8#2)
waveguide-grating##2##1##(2008-3#2)
waveguide-type optical##2##2##(2007-12#1)(2008-2#1)
waveguide-type##4##1##(2007-12#3)(2008-2#1)
waveguides and circuits##2##3##(2007-11#2)
waveguides and fibers##2##3##(2008-2#2)
waveguides and the##2##3##(2007-11#1)(2007-12#1)
waveguides and##19##2##(2007-11#4)(2007-12#5)(2008-2#6)(2008-3#3)(2011-1#1)
waveguides are also##2##3##(2007-12#2)
waveguides are##14##2##(2007-11#6)(2007-12#4)(2008-3#4)
waveguides as##3##2##(2008-3#2)(2013-8#1)
waveguides at 1##2##3##(2007-11#2)
waveguides at##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
waveguides by a##2##3##(2007-11#1)(2007-12#1)
waveguides by##10##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-3#3)
waveguides can be##3##3##(2007-12#1)(2008-3#2)
waveguides can##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
waveguides fabricated##3##2##(2008-2#3)
waveguides for sensor applications##2##4##(2008-10#1)(2008-2#1)
waveguides for the##2##3##(2008-2#2)
waveguides for##10##2##(2008-10#1)(2008-2#7)(2008-3#2)
waveguides formed by##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
waveguides formed##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
waveguides in sapphire##2##3##(2007-12#2)
waveguides in##12##2##(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#3)
waveguides induced by##4##3##(2007-12#4)
waveguides is reported##2##3##(2007-12#1)(2008-3#1)
waveguides is##5##2##(2007-12#1)(2008-3#4)
waveguides made##2##2##(2008-2#1)(2008-3#1)
waveguides on##2##2##(2007-11#1)(2008-2#1)
waveguides that##2##2##(2007-12#2)
waveguides was##2##2##(2008-3#2)
waveguides were fabricated from##3##4##(2007-11#1)(2008-2#2)
waveguides were fabricated##4##3##(2007-11#1)(2008-2#3)
waveguides were##8##2##(2007-11#1)(2008-2#4)(2008-3#3)
waveguides with a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
waveguides with an##2##3##(2007-11#1)(2008-2#1)
waveguides with discrete translational symmetry##2##5##(2007-12#2)
waveguides with the##2##3##(2008-3#2)
waveguides with##17##2##(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#6)
waveguides##246##1##(2007-11#49)(2007-12#56)(2008-10#4)(2008-2#64)(2008-3#69)(2010-8#1)(2011-1#1)(2013-8#2)
waveguiding layer##2##2##(2008-2#1)(2008-3#1)
waveguiding plate##2##2##(2008-3#2)
waveguiding##17##1##(2007-11#4)(2007-12#1)(2008-2#8)(2008-3#4)
wavelength absorption##2##2##(2008-10#1)(2008-7#1)
wavelength accuracy of##2##3##(2008-2#2)
wavelength and a##2##3##(2007-11#1)(2008-2#1)
wavelength and the wavelength##2##4##(2007-12#1)(2008-10#1)
wavelength and the##17##3##(1991-12#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-3#6)(2008-7#1)
wavelength and##43##2##(1991-12#1)(2007-11#7)(2007-12#8)(2008-10#4)(2008-2#4)(2008-3#14)(2008-7#2)(2009-9#1)(2013-1#2)
wavelength are##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
wavelength as##4##2##(2008-3#4)
wavelength at which##2##3##(2008-3#2)
wavelength at##12##2##(2008-10#7)(2008-2#1)(2008-3#3)(2012-12#1)
wavelength band##3##2##(2008-2#1)(2008-3#2)
wavelength bandpass centered at 30 nm##2##6##(2008-3#2)
wavelength bands##2##2##(2008-3#2)
wavelength between##2##2##(2007-12#1)(2008-2#1)
wavelength by##4##2##(2007-11#1)(2008-3#3)
wavelength calibration##3##2##(2007-11#2)(2008-3#1)
wavelength can be tuned##2##4##(2007-11#2)
wavelength can be##8##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-7#1)(2009-7#1)
wavelength change##3##2##(2007-12#1)(2008-3#2)
wavelength channels##3##2##(2007-11#1)(2008-3#2)
wavelength combinations##2##2##(2008-2#2)
wavelength control##2##2##(2007-12#1)(2008-3#1)
wavelength conversion of##4##3##(2007-12#4)
wavelength conversion with##2##3##(2007-12#2)
wavelength conversion##13##2##(2007-11#3)(2007-12#9)(2008-3#1)
wavelength converter##2##2##(2007-11#1)(2008-3#1)
wavelength converters##2##2##(2007-11#1)(2007-12#1)
wavelength could be tuned##2##4##(2007-11#1)(2007-12#1)
wavelength demultiplexing##2##2##(2007-12#1)(2008-3#1)
wavelength dependence of the##10##4##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#3)
wavelength dependence of##11##3##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#3)
wavelength dependence over the 633-1539-nm range##2##6##(2008-3#2)
wavelength dependence##15##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#7)
wavelength determination##4##2##(2006-4#1)(2008-10#2)(2008-3#1)
wavelength dispersive X-ray fluorescence spectroscopy##2##5##(2008-10#2)
wavelength dispersive##3##2##(2008-10#3)
wavelength division multiplexer##2##3##(2008-2#2)
wavelength division multiplexing##3##3##(2008-3#3)
wavelength division##5##2##(2008-2#2)(2008-3#3)
wavelength emission##2##2##(2008-10#2)
wavelength for##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-1#1)(2011-7#1)
wavelength has been##7##3##(2008-2#2)(2008-3#5)
wavelength has##8##2##(2008-2#2)(2008-3#6)
wavelength in a##2##3##(2007-12#2)
wavelength in the##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2013-1#1)
wavelength in three##2##3##(2007-12#1)(2008-3#1)
wavelength in##15##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#6)(2011-1#1)(2013-1#1)
wavelength interchange##3##2##(2007-12#3)
wavelength interval##4##2##(2008-10#2)(2008-3#2)
wavelength is at##2##3##(2008-10#2)
wavelength is increased##2##3##(2007-11#1)(2008-3#1)
wavelength is##26##2##(2007-11#5)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#9)(2013-8#3)
wavelength lambda =##2##3##(2008-2#1)(2008-3#1)
wavelength light##3##2##(2008-10#1)(2011-7#1)(2013-1#1)
wavelength mixing ratio##3##3##(2013-1#3)
wavelength mixing##4##2##(2013-1#4)
wavelength modulation SPR biosensor##4##4##(2008-10#4)
wavelength modulation of a distributed-feedback##2##5##(2008-3#2)
wavelength modulation spectroscopy with##3##4##(2008-2#1)(2008-3#2)
wavelength modulation spectroscopy##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
wavelength modulation##19##2##(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#8)
wavelength multiplexing##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
wavelength near##6##2##(1995-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
wavelength of 0##2##3##(2008-3#2)
wavelength of 1##18##3##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#8)
wavelength of 10##8##3##(2007-11#5)(2007-12#2)(2008-3#1)
wavelength of 1064 nm##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
wavelength of 1540 nm##2##4##(2007-12#2)
wavelength of 2##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
wavelength of 532 nm##2##4##(2008-2#1)(2008-3#1)
wavelength of 632##2##3##(2007-11#1)(2007-12#1)
wavelength of 635 nm##2##4##(2007-11#1)(2008-3#1)
wavelength of a##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
wavelength of lambda##2##3##(2008-2#1)(2008-3#1)
wavelength of light##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
wavelength of the fiber##2##4##(2007-11#2)
wavelength of the incident light##2##5##(2007-11#1)(2008-3#1)
wavelength of the incident##6##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
wavelength of the light##5##4##(1992-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
wavelength of the##40##3##(1992-4#1)(1995-5#1)(2006-4#2)(2007-11#9)(2007-12#6)(2008-10#2)(2008-2#6)(2008-3#13)
wavelength of ~1##2##3##(2007-11#1)(2007-12#1)
wavelength of##201##2##(1990-12#1)(1991-3#1)(1992-4#1)(1995-5#1)(1997-2#2)(2006-4#2)(2007-11#36)(2007-12#37)(2008-1#1)(2008-10#34)(2008-11#1)(2008-2#26)(2008-3#56)(2013-1#1)(2013-8#1)
wavelength on##2##2##(2007-12#1)(2008-3#1)
wavelength pair##3##2##(2008-2#3)
wavelength pairs##6##2##(2008-10#3)(2008-2#1)(2008-3#2)
wavelength programming##2##2##(2008-10#2)
wavelength purity##2##2##(2008-10#1)(2008-2#1)
wavelength range and##5##3##(2008-10#2)(2008-2#3)
wavelength range from##12##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#6)(2008-5#1)
wavelength range is##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
wavelength range of##12##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#6)
wavelength range was##2##3##(2007-11#1)(2008-10#1)
wavelength range##101##2##(2006-6#1)(2007-11#18)(2007-12#7)(2008-10#14)(2008-2#27)(2008-3#32)(2008-5#1)(2010-5#1)
wavelength ranges of##2##3##(2008-10#1)(2008-3#1)
wavelength ranges##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
wavelength ratio##2##2##(2008-2#2)
wavelength region from##2##3##(2007-12#1)(2008-3#1)
wavelength region has been##2##4##(2007-12#1)(2008-3#1)
wavelength region of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
wavelength region##30##2##(1990-8#1)(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#7)(2008-3#12)
wavelength regions##6##2##(2008-10#2)(2008-2#2)(2008-3#2)
wavelength scanning##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
wavelength selection in##3##3##(2008-10#2)(2008-9#1)
wavelength selection##10##2##(2008-10#7)(2008-3#1)(2008-9#2)
wavelength selectivity##3##2##(2008-3#2)(2008-9#1)
wavelength separation##2##2##(2008-2#1)(2008-3#1)
wavelength separations of ~1##2##4##(2007-12#2)
wavelength separations##3##2##(2007-12#3)
wavelength shift##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
wavelength shifts##3##2##(2008-2#1)(2008-3#2)
wavelength switching##3##2##(2007-12#2)(2008-3#1)
wavelength than##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
wavelength that is##2##3##(2008-3#2)
wavelength that##3##2##(2008-2#1)(2008-3#2)
wavelength the##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
wavelength to a##2##3##(2007-12#1)(2011-1#1)
wavelength to the##3##3##(2007-12#3)
wavelength to##13##2##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2012-3#1)
wavelength tuning and##2##3##(2008-3#1)(2008-9#1)
wavelength tuning from##2##3##(2007-11#1)(2007-12#1)
wavelength tuning in##2##3##(2007-12#2)
wavelength tuning of##2##3##(2007-11#1)(2007-12#1)
wavelength tuning##12##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#2)(2008-9#1)
wavelength uncertainty##3##2##(2008-2#3)
wavelength value of##2##3##(2008-10#2)
wavelength was continuously##2##3##(2007-12#1)(2008-2#1)
wavelength was found to be##2##5##(2007-11#1)(2008-3#1)
wavelength was##20##2##(2006-4#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2011-1#2)(2011-2#1)(2012-3#1)
wavelength were##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
wavelength windows##3##2##(2008-3#3)
wavelength with a##2##3##(2007-11#1)(2008-3#1)
wavelength with##6##2##(1990-8#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-3#1)
wavelength within##2##2##(1992-8#1)(2007-12#1)
wavelength##997##1##(1990-12#1)(1990-8#2)(1991-12#1)(1991-3#2)(1992-4#1)(1992-8#1)(1993-5#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-2#3)(2006-4#6)(2006-6#1)(2007-11#137)(2007-12#141)(2008-1#1)(2008-10#151)(2008-11#3)(2008-2#161)(2008-3#322)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#6)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#3)(2010-8#1)(2011-1#8)(2011-2#1)(2011-7#3)(2012-12#1)(2012-3#2)(2013-1#10)(2013-8#5)
wavelength)##8##1##(2007-11#1)(2008-2#1)(2008-3#6)
wavelength- and mode-selective coupler##2##4##(2007-11#2)
wavelength-conversion##3##1##(2007-11#2)(2008-3#1)
wavelength-dependent angular##2##2##(2008-2#2)
wavelength-dependent phase##3##2##(2007-11#1)(2008-3#2)
wavelength-dependent transmission##3##2##(2008-2#1)(2008-3#2)
wavelength-dependent##20##1##(1995-6#1)(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#10)
wavelength-dispersive##3##1##(2008-10#1)(2008-3#2)
wavelength-division demultiplexing##3##2##(2008-3#3)
wavelength-division multiplexed (WDM)##2##3##(2007-11#1)(2008-3#1)
wavelength-division multiplexed systems##2##3##(2007-11#1)(2007-12#1)
wavelength-division multiplexed##9##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#1)
wavelength-division multiplexer##2##2##(2007-11#1)(2008-3#1)
wavelength-division multiplexing applications##3##3##(2007-11#2)(2008-3#1)
wavelength-division multiplexing system##2##3##(2007-12#2)
wavelength-division multiplexing systems##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
wavelength-division multiplexing transmissions##2##3##(2007-11#2)
wavelength-division multiplexing##29##2##(2007-11#7)(2007-12#11)(2008-2#2)(2008-3#9)
wavelength-division multiplexing-passive optical net demultiplexer##2##5##(2008-3#2)
wavelength-division##50##1##(2007-11#11)(2007-12#14)(2008-2#4)(2008-3#21)
wavelength-division-multiplexed optical##3##2##(2007-11#3)
wavelength-division-multiplexed soliton transmission system##2##4##(2007-12#2)
wavelength-division-multiplexed soliton##3##2##(2007-11#1)(2007-12#2)
wavelength-division-multiplexed systems##2##2##(2007-12#1)(2008-2#1)
wavelength-division-multiplexed##11##1##(2007-11#4)(2007-12#5)(2008-2#2)
wavelength-division-multiplexing##3##1##(2008-2#2)(2008-3#1)
wavelength-drop##2##1##(2007-12#2)
wavelength-independent##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
wavelength-modulated##5##1##(2007-12#1)(2008-3#4)
wavelength-modulation (WM)##2##2##(2008-3#2)
wavelength-modulation absorption spectroscopy##2##3##(2007-12#1)(2008-3#1)
wavelength-modulation spectrometry in terms of##2##5##(2008-3#2)
wavelength-modulation spectrometry##4##2##(2008-3#4)
wavelength-modulation spectroscopy##2##2##(2008-2#1)(2008-3#1)
wavelength-modulation##11##1##(2007-12#1)(2008-2#2)(2008-3#8)
wavelength-multiplexed optical##2##2##(2008-3#2)
wavelength-multiplexed##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
wavelength-scanning interferometer with a##2##4##(2008-3#2)
wavelength-scanning interferometer with##3##3##(2008-3#3)
wavelength-scanning interferometry##2##2##(2008-3#2)
wavelength-scanning width##2##2##(2007-12#1)(2008-3#1)
wavelength-scanning##12##1##(2007-12#2)(2008-3#10)
wavelength-selective photodetector##2##2##(2008-3#2)
wavelength-selective##9##1##(2007-11#1)(2008-2#2)(2008-3#6)
wavelength-time##3##1##(2008-10#1)(2011-1#2)
wavelength-to-depth encoding##2##2##(2007-12#2)
wavelength-tunable##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
wavelength-tuned##2##1##(2008-3#2)
wavelength-tuning##2##1##(2008-2#2)
wavelengths (e##2##2##(2008-3#2)
wavelengths (i##2##2##(2008-11#2)
wavelengths and the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
wavelengths and with##2##3##(2007-12#1)(2008-3#1)
wavelengths and##18##2##(1995-6#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#5)(2008-5#1)
wavelengths are recorded##2##3##(2007-11#1)(2008-3#1)
wavelengths are##19##2##(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#6)(2011-1#1)
wavelengths as short as##2##4##(2007-11#1)(2008-2#1)
wavelengths as##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
wavelengths at which the##2##4##(2008-10#2)
wavelengths at which##3##3##(2008-10#2)(2008-3#1)
wavelengths at##5##2##(2008-10#4)(2008-3#1)
wavelengths between##2##2##(2008-2#1)(2008-3#1)
wavelengths by use of##2##4##(2007-12#1)(2008-2#1)
wavelengths by##4##2##(2007-12#1)(2008-2#3)
wavelengths can be##3##3##(2007-11#1)(2007-12#2)
wavelengths can##6##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)
wavelengths could##2##2##(2008-3#2)
wavelengths determined by the##2##4##(2007-11#1)(2007-12#1)
wavelengths employed##2##2##(1990-2#1)(2008-2#1)
wavelengths for##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
wavelengths from##15##2##(1996-5#1)(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#5)
wavelengths has been##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
wavelengths have##2##2##(2007-11#1)(2008-2#1)
wavelengths in the near##2##4##(2007-11#1)(2007-12#1)
wavelengths in the visible##5##4##(2008-3#4)(2009-12#1)
wavelengths in the##15##3##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#7)(2009-12#1)
wavelengths in##19##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#8)(2009-12#1)(2011-2#1)
wavelengths is##7##2##(2007-11#1)(2008-2#1)(2008-3#4)(2013-8#1)
wavelengths longer than approximately##2##4##(2008-3#2)
wavelengths longer than##4##3##(1991-5#1)(2008-3#3)
wavelengths near##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
wavelengths of 0##4##3##(2008-2#2)(2008-3#2)
wavelengths of 420##2##3##(2008-3#2)
wavelengths of excitation##5##3##(2008-10#4)(2010-5#1)
wavelengths of light##2##3##(2008-11#1)(2008-9#1)
wavelengths of the##11##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#4)(2008-7#2)
wavelengths of##59##2##(1990-8#1)(2007-11#6)(2007-12#5)(2008-10#11)(2008-11#1)(2008-2#9)(2008-3#20)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
wavelengths over##2##2##(2007-11#1)(2008-3#1)
wavelengths ranging from##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
wavelengths that##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
wavelengths the##4##2##(2008-2#1)(2008-3#3)
wavelengths through##2##2##(2008-2#1)(2008-3#1)
wavelengths to obtain##2##3##(2008-3#2)
wavelengths to##7##2##(1990-8#1)(2007-11#2)(2007-12#1)(2008-3#3)
wavelengths was obtained##2##3##(2007-11#1)(2008-3#1)
wavelengths was##8##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
wavelengths were chosen##2##3##(2008-10#1)(2008-3#1)
wavelengths were##12##2##(2007-11#1)(2008-10#9)(2008-3#2)
wavelengths when##2##2##(2008-3#1)(2008-7#1)
wavelengths where##2##2##(2008-10#1)(2008-2#1)
wavelengths with a##2##3##(2007-11#1)(2008-3#1)
wavelengths with##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
wavelengths##414##1##(1990-2#1)(1990-8#3)(1991-5#1)(1995-6#2)(1996-5#1)(2007-11#45)(2007-12#46)(2008-1#2)(2008-10#60)(2008-11#3)(2008-2#66)(2008-3#161)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#3)(2009-12#1)(2010-1#1)(2010-2#1)(2010-5#3)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
wavelengths)##2##1##(1995-6#1)(2008-3#1)
wavelet MRA and##2##3##(2008-10#2)
wavelet MRA##4##2##(2008-10#4)
wavelet analysis and##2##3##(2008-10#1)(2008-3#1)
wavelet analysis##3##2##(2008-10#2)(2008-3#1)
wavelet coefficients##4##2##(2007-11#1)(2008-3#1)(2008-6#2)
wavelet decomposition##2##2##(2008-3#1)(2010-8#1)
wavelet filter was found to yield a##2##7##(2008-2#2)
wavelet filter##4##2##(2008-2#4)
wavelet filters##2##2##(2008-2#2)
wavelet functions##3##2##(2008-3#1)(2010-8#2)
wavelet multiresolution##2##2##(2008-10#1)(2008-3#1)
wavelet neural network##2##3##(2008-10#2)
wavelet processor##2##2##(2008-2#2)
wavelet produced the best model##2##5##(2010-4#2)
wavelet transform##30##2##(2008-10#14)(2008-2#7)(2008-3#7)(2008-6#1)(2010-4#1)
wavelet transformer##2##2##(2008-2#2)
wavelet transforms##5##2##(2008-10#2)(2008-3#2)(2010-4#1)
wavelet type##2##2##(2010-4#2)
wavelet##96##1##(2007-11#2)(2008-10#37)(2008-2#19)(2008-3#22)(2008-6#5)(2010-4#8)(2010-8#3)
wavelet-based##4##1##(2008-10#1)(2008-3#2)(2009-3#1)
wavelet-matched filtering##2##2##(2008-2#2)
wavelet-packet noise-reduction##3##2##(2008-3#3)
wavelet-transform##2##1##(2007-11#1)(2008-3#1)
wavelets proposed by##2##3##(2008-2#2)
wavelets##9##1##(2008-2#6)(2008-6#3)
wavemeter##7##1##(2008-3#7)
wavenumber range##2##2##(2007-12#1)(2008-10#1)
wavenumber##10##1##(2007-12#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-5#2)
wavenumbers was##2##2##(2008-10#2)
wavenumbers##7##1##(1992-6#1)(2007-11#1)(2008-10#5)
waves 1##2##2##(2011-2#2)
waves and##12##2##(1991-9#1)(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)
waves are considered to##2##4##(1991-3#1)(2007-11#1)
waves are##15##2##(1991-3#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-3#5)(2008-8#1)
waves as##2##2##(1994-8#1)(2008-2#1)
waves at##3##2##(2008-10#1)(2009-9#1)(2010-7#1)
waves between##2##2##(2008-3#2)
waves by##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)
waves during##4##2##(2007-11#1)(2011-1#1)(2012-2#2)
waves for##5##2##(2007-11#1)(2008-3#2)(2012-3#1)(2013-8#1)
waves from a film##2##4##(2008-3#2)
waves from a##3##3##(2007-11#1)(2008-3#2)
waves from the##2##3##(2008-3#2)
waves from##6##2##(2007-11#1)(2008-3#5)
waves generated by##2##3##(1990-8#1)(2010-6#1)
waves generated##5##2##(1990-8#1)(1994-5#1)(2007-12#1)(2008-3#1)(2010-6#1)
waves in a##5##3##(1990-12#1)(1995-12#1)(2007-12#2)(2008-3#1)
waves in nonuniform periodic Bragg arrays##2##6##(2008-3#2)
waves in the##5##3##(1994-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
waves in##31##2##(1990-12#1)(1993-1#1)(1994-8#1)(1995-12#1)(2007-11#3)(2007-12#9)(2008-10#1)(2008-2#1)(2008-3#10)(2008-5#1)(2011-2#1)(2012-2#1)
waves increases##2##2##(2008-3#1)(2009-9#1)
waves inside##2##2##(2007-12#1)(2008-3#1)
waves is##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
waves obtained from##2##3##(2008-2#1)(2009-5#1)
waves of the##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
waves of##17##2##(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
waves on the##2##3##(2011-1#1)(2013-7#1)
waves on##6##2##(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#1)(2013-7#1)
waves propagating between an isotropic medium and an##2##8##(2007-11#2)
waves propagating##4##2##(2007-11#2)(2008-3#2)
waves that are##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
waves that propagate##2##3##(2007-11#1)(2008-3#1)
waves that##8##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
waves through a##3##3##(2008-3#3)
waves to##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
waves was##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
waves were##4##2##(1990-5#1)(2008-10#2)(2008-3#1)
waves with##7##2##(2007-11#3)(2007-12#2)(2008-2#1)(2013-8#1)
waves##264##1##(1990-12#1)(1990-5#3)(1990-8#1)(1991-3#4)(1991-9#1)(1993-1#3)(1993-3#1)(1993-9#1)(1994-5#2)(1994-8#3)(1995-12#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-5#1)(2007-11#34)(2007-12#39)(2008-10#19)(2008-11#1)(2008-2#18)(2008-3#77)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-3#1)(2009-5#5)(2009-8#1)(2009-9#3)(2010-11#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#6)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#7)
waviness and##4##2##(2008-3#4)
waviness scale##2##2##(2008-3#2)
waviness##11##1##(2008-2#1)(2008-3#10)
wax and oil##5##3##(2008-5#5)
wax and##6##2##(2008-5#5)(2012-3#1)
wax matrix at the surface region##2##6##(2008-5#2)
wax matrix##12##2##(2008-5#12)
wax tests of##2##3##(2007-12#2)
wax tests##3##2##(2007-12#3)
wax##48##1##(1991-2#1)(1992-6#4)(2007-12#3)(2008-10#14)(2008-11#1)(2008-5#19)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
wax-encased##5##1##(2008-10#5)
waxes were##3##2##(2008-10#2)(2008-5#1)
waxes##9##1##(2008-10#6)(2008-5#2)(2012-2#1)
waxy##8##1##(2007-11#3)(2007-12#3)(2008-5#1)(2012-2#1)
way a##5##2##(1990-9#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
way and the##2##3##(2008-10#1)(2011-2#1)
way and##9##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-3#2)
way are##3##2##(1996-3#1)(2008-10#2)
way around##3##2##(1991-9#1)(1992-1#1)(2012-1#1)
way as##17##2##(1991-9#2)(1993-3#1)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)
way but##2##2##(1995-11#1)(2006-10#1)
way by the##2##3##(2008-3#1)(2008-6#1)
way by##5##2##(1997-2#1)(2008-12#1)(2008-3#2)(2008-6#1)
way for a##5##3##(1992-1#1)(1992-3#1)(1995-3#1)(1995-4#1)(2011-1#1)
way for the##10##3##(1994-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
way for##50##2##(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-3#1)(1995-4#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
way forward for##2##3##(1996-8#1)(2009-10#1)
way forward in##2##3##(2008-10#1)(2008-11#1)
way forward##7##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#2)(2012-12#1)
way from##4##2##(1992-11#1)(1994-3#1)(2008-3#1)(2010-12#1)
way has##2##2##(1992-2#1)(2008-9#1)
way have##2##2##(2008-10#1)(2008-4#1)
way in the##3##3##(1990-11#1)(1995-3#1)(2008-10#1)
way in which the##7##4##(1992-1#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-5#1)
way in which##33##3##(1992-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-5#2)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)
way in##49##2##(1990-11#1)(1991-11#1)(1991-4#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#2)
way into the##2##3##(1994-3#1)(2008-11#1)
way into##5##2##(1994-3#1)(1995-6#1)(1996-2#1)(2007-7#1)(2008-11#1)
way is##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
way it is possible to##2##5##(1991-12#1)(2008-3#1)
way it is##5##3##(1991-12#1)(1992-3#1)(2008-3#2)(2009-10#1)
way it##7##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(2008-3#2)(2009-10#1)
way of a##2##3##(2008-2#1)(2013-8#1)
way of achieving##3##3##(2008-2#1)(2008-5#1)(2010-10#1)
way of comparing##2##3##(1994-6#1)(2008-10#1)
way of determining the##2##4##(2008-10#1)(2009-4#1)
way of doing things##2##4##(1991-3#1)(1995-2#1)
way of doing##5##3##(1991-3#1)(1993-11#1)(1995-2#1)(1996-3#1)(2012-2#1)
way of improving##2##3##(2010-12#1)(2010-8#1)
way of learning##2##3##(2009-11#1)(2013-8#1)
way of life##4##3##(1991-12#1)(1995-1#1)(2008-10#1)(2008-6#1)
way of obtaining##2##3##(1997-3#1)(2010-11#1)
way of the##8##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#1)
way of thinking##4##3##(1993-6#1)(1994-12#1)(2008-8#1)(2008-9#1)
way of using##2##3##(2008-10#1)(2008-2#1)
way of working##2##3##(1995-6#1)(2008-11#1)
way of##123##2##(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#8)(2008-2#5)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#6)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
way on##3##2##(1995-5#1)(1996-6#1)(2008-10#1)
way or##2##2##(1991-6#1)(1992-2#1)
way than##3##2##(1991-6#1)(2007-12#1)(2008-8#1)
way that it##5##3##(2008-11#2)(2008-3#2)(2011-2#1)
way that the##12##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2009-7#1)(2010-5#1)(2012-1#1)
way that##63##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-1#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#7)(2008-2#1)(2008-3#10)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
way the##19##2##(1995-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#2)(2008-6#1)(2010-11#1)(2011-1#1)
way they##12##2##(1994-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-8#1)
way to address##2##3##(2008-12#1)(2012-1#1)
way to assess the##2##4##(2007-10#1)(2008-10#1)
way to assess##4##3##(2007-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
way to avoid##2##3##(1995-1#1)(2011-2#1)
way to classify##2##3##(1995-12#1)(2008-5#1)
way to describe##2##3##(2007-12#1)(2008-2#1)
way to detect##2##3##(2007-12#1)(2008-6#1)
way to determine##3##3##(2008-3#1)(2008-4#1)(2009-12#1)
way to distinguish##2##3##(1992-12#1)(2012-2#1)
way to elucidate the##2##4##(2009-6#1)(2012-3#1)
way to evaluate the##2##4##(1991-2#1)(1993-12#1)
way to evaluate##3##3##(1991-2#1)(1993-12#1)(1995-2#1)
way to examine the##2##4##(1995-2#1)(2008-2#1)
way to explore the##2##4##(2007-12#1)(2010-2#1)
way to extend##2##3##(2007-11#1)(2008-6#1)
way to identify##2##3##(2008-9#1)(2012-3#1)
way to implement##2##3##(1996-1#1)(2008-11#1)
way to improve the##3##4##(1993-3#1)(2008-11#1)(2008-6#1)
way to improve##5##3##(1992-11#1)(1993-3#1)(1997-3#1)(2008-11#1)(2008-6#1)
way to increase##2##3##(1994-2#1)(2008-3#1)
way to integrate##3##3##(1993-2#1)(1997-2#1)(2008-9#1)
way to investigate the##3##4##(2007-11#1)(2008-8#1)(2010-12#1)
way to isolate##2##3##(1997-2#1)(2008-9#1)
way to learn##2##3##(2013-1#1)(2013-8#1)
way to measure##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
way to monitor##2##3##(2007-11#1)(2008-10#1)
way to obtain##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
way to predict##2##3##(2008-7#1)(2008-8#1)
way to prevent or##2##4##(2008-10#1)(2010-7#1)
way to prevent##6##3##(1996-9#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#1)
way to produce##2##3##(2008-10#1)(2008-4#1)
way to provide##2##3##(1991-2#1)(2008-11#1)
way to reach##2##3##(1994-3#1)(1996-1#1)
way to study the##2##4##(2008-10#1)(2008-9#1)
way to that of##2##4##(2008-1#1)(2008-9#1)
way to the##5##3##(1997-1#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
way to treat the##2##4##(2008-12#1)(2013-1#1)
way to treat##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
way to##221##2##(1990-12#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1996-1#4)(1996-2#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#12)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#11)(2008-9#9)(2009-10#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#2)
way toward##4##2##(1992-12#1)(1996-1#1)(2008-1#1)(2008-8#1)
way using##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
way we##11##2##(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#2)(2009-8#1)(2010-7#1)(2011-2#2)(2013-7#1)
way with##2##2##(2008-3#1)(2008-5#1)
way##891##1##(1990-11#2)(1990-12#4)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#3)(1991-9#5)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#6)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#7)(1993-2#3)(1993-3#6)(1993-6#2)(1993-8#1)(1994-1#3)(1994-12#5)(1994-2#5)(1994-3#8)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#6)(1995-11#4)(1995-12#8)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#10)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#5)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#12)(1997-3#3)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#3)(2006-10#4)(2007-10#1)(2007-11#21)(2007-12#21)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#10)(2008-10#109)(2008-11#48)(2008-12#24)(2008-2#24)(2008-3#46)(2008-4#8)(2008-5#17)(2008-6#14)(2008-7#28)(2008-8#30)(2008-9#22)(2009-10#13)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#9)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#6)(2010-8#11)(2010-9#3)(2011-1#15)(2011-2#26)(2012-1#8)(2012-12#9)(2012-2#13)(2012-3#14)(2013-1#12)(2013-7#4)(2013-8#16)
way&quot##2##1##(2008-12#2)
wayfinding##4##1##(2012-12#2)(2012-2#2)
ways and##9##2##(1991-3#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-9#1)(2013-1#1)
ways by which##2##3##(2008-3#1)(2013-1#1)
ways for##4##2##(1997-1#1)(2008-10#2)(2008-2#1)
ways forward##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
ways health care##2##3##(1992-3#1)(1994-3#1)
ways in which the##5##4##(1995-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)
ways in which these##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
ways in which to##3##4##(1996-3#1)(2008-3#2)
ways in which##43##3##(1991-3#2)(1992-12#1)(1992-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-7#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
ways in##48##2##(1991-3#2)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
ways not##2##2##(2007-8#1)(2009-11#1)
ways of achieving##3##3##(1990-6#1)(2007-11#1)(2008-3#1)
ways of coping and##2##4##(1990-10#1)(2011-2#1)
ways of coping##4##3##(1990-10#2)(2011-2#2)
ways of doing business##2##4##(1993-2#1)(1994-3#1)
ways of providing##3##3##(1992-12#1)(1994-3#1)(2008-1#1)
ways of thinking about##2##4##(1992-1#1)(2010-5#1)
ways of thinking##3##3##(1992-1#1)(2010-5#1)(2013-1#1)
ways of understanding development as a teacher##2##7##(2012-1#2)
ways of understanding development##3##4##(2012-1#3)
ways of using##3##3##(1991-2#1)(2007-7#1)(2010-12#1)
ways of##65##2##(1990-10#2)(1990-3#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-9#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#2)(2013-1#2)(2013-8#2)
ways that##26##2##(1990-7#1)(1992-3#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
ways the##3##2##(1996-2#1)(1996-3#1)(1997-4#1)
ways through which##2##3##(2008-5#1)(2010-4#1)
ways to avoid them##2##4##(2007-8#1)(2010-8#1)
ways to create##2##3##(2008-9#1)(2009-9#1)
ways to cut##2##3##(1990-4#1)(2008-8#1)
ways to determine the##2##4##(1994-1#1)(2008-2#1)
ways to develop##2##3##(1992-2#1)(2013-1#1)
ways to eliminate##2##3##(2008-4#1)(2010-11#1)
ways to enhance##2##3##(2007-4#1)(2012-3#1)
ways to help##2##3##(1994-1#1)(1995-9#1)
ways to improve the##4##4##(1994-2#1)(2008-8#1)(2008-9#1)(2010-4#1)
ways to improve##10##3##(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)
ways to increase the##3##4##(1996-9#1)(2011-1#1)(2012-12#1)
ways to increase##5##3##(1996-9#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
ways to measure the performance of fund development programs##2##9##(1995-1#1)(1995-3#1)
ways to overcome the##2##4##(1991-2#1)(2008-10#1)
ways to prevent##3##3##(1996-5#1)(2008-11#2)
ways to promote##2##3##(2008-12#1)(2013-7#1)
ways to reduce##4##3##(1993-2#1)(1996-12#1)(2007-11#2)
ways to support patients##2##4##(2008-1#1)(2011-1#1)
ways to support##3##3##(1992-3#1)(2008-1#1)(2011-1#1)
ways to work##2##3##(1996-12#1)(2008-12#1)
ways to##117##2##(1990-4#1)(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#5)(1994-9#1)(1995-1#4)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
ways when##2##2##(1993-1#1)(2008-7#1)
ways##400##1##(1990-10#2)(1990-11#1)(1990-3#3)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#4)(1992-1#2)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#4)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#3)(1994-1#2)(1994-12#5)(1994-2#8)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#2)(1996-3#7)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#4)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#6)(2007-4#3)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#28)(2008-11#18)(2008-12#10)(2008-2#7)(2008-3#13)(2008-4#5)(2008-5#14)(2008-6#5)(2008-7#20)(2008-8#13)(2008-9#11)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#4)(2010-11#5)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-2#11)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#7)(2012-9#1)(2013-1#15)(2013-7#4)(2013-8#5)
wcmmVtg##4##1##(2010-5#4)
we achieve the##2##3##(2007-12#1)(2009-9#1)
we achieve##11##2##(1995-11#1)(2007-11#2)(2007-12#4)(2008-3#2)(2008-6#1)(2009-9#1)
we achieved a##6##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#3)
we achieved an##3##3##(2008-2#1)(2008-3#2)
we achieved##25##2##(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#12)(2008-6#1)(2012-2#1)
we adapt the##2##3##(2008-8#2)
we add a##2##3##(2008-3#1)(2012-2#1)
we added##2##2##(1994-8#1)(2013-1#1)
we address key##2##3##(2008-11#2)
we address the##4##3##(2008-9#1)(2010-9#1)(2011-1#1)(2013-8#1)
we address##10##2##(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
we addressed the##2##3##(1994-8#1)(2012-3#1)
we addressed##3##2##(1994-8#1)(2009-8#1)(2012-3#1)
we administered##7##2##(1990-12#1)(1990-7#1)(1991-9#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-1#1)
we adopted##2##2##(1996-5#1)(2008-9#1)
we advocate##4##2##(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
we aim to##8##3##(2008-7#3)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
we aimed to investigate the##3##5##(2011-1#1)(2013-7#1)(2013-8#1)
we aimed to##13##3##(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
we aimed##14##2##(2007-8#2)(2008-1#1)(2008-11#2)(2008-7#2)(2009-8#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
we all##3##2##(1994-2#1)(1995-1#1)(2012-2#1)
we also demonstrate the##2##4##(2008-3#1)(2012-2#1)
we also demonstrate##4##3##(1991-12#1)(1993-12#1)(2008-3#1)(2012-2#1)
we also describe##2##3##(2008-2#1)(2009-6#1)
we also developed##2##3##(2008-8#1)(2012-3#1)
we also discuss the##3##4##(1992-5#1)(2008-2#1)(2009-8#1)
we also discuss##4##3##(1992-5#1)(2008-11#1)(2008-2#1)(2009-8#1)
we also examined##4##3##(1995-11#1)(2008-11#1)(2009-8#1)(2011-2#1)
we also found that##3##4##(2007-11#1)(2007-2#1)(2008-9#1)
we also found##8##3##(1993-9#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
we also investigate##3##3##(2008-6#1)(2008-8#2)
we also investigated the##3##4##(1994-6#1)(2008-10#1)(2008-4#1)
we also investigated##5##3##(1993-6#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-4#1)
we also measured##2##3##(1992-2#1)(1994-8#1)
we also observed a##2##4##(2007-10#1)(2008-3#1)
we also observed##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
we also present##5##3##(2007-12#1)(2008-3#3)(2011-1#1)
we also report##2##3##(2008-2#1)(2011-2#1)
we also review##2##3##(2008-8#1)(2009-12#1)
we also show that##2##4##(1993-8#1)(2008-2#1)
we also show##3##3##(1993-8#1)(2008-2#1)(2008-7#1)
we also used##3##3##(2008-9#2)(2009-10#1)
we also##72##2##(1991-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1996-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#4)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)
we amplified the##2##3##(1990-12#1)(2008-11#1)
we amplified##3##2##(1990-12#1)(2008-11#2)
we analyse the##6##3##(2008-11#1)(2008-7#3)(2009-5#1)(2012-5#1)
we analyse##9##2##(2008-11#1)(2008-7#4)(2009-5#1)(2011-2#1)(2011-3#1)(2012-5#1)
we analysed the##2##3##(1990-8#1)(2009-4#1)
we analysed##7##2##(1990-8#1)(1993-9#1)(1997-7#1)(2008-4#1)(2009-10#1)(2009-2#1)(2009-4#1)
we analytically##2##2##(2007-11#1)(2008-3#1)
we analyze in detail the##2##5##(2008-3#1)(2012-3#1)
we analyze the behavior of##2##5##(2007-12#1)(2008-3#1)
we analyze the results obtained in 20 patients treated with phrenic-musculocutaneous nerve transfer to restore elbow flexion after brachial plexus injuries##2##21##(2008-9#2)
we analyze the##16##3##(1990-8#1)(1994-1#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-6#1)(2011-2#1)
we analyze##27##2##(1990-8#1)(1993-6#1)(1994-1#1)(1995-1#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
we analyzed the clinical##3##4##(1991-3#1)(2006-10#1)(2011-2#1)
we analyzed the##28##3##(1990-11#1)(1990-9#1)(1991-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
we analyzed whether the##2##4##(1995-12#1)(2008-10#1)
we analyzed whether##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
we analyzed##61##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#2)(1994-12#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-2#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-6#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
we and##4##2##(1990-6#1)(2008-11#1)(2009-3#1)(2013-1#1)
we applied a##8##3##(1993-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-3#1)
we applied the##4##3##(1993-3#1)(1997-8#1)(2008-5#1)(2010-8#1)
we applied##22##2##(1993-12#1)(1993-3#1)(1993-6#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
we apply a##3##3##(1996-4#1)(2008-2#1)(2010-2#1)
we apply only##2##3##(2008-3#2)
we apply the##3##3##(2008-2#1)(2010-8#1)(2012-3#1)
we apply##16##2##(1996-4#1)(1997-8#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
we approach##3##2##(2008-10#1)(2008-4#1)(2013-7#1)
we are able to estimate the##2##6##(2008-10#1)(2009-11#1)
we are able to##18##4##(1990-7#1)(1994-5#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-11#2)(2010-12#1)
we are aware of the##2##5##(2007-10#1)(2008-3#1)
we are aware##5##3##(1993-6#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-3#1)
we are beginning to##2##4##(2007-4#1)(2008-8#1)
we are developing##3##3##(1995-2#1)(2008-11#1)(2011-1#1)
we are expecting the##2##4##(2010-8#2)
we are expecting##3##3##(1997-8#1)(2010-8#2)
we are faced with##2##4##(1995-12#1)(2010-11#1)
we are going to##3##4##(2012-3#1)(2013-1#2)
we are going##7##3##(1994-12#1)(2009-5#1)(2012-3#1)(2013-1#4)
we are in a##2##4##(2008-11#1)(2008-3#1)
we are not##3##3##(2008-12#1)(2008-4#1)(2011-2#1)
we are now##5##3##(1992-4#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
we are presenting a##2##4##(1992-11#1)(2008-10#1)
we are presenting##4##3##(1992-11#1)(2008-10#1)(2010-7#1)(2013-1#1)
we are reporting a case of##3##6##(2008-7#1)(2010-11#1)(2012-2#1)
we are to##5##3##(1992-9#1)(2006-10#1)(2008-12#1)(2010-3#1)(2013-1#1)
we are witnessing a##2##4##(2010-8#1)(2011-1#1)
we are##92##2##(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-6#2)(1994-1#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#1)
we argue that a##2##4##(2008-11#1)(2008-8#1)
we argue that the##4##4##(1992-2#1)(1996-10#1)(2007-12#1)(2008-8#1)
we argue that##17##3##(1992-11#1)(1992-2#1)(1996-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
we argue##19##2##(1992-11#1)(1992-2#1)(1996-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
we ask how##2##3##(2008-7#1)(2011-2#1)
we ask whether##2##3##(2008-7#1)(2009-2#1)
we ask##5##2##(1993-12#1)(2008-7#2)(2009-2#1)(2011-2#1)
we asked whether##6##3##(1995-2#1)(1996-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-7#1)
we asked##11##2##(1990-11#1)(1995-2#1)(1996-5#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-7#1)
we assess the##2##3##(1996-2#1)(2013-1#1)
we assess##5##2##(1996-2#1)(2007-5#1)(2008-8#2)(2013-1#1)
we assessed the effects of##3##5##(2009-10#1)(2012-3#2)
we assessed the##14##3##(1993-1#1)(1996-2#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-3#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
we assessed##30##2##(1993-1#1)(1993-3#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-3#1)(2011-2#2)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#2)
we assume that##5##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
we assume##8##2##(1995-12#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#2)
we assumed that##2##3##(1995-6#1)(2008-8#1)
we attempt to##12##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2012-2#1)(2012-3#1)
we attempted to evaluate the##2##5##(1996-6#1)(2008-10#1)
we attempted to evaluate##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
we attempted to identify##2##4##(2008-10#1)(2012-12#1)
we attempted to##19##3##(1990-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
we attempted##21##2##(1990-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
we attribute to the##2##4##(2008-7#1)(2008-9#1)
we attribute to##3##3##(2008-3#1)(2008-7#1)(2008-9#1)
we attribute##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)
we be##3##2##(1994-3#1)(2006-10#1)(2008-11#1)
we begin to##2##3##(2009-12#1)(2010-11#1)
we begin##3##2##(2008-11#1)(2009-12#1)(2010-11#1)
we believe are##4##3##(2006-12#1)(2007-12#2)(2012-2#1)
we believe is##19##3##(2007-12#3)(2008-2#1)(2008-3#14)(2008-9#1)
we believe it is##2##4##(2008-7#1)(2009-5#1)
we believe it##3##3##(1997-2#1)(2008-7#1)(2009-5#1)
we believe that it##2##4##(2008-1#1)(2012-3#1)
we believe that the##8##4##(1992-2#1)(1995-12#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-12#1)
we believe that##24##3##(1990-10#2)(1992-2#1)(1994-6#1)(1995-12#1)(1996-11#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
we believe##79##2##(1990-10#2)(1992-2#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-2#1)(2006-12#1)(2007-11#3)(2007-12#11)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#26)(2008-7#5)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
we blocked##2##2##(2007-11#1)(2009-3#1)
we briefly describe##2##3##(2008-7#1)(2012-2#1)
we briefly discuss##4##3##(2008-11#2)(2011-1#1)(2012-2#1)
we briefly review the##2##4##(2008-5#1)(2008-7#1)
we briefly summarize##2##3##(2008-11#1)(2008-7#1)
we briefly##14##2##(1993-12#1)(2008-11#3)(2008-5#1)(2008-7#3)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#2)
we built##3##2##(2008-3#2)(2008-8#1)
we calculate the##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
we calculate##9##2##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-2#1)
we calculated a##2##3##(1992-9#1)(1995-2#1)
we calculated the##3##3##(2008-3#2)(2012-5#1)
we calculated##13##2##(1992-6#1)(1992-9#1)(1995-2#1)(2008-2#1)(2008-3#3)(2010-8#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)
we call the##4##3##(2007-11#1)(2008-3#2)(2009-9#1)
we call##15##2##(1990-12#1)(1990-5#1)(1997-3#1)(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-9#2)
we called##3##2##(1992-3#1)(2008-5#1)(2010-8#1)
we can achieve##4##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)
we can calculate##2##3##(2008-3#1)(2008-7#1)
we can conclude that##3##4##(2011-2#1)(2011-7#1)(2013-1#1)
we can conclude##4##3##(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
we can control##2##3##(2007-12#1)(2011-2#1)
we can develop##2##3##(2008-10#1)(2009-9#1)
we can establish##2##3##(1995-6#1)(2013-8#1)
we can expect##3##3##(2008-3#1)(2010-3#2)
we can learn##3##3##(1993-12#2)(1996-2#1)
we can make##2##3##(1996-2#1)(2008-2#1)
we can now##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)
we can obtain##2##3##(2007-12#1)(2008-3#1)
we can predict##2##3##(2010-3#1)(2011-2#1)
we can rely on##2##4##(2008-7#1)(2008-8#1)
we can show that##2##4##(1994-2#1)(2008-5#1)
we can use the##2##4##(2007-11#1)(2007-12#1)
we can use##4##3##(2007-11#1)(2007-12#1)(2008-12#1)(2012-3#1)
we cannot completely discount the##2##5##(2008-10#2)
we cannot##11##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-6#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2012-2#1)
we captured##2##2##(2009-4#2)
we carried out Northern blot analysis##2##6##(1993-8#1)(1997-8#1)
we carried out a##7##4##(1991-6#2)(1997-5#1)(2008-3#1)(2010-1#1)(2010-12#1)(2012-2#1)
we carried out##14##3##(1991-6#2)(1993-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#2)
we characterize the##4##3##(2008-3#1)(2009-10#1)(2010-12#1)(2011-2#1)
we characterize##7##2##(2008-3#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
we characterized an##2##3##(2008-10#1)(2009-8#1)
we characterized the##6##3##(1993-9#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-2#1)(2012-3#1)
we characterized##15##2##(1993-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2009-8#1)(2010-2#1)(2012-2#2)(2012-3#1)
we chose##4##2##(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
we clarify the##2##3##(2008-3#2)
we cloned a cDNA##2##4##(1992-8#1)(2008-8#1)
we cloned a##3##3##(1992-8#1)(1997-6#1)(2008-8#1)
we cloned and sequenced##3##4##(1993-6#1)(1994-12#1)(1995-8#1)
we cloned and##6##3##(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-4#1)
we cloned the##3##3##(1994-8#1)(1997-7#1)(2008-5#1)
we cloned##17##2##(1991-9#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#1)
we collected##6##2##(2008-5#2)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
we combine##4##2##(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)
we combined##8##2##(1994-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-1#1)(2012-3#2)(2013-1#1)
we comment on##2##3##(1991-12#1)(2010-9#1)
we compare our##2##3##(2008-10#1)(2009-8#1)
we compare the performance of a##2##6##(2008-2#1)(2008-3#1)
we compare the performance of##3##5##(2008-2#1)(2008-3#2)
we compare the results##2##4##(2008-10#1)(2008-2#1)
we compare the##17##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#2)(2012-5#1)
we compare##37##2##(1996-3#1)(1996-9#1)(1997-7#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#6)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#3)(2012-5#1)
we compared performance under eight##2##5##(2008-6#2)
we compared the effects of##2##5##(1993-5#1)(1995-11#1)
we compared the effects##3##4##(1993-5#1)(1995-11#1)(2008-10#1)
we compared the results of##3##5##(2007-8#1)(2008-3#1)(2011-2#1)
we compared the##30##3##(1990-3#1)(1991-12#1)(1993-11#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
we compared##49##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-11#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-5#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
we compute the##5##3##(2008-2#1)(2008-7#1)(2009-3#1)(2010-2#1)(2012-2#1)
we compute##7##2##(2008-2#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-2#1)(2012-2#1)
we concentrate on##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
we conclude that both##2##4##(1990-11#1)(2008-8#1)
we conclude that inositol##2##4##(1993-5#2)
we conclude that the##18##4##(1990-5#2)(1991-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-8#1)(2007-12#2)(2008-10#5)(2008-5#1)(2008-7#1)
we conclude that there is##2##5##(2008-3#2)
we conclude that there##4##4##(1995-2#1)(2008-3#2)(2008-8#1)
we conclude that these##2##4##(1990-2#1)(1991-2#1)
we conclude that this##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
we conclude that##66##3##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-9#1)(1993-11#1)(1993-5#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#2)(2011-2#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
we conclude##69##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-9#1)(1993-11#1)(1993-5#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#4)(2011-2#2)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
we concluded that the##6##4##(1991-9#1)(1992-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
we concluded that##17##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-12#1)(1995-12#2)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2011-1#1)(2013-7#1)(2013-8#1)
we conduct a##2##3##(2007-8#1)(2008-8#1)
we conduct##4##2##(2007-8#1)(2008-8#1)(2008-9#1)(2009-7#1)
we conducted a study##2##4##(1996-3#1)(2013-1#1)
we conducted a##14##3##(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-10#2)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
we conducted several##2##3##(2008-10#1)(2008-3#1)
we conducted##33##2##(1996-3#1)(1997-4#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
we configure##2##2##(2008-2#2)
we confirm that##4##3##(1994-8#1)(2008-3#2)(2012-12#1)
we confirm##7##2##(1994-6#1)(1994-8#1)(2008-3#3)(2009-7#1)(2012-12#1)
we confirmed that##4##3##(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
we confirmed the##2##3##(2008-3#1)(2011-2#1)
we confirmed##9##2##(1992-8#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-6#1)(2011-2#2)(2012-2#1)
we consider a##4##3##(1990-8#1)(2008-10#1)(2009-10#1)(2013-8#1)
we consider our##2##3##(2008-10#1)(2008-11#1)
we consider that##3##3##(2008-5#1)(2010-7#1)(2011-2#1)
we consider the consequences##2##4##(2008-8#1)(2008-9#1)
we consider the##13##3##(1995-5#1)(1996-1#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
we consider to be##2##4##(2007-11#1)(2008-9#1)
we consider##53##2##(1990-8#1)(1990-9#1)(1991-3#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
we considered the##2##3##(1997-8#1)(2008-3#1)
we considered##4##2##(1994-11#1)(1997-8#1)(2008-3#1)(2012-12#1)
we construct a##3##3##(1997-4#1)(2008-6#1)(2008-8#1)
we construct an##2##3##(2008-2#1)(2008-3#1)
we construct##6##2##(1997-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
we constructed a cDNA library##3##5##(1993-3#1)(2008-8#1)(2008-9#1)
we constructed a plasmid##2##4##(1992-12#1)(1997-6#1)
we constructed a##15##3##(1991-6#1)(1992-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
we constructed##26##2##(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-11#3)(2008-8#1)(2008-9#3)(2009-8#1)(2012-2#1)(2012-3#1)
we continually strive to compare our group's performance to accepted standards of cost and production##2##15##(1994-3#2)
we continually##3##2##(1994-3#2)(2008-10#1)
we continue to##2##3##(1995-9#1)(2010-12#1)
we control the##2##3##(2007-11#1)(2008-3#1)
we could detect##4##3##(1993-8#1)(1995-12#1)(1996-12#1)(1997-6#1)
we could examine the##2##4##(2007-12#1)(2008-3#1)
we could not detect##2##4##(1993-8#1)(1994-8#1)
we could not##7##3##(1993-8#1)(1994-8#1)(2007-11#1)(2007-7#1)(2008-8#1)(2010-7#1)(2011-1#1)
we could provide##2##3##(1991-11#1)(2008-7#1)
we could show that the##2##5##(1997-7#1)(2008-11#1)
we could show that##4##4##(1997-7#1)(2008-11#1)(2009-6#1)(2011-1#1)
we could show##5##3##(1997-7#1)(2008-11#1)(2009-12#1)(2009-6#1)(2011-1#1)
we could##41##2##(1990-8#2)(1991-11#1)(1993-8#2)(1994-7#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-7#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#3)(2009-6#1)(2010-7#1)(2011-1#3)
we create a##2##3##(2008-2#1)(2008-8#1)
we create##4##2##(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)
we created a##6##3##(1995-8#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-3#1)
we created##7##2##(1995-8#1)(2008-7#2)(2009-10#2)(2011-2#1)(2012-3#1)
we critically evaluate##2##3##(2012-2#2)
we critically##4##2##(2008-10#1)(2009-12#1)(2012-2#2)
we cultured the##2##3##(1993-6#1)(2010-11#1)
we currently use##2##3##(2010-7#1)(2011-2#1)
we currently##5##2##(1994-3#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)
we deal with##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
we decided to##6##3##(1994-11#1)(1995-12#1)(1996-12#1)(2008-11#1)(2013-1#1)(2013-7#1)
we deduce##3##2##(2007-11#1)(2008-2#1)(2008-9#1)
we define the##2##3##(1991-8#1)(2008-7#1)
we define##7##2##(1991-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
we defined four##2##3##(2008-10#1)(2011-2#1)
we defined the##2##3##(1995-2#1)(2008-8#1)
we defined##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
we delineate##2##2##(1992-12#1)(2012-2#1)
we demonstrate a novel##3##4##(2008-11#1)(2012-2#2)
we demonstrate a simple##3##4##(2008-10#1)(2008-3#2)
we demonstrate a##13##3##(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#4)(2012-2#3)
we demonstrate by##3##3##(1997-7#1)(2008-3#1)(2010-11#1)
we demonstrate efficient##2##3##(2007-12#1)(2008-11#1)
we demonstrate for##2##3##(2008-10#1)(2008-8#1)
we demonstrate here##2##3##(2012-12#1)(2012-2#1)
we demonstrate how our lab##3##5##(2008-8#3)
we demonstrate how to##2##4##(2008-6#1)(2008-8#1)
we demonstrate how##10##3##(2008-10#1)(2008-6#1)(2008-8#5)(2010-8#1)(2012-2#1)(2013-1#1)
we demonstrate such##2##3##(2008-11#1)(2008-3#1)
we demonstrate that a##4##4##(1997-2#1)(2007-12#2)(2009-11#1)
we demonstrate that an##3##4##(1991-9#1)(1993-11#1)(2012-3#1)
we demonstrate that the##20##4##(1992-12#1)(1993-12#1)(1993-8#2)(1994-8#2)(1995-2#1)(1995-6#2)(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#3)
we demonstrate that these##2##4##(1994-6#1)(1997-4#1)
we demonstrate that this##3##4##(2008-3#1)(2009-10#1)(2013-8#1)
we demonstrate that##79##3##(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#3)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
we demonstrate the potential##2##4##(2008-2#2)
we demonstrate the##24##3##(1990-12#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
we demonstrate what##2##3##(2007-11#1)(2007-12#1)
we demonstrate##159##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#3)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#8)(2007-12#11)(2008-1#1)(2008-10#10)(2008-11#7)(2008-2#7)(2008-3#14)(2008-4#1)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#6)(2012-2#12)(2012-3#1)(2013-1#4)(2013-8#1)
we demonstrated a##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
we demonstrated that a##3##4##(1993-8#1)(2009-2#1)(2011-1#1)
we demonstrated that both##2##4##(1991-12#1)(2008-10#1)
we demonstrated that the##11##4##(1991-5#1)(1992-12#1)(1994-6#1)(1997-2#1)(2008-11#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
we demonstrated that this##2##4##(1996-2#1)(2008-5#1)
we demonstrated that##40##3##(1990-4#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
we demonstrated the##3##3##(1996-5#1)(2008-3#1)(2013-1#1)
we demonstrated##53##2##(1990-4#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-6#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
we derive a##8##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-5#1)(2011-1#1)
we derive explicit##2##3##(1995-5#1)(2008-3#1)
we derive##18##2##(1995-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#2)(2009-5#2)(2011-1#1)(2011-2#1)(2013-8#1)
we derived the##2##3##(2008-3#1)(2012-2#1)
we derived##5##2##(2008-3#3)(2012-2#2)
we describe 2##2##3##(2007-10#1)(2013-8#1)
we describe a case of##4##5##(2010-6#1)(2010-7#1)(2013-1#2)
we describe a method##3##4##(1990-12#1)(2008-12#1)(2011-2#1)
we describe a new method##3##5##(2008-11#1)(2008-7#1)(2012-2#1)
we describe a new##7##4##(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
we describe a novel##4##4##(2008-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
we describe a patient##2##4##(2008-4#1)(2010-11#1)
we describe a set of##2##5##(2008-4#1)(2010-11#1)
we describe a simple##5##4##(1990-11#1)(1990-12#1)(1990-8#1)(2008-11#1)(2012-2#1)
we describe a##61##3##(1990-11#1)(1990-12#3)(1990-8#1)(1992-11#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#1)
we describe an approach##3##4##(2008-7#1)(2009-5#1)(2010-5#1)
we describe an automated##2##4##(2008-10#1)(2009-9#1)
we describe an##15##3##(1994-12#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
we describe and##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
we describe for the first time a##2##7##(2008-10#1)(2008-6#1)
we describe how the##2##4##(2008-10#1)(2008-9#1)
we describe how##6##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-9#2)(2011-2#1)
we describe one##2##3##(2008-8#1)(2010-8#1)
we describe our approach to##2##5##(2011-2#1)(2012-12#1)
we describe our##6##3##(1994-11#1)(1997-9#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
we describe recent##3##3##(2008-7#1)(2012-1#1)(2013-1#1)
we describe six##2##3##(1997-3#1)(2007-7#1)
we describe some of the##2##5##(2009-9#1)(2010-7#1)
we describe some of##3##4##(1991-3#1)(2009-9#1)(2010-7#1)
we describe that##2##3##(2008-10#1)(2011-2#1)
we describe the application of##4##5##(2008-10#1)(2008-7#1)(2013-1#2)
we describe the application##5##4##(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#2)
we describe the basic##3##4##(2009-5#1)(2011-2#2)
we describe the construction of a##2##6##(1990-8#1)(2008-11#1)
we describe the construction of##3##5##(1990-8#1)(2008-11#1)(2011-1#1)
we describe the design##2##4##(2008-10#1)(2009-9#1)
we describe the experience##2##4##(2011-2#1)(2013-1#1)
we describe the features of this organism##17##7##(2011-2#17)
we describe the features of this##18##6##(2011-2#18)
we describe the features of##23##5##(2011-2#23)
we describe the first##2##4##(1997-6#1)(2008-9#1)
we describe the identification and##2##5##(1994-12#2)
we describe the identification##3##4##(1994-12#2)(2013-1#1)
we describe the in##2##4##(2008-11#1)(2012-12#1)
we describe the results of##3##5##(2008-2#1)(2008-6#1)(2013-8#1)
we describe the role of##2##5##(2011-2#1)(2013-1#1)
we describe the use of##4##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
we describe the##108##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#6)(1995-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-12#2)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#31)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
we describe two##6##3##(1990-10#1)(1992-11#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
we describe##256##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#2)(1991-12#1)(1991-3#2)(1992-11#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-6#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#1)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#40)(2012-1#1)(2012-12#7)(2012-2#14)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#4)
we described a##2##3##(2007-6#1)(2008-3#1)
we described the##5##3##(1994-6#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-7#1)
we described##7##2##(1994-6#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-7#1)
we design a##2##3##(2008-2#1)(2008-3#1)
we design##4##2##(1995-5#1)(2008-2#1)(2008-3#1)(2010-2#1)
we designated##2##2##(1994-12#1)(2008-10#1)
we designed a##5##3##(1996-2#1)(1997-6#1)(2008-1#1)(2008-7#1)(2010-2#1)
we designed and##2##3##(2008-10#1)(2008-9#1)
we designed can##2##3##(2008-3#1)(2008-9#1)
we designed the##3##3##(2008-2#1)(2008-7#2)
we designed two##2##3##(1993-12#1)(2013-1#1)
we designed##17##2##(1993-12#1)(1996-2#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#2)(2010-2#1)(2010-8#1)(2013-1#1)
we detail##2##2##(2007-9#1)(2013-1#1)
we detect##2##2##(1992-6#1)(2012-2#1)
we detected a##2##3##(1992-6#1)(1993-3#1)
we detected##10##2##(1992-6#1)(1993-3#1)(1993-6#1)(1995-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
we determine that##2##3##(2008-8#1)(2012-3#1)
we determine the##9##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#4)
we determine##16##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#6)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
we determined that the##3##4##(1992-12#1)(2008-2#1)(2008-3#1)
we determined that##8##3##(1992-12#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
we determined the expression##3##4##(2010-12#1)(2013-7#1)(2013-8#1)
we determined the##25##3##(1990-8#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
we determined whether##2##3##(1992-9#1)(1997-3#1)
we determined##48##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
we develop a general##2##4##(1996-3#1)(2013-1#1)
we develop a new##3##4##(2008-3#1)(2008-7#1)(2009-9#1)
we develop a simple##2##4##(1997-8#1)(2008-11#1)
we develop a##19##3##(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#3)(2013-8#2)
we develop an##6##3##(1997-3#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-2#1)
we develop and##3##3##(2008-3#1)(2008-9#1)(2012-3#1)
we develop##35##2##(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
we developed a model##4##4##(1996-5#1)(2008-3#1)(2008-8#1)(2013-1#1)
we developed a new##7##4##(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
we developed a novel##6##4##(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)
we developed a rapid##3##4##(2008-10#1)(2008-11#2)
we developed a##54##3##(1990-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#3)(2009-2#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
we developed an in##2##4##(1990-8#1)(2013-1#1)
we developed an##10##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-2#1)(2013-1#2)
we developed and optimized##2##4##(1997-2#1)(2008-10#1)
we developed and##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2013-8#1)
we developed novel##2##3##(2008-10#2)
we developed two in vitro##2##5##(2008-10#1)(2012-2#1)
we developed two##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
we developed##93##2##(1990-8#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#4)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2009-2#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
we devised an##2##3##(2008-10#1)(2008-5#1)
we devised##3##2##(2008-10#2)(2008-5#1)
we diagnosed this##3##3##(2009-1#1)(2010-6#2)
we diagnosed##9##2##(1997-8#1)(2007-8#2)(2008-10#1)(2009-1#1)(2010-6#2)(2011-2#1)(2012-1#1)
we did not find a##2##5##(2012-3#1)(2013-1#1)
we did not find##4##4##(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
we did not##9##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
we did##12##2##(1992-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
we directly##5##2##(1995-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
we discovered a##2##3##(2012-2#1)(2012-3#1)
we discovered that##6##3##(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
we discovered##11##2##(1990-5#1)(2007-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
we discuss a##4##3##(1995-2#1)(2008-8#1)(2011-2#1)(2013-8#1)
we discuss how##8##3##(2008-3#3)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
we discuss in##2##3##(2009-8#1)(2012-2#1)
we discuss our##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
we discuss possible##2##3##(2009-8#2)
we discuss potential##2##3##(2009-6#1)(2011-2#1)
we discuss recent advances in##3##5##(1994-3#1)(2010-7#1)(2012-12#1)
we discuss recent##7##3##(1994-3#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
we discuss several##4##3##(1994-2#1)(1995-9#1)(2008-11#1)(2008-7#1)
we discuss some of the##2##5##(2008-11#1)(2009-2#1)
we discuss some##4##3##(2008-11#2)(2009-2#1)(2010-5#1)
we discuss the implications of##2##5##(2008-8#1)(2011-2#1)
we discuss the importance of##3##5##(2008-11#2)(2011-2#1)
we discuss the possibility##2##4##(2011-1#1)(2011-2#1)
we discuss the possible##4##4##(2009-6#1)(2009-8#2)(2011-2#1)
we discuss the potential##2##4##(2009-8#2)
we discuss the role of##5##5##(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
we discuss the##75##3##(1991-12#1)(1992-11#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#9)(2010-1#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#11)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
we discuss these##3##3##(2009-8#1)(2010-12#1)(2010-6#1)
we discuss three##4##3##(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
we discuss two##2##3##(2007-11#1)(2008-9#1)
we discuss various##2##3##(2008-11#1)(2010-8#1)
we discuss##155##2##(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#12)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#15)(2009-9#2)(2010-1#2)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#18)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#5)
we discussed##2##2##(2008-10#1)(2009-8#1)
we distinguish##2##2##(2008-7#1)(2010-3#1)
we divided the##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
we divided##4##2##(2008-12#1)(2008-8#1)(2011-2#1)(2013-7#1)
we do not know how##2##5##(1991-3#1)(2012-3#1)
we do not know##4##4##(1991-3#1)(2008-10#2)(2012-3#1)
we do not##16##3##(1990-10#1)(1991-12#1)(1991-3#1)(1992-4#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-3#1)
we do with##3##3##(2008-8#1)(2010-10#2)
we do##38##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-1#1)(1996-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#8)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
we document the##4##3##(1995-6#1)(2008-11#1)(2008-9#1)(2011-3#1)
we document##5##2##(1995-6#1)(1997-1#1)(2008-11#1)(2008-9#1)(2011-3#1)
we documented##5##2##(2007-10#1)(2008-10#1)(2008-9#1)(2010-9#1)(2013-7#1)
we doing##3##2##(1991-3#1)(2008-11#1)(2012-12#1)
we don't##2##2##(1995-1#1)(2011-2#1)
we draw##2##2##(2008-9#1)(2011-2#1)
we elected to##2##3##(1991-3#1)(2012-12#1)
we emphasize the##4##3##(2007-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
we emphasize##5##2##(2007-10#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
we employ##3##2##(1992-9#1)(2007-12#1)(2008-8#1)
we employed a##2##3##(2006-6#1)(2008-10#1)
we employed##10##2##(1993-3#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#2)
we encounter##2##2##(2008-7#1)(2012-2#1)
we engineered##2##2##(2008-10#1)(2011-2#1)
we establish a##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
we establish##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#1)
we established a new##2##4##(1993-3#1)(2008-10#1)
we established a novel##2##4##(2008-10#1)(2013-1#1)
we established a##10##3##(1993-3#1)(1997-1#1)(2008-10#4)(2009-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
we established rat astrocyte cell lines containing the plasmid for production of recombinant rat Epo##2##15##(2008-11#2)
we established##21##2##(1990-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(1997-1#1)(2008-10#5)(2008-11#4)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
we estimate that the##2##4##(2007-12#1)(2008-11#1)
we estimate that##7##3##(1993-12#1)(1994-9#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#2)
we estimate the##3##3##(2008-3#2)(2013-1#1)
we estimate##16##2##(1993-12#1)(1994-9#1)(1996-11#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-3#3)(2008-8#1)(2010-3#1)(2013-1#2)
we estimated that at least##2##5##(2008-10#1)(2008-9#1)
we estimated that##6##3##(1992-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
we estimated the##9##3##(1990-2#1)(1995-12#1)(2008-3#4)(2008-7#1)(2008-9#1)(2013-7#1)
we estimated##17##2##(1990-2#1)(1992-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-7#2)
we evaluate its##2##3##(1992-12#1)(2008-3#1)
we evaluate the##6##3##(2007-7#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
we evaluate##10##2##(1992-12#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
we evaluated the effect of##4##5##(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
we evaluated the effects of##2##5##(2008-11#1)(2013-1#1)
we evaluated the expression of##2##5##(2011-2#1)(2012-12#1)
we evaluated the potential##2##4##(1992-12#1)(2008-10#1)
we evaluated the##34##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#1)
we evaluated whether##3##3##(1997-3#1)(2010-4#1)(2013-1#1)
we evaluated##55##2##(1990-12#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-3#1)(1997-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)
we examine a##2##3##(2008-9#1)(2010-3#1)
we examine how the##2##4##(2010-10#1)(2010-7#1)
we examine how##4##3##(2008-2#1)(2008-8#1)(2010-10#1)(2010-7#1)
we examine the hypothesis that##2##5##(2008-10#1)(2008-3#1)
we examine the impact of##2##5##(2008-3#1)(2010-8#1)
we examine the role of##2##5##(1991-2#1)(2010-3#1)
we examine the##21##3##(1991-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
we examine whether##3##3##(2008-7#1)(2008-8#1)(2009-10#1)
we examine##52##2##(1991-2#1)(1992-2#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
we examined (1)##2##3##(2007-8#1)(2012-3#1)
we examined how postwar appraisals of service mediated the effects of objective aspects of service##2##15##(2013-1#2)
we examined how##5##3##(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#2)
we examined relationships##2##3##(2008-12#1)(2010-7#1)
we examined the ability of##3##5##(1995-8#1)(2008-10#1)(2010-2#1)
we examined the activity of##2##5##(1995-12#1)(2008-10#1)
we examined the effect of##14##5##(1993-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-2#1)(2011-2#1)
we examined the effects of##14##5##(1992-8#1)(1993-3#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#1)(2012-12#1)
we examined the expression of##5##5##(1996-12#2)(1997-6#1)(2008-7#1)(2008-8#1)
we examined the expression##6##4##(1996-12#2)(1997-6#1)(2008-5#1)(2008-7#1)(2008-8#1)
we examined the functional##2##4##(1991-8#1)(1995-8#1)
we examined the influence of##2##5##(1990-2#1)(2008-10#1)
we examined the moderating effects of##2##6##(1996-1#1)(2011-2#1)
we examined the potential of##2##5##(1992-5#1)(2012-7#1)
we examined the relationship between##4##5##(1994-7#1)(1997-6#1)(2008-3#1)(2012-2#1)
we examined the##86##3##(1990-2#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#2)(1995-8#3)(1996-1#1)(1996-12#3)(1996-5#2)(1996-7#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-12#1)(2008-10#10)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-2#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#2)
we examined whether##14##3##(1990-11#1)(1993-12#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
we examined##150##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#3)(1995-12#3)(1995-2#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-12#4)(1996-5#2)(1996-7#1)(1997-4#2)(1997-6#2)(1997-8#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#14)(2008-11#21)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-2#2)(2010-7#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-7#2)(2013-1#9)(2013-8#2)
we expanded##2##2##(2010-8#1)(2013-1#1)
we expect that##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
we expect to##3##3##(2008-7#1)(2008-8#1)(2013-7#1)
we expect##12##2##(1993-1#1)(1997-7#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-7#2)
we experimentally##8##2##(2008-2#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
we explain how##2##3##(2008-10#1)(2010-11#1)
we explain the##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
we explain##9##2##(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)
we explicitly##2##2##(2008-2#1)(2008-3#1)
we exploit##2##2##(2007-11#1)(2008-6#1)
we exploited##2##2##(1991-5#1)(1994-5#1)
we explore the##21##3##(1993-12#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-8#6)(2009-8#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
we explore##31##2##(1993-12#1)(1994-3#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#6)(2009-8#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
we explored the##6##3##(1996-5#1)(1997-3#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
we explored##9##2##(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
we expressed in##2##3##(1990-11#1)(1994-11#1)
we expressed##3##2##(1990-11#1)(1994-11#1)(2008-7#1)
we extend our##2##3##(1996-3#1)(2009-2#1)
we extend the##5##3##(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-3#1)
we extend##11##2##(1996-12#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-3#1)
we extended the##4##3##(1990-5#1)(2009-5#1)(2011-2#1)(2012-3#1)
we extract the##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
we extract##5##2##(1992-12#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
we extracted##2##2##(1997-2#1)(1997-6#1)
we fabricated##6##2##(2008-2#1)(2008-3#3)(2009-5#1)(2012-2#1)
we faced##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
we failed to##3##3##(2008-6#1)(2011-2#1)(2012-1#1)
we fed##3##2##(1990-6#1)(2008-11#1)(2008-5#1)
we feel that##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
we feel##4##2##(2007-11#1)(2008-10#1)(2012-12#1)(2013-1#1)
we finally##2##2##(1995-6#1)(2008-7#1)
we find a##6##3##(1996-2#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
we find an##6##3##(2008-11#1)(2008-3#2)(2012-2#2)(2012-3#1)
we find that the##11##4##(1990-11#1)(1990-7#1)(1992-2#1)(1992-3#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2012-12#1)
we find that##44##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-12#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-8#2)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
we find the##2##3##(2007-12#1)(2013-8#1)
we find##73##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-12#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-7#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#10)(2008-8#4)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
we first describe##2##3##(2008-10#1)(2012-1#1)
we first developed##2##3##(2008-10#1)(2009-10#1)
we first discuss the##2##4##(2008-9#1)(2011-2#1)
we first examined##2##3##(2008-11#1)(2008-7#1)
we first summarize##2##3##(2008-7#1)(2008-8#1)
we first##26##2##(1994-2#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2011-10#1)(2011-2#1)(2012-1#1)
we fit##2##2##(2008-9#1)(2012-2#1)
we focus on a##4##4##(2008-9#1)(2010-10#1)(2011-1#1)(2013-8#1)
we focus on how##3##4##(2009-5#1)(2009-6#1)(2012-12#1)
we focus on the effects of##2##6##(2008-11#2)
we focus on the##13##4##(2008-1#2)(2008-11#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
we focus on two##3##4##(2008-4#1)(2010-6#1)(2010-7#1)
we focus on##37##3##(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
we focus our discussion on##2##5##(2010-3#1)(2011-1#1)
we focus our##3##3##(2008-10#1)(2010-3#1)(2011-1#1)
we focus##44##2##(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
we focused on subjective aspects of military service##2##8##(2013-1#2)
we focused on##5##3##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#2)
we follow the##2##3##(2008-2#1)(2012-12#1)
we follow##3##2##(2008-2#1)(2010-11#1)(2012-12#1)
we followed a##2##3##(2008-7#1)(2009-8#1)
we followed the##3##3##(1997-4#1)(2008-10#2)
we followed##5##2##(1997-4#1)(2008-10#2)(2008-7#1)(2009-8#1)
we formed##2##2##(2008-11#1)(2011-2#1)
we formulate a##2##3##(1994-2#1)(2010-1#1)
we formulate##3##2##(1994-2#1)(2010-1#1)(2012-2#1)
we found a high##2##4##(1992-9#1)(2008-1#1)
we found a significant##5##4##(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
we found a specific##2##4##(2009-10#2)
we found a##21##3##(1990-12#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
we found an##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
we found enhanced##2##3##(2008-11#1)(2008-3#1)
we found evidence of##2##4##(2012-3#1)(2013-1#1)
we found evidence that##3##4##(2008-7#1)(2009-10#1)(2011-2#1)
we found evidence##6##3##(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
we found in the##4##4##(1994-8#1)(2008-10#1)(2008-11#2)
we found in##5##3##(1994-8#1)(1996-8#1)(2008-10#1)(2008-11#2)
we found no differences##2##4##(1995-5#1)(2013-1#1)
we found no evidence for##2##5##(1995-12#1)(2009-8#1)
we found no evidence##4##4##(1995-12#1)(2008-6#1)(2009-8#1)(2013-1#1)
we found no##14##3##(1994-11#1)(1994-6#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
we found significant##2##3##(2008-7#1)(2008-8#1)
we found significantly##2##3##(2008-11#1)(2009-5#1)
we found that a##3##4##(2008-11#1)(2009-7#1)(2012-12#1)
we found that all##2##4##(2008-10#1)(2010-11#1)
we found that the majority##2##5##(2008-11#1)(2009-6#1)
we found that the##39##4##(1990-11#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-8#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-6#2)(2009-8#1)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
we found that there##3##4##(2011-1#1)(2011-2#1)(2012-2#1)
we found that this##2##4##(1990-5#1)(2012-2#1)
we found that##129##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-11#3)(1992-9#1)(1993-6#1)(1993-8#1)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#3)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#11)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
we found the following##2##4##(2008-8#1)(2008-9#1)
we found the##9##3##(1991-5#1)(1996-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)
we found two##3##3##(1995-2#1)(2008-3#1)(2009-2#1)
we found##250##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#3)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#3)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#19)(2008-12#3)(2008-2#1)(2008-3#13)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#16)(2008-9#7)(2009-10#4)(2009-11#2)(2009-2#4)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#4)(2010-11#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#16)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#8)
we functionally##2##2##(2006-6#1)(2010-2#1)
we further##3##2##(1995-11#1)(2008-3#1)(2009-8#1)
we gain##3##2##(1992-3#1)(2008-2#1)(2013-8#1)
we generalize##2##2##(2008-8#1)(2009-12#1)
we generate##2##2##(2008-3#2)
we generated a set of##2##5##(2008-3#2)
we generated a##4##3##(2007-12#1)(2008-11#1)(2008-3#2)
we generated transgenic##3##3##(2008-11#1)(2010-2#1)(2012-12#1)
we generated##21##2##(1994-8#1)(1995-8#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-11#5)(2008-2#2)(2008-3#4)(2008-8#1)(2010-2#1)(2012-12#2)
we give a##4##3##(1992-9#1)(2008-3#1)(2008-7#1)(2009-3#1)
we give##10##2##(1991-6#1)(1992-9#1)(2008-3#3)(2008-7#2)(2009-10#1)(2009-3#1)(2010-11#1)
we go?##2##2##(2007-10#1)(2008-10#1)
we grouped##2##2##(2008-8#1)(2012-3#1)
we had observed##2##3##(2008-1#1)(2008-5#1)
we had previously##2##3##(1996-10#1)(1997-2#1)
we had the##2##3##(1993-5#1)(2009-8#1)
we had##17##2##(1993-5#1)(1995-12#1)(1996-10#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
we have a##4##3##(1991-6#1)(1997-1#2)(2009-3#1)
we have achieved##4##3##(2007-11#3)(2008-2#1)
we have also##4##3##(2008-12#1)(2008-3#1)(2008-5#1)(2009-6#1)
we have always##2##3##(2007-8#1)(2008-12#1)
we have analysed the##2##4##(1996-3#1)(2008-7#1)
we have analysed##3##3##(1996-3#1)(2008-7#1)(2008-9#1)
we have analyzed the effects of##2##6##(2008-11#1)(2008-8#1)
we have analyzed the##7##4##(1995-2#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)
we have analyzed##11##3##(1990-5#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-8#1)
we have applied##4##3##(1990-9#1)(2007-11#1)(2008-2#1)(2011-2#1)
we have assayed##2##3##(1990-5#1)(1991-12#1)
we have assessed the##2##4##(2008-5#1)(2008-7#1)
we have assessed##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
we have attempted to##2##4##(2008-11#1)(2012-12#1)
we have been able to identify##2##6##(1991-12#1)(1997-4#1)
we have been able to##10##5##(1991-12#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#2)(2010-8#1)
we have been informed by the head of the Department of Chemistry at Sri Venkateswara University that the university authorities have taken disciplinary action against Professor Chiranjeevi##2##27##(2008-10#2)
we have been informed by the head of the Department of Chemistry at Sri Venkateswara University that the university authorities have taken disciplinary action against##3##25##(2008-10#3)
we have been##20##3##(1991-12#1)(1994-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-8#1)
we have begun##2##3##(1994-2#1)(2008-7#1)
we have calculated##2##3##(2006-6#1)(2008-3#1)
we have carried out##5##4##(1990-7#1)(1993-11#1)(1997-4#1)(2008-10#1)(2010-12#1)
we have characterized the##4##4##(1990-2#1)(1993-8#1)(1995-2#1)(2008-10#1)
we have characterized##8##3##(1990-2#1)(1991-2#2)(1993-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#1)
we have chosen##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
we have cloned and sequenced the##2##6##(1992-12#1)(1997-7#1)
we have cloned##5##3##(1991-5#1)(1992-12#1)(1993-6#1)(1997-7#1)(2008-5#1)
we have combined##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
we have come to##2##4##(1991-1#1)(2008-3#1)
we have compared the##6##4##(1993-11#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
we have compared##9##3##(1993-11#1)(1995-11#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
we have concluded that the##2##5##(2008-3#1)(2011-2#1)
we have concluded that##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
we have conducted a##2##4##(1991-12#1)(2011-2#1)
we have confirmed that##2##4##(1995-11#1)(2008-7#1)
we have confirmed##4##3##(1995-11#1)(2008-7#2)(2010-12#1)
we have constructed a##6##4##(1997-2#2)(1997-4#1)(2008-11#3)
we have constructed##13##3##(1990-5#1)(1992-12#1)(1993-8#1)(1994-12#1)(1997-2#2)(1997-4#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)
we have created##3##3##(2007-11#1)(2010-9#1)(2012-12#1)
we have demonstrated a##2##4##(2007-12#1)(2013-1#1)
we have demonstrated that the##2##5##(1992-8#1)(1994-8#1)
we have demonstrated that##10##4##(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-3#1)
we have demonstrated##22##3##(1992-6#1)(1992-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-4#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
we have described a##2##4##(1992-12#1)(1997-3#1)
we have described the##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
we have described##7##3##(1990-7#1)(1992-12#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
we have designated##3##3##(1990-5#1)(1991-7#1)(2007-11#1)
we have designed and##2##4##(2008-2#1)(2009-6#1)
we have designed##7##3##(1990-12#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)
we have detected##2##3##(1994-12#1)(1995-9#1)
we have determined a##2##4##(2008-10#1)(2008-8#1)
we have determined its##2##4##(1994-11#1)(1997-7#1)
we have determined the##8##4##(1991-12#2)(1993-6#2)(1993-9#1)(1994-12#1)(1997-3#1)(2008-3#1)
we have determined##15##3##(1991-12#2)(1992-9#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
we have developed a method##2##5##(1993-8#1)(2009-12#1)
we have developed a new method##3##6##(1992-3#1)(2008-10#1)(2008-3#1)
we have developed a new##5##5##(1992-3#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-3#1)
we have developed a novel##2##5##(2008-7#1)(2011-1#1)
we have developed a##27##4##(1990-12#1)(1991-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2011-1#4)(2012-2#1)(2012-3#1)(2013-1#1)
we have developed an##5##4##(1993-8#1)(1994-12#1)(2008-11#1)(2008-7#1)(2011-2#1)
we have developed and##2##4##(2011-1#1)(2013-1#1)
we have developed the##2##4##(2008-2#1)(2008-7#1)
we have developed##48##3##(1990-12#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-9#1)(2011-1#5)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
we have devised a##2##4##(2008-10#1)(2008-7#1)
we have devised##4##3##(1992-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
we have discovered##2##3##(1991-3#1)(2008-8#1)
we have documented in##2##4##(1996-6#1)(2008-10#1)
we have employed##2##3##(2007-8#1)(2010-8#1)
we have established an##2##4##(2008-11#1)(2009-3#1)
we have established the##2##4##(2010-1#1)(2011-1#1)
we have established two##2##4##(2008-10#1)(2008-5#1)
we have established##9##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#1)(2013-8#1)
we have evaluated the effect of##2##6##(1990-5#1)(1993-6#1)
we have evaluated the##6##4##(1990-5#1)(1993-6#1)(2008-11#1)(2008-6#2)(2010-3#1)
we have evaluated##10##3##(1990-12#1)(1990-5#1)(1992-12#1)(1993-6#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-3#1)(2012-3#1)
we have examined the effect of mianserin in combination with the selective dopamine (DA) D(2/3) receptor antagonist raclopride on conditioned avoidance response (CAR)##2##23##(2008-6#2)
we have examined the effect of##3##6##(2008-11#1)(2008-6#2)
we have examined the##12##4##(1991-3#1)(1992-6#1)(1994-2#1)(1997-4#2)(1997-7#1)(2008-11#2)(2008-6#2)(2008-7#2)
we have examined##20##3##(1990-12#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)
we have explored the##4##4##(1990-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
we have explored##6##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
we have expressed##5##3##(1990-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-7#1)
we have extended these results to##2##6##(1990-5#1)(1991-12#1)
we have extended##3##3##(1990-5#1)(1991-12#1)(2008-5#1)
we have followed##2##3##(2007-5#1)(2008-8#1)
we have found that a##2##5##(1991-11#1)(1995-2#1)
we have found that the##3##5##(1994-11#1)(2008-11#1)(2010-11#1)
we have found that these##2##5##(1993-11#1)(2008-1#1)
we have found that##13##4##(1991-11#1)(1993-11#1)(1994-11#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#1)
we have found##21##3##(1991-11#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
we have generated##6##3##(1990-12#1)(1995-2#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-7#1)
we have identified a##3##4##(1993-8#1)(1995-5#1)(2010-3#1)
we have identified and##4##4##(1990-12#1)(1995-2#1)(2008-10#1)(2013-1#1)
we have identified the##8##4##(1990-5#1)(1990-7#1)(1991-9#1)(1995-2#1)(1995-9#1)(2008-4#1)(2010-4#1)(2011-2#1)
we have identified three##2##4##(1990-11#1)(1991-5#1)
we have identified##30##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#3)(1995-5#1)(1995-9#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
we have implemented a##2##4##(2008-3#1)(2008-6#1)
we have implemented##4##3##(2007-12#1)(2008-3#2)(2008-6#1)
we have incorporated##2##3##(2007-5#1)(2009-8#1)
we have increased the##2##4##(2007-11#1)(2008-3#1)
we have initiated a##2##4##(1995-11#1)(2012-3#1)
we have initiated##4##3##(1995-11#2)(2008-10#1)(2012-3#1)
we have introduced a##2##4##(1993-11#1)(1995-8#1)
we have introduced##3##3##(1993-11#1)(1995-2#1)(1995-8#1)
we have investigated the effect of##2##6##(2008-12#1)(2008-7#1)
we have investigated the role of##3##6##(1997-2#1)(2008-10#1)(2008-7#1)
we have investigated the use of##2##6##(1991-5#1)(2008-7#1)
we have investigated the##22##4##(1991-5#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#5)(2010-11#1)(2012-2#1)
we have investigated whether##2##4##(1994-2#1)(2012-2#1)
we have investigated##27##3##(1990-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-6#2)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#5)(2010-11#1)(2012-2#2)
we have isolated a##5##4##(1993-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
we have isolated and##3##4##(1991-2#1)(1991-6#1)(1993-2#1)
we have isolated##16##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-2#2)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)
we have learned##4##3##(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)
we have located##2##3##(1996-12#1)(2008-2#1)
we have made a##2##4##(1990-11#1)(2007-11#1)
we have made an##2##4##(2009-7#1)(2011-2#1)
we have made##9##3##(1990-11#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
we have mapped the##3##4##(1994-12#1)(2008-11#1)(2008-7#1)
we have measured the##5##4##(1991-12#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-4#1)
we have modeled##2##3##(2008-3#1)(2010-4#1)
we have modified the##4##4##(1995-2#1)(2008-10#1)(2008-11#2)
we have named the##2##4##(2008-10#1)(2008-3#1)
we have named##6##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#2)
we have not##3##3##(1993-12#1)(1994-2#1)(1995-8#1)
we have now isolated##2##4##(1994-8#1)(1995-2#1)
we have now##9##3##(1990-9#1)(1991-11#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(2009-6#1)(2010-11#1)
we have observed a##2##4##(1990-3#1)(1996-3#1)
we have observed##11##3##(1990-3#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
we have obtained a##4##4##(1994-11#1)(2007-11#1)(2008-11#1)(2008-12#1)
we have obtained##11##3##(1992-9#2)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-11#1)
we have optimized the##3##4##(2008-11#1)(2011-2#1)(2012-1#1)
we have optimized##4##3##(2008-11#2)(2011-2#1)(2012-1#1)
we have performed a##2##4##(1992-6#1)(2008-7#1)
we have performed##7##3##(1992-6#1)(1994-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
we have prepared##2##3##(1994-11#1)(2008-11#1)
we have previously described##2##4##(1992-8#1)(1996-12#1)
we have previously shown that##2##5##(1990-12#1)(2013-1#1)
we have previously shown to be##2##6##(2008-10#1)(2008-11#1)
we have previously shown##4##4##(1990-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
we have previously##12##3##(1990-12#1)(1992-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
we have produced a##2##4##(2007-11#1)(2010-11#1)
we have produced##11##3##(1994-12#2)(1995-12#2)(2007-11#2)(2008-10#1)(2008-3#1)(2008-7#2)(2010-11#1)
we have proposed a##3##4##(2007-11#1)(2010-3#1)(2010-8#1)
we have proposed##4##3##(2007-11#1)(2008-11#1)(2010-3#1)(2010-8#1)
we have provided##2##3##(2008-3#2)
we have quantified##2##3##(1994-8#1)(2008-10#1)
we have recently shown that##4##5##(2008-11#1)(2009-8#3)
we have recently##9##3##(1997-3#1)(2008-11#2)(2009-2#1)(2009-8#5)
we have reported that##2##4##(2009-8#1)(2011-2#1)
we have reported##4##3##(2008-10#2)(2009-8#1)(2011-2#1)
we have resolved##2##3##(2007-12#1)(2008-3#1)
we have reviewed the literature##2##5##(1996-6#1)(2012-2#1)
we have reviewed the##4##4##(1996-6#1)(1997-7#1)(2008-10#1)(2012-2#1)
we have reviewed##11##3##(1994-12#1)(1994-2#1)(1996-6#1)(1997-7#1)(2006-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
we have screened##2##3##(1990-11#1)(1991-11#1)
we have seen##3##3##(1992-8#1)(2008-7#1)(2008-8#1)
we have shown that a##3##5##(2008-11#1)(2008-7#1)(2011-2#1)
we have shown that in the##2##6##(2009-9#1)(2012-12#1)
we have shown that the##7##5##(1992-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-8#1)
we have shown that##23##4##(1992-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-8#2)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
we have shown the##5##4##(1994-12#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-11#1)
we have shown##33##3##(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
we have sought##2##3##(1992-2#1)(2008-11#1)
we have studied by##2##4##(1993-11#1)(1997-2#1)
we have studied the effect of##2##6##(1993-1#1)(2008-12#1)
we have studied the expression of##2##6##(2008-7#1)(2008-9#1)
we have studied the expression##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
we have studied the##14##4##(1991-11#1)(1993-1#1)(1993-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
we have studied##25##3##(1990-5#1)(1991-11#1)(1992-9#1)(1993-1#1)(1993-11#2)(1995-9#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)
we have succeeded in##2##4##(2008-11#1)(2008-3#1)
we have successfully##4##3##(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)
we have synthesized##3##3##(1992-11#1)(1992-6#1)(2008-5#1)
we have taken##3##3##(1997-3#1)(1997-6#1)(2013-1#1)
we have termed##4##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-7#1)
we have tested the##4##4##(2008-10#1)(2008-11#1)(2009-6#1)(2012-3#1)
we have tested##5##3##(1997-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-3#1)
we have the##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2009-11#1)
we have to##5##3##(1992-12#1)(1995-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
we have transfected##3##3##(1990-5#1)(1991-12#1)(1994-8#1)
we have undertaken a##2##4##(2008-11#1)(2010-9#1)
we have undertaken##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
we have used a##8##4##(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)
we have used the##6##4##(1991-9#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2010-4#1)
we have used this##2##4##(1991-12#1)(2012-2#1)
we have used three##2##4##(1992-12#1)(2008-10#1)
we have used##34##3##(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-2#1)(1996-12#2)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
we have utilized the##2##4##(1990-12#1)(1994-5#1)
we have utilized##6##3##(1990-12#1)(1992-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2009-2#1)
we have witnessed##2##3##(2010-10#1)(2013-8#1)
we have##783##2##(1990-11#3)(1990-12#9)(1990-2#2)(1990-3#1)(1990-5#9)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#7)(1991-12#10)(1991-2#3)(1991-3#2)(1991-5#4)(1991-6#5)(1991-7#1)(1991-9#5)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#1)(1992-3#5)(1992-6#8)(1992-8#7)(1992-9#6)(1993-1#1)(1993-11#7)(1993-12#1)(1993-2#3)(1993-3#4)(1993-6#6)(1993-8#5)(1993-9#3)(1994-11#11)(1994-12#14)(1994-2#10)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#7)(1994-9#1)(1995-11#6)(1995-12#7)(1995-2#14)(1995-3#2)(1995-5#4)(1995-6#6)(1995-8#4)(1995-9#4)(1996-12#5)(1996-3#4)(1996-5#2)(1996-6#3)(1997-1#2)(1997-2#6)(1997-3#8)(1997-4#14)(1997-5#2)(1997-6#1)(1997-7#12)(1997-8#2)(2006-12#2)(2006-6#1)(2007-11#18)(2007-12#12)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#11)(2008-1#3)(2008-10#72)(2008-11#55)(2008-12#9)(2008-2#14)(2008-3#34)(2008-4#6)(2008-5#27)(2008-6#8)(2008-7#41)(2008-8#16)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#14)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#11)(2010-12#4)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#9)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#4)
we here report##2##3##(1996-10#1)(2007-8#1)
we here##6##2##(1996-10#1)(2007-8#1)(2012-1#1)(2012-2#2)(2012-3#1)
we herein##2##2##(2009-8#1)(2010-11#1)
we highlight the##2##3##(2008-10#1)(2013-1#1)
we highlight##11##2##(2008-10#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#3)
we hope to##2##3##(1993-12#1)(2013-8#1)
we hope##4##2##(1993-12#1)(2010-12#1)(2013-8#2)
we hypothesize that the##3##4##(1992-8#1)(1994-9#1)(2009-8#1)
we hypothesize that##10##3##(1992-8#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
we hypothesize##13##2##(1992-8#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)
we hypothesized that the##5##4##(1994-2#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
we hypothesized that##14##3##(1993-12#1)(1994-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
we identified a novel##4##4##(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)
we identified a single##3##4##(1990-8#1)(1993-2#1)(2008-10#1)
we identified a##18##3##(1990-8#1)(1993-2#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
we identified five##3##3##(1993-12#1)(2008-7#1)(2013-1#1)
we identified four##2##3##(1994-11#1)(2012-3#1)
we identified the##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-11#1)
we identified three##2##3##(1995-12#1)(2008-10#1)
we identified two##5##3##(1990-11#1)(1991-8#1)(2008-10#1)(2012-3#2)
we identified##76##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#5)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
we identify a##2##3##(2008-7#1)(2008-9#1)
we identify the##2##3##(1994-6#1)(2008-8#1)
we identify##16##2##(1990-11#1)(1991-1#1)(1994-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
we illustrate how##3##3##(1996-3#1)(2011-1#1)(2013-1#1)
we illustrate the approach##2##4##(2008-7#1)(2009-9#1)
we illustrate the method with##2##5##(2009-5#1)(2012-1#1)
we illustrate the##7##3##(1994-2#1)(2008-10#2)(2008-7#1)(2009-5#1)(2009-9#1)(2012-1#1)
we illustrate this##2##3##(2008-2#1)(2008-3#1)
we illustrate##19##2##(1994-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2011-1#2)(2012-1#1)(2013-1#1)
we implement##2##2##(2007-12#1)(2008-6#1)
we improve##4##2##(1992-5#1)(2008-2#1)(2009-7#1)(2012-2#1)
we in##4##2##(1991-3#1)(1994-11#1)(2007-12#1)(2009-7#1)
we include##6##2##(2006-12#1)(2008-2#1)(2008-3#2)(2009-5#1)(2013-8#1)
we increase the##2##3##(1991-2#1)(2008-8#1)
we increase##4##2##(1991-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
we infer##2##2##(2008-5#1)(2013-1#1)
we inferred that##2##3##(1993-12#1)(2013-1#1)
we inferred##3##2##(1993-12#1)(2013-1#2)
we initiated a##2##3##(2008-10#1)(2013-8#1)
we injected##3##2##(1997-2#1)(2008-11#1)(2008-7#1)
we inserted##2##2##(1996-2#1)(2008-9#1)
we insist##2##2##(2009-5#1)(2012-3#1)
we intend to##6##3##(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-7#1)
we interpret##5##2##(1993-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2011-1#1)
we interpreted##2##2##(2008-2#1)(2009-11#1)
we interviewed##2##2##(2009-4#1)(2012-12#1)
we introduce a new##2##4##(2008-7#1)(2013-8#1)
we introduce a##8##3##(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-2#1)(2013-8#1)
we introduce an##2##3##(2008-3#1)(2010-10#1)
we introduce the##2##3##(2008-3#1)(2010-7#1)
we introduce##16##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
we introduced a##2##3##(2008-10#1)(2008-2#1)
we introduced the##3##3##(1990-11#1)(1993-11#1)(2008-2#1)
we introduced##8##2##(1990-11#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2011-2#1)
we investigate how##2##3##(2008-3#1)(2010-8#1)
we investigate the effect of##2##5##(2008-2#1)(2008-3#1)
we investigate the feasibility of##2##5##(2008-2#1)(2012-3#1)
we investigate the##20##3##(1992-3#1)(1996-5#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-3#2)
we investigate whether##2##3##(2008-11#1)(2012-3#1)
we investigate##34##2##(1992-3#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-2#1)(2012-3#3)
we investigated how##2##3##(2008-10#1)(2008-11#1)
we investigated if##2##3##(2008-10#1)(2008-4#1)
we investigated in##2##3##(2008-6#1)(2011-2#1)
we investigated the capacity of##2##5##(1995-12#1)(2011-1#1)
we investigated the direct##2##4##(2008-10#1)(2013-1#1)
we investigated the distribution##2##4##(1997-2#1)(2007-10#1)
we investigated the effect of these##2##6##(1997-2#1)(2009-9#1)
we investigated the effect of##15##5##(1992-6#1)(1994-2#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
we investigated the effect##16##4##(1992-6#1)(1994-2#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
we investigated the effects of the##3##6##(2008-11#2)(2008-9#1)
we investigated the effects of##11##5##(1991-9#1)(1993-11#1)(1994-10#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2012-1#1)
we investigated the efficacy of##3##5##(2008-10#1)(2011-2#2)
we investigated the expression of##2##5##(2009-5#1)(2013-1#1)
we investigated the expression##3##4##(2009-5#1)(2012-3#1)(2013-1#1)
we investigated the possibility##2##4##(2010-4#1)(2011-2#1)
we investigated the possible##2##4##(2012-2#1)(2013-7#1)
we investigated the potential##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
we investigated the regulation of##2##5##(1996-12#1)(2010-11#1)
we investigated the response to##2##5##(1995-2#1)(2009-8#1)
we investigated the role of##4##5##(1995-12#1)(2008-6#1)(2010-6#1)(2012-2#1)
we investigated the##111##3##(1991-2#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#4)(1995-2#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
we investigated their##2##3##(1993-8#1)(2010-6#1)
we investigated whether the##2##4##(1995-8#1)(2011-2#1)
we investigated whether##18##3##(1993-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-7#1)(2006-10#1)(2008-5#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-6#2)(2011-2#1)(2012-1#1)(2013-1#1)
we investigated##163##2##(1991-2#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#5)(1995-2#2)(1995-8#1)(1996-12#4)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#3)(2009-12#3)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#5)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#4)
we isolated a cDNA clone##2##5##(1993-12#1)(1997-4#1)
we isolated a##5##3##(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1997-4#1)
we isolated and characterized##5##4##(1991-2#1)(1991-6#1)(1994-12#1)(2009-8#1)(2010-5#1)
we isolated and sequenced the##2##5##(1994-12#1)(1995-11#1)
we isolated and##7##3##(1991-2#1)(1991-6#1)(1994-12#2)(1995-11#1)(2009-8#1)(2010-5#1)
we isolated##18##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#3)(1995-11#1)(1997-4#2)(2008-10#2)(2008-11#2)(2009-8#1)(2010-5#1)
we know about the##4##4##(1995-5#1)(1996-2#1)(2008-10#1)(2013-1#1)
we know about##8##3##(1994-1#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#2)
we know how to##2##4##(1994-3#1)(2011-1#1)
we know how##4##3##(1994-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
we know little about##2##4##(2008-10#1)(2009-9#1)
we know more##2##3##(1991-12#1)(2008-5#1)
we know##37##2##(1991-12#1)(1992-3#1)(1994-1#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-9#1)(2010-10#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
we lack a##2##3##(2008-8#1)(2009-2#1)
we lack##3##2##(2007-7#1)(2008-8#1)(2009-2#1)
we learn from##6##3##(1991-3#1)(1993-6#1)(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)
we learn##10##2##(1991-3#1)(1993-12#1)(1993-6#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#2)
we learned from##3##3##(2008-7#1)(2009-4#1)(2012-2#1)
we learned##5##2##(1997-3#1)(2007-12#1)(2008-7#1)(2009-4#1)(2012-2#1)
we live##4##2##(2008-1#2)(2009-8#1)(2012-3#1)
we look at the##3##4##(1992-3#1)(1997-3#1)(1997-6#1)
we look##5##2##(1992-3#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-12#1)
we made a##3##3##(1991-2#1)(1996-6#1)(1997-7#1)
we made##11##2##(1991-2#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2012-2#1)(2013-8#1)
we make a##4##3##(2008-1#1)(2008-12#1)(2008-7#1)(2011-1#1)
we make##12##2##(1994-1#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)
we mapped##2##2##(2008-10#2)
we may conclude that##2##4##(2009-10#1)(2012-2#1)
we may find##2##3##(2010-9#1)(2012-3#1)
we may gain##2##3##(1994-10#1)(2012-3#1)
we may##19##2##(1993-11#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-8#1)(1995-9#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#2)
we measure the##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
we measure##11##2##(1991-11#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)(2008-8#2)
we measured an##4##3##(2007-11#1)(2008-11#1)(2008-3#2)
we measured binding##2##3##(1992-8#1)(1993-3#1)
we measured habitat##2##3##(2013-7#2)
we measured serum##2##3##(1991-8#1)(1993-2#1)
we measured the##23##3##(1991-12#1)(1991-2#1)(1991-8#1)(1993-8#1)(1994-11#1)(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#2)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
we measured##56##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-8#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
we might##3##2##(1995-5#1)(2008-7#1)(2010-2#1)
we model##6##2##(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
we modified the##2##3##(1994-12#1)(2008-3#1)
we modified##3##2##(1994-12#1)(2007-12#1)(2008-3#1)
we modify the##3##3##(2008-2#1)(2008-3#2)
we monitored##6##2##(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#2)(2010-4#1)
we move##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
we must also##2##3##(1995-5#1)(2010-12#1)
we must##23##2##(1991-12#1)(1993-2#1)(1994-1#2)(1995-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#4)(2010-3#4)(2011-1#1)(2011-2#1)
we mutated##2##2##(1995-2#1)(2008-4#1)
we named##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)
we need to rethink##2##4##(2010-3#1)(2011-3#1)
we need to##13##3##(1991-1#1)(1991-12#1)(1993-12#1)(1994-1#1)(1995-9#2)(1997-1#1)(2008-4#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
we need##26##2##(1991-1#1)(1991-12#2)(1993-12#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-9#2)(1997-1#2)(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
we needed to##2##3##(1994-12#1)(2008-2#1)
we needed##3##2##(1994-12#1)(2008-2#2)
we newly determined the sequences of##2##6##(1996-10#1)(1996-2#1)
we newly##3##2##(1995-8#1)(1996-10#1)(1996-2#1)
we no longer##2##3##(1995-5#1)(2010-3#1)
we not##4##2##(1993-2#2)(2008-10#1)(2010-3#1)
we note that##2##3##(2008-10#1)(2009-10#1)
we noted##4##2##(2007-11#3)(2012-2#1)
we noticed##4##2##(2007-10#1)(2007-11#2)(2008-5#1)
we now know that##2##4##(1993-2#1)(2008-1#1)
we now know##3##3##(1993-2#1)(2008-1#1)(2013-7#1)
we now report##3##3##(1991-12#1)(1993-2#1)(2008-8#1)
we now##13##2##(1990-2#1)(1991-12#2)(1992-6#1)(1993-2#2)(1994-12#1)(1996-9#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
we numerically##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
we observe that##4##3##(1997-2#1)(2008-11#1)(2008-2#1)(2009-8#1)
we observe the##2##3##(2007-11#1)(2008-3#1)
we observe##19##2##(1993-12#1)(1995-3#1)(1997-2#1)(2007-11#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#2)
we observed a##13##3##(1995-12#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2011-2#1)(2012-1#1)
we observed an increase in##2##5##(1994-6#1)(1995-12#1)
we observed an##5##3##(1990-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(2012-12#1)
we observed higher##2##3##(1992-8#1)(2011-2#1)
we observed no##2##3##(2008-8#1)(2011-2#1)
we observed that in##2##4##(2008-11#1)(2009-3#1)
we observed that the##8##4##(1991-5#1)(1993-3#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
we observed that##24##3##(1991-5#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
we observed the##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
we observed##90##2##(1990-3#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-5#1)(1997-7#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#2)
we obtain a##6##3##(1995-5#1)(2007-11#2)(2007-12#1)(2008-3#2)
we obtain an##2##3##(2007-12#1)(2008-10#1)
we obtain the##4##3##(2007-12#1)(2008-3#1)(2010-2#1)(2012-2#1)
we obtain##20##2##(1995-5#1)(1995-9#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-2#1)(2012-2#1)
we obtained a##12##3##(1994-6#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-6#1)
we obtained an##2##3##(2008-3#2)
we obtained the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-1#1)
we obtained with##2##3##(2008-10#1)(2008-2#1)
we obtained##56##2##(1992-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-11#8)(2007-12#5)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#10)(2008-3#6)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
we offer a##2##3##(2008-9#1)(2011-2#1)
we offer##5##2##(1991-3#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-7#1)
we often##2##2##(1992-2#1)(2009-7#1)
we operate##2##2##(2008-3#1)(2009-5#1)
we outline a##3##3##(2008-10#1)(2008-11#2)
we outline the##3##3##(2008-9#1)(2010-5#1)(2012-3#1)
we outline##11##2##(1992-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)
we perform a##3##3##(2007-11#1)(2008-1#1)(2012-2#1)
we perform an##2##3##(2008-10#1)(2008-7#1)
we perform##9##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)
we performed a prospective##2##4##(2008-8#1)(2011-2#1)
we performed a##17##3##(1992-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
we performed an##6##3##(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
we performed the##5##3##(1997-2#1)(2007-8#1)(2008-2#1)(2009-8#1)(2013-1#1)
we performed##56##2##(1991-6#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-2#1)(2007-11#2)(2007-5#1)(2007-8#5)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
we placed##2##2##(1992-3#1)(2008-3#1)
we point out##2##3##(2008-2#1)(2010-4#1)
we point##3##2##(1991-6#1)(2008-2#1)(2010-4#1)
we postulate that the##3##4##(1990-2#1)(1994-8#1)(1996-12#1)
we postulate that##6##3##(1990-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-9#1)(2007-12#1)
we postulate##8##2##(1990-2#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(2007-12#1)
we postulated##2##2##(2008-10#1)(2008-5#1)
we predict that##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
we predict the##3##3##(1992-9#1)(2008-3#1)(2008-8#1)
we predict##9##2##(1992-9#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
we predicted##4##2##(1993-12#1)(2009-5#1)(2009-8#1)(2011-2#1)
we prepare##2##2##(1993-9#1)(2007-12#1)
we prepared a##3##3##(1993-6#1)(1994-8#1)(2008-9#1)
we prepared an##3##3##(1991-2#1)(1994-12#1)(2008-11#1)
we prepared##12##2##(1991-2#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
we present a case of a##3##6##(2007-8#1)(2013-1#2)
we present a case of an##2##6##(2013-1#1)(2013-8#1)
we present a case of gastric##2##6##(2007-5#1)(2009-8#1)
we present a case of##15##5##(1997-7#1)(2007-5#1)(2007-8#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
we present a case##22##4##(1997-7#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
we present a conceptual framework of hypothesized risk factors for adult children of parents with chronic pain##2##17##(2013-1#2)
we present a method for##4##5##(1992-6#1)(2008-3#1)(2008-8#1)(2011-2#1)
we present a method##8##4##(1992-6#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-3#1)
we present a methodology##2##4##(2008-10#1)(2008-12#1)
we present a model##2##4##(2007-12#1)(2012-2#1)
we present a new##7##4##(1997-3#1)(2008-10#1)(2008-3#2)(2009-9#1)(2010-8#1)(2012-2#1)
we present a novel##3##4##(2008-2#1)(2008-5#1)(2008-8#1)
we present a patient who##3##5##(1990-9#1)(2008-1#1)(2013-1#1)
we present a patient##4##4##(1990-9#1)(2008-1#1)(2008-9#1)(2013-1#1)
we present a point process##2##5##(2009-9#1)(2010-5#1)
we present a rare case of##2##6##(2008-9#1)(2011-2#1)
we present a refined##2##4##(2008-11#1)(2008-3#1)
we present a review of the literature##2##7##(2008-2#1)(2008-4#1)
we present a review of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
we present a simple##3##4##(2007-11#1)(2008-8#1)(2008-9#1)
we present a study on##2##5##(2012-3#2)
we present a technique for##2##5##(2008-10#1)(2013-1#1)
we present a##101##3##(1990-9#1)(1992-6#2)(1995-12#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-11#1)(2009-5#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#1)
we present an algorithm for##2##5##(2008-3#1)(2013-1#1)
we present an analysis of the##2##6##(1995-8#1)(2008-7#1)
we present an analysis of##3##5##(1995-8#1)(2008-7#1)(2008-8#1)
we present an overview of the##2##6##(2010-8#1)(2012-3#1)
we present an overview of##3##5##(2008-10#1)(2010-8#1)(2012-3#1)
we present an##25##3##(1995-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
we present and##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
we present data from##2##4##(2008-7#1)(2013-8#1)
we present data that##2##4##(2008-3#2)
we present data##6##3##(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-8#1)
we present evidence from##3##4##(1994-3#1)(2008-4#1)(2009-10#1)
we present evidence that##5##4##(1994-11#1)(1994-6#1)(2008-2#1)(2008-7#1)(2008-9#1)
we present evidence##10##3##(1991-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)
we present experimental results##2##4##(2008-2#1)(2008-3#1)
we present experimental##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)
we present here##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
we present new##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
we present one##2##3##(2007-8#1)(2012-3#1)
we present our experience with##2##5##(2007-5#1)(2012-3#1)
we present our experience##5##4##(2007-5#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
we present our##14##3##(2007-5#1)(2007-7#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
we present relevant predictions from theoretical models that identify the interpersonal effects of chronic illness and pain on family relationships##2##20##(2013-1#2)
we present results from a##2##5##(1995-6#1)(2008-8#1)
we present results from##4##4##(1990-11#1)(1995-5#1)(1995-6#1)(2008-8#1)
we present results of a##2##5##(2008-3#1)(2008-5#1)
we present results of the##2##5##(1995-5#1)(2008-10#1)
we present results of##5##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
we present results##9##3##(1990-11#1)(1995-5#2)(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
we present the (1)H/(13)C/(15)N NMR assignments of the bases and sugars of the##2##13##(2009-7#2)
we present the case##2##4##(2011-2#1)(2012-2#1)
we present the complete##2##4##(1994-12#1)(2008-10#1)
we present the first case of##2##6##(2010-12#1)(2012-2#1)
we present the first case##3##5##(2008-10#1)(2010-12#1)(2012-2#1)
we present the first##5##4##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
we present the most##3##4##(2008-10#1)(2008-9#1)(2010-9#1)
we present the results obtained##2##5##(1995-11#1)(2008-10#1)
we present the results of##2##5##(2009-2#1)(2010-9#1)
we present the results##4##4##(1995-11#1)(2008-10#1)(2009-2#1)(2010-9#1)
we present the technique of##2##5##(2008-3#1)(2012-2#1)
we present the##35##3##(1991-8#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
we present two cases of##5##5##(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)
we present two##10##3##(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
we present what##2##3##(2008-2#1)(2008-3#1)
we present##267##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-5#2)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#18)(2008-11#8)(2008-12#4)(2008-2#11)(2008-3#26)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#17)(2008-8#12)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#3)(2011-1#9)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#5)
we presented##6##2##(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
we prevent##2##2##(1992-1#1)(2008-10#1)
we previously demonstrated##2##3##(2008-11#1)(2008-8#1)
we previously found in##2##4##(1993-3#1)(2010-2#1)
we previously introduced##2##3##(1996-2#1)(2008-2#1)
we previously##12##2##(1991-8#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)
we produced##9##2##(1994-5#1)(1995-12#1)(1996-12#1)(2007-12#2)(2008-3#3)(2013-1#1)
we propose a method##3##4##(1994-9#1)(2008-3#1)(2010-8#1)
we propose a model for##3##5##(1991-5#1)(2008-7#1)(2009-8#1)
we propose a new approach to##3##6##(1997-8#1)(2012-3#1)(2013-8#1)
we propose a new approach##4##5##(1997-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
we propose a new##13##4##(1993-9#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-8#1)(2012-3#3)(2013-1#1)(2013-8#1)
we propose a novel##3##4##(2008-3#1)(2010-8#1)(2013-1#1)
we propose a simple##3##4##(2008-11#1)(2008-2#1)(2008-8#1)
we propose a##54##3##(1991-5#1)(1993-9#1)(1994-9#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-8#2)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
we propose an alternative##4##4##(2008-11#1)(2009-2#1)(2012-2#1)(2012-3#1)
we propose an##14##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-10#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
we propose here a##2##4##(1995-11#1)(2008-11#1)
we propose that P2X receptors are extracellular##2##7##(2008-4#2)
we propose that a##5##4##(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
we propose that it##2##4##(2008-10#1)(2008-3#1)
we propose that the##12##4##(1991-9#1)(1992-12#1)(1993-3#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
we propose that these##4##4##(1997-4#1)(2008-10#1)(2008-6#1)(2012-3#1)
we propose that this##2##4##(1996-6#1)(2008-9#1)
we propose that##52##3##(1990-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
we propose the use of##2##5##(2008-7#1)(2012-12#1)
we propose the##11##3##(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2012-1#1)(2012-12#1)(2013-1#1)
we propose to use##3##4##(1992-5#1)(2008-2#1)(2008-7#1)
we propose to##12##3##(1992-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
we propose two##3##3##(2007-12#1)(2008-2#1)(2010-12#1)
we propose using##2##3##(2007-11#1)(2008-2#1)
we propose##168##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-8#1)(2008-10#18)(2008-11#7)(2008-2#8)(2008-3#18)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#5)
we proposed a##9##3##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
we proposed that##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2010-4#1)
we proposed the##2##3##(2008-10#1)(2013-1#1)
we proposed##18##2##(1993-8#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
we prospectively##2##2##(2007-10#1)(2010-4#1)
we prove that##4##3##(2008-3#1)(2008-7#2)(2013-8#1)
we proved that##2##3##(2008-9#1)(2011-2#1)
we provide a comprehensive overview of##2##6##(2008-11#1)(2011-2#1)
we provide a comprehensive##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
we provide a concise##2##4##(2008-11#1)(2012-12#1)
we provide a##14##3##(1992-6#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
we provide an overview of the##3##6##(2010-10#1)(2012-2#1)(2012-3#1)
we provide an overview of##6##5##(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#2)(2012-3#1)
we provide an overview##7##4##(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2012-2#2)(2012-3#1)
we provide an##11##3##(2008-7#3)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
we provide evidence that the##2##5##(1992-9#1)(2008-7#1)
we provide evidence that##11##4##(1990-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-7#2)(2011-1#1)
we provide insight into the##2##5##(2012-12#2)
we provide the first##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
we provide the##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
we provide##54##2##(1990-11#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)
we provided evidence##2##3##(1992-3#1)(1995-12#1)
we provided##4##2##(1992-3#1)(1995-12#1)(2008-11#1)(2010-11#1)
we purified a##2##3##(1991-5#1)(1992-11#1)
we purified the##3##3##(1992-7#1)(1992-9#1)(1995-6#1)
we purified##9##2##(1991-5#1)(1992-10#1)(1992-11#1)(1992-7#1)(1992-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)
we quantified the levels of##2##5##(1993-12#1)(2008-9#1)
we quantified the##3##3##(1993-12#1)(2008-9#1)(2012-2#1)
we quantified##9##2##(1990-2#1)(1993-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
we quantify the##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
we quantify##6##2##(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#2)(2013-8#1)
we quantitatively##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
we raised##4##2##(1991-9#1)(1996-5#1)(2008-10#1)(2008-5#1)
we realized##4##2##(2007-11#2)(2007-12#1)(2011-2#1)
we really##5##2##(1992-3#1)(2007-4#1)(2008-10#1)(2010-12#1)(2012-12#1)
we recently developed##2##3##(2008-3#1)(2011-2#1)
we recently reported##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
we recently##7##2##(2008-3#1)(2008-5#1)(2009-12#1)(2009-8#2)(2011-2#2)
we recombinantly##2##2##(1995-6#1)(2013-1#1)
we recommend a##3##3##(1993-3#1)(2008-10#1)(2010-5#1)
we recommend that##4##3##(1990-3#1)(1994-2#1)(2010-8#1)(2011-2#1)
we recommend the##4##3##(2007-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
we recommend##20##2##(1990-12#1)(1990-3#1)(1991-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-8#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-7#2)
we reconstruct##2##2##(2008-2#1)(2010-11#1)
we reconstructed##2##2##(2007-11#1)(2008-3#1)
we recorded##6##2##(1991-12#1)(1993-12#1)(2008-3#1)(2008-8#1)(2009-2#1)(2013-1#1)
we recovered##2##2##(2008-9#1)(2012-3#1)
we reduced##2##2##(2007-11#1)(2008-10#1)
we reexamine##2##2##(2008-8#2)
we refer to##9##3##(1992-6#1)(1995-6#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
we refer##12##2##(1992-6#1)(1995-6#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
we regard##2##2##(2012-2#2)
we registered##2##2##(1990-8#1)(2008-5#1)
we relate##2##2##(2008-11#1)(2008-3#1)
we remove##2##2##(2008-5#1)(2008-8#1)
we removed the##2##3##(2009-4#1)(2011-1#1)
we removed##3##2##(2009-4#1)(2011-1#1)(2011-2#1)
we report a 30-year-old##2##4##(2012-12#1)(2013-1#1)
we report a case of a##6##6##(2007-8#2)(2008-9#1)(2011-1#1)(2012-3#2)
we report a case of##20##5##(1991-11#1)(2007-8#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
we report a case##21##4##(1991-11#1)(2007-8#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-4#2)(2010-6#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
we report a female patient##2##5##(2012-12#2)
we report a new##3##4##(2008-12#1)(2008-7#1)(2012-2#1)
we report a novel##6##4##(1997-4#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-2#1)(2012-3#1)
we report a patient who##3##5##(2007-8#1)(2008-7#1)(2011-1#1)
we report a patient##4##4##(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
we report a rare case of##2##6##(2008-6#1)(2012-2#1)
we report a systematic investigation of the##2##7##(2010-5#1)(2012-2#1)
we report a systematic##3##4##(2010-5#1)(2010-6#1)(2012-2#1)
we report a##68##3##(1991-11#1)(1991-2#1)(1993-11#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#4)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#4)(2011-1#3)(2011-2#1)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
we report about##2##3##(2009-3#1)(2013-1#1)
we report an##7##3##(1996-12#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-1#1)
we report for the first time##4##6##(1995-6#1)(2008-10#1)(2008-7#1)(2009-2#1)
we report here a##2##4##(1992-12#1)(2008-12#1)
we report here##4##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
we report on a##6##4##(2007-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
we report on an##2##4##(2008-11#1)(2008-3#1)
we report on the identification of##2##6##(1990-7#1)(1991-5#1)
we report on the##15##4##(1990-2#1)(1990-7#1)(1991-5#1)(1995-11#1)(2008-10#3)(2008-3#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)
we report on two##2##4##(2008-3#1)(2013-1#1)
we report on##31##3##(1990-2#1)(1990-7#1)(1991-5#1)(1995-11#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
we report our experience with##2##5##(2007-12#1)(2011-2#1)
we report our experience##3##4##(1991-9#1)(2007-12#1)(2011-2#1)
we report results##2##3##(1992-9#1)(2008-11#1)
we report some##2##3##(1994-8#1)(1996-5#1)
we report that a##3##4##(1990-5#1)(1992-9#1)(2009-7#1)
we report that both##2##4##(1990-11#1)(1993-6#1)
we report that the##8##4##(1991-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-7#1)(2012-2#1)
we report that##51##3##(1990-11#2)(1990-2#1)(1990-5#2)(1991-2#1)(1991-9#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-8#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#6)
we report the NMR spectral##2##5##(2009-7#2)
we report the NMR##3##4##(2009-7#3)
we report the case of a##2##6##(2008-9#1)(2013-8#1)
we report the case of##3##5##(2008-9#1)(2010-5#1)(2013-8#1)
we report the case##4##4##(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
we report the cloning and##2##5##(1992-3#1)(1994-12#1)
we report the cloning##7##4##(1992-3#2)(1994-12#2)(1995-11#1)(2008-7#1)(2013-1#1)
we report the construction of##3##5##(1997-8#1)(2008-10#1)(2008-11#1)
we report the development of##2##5##(2008-10#1)(2013-8#1)
we report the expression##3##4##(1992-8#1)(2009-3#1)(2009-9#1)
we report the first experimental##2##5##(2008-7#1)(2012-2#1)
we report the first##7##4##(2008-3#2)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
we report the identification of a##4##6##(1990-11#1)(2008-10#1)(2009-6#1)(2012-3#1)
we report the identification of##6##5##(1990-11#1)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#1)
we report the identification##7##4##(1990-11#1)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#1)(2013-8#1)
we report the isolation of##3##5##(1995-2#1)(1997-3#1)(2008-10#1)
we report the isolation##4##4##(1993-6#1)(1995-2#1)(1997-3#1)(2008-10#1)
we report the production of##2##5##(2009-2#1)(2012-2#1)
we report the results of a##3##6##(2008-11#1)(2008-9#1)(2013-1#1)
we report the results of##5##5##(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
we report the study of##2##5##(2008-7#1)(2012-2#1)
we report the successful##2##4##(2007-8#1)(2010-6#1)
we report the synthesis of##5##5##(1995-11#1)(2007-11#1)(2008-10#1)(2009-6#1)(2012-2#1)
we report the synthesis##6##4##(1995-11#1)(2007-11#1)(2008-10#2)(2009-6#1)(2012-2#1)
we report the use of##2##5##(2008-10#1)(2008-11#1)
we report the##102##3##(1990-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-5#4)(2008-7#4)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#12)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2012-2#9)(2012-3#3)(2012-4#1)(2013-1#4)(2013-8#3)
we report two##4##3##(2008-7#1)(2010-2#1)(2011-1#1)(2012-12#1)
we report##310##2##(1990-11#3)(1990-2#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-8#2)(1995-11#3)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#2)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#22)(2008-8#4)(2008-9#6)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#3)(2009-7#20)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#5)(2011-1#13)(2011-2#10)(2012-12#9)(2012-2#27)(2012-3#8)(2012-4#1)(2013-1#9)(2013-7#1)(2013-8#5)
we reported a##3##3##(2009-8#1)(2011-2#2)
we reported that the##2##4##(1997-6#1)(2011-2#1)
we reported that##11##3##(1990-2#1)(1991-8#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-11#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)
we reported the##5##3##(1991-5#1)(1996-5#1)(2009-8#1)(2010-3#1)(2010-4#1)
we reported##23##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-6#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#3)
we resected##2##2##(2007-11#1)(2013-1#1)
we resolved##2##2##(2007-12#1)(2008-3#1)
we retrospectively analyzed the##2##4##(2007-7#1)(2007-8#1)
we retrospectively reviewed##2##3##(2007-8#1)(2008-1#1)
we retrospectively studied##2##3##(2008-4#1)(2009-8#1)
we retrospectively##8##2##(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
we reveal that##2##3##(2008-7#1)(2013-1#1)
we reveal##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
we review a##2##3##(2008-11#1)(2008-2#1)
we review and##2##3##(2011-1#1)(2012-12#1)
we review evidence for##2##4##(2008-11#1)(2013-8#1)
we review evidence##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
we review how##3##3##(2008-8#1)(2010-12#1)(2012-3#1)
we review its##2##3##(1990-12#1)(1992-12#1)
we review major##2##3##(2009-6#1)(2013-8#1)
we review our recent##2##4##(2009-3#1)(2011-2#1)
we review our##5##3##(1997-4#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
we review progress made in##2##5##(2012-12#1)(2012-2#1)
we review recent studies##2##4##(2012-2#1)(2013-1#1)
we review recent##8##3##(2008-11#3)(2008-2#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
we review some of the##2##5##(2008-5#1)(2009-5#1)
we review some##4##3##(1997-4#1)(2008-5#1)(2009-5#1)(2010-12#1)
we review studies##2##3##(2008-7#1)(2012-2#1)
we review the current knowledge of##2##6##(2008-1#1)(2013-1#1)
we review the current knowledge##3##5##(2008-1#1)(2008-11#1)(2013-1#1)
we review the current literature##2##5##(2008-3#1)(2010-9#1)
we review the current##8##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-9#1)(2013-1#2)
we review the currently##2##4##(2008-10#1)(2011-2#1)
we review the development##2##4##(2008-10#1)(2008-11#1)
we review the epidemiology##2##4##(2010-8#1)(2011-2#1)
we review the evidence##4##4##(2007-10#1)(2008-8#1)(2009-11#1)(2010-2#1)
we review the evolution##2##4##(1996-2#1)(2011-2#1)
we review the literature on the##2##6##(2011-2#1)(2012-2#1)
we review the literature on##3##5##(2011-2#2)(2012-2#1)
we review the literature##5##4##(1996-9#1)(2008-11#1)(2011-2#2)(2012-2#1)
we review the most##2##4##(2008-10#1)(2010-7#1)
we review the recent##2##4##(2010-12#1)(2011-1#1)
we review the results of##2##5##(2009-8#1)(2011-1#1)
we review the results##3##4##(2008-4#1)(2009-8#1)(2011-1#1)
we review the roles of##3##5##(2007-7#1)(2009-8#2)
we review the##67##3##(1991-9#1)(1996-2#1)(1996-9#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
we review these##2##3##(2009-3#1)(2010-4#1)
we review this##3##3##(2008-10#1)(2013-1#2)
we review those##2##3##(2008-11#1)(2009-5#1)
we review work##2##3##(1994-11#1)(2009-10#1)
we review##132##2##(1990-12#1)(1991-9#1)(1992-12#1)(1994-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#2)(2007-10#1)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#11)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#12)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#4)
we reviewed a##2##3##(1992-1#1)(2011-2#1)
we reviewed the##6##3##(2008-1#2)(2008-9#1)(2011-2#2)(2012-2#1)
we reviewed##19##2##(1992-1#1)(1996-11#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)
we routinely##2##2##(1997-4#1)(2009-5#1)
we sampled##3##2##(2008-10#1)(2008-6#1)(2009-11#1)
we saw##4##2##(1996-4#1)(2008-10#2)(2009-10#1)
we scan##2##2##(2008-3#2)
we screened a##3##3##(1993-8#1)(2008-8#1)(2013-1#1)
we screened the##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
we screened##15##2##(1993-8#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
we searched for the##2##4##(1992-12#1)(1994-9#1)
we searched for##11##3##(1990-7#1)(1992-12#1)(1994-11#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
we see in our##2##4##(1991-12#1)(2008-12#1)
we see that##2##3##(2008-2#1)(2009-4#1)
we see##9##2##(1991-12#1)(1993-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-10#1)
we seek to##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
we seek##4##2##(2008-3#1)(2010-4#1)(2013-1#1)(2013-8#1)
we selected a##6##3##(1990-12#2)(1995-8#1)(1997-5#1)(2008-5#2)
we selected the##2##3##(2011-2#1)(2012-2#1)
we selected##20##2##(1990-12#2)(1995-4#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
we separated##2##2##(1995-6#1)(2008-10#1)
we sequenced##3##2##(2008-8#1)(2012-3#2)
we set out to develop##2##5##(2009-9#1)(2011-1#1)
we set out to##3##4##(2009-9#1)(2010-11#1)(2011-1#1)
we set out##4##3##(2009-9#1)(2010-11#1)(2011-1#1)(2013-8#1)
we set##6##2##(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-8#2)
we shall describe the##2##4##(2008-10#1)(2013-1#1)
we shall##4##2##(2008-10#2)(2009-11#1)(2013-1#1)
we share our experiences##2##4##(1995-12#1)(2008-12#1)
we share##3##2##(1993-5#1)(1995-12#1)(2008-12#1)
we should be##2##3##(2008-10#1)(2008-9#1)
we should not##3##3##(2008-8#1)(2010-12#1)(2012-3#1)
we should strengthen the##2##4##(2012-3#2)
we should##15##2##(1992-11#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#2)(2012-3#3)
we show a novel##2##4##(1995-11#1)(2008-7#1)
we show a##8##3##(1995-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-12#1)
we show for##3##3##(1992-10#1)(2011-2#1)(2012-2#1)
we show how the##3##4##(2008-10#1)(2008-5#1)(2010-11#1)
we show how this##2##4##(2008-11#1)(2008-9#1)
we show how to##4##4##(1995-12#1)(2007-11#1)(2008-2#1)(2008-3#1)
we show how##17##3##(1991-3#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-11#1)(2011-2#1)
we show in##4##3##(1995-12#1)(2007-11#1)(2008-8#1)(2012-12#1)
we show that a##6##4##(2007-12#1)(2008-3#1)(2010-6#1)(2011-2#2)(2012-2#1)
we show that an##6##4##(1990-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
we show that at##2##4##(2008-1#1)(2013-8#1)
we show that both##4##4##(1992-8#1)(1993-8#1)(2007-12#1)(2012-12#1)
we show that by##2##4##(2007-11#1)(2007-12#1)
we show that for##2##4##(2008-2#1)(2008-3#1)
we show that if##2##4##(2007-12#1)(2013-1#1)
we show that in##6##4##(1997-1#1)(1997-7#1)(2008-9#2)(2012-12#2)
we show that it is possible to##4##7##(1990-5#1)(2008-2#2)(2009-2#1)
we show that it is##5##5##(1990-5#1)(2008-2#3)(2009-2#1)
we show that positive##2##4##(1994-12#1)(2008-9#1)
we show that such a##3##5##(2008-11#1)(2008-2#1)(2012-2#1)
we show that such##5##4##(2007-11#1)(2008-11#1)(2008-2#2)(2012-2#1)
we show that the optimal##2##5##(2008-3#2)
we show that the##70##4##(1990-5#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1997-2#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#6)(2008-3#9)(2008-6#2)(2008-7#3)(2008-8#2)(2009-8#2)(2009-9#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
we show that there are##2##5##(2008-3#1)(2009-9#1)
we show that there is a##2##6##(1997-1#1)(2008-3#1)
we show that there is##3##5##(1997-1#1)(2008-3#2)
we show that there##7##4##(1997-1#1)(2008-12#1)(2008-3#3)(2009-8#1)(2009-9#1)
we show that these##4##4##(1990-8#1)(1995-8#1)(2007-12#1)(2008-3#1)
we show that this##8##4##(1991-5#1)(1993-1#1)(2007-11#2)(2007-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
we show that##261##3##(1990-2#1)(1990-5#5)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#3)(1994-11#4)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-2#6)(1995-3#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-2#2)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#4)(2007-11#8)(2007-12#12)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#11)(2008-12#3)(2008-2#13)(2008-3#22)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#12)(2008-8#11)(2008-9#7)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#5)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#10)(2012-2#15)(2012-3#7)(2013-1#8)(2013-8#2)
we show the##13##3##(1993-6#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2009-3#1)(2010-11#1)(2012-2#1)(2012-8#1)
we show##338##2##(1990-11#1)(1990-2#1)(1990-5#6)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#4)(1995-12#2)(1995-2#6)(1995-3#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#4)(2007-11#12)(2007-12#17)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#14)(2008-12#4)(2008-2#18)(2008-3#29)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#21)(2008-8#17)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#6)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#11)(2012-2#21)(2012-3#7)(2012-8#1)(2013-1#8)(2013-8#2)
we showed a##2##3##(2008-10#1)(2013-1#1)
we showed here that##2##4##(1997-7#1)(2008-11#1)
we showed in##2##3##(2008-11#1)(2012-12#1)
we showed that a##2##4##(2008-10#1)(2012-3#1)
we showed that some##2##4##(2010-11#1)(2013-8#1)
we showed that the##8##4##(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
we showed that##34##3##(1990-5#1)(1991-7#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#3)(2009-8#3)(2010-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
we showed##42##2##(1990-5#1)(1991-7#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-6#1)(2008-9#3)(2009-8#3)(2010-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
we simulate the##2##3##(1996-4#1)(2008-2#1)
we simulate##3##2##(1996-4#1)(2008-2#1)(2010-10#1)
we simulated the##2##3##(2008-11#1)(2008-9#1)
we simulated##4##2##(1997-5#1)(2008-11#1)(2008-9#1)(2010-9#1)
we simultaneously##2##2##(2008-2#1)(2008-8#1)
we solve the##2##3##(1992-9#1)(2008-3#1)
we solve##3##2##(1992-9#1)(2008-3#1)(2012-2#1)
we sought to determine if##3##5##(1993-6#1)(1994-2#1)(2010-11#1)
we sought to determine whether##3##5##(1991-2#1)(1993-11#1)(2008-10#1)
we sought to determine##7##4##(1991-2#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-2#1)(2008-10#1)(2010-11#1)
we sought to identify##2##4##(2008-10#1)(2008-9#1)
we sought to##14##3##(1991-2#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)
we sought##16##2##(1991-2#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-6#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)
we spatially modulate the phase##2##5##(2008-3#2)
we specifically##2##2##(2009-6#1)(2012-12#1)
we speculate on the##3##4##(1996-3#1)(2007-12#1)(2012-12#1)
we speculate on##5##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-12#1)
we speculate that##8##3##(1991-9#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
we speculate##16##2##(1991-9#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
we still have##3##3##(1991-12#1)(1994-9#1)(2007-8#1)
we still##7##2##(1991-12#1)(1994-1#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
we studied a##2##3##(2008-3#1)(2012-2#1)
we studied how##2##3##(2008-10#2)
we studied its##2##3##(1991-6#1)(2008-10#1)
we studied the effects of##5##5##(1993-1#1)(1994-5#1)(1995-11#1)(1995-3#1)(1997-1#1)
we studied the impact of##2##5##(2008-7#1)(2013-1#1)
we studied the levels of##2##5##(2008-10#1)(2013-7#1)
we studied the role of##2##5##(1996-12#1)(1997-6#1)
we studied the##40##3##(1991-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2012-9#1)(2013-1#1)(2013-7#3)(2013-8#2)
we studied##79##2##(1991-12#2)(1991-6#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-8#3)(2010-7#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#4)(2013-7#4)(2013-8#2)
we study a##4##3##(2008-5#1)(2009-5#1)(2010-1#1)(2013-8#1)
we study the possible##2##4##(2007-12#1)(2008-10#1)
we study the##16##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-2#1)(2012-3#1)(2013-8#1)
we study##28##2##(1995-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2012-3#1)(2013-8#3)
we succeed##2##2##(1997-3#1)(2007-8#1)
we succeeded in##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
we successfully demonstrated##2##3##(2007-11#1)(2008-2#1)
we successfully##9##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-12#1)
we suggest that the same##2##5##(1994-12#1)(2012-2#1)
we suggest that the##11##4##(1990-11#1)(1990-12#1)(1992-12#1)(1994-12#1)(1994-6#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
we suggest that this##2##4##(1992-8#1)(2009-1#1)
we suggest that##44##3##(1990-11#1)(1990-12#2)(1990-6#2)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
we suggest the use of##2##5##(2008-2#1)(2008-3#1)
we suggest the##5##3##(1990-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
we suggest using##2##3##(1996-2#1)(2009-8#1)
we suggest##64##2##(1990-11#1)(1990-12#2)(1990-6#3)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-3#2)(2010-5#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
we summarise the##2##3##(1996-8#1)(2009-12#1)
we summarize findings##2##3##(2008-11#2)
we summarize our##2##3##(2009-8#1)(2010-6#1)
we summarize recent##4##3##(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
we summarize the evidence##2##4##(1995-5#1)(2010-11#1)
we summarize the role of##2##5##(2008-4#2)
we summarize the##14##3##(1995-5#1)(2008-1#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-7#1)(2011-2#2)
we summarize##31##2##(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#4)
we summarized##3##2##(2008-1#1)(2008-11#1)(2009-12#1)
we survey##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
we surveyed##4##2##(2008-1#1)(2008-11#1)(2011-10#1)(2011-2#1)
we synthesize##2##2##(2008-6#1)(2010-5#1)
we synthesized##2##2##(2008-12#1)(2012-3#1)
we systematically##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
we take##6##2##(1992-12#1)(1994-2#1)(2008-5#1)(2009-2#1)(2010-3#1)(2012-3#1)
we teach##2##2##(2008-3#1)(2012-2#1)
we tentatively##2##2##(1993-8#1)(2008-7#1)
we term##5##2##(1991-12#1)(1991-5#1)(2008-8#1)(2009-9#1)(2010-4#1)
we test the##6##3##(2008-2#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
we test this##2##3##(2008-9#1)(2011-2#1)
we test##13##2##(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
we tested a##6##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#1)
we tested the ability of##2##5##(1995-12#1)(2008-2#1)
we tested the effect of##2##5##(1995-12#1)(2013-1#1)
we tested the hypothesis that##2##5##(1992-8#1)(1995-2#1)
we tested the##19##3##(1992-8#1)(1993-12#1)(1994-6#1)(1995-12#2)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2013-1#2)
we tested whether##8##3##(1992-12#1)(1993-9#1)(1994-3#1)(1994-8#1)(1996-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
we tested##50##2##(1990-12#1)(1992-12#1)(1992-8#2)(1993-12#3)(1993-9#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#4)
we then##9##2##(1992-9#1)(1995-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
we theoretically##2##2##(2007-11#1)(2008-8#1)
we therefore##2##2##(1995-6#1)(2008-1#1)
we think that##3##3##(1995-6#1)(1997-3#1)(2012-2#1)
we think##5##2##(1995-6#1)(1997-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
we thought##2##2##(1994-2#1)(2011-2#1)
we thus##2##2##(1997-8#1)(2008-2#1)
we took advantage of the##2##5##(2008-12#1)(2008-7#1)
we took advantage of##3##4##(2008-12#1)(2008-7#1)(2009-9#1)
we trace the##2##3##(1995-4#1)(1997-2#1)
we transfected##3##2##(1990-5#1)(2008-11#1)(2008-3#1)
we treated with##2##3##(1996-9#1)(2008-8#1)
we treated##9##2##(1991-8#1)(1993-3#1)(1996-9#1)(2007-11#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
we tried to##13##3##(1990-12#1)(1991-5#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
we try to##4##3##(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#1)
we uncovered a##2##3##(2008-8#2)
we understand the##3##3##(2008-3#1)(2008-7#1)(2009-12#1)
we understand##6##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)
we undertook to##3##3##(1994-11#1)(2007-8#1)(2013-8#1)
we undertook##5##2##(1990-5#1)(1994-11#1)(2007-8#1)(2008-5#1)(2013-8#1)
we use a simple##3##4##(2008-10#3)
we use a##16##3##(1995-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#2)(2011-2#1)
we use an##2##3##(2010-2#1)(2011-1#1)
we use data from a##2##5##(1997-7#1)(2012-12#1)
we use data from##3##4##(1997-7#1)(2007-12#1)(2012-12#1)
we use data##4##3##(1997-7#1)(2007-12#1)(2011-2#1)(2012-12#1)
we use the##15##3##(1992-2#1)(1994-8#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)
we use this##3##3##(2007-11#1)(2008-3#1)(2010-10#1)
we use##81##2##(1992-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#11)(2008-11#4)(2008-3#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
we used a combination of##3##5##(2008-11#1)(2008-5#1)(2009-8#1)
we used a##33##3##(1992-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#5)(2008-5#2)(2008-9#3)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
we used an##5##3##(1993-3#1)(1996-5#1)(2008-10#1)(2008-2#1)(2010-1#1)
we used in##2##3##(2008-3#1)(2013-1#1)
we used quantitative##2##3##(1995-11#1)(2012-3#1)
we used the same##2##4##(2008-10#1)(2008-3#1)
we used the##27##3##(1991-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-3#2)
we used this##4##3##(1990-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
we used to##2##3##(1990-2#1)(2008-8#1)
we used two different methods##2##5##(2008-11#1)(2008-2#1)
we used two##6##3##(1990-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
we used##165##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#14)(2008-5#5)(2008-7#1)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#4)(2013-8#3)
we utilized a##2##3##(1992-10#1)(2010-8#1)
we utilized##7##2##(1990-5#1)(1992-10#1)(1994-9#1)(2007-12#1)(2009-11#1)(2010-12#1)(2010-8#1)
we varied##2##2##(1997-4#1)(2008-2#1)
we verified the##4##3##(2008-11#1)(2008-3#2)(2013-7#1)
we verify the##3##3##(1992-12#1)(2008-2#1)(2008-3#1)
we want to##8##3##(1994-3#1)(2008-11#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
we want##9##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
we wanted to compare the##2##5##(2011-2#1)(2013-1#1)
we wanted to compare##3##4##(2011-2#2)(2013-1#1)
we wanted to##9##3##(1995-5#2)(2008-10#1)(2011-1#1)(2011-2#4)(2013-1#1)
we were able to detect##3##5##(1990-12#1)(2010-5#1)(2013-1#1)
we were able to determine##3##5##(1993-8#1)(2008-10#2)
we were able to distinguish##2##5##(1991-11#1)(2008-3#1)
we were able to identify##3##5##(1990-7#1)(2008-8#1)(2011-2#1)
we were able to obtain##2##5##(2008-10#1)(2008-5#1)
we were able to##40##4##(1990-12#2)(1990-7#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-8#1)(1995-11#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
we were not able to##2##5##(2008-10#1)(2012-12#1)
we were unable to demonstrate##2##5##(1995-12#1)(2009-9#1)
we were unable to##4##4##(1995-12#1)(1996-2#1)(2009-9#1)(2012-2#1)
we were##57##2##(1990-12#2)(1990-7#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
we will be able to##3##5##(2008-10#1)(2008-7#2)
we will briefly##3##3##(1996-1#1)(2012-1#1)(2012-2#1)
we will consider the##2##4##(2008-7#1)(2011-2#1)
we will describe##2##3##(2008-10#1)(2013-8#1)
we will discuss how##2##4##(2009-5#1)(2012-2#1)
we will discuss the##10##4##(2008-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-1#1)(2013-1#1)
we will discuss##24##3##(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
we will examine##2##3##(2008-7#2)
we will explore##2##3##(1994-1#1)(1994-12#1)
we will focus on the##4##5##(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
we will focus on##7##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
we will have##3##3##(1995-2#1)(1997-3#1)(2013-8#1)
we will know if##2##4##(1997-3#1)(2013-1#1)
we will point out##2##4##(2009-5#1)(2010-11#1)
we will present##2##3##(2008-10#1)(2008-9#1)
we will provide##4##3##(2008-7#1)(2009-9#1)(2010-6#1)(2012-2#1)
we will review the##5##4##(2008-7#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
we will review##6##3##(2008-7#1)(2009-1#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
we will summarize our##2##4##(2011-2#1)(2013-8#1)
we will summarize the##2##4##(2008-7#1)(2011-1#1)
we will summarize##4##3##(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
we will try to##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
we will##96##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#2)(2007-4#1)(2007-6#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-4#6)(2008-7#12)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-6#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
we wish to##4##3##(1994-1#1)(1995-5#1)(1997-8#1)(2008-8#1)
we wished to##3##3##(1995-12#1)(1995-5#1)(2008-11#1)
we would##8##2##(1991-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
we##7998##1##(1990-10#5)(1990-11#24)(1990-12#36)(1990-2#18)(1990-3#4)(1990-4#1)(1990-5#36)(1990-6#8)(1990-7#11)(1990-8#22)(1990-9#7)(1991-1#3)(1991-11#12)(1991-12#37)(1991-2#21)(1991-3#17)(1991-4#1)(1991-5#21)(1991-6#17)(1991-7#4)(1991-8#10)(1991-9#25)(1992-1#4)(1992-10#5)(1992-11#15)(1992-12#29)(1992-2#12)(1992-3#37)(1992-4#2)(1992-5#8)(1992-6#29)(1992-7#2)(1992-8#27)(1992-9#35)(1993-1#7)(1993-11#20)(1993-12#41)(1993-2#15)(1993-3#26)(1993-5#5)(1993-6#32)(1993-8#34)(1993-9#15)(1994-1#19)(1994-10#3)(1994-11#43)(1994-12#60)(1994-2#38)(1994-3#24)(1994-5#7)(1994-6#29)(1994-7#2)(1994-8#45)(1994-9#18)(1995-1#6)(1995-11#33)(1995-12#64)(1995-2#68)(1995-3#14)(1995-4#2)(1995-5#37)(1995-6#46)(1995-8#32)(1995-9#15)(1996-1#4)(1996-10#4)(1996-11#5)(1996-12#38)(1996-2#39)(1996-3#15)(1996-4#8)(1996-5#28)(1996-6#10)(1996-7#4)(1996-8#9)(1996-9#10)(1997-1#17)(1997-2#40)(1997-3#39)(1997-4#42)(1997-5#7)(1997-6#21)(1997-7#44)(1997-8#27)(1997-9#1)(2006-10#9)(2006-12#5)(2006-6#3)(2007-10#28)(2007-11#187)(2007-12#205)(2007-2#4)(2007-4#6)(2007-5#11)(2007-6#5)(2007-7#27)(2007-8#69)(2007-9#4)(2008-1#77)(2008-10#605)(2008-11#423)(2008-12#78)(2008-2#248)(2008-3#519)(2008-4#60)(2008-5#163)(2008-6#71)(2008-7#352)(2008-8#292)(2008-9#191)(2009-1#7)(2009-10#62)(2009-11#26)(2009-12#36)(2009-2#34)(2009-3#29)(2009-4#23)(2009-5#59)(2009-6#42)(2009-7#65)(2009-8#132)(2009-9#53)(2010-1#16)(2010-10#29)(2010-11#66)(2010-12#71)(2010-2#35)(2010-3#51)(2010-4#34)(2010-5#31)(2010-6#37)(2010-7#24)(2010-8#60)(2010-9#23)(2011-1#114)(2011-10#2)(2011-2#348)(2011-3#8)(2011-7#2)(2012-1#30)(2012-12#124)(2012-2#284)(2012-3#185)(2012-4#1)(2012-5#6)(2012-7#5)(2012-8#2)(2012-9#1)(2013-1#256)(2013-7#56)(2013-8#130)
we'll##4##1##(2009-10#2)(2011-2#1)(2013-1#1)
we're##2##1##(1994-1#1)(1995-5#1)
we've##3##1##(2008-6#1)(2010-12#1)(2012-3#1)
weak CL##4##2##(2008-10#4)
weak CO(2)##2##2##(1991-5#1)(2007-11#1)
weak absorption of##2##3##(2008-2#1)(2008-3#1)
weak absorption##4##2##(1991-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
weak acid##5##2##(2008-10#3)(2008-11#1)(2010-12#1)
weak acidic##3##2##(2008-10#3)
weak acids##7##2##(2008-10#6)(2008-9#1)
weak affinity for##2##3##(1992-12#1)(1997-1#1)
weak and strong##2##3##(2008-11#1)(2008-2#1)
weak and transient##3##3##(1997-7#1)(2008-7#1)(2008-8#1)
weak and##12##2##(1997-1#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-8#1)(2012-1#1)
weak association equilibria##2##3##(2008-10#2)
weak association##3##2##(1994-2#1)(2008-10#2)
weak at##3##2##(2008-9#1)(2012-12#1)(2013-8#1)
weak binding##3##2##(1990-2#1)(1990-8#1)(1995-2#1)
weak but significant##2##3##(1990-11#1)(2008-10#1)
weak but statistically significant##2##4##(2007-10#1)(2007-12#1)
weak but##5##2##(1990-11#1)(2007-10#1)(2007-12#2)(2008-10#1)
weak competitors##2##2##(2008-8#2)
weak correlation with the##3##4##(1995-5#1)(1996-4#1)(2012-12#1)
weak correlation##6##2##(1995-5#1)(1996-4#1)(2008-10#2)(2009-5#1)(2012-12#1)
weak coupling##3##2##(2007-11#1)(2008-3#2)
weak dependence##2##2##(2007-11#1)(2008-10#1)
weak effect##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
weak electric##2##2##(2008-10#1)(2010-4#1)
weak expression##2##2##(1995-5#1)(1996-12#1)
weak ferromagnetic##2##2##(1997-7#1)(2007-11#1)
weak fluorescent##2##2##(2008-10#1)(2008-4#1)
weak for##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
weak hydrogen##2##2##(2007-11#1)(2013-1#1)
weak in##3##2##(1996-12#1)(1997-4#1)(2008-9#1)
weak inhibition##2##2##(1994-6#1)(2008-8#1)
weak inhibitory effect##2##3##(1996-2#1)(2008-4#1)
weak inhibitory##3##2##(1991-8#1)(1996-2#1)(2008-4#1)
weak link##2##2##(2008-10#1)(2008-12#1)
weak modes##2##2##(2010-10#2)
weak negative##2##2##(1994-12#1)(2008-9#1)
weak nonspecific binding##2##3##(1993-11#2)
weak optical##2##2##(2007-12#1)(2008-2#1)
weak or no##3##3##(1992-5#1)(1995-12#1)(2008-11#1)
weak or##8##2##(1992-3#1)(1992-5#1)(1995-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
weak patterns##2##2##(1995-3#1)(2011-2#1)
weak phase##2##2##(2008-3#2)
weak photorefractive##2##2##(2008-3#2)
weak points of##2##3##(1995-11#1)(2008-5#1)
weak points##3##2##(1992-6#1)(1995-11#1)(2008-5#1)
weak positive##2##2##(1994-2#1)(2007-10#1)
weak reaction##2##2##(2008-8#1)(2013-8#1)
weak scatterers##2##2##(2008-2#2)
weak signal##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
weak signals##2##2##(1991-5#1)(2008-10#1)
weak spectral##2##2##(2008-3#2)
weak tetanus##2##2##(1995-12#2)
weak to##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
weak##355##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#2)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#5)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(2006-12#1)(2007-10#3)(2007-11#17)(2007-12#17)(2007-2#1)(2007-5#1)(2008-10#82)(2008-11#8)(2008-12#4)(2008-2#11)(2008-3#24)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#14)(2008-9#9)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
weak)##3##1##(1996-2#1)(2008-8#1)(2012-2#1)
weaken the##5##2##(1995-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)
weaken##8##1##(1995-1#1)(1995-2#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2013-1#1)
weakened by##3##2##(1995-5#1)(2008-1#1)(2008-11#1)
weakened##15##1##(1993-12#1)(1995-5#1)(1995-9#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
weakening of the##4##3##(1996-6#1)(2008-5#1)(2010-12#1)(2013-1#1)
weakening of##8##2##(1996-4#2)(1996-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
weakening##15##1##(1996-4#5)(1996-6#1)(2006-10#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
weaker acids##2##2##(1995-5#2)
weaker and##2##2##(2008-10#2)
weaker association with##2##3##(2007-10#1)(2008-8#1)
weaker association##3##2##(1996-5#1)(2007-10#1)(2008-8#1)
weaker but##3##2##(1993-6#1)(1997-2#1)(2012-2#1)
weaker in##5##2##(1991-12#1)(1992-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
weaker than in the##3##4##(1994-9#1)(2008-3#1)(2011-2#1)
weaker than that of##2##4##(2008-10#1)(2013-1#1)
weaker than that##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
weaker than##9##2##(1994-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
weaker with age##2##3##(2008-7#1)(2009-7#1)
weaker with##3##2##(2008-7#1)(2009-7#1)(2012-2#1)
weaker##72##1##(1990-7#3)(1991-12#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-2#1)(2009-5#2)(2009-7#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
weakest link in##2##3##(2007-12#1)(2009-11#1)
weakest##12##1##(1994-3#1)(1995-12#1)(1996-2#1)(1996-4#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2012-3#2)
weakfish Cynoscion##2##2##(2010-8#2)
weakfish##4##1##(2010-8#2)(2013-7#2)
weakly absorbing particles##2##3##(2008-2#2)
weakly absorbing##13##2##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#5)
weakly acidic medium##3##3##(2008-10#3)
weakly acidic##11##2##(1990-8#1)(2008-10#10)
weakly and strongly absorbing aerosols##3##5##(2008-2#2)(2008-3#1)
weakly and##5##2##(1990-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
weakly associated with##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2013-7#1)
weakly basic##6##2##(1996-5#1)(2008-10#4)(2010-5#1)
weakly bound##3##2##(1991-5#1)(2010-12#1)(2010-7#1)
weakly by##2##2##(1994-12#1)(2008-3#1)
weakly confined##2##2##(2007-12#2)
weakly coordinating##2##2##(2008-10#2)
weakly correlated##2##2##(1995-2#1)(2008-9#1)
weakly electric fish##3##3##(1996-5#1)(2010-8#2)
weakly electric##4##2##(1996-5#2)(2010-8#2)
weakly expressed in##4##3##(1990-8#1)(2008-9#1)(2009-8#1)(2012-12#1)
weakly expressed##6##2##(1990-8#1)(1992-9#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)
weakly immobilized##2##2##(2008-11#2)
weakly in##3##2##(1990-2#1)(1997-2#1)(1997-8#1)
weakly inhibited##3##2##(1990-5#1)(1992-3#1)(2009-9#1)
weakly or not at all##2##5##(1992-10#1)(2008-11#1)
weakly or##4##2##(1992-10#1)(1994-3#1)(2008-11#1)(2008-2#1)
weakly pathogenic to##3##3##(2008-10#3)
weakly pathogenic##5##2##(2008-10#5)
weakly positive##4##2##(1993-9#1)(1994-12#1)(2007-7#1)(2010-3#1)
weakly reactive##2##2##(1992-9#1)(1994-12#1)
weakly related to##5##3##(2007-12#1)(2008-10#2)(2008-9#1)(2010-12#1)
weakly scattering##2##2##(2007-12#2)
weakly soluble##3##2##(2008-10#1)(2008-4#2)
weakly to##3##2##(1996-6#1)(1997-4#1)(1997-7#1)
weakly virulent isolates##2##3##(2008-10#2)
weakly virulent##4##2##(2008-10#4)
weakly with##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
weakly##158##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-5#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-7#1)(2008-10#39)(2008-11#9)(2008-2#13)(2008-3#11)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#7)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#1)(2013-7#1)
weakness and limited motion##3##4##(2008-6#3)
weakness and sensory loss##2##4##(2008-6#1)(2008-7#1)
weakness and sensory##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
weakness and##17##2##(1992-3#1)(1995-5#1)(2007-10#1)(2007-7#1)(2008-12#2)(2008-6#5)(2008-7#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
weakness as##3##2##(2008-7#1)(2009-3#1)(2012-2#1)
weakness in both legs##2##4##(2008-12#2)
weakness in the##2##3##(2007-5#1)(2012-3#1)
weakness in##8##2##(2007-5#1)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#3)
weakness of her##2##3##(1991-12#1)(2009-3#1)
weakness of the##5##3##(2007-12#1)(2008-12#1)(2008-3#1)(2009-1#1)(2012-2#1)
weakness of##16##2##(1991-12#1)(2007-10#3)(2007-12#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#2)
weakness or##2##2##(1991-8#1)(2008-12#1)
weakness that##2##2##(2008-5#1)(2008-7#1)
weakness was##3##2##(2007-11#1)(2012-12#1)(2012-2#1)
weakness with##2##2##(1994-3#1)(2008-7#1)
weakness##98##1##(1990-9#1)(1991-12#3)(1991-8#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#5)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#8)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#9)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#3)(2009-9#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#12)(2012-3#8)(2013-7#1)(2013-8#1)
weaknesses of##17##2##(1992-12#2)(1994-1#1)(1997-2#1)(1997-3#1)(2007-8#6)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
weaknesses were tabulated##5##3##(2007-8#5)
weaknesses##44##1##(1992-12#2)(1993-1#1)(1993-2#1)(1994-1#2)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#12)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#4)(2013-1#2)
wealth and##2##2##(2011-2#2)
wealth of data##2##3##(2012-12#2)
wealth of information to##2##4##(2010-11#1)(2011-10#1)
wealth of information##5##3##(1994-3#1)(1996-2#1)(2008-7#1)(2010-11#1)(2011-10#1)
wealth of sequences and annotation data brought about by genomics##2##10##(2009-5#1)(2011-2#1)
wealth of##25##2##(1993-1#1)(1994-3#1)(1996-2#1)(1997-7#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-12#3)(2012-3#1)
wealth##36##1##(1991-2#2)(1993-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-7#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#4)
wealthier nations##2##2##(2009-4#1)(2011-1#1)
wealthier##3##1##(1991-6#1)(2009-4#1)(2011-1#1)
wealthy countries##2##2##(2008-7#1)(2010-12#1)
wealthy##8##1##(1992-4#1)(1994-1#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-12#2)(2012-3#1)
weaned from##4##2##(1996-9#1)(2007-9#1)(2012-2#2)
weaned lambs##3##2##(1996-12#1)(2008-9#2)
weaned off the##2##3##(1990-3#1)(2012-2#1)
weaned##16##1##(1990-3#1)(1993-6#1)(1996-12#4)(1996-9#1)(2007-7#1)(2007-9#1)(2008-9#2)(2010-4#1)(2012-12#1)(2012-2#3)
weaning and##2##2##(2008-11#1)(2013-1#1)
weaning from mechanical ventilation##2##4##(2007-6#2)
weaning from##3##2##(2007-6#2)(2007-8#1)
weaning pap##3##2##(1997-4#3)
weaning##37##1##(1991-12#1)(1992-11#2)(1992-3#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#8)(2007-6#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#3)(2010-7#1)(2011-1#1)(2013-1#7)
weaning&quot##2##1##(1994-8#2)
weanling and adult##2##3##(1992-10#2)
weanling and##4##2##(1992-10#2)(1994-5#1)(1997-4#1)
weanling rats fed##2##3##(1992-11#1)(1993-6#1)
weanling rats##4##2##(1992-10#1)(1992-11#1)(1993-6#1)(2012-1#1)
weanling##11##1##(1991-5#1)(1992-10#4)(1992-11#1)(1993-6#1)(1994-5#1)(1997-4#2)(2012-1#1)
weapon in the##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
weapon to##2##2##(1995-2#1)(2013-1#1)
weapon##18##1##(1990-5#1)(1995-11#1)(1995-2#2)(1996-2#2)(1997-5#1)(2008-10#2)(2008-11#1)(2009-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
weapons is##2##2##(1990-2#1)(2008-10#1)
weapons##16##1##(1990-2#3)(1992-12#4)(1995-1#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-6#1)(2010-7#1)
wear a##3##2##(2008-12#1)(2008-9#1)(2012-12#1)
wear and tear##2##3##(2008-7#1)(2008-9#1)
wear and##8##2##(1996-6#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)
wear behaviour##2##2##(2009-7#1)(2011-2#1)
wear damage##2##2##(2008-8#2)
wear debris##6##2##(2008-8#6)
wear in##3##2##(2008-8#2)(2012-12#1)
wear metals##5##2##(2008-10#5)
wear of##2##2##(2008-8#1)(2011-2#1)
wear on the##2##3##(2007-8#1)(2013-1#1)
wear on##3##2##(2007-8#2)(2013-1#1)
wear particles##3##2##(2008-11#2)(2008-8#1)
wear properties##2##2##(2008-5#1)(2008-8#1)
wear rate was calculated##2##4##(2008-8#2)
wear rate was##3##3##(2008-8#3)
wear rate##5##2##(2008-5#1)(2008-8#4)
wear resistance##3##2##(2008-3#1)(2011-2#2)
wear was found for the##2##5##(2011-2#2)
wear was##4##2##(2008-8#2)(2011-2#2)
wear with##2##2##(2008-8#1)(2013-1#1)
wear zone##4##2##(2009-7#4)
wear##89##1##(1992-4#1)(1996-6#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#34)(2008-9#3)(2009-7#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#2)(2011-2#6)(2012-12#6)(2012-2#2)(2013-1#6)
wearable##4##1##(2008-3#1)(2009-11#1)(2010-8#1)(2013-1#1)
wearers##8##1##(1993-11#2)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
wearing the PK##2##3##(2013-1#2)
wearing the##3##2##(2013-1#3)
wearing##13##1##(1990-12#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-7#1)(2013-1#5)
wears##2##1##(1995-6#1)(2008-5#1)
weasel M##4##2##(2008-6#4)
weasel##8##1##(1994-8#3)(2008-6#5)
weather and##5##2##(1990-8#1)(2008-10#3)(2008-2#1)
weather as a##2##3##(2008-10#2)
weather conditions and##2##3##(2008-10#2)
weather conditions to the incidence of##2##6##(1990-8#1)(2008-10#1)
weather conditions##21##2##(1990-8#1)(2008-10#14)(2008-2#1)(2008-3#2)(2009-12#1)(2013-1#2)
weather data##8##2##(2008-10#8)
weather patterns##2##2##(2008-10#1)(2012-3#1)
weather variable##3##2##(2008-10#3)
weather variables and##2##3##(2008-10#2)
weather variables at##2##3##(2008-10#2)
weather variables only##3##3##(2008-10#3)
weather variables prior to the##2##5##(2012-3#2)
weather variables##19##2##(2008-10#15)(2012-3#4)
weather##100##1##(1990-8#2)(1992-3#2)(1996-2#1)(2008-10#71)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
weather-based##3##1##(2008-10#3)
weathered oil in##2##3##(2008-11#2)
weathered oil##4##2##(2008-11#4)
weathered##7##1##(2008-10#3)(2008-11#4)
weathering of##2##2##(2008-10#1)(2008-5#1)
weathering##8##1##(2008-10#6)(2008-5#1)(2010-7#1)
weave##2##1##(2008-10#2)
weaver##2##1##(1996-12#2)
weaving##2##1##(2008-12#1)(2008-3#1)
web and##2##2##(2008-4#1)(2008-8#1)
web is##3##2##(2008-11#1)(2008-9#2)
web of##7##2##(2008-10#2)(2008-11#2)(2009-10#1)(2009-8#1)(2013-1#1)
web page##2##2##(2009-10#1)(2012-3#1)
web server##3##2##(2007-6#2)(2008-7#1)
web site##2##2##(2008-11#1)(2008-4#1)
web sites##2##2##(2008-4#1)(2008-7#1)
web space##5##2##(2008-9#5)
web stability##2##2##(2008-9#2)
web tools##2##2##(2011-2#2)
web##68##1##(1990-5#1)(1996-12#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#5)(2008-7#11)(2008-8#6)(2008-9#19)(2009-10#2)(2009-8#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#1)
web-based clinical##2##2##(2008-10#1)(2013-1#1)
web-based course##2##2##(2010-10#2)
web-based distance learning##2##3##(2010-10#1)(2012-12#1)
web-based distance##3##2##(2010-10#2)(2012-12#1)
web-based learning##2##2##(2008-11#1)(2008-12#1)
web-based survey##2##2##(2012-1#1)(2012-3#1)
web-based training##2##2##(2010-12#2)
web-based##29##1##(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-10#5)(2010-12#5)(2010-4#1)(2010-5#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
webs and##4##2##(2008-8#2)(2008-9#2)
webs##19##1##(1996-12#1)(2008-8#6)(2008-9#9)(2012-12#2)(2012-2#1)
website (http##2##2##(2008-7#1)(2011-2#1)
website approaches##2##2##(2013-1#2)
website messaging##2##2##(2013-1#2)
website##19##1##(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
websites maintained by##2##3##(2013-1#2)
websites of##2##2##(2008-12#1)(2011-2#1)
websites to engage##2##3##(2012-2#1)(2013-1#1)
websites to##3##2##(2012-2#1)(2013-1#2)
websites##20##1##(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
wedge angles##2##2##(2008-3#2)
wedge biopsy of##2##3##(1990-11#1)(2012-3#1)
wedge filters##5##2##(2007-10#5)
wedge in##2##2##(2007-11#1)(2007-8#1)
wedge low tibial osteotomy##2##4##(2011-2#2)
wedge prisms##3##2##(2008-3#3)
wedge resections of##3##3##(2011-2#3)
wedge resections##4##2##(2007-8#1)(2011-2#3)
wedge##50##1##(1990-11#1)(1990-2#1)(1991-6#1)(1992-9#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-8#2)(2008-2#6)(2008-3#13)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#1)
wedge-shaped##5##1##(2007-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
wedged##5##1##(1992-3#1)(1993-10#1)(2007-12#2)(2008-3#1)
wedges##4##1##(2008-2#1)(2008-3#3)
wedging##7##1##(2007-11#1)(2007-8#6)
wee1+ gene product is##2##4##(1991-2#2)
wee1+##5##1##(1991-2#4)(1994-12#1)
weed control##6##2##(2008-10#1)(2011-2#5)
weed density##4##2##(2008-12#3)(2011-1#1)
weed habitats##3##2##(2008-10#3)
weed hosts##5##2##(2008-10#4)(2011-2#1)
weed in##2##2##(2008-10#2)
weed of##2##2##(2008-10#1)(2008-8#1)
weed species##4##2##(2008-10#3)(2008-12#1)
weed##45##1##(2008-10#25)(2008-12#9)(2008-5#1)(2008-8#2)(2011-1#2)(2011-2#6)
weeds and##3##2##(2008-10#2)(2008-12#1)
weeds in the##3##3##(2008-10#1)(2008-12#2)
weeds in##8##2##(2008-10#4)(2008-11#1)(2008-12#3)
weeds or##2##2##(2008-10#2)
weeds##33##1##(2008-10#18)(2008-11#1)(2008-12#9)(2011-2#1)(2013-8#4)
weeds)##2##1##(2008-10#1)(2008-12#1)
week 1##5##2##(2008-3#1)(2008-7#3)(2010-2#1)
week 10##4##2##(1993-9#1)(2013-1#3)
week 11##3##2##(2013-1#3)
week 12##10##2##(1991-3#1)(2008-5#3)(2008-7#1)(2013-1#3)(2013-8#2)
week 16##2##2##(2008-4#2)
week 2##3##2##(1992-3#1)(2013-1#2)
week 24##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
week 3##2##2##(1991-6#1)(2013-1#1)
week 4##4##2##(2008-5#2)(2011-1#1)(2013-1#1)
week 5##5##2##(2008-5#1)(2008-7#3)(2011-2#1)
week 6##2##2##(1993-9#1)(2011-1#1)
week 7##2##2##(1992-8#1)(2011-2#1)
week 8##3##2##(1996-7#1)(2008-7#1)(2008-9#1)
week after birth##3##3##(1990-12#1)(1996-3#1)(1997-6#1)
week after immunization##2##3##(1990-12#1)(2013-1#1)
week after the##7##3##(1995-3#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#1)
week after##27##2##(1990-12#2)(1991-2#2)(1995-3#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2013-1#3)
week and##12##2##(1990-11#1)(1993-12#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#3)(2013-8#1)
week at##2##2##(1990-3#1)(1995-6#1)
week before##4##2##(1996-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
week by##3##2##(1997-4#1)(2008-5#1)(2011-2#1)
week during the##3##3##(1992-6#2)(2007-7#1)
week during##4##2##(1992-6#2)(2007-7#1)(2008-1#1)
week following##6##2##(1990-12#1)(1991-2#1)(1995-5#1)(1996-8#1)(2008-7#1)(2010-3#1)
week for 14##5##3##(2008-11#1)(2008-9#4)
week for 27 weeks##2##4##(2008-9#2)
week for 3 weeks##3##4##(2008-8#1)(2008-9#2)
week for 6 weeks##3##4##(2008-10#2)(2009-1#1)
week for 6##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2009-1#1)
week for 8 weeks##2##4##(2010-1#1)(2013-1#1)
week for##55##2##(1990-3#1)(1991-3#1)(1991-6#1)(1995-12#1)(1996-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#27)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
week from the##2##3##(1996-11#1)(2008-12#1)
week from##6##2##(1994-9#1)(1996-11#1)(2008-10#2)(2008-12#1)(2012-2#1)
week history of##2##3##(1996-9#1)(2008-12#1)
week in##15##2##(1990-11#1)(1990-8#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2013-1#1)
week later##10##2##(1993-3#1)(1993-5#1)(1997-8#1)(2008-10#2)(2008-11#2)(2010-12#1)(2012-12#1)(2013-1#1)
week of 12-h##2##3##(2011-2#2)
week of age##5##3##(1992-4#1)(1996-5#1)(2007-11#1)(2008-12#2)
week of gestation##7##3##(1990-2#1)(1992-6#1)(1996-11#2)(2011-1#2)(2011-2#1)
week of life##2##3##(2007-11#1)(2011-2#1)
week of pregnancy##4##3##(1990-9#1)(1995-6#1)(2007-11#1)(2012-3#1)
week of the##4##3##(2007-11#1)(2008-11#1)(2008-9#1)(2011-1#1)
week of treatment##2##3##(1992-3#1)(2011-2#1)
week of##49##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-6#3)(1996-11#2)(1996-5#2)(1997-6#1)(2007-10#1)(2007-11#6)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-2#1)(2012-3#1)
week old##9##2##(1994-6#1)(1995-12#1)(1996-5#2)(1997-6#1)(2007-11#1)(2008-7#1)(2011-2#2)
week or##5##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
week period with##2##3##(1991-8#1)(2007-5#1)
week period##9##2##(1991-8#1)(1992-6#2)(2007-5#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
week postinfection##2##2##(2009-8#2)
week postinoculation##2##2##(2008-10#2)
week study##5##2##(1995-12#2)(1996-1#1)(2008-5#2)
week up to##2##3##(2007-2#1)(2013-1#1)
week was##3##2##(2008-6#1)(2011-1#1)(2013-1#1)
week were##2##2##(2008-7#1)(2013-1#1)
week when##2##2##(1993-8#1)(2008-10#1)
week with the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
week##435##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-12#6)(1995-3#2)(1995-5#1)(1995-6#5)(1996-1#3)(1996-11#4)(1996-12#3)(1996-3#3)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#5)(1997-8#3)(2007-10#6)(2007-11#11)(2007-2#3)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#34)(2008-11#18)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#23)(2008-6#5)(2008-7#19)(2008-8#7)(2008-9#31)(2009-1#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#16)(2011-2#24)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#37)(2013-7#1)(2013-8#6)
week) for##2##2##(1996-6#1)(2008-7#1)
week)##12##1##(1991-8#1)(1991-9#1)(1992-10#1)(1994-6#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-7#3)(2013-1#1)
week-long##2##1##(2008-11#2)
week-old##2##1##(1991-1#1)(2013-1#1)
weekdays##3##1##(2010-6#2)(2012-2#1)
weekend physical therapy##2##3##(1994-3#2)
weekend##8##1##(1991-12#1)(1994-3#6)(2010-5#1)
weekends##3##1##(1995-2#1)(2011-1#1)(2012-2#1)
weekly Kt/V urea##5##3##(2011-2#5)
weekly and##2##2##(2008-10#1)(2008-7#1)
weekly application##2##2##(1990-7#1)(2008-10#1)
weekly applications of##2##3##(2008-10#2)
weekly applications##3##2##(2008-10#3)
weekly basis##5##2##(1997-4#2)(2008-5#1)(2011-2#1)(2011-9#1)
weekly dose of##3##3##(1994-8#1)(2007-7#1)(2008-1#1)
weekly dose##5##2##(1991-6#1)(1994-8#1)(2007-7#2)(2008-1#1)
weekly doses of##2##3##(1994-2#1)(2008-10#1)
weekly doxorubicin##2##2##(1992-10#2)
weekly during the##2##3##(2008-10#1)(2011-2#1)
weekly during##3##2##(2008-10#2)(2011-2#1)
weekly for 2##2##3##(1992-3#1)(1992-6#1)
weekly for##13##2##(1992-3#1)(1992-6#1)(1992-8#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
weekly from##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2012-6#1)
weekly in##2##2##(2008-5#1)(2008-7#1)
weekly intake##2##2##(1992-12#1)(2011-2#1)
weekly intervals##5##2##(1994-7#1)(2008-10#2)(2008-3#1)(2008-6#1)
weekly schedule##2##2##(1993-2#1)(1994-8#1)
weekly sessions##2##2##(1992-1#1)(2012-12#1)
weekly to##2##2##(1997-3#1)(2008-1#1)
weekly visits##2##2##(1992-6#2)
weekly##129##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-2#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-8#2)(1995-3#1)(1997-2#1)(1997-3#3)(1997-4#2)(2007-11#1)(2007-12#3)(2007-7#5)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#4)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#13)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#14)(2011-9#1)(2012-1#1)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#5)
weeks (0##2##2##(2008-3#2)
weeks (1##2##2##(2008-10#2)
weeks (Regimen##2##2##(1992-8#2)
weeks (equivalent to average daily doses of approximately##8##8##(2008-8#1)(2008-9#7)
weeks (equivalent to##9##3##(2008-8#1)(2008-9#8)
weeks (mean##3##2##(2007-11#2)(2009-8#1)
weeks (range##5##2##(1991-2#1)(1991-3#1)(2011-2#2)(2012-2#1)
weeks 2##3##2##(1991-9#1)(2009-12#2)
weeks 4 and##2##3##(1994-5#1)(2008-5#1)
weeks 4##3##2##(1994-5#1)(2008-5#2)
weeks 6 and##2##3##(2007-7#1)(2011-2#1)
weeks after application##2##3##(2008-10#2)
weeks after birth##5##3##(1995-2#1)(1997-6#3)(2012-2#1)
weeks after discharge##3##3##(1994-3#1)(2007-12#1)(2008-1#1)
weeks after exposure to##2##4##(2008-7#1)(2008-8#1)
weeks after exposure##3##3##(1996-8#1)(2008-7#1)(2008-8#1)
weeks after fruit set##2##4##(2008-10#2)
weeks after harvest##3##3##(2008-10#3)
weeks after infection##2##3##(2009-10#1)(2010-7#1)
weeks after initiation of##2##4##(2009-7#1)(2013-7#1)
weeks after injury##5##3##(2012-3#5)
weeks after inoculation##15##3##(1995-2#1)(2008-10#14)
weeks after surgery##11##3##(1990-3#1)(1992-3#2)(1997-2#1)(2007-11#4)(2007-8#1)(2009-5#1)(2012-1#1)
weeks after termination of##2##4##(1993-12#1)(1996-12#1)
weeks after the first##2##4##(1992-4#1)(2008-10#1)
weeks after the initial##3##4##(2007-5#1)(2009-3#1)(2012-2#1)
weeks after the onset of##2##5##(1994-12#1)(2007-10#1)
weeks after the operation##2##4##(1994-9#1)(2008-7#1)
weeks after the surgery##2##4##(2009-7#1)(2011-2#1)
weeks after the##29##3##(1990-12#1)(1991-5#1)(1992-4#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
weeks after tracheal obstruction##2##4##(2013-1#2)
weeks after treatment##3##3##(1992-12#1)(2008-10#1)(2010-12#1)
weeks after##142##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#3)(1996-12#4)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#4)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#1)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#6)
weeks and 20##2##3##(2007-7#1)(2008-10#1)
weeks and 6##3##3##(1996-5#1)(2012-2#1)(2013-1#1)
weeks and a##2##3##(2008-10#1)(2008-9#1)
weeks and by##2##3##(2007-8#1)(2008-9#1)
weeks and consisted of##3##4##(2008-5#1)(2008-7#1)(2012-12#1)
weeks and in##6##3##(1991-9#1)(2007-11#1)(2008-9#4)
weeks and ten##2##3##(2008-5#1)(2011-1#1)
weeks and the##2##3##(1991-11#1)(2008-10#1)
weeks and then##3##3##(1991-6#1)(2008-12#1)(2008-3#1)
weeks and##67##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#7)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
weeks at 25 degrees C##2##5##(2008-10#1)(2008-8#1)
weeks at a##2##3##(2012-12#1)(2013-1#1)
weeks at the##3##3##(2008-10#1)(2013-1#2)
weeks at##11##2##(1992-11#1)(1992-6#1)(1995-3#1)(2008-10#2)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#3)
weeks before commercial harvest##2##4##(2008-10#2)
weeks before harvest##2##3##(2008-10#2)
weeks before the##2##3##(2007-11#1)(2008-7#1)
weeks before##19##2##(1990-12#1)(1992-4#1)(1992-5#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#10)(2008-7#1)(2008-8#1)(2013-1#1)
weeks by##2##2##(2010-7#1)(2012-1#1)
weeks duration##2##2##(1993-3#1)(2010-11#1)
weeks during the##4##3##(1990-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
weeks earlier in##2##3##(2008-10#2)
weeks following the##4##3##(1993-11#1)(1993-12#1)(2008-7#1)(2009-3#1)
weeks following treatment##2##3##(1995-11#1)(2007-7#1)
weeks following##16##2##(1993-11#1)(1993-12#1)(1995-11#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2011-1#1)
weeks for##5##2##(1991-2#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-9#1)
weeks full-time##2##2##(1995-12#2)
weeks gestation##6##2##(1991-2#1)(1994-12#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-1#1)
weeks gestation)##2##2##(2007-10#1)(2012-2#1)
weeks gestational age##4##3##(2008-11#2)(2010-11#1)(2012-12#1)
weeks had##5##2##(1994-3#1)(1995-9#1)(2008-7#1)(2008-9#1)(2011-2#1)
weeks in a##2##3##(2008-10#1)(2013-1#1)
weeks in culture##3##3##(1996-5#1)(2008-11#2)
weeks in patients with##2##4##(2008-10#1)(2008-7#1)
weeks in the grade III##3##5##(2013-8#3)
weeks in the grade##5##4##(2013-8#5)
weeks in the##10##3##(1992-4#1)(1995-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2013-8#5)
weeks in treated animals than in controls##2##7##(2011-2#2)
weeks in##43##2##(1990-10#1)(1992-4#1)(1993-2#1)(1993-3#2)(1993-6#2)(1994-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#5)
weeks incubation##3##2##(1992-2#3)
weeks later after##2##3##(1993-12#1)(2012-2#1)
weeks later with##2##3##(1997-3#1)(2008-10#1)
weeks later##37##2##(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-5#2)(1997-3#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#10)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-8#1)
weeks of age the##2##4##(1991-6#1)(1997-5#1)
weeks of age were##2##4##(1995-8#1)(2012-1#1)
weeks of age##36##3##(1990-11#1)(1990-3#1)(1991-6#3)(1992-3#2)(1993-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-3#2)(1997-5#1)(1997-6#4)(2008-10#7)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-1#3)(2013-1#1)
weeks of culture in##2##4##(2008-5#1)(2009-7#1)
weeks of culture##3##3##(2008-5#1)(2009-7#1)(2013-1#1)
weeks of follow-up##2##3##(1991-8#1)(1995-2#1)
weeks of gestation with##2##4##(2007-7#1)(2013-1#1)
weeks of gestation##17##3##(1990-2#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-3#1)(2007-7#2)(2008-11#3)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
weeks of gestational##2##3##(2008-11#1)(2008-7#1)
weeks of life and##2##4##(2008-5#2)
weeks of life with##2##4##(2008-10#1)(2011-1#1)
weeks of life##10##3##(1992-5#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-1#2)(2011-2#1)
weeks of pregnancy##6##3##(1994-3#2)(1995-6#1)(1995-8#1)(2008-7#1)(2009-1#1)
weeks of storage##2##3##(2008-10#2)
weeks of the study##2##4##(2008-9#2)
weeks of the##6##3##(1993-12#1)(2008-5#2)(2008-7#1)(2008-9#2)
weeks of their##3##3##(1994-12#1)(1995-1#1)(2010-3#1)
weeks of therapy##7##3##(1992-6#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-8#1)(2013-1#1)
weeks of treatment with a##2##5##(1990-11#1)(2013-1#1)
weeks of treatment with##4##4##(1990-11#1)(1992-11#1)(2007-7#1)(2013-1#1)
weeks of treatment##21##3##(1990-11#1)(1991-11#1)(1992-11#1)(1994-6#1)(1996-2#1)(1996-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2013-1#2)
weeks of##176##2##(1990-11#3)(1990-2#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-3#3)(1997-5#1)(1997-6#4)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#16)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#5)(2009-1#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#4)(2011-2#8)(2012-1#3)(2012-2#5)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#1)
weeks old male##2##3##(2011-2#1)(2013-1#1)
weeks old##8##2##(1992-9#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2011-2#1)(2013-1#1)
weeks old)##3##2##(2008-10#2)(2008-6#1)
weeks on##7##2##(1996-5#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-1#1)(2013-1#1)
weeks one##2##2##(1996-6#1)(2008-10#1)
weeks or by##2##3##(2008-9#2)
weeks or more##2##3##(2008-10#1)(2008-9#1)
weeks or##12##2##(1995-12#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-9#6)(2009-12#1)
weeks period##2##2##(2008-5#2)
weeks post discharge using##2##4##(2007-11#2)
weeks post discharge##3##3##(2007-11#3)
weeks post injection##2##3##(2007-11#2)
weeks post##10##2##(1993-10#1)(2007-10#1)(2007-11#5)(2007-8#1)(2008-10#1)(2010-12#1)
weeks post-capture##3##2##(2008-5#3)
weeks post-immunization were##2##3##(2009-5#2)
weeks post-immunization##4##2##(2009-5#4)
weeks post-implantation##2##2##(2008-5#1)(2013-1#1)
weeks post-injury##2##2##(2011-2#2)
weeks post-treatment##2##2##(2007-11#1)(2012-12#1)
weeks postbloom##8##2##(2008-10#8)
weeks postinoculation##3##2##(2008-10#3)
weeks postoperatively##6##2##(1992-2#1)(1994-3#1)(2008-10#1)(2012-12#2)(2012-3#1)
weeks postsurgery##2##2##(1991-3#1)(1992-12#1)
weeks prior to the##2##4##(1994-8#1)(2008-10#1)
weeks prior to##3##3##(1994-8#1)(2008-10#2)
weeks provided##2##2##(1991-6#1)(2008-5#1)
weeks respectively##3##2##(2007-11#1)(2008-1#1)(2008-9#1)
weeks resulted in##2##3##(2008-10#2)
weeks that##2##2##(2008-5#1)(2008-9#1)
weeks the results were##2##4##(2007-7#1)(2008-5#1)
weeks the##7##2##(1991-3#1)(1992-6#1)(1995-8#1)(1996-5#1)(2007-7#1)(2008-5#1)(2009-4#1)
weeks to 4##3##3##(2007-11#1)(2007-7#1)(2008-2#1)
weeks to several months##2##4##(1991-8#1)(1995-2#1)
weeks to##22##2##(1991-3#1)(1991-8#1)(1993-2#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#3)(2009-5#1)(2009-6#1)(2011-2#3)(2012-2#2)
weeks under##2##2##(2008-10#2)
weeks until##2##2##(1990-6#1)(1996-7#1)
weeks was##8##2##(1992-10#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
weeks were considered##2##3##(2008-9#1)(2013-1#1)
weeks were used##2##3##(1996-2#1)(2007-10#1)
weeks were##13##2##(1991-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
weeks with##13##2##(1990-9#1)(1991-6#1)(1995-12#1)(2007-6#1)(2008-5#1)(2008-6#2)(2008-9#3)(2010-3#1)(2013-1#1)(2013-8#1)
weeks without any##3##3##(1994-2#1)(2008-10#2)
weeks without##4##2##(1994-2#1)(2008-10#3)
weeks##1330##1##(1990-10#4)(1990-11#6)(1990-12#4)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#4)(1991-11#5)(1991-12#4)(1991-2#11)(1991-3#8)(1991-5#3)(1991-6#17)(1991-7#1)(1991-8#9)(1991-9#3)(1992-1#1)(1992-10#4)(1992-11#4)(1992-12#2)(1992-2#5)(1992-3#10)(1992-4#4)(1992-5#4)(1992-6#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#4)(1993-3#5)(1993-6#5)(1993-8#1)(1994-11#2)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#10)(1995-2#6)(1995-3#7)(1995-6#1)(1995-8#13)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#14)(1996-2#4)(1996-3#2)(1996-5#13)(1996-6#6)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#7)(1997-5#3)(1997-6#14)(1997-7#1)(1997-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#16)(2007-11#36)(2007-12#7)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#29)(2007-8#21)(2008-1#11)(2008-10#209)(2008-11#29)(2008-12#10)(2008-2#2)(2008-3#14)(2008-4#6)(2008-5#74)(2008-6#20)(2008-7#48)(2008-8#14)(2008-9#130)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#7)(2009-2#1)(2009-3#11)(2009-4#1)(2009-5#9)(2009-6#2)(2009-7#4)(2009-8#4)(2010-1#2)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#8)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#20)(2011-2#47)(2011-3#1)(2012-1#7)(2012-12#16)(2012-2#26)(2012-3#19)(2012-8#1)(2013-1#70)(2013-7#4)(2013-8#18)
weeks' gestation is##2##3##(1995-8#1)(2011-2#1)
weeks' gestation##19##2##(1992-2#1)(1993-12#2)(1993-3#1)(1995-8#3)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-8#1)
weeks'##22##1##(1992-2#2)(1993-12#2)(1993-3#1)(1995-8#3)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-7#1)(2011-2#2)(2012-8#1)
weeks) and##7##2##(1990-3#2)(1994-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
weeks) as well as##2##4##(1996-7#1)(2012-2#1)
weeks) in##4##2##(1992-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
weeks)##49##1##(1990-3#3)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(2007-11#6)(2008-1#2)(2008-10#3)(2008-5#6)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#1)
weevil##9##1##(2008-10#3)(2011-10#2)(2011-2#3)(2013-8#1)
weevils##5##1##(2008-7#1)(2011-2#4)
weigh##8##1##(1991-9#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-9#1)(2012-12#1)(2013-1#1)
weighed in the##2##3##(2008-10#2)
weighed in##3##2##(2008-10#3)
weighed##31##1##(1991-11#1)(1993-3#2)(1994-1#1)(1994-6#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#2)
weighing and##2##2##(1995-1#1)(2008-10#1)
weighing less than 1500 g##2##5##(2008-11#2)
weighing less than##3##3##(2008-11#2)(2012-2#1)
weighing of##3##2##(2008-10#2)(2008-7#1)
weighing the##4##2##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
weighing##36##1##(1991-6#2)(1994-3#2)(1995-1#1)(1997-4#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#3)
weighs in##2##2##(2008-6#1)(2008-7#1)
weighs##5##1##(1994-5#1)(1995-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
weight (BW)##4##2##(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
weight (r = 0##2##4##(2008-8#1)(2013-1#1)
weight (β = 0##2##4##(2011-2#2)
weight after##2##2##(2008-11#1)(2008-7#1)
weight among##2##2##(2008-11#1)(2013-1#1)
weight and body##8##3##(1996-8#1)(2007-12#2)(2008-7#1)(2008-9#2)(2012-1#1)(2012-2#1)
weight and feed conversion ratio##2##5##(2008-12#2)
weight and feed##3##3##(1997-3#1)(2008-12#2)
weight and height of##2##4##(2011-1#1)(2012-2#1)
weight and height##4##3##(2011-1#1)(2012-2#2)(2013-1#1)
weight and mandible weight##2##4##(2008-7#2)
weight and metabolism##2##3##(2008-3#2)
weight and the##6##3##(1990-12#1)(2008-12#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
weight and volume of##2##4##(1990-11#1)(1996-5#1)
weight and volume##4##3##(1990-11#1)(1996-5#1)(2008-3#1)(2011-2#1)
weight and##125##2##(1990-11#1)(1990-12#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-10#2)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#10)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#3)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-2#9)(2012-3#2)(2013-1#5)(2013-8#2)
weight are##4##2##(1991-11#1)(1991-2#1)(2008-10#1)(2008-5#1)
weight as well as##4##4##(1990-9#1)(1993-6#1)(2007-9#1)(2008-10#1)
weight as##7##2##(1990-9#1)(1992-6#1)(1993-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
weight associated with##2##3##(2008-5#1)(2008-7#1)
weight at birth##3##3##(1997-5#1)(2007-11#2)
weight at##9##2##(1991-11#1)(1995-11#1)(1997-5#1)(2007-11#2)(2008-7#1)(2010-2#1)(2010-4#1)(2013-7#1)
weight basis##2##2##(2008-10#1)(2008-7#1)
weight bearing##8##2##(2007-11#3)(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
weight by##3##2##(1991-10#1)(1995-6#1)(2007-12#1)
weight change from##2##3##(2009-9#1)(2013-1#1)
weight change##8##2##(1991-2#2)(2008-3#2)(2009-9#1)(2010-8#2)(2013-1#1)
weight changes##4##2##(2008-5#1)(2011-2#1)(2013-8#2)
weight compared with##2##3##(2008-10#2)
weight concerns and##2##3##(2007-12#2)
weight concerns##4##2##(2007-12#4)
weight control##11##2##(1994-2#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
weight control/obesity counselling##2##3##(1993-2#2)
weight data##2##2##(2008-7#1)(2012-12#1)
weight does not##2##3##(1994-12#1)(2009-6#1)
weight during pregnancy##2##3##(2012-12#1)(2013-1#1)
weight during the##3##3##(2008-7#1)(2008-9#2)
weight during##6##2##(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)(2013-7#1)
weight factors##4##2##(2008-10#1)(2008-3#3)
weight for each##2##3##(1995-2#1)(2011-1#1)
weight for height##3##3##(1991-12#1)(1993-2#1)(2008-12#1)
weight for the##3##3##(2008-10#2)(2010-4#1)
weight for##19##2##(1991-12#2)(1993-2#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
weight fractions of##2##3##(2007-12#1)(2008-10#1)
weight fractions##4##2##(2007-12#1)(2008-10#3)
weight from##3##2##(2008-10#1)(2008-5#1)(2009-12#1)
weight gain (WG) and##2##4##(2008-7#1)(2013-7#1)
weight gain after##2##3##(2007-12#1)(2013-1#1)
weight gain and##8##3##(1991-12#1)(1995-10#1)(1996-12#1)(2008-3#2)(2008-5#1)(2010-1#1)(2013-7#1)
weight gain during##2##3##(1997-7#1)(2008-12#1)
weight gain in children##2##4##(1991-2#1)(2013-1#1)
weight gain in##9##3##(1991-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
weight gain is##3##3##(2008-3#1)(2013-1#2)
weight gain of##5##3##(2008-9#4)(2010-4#1)
weight gain or##3##3##(1993-2#1)(2008-12#1)(2008-3#1)
weight gain than those##2##4##(2007-12#1)(2013-1#1)
weight gain than##3##3##(2007-12#1)(2013-1#2)
weight gain was##3##3##(2010-4#1)(2011-2#1)(2013-1#1)
weight gain##76##2##(1991-12#1)(1991-2#2)(1993-2#1)(1995-10#1)(1996-12#1)(1997-7#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#6)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#5)(2010-1#1)(2010-10#1)(2010-4#4)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#20)(2013-7#4)(2013-8#1)
weight gain)##2##2##(1992-8#1)(2008-12#1)
weight gains were##2##3##(2007-7#1)(2008-5#1)
weight gains##9##2##(1991-12#1)(2007-12#1)(2007-7#2)(2008-5#3)(2008-9#1)(2011-2#1)
weight growth##2##2##(1992-9#1)(2010-7#1)
weight heparin##22##2##(1995-5#1)(1996-6#1)(1997-2#2)(2007-10#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#4)
weight in diabetes##2##3##(2008-12#2)
weight in the##4##3##(1993-8#1)(2009-6#1)(2010-3#1)(2011-2#1)
weight in##44##2##(1991-11#1)(1991-12#1)(1993-8#1)(1996-8#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#19)(2009-6#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
weight increase##2##2##(1995-3#1)(2009-12#1)
weight increased##2##2##(2008-10#1)(2010-4#1)
weight is##7##2##(1992-11#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
weight loss after##2##3##(2008-5#1)(2010-8#1)
weight loss and##14##3##(1991-12#1)(1993-12#1)(1995-9#1)(2008-1#1)(2008-3#3)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
weight loss associated with##3##4##(2008-5#2)(2013-8#1)
weight loss between##2##3##(1992-8#1)(2013-1#1)
weight loss diets##3##3##(2008-3#3)
weight loss due to##2##4##(1993-2#1)(2008-3#1)
weight loss in animals bearing##2##5##(1992-8#2)
weight loss in##6##3##(1992-8#2)(2008-3#2)(2012-2#1)(2013-8#1)
weight loss is##5##3##(1994-11#2)(2008-3#1)(2011-1#1)(2012-2#1)
weight loss of##4##3##(1990-11#1)(1992-8#1)(2013-8#2)
weight loss program##2##3##(2008-4#1)(2013-8#1)
weight loss therapy##2##3##(2008-3#2)
weight loss with##2##3##(2008-3#1)(2013-8#1)
weight loss##117##2##(1990-11#1)(1991-12#2)(1992-12#1)(1992-8#4)(1993-12#2)(1993-2#1)(1994-11#3)(1995-12#1)(1995-2#1)(1995-9#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-3#21)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#11)
weight maintenance##2##2##(1997-3#1)(2012-2#1)
weight management##5##2##(2008-10#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-2#1)
weight markers##2##2##(2008-4#1)(2008-5#1)
weight matrix##4##2##(2008-3#3)(2008-9#1)
weight measurements##2##2##(1997-8#1)(2008-4#1)
weight of 1##4##3##(2008-10#1)(2008-12#1)(2008-8#2)
weight of 100##3##3##(2008-5#1)(2008-9#2)
weight of a##4##3##(1996-8#2)(2008-7#1)(2010-9#1)
weight of different body organs (breast##2##6##(2008-12#2)
weight of different##3##3##(2008-12#2)(2012-3#1)
weight of the evidence##2##4##(2008-10#1)(2008-11#1)
weight of the mammary glands##2##5##(2012-12#2)
weight of the##44##3##(1990-11#1)(1990-2#1)(1991-12#3)(1991-2#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-2#1)(1995-3#2)(1997-6#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#6)(2013-1#3)(2013-7#1)
weight of##178##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-7#5)(1991-12#3)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#11)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-9#2)(2011-2#4)(2012-1#3)(2012-12#6)(2012-3#6)(2013-1#6)(2013-7#2)
weight on##7##2##(1995-8#1)(2008-3#1)(2008-6#2)(2009-5#1)(2013-1#2)
weight or##9##2##(1994-12#1)(1996-11#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
weight per##5##2##(1996-12#2)(2008-12#1)(2009-6#1)(2010-9#1)
weight preoperatively##2##2##(2010-8#2)
weight proteins##5##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
weight ranged between##2##3##(2008-5#1)(2011-2#1)
weight ranged from##2##3##(1995-8#1)(2010-7#1)
weight ranged##4##2##(1995-8#1)(2008-5#1)(2010-7#1)(2011-2#1)
weight ratio and##2##3##(1994-6#1)(2011-2#1)
weight ratio##6##2##(1994-6#1)(1995-3#1)(2008-10#1)(2011-2#1)(2013-1#2)
weight ratios of##2##3##(2008-11#1)(2009-11#1)
weight ratios##5##2##(1997-4#2)(2008-10#1)(2008-11#1)(2009-11#1)
weight reduction##9##2##(1996-11#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
weight status was##2##3##(2008-9#1)(2013-1#1)
weight status##9##2##(2008-9#1)(2011-2#4)(2013-1#3)(2013-8#1)
weight terms##3##2##(2007-12#3)
weight than the##2##3##(1991-12#1)(2008-10#1)
weight than##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
weight the##2##2##(1993-3#1)(2012-2#1)
weight thiol##2##2##(1992-11#1)(1995-5#1)
weight to the##5##3##(1992-6#1)(1993-1#1)(2008-4#1)(2010-10#1)(2012-12#1)
weight to##16##2##(1991-1#1)(1992-6#1)(1993-1#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)
weight versus##2##2##(1993-2#1)(2008-5#1)
weight was not affected by##2##5##(2010-2#1)(2013-1#1)
weight was reduced##2##3##(1992-12#1)(2012-12#1)
weight was significantly##2##3##(2008-10#1)(2011-2#1)
weight was##31##2##(1990-11#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#2)(1995-3#1)(1996-8#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-3#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2013-1#2)
weight were examined##2##3##(1992-2#1)(2008-11#1)
weight were observed##2##3##(1996-12#1)(2008-10#1)
weight were##14##2##(1991-2#1)(1992-2#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-2#1)(2013-7#1)
weight within##2##2##(2008-10#1)(2008-11#1)
weight##1397##1##(1990-11#10)(1990-12#20)(1990-2#7)(1990-5#3)(1990-6#2)(1990-7#11)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#22)(1991-2#14)(1991-3#2)(1991-5#4)(1991-6#5)(1991-9#5)(1992-10#4)(1992-11#6)(1992-12#9)(1992-2#6)(1992-3#4)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#12)(1992-9#6)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#5)(1993-2#9)(1993-3#14)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#6)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#6)(1995-3#9)(1995-5#3)(1995-6#6)(1995-8#8)(1995-9#2)(1996-11#2)(1996-12#9)(1996-2#6)(1996-3#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#7)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2006-10#1)(2007-10#3)(2007-11#8)(2007-12#41)(2007-2#2)(2007-7#17)(2007-8#5)(2007-9#1)(2008-1#12)(2008-10#152)(2008-11#38)(2008-12#68)(2008-2#3)(2008-3#58)(2008-4#16)(2008-5#67)(2008-6#18)(2008-7#47)(2008-8#23)(2008-9#48)(2009-1#3)(2009-10#5)(2009-11#4)(2009-12#3)(2009-3#2)(2009-4#5)(2009-5#6)(2009-6#7)(2009-7#3)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#3)(2010-2#11)(2010-3#6)(2010-4#18)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#12)(2010-9#4)(2011-1#21)(2011-2#53)(2011-3#2)(2012-1#10)(2012-12#16)(2012-2#33)(2012-3#25)(2012-5#1)(2013-1#94)(2013-7#20)(2013-8#25)
weight) significantly##2##2##(1994-8#1)(2013-1#1)
weight)##26##1##(1992-11#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-9#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
weight-bearing##7##1##(1993-11#1)(1995-6#1)(1997-5#1)(2007-11#2)(2008-12#1)(2010-5#1)
weight-for-age##3##1##(1997-4#2)(2010-6#1)
weight-for-height##3##1##(1991-12#2)(2010-6#1)
weight-loss dynamics##4##2##(2013-8#4)
weight-loss##8##1##(2010-8#3)(2013-8#5)
weight-reducing##2##1##(2008-3#1)(2010-8#1)
weight-related beliefs and##3##3##(2011-2#3)
weight-related words and personal characteristics##2##5##(2007-12#2)
weight-related words##4##2##(2007-12#4)
weight-related##9##1##(2007-12#5)(2011-2#3)(2013-1#1)
weight/body weight##2##2##(1995-3#1)(2008-12#1)
weight]##2##1##(1991-6#1)(2012-3#1)
weighted DH(w)##2##2##(2008-10#2)
weighted average of##2##3##(2008-3#1)(2008-8#1)
weighted average##7##2##(1992-12#1)(1995-1#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-8#1)
weighted by the##2##3##(2008-3#2)
weighted by##7##2##(2008-3#3)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)
weighted cases##2##2##(1992-12#2)
weighted filtering##2##2##(2008-3#2)
weighted imaging##2##2##(2012-12#1)(2012-2#1)
weighted kappa##2##2##(1993-12#1)(2012-1#1)
weighted mean of##3##3##(2008-10#3)
weighted mean##6##2##(2008-10#5)(2011-2#1)
weighted nonlinear least-squares##2##3##(2008-3#2)
weighted sum of the##2##4##(2008-3#1)(2009-10#1)
weighted##82##1##(1990-8#2)(1992-12#3)(1992-2#1)(1992-3#1)(1993-12#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-8#1)
weighting and##2##2##(2007-11#1)(2008-3#1)
weighting factors##2##2##(2011-1#2)
weighting formula##2##2##(2007-11#2)
weighting is##2##2##(1990-8#1)(2012-3#1)
weighting method##4##2##(2008-10#1)(2011-1#3)
weighting of##3##2##(1995-2#1)(2007-11#1)(2010-8#1)
weighting the##2##2##(2008-8#1)(2013-7#1)
weighting##28##1##(1990-8#3)(1995-2#1)(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#11)(2012-3#1)(2013-1#1)(2013-7#1)
weights and volumes##2##3##(1994-3#1)(1995-12#1)
weights and##12##2##(1993-1#1)(1993-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
weights are##8##2##(1993-1#3)(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#1)
weights calculated##2##2##(1992-12#2)
weights for##6##2##(1991-2#1)(2007-11#2)(2008-10#2)(2010-3#1)
weights in 256 mg/kg##2##4##(2008-9#2)
weights in a##2##3##(2008-12#1)(2008-5#1)
weights in##11##2##(1990-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#5)
weights of 12 mg/kg males were significantly##2##7##(2008-9#2)
weights of 12 mg/kg males##3##5##(2008-9#3)
weights of 12 mg/kg##4##4##(2008-9#4)
weights of 350 and 700 mg/L males were significantly less than those of the control group##2##16##(2008-9#2)
weights of 350 and 700 mg/L males were##4##8##(2008-9#4)
weights of 350##5##3##(2008-9#4)(2013-1#1)
weights of 6 and 12 mg/kg males and females were##2##10##(2008-9#2)
weights of 6 and 12 mg/kg males and##3##8##(2008-9#3)
weights of 6 and 12 mg/kg##4##6##(2008-9#4)
weights of all dosed groups of##2##6##(2008-9#2)
weights of all##3##3##(2008-12#1)(2008-9#2)
weights of connections between the core##2##6##(1994-8#2)
weights of exposed males##2##4##(2008-9#2)
weights of males administered 50 mg/kg or greater and 200 mg/kg females were significantly less than those of the vehicle controls##2##21##(2008-9#2)
weights of males administered 50 mg/kg or greater##3##8##(2008-9#3)
weights of males administered 50##4##5##(2008-9#4)
weights of males administered##5##4##(2008-9#5)
weights of males##8##3##(2008-9#8)
weights of the##9##3##(1992-3#1)(1993-6#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)
weights of thymus##2##3##(2008-5#2)
weights of##100##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-8#3)(1996-12#1)(1996-8#1)(1997-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-8#6)(2008-9#48)(2010-12#1)(2011-2#1)(2013-1#2)
weights on##2##2##(2007-11#1)(2008-5#1)
weights to##4##2##(1993-1#1)(2008-2#1)(2008-9#1)(2013-1#1)
weights was##2##2##(2008-5#1)(2012-12#1)
weights were increased##2##3##(2008-9#2)
weights were significantly decreased in 800 mg/L##2##7##(2008-9#2)
weights were significantly##3##3##(2008-9#3)
weights were##15##2##(1993-2#1)(1995-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#8)
weights with##3##2##(1993-1#1)(2008-3#1)(2009-10#1)
weights##243##1##(1990-11#2)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#7)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#10)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#2)(1996-8#1)(1997-6#3)(1997-7#4)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#7)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#12)(2008-7#1)(2008-8#8)(2008-9#70)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
weihenstephanensis##5##1##(2011-2#5)
weirii##2##1##(2008-10#2)
welcome##10##1##(1991-1#1)(1995-2#1)(1996-11#1)(2007-12#1)(2007-2#2)(2008-8#1)(2009-6#1)(2010-3#1)(2011-2#1)
welcomed by##2##2##(1993-12#1)(1995-1#1)
welcomed the##2##2##(1993-11#1)(1993-6#1)
welcomed##7##1##(1993-11#1)(1993-12#1)(1993-6#1)(1995-1#1)(1996-11#1)(2008-11#1)(2008-8#1)
weld##3##1##(2008-10#1)(2008-3#2)
welding fume##3##2##(2008-10#3)
welding##15##1##(1996-1#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#7)
welfare of the##2##3##(1997-2#1)(2011-1#1)
welfare of##7##2##(1992-3#2)(1995-11#1)(1997-2#1)(2008-10#1)(2011-1#1)(2013-1#1)
welfare services##2##2##(1996-2#2)
welfare spending##2##2##(2013-1#2)
welfare state##2##2##(1996-8#2)
welfare states##2##2##(2013-1#2)
welfare##51##1##(1992-1#1)(1992-2#2)(1992-3#3)(1992-5#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#5)(1994-7#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#4)(1996-3#2)(1996-8#4)(1997-2#3)(2008-10#1)(2008-11#1)(2008-9#2)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#7)
well ELISA##2##2##(2008-10#1)(2013-8#1)
well above the##2##3##(2008-8#1)(2009-7#1)
well above##8##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-1#1)(1997-7#1)(2007-11#1)(2008-8#1)(2009-7#1)
well accepted by patients and##2##5##(1991-6#1)(2012-3#1)
well accepted by##4##3##(1991-6#1)(1994-8#1)(2010-2#1)(2012-3#1)
well accepted that##2##3##(1991-1#1)(2008-10#1)
well accepted##12##2##(1991-1#1)(1991-6#1)(1993-11#1)(1994-8#1)(2008-10#4)(2008-5#1)(2010-2#1)(2012-3#1)(2013-8#1)
well adapted to the##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
well adapted to##7##3##(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
well adapted##8##2##(1997-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
well advised to##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
well after##7##2##(1990-8#1)(1992-2#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)
well agree with those obtained by the method of standard additions##2##11##(2008-10#2)
well aligned##2##2##(2008-9#1)(2010-3#1)
well and were##2##3##(2008-10#1)(2008-2#1)
well and##17##2##(1991-11#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2009-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
well approximated by##3##3##(1992-9#1)(2008-3#2)
well approximated##6##2##(1992-9#1)(2008-2#1)(2008-3#3)(2009-9#1)
well are##2##2##(1996-2#1)(2008-11#1)
well as a large##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
well as a##115##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#3)(1997-3#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
well as all the##2##4##(1997-3#1)(2007-11#1)
well as all##6##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
well as an##30##3##(1992-2#1)(1995-2#2)(1996-5#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
well as for the##20##4##(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-12#1)(2013-1#2)
well as for##73##3##(1992-8#1)(1993-3#2)(1994-12#3)(1997-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
well as having a##2##4##(2008-8#1)(2011-2#1)
well as having##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
well as in##194##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#1)(1996-7#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#33)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
well as it##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
well as other##47##3##(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
well as our##5##3##(2008-3#1)(2008-6#2)(2008-8#1)(2012-12#1)
well as providing##4##3##(1996-1#1)(2008-10#1)(2008-9#1)(2010-6#1)
well as that of##13##4##(1990-5#1)(1992-3#1)(1993-11#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
well as that##15##3##(1990-5#1)(1992-3#1)(1993-11#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
well as the##613##3##(1990-11#2)(1990-12#3)(1990-2#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#4)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#6)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#2)(1997-8#1)(2007-10#3)(2007-11#6)(2007-12#15)(2007-2#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#99)(2008-11#24)(2008-12#6)(2008-2#12)(2008-3#35)(2008-4#10)(2008-5#21)(2008-6#10)(2008-7#27)(2008-8#14)(2008-9#16)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#4)(2009-7#7)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#14)(2011-2#25)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#15)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#6)
well as their##53##3##(1990-11#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-7#1)(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
well as to##97##3##(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#2)(2006-6#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#1)(2010-10#4)(2010-3#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
well as##3184##2##(1990-10#1)(1990-11#9)(1990-12#9)(1990-2#6)(1990-3#3)(1990-5#8)(1990-6#1)(1990-7#9)(1990-8#10)(1990-9#6)(1991-1#7)(1991-11#6)(1991-12#20)(1991-2#13)(1991-3#9)(1991-4#1)(1991-5#7)(1991-6#9)(1991-7#2)(1991-8#4)(1991-9#8)(1992-1#7)(1992-11#4)(1992-12#13)(1992-2#4)(1992-3#23)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#18)(1993-1#2)(1993-11#9)(1993-12#17)(1993-2#7)(1993-3#15)(1993-5#2)(1993-6#11)(1993-8#12)(1993-9#6)(1994-1#8)(1994-11#16)(1994-12#18)(1994-2#13)(1994-3#12)(1994-5#5)(1994-6#16)(1994-7#1)(1994-8#16)(1994-9#5)(1995-1#4)(1995-11#15)(1995-12#13)(1995-2#26)(1995-3#11)(1995-5#18)(1995-6#18)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#24)(1996-2#19)(1996-3#10)(1996-5#11)(1996-6#4)(1996-7#4)(1996-9#5)(1997-1#5)(1997-2#22)(1997-3#6)(1997-4#13)(1997-5#5)(1997-6#11)(1997-7#18)(1997-8#7)(1997-9#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#15)(2007-11#48)(2007-12#51)(2007-2#6)(2007-4#2)(2007-5#5)(2007-7#11)(2007-8#13)(2007-9#1)(2008-1#43)(2008-10#472)(2008-11#140)(2008-12#47)(2008-2#92)(2008-3#133)(2008-4#86)(2008-5#95)(2008-6#35)(2008-7#105)(2008-8#70)(2008-9#98)(2009-10#24)(2009-11#13)(2009-12#15)(2009-2#9)(2009-3#11)(2009-4#14)(2009-5#14)(2009-6#13)(2009-7#23)(2009-8#28)(2009-9#8)(2010-1#8)(2010-10#17)(2010-11#14)(2010-12#19)(2010-2#6)(2010-3#21)(2010-4#18)(2010-5#18)(2010-6#18)(2010-7#8)(2010-8#14)(2010-9#12)(2011-1#47)(2011-2#143)(2011-3#5)(2011-4#1)(2011-7#2)(2011-8#1)(2012-1#16)(2012-12#48)(2012-2#84)(2012-3#44)(2012-6#1)(2013-1#98)(2013-7#15)(2013-8#44)
well at##10##2##(1991-2#1)(1992-3#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)
well attended##2##2##(2008-5#1)(2012-3#1)
well balanced##3##2##(1994-7#1)(2007-8#1)(2008-6#1)
well be applied##2##3##(2008-10#1)(2010-8#1)
well be the##2##3##(1995-8#1)(2012-2#1)
well be##13##2##(1994-9#1)(1995-5#1)(1995-8#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
well before##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
well behaved##2##2##(2008-2#1)(2012-2#1)
well being##13##2##(1995-1#3)(1996-9#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-1#1)(2010-8#1)(2011-2#1)
well below that required##2##4##(2007-12#1)(2008-7#1)
well below that##4##3##(1997-5#1)(2007-12#1)(2008-7#1)(2010-11#1)
well below the##10##3##(1992-12#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-7#1)
well below##19##2##(1992-12#1)(1995-12#1)(1995-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-7#1)
well beyond the##2##3##(1997-1#1)(2012-12#1)
well beyond##3##2##(1992-3#1)(1997-1#1)(2012-12#1)
well but##3##2##(1994-8#1)(2008-10#1)(2008-12#1)
well by a##2##3##(2008-10#1)(2008-2#1)
well by the##4##3##(1996-4#1)(2008-10#2)(2008-3#1)
well by##12##2##(1991-3#1)(1992-4#1)(1996-4#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-9#1)
well characterized and##2##3##(2008-10#1)(2011-1#1)
well characterized in##5##3##(1995-11#1)(2008-11#1)(2008-8#2)(2009-4#1)
well characterized##18##2##(1990-11#1)(1991-12#1)(1992-6#1)(1994-8#1)(1995-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-7#1)
well children##3##2##(1996-1#1)(2012-2#1)(2013-1#1)
well connected##3##2##(1996-4#1)(2008-8#1)(2009-7#1)
well conserved among##2##3##(1997-2#1)(2008-7#1)
well conserved and##2##3##(2008-7#1)(2009-10#1)
well conserved##13##2##(1990-5#1)(1991-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-6#1)(2008-7#4)(2009-10#1)(2010-10#1)
well controlled with##2##3##(1994-12#1)(2011-1#1)
well controlled##11##2##(1994-12#2)(1997-8#1)(2008-10#1)(2008-12#2)(2008-6#1)(2009-2#1)(2010-10#1)(2011-1#1)(2012-3#1)
well correlated with##3##3##(1993-12#1)(1995-5#1)(2008-10#1)
well correlated##4##2##(1993-12#1)(1995-5#1)(2008-10#2)
well counter##2##2##(1992-10#1)(1994-12#1)
well defined and##4##3##(1990-2#1)(1996-2#1)(2009-9#1)(2011-1#1)
well defined at##2##3##(2008-7#1)(2010-6#1)
well defined but##2##3##(1992-2#1)(2008-11#1)
well defined flow conditions##2##4##(2008-10#1)(2008-11#1)
well defined in##3##3##(2008-10#1)(2008-3#2)
well defined##44##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)
well demarcated##2##2##(1993-9#1)(2012-12#1)
well depth##2##2##(2010-2#2)
well described by a##9##4##(1990-7#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)
well described by the beta-binomial##2##5##(2008-10#2)
well described by the##7##4##(1992-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)
well described by##18##3##(1990-7#1)(1992-2#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-4#1)
well described for##2##3##(2009-11#1)(2009-12#1)
well described in the##2##4##(2007-12#1)(2008-1#1)
well described in##7##3##(1991-6#1)(1994-9#1)(2007-12#1)(2008-1#1)(2009-12#1)(2009-8#1)(2013-1#1)
well described##38##2##(1990-7#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2010-4#1)(2011-2#4)(2013-1#1)(2013-8#1)
well designed##2##2##(2008-7#1)(2011-1#1)
well determined##2##2##(1992-3#1)(2008-3#1)
well developed##12##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-7#4)(2009-12#1)(2009-9#1)
well differentiated endocrine##2##3##(2011-2#2)
well differentiated##7##2##(1994-10#1)(1994-9#1)(2006-8#1)(2008-8#2)(2011-2#2)
well distributed##2##2##(2008-8#1)(2009-7#1)
well do##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
well documented and##7##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-6#1)(2011-2#1)
well documented in##5##3##(1991-4#1)(1997-8#1)(2007-8#1)(2008-12#1)(2009-6#1)
well documented that##4##3##(1994-2#1)(1995-6#1)(2008-7#1)(2011-2#1)
well documented##45##2##(1990-6#1)(1991-4#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-6#2)(2010-3#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
well established and##5##3##(2007-6#1)(2008-11#1)(2008-4#1)(2009-9#1)(2013-1#1)
well established as##2##3##(2008-11#1)(2013-8#1)
well established in the##3##4##(2008-5#1)(2009-10#1)(2013-1#1)
well established in##5##3##(1996-9#1)(2008-5#1)(2009-10#2)(2013-1#1)
well established since the##2##4##(2007-8#1)(2008-10#1)
well established that the##3##4##(1992-9#1)(2008-5#1)(2009-9#1)
well established that##10##3##(1992-9#1)(1994-11#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)
well established##68##2##(1991-11#1)(1991-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
well explained by##2##3##(2007-7#1)(2008-8#1)
well explained##3##2##(2007-7#1)(2008-8#1)(2013-8#1)
well extracted##2##2##(2008-10#1)(2008-7#1)
well fitted##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
well for all the##2##4##(2007-12#1)(2008-12#1)
well for all##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
well for the##4##3##(1993-3#1)(1995-9#1)(2008-3#1)(2012-2#1)
well for##27##2##(1993-3#1)(1995-9#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2011-2#2)(2012-2#1)(2013-1#1)
well formed##2##2##(1993-1#1)(2010-4#1)
well have##4##2##(1992-2#1)(1993-5#1)(1995-1#1)(2008-10#1)
well in a##2##3##(2011-1#1)(2013-1#1)
well in all##2##3##(2008-10#1)(2008-3#1)
well in both##2##3##(1997-3#1)(2009-7#1)
well in numerical##2##3##(2008-3#1)(2008-6#1)
well in the pH range##2##5##(2008-10#2)
well in the##11##3##(1995-2#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#1)(2013-8#1)
well in##42##2##(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-6#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
well influence the##2##3##(2008-7#1)(2008-9#1)
well informed about the##5##4##(1996-3#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-9#1)
well informed##8##2##(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)
well into the##6##3##(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
well into##7##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)
well is##3##2##(1994-2#1)(1996-2#1)(2007-2#1)
well known and##3##3##(1990-2#1)(1996-3#1)(1997-5#1)
well known as##2##3##(1992-6#1)(2008-7#1)
well known for their##2##4##(2008-1#1)(2008-5#1)
well known for##5##3##(2008-1#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
well known in the##3##4##(1996-3#1)(2008-12#1)(2009-10#1)
well known in##4##3##(1995-2#1)(1996-3#1)(2008-12#1)(2009-10#1)
well known that a##2##4##(1996-3#1)(2008-2#1)
well known that the##6##4##(1993-3#1)(1997-2#1)(2008-3#3)(2013-1#1)
well known that##33##3##(1991-6#1)(1992-6#1)(1993-3#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#6)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
well known to be##6##4##(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-8#1)
well known to##14##3##(1994-11#1)(1997-1#1)(2007-12#2)(2008-11#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
well known##122##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-5#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#3)
well localized##2##2##(1993-12#1)(2008-10#1)
well logs##2##2##(1997-5#1)(2013-1#1)
well managed##2##2##(2008-7#1)(2011-3#1)
well matched to##2##3##(2008-11#1)(2008-2#1)
well matched##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
well mixed##2##2##(2008-8#2)
well of a##2##3##(2008-11#1)(2008-9#1)
well of##6##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
well on##6##2##(1993-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-4#1)
well or better##2##3##(2008-11#1)(2008-9#1)
well or##4##2##(2008-11#1)(2008-9#2)(2012-2#1)
well organized##2##2##(2008-10#1)(2012-2#1)
well over a wide##3##4##(2007-11#1)(2008-10#2)
well over a##9##3##(1990-5#1)(2007-11#1)(2008-10#5)(2008-3#1)(2011-2#1)
well over##13##2##(1990-5#1)(1991-5#1)(1997-1#1)(2007-11#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-12#1)
well placed to##2##3##(2012-12#1)(2013-8#1)
well planned##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
well plate##2##2##(2008-11#2)
well positioned to##3##3##(2007-4#1)(2008-9#1)(2012-12#1)
well prepared##3##2##(1994-1#1)(1997-2#1)(2008-9#1)
well preserved after##2##3##(1994-3#1)(2012-3#1)
well preserved##8##2##(1990-11#1)(1994-3#2)(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)(2012-3#1)
well protected##2##2##(2008-10#1)(2008-9#1)
well proven##2##2##(1997-3#1)(2010-7#1)
well received by the##2##4##(2008-11#1)(2008-12#1)
well received by##3##3##(2008-11#1)(2008-12#2)
well received##4##2##(1996-3#1)(2008-11#1)(2008-12#2)
well recognised##4##2##(1993-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
well recognized and##3##3##(2008-10#1)(2009-9#1)(2012-12#1)
well recognized that##2##3##(1990-9#1)(2010-2#1)
well recognized##14##2##(1990-2#2)(1990-9#1)(1995-6#1)(1996-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)
well reported##2##2##(2007-8#1)(2008-5#1)
well represented##3##2##(1992-9#1)(2008-1#1)(2010-2#1)
well reproduced##2##2##(2011-2#2)
well resolved from##3##3##(1991-5#1)(2008-10#1)(2011-1#1)
well resolved##10##2##(1991-2#1)(1991-5#1)(2008-10#4)(2008-4#1)(2009-9#2)(2011-1#1)
well separated within##6##3##(1994-9#1)(2008-10#5)
well separated##19##2##(1990-8#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-10#15)
well simulated with##2##3##(1996-2#1)(2008-7#1)
well studied in##2##3##(2008-1#1)(2008-8#1)
well studied##11##2##(1991-12#1)(1995-11#1)(1997-3#1)(2008-1#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
well suitable for##2##3##(2008-10#2)
well suited as##2##3##(2007-12#1)(2008-10#1)
well suited for the##2##4##(1997-6#1)(2008-10#1)
well suited for##28##3##(1995-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2010-8#1)(2010-9#1)(2011-1#2)
well suited to the##6##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)
well suited to##21##3##(1991-5#2)(1993-11#1)(1993-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
well suited##52##2##(1991-5#2)(1993-11#1)(1993-2#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
well supported##2##2##(2008-11#1)(2012-12#1)
well that##3##2##(2011-2#1)(2013-1#2)
well the observed##2##3##(2007-12#1)(2008-9#1)
well the##22##2##(1990-11#1)(1996-11#1)(1996-5#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-4#1)(2013-1#1)
well to an##2##3##(1997-6#1)(2008-10#1)
well to the##5##3##(1992-12#1)(1993-12#1)(1996-6#1)(2007-7#1)(2008-10#1)
well to##28##2##(1992-12#1)(1993-12#1)(1994-5#1)(1995-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-7#4)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-3#1)
well tolerated and no##2##4##(2007-11#1)(2008-3#1)
well tolerated and##10##3##(1996-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#3)(2011-2#2)(2013-1#1)
well tolerated by patients##3##4##(1993-5#1)(2008-2#1)(2010-6#1)
well tolerated by the##4##4##(1992-8#1)(2007-8#1)(2008-5#2)
well tolerated by##12##3##(1992-11#1)(1992-12#1)(1992-8#1)(1993-5#1)(2007-8#2)(2008-2#1)(2008-5#3)(2009-4#1)(2010-6#1)
well tolerated for##2##3##(2008-7#1)(2012-12#1)
well tolerated in healthy##2##4##(1996-1#1)(2011-2#1)
well tolerated in the##4##4##(1993-11#1)(2007-11#1)(2008-11#2)
well tolerated in##10##3##(1993-11#1)(1996-1#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
well tolerated with##4##3##(1997-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
well tolerated##81##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#2)(1996-1#1)(1996-2#2)(1996-9#2)(1997-3#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)
well trained##5##2##(1993-11#1)(1994-8#1)(1996-2#1)(2011-1#1)(2012-2#1)
well under##6##2##(2007-11#1)(2008-2#3)(2008-8#1)(2013-7#1)
well understand the##2##3##(2008-10#2)
well understood in##3##3##(2008-10#2)(2011-2#1)
well understood that##2##3##(2010-12#1)(2013-1#1)
well understood##52##2##(1993-3#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
well using##2##2##(2008-10#1)(2009-6#1)
well validated##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
well vascularized##2##2##(2008-12#1)(2008-7#1)
well visualized##2##2##(1997-8#1)(2010-8#1)
well water and##2##3##(2008-10#2)
well water##7##2##(2008-10#6)(2011-2#1)
well when the##2##3##(2008-10#1)(2008-2#1)
well when##6##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
well with Monte Carlo##2##4##(2008-3#2)
well with a##10##3##(1994-3#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)
well with corresponding##2##3##(2008-10#1)(2008-3#1)
well with data##5##3##(2008-10#4)(2008-3#1)
well with existing##2##3##(2008-3#1)(2010-10#1)
well with experimental##3##3##(2008-11#1)(2008-3#1)(2009-7#1)
well with literature values##2##4##(2008-10#1)(2008-7#1)
well with no##2##3##(2007-12#1)(2010-10#1)
well with our##3##3##(2007-12#2)(2008-3#1)
well with previous##2##3##(2008-10#1)(2008-3#1)
well with results##2##3##(2008-10#2)
well with that##5##3##(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
well with the certified values##2##5##(2008-10#2)
well with the certified##3##4##(2008-10#3)
well with the corresponding##2##4##(2008-10#1)(2008-11#1)
well with the exact##2##4##(2008-2#1)(2008-3#1)
well with the experimental data##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
well with the experimental##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
well with the literature##2##4##(2008-10#2)
well with the observed##2##4##(1995-2#1)(2010-12#1)
well with the results of##2##5##(1991-12#1)(1992-9#1)
well with the results##5##4##(1990-11#1)(1991-12#1)(1992-9#1)(2008-10#2)
well with the standard##2##4##(2008-10#2)
well with the##71##3##(1990-11#1)(1990-8#1)(1991-12#2)(1991-9#1)(1992-6#2)(1992-9#1)(1994-7#1)(1995-2#2)(1997-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#25)(2008-11#4)(2008-2#7)(2008-3#8)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
well with their##4##3##(1994-8#1)(2008-11#2)(2013-7#1)
well with theoretical##2##3##(2007-12#1)(2008-3#1)
well with those found##3##4##(2008-10#3)
well with those obtained by a##2##6##(2008-10#2)
well with those obtained by the##6##6##(2008-10#6)
well with those obtained by##11##5##(2008-10#11)
well with those obtained with##2##5##(2008-10#2)
well with those obtained##15##4##(2008-10#14)(2008-3#1)
well with those of##2##4##(1993-11#1)(2008-10#1)
well with those##26##3##(1993-11#1)(1995-12#1)(2007-12#1)(2008-10#19)(2008-3#2)(2008-7#1)(2010-5#1)
well with##202##2##(1990-11#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#7)(2007-12#9)(2007-4#1)(2008-1#4)(2008-10#68)(2008-11#8)(2008-2#12)(2008-3#29)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
well within the##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-7#1)
well within##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-11#1)(2010-7#1)
well without##4##2##(2007-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
well##4941##1##(1990-10#2)(1990-11#14)(1990-12#13)(1990-2#11)(1990-3#5)(1990-5#11)(1990-6#5)(1990-7#11)(1990-8#16)(1990-9#9)(1991-1#8)(1991-11#10)(1991-12#27)(1991-2#18)(1991-3#14)(1991-4#3)(1991-5#13)(1991-6#13)(1991-7#2)(1991-8#5)(1991-9#9)(1992-1#7)(1992-10#2)(1992-11#6)(1992-12#19)(1992-2#12)(1992-3#35)(1992-4#2)(1992-5#6)(1992-6#15)(1992-7#1)(1992-8#10)(1992-9#26)(1993-1#3)(1993-11#18)(1993-12#28)(1993-2#8)(1993-3#20)(1993-5#4)(1993-6#15)(1993-8#16)(1993-9#8)(1994-1#15)(1994-10#2)(1994-11#24)(1994-12#29)(1994-2#20)(1994-3#16)(1994-5#8)(1994-6#17)(1994-7#3)(1994-8#24)(1994-9#11)(1995-1#10)(1995-10#1)(1995-11#23)(1995-12#19)(1995-2#35)(1995-3#15)(1995-5#23)(1995-6#22)(1995-8#7)(1995-9#3)(1996-1#9)(1996-10#2)(1996-11#4)(1996-12#31)(1996-2#34)(1996-3#19)(1996-4#4)(1996-5#19)(1996-6#7)(1996-7#5)(1996-8#1)(1996-9#9)(1997-1#13)(1997-2#30)(1997-3#15)(1997-4#20)(1997-5#10)(1997-6#21)(1997-7#23)(1997-8#14)(1997-9#1)(2006-10#8)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#19)(2007-11#78)(2007-12#87)(2007-2#10)(2007-4#4)(2007-5#7)(2007-6#2)(2007-7#26)(2007-8#32)(2007-9#1)(2008-1#73)(2008-10#792)(2008-11#224)(2008-12#65)(2008-2#152)(2008-3#242)(2008-4#110)(2008-5#135)(2008-6#58)(2008-7#179)(2008-8#103)(2008-9#128)(2009-1#4)(2009-10#31)(2009-11#17)(2009-12#25)(2009-2#13)(2009-3#14)(2009-4#22)(2009-5#20)(2009-6#18)(2009-7#31)(2009-8#33)(2009-9#19)(2010-1#11)(2010-10#24)(2010-11#20)(2010-12#29)(2010-2#17)(2010-3#28)(2010-4#21)(2010-5#25)(2010-6#22)(2010-7#14)(2010-8#28)(2010-9#13)(2011-1#71)(2011-2#202)(2011-3#7)(2011-4#2)(2011-7#3)(2011-8#1)(2012-1#21)(2012-12#68)(2012-2#121)(2012-3#62)(2012-4#1)(2012-6#1)(2013-1#148)(2013-3#1)(2013-7#23)(2013-8#68)
well-balanced##5##1##(1993-12#2)(2008-10#2)(2008-5#1)
well-being among people with greater depressive symptoms##2##7##(2010-4#2)
well-being among##5##2##(2008-7#1)(2009-7#1)(2010-4#2)(2013-8#1)
well-being and quality of life##4##5##(1997-8#2)(2008-1#1)(2008-9#1)
well-being and##16##2##(1991-8#2)(1994-3#1)(1996-7#1)(1997-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-2#1)
well-being are##3##2##(1992-3#1)(1993-6#1)(2009-11#1)
well-being as##2##2##(2008-2#1)(2008-7#1)
well-being in##5##2##(1996-7#1)(2009-7#1)(2011-2#2)(2012-2#1)
well-being index##2##2##(2008-11#1)(2008-5#1)
well-being is##2##2##(2008-1#1)(2011-2#1)
well-being of all##2##3##(2008-1#1)(2012-2#1)
well-being of the##5##3##(1991-9#1)(2008-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
well-being of youth##2##3##(2010-11#1)(2010-9#1)
well-being of##21##2##(1991-9#1)(1992-3#2)(1994-9#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
well-being was##2##2##(1991-8#1)(2012-2#1)
well-being which##2##2##(2008-12#1)(2011-2#1)
well-being##165##1##(1990-2#2)(1991-12#1)(1991-6#2)(1991-8#6)(1991-9#1)(1992-2#1)(1992-3#7)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-11#2)(1996-7#2)(1997-3#1)(1997-8#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#2)(2008-1#6)(2008-11#8)(2008-12#5)(2008-2#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#11)(2008-9#1)(2009-10#1)(2009-11#7)(2009-5#2)(2009-6#1)(2009-7#11)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#8)(2010-9#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#9)(2013-8#2)
well-characterized patients with##2##3##(2012-3#1)(2013-1#1)
well-characterized patients##3##2##(2010-5#1)(2012-3#1)(2013-1#1)
well-characterized##36##1##(1990-7#2)(1991-5#1)(1992-1#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-5#1)(1996-12#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
well-child##4##1##(1996-1#2)(1996-2#1)(2010-8#1)
well-chosen##3##1##(2007-12#1)(2008-3#1)(2010-10#1)
well-circumscribed##2##1##(2013-1#1)(2013-7#1)
well-conceived##2##1##(1991-2#1)(2009-1#1)
well-conserved##4##1##(1995-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
well-controlled##11##1##(1990-9#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
well-defined and##7##2##(1994-5#1)(2006-6#1)(2008-10#3)(2010-10#1)(2010-4#1)
well-defined anodic##2##2##(2008-10#2)
well-defined cathodic wave##2##3##(2008-10#2)
well-defined cathodic##3##2##(2008-10#3)
well-defined oxidation peak##3##3##(2008-10#3)
well-defined oxidation##4##2##(2008-10#4)
well-defined peak##2##2##(2008-10#2)
well-defined redox peaks##3##3##(2008-10#3)
well-defined redox##5##2##(2008-10#5)
well-defined reduction peak##2##3##(2008-10#2)
well-defined stable##2##2##(2008-10#1)(2012-2#1)
well-defined##104##1##(1990-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-5#2)(1996-4#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#2)(2007-12#2)(2007-4#1)(2008-10#39)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#6)(2013-1#4)(2013-8#1)
well-demarcated##3##1##(2011-1#1)(2012-3#1)(2013-1#1)
well-described##3##1##(2008-10#1)(2011-3#1)(2013-8#1)
well-designed studies##2##2##(2012-3#1)(2013-1#1)
well-designed##11##1##(1991-9#1)(1995-1#1)(1996-3#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
well-developed##13##1##(1993-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2012-2#1)
well-differentiated liposarcoma##3##2##(2008-6#1)(2013-1#2)
well-differentiated squamous cell carcinoma##2##4##(2009-10#1)(2010-8#1)
well-differentiated##15##1##(1990-3#1)(1992-2#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
well-dispersed##2##1##(2007-12#1)(2010-5#1)
well-documented case of##2##3##(1992-5#1)(1996-3#1)
well-documented case##3##2##(1992-5#1)(1996-3#1)(1996-4#1)
well-documented cases##2##2##(2006-12#1)(2008-11#1)
well-documented in Caucasian##2##3##(1997-3#1)(2010-3#1)
well-documented##29##1##(1990-9#1)(1992-5#1)(1993-11#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-3#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-4#1)(2009-7#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
well-established and##2##2##(1993-6#1)(2013-8#1)
well-established method##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
well-established##41##1##(1991-1#1)(1991-3#1)(1993-6#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
well-founded##2##1##(1994-9#1)(2013-1#1)
well-informed##4##1##(1994-7#1)(2007-11#1)(2010-11#1)(2011-2#1)
well-isolated##3##1##(1993-9#1)(2008-11#1)(2008-7#1)
well-known but##2##2##(1996-11#1)(2013-8#1)
well-known endemic areas in##2##4##(1996-11#2)
well-known endemic##3##2##(1996-11#3)
well-known for##2##2##(1993-12#1)(2010-11#1)
well-known risks of##2##3##(1994-6#1)(2013-1#1)
well-known technique for##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
well-known##112##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#2)(1995-6#1)(1996-11#4)(1996-4#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#9)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
well-mixed##3##1##(2008-11#1)(2008-2#1)(2008-8#1)
well-nourished##6##1##(2008-11#6)
well-ordered##6##1##(1993-8#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)
well-organized##5##1##(1992-6#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)
well-perfused##2##1##(2008-3#1)(2013-8#1)
well-plate##2##1##(2008-11#2)
well-preserved##3##1##(1996-9#1)(2007-12#1)(2012-2#1)
well-proven##3##1##(1990-10#1)(1990-2#1)(1997-6#1)
well-recognized##5##1##(1992-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
well-researched##2##1##(1992-1#1)(2010-8#1)
well-resolved##8##1##(1997-7#1)(2008-10#4)(2008-2#1)(2011-1#1)(2012-12#1)
well-separated peaks##2##2##(1997-2#1)(2008-10#1)
well-separated##6##1##(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#3)
well-shaped##2##1##(2008-10#1)(2008-3#1)
well-studied##11##1##(1997-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-2#1)
well-suited for the##2##3##(2008-7#1)(2008-8#1)
well-suited for##6##2##(1993-1#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-10#1)
well-supported##4##1##(2008-10#3)(2010-3#1)
well-tolerated and effective##2##3##(1995-4#1)(2008-1#1)
well-tolerated and##7##2##(1990-2#1)(1995-4#1)(2008-1#1)(2008-5#3)(2013-1#1)
well-tolerated##25##1##(1990-2#1)(1994-2#1)(1994-8#1)(1995-4#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#8)(2009-5#1)(2010-3#1)(2010-5#1)(2012-2#3)(2013-1#2)
well-trained##3##1##(1994-3#1)(2008-7#1)(2010-7#1)
well-understood##3##1##(1992-9#1)(1994-12#1)(2009-8#1)
well-vascularized tissue##2##2##(2007-12#1)(2008-9#1)
wellbeing and##2##2##(2008-10#1)(2008-3#1)
wellbeing in##2##2##(1996-6#1)(2011-2#1)
wellbeing of##2##2##(2008-5#1)(2011-1#1)
wellbeing##22##1##(1996-6#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)
wellness and##5##2##(2008-11#1)(2013-1#1)(2013-8#3)
wellness of##2##2##(2013-7#1)(2013-8#1)
wellness programs##2##2##(1992-12#2)
wellness##29##1##(1992-12#3)(1993-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-11#2)(2008-12#2)(2008-4#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#7)
wells by##2##2##(2008-10#1)(2008-2#1)
wells in##2##2##(1992-6#1)(2013-1#1)
wells of a##2##3##(1994-8#1)(1997-7#1)
wells of##3##2##(1990-12#1)(1994-8#1)(1997-7#1)
wells to##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
wells with##2##2##(2006-10#1)(2008-3#1)
wells##45##1##(1990-12#1)(1992-6#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-12#6)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#1)(2008-4#1)(2008-9#2)(2010-11#1)(2011-1#1)(2013-1#2)
wenrichi##2##1##(2008-9#2)
went down##2##2##(1990-8#1)(1995-5#1)
went far beyond##2##3##(1992-12#1)(1995-6#1)
went for##2##2##(1991-6#1)(2013-1#1)
went from a median of##3##5##(2013-1#3)
went from##7##2##(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#3)
went home##4##2##(1992-2#1)(1992-3#1)(1995-3#2)
went on to##3##3##(2008-10#2)(2008-12#1)
went on##5##2##(1992-1#1)(2008-10#2)(2008-12#1)(2009-7#1)
went out of##2##3##(1994-2#1)(2009-10#1)
went through##2##2##(2008-10#1)(2008-5#1)
went to##5##2##(1991-1#2)(1992-12#1)(1995-12#1)(2009-10#1)
went up by##2##3##(1990-8#1)(2008-7#1)
went up##3##2##(1990-8#1)(2008-7#2)
went##45##1##(1990-8#2)(1991-1#3)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1997-5#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-7#2)(2011-2#1)(2013-1#4)(2013-8#1)
were &gt##14##2##(1996-12#1)(1996-2#1)(1997-3#1)(2008-10#6)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
were &lt##19##2##(1995-2#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)
were &quot##16##2##(1991-9#2)(1994-1#1)(1995-3#1)(2007-12#1)(2008-7#2)(2009-5#1)(2009-7#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#3)
were (0##2##2##(2010-12#2)
were (1) to##2##3##(2009-1#1)(2013-1#1)
were (1)##3##2##(2009-1#1)(2013-1#2)
were (3##2##2##(2011-1#1)(2011-3#1)
were (5##2##2##(2008-10#1)(2011-1#1)
were (i) to##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
were (i)##5##2##(2008-10#3)(2008-5#1)(2008-8#1)
were 0##188##2##(1990-2#2)(1990-6#1)(1990-8#3)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#110)(2008-11#4)(2008-12#6)(2008-3#4)(2008-5#6)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
were 1 and##2##3##(2008-10#2)
were 1 to##2##3##(2008-10#1)(2008-5#1)
were 1##86##2##(1991-3#2)(1991-5#2)(1992-3#1)(1993-6#1)(1993-9#4)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#38)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-12#3)(2012-3#2)(2013-8#1)
were 1)##2##2##(1993-3#1)(2008-10#1)
were 10 and##2##3##(1992-3#1)(2008-10#1)
were 10 days##2##3##(1997-6#1)(2008-10#1)
were 10##17##2##(1991-11#1)(1992-3#1)(1996-6#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#1)
were 10%##2##2##(1996-5#1)(2008-2#1)
were 10(-3)##2##2##(2008-10#1)(2008-3#1)
were 100##9##2##(1990-10#1)(1991-6#1)(1994-7#1)(2008-1#1)(2008-10#1)(2009-6#1)(2011-3#1)(2012-3#1)(2013-7#1)
were 100%##7##2##(2008-10#4)(2008-12#1)(2008-8#1)(2012-3#1)
were 11 and##2##3##(1997-2#1)(2008-7#1)
were 11##16##2##(1990-8#1)(1992-3#1)(1993-1#1)(1994-12#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
were 12 and##2##3##(1992-6#1)(2008-10#1)
were 12##17##2##(1990-2#1)(1990-6#1)(1990-8#1)(1992-6#1)(1994-6#1)(2007-7#1)(2008-10#6)(2008-6#2)(2008-8#1)(2009-10#1)(2011-2#1)
were 125##2##2##(1991-11#1)(2008-3#1)
were 13 and##2##3##(2008-10#2)
were 13##10##2##(1994-9#1)(1997-2#1)(2007-11#1)(2008-10#6)(2011-1#1)
were 13%##3##2##(1997-3#1)(2008-10#1)(2010-3#1)
were 14##7##2##(1992-9#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#1)
were 1400##2##2##(2008-10#1)(2008-3#1)
were 15##11##2##(1990-6#1)(1991-5#1)(1994-11#1)(1996-3#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-3#1)
were 152##2##2##(2008-10#2)
were 153##2##2##(1993-6#1)(2009-6#1)
were 154##2##2##(1992-11#1)(2013-8#1)
were 156##2##2##(1991-2#1)(2007-8#1)
were 16##8##2##(1994-9#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-3#2)(2013-1#1)
were 17##12##2##(1990-8#1)(1993-8#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
were 18 and##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
were 18##9##2##(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#2)(2009-10#1)(2013-1#1)
were 19##7##2##(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2013-1#1)(2013-8#1)
were 19%##2##2##(2007-10#2)
were 2##71##2##(1991-2#1)(1992-11#1)(1993-1#2)(1993-3#1)(1993-6#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
were 20 and##5##3##(1992-6#1)(1997-2#1)(2008-10#2)(2013-1#1)
were 20##11##2##(1991-12#1)(1992-6#1)(1997-2#1)(2008-10#5)(2008-9#1)(2010-4#1)(2013-1#1)
were 20%##2##2##(1991-12#1)(1993-8#1)
were 200##4##2##(1990-12#1)(2008-10#2)(2008-11#1)
were 21##2##2##(2008-10#1)(2013-1#1)
were 218##2##2##(1990-11#1)(2007-8#1)
were 22##3##2##(2008-10#3)
were 23##4##2##(2007-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
were 230##3##2##(1992-11#1)(2008-5#2)
were 24##4##2##(1993-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
were 25##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
were 250##2##2##(2007-7#1)(2013-1#1)
were 26##5##2##(1993-12#1)(1995-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
were 27##3##2##(1994-8#1)(2008-5#1)(2011-2#1)
were 28##11##2##(1994-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-1#3)
were 29##6##2##(1994-3#1)(1995-3#1)(2008-10#1)(2008-4#2)(2012-3#1)
were 3 and##3##3##(2007-8#1)(2008-10#2)
were 3##47##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-3#1)(1993-8#1)(1997-6#2)(2007-12#2)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
were 30##12##2##(1990-12#1)(1991-8#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2010-2#1)(2011-1#1)(2013-1#1)
were 31##2##2##(2011-2#1)(2013-8#1)
were 32##4##2##(1994-9#1)(1997-6#1)(2008-1#1)(2012-2#1)
were 33##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
were 34##6##2##(1992-8#1)(1997-6#1)(2012-12#1)(2013-1#3)
were 35##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
were 35%##2##2##(1997-6#1)(2008-8#1)
were 351##2##2##(2009-7#1)(2011-1#1)
were 36##5##2##(1992-2#1)(1997-6#1)(2007-7#1)(2012-12#1)(2012-2#1)
were 37##6##2##(2007-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-3#1)
were 38##3##2##(1990-5#1)(2008-6#1)(2012-2#1)
were 39##9##2##(1991-12#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
were 4##30##2##(1990-9#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-9#1)(2009-4#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
were 40 mm##2##3##(1992-5#1)(2008-3#1)
were 40##8##2##(1992-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)
were 40%##2##2##(2010-3#1)(2012-3#1)
were 400##2##2##(2008-10#1)(2008-11#1)
were 41##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
were 42##5##2##(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#2)
were 43%##2##2##(1990-8#1)(1991-12#1)
were 44##4##2##(1991-9#1)(2008-1#1)(2008-10#1)(2008-7#1)
were 45 to##2##3##(2008-10#1)(2008-11#1)
were 45##4##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-11#1)
were 45%##2##2##(2007-7#1)(2009-5#1)
were 46##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2013-1#1)
were 49##4##2##(1991-4#1)(1995-10#1)(2008-10#1)(2008-12#1)
were 5 and##3##3##(2008-10#3)
were 5##35##2##(1992-3#1)(1993-2#1)(1993-6#1)(1993-9#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
were 50##5##2##(1990-11#1)(1991-2#1)(1993-8#1)(2008-3#1)(2011-2#1)
were 50%##2##2##(2008-9#1)(2013-1#1)
were 52##2##2##(1991-12#1)(2011-2#1)
were 53##2##2##(1993-1#1)(2008-2#1)
were 54% and##2##3##(1996-10#1)(2008-3#1)
were 54%##3##2##(1996-10#1)(2007-8#1)(2008-3#1)
were 56##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
were 56% and##2##3##(1991-2#1)(2011-2#1)
were 57##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
were 58##5##2##(2008-1#1)(2008-10#4)
were 58%##2##2##(1994-2#1)(2012-3#1)
were 6 months##2##3##(1991-2#1)(1996-5#1)
were 6##35##2##(1990-2#1)(1991-11#1)(1991-2#1)(1993-2#1)(1994-11#1)(1996-5#1)(1996-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2011-2#3)
were 60##4##2##(2008-1#2)(2008-12#1)(2012-1#1)
were 60%##2##2##(2008-7#1)(2013-1#1)
were 61%##2##2##(1994-2#1)(2007-7#1)
were 62##3##2##(2008-1#1)(2008-7#2)
were 64##3##2##(2008-4#1)(2008-6#1)(2010-3#1)
were 641##2##2##(2008-1#1)(2008-10#1)
were 66##2##2##(1997-8#1)(2007-12#1)
were 67%##2##2##(2007-7#1)(2008-10#1)
were 68##5##2##(1990-2#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
were 69##3##2##(2007-11#1)(2007-7#1)(2008-4#1)
were 7##17##2##(1991-12#1)(1993-6#1)(1994-12#1)(1996-11#1)(2008-10#10)(2008-3#1)(2009-11#1)(2011-1#1)
were 7%##2##2##(2008-7#1)(2013-1#1)
were 70##2##2##(1991-12#1)(2008-10#1)
were 72##2##2##(2008-12#1)(2008-9#1)
were 73% and##2##3##(1992-9#1)(1994-2#1)
were 74##3##2##(2008-1#1)(2011-2#2)
were 75##4##2##(1993-8#1)(2009-4#1)(2011-2#1)(2012-3#1)
were 75%##2##2##(1991-4#1)(1994-11#1)
were 76##3##2##(2011-2#2)(2013-1#1)
were 77##3##2##(2010-7#1)(2011-1#1)(2013-1#1)
were 78##2##2##(2010-3#2)
were 78%##2##2##(1990-3#1)(2012-2#1)
were 8##16##2##(1992-11#1)(1994-12#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(2008-10#6)(2010-10#1)(2011-1#2)(2011-2#1)
were 8%##2##2##(1994-8#1)(2007-10#1)
were 80##5##2##(1993-2#1)(1995-2#1)(2008-10#2)(2008-7#1)
were 82##2##2##(2008-10#1)(2008-8#1)
were 82%##2##2##(2008-10#1)(2008-3#1)
were 83##2##2##(2008-6#1)(2011-2#1)
were 84##3##2##(2008-10#2)(2008-12#1)
were 85##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
were 85%##2##2##(2007-10#1)(2007-12#1)
were 87##3##2##(1995-4#1)(2008-10#1)(2012-1#1)
were 88##3##2##(2010-8#1)(2011-1#2)
were 89##3##2##(2011-1#3)
were 9##8##2##(1994-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
were 90##2##2##(2008-10#2)
were 91##5##2##(1990-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-1#1)
were 92##2##2##(2008-10#2)
were 94##4##2##(2008-10#4)
were 95##7##2##(2007-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-1#1)
were 95%##2##2##(2008-10#1)(2012-3#1)
were 96##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
were 97##3##2##(1994-12#1)(2008-1#1)(2008-5#1)
were 97%##3##2##(2008-2#1)(2011-2#2)
were 98##5##2##(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-2#1)
were 98% identical with##2##4##(2008-10#2)
were 99##5##2##(2008-10#4)(2011-1#1)
were A##2##2##(2007-7#1)(2008-12#1)
were Aseptic##3##2##(1991-2#3)
were B##2##2##(1993-6#1)(1997-8#1)
were C##2##2##(2008-10#1)(2008-5#1)
were CVA16##2##2##(2013-8#2)
were Caucasian##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
were Chinese##2##2##(2008-7#1)(2008-8#1)
were Escherichia coli and##2##4##(1990-6#1)(2008-5#1)
were Escherichia coli##6##3##(1990-6#1)(1996-8#1)(2007-7#2)(2008-5#1)(2008-7#1)
were Group##2##2##(2008-10#2)
were Gómez##2##2##(2012-12#2)
were HBsAg##2##2##(2007-7#1)(2011-2#1)
were HCV##2##2##(2008-1#2)
were HEV71##2##2##(2013-8#2)
were HIV positive##4##3##(1993-11#2)(1997-6#1)(2011-2#1)
were ILI flu##2##3##(2010-4#2)
were L##3##2##(2008-10#2)(2008-5#1)
were M1##2##2##(2013-8#2)
were Malays##2##2##(2008-8#1)(2011-1#1)
were NPD##5##2##(2008-12#5)
were P##4##2##(1997-4#1)(2008-10#2)(2013-1#1)
were R##2##2##(2008-10#2)
were S##4##2##(1990-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
were Salmonella##3##2##(2011-2#3)
were Saudis##2##2##(2008-1#2)
were Soxhlet extracted##2##3##(2008-10#1)(2008-11#1)
were Streptococcus##2##2##(1997-8#1)(2008-7#1)
were T cells##3##3##(1992-6#1)(2008-11#1)(2008-9#1)
were T##4##2##(1992-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
were a few##3##3##(2008-12#1)(2008-9#2)
were a random##2##3##(2008-10#1)(2012-3#1)
were a reduction##2##3##(1990-10#1)(2008-10#1)
were a total of##3##4##(2007-10#1)(2012-12#1)(2013-7#1)
were a##53##2##(1990-10#1)(1991-5#1)(1991-6#1)(1993-12#1)(1995-3#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
were able to achieve##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
were able to adhere##2##4##(1996-12#1)(2011-2#1)
were able to bind##3##4##(1994-5#1)(1994-6#1)(2008-10#1)
were able to complement##2##4##(1990-5#1)(2008-10#1)
were able to define##2##4##(1990-12#1)(2008-12#1)
were able to demonstrate##2##4##(2008-7#1)(2012-2#1)
were able to detect and##2##5##(2008-10#1)(2010-5#1)
were able to detect as little as##2##7##(2008-10#2)
were able to detect##11##4##(1990-12#1)(2008-10#5)(2008-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
were able to distinguish between##2##5##(1990-7#1)(2013-8#1)
were able to distinguish##6##4##(1990-7#1)(1991-11#1)(2008-10#1)(2008-3#2)(2013-8#1)
were able to form##2##4##(1990-2#1)(2008-10#1)
were able to grow##3##4##(1994-12#1)(2008-10#1)(2011-2#1)
were able to identify the##2##5##(1990-7#1)(2008-5#1)
were able to identify##5##4##(1990-7#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-7#1)
were able to increase the##2##5##(2009-6#1)(2009-7#1)
were able to induce##6##4##(1991-5#1)(1995-12#1)(2007-10#1)(2008-10#2)(2008-11#1)
were able to obtain##3##4##(1992-2#1)(2008-10#1)(2008-5#1)
were able to perform##2##4##(2008-1#1)(2013-8#1)
were able to predict##2##4##(1997-2#1)(2008-10#1)
were able to produce##5##4##(1991-12#1)(1992-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
were able to reduce the##2##5##(1992-11#1)(2007-8#1)
were able to reduce##3##4##(1992-11#1)(2007-8#1)(2008-10#1)
were able to reflect the##2##5##(2007-5#1)(2008-10#1)
were able to reproduce##3##4##(1992-9#1)(2008-10#1)(2008-11#1)
were able to show##4##4##(2008-5#2)(2008-7#1)(2011-1#1)
were able to significantly##2##4##(2008-10#1)(2008-11#1)
were able to stimulate##2##4##(2008-11#1)(2008-5#1)
were able to successfully##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
were able to transmit##3##4##(2008-10#3)
were able to use##2##4##(2008-7#1)(2011-2#1)
were able to##177##3##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#11)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#4)(2013-8#3)
were able##178##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#4)(2013-8#3)
were abnormal##2##2##(1994-3#1)(2010-11#1)
were abolished by##4##3##(1990-2#1)(1995-5#1)(1997-4#1)(2008-8#1)
were abolished in##2##3##(1997-4#1)(2013-7#1)
were abolished##9##2##(1990-2#1)(1990-5#2)(1995-5#1)(1997-4#3)(2008-8#1)(2013-7#1)
were about 0##2##3##(1997-3#1)(2008-10#1)
were about 1##2##3##(2008-10#1)(2008-11#1)
were about 2##3##3##(1990-11#1)(2008-10#2)
were about 3##2##3##(1997-4#1)(2008-10#1)
were about##26##2##(1990-11#1)(1990-2#1)(1992-7#1)(1993-6#1)(1996-2#1)(1997-3#2)(1997-4#3)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)
were above##5##2##(1990-6#1)(1992-8#1)(2008-10#3)
were abrogated##2##2##(2008-3#1)(2011-1#1)
were absent in the##2##4##(2008-10#1)(2009-8#1)
were absent in##8##3##(1991-4#1)(1995-10#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-3#1)
were absent or##2##3##(1994-5#1)(2008-10#1)
were absent##21##2##(1991-4#1)(1994-5#1)(1994-6#1)(1995-10#1)(1997-3#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#3)(2013-8#1)
were absorbed in##2##3##(2008-10#1)(2009-8#1)
were absorbed##3##2##(2008-10#2)(2009-8#1)
were abstracted independently by 2 authors##2##6##(2009-9#2)
were abstracted##3##2##(2007-10#1)(2009-9#2)
were abundant##2##2##(2008-10#1)(2008-7#1)
were accentuated##2##2##(2008-5#1)(2008-7#1)
were acceptable##3##2##(2008-6#1)(2011-10#1)(2012-12#1)
were accepted as##2##3##(2008-11#1)(2011-1#1)
were accepted##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
were accompanied by##9##3##(1991-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
were accomplished by##4##3##(1990-9#1)(2008-10#1)(2008-2#2)
were accomplished##13##2##(1990-9#1)(1991-1#1)(1995-3#1)(2008-10#7)(2008-2#2)(2009-7#1)
were accounted for by##3##4##(1990-5#1)(1992-6#1)(2008-10#1)
were accounted for##5##3##(1990-5#1)(1992-6#1)(2008-10#3)
were accumulated##2##2##(1990-12#1)(1995-2#1)
were accurately##3##2##(1990-8#1)(2008-5#1)(2012-3#1)
were achieved after##2##3##(2008-11#1)(2008-5#1)
were achieved at##5##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
were achieved by the##3##4##(1991-8#1)(2008-10#1)(2008-6#1)
were achieved by using##2##4##(2008-10#2)
were achieved by##15##3##(1991-6#1)(1991-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
were achieved experimentally##2##3##(2007-12#1)(2008-3#1)
were achieved for the##2##4##(2008-10#2)
were achieved for##13##3##(1994-1#1)(2007-9#1)(2008-10#11)
were achieved in##19##3##(1997-8#2)(2007-11#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2013-1#1)
were achieved using##6##3##(1990-5#1)(2008-10#3)(2008-7#1)(2008-9#1)
were achieved when the experiments were carried out##2##8##(2008-10#2)
were achieved when the##3##4##(1997-4#1)(2008-10#2)
were achieved when##6##3##(1997-4#1)(2007-11#1)(2008-10#3)(2008-6#1)
were achieved with a##4##4##(2007-11#1)(2007-12#1)(2008-10#2)
were achieved with##11##3##(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#2)
were achieved within 1##2##4##(2008-10#2)
were achieved within##3##3##(2008-10#3)
were achieved without##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
were achieved##132##2##(1990-2#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#2)(2007-11#4)(2007-12#5)(2007-9#1)(2008-1#2)(2008-10#68)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#12)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#3)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#6)(2013-8#1)
were acquired by##3##3##(2008-10#2)(2008-3#1)
were acquired for##2##3##(2008-10#1)(2012-12#1)
were acquired from##4##3##(2007-11#1)(2008-2#2)(2011-1#1)
were acquired in##2##3##(1997-8#1)(2008-10#1)
were acquired on a 1##2##5##(2008-5#1)(2010-12#1)
were acquired with##2##3##(2007-11#1)(2008-3#1)
were acquired##25##2##(1997-8#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
were activated by##8##3##(1990-8#1)(1995-11#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)
were activated from the##2##4##(1993-12#2)
were activated in HC##2##4##(2008-11#2)
were activated in##4##3##(1993-9#1)(2008-11#2)(2008-9#1)
were activated##15##2##(1990-8#1)(1993-12#2)(1993-9#1)(1995-11#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#1)(2008-9#2)
were active in the##2##4##(1992-8#1)(2010-3#1)
were active in##6##3##(1992-5#1)(1992-8#1)(1997-2#1)(2008-12#1)(2009-10#1)(2010-3#1)
were active##12##2##(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-3#1)(2011-3#1)
were actively accumulated##2##3##(2008-12#2)
were actively##8##2##(1993-9#2)(1995-8#1)(1996-1#1)(1996-12#1)(2008-12#2)(2008-8#1)
were actually##2##2##(1994-11#1)(2013-1#1)
were acute##4##2##(1990-12#1)(2008-1#2)(2011-1#1)
were adapted from##2##3##(2012-2#1)(2012-3#1)
were adapted to##5##3##(2008-10#1)(2008-11#3)(2010-11#1)
were adapted##8##2##(2008-10#1)(2008-11#4)(2010-11#1)(2012-2#1)(2012-3#1)
were added as##2##3##(2008-10#1)(2008-11#1)
were added in the##2##4##(1997-8#1)(2013-1#1)
were added in##6##3##(1996-2#1)(1997-8#1)(2008-10#2)(2010-4#1)(2013-1#1)
were added into##2##3##(2008-10#1)(2008-12#1)
were added to a##2##4##(1991-5#1)(2008-10#1)
were added to soil lacking##2##5##(2008-10#2)
were added to soil##4##4##(2008-10#4)
were added to the medium##2##5##(2008-11#1)(2008-5#1)
were added to the##21##4##(1991-6#1)(1992-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-6#1)
were added to##46##3##(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)
were added##74##2##(1990-11#1)(1990-9#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#27)(2008-11#6)(2008-12#3)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#3)(2011-1#1)(2012-3#1)(2013-1#1)
were additional##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
were additionally##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
were additive##5##2##(1990-5#1)(1993-9#1)(2008-10#1)(2008-11#2)
were addressed using##2##3##(1994-9#1)(2008-10#1)
were addressed##5##2##(1994-9#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-11#1)
were adequate for##4##3##(1991-1#1)(1991-8#1)(2008-10#2)
were adequate##6##2##(1990-12#1)(1991-1#1)(1991-8#1)(2008-10#2)(2012-2#1)
were adjacent##3##2##(2008-10#1)(2013-1#2)
were adjusted by##2##3##(1993-12#1)(2008-10#1)
were adjusted for age##2##4##(2010-5#1)(2011-2#1)
were adjusted for##5##3##(1993-3#1)(2008-3#1)(2010-5#1)(2010-6#1)(2011-2#1)
were adjusted to##3##3##(1995-6#1)(2008-10#2)
were adjusted##16##2##(1993-12#1)(1993-3#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#2)(2010-5#1)(2010-6#1)(2011-2#2)(2013-7#1)
were administered 0##15##3##(2008-9#15)
were administered a##5##3##(1992-8#1)(1993-12#1)(1994-5#1)(2011-2#1)(2013-1#1)
were administered at##2##3##(2008-7#1)(2011-1#1)
were administered by##2##3##(1997-6#1)(2012-2#1)
were administered in##3##3##(1990-5#1)(1994-12#1)(1997-8#1)
were administered intraperitoneally##2##3##(1990-5#1)(2008-10#1)
were administered orally##2##3##(1995-3#1)(2008-10#1)
were administered the##4##3##(2008-11#1)(2008-9#1)(2009-11#1)(2011-1#1)
were administered to each##2##4##(1991-2#1)(1994-8#1)
were administered to the##3##4##(1992-3#1)(2007-7#1)(2013-1#1)
were administered to##16##3##(1991-2#1)(1992-3#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
were administered with##2##3##(2008-10#1)(2008-7#1)
were administered##97##2##(1990-5#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#4)(2008-9#23)(2009-11#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#2)
were administrated with##3##3##(2011-3#1)(2012-3#2)
were administrated##7##2##(2011-3#1)(2012-3#5)(2013-1#1)
were admitted in##4##3##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were admitted to hospital##2##4##(1997-6#1)(2007-8#1)
were admitted to our##4##4##(1997-8#1)(2007-8#1)(2011-1#1)(2012-12#1)
were admitted to the##4##4##(1995-11#1)(2007-2#1)(2008-3#1)(2013-1#1)
were admitted to##15##3##(1995-11#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were admitted with##3##3##(1997-8#1)(2010-12#1)(2011-2#1)
were admitted within##2##3##(1996-9#2)
were admitted##32##2##(1995-11#1)(1996-9#3)(1997-6#1)(1997-8#3)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
were adopted##4##2##(1995-5#1)(2008-10#1)(2013-1#2)
were adsorbed on##2##3##(1990-8#1)(2008-10#1)
were adsorbed##6##2##(1990-8#1)(2008-10#4)(2008-9#1)
were adult##2##2##(1996-11#1)(2012-3#1)
were adults##2##2##(2011-2#1)(2013-7#1)
were advanced##2##2##(2011-2#1)(2013-1#1)
were adversely affected in##2##4##(2008-7#1)(2011-2#1)
were advised to##2##3##(1997-8#1)(2008-10#1)
were affected by LH##2##4##(2009-10#2)
were affected by the##6##4##(1990-11#1)(2008-10#3)(2008-11#1)(2011-2#1)
were affected by##25##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#2)(1994-11#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
were affected in##3##3##(2008-10#1)(2008-6#1)(2012-9#1)
were affected more than##2##4##(2008-10#1)(2008-11#1)
were affected more##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
were affected significantly##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
were affected##49##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#2)(1991-1#1)(1992-1#1)(1993-12#1)(1994-11#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2010-4#1)(2011-2#7)(2012-9#1)(2013-8#1)
were affiliated to##2##3##(2011-2#1)(2012-12#1)
were affiliated##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
were affinity##2##2##(1990-11#1)(2010-3#1)
were afraid##2##2##(2007-8#1)(2012-12#1)
were after##2##2##(1995-12#2)
were again##3##2##(1993-1#1)(2008-6#1)(2011-2#1)
were age##7##2##(1990-11#1)(1993-12#1)(1994-12#1)(1996-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
were aged between##2##3##(2010-8#1)(2012-3#1)
were aged##6##2##(1991-8#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
were aggregated##3##2##(2008-10#2)(2013-1#1)
were aggressive##2##2##(2008-10#1)(2010-1#1)
were agreeing##2##2##(2008-7#1)(2011-2#1)
were aimed at##2##3##(1992-5#1)(1995-2#1)
were aligned with##2##3##(2008-10#1)(2011-1#1)
were aligned##6##2##(1991-5#1)(2008-10#2)(2008-6#1)(2009-10#1)(2011-1#1)
were alive at the##2##4##(2010-3#1)(2011-2#1)
were alive at##3##3##(1991-8#1)(2010-3#1)(2011-2#1)
were alive of which##4##4##(2008-12#4)
were alive##17##2##(1990-6#1)(1991-2#1)(1991-8#3)(2008-1#1)(2008-12#5)(2008-6#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
were all below##3##3##(2008-10#3)
were all found to##3##4##(1991-12#1)(2008-11#1)(2008-8#1)
were all lower than 1%##3##5##(2008-10#3)
were all more than 0##2##5##(2013-8#2)
were all sensitive to##2##4##(1994-11#1)(2008-10#1)
were all significantly decreased in##2##5##(1996-5#1)(2008-10#1)
were all significantly##5##3##(1996-5#1)(2008-10#3)(2011-1#1)
were all statistically##2##3##(1992-2#1)(2008-10#1)
were all within##2##3##(2008-10#1)(2008-11#1)
were all##70##2##(1990-2#1)(1990-9#2)(1991-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-3#1)(2007-7#1)(2007-9#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
were allocated into##3##3##(2008-10#1)(2012-2#2)
were allocated to the##3##4##(1994-2#1)(2008-12#2)
were allocated to##7##3##(1991-8#1)(1994-2#1)(2008-12#3)(2009-8#1)(2011-2#1)
were allocated##11##2##(1991-8#1)(1994-2#1)(2008-10#1)(2008-12#3)(2009-8#1)(2011-2#2)(2012-2#2)
were allotted##2##2##(2008-5#1)(2008-9#1)
were allowed a##2##3##(2008-10#1)(2011-2#1)
were allowed to bind to##2##5##(1990-12#1)(1992-3#1)
were allowed to##9##3##(1990-12#1)(1992-3#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
were allowed##16##2##(1990-12#1)(1992-3#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-2#1)
were almost completely##3##3##(1992-3#1)(1995-6#1)(2008-10#1)
were almost identical##3##3##(1991-8#1)(1996-5#1)(2008-9#1)
were almost the same as those of##2##7##(1993-6#1)(1997-8#1)
were almost the same as those##3##6##(1993-6#1)(1997-8#1)(2008-3#1)
were almost the same as##4##5##(1993-6#1)(1997-8#1)(2008-10#1)(2008-3#1)
were almost##26##2##(1991-8#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#2)
were alpha-pinene##2##2##(2008-10#1)(2008-12#1)
were already present##2##3##(2008-7#1)(2008-9#1)
were already##13##2##(1995-3#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-12#1)
were also a##2##3##(2007-5#1)(2009-6#1)
were also able to##4##4##(2008-12#1)(2008-3#1)(2009-8#1)(2010-3#1)
were also achieved##6##3##(2008-10#6)
were also affected##5##3##(1990-6#1)(1992-5#1)(2008-7#1)(2009-12#1)(2010-10#1)
were also analysed##3##3##(1993-8#1)(2008-10#2)
were also analyzed by##3##4##(1990-8#1)(1992-3#1)(2009-8#1)
were also analyzed in##2##4##(1997-6#1)(2011-2#1)
were also analyzed##12##3##(1990-8#1)(1992-3#1)(1994-12#1)(1997-6#1)(2008-10#4)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
were also apparent##2##3##(2008-5#1)(2008-9#1)
were also applied for##2##4##(2008-10#1)(2009-6#1)
were also asked to rank##2##5##(2010-12#1)(2013-8#1)
were also asked to##3##4##(2008-11#1)(2010-12#1)(2013-8#1)
were also assayed##4##3##(1991-2#1)(2008-10#1)(2013-1#2)
were also assessed##8##3##(1991-5#1)(1991-8#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
were also associated with##4##4##(2009-5#1)(2010-8#2)(2012-12#1)
were also avoided##2##3##(2012-12#2)
were also calculated and the##2##5##(1994-8#1)(2008-10#1)
were also calculated and##4##4##(1994-8#1)(2008-10#2)(2010-9#1)
were also calculated for##2##4##(1996-3#1)(2008-3#1)
were also calculated##11##3##(1994-8#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
were also carried out##6##4##(2008-10#4)(2008-12#1)(2008-5#1)
were also characterized by##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
were also characterized##7##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
were also collected##5##3##(1997-4#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
were also common##2##3##(1997-3#1)(2008-5#1)
were also comparable##2##3##(2011-1#1)(2011-2#1)
were also compared for##2##4##(1997-4#1)(2008-10#1)
were also compared with the##2##5##(2008-2#1)(2008-5#1)
were also compared with those##2##5##(2008-10#1)(2008-3#1)
were also compared with##7##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-10#1)
were also compared##13##3##(1995-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-10#1)(2012-12#1)
were also conducted##4##3##(2007-6#1)(2008-10#1)(2013-1#2)
were also confirmed by the##2##5##(1995-6#1)(2008-10#1)
were also confirmed by##5##4##(1995-6#1)(1997-2#1)(2008-10#3)
were also considered##6##3##(2008-10#4)(2008-4#1)(2008-5#1)
were also consistent with##2##4##(1995-2#1)(2008-10#1)
were also converted into##2##4##(1995-6#1)(2008-3#1)
were also correlated##2##3##(2008-10#2)
were also decreased##2##3##(2008-10#1)(2008-12#1)
were also defined##3##3##(1993-11#1)(2009-10#1)(2009-8#1)
were also demonstrated in##2##4##(1990-7#1)(1991-10#1)
were also demonstrated##3##3##(1990-7#1)(1991-10#1)(2007-11#1)
were also detected by##2##4##(1997-6#1)(2008-5#1)
were also detected in the##3##5##(2008-10#1)(2009-12#1)(2010-5#1)
were also detected in##7##4##(1993-2#1)(1996-12#2)(2008-10#1)(2009-12#1)(2010-5#1)(2012-2#1)
were also detected on##2##4##(2008-10#1)(2008-8#1)
were also detected##22##3##(1992-12#1)(1993-2#1)(1996-12#2)(1997-6#1)(2006-6#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-2#1)
were also determined##19##3##(1997-7#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#1)
were also developed##3##3##(2006-4#1)(2008-10#2)
were also different from##2##4##(2008-7#1)(2011-2#1)
were also discussed##9##3##(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-12#1)(2011-7#1)(2012-1#1)(2013-8#1)
were also done##3##3##(2008-5#2)(2013-8#1)
were also effective##2##3##(1990-5#1)(1992-5#1)
were also evaluated##14##3##(1993-12#1)(2008-10#3)(2008-3#3)(2008-6#1)(2008-7#2)(2009-8#1)(2011-1#2)(2012-12#1)
were also evident##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
were also examined by##2##4##(2007-12#1)(2008-9#1)
were also examined for##2##4##(2008-10#1)(2009-12#1)
were also examined to##2##4##(2008-10#1)(2009-7#1)
were also examined##25##3##(1991-8#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#2)(2007-10#1)(2007-12#2)(2008-10#10)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2011-1#1)
were also exposed to##2##4##(2008-11#1)(2012-3#1)
were also expressed in##2##4##(1995-11#1)(1997-4#1)
were also extracted##2##3##(2008-10#2)
were also fitted##2##3##(2008-3#1)(2011-2#1)
were also found for the##2##5##(1996-7#1)(2008-10#1)
were also found in##5##4##(1992-9#1)(1994-5#1)(2008-10#1)(2008-12#1)(2010-8#1)
were also found to be more##2##6##(1995-3#1)(2012-2#1)
were also found to be##6##5##(1995-3#1)(2007-10#1)(2009-10#1)(2012-2#2)(2013-1#1)
were also found to inhibit##2##5##(2010-11#1)(2011-2#1)
were also found to##14##4##(1992-9#2)(1995-3#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
were also found##34##3##(1990-12#1)(1992-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)
were also higher##2##3##(1994-2#1)(2009-9#1)
were also highly##2##3##(1991-2#1)(1992-11#1)
were also identified as##2##4##(2008-12#1)(2008-3#1)
were also identified##14##3##(1994-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)
were also included in the##2##5##(1996-3#1)(2008-10#1)
were also included##5##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
were also increased##4##3##(2008-10#1)(2008-9#2)(2013-1#1)
were also induced by##2##4##(1994-6#1)(2008-5#1)
were also induced##3##3##(1994-6#1)(2008-5#1)(2008-7#1)
were also inhibited by##4##4##(1992-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
were also integrated##2##3##(2008-10#2)
were also investigated and##2##4##(2008-10#2)
were also investigated in##2##4##(2008-10#1)(2008-7#1)
were also investigated##33##3##(1994-9#1)(2007-7#2)(2008-10#22)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-3#1)(2012-12#1)
were also isolated##7##3##(1993-6#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
were also lower##2##3##(2009-7#1)(2013-8#1)
were also made to##2##4##(2008-5#1)(2011-2#1)
were also made##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
were also measured at 25 degrees C##2##7##(2008-10#2)
were also measured at##3##4##(1991-6#1)(2008-10#2)
were also measured##20##3##(1990-11#1)(1990-3#1)(1991-6#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)
were also modified by##2##4##(1992-7#1)(2008-5#1)
were also modified##3##3##(1992-7#1)(2008-5#1)(2008-9#1)
were also monitored##2##3##(1997-4#1)(2008-10#1)
were also more likely##2##4##(2007-10#1)(2008-8#1)
were also more##8##3##(1995-5#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)
were also not##2##3##(1993-6#1)(2008-10#1)
were also noted##2##3##(1992-8#1)(2013-1#1)
were also noticed##2##3##(2008-12#1)(2013-1#1)
were also observed among##2##4##(2008-10#1)(2008-11#1)
were also observed between##2##4##(2008-11#1)(2008-2#1)
were also observed for##2##4##(1997-3#1)(2008-9#1)
were also observed in the##11##5##(1995-5#1)(1995-6#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
were also observed in##16##4##(1995-5#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
were also observed on##2##4##(2008-1#1)(2008-2#1)
were also observed##42##3##(1990-6#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
were also obtained from##6##4##(1992-12#1)(1994-12#1)(2008-10#1)(2008-5#2)(2010-5#1)
were also obtained in##2##4##(1990-8#1)(2007-11#1)
were also obtained##23##3##(1990-8#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-5#1)(2012-2#1)(2013-8#1)
were also operated on##2##4##(1991-2#1)(2010-8#1)
were also optimized##2##3##(2008-10#2)
were also performed with##3##4##(1992-8#1)(1994-5#1)(1996-1#1)
were also performed##6##3##(1992-8#1)(1994-5#1)(1996-1#1)(2008-10#1)(2008-2#1)(2010-3#1)
were also positive for##2##4##(1992-6#1)(2008-10#1)
were also positive##3##3##(1992-6#1)(1996-5#1)(2008-10#1)
were also predicted by##2##4##(1997-8#1)(2011-1#1)
were also predicted##3##3##(1997-6#1)(1997-8#1)(2011-1#1)
were also prepared##5##3##(1992-9#1)(1997-3#1)(2008-10#2)(2009-11#1)
were also present in##5##4##(1994-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)
were also present##10##3##(1994-2#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-3#1)(2008-10#2)(2008-7#2)(2012-12#1)
were also recorded##2##3##(1997-4#1)(2007-7#1)
were also reduced by##2##4##(2008-10#1)(2008-2#1)
were also reduced##4##3##(1993-12#1)(2008-10#2)(2008-2#1)
were also reported##2##3##(1993-1#1)(2011-2#1)
were also resistant##2##3##(2008-10#1)(2008-5#1)
were also revealed##3##3##(1991-1#1)(2011-1#1)(2011-2#1)
were also reviewed##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
were also seen in the##3##5##(1991-10#1)(2008-7#2)
were also seen in##4##4##(1991-10#1)(2008-5#1)(2008-7#2)
were also seen##6##3##(1991-10#1)(1992-6#1)(1992-9#1)(2008-5#1)(2008-7#2)
were also selected##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
were also shown to be##2##5##(1992-3#1)(2010-7#1)
were also shown to##5##4##(1992-3#1)(2008-10#2)(2010-7#1)(2012-2#1)
were also shown##6##3##(1992-3#1)(1997-2#1)(2008-10#2)(2010-7#1)(2012-2#1)
were also significant##2##3##(2007-2#1)(2011-1#1)
were also significantly higher##2##4##(1995-11#1)(2011-2#1)
were also significantly more likely to##2##6##(2009-5#1)(2010-9#1)
were also significantly##7##3##(1995-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#1)
were also similar to##2##4##(2008-10#1)(2008-8#1)
were also similar##5##3##(2008-10#1)(2008-8#2)(2009-12#1)(2011-1#1)
were also stained##5##3##(1993-12#1)(1995-12#2)(1996-12#1)(2008-5#1)
were also strongly positive for##2##5##(1991-9#1)(2008-5#1)
were also studied as##2##4##(2009-5#1)(2011-1#1)
were also studied for##3##4##(1995-3#1)(2008-10#1)(2013-8#1)
were also studied in detail##2##5##(2008-10#2)
were also studied in##5##4##(1990-3#1)(1995-1#1)(2008-10#2)(2008-3#1)
were also studied##31##3##(1990-3#1)(1991-11#1)(1992-8#1)(1995-1#1)(1995-3#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
were also subject##2##3##(2010-6#1)(2012-2#1)
were also successfully##3##3##(2008-10#3)
were also tested by##2##4##(2008-10#1)(2013-8#1)
were also tested for##2##4##(2008-10#2)
were also tested in##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)
were also tested on a##2##5##(1993-3#1)(2008-5#1)
were also tested on##3##4##(1993-3#1)(2008-5#1)(2008-9#1)
were also tested##18##3##(1993-12#1)(1993-3#1)(1994-3#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
were also the##4##3##(2008-10#1)(2008-2#1)(2009-8#1)(2013-1#1)
were also treated##2##3##(1990-2#1)(2008-10#1)
were also undertaken##3##3##(1994-10#2)(2008-10#1)
were also up-regulated in##2##4##(2008-10#1)(2008-11#1)
were also used in##2##4##(2008-10#1)(2009-6#1)
were also used to calculate the##2##6##(2008-5#1)(2010-7#1)
were also used to##9##4##(2008-10#6)(2008-5#1)(2008-9#1)(2010-7#1)
were also used##15##3##(2008-10#11)(2008-5#1)(2008-9#1)(2009-6#1)(2010-7#1)
were also very##4##3##(1990-5#1)(2008-10#2)(2008-7#1)
were also##776##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#3)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#3)(1996-1#2)(1996-12#12)(1996-2#2)(1996-3#3)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#8)(1997-6#4)(1997-7#2)(1997-8#3)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#216)(2008-11#17)(2008-12#14)(2008-2#11)(2008-3#16)(2008-4#4)(2008-5#35)(2008-6#8)(2008-7#28)(2008-8#18)(2008-9#16)(2009-10#3)(2009-11#3)(2009-12#8)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#16)(2011-10#1)(2011-2#25)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#11)(2012-2#15)(2012-3#3)(2013-1#22)(2013-7#1)(2013-8#10)
were altered by##3##3##(1995-12#1)(1996-12#2)
were altered##4##2##(1995-12#1)(1996-12#2)(2013-8#1)
were always present in##2##4##(1997-3#1)(2008-10#1)
were always##17##2##(1990-5#1)(1991-11#1)(1994-2#1)(1997-3#1)(1997-6#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#2)(2012-1#1)
were amended with##2##3##(2008-10#2)
were among the##6##3##(1990-9#1)(1996-1#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
were among##11##2##(1990-9#1)(1992-6#2)(1996-1#1)(1996-6#1)(1997-5#1)(2007-11#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
were amplified and sequenced##5##4##(2007-6#1)(2008-10#2)(2008-12#1)(2013-8#1)
were amplified and##8##3##(1992-6#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-8#1)
were amplified by PCR and##2##5##(2008-10#1)(2008-8#1)
were amplified by polymerase chain reaction##2##6##(2008-10#2)
were amplified by the##3##4##(1995-12#1)(1995-6#1)(2008-10#1)
were amplified by##10##3##(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-5#1)
were amplified from the##3##4##(1997-7#1)(2008-10#1)(2010-4#1)
were amplified from##9##3##(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#1)(2013-8#1)
were amplified using the##2##4##(1997-6#1)(2008-11#1)
were amplified using##4##3##(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
were amplified with##2##3##(1997-8#1)(2008-10#1)
were amplified##37##2##(1992-6#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#3)
were an##14##2##(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
were analysed according to the##2##5##(1994-3#1)(2008-7#1)
were analysed according to##4##4##(1991-9#1)(1994-3#1)(2008-7#1)(2008-9#1)
were analysed after##4##3##(2008-10#2)(2012-7#1)(2013-1#1)
were analysed and##7##3##(1990-2#1)(2008-10#5)(2008-9#1)
were analysed as##2##3##(2011-2#1)(2012-8#1)
were analysed by gas chromatography##3##5##(2008-10#3)
were analysed by gas##4##4##(1990-5#1)(2008-10#3)
were analysed by means of##5##5##(1991-8#2)(1992-3#1)(2008-5#1)(2009-6#1)
were analysed by using##3##4##(2012-1#1)(2013-1#2)
were analysed by##40##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-8#2)(1992-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#2)(2012-1#1)(2013-1#3)
were analysed for the##4##4##(2008-10#1)(2008-11#2)(2012-2#1)
were analysed for their##3##4##(2008-12#2)(2013-1#1)
were analysed for##17##3##(1991-12#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#1)
were analysed in the##2##4##(1996-2#1)(2007-2#1)
were analysed in##13##3##(1990-6#1)(1990-8#1)(1992-12#1)(1996-2#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
were analysed retrospectively##4##3##(1990-11#1)(1990-8#1)(1992-11#1)(1997-2#1)
were analysed to##4##3##(1996-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
were analysed using a##5##4##(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
were analysed using the##2##4##(2011-2#1)(2013-1#1)
were analysed using##25##3##(1992-8#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
were analysed with a##2##4##(2008-10#1)(2008-11#1)
were analysed with the##4##4##(2008-10#4)
were analysed with##10##3##(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)
were analysed##186##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#46)(2008-11#7)(2008-12#6)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#2)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#12)(2013-8#4)
were analytically##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
were analyzed according to the type of##2##7##(1993-11#1)(2012-3#1)
were analyzed according to the##3##5##(1993-11#1)(1995-12#1)(2012-3#1)
were analyzed according to##6##4##(1993-11#1)(1995-12#1)(2008-7#2)(2011-2#1)(2012-3#1)
were analyzed after##2##3##(1994-12#1)(2010-6#1)
were analyzed along##3##3##(2008-10#3)
were analyzed and compared with##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
were analyzed and compared##5##4##(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#2)
were analyzed and the results##2##5##(2008-10#2)
were analyzed and the##4##4##(2008-10#3)(2013-7#1)
were analyzed and##24##3##(1991-12#1)(1993-12#1)(1996-2#1)(2008-10#9)(2008-12#1)(2008-3#1)(2009-10#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#2)
were analyzed as##5##3##(1990-8#1)(2008-10#2)(2010-7#1)(2011-1#1)
were analyzed at##3##3##(2008-12#1)(2008-5#1)(2011-2#1)
were analyzed based on##2##4##(2008-10#1)(2008-11#1)
were analyzed by GC and GC/MS##2##6##(2008-11#1)(2008-12#1)
were analyzed by GC and##3##5##(2008-11#1)(2008-12#1)(2012-2#1)
were analyzed by a##7##4##(2008-10#2)(2008-3#2)(2008-9#1)(2010-9#1)(2013-1#1)
were analyzed by atomic##2##4##(2008-10#1)(2009-7#1)
were analyzed by gas chromatography##2##5##(2008-10#1)(2008-9#1)
were analyzed by gas chromatography-mass spectrometry##2##6##(2008-10#1)(2013-8#1)
were analyzed by gas##5##4##(2008-10#3)(2008-9#1)(2013-8#1)
were analyzed by high-performance liquid chromatography##2##6##(1992-2#1)(2008-5#1)
were analyzed by high-performance##3##4##(1992-2#1)(1993-11#1)(2008-5#1)
were analyzed by means of##2##5##(2008-10#1)(2008-7#1)
were analyzed by real-time##2##4##(2008-10#1)(2012-3#1)
were analyzed by reverse##4##4##(1990-12#1)(1996-12#1)(2008-11#1)(2008-6#1)
were analyzed by scanning electron microscopy##2##6##(2009-7#1)(2012-2#1)
were analyzed by scanning##3##4##(2007-12#1)(2009-7#1)(2012-2#1)
were analyzed by the proposed method##2##6##(2008-10#2)
were analyzed by the proposed##3##5##(2008-10#3)
were analyzed by the##10##4##(2007-10#1)(2008-10#6)(2011-2#2)(2013-1#1)
were analyzed by this##3##4##(1993-12#1)(2008-10#2)
were analyzed by use of##2##5##(1997-7#1)(2008-2#1)
were analyzed by using the##2##5##(2008-10#2)
were analyzed by using##7##4##(1997-7#1)(2008-10#4)(2008-6#1)(2013-8#1)
were analyzed by##117##3##(1990-12#2)(1990-2#1)(1990-7#2)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#2)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-12#2)(2008-10#36)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#8)(2008-6#2)(2008-7#1)(2008-9#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#6)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#3)
were analyzed during##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
were analyzed following##2##3##(2008-10#2)
were analyzed for a##2##4##(2008-10#1)(2009-8#1)
were analyzed for copper##2##4##(2008-10#2)
were analyzed for mating type##2##5##(2008-10#2)
were analyzed for the##5##4##(1997-2#1)(2008-10#2)(2008-4#1)(2011-2#1)
were analyzed for their##3##4##(1992-2#1)(2008-10#1)(2008-7#1)
were analyzed for virulence on##2##5##(2008-10#2)
were analyzed for virulence##3##4##(2008-10#3)
were analyzed for##58##3##(1990-5#1)(1990-6#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#27)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#1)
were analyzed from##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
were analyzed in a##6##4##(1994-1#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
were analyzed in detail##2##4##(1995-12#1)(2012-3#1)
were analyzed in order to##2##5##(1990-2#1)(2008-10#1)
were analyzed in relation to the##2##6##(1991-6#1)(2007-10#1)
were analyzed in terms of##5##5##(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#2)
were analyzed in the##4##4##(1992-2#1)(2008-10#3)
were analyzed in this##2##4##(2008-7#1)(2012-3#1)
were analyzed in##38##3##(1990-2#1)(1991-6#1)(1992-2#1)(1993-12#2)(1994-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)
were analyzed of##2##3##(2007-7#1)(2012-12#1)
were analyzed on##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
were analyzed retrospectively##4##3##(1990-6#1)(1997-8#1)(2013-1#2)
were analyzed separately##2##3##(1993-2#1)(2008-2#1)
were analyzed to determine the##5##5##(1995-1#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
were analyzed to determine their##2##5##(2008-10#1)(2013-1#1)
were analyzed to determine##9##4##(1994-2#1)(1995-1#1)(1995-12#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
were analyzed to##18##3##(1994-2#1)(1995-1#1)(1995-12#1)(2006-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-1#3)(2013-8#1)
were analyzed under##4##3##(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
were analyzed using Student's##2##4##(2010-12#1)(2013-7#1)
were analyzed using a##8##4##(1993-11#1)(2007-10#1)(2008-10#1)(2010-2#2)(2011-2#1)(2013-1#2)
were analyzed using the##7##4##(2008-10#2)(2008-12#2)(2010-12#1)(2011-2#1)(2013-8#1)
were analyzed using##45##3##(1993-11#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-5#1)(2007-10#1)(2007-5#1)(2008-10#11)(2008-12#4)(2008-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
were analyzed with a##2##4##(2008-11#1)(2008-12#1)
were analyzed with the##5##4##(2008-10#4)(2011-1#1)
were analyzed with##20##3##(1994-11#1)(1995-11#1)(2008-10#10)(2008-11#1)(2008-12#2)(2009-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
were analyzed##489##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-9#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#5)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#145)(2008-11#16)(2008-12#14)(2008-2#10)(2008-3#9)(2008-4#3)(2008-5#18)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#6)(2009-10#3)(2009-12#1)(2009-2#1)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#9)(2011-2#17)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#17)(2012-5#1)(2013-1#28)(2013-7#9)(2013-8#15)
were anemic##2##2##(1991-4#1)(2008-7#1)
were anesthetized and##2##3##(2008-3#1)(2011-2#1)
were anesthetized##8##2##(1990-12#1)(1992-3#2)(1995-12#1)(2008-3#1)(2009-12#1)(2011-2#2)
were annealed##2##2##(1994-12#1)(2008-2#1)
were antigenically related##2##3##(2008-5#2)
were antigenically##5##2##(1992-6#2)(2008-5#2)(2013-8#1)
were anxiety##2##2##(1990-10#1)(1996-9#1)
were any##4##2##(1994-12#1)(1996-9#1)(2008-11#1)(2011-3#1)
were apparent##13##2##(1990-6#1)(1992-9#1)(1993-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2013-1#2)
were apparently not##2##3##(1992-3#1)(2007-5#1)
were apparently##8##2##(1992-3#1)(1994-8#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
were applied according to##2##4##(2008-12#1)(2012-2#1)
were applied alone##2##3##(2008-10#2)
were applied and##2##3##(1992-9#1)(2008-11#1)
were applied as##4##3##(2008-1#1)(2008-10#3)
were applied at the##2##4##(2008-10#1)(2008-6#1)
were applied at##5##3##(2008-10#4)(2008-6#1)
were applied daily for##2##4##(2008-5#1)(2012-12#1)
were applied for the simultaneous determination of##2##7##(2008-10#2)
were applied for the##5##4##(2008-10#5)
were applied for##15##3##(2008-10#10)(2008-11#1)(2011-2#4)
were applied in the##2##4##(2008-10#2)
were applied in##11##3##(1990-7#1)(2008-10#7)(2008-5#1)(2009-10#1)(2012-8#1)
were applied into the##2##4##(1995-12#1)(2008-10#1)
were applied satisfactorily to the determination of##2##7##(2008-10#2)
were applied to a##3##4##(1992-5#1)(2008-2#1)(2008-5#1)
were applied to all##2##4##(2008-10#1)(2011-2#1)
were applied to determine##2##4##(2008-10#1)(2013-1#1)
were applied to the analysis of##4##6##(2008-10#4)
were applied to the determination of##12##6##(2008-10#12)
were applied to the determination##13##5##(2008-10#13)
were applied to the same##2##5##(1991-8#1)(2008-10#1)
were applied to the##42##4##(1991-8#1)(1997-3#1)(2007-8#1)(2008-10#31)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-3#1)(2012-2#1)
were applied to##101##3##(1991-8#1)(1992-5#2)(1992-6#1)(1994-9#1)(1996-5#1)(1997-2#2)(1997-3#1)(2007-8#2)(2008-10#66)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)
were applied with##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
were applied##173##2##(1990-7#1)(1991-8#1)(1992-5#2)(1992-6#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#2)(1997-2#2)(1997-3#1)(2007-8#2)(2008-1#1)(2008-10#102)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2012-8#2)(2013-1#4)
were approached##3##2##(2007-12#1)(2008-11#1)(2010-12#1)
were appropriate in##2##3##(2010-12#2)
were appropriate##5##2##(1996-3#1)(2008-8#1)(2010-12#2)(2012-12#1)
were approved by##2##3##(2008-8#1)(2010-8#1)
were approved##3##2##(2008-4#1)(2008-8#1)(2010-8#1)
were approximately 1##5##3##(1994-5#1)(2008-10#2)(2011-2#1)(2013-1#1)
were approximately 12##2##3##(1995-2#1)(2008-10#1)
were approximately 20##2##3##(2008-10#1)(2008-2#1)
were approximately 3##2##3##(2008-10#2)
were approximately twice##2##3##(2008-10#1)(2008-5#1)
were approximately##36##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-11#1)(1993-8#1)(1994-5#1)(1995-2#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
were arbitrarily##2##2##(2008-10#1)(2008-5#1)
were around##4##2##(2008-10#2)(2011-1#2)
were arranged in a##6##4##(2008-10#4)(2008-2#2)
were arranged in##9##3##(2008-10#5)(2008-12#1)(2008-2#2)(2012-1#1)
were arranged##13##2##(1997-2#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2009-1#1)(2012-1#1)
were arrayed##2##2##(2008-10#1)(2008-9#1)
were arrived at##4##3##(1994-5#1)(2008-10#3)
were artificially inoculated##4##3##(2008-10#4)
were artificially##6##2##(1992-8#1)(2008-10#4)(2013-1#1)
were as follows##41##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#2)(1993-12#2)(1993-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
were as high as##2##4##(1992-8#1)(2013-1#1)
were as##58##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#2)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
were ascertained##2##2##(1997-5#1)(2008-12#1)
were asked for##2##3##(2008-10#1)(2008-11#1)
were asked how##2##3##(1994-2#1)(2007-10#1)
were asked to answer##2##4##(2007-7#1)(2008-10#1)
were asked to complete the questionnaire##2##6##(2008-11#1)(2008-8#1)
were asked to complete##7##4##(1993-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#1)
were asked to describe##3##4##(2008-2#1)(2013-1#2)
were asked to evaluate the##2##5##(2008-11#1)(2012-12#1)
were asked to identify##2##4##(2008-11#1)(2013-8#1)
were asked to rate the##2##5##(1995-3#1)(1996-2#1)
were asked to rate their##3##5##(1993-1#1)(1993-2#1)(2008-12#1)
were asked to rate##9##4##(1991-6#1)(1993-1#1)(1993-2#1)(1995-3#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-12#1)
were asked to view##2##4##(1996-2#1)(2008-5#1)
were asked to##57##3##(1991-6#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-1#1)(2007-12#3)(2007-6#1)(2007-7#2)(2008-10#2)(2008-11#11)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#2)
were asked##67##2##(1991-6#1)(1992-6#2)(1993-1#2)(1993-12#2)(1993-2#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-1#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#12)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#7)(2013-8#2)
were aspirated##2##2##(1993-3#1)(2008-10#1)
were assayed against##2##3##(2007-11#1)(2012-12#1)
were assayed at##2##3##(1994-11#1)(2010-2#1)
were assayed by##2##3##(1997-7#1)(2008-5#1)
were assayed for the##2##4##(1990-2#1)(2008-10#1)
were assayed for their##3##4##(1992-3#1)(2012-2#1)(2013-1#1)
were assayed for##20##3##(1990-12#1)(1990-2#1)(1990-5#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-10#9)(2012-2#1)(2013-1#1)
were assayed in##10##3##(1991-10#1)(1991-2#1)(1992-8#1)(1995-11#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-7#1)
were assayed over a##2##4##(1994-8#1)(2008-10#1)
were assayed with##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
were assayed##58##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-10#21)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
were assembled in##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
were assembled into##2##3##(2008-2#1)(2011-1#1)
were assembled##8##2##(1992-5#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
were assesed##4##2##(2007-11#4)
were assessed after##2##3##(2008-10#1)(2009-5#1)
were assessed at a##2##4##(2008-12#1)(2008-3#1)
were assessed at baseline and##2##5##(2012-3#1)(2013-1#1)
were assessed at baseline##3##4##(2008-4#1)(2012-3#1)(2013-1#1)
were assessed at##11##3##(1995-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
were assessed by the##2##4##(1990-10#1)(2012-1#1)
were assessed by##32##3##(1990-10#1)(1990-12#1)(1992-2#1)(1992-9#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2009-1#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-8#3)
were assessed following##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
were assessed for the##2##4##(2007-7#1)(2012-3#1)
were assessed for their ability to##2##6##(1990-11#1)(1995-11#1)
were assessed for their##3##4##(1990-11#1)(1995-11#1)(2008-10#1)
were assessed for##23##3##(1990-11#1)(1995-11#1)(1996-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2010-7#1)(2011-2#2)(2012-3#2)
were assessed from##2##3##(1996-5#1)(2008-10#1)
were assessed in a##2##4##(1990-3#1)(2010-11#1)
were assessed in the##2##4##(2008-10#1)(2012-12#1)
were assessed in two##2##4##(1992-8#1)(1993-11#1)
were assessed in##24##3##(1990-11#1)(1990-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
were assessed on a##2##4##(2008-2#1)(2013-8#1)
were assessed on the##2##4##(1997-7#1)(2009-6#1)
were assessed on##11##3##(1990-12#1)(1997-7#2)(2008-10#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
were assessed over##2##3##(2008-5#1)(2011-2#1)
were assessed to##3##3##(2008-11#1)(2010-6#1)(2011-2#1)
were assessed using a##2##4##(2008-7#1)(2013-1#1)
were assessed using the##11##4##(1993-12#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-6#1)(2013-1#1)
were assessed using##19##3##(1993-12#1)(1996-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-6#1)(2013-1#2)(2013-8#1)
were assessed with the##3##4##(1995-11#1)(2012-2#1)(2013-8#1)
were assessed with##4##3##(1995-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
were assessed##215##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-3#3)(1997-4#2)(1997-7#2)(1997-8#1)(2006-6#2)(2007-10#1)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#35)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#8)(2012-4#2)(2013-1#12)(2013-7#1)(2013-8#9)
were assigned by##3##3##(1992-3#1)(2007-11#1)(2012-2#1)
were assigned into##2##3##(2009-7#1)(2012-3#1)
were assigned on##2##3##(1996-12#1)(1996-6#1)
were assigned randomly to one of##2##6##(1991-1#1)(1992-1#1)
were assigned randomly to receive##2##5##(2008-8#1)(2009-6#1)
were assigned randomly to##4##4##(1991-1#1)(1992-1#1)(2008-8#1)(2009-6#1)
were assigned randomly##5##3##(1991-1#1)(1992-1#1)(1995-3#1)(2008-8#1)(2009-6#1)
were assigned to chromosomes##2##4##(1996-12#1)(2008-10#1)
were assigned to concurrent##2##4##(2008-10#2)
were assigned to one of the##2##6##(2008-12#1)(2008-7#1)
were assigned to one of##3##5##(1994-3#1)(2008-12#1)(2008-7#1)
were assigned to receive##2##4##(2008-1#1)(2008-10#1)
were assigned to six##2##4##(2008-10#2)
were assigned to the##5##4##(1991-12#2)(1991-3#1)(2010-2#1)(2012-1#1)
were assigned to three##2##4##(2008-12#2)
were assigned to##32##3##(1991-12#3)(1991-2#1)(1991-3#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-10#9)(2008-12#4)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
were assigned##55##2##(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-1#1)(1992-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#2)(1996-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)
were associated to##2##3##(1990-2#1)(1990-6#1)
were associated with a history of##2##6##(1992-10#1)(1996-8#1)
were associated with a##12##4##(1991-2#1)(1992-10#1)(1993-11#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
were associated with an##3##4##(2007-10#1)(2008-6#1)(2008-7#1)
were associated with better##2##4##(1993-1#1)(2008-9#1)
were associated with black compared with white men##2##8##(2013-7#2)
were associated with both##2##4##(2008-10#1)(2012-3#1)
were associated with decreased##3##4##(1996-5#1)(2011-2#2)
were associated with greater##5##4##(2008-12#1)(2008-6#1)(2012-12#1)(2013-1#2)
were associated with higher levels of##2##6##(1994-2#1)(2009-5#1)
were associated with higher##4##4##(1994-2#1)(2009-5#1)(2010-5#1)(2012-12#1)
were associated with increased##6##4##(1993-3#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#2)
were associated with less##2##4##(2008-10#1)(2009-9#1)
were associated with lower levels of##2##6##(1995-3#1)(2009-5#1)
were associated with lower##7##4##(1995-3#1)(2007-12#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#1)
were associated with more##6##4##(1995-8#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-1#1)
were associated with partial resistance##2##5##(2008-10#2)
were associated with resistance##2##4##(2008-10#2)
were associated with significant##3##4##(1990-5#1)(2008-10#1)(2010-8#1)
were associated with the same##2##5##(2008-10#1)(2008-9#1)
were associated with the##15##4##(1990-5#1)(1993-2#1)(1993-6#1)(1994-3#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#2)
were associated with their##2##4##(2009-5#1)(2010-3#1)
were associated with##175##3##(1990-12#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#38)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#8)(2009-11#1)(2009-5#6)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#3)(2012-12#10)(2012-2#2)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#3)
were associated##187##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#8)(2009-11#1)(2009-5#6)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#3)(2012-12#11)(2012-2#3)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#3)
were assumed as##3##3##(1990-6#1)(1993-5#1)(2008-7#1)
were assumed to be##2##4##(2008-10#1)(2011-2#1)
were assumed to##5##3##(1990-5#1)(2008-10#2)(2011-2#1)(2012-12#1)
were assumed##10##2##(1990-5#1)(1990-6#1)(1993-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#2)(2012-12#1)
were asymptomatic in##2##3##(1997-3#1)(2013-1#1)
were asymptomatic##9##2##(1991-11#1)(1993-5#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-1#1)
were at a##4##3##(2008-10#1)(2008-12#2)(2008-7#1)
were at gametic equilibrium for##2##5##(2008-10#2)
were at gametic equilibrium##3##4##(2008-10#3)
were at high risk##3##4##(2007-10#1)(2010-10#2)
were at increased risk##2##4##(2012-12#1)(2013-8#1)
were at increased##3##3##(2008-11#1)(2012-12#1)(2013-8#1)
were at least##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
were at risk of##2##4##(2008-7#1)(2013-8#1)
were at risk##3##3##(2008-12#1)(2008-7#1)(2013-8#1)
were at significantly##2##3##(2009-8#1)(2011-2#1)
were at the##7##3##(1990-3#1)(1991-12#1)(1993-9#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
were at##43##2##(1990-3#1)(1991-11#1)(1991-12#1)(1993-12#1)(1993-9#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-10#2)(2008-10#7)(2008-11#2)(2008-12#6)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#2)(2010-10#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#3)
were attached to the##2##4##(2008-10#1)(2008-11#1)
were attached to##5##3##(1993-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
were attached##8##2##(1993-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
were attained by##2##3##(2008-10#1)(2013-8#1)
were attained##9##2##(1990-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2013-8#1)
were attempted##2##2##(2008-7#1)(2011-2#1)
were attending##4##2##(2007-7#1)(2008-11#1)(2011-2#1)(2012-12#1)
were attenuated by##3##3##(1990-2#1)(1995-12#1)(2010-5#1)
were attenuated##5##2##(1990-2#1)(1995-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
were attracted by##2##3##(2008-5#1)(2013-7#1)
were attracted##5##2##(2008-10#1)(2008-5#2)(2009-8#1)(2013-7#1)
were attributable to##5##3##(1995-6#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
were attributable##6##2##(1990-9#1)(1995-6#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
were attributed to administration of##2##5##(2008-9#2)
were attributed to differences in##2##5##(2008-10#2)
were attributed to exposure to aspartame##2##6##(2008-8#2)
were attributed to exposure to##5##5##(2008-8#2)(2008-9#3)
were attributed to the##3##4##(2008-10#2)(2008-9#1)
were attributed to##20##3##(1990-5#1)(1995-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#6)(2013-1#1)(2013-8#1)
were attributed##23##2##(1990-5#1)(1995-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#6)(2013-1#1)(2013-8#1)
were atypical##3##2##(1992-9#1)(2008-10#1)(2011-2#1)
were audio-recorded##2##2##(2012-12#2)
were audited##2##2##(1996-9#1)(2013-1#1)
were augmented in##2##3##(1992-8#1)(2009-6#1)
were augmented##3##2##(1992-8#1)(2009-6#1)(2011-2#1)
were automatically##4##2##(1994-6#2)(2008-10#2)
were available and##3##3##(2008-10#1)(2011-3#1)(2012-12#1)
were available for analysis##3##4##(2008-10#2)(2012-3#1)
were available for##13##3##(1995-5#1)(1996-9#1)(1997-5#1)(2007-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-6#1)(2012-12#1)(2012-3#1)
were available from##3##3##(1995-3#1)(1996-7#1)(2012-3#1)
were available in##4##3##(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
were available on##2##3##(1993-2#1)(2013-8#1)
were available to##5##3##(1996-1#1)(2007-7#1)(2008-5#1)(2010-8#1)(2012-3#1)
were available##45##2##(1991-4#1)(1992-2#1)(1993-2#1)(1994-7#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-7#1)(1996-9#2)(1997-5#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#7)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
were averaged and compared##2##4##(2008-12#1)(2008-2#1)
were averaged##3##2##(1992-8#1)(2008-12#1)(2008-2#1)
were avirulent on##2##3##(2008-10#2)
were avirulent##4##2##(2008-10#4)
were aware of HIV/AIDS##2##4##(2010-8#1)(2011-1#1)
were aware of the condition##2##5##(2008-11#1)(2011-2#1)
were aware of the##7##4##(1996-8#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
were aware of##11##3##(1996-1#1)(1996-8#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
were aware that##3##3##(1995-6#1)(1996-8#1)(2008-1#1)
were aware##15##2##(1995-6#1)(1996-1#1)(1996-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-8#1)
were back-extracted into##2##3##(2008-10#2)
were balanced##2##2##(2008-11#1)(2011-2#1)
were based on a##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
were based on the##11##4##(1990-9#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
were based on##38##3##(1990-12#1)(1990-9#1)(1991-6#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2009-9#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
were based upon##3##3##(1990-8#1)(1992-4#1)(1996-5#1)
were based##42##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-4#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
were basically##3##2##(2008-10#3)
were being##10##2##(1992-4#1)(1994-6#1)(1995-12#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-6#1)
were believed to##2##3##(2008-11#1)(2013-1#1)
were below 0##4##3##(2008-10#3)(2012-1#1)
were below 1##2##3##(1992-9#1)(2008-5#1)
were below 10##3##3##(1991-11#1)(2008-10#1)(2011-3#1)
were below 9%##3##3##(2008-10#3)
were below the##2##3##(1995-8#1)(2008-10#1)
were below##28##2##(1991-11#1)(1992-9#1)(1995-8#1)(2008-10#19)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-1#1)
were benign##3##2##(1990-2#1)(1991-11#1)(2008-3#1)
were best##3##2##(1993-11#1)(1993-8#1)(2007-11#1)
were better able to##2##4##(1992-2#1)(1996-5#1)
were better than 0##2##4##(2008-10#2)
were better than for##2##4##(2011-2#1)(2013-1#1)
were better than those obtained by##2##6##(2008-10#2)
were better than those obtained##3##5##(2008-10#3)
were better than##10##3##(2007-11#1)(2008-10#7)(2011-2#1)(2013-1#1)
were better##22##2##(1992-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-1#3)
were between 0##10##3##(1997-4#1)(2008-10#7)(2008-2#1)(2008-5#1)
were between 1 and##2##4##(2008-10#2)
were between 1##4##3##(2008-10#2)(2008-5#2)
were between 3##2##3##(1994-9#1)(2011-1#1)
were between 91##2##3##(2008-10#2)
were between 92 and##3##4##(2008-10#3)
were between 92##4##3##(2008-10#3)(2008-5#1)
were between 93 and##2##4##(2008-10#2)
were between##52##2##(1992-6#1)(1994-9#2)(1997-4#2)(2007-7#1)(2008-10#34)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
were biased##2##2##(1992-3#1)(2008-10#1)
were bigger than##2##3##(2007-9#1)(2008-10#1)
were bigger##3##2##(2007-11#1)(2007-9#1)(2008-10#1)
were bilateral##4##2##(2007-11#1)(2008-1#1)(2008-5#2)
were bilaterally##3##2##(1991-2#1)(2010-9#1)(2013-1#1)
were biologically tested##2##3##(2008-11#1)(2008-12#1)
were biologically##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
were biopsied##2##2##(1991-2#2)
were blended##2##2##(2007-11#1)(2008-10#1)
were blinded to##2##3##(2008-12#1)(2011-2#1)
were blocked by##10##3##(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#2)(1997-6#1)(2008-8#2)(2010-4#1)
were blocked in##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
were blocked##19##2##(1992-9#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#2)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-12#1)(2010-4#1)
were bonded with##3##3##(2009-7#2)(2013-1#1)
were bonded##5##2##(2008-2#1)(2009-7#2)(2009-8#1)(2013-1#1)
were borderline##2##2##(1990-2#1)(1991-6#1)
were born at the##4##4##(1990-2#1)(1991-11#1)(1995-2#1)(2008-12#1)
were born in##4##3##(1990-12#1)(1994-6#1)(2012-12#1)(2013-1#1)
were born##16##2##(1990-12#1)(1990-2#2)(1991-11#1)(1992-1#1)(1993-12#1)(1994-1#1)(1994-6#1)(1994-7#1)(1995-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
were both associated with##2##4##(2011-1#1)(2013-1#1)
were both at##2##3##(2008-10#1)(2008-8#1)
were both found to be##2##5##(1996-2#1)(2008-5#1)
were both found##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
were both immobilized on an anion-exchange column##2##7##(2008-10#2)
were both more##2##3##(2008-6#1)(2013-8#1)
were both tested##2##3##(2008-10#2)
were both##45##2##(1990-8#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-7#1)(1995-11#1)(1996-2#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
were bound to##3##3##(1990-2#1)(2008-10#2)
were bound##7##2##(1990-12#1)(1990-2#1)(1992-3#1)(2008-10#3)(2009-11#1)
were boys##2##2##(2008-12#1)(2011-2#1)
were breast-fed##2##2##(1991-11#2)
were breathing normally##2##3##(1996-3#2)
were bred##2##2##(2008-10#1)(2012-1#1)
were brought to the##2##4##(1991-11#1)(2008-3#1)
were brought##6##2##(1991-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
were built and##2##3##(2008-10#1)(2008-3#1)
were built with##2##3##(2008-10#2)
were built##10##2##(1992-12#1)(1993-11#1)(1996-3#1)(2008-10#5)(2008-3#2)
were buried in##2##3##(2008-10#2)
were buried##7##2##(2008-10#7)
were by far##2##3##(1994-11#1)(2008-11#1)
were by##4##2##(1994-11#1)(2008-10#1)(2008-11#2)
were ca##3##2##(2008-10#3)
were caged with##2##3##(2008-10#2)
were calculated after##2##3##(1997-7#1)(2008-10#1)
were calculated and compared with##2##5##(2008-10#1)(2011-1#1)
were calculated and compared##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
were calculated and the##2##4##(2008-10#1)(2013-8#1)
were calculated and##16##3##(2008-10#7)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
were calculated as##4##3##(1991-6#1)(2008-10#3)
were calculated at##2##3##(2008-10#2)
were calculated based on##3##4##(2008-10#2)(2008-7#1)
were calculated based##4##3##(2008-10#3)(2008-7#1)
were calculated by the##3##4##(1993-3#1)(2008-11#1)(2008-3#1)
were calculated by using the##2##5##(2008-10#1)(2009-1#1)
were calculated by using##3##4##(2008-10#1)(2008-7#1)(2009-1#1)
were calculated by##14##3##(1993-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
were calculated for all##2##4##(2008-10#1)(2008-2#1)
were calculated for each##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
were calculated for the##4##4##(1994-1#1)(1995-3#1)(2008-10#1)(2008-8#1)
were calculated for various##2##4##(2008-10#1)(2008-3#1)
were calculated for##28##3##(1994-1#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-8#3)(2011-2#1)(2012-12#2)(2013-1#1)
were calculated from the##5##4##(2008-10#3)(2008-11#1)(2008-2#1)
were calculated from##11##3##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-3#1)
were calculated in MPa##2##4##(2008-12#1)(2009-8#1)
were calculated in##5##3##(1995-5#1)(2008-10#1)(2008-12#1)(2009-8#1)(2012-12#1)
were calculated through##2##3##(2008-12#1)(2012-2#1)
were calculated to be##4##4##(1993-1#1)(2008-10#2)(2011-1#1)
were calculated to determine##2##4##(2007-7#1)(2008-10#1)
were calculated to##9##3##(1993-1#1)(2007-7#1)(2008-10#3)(2008-7#1)(2011-1#2)(2012-12#1)
were calculated using a##2##4##(2008-3#1)(2008-7#1)
were calculated using the equation##2##5##(2008-10#1)(2009-8#1)
were calculated using the method##2##5##(2008-10#2)
were calculated using the##13##4##(2007-11#1)(2008-10#5)(2008-11#1)(2009-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)
were calculated using##19##3##(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)
were calculated with##3##3##(2008-10#2)(2008-2#1)
were calculated##187##2##(1990-9#1)(1991-6#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(1996-12#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#82)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#7)(2008-5#3)(2008-7#7)(2008-8#4)(2009-1#1)(2009-4#1)(2009-8#3)(2010-3#4)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
were calibrated##4##2##(1993-3#1)(2008-10#2)(2008-3#1)
were called upon to##3##4##(2008-10#3)
were called##6##2##(1991-2#1)(2008-1#1)(2008-10#3)(2008-5#1)
were capable of infecting##3##4##(2008-10#3)
were capable of##20##3##(1993-11#1)(1993-12#1)(1995-6#1)(1997-8#1)(2008-10#10)(2008-11#2)(2009-12#1)(2010-5#1)(2012-2#2)
were captured by##2##3##(2011-2#2)
were captured in##4##3##(2008-10#2)(2008-5#1)(2010-8#1)
were captured##11##2##(1997-6#1)(2008-10#4)(2008-5#2)(2010-8#1)(2011-2#2)(2013-7#1)
were carefully studied##3##3##(2008-10#3)
were carefully##8##2##(2008-10#7)(2009-10#1)
were carried from##2##3##(2008-10#1)(2008-12#1)
were carried out and showed that##2##6##(2008-10#1)(2010-5#1)
were carried out and##5##4##(2008-10#2)(2008-5#2)(2010-5#1)
were carried out as##3##4##(2008-10#1)(2010-8#1)(2012-3#1)
were carried out at the##3##5##(1996-5#1)(2008-3#2)
were carried out at##16##4##(1996-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2009-8#1)
were carried out by means of##3##6##(1991-5#1)(2007-11#1)(2007-12#1)
were carried out by using##2##5##(2008-10#2)
were carried out by##19##4##(1991-5#2)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-3#1)(2008-5#1)
were carried out during##2##4##(2008-5#1)(2008-8#1)
were carried out for##5##4##(2007-7#1)(2008-10#2)(2008-7#1)(2012-2#1)
were carried out in a##9##5##(1992-3#1)(2008-10#5)(2008-7#1)(2013-1#2)
were carried out in aqueous##2##5##(2008-10#1)(2008-6#1)
were carried out in order to##3##6##(1992-6#1)(2008-10#2)
were carried out in the presence of##2##7##(2008-4#1)(2011-2#1)
were carried out in the##8##5##(1995-12#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)
were carried out in##46##4##(1990-6#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-7#1)(1995-12#1)(1997-1#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
were carried out on the##7##5##(2007-6#1)(2008-10#4)(2008-5#1)(2009-12#1)
were carried out on##17##4##(1994-5#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#2)(2009-12#1)(2010-2#2)(2011-2#1)
were carried out over the##2##5##(2008-10#2)
were carried out to assess##2##5##(2008-5#1)(2013-1#1)
were carried out to clarify the##2##6##(2008-6#1)(2010-5#1)
were carried out to determine the influence of##2##8##(2008-5#1)(2011-2#1)
were carried out to determine the##6##6##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
were carried out to determine##7##5##(1991-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
were carried out to evaluate the##2##6##(2008-10#1)(2008-12#1)
were carried out to investigate the##3##6##(2008-2#1)(2008-5#1)(2009-6#1)
were carried out to study##2##5##(2008-11#1)(2008-5#1)
were carried out to##37##4##(1991-8#1)(1996-7#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#4)(2008-5#5)(2008-6#2)(2009-6#1)(2009-7#1)(2010-2#3)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#2)
were carried out under##4##4##(2007-11#1)(2008-10#2)(2011-2#1)
were carried out using a##6##5##(2008-10#3)(2008-6#1)(2010-8#1)(2013-1#1)
were carried out using the##2##5##(2008-10#1)(2012-2#1)
were carried out using two##2##5##(2008-10#1)(2008-5#1)
were carried out using##20##4##(2007-12#1)(2008-10#12)(2008-5#1)(2008-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
were carried out with an##2##5##(1991-6#1)(2008-5#1)
were carried out with this##2##5##(1990-8#1)(2008-10#1)
were carried out with##19##4##(1990-8#1)(1991-6#1)(1993-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
were carried out##234##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#9)(2007-12#6)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#87)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#18)(2008-6#8)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#5)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
were carried##240##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#9)(2007-12#6)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#89)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#19)(2008-6#8)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#5)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
were carriers of##3##3##(2013-1#1)(2013-8#2)
were carriers##5##2##(1990-11#1)(2008-9#1)(2013-1#1)(2013-8#2)
were carrying##2##2##(2008-10#1)(2011-2#1)
were cast onto##2##3##(2008-10#2)
were cast##3##2##(2008-10#3)
were categorised as##4##3##(1994-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
were categorised##8##2##(1994-7#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
were categorized as##3##3##(2008-1#1)(2013-1#2)
were categorized by##2##3##(2010-10#1)(2013-3#1)
were categorized into three groups##2##5##(2008-10#1)(2012-2#1)
were categorized into two groups##2##5##(1995-12#1)(2008-10#1)
were categorized into##4##3##(1995-12#1)(2008-10#2)(2012-2#1)
were categorized##13##2##(1995-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-3#1)
were caught by##2##3##(1995-3#1)(2013-7#1)
were caught##4##2##(1995-3#1)(2008-7#1)(2008-8#1)(2013-7#1)
were caused by##14##3##(1990-6#1)(1994-12#1)(1996-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
were caused##16##2##(1990-6#1)(1991-5#1)(1994-12#1)(1996-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-3#1)(2011-1#2)(2011-2#1)(2013-8#1)
were certified##2##2##(1991-9#1)(2012-12#1)
were challenged by##3##3##(1993-12#1)(1997-6#1)(2008-10#1)
were challenged with the##2##4##(1991-8#1)(2008-10#1)
were challenged with##12##3##(1991-8#3)(1993-12#1)(2008-10#7)(2008-9#1)
were challenged##19##2##(1991-8#3)(1993-12#2)(1997-1#1)(1997-6#1)(2008-10#11)(2008-9#1)
were changed by##2##3##(1995-5#1)(2008-10#1)
were changed in the##2##4##(1995-1#1)(2010-1#1)
were changed to##2##3##(1993-8#1)(2011-2#1)
were changed##9##2##(1990-6#1)(1993-8#1)(1995-1#1)(1995-5#1)(2008-10#2)(2008-4#1)(2010-1#1)(2011-2#1)
were changes in the##2##4##(1990-5#1)(2008-10#1)
were changes in##5##3##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
were changes##6##2##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
were characterised##9##2##(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#1)(2012-12#1)
were characteristic for##2##3##(1997-3#1)(2011-2#1)
were characteristic##5##2##(1992-8#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
were characterized and the##2##4##(2008-10#1)(2008-9#1)
were characterized and##13##3##(1995-12#1)(1996-10#1)(1996-8#1)(2008-10#4)(2008-11#2)(2008-9#1)(2012-2#2)(2013-7#1)
were characterized as##6##3##(1992-3#1)(1997-3#1)(2008-10#3)(2008-8#1)
were characterized based on##2##4##(2008-10#2)
were characterized by a##3##4##(1995-12#1)(2008-10#1)(2008-12#1)
were characterized by an##2##4##(2008-10#1)(2009-11#1)
were characterized by determining##2##4##(2008-10#1)(2008-8#1)
were characterized by elemental##2##4##(1996-2#1)(2008-5#1)
were characterized by mating type##2##5##(2008-10#2)
were characterized by means of##3##5##(2008-10#2)(2009-8#1)
were characterized by pathogenicity##3##4##(2008-10#3)
were characterized by relatively##2##4##(2008-12#1)(2010-4#1)
were characterized by restriction##2##4##(1992-3#1)(2008-10#1)
were characterized by the##3##4##(2008-10#3)
were characterized by their##2##4##(1994-9#1)(2008-10#1)
were characterized by use of##2##5##(2007-11#1)(2013-1#1)
were characterized by using##3##4##(2007-11#1)(2008-5#1)(2009-9#1)
were characterized by various molecular methods and##3##7##(2008-10#3)
were characterized by various molecular methods##4##6##(2008-10#4)
were characterized by##79##3##(1990-7#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(2007-11#4)(2007-12#1)(2008-10#35)(2008-12#2)(2008-5#5)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#5)(2013-8#1)
were characterized first##2##3##(1990-9#1)(2008-5#1)
were characterized for##11##3##(1992-9#1)(1993-6#1)(1995-11#1)(2008-10#7)(2012-2#1)
were characterized in terms of##2##5##(2008-10#1)(2008-5#1)
were characterized in##12##3##(1992-12#1)(1994-8#1)(1995-2#1)(2008-10#5)(2008-5#1)(2012-12#2)(2013-8#1)
were characterized on the basis of##2##6##(2008-10#1)(2010-3#1)
were characterized using vegetative compatibility group (VCG)##2##7##(2008-10#2)
were characterized using##14##3##(2008-10#12)(2008-8#1)(2008-9#1)
were characterized with##4##3##(1990-8#1)(1994-12#1)(2008-10#2)
were characterized##168##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#4)(2007-12#2)(2008-10#82)(2008-11#4)(2008-12#2)(2008-5#7)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#2)
were checked for##2##3##(2007-7#1)(2008-5#1)
were checked on##2##3##(2008-10#2)
were checked using##2##3##(2008-10#2)
were checked##13##2##(2006-8#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-3#2)(2012-12#1)(2012-3#1)
were chemically and##2##3##(2010-4#1)(2012-12#1)
were chemically##7##2##(1995-3#1)(2007-11#1)(2008-10#2)(2010-4#1)(2012-12#1)(2012-2#1)
were children##2##2##(2007-12#1)(2007-7#1)
were chosen and##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
were chosen as model##2##4##(2008-10#2)
were chosen as the##2##4##(2008-10#1)(2008-4#1)
were chosen as##13##3##(1993-8#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#8)(2008-4#1)
were chosen at##2##3##(2008-3#1)(2011-2#1)
were chosen based on##2##4##(2008-10#1)(2010-6#1)
were chosen because they##2##4##(1993-12#1)(1996-2#1)
were chosen by##3##3##(2008-10#2)(2013-1#1)
were chosen for each##2##4##(2008-10#1)(2009-2#1)
were chosen for##8##3##(1996-8#1)(2007-12#1)(2008-10#3)(2009-2#1)(2011-2#1)(2012-1#1)
were chosen from the##3##4##(1996-7#1)(2008-10#1)(2008-8#1)
were chosen from##5##3##(1996-7#1)(2008-10#2)(2008-8#1)(2012-3#1)
were chosen in##4##3##(1994-2#1)(2008-10#2)(2013-7#1)
were chosen to be##2##4##(2008-10#2)
were chosen to##9##3##(1993-6#1)(1995-5#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)
were chosen##64##2##(1992-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
were chromatographed##3##2##(1990-8#2)(2008-10#1)
were chronic##4##2##(1997-4#1)(2007-2#1)(2008-5#1)(2012-12#1)
were chronically##2##2##(1991-12#1)(1992-5#1)
were cinnabar##2##2##(2008-10#1)(2008-5#1)
were clarified##2##2##(1994-5#1)(2008-8#1)
were classified according to the##5##5##(1991-8#1)(1994-9#1)(2007-8#1)(2008-2#1)(2012-3#1)
were classified according to##9##4##(1991-8#1)(1994-9#1)(1996-3#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
were classified as cases##2##4##(2008-12#1)(2010-4#1)
were classified as having##2##4##(1995-11#1)(1996-12#1)
were classified as##45##3##(1990-8#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-8#3)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#2)(2008-5#3)(2008-7#2)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
were classified by##8##3##(1995-12#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
were classified in four##2##4##(1992-6#1)(2013-7#1)
were classified in##4##3##(1990-9#1)(1992-6#1)(2008-10#1)(2013-7#1)
were classified into 3##2##4##(2007-10#1)(2011-1#1)
were classified into four##2##4##(2008-10#1)(2009-12#1)
were classified into one##2##4##(2008-10#1)(2009-5#1)
were classified into six##2##4##(2008-10#1)(2008-11#1)
were classified into three groups##3##5##(1997-6#1)(2010-4#1)(2013-8#1)
were classified into three##5##4##(1990-12#1)(1997-6#1)(2008-10#1)(2010-4#1)(2013-8#1)
were classified into two##3##4##(1994-2#1)(2008-10#2)
were classified into##29##3##(1990-12#1)(1994-2#1)(1997-6#2)(2007-10#3)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2013-8#1)
were classified with##2##3##(2008-10#1)(2010-8#1)
were classified##101##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-6#2)(1997-8#1)(2006-12#1)(2007-10#6)(2007-12#1)(2007-8#3)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
were cleared##2##2##(1992-12#1)(2011-1#1)
were clearly different##2##3##(2008-10#1)(2008-5#1)
were clearly differentiated##2##3##(2008-10#2)
were clearly##23##2##(1992-12#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
were clinical##2##2##(2010-6#1)(2012-3#1)
were clinically improved##2##3##(2008-5#2)
were clinically significant##2##3##(1997-8#1)(2012-3#1)
were clinically##10##2##(1990-9#1)(1992-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)(2012-12#1)(2012-3#1)
were clinicians##2##2##(1995-2#1)(2008-5#1)
were cloned and expressed in Escherichia coli##2##7##(1997-3#1)(2008-10#1)
were cloned and sequenced##13##4##(1992-6#1)(1993-12#1)(1994-12#1)(2008-10#8)(2008-5#1)(2008-8#1)
were cloned and##22##3##(1992-10#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-8#1)(1997-3#2)(2008-10#10)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)
were cloned from a##3##4##(1993-3#1)(1994-11#1)(2008-10#1)
were cloned from human##2##4##(1993-11#1)(1995-6#1)
were cloned from##14##3##(1990-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-6#1)(2010-5#1)
were cloned in##3##3##(1992-9#1)(2008-8#1)(2010-10#1)
were cloned into the##2##4##(2008-8#2)
were cloned into##7##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-6#1)
were cloned using##2##3##(1996-10#1)(2010-6#1)
were cloned##53##2##(1990-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-3#2)(1997-6#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-6#2)
were close to 100%##4##4##(2008-10#4)
were close to those obtained##2##5##(2008-10#2)
were close to those##3##4##(2008-10#2)(2008-8#1)
were close to##12##3##(1992-2#1)(2008-10#7)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)
were closed##2##2##(1997-8#1)(2013-8#1)
were closely associated with the##3##5##(1990-5#1)(2008-10#2)
were closely associated with##4##4##(1990-5#1)(2008-10#3)
were closely correlated##2##3##(1990-5#1)(1992-5#1)
were closely linked to##2##4##(2008-10#2)
were closely linked##3##3##(2008-10#2)(2008-8#1)
were closely related to##5##4##(2007-10#1)(2007-6#1)(2008-10#2)(2008-12#1)
were closely related##8##3##(2007-10#1)(2007-6#1)(2008-10#4)(2008-12#1)(2010-12#1)
were closely##24##2##(1990-5#2)(1991-12#1)(1991-8#1)(1992-5#1)(2007-10#1)(2007-6#1)(2008-10#10)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)
were closer to the##2##4##(2009-5#1)(2011-1#1)
were clustered into##3##3##(2008-10#2)(2011-1#1)
were clustered within##2##3##(1996-6#1)(2013-1#1)
were clustered##13##2##(1996-6#1)(2008-10#7)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
were co-cultured##2##2##(2008-5#1)(2012-4#1)
were co-immobilized##2##2##(2008-10#1)(2008-6#1)
were co-inoculated##5##2##(2008-10#5)
were co-transfected##2##2##(1994-9#1)(2008-11#1)
were coated with##4##3##(1990-12#1)(1994-3#1)(2008-10#2)
were coated##6##2##(1990-12#1)(1994-3#1)(2008-10#3)(2009-7#1)
were cocultured##2##2##(2008-10#1)(2008-8#1)
were coded##6##2##(1996-1#1)(2008-12#1)(2009-5#1)(2012-12#2)(2012-3#1)
were coinoculated with##4##3##(2008-10#4)
were coinoculated##5##2##(2008-10#5)
were collapsed##4##2##(2008-10#1)(2012-3#3)
were collated##2##2##(2008-6#1)(2013-8#1)
were collected and analyzed by the##2##6##(2008-10#1)(2013-8#1)
were collected and analyzed for##2##5##(2008-7#1)(2012-3#1)
were collected and analyzed##8##4##(1992-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
were collected and the##3##4##(2007-5#1)(2008-11#1)(2011-1#1)
were collected and their##3##4##(2008-5#2)(2009-5#1)
were collected and##26##3##(1992-1#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
were collected as a##2##4##(2008-10#1)(2012-12#1)
were collected as##5##3##(1996-3#1)(2008-10#2)(2008-11#1)(2012-12#1)
were collected at baseline and##2##5##(2008-3#1)(2011-1#1)
were collected at different##2##4##(2008-10#1)(2012-1#1)
were collected at the##5##4##(1995-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
were collected at##20##3##(1991-6#1)(1995-2#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#3)
were collected between##3##3##(2008-5#1)(2010-10#1)(2011-2#1)
were collected by means of##3##5##(1992-5#1)(2009-12#1)(2010-3#1)
were collected by using##2##4##(2008-10#1)(2013-1#1)
were collected by##17##3##(1990-8#1)(1992-3#1)(1992-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2009-12#1)(2010-3#1)(2011-2#3)(2013-1#2)
were collected during 1994##2##4##(2008-10#2)
were collected during a##2##4##(1991-6#1)(1993-2#1)
were collected during the period##2##5##(1994-9#1)(2013-8#1)
were collected during the##4##4##(1994-9#1)(2007-12#1)(2010-8#1)(2013-8#1)
were collected during##11##3##(1991-6#1)(1993-2#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2010-8#1)(2013-8#1)
were collected for a##4##4##(1994-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
were collected for analysis##2##4##(2008-10#1)(2012-2#1)
were collected for each##2##4##(2008-10#1)(2008-11#1)
were collected for##20##3##(1994-3#1)(1995-3#1)(1995-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
were collected from 1##4##4##(2008-10#3)(2009-7#1)
were collected from 150##2##4##(2008-6#1)(2010-3#1)
were collected from 58##3##4##(2008-12#1)(2009-11#1)(2010-11#1)
were collected from 90##2##4##(2011-1#1)(2013-8#1)
were collected from a##5##4##(2007-8#1)(2008-12#1)(2010-3#1)(2010-5#1)(2012-12#1)
were collected from different##4##4##(2008-10#3)(2013-8#1)
were collected from each##2##4##(2007-5#1)(2008-10#1)
were collected from five##3##4##(2008-10#2)(2013-1#1)
were collected from four##2##4##(2008-10#1)(2011-2#1)
were collected from patients##3##4##(1991-7#1)(2010-8#1)(2012-3#1)
were collected from ten##3##4##(2010-4#1)(2012-2#1)(2013-7#1)
were collected from the field##2##5##(2008-10#2)
were collected from the##15##4##(1991-6#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
were collected from three##2##4##(2008-10#1)(2008-5#1)
were collected from##133##3##(1990-3#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-6#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-5#4)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#1)(2008-12#10)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#7)
were collected in four##2##4##(1994-6#1)(2008-10#1)
were collected in the##11##4##(1992-8#1)(1994-9#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2013-1#1)
were collected in two##2##4##(2008-10#1)(2008-11#1)
were collected in##31##3##(1990-6#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-12#2)(2007-10#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
were collected monthly##2##3##(2008-10#1)(2013-7#1)
were collected on##11##3##(1993-6#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-4#1)(2012-3#1)
were collected over a##2##4##(2008-10#1)(2012-2#1)
were collected over two##2##4##(2008-4#1)(2010-8#1)
were collected over##6##3##(2007-6#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-2#1)
were collected prospectively##3##3##(1996-11#1)(2007-8#1)(2011-2#1)
were collected randomly from##2##4##(2008-10#1)(2008-12#1)
were collected randomly##3##3##(1997-6#1)(2008-10#1)(2008-12#1)
were collected through##10##3##(1994-2#1)(1996-1#1)(2010-10#1)(2012-1#1)(2012-3#3)(2013-7#1)(2013-8#2)
were collected to determine##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
were collected to##8##3##(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
were collected using a##3##4##(2008-10#1)(2010-6#1)(2013-1#1)
were collected using##9##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-6#1)(2013-1#2)
were collected via##3##3##(1991-8#2)(2011-2#1)
were collected while##2##3##(2008-10#1)(2008-11#1)
were collected with##6##3##(2007-12#1)(2008-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
were collected within##2##3##(2008-10#1)(2012-2#1)
were collected##403##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#3)(1997-2#2)(1997-6#2)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#94)(2008-11#11)(2008-12#21)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#25)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#5)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#6)(2011-1#14)(2011-2#23)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#9)(2012-3#12)(2013-1#24)(2013-7#11)(2013-8#16)
were colocalised in##2##3##(1997-3#2)
were colonized by the##2##4##(2008-10#2)
were colonized by##8##3##(1991-3#1)(2008-10#7)
were colonized##10##2##(1991-3#1)(2008-10#8)(2013-1#1)
were combined and analyzed##2##4##(2008-10#1)(2012-3#1)
were combined and##5##3##(2008-10#3)(2008-5#1)(2012-3#1)
were combined for##2##3##(2008-10#2)
were combined in the##2##4##(2008-10#2)
were combined in##4##3##(2008-10#4)
were combined to##7##3##(1991-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2011-1#1)(2013-8#1)
were combined with a##2##4##(2008-5#1)(2009-9#1)
were combined with##9##3##(1992-3#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-7#1)(2009-9#1)
were combined##36##2##(1990-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-5#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
were comfortable##2##2##(2008-11#1)(2009-5#1)
were common findings##2##3##(2007-10#1)(2011-2#1)
were common in the##2##4##(1997-3#1)(2012-12#1)
were common in##9##3##(1997-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-12#1)(2012-3#1)
were common to both##2##4##(2008-10#1)(2008-5#1)
were common to##5##3##(2008-10#1)(2008-2#1)(2008-5#2)(2012-2#1)
were common##22##2##(1997-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#4)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
were commonly isolated from##2##4##(2008-10#2)
were commonly isolated##3##3##(2008-10#3)
were commonly##7##2##(2008-10#6)(2012-3#1)
were community acquired##2##3##(2012-3#1)(2013-8#1)
were comparable and##2##3##(1992-6#1)(1995-5#1)
were comparable between##2##3##(2008-12#1)(2010-3#1)
were comparable in both##2##4##(2008-10#2)
were comparable in terms of##2##5##(1995-6#1)(2008-5#1)
were comparable in##7##3##(1995-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2009-11#1)(2013-1#1)
were comparable to that of##2##5##(2008-10#2)
were comparable to the##3##4##(2006-10#1)(2008-10#1)(2010-5#1)
were comparable to those obtained by##3##6##(2008-10#2)(2008-5#1)
were comparable to those obtained##4##5##(2008-10#3)(2008-5#1)
were comparable to those of the##2##6##(1991-12#1)(2008-10#1)
were comparable to those of##4##5##(1991-12#1)(2008-10#2)(2008-5#1)
were comparable to those##16##4##(1990-5#1)(1991-12#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#1)
were comparable to##30##3##(1990-5#1)(1991-12#1)(1993-12#2)(2006-10#1)(2008-10#16)(2008-11#3)(2008-5#2)(2008-8#2)(2010-5#1)(2013-1#1)
were comparable with respect to##2##5##(2008-10#1)(2011-2#1)
were comparable with those obtained by##3##6##(1997-7#1)(2008-10#2)
were comparable with those obtained##5##5##(1997-7#1)(2008-10#4)
were comparable with those##6##4##(1997-7#1)(2008-10#4)(2008-3#1)
were comparable with##14##3##(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
were comparable##71##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-12#2)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#2)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
were comparatively##3##2##(1991-8#1)(1992-9#1)(2008-10#1)
were compared according to##3##4##(2008-7#1)(2010-5#1)(2013-1#1)
were compared among##4##3##(1995-6#1)(2008-10#2)(2012-2#1)
were compared and discussed##3##4##(2008-10#3)
were compared and it was##2##5##(2008-10#1)(2008-3#1)
were compared and the##2##4##(2008-10#1)(2008-11#1)
were compared and##14##3##(1996-5#1)(2008-10#8)(2008-11#3)(2008-3#1)(2013-8#1)
were compared as##2##3##(2008-10#1)(2008-3#1)
were compared at##2##3##(1994-11#1)(2007-10#1)
were compared between the groups##2##5##(1995-4#1)(2011-2#1)
were compared between the two groups##2##6##(1996-2#1)(2011-2#1)
were compared between the##5##4##(1995-4#1)(1996-2#1)(2008-5#1)(2011-2#2)
were compared between##15##3##(1995-4#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#3)(2012-5#1)(2013-1#1)
were compared by##8##3##(1991-12#1)(1993-2#1)(1997-6#1)(2008-10#4)(2013-1#1)
were compared for each##2##4##(2008-3#1)(2011-2#1)
were compared for the##7##4##(1990-8#1)(1996-12#1)(2007-2#1)(2008-10#4)
were compared for their capacities to protect immunodeficient##2##8##(2008-5#2)
were compared for their##5##4##(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
were compared for##25##3##(1990-8#2)(1991-1#1)(1993-9#1)(1996-12#1)(1997-7#1)(2007-2#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#3)(2011-2#1)(2012-3#1)
were compared in different##3##4##(2008-12#1)(2008-8#1)(2012-12#1)
were compared in terms of##2##5##(2008-10#2)
were compared in##21##3##(1994-2#1)(1996-12#1)(1996-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-12#2)(2012-3#1)
were compared on##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
were compared statistically##2##3##(1994-3#1)(2008-10#1)
were compared to a##4##4##(1994-2#1)(1995-11#1)(1996-9#1)(2008-9#1)
were compared to determine the##2##5##(2010-1#1)(2010-8#1)
were compared to determine##3##4##(2010-1#1)(2010-8#1)(2011-2#1)
were compared to evaluate##2##4##(2013-1#1)(2013-8#1)
were compared to identify##2##4##(2008-9#1)(2011-2#1)
were compared to that of##2##5##(2008-10#2)
were compared to the data published##2##6##(2008-7#1)(2013-1#1)
were compared to the reference##2##5##(2008-10#2)
were compared to the##19##4##(1990-5#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-9#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
were compared to those obtained by the##2##7##(2008-10#2)
were compared to those obtained by using##2##7##(2008-10#1)(2010-4#1)
were compared to those obtained by##5##6##(2008-10#4)(2010-4#1)
were compared to those obtained with##2##6##(1994-9#1)(2008-10#1)
were compared to those obtained##8##5##(1994-9#1)(2008-10#6)(2010-4#1)
were compared to those of the##2##6##(1995-2#1)(2008-10#1)
were compared to those of##7##5##(1990-9#1)(1995-2#1)(2008-10#2)(2010-4#2)(2011-2#1)
were compared to those who##2##5##(1994-1#1)(2007-2#1)
were compared to those##21##4##(1990-9#1)(1991-4#1)(1994-1#1)(1994-9#1)(1995-2#1)(2007-2#1)(2008-10#9)(2008-12#1)(2008-8#1)(2010-4#3)(2011-2#1)
were compared to##87##3##(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-11#1)(1995-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#2)(2008-10#19)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-7#1)(2010-1#1)(2010-10#2)(2010-4#5)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
were compared using a##3##4##(1997-4#1)(2008-10#2)
were compared using##15##3##(1992-8#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#8)(2009-3#1)(2010-12#1)(2012-12#1)
were compared when##2##3##(2008-8#1)(2008-9#1)
were compared with 200 hospital visitor controls##2##7##(1993-9#2)
were compared with P##2##4##(2008-10#2)
were compared with a sample of##2##6##(2010-2#1)(2013-8#1)
were compared with a##14##4##(1991-8#1)(1997-1#1)(2008-10#6)(2008-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
were compared with conventional##2##4##(2008-10#2)
were compared with each other and##2##6##(2008-10#2)
were compared with each other##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
were compared with findings in##2##5##(1990-12#1)(1990-6#1)
were compared with one another##2##5##(2008-10#1)(2013-1#1)
were compared with other##5##4##(1993-11#1)(2008-10#2)(2012-2#1)(2013-8#1)
were compared with previous##2##4##(2008-11#1)(2012-3#1)
were compared with reference strains of##2##6##(2008-10#2)
were compared with respect to the##2##6##(1994-12#1)(2012-12#1)
were compared with respect to##5##5##(1992-10#1)(1994-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
were compared with results from##2##5##(2008-3#1)(2011-2#1)
were compared with results obtained##2##5##(2006-6#1)(2008-10#1)
were compared with results##4##4##(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
were compared with that of the##2##6##(1997-2#1)(2012-2#1)
were compared with that of##3##5##(1997-2#1)(2008-10#1)(2012-2#1)
were compared with that##4##4##(1997-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
were compared with the control group##2##6##(1994-3#1)(2007-11#1)
were compared with the results obtained using##2##7##(2008-10#2)
were compared with the results obtained##3##6##(2008-10#3)
were compared with the results##4##5##(2008-10#3)(2008-7#1)
were compared with the values##2##5##(2008-10#1)(2008-6#1)
were compared with the##46##4##(1992-10#1)(1992-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#2)(2013-8#3)
were compared with those from##5##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
were compared with those in##3##5##(2008-10#2)(2012-1#1)
were compared with those obtained by a##3##7##(2008-10#2)(2008-2#1)
were compared with those obtained by the##3##7##(2008-10#3)
were compared with those obtained by##12##6##(2008-10#10)(2008-2#1)(2008-3#1)
were compared with those obtained using##5##6##(2008-10#5)
were compared with those obtained with##4##6##(2008-10#3)(2008-6#1)
were compared with those obtained##23##5##(1996-5#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-6#1)
were compared with those of a##2##6##(1994-8#1)(2008-10#1)
were compared with those of other##2##6##(2008-10#1)(2008-7#1)
were compared with those of the##5##6##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
were compared with those of two##2##6##(2008-10#1)(2009-4#1)
were compared with those of##24##5##(1990-5#1)(1991-3#1)(1994-8#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-8#1)
were compared with those##69##4##(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-8#1)(1996-5#2)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#41)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
were compared with##263##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#103)(2008-11#10)(2008-12#3)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#7)
were compared##589##2##(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#4)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#7)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-2#3)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#215)(2008-11#20)(2008-12#6)(2008-2#9)(2008-3#21)(2008-4#3)(2008-5#15)(2008-6#6)(2008-7#19)(2008-8#9)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#20)(2012-1#3)(2012-12#6)(2012-2#15)(2012-3#8)(2012-4#1)(2012-5#1)(2013-1#12)(2013-8#13)
were compatible with the##2##4##(1990-8#1)(2008-7#1)
were compatible with##10##3##(1990-8#1)(1991-8#2)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
were compatible##11##2##(1990-8#1)(1991-8#2)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-2#1)
were competent##2##2##(1992-12#1)(2008-11#1)
were competitive inhibitors##2##3##(1991-5#1)(1994-5#1)
were competitive##4##2##(1990-5#1)(1991-5#1)(1992-9#1)(1994-5#1)
were complementary to##2##3##(2008-10#2)
were complemented with##3##3##(2008-6#1)(2009-10#1)(2013-7#1)
were complemented##4##2##(1991-12#1)(2008-6#1)(2009-10#1)(2013-7#1)
were complete##2##2##(2008-6#1)(2008-9#1)
were completed by the##2##4##(2006-10#1)(2008-10#1)
were completed by##7##3##(2006-10#1)(2008-10#2)(2008-4#2)(2011-2#1)(2013-1#1)
were completed for##2##3##(2007-12#1)(2012-1#1)
were completed in##6##3##(1991-11#2)(2008-5#2)(2008-8#1)(2011-2#1)
were completed##26##2##(1991-11#2)(1993-12#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-8#1)(2010-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
were completely abolished##2##3##(1990-5#1)(1997-6#1)
were completely blocked by##2##4##(1990-7#1)(1994-9#1)
were completely eliminated##2##3##(2008-8#1)(2010-2#1)
were completely or##2##3##(2008-10#1)(2008-9#1)
were completely resistant##2##3##(2008-10#2)
were completely separated##5##3##(1997-2#1)(2008-10#3)(2011-1#1)
were completely##49##2##(1990-5#2)(1990-7#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-9#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were complex##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-4#1)
were complexed with##2##3##(1996-2#1)(2008-10#1)
were composed of##10##3##(1991-6#1)(1991-8#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
were composed##12##2##(1991-6#1)(1991-8#1)(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
were compressed##4##2##(1992-7#1)(2007-11#1)(2010-5#1)(2013-8#1)
were comprised of##3##3##(1997-5#1)(2008-10#1)(2008-5#1)
were computed and##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
were computed for##2##3##(2008-10#1)(2010-12#1)
were computed from##2##3##(2008-5#1)(2009-6#1)
were computed to##2##3##(2009-3#1)(2012-2#1)
were computed##17##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
were computer##2##2##(2007-11#1)(2008-5#1)
were concentrated by##4##3##(1996-12#1)(2008-10#3)
were concentrated in the##2##4##(1993-12#1)(1996-5#1)
were concentrated in##5##3##(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#2)
were concentrated on##2##3##(2008-10#1)(2008-5#1)
were concentrated##15##2##(1993-12#1)(1993-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(2008-10#8)(2008-11#1)(2008-5#1)
were concerned about their##2##4##(1995-6#1)(2013-8#1)
were concerned about##5##3##(1995-6#3)(2013-8#2)
were concerned##12##2##(1990-10#1)(1991-6#1)(1995-6#3)(2007-5#1)(2007-7#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
were concordant with the##2##4##(2008-10#1)(2010-12#1)
were concordant##3##2##(2008-10#1)(2010-12#2)
were conditioned##4##2##(2008-10#3)(2011-1#1)
were conducted after##2##3##(2008-10#1)(2008-8#1)
were conducted and##5##3##(1991-12#1)(2008-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
were conducted at 25 degrees C##2##6##(2008-10#2)
were conducted at##13##3##(2007-5#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-6#1)
were conducted by##7##3##(1993-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
were conducted during##3##3##(1990-8#1)(2007-5#1)(2008-10#1)
were conducted for##3##3##(2008-12#1)(2008-6#1)(2013-1#1)
were conducted from##4##3##(2008-10#1)(2009-12#1)(2009-4#1)(2013-7#1)
were conducted in 1997##2##4##(2008-10#2)
were conducted in July##2##4##(1992-12#1)(2008-10#1)
were conducted in order to##2##5##(2008-10#1)(2012-3#1)
were conducted in the##2##4##(1993-8#1)(2008-4#1)
were conducted in##42##3##(1991-9#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
were conducted on the##3##4##(2008-10#1)(2008-3#1)(2010-10#1)
were conducted on##9##3##(2008-10#5)(2008-3#1)(2009-8#1)(2010-10#1)(2011-1#1)
were conducted to assess the impact of##2##7##(2008-10#2)
were conducted to assess##3##4##(2008-10#2)(2010-8#1)
were conducted to compare the##2##5##(1991-5#1)(2008-3#1)
were conducted to determine the##4##5##(2008-10#2)(2010-11#1)(2011-2#1)
were conducted to determine whether##2##5##(1995-2#1)(2008-10#1)
were conducted to determine##10##4##(1991-5#1)(1992-3#1)(1995-2#1)(2008-10#4)(2010-11#1)(2011-2#2)
were conducted to establish the##2##5##(1996-2#1)(2008-10#1)
were conducted to evaluate the##2##5##(2008-10#2)
were conducted to evaluate##3##4##(2008-10#2)(2012-12#1)
were conducted to examine the##2##5##(1996-1#1)(2008-11#1)
were conducted to examine##3##4##(1996-1#1)(2008-11#1)(2013-1#1)
were conducted to identify##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
were conducted to investigate the##4##5##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)
were conducted to measure##2##4##(2008-10#1)(2008-12#1)
were conducted to study the##5##5##(2008-10#4)(2008-12#1)
were conducted to test if##2##5##(2008-11#1)(2008-8#1)
were conducted to test##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
were conducted to##48##3##(1991-5#2)(1992-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)
were conducted using a##4##4##(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
were conducted using##10##3##(1991-12#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
were conducted with a##4##4##(1997-3#1)(2008-12#1)(2008-5#1)(2010-4#1)
were conducted with##38##3##(1991-8#1)(1995-1#1)(1996-1#1)(1997-3#2)(2007-12#2)(2008-10#7)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
were conducted##208##2##(1990-8#1)(1991-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-3#2)(2007-11#1)(2007-12#3)(2007-5#3)(2008-1#1)(2008-10#67)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#5)
were confined to the##5##4##(1992-8#1)(2008-10#1)(2008-5#1)(2008-7#2)
were confined to##8##3##(1992-8#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)
were confined##10##2##(1992-8#1)(1995-1#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
were confirmed and##2##3##(2008-10#1)(2011-2#1)
were confirmed as##3##3##(1992-11#1)(2010-8#1)(2011-2#1)
were confirmed at##2##3##(2008-10#1)(2011-2#1)
were confirmed by elemental##2##4##(2007-11#2)
were confirmed by the##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
were confirmed by##33##3##(1990-11#1)(1990-2#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
were confirmed for##2##3##(1997-2#1)(2009-6#1)
were confirmed in a##2##4##(1992-11#1)(2008-11#1)
were confirmed in##5##3##(1992-11#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#1)
were confirmed to be##3##4##(2008-10#2)(2013-1#1)
were confirmed to contain##2##4##(1996-12#1)(2008-5#1)
were confirmed to##10##3##(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#2)
were confirmed using##4##3##(1990-6#1)(1992-3#1)(2008-5#2)
were confirmed with##7##3##(2008-10#2)(2008-8#1)(2010-12#1)(2011-3#2)(2012-12#1)
were confirmed##80##2##(1990-11#1)(1990-2#1)(1990-6#1)(1992-11#2)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#3)(2012-12#2)(2012-2#1)(2013-1#4)
were congruent with##2##3##(2008-10#1)(2009-11#1)
were conjugated##3##2##(1995-2#1)(2008-5#1)(2012-12#1)
were connected in series##2##4##(2008-10#1)(2011-1#1)
were connected with the##2##4##(2007-11#2)
were connected with##5##3##(1990-2#1)(2007-11#2)(2008-12#1)(2011-2#1)
were connected##10##2##(1990-2#1)(2007-11#2)(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
were consecutively##2##2##(1996-9#1)(2008-10#1)
were conserved##7##2##(1993-2#1)(1994-11#1)(1994-9#1)(1995-8#1)(2008-10#2)(2008-5#1)
were considerable##4##2##(1990-9#1)(1994-9#1)(1995-12#1)(1996-1#1)
were considerably different##2##3##(2008-3#1)(2008-7#1)
were considerably##8##2##(1992-8#1)(1992-9#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
were considered and analyzed##2##4##(2012-3#1)(2013-1#1)
were considered and##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
were considered appropriate##2##3##(2010-12#2)
were considered as chemical descriptors to##2##6##(2008-10#2)
were considered as chemical descriptors##3##5##(2008-10#3)
were considered as##22##3##(1991-2#1)(1991-4#1)(1992-10#1)(1992-9#1)(1996-2#1)(1997-2#1)(2008-10#6)(2008-12#2)(2008-5#3)(2008-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
were considered at##2##3##(1990-5#1)(1996-1#1)
were considered for##5##3##(2008-10#2)(2010-8#1)(2012-12#1)(2013-1#1)
were considered good##2##3##(2007-8#1)(2011-2#1)
were considered in##2##3##(1994-3#1)(2008-10#1)
were considered normal##2##3##(2008-7#1)(2012-2#1)
were considered poor##2##3##(1991-3#1)(2012-12#1)
were considered significant##5##3##(1995-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
were considered the most reliable##2##5##(1993-12#2)
were considered the##4##3##(1993-12#2)(2008-10#1)(2008-7#1)
were considered to be related to##2##6##(1996-10#1)(2008-9#1)
were considered to be##15##4##(1990-10#1)(1991-6#1)(1994-6#1)(1996-10#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-1#1)(2012-2#1)
were considered to have##3##4##(1996-12#1)(2008-2#1)(2008-3#1)
were considered to##22##3##(1990-10#1)(1991-6#1)(1994-6#1)(1996-10#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)
were considered##132##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-9#1)(1993-12#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#26)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#6)(2008-7#7)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-10#1)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#2)
were consistent across##3##3##(1993-9#1)(2009-7#1)(2011-1#1)
were consistent between AxB(I) and##2##5##(2008-10#2)
were consistent in##2##3##(2008-10#2)
were consistent with a diagnosis of##3##6##(1991-8#1)(1997-8#1)(2008-11#1)
were consistent with a##9##4##(1991-12#1)(1991-8#1)(1993-11#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
were consistent with an##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
were consistent with previously reported##2##5##(2008-10#1)(2008-4#1)
were consistent with previously##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
were consistent with the##21##4##(1990-5#2)(1990-6#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
were consistent with theoretical##2##4##(2007-12#1)(2008-9#1)
were consistent with this##2##4##(2008-4#1)(2010-11#1)
were consistent with those##6##4##(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-3#1)
were consistent with##68##3##(1990-5#2)(1990-6#1)(1991-12#1)(1991-8#3)(1992-3#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
were consistent##80##2##(1990-5#2)(1990-6#1)(1991-12#1)(1991-8#3)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
were consistently associated with##3##4##(2008-10#2)(2012-12#1)
were consistently detected in##2##4##(2008-10#1)(2008-9#1)
were consistently greater##2##3##(2008-10#2)
were consistently higher than##2##4##(2008-10#1)(2008-9#1)
were consistently lower than##2##4##(1990-6#1)(1994-8#1)
were consistently more##3##3##(2008-12#1)(2008-6#1)(2009-9#1)
were consistently observed in##3##4##(1995-5#1)(2008-10#2)
were consistently observed##4##3##(1995-5#1)(2008-10#2)(2013-1#1)
were consistently##34##2##(1990-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-4#2)(2008-10#16)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-9#1)(2012-12#1)(2013-1#1)
were constituted##2##2##(1990-3#1)(2012-3#1)
were constitutively expressed in##2##4##(1997-7#1)(2008-6#1)
were constructed and analyzed##2##4##(1997-3#1)(2008-6#1)
were constructed and characterized##2##4##(1993-11#1)(2008-10#1)
were constructed and expressed##2##4##(1997-4#1)(2008-10#1)
were constructed and##16##3##(1993-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#3)(2013-1#1)
were constructed based on##2##4##(1995-6#1)(2008-12#1)
were constructed by site-directed mutagenesis##2##5##(1995-2#1)(1995-5#1)
were constructed by substituting##2##4##(1992-3#1)(1997-4#1)
were constructed by##14##3##(1992-3#1)(1993-12#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)
were constructed for the##2##4##(2008-10#2)
were constructed for##6##3##(1993-6#1)(2008-10#4)(2012-12#1)
were constructed from##7##3##(1990-5#1)(2008-10#4)(2008-9#1)(2011-2#1)
were constructed in##2##3##(1995-11#1)(2008-11#1)
were constructed of##2##3##(2008-10#1)(2011-2#1)
were constructed on the basis of##2##6##(1990-7#1)(1994-5#1)
were constructed on##3##3##(1990-7#1)(1994-5#1)(2008-10#1)
were constructed to##6##3##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
were constructed using a##2##4##(1990-5#1)(2011-2#1)
were constructed using##10##3##(1990-11#1)(1990-5#1)(1992-12#1)(2008-10#3)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
were constructed which##2##3##(1994-6#1)(2011-1#1)
were constructed with##4##3##(2007-7#1)(2008-10#2)(2008-9#1)
were constructed##105##2##(1990-11#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(2007-7#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#5)(2009-7#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
were consulted##2##2##(2010-7#1)(2011-2#1)
were consumed##5##2##(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)(2013-7#1)
were contacted and##2##3##(1995-1#1)(1996-1#1)
were contacted by##2##3##(1997-3#1)(2012-12#1)
were contacted##4##2##(1995-1#1)(1996-1#1)(1997-3#1)(2012-12#1)
were contained in##2##3##(1990-2#1)(2008-10#1)
were contaminated with##4##3##(2008-10#2)(2008-12#2)
were contaminated##8##2##(2008-10#3)(2008-11#2)(2008-12#3)
were continuous with##2##3##(1997-6#1)(2011-2#1)
were continuous##4##2##(1997-6#1)(2008-10#2)(2011-2#1)
were continuously##4##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
were contributed by the##2##4##(2008-10#2)
were contributed by##3##3##(2008-10#2)(2011-2#1)
were contributed##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
were control##2##2##(1995-12#1)(2013-8#1)
were controlled by a##4##4##(1994-12#1)(2008-10#3)
were controlled by##10##3##(1991-8#1)(1993-3#1)(1994-12#1)(2008-10#5)(2008-9#1)(2011-2#1)
were controlled##19##2##(1991-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-7#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#3)
were conventionally##3##2##(1996-5#1)(2008-10#2)
were converted into a##2##4##(1997-3#1)(2008-5#1)
were converted into the##2##4##(2008-10#2)
were converted into##8##3##(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)
were converted to laparotomy##2##4##(1995-3#1)(1996-1#1)
were converted to##15##3##(1990-12#2)(1990-8#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(2008-10#4)(2008-6#1)(2011-2#1)
were converted##26##2##(1990-12#2)(1990-8#1)(1991-5#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-5#2)(2008-6#1)(2011-2#1)
were cooked##2##2##(2010-2#1)(2010-4#1)
were cookies##2##2##(2012-2#2)
were coordinated##2##2##(2008-10#1)(2011-2#1)
were coronary##2##2##(2008-11#1)(2008-3#1)
were corrected for##3##3##(1991-5#1)(1991-8#1)(2008-9#1)
were corrected with a##2##4##(2007-11#1)(2008-2#1)
were corrected with##3##3##(2007-11#2)(2008-2#1)
were corrected##7##2##(1991-5#1)(1991-8#1)(2007-11#2)(2008-2#2)(2008-9#1)
were correctly classified as##2##4##(1993-8#2)
were correctly classified##4##3##(1993-8#2)(2008-10#1)(2008-7#1)
were correctly identified##2##3##(1996-11#1)(1997-6#1)
were correctly##12##2##(1991-12#1)(1993-6#1)(1993-8#2)(1994-9#1)(1995-9#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)
were correlated to the##2##4##(1996-12#1)(2008-10#1)
were correlated to##6##3##(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#1)
were correlated with the##14##4##(1992-3#1)(1992-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
were correlated with##41##3##(1990-12#1)(1990-7#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-3#2)(1996-5#3)(1997-8#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
were correlated##55##2##(1990-12#1)(1990-7#1)(1992-3#1)(1992-6#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-5#3)(1996-7#1)(1997-6#1)(1997-8#2)(2007-12#2)(2008-10#17)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
were correspondingly##2##2##(1996-12#1)(2008-8#1)
were corroborated by##2##3##(1990-7#1)(2008-8#1)
were countable##2##2##(2008-10#2)
were counted and##3##3##(2007-5#1)(2008-10#1)(2013-1#1)
were counted in##5##3##(1992-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)
were counted##19##2##(1992-10#1)(1992-12#1)(1993-12#1)(1994-11#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-1#1)
were coupled to##2##3##(2008-10#1)(2010-7#1)
were coupled with##4##3##(2008-10#2)(2009-11#1)(2010-3#1)
were coupled##7##2##(2008-10#3)(2009-11#1)(2010-3#1)(2010-7#1)(2011-2#1)
were covalently##4##2##(1990-7#1)(1992-12#1)(2008-10#2)
were covered in##3##3##(1994-9#1)(2008-10#1)(2013-8#1)
were covered with a##3##4##(2008-10#3)
were covered with##5##3##(1997-2#1)(2008-10#3)(2008-3#1)
were covered##11##2##(1994-9#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-8#1)(2013-8#1)
were created and assessed##2##4##(2008-10#1)(2008-11#1)
were created by##3##3##(2007-5#1)(2008-10#1)(2008-3#1)
were created for##4##3##(2007-5#1)(2008-10#1)(2008-7#1)(2013-7#1)
were created in##2##3##(2008-7#1)(2010-6#1)
were created using a##3##4##(1992-1#1)(2009-11#1)(2010-10#1)
were created using##4##3##(1992-1#1)(2009-11#1)(2010-10#1)(2010-12#1)
were created##28##2##(1991-12#1)(1992-1#1)(1993-1#1)(1997-3#1)(2007-5#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-7#1)
were critically evaluated##2##3##(2008-10#1)(2013-1#1)
were critically##4##2##(2008-10#2)(2013-1#1)(2013-8#1)
were cross-linked##2##2##(1993-8#1)(2008-6#1)
were cross-resistant to##3##3##(2008-5#3)
were crossed with the##2##4##(2008-10#2)
were crossed with##6##3##(2008-10#6)
were crossed##9##2##(2008-10#8)(2012-3#1)
were crosslinked##2##2##(1993-8#1)(2013-1#1)
were cryopreserved##2##2##(2008-9#2)
were cultivated in the##3##4##(2007-1#1)(2008-11#1)(2008-5#1)
were cultivated in##8##3##(2007-1#1)(2008-11#6)(2008-5#1)
were cultivated with##2##3##(2008-10#1)(2008-5#1)
were cultivated##13##2##(1990-12#1)(2007-1#1)(2008-10#2)(2008-11#6)(2008-5#2)(2011-3#1)
were culture positive##2##3##(2007-7#1)(2012-3#1)
were cultured and##2##3##(2008-9#1)(2013-1#1)
were cultured at##2##3##(1990-12#1)(1991-12#1)
were cultured for##6##3##(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-11#1)(2013-1#1)
were cultured in a medium containing##3##6##(1994-8#1)(2008-10#1)(2008-9#1)
were cultured in a medium##4##5##(1994-8#1)(2008-10#2)(2008-9#1)
were cultured in a##5##4##(1994-8#1)(2008-10#3)(2008-9#1)
were cultured in the##6##4##(1993-3#1)(2008-11#5)
were cultured in##27##3##(1992-12#2)(1993-12#1)(1993-3#1)(1994-8#1)(1996-12#1)(1996-2#1)(2006-6#1)(2008-10#4)(2008-11#11)(2008-12#1)(2008-9#1)(2011-2#1)(2012-4#1)
were cultured on##4##3##(2008-11#3)(2008-6#1)
were cultured under##4##3##(2008-11#3)(2008-5#1)
were cultured with the##2##4##(1997-2#1)(2011-3#1)
were cultured with##5##3##(1992-8#1)(1993-3#1)(1995-12#1)(1997-2#1)(2011-3#1)
were cultured##59##2##(1990-12#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#2)(2008-10#5)(2008-11#19)(2008-12#1)(2008-5#3)(2008-6#1)(2008-9#2)(2011-2#1)(2011-3#1)(2012-4#1)(2013-1#3)
were cured##6##2##(1995-11#1)(2008-1#1)(2008-5#2)(2008-7#1)(2013-1#1)
were current##3##2##(1997-6#1)(2007-12#1)(2012-2#1)
were currently##2##2##(1995-12#1)(2012-3#1)
were cut and##2##3##(2007-8#1)(2012-3#1)
were cut from##2##3##(2009-7#1)(2011-2#1)
were cut off##2##3##(2008-5#2)
were cut##11##2##(1995-6#1)(1997-2#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#2)(2011-2#1)(2012-3#1)
were cytotoxic to##2##3##(1993-9#1)(2012-3#1)
were cytotoxic##3##2##(1993-9#1)(2008-10#1)(2012-3#1)
were damaged##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
were dead##2##2##(2007-10#1)(2012-3#1)
were decapitated##2##2##(2008-7#1)(2013-8#1)
were decreased at##2##3##(2008-10#1)(2008-9#1)
were decreased by##10##3##(1991-8#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-3#1)
were decreased in##6##3##(1992-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)
were decreased significantly (P &lt##2##5##(1997-7#1)(2008-10#1)
were decreased significantly##4##3##(1997-7#1)(2008-10#2)(2008-12#1)
were decreased##40##2##(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#5)(2009-12#1)(2009-6#1)(2010-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
were decreases in the##2##4##(1991-12#1)(2012-12#1)
were decreasing##3##2##(2007-11#1)(2008-4#1)(2009-4#1)
were deduced##3##2##(1991-5#1)(2008-3#1)(2008-5#1)
were deemed to be##2##4##(1993-3#1)(2008-9#1)
were deemed##9##2##(1993-3#1)(1995-12#1)(1997-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
were defective in##2##3##(2009-2#1)(2009-6#1)
were deficient in##3##3##(2008-10#2)(2010-5#1)
were defined according to the##2##5##(2007-12#1)(2013-1#1)
were defined as##8##3##(1994-7#1)(1995-11#1)(2007-8#2)(2008-10#1)(2008-8#1)(2012-4#1)(2013-1#1)
were defined by the##2##4##(1995-6#1)(2011-2#1)
were defined by##9##3##(1992-6#1)(1995-6#1)(2008-10#3)(2009-3#1)(2010-1#1)(2011-2#1)(2012-1#1)
were defined in##4##3##(1991-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
were defined##40##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-3#2)(1992-6#1)(1993-12#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-4#1)(2013-1#5)
were degraded in##2##3##(1992-12#1)(1994-9#1)
were degraded##5##2##(1992-12#2)(1994-9#1)(2008-11#1)(2008-8#1)
were delayed in##2##3##(1997-6#1)(2008-10#1)
were delayed##4##2##(1991-6#1)(1997-6#1)(2008-10#1)(2011-2#1)
were deleted##4##2##(1992-12#1)(1995-2#2)(1997-6#1)
were delineated##3##2##(1993-11#1)(2008-10#1)(2009-11#1)
were delivered after##2##3##(2008-7#1)(2013-1#1)
were delivered at##2##3##(2008-10#2)
were delivered in##2##3##(2008-3#1)(2011-2#1)
were delivered into##2##3##(2008-10#2)
were delivered##13##2##(1992-8#1)(1994-7#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
were demonstrable##2##2##(1990-12#1)(1992-9#1)
were demonstrated by##5##3##(1993-12#1)(2008-10#2)(2008-6#1)(2013-1#1)
were demonstrated in the##3##4##(1991-10#1)(1997-3#1)(1997-8#1)
were demonstrated in##10##3##(1990-12#1)(1991-10#1)(1993-8#1)(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#2)
were demonstrated to be##6##4##(2007-11#1)(2008-10#2)(2008-11#2)(2013-1#1)
were demonstrated to have##2##4##(2008-2#1)(2011-1#1)
were demonstrated to##9##3##(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2011-1#1)(2013-1#1)
were demonstrated when##2##3##(1997-3#1)(2008-6#1)
were demonstrated with##3##3##(2008-3#2)(2008-7#1)
were demonstrated##58##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-3#1)(1997-3#3)(1997-8#1)(2007-11#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#9)(2008-5#4)(2008-6#2)(2008-7#3)(2011-1#2)(2011-3#2)(2013-1#2)(2013-8#1)
were densely##3##2##(1996-5#2)(2009-7#1)
were dependent on the##7##4##(1990-2#1)(1990-7#1)(1992-11#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-6#1)
were dependent on##12##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1992-11#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)
were dependent##13##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1992-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)
were depleted##2##2##(1993-11#1)(2008-12#1)
were deployed##5##2##(2007-5#1)(2008-10#3)(2011-2#1)
were deposited by electron beam evaporation##2##6##(2008-10#2)
were deposited by##3##3##(2008-10#2)(2008-3#1)
were deposited on##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
were deposited onto##2##3##(2008-3#1)(2009-12#1)
were deposited##16##2##(1992-12#1)(1997-1#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-2#2)(2008-3#3)(2009-12#1)
were depressed by##2##3##(1995-12#2)
were depressed##7##2##(1991-5#1)(1995-12#3)(1996-3#1)(1997-3#1)(2008-12#1)
were depression##2##2##(2007-10#1)(2009-5#1)
were derivatized using##2##3##(1992-8#1)(2011-1#1)
were derivatized with##3##3##(1990-8#2)(1995-2#1)
were derivatized##8##2##(1990-8#3)(1992-8#2)(1995-2#1)(2011-1#1)(2012-1#1)
were derived by##2##3##(2013-1#1)(2013-8#1)
were derived from a##3##4##(1997-3#1)(2008-10#2)
were derived from the##5##4##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
were derived from##26##3##(1993-9#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-2#1)
were derived to##2##3##(2008-10#2)
were derived using##2##3##(2008-10#2)
were derived##46##2##(1993-5#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#18)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#2)
were dermally administered 0##7##4##(2008-9#7)
were dermally administered##9##3##(2008-9#9)
were described as##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
were described by##2##3##(1997-3#1)(2008-10#1)
were described for##3##3##(2008-1#1)(2010-1#1)(2012-12#1)
were described in##8##3##(1991-4#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)
were described##50##2##(1991-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1997-3#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#1)
were designated as &quot##2##4##(2008-1#2)
were designated as race 0##2##5##(2008-10#2)
were designated as race 2##3##5##(2008-10#3)
were designated as race##6##4##(2008-10#6)
were designated as##11##3##(1997-8#1)(2008-1#2)(2008-10#6)(2008-8#1)(2008-9#1)
were designated race##2##3##(2008-10#2)
were designated##18##2##(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-8#1)(2008-9#1)
were designed and fabricated##2##4##(2008-3#2)
were designed and prepared##2##4##(2007-11#1)(2012-1#1)
were designed and synthesized as##2##5##(2008-11#1)(2010-5#1)
were designed and synthesized##8##4##(2008-10#2)(2008-11#1)(2010-5#1)(2011-3#3)(2012-12#1)
were designed and##19##3##(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-3#3)(2012-1#1)(2012-12#1)
were designed based on the##3##5##(2008-10#2)(2011-2#1)
were designed based on##4##4##(2008-10#2)(2011-2#1)(2012-12#1)
were designed for the##3##4##(2008-10#3)
were designed for##8##3##(2008-10#6)(2008-3#1)(2009-9#1)
were designed from conserved regions of##2##6##(2008-10#2)
were designed from##4##3##(1993-6#1)(2008-10#2)(2008-8#1)
were designed on##2##3##(2008-8#1)(2010-4#1)
were designed specifically for##2##4##(2008-10#2)
were designed to amplify##3##4##(2008-10#3)
were designed to change the##2##5##(1993-11#1)(2008-10#1)
were designed to evaluate the##3##5##(2008-10#1)(2008-5#1)(2012-12#1)
were designed to form##2##4##(1993-11#2)
were designed to identify##2##4##(1995-5#1)(2012-12#1)
were designed to perform##2##4##(2008-10#2)
were designed to provide##2##4##(1994-1#1)(2008-3#1)
were designed to test##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
were designed to##43##3##(1990-11#1)(1991-3#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1995-5#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-9#1)(2012-12#2)(2013-1#1)
were designed using##4##3##(2008-10#3)(2013-1#1)
were designed with a##3##4##(2008-3#1)(2009-9#1)(2010-3#1)
were designed##108##2##(1990-11#1)(1991-3#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#39)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#14)(2008-5#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#4)(2013-1#3)(2013-8#1)
were desorbed into##2##3##(2008-10#1)(2011-2#1)
were desorbed##3##2##(2008-10#2)(2011-2#1)
were detectable in##2##3##(1992-8#1)(2008-11#1)
were detectable on##2##3##(2008-10#1)(2008-4#1)
were detectable##15##2##(1992-8#1)(1993-8#1)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
were detected after##3##3##(2008-10#2)(2010-2#1)
were detected among isolates##2##4##(2008-10#2)
were detected among the##3##4##(2008-10#2)(2008-5#1)
were detected among##10##3##(2008-10#9)(2008-5#1)
were detected and the##2##4##(2008-10#1)(2008-5#1)
were detected and##7##3##(1990-11#1)(1994-6#1)(1995-6#1)(2008-10#3)(2008-5#1)
were detected as early as##3##5##(2008-10#2)(2009-7#1)
were detected as##10##3##(2007-12#1)(2008-10#6)(2008-9#2)(2009-7#1)
were detected at the##2##4##(2007-3#1)(2008-10#1)
were detected at##14##3##(1990-9#1)(1993-6#1)(1995-11#1)(1997-2#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)
were detected between##8##3##(2007-11#1)(2008-10#3)(2009-5#2)(2012-2#1)(2013-7#1)
were detected but##2##3##(2008-5#1)(2008-8#1)
were detected by Western##2##4##(2012-2#1)(2012-3#1)
were detected by a##2##4##(1994-12#1)(2008-10#1)
were detected by the polymerase chain reaction##2##7##(1995-8#1)(1996-9#1)
were detected by the##8##4##(1990-5#1)(1995-8#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
were detected by using##2##4##(2008-10#1)(2008-12#1)
were detected by##46##3##(1990-12#1)(1990-5#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-4#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
were detected consistently##2##3##(2008-10#2)
were detected during the##2##4##(2008-10#2)
were detected during##3##3##(1991-12#1)(2008-10#2)
were detected for a##2##4##(2008-10#1)(2012-12#1)
were detected for the##3##4##(2008-10#1)(2011-2#2)
were detected for##13##3##(1991-2#1)(1993-11#1)(2008-10#5)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)
were detected from the##2##4##(1997-4#1)(2008-10#1)
were detected from##8##3##(1997-4#1)(2008-10#5)(2008-11#1)(2008-8#1)
were detected in 3##2##4##(2011-2#1)(2012-3#1)
were detected in Abyssinian 14##2##5##(2008-10#2)
were detected in a##2##4##(1994-6#1)(2013-1#1)
were detected in all##3##4##(1997-6#1)(2008-10#2)
were detected in both##5##4##(1994-2#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-4#1)
were detected in human##2##4##(1990-2#1)(1992-8#1)
were detected in mouse##2##4##(1990-11#1)(2008-10#1)
were detected in other##2##4##(2008-10#1)(2008-8#1)
were detected in patients##3##4##(1991-2#1)(1992-3#1)(2009-3#1)
were detected in the brain of the##2##7##(1994-2#1)(1996-12#1)
were detected in the##40##4##(1990-12#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-5#2)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
were detected in these##2##4##(2008-10#2)
were detected in three##2##4##(2008-10#1)(2008-7#1)
were detected in two of##2##5##(1992-2#1)(2008-4#1)
were detected in two##3##4##(1992-2#1)(2008-4#1)(2008-9#1)
were detected in urine##2##4##(1996-12#1)(2008-10#1)
were detected in##165##3##(1990-11#2)(1990-12#2)(1990-2#2)(1991-2#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-6#1)(1994-8#3)(1995-11#5)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#5)(1996-5#2)(1997-2#2)(1997-3#1)(1997-6#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#61)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
were detected more##2##3##(2007-4#1)(2008-10#1)
were detected on chromosomes##2##4##(2008-10#2)
were detected on the##3##4##(1994-12#1)(2008-10#1)(2013-8#1)
were detected on##10##3##(1991-7#1)(1994-12#1)(2008-10#5)(2008-8#1)(2012-3#1)(2013-8#1)
were detected only in##2##4##(1996-12#1)(2012-1#1)
were detected over##2##3##(1990-12#1)(2008-10#1)
were detected using a##4##4##(1997-8#1)(2008-10#3)
were detected using##6##3##(1997-8#1)(2008-10#5)
were detected when##3##3##(2008-10#2)(2008-5#1)
were detected with the##3##4##(2008-10#3)
were detected with##15##3##(1990-11#1)(1990-8#1)(1992-9#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-5#1)(2009-7#1)(2013-7#1)
were detected within##3##3##(1993-3#1)(2008-10#1)(2009-8#1)
were detected##429##2##(1990-11#6)(1990-12#5)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-7#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-9#4)(1994-11#4)(1994-12#3)(1994-2#5)(1994-6#3)(1994-8#4)(1995-11#6)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#7)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#174)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#12)(2008-7#6)(2008-8#14)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#6)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#2)(2011-1#5)(2011-2#13)(2011-3#3)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#6)(2013-7#3)(2013-8#6)
were determined according to the##3##5##(1997-8#1)(2008-5#2)
were determined according to##4##4##(1997-6#1)(1997-8#1)(2008-5#2)
were determined along##2##3##(2008-2#1)(2010-10#1)
were determined and analyzed using##2##5##(2008-10#1)(2010-3#1)
were determined and analyzed##3##4##(1994-12#1)(2008-10#1)(2010-3#1)
were determined and compared in##2##5##(2008-11#1)(2008-12#1)
were determined and compared to##2##5##(1991-12#1)(1994-12#1)
were determined and compared with those of##2##7##(2008-10#1)(2011-2#1)
were determined and compared with those##4##6##(1990-9#1)(2008-10#2)(2011-2#1)
were determined and compared with##5##5##(1990-9#1)(2008-10#3)(2011-2#1)
were determined and compared##11##4##(1990-9#1)(1991-12#1)(1994-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-2#1)
were determined and the##4##4##(1990-7#1)(2008-10#2)(2010-8#1)
were determined and their##2##4##(2008-10#1)(2008-11#1)
were determined and##31##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-12#2)(1995-3#1)(1997-2#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#1)
were determined as well as##2##5##(2008-10#2)
were determined as##12##3##(1990-5#1)(1996-5#1)(2008-10#6)(2008-12#3)(2008-5#1)
were determined at 25 degrees C##5##6##(2008-10#5)
were determined at different##2##4##(2008-10#2)
were determined at##16##3##(1990-3#1)(1990-6#1)(2008-10#11)(2008-4#1)(2008-5#1)(2010-4#1)
were determined based on the##2##5##(2008-10#2)
were determined based on##5##4##(2008-10#4)(2009-7#1)
were determined before and##2##4##(2008-10#1)(2008-12#1)
were determined before##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
were determined between##3##3##(2008-10#2)(2008-5#1)
were determined by a flame atomic absorption spectrometer##2##8##(2008-10#2)
were determined by a##8##4##(1990-5#1)(1990-8#1)(1997-4#1)(2007-11#1)(2008-10#3)(2011-2#1)
were determined by an##2##4##(1993-9#1)(2008-10#1)
were determined by capillary electrophoresis##2##5##(2008-10#2)
were determined by capillary##3##4##(1994-9#1)(2008-10#2)
were determined by enzymatic##2##4##(2008-10#1)(2013-1#1)
were determined by flame atomic absorption##2##6##(2008-10#2)
were determined by flame##3##4##(2008-10#3)
were determined by gas chromatography with##2##6##(1997-6#1)(2008-10#1)
were determined by gas chromatography##5##5##(1997-6#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
were determined by gas chromatography-mass spectrometry##2##6##(1990-8#1)(1992-5#1)
were determined by gas##7##4##(1990-8#1)(1992-5#1)(1997-6#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
were determined by high##2##4##(2008-10#2)
were determined by inductively coupled plasma mass spectrometry (ICP-MS)##3##9##(2008-10#1)(2013-8#2)
were determined by inductively coupled plasma mass spectrometry##4##8##(2008-10#2)(2013-8#2)
were determined by inductively coupled plasma##5##6##(2008-10#3)(2013-8#2)
were determined by inductively coupled##6##5##(2008-10#4)(2013-8#2)
were determined by inductively##7##4##(2008-10#5)(2013-8#2)
were determined by least-squares fitting of theoretical##2##7##(2008-2#1)(2008-3#1)
were determined by least-squares fitting of##3##6##(2008-2#2)(2008-3#1)
were determined by matrix-assisted laser desorption/ionization##2##6##(2008-11#2)
were determined by means of##3##5##(2008-5#1)(2008-8#1)(2013-1#1)
were determined by radioimmunoassay##2##4##(1996-2#1)(1997-3#1)
were determined by spectroscopic##2##4##(2008-3#1)(2010-6#1)
were determined by the proposed##2##5##(2008-10#2)
were determined by the##13##4##(1995-11#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
were determined by using the##3##5##(2008-10#2)(2010-11#1)
were determined by using##8##4##(2008-10#7)(2010-11#1)
were determined by##144##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-8#1)(1992-3#3)(1992-5#1)(1992-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2007-10#1)(2007-11#1)(2008-10#60)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
were determined during a##2##4##(2008-5#1)(2011-2#1)
were determined during##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
were determined fluorimetrically##2##3##(1990-8#1)(2008-10#1)
were determined for 12##3##4##(1997-3#1)(2008-10#1)(2008-12#1)
were determined for each species##2##5##(2011-2#1)(2012-12#1)
were determined for each##7##4##(2007-8#1)(2008-10#4)(2011-2#1)(2012-12#1)
were determined for the##4##4##(1994-12#1)(1995-8#1)(2008-10#1)(2008-6#1)
were determined for##30##3##(1994-12#1)(1995-8#2)(1996-12#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)
were determined from the temperature dependence of##2##7##(1990-7#1)(2008-10#1)
were determined from the##13##4##(1990-7#1)(1991-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-3#1)(2009-8#1)(2009-9#1)
were determined from##31##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2009-8#2)(2009-9#1)(2012-12#1)(2012-2#1)
were determined in a##4##4##(1994-9#1)(2008-10#3)
were determined in all##2##4##(1995-3#1)(2008-10#1)
were determined in aqueous##2##4##(2008-10#2)
were determined in serum##2##4##(1995-3#1)(2008-10#1)
were determined in the serum##2##5##(2008-10#2)
were determined in the##11##4##(1994-11#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
were determined in##77##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#37)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
were determined on the##2##4##(1997-8#1)(2008-10#1)
were determined on##5##3##(1997-6#1)(1997-8#1)(2008-10#3)
were determined potentiometrically##3##3##(2008-10#3)
were determined satisfactorily##3##3##(2008-10#3)
were determined simultaneously##3##3##(2008-10#2)(2008-3#1)
were determined spectrophotometrically##2##3##(2008-10#1)(2012-2#1)
were determined through##2##3##(2008-10#1)(2008-3#1)
were determined to assess the viability of the method##2##9##(2008-10#2)
were determined to be 0##3##5##(2008-10#2)(2008-8#1)
were determined to be 10##2##5##(2008-10#2)
were determined to be##26##4##(1990-5#1)(1990-7#1)(1990-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#1)
were determined to##38##3##(1990-5#1)(1990-7#1)(1990-8#1)(1992-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-11#2)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#1)
were determined under##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
were determined using a##4##4##(1991-2#1)(1992-5#1)(2008-5#1)(2013-8#1)
were determined using an##2##4##(1993-12#1)(2008-5#1)
were determined using the##5##4##(2008-10#3)(2008-12#1)(2013-1#1)
were determined using##37##3##(1990-12#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-5#3)(2008-9#1)(2010-2#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
were determined with an accuracy of##2##6##(2008-3#2)
were determined with an##3##4##(1990-8#1)(2008-3#2)
were determined with satisfactory##3##4##(2008-10#3)
were determined with the##4##4##(2008-10#3)(2013-8#1)
were determined with##26##3##(1990-8#1)(2007-10#1)(2008-10#15)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
were determined without##3##3##(2008-10#3)
were determined##676##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#7)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#2)(1993-12#2)(1993-2#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#4)(1994-3#2)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#3)(1996-8#2)(1997-2#8)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#3)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#7)(2007-5#1)(2007-8#2)(2008-10#300)(2008-11#16)(2008-12#18)(2008-2#13)(2008-3#18)(2008-4#4)(2008-5#30)(2008-6#6)(2008-7#14)(2008-8#8)(2008-9#7)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#7)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#11)(2013-8#6)
were developed and implemented##2##4##(2008-2#1)(2010-11#1)
were developed and introduced##2##4##(2007-8#1)(2010-8#1)
were developed and##13##3##(1993-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-8#2)
were developed as##3##3##(2008-6#1)(2010-8#1)(2013-1#1)
were developed based on the##3##5##(2008-10#3)
were developed based on##5##4##(1993-3#1)(2008-10#4)
were developed by a##2##4##(2008-3#1)(2010-12#1)
were developed by the##3##4##(1990-12#1)(2008-10#1)(2008-2#1)
were developed by using##2##4##(2007-12#1)(2008-10#1)
were developed by##13##3##(1990-12#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-12#1)(2012-2#1)
were developed for the analysis of##2##6##(2008-10#2)
were developed for the determination of##4##6##(2008-10#4)
were developed for the##11##4##(1990-8#1)(2007-11#1)(2008-10#9)
were developed for##22##3##(1990-5#1)(1990-8#1)(1996-12#1)(2007-11#1)(2008-10#13)(2008-3#1)(2008-7#2)(2009-10#1)(2010-12#1)
were developed from the##2##4##(1997-8#1)(2011-2#1)
were developed from##7##3##(1997-8#1)(2008-10#4)(2008-7#1)(2011-2#1)
were developed in a##2##4##(2008-5#1)(2008-9#1)
were developed in order to##2##5##(2008-10#1)(2008-12#1)
were developed in this##2##4##(2008-10#1)(2008-8#1)
were developed in##13##3##(1990-6#1)(1991-9#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)
were developed that were##2##4##(2008-10#2)
were developed that##6##3##(1996-5#1)(2008-10#4)(2008-8#1)
were developed through##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
were developed to detect##2##4##(2008-10#2)
were developed to facilitate##2##4##(2007-12#1)(2008-8#1)
were developed to guide##2##4##(1994-3#1)(2008-10#1)
were developed to identify##2##4##(2008-10#1)(2012-1#1)
were developed to study the##2##5##(2008-10#2)
were developed to##22##3##(1992-1#1)(1994-3#1)(1994-9#1)(2007-12#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-3#1)
were developed using a##2##4##(2008-10#2)
were developed using##9##3##(2008-10#9)
were developed with##3##3##(2008-10#3)
were developed##170##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-9#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#86)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-8#3)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)
were developing##2##2##(1993-6#1)(2013-1#1)
were devised##3##2##(1991-8#1)(2008-10#2)
were devoid of##6##3##(1990-8#1)(1992-2#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-10#1)
were diagnosed after##3##3##(1990-2#1)(1992-10#1)(2007-12#1)
were diagnosed as having##5##4##(1991-4#1)(1995-11#1)(1996-6#1)(2006-10#1)(2009-2#1)
were diagnosed as##12##3##(1991-11#1)(1991-4#1)(1995-11#1)(1996-6#1)(2006-10#1)(2008-10#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-8#3)
were diagnosed in##8##3##(1992-2#1)(1992-5#1)(1993-8#1)(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
were diagnosed on##2##3##(1996-12#1)(2007-8#1)
were diagnosed to have##4##4##(1991-2#1)(2007-2#1)(2007-7#1)(2013-1#1)
were diagnosed with pre-eclampsia##2##4##(2011-2#2)
were diagnosed with##13##3##(1994-2#1)(1997-5#1)(2007-11#1)(2007-8#2)(2008-6#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
were diagnosed##60##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#3)(1995-12#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
were differences between##2##3##(2010-3#1)(2012-12#1)
were differences in##7##3##(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-8#1)(2013-1#1)
were differences##9##2##(1996-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-8#1)(2013-1#1)
were different and##3##3##(1994-11#1)(2008-10#1)(2013-7#1)
were different between##2##3##(2008-10#1)(2011-1#1)
were different for##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
were different from that seen after DEX##2##7##(1995-12#2)
were different from those##3##4##(1990-12#1)(2008-10#1)(2012-2#1)
were different from##9##3##(1990-12#1)(1995-12#2)(1997-4#1)(2008-10#4)(2012-2#1)
were different in##6##3##(2008-10#1)(2010-12#1)(2011-1#2)(2011-3#1)(2013-7#1)
were different##41##2##(1990-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-12#3)(1997-4#1)(2007-11#1)(2008-10#12)(2008-12#1)(2008-7#3)(2008-8#3)(2010-12#1)(2011-1#3)(2011-3#1)(2012-2#3)(2013-1#2)(2013-7#2)
were differentiable##2##2##(2008-10#1)(2011-2#1)
were differentially##5##2##(1994-12#1)(2008-10#2)(2009-10#1)(2009-8#1)
were differentiated by##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
were differentiated from##2##3##(2008-10#2)
were differentiated##9##2##(2008-10#5)(2008-7#1)(2009-11#1)(2011-2#1)(2011-3#1)
were difficult to##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
were difficult##5##2##(2008-10#2)(2008-7#1)(2011-1#1)(2012-3#1)
were diffusely positive##2##3##(2008-11#1)(2013-8#1)
were diffusely##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
were digested by microwave digestion##2##5##(2013-8#2)
were digested by##5##3##(2008-10#2)(2009-3#1)(2013-8#2)
were digested in##2##3##(2008-10#2)
were digested with##4##3##(1994-9#1)(1997-2#2)(2008-10#1)
were digested##14##2##(1992-6#1)(1994-9#1)(1997-2#2)(2008-10#7)(2009-3#1)(2013-8#2)
were digitized##4##2##(2008-12#2)(2008-3#1)(2013-1#1)
were diluted with##4##3##(2008-10#3)(2008-12#1)
were diluted##9##2##(1992-6#1)(2008-10#7)(2008-12#1)
were diminished##5##2##(1990-12#1)(1992-3#1)(1995-2#1)(2008-3#1)(2013-1#1)
were dipped in a##2##4##(1990-6#1)(2008-10#1)
were dipped in##5##3##(1990-6#2)(1993-12#1)(2007-3#1)(2008-10#1)
were dipped##6##2##(1990-6#2)(1993-12#1)(2007-3#1)(2008-10#2)
were direct##5##2##(1994-9#1)(1995-11#1)(1995-8#1)(2008-1#1)(2009-6#1)
were directed against the##2##4##(1993-8#1)(2008-10#1)
were directed to##3##3##(1995-11#1)(1995-12#1)(2008-11#1)
were directed##6##2##(1993-8#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#1)
were directly correlated with##2##4##(1996-9#1)(2008-10#1)
were directly introduced##2##3##(1995-2#1)(2008-10#1)
were directly related to##2##4##(1993-11#1)(2008-10#1)
were directly##31##2##(1990-12#1)(1990-8#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-6#1)(1996-9#1)(2007-11#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)
were discarded from##2##3##(2007-7#1)(2008-10#1)
were discharged home##2##3##(2007-10#2)
were discharged to##3##3##(1990-12#2)(2011-2#1)
were discharged##12##2##(1990-12#2)(1992-11#1)(1996-9#1)(2007-10#2)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
were discovered in the##3##4##(1990-3#1)(1991-12#1)(2012-3#1)
were discovered in##5##3##(1990-3#1)(1991-12#1)(1996-3#1)(2008-5#1)(2012-3#1)
were discovered to have##2##4##(1997-5#1)(2008-3#1)
were discovered##14##2##(1990-3#1)(1991-12#1)(1991-8#1)(1995-12#1)(1996-3#1)(1997-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
were discriminated by##2##3##(1997-6#1)(2008-10#1)
were discriminated##4##2##(1997-6#1)(2008-10#2)(2012-2#1)
were discussed and##8##3##(1990-3#1)(1992-3#1)(2008-10#3)(2008-12#1)(2009-8#1)(2010-2#1)
were discussed at##3##3##(1994-12#1)(2008-5#1)(2012-12#1)
were discussed in detail##3##4##(2008-10#3)
were discussed in##10##3##(1994-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
were discussed with##3##3##(1993-11#1)(1997-2#1)(2008-12#1)
were discussed##62##2##(1990-3#1)(1990-6#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-2#1)(2008-10#20)(2008-11#3)(2008-12#4)(2008-5#7)(2008-6#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#2)(2013-7#1)
were disease-free##2##2##(1991-2#1)(2013-8#1)
were dispensed##3##2##(2008-10#2)(2008-11#1)
were dispersed on##2##3##(2008-10#1)(2008-3#1)
were dispersed##6##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-2#1)
were displayed##4##2##(1997-4#1)(2008-12#1)(2008-5#2)
were disrupted##4##2##(2008-10#2)(2009-10#1)(2009-3#1)
were dissatisfied##2##2##(2008-7#1)(2008-8#1)
were dissected from##3##3##(2008-10#3)
were dissected##9##2##(1992-3#1)(1994-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-1#1)(2011-1#1)
were dissolved in##5##3##(1990-8#1)(2008-10#3)(2008-5#1)
were dissolved with##2##3##(2008-10#2)
were dissolved##7##2##(1990-8#1)(2008-10#5)(2008-5#1)
were distinct from the##2##4##(2008-10#2)
were distinct from##6##3##(2008-10#6)
were distinct##11##2##(2008-10#10)(2008-11#1)
were distinctive##2##2##(1993-12#1)(2008-10#1)
were distinctly##4##2##(1993-12#1)(2008-10#2)(2011-1#1)
were distinguished among the##2##4##(2008-10#2)
were distinguished from each other by##2##6##(2008-10#2)
were distinguished from##3##3##(1995-12#1)(2008-10#2)
were distinguished in##2##3##(2008-10#1)(2008-5#1)
were distinguished using##2##3##(2008-10#2)
were distinguished##17##2##(1991-11#1)(1995-12#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-3#1)
were distributed among##3##3##(1997-2#1)(2008-5#1)(2011-1#1)
were distributed between##2##3##(2008-11#1)(2009-7#1)
were distributed in a##2##4##(1992-8#1)(2008-10#1)
were distributed in the##3##4##(1996-12#1)(2011-1#1)(2013-8#1)
were distributed in##9##3##(1992-8#1)(1996-12#1)(2008-10#4)(2008-6#1)(2011-1#1)(2013-8#1)
were distributed over all##2##4##(2008-10#2)
were distributed over##3##3##(1993-12#1)(2008-10#2)
were distributed throughout the##4##4##(1993-12#1)(2008-10#2)(2008-5#1)
were distributed to all##2##4##(2007-11#1)(2010-8#1)
were distributed to##3##3##(2007-11#1)(2010-8#1)(2013-1#1)
were distributed##40##2##(1992-8#1)(1993-12#2)(1994-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(2007-11#2)(2008-10#13)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
were divergent##2##2##(2008-10#2)
were diverse##2##2##(1995-5#1)(2008-11#1)
were divided between##2##3##(1996-8#1)(2008-10#1)
were divided in 4 groups##2##5##(2007-11#1)(2011-2#1)
were divided in three groups according##2##6##(2007-6#1)(2013-1#1)
were divided in three groups##3##5##(2007-6#1)(2011-1#1)(2013-1#1)
were divided in three##4##4##(2007-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
were divided in##8##3##(2007-11#1)(2007-6#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
were divided into 2 groups##2##5##(1990-2#1)(2007-10#1)
were divided into 3 groups##4##5##(2007-10#1)(2007-11#1)(2008-10#1)(2013-1#1)
were divided into 4 groups##4##5##(1992-9#1)(2007-10#1)(2008-11#1)(2008-8#1)
were divided into five groups##3##5##(1990-12#1)(2008-10#1)(2011-2#1)
were divided into five##6##4##(1990-12#1)(1995-12#1)(2008-10#3)(2011-2#1)
were divided into four groups##10##5##(1991-2#1)(1992-1#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#2)
were divided into four##11##4##(1991-2#1)(1992-1#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#2)(2013-1#2)
were divided into groups##3##4##(1993-2#1)(2008-3#1)(2012-2#1)
were divided into six##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
were divided into the following##2##5##(2007-10#1)(2012-12#1)
were divided into three groups##12##5##(1994-6#1)(1995-1#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
were divided into three##16##4##(1994-6#1)(1995-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
were divided into two distinct##2##5##(2008-10#2)
were divided into two groups according to##3##7##(1997-7#1)(2008-3#2)
were divided into two groups based on##2##7##(2008-10#2)
were divided into two groups of##2##6##(2008-3#1)(2008-7#1)
were divided into two groups##25##5##(1992-3#1)(1995-12#1)(1995-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
were divided into two##33##4##(1992-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
were divided into##104##3##(1990-12#2)(1990-2#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#4)(2007-11#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-4#2)(2010-3#1)(2010-6#1)(2011-1#5)(2011-2#9)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#1)
were divided to##2##3##(2008-12#1)(2011-2#1)
were divided##119##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#4)(2007-11#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#6)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2009-4#2)(2010-3#1)(2010-6#1)(2011-1#6)(2011-2#11)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#1)
were documented by##2##3##(1993-2#1)(2008-11#1)
were documented in the##2##4##(1994-8#1)(2008-12#1)
were documented in##5##3##(1994-8#1)(2007-7#1)(2008-12#1)(2013-1#2)
were documented##13##2##(1990-8#1)(1993-2#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2011-2#1)(2013-1#2)
were dominant in##2##3##(2008-10#2)
were dominant##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
were dominated by the##5##4##(2008-10#1)(2008-9#1)(2011-10#1)(2011-2#2)
were dominated by##10##3##(2008-1#1)(2008-10#4)(2008-9#1)(2011-1#1)(2011-10#1)(2011-2#2)
were dominated##11##2##(2008-1#1)(2008-10#5)(2008-9#1)(2011-1#1)(2011-10#1)(2011-2#2)
were done at##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
were done by##9##3##(1992-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2013-1#1)
were done for##2##3##(1995-1#1)(2008-5#1)
were done from##3##3##(1994-3#1)(1996-3#1)(2011-2#1)
were done in##6##3##(1995-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-5#1)(2013-1#1)
were done on##4##3##(1996-5#1)(2008-12#1)(2008-5#1)(2013-8#1)
were done to##6##3##(1990-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
were done using##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
were done with##3##3##(1996-12#1)(2008-12#1)(2013-1#1)
were done##63##2##(1990-5#1)(1992-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-5#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#7)(2008-6#2)(2008-8#2)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
were dose-dependent##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
were dose-related##2##2##(1992-9#1)(2008-9#1)
were dosed with##2##3##(2008-10#1)(2008-5#1)
were dosed##3##2##(1995-12#1)(2008-10#1)(2008-5#1)
were down##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
were down-regulated and##2##3##(2010-4#1)(2013-8#1)
were down-regulated##4##2##(2008-10#2)(2010-4#1)(2013-8#1)
were downregulated##6##2##(2010-12#4)(2011-2#1)(2013-7#1)
were dramatically##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
were drawn from a##3##4##(2009-7#1)(2011-2#1)(2013-7#1)
were drawn from##11##3##(1993-12#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
were drawn##23##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
were dried##4##2##(2008-10#3)(2013-7#1)
were driven by##2##3##(2008-10#1)(2008-9#1)
were driven##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
were dropped##2##2##(2008-10#1)(2008-12#1)
were due to a##5##4##(1991-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-5#1)
were due to alterations##2##4##(1997-2#1)(2008-8#1)
were due to other##2##4##(2007-2#1)(2010-8#1)
were due to the##2##4##(2007-6#1)(2013-1#1)
were due to##25##3##(1991-5#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#2)
were each seen in##2##4##(2007-7#1)(2008-1#1)
were each##16##2##(1992-8#1)(1995-11#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
were earlier##2##2##(2007-7#1)(2008-12#1)
were early##3##2##(1990-6#1)(2009-8#1)(2010-3#1)
were easily identified by##2##4##(1992-2#1)(1996-12#1)
were easily##14##2##(1991-3#1)(1991-6#1)(1992-2#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-7#1)(2012-1#1)
were easy to##2##3##(1993-2#1)(2008-10#1)
were ecologically##2##2##(2008-10#1)(2008-8#1)
were effective for##3##3##(1997-3#1)(2008-10#2)
were effective in reducing the##2##5##(2007-8#1)(2008-10#1)
were effective in the##2##4##(2008-10#1)(2012-2#1)
were effective in##15##3##(1990-5#1)(1992-1#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
were effective##24##2##(1990-5#1)(1992-1#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
were effectively##11##2##(1992-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#2)(2009-7#1)(2012-2#2)(2013-1#1)
were efficient##7##2##(1997-3#1)(2008-10#4)(2008-3#1)(2010-11#1)
were efficiently transmitted##2##3##(2008-10#2)
were efficiently##11##2##(1991-6#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)
were eight##6##2##(1992-2#1)(1993-12#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-3#1)
were either absent or##2##4##(2008-10#1)(2008-8#1)
were either congruent or##2##4##(2012-1#1)(2013-8#1)
were either given##2##3##(1993-6#1)(1994-2#1)
were either homozygous##2##3##(2008-10#1)(2009-2#1)
were either not##2##3##(2008-10#1)(2008-7#1)
were either reduced##2##3##(1996-12#1)(2008-7#1)
were either treated##2##3##(1995-8#1)(2007-10#1)
were either##47##2##(1990-2#2)(1992-11#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-8#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
were elaborated##2##2##(2008-10#1)(2008-2#1)
were electrically stimulated##2##3##(1997-2#1)(2013-1#1)
were electrochemically##2##2##(2008-10#2)
were electrodeposited##2##2##(2008-10#2)
were elegible for##2##3##(1992-12#1)(2013-1#1)
were elevated in##12##3##(1991-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-2#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-6#1)
were elevated##21##2##(1990-11#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
were elicited##5##2##(1993-12#2)(1996-2#1)(2008-8#1)(2010-2#1)
were eligible for analysis##2##4##(2010-3#1)(2012-2#1)
were eligible for evaluation##4##4##(1997-7#2)(2011-2#2)
were eligible for the##2##4##(1997-7#1)(2012-3#1)
were eligible for this##2##4##(2013-1#1)(2013-8#1)
were eligible for##14##3##(1997-7#3)(2007-10#1)(2007-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
were eligible to##2##3##(2008-7#1)(2012-3#1)
were eligible##18##2##(1990-6#1)(1997-7#3)(2007-10#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
were eliminated by the##2##4##(2008-10#2)
were eliminated by##4##3##(1991-12#1)(2008-10#3)
were eliminated with##3##3##(2008-10#3)
were eliminated##17##2##(1991-12#1)(1994-9#1)(2007-2#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-2#1)
were elucidated by##6##3##(1990-7#1)(1995-11#2)(2007-1#1)(2009-2#1)(2011-3#1)
were elucidated on the basis of spectroscopic##2##7##(2008-10#1)(2013-1#1)
were elucidated on the basis of##3##6##(2008-10#1)(2008-8#1)(2013-1#1)
were elucidated##14##2##(1990-7#1)(1995-11#2)(2007-1#1)(2008-10#5)(2008-8#1)(2009-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
were eluted from the##6##4##(1992-12#1)(1994-9#1)(2008-10#4)
were eluted from##7##3##(1992-12#1)(1994-9#1)(2008-10#5)
were eluted in##2##3##(2008-10#2)
were eluted using##2##3##(1993-2#1)(2008-10#1)
were eluted with##5##3##(2008-10#5)
were eluted##24##2##(1990-8#1)(1992-12#1)(1993-2#1)(1994-9#1)(1997-2#1)(2008-10#19)
were embedded in##5##3##(2008-10#1)(2008-11#1)(2009-11#1)(2012-3#1)(2013-1#1)
were embolized##2##2##(1991-2#1)(2006-12#1)
were emitted##2##2##(2008-3#1)(2011-10#1)
were emphasised##2##2##(2008-10#1)(2010-2#1)
were employed as##5##3##(1993-3#1)(2008-10#3)(2010-5#1)
were employed for the##7##4##(2008-10#6)(2008-7#1)
were employed for##11##3##(2008-10#10)(2008-7#1)
were employed in the##5##4##(1992-9#1)(2007-12#2)(2008-12#1)(2013-1#1)
were employed in##8##3##(1992-9#1)(1997-7#1)(2007-12#2)(2008-11#1)(2008-12#1)(2010-11#1)(2013-1#1)
were employed to assess the##2##5##(1995-12#1)(1996-2#1)
were employed to confirm##2##4##(2008-7#1)(2013-8#1)
were employed to##25##3##(1994-11#1)(1994-9#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-7#1)(2011-3#1)(2013-8#3)
were employed##82##2##(1990-8#2)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-5#2)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#27)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-7#2)(2010-11#1)(2010-5#1)(2010-7#1)(2011-3#1)(2013-1#1)(2013-8#3)
were enclosed##2##2##(2008-10#2)
were encountered in##6##3##(1991-3#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
were encountered##12##2##(1991-2#1)(1991-3#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
were engaged in##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
were engaged##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
were engineered for##2##3##(1997-2#1)(2008-7#1)
were engineered to##2##3##(1994-8#1)(2010-2#1)
were engineered##4##2##(1994-8#1)(1997-2#1)(2008-7#1)(2010-2#1)
were enhanced by##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
were enhanced in the latently infected strain##2##7##(2008-10#2)
were enhanced in##3##3##(2008-10#2)(2008-7#1)
were enhanced##18##2##(1995-4#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
were enlarged##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
were enriched from##2##3##(1994-3#1)(2008-10#1)
were enriched in the##3##4##(1994-8#1)(2008-10#2)
were enriched in##7##3##(1990-12#1)(1993-6#1)(1994-8#1)(2008-10#3)(2009-8#1)
were enriched with##3##3##(2008-10#1)(2008-11#2)
were enriched##15##2##(1990-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1997-2#1)(2008-10#6)(2008-11#2)(2009-12#1)(2009-8#1)
were enrolled and##2##3##(2013-1#2)
were enrolled at##2##3##(2010-6#1)(2013-8#1)
were enrolled during the##2##4##(1995-9#1)(2007-7#1)
were enrolled for the study##2##5##(2008-3#1)(2010-7#1)
were enrolled for the##3##4##(2008-3#1)(2010-7#1)(2012-3#1)
were enrolled for##5##3##(2008-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
were enrolled in a prospective##2##5##(2007-7#1)(2008-9#1)
were enrolled in a##6##4##(2007-7#1)(2008-6#2)(2008-9#1)(2010-4#1)(2012-3#1)
were enrolled in the study##9##5##(1994-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)
were enrolled in the##10##4##(1994-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
were enrolled in this study##5##5##(1994-12#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
were enrolled in this##8##4##(1994-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
were enrolled in##35##3##(1991-12#1)(1994-12#1)(1994-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
were enrolled##71##2##(1990-3#1)(1991-12#1)(1994-12#1)(1994-2#1)(1995-9#1)(1997-2#1)(2007-10#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#2)
were entered in the##2##4##(2007-8#1)(2008-7#1)
were entered in this##2##4##(1990-2#1)(1994-7#1)
were entered in##4##3##(1990-2#1)(1994-7#1)(2007-8#1)(2008-7#1)
were entered into a##2##4##(2008-1#1)(2008-6#1)
were entered into the study##2##5##(2008-1#1)(2011-1#1)
were entered into the##3##4##(2007-7#1)(2008-1#1)(2011-1#1)
were entered into##5##3##(2007-7#1)(2008-1#2)(2008-6#1)(2011-1#1)
were entered##10##2##(1990-2#1)(1994-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)
were entirely##4##2##(2008-10#3)(2008-6#1)
were enucleated##2##2##(1994-8#1)(2008-9#1)
were enzymatically##2##2##(1995-5#1)(2008-5#1)
were equal in##2##3##(2008-10#1)(2012-3#1)
were equal to or##2##4##(1992-9#1)(2008-10#1)
were equal to##5##3##(1992-3#1)(1992-9#1)(1995-3#1)(2008-10#2)
were equal##14##2##(1992-3#1)(1992-9#1)(1995-3#1)(2007-8#1)(2008-10#6)(2008-8#1)(2011-2#2)(2012-3#1)
were equally effective against##2##4##(2008-10#2)
were equally effective in##2##4##(2008-10#2)
were equally effective##6##3##(2008-10#4)(2008-4#1)(2013-8#1)
were equally likely to##2##4##(1995-3#1)(2007-10#1)
were equally potent in##2##4##(1992-3#1)(2008-4#1)
were equally potent##3##3##(1991-9#1)(1992-3#1)(2008-4#1)
were equally susceptible to##2##4##(1995-11#1)(2008-10#1)
were equally susceptible##4##3##(1995-11#1)(1997-3#1)(2008-10#2)
were equally##29##2##(1991-9#1)(1992-3#2)(1992-8#1)(1994-2#1)(1995-11#2)(1995-3#1)(1997-3#1)(1997-9#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
were equipotent##2##2##(1995-12#1)(1995-3#1)
were equipped with##2##3##(1990-12#1)(2008-8#1)
were equivalent to##3##3##(1993-8#1)(1994-8#1)(2008-11#1)
were equivalent##8##2##(1993-8#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
were especially##4##2##(1990-9#1)(1994-6#1)(2008-10#1)(2009-9#1)
were essential for##2##3##(2008-10#2)
were essential##3##2##(2008-10#3)
were essentially##11##2##(1990-5#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
were established and##6##3##(1991-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)
were established as##7##3##(2007-11#1)(2008-10#4)(2008-11#1)(2012-3#1)
were established at##2##3##(1994-9#1)(2007-5#1)
were established between##2##3##(2008-10#1)(2008-5#1)
were established by means of##2##5##(2007-11#1)(2008-11#1)
were established by##11##3##(1992-8#1)(1993-11#1)(1994-12#1)(2007-11#2)(2008-10#3)(2008-11#3)
were established for the##6##4##(2008-10#3)(2008-6#1)(2011-2#1)(2012-12#1)
were established for##11##3##(1994-9#1)(2008-10#6)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)
were established from##4##3##(1996-2#1)(2008-10#1)(2008-11#2)
were established in the##4##4##(1997-4#1)(2008-10#3)
were established in##8##3##(1997-4#1)(2008-10#6)(2013-8#1)
were established on the basis of##2##6##(2007-11#2)
were established to##8##3##(2007-11#1)(2008-10#7)
were established using##2##3##(1997-9#1)(2008-5#1)
were established with##4##3##(2007-10#1)(2008-10#1)(2008-9#1)(2009-3#1)
were established##108##2##(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1994-12#1)(1994-9#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-10#1)(2007-11#6)(2007-5#1)(2008-10#56)(2008-11#9)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#5)(2009-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
were estimated and##3##3##(2008-10#2)(2012-12#1)
were estimated as 0##3##4##(2008-10#3)
were estimated as##11##3##(2008-10#11)
were estimated at each##2##4##(2008-10#2)
were estimated at##6##3##(1991-1#1)(2008-10#4)(2011-2#1)
were estimated by using##3##4##(1994-5#1)(2008-10#2)
were estimated by##18##3##(1993-9#1)(1994-5#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-5#1)(2009-8#1)
were estimated for each##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
were estimated for##9##3##(1995-11#1)(2008-10#6)(2008-5#1)(2011-2#1)
were estimated from a##2##4##(2008-12#1)(2008-5#1)
were estimated from the analytical curves##2##6##(2008-10#2)
were estimated from the##7##4##(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)
were estimated from##15##3##(2007-12#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
were estimated in##5##3##(1990-2#1)(2008-11#1)(2008-12#1)(2009-7#1)(2012-12#1)
were estimated to be 0##2##5##(1994-6#1)(2008-10#1)
were estimated to be less than##2##6##(1990-11#1)(2008-10#1)
were estimated to be##14##4##(1990-11#1)(1992-3#1)(1994-6#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-12#1)
were estimated to##21##3##(1990-11#1)(1992-3#1)(1993-3#1)(1994-6#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#3)
were estimated using##6##3##(2008-11#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
were estimated with##2##3##(2011-2#1)(2012-3#1)
were estimated##124##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#58)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#7)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
were euthanased##2##2##(1996-6#1)(1997-8#1)
were euthanized##2##2##(2008-10#1)(2011-2#1)
were evaluable for response##4##4##(1991-6#1)(2007-10#1)(2008-6#2)
were evaluable for##6##3##(1990-12#1)(1991-6#1)(2007-10#1)(2008-6#3)
were evaluable##12##2##(1990-10#1)(1990-12#1)(1990-2#3)(1991-3#1)(1991-6#1)(2007-10#1)(2008-6#3)(2008-7#1)
were evaluated according to##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
were evaluated after##3##3##(1992-4#1)(2008-2#1)(2013-1#1)
were evaluated and compared with##3##5##(2008-10#3)
were evaluated and compared##4##4##(2008-10#4)
were evaluated and the results##2##5##(2008-10#2)
were evaluated and the##6##4##(1991-5#1)(2008-10#5)
were evaluated and##20##3##(1991-5#1)(1992-3#1)(1992-6#1)(2008-10#14)(2008-11#1)(2011-2#1)(2012-2#1)
were evaluated as##12##3##(1996-9#1)(2008-10#4)(2008-6#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#1)
were evaluated at four##2##4##(2008-10#1)(2008-11#1)
were evaluated at the##2##4##(2008-10#2)
were evaluated at##8##3##(2008-10#5)(2008-11#1)(2011-2#1)(2013-1#1)
were evaluated based on##3##4##(2008-7#1)(2012-2#2)
were evaluated before##3##3##(1990-3#1)(2008-4#1)(2013-1#1)
were evaluated by a##2##4##(2007-8#1)(2008-11#1)
were evaluated by comparing the##2##5##(2008-10#2)
were evaluated by comparing##3##4##(2008-10#2)(2008-5#1)
were evaluated by means of a##2##6##(1991-12#1)(2008-6#1)
were evaluated by means of the##3##6##(2008-10#1)(2008-11#1)(2011-1#1)
were evaluated by means of##7##5##(1991-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)
were evaluated by measuring##2##4##(2008-10#1)(2009-11#1)
were evaluated by the analysis of##2##6##(2008-10#2)
were evaluated by the##7##4##(2007-8#1)(2008-10#5)(2008-6#1)
were evaluated by using##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
were evaluated by##59##3##(1991-12#1)(1992-12#1)(1992-3#1)(1995-3#1)(1997-6#1)(2007-10#2)(2007-8#3)(2008-10#25)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)
were evaluated during the##3##4##(1992-2#1)(2008-7#1)(2013-8#1)
were evaluated during##5##3##(1992-2#1)(1995-2#1)(1995-4#1)(2008-7#1)(2013-8#1)
were evaluated every##2##3##(2013-8#2)
were evaluated for analgesic##2##4##(2011-1#2)
were evaluated for efficacy##3##4##(1994-7#1)(2008-10#1)(2008-3#1)
were evaluated for gray leaf spot##2##6##(2008-10#2)
were evaluated for resistance to##4##5##(2008-10#4)
were evaluated for the determination of##3##6##(2008-10#3)
were evaluated for the##16##4##(1990-12#1)(1991-5#1)(2008-10#10)(2008-11#2)(2008-3#1)(2011-3#1)
were evaluated for their ability to##3##6##(1992-9#1)(2008-10#2)
were evaluated for their capacity to##2##6##(1991-11#1)(2011-1#1)
were evaluated for their effects on the##2##7##(2008-10#1)(2011-2#1)
were evaluated for their effects on##4##6##(2008-10#3)(2011-2#1)
were evaluated for their##16##4##(1991-11#1)(1992-9#1)(2008-10#9)(2008-12#1)(2011-1#2)(2011-2#1)(2012-12#1)
were evaluated for trace enrichment of metal ions##2##8##(2008-10#2)
were evaluated for##92##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-7#1)(2008-1#1)(2008-10#48)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
were evaluated four times##2##4##(2008-10#2)
were evaluated from the##3##4##(2008-3#1)(2008-5#1)(2008-6#1)
were evaluated from##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
were evaluated in 29##2##4##(1991-2#1)(2008-10#1)
were evaluated in a##3##4##(2008-12#1)(2008-3#1)(2008-7#1)
were evaluated in clinical trials##2##5##(2007-10#1)(2008-8#1)
were evaluated in detail##2##4##(2008-10#1)(2013-1#1)
were evaluated in greenhouse##2##4##(2008-10#2)
were evaluated in inoculated and##2##5##(2008-10#2)
were evaluated in relation to##2##5##(1991-12#1)(2009-12#1)
were evaluated in terms of##3##5##(2008-10#1)(2008-6#1)(2008-9#1)
were evaluated in the greenhouse for##2##6##(2008-10#2)
were evaluated in the presence of##2##6##(2008-10#1)(2008-12#1)
were evaluated in the presence##3##5##(2008-10#1)(2008-11#1)(2008-12#1)
were evaluated in the study##2##5##(2011-1#1)(2011-2#1)
were evaluated in the##13##4##(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
were evaluated in this##2##4##(2008-7#1)(2013-8#1)
were evaluated in three##2##4##(2008-10#2)
were evaluated in##75##3##(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-8#1)(1995-3#2)(1996-9#1)(1997-7#1)(2007-10#2)(2007-9#1)(2008-10#26)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
were evaluated on a##2##4##(2008-10#1)(2013-1#1)
were evaluated on the basis of##4##6##(1991-1#1)(2007-7#1)(2007-8#1)(2008-5#1)
were evaluated on the##6##4##(1990-7#1)(1991-1#1)(2007-7#1)(2007-8#1)(2008-5#1)(2013-8#1)
were evaluated on##11##3##(1990-7#1)(1991-1#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
were evaluated over##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
were evaluated through##2##3##(2007-8#1)(2011-2#1)
were evaluated to determine the##2##5##(2008-10#2)
were evaluated to determine their##2##5##(2008-10#2)
were evaluated to determine##4##4##(2008-10#4)
were evaluated to##11##3##(1994-5#1)(1997-3#1)(2008-10#9)
were evaluated under controlled##2##4##(2008-10#2)
were evaluated under##5##3##(1997-3#1)(2008-10#4)
were evaluated using a##2##4##(2008-10#1)(2013-1#1)
were evaluated using the##4##4##(2006-12#1)(2007-8#1)(2008-10#2)
were evaluated using##27##3##(1992-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-3#1)(2006-12#1)(2007-8#1)(2008-10#13)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#3)
were evaluated with a##2##4##(2008-3#1)(2011-2#1)
were evaluated with respect to the##2##6##(2011-2#1)(2012-2#1)
were evaluated with respect to##3##5##(2008-10#1)(2011-2#1)(2012-2#1)
were evaluated with the##3##4##(1996-11#1)(2008-10#1)(2013-1#1)
were evaluated with transvaginal color Doppler##2##6##(1995-3#2)
were evaluated with##15##3##(1995-2#1)(1995-3#2)(1996-11#1)(2008-10#6)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
were evaluated##517##2##(1990-12#1)(1990-3#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-2#3)(1995-3#5)(1995-4#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-9#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#6)(2007-11#4)(2007-12#1)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#223)(2008-11#12)(2008-12#12)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#11)(2008-6#15)(2008-7#14)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#13)(2011-2#18)(2011-3#2)(2012-12#7)(2012-2#9)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#22)(2013-7#4)(2013-8#10)
were evaporated to dryness##2##4##(2008-10#2)
were evaporated##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
were even##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
were evenly distributed##2##3##(2008-12#1)(2010-8#1)
were ever##2##2##(1995-1#1)(1997-3#1)
were evidenced in##2##3##(1994-3#1)(2008-10#1)
were evidenced##7##2##(1994-3#2)(2008-10#2)(2008-5#1)(2012-3#2)
were evident after##3##3##(1993-12#1)(1994-12#1)(2012-3#1)
were evident among##2##3##(1994-1#1)(2008-10#1)
were evident from##2##3##(2008-10#1)(2008-11#1)
were evident in##6##3##(1991-5#1)(1996-3#1)(2007-10#1)(2008-3#1)(2010-1#1)(2010-8#1)
were evident on##2##3##(1997-6#1)(2008-10#1)
were evident##31##2##(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#8)(2008-11#2)(2008-3#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#2)
were evoked##2##2##(1995-12#1)(2011-2#1)
were exacerbated##4##2##(1995-8#1)(2012-7#1)(2013-1#2)
were examined after##4##3##(1993-8#2)(1997-5#1)(2008-10#1)
were examined among##2##3##(1992-2#1)(2009-5#1)
were examined and compared##3##4##(1992-5#1)(2008-10#2)
were examined and the##2##4##(2008-10#2)
were examined and##15##3##(1992-5#1)(1994-1#1)(1996-6#1)(2007-12#1)(2008-10#8)(2011-2#2)(2013-1#1)
were examined as well##2##4##(2008-10#1)(2010-7#1)
were examined as##7##3##(2008-10#4)(2009-8#1)(2010-7#1)(2011-2#1)
were examined at different##2##4##(2008-8#1)(2011-2#1)
were examined at the##2##4##(1996-6#1)(2008-10#1)
were examined at##10##3##(1990-12#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
were examined by electron##2##4##(1993-11#1)(2008-7#1)
were examined by light microscopy##2##5##(2008-11#1)(2008-7#1)
were examined by means of##2##5##(2011-2#1)(2013-1#1)
were examined by microarray analysis##2##5##(2007-11#1)(2008-10#1)
were examined by scanning electron microscopy##2##6##(2008-10#1)(2013-1#1)
were examined by the##2##4##(2008-5#1)(2013-1#1)
were examined by transmission electron microscopy##2##6##(1997-6#1)(2008-10#1)
were examined by##51##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-11#1)(2009-6#1)(2010-5#1)(2010-9#1)(2011-2#2)(2013-1#6)
were examined for the presence of##4##6##(2008-10#3)(2008-5#1)
were examined for the##13##4##(1991-12#1)(1991-8#1)(1992-3#1)(2008-10#8)(2008-5#1)(2013-1#1)
were examined for their ability to##5##6##(1994-6#1)(2008-10#2)(2008-5#1)(2009-4#1)
were examined for their##12##4##(1991-2#1)(1992-2#1)(1993-12#1)(1994-6#1)(2008-10#6)(2008-5#1)(2009-4#1)
were examined for##61##3##(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
were examined from##2##3##(2010-1#1)(2010-8#1)
were examined histologically##2##3##(2008-7#1)(2013-1#1)
were examined histopathologically##2##3##(2008-5#1)(2012-1#1)
were examined immunohistochemically##2##3##(1995-12#1)(2008-4#1)
were examined in a##7##4##(1992-9#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-9#1)
were examined in cultured##2##4##(1995-12#1)(2008-11#1)
were examined in detail##2##4##(2008-10#2)
were examined in order to##3##5##(1996-12#2)(2008-10#1)
were examined in terms of##2##5##(2008-11#1)(2008-12#1)
were examined in the##10##4##(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
were examined in this study##5##5##(1991-4#1)(1992-9#1)(1995-6#1)(2008-10#2)
were examined in two##2##4##(1993-12#1)(2008-1#1)
were examined in vitro##3##4##(1994-8#1)(2008-10#2)
were examined in##71##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were examined on##4##3##(1993-12#1)(1995-12#1)(2010-7#1)(2010-8#1)
were examined over##2##3##(1991-3#1)(2008-10#1)
were examined pathologically##2##3##(1997-3#1)(1997-6#1)
were examined to determine whether##2##5##(1992-12#1)(1993-8#1)
were examined to determine which##2##5##(2008-10#2)
were examined to determine##6##4##(1992-12#1)(1993-8#1)(2008-10#4)
were examined to identify##2##4##(2008-10#1)(2008-6#1)
were examined to##10##3##(1992-12#1)(1993-8#1)(2008-10#6)(2008-11#1)(2008-6#1)
were examined twice##2##3##(2007-8#1)(2012-3#1)
were examined under##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2013-8#1)
were examined using a##4##4##(1994-5#1)(2008-10#2)(2008-6#1)
were examined using an##3##4##(1991-12#1)(1994-11#1)(2008-11#1)
were examined using light##2##4##(2008-10#1)(2008-7#1)
were examined using the##2##4##(1992-6#1)(2008-7#1)
were examined using##27##3##(1990-5#1)(1990-7#1)(1991-12#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-7#1)(1995-2#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#2)(2010-4#1)(2013-8#1)
were examined with different##2##4##(1996-10#1)(2012-2#1)
were examined with the##3##4##(1997-3#1)(2008-10#1)(2012-12#1)
were examined with##13##3##(1991-10#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
were examined##450##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#126)(2008-11#16)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#17)(2008-6#4)(2008-7#19)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#5)
were excellent##9##2##(1992-2#1)(1992-6#1)(1992-9#1)(1996-7#2)(1996-9#1)(2007-10#1)(2008-10#1)(2008-3#1)
were exchanged for##3##3##(1993-11#1)(2008-10#2)
were exchanged##5##2##(1993-11#1)(2007-7#1)(2008-10#2)(2009-5#1)
were excised##5##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
were excited by##3##3##(1993-12#1)(1997-3#1)(2008-3#1)
were excited with##2##3##(2008-3#2)
were excited##7##2##(1992-4#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-3#3)
were excluded because##2##3##(2007-10#1)(2008-10#1)
were excluded by##2##3##(1992-3#1)(2007-10#1)
were excluded from the analysis##3##5##(1993-12#1)(1996-11#1)(2011-2#1)
were excluded from the study##8##5##(1991-12#1)(2008-10#2)(2008-7#1)(2011-2#2)(2013-1#2)
were excluded from the##13##4##(1991-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(2008-10#2)(2008-7#1)(2011-2#3)(2013-1#2)
were excluded from##15##3##(1991-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#3)(2013-1#2)
were excluded if they##3##4##(2012-12#2)(2013-1#1)
were excluded##47##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-3#1)(2008-7#3)(2009-8#2)(2011-1#1)(2011-2#3)(2012-12#5)(2013-1#6)(2013-8#4)
were exclusively##5##2##(2008-10#4)(2010-6#1)
were excreted##2##2##(1991-12#1)(2008-10#1)
were executed##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
were exhausted##3##2##(2008-10#1)(2010-8#1)(2011-3#1)
were exhibited by##2##3##(1995-11#1)(1996-2#1)
were exhibited##3##2##(1995-11#1)(1996-2#1)(2008-10#1)
were expanded in##2##3##(1990-8#1)(2008-9#1)
were expected on the basis of##2##6##(1991-2#1)(1993-9#1)
were expected to##5##3##(1994-5#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
were expected##11##2##(1991-2#1)(1993-9#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2013-1#1)
were experienced##4##2##(1993-1#1)(2006-12#1)(2007-12#1)(2013-7#1)
were experiencing##4##2##(1996-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
were experimentally confirmed##3##3##(2008-2#1)(2008-3#1)(2009-6#1)
were experimentally observed##3##3##(2007-11#2)(2008-2#1)
were experimentally obtained##2##3##(2007-11#1)(2008-3#1)
were experimentally verified##2##3##(1990-2#1)(2007-12#1)
were experimentally##17##2##(1990-2#1)(1997-6#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-6#1)(2012-9#1)
were explained by assuming the presence of##2##7##(2008-10#2)
were explained by assuming the##3##5##(2008-10#3)
were explained by the##2##4##(2008-10#1)(2008-12#1)
were explained by##7##3##(2008-10#4)(2008-12#1)(2008-8#2)
were explained##10##2##(2008-10#7)(2008-12#1)(2008-8#2)
were explanted and##2##3##(2008-9#1)(2012-3#1)
were explanted##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
were exploited##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
were explored by##2##3##(1993-12#1)(2007-6#1)
were explored in a##2##4##(2008-10#1)(2010-1#1)
were explored in##4##3##(2007-12#1)(2008-10#2)(2010-1#1)
were explored##18##2##(1993-12#1)(1997-3#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
were exponentially distributed with an overall median of##2##8##(2008-8#2)
were exposed in##3##3##(2008-10#2)(2012-3#1)
were exposed only##2##3##(2008-9#2)
were exposed to 10##2##4##(1992-3#1)(2008-10#1)
were exposed to 25##2##4##(2008-10#2)
were exposed to a median of##2##6##(1990-2#2)
were exposed to a range of##2##6##(1997-4#1)(2010-5#1)
were exposed to a##12##4##(1990-2#2)(1994-6#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
were exposed to constant##2##4##(2008-10#1)(2012-4#1)
were exposed to different##3##4##(2008-10#2)(2013-1#1)
were exposed to more##2##4##(1990-2#1)(2008-4#1)
were exposed to the##9##4##(1991-9#1)(1992-5#1)(1995-8#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
were exposed to##108##3##(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-8#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(2007-11#2)(2007-7#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#13)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-4#1)(2012-8#1)(2013-1#4)
were exposed##130##2##(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1993-12#1)(1993-8#2)(1994-6#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#5)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#5)(2008-9#16)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#4)
were expressed as the##2##4##(1995-2#1)(2008-10#1)
were expressed as##8##3##(1993-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
were expressed at high levels##2##5##(1996-2#1)(2013-7#1)
were expressed at##7##3##(1995-11#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-7#1)
were expressed in a##4##4##(1993-8#1)(1995-8#1)(1997-7#1)(2008-11#1)
were expressed in all##4##4##(2008-5#1)(2011-2#1)(2012-3#2)
were expressed in the##7##4##(1995-2#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)
were expressed in vitro##2##4##(1995-8#1)(2008-10#1)
were expressed in##40##3##(1991-11#1)(1991-12#1)(1992-6#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#2)(2012-3#2)
were expressed ubiquitously##2##3##(1993-3#1)(1996-10#1)
were expressed##78##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-11#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
were extended to##2##3##(1994-12#1)(2008-10#1)
were extended##5##2##(1994-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
were extensively##3##2##(1995-3#1)(1997-4#1)(2013-1#1)
were extracted and then##2##4##(1997-7#1)(2008-10#1)
were extracted and##7##3##(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#1)
were extracted by##13##3##(1991-7#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
were extracted for##3##3##(2008-10#2)(2011-2#1)
were extracted from a##3##4##(2008-10#1)(2010-4#1)(2012-3#1)
were extracted from the##6##4##(2007-11#1)(2008-10#4)(2008-3#1)
were extracted from two##2##4##(2008-10#1)(2008-8#1)
were extracted from##30##3##(1993-2#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
were extracted in##2##3##(2008-10#2)
were extracted into chloroform##2##4##(2008-10#2)
were extracted into##4##3##(2008-10#4)
were extracted using##2##3##(1990-8#1)(2008-10#1)
were extracted with a##2##4##(2008-10#2)
were extracted with##19##3##(1996-5#1)(2008-10#12)(2008-5#3)(2008-6#1)(2008-7#1)(2011-1#1)
were extracted##96##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-8#1)(1993-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#49)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
were extrapolated##2##2##(2008-10#1)(2008-2#1)
were extremely sensitive##2##3##(2008-10#1)(2008-9#1)
were extremely##6##2##(1995-11#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
were fabricated and characterized##2##4##(2008-10#2)
were fabricated and##4##3##(2008-10#2)(2008-3#2)
were fabricated at the##2##4##(2008-10#1)(2008-2#1)
were fabricated by means of##3##5##(2007-11#1)(2008-3#2)
were fabricated by##16##3##(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2009-5#1)(2009-7#1)(2013-8#2)
were fabricated from##4##3##(2007-11#2)(2008-2#2)
were fabricated in photoresist##2##4##(2008-2#1)(2008-3#1)
were fabricated in##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
were fabricated on##2##3##(2008-2#1)(2008-3#1)
were fabricated to##2##3##(2008-2#1)(2009-12#1)
were fabricated using##2##3##(2009-11#2)
were fabricated with a##2##4##(2008-3#2)
were fabricated with##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
were fabricated##54##2##(2007-11#7)(2007-12#4)(2008-10#8)(2008-12#1)(2008-2#12)(2008-3#14)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#1)(2013-1#1)(2013-8#2)
were faced##3##2##(2007-5#1)(2008-10#1)(2009-5#1)
were factors##2##2##(1994-12#1)(2010-8#1)
were fairly##8##2##(1996-12#1)(2008-10#4)(2009-9#1)(2010-1#1)(2012-1#1)
were familiar##2##2##(1990-6#1)(2008-3#1)
were far more##2##3##(2008-10#1)(2013-1#1)
were far##5##2##(2007-10#1)(2008-10#2)(2008-11#1)(2013-1#1)
were faster to##2##3##(2008-9#1)(2010-5#1)
were faster##3##2##(2007-12#1)(2008-9#1)(2010-5#1)
were favorable##2##2##(2009-4#1)(2013-1#1)
were favored##2##2##(1995-3#1)(2008-10#1)
were fed 0##3##3##(2008-10#1)(2010-2#2)
were fed a##5##3##(1997-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
were fed as##2##3##(2010-2#1)(2010-4#1)
were fed daily##2##3##(2008-10#1)(2008-6#1)
were fed diets containing##6##4##(2008-7#1)(2008-8#3)(2008-9#2)
were fed diets##7##3##(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)
were fed inhibitors of##2##4##(2008-8#2)
were fed on##5##3##(1995-2#1)(1997-8#1)(2008-10#3)
were fed the##4##3##(1993-11#1)(2008-10#1)(2008-12#1)(2010-2#1)
were fed to##2##3##(2008-12#2)
were fed with##7##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
were fed##58##2##(1993-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#4)(2009-9#1)(2010-2#5)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#4)
were female and##4##3##(1997-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
were female##12##2##(1993-1#1)(1997-8#1)(2007-7#1)(2008-11#1)(2010-5#1)(2010-6#1)(2011-2#3)(2013-1#3)
were females and##6##3##(1991-8#1)(1992-5#1)(1995-10#1)(2007-10#1)(2008-8#1)(2013-1#1)
were females##15##2##(1991-8#1)(1992-5#1)(1995-10#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#2)
were fever##2##2##(2008-1#1)(2012-3#1)
were few##6##2##(1995-11#1)(1995-3#1)(2008-10#3)(2010-8#1)
were fewer hyphae##2##3##(2008-10#2)
were fewer##5##2##(2008-10#4)(2008-3#1)
were filled with##7##3##(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
were filled##8##2##(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-1#1)
were finally purified##2##3##(1993-11#1)(1996-5#1)
were finally##9##2##(1993-11#1)(1996-3#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#4)
were first applied to##2##4##(2008-8#1)(2011-2#1)
were first cousins##2##3##(2011-2#2)
were first described##3##3##(2008-5#2)(2011-2#1)
were first detected##3##3##(1993-3#1)(1995-11#1)(1997-6#1)
were first established in##2##4##(2008-11#1)(2012-2#1)
were first evaluated##2##3##(1997-6#1)(2008-10#1)
were first observed in##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
were first observed##8##3##(2008-10#6)(2008-7#1)(2012-1#1)
were first prepared##2##3##(2008-10#1)(2008-7#1)
were first tested##2##3##(1994-3#1)(2008-10#1)
were first##57##2##(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-6#2)(1997-7#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
were firstly##3##2##(2008-10#2)(2009-12#1)
were fit to a##2##4##(2008-10#1)(2010-11#1)
were fit to the##4##4##(2008-10#4)
were fit to##9##3##(2008-10#7)(2010-11#1)(2013-1#1)
were fit##10##2##(2008-10#8)(2010-11#1)(2013-1#1)
were fitted to a model##3##5##(2008-10#2)(2008-3#1)
were fitted to a##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
were fitted to the##7##4##(2008-10#4)(2008-2#2)(2008-3#1)
were fitted to##20##3##(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
were fitted with a##2##4##(2008-2#1)(2008-9#1)
were fitted with##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
were fitted##29##2##(1991-6#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
were five##7##2##(1994-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#2)
were fixated##2##2##(1991-9#1)(2007-11#1)
were fixed and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
were fixed at##3##3##(2008-10#2)(2010-2#1)
were fixed in##2##3##(2008-10#1)(2012-3#1)
were fixed with##3##3##(1990-8#1)(2012-2#2)
were fixed##18##2##(1990-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)
were flat##3##2##(2008-8#2)(2011-2#1)
were focused on##2##3##(2008-11#1)(2010-4#1)
were focused##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
were follow-up with colour-Doppler##2##4##(2011-2#2)
were followed by##6##3##(1994-6#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
were followed during the##2##4##(2008-11#1)(2013-1#1)
were followed for##12##3##(1990-2#1)(1991-4#1)(1992-11#1)(1993-2#2)(1996-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#2)
were followed in##2##3##(2012-3#1)(2013-1#1)
were followed over a##2##4##(2007-7#1)(2008-10#1)
were followed over##3##3##(2007-7#1)(2008-10#1)(2012-7#1)
were followed through##2##3##(2006-10#1)(2008-11#1)
were followed to##3##3##(1993-12#1)(2007-12#1)(2007-8#1)
were followed up at##5##4##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)
were followed up for a##2##5##(2007-8#1)(2013-8#1)
were followed up for three years##2##6##(1995-5#1)(1996-9#1)
were followed up for##11##4##(1991-9#1)(1995-5#1)(1996-9#1)(2007-7#2)(2007-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
were followed up##24##3##(1991-11#1)(1991-9#1)(1995-3#1)(1995-5#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were followed using##2##3##(2008-10#1)(2008-6#1)
were followed with##2##3##(2008-7#1)(2013-1#1)
were followed##71##2##(1990-2#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-2#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#3)(2012-6#1)(2012-7#2)(2013-1#8)(2013-8#1)
were followed-up at##2##3##(1991-6#1)(2011-2#1)
were followed-up for##2##3##(2007-7#1)(2008-1#1)
were followed-up##4##2##(1991-6#1)(2007-7#1)(2008-1#1)(2011-2#1)
were for##6##2##(1995-1#1)(1995-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
were forced to##2##3##(1996-6#1)(1997-5#1)
were forced##3##2##(1996-6#1)(1997-5#1)(2008-1#1)
were foreigners##2##2##(2007-2#2)
were formed by##10##3##(1991-5#1)(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2012-2#1)(2013-8#1)
were formed from the##2##4##(2008-11#1)(2012-2#1)
were formed from##5##3##(1994-8#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
were formed in the##3##4##(2008-10#2)(2008-5#1)
were formed in##8##3##(1991-5#1)(1995-6#1)(2008-10#4)(2008-5#1)(2008-7#1)
were formed on the##4##4##(1996-10#1)(2008-10#2)(2009-12#1)
were formed on##8##3##(1996-10#1)(2008-10#5)(2008-7#1)(2009-12#1)
were formed that##2##3##(2008-10#1)(2008-5#1)
were formed when##3##3##(1994-9#1)(1995-6#1)(2008-6#1)
were formed##58##2##(1990-11#1)(1991-5#2)(1991-6#1)(1993-6#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-6#3)(1996-10#1)(2007-11#3)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-11#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
were formulated as##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
were formulated in##2##3##(1994-12#1)(2008-5#1)
were formulated with##4##3##(1996-1#1)(2008-10#2)(2010-4#1)
were formulated##18##2##(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
were fortified##2##2##(2008-10#1)(2008-11#1)
were found (p&lt##2##3##(2008-5#1)(2010-4#1)
were found 1##2##3##(1992-9#1)(2013-8#1)
were found across##2##3##(2008-1#1)(2008-10#1)
were found after injections##2##4##(1991-2#1)(1995-2#1)
were found after##6##3##(1991-2#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#2)
were found along##2##3##(2010-8#1)(2011-2#1)
were found among the three##2##5##(2008-10#1)(2012-5#1)
were found among the##11##4##(1993-2#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-5#2)(2009-8#1)(2012-2#1)(2012-5#1)
were found among##21##3##(1993-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#9)(2008-5#2)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)
were found and##6##3##(1997-9#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#1)
were found as the##2##4##(1994-3#1)(2008-11#1)
were found as##9##3##(1994-3#1)(2008-10#3)(2008-11#3)(2008-12#1)(2012-12#1)
were found at the##7##4##(1997-5#1)(2008-10#3)(2008-12#2)(2008-7#1)
were found at##18##3##(1991-8#1)(1992-3#1)(1997-5#1)(2008-10#8)(2008-12#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#2)
were found based on##2##4##(2008-10#1)(2009-6#1)
were found between the indoor and##2##6##(2010-5#2)
were found between the two##2##5##(2008-10#1)(2008-7#1)
were found between the##22##4##(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1995-12#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#2)(2010-5#2)(2012-12#1)(2013-8#1)
were found between##55##3##(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-9#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
were found both##2##3##(1994-2#1)(1995-2#1)
were found by both##2##4##(2008-10#1)(2011-1#1)
were found by the##2##4##(1990-9#1)(2008-3#1)
were found by##8##3##(1990-9#1)(1994-5#1)(2007-10#1)(2008-10#3)(2008-3#1)(2011-1#1)
were found concerning##2##3##(2012-12#1)(2013-1#1)
were found during##3##3##(1990-6#1)(1995-9#1)(2010-9#1)
were found for both##2##4##(2007-12#1)(2008-10#1)
were found for each##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
were found for some##2##4##(2008-10#2)
were found for spiked concentration levels from##2##7##(2008-10#2)
were found for the determination of##2##6##(2008-10#2)
were found for the##11##4##(1996-6#1)(2007-11#1)(2008-10#6)(2008-7#1)(2011-1#1)(2013-7#1)
were found for##47##3##(1996-3#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
were found from##3##3##(2007-8#1)(2008-10#2)
were found highly##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
were found in 12%##2##4##(1992-9#1)(2008-8#1)
were found in 13##2##4##(2007-8#1)(2008-10#1)
were found in 43##2##4##(1994-6#1)(2012-3#1)
were found in 5##2##4##(2007-11#2)
were found in 7##2##4##(2007-11#1)(2008-10#1)
were found in 8##2##4##(2007-8#1)(2008-7#1)
were found in 90% of##2##5##(2007-8#1)(2008-10#1)
were found in M##2##4##(1996-5#1)(2011-10#1)
were found in a##5##4##(2008-10#3)(2008-5#1)(2011-2#1)
were found in all the##2##5##(2008-10#1)(2008-6#1)
were found in all##8##4##(1994-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-1#1)
were found in an##2##4##(1993-1#1)(2008-10#1)
were found in areas##2##4##(2008-10#2)
were found in both##8##4##(1992-8#1)(1994-2#1)(1996-5#2)(2008-10#2)(2008-6#1)(2008-7#1)
were found in concentrations##2##4##(2008-10#1)(2008-11#1)
were found in each of the##2##6##(2008-10#1)(2009-10#1)
were found in each##3##4##(2007-12#1)(2008-10#1)(2009-10#1)
were found in eight of the##2##6##(1992-3#1)(2008-7#1)
were found in patients with##2##5##(1990-12#1)(1995-12#1)
were found in patients##4##4##(1990-12#1)(1995-12#1)(2007-11#1)(2007-8#1)
were found in samples##2##4##(2008-10#2)
were found in seven##2##4##(1997-3#1)(2008-10#1)
were found in some##2##4##(2008-3#1)(2010-8#1)
were found in the faeces of##2##6##(1993-2#1)(2008-11#1)
were found in the group##2##5##(1993-8#1)(2013-1#1)
were found in the hippocampus##2##5##(1993-12#1)(1995-5#1)
were found in the present##2##5##(1997-3#1)(2013-8#1)
were found in the##78##4##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-6#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#3)(1997-4#1)(2007-5#1)(2007-6#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-5#2)(2013-1#3)(2013-7#2)(2013-8#2)
were found in these##2##4##(2008-10#1)(2008-5#1)
were found in this##2##4##(1993-2#1)(2008-5#1)
were found in two##5##4##(1993-12#1)(2007-12#1)(2008-10#2)(2008-5#1)
were found in##268##3##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-5#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#9)(1994-3#1)(1994-6#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#5)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2007-11#7)(2007-12#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#59)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#7)(2012-2#1)(2012-3#5)(2013-1#8)(2013-7#4)(2013-8#3)
were found infected##2##3##(2008-10#2)
were found mainly in##2##4##(1990-9#1)(2008-10#1)
were found mainly##3##3##(1990-9#1)(2008-10#2)
were found more##3##3##(1992-9#1)(2008-10#1)(2008-7#1)
were found most##4##3##(1991-10#1)(1992-3#1)(2008-10#1)(2012-2#1)
were found near##2##3##(1994-8#1)(2013-1#1)
were found not to##2##4##(2008-10#1)(2008-8#1)
were found on the##2##4##(1991-2#1)(2009-4#1)
were found on##10##3##(1991-2#1)(1992-12#1)(2008-10#6)(2009-11#1)(2009-4#1)
were found only in one##2##5##(2008-10#1)(2008-5#1)
were found only in the##2##5##(2008-10#1)(2009-10#1)
were found only in##8##4##(1991-9#1)(1995-11#1)(2008-10#4)(2008-5#1)(2009-10#1)
were found only within##2##4##(2008-10#1)(2008-7#1)
were found only##12##3##(1991-9#1)(1995-11#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
were found relevant##2##3##(2008-5#1)(2011-2#1)
were found statistically##2##3##(2011-2#2)
were found that##2##3##(1991-12#1)(2008-10#1)
were found to affect##4##4##(1992-3#1)(2008-10#1)(2008-12#1)(2010-4#1)
were found to be &gt##2##5##(2008-10#2)
were found to be 0##11##5##(2008-10#10)(2008-2#1)
were found to be 1##11##5##(1992-2#1)(2008-10#8)(2013-1#2)
were found to be 16##2##5##(1997-6#1)(2008-10#1)
were found to be 2##10##5##(1995-2#1)(2008-10#8)(2008-5#1)
were found to be 3##3##5##(2008-10#2)(2012-2#1)
were found to be 4##5##5##(1994-5#1)(1996-12#1)(2008-10#3)
were found to be 5##3##5##(2008-10#3)
were found to be 99##3##5##(2008-10#3)
were found to be a##3##5##(1994-2#1)(2008-10#2)
were found to be able to##2##6##(2008-10#2)
were found to be active against##2##6##(2007-11#1)(2011-1#1)
were found to be active##4##5##(1995-3#1)(2007-11#1)(2011-1#2)
were found to be associated with##3##6##(2006-10#1)(2011-2#1)(2012-2#1)
were found to be associated##4##5##(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
were found to be better than##2##6##(2008-10#1)(2008-5#1)
were found to be between##3##5##(2008-10#3)
were found to be close to##2##6##(1992-5#1)(2008-3#1)
were found to be comparable to those##2##7##(2008-10#1)(2008-7#1)
were found to be comparable to##3##6##(2008-10#2)(2008-7#1)
were found to be comparable with##3##6##(2008-10#3)
were found to be comparable##6##5##(2008-10#5)(2008-7#1)
were found to be completely##2##5##(1990-7#1)(2008-7#1)
were found to be composed of##2##6##(1994-6#1)(2008-10#1)
were found to be consistent with##4##6##(2008-10#1)(2008-3#2)(2008-7#1)
were found to be consistent##5##5##(2008-10#1)(2008-3#2)(2008-7#1)(2009-12#1)
were found to be dependent on##2##6##(1995-3#1)(2008-10#1)
were found to be differentially regulated##2##6##(2009-9#1)(2011-1#1)
were found to be effective in##3##6##(1990-3#1)(1994-3#1)(2010-7#1)
were found to be good##2##5##(1996-3#1)(2008-10#1)
were found to be greater in##2##6##(1996-7#1)(2010-3#1)
were found to be greater##3##5##(1996-7#1)(2008-2#1)(2010-3#1)
were found to be higher in normal##2##7##(2008-4#1)(2009-12#1)
were found to be higher##4##5##(2008-11#1)(2008-4#1)(2009-12#1)(2011-2#1)
were found to be highly correlated##2##6##(1997-2#1)(2008-7#1)
were found to be highly resistant to##2##7##(2008-10#1)(2008-8#1)
were found to be highly##9##5##(1992-5#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-3#1)
were found to be identical##3##5##(1990-8#1)(1997-6#1)(2008-2#1)
were found to be important##3##5##(1993-12#1)(2009-12#1)(2009-7#1)
were found to be in agreement with##2##7##(2008-10#2)
were found to be in good agreement##4##7##(2008-10#3)(2008-3#1)
were found to be in the range of##2##8##(2008-10#2)
were found to be in the##3##6##(1993-8#1)(2008-10#2)
were found to be in##13##5##(1993-8#1)(2008-10#9)(2008-3#1)(2008-8#1)(2012-12#1)
were found to be inactive when tested for##3##8##(1996-5#3)
were found to be independent of the##2##7##(2008-10#1)(2009-8#1)
were found to be independent##3##5##(2007-10#1)(2008-10#1)(2009-8#1)
were found to be ineffective##2##5##(1996-2#1)(2013-8#1)
were found to be infected by##2##6##(2008-10#2)
were found to be less##3##5##(2008-10#2)(2008-11#1)
were found to be linearly##2##5##(1995-3#1)(2008-10#1)
were found to be located in the##2##7##(1990-5#1)(2008-8#1)
were found to be located##3##5##(1990-5#1)(1997-6#1)(2008-8#1)
were found to be malignant##2##5##(1997-2#1)(2007-8#1)
were found to be more##5##5##(1997-1#1)(2008-5#1)(2008-8#2)(2010-3#1)
were found to be nearly identical##2##6##(1991-12#1)(1995-11#1)
were found to be positive for##2##6##(2007-7#1)(2013-8#1)
were found to be potent##2##5##(1990-2#1)(1991-5#1)
were found to be present in##2##6##(1995-8#1)(2008-10#1)
were found to be quite##2##5##(2008-10#1)(2008-3#1)
were found to be rather##2##5##(2008-10#2)
were found to be related to##3##6##(1995-6#1)(2008-7#2)
were found to be relatively##4##5##(2008-10#2)(2008-2#1)(2010-7#1)
were found to be rich in##2##6##(1995-11#1)(2008-11#1)
were found to be sensitive to##3##6##(1997-4#1)(2008-8#1)(2010-8#1)
were found to be sensitive##5##5##(1997-4#1)(2008-10#2)(2008-8#1)(2010-8#1)
were found to be significantly associated with##2##7##(2011-1#1)(2012-2#1)
were found to be significantly different##2##6##(2007-12#1)(2008-2#1)
were found to be significantly higher##3##6##(1996-1#1)(2008-4#1)(2011-1#1)
were found to be significantly##15##5##(1992-11#1)(1992-12#1)(1996-1#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#2)(2012-2#1)
were found to be similar to##2##6##(2008-10#2)
were found to be similar##5##5##(1993-3#1)(2008-10#3)(2008-3#1)
were found to be stable##2##5##(1992-6#1)(2008-10#1)
were found to be statistically##3##5##(2008-10#1)(2010-8#1)(2012-12#1)
were found to be strongly##3##5##(1991-12#1)(2008-2#1)(2008-8#1)
were found to be the main##3##6##(2007-7#1)(2008-10#1)(2008-11#1)
were found to be the most##4##6##(1991-6#1)(2008-6#1)(2013-1#1)(2013-7#1)
were found to be the same##2##6##(2008-7#1)(2008-8#1)
were found to be the##13##5##(1990-9#1)(1991-6#1)(1994-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#1)
were found to be tolerable##2##5##(2008-10#2)
were found to be unique##2##5##(2008-10#1)(2008-7#1)
were found to be useful##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
were found to be very##3##5##(1991-9#1)(2007-7#1)(2008-10#1)
were found to be##369##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-8#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#3)(1995-8#3)(1996-1#1)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#3)(1997-5#1)(1997-6#3)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#141)(2008-11#12)(2008-12#3)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#13)(2008-8#10)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
were found to bind##6##4##(1990-11#1)(1992-11#1)(1992-9#1)(1995-5#1)(1995-6#1)(2011-1#1)
were found to carry##2##4##(1993-6#1)(1995-9#1)
were found to code for P450##2##6##(1993-6#2)
were found to contain##12##4##(1991-8#1)(1994-12#2)(1995-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-10#4)(2008-12#1)
were found to correlate with##2##5##(2008-10#1)(2011-1#1)
were found to correlate##3##4##(1992-2#1)(2008-10#1)(2011-1#1)
were found to correspond to##2##5##(2008-10#2)
were found to decrease in##2##5##(1994-5#1)(2008-10#1)
were found to decrease##4##4##(1994-5#1)(2008-10#2)(2008-7#1)
were found to depend##3##4##(1991-1#1)(1997-7#1)(2008-3#1)
were found to display##2##4##(1990-12#1)(2008-10#1)
were found to either##2##4##(2008-10#1)(2010-11#1)
were found to enhance the##3##5##(2008-10#1)(2008-11#2)
were found to exert##2##4##(1995-3#1)(2008-10#1)
were found to express##2##4##(1994-9#1)(1995-11#1)
were found to give##5##4##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
were found to have a##7##5##(1991-12#1)(1993-3#1)(2007-10#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
were found to have an##2##5##(2008-10#1)(2008-2#1)
were found to have increased##2##5##(1992-9#1)(2009-11#1)
were found to have significant influence on extraction efficiency##2##9##(2008-10#2)
were found to have significant##4##5##(2008-10#4)
were found to have##57##4##(1991-12#2)(1991-9#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-7#1)(2007-10#2)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-9#4)(2009-11#1)(2012-2#5)(2012-3#2)(2013-8#1)
were found to increase##4##4##(1992-11#1)(1993-12#1)(1996-5#1)(2008-2#1)
were found to induce##3##4##(1993-6#1)(1995-12#1)(2008-10#1)
were found to inhibit##6##4##(1994-8#1)(2008-10#2)(2008-8#1)(2010-2#1)(2011-3#1)
were found to possess##2##4##(2008-11#1)(2009-11#1)
were found to react with##2##5##(1991-7#1)(2008-10#1)
were found to stimulate##3##4##(1990-10#1)(1994-9#1)(1995-2#1)
were found to vary##6##4##(1995-3#1)(1997-3#1)(2008-10#3)(2008-3#1)
were found to##584##3##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#8)(1993-3#2)(1993-6#5)(1993-8#3)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#6)(1995-12#3)(1995-2#6)(1995-3#5)(1995-5#2)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#7)(1996-2#3)(1996-3#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(2006-10#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#196)(2008-11#25)(2008-12#8)(2008-2#12)(2008-3#14)(2008-4#7)(2008-5#13)(2008-6#1)(2008-7#16)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#5)(2009-12#4)(2009-2#3)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#11)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#12)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#4)
were found under##2##3##(1994-10#1)(2008-10#1)
were found using the reported search##5##6##(2007-8#5)
were found using the##6##4##(2007-8#5)(2013-8#1)
were found using##8##3##(2007-8#5)(2009-8#1)(2013-1#1)(2013-8#1)
were found when a##2##4##(1997-8#1)(2008-10#1)
were found when##4##3##(1997-8#1)(2008-10#3)
were found which##2##3##(2011-2#1)(2012-12#1)
were found with##14##3##(1990-3#1)(1990-5#1)(1993-9#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
were found within the##2##4##(1993-12#1)(2008-5#1)
were found within##9##3##(1993-12#1)(1995-12#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-5#2)(2008-7#1)
were found##1331##2##(1990-10#1)(1990-11#5)(1990-12#8)(1990-2#6)(1990-3#5)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#12)(1991-2#4)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#5)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#8)(1992-5#3)(1992-6#3)(1992-8#5)(1992-9#8)(1993-1#3)(1993-11#4)(1993-12#14)(1993-2#6)(1993-3#2)(1993-6#8)(1993-8#6)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#11)(1994-3#5)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#10)(1995-12#8)(1995-2#11)(1995-3#6)(1995-5#4)(1995-6#6)(1995-8#3)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#10)(1996-2#6)(1996-3#3)(1996-5#9)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#12)(1997-4#13)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#4)(1997-9#1)(2006-10#1)(2006-6#1)(2007-10#7)(2007-11#18)(2007-12#16)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#15)(2008-1#8)(2008-10#397)(2008-11#41)(2008-12#28)(2008-2#16)(2008-3#19)(2008-4#10)(2008-5#40)(2008-6#7)(2008-7#44)(2008-8#23)(2008-9#15)(2009-10#3)(2009-11#8)(2009-12#5)(2009-2#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#10)(2010-4#5)(2010-5#8)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#21)(2011-10#1)(2011-2#32)(2011-3#2)(2012-1#3)(2012-12#11)(2012-2#17)(2012-3#19)(2012-4#1)(2012-5#3)(2013-1#31)(2013-7#12)(2013-8#17)
were founded##2##2##(1997-5#1)(2010-10#1)
were four##12##2##(1990-11#1)(1992-6#1)(2006-12#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-8#1)(2013-1#1)
were fractionated and##2##3##(2008-10#1)(2008-6#1)
were fractionated by##4##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
were fractionated##10##2##(1993-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-8#1)
were fragmented##3##2##(1991-9#1)(2008-11#1)(2009-9#1)
were free from##2##3##(2008-10#1)(2011-1#1)
were free of disease##2##4##(2008-6#1)(2013-7#1)
were free of##13##3##(1990-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-2#2)(2013-7#1)
were free##16##2##(1990-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#2)(2013-7#1)
were frequency##2##2##(2007-12#1)(2008-2#1)
were frequent##3##2##(2008-5#1)(2012-12#1)(2012-3#1)
were frequently and##2##3##(1990-12#1)(2009-7#1)
were frequently found##2##3##(1997-6#1)(2008-10#1)
were frequently observed##4##3##(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
were frequently present##2##3##(1994-12#1)(2012-12#1)
were frequently##17##2##(1990-12#1)(1994-12#1)(1997-2#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#2)(2012-12#1)(2013-1#1)(2013-8#1)
were from 0##3##3##(2008-10#2)(2011-1#1)
were from 5##2##3##(2008-10#1)(2008-6#1)
were from different##2##3##(2008-10#1)(2010-4#1)
were from the same##2##4##(2008-10#1)(2008-9#1)
were from the##9##3##(2008-10#2)(2008-9#2)(2011-1#2)(2013-8#3)
were from##47##2##(1994-5#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-7#4)(2008-10#21)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-4#1)(2011-1#4)(2012-3#1)(2013-8#3)
were frozen##2##2##(2008-1#1)(2008-10#1)
were fully active##2##3##(1995-2#1)(2008-10#1)
were fully##15##2##(1991-9#1)(1992-2#1)(1992-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#6)(2012-1#1)(2013-1#1)
were functional##4##2##(1994-3#1)(2007-10#1)(2008-4#1)(2008-7#1)
were functionalized with##2##3##(2009-11#1)(2011-1#1)
were functionalized##3##2##(2008-10#1)(2009-11#1)(2011-1#1)
were functioning##4##2##(1990-11#1)(2008-1#1)(2008-8#1)(2009-11#1)
were further analyzed using##2##4##(2008-10#1)(2010-6#1)
were further analyzed##3##3##(2008-10#1)(2010-6#1)(2013-8#1)
were further characterized by##3##4##(1990-12#1)(2008-10#2)
were further characterized##5##3##(1990-12#1)(2008-10#3)(2011-1#1)
were further confirmed by##2##4##(1996-2#1)(1997-1#1)
were further confirmed##4##3##(1991-4#1)(1996-2#1)(1997-1#1)(2008-10#1)
were further evaluated for##2##4##(1992-8#1)(2008-6#1)
were further evaluated##4##3##(1992-8#1)(1992-9#1)(2008-10#1)(2008-6#1)
were further examined using##2##4##(1993-3#1)(2012-3#1)
were further identified##2##3##(2008-10#1)(2009-8#1)
were further investigated by##2##4##(1992-6#1)(2008-10#1)
were further investigated##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2010-9#1)
were further processed##2##3##(2007-7#1)(2010-5#1)
were further purified##2##3##(1992-2#1)(2008-5#1)
were further studied##2##3##(1992-5#1)(2008-10#1)
were further substantiated##2##3##(1994-11#1)(2010-5#1)
were further tested##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
were further##59##2##(1990-12#1)(1990-8#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(2007-7#2)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
were fused by##2##3##(1991-5#1)(2008-9#1)
were fused to##7##3##(1991-10#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
were fused with##2##3##(1997-4#1)(1997-7#1)
were fused##11##2##(1991-10#1)(1991-5#1)(1993-8#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)
were gathered and analyzed##2##4##(1995-2#1)(2013-1#1)
were gathered from##4##3##(2008-3#1)(2008-7#1)(2009-5#1)(2010-9#1)
were gathered in##2##3##(2008-10#2)
were gathered##12##2##(1995-2#1)(1997-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
were generally higher##2##3##(2008-10#1)(2013-8#1)
were generally in##2##3##(2008-10#2)
were generally less##3##3##(1995-12#1)(2008-9#1)(2010-10#1)
were generally lower##2##3##(2008-10#1)(2010-8#1)
were generally mild and##3##4##(2007-11#1)(2011-2#1)(2012-2#1)
were generally mild##4##3##(1992-8#1)(2007-11#1)(2011-2#1)(2012-2#1)
were generally satisfied with##2##4##(1991-1#1)(1996-2#1)
were generally small##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
were generally##53##2##(1991-1#1)(1992-2#1)(1992-6#1)(1992-8#2)(1995-11#2)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#15)(2008-11#1)(2008-7#2)(2008-9#4)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
were generated and##8##3##(1991-8#1)(1995-12#1)(1997-9#1)(2008-12#2)(2008-3#1)(2011-2#1)(2012-1#1)
were generated at##2##3##(2007-12#1)(2008-10#1)
were generated by##13##3##(1990-11#1)(1994-12#1)(1995-6#1)(1996-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2013-1#1)
were generated for##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
were generated from##13##3##(1990-2#1)(1995-6#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)
were generated in the##5##4##(1993-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
were generated in##10##3##(1993-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2013-8#1)
were generated using##4##3##(2008-7#1)(2011-2#1)(2012-1#2)
were generated with a total##2##5##(2007-12#1)(2008-10#1)
were generated with a##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
were generated with##6##3##(1993-6#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-2#1)
were generated##83##2##(1990-11#1)(1990-2#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-9#1)(2007-11#1)(2007-12#5)(2008-10#29)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#4)(2013-1#1)(2013-8#1)
were genetically similar to##3##4##(1991-11#1)(2008-10#2)
were genetically similar##4##3##(1991-11#1)(2008-10#3)
were genetically##13##2##(1991-11#2)(2008-10#11)
were genotyped at##2##3##(2008-10#2)
were genotyped by##2##3##(2008-10#1)(2013-8#1)
were genotyped for the##2##4##(2008-10#2)
were genotyped for##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)
were genotyped##13##2##(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2013-8#2)
were genotypically distinct##3##3##(2008-10#3)
were genotypically##5##2##(2008-10#5)
were girls and##3##3##(2008-12#2)(2011-2#1)
were girls##5##2##(2008-12#2)(2010-1#1)(2011-2#1)(2013-1#1)
were given 5##3##3##(1992-5#1)(1997-7#1)(2008-10#1)
were given a gluten-free diet##2##5##(1991-2#2)
were given a single##2##4##(2008-10#1)(2013-1#1)
were given a##19##3##(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#1)
were given an##3##3##(1990-5#1)(1996-5#1)(2013-1#1)
were given as##2##3##(2013-1#1)(2013-8#1)
were given at different##2##4##(1993-3#1)(1994-8#1)
were given at##5##3##(1993-3#1)(1994-8#1)(2008-2#1)(2008-9#1)(2012-3#1)
were given drinking water containing##3##5##(2008-10#2)(2008-4#1)
were given either##2##3##(1990-11#1)(2012-2#1)
were given for##4##3##(1992-10#1)(1995-12#1)(2011-1#1)(2013-1#1)
were given the option##2##4##(2012-3#2)
were given the##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-11#1)(2012-3#2)
were given to##2##3##(2008-5#1)(2009-5#1)
were given two##2##3##(1993-11#1)(2009-12#1)
were given##110##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-3#3)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-5#3)(1997-4#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#2)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#4)
were glutamine##2##2##(2008-11#2)
were good##12##2##(2007-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
were graded##3##2##(2007-8#1)(2008-6#1)(2011-2#1)
were gradually increased##2##3##(1997-8#1)(2013-1#1)
were gradually##4##2##(1994-11#1)(1997-8#1)(2008-9#1)(2013-1#1)
were graft inoculated##2##3##(2008-10#2)
were grafted onto##2##3##(2008-10#1)(2008-7#1)
were grafted with##2##3##(2008-8#1)(2009-7#1)
were grafted##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)
were gram##2##2##(2013-8#2)
were granted##2##2##(1996-12#1)(2008-12#1)
were grazed on##2##3##(2010-2#1)(2011-1#1)
were greater (P&lt##2##3##(2009-4#2)
were greater for the##2##4##(1995-3#1)(2008-5#1)
were greater in cv##2##4##(2008-10#2)
were greater in##9##3##(1991-5#1)(1995-8#1)(1996-9#1)(2008-10#5)(2008-9#1)
were greater on the##3##4##(2007-10#2)(2011-2#1)
were greater on##4##3##(2007-10#2)(2008-10#1)(2011-2#1)
were greater than 0##2##4##(2008-10#1)(2011-1#1)
were greater than in##2##4##(2008-11#1)(2010-4#1)
were greater than those##5##4##(2008-8#1)(2008-9#3)(2011-2#1)
were greater than##15##3##(1993-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)
were greater when##2##3##(2008-10#2)
were greater##37##2##(1991-5#1)(1993-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-9#1)(2007-10#2)(2008-10#15)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-4#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)
were greatest at##2##3##(2007-8#1)(2008-10#1)
were greatest in##2##3##(2008-10#2)
were greatest##5##2##(2007-8#1)(2008-10#4)
were greatly decreased##2##3##(1995-8#1)(1996-5#1)
were greatly enhanced by##2##4##(2008-10#2)
were greatly reduced##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
were greatly##13##2##(1994-12#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
were grossly##2##2##(1995-6#1)(1996-11#1)
were ground##3##2##(2008-10#2)(2013-7#1)
were grouped according to the##2##5##(2008-1#1)(2011-2#1)
were grouped according to##4##4##(1997-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
were grouped by##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
were grouped in two##3##4##(1992-11#1)(2008-10#2)
were grouped in##5##3##(1992-11#1)(2008-10#4)
were grouped into 15##2##4##(2008-10#1)(2008-5#1)
were grouped into four##2##4##(2008-10#1)(2008-7#1)
were grouped into the##2##4##(2008-10#1)(2013-1#1)
were grouped into three##2##4##(2008-4#1)(2011-1#1)
were grouped into##13##3##(1995-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
were grouped##34##2##(1992-11#1)(1993-2#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
were growing##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2011-2#1)
were grown at##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
were grown by##4##3##(2007-11#2)(2008-10#1)(2008-8#1)
were grown for##3##3##(1993-8#1)(2008-12#1)(2008-7#1)
were grown hydroponically in##2##4##(2008-10#2)
were grown hydroponically##3##3##(2008-10#2)(2008-9#1)
were grown in a##4##4##(1992-11#1)(2008-10#1)(2008-11#2)
were grown in soil##4##4##(2008-10#2)(2008-5#1)(2010-11#1)
were grown in the presence of##3##6##(2008-10#3)
were grown in the##5##4##(2008-10#5)
were grown in##26##3##(1992-11#1)(2008-10#16)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2012-9#1)(2013-7#1)
were grown on basal medium##2##5##(2008-6#2)
were grown on microcarriers##2##4##(2008-11#2)
were grown on the##2##4##(2008-10#1)(2008-6#1)
were grown on##11##3##(1995-9#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#3)(2013-1#1)
were grown under##2##3##(2008-10#2)
were grown with##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
were grown##64##2##(1992-11#1)(1993-8#1)(1995-9#1)(2007-11#2)(2007-12#2)(2008-10#30)(2008-11#7)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-9#1)(2013-1#1)(2013-7#1)
were guided by##3##3##(2009-6#1)(2010-10#1)(2010-5#1)
were hardly##3##2##(1992-8#1)(2008-10#2)
were harvested and##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
were harvested for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
were harvested from##3##3##(2008-12#1)(2008-5#1)(2008-9#1)
were harvested##18##2##(2008-10#6)(2008-11#2)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#3)(2011-2#1)
were having##2##2##(2010-4#1)(2012-3#1)
were headache##2##2##(1997-6#1)(2010-12#1)
were healed##2##2##(1992-2#1)(2011-2#1)
were health##2##2##(2008-12#1)(2013-1#1)
were healthy subjects##2##3##(1994-5#1)(2013-1#1)
were healthy##3##2##(1994-5#1)(2012-3#1)(2013-1#1)
were heard##2##2##(1996-5#1)(1997-8#1)
were heated##2##2##(1990-3#1)(1994-8#1)
were heavier##3##2##(2008-5#1)(2010-4#1)(2013-7#1)
were heavily##3##2##(1995-12#1)(2008-2#1)(2010-8#1)
were held in##2##3##(2008-10#1)(2009-5#1)
were held with##4##3##(1996-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
were held##15##2##(1996-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-3#1)(2012-7#1)(2013-1#1)
were heterogeneous##2##2##(2008-10#1)(2013-1#1)
were heterogeneously##2##2##(1993-9#1)(2009-12#1)
were heterozygous for the##3##4##(1995-2#1)(2012-12#1)(2013-1#1)
were heterozygous for##4##3##(1993-12#1)(1995-2#1)(2012-12#1)(2013-1#1)
were heterozygous##8##2##(1991-12#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
were high (0##2##3##(2008-10#2)
were high affinity (Kd = 0##2##6##(1994-8#2)
were high in the##2##4##(1990-11#1)(2013-1#1)
were high in##5##3##(1990-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
were high##31##2##(1990-11#1)(1990-9#1)(1991-5#1)(1992-2#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#6)(2008-5#2)(2008-8#1)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
were higher (P &lt##3##4##(2010-2#3)
were higher among##3##3##(1991-1#1)(1996-3#1)(2006-10#1)
were higher and##3##3##(2010-8#1)(2011-1#1)(2013-7#1)
were higher at##2##3##(1993-3#1)(2013-7#1)
were higher by##2##3##(2008-10#2)
were higher for##5##3##(2008-10#3)(2009-2#1)(2013-8#1)
were higher in both##2##4##(2008-10#1)(2010-4#1)
were higher in left-pawed##2##4##(1997-2#2)
were higher in non reactional##2##5##(2011-2#2)
were higher in smokers##2##4##(2008-10#2)
were higher in the##10##4##(1991-12#1)(1992-6#1)(1997-7#1)(2007-5#2)(2008-11#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
were higher in##45##3##(1991-12#2)(1992-1#1)(1992-6#1)(1992-9#1)(1995-12#1)(1996-9#1)(1997-2#2)(1997-7#1)(2007-5#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
were higher than 95%##2##4##(2008-10#2)
were higher than for##2##4##(1993-6#1)(2008-9#1)
were higher than in##6##4##(1995-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
were higher than that in##2##5##(2008-9#1)(2011-1#1)
were higher than that of##2##5##(1991-8#1)(2011-1#1)
were higher than that##4##4##(1991-8#1)(2008-9#1)(2011-1#2)
were higher than the controls##2##5##(2008-10#1)(2011-1#1)
were higher than the##9##4##(1990-2#1)(2008-10#2)(2008-12#1)(2010-5#2)(2011-1#2)(2013-8#1)
were higher than those for##2##5##(2008-10#1)(2008-9#1)
were higher than those of##6##5##(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)
were higher than those##18##4##(1995-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-1#2)(2012-2#1)
were higher than##54##3##(1990-2#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2010-5#2)(2011-1#4)(2011-2#1)(2012-1#3)(2012-2#1)(2012-6#1)(2013-1#3)(2013-8#1)
were higher then control group##2##5##(2008-12#2)
were higher when the##2##4##(2008-6#1)(2012-2#1)
were higher when##3##3##(1994-2#1)(2008-6#1)(2012-2#1)
were higher##141##2##(1990-2#1)(1991-1#1)(1991-12#3)(1991-8#1)(1992-1#2)(1992-6#1)(1992-9#2)(1993-3#2)(1993-6#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-7#1)(2006-10#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#6)(2011-2#10)(2012-1#3)(2012-2#5)(2012-6#1)(2013-1#5)(2013-7#3)(2013-8#5)
were highest at##5##3##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
were highest for##2##3##(1993-1#1)(2008-9#1)
were highest in the adult adrenal##2##6##(1996-12#2)
were highest in the##7##4##(1996-12#3)(2008-10#1)(2008-7#1)(2012-1#1)(2013-8#1)
were highest in##11##3##(1996-12#3)(2008-10#3)(2008-7#2)(2008-9#1)(2012-1#1)(2013-8#1)
were highest##22##2##(1993-1#1)(1993-3#1)(1996-12#3)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
were highlighted##3##2##(1990-2#1)(1992-12#1)(2008-5#1)
were highly conserved##2##3##(1995-6#1)(2008-10#1)
were highly correlated with##8##4##(1993-6#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-9#1)
were highly correlated##13##3##(1990-8#1)(1993-6#1)(1995-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-9#1)
were highly dependent on##2##4##(2008-10#2)
were highly differentiated##2##3##(1990-9#1)(2008-10#1)
were highly effective in##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
were highly expressed during embryonic cardiac development##2##7##(1997-6#2)
were highly expressed in##5##4##(1994-12#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-3#1)
were highly expressed##7##3##(1994-12#1)(1997-6#2)(2008-11#1)(2008-8#1)(2010-12#1)(2012-3#1)
were highly homologous to##2##4##(1995-6#1)(2008-8#1)
were highly homologous##4##3##(1995-6#1)(1995-8#1)(2008-5#1)(2008-8#1)
were highly pathogenic on bean cultivars of both gene pools##2##10##(2008-10#2)
were highly pathogenic on##5##4##(2008-10#5)
were highly pathogenic##6##3##(2007-12#1)(2008-10#5)
were highly reproducible##2##3##(1995-12#1)(2008-10#1)
were highly resistant to##3##4##(2008-10#1)(2008-8#2)
were highly satisfied with##2##4##(2013-1#2)
were highly sensitive to##2##4##(1990-8#1)(2008-8#1)
were highly significant (P &lt##4##5##(2008-10#4)
were highly significant (P = 0##2##6##(2008-10#2)
were highly significant (P##7##4##(1992-8#1)(2008-10#6)
were highly significant##13##3##(1991-12#1)(1992-8#1)(2007-10#1)(2008-10#9)(2008-8#1)
were highly similar##3##3##(2008-10#2)(2012-2#1)
were highly specific and##2##4##(2008-10#2)
were highly susceptible##2##3##(2008-10#2)
were highly variable##5##3##(2008-10#2)(2008-8#1)(2009-8#2)
were highly virulent##3##3##(2008-10#3)
were highly##109##2##(1990-8#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-3#2)(1997-6#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#48)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#1)(2009-8#3)(2010-12#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
were histologically##4##2##(1991-2#1)(1995-4#1)(2007-8#1)(2008-5#1)
were homogeneous##2##2##(1996-7#1)(2012-2#1)
were homogenized##2##2##(1992-12#1)(1994-8#1)
were homologous to other known genes##2##6##(1996-12#2)
were homologous to##3##3##(1996-12#2)(1997-8#1)
were homozygous for the##2##4##(1995-12#1)(1995-2#1)
were homozygous##3##2##(1995-12#1)(1995-2#1)(2008-2#1)
were hospitalized at##2##3##(2008-1#1)(2012-2#1)
were hospitalized##9##2##(1991-6#1)(1992-5#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-12#1)(2012-2#1)(2013-1#1)
were host specific##2##3##(2008-10#2)
were housed in individual##2##4##(1992-3#1)(2010-2#1)
were housed in##4##3##(1992-3#2)(1993-6#1)(2010-2#1)
were housed##8##2##(1991-2#1)(1992-3#2)(1993-6#1)(2008-11#1)(2010-2#3)
were however##5##2##(2007-2#1)(2008-11#1)(2008-6#1)(2010-8#1)(2013-7#1)
were hybridized to##2##3##(2008-10#2)
were hybridized with##3##3##(1997-8#1)(2008-10#1)(2008-7#1)
were hybridized##5##2##(1997-8#1)(2008-10#3)(2008-7#1)
were hydrolyzed##5##2##(1993-9#1)(1994-5#1)(1995-6#1)(2006-6#1)(2008-10#1)
were hypercoagulable##2##2##(2007-7#2)
were hypersensitive to##2##3##(1997-3#1)(2012-3#1)
were hypertension##2##2##(2008-8#1)(2009-6#1)
were hypertensive##2##2##(2007-7#1)(2013-8#1)
were hypothesized to be##2##4##(1992-3#1)(2008-7#1)
were hypothesized to##5##3##(1992-3#1)(2008-12#1)(2008-7#1)(2009-8#2)
were identical for##2##3##(2008-10#2)
were identical in##3##3##(1992-11#1)(1992-8#1)(2008-11#1)
were identical or similar to hypothetical genes registered in databases##2##10##(1996-12#2)
were identical to that of##2##5##(1992-8#1)(2007-12#1)
were identical to the##4##4##(1990-7#1)(2008-10#2)(2008-12#1)
were identical to those of##2##5##(1993-1#1)(2008-10#1)
were identical to those##12##4##(1990-8#2)(1991-9#1)(1992-12#1)(1993-1#1)(2008-10#6)(2009-2#1)
were identical to##25##3##(1990-7#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1995-3#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2009-2#1)
were identical##45##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-1#1)(1995-3#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#21)(2008-11#3)(2008-12#1)(2009-2#1)(2011-2#1)(2012-3#1)
were identified after##2##3##(2008-8#1)(2013-8#1)
were identified among the##6##4##(2008-10#5)(2013-8#1)
were identified among##14##3##(1991-8#1)(2008-1#1)(2008-10#10)(2013-8#2)
were identified and characterized##2##4##(1991-9#1)(1995-6#1)
were identified and the##2##4##(1995-12#1)(2013-1#1)
were identified and their##2##4##(1991-4#1)(2008-10#1)
were identified and##33##3##(1991-4#1)(1991-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-10#9)(2008-5#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#4)(2013-8#1)
were identified as P##4##4##(2008-10#3)(2008-8#1)
were identified as S##2##4##(2008-10#2)
were identified as T##3##4##(1996-12#1)(2008-10#2)
were identified as X##2##4##(2008-10#2)
were identified as a##2##4##(1995-6#1)(2008-11#1)
were identified as being##2##4##(1991-2#1)(2013-7#1)
were identified as having##2##4##(2008-12#1)(2008-9#1)
were identified as independent##2##4##(2012-3#1)(2013-8#1)
were identified as key##2##4##(2010-4#1)(2013-8#1)
were identified as members of the##2##6##(1996-12#1)(2008-10#1)
were identified as optimal##2##4##(1996-12#1)(2012-3#1)
were identified as positive##2##4##(2008-10#1)(2008-5#1)
were identified as potential##3##4##(2008-10#1)(2009-6#1)(2010-4#1)
were identified as salt tolerant##2##5##(2008-12#2)
were identified as the##10##4##(1990-8#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
were identified as##105##3##(1990-5#1)(1990-8#2)(1991-2#2)(1991-5#2)(1992-5#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#1)(1997-4#1)(2007-10#2)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#4)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-8#2)(2011-2#4)(2012-2#2)(2012-3#4)(2013-7#1)(2013-8#4)
were identified at##5##3##(2008-10#1)(2008-9#2)(2012-12#2)
were identified based on##3##4##(1997-6#1)(2008-10#1)(2008-3#1)
were identified based upon##2##4##(2008-10#2)
were identified based##5##3##(1997-6#1)(2008-10#3)(2008-3#1)
were identified between##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
were identified by NH2-terminal##2##4##(1991-12#1)(1992-12#1)
were identified by gas##2##4##(2008-10#1)(2008-7#1)
were identified by restriction##2##4##(1993-6#1)(2008-10#1)
were identified by standard##2##4##(2007-7#1)(2012-3#1)
were identified by the##4##4##(1997-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
were identified by their##4##4##(2008-10#2)(2008-11#2)
were identified by using##2##4##(1992-3#1)(2013-8#1)
were identified by##67##3##(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#6)
were identified during##3##3##(2009-3#1)(2012-2#1)(2012-3#1)
were identified for inclusion##2##4##(2012-3#1)(2013-1#1)
were identified for resistance to##2##5##(2008-10#2)
were identified for resistance##3##4##(2008-10#3)
were identified for the##6##4##(1994-12#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-8#2)
were identified for##17##3##(1991-12#1)(1994-12#1)(1995-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
were identified from a##2##4##(2008-10#1)(2008-6#1)
were identified from the##7##4##(2008-10#4)(2008-11#1)(2011-1#1)(2013-8#1)
were identified from##25##3##(1992-5#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
were identified in a##4##4##(1990-6#1)(1992-6#1)(1994-12#1)(2008-10#1)
were identified in the##18##4##(1991-6#1)(1991-7#1)(1993-6#1)(1996-8#1)(1997-2#2)(2008-10#6)(2009-10#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
were identified in this study##2##5##(2008-10#1)(2010-11#1)
were identified in this##3##4##(1997-7#1)(2008-10#1)(2010-11#1)
were identified in##62##3##(1990-6#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#20)(2008-11#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#4)(2013-8#1)
were identified including##2##3##(2008-12#1)(2011-2#1)
were identified on chromosomes 1##2##5##(2008-10#1)(2008-9#1)
were identified on chromosomes##4##4##(2008-10#3)(2008-9#1)
were identified on the##3##4##(2007-12#1)(2008-5#1)(2009-4#1)
were identified on##11##3##(1995-8#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-4#1)
were identified that are##2##4##(2008-10#1)(2012-3#1)
were identified that could##2##4##(2008-10#1)(2008-9#1)
were identified that##9##3##(2008-10#5)(2008-5#1)(2008-9#1)(2012-3#1)(2013-8#1)
were identified through the##3##4##(1995-12#1)(1997-5#1)(2008-5#1)
were identified through##4##3##(1995-12#1)(1997-5#1)(2008-10#1)(2008-5#1)
were identified throughout the##2##4##(2008-11#1)(2013-1#1)
were identified to be##2##4##(1990-12#1)(2008-11#1)
were identified to species##2##4##(2008-10#1)(2008-5#1)
were identified to the##2##4##(2008-5#1)(2010-1#1)
were identified to##13##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
were identified using bulked segregant analysis##2##6##(2008-10#1)(2008-5#1)
were identified using the##7##4##(2007-7#1)(2007-8#5)(2008-10#1)
were identified using##22##3##(1994-12#1)(2007-7#1)(2007-8#5)(2008-10#7)(2008-11#2)(2008-5#1)(2010-8#2)(2011-2#1)(2012-3#2)
were identified which##3##3##(1994-11#1)(2008-11#1)(2008-7#1)
were identified with a##4##4##(2008-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
were identified with##14##3##(1997-9#1)(2008-10#6)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
were identified within the##3##4##(2008-10#2)(2012-2#1)
were identified within##5##3##(2007-7#1)(2008-10#3)(2012-2#1)
were identified##606##2##(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#3)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#2)(1997-9#1)(2007-10#4)(2007-11#2)(2007-12#8)(2007-2#3)(2007-7#4)(2007-8#5)(2008-1#3)(2008-10#179)(2008-11#20)(2008-12#13)(2008-3#3)(2008-4#3)(2008-5#25)(2008-6#6)(2008-7#12)(2008-8#9)(2008-9#16)(2009-10#3)(2009-3#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#5)(2011-1#8)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#14)(2012-2#12)(2012-3#15)(2012-5#1)(2013-1#28)(2013-7#3)(2013-8#25)
were illustrated##4##2##(1994-11#1)(2008-10#2)(2010-1#1)
were imaged at##2##3##(2008-2#1)(2012-12#1)
were imaged##10##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2012-12#1)
were immediately##5##2##(1992-9#1)(1997-5#1)(2008-3#1)(2010-12#1)(2013-1#1)
were immersed in##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
were immobilized in a##2##4##(2008-10#1)(2008-11#1)
were immobilized in##5##3##(2008-10#3)(2008-11#2)
were immobilized on the##2##4##(2008-10#2)
were immobilized on##8##3##(1991-5#1)(1993-6#1)(2008-10#6)
were immobilized onto##3##3##(2008-10#3)
were immobilized with##2##3##(2008-10#1)(2010-5#1)
were immobilized##22##2##(1991-5#1)(1993-6#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-7#1)(2010-5#1)
were immune to the##2##4##(2008-10#2)
were immune to##3##3##(2008-10#3)
were immunized with##4##3##(1990-12#1)(1994-9#1)(2007-10#1)(2008-7#1)
were immunized##7##2##(1990-12#1)(1994-9#1)(1995-11#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)
were immunohistochemically stained##2##3##(1992-6#1)(2008-7#1)
were immunohistochemically##3##2##(1992-6#1)(2008-7#1)(2011-2#1)
were immunoprecipitated with##2##3##(1990-5#1)(1996-2#1)
were immunoprecipitated##3##2##(1990-5#1)(1993-2#1)(1996-2#1)
were immunoreactive for##5##3##(1995-5#1)(1997-2#3)(2013-1#1)
were impaired in##2##3##(2008-10#1)(2008-7#1)
were impaired##5##2##(2008-10#2)(2008-4#1)(2008-7#1)(2009-2#1)
were implant##3##2##(2013-1#3)
were implanted and##2##3##(2008-3#1)(2008-9#1)
were implanted in the##2##4##(1997-7#1)(2007-7#1)
were implanted in##6##3##(1990-8#1)(1997-7#1)(2007-7#2)(2008-9#1)(2009-3#1)
were implanted into##4##3##(1993-1#1)(2008-3#1)(2008-5#1)(2012-1#1)
were implanted##19##2##(1990-7#1)(1990-8#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2012-1#1)
were implemented and##2##3##(2008-10#1)(2008-3#1)
were implemented by##2##3##(2008-11#1)(2012-2#1)
were implemented in the Health##2##5##(1994-1#1)(1997-2#1)
were implemented in the##3##4##(1994-1#1)(1997-2#1)(2008-10#1)
were implemented in##5##3##(1994-1#2)(1997-2#1)(2008-10#2)
were implemented##11##2##(1994-1#2)(1994-3#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2012-2#1)
were implicated##4##2##(2008-1#1)(2008-11#1)(2008-5#1)(2010-1#1)
were important for##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
were important in##3##3##(2008-10#3)
were important##13##2##(1990-8#1)(1991-9#1)(1993-6#1)(1996-1#1)(2008-10#4)(2008-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
were imported into the##2##4##(2008-10#1)(2011-1#1)
were imported##5##2##(2007-2#1)(2007-6#1)(2008-10#1)(2011-1#2)
were impregnated##2##2##(2008-10#1)(2008-2#1)
were improved after##2##3##(1996-6#1)(2008-7#1)
were improved by the addition of##2##6##(2008-6#1)(2010-2#1)
were improved by##4##3##(2008-11#1)(2008-12#1)(2008-6#1)(2010-2#1)
were improved in##4##3##(1991-6#1)(2008-10#1)(2010-12#1)(2010-2#1)
were improved significantly##2##3##(2008-10#1)(2012-2#1)
were improved##21##2##(1990-6#1)(1991-6#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#2)(2012-2#2)
were in Child's grade C##2##5##(2012-3#2)
were in VCG##3##3##(2008-10#3)
were in VCG1A##2##3##(2008-10#2)
were in a good agreement with the##2##7##(2008-10#2)
were in a good##4##4##(2008-10#2)(2008-7#2)
were in a##14##3##(1993-8#1)(1996-7#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#3)
were in accordance with the##2##5##(2008-10#1)(2009-8#1)
were in accordance with##3##4##(2008-10#1)(2008-12#1)(2009-8#1)
were in agreement with certified values##2##6##(2008-10#2)
were in agreement with the certified##3##6##(2008-10#3)
were in agreement with the##4##5##(2008-10#4)
were in agreement with those obtained by a##2##8##(2008-10#2)
were in agreement with those obtained by the##2##8##(2008-10#2)
were in agreement with those obtained by##6##7##(2008-10#6)
were in agreement with those obtained with##2##7##(2008-10#2)
were in agreement with those obtained##9##6##(2008-10#8)(2008-5#1)
were in agreement with those##12##5##(1992-1#1)(2008-10#10)(2008-5#1)
were in agreement with##20##4##(1992-1#1)(2007-11#1)(2008-10#16)(2008-12#1)(2008-5#1)
were in agreement##24##3##(1992-1#1)(1994-6#1)(2007-11#1)(2008-10#18)(2008-12#1)(2008-5#1)(2010-11#1)
were in all cases##3##4##(2008-10#2)(2008-5#1)
were in all##5##3##(2008-10#4)(2008-5#1)
were in asymmetric synaptic contact with dendritic##2##7##(1997-2#2)
were in different##2##3##(2008-10#1)(2013-8#1)
were in excellent agreement##2##4##(2008-10#2)
were in general agreement with##3##5##(2008-2#2)(2008-3#1)
were in general##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
were in genotype##2##3##(2008-10#2)
were in good agreement with certified values##3##7##(2008-10#3)
were in good agreement with the certified values and##2##9##(2008-10#2)
were in good agreement with the certified values##5##8##(2008-10#5)
were in good agreement with the certified##6##7##(2008-10#6)
were in good agreement with the##15##6##(1992-9#1)(2008-10#12)(2008-3#2)
were in good agreement with those obtained by an##2##9##(2008-10#2)
were in good agreement with those obtained by##9##8##(2008-10#9)
were in good agreement with those obtained##11##7##(2008-10#11)
were in good agreement with those reported by the##2##9##(2008-10#2)
were in good agreement with those reported##3##7##(2008-10#3)
were in good agreement with those##17##6##(2008-10#17)
were in good agreement with##47##5##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#38)(2008-2#1)(2008-3#4)(2008-7#1)
were in good agreement##55##4##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#43)(2008-2#2)(2008-3#6)(2008-7#1)
were in good##56##3##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#43)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#1)
were in part##2##3##(1995-2#1)(2008-5#1)
were in reality##2##3##(2008-10#1)(2010-3#1)
were in reasonable agreement with the##2##6##(2008-5#2)
were in satisfactory agreement with##2##5##(2008-10#1)(2008-2#1)
were in satisfactory##3##3##(2008-10#2)(2008-2#1)
were in sinus rhythm##2##4##(1995-12#1)(2007-8#1)
were in stage##2##3##(1990-9#1)(2006-8#1)
were in the age##4##4##(2008-11#1)(2010-5#1)(2011-1#1)(2013-8#1)
were in the concentration range of##2##6##(2008-10#1)(2011-1#1)
were in the early##2##4##(1995-4#1)(2008-9#1)
were in the immediate vicinity of##2##6##(2008-10#2)
were in the order##2##4##(1990-5#1)(2008-10#1)
were in the range 0##3##5##(2008-10#2)(2008-3#1)
were in the range 1##3##5##(2008-10#3)
were in the range of 0##4##6##(2008-10#4)
were in the range of##18##5##(2008-10#15)(2012-1#1)(2012-3#1)(2013-1#1)
were in the range##29##4##(1990-8#1)(2008-10#24)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
were in the ranges of 1##3##6##(2008-10#2)(2013-8#1)
were in the ranges of##5##5##(2008-10#4)(2013-8#1)
were in the ranges##8##4##(2008-10#6)(2013-8#2)
were in the renal##2##4##(2008-4#2)
were in the same clade##2##5##(2008-10#2)
were in the same##4##4##(1992-2#1)(2008-10#2)(2008-11#1)
were in the size range##3##5##(1995-3#1)(2008-7#2)
were in the##93##3##(1990-5#2)(1990-8#1)(1992-2#1)(1993-8#2)(1995-3#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#46)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-3#4)(2013-1#1)(2013-8#4)
were in vitro sensitive to##2##5##(1991-2#2)
were in##292##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-5#2)(1997-8#1)(1997-9#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#145)(2008-11#7)(2008-12#7)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#10)(2008-7#10)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#8)(2013-1#2)(2013-8#5)
were inactivated by##2##3##(1991-5#1)(2008-11#1)
were inactive##9##2##(1991-5#2)(1992-8#1)(1992-9#1)(1994-5#1)(1995-12#1)(1997-1#1)(1997-6#1)(2008-12#1)
were inadequate##3##2##(1992-12#1)(2008-10#2)
were included and##2##3##(2008-10#2)
were included as##5##3##(1996-1#1)(1997-6#1)(2008-12#1)(2011-2#2)
were included for the##2##4##(2007-7#1)(2010-4#1)
were included for##6##3##(1994-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
were included in a##4##4##(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#1)
were included in the analysis##3##5##(2008-12#1)(2008-5#1)(2008-8#1)
were included in the experiments##2##5##(2008-11#2)
were included in the final##2##5##(1997-6#1)(2009-7#1)
were included in the statistical analysis##2##6##(2008-8#1)(2013-8#1)
were included in the study and##3##6##(2007-9#1)(2008-11#1)(2008-6#1)
were included in the study##31##5##(1990-11#1)(1992-9#1)(1993-12#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-11#2)(2008-6#1)(2008-7#4)(2010-3#1)(2011-1#6)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
were included in the##57##4##(1990-11#1)(1992-9#1)(1993-12#1)(1994-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#6)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
were included in this retrospective study##2##6##(2008-6#1)(2011-1#1)
were included in this retrospective##3##5##(2008-6#1)(2011-1#2)
were included in this review##2##5##(2009-2#1)(2013-8#1)
were included in this study##16##5##(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)
were included in this##27##4##(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
were included in##102##3##(1990-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#9)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#4)
were included to##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
were included who##2##3##(2011-2#1)(2013-8#1)
were included##184##2##(1990-11#1)(1990-6#1)(1991-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-10#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-3#2)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#21)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#19)(2013-7#2)(2013-8#9)
were incompatible with##2##3##(2008-10#1)(2008-9#1)
were inconclusive##5##2##(1993-8#1)(1994-12#1)(2008-10#1)(2008-12#1)(2009-8#1)
were inconsistent##2##2##(2008-10#1)(2012-12#1)
were incorporated in##3##3##(1990-2#1)(2008-10#1)(2010-5#1)
were incorporated into an##2##4##(1995-6#1)(2008-5#1)
were incorporated into the##3##4##(2007-11#1)(2008-5#1)(2008-8#1)
were incorporated into##10##3##(1995-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)
were incorporated to##2##3##(2013-1#2)
were incorporated##17##2##(1990-2#1)(1995-6#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-5#1)(2013-1#2)
were increased after##3##3##(1991-10#1)(2011-2#1)(2013-1#1)
were increased and##2##3##(1994-6#2)
were increased at##2##3##(1993-12#1)(1997-7#1)
were increased by##10##3##(1991-3#1)(1992-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)
were increased during##2##3##(1991-5#1)(2010-11#1)
were increased from##4##3##(2008-10#3)(2008-11#1)
were increased in 400##2##4##(2008-9#2)
were increased in males and females##2##6##(2008-9#2)
were increased in males##3##4##(2008-9#3)
were increased in the##7##4##(1992-12#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
were increased in##24##3##(1991-12#1)(1992-12#1)(1992-4#1)(1994-8#1)(1995-11#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#9)(2009-3#1)(2009-8#1)(2013-1#1)
were increased incidences##3##3##(2008-9#3)
were increased to##5##3##(1990-6#1)(1993-8#1)(1995-12#1)(1996-2#1)(1996-5#1)
were increased up to##2##4##(2008-10#2)
were increased##85##2##(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#15)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#3)(2011-3#4)(2012-2#1)(2013-1#2)(2013-8#1)
were increasingly##2##2##(1990-12#1)(2008-9#1)
were incubated at##7##3##(1992-3#1)(2008-10#6)
were incubated for 24 h##2##5##(2008-12#1)(2009-6#1)
were incubated for##7##3##(1993-6#1)(1994-6#1)(1995-11#1)(1995-8#1)(2008-12#1)(2009-6#1)(2012-3#1)
were incubated in a##2##4##(2008-10#1)(2008-8#1)
were incubated in the presence of##3##6##(1991-3#1)(1991-5#1)(1994-12#1)
were incubated in the##5##4##(1991-12#1)(1991-3#1)(1991-5#1)(1994-12#1)(2008-10#1)
were incubated in##16##3##(1991-12#1)(1991-3#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-10#5)(2008-11#4)(2008-8#1)
were incubated on##2##3##(2008-10#1)(2010-3#1)
were incubated with the##4##4##(1990-12#2)(1990-8#1)(1991-2#1)
were incubated with##33##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#2)(1992-12#3)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-11#1)(2013-8#1)
were incubated##72##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#3)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
were indeed##5##2##(1997-8#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-2#1)
were independent in##2##3##(1994-8#1)(2008-7#1)
were independent of the##5##4##(1993-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
were independent of##12##3##(1990-2#1)(1991-12#1)(1992-8#1)(1993-6#1)(2008-10#4)(2008-5#2)(2008-8#1)(2012-3#1)
were independent risk factors##2##4##(2011-2#1)(2013-1#1)
were independent##18##2##(1990-2#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
were independently associated with##5##4##(1992-4#1)(1995-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
were independently reviewed by two##2##5##(1992-8#1)(2011-2#1)
were independently##13##2##(1991-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1995-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
were indicated##2##2##(2008-12#1)(2010-8#1)
were indication for RT##2##4##(2010-3#2)
were indicative of a##2##4##(2008-10#1)(2013-1#1)
were indicative of the##2##4##(2007-5#1)(2008-10#1)
were indicative of##9##3##(1993-1#1)(2007-5#1)(2008-10#2)(2010-10#1)(2012-12#1)(2013-1#3)
were indirectly related to grades through##2##6##(2009-7#2)
were indistinguishable from each other##2##5##(1997-3#1)(2008-10#1)
were indistinguishable from##7##3##(1992-8#1)(1994-8#1)(1997-3#1)(2008-10#3)(2008-12#1)
were indistinguishable##13##2##(1992-8#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-12#1)
were individually##10##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#2)
were induced by the##4##4##(1990-12#1)(1994-12#1)(2007-12#1)(2008-11#1)
were induced by##13##3##(1990-12#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2011-10#1)(2013-1#1)
were induced from##2##3##(2008-12#1)(2013-1#1)
were induced in experimental##2##4##(2008-10#1)(2009-8#1)
were induced in##7##3##(1993-3#1)(1994-5#1)(2008-10#2)(2008-8#1)(2009-7#1)(2009-8#1)
were induced to##3##3##(1993-3#1)(2008-5#1)(2008-9#1)
were induced with##3##3##(1995-12#1)(2008-10#1)(2010-7#1)
were induced##40##2##(1990-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#2)(2011-10#1)(2013-1#2)
were ineffective in##3##3##(1992-8#1)(2008-10#2)
were ineffective##16##2##(1990-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#2)(2008-10#4)(2008-12#1)(2008-5#1)(2009-10#1)(2009-7#1)
were infant##2##2##(2007-8#2)
were infected and##2##3##(2008-10#2)
were infected by HIV##2##4##(1993-6#1)(2008-12#1)
were infected by##10##3##(1993-6#1)(1995-9#1)(2008-10#6)(2008-12#1)(2012-3#1)
were infected in##3##3##(1993-8#1)(1996-11#1)(2012-3#1)
were infected with P##2##4##(2007-7#2)
were infected with the##4##4##(1994-5#1)(1997-6#2)(2008-10#1)
were infected with##27##3##(1991-8#1)(1992-5#1)(1994-5#1)(1997-3#1)(1997-4#1)(1997-6#3)(2007-6#1)(2007-7#2)(2008-10#10)(2008-5#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
were infected##53##2##(1991-8#1)(1992-5#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-6#3)(2007-6#1)(2007-7#2)(2008-10#24)(2008-12#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)
were infections in##2##3##(2008-1#1)(2011-1#1)
were infectious by biolistic inoculation to##3##6##(2008-10#3)
were infectious in##2##3##(1997-3#1)(2008-10#1)
were infectious on##2##3##(2008-10#1)(2008-9#1)
were infectious##10##2##(1996-3#1)(1997-3#1)(2008-10#7)(2008-9#1)
were inferior##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
were inferred from the##2##4##(2008-3#1)(2008-6#1)
were inferred from##5##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
were inferred##10##2##(1995-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-8#1)(2010-8#1)
were infested with##8##3##(1996-12#2)(2008-10#6)
were infested##10##2##(1996-12#2)(2008-10#7)(2011-2#1)
were infiltrated##2##2##(1990-2#1)(2008-10#1)
were influenced by the##4##4##(1992-12#1)(1993-8#1)(1995-11#1)(2008-10#1)
were influenced by##10##3##(1992-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-11#1)(2008-10#3)(2008-9#1)(2012-2#1)
were influenced##14##2##(1992-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-11#1)(1997-3#1)(2008-10#4)(2008-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
were influenza A##2##3##(1992-6#1)(2011-2#1)
were influenza##3##2##(1992-6#2)(2011-2#1)
were infrequent and##2##3##(2008-1#1)(2008-7#1)
were infrequent##3##2##(2008-1#1)(2008-7#2)
were infused##2##2##(1991-5#1)(1997-2#1)
were inherited##2##2##(1992-6#1)(2008-10#1)
were inhibited by electrical stimulation of the hepatic branch of the vagus##3##12##(1993-12#3)
were inhibited by the##5##4##(1992-12#1)(1993-3#1)(1995-12#1)(2008-11#1)(2008-4#1)
were inhibited by##21##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#3)(2008-4#1)
were inhibited with##2##3##(2008-10#1)(2009-10#1)
were inhibited##30##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-10#5)(2008-11#3)(2008-4#1)(2009-10#1)(2010-8#1)(2011-2#1)
were inhibitors##2##2##(1994-5#1)(1995-3#1)
were inhibitory to##3##3##(2008-10#3)
were inhibitory##4##2##(1994-3#1)(2008-10#3)
were initially identified##2##3##(2007-2#1)(2011-2#1)
were initially not##2##3##(1997-3#1)(2007-12#1)
were initially tested for##2##4##(1992-8#1)(1995-3#1)
were initially##26##2##(1991-3#1)(1991-5#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#6)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#2)(2013-7#1)
were initiated in##2##3##(1991-2#1)(2008-7#1)
were initiated##11##2##(1991-2#1)(1993-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
were injected at##2##3##(1995-12#1)(2008-10#1)
were injected by##2##3##(2007-8#1)(2008-10#1)
were injected directly into##3##4##(2008-10#3)
were injected i##3##3##(1997-4#1)(2010-1#2)
were injected in a##2##4##(1992-11#1)(2008-10#1)
were injected in##3##3##(1992-11#1)(2008-10#1)(2011-1#1)
were injected into a##3##4##(1990-8#1)(2008-10#2)
were injected into the flow line by an open sandwich method##2##11##(2008-10#2)
were injected into the graphite tube##2##6##(2008-10#2)
were injected into the##12##4##(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
were injected into##19##3##(1990-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#2)
were injected intraperitoneally with##4##4##(1992-11#1)(1995-3#1)(2008-11#1)(2008-5#1)
were injected intraperitoneally##5##3##(1992-11#1)(1995-3#1)(2008-11#1)(2008-5#1)(2010-5#1)
were injected onto a##2##4##(2008-10#2)
were injected onto##3##3##(2008-10#2)(2008-11#1)
were injected with##8##3##(1990-7#1)(1991-2#1)(1995-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
were injected##58##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-11#2)(1995-12#2)(1995-3#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#3)
were injured by##2##3##(2008-8#1)(2011-2#1)
were injured in##2##3##(1990-9#1)(2012-3#1)
were injured##4##2##(1990-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
were inoculated and incubated in##2##5##(2008-10#2)
were inoculated and incubated##3##4##(2008-10#3)
were inoculated and##4##3##(2008-10#4)
were inoculated at the##5##4##(2008-10#5)
were inoculated at##11##3##(2008-10#11)
were inoculated by##2##3##(2008-10#2)
were inoculated in the greenhouse with##2##6##(2008-10#2)
were inoculated in the##3##4##(2008-10#3)
were inoculated in##8##3##(2008-10#6)(2008-5#2)
were inoculated into##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
were inoculated on##3##3##(1994-9#1)(2008-10#2)
were inoculated onto a##2##4##(2008-10#2)
were inoculated onto##5##3##(2008-10#3)(2011-2#1)(2012-2#1)
were inoculated together##2##3##(2008-10#2)
were inoculated with P##3##4##(2008-10#3)
were inoculated with a##6##4##(2008-10#5)(2011-2#1)
were inoculated with an##2##4##(2008-10#2)
were inoculated with conidia of##2##5##(2008-10#2)
were inoculated with conidial suspensions of##2##6##(2008-10#2)
were inoculated with one of two##2##6##(1997-3#1)(2008-10#1)
were inoculated with the##2##4##(2008-10#2)
were inoculated with##48##3##(1991-3#1)(1997-3#1)(1997-6#1)(2008-10#40)(2011-2#1)(2012-2#1)(2012-3#3)
were inoculated##110##2##(1991-12#1)(1991-3#1)(1992-2#1)(1994-9#1)(1997-3#1)(1997-6#2)(2008-10#89)(2008-12#1)(2008-5#4)(2010-8#1)(2011-10#1)(2011-2#2)(2012-2#2)(2012-3#3)
were input##2##2##(2012-3#1)(2013-8#1)
were insensitive to the toxin##2##5##(2008-10#2)
were insensitive to##7##3##(1993-9#1)(2008-10#5)(2008-11#1)
were inserted between##2##3##(2008-5#1)(2008-6#1)
were inserted in the##2##4##(2007-8#1)(2008-10#1)
were inserted in##5##3##(1991-2#1)(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
were inserted into a##3##4##(1993-11#1)(1995-2#1)(2008-12#1)
were inserted into the##5##4##(1991-5#1)(2007-8#1)(2010-6#2)(2011-2#1)
were inserted into##12##3##(1991-12#1)(1991-5#1)(1993-11#1)(1995-2#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-6#2)(2011-2#1)(2013-1#1)
were inserted##21##2##(1991-12#1)(1991-2#1)(1991-5#1)(1993-11#1)(1995-2#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#2)(2011-2#1)(2013-1#2)(2013-8#1)
were inspected##2##2##(2011-2#2)
were installed##2##2##(2008-2#1)(2011-1#1)
were instituted##2##2##(2007-6#1)(2009-4#1)
were instructed to perform##2##4##(2010-9#1)(2011-2#1)
were instructed to##8##3##(1991-2#1)(1994-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
were instructed##12##2##(1991-2#1)(1994-2#1)(1995-5#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
were insufficient to##2##3##(2008-10#1)(2008-8#1)
were intact##3##2##(2008-11#1)(2008-6#1)(2010-12#1)
were integrated into the##3##4##(1991-6#1)(1997-7#1)(2008-9#1)
were integrated into##6##3##(1991-6#1)(1994-12#1)(1997-7#1)(2008-12#1)(2008-9#1)(2010-3#1)
were integrated##11##2##(1991-6#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)
were intensely##3##2##(1995-12#2)(2008-7#1)
were intensively studied for##2##4##(2008-10#1)(2009-5#1)
were intensively##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
were interested in##3##3##(1997-3#1)(2010-2#1)(2011-9#1)
were interested##4##2##(1997-3#1)(2007-8#1)(2010-2#1)(2011-9#1)
were intermediate between##2##3##(2008-10#1)(2008-5#1)
were intermediate in##3##3##(1995-3#1)(2008-10#2)
were intermediate##8##2##(1995-3#1)(2008-10#5)(2008-12#1)(2008-5#1)
were internally##3##2##(2008-10#1)(2013-8#2)
were interpersonal##2##2##(2008-9#1)(2009-3#1)
were interpretable##2##2##(2008-7#1)(2009-8#1)
were interpreted as##6##3##(1993-6#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-8#1)
were interpreted in terms of a##2##6##(1990-11#1)(1993-11#1)
were interpreted in terms of complex##2##6##(2008-10#2)
were interpreted in terms of##5##5##(1990-11#1)(1990-7#1)(1993-11#1)(2008-10#2)
were interpreted in##6##3##(1990-11#1)(1990-7#1)(1993-11#1)(2008-10#2)(2012-3#1)
were interpreted on the basis of##2##6##(1994-5#1)(2008-10#1)
were interpreted to be##2##4##(1996-2#1)(2008-10#1)
were interpreted to##4##3##(1996-2#1)(2008-10#3)
were interpreted##22##2##(1990-11#2)(1990-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-2#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-9#1)(2009-7#1)(2012-3#1)(2013-8#1)
were interrupted##2##2##(1990-8#1)(1997-4#1)
were interviewed about their##4##4##(1994-3#1)(1996-6#1)(1997-6#1)(2009-9#1)
were interviewed about##5##3##(1994-3#1)(1996-6#1)(1997-6#1)(2008-11#1)(2009-9#1)
were interviewed and##2##3##(1995-1#1)(2008-12#1)
were interviewed by trained##2##4##(2009-5#1)(2011-2#1)
were interviewed during##3##3##(2009-6#1)(2012-3#1)(2013-1#1)
were interviewed for##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
were interviewed in##4##3##(1990-12#1)(1992-3#1)(2008-1#1)(2011-1#1)
were interviewed in-depth##2##3##(2013-1#1)(2013-8#1)
were interviewed individually##2##3##(2008-12#1)(2012-12#1)
were interviewed to##3##3##(1990-8#1)(1994-1#1)(2010-10#1)
were interviewed using a semistructured##2##5##(2010-9#1)(2011-1#1)
were interviewed using a structured questionnaire##2##6##(2008-8#1)(2011-1#1)
were interviewed using a##8##4##(2008-8#1)(2009-5#1)(2010-9#1)(2011-1#3)(2012-12#1)(2013-1#1)
were interviewed using the##4##4##(1992-2#1)(2007-7#1)(2008-7#1)(2011-1#1)
were interviewed using##13##3##(1992-2#1)(1995-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-1#4)(2012-12#1)(2013-1#1)
were interviewed with a##4##4##(1992-8#1)(1993-6#1)(2008-7#1)(2010-8#1)
were interviewed with##5##3##(1992-8#1)(1993-6#1)(2008-7#1)(2010-8#1)(2013-1#1)
were interviewed##74##2##(1990-12#2)(1990-8#2)(1991-3#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
were interwoven##2##2##(2009-9#1)(2010-1#1)
were intraperitoneally injected with##2##4##(1994-5#1)(2009-5#1)
were introduced and##2##3##(1990-8#1)(2013-1#1)
were introduced as##3##3##(1997-8#1)(2008-10#2)
were introduced by##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
were introduced in the##3##4##(1996-2#1)(2008-10#2)
were introduced in##6##3##(1990-2#1)(1996-2#1)(2008-10#3)(2008-8#1)
were introduced into a##2##4##(2008-10#1)(2008-3#1)
were introduced into the##5##4##(2008-10#5)
were introduced into##21##3##(1993-8#1)(1995-6#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#1)
were introduced to the##2##4##(1994-1#1)(2008-10#1)
were introduced to##4##3##(1994-1#1)(2008-10#2)(2008-3#1)
were introduced##62##2##(1990-11#1)(1990-2#1)(1990-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-8#2)(2008-10#25)(2008-11#3)(2008-3#3)(2008-6#2)(2008-8#7)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
were inversely correlated with##3##4##(1997-4#1)(2008-9#1)(2011-1#1)
were inversely related to the##2##5##(1995-12#1)(2009-8#1)
were inversely related to##4##4##(1995-12#1)(2008-9#1)(2009-8#1)(2011-2#1)
were inversely related##5##3##(1995-12#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)
were inversely##8##2##(1995-12#1)(1997-4#1)(2008-12#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)
were inverted##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
were invested in##2##3##(2011-2#2)
were invested##3##2##(2011-2#2)(2013-1#1)
were investigated and compared with the##3##6##(2008-10#1)(2008-3#1)(2013-1#1)
were investigated and optimized##5##4##(2008-10#3)(2010-4#1)(2012-1#1)
were investigated and the##5##4##(2008-10#4)(2011-1#1)
were investigated and##20##3##(2007-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-1#1)
were investigated as a##2##4##(1997-7#1)(2008-7#1)
were investigated as##11##3##(1992-8#1)(1997-7#1)(2008-10#6)(2008-6#1)(2008-7#1)(2012-5#1)
were investigated at##6##3##(1993-9#1)(2007-10#1)(2008-10#3)(2008-3#1)
were investigated by means of a##2##6##(1990-8#1)(2008-3#1)
were investigated by means of##7##5##(1990-8#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)
were investigated by measuring##2##4##(1991-9#1)(2008-5#1)
were investigated by transmission electron microscopy##3##6##(2008-10#2)(2008-7#1)
were investigated by univariate method##2##5##(2008-10#2)
were investigated by use of##2##5##(2007-12#1)(2008-3#1)
were investigated by using##2##4##(2008-10#1)(2009-7#1)
were investigated by##48##3##(1990-8#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#2)
were investigated during the##2##4##(2008-10#1)(2013-1#1)
were investigated during##5##3##(1996-7#1)(2007-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
were investigated experimentally##4##3##(1997-2#1)(2008-10#2)(2008-9#1)
were investigated for the##6##4##(1993-8#1)(2007-11#1)(2008-10#3)(2011-2#1)
were investigated for their##4##4##(1997-4#1)(2009-12#1)(2012-2#1)(2013-1#1)
were investigated for##24##3##(1993-8#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
were investigated from##2##3##(2008-10#1)(2008-5#1)
were investigated in a group of##2##6##(1995-11#1)(2008-9#1)
were investigated in a##11##4##(1995-11#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#2)
were investigated in detail and optimized##3##6##(2008-10#3)
were investigated in detail and##4##5##(2008-10#4)
were investigated in detail##18##4##(2008-10#16)(2008-6#1)(2011-1#1)
were investigated in human##2##4##(1990-12#1)(2011-3#1)
were investigated in male Sprague-Dawley rats##2##6##(1996-2#1)(2008-4#1)
were investigated in order to##3##5##(2008-10#3)
were investigated in rats##5##4##(1994-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-7#1)
were investigated in the##4##4##(2008-10#2)(2008-4#1)(2008-5#1)
were investigated in this study##2##5##(1997-4#1)(2008-12#1)
were investigated in this##5##4##(1997-4#1)(2008-10#2)(2008-12#2)
were investigated in vitro##4##4##(1990-11#1)(1992-11#1)(1996-12#1)(2006-6#1)
were investigated in vivo and in vitro##2##7##(1990-11#1)(2008-10#1)
were investigated in vivo##5##4##(1990-11#1)(1990-5#1)(1993-11#1)(1996-12#1)(2008-10#1)
were investigated in##109##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-5#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2008-10#34)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2012-4#1)
were investigated on fly ash samples that##2##7##(2008-10#2)
were investigated on the##2##4##(1992-3#1)(2008-10#1)
were investigated on##7##3##(1992-3#1)(1995-12#1)(2008-10#3)(2008-9#1)(2010-7#1)
were investigated successfully##2##3##(2008-10#1)(2008-3#1)
were investigated through##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
were investigated to acquire the optimum##2##6##(2008-10#2)
were investigated to determine the##2##5##(2008-10#1)(2013-1#1)
were investigated to improve the##2##5##(2008-10#1)(2008-2#1)
were investigated to##23##3##(1991-12#1)(2008-10#16)(2008-2#2)(2008-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
were investigated under##3##3##(1994-5#1)(1996-6#1)(2008-10#1)
were investigated using a##3##4##(1993-12#1)(2011-2#1)(2012-1#1)
were investigated using in vitro##2##5##(2008-11#1)(2008-5#1)
were investigated using the##5##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
were investigated using##38##3##(1991-5#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#1)
were investigated with regard to##4##5##(1995-5#1)(2008-10#2)(2013-1#1)
were investigated with respect to their##2##6##(2008-5#1)(2008-7#1)
were investigated with the##4##4##(2008-10#3)(2013-8#1)
were investigated with##22##3##(1991-12#1)(1995-11#1)(1995-5#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
were investigated##575##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#5)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#4)(1993-3#4)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#7)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#9)(2007-3#1)(2008-1#1)(2008-10#254)(2008-11#18)(2008-12#9)(2008-2#8)(2008-3#18)(2008-4#2)(2008-5#16)(2008-6#8)(2008-7#11)(2008-8#7)(2008-9#8)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#6)(2009-8#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#3)(2011-1#6)(2011-10#1)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#5)(2012-4#1)(2012-5#1)(2012-6#1)(2013-1#13)(2013-8#3)
were invited to answer##2##4##(2008-11#1)(2013-1#1)
were invited to attend##3##4##(1992-5#1)(2008-10#1)(2012-2#1)
were invited to participate##5##4##(2007-10#1)(2008-11#1)(2011-1#1)(2012-12#2)
were invited to##13##3##(1991-6#1)(1992-5#1)(2007-10#1)(2008-10#2)(2008-11#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
were invited##16##2##(1991-6#2)(1992-5#1)(1996-11#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-11#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
were involved in a##3##4##(2006-10#1)(2008-11#1)(2010-11#1)
were involved in the study##2##5##(1991-4#1)(2007-7#1)
were involved in the##9##4##(1991-4#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
were involved in##26##3##(1991-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
were involved##32##2##(1991-4#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-1#2)(1996-5#1)(2006-10#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
were irradiated at##2##3##(1991-2#1)(2008-10#1)
were irradiated by##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
were irradiated with a##2##4##(2011-2#1)(2012-3#1)
were irradiated with##5##3##(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
were irradiated##14##2##(1991-2#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
were irregular##3##2##(1994-3#1)(2008-1#2)
were irrelevant##2##2##(1990-12#1)(2010-5#1)
were isolated after##3##3##(1991-9#1)(1995-2#1)(2008-10#1)
were isolated and characterized##5##4##(1990-8#1)(1992-12#1)(1993-6#1)(2008-10#1)(2013-8#1)
were isolated and cloned##2##4##(2008-8#2)
were isolated and identified##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
were isolated and purified by##2##5##(1995-11#1)(2008-9#1)
were isolated and purified from##3##5##(1994-6#1)(2008-10#1)(2008-12#1)
were isolated and purified##5##4##(1994-6#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
were isolated and sequenced##3##4##(1991-6#1)(1993-3#1)(1995-8#1)
were isolated and##34##3##(1990-5#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2012-2#1)(2013-8#1)
were isolated as##2##3##(1990-2#1)(2008-11#1)
were isolated at##5##3##(2008-10#4)(2008-12#1)
were isolated by a##2##4##(1993-3#1)(2008-10#1)
were isolated by screening##2##4##(1990-5#1)(1991-6#1)
were isolated by##20##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1996-12#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#1)
were isolated for the##2##4##(2008-5#1)(2012-12#1)
were isolated for##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
were isolated from Brazilian##2##4##(2008-6#2)
were isolated from a P1 library of the Arabidopsis thaliana##2##10##(1997-6#1)(1997-8#1)
were isolated from a human##3##5##(1993-8#1)(1994-11#1)(2008-11#1)
were isolated from a##17##4##(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
were isolated from an##2##4##(1990-11#1)(1991-1#1)
were isolated from diseased##3##4##(2008-10#3)
were isolated from human##6##4##(1991-2#1)(1996-12#1)(2008-11#2)(2008-8#1)(2013-8#1)
were isolated from the leaves of##2##6##(2008-8#1)(2011-3#1)
were isolated from the##23##4##(1991-12#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2010-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
were isolated from this##2##4##(2008-10#1)(2011-3#1)
were isolated from tobacco##3##4##(2008-10#3)
were isolated from two##2##4##(1990-8#1)(2008-8#1)
were isolated from##132##3##(1990-11#2)(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2007-1#1)(2007-11#1)(2007-7#4)(2008-10#43)(2008-11#7)(2008-12#4)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#8)(2009-10#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#5)(2013-1#3)(2013-8#3)
were isolated in the##2##4##(2007-12#1)(2008-8#1)
were isolated in##11##3##(1997-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-8#1)(2010-2#1)
were isolated into##2##3##(2008-10#1)(2009-12#1)
were isolated that##3##3##(1990-8#1)(1994-11#1)(2008-10#1)
were isolated using##4##3##(1990-7#1)(1993-8#1)(1997-7#1)(2011-2#1)
were isolated with##2##3##(2008-10#1)(2011-1#1)
were isolated##261##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#4)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#5)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#1)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#5)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#6)(2007-8#2)(2008-10#74)(2008-11#14)(2008-12#11)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#17)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-2#2)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#6)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#6)
were isolates from##2##3##(2008-10#2)
were isolates##3##2##(2008-10#3)
were issued to##2##3##(1992-6#1)(1996-9#1)
were issued##5##2##(1992-6#1)(1993-3#1)(1996-9#1)(2010-7#1)(2011-2#1)
were judged to be##7##4##(1992-12#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
were judged##11##2##(1992-12#1)(1995-2#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-10#1)
were just as likely to##2##5##(1990-2#1)(2013-1#1)
were kept alive##2##3##(2011-2#2)
were kept as##2##3##(1996-12#1)(2013-1#1)
were kept at##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
were kept for##2##3##(1996-9#1)(2008-10#1)
were kept in a##2##4##(2008-12#1)(2008-5#1)
were kept in##7##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)
were kept##26##2##(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2013-1#1)
were key in##2##3##(1996-3#1)(2008-10#1)
were key##5##2##(1996-3#1)(2008-10#2)(2008-2#1)(2010-1#1)
were killed 24##2##3##(2007-10#1)(2013-1#1)
were killed and##2##3##(1997-3#1)(2009-12#1)
were killed at##2##3##(2008-7#1)(2008-9#1)
were killed##15##2##(1991-12#1)(1996-12#1)(1997-3#1)(2007-10#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#2)
were labeled by##3##3##(1995-6#1)(2008-10#1)(2010-12#1)
were labeled with##8##3##(1990-2#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(2009-8#1)
were labeled##20##2##(1990-2#1)(1992-12#2)(1992-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#2)(1997-3#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-7#1)
were labelled with##2##3##(1993-2#1)(1995-12#1)
were labelled##5##2##(1993-2#1)(1993-6#1)(1995-12#2)(1997-8#1)
were lack of##4##3##(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
were lack##5##2##(2007-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
were lacking##2##2##(2008-10#2)
were large##9##2##(1992-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-12#1)
were largely##10##2##(1992-8#1)(1994-2#1)(1994-9#1)(1996-1#1)(2008-10#2)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#1)
were larger in##3##3##(1996-2#1)(2008-5#1)(2010-8#1)
were larger than the##2##4##(2007-10#1)(2010-9#1)
were larger than those produced in##2##6##(2008-10#2)
were larger than those##5##4##(1991-5#1)(1994-8#1)(2008-10#2)(2009-7#1)
were larger than##7##3##(1991-5#1)(1994-8#1)(2007-10#1)(2008-10#2)(2009-7#1)(2010-9#1)
were larger##15##2##(1991-5#1)(1992-7#1)(1994-8#2)(1996-2#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)(2010-9#1)
were later##5##2##(2008-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#1)
were launched##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
were learned##4##2##(1991-2#1)(1996-2#1)(2008-12#1)(2011-2#1)
were least##7##2##(1992-2#1)(1993-6#1)(2008-10#5)
were left for##2##3##(2011-2#1)(2013-1#1)
were left in##3##3##(2008-5#2)(2013-1#1)
were left untreated##2##3##(1992-2#1)(1994-6#1)
were left##10##2##(1992-2#1)(1994-6#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
were less abundant##2##3##(1994-2#1)(2008-6#1)
were less accurate##2##3##(2008-1#1)(2009-7#1)
were less affected than##2##4##(1993-12#1)(2008-11#1)
were less affected##4##3##(1993-12#1)(1993-6#1)(2008-11#1)(2008-8#1)
were less effective than##2##4##(1995-11#1)(2012-12#1)
were less effective##6##3##(1991-12#1)(1992-2#1)(1995-11#1)(2008-10#2)(2012-12#1)
were less efficient##2##3##(2008-10#2)
were less frequent##2##3##(2008-8#1)(2013-1#1)
were less likely than##2##4##(1995-2#1)(1995-6#1)
were less likely to be##6##5##(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)
were less likely to die in acute care##2##8##(2011-2#2)
were less likely to have a##2##6##(1995-11#1)(1995-12#1)
were less likely to provide##2##5##(1995-12#1)(2011-2#1)
were less likely to receive##2##5##(2011-2#1)(2012-3#1)
were less likely to##23##4##(1995-11#1)(1995-12#3)(1997-2#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#2)(2011-2#7)(2012-12#1)(2012-3#1)
were less likely##25##3##(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#2)(2011-2#7)(2012-12#1)(2012-3#1)
were less potent##3##3##(1994-6#1)(1994-8#1)(1995-12#1)
were less pronounced in##2##4##(1996-5#1)(2011-1#1)
were less pronounced##4##3##(1996-5#1)(2009-12#1)(2009-9#1)(2011-1#1)
were less sensitive to##3##4##(1995-5#1)(2008-10#2)
were less sensitive##4##3##(1995-5#1)(2008-10#2)(2010-10#1)
were less susceptible to##2##4##(1996-12#1)(2008-10#1)
were less than 0##4##4##(2008-10#1)(2008-3#2)(2011-1#1)
were less than 1##4##4##(2008-10#3)(2012-2#1)
were less than 2%##2##4##(2008-10#2)
were less than 3##2##4##(2008-10#1)(2012-3#1)
were less than the mean of the components##2##8##(2008-10#2)
were less than the##4##4##(1996-12#1)(2008-10#3)
were less than those of the controls##6##7##(2008-8#1)(2008-9#5)
were less than those of the vehicle controls during##2##9##(2008-9#2)
were less than those of the vehicle controls##4##8##(2008-9#4)
were less than those of the vehicle##5##7##(2008-9#5)
were less than those of the##14##6##(1990-5#1)(2008-8#1)(2008-9#12)
were less than those of##15##5##(1990-5#1)(1991-3#1)(2008-8#1)(2008-9#12)
were less than those##17##4##(1990-5#1)(1991-3#1)(1993-8#1)(1995-12#1)(2008-8#1)(2008-9#12)
were less than##48##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-12#2)(1996-5#1)(2008-10#17)(2008-3#2)(2008-8#1)(2008-9#13)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
were less tolerant##2##3##(2008-10#1)(2008-11#1)
were less virulent##2##3##(2008-10#2)
were less##156##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-3#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#6)(1995-2#2)(1995-5#1)(1995-6#3)(1996-12#3)(1996-5#2)(1997-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#42)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#17)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#3)(2011-1#3)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
were liberated##2##2##(2008-10#1)(2009-8#1)
were licensed##2##2##(1992-1#1)(2007-12#1)
were light##2##2##(2008-10#2)
were like##2##2##(1992-12#1)(2010-6#1)
were likely due to##2##4##(1995-12#1)(2008-11#1)
were likely to##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
were likely##12##2##(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2011-2#3)
were likewise##2##2##(2008-10#1)(2008-9#1)
were limited by##2##3##(2007-11#1)(2008-9#1)
were limited to the##4##4##(1991-5#1)(2008-10#2)(2008-5#1)
were limited to##6##3##(1991-5#1)(2008-10#4)(2008-5#1)
were limited##15##2##(1991-5#1)(1994-2#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)
were linear (r&gt##2##3##(2008-10#2)
were linear between##3##3##(2008-10#3)
were linear for##2##3##(2008-10#2)
were linear from##3##3##(2008-10#3)
were linear functions of##2##4##(1990-11#1)(2008-10#1)
were linear in the concentration range##2##6##(2008-10#2)
were linear in the concentration##4##5##(2008-10#4)
were linear in the range from##3##6##(1990-8#2)(2008-10#1)
were linear in the range of##7##6##(2008-10#7)
were linear in the range##11##5##(1990-8#2)(2008-10#9)
were linear in the##18##4##(1990-8#2)(2008-10#16)
were linear in##20##3##(1990-8#2)(1992-3#1)(2008-10#17)
were linear over a wide concentration range from##2##8##(2008-10#2)
were linear over the concentration range of 0##2##8##(2008-10#2)
were linear over the concentration range of##3##7##(2008-10#3)
were linear over the range 1-30##2##6##(1996-5#1)(2008-10#1)
were linear over the range of 0##2##7##(2008-10#2)
were linear over the range##8##5##(1996-5#1)(2008-10#7)
were linear over the##12##4##(1996-5#1)(2008-10#11)
were linear over##16##3##(1996-5#1)(2008-10#15)
were linear up to##2##4##(2008-10#2)
were linear##54##2##(1990-11#1)(1990-8#2)(1992-3#1)(1996-5#1)(2008-10#48)(2008-3#1)
were linearly related to the##2##5##(1994-11#1)(2008-10#1)
were linearly related to##3##4##(1993-12#1)(1994-11#1)(2008-10#1)
were linearly related##4##3##(1993-12#1)(1994-11#1)(2008-10#1)(2008-6#1)
were linearly##7##2##(1993-12#1)(1994-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
were lined by##3##3##(1990-6#2)(2008-11#1)
were linked by##2##3##(1997-1#1)(2008-9#1)
were linked to the##5##4##(2008-10#3)(2009-12#1)(2011-2#1)
were linked to##18##3##(1992-10#1)(1993-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-12#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#2)
were linked##24##2##(1990-9#1)(1992-10#1)(1993-3#1)(1997-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#2)
were listed##3##2##(1995-8#1)(2008-10#1)(2011-3#1)
were little##4##2##(1993-6#1)(1994-11#1)(1997-7#1)(2008-10#1)
were liver##2##2##(1992-8#1)(2013-8#1)
were living with a##2##4##(1990-2#1)(2012-12#1)
were living with##5##3##(1990-2#1)(1992-9#1)(2008-6#1)(2008-7#1)(2012-12#1)
were living##8##2##(1990-2#1)(1992-9#1)(1995-6#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
were loaded in##2##3##(2008-12#1)(2009-7#1)
were loaded with##3##3##(1990-11#1)(1992-5#1)(1994-2#1)
were loaded##9##2##(1990-11#1)(1992-5#2)(1994-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2013-1#1)
were local##4##2##(1994-9#1)(1996-8#1)(2007-11#1)(2007-2#1)
were localized in the##4##4##(1992-9#2)(2008-10#2)
were localized in##12##3##(1992-9#2)(1993-11#1)(1994-12#1)(1996-5#1)(2008-10#7)
were localized to##6##3##(1991-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-11#1)
were localized##23##2##(1991-5#1)(1992-9#2)(1993-11#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)
were located at the##5##4##(1996-5#1)(1997-3#1)(2007-2#1)(2008-12#1)(2008-7#1)
were located at##7##3##(1994-9#1)(1996-5#1)(1997-3#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-5#1)
were located in the cervical##2##5##(1995-11#1)(2013-8#1)
were located in the##21##4##(1990-11#1)(1991-8#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-2#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
were located in their##2##4##(1996-10#1)(1996-5#1)
were located in##31##3##(1990-11#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
were located near##3##3##(2008-10#2)(2013-8#1)
were located on chromosome##2##4##(1997-2#1)(2008-8#1)
were located on chromosomes##2##4##(1996-12#1)(2008-8#1)
were located on##9##3##(1995-12#1)(1996-12#2)(1997-2#1)(2008-10#3)(2008-8#2)
were located##68##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-8#1)(1997-2#2)(1997-3#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#5)
were long##2##2##(2008-10#1)(2010-8#1)
were longer than##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
were longer##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
were lost to follow-up##3##4##(2008-11#1)(2013-1#2)
were lost to##6##3##(1993-12#1)(1996-3#1)(2008-11#2)(2013-1#2)
were lost##9##2##(1990-3#1)(1993-12#1)(1994-8#1)(1996-3#1)(2008-11#2)(2008-5#1)(2013-1#2)
were low affinity (Kd = 0##2##6##(1994-8#2)
were low and##2##3##(1995-11#1)(2009-5#1)
were low compared to##2##4##(2010-8#1)(2011-1#1)
were low compared##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
were low during##2##3##(1995-12#1)(1996-2#1)
were low enough##2##3##(1995-3#1)(1995-8#1)
were low in##4##3##(1992-6#1)(1995-3#1)(2008-10#2)
were low to##2##3##(2008-10#2)
were low##34##2##(1990-2#1)(1992-3#1)(1992-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(2008-10#10)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-8#1)
were lower after##2##3##(1996-5#1)(2008-4#1)
were lower and##2##3##(2008-12#1)(2010-8#1)
were lower at##4##3##(1994-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
were lower for##4##3##(1993-2#1)(1995-1#1)(2008-12#1)(2011-2#1)
were lower in the##8##4##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
were lower in##20##3##(1991-12#1)(1993-1#1)(1997-2#1)(2008-10#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#2)(2013-8#1)
were lower than 0##2##4##(2008-10#2)
were lower than 2%##2##4##(2008-10#2)
were lower than 3##3##4##(2008-10#3)
were lower than in controls##2##5##(1992-11#1)(2008-7#1)
were lower than in the##2##5##(2008-12#1)(2013-1#1)
were lower than in those##2##5##(2011-2#2)
were lower than in##7##4##(1992-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
were lower than the##3##4##(2007-7#1)(2010-8#1)(2011-1#1)
were lower than those of##3##5##(1995-8#1)(2008-10#1)(2012-1#1)
were lower than those##6##4##(1990-8#1)(1995-8#1)(2008-10#1)(2008-12#1)(2012-1#1)(2013-1#1)
were lower than##42##3##(1990-8#1)(1990-9#1)(1992-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#21)(2008-12#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#3)
were lower##84##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-11#1)(1993-1#1)(1993-2#1)(1994-2#2)(1995-1#2)(1995-8#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#28)(2008-12#5)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#4)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#2)
were lowered##5##2##(1990-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
were lowest at##2##3##(2007-5#1)(2008-10#1)
were lowest##5##2##(2007-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
were lyophilized##2##2##(2008-10#2)
were macroscopically##2##2##(2007-10#1)(2013-1#1)
were made according##2##3##(2010-8#1)(2012-3#1)
were made and##2##3##(2008-10#1)(2008-12#1)
were made at##8##3##(1990-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
were made based on##3##4##(1990-11#1)(2008-5#1)(2010-10#1)
were made between##5##3##(2008-10#4)(2009-12#1)
were made by using##3##4##(2008-10#3)
were made by##20##3##(1991-3#1)(1992-10#1)(1994-12#1)(1995-11#1)(2007-11#2)(2008-10#10)(2008-5#1)(2008-7#2)(2008-9#1)
were made directly##2##3##(2008-11#1)(2008-9#1)
were made during##3##3##(1996-1#1)(2008-10#1)(2008-4#1)
were made for each##2##4##(2008-10#2)
were made for the##2##4##(2008-3#1)(2012-12#1)
were made for##12##3##(1994-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)(2013-1#2)
were made from a##2##4##(1993-12#1)(2009-7#1)
were made from##17##3##(1993-12#1)(1995-12#2)(1995-2#1)(1997-2#1)(2007-6#1)(2008-10#7)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
were made in a##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
were made in order to##2##5##(2008-11#1)(2012-7#1)
were made in the##6##4##(1992-3#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-7#1)
were made in##23##3##(1991-2#1)(1992-3#1)(1995-12#1)(1995-5#1)(1997-4#1)(1997-9#1)(2008-10#6)(2008-11#2)(2008-3#5)(2008-7#1)(2009-5#1)(2009-7#1)(2012-7#1)
were made into the##2##4##(1992-10#1)(1996-5#1)
were made into##3##3##(1992-10#1)(1996-5#1)(2008-9#1)
were made of the##4##4##(1991-3#1)(1997-8#1)(2008-10#1)(2012-2#1)
were made of##9##3##(1991-3#1)(1993-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-3#2)(2012-2#1)(2012-3#1)
were made on the##2##4##(2008-10#1)(2008-3#1)
were made on##6##3##(2008-10#3)(2008-3#2)(2013-7#1)
were made over##3##3##(2008-10#2)(2010-8#1)
were made that##2##3##(1994-2#1)(2008-11#1)
were made to reduce the##2##5##(1993-3#1)(2008-2#1)
were made to the##2##4##(1995-8#1)(2008-12#1)
were made to##19##3##(1993-2#1)(1993-3#1)(1995-8#1)(1996-3#1)(1997-5#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-8#1)
were made up##2##3##(1992-8#1)(2008-5#1)
were made using a##3##4##(1995-11#1)(2008-10#2)
were made using both##2##4##(2008-10#2)
were made using##13##3##(1991-5#1)(1993-8#1)(1995-11#1)(2008-10#8)(2008-11#1)(2008-7#1)
were made with##8##3##(1991-4#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-7#1)
were made##205##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#67)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#17)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#2)
were mailed##5##2##(1991-8#1)(1993-12#1)(1993-3#1)(2008-1#1)(2010-11#1)
were mainly associated with##2##4##(2008-10#1)(2011-3#1)
were mainly##25##2##(1990-5#1)(1991-12#1)(1991-5#1)(1997-8#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
were maintained at##6##3##(1994-5#1)(1996-5#1)(2008-10#3)(2008-7#1)
were maintained for 6##2##4##(1996-5#1)(2008-10#1)
were maintained for##8##3##(1990-6#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-12#1)
were maintained in the##4##4##(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
were maintained in##10##3##(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
were maintained on##5##3##(1994-8#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-8#1)
were maintained under##3##3##(2008-11#2)(2012-12#1)
were maintained##49##2##(1990-6#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#2)(1997-4#7)(2007-11#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
were major##5##2##(2008-3#1)(2008-5#1)(2009-6#1)(2012-3#1)(2013-1#1)
were malaria##2##2##(1991-12#1)(2008-1#1)
were male and##4##3##(1991-3#1)(2010-5#1)(2013-1#2)
were male##20##2##(1990-9#1)(1991-3#1)(1994-3#1)(1997-8#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-3#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
were males and six##2##4##(1990-2#1)(2007-7#1)
were males and##7##3##(1990-2#1)(1991-2#1)(1991-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2013-8#1)
were males##20##2##(1990-2#1)(1991-2#1)(1991-6#1)(2007-10#1)(2007-7#2)(2008-1#3)(2008-4#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
were malignant##3##2##(1992-5#1)(1993-8#1)(1994-3#1)
were managed by##4##3##(1992-8#1)(2007-7#1)(2008-10#1)(2013-1#1)
were managed conservatively##2##3##(2008-11#1)(2013-1#1)
were managed using##2##3##(2008-12#1)(2008-3#1)
were managed with##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
were managed##17##2##(1992-8#1)(1994-2#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#3)(2013-7#1)
were manipulated in##2##3##(2008-10#1)(2012-3#1)
were manipulated##4##2##(2008-10#2)(2010-10#1)(2012-3#1)
were manually##2##2##(2008-10#1)(2008-6#1)
were manufactured by##2##3##(2008-10#1)(2008-2#1)
were manufactured##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-4#1)
were many##10##2##(1996-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#2)
were mapped at##2##3##(2008-10#2)
were mapped in##3##3##(2008-10#2)(2008-5#1)
were mapped on the##4##4##(1996-8#1)(1997-8#1)(2008-8#1)(2013-8#1)
were mapped on##5##3##(1996-10#1)(1996-8#1)(1997-8#1)(2008-8#1)(2013-8#1)
were mapped to##5##3##(1992-3#1)(1993-12#1)(1996-3#1)(2008-10#1)(2013-1#1)
were mapped##23##2##(1992-3#1)(1993-12#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#2)(2013-1#1)(2013-8#1)
were marginally##2##2##(2007-2#1)(2008-10#1)
were marked and##2##3##(2008-5#1)(2008-8#1)
were marked##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
were markedly altered##2##3##(2008-10#2)
were markedly decreased##4##3##(1990-2#1)(2008-10#2)(2008-8#1)
were markedly different##2##3##(2008-4#1)(2008-5#1)
were markedly inhibited##3##3##(1990-5#2)(2008-10#1)
were markedly reduced##2##3##(1994-12#1)(1996-2#1)
were markedly##24##2##(1990-2#1)(1990-5#2)(1991-12#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-8#1)(2010-7#1)(2013-7#1)(2013-8#1)
were married or##2##3##(1994-6#1)(2007-12#1)
were married to men##2##4##(1994-6#2)
were married##9##2##(1994-6#3)(1996-5#1)(2007-12#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
were matched according to##3##4##(1993-12#1)(2008-5#2)
were matched by##2##3##(2013-1#2)
were matched for##5##3##(1991-12#1)(1996-3#1)(2008-3#1)(2008-8#1)(2009-10#1)
were matched to##2##3##(2008-11#1)(2008-9#1)
were matched with##5##3##(1993-1#1)(1995-2#1)(2008-5#1)(2008-8#1)(2009-7#1)
were matched##17##2##(1991-12#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2013-1#2)
were mated##4##2##(1992-3#2)(2008-10#2)
were mature at 8 weeks##3##5##(2007-7#3)
were mature at##4##3##(2007-7#4)
were mature##8##2##(2007-7#4)(2008-10#1)(2008-5#3)
were measured after##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
were measured and analyzed##2##4##(2008-12#1)(2009-10#1)
were measured and compared between##2##5##(1995-12#1)(2011-2#1)
were measured and compared with##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
were measured and compared##6##4##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
were measured and found to##2##5##(2007-11#1)(2012-3#1)
were measured and used to##2##5##(1996-2#1)(2008-10#1)
were measured and##24##3##(1991-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-8#1)(2007-11#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
were measured as a function of##4##6##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
were measured as the##2##4##(2007-8#1)(2008-10#1)
were measured as##12##3##(1994-3#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#1)(2013-1#1)
were measured at a##2##4##(2008-10#1)(2008-3#1)
were measured at four##4##4##(2008-11#1)(2008-3#1)(2010-5#1)(2013-3#1)
were measured at the##6##4##(2007-10#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-4#1)
were measured at##32##3##(1993-11#1)(1996-12#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-4#1)(2013-1#1)(2013-3#1)(2013-8#2)
were measured before and##3##4##(1992-6#1)(2008-3#1)(2011-1#1)
were measured before##9##3##(1992-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
were measured by RIA##2##4##(1991-12#1)(1991-6#1)
were measured by a##6##4##(2007-12#1)(2008-10#2)(2008-3#2)(2011-3#1)
were measured by in##2##4##(1996-12#1)(2008-10#1)
were measured by the##6##4##(1992-3#1)(2007-12#1)(2008-10#3)(2011-1#1)
were measured by use of##2##5##(2007-12#1)(2008-3#1)
were measured by using##4##4##(2008-10#1)(2008-2#1)(2008-5#1)(2013-8#1)
were measured by##64##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-12#3)(2007-7#1)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#3)(2009-1#1)(2009-10#1)(2009-9#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#4)
were measured directly##2##3##(2008-10#2)
were measured during##3##3##(1992-2#1)(2010-8#1)(2013-1#1)
were measured every##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
were measured for each##2##4##(1995-11#1)(2013-7#1)
were measured for the##3##4##(1996-5#1)(2008-3#1)(2008-5#1)
were measured for##15##3##(1991-5#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2013-7#1)(2013-8#1)
were measured from the##3##4##(1991-5#1)(2008-12#1)(2008-3#1)
were measured from##6##3##(1991-5#1)(1992-5#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#1)
were measured in 12##2##4##(2008-7#1)(2008-8#1)
were measured in a series of##2##6##(2008-7#1)(2008-8#1)
were measured in a##4##4##(1996-2#1)(2008-7#1)(2008-8#1)(2009-9#1)
were measured in all##2##4##(2011-2#1)(2012-2#1)
were measured in aqueous##2##4##(1995-11#1)(2008-10#1)
were measured in both##2##4##(1994-3#1)(2013-7#1)
were measured in comparison with##2##5##(1992-11#1)(2008-4#1)
were measured in plasma##2##4##(1990-2#1)(1993-2#1)
were measured in the same##2##5##(2008-3#1)(2008-7#1)
were measured in the##18##4##(1991-5#1)(1994-2#1)(1994-7#1)(1995-12#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)
were measured in vitro##2##4##(1990-6#1)(2008-10#1)
were measured in##95##3##(1990-2#4)(1990-3#3)(1990-6#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)
were measured including##2##3##(2008-12#2)
were measured on##7##3##(1995-3#1)(1995-5#1)(2006-12#1)(2007-11#1)(2008-10#2)(2012-3#1)
were measured over a broad temperature range##2##7##(2008-2#2)
were measured over a##4##4##(1991-9#1)(2008-2#2)(2011-2#1)
were measured over the##2##4##(1996-5#1)(2008-3#1)
were measured over##8##3##(1991-9#1)(1996-5#1)(2006-10#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-8#1)
were measured preoperatively and at 6-month follow-up##2##7##(2008-9#2)
were measured prior to##2##4##(2008-5#2)
were measured simultaneously in##2##4##(2008-10#1)(2008-5#1)
were measured simultaneously##5##3##(1992-3#1)(2008-10#2)(2008-2#1)(2008-5#1)
were measured to be##2##4##(2008-3#2)
were measured to determine##3##4##(1992-12#1)(2008-10#1)(2010-4#1)
were measured to##13##3##(1992-12#1)(1992-5#1)(1993-3#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-6#1)(2010-4#1)(2011-2#1)
were measured under##2##3##(2008-10#1)(2008-8#1)
were measured using a##5##4##(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-2#1)
were measured using the##5##4##(1993-2#2)(2008-7#2)(2013-1#1)
were measured using##25##3##(1990-5#1)(1993-2#2)(1994-11#1)(1994-2#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
were measured versus##2##3##(2007-12#1)(2008-3#1)
were measured with a new##2##5##(2008-10#1)(2008-3#1)
were measured with a##14##4##(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#8)
were measured with an##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
were measured with##35##3##(1991-8#1)(1994-6#2)(1995-3#1)(1996-5#2)(2007-11#2)(2007-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#11)(2008-5#1)(2009-12#1)
were measured within the##2##4##(2008-10#1)(2008-11#1)
were measured within##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
were measured##478##2##(1990-11#1)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#3)(1994-7#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#3)(1996-5#7)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#8)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#89)(2008-11#13)(2008-12#11)(2008-2#14)(2008-3#52)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#16)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#3)(2011-1#9)(2011-2#15)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#6)(2012-4#1)(2012-5#1)(2013-1#15)(2013-3#1)(2013-7#5)(2013-8#14)
were mediated by##3##3##(2008-4#2)(2010-7#1)
were mediated##4##2##(1995-12#1)(2008-4#2)(2010-7#1)
were meeting##2##2##(2007-12#1)(2012-12#1)
were members of a##4##4##(1991-7#1)(2008-10#2)(2009-2#1)
were members of the##5##4##(1993-1#1)(1997-1#1)(2008-10#3)
were members of##10##3##(1991-7#1)(1993-1#1)(1997-1#1)(2008-10#6)(2009-2#1)
were men##7##2##(1990-6#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
were mentally retarded##2##3##(1991-6#1)(1997-8#1)
were merged with##4##3##(1993-3#1)(2007-5#1)(2008-10#2)
were merged##6##2##(1993-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2011-2#1)
were met##3##2##(1995-2#1)(2007-5#1)(2008-9#1)
were metabolised##2##2##(1994-8#2)
were metastases##2##2##(2008-4#1)(2008-7#1)
were methionine##2##2##(2008-10#2)
were methods##2##2##(2008-10#1)(2008-6#1)
were methylated##3##2##(2008-7#1)(2009-10#1)(2010-11#1)
were microinjected with##2##3##(1993-12#1)(2008-11#1)
were migrants##2##2##(2010-8#1)(2011-2#1)
were mild##4##2##(2007-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
were mimicked by##2##3##(1993-6#1)(1997-1#1)
were mimicked##3##2##(1993-6#1)(1997-1#1)(2007-12#1)
were minimal##9##2##(1990-6#1)(1991-8#1)(1992-2#1)(1993-2#1)(1997-3#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-7#1)
were minimized by##4##3##(1993-12#1)(1997-2#1)(2008-10#2)
were minimized##6##2##(1993-12#1)(1997-2#1)(2008-10#3)(2008-3#1)
were minor##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
were misclassified as##2##3##(1993-8#2)
were missed by##2##3##(2008-11#1)(2012-2#1)
were missed or##2##3##(2008-9#1)(2012-12#1)
were missed##6##2##(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
were missing##3##2##(1992-11#1)(1996-2#1)(2008-12#1)
were misused in the context of##2##6##(2013-8#2)
were mixed and##5##3##(2008-10#2)(2009-9#1)(2012-2#1)(2013-1#1)
were mixed in different##2##4##(2008-10#1)(2013-8#1)
were mixed in##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
were mixed together##2##3##(1992-8#1)(2008-9#1)
were mixed with##3##3##(2008-7#1)(2010-5#1)(2011-2#1)
were mixed##24##2##(1990-12#1)(1990-2#1)(1992-8#1)(1993-11#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
were modeled##6##2##(2007-10#1)(2008-2#1)(2009-9#1)(2010-4#1)(2013-1#2)
were modelled using##2##3##(2010-4#1)(2011-2#1)
were moderate##5##2##(1991-2#1)(1994-7#1)(1996-3#2)(2012-5#1)
were moderated by##2##3##(2010-1#1)(2010-2#1)
were moderately disabled##2##3##(2013-8#2)
were moderately##11##2##(1993-9#1)(1996-6#1)(2006-12#1)(2007-7#1)(2008-10#3)(2009-2#1)(2010-4#1)(2013-8#2)
were modest##3##2##(1997-3#1)(2008-3#1)(2009-7#1)
were modified by##4##3##(2008-10#3)(2008-6#1)
were modified with##2##3##(1992-3#1)(1993-11#1)
were modified##14##2##(1992-3#1)(1993-11#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
were modulated by##3##3##(2008-11#2)(2013-1#1)
were modulated##4##2##(2008-11#2)(2010-4#1)(2013-1#1)
were molecularly##3##2##(2008-10#3)
were monitored after##2##3##(1991-8#1)(2008-10#1)
were monitored and##2##3##(2008-6#1)(2010-5#1)
were monitored at##2##3##(2008-10#1)(2010-3#1)
were monitored by##9##3##(1991-3#1)(1991-9#1)(1996-3#1)(2008-10#5)(2008-11#1)
were monitored during##2##3##(2008-10#1)(2013-8#1)
were monitored for##10##3##(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)
were monitored in a##2##4##(1994-9#1)(2008-5#1)
were monitored in real time using##2##6##(1995-12#1)(2008-10#1)
were monitored in real time##3##5##(1995-12#1)(2008-10#2)
were monitored in##11##3##(1990-7#1)(1994-9#1)(1995-12#1)(2008-10#5)(2008-5#1)(2008-7#2)
were monitored on-line##2##3##(2008-11#1)(2008-7#1)
were monitored over a##4##4##(1997-4#1)(2008-10#3)
were monitored over##6##3##(1997-4#1)(2008-10#5)
were monitored throughout the cultivation##2##5##(2008-6#2)
were monitored using##5##3##(2008-10#3)(2009-6#1)(2010-8#1)
were monitored##74##2##(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-10#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#31)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#4)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
were more abundant in the##2##5##(2008-10#1)(2009-10#1)
were more abundant in##3##4##(2008-10#1)(2009-10#1)(2013-7#1)
were more abundant##4##3##(2008-10#2)(2009-10#1)(2013-7#1)
were more activated in the script event##2##7##(1996-2#2)
were more active in##2##4##(1994-5#1)(2011-2#1)
were more active than##2##4##(2008-5#1)(2011-2#1)
were more active##4##3##(1994-5#1)(2008-5#1)(2011-2#2)
were more closely related to each other##2##7##(2008-10#2)
were more closely related to##4##5##(2008-10#4)
were more closely related##5##4##(2008-10#5)
were more common among##2##4##(1997-4#1)(2013-8#1)
were more common in the##3##5##(2006-8#1)(2008-1#1)(2008-9#1)
were more common in##9##4##(1993-10#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#3)
were more common##14##3##(1993-10#1)(1997-4#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
were more commonly##2##3##(2007-7#1)(2013-8#1)
were more complex##2##3##(1990-8#1)(2008-10#1)
were more concerned with##2##4##(2009-5#1)(2010-8#1)
were more easily##3##3##(1994-6#1)(2009-4#1)(2011-1#1)
were more effective at##2##4##(2008-10#1)(2013-1#1)
were more effective in##4##4##(1995-8#1)(2008-10#2)(2008-5#1)
were more effective than##6##4##(2008-10#3)(2008-11#1)(2008-4#1)(2013-1#1)
were more effective##12##3##(1995-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#2)
were more efficient##2##3##(2008-10#1)(2008-5#1)
were more evident at##2##4##(2008-12#1)(2008-5#1)
were more evident##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
were more favorable##2##3##(2009-4#1)(2010-4#1)
were more favourable in##2##4##(2011-1#1)(2012-2#1)
were more favourable##3##3##(1990-9#1)(2011-1#1)(2012-2#1)
were more frequent in##5##4##(1990-8#1)(2007-8#2)(2011-2#1)(2013-1#1)
were more frequent than##2##4##(1990-6#1)(2008-10#1)
were more frequent##8##3##(1990-6#1)(1990-8#1)(2007-8#2)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
were more frequently mechanically ventilated##2##5##(1990-12#1)(2011-2#1)
were more frequently##12##3##(1990-12#2)(1993-8#1)(1994-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#3)(2013-1#1)
were more highly##2##3##(2008-10#1)(2008-12#1)
were more impaired in##2##4##(2008-12#2)
were more impaired than##2##4##(1996-7#1)(2008-12#1)
were more impaired##4##3##(1996-7#1)(2008-12#3)
were more important##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
were more likely than men to##2##6##(2008-12#2)
were more likely than##9##4##(1991-8#1)(1993-1#1)(2008-12#5)(2010-10#1)(2012-3#1)
were more likely to achieve##2##5##(2007-2#1)(2013-1#1)
were more likely to be vaccinated than##2##7##(2007-2#1)(2009-5#1)
were more likely to be##18##5##(1993-12#1)(1994-3#1)(1995-3#1)(1996-3#2)(2007-2#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-5#2)(2010-10#1)(2011-2#1)(2013-1#3)
were more likely to die##2##5##(2008-8#1)(2012-12#1)
were more likely to engage in##2##6##(2008-1#1)(2009-7#1)
were more likely to experience##2##5##(2008-12#1)(2013-1#1)
were more likely to have a##2##6##(2008-3#1)(2008-6#1)
were more likely to have##10##5##(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
were more likely to report##7##5##(1995-12#1)(2009-5#2)(2009-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
were more likely to show relatively high mental status scores (i##2##11##(2010-12#2)
were more likely to show relatively##3##6##(2010-12#3)
were more likely to survive##2##5##(1995-2#1)(2008-8#1)
were more likely to##70##4##(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-3#2)(2006-10#1)(2007-11#1)(2007-2#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#5)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
were more likely##79##3##(1991-12#1)(1991-8#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-3#2)(2006-10#1)(2007-11#1)(2007-2#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#11)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#5)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#2)
were more numerous##3##3##(1993-12#1)(1994-2#1)(2013-8#1)
were more often##4##3##(1996-6#1)(2008-7#2)(2010-8#1)
were more persistent##2##3##(2008-12#1)(2008-8#1)
were more potent##3##3##(1990-5#1)(1995-11#1)(1995-3#1)
were more prevalent in##3##4##(1996-12#2)(2013-1#1)
were more prevalent##4##3##(1996-12#2)(2008-10#1)(2013-1#1)
were more pronounced in##3##4##(1997-6#1)(2008-8#1)(2010-2#1)
were more pronounced##5##3##(1997-6#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)
were more reliable##2##3##(2008-10#1)(2008-12#1)
were more resistant than##5##4##(2008-10#3)(2008-11#1)(2011-2#1)
were more resistant to##2##4##(2008-10#1)(2011-2#1)
were more resistant##7##3##(2008-10#4)(2008-11#1)(2011-2#2)
were more responsive to##2##4##(1994-11#1)(2008-10#1)
were more sensitive than##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
were more sensitive to##6##4##(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)
were more sensitive##11##3##(1995-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-9#1)(2011-2#1)
were more severe##2##3##(2008-5#1)(2011-2#1)
were more severely##2##3##(1994-1#1)(2008-10#1)
were more similar##2##3##(2008-10#1)(2010-4#1)
were more strongly##3##3##(1997-2#1)(2009-8#1)(2012-3#1)
were more susceptible to##12##4##(1990-7#1)(1991-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(2008-10#5)(2012-12#1)
were more than 10##2##4##(1990-8#1)(2008-10#1)
were more than doubled##2##4##(1990-8#1)(1992-3#1)
were more than in the control group##2##7##(2011-1#2)
were more than in##3##4##(2008-12#1)(2011-1#2)
were more than##17##3##(1990-8#2)(1991-5#1)(1992-3#1)(1993-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#1)(2013-1#1)
were more tolerant##2##3##(2008-12#1)(2012-9#1)
were more translucent than##2##4##(2012-2#2)
were more uniform and##2##4##(2008-10#2)
were more variable##2##3##(2008-10#2)
were more virulent than##2##4##(2008-10#2)
were more virulent##5##3##(2008-10#5)
were more vulnerable##2##3##(2008-10#1)(2011-2#1)
were more##343##2##(1990-12#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2006-10#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#75)(2008-11#8)(2008-12#23)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#7)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#7)(2011-2#15)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#4)(2012-9#1)(2013-1#20)(2013-7#2)(2013-8#6)
were morphologically indistinguishable from##2##4##(2008-10#2)
were morphologically##7##2##(2008-10#5)(2008-12#1)(2008-5#1)
were most affected##3##3##(2008-10#1)(2008-12#1)(2010-3#1)
were most common##4##3##(1994-12#1)(2008-12#1)(2012-3#2)
were most commonly##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
were most evident##2##3##(1996-12#1)(2008-11#1)
were most frequently##2##3##(2008-5#1)(2011-2#1)
were most likely to##4##4##(1995-3#1)(2007-12#1)(2008-12#1)(2013-1#1)
were most likely##7##3##(1995-3#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#2)
were most often##2##3##(2010-4#1)(2011-1#1)
were most prominent##3##3##(1995-5#1)(2008-5#1)(2008-7#1)
were most susceptible##2##3##(2008-10#2)
were most##52##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
were mostly in##3##3##(1991-2#1)(1993-2#2)
were mostly##28##2##(1991-2#1)(1992-5#1)(1993-12#1)(1993-2#2)(1994-9#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-3#3)(2013-1#1)
were motile##3##2##(1995-2#1)(2008-12#2)
were motivated to##2##3##(2009-6#1)(2012-3#1)
were mounted in a##2##4##(2008-10#1)(2013-1#1)
were mounted in##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
were mounted##5##2##(1993-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
were much better than those obtained##2##6##(2008-10#1)(2012-3#1)
were much better##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
were much greater than##2##4##(2008-10#1)(2008-8#1)
were much higher than the##2##5##(2008-3#1)(2008-9#1)
were much higher than those##3##5##(1991-12#1)(2008-10#1)(2008-8#1)
were much higher than##5##4##(1991-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
were much higher##8##3##(1991-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
were much less affected##2##4##(1991-5#1)(1996-2#1)
were much less##6##3##(1991-5#1)(1992-1#1)(1994-8#1)(1996-2#1)(2007-11#1)(2008-11#1)
were much lower compared##2##4##(2008-5#1)(2011-1#1)
were much lower than those##2##5##(2008-6#1)(2010-5#1)
were much lower##6##3##(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
were much more dissatisfied with their bodies than##2##8##(2008-9#2)
were much more sensitive to##2##5##(1993-8#1)(1995-2#1)
were much more##10##3##(1990-6#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-8#1)(2013-1#1)
were much##43##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-2#2)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)
were multiple##2##2##(1991-2#1)(2008-9#1)
were mutated##3##2##(1994-8#1)(2008-4#2)
were named##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
were narrow and##2##3##(2008-10#1)(2008-7#1)
were narrow##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
were near##5##2##(1997-3#1)(2008-10#3)(2008-5#1)
were nearly identical##2##3##(1992-11#1)(2008-10#1)
were nearly##7##2##(1992-11#1)(1992-2#1)(2008-10#4)(2008-5#1)
were nebulized and##2##3##(1991-1#1)(2008-10#1)
were necessary for the##3##4##(2008-10#2)(2008-8#1)
were necessary for##6##3##(1991-8#1)(1997-3#1)(2008-10#3)(2008-8#1)
were necessary to##8##3##(1990-5#1)(1992-7#1)(1992-9#1)(1997-5#1)(2008-10#3)(2013-1#1)
were necessary##20##2##(1990-5#1)(1991-8#1)(1992-7#1)(1992-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#7)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#2)
were necropsied##2##2##(2007-6#1)(2008-5#1)
were needed to##5##3##(1991-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
were needed##10##2##(1991-9#1)(1994-8#1)(1996-6#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
were negative for all##2##4##(1993-9#1)(2011-2#1)
were negative for the##3##4##(2008-12#1)(2011-2#2)
were negative for##15##3##(1990-2#1)(1992-2#1)(1993-9#2)(1994-7#1)(1997-5#2)(2008-12#1)(2008-4#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
were negative in all the##2##5##(2008-5#1)(2011-2#1)
were negative in##6##3##(1997-8#1)(2008-10#1)(2008-5#1)(2011-10#1)(2011-2#2)
were negative##41##2##(1990-2#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-9#2)(1994-7#1)(1997-5#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#3)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#4)(2013-8#1)
were negatively associated with##3##4##(2011-2#2)(2013-1#1)
were negatively associated##4##3##(2009-7#1)(2011-2#2)(2013-1#1)
were negatively correlated with##7##4##(1992-5#1)(2008-10#4)(2010-12#1)(2011-1#1)
were negatively correlated##12##3##(1992-5#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
were negatively related to##2##4##(1992-2#1)(2008-10#1)
were negatively##20##2##(1992-2#1)(1992-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
were negligible##5##2##(1991-8#1)(2008-10#3)(2008-6#1)
were neither##5##2##(1993-12#1)(1996-7#1)(2007-5#1)(2008-1#1)(2012-12#1)
were nephrotic syndrome##2##3##(2007-7#1)(2008-1#1)
were never##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
were new##2##2##(1997-8#1)(2008-7#1)
were newly identified as##2##4##(1995-12#1)(1995-2#1)
were newly##4##2##(1995-12#1)(1995-2#1)(2008-12#1)(2008-3#1)
were nine##3##2##(1993-3#1)(2010-12#1)(2011-2#1)
were no cases of##3##4##(1991-2#1)(2011-2#2)
were no changes in##2##4##(2008-11#1)(2013-8#1)
were no changes##3##3##(2008-11#1)(2009-3#1)(2013-8#1)
were no clinical##2##3##(1991-9#1)(2008-7#1)
were no clinically significant changes in##2##6##(1996-1#1)(2007-11#1)
were no clinically##3##3##(1996-1#1)(2007-11#1)(2012-2#1)
were no complications##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
were no deaths in##2##4##(2008-4#1)(2008-8#1)
were no deaths##5##3##(1993-9#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)
were no differences between the##3##5##(2008-6#1)(2010-4#1)(2013-1#1)
were no differences between##6##4##(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
were no differences in the##6##5##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
were no differences in##19##4##(1990-11#1)(1993-1#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were no differences##30##3##(1990-11#1)(1990-3#1)(1993-1#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
were no interferences##2##3##(2008-10#2)
were no longer detectable##2##4##(1994-12#1)(1996-12#1)
were no longer observed##2##4##(1992-8#1)(2008-10#1)
were no longer significant##2##4##(2010-8#1)(2012-5#1)
were no longer##10##3##(1992-8#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-12#1)(2008-10#3)(2010-8#1)(2012-5#1)
were no more##2##3##(2007-10#1)(2008-10#1)
were no recurrences##4##3##(1991-6#1)(1995-5#1)(2010-3#1)(2012-2#1)
were no serious complications##3##4##(1990-2#1)(2008-5#1)(2012-2#1)
were no serious##5##3##(1990-2#1)(2008-5#2)(2012-2#1)(2013-1#1)
were no significant (P##2##4##(2008-10#2)
were no significant changes in##7##5##(1993-12#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
were no significant changes##8##4##(1993-12#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
were no significant differences among##3##5##(2008-10#1)(2011-2#1)(2012-2#1)
were no significant differences between groups in##2##7##(2011-2#1)(2013-1#1)
were no significant differences between groups##4##6##(1994-5#1)(2011-2#1)(2013-1#2)
were no significant differences between the##3##6##(1995-4#1)(2007-8#1)(2008-12#1)
were no significant differences between##11##5##(1990-12#1)(1992-1#1)(1994-5#1)(1995-4#1)(1997-7#1)(2007-8#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-1#2)
were no significant differences in the##10##6##(1991-8#1)(1994-12#1)(1997-2#1)(1997-7#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
were no significant differences in##24##5##(1991-2#1)(1991-8#1)(1993-1#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
were no significant differences##49##4##(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-4#1)(1996-2#1)(1997-2#1)(1997-7#2)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
were no significant effects of##2##5##(2011-2#1)(2013-1#1)
were no significant effects##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
were no significant##73##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-2#1)(1997-2#1)(1997-7#2)(2006-12#1)(2007-6#1)(2007-8#3)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#8)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
were no signs of##5##4##(1993-1#1)(1993-6#1)(2007-8#1)(2008-10#1)(2011-2#1)
were no statistically significant differences between##6##6##(2009-10#1)(2010-12#2)(2012-3#1)(2013-1#2)
were no statistically significant differences##12##5##(1996-1#1)(1996-7#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
were no statistically significant##13##4##(1996-1#1)(1996-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
were no statistically##14##3##(1996-1#1)(1996-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
were no treatment-related##3##3##(2008-9#3)
were no##251##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-1#5)(1993-12#4)(1993-6#2)(1993-9#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#3)(1997-7#3)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#2)(2007-7#2)(2007-8#10)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#17)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-12#3)(2010-3#3)(2010-4#4)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#18)(2012-12#2)(2012-2#11)(2012-3#10)(2012-5#1)(2013-1#15)(2013-8#6)
were non-linear##2##2##(1995-8#1)(2008-10#1)
were non-smokers##2##2##(1993-2#1)(2011-2#1)
were non/limited users##2##3##(2008-9#2)
were nonpathogenic on##4##3##(2008-10#4)
were nonpathogenic##10##2##(2008-10#10)
were nonreactive with##3##3##(1994-12#1)(1994-6#1)(1994-9#1)
were normal but##2##3##(2012-2#1)(2013-1#1)
were normal in##3##3##(1990-9#1)(1992-8#1)(2012-12#1)
were normal##31##2##(1990-6#1)(1990-9#2)(1992-10#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
were normalized##8##2##(1990-9#1)(1993-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
were normally##2##2##(1990-12#1)(1995-6#1)
were not able to##9##4##(2008-10#3)(2008-11#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
were not affected by the##6##5##(1990-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
were not affected by##20##4##(1990-11#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2010-2#1)(2013-1#1)
were not affected in##2##4##(2012-12#1)(2012-2#1)
were not affected significantly by##2##5##(1997-7#1)(2008-12#1)
were not affected when##2##4##(1990-7#1)(2008-10#1)
were not affected##33##3##(1990-11#1)(1990-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-8#2)(1996-2#1)(1997-2#1)(1997-7#2)(2008-10#8)(2008-11#2)(2008-12#4)(2008-4#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
were not all##2##3##(2008-10#2)
were not altered by##7##4##(1990-5#1)(1993-8#1)(1994-6#1)(1995-12#1)(2007-10#1)(2008-11#1)(2011-2#1)
were not altered##8##3##(1990-5#1)(1993-8#1)(1994-6#1)(1995-12#1)(2007-10#1)(2008-11#2)(2011-2#1)
were not always##4##3##(2008-10#1)(2009-4#1)(2010-3#1)(2010-8#1)
were not amplified from##2##4##(2008-10#2)
were not apparent##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
were not as##7##3##(2008-10#3)(2008-5#1)(2008-9#1)(2009-7#2)
were not associated with the##3##5##(1996-12#1)(2007-8#1)(2008-10#1)
were not associated with##15##4##(1990-3#1)(1992-2#1)(1992-3#1)(1993-9#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-8#1)
were not associated##16##3##(1990-3#1)(1992-2#1)(1992-3#1)(1993-9#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
were not at##2##3##(1990-3#1)(2012-2#1)
were not available##2##3##(2008-10#1)(2008-6#1)
were not aware of##2##4##(2011-2#1)(2012-12#1)
were not being##2##3##(2011-2#1)(2013-1#1)
were not changed##5##3##(1991-12#1)(1992-3#1)(1993-12#1)(1995-12#1)(2008-8#1)
were not conclusive##2##3##(1997-4#1)(2013-1#1)
were not conducive##2##3##(2008-10#2)
were not conducted##2##3##(1991-12#1)(2008-10#1)
were not considered##6##3##(1990-5#1)(2008-10#4)(2011-2#1)
were not consistent with##3##4##(1997-7#1)(2008-10#1)(2008-11#1)
were not consistent##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
were not correlated with##5##4##(2008-10#4)(2013-1#1)
were not correlated##7##3##(2008-10#6)(2013-1#1)
were not decreased##2##3##(1993-12#1)(1993-3#1)
were not dependent on##2##4##(1994-9#1)(2008-12#1)
were not designed##2##3##(1992-11#1)(2009-10#1)
were not detectable##3##3##(1992-9#1)(2010-12#1)(2012-3#1)
were not detected at##2##4##(2008-10#1)(2008-5#1)
were not detected in any of##2##6##(1996-12#1)(2007-7#1)
were not detected in any##3##5##(1996-12#1)(1997-6#1)(2007-7#1)
were not detected in the##2##5##(1994-12#1)(2008-10#1)
were not detected in##15##4##(1991-12#1)(1992-10#1)(1994-12#2)(1995-11#1)(1996-12#1)(1997-3#1)(1997-6#2)(2007-7#1)(2008-10#5)
were not detected within the confines of the plot sizes tested##2##11##(2008-10#2)
were not detected##32##3##(1991-12#1)(1991-5#1)(1992-10#1)(1993-9#1)(1994-12#2)(1994-8#2)(1995-11#1)(1996-12#1)(1997-3#1)(1997-6#3)(2007-7#1)(2008-10#8)(2008-12#2)(2008-5#3)(2009-6#1)(2011-2#2)(2013-8#1)
were not different from##2##4##(1992-3#1)(2008-10#1)
were not different##6##3##(1992-3#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-7#1)
were not diminished##2##3##(1992-3#1)(2009-12#1)
were not due to the##2##5##(2008-7#1)(2011-1#1)
were not due to##6##4##(1994-2#1)(1994-3#1)(1995-8#1)(2007-10#1)(2008-7#1)(2011-1#1)
were not effective at##2##4##(1994-11#1)(2011-2#1)
were not effective##5##3##(1994-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
were not efficient##2##3##(2008-10#1)(2009-11#1)
were not elevated in##2##4##(1992-8#1)(1993-6#1)
were not encountered##2##3##(1990-3#1)(1994-8#1)
were not evaluable##2##3##(1991-6#1)(2008-7#1)
were not evaluated##2##3##(2011-2#1)(2012-2#1)
were not evident in##2##4##(2008-10#2)
were not evident##5##3##(2007-12#1)(2008-10#3)(2011-1#1)
were not exposed to the##3##5##(2008-10#1)(2008-12#1)(2008-7#1)
were not formed##3##3##(2008-10#3)
were not found in the##2##5##(1993-12#1)(1995-6#1)
were not found in##9##4##(1990-3#1)(1992-5#1)(1993-12#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-8#2)(2011-2#1)
were not found to be##5##5##(1995-6#1)(1997-3#1)(1997-4#1)(2009-7#1)(2011-2#1)
were not found to##7##4##(1995-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-5#1)(2009-7#1)(2011-2#1)
were not found##24##3##(1990-3#1)(1990-6#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-8#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-5#2)(2008-8#2)(2009-10#1)(2009-7#1)(2011-2#2)
were not fully##3##3##(1996-3#1)(2008-3#1)(2011-2#1)
were not genotoxic##2##3##(1997-4#1)(2013-1#1)
were not greatly affected by##2##5##(2008-10#1)(2008-7#1)
were not higher than##3##4##(1990-5#1)(2008-10#2)
were not higher##4##3##(1990-5#1)(2008-10#2)(2008-11#1)
were not identical##2##3##(1990-7#1)(2009-5#1)
were not identified##5##3##(1990-11#1)(1995-4#1)(2008-10#1)(2009-3#1)(2011-1#1)
were not impaired##2##3##(1993-12#1)(1994-3#1)
were not in##2##3##(2008-7#2)
were not included in the##3##5##(2007-6#1)(2007-7#1)(2010-1#1)
were not included in##5##4##(2007-6#1)(2007-7#1)(2008-11#1)(2010-1#1)(2012-3#1)
were not included##8##3##(1990-9#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-4#2)(2010-1#1)(2012-3#1)
were not infected##3##3##(2008-10#2)(2008-5#1)
were not influenced##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
were not involved in##3##4##(1993-6#1)(2008-6#1)(2008-9#1)
were not involved##4##3##(1993-6#1)(2008-6#1)(2008-9#1)(2011-2#1)
were not likely to##2##4##(1992-2#1)(2008-12#1)
were not linked to##2##4##(2008-10#2)
were not modified by##2##4##(1994-3#1)(2008-4#1)
were not more##4##3##(1991-3#1)(1992-11#1)(2008-12#1)(2011-1#1)
were not observed in the##3##5##(2008-10#2)(2010-12#1)
were not observed in##11##4##(1992-5#1)(1994-8#1)(1995-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-12#1)(2012-1#1)
were not observed to##2##4##(1991-7#1)(2008-10#1)
were not observed##29##3##(1990-10#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2010-12#1)(2010-7#1)(2012-1#1)
were not obtained##2##3##(1994-9#1)(2007-5#1)
were not obvious##2##3##(2007-11#1)(2008-7#1)
were not on##3##3##(2008-5#2)(2012-1#1)
were not only##7##3##(1990-5#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)
were not or##2##3##(2008-10#2)
were not performed##2##3##(1992-9#1)(1994-12#1)
were not predictive of##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
were not predictive##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
were not present in the##2##5##(2008-10#1)(2008-12#1)
were not present##5##3##(2008-10#2)(2008-12#1)(2010-6#1)(2012-12#1)
were not previously##3##3##(1991-5#1)(2008-10#1)(2010-4#1)
were not receiving##2##3##(2008-5#1)(2008-7#1)
were not recovered##2##3##(2008-10#2)
were not reduced in##2##4##(1993-12#1)(1993-3#1)
were not related to the##4##5##(1992-11#1)(1992-5#1)(2009-5#1)(2010-8#1)
were not related to##14##4##(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-8#1)(2011-1#1)
were not reported##2##3##(1993-3#1)(2008-9#1)
were not required for##3##4##(1991-8#1)(1995-5#1)(1997-3#1)
were not required##6##3##(1991-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-3#1)(2013-1#1)
were not seen in##2##4##(1995-11#1)(2007-12#1)
were not seen within the##2##5##(1997-3#1)(2013-1#1)
were not seen##5##3##(1995-11#1)(1997-3#1)(2007-12#1)(2010-12#1)(2013-1#1)
were not severe##2##3##(2008-1#1)(2011-2#1)
were not significant and##2##4##(1997-4#1)(2008-10#1)
were not significant for##2##4##(2008-10#1)(2008-12#1)
were not significant##28##3##(1992-2#2)(1994-12#1)(1994-9#1)(1995-6#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#5)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#1)(2009-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
were not significantly affected by##3##5##(2008-10#2)(2010-2#1)
were not significantly affected##5##4##(1994-2#1)(1995-12#1)(2008-10#2)(2010-2#1)
were not significantly correlated with##3##5##(2008-10#1)(2008-7#2)
were not significantly correlated##4##4##(1990-8#1)(2008-10#1)(2008-7#2)
were not significantly different among the##2##6##(2008-12#1)(2008-7#1)
were not significantly different among##4##5##(2008-10#2)(2008-12#1)(2008-7#1)
were not significantly different between##5##5##(1996-12#1)(1996-7#1)(2008-10#1)(2008-7#1)(2009-11#1)
were not significantly different from controls##2##6##(1991-12#1)(2008-7#1)
were not significantly different from the##2##6##(2008-10#1)(2012-3#1)
were not significantly different from those##2##6##(2008-8#1)(2010-8#1)
were not significantly different from##14##5##(1991-12#1)(1995-12#1)(2008-10#7)(2008-7#1)(2008-8#2)(2010-8#1)(2012-3#1)
were not significantly different in the##2##6##(1992-3#1)(2008-11#1)
were not significantly different in##5##5##(1992-3#1)(2008-11#1)(2008-12#2)(2011-2#1)
were not significantly different##41##4##(1990-9#1)(1991-12#1)(1992-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#3)(2008-8#3)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
were not significantly##66##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-7#1)(2008-10#22)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#5)(2008-8#3)(2009-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
were not so##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
were not spatially##2##3##(2008-10#2)
were not stable##2##3##(2008-10#1)(2009-9#1)
were not statistically different between##2##5##(2012-3#2)
were not statistically different##8##4##(1994-2#1)(1997-8#1)(2008-10#2)(2009-1#1)(2011-2#1)(2012-3#2)
were not statistically significant (p##2##5##(2008-1#1)(2008-12#1)
were not statistically significant##19##4##(1992-2#1)(1996-3#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
were not statistically##28##3##(1992-2#1)(1994-2#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-12#1)(2008-8#1)(2009-1#1)(2010-10#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
were not successful in##2##4##(1992-2#1)(2008-10#1)
were not successful##7##3##(1990-5#1)(1991-2#1)(1992-2#1)(2008-10#3)(2012-2#1)
were not taking their##2##4##(2010-1#2)
were not taking##5##3##(2008-7#1)(2010-1#4)
were not the##2##3##(2008-10#1)(2011-1#1)
were not treated##3##3##(1996-6#1)(2008-11#1)(2013-1#1)
were not uniform##2##3##(1991-1#1)(2008-10#1)
were not used##2##3##(2011-2#1)(2012-2#1)
were not useful##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
were not usually##2##3##(1995-2#1)(2008-10#1)
were not utilized##2##3##(1994-11#1)(2008-10#1)
were not validated##2##3##(2008-10#1)(2011-2#1)
were not very##2##3##(1991-2#1)(2013-8#1)
were not visible##2##3##(2007-11#1)(2008-10#1)
were not well##3##3##(1996-1#1)(2012-12#1)(2012-2#1)
were not##745##2##(1990-10#1)(1990-11#2)(1990-3#4)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#10)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#6)(1993-9#7)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#5)(1994-6#2)(1994-8#6)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#7)(1996-2#4)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#2)(2006-10#1)(2006-12#2)(2007-10#9)(2007-11#6)(2007-12#7)(2007-2#4)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#187)(2008-11#18)(2008-12#26)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#21)(2008-6#4)(2008-7#25)(2008-8#14)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#11)(2011-2#33)(2011-3#1)(2012-1#3)(2012-12#13)(2012-2#9)(2012-3#6)(2013-1#26)(2013-8#9)
were notable##2##2##(2012-3#2)
were noted after##2##3##(2008-5#1)(2008-7#1)
were noted among##3##3##(1994-1#1)(2008-10#1)(2008-7#1)
were noted at##3##3##(2006-10#1)(2010-8#1)(2013-1#1)
were noted between##4##3##(1995-2#1)(2009-2#1)(2010-3#1)(2012-12#1)
were noted down##2##3##(2007-11#1)(2010-7#1)
were noted during##2##3##(1990-8#1)(1993-1#1)
were noted for##5##3##(1990-6#1)(1993-9#1)(2008-10#2)(2009-11#1)
were noted in the##7##4##(1995-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
were noted in##29##3##(1990-12#1)(1991-4#1)(1992-1#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
were noted to##2##3##(2008-12#1)(2012-2#1)
were noted with##2##3##(1991-2#1)(1993-9#1)
were noted within##2##3##(2007-7#1)(2008-10#1)
were noted##91##2##(1990-12#1)(1990-2#1)(1990-6#3)(1990-8#1)(1991-2#2)(1991-3#2)(1991-4#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-4#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#6)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-12#2)(2008-5#3)(2008-7#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#5)
were noticeably##2##2##(1995-11#1)(2008-9#1)
were noticed in##3##3##(1996-1#1)(2008-10#1)(2008-8#1)
were noticed##8##2##(1993-11#1)(1994-2#1)(1996-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-6#1)
were notified##2##2##(2010-10#1)(2012-12#1)
were now##2##2##(1997-3#1)(2008-7#1)
were numerous##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
were nurses##3##2##(1993-3#1)(2011-1#1)(2012-3#1)
were obese##7##2##(2008-3#2)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#2)
were observed (P##3##3##(1994-12#1)(2011-1#1)(2013-1#1)
were observed across##2##3##(2007-5#1)(2008-11#1)
were observed after##14##3##(1990-2#1)(1992-11#1)(1995-3#1)(2008-10#3)(2008-12#2)(2008-7#1)(2009-10#1)(2012-1#1)(2012-3#2)(2013-1#1)
were observed among different##2##4##(2008-10#1)(2013-1#1)
were observed among isolates in##2##5##(2008-10#2)
were observed among isolates##4##4##(2008-10#4)
were observed among the##2##4##(2008-10#1)(2008-6#1)
were observed among these three##2##5##(1997-2#1)(2008-10#1)
were observed among##17##3##(1997-2#1)(2008-10#11)(2008-12#1)(2008-6#1)(2008-8#1)(2013-1#2)
were observed and the##2##4##(2008-12#1)(2008-5#1)
were observed and##13##3##(1990-2#1)(1991-3#1)(1992-6#1)(1993-1#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
were observed as##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
were observed associated##2##3##(1995-2#1)(2013-1#1)
were observed at the end of the##2##7##(2008-8#1)(2013-1#1)
were observed at the end of##3##6##(2008-8#1)(2011-2#1)(2013-1#1)
were observed at the##15##4##(1993-3#1)(1993-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
were observed at##40##3##(1991-11#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-3#1)(1997-6#5)(2007-11#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
were observed before##2##3##(2008-10#1)(2012-3#1)
were observed between control and##2##5##(1991-5#1)(2008-10#1)
were observed between groups##2##4##(2008-5#2)
were observed between the two groups##2##6##(2008-10#1)(2011-2#1)
were observed between the two##5##5##(1994-6#1)(1995-5#1)(2008-10#2)(2011-2#1)
were observed between the##13##4##(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#2)
were observed between##40##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
were observed by##10##3##(1992-2#1)(1992-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)
were observed during the##8##4##(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)
were observed during##18##3##(1993-8#1)(1995-12#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
were observed feeding##2##3##(2008-5#1)(2008-6#1)
were observed first##2##3##(2007-8#1)(2008-10#1)
were observed for all the##2##5##(2008-10#2)
were observed for all##4##4##(2008-10#4)
were observed for both##3##4##(1993-11#1)(1996-2#1)(2008-10#1)
were observed for most of the##2##6##(2007-11#1)(2008-10#1)
were observed for mouth and pharynx##2##6##(1990-8#2)
were observed for the##15##4##(1991-1#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-2#1)(1996-5#1)(2007-11#1)(2008-10#6)(2008-6#1)(2011-2#1)
were observed for##54##3##(1990-12#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#3)(2008-10#23)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
were observed from the##2##4##(2010-3#1)(2011-2#1)
were observed from##10##3##(2007-12#1)(2008-10#6)(2008-3#1)(2010-3#1)(2011-2#1)
were observed in 4##2##4##(2008-1#1)(2013-8#1)
were observed in a##8##4##(1990-5#1)(2007-12#2)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
were observed in all##5##4##(1993-8#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
were observed in any##2##4##(1996-12#1)(2008-10#1)
were observed in both##2##4##(2008-12#1)(2012-2#1)
were observed in cells##2##4##(1992-8#1)(1995-8#1)
were observed in comparison##2##4##(2008-10#1)(2013-7#1)
were observed in four##2##4##(2007-8#2)
were observed in male and female##2##6##(1995-11#1)(2008-9#1)
were observed in many##2##4##(1994-12#1)(2009-12#1)
were observed in only one##2##5##(1993-12#1)(2008-4#1)
were observed in only##5##4##(1990-2#1)(1990-9#1)(1991-4#1)(1993-12#1)(2008-4#1)
were observed in patients##3##4##(2007-11#1)(2008-6#1)(2008-7#1)
were observed in poults fed##2##5##(2008-5#2)
were observed in relation to##2##5##(2008-5#1)(2008-6#1)
were observed in some##2##4##(1994-5#1)(2008-10#1)
were observed in subjects##2##4##(1992-2#1)(2008-7#1)
were observed in the control##2##5##(1994-5#1)(2008-10#1)
were observed in the hippocampus##2##5##(1992-12#1)(1995-12#1)
were observed in the olfactory bulb##2##6##(2008-6#1)(2008-7#1)
were observed in the presence of##2##6##(1995-11#1)(2008-10#1)
were observed in the ranges of##3##6##(2008-10#2)(2011-1#1)
were observed in the ultraendurance runners##2##6##(2013-8#2)
were observed in the##85##4##(1990-5#1)(1990-6#1)(1991-12#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-9#1)(2007-12#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
were observed in these##2##4##(1994-11#1)(2012-2#1)
were observed in this##3##4##(1992-3#1)(2008-10#1)(2010-5#1)
were observed in##255##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-8#2)(1996-12#5)(1996-2#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#53)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#12)(2008-6#9)(2008-7#10)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#1)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#5)
were observed more##2##3##(1995-6#1)(2011-2#1)
were observed on V/K##2##4##(1992-3#2)
were observed on the##6##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)
were observed on##20##3##(1990-11#1)(1991-6#1)(1992-3#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
were observed once##2##3##(2011-2#1)(2012-6#1)
were observed only at##2##4##(1994-3#1)(2013-1#1)
were observed only in the##6##5##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
were observed only in##8##4##(1990-3#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)
were observed only##10##3##(1990-3#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-1#1)
were observed over##5##3##(2008-10#4)(2013-8#1)
were observed regardless of##2##4##(2008-11#1)(2008-9#1)
were observed to be##5##4##(2008-10#2)(2008-11#1)(2012-12#2)
were observed to##20##3##(1993-6#1)(1997-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
were observed under##3##3##(2008-10#1)(2008-9#1)(2013-7#1)
were observed using##2##3##(1996-2#1)(1996-5#1)
were observed when the two##2##5##(1991-8#1)(2008-10#1)
were observed when the##7##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-4#1)
were observed when##19##3##(1990-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-11#1)(1994-3#1)(2008-10#7)(2008-11#2)(2008-3#2)(2010-4#1)(2013-1#1)
were observed while##2##3##(2008-10#1)(2011-1#1)
were observed with the##6##4##(1992-8#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2013-1#1)
were observed with##23##3##(1991-1#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-5#1)(1997-4#2)(2008-10#7)(2008-11#1)(2008-5#3)(2009-12#1)(2011-1#1)(2011-3#1)(2013-1#2)
were observed within##4##3##(1991-6#1)(1996-12#1)(2008-10#2)
were observed without##2##3##(1990-11#1)(1997-3#1)
were observed##855##2##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#4)(1990-5#4)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#7)(1992-5#3)(1992-6#5)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#4)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#2)(1995-3#10)(1995-5#4)(1995-6#4)(1995-8#4)(1996-11#1)(1996-12#9)(1996-2#5)(1996-3#3)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#7)(1997-3#6)(1997-4#9)(1997-6#8)(1997-7#2)(1997-8#6)(1997-9#1)(2007-10#3)(2007-11#16)(2007-12#9)(2007-5#2)(2007-7#1)(2007-8#10)(2008-1#2)(2008-10#228)(2008-11#25)(2008-12#15)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#49)(2008-6#16)(2008-7#24)(2008-8#12)(2008-9#11)(2009-10#2)(2009-11#2)(2009-12#5)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#4)(2010-4#7)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#6)(2011-1#13)(2011-2#18)(2011-3#4)(2012-1#5)(2012-12#8)(2012-2#12)(2012-3#10)(2012-6#1)(2013-1#35)(2013-7#2)(2013-8#11)
were obtained after the##2##4##(2008-9#2)
were obtained after##10##3##(1990-2#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-1#1)
were obtained and analyzed##2##4##(2008-10#1)(2008-3#1)
were obtained and one of##2##5##(2008-8#1)(2008-9#1)
were obtained and the##5##4##(2008-10#4)(2011-2#1)
were obtained and##20##3##(1997-3#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)
were obtained as a##2##4##(2008-10#1)(2008-6#1)
were obtained as##6##3##(2008-10#4)(2008-3#1)(2008-6#1)
were obtained at 0##2##4##(2008-5#2)
were obtained at a repetition rate of##2##7##(2007-12#2)
were obtained at a##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
were obtained at the##6##4##(2007-12#1)(2008-10#5)
were obtained at various##2##4##(1997-8#1)(2008-6#1)
were obtained at##30##3##(1990-7#1)(1992-8#1)(1997-5#1)(1997-8#1)(2007-12#3)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#2)(2010-5#1)
were obtained before##2##3##(1995-2#1)(2013-1#1)
were obtained between##2##3##(2008-10#1)(2012-1#1)
were obtained both##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
were obtained by Southern blot##2##5##(2008-10#1)(2008-9#1)
were obtained by a##3##4##(1993-12#1)(1996-8#1)(2008-10#1)
were obtained by single##2##4##(2008-10#1)(2013-1#1)
were obtained by taking a##2##5##(1990-10#1)(2008-10#1)
were obtained by the##6##4##(1997-3#1)(2008-10#5)
were obtained by use of##3##5##(2007-11#1)(2008-3#2)
were obtained by using a##2##5##(2008-10#1)(2011-1#1)
were obtained by using electrodes##2##5##(2008-10#2)
were obtained by using##10##4##(1992-8#1)(2008-10#7)(2008-8#1)(2011-1#1)
were obtained by##73##3##(1990-10#1)(1991-6#1)(1992-8#2)(1993-12#1)(1993-9#1)(1994-6#2)(1994-8#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#34)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
were obtained compared with##2##4##(2008-10#2)
were obtained during##4##3##(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
were obtained following##2##3##(2013-1#1)(2013-7#1)
were obtained for 0##4##4##(2008-10#4)
were obtained for all elements##2##5##(2011-2#2)
were obtained for all the##4##5##(2008-10#4)
were obtained for all##9##4##(2008-10#7)(2011-2#2)
were obtained for both##4##4##(2008-10#3)(2008-2#1)
were obtained for different##3##4##(2008-10#2)(2008-3#1)
were obtained for each compound##2##5##(2008-10#2)
were obtained for each##8##4##(2008-10#5)(2010-5#1)(2012-12#1)(2013-1#1)
were obtained for most##2##4##(2008-10#2)
were obtained for the determination of##4##6##(2008-10#4)
were obtained for the three##3##5##(2008-10#2)(2010-12#1)
were obtained for the##24##4##(1991-12#1)(1994-11#1)(2007-12#1)(2008-10#19)(2008-11#1)(2010-12#1)
were obtained for this##3##4##(1997-2#1)(2007-8#1)(2008-10#1)
were obtained for untreated and NEM-treated cells##2##7##(1995-8#2)
were obtained for##120##3##(1991-1#1)(1991-12#1)(1993-6#2)(1994-11#1)(1995-2#1)(1995-8#2)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#82)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
were obtained from 0##2##4##(2008-10#2)
were obtained from 10##2##4##(2006-12#1)(2008-10#1)
were obtained from 15##3##4##(2008-6#1)(2008-7#1)(2011-2#1)
were obtained from 5##2##4##(1993-2#1)(1995-8#1)
were obtained from 72##2##4##(2008-7#1)(2011-1#1)
were obtained from a##10##4##(1992-8#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
were obtained from diseased##2##4##(2008-10#2)
were obtained from rice##2##4##(2008-10#2)
were obtained from subjects##2##4##(1995-12#1)(2008-7#1)
were obtained from the results##2##5##(2008-10#1)(2010-2#1)
were obtained from the##25##4##(1991-12#1)(1991-6#1)(1995-3#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-8#2)
were obtained from three##2##4##(1990-12#1)(2012-2#1)
were obtained from##126##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#37)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
were obtained in a##2##4##(1990-11#1)(1996-2#1)
were obtained in all##2##4##(1993-8#1)(2008-10#1)
were obtained in both cases##3##5##(2008-10#3)
were obtained in both##4##4##(2008-10#4)
were obtained in the concentration range##2##6##(2008-10#2)
were obtained in the##16##4##(2008-10#13)(2008-11#1)(2008-2#1)(2008-8#1)
were obtained in##60##3##(1990-11#2)(1990-2#1)(1991-12#1)(1991-6#1)(1993-8#1)(1994-8#2)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#29)(2008-11#3)(2008-2#1)(2008-5#6)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
were obtained on all##2##4##(2007-10#1)(2008-9#1)
were obtained on##6##3##(1995-12#1)(1995-3#1)(2007-10#2)(2007-12#1)(2008-9#1)
were obtained over the##4##4##(2008-10#3)(2008-3#1)
were obtained over##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2012-4#1)
were obtained respectively##2##3##(1993-8#1)(1997-3#1)
were obtained showing##2##3##(1991-3#1)(2008-10#1)
were obtained simultaneously##2##3##(1991-12#1)(2008-2#1)
were obtained that##3##3##(1990-11#1)(1992-11#1)(2008-10#1)
were obtained through a##2##4##(1990-9#1)(2007-12#1)
were obtained through the##3##4##(2008-10#1)(2013-1#2)
were obtained through##8##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-9#2)(2012-3#1)(2013-1#2)
were obtained to assess the##2##5##(2008-7#1)(2011-2#1)
were obtained to determine##2##4##(1994-3#1)(2008-10#1)
were obtained to##10##3##(1992-11#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)
were obtained under the##3##4##(2008-10#2)(2008-3#1)
were obtained upon##2##3##(2008-10#1)(2009-6#1)
were obtained using a##10##4##(1994-5#1)(1997-7#1)(2008-10#6)(2008-5#1)(2009-10#1)
were obtained using the##6##4##(2008-10#4)(2008-3#1)(2013-1#1)
were obtained using##31##3##(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2013-1#1)
were obtained when the##2##4##(2008-10#1)(2013-7#1)
were obtained when##16##3##(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-6#2)(2013-7#1)
were obtained with a##14##4##(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2009-9#1)
were obtained with an##2##4##(2007-8#1)(2008-3#1)
were obtained with both##2##4##(1990-8#1)(2008-10#1)
were obtained with the##13##4##(1992-5#1)(1995-8#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-8#1)(2013-7#1)
were obtained with##52##3##(1990-8#1)(1992-5#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
were obtained without##2##3##(2007-12#1)(2010-3#1)
were obtained##809##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#3)(1992-11#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#6)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#4)(1995-6#3)(1995-8#5)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#6)(2006-12#1)(2007-10#6)(2007-11#9)(2007-12#20)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#370)(2008-11#25)(2008-12#10)(2008-2#14)(2008-3#30)(2008-4#1)(2008-5#28)(2008-6#13)(2008-7#16)(2008-8#20)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#20)(2011-3#2)(2012-1#4)(2012-12#4)(2012-2#8)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#16)(2013-7#4)(2013-8#8)
were obvious##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
were obviously##4##2##(1992-6#1)(2008-10#1)(2008-3#1)(2008-9#1)
were occasionally observed##2##3##(1996-5#1)(2008-10#1)
were occasionally##5##2##(1996-5#1)(1997-3#1)(2008-10#3)
were occluded##2##2##(2007-8#1)(2008-10#1)
were of 0##2##3##(2008-10#2)
were of a##3##3##(1992-10#1)(1994-6#1)(2008-11#1)
were of grade##5##3##(2013-8#5)
were of no##2##3##(2010-1#1)(2011-1#1)
were of particular interest##2##4##(1991-12#1)(1996-12#1)
were of similar##2##3##(1994-2#1)(2008-12#1)
were of the order of##5##5##(2008-10#4)(2008-2#1)
were of the same##2##4##(2008-10#1)(2008-3#1)
were of the##14##3##(1995-4#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)
were of##65##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-10#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-4#2)(1996-12#1)(1996-5#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-11#1)(2010-1#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
were offered##11##2##(1991-1#1)(1992-12#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)
were offset by##3##3##(1993-12#1)(1996-5#1)(2013-8#1)
were often associated with##2##4##(1990-5#1)(1996-7#1)
were often found##2##3##(2008-10#2)
were often observed##2##3##(1993-12#1)(2008-7#1)
were often##27##2##(1990-3#1)(1990-5#1)(1991-8#1)(1993-12#1)(1996-2#2)(1996-7#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#4)(2010-7#1)(2011-2#3)
were older than the other##2##5##(1994-6#1)(2008-12#1)
were older than##7##3##(1992-6#1)(1994-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
were older##9##2##(1992-6#1)(1994-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-5#1)(2013-1#1)
were oligo-anuric##2##2##(2008-4#2)
were on a##2##3##(1995-3#1)(2008-11#1)
were on average##5##3##(1996-11#1)(2007-10#1)(2008-10#2)(2008-11#1)
were on the##3##3##(1991-9#1)(2008-10#1)(2011-2#1)
were on##30##2##(1991-9#1)(1993-3#1)(1995-10#1)(1995-3#1)(1996-11#1)(2007-10#1)(2007-7#2)(2008-1#6)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#2)(2010-2#1)(2011-2#3)(2012-5#1)(2013-1#1)
were on-line##3##2##(2008-10#3)
were once##5##2##(1990-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)
were one##3##2##(1996-12#1)(2008-10#1)(2010-3#1)
were only 2##2##3##(1994-9#1)(2007-8#1)
were only a##2##3##(1997-3#1)(1997-7#1)
were only detected in##2##4##(2008-10#1)(2008-11#1)
were only detected##3##3##(2008-10#2)(2008-11#1)
were only found##3##3##(1991-7#1)(2009-7#1)(2012-3#1)
were only observed##3##3##(1994-6#2)(2009-7#1)
were only slightly##3##3##(1990-12#1)(1991-11#1)(1995-11#1)
were only weakly pathogenic to##2##5##(2008-10#2)
were only##57##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-8#1)(1993-8#2)(1994-6#2)(1994-9#1)(1995-11#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
were open##5##2##(1992-9#1)(1994-11#2)(2008-10#2)
were opened##2##2##(1997-6#1)(2008-7#1)
were operated by##2##3##(2007-11#1)(2012-2#1)
were operated for##4##3##(1990-5#1)(1992-5#1)(2011-2#1)(2013-8#1)
were operated on for##3##4##(1991-8#1)(2007-8#1)(2008-10#1)
were operated on using##2##4##(1992-1#1)(2007-8#1)
were operated on##11##3##(1991-6#1)(1991-8#1)(1992-1#1)(1993-2#1)(1993-3#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)
were operated upon##4##3##(1991-3#1)(1991-6#1)(1992-6#1)(1997-3#1)
were operated using##2##3##(1993-11#1)(2007-11#1)
were operated##35##2##(1990-5#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-3#1)(1995-3#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-11#4)(2007-8#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
were operating in##2##3##(1991-3#1)(2008-5#1)
were operative##2##2##(2008-10#2)
were optimal##2##2##(2008-7#1)(2012-3#1)
were optimally##2##2##(1992-6#1)(2008-10#1)
were optimised by experimental##2##4##(2008-10#2)
were optimised by##5##3##(2008-10#5)
were optimised for the##2##4##(2008-10#2)
were optimised in order to##3##5##(2008-10#3)
were optimised to##2##3##(2008-10#2)
were optimised using##3##3##(2008-10#3)
were optimised##32##2##(2008-10#32)
were optimized and a##2##4##(2008-10#2)
were optimized and the##2##4##(2008-10#2)
were optimized and##9##3##(2008-10#8)(2010-5#1)
were optimized by a##2##4##(2008-10#2)
were optimized by both static and dynamic methods##2##8##(2008-10#2)
were optimized by the##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
were optimized by##14##3##(1995-5#1)(2008-10#11)(2008-3#1)(2011-1#1)
were optimized for the##7##4##(2008-10#7)
were optimized for##15##3##(2008-10#12)(2008-2#1)(2010-5#1)(2011-1#1)
were optimized in terms of##2##5##(2008-10#1)(2011-3#1)
were optimized in##4##3##(2008-10#3)(2011-3#1)
were optimized to obtain##2##4##(2008-10#2)
were optimized to##6##3##(1991-5#1)(2008-10#4)(2008-3#1)
were optimized using a##2##4##(2008-10#2)
were optimized using##4##3##(2008-10#4)
were optimized##107##2##(1990-7#1)(1990-8#1)(1991-5#1)(1995-5#1)(2008-10#88)(2008-2#1)(2008-3#3)(2008-4#1)(2010-5#2)(2011-1#3)(2011-3#1)(2013-1#1)(2013-8#3)
were or##2##2##(1994-2#1)(2008-10#1)
were orally administered##2##3##(1996-12#2)
were orally infected with##2##4##(1992-8#1)(2008-12#1)
were orally##5##2##(1992-8#1)(1996-12#2)(2008-10#1)(2008-12#1)
were ordered##5##2##(1994-9#1)(1996-5#1)(2008-12#2)(2009-11#1)
were organized into##4##3##(1993-12#1)(1996-3#1)(2008-7#1)(2008-8#1)
were organized##6##2##(1992-12#1)(1993-12#1)(1996-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
were oriented##2##2##(2008-6#2)
were originally developed as##2##4##(2008-10#1)(2008-11#1)
were originally developed for##2##4##(2008-10#1)(2012-3#1)
were originally developed##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
were originally isolated##2##3##(2008-10#1)(2011-2#1)
were originally##17##2##(1990-5#1)(1992-10#1)(1992-12#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
were otherwise##4##2##(1992-5#1)(1995-2#1)(2008-7#1)(2008-9#1)
were out of##2##3##(1994-6#1)(1997-9#1)
were outlined##2##2##(1990-8#1)(2012-12#1)
were over one##2##3##(2008-10#2)
were over##17##2##(1994-7#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
were overexpressed##4##2##(1995-2#1)(1997-7#1)(2008-11#1)(2010-12#1)
were overlapped##2##2##(1997-6#1)(2009-6#1)
were overweight and##4##3##(2008-10#1)(2011-1#1)(2013-8#2)
were overweight or obese##2##4##(2013-8#2)
were overweight##8##2##(2008-10#2)(2008-3#1)(2011-1#1)(2013-8#4)
were oxidized by##2##3##(2008-10#2)
were oxidized##7##2##(2007-11#1)(2008-10#4)(2008-11#1)(2011-2#1)
were pH 7##2##3##(2008-10#1)(2008-6#1)
were pH##7##2##(2008-10#5)(2008-6#2)
were packaged into##2##3##(1995-8#1)(2008-8#1)
were packaged##3##2##(1995-8#1)(2008-8#2)
were packed into a##2##4##(2008-10#2)
were packed##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
were paid##2##2##(1995-3#1)(2008-10#1)
were paired in##2##3##(2008-10#1)(2009-9#1)
were palmitic##2##2##(2008-12#1)(2008-7#1)
were parallel##2##2##(1995-2#1)(2008-10#1)
were parasitized by##3##3##(2008-6#3)
were part of a##3##4##(1991-6#1)(1996-1#1)(2008-11#1)
were part of the##5##4##(1991-9#1)(1997-3#1)(2008-10#1)(2009-10#1)(2013-8#1)
were part of##10##3##(1991-6#1)(1991-9#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-10#1)(2013-8#1)
were partial##2##2##(1992-3#1)(1994-5#1)
were partially purified from##2##4##(1990-7#1)(2008-10#1)
were partially##18##2##(1990-7#1)(1993-8#1)(1994-8#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
were particularly##5##2##(1997-6#1)(2007-12#1)(2008-10#1)(2009-1#1)(2012-12#1)
were partitioned##2##2##(2008-10#1)(2008-2#1)
were partly##2##2##(1995-12#1)(2012-5#1)
were pathogenic on##14##3##(2008-10#14)
were pathogenic to##10##3##(2008-10#10)
were pathogenic##27##2##(2008-10#26)(2008-5#1)
were pathologically##3##2##(1992-2#1)(2008-5#1)(2012-2#1)
were patients##3##2##(1995-12#1)(2008-9#1)(2013-1#1)
were patterned##2##2##(2008-3#1)(2010-4#1)
were penetrated by the##2##4##(2008-10#2)
were perceived by##2##3##(1992-2#1)(2008-11#1)
were perceived##4##2##(1992-2#1)(2008-11#1)(2008-12#1)(2012-3#1)
were performed after##2##3##(1993-6#1)(2008-10#1)
were performed and the##2##4##(2008-12#1)(2011-2#1)
were performed and##9##3##(1992-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
were performed as##2##3##(1995-2#1)(2006-6#1)
were performed at 10##2##4##(2008-10#1)(2012-3#1)
were performed at different##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
were performed at the##3##4##(2007-7#1)(2008-11#1)(2008-7#1)
were performed at three##2##4##(1995-5#1)(2008-12#1)
were performed at##23##3##(1992-3#1)(1993-3#1)(1994-7#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
were performed before##2##3##(1990-11#1)(2008-4#1)
were performed between##2##3##(2008-10#2)
were performed by means of##2##5##(2008-10#1)(2008-2#1)
were performed by the##2##4##(1995-1#1)(2008-3#1)
were performed by two##2##4##(2008-10#1)(2013-1#1)
were performed by using##2##4##(2008-5#1)(2012-1#1)
were performed by##30##3##(1991-6#1)(1993-3#1)(1994-8#1)(1995-1#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
were performed during the##4##4##(1990-8#1)(1996-6#1)(1996-9#1)(2008-3#1)
were performed during##5##3##(1990-8#1)(1996-6#1)(1996-9#1)(2008-3#1)(2012-2#1)
were performed for a##2##4##(2008-3#1)(2008-5#1)
were performed for each##2##4##(2008-10#1)(2008-8#1)
were performed for the##5##4##(1995-5#1)(2008-10#4)
were performed for##20##3##(1995-5#1)(2007-8#1)(2008-10#7)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#1)
were performed from##4##3##(1990-5#1)(2007-11#1)(2008-10#1)(2013-7#1)
were performed in a##7##4##(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2013-1#1)
were performed in all##4##4##(1994-5#1)(1996-7#1)(2008-5#1)(2011-2#1)
were performed in non-hospital##2##4##(1996-1#2)
were performed in order to##6##5##(1990-8#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-7#1)
were performed in our##2##4##(2007-11#1)(2008-9#1)
were performed in the##8##4##(1995-11#1)(1996-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-11#1)(2012-12#1)(2013-1#1)
were performed in two##2##4##(2007-8#1)(2008-11#1)
were performed in##69##3##(1990-6#1)(1990-8#2)(1991-4#1)(1993-12#2)(1993-6#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-1#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-12#3)(2013-1#4)
were performed on a##3##4##(1997-5#1)(2008-11#1)(2010-6#1)
were performed on an##2##4##(2008-10#2)
were performed on day##2##4##(1993-12#1)(1997-3#1)
were performed on different##3##4##(1996-5#1)(2008-5#1)(2010-3#1)
were performed on the##10##4##(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
were performed on two##2##4##(2008-5#1)(2011-2#1)
were performed on##58##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-2#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#5)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
were performed regarding##2##3##(1997-8#1)(2009-10#1)
were performed through##2##3##(2008-3#1)(2009-3#1)
were performed to assess the##2##5##(1995-11#1)(2013-1#1)
were performed to assess##3##4##(1995-11#1)(2013-1#1)(2013-8#1)
were performed to better##2##4##(2008-10#2)
were performed to characterize the##2##5##(2007-11#1)(2008-10#1)
were performed to confirm##2##4##(2007-10#1)(2013-8#1)
were performed to determine if##3##5##(1990-12#1)(1997-3#1)(2008-10#1)
were performed to determine the##6##5##(1990-9#1)(1993-11#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-7#1)
were performed to determine whether##2##5##(1997-1#1)(2012-12#1)
were performed to determine##15##4##(1990-12#1)(1990-9#1)(1993-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
were performed to elucidate##2##4##(2008-10#2)
were performed to estimate the##2##5##(2010-11#1)(2013-1#1)
were performed to estimate##3##4##(2007-10#1)(2010-11#1)(2013-1#1)
were performed to evaluate the##3##5##(2008-3#2)(2008-5#1)
were performed to examine the##2##5##(1995-12#1)(2009-7#1)
were performed to identify##2##4##(2009-4#1)(2012-3#1)
were performed to investigate the##3##5##(1995-5#1)(2008-3#1)(2008-8#1)
were performed to select##2##4##(2008-10#1)(2011-3#1)
were performed to study the##2##5##(2008-10#1)(2011-2#1)
were performed to validate the##2##5##(2008-3#2)
were performed to##59##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
were performed twice##2##3##(2007-8#1)(2008-5#1)
were performed under##6##3##(1992-11#1)(1994-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-3#1)
were performed using a##5##4##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-7#1)
were performed using the##4##4##(1992-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
were performed using##25##3##(1992-3#1)(1993-1#1)(1995-12#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-10#8)(2008-5#2)(2008-6#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
were performed with a##10##4##(1990-12#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)
were performed with several##2##4##(2008-10#2)
were performed with the##6##4##(1997-7#1)(2008-11#2)(2008-5#1)(2009-3#1)(2012-3#1)
were performed with##35##3##(1990-12#1)(1992-11#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1997-7#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2009-3#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
were performed within##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
were performed##470##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-12#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-4#1)(1995-5#5)(1996-1#3)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#5)(2006-10#2)(2006-6#1)(2007-10#4)(2007-11#6)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#13)(2008-1#6)(2008-10#102)(2008-11#12)(2008-12#8)(2008-2#12)(2008-3#29)(2008-4#2)(2008-5#24)(2008-6#8)(2008-7#15)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#18)(2011-3#5)(2012-1#2)(2012-12#11)(2012-2#7)(2012-3#8)(2012-7#1)(2013-1#17)(2013-7#2)(2013-8#4)
were performing##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
were perfused with##2##3##(2008-9#2)
were perfused##3##2##(1996-12#1)(2008-9#2)
were periodically##4##2##(2007-11#1)(2008-10#3)
were permeabilized##3##2##(1992-5#1)(1992-6#1)(1993-8#1)
were persistent##3##2##(1991-2#1)(1997-8#1)(2008-9#1)
were persons##2##2##(1993-6#1)(2006-10#1)
were phenotypically##2##2##(1997-8#1)(2008-10#1)
were phosphorylated by##2##3##(1991-2#1)(2010-11#1)
were phosphorylated##4##2##(1991-2#1)(1995-6#1)(2007-11#1)(2010-11#1)
were photographed##2##2##(2008-3#1)(2012-12#1)
were physically##4##2##(1990-12#1)(2008-7#1)(2009-5#1)(2010-10#1)
were phytotoxic to##2##3##(2008-10#2)
were placed for##2##3##(2009-8#1)(2010-3#1)
were placed in a##7##4##(2008-10#2)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#1)
were placed in contact with##2##5##(2008-10#2)
were placed in the##8##4##(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-10#1)
were placed in##37##3##(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-7#2)(2008-10#15)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
were placed into##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
were placed on a##2##4##(2007-5#1)(2008-10#1)
were placed on the##3##4##(2007-7#1)(2008-10#2)
were placed on##8##3##(2007-5#1)(2007-7#1)(2008-10#4)(2010-4#1)(2013-1#1)
were placed to##2##3##(2008-9#1)(2011-1#1)
were placed under##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
were placed##73##2##(1993-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-7#5)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
were planned##3##2##(1991-6#1)(2008-5#1)(2012-12#1)
were planted in a randomized##2##5##(2008-10#2)
were planted in a##3##4##(2008-10#3)
were planted in##12##3##(2008-10#9)(2008-12#1)(2008-5#1)(2008-9#1)
were planted with three##2##4##(2008-10#2)
were planted with##3##3##(2008-10#3)
were planted##18##2##(2008-10#15)(2008-12#1)(2008-5#1)(2008-9#1)
were plated in##3##3##(2008-12#1)(2013-1#2)
were plated on a##2##4##(2008-10#1)(2012-4#1)
were plated on the##2##4##(1992-6#1)(2012-4#1)
were plated on##6##3##(1992-6#1)(2008-10#2)(2008-5#1)(2012-4#2)
were plated##9##2##(1992-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-4#2)(2013-1#2)
were played##4##2##(1991-12#1)(1993-1#3)
were plotted against those##2##4##(2008-10#1)(2008-5#1)
were plotted against##4##3##(2008-10#3)(2008-5#1)
were plotted##9##2##(2007-10#1)(2008-10#4)(2008-5#2)(2013-1#1)(2013-8#1)
were polymerase chain reaction amplified##2##5##(2008-10#1)(2009-5#1)
were polymerase chain reaction##3##4##(2008-10#2)(2009-5#1)
were polymerase chain##4##3##(2008-10#3)(2009-5#1)
were polymicrobial##2##2##(2007-7#2)
were polymorphic and##2##3##(2008-10#2)
were polymorphic for##2##3##(2008-10#2)
were polymorphic##10##2##(2008-10#8)(2008-4#1)(2013-7#1)
were pooled##4##2##(2008-10#2)(2008-7#1)(2011-1#1)
were poor substrates##2##3##(1990-11#1)(1995-8#1)
were poor##10##2##(1990-11#1)(1994-3#1)(1995-8#1)(1996-11#1)(2007-10#1)(2008-10#3)(2008-8#1)(2011-2#1)
were poorly##9##2##(1992-6#1)(1995-1#1)(1997-3#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-8#1)
were positioned##7##2##(1992-9#1)(1996-6#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
were positive and##3##3##(1994-6#1)(2007-2#1)(2012-12#1)
were positive by##5##3##(1992-6#1)(1995-4#1)(2007-7#2)(2013-8#1)
were positive for P##2##4##(2007-7#2)
were positive for S scabiei##2##5##(1990-3#2)
were positive for both ACA and ANA##2##7##(2011-2#2)
were positive for helminths##2##4##(2012-12#2)
were positive for one##2##4##(2007-7#1)(2011-2#1)
were positive for the##7##4##(1991-8#1)(1992-2#1)(2007-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
were positive for##47##3##(1990-3#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-2#2)(1992-5#1)(1994-2#1)(2007-5#1)(2007-7#10)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#3)
were positive in##15##3##(1990-3#1)(1995-12#1)(1997-2#1)(2007-7#3)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#2)(2013-1#3)
were positive to##2##3##(1990-2#1)(1996-6#1)
were positive##97##2##(1990-2#2)(1990-3#4)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-2#2)(1992-5#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-7#2)(1995-12#2)(1995-4#2)(1996-12#1)(1996-6#1)(1997-2#1)(2007-2#2)(2007-5#1)(2007-7#17)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-11#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#4)
were positively associated with##5##4##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
were positively associated##7##3##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
were positively correlated to##2##4##(2008-10#1)(2008-7#1)
were positively correlated with infection##2##5##(2008-10#1)(2010-12#1)
were positively correlated with##13##4##(2008-10#5)(2010-11#1)(2010-12#1)(2011-10#2)(2011-2#1)(2012-1#1)(2013-1#2)
were positively correlated##19##3##(2008-10#6)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-10#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
were positively identified##2##3##(2008-10#2)
were positively related to##5##4##(1992-2#1)(2007-12#1)(2008-9#1)(2009-11#1)(2011-2#1)
were positively selected##3##3##(2008-4#1)(2010-8#2)
were positively##36##2##(1992-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-10#2)(2011-2#5)(2012-1#1)(2013-1#4)(2013-8#1)
were possible to##2##3##(2007-11#1)(2013-1#1)
were possible##13##2##(2007-11#1)(2008-1#1)(2008-10#8)(2008-3#1)(2009-4#1)(2013-1#1)
were possibly##2##2##(1994-9#1)(2011-2#1)
were postulated to be##3##4##(2008-1#1)(2008-10#2)
were postulated##4##2##(2008-1#1)(2008-10#2)(2008-7#1)
were potent inhibitors of##3##4##(1994-6#1)(1995-3#1)(1997-7#1)
were potent##5##2##(1994-6#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)
were potentiated by##2##3##(1990-7#1)(2007-10#1)
were practically identical##2##3##(1995-2#1)(1997-2#1)
were practically##8##2##(1990-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)
were pre-trained by##2##3##(2008-6#2)
were pre-treated with##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
were preceded by##3##3##(1991-3#1)(1994-12#1)(2013-8#1)
were preceded##4##2##(1991-3#1)(1994-12#1)(2012-3#1)(2013-8#1)
were precipitated##4##2##(1995-11#1)(1996-5#1)(2008-6#1)(2013-1#1)
were precisely##4##2##(1997-2#1)(2008-11#1)(2012-2#1)(2012-3#1)
were preconcentrated in a membrane cell##2##6##(2008-10#2)
were preconcentrated in##3##3##(2008-10#3)
were preconcentrated on the##2##4##(2008-10#2)
were preconcentrated on##3##3##(2008-10#3)
were preconcentrated onto the##2##4##(2008-10#2)
were preconcentrated##11##2##(2008-10#11)
were predicted by the##4##4##(2008-10#1)(2008-4#1)(2012-1#1)(2012-3#1)
were predicted for##2##3##(2007-11#1)(2008-7#1)
were predicted in the##2##4##(1997-6#1)(2008-8#1)
were predicted in##3##3##(1997-6#1)(2008-8#1)(2011-2#1)
were predicted to##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
were predicted##21##2##(1990-7#1)(1995-12#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
were predictive of##4##3##(2008-12#1)(2010-11#1)(2010-8#1)(2012-3#1)
were predictive##5##2##(2007-8#1)(2008-12#1)(2010-11#1)(2010-8#1)(2012-3#1)
were predominant in the##2##4##(2009-12#1)(2012-2#1)
were predominant in##5##3##(1994-2#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#1)
were predominant##12##2##(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#2)(2007-11#1)(2007-7#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
were predominantly##16##2##(1992-12#1)(1994-1#1)(1994-2#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
were preferably##2##2##(2008-10#1)(2008-11#1)
were preferentially##2##2##(1993-6#1)(2008-6#1)
were preferred by##2##3##(2008-10#1)(2011-2#1)
were preferred##3##2##(2008-10#2)(2011-2#1)
were preformed##2##2##(2011-2#2)
were preincubated##2##2##(1994-3#1)(2008-8#1)
were premedicated with##2##3##(1996-6#1)(2012-3#1)
were prepared and analysed##3##4##(1995-8#1)(2008-10#1)(2008-5#1)
were prepared and evaluated##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
were prepared and investigated as##3##5##(2008-10#3)
were prepared and investigated##4##4##(2007-12#1)(2008-10#3)
were prepared and tested for their##2##6##(1993-11#1)(2007-11#1)
were prepared and tested##3##4##(1993-11#1)(2007-11#2)
were prepared and their##2##4##(2008-10#1)(2009-12#1)
were prepared and##26##3##(1992-12#1)(1993-11#1)(1995-8#1)(2007-11#4)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2012-8#1)
were prepared as##6##3##(1991-12#1)(1991-8#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
were prepared by a##3##4##(2007-11#1)(2008-10#2)
were prepared by catalytic##2##4##(1992-8#1)(2008-10#1)
were prepared by dissolving##2##4##(2008-5#1)(2010-4#1)
were prepared by incorporating##2##4##(2008-10#2)
were prepared by mixing##2##4##(2008-10#2)
were prepared by the##8##4##(2008-10#2)(2008-12#2)(2008-2#1)(2010-5#1)(2011-1#1)(2013-8#1)
were prepared by using##2##4##(2008-10#2)
were prepared by##56##3##(1991-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-3#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
were prepared containing##2##3##(1997-7#1)(2008-10#1)
were prepared for##9##3##(1992-2#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-7#1)
were prepared from a##3##4##(2008-10#1)(2008-5#2)
were prepared from the##4##4##(1995-12#1)(2007-11#2)(2008-11#1)
were prepared from##23##3##(1990-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1997-4#1)(1997-6#1)(2007-11#4)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-2#1)
were prepared in##9##3##(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2013-1#1)
were prepared of##2##3##(2008-5#1)(2011-1#1)
were prepared on##2##3##(1993-1#1)(2008-10#1)
were prepared spiking##2##3##(2008-10#2)
were prepared to##3##3##(2008-10#2)(2010-3#1)
were prepared using a##3##4##(2008-12#1)(2008-5#1)(2008-9#1)
were prepared using the##2##4##(2008-5#1)(2011-2#1)
were prepared using##13##3##(1990-2#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
were prepared via##3##3##(2008-10#2)(2008-4#1)
were prepared with a##3##4##(2008-10#2)(2008-3#1)
were prepared with##8##3##(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2013-8#1)
were prepared##197##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-9#1)(2007-11#11)(2007-12#3)(2008-1#1)(2008-10#67)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#20)(2008-7#5)(2008-8#6)(2008-9#4)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-3#4)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#4)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#3)
were prescribed##11##2##(1997-6#1)(2008-11#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-7#1)
were present among##2##3##(2008-10#2)
were present as a##2##4##(1992-9#1)(2008-8#1)
were present as##5##3##(1990-12#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
were present at a##2##4##(1994-3#1)(2011-2#1)
were present at low##2##4##(1993-9#1)(1994-8#1)
were present at##14##3##(1992-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-9#1)(2008-10#6)(2011-2#1)(2011-3#1)(2012-12#1)
were present but##2##3##(1994-8#1)(2011-1#1)
were present in 9##2##4##(2008-7#1)(2013-1#1)
were present in a##3##4##(1991-12#1)(1992-3#1)(1992-6#1)
were present in about##2##4##(2008-6#1)(2008-8#1)
were present in all##5##4##(2008-10#2)(2011-2#3)
were present in collections from##2##5##(2008-10#2)
were present in only##2##4##(1990-12#1)(2010-4#1)
were present in the central##3##5##(1992-12#1)(1995-12#1)(2008-10#1)
were present in the##23##4##(1990-12#1)(1992-12#2)(1992-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(2006-8#1)(2008-10#7)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2012-3#1)
were present in these##2##4##(2008-10#1)(2008-3#1)
were present in##80##3##(1990-12#3)(1990-9#1)(1991-12#1)(1991-3#2)(1992-12#2)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#22)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)
were present on the##3##4##(1991-6#1)(1996-5#1)(2012-3#1)
were present on##5##3##(1991-6#1)(1996-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
were present only##2##3##(1994-3#1)(1997-6#1)
were present throughout the##2##4##(2008-10#1)(2008-7#1)
were present throughout##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
were present together##2##3##(2008-10#1)(2012-7#1)
were present within##2##3##(1994-12#1)(2008-10#1)
were present##157##2##(1990-11#1)(1990-12#4)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-6#2)(1992-12#2)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#45)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#1)
were presented as##2##3##(1991-12#1)(2008-10#1)
were presented at the##9##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2013-8#1)
were presented at##11##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2013-8#1)
were presented for##2##3##(2008-11#1)(2009-10#1)
were presented in the##2##4##(2008-5#1)(2008-9#1)
were presented in##4##3##(2008-5#2)(2008-9#1)(2013-8#1)
were presented to the##2##4##(1993-12#1)(1993-3#1)
were presented to##9##3##(1993-12#1)(1993-3#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-10#1)(2012-12#1)
were presented with##7##3##(1997-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
were presented##63##2##(1991-12#1)(1992-11#2)(1993-12#2)(1993-3#1)(1994-3#1)(1994-9#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#14)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
were preserved in##2##3##(1996-12#1)(2008-11#1)
were preserved with##2##3##(2008-10#2)
were preserved##7##2##(1996-12#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
were presumably##3##2##(1992-3#1)(2008-10#2)
were pretreated with##10##3##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#3)(1993-8#1)(2008-5#1)(2010-3#1)(2013-1#1)
were pretreated##11##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#3)(1993-8#1)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)
were prevalent##5##2##(2008-10#3)(2009-9#1)(2012-3#1)
were prevented by##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2012-3#1)
were prevented##7##2##(1994-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
were previously extracted from##2##4##(2008-10#2)
were previously identified##2##3##(1994-9#1)(2008-10#1)
were previously reported##3##3##(1996-12#2)(2011-2#1)
were previously shown to be##2##5##(1991-5#1)(2009-4#1)
were previously shown to##5##4##(1991-5#1)(1993-3#1)(2008-10#1)(2008-11#1)(2009-4#1)
were previously unrecognized##2##3##(1996-2#1)(2008-8#1)
were previously##36##2##(1991-5#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
were primarily##11##2##(1991-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
were primary##5##2##(1990-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2010-8#1)
were primed with##2##3##(2008-10#1)(2010-8#1)
were primed##4##2##(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
were principally##2##2##(1996-12#1)(2008-7#1)
were printed##2##2##(2008-2#1)(2008-7#1)
were prior##2##2##(1995-5#1)(2011-2#1)
were probably##13##2##(1991-12#1)(1992-11#1)(1993-6#1)(1995-3#1)(1996-4#1)(1997-3#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)
were probed with##3##3##(1991-5#1)(1997-3#1)(2008-10#1)
were probed##5##2##(1991-5#1)(1997-3#1)(2008-10#2)(2008-3#1)
were processed by the##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
were processed by##6##3##(2008-10#4)(2011-1#1)(2013-8#1)
were processed for##9##3##(1996-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
were processed in##2##3##(1991-9#1)(2008-10#1)
were processed with##2##3##(2008-5#1)(2008-7#1)
were processed##27##2##(1990-5#1)(1990-6#1)(1991-9#1)(1996-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#3)
were produced against##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
were produced and##7##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)
were produced at the##2##4##(2007-11#1)(2008-10#1)
were produced at##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
were produced by fusing##2##4##(2008-11#2)
were produced by##22##3##(1991-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
were produced from##4##3##(1994-11#1)(2008-10#3)
were produced in Escherichia coli##2##5##(1992-8#1)(1993-6#1)
were produced in an##2##4##(1994-5#1)(2008-11#1)
were produced in less##2##4##(2008-11#1)(2008-9#1)
were produced in the##2##4##(1993-1#1)(2008-10#1)
were produced in##19##3##(1990-5#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-5#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-9#1)(2012-3#1)
were produced on the##3##4##(2008-10#3)
were produced on##9##3##(2008-10#8)(2008-2#1)
were produced through##2##3##(1992-8#1)(2008-8#1)
were produced via##2##3##(1995-12#1)(2008-10#1)
were produced with##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
were produced##101##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#4)(1997-2#2)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#39)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#2)
were profiled##2##2##(2008-10#1)(2008-5#1)
were progressively##2##2##(1997-2#1)(2008-11#1)
were projected more##2##3##(2010-3#2)
were projected##3##2##(2010-3#2)(2011-7#1)
were prolonged##5##2##(1992-6#1)(1996-3#2)(2007-8#1)(2008-7#1)
were prominent in##2##3##(2008-3#1)(2013-1#1)
were promoted##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
were promptly##3##2##(1994-3#1)(2009-10#1)(2011-2#1)
were propagated##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
were prophylactic##2##2##(2011-2#1)(2013-1#1)
were proportional to the concentration of##2##6##(1990-8#1)(2008-10#1)
were proportional to the##5##4##(1990-8#1)(2008-10#3)(2012-2#1)
were proportional to##7##3##(1990-8#1)(2008-10#4)(2008-5#1)(2012-2#1)
were proposed and##2##3##(2008-10#2)
were proposed for the assay of##3##6##(2008-10#3)
were proposed for the##4##4##(2008-10#4)
were proposed for##6##3##(2008-10#5)(2013-1#1)
were proposed##20##2##(1996-12#1)(2008-10#13)(2008-11#1)(2008-8#1)(2009-4#1)(2010-8#1)(2013-1#2)
were prospectively enrolled##2##3##(2007-8#1)(2013-1#1)
were prospectively evaluated##2##3##(2007-7#1)(2013-8#1)
were prospectively included##2##3##(2011-2#1)(2013-1#1)
were prospectively##13##2##(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
were protected against the##2##4##(2008-9#1)(2012-2#1)
were protected against##4##3##(1995-12#1)(1995-2#1)(2008-9#1)(2012-2#1)
were protected from##6##3##(1993-9#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
were protected##15##2##(1993-9#1)(1995-12#1)(1995-2#2)(1995-5#4)(1997-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
were proved to be##2##4##(1993-2#1)(2008-12#1)
were proved to##3##3##(1993-2#1)(2008-10#1)(2008-12#1)
were proven to be##2##4##(2008-9#1)(2013-1#1)
were provided by##3##3##(2009-9#1)(2010-4#1)(2011-2#1)
were provided for##3##3##(1996-3#1)(2008-10#2)
were provided to##3##3##(1995-3#1)(1996-1#1)(2008-5#1)
were provided with##6##3##(2008-11#2)(2008-5#1)(2012-12#1)(2013-7#1)(2013-8#1)
were provided##29##2##(1991-12#1)(1992-6#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#3)(2009-9#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
were published in##4##3##(1997-8#1)(2007-12#1)(2008-5#1)(2011-2#1)
were published##16##2##(1991-1#1)(1991-12#1)(1993-11#1)(1994-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
were pulmonary##2##2##(2008-1#1)(2011-2#1)
were purified and##6##3##(1994-5#1)(1997-2#1)(1997-6#1)(2008-10#2)(2012-12#1)
were purified by affinity chromatography##2##5##(2008-6#1)(2008-9#1)
were purified by using##2##4##(2008-8#1)(2010-12#1)
were purified by##13##3##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-8#2)(1995-12#1)(1997-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
were purified from the##2##4##(1990-11#1)(2008-7#1)
were purified from##16##3##(1990-11#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)
were purified to homogeneity and##2##5##(1992-8#1)(1997-4#1)
were purified to homogeneity##3##4##(1992-8#1)(1995-2#1)(1997-4#1)
were purified to near homogeneity##3##5##(1991-2#1)(2008-4#1)(2012-2#1)
were purified to##7##3##(1991-2#1)(1992-8#1)(1995-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2012-2#1)
were purified##45##2##(1990-11#2)(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-8#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
were purposively##2##2##(2010-11#1)(2010-3#1)
were put in##4##3##(2008-12#1)(2008-6#1)(2010-1#2)
were put into##2##3##(1995-3#1)(2011-1#1)
were put##8##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-1#2)(2011-1#1)
were qualified##4##2##(2007-11#1)(2008-11#1)(2012-3#2)
were qualitatively similar to##2##4##(1994-3#1)(1996-5#1)
were qualitatively##4##2##(1994-3#1)(1996-5#1)(2008-10#1)(2008-11#1)
were quality##2##2##(2013-1#1)(2013-8#1)
were quantified by##8##3##(1990-12#1)(2006-6#1)(2008-10#3)(2008-7#1)(2010-11#1)(2012-1#1)
were quantified in the##2##4##(2007-12#1)(2008-10#1)
were quantified in##7##3##(2007-12#1)(2008-10#5)(2008-3#1)
were quantified using a##2##4##(2009-10#1)(2009-7#1)
were quantified using##7##3##(2008-10#3)(2008-7#2)(2009-10#1)(2009-7#1)
were quantified##30##2##(1990-12#1)(2006-6#1)(2007-12#1)(2008-10#15)(2008-3#2)(2008-5#1)(2008-7#4)(2009-10#1)(2009-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
were quantitated in##3##3##(2008-12#1)(2010-12#1)(2011-2#1)
were quantitated##4##2##(1994-12#1)(2008-12#1)(2010-12#1)(2011-2#1)
were quantitative##7##2##(1992-11#1)(2008-10#6)
were quantitatively determined in##2##4##(1996-12#1)(2011-2#1)
were quantitatively determined##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
were quantitatively evaluated##3##3##(1995-8#1)(2010-5#1)(2012-2#1)
were quantitatively recovered##4##3##(1997-2#1)(2008-10#3)
were quantitatively##21##2##(1990-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#12)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
were questioned about##2##3##(1991-11#1)(2012-12#1)
were questioned##4##2##(1991-11#1)(1993-3#1)(1996-8#1)(2012-12#1)
were quickly##2##2##(2008-10#1)(2008-11#1)
were quite different from##3##4##(1992-12#1)(1997-8#1)(2009-8#1)
were quite different##4##3##(1992-12#1)(1997-4#1)(1997-8#1)(2009-8#1)
were quite similar to those##2##5##(1993-6#1)(2008-11#1)
were quite similar##3##3##(1993-6#1)(2008-11#1)(2008-5#1)
were quite variable##2##3##(1994-3#1)(2012-3#1)
were quite##17##2##(1992-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
were race 2##3##3##(2008-10#3)
were race##4##2##(2008-10#4)
were radiographed##2##2##(2009-4#1)(2011-2#1)
were radiolabeled##2##2##(1992-2#1)(1992-3#1)
were raised against##2##3##(1995-3#1)(2008-11#1)
were raised in rabbits against##2##5##(1991-7#1)(2008-5#1)
were raised in rabbits##3##4##(1990-8#1)(1991-7#1)(2008-5#1)
were raised in##8##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-8#1)(1992-9#1)(2008-10#1)(2008-5#1)(2012-3#1)
were raised##24##2##(1990-11#1)(1990-8#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
were random##2##2##(2008-10#2)
were randomised##2##2##(2008-3#1)(2012-2#1)
were randomized in two groups##2##5##(2011-2#2)
were randomized in##4##3##(1993-8#1)(2008-7#1)(2011-2#2)
were randomized into two groups##2##5##(1991-2#1)(2008-8#1)
were randomized into##6##3##(1991-2#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
were randomized to either##3##4##(2009-9#1)(2010-4#1)(2012-3#1)
were randomized to receive either##2##5##(2008-6#1)(2013-1#1)
were randomized to receive placebo##2##5##(2008-7#1)(2011-2#1)
were randomized to receive##6##4##(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
were randomized to the##2##4##(2008-4#1)(2012-3#1)
were randomized to##25##3##(1992-8#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#5)
were randomized##38##2##(1991-2#1)(1992-8#1)(1993-8#1)(1996-5#1)(2007-10#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#6)
were randomly allocated into two groups##2##6##(2007-8#1)(2010-12#1)
were randomly allocated into##5##4##(2007-8#1)(2008-10#2)(2010-12#1)(2012-3#1)
were randomly allocated to receive##4##5##(1991-8#1)(2010-12#1)(2010-7#1)(2013-1#1)
were randomly allocated to##7##4##(1991-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2013-1#1)(2013-7#1)
were randomly allocated##13##3##(1991-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#2)(2010-7#1)(2012-3#2)(2013-1#1)(2013-7#1)
were randomly assigned either to##2##5##(1990-5#1)(2011-1#1)
were randomly assigned into two groups##2##6##(2010-7#1)(2013-8#1)
were randomly assigned into##5##4##(2007-11#1)(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
were randomly assigned to 1##2##5##(2008-12#1)(2013-8#1)
were randomly assigned to a##4##5##(2008-12#2)(2012-2#1)(2013-1#1)
were randomly assigned to either a##3##6##(2008-12#1)(2008-4#1)(2013-1#1)
were randomly assigned to either the##2##6##(2008-11#1)(2009-11#1)
were randomly assigned to either##5##5##(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
were randomly assigned to one of four groups##2##8##(2011-2#2)
were randomly assigned to one of the##2##7##(2010-4#1)(2013-8#1)
were randomly assigned to one of##6##6##(2008-4#1)(2010-4#2)(2011-2#2)(2013-8#1)
were randomly assigned to receive##6##5##(1990-9#1)(1993-1#1)(1994-2#1)(2011-2#1)(2012-2#2)
were randomly assigned to three groups##2##6##(2009-3#1)(2011-2#1)
were randomly assigned to three##3##5##(2009-3#1)(2010-10#1)(2011-2#1)
were randomly assigned to two groups##2##6##(2008-11#1)(2008-5#1)
were randomly assigned to two##3##5##(1993-1#1)(2008-11#1)(2008-5#1)
were randomly assigned to##45##4##(1990-9#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-1#2)(1994-2#1)(2008-11#2)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
were randomly assigned##54##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-1#2)(1994-2#1)(2007-11#2)(2008-11#2)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#3)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#3)
were randomly collected from##2##4##(2008-12#1)(2011-1#1)
were randomly divided into five groups##3##6##(2010-1#1)(2010-7#1)(2011-3#1)
were randomly divided into four groups##3##6##(2008-10#1)(2010-7#1)(2013-1#1)
were randomly divided into four##4##5##(2008-10#1)(2009-8#1)(2010-7#1)(2013-1#1)
were randomly divided into two groups of##2##7##(2008-10#1)(2008-5#1)
were randomly divided into two groups##6##6##(1993-2#1)(1994-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
were randomly divided into two##7##5##(1993-2#1)(1994-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
were randomly divided into##19##4##(1993-12#1)(1993-2#1)(1994-7#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
were randomly divided##20##3##(1993-12#1)(1993-2#1)(1994-7#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
were randomly evaluated##2##3##(1995-2#1)(2011-2#1)
were randomly sampled from##2##4##(2008-10#2)
were randomly sampled##3##3##(2008-10#3)
were randomly selected and##2##4##(2008-12#1)(2008-8#1)
were randomly selected for##4##4##(1996-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
were randomly selected from the register of the##2##8##(2007-2#2)
were randomly selected from the##3##5##(2007-2#2)(2008-1#1)
were randomly selected from##6##4##(1992-11#1)(1996-12#1)(2007-2#2)(2008-1#1)(2010-3#1)
were randomly selected to##2##4##(1995-6#1)(2009-7#1)
were randomly selected##19##3##(1992-11#1)(1995-6#1)(1996-12#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
were randomly##123##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-3#1)(1997-6#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#11)(2008-3#3)(2008-4#2)(2008-5#6)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#4)(2011-1#3)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#3)
were ranged from##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
were ranked as the##2##4##(1991-3#1)(2011-2#1)
were ranked##9##2##(1991-3#1)(1991-6#1)(1993-12#1)(1995-1#1)(1995-3#1)(2008-5#1)(2011-2#2)(2012-12#1)
were rapid##2##2##(2008-10#1)(2008-12#1)
were rapidly and##2##3##(2008-5#1)(2008-8#1)
were rapidly reversible inhibitors with##2##5##(1990-5#2)
were rapidly##10##2##(1990-5#2)(1993-9#1)(1997-2#1)(2007-6#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)
were rare##12##2##(2008-10#7)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
were rarely found##3##3##(1990-9#1)(1991-12#1)(1991-3#1)
were rarely observed##3##3##(1990-3#1)(1997-3#1)(2008-10#1)
were rarely##8##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1997-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
were rated as##6##3##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-7#1)
were rated by##3##3##(1991-2#1)(2008-10#1)(2008-12#1)
were rated higher##2##3##(1993-12#2)
were rated on a##2##4##(2008-7#1)(2010-12#1)
were rated##19##2##(1991-2#1)(1993-12#2)(1993-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#2)(2011-2#1)
were re-analyzed##2##2##(2009-4#1)(2012-2#1)
were re-examined##4##2##(1991-8#1)(1992-5#1)(1995-12#1)(1996-12#1)
were re-tested##2##2##(1994-8#1)(2011-2#1)
were reached for##2##3##(2008-10#1)(2013-1#1)
were reached in##2##3##(2008-11#1)(2008-2#1)
were reached with##2##3##(1990-12#1)(2008-10#1)
were reached##13##2##(1990-12#1)(1994-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
were reacted with##2##3##(2006-6#1)(2008-11#1)
were reacted##3##2##(2006-6#1)(2008-10#1)(2008-11#1)
were reactive with##2##3##(1995-12#1)(1996-12#1)
were reactive##4##2##(1994-8#1)(1995-12#1)(1996-12#1)(2008-11#1)
were read##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
were readily##16##2##(1992-6#2)(1994-11#1)(1995-2#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
were ready##2##2##(2008-11#1)(2008-12#1)
were realized##6##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
were reanalysed##2##2##(2008-10#2)
were reared in##3##3##(2008-12#3)
were reared on##3##3##(2008-6#1)(2008-9#1)(2013-1#1)
were reared##9##2##(1997-7#1)(2007-7#1)(2008-12#3)(2008-6#1)(2008-9#1)(2010-8#1)(2013-1#1)
were reasonably##3##2##(2008-10#2)(2008-11#1)
were reassessed##2##2##(1995-2#1)(2007-1#1)
were recalculated##2##2##(1994-1#1)(2008-10#1)
were received from##4##3##(1994-2#1)(2007-12#1)(2012-3#2)
were received##12##2##(1992-12#1)(1994-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2010-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
were receiving##8##2##(1993-10#1)(1995-12#1)(1995-5#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
were recently introduced##2##3##(1990-6#1)(2011-2#1)
were recently proposed##2##3##(2008-2#1)(2012-2#1)
were recently shown to##2##4##(1993-3#1)(2009-10#1)
were recently##13##2##(1990-6#1)(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)
were recognized by the##3##4##(1995-2#1)(1995-8#1)(2008-10#1)
were recognized by##5##3##(1995-2#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
were recognized in##2##3##(1996-9#1)(2007-8#1)
were recognized on##3##3##(1991-2#1)(1995-12#1)(2008-9#1)
were recognized##21##2##(1991-2#1)(1992-5#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)
were recommended##4##2##(1994-11#2)(2008-10#1)(2013-1#1)
were reconstituted##2##2##(1997-4#1)(2008-4#1)
were reconstructed by##2##3##(2008-3#1)(2008-9#1)
were reconstructed with##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
were reconstructed##14##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
were recorded after##2##3##(1990-10#1)(1993-9#1)
were recorded and analyzed##2##4##(2007-10#1)(2008-6#1)
were recorded and the##2##4##(1996-3#1)(2008-8#1)
were recorded and##12##3##(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)
were recorded as##5##3##(1990-6#1)(2008-10#2)(2010-11#1)(2011-2#1)
were recorded at the beginning of##2##6##(2008-5#1)(2013-7#1)
were recorded at the##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2013-7#1)
were recorded at##13##3##(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2013-7#1)
were recorded before and##2##4##(1993-1#1)(2007-2#1)
were recorded before##4##3##(1992-12#1)(1993-1#1)(1995-12#1)(2007-2#1)
were recorded between##3##3##(2008-10#2)(2008-12#1)
were recorded by use of a##3##6##(1996-5#1)(2007-12#2)
were recorded by##9##3##(1996-5#1)(2007-12#2)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
were recorded continuously##2##3##(1991-10#1)(2008-7#1)
were recorded during##7##3##(1996-3#1)(2007-7#1)(2008-3#1)(2008-7#1)(2013-7#1)(2013-8#2)
were recorded every 5 min##2##5##(1993-6#1)(2012-3#1)
were recorded every##4##3##(1993-6#1)(2008-12#1)(2008-7#1)(2012-3#1)
were recorded for the##2##4##(2010-12#1)(2013-1#1)
were recorded for##11##3##(1991-9#1)(1993-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-12#1)(2013-1#2)
were recorded from 11##2##4##(1996-5#1)(2008-11#1)
were recorded from the##4##4##(1996-6#1)(2011-1#1)(2012-7#1)(2013-7#1)
were recorded from##12##3##(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-7#1)
were recorded in a##3##4##(1993-6#1)(2007-12#1)(2008-10#1)
were recorded in the##9##4##(1993-12#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
were recorded in##32##3##(1991-12#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#3)(1997-6#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
were recorded on a##2##4##(2008-5#1)(2008-7#1)
were recorded on##3##3##(2007-11#1)(2008-5#1)(2008-7#1)
were recorded over the##3##4##(1993-9#1)(2008-10#1)(2008-7#1)
were recorded over##4##3##(1993-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
were recorded simultaneously##2##3##(2007-8#1)(2008-3#1)
were recorded through##2##3##(2010-8#1)(2013-1#1)
were recorded using an##2##4##(2008-7#1)(2011-2#1)
were recorded using##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
were recorded with a##3##4##(1995-8#1)(2008-10#1)(2008-3#1)
were recorded with an##4##4##(2008-3#2)(2008-5#1)(2008-7#1)
were recorded with##13##3##(1993-9#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)
were recorded##223##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-3#1)(1994-8#1)(1995-12#5)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#33)(2008-11#6)(2008-12#7)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#12)(2008-8#4)(2008-9#4)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#10)(2012-12#1)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#12)(2013-7#3)(2013-8#5)
were recovered and##2##3##(2008-10#2)
were recovered by##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
were recovered from a##3##4##(2008-10#3)
were recovered from diseased##3##4##(2008-10#3)
were recovered from noncultivated hosts##2##5##(2008-10#2)
were recovered from the##6##4##(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)
were recovered from##35##3##(2008-10#28)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)
were recovered in the##2##4##(1993-8#1)(1995-8#1)
were recovered in##5##3##(1993-8#1)(1995-1#1)(1995-8#1)(2008-10#2)
were recovered on##2##3##(2008-10#2)
were recovered##65##2##(1990-3#1)(1993-8#1)(1995-1#1)(1995-8#1)(2008-10#49)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
were recruited and##5##3##(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
were recruited by##3##3##(2008-12#1)(2009-5#1)(2012-1#1)
were recruited during the##2##4##(2007-2#1)(2013-1#1)
were recruited for the study##3##5##(2010-8#1)(2011-2#1)(2012-12#1)
were recruited for the##4##4##(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
were recruited for this study##4##5##(1995-3#1)(2008-1#1)(2008-12#1)(2013-1#1)
were recruited for this##6##4##(1995-3#1)(2008-1#1)(2008-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
were recruited for##12##3##(1995-3#1)(2008-1#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
were recruited from community##2##4##(2008-12#1)(2009-5#1)
were recruited from two##2##4##(2008-9#1)(2013-1#1)
were recruited from##12##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
were recruited in the study##2##5##(2008-7#1)(2012-2#1)
were recruited in##5##3##(2008-4#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-8#1)
were recruited into the study##2##5##(2008-4#1)(2011-1#1)
were recruited into the##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
were recruited into##5##3##(1994-3#1)(2008-1#1)(2008-4#1)(2011-1#1)(2013-1#1)
were recruited through##3##3##(1995-1#1)(2007-12#1)(2013-8#1)
were recruited to participate in##2##5##(2008-6#1)(2011-1#1)
were recruited to##3##3##(2008-2#1)(2008-6#1)(2011-1#1)
were recruited##65##2##(1994-3#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#14)(2013-8#5)
were rectilinear over the##4##4##(2008-10#4)
were rectilinear##5##2##(2008-10#5)
were reduced (P &lt##2##4##(1992-12#1)(2010-2#1)
were reduced and##2##3##(1991-5#1)(2007-10#1)
were reduced as##5##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
were reduced by 1-3 logs in 30##2##7##(1997-4#2)
were reduced by the##3##4##(1994-11#1)(2008-10#2)
were reduced by##22##3##(1990-8#1)(1991-6#1)(1993-12#1)(1994-11#1)(1995-3#1)(1997-1#1)(1997-4#2)(2007-10#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
were reduced for##2##3##(2008-10#2)
were reduced from##3##3##(1995-12#2)(2008-5#1)
were reduced in a dose-dependent fashion##2##6##(1992-12#1)(2008-5#1)
were reduced in the##3##4##(1996-12#1)(1996-5#1)(2010-7#1)
were reduced in##15##3##(1991-10#1)(1992-12#1)(1992-2#1)(1996-12#2)(1996-5#1)(2008-10#3)(2008-5#1)(2008-7#4)(2010-7#1)
were reduced significantly##3##3##(2008-10#1)(2010-2#2)
were reduced to##8##3##(1993-3#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
were reduced under##3##3##(2012-1#1)(2012-6#1)(2013-1#1)
were reduced##87##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#4)(1995-3#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#3)(2007-10#2)(2007-12#2)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#1)(2009-9#1)(2010-2#3)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-6#1)(2013-1#2)
were reexamined##4##2##(1996-5#2)(2008-10#1)(2008-9#1)
were referred by##3##3##(1990-12#2)(2013-1#1)
were referred for##3##3##(1990-2#1)(1992-9#1)(2008-10#1)
were referred to the##4##4##(1990-12#1)(1993-3#1)(1995-6#1)(2008-7#1)
were referred to us##2##4##(1995-11#1)(2011-2#1)
were referred to##8##3##(1990-12#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
were referred##15##2##(1990-12#3)(1990-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
were reflected in the##3##4##(2008-5#1)(2008-6#1)(2008-8#1)
were reflected in##5##3##(1994-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were reflected##6##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were refused##2##2##(1995-12#1)(1995-6#1)
were regarded as factors in the optimization##3##7##(2008-10#3)
were regarded as factors in the##4##6##(2008-10#4)
were regarded as##7##3##(1993-12#1)(2008-10#4)(2008-11#1)(2012-3#1)
were regenerated##4##2##(2008-9#2)(2013-1#2)
were registered and##2##3##(1991-9#1)(2007-8#1)
were registered during##2##3##(2008-5#2)
were registered in a##2##4##(1996-6#1)(2008-7#1)
were registered in the##3##4##(1993-8#1)(1995-6#1)(2013-1#1)
were registered in##12##3##(1990-2#1)(1991-6#1)(1992-11#1)(1993-8#1)(1995-6#2)(1995-8#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-7#1)(2013-1#1)
were registered with##3##3##(1990-10#1)(2008-5#1)(2010-1#1)
were registered##33##2##(1990-10#1)(1990-2#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-8#1)(1993-9#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#2)
were regressed against##2##3##(2008-10#1)(2013-1#1)
were regressed##3##2##(2008-10#2)(2013-1#1)
were regular##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
were regularly##2##2##(2008-12#1)(2011-2#1)
were rejected##2##2##(2008-9#2)
were related to a##2##4##(1991-8#1)(2010-11#1)
were related to the##15##4##(1993-5#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
were related to their##4##4##(1991-1#1)(1991-2#1)(2008-10#1)(2010-8#1)
were related to##58##3##(1991-1#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-12#2)(1993-5#1)(1996-1#1)(1996-3#1)(1996-6#2)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#3)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-5#1)(2013-1#3)(2013-8#1)
were related with##2##3##(1993-12#1)(2012-3#1)
were related##68##2##(1991-1#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-12#3)(1993-5#1)(1996-1#1)(1996-3#1)(1996-6#2)(1997-6#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#2)(2009-7#4)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
were relatively low##2##3##(2008-7#1)(2011-2#1)
were relatively small##2##3##(1992-8#1)(2009-7#1)
were relatively##22##2##(1990-11#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
were released as##2##3##(1993-11#1)(2008-6#1)
were released from the##3##4##(1992-6#1)(1994-5#1)(2008-10#1)
were released from##6##3##(1992-6#1)(1994-5#1)(2008-10#2)(2012-12#1)(2013-1#1)
were released with##3##3##(1992-8#1)(1994-11#1)(2008-10#1)
were released##23##2##(1991-1#1)(1991-12#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-5#1)(2008-10#8)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
were reliable##2##2##(2008-10#1)(2008-12#1)
were relieved##4##2##(1997-8#1)(2008-1#2)(2011-2#1)
were remarkable##3##2##(1993-11#1)(1993-2#1)(2011-2#1)
were remarkably similar in##2##4##(2007-11#1)(2010-2#1)
were remarkably similar##4##3##(1991-1#1)(1995-6#1)(2007-11#1)(2010-2#1)
were remarkably##8##2##(1991-1#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-1#1)
were removed after##2##3##(2007-8#1)(2013-8#1)
were removed along with##2##4##(2006-12#1)(2009-8#1)
were removed and the##2##4##(1993-8#1)(1995-12#1)
were removed and##7##3##(1993-8#1)(1995-12#1)(1997-3#1)(2008-12#2)(2008-7#1)(2013-1#1)
were removed at##4##3##(1990-8#1)(1994-3#1)(2008-7#1)(2013-1#1)
were removed by##9##3##(1993-6#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
were removed for##2##3##(2006-6#1)(2008-10#1)
were removed from the##7##4##(1996-12#1)(2008-10#4)(2008-5#1)(2008-7#1)
were removed from##15##3##(1991-3#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2013-1#1)
were removed surgically and##2##4##(2010-7#1)(2011-2#1)
were removed surgically##3##3##(2008-8#1)(2010-7#1)(2011-2#1)
were removed within##3##3##(2008-10#2)(2011-2#1)
were removed without##2##3##(1991-3#1)(2006-12#1)
were removed##67##2##(1990-8#1)(1991-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#2)(1997-3#1)(2006-12#2)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
were renal##2##2##(1997-3#1)(2008-1#1)
were rendered##6##2##(1996-2#1)(1997-2#1)(1997-7#1)(2008-12#1)(2010-3#1)(2011-7#1)
were repeated after##2##3##(2008-7#1)(2013-1#1)
were repeated every 28 days##2##5##(1990-2#1)(1992-2#1)
were repeated every##3##3##(1990-2#1)(1992-2#1)(2007-10#1)
were repeated##9##2##(1990-2#1)(1990-5#1)(1992-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
were repeatedly exposed to##2##4##(1993-12#2)
were repeatedly observed##2##3##(1992-5#1)(2008-7#1)
were repeatedly##10##2##(1991-1#1)(1992-5#1)(1993-12#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-2#1)
were replaced by##5##3##(1991-9#1)(1994-5#1)(1995-11#1)(2008-9#1)(2013-8#1)
were replaced with##4##3##(1994-6#1)(1995-5#1)(1995-6#1)(1996-2#1)
were replaced##11##2##(1991-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-9#1)(2013-8#1)
were replanted##3##2##(2008-10#2)(2008-9#1)
were replicated##2##2##(1994-8#1)(2008-10#1)
were reported and##4##3##(2007-2#1)(2008-11#1)(2009-8#1)(2013-1#1)
were reported as##2##3##(2011-1#1)(2012-3#1)
were reported by##8##3##(1991-11#1)(1994-5#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-7#1)(2013-1#1)
were reported for the first time##3##6##(2008-10#1)(2008-11#1)(2010-9#1)
were reported for the first##4##5##(1991-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
were reported for##8##3##(1991-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-9#1)(2012-1#1)
were reported from##2##3##(1993-6#1)(2013-8#1)
were reported in the##4##4##(1991-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
were reported in##15##3##(1991-11#1)(1991-12#1)(1993-9#1)(1996-8#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
were reported to be##7##4##(1993-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
were reported to have##2##4##(1992-5#1)(2008-10#1)
were reported to the Norwegian##2##5##(1994-9#1)(1997-8#1)
were reported to the##3##4##(1993-3#1)(1994-9#1)(1997-8#1)
were reported to##12##3##(1992-5#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
were reported with##2##3##(2008-10#1)(2012-12#1)
were reported##93##2##(1990-12#1)(1990-5#1)(1991-11#2)(1991-12#2)(1991-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-8#2)(1997-3#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
were reportedly##3##2##(2007-2#1)(2010-3#1)(2013-1#1)
were representative of the##2##4##(2008-10#1)(2010-11#1)
were represented by the##2##4##(2008-10#1)(2013-7#1)
were represented by##8##3##(2007-10#1)(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#1)
were represented##12##2##(1994-9#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-7#1)
were reproduced##3##2##(2007-12#1)(2008-10#2)
were reproducible to##2##3##(2008-3#2)
were reproducible##4##2##(2007-8#1)(2008-10#1)(2008-3#2)
were requested to##2##3##(2008-11#1)(2010-1#1)
were requested##3##2##(2008-11#2)(2010-1#1)
were required for the##2##4##(2008-10#2)
were required for##10##3##(1995-6#1)(2008-10#6)(2008-11#2)(2013-8#1)
were required to complete##2##4##(2008-12#1)(2013-7#1)
were required to##19##3##(1990-12#1)(1993-12#1)(1994-3#3)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-7#1)
were required##38##2##(1990-11#1)(1990-12#1)(1993-12#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(2007-7#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
were researched##2##2##(2008-12#1)(2013-1#1)
were resected and##2##3##(2007-5#1)(2008-12#1)
were resected##6##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
were resident##3##2##(2008-1#1)(2010-8#1)(2013-1#1)
were residents##2##2##(2011-2#1)(2012-12#1)
were resistant to both##5##4##(1991-2#1)(2008-10#4)
were resistant to penicillin##2##4##(2007-8#1)(2013-8#1)
were resistant to the action of##2##6##(1994-11#1)(1995-2#1)
were resistant to the##3##4##(1994-11#1)(1995-2#1)(2008-10#1)
were resistant to##44##3##(1991-2#1)(1991-4#1)(1993-11#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(2007-7#2)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#4)(2010-12#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
were resistant##51##2##(1991-2#1)(1991-4#1)(1993-11#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(2007-7#3)(2007-8#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2010-12#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
were resolved and##2##3##(2008-10#2)
were resolved by consensus##5##4##(2009-9#1)(2010-2#1)(2012-12#3)
were resolved by electrophoresis##2##4##(1994-11#1)(1995-2#1)
were resolved by##18##3##(1990-5#1)(1993-6#1)(1994-11#2)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-2#1)(2012-12#3)
were resolved with##2##3##(1990-8#1)(2008-10#1)
were resolved##32##2##(1990-5#1)(1990-8#1)(1992-10#1)(1993-6#1)(1994-11#2)(1995-2#1)(1995-6#1)(1996-5#2)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#3)
were respectively##12##2##(1990-3#1)(1994-6#1)(2008-10#7)(2008-11#1)(2008-8#1)(2011-2#1)
were respiratory distress##2##3##(1990-3#1)(1995-5#1)
were responsible for the##7##4##(1995-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#2)
were responsible for##21##3##(1990-12#1)(1990-3#1)(1993-3#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-10#9)(2008-8#1)(2010-1#1)(2010-5#1)(2013-1#1)(2013-8#2)
were responsive to##4##3##(1992-2#1)(1993-12#1)(1997-7#1)(2011-2#1)
were restored##9##2##(1990-12#1)(1990-5#1)(1995-5#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-8#2)(2013-1#1)
were restrained##4##2##(1996-2#1)(2008-4#1)(2008-7#2)
were restricted to the##4##4##(2008-10#2)(2008-2#1)(2008-5#1)
were restricted to##13##3##(1995-6#1)(1996-7#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-5#2)(2012-12#1)
were restricted##15##2##(1995-6#1)(1996-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2012-12#1)
were resulted##2##2##(2008-11#1)(2008-12#1)
were resuspended in##2##3##(1994-8#1)(2008-11#1)
were resuspended##3##2##(1994-8#1)(2008-11#2)
were retained##11##2##(1993-11#1)(1993-9#1)(1995-3#2)(1996-12#1)(2008-10#5)(2008-5#1)
were retested##3##2##(1994-3#1)(2007-10#1)(2013-1#1)
were retrieved from##2##3##(2008-3#2)
were retrieved in##2##3##(2008-10#1)(2013-8#1)
were retrieved##10##2##(1993-11#1)(2007-11#1)(2008-10#3)(2008-3#2)(2013-1#1)(2013-8#2)
were retrospectively analysed##2##3##(1995-5#1)(2011-2#1)
were retrospectively analyzed##5##3##(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
were retrospectively evaluated##3##3##(1992-10#1)(2007-8#1)(2011-2#1)
were retrospectively reviewed to##2##4##(2007-7#1)(2012-2#1)
were retrospectively reviewed##15##3##(1997-8#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
were retrospectively studied##4##3##(1995-10#1)(2007-7#1)(2008-1#1)(2011-2#1)
were retrospectively##33##2##(1990-12#1)(1991-2#1)(1992-10#1)(1995-10#1)(1995-5#1)(1997-8#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
were returned by##3##3##(1993-3#1)(1996-1#1)(1997-3#1)
were returned to##2##3##(1992-2#1)(2010-10#1)
were returned##15##2##(1992-2#1)(1993-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#3)(2008-8#1)(2009-2#1)(2010-10#1)(2010-11#1)
were revealed AluI(-) PstI(-) SmaI(+) BssHII(+)##2##6##(2011-1#2)
were revealed between##2##3##(2011-1#1)(2013-8#1)
were revealed by##5##3##(1995-8#1)(1996-9#1)(2008-10#1)(2010-12#1)(2012-2#1)
were revealed in the##3##4##(2013-1#3)
were revealed to##4##3##(1990-5#1)(1991-2#1)(2008-11#1)(2008-8#1)
were revealed##28##2##(1990-5#1)(1991-2#1)(1992-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
were reversed##3##2##(1996-12#1)(2008-12#1)(2009-9#1)
were reversible##2##2##(1993-12#1)(1996-5#1)
were reviewed and##4##3##(1996-3#1)(2006-8#1)(2008-7#1)(2009-8#1)
were reviewed at##4##3##(1996-1#1)(2007-8#1)(2008-8#1)(2010-10#1)
were reviewed by##2##3##(1996-1#1)(2011-2#1)
were reviewed for##4##3##(1995-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
were reviewed from##2##3##(1991-8#1)(2011-1#1)
were reviewed retrospectively##2##3##(1993-8#1)(2007-8#1)
were reviewed to##2##3##(2010-6#2)
were reviewed with##2##3##(1990-3#1)(1996-6#1)
were reviewed##68##2##(1990-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-6#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
were revised##4##2##(1993-2#1)(2008-8#1)(2010-5#1)(2012-2#1)
were rewarded##2##2##(1993-6#1)(2010-2#1)
were rewarmed##2##2##(1990-9#1)(1992-1#1)
were rich in##4##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
were risk factors##4##3##(2008-7#1)(2011-1#2)(2013-8#1)
were robust##3##2##(1996-5#1)(2008-9#1)(2012-3#1)
were routinely##6##2##(1990-3#1)(1991-11#1)(1993-8#1)(1994-2#1)(2008-3#1)(2008-5#1)
were ruled out as##2##4##(1992-12#1)(2008-3#1)
were ruled out##5##3##(1990-3#1)(1992-12#1)(2008-3#1)(2010-2#1)(2012-12#1)
were run##2##2##(2008-10#1)(2008-3#1)
were rurality##2##2##(2011-2#2)
were sacrificed and##3##3##(1996-5#1)(2008-10#1)(2008-7#1)
were sacrificed at the end of##4##6##(1994-2#1)(1997-4#3)
were sacrificed at##10##3##(1994-2#1)(1994-6#1)(1995-11#1)(1997-4#3)(2008-10#1)(2008-7#1)(2010-1#1)(2013-1#1)
were sacrificed on##2##3##(1996-12#1)(2006-6#1)
were sacrificed##25##2##(1992-12#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-4#3)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#3)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were safe and well tolerated##2##5##(1996-1#1)(2008-8#1)
were safe and##3##3##(1996-1#1)(2008-7#1)(2008-8#1)
were safe to##2##3##(1997-4#1)(2012-3#1)
were safe##5##2##(1996-1#1)(1997-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
were sampled and analyzed##2##4##(2008-10#1)(2013-1#1)
were sampled and##4##3##(2008-10#2)(2008-12#1)(2013-1#1)
were sampled at##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
were sampled by##2##3##(2011-2#1)(2013-7#1)
were sampled during##2##3##(2008-10#1)(2008-5#1)
were sampled from brown spot lesions##2##6##(2008-10#2)
were sampled from##13##3##(2008-10#11)(2008-8#1)(2009-7#1)
were sampled in##7##3##(2008-10#5)(2008-5#2)
were sampled three times##3##4##(2008-10#3)
were sampled three##4##3##(2008-10#3)(2013-8#1)
were sampled to##2##3##(2008-10#2)
were sampled##49##2##(2008-10#31)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
were satisfactorily##4##2##(2008-10#4)
were satisfactory for##2##3##(2008-10#2)
were satisfactory with##2##3##(2008-10#2)
were satisfactory##21##2##(1990-9#1)(1991-5#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-7#1)(2008-9#1)
were satisfied with the##12##4##(1991-1#1)(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
were satisfied with their##5##4##(2008-3#1)(2008-9#1)(2009-5#2)(2010-3#1)
were satisfied with##19##3##(1990-2#1)(1991-1#1)(1991-2#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
were satisfied##23##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-5#1)(1993-3#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
were saved##2##2##(2007-7#1)(2008-12#1)
were scanned##4##2##(2008-10#1)(2008-7#1)(2009-2#1)(2010-4#1)
were scarcely##2##2##(2008-10#1)(2008-9#1)
were scattered throughout the##2##4##(2008-7#1)(2011-2#1)
were scattered##3##2##(2008-7#2)(2011-2#1)
were scheduled for elective##2##4##(1993-10#1)(1996-3#1)
were scheduled for##5##3##(1993-1#1)(1993-10#1)(1996-3#1)(2008-5#1)(2011-2#1)
were scored for variation at##2##5##(2008-10#2)
were scored for##5##3##(1997-8#1)(2008-10#3)(2008-7#1)
were scored using a##2##4##(2008-10#1)(2013-1#1)
were scored##15##2##(1994-12#1)(1997-8#2)(2007-10#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
were screened against the##2##4##(2008-10#2)
were screened and##4##3##(2008-10#2)(2011-3#1)(2012-3#1)
were screened by##6##3##(2007-7#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-1#1)
were screened during the##2##4##(2008-1#1)(2008-11#1)
were screened for resistance to##3##5##(2008-10#3)
were screened for the presence of##2##6##(1994-11#1)(2008-10#1)
were screened for the##4##4##(1991-6#1)(1994-11#1)(2008-10#2)
were screened for their##5##4##(1990-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
were screened for##38##3##(1990-2#1)(1990-5#2)(1991-6#1)(1994-11#1)(1994-12#1)(1996-6#1)(2007-7#2)(2008-1#1)(2008-10#16)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
were screened in##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
were screened to##5##3##(2008-10#2)(2008-5#1)(2011-2#1)(2011-3#1)
were screened with a##2##4##(2008-10#1)(2011-2#1)
were screened##73##2##(1990-2#1)(1990-5#2)(1991-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1996-6#1)(1997-4#1)(2007-7#3)(2008-1#2)(2008-10#26)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
were sealed##2##2##(2008-10#1)(2008-6#1)
were searched for##11##3##(1994-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#2)(2011-2#2)(2012-3#2)
were searched##23##2##(1994-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-7#2)(2009-9#1)(2011-2#3)(2012-12#5)(2012-3#3)(2013-1#1)
were secreted into the##2##4##(1993-3#1)(1993-6#1)
were secreted##6##2##(1991-9#1)(1992-9#1)(1993-3#1)(1993-6#1)(2008-11#1)(2008-6#1)
were sectioned##2##2##(1997-2#1)(2008-10#1)
were seeded in##2##3##(2008-5#1)(2012-3#1)
were seeded on##3##3##(1990-8#1)(2008-10#1)(2008-5#1)
were seeded onto##4##3##(2008-11#1)(2010-11#1)(2012-4#1)(2012-8#1)
were seeded with##2##3##(2008-10#1)(2012-2#1)
were seeded##12##2##(1990-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2010-11#1)(2012-2#1)(2012-3#1)(2012-4#1)(2012-8#1)
were seen after##2##3##(1992-2#1)(2010-3#1)
were seen as the##2##4##(1996-2#1)(2008-11#1)
were seen as##3##3##(1995-1#1)(1996-2#1)(2008-11#1)
were seen at##2##3##(1991-11#1)(2008-9#1)
were seen between##2##3##(1997-6#1)(2008-12#1)
were seen comparing##2##3##(1993-9#1)(2013-1#1)
were seen during a three week period##2##7##(1992-6#2)
were seen during a##3##4##(1992-6#2)(2008-4#1)
were seen during##7##3##(1992-6#2)(1997-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2012-3#1)
were seen for##3##3##(1992-10#1)(1994-9#1)(1995-2#1)
were seen in 2##2##4##(2006-10#1)(2008-7#1)
were seen in all patients##2##5##(2008-5#1)(2008-6#1)
were seen in all##5##4##(2008-5#2)(2008-6#1)(2009-8#1)(2010-1#1)
were seen in both##3##4##(1996-12#1)(1997-6#1)(2008-10#1)
were seen in groups##3##4##(1992-9#1)(2007-8#1)(2011-2#1)
were seen in nervous tissue##2##5##(2011-1#2)
were seen in the##21##4##(1990-12#1)(1991-12#2)(1994-11#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
were seen in##78##3##(1990-12#1)(1991-11#1)(1991-12#5)(1991-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#4)(1997-2#1)(1997-3#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-11#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
were seen on the##2##4##(2007-7#1)(2011-2#1)
were seen on##5##3##(1995-12#1)(2007-7#1)(2008-2#1)(2008-7#1)(2011-2#1)
were seen to have##2##4##(2008-11#1)(2008-12#1)
were seen to##8##3##(1990-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2013-8#1)
were seen with##7##3##(1991-6#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
were seen##150##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#5)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#5)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#15)(2008-11#7)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-8#1)(2010-1#1)(2010-11#2)(2010-3#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#1)
were segmented into##2##3##(2008-2#1)(2008-5#1)
were selected according to##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
were selected and##8##3##(1996-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
were selected as analytical wavelengths##2##5##(2008-10#2)
were selected as the##4##4##(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
were selected as##12##3##(1997-3#1)(2008-10#6)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
were selected at random##2##4##(1992-5#1)(1996-12#1)
were selected at##3##3##(1992-5#1)(1996-12#1)(2008-12#1)
were selected based on their##2##5##(2008-12#1)(2011-1#1)
were selected based##3##3##(2007-6#1)(2008-12#1)(2011-1#1)
were selected by the##2##4##(1995-6#1)(2008-8#1)
were selected by##8##3##(1993-2#1)(1995-6#1)(1996-10#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
were selected for a##2##4##(1990-2#1)(2012-12#1)
were selected for further study##2##5##(1995-3#1)(2008-10#1)
were selected for further##3##4##(1995-3#1)(2008-10#2)
were selected for increased sensitivity to##2##6##(2008-8#2)
were selected for resistance##2##4##(2008-10#2)
were selected for the##8##4##(2008-10#3)(2008-9#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
were selected for their##2##4##(2008-10#2)
were selected for this study##3##5##(2008-12#1)(2013-1#2)
were selected for this##4##4##(2008-12#1)(2013-1#3)
were selected for##43##3##(1990-2#1)(1995-3#1)(1997-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
were selected from a large##3##5##(1993-9#1)(1997-8#1)(2008-5#1)
were selected from a##6##4##(1993-9#1)(1994-8#1)(1997-8#1)(2008-5#2)(2013-1#1)
were selected from the##5##4##(1997-8#2)(2008-10#2)(2013-8#1)
were selected from##22##3##(1993-9#1)(1994-8#1)(1997-8#3)(2007-10#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
were selected in the##2##4##(2008-10#1)(2008-11#1)
were selected in##6##3##(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
were selected on the basis of##2##6##(1995-8#1)(2008-1#1)
were selected on##4##3##(1995-4#1)(1995-8#1)(2008-1#1)(2008-9#1)
were selected randomly from##2##4##(1994-3#1)(2008-10#1)
were selected that##2##3##(2008-7#1)(2012-2#1)
were selected to represent##2##4##(1991-12#1)(2008-10#1)
were selected to##20##3##(1991-12#1)(1997-2#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#2)(2013-8#1)
were selected##173##2##(1990-2#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#4)(2006-6#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#51)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#7)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#5)
were selective##3##2##(2008-10#3)
were selectively##9##2##(1991-5#1)(2008-10#5)(2008-7#1)(2008-8#1)(2012-2#1)
were self-administered##2##2##(2009-5#1)(2010-9#1)
were selfed to##2##3##(2008-10#2)
were sensitive to all##2##4##(2008-10#1)(2011-2#1)
were sensitive to metalaxyl##3##4##(2008-10#3)
were sensitive to the##4##4##(1990-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
were sensitive to##30##3##(1990-12#2)(1990-6#1)(1991-2#1)(1992-2#1)(1993-3#1)(1995-8#1)(1996-12#1)(1997-5#1)(2007-10#1)(2008-10#11)(2008-12#2)(2008-9#1)(2009-2#1)(2011-2#2)(2012-2#2)(2013-1#1)
were sensitive##41##2##(1990-12#3)(1990-6#1)(1991-2#1)(1992-2#1)(1993-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#19)(2008-12#2)(2008-9#1)(2009-2#1)(2011-2#2)(2012-2#2)(2013-1#1)
were sensitized with##2##3##(1992-12#2)
were sensitized##3##2##(1992-12#2)(2008-10#1)
were sent a questionnaire##2##4##(1993-12#1)(1996-9#1)
were sent a##3##3##(1993-12#1)(1996-9#1)(1997-2#1)
were sent to a##2##4##(1994-2#1)(1995-11#1)
were sent to the##2##4##(2008-3#1)(2010-10#1)
were sent to##10##3##(1990-6#1)(1994-2#1)(1995-11#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2010-10#1)(2011-1#1)
were sent##20##2##(1990-6#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
were separated and quantified##2##4##(1997-2#1)(2008-10#1)
were separated and##7##3##(1991-5#1)(1993-8#1)(1994-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-12#1)
were separated by 15 degrees##2##5##(2007-11#1)(2009-5#1)
were separated by HPLC##2##4##(1995-3#1)(2008-10#1)
were separated by a##2##4##(2008-10#1)(2013-1#1)
were separated by capillary##2##4##(2008-10#2)
were separated by cation exchange chromatography##2##6##(2008-10#1)(2009-3#1)
were separated by high-performance liquid chromatography (HPLC)##2##7##(1990-8#1)(2008-10#1)
were separated by ion-exchange chromatography##2##5##(1990-8#1)(1997-1#1)
were separated by native gel electrophoresis##2##6##(2008-11#2)
were separated by reversed-phase##2##4##(1995-6#1)(1996-5#1)
were separated by##38##3##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#4)(1991-12#1)(1992-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-1#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
were separated from the##5##4##(1992-3#1)(2008-10#2)(2008-11#1)(2012-2#1)
were separated from##15##3##(1991-2#1)(1992-3#1)(1994-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2009-8#1)(2011-3#1)(2012-2#1)
were separated in a##5##4##(1994-9#2)(2008-10#3)
were separated in##12##3##(1994-9#2)(2008-10#10)
were separated into four##2##4##(2008-10#1)(2012-2#1)
were separated into##11##3##(1994-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-7#1)(2010-4#1)(2012-2#1)
were separated on a C18 column##2##6##(2008-10#1)(2011-1#1)
were separated on a##10##4##(1992-2#1)(1997-2#1)(2008-10#4)(2008-5#1)(2011-1#3)
were separated on an##2##4##(2007-7#1)(2011-2#1)
were separated on the stationary phase##2##6##(2008-10#2)
were separated on the##4##4##(2008-10#4)
were separated on##18##3##(1992-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-10#8)(2008-5#1)(2011-1#3)(2011-2#1)
were separated quantitatively##2##3##(2008-10#2)
were separated using##2##3##(1990-8#1)(1992-8#1)
were separated with a##2##4##(2008-10#2)
were separated with##6##3##(1990-8#1)(1992-2#1)(1995-6#1)(2008-10#3)
were separated without##2##3##(2008-10#2)
were separated##127##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#6)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#2)(1994-12#1)(1994-9#5)(1995-2#1)(1995-3#1)(1995-6#3)(1996-2#1)(1996-5#4)(1997-1#1)(1997-2#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#53)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#2)
were separately##2##2##(2008-3#1)(2008-6#1)
were sequenced and compared##2##4##(2008-10#1)(2009-10#1)
were sequenced and##9##3##(1996-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-10#1)(2013-8#1)
were sequenced from##3##3##(1993-6#2)(2008-10#1)
were sequenced##36##2##(1990-12#1)(1991-12#2)(1992-3#1)(1993-2#2)(1993-6#2)(1994-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-9#1)(2006-8#1)(2008-10#11)(2008-4#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
were sequentially aspirated##2##3##(2008-10#2)
were sequentially introduced into##3##4##(1994-3#1)(2008-10#2)
were sequentially##8##2##(1994-3#1)(2008-10#6)(2008-11#1)
were seriously##2##2##(1994-12#1)(2013-8#1)
were serologically##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
were seronegative##2##2##(1991-8#1)(2011-2#1)
were serotyped by##2##3##(1993-2#1)(2011-1#1)
were serum##2##2##(2006-10#1)(2011-1#1)
were served##2##2##(1995-11#1)(1997-2#1)
were set up##2##3##(2008-10#1)(2008-5#1)
were set##9##2##(1995-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-12#2)
were seven##4##2##(2007-7#1)(2008-1#1)(2008-5#1)(2011-2#1)
were several##5##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
were severe##2##2##(1992-9#1)(1997-8#1)
were severely##7##2##(1990-5#1)(1993-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-2#1)
were sexed##2##2##(1996-12#1)(2008-10#1)
were sexual##2##2##(1993-2#1)(2008-10#1)
were sexually active##4##3##(2011-2#1)(2012-12#1)(2013-1#2)
were sexually##6##2##(1996-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
were sham##2##2##(1993-5#1)(2008-10#1)
were shared among##2##3##(2008-10#1)(2012-3#1)
were shared by##4##3##(1992-9#1)(2008-10#2)(2012-2#1)
were shared##11##2##(1992-9#1)(1997-9#1)(2007-4#1)(2008-10#4)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
were shifted to##3##3##(1990-12#1)(1993-12#1)(2013-1#1)
were shifted##5##2##(1990-12#1)(1993-12#1)(1995-11#1)(2013-1#1)(2013-8#1)
were shortened##2##2##(2008-1#1)(2013-8#1)
were shorter and##2##3##(2010-6#1)(2011-1#1)
were shorter##4##2##(1994-11#1)(2010-6#1)(2011-1#2)
were showed##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
were showing##2##2##(2008-11#2)
were shown by##3##3##(1997-2#1)(2008-10#2)
were shown for##2##3##(1990-3#1)(2013-1#1)
were shown in##4##3##(1992-8#1)(2008-10#2)(2013-8#1)
were shown to alter##2##4##(1994-9#1)(2008-11#1)
were shown to be covalently##2##5##(1993-6#1)(2008-5#1)
were shown to be more##2##5##(2008-11#1)(2012-1#1)
were shown to be significantly##2##5##(1994-7#1)(2008-3#1)
were shown to be the##2##5##(2008-11#1)(2009-5#1)
were shown to be##44##4##(1990-7#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
were shown to contain##2##4##(1991-6#1)(2008-10#1)
were shown to have less##2##5##(1997-6#1)(2010-8#1)
were shown to have##11##4##(1997-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#2)(2010-8#1)(2011-1#1)
were shown to##96##3##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
were shown##118##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#27)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
were significant (P &lt##2##4##(2008-10#1)(2010-3#1)
were significant and##2##3##(1993-8#1)(1995-3#1)
were significant associations between##3##4##(2008-3#1)(2010-1#1)(2011-2#1)
were significant correlations between##3##4##(1992-2#1)(2007-2#1)(2008-7#1)
were significant differences among##5##4##(1993-2#1)(2008-10#2)(2012-3#1)(2013-8#1)
were significant differences between the##5##5##(1991-9#1)(1994-9#1)(2008-10#1)(2009-12#1)(2012-12#1)
were significant differences between##11##4##(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(2008-10#2)(2008-12#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
were significant differences in the##5##5##(1995-12#1)(1996-7#1)(2008-12#1)(2008-7#1)(2011-2#1)
were significant differences in##12##4##(1995-12#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
were significant differences##30##3##(1991-9#1)(1993-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-7#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
were significant for##3##3##(1996-5#1)(2008-10#1)(2011-1#1)
were significant improvements in##3##4##(2007-2#1)(2008-3#1)(2013-1#1)
were significant predictors of##8##4##(1994-2#1)(1996-1#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
were significant##92##2##(1990-6#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-5#1)(1996-7#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#15)(2008-11#1)(2008-12#6)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#3)(2010-1#1)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
were significantly (P &lt##14##4##(1993-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#3)(2013-1#1)
were significantly (P##15##3##(1990-12#1)(1993-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#3)(2013-1#1)
were significantly (P&lt##2##3##(2008-10#2)
were significantly (p &lt##4##4##(1997-4#1)(2008-12#2)(2008-9#1)
were significantly affected by both##2##5##(2008-10#2)
were significantly affected by wheat type##2##6##(2008-10#2)
were significantly affected by##7##4##(1995-12#1)(2008-10#5)(2008-5#1)
were significantly and positively##2##4##(2008-10#1)(2009-7#1)
were significantly associated with the##2##5##(2011-1#1)(2013-1#1)
were significantly associated with##17##4##(1997-4#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2011-1#3)(2012-2#2)(2013-1#2)
were significantly associated##19##3##(1997-4#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2011-1#3)(2012-2#2)(2013-1#2)
were significantly attenuated##3##3##(1994-11#1)(1997-7#1)(2008-7#1)
were significantly better##3##3##(2007-11#1)(2010-3#1)(2012-2#1)
were significantly changed##3##3##(1993-12#1)(1995-3#1)(2010-11#1)
were significantly correlated in##2##4##(2011-2#2)
were significantly correlated with the##3##5##(1990-8#1)(1995-5#1)(2008-7#1)
were significantly correlated with##10##4##(1990-8#1)(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
were significantly correlated##15##3##(1990-8#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-7#2)(2011-2#3)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
were significantly decreased in the##3##5##(1993-12#1)(1995-5#1)(2008-10#1)
were significantly decreased in##8##4##(1993-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-9#2)(2011-1#1)(2011-2#1)
were significantly decreased##20##3##(1991-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-12#2)(2008-9#5)(2011-1#2)(2011-2#2)(2013-8#1)
were significantly different among##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
were significantly different between the##2##5##(1990-7#1)(1995-4#1)
were significantly different between##4##4##(1990-7#1)(1995-4#1)(2008-8#1)(2013-1#1)
were significantly different from the##4##5##(1992-11#1)(1994-5#1)(2008-10#1)(2013-1#1)
were significantly different from zero (P &lt##2##7##(2008-10#2)
were significantly different from##10##4##(1992-11#1)(1993-8#1)(1994-5#1)(2008-10#6)(2013-1#1)
were significantly different in##3##4##(2008-10#2)(2008-5#1)
were significantly different##35##3##(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-4#1)(2008-10#12)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2013-1#3)(2013-8#1)
were significantly differentiated from##2##4##(2008-10#2)
were significantly differentiated##5##3##(2008-10#4)(2012-5#1)
were significantly diminished##3##3##(1991-2#1)(1996-5#1)(2008-10#1)
were significantly elevated in the##2##5##(1995-12#1)(2008-10#1)
were significantly elevated in##3##4##(1993-8#1)(1995-12#1)(2008-10#1)
were significantly elevated##8##3##(1990-11#1)(1992-8#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
were significantly enhanced by##2##4##(2008-10#1)(2008-11#1)
were significantly enhanced##4##3##(1994-8#1)(1996-5#1)(2008-10#1)(2008-11#1)
were significantly greater in##3##4##(2007-7#1)(2008-10#1)(2008-7#1)
were significantly greater than the##3##5##(2008-1#1)(2008-10#1)(2012-3#1)
were significantly greater than those in the##4##7##(2008-9#4)
were significantly greater than those of the vehicle controls##3##9##(2008-9#3)
were significantly greater than those of##4##6##(2008-5#1)(2008-9#3)
were significantly greater than those##8##5##(2008-5#1)(2008-9#7)
were significantly greater than##15##4##(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#9)(2012-3#1)
were significantly greater##20##3##(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#9)(2012-3#1)
were significantly higher after##2##4##(2007-10#1)(2008-6#1)
were significantly higher among##3##4##(1997-4#1)(2008-7#1)(2008-8#1)
were significantly higher for both##2##5##(2008-10#1)(2009-1#1)
were significantly higher for##4##4##(2008-10#1)(2009-1#1)(2011-2#2)
were significantly higher in patients with##5##6##(1993-11#1)(1996-12#1)(2008-7#2)(2013-1#1)
were significantly higher in the##19##5##(1992-12#1)(1995-11#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
were significantly higher in those##2##5##(2009-6#1)(2012-3#1)
were significantly higher in##45##4##(1992-12#2)(1992-5#1)(1993-11#1)(1993-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#7)(2009-6#2)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#1)
were significantly higher on##2##4##(2008-10#1)(2012-9#1)
were significantly higher than control##2##5##(2008-11#1)(2009-11#1)
were significantly higher than in##6##5##(2008-10#1)(2011-1#3)(2011-2#1)(2013-1#1)
were significantly higher than those in the##4##7##(1994-3#1)(1996-7#2)(2011-2#1)
were significantly higher than those in##5##6##(1993-3#1)(1994-3#1)(1996-7#2)(2011-2#1)
were significantly higher than those of the##2##7##(2008-10#1)(2011-1#1)
were significantly higher than those of##7##6##(1994-12#1)(1994-6#1)(2008-10#2)(2010-8#1)(2011-1#1)(2013-1#1)
were significantly higher than those##15##5##(1990-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-7#2)(2008-10#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
were significantly higher than##33##4##(1990-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-7#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
were significantly higher with##3##4##(2007-11#1)(2008-9#1)(2009-4#1)
were significantly higher##101##3##(1990-8#1)(1991-8#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#3)(1995-12#1)(1996-12#2)(1996-6#1)(1996-7#4)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#7)(2011-2#10)(2012-12#1)(2012-2#1)(2012-3#4)(2012-5#1)(2012-9#1)(2013-1#6)(2013-8#1)
were significantly impaired in the##2##5##(1994-3#1)(1997-2#1)
were significantly impaired##4##3##(1993-3#1)(1994-3#2)(1997-2#1)
were significantly improved##4##3##(1991-8#1)(2008-7#1)(2011-2#1)(2011-3#1)
were significantly increased by##6##4##(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
were significantly increased from##3##4##(1994-3#1)(2011-2#1)(2013-1#1)
were significantly increased in 400 and 800 mg/L females##2##9##(2008-9#2)
were significantly increased in all exposed groups of males##2##9##(2008-9#2)
were significantly increased in both##2##5##(2008-10#1)(2008-9#1)
were significantly increased in the##5##5##(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2013-8#1)
were significantly increased in##26##4##(1991-12#1)(1991-2#1)(1993-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-9#13)(2010-11#1)(2011-2#1)(2013-8#1)
were significantly increased##50##3##(1991-12#1)(1991-2#1)(1993-2#1)(1994-3#1)(1994-5#2)(1995-12#2)(1995-3#2)(1996-2#2)(1996-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#18)(2010-11#1)(2011-2#2)(2013-1#2)(2013-8#1)
were significantly larger##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
were significantly less likely to##2##5##(2007-11#1)(2013-1#1)
were significantly less than those of the vehicle controls##8##9##(2008-9#8)
were significantly less than those of the##13##7##(1991-11#1)(2008-9#12)
were significantly less than##16##4##(1991-11#1)(1997-6#1)(2008-10#1)(2008-9#12)(2011-2#1)
were significantly less##26##3##(1991-1#1)(1991-11#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-9#12)(2009-10#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
were significantly longer##2##3##(1996-5#1)(2013-8#1)
were significantly lower at##4##4##(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)
were significantly lower compared with##2##5##(2007-10#1)(2011-2#1)
were significantly lower for##4##4##(1990-12#1)(2008-10#3)
were significantly lower in patients with##2##6##(1990-2#1)(2012-3#1)
were significantly lower in the##5##5##(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
were significantly lower in##19##4##(1990-2#2)(1991-12#2)(1992-2#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
were significantly lower than in##2##5##(1993-2#1)(1996-7#1)
were significantly lower than the##3##5##(2008-10#2)(2008-5#1)
were significantly lower than those in the##2##7##(2011-2#1)(2012-3#1)
were significantly lower than those in##3##6##(2011-2#1)(2012-3#1)(2013-1#1)
were significantly lower than those of##2##6##(2008-10#1)(2011-2#1)
were significantly lower than those##5##5##(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
were significantly lower than##14##4##(1993-2#1)(1996-7#1)(2008-10#3)(2008-5#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
were significantly lower##48##3##(1990-12#1)(1990-2#2)(1991-12#2)(1992-2#1)(1993-2#1)(1994-2#1)(1996-7#2)(2007-10#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
were significantly lowered##4##3##(1994-8#1)(2007-11#1)(2008-11#1)(2010-5#1)
were significantly more aggressive than##2##5##(2008-10#2)
were significantly more frequent##2##4##(2008-1#1)(2011-1#1)
were significantly more likely than##2##5##(2011-1#1)(2013-1#1)
were significantly more likely to##3##5##(2007-11#1)(2008-12#1)(2008-9#1)
were significantly more likely##5##4##(2007-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
were significantly more satisfied with their##2##6##(1993-3#1)(2007-1#1)
were significantly more variable##2##4##(2008-3#1)(2008-9#1)
were significantly more virulent than##2##5##(2008-10#2)
were significantly more##25##3##(1993-3#1)(1995-11#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-1#2)(2013-1#2)
were significantly reduced at the##2##5##(2008-10#1)(2008-7#1)
were significantly reduced at##3##4##(2008-10#2)(2008-7#1)
were significantly reduced by##4##4##(1995-12#2)(1996-5#1)(1997-3#1)
were significantly reduced compared##2##4##(2008-4#1)(2011-2#1)
were significantly reduced in the##2##5##(1995-11#1)(2013-1#1)
were significantly reduced in##10##4##(1991-12#1)(1995-11#2)(1995-8#1)(1996-12#1)(2008-10#3)(2013-1#1)(2013-7#1)
were significantly reduced##29##3##(1991-12#1)(1995-11#2)(1995-12#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
were significantly related to##3##4##(1993-12#1)(2008-8#1)(2011-1#1)
were significantly relieved in the 'benifuuki'##2##6##(2008-11#2)
were significantly shorter##2##3##(2008-10#1)(2008-11#1)
were significantly smaller in##2##4##(1991-11#1)(1991-12#1)
were significantly smaller than those##2##5##(2008-7#1)(2011-2#1)
were significantly smaller##6##3##(1991-11#1)(1991-12#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
were significantly suppressed##3##3##(2008-11#1)(2009-10#1)(2011-2#1)
were significantly younger than##2##4##(2007-10#2)
were significantly younger##4##3##(2007-10#2)(2008-12#1)(2011-2#1)
were significantly##523##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#6)(1995-12#8)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#4)(1996-6#2)(1996-7#6)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2007-1#1)(2007-10#10)(2007-11#5)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#93)(2008-11#11)(2008-12#17)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#22)(2008-8#8)(2008-9#53)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#19)(2011-10#1)(2011-2#33)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#10)(2012-5#3)(2012-9#1)(2013-1#28)(2013-7#1)(2013-8#8)
were silent##2##2##(1993-8#1)(2008-2#1)
were similar across##3##3##(1991-3#1)(1994-3#1)(2012-3#1)
were similar and##2##3##(2008-10#1)(2008-11#1)
were similar between the##2##4##(2007-8#1)(2013-1#1)
were similar between treatment##2##4##(2012-12#1)(2012-3#1)
were similar between##13##3##(1992-12#1)(1994-11#1)(1994-5#1)(1995-8#1)(2007-8#1)(2008-10#1)(2010-8#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#2)
were similar for all##2##4##(2008-10#1)(2011-2#1)
were similar for both##2##4##(2008-10#1)(2008-11#1)
were similar for each##2##4##(2008-10#2)
were similar for the##3##4##(1992-1#1)(2008-10#1)(2010-3#1)
were similar for##17##3##(1992-1#1)(1992-12#1)(2008-10#8)(2008-11#1)(2008-9#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
were similar in all##2##4##(1994-8#1)(2008-10#1)
were similar in both groups##9##5##(1990-8#1)(1991-12#1)(1994-12#1)(1997-2#1)(2007-11#1)(2008-5#2)(2009-3#1)(2013-1#1)
were similar in both the##2##5##(2011-2#1)(2012-3#1)
were similar in both##15##4##(1990-8#1)(1991-12#1)(1993-8#1)(1994-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
were similar in cases##2##4##(1991-7#1)(2011-2#1)
were similar in patients##2##4##(1994-12#1)(2013-8#1)
were similar in the two groups##4##6##(1990-12#1)(2007-8#2)(2012-2#1)
were similar in the##11##4##(1990-12#1)(1995-12#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-8#1)(2012-12#1)(2012-2#1)
were similar in##59##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1991-7#1)(1993-12#1)(1993-8#3)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#3)(1996-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were similar or##2##3##(2008-10#1)(2012-12#1)
were similar to each other##3##5##(1997-8#1)(2008-10#2)
were similar to that of##2##5##(1996-12#1)(2008-10#1)
were similar to the##16##4##(1990-11#1)(1992-2#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-4#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
were similar to those found in##2##6##(1993-12#1)(1996-2#1)
were similar to those in##2##5##(1993-12#1)(1994-12#1)
were similar to those observed in other##2##7##(1994-5#1)(2008-5#1)
were similar to those observed in the##2##7##(1997-8#1)(2008-10#1)
were similar to those observed in##4##6##(1994-5#1)(1997-8#1)(2008-10#1)(2008-5#1)
were similar to those obtained with##2##6##(1992-6#1)(2008-10#1)
were similar to those obtained##4##5##(1992-6#1)(2008-10#3)
were similar to those of the vehicle control groups##3##9##(2008-9#3)
were similar to those of the vehicle controls##8##8##(2008-9#8)
were similar to those of the vehicle##11##7##(2008-9#11)
were similar to those of the##18##6##(1993-8#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#11)(2011-2#1)
were similar to those of##31##5##(1990-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#13)(2011-2#1)
were similar to those##47##4##(1990-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#13)(2009-4#1)(2011-2#1)(2012-3#2)
were similar to##83##3##(1990-11#1)(1990-12#1)(1990-3#1)(1992-2#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-8#2)(2007-12#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#13)(2009-4#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
were similar with the##2##4##(1990-2#1)(2008-3#1)
were similar with##4##3##(1990-2#1)(1991-2#1)(2007-8#1)(2008-3#1)
were similar##236##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-8#4)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#7)(2008-1#1)(2008-10#52)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#16)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#7)(2013-8#4)
were similarly##6##2##(1990-11#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2011-2#1)
were simply##2##2##(1994-12#1)(2008-11#1)
were simulated using##2##3##(2013-1#2)
were simulated##9##2##(1993-12#1)(1993-9#1)(1997-2#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
were simultaneously added##2##3##(1993-6#1)(2008-10#1)
were simultaneously amplified##2##3##(2008-10#2)
were simultaneously detected in##2##4##(2008-10#1)(2008-4#1)
were simultaneously detected##3##3##(2007-7#1)(2008-10#1)(2008-4#1)
were simultaneously determined by##2##4##(2008-10#2)
were simultaneously determined in##3##4##(2008-10#3)
were simultaneously determined##5##3##(2008-10#5)
were simultaneously recorded##2##3##(1997-6#1)(2007-12#1)
were simultaneously separated##2##3##(1990-8#1)(2008-10#1)
were simultaneously studied by applying a Plackett-Burman design (PBD)##2##9##(2008-10#2)
were simultaneously studied##3##3##(2008-10#2)(2008-5#1)
were simultaneously##32##2##(1990-8#1)(1993-6#1)(1994-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#18)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-9#1)(2013-1#1)
were singly##2##2##(2008-10#1)(2008-3#1)
were six##5##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
were slaughtered and##2##3##(1997-5#1)(2008-12#1)
were slaughtered at the##3##4##(1996-12#1)(2011-1#1)(2012-2#1)
were slaughtered at##5##3##(1996-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
were slaughtered##11##2##(1994-7#1)(1996-12#1)(1997-5#1)(2008-12#1)(2008-9#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#1)
were slightly better##2##3##(2008-10#2)
were slightly higher than those##3##5##(1994-8#1)(2008-10#1)(2008-6#1)
were slightly higher##6##3##(1992-1#1)(1992-9#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-6#1)
were slightly lower##2##3##(1994-2#1)(2008-11#1)
were slightly more##3##3##(1992-5#1)(2008-9#1)(2012-5#1)
were slightly##25##2##(1991-11#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#8)(2008-11#2)(2008-6#1)(2008-9#1)(2009-2#1)(2012-5#1)
were slow to##2##3##(2008-11#1)(2009-4#1)
were slow##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2009-4#1)
were slower##5##2##(1993-6#1)(2007-12#1)(2008-7#2)(2010-3#1)
were slowly##2##2##(1992-3#1)(1992-6#1)
were small and##3##3##(1992-8#1)(1994-2#1)(2008-10#1)
were small##11##2##(1991-6#1)(1992-8#1)(1994-2#2)(2008-10#4)(2009-7#1)(2011-2#1)(2012-12#1)
were smaller and produced##2##4##(2008-10#2)
were smaller than those##2##4##(2008-10#1)(2008-5#1)
were smaller than##10##3##(1992-5#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)
were smaller##16##2##(1992-5#1)(2007-10#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)
were smokers or##2##3##(1991-3#1)(2008-4#1)
were smokers##11##2##(1991-3#1)(1993-6#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-5#1)(2011-2#2)(2013-8#1)
were soaked in a##2##4##(2008-10#2)
were soaked##4##2##(2008-10#4)
were solubilized with##2##3##(1990-2#1)(1994-12#1)
were solubilized##6##2##(1990-11#1)(1990-2#2)(1990-8#1)(1994-12#1)(2008-5#1)
were solved by##2##3##(1992-8#1)(2013-1#1)
were solved##4##2##(1992-8#1)(2007-9#1)(2008-10#1)(2013-1#1)
were some differences in##3##4##(1991-6#1)(2007-6#1)(2008-5#1)
were some differences##4##3##(1991-6#1)(2007-6#1)(2008-5#1)(2012-12#1)
were some limitations to##2##4##(1994-12#1)(2008-11#1)
were some##13##2##(1991-6#1)(1993-5#1)(1994-1#1)(1994-12#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
were sometimes##5##2##(1991-5#1)(2008-10#1)(2010-8#1)(2013-1#2)
were somewhat less##2##3##(1997-5#1)(2007-10#1)
were somewhat##6##2##(1991-1#1)(1995-6#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-10#1)
were sorbed##4##2##(2008-10#4)
were sorted by##2##3##(1996-12#1)(2008-7#1)
were sorted into 3##2##4##(2007-10#1)(2012-3#1)
were sorted##6##2##(1994-2#1)(1996-12#2)(2007-10#1)(2008-7#1)(2012-3#1)
were sought from##2##3##(2007-12#1)(2012-12#1)
were sought using##3##3##(2008-11#2)(2008-12#1)
were sought##10##2##(1992-6#1)(1993-2#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2012-12#1)(2013-1#1)
were spared##3##2##(1991-4#1)(2006-10#1)(2010-6#1)
were spatially correlated in##2##4##(2008-10#2)
were spatially##7##2##(2007-11#1)(2008-10#4)(2009-5#1)(2012-2#1)
were specially##2##2##(2008-10#2)
were specific for##6##3##(1997-6#1)(2008-10#5)
were specific since##2##3##(2008-4#1)(2013-1#1)
were specific to##5##3##(2008-10#4)(2011-2#1)
were specific##16##2##(1991-9#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-10#9)(2008-4#1)(2011-2#1)(2013-1#1)
were specifically detected##2##3##(2008-10#1)(2008-4#1)
were specifically##10##2##(1992-8#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
were spiked with##9##3##(1990-12#1)(2008-10#8)
were spiked##10##2##(1990-12#1)(2008-10#9)
were split##2##2##(1997-5#1)(2013-8#1)
were spontaneously##2##2##(1996-11#1)(2008-11#1)
were sprayed on##2##3##(2008-10#2)
were sprayed with a##2##4##(2008-10#2)
were sprayed with the##2##4##(2008-10#2)
were sprayed with##8##3##(2008-10#6)(2008-8#1)(2011-2#1)
were sprayed##13##2##(2008-10#10)(2008-8#1)(2011-2#2)
were spread over##2##3##(2008-10#2)
were spread##3##2##(2008-10#2)(2008-9#1)
were sputter deposited on##2##4##(2008-2#1)(2008-3#1)
were stabilized##5##2##(1994-11#1)(2007-8#2)(2008-10#2)
were stable for at least##3##5##(1993-8#1)(2008-10#2)
were stable for##5##3##(1993-8#1)(2008-10#4)
were stable in##2##3##(1991-2#1)(2010-4#1)
were stable over##5##3##(2007-12#2)(2008-10#2)(2008-11#1)
were stable throughout the##2##4##(1994-6#1)(2012-1#1)
were stable##28##2##(1991-2#1)(1993-8#1)(1994-6#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
were stably transfected##2##3##(1995-2#1)(2008-11#1)
were stably##5##2##(1990-12#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-11#1)
were stage I##2##3##(1996-2#1)(2008-10#1)
were stage##3##2##(1991-2#1)(1996-2#1)(2008-10#1)
were staged according to the##2##5##(1990-8#1)(2008-6#1)
were staged##5##2##(1990-8#1)(1992-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
were stained by the##2##4##(1997-2#1)(2008-10#1)
were stained by##4##3##(1996-12#1)(1997-2#1)(2008-10#1)(2011-2#1)
were stained for##2##3##(2008-10#1)(2008-8#1)
were stained in##2##3##(2008-12#2)
were stained positively##2##3##(1996-12#1)(2012-1#1)
were stained with the##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
were stained with##10##3##(1991-5#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
were stained##26##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
were standardized##6##2##(1990-3#1)(1993-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
were started on##2##3##(2006-10#1)(2008-7#1)
were started##6##2##(1995-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-8#1)
were statistically analyzed##4##3##(1994-8#1)(2008-10#1)(2010-5#1)(2012-3#1)
were statistically comparable with those obtained by##2##7##(2008-10#2)
were statistically compared with##4##4##(2008-10#4)
were statistically compared##5##3##(2008-10#5)
were statistically evaluated##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
were statistically higher##2##3##(2010-1#1)(2010-12#1)
were statistically non-significant##2##3##(2008-10#2)
were statistically processed##2##3##(1995-6#1)(2008-8#1)
were statistically significant (P &lt##2##5##(1994-12#1)(2008-7#1)
were statistically significant in the##2##5##(2008-7#1)(2010-1#1)
were statistically significant in##3##4##(2008-11#1)(2008-7#1)(2010-1#1)
were statistically significant predictors of##2##5##(2008-11#1)(2011-2#1)
were statistically significant predictors##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
were statistically significant##29##3##(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#1)(2010-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
were statistically significantly##4##3##(2011-1#1)(2012-1#2)(2013-8#1)
were statistically similar##3##3##(2008-10#1)(2013-1#2)
were statistically##68##2##(1990-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
were still alive##2##3##(1997-2#1)(2011-2#1)
were still being##2##3##(1991-8#1)(2008-11#1)
were still higher than##2##4##(1997-5#1)(2008-6#1)
were still in##4##3##(1991-12#1)(2007-1#1)(2008-1#1)(2009-7#1)
were still on##2##3##(1995-5#1)(2007-7#1)
were still present##2##3##(1992-8#1)(2009-12#1)
were still protected##2##3##(1991-9#1)(1997-4#1)
were still##41##2##(1990-12#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-6#1)(2009-12#1)(2009-7#1)(2011-2#3)(2012-12#2)(2013-1#2)
were stimulated by##5##3##(1990-11#2)(1991-2#1)(1995-8#1)(2008-11#1)
were stimulated for##2##3##(1994-6#1)(1997-3#1)
were stimulated in##2##3##(1993-11#1)(2008-5#1)
were stimulated with##8##3##(1990-2#1)(1991-3#1)(1992-6#1)(1993-9#1)(2008-10#2)(2008-11#2)
were stimulated##21##2##(1990-11#2)(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)
were stored in water or##2##5##(2008-12#1)(2008-3#1)
were stored in##5##3##(2008-11#1)(2008-12#2)(2008-3#1)(2009-8#1)
were stored##7##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-8#1)(2011-2#1)
were strain##2##2##(1994-8#1)(2008-10#1)
were stratified according to##3##4##(1990-5#1)(1994-12#1)(2011-2#1)
were stratified by##4##3##(2007-7#1)(2008-7#1)(2011-2#1)(2012-12#1)
were stratified into a##2##4##(2011-2#2)
were stratified into three categories##2##5##(2010-12#2)
were stratified into three##3##4##(2008-5#1)(2010-12#2)
were stratified into##5##3##(2008-5#1)(2010-12#2)(2011-2#2)
were stratified##14##2##(1990-5#1)(1994-12#1)(1995-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-5#1)
were strictly conserved##2##3##(1995-5#1)(2008-10#1)
were strictly##5##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
were strikingly##2##2##(2008-7#1)(2009-4#1)
were strong##7##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)
were stronger in##2##3##(1993-9#1)(2008-9#1)
were strongly associated with##3##4##(2009-7#2)(2011-1#1)
were strongly associated##4##3##(1991-6#1)(2009-7#2)(2011-1#1)
were strongly correlated with##2##4##(2008-7#1)(2012-3#1)
were strongly correlated##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
were strongly influenced by##2##4##(1995-3#1)(2013-1#1)
were strongly inhibited##2##3##(1993-9#1)(1996-4#1)
were strongly positive for##2##4##(1993-8#1)(2007-5#1)
were strongly positive##4##3##(1993-8#1)(2007-5#1)(2008-10#1)(2008-4#1)
were strongly reduced##2##3##(2008-10#2)
were strongly##31##2##(1991-6#1)(1991-8#1)(1992-12#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-4#1)(1997-2#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
were structured##2##2##(2008-11#1)(2008-8#1)
were students##2##2##(2008-10#1)(2012-2#1)
were studied after##3##3##(1995-12#1)(1996-5#1)(2012-1#1)
were studied and compared with##2##5##(2008-3#1)(2008-7#1)
were studied and compared##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
were studied and optimized##10##4##(2008-10#10)
were studied and the##5##4##(2008-10#5)
were studied and were##2##4##(2008-10#2)
were studied and##38##3##(1990-7#1)(2007-8#2)(2008-10#27)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
were studied as well as##2##5##(2008-10#2)
were studied as well##3##4##(2008-10#3)
were studied as##8##3##(2008-10#5)(2008-2#1)(2009-10#1)(2010-2#1)
were studied at four##2##4##(2008-10#1)(2011-2#1)
were studied at the##2##4##(2007-10#1)(2008-10#1)
were studied at##12##3##(1990-6#1)(1995-10#1)(1995-11#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)
were studied by differential scanning calorimetry##2##6##(1993-8#1)(2011-2#1)
were studied by flow##3##4##(1994-5#1)(2008-10#1)(2012-1#1)
were studied by measuring##2##4##(2008-10#1)(2012-2#1)
were studied by principal component analysis (PCA)##2##7##(2008-10#2)
were studied by using##6##4##(2008-10#4)(2008-11#1)(2008-9#1)
were studied by##60##3##(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-8#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
were studied during a##2##4##(2007-2#1)(2008-10#1)
were studied during##4##3##(2007-2#1)(2008-10#1)(2008-5#1)(2013-7#1)
were studied electrophysiologically using##2##4##(1990-7#1)(1996-2#1)
were studied electrophysiologically##3##3##(1990-7#1)(1992-8#1)(1996-2#1)
were studied for the first time##3##6##(2008-10#1)(2008-12#1)(2010-3#1)
were studied for the##7##4##(1990-8#1)(1991-2#1)(2008-10#2)(2008-12#1)(2010-3#1)(2013-8#1)
were studied for their ability to##2##6##(1992-2#1)(1995-12#1)
were studied for their##3##4##(1992-2#1)(1995-12#1)(2008-11#1)
were studied for##23##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-8#1)(1995-12#1)(1996-8#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2010-3#1)(2013-8#2)
were studied from##4##3##(1991-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
were studied in 14##2##4##(1991-8#1)(2008-5#1)
were studied in a##10##4##(1991-8#1)(2008-10#3)(2008-3#1)(2008-7#4)(2011-2#1)
were studied in an##2##4##(2008-10#1)(2008-11#1)
were studied in detail##5##4##(2008-10#5)
were studied in different##2##4##(1992-6#1)(2007-1#1)
were studied in male Fischer 344 rats##2##7##(1992-12#1)(2008-7#1)
were studied in order to##5##5##(1995-6#1)(2008-10#4)
were studied in rat##3##4##(1995-6#1)(1996-5#1)(1997-2#1)
were studied in relation to##2##5##(2008-10#1)(2008-5#1)
were studied in the##18##4##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1992-6#1)(1993-12#1)(1996-2#2)(1997-3#1)(2007-10#1)(2008-10#4)(2008-5#2)(2008-8#1)
were studied in two##2##4##(2008-10#1)(2011-2#1)
were studied in##108##3##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-12#4)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#28)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#6)(2008-8#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-7#1)
were studied on the##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
were studied on##7##3##(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-10#1)
were studied over a##2##4##(1994-7#1)(1997-2#1)
were studied potentiometrically (H(+)-glass electrode)##2##5##(2008-10#2)
were studied potentiometrically in aqueous solution##2##6##(2008-10#2)
were studied potentiometrically##4##3##(2008-10#4)
were studied prospectively##2##3##(2008-11#1)(2013-8#1)
were studied retrospectively##6##3##(1990-9#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)
were studied through##2##3##(2008-3#1)(2008-9#1)
were studied to assess##2##4##(1995-2#1)(2008-10#1)
were studied to determine the##2##5##(2008-10#1)(2011-2#1)
were studied to determine their##2##5##(2008-11#1)(2008-12#1)
were studied to determine##7##4##(1993-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
were studied to evaluate their##2##5##(2008-10#1)(2012-2#1)
were studied to evaluate##4##4##(1991-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
were studied to##24##3##(1991-8#1)(1993-11#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
were studied under different##2##4##(2008-10#2)
were studied under the##2##4##(2008-10#1)(2009-5#1)
were studied under##12##3##(1991-2#1)(1992-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#1)
were studied using a##2##4##(2008-10#2)
were studied using the##6##4##(1993-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
were studied using##37##3##(1990-5#1)(1991-12#1)(1993-3#1)(1994-9#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
were studied with the##2##4##(2008-7#1)(2012-3#1)
were studied with##10##3##(1991-11#1)(1996-7#1)(2008-10#4)(2008-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
were studied##653##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#3)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#4)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#5)(1996-5#6)(1996-7#1)(1996-8#1)(1997-2#8)(1997-3#1)(1997-5#1)(1997-8#5)(2006-10#1)(2007-1#1)(2007-10#9)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#257)(2008-11#16)(2008-12#12)(2008-2#5)(2008-3#14)(2008-4#4)(2008-5#21)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#14)(2012-3#8)(2013-1#8)(2013-7#4)(2013-8#14)
were studies and##2##3##(1991-2#1)(2008-10#1)
were studies##4##2##(1991-2#1)(2008-10#2)(2008-12#1)
were subcloned and sequenced##2##4##(1991-11#1)(1993-11#1)
were subcloned into the##2##4##(1994-5#1)(2008-10#1)
were subcloned##5##2##(1991-11#1)(1992-3#1)(1993-11#1)(1994-5#1)(2008-10#1)
were subcultured##3##2##(2008-10#3)
were subdivided into##3##3##(1997-1#1)(2008-6#1)(2012-3#1)
were subject to##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
were subjected to a##9##4##(1995-3#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2012-12#1)(2013-1#1)
were subjected to an##2##4##(2007-6#1)(2008-11#1)
were subjected to different##2##4##(2008-10#1)(2008-11#1)
were subjected to four##2##4##(2007-8#1)(2008-12#1)
were subjected to the##8##4##(1997-4#3)(2008-10#2)(2008-12#1)(2012-1#1)(2013-1#1)
were subjected to this##2##4##(1992-1#1)(2008-12#1)
were subjected to three##2##4##(2007-11#1)(2008-10#1)
were subjected to##116##3##(1990-10#1)(1990-11#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#6)(2007-8#4)(2008-10#22)(2008-11#5)(2008-12#7)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#1)
were subjected##118##2##(1990-10#1)(1990-11#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#3)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#6)(2007-8#4)(2008-10#23)(2008-11#5)(2008-12#8)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#1)
were submitted for##2##3##(2008-5#1)(2011-2#1)
were submitted to a##7##4##(1991-12#1)(1994-2#1)(2007-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
were submitted to the##3##4##(2008-11#1)(2008-6#1)(2010-6#1)
were submitted to##24##3##(1990-6#1)(1991-12#1)(1991-2#2)(1992-10#1)(1992-5#1)(1993-12#1)(1994-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-6#1)(2011-2#2)(2013-1#1)
were submitted##30##2##(1990-6#1)(1991-12#1)(1991-2#2)(1992-10#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
were subsequently analyzed##2##3##(1996-12#1)(2008-10#1)
were subsequently determined##2##3##(2008-10#2)
were subsequently used##2##3##(2008-10#1)(2008-8#1)
were subsequently##35##2##(1990-5#1)(1991-2#1)(1993-6#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#15)(2008-11#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-6#1)(2010-10#1)(2013-1#2)
were substantially higher##2##3##(1995-8#1)(1996-12#1)
were substantially lower than##2##4##(1993-12#1)(2008-10#1)
were substantially lower##4##3##(1993-12#1)(1997-2#1)(2007-10#1)(2008-10#1)
were substantially reduced##3##3##(2008-5#1)(2010-5#1)(2012-2#1)
were substantially##13##2##(1993-12#1)(1994-5#1)(1995-8#2)(1996-12#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-5#1)(2010-5#1)(2012-2#1)
were substituted by##2##3##(1991-2#1)(1995-6#1)
were substituted##4##2##(1991-2#1)(1995-11#1)(1995-6#1)(2008-7#1)
were substrates##3##2##(1992-6#1)(1994-8#1)(2012-3#1)
were successful in##5##3##(1997-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
were successful##14##2##(1990-8#1)(1992-2#1)(1993-9#1)(1995-1#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
were successfully analyzed using the proposed method##2##7##(2008-10#2)
were successfully analyzed##4##3##(2008-10#4)
were successfully applied for the determination of##2##7##(2008-10#2)
were successfully applied for the##6##5##(2008-10#6)
were successfully applied to the determination of##3##7##(2008-10#3)
were successfully applied to the##4##5##(2008-10#4)
were successfully applied to##6##4##(2008-10#5)(2008-5#1)
were successfully applied##12##3##(2008-10#11)(2008-5#1)
were successfully assigned##2##3##(1996-8#1)(2010-3#1)
were successfully detected##2##3##(2008-10#2)
were successfully determined by##2##4##(2008-10#2)
were successfully determined with##2##4##(1990-8#1)(2008-10#1)
were successfully determined##6##3##(1990-8#1)(2008-10#5)
were successfully generated##2##3##(2007-12#1)(2008-11#1)
were successfully isolated##3##3##(1997-3#1)(2008-8#1)(2011-1#1)
were successfully managed##2##3##(2012-2#1)(2013-1#1)
were successfully obtained experimentally##2##4##(2007-12#1)(2008-3#1)
were successfully obtained##5##3##(2007-12#1)(2008-3#2)(2008-8#1)(2010-4#1)
were successfully performed##2##3##(2007-8#1)(2008-7#1)
were successfully produced##2##3##(2008-5#1)(2012-6#1)
were successfully separated##4##3##(1997-2#1)(2008-10#3)
were successfully treated by##4##4##(1991-8#1)(1992-9#1)(2007-8#1)(2008-7#1)
were successfully treated with##3##4##(1995-3#1)(2006-10#1)(2012-12#1)
were successfully treated##8##3##(1991-8#1)(1992-9#1)(1995-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-12#1)
were successfully used for##2##4##(2008-10#2)
were successfully used in##2##4##(2008-10#2)
were successfully used to separate##2##5##(2008-10#2)
were successfully used to##3##4##(2007-12#1)(2008-10#2)
were successfully used##7##3##(2007-12#1)(2008-10#6)
were successfully##101##2##(1990-8#1)(1991-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#42)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#6)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#2)
were successively##2##2##(1992-8#1)(2008-10#1)
were suffering from##5##3##(1992-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
were sufficient for the##2##4##(2008-10#1)(2011-2#1)
were sufficient for##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
were sufficient to allow##2##4##(2008-10#1)(2008-3#1)
were sufficient to##6##3##(1992-5#1)(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#2)
were sufficient##10##2##(1992-5#1)(1993-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2011-2#1)
were sufficiently##3##2##(2007-12#1)(2008-10#1)(2009-2#1)
were suggested##6##2##(1994-2#1)(1994-8#1)(1997-8#1)(2008-10#2)(2013-1#1)
were suggestive of a##2##4##(2008-1#1)(2009-1#1)
were suggestive of##7##3##(2007-7#1)(2008-1#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-8#2)
were suitable for the##3##4##(2008-10#3)
were suitable for##5##3##(2008-10#4)(2008-11#1)
were suitable##6##2##(2008-10#5)(2008-11#1)
were summarized##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
were summed up##2##3##(1997-6#1)(2013-7#1)
were summed##3##2##(1997-6#1)(2011-1#1)(2013-7#1)
were superior in##2##3##(1990-8#1)(2008-10#1)
were superior to those##2##4##(2008-5#1)(2009-4#1)
were superior to##6##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
were superior##9##2##(1990-8#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
were supplemented with##2##3##(2007-5#1)(2011-2#1)
were supplemented##3##2##(2007-5#1)(2008-10#1)(2011-2#1)
were supplied##2##2##(2008-10#1)(2008-11#1)
were supported by in situ##2##5##(2008-3#1)(2008-5#1)
were supported by##9##3##(1995-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-6#1)(2013-1#1)
were supported##13##2##(1993-12#1)(1995-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-6#3)(2013-1#1)
were suppressed by##3##3##(1995-11#1)(1995-12#1)(2008-11#1)
were suppressed in##3##3##(1993-9#1)(1996-6#1)(2008-11#1)
were suppressed##9##2##(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(2007-12#1)(2008-11#2)
were surgically removed##2##3##(2011-1#1)(2011-2#1)
were surgically treated using the##2##5##(2006-12#1)(2011-2#1)
were surgically treated##4##3##(1992-9#1)(2006-12#1)(2007-8#1)(2011-2#1)
were surgically##6##2##(1992-9#1)(2006-12#1)(2007-8#1)(2011-1#1)(2011-2#2)
were surprisingly##2##2##(2007-10#1)(2008-8#1)
were surveyed about##3##3##(2008-12#1)(2008-4#1)(2009-9#1)
were surveyed by##3##3##(1990-12#1)(2008-5#1)(2010-2#1)
were surveyed for##3##3##(2007-5#1)(2008-10#1)(2012-3#1)
were surveyed in the##2##4##(2008-10#1)(2008-11#1)
were surveyed in##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2012-12#2)
were surveyed regarding their##2##4##(1995-1#1)(2007-10#1)
were surveyed regarding##6##3##(1991-5#2)(1993-1#1)(1995-1#1)(2007-10#1)(2008-9#1)
were surveyed to determine how##2##5##(1996-1#1)(2007-12#1)
were surveyed to determine##3##4##(1996-1#1)(2007-12#1)(2008-10#1)
were surveyed to##5##3##(1995-1#1)(1996-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
were surveyed with##2##3##(1995-12#1)(2010-2#1)
were surveyed##45##2##(1990-12#1)(1991-5#2)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)
were susceptible in##2##3##(2008-5#1)(2011-2#1)
were susceptible to both##2##4##(1993-6#1)(2008-11#1)
were susceptible to infection##2##4##(2008-10#2)
were susceptible to race##2##4##(2008-10#2)
were susceptible to the##2##4##(2008-10#1)(2008-5#1)
were susceptible to##22##3##(1993-6#1)(1995-2#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-10#1)(2012-2#1)
were susceptible##28##2##(1993-6#1)(1995-2#1)(2008-10#15)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2011-10#2)(2011-2#2)(2012-2#1)
were suspected to have Down's syndrome after##2##7##(1990-2#2)
were suspected##5##2##(1990-2#2)(1992-8#1)(2007-8#1)(2008-1#1)
were suspended in##7##3##(1994-6#1)(1996-1#1)(2008-10#3)(2008-5#1)(2012-2#1)
were suspended##8##2##(1994-6#1)(1996-1#1)(2008-10#4)(2008-5#1)(2012-2#1)
were sustained until the##2##4##(2008-3#1)(2008-9#1)
were sustained##4##2##(1991-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
were symptomatic and##2##3##(1996-8#1)(2010-8#1)
were symptomatic##6##2##(1996-8#1)(2007-8#1)(2008-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
were synthesised and##2##3##(2007-11#1)(2011-2#1)
were synthesised##4##2##(2007-11#2)(2008-10#1)(2011-2#1)
were synthesized and characterized##2##4##(1994-8#1)(2011-1#1)
were synthesized and coated##2##4##(2008-10#1)(2013-1#1)
were synthesized and evaluated for##2##5##(1992-12#1)(2007-11#1)
were synthesized and evaluated##4##4##(1992-12#1)(1993-1#1)(2007-11#2)
were synthesized and examined##2##4##(2008-10#1)(2009-7#1)
were synthesized and secreted##2##4##(1993-12#1)(2009-3#1)
were synthesized and tested##2##4##(1993-3#1)(2008-11#1)
were synthesized and their##6##4##(1990-2#1)(1991-7#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
were synthesized and used as##2##5##(2008-10#2)
were synthesized and##35##3##(1990-2#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1996-2#1)(2007-11#3)(2008-10#10)(2008-11#3)(2008-8#2)(2009-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
were synthesized as##3##3##(2007-11#1)(2008-5#1)(2011-1#1)
were synthesized by sol-gel method##3##5##(2008-10#3)
were synthesized by solid-phase##2##4##(1990-12#1)(2008-9#1)
were synthesized by using##2##4##(1991-3#1)(2008-10#1)
were synthesized by##20##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-6#1)(1993-8#1)(1995-11#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2011-1#1)(2013-8#1)
were synthesized chemically##2##3##(1994-8#1)(2008-8#1)
were synthesized for##2##3##(2008-10#2)
were synthesized from##8##3##(1990-8#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-12#1)(2010-3#1)
were synthesized in water##2##4##(2008-10#1)(2013-8#1)
were synthesized in##9##3##(1992-12#1)(1994-6#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2010-6#1)(2013-8#1)
were synthesized on##3##3##(1992-6#1)(1997-3#1)(2008-10#1)
were synthesized using a##3##4##(2008-10#2)(2008-8#1)
were synthesized using##6##3##(1995-3#1)(2008-10#3)(2008-5#1)(2008-8#1)
were synthesized via a##2##4##(1996-5#1)(2009-2#1)
were synthesized via##3##3##(1996-5#1)(2008-11#1)(2009-2#1)
were synthesized with##4##3##(2008-10#1)(2008-2#1)(2008-5#2)
were synthesized##119##2##(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#3)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#2)(1996-2#2)(1996-5#1)(1997-3#1)(2007-11#8)(2007-12#1)(2008-10#31)(2008-11#7)(2008-2#1)(2008-5#6)(2008-6#1)(2008-8#6)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
were systematically investigated##5##3##(2008-10#5)
were systematically reviewed using##2##4##(2012-12#2)
were systematically studied##4##3##(2008-10#3)(2013-8#1)
were systematically##24##2##(1992-8#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#10)(2008-5#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#3)
were tabulated##6##2##(2007-8#5)(2010-8#1)
were tagged##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
were tailored##2##2##(2011-2#2)
were taken and##3##3##(2008-10#2)(2013-1#1)
were taken as inputs for##2##5##(2008-10#2)
were taken as the##2##4##(2008-11#1)(2008-5#1)
were taken as##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)
were taken at 1##2##4##(2013-1#2)
were taken at##10##3##(1994-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
were taken before and##2##4##(2008-10#1)(2013-8#1)
were taken before##5##3##(1990-3#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
were taken by##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
were taken for##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2012-3#1)
were taken from the##16##4##(1995-12#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
were taken from##38##3##(1994-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#4)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
were taken in the##2##4##(2013-7#2)
were taken in##7##3##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-7#3)
were taken into account##4##4##(1990-9#1)(2008-10#1)(2009-7#1)(2010-3#1)
were taken into##5##3##(1990-9#1)(2008-10#2)(2009-7#1)(2010-3#1)
were taken of##3##3##(1995-6#1)(2011-2#1)(2012-3#1)
were taken on##6##3##(1993-1#1)(1996-3#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-6#1)
were taken to##3##3##(1991-2#1)(2008-10#1)(2012-12#1)
were taken##124##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#22)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#13)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#4)
were taking##7##2##(1994-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-4#1)(2013-1#1)
were targeted##2##2##(1996-2#1)(2008-10#1)
were taught##3##2##(1993-12#2)(2008-10#1)
were tentatively##2##2##(1996-2#1)(2008-10#1)
were terminated##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
were tested against a##2##4##(2008-10#1)(2008-8#1)
were tested against##11##3##(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)
were tested and the##3##4##(1991-3#1)(1996-12#1)(2008-11#1)
were tested and##13##3##(1991-3#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)(2010-4#1)
were tested as a##2##4##(1993-12#1)(1995-5#1)
were tested as solid##2##4##(2008-10#2)
were tested as##16##3##(1990-11#3)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#1)(2007-10#1)(2008-10#5)(2008-11#2)(2013-1#1)
were tested at the##3##4##(1992-2#1)(1993-12#1)(2008-4#1)
were tested at##12##3##(1992-2#1)(1993-12#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#2)(2013-1#1)
were tested between##2##3##(2012-12#1)(2013-1#1)
were tested by the##2##4##(1994-12#1)(2013-1#1)
were tested by##17##3##(1994-12#2)(1995-8#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
were tested for differences in##3##5##(1997-5#1)(2008-10#2)
were tested for pathogenicity on##3##5##(2008-10#3)
were tested for resistance to##2##5##(2008-10#2)
were tested for susceptibility to##2##5##(2008-10#2)
were tested for the ability to##2##6##(1991-11#1)(2008-10#1)
were tested for the presence of##3##6##(1992-9#1)(2008-10#1)(2013-1#1)
were tested for the##9##4##(1991-11#1)(1992-9#1)(1994-2#1)(2008-10#4)(2008-7#1)(2013-1#1)
were tested for their ability to inhibit##3##7##(1994-5#1)(1994-8#1)(2008-10#1)
were tested for their ability to transmit##2##7##(2008-10#2)
were tested for their ability to##10##6##(1992-6#1)(1994-5#1)(1994-8#1)(2007-6#1)(2008-10#6)
were tested for their effect on##2##6##(2008-10#1)(2008-5#1)
were tested for their##28##4##(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(2007-6#1)(2008-10#12)(2008-4#1)(2008-5#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
were tested for virulence to##2##5##(2008-10#2)
were tested for virulence##5##4##(2008-10#4)(2009-2#1)
were tested for##103##3##(1990-12#1)(1991-11#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-2#1)(1997-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#40)(2008-11#3)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-3#3)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#3)
were tested in a##6##4##(1991-6#1)(1997-7#1)(2008-10#1)(2008-7#2)(2012-2#1)
were tested in an##4##4##(1990-11#1)(2008-10#2)(2008-11#1)
were tested in order to##2##5##(2008-10#2)
were tested in the greenhouse##2##5##(2008-10#2)
were tested in the##8##4##(1990-6#1)(1993-3#1)(2008-10#3)(2008-5#1)(2011-1#2)
were tested in##40##3##(1990-11#1)(1990-6#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-7#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
were tested on a##2##4##(1994-3#1)(2008-10#1)
were tested on##14##3##(1992-11#1)(1992-3#1)(1994-3#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#2)(2009-1#1)(2010-3#1)
were tested separately and together for suppression of Botrytis cinerea on strawberry leaves##2##13##(2008-10#2)
were tested through##2##3##(2008-5#2)
were tested to evaluate the##2##5##(1992-2#1)(2008-10#1)
were tested to##12##3##(1990-5#1)(1992-2#1)(1997-5#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-9#1)
were tested under field conditions##2##5##(2008-10#2)
were tested under##5##3##(2008-10#2)(2008-11#1)(2009-3#2)
were tested using a##2##4##(2008-12#1)(2011-2#1)
were tested using the##4##4##(1996-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
were tested using##13##3##(1990-2#1)(1995-2#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#2)
were tested with human##2##4##(1993-6#1)(1994-3#1)
were tested with the##4##4##(2008-10#3)(2008-7#1)
were tested with##27##3##(1993-6#1)(1994-3#1)(1996-2#2)(1996-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
were tested##363##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#5)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#5)(1996-2#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#2)(2006-11#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#141)(2008-11#13)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#21)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#3)(2009-6#1)(2009-7#2)(2010-3#7)(2010-4#1)(2011-1#6)(2011-2#13)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#12)(2013-8#1)
were that##4##2##(1994-3#1)(2007-8#1)(2008-11#1)(2008-2#1)
were the best##4##3##(1992-8#1)(1993-3#1)(2008-5#1)(2011-2#1)
were the commonest findings##2##4##(2008-1#2)
were the commonest##3##3##(2008-1#2)(2008-7#1)
were the dominant##2##3##(2008-5#2)
were the first##3##3##(1992-2#1)(2007-11#1)(2007-7#1)
were the following##3##3##(1990-12#1)(2008-10#1)(2013-1#1)
were the highest in##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
were the highest##5##3##(1995-8#1)(2008-10#2)(2008-12#1)(2008-9#1)
were the important##2##3##(2008-11#1)(2008-9#1)
were the largest##2##3##(2008-6#1)(2009-7#1)
were the leading##3##3##(2007-7#1)(2008-7#1)(2013-8#1)
were the least##5##3##(2008-10#2)(2010-7#1)(2011-2#2)
were the lower values than##2##5##(2011-2#2)
were the lowest in##2##4##(2007-8#1)(2008-10#1)
were the lowest##3##3##(2007-8#1)(2008-10#2)
were the main indications to surgery##2##6##(1991-5#1)(1993-3#1)
were the main##15##3##(1991-11#1)(1991-5#1)(1992-2#1)(1993-2#1)(1993-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#3)(2013-8#1)
were the major##6##3##(2008-1#1)(2008-10#1)(2008-12#2)(2010-11#1)(2012-3#1)
were the most abundant##5##4##(2008-8#1)(2010-4#1)(2010-8#2)(2013-7#1)
were the most common histological##2##5##(2008-1#1)(2012-2#1)
were the most common##16##4##(1990-6#1)(1992-2#1)(1997-3#1)(2007-10#3)(2008-1#3)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
were the most commonly##3##4##(2008-5#1)(2008-8#1)(2010-8#1)
were the most effective##5##4##(1994-12#1)(1995-12#1)(1997-2#1)(2007-7#1)(2008-10#1)
were the most frequent##7##4##(1991-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
were the most frequently detected and occurred in##2##8##(2008-10#2)
were the most frequently detected##3##5##(2008-10#2)(2011-2#1)
were the most frequently prescribed##2##5##(2008-11#1)(2010-5#1)
were the most frequently used##2##5##(1995-12#1)(2008-11#1)
were the most frequently##9##4##(1995-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-5#1)(2011-2#1)
were the most important##7##4##(1994-6#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)
were the most potent##3##4##(1993-1#1)(1994-8#1)(2008-8#1)
were the most prevalent##5##4##(2008-1#1)(2008-10#2)(2008-5#1)(2011-1#1)
were the most prominent##2##4##(2008-10#2)
were the most sensitive##3##4##(2008-10#1)(2008-5#2)
were the most severe##2##4##(2008-10#2)
were the most significant##3##4##(1991-2#1)(2007-7#1)(2013-8#1)
were the most suitable##2##4##(2008-8#1)(2011-2#1)
were the most##103##3##(1990-6#2)(1991-12#1)(1991-2#2)(1991-6#2)(1992-2#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1997-2#1)(1997-3#1)(2007-10#3)(2007-7#3)(2008-1#4)(2008-10#20)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
were the only ones##2##4##(2008-10#1)(2013-1#1)
were the only##11##3##(2008-10#4)(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
were the predominant##9##3##(1991-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2013-1#1)
were the result of the##2##5##(2008-10#1)(2012-12#1)
were the result of##4##4##(2008-10#3)(2012-12#1)
were the results of##2##4##(2009-8#1)(2012-3#1)
were the same as that##2##5##(2008-11#1)(2008-9#1)
were the same as##4##4##(1991-8#1)(1997-6#1)(2008-11#1)(2008-9#1)
were the same for all##3##5##(1994-2#1)(2008-10#2)
were the same or##2##4##(1991-2#1)(1996-2#1)
were the same##17##3##(1991-2#1)(1991-8#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-6#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)
were the strongest##2##3##(2007-12#2)
were the surgical##2##3##(2011-2#1)(2013-1#1)
were the transition##2##3##(2008-10#1)(2012-12#1)
were the two main##2##4##(1992-3#1)(2008-4#1)
were the two##7##3##(1990-2#1)(1991-12#1)(1992-3#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
were the use of##2##4##(2008-10#1)(2011-2#1)
were the variables##2##3##(2008-10#1)(2012-12#1)
were the##350##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#5)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#7)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-7#9)(2007-8#3)(2008-1#9)(2008-10#80)(2008-11#10)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#19)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#4)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#9)(2011-1#5)(2011-2#26)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#5)
were then analyzed by##2##4##(1994-3#1)(2008-10#1)
were then applied to##2##4##(2008-10#1)(2008-11#1)
were then applied##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
were then asked to##2##4##(2008-10#1)(2008-9#1)
were then characterized by##4##4##(1992-6#1)(1994-9#1)(2008-10#2)
were then characterized##5##3##(1992-11#1)(1992-6#1)(1994-9#1)(2008-10#2)
were then compared to##4##4##(1993-11#1)(2007-10#1)(2008-10#1)(2008-7#1)
were then compared with the##4##5##(1995-6#1)(2008-5#1)(2008-8#1)(2012-2#1)
were then compared with##6##4##(1995-6#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)
were then compared##12##3##(1993-11#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)
were then determined by##2##4##(1993-12#1)(2008-10#1)
were then eluted##4##3##(1990-12#1)(2008-10#3)
were then evaluated in##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
were then evaluated##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
were then examined##2##3##(1992-2#1)(2008-10#1)
were then irradiated##2##3##(2008-3#1)(2013-1#1)
were then measured##2##3##(1990-12#1)(1991-3#1)
were then separated##2##3##(1995-2#1)(1997-2#1)
were then sequentially##3##3##(1997-2#1)(2008-10#2)
were then subjected to##4##4##(2008-10#1)(2008-12#1)(2009-7#1)(2012-3#1)
were then tested##5##3##(1991-9#1)(1993-12#1)(2008-10#1)(2008-9#1)(2012-1#1)
were then transferred to##2##4##(1994-5#1)(2008-10#1)
were then transferred##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
were then treated##2##3##(1992-3#1)(2007-11#1)
were then used for##2##4##(1992-6#1)(2011-1#1)
were then used in##2##4##(1994-1#1)(2008-10#1)
were then used to##12##4##(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-7#2)(2009-6#1)(2011-2#1)
were then used##17##3##(1992-6#1)(1993-11#1)(1994-1#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-7#2)(2009-6#1)(2011-1#1)(2011-2#1)
were then##152##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#40)(2008-11#8)(2008-12#4)(2008-3#5)(2008-5#6)(2008-7#7)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
were there##2##2##(2007-6#1)(2008-10#1)
were thereafter##3##2##(1993-5#1)(2008-10#1)(2012-1#1)
were therefore##5##2##(1990-9#1)(1994-11#1)(1996-7#1)(2008-10#1)(2009-5#1)
were thoroughly investigated##4##3##(2008-10#3)(2010-4#1)
were thoroughly##7##2##(2008-10#4)(2008-7#1)(2010-4#1)(2013-1#1)
were those who##3##3##(1993-3#1)(2008-11#1)(2008-7#1)
were those with##2##3##(2008-10#1)(2009-2#1)
were those##15##2##(1993-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
were thought to be##2##4##(1990-6#1)(2008-7#1)
were thought to##4##3##(1990-6#1)(1996-9#1)(2008-10#1)(2008-7#1)
were thought##5##2##(1990-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
were three##10##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-11#1)(2010-8#1)(2013-8#1)
were thus determined in the ranges##2##6##(2008-10#2)
were thus determined##3##3##(2008-10#3)
were thus identified##2##3##(2008-10#1)(2008-7#1)
were thus not##2##3##(2008-10#1)(2008-8#1)
were thus##20##2##(1991-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(2007-12#2)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
were thymol##2##2##(2008-12#1)(2012-2#1)
were tightly##3##2##(1995-6#1)(2008-10#1)(2013-8#1)
were titrated##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
were to (1)##2##3##(2009-7#1)(2013-1#1)
were to (i) determine##2##4##(2008-10#2)
were to (i)##5##3##(2008-10#3)(2010-12#1)(2013-1#1)
were to analyze##2##3##(2008-10#1)(2012-3#1)
were to assess the##2##4##(2008-10#1)(2012-3#1)
were to be used##3##4##(1992-2#1)(2013-1#2)
were to be##6##3##(1992-2#1)(2008-12#1)(2008-2#1)(2011-1#1)(2013-1#2)
were to determine the effect of##2##6##(2008-10#1)(2008-8#1)
were to determine the prevalence of##5##6##(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#1)
were to determine the##16##4##(1996-1#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-10#1)(2011-2#2)
were to determine##20##3##(1996-1#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
were to develop##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
were to establish##2##3##(2008-10#1)(2013-1#1)
were to evaluate the##7##4##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#2)
were to evaluate##10##3##(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2012-3#2)
were to examine the##4##4##(2008-11#1)(2010-11#1)(2012-2#1)(2013-8#1)
were to identify##5##3##(2007-4#1)(2008-10#2)(2008-11#1)(2013-1#1)
were to investigate the##3##4##(2008-9#1)(2010-2#1)(2011-2#1)
were to investigate##4##3##(2008-12#1)(2008-9#1)(2010-2#1)(2011-2#1)
were to provide##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
were to study the##4##4##(2008-10#2)(2013-1#2)
were to undergo##2##3##(2007-10#1)(2007-12#1)
were to##115##2##(1992-12#2)(1992-2#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#3)(1997-6#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#27)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#13)(2013-8#1)
were together##2##2##(2008-12#1)(2008-4#1)
were told##3##2##(1995-6#1)(2008-3#1)(2013-1#1)
were tolerant##3##2##(2008-10#2)(2011-10#1)
were tolerated at##3##3##(1997-3#1)(2008-10#2)
were tolerated##5##2##(1997-3#1)(2008-10#4)
were too low to##2##4##(2008-10#1)(2013-1#1)
were too small##2##3##(1992-10#1)(1994-9#1)
were too##10##2##(1992-10#1)(1994-9#1)(1996-3#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
were total##2##2##(2008-3#1)(2012-2#1)
were totally removed##2##3##(2008-7#2)
were totally##10##2##(1991-9#1)(1993-6#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-10#2)(2010-3#1)
were toxic to##2##3##(2008-10#1)(2008-7#1)
were toxic##3##2##(2008-10#2)(2008-7#1)
were traced##3##2##(2008-10#2)(2010-8#1)
were tracked##2##2##(1992-11#1)(2010-8#1)
were trained and tested##2##4##(1994-3#1)(2010-8#1)
were trained in##4##3##(1990-7#1)(1991-2#1)(1996-8#1)(1997-4#1)
were trained on a##5##4##(1993-12#1)(1993-3#2)(1993-5#1)(2011-2#1)
were trained on the##2##4##(1993-12#1)(1997-2#1)
were trained on##9##3##(1993-12#3)(1993-3#2)(1993-5#1)(1994-3#1)(1997-2#1)(2011-2#1)
were trained to discriminate##3##4##(1991-12#1)(1992-10#1)(1993-12#1)
were trained to##8##3##(1991-12#1)(1992-10#1)(1992-11#2)(1993-12#1)(1993-6#1)(2008-10#1)(2012-3#1)
were trained##27##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#2)(1992-12#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#1)(1994-3#2)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)
were transcribed and analyzed##2##4##(1995-1#1)(2008-4#1)
were transcribed and##4##3##(1993-2#1)(1995-1#1)(2008-4#1)(2010-3#1)
were transcribed##10##2##(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-1#1)(2013-1#1)
were transfected into human##2##4##(2008-8#1)(2011-2#1)
were transfected into##8##3##(1991-2#1)(1993-3#1)(1994-6#1)(2008-11#2)(2008-8#2)(2011-2#1)
were transfected with a plasmid##2##5##(2008-11#1)(2010-11#1)
were transfected with a##3##4##(2008-11#1)(2008-8#1)(2010-11#1)
were transfected with the##3##4##(1994-2#1)(1994-8#1)(2008-11#1)
were transfected with##13##3##(1994-2#1)(1994-8#1)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-3#1)
were transfected##23##2##(1991-2#2)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#7)(2008-8#3)(2008-9#1)(2010-11#2)(2011-2#2)(2012-3#1)
were transferred from the Department of Oncology##2##7##(1993-3#2)
were transferred from##4##3##(1993-3#2)(2008-10#1)(2008-7#1)
were transferred in##2##3##(2007-11#1)(2008-12#1)
were transferred into##7##3##(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-6#1)
were transferred to a##3##4##(2008-10#1)(2008-11#2)
were transferred to##15##3##(1990-9#1)(1997-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)
were transferred##33##2##(1990-9#1)(1993-3#2)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-7#2)(2008-8#3)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#1)
were transformed into##4##3##(1996-5#1)(2008-10#1)(2008-5#2)
were transformed to##3##3##(2008-10#2)(2008-11#1)
were transformed with a##2##4##(2008-10#2)
were transformed with the##3##4##(2008-10#3)
were transformed with##7##3##(2008-10#7)
were transformed##16##2##(1996-5#1)(2008-10#11)(2008-11#2)(2008-5#2)
were transfused##3##2##(1994-9#3)
were transient##2##2##(2008-1#1)(2008-10#1)
were transiently expressed in##2##4##(2008-8#2)
were transiently##3##2##(1991-12#1)(2008-8#2)
were translocated##2##2##(2008-10#1)(2009-8#1)
were transmitted from##3##3##(2007-9#1)(2008-10#1)(2008-7#1)
were transmitted##10##2##(1997-4#1)(1997-8#1)(2007-9#1)(2008-10#5)(2008-7#1)(2013-1#1)
were transplanted between##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
were transplanted into##5##3##(2008-10#3)(2009-12#1)(2011-2#1)
were transplanted##16##2##(2007-7#1)(2008-1#4)(2008-10#4)(2008-4#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-7#1)
were trapped by##2##3##(2007-12#1)(2008-10#1)
were trapped in##2##3##(2008-10#2)
were trapped##7##2##(1991-8#1)(1994-11#1)(2007-12#1)(2008-10#4)
were trauma##2##2##(2007-11#1)(2013-1#1)
were treated and##2##3##(2008-11#1)(2008-7#1)
were treated as##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
were treated at our department##2##5##(1990-9#1)(1997-3#1)
were treated at our##5##4##(1990-6#1)(1990-9#1)(1997-3#1)(2010-3#1)(2011-2#1)
were treated at the##4##4##(1991-6#2)(1993-6#1)(2008-10#1)
were treated at##11##3##(1990-6#1)(1990-9#1)(1991-6#2)(1993-6#1)(1997-3#1)(2008-10#2)(2010-3#1)(2011-1#1)(2011-2#1)
were treated between##3##3##(1992-6#1)(2008-10#1)(2012-3#1)
were treated by a##5##4##(1990-12#1)(1996-11#1)(1997-3#1)(2008-10#1)(2012-2#1)
were treated by definitive##2##4##(1991-4#1)(1994-12#1)
were treated by radiotherapy##2##4##(1990-12#1)(2007-11#1)
were treated by subtotal parathyroidectomy##2##5##(1991-5#1)(1993-3#1)
were treated by the##3##4##(1995-11#1)(2007-11#1)(2012-2#1)
were treated by##56##3##(1990-12#2)(1990-3#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-7#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#8)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
were treated conservatively##5##3##(1997-8#1)(2008-7#2)(2012-12#1)(2013-1#1)
were treated for adenocarcinoma of the##2##6##(1990-9#1)(1994-2#1)
were treated for##20##3##(1990-9#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-7#1)
were treated in our department##3##5##(1993-6#1)(2008-1#1)(2012-2#1)
were treated in our##5##4##(1991-2#1)(1993-6#1)(2007-7#1)(2008-1#1)(2012-2#1)
were treated in the##3##4##(1992-9#1)(1995-11#1)(2006-10#1)
were treated in##20##3##(1991-2#1)(1992-9#1)(1993-6#1)(1995-11#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
were treated once##2##3##(2008-10#1)(2008-5#1)
were treated over##2##3##(1990-10#1)(2008-7#1)
were treated successfully by##2##4##(2008-7#1)(2011-2#1)
were treated successfully with##2##4##(1995-11#1)(2013-1#1)
were treated successfully##6##3##(1995-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
were treated surgically##7##3##(1997-2#1)(2007-7#1)(2007-8#2)(2008-7#1)(2011-1#1)(2013-1#1)
were treated twice##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
were treated using the##2##4##(2007-8#1)(2008-6#1)
were treated using##4##3##(1990-3#1)(2007-8#1)(2008-10#1)(2008-6#1)
were treated with 0##3##4##(1994-11#1)(2008-4#1)(2011-2#1)
were treated with 1##4##4##(1990-12#1)(2008-10#3)
were treated with 3##2##4##(1990-12#1)(1993-2#1)
were treated with CO2 laser##2##5##(1995-2#1)(1996-1#1)
were treated with a combination of##4##6##(1991-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
were treated with a combination##5##5##(1990-2#1)(1991-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
were treated with a food supplement based on##2##8##(2008-5#2)
were treated with a##19##4##(1990-2#1)(1990-6#1)(1991-2#1)(1992-10#1)(1992-3#1)(1992-5#1)(1995-5#1)(1997-8#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#1)
were treated with an##3##4##(1990-8#1)(1994-6#1)(2008-10#1)
were treated with cyclophosphamide##2##4##(2007-7#1)(2008-1#1)
were treated with either##3##4##(1994-11#1)(1994-2#1)(2008-3#1)
were treated with intravenous##2##4##(2011-1#1)(2012-12#1)
were treated with lithium##2##4##(1995-11#1)(2009-8#1)
were treated with oral##2##4##(1991-4#1)(2013-8#1)
were treated with pulse##2##4##(2007-7#2)
were treated with the##12##4##(1991-5#1)(1991-8#1)(1992-6#1)(1994-9#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#2)(2012-3#1)(2013-1#2)
were treated with two##4##4##(1990-12#1)(1997-7#2)(2008-8#1)
were treated with##201##3##(1990-12#5)(1990-2#3)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-2#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#4)(1995-2#3)(1995-3#1)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#3)(1997-7#4)(1997-8#2)(2007-10#5)(2007-11#4)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#7)(2008-7#8)(2008-8#4)(2008-9#5)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#4)
were treated##391##2##(1990-10#2)(1990-12#7)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#6)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-11#8)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#5)(2006-10#2)(2007-10#5)(2007-11#12)(2007-2#1)(2007-4#1)(2007-7#7)(2007-8#9)(2008-1#4)(2008-10#45)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#12)(2008-6#11)(2008-7#24)(2008-8#5)(2008-9#6)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-6#2)(2011-1#6)(2011-2#22)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#17)(2013-7#3)(2013-8#6)
were treatment failures##2##3##(1996-11#1)(2007-10#1)
were tried to be##2##4##(2008-8#1)(2013-1#1)
were tried##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
were triggered by##2##3##(2008-7#1)(2012-2#1)
were triggered##3##2##(2008-7#1)(2010-8#1)(2012-2#1)
were twice as many##2##4##(2009-11#1)(2013-1#1)
were twice as##3##3##(2009-11#1)(2011-2#1)(2013-1#1)
were twice##5##2##(1995-12#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-1#1)
were twins##2##2##(2008-10#1)(2008-12#1)
were two types##2##3##(2008-10#1)(2008-8#1)
were two##24##2##(1990-2#1)(1992-8#1)(1994-2#2)(1995-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
were two-##2##2##(2008-10#1)(2008-2#1)
were type##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)
were typed##3##2##(1994-12#1)(2008-5#1)(2011-2#1)
were typical of the##2##4##(1994-11#1)(2008-10#1)
were typical of##4##3##(1994-11#1)(2007-1#1)(2008-10#2)
were typical##5##2##(1994-11#1)(2007-1#1)(2008-10#3)
were typically##3##2##(2008-10#2)(2008-2#1)
were ultrasound##2##2##(1996-3#1)(2008-10#1)
were unable to achieve##3##4##(2008-10#1)(2008-12#1)(2010-12#1)
were unable to demonstrate##5##4##(1991-2#1)(1995-12#1)(1997-3#1)(2008-8#1)(2009-9#1)
were unable to perform##2##4##(2008-1#1)(2008-7#1)
were unable to transmit##2##4##(2008-10#2)
were unable to##35##3##(1990-11#1)(1991-2#1)(1991-8#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
were unaffected by the presence of##2##6##(2008-10#2)
were unaffected by the presence or absence of##2##8##(2008-10#2)
were unaffected by the presence##4##5##(2008-10#4)
were unaffected by the##7##4##(1991-8#1)(1992-3#1)(1996-12#1)(2008-10#4)
were unaffected by##16##3##(1990-12#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-8#1)(1996-12#1)(2008-10#5)(2008-5#1)(2008-8#1)(2013-1#1)
were unaffected in##2##3##(1996-5#1)(2008-7#1)
were unaffected##24##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
were unaltered##6##2##(1993-8#1)(1997-7#1)(2008-8#2)(2011-1#1)(2012-2#1)
were unaware##2##2##(1996-9#1)(2010-5#1)
were uncertain##2##2##(1991-2#1)(2009-5#1)
were unchanged by##2##3##(1991-2#1)(2013-1#1)
were unchanged in##2##3##(1995-12#1)(2010-5#1)
were unchanged##20##2##(1991-2#2)(1993-3#1)(1993-6#1)(1995-12#2)(1996-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2013-1#2)
were uncommon##2##2##(2007-10#1)(2012-12#1)
were uncorrelated##2##2##(2008-10#1)(2010-2#1)
were under control##2##3##(2008-1#1)(2011-2#1)
were under the age of##2##5##(2008-9#1)(2011-2#1)
were under the influence of##2##5##(1995-8#1)(2013-8#1)
were under the##5##3##(1995-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
were under##14##2##(1991-3#1)(1995-5#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#2)(2013-8#1)
were underestimated##2##2##(1997-7#1)(2008-7#1)
were undertaken in##2##3##(2008-9#1)(2011-1#1)
were undertaken to##7##3##(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-6#1)(1997-7#1)(2008-10#1)
were undertaken using the##2##4##(2008-10#1)(2013-1#1)
were undertaken using##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
were undertaken##22##2##(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-6#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#2)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#4)
were undetectable in##5##3##(1990-11#2)(1991-12#1)(1992-3#1)(1995-6#1)
were undetectable##6##2##(1990-11#2)(1991-12#1)(1992-3#1)(1995-6#1)(2008-12#1)
were uneventful##2##2##(1993-2#1)(2011-1#1)
were unexpectedly##2##2##(1996-12#1)(2008-8#1)
were uniform##2##2##(2008-10#2)
were uniformly susceptible to##2##4##(2008-10#2)
were uniformly susceptible##3##3##(2008-10#3)
were uniformly##7##2##(2008-10#6)(2010-3#1)
were unilaterally##2##2##(1990-6#1)(2009-7#1)
were unique in##2##3##(1990-4#1)(2008-11#1)
were unique to CLP##2##4##(2012-3#2)
were unique to##8##3##(1991-12#1)(1997-4#1)(2008-10#4)(2012-3#2)
were unique##13##2##(1990-4#1)(1991-12#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2012-3#2)(2013-8#1)
were uniquely##3##2##(2008-10#1)(2010-4#2)
were unknown##3##2##(1994-12#1)(1997-8#1)(2008-7#1)
were unlike##2##2##(1993-12#1)(2008-10#1)
were unlikely to be##3##4##(2008-10#1)(2008-5#1)(2010-1#1)
were unlinked##2##2##(1994-9#1)(2008-10#1)
were unrelated to##7##3##(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-4#1)
were unremarkable##2##2##(1995-11#1)(2012-3#1)
were unresponsive to##3##3##(1992-8#1)(1993-2#1)(2008-11#1)
were unresponsive##4##2##(1992-8#1)(1993-2#1)(2008-11#1)(2011-2#1)
were unsatisfactory##2##2##(1990-10#1)(2008-10#1)
were unstable##3##2##(2007-8#1)(2008-11#1)(2012-2#1)
were unsuccessful##7##2##(1995-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)
were up to 1##2##4##(2008-10#2)
were up to##10##3##(1996-12#1)(2008-10#7)(2008-11#1)(2008-8#1)
were up-regulated in##2##3##(1995-11#1)(2011-3#1)
were up-regulated##10##2##(1995-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-3#1)(2013-8#1)
were upregulated in the##2##4##(2012-1#1)(2013-1#1)
were upregulated in##4##3##(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
were upregulated##8##2##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
were used according to the##3##5##(1994-1#1)(2007-11#1)(2011-2#1)
were used alone##2##3##(1991-1#1)(2008-10#1)
were used and compared as##2##5##(2008-10#1)(2008-2#1)
were used and compared##3##4##(2008-10#2)(2008-2#1)
were used and##12##3##(1990-3#1)(1992-9#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-4#1)(2013-1#1)
were used as a model##4##5##(1991-5#1)(2008-10#1)(2008-6#1)(2010-8#1)
were used as a##12##4##(1991-5#1)(1996-9#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-6#1)(2010-8#1)(2012-6#1)
were used as age-matched controls##2##5##(2008-7#2)
were used as an##4##4##(1992-2#1)(2007-5#1)(2008-10#2)
were used as chemical##2##4##(2008-10#2)
were used as controls##8##4##(1990-12#1)(1992-2#1)(1995-8#1)(1996-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)
were used as criteria##2##4##(2008-10#1)(2008-12#1)
were used as host##2##4##(2008-10#1)(2008-3#1)
were used as input for##2##5##(2008-10#1)(2012-12#1)
were used as input##3##4##(2008-10#2)(2012-12#1)
were used as internal standards##2##5##(2008-10#2)
were used as markers##3##4##(2008-10#3)
were used as positive##2##4##(1993-9#1)(2013-1#1)
were used as probes to##2##5##(1993-11#1)(2008-10#1)
were used as substrates##5##4##(1994-5#2)(1994-8#1)(2007-11#1)(2008-6#1)
were used as test##3##4##(1995-8#1)(2008-10#2)
were used as the basis for##2##6##(2008-10#1)(2010-3#1)
were used as the##19##4##(1991-12#1)(1994-6#1)(1996-5#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2012-9#1)
were used as##143##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-2#2)(1993-11#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-5#3)(1996-9#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#55)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-6#2)(2012-9#1)(2013-1#3)(2013-8#3)
were used at##4##3##(2008-10#3)(2008-11#1)
were used by##6##3##(1997-9#1)(2008-10#1)(2008-3#1)(2010-3#2)(2012-2#1)
were used for a##5##4##(1990-2#1)(1994-1#1)(1996-8#1)(2008-10#2)
were used for analysis##3##4##(2008-10#1)(2010-6#1)(2012-12#1)
were used for calibration##3##4##(2008-10#3)
were used for comparison##3##4##(2007-8#1)(2008-10#2)
were used for constructing##3##4##(2008-10#2)(2009-10#1)
were used for determination of##2##5##(2008-10#1)(2008-7#1)
were used for each##2##4##(2008-10#2)
were used for sequential injection chromatographic separations in our study##2##10##(2008-10#2)
were used for statistical##3##4##(1996-12#1)(2008-6#1)(2008-9#1)
were used for the determination of##4##6##(2008-10#4)
were used for the evaluation of the##2##7##(1997-3#1)(2012-1#1)
were used for the evaluation of##3##6##(1997-3#1)(2008-10#1)(2012-1#1)
were used for the##46##4##(1993-6#1)(1994-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
were used for this purpose##4##5##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
were used for this study##3##5##(1993-3#1)(2008-10#1)(2008-5#1)
were used for this##8##4##(1993-3#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2012-2#1)
were used for##157##3##(1990-2#1)(1990-5#1)(1990-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-3#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#72)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#2)
were used in a##9##4##(1995-2#1)(1996-3#1)(2008-10#5)(2008-12#1)(2013-8#1)
were used in all##3##4##(2008-10#1)(2011-2#2)
were used in an##2##4##(1994-5#1)(2008-3#1)
were used in combination##4##4##(1993-12#2)(2008-10#1)(2008-11#1)
were used in conjunction with##5##5##(1992-9#1)(1996-2#1)(1996-9#1)(2007-7#1)(2009-12#1)
were used in order to##8##5##(1994-6#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
were used in the analysis##2##5##(1995-5#1)(2008-10#1)
were used in the study##2##5##(2009-3#1)(2010-8#1)
were used in the##22##4##(1995-5#1)(2007-11#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-3#1)
were used in these##2##4##(2008-10#1)(2008-7#1)
were used in this study to##2##6##(1996-12#1)(2011-2#1)
were used in this study##13##5##(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
were used in this##15##4##(1994-12#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
were used in two##2##4##(2008-5#1)(2010-8#1)
were used in##110##3##(1992-9#1)(1993-12#2)(1994-12#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#42)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
were used more##2##3##(2007-8#1)(2011-2#1)
were used on##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
were used over##3##3##(2008-10#2)(2008-12#1)
were used to address##2##4##(2008-10#1)(2011-2#1)
were used to amplify the##2##5##(2008-10#1)(2012-12#1)
were used to amplify##5##4##(2007-6#1)(2008-10#2)(2008-8#1)(2012-12#1)
were used to analyse##2##4##(2008-10#2)
were used to analyze the##9##5##(1994-12#1)(2008-10#2)(2008-8#3)(2012-2#1)(2012-3#1)(2013-1#1)
were used to analyze##13##4##(1994-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#3)(2012-2#1)(2012-3#1)(2013-1#1)
were used to assess the impact of##2##7##(2008-10#1)(2008-11#1)
were used to assess the##10##5##(1994-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
were used to assess##27##4##(1990-7#1)(1991-6#1)(1994-11#1)(1996-12#1)(1997-2#1)(2008-10#7)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
were used to assign##2##4##(1996-5#1)(2010-4#1)
were used to build##3##4##(2008-10#2)(2010-5#1)
were used to calculate a##2##5##(1993-11#1)(2009-8#1)
were used to calculate the##5##5##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
were used to calculate##11##4##(1992-5#1)(1993-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#2)
were used to characterize the##6##5##(2008-10#4)(2011-2#1)(2013-8#1)
were used to characterize##12##4##(1991-9#1)(2008-10#7)(2008-11#2)(2011-2#1)(2013-8#1)
were used to check the prediction ability of the##2##9##(2008-10#2)
were used to check the##3##5##(2008-10#2)(2008-12#1)
were used to check##5##4##(2008-10#4)(2008-12#1)
were used to classify##2##4##(1993-12#1)(1995-2#1)
were used to collect data##6##5##(2007-2#1)(2008-11#2)(2010-10#1)(2012-3#2)
were used to collect##10##4##(2007-2#1)(2008-10#2)(2008-11#3)(2010-10#1)(2010-5#1)(2012-3#2)
were used to compare the##3##5##(2008-10#1)(2011-1#2)
were used to compare##4##4##(2008-10#2)(2011-1#2)
were used to confirm##2##4##(2008-10#1)(2011-2#1)
were used to construct a##2##5##(2008-10#2)
were used to construct##6##4##(1993-8#1)(1997-2#1)(2008-10#4)
were used to create##3##4##(1995-6#1)(2008-8#1)(2010-4#1)
were used to define the##2##5##(1997-3#1)(2010-10#1)
were used to define##3##4##(1990-11#1)(1997-3#1)(2010-10#1)
were used to demonstrate the feasibility of##2##7##(2008-10#2)
were used to demonstrate the##5##5##(2008-10#3)(2008-3#1)(2008-5#1)
were used to demonstrate##6##4##(2008-10#4)(2008-3#1)(2008-5#1)
were used to derive##2##4##(2008-11#1)(2011-2#1)
were used to describe the##5##5##(1994-2#1)(2008-10#3)(2011-2#1)
were used to describe##7##4##(1993-3#1)(1994-2#1)(2008-10#3)(2010-3#1)(2011-2#1)
were used to design##5##4##(2008-10#4)(2008-5#1)
were used to detect the##3##5##(1996-5#1)(2008-10#2)
were used to detect##6##4##(1996-5#1)(2007-12#1)(2008-10#3)(2008-5#1)
were used to determine genetic relationships##2##6##(2008-10#2)
were used to determine significant##2##5##(2008-10#1)(2012-2#1)
were used to determine the##26##5##(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-1#1)(2012-2#1)(2012-3#2)
were used to determine whether##3##5##(2007-12#1)(2008-10#2)
were used to determine##49##4##(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
were used to develop a##2##5##(1996-3#1)(2012-12#1)
were used to develop the##2##5##(2008-10#1)(2013-8#1)
were used to develop##12##4##(1993-3#1)(1995-1#1)(1996-3#1)(2008-10#4)(2008-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
were used to differentiate##2##4##(2008-5#1)(2008-7#1)
were used to drive the##2##5##(2008-8#1)(2009-8#1)
were used to elucidate##2##4##(2008-10#2)
were used to enhance##2##4##(2008-10#2)
were used to establish##3##4##(1991-1#1)(2011-1#1)(2012-2#1)
were used to estimate the##9##5##(1997-2#1)(2007-8#1)(2008-10#4)(2008-3#2)(2011-1#1)
were used to estimate##15##4##(1990-9#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#1)
were used to evaluate the##12##5##(1993-1#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-5#1)(2012-2#1)(2013-1#1)
were used to evaluate##18##4##(1993-1#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-12#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
were used to examine the effect of##2##7##(1996-12#1)(2007-5#1)
were used to examine the##6##5##(1994-11#1)(1996-12#1)(2007-5#1)(2008-10#2)(2012-2#1)
were used to examine##17##4##(1992-3#1)(1994-11#1)(1996-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#1)
were used to explore the##3##5##(2009-12#1)(2009-5#1)(2012-2#1)
were used to explore##6##4##(1997-3#1)(2008-10#2)(2009-12#1)(2009-5#1)(2012-2#1)
were used to express##2##4##(2008-11#1)(2008-9#1)
were used to fabricate##2##4##(2008-3#1)(2008-7#1)
were used to fit the##2##5##(2008-10#1)(2008-9#1)
were used to fit##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
were used to follow the##2##5##(1991-12#1)(2008-10#1)
were used to further clarify the nature of##2##8##(2008-10#2)
were used to generate##6##4##(1997-3#1)(2008-10#5)
were used to identify and##2##5##(1994-8#1)(2011-2#1)
were used to identify markers linked to##2##7##(2008-10#2)
were used to identify predictors of##2##6##(2007-10#1)(2009-5#1)
were used to identify the##8##5##(1994-12#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
were used to identify##31##4##(1992-8#1)(1994-12#1)(1994-8#1)(2007-10#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
were used to improve the##3##5##(2008-10#1)(2008-3#2)
were used to improve##4##4##(2008-10#1)(2008-3#2)(2009-2#1)
were used to increase the##2##5##(2008-10#1)(2011-2#1)
were used to increase##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
were used to infer the##2##5##(1994-3#1)(2010-8#1)
were used to inoculate##4##4##(2008-10#4)
were used to investigate the effect of##3##7##(1993-3#1)(2008-10#1)(2013-1#1)
were used to investigate the effects of##2##7##(2008-8#1)(2009-8#1)
were used to investigate the response##2##6##(1993-11#1)(2008-9#1)
were used to investigate the role of##2##7##(2008-6#1)(2011-2#1)
were used to investigate the##24##5##(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
were used to investigate##32##4##(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
were used to isolate##3##4##(1991-8#1)(1994-11#1)(1994-8#1)
were used to make##3##4##(2008-3#1)(2008-9#1)(2010-10#1)
were used to map##2##4##(1993-12#1)(2008-10#1)
were used to measure the##6##5##(1990-12#1)(1994-5#1)(1995-6#1)(2008-7#1)(2012-12#1)(2012-3#1)
were used to measure##13##4##(1990-12#1)(1991-2#1)(1993-9#1)(1994-5#1)(1995-6#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-12#2)(2012-3#1)
were used to model the##3##5##(2008-10#2)(2009-7#1)
were used to model##4##4##(2008-10#2)(2009-7#1)(2013-7#1)
were used to modify##2##4##(2008-10#2)
were used to monitor##5##4##(1995-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
were used to observe##3##4##(2008-4#1)(2011-1#1)(2013-1#1)
were used to obtain##9##4##(1991-11#1)(1993-6#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
were used to predict the##3##5##(1992-4#1)(2009-6#1)(2009-9#1)
were used to predict##10##4##(1992-4#1)(1995-6#1)(2007-10#1)(2008-10#4)(2009-6#1)(2009-9#1)(2013-1#1)
were used to prepare##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
were used to probe##4##4##(1991-12#1)(1994-3#1)(2008-8#1)(2009-12#1)
were used to produce the##2##5##(2008-3#1)(2011-3#1)
were used to produce##6##4##(1992-9#1)(2008-10#3)(2008-3#1)(2011-3#1)
were used to quantify##2##4##(2008-10#2)
were used to rapidly detect microbial contamination##2##7##(2012-2#2)
were used to record##2##4##(1996-5#1)(2008-2#1)
were used to remove##2##4##(2008-10#1)(2008-5#1)
were used to represent the##2##5##(2008-10#1)(2008-12#1)
were used to represent##3##4##(2008-10#2)(2008-12#1)
were used to reveal##2##4##(1997-2#1)(2008-10#1)
were used to screen##3##4##(1992-8#1)(2008-8#1)(2008-9#1)
were used to secure the##2##5##(2008-10#1)(2013-1#1)
were used to separate##3##4##(2008-10#3)
were used to show that##2##5##(1994-9#1)(2008-11#1)
were used to show the##2##5##(2008-10#1)(2008-3#1)
were used to show##4##4##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
were used to simulate the##2##5##(2007-11#1)(2008-3#1)
were used to simulate##3##4##(2007-11#1)(2008-3#1)(2008-8#1)
were used to study the effect of the radiation on##2##10##(2013-7#2)
were used to study the effect of##5##7##(1992-3#1)(2008-7#1)(2008-8#1)(2013-7#2)
were used to study the population##2##6##(2008-10#2)
were used to study the relationship between##2##7##(2008-10#2)
were used to study the##25##5##(1992-3#1)(1993-12#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#3)
were used to study##32##4##(1990-9#1)(1992-3#1)(1993-12#1)(1993-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#2)(2013-7#3)
were used to synthesize##2##4##(2008-10#1)(2008-9#1)
were used to test the##4##5##(2008-10#2)(2008-11#1)(2013-7#1)
were used to test##11##4##(2008-10#4)(2008-11#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-7#1)
were used to track##2##4##(2008-10#1)(2008-6#1)
were used to validate the##5##5##(2008-10#5)
were used to validate##6##4##(1995-3#1)(2008-10#5)
were used to##585##3##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#4)(1997-2#4)(1997-3#3)(1997-5#1)(2007-10#6)(2007-11#7)(2007-12#8)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#209)(2008-11#20)(2008-12#11)(2008-2#6)(2008-3#19)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#11)(2008-8#19)(2008-9#9)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#6)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#20)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#14)(2012-3#9)(2013-1#15)(2013-7#7)(2013-8#7)
were used together##2##3##(2008-10#1)(2008-3#1)
were used with##9##3##(1990-2#1)(1995-12#1)(2008-1#2)(2008-10#3)(2008-7#1)(2013-1#1)
were used##1197##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#1)(1993-3#7)(1993-6#2)(1993-8#4)(1993-9#5)(1994-1#2)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#9)(1995-3#3)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-12#10)(1996-2#4)(1996-3#2)(1996-5#8)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2006-6#1)(2007-10#11)(2007-11#19)(2007-12#10)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#10)(2008-1#10)(2008-10#431)(2008-11#40)(2008-12#35)(2008-2#15)(2008-3#33)(2008-4#4)(2008-5#29)(2008-6#20)(2008-7#22)(2008-8#30)(2008-9#16)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#8)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-2#3)(2010-3#8)(2010-4#5)(2010-5#9)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#11)(2011-2#40)(2011-3#4)(2012-1#3)(2012-12#16)(2012-2#22)(2012-3#14)(2012-6#2)(2012-9#1)(2013-1#35)(2013-7#7)(2013-8#17)
were useful for the##2##4##(2011-2#1)(2013-1#1)
were useful for##6##3##(1994-7#1)(1997-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
were useful in##2##3##(2008-7#1)(2011-2#1)
were useful to##2##3##(1996-1#1)(2008-10#1)
were useful##12##2##(1992-2#1)(1994-7#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-7#1)(2010-8#2)(2011-2#2)(2013-1#1)
were using a##2##3##(1993-2#1)(2013-1#1)
were using an##2##3##(2013-1#2)
were using the##2##3##(1991-6#1)(2008-11#1)
were using##14##2##(1991-6#1)(1993-2#1)(2008-10#1)(2008-11#4)(2008-9#1)(2013-1#5)(2013-8#1)
were usually##12##2##(1993-6#1)(1994-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
were utilised to##4##3##(2007-10#1)(2008-10#3)
were utilised##5##2##(2007-10#1)(2007-11#1)(2008-10#3)
were utilized as the##2##4##(1996-5#1)(2008-6#1)
were utilized as##5##3##(1993-3#1)(1996-5#1)(2008-5#1)(2008-6#1)(2009-11#1)
were utilized for the##3##4##(2008-10#3)
were utilized for##7##3##(2008-10#5)(2008-6#1)(2012-2#1)
were utilized in a##2##4##(2008-10#1)(2012-2#1)
were utilized in##5##3##(1992-9#1)(1995-3#1)(1996-2#1)(2008-10#1)(2012-2#1)
were utilized to identify##2##4##(2007-12#1)(2013-8#1)
were utilized to##8##3##(1995-1#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#2)
were utilized##27##2##(1992-9#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#10)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#2)(2013-8#2)
were vaccinated with##2##3##(1997-3#1)(1997-6#1)
were vaccinated##6##2##(1995-9#1)(1997-3#1)(1997-6#1)(2008-5#1)(2010-4#1)(2011-2#1)
were validated as##2##3##(2008-10#1)(2010-8#1)
were validated by using##3##4##(2008-10#3)
were validated by##11##3##(1990-9#1)(2008-10#9)(2010-12#1)
were validated over##2##3##(2008-10#2)
were validated##24##2##(1990-9#1)(2007-10#1)(2008-10#16)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2013-1#1)
were variable##5##2##(1994-2#1)(2008-10#3)(2012-12#1)
were varied between 0##2##4##(2008-10#2)
were varied from##4##3##(1994-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
were varied in##5##3##(1994-2#1)(2008-10#2)(2008-2#1)(2013-1#1)
were varied to##2##3##(1994-9#1)(2007-12#1)
were varied##16##2##(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
were vegetatively compatible##3##3##(2008-10#3)
were vegetatively incompatible##2##3##(2008-10#2)
were vegetatively##7##2##(2008-10#7)
were verified by the##2##4##(2008-3#1)(2010-12#1)
were verified by##5##3##(1991-5#1)(1993-8#1)(2008-3#1)(2010-12#1)(2012-4#1)
were verified##11##2##(1990-12#1)(1991-5#1)(1993-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-12#1)(2010-6#1)(2012-4#1)
were very different##2##3##(2008-10#1)(2012-3#1)
were very high##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
were very low compared with##2##5##(2007-2#1)(2013-1#1)
were very low##10##3##(1995-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2012-2#1)(2012-8#1)(2013-1#1)
were very positive##4##3##(1993-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
were very similar to the##2##5##(2008-10#2)
were very similar to##6##4##(1992-11#1)(1992-3#1)(1994-6#1)(1996-12#1)(2008-10#2)
were very similar##13##3##(1992-11#1)(1992-3#1)(1993-12#1)(1994-6#1)(1996-12#1)(2008-10#6)(2008-11#1)(2011-1#1)
were very small##2##3##(1992-11#1)(2013-7#1)
were very specific##2##3##(2008-10#1)(2010-8#1)
were very weakly labeled##2##4##(1993-1#2)
were very##64##2##(1990-10#1)(1990-4#1)(1992-11#2)(1992-3#1)(1993-1#3)(1993-12#2)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)
were viable at 60 days##2##5##(2008-9#2)
were viable##7##2##(1995-2#1)(1996-2#1)(2008-10#2)(2008-9#2)(2013-1#1)
were viewed as##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
were viewed by##2##3##(1991-2#1)(2012-3#1)
were viewed##5##2##(1991-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-3#1)
were virtually absent##3##3##(2008-5#1)(2008-8#1)(2009-11#1)
were virtually##4##2##(1990-5#1)(2008-5#1)(2008-8#1)(2009-11#1)
were virulent on##5##3##(2008-10#5)
were virulent to##2##3##(2008-10#2)
were virulent##9##2##(2008-10#8)(2008-5#1)
were visible in##2##3##(1993-12#1)(2013-8#1)
were visible##10##2##(1993-12#1)(1995-4#1)(2008-10#6)(2012-1#1)(2013-8#1)
were visited##2##2##(2010-12#1)(2011-2#1)
were visualized by##6##3##(2008-10#4)(2010-3#1)(2013-1#1)
were visualized in##2##3##(1995-12#1)(1996-2#1)
were visualized##12##2##(1993-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2010-3#1)(2013-1#1)
were warranted##2##2##(1996-3#1)(2011-3#1)
were washed and##2##3##(1991-9#1)(2008-10#1)
were washed from##2##3##(2008-10#2)
were washed##8##2##(1990-8#1)(1991-9#1)(2008-10#5)(2008-8#1)
were weak##5##2##(1994-8#1)(2008-10#1)(2008-12#1)(2009-6#1)(2012-2#1)
were weaker but##2##3##(1993-6#1)(1997-2#1)
were weaker##3##2##(1993-6#1)(1994-7#1)(1997-2#1)
were weakly##4##2##(2008-10#4)
were weaned at##2##3##(1993-6#1)(2010-4#1)
were weaned##4##2##(1990-3#1)(1993-6#1)(2007-7#1)(2010-4#1)
were weighed and##5##3##(1993-3#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-4#1)
were weighed##6##2##(1993-3#2)(2008-10#1)(2008-12#1)(2009-4#1)(2010-4#1)
were well controlled##2##3##(2008-12#1)(2011-1#1)
were well preserved##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
were well resolved from##2##4##(1991-5#1)(2008-10#1)
were well resolved##3##3##(1991-5#1)(2008-10#2)
were well separated and##4##4##(1990-8#1)(2008-10#3)
were well separated in##2##4##(2008-10#2)
were well separated within##2##4##(1994-9#1)(2008-10#1)
were well separated##9##3##(1990-8#1)(1994-9#1)(2008-10#7)
were well tolerated##6##3##(1994-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
were well##51##2##(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-3#2)(1997-7#1)(1997-8#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
were well-tolerated##2##2##(2008-5#1)(2013-1#1)
were widely distributed##3##3##(1997-4#1)(2008-10#2)
were widely##7##2##(1990-6#1)(1996-7#1)(1997-4#1)(2008-10#3)(2008-11#1)
were widespread##4##2##(2008-10#3)(2008-8#1)
were willing to participate in a national health campaign to screen blood pressure of dental##2##15##(2008-1#2)
were willing to participate in##3##5##(1994-12#1)(2008-1#2)
were willing to##8##3##(1992-12#1)(1994-12#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-5#1)(2013-1#1)
were willing##10##2##(1992-12#1)(1994-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-8#1)(2009-5#1)(2010-8#1)(2013-1#1)
were with##9##2##(1991-2#1)(1992-1#1)(1993-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
were withdrawn because of##2##4##(1992-11#1)(2008-12#1)
were withdrawn##8##2##(1992-11#1)(1996-12#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-3#1)
were within 10%##2##3##(2008-10#2)
were within normal limits##2##4##(1990-8#1)(2008-9#1)
were within normal range##4##4##(2008-7#4)
were within normal##6##3##(1990-8#1)(2008-7#4)(2008-9#1)
were within the normal range##2##5##(2008-12#1)(2010-3#1)
were within the range of##2##5##(2008-5#1)(2011-2#1)
were within the##10##3##(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2010-3#1)(2011-2#1)
were within##33##2##(1990-8#1)(1992-1#1)(1997-5#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
were without any##2##3##(1995-3#1)(2008-5#1)
were without effect on the##2##5##(1993-6#1)(2008-10#1)
were without effect##3##3##(1993-6#1)(1994-6#1)(2008-10#1)
were without##11##2##(1992-6#1)(1993-1#1)(1993-6#1)(1994-6#2)(1995-3#1)(1996-2#1)(2008-10#3)(2008-5#1)
were women and##3##3##(2008-1#1)(2010-11#1)(2013-1#1)
were women with##3##3##(1994-12#1)(2008-9#1)(2012-12#1)
were women##11##2##(1993-9#1)(1994-12#1)(1996-8#1)(2008-1#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
were worked out##6##3##(2008-10#6)
were worse in##2##3##(1990-12#1)(1996-7#1)
were written at##2##3##(2008-12#1)(2008-2#1)
were written by##2##3##(1992-6#1)(2007-12#1)
were written##6##2##(1992-6#2)(2007-12#2)(2008-12#1)(2008-2#1)
were x-rayed##2##2##(2007-11#1)(2012-2#1)
were young##3##2##(2008-10#1)(2012-3#2)
were younger and##2##3##(1995-3#1)(2008-7#1)
were younger than##5##3##(1990-6#1)(1991-2#1)(1997-3#1)(2007-10#1)(2008-12#1)
were younger##12##2##(1990-6#1)(1991-2#1)(1991-4#1)(1995-3#1)(1997-3#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#1)
were zero##2##2##(2008-10#1)(2008-2#1)
were ~0##2##2##(2007-12#1)(2008-2#1)
were##39130##1##(1990-10#31)(1990-11#112)(1990-12#174)(1990-2#140)(1990-3#75)(1990-4#2)(1990-5#130)(1990-6#99)(1990-7#70)(1990-8#160)(1990-9#79)(1991-1#40)(1991-10#14)(1991-11#59)(1991-12#190)(1991-2#157)(1991-3#68)(1991-4#33)(1991-5#117)(1991-6#124)(1991-7#18)(1991-8#109)(1991-9#74)(1992-1#36)(1992-10#31)(1992-11#86)(1992-12#126)(1992-2#113)(1992-3#168)(1992-4#13)(1992-5#78)(1992-6#133)(1992-7#5)(1992-8#149)(1992-9#116)(1993-1#84)(1993-10#7)(1993-11#108)(1993-12#274)(1993-2#106)(1993-3#157)(1993-5#19)(1993-6#132)(1993-8#159)(1993-9#112)(1994-1#39)(1994-10#4)(1994-11#127)(1994-12#178)(1994-2#145)(1994-3#158)(1994-5#119)(1994-6#111)(1994-7#46)(1994-8#152)(1994-9#112)(1995-1#48)(1995-10#6)(1995-11#178)(1995-12#266)(1995-2#185)(1995-3#171)(1995-4#22)(1995-5#109)(1995-6#142)(1995-8#102)(1995-9#13)(1996-1#74)(1996-10#22)(1996-11#30)(1996-12#253)(1996-2#162)(1996-3#101)(1996-4#3)(1996-5#207)(1996-6#64)(1996-7#46)(1996-8#31)(1996-9#61)(1997-1#36)(1997-2#201)(1997-3#213)(1997-4#175)(1997-5#64)(1997-6#164)(1997-7#105)(1997-8#172)(1997-9#14)(2006-10#35)(2006-11#3)(2006-12#20)(2006-4#2)(2006-6#21)(2006-8#14)(2007-1#13)(2007-10#257)(2007-11#419)(2007-12#345)(2007-2#86)(2007-3#4)(2007-4#10)(2007-5#63)(2007-6#35)(2007-7#299)(2007-8#341)(2007-9#16)(2008-1#307)(2008-10#11346)(2008-11#1267)(2008-12#891)(2008-2#338)(2008-3#798)(2008-4#242)(2008-5#1339)(2008-6#432)(2008-7#1050)(2008-8#727)(2008-9#784)(2009-1#19)(2009-10#103)(2009-11#103)(2009-12#91)(2009-2#64)(2009-3#64)(2009-4#79)(2009-5#123)(2009-6#70)(2009-7#172)(2009-8#139)(2009-9#75)(2010-1#90)(2010-10#78)(2010-11#103)(2010-12#124)(2010-2#103)(2010-3#169)(2010-4#198)(2010-5#142)(2010-6#79)(2010-7#61)(2010-8#234)(2010-9#36)(2011-1#600)(2011-10#24)(2011-2#1432)(2011-3#88)(2011-7#6)(2011-9#3)(2012-1#170)(2012-12#444)(2012-2#559)(2012-3#595)(2012-4#18)(2012-5#24)(2012-6#10)(2012-7#14)(2012-8#10)(2012-9#6)(2013-1#1342)(2013-3#2)(2013-7#178)(2013-8#664)
weren't##3##1##(2008-11#1)(2012-3#2)
west and##2##2##(2008-10#2)
west coast##4##2##(2007-5#1)(2009-12#1)(2010-8#2)
west of Iran##3##3##(2008-12#2)(2012-12#1)
west of the##3##3##(1996-4#1)(2008-10#2)
west of##12##2##(1996-11#1)(1996-4#1)(1997-8#1)(2008-10#4)(2008-12#2)(2009-6#1)(2012-12#1)(2013-8#1)
west##39##1##(1991-4#1)(1992-11#1)(1995-10#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-5#3)(2008-10#12)(2008-12#4)(2008-6#1)(2009-12#1)(2009-6#1)(2010-8#5)(2012-12#1)(2013-8#2)
westermani##3##1##(1996-6#1)(1997-6#2)
western Canada##10##2##(1994-3#1)(2008-10#8)(2013-8#1)
western Colombia##2##2##(2008-12#1)(2008-5#1)
western Europe##2##2##(2008-10#1)(2010-8#1)
western European##2##2##(2011-2#1)(2012-1#1)
western France##2##2##(2008-10#1)(2008-7#1)
western Germany##6##2##(1992-1#1)(2008-11#1)(2009-10#3)(2013-1#1)
western Minnesota##2##2##(2008-10#2)
western Nepal##2##2##(2008-7#2)
western North America##10##3##(2008-10#8)(2008-2#1)(2008-8#1)
western North##12##2##(2008-10#8)(2008-2#2)(2008-3#1)(2008-8#1)
western Sydney and##2##3##(2007-2#2)
western United States##4##3##(2008-10#3)(2013-1#1)
western Washington##2##2##(2008-10#2)
western analysis##3##2##(2008-10#2)(2008-4#1)
western and central##3##3##(2008-10#3)
western and##4##2##(2008-1#1)(2008-10#3)
western blot analysis##6##3##(1993-6#1)(2008-10#4)(2008-11#1)
western blot##13##2##(1993-6#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)
western blots##3##2##(2008-4#1)(2008-5#1)(2009-9#1)
western blotting using##2##3##(1996-12#1)(2008-11#1)
western blotting##16##2##(1994-11#1)(1996-12#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
western blotting)##2##2##(2008-2#1)(2008-4#1)
western corn rootworm larvae##3##4##(2011-2#3)
western corn rootworm##6##3##(2011-2#6)
western countries##7##2##(1990-3#1)(1992-9#1)(2007-10#1)(2008-10#1)(2009-2#3)
western flower thrips##6##3##(2008-10#3)(2009-8#1)(2011-2#2)
western gray squirrels##3##3##(2010-6#3)
western gray##4##2##(2010-6#4)
western immunoblot##2##2##(2008-10#2)
western immunoblotting##2##2##(2008-10#2)
western isolates##2##2##(2008-10#2)
western medical injections were##2##4##(2011-2#2)
western medical injections##5##3##(2011-2#5)
western medical##7##2##(1991-12#1)(2011-2#5)(2013-8#1)
western medicine##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
western music##2##2##(1993-1#2)
western populations##8##2##(2008-10#7)(2008-12#1)
western redbud##2##2##(2008-10#2)
western society##2##2##(1991-12#2)
western white pine##10##3##(2008-10#10)
western world##7##2##(1990-2#1)(1996-2#1)(1997-7#1)(2008-1#2)(2008-11#1)(2008-2#1)
western yellows##4##2##(2008-10#4)
western##211##1##(1990-2#1)(1990-3#1)(1991-12#4)(1992-1#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#3)(2007-10#2)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#5)(2008-10#88)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#4)(2009-2#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#5)(2010-8#2)(2011-2#19)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
western-blot##2##1##(2007-10#2)
wet and dry##3##3##(2008-10#2)(2010-8#1)
wet and##4##2##(1997-5#1)(2008-10#2)(2010-8#1)
wet ashing with H(2)SO(4)##2##4##(2008-10#2)
wet ashing##7##2##(2008-10#7)
wet cell##2##2##(1992-2#2)
wet chemical procedures##2##3##(2008-10#2)
wet chemical##4##2##(2007-12#1)(2008-10#3)
wet conditions##4##2##(2008-10#4)
wet cupping##4##2##(2013-1#4)
wet digestion methods##5##3##(2008-10#5)
wet digestion procedure##2##3##(2008-10#2)
wet digestion##9##2##(2008-10#9)
wet etched##2##2##(2008-2#2)
wet etching##2##2##(2008-10#1)(2008-3#1)
wet heat##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
wet mass of##2##3##(2010-8#2)
wet mass##3##2##(2010-8#3)
wet mopping##3##2##(1997-2#3)
wet mount##4##2##(2007-7#1)(2011-2#1)(2013-8#2)
wet period of##2##3##(2008-10#2)
wet period##10##2##(2008-10#9)(2008-5#1)
wet periods##2##2##(2008-10#2)
wet season##8##2##(2007-5#5)(2008-10#1)(2008-5#2)
wet shave##2##2##(2008-4#1)(2008-5#1)
wet washing##2##2##(1997-2#2)
wet weight##5##2##(1990-2#1)(2008-10#1)(2008-7#2)(2009-4#1)
wet weight)##2##2##(1992-11#1)(2008-10#1)
wet wipes##3##2##(2008-5#3)
wet wt##2##2##(2008-11#2)
wet wt)##2##2##(2008-11#2)
wet##134##1##(1990-2#1)(1990-8#1)(1992-11#1)(1992-2#2)(1996-12#3)(1997-2#6)(1997-4#2)(1997-5#1)(2007-12#1)(2007-5#5)(2007-7#1)(2008-10#59)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#3)
wet&quot##2##1##(2011-2#2)
wet-chemical synthesis##2##2##(2010-4#2)
wet-chemical##3##1##(2009-5#1)(2010-4#2)
wet-dog shakes##3##2##(1995-12#3)
wet-lab##2##1##(2008-8#2)
wet/dry weight ratio##2##3##(2013-1#2)
wether##2##1##(1990-12#1)(2011-2#1)
wetland##6##1##(2008-10#2)(2013-1#3)(2013-7#1)
wetlands in Northeast Thailand##2##4##(2008-12#2)
wetlands##4##1##(2008-12#2)(2008-5#1)(2013-7#1)
wetness and##6##2##(2008-10#6)
wetness duration (WD)##2##3##(2008-10#2)
wetness duration and##3##3##(2008-10#3)
wetness duration at##3##3##(2008-10#3)
wetness duration on##3##3##(2008-10#3)
wetness duration##28##2##(2008-10#28)
wetness durations##5##2##(2008-10#5)
wetness for##3##2##(2008-10#3)
wetness of##2##2##(2008-10#2)
wetness periods##3##2##(2008-10#3)
wetness regimes##2##2##(2008-10#2)
wetness was required##2##3##(2008-10#2)
wetness was##8##2##(2008-10#8)
wetness were##2##2##(2008-10#2)
wetness##106##1##(2008-10#104)(2008-5#1)(2008-8#1)
wetness)##2##1##(2008-10#2)
wettability and##2##2##(2009-7#1)(2010-4#1)
wettability of the##2##3##(2008-10#1)(2008-5#1)
wettability##5##1##(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)
wettable sulfur##3##2##(2011-2#3)
wettable##5##1##(2008-10#2)(2011-2#3)
wetted##3##1##(2008-10#2)(2008-3#1)
wetter##2##1##(2008-10#2)
wetting and drying##4##3##(2008-10#4)
wetting film extraction system##2##4##(2008-10#2)
wetting film extraction##3##3##(2008-10#3)
wetting film##9##2##(2008-10#8)(2011-1#1)
wetting##36##1##(1990-12#1)(1993-2#1)(2008-10#20)(2008-3#2)(2008-5#3)(2009-11#1)(2010-10#1)(2010-4#2)(2011-1#2)(2012-2#2)(2013-8#1)
whale##11##1##(1992-11#1)(1993-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(2012-2#1)(2012-3#4)
what a##4##2##(1991-2#2)(1993-11#1)(2008-3#1)
what allows##2##2##(2007-11#1)(2011-2#1)
what appears to be##2##4##(2008-7#1)(2009-3#1)
what are believed to be the first##2##7##(2007-11#1)(2008-2#1)
what are believed to be the##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
what are the##15##3##(1990-10#2)(1991-6#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2012-3#1)
what are they and##2##4##(1994-3#1)(1997-3#1)
what are to our knowledge the first##3##7##(2007-11#1)(2007-12#2)
what are to##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
what are we##3##3##(1991-3#1)(1992-2#1)(2012-12#1)
what are##29##2##(1990-10#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
what aspects##2##2##(1991-3#1)(2011-2#1)
what can be done##3##4##(1992-11#1)(1997-1#1)(2008-11#1)
what can be learned##2##4##(2008-12#1)(2008-7#1)
what can be##11##3##(1992-11#1)(1997-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
what can it##2##3##(1997-4#1)(2012-12#1)
what can we##3##3##(1991-3#1)(1993-2#1)(2010-9#1)
what can##20##2##(1991-3#1)(1992-11#1)(1993-2#1)(1997-1#1)(1997-4#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
what causes##3##2##(1996-6#1)(2008-11#1)(2013-1#1)
what changes##2##2##(1996-2#1)(2008-10#1)
what confidence##2##2##(1991-12#1)(2008-12#1)
what constitute##2##2##(1996-2#1)(2009-4#1)
what constitutes a good##2##4##(2010-10#1)(2012-2#1)
what constitutes a##4##3##(1992-9#1)(1995-2#1)(2010-10#1)(2012-2#1)
what constitutes an##2##3##(2010-12#1)(2013-1#1)
what constitutes##13##2##(1992-9#1)(1994-12#1)(1995-2#2)(1995-3#1)(2009-5#1)(2010-10#2)(2010-12#1)(2012-2#1)(2013-1#3)
what consumers##2##2##(1991-2#1)(2008-12#1)
what could be##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
what could##4##2##(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
what do##8##2##(1994-12#2)(1994-3#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2013-1#1)
what does it##4##3##(2008-7#1)(2012-12#2)(2013-8#1)
what does the##2##3##(2008-11#1)(2012-3#1)
what does##13##2##(1992-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-12#2)(2012-3#1)(2013-8#2)
what each##2##2##(1996-2#1)(2011-2#1)
what employers##2##2##(1996-2#1)(2008-6#1)
what equipment##2##2##(1994-6#1)(1997-2#1)
what evidence there is##2##4##(1997-5#1)(2008-8#1)
what exactly is##2##3##(1997-3#1)(2009-9#1)
what exactly##3##2##(1997-3#1)(2008-5#1)(2009-9#1)
what extent is##2##3##(2009-8#1)(2011-2#1)
what extent##30##2##(1992-1#1)(1992-12#1)(1992-5#1)(1994-3#1)(1995-6#2)(1996-12#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)
what factors are##2##3##(1994-12#1)(2012-2#1)
what factors influence##2##3##(1996-1#1)(2013-8#1)
what factors##11##2##(1994-12#1)(1995-1#1)(1996-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
what had been##3##3##(2008-6#1)(2008-9#1)(2009-9#1)
what happened to##2##3##(2008-10#1)(2008-7#1)
what happens##3##2##(2008-12#1)(2008-6#1)(2008-7#1)
what has been found in##2##5##(2008-10#1)(2008-5#1)
what has been reported##2##4##(1990-8#1)(2010-4#1)
what has been##16##3##(1990-8#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
what has##20##2##(1990-8#1)(1992-3#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#1)
what have we##3##3##(1995-9#1)(2008-8#1)(2009-4#1)
what his##2##2##(2008-7#1)(2009-7#1)
what information##4##2##(1996-1#1)(1997-8#1)(2010-12#1)(2011-1#1)
what is a##2##3##(2007-7#1)(2008-7#1)
what is an##2##3##(1996-3#1)(2008-6#1)
what is being##2##3##(2008-11#1)(2010-1#1)
what is believed to be a novel##2##7##(2008-3#2)
what is believed to be a##3##6##(2007-11#1)(2008-3#2)
what is believed to be the first experimental observation of##2##10##(2007-11#1)(2007-12#1)
what is believed to be the first experimental##3##8##(2007-11#1)(2007-12#2)
what is believed to be the first observation of##4##9##(2007-11#1)(2007-12#3)
what is believed to be the first time##16##8##(2007-11#12)(2007-12#4)
what is believed to be the first##29##7##(2007-11#17)(2007-12#12)
what is believed to be the##30##6##(2007-11#18)(2007-12#12)
what is believed to be##34##5##(2007-11#20)(2007-12#12)(2008-3#2)
what is called##2##3##(1993-12#1)(2008-7#1)
what is considered##2##3##(2008-7#1)(2008-9#1)
what is currently known about##3##5##(2007-11#1)(2009-8#1)(2013-1#1)
what is currently##6##3##(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
what is expected##4##3##(1992-12#1)(1992-6#1)(2008-8#1)(2008-9#1)
what is happening##2##3##(1997-2#1)(2008-4#1)
what is it##2##3##(1996-1#1)(2012-12#1)
what is known about the##9##5##(1994-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2013-1#1)
what is known about##13##4##(1992-1#1)(1994-9#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
what is known##16##3##(1992-1#1)(1994-9#1)(1995-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
what is meant by &quot##2##5##(1995-6#1)(2012-1#1)
what is meant by##4##4##(1995-6#1)(2008-12#1)(2008-8#1)(2012-1#1)
what is observed##3##3##(1995-12#1)(1995-3#1)(2012-3#1)
what is possible##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
what is required to##2##4##(2008-10#1)(2008-11#1)
what is seen##3##3##(2008-11#1)(2008-12#2)
what is the impact##2##4##(1994-3#1)(2008-7#1)
what is the##15##3##(1991-12#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#2)
what is to our knowledge a##2##6##(2007-12#2)
what is to our knowledge the first demonstration of##2##9##(2007-11#1)(2007-12#1)
what is to our knowledge the first experimental##5##8##(2007-11#1)(2007-12#3)(2008-3#1)
what is to our knowledge the first time##7##8##(2007-12#6)(2008-3#1)
what is to our knowledge the first##33##7##(2007-11#11)(2007-12#16)(2008-2#3)(2008-3#3)
what is to our knowledge the##35##6##(2007-11#12)(2007-12#17)(2008-2#3)(2008-3#3)
what is to our knowledge##37##5##(2007-11#12)(2007-12#19)(2008-2#3)(2008-3#3)
what is to##40##3##(2007-11#12)(2007-12#19)(2008-2#5)(2008-3#3)(2012-3#1)
what is##200##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#9)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-11#37)(2007-12#32)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#11)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#7)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#5)(2013-1#9)(2013-8#1)
what it has##2##3##(2008-11#1)(2010-12#1)
what it is##4##3##(2008-1#2)(2008-7#1)(2009-10#1)
what it means to the##2##5##(1991-1#1)(2008-5#1)
what it means to##6##4##(1991-1#1)(1996-12#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
what it means##7##3##(1991-1#1)(1996-12#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#2)
what it takes to##2##4##(1993-12#1)(2008-7#1)
what it##24##2##(1990-11#1)(1991-1#1)(1993-12#1)(1995-1#1)(1996-12#1)(2008-1#5)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#2)(2013-1#2)
what kind of##7##3##(1994-6#1)(1995-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
what level of##2##3##(1993-1#1)(2008-1#1)
what makes it##2##3##(2008-10#1)(2013-7#1)
what makes them##2##3##(2008-10#1)(2011-2#1)
what makes##7##2##(1996-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
what many refer to as##2##5##(2011-2#1)(2012-12#1)
what many##3##2##(2011-2#1)(2012-12#2)
what may be##3##3##(1993-8#1)(2008-1#1)(2009-8#1)
what may##10##2##(1992-8#1)(1993-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(2007-11#1)(2008-1#1)(2009-3#1)(2009-8#1)(2013-1#1)
what might be##3##3##(1991-12#1)(2008-7#1)(2009-7#1)
what might##5##2##(1991-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-7#1)
what nurse educators##2##3##(2012-3#2)
what one##4##2##(1995-1#1)(1995-11#1)(2008-12#1)(2009-11#1)
what percentage of##2##3##(2007-12#1)(2011-2#1)
what role##6##2##(1993-12#1)(1995-1#1)(1997-8#1)(2008-11#1)(2008-4#1)(2009-7#1)
what seems##3##2##(1991-3#1)(2008-2#1)(2009-5#1)
what should##5##2##(1991-3#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-12#1)
what the facility should##2##4##(1994-12#2)
what the health services##2##4##(1990-8#2)
what the public##2##3##(2008-10#1)(2013-1#1)
what the##29##2##(1990-2#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-2#1)(1994-12#3)(1996-1#1)(1997-3#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
what their##7##2##(1994-12#1)(1995-1#1)(2007-2#1)(2008-3#2)(2010-1#1)(2012-12#1)
what these##3##2##(2008-5#1)(2009-5#1)(2010-10#1)
what they believe is##2##4##(1995-1#1)(2012-3#1)
what they can##2##3##(2008-12#1)(2009-9#1)
what they do##3##3##(1992-12#1)(1995-1#1)(1995-2#1)
what they have##2##3##(1994-12#1)(1996-11#1)
what they want##2##3##(1994-12#1)(1996-8#1)
what they wanted##2##3##(2009-5#1)(2011-2#1)
what they##35##2##(1992-11#1)(1992-12#3)(1994-12#4)(1995-1#2)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
what to our knowledge is a new##3##7##(2008-3#3)
what to our knowledge is a novel optical##2##8##(2008-3#2)
what to our knowledge is a novel##4##7##(2008-2#1)(2008-3#3)
what to our knowledge is a##7##6##(2008-2#1)(2008-3#6)
what to watch out##2##4##(1995-12#1)(1997-2#1)
what to##17##2##(1994-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#7)(2010-5#1)
what tobacco##2##2##(1990-2#1)(2009-7#1)
what type of##3##3##(1990-10#1)(2008-12#1)(2010-5#1)
what was considered a##2##4##(2008-3#1)(2009-7#1)
what was expected##2##3##(1993-3#1)(2008-8#1)
what was##12##2##(1993-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
what we believe are the first##2##6##(2007-12#2)
what we believe is a new##8##6##(2008-3#8)
what we believe is a novel##3##6##(2008-3#3)
what we believe is a##11##5##(2008-3#11)
what we believe is the first##7##6##(2007-12#3)(2008-2#1)(2008-3#3)
what we believe is##18##4##(2007-12#3)(2008-2#1)(2008-3#14)
what we believe to be a novel method##2##8##(2008-3#2)
what we believe to be a novel##6##7##(2007-11#1)(2008-3#5)
what we believe to be a##7##6##(2007-11#1)(2008-3#6)
what we believe to be the first application of##2##9##(2007-12#1)(2008-3#1)
what we believe to be the first##12##7##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#4)
what we believe to be##21##5##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#11)(2008-9#1)
what we believe##41##3##(2007-11#2)(2007-12#11)(2008-2#2)(2008-3#25)(2008-9#1)
what we call##3##3##(2008-10#1)(2009-10#1)(2009-9#1)
what we can do##2##4##(1992-3#1)(2008-11#1)
what we do with what we know##2##7##(2010-10#2)
what we do##3##3##(2010-10#2)(2010-12#1)
what we have##2##3##(2008-9#1)(2010-12#1)
what we know about##3##4##(1994-1#1)(1996-2#1)(2013-1#1)
what we know and##2##4##(2009-5#1)(2010-12#1)
what we know##9##3##(1992-3#1)(1994-1#1)(1995-3#1)(1996-2#1)(2009-5#1)(2010-10#2)(2010-12#1)(2013-1#1)
what we need to do##2##5##(2008-4#1)(2012-12#1)
what we need to##3##4##(2008-4#1)(2012-12#1)(2013-1#1)
what we previously##2##3##(1991-8#1)(2010-2#1)
what we term the##2##4##(2008-8#1)(2009-9#1)
what we##76##2##(1991-12#1)(1991-8#1)(1992-3#2)(1994-1#2)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-11#3)(2007-12#11)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#25)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-12#3)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
what were the##2##3##(1993-3#1)(2011-2#1)
what will be a##2##4##(2012-12#2)
what will be##3##3##(1991-12#1)(2012-12#2)
what will##8##2##(1991-12#1)(1993-3#1)(1997-1#1)(2008-1#1)(2008-12#2)(2012-12#2)
what works and what does not##2##6##(1992-12#1)(2007-7#1)
what works##5##2##(1992-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)
what would be expected##4##4##(1992-6#1)(2008-6#1)(2008-7#2)
what would be##8##3##(1992-6#1)(1993-12#1)(2007-12#2)(2008-6#1)(2008-7#2)(2009-7#1)
what would##11##2##(1992-6#1)(1993-12#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-7#1)
what you don't##2##3##(1994-2#1)(2009-5#1)
what you##5##2##(1994-2#2)(1994-3#1)(2009-5#2)
what your##2##2##(1995-2#1)(2008-12#1)
what##889##1##(1990-10#3)(1990-11#1)(1990-2#4)(1990-5#1)(1990-8#5)(1991-1#4)(1991-12#7)(1991-2#7)(1991-3#12)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#6)(1993-8#1)(1994-1#10)(1994-12#16)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#10)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#4)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#5)(1996-12#4)(1996-2#9)(1996-3#13)(1996-6#3)(1996-8#2)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#45)(2007-12#54)(2007-2#4)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#12)(2008-10#30)(2008-11#44)(2008-12#24)(2008-2#19)(2008-3#49)(2008-4#14)(2008-5#10)(2008-6#12)(2008-7#30)(2008-8#21)(2008-9#21)(2009-10#5)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#10)(2009-6#2)(2009-7#9)(2009-8#7)(2009-9#9)(2010-1#3)(2010-10#13)(2010-11#1)(2010-12#10)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#5)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#28)(2012-1#10)(2012-12#21)(2012-2#12)(2012-3#21)(2012-7#1)(2013-1#29)(2013-7#5)(2013-8#11)
what&quot##4##1##(1994-2#1)(2008-5#1)(2009-2#1)(2013-8#1)
what's not##3##2##(2007-12#1)(2007-9#1)(2008-4#1)
what's##10##1##(1991-1#1)(1996-11#1)(1997-1#1)(2007-12#1)(2007-9#2)(2008-1#2)(2008-4#1)(2012-12#1)
whatever the time period##2##4##(2009-2#2)
whatever the##9##2##(1997-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2013-1#1)
whatever their##3##2##(1993-12#1)(2006-12#1)(2008-7#1)
whatever##22##1##(1991-12#1)(1991-3#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-5#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2010-5#1)(2013-1#1)
whatsoever##3##1##(1992-1#1)(1996-6#1)(2008-7#1)
whcih##2##1##(2007-11#1)(2007-8#1)
wheal##2##1##(1990-7#1)(2008-5#1)
wheals##3##1##(2010-6#3)
wheat (T##3##2##(2008-10#2)(2012-3#1)
wheat (Triticum aestivum L##5##4##(2008-11#1)(2008-12#2)(2008-5#2)
wheat (Triticum aestivum##6##3##(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)
wheat (Triticum aestivum) and##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
wheat (Triticum aestivum) worldwide##2##4##(2008-10#2)
wheat (Triticum aestivum)##12##3##(2008-10#9)(2008-11#1)(2008-12#1)(2008-9#1)
wheat (Triticum and Aegilops spp##2##5##(2008-10#2)
wheat (Triticum##23##2##(2008-10#14)(2008-11#2)(2008-12#3)(2008-5#2)(2008-9#1)(2012-3#1)
wheat DH##3##2##(2008-8#3)
wheat DHs##2##2##(2008-8#2)
wheat and barley##10##3##(1992-8#1)(2008-10#8)(2008-8#1)
wheat and corn##2##3##(2008-10#2)
wheat and to##2##3##(1990-3#1)(2008-10#1)
wheat and wild##3##3##(2008-10#3)
wheat and##30##2##(1990-3#1)(1992-8#1)(2008-10#24)(2008-11#1)(2008-5#1)(2008-8#2)
wheat are##3##2##(2008-10#3)
wheat bran and##2##3##(1993-11#1)(1997-2#1)
wheat bran##8##2##(1993-11#3)(1997-2#1)(1997-8#1)(2008-10#3)
wheat breeding programs##3##3##(2008-10#3)
wheat breeding##4##2##(2008-10#4)
wheat bugs##5##2##(2013-8#5)
wheat by##4##2##(2008-10#3)(2008-5#1)
wheat canopies##2##2##(2008-10#2)
wheat chromosome 1B##2##3##(2008-10#2)
wheat chromosome##10##2##(2008-10#7)(2008-5#2)(2008-9#1)
wheat chromosomes##8##2##(2008-5#5)(2008-8#2)(2008-9#1)
wheat crop##4##2##(2008-10#3)(2008-12#1)
wheat cropping##2##2##(2008-10#1)(2013-8#1)
wheat cultivar that has been##2##5##(2008-10#2)
wheat cultivar##10##2##(2008-10#10)
wheat cultivar-specific##3##2##(2008-10#3)
wheat cultivars and##3##3##(2008-10#3)
wheat cultivars differing in##2##4##(2008-10#1)(2008-12#1)
wheat cultivars in the##2##4##(2008-10#2)
wheat cultivars in##3##3##(2008-10#3)
wheat cultivars than in##2##4##(2008-10#2)
wheat cultivars were##2##3##(2008-10#2)
wheat cultivars with##3##3##(2008-10#2)(2011-10#1)
wheat cultivars##36##2##(2008-10#30)(2008-12#5)(2011-10#1)
wheat cultivation##2##2##(2008-10#2)
wheat cv##9##2##(2008-10#9)
wheat cvs##3##2##(2008-10#3)
wheat debris##2##2##(2008-10#2)
wheat differential##2##2##(2008-10#2)
wheat farming with##2##3##(2008-12#2)
wheat farming##3##2##(2008-12#3)
wheat fields in eastern##2##4##(2008-10#2)
wheat fields in##4##3##(2008-10#3)(2013-8#1)
wheat fields##10##2##(2008-10#9)(2013-8#1)
wheat flour with##2##3##(2008-10#2)
wheat flour##16##2##(2008-10#12)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
wheat for##2##2##(2008-10#2)
wheat from Hessian##2##3##(2011-2#2)
wheat from the##2##3##(2008-10#1)(2013-7#1)
wheat from##13##2##(2008-10#10)(2011-2#2)(2013-7#1)
wheat genotypes was##2##3##(2008-10#2)
wheat genotypes##19##2##(2008-10#17)(2008-12#1)(2012-3#1)
wheat germ agglutinin (WGA)##3##4##(1991-12#1)(1994-11#1)(2008-7#1)
wheat germ agglutinin##11##3##(1991-12#2)(1992-6#3)(1993-6#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#2)
wheat germ agglutinin/ovomucoid-gold complex##3##4##(2008-10#3)
wheat germ extract##2##3##(2008-9#2)
wheat germ lectin##2##3##(1990-11#1)(1993-8#1)
wheat germ plasm##2##3##(2008-10#2)
wheat germ##26##2##(1990-11#1)(1990-12#1)(1991-12#3)(1992-6#3)(1993-6#1)(1993-8#1)(1994-11#1)(1997-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)
wheat gluten##2##2##(2008-10#1)(2008-11#1)
wheat grain##6##2##(2008-10#5)(2008-12#1)
wheat grains##2##2##(2008-10#2)
wheat grown in a##2##4##(2008-10#2)
wheat grown in##3##3##(2008-10#3)
wheat grown##4##2##(2008-10#3)(2008-12#1)
wheat heads##2##2##(2008-10#2)
wheat in Europe##2##3##(2012-2#2)
wheat in France##2##3##(2008-10#1)(2008-8#1)
wheat in North America##2##4##(2008-10#2)
wheat in the##4##3##(2008-10#3)(2011-2#1)
wheat in##21##2##(2008-10#14)(2008-8#3)(2011-2#1)(2012-2#2)(2013-8#1)
wheat infected##2##2##(2008-10#2)
wheat is##7##2##(2008-10#7)
wheat kernels##2##2##(2008-10#1)(2008-12#1)
wheat leaf and##2##3##(2008-10#2)
wheat leaf rust severity##2##4##(2008-10#2)
wheat leaf rust##14##3##(2008-10#14)
wheat leaf##17##2##(2008-10#17)
wheat leaves##7##2##(2008-10#7)
wheat line##6##2##(2008-10#5)(2008-8#1)
wheat lines and##2##3##(2008-10#2)
wheat lines with##2##3##(2008-10#1)(2008-8#1)
wheat lines##17##2##(2008-10#16)(2008-8#1)
wheat may be##2##3##(2008-10#1)(2011-10#1)
wheat microsatellite##2##2##(2008-5#2)
wheat mosaic virus (SBWMV)##3##4##(2008-10#2)(2008-8#1)
wheat mosaic virus##7##3##(2008-10#3)(2008-8#4)
wheat mosaic##8##2##(2008-10#4)(2008-8#4)
wheat or##3##2##(2008-10#2)(2010-1#1)
wheat over##2##2##(2008-10#2)
wheat particles##2##2##(2008-8#2)
wheat pathogen##2##2##(2008-10#2)
wheat planting##2##2##(2008-10#2)
wheat plants was##2##3##(2008-10#1)(2008-12#1)
wheat plants were##2##3##(2008-10#2)
wheat plants##14##2##(2008-10#8)(2008-12#5)(2011-10#1)
wheat powdery mildew##5##3##(2008-10#5)
wheat production with##2##3##(2008-12#2)
wheat production##7##2##(2008-10#2)(2008-12#5)
wheat protein fractions##2##3##(1991-12#2)
wheat protein##4##2##(1991-12#2)(2008-11#1)(2008-5#1)
wheat resistance to##2##3##(2008-10#2)
wheat roots##2##2##(2008-10#2)
wheat rust##2##2##(2008-10#2)
wheat samples were##2##3##(2008-10#2)
wheat samples##5##2##(2008-10#5)
wheat seed##5##2##(2008-10#2)(2008-12#3)
wheat seedlings##4##2##(2008-10#4)
wheat seeds##2##2##(2008-10#1)(2008-12#1)
wheat species##2##2##(2008-12#2)
wheat spikes##5##2##(2008-10#5)
wheat spindle streak mosaic##2##4##(2008-10#1)(2008-8#1)
wheat starch##6##2##(1991-12#2)(2008-7#3)(2010-8#1)
wheat stem##2##2##(2008-10#2)
wheat stillage##2##2##(2011-2#2)
wheat straw##2##2##(2008-10#1)(2011-1#1)
wheat streak mosaic virus##3##4##(2008-10#3)
wheat streak mosaic##4##3##(2008-10#4)
wheat stripe rust##9##3##(2008-10#9)
wheat stubble##2##2##(2008-10#2)
wheat than##3##2##(2008-10#3)
wheat that##5##2##(2008-10#5)
wheat tissues##2##2##(2008-10#2)
wheat to##6##2##(2008-10#3)(2010-6#1)(2011-2#2)
wheat treated with##2##3##(2008-10#1)(2008-12#1)
wheat type (spring versus winter wheat)##2##6##(2008-10#2)
wheat type##3##2##(2008-10#3)
wheat under##2##2##(2008-10#1)(2008-12#1)
wheat using##2##2##(2008-10#2)
wheat was##9##2##(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#1)
wheat were##5##2##(2008-10#5)
wheat with##4##2##(2008-10#3)(2008-12#1)
wheat worldwide##5##2##(2008-10#4)(2011-10#1)
wheat yield##5##2##(2008-10#2)(2008-12#2)(2008-8#1)
wheat##776##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#10)(1992-12#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2008-1#2)(2008-10#561)(2008-11#9)(2008-12#46)(2008-4#1)(2008-5#26)(2008-7#5)(2008-8#33)(2008-9#10)(2009-12#3)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-10#6)(2011-2#13)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#12)
wheat) and##2##2##(2008-10#2)
wheat)##7##1##(2008-10#7)
wheat-cultivated##2##1##(2008-10#2)
wheat-dependent##2##1##(2010-6#2)
wheat-germ agglutinin and##2##3##(1995-11#2)
wheat-germ agglutinin##4##2##(1995-11#4)
wheat-germ##5##1##(1991-5#1)(1995-11#4)
wheat-growing region##2##2##(2008-10#2)
wheat-growing regions##4##2##(2008-10#4)
wheat-growing##9##1##(2008-10#9)
wheat-producing##2##1##(2008-10#2)
wheatgrass##6##1##(2008-10#3)(2008-8#3)
wheats##4##1##(2008-10#4)
wheel##2##1##(2008-3#1)(2008-7#1)
wheelchair and wheelchair passenger##2##4##(2013-1#2)
wheelchair and##3##2##(2013-1#3)
wheelchair passenger##4##2##(2013-1#4)
wheelchair##14##1##(2007-8#1)(2008-1#1)(2009-3#1)(2013-1#11)
wheeze and##2##2##(2010-4#1)(2012-3#1)
wheeze in##2##2##(1991-11#1)(2008-1#1)
wheeze##11##1##(1991-11#1)(2007-2#4)(2008-1#1)(2008-12#1)(2010-4#1)(2012-3#2)(2013-8#1)
wheezing illness##2##2##(2008-10#1)(2010-5#1)
wheezing##12##1##(1996-3#1)(2007-2#1)(2008-1#3)(2008-10#1)(2010-2#1)(2010-5#2)(2010-6#2)(2013-1#1)
wheezing/asthma##2##1##(2013-1#2)
when &quot##3##2##(1993-1#2)(1997-7#1)
when 0##4##2##(2008-10#2)(2008-8#1)(2010-5#1)
when 1##4##2##(1990-6#1)(2008-10#3)
when 11##2##2##(2008-10#1)(2012-12#1)
when 2##2##2##(1997-6#1)(2008-10#1)
when 50##2##2##(2008-10#1)(2008-11#1)
when A##2##2##(2008-10#1)(2008-6#1)
when AmB##2##2##(1997-2#2)
when Aspergillus##2##2##(2008-10#1)(2008-6#1)
when BRJ##2##2##(1994-6#2)
when C##3##2##(1990-8#1)(2008-10#1)(2011-1#1)
when Chl##2##2##(2008-3#2)
when Cu##2##2##(1995-3#2)
when Cx43##2##2##(2008-6#2)
when DL-propranolol was##2##3##(2008-9#2)
when DNA was##2##3##(2008-10#1)(2009-6#1)
when DNA##4##2##(2008-10#2)(2008-2#1)(2009-6#1)
when ER##2##2##(1995-2#1)(2008-7#1)
when ET was##2##3##(1994-9#2)
when HGF was added##3##4##(2008-11#3)
when HSF##2##2##(1990-11#1)(2008-5#1)
when Hb &lt##2##3##(1996-12#2)
when I was##4##3##(2008-10#1)(2008-2#1)(2010-8#1)(2013-7#1)
when I##6##2##(1992-3#1)(2008-10#1)(2008-2#1)(2010-8#1)(2010-9#1)(2013-7#1)
when L-NAME was##2##3##(1996-5#1)(1997-7#1)
when NaCl is##2##3##(1993-12#1)(2008-10#1)
when P##4##2##(2008-10#3)(2012-3#1)
when PCR##3##2##(2008-10#2)(2008-2#1)
when R##2##2##(2008-10#2)
when RIW credit##2##3##(1991-12#2)
when T##2##2##(2008-10#1)(2008-5#1)
when [L]/[M(+)]##2##2##(2008-10#2)
when a 0##2##3##(1997-8#1)(2008-10#1)
when a change##2##3##(2008-9#1)(2009-10#1)
when a child##3##3##(1991-8#1)(2008-10#1)(2008-11#1)
when a conventional##2##3##(2007-11#1)(2008-7#1)
when a free##2##3##(1990-9#1)(2012-12#1)
when a general satisfaction question appears##2##6##(1993-12#2)
when a grating is##2##4##(2008-3#2)
when a group##3##3##(1990-5#1)(1993-2#1)(1997-3#1)
when a high##2##3##(2008-10#1)(2008-8#1)
when a large volume##2##4##(1995-3#1)(2008-10#1)
when a large##4##3##(1995-3#1)(2008-10#2)(2008-3#1)
when a mixture of##3##4##(1992-6#1)(2008-2#1)(2013-1#1)
when a more##2##3##(2009-10#1)(2013-1#1)
when a plane##2##3##(2008-3#2)
when a prolonged##2##3##(2008-10#1)(2011-2#1)
when a sample##2##3##(2008-10#2)
when a single##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
when a small number of##2##5##(2008-11#1)(2008-3#1)
when a small##4##3##(2007-12#2)(2008-11#1)(2008-3#1)
when a##179##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-5#2)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-8#4)(2007-11#5)(2007-12#7)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#33)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#23)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
when absolutely##2##2##(2008-3#1)(2012-12#1)
when absorption##2##2##(2008-3#2)
when access to##2##3##(1992-2#1)(1993-6#1)
when accompanied##2##2##(2008-11#1)(2011-2#1)
when accounting for##2##3##(2007-4#1)(2012-2#1)
when actin##2##2##(1991-5#1)(2012-2#1)
when activated##4##2##(1995-11#1)(2008-10#1)(2008-4#1)(2009-6#1)
when active##3##2##(1994-2#1)(2008-10#1)(2011-10#1)
when added to the##4##4##(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
when added to##7##3##(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-7#1)
when added##11##2##(1990-5#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-7#1)
when additional##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
when addressing##4##2##(2008-12#2)(2008-7#1)(2011-2#1)
when administered alone##2##3##(1997-4#1)(2011-2#1)
when administered in the##2##4##(1997-4#1)(2013-7#1)
when administered in##7##3##(1997-4#1)(2008-5#2)(2011-2#1)(2013-7#2)(2013-8#1)
when administered to##4##3##(1994-2#1)(2007-8#1)(2009-4#1)(2013-1#1)
when administered with##2##3##(2007-11#1)(2008-11#1)
when administered##23##2##(1994-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-4#3)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
when administering##3##2##(2007-10#1)(2008-6#1)(2012-12#1)
when adsorbed on##2##3##(2008-10#2)
when age was##2##3##(2011-1#2)
when air##2##2##(2008-10#2)
when all of##2##3##(2008-4#1)(2013-8#1)
when all the##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
when all##18##2##(1992-3#1)(1993-12#1)(1993-9#1)(1996-5#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#2)
when an appropriate##2##3##(2008-10#2)
when an object is located inside a scattering medium##2##9##(2008-3#2)
when an object##3##3##(2008-3#3)
when an##27##2##(1993-12#2)(1996-12#1)(1996-3#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-9#1)(2012-3#3)
when analysing a##2##3##(1997-4#1)(2008-10#1)
when analysing##4##2##(1994-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
when analyzed by##3##3##(1991-12#1)(2010-5#1)(2011-1#1)
when analyzed##5##2##(1991-12#1)(1993-11#1)(1995-2#1)(2010-5#1)(2011-1#1)
when analyzing##6##2##(1993-3#1)(2008-10#3)(2008-4#1)(2008-8#1)
when and how to##3##4##(1991-6#1)(2008-9#1)(2009-8#1)
when and how##9##3##(1991-6#1)(1994-3#1)(1997-5#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-2#1)
when and where##4##3##(1992-3#1)(1994-2#1)(2010-9#1)(2012-2#1)
when and##15##2##(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-5#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
when animals were##2##3##(1993-6#1)(1997-1#1)
when animals##3##2##(1993-6#1)(1997-1#1)(2008-11#1)
when aphids were fed on source plants containing##2##8##(2008-10#2)
when applied as##2##3##(2008-10#1)(2008-3#1)
when applied at##2##3##(2008-10#1)(2012-8#1)
when applied in combination with##2##5##(2008-10#2)
when applied in the##2##4##(1991-12#1)(2008-10#1)
when applied in##6##3##(1991-12#1)(1995-12#1)(2008-10#4)
when applied to normal##2##4##(2008-11#1)(2008-5#1)
when applied to patients with##2##5##(2008-1#1)(2008-12#1)
when applied to the##3##4##(1993-3#1)(2008-10#2)
when applied to##26##3##(1993-3#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#2)(2013-8#2)
when applied##49##2##(1991-12#1)(1993-3#1)(1995-12#2)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#2)(2012-3#1)(2012-8#1)(2013-8#2)
when applying a##2##3##(2008-5#2)
when applying the##2##3##(2008-2#1)(2008-4#1)
when applying##8##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-4#1)(2012-2#1)
when appropriate##6##2##(1993-12#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)
when asked##2##2##(2008-11#1)(2012-2#1)
when assayed in the presence of##3##6##(1990-10#1)(1992-11#1)(1992-3#1)
when assayed in##7##3##(1990-10#1)(1992-11#1)(1992-3#1)(1995-11#1)(1995-2#2)(2012-12#1)
when assayed##11##2##(1990-10#1)(1990-12#1)(1992-11#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(2008-10#1)(2008-11#1)(2012-12#1)
when assessed##5##2##(1995-12#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
when assessing a child with##2##5##(2008-10#1)(2010-7#1)
when assessing the##4##3##(1992-3#1)(1996-9#1)(2008-3#1)(2008-8#1)
when assessing##9##2##(1992-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#1)
when associated with##4##3##(1994-6#1)(2007-5#1)(2008-8#1)(2011-2#1)
when associated##5##2##(1994-6#1)(2007-5#1)(2008-5#1)(2008-8#1)(2011-2#1)
when attempting to##10##3##(1995-3#1)(1997-3#1)(2007-7#1)(2008-4#3)(2008-7#2)(2009-1#1)(2011-2#1)
when attitude objects are temporally distant vs##2##7##(2009-11#2)
when available##7##2##(1995-12#1)(2007-4#1)(2008-2#2)(2008-5#1)(2009-7#1)(2011-1#1)
when averaged##2##2##(2008-3#1)(2011-2#1)
when avirulent strains##2##3##(2008-10#2)
when bacteria##2##2##(1996-12#1)(2008-5#1)
when beginning##2##2##(2013-1#1)(2013-8#1)
when both the##2##3##(1995-12#1)(2008-11#1)
when both##23##2##(1995-12#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-9#1)(2010-9#1)(2011-10#1)(2012-12#1)(2012-3#1)(2012-7#1)
when bound to##3##3##(1991-10#1)(1991-5#1)(1993-3#1)
when calculated##2##2##(2008-10#1)(2008-3#1)
when calculating the##2##3##(2008-10#1)(2008-3#1)
when calculating##5##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
when caring for##2##3##(2010-3#1)(2013-1#1)
when carried out in##2##4##(2008-2#1)(2008-7#1)
when carried out##3##3##(1990-9#1)(2008-2#1)(2008-7#1)
when cell##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
when cells are stimulated##2##4##(1990-12#1)(2008-4#1)
when cells are##3##3##(1990-12#1)(2008-4#1)(2009-12#1)
when cells were exposed to##2##5##(1992-5#1)(2008-10#1)
when cells were##8##3##(1992-5#1)(1993-6#1)(1995-9#1)(1997-7#1)(2008-10#3)(2008-11#1)
when cells##14##2##(1990-12#1)(1992-5#1)(1993-6#1)(1995-9#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2009-12#1)
when certain##2##2##(2008-10#1)(2008-9#1)
when challenged by##2##3##(2008-10#1)(2008-7#1)
when challenged with##6##3##(1991-8#1)(1991-9#1)(2008-10#2)(2008-12#1)(2012-2#1)
when challenged##9##2##(1991-8#1)(1991-9#1)(2008-10#3)(2008-12#1)(2008-7#2)(2012-2#1)
when changes##2##2##(1996-7#1)(2013-8#1)
when changing##2##2##(1993-2#1)(2008-2#1)
when chicks were##2##3##(1997-6#2)
when children were##2##3##(2009-10#2)
when choosing a##4##3##(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)
when choosing##11##2##(1993-12#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
when clinical##2##2##(1997-8#1)(2007-11#1)
when cloacal##2##2##(1996-12#2)
when coated##2##2##(1997-3#1)(2009-5#1)
when cocultured with##2##3##(1995-2#1)(2008-7#1)
when coinoculated with##2##3##(2008-10#2)
when coinoculated##4##2##(2008-10#4)
when collecting##2##2##(2008-10#1)(2008-2#1)
when combined with a##2##4##(1996-12#1)(2008-7#1)
when combined with the##4##4##(1996-2#1)(2008-2#1)(2010-2#2)
when combined with##27##3##(1992-3#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#2)(2011-1#1)(2012-12#1)(2013-8#1)
when combined##28##2##(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#2)(2011-1#1)(2012-12#1)(2013-8#1)
when communicating##2##2##(2010-4#1)(2012-1#1)
when compared to CD##2##4##(2013-8#2)
when compared to a##3##4##(2007-7#1)(2008-10#2)
when compared to bare metal stents##2##6##(2008-11#1)(2008-12#1)
when compared to cells##2##4##(1992-8#1)(2008-11#1)
when compared to control##4##4##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
when compared to controls##4##4##(2008-1#1)(2008-12#2)(2009-3#1)
when compared to infection with##2##5##(2008-7#2)
when compared to normal##4##4##(1991-9#1)(1992-8#1)(1993-11#1)(2008-7#1)
when compared to other##2##4##(2008-10#1)(2013-7#1)
when compared to solvent extraction##2##5##(2008-10#2)
when compared to that of##2##5##(1997-7#1)(2008-10#1)
when compared to that##3##4##(1994-5#1)(1997-7#1)(2008-10#1)
when compared to the control group##2##6##(2010-7#1)(2012-2#1)
when compared to the control##4##5##(2008-12#1)(2010-7#1)(2012-2#1)(2013-7#1)
when compared to the reference##2##5##(2008-10#1)(2008-12#1)
when compared to the##41##4##(1990-6#1)(1991-2#1)(1991-5#1)(1993-1#1)(1993-6#1)(1994-8#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-7#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-7#4)(2009-10#1)(2009-6#1)(2010-7#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-7#2)
when compared to their##4##4##(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
when compared to those##4##4##(1995-12#1)(2008-10#1)(2008-7#2)
when compared to untreated##2##4##(1995-3#1)(2008-10#1)
when compared to##137##3##(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#15)(2008-12#10)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#3)(2009-8#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#4)(2013-8#5)
when compared with a##7##4##(2008-10#4)(2008-2#1)(2008-7#1)(2011-2#1)
when compared with control##3##4##(1990-7#1)(2007-3#1)(2008-11#1)
when compared with controls##2##4##(2008-10#1)(2008-7#1)
when compared with conventional##3##4##(1991-5#1)(2008-10#2)
when compared with data##2##4##(2008-1#1)(2008-10#1)
when compared with healthy##2##4##(1991-7#1)(2012-1#1)
when compared with other##5##4##(1995-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
when compared with patients with##2##5##(2011-2#1)(2012-3#1)
when compared with the control##5##5##(1997-6#1)(2008-10#2)(2008-5#1)(2010-12#1)
when compared with the standard##2##5##(2008-10#2)
when compared with the##36##4##(1990-12#1)(1991-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-7#1)(2008-10#14)(2008-2#1)(2008-5#3)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)
when compared with their##3##4##(1997-4#1)(2008-3#1)(2013-8#1)
when compared with those##2##4##(1990-11#1)(2010-4#1)
when compared with##136##3##(1990-11#1)(1990-12#2)(1990-7#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#4)(2008-5#8)(2008-7#6)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
when compared##276##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-7#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1996-12#3)(1996-2#3)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#61)(2008-11#22)(2008-12#15)(2008-2#3)(2008-3#4)(2008-5#13)(2008-6#1)(2008-7#16)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#4)(2013-8#7)
when comparing all##2##3##(1996-2#1)(2009-2#1)
when comparing between##2##3##(2008-9#2)
when comparing the##7##3##(1996-3#1)(2008-10#3)(2008-8#2)(2012-3#1)
when comparing##23##2##(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#7)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2011-1#1)(2012-3#2)
when competing##2##2##(1990-7#1)(2012-3#1)
when competition between##2##3##(2008-8#1)(2009-10#1)
when competition was##2##3##(2008-8#2)
when competition##5##2##(2008-8#4)(2009-10#1)
when complexed to##2##3##(1990-2#1)(2008-10#1)
when complexed with##3##3##(1992-3#1)(1994-3#1)(2008-10#1)
when complexed##5##2##(1990-2#1)(1992-3#1)(1994-3#1)(2008-10#2)
when complexity of disease was considered##2##6##(1995-3#2)
when concentrated H(2)SO(4)##2##3##(2008-10#2)
when concentration of##2##3##(2008-11#1)(2011-2#1)
when concentration##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
when concentrations of##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
when concentrations##4##2##(1990-7#1)(2008-10#1)(2008-6#1)(2010-5#1)
when conditioned##2##2##(2008-11#2)
when conditions##2##2##(2008-10#2)
when conducting##2##2##(2008-9#1)(2009-10#1)
when confronted by##2##3##(1994-3#1)(2008-10#1)
when confronted with##2##3##(1992-2#1)(2008-7#1)
when confronted##4##2##(1992-2#1)(1994-3#1)(2008-10#1)(2008-7#1)
when conservative aa##2##3##(1991-6#1)(1993-2#1)
when conservative##4##2##(1991-6#1)(1993-2#1)(1997-8#1)(2008-10#1)
when considered##2##2##(2008-7#1)(2011-2#1)
when considering the##2##3##(2008-6#1)(2012-8#1)
when considering##13##2##(1995-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-8#1)(2013-8#2)
when controlling for##2##3##(2012-2#1)(2013-8#1)
when conventional##5##2##(1994-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-8#1)
when cooperation##2##2##(2008-8#2)
when copper##2##2##(2008-5#2)
when corrected for##2##3##(1995-3#1)(2007-11#1)
when coupled with a##2##4##(2008-11#1)(2008-3#1)
when coupled with##4##3##(1995-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
when coupled##5##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
when crossed with##2##3##(2008-10#2)
when cultivated##3##2##(2008-11#3)
when cultured in the presence of##3##6##(2008-11#1)(2008-4#1)(2008-6#1)
when cultured in the##4##4##(2008-11#2)(2008-4#1)(2008-6#1)
when cultured in##9##3##(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#2)(2012-4#1)
when cultured with##2##3##(1993-8#1)(2008-11#1)
when cultured##12##2##(1993-8#1)(2008-11#6)(2008-4#1)(2008-6#1)(2008-7#2)(2012-4#1)
when cultures were##2##3##(1990-12#1)(2011-2#1)
when cultures##3##2##(1990-12#1)(2010-3#1)(2011-2#1)
when daily##2##2##(1992-9#1)(2008-10#1)
when data are##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
when data##5##2##(1995-12#1)(2008-10#1)(2009-11#1)(2009-9#1)(2011-2#1)
when day shifts were supported##2##5##(2010-6#2)
when dealing with##9##3##(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#1)
when deciding to##2##3##(2008-10#1)(2008-7#1)
when deciding##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
when delivered alone##2##3##(1994-2#1)(2009-5#1)
when delivered by##2##3##(1994-12#1)(1996-2#1)
when delivered##5##2##(1994-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(2009-5#1)
when describing##2##2##(2008-1#1)(2012-2#1)
when designing a##4##3##(1997-3#1)(2010-8#2)(2011-2#1)
when designing an##2##3##(2008-4#1)(2008-9#1)
when designing##10##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#2)(2011-1#2)(2011-2#1)
when desired##2##2##(2008-5#1)(2012-12#1)
when determined##2##2##(2008-10#1)(2008-11#1)
when determining 0##2##3##(2008-10#2)
when determining the##4##3##(1993-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
when determining##12##2##(1993-12#1)(1993-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#1)
when developed##3##2##(1993-1#1)(2008-10#2)
when developing a##2##3##(2008-10#1)(2012-2#1)
when developing##9##2##(2008-10#3)(2008-11#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
when diagnosing##2##2##(1992-9#1)(2012-3#1)
when dietitians##2##2##(1993-12#1)(1994-2#1)
when different##6##2##(2008-10#4)(2008-3#1)(2009-11#1)
when directly##2##2##(1997-4#1)(2008-11#1)
when discussing the##2##3##(2008-10#1)(2010-3#1)
when discussing##4##2##(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)
when disease##7##2##(2008-10#5)(2010-7#1)(2012-1#1)
when drug##2##2##(2007-7#1)(2011-2#1)
when drugs##2##2##(1991-2#1)(1997-4#1)
when each should be##2##4##(1992-12#1)(2008-4#1)
when each volunteer received a single dose of 5 mg zolpidem and##2##11##(2011-2#2)
when each##9##2##(1992-12#1)(1996-2#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)
when early##3##2##(2007-12#1)(2007-8#1)(2008-5#1)
when either sufficient or no##2##5##(2008-2#1)(2008-3#1)
when either the##3##3##(2007-10#1)(2008-2#1)(2008-4#1)
when either##15##2##(1991-12#1)(1992-10#1)(1992-12#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)
when electrophoresis was performed##2##4##(2008-5#2)
when elevated##3##2##(1990-12#1)(2011-2#1)(2012-7#1)
when employing##2##2##(1995-1#1)(1996-5#1)
when encountering##2##2##(2009-9#1)(2012-12#1)
when endonuclease III was##2##4##(1995-2#2)
when endoscopic##2##2##(1997-8#1)(2008-5#1)
when energized with##2##3##(1990-11#2)
when entering##2##2##(1993-3#1)(2012-3#1)
when environmental##2##2##(2008-10#1)(2008-8#1)
when establishing##2##2##(2008-4#1)(2010-1#1)
when estimating##2##2##(1997-7#1)(2010-8#1)
when evaluated##5##2##(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)
when evaluating##7##2##(1993-2#1)(1995-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
when evidence is##2##3##(1993-12#2)
when examined by##4##3##(2008-10#3)(2008-7#1)
when examined##8##2##(1994-5#1)(1997-3#1)(2008-10#5)(2008-7#1)
when examining##4##2##(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
when excited at##6##3##(1996-12#1)(2007-11#4)(2008-10#1)
when excited by##2##3##(1997-4#1)(2008-3#1)
when excited##10##2##(1996-12#1)(1997-4#1)(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
when excluding##2##2##(1997-3#1)(2008-10#1)
when experiments##2##2##(2008-10#2)
when exposed to a##3##4##(2008-11#1)(2008-2#1)(2009-4#1)
when exposed to##19##3##(1990-11#1)(1990-2#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#3)(2009-11#1)(2009-4#1)(2013-8#1)
when exposed##23##2##(1990-11#1)(1990-2#1)(1994-12#1)(1997-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#3)(2009-11#1)(2009-4#1)(2013-8#1)
when exposure##2##2##(2008-10#1)(2008-7#1)
when expressed as a##2##4##(2007-12#1)(2009-6#1)
when expressed as##3##3##(2007-12#2)(2009-6#1)
when expressed in##8##3##(1991-2#1)(1991-9#1)(1992-10#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)
when expressed##16##2##(1991-2#1)(1991-9#1)(1992-10#1)(1995-2#2)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-8#1)
when expressing##2##2##(1995-6#1)(1997-3#1)
when extracellular##2##2##(1991-9#1)(1995-12#1)
when extrapolating##2##2##(2008-2#1)(2009-9#1)
when faced with a##3##4##(2008-10#1)(2010-8#1)(2011-2#1)
when faced with the##2##4##(2008-1#1)(2010-5#1)
when faced with##7##3##(1994-6#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)
when facing health##2##3##(1990-12#1)(2008-7#1)
when facing##5##2##(1990-12#1)(2008-7#2)(2009-5#1)(2013-8#1)
when feeding##3##2##(2008-6#1)(2008-9#1)(2009-4#1)
when females##3##2##(2008-6#1)(2008-9#2)
when few##3##2##(2008-10#2)(2008-9#1)
when figures##2##2##(2008-9#2)
when fluorescein##2##2##(1995-5#1)(2009-8#1)
when focusing on##2##3##(2007-12#2)
when followed by##2##3##(2010-6#1)(2011-1#1)
when free##2##2##(2007-11#1)(2008-10#1)
when frequency-doubled##2##2##(2008-3#2)
when fruit##2##2##(2008-10#2)
when fused to##3##3##(1991-10#1)(2008-6#1)(2010-10#1)
when fused##4##2##(1991-10#1)(2008-10#1)(2008-6#1)(2010-10#1)
when genetic##2##2##(2009-2#1)(2010-4#1)
when given 6 or##2##4##(1994-5#1)(1995-3#1)
when given as a##3##4##(1991-6#1)(1992-12#1)(2008-7#1)
when given orally or##2##4##(1992-12#1)(2008-5#1)
when given orally##3##3##(1992-12#1)(2006-10#1)(2008-5#1)
when given##19##2##(1991-6#1)(1992-10#1)(1992-12#2)(1992-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
when glucokinase was##2##3##(1990-7#1)(2008-11#1)
when glucose##2##2##(2008-6#2)
when going##2##2##(2008-10#1)(2011-1#1)
when greater##3##2##(1992-11#1)(2008-5#1)(2009-10#1)
when grown at 33##2##4##(2008-10#2)
when grown at##3##3##(2008-10#3)
when grown in MS medium##2##5##(2008-10#2)
when grown in the presence of##3##6##(1992-9#1)(1994-3#1)(2011-1#1)
when grown in##9##3##(1992-9#1)(1994-3#1)(1995-2#1)(2008-10#5)(2011-1#1)
when grown on##5##3##(1990-5#1)(1991-9#1)(2008-10#2)(2008-6#1)
when grown##20##2##(1990-5#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-2#1)(2008-10#11)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)
when growth took place under vacuum##2##6##(2011-2#2)
when growth##3##2##(2011-2#3)
when he was##2##3##(1994-12#1)(2007-12#1)
when he##11##2##(1990-8#1)(1993-11#1)(1994-12#1)(2007-12#2)(2008-1#1)(2008-12#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
when healthy##2##2##(2008-10#1)(2008-9#1)
when heart##2##2##(1994-5#1)(1995-12#1)
when heated to##2##3##(2010-2#2)
when high##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
when higher##2##2##(2011-1#1)(2013-7#1)
when his##2##2##(1995-6#1)(2008-6#1)
when honey was added to the diets##2##7##(2008-6#2)
when hospitals##2##2##(1995-2#1)(1996-2#1)
when human##2##2##(1991-8#1)(2008-10#1)
when hydrolyzed##2##2##(2008-10#1)(2010-3#1)
when identified##2##2##(2006-10#1)(2012-2#1)
when identifying the##2##3##(2008-4#1)(2010-9#1)
when identifying##3##2##(2008-4#1)(2010-9#1)(2012-12#1)
when immobilized on##2##3##(2008-10#1)(2008-11#1)
when immobilized##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
when implementing##4##2##(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#1)
when in a##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
when in contact with##2##4##(2008-7#2)
when in the##4##3##(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)
when in##18##2##(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
when incorporated into##2##3##(1992-12#1)(2007-6#1)
when incorporated##4##2##(1990-2#1)(1992-12#1)(2007-6#1)(2008-5#1)
when increasing amounts of##3##4##(1991-5#2)(1992-3#1)
when increasing concentrations of##2##4##(1990-11#1)(1992-12#1)
when increasing##8##2##(1990-11#1)(1991-5#2)(1992-12#1)(1992-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
when incubated at 50 degrees C##2##6##(2008-10#1)(2008-6#1)
when incubated at##4##3##(1997-1#1)(2008-10#1)(2008-6#1)(2008-9#1)
when incubated with##5##3##(1993-6#1)(1993-8#1)(1994-5#1)(1997-7#1)(2008-7#1)
when incubated##12##2##(1993-6#1)(1993-8#1)(1994-5#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#1)
when indicated##5##2##(1994-2#1)(2007-12#1)(2008-5#1)(2009-4#1)(2011-2#1)
when individually##2##2##(1993-12#1)(2012-3#1)
when individuals##6##2##(1991-12#1)(2008-5#1)(2008-9#2)(2009-9#1)(2012-12#1)
when infected by##2##3##(2008-10#2)
when infected with##3##3##(2008-10#2)(2011-10#1)
when infected##7##2##(1997-4#1)(2008-10#5)(2011-10#1)
when information##3##2##(2008-4#1)(2008-6#1)(2008-7#1)
when injected i##2##3##(1994-11#1)(1997-4#1)
when injected into##5##3##(1992-11#1)(1997-3#1)(2008-1#1)(2008-6#1)(2010-8#1)
when injected subcutaneously##2##3##(1994-6#1)(2008-8#1)
when injected##12##2##(1992-11#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-6#2)(2008-8#1)(2010-8#1)
when inoculated at anthesis##2##4##(2008-10#2)
when inoculated at##3##3##(2008-10#3)
when inoculated in##2##3##(1997-4#1)(2008-10#1)
when inoculated onto##2##3##(2008-10#2)
when inoculated with a##2##4##(2008-10#1)(2008-12#1)
when inoculated with##4##3##(2008-10#3)(2008-12#1)
when inoculated##20##2##(1997-4#1)(2008-10#17)(2008-12#1)(2008-5#1)
when inserted in##2##3##(1991-6#1)(1995-2#1)
when inserted##4##2##(1991-3#1)(1991-6#1)(1995-2#1)(2012-2#1)
when insulin##2##2##(2008-9#1)(2011-1#1)
when integrated with##2##3##(2008-3#1)(2012-3#1)
when integrating##2##2##(2008-3#1)(2008-6#1)
when interferograms##2##2##(2008-2#1)(2008-3#1)
when interpreting##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
when introduced into##2##3##(1994-12#1)(1995-2#1)
when introduced##5##2##(1994-12#1)(1995-2#1)(2008-10#2)(2009-6#1)
when investigating##7##2##(1991-2#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
when irradiated with##2##3##(2008-11#1)(2008-3#1)
when irradiated##3##2##(2008-11#1)(2008-3#1)(2010-1#1)
when is it##2##3##(1991-12#1)(1995-3#1)
when is##3##2##(1991-12#2)(1995-3#1)
when isolated##4##2##(1993-6#1)(2007-8#1)(2008-10#2)
when it comes to##6##4##(1991-3#1)(1996-9#1)(2009-11#2)(2010-12#1)(2011-2#1)
when it comes##7##3##(1991-3#1)(1995-12#1)(1996-9#1)(2009-11#2)(2010-12#1)(2011-2#1)
when it is applied##2##4##(1991-12#1)(2007-12#1)
when it is appropriate to transfer a patient##2##8##(1993-1#1)(1993-2#1)
when it is associated with##2##5##(2011-1#1)(2011-2#1)
when it is in##2##4##(1990-2#1)(2008-10#1)
when it is not##3##4##(2007-12#1)(2008-3#1)(2010-5#1)
when it is used##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
when it is##54##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-8#1)(2007-11#2)(2007-12#7)(2008-10#6)(2008-3#7)(2008-4#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
when it occurs##4##3##(2008-7#1)(2009-10#1)(2010-11#1)(2013-8#1)
when it was applied to the##3##6##(2008-10#2)(2010-4#1)
when it was applied##4##4##(2008-10#2)(2008-5#1)(2010-4#1)
when it was assumed that the##2##6##(2008-6#2)
when it was calculated by use of the##2##8##(2008-3#2)
when it was combined with##2##5##(2008-10#1)(2008-3#1)
when it was incubated##2##4##(2008-7#2)
when it was used##3##4##(1990-6#1)(2008-8#2)
when it was##35##3##(1990-12#1)(1990-6#1)(1991-3#1)(1992-2#1)(1992-7#1)(1995-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-4#2)(2012-2#2)(2013-1#1)
when it##122##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#3)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-9#1)(2007-11#3)(2007-12#9)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#4)(2013-1#2)(2013-8#3)
when its##11##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-8#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
when k approximately##2##3##(2008-3#2)
when known##2##2##(1995-3#2)
when lactofen was applied at the##2##6##(2008-10#2)
when large##3##2##(2007-11#1)(2008-10#2)
when larger##2##2##(2008-10#1)(2012-2#1)
when lasR is controlled by##2##5##(1995-2#2)
when leaves were soaked##2##4##(2008-10#2)
when leaves were##4##3##(2008-10#4)
when leaves##5##2##(2008-10#4)(2008-9#1)
when left##2##2##(1992-9#1)(2008-7#1)
when light##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
when linked##2##2##(1994-2#1)(2008-10#1)
when living in##2##3##(1996-11#1)(2010-9#1)
when living with##2##3##(2010-10#1)(2012-12#1)
when living##4##2##(1996-11#1)(2010-10#1)(2010-9#1)(2012-12#1)
when local##2##2##(2008-4#1)(2008-9#1)
when lophophores are tightly packed and excurrents are vented through chimneys##2##11##(2008-9#2)
when low##2##2##(1991-12#1)(2007-7#1)
when maintained##3##2##(1997-1#1)(2008-10#1)(2010-8#1)
when making##11##2##(1994-1#2)(1996-3#1)(1997-3#1)(2007-8#1)(2008-11#2)(2008-8#1)(2009-5#1)(2013-7#1)(2013-8#1)
when male##2##2##(2008-8#1)(2008-9#1)
when many##3##2##(1994-1#1)(2007-11#1)(2008-10#1)
when mean##2##2##(2008-10#1)(2008-7#1)
when measured in##2##3##(1991-12#1)(1993-11#1)
when measured##7##2##(1991-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
when measuring##3##2##(1993-12#1)(2008-10#1)(2008-12#1)
when medical##2##2##(1990-11#1)(2009-4#1)
when medication##2##2##(2008-2#1)(2009-9#1)
when methamphetamine was administered 3 h##2##6##(1995-3#2)
when methamphetamine##3##2##(1995-3#3)
when methotrexate##2##2##(1993-12#2)
when microinjected into##2##3##(1991-12#2)
when mixed with##3##3##(1994-8#1)(2008-10#1)(2011-3#1)
when mixed##5##2##(1994-8#1)(2008-10#3)(2011-3#1)
when model##2##2##(2008-7#1)(2011-2#1)
when monitoring##2##2##(2007-12#1)(2011-1#1)
when more than 50 % of the population were##2##9##(2012-12#2)
when more than##4##3##(2008-3#1)(2008-5#1)(2012-12#2)
when more##8##2##(1994-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)
when most##2##2##(1992-9#1)(2008-8#1)
when mothers##3##2##(1990-2#1)(1991-11#1)(2009-9#1)
when moving##2##2##(2008-10#1)(2010-4#1)
when multiple##3##2##(2007-9#1)(2008-4#1)(2012-2#1)
when mutated##3##2##(2008-10#1)(2009-6#1)(2011-1#1)
when myogenic autoregulation is##2##4##(2009-1#2)
when myosin##2##2##(1991-5#2)
when n##2##2##(2007-11#2)
when natural##2##2##(2008-10#1)(2013-1#1)
when necessary##10##2##(1991-8#1)(1992-9#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
when needed##6##2##(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)
when neither##2##2##(2008-9#1)(2010-1#1)
when new##2##2##(2007-8#1)(2008-9#1)
when no##17##2##(1991-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
when normalized##2##2##(2008-10#1)(2008-2#1)
when observations##2##2##(1995-11#1)(1996-4#1)
when obtaining##2##2##(1991-9#1)(1996-12#1)
when offspring##2##2##(2008-8#2)
when on##2##2##(2008-1#1)(2008-11#1)
when one can##2##3##(1992-6#1)(1994-2#1)
when one control measure##2##4##(2008-10#2)
when one has##3##3##(1995-3#1)(1995-9#1)(2013-8#1)
when one is dealing with##3##5##(2007-11#1)(2008-3#2)
when one is##7##3##(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#3)(2012-2#1)
when one of the parents##2##5##(2008-5#1)(2013-1#1)
when one of the##4##4##(1994-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
when one or more##2##4##(1992-3#1)(2008-2#1)
when one or##3##3##(1992-3#1)(2008-2#1)(2008-9#1)
when one uses##2##3##(2008-2#1)(2008-3#1)
when one##34##2##(1992-3#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#3)(2012-2#1)(2013-1#1)(2013-8#2)
when only a##3##3##(1995-12#1)(2008-3#1)(2009-12#1)
when only##17##2##(1990-6#1)(1992-4#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
when open##2##2##(1991-12#1)(1994-3#1)
when operated##2##2##(2008-3#2)
when other group members were##2##5##(2008-9#2)
when other##9##2##(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#2)
when oxidized##2##2##(1992-3#1)(1994-8#1)
when p was 0##2##4##(2008-10#2)
when p was##3##3##(2008-10#2)(2013-1#1)
when p##5##2##(2008-10#4)(2013-1#1)
when pH##2##2##(2008-10#1)(2008-3#1)
when pain is first evident##2##5##(2007-7#2)
when parental##2##2##(2008-9#1)(2010-1#1)
when parents##2##2##(2008-9#1)(2010-1#1)
when partial##2##2##(2008-10#1)(2009-5#1)
when participants had##2##3##(2008-11#1)(2009-11#1)
when participants##5##2##(2007-6#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-5#1)
when pathogen##3##2##(2008-10#3)
when patient presents with##2##4##(2011-1#1)(2013-1#1)
when patients with##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
when patients##10##2##(1994-2#1)(1997-1#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
when people##2##2##(2008-4#1)(2008-6#1)
when performed by##2##3##(2009-10#2)
when performed in##2##3##(2008-10#1)(2012-2#1)
when performed##7##2##(1996-11#1)(2007-10#1)(2008-10#1)(2009-10#2)(2012-12#1)(2012-2#1)
when performing a##3##3##(1991-5#1)(1995-2#1)(2007-8#1)
when performing##6##2##(1991-5#1)(1995-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
when phase##2##2##(2008-2#1)(2008-3#1)
when physical##2##2##(1994-3#1)(2008-7#1)
when physicians##2##2##(1991-2#1)(1993-12#1)
when placed in##2##3##(2008-10#1)(2008-3#1)
when placed##5##2##(1993-12#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
when planning the##2##3##(1995-2#1)(2008-6#1)
when planning##9##2##(1992-11#1)(1992-8#1)(1995-2#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-8#1)
when plant##2##2##(2008-10#1)(2008-9#1)
when plants were##5##3##(2008-10#3)(2008-12#1)(2008-8#1)
when playing on##2##3##(1990-6#1)(2013-1#1)
when populations##2##2##(2008-10#1)(2008-9#1)
when possible##7##2##(1991-2#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-5#2)(2013-1#1)
when practiced##2##2##(2008-3#1)(2009-9#1)
when predation is present##2##4##(2008-9#2)
when predation##3##2##(2008-8#1)(2008-9#2)
when predator##2##2##(2008-9#1)(2012-3#1)
when prepared##3##2##(1996-2#1)(2010-4#1)(2013-8#1)
when preparing##2##2##(1992-2#1)(2008-9#1)
when present at##3##3##(1991-9#1)(1993-8#1)(2008-10#1)
when present during##2##3##(1994-2#1)(2013-8#1)
when present in the##2##4##(2008-10#2)
when present in##4##3##(1994-3#1)(2008-10#3)
when present##11##2##(1991-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(2008-10#5)(2010-5#1)(2013-8#1)
when presented in##2##3##(2009-8#1)(2010-7#1)
when presented with##2##3##(2009-6#2)
when presented##4##2##(2009-6#2)(2009-8#1)(2010-7#1)
when primary##2##2##(1992-4#1)(2008-10#1)
when processing##2##2##(1996-12#1)(2012-12#1)
when produced##2##2##(2008-10#1)(2008-9#1)
when proliferation##3##2##(2008-11#2)(2008-4#1)
when properly##2##2##(2008-2#2)
when protein##3##2##(1990-12#1)(2008-5#1)(2011-2#1)
when providing care to##2##4##(2008-7#1)(2011-1#1)
when pumped at##2##3##(2007-11#1)(2008-3#1)
when pumped by a##2##4##(2008-2#1)(2008-3#1)
when pumped by##4##3##(2008-2#1)(2008-3#3)
when pumped##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
when rain begins at night##2##5##(2008-10#2)
when rats were##2##3##(1991-12#1)(2008-5#1)
when reading text##2##3##(2010-7#1)(2013-1#1)
when reading##3##2##(2008-2#1)(2010-7#1)(2013-1#1)
when recognized##2##2##(1992-3#1)(1992-5#1)
when recombinant##2##2##(1991-3#1)(2011-2#1)
when recording##2##2##(2008-2#1)(2012-2#1)
when recovering##3##2##(2007-11#1)(2009-8#1)(2013-1#1)
when referring##2##2##(1995-3#1)(2010-12#1)
when repeated##2##2##(1996-3#2)
when reproducing##2##2##(2012-2#1)(2013-8#1)
when required##3##2##(1994-5#1)(1996-2#1)(2008-10#1)
when resources are##3##3##(2008-9#2)(2009-10#1)
when reviewing##4##2##(1995-3#1)(2009-4#2)(2010-4#1)
when sampling##2##2##(2008-10#1)(2008-5#1)
when sated##4##2##(1993-6#4)
when saturated##2##2##(2008-3#1)(2008-6#1)
when scaling##2##2##(2008-3#1)(2010-8#1)
when searching for##3##3##(1990-11#1)(2008-8#2)
when searching##5##2##(1990-11#1)(1993-3#1)(1994-3#1)(2008-8#2)
when seeded##2##2##(1993-9#1)(2008-11#1)
when seeking##3##2##(1993-3#1)(1995-3#1)(2011-2#1)
when selecting##4##2##(1991-12#1)(2008-4#1)(2008-7#1)(2010-3#1)
when serum##2##2##(1992-3#1)(2008-11#1)
when several##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
when severe##2##2##(2011-10#1)(2012-12#1)
when sexual##2##2##(2009-9#1)(2012-3#1)
when she##3##2##(1995-6#1)(2011-2#1)(2013-1#1)
when shorter##2##2##(2008-10#2)
when significant##3##2##(1993-11#1)(1994-12#1)(2012-2#1)
when small amounts of##2##4##(2008-10#2)
when small##3##2##(2008-10#2)(2008-2#1)
when soil was##2##3##(2008-10#2)
when soil##3##2##(2008-10#3)
when soils were##2##3##(2008-10#2)
when some##2##2##(1990-2#1)(2008-3#1)
when spatial##4##2##(2007-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
when species##4##2##(2008-8#3)(2008-9#1)
when sperm are##2##3##(1994-8#1)(2008-8#1)
when spermatozoa were##2##3##(2008-8#2)
when spermatozoa##3##2##(2008-8#3)
when stacked##2##2##(2008-3#1)(2008-4#1)
when standing##2##2##(2007-12#1)(2013-1#1)
when starting up with research##2##5##(2008-7#2)
when starting##3##2##(2008-7#2)(2011-2#1)
when stimulated with the aedeagi of##2##6##(2008-8#2)
when stimulated with##4##3##(1991-2#1)(2008-8#3)
when stimulated##5##2##(1991-2#1)(1994-6#1)(2008-8#3)
when stored at 4 degrees C##2##6##(2008-10#2)
when stored at##5##3##(2008-10#4)(2008-6#1)
when stored##7##2##(2007-12#1)(2008-10#5)(2008-6#1)
when strains##2##2##(2008-10#1)(2011-1#1)
when students##2##2##(2008-11#2)
when studied##2##2##(1994-2#1)(2008-5#1)
when studying the##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
when studying##5##2##(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-3#1)
when subjected to strong##2##4##(1997-5#1)(2008-9#1)
when subjected to##8##3##(1997-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2013-1#1)
when subjects lifted##2##3##(2012-12#2)
when subjects##8##2##(1995-11#1)(1996-5#1)(2008-11#3)(2012-12#3)
when submitted to##2##3##(2008-10#1)(2008-5#1)
when such##5##2##(1992-1#1)(1994-9#1)(2008-11#1)(2008-4#1)(2009-11#1)
when supplemented with##2##3##(2008-10#1)(2011-1#1)
when surgery is##3##3##(1991-12#1)(2008-1#1)(2009-7#1)
when surgical##3##2##(1997-3#1)(2011-2#1)(2012-2#1)
when survival##2##2##(1990-8#1)(1994-2#1)
when symptoms##2##2##(1991-4#1)(2011-2#1)
when taking into account##3##4##(2008-10#1)(2008-11#1)(2013-7#1)
when taking##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-7#1)
when targeted against##2##3##(2008-10#2)
when targeted##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
when temperature##2##2##(1994-3#1)(2008-10#1)
when temperatures from##2##3##(2008-10#1)(2008-5#1)
when temperatures##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
when tested against a##2##4##(1992-3#1)(1994-6#1)
when tested against##4##3##(1992-3#1)(1994-6#1)(2011-2#2)
when tested by Western blot and##2##6##(1994-5#1)(1997-4#1)
when tested by##4##3##(1994-5#1)(1995-12#1)(1997-4#1)(2008-6#1)
when tested for##4##3##(1992-2#1)(1996-5#3)
when tested in##3##3##(1990-4#1)(1992-6#1)(1997-6#1)
when tested on##2##3##(2008-8#1)(2008-9#1)
when tested under##2##3##(1992-2#1)(2009-7#1)
when tested with##4##3##(1990-12#1)(2008-10#2)(2008-5#1)
when tested##26##2##(1990-12#1)(1990-4#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-5#3)(1997-4#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)
when testing##2##2##(1994-8#1)(2008-10#1)
when tests were conducted at##2##5##(2008-10#2)
when the age of##2##4##(2008-10#1)(2013-8#1)
when the air temperature##2##4##(2008-10#1)(2008-6#1)
when the air##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
when the amount of##2##4##(1995-2#1)(2008-10#1)
when the angle##2##3##(2008-3#2)
when the animals##3##3##(1990-5#1)(1992-12#1)(2013-8#1)
when the appropriate##3##3##(1997-3#1)(2007-12#1)(2008-11#1)
when the bacteria were applied##2##5##(2008-10#2)
when the beam is##2##4##(2007-11#1)(2008-3#1)
when the beam##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
when the bladder was##2##4##(1997-7#2)
when the bulk flow velocity was##2##6##(2008-7#2)
when the calibration##2##3##(1995-9#1)(2008-10#1)
when the cavity##2##3##(2007-12#1)(2008-3#1)
when the cell density was##2##5##(2008-11#2)
when the cell density##3##4##(2008-11#3)
when the cell growth##2##4##(2008-11#2)
when the cell##9##3##(2008-11#7)(2008-2#1)(2008-8#1)
when the cells are##3##4##(1991-5#1)(1992-6#1)(1993-12#1)
when the cells were enriched with##2##6##(2008-11#2)
when the cells were##7##4##(1990-12#1)(1991-8#1)(1994-3#1)(1995-8#1)(2008-11#3)
when the cells##11##3##(1990-12#1)(1991-5#2)(1991-8#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-8#1)(2008-11#3)
when the central##2##3##(2007-12#1)(2008-3#1)
when the charging voltage##2##4##(2007-11#2)
when the child is##2##4##(2012-1#1)(2013-1#1)
when the child##4##3##(1990-12#1)(2010-6#1)(2012-1#1)(2013-1#1)
when the chlorine concentration##2##4##(1992-11#2)
when the clinical##2##3##(1996-11#1)(2009-5#1)
when the concentration of IAA##2##5##(2008-9#2)
when the concentration of##7##4##(1994-8#1)(2008-10#2)(2008-9#2)(2009-8#1)(2013-8#1)
when the concentration ratio##2##4##(2008-10#2)
when the concentration##10##3##(1994-8#1)(2008-10#5)(2008-9#2)(2009-8#1)(2013-8#1)
when the coupling##2##3##(2007-11#1)(2013-8#1)
when the culture##2##3##(2008-10#1)(2008-11#1)
when the damage##2##3##(2013-1#2)
when the data are##2##4##(1995-12#1)(2013-8#1)
when the data##5##3##(1990-7#1)(1995-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
when the diagnosis is made##2##5##(2008-7#1)(2013-1#1)
when the diagnosis is##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
when the diagnosis was##2##4##(1993-3#1)(2012-3#1)
when the diagnosis##5##3##(1993-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
when the difference of female fecundity is##2##7##(2008-9#2)
when the difference##3##3##(2007-11#1)(2008-9#2)
when the disease is##2##4##(2007-8#1)(2010-3#1)
when the disease##4##3##(2007-8#2)(2008-10#1)(2010-3#1)
when the distance##2##3##(2008-2#1)(2011-2#1)
when the dose##3##3##(1991-2#1)(1995-3#1)(2007-11#1)
when the drug is##2##4##(1992-3#1)(1994-6#1)
when the drug was##3##4##(1992-9#1)(1993-12#1)(1994-5#1)
when the drug##5##3##(1992-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)
when the dye##2##3##(1994-12#1)(2008-3#1)
when the dynamic##2##3##(2008-10#1)(2013-7#1)
when the effects of##2##4##(1991-12#1)(2008-3#1)
when the electrodes##2##3##(2008-10#1)(2013-1#1)
when the enzyme##2##3##(1991-9#1)(1996-2#1)
when the epithelium##2##3##(1995-8#1)(2009-10#1)
when the fill##2##3##(2008-3#2)
when the first##2##3##(1994-5#1)(2011-2#1)
when the flow rate##3##4##(2008-10#3)
when the form##2##3##(2007-12#1)(2008-3#1)
when the frequencies##2##3##(1993-3#1)(2008-3#1)
when the frequency##2##3##(2008-10#2)
when the fringe##2##3##(2007-12#1)(2008-3#1)
when the fundamental##2##3##(2007-11#1)(2008-3#1)
when the grating##3##3##(2008-2#1)(2008-3#2)
when the horse was##2##4##(2012-12#2)
when the human##2##3##(1990-12#1)(2008-11#1)
when the images are##4##4##(2008-3#2)(2012-2#2)
when the incident beams##2##4##(2007-11#1)(2007-12#1)
when the incident light is##2##5##(2007-12#2)
when the incident##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
when the infant##2##3##(1991-11#2)
when the initial##6##3##(2008-10#1)(2008-6#3)(2008-8#1)(2011-2#1)
when the intensity of the##2##5##(2007-12#1)(2008-3#1)
when the intensity##3##3##(2007-12#1)(2008-3#2)
when the interval##2##3##(2008-10#1)(2008-5#1)
when the knee is extended##2##5##(1997-8#2)
when the knee is flexed##2##5##(1997-8#2)
when the knee is##4##4##(1997-8#4)
when the knee was extended and##2##6##(1997-8#2)
when the knee was extended##3##5##(1997-8#3)
when the knee was flexed##3##5##(1997-8#3)
when the knee was##6##4##(1997-8#6)
when the knee##10##3##(1997-8#10)
when the laser##5##3##(2008-2#2)(2008-3#2)(2013-8#1)
when the latter##2##3##(2008-10#1)(2010-2#1)
when the layer is##2##4##(2008-3#2)
when the ligand is sensitive to chemical conditions required for oligonucleotide deprotection##2##12##(2008-4#2)
when the ligand is##5##4##(2008-10#1)(2008-4#4)
when the liquid is##2##4##(1997-6#1)(2011-2#1)
when the local elements were##2##5##(2008-4#2)
when the local##3##3##(2008-4#2)(2008-9#1)
when the low##2##3##(1996-12#1)(2008-7#1)
when the main vector species is##4##6##(2008-10#4)
when the mean##2##3##(2008-2#1)(2013-1#1)
when the measurements##2##3##(2008-3#2)
when the median##2##3##(2008-10#2)
when the medium was##2##4##(1991-2#1)(1993-11#1)
when the medium##3##3##(1991-2#1)(1993-11#1)(2008-11#1)
when the membrane##2##3##(1992-12#1)(1996-5#1)
when the membranes were##2##4##(1993-8#1)(2008-10#1)
when the metal##2##3##(1995-3#1)(2008-10#1)
when the mice were##2##4##(2008-7#1)(2013-1#1)
when the missing##2##3##(2009-12#1)(2009-5#1)
when the mission of caring is##2##6##(2012-3#2)
when the mixture of the##2##5##(1990-7#1)(2008-10#1)
when the new##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
when the number of##9##4##(1992-9#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
when the number##10##3##(1992-9#1)(1995-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
when the numerical aperture##2##4##(2008-3#2)
when the nutrient was released by##2##6##(2013-8#2)
when the object is##3##4##(2008-3#2)(2011-1#1)
when the optical##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
when the original##2##3##(2008-3#1)(2013-1#1)
when the pH of the##2##5##(1994-6#1)(2008-10#1)
when the pH of##3##4##(1994-6#1)(2008-10#1)(2008-11#1)
when the pH was##2##4##(1995-5#1)(2013-8#1)
when the pH##6##3##(1994-6#1)(1995-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
when the pain is##3##4##(1990-6#1)(2007-7#1)(2008-9#1)
when the particle size##2##4##(2008-10#1)(2013-8#1)
when the particle was##2##4##(2008-10#1)(2010-4#1)
when the particle##4##3##(2008-10#2)(2010-4#1)(2013-8#1)
when the patient suffered##2##4##(1993-2#1)(2008-12#1)
when the patient was##3##4##(1991-11#1)(2009-11#1)(2011-2#1)
when the patient##11##3##(1991-11#1)(1992-3#1)(1993-2#1)(1997-6#1)(2007-7#1)(2008-12#1)(2009-11#1)(2010-3#1)(2011-2#2)(2011-3#1)
when the patients##4##3##(1992-6#1)(1993-1#1)(1993-11#1)(1995-2#1)
when the phase##2##3##(2007-11#1)(2008-2#1)
when the plane##2##3##(2008-2#1)(2008-3#1)
when the plants were##2##4##(1997-6#1)(2008-10#1)
when the presence of##2##4##(1991-5#1)(2008-12#1)
when the primary##2##3##(1995-12#1)(1995-8#1)
when the probability##2##3##(2008-3#1)(2012-3#1)
when the probe##2##3##(2007-12#1)(2008-2#1)
when the proper##2##3##(2008-10#1)(2008-3#1)
when the protective time was##2##5##(2008-10#2)
when the protein##4##3##(1990-12#1)(1993-12#1)(1993-3#2)
when the pulse width falls below##2##6##(2008-3#2)
when the pulse width##4##4##(2008-3#4)
when the pulse##6##3##(2007-12#2)(2008-3#4)
when the pump##2##3##(2008-3#2)
when the rates##2##3##(1995-5#1)(2008-7#1)
when the ratio of##2##4##(2008-10#2)
when the refractive indices##2##4##(2008-2#1)(2008-3#1)
when the refractive##3##3##(2008-2#1)(2008-3#2)
when the results##4##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)
when the same##5##3##(1992-12#1)(1992-6#1)(1993-12#1)(2008-10#1)(2009-11#1)
when the sample##6##3##(2008-10#2)(2008-3#2)(2008-6#1)(2011-2#1)
when the samples were##3##4##(2008-3#1)(2008-5#1)(2010-6#1)
when the scattering##2##3##(2007-12#1)(2008-2#1)
when the second##2##3##(1997-2#1)(2008-3#1)
when the secondary##2##3##(2008-10#1)(2008-7#1)
when the separation##2##3##(2008-10#1)(2008-2#1)
when the signal is##2##4##(2008-3#2)
when the small##2##3##(1990-12#1)(2008-3#1)
when the specific##3##3##(1994-5#1)(2013-1#1)(2013-8#1)
when the stimuli##2##3##(1992-11#2)
when the substrate##4##3##(1993-11#1)(1994-3#1)(2008-3#2)
when the surface##2##3##(2008-3#1)(2008-6#1)
when the system##2##3##(2008-10#1)(2008-3#1)
when the target##5##3##(2008-10#1)(2008-3#3)(2010-5#1)
when the temperature increases##2##4##(2007-12#1)(2013-8#1)
when the temperature is decreased##2##5##(1995-2#2)
when the temperature is##4##4##(1995-2#2)(2008-10#1)(2008-11#1)
when the temperature##7##3##(1995-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
when the three##2##3##(2008-10#1)(2008-12#1)
when the threshold##3##3##(2008-9#1)(2009-8#1)(2013-8#1)
when the tip is above the##2##6##(2007-11#2)
when the two##6##3##(1991-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
when the unattended stimulus was##2##5##(2010-5#2)
when the unattended stimulus##3##4##(2010-5#3)
when the underlying##2##3##(1995-9#1)(2008-4#1)
when the value of##3##4##(1996-3#1)(2008-3#1)(2008-8#1)
when the volume of##4##4##(1992-12#1)(1997-8#1)(2008-10#2)
when the water content##2##4##(2008-10#2)
when the wavelength##2##3##(2007-12#1)(2008-3#1)
when the##956##2##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#2)(1991-11#5)(1991-12#3)(1991-2#4)(1991-3#5)(1991-5#5)(1991-8#3)(1991-9#3)(1992-10#3)(1992-11#5)(1992-12#6)(1992-2#2)(1992-3#6)(1992-5#2)(1992-6#8)(1992-9#6)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#1)(1993-3#7)(1993-6#3)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#9)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#9)(1995-3#3)(1995-5#6)(1995-6#2)(1995-8#5)(1995-9#3)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#8)(1997-3#3)(1997-4#1)(1997-5#6)(1997-6#6)(1997-7#5)(1997-8#14)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#29)(2007-12#32)(2007-7#5)(2007-8#7)(2008-1#2)(2008-10#157)(2008-11#46)(2008-12#5)(2008-2#46)(2008-3#112)(2008-4#16)(2008-5#17)(2008-6#16)(2008-7#19)(2008-8#19)(2008-9#27)(2009-10#6)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#5)(2009-7#2)(2009-8#8)(2009-9#6)(2010-1#3)(2010-10#1)(2010-11#5)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#12)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#19)
when their UPDRS-III##2##3##(2008-7#2)
when their concentration is##3##4##(2008-10#2)(2008-11#1)
when their concentrations were##2##4##(1992-6#1)(2013-1#1)
when their##23##2##(1990-2#1)(1992-6#1)(1995-3#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#2)
when therapy was##2##3##(1997-2#1)(2013-8#1)
when there are no##2##4##(2008-9#2)
when there are##11##3##(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2011-2#2)(2012-3#1)
when there is a##13##4##(1991-1#1)(1993-8#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-9#1)(2012-3#1)(2013-1#1)
when there is an##2##4##(1992-6#1)(1996-11#1)
when there is no##5##4##(2007-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)
when there is##30##3##(1991-1#1)(1992-6#1)(1993-8#1)(1996-11#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#3)(2009-4#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#1)
when there was a##2##4##(1990-2#1)(1995-6#1)
when there was no##3##4##(2007-8#1)(2008-10#1)(2009-9#1)
when there was##7##3##(1990-2#1)(1995-11#1)(1995-6#1)(2007-8#1)(2008-10#2)(2009-9#1)
when there were##2##3##(1990-11#1)(2008-7#1)
when there##50##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-4#4)(2008-7#1)(2008-9#6)(2009-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)
when these cells##2##3##(1992-12#1)(1995-2#1)
when these sequences are##2##4##(2008-7#1)(2008-9#1)
when these two##4##3##(1991-12#1)(1991-2#1)(1992-11#1)(2008-3#1)
when these##33##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2013-1#2)
when they are##30##3##(1990-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-12#1)(2013-1#2)
when they can##2##3##(2007-8#1)(2008-5#1)
when they did not##2##4##(2009-10#2)
when they did##3##3##(1995-6#1)(2009-10#2)
when they had##2##3##(1997-5#1)(2009-11#1)
when they have##4##3##(2008-2#1)(2008-5#1)(2010-4#1)(2012-1#1)
when they reach adulthood##2##4##(1996-6#1)(2011-2#1)
when they undergo##2##3##(1991-3#1)(2008-11#1)
when they were##20##3##(1990-10#1)(1991-3#1)(1993-6#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#2)(2009-10#1)(2010-5#1)(2010-6#1)(2011-1#1)
when they##105##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-3#3)(1992-11#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-5#2)(1997-6#1)(1997-8#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2009-10#3)(2009-11#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)
when this assumption##2##3##(1994-11#1)(1997-8#1)
when this method##2##3##(2008-10#1)(2008-3#1)
when this##23##2##(1990-10#1)(1991-12#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)
when those##3##2##(1992-2#1)(2008-11#1)(2008-8#1)
when tissue##2##2##(2008-1#1)(2008-4#1)
when to##14##2##(1992-9#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
when topically applied##2##3##(2008-5#2)
when transfected into##2##3##(1991-6#1)(2008-9#1)
when transfected##4##2##(1991-6#1)(1992-12#1)(1996-2#1)(2008-9#1)
when transiently##2##2##(1993-3#1)(1995-12#1)
when transitioning from##2##3##(2008-10#1)(2009-8#1)
when transitioning##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
when transplanted##2##2##(2008-11#1)(2011-2#1)
when treated with##5##3##(1994-11#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-2#1)
when treated##9##2##(1994-11#1)(1997-6#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
when treating patients with##4##4##(1992-4#1)(1992-9#1)(1993-2#1)(2010-12#1)
when treating the##2##3##(2008-7#1)(2013-1#1)
when treating##10##2##(1992-4#1)(1992-9#1)(1993-2#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
when treatment##4##2##(1994-3#1)(1996-3#1)(2009-10#1)(2011-10#1)
when trees were##2##3##(2008-10#2)
when trees##3##2##(2008-10#3)
when trying to##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
when two gratings are used is simplified##2##7##(2008-3#2)
when two or more##2##4##(1995-6#1)(2006-4#1)
when two##15##2##(1991-11#1)(1992-2#1)(1995-5#1)(1995-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
when used alone##6##3##(1990-2#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)
when used as##10##3##(2008-10#5)(2008-11#2)(2009-12#2)(2012-3#1)
when used for##2##3##(2008-11#1)(2010-3#1)
when used in a##2##4##(2008-10#2)
when used in combination with##4##5##(1992-1#1)(2008-5#1)(2010-4#1)(2011-2#1)
when used in combination##5##4##(1992-1#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
when used in the##2##4##(1990-3#1)(2008-11#1)
when used in##16##3##(1990-3#1)(1992-1#1)(2008-10#4)(2008-11#4)(2008-5#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
when used to treat##3##4##(1994-11#1)(2008-5#1)(2011-2#1)
when used to##10##3##(1991-12#1)(1994-11#1)(1996-12#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)
when used with##5##3##(1991-2#1)(1997-1#1)(2008-3#1)(2008-7#1)(2010-7#1)
when used##55##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-1#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#16)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
when using a##4##3##(1995-2#1)(2008-10#2)(2008-2#1)
when using the##15##3##(1992-11#1)(1995-1#1)(1996-3#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2010-7#1)
when using this##3##3##(1992-2#1)(2008-10#1)(2008-12#1)
when using##56##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-10#21)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
when various##2##2##(1995-5#1)(2008-10#1)
when viewed from the##2##4##(2008-3#1)(2010-12#1)
when viewed from##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
when viewed##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2010-12#1)
when viewing##2##2##(2008-10#1)(2008-11#1)
when visiting##2##2##(1992-12#1)(2008-11#1)
when visual##4##2##(1993-12#1)(2007-9#1)(2008-12#1)(2010-9#1)
when visualized##2##2##(2008-1#1)(2008-10#1)
when vitamin##2##2##(2012-2#1)(2013-1#1)
when water##3##2##(1993-2#1)(2007-5#1)(2008-10#1)
when we apply##2##3##(2008-2#1)(2008-3#1)
when we have##2##3##(2008-2#1)(2011-1#1)
when we use##2##3##(2008-11#1)(2010-8#1)
when we used##2##3##(2008-2#2)
when we##24##2##(1993-12#1)(1993-2#1)(1994-2#1)(2007-11#1)(2008-11#2)(2008-2#4)(2008-3#7)(2008-5#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
when weather supported mild epidemics##3##5##(2008-10#3)
when weather supported severe epidemics##4##5##(2008-10#4)
when weather supported##7##3##(2008-10#7)
when wild-type cells are##2##4##(1995-8#2)
when wild-type##3##2##(1995-8#2)(1997-3#1)
when words##2##2##(1996-2#1)(2010-7#1)
when working in the##2##4##(1992-6#1)(2008-3#1)
when working with##10##3##(1991-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#1)(2010-8#1)
when working##12##2##(1991-8#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-9#1)(2010-8#1)
when writing##2##2##(2007-11#1)(2008-4#1)
when you##3##2##(1994-3#1)(1996-3#1)(2007-12#1)
when younger than 45 years##3##5##(2010-3#3)
when##4856##1##(1990-10#4)(1990-11#17)(1990-12#25)(1990-2#15)(1990-3#2)(1990-4#1)(1990-5#11)(1990-6#8)(1990-7#14)(1990-8#9)(1990-9#8)(1991-1#2)(1991-10#2)(1991-11#7)(1991-12#33)(1991-2#20)(1991-3#18)(1991-4#3)(1991-5#17)(1991-6#13)(1991-7#1)(1991-8#14)(1991-9#12)(1992-1#4)(1992-10#8)(1992-11#13)(1992-12#18)(1992-2#17)(1992-3#30)(1992-4#4)(1992-5#8)(1992-6#25)(1992-7#5)(1992-8#8)(1992-9#19)(1993-1#13)(1993-10#2)(1993-11#18)(1993-12#49)(1993-2#17)(1993-3#19)(1993-6#21)(1993-8#18)(1993-9#7)(1994-1#8)(1994-11#11)(1994-12#17)(1994-2#22)(1994-3#28)(1994-5#22)(1994-6#18)(1994-7#1)(1994-8#20)(1994-9#12)(1995-1#6)(1995-10#1)(1995-11#16)(1995-12#26)(1995-2#38)(1995-3#33)(1995-5#18)(1995-6#25)(1995-8#17)(1995-9#6)(1996-1#4)(1996-11#11)(1996-12#31)(1996-2#26)(1996-3#18)(1996-4#2)(1996-5#17)(1996-6#6)(1996-7#1)(1996-8#3)(1996-9#8)(1997-1#10)(1997-2#23)(1997-3#23)(1997-4#21)(1997-5#11)(1997-6#17)(1997-7#22)(1997-8#27)(2006-10#8)(2006-12#1)(2006-4#2)(2006-6#2)(2007-10#9)(2007-11#79)(2007-12#89)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#5)(2007-6#6)(2007-7#21)(2007-8#31)(2007-9#2)(2008-1#39)(2008-10#921)(2008-11#226)(2008-12#67)(2008-2#137)(2008-3#298)(2008-4#76)(2008-5#115)(2008-6#81)(2008-7#158)(2008-8#145)(2008-9#146)(2009-1#4)(2009-10#36)(2009-11#20)(2009-12#6)(2009-2#10)(2009-3#5)(2009-4#11)(2009-5#20)(2009-6#18)(2009-7#16)(2009-8#33)(2009-9#21)(2010-1#14)(2010-10#11)(2010-11#11)(2010-12#15)(2010-2#15)(2010-3#22)(2010-4#26)(2010-5#22)(2010-6#10)(2010-7#10)(2010-8#32)(2010-9#9)(2011-1#49)(2011-10#8)(2011-2#145)(2011-3#5)(2011-7#1)(2012-1#12)(2012-12#52)(2012-2#71)(2012-3#51)(2012-4#2)(2012-7#3)(2012-8#2)(2013-1#98)(2013-7#15)(2013-8#69)
when?##2##1##(1993-7#1)(2008-6#1)
whenever a##4##2##(1993-11#1)(2008-10#2)(2008-7#1)
whenever feasible##2##2##(2008-6#1)(2011-2#1)
whenever possible##7##2##(1995-1#1)(1996-3#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
whenever the##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
whenever##40##1##(1990-10#1)(1991-12#1)(1993-11#2)(1994-5#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
whenthe##3##1##(2008-11#3)
where &quot##2##2##(1997-7#2)
where 0 = not at all appropriate/useful and 10 = very appropriate/useful)##2##12##(2013-1#2)
where 0##3##2##(2008-2#1)(2013-1#2)
where A is##2##3##(2008-10#1)(2008-2#1)
where A##5##2##(1997-8#2)(2008-10#2)(2008-2#1)
where Cr(III) is##2##3##(2008-10#2)
where H##2##2##(2008-3#2)
where I(0) and I(100) represent the detected##2##7##(2008-10#2)
where K is##2##3##(1990-8#1)(2008-7#1)
where K##4##2##(1990-8#1)(1996-2#1)(2008-7#2)
where L is##2##3##(2007-11#1)(2013-1#1)
where L##5##2##(1997-7#1)(2007-11#1)(2008-10#2)(2013-1#1)
where M is##2##3##(2007-11#1)(2009-12#1)
where M##3##2##(1997-7#1)(2007-11#1)(2009-12#1)
where N is a##2##4##(2008-7#2)
where N is the number of##2##6##(2007-11#1)(2008-8#1)
where N is the##3##4##(2007-11#1)(2008-3#1)(2008-8#1)
where N is##5##3##(2007-11#1)(2008-3#1)(2008-7#2)(2008-8#1)
where N##7##2##(2007-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)
where NO##2##2##(1994-2#1)(2011-2#1)
where O##2##2##(2008-10#1)(2008-3#1)
where P##3##2##(2007-12#1)(2008-10#2)
where Phytophthora##2##2##(2008-10#2)
where T##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
where T3##2##2##(1996-5#1)(2008-12#1)
where X =##2##3##(1992-6#1)(1995-5#1)
where X is##2##3##(1992-8#1)(2011-2#1)
where X##4##2##(1992-6#1)(1992-8#1)(1995-5#1)(2011-2#1)
where a group##3##3##(1997-8#1)(2008-8#1)(2010-6#1)
where a large number of##2##5##(1993-11#1)(2009-12#1)
where a large##3##3##(1993-11#1)(2009-12#1)(2012-12#1)
where a more##2##3##(1992-3#1)(2009-10#1)
where a##56##2##(1991-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#4)(2013-1#4)(2013-8#1)
where absorption##2##2##(2007-11#1)(2008-10#1)
where agonist onset##2##3##(2008-7#2)
where all##4##2##(1990-5#1)(1992-1#1)(2008-9#1)(2013-8#1)
where an##12##2##(1991-5#1)(1991-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
where and how the##2##4##(2008-10#1)(2008-5#1)
where and how##3##3##(1994-1#1)(2008-10#1)(2008-5#1)
where and when##2##3##(1994-3#1)(2008-7#1)
where and##5##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
where antibiotics are##2##3##(1992-6#2)
where appropriate##6##2##(1991-6#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-9#1)
where are we##5##3##(1990-6#1)(2006-10#1)(2008-10#1)(2013-1#2)
where are##7##2##(1990-6#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#2)
where as##5##2##(2008-10#1)(2008-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
where at least##2##3##(1996-6#1)(2012-12#1)
where available##2##2##(1997-5#1)(2008-1#1)
where bare##2##2##(2008-11#1)(2009-11#1)
where blacks live##2##3##(2009-9#2)
where blood##3##2##(1993-12#2)(2008-10#1)
where both##17##2##(1996-1#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#2)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#2)
where cell##5##2##(2008-1#1)(2008-11#3)(2008-5#1)
where cells are##2##3##(2008-11#2)
where cells##3##2##(2008-11#2)(2008-7#1)
where changes##2##2##(2008-5#1)(2008-7#1)
where common##2##2##(1990-5#1)(2008-10#1)
where conventional##2##2##(2008-10#1)(2008-2#1)
where cost##2##2##(2008-10#1)(2008-11#1)
where data##3##2##(2008-10#1)(2008-7#1)(2009-11#1)
where different##2##2##(2008-10#1)(2008-8#1)
where direct##2##2##(2008-11#1)(2008-12#1)
where disease pressure was##3##4##(2008-10#3)
where do we##2##3##(2008-7#1)(2008-8#1)
where do##4##2##(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
where each##4##2##(1990-7#1)(2008-1#1)(2008-3#2)
where early##2##2##(1997-3#1)(2013-1#1)
where either##2##2##(1995-6#1)(2008-8#1)
where environmental##2##2##(2008-8#1)(2012-2#1)
where epidemics occur##2##3##(2008-10#2)
where excess##3##2##(1991-12#1)(2007-11#1)(2008-3#1)
where extensive##4##2##(1994-12#1)(1994-8#1)(2008-10#1)(2008-7#1)
where failure##2##2##(2009-7#1)(2013-1#1)
where females##2##2##(2008-8#2)
where first##2##2##(2008-3#1)(2011-1#1)
where full##2##2##(1992-6#1)(2007-11#1)
where further##2##2##(2007-8#1)(2008-11#1)
where future##2##2##(2008-11#1)(2010-10#1)
where growth was##2##3##(2008-8#2)
where growth##3##2##(2008-10#1)(2008-8#2)
where h is the scattering depth##2##6##(2008-3#2)
where he was##2##3##(1995-3#1)(2011-1#1)
where he##8##2##(1995-3#1)(2007-4#1)(2008-10#1)(2010-1#1)(2011-1#1)(2012-3#2)(2013-1#1)
where he/she##3##2##(2008-7#1)(2012-2#2)
where health care##2##3##(1991-12#1)(2008-7#1)
where health##6##2##(1991-12#1)(2008-7#2)(2009-5#1)(2012-12#1)(2013-8#1)
where high##6##2##(1993-8#1)(2007-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
where host##2##2##(2008-10#1)(2008-8#1)
where in the##2##3##(1993-3#1)(2008-10#1)
where in##7##2##(1993-3#1)(2008-10#2)(2008-12#1)(2011-2#2)(2012-3#1)
where increased##2##2##(1994-3#1)(2008-11#1)
where increasing##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
where individual##2##2##(2008-6#1)(2011-9#1)
where infected##2##2##(2008-10#2)
where infection##2##2##(2008-10#2)
where information##2##2##(2010-4#1)(2010-9#1)
where initial##2##2##(2008-10#1)(2008-3#1)
where is the##3##3##(1994-12#1)(1996-2#1)(1996-3#1)
where is##5##2##(1994-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)
where it acts##2##3##(2008-7#1)(2012-12#1)
where it can be##3##4##(1992-1#1)(2008-7#1)(2013-8#1)
where it can cause##2##4##(2008-10#1)(2008-9#1)
where it can##6##3##(1992-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-8#1)
where it causes##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
where it could##2##3##(1991-8#1)(1994-8#1)
where it has been##2##4##(2008-10#1)(2008-11#1)
where it has##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2009-6#1)
where it is associated with##2##5##(1990-5#1)(2010-10#1)
where it is shown##2##4##(2008-3#1)(2010-4#1)
where it is##26##3##(1990-2#1)(1990-5#1)(1992-7#1)(1994-11#1)(1994-5#1)(1995-2#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
where it mediates##2##3##(1997-2#1)(2012-2#1)
where it might##2##3##(1991-12#1)(2008-10#1)
where it should##2##3##(2008-11#1)(2008-4#1)
where it was##9##3##(1992-9#1)(1994-8#1)(1994-9#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
where it##83##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-3#1)(1997-2#2)(2007-12#4)(2007-7#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
where its##7##2##(1994-10#1)(2008-10#3)(2008-4#2)(2011-2#1)
where lambda is the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
where light is##2##3##(2008-9#1)(2012-2#1)
where low##3##2##(1995-2#1)(2008-5#1)(2008-7#1)
where m is the##2##4##(2007-12#1)(2008-10#1)
where m##5##2##(1991-8#1)(2007-12#1)(2008-10#3)
where major##2##2##(1990-11#1)(1996-9#1)
where males##2##2##(2008-5#1)(2009-9#1)
where many##4##2##(1994-12#1)(1995-5#1)(2008-10#1)(2008-8#1)
where medical##3##2##(1993-3#1)(1994-12#1)(1997-8#1)
where molecular##2##2##(2008-10#2)
where more than##3##3##(1992-5#1)(2008-6#1)(2011-2#1)
where more##7##2##(1990-6#1)(1992-5#1)(2007-10#1)(2008-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
where mortality##2##2##(1991-6#1)(2008-8#1)
where most##4##2##(1997-6#1)(2008-12#1)(2009-7#1)(2012-2#1)
where mostly##2##2##(1996-12#2)
where multiple##6##2##(1992-6#1)(2008-10#2)(2009-12#1)(2010-8#1)(2012-12#1)
where mutations##2##2##(2008-4#1)(2013-8#1)
where n is the number of conjugated pi-electron double bonds##2##10##(2010-2#2)
where n is the number of##3##6##(2008-8#1)(2010-2#2)
where n is the##4##4##(2007-12#1)(2008-8#1)(2010-2#2)
where natural##2##2##(2008-10#2)
where necessary##2##2##(2008-4#1)(2012-2#1)
where neither##2##2##(2008-10#1)(2012-2#1)
where neuronal##2##2##(2008-6#1)(2008-7#1)
where new##3##2##(1994-3#1)(2008-7#1)(2009-8#1)
where next?##2##2##(1997-2#1)(2008-1#1)
where no##14##2##(1990-11#1)(1990-12#1)(1992-12#1)(1995-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)(2012-12#2)(2012-3#1)
where numerous##2##2##(2007-8#1)(2010-1#1)
where nurses##2##2##(2008-1#1)(2008-11#1)
where one##8##2##(1992-3#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#2)
where only one##2##3##(2008-7#1)(2008-8#1)
where only the##5##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-12#1)
where only##18##2##(1990-5#1)(1994-5#1)(2007-12#1)(2008-10#7)(2008-12#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-4#1)(2012-1#1)
where other##5##2##(1991-12#2)(1995-3#1)(1996-3#1)(2008-10#1)
where participants##2##2##(2008-11#2)
where people##4##2##(1991-3#1)(1996-5#1)(2010-4#1)(2011-2#1)
where possible##11##2##(1992-12#1)(1992-9#1)(1995-5#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
where reduction of##2##3##(1992-9#1)(2008-10#1)
where relief##2##2##(2013-7#2)
where research##2##2##(2013-1#1)(2013-8#1)
where sample##3##2##(2008-10#3)
where selected##2##2##(1991-9#1)(2008-10#1)
where selective##2##2##(1990-11#1)(1993-12#1)
where she##4##2##(1994-1#1)(1997-3#1)(2011-2#1)(2012-12#1)
where simple##2##2##(1993-3#1)(2008-8#1)
where small##4##2##(2008-3#1)(2008-4#2)(2010-7#1)
where soil##2##2##(2008-10#1)(2008-12#1)
where some##5##2##(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
where strain 70T01##2##3##(2008-10#2)
where students##4##2##(1997-3#1)(2008-11#2)(2008-12#1)
where substantial##2##2##(1993-12#1)(2008-10#1)
where such##2##2##(1993-12#1)(2012-12#1)
where surgical##2##2##(1992-6#1)(2007-8#1)
where temperature##2##2##(2008-10#2)
where the abdominal wall has been##2##6##(2011-2#2)
where the analyte##3##3##(2008-10#2)(2008-7#1)
where the analytes are##2##4##(2008-10#2)
where the analytical signal##2##4##(2008-10#2)
where the antigen##2##3##(1994-11#1)(2008-4#1)
where the assembly of##2##4##(2008-11#1)(2009-11#1)
where the binding##2##3##(1990-2#1)(1994-12#1)
where the clinical picture##2##4##(1990-2#1)(1990-8#1)
where the coating##2##3##(2008-3#2)
where the corresponding FTIR##2##4##(2008-10#2)
where the corresponding##3##3##(2008-10#3)
where the data##2##3##(1994-2#1)(2013-8#1)
where the different##2##3##(2008-10#1)(2008-2#1)
where the disease has##2##4##(2008-10#1)(2012-2#1)
where the disease is endemic##2##5##(2008-5#1)(2012-12#1)
where the disease is##4##4##(1995-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
where the disease was first##2##5##(2008-10#2)
where the disease was##3##4##(1993-1#1)(2008-10#2)
where the disease##9##3##(1993-1#1)(1995-3#1)(2008-10#4)(2008-5#1)(2012-12#1)(2012-2#1)
where the electrode##4##3##(2008-10#4)
where the first##3##3##(2008-10#2)(2012-12#1)
where the flux averaged##2##4##(2008-5#2)
where the formation of##2##4##(2008-10#2)
where the frequency of##2##4##(1990-12#1)(2008-1#1)
where the fungus##2##3##(2008-10#2)
where the major##2##3##(1997-7#1)(2009-10#1)
where the maximum##2##3##(2008-10#2)
where the mean time to co-invasion##2##6##(2008-8#2)
where the mode##2##3##(1997-6#1)(2008-3#1)
where the palm##2##3##(2008-10#2)
where the patient was##2##4##(1990-5#1)(1997-6#1)
where the patient##4##3##(1990-5#1)(1997-6#1)(2010-4#1)(2013-8#1)
where the patients##2##3##(2008-10#1)(2008-7#1)
where the population is##2##4##(1991-12#1)(2008-8#1)
where the presence of##2##4##(1993-8#1)(2008-10#1)
where the protein is native##2##5##(1997-2#2)
where the protein##4##3##(1995-6#1)(1997-2#2)(2010-10#1)
where the pulse##2##3##(1992-11#1)(2007-12#1)
where the receptor##2##3##(1994-5#1)(1997-7#1)
where the risk of##2##4##(1990-9#1)(2008-3#1)
where the sample##2##3##(2008-10#1)(2008-7#1)
where the sexual state##2##4##(2008-10#2)
where the size##2##3##(2008-3#1)(2012-12#1)
where the sorption##2##3##(2008-10#2)
where the sources##2##3##(2008-4#1)(2011-1#1)
where the terms##2##3##(2008-11#1)(2008-7#1)
where the traditional##2##3##(2008-10#1)(2012-12#1)
where the treatment was##2##4##(1995-11#1)(1995-12#1)
where the tumor##2##3##(2008-1#1)(2010-3#1)
where the two##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
where the virus##2##3##(2007-12#1)(2007-2#1)
where the##392##2##(1990-12#2)(1990-2#4)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#4)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2006-4#1)(2007-10#3)(2007-11#4)(2007-12#8)(2007-2#3)(2007-7#1)(2008-1#6)(2008-10#92)(2008-11#11)(2008-12#4)(2008-2#16)(2008-3#27)(2008-4#7)(2008-5#10)(2008-6#5)(2008-7#15)(2008-8#14)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#4)
where their##6##2##(1991-8#1)(1995-2#1)(2008-10#1)(2008-4#1)(2009-9#1)(2012-12#1)
where there are no##2##4##(2008-10#1)(2012-2#1)
where there are##6##3##(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
where there is a high##2##5##(1995-8#1)(2008-6#1)
where there is a##6##4##(1995-8#1)(2007-2#1)(2008-6#1)(2008-8#1)(2010-2#1)(2013-1#1)
where there is no##5##4##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)
where there is##18##3##(1994-12#1)(1995-8#1)(1996-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-8#3)(2010-2#1)(2013-1#1)(2013-8#1)
where there was##6##3##(1991-12#1)(2007-8#1)(2008-10#4)
where there were##2##3##(2008-10#1)(2008-12#1)
where there##36##2##(1991-12#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-5#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
where these##11##2##(1996-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
where they are introduced than##2##5##(2008-8#2)
where they are##17##3##(1991-8#1)(1995-6#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-8#3)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
where they can be##2##4##(2008-9#1)(2010-3#1)
where they can##4##3##(1995-2#1)(2008-10#1)(2008-9#1)(2010-3#1)
where they may##4##3##(1994-1#1)(1994-12#1)(2007-12#1)(2008-10#1)
where they were##5##3##(1995-5#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
where they##63##2##(1991-8#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1997-1#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-2#4)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
where this drug##2##3##(2007-10#1)(2012-3#1)
where this is##2##3##(2011-2#2)
where this##19##2##(1991-12#1)(1991-6#1)(1992-11#1)(1995-12#1)(2007-10#1)(2007-2#1)(2008-10#4)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
where three##2##2##(2008-10#1)(2008-5#1)
where time##2##2##(2008-11#1)(2008-9#1)
where to##6##2##(1992-3#1)(1992-9#1)(1996-12#1)(2008-12#1)(2008-4#1)(2009-2#1)
where tuberculosis##2##2##(1995-3#1)(1997-8#1)
where two##9##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2012-2#1)
where use##2##2##(1994-12#1)(1996-9#1)
where very##3##2##(1991-12#1)(2007-12#1)(2008-9#1)
where we are going##3##4##(1994-12#1)(2009-5#1)(2013-1#1)
where we are##4##3##(1994-12#1)(2009-5#1)(2013-1#2)
where we can##2##3##(1991-12#1)(2009-10#1)
where we have##3##3##(1994-12#1)(2008-6#1)(2011-1#1)
where we##16##2##(1991-12#1)(1994-12#2)(1997-2#1)(1997-6#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
where weather##2##2##(2008-10#2)
where x##2##2##(2008-2#1)(2008-5#1)
where you##3##2##(1996-1#2)(2008-7#1)
where##1806##1##(1990-11#7)(1990-12#3)(1990-2#7)(1990-3#1)(1990-5#9)(1990-6#6)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#13)(1991-2#1)(1991-3#2)(1991-5#6)(1991-6#7)(1991-7#1)(1991-8#8)(1991-9#2)(1992-1#3)(1992-11#9)(1992-12#5)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#13)(1992-7#1)(1992-8#5)(1992-9#6)(1993-1#2)(1993-11#5)(1993-12#8)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#3)(1994-1#4)(1994-10#1)(1994-11#12)(1994-12#13)(1994-2#17)(1994-3#8)(1994-5#5)(1994-6#3)(1994-8#10)(1994-9#5)(1995-1#2)(1995-11#8)(1995-12#5)(1995-2#16)(1995-3#10)(1995-4#1)(1995-5#5)(1995-6#8)(1995-8#4)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#9)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#13)(1997-3#10)(1997-4#8)(1997-5#5)(1997-6#6)(1997-7#10)(1997-8#9)(2006-10#2)(2006-4#1)(2007-10#6)(2007-11#17)(2007-12#33)(2007-2#9)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#10)(2007-9#1)(2008-1#22)(2008-10#364)(2008-11#65)(2008-12#34)(2008-2#37)(2008-3#80)(2008-4#37)(2008-5#41)(2008-6#23)(2008-7#71)(2008-8#79)(2008-9#32)(2009-10#11)(2009-11#6)(2009-12#11)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#6)(2009-6#7)(2009-7#5)(2009-8#6)(2009-9#9)(2010-1#5)(2010-10#8)(2010-11#6)(2010-12#4)(2010-2#5)(2010-3#9)(2010-4#11)(2010-5#6)(2010-6#3)(2010-7#3)(2010-8#14)(2010-9#3)(2011-1#23)(2011-2#59)(2011-9#2)(2012-1#5)(2012-12#23)(2012-2#32)(2012-3#18)(2012-5#1)(2013-1#53)(2013-7#9)(2013-8#28)
whereas 10##2##2##(2008-10#1)(2008-4#1)
whereas 11##3##2##(2006-8#1)(2008-11#1)(2010-3#1)
whereas 16##2##2##(1991-8#1)(2013-8#1)
whereas 2##2##2##(1994-11#1)(2007-7#1)
whereas 3##2##2##(1991-2#1)(2007-9#1)
whereas 3- and 4-year-old children##2##5##(2008-2#2)
whereas 41##3##2##(1994-6#1)(2008-10#1)(2008-8#1)
whereas 5##2##2##(1996-6#1)(2008-10#1)
whereas 9##2##2##(1992-9#1)(2007-10#1)
whereas Cr(VI)##2##2##(2008-10#2)
whereas MICs##2##2##(2008-5#1)(2008-7#1)
whereas P##4##2##(2008-10#3)(2008-5#1)
whereas Rufous-breasted Hermit##2##3##(2008-9#2)
whereas S##3##2##(2008-10#2)(2011-2#1)
whereas SF##2##2##(2012-1#2)
whereas WSS generated from the computational model ranged from 0##2##10##(2011-2#2)
whereas a phase##2##3##(1997-6#1)(2008-3#1)
whereas a significant association##2##4##(1990-8#1)(1992-2#1)
whereas a significant##3##3##(1990-8#1)(1992-2#1)(1995-8#1)
whereas a##39##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-6#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
whereas addition of##2##3##(2008-10#1)(2008-4#1)
whereas after##2##2##(1996-6#1)(2007-11#1)
whereas all other##2##3##(2008-10#1)(2008-3#1)
whereas all the##2##3##(1996-11#1)(2008-10#1)
whereas all##12##2##(1991-6#1)(1996-11#1)(1997-6#1)(2007-10#1)(2008-10#6)(2008-3#1)(2012-3#1)
whereas an increase##2##3##(1990-12#1)(2008-10#1)
whereas an##11##2##(1990-12#1)(1990-6#1)(1991-8#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-5#2)(2013-8#1)
whereas another##2##2##(2008-6#1)(2010-9#1)
whereas apo A-II/DMPC complexes##2##4##(1990-12#2)
whereas at##8##2##(1990-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
whereas binding to##2##3##(1991-9#1)(1994-8#1)
whereas both##6##2##(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)
whereas cells##2##2##(1994-8#1)(2012-2#1)
whereas chasmogamous cultivars##2##3##(2008-10#2)
whereas classical##2##2##(1993-6#1)(1994-6#1)
whereas complex pathotypes##2##3##(2008-10#2)
whereas expression of##2##3##(1993-9#1)(1995-8#1)
whereas female##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
whereas five##4##2##(1992-11#1)(2008-10#3)
whereas for the##3##3##(2008-10#2)(2008-2#1)
whereas for##16##2##(1991-12#1)(1994-12#1)(1995-5#1)(2006-10#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-6#1)
whereas genes##3##2##(2008-10#2)(2012-3#1)
whereas glucose##2##2##(1990-8#1)(1994-3#1)
whereas high##4##2##(2008-10#3)(2008-6#1)
whereas higher##4##2##(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)
whereas human##3##2##(1992-2#1)(1997-7#2)
whereas in BT##2##3##(2007-7#2)
whereas in other##2##3##(1997-2#1)(2011-2#1)
whereas in the presence of##2##5##(1990-8#1)(1993-11#1)
whereas in the second##2##4##(2008-10#1)(2010-7#1)
whereas in the##24##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-4#1)(1993-11#1)(1993-9#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
whereas in##82##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-11#3)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
whereas insulin and phorbol esters##2##5##(1995-6#1)(1996-2#1)
whereas isolates from##3##3##(2008-10#3)
whereas isolates in##2##3##(2008-10#2)
whereas isolates of##3##3##(2008-10#3)
whereas isolates##9##2##(2008-10#9)
whereas it did not##2##4##(1997-2#1)(2008-11#1)
whereas it had no effect##2##5##(1993-12#1)(2008-4#1)
whereas it had##4##3##(1993-12#1)(1996-2#1)(2008-4#1)(2010-4#1)
whereas it increased##2##3##(1994-8#1)(1996-9#1)
whereas it inhibited##2##3##(1994-11#1)(2008-11#1)
whereas it is##8##3##(1990-6#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-2#1)
whereas it remains##2##3##(2008-3#1)(2012-3#1)
whereas it was##12##3##(1990-5#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-8#1)
whereas it##43##2##(1990-5#1)(1990-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-11#2)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
whereas its##12##2##(1990-12#1)(1994-3#1)(1997-2#1)(2007-10#1)(2008-3#1)(2008-4#3)(2008-6#1)(2009-11#1)(2010-8#1)(2013-1#1)
whereas large##2##2##(1990-8#1)(1997-6#1)
whereas less##3##2##(2006-6#1)(2008-10#1)(2008-4#1)
whereas low##2##2##(2008-10#1)(2008-12#1)
whereas lower##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
whereas men##3##2##(2010-12#1)(2010-6#1)(2013-8#1)
whereas mild##2##2##(1994-9#2)
whereas more##3##2##(2008-6#1)(2008-7#1)(2008-9#1)
whereas most of the##5##4##(1990-11#1)(1990-5#1)(2008-10#1)(2008-5#2)
whereas most##6##2##(1990-11#1)(1990-5#1)(2008-10#2)(2008-5#2)
whereas neither##2##2##(1994-6#1)(1997-7#1)
whereas no age##2##3##(1991-12#1)(2008-7#1)
whereas no effect##2##3##(1992-9#1)(2010-2#1)
whereas no significant##4##3##(1991-6#1)(2008-5#2)(2008-7#1)
whereas no such##2##3##(1995-3#1)(1997-4#1)
whereas no transmission##2##3##(2008-10#2)
whereas no##25##2##(1990-2#2)(1991-12#1)(1991-6#2)(1992-9#1)(1993-6#2)(1994-2#1)(1995-3#1)(1996-6#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2010-11#1)(2010-2#1)
whereas none of the##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
whereas none of##4##3##(1995-12#1)(1995-2#1)(2008-10#1)(2013-1#1)
whereas nuclei##2##2##(2008-11#1)(2008-2#1)
whereas on##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
whereas one##3##2##(1994-9#1)(2008-7#1)(2011-2#1)
whereas only a few##2##4##(1996-5#1)(2008-12#1)
whereas only a##6##3##(1996-5#1)(2008-10#2)(2008-12#1)(2010-4#1)(2010-6#1)
whereas only##25##2##(1992-12#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
whereas other##12##2##(1990-7#1)(1990-8#1)(1994-6#1)(1996-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
whereas others are##2##3##(2008-10#1)(2008-6#1)
whereas others had##2##3##(1995-2#1)(2008-10#1)
whereas others have##2##3##(2011-1#1)(2012-1#1)
whereas others##18##2##(1994-8#1)(1995-2#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
whereas participants##2##2##(2010-12#1)(2010-4#1)
whereas plasma##5##2##(1991-2#1)(1995-11#1)(2008-12#1)(2008-7#2)
whereas sensitivity##2##2##(2008-10#2)
whereas single##2##2##(2007-10#1)(2007-8#1)
whereas some##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
whereas strain##2##2##(2008-10#1)(2008-6#1)
whereas stroke##2##2##(1990-3#1)(2007-7#1)
whereas that of##10##3##(1990-3#1)(1990-6#1)(1990-8#1)(1992-8#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-8#1)
whereas that##16##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-8#1)(1994-7#1)(1995-12#1)(1997-2#2)(2008-10#4)(2008-2#1)(2008-8#1)(2012-2#1)
whereas the A##2##3##(1993-11#1)(2011-2#1)
whereas the PM of##2##4##(2008-7#2)
whereas the Rippey and##2##4##(2008-3#2)
whereas the activity of##2##4##(2007-8#1)(2009-8#1)
whereas the activity##3##3##(1994-6#1)(2007-8#1)(2009-8#1)
whereas the amplitude##3##3##(2008-3#2)(2008-6#1)
whereas the basal##2##3##(1995-12#1)(2008-7#1)
whereas the concentration of##2##4##(2007-12#1)(2008-10#1)
whereas the control group##2##4##(2008-12#1)(2013-1#1)
whereas the corresponding##4##3##(1990-9#1)(1992-12#1)(2008-10#1)(2008-3#1)
whereas the distribution of##2##4##(1993-8#1)(2009-12#1)
whereas the effect of##4##4##(1993-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
whereas the effects of##2##4##(2008-3#1)(2009-9#1)
whereas the experimental##2##3##(2008-9#1)(2012-2#1)
whereas the exponential##2##3##(2008-10#2)
whereas the highest##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
whereas the increase##2##3##(1993-12#1)(2008-5#1)
whereas the instantaneous mean is##2##5##(2009-9#1)(2010-5#1)
whereas the intensity model##2##4##(2008-3#2)
whereas the late##2##3##(1993-6#1)(2012-2#1)
whereas the latter is##2##4##(1990-8#1)(2008-10#1)
whereas the latter##5##3##(1990-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
whereas the level of tryptophan##2##5##(2009-8#2)
whereas the mean##2##3##(1992-8#1)(2010-10#1)
whereas the number of##2##4##(1990-7#1)(2008-8#1)
whereas the opposite##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
whereas the other two##3##4##(1990-11#1)(2008-10#2)
whereas the other##22##3##(1990-11#1)(1990-2#1)(1992-6#1)(1994-9#1)(1995-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2013-8#1)
whereas the pair##2##3##(2008-10#1)(2008-12#1)
whereas the patients##2##3##(1990-2#1)(1993-8#1)
whereas the performance of the##2##5##(1993-3#1)(2010-7#1)
whereas the phosphatase##2##3##(1994-9#1)(2008-10#1)
whereas the presence of##2##4##(1991-12#1)(2011-2#1)
whereas the proportion of##2##4##(1991-12#1)(2012-2#1)
whereas the remaining##6##3##(1993-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
whereas the role of##2##4##(1992-8#1)(1994-8#1)
whereas the same##6##3##(1990-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(2007-12#1)(2010-10#1)
whereas the second and##2##4##(1990-3#1)(2008-5#1)
whereas the second##10##3##(1990-3#1)(1991-9#1)(2008-10#4)(2008-5#2)(2008-8#1)(2013-7#1)
whereas the smaller##3##3##(1990-11#1)(1994-2#1)(2010-11#1)
whereas the third##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
whereas the three##2##3##(1990-8#1)(2008-1#1)
whereas the virus##2##3##(2008-10#2)
whereas the##404##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-4#1)(1991-5#4)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#6)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#85)(2008-11#10)(2008-12#7)(2008-2#10)(2008-3#34)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#9)(2008-9#8)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#14)(2012-12#1)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#3)
whereas their##4##2##(1991-5#1)(2007-11#1)(2008-9#1)(2009-7#1)
whereas there was no significant##2##5##(1991-8#1)(2011-1#1)
whereas there was no statistical difference##2##6##(1991-5#1)(1996-6#1)
whereas there was no##6##4##(1991-5#1)(1991-8#1)(1992-12#1)(1996-6#1)(2007-10#1)(2011-1#1)
whereas there was##9##3##(1991-5#1)(1991-8#1)(1992-12#1)(1996-12#1)(1996-6#1)(2007-10#1)(2008-10#2)(2011-1#1)
whereas there were##2##3##(1994-9#1)(1995-5#1)
whereas there##12##2##(1991-5#1)(1991-8#1)(1992-12#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-6#1)(2007-10#1)(2008-10#2)(2011-1#1)(2013-7#1)
whereas they are##2##3##(2008-10#1)(2008-2#1)
whereas they were##3##3##(1991-4#1)(1992-3#1)(1995-3#1)
whereas they##15##2##(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-1#1)(2012-2#1)
whereas this was##2##3##(2013-1#1)(2013-7#1)
whereas this##9##2##(1990-3#1)(1992-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)(2013-7#1)
whereas those collected##2##3##(2008-10#1)(2008-3#1)
whereas those in##2##3##(2008-10#2)
whereas those infected by##2##4##(2008-10#2)
whereas those of##6##3##(1992-6#1)(1992-8#1)(1997-6#1)(2008-10#2)(2008-5#1)
whereas those with##5##3##(1991-2#1)(1992-9#1)(1993-5#1)(1994-12#1)(2008-3#1)
whereas those##28##2##(1991-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1997-6#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#2)(2009-9#1)(2010-4#2)(2011-2#1)(2013-8#1)
whereas three##2##2##(2008-10#1)(2008-5#1)
whereas total##2##2##(2008-10#2)
whereas treatment##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
whereas two##5##2##(1993-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
whereas under##2##2##(2008-10#1)(2008-2#1)
whereas weight##2##2##(1993-2#1)(2008-7#1)
whereas when##4##2##(1992-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
whereas with##5##2##(1990-9#1)(1993-8#1)(1995-11#1)(2008-3#1)(2008-6#1)
whereas##1656##1##(1990-10#1)(1990-11#10)(1990-12#12)(1990-2#13)(1990-3#7)(1990-5#12)(1990-6#5)(1990-7#3)(1990-8#15)(1990-9#5)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#12)(1991-2#8)(1991-3#1)(1991-4#3)(1991-5#7)(1991-6#8)(1991-7#1)(1991-8#5)(1991-9#8)(1992-1#1)(1992-10#4)(1992-11#5)(1992-12#7)(1992-2#4)(1992-3#6)(1992-5#1)(1992-6#6)(1992-7#4)(1992-8#7)(1992-9#10)(1993-1#2)(1993-11#13)(1993-12#9)(1993-2#5)(1993-3#9)(1993-5#4)(1993-6#8)(1993-8#9)(1993-9#9)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#12)(1994-3#6)(1994-5#5)(1994-6#11)(1994-7#2)(1994-8#19)(1994-9#14)(1995-11#11)(1995-12#18)(1995-2#15)(1995-3#9)(1995-5#5)(1995-6#9)(1995-8#9)(1996-11#1)(1996-12#8)(1996-2#16)(1996-3#1)(1996-4#1)(1996-5#10)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#7)(1997-6#9)(1997-7#14)(1997-8#6)(2006-10#3)(2006-6#3)(2006-8#1)(2007-10#7)(2007-11#26)(2007-12#18)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#9)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#373)(2008-11#51)(2008-12#18)(2008-2#33)(2008-3#80)(2008-4#27)(2008-5#45)(2008-6#22)(2008-7#45)(2008-8#27)(2008-9#28)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#11)(2009-9#6)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#4)(2010-3#9)(2010-4#11)(2010-5#7)(2010-6#6)(2010-7#4)(2010-8#10)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#49)(2011-3#1)(2012-1#7)(2012-12#8)(2012-2#25)(2012-3#20)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#31)(2013-7#5)(2013-8#19)
whereby a well-defined cathodic##2##4##(2008-10#2)
whereby a##8##2##(2007-12#1)(2008-10#3)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
whereby an##2##2##(2007-12#1)(2008-1#1)
whereby the##17##2##(1991-2#1)(1994-9#1)(1995-2#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
whereby they##3##2##(1994-3#1)(2008-12#1)(2009-5#1)
whereby##85##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1996-1#2)(1996-2#1)(1996-5#2)(1997-1#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
wherein a##3##2##(2007-7#1)(2008-10#1)(2008-7#1)
wherein both##3##2##(1993-11#1)(2008-3#1)(2008-4#1)
wherein the##16##2##(1991-5#1)(1993-9#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-4#1)(2010-8#2)(2012-12#1)(2012-3#1)
wherein##36##1##(1991-5#1)(1993-11#1)(1993-9#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
whereupon##2##1##(2008-10#2)
wherever possible##4##2##(1993-12#1)(2008-4#1)(2013-1#2)
wherever##8##1##(1993-12#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#2)
whether C##2##2##(2008-10#1)(2012-1#1)
whether CRP levels are##2##4##(2007-10#2)
whether OCT##2##2##(2011-2#1)(2013-1#1)
whether a clade constitutes##2##4##(2008-8#2)
whether a particular##2##3##(2008-1#1)(2012-2#1)
whether a protein##2##3##(2008-4#2)
whether a similar##2##3##(1996-5#1)(2008-7#1)
whether a single##2##3##(2007-11#1)(2010-4#1)
whether a small##2##3##(1993-2#1)(1995-5#1)
whether a##59##2##(1991-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
whether additional##2##2##(2007-8#1)(2009-8#1)
whether age##4##2##(2010-3#3)(2013-8#1)
whether alveolar bone is##2##4##(2011-2#2)
whether an##10##2##(1990-6#1)(1991-6#1)(1996-2#1)(2007-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)
whether and how these##2##4##(2009-5#1)(2011-2#1)
whether and how##8##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#2)(2013-1#1)
whether and to what extent##3##5##(1996-12#1)(2010-8#1)(2011-2#1)
whether and##13##2##(1996-12#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-5#1)(2010-8#1)(2011-2#3)(2013-1#1)
whether any##7##2##(1990-11#1)(1991-8#1)(1992-12#1)(1993-11#1)(1995-11#1)(2008-11#1)(2010-3#1)
whether axillary##2##2##(1994-12#1)(1994-7#1)
whether both##2##2##(1994-8#1)(2008-10#1)
whether cells##2##2##(1996-2#1)(2008-4#1)
whether changes in##2##3##(2008-11#1)(2008-9#1)
whether children with##2##3##(1994-2#1)(2012-2#1)
whether children##3##2##(1994-2#1)(2008-12#1)(2012-2#1)
whether chronic##2##2##(1990-11#1)(2008-10#1)
whether cigarette##2##2##(2009-7#1)(2013-1#1)
whether clinical##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
whether congruent##2##2##(2012-1#2)
whether cosmetics##2##2##(2008-5#2)
whether cultured##3##2##(1993-9#1)(2008-11#2)
whether deficits in communication skills##2##5##(2012-2#2)
whether differences##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
whether different##4##2##(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
whether each##2##2##(1994-12#1)(2012-3#1)
whether efficiency of##2##3##(1993-2#1)(2012-2#1)
whether expressed per mg protein or per total kidney cortex##2##10##(1994-8#2)
whether expressed##3##2##(1994-8#2)(2009-8#1)
whether expression of##3##3##(1994-7#1)(1994-8#1)(2010-11#1)
whether he had##2##3##(1991-6#1)(2013-1#1)
whether health##2##2##(1994-3#1)(2012-3#1)
whether high##3##2##(1997-7#1)(2009-9#1)(2012-6#1)
whether human##2##2##(1997-1#1)(2009-12#1)
whether in a##2##3##(1991-3#1)(1993-5#1)
whether in##6##2##(1991-3#1)(1991-9#1)(1993-5#1)(1995-12#1)(2008-12#1)(2011-2#1)
whether increased##3##2##(1992-2#1)(1993-8#1)(2012-3#1)
whether it is a##4##4##(1994-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
whether it is isolated or##2##5##(1996-12#1)(2007-12#1)
whether it is possible to##2##5##(2008-10#1)(2008-11#1)
whether it is##25##3##(1994-5#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
whether it was##7##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)(2013-8#1)
whether it##42##2##(1990-5#1)(1992-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-5#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
whether its##3##2##(1992-5#1)(1994-6#1)(1995-11#1)
whether low##5##2##(2007-8#2)(2008-4#1)(2012-6#1)(2013-1#1)
whether medical##2##2##(2009-4#1)(2011-2#1)
whether older##2##2##(2008-11#1)(2010-8#1)
whether one is dealing with##2##5##(1994-3#1)(2007-12#1)
whether one##5##2##(1993-9#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-2#1)
whether or not a##5##4##(1991-1#1)(2007-11#1)(2008-11#2)(2008-5#1)
whether or not it is##2##5##(1992-9#1)(2011-2#1)
whether or not the##15##4##(1990-7#1)(1991-7#2)(1994-12#1)(1994-2#1)(1995-8#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
whether or not they are##2##5##(1990-11#1)(1997-3#1)
whether or not they##7##4##(1990-11#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2012-2#1)(2013-1#1)
whether or not to##2##4##(1991-3#1)(2013-1#1)
whether or not##58##3##(1990-11#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#7)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-10#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
whether other##3##2##(1990-8#1)(1991-3#1)(2012-3#1)
whether parents##2##2##(1994-2#1)(2008-9#1)
whether patients with##2##3##(2008-7#2)
whether patients##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
whether patients' perception of early##2##5##(2013-1#2)
whether patients'##3##2##(1994-2#1)(2013-1#2)
whether prenatal##2##2##(1995-6#1)(2008-10#1)
whether providing information##2##3##(1996-2#1)(1997-3#1)
whether providing##3##2##(1996-2#1)(1997-3#1)(2013-1#1)
whether rTMS##2##2##(2010-7#1)(2013-1#1)
whether similar##5##2##(2008-10#3)(2008-8#1)(2010-6#1)
whether single##2##2##(1996-12#1)(2010-6#1)
whether skin##2##2##(2008-11#1)(2013-1#1)
whether social##4##2##(2009-10#1)(2009-12#1)(2010-4#1)(2012-3#1)
whether such differences##2##3##(1992-8#1)(2013-1#1)
whether such##13##2##(1990-5#1)(1992-8#1)(1996-12#1)(1997-4#2)(2008-10#1)(2008-2#1)(2008-8#2)(2009-8#1)(2010-2#1)(2013-1#2)
whether the adjective described##2##4##(2008-11#2)
whether the adjective##3##3##(2008-11#3)
whether the clinical##2##3##(2010-3#1)(2011-2#1)
whether the drug##2##3##(2008-5#1)(2008-8#1)
whether the effect##2##3##(1991-12#1)(1994-8#1)
whether the effects of##3##4##(1997-1#1)(2008-10#1)(2009-2#1)
whether the effects##5##3##(1997-1#1)(2008-10#1)(2009-11#1)(2009-2#1)(2012-1#1)
whether the instrument##2##3##(2008-3#1)(2010-10#1)
whether the interventions##2##3##(2009-6#2)
whether the level of##2##4##(2007-10#1)(2008-10#1)
whether the location##2##3##(1994-8#1)(2008-10#1)
whether the observed##2##3##(2009-8#1)(2013-8#1)
whether the presence of##2##4##(1997-4#1)(2011-2#1)
whether the reduced##2##3##(2008-1#1)(2008-7#1)
whether the relationship##3##3##(1994-2#1)(2010-2#2)
whether the stimulus##2##3##(1991-1#1)(2008-11#1)
whether the target##2##3##(2008-3#1)(2012-2#1)
whether the type of##2##4##(1993-12#1)(2008-8#1)
whether the use of##4##4##(1994-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
whether the##271##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#2)(2007-11#3)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#20)(2008-11#14)(2008-12#5)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#6)(2008-7#4)(2008-8#12)(2008-9#4)(2009-10#3)(2009-11#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
whether their##4##2##(1993-1#1)(1995-2#1)(2008-3#1)(2010-3#1)
whether there are differences in##2##5##(2009-3#1)(2013-1#1)
whether there are differences##3##4##(2009-3#1)(2010-7#1)(2013-1#1)
whether there are##8##3##(1996-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
whether there is a##7##4##(1995-2#1)(2008-11#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
whether there is an##2##4##(1992-12#1)(2009-12#1)
whether there is##13##3##(1992-12#1)(1995-2#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
whether there was a##2##4##(2007-12#1)(2008-7#1)
whether there was##8##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
whether there were##2##3##(2007-10#1)(2008-11#1)
whether there##36##2##(1992-12#1)(1992-2#1)(1995-12#1)(1995-2#2)(1996-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
whether these alterations##3##3##(1996-5#1)(2011-1#1)(2012-1#1)
whether these are##2##3##(1995-12#1)(1997-4#1)
whether these effects are##2##4##(2009-11#1)(2012-2#1)
whether these effects##3##3##(2008-1#1)(2009-11#1)(2012-2#1)
whether these techniques can##2##4##(2008-10#1)(2008-7#1)
whether these##36##2##(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
whether they are##12##3##(1994-9#1)(1996-2#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)
whether they be##2##3##(2009-8#1)(2010-11#1)
whether they contain##2##3##(2007-12#1)(2008-5#1)
whether they may be##2##4##(2007-10#1)(2008-6#1)
whether they should be##2##4##(1995-2#1)(1997-1#1)
whether they were##6##3##(1994-1#1)(1995-1#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
whether they##48##2##(1990-3#1)(1994-1#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#2)(1997-1#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-4#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)
whether this also##2##3##(1996-2#1)(2008-6#1)
whether this increase##2##3##(1997-2#1)(2008-11#1)
whether this is a##2##4##(2008-5#1)(2008-7#1)
whether this is##6##3##(1994-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
whether this new##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
whether this##51##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-5#1)(2006-10#2)(2007-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
whether those##3##2##(2009-5#1)(2012-2#1)(2013-1#1)
whether to apply or##2##4##(2008-10#2)
whether to apply##3##3##(2008-10#3)
whether to continue##2##3##(1997-1#1)(2008-12#1)
whether to leave the##2##4##(2008-8#1)(2008-9#1)
whether to use##4##3##(1996-1#1)(2008-12#1)(2008-7#1)(2012-2#1)
whether to##27##2##(1990-2#1)(1991-1#1)(1996-1#1)(1996-2#2)(1997-1#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
whether transcription##2##2##(1993-2#1)(2010-10#1)
whether treatment##2##2##(1990-11#1)(2011-1#1)
whether two##3##2##(1995-2#1)(2008-11#1)(2011-1#1)
whether use of##2##3##(2007-8#1)(2008-11#1)
whether variation in##2##3##(2010-3#1)(2012-3#1)
whether variation##3##2##(1990-6#1)(2010-3#1)(2012-3#1)
whether we could##2##3##(1991-11#1)(1996-12#1)
whether we have##2##3##(2008-11#1)(2009-11#1)
whether we##7##2##(1991-11#1)(1994-1#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-7#1)
whether women##3##2##(1992-4#1)(2008-6#1)(2013-1#1)
whether##1320##1##(1990-10#1)(1990-11#7)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#10)(1990-6#6)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#6)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#5)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#14)(1993-2#6)(1993-3#9)(1993-5#1)(1993-6#6)(1993-8#7)(1993-9#6)(1994-1#5)(1994-11#2)(1994-12#11)(1994-2#13)(1994-3#11)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#16)(1994-9#4)(1995-1#1)(1995-11#7)(1995-12#18)(1995-2#12)(1995-3#7)(1995-5#9)(1995-6#3)(1995-8#6)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#12)(1996-2#14)(1996-3#3)(1996-4#3)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#8)(1997-2#9)(1997-3#9)(1997-4#9)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#3)(2006-10#6)(2006-6#2)(2007-10#12)(2007-11#10)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#21)(2007-9#1)(2008-1#10)(2008-10#90)(2008-11#70)(2008-12#25)(2008-2#9)(2008-3#25)(2008-4#18)(2008-5#38)(2008-6#22)(2008-7#41)(2008-8#55)(2008-9#34)(2009-1#3)(2009-10#8)(2009-11#9)(2009-12#10)(2009-2#4)(2009-3#5)(2009-4#5)(2009-5#8)(2009-6#6)(2009-7#10)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#7)(2010-12#8)(2010-2#11)(2010-3#8)(2010-4#8)(2010-5#5)(2010-6#7)(2010-7#8)(2010-8#9)(2010-9#1)(2011-1#12)(2011-2#59)(2011-3#1)(2012-1#10)(2012-12#14)(2012-2#38)(2012-3#29)(2012-5#2)(2012-6#2)(2012-7#1)(2013-1#57)(2013-7#10)(2013-8#16)
whey by##3##2##(2008-10#1)(2008-6#2)
whey components##3##2##(2008-10#3)
whey lactose##2##2##(2008-6#2)
whey protein isolate##2##3##(2013-1#2)
whey protein##4##2##(2008-10#1)(2010-4#1)(2013-1#2)
whey##30##1##(1993-2#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-6#7)(2008-7#6)(2010-4#1)(2013-1#2)
whiH##2##1##(2008-8#2)
which &quot##3##2##(1996-11#1)(2008-1#1)(2013-8#1)
which (a)##2##2##(2008-3#1)(2013-1#1)
which (i)##2##2##(1990-8#1)(1993-3#1)
which 1##5##2##(1996-2#1)(1997-1#1)(2007-7#1)(2011-3#1)(2013-8#1)
which 10##3##2##(2007-8#1)(2008-10#2)
which 13##4##2##(2007-8#2)(2008-7#1)(2011-2#1)
which 14##2##2##(1991-12#1)(2008-12#1)
which 26##2##2##(1995-12#1)(2008-8#1)
which 3##3##2##(1993-5#1)(2011-2#1)(2013-8#1)
which 4##4##2##(2007-8#1)(2008-10#1)(2008-9#2)
which 60##2##2##(2008-5#1)(2013-1#1)
which 8##2##2##(1991-11#1)(2013-8#1)
which A##3##2##(1995-8#1)(2008-10#1)(2012-3#1)
which Buffon##2##2##(2008-12#2)
which C##2##2##(2007-12#2)
which CR##2##2##(1994-5#1)(2008-7#1)
which Canadian##2##2##(2007-12#1)(2011-2#1)
which DNA is##2##3##(2008-10#2)
which DNA##8##2##(1994-10#1)(1997-4#1)(2008-10#5)(2009-4#1)
which Gd(3+) has the greatest enhancement##2##6##(2008-10#2)
which I##5##2##(1995-2#1)(1995-8#1)(2008-11#1)(2008-9#1)(2013-8#1)
which Medicare##3##2##(1997-3#1)(2008-7#1)(2012-3#1)
which P##2##2##(2008-10#2)
which RNA##2##2##(1993-8#1)(1994-8#1)
which S##2##2##(2008-10#1)(2012-7#1)
which T cells##2##3##(1995-2#1)(2008-8#1)
which T##4##2##(1990-12#1)(1995-2#1)(2008-10#1)(2008-8#1)
which UV##2##2##(2008-10#1)(2011-2#1)
which Wolbachia##2##2##(2008-8#1)(2008-9#1)
which a direct##2##3##(1992-2#1)(2007-11#1)
which a microscope##2##3##(2008-2#1)(2008-9#1)
which a sample##2##3##(2007-11#1)(2008-10#1)
which a specific##2##3##(2008-4#1)(2009-5#1)
which a subject##4##3##(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)
which a##169##2##(1990-11#1)(1990-5#2)(1990-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#9)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#16)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#4)
which about##2##2##(1997-4#1)(2008-10#1)
which accommodates##2##2##(1994-3#1)(1996-5#1)
which accompanies##3##2##(1990-5#1)(1991-5#1)(2007-12#1)
which accompany##2##2##(1997-1#1)(1997-2#1)
which account for##2##3##(2011-2#2)
which accounted for##6##3##(2008-10#5)(2010-5#1)
which accounts for the##4##4##(1990-8#1)(2009-5#1)(2009-9#1)(2012-2#1)
which accounts for##8##3##(1990-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
which accumulate in the##2##4##(1991-12#1)(2008-9#1)
which accumulates##2##2##(1995-3#1)(2008-5#1)
which achieved##4##2##(2008-7#1)(2012-12#1)(2012-2#2)
which act as##5##3##(1994-5#1)(1994-8#1)(2008-11#1)(2008-5#1)(2008-6#1)
which act##10##2##(1990-11#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
which acted##2##2##(2008-3#1)(2008-8#1)
which activate##5##2##(1992-8#2)(1994-11#1)(2008-10#1)(2008-11#1)
which activated##2##2##(1997-8#1)(2008-8#1)
which activates##7##2##(1991-11#1)(1994-8#1)(1997-2#1)(2008-7#1)(2008-9#2)(2011-2#1)
which activation##2##2##(2008-4#2)
which actively##2##2##(2008-12#1)(2013-1#1)
which acts as a##9##4##(1992-4#1)(1992-6#1)(1994-12#1)(1994-6#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
which acts as an##4##4##(1994-5#1)(2008-4#1)(2008-6#1)(2013-1#1)
which acts as the##2##4##(1994-5#1)(2008-10#1)
which acts as##15##3##(1992-4#1)(1992-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2013-1#1)
which acts##19##2##(1992-4#1)(1992-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1996-3#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
which address##2##2##(1992-3#1)(2012-2#1)
which addresses the##2##3##(1994-1#1)(2008-7#1)
which affect the##9##3##(1991-12#1)(1993-9#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)
which affect##14##2##(1991-12#1)(1993-9#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
which affected the##2##3##(2007-12#1)(2010-8#1)
which affected##4##2##(1995-11#1)(2007-12#1)(2008-8#1)(2010-8#1)
which affects a##2##3##(2008-10#1)(2008-3#1)
which affects the##3##3##(2008-12#1)(2008-8#1)(2012-12#1)
which affects##15##2##(1991-12#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
which affords the##2##3##(2008-9#1)(2012-2#1)
which after##4##2##(1995-3#1)(2007-8#2)(2008-11#1)
which aggregates##2##2##(1994-2#1)(2008-5#1)
which agreed##2##2##(2008-3#1)(2011-1#1)
which agrees with the##3##4##(2007-11#1)(2008-2#1)(2008-8#1)
which agrees##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
which aim at##2##3##(2011-2#1)(2013-8#1)
which aim to##2##3##(2008-10#1)(2011-2#1)
which aim##4##2##(2008-10#1)(2011-2#2)(2013-8#1)
which aimed to##3##3##(2012-3#3)
which aimed##4##2##(2008-10#1)(2012-3#3)
which aims at##2##3##(2008-7#1)(2010-1#1)
which aims to##3##3##(2008-11#1)(2008-6#1)(2009-12#1)
which aims##5##2##(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#1)
which all the##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
which all were##2##3##(2008-11#1)(2010-1#1)
which all##31##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#2)
which allow a##2##3##(1990-7#1)(2008-6#1)
which allow for##2##3##(1992-6#1)(2009-5#1)
which allow the##5##3##(1993-6#1)(2008-10#2)(2008-4#1)(2008-8#1)
which allow us to##3##4##(1990-11#1)(2007-11#1)(2013-8#1)
which allow##21##2##(1990-11#1)(1990-7#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1996-6#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-11#1)(2013-8#1)
which allowed for##2##3##(2008-3#1)(2009-9#1)
which allowed the determination of##3##5##(2008-10#3)
which allowed the##9##3##(1993-1#1)(2008-10#6)(2008-11#1)(2009-7#1)
which allowed to##2##3##(1990-11#1)(2008-10#1)
which allowed##30##2##(1990-11#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-6#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#2)(2013-1#1)
which allows a##4##3##(1993-2#1)(1997-6#1)(2006-4#1)(2008-10#1)
which allows for a##2##4##(2008-10#1)(2008-6#1)
which allows for the##4##4##(1990-5#1)(2008-3#2)(2008-4#1)
which allows for##13##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#1)
which allows one to##3##4##(2007-12#2)(2008-10#1)
which allows the use of##2##5##(2008-5#1)(2011-1#1)
which allows the##24##3##(1990-3#1)(1991-5#1)(1992-9#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-12#1)(2010-7#1)(2011-1#2)
which allows to##6##3##(1991-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-3#1)
which allows us to##3##4##(1990-2#1)(2008-3#1)(2012-3#1)
which allows users to##2##4##(2008-4#1)(2011-3#1)
which allows##86##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#2)(2010-12#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
which alone##2##2##(1997-1#1)(2009-6#1)
which already##2##2##(1991-9#1)(1996-3#1)
which also affects##2##3##(2011-1#1)(2012-2#1)
which also binds##2##3##(1995-2#1)(2008-7#1)
which also contains##2##3##(1991-12#1)(2008-3#1)
which also has##2##3##(1990-7#1)(2007-8#1)
which also included##2##3##(2008-10#1)(2012-3#1)
which also includes##3##3##(1993-9#1)(1994-12#1)(2008-10#1)
which also influence##2##3##(2008-11#1)(2012-2#1)
which also provides a##2##4##(1997-1#1)(2008-10#1)
which also showed##3##3##(1991-5#1)(1991-8#1)(1993-12#1)
which also##65##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
which alter##3##2##(1990-6#1)(1995-12#1)(1995-6#1)
which alters##3##2##(1991-12#1)(1995-8#1)(2008-7#1)
which amino##2##2##(1992-6#1)(1995-12#1)
which ammonia##2##2##(1990-8#1)(2008-10#1)
which an intense##2##3##(2008-10#2)
which an##41##2##(1990-11#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1993-12#1)(1995-3#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-11#2)(2008-3#7)(2008-4#1)(2009-9#1)(2010-11#1)(2011-2#2)(2011-8#1)(2012-12#2)(2013-1#2)
which analytical##2##2##(2008-10#1)(2008-2#1)
which animals##2##2##(1992-8#1)(2009-8#1)
which antibodies##2##2##(2008-4#1)(2008-9#1)
which antibody##2##2##(1993-8#1)(1995-2#1)
which any##2##2##(1991-6#1)(2012-12#1)
which apoptotic##2##2##(2008-7#1)(2008-9#1)
which apothecia##2##2##(2008-10#2)
which apparently##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
which appear as##2##3##(1990-12#1)(2010-6#1)
which appear to be##5##4##(1990-5#1)(1995-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
which appear to##11##3##(1990-5#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
which appear##19##2##(1990-12#1)(1990-5#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
which appeared in##5##3##(1990-12#1)(1992-2#1)(1994-8#1)(1995-3#1)(2008-5#1)
which appeared to be##7##4##(1990-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)
which appeared to##15##3##(1990-2#1)(1990-5#1)(1990-6#1)(1993-12#1)(1995-12#1)(1995-6#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#1)
which appeared##24##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#2)(2010-8#1)
which appears in##2##3##(2008-9#1)(2010-5#1)
which appears to be a##3##5##(1990-12#1)(1994-11#1)(1995-5#1)
which appears to be##13##4##(1990-12#1)(1990-7#1)(1990-9#1)(1991-4#1)(1993-11#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
which appears to##16##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-4#1)(1993-11#2)(1994-11#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)
which appears##20##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-4#1)(1993-11#2)(1994-11#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
which applies##2##2##(2008-10#1)(2008-2#1)
which apply##2##2##(2007-12#1)(2008-4#1)
which approach##2##2##(2008-10#1)(2008-5#1)
which approximately##2##2##(1992-3#1)(1994-11#1)
which are DNA##2##3##(1995-5#1)(2008-10#1)
which are able to##3##4##(1994-6#1)(2008-10#1)(2010-7#1)
which are acceptable##2##3##(1994-3#1)(2012-2#1)
which are all##4##3##(1995-2#1)(1997-4#1)(2008-10#1)(2009-11#1)
which are already##2##3##(1992-10#1)(2009-5#1)
which are also##4##3##(1991-5#1)(2008-2#1)(2010-10#1)(2011-3#1)
which are associated with the##3##5##(1995-5#1)(2008-10#1)(2013-8#1)
which are associated with##9##4##(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
which are at##2##3##(2007-12#1)(2007-4#1)
which are attached##2##3##(2008-10#1)(2009-1#1)
which are available##2##3##(2007-8#1)(2008-4#1)
which are based on##8##4##(1992-5#1)(1992-9#1)(1994-9#1)(1995-9#1)(2008-10#3)(2010-5#1)
which are based##10##3##(1991-12#1)(1992-5#1)(1992-9#1)(1994-9#1)(1995-9#1)(2008-10#3)(2008-9#1)(2010-5#1)
which are being increasingly##2##4##(2008-4#1)(2008-9#1)
which are believed to be##2##5##(2007-11#1)(2007-12#1)
which are believed to##3##4##(1991-9#1)(2007-11#1)(2007-12#1)
which are biologically different from##2##5##(2008-10#1)(2010-3#1)
which are biologically##3##3##(1992-12#1)(2008-10#1)(2010-3#1)
which are both##4##3##(1992-9#1)(2007-11#1)(2008-10#1)(2011-2#1)
which are carried##2##3##(2007-11#1)(2008-7#1)
which are characteristic for a given molecule (fluorophore)##2##8##(2008-1#1)(2008-4#1)
which are characteristic for##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
which are characteristic##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)
which are characterized by##6##4##(1992-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
which are characterized##7##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2013-1#1)
which are close##2##3##(1996-12#1)(2006-4#1)
which are common##2##3##(2008-3#1)(2008-8#1)
which are commonly referred to as##2##6##(2008-10#1)(2008-3#1)
which are commonly used##2##4##(1995-12#1)(2008-10#1)
which are commonly##7##3##(1995-12#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#1)
which are comparable##2##3##(2008-10#1)(2012-1#1)
which are compared##2##3##(1994-5#1)(2008-3#1)
which are composed of##2##4##(1997-4#1)(2008-10#1)
which are considered to be##2##5##(2010-3#1)(2013-8#1)
which are considered##3##3##(2008-10#1)(2010-3#1)(2013-8#1)
which are consistent with##3##4##(2008-10#1)(2008-8#1)(2009-12#1)
which are critical for##2##4##(1993-8#1)(2008-11#1)
which are critical##3##3##(1993-8#1)(2008-11#1)(2008-9#1)
which are currently being##2##4##(2008-11#1)(2008-12#1)
which are currently the##2##4##(2007-11#1)(2008-5#1)
which are currently##8##3##(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-2#1)
which are described##5##3##(1996-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
which are designed to##2##4##(1997-4#1)(2008-11#1)
which are designed##3##3##(1997-4#1)(2007-12#1)(2008-11#1)
which are detected##2##3##(2008-3#2)
which are different from##2##4##(2008-9#1)(2010-3#1)
which are differentially expressed##2##4##(1992-6#1)(2008-10#1)
which are differentially##3##3##(1991-9#1)(1992-6#1)(2008-10#1)
which are differently##2##3##(1995-2#1)(2007-11#1)
which are difficult to##4##4##(2008-3#1)(2009-5#1)(2010-3#1)(2012-2#1)
which are directly##2##3##(2008-10#2)
which are discussed##3##3##(1990-8#1)(1991-3#1)(2013-1#1)
which are due to##3##4##(2008-11#1)(2008-2#1)(2010-8#1)
which are effective##2##3##(1995-11#1)(2007-11#1)
which are endemic in##2##4##(2007-12#1)(2012-12#1)
which are essential for##4##4##(1994-8#1)(2007-12#1)(2010-9#1)(2012-2#1)
which are essential to##3##4##(1995-5#1)(2007-8#1)(2008-11#1)
which are essential##9##3##(1994-8#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-9#1)(2012-2#1)(2013-1#2)
which are expressed in##2##4##(1992-6#1)(2008-11#1)
which are expressed##4##3##(1992-6#1)(2008-11#1)(2008-7#1)(2008-9#1)
which are extremely##2##3##(1995-5#1)(2008-10#1)
which are features of##2##4##(2008-10#1)(2012-2#1)
which are formed##4##3##(1994-2#1)(1996-5#1)(2008-10#2)
which are found to##2##4##(2008-7#1)(2008-8#1)
which are found##5##3##(1992-8#1)(2008-7#2)(2008-8#1)(2013-1#1)
which are frequent##2##3##(1991-12#1)(2010-11#1)
which are frequently##3##3##(2008-7#1)(2010-3#1)(2011-2#1)
which are generally associated##2##4##(1997-1#1)(2010-12#1)
which are generally##10##3##(1990-12#1)(1995-2#1)(1996-12#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
which are highly##7##3##(1994-6#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-12#1)
which are important for the##3##5##(1997-2#1)(1997-4#1)(2008-10#1)
which are important for##5##4##(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
which are important in##2##4##(1994-6#1)(2008-10#1)
which are important##9##3##(1994-6#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#1)
which are in##13##3##(1990-12#1)(1990-3#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-2#1)(2012-3#1)(2013-7#1)
which are independent of##3##4##(1990-8#1)(1996-2#1)(2008-7#1)
which are indicative of##2##4##(2007-12#1)(2008-3#1)
which are involved in the##4##5##(1992-6#1)(1996-9#1)(2008-10#1)(2008-7#1)
which are involved in##9##4##(1992-6#1)(1994-3#1)(1995-6#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-7#1)
which are isolated##2##3##(1990-2#1)(2010-5#1)
which are known as##3##4##(1993-3#1)(2007-11#1)(2008-3#1)
which are known to be involved in##3##7##(1991-8#1)(2008-11#1)(2008-4#1)
which are known to be##7##5##(1991-8#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)
which are known to induce##3##5##(1994-10#1)(1994-12#1)(1995-9#1)
which are known to interfere with other previously suggested sensors##2##10##(2008-10#2)
which are known to interfere with##3##6##(2008-10#3)
which are known to interfere##4##5##(2008-10#4)
which are known to##24##4##(1991-8#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2013-1#1)
which are known##29##3##(1991-8#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2013-1#1)
which are largely##2##3##(2008-12#1)(2010-12#1)
which are likely to##4##4##(1990-6#1)(1997-3#1)(2009-7#1)(2013-8#1)
which are linked to##3##4##(2008-5#1)(2010-10#1)(2013-8#1)
which are located in the##2##5##(1991-2#1)(2008-7#1)
which are located within the##2##5##(1994-12#1)(1995-8#1)
which are located##6##3##(1991-2#1)(1994-12#1)(1995-8#1)(2007-12#1)(2008-7#1)(2008-8#1)
which are made of##2##4##(1993-2#1)(1994-12#1)
which are mainly##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
which are major##2##3##(2008-10#1)(2010-11#1)
which are markers of the##2##5##(2008-10#2)
which are measured##2##3##(1994-2#1)(2007-11#1)
which are mediated by##2##4##(1993-6#1)(2008-4#1)
which are mediated##3##3##(1991-2#1)(1993-6#1)(2008-4#1)
which are members of the##3##5##(1992-11#1)(2008-10#2)
which are more##10##3##(1990-2#1)(1991-3#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-5#1)(2010-2#1)(2013-1#1)
which are most##2##3##(1996-3#1)(2008-10#1)
which are much smaller than the##2##6##(2007-12#1)(2008-10#1)
which are much##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
which are necessary##2##3##(1997-4#1)(2011-2#1)
which are not readily##2##4##(1993-2#1)(1996-12#1)
which are not##24##3##(1990-12#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-12#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)
which are of##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)
which are often##10##3##(1992-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-2#1)(2012-1#1)
which are particularly##2##3##(1995-12#1)(2008-9#1)
which are present in the##2##5##(1993-11#1)(2008-11#1)
which are present in##5##4##(1991-12#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
which are present##6##3##(1991-12#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
which are probably##2##3##(2008-11#1)(2008-5#1)
which are produced by##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
which are produced##4##3##(2008-10#2)(2008-8#1)(2012-3#1)
which are quite##2##3##(2008-5#1)(2013-1#1)
which are readily##2##3##(2008-10#1)(2008-7#1)
which are reflected in##2##4##(1992-3#1)(2010-5#1)
which are regulated by##5##4##(1992-2#1)(1994-3#1)(1995-5#1)(2011-1#1)(2013-1#1)
which are regulated##6##3##(1992-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(2011-1#1)(2013-1#1)
which are related to the##4##5##(1992-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
which are related##5##3##(1992-8#1)(2008-10#2)(2008-3#1)(2010-4#1)
which are relatively##2##3##(1994-6#1)(2008-10#1)
which are relevant for##3##4##(1994-5#1)(1995-5#1)(2009-10#1)
which are required for##3##4##(1997-7#1)(2008-10#1)(2008-2#1)
which are required##4##3##(1997-7#1)(2008-10#1)(2008-2#1)(2012-3#1)
which are resistant to##2##4##(2008-10#2)
which are resistant##3##3##(2008-10#3)
which are responsible for the##4##5##(1991-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
which are responsible for##7##4##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-8#1)
which are selective##2##3##(1993-6#1)(1997-2#1)
which are sensitive to##2##4##(2008-8#1)(2011-2#1)
which are separated by an##2##5##(1997-2#1)(2008-3#1)
which are separated by##3##4##(1997-2#2)(2008-3#1)
which are separated##4##3##(1994-9#1)(1997-2#2)(2008-3#1)
which are similar to##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
which are simultaneously##2##3##(2008-3#1)(2010-8#1)
which are specialized##2##3##(2008-5#1)(2011-2#1)
which are specific to##2##4##(1992-6#1)(2008-7#1)
which are specific##4##3##(1992-6#1)(1994-5#1)(2008-7#2)
which are still##2##3##(1990-3#1)(2009-5#1)
which are strongly##2##3##(2009-3#1)(2011-2#1)
which are subject to##2##4##(2008-11#1)(2012-2#1)
which are subsequently##2##3##(1997-3#1)(2008-11#1)
which are sufficiently##2##3##(2008-10#1)(2008-3#1)
which are suitable##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
which are termed##2##3##(2008-2#1)(2013-8#1)
which are the main##3##4##(1997-4#1)(2007-8#1)(2013-8#1)
which are the##20##3##(1993-8#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
which are then used##2##4##(2008-2#1)(2008-5#1)
which are then##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-1#1)
which are thought to##5##4##(1994-2#1)(1995-12#1)(2008-12#1)(2008-7#1)(2008-8#1)
which are tightly##2##3##(2012-2#1)(2013-7#1)
which are to##2##3##(1996-8#1)(2008-11#1)
which are traditionally##2##3##(2008-10#1)(2008-5#1)
which are typical of##2##4##(2008-3#1)(2011-2#1)
which are typical##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
which are unable to##3##4##(1993-11#1)(1994-3#1)(2008-10#1)
which are unique##2##3##(1991-12#1)(1991-6#1)
which are up to##2##4##(2007-12#1)(2008-11#1)
which are used as##2##4##(2008-10#1)(2010-7#1)
which are used in##6##4##(1991-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
which are used to##5##4##(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
which are used##18##3##(1991-11#1)(1992-6#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2010-7#1)(2010-8#2)(2011-1#1)
which are useful##3##3##(1996-5#1)(2008-2#1)(2008-4#1)
which are usually##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
which are valuable##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
which are very##2##3##(2007-8#1)(2008-7#1)
which are well##2##3##(1990-12#1)(2012-2#1)
which are widely##2##3##(2008-7#1)(2011-2#1)
which are yet##2##3##(2008-11#1)(2009-3#1)
which are##776##2##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#8)(1991-2#4)(1991-3#3)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#4)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#6)(1994-5#7)(1994-6#4)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#2)(1995-5#9)(1995-6#2)(1995-8#2)(1995-9#3)(1996-10#1)(1996-12#5)(1996-2#6)(1996-3#2)(1996-5#4)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#7)(1997-6#3)(1997-7#4)(1997-8#1)(2006-4#1)(2007-11#14)(2007-12#22)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#5)(2008-1#8)(2008-10#109)(2008-11#46)(2008-12#6)(2008-2#13)(2008-3#37)(2008-4#21)(2008-5#31)(2008-6#7)(2008-7#35)(2008-8#24)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#2)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#8)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#9)(2010-9#2)(2011-1#10)(2011-2#22)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#16)(2012-3#4)(2013-1#21)(2013-7#3)(2013-8#14)
which areas##2##2##(1996-3#1)(2013-1#1)
which arise in##2##3##(2008-11#1)(2011-1#1)
which arise##6##2##(1990-7#1)(1992-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-1#1)
which arises from the##2##4##(2011-2#1)(2013-8#1)
which arises from##4##3##(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
which arises##5##2##(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
which arose from##2##3##(2008-10#1)(2008-7#1)
which arrest##2##2##(2008-11#2)
which aspects of##2##3##(2008-11#1)(2012-3#1)
which assess##2##2##(2008-10#1)(2012-3#1)
which assists##2##2##(2008-10#1)(2013-1#1)
which assumes that the##3##4##(1992-2#1)(2008-10#1)(2008-5#1)
which assumes that##5##3##(1992-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
which assumes##8##2##(1992-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)
which at least##2##3##(1997-6#1)(2008-7#1)
which at##7##2##(1990-7#1)(1992-8#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-7#1)
which attempt##2##2##(2008-7#1)(2009-12#1)
which avoids##3##2##(2008-3#1)(2009-12#1)(2009-9#1)
which bacteria##2##2##(2008-10#2)
which balances the##2##3##(2008-8#1)(2009-10#1)
which based on the##2##4##(2008-10#2)
which basically##2##2##(2007-7#1)(2008-11#1)
which bears##2##2##(2008-11#1)(2008-9#1)
which became the##3##3##(1992-2#1)(2008-4#1)(2009-7#1)
which became##6##2##(1992-2#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-4#1)(2009-7#1)
which become##3##2##(1995-6#1)(2008-10#1)(2010-5#1)
which becomes##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
which began in##2##3##(1995-12#1)(2009-7#1)
which began##3##2##(1995-12#1)(1997-8#1)(2009-7#1)
which behaves##2##2##(2012-2#1)(2013-7#1)
which behavioral##2##2##(2008-9#1)(2010-10#1)
which belong to the##3##4##(1992-9#1)(2008-12#1)(2008-5#1)
which belong to##4##3##(1992-9#1)(2008-12#1)(2008-5#2)
which belongs to the actinobacterial family##2##6##(2011-2#2)
which belongs to the family##3##5##(2011-2#3)
which belongs to the##12##4##(1996-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#5)(2012-2#1)
which belongs to##14##3##(1996-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#5)(2012-2#1)(2012-3#1)
which belongs##15##2##(1996-12#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#5)(2012-2#1)(2012-3#1)
which best##2##2##(2008-10#1)(2012-2#1)
which bind to the##3##4##(1990-12#1)(1994-2#1)(1995-6#1)
which bind to##5##3##(1990-12#1)(1993-6#1)(1994-2#1)(1995-6#1)(1997-7#1)
which bind##10##2##(1990-12#1)(1990-5#1)(1993-11#1)(1993-6#2)(1994-2#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-4#1)
which binds specifically##2##3##(1992-12#1)(2008-9#1)
which binds the##4##3##(1993-8#1)(1995-5#1)(2008-11#1)(2009-7#1)
which binds to and##2##4##(1994-5#1)(2008-4#1)
which binds to the##3##4##(1990-7#1)(1990-8#1)(2008-9#1)
which binds to##14##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-9#2)
which binds with high affinity to##2##6##(1995-3#1)(2007-11#1)
which binds##30##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#3)(2009-7#1)(2011-2#1)
which block##2##2##(1991-2#1)(2011-3#1)
which blocks##4##2##(1994-2#1)(1995-2#1)(1996-5#1)(2010-3#1)
which both the##6##3##(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#2)(2011-2#1)
which both##25##2##(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#2)
which bound to the##3##4##(1990-12#1)(1990-7#1)(1993-8#1)
which bound to##7##3##(1990-12#2)(1990-7#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-8#1)
which bridge the##2##3##(1995-12#1)(1996-2#1)
which brings##2##2##(2008-10#1)(2012-2#1)
which builds##3##2##(1997-1#1)(2008-1#1)(2008-10#1)
which can achieve##2##3##(2008-2#1)(2011-1#1)
which can acquire##2##3##(2007-12#1)(2009-5#1)
which can act as##2##4##(2008-5#1)(2013-8#1)
which can affect the##3##4##(2008-3#2)(2010-10#1)
which can affect##4##3##(1995-11#1)(2008-3#2)(2010-10#1)
which can also be##4##4##(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)
which can also##6##3##(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-7#1)
which can be achieved by##2##5##(2008-8#1)(2009-6#1)
which can be achieved##4##4##(1994-5#1)(2008-8#1)(2009-6#1)(2009-7#1)
which can be applied to##3##5##(2008-10#1)(2008-4#1)(2008-9#1)
which can be applied##7##4##(1995-5#1)(2008-10#4)(2008-4#1)(2008-9#1)
which can be associated with##2##5##(2007-12#1)(2009-9#1)
which can be attributed to the##2##6##(2007-12#1)(2008-11#1)
which can be attributed##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
which can be compared with##2##5##(1992-2#1)(1993-9#1)
which can be considered##2##4##(2008-5#1)(2011-1#1)
which can be controlled##2##4##(2008-10#1)(2008-7#1)
which can be converted into##3##5##(1996-5#1)(2009-9#1)(2010-5#1)
which can be detected##2##4##(1993-12#1)(2009-7#1)
which can be determined by##3##5##(1990-8#1)(1992-3#1)(2008-10#1)
which can be differentiated##2##4##(1991-11#1)(2007-12#1)
which can be divided into two##2##6##(2008-11#1)(2008-8#1)
which can be divided into##3##5##(2008-1#1)(2008-11#1)(2008-8#1)
which can be easily##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
which can be enhanced##2##4##(2008-10#1)(2009-11#1)
which can be explained##2##4##(1990-5#1)(2008-10#1)
which can be formed##2##4##(2008-2#1)(2008-4#1)
which can be further##2##4##(2007-11#1)(2008-10#1)
which can be helpful##2##4##(2008-3#1)(2012-2#1)
which can be identified##2##4##(1993-3#1)(1993-6#1)
which can be implemented##2##4##(1993-9#1)(2008-3#1)
which can be induced by##2##5##(1997-8#1)(2008-11#1)
which can be induced##3##4##(1997-8#1)(2008-11#2)
which can be interpreted##2##4##(1995-3#1)(1996-5#1)
which can be mainly##2##4##(2008-11#1)(2012-2#1)
which can be modulated##2##4##(1992-12#1)(2008-3#1)
which can be obtained##2##4##(2008-1#1)(2008-3#1)
which can be regarded as##2##5##(1994-2#1)(2007-12#1)
which can be restored by LIF replacement##2##7##(2008-4#2)
which can be restored by##3##5##(1990-11#1)(2008-4#2)
which can be seen in##2##5##(2008-12#1)(2008-7#1)
which can be seen##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
which can be solved##2##4##(2008-7#2)
which can be treated##2##4##(1990-12#1)(1996-11#1)
which can be used as a##3##6##(1996-3#1)(2007-11#1)(2008-10#1)
which can be used as##5##5##(1992-6#1)(1994-9#1)(1996-3#1)(2007-11#1)(2008-10#1)
which can be used by##2##5##(1995-6#1)(2008-12#1)
which can be used for the##4##6##(2008-10#3)(2012-1#1)
which can be used for##14##5##(1994-5#1)(1994-6#1)(1997-4#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)
which can be used in##2##5##(1992-8#1)(2013-1#1)
which can be used to detect##2##6##(2008-4#1)(2012-3#1)
which can be used to##13##5##(1990-12#1)(1991-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-10#1)(2010-3#1)(2011-1#1)(2012-3#1)
which can be used##39##4##(1990-12#1)(1991-1#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-4#2)(1997-7#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2009-10#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#1)
which can be##209##3##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#13)(2008-12#2)(2008-2#6)(2008-3#9)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2011-1#5)(2011-2#7)(2011-7#1)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#6)
which can bind##3##3##(1991-9#1)(2008-11#1)(2008-8#1)
which can cause##12##3##(1997-3#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
which can convert##3##3##(1993-12#1)(1993-5#1)(2013-1#1)
which can directly##2##3##(1992-1#1)(2009-7#1)
which can either##2##3##(1992-6#1)(2008-11#1)
which can explain##2##3##(2008-5#1)(2011-2#1)
which can facilitate##2##3##(2012-3#1)(2013-1#1)
which can give##3##3##(2008-3#1)(2008-8#1)(2010-6#1)
which can have a##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
which can have##5##3##(2007-12#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
which can help##3##3##(1995-1#1)(2008-5#1)(2011-3#1)
which can in turn##2##4##(1996-12#1)(2008-5#1)
which can incorporate##2##3##(1997-7#1)(2008-10#1)
which can increase##2##3##(2008-10#1)(2008-9#1)
which can influence##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
which can inhibit##2##3##(2008-5#1)(2011-3#1)
which can interact with##2##4##(1995-6#1)(2010-5#1)
which can interact##3##3##(1992-9#1)(1995-6#1)(2010-5#1)
which can interfere with the##2##5##(2008-10#1)(2008-2#1)
which can interfere##3##3##(2008-10#2)(2008-2#1)
which can lead to##10##4##(1990-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-7#1)(2012-2#1)
which can measure##2##3##(1997-6#1)(2009-9#1)
which can not be reduced on the Hg electrode##2##9##(2008-10#2)
which can occur##2##3##(2008-9#1)(2009-5#1)
which can often##3##3##(1996-3#1)(2008-8#1)(2010-6#1)
which can otherwise be##2##4##(2007-12#1)(2008-2#1)
which can play a##2##4##(2008-10#1)(2008-8#1)
which can range##2##3##(2008-2#1)(2011-2#1)
which can result in##2##4##(2008-9#1)(2011-2#1)
which can serve as a##2##5##(2008-11#2)
which can serve as##3##4##(2008-11#2)(2008-3#1)
which can significantly##2##3##(2008-11#1)(2008-2#1)
which can thus##2##3##(2007-12#1)(2008-3#1)
which can##385##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#7)(2007-12#11)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#54)(2008-11#24)(2008-12#6)(2008-2#14)(2008-3#20)(2008-4#10)(2008-5#10)(2008-6#3)(2008-7#14)(2008-8#9)(2008-9#11)(2009-10#1)(2009-11#3)(2009-5#5)(2009-6#2)(2009-7#4)(2009-9#3)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#1)(2011-1#9)(2011-2#12)(2011-3#2)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#16)(2013-7#1)(2013-8#2)
which cannot be##14##3##(1991-5#1)(1992-5#1)(1992-6#1)(1994-11#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-12#1)(2013-7#1)
which cannot##18##2##(1991-5#1)(1992-5#1)(1992-6#1)(1994-11#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2009-12#1)(2013-7#1)
which capabilities##2##2##(2008-11#1)(2011-2#1)
which captures##2##2##(1992-11#1)(2008-9#1)
which carried the##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
which carried##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
which carries the##2##3##(1995-8#1)(1997-2#1)
which carries##5##2##(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#2)
which case##8##2##(1991-6#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-6#1)(2012-12#1)
which catalyses##2##2##(1995-12#1)(2008-6#1)
which catalyzes the conversion of##2##5##(2008-10#1)(2008-11#1)
which catalyzes the reversible##3##4##(1990-11#1)(1992-3#1)(1993-8#1)
which catalyzes the##11##3##(1990-11#1)(1990-7#1)(1991-11#1)(1992-3#2)(1992-8#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
which catalyzes##13##2##(1990-11#1)(1990-7#1)(1991-11#1)(1992-3#2)(1992-8#1)(1993-8#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
which cause a##2##3##(2008-9#1)(2011-1#1)
which cause the##2##3##(1996-12#1)(2008-10#1)
which cause##19##2##(1995-12#1)(1996-12#2)(1997-6#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
which caused symptoms##2##3##(2008-10#2)
which caused the##2##3##(1995-3#1)(2008-10#1)
which caused##14##2##(1992-2#1)(1994-3#1)(1995-3#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-2#1)(2009-11#1)(2012-2#1)
which causes a##3##3##(2008-10#2)(2013-7#1)
which causes severe##2##3##(2008-10#1)(2010-11#1)
which causes the##5##3##(1993-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
which causes##39##2##(1992-8#1)(1993-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#3)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
which ceased##2##2##(2008-11#1)(2009-12#1)
which cell proliferation##3##3##(1991-2#1)(2008-7#1)(2009-5#1)
which cell##5##2##(1991-2#1)(2008-11#2)(2008-7#1)(2009-5#1)
which cells and##2##3##(2006-6#1)(2011-1#1)
which cells##3##2##(2006-6#1)(2010-10#1)(2011-1#1)
which change##2##2##(1991-6#1)(2008-5#1)
which changed##3##2##(1991-12#1)(2010-8#1)(2013-1#1)
which changes##9##2##(1990-11#1)(1992-9#2)(1994-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-8#1)
which characteristically##2##2##(1994-8#1)(2008-10#1)
which characterize##3##2##(2008-10#1)(2011-2#2)
which characterizes##2##2##(1992-8#1)(2012-1#1)
which children##2##2##(2009-9#1)(2010-9#1)
which clearly showed##2##3##(1995-2#1)(2008-10#1)
which clearly##9##2##(1990-12#1)(1991-5#1)(1994-1#1)(1995-2#1)(2008-10#2)(2010-1#1)(2011-3#1)(2012-3#1)
which cleaves##3##2##(1991-9#2)(1995-8#1)
which clinical##3##2##(1990-10#1)(1992-2#1)(2008-4#1)
which closely##4##2##(1995-2#1)(2008-1#1)(2008-9#1)(2010-1#1)
which clustered##2##2##(1993-2#1)(2008-10#1)
which co-exist##2##2##(2008-10#1)(2009-5#1)
which code##2##2##(1990-5#1)(1996-8#1)
which coded for a##2##4##(1990-12#1)(1990-5#1)
which coded for##3##3##(1990-12#1)(1990-5#2)
which codes for a##2##4##(1994-12#1)(1996-2#1)
which codes for the##5##4##(1991-9#1)(1993-12#1)(2008-10#2)(2008-7#1)
which codes for##7##3##(1991-9#1)(1993-12#1)(1994-12#1)(1996-2#1)(2008-10#2)(2008-7#1)
which coincided with a##2##4##(1994-7#1)(2008-11#1)
which coincided with the##4##4##(1993-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
which coincided with##9##3##(1993-8#1)(1994-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)(2012-3#1)
which coincides with the##3##4##(1995-8#1)(2008-10#2)
which coincides with##4##3##(1995-8#1)(2008-10#2)(2008-2#1)
which collectively##2##2##(2008-10#1)(2009-5#1)
which combined the##3##3##(2008-10#2)(2008-8#1)
which combines a##3##3##(1996-3#1)(2007-11#1)(2010-6#1)
which combines an##2##3##(2008-10#2)
which combines the##2##3##(2008-10#1)(2012-2#1)
which combines##14##2##(1993-2#1)(1996-3#1)(1997-7#1)(2007-11#2)(2008-10#4)(2008-3#1)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
which commonly##3##2##(2008-10#2)(2011-2#1)
which community##2##2##(1995-3#1)(2007-7#1)
which compare##2##2##(1993-12#1)(2008-10#1)
which compared##4##2##(2008-7#1)(2012-12#2)(2013-7#1)
which compares favourably with##2##4##(1991-9#1)(2008-7#1)
which compares##8##2##(1991-9#1)(2008-10#4)(2008-6#1)(2008-7#1)(2011-2#1)
which competition##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
which complete##3##2##(2006-12#1)(2008-6#1)(2013-7#1)
which complicates##2##2##(2008-4#1)(2013-1#1)
which component of the##2##4##(1995-5#1)(2008-10#1)
which components##2##2##(1996-3#1)(2008-11#1)
which comprise##2##2##(1992-8#1)(2009-9#1)
which comprised##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
which comprises the##3##3##(1990-7#1)(1995-5#1)(2008-3#1)
which comprises##7##2##(1990-7#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)
which condition##3##2##(2008-10#2)(2011-1#1)
which conditions##5##2##(2008-10#3)(2008-3#1)(2008-7#1)
which confer##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
which conferred##2##2##(2008-10#1)(2008-11#1)
which confirm the##2##3##(1992-6#1)(2009-6#1)
which confirm##3##2##(1992-6#1)(2009-6#1)(2013-7#1)
which confirmed##5##2##(1995-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)
which confirms the##2##3##(1991-6#1)(1992-5#1)
which conflict##2##2##(2009-7#1)(2009-9#1)
which consider the##3##3##(1992-3#1)(2008-11#1)(2008-12#1)
which considerably##2##2##(2008-5#1)(2011-2#1)
which considers the##2##3##(1990-12#1)(2008-4#1)
which considers##4##2##(1990-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
which consist of##5##3##(1992-1#1)(1992-3#1)(1995-5#1)(2008-2#1)(2012-12#1)
which consisted of a##2##4##(1995-2#1)(2008-9#1)
which consisted of the##2##4##(2008-10#1)(2008-11#1)
which consisted of##15##3##(1990-2#1)(1991-12#1)(1993-5#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
which consisted##16##2##(1990-2#1)(1991-12#1)(1993-5#1)(1995-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
which consistently##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
which consists in determining the##2##5##(2008-2#2)
which consists in##5##3##(1997-7#1)(2008-2#2)(2012-2#2)
which consists of a##8##4##(1997-2#1)(2007-11#1)(2007-7#1)(2008-3#3)(2011-2#1)(2012-2#1)
which consists of the##4##4##(1995-6#2)(1997-8#1)(2008-7#1)
which consists of two##3##4##(1994-5#1)(1996-4#1)(2008-11#1)
which consists of##27##3##(1994-5#1)(1995-6#2)(1996-4#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-2#2)(2013-8#1)
which consists##32##2##(1994-5#1)(1995-6#2)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-2#4)(2013-8#1)
which constitute the##2##3##(2008-10#2)
which constitute##7##2##(1995-2#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-8#1)
which constitutes a##2##3##(1992-11#1)(2008-11#1)
which constitutes the##4##3##(1990-11#1)(2007-5#1)(2008-10#1)(2009-8#1)
which constitutes##9##2##(1990-11#1)(1992-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)
which contain DOM##2##3##(2008-10#2)
which contain leader region of##2##5##(2008-9#2)
which contain the##4##3##(1990-11#1)(1991-9#1)(2008-8#1)(2012-2#1)
which contain##31##2##(1990-11#2)(1991-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#1)(1997-2#2)(1997-4#1)(2007-12#2)(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
which contained a##6##3##(1991-9#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)
which contained an##2##3##(1995-2#1)(2008-10#1)
which contained either##2##3##(1995-12#1)(1995-6#1)
which contained several##2##3##(1990-11#1)(1997-7#1)
which contained the##3##3##(1994-6#1)(2008-10#1)(2008-11#1)
which contained##36##2##(1990-11#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#2)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
which contains a##10##3##(1992-3#1)(1992-8#1)(1993-11#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
which contains an##2##3##(1997-7#1)(2008-9#1)
which contains four##3##3##(1991-6#1)(1995-6#2)
which contains the##9##3##(1991-2#1)(1993-8#1)(1994-12#2)(1994-8#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-5#1)
which contains two##2##3##(1992-3#1)(2008-10#1)
which contains##56##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
which continued##2##2##(2008-5#2)
which continuously##2##2##(2008-11#2)
which contrasts to##2##3##(1992-3#1)(2010-5#1)
which contrasts with##3##3##(1990-5#1)(2008-3#1)(2008-8#1)
which contrasts##8##2##(1990-5#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-10#1)(2010-5#1)
which contribute to the##2##4##(2008-7#1)(2012-3#1)
which contribute to##4##3##(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
which contribute##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
which contributed to the##2##4##(2008-11#1)(2008-3#1)
which contributed to##3##3##(1995-3#1)(2008-11#1)(2008-3#1)
which contributes to a##2##4##(2008-10#1)(2008-7#1)
which contributes to the##2##4##(1996-9#1)(2012-2#1)
which contributes to##10##3##(1996-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
which contributes##11##2##(1996-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
which control##7##2##(1990-9#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)
which controls the##3##3##(1993-3#1)(1997-2#1)(2008-9#1)
which controls##8##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)
which conventional##2##2##(2011-1#1)(2013-1#1)
which converts the##2##3##(1997-1#1)(2008-9#1)
which converts##7##2##(1990-5#1)(1991-8#1)(1992-8#1)(1994-11#1)(1997-1#1)(2008-4#1)(2008-9#1)
which correlate##3##2##(1994-8#1)(2010-12#1)(2013-8#1)
which correlated with##6##3##(1990-2#1)(1993-8#1)(1996-12#1)(2006-10#1)(2008-10#1)(2009-9#1)
which correlated##12##2##(1990-2#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-9#2)
which correlates with the##6##4##(1992-9#1)(1993-5#1)(1995-2#1)(1997-9#1)(2007-12#1)(2008-9#1)
which correlates##9##2##(1992-9#1)(1993-5#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-9#1)
which correspond to relatively long and nearly full-length transcripts##2##9##(1996-10#1)(1996-2#1)
which correspond to the##4##4##(1996-3#1)(1997-2#1)(2008-10#1)(2010-8#1)
which correspond to##14##3##(1994-8#1)(1995-9#3)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)
which correspond with##2##3##(2008-10#1)(2012-3#1)
which correspond##17##2##(1994-8#1)(1995-9#3)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-3#1)
which corresponded to the##2##4##(1990-5#1)(2008-11#1)
which corresponded to##11##3##(1990-5#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
which corresponds to a##11##4##(1994-12#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)
which corresponds to an##4##4##(2007-12#1)(2008-2#1)(2011-2#1)(2012-12#1)
which corresponds to the size of##2##6##(1997-1#1)(2008-3#1)
which corresponds to the##11##4##(1990-8#1)(1991-5#1)(1994-11#1)(1994-5#1)(1997-1#1)(2008-10#4)(2008-3#1)(2008-8#1)
which corresponds to##35##3##(1990-8#1)(1991-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-1#1)(2007-11#3)(2007-12#4)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
which could account for##2##4##(2008-1#1)(2008-10#1)
which could affect the##2##4##(2008-10#2)
which could affect##3##3##(2008-10#2)(2013-1#1)
which could also be##2##4##(2008-10#1)(2010-5#1)
which could be a##3##4##(1990-11#1)(2008-12#1)(2012-3#1)
which could be attributed to##2##5##(1995-12#1)(2008-3#1)
which could be detected##3##4##(1993-9#1)(2008-10#1)(2008-8#1)
which could be further##2##4##(2008-10#1)(2008-5#1)
which could be incorporated##2##4##(1996-12#1)(2008-10#1)
which could be interpreted##2##4##(2006-10#1)(2008-5#1)
which could be present##2##4##(1996-5#1)(2008-11#1)
which could be related to the##2##6##(1993-8#1)(2011-2#1)
which could be related to##4##5##(1992-12#1)(1993-8#1)(2011-2#2)
which could be used in the##2##6##(1990-2#1)(2007-7#1)
which could be used in##3##5##(1990-2#1)(1997-7#1)(2007-7#1)
which could be used to##2##5##(2008-10#2)
which could be used##6##4##(1990-2#1)(1990-7#1)(1997-7#1)(2007-7#1)(2008-10#2)
which could be##68##3##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-8#2)(1993-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#1)
which could bind##2##3##(1994-6#1)(1995-6#1)
which could cause##2##3##(2008-10#1)(2011-2#1)
which could easily##2##3##(2010-1#1)(2012-3#1)
which could encode a##2##4##(1990-11#1)(1991-9#1)
which could explain##3##3##(1996-5#1)(2008-10#1)(2011-10#1)
which could have##3##3##(1997-5#1)(2007-10#1)(2010-5#1)
which could indicate##2##3##(2008-10#1)(2013-8#1)
which could involve##3##3##(2008-11#1)(2008-9#1)(2013-7#1)
which could lead to##5##4##(2007-7#1)(2009-2#1)(2011-2#2)(2013-1#1)
which could mediate##2##3##(1997-7#1)(2007-11#1)
which could not be explained##2##5##(1990-8#1)(2012-2#1)
which could not be##9##4##(1990-8#1)(1991-9#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
which could not##12##3##(1990-8#1)(1991-9#1)(1992-11#1)(1993-2#1)(1995-6#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
which could occur##2##3##(2007-2#1)(2013-1#1)
which could play a##3##4##(1994-11#1)(1994-6#1)(2009-11#1)
which could potentially##4##3##(1990-5#1)(2008-10#2)(2009-12#1)
which could prevent##2##3##(2008-7#1)(2008-9#1)
which could provide##2##3##(2011-2#1)(2013-8#1)
which could satisfy the sample examination request and provide scientific rationale for determining##2##13##(2013-8#2)
which could serve##2##3##(1992-3#1)(2010-8#1)
which could then##2##3##(1997-4#1)(2008-12#1)
which could##171##2##(1990-11#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#2)(1995-2#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#32)(2008-11#7)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#7)(2009-11#2)(2009-12#2)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#6)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#4)
which couples the dynamics of##2##5##(2007-12#1)(2013-8#1)
which couples##3##2##(1993-8#1)(2007-12#1)(2013-8#1)
which cover##5##2##(1994-12#1)(1995-9#1)(2007-11#1)(2009-5#1)(2011-2#1)
which covered##3##2##(1997-2#2)(2008-9#1)
which covers the##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
which covers##5##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#2)
which create##3##2##(1990-11#1)(1990-5#1)(2011-2#1)
which created##4##2##(1990-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
which current##3##2##(2008-11#1)(2008-8#2)
which currently##4##2##(2008-10#1)(2008-8#2)(2008-9#1)
which damage##3##2##(1997-4#1)(2008-10#1)(2009-8#1)
which data from##2##3##(1997-3#1)(2009-11#1)
which data##5##2##(1997-3#1)(2008-3#1)(2009-11#1)(2012-12#2)
which declined##2##2##(1996-1#1)(2012-12#1)
which decrease with##2##3##(2008-5#1)(2013-7#1)
which decrease##3##2##(2008-2#1)(2008-5#1)(2013-7#1)
which decreased##4##2##(1995-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
which decreases##2##2##(2008-5#1)(2010-11#1)
which defeats##2##2##(2008-10#2)
which defines the##2##3##(1990-11#1)(2008-10#1)
which degrades the##2##3##(2007-11#1)(2008-3#1)
which degrades##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
which delivers##4##2##(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
which demonstrate that##4##3##(1990-8#1)(1995-5#1)(2009-3#1)(2010-4#1)
which demonstrate##8##2##(1990-8#1)(1995-5#1)(2007-12#1)(2008-11#1)(2009-3#1)(2009-4#1)(2010-4#1)(2012-3#1)
which demonstrated a##5##3##(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
which demonstrated that##2##3##(2008-5#1)(2009-8#1)
which demonstrated##15##2##(1991-8#1)(1994-2#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
which demonstrates that even##2##4##(2008-7#1)(2008-8#1)
which demonstrates that##6##3##(1990-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
which demonstrates the##4##3##(1996-1#1)(2008-10#3)
which demonstrates##12##2##(1990-7#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
which depend on the##5##4##(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)
which depend on##7##3##(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
which depend##8##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
which depends on the##6##4##(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
which depends on##8##3##(1994-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
which depends only on##2##4##(2008-5#1)(2009-12#1)
which depends##16##2##(1994-6#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2009-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
which describe the##2##3##(2007-8#1)(2008-10#1)
which describe##4##2##(2007-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
which describes the dependence##2##4##(2008-10#2)
which describes the##6##3##(2008-10#3)(2008-3#2)(2013-8#1)
which describes##8##2##(1994-12#1)(2008-10#3)(2008-3#3)(2013-8#1)
which destroy##2##2##(1996-1#1)(1997-7#1)
which detailed##3##2##(1990-8#1)(1995-5#1)(1995-6#1)
which details##2##2##(2008-8#1)(2012-1#1)
which detected##2##2##(2011-2#1)(2013-7#1)
which deteriorates##3##2##(2007-11#1)(2008-2#1)(2013-1#1)
which determine the##6##3##(1991-3#1)(1992-6#1)(1995-12#1)(1997-2#1)(2008-10#2)
which determine##8##2##(1990-7#1)(1991-3#1)(1992-6#1)(1992-8#1)(1995-12#1)(1997-2#1)(2008-10#2)
which determines the##2##3##(1990-8#1)(2008-2#1)
which determines##3##2##(1990-8#1)(2008-2#1)(2011-2#1)
which develop##2##2##(2008-4#1)(2008-5#1)
which developed in##2##3##(2008-4#1)(2008-6#1)
which developed##6##2##(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
which device##2##2##(1991-6#1)(2008-11#1)
which did not demonstrate any##2##5##(1990-10#1)(2009-4#1)
which did not have##2##4##(1993-9#1)(2008-5#1)
which did not include##2##4##(1997-5#1)(2013-8#1)
which did not inhibit##2##4##(1991-9#1)(2008-10#1)
which did not react with##2##5##(1997-7#1)(2008-5#1)
which did not##27##3##(1990-10#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-7#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#3)(2009-12#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-8#2)
which died##3##2##(1991-8#1)(1995-9#1)(2007-11#1)
which differ by##2##3##(1991-12#1)(1997-9#1)
which differ from##3##3##(1997-7#1)(2006-12#1)(2008-8#1)
which differ in the##2##4##(1992-9#1)(2008-10#1)
which differ in##5##3##(1990-5#1)(1992-9#1)(1995-2#1)(1996-2#1)(2008-10#1)
which differ significantly in##2##4##(1993-11#1)(2008-12#1)
which differ##15##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(1997-9#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
which differed in the##2##4##(2008-10#1)(2010-4#1)
which differed in##6##3##(1992-3#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-4#1)
which differed significantly##2##3##(2008-10#1)(2009-10#1)
which differed##11##2##(1992-3#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#1)
which different##9##2##(1996-4#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-8#3)(2011-2#1)
which differentiate into##2##3##(2007-12#1)(2008-11#1)
which differentiate##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
which differs from the##6##4##(1991-9#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2010-5#1)
which differs from##10##3##(1991-12#1)(1991-9#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#2)
which differs in##2##3##(1991-2#1)(1997-7#1)
which differs##14##2##(1991-12#1)(1991-2#1)(1991-9#1)(1994-12#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-5#1)(2011-2#2)(2013-1#1)
which direct##5##2##(1991-5#1)(1994-2#1)(1994-5#1)(2007-12#1)(2008-10#1)
which directly##6##2##(1994-5#1)(1996-2#1)(1996-5#1)(2010-5#1)(2011-1#2)
which disappeared after##2##3##(1997-7#1)(2008-11#1)
which disappeared##3##2##(1997-7#1)(2008-11#2)
which disease##5##2##(1997-3#1)(2008-10#3)(2008-9#1)
which dispersal##2##2##(2008-10#1)(2008-8#1)
which display##8##2##(1992-12#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
which displays##4##2##(1990-12#1)(1992-3#1)(1994-11#1)(2011-1#1)
which distinguish##2##2##(1991-6#1)(2008-11#1)
which distinguishes##2##2##(1992-6#1)(1994-12#1)
which diverged##2##2##(2009-8#1)(2012-3#1)
which do not exhibit##4##4##(1997-6#1)(1997-8#1)(2008-10#1)(2009-5#1)
which do not have##2##4##(1993-11#1)(2008-10#1)
which do not require##2##4##(2008-3#1)(2013-1#1)
which do not##24##3##(1992-9#1)(1993-11#1)(1994-2#1)(1996-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#1)
which do##26##2##(1992-9#1)(1993-11#1)(1994-2#1)(1996-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2013-1#1)
which does not affect##2##4##(2008-10#1)(2009-10#1)
which does not allow##2##4##(2008-10#2)
which does not contain the##2##5##(1996-12#1)(2008-10#1)
which does not contain##3##4##(1991-9#1)(1996-12#1)(2008-10#1)
which does not produce##3##4##(2008-10#3)
which does not require a##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
which does not require any##2##5##(2008-10#1)(2012-2#1)
which does not require##8##4##(1990-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)
which does not use##2##4##(2010-8#1)(2011-2#1)
which does not##40##3##(1990-5#1)(1991-9#2)(1992-6#2)(1992-9#1)(1994-2#1)(1995-6#1)(1996-12#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-5#3)(2008-7#1)(2009-10#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
which dominated##2##2##(2008-10#1)(2010-8#1)
which dominates##2##2##(2008-9#1)(2009-5#1)
which drugs##2##2##(2006-10#1)(2008-1#1)
which each chip consists of a one-dimensional array of 12 devices##2##11##(2008-3#2)
which each chip##3##3##(2008-3#3)
which each of##4##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-7#1)
which each##23##2##(1994-2#1)(1995-2#1)(1995-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)
which effect##2##2##(1997-7#1)(2011-1#1)
which effectively##5##2##(1993-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)
which efficiently##2##2##(2008-3#1)(2008-7#1)
which either##7##2##(1994-6#1)(2007-8#1)(2008-10#1)(2008-8#2)(2010-3#1)(2011-2#1)
which electrochemical##2##2##(2008-10#2)
which elicit##3##2##(1994-11#1)(2007-6#1)(2009-12#1)
which elicits##2##2##(2008-10#1)(2009-12#1)
which eliminates the need##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
which eliminates##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
which eluted##2##2##(1991-8#1)(2008-10#1)
which emerged from a##2##4##(1991-12#1)(2008-11#1)
which emerged from##3##3##(1991-12#1)(2008-11#1)(2010-12#1)
which emerged##8##2##(1991-12#1)(1992-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
which emphasized the##2##3##(2008-4#2)
which emphasizes##2##2##(1994-2#1)(2012-3#1)
which employed##2##2##(2008-10#1)(2008-12#1)
which employees##3##2##(1993-1#1)(2008-12#2)
which employs two##2##3##(2008-10#1)(2008-3#1)
which employs##7##2##(1990-8#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#2)
which enable##6##2##(1992-9#1)(1993-1#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
which enabled the##2##3##(1991-6#1)(2008-4#1)
which enabled##3##2##(1991-6#1)(2008-11#1)(2008-4#1)
which enables a##2##3##(1991-5#1)(2008-7#1)
which enables the##12##3##(1991-2#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-4#1)(2010-3#1)
which enables us to##3##4##(1996-3#1)(2009-10#1)(2013-8#1)
which enables##30##2##(1990-3#1)(1991-2#1)(1991-5#1)(1992-3#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2013-1#1)(2013-8#1)
which encode for##2##3##(1994-6#1)(2008-10#1)
which encode##15##2##(1990-11#1)(1990-8#1)(1992-4#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)
which encoded##5##2##(1990-7#1)(1991-11#1)(1992-3#1)(2008-10#1)(2008-9#1)
which encodes a novel##3##4##(1992-7#1)(1992-9#1)(1993-8#1)
which encodes a protein of##3##5##(1992-9#1)(1994-11#1)(1994-12#1)
which encodes a protein with##3##5##(1994-12#1)(2008-8#2)
which encodes a protein##7##4##(1992-9#1)(1994-11#1)(1994-12#2)(1997-3#1)(2008-8#2)
which encodes a small##2##4##(1993-8#1)(1996-8#1)
which encodes a##27##3##(1990-11#1)(1990-6#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#2)(1994-11#2)(1994-12#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#2)(2008-10#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#1)
which encodes an##2##3##(2008-10#2)
which encodes for##2##3##(1996-12#1)(1997-3#1)
which encodes the##9##3##(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-12#1)(1995-6#1)(2008-11#1)(2012-12#1)
which encodes##48##2##(1990-11#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#5)(1994-8#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)(2012-12#2)(2012-3#1)
which encompasses##4##2##(1990-7#1)(1994-12#1)(2008-10#1)(2009-5#1)
which ends##2##2##(2007-12#1)(2008-3#1)
which enhance the##2##3##(2008-10#1)(2008-4#1)
which enhance##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
which enhanced##2##2##(1993-3#1)(2008-6#1)
which enhances the##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
which enhances##10##2##(1992-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)
which ensures##5##2##(1991-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
which enters the##2##3##(2007-12#1)(2008-10#1)
which environmental##3##2##(2008-1#1)(2008-11#1)(2008-7#1)
which equals##2##2##(2008-7#1)(2008-8#1)
which established##3##2##(2007-12#1)(2008-10#2)
which establishes a##2##3##(2007-12#1)(2008-6#1)
which establishes##3##2##(1994-6#1)(2007-12#1)(2008-6#1)
which estimates##3##2##(1996-2#1)(2007-11#1)(2010-8#1)
which evaluated the##2##3##(2010-2#1)(2013-1#1)
which evaluates##2##2##(1992-1#1)(2013-8#1)
which eventually led to##2##4##(2007-7#1)(2008-10#1)
which eventually##7##2##(1992-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
which examined##2##2##(1997-3#1)(2010-11#1)
which exceeded##4##2##(1992-9#1)(1997-7#1)(2008-10#2)
which exceeds##2##2##(1990-11#1)(2008-3#1)
which exert##2##2##(1994-11#1)(2008-10#1)
which exerts a much##2##4##(1995-12#1)(2008-5#1)
which exerts a##3##3##(1993-6#1)(1995-12#1)(2008-5#1)
which exhibit a high##2##4##(1990-6#1)(2008-10#1)
which exhibit a##3##3##(1990-6#1)(2008-10#2)
which exhibit##14##2##(1990-6#1)(1994-11#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-9#1)(2011-2#1)
which exhibited a##2##3##(1994-8#1)(2008-11#1)
which exhibited##10##2##(1993-8#1)(1994-8#1)(1996-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2011-2#1)
which exhibits high##2##3##(1992-3#1)(2008-10#1)
which exhibits##10##2##(1992-3#1)(1995-3#1)(2008-10#7)(2008-7#1)
which exist in a##2##4##(1991-1#1)(1995-3#1)
which exist in##5##3##(1991-1#1)(1993-6#1)(1995-3#1)(2008-9#1)(2011-2#1)
which existing##2##2##(2008-11#1)(2012-3#1)
which exists in##2##3##(1993-3#1)(2008-8#1)
which exists##4##2##(1992-4#1)(1993-3#1)(2008-10#1)(2008-8#1)
which exogenous##2##2##(2007-11#1)(2008-7#1)
which experience##2##2##(1996-6#1)(2008-8#1)
which experimental##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
which explain##2##2##(2007-11#1)(2009-10#1)
which explained##2##2##(2009-12#1)(2013-1#1)
which explains the##2##3##(2009-7#1)(2013-1#1)
which explains##3##2##(1992-5#1)(2009-7#1)(2013-1#1)
which express##7##2##(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
which expressed##5##2##(1992-8#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
which expresses a##2##3##(1993-3#1)(2012-2#1)
which expresses the##2##3##(1995-12#1)(2008-10#1)
which expresses##7##2##(1993-12#1)(1993-3#1)(1995-12#1)(1997-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
which extend##3##2##(1995-12#1)(1997-1#1)(2008-10#1)
which extended##3##2##(2009-5#1)(2009-7#1)(2012-2#1)
which extends##2##2##(2008-10#1)(2008-12#1)
which facilitate the##3##3##(1993-6#1)(2007-11#1)(2009-8#1)
which facilitate##5##2##(1992-5#1)(1993-6#1)(2007-11#1)(2008-10#1)(2009-8#1)
which facilitated the##2##3##(2011-2#1)(2013-1#1)
which facilitated##3##2##(2009-7#1)(2011-2#1)(2013-1#1)
which facilitates the##3##3##(1996-12#1)(2008-3#2)
which facilitates##10##2##(1996-12#1)(1997-3#1)(2008-10#1)(2008-3#3)(2008-7#2)(2011-2#1)(2013-1#1)
which factors influence##2##3##(2007-8#1)(2012-2#1)
which factors##4##2##(1991-6#1)(2007-8#1)(2008-9#1)(2012-2#1)
which fail to##3##3##(1995-1#1)(1997-7#1)(2008-10#1)
which favor##2##2##(1991-1#1)(2011-2#1)
which favors genotypes##2##3##(2008-8#2)
which favors##5##2##(2008-10#1)(2008-8#3)(2012-2#1)
which feed##2##2##(1992-3#1)(2008-2#1)
which females##4##2##(2008-8#2)(2008-9#2)
which finally##2##2##(2008-10#1)(2011-2#1)
which first##3##2##(1994-5#1)(2007-12#1)(2008-1#1)
which fit##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
which five##2##2##(1994-3#1)(2008-10#1)
which focus on##4##3##(1990-9#1)(1996-2#1)(2008-12#1)(2010-8#1)
which focuses on##4##3##(1996-2#1)(2010-2#1)(2010-8#1)(2011-2#1)
which focuses##5##2##(1996-2#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)
which follows##3##2##(1990-8#1)(1994-2#1)(2008-3#1)
which foods##2##2##(1994-3#1)(2008-4#1)
which form an##2##3##(2008-3#1)(2008-4#1)
which form meiotic##3##3##(2008-12#3)
which form##17##2##(1990-5#1)(1993-8#1)(1996-5#2)(1997-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
which formed a##2##3##(2008-10#1)(2008-8#1)
which formed##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
which forms a##4##3##(1993-9#1)(2008-10#3)
which forms part of##2##4##(1992-6#1)(2008-11#1)
which forms the##3##3##(1992-6#1)(1997-9#1)(2008-10#1)
which forms##14##2##(1990-2#1)(1992-6#2)(1993-10#1)(1993-9#1)(1997-9#1)(2008-10#7)(2008-11#1)
which found##3##2##(1992-1#1)(1997-2#1)(2008-12#1)
which four##7##2##(1991-2#1)(1991-7#1)(1993-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
which fragments##2##2##(1993-2#1)(1993-8#1)
which free##2##2##(1995-12#1)(2008-10#1)
which frequently##5##2##(1996-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-8#1)
which from##2##2##(1996-3#1)(2012-3#1)
which function in##3##3##(1990-2#1)(1993-3#1)(2008-11#1)
which function##4##2##(1990-2#1)(1993-3#1)(1995-8#1)(2008-11#1)
which functional##2##2##(2009-10#1)(2012-2#1)
which functions as a##2##4##(1995-9#1)(2012-12#1)
which functions##3##2##(1994-5#1)(1995-9#1)(2012-12#1)
which further##8##2##(1994-3#1)(2008-10#3)(2008-5#1)(2009-11#1)(2009-8#1)(2010-3#1)
which future##2##2##(2008-10#1)(2008-11#1)
which gave rise to the##2##5##(2008-8#1)(2009-8#1)
which gave rise to##3##4##(1994-12#1)(2008-8#1)(2009-8#1)
which gave##8##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-8#1)(2012-1#1)
which gene##2##2##(2008-10#1)(2010-10#1)
which generally was found to be sustained in the 2-year survey##2##11##(2013-1#2)
which generally##4##2##(1993-3#1)(2008-10#1)(2013-1#2)
which generate##2##2##(1991-3#1)(2008-10#1)
which generated##3##2##(2008-10#1)(2008-3#2)
which generates##9##2##(1992-12#1)(1992-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-12#2)(2010-3#1)
which genes are##4##3##(2008-6#1)(2008-9#1)(2009-6#1)(2012-3#1)
which genes##5##2##(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-3#1)
which give rise to the##2##5##(2007-11#1)(2012-12#1)
which give rise to##9##4##(1994-11#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2012-12#1)
which give##11##2##(1994-11#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2012-12#1)
which gives a##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
which gives rise to the##2##5##(1997-2#1)(2008-3#1)
which gives rise to##3##4##(1997-2#1)(2008-11#1)(2008-3#1)
which gives the##2##3##(1996-5#1)(2008-10#1)
which gives##15##2##(1991-5#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-7#1)(2011-2#1)
which goes##2##2##(2008-10#1)(2011-2#1)
which governs##2##2##(1996-3#1)(2012-12#1)
which greatly increases the selectivity##3##5##(2008-10#3)
which greatly increases the##4##4##(2007-7#1)(2008-10#3)
which greatly reduces##2##3##(2007-11#1)(2012-3#1)
which greatly simplifies the##2##4##(2008-10#1)(2008-3#1)
which greatly##11##2##(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-3#1)(2012-3#1)
which group##2##2##(2008-2#1)(2008-8#1)
which grown at##2##3##(2008-12#2)
which guarantee##2##2##(2008-7#1)(2012-12#1)
which guarantees##2##2##(1996-12#1)(2008-7#1)
which had a##9##3##(1993-6#1)(1995-12#1)(1996-9#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-8#2)
which had acquired##2##3##(1993-9#1)(2008-10#1)
which had an##3##3##(1991-12#1)(2007-11#1)(2012-2#1)
which had been generated##2##4##(1994-11#1)(2008-11#1)
which had been previously##4##4##(1990-10#1)(1992-9#1)(1993-6#1)(2008-10#1)
which had been shown to##2##5##(1992-2#1)(2008-10#1)
which had been##38##3##(1990-10#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-6#2)(2010-4#1)(2010-8#1)(2011-1#2)
which had little##2##3##(1991-10#1)(2008-11#1)
which had no##5##3##(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
which had not been##3##4##(1995-6#1)(2008-10#1)(2008-6#1)
which had previously been##4##4##(1990-5#2)(1996-12#1)(2008-2#1)
which had the##3##3##(2008-10#2)(2008-9#1)
which had##114##2##(1990-10#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#23)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#6)
which half##2##2##(2008-3#1)(2010-4#1)
which has a high##5##4##(2008-10#3)(2008-5#1)(2013-8#1)
which has a maximum absorption peak at##2##7##(2008-10#2)
which has a##41##3##(1990-2#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#2)
which has already been##2##4##(2010-8#1)(2012-2#1)
which has an absorption maximum at##3##6##(2008-10#3)
which has an##13##3##(1990-2#1)(1990-5#1)(1996-2#1)(1997-7#1)(2008-10#7)(2008-7#1)(2012-12#1)
which has as##2##3##(1994-2#1)(2008-10#1)
which has been attributed to##2##5##(2007-7#1)(2010-2#1)
which has been demonstrated##2##4##(1995-3#1)(2008-4#1)
which has been implicated in##2##5##(1992-10#1)(1992-3#1)
which has been known##2##4##(1997-8#1)(2008-10#1)
which has been postulated##2##4##(1996-2#1)(2012-2#1)
which has been proposed##2##4##(1990-5#1)(2008-6#1)
which has been reported to##2##5##(1993-6#1)(2008-10#1)
which has been reported##3##4##(1993-6#1)(2008-10#1)(2011-1#1)
which has been shown in##2##5##(1994-11#1)(2010-5#1)
which has been shown to be a##2##7##(1994-2#1)(1994-9#1)
which has been shown to be regulated##2##7##(1991-2#1)(2011-2#1)
which has been shown to be##10##6##(1991-2#1)(1991-5#1)(1992-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
which has been shown to##19##5##(1991-2#1)(1991-5#1)(1992-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(2007-11#1)(2008-11#3)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
which has been shown##23##4##(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(2007-11#1)(2008-11#3)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
which has been the##2##4##(2008-10#1)(2010-5#1)
which has been used for##4##5##(2008-10#1)(2009-5#1)(2010-10#1)(2011-2#1)
which has been used##8##4##(2008-10#3)(2008-7#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)
which has been widely##2##4##(1990-8#1)(2010-4#1)
which has been##103##3##(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-8#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
which has emerged as a##2##5##(2008-11#1)(2008-4#1)
which has emerged##3##3##(2007-2#1)(2008-11#1)(2008-4#1)
which has high affinity for##2##5##(1994-8#1)(2011-2#1)
which has high##7##3##(1994-8#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
which has increased##3##3##(1994-1#1)(2007-2#1)(2008-10#1)
which has its##2##3##(1993-2#1)(1994-3#1)
which has led to##3##4##(1990-11#1)(2008-10#1)(2011-2#1)
which has much##2##3##(1990-8#1)(1994-11#1)
which has never been described in##2##6##(1993-9#1)(2012-12#1)
which has never been##4##4##(1991-5#1)(1993-9#1)(2008-8#1)(2012-12#1)
which has no##3##3##(1992-12#1)(2008-10#2)
which has not been previously reported##2##6##(1996-12#1)(2008-10#1)
which has not been previously##3##5##(1996-12#1)(2008-10#1)(2008-7#1)
which has not been##7##4##(1991-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)
which has not previously been##2##5##(2008-10#1)(2010-4#1)
which has not##11##3##(1990-11#1)(1991-6#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-4#1)(2010-7#1)
which has occurred##2##3##(1990-2#1)(2009-5#1)
which has potential##2##3##(1994-9#1)(2008-10#1)
which has previously been##2##4##(1990-8#1)(2008-10#1)
which has provided##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
which has received##3##3##(2008-10#2)(2008-11#1)
which has resulted in##2##4##(2008-10#1)(2013-7#1)
which has the ability to##2##5##(2008-11#1)(2008-5#1)
which has the ability##3##4##(2008-11#1)(2008-5#1)(2011-1#1)
which has the highest##2##4##(2008-10#1)(2008-6#1)
which has the potential to##2##5##(1994-11#1)(2009-10#1)
which has the same##2##4##(1994-6#1)(2008-3#1)
which has the##15##3##(1994-11#1)(1994-6#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-6#1)(2011-1#1)
which has three##2##3##(2007-11#1)(2013-8#1)
which has to be##3##4##(1990-10#1)(2008-3#1)(2008-7#1)
which has until now##2##4##(2008-10#1)(2012-2#1)
which has##308##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#5)(1990-5#3)(1990-8#4)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#66)(2008-11#13)(2008-12#1)(2008-2#5)(2008-3#13)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#2)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#6)
which have a high##2##4##(1997-5#1)(2013-8#1)
which have a##16##3##(1990-11#1)(1992-11#1)(1992-6#1)(1997-5#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-2#1)(2013-8#1)
which have already been##2##4##(1996-2#1)(2008-11#1)
which have an##4##3##(2008-12#1)(2011-2#1)(2012-2#2)
which have been assigned to##2##5##(1990-7#1)(1996-6#1)
which have been characterized##2##4##(1992-3#1)(2008-10#1)
which have been completely explained##2##5##(2013-1#2)
which have been confirmed##2##4##(2007-11#1)(2008-10#1)
which have been considered to be##2##6##(2007-10#1)(2010-8#1)
which have been developed##3##4##(1991-12#1)(1994-3#1)(2009-12#1)
which have been employed##2##4##(2007-11#1)(2010-2#1)
which have been implemented##2##4##(2008-11#1)(2008-3#1)
which have been implicated in##2##5##(1994-2#1)(2013-7#1)
which have been proposed##2##4##(1990-8#1)(2013-8#1)
which have been reported in##2##5##(1990-8#1)(1997-2#1)
which have been reported to##2##5##(1994-12#1)(2008-10#1)
which have been reported##4##4##(1990-8#1)(1994-12#1)(1997-2#1)(2008-10#1)
which have been shown to be associated with##2##8##(2008-4#1)(2011-1#1)
which have been shown to be##4##6##(1994-6#1)(2008-4#1)(2008-8#1)(2011-1#1)
which have been shown to have##2##6##(2008-7#1)(2009-3#1)
which have been shown to##12##5##(1992-5#1)(1994-6#1)(1995-5#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2011-1#1)(2012-12#1)
which have been shown##13##4##(1992-5#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2011-1#1)(2012-12#1)
which have been used##2##4##(1997-4#1)(2012-12#1)
which have been##83##3##(1990-10#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-3#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
which have different##2##3##(1990-11#1)(1997-4#1)
which have direct##2##3##(2010-7#1)(2011-1#1)
which have had##2##3##(1995-6#1)(1996-1#1)
which have high##2##3##(1994-11#1)(1995-2#1)
which have incorporated##2##3##(2008-9#2)
which have limited##3##3##(1992-2#1)(2008-8#1)(2012-2#1)
which have no##2##3##(1997-7#1)(2008-7#1)
which have not been##3##4##(1993-2#1)(2007-11#1)(2008-1#1)
which have not##4##3##(1993-2#1)(2007-11#1)(2008-1#1)(2008-7#1)
which have occurred##2##3##(2008-10#1)(2011-2#1)
which have only##2##3##(1993-9#1)(1995-8#1)
which have previously been shown to##2##6##(2010-8#1)(2011-1#1)
which have previously been##5##4##(1996-3#1)(1997-2#1)(2008-8#1)(2010-8#1)(2011-1#1)
which have received##2##3##(1995-1#1)(2009-8#1)
which have shown##5##3##(1997-1#1)(2008-5#1)(2008-7#1)(2012-2#2)
which have similar##3##3##(1996-8#1)(2008-7#1)(2012-12#1)
which have sometimes been##2##4##(2008-7#1)(2008-8#1)
which have the potential to##2##5##(1996-4#1)(2011-2#1)
which have the##4##3##(1990-2#1)(1996-1#1)(1996-4#1)(2011-2#1)
which have to be##3##4##(1994-1#1)(2008-11#1)(2012-3#1)
which have unique##2##3##(1990-8#1)(2008-11#1)
which have##222##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-7#1)(1990-8#4)(1991-12#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2008-1#3)(2008-10#23)(2008-11#12)(2008-12#5)(2008-3#2)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#15)(2008-8#7)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-10#1)(2011-2#6)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#2)
which he had##2##3##(1996-2#1)(2008-11#1)
which he##11##2##(1994-3#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-1#1)(2012-2#1)(2013-1#1)
which health care is##2##4##(1992-2#1)(1997-3#1)
which health care##3##3##(1992-2#1)(1994-3#1)(1997-3#1)
which health##6##2##(1992-2#1)(1994-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2011-1#1)
which help to##2##3##(2008-10#1)(2011-2#1)
which help##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
which helped to##2##3##(2008-7#1)(2011-2#1)
which helped##4##2##(2007-7#1)(2008-7#1)(2009-7#1)(2011-2#1)
which helps to reduce the##2##5##(2008-10#1)(2008-3#1)
which helps to##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
which helps##9##2##(1997-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
which highlight the##3##3##(2007-8#1)(2009-12#1)(2013-8#1)
which highlights the##2##3##(1992-9#1)(2010-5#1)
which highly##2##2##(2008-11#1)(2009-10#1)
which home##2##2##(1995-3#1)(2008-11#1)
which hospitals##2##2##(1994-1#1)(1996-2#1)
which however##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
which human T##2##3##(2008-4#1)(2011-1#1)
which human##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
which hydrogen##2##2##(1991-8#1)(2009-7#1)
which hydrolyses##2##2##(1997-3#2)
which identified##3##2##(2008-11#1)(2009-8#1)(2011-1#1)
which identifies##3##2##(1993-2#1)(2008-11#1)(2008-9#1)
which if##2##2##(2008-5#1)(2008-7#1)
which ignore##2##2##(1995-12#1)(2009-7#1)
which illustrate the##2##3##(2008-10#1)(2008-4#1)
which illustrate##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
which illustrates##2##2##(1995-5#1)(2008-2#1)
which imaging##2##2##(2011-2#2)
which impeded##2##2##(2008-12#1)(2008-5#1)
which implies that the##3##4##(2008-2#1)(2008-5#1)(2009-8#1)
which implies that##8##3##(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#1)
which implies##12##2##(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
which improve##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
which improved the##2##3##(2008-10#2)
which improved##3##2##(2008-10#2)(2008-11#1)
which improves the##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
which improves##5##2##(1990-11#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-9#1)
which in a##2##3##(2008-10#1)(2010-9#1)
which in the presence of##2##5##(2008-10#1)(2010-11#1)
which in the##9##3##(1992-1#1)(2008-10#4)(2008-12#1)(2008-8#1)(2010-1#1)(2010-11#1)
which in turn activates##2##4##(1995-2#1)(1995-6#1)
which in turn affects##2##4##(2009-11#1)(2010-11#1)
which in turn are##4##4##(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
which in turn has##2##4##(1996-6#1)(2008-11#1)
which in turn is related to##2##6##(2010-10#1)(2013-1#1)
which in turn is##9##4##(1990-12#1)(1994-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
which in turn leads to##2##5##(2008-8#1)(2010-12#1)
which in turn may##3##4##(1992-8#1)(1996-12#1)(2009-8#1)
which in turn provides##2##4##(1994-12#1)(2007-12#1)
which in turn reduces##2##4##(1995-12#1)(2009-5#1)
which in turn should##2##4##(2008-11#1)(2012-3#1)
which in turn suggests that##2##5##(1995-12#1)(2008-3#1)
which in turn were##2##4##(1995-3#1)(2008-12#1)
which in turn##69##3##(1990-12#1)(1990-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-2#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
which in##98##2##(1990-12#1)(1990-2#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-12#4)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
which include a##3##3##(1995-9#1)(2007-12#1)(2008-10#1)
which include the##5##3##(1994-8#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
which include##43##2##(1991-5#1)(1992-9#1)(1994-12#2)(1994-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
which included a##4##3##(2008-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
which included four##2##3##(2008-10#1)(2011-2#1)
which included the##6##3##(1993-12#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-3#1)
which included##31##2##(1990-12#1)(1991-6#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
which includes a##2##3##(2008-11#1)(2012-2#1)
which includes an##3##3##(1992-1#1)(1993-2#1)(2008-3#1)
which includes several##2##3##(1992-9#1)(2012-8#1)
which includes the##11##3##(1990-8#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-2#2)(2007-12#1)(2008-10#2)(2008-12#1)(2010-8#1)
which includes##57##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#2)(1996-12#2)(1996-6#1)(1997-3#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#2)
which incorporates the##2##3##(1996-12#1)(2012-2#1)
which incorporates##7##2##(1991-12#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-12#1)(2008-3#1)(2012-2#1)
which increase the##2##3##(2008-10#1)(2008-7#1)
which increase##5##2##(1993-8#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-7#1)
which increased the##5##3##(1991-3#1)(2008-10#3)(2008-6#1)
which increased with##2##3##(1991-9#1)(1996-2#1)
which increased##14##2##(1991-3#1)(1991-9#1)(1992-6#1)(1994-3#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)
which increases the kinoform size##2##5##(2008-2#2)
which increases the number of##2##5##(2008-10#1)(2008-3#1)
which increases the##7##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)
which increases with age##2##4##(2008-4#1)(2013-7#1)
which increases with##4##3##(2007-11#1)(2008-4#1)(2008-9#1)(2013-7#1)
which increases##20##2##(1992-3#1)(1995-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
which indicate that##8##3##(1994-11#1)(1995-3#1)(2008-10#3)(2008-11#2)(2013-8#1)
which indicate##9##2##(1993-3#1)(1994-11#1)(1995-3#1)(2008-10#3)(2008-11#2)(2013-8#1)
which indicated that the##5##4##(2008-10#1)(2008-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
which indicated that##9##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
which indicated the occurrence of##2##5##(2008-11#1)(2008-3#1)
which indicated the##7##3##(2008-10#2)(2008-11#1)(2008-3#2)(2012-2#1)(2013-1#1)
which indicated##18##2##(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
which indicates a##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
which indicates that the##12##4##(1992-6#1)(1993-11#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
which indicates that##31##3##(1992-3#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-9#1)(2010-8#1)(2011-2#2)(2013-8#2)
which indicates the##8##3##(1992-1#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
which indicates##50##2##(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#2)(2009-9#2)(2010-8#2)(2011-2#3)(2012-1#1)(2013-8#4)
which individual##3##2##(1990-2#1)(2008-7#1)(2008-9#1)
which individuals##7##2##(1993-12#1)(1995-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
which induce##4##2##(1992-12#1)(1994-11#1)(2012-12#1)(2012-2#1)
which induced a##3##3##(1990-12#1)(1993-8#1)(2008-10#1)
which induced##9##2##(1990-12#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-11#2)
which induces a##3##3##(1992-12#1)(1995-5#1)(2008-3#1)
which induces the##3##3##(1994-6#1)(1996-3#1)(2008-11#1)
which induces##17##2##(1992-12#1)(1992-5#1)(1994-6#1)(1995-5#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
which infants##2##2##(1990-5#1)(1991-12#1)
which infectious##3##2##(2008-10#2)(2008-9#1)
which influence the##4##3##(1993-6#1)(2008-11#1)(2008-8#1)(2013-8#1)
which influence their##2##3##(2010-9#1)(2013-8#1)
which influence##11##2##(1993-6#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-8#2)
which information is##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
which inhaled##2##2##(1996-3#1)(1996-7#1)
which inhibit the##2##3##(1996-2#1)(2008-10#1)
which inhibit##6##2##(1996-2#1)(2006-6#1)(2008-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
which inhibited##3##2##(1991-12#1)(1991-8#1)(1993-6#1)
which inhibits the##6##3##(1992-9#1)(1994-11#1)(1994-7#1)(1996-2#1)(2008-10#1)(2013-1#1)
which inhibits##21##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#2)(1994-11#3)(1994-2#1)(1994-7#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#1)
which initially##3##2##(2008-10#1)(2008-7#1)(2009-4#1)
which instead##2##2##(2008-3#1)(2010-8#1)
which integrate##2##2##(1995-5#1)(2008-11#1)
which integrates##7##2##(1996-1#1)(2007-12#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
which interact with##2##3##(1993-8#1)(1997-3#1)
which interact##4##2##(1993-11#1)(1993-8#1)(1995-2#1)(1997-3#1)
which interactions##2##2##(2007-10#1)(2008-5#1)
which interacts with##3##3##(1992-9#1)(1997-4#1)(2012-3#1)
which interfere with the##2##4##(2006-10#1)(2008-10#1)
which interfere with##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
which interfere##5##2##(2006-10#1)(2008-10#3)(2008-11#1)
which introduces additional##2##3##(1995-3#1)(2008-3#1)
which introduces##4##2##(1995-3#1)(2008-3#1)(2008-4#1)(2008-9#1)
which invariably##3##2##(2009-12#1)(2009-5#1)(2011-1#1)
which investigated the##2##3##(1993-12#1)(1997-2#1)
which involve##4##2##(1993-3#1)(2008-5#2)(2011-2#1)
which involved the##3##3##(1992-5#1)(2010-8#1)(2013-1#1)
which involved##8##2##(1992-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#2)
which involves a##5##3##(1996-5#1)(2007-10#1)(2008-10#1)(2008-9#1)(2011-3#1)
which involves gamma phosphate cleavage from ATP##2##7##(2013-1#2)
which involves the use of##2##5##(1992-8#1)(2008-10#1)
which involves the##4##3##(1992-8#1)(1997-8#1)(2008-10#1)(2012-12#1)
which involves##23##2##(1992-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-10#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#4)(2011-3#1)(2012-12#1)(2013-1#2)
which is 10##2##3##(2008-10#1)(2008-3#1)
which is 2##2##3##(2007-11#1)(2011-2#1)
which is 4##2##3##(2008-7#1)(2008-9#1)
which is a common##3##4##(1993-12#1)(2008-4#1)(2008-7#1)
which is a competitive antagonist##2##5##(2008-11#1)(2008-3#1)
which is a component of##3##5##(1994-2#1)(1994-8#1)(2008-11#1)
which is a component##4##4##(1994-2#1)(1994-8#1)(2008-11#1)(2013-1#1)
which is a direct##2##4##(2008-10#2)
which is a key##3##4##(1991-2#1)(2008-10#1)(2008-8#1)
which is a liquid at##2##5##(1996-1#1)(1996-2#1)
which is a major##4##4##(1992-12#1)(2007-12#2)(2011-9#1)
which is a mediator of##2##5##(2008-11#1)(2010-5#1)
which is a more##3##4##(2008-10#2)(2009-5#1)
which is a new##2##4##(1997-6#1)(2008-7#1)
which is a potent##2##4##(2008-5#1)(2008-7#1)
which is a prerequisite for##3##5##(2008-11#1)(2008-3#1)(2008-4#1)
which is a significant##2##4##(1997-3#1)(2008-7#1)
which is a specific##3##4##(1992-12#1)(2008-11#2)
which is a substrate for##2##5##(1992-7#2)
which is a##105##3##(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#3)(1992-4#2)(1992-7#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-7#2)(2008-10#23)(2008-11#9)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#2)(2009-12#2)(2009-5#2)(2009-8#3)(2009-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
which is able to improve##2##5##(2008-8#2)
which is able to##5##4##(1991-6#1)(2008-10#1)(2008-8#2)(2008-9#1)
which is about##6##3##(1995-3#1)(2008-10#3)(2009-5#1)(2012-12#1)
which is absent in##2##4##(1993-11#1)(2008-10#1)
which is absent##3##3##(1990-12#1)(1993-11#1)(2008-10#1)
which is accepted##2##3##(2008-10#1)(2008-11#1)
which is accompanied by##2##4##(1996-2#1)(2012-12#1)
which is accomplished by##2##4##(1996-12#1)(2007-8#1)
which is achieved##2##3##(2008-10#1)(2008-2#1)
which is activated##2##3##(2008-11#1)(2010-11#1)
which is affected##2##3##(1995-6#1)(2008-3#1)
which is almost constant over a pH range of##2##9##(2008-10#2)
which is almost##4##3##(1995-12#1)(2008-10#3)
which is already##2##3##(1990-12#1)(2011-2#1)
which is also a##2##4##(2007-7#1)(2008-10#1)
which is also##21##3##(1990-5#1)(1991-11#1)(1993-8#1)(1995-6#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
which is always##2##3##(2008-9#1)(2009-5#1)
which is an autosomal##2##4##(2008-7#1)(2013-8#1)
which is an essential##2##4##(2008-11#1)(2009-6#1)
which is an extension of##2##5##(2008-3#1)(2013-8#1)
which is an important factor##2##5##(2010-9#1)(2013-1#1)
which is an important##11##4##(1995-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
which is an indicator##2##4##(2008-10#1)(2008-12#1)
which is an##42##3##(1992-8#1)(1994-9#1)(1995-2#2)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
which is applicable for##2##4##(2007-11#1)(2008-2#1)
which is applicable to many##2##5##(1994-3#1)(2008-8#1)
which is applicable##4##3##(1994-3#1)(2007-11#1)(2008-2#1)(2008-8#1)
which is approximately##7##3##(1994-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
which is as low as##2##5##(2007-11#1)(2008-10#1)
which is as##5##3##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
which is associated with a##2##5##(1990-8#1)(2008-10#1)
which is associated with the##4##5##(1993-8#1)(1994-9#1)(2006-6#1)(2011-2#1)
which is associated with##10##4##(1990-8#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
which is at##2##3##(2008-10#1)(2008-3#1)
which is attributed to the##3##5##(1996-4#1)(2009-6#1)(2012-2#1)
which is attributed to##6##4##(1996-4#1)(2008-3#1)(2008-8#1)(2009-6#2)(2012-2#1)
which is available to authorized users##17##6##(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
which is available##20##3##(1992-3#1)(2008-10#1)(2008-9#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#5)(2012-3#2)(2013-1#1)
which is based on a##2##5##(2007-11#1)(2008-3#1)
which is based on the##14##5##(2008-10#6)(2008-3#6)(2008-5#1)(2008-6#1)
which is based on##35##4##(1994-5#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-3#10)(2008-5#2)(2008-6#1)(2010-7#1)(2011-10#1)(2012-1#1)(2012-2#2)(2013-1#1)
which is based only on##2##5##(2007-6#1)(2007-8#1)
which is based##38##3##(1994-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#10)(2008-5#2)(2008-6#1)(2010-7#1)(2011-1#1)(2011-10#1)(2012-1#1)(2012-2#2)(2013-1#1)
which is believed to be##2##5##(1994-11#1)(1994-5#1)
which is believed to##5##4##(1990-7#1)(1994-11#1)(1994-5#1)(1996-1#1)(1996-12#1)
which is beneficial##2##3##(2008-5#1)(2013-1#1)
which is better##3##3##(1990-9#1)(2008-3#1)(2010-8#1)
which is both##2##3##(1995-1#1)(2011-2#1)
which is calculated##2##3##(2008-3#1)(2008-9#1)
which is called##2##3##(2008-11#1)(2012-3#1)
which is capable of##8##4##(1990-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-8#1)
which is caused by mutations##2##5##(2007-7#2)
which is caused by the##2##5##(2008-10#1)(2013-8#1)
which is caused by##5##4##(2007-7#2)(2008-10#1)(2008-8#1)(2013-8#1)
which is caused##7##3##(2007-7#2)(2008-10#3)(2008-8#1)(2013-8#1)
which is characteristic of##3##4##(1991-5#1)(2007-11#1)(2008-5#1)
which is characterized by##9##4##(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2010-3#1)(2010-6#1)
which is close to the##3##5##(2008-2#1)(2008-3#2)
which is close to##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
which is closely related to##2##5##(2008-10#1)(2008-4#1)
which is closely related##3##4##(1997-2#1)(2008-10#1)(2008-4#1)
which is closely##4##3##(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
which is commercially available##2##4##(2008-10#1)(2012-3#1)
which is commercially##3##3##(2008-10#1)(2010-4#1)(2012-3#1)
which is common in##2##4##(1993-12#1)(2012-12#1)
which is common to##2##4##(1991-5#1)(1997-4#1)
which is common##4##3##(1991-5#1)(1993-12#1)(1997-4#1)(2012-12#1)
which is commonly used##3##4##(1992-11#1)(2007-11#1)(2008-10#1)
which is commonly##7##3##(1992-11#1)(2007-11#1)(2008-10#2)(2012-3#2)(2013-8#1)
which is comparable to##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
which is comparable with the##2##5##(2008-5#1)(2010-3#1)
which is comparable##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
which is compared##2##3##(2008-10#1)(2008-3#1)
which is compatible with##3##4##(1993-8#1)(2008-9#1)(2011-2#1)
which is complete##2##3##(1990-2#1)(2008-10#1)
which is composed of##4##4##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
which is conserved in##3##4##(1994-12#1)(1995-2#1)(2008-8#1)
which is conserved##6##3##(1992-3#1)(1992-6#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-8#1)
which is considerably##2##3##(2007-12#1)(2009-6#1)
which is considered a##2##4##(1992-12#1)(2010-5#1)
which is considered to be##5##5##(1994-11#1)(1994-9#1)(2008-11#1)(2011-2#1)(2013-8#1)
which is considered to##7##4##(1994-11#1)(1994-9#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
which is considered##11##3##(1992-12#1)(1994-11#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
which is consistent with a##3##5##(2008-10#1)(2008-2#1)(2011-1#1)
which is consistent with the##8##5##(1993-12#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#2)
which is consistent with##21##4##(1993-12#1)(1995-6#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-2#4)(2008-8#1)(2008-9#3)(2010-10#1)(2011-1#1)(2013-1#2)
which is consistent##23##3##(1993-11#1)(1993-12#1)(1995-6#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-2#4)(2008-8#1)(2008-9#3)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
which is controlled by##2##4##(2007-11#2)
which is correlated##2##3##(1992-12#1)(1992-9#1)
which is coupled##2##3##(2008-11#1)(2008-2#1)
which is critical for##8##4##(1992-12#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
which is critical##9##3##(1992-12#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
which is crucial for##2##4##(2008-7#1)(2009-8#1)
which is crucial##3##3##(2007-7#1)(2008-7#1)(2009-8#1)
which is currently the##3##4##(2008-10#1)(2011-2#2)
which is currently##9##3##(1991-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#3)
which is decreased linearly by addition of##2##7##(2008-10#2)
which is defined as the##5##5##(2008-10#2)(2008-3#2)(2008-9#1)
which is defined as##6##4##(1992-2#1)(2008-10#2)(2008-3#2)(2008-9#1)
which is defined##8##3##(1992-2#1)(1997-6#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-3#1)
which is demonstrated##3##3##(2008-10#1)(2008-2#2)
which is dependent on##3##4##(1990-11#1)(2008-10#1)(2008-8#1)
which is dependent##4##3##(1990-11#1)(2008-10#1)(2008-8#1)(2009-10#1)
which is derived##2##3##(1997-5#1)(2013-1#1)
which is described in##3##4##(1997-6#1)(2008-4#1)(2013-1#1)
which is designed to##2##4##(1995-1#1)(2013-1#1)
which is detected in##2##4##(1990-11#1)(2008-9#1)
which is detected spectrophotometrically at##2##5##(2008-10#2)
which is detected##6##3##(1990-11#1)(2008-10#4)(2008-9#1)
which is determined##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
which is diagnostic for##2##4##(1996-2#1)(2011-1#1)
which is different from##4##4##(1991-1#1)(1993-8#1)(2008-10#1)(2008-7#1)
which is different##5##3##(1991-1#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
which is directed to##2##4##(1992-5#1)(2006-6#1)
which is directed##3##3##(1992-5#1)(1994-5#1)(2006-6#1)
which is directly##3##3##(2007-11#1)(2008-10#1)(2009-8#1)
which is discussed in##4##4##(2008-3#3)(2010-2#1)
which is discussed##5##3##(2008-3#3)(2009-8#1)(2010-2#1)
which is distributed##2##3##(2009-8#1)(2010-6#1)
which is dominated by##2##4##(2008-3#1)(2008-5#1)
which is dramatically##2##3##(1997-2#1)(2008-10#1)
which is due to the##2##5##(2007-12#1)(2008-3#1)
which is due to##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
which is encoded##2##3##(2009-7#1)(2011-1#1)
which is equivalent to##4##4##(1997-4#1)(1997-5#1)(2008-10#2)
which is equivalent##5##3##(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#1)
which is especially##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
which is essential for the##3##5##(2007-7#1)(2008-11#2)
which is essential for##10##4##(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
which is essential to##2##4##(2008-2#1)(2008-5#1)
which is essential##13##3##(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
which is evolutionarily##2##3##(1995-6#1)(2012-3#1)
which is expected to##2##4##(2008-10#1)(2010-6#1)
which is expressed in##2##4##(1991-5#1)(1995-2#1)
which is expressed##5##3##(1991-5#1)(1993-12#1)(1995-2#1)(1997-7#1)(2008-10#1)
which is extremely##2##3##(2008-12#1)(2010-5#1)
which is facilitated by##2##4##(1990-2#1)(2008-11#1)
which is far##2##3##(2007-11#1)(2010-8#1)
which is formed by rotation of the beam-splitter grating around##2##10##(2008-3#2)
which is formed by##4##4##(2007-12#1)(2008-3#3)
which is formed##5##3##(1990-7#1)(2007-12#1)(2008-3#3)
which is found in##4##4##(1990-11#1)(1993-9#1)(2008-7#1)(2010-8#1)
which is found##6##3##(1990-11#1)(1993-9#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-2#1)
which is frequently##2##3##(2008-10#2)
which is further##2##3##(1993-12#1)(2008-10#1)
which is generally##4##3##(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
which is generated##2##3##(2008-11#1)(2008-8#1)
which is given##2##3##(1997-8#1)(2012-2#1)
which is higher than##2##4##(2008-10#1)(2009-4#1)
which is higher##3##3##(1993-11#1)(2008-10#1)(2009-4#1)
which is highly conserved##4##4##(1990-8#1)(1994-12#2)(2008-9#1)
which is highly selective##2##4##(2008-10#2)
which is highly##15##3##(1990-8#1)(1994-12#2)(1995-8#2)(1997-3#1)(2007-11#1)(2008-10#5)(2008-7#1)(2008-9#2)
which is however##2##3##(2008-12#2)
which is identical to##2##4##(1991-5#1)(1995-12#1)
which is identical##5##3##(1991-5#1)(1991-9#1)(1993-6#1)(1995-12#1)(2007-11#1)
which is implemented##2##3##(2008-10#1)(2008-3#1)
which is important for##9##4##(1992-12#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)(2013-7#1)
which is in agreement with that##2##6##(2008-10#2)
which is in agreement with the##3##6##(2007-8#1)(2008-10#1)(2008-7#1)
which is in agreement with##7##5##(1990-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-12#1)
which is in contrast to the##3##6##(1997-7#1)(2008-10#1)(2008-11#1)
which is in contrast to##6##5##(1994-3#1)(1997-7#1)(2008-10#3)(2008-11#1)
which is in contrast##7##4##(1994-3#1)(1997-7#1)(2008-10#4)(2008-11#1)
which is in good agreement with the value##2##8##(2008-10#1)(2009-12#1)
which is in good agreement with the##4##7##(1993-9#1)(2008-10#2)(2009-12#1)
which is in good agreement with##5##6##(1993-9#1)(2008-10#2)(2008-3#1)(2009-12#1)
which is in turn##2##4##(1990-8#1)(2008-10#1)
which is in##32##3##(1990-12#1)(1990-8#1)(1993-9#1)(1994-3#1)(1997-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
which is included in a##2##5##(2008-11#1)(2008-5#1)
which is inconsistent with##2##4##(2008-12#1)(2008-3#1)
which is independent of protein##2##5##(1993-3#1)(1993-6#1)
which is independent of##3##4##(1992-9#1)(1993-3#1)(1993-6#1)
which is indispensable for##2##4##(1997-3#1)(2008-11#1)
which is indispensable##3##3##(1997-3#1)(2008-11#1)(2008-4#1)
which is induced by##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
which is inhibited by##2##4##(1991-12#1)(1994-8#1)
which is insensitive to##2##4##(2008-10#1)(2008-3#1)
which is introduced##3##3##(2008-10#3)
which is involved in the##5##5##(1990-8#1)(1994-8#1)(2008-5#1)(2008-8#1)(2010-11#1)
which is involved in##14##4##(1990-8#1)(1991-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)
which is known to be a##2##6##(1994-11#1)(2008-11#1)
which is known to be##6##5##(1992-3#1)(1994-11#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-4#1)
which is known to enhance##2##5##(1992-3#1)(2008-11#1)
which is known to induce##2##5##(1990-2#1)(2008-10#1)
which is known to##20##4##(1990-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-3#1)(2012-2#2)
which is known##22##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-2#2)
which is largely##4##3##(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
which is larger than##2##4##(2008-2#1)(2008-3#1)
which is likely##2##3##(1990-12#1)(2008-7#1)
which is limited##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
which is linked to##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
which is located at##2##4##(1995-12#1)(1995-6#1)
which is located in the##3##5##(2007-12#1)(2008-9#1)(2013-8#1)
which is located on chromosome##2##5##(2008-1#1)(2008-8#1)
which is located##9##3##(1995-12#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
which is mainly##2##3##(2008-11#1)(2009-7#1)
which is measured at##2##4##(2008-10#2)
which is measured##7##3##(2008-10#6)(2011-1#1)
which is mediated by##7##4##(1993-3#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)
which is monitored at##2##4##(2008-10#2)
which is monitored##3##3##(2008-10#3)
which is more in keeping with the##2##7##(1997-8#1)(2009-8#1)
which is more sensitive##2##4##(1991-8#1)(1992-8#1)
which is more than##2##4##(2007-12#2)
which is more##12##3##(1991-2#1)(1991-8#1)(1992-6#1)(1992-8#1)(1997-8#1)(2007-12#3)(2008-10#1)(2009-6#1)(2009-8#1)(2013-1#1)
which is most widely used##2##5##(2008-1#1)(2008-11#1)
which is most##6##3##(1992-2#1)(1994-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2012-2#1)
which is mostly##2##3##(2008-10#1)(2012-12#1)
which is much less##2##4##(2008-7#1)(2011-2#1)
which is much lower than##2##5##(2008-10#1)(2012-1#1)
which is much##10##3##(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
which is necessary for##6##4##(1997-7#1)(2007-11#1)(2008-3#2)(2008-4#1)(2010-7#1)
which is necessary to##2##4##(1995-2#1)(2008-2#1)
which is necessary##11##3##(1995-2#1)(1997-7#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2010-7#1)
which is neither##2##3##(1993-3#1)(1997-4#1)
which is normally##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
which is not a##3##4##(1995-2#1)(2011-1#1)(2013-1#1)
which is not always##2##4##(1992-3#1)(2008-11#1)
which is not an##3##4##(1992-3#1)(2008-3#2)
which is not easily##2##4##(2008-10#1)(2008-6#1)
which is not found in##2##5##(2008-7#1)(2008-8#1)
which is not only##2##4##(1990-11#1)(2013-7#1)
which is not possible##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
which is not sensitive to##2##5##(1991-6#1)(2007-11#1)
which is not the##2##4##(2008-11#1)(2008-3#1)
which is not##48##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
which is now##7##3##(1991-3#1)(1992-1#1)(1994-5#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-7#1)
which is obviously##2##3##(2008-10#1)(2013-1#1)
which is of great##2##4##(2008-2#1)(2012-2#1)
which is of##9##3##(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#2)
which is often a##2##4##(2008-11#1)(2013-8#1)
which is often##15##3##(1991-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
which is one of the most common##2##7##(2008-4#1)(2013-1#1)
which is one of the most##5##6##(2008-10#3)(2008-4#1)(2013-1#1)
which is one of the##16##5##(1990-7#1)(1992-12#1)(1994-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
which is one of##17##4##(1990-7#1)(1992-12#1)(1994-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
which is one##19##3##(1990-7#1)(1992-12#1)(1994-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
which is only##3##3##(1996-12#1)(1996-6#1)(2008-2#1)
which is part of the##3##5##(1991-12#1)(2008-11#1)(2011-2#1)
which is part of##5##4##(1991-12#1)(1997-7#1)(2007-2#1)(2008-11#1)(2011-2#1)
which is placed##2##3##(2008-10#1)(2008-2#1)
which is poorly##2##3##(2008-10#1)(2010-12#1)
which is possible##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
which is present in the##2##5##(1993-6#1)(2008-10#1)
which is present in##9##4##(1990-2#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(2008-10#3)(2013-1#1)
which is present##10##3##(1990-2#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(2008-10#3)(2009-6#1)(2013-1#1)
which is primarily##2##3##(1994-8#1)(2008-3#1)
which is probably related to##2##5##(1996-2#1)(2011-1#1)
which is probably##4##3##(1996-2#1)(2008-5#1)(2010-12#1)(2011-1#1)
which is produced by##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
which is produced##7##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
which is proportional to the##2##5##(2007-12#1)(2008-3#1)
which is proportional to##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
which is proportional##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
which is proposed to be##2##5##(2008-5#1)(2011-2#1)
which is quite##2##3##(2008-3#1)(2008-8#1)
which is rapidly##2##3##(1992-5#1)(2006-6#1)
which is readily##2##3##(1991-5#1)(1995-2#1)
which is reduced##2##3##(1997-2#1)(2008-10#1)
which is reflected from the##2##5##(2008-3#2)
which is reflected in##2##4##(1996-12#1)(2009-11#1)
which is reflected##4##3##(1996-12#1)(2008-3#2)(2009-11#1)
which is regulated by##3##4##(1993-12#1)(1993-3#1)(1994-12#1)
which is related to the##4##5##(2008-10#2)(2008-6#1)(2008-8#1)
which is related to##5##4##(1990-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
which is related##6##3##(1990-12#1)(1994-2#1)(2008-10#2)(2008-6#1)(2008-8#1)
which is relatively##3##3##(1992-4#1)(1994-2#1)(2008-10#1)
which is relevant for##2##4##(2008-3#1)(2010-12#1)
which is reported##2##3##(1991-8#1)(2008-11#1)
which is represented by##3##4##(1990-12#1)(1997-6#1)(1997-8#1)
which is required for the##3##5##(1996-8#1)(2008-10#1)(2008-2#1)
which is required for##8##4##(1992-3#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-6#1)(2013-8#1)
which is resistant to##2##4##(2008-10#1)(2011-2#1)
which is responsible for the##7##5##(1993-9#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-5#1)
which is responsible for##10##4##(1993-9#1)(1994-8#1)(1996-2#2)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#1)
which is safe##2##3##(2007-12#1)(2012-3#1)
which is secreted##4##3##(1991-2#1)(1997-2#1)(1997-6#1)(2008-8#1)
which is sensitive to##3##4##(2007-7#1)(2008-10#1)(2008-12#1)
which is sensitive##5##3##(2007-7#1)(2008-10#3)(2008-12#1)
which is shown to be##3##5##(1994-3#1)(2010-2#1)(2011-2#1)
which is shown to##6##4##(1994-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2010-2#1)(2011-2#1)
which is shown##7##3##(1994-3#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-2#1)(2010-2#1)(2011-2#1)
which is significantly##4##3##(1993-8#1)(2007-11#1)(2008-11#1)(2008-12#1)
which is similar to that of the##2##7##(1991-9#1)(1997-2#1)
which is similar to the##6##5##(1992-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2012-3#1)
which is similar to##9##4##(1991-9#1)(1992-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-2#2)(2012-3#1)
which is small enough##2##4##(2007-11#1)(2008-10#1)
which is small##3##3##(2007-11#2)(2008-10#1)
which is specific for##2##4##(1990-5#1)(2013-8#1)
which is stable##2##3##(1991-5#1)(2008-10#1)
which is still##3##3##(2008-10#1)(2008-2#1)(2009-3#1)
which is strongly associated with##3##5##(1997-8#1)(2011-2#1)(2011-7#1)
which is strongly##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2011-7#1)
which is subsequently##8##3##(1990-2#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)
which is suggested to##2##4##(1994-9#1)(2008-10#1)
which is suggestive of##2##4##(1995-12#1)(1995-2#1)
which is suitable for the##2##5##(1996-2#1)(2008-10#1)
which is suitable for##3##4##(1996-2#1)(2008-10#2)
which is supported by##3##4##(1992-3#1)(1997-2#1)(1997-5#1)
which is susceptible to##3##4##(2008-10#3)
which is susceptible##4##3##(2008-10#4)
which is synthesised##2##3##(1992-8#1)(2013-7#1)
which is ten times##2##4##(1992-2#1)(2008-10#1)
which is the basis for the##2##6##(1997-6#1)(2008-7#1)
which is the basis of##2##5##(2008-10#1)(2008-6#1)
which is the basis##4##4##(1997-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
which is the first##4##4##(1995-8#1)(2008-10#2)(2013-8#1)
which is the highest##2##4##(2007-11#1)(2008-12#1)
which is the key##2##4##(2007-11#1)(2008-1#1)
which is the largest##2##4##(1991-5#1)(2011-2#1)
which is the major##2##4##(2008-10#1)(2008-11#1)
which is the most severe##2##5##(2008-10#1)(2013-8#1)
which is the most widely##2##5##(2008-3#1)(2008-8#1)
which is the most##12##4##(2008-10#2)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
which is the primary##3##4##(2008-1#1)(2008-7#1)(2010-8#1)
which is the result of##2##5##(2007-10#1)(2007-12#1)
which is the same as that of##2##7##(1990-12#1)(1990-7#1)
which is the same as that##5##6##(1990-12#1)(1990-7#1)(1993-8#1)(2008-10#1)(2008-8#1)
which is the same as##6##5##(1990-12#1)(1990-7#1)(1993-8#1)(2008-10#2)(2008-8#1)
which is the same##9##4##(1990-12#1)(1990-7#1)(1993-8#1)(1994-6#1)(1995-11#1)(2008-10#2)(2008-8#1)(2012-2#1)
which is the type##2##4##(2011-2#2)
which is the##90##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-7#1)(2010-5#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
which is then oxidized##2##4##(2008-10#1)(2008-11#1)
which is then##12##3##(1992-12#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)
which is thought to be involved in##2##7##(1995-8#1)(2008-7#1)
which is thought to be##4##5##(1992-11#1)(1994-9#1)(1995-8#1)(2008-7#1)
which is thought to##11##4##(1991-12#2)(1992-11#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-8#1)(2008-5#1)(2008-7#1)(2012-1#1)
which is thought##12##3##(1991-12#2)(1992-11#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-8#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)
which is tightly##2##3##(2008-10#1)(2012-2#1)
which is to##6##3##(1993-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2012-3#1)(2013-1#1)
which is toxic##2##3##(1992-12#1)(1995-8#1)
which is typical of##3##4##(2008-12#1)(2008-2#1)(2010-10#1)
which is typical##4##3##(2007-11#1)(2008-12#1)(2008-2#1)(2010-10#1)
which is typically##2##3##(2007-11#1)(2008-10#1)
which is unable to##2##4##(2008-6#1)(2010-10#1)
which is under##2##3##(2008-5#2)
which is unique to the##2##5##(2009-10#1)(2011-2#1)
which is unique to##3##4##(1993-2#1)(2009-10#1)(2011-2#1)
which is unique##4##3##(1990-5#1)(1993-2#1)(2009-10#1)(2011-2#1)
which is upregulated##2##3##(2008-6#1)(2009-8#1)
which is used as a##2##5##(2008-10#1)(2008-4#1)
which is used as an##2##5##(2011-2#1)(2012-12#1)
which is used as##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
which is used in the##3##5##(1990-11#1)(1996-9#1)(2010-8#1)
which is used in##5##4##(1990-11#1)(1992-12#1)(1996-9#1)(2010-8#1)(2011-2#1)
which is used to##6##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
which is used##17##3##(1990-11#1)(1992-12#1)(1996-9#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
which is useful for##7##4##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-8#1)(2011-1#1)
which is useful##8##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2010-8#1)(2011-1#1)
which is usually##5##3##(2007-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)
which is utilized##2##3##(2008-2#1)(2008-6#1)
which is valid for##2##4##(1995-3#1)(2008-2#1)
which is very close to the##2##6##(2008-10#1)(2012-3#1)
which is very similar##2##4##(1994-11#1)(2008-10#1)
which is very##14##3##(1994-11#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-5#2)(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)
which is well within the##2##5##(2008-2#1)(2010-11#1)
which is well##4##3##(1995-12#1)(2008-10#1)(2008-2#1)(2010-11#1)
which is why##2##3##(2011-2#1)(2013-1#1)
which is widely used for##2##5##(2008-11#1)(2011-1#1)
which is widely used##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
which is widely##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)
which is within the##3##4##(1993-8#1)(1995-2#1)(2008-3#1)
which is##1620##2##(1990-11#10)(1990-12#8)(1990-2#7)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#9)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#10)(1991-2#7)(1991-3#3)(1991-5#12)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#9)(1992-1#1)(1992-11#6)(1992-12#14)(1992-2#5)(1992-3#10)(1992-4#5)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#6)(1992-9#8)(1993-1#1)(1993-11#7)(1993-12#10)(1993-2#2)(1993-3#8)(1993-6#8)(1993-8#12)(1993-9#8)(1994-10#1)(1994-11#8)(1994-12#9)(1994-2#8)(1994-3#7)(1994-5#7)(1994-6#1)(1994-7#2)(1994-8#9)(1994-9#7)(1995-1#3)(1995-11#7)(1995-12#8)(1995-2#18)(1995-3#8)(1995-5#2)(1995-6#11)(1995-8#11)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#16)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#11)(1997-3#7)(1997-4#5)(1997-5#3)(1997-6#10)(1997-7#7)(1997-8#9)(2006-10#2)(2006-6#4)(2007-10#2)(2007-11#38)(2007-12#45)(2007-2#1)(2007-6#1)(2007-7#13)(2007-8#6)(2008-1#14)(2008-10#287)(2008-11#68)(2008-12#21)(2008-2#45)(2008-3#94)(2008-4#26)(2008-5#43)(2008-6#11)(2008-7#43)(2008-8#36)(2008-9#28)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#9)(2009-6#8)(2009-7#8)(2009-8#12)(2009-9#6)(2010-1#2)(2010-10#5)(2010-11#7)(2010-12#5)(2010-2#3)(2010-3#8)(2010-4#2)(2010-5#9)(2010-6#6)(2010-7#4)(2010-8#14)(2010-9#3)(2011-1#17)(2011-10#1)(2011-2#54)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#7)(2012-12#8)(2012-2#28)(2012-3#31)(2013-1#39)(2013-7#6)(2013-8#22)
which isolates##2##2##(2008-10#1)(2008-7#1)
which it can be##3##4##(1990-11#1)(2008-8#1)(2012-3#1)
which it can##5##3##(1990-11#1)(1994-3#1)(2008-11#1)(2008-8#1)(2012-3#1)
which it has been##2##4##(2008-10#1)(2008-3#1)
which it has##3##3##(2008-10#2)(2008-3#1)
which it is possible to##2##5##(1992-3#1)(2008-9#1)
which it is##25##3##(1990-5#2)(1992-3#1)(1994-12#1)(1995-2#1)(1996-5#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-12#1)(2011-1#2)(2012-12#1)(2013-8#1)
which it may##2##3##(1995-9#1)(2007-11#1)
which it was isolated##2##4##(1995-3#1)(2012-3#1)
which it was##8##3##(1991-5#1)(1995-3#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
which it##65##2##(1990-11#1)(1990-5#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#2)(2007-11#1)(2008-1#3)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
which its##4##2##(1997-1#1)(2008-10#1)(2011-2#1)(2013-1#1)
which lack##4##2##(1994-2#1)(1994-8#1)(2008-3#1)(2008-4#1)
which lacked##3##2##(1994-3#1)(1997-4#1)(2008-10#1)
which lacks the##8##3##(1991-5#1)(1991-8#1)(1995-12#1)(1997-6#1)(2008-7#2)(2011-2#1)(2012-3#1)
which lacks##15##2##(1991-5#1)(1991-8#1)(1993-6#2)(1993-8#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
which large##3##2##(2008-10#1)(2008-11#2)
which lasing##2##2##(2007-12#1)(2008-3#1)
which lasted for##3##3##(1991-6#1)(2008-12#1)(2011-2#1)
which lasted##5##2##(1991-6#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)
which later##2##2##(1994-5#1)(1996-3#1)
which lead to a##2##4##(2007-11#1)(2008-3#1)
which lead to the##2##4##(1990-6#1)(2009-8#1)
which lead to##11##3##(1990-6#1)(1992-6#2)(2007-11#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-3#1)(2010-9#1)(2013-8#1)
which lead##12##2##(1990-6#1)(1992-6#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-3#1)(2010-9#1)(2013-8#1)
which leads to a##5##4##(1992-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
which leads to an##4##4##(1992-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
which leads to metabolic##2##4##(2007-10#1)(2012-3#1)
which leads to the##4##4##(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
which leads to##42##3##(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
which leads##44##2##(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
which learning##2##2##(1997-2#1)(2010-5#1)
which led to a##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
which led to the##5##4##(1992-5#1)(1996-5#1)(2009-11#1)(2009-5#1)(2012-12#1)
which led to##19##3##(1991-12#1)(1992-5#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#2)(2011-2#1)(2012-12#1)(2012-2#2)
which led##20##2##(1991-12#1)(1992-5#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
which liability##2##2##(1991-3#1)(1992-3#1)
which lies between the##2##4##(1992-12#1)(2007-12#1)
which lies outside the##2##4##(1995-2#1)(2008-4#1)
which lies##6##2##(1992-12#1)(1995-2#1)(1997-3#1)(2007-12#2)(2008-4#1)
which life##2##2##(2010-1#1)(2011-2#1)
which likely##3##2##(1994-5#1)(2008-1#1)(2012-3#1)
which limit the##2##3##(2008-9#1)(2009-7#1)
which limit##4##2##(2007-7#1)(2008-10#1)(2008-9#1)(2009-7#1)
which limits##3##2##(1997-4#1)(2010-1#1)(2011-2#1)
which links##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
which liquid##2##2##(2008-10#1)(2008-3#1)
which live##2##2##(2008-5#2)
which long-term##2##2##(1996-2#1)(2012-3#1)
which looks##2##2##(1994-2#1)(2008-5#1)
which low levels##2##3##(2008-10#1)(2008-7#1)
which low##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
which made##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
which mainly##5##2##(1991-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
which maintained##2##2##(2008-7#1)(2009-3#1)
which maintains the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
which maintains##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
which major##2##2##(1994-2#1)(2008-7#1)
which make it##4##3##(1990-5#1)(1995-3#1)(2009-8#1)(2013-8#1)
which make the##2##3##(2008-10#1)(2012-3#1)
which make them##2##3##(2008-10#2)
which make up the##3##4##(2008-5#2)(2011-1#1)
which make##19##2##(1990-5#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-4#1)(2006-10#1)(2008-10#3)(2008-5#2)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-8#2)
which makes it a powerful##2##5##(2008-7#1)(2012-3#1)
which makes it a##3##4##(2008-12#1)(2008-7#1)(2012-3#1)
which makes it possible##2##4##(2008-10#2)
which makes it##13##3##(1993-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
which makes possible a##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
which makes the system##2##4##(2008-10#1)(2008-11#1)
which makes the##8##3##(1993-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-8#1)
which makes them##5##3##(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)
which makes use of##3##4##(1994-12#1)(2007-12#1)(2008-10#1)
which makes##43##2##(1990-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#2)(2010-12#1)(2010-4#2)(2011-2#1)(2012-3#2)(2013-8#2)
which manifests itself##2##3##(2008-5#1)(2010-8#1)
which manifests##4##2##(2007-7#1)(2008-11#1)(2008-5#1)(2010-8#1)
which many##4##2##(1996-8#1)(1997-1#1)(2007-12#1)(2008-10#1)
which maps to##2##3##(1997-7#1)(2008-6#1)
which maps##3##2##(1993-3#1)(1997-7#1)(2008-6#1)
which markedly##2##2##(1993-8#1)(2007-8#1)
which matched the##2##3##(1995-2#1)(2008-11#1)
which may account for##2##4##(2008-10#1)(2010-3#1)
which may act as##3##4##(1996-2#1)(2008-10#1)(2012-2#1)
which may affect the##4##4##(2008-1#1)(2008-12#1)(2011-1#1)(2012-3#1)
which may affect##9##3##(1991-11#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2012-3#1)
which may allow##2##3##(2008-10#1)(2008-3#1)
which may also be##2##4##(1992-8#1)(2008-3#1)
which may also##4##3##(1992-8#1)(1994-9#1)(2008-3#1)(2009-12#1)
which may appear##3##3##(1990-8#1)(1994-8#1)(2012-1#1)
which may be associated with the##2##6##(1992-12#1)(1996-3#1)
which may be associated with##3##5##(1992-12#1)(1996-3#1)(2011-2#1)
which may be attributed to the##2##6##(1995-3#1)(2008-10#1)
which may be attributed to##5##5##(1995-3#1)(1996-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
which may be considered##3##4##(1994-2#1)(2008-12#1)(2010-8#1)
which may be due to the##2##6##(2008-9#1)(2012-3#1)
which may be due to##4##5##(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
which may be due##5##4##(2008-10#1)(2008-9#2)(2011-2#1)(2012-3#1)
which may be either##2##4##(1990-8#1)(2007-11#1)
which may be involved in##2##5##(1991-6#1)(1994-8#1)
which may be more##3##4##(1991-2#1)(2008-8#1)(2011-2#1)
which may be of importance in##2##6##(1990-12#1)(1995-8#1)
which may be of##8##4##(1990-12#1)(1990-8#1)(1992-3#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-11#1)(2010-4#1)
which may be present##2##4##(2008-10#2)
which may be related to##6##5##(1990-6#1)(1991-6#1)(1997-2#1)(2007-12#1)(2009-12#1)(2010-2#1)
which may be relevant##2##4##(1996-2#1)(1996-5#1)
which may be responsible for the##2##6##(1993-12#1)(1994-3#1)
which may be responsible for##7##5##(1990-8#1)(1993-12#2)(1994-3#1)(1996-12#1)(2008-10#2)
which may be the##2##4##(1997-3#1)(2008-12#1)
which may be used in##2##5##(1995-1#1)(2008-3#1)
which may be used##4##4##(1995-1#1)(2008-10#1)(2008-3#1)(2010-5#1)
which may be useful in##2##5##(2007-11#1)(2009-5#1)
which may be useful##3##4##(1994-6#1)(2007-11#1)(2009-5#1)
which may be##124##3##(1990-12#1)(1990-6#1)(1990-8#3)(1991-2#2)(1991-6#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#15)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
which may cause##8##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
which may contain##4##3##(1990-5#1)(2007-12#1)(2008-5#1)(2008-8#1)
which may contribute to the##6##5##(1990-3#1)(1992-6#1)(1994-3#1)(1996-10#1)(2011-2#1)(2012-12#1)
which may contribute to##11##4##(1990-3#1)(1992-6#1)(1994-3#1)(1996-10#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-7#1)
which may correspond to##3##4##(1990-5#1)(1993-11#1)(1997-3#1)
which may enable the##2##4##(2008-10#1)(2011-2#1)
which may explain the##3##4##(1990-12#1)(1991-1#1)(1996-5#1)
which may explain##5##3##(1990-12#1)(1991-1#1)(1991-8#1)(1993-9#1)(1996-5#1)
which may facilitate the##2##4##(2009-12#1)(2013-7#1)
which may function as##2##4##(1992-9#1)(2008-5#1)
which may give rise to##2##5##(1991-3#1)(1996-12#1)
which may have a##2##4##(1995-3#1)(2012-2#1)
which may have been##4##4##(2008-10#1)(2008-7#1)(2009-5#1)(2013-7#1)
which may have contributed to the##2##6##(2008-10#1)(2010-4#1)
which may have##18##3##(1992-11#1)(1993-11#1)(1993-3#1)(1995-3#1)(2007-12#2)(2008-10#3)(2008-7#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
which may help in##2##4##(2007-10#1)(2008-10#1)
which may help to explain##2##5##(2009-12#1)(2012-2#1)
which may help to##5##4##(2008-5#1)(2008-6#1)(2009-12#1)(2012-2#1)(2012-9#1)
which may help##7##3##(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2012-2#1)(2012-9#1)
which may in##2##3##(2008-8#1)(2013-1#1)
which may include##5##3##(1995-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2013-8#1)
which may increase##3##3##(1994-2#1)(2008-3#1)(2008-7#1)
which may indicate##2##3##(2008-10#1)(2008-9#1)
which may influence##4##3##(1992-3#1)(1994-9#1)(1995-6#1)(2008-12#1)
which may involve##3##3##(1990-5#1)(1992-9#1)(1993-8#1)
which may justify a##2##4##(1990-12#1)(1997-8#1)
which may justify##3##3##(1990-12#1)(1997-8#1)(2008-5#1)
which may lead to##13##4##(1995-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
which may mimic##3##3##(2007-5#1)(2010-3#1)(2012-2#1)
which may not##2##3##(2008-11#2)
which may occur in##4##4##(1990-8#1)(1993-2#1)(2010-4#1)(2013-8#1)
which may occur##9##3##(1990-8#1)(1993-2#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
which may offer##3##3##(2006-10#1)(2007-10#1)(2010-11#1)
which may or may not be##2##6##(2007-10#1)(2008-7#1)
which may play a role in##2##6##(1991-11#1)(2008-7#1)
which may play##3##3##(1991-11#1)(1992-10#1)(2008-7#1)
which may predispose##2##3##(1997-8#1)(2009-12#1)
which may produce##2##3##(1990-9#1)(1996-12#1)
which may provide a##2##4##(1992-9#1)(2007-11#1)
which may provide an##2##4##(2008-10#1)(2013-1#1)
which may provide##5##3##(1992-9#1)(1994-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
which may reflect##3##3##(1993-2#1)(2009-10#1)(2011-2#1)
which may relate to##2##4##(1993-5#1)(2008-8#1)
which may represent a##2##4##(1996-5#1)(2008-10#1)
which may represent##4##3##(1996-5#1)(2008-10#1)(2008-9#1)(2010-12#1)
which may require##2##3##(1992-3#1)(2008-11#1)
which may result from##2##4##(2008-8#1)(2012-2#1)
which may result in##4##4##(1995-8#1)(2008-10#2)(2008-5#1)
which may result##6##3##(1995-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty##2##12##(2008-4#2)
which may reveal novel##3##4##(2008-4#2)(2012-2#1)
which may serve as##3##4##(1993-2#1)(1994-12#1)(2009-4#1)
which may vary##2##3##(2009-12#1)(2013-1#1)
which may##368##2##(1990-12#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#3)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#3)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#4)(2006-10#1)(2007-10#4)(2007-11#6)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#15)(2008-12#7)(2008-2#1)(2008-3#7)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#12)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#6)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#14)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#3)(2012-2#12)(2012-3#6)(2012-9#1)(2013-1#13)(2013-7#4)(2013-8#6)
which means that a##2##4##(1991-12#1)(2008-10#1)
which means that the##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
which means that##8##3##(1990-2#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
which means##12##2##(1990-2#1)(1991-12#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2013-1#1)
which meant that##2##3##(2008-10#1)(2011-3#1)
which meant##3##2##(1990-8#1)(2008-10#1)(2011-3#1)
which measured exposure during##2##4##(1993-1#2)
which measured##7##2##(1993-1#2)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
which measurements##3##2##(1990-2#1)(2007-11#1)(2008-3#1)
which measures the##5##3##(1990-8#1)(2008-2#1)(2008-3#2)(2012-12#1)
which measures##12##2##(1990-8#1)(1991-6#1)(1992-1#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-9#1)(2012-12#1)(2013-8#1)
which mechanism##2##2##(1997-1#1)(2010-11#1)
which mediate##5##2##(1991-6#1)(1994-8#1)(1995-6#1)(2008-8#1)(2012-2#1)
which mediates the##2##3##(1993-2#1)(2009-7#1)
which mediates##9##2##(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1997-2#1)(2007-8#1)(2009-7#1)
which medical##3##2##(1995-2#1)(1997-1#1)(2007-8#1)
which meets the##2##3##(2008-10#1)(2013-1#1)
which membrane##2##2##(2008-6#1)(2009-5#1)
which men##2##2##(2009-5#2)
which met##3##2##(2008-2#1)(2010-1#1)(2011-2#1)
which might also##2##3##(2010-10#1)(2012-2#1)
which might be due to##2##5##(1993-8#1)(2008-10#1)
which might be explained by##2##5##(1997-5#1)(2008-10#1)
which might be involved in##2##5##(1994-2#1)(1997-8#1)
which might be##18##3##(1990-8#1)(1992-12#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#3)(2010-4#1)(2011-2#1)
which might explain the##3##4##(1990-2#1)(1991-11#1)(2008-5#1)
which might explain##4##3##(1990-2#1)(1991-11#1)(2008-5#1)(2009-6#1)
which might have a protective effect##2##6##(2008-7#1)(2011-2#1)
which might have a##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
which might have##5##3##(1996-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
which might induce##2##3##(2008-11#1)(2011-2#1)
which might lead to##2##4##(1995-11#1)(2008-3#1)
which might##51##2##(1990-2#2)(1990-8#2)(1991-11#1)(1991-6#1)(1992-12#2)(1993-8#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-6#2)(2010-10#1)(2010-4#1)(2011-2#4)(2012-2#3)
which migrate##2##2##(1992-10#1)(2009-5#1)
which mimic the##2##3##(1990-8#1)(2008-8#1)
which mimic##3##2##(1990-8#1)(2007-10#1)(2008-8#1)
which mimics##6##2##(1990-11#2)(1990-7#1)(1993-12#1)(1997-7#1)(2008-10#1)
which minimizes##2##2##(1996-12#1)(2008-3#1)
which model##3##2##(1994-11#1)(2008-9#1)(2012-3#1)
which models##2##2##(2007-12#1)(2008-8#1)
which modifies##2##2##(2008-12#1)(2013-1#1)
which modify##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
which modulate##4##2##(1995-5#1)(1997-7#1)(2008-4#1)(2009-3#1)
which modulates##3##2##(1994-9#1)(2008-11#1)(2008-4#1)
which molecular##5##2##(1994-5#1)(1994-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
which monitors##2##2##(2008-10#1)(2008-7#1)
which more##5##2##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
which most likely##4##3##(1994-2#1)(1995-3#1)(2006-10#1)(2008-7#1)
which most##8##2##(1994-2#1)(1995-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
which mostly##2##2##(1997-2#1)(2007-8#1)
which mothers##3##2##(2009-5#2)(2009-6#1)
which motivated the##2##3##(1996-6#1)(2009-4#1)
which multiple##6##2##(2008-1#1)(2008-10#1)(2008-8#2)(2009-12#1)(2009-5#1)
which must be considered##2##4##(1993-11#1)(1994-9#1)
which must be taken into##2##5##(1991-11#1)(1995-3#1)
which must be##13##3##(1990-11#1)(1991-11#1)(1993-11#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-2#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
which must##15##2##(1990-11#1)(1991-11#1)(1993-11#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
which nearly##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
which need a##2##3##(2007-12#1)(2011-2#1)
which need to be##6##4##(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2011-1#1)
which need to##7##3##(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)
which need##9##2##(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
which needs further##2##3##(2008-1#1)(2012-12#1)
which needs to be##3##4##(2009-2#1)(2009-5#1)(2013-7#1)
which needs##7##2##(2007-7#1)(2008-1#1)(2008-12#1)(2009-2#1)(2009-5#1)(2012-12#1)(2013-7#1)
which neither##2##2##(1992-1#1)(2006-6#1)
which neural##2##2##(1996-2#1)(2008-11#1)
which neurons##2##2##(1997-3#1)(2009-5#1)
which nevertheless##2##2##(2008-7#1)(2009-5#1)
which new##5##2##(1997-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)
which no##20##2##(1990-11#1)(1992-5#2)(1992-9#1)(1993-2#1)(1994-2#1)(1997-2#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)
which nonlinear##2##2##(2008-3#2)
which normally##7##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-7#1)
which not only##7##3##(1995-12#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)
which now##5##2##(1991-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-5#1)
which nursing##2##2##(2008-11#1)(2008-12#1)
which obeys##2##2##(2008-10#2)
which observed##2##2##(2008-8#2)
which occupy##2##2##(1991-8#1)(2009-5#1)
which occur at##3##3##(1991-2#1)(1994-5#1)(2010-12#1)
which occur in these##2##4##(1994-5#1)(2008-7#1)
which occur in##7##3##(1990-7#1)(1993-2#1)(1994-5#2)(2008-7#1)(2009-6#1)(2010-11#1)
which occur##18##2##(1990-7#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-5#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)
which occurred as a##2##4##(2010-11#1)(2012-12#1)
which occurred at the##2##4##(1995-8#1)(2008-10#1)
which occurred at##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
which occurred during##2##3##(1995-6#1)(2011-1#1)
which occurred in a##3##4##(1991-11#1)(1991-9#1)(2008-11#1)
which occurred in the##2##4##(1995-8#1)(2011-2#1)
which occurred in##8##3##(1990-10#1)(1990-9#1)(1991-11#1)(1991-9#1)(1995-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
which occurred##26##2##(1990-10#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1995-6#2)(1995-8#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#1)
which occurs after##2##3##(1996-5#1)(2008-10#1)
which occurs at##3##3##(1990-11#1)(1997-7#1)(2008-10#1)
which occurs in the##4##4##(1995-6#1)(2007-10#1)(2008-5#1)(2010-9#1)
which occurs in##12##3##(1994-3#1)(1994-8#1)(1995-6#2)(2007-10#1)(2008-10#2)(2008-5#2)(2008-6#1)(2010-9#1)(2011-2#1)
which occurs##29##2##(1990-11#1)(1990-12#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#3)(1996-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-5#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
which of the##8##3##(1990-6#1)(1994-3#1)(1995-5#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-2#1)
which of these##5##3##(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
which of##15##2##(1990-6#1)(1994-3#2)(1995-5#1)(1996-1#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2012-2#1)
which offers##6##2##(1997-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-3#1)
which often can##2##3##(1994-9#1)(2008-3#1)
which often##13##2##(1992-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
which on the one hand##2##5##(1991-3#1)(2007-11#1)
which on##7##2##(1990-2#1)(1991-3#1)(2007-11#2)(2008-8#1)(2009-5#1)(2011-1#1)
which one can##4##3##(1992-6#1)(2008-2#1)(2008-3#2)
which one is##3##3##(2008-10#2)(2008-6#1)
which one##29##2##(1991-9#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-6#1)(1996-3#1)(1996-9#1)(1997-3#2)(2007-12#2)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)
which only a##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
which only one##2##3##(2007-11#1)(2009-6#1)
which only##26##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-3#1)(1997-2#2)(2007-11#1)(2007-5#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-8#1)
which opens##3##2##(2007-12#1)(2009-5#1)(2010-2#1)
which operates in##2##3##(2008-3#2)
which operates##6##2##(1994-8#1)(2007-12#1)(2008-3#3)(2008-7#1)
which originated##2##2##(1993-12#1)(2008-10#1)
which originates from##2##3##(2008-10#2)
which other##3##2##(1995-2#1)(2007-11#1)(2009-9#1)
which otherwise##2##2##(1991-5#1)(1995-3#1)
which our##3##2##(2006-10#1)(2009-4#1)(2010-4#1)
which over##2##2##(1992-9#1)(2008-10#1)
which overcomes the##3##3##(2007-12#1)(2008-10#2)
which overexpress##3##2##(1990-5#1)(2008-11#1)(2011-1#1)
which overlapped##2##2##(2008-10#2)
which oxidizes the##2##3##(1991-7#1)(2008-10#1)
which parallel the##2##3##(1993-8#1)(1997-2#1)
which parameter##2##2##(2008-10#1)(2009-10#1)
which parents are##3##3##(1992-11#1)(1992-2#1)(1995-12#1)
which parents##6##2##(1992-11#1)(1992-2#1)(1994-2#1)(1995-12#1)(2010-10#1)(2012-12#1)
which partially##4##2##(1990-11#1)(1992-6#1)(2008-10#2)
which participants##9##2##(1994-7#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-5#1)(2009-9#1)(2012-12#1)
which participate in the##2##4##(1992-5#1)(1994-8#1)
which participate in##4##3##(1990-11#1)(1992-5#1)(1994-8#1)(2013-1#1)
which passes##2##2##(1994-8#1)(2008-10#1)
which patients benefit the most##2##5##(2008-8#1)(2013-1#1)
which patients may##2##3##(2008-10#1)(2008-6#1)
which patients need##2##3##(1996-8#1)(2008-11#1)
which patients will##2##3##(2006-10#1)(2008-5#1)
which patients with##4##3##(1994-2#1)(2008-1#1)(2008-11#1)(2012-2#1)
which patients##22##2##(1993-12#1)(1993-3#1)(1994-2#2)(1996-12#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
which peaked approximately##2##3##(1991-12#1)(2008-10#1)
which peaked##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
which people##2##2##(2009-5#1)(2011-1#1)
which performs##2##2##(2008-10#1)(2008-2#1)
which permit the##2##3##(2008-2#1)(2008-5#1)
which permit##4##2##(1997-3#1)(2007-11#1)(2008-2#1)(2008-5#1)
which permits an##2##3##(1994-12#1)(2008-10#1)
which permits the determination of##2##5##(2008-10#2)
which permits the use of##2##5##(2007-12#1)(2008-3#1)
which permits the##7##3##(1990-12#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
which permits to classify the present method as green##2##9##(2008-10#2)
which permits##21##2##(1990-12#2)(1991-2#1)(1994-12#1)(1995-3#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#2)(2010-11#1)
which permitted##5##2##(1994-12#1)(2008-10#2)(2008-6#1)(2012-2#1)
which persisted for##2##3##(2009-12#1)(2012-2#1)
which persisted##6##2##(1991-12#1)(1992-9#1)(1993-5#1)(2008-7#1)(2009-12#1)(2012-2#1)
which pesticides##2##2##(2008-10#2)
which phase##2##2##(2008-3#1)(2008-5#1)
which physicians##2##2##(1991-12#1)(1993-2#1)
which physiologic##2##2##(1994-3#1)(2010-7#1)
which plants##2##2##(2008-10#2)
which play a role in##3##5##(2008-3#1)(2008-5#1)(2010-7#1)
which play a##6##3##(1990-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-7#1)
which play an important role in##2##6##(2008-10#1)(2012-2#1)
which play an important##3##4##(1995-6#1)(2008-10#1)(2012-2#1)
which play##13##2##(1990-5#1)(1992-12#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)(2010-7#1)(2010-9#1)(2012-2#1)
which plays a crucial role in##2##6##(2008-11#1)(2009-12#1)
which plays a key role in the##2##7##(1991-5#1)(2011-1#1)
which plays a##5##3##(1991-5#1)(2008-11#1)(2009-12#1)(2010-2#1)(2011-1#1)
which plays an important role in##2##6##(1993-11#1)(2008-10#1)
which plays an##3##3##(1993-11#1)(1997-3#1)(2008-10#1)
which plays##9##2##(1991-5#1)(1993-11#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-2#1)(2011-1#1)
which points to##2##3##(1990-5#1)(2006-10#1)
which points##3##2##(1990-5#1)(1995-12#1)(2006-10#1)
which policy##2##2##(1993-12#1)(1994-1#1)
which populations of##2##3##(2008-10#2)
which poses##2##2##(1997-2#1)(2009-2#1)
which posses##2##2##(2008-11#1)(2010-8#1)
which possess intrinsic tyrosine kinase activity##2##6##(1992-7#1)(1995-8#1)
which possess##6##2##(1992-7#1)(1995-8#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-5#1)
which possessed##4##2##(1991-9#1)(1997-4#1)(2008-10#2)
which possesses a##2##3##(1990-7#1)(2008-10#1)
which possesses##5##2##(1990-10#1)(1990-7#1)(2008-10#2)(2008-11#1)
which possibly##2##2##(2011-2#2)
which predict##2##2##(2008-11#1)(2013-8#1)
which predicts that##2##3##(1997-6#1)(2008-3#1)
which predicts##4##2##(1997-6#2)(2008-3#1)(2011-2#1)
which predominates in##2##3##(1992-6#1)(2008-5#1)
which preferentially binds##2##3##(1995-11#1)(2008-11#1)
which present##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
which presented to##2##3##(2013-1#2)
which presented with##3##3##(2008-7#2)(2013-1#1)
which presented##9##2##(2008-12#1)(2008-7#3)(2008-8#1)(2012-2#1)(2013-1#3)
which presents a##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
which presents##6##2##(1990-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)
which preserves the##2##3##(2008-9#1)(2013-1#1)
which preserves##4##2##(1996-3#1)(2008-9#1)(2012-1#1)(2013-1#1)
which prevent##2##2##(1990-11#1)(2011-2#1)
which prevented the##2##3##(1991-3#1)(2013-1#1)
which prevented##3##2##(1991-3#1)(2008-11#1)(2013-1#1)
which prevents the##2##3##(1995-2#1)(2009-12#1)
which prevents##7##2##(1992-3#1)(1995-2#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-12#1)
which previously##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
which primarily##3##2##(1996-2#1)(2007-7#1)(2012-2#1)
which prior##2##2##(2009-10#1)(2013-1#1)
which probably##8##2##(1991-8#1)(1992-6#1)(1995-2#1)(1997-7#1)(2007-12#2)(2008-10#1)(2013-8#1)
which produce##6##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)
which produced##7##2##(1990-8#1)(1991-9#1)(1995-2#1)(2008-10#3)(2008-8#1)
which produces a##5##3##(1990-2#1)(2008-10#2)(2008-3#1)(2008-6#1)
which produces an##2##3##(2007-12#1)(2008-5#1)
which produces##15##2##(1990-2#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)
which product-line management##2##3##(1994-3#2)
which products##3##2##(2008-11#1)(2011-2#2)
which prolonged the##2##3##(1994-9#1)(2012-2#1)
which promote##5##2##(1995-6#1)(1996-3#1)(1996-5#1)(2008-1#1)(2009-10#1)
which promotes##2##2##(1990-7#1)(1994-11#1)
which prompted##2##2##(2008-11#1)(2009-3#1)
which protect##3##2##(1995-11#2)(1995-2#1)
which protects the##2##3##(2007-12#1)(2008-9#1)
which protects##4##2##(1995-3#1)(2007-12#1)(2008-5#1)(2008-9#1)
which protein##3##2##(2009-5#1)(2010-4#1)(2011-2#1)
which proteins##2##2##(2010-12#1)(2012-2#1)
which proved to be the most##2##6##(1995-12#1)(2008-10#1)
which proved to be##4##4##(1992-6#1)(1995-12#1)(2008-1#1)(2008-10#1)
which proved##7##2##(1992-6#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#1)
which proves that##2##3##(2010-4#1)(2011-2#1)
which proves##3##2##(2009-7#1)(2010-4#1)(2011-2#1)
which provide for##2##3##(2008-7#1)(2008-8#1)
which provide##7##2##(1994-3#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
which provided a##2##3##(2008-10#2)
which provided the##2##3##(1995-6#1)(2008-10#1)
which provided##11##2##(1994-2#1)(1995-6#1)(2008-10#7)(2008-5#1)(2008-9#1)
which provider##2##2##(1995-2#1)(1996-12#1)
which providers##2##2##(1994-12#1)(1997-1#1)
which provides a##12##3##(2006-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#2)(2013-1#1)(2013-7#1)
which provides both##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
which provides evidence##2##3##(2008-11#1)(2008-5#1)
which provides excellent##2##3##(1991-12#1)(2012-2#1)
which provides high##2##3##(2008-11#1)(2008-6#1)
which provides insight##2##3##(2008-10#1)(2013-1#1)
which provides insights into##2##4##(2008-4#1)(2010-11#1)
which provides the##5##3##(1990-2#1)(1994-2#1)(1994-3#1)(2008-9#1)(2012-2#1)
which provides##47##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2010-11#2)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
which psychological##2##2##(2008-5#1)(2008-7#1)
which public health##2##3##(1996-3#1)(1997-3#1)
which public##3##2##(1996-3#1)(1997-3#1)(2008-12#1)
which puts##2##2##(2008-4#1)(2009-7#1)
which quantify##2##2##(2008-10#1)(2008-8#1)
which quantitative##2##2##(2011-1#1)(2012-3#1)
which radial##2##2##(2007-12#1)(2008-3#1)
which radiation##2##2##(2008-2#2)
which range##2##2##(2008-10#1)(2012-3#1)
which ranged between##2##3##(2008-10#1)(2012-12#1)
which ranged from 0##3##4##(2008-10#1)(2009-12#2)
which ranged from##6##3##(1993-3#1)(1993-8#1)(1996-12#1)(2008-10#1)(2009-12#2)
which ranged##8##2##(1993-3#1)(1993-8#1)(1996-12#1)(2008-10#2)(2009-12#2)(2012-12#1)
which ranges from##2##3##(2008-10#1)(2008-12#1)
which rapidly##2##2##(2006-10#1)(2008-10#1)
which reached a##3##3##(1993-12#1)(1996-2#1)(2013-1#1)
which reached##8##2##(1993-12#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#2)
which reacted with a##2##4##(1993-3#1)(2008-5#1)
which reacted with##4##3##(1993-3#1)(2007-11#1)(2008-5#2)
which reacts with##10##3##(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-8#1)
which reacts##12##2##(1990-5#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-8#1)
which receive##2##2##(1993-12#1)(2012-12#1)
which received bilateral##2##3##(1994-3#2)
which received##18##2##(1991-11#1)(1992-5#1)(1994-3#3)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
which receptor##2##2##(1993-12#1)(1994-5#1)
which recognise##2##2##(1994-8#1)(1997-1#1)
which recognize##5##2##(1990-7#1)(1992-6#1)(1995-11#1)(2008-11#1)(2008-4#1)
which recognized##2##2##(2008-10#1)(2008-8#1)
which recognizes an##2##3##(1996-2#1)(2008-10#1)
which recognizes the##2##3##(1994-5#1)(1997-4#1)
which recognizes##6##2##(1994-5#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2009-8#1)
which recombinant##2##2##(2006-10#1)(2008-11#1)
which recurred##2##2##(1993-6#1)(2013-1#1)
which reduce the##2##3##(2007-8#1)(2013-7#1)
which reduce##3##2##(2007-8#1)(2008-12#1)(2013-7#1)
which reduced the##4##3##(1990-3#1)(1990-6#1)(2008-10#2)
which reduced##9##2##(1990-3#1)(1990-6#1)(1992-11#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
which reduces sample##2##3##(2008-10#1)(2010-11#1)
which reduces the##5##3##(1991-11#1)(1996-2#1)(2008-3#3)
which reduces##8##2##(1991-11#1)(1996-2#1)(2008-10#1)(2008-3#3)(2010-1#1)(2010-11#1)
which refer##2##2##(1996-1#1)(2010-3#1)
which reflect the##2##3##(1995-4#1)(2008-9#1)
which reflect##3##2##(1995-12#1)(1995-4#1)(2008-9#1)
which reflects the##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
which reflects##8##2##(1990-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2011-2#1)
which regulate##8##2##(1991-2#1)(1993-3#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-8#1)
which regulates the##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
which regulates##8##2##(1994-12#1)(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)
which relate to##2##3##(2008-11#1)(2008-9#1)
which related to##2##3##(2008-10#2)
which relates the##4##3##(1990-2#1)(1992-6#1)(2008-10#1)(2008-3#1)
which relates to the##2##4##(1993-9#1)(2012-12#1)
which relates to##3##3##(1993-9#1)(2008-5#1)(2012-12#1)
which relates##7##2##(1990-2#1)(1992-6#1)(1993-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
which release##2##2##(1994-2#1)(2009-8#1)
which released##2##2##(2008-10#1)(2012-2#1)
which releases##3##2##(2008-10#2)(2009-2#1)
which relies on the##3##4##(1992-5#1)(2007-11#1)(2008-9#1)
which relies on##5##3##(1992-5#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-9#1)
which remain##10##2##(1990-5#1)(1993-12#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
which remained##4##2##(1993-11#1)(1993-12#2)(1994-2#1)
which remains a##2##3##(2008-7#1)(2012-3#1)
which remains to be##2##4##(1995-12#1)(1997-7#1)
which remains unchanged##2##3##(2008-5#1)(2012-3#1)
which remains##9##2##(1993-1#1)(1995-12#1)(1997-7#1)(2007-10#1)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
which removed##2##2##(1997-3#1)(2013-1#1)
which removes lesions##2##3##(2008-11#2)
which removes the##4##3##(2007-11#2)(2007-8#1)(2008-2#1)
which removes##7##2##(1992-3#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#1)
which renders##2##2##(1995-2#1)(2008-4#1)
which replace##2##2##(2008-10#1)(2008-12#1)
which replaces the##3##3##(1994-12#1)(2008-3#1)(2012-3#1)
which reported##3##2##(2008-8#1)(2010-11#1)(2012-12#1)
which reportedly##2##2##(1990-11#1)(2012-12#1)
which represent an##2##3##(2011-2#1)(2013-1#1)
which represent the##4##3##(1990-8#1)(1993-6#1)(2010-7#1)(2011-2#1)
which represent##11##2##(1990-8#1)(1993-6#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
which represented##4##2##(2008-10#2)(2008-6#1)(2013-7#1)
which represents a relatively##2##4##(2007-6#1)(2008-7#1)
which represents a##8##3##(1991-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-6#1)
which represents the##6##3##(1990-8#1)(2008-10#2)(2009-7#1)(2010-8#1)(2011-2#1)
which represents##17##2##(1990-8#1)(1991-2#1)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
which require a##2##3##(2007-12#1)(2013-1#1)
which require##20##2##(1990-12#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#4)
which required a##2##3##(2008-1#1)(2009-7#1)
which required##10##2##(1992-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-7#2)(2009-7#1)
which requires a##2##3##(1994-1#1)(2011-2#1)
which requires an##2##3##(2008-1#1)(2009-4#1)
which requires no##2##3##(2007-12#1)(2008-10#1)
which requires only##3##3##(1997-8#1)(2007-11#1)(2008-1#1)
which requires the##2##3##(1995-6#1)(2008-7#1)
which requires##26##2##(1994-1#1)(1994-6#1)(1994-8#2)(1995-6#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#2)
which resemble##5##2##(1991-5#1)(1993-3#1)(1994-6#1)(2007-4#1)(2012-2#1)
which resembles##3##2##(1993-6#1)(2008-6#1)(2013-1#1)
which resides##2##2##(1994-11#1)(2009-5#1)
which resolved after##2##3##(2007-12#1)(2007-8#1)
which resolved following##2##3##(2008-7#1)(2008-8#1)
which resolved##4##2##(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
which respectively##2##2##(2008-8#1)(2008-9#1)
which respond to##3##3##(1992-9#1)(1994-6#1)(2011-1#1)
which respond##4##2##(1992-9#1)(1994-6#1)(2008-10#1)(2011-1#1)
which responded##3##2##(1993-6#1)(1995-9#1)(2008-11#1)
which responds to##4##3##(2008-10#1)(2008-8#1)(2009-8#1)(2013-8#1)
which responds##5##2##(1996-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-8#1)
which restrict##4##2##(1992-12#1)(1992-4#1)(1994-2#1)(2008-5#1)
which restricted##2##2##(1997-6#1)(2008-8#1)
which restricts its##2##3##(1994-8#1)(2008-9#1)
which restricts##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
which result from a##2##4##(1996-1#1)(1996-5#1)
which result from##5##3##(1994-8#1)(1996-1#1)(1996-5#1)(1997-3#1)(2011-1#1)
which result in a##2##4##(2007-12#1)(2008-3#1)
which result in the##3##4##(2007-10#1)(2009-10#1)(2010-9#1)
which result in##13##3##(1991-9#1)(1994-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-9#1)(2011-2#1)
which result##18##2##(1991-9#1)(1994-11#1)(1994-8#1)(1996-1#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
which resulted from the##2##4##(2008-3#1)(2012-12#1)
which resulted from##5##3##(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
which resulted in a sensitive fluorescence derivatizing##2##7##(2008-10#2)
which resulted in a##12##4##(1995-3#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
which resulted in the##9##4##(1993-3#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-6#1)(2009-7#1)(2010-4#1)
which resulted in##45##3##(1990-8#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-7#3)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
which resulted##50##2##(1990-8#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
which results from a deficit##2##5##(2012-1#2)
which results from a##3##4##(2009-4#1)(2012-1#2)
which results from the##2##4##(2007-12#1)(2008-11#1)
which results from##10##3##(1993-11#1)(1993-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-1#2)
which results in a lower##2##5##(1992-3#1)(2008-10#1)
which results in a##12##4##(1990-8#1)(1992-1#1)(1992-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)
which results in an##3##4##(1992-8#1)(2008-3#1)(2008-7#1)
which results in the formation of##3##6##(1996-5#1)(2008-10#1)(2012-2#1)
which results in the##13##4##(1990-5#2)(1992-3#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-12#1)(2012-2#2)
which results in##50##3##(1990-5#3)(1990-8#1)(1992-1#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-8#1)(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-2#3)(2013-1#1)
which results##61##2##(1990-5#3)(1990-8#1)(1992-1#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-8#1)(1996-5#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#1)(2012-1#2)(2012-2#3)(2013-1#1)
which retained##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
which retains##2##2##(1993-8#1)(2008-7#1)
which reveal that##2##3##(1994-5#1)(1994-6#1)
which reveal##4##2##(1994-5#1)(1994-6#1)(1996-2#1)(2008-3#1)
which revealed a##4##3##(1990-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
which revealed that##4##3##(1995-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
which revealed the##2##3##(1994-11#1)(2010-4#1)
which revealed##19##2##(1990-9#1)(1992-8#1)(1994-11#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
which reveals the##2##3##(2008-8#1)(2009-3#1)
which reveals##5##2##(1993-6#1)(2008-10#1)(2008-8#1)(2009-3#2)
which reverse##2##2##(1994-11#1)(2008-3#1)
which risk##2##2##(2008-7#1)(2011-1#1)
which rodent##2##2##(1995-6#1)(2010-6#1)
which runs##2##2##(1997-7#1)(2008-6#1)
which rural##2##2##(1996-3#2)
which samples##4##2##(2008-10#1)(2008-4#2)(2010-8#1)
which scales linearly with the##2##5##(2008-2#1)(2010-4#1)
which scattering##2##2##(2008-2#1)(2008-3#1)
which school##2##2##(2009-9#1)(2012-12#1)
which scores accuracy as null##2##5##(2013-1#2)
which secreted##2##2##(1994-9#1)(2008-11#1)
which seek##2##2##(1991-6#1)(1991-7#1)
which seem to be##3##4##(1995-12#1)(2008-10#2)
which seemed##2##2##(2008-10#1)(2008-7#1)
which seems to be##3##4##(1992-3#1)(2008-10#2)
which seems to##5##3##(1992-3#1)(1993-11#1)(2008-10#2)(2008-7#1)
which seems##7##2##(1992-1#1)(1992-3#1)(1993-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
which selection##2##2##(2007-11#1)(2009-2#1)
which selectively##5##2##(1991-5#1)(1992-3#1)(1994-2#1)(1994-3#1)(2008-7#1)
which separate##2##2##(2007-8#1)(2013-8#1)
which separates##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
which serve as##4##3##(1990-8#1)(1993-11#1)(2008-10#1)(2011-2#1)
which serve##8##2##(1990-11#1)(1990-8#1)(1991-12#1)(1993-11#1)(1995-5#1)(2008-10#2)(2011-2#1)
which served as a##2##4##(2008-3#1)(2009-10#1)
which served as##3##3##(1994-8#1)(2008-3#1)(2009-10#1)
which served##4##2##(1994-8#1)(2008-10#1)(2008-3#1)(2009-10#1)
which serves as a##4##4##(1993-11#1)(2008-10#2)(2008-5#1)
which serves as the##2##4##(2008-7#1)(2010-2#1)
which serves as##7##3##(1993-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
which serves to##2##3##(1990-5#1)(2008-4#1)
which serves##9##2##(1990-5#1)(1993-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
which set the##2##3##(2007-5#1)(2008-11#1)
which sets##2##2##(1992-1#1)(2009-5#1)
which seven##5##2##(2007-5#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
which several members##2##3##(2007-10#1)(2008-10#1)
which several##7##2##(1996-5#1)(2007-10#1)(2008-10#2)(2008-8#1)(2012-2#1)(2012-3#1)
which severely##2##2##(2007-8#1)(2008-10#1)
which sex##2##2##(2008-8#1)(2008-9#1)
which share##4##2##(1990-12#1)(1991-5#1)(2007-7#1)(2012-12#1)
which shared##2##2##(2008-11#1)(2010-4#1)
which shares a##2##3##(1991-6#1)(1997-6#1)
which shares##10##2##(1990-5#1)(1991-6#1)(1992-3#1)(1994-12#1)(1997-3#2)(1997-6#1)(1997-7#1)(2008-7#1)(2009-9#1)
which she##3##2##(2007-2#1)(2009-10#1)(2009-3#1)
which should be considered in##2##5##(1991-8#1)(2012-3#1)
which should be considered##6##4##(1991-8#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
which should be performed in##2##5##(2010-6#1)(2011-2#1)
which should be performed##3##4##(1996-11#1)(2010-6#1)(2011-2#1)
which should be the##2##4##(1991-8#1)(1993-12#1)
which should be useful for##2##5##(2007-11#1)(2013-7#1)
which should be useful##3##4##(1994-6#1)(2007-11#1)(2013-7#1)
which should be##42##3##(1990-6#1)(1991-6#1)(1991-8#2)(1992-10#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
which should not be##2##4##(1997-3#1)(2011-2#1)
which should##57##2##(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-10#1)(1993-12#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#2)
which show a##6##3##(1990-6#1)(1994-5#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
which show some##4##3##(1994-6#1)(1996-10#1)(1996-2#1)(2012-3#1)
which show that the##2##4##(1996-2#1)(2011-1#1)
which show that##3##3##(1991-5#1)(1996-2#1)(2011-1#1)
which show the existence of##2##5##(2008-10#2)
which show##24##2##(1990-6#1)(1991-11#1)(1991-5#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-2#2)(1996-7#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
which showed a##12##3##(1990-2#1)(1991-12#1)(1991-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-8#1)
which showed high##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
which showed low##2##3##(1996-12#1)(2008-10#1)
which showed no##2##3##(1990-3#1)(2008-10#1)
which showed relatively greater activity to thinking about##2##8##(2008-6#2)
which showed that the##3##4##(1991-5#1)(1992-12#1)(2008-11#1)
which showed that##12##3##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
which showed the##7##3##(1990-11#1)(1991-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(2009-12#1)(2011-2#1)
which showed##76##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-7#2)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
which shows a##9##3##(1990-12#1)(1990-7#1)(1992-5#1)(1993-11#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)
which shows that the##2##4##(2007-12#1)(2008-2#1)
which shows that##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
which shows the##6##3##(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
which shows##30##2##(1990-12#1)(1990-7#1)(1992-12#1)(1992-5#1)(1993-11#1)(1995-2#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
which signals##3##2##(1997-7#1)(2008-11#1)(2008-2#1)
which significant##3##2##(1996-10#1)(2008-10#1)(2010-12#1)
which significantly##5##2##(1994-2#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#1)
which similar##2##2##(1995-12#1)(2008-10#1)
which simple##2##2##(2008-3#1)(2008-8#1)
which simulates##4##2##(1996-3#1)(2008-8#1)(2009-10#1)(2011-1#1)
which simultaneously##8##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#2)
which small##4##2##(1994-12#1)(2008-10#2)(2008-3#1)
which social##2##2##(2008-11#1)(2008-5#1)
which some##8##2##(1990-5#1)(1990-6#1)(1994-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)
which species##4##2##(2008-10#2)(2008-8#1)(2012-3#1)
which specifically recognized##2##3##(1995-8#1)(2008-11#1)
which specifically##10##2##(1992-9#1)(1994-12#1)(1994-6#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
which sperm##2##2##(1994-5#1)(2007-12#1)
which spontaneously##2##2##(1994-3#1)(2008-7#1)
which spread##2##2##(1990-5#1)(2011-1#1)
which stabilize DNA##2##3##(1995-5#2)
which stabilize##4##2##(1990-8#2)(1995-5#2)
which stabilizes##2##2##(2008-11#1)(2013-8#1)
which stained with##3##3##(2008-5#2)(2013-8#1)
which stained##4##2##(2007-12#1)(2008-5#2)(2013-8#1)
which started##3##2##(1991-2#2)(2007-11#1)
which states that##2##3##(2012-2#1)(2013-8#1)
which statistical##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
which still##2##2##(1997-7#1)(2008-9#1)
which stimulates##9##2##(1992-9#1)(1994-11#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
which strongly##3##2##(1993-3#1)(2008-10#1)(2008-9#1)
which students##5##2##(1996-1#1)(2008-11#3)(2012-1#1)
which subjects##3##2##(2008-11#1)(2009-8#1)(2010-5#1)
which subsequently undergo##2##3##(1996-5#1)(2008-10#1)
which subsequently##11##2##(1996-12#1)(1996-5#1)(2008-10#6)(2008-8#1)(2010-2#1)(2012-12#1)
which substantially##2##2##(2007-11#1)(2008-8#1)
which successful##2##2##(2008-5#1)(2008-9#1)
which such##9##2##(1994-11#1)(1994-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
which sufficient##3##2##(1992-11#1)(2008-3#1)(2008-8#1)
which suggest that##3##3##(2008-10#1)(2008-6#2)
which suggest their##2##3##(2007-12#1)(2011-2#1)
which suggest##9##2##(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-12#1)
which suggested that the##5##4##(1995-5#1)(2008-10#2)(2008-12#1)(2008-9#1)
which suggested that##8##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
which suggested the existence of##2##5##(1997-6#1)(2010-8#1)
which suggested the##3##3##(1997-6#1)(2008-10#1)(2010-8#1)
which suggested##19##2##(1993-8#1)(1995-5#1)(1997-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
which suggests that S##2##4##(2008-10#1)(2008-8#1)
which suggests that some##2##4##(2010-11#1)(2013-1#1)
which suggests that the##10##4##(1993-8#1)(1994-8#2)(1996-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)
which suggests that there##2##4##(2008-8#1)(2009-11#1)
which suggests that these##2##4##(1995-2#1)(2010-3#1)
which suggests that they##3##4##(2008-11#1)(2008-5#1)(2013-1#1)
which suggests that this##5##4##(1992-3#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
which suggests that##40##3##(1991-4#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2009-11#1)(2010-11#2)(2010-3#1)(2013-1#2)(2013-7#1)
which suggests the##2##3##(2011-2#1)(2013-8#1)
which suggests##47##2##(1991-4#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2009-11#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
which summarizes##3##2##(2008-10#3)
which supply the##2##3##(2007-12#2)
which support the##2##3##(2008-11#1)(2008-9#1)
which support##5##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
which supports a##4##3##(1990-7#1)(1994-2#1)(1995-2#1)(2007-11#1)
which supports the##7##3##(1997-4#2)(2008-11#1)(2008-8#1)(2010-4#1)(2013-7#1)(2013-8#1)
which supports##17##2##(1990-7#1)(1994-2#1)(1995-2#1)(1997-4#2)(1997-6#1)(2007-11#2)(2007-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-7#1)(2013-8#1)
which suppressed the dissolution and oxidation of Ag effectively##2##9##(2013-1#2)
which suppresses##4##2##(1993-8#1)(1994-3#1)(1997-1#1)(2008-7#1)
which survived##3##2##(1996-12#1)(2008-10#1)(2008-6#1)
which symptoms##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
which synthesized##2##2##(1995-8#1)(2008-5#1)
which take##4##2##(1990-3#1)(2008-10#1)(2009-12#1)(2011-2#1)
which takes advantage of the##3##5##(1993-8#1)(2008-3#1)(2011-1#1)
which takes into account##3##4##(1996-5#1)(2008-3#1)(2009-10#1)
which takes place##2##3##(2008-10#2)
which takes the##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
which takes##14##2##(1993-8#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-3#3)(2009-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
which target##2##2##(2009-12#1)(2012-2#1)
which targeted##3##2##(1994-3#1)(2012-12#1)(2012-2#1)
which targets##3##2##(2009-8#1)(2010-12#2)
which tend to develop##2##4##(1996-12#1)(2008-10#1)
which tend to##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
which tended to##2##3##(1997-6#1)(2010-8#1)
which tends to##3##3##(2008-5#1)(2011-2#2)
which test##2##2##(2008-10#1)(2008-2#1)
which that##3##2##(1991-12#1)(1991-3#1)(2008-4#1)
which the absorption##2##3##(2007-11#1)(2008-3#1)
which the accuracy##2##3##(2008-10#1)(2008-2#1)
which the amount of##2##4##(1991-11#1)(2008-12#1)
which the amount##3##3##(1991-11#1)(2008-12#1)(2012-3#1)
which the analyte##3##3##(2008-10#3)
which the animals were##2##4##(1994-3#1)(2009-3#1)
which the animals##4##3##(1993-3#1)(1994-3#1)(2008-8#1)(2009-3#1)
which the authors##4##3##(2007-11#1)(2008-3#1)(2008-4#1)(2010-5#1)
which the bone##2##3##(1995-6#1)(2011-1#1)
which the brain##3##3##(2007-8#1)(2008-4#1)(2008-9#1)
which the cavity##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
which the cell##3##3##(2008-11#1)(2008-3#1)(2009-11#1)
which the cells were##2##4##(1991-12#1)(2008-11#1)
which the cells##5##3##(1991-12#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)
which the child##2##3##(2009-11#1)(2010-10#1)
which the drug##2##3##(1994-8#1)(2010-5#1)
which the effective##2##3##(2008-10#1)(2008-3#1)
which the enzyme##4##3##(1992-8#1)(1993-8#1)(2008-10#1)(2009-5#1)
which the experimental##2##3##(2008-3#1)(2009-5#1)
which the exposure##2##3##(2008-3#1)(2008-7#1)
which the expression of##3##4##(1991-12#1)(1997-6#1)(2013-1#1)
which the expression##5##3##(1991-12#1)(1997-6#1)(2007-11#1)(2011-2#1)(2013-1#1)
which the first##6##3##(1994-12#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
which the gamma 1(34##2##4##(1995-2#2)
which the gene##3##3##(1996-2#1)(2008-10#1)(2008-4#1)
which the height##2##3##(2008-10#1)(2008-2#1)
which the hydrolysis of##2##4##(2008-10#1)(2010-3#1)
which the influence of##2##4##(2008-10#1)(2008-3#1)
which the influences of##2##4##(2008-10#1)(2008-9#1)
which the latter##2##3##(2008-8#1)(2011-2#1)
which the light##3##3##(2008-3#3)
which the lower##2##3##(1992-10#1)(2013-1#1)
which the main##3##3##(1997-8#2)(2008-10#1)
which the major##3##3##(2008-10#2)(2008-11#1)
which the majority of##3##4##(1990-2#1)(2008-4#1)(2010-5#1)
which the majority##4##3##(1990-2#1)(2008-4#1)(2008-8#1)(2010-5#1)
which the maximum##7##3##(1993-8#1)(1994-3#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#1)
which the medical##2##3##(1995-3#1)(2013-1#1)
which the molecular##3##3##(2007-12#1)(2008-11#1)(2009-3#1)
which the most##5##3##(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#2)
which the name##8##3##(1992-5#1)(2008-10#7)
which the nonlinear##2##3##(2007-12#2)
which the number of##2##4##(2007-11#1)(2008-9#1)
which the object is##3##4##(2008-2#1)(2008-3#2)
which the only##4##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-4#1)
which the optimal##2##3##(1996-9#1)(2013-8#1)
which the output##2##3##(2008-10#1)(2008-3#1)
which the patient was##2##4##(1993-2#1)(2008-7#1)
which the patient##7##3##(1991-1#1)(1993-2#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
which the phase##2##3##(2007-12#1)(2008-3#1)
which the population##2##3##(2008-10#1)(2008-9#1)
which the primary##2##3##(2008-10#1)(2008-5#1)
which the productive##2##3##(1992-6#1)(1993-11#1)
which the proximal##2##3##(1994-5#1)(2009-3#1)
which the reader##2##3##(1992-2#1)(2008-7#1)
which the regulation of##2##4##(1995-3#1)(2008-7#1)
which the results of##2##4##(1991-12#1)(2009-4#1)
which the results##3##3##(1990-3#1)(1991-12#1)(2009-4#1)
which the sample##4##3##(1992-12#1)(2008-10#3)
which the scanning##2##3##(2007-12#1)(2008-3#1)
which the signal##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
which the site##2##3##(1994-8#1)(2008-5#1)
which the solution##2##3##(2008-10#2)
which the spatial##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
which the specific##2##3##(1993-5#1)(2012-12#1)
which the spectral##2##3##(2007-11#1)(2008-10#1)
which the stratum corneum was removed##2##6##(1992-8#2)
which the surface##2##3##(2008-10#1)(2008-3#1)
which the surgical##2##3##(1993-9#1)(2013-8#1)
which the system##2##3##(1996-8#1)(2008-8#1)
which the target##6##3##(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#1)
which the theory##2##3##(1997-2#1)(2011-2#1)
which the two##5##3##(2007-12#2)(2008-3#1)(2008-9#1)(2013-1#1)
which the use of##3##4##(1997-7#1)(2008-10#1)(2013-8#1)
which the values##2##3##(2008-10#1)(2010-4#1)
which the various##2##3##(1991-2#1)(1997-7#1)
which the virus##4##3##(2008-10#3)(2010-4#1)
which the wild-type##3##3##(1992-6#1)(1994-8#1)(2008-7#1)
which the##842##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#3)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#5)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#5)(1993-1#1)(1993-11#6)(1993-12#1)(1993-2#4)(1993-3#5)(1993-5#2)(1993-6#3)(1993-8#7)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#7)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#10)(1995-5#7)(1995-6#5)(1995-8#2)(1996-12#3)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#6)(1997-4#2)(1997-6#5)(1997-7#9)(1997-8#3)(2006-12#1)(2007-1#2)(2007-10#3)(2007-11#28)(2007-12#23)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#8)(2008-1#10)(2008-10#145)(2008-11#26)(2008-12#3)(2008-2#41)(2008-3#82)(2008-4#18)(2008-5#28)(2008-6#3)(2008-7#23)(2008-8#23)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#2)(2013-1#18)(2013-8#8)
which their##9##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
which themselves##3##2##(1991-6#1)(2007-12#1)(2008-6#1)
which then can be##2##4##(1990-12#1)(2008-8#1)
which then reacts##2##3##(1997-7#1)(2008-10#1)
which then undergoes##2##3##(1990-5#1)(2009-10#1)
which then##21##2##(1990-12#1)(1990-5#1)(1992-3#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
which there are##8##3##(1992-6#1)(1993-12#1)(1995-5#1)(2006-7#1)(2008-10#2)(2008-3#2)
which there is a##6##4##(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
which there is an##2##4##(2008-3#1)(2012-12#1)
which there is no##6##4##(1994-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
which there is##23##3##(1990-3#1)(1994-11#1)(1994-12#1)(1995-2#2)(1996-9#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
which there was##2##3##(2010-6#1)(2012-12#1)
which there##36##2##(1990-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-9#1)(1997-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
which therefore##4##2##(1991-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
which these agents##3##3##(1990-2#1)(1994-11#1)(1995-3#1)
which these##34##2##(1990-2#1)(1990-6#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
which they are##19##3##(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#3)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
which they can be##3##4##(1990-12#1)(2008-2#1)(2011-2#1)
which they can##6##3##(1990-12#1)(2008-2#1)(2008-9#1)(2011-2#3)
which they generate##2##3##(1995-2#1)(1996-2#1)
which they had previously##2##4##(2008-12#1)(2010-4#1)
which they had##5##3##(1996-3#1)(2008-12#1)(2008-8#1)(2010-4#1)(2013-7#1)
which they have been##4##4##(1991-12#1)(1997-5#1)(2010-5#1)(2011-2#1)
which they have##6##3##(1991-12#1)(1996-11#1)(1997-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
which they may##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
which they perceive##2##3##(2008-10#1)(2008-11#1)
which they perceived##2##3##(2010-7#1)(2012-3#1)
which they shared##2##3##(2008-10#1)(2010-11#1)
which they were##17##3##(1993-6#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-11#1)
which they will##3##3##(1996-3#2)(2008-9#1)
which they##130##2##(1990-12#2)(1990-2#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-6#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#7)(2009-10#2)(2009-5#3)(2010-11#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
which this can be##2##4##(2007-8#1)(2010-5#1)
which this effect##2##3##(2008-10#1)(2010-1#1)
which this occurs are##2##4##(2008-11#1)(2012-12#1)
which this occurs is##2##4##(2008-7#1)(2013-8#1)
which this occurs##7##3##(1992-9#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
which this##41##2##(1990-6#1)(1990-7#1)(1992-3#1)(1992-9#1)(1993-10#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#2)(2010-11#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
which three##6##2##(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
which time##11##2##(1992-12#1)(1992-6#1)(1992-9#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2011-1#1)(2013-1#1)
which to base##6##3##(1992-12#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-2#1)
which to build##2##3##(1996-1#1)(2007-12#1)
which to examine the##3##4##(1992-2#1)(2009-8#1)(2013-8#1)
which to explore the##2##4##(2008-3#1)(2009-7#1)
which to improve##2##3##(2008-3#1)(2013-8#1)
which to investigate the##3##4##(1996-2#1)(2008-7#1)(2009-5#1)
which to make##3##3##(2008-2#1)(2008-3#1)(2011-8#1)
which to measure the##2##4##(1994-3#2)
which to measure##5##3##(1990-11#1)(1994-3#2)(2008-3#2)
which to our knowledge##2##4##(2007-12#1)(2008-11#1)
which to study the##4##4##(1991-5#1)(1994-8#1)(1995-2#1)(1997-3#1)
which to study##9##3##(1991-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-3#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
which to##77##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#16)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#3)
which together with the##3##4##(1997-7#1)(2009-10#1)(2011-2#1)
which together with##5##3##(1997-7#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
which together##12##2##(1991-7#1)(1993-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#2)(2011-2#1)
which took place##2##3##(2008-5#1)(2009-6#1)
which took##4##2##(1996-3#1)(2008-12#1)(2008-5#1)(2009-6#1)
which traditional##3##2##(2007-11#1)(2007-8#1)(2012-12#1)
which training##2##2##(1996-3#1)(2013-8#1)
which transcription##2##2##(1995-11#1)(2008-2#1)
which transfer##2##2##(1990-8#1)(2008-10#1)
which treatment is##2##3##(2010-12#1)(2013-1#1)
which treatment was##2##3##(1993-2#1)(2010-1#1)
which treatment##8##2##(1993-2#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-1#1)(2010-12#1)(2013-1#1)
which trigger##4##2##(1990-5#1)(2008-10#1)(2013-1#2)
which triggers##4##2##(1995-12#1)(2008-7#1)(2012-3#2)
which turned##2##2##(2008-5#1)(2012-2#1)
which turns##2##2##(1993-2#1)(2008-11#1)
which two##18##2##(1992-12#1)(1992-9#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)
which type of##4##3##(1993-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
which types of##3##3##(1994-2#1)(2008-11#1)(2008-4#1)
which typically##7##2##(1995-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-7#1)
which ultimately##6##2##(1992-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
which under##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
which undergo a##2##3##(2007-11#1)(2010-7#1)
which undergo##5##2##(1996-12#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-7#1)
which undergoes a##3##3##(1996-5#2)(2008-10#1)
which undergoes##7##2##(1991-5#1)(1993-11#1)(1996-5#2)(2008-10#1)(2009-8#1)(2011-2#1)
which underlie the##3##3##(2008-5#2)(2009-4#1)
which underlie##5##2##(1994-12#1)(2008-5#2)(2009-4#1)(2011-2#1)
which underlies##2##2##(1997-2#1)(2008-8#1)
which underwent##2##2##(1990-6#1)(2007-11#1)
which use the##2##3##(2008-1#1)(2008-3#1)
which use this##2##3##(2008-3#1)(2010-8#1)
which use##10##2##(1992-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-10#1)(2009-12#1)(2010-8#1)(2012-1#1)
which used the##2##3##(1996-2#1)(2008-10#1)
which used##6##2##(1990-11#1)(1996-2#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-12#1)
which uses a##7##3##(2008-10#3)(2008-3#2)(2008-9#1)(2010-8#1)
which uses an##2##3##(1996-12#1)(2008-3#1)
which uses the##4##3##(1995-2#1)(2007-12#2)(2012-2#1)
which uses##28##2##(1990-12#1)(1991-2#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-12#2)(2007-11#1)(2007-12#2)(2008-10#6)(2008-3#3)(2008-4#1)(2008-9#2)(2010-8#2)(2012-2#1)
which usually occurs##2##3##(1990-6#1)(2012-3#1)
which usually##13##2##(1990-5#1)(1990-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
which utilize##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
which utilizes a##2##3##(1993-12#1)(2008-10#1)
which utilizes##10##2##(1990-10#1)(1993-12#1)(1993-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)
which variables##2##2##(2007-11#1)(2010-1#1)
which varied in##2##3##(2007-12#1)(2009-7#1)
which varied##4##2##(1992-3#1)(2007-12#1)(2009-7#1)(2013-7#1)
which varies##4##2##(1996-2#1)(2006-6#1)(2008-10#2)
which various##6##2##(1993-9#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-12#1)
which vary##2##2##(1990-8#1)(2010-3#1)
which virus##2##2##(1995-12#1)(2008-10#1)
which was 0##2##3##(1991-9#1)(2008-6#1)
which was a##7##3##(1994-11#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-1#1)(2010-6#1)(2011-2#1)
which was abolished by##2##4##(1995-12#1)(2013-1#1)
which was abolished##4##3##(1991-9#1)(1995-12#1)(1996-12#1)(2013-1#1)
which was about##2##3##(2008-11#2)
which was absent in##3##4##(1993-6#1)(1994-11#1)(2008-10#1)
which was absent##4##3##(1992-12#1)(1993-6#1)(1994-11#1)(2008-10#1)
which was accidentally##2##3##(2007-10#1)(2007-8#1)
which was accompanied by##2##4##(2009-9#1)(2012-3#1)
which was accompanied##3##3##(2009-9#1)(2010-6#1)(2012-3#1)
which was achieved##2##3##(2008-10#1)(2008-12#1)
which was added to the##2##5##(2008-10#2)
which was administered to##2##4##(1996-3#1)(2008-11#1)
which was adopted##2##3##(2008-10#1)(2011-2#1)
which was also observed##2##4##(2008-10#1)(2011-2#1)
which was also##8##3##(1990-12#1)(1990-5#1)(1996-5#1)(2008-10#3)(2008-9#1)(2011-2#1)
which was applied##2##3##(1991-12#1)(2008-10#1)
which was associated with a##2##5##(1991-6#1)(2012-1#1)
which was associated with##5##4##(1991-6#1)(1992-8#1)(2008-10#1)(2010-6#1)(2012-1#1)
which was attributed to##2##4##(1992-5#1)(2008-12#1)
which was based on##7##4##(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
which was based upon##2##4##(2008-10#2)
which was based##9##3##(2008-10#5)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
which was blocked by##4##4##(1991-9#1)(1993-3#1)(1995-12#1)(2012-2#1)
which was blocked##5##3##(1991-9#1)(1993-3#1)(1995-12#1)(2008-11#1)(2012-2#1)
which was carried out##3##4##(1991-5#1)(2008-1#1)(2013-1#1)
which was caused by the##2##5##(2008-8#1)(2012-3#1)
which was caused by##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
which was conducted##2##3##(2008-1#1)(2008-5#1)
which was confirmed as##2##4##(2008-10#1)(2011-1#1)
which was confirmed by the##2##5##(2008-10#2)
which was confirmed by##7##4##(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-8#1)
which was confirmed##12##3##(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
which was considerably##2##3##(1994-11#1)(2012-2#1)
which was considered to##2##4##(2007-7#1)(2010-7#1)
which was consistent with the##3##5##(2008-10#2)(2008-9#1)
which was consistent with##7##4##(1990-5#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-9#1)(2010-6#1)
which was constructed##2##3##(2008-10#2)
which was converted to##2##4##(1991-5#1)(2007-11#1)
which was converted##3##3##(1991-5#1)(2007-11#1)(2008-10#1)
which was demonstrated by##2##4##(2007-10#1)(2008-11#1)
which was demonstrated##3##3##(1996-3#1)(2007-10#1)(2008-11#1)
which was designed to##3##4##(1996-1#1)(1996-7#1)(1997-4#1)
which was designed##5##3##(1996-1#1)(1996-7#1)(1997-4#1)(2008-2#1)(2012-3#1)
which was detected by##2##4##(1994-5#1)(2008-11#1)
which was detected##4##3##(1994-5#1)(2008-11#1)(2009-6#1)(2009-7#1)
which was determined##6##3##(1992-6#1)(1993-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
which was developed in##4##4##(2008-10#2)(2008-12#1)(2008-3#1)
which was developed to##2##4##(2008-10#2)
which was developed##8##3##(1990-12#1)(2008-10#5)(2008-12#1)(2008-3#1)
which was diagnosed##5##3##(1990-6#1)(1991-5#1)(2007-5#1)(2008-7#1)(2012-2#1)
which was different##2##3##(2008-8#1)(2009-10#1)
which was discovered by##2##4##(1990-5#1)(2008-1#1)
which was discovered##3##3##(1990-5#1)(2008-1#1)(2012-12#1)
which was elevated##2##3##(2012-2#2)
which was established##2##3##(1992-2#1)(2008-11#1)
which was evaluated by a##2##5##(2008-5#1)(2011-1#1)
which was evidenced by##2##4##(1996-12#1)(2008-11#1)
which was evident from the##2##5##(2013-1#2)
which was evident##3##3##(2008-8#1)(2013-1#2)
which was excised##2##3##(2009-3#1)(2013-8#1)
which was expressed##2##3##(1992-3#1)(2008-10#1)
which was first described in##2##5##(2008-10#1)(2008-2#1)
which was first##6##3##(1993-8#1)(1994-2#1)(2007-5#1)(2008-10#2)(2008-2#1)
which was flanked by##2##4##(2008-8#1)(2012-3#1)
which was followed by a##2##5##(1990-11#1)(2010-10#1)
which was followed##3##3##(1990-11#1)(2010-10#1)(2013-8#1)
which was formed by##2##4##(2011-2#1)(2012-1#1)
which was found to be the most##2##7##(2008-10#1)(2008-9#1)
which was found to be the##3##6##(2008-10#2)(2008-9#1)
which was found to be##12##5##(1991-11#1)(1993-12#1)(1995-11#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
which was found to##17##4##(1991-11#1)(1993-12#1)(1993-6#1)(1995-11#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)
which was found##23##3##(1991-11#1)(1993-12#1)(1993-6#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
which was further##6##3##(1993-11#1)(1996-5#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
which was greater than##2##4##(1991-12#1)(1991-5#1)
which was greater##3##3##(1991-12#1)(1991-5#1)(2008-10#1)
which was higher than that##2##5##(1996-5#1)(2008-12#1)
which was higher##3##3##(1996-5#1)(1997-7#1)(2008-12#1)
which was identified as##2##4##(1994-11#1)(2008-11#1)
which was in##5##3##(1990-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
which was induced by##3##4##(1990-12#1)(2008-3#1)(2008-6#1)
which was inhibited by##2##4##(1995-6#1)(1997-1#1)
which was inhibited##4##3##(1991-8#1)(1995-6#1)(1997-1#1)(2011-3#1)
which was initially##3##3##(1991-2#1)(2007-11#1)(2007-7#1)
which was introduced##2##3##(1997-7#1)(2008-10#1)
which was known##2##3##(2008-10#1)(2008-6#1)
which was later##2##3##(2007-8#1)(2008-4#1)
which was launched aboard the##2##5##(2008-2#1)(2008-3#1)
which was limited##2##3##(2008-3#1)(2012-2#1)
which was located##2##3##(1997-3#1)(2013-8#1)
which was made##2##3##(1995-6#1)(2008-10#1)
which was maintained##2##3##(1995-12#1)(2008-6#1)
which was managed with##2##4##(2008-1#1)(2011-2#1)
which was managed##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
which was mapped##2##3##(1995-6#1)(2008-10#1)
which was measured at##2##4##(2008-10#2)
which was measured by##3##4##(2007-11#1)(2008-11#1)(2012-3#1)
which was measured##7##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)
which was monitored##3##3##(2008-10#2)(2008-3#1)
which was more##4##3##(2008-11#2)(2008-2#1)(2013-1#1)
which was most##2##3##(2010-10#1)(2013-8#1)
which was much##2##3##(2008-10#2)
which was named##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
which was never##2##3##(2008-5#1)(2012-3#1)
which was not altered by##2##5##(1995-11#1)(1995-3#1)
which was not detected##2##4##(2008-10#1)(2012-2#1)
which was not found in##2##5##(2008-10#1)(2008-9#1)
which was not found##4##4##(2008-10#2)(2008-9#1)(2012-12#1)
which was not observed##2##4##(1994-11#1)(2008-7#1)
which was not possible##2##4##(2008-3#1)(2008-5#1)
which was not statistically different from that##2##7##(1992-5#1)(2012-3#1)
which was not statistically##4##4##(1992-5#1)(2007-10#1)(2012-3#1)(2013-8#1)
which was not##37##3##(1990-12#2)(1990-7#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
which was observed in##2##4##(2008-5#1)(2008-6#1)
which was observed with##2##4##(2008-10#1)(2008-5#1)
which was observed##9##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#1)
which was obtained from##2##4##(1994-8#1)(1997-8#1)
which was obtained##4##3##(1991-9#1)(1994-8#1)(1997-8#1)(2008-3#1)
which was of##2##3##(2008-6#1)(2008-7#1)
which was only expressed in##2##5##(2008-8#1)(2012-3#1)
which was only##3##3##(2008-5#1)(2008-8#1)(2012-3#1)
which was optimal for##2##4##(1995-2#1)(2008-10#1)
which was optimized##2##3##(2008-3#1)(2010-10#1)
which was originally##2##3##(1995-12#1)(2011-2#1)
which was packed with a molybdate-form ion exchange resin##2##9##(2008-10#2)
which was packed##3##3##(2008-10#3)
which was partially##3##3##(1993-11#1)(2007-5#1)(2008-10#1)
which was performed##2##3##(2007-8#1)(2008-10#1)
which was positively##2##3##(2008-10#1)(2008-8#1)
which was present in##4##4##(1991-5#2)(1991-9#1)(2008-10#1)
which was prevented by##3##4##(1994-2#1)(1996-12#1)(2011-1#1)
which was previously##7##3##(1991-12#1)(1992-3#1)(1994-11#1)(1995-6#1)(2007-2#1)(2008-10#1)(2011-2#1)
which was produced##2##3##(1995-2#1)(2008-7#1)
which was proportional to the##2##5##(2008-10#1)(2008-7#1)
which was proved to be##2##5##(1996-2#1)(2007-7#1)
which was proved##3##3##(1996-2#1)(2007-7#1)(2008-10#1)
which was provided by the##2##5##(2008-8#1)(2013-8#1)
which was reacted with##3##4##(2007-11#2)(2008-11#1)
which was recently##2##3##(2008-10#1)(2008-3#1)
which was recovered##2##3##(1993-12#1)(2013-1#1)
which was reduced##2##3##(2008-7#1)(2013-1#1)
which was reflected##2##3##(2010-5#1)(2011-2#1)
which was related to##2##4##(2008-10#2)
which was released##2##3##(1991-5#1)(1994-11#1)
which was reported##2##3##(1991-2#1)(1996-8#1)
which was resected##2##3##(2007-8#2)
which was responsible for##3##4##(1990-6#1)(1991-2#1)(2007-8#1)
which was reversed by##2##4##(1994-6#1)(1997-4#1)
which was reversed##3##3##(1991-12#1)(1994-6#1)(1997-4#1)
which was sensitive##2##3##(1991-2#1)(2008-10#1)
which was set##2##3##(2008-10#2)
which was shown to##2##4##(1992-12#1)(1997-1#1)
which was shown##3##3##(1992-12#1)(1997-1#1)(2007-11#1)
which was significantly higher##2##4##(1991-11#1)(2008-5#1)
which was significantly##11##3##(1991-11#1)(1991-5#1)(1996-12#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
which was similar to that##2##5##(1993-8#1)(1995-12#1)
which was similar to##3##4##(1993-8#1)(1995-12#1)(2012-2#1)
which was similar##4##3##(1993-8#1)(1995-12#1)(2008-11#1)(2012-2#1)
which was simple##2##3##(2008-10#2)
which was slightly##2##3##(2008-11#1)(2010-8#1)
which was specifically##3##3##(1991-9#1)(2008-6#1)(2008-8#1)
which was stable##3##3##(1991-5#1)(1992-2#1)(2007-12#1)
which was started##2##3##(2011-2#1)(2013-8#1)
which was statistically significant##2##4##(2008-4#1)(2008-7#1)
which was stimulated by##2##4##(2008-10#1)(2008-9#1)
which was subsequently shown to##2##5##(1991-2#1)(2008-7#1)
which was subsequently##3##3##(1991-2#1)(2008-7#2)
which was successfully treated with##2##5##(2008-10#1)(2011-2#1)
which was successfully treated##5##4##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
which was successfully##8##3##(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#2)
which was supported##2##3##(2008-10#1)(2008-12#1)
which was supposed to##2##4##(2012-2#1)(2013-7#1)
which was tested##2##3##(2008-10#1)(2008-3#1)
which was the most##2##4##(1991-8#1)(2008-10#1)
which was the##7##3##(1991-8#1)(2007-12#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-1#1)
which was then merged with potassium##2##6##(2008-10#2)
which was then##14##3##(1990-12#1)(1993-11#1)(1994-8#1)(1995-2#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)
which was to##2##3##(1994-12#1)(2010-1#1)
which was treated by##3##4##(2007-8#1)(2008-12#1)(2009-5#1)
which was treated medically##2##4##(2008-12#1)(2011-2#1)
which was treated with##2##4##(2006-10#1)(2012-3#1)
which was treated##10##3##(1990-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#3)(2009-5#1)(2011-2#1)(2012-3#1)
which was used as a##2##5##(1993-8#1)(2008-10#1)
which was used as the##3##5##(1995-6#1)(2008-10#2)
which was used as##5##4##(1993-8#1)(1995-6#1)(2008-10#3)
which was used for##2##4##(2008-10#1)(2008-3#1)
which was used in##3##4##(2008-10#3)
which was used to##6##4##(1991-3#1)(2008-10#3)(2008-2#1)(2012-2#1)
which was used##17##3##(1991-3#1)(1993-8#1)(1995-6#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
which was verified by##2##4##(2008-10#2)
which was##714##2##(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#2)(1991-5#10)(1991-6#1)(1991-8#2)(1991-9#6)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#4)(1994-11#10)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#8)(1995-8#3)(1996-1#1)(1996-12#8)(1996-2#2)(1996-3#2)(1996-5#5)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#6)(1997-8#2)(2006-10#1)(2007-10#4)(2007-11#12)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#11)(2008-1#7)(2008-10#144)(2008-11#32)(2008-12#14)(2008-2#10)(2008-3#20)(2008-4#5)(2008-5#22)(2008-6#14)(2008-7#22)(2008-8#17)(2008-9#11)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#2)(2010-12#1)(2010-5#3)(2010-6#5)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#22)(2011-3#4)(2012-1#4)(2012-12#9)(2012-2#18)(2012-3#11)(2013-1#17)(2013-7#3)(2013-8#14)
which way##2##2##(1993-11#1)(1997-2#1)
which we believe##2##3##(2006-12#1)(2008-9#1)
which we call the##2##4##(2007-11#1)(2008-3#1)
which we call##6##3##(1990-12#1)(1997-3#1)(2007-11#3)(2008-3#1)
which we can##2##3##(2008-10#1)(2009-5#1)
which we define as##2##4##(2008-10#1)(2012-2#1)
which we designate##2##3##(1993-6#1)(1994-11#1)
which we found the##2##4##(2009-7#1)(2011-2#1)
which we found to be##2##5##(2009-5#1)(2012-3#1)
which we found##4##3##(2009-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
which we had##2##3##(1996-10#1)(2008-11#1)
which we have designated##2##4##(1991-7#1)(2007-11#1)
which we have named##3##4##(2008-10#1)(2008-3#2)
which we have previously##4##4##(1996-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
which we have termed##3##4##(1995-8#1)(2008-10#1)(2008-7#1)
which we have##17##3##(1991-12#1)(1991-7#1)(1992-9#1)(1994-12#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
which we identified##4##3##(1997-2#1)(2008-5#1)(2010-11#1)(2010-12#1)
which we interpret##2##3##(2007-12#1)(2008-2#1)
which we measure##2##3##(2008-8#2)
which we now##2##3##(1994-12#1)(2013-1#1)
which we produced##2##3##(2007-12#1)(2008-3#1)
which we refer to as##2##5##(1992-6#1)(1995-6#1)
which we refer to##3##4##(1992-6#1)(1995-6#1)(2011-2#1)
which we refer##4##3##(1992-6#1)(1995-6#1)(2007-12#1)(2011-2#1)
which we show to be##2##5##(2007-12#1)(2008-2#1)
which we show##4##3##(1990-5#1)(2007-12#1)(2008-2#1)(2008-7#1)
which we term##3##3##(1991-12#1)(1991-5#1)(2010-4#1)
which we use##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
which we##127##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#9)(2007-12#9)(2008-1#3)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)
which went##2##2##(1992-1#1)(2009-10#1)
which were able to##2##4##(2008-10#2)
which were all##3##3##(2012-3#3)
which were also##3##3##(1992-6#1)(2008-10#2)
which were amplified by##3##4##(1996-12#1)(2008-10#1)(2008-11#1)
which were analyzed##2##3##(1995-12#1)(2013-7#1)
which were approximately##2##3##(1992-11#1)(2008-10#1)
which were associated with##2##4##(2010-3#1)(2010-8#1)
which were both##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
which were characterized by##3##4##(1991-12#1)(2008-10#1)(2011-1#1)
which were characterized##5##3##(1991-12#1)(1992-9#1)(1997-8#1)(2008-10#1)(2011-1#1)
which were collected##4##3##(2008-11#1)(2010-12#1)(2013-8#2)
which were common to##2##4##(2008-5#1)(2012-2#1)
which were completely##2##3##(1990-5#1)(1990-7#1)
which were considered##3##3##(1992-1#1)(1992-11#1)(2012-2#1)
which were consistent with##4##4##(1997-5#1)(2008-2#1)(2008-4#1)(2009-9#1)
which were derived from a##2##5##(1997-3#1)(2008-10#1)
which were detected##2##3##(1994-8#1)(2008-11#1)
which were determined##3##3##(1990-7#1)(1995-5#1)(2008-7#1)
which were developed##2##3##(2008-10#2)
which were distributed##2##3##(2007-11#1)(2008-9#1)
which were divided##2##3##(1995-1#1)(2008-12#1)
which were either##4##3##(1997-6#1)(2008-10#2)(2012-1#1)
which were eluted from the column through##2##7##(2008-10#2)
which were filled with##2##4##(1995-12#1)(2012-1#1)
which were found to be significantly##2##6##(2008-2#1)(2011-1#1)
which were found to be##3##5##(1994-3#1)(2008-2#1)(2011-1#1)
which were found to##5##4##(1994-3#1)(2008-2#1)(2010-11#1)(2011-1#1)(2012-3#1)
which were found##7##3##(1994-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)(2012-3#1)
which were from##2##3##(2008-10#2)
which were further##3##3##(1992-2#1)(1995-6#1)(2008-11#1)
which were identified as##5##4##(1991-2#2)(1991-5#1)(1994-3#1)(2008-10#1)
which were identified by##4##4##(1992-3#2)(1997-2#1)(2008-7#1)
which were identified##11##3##(1991-2#2)(1991-5#1)(1992-3#2)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
which were immunoreactive for##2##4##(1997-2#2)
which were in good agreement with##2##6##(2008-10#1)(2008-7#1)
which were in##6##3##(1990-11#1)(1991-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
which were increased##2##3##(1993-8#1)(1994-6#1)
which were initially##2##3##(1997-3#1)(1997-8#1)
which were inversely##2##3##(1997-4#1)(2008-12#1)
which were isolated from##3##4##(2008-10#1)(2008-11#2)
which were kept under##2##4##(2008-9#1)(2011-3#1)
which were located on the##2##5##(1995-12#1)(1996-12#1)
which were more##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
which were not##10##3##(1992-9#1)(1993-8#1)(2007-11#1)(2008-10#5)(2008-3#1)(2010-10#1)
which were obtained from##2##4##(1995-6#1)(2008-10#1)
which were obtained##3##3##(1995-6#1)(2008-10#2)
which were oxidized##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
which were packed##2##3##(2008-5#1)(2008-9#1)
which were prepared##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
which were present##2##3##(2008-10#2)
which were presented at the##2##5##(2008-6#1)(2013-8#1)
which were presented at##3##4##(2008-3#1)(2008-6#1)(2013-8#1)
which were previously##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
which were processed##2##3##(1990-5#1)(2013-8#1)
which were recognized on##2##4##(1991-2#1)(2008-9#1)
which were recognized##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
which were reduced in##2##4##(2008-7#2)
which were reduced##3##3##(2007-10#1)(2008-7#2)
which were related to the##3##5##(2007-8#1)(2008-10#2)
which were related to##4##4##(2007-8#1)(2008-10#2)(2008-3#1)
which were released from##2##4##(2008-10#1)(2012-12#1)
which were released##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
which were required for##2##4##(2008-10#1)(2008-11#1)
which were responsible for the##2##5##(2013-1#1)(2013-8#1)
which were set##3##3##(1995-3#1)(2008-1#1)(2012-12#1)
which were shown to##2##4##(2009-4#1)(2013-8#1)
which were significantly different##2##4##(1994-5#1)(2010-8#1)
which were significantly##5##3##(1994-5#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
which were similar in##2##4##(2011-2#1)(2012-3#1)
which were similar to those##2##5##(1997-8#1)(2008-10#1)
which were similar to##3##4##(1997-8#1)(2008-10#2)
which were similar##5##3##(1997-8#1)(2008-10#2)(2011-2#1)(2012-3#1)
which were studied##2##3##(1993-1#1)(2013-8#1)
which were subjected to##2##4##(2008-10#1)(2008-11#1)
which were submitted to a##2##5##(2009-7#1)(2011-2#1)
which were subsequently##2##3##(1993-6#1)(2008-8#1)
which were successfully treated##2##4##(2008-7#1)(2012-12#1)
which were suggestive of##2##4##(2013-8#2)
which were tested for##2##4##(2008-8#1)(2011-2#1)
which were tested##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
which were the most##2##4##(2010-1#1)(2011-2#1)
which were the##5##3##(1991-2#1)(1995-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
which were then##6##3##(1995-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
which were thought##2##3##(1990-6#1)(2008-11#1)
which were transfected##2##3##(1991-2#1)(2011-2#1)
which were treated by##2##4##(1990-3#1)(2008-11#1)
which were treated with##3##4##(1995-3#1)(2013-1#1)(2013-7#1)
which were treated##7##3##(1990-3#1)(1992-6#1)(1995-3#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
which were used for##2##4##(1996-6#1)(2008-11#1)
which were used to##3##4##(1994-12#1)(1995-2#1)(2007-8#1)
which were used##10##3##(1994-12#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-11#2)(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
which were very##2##3##(2007-2#1)(2012-3#1)
which were##427##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#9)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1996-12#5)(1996-2#1)(1996-6#3)(1997-2#4)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#7)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#85)(2008-11#23)(2008-12#6)(2008-2#5)(2008-3#13)(2008-4#2)(2008-5#11)(2008-6#7)(2008-7#12)(2008-8#10)(2008-9#12)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-2#13)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#15)(2013-7#3)(2013-8#17)
which when##6##2##(1996-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)
which will allow##2##3##(2008-1#1)(2008-7#1)
which will also##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
which will appear in the next issue##2##7##(1992-3#1)(2010-5#1)
which will appear in the##3##5##(1992-3#1)(1995-1#1)(2010-5#1)
which will appear in##4##4##(1992-3#1)(1993-1#1)(1995-1#1)(2010-5#1)
which will appear##5##3##(1992-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(2010-5#1)
which will be discussed##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
which will be##13##3##(1993-2#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
which will facilitate##2##3##(2008-12#1)(2011-2#1)
which will help##2##3##(1994-1#1)(2008-7#1)
which will hopefully##2##3##(2008-12#1)(2008-3#1)
which will provide##2##3##(2010-5#1)(2013-8#1)
which will result in the##2##5##(2006-6#1)(2007-7#1)
which will result in##3##4##(2006-6#1)(2007-7#1)(2009-8#1)
which will##73##2##(1990-3#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-5#2)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#4)
which would be##9##3##(1992-9#1)(1993-6#1)(1994-6#1)(2008-11#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
which would result in a##2##5##(1993-9#1)(2008-10#1)
which would result in##3##4##(1993-9#1)(1994-9#1)(2008-10#1)
which would##38##2##(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
which yielded four##2##3##(1995-6#1)(2009-10#1)
which yielded##9##2##(1993-11#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2013-7#1)
which yields a##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
which yields an##2##3##(1996-12#1)(2007-11#1)
which yields##9##2##(1994-12#1)(1996-12#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)
which##14011##1##(1990-10#9)(1990-11#71)(1990-12#65)(1990-2#52)(1990-3#24)(1990-5#77)(1990-6#29)(1990-7#39)(1990-8#77)(1990-9#14)(1991-1#11)(1991-10#3)(1991-11#28)(1991-12#86)(1991-2#59)(1991-3#30)(1991-4#5)(1991-5#70)(1991-6#43)(1991-7#11)(1991-8#28)(1991-9#57)(1992-1#24)(1992-10#13)(1992-11#29)(1992-12#71)(1992-2#37)(1992-3#87)(1992-4#16)(1992-5#39)(1992-6#73)(1992-7#4)(1992-8#56)(1992-9#69)(1993-1#20)(1993-10#3)(1993-11#62)(1993-12#72)(1993-2#50)(1993-3#70)(1993-5#12)(1993-6#63)(1993-8#78)(1993-9#47)(1994-1#14)(1994-10#4)(1994-11#75)(1994-12#97)(1994-2#97)(1994-3#81)(1994-5#62)(1994-6#43)(1994-7#11)(1994-8#81)(1994-9#42)(1995-1#17)(1995-11#39)(1995-12#96)(1995-2#113)(1995-3#87)(1995-4#3)(1995-5#55)(1995-6#96)(1995-8#60)(1995-9#18)(1996-1#28)(1996-10#6)(1996-11#10)(1996-12#97)(1996-2#97)(1996-3#61)(1996-4#11)(1996-5#64)(1996-6#28)(1996-7#9)(1996-8#21)(1996-9#18)(1997-1#43)(1997-2#97)(1997-3#82)(1997-4#73)(1997-5#16)(1997-6#58)(1997-7#91)(1997-8#54)(1997-9#4)(2006-10#19)(2006-12#8)(2006-4#4)(2006-6#16)(2006-7#2)(2007-1#2)(2007-10#40)(2007-11#258)(2007-12#315)(2007-2#20)(2007-3#1)(2007-4#6)(2007-5#14)(2007-6#6)(2007-7#71)(2007-8#90)(2007-9#5)(2008-1#139)(2008-10#2151)(2008-11#628)(2008-12#175)(2008-2#288)(2008-3#621)(2008-4#229)(2008-5#384)(2008-6#143)(2008-7#475)(2008-8#403)(2008-9#299)(2009-1#5)(2009-10#71)(2009-11#35)(2009-12#59)(2009-2#22)(2009-3#34)(2009-4#24)(2009-5#99)(2009-6#45)(2009-7#73)(2009-8#93)(2009-9#53)(2010-1#31)(2010-10#48)(2010-11#49)(2010-12#60)(2010-2#27)(2010-3#53)(2010-4#56)(2010-5#68)(2010-6#38)(2010-7#44)(2010-8#107)(2010-9#25)(2011-1#157)(2011-10#3)(2011-2#457)(2011-3#32)(2011-7#4)(2011-8#4)(2011-9#1)(2012-1#51)(2012-12#149)(2012-2#281)(2012-3#192)(2012-5#2)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#325)(2013-7#63)(2013-8#212)
whichever##2##1##(2008-11#1)(2010-4#1)
whichis##2##1##(2008-11#2)
while &quot##2##2##(2010-3#1)(2011-1#1)
while 1##2##2##(1991-5#1)(1992-11#1)
while 100 microM##2##3##(1990-8#1)(2009-6#1)
while 14%##2##2##(1993-3#1)(2008-10#1)
while 2##7##2##(1996-12#1)(1997-3#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-3#1)
while 22%##2##2##(1996-9#1)(2009-10#1)
while 25##4##2##(1993-11#1)(2008-8#1)(2013-1#2)
while 27%##2##2##(1992-9#1)(2007-7#1)
while 3##5##2##(1990-11#1)(1991-11#1)(1992-12#1)(2008-10#1)(2008-12#1)
while 34##2##2##(1994-11#1)(2012-2#1)
while 46%##2##2##(2008-10#1)(2012-3#1)
while 5##2##2##(2008-10#1)(2008-7#1)
while 84##2##2##(2008-1#1)(2008-3#1)
while 9##2##2##(2010-2#1)(2012-3#1)
while ARA##2##2##(2012-1#2)
while B##5##2##(2008-10#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
while CMV infection##2##3##(2012-2#2)
while Cd##2##2##(1995-3#1)(2008-10#1)
while Cr(VI) is##2##3##(2008-10#2)
while Cr(VI)##4##2##(2008-10#4)
while D-leucine did not##2##4##(2008-11#2)
while H##2##2##(2011-1#1)(2012-2#1)
while H2##3##2##(2008-10#2)(2010-5#1)
while HA##2##2##(2007-8#1)(2008-10#1)
while LIN-12##2##2##(2007-12#2)
while PKC##2##2##(1993-3#1)(2008-11#1)
while Western blotting##2##3##(2008-9#2)
while Western##3##2##(2008-9#2)(2009-9#1)
while Zn##2##2##(1997-4#1)(2008-10#1)
while a locus##2##3##(1997-5#2)
while a second##5##3##(1996-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
while a third##2##3##(1990-5#1)(2008-9#1)
while a##51##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-5#2)(1997-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
while activation of the##2##4##(1992-8#1)(2009-5#1)
while activation of##3##3##(1992-8#1)(2009-5#1)(2013-1#1)
while activity##2##2##(1992-6#1)(2008-11#1)
while addition of##4##3##(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
while adjusting for##2##3##(2013-1#2)
while affecting##2##2##(1990-12#1)(2008-2#1)
while all##8##2##(1992-6#1)(1994-11#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
while allele B gave##2##4##(2010-2#2)
while allowing##7##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)
while almost##2##2##(2008-3#1)(2011-2#1)
while also##9##2##(1990-3#1)(1991-9#1)(1995-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-12#1)
while among##2##2##(2008-4#1)(2011-1#1)
while an increase##2##3##(2007-8#1)(2008-8#1)
while an##11##2##(1991-3#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)
while another##6##2##(1994-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
while at pH 4##2##4##(1994-5#1)(2008-10#1)
while at pH##4##3##(1991-8#1)(1994-5#1)(2008-10#2)
while at the same time##10##5##(1995-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-8#1)
while at the##12##3##(1995-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-8#1)(2009-9#1)
while at##22##2##(1991-8#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-4#1)
while avoiding##4##2##(1992-2#1)(1995-12#1)(2008-2#2)
while balancing##2##2##(2008-11#1)(2008-8#1)
while being##15##2##(1991-12#1)(1991-5#1)(1992-8#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
while both##5##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)
while bound to##2##3##(1992-11#1)(2008-4#1)
while carrying a##2##3##(2008-9#2)
while cell##6##2##(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
while cells##6##2##(2008-11#5)(2008-4#1)
while clinical##2##2##(2007-10#1)(2011-1#1)
while concentrations##2##2##(2008-10#2)
while conserving the##2##3##(2007-12#1)(2008-3#1)
while constraining##2##2##(2008-2#1)(2012-2#1)
while contralateral##2##2##(2007-12#1)(2013-1#1)
while control groups##2##3##(1993-3#1)(2012-3#1)
while controlling for##4##3##(2008-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
while controls##2##2##(2009-5#1)(2013-8#1)
while cutting##2##2##(1994-1#1)(1995-3#1)
while data on##2##3##(1991-12#1)(1992-6#1)
while data##5##2##(1991-12#1)(1991-5#1)(1992-6#1)(2008-3#1)(2010-5#1)
while decreasing the##2##3##(2010-1#1)(2012-2#1)
while decreasing##7##2##(2008-11#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
while degradation##2##2##(1990-8#1)(2008-11#1)
while demographic##2##2##(2008-9#1)(2013-1#1)
while differences##2##2##(1993-1#1)(1994-3#1)
while drinking##2##2##(1994-2#2)
while each##2##2##(1995-2#1)(2011-3#1)
while either##2##2##(2008-9#1)(2011-2#1)
while electron##2##2##(1992-9#1)(2009-9#1)
while enhancing##4##2##(1997-1#1)(2009-9#1)(2010-10#1)(2011-1#1)
while ensuring realistic##2##3##(2008-6#1)(2009-8#1)
while ensuring##7##2##(1996-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-2#1)
while ethanol and##2##3##(2009-12#2)
while ethanol##4##2##(2008-10#1)(2009-12#2)(2010-3#1)
while exerting##2##2##(2012-2#1)(2013-1#1)
while expression of the##2##4##(2008-11#1)(2013-7#1)
while expression of##3##3##(1997-7#1)(2008-11#1)(2013-7#1)
while external##3##2##(2007-8#1)(2009-6#1)(2011-1#1)
while feeding on##3##3##(2008-10#2)(2008-5#1)
while five##4##2##(1994-12#1)(1995-12#1)(2007-12#1)(2013-1#1)
while for the other##3##4##(2008-10#2)(2013-1#1)
while for the##11##3##(1992-11#1)(1996-2#1)(2008-10#3)(2008-9#2)(2012-2#1)(2013-1#2)(2013-7#1)
while for##24##2##(1992-11#1)(1994-1#1)(1995-12#1)(1996-2#1)(2007-10#1)(2008-10#9)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)
while four##4##2##(1996-6#1)(1997-3#1)(2007-7#1)(2010-3#1)
while friction##2##2##(2010-10#1)(2012-2#1)
while from##2##2##(2007-11#1)(2010-6#1)
while further##5##2##(1991-12#1)(1994-3#1)(2008-1#1)(2008-7#1)(2013-1#1)
while generally##2##2##(1991-1#1)(1993-10#1)
while genistein had a##2##4##(2008-4#2)
while girls##2##2##(1994-12#1)(2012-2#1)
while giving##2##2##(1993-11#1)(2007-11#1)
while group##2##2##(2006-6#1)(2010-7#1)
while having normal##2##3##(1994-8#1)(2008-11#1)
while having##4##2##(1991-3#1)(1994-8#1)(1997-1#1)(2008-11#1)
while high##5##2##(1992-11#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-6#1)
while higher##7##2##(1993-8#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
while his##2##2##(1991-3#1)(1992-6#1)
while if##2##2##(2008-7#1)(2009-12#1)
while implantation of estrogen pellets##2##5##(1993-9#2)
while in 7##2##3##(1990-12#1)(1991-6#1)
while in all##2##3##(2008-10#1)(2011-2#1)
while in others##2##3##(2008-12#1)(2008-7#1)
while in the absence of##2##5##(1996-2#1)(1997-4#1)
while in the control group it##2##6##(2007-7#1)(2008-11#1)
while in the post-I group##2##5##(2009-3#2)
while in the second##3##4##(1990-3#1)(2007-8#1)(2008-3#1)
while in the##32##3##(1990-10#1)(1990-12#1)(1990-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#4)(2009-4#1)(2009-7#2)(2011-1#1)(2013-1#1)
while in##79##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1991-1#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1995-1#1)(1995-5#2)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-3#4)(2009-4#2)(2009-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
while increased##4##2##(1995-12#1)(1995-2#1)(2008-10#1)(2011-2#1)
while increasing the##3##3##(1995-2#1)(1996-12#1)(2007-12#1)
while increasing##6##2##(1992-5#1)(1995-1#1)(1995-2#1)(1996-12#1)(2007-12#1)(2008-10#1)
while individuals of##2##3##(2008-8#2)
while individuals##3##2##(2008-11#1)(2008-8#2)
while infected##2##2##(1997-5#1)(2008-10#1)
while inhibiting##2##2##(1996-2#1)(2012-2#1)
while inorganic##2##2##(2008-10#1)(2010-11#1)
while it had no effect##2##5##(1997-3#1)(2008-2#1)
while it has##2##3##(2008-10#1)(2010-6#1)
while it increased##3##3##(1996-12#1)(1996-5#1)(2008-7#1)
while it inhibited##2##3##(1997-4#1)(2008-11#1)
while it is##11##3##(1995-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
while it was##5##3##(1992-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
while it##37##2##(1990-5#1)(1991-12#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
while its effect on##2##4##(1995-11#1)(2012-3#1)
while its function##2##3##(2008-8#1)(2011-2#1)
while its##9##2##(1990-3#1)(1993-8#1)(1995-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
while keeping the##3##3##(2008-10#1)(2008-3#2)
while keeping##7##2##(1992-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-12#1)
while knowledge##2##2##(2011-2#1)(2012-2#1)
while late##2##2##(2011-2#1)(2012-7#1)
while leaving the##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
while leaving##5##2##(1992-11#1)(2008-10#1)(2010-4#1)(2012-2#2)
while less##4##2##(1990-3#1)(1993-5#1)(2008-10#1)(2008-8#1)
while limiting##4##2##(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)
while little##2##2##(1992-9#1)(2010-12#1)
while low##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
while maintaining a##11##3##(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
while maintaining good##2##3##(2008-10#2)
while maintaining high##2##3##(2008-10#2)
while maintaining patient##3##3##(2008-10#1)(2008-11#2)
while maintaining quality of care##2##5##(1994-1#1)(1996-1#1)
while maintaining quality##7##3##(1991-12#1)(1994-1#1)(1996-1#2)(1997-2#1)(2008-11#1)(2013-1#1)
while maintaining the same##2##4##(1994-12#1)(2008-11#1)
while maintaining the##6##3##(1990-6#1)(1993-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
while maintaining their##2##3##(1991-12#1)(1996-7#1)
while maintaining##53##2##(1990-6#1)(1991-12#2)(1991-3#1)(1991-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-1#2)(1996-7#1)(1997-2#1)(2007-12#4)(2007-7#1)(2008-10#8)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
while males##2##2##(1997-3#1)(2008-6#1)
while manipulating##2##2##(2008-7#1)(2013-1#1)
while many##3##2##(1995-2#1)(2010-12#1)(2012-12#1)
while maximizing##2##2##(1996-3#1)(2010-12#1)
while maximum##2##2##(2008-10#1)(2010-5#1)
while medical##2##2##(1995-1#1)(1996-3#1)
while minimizing the impact##2##4##(2008-10#1)(2008-2#1)
while minimizing the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
while minimizing##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
while moisture##2##2##(2008-10#1)(2010-4#1)
while more than##2##3##(2008-10#1)(2011-2#1)
while more##4##2##(1994-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
while most of the##2##4##(2008-11#1)(2008-7#1)
while most of##3##3##(2008-11#1)(2008-7#1)(2010-4#1)
while most##10##2##(1991-6#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-8#2)
while moving##2##2##(2007-11#1)(2008-3#1)
while muscarinic##2##2##(1993-12#1)(1995-12#1)
while navigating##2##2##(2010-9#1)(2012-1#1)
while no changes were observed in##2##6##(1994-8#1)(2008-7#1)
while no changes were##3##4##(1994-8#1)(2008-7#1)(2012-3#1)
while no difference##2##3##(2011-2#1)(2012-12#1)
while no differences were##2##4##(2008-7#1)(2010-12#1)
while no effect was##2##4##(1996-12#1)(2008-10#1)
while no or##3##3##(1992-12#1)(1995-11#1)(2008-10#1)
while no significant differences were##2##5##(2013-1#1)(2013-7#1)
while no significant##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
while no specific##2##3##(1990-12#1)(2008-5#1)
while no##29##2##(1990-12#1)(1991-12#1)(1992-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
while none of the##3##4##(2008-4#1)(2008-9#1)(2012-12#1)
while none##4##2##(1995-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
while not affecting##3##3##(1990-7#1)(2007-8#1)(2008-10#1)
while not##12##2##(1990-7#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-9#2)(2010-3#1)(2012-3#1)
while offering##2##2##(2008-8#1)(2009-12#1)
while on cardiopulmonary bypass##3##4##(2007-8#3)
while on the other hand##2##5##(1991-11#1)(1991-3#1)
while on the##4##3##(1991-11#1)(1991-3#1)(2007-12#1)(2012-3#1)
while on##16##2##(1991-11#1)(1991-3#1)(1997-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-1#1)(2012-3#1)
while one also had##2##4##(2007-11#1)(2007-12#1)
while one of the##2##4##(1990-5#1)(2008-10#1)
while one of##3##3##(1990-5#1)(1991-6#1)(2008-10#1)
while one patient##2##3##(2007-7#2)
while one##12##2##(1990-5#1)(1991-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-12#1)
while only a##2##3##(1996-5#1)(2008-7#1)
while only the##2##3##(1994-5#1)(2010-4#1)
while only##22##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
while operating at##2##3##(2008-10#1)(2008-3#1)
while optimizing the##2##3##(1996-6#1)(2008-6#1)
while other cells##2##3##(1996-5#1)(2008-11#1)
while other##18##2##(1991-12#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)
while others are##6##3##(1994-8#1)(1996-2#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
while others do not##4##4##(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
while others found the##2##4##(2008-11#1)(2008-3#1)
while others may##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
while others##31##2##(1991-12#1)(1992-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#2)(2006-10#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-11#1)(2012-2#2)(2012-3#2)(2013-8#1)
while our##2##2##(1995-3#1)(2012-12#1)
while patient survival##2##3##(2008-1#1)(2008-4#1)
while patients##2##2##(1991-3#1)(2012-1#1)
while performing axillary##2##3##(2013-1#2)
while performing##5##2##(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#2)
while plant##2##2##(2008-10#2)
while plasma##2##2##(1997-7#1)(2008-1#1)
while playing##3##2##(1990-6#1)(2008-11#1)(2013-1#1)
while pointing##2##2##(2011-2#1)(2012-12#1)
while preserving the##6##3##(2007-10#1)(2007-11#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)
while preserving their##2##3##(2010-8#2)
while preserving##14##2##(1991-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)
while productivity##2##2##(2007-5#1)(2011-2#1)
while progesterone##3##2##(1990-11#1)(1994-9#1)(2010-8#1)
while promoting##2##2##(1994-11#1)(2013-1#1)
while providing##13##2##(1994-2#1)(1997-3#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-9#1)(2011-2#1)
while reading##2##2##(2008-11#1)(2013-8#1)
while receiving##2##2##(1993-3#1)(2012-12#1)
while recombinant##2##2##(2008-11#2)
while recording##2##2##(2008-10#1)(2009-5#1)
while recoveries##3##2##(2008-10#3)
while red##2##2##(2008-9#1)(2011-2#1)
while reduced##3##2##(1992-10#1)(1993-12#1)(2011-2#1)
while reducing the##3##3##(1992-2#1)(2008-3#1)(2011-2#1)
while reducing##9##2##(1992-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
while relatively##3##2##(1997-8#1)(2008-9#1)(2011-1#1)
while remaining##4##2##(1995-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
while requiring##2##2##(2007-7#1)(2008-10#1)
while retaining the##2##3##(2008-10#1)(2008-3#1)
while retaining##11##2##(1995-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#3)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
while root##2##2##(2008-10#1)(2008-9#1)
while samples##2##2##(1997-4#1)(2008-5#1)
while sensitive##2##2##(2008-4#1)(2012-3#1)
while serum##3##2##(2008-7#2)(2011-1#1)
while several##2##2##(2008-5#1)(2013-1#1)
while she was##2##3##(2007-7#1)(2010-11#1)
while significant##2##2##(1992-6#1)(1993-8#1)
while simultaneously##3##2##(2008-1#1)(2008-3#2)
while sitting##2##2##(2010-9#2)
while soil##2##2##(2008-10#1)(2012-6#1)
while some of##3##3##(1992-3#1)(1993-12#1)(2011-1#1)
while some##6##2##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-3#1)
while sparing normal##2##3##(1994-3#1)(1994-5#1)
while sparing##3##2##(1994-3#1)(1994-5#1)(2012-3#1)
while still##8##2##(1991-12#1)(1995-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
while strains##2##2##(2008-10#2)
while subjects##3##2##(2008-11#1)(2010-11#1)(2013-8#1)
while substantial##2##2##(1992-3#1)(1995-12#1)
while taking##5##2##(2007-12#1)(2007-8#1)(2008-3#1)(2010-4#1)(2011-1#1)
while temperature##3##2##(2008-10#2)(2008-9#1)
while ten##2##2##(1990-12#1)(2011-2#1)
while that for##5##3##(1991-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)
while that from##2##3##(1994-8#1)(2008-10#1)
while that in##3##3##(1993-2#1)(2008-10#1)(2010-5#1)
while that of the##5##4##(1990-11#1)(1991-5#1)(1993-11#1)(2008-11#1)(2008-8#1)
while that of##15##3##(1990-11#1)(1991-5#2)(1993-11#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
while that##29##2##(1990-11#1)(1991-5#3)(1993-11#1)(1993-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2013-8#1)
while the addition of##2##4##(1996-2#1)(2008-10#1)
while the amount of##2##4##(1997-2#2)
while the average##3##3##(1995-3#1)(2007-12#1)(2013-1#1)
while the best##2##3##(2008-10#2)
while the beta##2##3##(1990-7#2)
while the cells##2##3##(2008-11#1)(2013-1#1)
while the combined##2##3##(1991-9#1)(1992-11#1)
while the comparative##2##3##(1990-6#1)(2011-2#1)
while the conductivity##2##3##(2008-10#1)(2009-11#1)
while the control group did not##2##6##(2007-10#1)(2008-3#1)
while the control group was##2##5##(2008-12#1)(2009-10#1)
while the control group##5##4##(2007-10#1)(2008-12#2)(2008-3#1)(2009-10#1)
while the control##7##3##(2007-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2013-8#1)
while the corresponding##3##3##(1991-8#1)(1992-2#1)(2010-4#1)
while the detection limit##2##4##(2008-10#2)
while the detection##3##3##(1995-6#1)(2008-10#2)
while the diffractive performance fundamentally surpasses conventional telescopes because of the absence of pupil obstruction##2##15##(2008-2#1)(2008-3#1)
while the effect##2##3##(1996-2#1)(2008-10#1)
while the error##2##3##(2013-1#1)(2013-8#1)
while the expression of##2##4##(2008-8#1)(2013-8#1)
while the expression##4##3##(2008-8#2)(2009-6#1)(2013-8#1)
while the final##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
while the firing rate##2##4##(1995-12#1)(2008-11#1)
while the fourth##2##3##(2008-1#2)
while the full##2##3##(2007-11#1)(2008-10#1)
while the holistic##2##3##(1997-6#2)
while the incidence of##2##4##(2010-12#1)(2013-1#1)
while the initial##2##3##(1995-4#1)(1997-7#1)
while the laser##3##3##(2007-11#1)(2008-3#2)
while the latter##7##3##(1992-6#1)(1993-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
while the level of##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
while the levels of##2##4##(1997-7#1)(2008-11#1)
while the lowest##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-8#1)
while the monoesters##4##3##(1992-12#4)
while the more##2##3##(1990-5#1)(2009-5#1)
while the most common##2##4##(2007-8#1)(2011-2#1)
while the most##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
while the number of##4##4##(1991-8#1)(1995-12#1)(2008-11#1)(2011-2#1)
while the one##2##3##(1991-9#1)(2008-10#1)
while the other five##2##4##(2008-10#1)(2008-11#1)
while the other four##2##4##(1995-9#1)(2008-1#1)
while the other##27##3##(1990-12#1)(1990-5#1)(1993-12#1)(1994-7#1)(1995-3#1)(1995-6#1)(1995-9#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)(2013-1#1)
while the others##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
while the overall##2##3##(1991-11#1)(2010-3#1)
while the patient##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
while the percentage of##3##4##(2008-10#1)(2008-11#2)
while the phase##3##3##(2007-11#2)(2008-10#1)
while the polar##2##3##(1995-3#1)(2008-10#1)
while the population size##2##4##(2008-10#1)(2008-8#1)
while the population##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
while the presence of##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
while the prevalence of the##2##5##(2013-1#2)
while the prevalence##3##3##(1996-3#1)(2013-1#2)
while the rate of detected chromosome##2##6##(2012-3#2)
while the rate##3##3##(1997-7#1)(2012-3#2)
while the reaction##2##3##(1996-5#1)(2008-11#1)
while the remaining four##2##4##(1991-12#1)(2008-7#1)
while the remaining##12##3##(1991-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
while the response to##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
while the response##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
while the risk##3##3##(2007-2#1)(2008-12#1)(2008-8#1)
while the same##2##3##(2008-10#1)(2008-11#1)
while the second is##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
while the second one##2##4##(2008-10#1)(2008-8#1)
while the second##12##3##(1992-3#2)(1996-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2009-7#1)(2013-1#1)
while the secondary##2##3##(1990-5#1)(1991-5#1)
while the sensitivity##2##3##(1997-3#1)(2008-10#1)
while the separation##2##3##(2008-3#1)(2013-1#1)
while the smaller##2##3##(2008-10#2)
while the specific##2##3##(2008-11#2)
while the subject##2##3##(2007-10#1)(2010-8#1)
while the third##5##3##(1992-3#1)(1996-4#1)(2008-10#2)(2008-8#1)
while the total##3##3##(1991-9#1)(2008-10#2)
while the two##3##3##(1992-11#1)(2008-6#1)(2011-2#1)
while the uptake##2##3##(1993-12#1)(1995-11#1)
while the variation of transmission among ten gratings is 0##2##10##(2013-8#2)
while the##569##2##(1990-11#1)(1990-12#2)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#4)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#6)(1993-12#4)(1993-3#4)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#7)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#3)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#7)(1996-3#7)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#7)(1997-3#4)(1997-4#1)(1997-6#6)(1997-7#5)(1997-8#5)(2007-10#6)(2007-11#7)(2007-12#11)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#7)(2008-1#6)(2008-10#103)(2008-11#31)(2008-12#10)(2008-2#7)(2008-3#8)(2008-4#6)(2008-5#18)(2008-6#5)(2008-7#13)(2008-8#20)(2008-9#12)(2009-10#4)(2009-11#3)(2009-3#4)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#23)(2013-7#4)(2013-8#16)
while their##13##2##(1991-12#1)(1993-12#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2011-1#1)
while there are##2##3##(2006-12#1)(2009-10#1)
while there is still##2##4##(2007-12#1)(2012-3#1)
while there is##3##3##(1997-5#1)(2007-12#1)(2012-3#1)
while there was a##3##4##(1990-12#1)(2008-11#1)(2011-2#1)
while there was no##2##4##(2008-7#1)(2010-12#1)
while there was##6##3##(1990-12#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)
while there were##2##3##(1997-7#1)(2008-4#1)
while there##15##2##(1990-12#1)(1991-3#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
while these##4##2##(1994-11#1)(2008-11#1)(2008-12#1)(2011-10#1)
while they are##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)
while they were##4##3##(1994-3#1)(1996-3#1)(1996-7#1)(2013-8#1)
while they##22##2##(1990-8#1)(1993-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
while this##8##2##(1992-5#1)(1996-5#1)(1997-3#1)(2008-10#2)(2012-12#2)(2012-2#1)
while those for the##2##4##(1990-8#1)(1996-2#1)
while those from##3##3##(2008-10#2)(2008-11#1)
while those in the##3##4##(1990-8#1)(1993-9#1)(2008-7#1)
while those in##6##3##(1990-8#1)(1993-9#1)(2008-10#2)(2008-7#1)(2012-3#1)
while those of##8##3##(1990-12#1)(1992-6#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-9#1)
while those with##3##3##(1996-2#1)(2008-10#1)(2009-8#1)
while those##32##2##(1990-12#1)(1990-8#2)(1992-6#1)(1993-9#1)(1994-12#1)(1996-2#3)(1996-5#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-3#1)
while three##5##2##(1992-2#1)(1993-6#1)(2008-10#2)(2013-1#1)
while tissue##2##2##(1996-12#1)(2009-3#1)
while total##6##2##(1993-12#1)(1994-8#1)(1996-2#1)(2007-5#1)(2008-5#1)(2012-7#1)
while treating##2##2##(2011-2#1)(2013-8#1)
while two other##2##3##(1993-12#1)(1995-6#1)
while two##10##2##(1993-12#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
while under the influence of alcohol##2##6##(2008-7#1)(2013-8#1)
while under the influence of psilocybin##2##6##(2013-8#2)
while under the influence of##4##5##(2008-7#1)(2013-8#3)
while under##5##2##(2008-7#1)(2008-9#1)(2013-8#3)
while undergoing##3##2##(2007-5#1)(2009-12#1)(2010-11#1)
while unilateral##2##2##(1990-5#1)(1991-5#1)
while unladen##2##2##(2008-9#2)
while using##9##2##(1992-2#1)(1993-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-8#1)
while varying the##3##3##(2008-10#2)(2008-8#1)
while varying##5##2##(1991-2#1)(2008-10#3)(2008-8#1)
while very##2##2##(1997-3#1)(2011-2#1)
while we##2##2##(2008-11#1)(2008-3#1)
while with the##2##3##(1992-3#1)(2008-10#1)
while working##3##2##(2007-2#1)(2011-2#1)(2012-12#1)
while##2600##1##(1990-10#1)(1990-11#10)(1990-12#13)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#12)(1990-6#4)(1990-7#8)(1990-8#12)(1990-9#2)(1991-1#4)(1991-11#6)(1991-12#24)(1991-2#3)(1991-3#14)(1991-5#14)(1991-6#6)(1991-8#4)(1991-9#8)(1992-1#1)(1992-10#4)(1992-11#11)(1992-12#9)(1992-2#8)(1992-3#18)(1992-5#4)(1992-6#16)(1992-8#7)(1992-9#7)(1993-1#6)(1993-10#1)(1993-11#12)(1993-12#19)(1993-2#8)(1993-3#15)(1993-5#1)(1993-6#10)(1993-8#14)(1993-9#9)(1994-1#3)(1994-11#15)(1994-12#14)(1994-2#10)(1994-3#11)(1994-5#11)(1994-6#11)(1994-7#3)(1994-8#10)(1994-9#9)(1995-1#7)(1995-11#11)(1995-12#26)(1995-2#17)(1995-3#18)(1995-4#1)(1995-5#8)(1995-6#11)(1995-8#9)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#17)(1996-2#23)(1996-3#15)(1996-4#2)(1996-5#17)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#19)(1997-3#15)(1997-4#12)(1997-5#7)(1997-6#10)(1997-7#11)(1997-8#10)(2006-10#1)(2006-12#2)(2006-6#2)(2007-10#14)(2007-11#28)(2007-12#41)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#7)(2007-6#4)(2007-7#27)(2007-8#22)(2008-1#28)(2008-10#389)(2008-11#132)(2008-12#41)(2008-2#34)(2008-3#61)(2008-4#48)(2008-5#57)(2008-6#25)(2008-7#76)(2008-8#79)(2008-9#67)(2009-1#1)(2009-10#14)(2009-11#14)(2009-12#13)(2009-2#2)(2009-3#11)(2009-4#5)(2009-5#12)(2009-6#10)(2009-7#14)(2009-8#12)(2009-9#8)(2010-1#3)(2010-10#5)(2010-11#16)(2010-12#18)(2010-2#6)(2010-3#12)(2010-4#11)(2010-5#17)(2010-6#4)(2010-7#4)(2010-8#20)(2010-9#7)(2011-1#37)(2011-10#3)(2011-2#82)(2011-3#6)(2012-1#14)(2012-12#32)(2012-2#59)(2012-3#38)(2012-5#1)(2012-6#2)(2012-7#2)(2013-1#93)(2013-7#15)(2013-8#56)
whilst allowing##2##2##(2011-2#1)(2013-1#1)
whilst also##2##2##(2011-1#1)(2012-8#1)
whilst for the##2##3##(2008-10#1)(2012-12#1)
whilst in the##2##3##(2008-12#1)(2008-5#1)
whilst in##6##2##(1994-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)
whilst the##8##2##(1992-6#1)(1993-12#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)
whilst there##2##2##(2007-8#1)(2012-3#1)
whilst those in##2##3##(2007-11#1)(2012-12#1)
whilst##88##1##(1990-5#1)(1991-2#2)(1992-6#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#3)(1996-12#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#5)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#6)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#1)
whiplash##4##1##(2008-12#2)(2011-2#1)(2013-1#1)
whirlpool bath]##2##2##(1992-11#2)
whirlpool-spas##2##1##(1992-11#2)
whirlpools should be##2##3##(1992-11#2)
whirlpools##4##1##(1992-11#4)
whisker stimulation##3##2##(1997-3#3)
whiskers##7##1##(1997-3#1)(2008-10#6)
whispering gallery modes##3##3##(2007-12#2)(2008-3#1)
whispering##4##1##(2007-12#3)(2008-3#1)
whispering-gallery mode##2##2##(2011-1#2)
whispering-gallery modes (WGMs)##3##3##(2007-11#2)(2009-6#1)
whispering-gallery modes in##2##3##(2007-11#1)(2007-12#1)
whispering-gallery modes##17##2##(2007-11#7)(2007-12#9)(2009-6#1)
whispering-gallery##19##1##(2007-11#7)(2007-12#9)(2009-6#1)(2011-1#2)
whispering-gallery-mode##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
whistleblowing##5##1##(2011-1#4)(2013-8#1)
whistling##2##1##(2008-2#2)
white New Zealand rabbits##3##4##(1992-3#2)(2011-2#1)
white adipose tissue##2##3##(2008-10#1)(2012-2#1)
white and red wines##2##4##(2008-10#2)
white and red##3##3##(2008-10#3)
white and yellow##2##3##(2008-12#1)(2009-10#1)
white and##15##2##(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
white background##2##2##(1993-5#1)(2008-2#1)
white blood cell (WBC)##2##4##(2008-10#2)
white blood cell count of##2##5##(2008-10#1)(2008-7#1)
white blood cell count##6##4##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
white blood cell differentials##3##4##(2008-10#3)
white blood cell##15##3##(1996-12#1)(2007-12#1)(2008-10#7)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
white blood cells in##2##4##(1996-9#1)(2008-9#1)
white blood cells##16##3##(1991-11#1)(1992-5#1)(1994-8#2)(1996-9#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
white blood count##2##3##(1990-9#1)(2007-8#1)
white blood##33##2##(1990-9#1)(1991-11#1)(1992-5#1)(1994-8#2)(1996-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-7#2)(2008-9#3)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
white cell##5##2##(1991-3#2)(1994-3#1)(1997-6#1)(2008-10#1)
white cells##3##2##(1991-3#1)(2008-5#1)(2008-9#1)
white cloud mountain minnow##4##4##(2010-5#4)
white coat effect##2##3##(2008-7#2)
white coat hypertension##2##3##(2008-7#2)
white coat##5##2##(2007-5#1)(2008-7#4)
white crests##3##2##(2008-9#3)
white female##2##2##(2008-7#1)(2012-12#1)
white fir##9##2##(2008-10#9)
white follicles##4##2##(2008-12#4)
white forelock##2##2##(2008-7#1)(2008-9#1)
white grubs in a Fraser fir##2##6##(2011-2#2)
white in##2##2##(1995-6#1)(2008-10#1)
white leaf##3##2##(2008-10#3)
white leghorn##2##2##(1997-6#2)
white lies##3##2##(2008-1#3)
white light##16##2##(2007-11#3)(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#3)(2009-4#1)(2013-1#2)
white maize food##2##3##(1997-4#2)
white male albino rats##2##4##(2008-10#2)
white male##4##2##(1992-6#1)(1994-12#1)(2008-10#2)
white man##3##2##(1992-2#1)(2007-7#1)(2011-2#1)
white matter abnormalities##2##3##(2008-8#1)(2012-12#1)
white matter and##5##3##(1991-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-7#1)
white matter in the##2##4##(1991-12#1)(2011-1#1)
white matter of the##3##4##(2008-6#1)(2008-7#1)(2011-1#1)
white matter were##2##3##(1990-7#1)(1996-11#1)
white matter##54##2##(1990-5#1)(1990-7#2)(1991-12#3)(1993-12#2)(1993-6#1)(1995-12#1)(1995-5#2)(1995-8#4)(1996-11#2)(1996-5#3)(1997-2#1)(2007-10#2)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#2)(2009-7#1)(2010-12#9)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
white men##6##2##(1990-3#1)(2009-5#1)(2009-7#1)(2013-7#3)
white mold##4##2##(2008-10#2)(2012-2#2)
white muscle##3##2##(2010-1#1)(2013-1#2)
white noise##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
white paper##3##2##(2008-3#1)(2012-2#2)
white papers##2##2##(1996-2#2)
white patients##2##2##(1992-2#1)(1995-12#1)
white pine (P##2##3##(2008-10#2)
white pine (Pinus##5##3##(2008-10#5)
white pine blister rust##17##4##(2008-10#17)
white pine blister##18##3##(2008-10#18)
white pine species##2##3##(2008-10#2)
white pine##38##2##(2008-10#38)
white population##2##2##(2011-2#2)
white rot fungus##2##3##(2008-6#1)(2009-9#1)
white rot##6##2##(2008-10#2)(2008-6#1)(2009-9#3)
white sea catfish##2##3##(2008-10#2)
white spot lesion formation##3##4##(2009-7#3)
white spot lesion##4##3##(2009-7#4)
white spot##5##2##(2009-7#5)
white spruce##2##2##(2008-10#2)
white to##3##2##(1993-5#1)(2008-10#2)
white wine samples##2##3##(2008-10#2)
white wine##7##2##(2008-10#7)
white wines by their##2##4##(2008-10#2)
white wines##12##2##(2008-10#12)
white##421##1##(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-11#3)(1991-12#3)(1991-3#3)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-12#4)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#3)(2006-4#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#133)(2008-11#6)(2008-12#9)(2008-2#8)(2008-3#13)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#11)(2009-10#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#9)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#10)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#19)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#3)
white-light continuum##7##2##(2007-11#3)(2007-12#4)
white-light interferometry##8##2##(2007-11#3)(2008-3#5)
white-light source##2##2##(2008-1#1)(2008-3#1)
white-light##40##1##(2007-11#11)(2007-12#8)(2008-1#1)(2008-2#2)(2008-3#18)
white-lipped##3##1##(2008-5#3)
white-noise##3##1##(2007-11#1)(2008-3#1)(2008-7#1)
white-noise-like images##2##2##(2008-3#2)
white-noise-like##3##1##(2008-3#3)
white-pupil##2##1##(2008-3#2)
white-rot fungus##2##2##(2008-11#1)(2011-1#1)
whitecaps##2##1##(2008-2#1)(2008-3#1)
whiteflies that##3##2##(2008-10#3)
whiteflies were##3##2##(2008-10#3)
whiteflies##23##1##(2008-10#21)(2011-2#2)
whitefly (Bemisia##2##2##(2008-10#2)
whitefly survival##2##2##(2008-10#2)
whitefly transmission##2##2##(2008-10#2)
whitefly vector##6##2##(2008-10#6)
whitefly##28##1##(2008-10#27)(2011-2#1)
whitefly-transmitted geminivirus from##2##3##(2008-10#2)
whitefly-transmitted geminivirus##5##2##(2008-10#5)
whitefly-transmitted##14##1##(2008-10#13)(2008-8#1)
whitemouth croaker Micropogonias furnieri in##2##5##(2010-8#2)
whitemouth croaker##3##2##(2010-8#3)
whitening agent##2##2##(2008-5#2)
whitening and##2##2##(2009-8#1)(2011-2#1)
whitening effect##3##2##(2008-5#3)
whitening formulation##2##2##(2008-5#2)
whitening##23##1##(2008-3#1)(2008-5#18)(2009-8#1)(2011-2#2)(2012-8#1)
whites and##2##2##(2011-2#1)(2012-2#1)
whites with##4##2##(2011-1#1)(2011-2#2)(2012-3#1)
whites##26##1##(1991-11#1)(1993-3#1)(1994-12#1)(1995-12#2)(1996-3#1)(1997-3#1)(2007-10#1)(2008-1#2)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)
whitish type##2##2##(2008-10#2)
whitish##3##1##(2008-10#2)(2012-3#1)
who achieved a##2##3##(2012-2#1)(2012-3#1)
who achieved##7##2##(1990-12#1)(2007-7#1)(2012-2#2)(2012-3#2)(2013-1#1)
who acquire##2##2##(1990-9#1)(2008-8#1)
who actually##2##2##(1994-2#1)(1996-1#1)
who admitted##2##2##(2011-2#1)(2012-2#1)
who all##2##2##(1996-9#1)(2008-7#1)
who also had##4##3##(1993-3#1)(2008-1#1)(2009-4#1)(2013-8#1)
who also##9##2##(1990-11#1)(1993-3#1)(1994-5#1)(2008-1#1)(2009-4#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
who are &quot##2##3##(1992-2#1)(2009-6#1)
who are able to##3##4##(1991-8#1)(2008-11#2)
who are already##4##3##(1991-2#1)(2008-6#1)(2011-2#2)
who are at an##2##4##(2008-12#1)(2012-3#1)
who are at increased risk for##2##6##(1994-12#1)(2010-10#1)
who are at risk for##4##5##(1990-5#1)(2008-1#2)(2008-11#1)
who are at risk of##3##5##(2008-12#1)(2013-1#1)(2013-7#1)
who are at risk##8##4##(1990-5#1)(1990-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-7#1)
who are at##17##3##(1990-5#1)(1990-9#1)(1991-12#1)(1994-12#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
who are candidates for##2##4##(2008-11#1)(2008-6#1)
who are committed to##2##4##(1994-2#1)(2012-3#1)
who are concerned about##3##4##(1993-11#1)(1993-3#1)(2008-12#1)
who are deaf##2##3##(2011-2#2)
who are exposed to##3##4##(2008-10#1)(2009-7#1)(2011-2#1)
who are extremely##2##3##(2008-1#1)(2013-1#1)
who are faced with##2##4##(1993-3#1)(1997-1#1)
who are immunosuppressed##2##3##(2007-12#1)(2009-8#1)
who are likely to be##3##5##(1997-3#1)(2007-12#1)(2008-11#1)
who are likely to##6##4##(1997-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
who are living with##2##4##(1997-6#1)(2009-7#1)
who are more##2##3##(1993-3#1)(2012-2#1)
who are not on##2##4##(2008-5#1)(2012-1#1)
who are not##15##3##(1993-1#1)(1995-12#1)(1995-9#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
who are now##2##3##(1992-2#1)(2008-7#1)
who are obese##3##3##(2008-3#1)(2009-9#1)(2011-1#1)
who are often not##2##4##(1992-3#1)(2007-6#1)
who are often##3##3##(1992-3#1)(1996-11#1)(2007-6#1)
who are on a ddI- and/or d4T-containing antiretroviral drug regimen##2##10##(2008-11#2)
who are on##7##3##(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-2#1)(2011-2#1)
who are physically##2##3##(1992-3#1)(2013-1#1)
who are refractory to##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
who are relatively##2##3##(2009-10#1)(2011-2#1)
who are responsible for##3##4##(1993-3#1)(1997-2#1)(2008-12#1)
who are responsible##4##3##(1993-3#1)(1997-2#1)(2008-11#1)(2008-12#1)
who are suspected of having##2##5##(2010-12#1)(2012-12#1)
who are the##2##3##(1996-2#1)(2008-10#1)
who are unable to##2##4##(1994-12#1)(2007-12#1)
who are undergoing##4##3##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
who are uninsured##2##3##(1995-1#1)(2011-2#1)
who are##226##2##(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#6)(1994-1#2)(1994-12#3)(1994-2#2)(1994-7#1)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#4)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-5#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#10)(2008-11#16)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#16)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#6)
who arrived##2##2##(2008-10#1)(2012-3#1)
who assist##2##2##(1993-3#1)(2008-8#1)
who ate##2##2##(1991-6#1)(2011-1#1)
who attended the class##2##4##(2007-10#2)
who attended the##6##3##(1993-6#1)(1995-1#1)(2007-10#2)(2007-5#1)(2013-8#1)
who attended##9##2##(1993-6#1)(1995-1#1)(2007-10#2)(2007-5#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
who became infected##2##3##(1996-5#1)(1997-5#1)
who became##7##2##(1996-5#1)(1997-5#1)(2007-2#1)(2008-10#1)(2012-2#1)(2013-1#2)
who become##2##2##(1994-1#1)(2008-12#1)
who believe##2##2##(1996-1#1)(2008-12#1)
who benefit from##2##3##(2008-10#1)(2012-3#1)
who benefit##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
who both##3##2##(1993-9#1)(2008-11#1)(2008-4#1)
who came##3##2##(1990-3#1)(2011-1#1)(2012-2#1)
who can afford##2##3##(1996-2#1)(2009-8#1)
who can##16##2##(1992-3#1)(1994-7#1)(1995-1#1)(1996-2#2)(1996-3#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-1#1)
who cannot##4##2##(1994-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
who care for children with complex##2##6##(2008-11#2)
who care for##7##3##(1992-3#1)(2007-12#1)(2008-11#3)(2008-12#1)(2012-3#1)
who cared for##2##3##(1991-6#1)(2010-11#1)
who choose##2##2##(2012-3#1)(2013-1#1)
who claimed##4##2##(1995-12#2)(1995-6#2)
who collectively looked after##2##4##(2007-7#1)(2008-1#1)
who come from##2##3##(2008-11#1)(2008-8#1)
who complained of##6##3##(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)
who completed a##3##3##(2007-7#1)(2009-11#1)(2013-1#1)
who completed an##3##3##(2008-1#1)(2010-10#1)(2013-1#1)
who completed the questionnaire##2##4##(1992-6#1)(2012-2#1)
who completed the##8##3##(1992-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#3)
who completed##23##2##(1992-6#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#6)
who conceived after##2##3##(1994-3#1)(2011-1#1)
who conduct##2##2##(1995-3#1)(2009-3#1)
who contacted##2##2##(1994-2#1)(2012-3#1)
who continue to##3##3##(1993-11#1)(2007-2#1)(2008-10#1)
who continued##3##2##(1991-3#1)(2008-11#1)(2013-8#1)
who contracted HIV##4##3##(1996-5#2)(1997-5#2)
who contracted##6##2##(1996-5#3)(1997-4#1)(1997-5#2)
who contributed##2##2##(1997-8#1)(2011-2#1)
who could be##2##3##(1995-5#1)(1997-2#1)
who could benefit from##2##4##(1992-12#1)(2008-11#1)
who could not be##3##4##(2007-8#1)(2008-3#1)(2008-6#1)
who could not##5##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)
who could##11##2##(1992-12#1)(1995-5#1)(1997-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)
who delivered##2##2##(1992-2#1)(2008-12#1)
who demonstrated##2##2##(1994-2#1)(2010-1#1)
who desire##2##2##(2007-8#1)(2008-9#1)
who develop##8##2##(1993-11#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
who developed a##14##3##(1993-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
who developed acute##3##3##(1992-10#1)(2010-4#1)(2012-12#1)
who developed an##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
who developed bilateral##2##3##(2007-10#1)(2011-1#1)
who developed metastatic##2##3##(2008-6#1)(2011-3#1)
who developed primary##2##3##(1997-3#1)(2007-5#1)
who developed progressive##2##3##(2006-10#2)
who developed severe##2##3##(1992-11#1)(2011-1#1)
who developed the##2##3##(2008-9#1)(2011-1#1)
who developed##80##2##(1990-3#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1997-3#1)(2006-10#6)(2007-10#4)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#5)
who did and did not##3##5##(1993-3#1)(2012-1#1)(2012-12#1)
who did not achieve##2##4##(2008-10#1)(2008-6#1)
who did not engage in##2##5##(2008-3#1)(2010-7#1)
who did not have##9##4##(1992-11#1)(1995-4#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2013-1#1)
who did not receive any##4##5##(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
who did not receive##11##4##(1993-1#1)(1994-6#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-7#1)(2012-3#1)(2013-1#2)
who did not respond to##2##5##(1990-2#1)(1994-12#1)
who did not##54##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-11#2)(1993-1#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-4#1)(1997-2#1)(2007-10#4)(2007-12#2)(2007-2#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#5)
who did the under-five##2##4##(2008-2#2)
who did##65##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-11#2)(1993-1#2)(1993-3#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-2#1)(1997-2#1)(2007-10#4)(2007-12#2)(2007-2#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
who die##2##2##(1991-8#1)(1997-5#1)
who died at##2##3##(1991-8#1)(2008-7#1)
who died during the##2##4##(1997-4#1)(2013-1#1)
who died during##3##3##(1991-7#1)(1997-4#1)(2013-1#1)
who died from##3##3##(1994-11#1)(1994-9#1)(1995-6#1)
who died in##2##3##(1991-8#1)(2010-2#1)
who died of##4##3##(1992-4#1)(1995-11#1)(2011-2#2)
who died suddenly##2##3##(1991-8#1)(1991-9#1)
who died##23##2##(1991-7#1)(1991-8#3)(1991-9#1)(1992-4#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-7#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
who do not have##2##4##(1996-1#1)(2009-10#1)
who do not respond to##4##5##(1993-12#1)(1996-5#1)(1997-8#1)(2011-2#1)
who do not##17##3##(1993-12#1)(1993-2#1)(1996-1#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
who do##22##2##(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-3#2)(2013-8#1)
who does##2##2##(1991-3#1)(1994-2#1)
who engage in##2##3##(2008-6#1)(2013-1#1)
who engaged in sexting##2##4##(2013-1#2)
who engaged in##4##3##(1996-5#1)(2009-10#1)(2013-1#2)
who entered the study##2##4##(1991-2#1)(1995-1#1)
who entered##3##2##(1991-2#1)(1992-6#1)(1995-1#1)
who exhibited a##2##3##(2007-10#1)(2008-9#1)
who exhibited##6##2##(1997-3#1)(1997-7#1)(2007-10#1)(2008-9#1)(2011-2#2)
who experience##9##2##(1991-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
who experienced a##2##3##(2007-10#1)(2007-5#1)
who experienced febrile neutropenia##2##4##(2008-7#2)
who experienced more##2##3##(2011-2#1)(2012-1#1)
who experienced##12##2##(1992-1#1)(2007-10#1)(2007-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
who expired##3##2##(1992-9#1)(2007-7#2)
who expose##2##2##(2008-12#1)(2008-7#1)
who expressed##4##2##(1991-2#2)(2011-1#1)(2012-2#1)
who fail to##2##3##(1993-12#1)(2011-3#1)
who fail##4##2##(1993-12#1)(2007-7#1)(2008-11#1)(2011-3#1)
who failed to##4##3##(1995-2#1)(2008-1#1)(2008-6#1)(2012-2#1)
who failed##7##2##(1995-2#1)(2008-1#1)(2008-11#2)(2008-6#1)(2012-2#1)(2013-8#1)
who fall##3##2##(1994-12#1)(2008-7#1)(2009-4#1)
who fell##2##2##(1996-9#1)(2013-1#1)
who felt that there was an improvement in their wrinkles after##2##11##(2008-5#2)
who felt that##3##3##(1997-1#1)(2008-5#2)
who felt##5##2##(1997-1#1)(2008-5#2)(2013-1#1)(2013-7#1)
who fulfilled the##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
who gave birth to##2##4##(1996-5#1)(2012-3#1)
who gave birth##3##3##(1996-5#1)(2009-11#1)(2012-3#1)
who gave##4##2##(1996-5#1)(2009-11#1)(2010-1#1)(2012-3#1)
who got infected with##2##4##(1993-8#1)(2007-10#1)
who got##3##2##(1992-3#1)(1993-8#1)(2007-10#1)
who had a##27##3##(1990-11#1)(1990-8#1)(1992-5#1)(1996-7#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-10#3)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-6#1)(2009-7#1)(2010-6#2)(2011-1#1)(2012-3#1)(2013-1#2)
who had acute##2##3##(2007-7#1)(2012-2#1)
who had an##6##3##(1991-3#1)(2007-10#1)(2008-6#2)(2008-7#1)(2013-1#1)
who had attempted##2##3##(1992-1#1)(2008-11#1)
who had been on##2##4##(2008-1#1)(2008-7#1)
who had been previously##2##4##(1992-6#1)(2013-8#1)
who had been treated for##2##5##(2008-10#1)(2008-6#1)
who had been treated with##2##5##(1995-11#1)(2008-7#1)
who had been treated##6##4##(1995-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)
who had been##31##3##(1990-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-3#1)(2011-2#3)(2013-8#2)
who had both##2##3##(2007-10#1)(2008-12#1)
who had breast##2##3##(1993-11#1)(2008-7#1)
who had completed##2##3##(1993-2#1)(2010-8#1)
who had contact with##2##4##(2007-12#1)(2012-12#1)
who had developed##2##3##(2007-7#1)(2013-8#1)
who had died##2##3##(1990-10#1)(1997-3#1)
who had ever##3##3##(1993-2#1)(2008-12#2)
who had experienced##6##3##(1994-6#1)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
who had had##9##3##(1993-10#1)(1993-2#1)(1997-2#1)(2007-10#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
who had intraplaque hemorrhage##2##4##(2007-10#2)
who had long Barrett's esophagus##2##5##(2013-8#2)
who had lost##2##3##(2008-5#1)(2009-5#1)
who had negative##2##3##(1994-12#1)(2007-2#1)
who had never used##2##4##(2013-1#1)(2013-8#1)
who had never##4##3##(1993-9#1)(2013-1#2)(2013-8#1)
who had no##9##3##(1991-11#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
who had not received##2##4##(1992-10#1)(2007-8#1)
who had not undergone##2##4##(2008-11#1)(2012-3#1)
who had not used##2##4##(1993-2#1)(2013-8#1)
who had not##17##3##(1991-2#1)(1992-10#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
who had participated in##3##4##(1991-12#1)(2009-6#1)(2013-1#1)
who had presented##2##3##(1997-2#1)(2010-5#1)
who had previously been active in sports##2##7##(2007-11#1)(2007-8#1)
who had previously been##3##4##(2006-10#1)(2007-11#1)(2007-8#1)
who had previously undergone##2##4##(1997-7#1)(2008-9#1)
who had previously##5##3##(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-9#1)
who had received a##2##4##(2008-9#1)(2010-10#1)
who had received##15##3##(1990-2#1)(1991-3#1)(1993-10#1)(1996-1#1)(2007-8#2)(2008-6#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
who had recently undergone##2##4##(1995-3#1)(2007-12#1)
who had recently##4##3##(1995-3#1)(1995-6#2)(2007-12#1)
who had recurrent##2##3##(2009-3#1)(2013-1#1)
who had residual##2##3##(1997-8#1)(2012-3#1)
who had severe##2##3##(2008-11#1)(2008-7#1)
who had suffered a##2##4##(2008-7#1)(2010-7#1)
who had the##3##3##(1992-12#1)(2011-1#2)
who had undergone a##3##4##(1990-11#1)(2008-9#2)
who had undergone liver##2##4##(1991-8#1)(2009-2#1)
who had undergone##29##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-6#1)(1994-12#1)(1994-3#4)(1995-11#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#3)
who had used##3##3##(2007-11#1)(2011-10#1)(2013-8#1)
who had visited##2##3##(1993-9#1)(1997-6#1)
who had##335##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-8#2)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#1)(1993-2#6)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#5)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#3)(2006-10#4)(2007-10#11)(2007-11#6)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#10)(2007-8#6)(2008-1#6)(2008-10#5)(2008-11#16)(2008-12#10)(2008-3#2)(2008-5#4)(2008-6#6)(2008-7#14)(2008-8#1)(2008-9#10)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-3#4)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#6)(2011-10#1)(2011-2#17)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#10)(2013-1#22)(2013-7#1)(2013-8#16)
who has been##5##3##(2008-6#1)(2008-9#2)(2010-11#1)(2012-3#1)
who has failed##2##3##(2008-11#1)(2011-1#1)
who has suffered##2##3##(1996-3#1)(2007-11#1)
who has##19##2##(1991-3#1)(1996-1#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
who have a history of##2##5##(2008-1#1)(2011-2#1)
who have a##13##3##(1990-10#1)(1993-12#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-10#1)(2011-2#1)(2012-2#2)
who have been##17##3##(1991-12#1)(1992-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-3#1)
who have cancer##2##3##(1992-3#1)(2008-7#1)
who have complex##3##3##(1995-5#1)(2008-11#2)
who have experienced##3##3##(2008-2#1)(2013-1#2)
who have failed##4##3##(1994-5#1)(2008-5#1)(2008-8#1)(2008-9#1)
who have finished##2##3##(1992-1#1)(1996-8#1)
who have had limited##2##4##(1992-3#1)(1996-1#1)
who have had##10##3##(1992-10#1)(1992-3#1)(1996-1#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-1#1)
who have inherited##2##3##(1990-11#1)(2008-4#1)
who have limited##2##3##(1991-3#1)(2012-2#1)
who have never##2##3##(2009-5#1)(2011-1#1)
who have normal##2##3##(2008-1#1)(2011-2#1)
who have not##5##3##(1993-2#1)(1993-3#1)(2008-12#1)(2010-3#1)(2012-12#1)
who have other##2##3##(2008-4#1)(2008-8#1)
who have received##5##3##(1994-9#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
who have sex with men (MSM)##5##6##(2009-5#4)(2011-2#1)
who have sex with men and##2##6##(2009-5#1)(2009-7#1)
who have sex with men##17##5##(1996-5#1)(2008-10#1)(2008-11#1)(2009-5#9)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
who have suffered a##2##4##(2008-12#1)(2009-10#1)
who have suffered##3##3##(1995-11#1)(2008-12#1)(2009-10#1)
who have survived##2##3##(1990-5#1)(2009-5#1)
who have sustained##2##3##(2010-9#1)(2013-1#1)
who have taken##2##3##(1994-9#1)(2010-9#1)
who have the clinical##2##4##(1992-3#1)(2010-10#1)
who have the##9##3##(1992-3#1)(1996-2#1)(1997-3#1)(2007-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
who have undergone##10##3##(1990-9#1)(1996-3#1)(2008-7#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
who have##189##2##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#4)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#3)(2008-1#5)(2008-10#4)(2008-11#8)(2008-12#7)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#3)(2009-5#12)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#4)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#9)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#10)(2013-8#4)
who heads##2##2##(1992-8#1)(1997-2#1)
who identify with the##2##4##(2010-3#1)(2010-8#1)
who identify##3##2##(2008-11#1)(2010-3#1)(2010-8#1)
who implement##2##2##(1993-2#1)(1994-2#1)
who in turn##2##3##(1992-1#1)(1996-3#1)
who in##7##2##(1992-1#1)(1996-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)
who initially##2##2##(1996-6#1)(2011-2#1)
who inject drugs##3##3##(2013-1#3)
who intend to##3##3##(2008-2#1)(2010-12#1)(2011-2#1)
who is also##2##3##(1992-12#1)(2010-9#1)
who is at##3##3##(1994-2#1)(1997-1#1)(2011-2#1)
who is likely to##2##4##(1990-8#1)(2007-10#1)
who is the##2##3##(1995-3#1)(2008-1#1)
who is##38##2##(1990-11#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
who kept##3##2##(1995-8#3)
who knew their##2##3##(1990-6#1)(2012-3#1)
who lack a##2##3##(1994-3#1)(2008-10#1)
who lack##4##2##(1994-3#1)(2007-10#1)(2007-12#1)(2008-10#1)
who lacked##2##2##(2008-1#1)(2008-9#1)
who later##4##2##(1990-8#1)(1991-12#1)(1994-2#1)(2007-10#1)
who leave##2##2##(1992-3#1)(1996-1#1)
who live in##3##3##(1996-12#1)(2007-2#1)(2008-7#1)
who live##5##2##(1992-1#1)(1996-12#1)(2007-2#1)(2008-7#1)(2013-1#1)
who lived##4##2##(1992-3#1)(1992-6#1)(2007-11#1)(2008-12#1)
who lose##2##2##(1995-6#1)(2010-9#1)
who lost##4##2##(1994-2#1)(1995-12#1)(2013-1#2)
who made##4##2##(1992-1#1)(2007-5#1)(2009-10#1)(2011-2#1)
who make##2##2##(1996-2#1)(1997-3#1)
who may be##5##3##(1996-12#1)(2008-11#2)(2008-7#1)(2013-1#1)
who may not have##2##4##(1993-12#1)(2008-6#1)
who may not##3##3##(1993-12#1)(2008-6#1)(2012-12#1)
who may##20##2##(1991-4#1)(1992-3#2)(1993-12#1)(1995-12#1)(1996-12#1)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
who meets##2##2##(2011-2#1)(2012-12#1)
who met DSM-IV criteria for##2##5##(2008-6#1)(2012-3#1)
who met the inclusion criteria were##2##6##(2010-6#1)(2012-3#1)
who met the inclusion criteria##3##5##(2010-6#2)(2012-3#1)
who met the##9##3##(2007-10#1)(2007-12#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
who met##13##2##(2007-10#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
who might benefit##2##3##(2008-12#1)(2008-8#1)
who might##4##2##(1991-3#1)(2008-12#1)(2008-8#1)(2010-3#1)
who move##2##2##(1996-1#1)(1997-1#1)
who must##4##2##(1992-6#1)(1994-1#1)(1995-12#1)(2008-9#1)
who need##9##2##(1991-3#1)(1992-10#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-12#1)(2008-3#1)(2010-3#1)(2011-2#1)
who needs##3##2##(1996-1#1)(2008-4#1)(2008-9#1)
who never had##2##3##(1990-8#1)(2009-12#1)
who never##7##2##(1990-8#1)(1996-1#1)(1997-3#1)(2009-12#1)(2009-5#2)(2013-8#1)
who often##2##2##(1992-8#1)(2007-11#1)
who only##2##2##(1996-12#1)(2011-2#1)
who opt for##2##3##(2008-10#1)(2013-1#1)
who originate from##2##3##(1993-6#1)(2011-2#1)
who participate in##4##3##(1996-9#1)(2007-10#1)(2008-11#2)
who participated in a##3##4##(2009-11#1)(2012-12#1)(2012-3#1)
who participated in focus groups##2##5##(2008-6#1)(2011-1#1)
who participated in the study##2##5##(1996-1#1)(2010-3#1)
who participated in the##5##4##(1992-11#1)(1994-6#1)(1996-1#1)(2010-3#1)(2011-2#1)
who participated in##18##3##(1992-11#1)(1994-6#1)(1995-6#1)(1996-1#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
who participated##19##2##(1992-11#1)(1994-6#1)(1995-6#1)(1996-1#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
who participates in the##2##4##(1995-5#1)(1997-3#1)
who participates##3##2##(1995-1#1)(1995-5#1)(1997-3#1)
who pay##2##2##(1992-3#1)(1996-3#1)
who perceive##2##2##(1996-6#1)(2007-12#1)
who perceived the##2##3##(2009-5#1)(2010-11#1)
who perceived##5##2##(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2013-1#1)
who performed##3##2##(2008-8#1)(2011-1#1)(2012-3#1)
who planned to##2##3##(2007-2#2)
who present to##3##3##(2007-5#1)(2008-3#1)(2009-6#1)
who present with##15##3##(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-3#1)(2009-7#1)(2011-1#2)(2011-2#2)(2013-8#1)
who present##22##2##(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
who presented at a##2##4##(2008-11#1)(2010-6#1)
who presented at the age of##2##6##(2007-7#2)
who presented at##6##3##(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
who presented to our##3##4##(2008-7#1)(2013-1#1)(2013-8#1)
who presented to the emergency department##2##6##(2007-10#1)(2007-5#1)
who presented to the##4##4##(2007-10#1)(2007-5#2)(2008-10#1)
who presented to##8##3##(2007-10#1)(2007-5#2)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
who presented with a painless swelling##2##6##(2007-7#1)(2011-2#1)
who presented with a painless##3##5##(2007-7#1)(2008-7#1)(2011-2#1)
who presented with a##22##4##(1991-12#1)(1992-10#1)(1996-6#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
who presented with acute##3##4##(2007-8#1)(2008-12#1)(2010-8#1)
who presented with an##6##4##(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
who presented with bilateral##3##4##(2008-7#1)(2010-5#1)(2013-8#1)
who presented with complaints of##2##5##(2007-7#1)(2013-7#1)
who presented with features of##2##5##(2009-5#1)(2010-4#1)
who presented with features##3##4##(2009-5#1)(2010-4#1)(2012-3#1)
who presented with headache##2##4##(2008-12#1)(2012-12#1)
who presented with severe##3##4##(2007-10#1)(2010-5#1)(2011-2#1)
who presented with subarachnoid haemorrhage##2##5##(2008-7#2)
who presented with sudden##2##4##(2007-10#1)(2008-7#1)
who presented with##105##3##(1991-12#1)(1992-10#1)(1992-12#1)(1994-12#2)(1996-6#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#5)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#4)
who presented##137##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-4#1)(1994-12#2)(1996-6#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-10#3)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#5)(2010-6#4)(2010-8#1)(2011-1#6)(2011-2#11)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#16)(2013-7#3)(2013-8#5)
who presents with a##2##4##(1997-3#1)(2007-12#1)
who presents with##7##3##(1997-3#1)(2006-5#4)(2007-12#1)(2010-6#1)
who presents##10##2##(1997-3#1)(2006-5#6)(2007-12#1)(2008-3#1)(2010-6#1)
who produce##2##2##(1996-11#1)(2012-3#1)
who promoted the##2##3##(2011-2#1)(2012-3#1)
who provide care##2##3##(1991-2#1)(2008-9#1)
who provide##9##2##(1991-2#1)(1993-12#1)(1995-3#1)(2007-2#2)(2008-11#1)(2008-9#2)(2009-11#1)
who provided##5##2##(1996-5#1)(1997-3#1)(2008-11#1)(2010-3#1)(2012-12#1)
who provides##2##2##(1994-1#1)(1997-3#1)
who quit smoking##2##3##(2008-11#1)(2013-1#1)
who quit##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
who rarely##2##2##(1993-6#1)(2007-7#1)
who reached##2##2##(1993-9#1)(2008-6#1)
who receive the##2##3##(1994-6#1)(1997-8#1)
who receive##14##2##(1994-5#1)(1994-6#2)(1996-12#1)(1997-6#1)(1997-8#2)(2008-4#1)(2008-6#1)(2009-11#1)(2010-4#2)(2012-2#1)(2013-8#1)
who received a##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
who received an##2##3##(2007-10#1)(2012-2#1)
who received and##2##3##(1993-10#1)(2007-7#1)
who received antegrade##2##3##(2007-9#2)
who received home##3##3##(1997-4#1)(2011-2#1)(2012-12#1)
who received no##2##3##(2011-1#1)(2013-1#1)
who received radiotherapy##2##3##(1992-12#1)(2008-6#1)
who received the##2##3##(2008-12#1)(2010-4#1)
who received##78##2##(1990-11#1)(1990-6#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-1#2)(1993-10#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#2)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#4)
who refused to##2##3##(1992-12#1)(1995-6#1)
who refused##3##2##(1992-12#1)(1995-12#1)(1995-6#1)
who relapsed##3##2##(1990-8#1)(1997-4#1)(2013-7#1)
who remained##2##2##(1990-9#1)(2008-10#1)
who report##4##2##(1996-6#1)(2007-12#1)(2013-1#1)(2013-8#1)
who reported being##2##3##(2009-4#1)(2009-5#1)
who reported high##2##3##(2008-11#1)(2008-7#1)
who reported##23##2##(1993-1#4)(1993-9#1)(1994-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
who represented##2##2##(1991-8#1)(2008-12#1)
who require##8##2##(1992-1#2)(1994-6#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-10#1)(2013-8#1)
who required##9##2##(1990-8#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-8#1)(1996-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
who requires##2##2##(2007-8#1)(2008-3#1)
who reside in##2##3##(1992-6#1)(2010-4#1)
who resided in##3##3##(2007-10#1)(2009-7#1)(2013-8#1)
who respond to##2##3##(1994-2#1)(2013-1#1)
who respond##3##2##(1993-11#1)(1994-2#1)(2013-1#1)
who responded to##2##3##(1992-8#1)(2006-12#1)
who responded##3##2##(1992-8#1)(2006-12#1)(2011-2#1)
who return##2##2##(1995-5#1)(2013-1#1)
who returned##4##2##(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
who said##3##2##(1995-6#1)(2008-10#1)(2009-4#1)
who score##2##2##(2009-7#1)(2011-2#1)
who scored at least 70 on the##2##7##(2008-1#2)
who scored##6##2##(2007-7#1)(2008-1#4)(2008-9#1)
who seek##4##2##(1993-2#1)(2008-3#1)(2009-5#1)(2012-2#1)
who seem to##2##3##(1990-3#1)(1995-1#1)
who self-reported##2##2##(2008-3#1)(2011-1#1)
who serve##2##2##(1994-2#2)
who served in##2##3##(2010-11#1)(2011-2#1)
who served##4##2##(1993-2#1)(2010-1#1)(2010-11#1)(2011-2#1)
who share##2##2##(2008-1#1)(2008-4#1)
who should be##3##3##(2008-2#1)(2008-4#1)(2012-3#1)
who should have a thorough understanding of how it works##3##10##(2008-4#2)(2008-9#1)
who should##10##2##(1993-12#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)
who showed##13##2##(1990-10#1)(1991-11#1)(1993-6#1)(1994-2#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#2)(2013-1#2)
who smoke##2##2##(1993-8#1)(2008-1#1)
who smoked (2##2##3##(2011-2#2)
who smoked##4##2##(2011-2#3)(2013-8#1)
who sought##2##2##(2007-7#1)(2009-9#1)
who spent more time in##2##5##(2009-7#2)
who spoke##2##2##(2008-10#1)(2009-8#1)
who started sexual activity##2##4##(2013-8#2)
who started##4##2##(2011-2#2)(2013-8#2)
who stayed in##2##3##(2007-1#1)(2012-3#1)
who stayed##3##2##(2007-1#1)(2012-3#1)(2013-1#1)
who stutter have##2##3##(2008-2#2)
who stutter##10##2##(2008-2#8)(2012-12#2)
who subsequently##4##2##(1994-3#1)(1996-8#1)(2006-10#1)(2010-6#1)
who suffer from chronic##2##4##(2008-11#1)(2012-2#1)
who suffer from##6##3##(1990-5#1)(2007-10#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
who suffer##12##2##(1990-5#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
who suffered a##3##3##(1990-9#1)(1996-3#1)(2007-10#1)
who suffered an##2##3##(1991-3#1)(2013-8#1)
who suffered from##8##3##(1993-9#1)(2007-10#3)(2008-7#2)(2011-2#1)(2013-1#1)
who suffered##21##2##(1990-9#1)(1991-3#1)(1993-9#1)(1996-3#1)(1997-3#1)(2007-10#5)(2007-11#1)(2007-8#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
who supported##2##2##(2008-11#2)
who survive##2##2##(2007-10#1)(2012-3#1)
who survived for##2##3##(2009-2#1)(2011-2#1)
who survived##6##2##(1992-6#1)(1995-2#1)(2008-11#1)(2009-2#1)(2011-2#1)(2011-3#1)
who sustained a##6##3##(2007-10#1)(2008-7#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
who sustained an##2##3##(2012-2#1)(2013-1#1)
who sustained##12##2##(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
who take part in##2##4##(1992-3#1)(2008-11#1)
who take##7##2##(1990-5#1)(1992-3#1)(1995-1#2)(1995-9#1)(1996-2#1)(2008-11#1)
who then##3##2##(1993-6#1)(2007-8#1)(2013-1#1)
who thought##2##2##(2007-11#1)(2008-10#1)
who took part in##2##4##(1995-6#1)(2012-12#1)
who took##9##2##(1995-6#1)(1996-6#1)(1996-7#2)(2007-7#1)(2008-3#2)(2010-1#1)(2012-12#1)
who treat##2##2##(1997-8#1)(2007-12#1)
who typically##3##2##(2008-11#1)(2008-9#1)(2012-1#1)
who undergo##8##2##(1993-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
who underwent PD+HD therapy##2##4##(2011-2#2)
who underwent a##9##3##(2007-10#2)(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
who underwent an endoscopic##2##4##(2011-2#2)
who underwent an##3##3##(2007-8#1)(2011-2#2)
who underwent atrial##2##3##(2008-11#1)(2012-2#1)
who underwent biopsy##3##3##(2010-11#1)(2012-3#1)(2013-7#1)
who underwent cardiac##2##3##(2008-11#1)(2012-3#1)
who underwent radical##2##3##(1994-7#1)(1997-7#1)
who underwent resection of##2##4##(2007-11#1)(2012-12#1)
who underwent surgery after##2##4##(2008-7#1)(2013-1#1)
who underwent surgery##10##3##(2007-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
who underwent surgical treatment##2##4##(1993-6#1)(2011-2#1)
who underwent surgical##5##3##(1993-6#1)(1996-3#1)(2007-8#1)(2011-2#1)(2012-3#1)
who underwent the##2##3##(2011-2#1)(2012-12#1)
who underwent thoracic##2##3##(2007-8#1)(2008-6#1)
who underwent total##7##3##(2007-11#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)
who underwent##147##2##(1990-8#1)(1991-1#2)(1991-11#1)(1991-6#2)(1991-8#1)(1992-3#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-7#1)(1996-3#2)(1996-9#2)(1997-7#1)(2007-10#4)(2007-11#9)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-3#2)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#27)(2012-12#6)(2012-2#5)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#2)
who until##2##2##(2008-2#2)
who use the##2##3##(1996-3#1)(2008-9#1)
who use##15##2##(1991-5#1)(1992-9#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-3#1)
who used a##2##3##(2008-11#1)(2013-1#1)
who used the##3##3##(1994-5#2)(2009-7#1)
who used##19##2##(1994-5#2)(1995-1#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-11#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
who uses##5##2##(1992-12#1)(1994-6#1)(1995-3#1)(2008-9#1)(2010-12#1)
who utilized##3##2##(1996-2#2)(2012-3#1)
who view##2##2##(1996-3#1)(2009-12#1)
who viewed their##2##3##(2009-5#1)(2009-7#1)
who visited##3##2##(1994-2#1)(2010-8#1)(2012-3#1)
who volunteer##3##2##(1991-12#1)(1993-2#1)(1994-2#1)
who want to take##2##4##(1992-9#1)(1993-12#1)
who want to##10##3##(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
who was a##3##3##(1990-3#1)(2009-7#1)(2013-8#1)
who was admitted with##3##4##(1997-5#1)(2011-2#1)(2013-1#1)
who was admitted##5##3##(1997-5#1)(2011-2#3)(2013-1#1)
who was awarded the##2##4##(2008-7#1)(2010-7#1)
who was diagnosed as##2##4##(2007-7#1)(2008-11#1)
who was diagnosed later##2##4##(2008-7#1)(2011-1#1)
who was diagnosed with##2##4##(1994-1#1)(2012-2#1)
who was diagnosed##8##3##(1994-1#1)(2007-7#2)(2008-11#1)(2008-7#1)(2011-1#2)(2012-2#1)
who was found to have##3##5##(2008-1#1)(2008-12#1)(2008-7#1)
who was found##4##3##(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)
who was initially diagnosed##2##4##(2008-7#1)(2012-3#1)
who was not##2##3##(1995-3#1)(2008-11#1)
who was on##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
who was recently##2##3##(2008-10#1)(2008-7#1)
who was referred##3##3##(2008-12#2)(2011-2#1)
who was successfully treated with##2##5##(2011-2#2)
who was successfully treated##3##4##(2011-2#2)(2013-1#1)
who was treated for##2##4##(2009-5#1)(2010-3#1)
who was treated with##2##4##(1997-8#1)(2009-9#1)
who was treated##9##3##(1997-8#1)(2007-8#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
who was##84##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-11#1)(1991-3#2)(1991-7#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#5)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-6#1)(2008-7#6)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#10)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
who watch##2##2##(1995-2#1)(2009-7#1)
who went home##2##3##(1995-3#2)
who went##3##2##(1991-6#1)(1995-3#2)
who were admitted in our##2##5##(2011-2#1)(2013-1#1)
who were admitted in##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
who were admitted to the##2##5##(1995-11#1)(2007-2#1)
who were admitted to##6##4##(1995-11#1)(2007-2#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
who were admitted##12##3##(1995-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
who were at##3##3##(1991-11#1)(2008-11#1)(2008-12#1)
who were born##3##3##(1994-1#1)(2011-1#1)(2012-12#1)
who were confirmed to have##2##5##(2011-2#1)(2013-1#1)
who were diagnosed as having##2##5##(1996-6#1)(2006-10#1)
who were diagnosed with##3##4##(1994-2#1)(2008-6#1)(2012-3#1)
who were diagnosed##5##3##(1994-2#1)(1996-6#1)(2006-10#1)(2008-6#1)(2012-3#1)
who were discharged##4##3##(1992-11#1)(2007-10#1)(2008-7#1)(2012-12#1)
who were either##3##3##(2007-10#1)(2008-6#1)(2013-8#1)
who were eligible for##2##4##(2007-10#1)(2012-3#1)
who were eligible##3##3##(1990-6#1)(2007-10#1)(2012-3#1)
who were employed##2##3##(1993-3#1)(1994-2#1)
who were enrolled in##6##4##(2008-7#1)(2009-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
who were enrolled##7##3##(2008-7#1)(2009-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
who were examined##4##3##(1991-3#1)(1993-3#2)(1996-6#1)
who were experiencing##2##3##(2008-7#1)(2011-2#1)
who were exposed to##3##4##(2009-12#1)(2009-7#1)(2012-12#1)
who were free of##2##4##(2008-10#1)(2008-3#1)
who were given##4##3##(1997-8#1)(2007-12#1)(2008-5#1)(2012-2#1)
who were identified##2##3##(1990-6#1)(2008-12#1)
who were in##3##3##(1991-12#1)(1996-7#1)(2010-11#1)
who were included in the##2##5##(2007-7#1)(2008-12#1)
who were interviewed##3##3##(2008-11#1)(2009-6#1)(2013-8#1)
who were involved in##3##4##(1995-1#1)(2008-11#1)(2010-11#1)
who were married##3##3##(1994-6#1)(2007-12#1)(2013-1#1)
who were more##3##3##(1994-1#1)(2007-12#1)(2008-12#1)
who were newly##2##3##(1995-2#1)(2008-3#1)
who were not##13##3##(1992-2#1)(1992-3#1)(1993-8#1)(1996-3#1)(2007-2#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
who were observed##2##3##(2008-7#1)(2012-12#1)
who were on##2##3##(2007-7#1)(2008-8#1)
who were operated##4##3##(1996-9#1)(2007-11#1)(2008-1#1)(2013-8#1)
who were questioned##2##3##(1996-8#1)(2012-12#1)
who were randomly##2##3##(2010-3#1)(2013-8#1)
who were receiving##2##3##(1993-10#1)(2012-3#1)
who were registered##2##3##(1990-10#1)(1993-1#1)
who were scheduled for##2##4##(1993-1#1)(1996-3#1)
who were sexually##2##3##(1996-11#1)(2013-1#1)
who were smokers##2##3##(2008-4#1)(2011-2#1)
who were symptomatic at baseline##2##5##(2012-2#1)(2012-3#1)
who were symptomatic##3##3##(2008-1#1)(2012-2#1)(2012-3#1)
who were then##2##3##(1996-3#1)(2008-9#1)
who were treated between##2##4##(2008-10#1)(2012-3#1)
who were treated by##4##4##(1995-11#1)(1996-11#1)(2007-11#1)(2008-7#1)
who were treated for##3##4##(2008-11#1)(2008-4#1)(2009-3#1)
who were treated in our department##2##6##(2008-1#1)(2012-2#1)
who were treated in##3##4##(2008-1#1)(2011-2#1)(2012-2#1)
who were treated with##10##4##(1990-3#1)(1991-12#1)(1995-11#2)(2007-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
who were treated##23##3##(1990-3#1)(1991-12#1)(1995-11#3)(1996-11#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
who were unable to##2##4##(2011-2#1)(2013-1#1)
who were undergoing##5##3##(1994-12#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-8#1)
who were younger than##2##4##(1991-2#1)(2007-10#1)
who were younger##3##3##(1991-2#1)(2007-10#1)(2012-2#1)
who were##271##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#1)(1993-1#3)(1993-10#1)(1993-12#1)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#3)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#1)(1996-11#2)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#4)(2007-2#6)(2007-4#1)(2007-7#4)(2007-8#4)(2008-1#9)(2008-10#6)(2008-11#8)(2008-12#7)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#6)(2008-9#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#17)(2012-1#1)(2012-12#12)(2012-2#8)(2012-3#12)(2012-5#1)(2013-1#13)(2013-8#9)
who will develop##2##3##(1993-11#1)(2008-3#1)
who will not##2##3##(1994-5#1)(2010-3#1)
who will perform##2##3##(1990-6#1)(1993-3#1)
who will take##2##3##(1995-12#1)(2008-12#1)
who will work##2##3##(1994-1#1)(1995-6#1)
who will##30##2##(1990-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-1#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
who wish to use##3##4##(1991-5#1)(2008-12#1)(2010-5#1)
who wish to##14##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1996-5#1)(2007-12#1)(2008-12#3)(2009-5#1)(2010-5#1)(2011-2#1)
who work in##6##3##(1990-3#1)(1991-2#1)(1994-12#1)(1996-12#1)(2009-5#1)(2013-1#1)
who work with older people##2##5##(2010-10#2)
who work with older##3##4##(1991-12#1)(2010-10#2)
who work with##6##3##(1991-12#1)(1996-1#1)(2007-12#1)(2008-11#1)(2010-10#2)
who work within##2##3##(2008-1#1)(2010-10#1)
who work##17##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-10#3)(2011-2#1)(2013-1#2)
who worked in##3##3##(1993-1#2)(1997-5#1)
who worked##6##2##(1993-1#2)(1997-3#1)(1997-5#1)(2008-11#1)(2013-1#1)
who would be##3##3##(1994-3#1)(2010-3#1)(2012-12#1)
who would benefit from##2##4##(2007-12#1)(2010-9#1)
who would benefit##3##3##(2007-12#1)(2010-4#1)(2010-9#1)
who would##17##2##(1994-3#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-1#4)(2008-11#1)(2008-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
who##2945##1##(1990-10#6)(1990-11#8)(1990-12#3)(1990-2#4)(1990-3#11)(1990-5#5)(1990-6#11)(1990-8#9)(1990-9#10)(1991-1#3)(1991-11#9)(1991-12#18)(1991-2#12)(1991-3#15)(1991-4#4)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#11)(1991-9#2)(1992-1#15)(1992-10#7)(1992-11#5)(1992-12#10)(1992-2#13)(1992-3#30)(1992-4#2)(1992-5#4)(1992-6#11)(1992-8#3)(1992-9#5)(1993-1#20)(1993-10#4)(1993-11#6)(1993-12#14)(1993-2#18)(1993-3#27)(1993-6#11)(1993-8#5)(1993-9#9)(1994-1#17)(1994-11#2)(1994-12#19)(1994-2#30)(1994-3#17)(1994-5#6)(1994-6#13)(1994-7#4)(1994-9#6)(1995-1#20)(1995-11#10)(1995-12#22)(1995-2#14)(1995-3#12)(1995-4#2)(1995-5#5)(1995-6#15)(1995-8#5)(1995-9#3)(1996-1#17)(1996-11#8)(1996-12#7)(1996-2#15)(1996-3#16)(1996-5#17)(1996-6#14)(1996-7#5)(1996-8#6)(1996-9#12)(1997-1#8)(1997-2#16)(1997-3#23)(1997-4#12)(1997-5#13)(1997-6#8)(1997-7#7)(1997-8#11)(2006-10#20)(2006-12#2)(2006-5#7)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#56)(2007-11#25)(2007-12#35)(2007-2#25)(2007-4#3)(2007-5#8)(2007-6#4)(2007-7#53)(2007-8#48)(2007-9#4)(2008-1#76)(2008-10#68)(2008-11#131)(2008-12#71)(2008-2#27)(2008-3#38)(2008-4#31)(2008-5#42)(2008-6#43)(2008-7#119)(2008-8#37)(2008-9#48)(2009-1#2)(2009-10#12)(2009-11#9)(2009-12#7)(2009-2#3)(2009-3#12)(2009-4#13)(2009-5#37)(2009-6#11)(2009-7#26)(2009-8#9)(2009-9#10)(2010-1#12)(2010-10#22)(2010-11#16)(2010-12#17)(2010-2#4)(2010-3#25)(2010-4#12)(2010-5#21)(2010-6#15)(2010-7#9)(2010-8#11)(2010-9#8)(2011-1#72)(2011-10#1)(2011-2#180)(2011-3#3)(2012-1#15)(2012-12#80)(2012-2#69)(2012-3#85)(2012-5#1)(2013-1#188)(2013-7#10)(2013-8#85)
who?##2##1##(1993-1#1)(2008-12#1)
whole analysis##3##2##(2008-10#3)
whole and##10##2##(1993-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2013-8#1)
whole animal##5##2##(1991-9#1)(2008-11#1)(2008-7#3)
whole bacterial cells##2##3##(2008-10#1)(2008-7#1)
whole blood and##4##3##(2006-6#2)(2008-10#1)(2013-1#1)
whole blood by##4##3##(2008-10#3)(2008-2#1)
whole blood donation##3##3##(2007-9#3)
whole blood from##3##3##(1996-2#1)(2008-10#2)
whole blood method##2##3##(1991-2#1)(2008-4#1)
whole blood or##2##3##(2012-2#1)(2013-8#1)
whole blood samples##5##3##(2008-10#4)(2008-3#1)
whole blood using##2##3##(2008-10#2)
whole blood was##3##3##(2007-9#2)(2008-10#1)
whole blood water##4##3##(1993-2#4)
whole blood were##2##3##(2008-10#2)
whole blood##88##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#2)(1993-2#6)(1996-12#3)(1996-2#3)(1996-5#1)(1997-6#1)(2006-6#4)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#5)(2008-10#28)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-9#3)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#1)
whole body autoradiography##2##3##(1994-5#1)(2008-10#1)
whole body dose##2##3##(2008-7#2)
whole body glucose##2##3##(2008-1#2)
whole body sweat rate##3##4##(2008-5#3)
whole body##28##2##(1992-3#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-11#2)(2008-1#2)(2008-10#6)(2008-5#4)(2008-7#6)(2012-12#1)(2012-2#1)(2012-3#1)
whole brain##7##2##(1990-12#1)(1991-12#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-7#1)
whole breast irradiation##2##3##(2011-2#1)(2013-1#1)
whole breast##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
whole cell extracts##2##3##(1994-8#1)(2008-9#1)
whole cell##16##2##(1990-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-5#1)(2011-3#1)(2012-2#1)
whole cells and##2##3##(1995-12#1)(2008-1#1)
whole cells##10##2##(1995-12#2)(1995-3#1)(2008-1#2)(2008-10#1)(2008-9#1)(2010-7#1)(2013-1#2)
whole chromosome painting##2##3##(2009-2#1)(2012-3#1)
whole chromosome##3##2##(2007-11#1)(2009-2#1)(2012-3#1)
whole chromosomes or##2##3##(1994-12#1)(2012-3#1)
whole concentration##2##2##(2008-10#2)
whole egg and##2##3##(2011-2#2)
whole embryo culture##4##3##(1993-12#2)(1995-3#2)
whole experimental##2##2##(2008-11#1)(2008-3#1)
whole genome analysis##3##3##(2008-4#1)(2009-10#1)(2012-3#1)
whole genome of##2##3##(2010-3#1)(2011-1#1)
whole genome sequences##2##3##(2008-10#1)(2008-4#1)
whole genome sequencing##3##3##(2009-9#1)(2010-5#1)(2012-3#1)
whole genome##25##2##(1997-5#1)(2008-10#2)(2008-4#2)(2008-7#7)(2008-8#1)(2009-10#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#2)
whole genomic sequence##2##3##(2008-10#1)(2010-7#1)
whole grain##5##2##(2010-1#4)(2012-12#1)
whole grains##15##2##(2010-1#7)(2012-1#1)(2012-12#6)(2012-2#1)
whole hand prehension##2##3##(1996-2#2)
whole in##2##2##(2008-10#1)(2012-3#1)
whole intact E##2##3##(2008-10#2)
whole intact##3##2##(2008-10#3)
whole is##3##2##(1992-3#1)(2007-10#1)(2009-10#1)
whole kidney##2##2##(2008-10#1)(2008-12#1)
whole larvae##2##2##(2008-7#1)(2008-8#1)
whole lung lavage##3##3##(2010-7#2)(2012-2#1)
whole method was##2##3##(2008-10#2)
whole method##4##2##(2008-10#3)(2008-11#1)
whole milk##5##2##(2008-10#2)(2011-1#1)(2012-2#2)
whole milk)##2##2##(2008-10#2)
whole mount##6##2##(1996-5#2)(1997-7#1)(2008-5#1)(2008-8#1)(2008-9#1)
whole mounts##3##2##(1992-8#1)(2007-12#1)(2008-9#1)
whole new##4##2##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
whole or##2##2##(2008-5#1)(2008-6#1)
whole organism##4##2##(2008-12#1)(2008-2#1)(2008-7#1)(2010-9#1)
whole peripheral blood##2##3##(2008-4#1)(2008-9#1)
whole plane##2##2##(2008-2#1)(2008-3#1)
whole plant##6##2##(2008-10#6)
whole plants of##2##3##(2007-1#1)(2008-10#1)
whole plants##9##2##(2007-1#1)(2008-10#8)
whole plasma##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
whole procedure were##2##3##(2008-10#2)
whole procedure##9##2##(1996-11#1)(2008-10#6)(2008-11#1)(2011-2#1)
whole process##10##2##(1995-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
whole range of##4##3##(2007-12#2)(2008-5#1)(2013-8#1)
whole rat##2##2##(1991-3#1)(1995-12#1)
whole serum and the non-protein fraction of serum##2##8##(2008-7#2)
whole set of##4##3##(2008-10#3)(2008-3#1)
whole set##5##2##(2008-10#3)(2008-3#1)(2010-2#1)
whole skull##2##2##(2008-11#2)
whole system##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
whole there##2##2##(2008-10#1)(2008-8#1)
whole thin##2##2##(1995-6#1)(2008-12#1)
whole tissue homogenates##2##3##(1995-12#1)(2008-4#1)
whole tissue##6##2##(1995-12#1)(1997-4#1)(2008-11#1)(2008-4#1)(2010-9#2)
whole transcriptome##2##2##(2009-12#2)
whole virus##3##2##(2007-11#2)(2008-5#1)
whole##704##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-2#2)(1992-3#2)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#6)(1993-2#9)(1993-3#2)(1993-8#3)(1993-9#2)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#8)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#9)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2006-6#4)(2007-1#1)(2007-10#4)(2007-11#17)(2007-12#12)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#10)(2008-10#145)(2008-11#20)(2008-12#8)(2008-2#16)(2008-3#25)(2008-4#21)(2008-5#19)(2008-6#3)(2008-7#28)(2008-8#16)(2008-9#16)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#1)(2009-4#5)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#12)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#6)(2010-7#6)(2010-8#12)(2010-9#4)(2011-1#8)(2011-2#19)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#14)(2012-2#13)(2012-3#8)(2012-9#1)(2013-1#16)(2013-8#10)
whole-blood##7##1##(1991-11#1)(2008-9#6)
whole-body concentrations of 11-ketotestosterone##2##4##(2010-8#2)
whole-body extracts##2##2##(2013-8#2)
whole-body irradiation##2##2##(1991-5#1)(2008-6#1)
whole-body vibration##2##2##(2013-8#2)
whole-body##20##1##(1991-5#1)(1992-3#2)(1995-5#1)(1996-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#2)(2012-2#1)(2013-8#8)
whole-brain irradiation##3##2##(1997-4#3)
whole-brain##5##1##(1997-3#1)(1997-4#3)(2013-1#1)
whole-cell and##2##2##(1995-2#1)(2011-3#1)
whole-cell biocatalysis##2##2##(2011-1#1)(2012-2#1)
whole-cell biocatalysts##2##2##(2011-1#1)(2013-1#1)
whole-cell configuration##3##2##(1993-12#1)(1993-3#1)(1995-5#1)
whole-cell currents##3##2##(1993-3#1)(2008-8#2)
whole-cell lysates##3##2##(1997-3#1)(2008-4#2)
whole-cell patch clamp##4##3##(1990-7#1)(1996-5#1)(2009-12#1)(2011-2#1)
whole-cell patch-clamp##3##2##(1995-12#1)(2008-8#2)
whole-cell recording##3##2##(1995-12#1)(2008-8#2)
whole-cell recordings##5##2##(1991-9#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
whole-cell voltage-clamp##3##2##(1997-2#1)(2008-8#1)(2009-12#1)
whole-cell##54##1##(1990-7#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-12#1)(1993-3#2)(1994-11#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-8#9)(2009-12#2)(2011-1#4)(2011-2#1)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#1)
whole-field##8##1##(2007-11#2)(2007-12#3)(2008-3#2)(2008-8#1)
whole-genome amplification##2##2##(2008-4#1)(2012-2#1)
whole-genome sequences##2##2##(2008-4#1)(2008-7#1)
whole-genome##15##1##(2008-4#3)(2008-7#7)(2010-10#1)(2010-3#1)(2012-2#2)(2012-3#1)
whole-head##2##1##(1994-3#1)(1996-5#1)
whole-leaf##2##1##(2008-10#2)
whole-lung##2##1##(1994-2#1)(2007-8#1)
whole-mount##4##1##(2008-4#1)(2008-8#2)(2010-11#1)
whole-organism##6##1##(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)
whole-plant##7##1##(2008-10#6)(2009-8#1)
wholesale##3##1##(2008-12#2)(2013-8#1)
wholesome diet##2##2##(2010-6#2)
wholesome##3##1##(2007-11#1)(2010-6#2)
wholly or partially##2##3##(1994-8#1)(2007-8#1)
wholly or##3##2##(1994-8#1)(2007-8#1)(2008-11#1)
wholly##13##1##(1990-6#1)(1994-8#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-8#1)
whom 37##2##2##(2008-11#1)(2010-4#1)
whom a##10##2##(1990-3#1)(1991-2#1)(1993-2#1)(1995-5#1)(1996-1#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-3#1)(2013-1#1)
whom an##4##2##(1990-12#1)(1991-8#1)(1997-6#1)(2013-1#1)
whom it was##2##3##(1990-3#1)(2012-3#1)
whom it##8##2##(1990-3#1)(1991-11#1)(2008-1#2)(2008-7#1)(2010-7#1)(2012-3#2)
whom no##5##2##(1990-2#1)(1992-3#1)(2007-8#1)(2010-6#1)(2013-8#1)
whom the##27##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-3#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#2)
whom they##3##2##(1995-1#1)(2010-4#1)(2011-2#1)
whom##237##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#7)(1991-12#1)(1991-2#4)(1991-3#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-2#4)(1992-3#4)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#3)(1995-6#3)(1996-1#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#10)(2008-10#6)(2008-11#8)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#1)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#2)
whom?##3##1##(1991-1#1)(1991-12#1)(1992-12#1)
whom?]##2##1##(1992-4#1)(1992-5#1)
whooping cough##5##2##(1995-5#1)(1997-8#2)(2008-8#2)
whorl##4##1##(2008-10#1)(2011-2#3)
whorls and##2##2##(2006-12#1)(2010-12#1)
whorls##4##1##(2006-12#1)(2008-7#2)(2010-12#1)
whose IM fields were treated with Co60##2##7##(2007-10#2)
whose absence##2##2##(1992-5#1)(2011-2#1)
whose actions##2##2##(1991-6#1)(1992-2#1)
whose activity can be##2##4##(2007-11#1)(2008-10#1)
whose activity is regulated by##2##5##(1990-8#1)(2009-8#1)
whose activity is##5##3##(1990-8#1)(1991-3#1)(2008-11#1)(2009-8#1)(2012-12#1)
whose activity##13##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1995-5#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2012-12#1)
whose amino acid##2##3##(1993-11#1)(2008-6#1)
whose amplitude##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
whose arteries##2##2##(1990-3#2)
whose average##2##2##(2008-11#1)(2008-4#1)
whose back electrochemical reduction was detected on##2##7##(2008-10#2)
whose binding##4##2##(1991-5#1)(1995-5#1)(2008-10#1)(2010-11#1)
whose cellular##2##2##(2011-1#1)(2011-2#1)
whose central##2##2##(1994-1#1)(2007-11#1)
whose cerebellar##3##2##(1994-2#1)(2011-2#2)
whose characteristics##2##2##(2008-10#1)(2008-4#1)
whose children##3##2##(1991-3#1)(2008-9#1)(2009-6#1)
whose clinical##2##2##(1990-9#1)(2007-10#1)
whose condition##2##2##(2012-12#2)
whose deduced##2##2##(1995-6#2)
whose dimensions are comparable##2##4##(2008-10#1)(2008-3#1)
whose disease##2##2##(1990-8#1)(2012-12#1)
whose donors were mismatched for##2##5##(1990-11#2)
whose electrochemical reduction back to##2##5##(2008-10#2)
whose epitope##2##2##(1997-7#1)(2006-6#1)
whose expression is##4##3##(1994-2#1)(1995-11#1)(2008-10#1)(2009-4#1)
whose expression was##4##3##(1993-6#1)(1994-12#1)(2008-10#1)(2008-8#1)
whose expression##15##2##(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(2008-10#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
whose father##2##2##(2007-10#1)(2012-12#1)
whose formation##4##2##(1992-4#1)(1996-2#1)(1996-5#1)(2008-7#1)
whose frequencies##2##2##(2007-12#1)(2008-10#1)
whose function is##2##3##(2008-8#1)(2009-8#1)
whose function##4##2##(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
whose functions##2##2##(1994-12#1)(1996-12#1)
whose genome##4##2##(2008-4#1)(2008-7#2)(2011-10#1)
whose growth##3##2##(2008-8#1)(2009-9#1)(2012-3#1)
whose high##2##2##(2008-11#1)(2008-9#1)
whose individual##2##2##(2008-10#1)(2008-8#1)
whose intensity##3##2##(2007-11#1)(2008-3#2)
whose last##3##2##(1994-5#1)(2008-9#2)
whose levels##5##2##(1991-12#1)(1992-11#1)(1996-5#1)(2008-10#1)(2008-11#1)
whose magnitude depends on the##2##5##(2008-3#2)
whose main##5##2##(1992-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
whose mandate is to##2##4##(1992-9#1)(1996-3#1)
whose mandate##3##2##(1991-3#1)(1992-9#1)(1996-3#1)
whose mean IFD##2##3##(1991-9#2)
whose mean age was##2##4##(2008-12#1)(2008-3#1)
whose mean##5##2##(1991-9#2)(1995-12#1)(2008-12#1)(2008-3#1)
whose members##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
whose molecular##3##2##(1992-8#1)(2008-4#1)(2011-3#1)
whose mothers did not have pre-eclampsia##3##6##(2011-2#3)
whose mothers had pre-eclampsia were##2##5##(2011-2#2)
whose mothers were##3##3##(2009-5#2)(2011-2#1)
whose mothers##12##2##(2008-9#1)(2009-5#2)(2009-9#3)(2011-2#6)
whose normal function is##2##4##(1997-8#1)(2008-4#1)
whose only##4##2##(1991-12#1)(2006-12#1)(2007-10#1)(2008-2#1)
whose output##2##2##(2008-2#1)(2008-3#1)
whose parameters##2##2##(2008-11#1)(2008-5#1)
whose parents had##2##3##(2010-11#1)(2013-1#1)
whose parents were##5##3##(1994-6#3)(2008-11#1)(2013-8#1)
whose parents##13##2##(1991-2#1)(1994-6#3)(2008-11#1)(2008-12#1)(2010-11#3)(2011-2#2)(2013-1#1)(2013-8#1)
whose predicted response is##2##4##(2012-2#2)
whose predicted##4##2##(1994-12#2)(2012-2#2)
whose preparatory work was initiated on##3##6##(2010-12#3)
whose presence##3##2##(1993-8#1)(1994-2#1)(2009-5#1)
whose primary##4##2##(1995-1#1)(2008-3#1)(2008-5#1)(2011-2#1)
whose product##2##2##(1995-2#1)(1995-6#1)
whose products are##5##3##(1994-8#1)(1994-9#1)(2007-12#2)(2008-11#1)
whose properties##3##2##(2007-12#1)(2008-3#2)
whose refractive index is##2##4##(2008-3#2)
whose second##2##2##(2008-2#1)(2012-2#1)
whose sequence##2##2##(2007-6#1)(2008-8#1)
whose sequences##2##2##(1994-8#1)(1995-6#1)
whose significance##2##2##(2008-3#1)(2009-8#1)
whose size##2##2##(2007-11#1)(2008-3#1)
whose sizes##2##2##(2008-2#1)(2008-7#1)
whose source of skill acquisition was##2##6##(2011-1#2)
whose source of##3##3##(2007-12#1)(2011-1#2)
whose structure##3##2##(1997-7#1)(2008-3#1)(2008-7#1)
whose structures have##2##3##(2008-10#1)(2008-7#1)
whose symptoms##3##2##(1991-3#1)(2008-6#1)(2013-1#1)
whose tertiary structure##2##3##(1992-4#1)(2008-4#1)
whose thickness##2##2##(2006-4#1)(2008-5#1)
whose time has come##2##4##(1991-2#1)(1996-12#1)
whose transverse##2##2##(2007-12#1)(2008-2#1)
whose tumors##4##2##(1993-1#1)(2010-3#1)(2012-12#2)
whose values##3##2##(1990-7#1)(2008-7#1)(2009-4#1)
whose wavelength##2##2##(2007-12#1)(2008-2#1)
whose width##2##2##(2007-11#1)(2008-11#1)
whose##567##1##(1990-11#2)(1990-3#3)(1990-5#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-12#5)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#3)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#4)(1995-6#8)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#3)(1996-5#5)(1996-6#1)(1997-2#3)(1997-3#6)(1997-4#3)(1997-7#4)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#3)(2007-10#6)(2007-11#8)(2007-12#18)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#50)(2008-11#20)(2008-12#4)(2008-2#18)(2008-3#33)(2008-4#14)(2008-5#17)(2008-6#5)(2008-7#23)(2008-8#15)(2008-9#15)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#7)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-10#1)(2011-2#27)(2011-3#1)(2012-1#1)(2012-12#12)(2012-2#15)(2012-3#9)(2013-1#9)(2013-8#10)
why a##8##2##(1993-9#1)(1994-2#1)(1996-12#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-12#1)
why an##2##2##(1991-3#1)(2008-3#1)
why and##2##2##(2008-1#1)(2008-11#1)
why are they##2##3##(1996-12#1)(2012-12#1)
why are##5##2##(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2012-12#1)
why certain##5##2##(2008-10#2)(2011-2#2)(2013-8#1)
why classical##2##2##(2009-5#1)(2010-11#1)
why do##5##2##(1991-6#1)(1995-2#1)(1997-6#2)(2007-4#1)
why does##2##2##(1995-9#1)(2012-12#1)
why he##4##2##(1994-1#1)(1996-2#1)(2011-1#1)(2012-12#1)
why health##2##2##(1997-3#1)(2012-3#1)
why healthcare##3##2##(1991-9#1)(1992-12#1)(1996-12#1)
why it is important for##2##5##(2009-9#1)(2011-2#1)
why it is necessary to##2##5##(1991-1#1)(2011-1#1)
why it is##6##3##(1991-1#1)(1991-2#1)(1997-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
why no##2##2##(2008-10#1)(2012-2#1)
why our##2##2##(1996-3#1)(2010-2#1)
why people##4##2##(2009-6#2)(2012-12#1)(2013-8#1)
why some##4##2##(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#1)
why the two##2##3##(2008-7#1)(2008-9#1)
why the##33##2##(1991-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
why these##3##2##(2008-10#2)(2009-8#1)
why they work##2##3##(1996-3#1)(2010-12#1)
why they##9##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2013-1#1)
why this##3##2##(1995-8#1)(1996-3#1)(2013-8#1)
why we##4##2##(1997-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
why women with apocrine##2##4##(1993-1#1)(2008-4#1)
why women##4##2##(1993-1#1)(2007-4#2)(2008-4#1)
why##233##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-5#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-2#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#17)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#5)(2009-11#3)(2009-12#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#10)(2013-8#6)
wich##2##1##(2007-8#2)
wide QRS##3##2##(1991-3#1)(2009-10#1)(2012-3#1)
wide a##2##2##(2008-10#1)(2008-8#1)
wide acceptance##4##2##(2008-10#2)(2008-7#1)(2008-9#1)
wide and##6##2##(1991-12#1)(1996-12#1)(2007-5#1)(2008-10#2)(2008-8#1)
wide angle##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
wide application of##2##3##(1994-3#1)(2008-10#1)
wide application##3##2##(1994-3#1)(2008-10#2)
wide applications in##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
wide approach##2##2##(2007-8#1)(2010-11#1)
wide area of##2##3##(2008-10#1)(2008-3#1)
wide area##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
wide areas##3##2##(1990-6#1)(2008-2#1)(2013-1#1)
wide array of##10##3##(1997-2#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2013-1#1)
wide availability and##3##3##(2008-4#1)(2009-1#2)
wide availability##4##2##(2008-4#1)(2009-1#2)(2011-2#1)
wide bandwidth of the##2##4##(2007-12#1)(2008-3#1)
wide bandwidth##4##2##(2007-12#1)(2008-3#3)
wide clinical##2##2##(2009-5#1)(2012-3#1)
wide concentration range (1##9##4##(2008-10#9)
wide concentration range of##4##4##(2008-10#4)
wide concentration range##33##3##(1993-8#1)(2008-10#32)
wide concentration ranges##3##3##(2008-10#3)
wide concentration##36##2##(1993-8#1)(2008-10#35)
wide distribution of##2##3##(1994-11#1)(2008-5#1)
wide distribution##6##2##(1994-11#1)(1996-12#1)(2008-5#2)(2008-9#1)(2011-2#1)
wide diversity of##3##3##(2008-10#1)(2010-3#1)(2011-1#1)
wide dynamic range of##2##4##(2008-10#1)(2010-5#1)
wide dynamic range##9##3##(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2011-1#1)
wide dynamic##10##2##(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2010-7#1)(2011-1#1)
wide excision of breast##2##4##(1995-4#2)
wide excision of##4##3##(1992-2#2)(1995-4#2)
wide excision##6##2##(1992-2#2)(1995-4#2)(2007-11#1)(2010-11#1)
wide field of##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
wide field##4##2##(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
wide geographic##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
wide geographical scales##2##3##(2013-7#2)
wide geographical##4##2##(2008-10#1)(2012-5#1)(2013-7#2)
wide interindividual##2##2##(1993-12#1)(2008-12#1)
wide linear dynamic##2##3##(2008-10#2)
wide linear range and##3##4##(2008-10#3)
wide linear range from 0##2##5##(2008-10#1)(2013-1#1)
wide linear range from##3##4##(2008-10#2)(2013-1#1)
wide linear range##11##3##(2008-10#9)(2010-4#1)(2013-1#1)
wide linear response##2##3##(2008-10#1)(2013-1#1)
wide linear##16##2##(2008-10#13)(2010-4#1)(2013-1#2)
wide local excision##10##3##(1990-2#1)(1994-12#1)(2008-6#3)(2008-9#2)(2009-5#1)(2010-8#1)(2012-2#1)
wide neck##2##2##(1997-3#2)
wide or marginal resection##2##4##(2008-6#2)
wide or marginal##3##3##(2008-6#3)
wide or##4##2##(2008-11#1)(2008-6#3)
wide pH range of 3##2##5##(2008-10#2)
wide pH range of##5##4##(2008-10#4)(2010-2#1)
wide pH range##18##3##(1993-8#1)(2008-10#16)(2010-2#1)
wide pH##21##2##(1993-8#1)(2008-10#19)(2010-2#1)
wide parameter##2##2##(2007-12#1)(2012-2#1)
wide range from##2##3##(2007-11#1)(2008-10#1)
wide range in##3##3##(1991-4#1)(2008-10#2)
wide range of applications##7##4##(2008-10#2)(2008-3#2)(2008-7#1)(2010-12#1)(2012-2#1)
wide range of biological##3##4##(2008-11#1)(2010-3#1)(2012-3#1)
wide range of cancers##2##4##(2009-11#1)(2011-2#1)
wide range of concentration##2##4##(2008-10#2)
wide range of different##4##4##(1997-6#1)(2007-12#1)(2009-10#1)(2011-1#1)
wide range of pH##9##4##(1994-3#1)(2008-10#6)(2008-5#1)(2013-1#1)
wide range of strategic##2##4##(1994-2#1)(2008-12#1)
wide range of therapeutic##2##4##(1991-11#1)(2008-5#1)
wide range of topics##3##4##(2008-5#2)(2012-2#1)
wide range of##269##3##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#4)(2007-12#6)(2007-8#3)(2008-1#3)(2008-10#64)(2008-11#15)(2008-12#3)(2008-2#9)(2008-3#20)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#14)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#3)
wide range##288##2##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#7)(2007-12#7)(2007-8#3)(2008-1#3)(2008-10#70)(2008-11#15)(2008-12#3)(2008-2#13)(2008-3#23)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#14)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#3)
wide ranges##2##2##(1992-8#1)(2012-3#1)
wide ranging##2##2##(2009-1#1)(2009-8#1)
wide resection with##2##3##(1992-9#1)(2008-6#1)
wide resection##4##2##(1992-9#1)(2008-6#1)(2008-9#2)
wide scale##3##2##(2009-12#1)(2010-6#1)(2013-8#1)
wide size##3##2##(2007-12#1)(2008-10#1)(2010-8#1)
wide spectrum of##21##3##(1990-6#1)(1991-2#1)(1993-3#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#2)
wide spectrum##26##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-5#1)(1993-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#2)
wide spread##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
wide surgical excision##4##3##(2008-5#1)(2008-6#1)(2013-1#2)
wide surgical##5##2##(2008-5#1)(2008-6#1)(2013-1#2)(2013-7#1)
wide temperature range##3##3##(1993-8#1)(2008-2#1)(2008-3#1)
wide to##2##2##(2007-12#1)(2008-8#1)
wide tuning##2##2##(2007-11#1)(2008-3#1)
wide use in##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
wide use of##3##3##(1992-5#1)(2007-8#1)(2008-2#1)
wide use##7##2##(1992-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
wide variability##3##2##(1993-6#1)(2007-10#1)(2008-8#1)
wide variation in##13##3##(1996-12#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-3#2)
wide variation##15##2##(1996-12#1)(1996-3#1)(1997-3#2)(1997-6#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-3#2)
wide variations in##2##3##(1997-3#1)(2008-11#1)
wide variations##4##2##(1997-3#1)(1997-8#1)(2008-11#1)(2012-3#1)
wide variety of other metal ions##6##6##(2008-10#6)
wide variety of other##13##4##(1994-12#1)(2008-10#11)(2011-3#1)
wide variety of sequence##3##4##(2008-2#1)(2008-4#2)
wide variety of##134##3##(1990-2#1)(1990-5#1)(1992-11#1)(1992-3#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#4)(2008-10#24)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#5)(2012-3#1)(2013-8#1)
wide virulence##2##2##(2008-10#2)
wide working##2##2##(2008-10#2)
wide##869##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#6)(1996-4#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#21)(2007-12#27)(2007-5#1)(2007-8#10)(2008-1#10)(2008-10#220)(2008-11#29)(2008-12#11)(2008-2#30)(2008-3#70)(2008-4#16)(2008-5#24)(2008-6#22)(2008-7#33)(2008-8#18)(2008-9#20)(2009-1#3)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#10)(2011-1#11)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#14)(2012-3#12)(2012-5#1)(2013-1#22)(2013-7#3)(2013-8#5)
wide)##4##1##(1990-12#1)(2007-11#1)(2008-10#1)(2010-10#1)
wide-angle##12##1##(2007-11#1)(2008-2#2)(2008-3#9)
wide-area network##2##2##(1992-2#1)(1996-12#1)
wide-area##4##1##(1992-2#1)(1996-12#1)(2008-2#1)(2013-1#1)
wide-field and##2##2##(2008-3#1)(2008-9#1)
wide-field fluorescence lifetime images of##2##5##(2011-1#2)
wide-field fluorescence lifetime##3##3##(2007-11#1)(2011-1#2)
wide-field interferometric##2##2##(2011-1#2)
wide-field##11##1##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#4)
wide-range##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
wide-ranging##10##1##(1991-3#1)(1995-12#1)(1996-1#1)(1997-1#1)(2007-8#1)(2008-3#1)(2010-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
wide-scale##2##1##(2008-10#2)
wide-spectrum##4##1##(1990-12#1)(1992-9#1)(2008-5#1)(2013-1#1)
wide-spread use of##3##3##(2009-10#1)(2009-4#1)(2012-1#1)
wide-spread##9##1##(1991-6#1)(1992-3#1)(1992-6#1)(2008-1#1)(2009-10#1)(2009-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
wideband ultrasound detection##2##3##(2009-5#2)
wideband##14##1##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#3)(2009-5#2)
widely accepted as a##2##4##(2008-11#1)(2013-1#1)
widely accepted as##4##3##(1993-12#1)(2008-11#2)(2013-1#1)
widely accepted that##9##3##(1994-9#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-3#1)
widely accepted theory##2##3##(2008-1#1)(2008-4#1)
widely accepted##36##2##(1991-3#1)(1991-6#1)(1993-12#2)(1994-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
widely acknowledged in the literature##2##5##(2008-11#2)
widely acknowledged##5##2##(1993-12#1)(1997-5#1)(2008-11#2)(2008-5#1)
widely across##2##2##(1994-2#1)(2013-1#1)
widely adopted##6##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)
widely and##2##2##(1993-12#1)(2007-7#1)
widely applicable##6##2##(1990-9#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
widely applied in##4##3##(1990-9#1)(2008-8#1)(2013-8#2)
widely applied##7##2##(1990-9#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-8#2)
widely appreciated##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
widely assumed##3##2##(1990-6#1)(2008-8#1)(2013-1#1)
widely available and##2##3##(2008-7#1)(2009-1#1)
widely available##18##2##(1993-11#1)(1997-4#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
widely believed that##2##3##(1995-12#1)(2008-5#1)
widely believed to##2##3##(2009-5#1)(2009-7#1)
widely believed##4##2##(1995-12#1)(2008-5#1)(2009-5#1)(2009-7#1)
widely between the##2##3##(2008-11#1)(2012-3#1)
widely between##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
widely comparable##2##2##(2008-10#2)
widely considered a##2##3##(2009-4#1)(2009-6#1)
widely considered##5##2##(1994-8#1)(2008-7#1)(2009-4#1)(2009-6#1)(2012-3#1)
widely cultivated##2##2##(2008-10#1)(2008-12#1)
widely demonstrated##2##2##(1993-12#1)(2008-6#1)
widely different##6##2##(1993-8#1)(1994-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
widely differing##2##2##(2008-10#1)(2008-9#1)
widely discussed##5##2##(1994-2#1)(2008-11#1)(2009-6#1)(2009-9#1)(2013-1#1)
widely dispersed##2##2##(2008-11#1)(2011-2#1)
widely disseminated to##2##3##(1996-1#1)(1996-2#1)
widely disseminated##3##2##(1995-6#1)(1996-1#1)(1996-2#1)
widely distributed along the##2##4##(1997-4#1)(2013-7#1)
widely distributed among##2##3##(2008-12#1)(2008-8#1)
widely distributed in the##3##4##(1993-11#1)(2008-7#1)(2009-12#1)
widely distributed in##12##3##(1993-11#1)(1993-3#1)(1996-5#1)(2008-10#4)(2008-7#1)(2009-12#1)(2011-2#2)(2013-7#1)
widely distributed species##2##3##(2012-3#1)(2013-7#1)
widely distributed throughout the##2##4##(2010-5#1)(2010-8#1)
widely distributed throughout##3##3##(2008-10#1)(2010-5#1)(2010-8#1)
widely distributed##36##2##(1990-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#3)
widely documented##3##2##(1990-7#1)(1993-12#1)(2008-11#1)
widely employed in##2##3##(2008-11#1)(2008-2#1)
widely employed##7##2##(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)
widely expressed##6##2##(1993-12#1)(1997-7#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-3#1)
widely from##5##2##(1990-12#1)(1994-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
widely grown in the United States##2##6##(2008-10#2)
widely grown in##4##3##(2008-10#3)(2011-2#1)
widely grown##6##2##(2008-10#5)(2011-2#1)
widely held##3##2##(1994-2#1)(2008-7#1)(2010-10#1)
widely implemented##3##2##(1992-1#1)(2008-7#1)(2008-9#1)
widely in the##3##3##(1996-12#1)(2008-11#1)(2011-3#1)
widely in their ability to##2##5##(1991-2#1)(2008-5#1)
widely in their##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
widely in##22##2##(1991-2#1)(1993-5#1)(1994-11#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
widely investigated in##2##3##(2009-8#1)(2012-2#1)
widely investigated##5##2##(1990-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
widely involved in##2##3##(2008-6#1)(2011-2#1)
widely known##8##2##(1994-3#1)(1996-1#1)(2007-11#1)(2007-6#1)(2008-2#2)(2008-4#1)(2009-5#1)
widely prescribed##4##2##(1996-2#1)(2007-10#1)(2008-11#1)(2008-5#1)
widely prevalent##2##2##(2012-2#1)(2013-8#1)
widely recognised##2##2##(2008-11#2)
widely recognized as the##3##4##(2008-12#1)(2008-9#1)(2010-12#1)
widely recognized##7##2##(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
widely regarded as##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
widely reported in##4##3##(2007-12#1)(2008-9#1)(2009-3#1)(2013-1#1)
widely reported##9##2##(1991-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#1)
widely separated##3##2##(1995-2#1)(1995-5#1)(2008-11#1)
widely spaced##6##2##(1992-2#1)(2008-2#3)(2009-8#1)(2010-6#1)
widely spread##2##2##(2007-12#1)(2010-8#1)
widely studied##10##2##(1997-3#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
widely throughout##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
widely to##5##2##(1993-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2013-8#1)
widely tunable##10##2##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
widely used as a model##3##5##(2008-9#1)(2009-9#1)(2010-1#1)
widely used as a##10##4##(1992-11#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
widely used as an##5##4##(1996-8#1)(2008-1#1)(2008-5#1)(2010-11#1)(2010-8#1)
widely used as##20##3##(1992-11#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
widely used by##3##3##(1997-4#1)(2008-8#1)(2008-9#1)
widely used drug in##2##4##(2008-1#1)(2008-7#1)
widely used drug##3##3##(2008-1#1)(2008-7#1)(2008-8#1)
widely used for both##2##4##(2008-1#1)(2008-10#1)
widely used for the control of##2##6##(1997-6#1)(2008-10#1)
widely used for the production of recombinant proteins##2##8##(2008-11#2)
widely used for the##13##4##(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#1)(2013-8#1)
widely used for##32##3##(1995-3#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#3)(2013-1#1)(2013-8#1)
widely used herbicide##5##3##(1995-8#1)(2008-10#4)
widely used in Japan##3##4##(2008-10#2)(2010-6#1)
widely used in clinical##2##4##(2008-10#1)(2010-11#1)
widely used in cosmetics and##2##5##(2008-5#2)
widely used in food##2##4##(2008-6#1)(2012-3#1)
widely used in the treatment of##3##6##(2010-11#1)(2010-12#1)(2010-8#1)
widely used in the##11##4##(2008-1#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
widely used in##59##3##(1990-11#1)(1990-6#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
widely used method##3##3##(1995-2#1)(2008-4#1)(2013-8#1)
widely used rodent##2##3##(2011-1#1)(2012-3#1)
widely used technique for##3##4##(2008-3#1)(2010-5#1)(2013-1#1)
widely used technique##5##3##(1996-8#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
widely used to assess##2##4##(2008-11#1)(2010-5#1)
widely used to monitor patients##2##5##(1990-2#1)(2008-10#1)
widely used to study##3##4##(1996-5#1)(2009-9#1)(2012-3#1)
widely used to##18##3##(1990-2#1)(1990-8#1)(1994-3#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
widely used##235##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-1#7)(2008-10#39)(2008-11#17)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#13)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#9)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#2)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#8)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#4)
widely utilized for##2##3##(2008-10#1)(2008-9#1)
widely utilized##7##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-11#1)(2010-8#1)
widely varying##2##2##(1996-12#1)(2008-3#1)
widely with##2##2##(1991-11#1)(2008-10#1)
widely##610##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#4)(1996-12#2)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#3)(2007-10#1)(2007-11#10)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#10)(2008-10#83)(2008-11#48)(2008-12#9)(2008-2#22)(2008-3#25)(2008-4#23)(2008-5#17)(2008-6#9)(2008-7#15)(2008-8#12)(2008-9#22)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#4)(2010-4#2)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#7)(2011-1#10)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#16)(2012-3#19)(2013-1#19)(2013-7#4)(2013-8#11)
widely-used##6##1##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
widen the horizon of##2##4##(2008-12#1)(2010-8#1)
widen the##7##2##(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-8#1)
widen##11##1##(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)
widened##7##1##(1990-11#1)(1995-8#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
widening in##4##2##(2011-2#4)
widening of the##4##3##(1992-11#1)(2008-1#1)(2008-7#1)(2010-1#1)
widening of##6##2##(1992-11#1)(2008-1#1)(2008-7#1)(2010-1#1)(2013-1#2)
widening the##2##2##(2008-10#1)(2008-8#1)
widening##23##1##(1992-11#1)(1997-8#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#6)(2011-3#1)(2013-1#3)
widens the##3##2##(1997-4#1)(2007-11#1)(2008-8#1)
widens##5##1##(1997-4#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
wider and the##3##3##(2008-10#2)(2013-1#1)
wider and##5##2##(2007-10#1)(2008-10#2)(2009-11#1)(2013-1#1)
wider applicability##2##2##(2008-2#1)(2012-2#1)
wider application of##2##3##(2008-9#1)(2011-2#1)
wider availability##2##2##(2010-8#1)(2012-12#1)
wider dynamic range##4##3##(2008-10#2)(2008-3#2)
wider issues##2##2##(1996-11#1)(2008-11#1)
wider range of##10##3##(1994-12#2)(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
wider range##12##2##(1994-12#2)(1996-1#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
wider side of the face##2##5##(2012-12#2)
wider spectrum##2##2##(2008-9#1)(2013-8#1)
wider than the range of##2##5##(2008-8#2)
wider than the##3##3##(2008-3#1)(2008-8#2)
wider than##4##2##(2008-10#1)(2008-3#1)(2008-8#2)
wider use##4##2##(1992-1#1)(1997-2#1)(2007-8#1)(2012-3#1)
wider virulence##2##2##(2008-10#2)
wider##126##1##(1991-12#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-11#2)(1997-2#2)(1997-7#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#4)
widespread acceptance##2##2##(1996-12#1)(2008-7#1)
widespread adoption of##2##3##(1995-1#1)(2010-12#1)
widespread adoption##3##2##(1995-1#1)(2010-12#1)(2010-8#1)
widespread among##6##2##(1994-8#1)(1995-8#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
widespread and##7##2##(1997-3#1)(2008-1#1)(2008-10#2)(2010-6#1)(2011-2#1)(2012-3#1)
widespread application in the##3##4##(2008-1#1)(2010-7#1)(2011-2#1)
widespread application in##4##3##(2008-1#1)(2008-7#1)(2010-7#1)(2011-2#1)
widespread application##6##2##(1997-1#1)(2008-1#2)(2008-7#1)(2010-7#1)(2011-2#1)
widespread attention##4##2##(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)
widespread but##2##2##(1992-8#1)(2008-5#1)
widespread class of##2##3##(2008-9#1)(2013-1#1)
widespread deployment of##2##3##(2008-10#2)
widespread deployment##3##2##(2008-10#3)
widespread disease in##2##3##(2006-10#1)(2008-10#1)
widespread disease##5##2##(2006-10#1)(2008-10#4)
widespread distribution of##9##3##(1992-8#1)(1993-6#1)(2008-10#2)(2008-11#1)(2008-4#2)(2012-3#1)(2013-1#1)
widespread distribution##13##2##(1992-8#1)(1993-6#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2012-3#2)(2013-1#1)
widespread environmental##3##2##(1994-3#1)(2008-10#2)
widespread exposure##2##2##(1990-7#1)(1993-3#1)
widespread expression##2##2##(1995-5#1)(1996-12#1)
widespread implementation of##2##3##(1996-2#1)(2007-11#1)
widespread in nature##2##3##(2013-1#2)
widespread in southern##2##3##(2008-10#1)(2013-1#1)
widespread in##12##2##(2007-11#2)(2008-10#3)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
widespread influenza##2##2##(1992-6#1)(2009-12#1)
widespread introduction of##2##3##(2008-4#1)(2011-1#1)
widespread knowledge##2##2##(1990-6#1)(2013-1#1)
widespread loss of##2##3##(2008-7#1)(2013-1#1)
widespread metastasis##2##2##(2011-1#1)(2012-1#1)
widespread metastatic disease##2##3##(2008-6#1)(2011-3#1)
widespread occurrence in##2##3##(2008-10#1)(2008-9#1)
widespread occurrence of##4##3##(1996-12#1)(1997-7#1)(2008-10#1)(2008-9#1)
widespread occurrence##6##2##(1996-12#1)(1997-7#1)(2008-10#2)(2008-9#2)
widespread over##2##2##(2010-1#1)(2013-1#1)
widespread pain##3##2##(1997-4#2)(2011-2#1)
widespread problems##2##2##(1997-6#1)(2008-12#1)
widespread throughout##2##2##(2008-10#1)(2013-8#1)
widespread use in##2##3##(1997-5#1)(2007-12#1)
widespread use is hampered by##2##5##(1990-2#1)(2009-3#1)
widespread use of##18##3##(1993-12#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#4)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#1)
widespread use##33##2##(1990-2#1)(1991-12#1)(1993-12#1)(1993-3#1)(1996-11#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
widespread##259##1##(1990-2#1)(1990-6#2)(1990-7#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-3#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2008-1#3)(2008-10#52)(2008-11#5)(2008-12#6)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#16)(2008-8#8)(2008-9#9)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#2)
widow##2##1##(2008-10#1)(2009-4#1)
widowbird##2##1##(2008-8#2)
widowed##3##1##(2007-2#1)(2011-1#1)(2011-2#1)
width and height##2##3##(2007-12#1)(2013-1#1)
width and of##2##3##(2007-12#1)(2008-10#1)
width and output power##2##4##(2008-2#2)
width and the##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
width and##23##2##(2007-11#2)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#6)(2008-7#2)(2009-4#1)(2010-10#1)(2013-1#1)
width as##2##2##(2008-3#1)(2012-12#1)
width at half-maximum##11##3##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2013-8#2)
width at##15##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#4)(2013-8#2)
width between##2##2##(2008-10#1)(2008-11#1)
width for##4##2##(1997-7#1)(2008-10#1)(2008-3#1)(2012-3#1)
width in##4##2##(2007-11#4)
width is approximately##2##3##(2008-2#1)(2008-3#1)
width is##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
width of a##2##3##(2008-2#1)(2008-3#1)
width of the##48##3##(1993-12#1)(1993-9#1)(1996-4#1)(1997-3#1)(2007-11#6)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#14)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
width of##81##2##(1993-12#1)(1993-9#1)(1994-9#1)(1996-2#1)(1996-4#2)(1997-3#1)(2007-11#8)(2007-12#8)(2008-10#12)(2008-11#1)(2008-2#7)(2008-3#26)(2008-5#2)(2008-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
width that is##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
width to##3##2##(2008-2#2)(2008-8#1)
width was##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
width were##3##2##(2008-10#2)(2008-3#1)
width##256##1##(1992-2#1)(1993-12#3)(1993-9#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-4#2)(1997-3#1)(1997-7#1)(2007-11#28)(2007-12#29)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#25)(2008-3#71)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#5)(2010-11#1)(2011-2#3)(2012-1#2)(2012-12#8)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#3)
width)##2##1##(2008-11#1)(2009-11#1)
widths and##6##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
widths are##4##2##(2007-12#2)(2008-3#2)
widths of the##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
widths of##8##2##(1991-12#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
widths were##3##2##(2008-7#2)(2009-5#1)
widths##43##1##(1991-12#1)(1991-8#1)(1995-5#1)(2007-11#8)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#13)(2008-7#5)(2008-8#1)(2009-5#2)
wife and I##2##3##(2010-5#1)(2012-2#1)
wife##11##1##(1990-11#1)(1992-6#2)(1996-5#1)(1997-6#1)(2008-11#1)(2008-9#1)(2009-1#1)(2010-5#1)(2012-2#1)(2013-8#1)
wiggler##2##1##(1990-12#1)(2008-3#1)
wigs after xenogeneic hair transplantation##2##5##(2012-3#2)
wigs##9##1##(2012-3#9)
wild APP##2##2##(1991-9#2)
wild P##2##2##(2008-10#2)
wild Senegal doves##2##3##(2008-5#2)
wild Solanum spp##5##3##(2008-10#5)
wild Solanum##7##2##(2008-10#7)
wild and cultivated##6##3##(2008-10#5)(2013-8#1)
wild and domestic animals##2##4##(1990-3#1)(2012-2#1)
wild and domestic##4##3##(1990-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
wild and##14##2##(1990-3#1)(2008-10#5)(2008-8#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
wild annual sunflowers (Helianthus spp##2##5##(2008-8#2)
wild birds##4##2##(2007-2#1)(2011-2#3)
wild chimpanzees##3##2##(2007-12#2)(2012-2#1)
wild chokecherry##2##2##(2008-10#2)
wild grass-infecting##2##2##(2008-10#2)
wild host##3##2##(2008-10#3)
wild males##2##2##(2008-8#1)(2012-12#1)
wild mammals kept in##2##4##(1996-12#2)
wild mouse##2##2##(1994-12#1)(2008-10#1)
wild oats##4##2##(2008-10#4)
wild olive##2##2##(2008-10#2)
wild plants##2##2##(2008-10#2)
wild populations##7##2##(2008-5#1)(2008-9#1)(2009-2#3)(2013-1#1)(2013-8#1)
wild relatives##2##2##(2008-10#1)(2008-5#1)
wild rice##2##2##(2008-5#1)(2008-8#1)
wild species of##3##3##(2008-5#2)(2011-2#1)
wild species##9##2##(2008-10#1)(2008-5#3)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
wild strain##3##2##(1997-2#2)(2008-10#1)
wild type (WT)##5##3##(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
wild type alpha2M##2##3##(2008-11#2)
wild type and latently infected strains##2##6##(2008-10#2)
wild type and mutant##2##4##(2008-8#2)
wild type and##7##3##(2008-10#3)(2008-11#1)(2008-8#3)
wild type is##2##3##(2008-8#2)
wild type on##2##3##(1997-3#1)(2008-10#1)
wild type p53##2##3##(2008-5#1)(2009-5#1)
wild type strain##10##3##(1991-2#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-8#4)(2008-9#2)
wild type strains##2##3##(1990-5#1)(1997-8#1)
wild type were##2##3##(1995-2#1)(2008-10#1)
wild type##125##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-8#2)(1992-6#1)(1992-8#2)(1993-11#5)(1993-3#4)(1993-8#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#3)(2008-10#26)(2008-11#9)(2008-12#2)(2008-3#4)(2008-5#2)(2008-8#15)(2008-9#5)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#3)
wild type)##2##2##(1995-2#1)(2008-10#1)
wild vegetation without trees##2##4##(2013-1#2)
wild vegetation##5##2##(2011-2#1)(2013-1#4)
wild##288##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-6#1)(1992-8#2)(1993-11#5)(1993-3#4)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#2)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#3)(2007-1#1)(2007-12#2)(2007-2#1)(2008-10#86)(2008-11#12)(2008-12#5)(2008-3#4)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#31)(2008-9#9)(2009-2#5)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#8)
wild-caught individuals##2##2##(2009-5#2)
wild-caught##6##1##(2007-12#1)(2008-8#1)(2009-5#2)(2010-4#1)(2010-8#1)
wild-derived mouse stocks##3##3##(2009-5#3)
wild-derived##6##1##(2009-11#2)(2009-5#3)(2012-3#1)
wild-type (WT) and##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
wild-type (WT)##8##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#2)(2013-1#1)
wild-type (wt)##3##2##(1990-5#1)(1997-2#1)(1997-7#1)
wild-type CHO##2##2##(1993-9#1)(2008-11#1)
wild-type CN##3##2##(2008-9#3)
wild-type E##2##2##(1994-11#1)(2011-2#1)
wild-type H-NS##2##2##(2011-1#2)
wild-type Hx##2##2##(1994-8#2)
wild-type MRP##2##2##(2008-11#2)
wild-type Mb##3##2##(1994-5#3)
wild-type P##2##2##(2008-10#2)
wild-type Philippine strain##2##3##(2008-10#2)
wild-type RNA1##2##2##(2008-10#2)
wild-type TRbeta1##3##2##(1995-8#3)
wild-type X##2##2##(2008-10#2)
wild-type and Del 49 enzymes were##2##6##(1995-2#2)
wild-type and Del 49 enzymes##3##5##(1995-2#3)
wild-type and Del 49##4##4##(1995-2#4)
wild-type and a##2##3##(1996-10#1)(2013-1#1)
wild-type and mutant enzymes##2##4##(1990-12#1)(1995-2#1)
wild-type and mutant##13##3##(1990-12#1)(1990-8#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-7#2)
wild-type and rtN236T mutant##2##4##(2013-1#2)
wild-type and rtN236T##3##3##(2013-1#3)
wild-type and##43##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#5)(1995-6#1)(1996-10#1)(1997-3#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#4)(2010-10#1)(2011-3#1)(2012-12#1)(2013-1#4)
wild-type animals##3##2##(1996-2#1)(2009-8#1)(2012-3#1)
wild-type background##3##2##(1990-11#1)(2008-9#2)
wild-type barley##2##2##(2008-10#2)
wild-type cells##8##2##(1991-7#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-3#1)(2008-7#1)(2009-9#1)
wild-type colonies##2##2##(2008-10#2)
wild-type enzyme##32##2##(1990-10#4)(1990-8#3)(1991-5#1)(1992-6#4)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#7)(2008-4#2)
wild-type gene##3##2##(1990-5#1)(1991-12#1)(1992-9#1)
wild-type histidase##3##2##(1994-5#2)(1994-6#1)
wild-type human##2##2##(2008-3#1)(2008-9#1)
wild-type isolate##6##2##(2008-10#6)
wild-type isolates##7##2##(2008-10#7)
wild-type level##4##2##(1990-5#1)(1995-2#2)(2009-6#1)
wild-type levels##2##2##(1995-2#1)(1995-6#1)
wild-type mice##5##2##(1993-12#1)(1996-12#1)(1996-6#1)(2010-11#1)(2011-2#1)
wild-type or kinase-negative receptors##2##4##(1997-7#2)
wild-type or##6##2##(1997-7#3)(2008-1#1)(2008-9#1)(2010-2#1)
wild-type p53 protein##3##3##(1990-12#1)(1991-5#1)(1994-9#1)
wild-type p53##8##2##(1990-12#1)(1991-5#3)(1993-11#2)(1993-9#1)(1994-9#1)
wild-type parent##2##2##(1995-2#1)(2008-10#1)
wild-type plants##3##2##(2008-5#1)(2008-9#1)(2009-10#1)
wild-type protein##5##2##(1990-8#1)(1994-5#1)(1994-6#1)(2011-1#1)(2011-2#1)
wild-type recombinant##2##2##(1995-5#2)
wild-type regulatory subunit##2##3##(1995-2#2)
wild-type strain of##3##3##(2008-10#3)
wild-type strain##28##2##(2008-10#23)(2008-6#2)(2008-7#2)(2009-6#1)
wild-type strains and##4##3##(2008-10#3)(2011-1#1)
wild-type strains in##2##3##(2008-10#2)
wild-type strains##14##2##(2008-10#10)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
wild-type tomato##3##2##(2008-10#1)(2008-5#2)
wild-type virus##8##2##(1993-6#1)(2008-10#5)(2011-3#1)(2013-1#1)
wild-type viruses##2##2##(2008-10#1)(2013-1#1)
wild-type yeast##2##2##(1995-2#1)(1995-8#1)
wild-type##403##1##(1990-10#4)(1990-11#1)(1990-12#3)(1990-5#5)(1990-7#1)(1990-8#6)(1991-10#1)(1991-12#3)(1991-5#6)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-4#2)(1992-6#9)(1992-8#1)(1992-9#4)(1993-11#5)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#7)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#13)(1994-6#5)(1994-8#5)(1994-9#1)(1995-12#3)(1995-2#28)(1995-3#1)(1995-5#6)(1995-6#11)(1995-8#10)(1995-9#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-11#3)(2008-1#1)(2008-10#101)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#14)(2008-8#11)(2008-9#13)(2009-10#4)(2009-2#1)(2009-6#4)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#2)(2010-2#2)(2011-1#7)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#11)(2013-8#1)
wildlife conservation##2##2##(2012-2#1)(2013-1#1)
wildlife crime##2##2##(2011-1#2)
wildlife forensic##2##2##(2008-12#2)
wildlife species##2##2##(2008-12#2)
wildlife zoonotic##2##2##(2011-1#2)
wildlife##24##1##(1990-3#4)(2008-10#1)(2008-12#7)(2008-9#1)(2011-1#4)(2012-2#3)(2013-1#3)(2013-7#1)
wildtype and##2##2##(2008-7#1)(2012-2#1)
wildtype mu##2##2##(1991-9#2)
wildtype##14##1##(1990-5#1)(1991-9#2)(1992-12#2)(2008-10#2)(2008-7#3)(2009-11#1)(2010-11#1)(2012-2#2)
wiley##2##1##(2008-7#1)(2011-2#1)
will &quot##2##2##(1994-3#1)(2008-10#1)
will accomplish##2##2##(1997-7#1)(2008-10#1)
will achieve its##2##3##(1991-12#1)(1994-1#1)
will achieve##8##2##(1991-12#1)(1994-1#3)(2008-3#2)(2008-8#1)(2010-5#1)
will activate##2##2##(2007-8#1)(2008-7#1)
will adapt##2##2##(1994-1#1)(1997-6#1)
will address some of the issues##2##6##(1991-12#1)(1993-11#1)
will address the various##3##4##(1994-3#2)(1995-3#1)
will address the##10##3##(1991-1#1)(1994-3#2)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-7#1)
will address##20##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
will advance##3##2##(2009-3#1)(2009-9#1)(2012-2#1)
will affect the##13##3##(1991-1#1)(1993-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#1)(2010-9#1)
will affect##19##2##(1991-1#1)(1993-1#1)(1993-2#2)(1994-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
will aid in the development of##3##6##(2008-11#1)(2008-7#1)(2012-2#1)
will aid in the##5##4##(1995-5#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
will aid in##8##3##(1995-5#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
will aid the##2##3##(1992-12#1)(2009-7#1)
will aid##13##2##(1992-12#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-7#2)(2009-7#2)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
will all##3##2##(2008-1#1)(2008-2#1)(2013-1#1)
will allow a##2##3##(1993-5#1)(2008-11#1)
will allow for the##2##4##(2008-10#1)(2009-8#1)
will allow for##7##3##(1995-1#1)(1997-3#1)(2008-10#2)(2008-12#1)(2009-8#1)(2010-3#1)
will allow more##2##3##(2007-10#1)(2013-8#1)
will allow the##11##3##(1990-9#1)(1991-2#1)(1994-3#1)(1994-5#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)
will allow us to##3##4##(1993-2#1)(2008-10#1)(2008-7#1)
will allow us##4##3##(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
will allow##59##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
will also affect the##2##4##(2008-3#1)(2008-6#1)
will also allow##2##3##(1991-12#1)(2008-2#1)
will also be addressed##2##4##(1995-12#1)(2008-8#1)
will also be discussed##8##4##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)
will also be highlighted##2##4##(1992-3#1)(1997-1#1)
will also be useful in##2##5##(2008-5#1)(2013-8#1)
will also be##27##3##(1992-2#2)(1992-3#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-8#1)
will also depend on the##2##5##(1992-3#1)(1992-6#1)
will also discuss the##3##4##(1993-12#1)(2008-10#1)(2010-6#1)
will also discuss##5##3##(1993-12#1)(2008-10#1)(2008-7#1)(2010-6#1)(2013-8#1)
will also have##2##3##(1993-3#1)(2011-2#1)
will also help##3##3##(1994-12#1)(2008-8#1)(2008-9#1)
will also##80##2##(1991-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
will always be##2##3##(1991-2#1)(1995-1#1)
will always##3##2##(1991-2#1)(1995-1#1)(2008-3#1)
will and##5##2##(1992-1#1)(1993-6#1)(2008-12#1)(2010-12#2)
will appear in##6##3##(1992-3#2)(1993-1#1)(1994-1#1)(1995-1#1)(2010-5#1)
will appear##10##2##(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#2)(1995-1#1)(2008-7#1)(2010-5#1)
will apply##2##2##(1994-3#1)(2008-10#1)
will appreciate##2##2##(1992-1#1)(2008-9#1)
will argue that##2##3##(1996-2#1)(2010-3#1)
will arise##3##2##(1993-1#1)(1996-11#1)(2008-6#1)
will assist in the##2##4##(2008-10#1)(2008-5#1)
will assist in##7##3##(1992-8#1)(2008-10#3)(2008-5#1)(2009-7#1)(2013-7#1)
will assist the##2##3##(2008-10#1)(2008-2#1)
will assist##14##2##(1992-8#1)(1995-1#2)(1995-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2009-7#1)(2013-7#1)
will at##2##2##(1992-12#1)(1996-3#1)
will attempt to##4##3##(1996-5#1)(2008-1#1)(2008-5#1)(2012-2#1)
will automatically##2##2##(1996-2#1)(2008-5#1)
will be a challenge to##2##5##(2008-10#1)(2008-2#1)
will be a useful tool##2##5##(2008-10#1)(2008-11#1)
will be a##26##3##(1994-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2012-12#2)
will be able to interpret##2##5##(1991-3#1)(2008-7#1)
will be able to##16##4##(1991-12#1)(1991-3#1)(1993-2#1)(1996-1#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
will be achieved##3##3##(2007-10#1)(2008-5#1)(2011-2#1)
will be addressed##8##3##(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)(2010-5#1)(2011-2#2)
will be administered##3##3##(1990-6#1)(2008-5#2)
will be also discussed##2##4##(2008-11#2)
will be also##5##3##(2008-11#2)(2008-12#1)(2009-5#1)(2011-2#1)
will be an##7##3##(1996-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2012-2#1)
will be analyzed##2##3##(1996-1#1)(2007-8#1)
will be applicable to##2##4##(2008-10#2)
will be applicable##3##3##(2008-10#3)
will be at##3##3##(1992-6#1)(1995-2#1)(2008-5#1)
will be available##3##3##(1990-11#1)(1996-2#1)(1997-1#1)
will be beneficial for##2##4##(2008-10#1)(2012-12#1)
will be beneficial in##2##4##(2008-10#1)(2008-3#1)
will be beneficial##7##3##(2008-10#2)(2008-3#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
will be better able to##3##5##(1992-12#1)(1997-3#1)(2008-11#1)
will be better prepared to##2##5##(1994-1#1)(1997-1#1)
will be better##6##3##(1992-12#1)(1994-1#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-8#1)
will be compared##4##3##(1995-2#1)(2008-10#1)(2012-12#1)(2013-8#1)
will be compromised##2##3##(1996-1#1)(2012-1#1)
will be conducted in##2##4##(1997-6#1)(2008-5#1)
will be conducted##3##3##(1997-6#1)(2008-5#2)
will be considered a##2##4##(1994-12#1)(1994-2#1)
will be defined##2##3##(1995-12#1)(1997-3#1)
will be demonstrated##5##3##(1995-2#1)(2008-10#2)(2011-1#1)(2011-2#1)
will be dependent##3##3##(1995-1#1)(1997-8#1)(2008-8#1)
will be described in detail##2##5##(2008-5#1)(2011-1#1)
will be described in##4##4##(1995-3#1)(2008-3#1)(2008-5#1)(2011-1#1)
will be described##14##3##(1991-5#1)(1995-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-3#1)
will be determined by##2##4##(2008-3#1)(2010-4#1)
will be determined##4##3##(1995-8#1)(2008-3#1)(2008-5#1)(2010-4#1)
will be developed##3##3##(1997-1#1)(2008-11#2)
will be difficult##4##3##(1991-7#1)(1994-12#1)(1997-6#1)(2008-6#1)
will be discussed along with##2##5##(2007-11#1)(2010-8#1)
will be discussed as##2##4##(2008-5#1)(2010-11#1)
will be discussed in this##4##5##(2008-3#1)(2008-8#1)(2010-12#1)(2012-2#1)
will be discussed in##8##4##(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)(2012-2#2)
will be discussed##61##3##(1990-3#1)(1992-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)
will be emphasized##2##3##(2008-5#1)(2011-3#1)
will be especially useful##2##4##(1991-12#1)(2008-10#1)
will be essential for##5##4##(2007-12#1)(2009-7#1)(2010-8#1)(2011-2#2)
will be essential to##2##4##(2008-10#1)(2011-1#1)
will be essential##10##3##(1992-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)
will be evaluated##7##3##(1996-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
will be examined##5##3##(1991-1#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-4#1)
will be expected to##3##4##(2008-6#1)(2010-8#1)(2013-8#1)
will be explained##3##3##(1997-3#1)(2007-6#1)(2008-7#1)
will be explored in##3##4##(2007-10#1)(2008-11#1)(2008-6#1)
will be explored##5##3##(2007-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
will be facilitated by the##2##5##(1995-1#1)(1995-12#1)
will be followed##3##3##(1997-5#1)(2011-2#1)(2013-1#1)
will be formed##3##3##(1997-2#1)(2008-3#2)
will be further##2##3##(2008-5#1)(2013-1#1)
will be given to##2##4##(1992-12#1)(2008-11#1)
will be given##7##3##(1991-5#1)(1992-12#2)(2007-8#1)(2008-11#3)
will be greatly##2##3##(1997-4#1)(2010-4#1)
will be helpful for##2##4##(2007-8#1)(2010-7#1)
will be helpful to##4##4##(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
will be helpful##7##3##(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)
will be highlighted in each article##2##6##(1994-12#1)(1995-1#1)
will be highlighted##6##3##(1994-12#1)(1995-1#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
will be identified##3##3##(1997-2#1)(2008-11#1)(2011-1#1)
will be illustrated##5##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#2)
will be implemented##3##3##(1991-2#1)(1996-8#1)(2012-12#1)
will be important for##2##4##(1995-12#1)(1996-2#1)
will be important in##2##4##(2008-6#1)(2010-10#1)
will be important to##4##4##(1997-6#1)(1997-7#1)(2008-10#1)(2009-5#1)
will be important##8##3##(1995-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-10#1)
will be improved##2##3##(1993-11#1)(2012-2#1)
will be in##2##3##(1996-1#1)(2011-1#1)
will be inadequate##2##3##(1993-3#1)(2008-8#1)
will be included to##2##4##(2008-12#1)(2008-4#1)
will be included##5##3##(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)
will be increased##2##3##(2008-11#1)(2011-2#1)
will be increasingly important##2##4##(1996-2#1)(2009-8#1)
will be informative##2##3##(2008-8#1)(2009-5#1)
will be instrumental##2##3##(1996-3#1)(2012-2#1)
will be introduced##5##3##(2008-10#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
will be invaluable##2##3##(1995-1#1)(2008-7#1)
will be investigated##2##3##(2008-3#1)(2013-8#1)
will be key##2##3##(2008-1#1)(2010-10#1)
will be launched in Japan##2##5##(2008-5#2)
will be launched##3##3##(2008-3#1)(2008-5#2)
will be less##4##3##(1993-1#1)(2008-10#2)(2008-5#1)
will be limited##2##3##(1995-12#1)(2008-11#1)
will be made##2##3##(1990-3#1)(2008-2#1)
will be measured##2##3##(1995-3#1)(2007-9#1)
will be minimized##2##3##(1995-9#1)(2008-3#1)
will be more##12##3##(1997-3#2)(1997-7#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2011-2#2)(2013-8#1)
will be much##2##3##(1991-11#1)(1991-6#1)
will be necessary to##10##4##(2007-8#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
will be necessary##16##3##(1992-3#3)(2007-8#1)(2008-5#2)(2008-7#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
will be needed to clarify the##2##6##(2008-10#2)
will be needed to##8##4##(1991-12#1)(2008-10#4)(2008-7#1)(2009-11#1)(2011-1#1)
will be needed##14##3##(1990-6#1)(1991-12#1)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-11#1)(2011-1#1)
will be no##2##3##(1995-8#1)(2008-10#1)
will be of great##2##4##(2008-10#1)(2009-5#1)
will be of##6##3##(1993-5#1)(2008-10#2)(2009-5#1)(2010-11#1)(2010-8#1)
will be offered##2##3##(2008-5#1)(2011-2#1)
will be on the##5##4##(1996-5#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)
will be on##7##3##(1996-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-1#1)
will be outlined##5##3##(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2012-2#1)
will be particularly useful for##2##5##(2008-10#1)(2008-4#1)
will be particularly useful##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
will be particularly##5##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)
will be possible##7##3##(1991-12#1)(1992-3#1)(1992-9#1)(2007-4#1)(2008-8#1)(2009-8#1)(2010-12#1)
will be presented and##2##4##(2008-11#1)(2012-2#1)
will be presented in##2##4##(2008-3#1)(2010-8#1)
will be presented##20##3##(1991-5#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-10#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
will be proposed##2##3##(1997-1#1)(2009-7#1)
will be provided##5##3##(1995-12#1)(1997-2#1)(2008-12#1)(2008-8#1)(2012-3#1)
will be published in the summer##2##6##(1995-1#1)(1996-1#1)
will be published in the##4##5##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)
will be published in##5##4##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-4#1)
will be published on December 31##2##6##(2010-12#2)
will be published on##3##4##(2010-12#3)
will be published##8##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-4#1)(2010-12#3)
will be randomly assigned##2##4##(2007-10#1)(2007-8#1)
will be randomly##3##3##(2007-10#1)(2007-8#1)(2008-7#1)
will be ready for##2##4##(1994-3#1)(2011-2#1)
will be recruited##2##3##(2007-8#1)(2008-5#1)
will be required and##2##4##(1990-6#1)(2011-2#1)
will be required to##9##4##(1992-2#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)
will be required##18##3##(1990-6#1)(1992-2#1)(1993-12#1)(1994-9#1)(1996-2#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#2)
will be reviewed##18##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
will be seen##2##3##(2007-11#1)(2010-9#1)
will be sent to##2##4##(2009-12#1)(2011-3#1)
will be shared##2##3##(2009-6#1)(2012-2#1)
will be shown to be##2##5##(1992-9#1)(2008-10#1)
will be shown to##3##4##(1991-1#1)(1992-9#1)(2008-10#1)
will be shown##5##3##(1991-1#1)(1992-9#1)(2008-10#2)(2008-3#1)
will be summarized##3##3##(1993-2#1)(1997-1#1)(2013-7#1)
will be taken##3##3##(1992-1#1)(2008-11#1)(2008-7#1)
will be the development of##2##5##(1996-3#2)
will be the greatest##2##4##(2008-10#1)(2012-12#1)
will be the key to##2##5##(1994-3#1)(2011-9#1)
will be the key##3##4##(1994-3#1)(2009-8#1)(2011-9#1)
will be the##27##3##(1991-12#3)(1994-1#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-3#2)(1996-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-9#1)(2012-12#1)(2012-2#1)
will be those who##2##4##(1993-12#1)(2008-5#1)
will be those##3##3##(1993-12#1)(2007-4#1)(2008-5#1)
will be to develop##2##4##(2008-1#1)(2008-7#1)
will be to##8##3##(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)
will be treated##2##3##(1994-9#1)(2008-10#1)
will be unable to##2##4##(1992-2#1)(1997-7#1)
will be used as##2##4##(2008-10#1)(2011-1#1)
will be used for risk-selection##2##5##(2008-7#2)
will be used for##4##4##(2008-3#1)(2008-7#2)(2013-8#1)
will be used in the##2##5##(2008-3#1)(2013-1#1)
will be used in##3##4##(2007-10#1)(2008-3#1)(2013-1#1)
will be used to##14##4##(1992-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-1#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-9#1)
will be used##25##3##(1992-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-1#3)(2007-10#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
will be useful for further##2##5##(2008-10#1)(2011-1#1)
will be useful for studying the##2##6##(1992-12#1)(2008-11#1)
will be useful for studying##4##5##(1992-12#1)(1995-2#1)(2007-12#1)(2008-11#1)
will be useful for the##5##5##(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)
will be useful for##20##4##(1991-2#1)(1992-12#1)(1992-8#1)(1995-2#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#1)
will be useful in the##2##5##(1991-5#1)(1997-8#1)
will be useful in##12##4##(1991-5#1)(1992-3#1)(1992-5#1)(1997-8#2)(2006-10#1)(2008-10#3)(2008-9#1)(2011-2#1)(2013-8#1)
will be useful to##5##4##(2008-11#2)(2008-8#1)(2012-2#1)(2013-7#1)
will be useful##40##3##(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
will be valuable for future##2##5##(2008-10#1)(2012-3#1)
will be valuable in##2##4##(2006-10#1)(2008-2#1)
will be valuable##6##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-2#1)(2012-3#1)
will be very useful in##2##5##(1993-11#1)(2009-2#1)
will be##838##2##(1990-11#1)(1990-3#2)(1990-6#3)(1991-1#3)(1991-11#2)(1991-12#9)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#7)(1992-2#3)(1992-3#15)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#10)(1993-2#5)(1993-3#2)(1993-5#1)(1994-1#4)(1994-12#8)(1994-2#7)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#7)(1995-1#9)(1995-12#9)(1995-2#9)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#7)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#9)(1996-4#4)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#9)(1997-2#9)(1997-3#11)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#5)(2006-10#4)(2007-10#8)(2007-11#4)(2007-12#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#11)(2008-10#87)(2008-11#49)(2008-12#15)(2008-2#11)(2008-3#22)(2008-4#14)(2008-5#44)(2008-6#9)(2008-7#30)(2008-8#29)(2008-9#10)(2009-10#8)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#1)(2009-5#9)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#3)(2010-10#6)(2010-11#7)(2010-12#6)(2010-2#1)(2010-3#11)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#2)(2011-1#13)(2011-2#24)(2011-3#7)(2011-9#1)(2012-1#1)(2012-12#15)(2012-2#20)(2012-3#9)(2013-1#13)(2013-7#9)(2013-8#9)
will become a powerful tool##2##5##(2008-10#2)
will become a##5##3##(1992-2#1)(2008-10#2)(2009-5#1)(2012-2#1)
will become available##2##3##(1993-11#1)(2013-1#1)
will become even more critical##2##5##(1992-12#1)(1995-5#1)
will become even more##3##4##(1992-12#1)(1995-5#1)(1997-1#1)
will become ever more important##2##5##(1995-12#1)(1995-2#1)
will become increasingly important to##2##5##(1994-3#1)(2007-5#1)
will become more##4##3##(1995-3#1)(1997-4#1)(2009-11#1)(2010-8#1)
will become standard##2##3##(1997-8#1)(2010-12#1)
will become the##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
will become##35##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
will begin##2##2##(1996-3#1)(2010-12#1)
will benefit from the##2##4##(2007-5#1)(2008-10#1)
will benefit from##3##3##(1990-3#1)(2007-5#1)(2008-10#1)
will benefit##11##2##(1990-3#1)(1992-3#1)(1996-2#1)(1997-1#1)(2007-5#1)(2008-10#4)(2008-5#1)(2011-1#1)
will briefly describe##2##3##(2008-7#2)
will briefly discuss##2##3##(2010-5#1)(2012-1#1)
will briefly summarize the##2##4##(2008-2#1)(2012-2#1)
will briefly##8##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-5#1)(2012-1#1)(2012-2#1)
will bring about##2##3##(1994-8#1)(2011-2#1)
will bring##7##2##(1991-6#1)(1994-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
will cause a##2##3##(1993-11#1)(2008-3#1)
will cause##9##2##(1993-11#1)(1994-12#1)(1996-12#1)(1997-7#1)(2008-3#2)(2008-9#1)(2011-2#2)
will center##3##2##(1992-3#1)(1995-1#1)(1997-1#1)
will centre on##2##3##(2008-10#2)
will certainly##7##2##(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)
will change with##2##3##(1992-6#1)(2013-8#1)
will change##7##2##(1992-6#1)(1995-2#1)(1996-4#1)(2008-8#2)(2010-11#1)(2013-8#1)
will characterize##2##2##(2008-8#1)(2008-9#1)
will clarify##2##2##(2010-11#1)(2011-2#1)
will clearly##2##2##(1993-11#1)(2012-2#1)
will come into##2##3##(2008-11#2)
will come with##2##3##(2007-5#1)(2008-10#1)
will come##8##2##(1992-3#1)(1994-12#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2012-3#1)
will compare##3##2##(2007-7#1)(2008-5#1)(2011-1#1)
will concentrate on##2##3##(1994-9#1)(2010-12#1)
will conclude##5##2##(1994-1#2)(2008-1#1)(2008-4#1)(2008-7#1)
will consider the##5##3##(2008-10#1)(2008-6#1)(2008-7#2)(2011-2#1)
will consider##8##2##(1994-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-8#1)
will consist of##2##3##(2008-2#1)(2008-5#1)
will consist##3##2##(1995-6#1)(2008-2#1)(2008-5#1)
will consumers##2##2##(1996-3#1)(2008-7#1)
will contain##2##2##(1993-11#1)(2007-11#1)
will continue to be a##2##5##(2008-6#1)(2008-9#1)
will continue to be##6##4##(1993-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2008-6#1)(2008-9#1)
will continue to evolve##2##4##(2007-12#1)(2008-3#1)
will continue to offer##2##4##(1997-8#1)(2010-7#1)
will continue to require##2##4##(1992-3#1)(2008-1#1)
will continue to##36##3##(1990-11#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-6#1)(2013-8#1)
will continue##43##2##(1990-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-6#1)(2013-8#1)
will contribute to the understanding of##2##6##(2008-9#1)(2010-5#1)
will contribute to the##5##4##(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-8#1)
will contribute to understanding##2##4##(2008-11#1)(2012-9#1)
will contribute to##14##3##(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-9#1)(2013-8#1)
will contribute##17##2##(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#2)(2012-9#1)(2013-8#1)
will control##2##2##(1996-2#1)(2008-9#1)
will create##3##2##(1993-2#1)(1994-12#1)(1995-3#1)
will cure##2##2##(2008-11#1)(2008-6#1)
will deal with##2##3##(2008-11#1)(2012-3#1)
will decide##3##2##(2008-1#1)(2008-10#1)(2013-7#1)
will decline with##2##3##(1996-3#1)(2008-8#1)
will decrease##7##2##(1991-8#1)(1993-12#1)(1993-2#1)(1996-2#1)(1996-9#1)(2008-8#1)(2008-9#1)
will define##3##2##(1994-1#2)(2012-2#1)
will deliver##3##2##(1996-9#1)(2007-2#1)(2012-12#1)
will demand##3##2##(1992-3#1)(1993-12#1)(2011-2#1)
will demonstrate that##4##3##(1994-1#1)(2008-10#1)(2008-5#2)
will demonstrate##6##2##(1994-1#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#2)
will depend on the##9##4##(1990-2#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-8#1)
will depend on##18##3##(1990-2#1)(1994-12#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#1)
will depend##19##2##(1990-2#1)(1993-2#1)(1994-12#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#1)
will describe some##2##3##(2008-5#1)(2013-8#1)
will describe the##10##3##(1992-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-1#2)(2008-4#1)(2008-9#2)(2010-10#1)
will describe this##2##3##(2008-10#1)(2008-5#1)
will describe##17##2##(1992-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-2#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-9#2)(2010-10#1)(2013-8#2)
will detect##3##2##(2008-10#2)(2008-4#1)
will determine the##3##3##(1994-5#1)(1995-3#1)(2013-8#1)
will determine##6##2##(1992-12#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-1#1)(2013-8#1)
will develop a##2##3##(1994-12#1)(1996-1#1)
will develop##9##2##(1993-11#1)(1994-12#1)(1996-1#2)(1997-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
will die##2##2##(2008-6#1)(2009-6#1)
will differ in##2##3##(2008-8#1)(2012-6#1)
will direct##2##2##(1994-8#1)(2009-10#1)
will discuss about##2##3##(2012-3#2)
will discuss how##6##3##(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-2#1)
will discuss recent##2##3##(2009-6#1)(2011-2#1)
will discuss the development of##2##5##(2008-10#1)(2008-11#1)
will discuss the role##2##4##(2012-3#1)(2013-1#1)
will discuss the##32##3##(1991-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
will discuss various##2##3##(2008-12#1)(2010-8#1)
will discuss##65##2##(1991-1#1)(1992-3#1)(1993-1#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)
will display##2##2##(1991-1#1)(2009-10#1)
will do##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
will double##3##2##(1990-6#1)(1993-8#1)(2007-8#1)
will dramatically##2##2##(1997-3#1)(2008-11#1)
will effect##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
will eliminate##2##2##(1994-3#1)(1997-1#1)
will elucidate##2##2##(2009-5#1)(2011-2#1)
will enable a##3##3##(1993-2#1)(2008-10#1)(2013-1#1)
will enable new##2##3##(2008-4#1)(2012-2#1)
will enable the##8##3##(1996-9#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-9#1)(2011-2#2)
will enable##27##2##(1993-2#2)(1996-2#1)(1996-9#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
will encourage##2##2##(1992-12#1)(2008-12#1)
will enhance our ability to##2##5##(2008-4#1)(2012-12#1)
will enhance our understanding of the##2##6##(1991-3#1)(2008-7#1)
will enhance our understanding of##3##5##(1991-3#1)(2008-7#1)(2013-1#1)
will enhance our##7##3##(1991-3#1)(1995-12#1)(1996-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
will enhance the##7##3##(1992-11#1)(1992-12#1)(1993-3#1)(1995-1#1)(1997-1#1)(2009-6#1)(2011-2#1)
will enhance##18##2##(1991-3#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
will enroll up to##2##4##(2008-5#2)
will enroll##3##2##(2008-5#3)
will ensure that##2##3##(1991-3#1)(1993-2#1)
will ensure##6##2##(1991-3#1)(1993-2#2)(1994-2#1)(2008-11#1)(2011-2#1)
will establish a##2##3##(1990-12#1)(2008-7#1)
will establish##3##2##(1990-12#1)(2008-7#2)
will evaluate##4##2##(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
will eventually be##3##3##(1992-3#1)(1992-6#1)(2008-12#1)
will eventually##10##2##(1992-3#1)(1992-6#1)(1993-12#1)(1995-2#1)(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
will evolve into##2##3##(1992-12#1)(1997-2#1)
will evolve##4##2##(1992-12#1)(1997-2#1)(2008-7#1)(2008-8#1)
will examine the##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-2#1)
will examine##13##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-6#1)(2012-2#2)
will exhibit##2##2##(2009-11#1)(2009-7#1)
will expand the##2##3##(2008-1#1)(2010-11#1)
will expand##6##2##(1995-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-7#1)(2010-11#1)
will expedite##2##2##(2008-10#1)(2008-5#1)
will experience##6##2##(1990-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
will explain##2##2##(1993-12#1)(2008-9#1)
will exploit##2##2##(2008-7#1)(2009-3#1)
will explore a##2##3##(1994-12#1)(2008-11#1)
will explore the##4##3##(1991-12#1)(1996-1#1)(2008-11#1)(2009-4#1)
will explore##13##2##(1991-12#1)(1991-5#1)(1994-1#3)(1994-12#1)(1996-1#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-4#1)
will express##2##2##(2008-2#1)(2008-8#1)
will extend the##3##3##(1994-5#1)(2008-11#1)(2008-3#1)
will extend##5##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#2)
will face challenges in##2##4##(1997-3#1)(2007-3#1)
will face challenges##3##3##(1997-3#1)(2007-3#1)(2008-7#1)
will face##7##2##(1994-1#1)(1997-1#1)(1997-3#1)(2007-3#1)(2008-4#1)(2008-7#1)(2010-3#1)
will facilitate further##2##3##(1995-3#1)(2008-9#1)
will facilitate map-based cloning of the##2##6##(2008-8#1)(2008-9#1)
will facilitate the development of##4##5##(1994-6#1)(2007-11#1)(2008-1#1)(2008-7#1)
will facilitate the positional cloning##2##5##(1995-6#1)(2008-9#1)
will facilitate the##16##3##(1992-10#1)(1994-6#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#1)(2013-1#2)
will facilitate##40##2##(1992-10#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-3#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
will fall##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
will finally##2##2##(1996-2#1)(2012-2#1)
will find wide##2##3##(2007-11#1)(2012-3#1)
will find##8##2##(1994-1#2)(1995-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
will first##5##2##(2008-12#1)(2008-4#1)(2012-2#1)(2013-8#2)
will focus on chief technologists and will be published in the##2##11##(1995-1#1)(1995-2#1)
will focus on recent##2##4##(2008-1#1)(2013-1#1)
will focus on the##22##4##(1994-3#1)(1995-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
will focus on##47##3##(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-1#4)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#7)(2009-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
will focus##48##2##(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-1#4)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
will force##2##2##(1994-3#1)(2008-8#1)
will form##4##2##(1994-3#2)(2008-2#1)(2008-7#1)
will function##2##2##(1993-1#1)(2013-8#1)
will further provide##2##3##(2008-7#1)(2013-8#1)
will further reduce the##2##4##(2007-7#1)(2008-11#1)
will further##10##2##(1993-1#1)(1994-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
will gain##2##2##(2008-4#1)(2011-2#1)
will generally##2##2##(2008-10#2)
will get##2##2##(1996-5#1)(2008-11#1)
will give an##2##3##(2008-5#1)(2010-12#1)
will give the##2##3##(1991-12#1)(2007-10#1)
will give##10##2##(1990-9#1)(1991-12#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-12#1)(2013-7#1)
will go##4##2##(1993-2#1)(1994-3#1)(2008-4#1)(2010-8#1)
will greatly enhance our##2##4##(2008-10#1)(2009-2#1)
will greatly enhance##3##3##(2008-10#2)(2009-2#1)
will greatly##7##2##(1994-1#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-2#1)(2009-2#1)
will grow in##2##3##(1994-3#1)(2008-7#1)
will grow##3##2##(1994-3#1)(2008-7#1)(2008-8#1)
will guide##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
will have a##19##3##(1991-6#1)(1992-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#2)(2012-3#1)
will have an important##2##4##(1996-4#1)(2008-1#1)
will have an##3##3##(1996-4#1)(2008-1#1)(2009-12#1)
will have applications##2##3##(2007-11#1)(2007-12#1)
will have major##2##3##(2008-7#2)
will have on##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
will have properties##2##3##(2008-3#1)(2008-8#1)
will have the##6##3##(1993-12#1)(1994-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-8#1)
will have to be##16##4##(1990-10#1)(1990-6#1)(1992-11#2)(1994-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#2)
will have to demonstrate##2##4##(1994-2#1)(2008-7#1)
will have to make##2##4##(1993-3#1)(1995-2#1)
will have to##26##3##(1990-10#1)(1990-2#1)(1990-6#1)(1992-11#2)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-2#2)(2013-1#1)
will have##96##2##(1990-10#1)(1990-2#1)(1990-6#2)(1991-6#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
will help elucidate the mechanisms of##2##6##(2009-3#1)(2012-2#1)
will help elucidate the##3##4##(1997-7#1)(2009-3#1)(2012-2#1)
will help elucidate##4##3##(1997-7#1)(2009-3#1)(2009-6#1)(2012-2#1)
will help in the##2##4##(1995-6#1)(1996-1#1)
will help in##9##3##(1995-6#1)(1996-1#1)(2007-7#1)(2009-12#2)(2011-2#1)(2012-3#2)(2013-1#1)
will help physicians##2##3##(2008-11#1)(2008-3#1)
will help researchers in##2##4##(2008-10#1)(2010-6#1)
will help the clinician##2##4##(1993-1#1)(2007-4#1)
will help the##6##3##(1993-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)
will help to develop##2##4##(1994-5#1)(2008-10#1)
will help to##10##3##(1994-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)
will help us to##3##4##(1992-2#1)(2008-3#1)(2010-5#1)
will help us##7##3##(1992-2#1)(2008-1#1)(2008-3#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
will help you##2##3##(1993-1#1)(1995-2#1)
will help##59##2##(1991-12#1)(1992-2#1)(1993-1#2)(1993-2#2)(1994-1#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)
will highlight the##2##3##(1995-2#1)(2010-5#1)
will highlight##5##2##(1995-2#1)(2008-11#1)(2010-5#1)(2011-1#2)
will hold##2##2##(1996-5#1)(2008-3#1)
will hopefully improve##2##3##(2008-10#1)(2010-8#1)
will hopefully##10##2##(1992-8#1)(1993-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)
will identify the##4##3##(2008-11#1)(2008-2#1)(2009-2#1)(2009-5#1)
will identify##8##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-2#1)(2009-5#1)
will impact##3##2##(1994-1#1)(1996-3#1)(2013-8#1)
will implement##2##2##(1994-12#1)(1997-1#1)
will improve our understanding of##2##5##(2007-10#1)(2009-6#1)
will improve the outcome of##2##5##(2008-3#1)(2010-3#1)
will improve the##8##3##(1991-11#1)(1997-2#1)(1997-7#1)(2008-3#3)(2008-8#1)(2010-3#1)
will improve##19##2##(1991-11#1)(1994-1#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
will in turn##2##3##(2008-5#1)(2009-8#1)
will in##4##2##(1992-6#1)(2008-5#1)(2009-8#1)(2012-3#1)
will include a##2##3##(1996-1#1)(2008-5#1)
will include the##3##3##(2007-8#1)(2008-11#2)
will include##10##2##(1996-1#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)
will increase by##2##3##(1991-1#1)(1992-2#1)
will increase in the##2##4##(1991-12#1)(2012-12#1)
will increase in##4##3##(1991-11#1)(1991-12#1)(2008-3#1)(2012-12#1)
will increase the##10##3##(1990-3#1)(1993-11#1)(1993-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-7#1)
will increase their economic leverage with##2##6##(1994-1#2)
will increase their##3##3##(1994-1#2)(2008-11#1)
will increase to##2##3##(1990-12#1)(2009-2#1)
will increase##42##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-2#2)(1993-11#1)(1993-2#1)(1994-1#2)(1994-2#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
will increasingly##2##2##(1991-3#1)(2013-8#1)
will indicate##2##2##(2008-9#1)(2012-12#1)
will induce##2##2##(1991-2#1)(2007-11#1)
will inevitably##4##2##(1993-12#1)(2008-3#1)(2011-2#1)(2012-5#1)
will influence the##4##3##(1994-9#1)(2007-8#1)(2011-3#1)(2012-6#1)
will influence##7##2##(1990-12#1)(1994-9#1)(2007-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-6#1)
will inhibit##2##2##(1996-12#1)(1997-4#1)
will introduce the##2##3##(2008-4#1)(2010-11#1)
will introduce##3##2##(1991-12#1)(2008-4#1)(2010-11#1)
will involve the##2##3##(2008-10#1)(2008-7#1)
will involve##6##2##(1993-11#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
will it be##2##3##(1997-8#1)(2008-9#1)
will it##3##2##(1997-8#1)(2008-11#1)(2008-9#1)
will keep##3##2##(1994-3#2)(2008-10#1)
will know##4##2##(1994-1#1)(1997-3#1)(1997-4#1)(2013-1#1)
will lay##2##2##(1992-12#1)(2010-10#1)
will lead to a better##2##5##(2010-3#1)(2011-2#1)
will lead to a##8##4##(1990-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
will lead to improved##2##4##(2008-1#1)(2011-10#1)
will lead to the##4##4##(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
will lead to##30##3##(1990-3#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#3)
will lead##33##2##(1990-3#1)(1991-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#3)
will learn to##2##3##(1992-1#1)(1995-12#1)
will likely be##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
will likely benefit from##2##4##(2010-12#1)(2012-2#1)
will likely result in##3##4##(1996-2#1)(1997-1#1)(2009-3#1)
will likely##25##2##(1992-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
will limit the##2##3##(2008-11#1)(2008-3#1)
will limit##4##2##(1993-2#1)(1997-1#1)(2008-11#1)(2008-3#1)
will look at##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
will make a##2##3##(2008-10#1)(2009-10#1)
will make it##5##3##(1995-1#1)(1996-5#1)(1997-1#1)(2008-10#1)(2009-8#1)
will make the##2##3##(1996-3#1)(2011-1#1)
will make##21##2##(1992-3#1)(1993-12#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#2)(2009-10#1)(2009-8#1)(2011-1#3)(2011-2#1)(2013-7#1)
will manage##2##2##(1994-2#1)(2007-3#1)
will mature##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
will maximize the##2##3##(2008-5#1)(2012-2#1)
will maximize##3##2##(2008-5#1)(2012-2#1)(2012-3#1)
will measure##3##2##(1995-2#1)(2008-3#2)
will meet the##4##3##(1993-2#1)(1994-12#1)(2008-11#1)(2008-3#1)
will meet##6##2##(1993-2#2)(1994-1#1)(1994-12#1)(2008-11#1)(2008-3#1)
will mimic the##2##3##(2008-9#2)
will more##4##2##(1994-1#1)(1995-12#1)(2007-2#1)(2012-5#1)
will most probably##2##3##(1994-11#1)(1997-8#1)
will most##6##2##(1994-11#1)(1996-1#1)(1997-8#1)(2008-1#1)(2011-3#1)(2012-3#1)
will move##3##2##(2008-11#1)(2009-5#1)(2011-1#1)
will naturally##3##2##(1996-12#1)(1996-3#2)
will need a##2##3##(1995-1#1)(2011-2#1)
will need to be addressed##3##5##(1992-9#1)(2007-7#1)(2008-8#1)
will need to be##11##4##(1992-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2012-12#1)
will need to develop##4##4##(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)
will need to##26##3##(1992-2#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2011-2#1)(2012-12#1)
will need##31##2##(1992-2#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#2)(1995-2#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2011-2#2)(2012-12#2)
will no doubt be##2##4##(1995-5#1)(2008-12#1)
will no doubt##4##3##(1992-1#1)(1995-5#1)(2008-12#1)(2013-8#1)
will no longer##2##3##(1994-12#1)(2013-1#1)
will no##6##2##(1992-1#1)(1994-12#1)(1995-5#1)(2008-12#1)(2013-1#1)(2013-8#1)
will not affect##2##3##(1997-8#1)(2008-12#1)
will not be able to##3##5##(1991-3#1)(2007-4#1)(2008-11#1)
will not be available##2##4##(1997-8#1)(2008-10#1)
will not be realized until##2##5##(2008-10#1)(2009-4#1)
will not be the##2##4##(1996-12#1)(2008-10#1)
will not be##30##3##(1991-3#1)(1992-11#1)(1992-3#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-8#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-8#2)(2009-4#1)(2010-3#1)
will not come from the##3##5##(1995-6#1)(1996-2#1)(2008-6#1)
will not only##5##3##(1994-2#1)(1997-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
will not survive##2##3##(1993-3#1)(1996-4#1)
will not##74##2##(1990-10#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-1#2)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#3)(1997-8#2)(2007-11#3)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-4#2)(2010-3#1)(2010-4#1)(2011-3#2)(2012-5#1)(2013-1#2)
will now be##2##3##(1997-1#1)(2011-2#1)
will occur at##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
will occur##13##2##(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
will of##2##2##(1994-7#1)(2009-11#1)
will offer a##2##3##(2008-3#1)(2010-12#1)
will offer##3##2##(2007-11#1)(2008-3#1)(2010-12#1)
will often be##4##3##(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
will often##11##2##(1996-12#1)(1996-3#1)(2007-5#1)(2008-11#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
will only be##8##3##(1996-6#1)(1997-3#1)(1997-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
will only increase##2##3##(1993-2#1)(1995-1#1)
will only##16##2##(1993-2#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#1)
will open##3##2##(1995-4#1)(2008-9#1)(2009-8#1)
will operate##3##2##(2008-7#1)(2008-9#1)(2012-3#1)
will optimize the##2##3##(2007-12#1)(2007-8#1)
will optimize##4##2##(2007-12#1)(2007-8#1)(2008-2#1)(2012-2#1)
will outline the##2##3##(2008-7#1)(2010-6#1)
will outline##4##2##(1994-1#2)(2008-7#1)(2010-6#1)
will pass through the##2##4##(2008-10#1)(2008-3#1)
will pass##5##2##(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#1)
will pave the way##2##4##(2010-12#1)(2012-2#1)
will pay##6##2##(1992-12#1)(1995-6#2)(1997-2#1)(2008-1#1)(2010-4#1)
will permit##7##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
will persist##2##2##(2008-1#1)(2011-1#1)
will place##2##2##(2008-10#1)(2008-3#1)
will play a critical role in##2##6##(2009-6#1)(2012-3#1)
will play a role in##3##5##(1994-3#1)(2008-10#1)(2010-5#1)
will play a##7##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-3#1)
will play an important role##3##5##(2008-3#1)(2008-7#1)(2012-2#1)
will play an important##4##4##(2007-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
will play an##6##3##(2007-12#1)(2008-3#1)(2008-7#1)(2011-7#1)(2012-2#1)(2012-3#1)
will play##15##2##(1994-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-7#1)(2012-2#1)(2012-3#3)
will present a##3##3##(1994-3#1)(2008-10#1)(2009-6#1)
will present the##2##3##(1993-2#1)(2009-12#1)
will present##12##2##(1993-2#2)(1994-3#1)(1994-6#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2012-1#1)
will preserve##2##2##(1993-11#1)(1994-1#1)
will probably be more##2##4##(2008-3#1)(2010-1#1)
will probably be##7##3##(1992-2#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)(2012-2#1)
will probably have##2##3##(1992-6#1)(1993-2#1)
will probably represent##2##3##(2008-7#1)(2012-2#1)
will probably##21##2##(1991-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-2#2)
will produce##6##2##(1991-1#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)
will progress##4##2##(2008-5#1)(2008-7#1)(2009-10#2)
will promote the##2##3##(2008-10#1)(2008-11#1)
will promote##10##2##(1994-12#1)(1995-5#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
will prove to be##2##4##(2011-3#1)(2013-8#1)
will prove##6##2##(1992-8#1)(2008-7#1)(2010-3#1)(2011-3#1)(2012-3#1)(2013-8#1)
will provide a##23##3##(1993-11#1)(1994-3#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)
will provide additional##2##3##(1995-1#1)(2012-2#1)
will provide an overview of the current##2##7##(2009-4#1)(2013-8#1)
will provide an overview of the##4##6##(1991-1#1)(2009-4#1)(2011-2#1)(2013-8#1)
will provide an overview of##6##5##(1991-1#1)(1995-1#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
will provide an##11##3##(1991-1#1)(1995-1#1)(2006-6#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
will provide further##2##3##(2008-7#1)(2010-2#1)
will provide guidance##2##3##(2008-11#1)(2009-10#1)
will provide important##2##3##(2011-2#1)(2013-1#1)
will provide information##2##3##(1995-3#1)(1996-2#1)
will provide new##4##3##(2008-11#2)(2008-4#1)(2010-3#1)
will provide reports on##2##4##(1994-1#1)(1994-2#1)
will provide the reader with an##2##6##(1997-3#1)(2009-12#1)
will provide the##8##3##(1990-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-10#1)
will provide useful information##2##4##(2008-10#1)(2008-7#1)
will provide valuable##3##3##(2008-3#1)(2010-4#1)(2013-8#1)
will provide##94##2##(1990-11#1)(1991-1#2)(1991-2#1)(1993-11#1)(1994-1#1)(1994-2#3)(1994-3#5)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2011-10#1)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#2)
will quickly##2##2##(2008-4#2)
will reach the##2##3##(1997-6#1)(2011-1#1)
will reach##5##2##(1993-3#1)(1994-9#1)(1997-6#1)(2011-1#1)(2013-8#1)
will receive either GS-4104 or placebo for##2##7##(2008-5#2)
will receive##8##2##(1993-12#1)(1993-3#1)(1995-1#1)(1997-5#2)(2008-5#3)
will recognize##3##2##(1994-3#1)(1996-1#1)(2013-7#1)
will reduce the##7##3##(1991-2#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
will reduce##17##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
will remain##16##2##(1992-3#1)(1993-8#1)(1994-2#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-4#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#1)
will remove##2##2##(2008-12#1)(2008-8#1)
will represent##2##2##(2007-3#1)(2008-3#1)
will require a##10##3##(1992-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1997-7#1)(2008-2#1)(2009-11#1)(2011-2#2)(2012-12#1)
will require better##2##3##(1997-3#1)(2011-2#1)
will require extensive##2##3##(1993-2#1)(1994-12#1)
will require more##6##3##(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)
will require substantial##2##3##(1994-12#1)(1994-9#1)
will require the use of##2##5##(1995-5#1)(2008-7#1)
will require the##5##3##(1995-5#1)(2008-10#2)(2008-7#1)(2013-1#1)
will require##59##2##(1992-3#2)(1993-2#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-12#2)(1996-3#3)(1997-3#1)(1997-7#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#2)
will respond to##2##3##(2008-4#1)(2010-3#1)
will respond##3##2##(1990-11#1)(2008-4#1)(2010-3#1)
will result from##2##3##(1993-2#1)(1994-9#1)
will result in a##5##4##(1991-2#1)(1994-12#1)(2008-10#1)(2009-7#1)(2013-8#1)
will result in the##4##4##(2006-6#1)(2007-7#1)(2008-3#1)(2011-2#1)
will result in##20##3##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-7#1)(2009-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
will result##24##2##(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
will reveal##3##2##(1997-7#1)(2009-8#1)(2010-12#1)
will review the current##4##4##(2008-5#2)(2008-9#1)(2010-12#1)
will review the##24##3##(1992-3#1)(1994-3#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
will review these##3##3##(1995-1#1)(2008-7#1)(2010-3#1)
will review this##2##3##(1994-3#1)(2009-5#1)
will review##37##2##(1991-2#1)(1992-3#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-1#1)(1997-1#2)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
will save##2##2##(1997-8#1)(2009-3#1)
will see a##2##3##(1996-12#1)(2010-8#1)
will see##5##2##(1996-12#1)(2008-11#1)(2009-4#2)(2010-8#1)
will serve as a##2##4##(1991-6#1)(2008-7#1)
will serve as##3##3##(1991-6#1)(1996-12#1)(2008-7#1)
will serve to##2##3##(1992-4#1)(2008-11#1)
will serve##7##2##(1991-6#1)(1992-4#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-7#1)
will shift##3##2##(1996-3#1)(2007-7#1)(2008-2#1)
will show that##8##3##(1994-1#2)(1994-3#2)(1996-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
will show##10##2##(1994-1#2)(1994-3#2)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
will significantly##3##2##(1997-1#1)(2007-11#1)(2008-11#1)
will soon be##5##3##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
will soon##6##2##(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
will spend##4##2##(1992-3#1)(1996-2#1)(2008-7#1)(2011-2#1)
will spontaneously##2##2##(2008-6#1)(2010-8#1)
will still##3##2##(1992-3#1)(1996-6#1)(2009-10#1)
will stimulate##4##2##(1992-2#1)(1994-1#1)(2008-10#1)(2008-11#1)
will strengthen##2##2##(2012-12#1)(2012-3#1)
will substantially##2##2##(2008-8#2)
will succeed in##2##3##(1997-2#1)(2008-11#1)
will succeed##3##2##(1997-2#1)(2008-11#1)(2008-3#1)
will suffer from##2##3##(2008-7#2)
will suffer##3##2##(2008-7#2)(2008-9#1)
will suggest that##3##3##(1996-11#1)(2008-12#1)(2013-1#1)
will summarize the structural##2##4##(1994-11#1)(2013-1#1)
will summarize the##6##3##(1994-11#1)(2007-7#1)(2008-7#2)(2011-1#1)(2013-1#1)
will summarize these##2##3##(2008-7#1)(2013-1#1)
will summarize##14##2##(1994-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
will support a##3##3##(1993-12#1)(1994-1#1)(2007-12#1)
will support the##2##3##(1995-12#1)(2008-9#1)
will support##8##2##(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
will survive##2##2##(1994-12#1)(2008-10#1)
will take a##2##3##(1992-3#1)(1994-12#1)
will take place##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
will take time##2##3##(1996-3#1)(1997-2#1)
will take##13##2##(1992-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)
will test##3##2##(1992-12#1)(1993-2#1)(2012-3#1)
will the##4##2##(1994-9#1)(1997-1#1)(2008-7#1)(2010-9#1)
will then be##2##3##(2008-2#1)(2010-11#1)
will then##8##2##(1993-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-11#1)(2013-8#1)
will therefore##7##2##(1997-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-1#2)
will they##2##2##(2008-10#1)(2012-3#1)
will thus##2##2##(1996-2#1)(2013-8#1)
will to##6##2##(2008-11#1)(2008-4#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
will travel##2##2##(1996-1#1)(2008-10#1)
will try to##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
will typically##3##2##(2008-4#1)(2010-10#1)(2011-2#1)
will ultimately##9##2##(1992-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2009-6#1)(2010-12#1)(2011-1#1)
will undergo##3##2##(2009-9#1)(2011-1#1)(2013-1#1)
will undoubtedly be##2##3##(1995-12#1)(1996-11#1)
will undoubtedly##7##2##(1991-12#2)(1995-12#1)(1996-11#1)(2008-7#2)(2008-8#1)
will use the##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
will use##7##2##(1991-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2012-12#1)
will usher in##2##3##(1991-5#1)(2009-5#1)
will usually##3##2##(1995-1#1)(2008-8#1)(2013-8#1)
will vary##8##2##(1994-1#1)(1997-1#1)(2008-10#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-7#1)
will want##2##2##(1992-3#1)(2008-4#1)
will work##6##2##(1994-1#1)(1994-12#1)(1995-6#1)(2008-2#2)(2008-5#1)
will yield the##2##3##(2008-2#1)(2009-6#1)
will yield##6##2##(1991-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#1)
will##3207##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#5)(1990-5#1)(1990-6#7)(1990-9#2)(1991-1#14)(1991-11#5)(1991-12#26)(1991-2#10)(1991-3#8)(1991-5#6)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#8)(1992-10#1)(1992-11#5)(1992-12#25)(1992-2#15)(1992-3#39)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#5)(1992-9#9)(1993-1#13)(1993-11#12)(1993-12#27)(1993-2#35)(1993-3#18)(1993-5#2)(1993-6#1)(1993-8#2)(1994-1#52)(1994-11#4)(1994-12#36)(1994-2#26)(1994-3#55)(1994-5#10)(1994-6#7)(1994-7#3)(1994-8#4)(1994-9#14)(1995-1#35)(1995-11#1)(1995-12#33)(1995-2#33)(1995-3#21)(1995-4#2)(1995-5#10)(1995-6#15)(1995-8#4)(1995-9#2)(1996-1#29)(1996-11#5)(1996-12#28)(1996-2#29)(1996-3#47)(1996-4#7)(1996-5#17)(1996-6#7)(1996-8#4)(1996-9#9)(1997-1#42)(1997-2#30)(1997-3#35)(1997-4#12)(1997-5#10)(1997-6#9)(1997-7#14)(1997-8#16)(2006-10#9)(2006-6#2)(2007-1#1)(2007-10#13)(2007-11#25)(2007-12#22)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#10)(2007-6#3)(2007-7#20)(2007-8#18)(2007-9#1)(2008-1#61)(2008-10#262)(2008-11#147)(2008-12#50)(2008-2#45)(2008-3#85)(2008-4#56)(2008-5#116)(2008-6#31)(2008-7#161)(2008-8#97)(2008-9#71)(2009-1#3)(2009-10#22)(2009-11#10)(2009-12#17)(2009-2#7)(2009-3#10)(2009-4#13)(2009-5#32)(2009-6#14)(2009-7#13)(2009-8#17)(2009-9#11)(2010-1#4)(2010-10#16)(2010-11#16)(2010-12#25)(2010-2#2)(2010-3#37)(2010-4#16)(2010-5#18)(2010-6#8)(2010-7#5)(2010-8#37)(2010-9#7)(2011-1#40)(2011-10#3)(2011-2#109)(2011-3#12)(2011-7#1)(2011-9#1)(2012-1#6)(2012-12#40)(2012-2#76)(2012-3#53)(2012-5#3)(2012-6#3)(2012-9#1)(2013-1#56)(2013-7#18)(2013-8#51)
willful##3##1##(1996-5#1)(2010-4#2)
willing to participate in the##3##5##(1994-12#1)(1994-2#1)(2012-2#1)
willing to participate in##6##4##(1994-12#1)(1994-2#1)(2008-1#2)(2012-2#1)(2012-3#1)
willing to pay for##3##4##(1994-1#1)(2007-2#1)(2008-10#1)
willing to pay##4##3##(1994-1#1)(2007-2#1)(2007-7#1)(2008-10#1)
willing to provide##2##3##(1996-3#1)(2009-5#1)
willing to##32##2##(1991-2#1)(1991-5#1)(1992-12#2)(1994-1#2)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-5#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
willing##36##1##(1991-2#1)(1991-5#1)(1992-12#2)(1994-1#2)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#2)(2009-5#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
willingness and##2##2##(2010-8#1)(2012-2#1)
willingness of a young child to cooperate##2##7##(1996-2#2)
willingness of##6##2##(1996-2#2)(2007-10#2)(2007-7#1)(2008-1#1)
willingness to mate##2##3##(2009-9#2)
willingness to pay##5##3##(2007-7#3)(2012-12#2)
willingness to##24##2##(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-9#1)(1996-11#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-9#2)(2011-1#1)(2012-12#2)(2013-1#2)
willingness##32##1##(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-9#1)(1996-11#1)(1996-2#2)(2007-10#2)(2007-7#4)(2008-1#2)(2008-11#1)(2008-7#1)(2009-5#1)(2009-9#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
willow and##2##2##(2008-6#1)(2008-8#1)
willow##7##1##(2008-6#4)(2008-8#2)(2012-3#1)
wilt and canker##2##3##(2008-10#2)
wilt and##9##2##(2008-10#9)
wilt by##2##2##(2008-10#2)
wilt caused by##2##3##(2008-10#2)
wilt development##5##2##(2008-10#5)
wilt disease and##2##3##(2008-10#2)
wilt disease##14##2##(2008-10#11)(2008-12#3)
wilt diseases##4##2##(2008-10#4)
wilt epidemics##5##2##(2008-10#5)
wilt in some##2##3##(2008-10#2)
wilt in##6##2##(2008-10#6)
wilt incidence and severity##4##4##(2008-10#4)
wilt incidence##6##2##(2008-10#6)
wilt of chickpea##4##3##(2008-10#4)
wilt of cucumber by##2##4##(2008-10#2)
wilt of cucumber##3##3##(2008-10#3)
wilt of radish##2##3##(2008-10#2)
wilt of tomato##6##3##(2008-10#6)
wilt of##29##2##(2008-10#29)
wilt on##3##2##(2008-10#3)
wilt pathogen##5##2##(2008-10#5)
wilt resistance in##2##3##(2008-10#2)
wilt resistance##4##2##(2008-10#4)
wilt symptom development##2##3##(2008-10#2)
wilt symptom##3##2##(2008-10#3)
wilt symptoms in response to##2##5##(2008-10#2)
wilt symptoms in##4##3##(2008-10#4)
wilt symptoms were##2##3##(2008-10#2)
wilt symptoms when##2##3##(2008-10#2)
wilt symptoms##14##2##(2008-10#14)
wilt virus##35##2##(2008-10#35)
wilt was##5##2##(2008-10#5)
wilt##200##1##(2008-10#196)(2008-12#3)(2011-1#1)
wilt&quot##2##1##(2008-10#2)
wilt-resistant##6##1##(2008-10#6)
wilt-susceptible and wilt-resistant##2##3##(2008-10#2)
wilt-susceptible##6##1##(2008-10#6)
wilted##3##1##(2008-10#3)
wilting in##3##2##(2008-10#3)
wilting of##2##2##(2008-10#2)
wilting symptoms##2##2##(2008-10#2)
wilting##14##1##(2008-10#13)(2008-12#1)
win their##2##2##(1991-3#1)(1996-1#1)
win##16##1##(1990-8#1)(1991-3#1)(1992-2#2)(1995-12#1)(1996-1#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2013-8#1)
win&quot##2##1##(2008-11#1)(2008-8#1)
win-win##3##1##(1992-1#1)(1993-1#1)(1994-1#1)
wind and temperature##4##3##(2008-2#1)(2008-3#3)
wind and##11##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)
wind currents##2##2##(2008-10#1)(2012-2#1)
wind direction##7##2##(2008-10#4)(2008-12#1)(2008-5#2)
wind fields##3##2##(2008-11#1)(2008-2#2)
wind from##2##2##(2008-10#1)(2008-3#1)
wind lidar##6##2##(2008-2#1)(2008-3#5)
wind measurement##2##2##(2008-2#2)
wind measurements with##2##3##(2008-2#1)(2008-3#1)
wind measurements##5##2##(2008-2#2)(2008-3#3)
wind patterns##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
wind speed##17##2##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#7)(2009-7#1)
wind speeds##8##2##(2007-12#2)(2008-10#2)(2008-3#4)
wind trajectories##4##2##(2008-8#4)
wind tunnel##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)
wind velocity##5##2##(2008-10#1)(2008-3#3)(2008-5#1)
wind##126##1##(2007-11#1)(2007-12#5)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#44)(2008-5#9)(2008-8#11)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2012-2#2)(2013-8#1)
wind-dispersed ascospores##3##2##(2008-10#3)
wind-dispersed##5##1##(2008-10#4)(2009-8#1)
wind-driven rains##2##2##(2008-10#2)
wind-driven##3##1##(2008-10#2)(2008-2#1)
wind-speed##2##1##(2008-3#2)
windbeutel##2##1##(1991-5#2)
windborne ascospores##2##2##(2008-10#2)
windborne##4##1##(2008-10#3)(2013-8#1)
window and##2##2##(2008-3#1)(2009-7#1)
window by##2##2##(2008-3#1)(2013-8#1)
window for##5##2##(2007-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
window in the##3##3##(2008-2#2)(2011-2#1)
window in##5##2##(2007-10#1)(2007-12#1)(2008-2#2)(2011-2#1)
window is a##2##3##(2007-12#1)(2012-2#1)
window is##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2011-1#1)(2012-2#1)
window materials##2##2##(2007-12#1)(2008-2#1)
window of approximately##3##3##(2008-3#3)
window of opportunity for##3##4##(2008-3#1)(2010-6#1)(2013-1#1)
window of opportunity##6##3##(2008-3#2)(2009-8#1)(2010-5#1)(2010-6#1)(2013-1#1)
window of the##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-7#1)
window of##22##2##(1994-11#1)(1996-9#1)(2008-10#3)(2008-3#9)(2008-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-7#1)(2013-1#1)(2013-8#1)
window regions##2##2##(2008-2#1)(2008-3#1)
window technique##2##2##(1990-5#1)(2013-1#1)
window to##2##2##(2008-10#1)(2012-3#1)
window was not##2##3##(2007-10#1)(2008-10#1)
window was##4##2##(2007-10#1)(2008-10#3)
window##126##1##(1990-5#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(2007-10#5)(2007-11#7)(2007-12#8)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#12)(2008-3#23)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#2)(2009-8#2)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#2)(2013-8#5)
window&quot##2##1##(1995-5#1)(2008-9#1)
windowed##4##1##(2007-11#3)(2012-2#1)
windowing##2##1##(2008-3#1)(2009-2#1)
windows and##2##2##(2008-10#1)(2012-2#1)
windows are##2##2##(2008-3#1)(2008-6#1)
windows at##2##2##(2008-6#1)(2011-1#1)
windows for##2##2##(2007-12#1)(2008-8#1)
windows of the##2##3##(2008-7#1)(2013-1#1)
windows of##4##2##(1996-5#1)(2008-3#1)(2008-7#1)(2013-1#1)
windows##38##1##(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#14)(2008-6#3)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#2)(2012-2#3)(2013-1#1)
winds from##2##2##(2008-2#1)(2008-3#1)
winds in##2##2##(1992-7#1)(2008-3#1)
winds##19##1##(1992-3#1)(1992-7#2)(1994-1#1)(1994-3#1)(1996-4#2)(2008-2#2)(2008-3#10)
windshields##3##1##(2008-10#2)(2008-3#1)
wine and beer##2##3##(2008-10#1)(2009-7#1)
wine and##10##2##(2008-10#7)(2008-7#1)(2009-7#1)(2011-1#1)
wine by##2##2##(2008-10#2)
wine fermentation##2##2##(2012-3#2)
wine or##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
wine quality and##2##3##(2008-10#2)
wine quality##5##2##(2008-10#5)
wine samples by##2##3##(2008-10#2)
wine samples from##2##3##(2008-10#2)
wine samples##24##2##(2008-10#24)
wine type##2##2##(2008-10#2)
wine using##4##2##(2008-10#4)
wine was##2##2##(2008-10#2)
wine yeast##3##2##(2012-3#3)
wine##131##1##(1992-1#1)(1994-1#1)(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#98)(2008-7#11)(2009-3#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#5)(2013-1#1)
wines according to their##2##4##(2008-10#2)
wines according to##5##3##(2008-10#5)
wines and##9##2##(2008-10#8)(2011-1#1)
wines are##2##2##(2008-10#2)
wines based on##2##3##(2008-10#2)
wines by their##3##3##(2008-10#3)
wines by##6##2##(2008-10#6)
wines from the##4##3##(2008-10#4)
wines from##10##2##(2008-10#10)
wines of##2##2##(2008-10#2)
wines using a##2##3##(2008-10#2)
wines using the##2##3##(2008-10#2)
wines using##7##2##(2008-10#6)(2011-1#1)
wines was determined##3##3##(2008-10#3)
wines was##4##2##(2008-10#4)
wines were##2##2##(2008-10#2)
wines##92##1##(2008-10#89)(2011-1#3)
wing fanning##2##2##(2013-8#2)
wing motion##2##2##(2007-12#2)
wing scales##2##2##(2008-2#1)(2008-3#1)
wing##29##1##(1991-11#2)(2007-12#12)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#6)(2009-4#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
winged##2##1##(2007-12#1)(2013-1#1)
wings and##2##2##(2007-12#2)
wings clipped##2##2##(2008-11#1)(2013-8#1)
wings of the##3##3##(1995-5#1)(2008-3#2)
wings of##7##2##(1995-5#1)(2008-2#2)(2008-3#2)(2013-1#2)
wings##24##1##(1990-9#1)(1991-12#1)(1995-5#1)(2007-12#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-9#1)(2012-2#2)(2013-1#3)(2013-8#2)
winner of the##2##3##(1993-3#1)(2013-8#1)
winner##7##1##(1993-3#1)(1996-12#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-8#1)
winner's##2##1##(2011-2#2)
winners in##2##2##(2009-9#1)(2013-7#1)
winners##16##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#2)(2007-4#1)(2008-8#1)(2009-9#3)(2013-7#1)
winning the##2##2##(1992-11#1)(2008-7#1)
winning##15##1##(1991-3#1)(1992-11#1)(1993-3#1)(1995-1#1)(1996-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-9#2)(2013-1#2)(2013-8#1)
wins##6##1##(1991-8#1)(1993-1#1)(1993-12#1)(1996-12#1)(2008-10#1)(2011-2#1)
winter and spring##5##3##(2008-10#3)(2008-11#1)(2013-7#1)
winter and##8##2##(1995-11#1)(2008-10#5)(2008-11#1)(2013-7#1)
winter barley (Hordeum##2##3##(2008-10#1)(2008-11#1)
winter barley cv##2##3##(2008-10#2)
winter barley##9##2##(2008-10#7)(2008-11#2)
winter cereals##3##2##(2008-10#3)
winter in##2##2##(2013-1#1)(2013-8#1)
winter months##8##2##(1991-8#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-4#1)(2011-1#1)
winter of##6##2##(1996-9#1)(2007-6#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-8#1)
winter oilseed rape##3##3##(2008-10#3)
winter period##2##2##(2008-10#1)(2011-2#1)
winter rye##2##2##(2008-10#1)(2008-12#1)
winter season##2##2##(2008-10#1)(2008-5#1)
winter seasons##2##2##(1997-6#1)(2011-2#1)
winter survival##2##2##(2008-10#2)
winter temperature##2##2##(2008-10#1)(2008-7#1)
winter temperatures prevailing##2##3##(2008-10#2)
winter temperatures##4##2##(2008-10#3)(2010-8#1)
winter to##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
winter wheat (Triticum aestivum)##3##4##(2008-10#2)(2008-12#1)
winter wheat (Triticum##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
winter wheat as##3##3##(1992-3#1)(2008-10#1)(2008-12#1)
winter wheat biomass estimation##2##4##(2013-8#2)
winter wheat biomass##3##3##(2013-8#3)
winter wheat cultivar##2##3##(2008-10#2)
winter wheat cultivars##5##3##(2008-10#5)
winter wheat genotypes##3##3##(2008-10#3)
winter wheat were##2##3##(2008-10#2)
winter wheat##44##2##(1992-3#1)(2008-10#34)(2008-12#3)(2008-5#2)(2012-2#1)(2013-8#3)
winter##182##1##(1991-8#2)(1992-3#1)(1993-3#1)(1994-12#1)(1995-11#5)(1995-2#1)(1996-9#1)(1997-3#1)(1997-6#4)(2007-10#2)(2007-6#1)(2007-7#1)(2008-10#87)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#3)(2009-11#1)(2009-4#2)(2010-4#1)(2010-5#1)(2010-8#7)(2011-1#1)(2011-2#3)(2012-2#5)(2012-4#1)(2013-1#4)(2013-7#4)(2013-8#9)
winter) at##2##2##(2008-10#2)
winter)##4##1##(2008-10#3)(2011-2#1)
winter/spring##3##1##(2011-2#2)(2012-3#1)
winterform and summerform pear psylla##2##5##(2008-10#2)
winters##5##1##(2008-10#2)(2008-9#1)(2010-8#1)(2012-4#1)
wintertime##2##1##(2007-10#1)(2008-2#1)
wipe##2##1##(2008-3#1)(2008-5#1)
wipes##11##1##(2008-5#11)
wire and a##2##3##(2008-10#2)
wire and cable extrusion##2##4##(2008-9#2)
wire and##9##2##(2008-10#2)(2008-9#2)(2009-3#3)(2009-7#2)
wire as##3##2##(2008-10#3)
wire electrode##3##2##(2008-10#3)
wire electrodes##4##2##(2008-10#3)(2012-12#1)
wire grid polarizer##3##3##(2008-3#3)
wire grid polarizers##2##3##(2008-3#2)
wire grid##5##2##(2008-3#5)
wire in the##3##3##(1996-6#1)(2008-11#1)(2009-11#1)
wire in##4##2##(1996-6#1)(2007-11#1)(2008-11#1)(2009-11#1)
wire is##4##2##(2008-10#2)(2008-3#1)(2009-11#1)
wire nuts##2##2##(2011-2#2)
wire placement in the sternoclavicular joint##2##6##(2007-8#2)
wire technique##4##2##(2007-8#4)
wire twists##8##2##(2007-8#8)
wire was##7##2##(2007-8#3)(2008-10#2)(2012-1#2)
wire with##2##2##(2008-10#1)(2012-1#1)
wire##117##1##(1990-5#1)(1992-11#1)(1996-2#1)(1996-6#1)(2007-11#3)(2007-12#1)(2007-8#26)(2008-10#32)(2008-11#3)(2008-2#1)(2008-3#9)(2008-7#2)(2008-9#2)(2009-11#3)(2009-3#8)(2009-5#1)(2009-7#4)(2010-9#1)(2011-2#11)(2012-1#5)(2012-12#1)
wire)##3##1##(2008-10#3)
wired##5##1##(2007-8#2)(2008-6#1)(2008-7#2)
wireless ECG##3##2##(2010-8#3)
wireless network##2##2##(2008-7#1)(2010-8#1)
wireless personal digital##2##3##(2008-12#2)
wireless technology##2##2##(2010-8#1)(2013-1#1)
wireless telephone system##2##3##(2010-2#2)
wireless telephone##4##2##(2010-2#4)
wireless##38##1##(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#4)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#3)(2010-2#4)(2010-3#1)(2010-5#1)(2010-8#9)(2012-3#1)(2013-1#1)
wirelessly##3##1##(2008-12#1)(2010-5#1)(2012-3#1)
wires and##3##2##(2008-2#2)(2011-2#1)
wires in a##2##3##(2008-4#1)(2012-2#1)
wires in##3##2##(2008-4#2)(2012-2#1)
wires of##2##2##(2007-8#1)(2009-11#1)
wires or##2##2##(1992-3#1)(2011-2#1)
wires were##3##2##(2008-10#2)(2008-11#1)
wires##46##1##(1991-8#1)(1992-3#1)(1992-8#1)(1996-6#1)(2007-12#3)(2007-8#7)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#2)(2009-11#2)(2009-3#2)(2009-9#2)(2010-12#2)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
wireworm populations##2##2##(2011-2#2)
wireworm##5##1##(2011-2#5)
wiring for chronic total##2##4##(2008-11#2)
wiring##7##1##(2008-10#2)(2008-11#3)(2010-2#1)(2011-1#1)
wisdom##10##1##(1993-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#2)(2011-2#1)(2012-3#1)
wise to##3##2##(1994-2#1)(1996-1#1)(2013-1#1)
wise##11##1##(1992-2#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-8#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
wisely##6##1##(1993-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
wish to have##2##3##(1992-2#1)(1997-8#1)
wish to pursue##3##3##(1992-1#1)(2008-11#1)(2012-2#1)
wish to use##4##3##(1991-5#1)(1991-6#1)(2008-12#1)(2010-5#1)
wish to##34##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#1)(1995-5#1)(1996-5#1)(1997-8#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
wish##42##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#2)(1994-1#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-8#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
wished to continue its use##2##5##(2012-3#2)
wished to##10##2##(1992-12#1)(1992-6#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-11#1)(2011-2#1)(2012-3#2)
wished##11##1##(1992-12#1)(1992-6#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#2)
wishes and##2##2##(1992-4#1)(2011-2#1)
wishes to##6##2##(1993-12#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-3#1)
wishes##15##1##(1990-11#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1997-2#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
wishing to preserve their##2##4##(2009-7#1)(2012-2#1)
wishing to##15##2##(1994-2#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)
wistar rats##4##2##(2007-4#1)(2008-12#2)(2013-1#1)
wit##5##1##(1997-3#1)(2007-7#1)(2008-10#2)(2011-2#1)
witch##2##1##(2007-11#1)(2008-10#1)
witchcraft and##3##2##(2008-10#2)(2008-12#1)
witchcraft##7##1##(1993-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)
witches' broom##2##2##(2008-10#2)
witches'-broom disease##3##2##(2008-10#3)
witches'-broom in##2##2##(2008-10#2)
witches'-broom##17##1##(2008-10#17)
with % protection of##3##4##(2011-1#3)
with %##4##2##(1990-8#1)(2011-1#3)
with &gt##16##2##(1993-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
with &lt##7##2##(2008-10#3)(2008-12#1)(2008-2#1)(2010-3#1)(2012-3#1)
with &quot##30##2##(1990-11#1)(1990-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#3)(1995-2#1)(1995-8#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-5#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
with (R##2##2##(1996-2#2)
with (i)##4##2##(1991-2#1)(2008-10#2)(2008-11#1)
with -0##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
with 0##156##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-11#4)(2007-12#2)(2008-10#73)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)
with 1 %##2##3##(2008-6#1)(2010-10#1)
with 1 M##5##3##(1993-3#1)(1995-6#1)(2008-10#3)
with 1 and##6##3##(1990-11#1)(1995-12#1)(2007-7#1)(2008-10#3)
with 1 mM##5##3##(1991-3#1)(1993-6#1)(1993-8#1)(1995-8#1)(2012-12#1)
with 1 microM##3##3##(1992-12#1)(1994-8#1)(1997-7#1)
with 1 ml of##3##4##(1992-3#1)(2008-10#2)
with 1 ml##5##3##(1992-3#1)(1996-12#1)(2008-10#3)
with 1 mm of##2##4##(2008-9#1)(2009-8#1)
with 1 mm##3##3##(2008-9#1)(2009-8#1)(2011-2#1)
with 1 muM indirubin-3'-monoxime or carrier control##4##7##(2008-10#4)
with 1 nM##4##3##(1990-12#1)(1995-12#3)
with 1 x##4##3##(2008-10#3)(2008-8#1)
with 1##147##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-12#5)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#57)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#1)
with 1%##10##2##(1993-6#1)(1996-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-6#1)(2013-7#1)
with 1-##4##2##(2008-7#1)(2011-2#3)
with 1-(2-pyridylazo)-2-naphthol (PAN)##4##3##(2008-10#4)
with 1-(2-pyridylazo)-2-naphthol##7##2##(2008-10#7)
with 1-(2-thiasolylazo)-2-naphthol##2##2##(2008-10#2)
with 1-W##2##2##(2007-11#2)
with 1-year##2##2##(2007-8#1)(2010-8#1)
with 10 &lt##4##3##(2008-7#4)
with 10 injections##2##3##(1993-3#1)(2008-10#1)
with 10 mM##2##3##(1993-3#1)(2008-6#1)
with 10 microM##4##3##(1991-5#1)(1991-9#1)(1992-11#1)(1993-9#1)
with 10 ml of##6##4##(2008-10#6)
with 10 ml##7##3##(1995-2#1)(2008-10#6)
with 10 nM##3##3##(1992-3#1)(1994-6#1)(1995-12#1)
with 10 nematodes##3##3##(2008-10#3)
with 10 nm##2##3##(2011-1#2)
with 10##60##2##(1990-5#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-7#1)
with 10% FBS##3##3##(2007-11#1)(2008-11#2)
with 10% fat##3##3##(2010-4#3)
with 10% fetal##2##3##(1990-7#1)(2008-11#1)
with 10%##16##2##(1990-7#1)(1990-8#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-5#1)(2009-12#1)(2010-4#4)
with 10(-4) M##2##3##(1992-12#2)
with 10(-7)##2##2##(2008-11#2)
with 10- and##2##3##(2008-10#1)(2008-3#1)
with 10-fold##2##2##(1992-6#1)(2011-1#1)
with 100 lice##2##3##(1996-12#2)
with 100 mg of##2##4##(2008-10#1)(2008-5#1)
with 100 mg##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
with 100 mg/kg##2##3##(1991-3#1)(1992-3#1)
with 100 microM acetylcholine##2##4##(1995-11#2)
with 100 microM##3##3##(1990-12#1)(1995-11#2)
with 100 micrograms##2##3##(1990-6#1)(1991-12#1)
with 100 mul##2##3##(2008-10#2)
with 100 nM alpha-MSH for##2##5##(1995-2#2)
with 100 nM alpha-MSH##3##4##(1995-2#3)
with 100 nM##5##3##(1992-3#1)(1994-9#1)(1995-2#3)
with 100##34##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#3)(1996-12#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
with 100% accuracy##2##3##(2008-10#1)(2010-3#1)
with 100%##6##2##(2008-10#4)(2010-3#1)(2012-12#1)
with 100-fs pulses##2##3##(2007-12#2)
with 100-fs##3##2##(2007-11#1)(2007-12#2)
with 105##2##2##(2008-12#1)(2010-2#1)
with 11##10##2##(1993-2#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-9#1)(2013-1#1)
with 11%##2##2##(2006-8#1)(2012-12#1)
with 11-mercaptoundecanoic acid##2##3##(2008-10#2)
with 110 microm##2##3##(2009-8#2)
with 11C-raclopride##2##2##(1996-5#2)
with 12##25##2##(1991-11#1)(1991-5#1)(1995-12#1)(1997-5#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
with 12-##2##2##(2008-10#2)
with 120##4##2##(1990-12#1)(1996-3#1)(2008-5#1)(2013-1#1)
with 125I-TSST-1 for binding to class II MHC##2##8##(1993-3#2)
with 128##2##2##(2008-2#1)(2013-7#1)
with 13##8##2##(1996-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
with 132##2##2##(1995-2#1)(2008-11#1)
with 14 and##3##3##(1995-3#1)(2008-10#2)
with 14##14##2##(1990-2#1)(1995-3#1)(1997-5#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
with 140##2##2##(1995-12#1)(2008-10#1)
with 147##2##2##(1991-12#1)(2008-3#1)
with 15 isolates##2##3##(2008-10#2)
with 15 ml of##2##4##(2008-10#2)
with 15##15##2##(1990-6#1)(1994-9#1)(1996-8#1)(2008-10#7)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
with 15%##4##2##(2008-5#1)(2010-4#2)(2013-1#1)
with 15-crown-5##2##2##(2008-10#2)
with 16##9##2##(1994-9#1)(1996-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
with 16%##2##2##(2006-8#1)(2008-2#1)
with 16-membered cyclic tetrathioether##2##4##(2008-10#2)
with 160##3##2##(1997-7#1)(2008-2#1)(2011-2#1)
with 17##5##2##(1993-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2013-7#1)
with 18##9##2##(1990-6#1)(1992-6#1)(1995-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
with 180##2##2##(2008-10#1)(2008-5#1)
with 186##2##2##(2008-8#1)(2010-5#1)
with 19##5##2##(2008-10#2)(2008-6#1)(2009-5#1)(2010-4#1)
with 193-nm##2##2##(2008-2#1)(2008-3#1)
with 1H##2##2##(1996-5#1)(2011-3#1)
with 1M nitric acid##2##4##(2008-10#2)
with 1M##3##2##(2008-10#3)
with 1O2*##2##2##(1994-12#2)
with 1moll(-1)##2##2##(2008-10#2)
with 2 M##3##3##(2008-10#3)
with 2 children##2##3##(1992-4#2)
with 2 mg of oral granisetron##2##6##(2010-12#2)
with 2 mg##3##3##(2010-12#2)(2011-2#1)
with 2 ml##2##3##(1996-12#1)(2008-10#1)
with 2 mol l(-1)##6##4##(2008-10#6)
with 2 or 3##2##4##(2008-10#1)(2013-1#1)
with 2##87##2##(1991-12#1)(1992-4#2)(1992-8#1)(1993-11#1)(1993-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#37)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#2)(2010-3#1)(2011-2#2)(2013-1#4)(2013-7#2)
with 2% of##2##3##(2008-10#1)(2008-11#1)
with 2%##10##2##(1993-1#1)(2008-10#4)(2008-11#4)(2013-1#1)
with 2'##2##2##(2008-10#1)(2008-4#1)
with 2(2+)##2##2##(1996-2#2)
with 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP)##2##3##(2008-10#2)
with 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##4##2##(2008-10#4)
with 2-acetylpyridine-4-phenyl-3-thiosemicarbazone##2##2##(2008-10#2)
with 2-aminothiophenol##2##2##(2008-10#1)(2012-2#1)
with 2-chloro-1-methylpyridinium iodide##2##3##(2008-10#2)
with 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester (PC-88A)##2##7##(2008-10#2)
with 2-methacryloyloxyethyl##2##2##(2008-11#2)
with 2-methyl-8-quinolinol (HMQ)##3##3##(2008-10#3)
with 2-methyl-8-quinolinol##5##2##(2008-10#5)
with 2-naphthol-3##2##2##(2008-10#2)
with 2-oxoglutarate##2##2##(1992-6#1)(2008-10#1)
with 20 microM##2##3##(1990-5#1)(1996-2#1)
with 20##18##2##(1990-5#1)(1990-7#1)(1994-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#1)
with 20% of the##2##4##(2008-10#2)
with 20%##12##2##(1994-7#2)(2007-11#1)(2008-10#7)(2008-5#1)(2010-6#1)
with 20-s##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
with 200##11##2##(1990-6#1)(1993-9#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#2)(2012-1#1)
with 20mM##3##2##(2008-10#3)
with 20ml##2##2##(2008-10#2)
with 21##4##2##(2008-10#2)(2010-10#2)
with 218##2##2##(2008-10#1)(2010-4#1)
with 22##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
with 23##6##2##(1997-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)
with 230##3##2##(2008-12#1)(2009-7#1)(2012-2#1)
with 24##7##2##(1997-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
with 24-h##2##2##(1995-11#1)(2008-10#1)
with 24-mum##2##2##(2007-12#1)(2008-2#1)
with 25 mM##2##3##(2008-10#2)
with 25##11##2##(1993-12#1)(2008-10#6)(2008-2#1)(2010-3#1)(2011-2#2)
with 25%##5##2##(1995-2#1)(2008-10#2)(2008-2#1)(2008-9#1)
with 250##6##2##(1993-11#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-6#1)
with 25mg of##2##3##(2008-10#2)
with 26##5##2##(1995-2#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
with 26%##2##2##(2008-8#1)(2011-1#1)
with 27##5##2##(1990-7#1)(2007-12#2)(2008-1#1)(2008-5#1)
with 270##2##2##(2008-10#1)(2008-3#1)
with 28##4##2##(1995-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
with 29##4##2##(2008-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
with 2moll(-1) HCl##2##3##(2008-10#2)
with 3 and##2##3##(1995-8#1)(2008-10#1)
with 3 induction courses##2##4##(2007-4#2)
with 3 mL of 2##2##5##(2013-1#2)
with 3 or##2##3##(1993-12#1)(2008-4#1)
with 3##46##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-8#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-4#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
with 3%##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)
with 3(1-imidazolyl)propyl##2##2##(2008-10#2)
with 3-4##2##2##(1995-5#1)(2011-2#1)
with 3-hydroxy-3-methylglutaric aciduria##2##3##(1990-8#2)
with 3-methyl##2##2##(2008-10#1)(2008-11#1)
with 30 mM##2##3##(1993-6#1)(2011-2#1)
with 30 microM##2##3##(1990-11#1)(1997-8#1)
with 30##18##2##(1990-11#1)(1991-12#1)(1993-2#1)(1993-6#1)(1996-7#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-10#6)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
with 30% H2O2##2##3##(2007-11#2)
with 30% of##2##3##(2008-10#1)(2013-1#1)
with 30% rat liver S9##2##5##(2008-8#2)
with 30%##10##2##(1994-9#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2013-1#1)
with 300 mg##2##3##(1990-2#1)(1991-11#1)
with 300##5##2##(1990-2#1)(1991-11#1)(2008-10#2)(2011-1#1)
with 31##3##2##(1991-12#1)(2008-12#2)
with 31%##2##2##(2007-8#1)(2008-2#1)
with 32##7##2##(1996-3#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-8#1)(2010-10#1)
with 33##2##2##(2008-5#1)(2008-9#1)
with 34##2##2##(1992-3#1)(2009-10#1)
with 35##5##2##(1991-12#1)(1993-9#1)(2008-10#1)(2009-10#1)(2010-10#1)
with 35% of##2##3##(1995-2#1)(2008-3#1)
with 35%##3##2##(1995-2#1)(2008-12#1)(2008-3#1)
with 35S-labeled##2##2##(1995-2#1)(1997-4#1)
with 36##5##2##(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)
with 37##6##2##(1992-3#1)(1996-2#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
with 37%##2##2##(1992-8#1)(2008-2#1)
with 38 residues (PACAP38)##2##4##(1990-7#2)
with 38##4##2##(1990-7#2)(2012-3#1)(2013-1#1)
with 38%##2##2##(2008-10#1)(2008-5#1)
with 39##2##2##(1992-5#1)(2007-8#1)
with 3D##7##2##(1995-11#2)(2007-11#1)(2007-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
with 4 M HCl##2##4##(2008-10#2)
with 4 M##3##3##(1993-6#1)(2008-10#2)
with 4 children##3##3##(1992-4#3)
with 4 of##2##3##(2011-2#1)(2012-12#1)
with 4##47##2##(1992-11#1)(1992-4#3)(1992-6#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
with 4% (v/v)##2##3##(2008-10#2)
with 4%##5##2##(1997-4#1)(2008-10#4)
with 4-(2-pyridylazo)-resorcinol (PAR)##2##3##(2008-10#2)
with 4-(2-pyridylazo)-resorcinol##3##2##(2008-10#3)
with 4-aminoantipyrine in the presence of##2##6##(2008-10#2)
with 4-aminoantipyrine in##3##3##(2008-10#3)
with 4-aminoantipyrine##4##2##(2008-10#4)
with 4-bromomethyl-7-methoxycoumarin##2##2##(1993-2#2)
with 40##7##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
with 40%##4##2##(2008-10#2)(2008-6#1)(2010-9#1)
with 400##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
with 42##4##2##(1993-1#1)(2008-10#2)(2008-2#1)
with 42%##2##2##(2013-1#1)(2013-7#1)
with 44##2##2##(2008-10#1)(2008-11#1)
with 44%##2##2##(1991-12#1)(2008-5#1)
with 45##3##2##(1997-4#1)(2011-2#2)
with 47##4##2##(1992-3#1)(2008-5#1)(2010-11#1)(2012-12#1)
with 48%##2##2##(2007-12#1)(2011-1#1)
with 5 mM glycine##2##4##(1997-1#2)
with 5 mM##5##3##(1990-8#1)(1994-2#1)(1997-1#2)(2008-10#1)
with 5 ml of dimethylformamide (DMF) and the##4##8##(2008-10#4)
with 5 ml of##6##4##(2008-10#6)
with 5 x 10(3)##3##4##(1996-12#2)(2008-10#1)
with 5 x##5##3##(1996-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
with 5##52##2##(1990-8#1)(1991-7#1)(1992-10#1)(1992-3#1)(1993-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#22)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
with 5% formalin##2##3##(1996-12#2)
with 5% of##2##3##(1997-4#1)(2008-10#1)
with 5%##18##2##(1991-5#1)(1992-3#1)(1994-3#1)(1996-12#2)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
with 5-Br-PADAP and##2##3##(2008-10#2)
with 5-Br-PADAP##3##2##(2008-10#3)
with 5-FU##3##2##(1993-8#1)(2008-10#1)(2008-11#1)
with 5-HT##3##2##(1991-2#1)(1995-12#1)(1996-12#1)
with 5-NO(2)##2##2##(2008-10#2)
with 5-fluorouracil##6##2##(1990-2#1)(1992-12#2)(1992-2#1)(2008-10#1)(2008-5#1)
with 50 healthy##2##3##(2011-2#2)
with 50 mM##4##3##(1990-12#1)(1994-2#2)(1994-9#1)
with 50 microM PQ##2##4##(1995-8#2)
with 50 microM##5##3##(1992-6#1)(1992-8#1)(1994-3#1)(1995-8#2)
with 50 to##2##3##(2008-10#1)(2008-6#1)
with 50##22##2##(1990-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-8#3)(1997-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#2)
with 50% inhibition at##3##4##(1993-11#3)
with 50%##8##2##(1992-6#1)(1993-11#3)(1994-5#1)(2008-10#1)(2008-2#1)(2008-6#1)
with 500 mg##2##3##(2008-1#1)(2008-11#1)
with 500 microns##2##3##(1994-5#2)
with 500##10##2##(1993-11#1)(1994-5#2)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-2#1)
with 51%##2##2##(1996-6#1)(2011-2#1)
with 53##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
with 56##2##2##(2008-5#2)
with 58##2##2##(2008-10#1)(2008-5#1)
with 5mum##2##2##(2008-10#2)
with 6 MV and##2##4##(2012-1#1)(2013-1#1)
with 6##17##2##(1990-11#1)(1991-6#1)(1992-10#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-9#1)(2011-2#2)(2012-1#1)(2013-1#4)
with 60##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
with 60%##2##2##(2009-11#1)(2012-12#1)
with 60-ps##2##2##(2007-12#2)
with 62##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
with 64##4##2##(1996-9#1)(2007-9#1)(2008-4#1)(2011-2#1)
with 65%##3##2##(1992-11#1)(1993-11#1)(2008-12#1)
with 66##4##2##(2008-6#1)(2012-2#1)(2012-3#2)
with 68##4##2##(2007-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
with 69%##2##2##(2007-7#1)(2008-12#1)
with 7##12##2##(1991-5#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-3#1)(2010-5#1)(2013-1#1)
with 7%##2##2##(2007-12#1)(2008-2#1)
with 7-amino-3-(2-bromoethoxy)-4-chloroisocoumarin##2##2##(1991-3#2)
with 7-mx##2##2##(2010-1#2)
with 70##2##2##(1991-5#1)(2008-10#1)
with 70% ethanol##2##3##(2008-5#1)(2013-8#1)
with 70%##3##2##(2008-5#1)(2008-6#1)(2013-8#1)
with 700##2##2##(2008-11#1)(2008-5#1)
with 71%##3##2##(1990-9#1)(1991-12#1)(2008-7#1)
with 73%##2##2##(2008-10#1)(2008-7#1)
with 75##2##2##(1992-9#1)(2011-2#1)
with 75%##2##2##(2008-7#1)(2010-3#1)
with 79% of##2##3##(2008-12#1)(2013-1#1)
with 8##10##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
with 8%##3##2##(1991-11#1)(2008-7#1)(2008-8#1)
with 8-[(4-bromo-2##2##2##(1990-7#2)
with 8-hydroxyquinoline and##2##3##(2008-10#2)
with 8-hydroxyquinoline immobilized polyacrylonitrile##2##4##(2008-10#2)
with 8-hydroxyquinoline immobilized##3##3##(2008-10#3)
with 8-hydroxyquinoline##8##2##(1990-2#1)(2008-10#7)
with 80##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
with 80%##4##2##(2008-12#1)(2008-3#1)(2010-3#1)(2013-1#1)
with 800##2##2##(2007-11#1)(2008-10#1)
with 83%##2##2##(1991-8#1)(2008-10#1)
with 85##5##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
with 89##3##2##(2007-7#1)(2008-10#1)(2009-11#1)
with 9##8##2##(1992-6#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)
with 9%##2##2##(2007-11#1)(2011-2#1)
with 90##2##2##(2007-11#1)(2008-11#1)
with 90% of##2##3##(2010-3#2)
with 90%##6##2##(2008-10#2)(2008-8#1)(2010-3#2)(2011-2#1)
with 95##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
with 95% confidence interval (CI)##3##5##(2007-10#1)(2008-6#1)(2010-4#1)
with 95% confidence intervals##4##4##(2010-11#1)(2010-3#1)(2010-9#1)(2011-2#1)
with 95% confidence##7##3##(2007-10#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
with 95%##11##2##(1990-10#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
with 97##2##2##(2008-4#1)(2012-3#1)
with 99##2##2##(2007-12#1)(2008-3#1)
with 99%##2##2##(2008-10#1)(2010-4#1)
with 99mTc##2##2##(1990-12#1)(2008-7#1)
with A##15##2##(1991-5#1)(1993-5#1)(1996-2#1)(1997-5#2)(2008-10#7)(2012-3#1)(2013-8#2)
with A/Sydney/5/97##3##2##(2011-1#3)
with A1 + A2 sporangia##3##5##(2008-10#3)
with A23187##4##2##(1990-2#1)(1994-6#1)(1995-11#2)
with AA##3##2##(1993-8#2)(2008-10#1)
with AAL-TA##2##2##(2008-10#2)
with AARR syndrome##2##3##(2011-1#2)
with AAS##2##2##(2008-10#2)
with ABT-737##2##2##(2012-12#2)
with ABVD##2##2##(1994-12#1)(2013-1#1)
with ACD##2##2##(2009-8#2)
with ACE##3##2##(1996-6#1)(2008-5#1)(2008-9#1)
with ACE-inhibitors##2##2##(1990-2#1)(1993-2#1)
with ACL##2##2##(2007-11#1)(2013-1#1)
with ACS##3##2##(2008-3#2)(2010-4#1)
with AD##12##2##(1991-1#1)(1996-2#1)(2007-6#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
with ADHD and##5##3##(2009-8#1)(2010-8#1)(2012-2#3)
with ADHD##14##2##(1996-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-8#1)
with ADPKD##4##2##(2013-1#4)
with AFP##4##2##(2008-10#3)(2013-1#1)
with AIDS and that##2##4##(2008-11#2)
with AIDS and##8##3##(1994-3#1)(1995-6#2)(1996-11#1)(2008-11#2)(2009-2#1)(2011-2#1)
with AIDS in the##2##4##(1996-3#1)(1997-3#1)
with AIDS in##4##3##(1993-8#2)(1996-3#1)(1997-3#1)
with AIDS was##2##3##(1995-12#1)(2007-10#1)
with AIDS##57##2##(1991-2#1)(1991-5#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#4)(1994-3#1)(1995-12#4)(1995-2#4)(1995-6#6)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-5#2)(1997-6#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-5#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#4)
with ALA and light##2##4##(1992-8#2)
with ALA-induced porphyrins##2##3##(1992-9#2)
with ALCL##3##2##(1997-3#1)(2011-2#2)
with ALL and##4##3##(2011-2#4)
with ALL treated in##2##4##(2011-2#2)
with ALL##8##2##(2010-6#1)(2011-2#7)
with AM1##2##2##(1997-7#2)
with AMD##2##2##(2011-2#2)
with AMI##6##2##(1990-12#2)(1995-12#2)(2006-8#1)(2008-3#1)
with AML##5##2##(1992-10#1)(2008-10#1)(2010-1#1)(2011-2#2)
with AN##2##2##(2007-7#1)(2013-1#1)
with ANOVA##2##2##(2007-11#1)(2008-12#1)
with AOD and##2##3##(2012-12#1)(2012-3#1)
with AOD##4##2##(2012-12#3)(2012-3#1)
with AP##3##2##(1996-12#3)
with APDC and##2##3##(2008-10#2)
with APDC##6##2##(2008-10#6)
with APP and##2##3##(1995-12#1)(2008-11#1)
with APS##2##2##(1991-12#1)(2012-3#1)
with AR##9##2##(1995-3#5)(2008-10#1)(2011-2#3)
with AR-mediated##2##2##(2008-9#1)(2010-12#1)
with ARDS and##2##3##(1997-1#1)(2008-8#1)
with ARDS##6##2##(1990-2#1)(1991-9#2)(1997-1#2)(2008-8#1)
with ARF##2##2##(1993-6#1)(2008-4#1)
with ARIS##2##2##(1992-8#2)
with AS##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
with ASAD##2##2##(2012-2#2)
with ASD##4##2##(2011-2#1)(2012-2#2)(2013-1#1)
with ASM##5##2##(2008-10#5)
with ATP and##4##3##(1991-9#1)(1995-11#1)(1996-2#1)(2008-4#1)
with ATP##10##2##(1990-7#1)(1991-9#1)(1993-6#1)(1995-11#2)(1996-2#1)(2008-4#2)(2009-7#1)(2010-10#1)
with ATRA##2##2##(2007-4#1)(2013-1#1)
with Absidia corymbifera##2##3##(2008-5#2)
with Acro-LDL were##2##3##(2013-1#2)
with African##2##2##(2008-3#1)(2008-4#1)
with Ag##2##2##(1993-1#1)(2007-12#1)
with Ag(+)##3##2##(2008-10#3)
with Ag-NOR counts and##2##4##(1994-7#2)
with Agrobacterium tumefaciens##2##3##(2008-10#1)(2008-9#1)
with Agrobacterium##3##2##(2006-12#1)(2008-10#1)(2008-9#1)
with Al(2)(SO(4))(3)##4##2##(2008-10#4)
with AlH(3)##2##2##(1996-2#2)
with Ala##4##2##(1990-7#1)(1992-3#1)(1992-6#1)(1995-3#1)
with Alizarin Red S (ARS)##2##5##(2008-10#2)
with Alizarin Red S##7##4##(2008-10#7)
with Alport syndrome##2##3##(2011-2#2)
with Alport##3##2##(2011-2#3)
with Alzheimer disease##3##3##(1990-3#1)(1994-8#2)
with Alzheimer paired helical filaments##2##5##(1992-6#2)
with Alzheimer##6##2##(1990-3#1)(1992-6#2)(1994-8#2)(2013-8#1)
with Alzheimer's Disease##2##3##(1995-11#1)(2008-10#1)
with Alzheimer's disease (AD)##6##4##(1996-5#1)(2007-6#1)(2008-6#1)(2008-7#2)(2012-2#1)
with Alzheimer's disease##27##3##(1990-7#1)(1991-1#1)(1991-7#2)(1992-12#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-6#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2009-6#1)(2009-9#1)(2012-2#1)
with Alzheimer's##29##2##(1990-7#1)(1991-1#1)(1991-7#2)(1992-12#2)(1994-5#1)(1995-11#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-6#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2009-6#1)(2009-9#1)(2012-2#1)
with Amberlite XAD-2 coated with 1-(2-pyridylazo)-2-naphthol##2##6##(2008-10#2)
with Amberlite XAD-2##3##3##(2008-10#3)
with Amberlite XAD-4 resin##2##4##(2008-10#2)
with Amberlite XAD-4##5##3##(2008-10#5)
with Amberlite##11##2##(2008-10#11)
with Amberlyst 36##2##3##(2008-10#2)
with American##2##2##(2012-2#1)(2013-1#1)
with Ampicillin##2##2##(2008-8#1)(2009-12#1)
with Anorexia##2##2##(2008-11#2)
with Antega stem##2##3##(2013-1#2)
with Antega##3##2##(2013-1#3)
with Applications##2##2##(2009-12#1)(2012-3#1)
with ArF##3##2##(2008-2#2)(2008-3#1)
with Arsenazo III##4##3##(2008-10#4)
with AsA and##2##3##(1992-3#1)(2008-11#1)
with AsA##3##2##(1992-3#1)(2008-11#2)
with Aspergillus flavus and##2##4##(2008-10#2)
with Aspergillus##4##2##(2008-10#3)(2008-7#1)
with Asthma##2##2##(2012-1#1)(2013-1#1)
with Au##3##2##(2008-10#3)
with B##30##2##(1991-11#1)(1992-12#1)(1996-12#2)(2007-12#1)(2008-10#15)(2008-4#2)(2008-9#2)(2009-2#1)(2010-6#3)(2012-3#1)(2013-1#1)
with B18C6##2##2##(2008-10#2)
with BA##2##2##(2008-10#1)(2008-7#1)
with BABA##4##2##(2008-10#4)
with BCGC cocultures##2##3##(2008-11#2)
with BD##5##2##(2008-11#1)(2013-8#4)
with BF##2##2##(2008-10#2)
with BII phobia##2##3##(2012-2#2)
with BMI &gt##2##3##(2008-6#1)(2008-9#1)
with BMI##8##2##(2007-12#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#1)(2013-1#2)
with BMP-2##2##2##(2012-12#1)(2012-3#1)
with BNR 48 h prior to their challenge##2##8##(2008-10#2)
with BNR##5##2##(2008-10#5)
with BOS##2##2##(2012-2#2)
with BP##2##2##(1995-3#1)(2010-4#1)
with BPD##5##2##(1997-5#1)(2009-8#2)(2009-9#1)(2010-5#1)
with BPI##2##2##(1997-5#1)(2008-5#1)
with BSA##4##2##(2008-10#2)(2008-11#1)(2009-9#1)
with BYDV##4##2##(2008-10#3)(2008-8#1)
with Bacillus thuringiensis##2##3##(2008-10#2)
with Barrett's esophagus##2##3##(2013-1#2)
with Bay##2##2##(1996-2#1)(1996-9#1)
with Bayer##2##2##(2008-10#1)(2008-5#1)
with Bayesian##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
with Beet##2##2##(2008-10#2)
with Biological Control##2##3##(2008-10#2)
with Bortezomib##3##2##(2010-8#1)(2012-12#2)
with Botryosphaeria dothidea##2##3##(2008-10#2)
with Botryosphaeria##3##2##(2008-10#2)(2011-10#1)
with Botrytis cinerea##2##3##(2008-10#2)
with Bragg gratings##2##3##(2007-12#1)(2008-3#1)
with Bragg##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
with Breast Cancer##2##3##(1994-12#1)(2013-1#1)
with Brucella##3##2##(2007-8#1)(2010-4#2)
with BuLi##2##2##(1996-5#1)(2009-8#1)
with Buerger's disease##3##3##(1997-8#3)
with Burkitt's lymphoma##2##3##(2008-1#1)(2009-2#1)
with C##37##2##(1991-8#1)(1992-3#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#20)(2008-5#3)(2008-8#2)(2008-9#2)(2010-2#1)(2010-8#1)(2013-1#3)
with C(18)##3##2##(2008-10#3)
with C(60)##2##2##(2008-10#1)(2008-2#1)
with C(60)-SIMS##2##2##(2012-12#2)
with C-terminal##2##2##(1994-11#2)
with C1##2##2##(1997-5#1)(2012-3#1)
with C3##3##2##(1991-2#1)(1993-6#1)(2008-10#1)
with CA##6##2##(1994-5#1)(2008-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
with CA15##3##2##(1990-8#3)
with CAA##2##2##(2007-8#2)
with CACO estimates##2##3##(2012-1#2)
with CAD (A##2##3##(2008-4#2)
with CAD##10##2##(1997-8#1)(2008-3#3)(2008-4#5)(2011-1#1)
with CAPD##2##2##(1992-5#1)(2008-1#1)
with CBF-A and CBF-B##2##4##(1995-2#2)
with CBF-A##3##2##(1995-2#3)
with CC##2##2##(1991-8#2)
with CCD##2##2##(2008-5#1)(2008-9#1)
with CCEs##2##2##(2008-10#2)
with CD##7##2##(1994-3#1)(2008-10#1)(2008-2#3)(2012-2#1)(2013-8#1)
with CD4 counts##3##3##(1994-11#1)(2011-1#1)(2012-12#1)
with CD4##4##2##(1994-11#1)(2009-8#1)(2011-1#1)(2012-12#1)
with CD4+ counts of##2##4##(1992-8#1)(2010-8#1)
with CD73##2##2##(2008-4#2)
with CD8(+) T cell exhaustion##2##5##(2010-5#2)
with CDDP##2##2##(2008-4#1)(2013-1#1)
with CDGP and##2##3##(2011-2#2)
with CDGP##8##2##(2011-1#4)(2011-2#4)
with CE##2##2##(2008-10#1)(2008-5#1)
with CECT##2##2##(2012-12#2)
with CEUS##2##2##(2010-12#2)
with CF##4##2##(1992-10#1)(1997-1#1)(2013-1#2)
with CFC##2##2##(1996-1#1)(1996-2#1)
with CGRP##3##2##(1992-6#3)
with CGRP-like immunoreactivity##2##3##(1992-6#1)(1997-3#1)
with CH(2)Cl(2)##2##2##(2008-10#2)
with CHARGE##2##2##(2008-9#2)
with CHCl(3) and##2##3##(2008-10#2)
with CHD##3##2##(2010-10#1)(2010-9#2)
with CHO cells##2##3##(2008-11#2)
with CHX##2##2##(2013-1#2)
with CIN##2##2##(1995-9#1)(2012-3#1)
with CJC##2##2##(2008-7#2)
with CKD##4##2##(2009-1#1)(2010-4#2)(2011-2#1)
with CL reagent##2##3##(2008-10#2)
with CL##4##2##(2008-10#4)
with CM-glucan##2##2##(2008-5#2)
with CML##4##2##(2007-11#2)(2008-6#1)(2010-11#1)
with CMT##4##2##(2009-10#1)(2013-7#3)
with CMT1A##2##2##(1997-3#1)(2013-1#1)
with CMV##4##2##(2008-10#4)
with CNBr##3##2##(1990-5#1)(1992-12#1)(1993-8#1)
with CNS involvement##2##3##(2011-2#2)
with CNS##7##2##(1997-3#1)(2007-7#1)(2008-7#2)(2011-2#3)
with CO##4##2##(1991-2#1)(1994-11#1)(1996-12#1)(1996-2#1)
with CO(2)##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
with CO2 laser laparoscopy##2##4##(1995-2#2)
with CO2 laser##5##3##(1991-6#1)(1995-2#2)(1996-1#1)(2008-4#1)
with CO2##7##2##(1991-6#1)(1995-2#2)(1996-1#1)(2007-12#1)(2008-4#1)(2008-6#1)
with COPD##23##2##(1991-4#1)(1997-1#1)(1997-7#2)(2008-12#1)(2008-7#3)(2009-1#1)(2010-10#4)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#5)
with CP is##2##3##(2011-2#2)
with CP##7##2##(2008-10#1)(2011-2#6)
with CPL##2##2##(2010-12#2)
with CQI##2##2##(1994-2#1)(1995-1#1)
with CR##4##2##(1991-6#1)(2008-10#2)(2009-5#1)
with CRC##3##2##(2009-12#1)(2012-3#2)
with CRF##5##2##(2007-7#1)(2008-1#2)(2009-3#1)(2011-2#1)
with CS##5##2##(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#1)
with CS-20##2##2##(2008-10#2)
with CSCs##2##2##(2009-9#1)(2012-12#1)
with CT and MRI##3##4##(2008-1#1)(2008-2#1)(2012-2#1)
with CT and##4##3##(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)
with CT##12##2##(1997-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#5)(2012-2#1)
with CTA##2##2##(2008-7#1)(2011-2#1)
with CVD##7##2##(2008-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2012-3#1)
with CWM treatments##2##3##(2008-10#2)
with CWM##3##2##(2008-10#3)
with CYC##2##2##(2010-12#2)
with CYP2A6##2##2##(2008-8#2)
with Ca2+##6##2##(1990-7#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(2008-5#1)
with Cancer##2##2##(2010-7#1)(2012-2#1)
with Candida albicans##2##3##(2008-5#2)
with Candida##9##2##(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#2)(2013-1#1)
with Castleman disease##2##3##(2011-2#2)
with Caucasian##3##2##(2008-5#1)(2009-9#1)(2010-8#1)
with Cd##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
with Cd(2+)##4##2##(2008-10#4)
with Cd(II)##2##2##(2008-10#2)
with CdCl2 or Cd-MT##2##4##(1995-3#2)
with CdCl2##4##2##(1995-3#4)
with Ce##3##2##(2008-10#2)(2008-3#1)
with Ceftazidime##2##2##(1991-3#1)(2008-8#1)
with Chelex-100##2##2##(2008-10#2)
with Child-Pugh class##2##3##(2011-2#2)
with Chinese##2##2##(1994-3#1)(2008-9#1)
with Chronic Renal Failure##2##4##(2007-7#1)(2008-12#1)
with Ciprofloxacin against##2##3##(2008-8#2)
with Citrus##2##2##(2008-10#2)
with Claude##2##2##(1996-2#1)(2008-4#1)
with Clostridium##4##2##(1992-3#1)(2007-7#1)(2008-6#1)(2013-1#1)
with Co##2##2##(2008-10#2)
with Co(II) and##2##3##(2008-10#2)
with Co(II) in the presence of##2##6##(2008-10#2)
with Co(II)##5##2##(1990-12#1)(2008-10#4)
with Co60##8##2##(2007-10#8)
with CoQ10##5##2##(1991-5#3)(2013-1#2)
with Colletotrichum##2##2##(2008-10#2)
with Complex##2##2##(2008-10#1)(2008-12#1)
with ConA and##2##3##(1995-12#2)
with ConA##3##2##(1995-12#3)
with Concanavalin A (ConA)##2##4##(1995-12#1)(2008-10#1)
with Coomassie##3##2##(1993-8#1)(2008-4#2)
with Cor Pulmonale##2##3##(2012-12#2)
with Coronary Artery Disease##2##4##(2013-1#2)
with Coxsakievirus A16##2##3##(2008-8#2)
with Cr(4+)##4##2##(2008-2#1)(2008-3#3)
with Cr(III)##2##2##(2008-10#1)(2011-2#1)
with Cremophor-containing paclitaxel##2##3##(2008-3#2)
with Crohn's disease and##3##4##(2010-12#2)(2013-8#1)
with Crohn's disease who was##2##5##(1997-5#1)(2010-12#1)
with Crohn's disease who##4##4##(1997-5#1)(2008-10#1)(2010-12#2)
with Crohn's disease##17##3##(1994-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-12#9)(2011-2#1)(2012-2#2)(2013-8#1)
with Crohn's##18##2##(1994-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2010-12#9)(2011-2#1)(2012-2#2)(2013-8#2)
with Cronbach's##2##2##(2010-10#1)(2012-3#1)
with Cryptosporidium##2##2##(1996-12#1)(2007-7#1)
with Cu##3##2##(2008-10#1)(2008-11#2)
with Cu(2+)##2##2##(2008-10#1)(2009-8#1)
with Cu(I)##2##2##(2008-10#2)
with Cu(II) and##3##3##(2008-10#3)
with Cu(II)##9##2##(1990-8#1)(1992-9#1)(1995-2#1)(2008-10#6)
with Cucumber mosaic virus (CMV)##2##5##(2008-10#2)
with CupPrint##2##2##(2013-8#2)
with Cushing's disease##2##3##(1990-3#1)(2009-4#1)
with Cushing's##3##2##(1990-3#1)(2009-4#1)(2011-2#1)
with Cyanex 923##3##3##(2008-10#3)
with Cyanex##4##2##(2008-10#4)
with D##9##2##(1991-8#1)(2008-10#6)(2008-3#1)(2008-5#1)
with D-##2##2##(1994-12#1)(2008-10#1)
with D-Squame##2##2##(2008-5#2)
with D2##2##2##(1996-5#1)(2008-3#1)
with DAPI##2##2##(2009-12#1)(2009-5#1)
with DB18C6##2##2##(2008-10#2)
with DBMBSA##2##2##(2008-10#2)
with DCA##3##2##(1995-3#2)(2008-10#1)
with DDD##2##2##(2011-2#1)(2012-2#1)
with DDTC##2##2##(2008-10#2)
with DEB##2##2##(2008-4#1)(2008-7#1)
with DEPC##2##2##(1992-6#2)
with DG extract##2##3##(2011-1#2)
with DI##3##2##(1997-8#1)(2008-10#1)(2012-12#1)
with DIC##3##2##(2010-3#2)(2012-3#1)
with DM2##2##2##(2008-7#1)(2012-3#1)
with DMD##3##2##(2007-8#3)
with DMI history##2##3##(2008-10#2)
with DMI##3##2##(2008-10#3)
with DMSO##5##2##(1991-9#1)(1995-2#1)(2008-10#3)
with DNA and##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
with DNA fingerprint##2##3##(2008-10#2)
with DNA from##6##3##(1993-6#1)(1995-8#1)(2008-10#4)
with DNA is##4##3##(1992-3#1)(2008-10#2)(2008-9#1)
with DNA ligase##2##3##(1993-3#1)(1997-7#1)
with DNA microarray##2##3##(2008-7#1)(2011-2#1)
with DNA recombination##2##3##(2008-9#2)
with DNA was##3##3##(1991-5#1)(1994-6#1)(1995-5#1)
with DNA##71##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-3#3)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-5#3)(1995-8#1)(1997-3#2)(1997-7#1)(2008-10#22)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with DNAbeta##6##2##(2008-10#6)
with DO##2##2##(2008-10#2)
with DOC##2##2##(1992-9#2)
with DON##2##2##(2008-10#2)
with DS##2##2##(1991-1#2)
with DWM##3##2##(2010-11#3)
with DZP##2##2##(1993-12#2)
with Deflux##3##2##(2008-10#2)(2008-6#1)
with Delta##2##2##(2008-10#1)(2013-8#1)
with DeltaFerrin(TM)##2##2##(2008-11#2)
with Depression##2##2##(2009-12#1)(2012-2#1)
with Diabetes##3##2##(2012-3#2)(2013-1#1)
with Different##4##2##(2008-10#2)(2008-11#1)(2009-9#1)
with Differential##2##2##(2009-10#1)(2012-12#1)
with Disabilities##28##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-5#1)(1997-5#3)(2008-12#1)(2012-2#1)
with Down Syndrome##2##3##(2010-4#1)(2013-1#1)
with Down syndrome##15##3##(1990-3#1)(1992-5#1)(2008-11#1)(2008-12#2)(2010-4#3)(2012-12#2)(2013-1#5)
with Down##17##2##(1990-3#1)(1992-5#1)(2008-11#1)(2008-12#2)(2010-4#4)(2012-12#2)(2013-1#6)
with Down's syndrome in the##2##5##(1990-2#2)
with Down's syndrome##5##3##(1990-2#2)(1991-1#1)(1996-5#1)(2008-7#1)
with Down's##6##2##(1990-2#2)(1991-1#1)(1991-8#1)(1996-5#1)(2008-7#1)
with Dr Weed##2##3##(2010-8#2)
with Dr##4##2##(2010-8#2)(2012-3#1)(2013-1#1)
with Drosophila##2##2##(1993-2#1)(2008-10#1)
with Duchenne muscular dystrophy##3##4##(1995-12#1)(2008-7#1)(2011-2#1)
with Duchenne##4##2##(1995-12#1)(2007-8#1)(2008-7#1)(2011-2#1)
with Dutch##2##2##(2008-6#1)(2010-9#1)
with E##15##2##(1990-12#1)(1997-4#1)(2008-10#6)(2008-11#3)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#1)
with E-cadherin##2##2##(1991-12#1)(1991-5#1)
with E2##3##2##(1990-11#2)(2010-5#1)
with E2F##3##2##(1992-8#1)(2012-2#2)
with EA##3##2##(2008-5#1)(2013-7#2)
with EBV##4##2##(1993-8#1)(1993-9#1)(1995-2#1)(2008-9#1)
with EC law##2##3##(2008-7#2)
with EC##3##2##(2008-7#2)(2011-2#1)
with EC50 of##2##3##(1994-11#1)(2011-3#1)
with EC50##5##2##(1994-11#1)(2008-11#2)(2011-3#2)
with ECB##2##2##(2008-10#2)
with ECG##2##2##(1996-3#1)(2008-3#1)
with ECMO##4##2##(2007-8#2)(2011-3#1)(2012-1#1)
with ECT##2##2##(2008-12#2)
with ED50##2##2##(1991-8#1)(1994-8#1)
with EDTA##24##2##(1991-9#1)(1993-6#1)(1995-12#1)(2008-10#19)(2008-5#1)(2010-3#1)
with EE##2##2##(2009-11#1)(2013-8#1)
with EGF##8##2##(1990-8#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-3#2)(1994-6#1)(2008-4#1)
with EGT##2##2##(2009-6#2)
with EGTA##2##2##(1994-6#2)
with EN##2##2##(2013-1#2)
with EPI##2##2##(2008-9#2)
with ER##6##2##(1991-12#1)(1993-9#1)(1996-5#1)(1997-7#1)(2007-10#1)(2008-8#1)
with ERCP##2##2##(2008-2#1)(2013-1#1)
with ERs##3##2##(2008-10#1)(2008-8#2)
with ES##2##2##(2010-5#2)
with ET##3##2##(1995-11#1)(2008-10#1)(2012-3#1)
with ETAAS##2##2##(2008-10#2)
with Enalapril##2##2##(2008-4#2)
with Ender##3##2##(2007-11#1)(2007-8#2)
with English as an additional language##3##6##(2008-2#3)
with English##4##2##(2008-2#3)(2008-8#1)
with Entecavir 0##2##3##(2013-1#2)
with Epstein-Barr virus (EBV)##2##4##(1992-2#1)(2008-2#1)
with Eriochrome##2##2##(2008-10#2)
with Erwinia amylovora##2##3##(2008-10#2)
with Escherichia coli##5##3##(1994-8#1)(1995-12#1)(1997-3#1)(2008-11#1)(2013-1#1)
with Essential##2##2##(2011-2#1)(2013-1#1)
with Euclidean##2##2##(2008-6#1)(2013-8#1)
with European corn borer##3##4##(2008-10#1)(2011-2#2)
with European##7##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#4)
with Evans##4##2##(2010-5#1)(2012-2#3)
with Exosurf##2##2##(1997-1#2)
with F##11##2##(1995-8#1)(2008-10#8)(2008-12#1)(2011-10#1)
with FA##3##2##(1992-8#1)(2008-10#1)(2008-8#1)
with FAP##2##2##(2008-4#1)(2009-12#1)
with FAs##2##2##(2008-10#2)
with FCM clustered##3##3##(2010-8#3)
with FGF-2##3##2##(2008-11#3)
with FGFs##2##2##(2008-7#2)
with FGS had##2##3##(1996-12#2)
with FGS##5##2##(1996-12#5)
with FHP##2##2##(2010-9#2)
with FI-FAAS##2##2##(2008-10#2)
with FISH##2##2##(1997-3#1)(2008-9#1)
with FITC-conjugated##3##2##(2006-6#1)(2008-5#1)(2008-8#1)
with FM##3##2##(2008-8#1)(2009-11#1)(2010-12#1)
with FN##4##2##(1994-9#1)(2008-7#2)(2012-2#1)
with FPG##3##2##(1994-12#3)
with Fabry-Perot arms##2##3##(2008-3#2)
with Fabry-Perot##3##2##(2008-2#1)(2008-3#2)
with Fe at 56 and 112 mug/ml compared with##2##9##(2008-10#2)
with Fe##3##2##(2008-10#3)
with Fe(II)##3##2##(2008-10#3)
with Fe(III) in the##2##4##(2008-10#2)
with Fe(III)##6##2##(2008-10#6)
with Fluorescent##2##2##(2007-2#1)(2008-10#1)
with Foc-5##3##2##(2008-10#3)
with Fontan##2##2##(2008-10#1)(2010-5#1)
with Forestier's##3##2##(2007-8#2)(2008-12#1)
with Fourier transform infrared##2##4##(2008-10#1)(2008-3#1)
with Fourier##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2011-1#1)
with Frejka pillow##3##3##(2007-8#3)
with Full Text##2##3##(2013-1#2)
with Fura-2##2##2##(1990-12#1)(1995-8#1)
with Fusarium graminearum##4##3##(2008-10#4)
with Fusarium oxysporum f##3##4##(2008-10#3)
with Fusarium##11##2##(2008-10#11)
with G##6##2##(1995-11#1)(1995-6#1)(2008-10#4)
with G-CSF##2##2##(2008-6#1)(2008-7#1)
with G-proteins##2##2##(1997-7#1)(2013-1#1)
with GA##3##2##(2008-10#2)(2008-5#1)
with GAP##3##2##(1991-12#1)(1992-12#2)
with GB##2##2##(2013-8#2)
with GC/ECD##2##2##(2008-10#2)
with GDM##6##2##(2008-1#2)(2009-3#2)(2011-2#2)
with GDP##2##2##(1991-12#1)(2008-6#1)
with GE7##2##2##(2008-8#2)
with GFP##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)
with GH deficiency##2##3##(1997-8#1)(2008-4#1)
with GH##3##2##(1997-8#1)(2008-4#1)(2013-7#1)
with GHD##2##2##(2012-3#2)
with GI##2##2##(2011-2#1)(2012-12#1)
with GM-CSF##3##2##(1991-8#1)(1992-3#1)(2008-8#1)
with GM1##7##2##(1993-3#1)(1993-5#1)(2008-10#1)(2012-3#4)
with GPs##2##2##(2011-1#1)(2011-2#1)
with GR##2##2##(2011-2#2)
with GSH##2##2##(1994-9#1)(2008-10#1)
with GTN##2##2##(2007-10#2)
with GTP or##2##3##(2008-6#1)(2011-1#1)
with Gaucher disease##2##3##(1994-11#1)(2008-10#1)
with Gaussian##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
with Gd-DTPA contrast enhanced allows##2##5##(2007-11#2)
with Glomerella##2##2##(2008-10#2)
with Glu##2##2##(1992-3#1)(1994-6#1)
with Glucolevel##2##2##(2008-10#2)
with Golgi##2##2##(1996-5#1)(2012-2#1)
with Group I##3##3##(2010-7#3)
with Group P##3##3##(2010-7#3)
with Group##6##2##(2010-7#6)
with H##11##2##(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
with H(+)##2##2##(2008-10#2)
with H(2)##2##2##(2008-7#1)(2011-2#1)
with H(2)O(2)##5##2##(2008-10#5)
with H(2)SO(4)##3##2##(2008-10#3)
with H(2)SiPh(2)##2##2##(1996-2#2)
with H2O2 in##2##3##(1995-8#1)(1997-8#1)
with H2O2##8##2##(1990-2#1)(1992-9#2)(1995-8#3)(1997-8#2)
with HA and##3##3##(2008-10#2)(2013-8#1)
with HBV##8##2##(1995-2#1)(2008-10#2)(2009-8#1)(2012-1#2)(2013-1#2)
with HBsAg-negative and anti-HCV-positive HCC##2##5##(2008-4#2)
with HC##4##2##(2008-11#1)(2012-3#3)
with HCC##5##2##(1992-3#1)(1993-2#1)(2008-10#2)(2013-8#1)
with HCMV##2##2##(1997-3#2)
with HCV##13##2##(1994-8#1)(2006-10#3)(2008-1#1)(2009-8#2)(2012-12#4)(2013-1#2)
with HCl and HNO(3)##2##4##(2008-10#2)
with HCl and##4##3##(2008-10#4)
with HCl##8##2##(2007-11#1)(2008-10#7)
with HD##5##2##(1993-9#1)(1996-8#1)(2008-7#1)(2011-2#2)
with HDL##3##2##(1995-5#1)(2008-4#1)(2012-2#1)
with HELLP syndrome##2##3##(2008-4#2)
with HELLP##3##2##(2008-4#3)
with HFA134a##3##2##(1996-1#2)(1996-2#1)
with HHBIM-NTf2 and HOBIM-NTf2##2##4##(2011-1#2)
with HIPAA's NPI##3##3##(2008-4#2)(2008-6#1)
with HIV and AIDS##2##4##(1995-12#1)(2010-8#1)
with HIV and TB##2##4##(1993-5#1)(2010-4#1)
with HIV and##11##3##(1993-5#1)(1995-12#1)(1996-1#1)(2008-10#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)
with HIV disease##2##3##(1992-1#1)(1995-6#1)
with HIV in##3##3##(1991-6#1)(2008-4#1)(2009-10#1)
with HIV infection in##2##4##(1996-8#1)(2011-1#1)
with HIV infection##13##3##(1992-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#2)
with HIV or##3##3##(1991-6#1)(1993-1#1)(1995-6#1)
with HIV##82##2##(1990-6#1)(1991-1#1)(1991-11#2)(1991-6#2)(1992-1#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-12#5)(1995-6#4)(1996-1#3)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2013-1#3)
with HIV-1 infection##8##3##(1990-2#2)(1991-9#1)(2008-11#1)(2008-2#2)(2010-11#2)
with HIV-1##14##2##(1990-2#2)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-2#2)(2010-11#2)(2011-3#1)
with HIV-infected##3##2##(1993-1#1)(1993-6#1)(1996-9#1)
with HIV/AIDS and##3##3##(2009-7#1)(2011-1#1)(2013-1#1)
with HIV/AIDS in Jamaica##2##4##(2009-7#2)
with HIV/AIDS in##5##3##(2009-7#3)(2011-1#2)
with HIV/AIDS##32##2##(1992-12#1)(1995-3#2)(1997-5#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#7)(2011-1#9)(2013-1#3)
with HLA##2##2##(1997-9#1)(2008-1#1)
with HLA-B52##3##2##(1997-8#3)
with HLE##2##2##(1992-12#1)(1993-8#1)
with HMC##2##2##(1992-11#2)
with HMO(4)Q##3##2##(2008-10#3)
with HMOs##2##2##(1995-12#1)(1997-1#1)
with HMQ into##2##3##(2008-10#2)
with HNO(3) alone##2##3##(2008-10#2)
with HNO(3) and H(2)O(2)##2##4##(2008-10#2)
with HNO(3) and##3##3##(2008-10#3)
with HNO(3)##9##2##(2008-10#9)
with HPE##2##2##(2011-1#2)
with HPLC##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2011-3#1)
with HPV##4##2##(1991-2#1)(1993-9#1)(1994-1#1)(2011-1#1)
with HQ##2##2##(1992-3#1)(2008-10#1)
with HRP##2##2##(2008-10#2)
with HSA##4##2##(2008-10#4)
with HSP70-peptides##2##2##(2008-9#2)
with HSV-1##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
with HU##2##2##(1997-6#1)(2008-10#1)
with HUS##2##2##(2013-1#2)
with HbA1c##3##2##(2012-4#1)(2012-5#2)
with Hba1c##2##2##(2011-1#2)
with Helicobacter pylori##4##3##(1996-11#1)(1997-1#1)(2008-12#1)(2013-8#1)
with Hg(2+)##2##2##(2008-10#2)
with Hg(II)##5##2##(2008-10#5)
with Hg2+##2##2##(1993-12#2)
with Hgb &gt##2##3##(2008-7#2)
with High##3##2##(1997-3#1)(2008-10#1)(2008-3#1)
with Hodgkin's disease##4##3##(1992-6#1)(2011-2#3)
with Hodgkin's##6##2##(1992-6#1)(2008-7#2)(2011-2#3)
with Host##2##2##(2008-10#2)
with HpaG(Xooc)##2##2##(2008-10#2)
with Human##2##2##(2010-8#1)(2011-2#1)
with Huntington's disease##2##3##(2008-7#1)(2011-2#1)
with I##6##2##(1996-2#2)(1997-7#2)(2008-10#2)
with I-B4##2##2##(1997-2#2)
with IBA##2##2##(2008-10#1)(2008-12#1)
with IBD##2##2##(2010-12#2)
with IBS##2##2##(1997-6#1)(2013-1#1)
with IBV##4##2##(1997-3#1)(1997-6#2)(2008-5#1)
with IC(50) at##2##3##(2008-11#1)(2012-12#1)
with IC(50) values of##4##4##(2008-4#1)(2011-2#1)(2013-1#2)
with IC(50) values##7##3##(2008-10#3)(2008-4#1)(2011-2#1)(2013-1#2)
with IC(50)##10##2##(2008-10#4)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
with IC50 values of 1##2##5##(1990-8#1)(1992-12#1)
with IC50 values of approximately 1##2##6##(1990-8#1)(1992-5#1)
with IC50 values of##11##4##(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1995-12#2)(1995-5#1)
with IC50 values##12##3##(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#1)
with IC50##16##2##(1990-5#1)(1990-8#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(2008-11#1)(2011-3#2)
with IC50s##2##2##(1995-3#1)(1995-5#1)
with ICP-MS detection##2##3##(2008-10#2)
with ICP-MS##6##2##(2008-10#6)
with ICP-OES##2##2##(2008-10#1)(2010-5#1)
with ID##3##2##(2012-12#3)
with IDC##2##2##(1997-3#2)
with IDDM##3##2##(1995-3#3)
with IGF-I##3##2##(1991-5#1)(2008-6#1)(2010-5#1)
with IGHD##2##2##(2008-1#2)
with IL-1 beta##2##3##(1993-3#1)(1995-12#1)
with IL-1##7##2##(1990-12#3)(1993-3#1)(1995-12#2)(1995-6#1)
with IL-12##2##2##(2008-4#2)
with IL-1ra##2##2##(1992-3#1)(1995-2#1)
with IL-2 and##2##3##(1995-12#1)(2008-11#1)
with IL-2##5##2##(1991-6#2)(1994-11#1)(1995-12#1)(2008-11#1)
with IL-4##2##2##(1992-5#1)(2012-1#1)
with IL-6##2##2##(1996-12#1)(2011-2#1)
with IM fields treated with Co60##3##6##(2007-10#3)
with IM##4##2##(2007-10#3)(2007-2#1)
with IMT##2##2##(2008-1#1)(2013-1#1)
with IP##3##2##(2008-10#1)(2008-7#2)
with IP6##2##2##(2008-10#2)
with IPSB##2##2##(1996-1#2)
with IR and##2##3##(2008-10#1)(2008-3#1)
with IR##4##2##(2008-10#1)(2008-3#2)(2013-8#1)
with ISIS 12449##2##3##(2008-10#2)
with ITS##2##2##(2008-10#2)
with IVIG has been shown##2##5##(2007-12#2)
with IgA nephropathy##2##3##(2009-6#1)(2013-8#1)
with IgA##4##2##(1996-12#1)(2007-2#1)(2009-6#1)(2013-8#1)
with IgG anti-Toxoplasma titers##2##4##(2007-10#2)
with IgG##4##2##(1990-2#1)(2007-10#2)(2007-2#1)
with Ilizarov##2##2##(2007-8#2)
with Impaired Glucose Tolerance##2##4##(2008-3#1)(2012-3#1)
with Impaired##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
with Implications##2##2##(1996-12#1)(2011-1#1)
with In##2##2##(2008-10#1)(2008-3#1)
with Indian standard series##2##4##(2007-7#2)
with Infliximab##2##2##(2010-12#2)
with International##2##2##(2008-9#1)(2012-3#1)
with JH##2##2##(1992-6#1)(1995-11#1)
with Japanese cedar pollinosis##2##4##(2008-11#1)(2012-12#1)
with Japanese##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
with John##2##2##(2008-7#1)(2010-7#1)
with K##2##2##(2008-10#1)(2008-4#1)
with K(2)S(2)O(8)##2##2##(2008-10#2)
with K562##2##2##(1995-11#1)(2008-11#1)
with KBr##2##2##(2008-10#2)
with KBrO(3)##2##2##(2008-10#2)
with KCN##2##2##(1990-7#1)(2008-10#1)
with KCl##2##2##(1996-2#1)(2008-10#1)
with KI##3##2##(2008-10#3)
with KMnO(4)##3##2##(2008-10#3)
with KOH##2##2##(2008-10#1)(2008-5#1)
with KP1 and##2##3##(1991-2#2)
with KS##3##2##(1991-12#1)(1992-2#1)(2013-1#1)
with KT##3##2##(2011-2#1)(2013-1#2)
with Kasabach-Merritt syndrome##2##3##(2008-7#2)
with Kawasaki##2##2##(1993-12#1)(1996-3#1)
with Kd##3##2##(1990-5#1)(1994-3#1)(1995-6#1)
with Ki =##3##3##(1990-7#2)(1994-8#1)
with Ki values##2##3##(1990-2#1)(1995-3#1)
with Ki##6##2##(1990-2#1)(1990-5#1)(1990-7#2)(1994-8#1)(1995-3#1)
with Kirschner wires##2##3##(2007-8#1)(2009-3#1)
with Km##4##2##(1991-5#1)(1995-2#1)(1995-6#1)(1997-8#1)
with L##7##2##(1996-12#1)(1997-7#1)(2008-10#4)(2008-11#1)
with L-arginine##5##2##(1991-6#1)(1997-2#2)(1997-7#2)
with LA##2##2##(2008-11#2)
with LAK cells##2##3##(1990-12#2)
with LBP##4##2##(2012-12#2)(2012-2#2)
with LC and##2##3##(2008-10#2)
with LC##3##2##(2008-10#3)
with LCM##2##2##(2010-12#2)
with LChD##5##2##(2008-10#5)
with LDL##2##2##(1991-12#1)(1995-12#1)
with LED##2##2##(2008-11#1)(2008-7#1)
with LFS##2##2##(1990-12#2)
with LGBTQ parents##2##3##(2009-7#2)
with LH-RH##2##2##(1991-2#1)(1993-1#1)
with LIF##4##2##(2008-11#2)(2008-3#2)
with LJ and MGIT##2##4##(2013-1#2)
with LMA##2##2##(2008-8#1)(2010-7#1)
with LN##2##2##(2008-1#2)
with LPL##3##2##(1991-12#2)(1993-8#1)
with LPS + IFN gamma##2##5##(1993-3#2)
with LPS##6##2##(1993-3#2)(2008-10#1)(2008-11#2)(2011-2#1)
with LVH##2##2##(2010-8#2)
with Lactobacillus##3##2##(2008-11#3)
with Leber hereditary optic neuropathy##2##5##(1992-9#2)
with Leptospira interrogans serovar hardjo##2##5##(1991-8#2)
with Lewy bodies##5##3##(2008-7#5)
with Li metal in absolute ethanol-tetrahydrofuran mixture to##2##8##(2007-11#2)
with Li##3##2##(2007-11#2)(2008-2#1)
with LiCl##2##2##(1992-6#1)(1993-12#1)
with LiNbO(3)##2##2##(2007-11#1)(2008-3#1)
with Listeria monocytogenes##3##3##(1996-12#2)(2012-2#1)
with Lr34##2##2##(2008-10#2)
with Lys##2##2##(1990-5#1)(2008-11#1)
with M##26##2##(1992-5#1)(1996-4#1)(1997-7#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#3)(2012-3#2)
with M(2)##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
with M(r)##2##2##(1995-11#1)(2012-3#1)
with M8##2##2##(1992-8#2)
with MA##2##2##(1995-11#1)(2012-3#1)
with MB##2##2##(2008-10#1)(2013-1#1)
with MBP-RT##2##2##(1997-6#2)
with MBTH##2##2##(2008-10#2)
with MCAD deficiency##2##3##(1990-8#2)
with MCI##3##2##(2009-10#2)(2013-8#1)
with MDEA##2##2##(2009-10#2)
with MEKC##2##2##(2008-10#2)
with MEL##3##2##(2008-11#2)(2008-9#1)
with MGR586##2##2##(2008-10#2)
with MHC class II##2##4##(1995-5#1)(2008-9#1)
with MHC class##3##3##(1995-5#1)(2008-9#2)
with MIMS##2##2##(2008-10#2)
with MINTEQA2##2##2##(2008-10#2)
with MM and##2##3##(2008-1#1)(2008-7#1)
with MM##4##2##(2008-1#2)(2008-7#1)(2010-4#1)
with MPTP or DPM individually##2##5##(2008-7#2)
with MPTP##6##2##(2008-7#6)
with MR##6##2##(1991-11#1)(1995-3#4)(2011-1#1)
with MRI##4##2##(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
with MS##14##2##(1995-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#4)(2012-3#4)
with MTs##3##2##(2008-10#2)(2008-11#1)
with Marek's disease##3##3##(1997-6#2)(2008-5#1)
with Marfan syndrome##5##3##(2007-8#1)(2008-8#2)(2009-3#1)(2009-7#1)
with Marfan##6##2##(2007-8#1)(2008-8#3)(2009-3#1)(2009-7#1)
with Marfan's syndrome##2##3##(2007-8#2)
with Medicaid##5##2##(1992-1#1)(1994-1#1)(1994-3#1)(1995-1#1)(1997-2#1)
with Medical##2##2##(1994-3#1)(1995-1#1)
with Medicare managed care##2##4##(1995-12#1)(1997-3#1)
with Medicare##6##2##(1994-1#1)(1995-12#3)(1997-1#1)(1997-3#1)
with MetS##4##2##(2010-10#1)(2011-1#2)(2013-8#1)
with Metastatic##3##2##(2008-11#1)(2008-6#1)(2010-6#1)
with Mg levels##2##3##(2008-10#2)
with Mg##4##2##(2007-12#1)(2008-10#3)
with Mg2+##4##2##(1992-3#1)(1995-2#1)(1995-6#2)
with Microsoft##2##2##(2008-10#2)
with Microsphaeropsis sp##4##3##(2008-10#4)
with Mie theory##4##3##(2008-2#1)(2008-3#3)
with Mie##5##2##(2008-2#2)(2008-3#3)
with Monilinia fructicola##2##3##(2008-10#2)
with Monte Carlo simulations and##2##5##(2008-2#1)(2008-3#1)
with Monte Carlo simulations##7##4##(2008-12#1)(2008-2#3)(2008-3#3)
with Monte Carlo##13##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#6)
with Mr##3##2##(1990-11#1)(2008-10#1)(2008-11#1)
with Multiple##3##2##(1996-2#1)(2007-11#1)(2013-1#1)
with Mycobacterium tuberculosis##2##3##(1996-11#1)(2008-7#1)
with Mycobacterium##5##2##(1991-11#1)(1996-11#1)(1997-8#1)(2008-7#1)(2011-1#1)
with Mycoplasma##3##2##(1997-3#1)(2012-3#1)(2013-1#1)
with Mycosphaerella graminicola##2##3##(2008-10#2)
with N at##2##3##(2008-10#2)
with N##28##2##(1990-8#1)(1991-8#1)(1995-3#1)(2008-10#21)(2008-2#2)(2008-5#1)(2009-11#1)
with N(2)##3##2##(1997-6#1)(2008-3#2)
with N-(1-naphthyl)ethylenediamine##4##2##(2008-10#3)(2008-5#1)
with N-acetylcysteine##6##2##(1991-11#1)(1991-9#2)(1992-6#1)(2008-10#1)(2012-3#1)
with N-acetylglucosamine##3##2##(1990-12#1)(1990-2#1)(1991-5#1)
with N-bromosuccinimide##4##2##(2008-10#4)
with N-fatty acyl##2##3##(1990-12#2)
with N-methyl-N'-nitro-N-nitrosoguanidine##2##2##(1997-3#1)(1997-4#1)
with N-myc##2##2##(1994-10#2)
with N-n-octylaniline##4##2##(2008-10#4)
with N-terminal##3##2##(1991-10#1)(1992-8#1)(1994-11#1)
with NADP##2##2##(1990-7#1)(1995-5#1)
with NBL##2##2##(2011-2#2)
with NCA##2##2##(1994-2#1)(2011-2#1)
with NE##3##2##(1994-6#2)(2008-4#1)
with NF-kappa B##3##3##(1995-12#3)
with NGF treatment##2##3##(1992-12#2)
with NGF##3##2##(1992-12#2)(1994-8#1)
with NIDDM##2##2##(1991-7#2)
with NIPRD-AM1##2##2##(2011-2#2)
with NIRS##2##2##(2008-10#2)
with NL-3 D##2##3##(2008-10#2)
with NL-3##3##2##(2008-10#3)
with NMDA##3##2##(1993-5#1)(1994-2#1)(2008-7#1)
with NMS##2##2##(1996-5#1)(2012-3#1)
with NP##2##2##(2007-11#1)(2012-12#1)
with NSAIDs##3##2##(1993-11#1)(2007-11#1)(2011-2#1)
with NSCLC##6##2##(1991-2#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-8#1)
with NaB##2##2##(1992-3#2)
with NaBH(4)##2##2##(1996-5#1)(2008-10#1)
with NaBH4 to##2##3##(2007-11#2)
with NaBH4##4##2##(1995-3#1)(2007-11#3)
with NaCl##8##2##(1992-3#1)(1995-11#1)(2007-3#2)(2008-10#4)
with NaH##2##2##(1996-2#1)(1996-5#1)
with NaIO(4)##2##2##(1996-5#1)(2008-11#1)
with NaNO(2)##2##2##(2008-10#2)
with NaOH##2##2##(2008-10#1)(2012-2#1)
with Nafion##3##2##(2008-10#3)
with National Institute##2##3##(2008-12#1)(2008-3#1)
with National##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
with Nd##4##2##(2007-12#3)(2008-2#1)
with Nernstian compliance (29##3##4##(2008-10#3)
with Nernstian slope of##3##4##(2008-10#3)
with Nernstian##6##2##(2008-10#6)
with Nervoheel N##2##3##(2008-10#2)
with Ni##2##2##(2008-10#1)(2008-2#1)
with Ni3S2##3##2##(1994-5#2)(1995-3#1)
with NifA##4##2##(2008-4#2)(2008-9#2)
with O##6##2##(2007-11#1)(2008-10#5)
with O(2)##2##2##(2008-10#1)(2010-7#1)
with O2- to form##2##4##(1994-6#2)
with O4##2##2##(1995-2#1)(2008-3#1)
with OA (p##2##3##(1992-3#1)(1993-2#1)
with OA##8##2##(1992-3#2)(1993-2#1)(1993-6#1)(1994-11#1)(2008-9#1)(2010-11#2)
with OCT##5##2##(2007-11#1)(2011-2#3)(2011-7#1)
with OH radicals##2##3##(1997-2#1)(2007-11#1)
with OH##4##2##(1997-2#1)(2007-11#1)(2008-3#2)
with OMP##2##2##(2008-12#2)
with OMS##2##2##(2011-2#2)
with OPV##3##2##(1995-5#3)
with OR##2##2##(2012-2#2)
with OVA##5##2##(1993-12#2)(2008-11#3)
with Oasis##2##2##(2008-10#2)
with Ophiostoma##2##2##(2008-10#2)
with Org 10172##2##3##(1997-2#2)
with Other##2##2##(2008-10#1)(2012-3#1)
with P values as 0##2##5##(2011-1#2)
with P##49##2##(1992-5#2)(1996-10#1)(1997-5#1)(2007-7#2)(2008-10#33)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
with PAH##2##2##(2010-10#2)
with PAHs##2##2##(2008-10#2)
with PAI-1##2##2##(2008-4#1)(2011-2#1)
with PAN##4##2##(2008-10#4)
with PAR##3##2##(2008-10#3)
with PAULA##2##2##(2009-3#2)
with PBN##3##2##(1993-3#1)(1993-6#2)
with PCA##3##2##(2008-10#2)(2010-5#1)
with PCE##2##2##(2009-2#1)(2012-12#1)
with PCNA##2##2##(1995-6#1)(2009-8#1)
with PCOS had##3##3##(2008-3#3)
with PCOS##7##2##(2008-3#4)(2008-4#2)(2010-11#1)
with PCR##10##2##(1990-9#1)(1991-4#2)(1994-3#1)(1994-5#1)(1997-8#1)(2008-10#2)(2008-12#2)
with PCV-2b##2##2##(2012-3#2)
with PD and##5##3##(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
with PD##24##2##(1990-6#1)(2008-10#1)(2008-7#12)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#3)
with PDS##2##2##(2011-1#2)
with PEG 6000##2##3##(2008-12#2)
with PEG##3##2##(2008-12#2)(2008-7#1)
with PET##4##2##(1993-9#1)(1996-5#1)(2008-8#1)(2011-1#1)
with PF-68##2##2##(2011-2#2)
with PH##2##2##(2009-4#1)(2011-1#1)
with PHA##5##2##(1995-8#1)(2007-2#1)(2013-1#3)
with PLS##3##2##(2008-10#2)(2013-8#1)
with PLSVC##3##2##(2010-11#2)(2011-2#1)
with PMA##2##2##(1995-2#1)(1997-1#1)
with PMMA##2##2##(2008-10#2)
with PMMV-k##2##2##(1997-6#2)
with PNRSV##2##2##(2008-10#2)
with PPHP##2##2##(2010-6#2)
with PPV-D##2##2##(2008-10#2)
with PPy-calcion film as the active part##2##7##(2008-10#2)
with PPy-calcion##3##2##(2008-10#3)
with PRCA##2##2##(2007-10#2)
with PS##2##2##(2008-10#1)(2013-1#1)
with PSS##2##2##(2007-10#2)
with PSV##3##2##(2008-10#3)
with PTDM##3##2##(2008-1#3)
with PTSD##2##2##(2008-6#1)(2012-12#1)
with PVA##3##2##(1997-6#1)(2012-3#2)
with PVC##2##2##(2008-10#2)
with PVX##7##2##(2008-10#7)
with Paget's disease##4##3##(1990-6#1)(1991-5#1)(1994-12#1)(2007-11#1)
with Pantoea##3##2##(2008-10#3)
with Parineb##3##2##(1996-12#3)
with Parkinson disease##3##3##(2013-1#1)(2013-8#2)
with Parkinson##6##2##(2012-12#1)(2013-1#1)(2013-8#4)
with Parkinson's disease (PD)##10##4##(2007-10#1)(2008-7#8)(2013-1#1)
with Parkinson's disease##29##3##(1991-5#1)(1993-2#1)(2007-10#2)(2008-7#17)(2009-10#1)(2011-2#1)(2012-12#3)(2013-1#3)
with Parkinson's##30##2##(1991-5#1)(1993-2#1)(2007-10#2)(2008-7#17)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#3)(2013-1#3)
with Patent Blue V##2##4##(2008-10#2)
with Pb(II)##2##2##(2008-10#2)
with Peers##2##2##(2012-12#1)(2013-1#1)
with Peg-Interferon and##2##3##(2013-1#2)
with Percutaneous##2##2##(1990-2#1)(2010-8#1)
with Phe##2##2##(1995-2#2)
with Phellinus##2##2##(2008-10#1)(2008-8#1)
with Phytophthora cinnamomi##2##3##(2008-10#2)
with Phytophthora sojae f##2##4##(1997-6#2)
with Phytophthora##5##2##(1997-6#2)(2008-10#3)
with Plasmodium falciparum##2##3##(2008-8#1)(2012-12#1)
with Plasmodium##3##2##(1993-8#1)(2008-8#1)(2012-12#1)
with PoBH##2##2##(1997-6#2)
with Poly-lys##2##2##(1990-6#2)
with Potato##2##2##(2008-10#2)
with Practice Nurses##2##3##(2008-11#2)
with Pro##2##2##(1993-3#1)(1995-3#1)
with Prolonged##2##2##(2010-1#1)(2010-5#1)
with Przhevalskiana larvae##2##3##(2008-12#2)
with Ps95##2##2##(2008-10#2)
with Pseudomonas fluorescens B5##2##4##(2008-10#2)
with Pseudomonas fluorescens##4##3##(2008-10#4)
with Pseudomonas##8##2##(1997-2#1)(2008-10#6)(2013-1#1)
with Psoriasis and##2##3##(2010-6#1)(2013-1#1)
with Pythium##4##2##(2008-10#4)
with QCT##2##2##(1994-8#2)
with QRS durations##2##3##(2008-10#2)
with QRS##3##2##(2008-10#3)
with R##43##2##(1996-5#1)(2007-12#1)(2008-10#40)(2009-6#1)
with R(2)##2##2##(2008-10#1)(2008-3#1)
with R-PIA##4##2##(1997-1#4)
with RA or##2##3##(1993-3#1)(2008-11#1)
with RA##18##2##(1991-9#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-9#1)(2008-11#2)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
with RAPs##2##2##(2008-10#2)
with RCC##2##2##(2011-2#1)(2013-1#1)
with RH##2##2##(2008-10#2)
with RI##2##2##(2013-1#2)
with RLS##2##2##(2008-10#1)(2012-12#1)
with RM##3##2##(1994-12#3)
with RNA##14##2##(1990-11#1)(1991-6#1)(1992-3#7)(1994-3#1)(1997-6#1)(2008-4#1)(2009-7#1)(2013-1#1)
with RNase##2##2##(1993-11#1)(2008-9#1)
with RSD =##2##3##(2008-10#2)
with RSD##4##2##(2008-10#3)(2012-1#1)
with RT##3##2##(1997-6#1)(2011-2#2)
with RT-PCR##3##2##(2008-8#2)(2012-2#1)
with RU1##2##2##(2008-10#2)
with Raman##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
with Ras##2##2##(1995-5#1)(1997-6#1)
with Reduced Secondary Spectrum##2##4##(2008-3#2)
with Related##2##2##(2008-10#2)
with Resistance to##3##3##(2008-10#3)
with Rett syndrome##2##3##(1997-5#2)
with Rh##2##2##(1992-9#1)(2008-10#1)
with Rhizoctonia solani##4##3##(2008-10#4)
with Rhodamine##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
with RsaI##2##2##(2008-10#2)
with S##31##2##(1990-3#1)(1990-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(2007-7#1)(2008-10#13)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#5)
with S222 preferred over S218##2##5##(1995-2#2)
with S9##2##2##(1992-8#1)(1996-12#1)
with SA##2##2##(2008-10#1)(2013-1#1)
with SARS##4##2##(2007-7#2)(2008-10#1)(2008-4#1)
with SBP##2##2##(2010-4#1)(2013-1#1)
with SBWMV##2##2##(2008-10#1)(2008-8#1)
with SCA##2##2##(2009-4#1)(2010-1#1)
with SCD and##2##3##(2007-7#1)(2009-4#1)
with SCN(-)##2##2##(2008-10#2)
with SDS and##2##3##(2008-4#1)(2013-8#1)
with SDS##4##2##(1996-5#1)(2008-11#1)(2008-4#1)(2013-8#1)
with SGP##3##2##(1994-11#2)(2013-1#1)
with SH##2##2##(2008-10#2)
with SHLI##2##2##(2011-2#2)
with SIJ##2##2##(2010-1#1)(2012-2#1)
with SIV-PBj14##3##2##(1997-3#3)
with SK##2##2##(1993-8#2)
with SLCV-E##2##2##(2008-10#2)
with SLE##4##2##(2006-10#1)(2011-2#2)(2012-12#1)
with SMV##2##2##(2008-10#2)
with SPE clean-up and##2##4##(2008-10#2)
with SPSS##2##2##(2013-1#2)
with SRP##3##2##(2012-3#3)
with SS##7##2##(2007-11#6)(2009-11#1)
with ST##2##2##(2008-3#2)
with STM##2##2##(2008-7#1)(2008-8#1)
with STS and synchronous metastases should##2##6##(2008-6#2)
with STS and synchronous metastases##3##5##(2008-6#3)
with STS and##4##3##(2008-6#4)
with STS markers##2##3##(1996-6#1)(2008-7#1)
with STS##11##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-6#7)(2008-7#1)
with SWNTs##2##2##(2008-7#2)
with Saccharomyces cerevisiae##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
with Saccharomyces##4##2##(1993-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
with Salmonella##4##2##(1990-12#1)(1991-8#1)(1997-3#2)
with Schistosoma japonicum was##2##4##(2008-8#1)(2012-3#1)
with Schistosoma##3##2##(1996-12#1)(2008-8#1)(2012-3#1)
with Sclerotinia sclerotiorum##2##3##(2008-10#2)
with Sephadex##3##2##(2008-10#3)
with Ser##2##2##(1991-9#1)(2012-2#1)
with Sertoli##2##2##(2009-10#1)(2011-2#1)
with Sevoflurane##2##2##(2012-3#2)
with Shc##2##2##(2012-2#2)
with Sjögren's syndrome##2##3##(2007-11#1)(2009-8#1)
with SmithKline Beecham##2##3##(2008-5#2)
with SonoVue##2##2##(2008-7#2)
with Southern blot##2##3##(2008-8#1)(2008-9#1)
with Soxhlet##2##2##(2008-10#2)
with Soybean##2##2##(2008-10#2)
with Special Reference to##3##4##(1996-9#1)(2008-1#1)(2008-6#1)
with Special##7##2##(1994-3#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
with Specific Language Impairment##2##4##(2009-8#1)(2011-1#1)
with Specific##4##2##(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
with SsEno##2##2##(2009-6#2)
with St##2##2##(2008-10#1)(2011-2#1)
with Staphylococcus aureus V8 proteinase##2##5##(1990-5#2)
with Staphylococcus aureus and##2##4##(2007-7#1)(2010-6#1)
with Staphylococcus aureus##5##3##(1990-5#3)(2007-7#1)(2010-6#1)
with Streptococcus pyogenes##2##3##(1995-8#1)(2011-2#1)
with Streptococcus##4##2##(1995-8#1)(1997-6#1)(2009-6#1)(2011-2#1)
with T antigen##2##3##(1993-8#2)
with T cell##4##3##(1991-9#1)(1994-11#1)(2008-4#1)(2008-9#1)
with T##20##2##(1991-8#1)(1991-9#1)(1993-8#2)(1994-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
with T1##6##2##(1991-12#1)(1991-4#1)(2008-10#2)(2008-12#2)
with T1D##6##2##(2007-5#3)(2013-8#3)
with T2##3##2##(2008-12#2)(2013-1#1)
with T2-weighted##2##2##(1996-5#1)(2011-2#1)
with T2DM##2##2##(2013-1#2)
with T2HCA##2##2##(2013-1#2)
with T3##3##2##(2008-10#2)(2008-12#1)
with T4##5##2##(1994-12#1)(2008-10#1)(2008-12#2)(2011-1#1)
with T7 RNA polymerase##2##4##(1993-11#1)(2008-8#1)
with T7##3##2##(1993-11#1)(1995-8#1)(2008-8#1)
with TA##3##2##(1997-8#2)(2008-10#1)
with TAH##2##2##(1996-2#2)
with TAN##2##2##(2008-10#2)
with TB##4##2##(2008-1#2)(2010-5#1)(2011-2#1)
with TBI##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
with TCA or##2##3##(1995-3#2)
with TCD##3##2##(1996-6#2)(2007-10#1)
with TGF-beta 1##2##3##(1990-5#1)(1992-3#1)
with TGF-beta##4##2##(1990-5#1)(1992-3#1)(2008-11#2)
with TKAs that used##2##4##(2013-1#2)
with TLS##2##2##(2008-10#1)(2008-7#1)
with TM increases of##2##4##(1991-8#2)
with TMA dust##2##3##(2008-10#2)
with TMA##3##2##(1995-11#1)(2008-10#2)
with TMAH##2##2##(2008-10#2)
with TMV-OM##2##2##(1997-6#2)
with TNF alpha##2##3##(1995-2#1)(2008-6#1)
with TNF##3##2##(1995-2#1)(1997-7#1)(2008-6#1)
with TNF-alpha##7##2##(1992-3#2)(1995-12#1)(2008-8#1)(2008-9#1)(2009-9#2)
with TNFalpha and cisplatin##2##4##(2008-6#2)
with TNFalpha##4##2##(2008-10#1)(2008-6#3)
with TPA or##2##3##(1993-6#1)(1995-8#1)
with TPA resulted in##2##4##(1990-2#1)(1996-5#1)
with TPA##7##2##(1990-12#1)(1990-2#1)(1993-6#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-2#1)
with TRH##3##2##(1992-2#1)(2013-7#2)
with TSH##3##2##(1993-8#1)(2011-1#1)(2012-3#1)
with TSP##2##2##(1991-2#1)(2007-3#1)
with TTA in##2##3##(2007-11#1)(2008-10#1)
with TTA##3##2##(2007-11#1)(2008-10#2)
with TV shearography##2##3##(2008-3#2)
with TYLCV##4##2##(2008-10#4)
with Taiwan strains##3##3##(2008-8#3)
with Takayasu arteritis##7##3##(1997-8#7)
with Taq DNA polymerase##2##4##(1997-4#1)(2008-5#1)
with TaqI##2##2##(1993-2#1)(2008-10#1)
with TaqMan##2##2##(2008-10#2)
with Those of##2##3##(2008-10#2)
with TiO(2)##3##2##(2013-1#3)
with TiO2##2##2##(2008-10#2)
with Tomato spotted wilt virus (TSWV)##2##6##(2008-10#2)
with Tomato spotted wilt virus##4##5##(2008-10#4)
with Tomato##5##2##(2008-10#5)
with Trichinella##2##2##(1990-12#1)(1996-12#1)
with Trichoderma##8##2##(2008-10#7)(2008-6#1)
with Triton X-100##5##3##(1990-11#1)(1991-8#1)(1994-3#1)(2008-4#1)(2008-7#1)
with Triton X-114##2##3##(1992-3#1)(1995-5#1)
with Triton##10##2##(1990-11#1)(1991-8#3)(1992-3#1)(1994-3#1)(1995-5#1)(2008-4#1)(2008-7#2)
with TuMV##3##2##(2008-10#3)
with Two##2##2##(2008-3#2)
with Type 1 diabetes##2##4##(2010-9#1)(2011-1#1)
with Type 1##3##3##(2010-9#1)(2011-1#1)(2013-1#1)
with Type 2 Diabetes##3##4##(2008-3#1)(2013-1#1)(2013-7#1)
with Type 2##6##3##(1994-12#2)(2008-3#2)(2013-1#1)(2013-7#1)
with Type##9##2##(1994-12#2)(2008-3#2)(2010-9#1)(2011-1#1)(2013-1#2)(2013-7#1)
with U##7##2##(1994-1#1)(2008-10#6)
with UA/NSTEMI##2##2##(2008-3#2)
with UC##2##2##(2012-2#2)
with UCS##2##2##(2008-11#2)
with UES##2##2##(2013-8#2)
with UV absorbance detection##2##4##(1996-5#1)(2008-10#1)
with UV absorbance##4##3##(1996-5#1)(2008-10#3)
with UV and##2##3##(2008-10#2)
with UV at##3##3##(2008-10#2)(2008-9#1)
with UV detection at##6##4##(2008-10#5)(2010-3#1)
with UV detection was##2##4##(2008-10#2)
with UV detection##23##3##(1994-9#1)(2008-10#20)(2010-3#1)(2011-1#1)
with UV light##10##3##(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)
with UV##48##2##(1994-9#1)(1995-3#1)(1995-5#2)(1996-5#2)(2007-11#1)(2007-12#1)(2008-10#31)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)
with UV-vis##2##2##(2008-10#2)
with UVB##2##2##(2008-11#1)(2008-5#1)
with University##3##2##(2008-11#1)(2010-11#1)(2010-3#1)
with Upper Gastrointestinal bleeding##2##4##(2013-1#2)
with V##11##2##(2008-10#8)(2008-6#2)(2011-1#1)
with V108LRUH1##2##2##(2008-10#2)
with V4 lesions##3##3##(1992-11#3)
with VAD##2##2##(2010-6#1)(2012-3#1)
with VEGF##2##2##(2009-11#1)(2013-1#1)
with VLDL##3##2##(1992-12#3)
with VPA##5##2##(2011-2#5)
with Vf##2##2##(2008-10#1)(2008-5#1)
with Viral##2##2##(2008-10#1)(2010-7#1)
with Virulence in##2##3##(2008-10#2)
with Von Recklinghausen's##2##3##(1994-6#1)(2008-10#1)
with WD##3##2##(2008-10#1)(2008-8#2)
with Waardenburg syndrome##5##3##(2008-9#5)
with Werner syndrome##2##3##(1992-9#1)(2012-8#1)
with Western blotting##3##3##(1993-11#1)(2010-12#1)(2011-3#1)
with Western##4##2##(1993-11#1)(2010-12#1)(2011-2#1)(2011-3#1)
with X##5##2##(1997-7#1)(2008-10#4)
with X-ray diffraction##2##3##(2008-10#1)(2013-1#1)
with X-ray##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
with X-rays and##2##3##(1996-6#1)(2011-2#1)
with X-rays##4##2##(1996-6#1)(2008-4#1)(2011-2#1)(2013-1#1)
with XACML##2##2##(2010-8#2)
with XRCC4##2##2##(1997-7#2)
with Xanthomonas campestris pv##2##4##(2008-10#2)
with Xanthomonas##3##2##(2008-10#3)
with Y##2##2##(1992-11#1)(2008-10#1)
with YAC clones##2##3##(1996-10#1)(1996-12#1)
with YACs##2##2##(1996-10#1)(1997-2#1)
with Zeeman##2##2##(2008-10#2)
with Zeeman-effect background##2##3##(2008-10#2)
with Zn##3##2##(1993-12#1)(2008-5#2)
with Zn(2+)##4##2##(2008-10#3)(2012-12#1)
with Zn(II)##2##2##(2010-11#2)
with ZnS##2##2##(2007-11#1)(2008-10#1)
with ZnSO(4) prevented##2##3##(2008-10#2)
with ZnSO(4)##3##2##(2008-10#3)
with Zr##2##2##(2008-10#1)(2008-3#1)
with [1##2##2##(1996-2#2)
with a &quot##5##3##(1994-9#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)
with a 0##11##3##(1994-3#1)(2008-10#6)(2008-3#3)(2012-2#1)
with a 1 mm##2##4##(2008-10#2)
with a 1##18##3##(1993-8#1)(1995-2#1)(1995-3#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2013-1#1)
with a 1-mm-thick##2##3##(2007-12#1)(2008-3#1)
with a 10##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
with a 10-##3##3##(2007-11#2)(2008-10#1)
with a 10-fold##4##3##(1993-11#1)(1994-6#1)(1995-9#1)(2010-1#1)
with a 100% water mobile phase##2##6##(2008-10#2)
with a 100%##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
with a 2##9##3##(1993-3#1)(1994-6#1)(1995-8#1)(2007-12#2)(2008-10#3)(2008-2#1)
with a 2%##2##3##(1991-8#1)(2008-10#1)
with a 2-3##2##3##(1991-2#1)(2008-1#1)
with a 2-week##3##3##(1991-2#1)(2008-10#2)
with a 20##2##3##(2008-10#2)
with a 20%##2##3##(2008-5#1)(2013-8#1)
with a 21##2##3##(1993-8#1)(1995-2#1)
with a 3##10##3##(1990-11#1)(1992-3#1)(1996-2#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
with a 3-4-fold##2##3##(1994-8#1)(2008-10#1)
with a 30##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
with a 4##4##3##(2008-10#1)(2008-2#1)(2013-1#2)
with a 40##2##3##(2008-3#1)(2009-2#1)
with a 45 degrees##2##4##(2008-3#2)
with a 5##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
with a 5%##4##3##(1991-2#1)(2008-10#1)(2008-5#1)(2010-9#1)
with a 50%##7##3##(1992-10#1)(1994-6#1)(1995-11#1)(2007-11#1)(2008-6#2)(2011-2#1)
with a 50/50##2##3##(2007-12#2)
with a 6##2##3##(1995-2#1)(2008-3#1)
with a 670-nm##2##3##(2007-12#1)(2008-3#1)
with a 7##2##3##(1994-5#1)(2008-2#1)
with a 9##3##3##(2008-10#2)(2012-2#1)
with a 90%##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
with a 95% confidence##2##4##(1991-7#1)(2008-3#1)
with a = 10##3##4##(1996-2#3)
with a = 11##4##4##(1996-2#2)(1997-7#2)
with a = 13##4##4##(1996-2#1)(1997-7#3)
with a = 21##2##4##(1996-2#1)(1997-7#1)
with a = 8##4##4##(1996-2#2)(1997-7#2)
with a = 9##2##4##(1996-2#1)(2007-11#1)
with a =##26##3##(1992-12#1)(1992-9#1)(1996-2#14)(1997-7#9)(2007-11#1)
with a Bragg grating##2##4##(2008-3#2)
with a C##2##3##(2008-10#2)
with a C(18)##3##3##(2008-10#3)
with a C-terminal##2##3##(1997-7#1)(2009-10#1)
with a C18##2##3##(1996-5#1)(2011-1#1)
with a CCD array is##2##5##(2008-2#1)(2008-3#1)
with a CCD camera##7##4##(2007-11#3)(2008-3#4)
with a CCD##12##3##(2007-11#3)(2008-2#1)(2008-3#8)
with a CO(2) laser##2##4##(2007-11#1)(2008-2#1)
with a Co(2+)##3##3##(2007-11#1)(2008-3#2)
with a DNA fragment containing##2##5##(1990-5#1)(1995-2#1)
with a DNA fragment##3##4##(1990-5#1)(1995-2#1)(2008-8#1)
with a DNA##4##3##(1990-5#1)(1995-2#1)(2008-11#1)(2008-8#1)
with a European American##2##4##(2009-11#2)
with a European##3##3##(2009-11#2)(2011-2#1)
with a FWHM of##3##4##(2007-11#1)(2008-3#2)
with a FWHM##6##3##(2007-11#3)(2007-12#1)(2008-3#2)
with a Fabry-Perot interferometer##3##4##(2008-3#3)
with a Fabry-Perot##4##3##(2007-11#1)(2008-3#3)
with a Fourier transform infrared##2##5##(2008-10#1)(2008-3#1)
with a Fourier transform##3##4##(2008-10#1)(2008-3#2)
with a Fourier##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
with a Fourier-transform spectrometer##2##4##(2008-3#2)
with a Fourier-transform##3##3##(2008-3#3)
with a GaAs##2##3##(2008-2#1)(2008-3#1)
with a Gaussian##10##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2009-6#1)
with a He-Ne laser##3##4##(2008-3#3)
with a Kd in the##2##5##(1990-11#1)(1992-12#1)
with a Kd of##7##4##(1990-10#1)(1990-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-8#1)
with a Kd##10##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-8#1)
with a Ki = 3##2##5##(1991-12#2)
with a Ki =##3##4##(1991-12#3)
with a Ki of##5##4##(1991-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)
with a Ki##8##3##(1991-12#3)(1991-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)
with a LOD##2##3##(2008-10#2)
with a Mach-Zehnder##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
with a Monte Carlo##3##4##(2008-3#3)
with a Mr of##2##4##(1991-7#1)(1994-11#1)
with a NA of##2##4##(2007-12#1)(2008-3#1)
with a Nafion(R)-membrane##2##3##(2008-10#2)
with a Nernstian slope of 29##3##6##(2008-10#3)
with a Nernstian slope of 59##3##6##(2008-10#3)
with a Nernstian slope of##12##5##(2008-10#12)
with a PCR##2##3##(1990-8#1)(2008-10#1)
with a PCR-based##2##3##(1997-8#1)(2008-10#1)
with a QTL##2##3##(2008-10#1)(2008-8#1)
with a R##9##3##(1997-2#1)(2008-10#8)
with a RSD##2##3##(2008-10#2)
with a Rasch model##2##4##(2012-2#2)
with a SD of##3##4##(2013-8#3)
with a TM of##2##4##(1991-8#2)
with a baculovirus expressing##2##4##(2008-11#1)(2008-7#1)
with a baculovirus expression vector system##2##6##(2008-11#2)
with a baculovirus##4##3##(2008-11#3)(2008-7#1)
with a balloon##3##3##(1996-6#1)(2013-1#2)
with a bandwidth of##4##4##(2007-11#3)(2007-9#1)
with a bare##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
with a barrier of##2##4##(1994-11#1)(1996-2#1)
with a baseline established between##2##5##(2008-10#2)
with a baseline##6##3##(1996-1#1)(2007-12#1)(2008-10#3)(2008-6#1)
with a basic##3##3##(2008-10#2)(2013-8#1)
with a beam quality of##2##5##(2007-11#1)(2007-12#1)
with a beam quality##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
with a beam##10##3##(2007-11#3)(2007-12#1)(2008-3#6)
with a bending##2##3##(1997-2#1)(2007-12#1)
with a best##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
with a beta##2##3##(1991-2#1)(2008-10#1)
with a better understanding of##2##5##(2009-10#1)(2011-1#1)
with a better##16##3##(1994-6#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2011-1#2)(2012-3#2)(2013-1#1)
with a bile acid##2##4##(1991-6#1)(2008-10#1)
with a bimodal##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
with a binary##9##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#4)
with a binding##2##3##(1992-11#1)(2008-9#1)
with a biological##2##3##(1992-11#1)(2009-8#1)
with a biphasic##3##3##(1990-2#1)(1993-11#1)(2008-7#1)
with a bipolar##2##3##(1993-8#1)(1997-5#1)
with a blood pressure##3##4##(1997-2#1)(2008-7#1)(2011-1#1)
with a blood##5##3##(1997-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
with a blue##2##3##(2007-11#1)(2008-10#1)
with a body##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
with a bone##3##3##(1995-12#1)(2008-6#2)
with a breast lump##2##4##(1990-10#1)(1991-12#1)
with a brief discussion on##2##5##(2008-2#1)(2008-6#1)
with a brief discussion##3##4##(2008-2#1)(2008-6#1)(2012-12#1)
with a brief introduction to##2##5##(2008-7#1)(2012-2#1)
with a brief overview of##2##5##(2007-7#1)(2008-4#1)
with a brief review of the literature##2##7##(2008-8#1)(2009-5#1)
with a brief review of##3##5##(2008-6#1)(2008-8#1)(2009-5#1)
with a brief##15##3##(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
with a broad range of##5##5##(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
with a broad range##6##4##(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
with a broad spectrum of##5##5##(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
with a broad##16##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
with a bulk acoustic wave sensor##2##6##(2008-10#2)
with a bulk acoustic##3##4##(2008-10#3)
with a cDNA##2##3##(1991-9#1)(1995-2#1)
with a calcium##3##3##(1990-2#1)(1991-6#1)(2008-11#1)
with a calculated M(r) of##3##5##(1993-6#1)(1993-9#1)(1994-12#1)
with a calculated molecular mass of##2##6##(1993-3#1)(1996-6#1)
with a calculated molecular weight of##2##6##(1990-12#1)(1995-6#1)
with a calculated molecular##4##4##(1990-12#1)(1993-3#1)(1995-6#1)(1996-6#1)
with a calculated##13##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-6#1)(2008-10#1)
with a capacity##2##3##(2008-10#1)(2009-7#1)
with a carbon fiber##2##4##(2008-10#2)
with a carbon##6##3##(2008-10#5)(2008-7#1)
with a careful##2##3##(2008-10#1)(2012-12#1)
with a carrier##5##3##(1990-2#1)(1995-11#1)(1997-3#1)(2008-10#2)
with a case of##2##4##(2008-9#1)(2009-5#1)
with a case##4##3##(1996-12#1)(2008-11#1)(2008-9#1)(2009-5#1)
with a catalytic##2##3##(2008-10#1)(2009-10#1)
with a cationic slope of##3##5##(2008-10#3)
with a cationic##9##3##(2008-10#8)(2008-5#1)
with a cell##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
with a cellular##2##3##(1991-9#1)(1997-1#1)
with a cellulose acetate##2##4##(2008-10#2)
with a cellulose##4##3##(2008-10#3)(2008-7#1)
with a center wavelength of##2##5##(2007-12#1)(2008-3#1)
with a center##6##3##(2007-12#2)(2008-10#2)(2008-3#2)
with a central##9##3##(1995-11#1)(1995-12#1)(2007-10#1)(2007-12#2)(2008-10#2)(2009-4#1)(2012-2#1)
with a centrifugal##2##3##(2007-8#1)(2010-8#1)
with a cerebral##2##3##(1997-3#1)(2011-2#1)
with a certain##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
with a certified reference material##3##5##(2008-10#2)(2011-2#1)
with a certified##4##3##(2008-10#3)(2011-2#1)
with a cervical##4##3##(2007-8#1)(2009-10#2)(2012-12#1)
with a challenging##3##3##(2008-10#1)(2013-8#2)
with a change in the refractive index##2##7##(2008-2#2)
with a change in the##5##5##(1991-9#1)(2008-10#1)(2008-2#2)(2009-2#1)
with a change in##7##4##(1991-9#2)(2008-10#1)(2008-11#1)(2008-2#2)(2009-2#1)
with a change##8##3##(1991-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2009-2#1)
with a channel##2##3##(2008-3#1)(2012-2#1)
with a chaotic##2##3##(2007-12#1)(2012-2#1)
with a characteristic size of the order of##2##8##(1996-4#1)(2007-11#1)
with a characteristic##6##3##(1991-2#1)(1993-6#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-5#1)
with a charged##2##3##(1997-2#1)(2009-1#1)
with a chelating##2##3##(1995-3#1)(2008-10#1)
with a chemical##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
with a chemiluminescence##4##3##(2008-10#3)(2008-5#1)
with a chief complaint of##3##5##(2008-12#2)(2012-12#1)
with a choice##2##3##(2008-9#2)
with a chronic condition##2##4##(1992-12#1)(2009-5#1)
with a chronic##8##3##(1992-12#1)(1992-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2012-2#1)
with a circular##2##3##(2007-11#1)(2008-3#1)
with a classical##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
with a clear##7##3##(1990-6#1)(1990-7#1)(1991-1#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
with a clinical diagnosis of##3##5##(2008-7#1)(2008-9#1)(2011-2#1)
with a clinical picture of##2##5##(1990-3#1)(1992-10#1)
with a clinical picture##3##4##(1990-3#1)(1992-10#1)(2009-3#1)
with a clinical##16##3##(1990-3#1)(1992-10#1)(1992-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#2)(2013-1#2)
with a close##2##3##(1990-9#1)(1997-8#1)
with a coarse##3##3##(2008-6#1)(2009-7#1)(2012-3#1)
with a cochlear implant##6##4##(2008-9#6)
with a coefficient of variation##2##5##(2008-10#2)
with a coefficient of##4##4##(1990-2#1)(2008-10#3)
with a coherent##2##3##(2007-11#1)(2008-3#1)
with a cohesive##2##3##(1993-11#1)(2008-12#1)
with a collimated##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
with a collinear configuration##2##4##(2007-12#2)
with a colorimetric##2##3##(2008-10#2)
with a column##3##3##(1990-8#1)(2008-10#2)
with a combination of the##2##5##(1992-3#1)(2013-8#1)
with a combination of##30##4##(1990-7#1)(1991-2#2)(1991-6#1)(1992-3#1)(1993-8#2)(1994-8#1)(1995-3#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
with a combination##32##3##(1990-2#1)(1990-7#1)(1991-2#2)(1991-6#1)(1992-3#1)(1993-8#2)(1994-8#1)(1995-3#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
with a combined standard uncertainty of 0##2##7##(2008-3#2)
with a combined##6##3##(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-3#2)
with a commercial##17##3##(1995-2#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#2)(2012-2#1)(2013-7#1)
with a commercially available##9##4##(1991-12#1)(1993-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)
with a common interest in##2##5##(2008-7#1)(2008-8#1)
with a common##13##3##(1990-7#1)(1991-3#1)(1991-9#1)(1993-12#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
with a compact##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
with a comparable##2##3##(2008-11#1)(2013-1#1)
with a compartmental##3##3##(1992-9#1)(2008-5#1)(2010-10#1)
with a compatible##3##3##(2007-12#1)(2008-10#2)
with a competitive##2##3##(2008-10#1)(2011-2#1)
with a complementary##2##3##(2008-3#1)(2008-4#1)
with a complete##7##3##(1991-4#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
with a complex of##2##4##(2008-10#1)(2008-4#1)
with a complex##8##3##(1995-12#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-10#1)(2010-3#1)(2011-2#1)
with a complimentary##2##3##(2007-11#1)(2008-5#1)
with a composite##3##3##(2008-9#1)(2012-2#2)
with a composition##2##3##(2007-11#1)(2008-10#1)
with a compound##2##3##(2008-10#1)(2008-3#1)
with a comprehensive##5##3##(1991-8#1)(1995-12#1)(2008-12#1)(2008-2#1)(2009-11#1)
with a computational model##2##4##(2008-11#1)(2008-2#1)
with a computer program##2##4##(1994-9#1)(2008-10#1)
with a computer##5##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
with a computerized##2##3##(2008-10#1)(2008-9#1)
with a concave##2##3##(2007-11#1)(2008-3#1)
with a concentration gradient##2##4##(2008-10#1)(2012-2#1)
with a concentration of##7##4##(1990-8#1)(1993-12#1)(2008-10#5)
with a concentration##12##3##(1990-8#1)(1993-12#1)(2008-10#9)(2012-2#1)
with a concomitant decrease##2##4##(1992-11#1)(1994-2#1)
with a concomitant##6##3##(1992-11#1)(1992-6#1)(1993-8#1)(1994-2#1)(1996-6#1)(2010-2#1)
with a conditionally processed##2##4##(1993-8#2)
with a confocal microscope##2##4##(2007-12#1)(2008-3#1)
with a confocal##8##3##(2007-11#2)(2007-12#2)(2008-3#4)
with a conidial suspension##4##4##(2008-10#4)
with a consensus##4##3##(1990-8#1)(1991-12#1)(2008-6#2)
with a consequent##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2010-3#1)
with a considerable##2##3##(1994-8#1)(2007-8#1)
with a constant##12##3##(1991-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)
with a constitutively##2##3##(2008-7#2)
with a construct##2##3##(1990-5#1)(1993-2#1)
with a continuous##9##3##(1997-7#1)(2007-12#1)(2008-10#3)(2008-3#4)
with a continuous-wave (cw) laser##2##5##(2008-2#1)(2008-3#1)
with a continuous-wave optical parametric oscillator##2##6##(2007-12#2)
with a continuous-wave##10##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#2)
with a continuously##2##3##(2008-2#1)(2008-3#1)
with a control##9##3##(1991-2#1)(1996-9#1)(1997-7#1)(2008-10#2)(2008-3#2)(2012-2#1)(2013-1#1)
with a convenient##2##3##(2008-10#1)(2008-11#1)
with a conventional length electrode##3##5##(2012-2#3)
with a conventional##17##3##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#2)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#3)
with a conventionally##2##3##(2008-10#1)(2008-3#1)
with a copper##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
with a core##2##3##(1996-3#1)(2007-12#1)
with a corneometer##2##3##(2008-5#2)
with a correlation coefficient (R(2))##2##5##(2008-10#2)
with a correlation coefficient 0##2##5##(2008-10#2)
with a correlation coefficient of 0##22##6##(2008-10#21)(2010-4#1)
with a correlation coefficient of linear regression of 0##2##9##(2008-10#2)
with a correlation coefficient of##24##5##(2008-10#23)(2010-4#1)
with a correlation coefficient##31##4##(1990-8#1)(2008-10#28)(2008-8#1)(2010-4#1)
with a correlation factor of 0##3##6##(2008-10#3)
with a correlation factor##4##4##(2008-10#4)
with a correlation##36##3##(1990-8#1)(2008-10#33)(2008-8#1)(2010-4#1)
with a corresponding increase in##2##5##(1991-3#1)(2008-5#1)
with a corresponding##5##3##(1991-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
with a coupled##3##3##(2008-10#2)(2008-3#1)
with a course of##2##4##(2006-10#1)(2007-8#1)
with a course##3##3##(2006-10#1)(2007-8#2)
with a critical##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
with a cubic##3##3##(2007-12#2)(2008-10#1)
with a current##3##3##(2007-12#1)(2008-7#1)(2011-3#1)
with a cutoff##2##3##(2011-3#1)(2012-2#1)
with a cw##3##3##(2007-12#3)
with a daily dose of##2##5##(1990-11#1)(2008-10#1)
with a decrease in the##9##5##(1994-11#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-2#1)
with a decrease in##23##4##(1990-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-7#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-7#3)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
with a decrease of##4##4##(1996-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
with a decrease##29##3##(1990-12#1)(1991-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
with a decreased risk for##2##5##(1993-12#1)(2007-4#1)
with a decreased risk of##3##5##(1996-9#1)(2011-2#1)(2013-7#1)
with a decreased risk##5##4##(1993-12#1)(1996-9#1)(2007-4#1)(2011-2#1)(2013-7#1)
with a decreased##14##3##(1990-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1996-9#1)(2007-4#1)(2008-11#1)(2009-12#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-7#1)
with a deduced##2##3##(1990-11#1)(1997-9#1)
with a deep LMS##2##4##(2008-6#2)
with a deep##3##3##(1991-5#1)(2008-6#2)
with a defective##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
with a defined##3##3##(2008-3#1)(2009-8#1)(2011-2#1)
with a definite##2##3##(2008-6#1)(2012-2#1)
with a definitive##2##3##(1997-8#1)(2013-1#1)
with a deformable mirror##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
with a deformable##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
with a degree##3##3##(1991-2#1)(1995-5#1)(2008-12#1)
with a delay##4##3##(2008-10#1)(2008-5#2)(2008-6#1)
with a deletion##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
with a dense##4##3##(1996-1#1)(2008-4#1)(2008-9#1)(2010-6#1)
with a depth resolution of##2##5##(2008-3#2)
with a depth##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
with a description of the##2##5##(2011-2#1)(2013-1#1)
with a description of##8##4##(1991-2#1)(1992-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
with a desired##2##3##(1992-9#1)(2007-12#1)
with a detailed##7##3##(1992-8#1)(1994-3#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)
with a detection limit (3sigma) of 0##4##7##(2008-10#4)
with a detection limit (LD) of 0##2##7##(2008-10#2)
with a detection limit (S/N=3) of 0##2##7##(2008-10#2)
with a detection limit 1##2##5##(2008-10#2)
with a detection limit down to##2##6##(2008-10#2)
with a detection limit of 0##45##6##(1992-11#1)(2008-10#42)(2008-11#1)(2010-4#1)
with a detection limit of 1 muM##2##7##(2008-10#2)
with a detection limit of 1##25##6##(1996-5#1)(2008-10#24)
with a detection limit of 1ppm##2##6##(2008-10#2)
with a detection limit of 2##7##6##(2008-10#7)
with a detection limit of 3##4##6##(2008-10#4)
with a detection limit of 4##6##6##(2008-10#6)
with a detection limit of 5##6##6##(2008-10#6)
with a detection limit of 6##6##6##(2008-10#4)(2010-5#2)
with a detection limit of 8##4##6##(2008-10#4)
with a detection limit of 9##2##6##(2008-10#2)
with a detection limit of c(L)=0##2##6##(2008-10#2)
with a detection limit of##128##5##(1992-11#1)(1996-5#1)(2008-10#120)(2008-11#2)(2008-3#1)(2010-4#1)(2010-5#2)
with a detection limit##147##4##(1992-11#1)(1993-8#1)(1996-5#1)(2008-10#138)(2008-11#2)(2008-3#1)(2010-4#1)(2010-5#2)
with a detection sensitivity of##2##5##(2008-10#1)(2008-3#1)
with a detection##152##3##(1992-11#1)(1993-8#1)(1996-5#1)(2008-10#139)(2008-11#2)(2008-3#5)(2010-4#1)(2010-5#2)
with a diagnosis of##21##4##(1991-8#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
with a diagnosis##22##3##(1991-8#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#2)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
with a diameter of about##2##5##(2007-12#1)(2008-1#1)
with a diameter of##11##4##(1994-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-1#1)(2013-1#1)
with a diameter##15##3##(1994-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2012-1#1)(2013-1#1)
with a diamond##2##3##(2008-3#1)(2013-1#1)
with a difference##2##3##(1990-11#1)(2008-3#1)
with a different##14##3##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-10#1)(2010-2#1)
with a differential##4##3##(1997-3#1)(2007-11#2)(2008-2#1)
with a diffraction efficiency of##2##5##(2008-2#1)(2008-3#1)
with a diffraction grating##2##4##(2007-12#1)(2008-2#1)
with a diffraction##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
with a diffractive optical element##3##5##(2007-12#2)(2008-3#1)
with a diffractive##4##3##(2007-12#2)(2008-3#2)
with a digital##5##3##(1992-5#1)(2008-10#1)(2008-3#2)(2013-7#1)
with a diode array detector##2##5##(2008-10#2)
with a diode##3##3##(2008-10#2)(2008-2#1)
with a diode-pumped##2##3##(2007-11#1)(2007-12#1)
with a direct##6##3##(1992-6#1)(1992-9#1)(1994-11#1)(1996-5#1)(1996-6#1)(2007-11#1)
with a discussion of some of the##3##7##(1997-3#1)(2008-4#1)(2008-8#1)
with a discussion of some of##4##6##(1997-3#1)(1997-4#1)(2008-4#1)(2008-8#1)
with a discussion of the##12##5##(1992-3#1)(1993-2#1)(1994-3#1)(1995-3#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-5#1)(2010-9#1)(2012-2#1)
with a discussion of##27##4##(1992-3#2)(1993-2#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#2)
with a discussion##29##3##(1992-3#2)(1993-2#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#2)
with a disease##2##3##(2008-10#2)
with a disorder##2##3##(1994-8#1)(2009-9#1)
with a distal##4##3##(1997-4#1)(2007-10#1)(2008-6#1)(2008-9#1)
with a distance of 1##2##5##(2007-8#1)(2008-9#1)
with a distance##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
with a distinct##7##3##(1991-1#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)
with a distinctive##2##3##(1994-8#1)(2007-7#1)
with a distorted diffraction grating##2##5##(2008-3#2)
with a distributed-feedback laser##2##4##(2007-11#2)
with a distributed-feedback##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
with a diverse##3##3##(1990-8#1)(2006-10#1)(2013-1#1)
with a domain arrangement of##2##5##(1990-5#2)
with a dorsal##2##3##(2008-9#2)
with a dose of##6##4##(2007-11#2)(2007-12#2)(2008-12#1)(2011-2#1)
with a dose##9##3##(1991-6#1)(1992-10#1)(2007-11#2)(2007-12#2)(2008-12#1)(2009-11#1)(2011-2#1)
with a double membrane##2##4##(2008-10#1)(2008-9#1)
with a double##9##3##(1992-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-7#1)
with a double-etalon##2##3##(2008-2#2)
with a double-focusing mass##2##4##(2008-10#1)(2008-4#1)
with a doubling time of##2##5##(2008-11#2)
with a dramatic##2##3##(2008-12#1)(2013-8#1)
with a drop in##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
with a dry##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
with a dual enzyme electrode##2##5##(2008-10#2)
with a dual source##2##4##(2012-1#1)(2012-12#1)
with a dual##5##3##(2008-10#2)(2008-3#1)(2012-1#1)(2012-12#1)
with a duration##3##3##(1997-8#1)(2008-9#1)(2013-1#1)
with a dye##2##3##(2008-11#1)(2008-9#1)
with a dynamic range of##3##5##(2008-10#2)(2008-2#1)
with a dynamic##7##3##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)
with a failure##2##3##(2007-12#1)(2008-4#1)
with a family history of##5##5##(2008-3#2)(2009-9#1)(2013-1#1)(2013-8#1)
with a family history##6##4##(2008-3#2)(2008-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
with a far##2##3##(1994-10#1)(2009-8#1)
with a fast algorithm##2##4##(2007-11#1)(2008-2#1)
with a fast response##5##4##(2008-10#5)
with a fast##11##3##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#4)
with a fatal##3##3##(2008-12#1)(2008-2#1)(2013-1#1)
with a favorable##5##3##(2008-12#1)(2010-7#1)(2012-3#2)(2013-1#1)
with a femtosecond laser##2##4##(2007-12#2)
with a femtosecond##3##3##(2007-12#2)(2008-2#1)
with a ferroelectric liquid-crystal spatial light modulator##2##7##(2008-2#1)(2008-3#1)
with a fetal##2##3##(2008-11#1)(2013-1#1)
with a few exceptions##2##4##(2011-1#1)(2012-3#1)
with a few noted exceptions##2##5##(2008-10#2)
with a few##16##3##(1995-6#1)(1997-6#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-3#2)
with a fiber##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
with a fiber-optic##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
with a fibrate##2##3##(2008-1#1)(2008-5#1)
with a field of view##2##5##(2008-2#1)(2008-3#1)
with a field##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
with a final##6##3##(1990-3#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
with a finding##2##3##(2010-5#1)(2013-1#1)
with a fine##3##3##(2008-10#2)(2008-3#1)
with a finite##4##3##(2007-11#1)(2008-11#1)(2008-3#2)
with a first##4##3##(1992-2#1)(1992-8#1)(2008-10#1)(2011-1#1)
with a first-order##3##3##(1995-6#1)(2007-12#1)(2008-10#1)
with a fixed number of##2##5##(2007-11#1)(2009-5#1)
with a fixed##10##3##(1994-5#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-5#1)(2012-12#1)
with a flat##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
with a flexible##2##3##(1995-8#1)(2010-7#1)
with a flow injection (FI) system##2##6##(2008-10#2)
with a flow injection system##2##5##(2008-10#2)
with a flow injection##5##4##(2008-10#5)
with a flow rate of 1##4##6##(2008-10#3)(2008-5#1)
with a flow rate of##5##5##(2008-10#4)(2008-5#1)
with a flow##12##3##(2008-10#9)(2008-5#1)(2008-9#1)(2012-2#1)
with a flow-through##3##3##(2008-10#2)(2013-1#1)
with a fluid##2##3##(2008-10#1)(2008-7#1)
with a fluid-fluid level##2##4##(2011-2#2)
with a fluorescein derivative##2##4##(2008-10#2)
with a fluorescence detector##2##4##(2008-10#2)
with a fluorescence##4##3##(1997-3#1)(2008-10#2)(2008-3#1)
with a fluorescent marker##2##4##(1994-2#1)(2007-11#1)
with a fluorescent##6##3##(1994-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
with a fluorinated##2##3##(1992-12#1)(2008-10#1)
with a fluorophore##2##3##(1992-3#1)(2008-2#1)
with a focal length##2##4##(2007-11#1)(2008-2#1)
with a focal##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
with a focus on the##6##5##(1995-12#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-10#1)(2013-1#1)
with a focus on##28##4##(1994-1#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
with a focused##4##3##(2008-2#1)(2008-3#3)
with a food##4##3##(2008-10#1)(2008-5#3)
with a foot##2##3##(2006-10#1)(2013-8#1)
with a form of##2##4##(1991-12#1)(1995-8#1)
with a fractional##2##3##(1996-12#1)(2008-3#1)
with a framework for understanding##2##5##(2008-12#1)(2010-4#1)
with a framework##3##3##(2008-12#1)(2010-4#1)(2011-2#1)
with a free##5##3##(1995-5#1)(1996-5#1)(2006-12#1)(2007-11#1)(2011-2#1)
with a frequency of 1##2##5##(2008-11#1)(2008-3#1)
with a frequency of##9##4##(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2013-1#1)
with a frequency-doubled##3##3##(2008-2#2)(2008-3#1)
with a frequency-modulated##2##3##(2008-3#2)
with a full width at##2##5##(2007-11#1)(2008-3#1)
with a full##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
with a fully##4##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
with a functioning##2##3##(1995-2#1)(2013-1#1)
with a fungicide##3##3##(2008-10#3)
with a fused-silica microsphere##2##4##(2007-12#2)
with a fused-silica##3##3##(2007-11#1)(2007-12#2)
with a gain##3##3##(2007-11#2)(2008-3#1)
with a galvanic hydrogen cyanide sensor##2##6##(2008-10#2)
with a gas##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
with a general practitioner##2##4##(1993-6#1)(2010-1#1)
with a general##4##3##(1993-3#1)(1993-6#1)(1997-5#1)(2010-1#1)
with a generalized##2##3##(2008-10#1)(2012-3#1)
with a genetic##5##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
with a giant##6##3##(1993-6#1)(2006-12#1)(2009-8#1)(2010-6#1)(2011-2#2)
with a given##11##3##(1997-2#1)(2007-12#1)(2007-7#1)(2008-2#3)(2008-3#3)(2008-9#1)(2012-2#1)
with a glass impact bead##2##5##(2008-10#2)
with a glass##5##3##(2007-12#1)(2008-10#3)(2013-1#1)
with a global##3##3##(2007-11#1)(2008-8#1)(2012-1#1)
with a glucose##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
with a gold##3##3##(2008-10#2)(2008-3#1)
with a good precision##3##4##(2008-10#3)
with a good prognosis##2##4##(2008-10#1)(2012-3#1)
with a good##29##3##(1994-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-8#2)
with a grade##2##3##(1991-2#1)(2013-1#1)
with a gradient elution##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
with a gradient of##2##4##(2008-2#1)(2008-4#1)
with a gradient solvent system of##2##6##(2008-10#1)(2012-3#1)
with a gradient##8##3##(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
with a gradual##3##3##(1994-9#1)(2008-10#2)
with a graphite##2##3##(2008-10#2)
with a grating##4##3##(2007-11#1)(2008-3#3)
with a great deal of##2##5##(1993-9#1)(2012-12#1)
with a great potential for the##2##6##(1997-8#1)(2009-10#1)
with a great variety of##2##5##(1997-6#1)(2008-7#1)
with a great##8##3##(1993-9#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-3#1)(2012-12#1)
with a greater number of##2##5##(2008-12#1)(2008-7#1)
with a greater##13##3##(1995-2#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-8#1)
with a green fluorescent protein (GFP)##2##6##(2008-10#2)
with a group of##9##4##(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#2)(2012-12#1)
with a group##12##3##(1991-11#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#2)(2012-12#1)
with a growing##4##3##(1993-1#1)(1996-3#1)(1997-6#1)(2013-1#1)
with a growth##4##3##(1994-8#1)(1996-12#1)(2008-5#1)(2013-1#1)
with a half-maximal##3##3##(1991-8#2)(1994-8#1)
with a half-time of approximately##2##5##(1992-12#1)(1992-6#1)
with a hanging mercury drop electrode##2##6##(2008-10#2)
with a hanging##3##3##(2008-10#2)(2008-11#1)
with a hard##2##3##(2007-12#1)(2008-2#1)
with a hazard ratio##2##4##(1993-9#1)(2013-1#1)
with a herd##2##3##(1992-5#1)(1996-12#1)
with a heterobifunctional##2##3##(1992-11#1)(2008-7#1)
with a heterogeneous##3##3##(1992-6#1)(2008-8#1)(2010-3#1)
with a high abundance of##2##5##(2007-5#1)(2009-5#1)
with a high accuracy##4##4##(2008-3#2)(2011-2#1)(2013-8#1)
with a high affinity##2##4##(1992-11#1)(2008-10#1)
with a high concentration of##2##5##(1992-5#1)(2008-3#1)
with a high correlation##2##4##(2008-10#1)(2011-2#1)
with a high degree of accuracy##2##6##(2008-3#1)(2013-1#1)
with a high degree of confidence##2##6##(2008-10#1)(2008-3#1)
with a high degree of precision##3##6##(2007-11#1)(2008-11#1)(2010-12#1)
with a high degree of selectivity##2##6##(2008-10#2)
with a high degree of sensitivity##3##6##(2007-12#1)(2008-10#2)
with a high degree of##21##5##(1996-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2013-1#1)
with a high dose of##4##5##(1995-3#2)(2013-1#1)(2013-8#1)
with a high flow##2##4##(1995-3#1)(1996-9#1)
with a high incidence of##3##5##(2007-10#2)(2007-7#1)
with a high level of##7##5##(1992-9#1)(1994-8#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-11#1)
with a high molecular weight##3##5##(1995-6#1)(1996-12#1)(2008-10#1)
with a high mortality rate##7##5##(1992-9#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)
with a high mortality##8##4##(1992-9#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)
with a high number of##4##5##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
with a high numerical aperture##2##5##(2007-12#1)(2008-3#1)
with a high percentage of##3##5##(1996-3#1)(2008-11#1)(2012-3#1)
with a high prevalence of##3##5##(2007-8#1)(2008-1#2)
with a high probability of##2##5##(2007-11#1)(2008-11#1)
with a high probability##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
with a high proportion of##2##5##(2008-10#1)(2008-7#1)
with a high rate of##8##5##(1991-6#1)(1993-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
with a high risk of##4##5##(1990-3#1)(2010-8#1)(2012-12#1)(2013-7#1)
with a high risk##5##4##(1990-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-7#1)
with a high sensitivity and specificity##2##6##(2008-4#1)(2013-1#1)
with a high sensitivity##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
with a high signal-to-noise ratio##2##5##(2007-12#1)(2008-3#1)
with a high success rate##3##5##(1996-11#1)(2012-12#1)(2013-8#1)
with a high yield##3##4##(1994-3#1)(2008-5#1)(2013-1#1)
with a high##166##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#8)(2008-12#1)(2008-3#11)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
with a high-finesse Fabry-Perot cavity##2##5##(2007-12#1)(2008-3#1)
with a high-finesse Fabry-Perot##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
with a high-finesse##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
with a high-grade##2##3##(1997-1#1)(2008-6#1)
with a high-intensity##2##3##(2007-11#1)(2008-3#1)
with a high-power##2##3##(2007-12#1)(2008-2#1)
with a high-resolution##2##3##(2008-2#1)(2008-3#1)
with a high-speed##2##3##(2007-11#1)(2008-3#1)
with a higher affinity##2##4##(1990-11#1)(1992-6#1)
with a higher incidence in##2##5##(2010-3#1)(2011-2#1)
with a higher incidence of##2##5##(2008-10#1)(2013-1#1)
with a higher incidence##4##4##(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
with a higher level of##2##5##(1997-8#1)(2008-7#1)
with a higher##37##3##(1990-11#1)(1991-12#2)(1992-6#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
with a highly##8##3##(1993-2#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
with a histologic diagnosis of##2##5##(1990-10#1)(1995-3#1)
with a history of SLI##4##5##(2012-3#4)
with a history of breast##2##5##(1994-7#1)(2008-1#1)
with a history of chronic##2##5##(1992-10#1)(2012-1#1)
with a history of familial##2##5##(1993-6#1)(2007-10#1)
with a history of hysterectomy##2##5##(2010-12#1)(2012-3#1)
with a history of lateral ligament sprain##3##7##(2007-11#3)
with a history of multiple##2##5##(2008-11#1)(2013-8#1)
with a history of previous##2##5##(1996-7#1)(2008-11#1)
with a history of recent##2##5##(1992-3#1)(2012-3#1)
with a history of significant##2##5##(2007-8#1)(2011-2#1)
with a history of##88##4##(1990-12#1)(1990-3#2)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-7#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(2007-10#4)(2007-11#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#10)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#4)
with a history##90##3##(1990-12#1)(1990-3#2)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-7#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(2007-10#4)(2007-11#4)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#10)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#6)
with a hitherto##2##3##(1995-6#1)(2013-1#1)
with a hollow##2##3##(2008-7#2)
with a homogeneous##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
with a hospital##3##3##(1993-12#1)(1996-3#2)
with a huge##5##3##(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-2#1)
with a human c-myc gene##2##5##(1993-3#1)(2008-11#1)
with a human##10##3##(1992-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-11#2)(2008-8#1)
with a hybrid##2##3##(2007-11#1)(2008-10#1)
with a hydrogen##2##3##(2008-10#1)(2008-5#1)
with a hydrophilic matrix (Asahipak##2##5##(1990-8#2)
with a hydrophobic##2##3##(1993-6#1)(2008-10#1)
with a hydroxyl group##2##4##(2008-11#2)
with a hypothetical protein##2##4##(1995-9#1)(1996-3#1)
with a hypothetical##3##3##(1995-11#1)(1995-9#1)(1996-3#1)
with a juvenile hormone##2##4##(1995-11#1)(2008-8#1)
with a kcat/Km##2##3##(1993-8#1)(1995-2#1)
with a known##12##3##(1991-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#2)
with a laboratory##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
with a lack of##4##4##(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
with a large amount of##2##5##(2008-12#1)(2008-6#1)
with a large area of##2##5##(1992-5#1)(2008-10#1)
with a large dispersion of the##2##6##(1990-3#1)(2008-3#1)
with a large excess of##3##5##(1991-11#1)(1995-2#1)(2008-2#1)
with a large number of##4##5##(2007-12#1)(2008-7#1)(2008-9#1)(2009-5#1)
with a large proportion of##3##5##(1992-12#1)(1997-4#1)(2008-10#1)
with a large variety of##3##5##(1997-7#1)(2008-10#1)(2008-3#1)
with a large##65##3##(1990-3#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#8)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
with a larger##6##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
with a laryngectomy##3##3##(2007-8#1)(2011-1#2)
with a laser beam##3##4##(2007-12#2)(2008-3#1)
with a laser diode##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
with a laser##14##3##(1995-6#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#6)(2012-3#1)
with a laser-diode-pumped##3##3##(2007-12#3)
with a late##2##3##(2007-12#1)(2008-1#1)
with a lateral##3##3##(2008-2#2)(2009-1#1)
with a layer of##4##4##(2008-10#1)(2008-3#2)(2008-5#1)
with a learning##3##3##(2008-10#1)(2008-11#2)
with a left##4##3##(2007-9#1)(2008-1#2)(2008-7#1)
with a length of##5##4##(1992-12#1)(1995-2#1)(1997-8#1)(2008-3#2)
with a lens##2##3##(2008-10#1)(2011-1#1)
with a lesion##2##3##(1996-2#1)(2013-1#1)
with a less##4##3##(1992-5#1)(1996-11#1)(2007-12#1)(2008-3#1)
with a lesser degree of##2##5##(1991-5#1)(1997-1#1)
with a lesser##4##3##(1990-8#1)(1991-5#1)(1997-1#1)(2008-3#1)
with a life-threatening##2##3##(1990-8#1)(2011-3#1)
with a light##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
with a likelihood ratio##2##4##(2008-3#1)(2013-1#1)
with a limit of detection of 0##4##7##(2008-10#4)
with a limit of detection of 1##2##7##(2008-10#2)
with a limit of detection of##11##6##(2008-10#11)
with a limit of detection##17##5##(2008-10#17)
with a limit of##18##4##(2008-10#18)
with a limit##19##3##(2008-10#19)
with a limited amount of tissue##2##6##(2008-4#1)(2010-8#1)
with a limited number of##3##5##(1993-9#1)(2008-5#1)(2012-2#1)
with a limited##10##3##(1990-12#1)(1993-9#1)(2007-12#1)(2008-4#1)(2008-5#2)(2010-8#2)(2012-12#1)(2012-2#1)
with a linear calibration##2##4##(2008-10#2)
with a linear correlation coefficient of 0##3##7##(1992-11#1)(2008-10#2)
with a linear dynamic range##4##5##(2008-10#4)
with a linear range between 1##2##6##(2008-10#2)
with a linear range from##3##5##(2008-10#3)
with a linear range of 0##2##6##(2008-10#2)
with a linear range of##4##5##(2008-10#4)
with a linear range##9##4##(2008-10#9)
with a linear response over##2##5##(2008-10#1)(2010-3#1)
with a linear response##4##4##(1996-12#1)(2008-10#2)(2010-3#1)
with a linear##27##3##(1992-11#1)(1996-12#1)(2008-10#23)(2008-8#1)(2010-3#1)
with a linearly polarized##2##4##(2007-12#1)(2008-2#1)
with a linearly##3##3##(2007-12#2)(2008-2#1)
with a linewidth of##2##4##(2007-11#1)(2008-2#1)
with a lipid##4##3##(2007-11#1)(2008-4#1)(2011-2#2)
with a liquid##4##3##(2008-3#4)
with a liquid-crystal##4##3##(2007-12#1)(2008-3#3)
with a list of##4##4##(2008-10#1)(2008-2#1)(2009-12#1)(2013-7#1)
with a literature review##2##4##(2008-6#1)(2009-8#1)
with a lithium##2##3##(2008-3#1)(2010-5#1)
with a little##2##3##(2011-1#1)(2012-3#1)
with a live##4##3##(1995-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
with a local##3##3##(1996-5#1)(2008-3#1)(2012-2#1)
with a localized##2##3##(2007-12#1)(2008-10#1)
with a logarithmic##2##3##(2008-10#1)(2009-7#1)
with a logistic##2##3##(2008-10#1)(2010-8#1)
with a long history of##3##5##(2007-7#1)(2008-10#2)
with a long##15##3##(1991-12#1)(1993-2#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
with a long-term##2##3##(2008-6#1)(2010-3#1)
with a longer duration##2##4##(2008-11#1)(2012-3#1)
with a longer##6##3##(1990-12#1)(1993-11#1)(1995-2#1)(2008-11#1)(2012-2#1)(2012-3#1)
with a loop sequence complementary to the TAR loop##2##9##(1994-8#2)
with a loss of##5##4##(1990-12#1)(1992-3#1)(2007-12#1)(2011-2#1)(2013-8#1)
with a lot of##2##4##(2007-12#1)(2013-1#1)
with a low degree of##4##5##(1991-6#1)(1995-2#1)(1996-3#1)(2011-2#1)
with a low detection limit of##3##6##(2008-10#2)(2013-1#1)
with a low detection limit##4##5##(2008-10#3)(2013-1#1)
with a low dose##2##4##(2008-7#1)(2013-1#1)
with a low incidence of##4##5##(2008-5#1)(2011-2#2)(2013-1#1)
with a low level##2##4##(1992-9#1)(2008-10#1)
with a low prevalence##2##4##(2008-1#1)(2012-3#1)
with a low rate of##2##5##(1993-6#1)(2009-12#1)
with a low risk of##2##5##(1992-5#1)(2008-6#1)
with a low risk##3##4##(1992-5#1)(2008-6#1)(2009-3#1)
with a low##54##3##(1990-5#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#2)(1995-11#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
with a low-cost##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
with a low-power##2##3##(2007-11#1)(2008-2#1)
with a low-volume##2##3##(1997-8#1)(2008-10#1)
with a lower detection limit of##3##6##(2008-10#3)
with a lower frequency of##3##5##(2007-5#1)(2008-10#1)(2012-3#1)
with a lower limit of detection of##2##7##(2008-10#2)
with a lower limit of##3##5##(1996-5#1)(2008-10#2)
with a lower risk of##2##5##(2008-10#1)(2013-1#1)
with a lower##24##3##(1990-9#1)(1991-12#1)(1992-3#1)(1996-5#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
with a magnetic stirrer##2##4##(2008-10#1)(2008-11#1)
with a major##5##3##(1994-12#1)(1994-9#1)(1995-3#1)(2007-2#1)(2009-9#1)
with a majority##2##3##(1990-3#1)(2012-12#1)
with a male##2##3##(2008-1#1)(2008-12#1)
with a manual##2##3##(1994-12#1)(2008-10#1)
with a marked decrease in the##2##6##(1994-3#1)(1997-7#1)
with a marked decrease in##3##5##(1994-3#1)(1997-7#1)(2008-7#1)
with a marked increase in##2##5##(1997-3#1)(2008-3#1)
with a marked reduction in##2##5##(1992-3#1)(2008-10#1)
with a marked##12##3##(1992-3#1)(1994-3#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-5#1)
with a mass of##2##4##(1990-7#1)(2009-2#1)
with a mass spectrometer##2##4##(2008-10#2)
with a mass##10##3##(1990-5#1)(1990-7#1)(2007-8#1)(2008-10#5)(2009-2#1)(2013-7#1)
with a massive##3##3##(2007-8#1)(2008-12#1)(2008-6#1)
with a master's##2##3##(1994-12#2)
with a matched##3##3##(1993-8#1)(1997-1#1)(2013-1#1)
with a mathematical model##3##4##(2008-10#1)(2008-3#1)(2009-11#1)
with a maximal viable cell density##2##6##(2008-11#2)
with a maximal##6##3##(1993-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
with a maximum at##4##4##(1997-2#1)(2008-10#2)(2013-8#1)
with a maximum diameter of##2##5##(1993-9#1)(2008-12#1)
with a maximum overall##2##4##(2008-2#1)(2008-3#1)
with a maximum value of##2##5##(2008-10#1)(2009-4#1)
with a maximum##30##3##(1991-2#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-9#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2009-4#1)(2013-7#1)(2013-8#1)
with a mean age of 32##2##6##(2008-1#1)(2010-3#1)
with a mean age of 45##2##6##(2007-7#1)(2007-8#1)
with a mean age of##31##5##(1992-3#1)(1993-1#1)(1995-10#1)(1996-2#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-12#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
with a mean age##32##4##(1992-3#1)(1993-1#1)(1995-10#1)(1996-2#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-12#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
with a mean duration of##3##5##(1991-2#1)(2008-6#1)(2012-2#1)
with a mean duration##4##4##(1991-2#1)(2008-6#1)(2008-7#1)(2012-2#1)
with a mean follow-up of##3##5##(1993-9#1)(1996-6#1)(2008-10#1)
with a mean of##8##4##(1990-2#2)(1992-1#2)(1993-8#1)(2007-7#1)(2008-4#1)(2008-5#1)
with a mean relative error of e(r)&lt##2##7##(2008-10#2)
with a mean relative error of##3##6##(2008-10#3)
with a mean survival period of##2##6##(2008-6#1)(2008-7#1)
with a mean##83##3##(1990-2#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-6#1)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#10)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-1#2)(2009-3#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)
with a measure of##2##4##(2008-10#1)(2008-9#1)
with a measured##2##3##(2008-2#2)
with a measurement##2##3##(2008-10#1)(2008-3#1)
with a mechanical##2##3##(2007-8#1)(2009-12#1)
with a median age of 56 years##2##7##(2007-11#1)(2008-6#1)
with a median age of##6##5##(1992-5#1)(2007-11#1)(2008-6#1)(2011-1#2)(2013-1#1)
with a median follow-up of##4##5##(1990-12#1)(1990-2#1)(2008-6#2)
with a median follow-up##5##4##(1990-12#1)(1990-2#1)(2008-6#2)(2013-1#1)
with a median of##7##4##(1997-2#1)(2008-10#3)(2008-6#1)(2008-7#1)(2013-1#1)
with a median survival##2##4##(1991-4#1)(2008-10#1)
with a median time##2##4##(2010-3#1)(2013-1#1)
with a median##30##3##(1990-12#1)(1990-2#1)(1991-4#1)(1992-5#1)(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-6#5)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#6)
with a medical##4##3##(1994-12#1)(1995-1#1)(2012-2#1)(2013-1#1)
with a membrane##7##3##(2007-8#1)(2008-10#4)(2008-11#1)(2009-5#1)
with a membrane-permeable##2##3##(1994-2#1)(2008-8#1)
with a mental##3##3##(1994-1#1)(1995-12#1)(2013-8#1)
with a mercury film##2##4##(2008-10#2)
with a mercury##3##3##(2008-10#3)
with a metal##2##3##(2008-10#2)
with a metallic##2##3##(2007-12#1)(2008-10#1)
with a metastatic##3##3##(1992-6#1)(2007-5#1)(2008-4#1)
with a method that##2##4##(1990-12#1)(2008-4#1)
with a method##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
with a micellar##2##3##(2008-10#1)(2009-8#1)
with a microfabricated##2##3##(2007-11#1)(2008-10#1)
with a micromachined##2##3##(2008-2#1)(2008-3#1)
with a microscope##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
with a mild##2##3##(1992-10#1)(2008-5#1)
with a mildly##2##3##(2008-4#1)(2013-1#1)
with a miniature##2##3##(2008-10#1)(2008-3#1)
with a minimal##5##3##(1995-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
with a minimally##2##3##(2010-9#1)(2011-2#1)
with a minimum detectability (S/N=3) of##2##6##(2008-10#2)
with a minimum of##7##4##(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)
with a minimum##19##3##(1990-11#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-3#1)
with a minor##3##3##(1996-8#1)(1997-5#1)(2012-12#1)
with a mirrorless##2##3##(2007-11#2)
with a mitochondrial##3##3##(1992-9#1)(2008-10#1)(2012-2#1)
with a mixed##4##3##(1995-5#1)(1997-4#1)(2008-10#1)(2009-6#1)
with a mixture of nitric##2##5##(2008-10#2)
with a mixture of the##2##5##(2007-6#1)(2008-8#1)
with a mixture of water and##2##6##(2007-12#1)(2008-3#1)
with a mixture of##32##4##(1990-12#1)(1992-10#1)(1992-8#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
with a mobile phase containing##3##5##(1990-8#1)(2008-10#2)
with a mobile phase of##2##5##(2008-10#2)
with a mobile phase##7##4##(1990-8#1)(2008-10#6)
with a mobile##8##3##(1990-8#1)(2008-10#6)(2008-7#1)
with a mode-locked##3##3##(2007-12#2)(2008-3#1)
with a mode-mismatched##2##3##(2008-3#2)
with a model based on the##2##6##(2007-12#1)(2008-3#1)
with a model in which##5##5##(1990-2#1)(1992-2#1)(1993-11#1)(2008-10#1)(2008-2#1)
with a model of##3##4##(1992-6#1)(1995-3#1)(2008-3#1)
with a model that##2##4##(2008-11#1)(2008-2#1)
with a model##20##3##(1990-2#1)(1992-2#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-3#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-12#1)
with a moderate##6##3##(1993-6#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
with a moderately##3##3##(1996-2#1)(2008-10#1)(2008-6#1)
with a modified##16##3##(2007-12#2)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#3)
with a modulation##2##3##(2008-3#2)
with a moisturizing##2##3##(2007-7#1)(2008-5#1)
with a molar absorptivity of##2##5##(2008-10#2)
with a molar absorptivity##3##4##(2008-10#3)
with a molar mass##2##4##(2008-10#1)(2013-1#1)
with a molar ratio##2##4##(2008-10#2)
with a molar##7##3##(2008-10#6)(2013-1#1)
with a molecular mass of about##3##6##(1992-8#1)(1993-11#1)(1994-8#1)
with a molecular mass of##14##5##(1990-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-11#1)
with a molecular mass##16##4##(1990-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#6)(2008-11#1)
with a molecular weight of about 35##2##7##(1991-5#1)(1993-3#1)
with a molecular weight of##12##5##(1990-11#1)(1990-7#3)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(2008-11#1)(2012-1#3)
with a molecular weight##14##4##(1990-11#1)(1990-7#3)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(2008-10#1)(2008-11#2)(2012-1#3)
with a molecular##32##3##(1990-11#1)(1990-7#4)(1991-11#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#8)(2008-11#3)(2012-1#3)
with a molecularly##2##3##(2008-10#1)(2013-1#1)
with a monochromatic##2##3##(2007-12#1)(2008-3#1)
with a monoclonal antibody against the##2##6##(1993-8#1)(1993-9#1)
with a monoclonal antibody against##4##5##(1992-11#1)(1993-8#1)(1993-9#1)(1995-12#1)
with a monoclonal antibody specific for##2##6##(1990-12#1)(2008-10#1)
with a monoclonal antibody##6##4##(1990-12#1)(1992-11#1)(1993-8#1)(1993-9#1)(1995-12#1)(2008-10#1)
with a moral##2##3##(2008-11#1)(2010-10#1)
with a more##19##3##(1990-8#1)(1991-4#1)(1993-3#1)(1994-3#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
with a morphological##2##3##(1991-4#1)(2008-2#1)
with a mortality rate##2##4##(2007-12#1)(2013-7#1)
with a motorized shaver##2##4##(2008-9#2)
with a mouse##2##3##(1994-11#1)(2008-9#1)
with a much##3##3##(1994-5#1)(2007-10#1)(2008-10#1)
with a multichannel##3##3##(2008-3#3)
with a multimode##2##3##(2007-12#1)(2008-2#1)
with a multiple##3##3##(1992-9#1)(1994-2#1)(2008-3#1)
with a multitude of##2##4##(2012-1#1)(2012-12#1)
with a multivariate##2##3##(2008-10#1)(2009-12#1)
with a myocardial infarction##2##4##(2008-11#1)(2013-1#1)
with a narrow##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#1)
with a national##2##3##(1993-2#1)(2008-1#1)
with a near##2##3##(2008-10#2)
with a near-Nernstian slope##2##4##(2008-10#2)
with a near-Nernstian##3##3##(2008-10#3)
with a nearly##5##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-1#1)
with a need for##3##4##(2007-11#1)(2007-7#1)(2007-8#1)
with a need##4##3##(1992-12#1)(2007-11#1)(2007-7#1)(2007-8#1)
with a negative leishmanin skin test##2##6##(2008-7#2)
with a negative##8##3##(1991-6#1)(1992-6#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-7#1)
with a negligible##2##3##(2007-12#1)(2008-3#1)
with a network of##2##4##(2008-10#1)(2008-5#1)
with a network##3##3##(2008-10#1)(2008-5#2)
with a neural##2##3##(1995-12#1)(2007-12#1)
with a neutral##3##3##(2008-10#2)(2012-9#1)
with a new fluorescent probe 1##2##6##(2008-10#2)
with a new procedure##2##4##(1992-3#1)(2011-2#1)
with a new##50##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-3#2)(1996-9#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
with a newly designed##2##4##(2008-10#2)
with a newly developed##3##4##(1994-12#1)(2008-2#2)
with a newly##7##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)
with a non-functioning pituitary macroadenoma##2##5##(2008-8#2)
with a non-ionic surfactant##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
with a non-ionic##4##3##(1994-9#1)(2008-10#1)(2008-5#2)
with a noncollinear##2##3##(2008-3#2)
with a nonlinear optical loop mirror (NOLM)##2##7##(2007-11#1)(2007-12#1)
with a nonlinear optical loop mirror##3##6##(2007-11#2)(2007-12#1)
with a nonlinear optical##4##4##(2007-11#2)(2007-12#2)
with a nonlinear##11##3##(1996-2#1)(2007-11#4)(2007-12#4)(2008-2#1)(2008-3#1)
with a nonselective##2##3##(2006-10#1)(2008-2#1)
with a normal##16##3##(1991-5#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-12#2)(2013-1#1)
with a novel double##2##4##(2008-10#2)
with a novel##22##3##(1991-9#1)(1993-9#1)(1995-12#1)(1996-12#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2009-7#1)(2009-9#1)(2011-1#1)(2013-8#1)
with a nucleotide diversity of 0##2##6##(2008-10#2)
with a nucleotide##3##3##(2008-10#3)
with a number of drugs##2##5##(1993-12#1)(2008-8#1)
with a number of##24##4##(1990-8#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-2#1)(1997-4#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
with a numerical aperture of 0##3##6##(2007-12#1)(2008-3#2)
with a numerical aperture of 1##2##6##(2008-2#1)(2008-3#1)
with a numerical aperture of##5##5##(2007-12#1)(2008-2#1)(2008-3#3)
with a numerical##8##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
with a one-dimensional##4##3##(2008-2#1)(2008-3#3)
with a pH optimum##2##4##(1990-2#1)(2008-9#1)
with a pH##5##3##(1990-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
with a pI##2##3##(1990-12#1)(2008-6#1)
with a pKa##2##3##(1992-6#1)(1995-2#1)
with a packed##2##3##(2008-10#1)(2008-7#1)
with a painful##2##3##(2008-12#1)(2009-3#1)
with a pair of##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
with a palpable##3##3##(2013-1#2)(2013-7#1)
with a panel of monoclonal antibodies##3##6##(1990-12#1)(1991-2#1)(1995-2#1)
with a panel of##8##4##(1990-12#1)(1991-2#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)
with a parallel##4##3##(1994-11#1)(1995-3#1)(2008-3#2)
with a partial##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
with a partially##3##3##(1991-12#1)(1994-7#1)(2010-8#1)
with a particle##2##3##(2008-10#1)(2008-2#1)
with a particular emphasis on lithium and valproate##2##8##(2009-8#2)
with a particular emphasis on the use of##2##8##(1994-9#1)(2008-5#1)
with a particular emphasis on the##3##6##(1994-9#1)(2006-10#1)(2008-5#1)
with a particular emphasis on##6##5##(1994-9#1)(2006-10#1)(2008-5#1)(2009-8#2)(2011-2#1)
with a particular emphasis##8##4##(1994-9#1)(2006-10#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
with a particular focus on the##3##6##(1996-2#1)(2008-9#1)(2009-2#1)
with a particular focus on##5##5##(1996-2#1)(2008-9#1)(2009-2#1)(2010-12#1)(2012-12#1)
with a particular##19##3##(1994-9#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
with a pathogenic##2##3##(2008-10#1)(2008-2#1)
with a patient##3##3##(1994-1#1)(2010-8#1)(2013-8#1)
with a peak power of##2##5##(2007-11#1)(2007-12#1)
with a peak##10##3##(1994-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-2#2)
with a pelvic##4##3##(2008-6#1)(2012-1#1)(2013-1#2)
with a peptide##2##3##(1994-11#1)(2008-4#1)
with a percentage of##2##4##(2008-11#1)(2013-1#1)
with a performance##2##3##(2008-10#1)(2008-3#1)
with a perimesencephalic##2##3##(2008-7#2)
with a period length of##2##5##(2008-7#1)(2009-9#1)
with a period of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
with a period##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)
with a periodically##2##3##(2008-10#1)(2008-3#1)
with a peripheral##2##3##(2008-7#1)(2011-2#1)
with a persistent##6##3##(1991-6#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)
with a phase##4##3##(1993-11#1)(2007-11#3)
with a phase-conjugate##3##3##(2008-2#2)(2008-3#1)
with a phase-only##2##3##(2008-3#2)
with a phase-shifting##3##3##(2008-2#1)(2008-3#2)
with a photo-diode array detector##3##5##(2008-10#3)
with a photo-diode array##4##4##(2008-10#4)
with a photodiode array detector##4##5##(2008-10#4)
with a photodiode##5##3##(2008-10#5)
with a photon scanning tunneling microscope##3##6##(2007-12#3)
with a photoreactive##2##3##(1990-11#1)(1994-8#1)
with a photorefractive##2##3##(2007-11#1)(2008-2#1)
with a photoresist##2##3##(2008-2#1)(2008-7#1)
with a picosecond pulsed laser##2##5##(2007-11#2)
with a pituitary##2##3##(1991-6#1)(2006-12#1)
with a placebo##5##3##(1995-5#1)(2008-5#2)(2008-7#2)
with a planar##5##3##(2008-2#2)(2008-3#3)
with a plant##4##3##(2008-10#3)(2008-8#1)
with a plasmid encoding##2##4##(2010-11#1)(2010-6#1)
with a plasmid##4##3##(2008-10#1)(2008-11#1)(2010-11#1)(2010-6#1)
with a platinum electrode##2##4##(1991-5#1)(2008-10#1)
with a platinum##3##3##(1991-5#1)(2008-10#2)
with a plug##3##3##(2008-10#2)(2011-2#1)
with a point##3##3##(2008-3#1)(2009-9#1)(2010-5#1)
with a polar##2##3##(2008-10#1)(2012-1#1)
with a polarized laser beam##2##5##(2008-3#2)
with a polarized##3##3##(2007-12#1)(2008-3#2)
with a polyclonal antiserum##2##4##(2008-10#2)
with a polyclonal##5##3##(1991-2#1)(1992-6#1)(1997-1#1)(2008-10#2)
with a polymer##2##3##(2008-2#1)(2010-4#1)
with a poor outcome##6##4##(1990-9#1)(2007-10#1)(2008-8#1)(2011-2#2)(2012-3#1)
with a poor prognosis in##2##5##(2011-2#2)
with a poor prognosis##13##4##(1994-12#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#3)(2013-1#1)
with a poor##20##3##(1990-9#1)(1994-12#1)(1994-6#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#1)
with a population of##2##4##(2008-7#2)
with a population##3##3##(2008-6#1)(2008-7#2)
with a porcine##2##3##(1991-6#1)(1994-11#1)
with a portable##3##3##(2008-10#2)(2008-3#1)
with a position-sensitive##2##3##(2007-11#1)(2008-3#1)
with a positive direct antiglobulin test##2##6##(1992-9#1)(1994-3#1)
with a positive family history##3##5##(1997-5#1)(2008-9#1)(2011-2#1)
with a positive leishmanin skin test##2##6##(2008-7#2)
with a positive zeta potential##2##5##(2008-5#2)
with a positive##21##3##(1990-6#1)(1992-3#1)(1992-9#1)(1994-3#2)(1997-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-8#1)(2011-2#3)(2013-1#1)
with a possibility##2##3##(1996-12#1)(2008-10#1)
with a possible##4##3##(2007-8#1)(2008-1#1)(2011-2#1)(2012-1#1)
with a postoperative##3##3##(2007-8#1)(2013-1#2)
with a potassium##2##3##(1992-3#1)(2011-2#1)
with a potency similar to that of##2##7##(1992-12#1)(2008-5#1)
with a potency similar to##3##5##(1992-12#2)(2008-5#1)
with a potency##4##3##(1992-12#2)(2008-5#2)
with a potential to promote##2##5##(2007-10#1)(2008-10#1)
with a potential to##3##4##(2007-10#1)(2008-10#1)(2008-2#1)
with a potential##9##3##(1997-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#2)
with a potentially##3##3##(1995-2#1)(1996-6#1)(2008-11#1)
with a potentiometric##3##3##(2008-10#3)
with a power of##2##4##(2007-12#1)(2008-10#1)
with a power##3##3##(2007-12#2)(2008-10#1)
with a pre-concentration##2##3##(2008-10#2)
with a precise##2##3##(1990-7#1)(2007-11#1)
with a precision better than##2##5##(2008-10#1)(2008-2#1)
with a precision error ranging from 5% to 10%##2##9##(2008-3#2)
with a precision of 2##2##5##(2008-10#2)
with a precision of approximately##3##5##(2008-3#3)
with a precision of##13##4##(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#5)
with a precision##22##3##(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#9)(2012-2#1)
with a preconcentration##3##3##(2008-10#3)
with a predicted molecular mass of##2##6##(1994-12#1)(2008-10#1)
with a predicted molecular##3##4##(1994-12#1)(2008-10#2)
with a predicted##8##3##(1990-12#1)(1991-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(2008-10#3)
with a predominant##2##3##(1992-8#1)(2008-4#1)
with a predominantly##3##3##(1991-5#1)(2007-12#1)(2011-1#1)
with a preselected##2##3##(2008-10#1)(2008-2#1)
with a prevalence of##3##4##(1997-7#1)(2008-5#1)(2008-6#1)
with a previous history of##3##5##(2008-10#1)(2010-12#1)(2011-2#1)
with a previous##10##3##(1992-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
with a previously described##2##4##(2008-10#1)(2008-5#1)
with a previously published##2##4##(2008-10#1)(2010-10#1)
with a previously reported##2##4##(1995-2#1)(2008-10#1)
with a previously##11##3##(1995-2#1)(2008-10#5)(2008-5#1)(2009-10#1)(2010-10#1)(2010-5#1)(2013-1#1)
with a primary diagnosis##2##4##(2007-10#1)(2008-11#1)
with a primary##11##3##(1992-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)(2011-2#1)
with a primer pair##2##4##(1992-2#1)(2008-10#1)
with a primer##3##3##(1992-2#1)(2008-10#1)(2008-5#1)
with a prior history of##2##5##(2007-7#1)(2013-8#1)
with a prior##5##3##(1997-3#1)(2007-7#1)(2008-11#1)(2010-12#1)(2013-8#1)
with a prism##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
with a probability##2##3##(2009-4#1)(2012-7#1)
with a probe##3##3##(1991-9#1)(1994-5#1)(2008-10#1)
with a procedure##2##3##(1990-9#1)(2008-10#1)
with a profile of##2##4##(1995-2#1)(2013-1#1)
with a progressive##4##3##(1990-12#1)(1994-8#1)(2008-7#1)(2009-12#1)
with a prolonged##2##3##(1993-8#1)(2012-2#1)
with a pronounced##2##3##(2008-10#2)
with a propensity to##2##4##(2008-9#1)(2009-5#1)
with a proper##2##3##(2008-5#1)(2013-8#1)
with a protecting##2##3##(2008-10#2)
with a protein##5##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
with a protocol##2##3##(1991-4#1)(2008-4#1)
with a proximal##2##3##(2009-5#1)(2009-9#1)
with a pulse duration of##2##5##(2008-2#1)(2008-3#1)
with a pulse energy of##2##5##(2007-11#2)
with a pulse width of##4##5##(2007-11#1)(2007-12#3)
with a pulse width##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
with a pulse##12##3##(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
with a pulsed##5##3##(2008-10#1)(2008-3#4)
with a pump peak##2##4##(2007-12#2)
with a pump##3##3##(2007-11#1)(2007-12#2)
with a pure##2##3##(1992-3#1)(2008-3#1)
with a purified##4##3##(1992-11#1)(1992-3#1)(2008-4#1)(2012-2#1)
with a purity of &gt##2##5##(1994-6#1)(2009-3#1)
with a purity##3##3##(1994-3#1)(1994-6#1)(2009-3#1)
with a purposive sample of##2##5##(2008-12#1)(2011-1#1)
with a pyroelectric##2##3##(2007-12#1)(2011-1#1)
with a quadratic##2##3##(2007-11#1)(2008-10#1)
with a quadrupole mass##2##4##(2008-10#2)
with a qualitative##2##3##(2008-10#1)(2008-2#1)
with a quality of life##2##5##(2011-1#1)(2011-2#1)
with a quality##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
with a quantitative##2##3##(2008-3#1)(2008-8#1)
with a quantum##2##3##(2007-11#1)(2008-10#1)
with a quartz##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
with a quaternary##2##3##(1997-2#1)(2008-10#1)
with a radial##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
with a random distribution of##2##5##(2008-12#1)(2008-3#1)
with a random sample of##2##5##(1992-5#1)(2010-8#1)
with a random##7##3##(1991-3#1)(1992-5#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
with a randomized##2##3##(1992-2#1)(2008-12#1)
with a randomly##3##3##(1991-6#1)(2008-3#2)
with a range of 0##2##5##(2008-10#1)(2013-1#1)
with a range of health##2##5##(2008-10#1)(2013-1#1)
with a range of linearity##2##5##(2008-10#2)
with a range of physical##2##5##(2007-12#1)(2008-10#1)
with a range of##23##4##(1990-5#1)(1994-6#1)(2007-12#1)(2008-10#10)(2008-6#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#4)
with a range##29##3##(1990-5#1)(1994-6#1)(2007-12#2)(2008-10#11)(2008-3#2)(2008-6#2)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#4)
with a rapid##10##3##(1990-5#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
with a rapidly growing##3##4##(2010-8#1)(2011-1#2)
with a rapidly##6##3##(1993-2#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-1#2)
with a rare##5##3##(2007-8#1)(2009-11#1)(2010-3#1)(2012-12#1)(2012-3#1)
with a rash##2##3##(1995-11#1)(2007-2#1)
with a rat##2##3##(1993-2#1)(2008-11#1)
with a rate constant of##3##5##(1992-6#2)(2008-10#1)
with a rate constant##4##4##(1992-6#2)(2008-10#1)(2008-7#1)
with a rate##7##3##(1992-6#2)(2008-10#2)(2008-12#1)(2008-7#1)(2011-1#1)
with a rather##2##3##(2008-8#1)(2013-8#1)
with a ray-tracing##2##3##(2008-3#2)
with a reagent stream##2##4##(2008-10#2)
with a reagent##3##3##(2008-10#3)
with a real##3##3##(1996-8#1)(2008-3#1)(2008-5#1)
with a real-time##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
with a recent##4##3##(1992-9#1)(1996-3#1)(2008-1#1)(2013-1#1)
with a recently##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
with a recombinant baculovirus##4##4##(1993-6#1)(1993-8#1)(2008-10#1)(2008-7#1)
with a recombinant##10##3##(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)
with a recovery of##6##4##(1995-12#1)(2008-10#3)(2008-7#1)(2010-4#1)
with a recovery##9##3##(1995-12#1)(2008-10#6)(2008-7#1)(2010-4#1)
with a recurrent##2##3##(2008-7#1)(2009-8#1)
with a red##2##3##(2008-10#1)(2008-2#1)
with a redox##3##3##(1995-2#1)(2008-10#2)
with a reduced##8##3##(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#1)
with a reduction in the##5##5##(2008-10#3)(2010-4#1)(2011-2#1)
with a reduction in##22##4##(1990-11#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-10#5)(2008-3#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
with a reduction of##8##4##(1990-12#1)(1993-11#1)(1993-12#1)(2008-10#2)(2008-4#1)(2009-7#1)(2013-1#1)
with a reduction##31##3##(1990-11#1)(1990-12#1)(1993-11#2)(1993-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-6#1)(2008-10#7)(2008-3#2)(2008-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
with a reference plane wave##2##5##(2007-11#1)(2008-3#1)
with a reference##15##3##(1993-9#1)(1996-12#1)(2007-11#2)(2008-10#4)(2008-2#2)(2008-3#5)
with a reflective##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
with a region of##2##4##(2008-10#1)(2008-6#1)
with a regression coefficient of##2##5##(2008-10#2)
with a regular##2##3##(1991-12#1)(2007-11#1)
with a relative error of##3##5##(2008-10#3)
with a relative error##4##4##(2008-10#4)
with a relative molecular mass of##3##6##(1991-12#1)(1993-8#1)(2008-11#1)
with a relative standard deviation (R##5##6##(2008-10#5)
with a relative standard deviation (RSD) of##2##7##(2008-10#2)
with a relative standard deviation of &lt##2##7##(2008-10#2)
with a relative standard deviation of 0##3##7##(2008-10#3)
with a relative standard deviation of 1##6##7##(2008-10#6)
with a relative standard deviation of 2##7##7##(2008-10#7)
with a relative standard deviation of 4##2##7##(2008-10#2)
with a relative standard deviation of less than##5##8##(2008-10#5)
with a relative standard deviation of##29##6##(2008-10#29)
with a relative standard deviation##41##5##(2008-10#41)
with a relative uncertainty of##4##5##(2007-12#2)(2008-3#2)
with a relative##66##3##(1991-12#1)(1991-3#1)(1991-9#1)(1993-8#1)(2007-11#1)(2007-12#2)(2008-10#50)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
with a relatively low potency##2##5##(2008-3#1)(2008-4#1)
with a relatively low##7##4##(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#2)(2012-2#1)
with a relatively##16##3##(1990-11#1)(1991-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
with a relaxation##2##3##(1990-7#1)(2008-3#1)
with a release of##2##4##(1994-3#1)(2008-10#1)
with a release##3##3##(1992-3#1)(1994-3#1)(2008-10#1)
with a repeatability##2##3##(2008-10#2)
with a repetition rate as##2##5##(2007-11#1)(2008-3#1)
with a repetition rate of##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
with a repetition rate##6##4##(2007-11#2)(2007-12#2)(2008-3#2)
with a repetitive DNA probe##2##5##(2008-10#2)
with a reported##5##3##(1994-3#1)(1994-9#1)(2008-10#2)(2010-8#1)
with a reporter gene under the control of##2##8##(1994-5#2)
with a reporter##3##3##(1994-12#1)(1994-5#2)
with a representative##2##3##(2008-10#1)(2011-2#1)
with a reproducibility of##2##4##(1994-9#1)(2008-5#1)
with a resolution of 0##2##5##(2007-11#1)(2008-3#1)
with a resolution of 1##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
with a resolution of 2##2##5##(2008-10#1)(2008-3#1)
with a resolution of approximately##2##5##(2007-12#1)(2008-3#1)
with a resolution of##19##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#11)
with a resolution##20##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#12)
with a response rate of##2##5##(1992-2#1)(2011-2#1)
with a response time of##5##5##(2007-11#1)(2008-10#3)(2008-2#1)
with a response time##6##4##(2007-11#1)(2008-10#4)(2008-2#1)
with a response##12##3##(1992-2#1)(2007-11#1)(2008-10#7)(2008-2#1)(2011-2#1)(2012-2#1)
with a restriction enzyme that##2##5##(1996-12#1)(1997-7#1)
with a return##2##3##(1997-3#1)(2008-12#1)
with a review of the literature##11##6##(1991-6#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
with a review of the relevant literature##4##7##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
with a review of the relevant##5##6##(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
with a review of the##20##5##(1991-2#1)(1991-6#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#4)(2012-2#3)(2013-1#2)
with a review of##24##4##(1991-2#1)(1991-6#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-7#1)
with a review##25##3##(1991-2#1)(1991-6#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-7#1)
with a rich##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
with a right##6##3##(1993-3#1)(1995-8#1)(1996-5#1)(2007-8#1)(2008-8#1)(2010-11#1)
with a ring##3##3##(2008-10#1)(2008-3#2)
with a rise in##3##4##(2008-10#3)
with a rise##4##3##(2008-10#4)
with a risk of##3##4##(2009-7#1)(2011-2#1)(2012-12#1)
with a risk##6##3##(1996-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)
with a role for##4##4##(1990-3#1)(1993-12#1)(1996-12#1)(2011-1#1)
with a role in amino-acid metabolism##2##6##(2010-10#2)
with a role in##6##4##(2009-10#1)(2009-6#1)(2010-10#2)(2012-2#1)(2012-3#1)
with a role of##2##4##(1996-3#1)(2013-8#1)
with a role##12##3##(1990-3#1)(1993-12#1)(1996-12#1)(1996-3#1)(2009-10#1)(2009-6#1)(2010-10#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
with a room-temperature##3##3##(2007-12#2)(2008-3#1)
with a rotating##2##3##(1990-12#1)(2008-3#1)
with a rotational##3##3##(1990-7#1)(2008-2#1)(2008-3#1)
with a rough##2##3##(2008-2#2)
with a ruptured##2##3##(1995-12#1)(2008-7#1)
with a sample of##9##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-2#1)(2013-8#1)
with a sample throughput of##4##5##(2008-10#4)
with a sample##24##3##(2007-12#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
with a sampling frequency of##9##5##(2008-10#8)(2010-9#1)
with a sampling rate of about##2##6##(2008-10#2)
with a sampling rate of##7##5##(2008-10#6)(2008-3#1)
with a sampling time of##2##5##(2008-10#1)(2008-3#1)
with a sampling##20##3##(2008-10#16)(2008-3#2)(2010-9#1)(2012-2#1)
with a satellite##2##3##(2008-10#1)(2008-2#1)
with a scanning##5##3##(2008-2#1)(2008-3#4)
with a scenario of##3##4##(2008-10#3)
with a second##15##3##(1990-12#2)(1993-2#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-5#1)
with a second-order##4##3##(1994-5#1)(1996-5#1)(2008-3#2)
with a secondary##4##3##(1990-9#1)(2008-3#1)(2008-4#1)(2011-2#1)
with a selective##4##3##(1995-12#1)(2007-8#1)(2008-10#1)(2008-4#1)
with a self-assembled monolayer of##3##5##(2008-10#2)(2008-3#1)
with a self-assembled monolayer##4##4##(2008-10#3)(2008-3#1)
with a self-pumped phase-conjugate mirror##4##5##(2008-2#2)(2008-3#2)
with a semiconductor saturable-absorber mirror##2##5##(2007-12#1)(2008-3#1)
with a semiconductor##5##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
with a sense of##2##4##(2007-8#1)(2008-12#1)
with a sensitivity of 0##3##5##(2008-10#2)(2008-3#1)
with a sensitivity of 2##2##5##(2008-10#2)
with a sensitivity of 3##2##5##(2008-10#1)(2008-3#1)
with a sensitivity of 91##2##5##(1990-9#1)(1997-8#1)
with a sensitivity of##13##4##(1990-6#1)(1990-9#1)(1997-8#1)(2008-10#5)(2008-3#4)(2008-6#1)
with a sensitivity that##2##4##(2008-10#2)
with a sensitivity##18##3##(1990-6#1)(1990-9#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-3#4)(2008-6#1)
with a sensor##3##3##(2007-12#1)(2008-3#2)
with a separation##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
with a sequence##2##3##(1994-8#1)(2013-1#1)
with a sequential injection##3##4##(2008-10#3)
with a sequential##5##3##(1990-7#1)(2008-10#3)(2008-2#1)
with a series of##14##4##(1991-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)(2009-12#1)(2012-2#1)
with a set of##20##4##(1993-6#1)(1994-8#1)(1995-12#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
with a set##22##3##(1993-6#1)(1994-8#1)(1995-12#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
with a severe mental illness##2##5##(2008-6#1)(2011-1#1)
with a severe##12##3##(1996-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
with a shallow random rough##2##5##(2008-3#2)
with a shallow##3##3##(2008-10#1)(2008-3#2)
with a shape##2##3##(2008-2#2)
with a sharp increase##2##4##(2008-10#1)(2008-11#1)
with a shift from##2##4##(1993-1#1)(2009-9#1)
with a shift##4##3##(1993-1#1)(1993-8#1)(2008-10#1)(2009-9#1)
with a short history of##2##5##(1993-12#1)(2008-7#1)
with a short time separation##3##5##(2008-3#3)
with a short##23##3##(1991-10#1)(1991-12#2)(1992-8#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-9#1)(2008-10#3)(2008-3#5)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-1#1)
with a short-term##2##3##(2007-7#1)(2008-11#1)
with a shorter length of##2##5##(2008-9#1)(2013-1#1)
with a shorter##7##3##(1993-11#1)(1993-3#1)(1997-2#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
with a shot-per-shot##2##3##(2008-2#2)
with a signal peptide##2##4##(1992-8#1)(2008-10#1)
with a signal##5##3##(1992-8#2)(2007-11#1)(2007-12#1)(2008-10#1)
with a signal-to-noise ratio of 3##3##6##(2007-12#1)(2008-10#1)(2008-3#1)
with a signal-to-noise ratio of 5##2##6##(2008-10#1)(2008-3#1)
with a signal-to-noise ratio of##9##5##(2007-12#2)(2008-10#2)(2008-3#5)
with a signal-to-noise ratio##10##4##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#5)
with a signal-to-noise##11##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#6)
with a significant decrease in##4##5##(1997-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
with a significant decrease##5##4##(1997-1#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
with a significant impact on##2##5##(2007-12#1)(2008-12#1)
with a significant increase in the##5##6##(1992-11#1)(1995-6#1)(2007-12#1)(2008-1#2)
with a significant increase in##9##5##(1992-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-1#2)(2008-3#1)(2012-1#1)
with a significant increase of##3##5##(1990-9#1)(2008-8#2)
with a significant increase##14##4##(1990-9#1)(1992-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-8#2)(2012-1#1)(2012-12#1)
with a significant rise in##2##5##(2008-12#1)(2013-8#1)
with a significant##50##3##(1990-6#1)(1990-9#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#3)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
with a significantly increased##4##4##(1992-10#1)(2008-1#1)(2008-9#2)
with a significantly##8##3##(1992-10#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-3#1)
with a silica##2##3##(2008-10#2)
with a similar potency and##2##5##(1993-8#2)
with a similar potency##3##4##(1993-8#2)(1994-8#1)
with a similar##25##3##(1991-2#1)(1991-9#1)(1993-3#1)(1993-8#3)(1994-1#1)(1994-8#1)(1996-1#1)(1996-12#2)(1996-5#1)(2006-10#1)(2008-10#6)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)
with a simple model##2##4##(2007-12#1)(2008-7#1)
with a simple##29##3##(1991-2#1)(1991-6#1)(1996-12#1)(1997-1#1)(2007-11#2)(2007-12#5)(2008-10#5)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)
with a simplified##2##3##(1994-2#1)(2008-3#1)
with a simulated##3##3##(2008-3#2)(2008-5#1)
with a simultaneous##3##3##(1990-12#1)(2007-2#1)(2010-12#1)
with a single dose of##3##5##(1991-2#1)(1997-5#1)(2007-11#1)
with a single patch##3##4##(2007-8#2)(2012-2#1)
with a single screw##2##4##(2008-8#1)(2008-9#1)
with a single##83##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-5#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-2#1)(2013-8#1)
with a site##2##3##(1995-3#1)(2008-9#1)
with a size of##2##4##(2007-11#1)(2008-8#1)
with a size range of##2##5##(1997-3#1)(2010-12#1)
with a size range##3##4##(1997-3#1)(2010-12#1)(2013-7#1)
with a size##8##3##(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-7#1)
with a slab optical waveguide##2##5##(2008-10#2)
with a slight increase in##2##5##(2008-7#1)(2009-8#1)
with a slight##5##3##(1994-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-3#1)
with a slightly##4##3##(1991-8#1)(2008-3#1)(2008-9#1)(2012-12#1)
with a slit##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)
with a slit-beam-profile reflectometer##2##4##(2007-12#2)
with a slope efficiency of##8##5##(2007-12#5)(2008-2#2)(2008-3#1)
with a slope of -0##3##5##(1994-12#1)(2008-10#2)
with a slope of 28##2##5##(2008-10#2)
with a slope of 29##5##5##(2008-10#5)
with a slope of 58##2##5##(2008-10#2)
with a slope of##29##4##(1994-12#1)(2008-10#28)
with a slope##41##3##(1994-12#1)(2007-12#5)(2008-10#31)(2008-2#2)(2008-3#2)
with a slow##2##3##(2008-3#1)(2012-12#1)
with a slowly##3##3##(2008-3#2)(2012-3#1)
with a small amount of##3##5##(1997-4#1)(2008-10#1)(2008-11#1)
with a small number of cases##2##6##(1994-9#1)(2010-12#1)
with a small number of##7##5##(1994-9#1)(2008-10#1)(2008-3#4)(2010-12#1)
with a small number##8##4##(1994-9#1)(2008-10#1)(2008-3#4)(2008-5#1)(2010-12#1)
with a small radius##2##4##(2008-2#1)(2008-3#1)
with a small volume of##7##5##(2008-10#7)
with a small##42##3##(1994-9#1)(1997-4#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-2#6)(2008-3#11)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
with a smaller##8##3##(1990-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
with a smooth surface##2##4##(1994-7#1)(2008-8#1)
with a smooth##3##3##(1994-7#1)(2007-12#1)(2008-8#1)
with a solid phase##2##4##(2008-10#2)
with a solid##9##3##(1994-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2013-1#1)
with a solitary##5##3##(2008-6#1)(2008-7#1)(2010-6#2)(2012-12#1)
with a solution of##6##4##(2008-10#5)(2008-2#1)
with a solution##8##3##(2008-10#7)(2008-2#1)
with a solvent extraction##2##4##(2008-10#2)
with a sound##2##3##(2011-2#1)(2012-2#1)
with a source of##2##4##(2008-3#1)(2012-3#1)
with a spacer device##3##4##(1996-1#2)(2008-3#1)
with a spacer##10##3##(1996-1#3)(2007-11#2)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
with a spatial frequency of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
with a spatial resolution of##7##5##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-5#1)
with a spatial resolution##8##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#1)
with a spatial##16##3##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#4)(2008-5#1)(2011-3#1)(2012-2#1)
with a spatially##2##3##(2007-12#1)(2008-3#1)
with a special focus on##3##5##(2008-4#1)(2009-7#1)(2011-2#1)
with a special interest##2##4##(2007-2#1)(2008-10#1)
with a special reference to##3##5##(1993-8#1)(1996-2#1)(2008-7#1)
with a special regard to the##2##6##(1994-5#1)(2008-10#1)
with a special##14##3##(1993-8#1)(1994-5#1)(1996-2#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
with a specially designed##2##4##(2008-2#1)(2008-3#1)
with a specific activity of##2##5##(1994-5#1)(2009-9#1)
with a specific genetic##2##4##(2008-4#1)(2011-2#1)
with a specific monoclonal antibody##2##5##(1994-10#1)(2008-10#1)
with a specific##32##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-2#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-7#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
with a specificity of##2##4##(1993-2#1)(1997-3#1)
with a speckle interferometer##2##4##(2007-11#1)(2008-3#1)
with a spectral resolution of##2##5##(2007-12#2)
with a spectral resolution##3##4##(2007-12#2)(2008-2#1)
with a spectral##6##3##(2007-12#3)(2008-2#2)(2008-3#1)
with a spectrophotometer##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
with a spectrophotometric reference method##2##5##(2008-10#2)
with a spherical##4##3##(2008-2#1)(2008-3#3)
with a spontaneous##2##3##(2006-10#1)(2008-8#1)
with a spouse##3##3##(1990-2#1)(1994-2#1)(2012-12#1)
with a square##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
with a stable##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
with a stack of##2##4##(2008-3#2)
with a standard deviation of 0##2##6##(2008-3#1)(2009-2#1)
with a standard deviation of##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)
with a standard deviation##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)
with a standard error of##2##5##(2008-10#1)(2008-2#1)
with a standard reference##2##4##(2008-10#2)
with a standard##31##3##(2007-11#1)(2008-1#1)(2008-10#15)(2008-2#7)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)
with a standardized##3##3##(1993-6#1)(2008-7#1)(2011-1#1)
with a static##2##3##(2007-12#1)(2008-10#1)
with a stationary##2##3##(2007-11#1)(2008-3#1)
with a statistical##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
with a steady-state##3##3##(2008-10#2)(2008-3#1)
with a step##2##3##(2008-10#1)(2008-3#1)
with a stoichiometry of##3##4##(1990-2#1)(1990-7#1)(1994-6#1)
with a stream of##3##4##(2008-10#3)
with a strict##4##3##(1997-6#1)(2008-3#1)(2008-4#1)(2008-9#1)
with a strictly##2##3##(2008-10#2)
with a stroke##2##3##(1992-2#1)(2007-9#1)
with a strong tendency to##2##5##(2012-1#1)(2013-1#1)
with a strong##13##3##(1992-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-5#1)(2009-7#1)(2012-1#1)(2013-1#1)
with a strongly##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
with a structural##2##3##(2007-12#1)(2011-2#1)
with a structure##3##3##(1995-6#1)(2008-3#1)(2008-5#1)
with a structured interview##2##4##(2006-10#1)(2010-8#1)
with a sub-sample of##2##4##(2008-10#1)(2008-12#1)
with a subsequent##4##3##(1991-9#1)(1992-5#1)(2008-10#1)(2011-2#1)
with a subset of the##3##5##(2012-3#1)(2013-1#2)
with a substance##2##3##(2008-6#1)(2008-9#1)
with a successful outcome##2##4##(2007-8#1)(2012-2#1)
with a suitable##6##3##(2008-10#5)(2010-2#1)
with a suitably##2##3##(2007-12#1)(2008-4#1)
with a summary of##2##4##(2008-10#1)(2011-2#1)
with a superficial LMS##2##4##(2008-6#2)
with a superficial##3##3##(2008-6#3)
with a superior##3##3##(1997-6#1)(2007-12#1)(2009-12#1)
with a superluminescent diode##3##4##(2008-2#2)(2008-3#1)
with a surface##5##3##(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#1)
with a surgical##3##3##(2012-3#1)(2013-1#2)
with a susceptible##2##3##(2008-10#2)
with a suspension containing##2##4##(2008-10#1)(2008-5#1)
with a suspension##3##3##(2008-10#2)(2008-5#1)
with a swelling##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
with a symmetrical##2##3##(1990-8#1)(2008-10#1)
with a symptomatic##3##3##(1992-9#1)(2008-8#1)(2011-2#1)
with a synchrotron##2##3##(2008-4#1)(2008-5#1)
with a syndrome##2##3##(2008-7#1)(2010-3#1)
with a synthetic aperture##2##4##(2007-11#1)(2008-3#1)
with a synthetic##8##3##(1993-9#1)(1995-11#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
with a syringe##2##3##(2008-10#1)(2008-5#1)
with a system##2##3##(2007-12#1)(2008-3#1)
with a tabletop##3##3##(2007-12#3)
with a tapered##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
with a target##6##3##(2008-10#3)(2009-9#1)(2011-1#1)(2011-2#1)
with a targeted##2##3##(1993-9#1)(1994-9#1)
with a temperature##5##3##(2008-2#1)(2008-3#3)(2008-5#1)
with a temperature-sensitive##2##3##(1995-6#1)(1995-9#1)
with a tendency to##2##4##(2008-5#1)(2010-2#1)
with a tendency##4##3##(2008-5#1)(2009-5#1)(2010-2#1)(2011-2#1)
with a test##2##3##(2008-10#1)(2008-11#1)
with a theoretical model##4##4##(2007-11#1)(2008-3#2)(2011-1#1)
with a theoretical##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2011-1#1)
with a thermally##2##3##(2008-10#1)(2008-2#1)
with a thick##2##3##(2008-2#1)(2010-5#1)
with a thickness of##3##4##(2007-12#1)(2008-3#1)(2009-7#1)
with a thin film##2##4##(2008-10#2)
with a thin##10##3##(1991-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#1)
with a third party##2##4##(2008-10#1)(2012-12#1)
with a third##3##3##(1990-3#1)(2008-10#1)(2012-12#1)
with a third-generation cephalosporin##2##4##(2011-2#2)
with a three##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
with a three-dimensional##4##3##(2008-2#1)(2008-3#2)(2010-3#1)
with a threshold concentration of##2##5##(1995-11#1)(2008-5#1)
with a threshold##5##3##(1995-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2012-2#1)
with a time constant of##3##5##(1995-5#1)(1996-5#1)(2008-10#1)
with a time resolution of##4##5##(2007-11#1)(2008-3#3)
with a time resolution##6##4##(2007-11#1)(2007-12#1)(2008-3#4)
with a time##12##3##(1995-5#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-7#1)
with a titer of 1##2##5##(1992-9#2)
with a titer##3##3##(1992-9#2)(2008-10#1)
with a top##2##3##(2007-11#1)(2008-2#1)
with a torque between 25 to 35 Ncm##2##8##(2013-1#2)
with a torque##3##3##(2013-1#3)
with a total length of##2##5##(2013-8#2)
with a total of##19##4##(1991-11#1)(1994-12#1)(1997-3#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
with a total run time of##3##6##(1996-5#1)(2008-10#1)(2008-3#1)
with a total##35##3##(1991-11#1)(1992-11#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
with a trace##3##3##(2008-5#3)
with a traditional##5##3##(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
with a transient##4##3##(1997-7#1)(2007-10#1)(2008-5#1)(2010-12#1)
with a transmission##2##3##(2008-2#1)(2008-5#1)
with a transparent##2##3##(2008-10#1)(2008-3#1)
with a transversely##3##3##(2007-11#1)(2008-10#2)
with a trend towards##2##4##(1995-5#1)(2010-3#1)
with a trend##3##3##(1995-5#1)(2008-11#1)(2010-3#1)
with a triangular##2##3##(2008-3#1)(2010-6#1)
with a tryptophan##2##3##(1991-5#1)(1992-6#1)
with a tumor of##2##4##(2011-2#1)(2013-1#1)
with a tumor##8##3##(1990-12#1)(1990-6#1)(1994-12#1)(1995-4#1)(2007-8#1)(2011-2#1)(2013-1#2)
with a tunable##5##3##(2007-12#2)(2008-3#3)
with a tungsten tube atomizer##2##5##(2008-10#2)
with a tungsten##4##3##(2008-10#4)
with a tuning##2##3##(2007-12#1)(2008-2#1)
with a twisted-nematic liquid-crystal display##2##5##(2007-12#2)
with a two##3##3##(1991-12#1)(2008-1#1)(2008-10#1)
with a two-dimensional photonic crystal##2##5##(2007-11#1)(2007-12#1)
with a two-dimensional##8##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
with a two-state##2##3##(1994-5#1)(1995-6#1)
with a two-step##2##3##(1997-7#1)(2008-10#1)
with a two-wavelength##2##3##(2008-2#1)(2008-3#1)
with a twofold increase in sensitivity##2##6##(2008-2#2)
with a type##3##3##(2007-12#1)(2008-3#1)(2012-12#1)
with a typical##3##3##(1994-8#1)(2008-3#1)(2012-2#1)
with a uniform##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
with a unique tissue##2##4##(1993-9#1)(2008-5#1)
with a unique##14##3##(1992-1#1)(1993-1#1)(1993-9#1)(1994-9#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
with a use of##2##4##(2007-8#2)
with a value of##4##4##(2008-10#1)(2008-3#2)(2010-12#1)
with a variable##6##3##(2007-11#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-1#1)
with a variety of medical##2##5##(2010-8#1)(2012-3#1)
with a variety of##50##4##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
with a vascular##2##3##(2008-4#1)(2010-5#1)
with a vast##2##3##(2011-1#1)(2013-7#1)
with a vector##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
with a vertical resolution of 3 km##2##7##(2008-3#2)
with a vertical##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
with a very fast##2##4##(2007-12#1)(2008-10#1)
with a very high##7##4##(1990-12#1)(1996-3#1)(1997-4#1)(1997-6#2)(2008-5#1)(2009-12#1)
with a very low##4##4##(1990-5#1)(1992-9#1)(2008-10#2)
with a very small##4##4##(1992-9#1)(1995-12#1)(2008-3#1)(2008-5#1)
with a very##27##3##(1990-12#1)(1990-5#1)(1991-8#1)(1992-6#1)(1992-9#2)(1995-12#1)(1996-3#1)(1997-4#1)(1997-6#2)(2007-12#4)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#2)(2009-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
with a viability##2##3##(2008-11#2)
with a view to defining##2##5##(1991-6#1)(1997-4#1)
with a view to determine##2##5##(2007-7#1)(2008-10#1)
with a view to developing##2##5##(2008-5#1)(2011-1#1)
with a view to enhance patient compliance##2##7##(2010-3#2)
with a view to##18##4##(1991-3#1)(1991-6#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#3)(2011-1#1)(2012-2#1)
with a view##19##3##(1991-3#1)(1991-6#1)(1995-12#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#3)(2011-1#1)(2012-2#1)
with a virus titer of 10(6##2##6##(2008-11#2)
with a virus##4##3##(1997-1#1)(2008-10#1)(2008-11#2)
with a visible##2##3##(2007-11#1)(2008-2#1)
with a visual##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
with a volume of##3##4##(1996-2#1)(2008-11#1)(2010-8#1)
with a volume##7##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-1#1)
with a waist-to-hip ratio##2##4##(1990-9#2)
with a wall-jet##4##3##(2008-10#4)
with a water##7##3##(1991-2#1)(2008-10#4)(2008-11#1)(2008-7#1)
with a water-soluble##3##3##(2008-5#1)(2008-9#1)(2012-2#1)
with a waveguide##2##3##(2008-3#2)
with a wavelength near##2##4##(2007-12#1)(2008-3#1)
with a wavelength of##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
with a wavelength##9##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#4)(2010-8#1)
with a weak##2##3##(1992-9#1)(2007-11#1)
with a weakly basic##2##4##(2008-10#2)
with a weakly##4##3##(2007-12#1)(2008-10#2)(2010-3#1)
with a weight##2##3##(1992-8#1)(2008-6#1)
with a well-defined##2##3##(1997-5#1)(2011-2#1)
with a well-differentiated##3##3##(2007-12#1)(2008-6#1)(2010-8#1)
with a wide range of##10##5##(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
with a wide spectrum of##4##5##(2008-3#1)(2008-7#2)(2013-1#1)
with a wide variety of##5##5##(1994-5#1)(2008-4#2)(2009-12#1)(2009-5#1)
with a wide##24##3##(1991-9#1)(1994-5#1)(1995-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
with a widely##2##3##(1996-2#1)(2008-5#1)
with a width of##2##4##(1996-4#1)(2007-11#1)
with a wild-type##2##3##(2008-11#1)(2011-1#1)
with a working##4##3##(1993-8#1)(2008-10#3)
with a yield of##4##4##(1992-8#1)(1997-6#2)(2013-1#1)
with a yield##5##3##(1992-8#1)(1994-6#1)(1997-6#2)(2013-1#1)
with a##7466##2##(1990-10#6)(1990-11#21)(1990-12#32)(1990-2#22)(1990-3#17)(1990-4#1)(1990-5#16)(1990-6#10)(1990-7#22)(1990-8#24)(1990-9#15)(1991-1#2)(1991-10#1)(1991-11#9)(1991-12#29)(1991-2#25)(1991-3#11)(1991-4#6)(1991-5#16)(1991-6#23)(1991-7#3)(1991-8#16)(1991-9#18)(1992-1#7)(1992-10#12)(1992-11#18)(1992-12#18)(1992-2#15)(1992-3#33)(1992-4#1)(1992-5#12)(1992-6#23)(1992-7#1)(1992-8#22)(1992-9#24)(1993-1#9)(1993-11#20)(1993-12#22)(1993-2#19)(1993-3#17)(1993-5#3)(1993-6#26)(1993-8#34)(1993-9#17)(1994-1#5)(1994-10#2)(1994-11#21)(1994-12#37)(1994-2#13)(1994-3#21)(1994-5#16)(1994-6#20)(1994-7#4)(1994-8#30)(1994-9#17)(1995-1#1)(1995-10#1)(1995-11#23)(1995-12#36)(1995-2#42)(1995-3#24)(1995-4#3)(1995-5#22)(1995-6#21)(1995-8#9)(1995-9#6)(1996-1#9)(1996-10#2)(1996-11#5)(1996-12#26)(1996-2#41)(1996-3#18)(1996-4#2)(1996-5#22)(1996-6#12)(1996-7#4)(1996-8#7)(1996-9#10)(1997-1#14)(1997-2#27)(1997-3#30)(1997-4#22)(1997-5#14)(1997-6#15)(1997-7#38)(1997-8#23)(1997-9#2)(2006-10#12)(2006-12#6)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#30)(2007-11#255)(2007-12#357)(2007-2#13)(2007-4#1)(2007-5#9)(2007-6#2)(2007-7#29)(2007-8#71)(2007-9#7)(2008-1#60)(2008-10#1662)(2008-11#184)(2008-12#81)(2008-2#363)(2008-3#773)(2008-4#100)(2008-5#154)(2008-6#92)(2008-7#190)(2008-8#100)(2008-9#112)(2009-1#8)(2009-10#18)(2009-11#20)(2009-12#20)(2009-2#14)(2009-3#21)(2009-4#11)(2009-5#33)(2009-6#13)(2009-7#19)(2009-8#29)(2009-9#25)(2010-1#10)(2010-10#19)(2010-11#9)(2010-12#33)(2010-2#11)(2010-3#33)(2010-4#25)(2010-5#26)(2010-6#19)(2010-7#12)(2010-8#34)(2010-9#7)(2011-1#69)(2011-10#1)(2011-2#204)(2011-3#9)(2011-9#1)(2012-1#30)(2012-12#65)(2012-2#104)(2012-3#88)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#217)(2013-2#1)(2013-7#25)(2013-8#92)
with abdominal pain and##3##4##(2010-12#2)(2011-1#1)
with abdominal pain associated##2##4##(1993-9#1)(2010-1#1)
with abdominal pain##18##3##(1993-6#1)(1993-9#1)(1997-8#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
with abdominal tuberculosis##2##3##(2011-1#2)
with abdominal##34##2##(1990-9#1)(1991-2#1)(1991-4#1)(1993-6#1)(1993-9#1)(1995-12#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-12#3)(2011-1#3)(2011-2#6)(2012-12#1)(2013-1#7)(2013-8#1)
with aberrant##4##2##(2010-1#1)(2011-2#1)(2012-3#2)
with ability to##3##3##(2008-12#1)(2009-6#1)(2012-2#1)
with abnormal liquor volume##3##4##(2012-12#3)
with abnormal sleep##2##3##(1992-11#1)(2007-12#1)
with abnormal##36##2##(1990-6#1)(1990-8#1)(1991-11#2)(1992-11#1)(1992-12#1)(1993-11#4)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#2)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#4)
with abnormalities of##2##3##(1991-5#1)(2008-6#1)
with abnormalities##5##2##(1991-5#1)(1995-12#1)(2008-6#2)(2011-2#1)
with abnormally##2##2##(1990-12#1)(1997-5#1)
with about 80% of the##2##5##(1991-11#1)(2008-12#1)
with about one##2##3##(1995-5#1)(2008-9#1)
with about##17##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-6#1)(1994-9#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-8#1)
with above-average##2##2##(2008-10#1)(2008-8#1)
with absence of the##4##4##(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
with absence of##6##3##(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
with absorption bands##3##3##(2008-10#2)(2008-3#1)
with absorption##8##2##(2008-10#4)(2008-2#2)(2008-3#2)
with abundant##4##2##(2008-1#2)(2008-10#1)(2009-8#1)
with academic##6##2##(2008-12#2)(2008-2#1)(2011-1#1)(2011-2#1)(2012-1#1)
with acarbose##3##2##(1994-12#3)
with acceptable accuracy and precision##2##5##(2008-10#2)
with acceptable accuracy##3##3##(2008-10#2)(2012-2#1)
with acceptable results##2##3##(2011-3#1)(2012-12#1)
with acceptable##18##2##(2006-10#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
with accepted##2##2##(2008-10#1)(2009-5#1)
with access to the##3##4##(1994-12#1)(2010-2#1)(2012-3#1)
with access to##4##3##(1994-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
with accessibility##2##2##(1995-1#1)(2013-1#1)
with accidental##2##2##(1991-8#1)(2013-1#1)
with accompanying##4##2##(2008-1#1)(2008-10#1)(2010-3#1)(2012-2#1)
with accumulation time##2##3##(2008-10#2)
with accumulation##4##2##(1991-9#1)(2008-10#3)
with accuracies##2##2##(2008-3#2)
with accuracy of##3##3##(1997-6#1)(2008-10#2)
with accuracy##5##2##(1997-6#1)(2008-10#2)(2008-3#1)(2009-5#1)
with accurate##4##2##(2006-10#1)(2007-2#1)(2010-3#1)(2013-7#1)
with acetamide##2##2##(2008-10#1)(2008-6#1)
with acetate##2##2##(1996-5#1)(2008-10#1)
with acetic acid##6##3##(1997-4#1)(2008-10#2)(2008-6#1)(2012-12#1)(2013-1#1)
with acetic anhydride##2##3##(2008-10#1)(2008-11#1)
with acetic##9##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-6#1)(2012-12#2)(2013-1#1)
with acetone##2##2##(2008-10#1)(2008-5#1)
with acetonitrile##9##2##(1997-2#1)(2008-10#8)
with acetonitrile-water mixtures##2##3##(2008-10#2)
with acetonitrile-water##6##2##(2008-10#5)(2011-1#1)
with acetylcholinesterase##2##2##(2008-10#2)
with achalasia##3##2##(1990-12#1)(1992-9#1)(2013-1#1)
with achondroplasia##2##2##(2011-1#1)(2013-1#1)
with acid##5##2##(1996-3#1)(2008-10#3)(2008-6#1)
with acidic molybdate##2##3##(2008-10#2)
with acidic potassium permanganate in the presence of##2##8##(2008-10#2)
with acidic potassium permanganate##5##4##(2008-10#5)
with acidic##12##2##(1990-2#1)(2008-1#1)(2008-10#9)(2008-8#1)
with acidification##2##2##(1994-6#1)(2008-10#1)
with acidified##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
with acoustic##2##2##(2007-5#1)(2008-7#1)
with acquired immune deficiency syndrome##2##5##(1994-3#1)(2011-2#1)
with acquired immunodeficiency syndrome (AIDS)##2##5##(1991-12#1)(1994-6#1)
with acquired immunodeficiency syndrome##4##4##(1991-12#2)(1994-6#1)(2008-2#1)
with acquired##10##2##(1991-12#2)(1994-3#2)(1994-6#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-1#1)
with acquisition of##3##3##(1993-6#1)(1994-8#1)(2012-2#1)
with acquisition##4##2##(1993-6#2)(1994-8#1)(2012-2#1)
with acridone-N-acetyl chloride##2##3##(2008-10#2)
with acrolein##2##2##(2013-1#2)
with acrylic glue##4##3##(1997-3#2)(1997-6#2)
with acrylic##5##2##(1997-3#2)(1997-6#2)(2010-4#1)
with actin filaments##2##3##(1997-7#1)(2008-10#1)
with actin##9##2##(1991-5#1)(1994-8#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
with activated carbon##5##3##(2008-10#5)
with activated##12##2##(1993-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)
with activation of the##2##4##(1990-5#1)(2010-12#1)
with activation of##5##3##(1990-5#2)(2010-10#1)(2010-12#1)(2012-3#1)
with activation##9##2##(1990-5#2)(1992-2#1)(1995-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-3#1)
with active disease##5##3##(1990-3#1)(1991-5#1)(2008-7#3)
with active phase locking##2##4##(2007-12#2)
with active##27##2##(1990-3#1)(1991-5#1)(1991-6#1)(1994-9#1)(1996-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#4)(2009-11#1)(2009-6#2)(2010-1#1)(2010-12#2)(2010-5#1)(2012-3#3)(2013-1#1)
with activity and##2##3##(1992-2#1)(1993-5#1)
with activity in the##2##4##(2008-11#1)(2010-3#1)
with activity##11##2##(1992-2#1)(1992-6#1)(1993-5#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-12#1)
with actual conditions##2##3##(2008-2#1)(2008-7#1)
with actual##9##2##(1992-12#1)(1995-2#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)
with acute abdominal pain##3##4##(2007-2#1)(2008-12#1)(2013-1#1)
with acute and chronic liver disease##2##6##(2013-1#2)
with acute and chronic##3##4##(2013-1#2)(2013-8#1)
with acute and##4##3##(2008-7#1)(2013-1#2)(2013-8#1)
with acute aortic##2##3##(2007-8#1)(2012-1#1)
with acute asthma##2##3##(2008-1#1)(2008-10#1)
with acute chest pain##3##4##(2008-3#2)(2011-2#1)
with acute coronary syndrome in the##3##6##(2008-3#2)(2008-7#1)
with acute coronary syndrome##17##4##(2008-10#2)(2008-11#5)(2008-3#5)(2008-7#2)(2011-2#3)
with acute coronary syndromes##10##4##(2008-10#1)(2008-3#7)(2008-7#1)(2009-12#1)
with acute coronary##31##3##(2008-10#5)(2008-11#5)(2008-3#12)(2008-7#3)(2009-10#1)(2009-12#1)(2011-2#3)(2013-8#1)
with acute decompensated##2##3##(2008-3#2)
with acute hepatitis##3##3##(1996-3#1)(2012-3#2)
with acute ischaemic stroke##3##4##(1997-5#1)(2008-8#1)(2009-11#1)
with acute ischemic stroke##9##4##(2007-10#5)(2008-10#1)(2009-6#1)(2012-12#2)
with acute ischemic##10##3##(2007-10#6)(2008-10#1)(2009-6#1)(2012-12#2)
with acute leukemia##5##3##(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)
with acute liver##2##3##(1992-6#1)(2010-12#1)
with acute lymphoblastic leukemia##4##4##(2008-10#1)(2009-4#1)(2011-2#2)
with acute lymphoblastic##6##3##(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#3)
with acute myelocytic leukemia##2##4##(1991-2#1)(2011-2#1)
with acute myelogenous leukemia##2##4##(1994-12#2)
with acute myeloid leukemia##7##4##(1994-5#1)(2007-7#1)(2008-11#1)(2011-2#4)
with acute myeloid##8##3##(1994-5#1)(2007-7#1)(2008-11#1)(2011-2#4)(2012-3#1)
with acute myocardial infarction##16##4##(1992-3#1)(1992-6#1)(1992-9#2)(1995-12#2)(1997-3#1)(2008-10#1)(2008-3#5)(2010-11#1)(2011-1#1)(2013-1#1)
with acute myocardial##18##3##(1990-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1995-12#2)(1997-3#1)(2008-10#1)(2008-3#6)(2010-11#1)(2011-1#1)(2013-1#1)
with acute onset of##4##4##(1997-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
with acute onset##6##3##(1997-3#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
with acute or chronic##2##4##(2008-7#1)(2012-2#1)
with acute pancreatitis##3##3##(1990-3#1)(2008-3#1)(2009-8#1)
with acute promyelocytic leukemia (APL)##2##5##(2007-4#1)(2008-8#1)
with acute promyelocytic leukemia##4##4##(2007-12#1)(2007-4#2)(2008-8#1)
with acute renal failure (ARF)##2##5##(2008-4#1)(2012-3#1)
with acute renal failure##8##4##(2007-7#1)(2008-1#2)(2008-4#4)(2012-3#1)
with acute renal##9##3##(2007-7#1)(2008-1#2)(2008-4#4)(2011-2#1)(2012-3#1)
with acute respiratory##6##3##(2008-11#1)(2012-12#1)(2013-1#1)(2013-8#3)
with acute sinusitis##2##3##(1993-2#1)(2011-1#1)
with acute stroke##9##3##(1994-6#1)(2007-10#5)(2007-9#1)(2008-8#2)
with acute##218##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1995-12#2)(1996-3#1)(1997-3#2)(1997-5#1)(1997-8#2)(2006-12#1)(2007-10#15)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#7)(2008-12#1)(2008-3#25)(2008-4#4)(2008-5#5)(2008-7#12)(2008-8#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#26)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#10)(2013-1#8)(2013-8#9)
with acyl##2##2##(1996-2#1)(2013-1#1)
with adaptive optics##3##3##(2007-11#2)(2008-3#1)
with adaptive##8##2##(1997-3#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)
with added##10##2##(1990-5#1)(1991-1#1)(1993-8#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
with addition of##10##3##(1991-8#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-3#1)(2011-1#1)
with additional##42##2##(1990-8#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-7#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
with additive effects##3##3##(2008-10#3)
with additive##5##2##(2008-10#4)(2008-2#1)
with adenoregulin##2##2##(1994-5#2)
with adenosine##4##2##(1997-6#1)(2008-5#3)
with adenovirus##2##2##(2008-11#1)(2008-8#1)
with adequate##14##2##(1990-2#1)(1990-9#1)(1992-9#2)(1993-2#1)(1993-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
with adherence to treatment##2##4##(2012-12#1)(2012-3#1)
with adherence to##3##3##(2012-12#2)(2012-3#1)
with adherence##7##2##(1996-3#1)(2008-9#1)(2010-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
with adhesion##3##2##(1993-6#1)(1994-6#1)(2008-4#1)
with adjacent cells##2##3##(2008-3#1)(2009-10#1)
with adjacent skin invasion##2##4##(2009-5#2)
with adjacent##11##2##(1993-1#1)(1993-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#2)(2009-5#2)(2010-6#1)(2011-2#1)
with adjunctive##2##2##(1996-3#1)(2010-12#1)
with adjustable##2##2##(2007-12#1)(2008-2#1)
with adjustment##2##2##(2010-5#1)(2011-1#1)
with adjuvant chemotherapy##3##3##(2008-7#1)(2010-3#2)
with adjuvant##9##2##(1991-4#1)(1991-8#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-3#2)(2013-1#1)
with administration of##4##3##(1995-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
with adolescent##2##2##(1991-2#1)(2008-6#1)
with adolescents##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
with adriamycin##3##2##(1993-12#1)(2008-7#1)(2010-3#1)
with adsorbed##2##2##(2008-11#1)(2013-8#1)
with adsorptive##4##2##(2008-10#4)
with adult learning##2##3##(1995-2#1)(1995-3#1)
with adult##11##2##(1991-9#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
with adults##3##2##(1992-11#1)(2008-12#1)(2012-12#1)
with advanced age##2##3##(1990-6#1)(2007-11#1)
with advanced breast cancer##8##4##(1990-10#1)(1991-6#2)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)
with advanced breast##9##3##(1990-10#1)(1991-6#2)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2011-2#1)
with advanced cancer##6##3##(1992-5#1)(2007-11#1)(2008-7#2)(2012-3#2)
with advanced disease##3##3##(2008-9#1)(2010-7#1)(2010-8#1)
with advanced measurable##2##3##(1990-8#1)(1991-4#1)
with advanced ovarian cancer##4##4##(1991-8#2)(1992-2#2)
with advanced pulmonary fibrosis##2##4##(2006-10#2)
with advanced stage##2##3##(2012-1#1)(2012-12#1)
with advanced##83##2##(1990-10#3)(1990-2#2)(1990-6#1)(1990-8#2)(1991-4#1)(1991-6#3)(1991-8#3)(1992-10#1)(1992-2#3)(1992-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#3)(2007-11#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#4)(2008-7#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)
with advanced-stage##3##2##(2008-7#2)(2011-2#1)
with advances in##2##3##(2008-3#1)(2008-9#1)
with advances##3##2##(2008-3#1)(2008-9#1)(2009-10#1)
with advancing age and##2##4##(1993-3#1)(1996-5#1)
with advancing age##9##3##(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1996-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
with advancing##11##2##(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1996-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
with adverse drug reactions##2##4##(2008-11#1)(2013-8#1)
with adverse outcomes##4##3##(1994-1#1)(2012-2#3)
with adverse##20##2##(1994-1#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#2)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
with aerosols##3##2##(1997-1#1)(2008-10#1)(2008-3#1)
with affected##2##2##(2007-11#1)(2008-4#1)
with affiliation##2##2##(1995-1#1)(2008-10#1)
with affinity constants of##2##4##(2008-8#2)
with affinity for dopamine##2##4##(1993-8#2)
with affinity for the##2##4##(1993-8#1)(2008-10#1)
with affinity for##8##3##(1993-8#3)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)
with affinity##12##2##(1993-8#3)(1995-2#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)
with aflatoxin content##2##3##(2008-10#2)
with aflatoxin##4##2##(2008-10#4)
with agar##2##2##(2008-10#1)(2012-2#1)
with agarose gel##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
with age (P##2##3##(1991-9#1)(1993-2#1)
with age and##14##3##(1994-6#1)(1995-3#1)(2008-1#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
with age for##4##3##(2008-12#1)(2008-3#1)(2011-2#2)
with age from##2##3##(2007-7#1)(2012-3#1)
with age in both##3##4##(2008-3#1)(2008-7#1)(2009-5#1)
with age in brain##2##4##(1990-3#2)
with age in the##3##4##(1990-11#1)(2008-7#1)(2011-1#1)
with age in##16##3##(1990-11#1)(1990-3#4)(1994-11#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-5#1)(2011-1#1)
with age of##3##3##(2008-10#2)(2008-5#1)
with age while##2##3##(1997-7#1)(2012-3#1)
with age##161##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#8)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#4)(1991-8#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-3#3)(1995-6#1)(1995-8#3)(1996-3#1)(1996-5#5)(1997-7#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#12)(2008-7#21)(2008-8#3)(2008-9#6)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-3#2)(2010-8#2)(2011-1#7)(2011-2#10)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-3#2)(2013-7#3)(2013-8#4)
with age-matched controls##2##3##(1994-5#1)(2007-10#1)
with age-related macular degeneration (ARMD)##2##5##(2011-1#1)(2011-2#1)
with age-related macular degeneration##4##4##(2011-1#2)(2011-2#2)
with age-related macular##5##3##(2011-1#2)(2011-2#3)
with ageing##5##2##(1996-5#1)(2008-11#1)(2008-5#2)(2010-4#1)
with ages##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
with aggression##2##2##(2008-12#1)(2013-1#1)
with aggressive management##2##3##(2011-2#1)(2013-1#1)
with aggressive##8##2##(2008-10#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
with aging and##2##3##(1993-12#1)(2012-3#1)
with aging are##2##3##(2011-2#1)(2013-7#1)
with aging##24##2##(1991-1#1)(1993-1#3)(1993-12#1)(1994-6#1)(1994-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#7)(2009-12#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-7#2)
with agitation##2##2##(2008-6#1)(2011-2#1)
with air##15##2##(1991-12#2)(1993-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2013-1#1)
with airway##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-12#1)
with alanine##3##2##(1994-11#2)(1995-6#1)
with alanines##3##2##(1995-2#3)
with albendazole##2##2##(2009-10#1)(2011-2#1)
with albumin##6##2##(1992-6#1)(1993-9#1)(1995-2#1)(2008-1#1)(2008-7#2)
with alcalase##2##2##(2010-2#2)
with alcohol and##2##3##(1992-12#1)(2008-9#1)
with alcohol dependence##5##3##(2008-10#1)(2008-2#3)(2010-1#1)
with alcohol##16##2##(1992-12#1)(1997-8#3)(2008-10#1)(2008-2#3)(2008-6#1)(2008-9#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
with alcoholic liver disease##5##4##(1993-12#1)(1994-7#2)(2008-8#1)(2010-12#1)
with alcoholic##6##2##(1993-12#2)(1994-7#2)(2008-8#1)(2010-12#1)
with alcoholism##3##2##(1997-5#1)(2008-7#1)(2012-12#1)
with aldehydes##2##2##(1996-5#2)
with alendronate##4##2##(2008-11#3)(2008-8#1)
with alfalfa##2##2##(2008-10#1)(2008-11#1)
with alignment##2##2##(2008-3#1)(2008-7#1)
with alkali##3##2##(2008-10#2)(2008-5#1)
with alkaline earth and##2##4##(2008-10#1)(2009-7#1)
with alkaline earth##3##3##(2008-10#2)(2009-7#1)
with alkaline phosphatase##4##3##(1991-2#1)(1991-5#1)(2008-10#2)
with alkaline sodium##2##3##(2008-10#2)
with alkaline##15##2##(1991-2#1)(1991-5#1)(1993-6#1)(2008-10#10)(2008-9#1)(2009-7#1)
with alkyl##3##2##(1990-11#1)(2008-4#1)(2008-5#1)
with alkylating##2##2##(2008-11#2)
with all four##2##3##(1995-5#1)(2008-10#1)
with all of##4##3##(1992-3#1)(1994-9#1)(2008-8#2)
with all other##11##3##(1995-6#1)(2008-10#3)(2009-2#1)(2009-4#3)(2009-8#1)(2011-2#1)(2013-8#1)
with all possible##5##3##(1994-12#1)(1995-5#1)(2008-10#1)(2008-4#1)(2009-9#1)
with all the other##2##4##(2008-12#1)(2013-1#1)
with all the##8##3##(1990-12#1)(1990-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#2)
with all three##7##3##(1995-12#1)(2008-10#4)(2008-5#1)(2008-8#1)
with all types of##2##4##(1990-12#1)(1992-3#1)
with all##92##2##(1990-12#2)(1990-8#1)(1991-6#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#2)(1995-9#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-3#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
with allele##2##2##(1993-3#1)(2008-10#1)
with allergic rhinitis##6##3##(2008-4#1)(2012-12#2)(2012-2#2)(2013-1#1)
with allergic##9##2##(2007-11#1)(2008-4#1)(2009-6#1)(2010-5#1)(2012-12#2)(2012-2#2)(2013-1#1)
with allodynia##2##2##(1996-6#1)(2008-9#1)
with allogeneic##3##2##(1994-9#1)(2008-9#1)(2012-3#1)
with allograft##4##2##(2008-7#1)(2009-10#1)(2009-3#1)(2012-3#1)
with allosteric##2##2##(1990-8#1)(2012-2#1)
with almost no##2##3##(2008-2#1)(2008-5#1)
with almost##11##2##(1992-11#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-5#1)(2011-2#1)
with alopecia areata##2##3##(2007-7#2)
with alpha##12##2##(1990-12#1)(1992-8#1)(1993-12#1)(1993-3#3)(1994-5#1)(1995-11#1)(1995-6#1)(1996-5#1)(2007-2#1)(2011-2#1)
with alpha-##2##2##(1992-8#1)(2008-10#1)
with alpha-(2-benzimidazolyl)-alpha'##2##2##(2008-10#2)
with alpha-amylase##2##2##(2008-6#1)(2013-1#1)
with alpha-chymotrypsin and##2##3##(1993-11#1)(1996-12#1)
with alpha-chymotrypsin##3##2##(1993-11#1)(1996-12#1)(1996-5#1)
with alpha-lytic protease##2##3##(1993-11#2)
with alpha-tocopherol##3##2##(1991-12#1)(1994-9#1)(2008-10#1)
with already##2##2##(1994-1#1)(2008-11#1)
with alteration of the host hyphae prior to contact with the antagonist##2##12##(2008-10#2)
with alteration##3##2##(2008-10#2)(2008-11#1)
with alterations in##4##3##(1996-5#1)(2008-1#1)(2008-4#1)(2013-8#1)
with alterations##6##2##(1995-12#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-4#1)(2013-8#1)
with altered expression##2##3##(2008-7#1)(2009-9#1)
with altered##13##2##(1991-12#1)(1993-3#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#2)(2013-1#1)
with alternating layers of##2##4##(2008-10#1)(2008-2#1)
with alternating##6##2##(1990-2#1)(1991-5#1)(2008-10#2)(2008-2#1)(2008-7#1)
with alternative##7##2##(1993-2#1)(1993-6#1)(1995-2#1)(2008-10#3)(2008-4#1)
with altitude##4##2##(2008-3#3)(2008-8#1)
with aluminium##4##2##(2008-10#4)
with aluminon##2##2##(2008-10#2)
with aluminum##2##2##(1991-5#1)(2008-10#1)
with ambiguous genitalia##5##3##(2007-7#1)(2008-10#4)
with ambiguous##9##2##(1993-6#1)(2007-7#1)(2008-10#4)(2010-3#1)(2011-2#2)
with ambulatory##2##2##(1996-3#1)(2008-7#1)
with amines##3##2##(1995-3#1)(2008-10#2)
with amino acid sequences of##2##5##(1994-11#1)(2008-10#1)
with amino acid sequences##3##4##(1994-11#1)(1995-9#1)(2008-10#1)
with amino acid##6##3##(1992-11#1)(1994-11#1)(1995-5#1)(1995-9#1)(2008-10#1)(2010-11#1)
with amino acids##2##3##(2008-10#1)(2008-11#1)
with amino##10##2##(1992-11#1)(1994-11#1)(1995-5#1)(1995-9#1)(2008-10#4)(2008-11#1)(2010-11#1)
with aminopenicillins##2##2##(1995-3#1)(1996-3#1)
with amiodarone##3##2##(1990-5#1)(2007-8#1)(2008-4#1)
with amlodipine##2##2##(2008-3#1)(2012-12#1)
with ammonia and##4##3##(1994-2#1)(2008-10#2)(2009-8#1)
with ammonia##9##2##(1994-2#1)(2008-10#7)(2009-8#1)
with ammonium chloride##2##3##(2008-10#1)(2008-6#1)
with ammonium diethyl dithiophosphate##2##4##(2008-10#2)
with ammonium molybdate##2##3##(2008-10#2)
with ammonium pyrrolidine dithiocarbamate (APDC) and##3##6##(2008-10#3)
with ammonium pyrrolidine dithiocarbamate (APDC)##6##5##(2008-10#6)
with ammonium pyrrolidine dithiocarbamate##7##4##(2008-10#7)
with ammonium thiocyanate solution##2##4##(2008-10#2)
with ammonium##25##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-8#1)(2008-10#20)(2008-6#1)
with amniotic membrane##2##3##(2011-1#2)
with amoxycillin##2##2##(1991-3#1)(1997-3#1)
with amperometric detection at a##2##5##(2008-10#2)
with amperometric detection at anodized##2##5##(2008-10#2)
with amperometric detection at##6##4##(2008-10#6)
with amperometric detection using##3##4##(2008-10#3)
with amperometric detection was##2##4##(2008-10#2)
with amperometric detection##25##3##(2008-10#25)
with amphetamine##3##2##(1993-6#1)(1996-6#1)(2008-4#1)
with amphotericin B##3##3##(1990-11#1)(2007-12#1)(2008-12#1)
with amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#2)
with amplified fragment length polymorphism (AFLP)##4##6##(2008-10#4)
with amplified fragment length polymorphism##5##5##(2008-10#5)
with amplified sensitivity##2##3##(2008-10#2)
with amplified##7##2##(2008-10#7)
with amplitude##2##2##(2008-3#2)
with amplitudes##2##2##(2008-3#2)
with amputation##2##2##(2010-3#1)(2013-1#1)
with amputation's##2##2##(2013-1#2)
with amyloidosis##2##2##(1993-2#1)(2011-2#1)
with an AVM##2##3##(2008-7#2)
with an African##3##3##(1993-6#2)(2009-11#1)
with an Ar##3##3##(2008-10#2)(2008-2#1)
with an EC(50)##2##3##(2012-2#1)(2013-1#1)
with an EC50 of##2##4##(1994-9#1)(1997-2#1)
with an ED50 of##2##4##(1992-3#1)(1994-8#1)
with an ED50##3##3##(1992-3#1)(1994-8#1)(1996-2#1)
with an ELISA##2##3##(2008-10#2)
with an ESR spectrometer##2##4##(2008-10#2)
with an IC(50)##2##3##(2008-10#1)(2013-1#1)
with an IC50 of 1##2##5##(1993-12#1)(1995-8#1)
with an IC50 of 20 microM##2##6##(1994-8#2)
with an IC50 of##12##4##(1991-8#1)(1991-9#1)(1993-12#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-2#2)(1997-4#1)(2010-11#1)
with an IC50 value of##3##5##(1991-9#2)(2008-5#1)
with an IC50##16##3##(1991-8#1)(1991-9#3)(1993-12#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-2#2)(1997-4#1)(2008-12#1)(2008-5#1)(2010-11#1)
with an M(r) of##2##4##(1992-12#1)(1995-5#1)
with an N-terminal##3##3##(1995-3#1)(1995-5#1)(2008-10#1)
with an OR##2##3##(2008-11#1)(2013-1#1)
with an R##3##3##(2008-10#3)
with an STI##2##3##(2008-12#2)
with an abdominal##3##3##(1992-5#1)(2008-7#1)(2010-1#1)
with an ability to##3##4##(1992-11#1)(1994-2#1)(2009-6#1)
with an ability##4##3##(1992-11#1)(1994-2#1)(2008-10#1)(2009-6#1)
with an abnormal##7##3##(1990-5#1)(1993-11#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-9#1)(2010-11#1)
with an absolute accuracy of##2##5##(2008-3#2)
with an absolute##3##3##(2008-3#3)
with an absorption coefficient of##2##5##(2008-2#1)(2008-3#1)
with an absorption##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
with an abundance of##2##4##(2008-2#1)(2008-7#1)
with an accelerated##2##3##(1992-2#1)(2011-1#1)
with an acceptable##4##3##(1991-3#1)(1997-6#1)(2008-5#1)(2010-7#1)
with an accumulation of##2##4##(1994-5#1)(2008-6#1)
with an accumulation##5##3##(1994-5#1)(2008-10#2)(2008-3#1)(2008-6#1)
with an accuracy of +/-0##2##5##(2007-11#1)(2008-3#1)
with an accuracy of 89%##2##5##(1993-8#1)(2008-11#1)
with an accuracy of 94##2##5##(2008-7#1)(2011-2#1)
with an accuracy of better than 5% and##2##8##(2008-2#1)(2008-3#1)
with an accuracy of better than##4##6##(2008-2#2)(2008-3#2)
with an accuracy of##23##4##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-7#2)(2011-2#1)(2012-1#1)
with an accuracy##25##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#10)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)
with an accurate##2##3##(1991-11#1)(2008-10#1)
with an achromatic phase shifter##2##5##(2007-11#2)
with an achromatic##3##3##(2007-11#2)(2008-3#1)
with an acid##2##3##(2008-10#2)
with an acidified methanolic solution##2##5##(2008-10#2)
with an acousto-optic modulator##2##4##(2007-11#1)(2008-2#1)
with an acousto-optic##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
with an acrophase##3##3##(2008-11#1)(2010-8#2)
with an activated carbon##2##4##(2008-10#2)
with an activated##4##3##(1997-3#1)(2008-10#2)(2008-7#1)
with an active##6##3##(1990-12#1)(2008-10#1)(2008-2#2)(2009-6#1)(2013-7#1)
with an actuarial survival of##2##5##(1993-9#1)(1996-11#1)
with an acute abdomen##2##4##(1991-6#1)(2009-9#1)
with an acute onset of##2##5##(2008-11#1)(2012-12#1)
with an acute##10##3##(1991-6#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-2#1)(2009-9#1)(2011-1#1)(2012-12#1)
with an adaptive##3##3##(1990-11#1)(2007-12#1)(2008-3#1)
with an additional##13##3##(1994-6#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
with an additive##2##3##(1994-9#1)(2008-3#1)
with an adequate##11##3##(1991-3#1)(1993-12#1)(1994-3#1)(1996-2#1)(2008-10#3)(2008-2#1)(2009-5#1)(2011-1#1)(2011-2#1)
with an adjuvant##2##3##(1991-5#1)(1995-5#1)
with an advanced stage##2##4##(1991-8#1)(2013-1#1)
with an advanced##5##3##(1991-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
with an affinity##3##3##(1992-9#1)(1994-5#1)(2008-10#1)
with an age##2##3##(1997-6#1)(2008-7#1)
with an aggressive##2##3##(1993-3#1)(2008-10#1)
with an agrocin##2##3##(2008-10#2)
with an air stream##2##4##(2008-5#1)(2008-6#1)
with an air##3##3##(2007-11#1)(2008-5#1)(2008-6#1)
with an alanine##4##3##(1992-6#3)(2007-6#1)
with an alkaline##3##3##(1990-8#1)(1995-3#1)(2008-10#1)
with an all-solid-state##2##3##(2008-10#1)(2008-3#1)
with an almost##2##3##(2007-10#1)(2008-7#1)
with an altered##5##3##(1996-5#1)(2008-10#1)(2008-12#1)(2012-1#1)(2013-8#1)
with an alternative##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
with an aluminum##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
with an amino##4##3##(1994-12#1)(2008-10#1)(2008-11#2)
with an ammonium##2##3##(2008-10#2)
with an amplitude of##2##4##(1991-8#1)(2008-6#1)
with an amplitude##4##3##(1991-8#1)(1994-6#1)(2008-3#1)(2008-6#1)
with an analysis of the##3##5##(2008-8#1)(2009-5#1)(2012-2#1)
with an analysis of##4##4##(1992-6#1)(2008-8#1)(2009-5#1)(2012-2#1)
with an analysis##7##3##(1992-6#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#1)
with an analytic##2##3##(2008-3#2)
with an analytical##2##3##(2008-10#2)
with an angle of##2##4##(1997-7#1)(2008-2#1)
with an angle##3##3##(1997-7#1)(2008-2#2)
with an anion##2##3##(2008-10#2)
with an anion-exchange##2##3##(2008-10#2)
with an annual##2##3##(2008-10#1)(2012-12#1)
with an annular##2##3##(2008-3#1)(2009-6#1)
with an antibiotic##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
with an antibody against##2##4##(1992-9#1)(2012-2#1)
with an antibody specific for the##2##6##(1994-11#1)(1995-2#1)
with an antibody##12##3##(1992-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#2)(2012-2#1)
with an antisense RNA transcript##2##5##(1994-11#1)(1995-2#1)
with an aperture size of 100 nm##2##7##(2007-12#1)(2008-3#1)
with an apparent Kd of##2##5##(1990-5#2)
with an apparent Kd##3##4##(1990-5#2)(1994-5#1)
with an apparent molar absorptivity of##3##6##(2008-10#3)
with an apparent molecular##3##4##(1990-11#1)(1997-2#1)(2008-10#1)
with an apparent##29##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-2#1)(2008-10#7)(2008-7#1)
with an application to##2##4##(2008-10#1)(2013-7#1)
with an application##3##3##(1992-9#1)(2008-10#1)(2013-7#1)
with an applied##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
with an appropriate##15##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
with an approximate##2##3##(1990-12#1)(1992-6#1)
with an approximately##2##3##(1994-3#1)(2008-1#1)
with an aqueous##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
with an arbitrary##4##3##(2007-12#2)(2008-2#2)
with an argon##2##3##(2008-9#1)(2009-11#1)
with an array of##6##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
with an array##7##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
with an artificial##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
with an assay##2##3##(2008-10#1)(2008-6#1)
with an association##3##3##(1990-8#1)(1996-5#1)(2012-3#1)
with an asymptomatic##3##3##(2007-7#1)(2010-6#1)(2012-3#1)
with an atomic force microscope##4##5##(2007-11#1)(2008-3#3)
with an atomic##5##3##(2007-11#1)(2008-11#1)(2008-3#3)
with an attractive##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
with an atypical##3##3##(1993-10#1)(2007-10#1)(2012-3#1)
with an atypically##2##3##(2008-10#1)(2012-3#1)
with an autologous##2##3##(2011-2#1)(2013-1#1)
with an automated##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
with an automatic##2##3##(1990-8#1)(2012-3#1)
with an autosomal dominant##3##4##(1997-6#1)(2008-7#1)(2008-8#1)
with an autosomal recessive##2##4##(2008-1#1)(2008-4#1)
with an autosomal##5##3##(1997-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
with an average age of 34##2##6##(2008-9#1)(2013-1#1)
with an average age of 43 years##2##7##(2008-9#1)(2013-1#1)
with an average age of##9##5##(1990-12#1)(1994-12#1)(2007-8#1)(2008-9#3)(2009-10#1)(2013-1#2)
with an average error of##2##5##(2007-12#1)(2013-8#1)
with an average follow-up##2##4##(2008-6#1)(2008-7#1)
with an average insert size of##3##6##(1997-2#1)(1997-6#1)(2008-8#1)
with an average insert##4##4##(1996-10#1)(1997-2#1)(1997-6#1)(2008-8#1)
with an average molecular weight of##2##6##(2008-10#2)
with an average molecular##3##4##(1990-5#1)(2008-10#2)
with an average of 0##3##5##(2008-10#2)(2013-7#1)
with an average of 4##2##5##(1990-7#1)(2008-9#1)
with an average of##18##4##(1990-7#4)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2013-7#1)
with an average particle size of##2##6##(2008-10#1)(2008-8#1)
with an average power of##6##5##(2007-11#2)(2007-12#4)
with an average power##7##4##(2007-11#2)(2007-12#4)(2008-3#1)
with an average relative error of##2##6##(2008-10#1)(2013-8#1)
with an average relative##3##4##(2008-10#2)(2013-8#1)
with an average specific##3##4##(2008-11#2)(2008-6#1)
with an average value of##2##5##(1990-8#1)(2008-10#1)
with an average weight of##2##5##(2008-12#1)(2008-7#1)
with an average##88##3##(1990-12#1)(1990-5#1)(1990-7#4)(1990-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
with an earlier##5##3##(1991-5#1)(1995-3#1)(2008-1#1)(2008-10#1)(2013-8#1)
with an early##6##3##(1990-8#1)(1997-1#1)(2007-7#1)(2008-5#1)(2013-1#1)(2013-8#1)
with an eating disorder##2##4##(2011-2#2)
with an effective##6##3##(2007-11#2)(2008-10#2)(2008-3#1)(2011-1#1)
with an efficiency of##3##4##(2007-11#1)(2008-11#1)(2008-6#1)
with an efficiency that##2##4##(2008-10#1)(2009-5#1)
with an efficiency##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)
with an efficient##3##3##(1993-3#1)(2008-2#1)(2012-2#1)
with an elastic##3##3##(2008-11#1)(2010-4#1)(2011-2#1)
with an electro-optic modulator##2##4##(2008-3#2)
with an electro-optic##4##3##(2007-12#1)(2008-3#3)
with an electrochemical##2##3##(2008-10#1)(2008-6#1)
with an electron capture detector (GC-ECD)##2##6##(2008-10#2)
with an electron capture detector##3##5##(2008-10#3)
with an electron##6##3##(2008-10#5)(2008-7#1)
with an electronic##5##3##(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
with an elevated level of##2##5##(1990-5#1)(1993-9#1)
with an elevated risk of##2##5##(2009-10#1)(2012-2#1)
with an elevated##8##3##(1990-5#1)(1992-9#1)(1993-9#1)(2009-10#1)(2010-2#1)(2011-2#2)(2012-2#1)
with an emission##2##3##(2008-3#2)
with an emphasis on diabetes##2##5##(2013-8#2)
with an emphasis on the##4##5##(2007-12#1)(2010-9#1)(2012-2#2)
with an emphasis on##21##4##(1992-12#1)(2007-12#3)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
with an emphasis##24##3##(1992-1#1)(1992-12#1)(1996-6#1)(2006-10#1)(2007-12#3)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
with an energy of##2##4##(2007-11#1)(2012-2#1)
with an energy##3##3##(2007-11#1)(2012-2#2)
with an enhanced##2##3##(1992-3#1)(2011-2#1)
with an enzyme##5##3##(1992-12#1)(1993-6#2)(1995-2#1)(2008-10#1)
with an epifluorescence microscope##2##4##(1994-5#1)(2008-10#1)
with an equal number of##2##5##(1991-7#1)(2012-2#1)
with an equal##3##3##(1991-7#1)(1992-6#1)(2012-2#1)
with an equilibrium##3##3##(1994-5#1)(2008-10#2)
with an equivalent##3##3##(1991-2#1)(2008-2#1)(2008-3#1)
with an error of##3##4##(2008-10#2)(2008-2#1)
with an error##8##3##(2008-10#3)(2008-2#5)
with an established##4##3##(1992-9#1)(2008-3#1)(2010-6#1)(2011-2#1)
with an estimated detection##2##4##(2008-10#2)
with an estimated incidence##3##4##(2008-6#1)(2011-2#1)(2013-7#1)
with an estimated molecular weight of##3##6##(1993-11#1)(2008-10#1)(2009-9#1)
with an estimated molecular##4##4##(1993-11#1)(1995-2#1)(2008-10#1)(2009-9#1)
with an estimated prevalence of##2##5##(1996-2#1)(2008-11#1)
with an estimated##21##3##(1990-6#1)(1993-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-7#1)
with an estrogen receptor##2##4##(1991-2#1)(2013-1#1)
with an evaluation##2##3##(2008-10#1)(2012-1#1)
with an even##2##3##(2010-12#1)(2012-12#1)
with an exact ray trace##2##5##(2008-3#2)
with an exact##6##3##(2007-11#1)(2008-2#2)(2008-3#3)
with an excellent correlation##2##4##(2008-10#1)(2008-5#1)
with an excellent##12##3##(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#1)
with an excess of##5##4##(1990-12#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-11#1)
with an excess##6##3##(1990-12#1)(1996-5#1)(2008-10#1)(2008-8#2)(2009-11#1)
with an excitation wavelength of##3##5##(1997-2#1)(2008-10#2)
with an excitation wavelength##4##4##(1997-2#1)(2008-10#2)(2008-2#1)
with an excitation##5##3##(1997-2#1)(2008-10#3)(2008-2#1)
with an existing##2##3##(2008-2#2)
with an expanded##2##3##(2008-10#1)(2008-11#1)
with an expected##2##3##(1995-9#1)(2008-6#1)
with an experienced##2##3##(2008-11#1)(2011-2#1)
with an experimental painful peripheral neuropathy##2##6##(1996-5#2)
with an experimental##3##3##(1996-5#2)(2008-10#1)
with an extended##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
with an extensive##2##3##(2008-7#1)(2013-8#1)
with an external##3##3##(2007-12#2)(2008-10#1)
with an extra##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
with an extraction efficiency of##2##5##(2008-10#2)
with an extraction##4##3##(1991-8#1)(2008-10#3)
with an extreme##2##3##(2007-8#1)(2010-3#1)
with an extremely large##2##4##(2008-3#1)(2011-2#1)
with an extremely##9##3##(2006-12#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-4#1)(2011-2#2)(2013-1#1)
with an eye on##2##4##(2008-11#1)(2008-12#1)
with an eye toward##3##4##(1993-3#1)(1996-3#1)(2008-4#1)
with an eye##6##3##(1993-3#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-1#1)
with an i##2##3##(1994-2#1)(1995-5#1)
with an ideal##2##3##(2008-3#1)(2008-7#1)
with an identical##2##3##(2009-3#1)(2011-2#1)
with an imaging##4##3##(2007-11#2)(2008-3#1)(2008-7#1)
with an important##4##3##(1990-8#1)(1993-8#1)(1995-5#1)(2008-5#1)
with an improved safety profile##3##5##(2008-2#1)(2008-4#1)(2008-8#1)
with an improved##14##3##(1992-3#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)
with an improvement in##5##4##(1991-12#1)(1991-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
with an improvement##7##3##(1991-12#1)(1991-8#1)(2007-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
with an in situ##3##4##(2008-3#3)
with an in vitro##2##4##(1996-2#1)(2008-5#1)
with an in vivo##2##4##(1994-11#1)(1996-12#1)
with an in##7##3##(1994-11#1)(1996-12#1)(1996-2#1)(2008-3#3)(2008-5#1)
with an incidence of 0##2##5##(2013-1#2)
with an incidence of##6##4##(2007-5#1)(2007-8#1)(2010-10#1)(2013-1#3)
with an incidence##12##3##(1992-8#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#4)
with an incident##2##3##(2007-12#1)(2008-2#1)
with an increase in leaf##2##5##(2008-10#1)(2012-9#1)
with an increase in temperature##2##5##(1997-2#2)
with an increase in the maximum rate of resource##2##9##(2008-8#2)
with an increase in the ratio of##2##7##(2008-6#1)(2011-1#1)
with an increase in the##16##5##(1991-9#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
with an increase in##51##4##(1990-2#1)(1990-6#1)(1990-7#2)(1991-9#1)(1992-3#1)(1993-11#2)(1993-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#4)(2012-9#1)(2013-1#2)(2013-7#1)
with an increase of the##2##5##(2008-10#1)(2008-8#1)
with an increase of##7##4##(1990-8#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
with an increase##59##3##(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#2)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#4)(2012-9#1)(2013-1#3)(2013-7#1)
with an increased density##2##4##(2008-11#1)(2008-7#1)
with an increased production of##2##5##(2008-7#1)(2009-5#1)
with an increased rate of##3##5##(1997-6#1)(2008-10#1)(2012-12#1)
with an increased risk of##19##5##(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1997-3#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-3#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
with an increased risk##28##4##(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1997-3#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-3#3)(2009-10#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)
with an increased##59##3##(1990-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-3#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#6)(2013-7#1)
with an increasing number of##2##5##(1993-3#1)(2011-1#1)
with an increasing##6##3##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-1#1)
with an independent measure of##2##5##(1996-7#2)
with an independent##6##3##(1996-7#2)(2007-11#1)(2008-10#2)(2008-6#1)
with an index of refraction##2##5##(2008-3#2)
with an index##3##3##(2007-11#1)(2008-3#2)
with an indication##2##3##(2008-1#1)(2010-9#1)
with an inexpensive##2##3##(2007-11#1)(2008-10#1)
with an inflammatory##6##3##(1991-8#2)(2008-9#4)
with an infrared##2##3##(2008-3#1)(2008-7#1)
with an inhibitor of##2##4##(1992-3#1)(2012-2#1)
with an initial focus on##2##5##(2008-7#2)
with an initial##10##3##(1992-1#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-2#1)
with an injection##3##3##(1993-1#1)(1994-9#1)(2008-10#1)
with an inner##2##3##(2007-12#2)
with an insertion##2##3##(1993-6#1)(2013-1#1)
with an insight##2##3##(2008-7#1)(2010-8#1)
with an intact##3##3##(1993-11#1)(2008-9#1)(2009-12#1)
with an integrated##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
with an intensity of 1##2##5##(2007-12#1)(2008-3#1)
with an intensity##3##3##(2007-12#2)(2008-3#1)
with an intensity-recording device##2##4##(2008-3#2)
with an interaction length of 1##2##6##(2007-12#1)(2008-3#1)
with an intercalation binding mode##2##5##(1992-3#2)
with an interference##4##3##(1997-7#1)(2008-3#2)(2009-10#1)
with an intermediate##3##3##(2008-2#1)(2008-8#1)(2009-2#1)
with an internal diameter of##2##5##(2008-10#1)(2013-1#1)
with an internal##5##3##(1991-5#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
with an interval of##5##4##(1991-6#2)(1996-12#1)(1997-4#1)(2008-6#1)
with an intracavity##8##3##(2007-11#3)(2007-12#4)(2008-3#1)
with an inversion scheme##2##4##(2008-3#2)
with an inversion##3##3##(2008-2#1)(2008-3#2)
with an inverted repeat at the 5' and 3' ends and two open reading frames##2##15##(2008-10#2)
with an inverted##4##3##(2008-10#2)(2009-11#1)(2013-1#1)
with an ion##3##3##(2008-10#3)
with an isoelectric point##2##4##(1996-5#1)(2008-10#1)
with an isolated##8##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
with an iterative##4##3##(2008-3#3)(2010-10#1)
with an offset##2##3##(2008-3#2)
with an on-line sample##2##4##(2008-10#2)
with an on-line##4##3##(2008-10#3)(2010-5#1)
with an ongoing##2##3##(1993-3#1)(1994-12#1)
with an opaque##2##3##(2008-3#2)
with an open reading frame of##2##6##(1991-12#1)(1995-2#1)
with an open reading frame##6##5##(1991-12#2)(1995-2#1)(2008-7#3)
with an open technique##2##4##(2007-8#2)
with an open##13##3##(1991-12#2)(1991-6#1)(1995-2#1)(1996-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)
with an opening##2##3##(2008-3#1)(2008-9#1)
with an opportunity to##6##4##(1995-1#1)(1997-3#1)(2008-11#2)(2008-7#1)(2012-3#1)
with an optical fiber##2##4##(2008-10#1)(2008-3#1)
with an optical microscope##2##4##(2007-12#1)(2008-10#1)
with an optical ring##3##4##(2008-3#3)
with an optical slope efficiency of##2##6##(2008-2#2)
with an optical slope efficiency##3##5##(2007-12#1)(2008-2#2)
with an optical##24##3##(2007-12#4)(2008-10#3)(2008-2#5)(2008-3#11)(2008-4#1)
with an optically##3##3##(2008-10#1)(2008-3#2)
with an optimal##5##3##(1991-12#1)(1992-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
with an optimized##3##3##(1992-11#1)(2007-12#1)(2008-7#1)
with an optimum at##2##4##(2008-10#2)
with an optimum range##2##4##(2008-10#2)
with an optimum##11##3##(1993-6#1)(1994-8#1)(1996-3#1)(2007-11#1)(2008-10#6)(2008-3#1)
with an oral ED50 =##2##5##(1995-3#2)
with an oral##5##3##(1990-8#1)(1994-6#1)(1995-3#2)(2008-5#1)
with an order of potency##2##5##(1994-3#2)
with an organic solvent##2##4##(1992-3#1)(2008-10#1)
with an organic##6##3##(1992-3#1)(1994-9#1)(2008-10#3)(2008-2#1)
with an orientation##2##3##(1994-5#1)(2008-8#1)
with an outbreak of##2##4##(1997-4#1)(2012-2#1)
with an outbreak##3##3##(1997-4#1)(2012-12#1)(2012-2#1)
with an outer diameter of##3##5##(2008-2#1)(2008-8#1)(2012-2#1)
with an outer##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
with an outlier##2##3##(1993-12#1)(1993-3#1)
with an output power of 1 W##2##7##(2007-12#1)(2008-3#1)
with an output power of##6##5##(2007-11#2)(2007-12#2)(2008-3#2)
with an output##8##3##(2007-11#2)(2007-12#2)(2008-3#4)
with an overall incidence of 0##2##6##(2008-1#1)(2012-2#1)
with an overall incidence of##3##5##(2008-1#1)(2010-4#1)(2012-2#1)
with an overall response##2##4##(2008-10#1)(2008-3#1)
with an overall##19##3##(1992-10#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
with an overinstrumented apex##2##4##(2013-1#2)
with an overpotential##2##3##(2008-10#2)
with an overview of##2##4##(2008-4#1)(2008-5#1)
with an overview##3##3##(2008-4#1)(2008-5#2)
with an ultranarrow##2##3##(2007-12#1)(2008-2#1)
with an ultrashort##2##3##(2007-12#1)(2008-3#1)
with an ultrasonic##3##3##(1990-9#1)(2007-11#1)(2008-10#1)
with an ultraviolet##2##3##(2008-10#1)(2008-2#1)
with an uncertainty of##4##4##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
with an uncertainty##6##3##(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
with an uncoated##3##3##(2007-12#2)(2008-3#1)
with an underlying##7##3##(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
with an understanding of the##3##5##(1993-2#1)(2007-7#1)(2008-10#1)
with an uneventful##2##3##(2011-2#1)(2012-12#1)
with an unfavorable##2##3##(2010-5#1)(2011-2#1)
with an unknown##5##3##(2007-7#2)(2008-2#1)(2012-12#1)(2012-3#1)
with an unusual presentation##3##4##(1997-8#1)(2008-7#1)(2012-3#1)
with an unusual##7##3##(1990-6#1)(1992-9#1)(1993-8#1)(1997-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
with an unusually long##2##4##(1990-12#1)(1994-8#1)
with an upside-down tapered lens##2##5##(2008-3#2)
with an##1753##2##(1990-11#3)(1990-12#10)(1990-2#2)(1990-3#1)(1990-5#10)(1990-6#5)(1990-7#7)(1990-8#13)(1990-9#2)(1991-11#5)(1991-12#8)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#6)(1991-6#6)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#6)(1992-3#15)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#6)(1992-9#8)(1993-1#4)(1993-10#1)(1993-11#8)(1993-12#8)(1993-2#2)(1993-3#9)(1993-5#1)(1993-6#7)(1993-8#7)(1993-9#8)(1994-11#6)(1994-12#7)(1994-2#6)(1994-3#11)(1994-5#11)(1994-6#4)(1994-7#1)(1994-8#11)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#9)(1995-5#6)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#12)(1996-3#3)(1996-5#10)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#8)(1997-7#6)(1997-8#5)(2006-10#4)(2006-12#4)(2006-4#1)(2007-10#8)(2007-11#47)(2007-12#66)(2007-2#2)(2007-4#1)(2007-5#7)(2007-6#3)(2007-7#9)(2007-8#14)(2008-1#16)(2008-10#290)(2008-11#60)(2008-12#20)(2008-2#86)(2008-3#170)(2008-4#18)(2008-5#36)(2008-6#27)(2008-7#59)(2008-8#31)(2008-9#28)(2009-10#11)(2009-11#6)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#7)(2009-6#6)(2009-7#4)(2009-8#4)(2009-9#5)(2010-1#3)(2010-10#10)(2010-11#5)(2010-12#7)(2010-2#3)(2010-3#6)(2010-4#8)(2010-5#8)(2010-6#6)(2010-7#4)(2010-8#8)(2010-9#3)(2011-1#17)(2011-10#1)(2011-2#44)(2011-3#2)(2012-1#5)(2012-12#14)(2012-2#32)(2012-3#21)(2012-5#1)(2012-9#1)(2013-1#56)(2013-7#7)(2013-8#15)
with anabolic##2##2##(1991-3#2)
with analgesic##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
with analogous##5##2##(2008-10#2)(2008-3#1)(2010-5#1)(2011-1#1)
with analyses of##3##3##(1990-12#1)(1995-12#1)(1997-7#1)
with analyses##5##2##(1990-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
with analysis and##2##3##(2008-10#1)(2011-1#1)
with analysis by##2##3##(2008-10#2)
with analysis of the##2##4##(2008-8#1)(2010-12#1)
with analysis of##6##3##(1994-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
with analysis##13##2##(1994-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#2)(2012-2#1)
with analyte##3##2##(1997-2#1)(2008-10#2)
with analytical##11##2##(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)
with anaphylaxis##3##2##(2008-8#1)(2013-1#2)
with anatomic##2##2##(2008-1#1)(2011-7#1)
with ancillary##2##2##(1994-6#1)(2008-6#1)
with and without a family history of alcoholism##2##8##(1991-1#1)(1994-2#1)
with and without a family history of##3##7##(1991-1#1)(1994-2#1)(2008-3#1)
with and without a##13##4##(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-2#1)(2007-12#2)(2008-3#4)(2012-3#2)
with and without an##2##4##(2007-12#1)(2008-10#1)
with and without contrast##2##4##(2008-7#1)(2013-7#1)
with and without dementia in##3##5##(2008-7#2)(2012-3#1)
with and without dementia##4##4##(2008-7#3)(2012-3#1)
with and without half-visors##2##4##(2010-1#2)
with and without large-volume sample stacking##2##6##(2008-10#2)
with and without oesophageal varices##2##5##(2009-8#1)(2013-1#1)
with and without osteoporosis##3##4##(2010-3#3)
with and without previous##5##4##(1992-3#1)(2007-8#2)(2008-10#1)(2010-11#1)
with and without the addition of##2##6##(1995-2#1)(2008-10#1)
with and without the presence of##2##6##(1996-7#1)(2007-12#1)
with and without the##14##4##(1991-8#1)(1994-11#1)(1995-2#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-11#1)
with and without tobacco##2##4##(1992-8#1)(2013-1#1)
with and without##195##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#12)(2007-6#1)(2007-8#5)(2008-10#30)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#17)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#2)
with and##232##2##(1990-11#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#3)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#12)(2007-6#1)(2007-8#5)(2008-10#35)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#18)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#18)(2013-7#1)(2013-8#4)
with androgen##6##2##(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
with androgens##2##2##(1994-9#1)(2009-4#1)
with anemia##6##2##(1992-6#1)(2007-8#1)(2008-7#1)(2009-10#1)(2011-2#2)
with aneurysm##2##2##(1995-11#1)(2010-8#1)
with aneurysmal##3##2##(1995-11#1)(2013-1#2)
with aneurysms##5##2##(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
with angina pectoris##2##3##(1992-4#1)(2007-8#1)
with angina##6##2##(1992-4#1)(2007-8#4)(2008-3#1)
with angiogenesis and##2##3##(2010-6#1)(2010-8#1)
with angiogenesis##5##2##(1991-3#1)(1996-10#1)(2008-6#1)(2010-6#1)(2010-8#1)
with angiographically##4##2##(1990-8#1)(1994-11#1)(1996-8#1)(2008-12#1)
with angiography##2##2##(1993-6#1)(2011-2#1)
with angiotensin II##2##3##(1995-11#2)
with angiotensin##4##2##(1992-9#1)(1995-11#2)(1995-12#1)
with angle##3##2##(2008-2#2)(2008-3#1)
with angled##2##2##(2007-11#1)(2010-3#1)
with angular perturbations##2##3##(2013-1#2)
with angular##5##2##(2008-10#1)(2008-3#2)(2013-1#2)
with anhydrous##2##2##(2008-10#1)(2013-8#1)
with animal cells##2##3##(2008-11#2)
with animal models##3##3##(1992-1#1)(2008-7#1)(2011-2#1)
with animal##8##2##(1990-12#1)(1990-5#1)(1991-8#1)(1992-1#1)(2008-11#2)(2008-7#1)(2011-2#1)
with animals##5##2##(1995-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
with anion##2##2##(2008-10#2)
with anion-exchange##2##2##(2008-10#2)
with anionic sites##2##3##(2008-10#2)
with anionic##5##2##(2008-10#4)(2008-5#1)
with aniracetam (50 nmol/mouse)##2##4##(1995-12#2)
with ankylosing spondylitis (AS)##2##4##(2008-10#1)(2011-2#1)
with ankylosing spondylitis##3##3##(2008-10#1)(2011-2#2)
with ankylosing##4##2##(2008-10#2)(2011-2#2)
with anomalous##5##2##(2007-8#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
with anoplasty##2##2##(1990-3#2)
with anorectic##2##2##(1997-7#1)(2008-4#1)
with anorexia nervosa (AN)##2##4##(2007-7#2)
with anorexia nervosa##4##3##(1991-11#1)(2007-7#2)(2011-2#1)
with anorexia##7##2##(1991-11#1)(1996-6#1)(2007-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
with another DNA##2##3##(1993-12#1)(1994-8#1)
with another group of##2##4##(1992-12#1)(1997-4#1)
with another protein##2##3##(1997-4#1)(2008-4#1)
with another##39##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-4#3)(2008-6#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2012-3#1)(2013-1#1)
with antagonist##2##2##(2008-10#2)
with antagonistic activity##2##3##(1990-2#1)(2008-10#1)
with antagonists##2##2##(2008-10#2)
with anterior and posterior##2##4##(2007-11#1)(2012-3#1)
with anterior stabilization##2##3##(2007-11#2)
with anterior##7##2##(2007-11#3)(2007-8#1)(2008-7#1)(2012-12#1)(2012-3#1)
with anti##2##2##(1990-11#1)(2008-10#1)
with anti-A##4##2##(1992-12#1)(1995-12#3)
with anti-Fas antibody##2##3##(2008-8#2)
with anti-Hu##2##2##(1996-11#1)(2009-3#1)
with anti-IL-6##2##2##(2008-10#1)(2013-1#1)
with anti-Ro##2##2##(2008-7#2)
with anti-angiogenic therapies##2##3##(1997-1#1)(2013-8#1)
with anti-human##2##2##(1994-9#1)(1997-5#1)
with anti-phosphotyrosine##2##2##(1992-12#1)(1997-1#1)
with anti-psychotic##2##2##(2013-8#2)
with anti-tubercular chemotherapy##2##3##(2008-7#2)
with antibiotic therapy##2##3##(2008-12#1)(2012-12#1)
with antibiotic##6##2##(1991-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
with antibiotics alone##3##3##(1991-1#1)(2007-7#1)(2010-5#1)
with antibiotics and##3##3##(1996-11#2)(2007-12#1)
with antibiotics in##2##3##(1994-12#1)(2011-2#1)
with antibiotics##23##2##(1990-5#1)(1991-1#1)(1991-4#1)(1994-12#1)(1995-11#2)(1996-11#2)(1996-6#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
with antibodies against the##2##4##(1991-9#1)(1997-1#1)
with antibodies against##10##3##(1991-9#1)(1992-12#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
with antibodies and##2##3##(2008-10#1)(2008-9#1)
with antibodies directed against##2##4##(1994-8#1)(1997-3#1)
with antibodies specific for##3##4##(1993-6#1)(1995-12#1)(2008-7#1)
with antibodies specific##4##3##(1993-6#1)(1995-12#1)(2008-7#1)(2008-9#1)
with antibodies to the##2##4##(1993-12#1)(1996-6#1)
with antibodies to##12##3##(1990-8#1)(1990-9#1)(1992-12#2)(1992-9#1)(1993-12#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-5#1)(2008-7#1)
with antibodies##37##2##(1990-8#1)(1990-9#1)(1991-9#1)(1992-12#3)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#3)(2010-5#1)(2011-1#1)(2011-2#1)
with antibody against##3##3##(1991-5#2)(1993-11#1)
with antibody to##3##3##(1992-8#1)(1992-9#1)(2008-10#1)
with antibody##11##2##(1991-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(2008-10#2)(2008-12#1)
with anticancer##2##2##(1993-1#1)(2009-9#1)
with anticipated body image dissatisfaction##2##5##(2007-12#2)
with anticipated##4##2##(1996-12#1)(2007-12#2)(2007-9#1)
with anticipatory##2##2##(1992-12#1)(2007-2#1)
with anticoagulants##2##2##(2008-7#2)
with anticonvulsant##3##2##(1994-2#1)(1997-3#1)(2008-9#1)
with antidepressants##4##2##(1993-12#1)(1997-6#1)(2008-9#1)(2009-7#1)
with antiestrogen##3##2##(1991-9#1)(1992-5#2)
with antifungal agents##2##3##(2011-2#1)(2013-8#1)
with antifungal##6##2##(2007-12#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
with antigen##6##2##(1993-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-11#1)
with antigenic##2##2##(1994-11#1)(2012-3#1)
with antigens##2##2##(2008-10#1)(2008-4#1)
with antihypertensive drugs##6##3##(1990-9#1)(1992-2#1)(2008-3#2)(2008-7#1)(2010-5#1)
with antihypertensive##10##2##(1990-9#1)(1992-2#1)(2008-1#1)(2008-3#5)(2008-7#1)(2010-5#1)
with antimicrobial##3##2##(2008-5#1)(2010-4#1)(2012-3#1)
with antimicrobials##2##2##(2008-5#1)(2012-3#1)
with antimycin A##2##3##(1992-11#1)(2010-12#1)
with antineoplastic##2##2##(1991-6#1)(2012-3#1)
with antioxidant properties##2##3##(1994-9#1)(2009-8#1)
with antioxidant##4##2##(1991-9#1)(1994-9#1)(2008-5#1)(2009-8#1)
with antioxidants such as glutathione##2##5##(2008-5#2)
with antioxidants##4##2##(1991-9#1)(2008-1#1)(2008-5#2)
with antiphospholipid antibodies##2##3##(1992-5#1)(2011-1#1)
with antiphospholipid syndrome##2##3##(1997-8#1)(2012-3#1)
with antiphospholipid##4##2##(1992-5#1)(1997-8#1)(2011-1#1)(2012-3#1)
with antiplatelet drugs##3##3##(1990-11#1)(2008-5#1)(2008-8#1)
with antiplatelet##4##2##(1990-11#1)(2008-5#1)(2008-8#1)(2013-8#1)
with antiproliferative##2##2##(1995-2#2)
with antipsychotic##2##2##(1995-2#1)(2008-3#1)
with antiretroviral therapy##5##3##(2006-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)
with antiretroviral##6##2##(2006-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#2)
with antisense##2##2##(1991-9#1)(1996-12#1)
with antisera##2##2##(1994-6#1)(2008-10#1)
with antiserum##5##2##(1990-11#2)(1993-11#1)(1994-2#1)(1997-4#1)
with antisocial personality disorder##2##4##(1991-1#1)(2011-2#1)
with antisocial personality##3##3##(1991-1#1)(1994-2#1)(2011-2#1)
with antisocial##4##2##(1991-1#1)(1994-2#1)(2007-9#1)(2011-2#1)
with antituberculous therapy##2##3##(2007-12#1)(2008-1#1)
with antitumor##2##2##(1994-5#1)(2008-9#1)
with antiviral##2##2##(1997-4#1)(2009-8#1)
with ants##2##2##(2008-5#1)(2012-2#1)
with anxiety and##3##3##(1996-10#1)(2008-12#1)(2009-10#1)
with anxiety disorders##2##3##(2013-8#2)
with anxiety##9##2##(1991-12#1)(1994-3#1)(1996-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2013-1#1)(2013-8#2)
with any cancer diagnosed when younger than 45 years##2##9##(2010-3#2)
with any known##2##3##(2008-10#1)(2008-9#1)
with any of the other##2##5##(1990-5#1)(2008-10#1)
with any of the##14##4##(1990-5#1)(1992-9#1)(1994-11#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-12#1)(2008-7#1)(2012-3#1)
with any of##15##3##(1990-5#1)(1992-9#1)(1994-11#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-12#1)(2008-7#1)(2012-3#1)
with any other##9##3##(1993-11#2)(1994-3#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
with any##63##2##(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-6#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with aortic arch##3##3##(2007-8#2)(2008-8#1)
with aortic regurgitation##2##3##(1995-3#1)(2008-11#1)
with aortic stenosis##2##3##(2012-2#2)
with aortic##16##2##(1990-12#1)(1995-3#1)(2007-8#5)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#2)(2012-2#3)
with aphasia experience having conversations##2##5##(2012-3#2)
with aphasia##7##2##(2012-3#5)(2013-1#1)(2013-8#1)
with aphid##2##2##(2008-10#2)
with aplastic anaemia##2##3##(2012-2#2)
with apocrine changes##2##3##(1993-1#1)(2008-4#1)
with apocrine##4##2##(1993-1#2)(2008-12#1)(2008-4#1)
with apolipoprotein E##2##3##(1991-12#1)(1994-8#1)
with apolipoprotein##5##2##(1991-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(2013-1#1)
with apoptosis##5##2##(1994-10#1)(2008-10#1)(2008-9#2)(2009-9#1)
with apparent molecular masses##2##4##(1997-2#1)(2008-10#1)
with apparent molecular##4##3##(1990-5#1)(1996-12#1)(1997-2#1)(2008-10#1)
with apparent##13##2##(1990-12#1)(1990-5#1)(1992-4#1)(1993-8#2)(1994-6#2)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
with apparently##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
with apple##3##2##(2008-10#3)
with application in##2##3##(2008-10#1)(2008-3#1)
with application of##10##3##(1995-6#1)(2007-11#1)(2008-10#5)(2011-1#1)(2013-1#2)
with application to##8##3##(1992-6#1)(1993-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-11#1)
with application##21##2##(1992-6#1)(1993-12#1)(1995-6#1)(1997-4#1)(2007-11#2)(2008-10#7)(2008-3#3)(2009-11#1)(2011-1#1)(2013-1#3)
with applications in##5##3##(2008-11#1)(2008-3#2)(2009-11#1)(2010-11#1)
with applications to##4##3##(1997-8#1)(2008-10#1)(2008-3#1)(2010-6#1)
with applications##11##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-8#1)
with appropriate analytical##2##3##(2008-10#2)
with appropriate control##2##3##(2008-3#1)(2008-4#1)
with appropriate drugs##2##3##(2006-10#1)(2011-2#1)
with appropriate information##2##3##(1995-12#1)(2007-2#1)
with appropriate##41##2##(1990-12#1)(1990-3#1)(1993-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#7)(2008-4#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with approximately 25%##2##3##(2008-10#1)(2008-3#1)
with approximately 50%##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
with approximately equal##2##3##(1993-11#1)(2008-11#1)
with approximately##35##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#2)(1993-11#1)(1995-6#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-3#8)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
with aprepitant##2##2##(2008-7#2)
with aqua regia##2##3##(2008-10#2)
with aqueous acetonitrile##3##3##(2008-10#3)
with aqueous solutions##4##3##(2008-10#2)(2010-3#1)(2011-2#1)
with aqueous standards##5##3##(2008-10#5)
with aqueous##22##2##(1994-11#1)(1996-5#2)(2008-10#17)(2010-3#1)(2011-2#1)
with arachidonic acid##5##3##(1994-12#2)(1995-11#2)(2010-1#1)
with arbitrarily##3##2##(2007-11#2)(2009-5#1)
with arbitrary location and##2##4##(2008-2#1)(2008-3#1)
with arbitrary##16##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)(2008-6#1)(2011-1#1)
with area##2##2##(2010-10#1)(2012-3#1)
with arginine##2##2##(1996-2#1)(2008-9#1)
with arm cavities##2##3##(2008-2#2)
with arm##4##2##(2008-2#2)(2008-3#1)(2008-5#1)
with aromatic##4##2##(1994-8#1)(1996-5#1)(2008-10#2)
with arousal##2##2##(1993-5#1)(2008-11#1)
with arrhythmias##2##2##(1993-2#1)(1996-8#1)
with arsenic##2##2##(2008-10#2)
with arsenobetaine##2##2##(2008-10#2)
with arterial##2##2##(2008-7#1)(2013-8#1)
with arteriovenous fistulae##2##3##(1996-9#2)
with arteriovenous##7##2##(1996-6#1)(1996-9#2)(1997-6#1)(2007-7#1)(2008-7#1)(2012-3#1)
with arthritis##3##2##(2006-10#1)(2008-1#1)(2013-8#1)
with artificial neural##3##3##(2008-10#3)
with artificial##10##2##(1991-9#1)(1994-11#1)(1995-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
with aryl##2##2##(2008-7#1)(2009-5#1)
with as few as##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
with as little as##3##4##(1993-9#1)(2008-4#1)(2011-2#1)
with as many as##2##4##(1995-2#1)(2008-3#1)
with as many##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
with as much as 0##2##5##(2007-11#1)(2007-12#1)
with as much as##9##4##(1994-8#1)(2007-11#4)(2007-12#3)(2008-10#1)
with as##19##2##(1993-9#1)(1994-8#1)(1995-2#1)(2007-11#4)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
with asbestos##2##2##(1991-12#1)(1992-11#1)
with ascending tetraparesis##2##3##(2007-10#2)
with ascites and##3##3##(2007-12#1)(2008-10#2)
with ascites##11##2##(1991-4#2)(2007-12#4)(2008-10#2)(2011-2#2)(2013-8#1)
with ascorbic acid and##2##4##(2008-10#2)
with ascorbic acid##5##3##(1993-12#1)(2008-10#3)(2008-5#1)
with ascospores##2##2##(2008-10#2)
with aspartate in the##2##4##(1995-6#2)
with aspartate##4##2##(1992-6#1)(1995-6#3)
with aspect ratios##3##3##(1991-12#1)(2008-3#1)(2009-11#1)
with aspects of##2##3##(1990-10#1)(1992-2#1)
with aspects##3##2##(1990-10#1)(1992-2#1)(2008-5#1)
with aspiration##2##2##(1993-5#2)
with aspirin in##2##3##(2007-10#1)(2008-11#1)
with aspirin##9##2##(1993-11#1)(1996-11#1)(1997-6#1)(2007-10#2)(2008-11#2)(2008-3#1)(2013-8#1)
with assessment of##3##3##(1996-1#1)(2008-11#1)(2008-5#1)
with assessments##2##2##(2008-11#1)(2008-8#1)
with associated##16##2##(1991-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
with association##2##2##(1993-11#1)(2008-10#1)
with asthma and##6##3##(1996-7#1)(2011-2#1)(2012-12#3)(2013-1#1)
with asthma in##2##3##(1993-12#1)(2008-11#1)
with asthma##38##2##(1992-1#1)(1993-1#1)(1993-12#3)(1993-9#1)(1995-6#1)(1996-2#2)(1996-7#2)(2007-11#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#2)(2010-5#4)(2010-9#2)(2011-2#2)(2012-12#6)(2012-2#1)(2013-1#1)
with asymmetric##4##2##(1995-2#1)(1997-6#1)(2007-11#1)(2012-2#1)
with asymptomatic severe##2##3##(2008-8#1)(2011-2#1)
with asymptomatic##8##2##(1994-12#1)(1996-12#1)(1996-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-2#1)
with at least a##2##4##(1997-3#1)(2007-8#1)
with at least one##3##4##(1991-12#1)(2013-1#2)
with at least two##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
with at least##18##3##(1990-3#1)(1991-12#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#4)
with at##21##2##(1990-3#1)(1991-12#1)(1991-3#1)(1994-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#4)
with ataxia telangiectasia##2##3##(2008-7#2)
with ataxia##3##2##(2008-7#3)
with atherosclerosis##4##2##(1991-9#1)(2008-3#1)(2008-5#1)(2011-1#1)
with atherosclerotic##6##2##(1990-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
with atlantoaxial##3##2##(2008-12#2)(2012-12#1)
with atmospheric air##2##3##(2013-8#2)
with atmospheric##6##2##(1995-11#1)(2008-3#2)(2013-8#3)
with atomic absorption spectrometry##6##4##(2008-10#6)
with atomic absorption##9##3##(1992-3#1)(2008-10#8)
with atomic fluorescence spectrometry##2##4##(2008-10#2)
with atomic fluorescence##3##3##(2008-10#3)
with atomic force microscopy (AFM)##2##5##(2008-10#2)
with atomic force microscopy and##2##5##(2008-10#1)(2008-2#1)
with atomic force microscopy##5##4##(2008-10#3)(2008-2#1)(2009-9#1)
with atomic##23##2##(1992-3#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-2#1)(2008-7#1)(2009-9#1)
with atopic dermatitis (AD)##2##4##(2011-1#1)(2012-1#1)
with atopic dermatitis##7##3##(1992-9#1)(2007-11#1)(2011-1#2)(2012-1#2)(2013-1#1)
with atopic##9##2##(1992-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-1#2)(2013-1#1)
with atopy##2##2##(2007-7#1)(2008-1#1)
with atorvastatin 80 mg/day##2##4##(2008-5#2)
with atorvastatin 80##3##3##(2008-5#3)
with atorvastatin##9##2##(2008-5#4)(2011-1#5)
with atracurium##2##2##(2010-7#2)
with atraumatic##3##2##(1994-8#1)(1996-2#1)(2007-5#1)
with atrazine##3##2##(2013-1#3)
with atrial fibrillation##8##3##(1996-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
with atrial##9##2##(1996-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#2)
with atrioventricular##2##2##(2008-11#1)(2008-7#1)
with atrophy##3##2##(1997-1#1)(2007-7#1)(2009-9#1)
with atropine##4##2##(1994-8#1)(1997-7#1)(2008-7#1)(2008-8#1)
with attention deficit hyperactivity disorder##4##5##(2008-11#1)(2009-12#1)(2010-1#1)(2013-7#1)
with attention deficit##5##3##(2008-11#1)(2008-9#1)(2009-12#1)(2010-1#1)(2013-7#1)
with attention deficit/hyperactivity disorder##2##4##(1997-8#1)(2011-2#1)
with attention to##3##3##(1996-2#1)(2010-3#1)(2012-3#1)
with attention##12##2##(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
with attention-deficit/hyperactivity disorder (ADHD)##2##4##(2008-2#2)
with attention-deficit/hyperactivity disorder##5##3##(2008-2#4)(2011-2#1)
with attenuated##2##2##(2009-9#1)(2013-1#1)
with atypical##9##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)
with auditory##5##2##(1996-2#1)(2008-9#3)(2012-1#1)
with authentic##7##2##(1990-2#3)(1991-5#1)(1993-11#1)(1994-8#1)(2012-3#1)
with autism spectrum disorders##2##4##(2012-2#2)
with autism spectrum##4##3##(2012-2#2)(2013-1#2)
with autism##12##2##(1997-8#1)(2007-8#2)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
with autistic##4##2##(1997-8#1)(2012-1#1)(2012-2#2)
with autogenous##4##2##(2007-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
with autoimmune diseases##2##3##(2012-1#2)
with autoimmune hepatitis##4##3##(1996-11#1)(2006-10#1)(2011-1#2)
with autoimmune polyglandular syndrome type##2##5##(2012-3#1)(2013-1#1)
with autoimmune##14##2##(1990-3#1)(1994-3#1)(1996-11#1)(2006-10#2)(2008-10#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
with autologous##5##2##(1990-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2012-2#1)
with automated##8##2##(1993-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#2)
with automatic##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
with automation##5##2##(2008-10#5)
with autonomic dysfunction##2##3##(2008-12#2)
with autonomic nerve differentiation##2##4##(2009-7#2)
with autonomic##5##2##(1990-9#1)(2008-12#2)(2009-7#2)
with autoradiography##2##2##(1990-11#1)(1993-12#1)
with autoregressive##2##2##(1996-7#1)(2013-1#1)
with autosomal dominant polycystic kidney disease (ADPKD)##4##7##(1997-1#2)(2013-1#2)
with autosomal dominant polycystic kidney##5##5##(1997-1#2)(2013-1#3)
with autosomal dominant##8##3##(1997-1#2)(1997-5#1)(1997-8#1)(2008-7#1)(2013-1#3)
with autosomal##10##2##(1997-1#2)(1997-5#1)(1997-8#1)(2008-7#2)(2011-1#1)(2013-1#3)
with autosomal-dominant##2##2##(1997-5#2)
with available##13##2##(1992-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
with average output powers##2##4##(2007-11#1)(2007-12#1)
with average recovery##2##3##(2008-10#2)
with average##37##2##(1991-12#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-3#2)(1996-12#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#3)(2011-2#2)(2012-2#1)
with avian##5##2##(1997-3#1)(1997-6#1)(2008-5#2)(2009-5#1)
with axial symmetry##3##3##(1993-11#1)(2007-11#1)(2008-3#1)
with axial##9##2##(1993-11#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-3#3)(2008-7#1)(2010-3#1)
with axillary##3##2##(1993-8#1)(1995-4#1)(2008-10#1)
with axis##2##2##(1994-6#1)(2008-10#1)
with azide##2##2##(1993-11#1)(1994-5#1)
with azithromycin##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
with azobenzene##2##2##(2007-11#1)(2008-3#1)
with azomethine-H##2##2##(2008-10#2)
with azoxystrobin##2##2##(2008-10#2)
with azygos continuation##2##3##(2007-8#2)
with bFGF##5##2##(1990-12#1)(1994-11#1)(2008-11#2)(2008-5#1)
with bPL##2##2##(1995-11#2)
with back pain and##3##4##(2008-12#2)(2008-6#1)
with back pain##12##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-6#2)(2009-1#1)(2010-12#2)(2012-2#1)(2013-1#1)
with back propagation##3##3##(2008-10#1)(2010-8#2)
with back##16##2##(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#2)(2009-1#1)(2010-12#2)(2010-8#2)(2012-2#1)(2013-1#1)
with background##5##2##(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#1)
with bacteremia##4##2##(1990-3#1)(2007-12#1)(2008-7#1)(2013-1#1)
with bacteria##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
with bacterial components##3##3##(1996-12#2)(2008-11#1)
with bacterial culture##2##3##(2008-10#1)(2008-12#1)
with bacterial populations##2##3##(2008-10#2)
with bacterial##23##2##(1990-12#1)(1992-11#1)(1996-12#2)(1997-3#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
with bacteriorhodopsin##2##2##(2007-12#1)(2008-2#1)
with baculovirus##2##2##(2008-11#1)(2008-7#1)
with bad##4##2##(1992-9#1)(1995-8#1)(2007-7#1)(2011-3#1)
with balanced##3##2##(1995-12#2)(2008-3#1)
with balloon##4##2##(1991-3#1)(1994-11#1)(2008-11#1)(2008-3#1)
with band ligation##4##3##(2013-1#4)
with band##5##2##(1993-11#1)(2013-1#4)
with bands of##2##3##(2007-12#1)(2008-10#1)
with bands##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
with bare##7##2##(2008-10#4)(2008-11#1)(2008-12#1)(2009-11#1)
with barium##2##2##(2008-10#2)
with barley##2##2##(2008-10#1)(2008-8#1)
with basal##3##2##(2007-7#1)(2010-11#1)(2012-2#1)
with base##3##2##(1992-3#1)(1994-5#1)(1997-7#1)
with baseline peritoneal##2##3##(2011-2#2)
with baseline resolution##2##3##(2008-10#2)
with baseline##19##2##(1996-6#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#7)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#3)
with basic##7##2##(1990-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
with basilar artery##3##3##(2007-10#1)(2008-8#1)(2012-12#1)
with basilar##4##2##(2007-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
with bcl-2##2##2##(2008-11#2)
with bead injection##4##3##(2008-10#4)
with beam##3##2##(1995-9#1)(2007-11#1)(2008-3#1)
with behavior##3##2##(2008-11#1)(2009-9#1)(2011-1#1)
with behavioral disorders##2##3##(1990-11#1)(2010-5#1)
with behavioral##9##2##(1990-11#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
with behaviors that were##2##4##(2008-11#1)(2009-4#1)
with behavioural disturbances in##2##4##(2011-1#2)
with behavioural##3##2##(1992-9#1)(2011-1#2)
with being##7##2##(1996-5#1)(2009-9#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
with beneficial##2##2##(2008-10#1)(2012-1#1)
with benefit##2##2##(1996-12#1)(2008-3#1)
with benefits##3##2##(2008-10#2)(2012-3#1)
with benign endometrial tissue##2##4##(1995-3#2)
with benign prostatic##3##3##(1990-11#1)(1990-9#2)
with benign##26##2##(1990-11#1)(1990-9#4)(1991-8#1)(1992-5#1)(1992-9#3)(1993-5#1)(1994-8#1)(1994-9#2)(1995-3#2)(2007-5#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-4#1)(2011-1#1)(2013-1#2)(2013-7#1)
with benzene##3##2##(1993-11#1)(2008-10#2)
with benzo-18-crown-6##2##2##(2008-10#2)
with berry age##2##3##(2008-10#2)
with best##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)(2013-1#1)
with beta 2 and gamma 2L subunits##2##7##(1995-11#2)
with beta gamma##3##3##(1993-3#3)
with beta##10##2##(1990-5#1)(1993-3#3)(1993-8#1)(1995-11#2)(2008-10#1)(2008-2#1)(2013-1#1)
with beta-CD##10##2##(1994-3#1)(2008-10#5)(2008-11#1)(2008-6#3)
with beta-D-xyloside##2##2##(1990-5#2)
with beta-cyclodextrin (beta-CD)##5##3##(2008-10#5)
with beta-cyclodextrin##12##2##(2007-11#1)(2008-10#11)
with betahistine##2##2##(2008-2#2)
with better adherence##2##3##(2008-11#1)(2009-7#1)
with better prognosis##5##3##(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#2)
with better surgical##2##3##(1995-8#1)(2011-3#1)
with better than##2##3##(2007-11#1)(2008-3#1)
with better##37##2##(1993-1#1)(1995-8#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
with bevacizumab and##2##3##(2008-7#2)
with bias current modulation##2##4##(2007-12#2)
with biased##2##2##(1997-6#1)(2008-9#1)
with bicarbonate##2##2##(1990-11#1)(2008-11#1)
with big##2##2##(2009-8#1)(2011-2#1)
with bilateral adnexectomy##2##3##(1994-7#1)(2008-10#1)
with bilateral breast##2##3##(1992-2#1)(1995-4#1)
with bilateral disease##2##3##(2012-2#2)
with bilateral horizontal##2##3##(2007-10#1)(2011-1#1)
with bilateral multiple##2##3##(2007-10#1)(2007-5#1)
with bilateral##44##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-7#1)(1995-3#1)(1995-4#1)(1997-6#1)(2007-10#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-2#4)(2013-1#5)(2013-8#1)
with bilayers##3##2##(2008-10#3)
with bile##2##2##(1990-8#2)
with biliary##3##2##(1994-6#1)(2012-2#1)(2013-1#1)
with binary##5##2##(2007-12#3)(2008-10#1)(2008-2#1)
with binding sites##2##3##(2008-10#1)(2008-11#1)
with binding##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
with binge##2##2##(2008-4#1)(2009-5#1)
with bioactivity##2##2##(2008-10#1)(2008-11#1)
with biochemical and##2##3##(1990-9#1)(2013-1#1)
with biochemical##3##2##(1990-9#1)(1993-11#1)(2013-1#1)
with biocontrol agents##2##3##(2008-10#2)
with biodegradable##3##2##(2007-12#1)(2007-8#1)(2010-5#1)
with biological activity##2##3##(2007-2#1)(2008-7#1)
with biological control##3##3##(2008-10#3)
with biological data##2##3##(2008-10#1)(2011-2#1)
with biological##14##2##(1997-6#1)(2006-12#1)(2007-2#1)(2008-10#5)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#1)
with biomass##2##2##(2008-10#1)(2008-6#1)
with biomechanical##2##2##(2008-12#1)(2009-7#1)
with biomolecules##2##2##(2008-10#1)(2008-7#1)
with biopolymer##2##2##(2008-10#2)
with biopsies##2##2##(1992-3#1)(2013-8#1)
with biopsy##11##2##(1990-11#1)(1991-6#1)(1997-8#1)(2008-1#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
with biosynthetic##2##2##(1995-12#1)(2008-5#1)
with biotic##2##2##(2008-10#1)(2008-8#1)
with biotin##2##2##(1992-6#1)(2008-4#1)
with biotinylated protein##2##3##(1990-12#2)
with biotinylated##4##2##(1990-12#2)(1992-11#1)(1993-6#1)
with biphasic##2##2##(2008-10#1)(2012-1#1)
with bipolar coagulation##2##3##(1995-3#1)(2006-12#1)
with bipolar disorder##14##3##(2008-6#1)(2008-8#1)(2009-11#3)(2009-3#1)(2012-12#1)(2012-3#3)(2013-8#4)
with bipolar##21##2##(1995-11#1)(1995-3#1)(1996-7#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-11#3)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-8#4)
with birefringent##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with birth weights##2##3##(2008-11#2)
with birth##3##2##(2008-11#2)(2012-3#1)
with birthing##2##2##(1996-12#1)(2009-6#1)
with bis(2##2##2##(1990-8#1)(2008-10#1)
with bismuth film##2##3##(2008-10#2)
with bismuth##5##2##(2008-10#4)(2010-11#1)
with bisphosphonate therapy##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
with bisphosphonate##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2012-12#1)
with bisphosphonates##6##2##(2007-11#1)(2008-8#1)(2010-1#1)(2010-3#2)(2010-4#1)
with black and##2##3##(2011-2#2)
with black##5##2##(2011-2#3)(2013-7#2)
with bladder exstrophy##4##3##(2008-10#4)
with bladder##9##2##(1995-2#1)(2007-9#1)(2008-10#6)(2013-1#1)
with bleeding##13##2##(1991-9#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-1#4)(2012-2#1)(2013-1#3)
with blight##2##2##(2008-10#2)
with blocked##2##2##(2008-10#1)(2012-12#1)
with blocking##2##2##(2007-11#1)(2008-11#1)
with blood##16##2##(1992-6#1)(1993-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2009-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
with blue##3##2##(1990-12#1)(2008-3#1)(2013-1#1)
with body composition##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
with body mass index##2##4##(2011-1#1)(2011-2#1)
with body mass##4##3##(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
with body shape##4##3##(2007-7#4)
with body size##3##3##(2007-12#1)(2008-8#1)(2009-8#1)
with body weight##2##3##(2007-7#1)(2008-7#1)
with body##21##2##(1994-8#1)(2007-12#3)(2007-7#6)(2008-1#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
with boiling##2##2##(2007-11#1)(2008-10#1)
with bolus##2##2##(1996-11#1)(2011-2#1)
with bone cement##2##3##(2007-11#1)(2007-8#1)
with bone grafting##2##3##(1996-3#1)(2011-2#1)
with bone loss##2##3##(2010-5#1)(2011-1#1)
with bone marrow fibrosis##2##4##(2009-8#2)
with bone marrow##9##3##(1992-2#1)(2006-10#1)(2009-8#2)(2010-11#1)(2010-6#1)(2012-12#1)(2013-1#2)
with bone metastases from solid##2##5##(2008-7#1)(2013-7#1)
with bone metastases from##6##4##(2008-10#1)(2008-7#4)(2013-7#1)
with bone metastases##21##3##(1990-2#1)(1994-7#1)(2007-11#8)(2008-10#2)(2008-7#5)(2011-2#3)(2013-7#1)
with bone metastasis##2##3##(1990-2#1)(1994-12#1)
with bone mineral##2##3##(2008-1#1)(2008-4#1)
with bone tumors##2##3##(2011-1#2)
with bone##60##2##(1990-2#2)(1991-11#1)(1991-5#1)(1992-2#1)(1994-12#1)(1994-7#1)(1996-3#2)(1997-8#1)(2006-10#1)(2007-11#11)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#5)(2009-8#2)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
with bony##4##2##(2007-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
with bootstrap##2##2##(2008-10#2)
with borate##2##2##(2008-10#2)
with borderline##5##2##(1992-1#1)(1993-12#1)(2007-7#1)(2008-1#1)(2009-9#1)
with boron##3##2##(1994-3#1)(2008-10#1)(2009-5#1)
with bortezomib##2##2##(2011-2#1)(2012-2#1)
with botanical##2##2##(2008-12#1)(2013-8#1)
with both a##6##3##(1997-8#1)(2008-10#1)(2008-3#3)(2012-12#1)
with both benign and##2##4##(2007-5#1)(2012-2#1)
with both clinical##2##3##(1997-1#1)(2013-8#1)
with both conventional##2##3##(2008-10#1)(2008-3#1)
with both devices##2##3##(2008-3#1)(2008-5#1)
with both fluoroionophores##2##3##(2008-10#2)
with both in vitro##2##4##(1991-11#1)(2011-1#1)
with both lasers##2##3##(1992-9#1)(2008-3#1)
with both methods##4##3##(1990-12#1)(1990-8#1)(2008-10#2)
with both microsatellite markers##2##4##(1994-6#2)
with both of these##4##4##(1993-6#1)(1997-2#1)(2007-5#1)(2008-11#1)
with both of##5##3##(1993-6#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-11#1)
with both parents##2##3##(2011-2#1)(2013-1#1)
with both pathogens##2##3##(2008-10#2)
with both sexual and asexual reproduction##2##6##(2008-10#2)
with both simulated and##2##4##(2008-3#2)
with both surgery and##2##4##(1992-2#1)(2012-1#1)
with both techniques##3##3##(1997-8#1)(2008-10#1)(2012-12#1)
with both the##30##3##(1990-7#1)(1990-8#1)(1991-10#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-7#1)(2012-3#1)(2013-8#1)
with both type 1 and type 2 diabetes##3##8##(2008-1#1)(2008-8#1)(2013-1#1)
with both type 1##4##4##(2008-1#1)(2008-8#1)(2009-11#1)(2013-1#1)
with both types of##4##4##(2008-10#3)(2011-2#1)
with both viruses##5##3##(1995-12#1)(2008-10#4)
with both##260##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#3)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-6#2)(1997-8#2)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#57)(2008-11#16)(2008-12#4)(2008-2#2)(2008-3#17)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
with both)##2##2##(2008-6#2)
with bottom##2##2##(2008-10#1)(2011-2#1)
with bound##3##2##(1991-12#1)(2008-2#1)(2010-4#1)
with bovine serum albumin (BSA)##8##5##(2008-10#6)(2008-11#1)(2009-9#1)
with bovine serum albumin##11##4##(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2009-9#1)
with bovine##19##2##(1990-8#1)(1991-12#1)(1994-5#1)(1994-9#1)(1997-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
with bradykinin##3##2##(1991-12#3)
with brain damage##2##3##(1995-8#1)(2007-10#1)
with brain lesions##2##3##(1991-2#1)(1994-3#1)
with brain metastases##2##3##(1991-2#1)(2010-8#1)
with brain##18##2##(1991-12#1)(1991-2#3)(1994-3#1)(1995-11#1)(1995-8#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-3#1)
with breast cancer and primary biliary cirrhosis##2##7##(1992-12#2)
with breast cancer and their##3##5##(1994-3#1)(1996-3#1)(2013-1#1)
with breast cancer and with unknown primary site of cancer##2##10##(2007-11#2)
with breast cancer and##15##4##(1990-12#1)(1990-2#1)(1992-12#2)(1992-2#1)(1993-11#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-11#4)(2008-7#1)(2013-1#1)
with breast cancer treated with adjuvant##2##6##(2008-7#1)(2013-1#1)
with breast cancer who##3##4##(2012-3#1)(2013-1#2)
with breast cancer##59##3##(1990-12#2)(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#2)(1992-2#3)(1993-1#1)(1993-11#4)(1994-12#3)(1994-3#2)(1995-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#4)(2008-10#2)(2008-4#2)(2008-7#7)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#11)
with breast carcinoma##2##3##(1991-4#1)(1993-2#1)
with breast or prostate cancer##2##5##(2008-7#2)
with breast##73##2##(1990-12#2)(1990-2#1)(1990-8#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#3)(1993-1#1)(1993-11#5)(1993-2#1)(1994-12#3)(1994-3#2)(1995-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(1997-8#3)(2007-10#1)(2007-11#6)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#11)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#12)
with breathing##2##2##(2008-7#1)(2012-2#1)
with brefeldin A##3##3##(1990-7#1)(1997-7#1)(2009-8#1)
with brief##6##2##(1991-2#1)(2008-11#1)(2012-12#3)(2012-3#1)
with broad##8##2##(1990-12#1)(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-5#1)(2012-2#1)
with broadband##4##2##(2007-11#2)(2008-3#2)
with broccoli##2##2##(2008-10#2)
with bromate##2##2##(2008-10#2)
with bromide##2##2##(2008-10#2)
with bromine in CCl(4)##2##4##(1996-5#2)
with bromine in##3##3##(1996-5#2)(2008-10#1)
with bromine##7##2##(1996-5#2)(2008-10#5)
with bromobenzene##4##2##(1992-3#4)
with bromocresol green##2##3##(2008-10#2)
with bromocriptine##3##2##(1991-1#1)(1993-2#1)(2013-8#1)
with bromodeoxyuridine##2##2##(1993-11#1)(1997-8#1)
with bronchial obstruction##2##3##(2008-7#1)(2013-1#1)
with bronchial##6##2##(1992-9#2)(1996-9#1)(2008-7#1)(2013-1#2)
with bronchogenic carcinoma##2##3##(2007-7#1)(2010-5#1)
with buccal##2##2##(2010-3#1)(2013-1#1)
with buffer containing##2##3##(1990-12#1)(1993-11#1)
with buffer##6##2##(1990-12#1)(1990-8#1)(1993-11#1)(1993-5#1)(2007-12#1)(2008-4#1)
with buffered saline##2##3##(1994-11#2)
with built-in##2##2##(2010-4#2)
with bulimia##3##2##(1991-1#1)(1997-7#1)(2007-7#1)
with bulk##2##2##(2008-2#1)(2008-7#1)
with bulky cations##2##3##(2008-10#2)
with bullying##2##2##(2008-11#1)(2009-7#1)
with bupropion##2##2##(2008-6#1)(2013-8#1)
with burns##2##2##(2008-12#1)(2008-5#1)
with business##2##2##(1994-2#1)(1997-2#1)
with butterfly##2##2##(2012-3#1)(2013-1#1)
with butyrate##2##2##(1993-6#1)(2008-11#1)
with by##4##2##(1996-2#1)(1996-6#1)(2008-3#1)(2008-5#1)
with c-myc##4##2##(1991-4#2)(1992-8#1)(1997-7#1)
with cAMP##3##2##(1990-5#1)(1991-3#1)(1992-6#1)
with cDNA##5##2##(1990-12#1)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
with ca##2##2##(2008-10#1)(2009-9#1)
with cabergoline##3##2##(2008-7#2)(2011-1#1)
with cadmium##5##2##(1992-12#1)(1995-5#1)(2007-11#1)(2008-10#2)
with caffeine##5##2##(1995-8#3)(1996-5#1)(2008-8#1)
with calcein##2##2##(2008-10#2)
with calcific aortic stenosis##2##4##(2007-8#1)(2008-5#1)
with calcification##4##2##(1990-6#1)(2008-7#1)(2012-3#2)
with calcifications##3##2##(1997-8#2)(2011-2#1)
with calcitonin##2##2##(1992-6#1)(2007-8#1)
with calcium dobesilate##2##3##(1990-3#2)
with calcium ionophore##2##3##(1995-11#2)
with calcium##18##2##(1990-3#2)(1990-7#1)(1992-5#1)(1995-11#2)(1995-12#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-1#1)
with calcium-channel blockers##2##3##(1992-12#1)(2008-11#1)
with calculated##10##2##(1993-8#1)(1993-9#1)(1996-2#1)(2008-2#5)(2008-8#1)(2013-8#1)
with calculations##6##2##(2007-12#1)(2008-3#5)
with calibrated##2##2##(2008-3#2)
with calibration##5##2##(1991-1#1)(2008-10#3)(2008-5#1)
with calmodulin##5##2##(1993-6#4)(1994-3#1)
with cancer and##11##3##(1992-12#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-7#3)(2008-8#1)(2012-12#1)(2012-2#1)
with cancer have##2##3##(2008-11#1)(2008-7#1)
with cancer in##2##3##(1992-8#1)(2011-2#1)
with cancer of the##23##4##(1990-9#3)(1991-2#2)(1991-8#1)(1992-11#1)(2008-7#15)(2012-3#1)
with cancer of##24##3##(1990-9#3)(1991-12#1)(1991-2#2)(1991-8#1)(1992-11#1)(2008-7#15)(2012-3#1)
with cancer patients##2##3##(1993-3#1)(2008-10#1)
with cancer who##4##3##(2008-7#3)(2008-8#1)
with cancer##140##2##(1990-6#1)(1990-9#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-1#2)(1993-3#3)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-9#2)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#53)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#9)(2010-4#1)(2010-7#2)(2010-9#5)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#1)
with cancer-related##2##2##(2008-11#1)(2008-7#1)
with cancer]##2##2##(1996-9#1)(2012-3#1)
with canonical##2##2##(2008-10#1)(2013-1#1)
with canopy size##2##3##(2008-10#2)
with capecitabine in##2##3##(2009-5#1)(2013-1#1)
with capecitabine##3##2##(2009-5#1)(2013-1#2)
with capillary electrophoresis##6##3##(2008-10#6)
with capillary gas chromatography##3##4##(1994-9#2)(2008-10#1)
with capillary isotachophoresis##2##3##(2008-10#2)
with capillary zone electrophoresis##2##4##(1990-8#1)(2008-10#1)
with capillary##13##2##(1990-8#1)(1994-9#2)(2008-10#10)
with capsaicin##4##2##(1992-6#1)(2008-11#2)(2012-3#1)
with capsular##2##2##(1990-5#1)(2007-10#1)
with captopril##4##2##(1990-11#1)(1992-12#1)(1994-5#1)(1995-8#1)
with carbohydrate##2##2##(1990-2#1)(2011-2#1)
with carbon dioxide##2##3##(1996-12#1)(2008-10#1)
with carbon nanotubes##5##3##(2007-11#1)(2008-10#1)(2008-7#2)(2010-2#1)
with carbon##16##2##(1992-6#1)(1994-11#1)(1996-12#2)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#2)(2010-2#1)
with carbon-13##3##2##(2008-10#3)
with carbonyl##2##2##(2007-11#1)(2008-10#1)
with carboplatin##2##2##(1995-9#1)(2009-8#1)
with carboxylate##3##2##(1993-6#2)(2012-12#1)
with carboxylic ligands##3##3##(2008-10#3)
with carboxylic##5##2##(2008-10#5)
with carcinoma of the gallbladder##2##5##(2009-3#1)(2010-12#1)
with carcinoma of the##4##4##(1994-3#2)(2009-3#1)(2010-12#1)
with carcinoma##8##2##(1992-5#2)(1994-3#2)(1995-8#1)(2009-3#1)(2010-12#1)(2013-1#1)
with cardiac index (r =##2##5##(1991-3#2)
with cardiac injuries##3##3##(2007-8#2)(2008-1#1)
with cardiac magnetic resonance imaging##3##5##(2008-3#2)(2013-3#1)
with cardiac magnetic resonance##4##4##(2008-3#3)(2013-3#1)
with cardiac troponin##2##3##(1991-12#1)(2011-2#1)
with cardiac##29##2##(1990-12#1)(1991-12#1)(1991-3#2)(1994-3#1)(1995-11#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#5)(2008-6#1)(2010-10#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-3#1)
with cardiogenic shock##3##3##(1997-5#1)(2008-11#1)(2009-4#1)
with cardiopulmonary bypass##3##3##(2007-8#2)(2007-9#1)
with cardiopulmonary##4##2##(2007-8#2)(2007-9#1)(2013-1#1)
with cardiovascular disease (CVD)##2##4##(2008-3#2)
with cardiovascular disease##9##3##(1993-12#1)(2008-1#1)(2008-3#2)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
with cardiovascular diseases##2##3##(2011-1#1)(2012-12#1)
with cardiovascular risk##3##3##(2008-11#1)(2013-1#1)(2013-8#1)
with cardiovascular##28##2##(1993-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
with care of the##2##4##(2008-11#1)(2013-1#1)
with care provided in##2##4##(1996-2#1)(1997-1#1)
with care##13##2##(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#3)(2008-11#2)(2008-5#1)(2008-6#1)(2013-1#1)
with careful planning##2##3##(1992-3#1)(2007-8#1)
with careful##8##2##(1991-3#1)(1992-3#1)(1995-3#1)(2007-8#2)(2010-1#1)(2012-12#1)(2013-8#1)
with carefully##2##2##(2008-1#1)(2008-11#1)
with carotid endarterectomy##2##3##(2007-10#1)(2008-11#1)
with carotid stenosis##2##3##(1991-11#1)(2007-10#1)
with carotid##6##2##(1991-11#1)(1991-12#1)(2007-10#2)(2008-1#1)(2008-11#1)
with carpal tunnel syndrome##2##4##(2007-8#1)(2008-9#1)
with carpal tunnel##3##3##(2007-8#1)(2008-9#2)
with carpal##4##2##(2007-8#1)(2008-9#3)
with carrier##2##2##(2008-11#1)(2008-7#1)
with cartilage##5##2##(2008-9#1)(2009-1#1)(2010-10#1)(2010-8#1)(2012-1#1)
with carvacrol##2##2##(2008-11#2)
with case##2##2##(1993-12#1)(2011-2#1)
with cases##3##2##(1990-5#1)(2012-12#1)(2012-2#1)
with castor bean##2##3##(2008-6#1)(2013-8#1)
with catalase##2##2##(1997-4#1)(2008-10#1)
with catalytic##10##2##(1990-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-2#1)
with cataract##3##2##(1997-3#1)(2008-3#1)(2013-1#1)
with catechol##4##2##(2008-10#4)
with catecholamines##2##2##(2007-9#1)(2008-10#1)
with cathepsin##2##2##(1992-5#1)(1995-2#1)
with catheter##3##2##(1995-11#1)(2008-7#1)(2010-12#1)
with cathodic##2##2##(2008-10#2)
with cation##2##2##(2008-10#2)
with cationic slopes of##2##4##(2008-10#2)
with cationic##7##2##(1994-5#1)(1995-2#1)(2008-10#4)(2011-2#1)
with caution in##2##3##(1990-5#1)(2008-2#1)
with caveolin##3##2##(1995-6#3)
with cefazolin##2##2##(2011-2#2)
with cefotetan##2##2##(1994-6#2)
with celiac disease##3##3##(2007-5#1)(2012-12#1)(2013-8#1)
with cell cycle##4##3##(1992-10#1)(1995-9#1)(1997-7#1)(2013-1#1)
with cell membranes##3##3##(1990-8#1)(2008-11#2)
with cell survival##2##3##(2008-7#1)(2010-8#1)
with cell wall##4##3##(2008-10#2)(2008-5#1)(2012-1#1)
with cell##32##2##(1990-8#1)(1992-10#1)(1994-11#1)(1994-6#1)(1995-9#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-8#1)(2012-1#1)(2013-1#2)
with cell-free##2##2##(1991-9#1)(1992-11#1)
with cells cultured##2##3##(2008-11#1)(2012-1#1)
with cells of##2##3##(2007-12#1)(2008-5#1)
with cells##16##2##(1992-6#1)(1993-6#1)(1997-7#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-1#1)(2012-12#1)
with cellular##8##2##(1994-11#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-3#1)
with cellulite##2##2##(2008-5#2)
with cement##3##2##(1997-6#1)(2007-11#2)
with cemented acetabular##2##3##(2008-11#1)(2008-8#1)
with cemented##3##2##(2008-11#2)(2008-8#1)
with central and##2##3##(2010-11#1)(2010-8#1)
with central auditory disorders##2##4##(2008-9#2)
with central venous##2##3##(2008-7#2)
with central##14##2##(1994-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)
with cephalosporin##6##2##(1994-6#1)(2011-1#1)(2011-2#4)
with cerebellar##3##2##(1995-6#1)(2008-7#2)
with cerebral infarction##2##3##(1990-3#1)(1994-9#1)
with cerebral palsy (CP)##3##4##(2009-4#1)(2011-2#2)
with cerebral palsy##8##3##(2007-11#1)(2009-3#2)(2009-4#1)(2011-2#3)(2012-12#1)
with cerebral sequelae##2##3##(1990-12#2)
with cerebral##22##2##(1990-12#2)(1990-3#1)(1994-9#1)(1997-8#1)(2007-10#3)(2007-11#1)(2008-7#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
with cerebroside B##2##3##(2008-10#2)
with cerebrospinal fluid (CSF)##2##4##(2006-12#1)(2008-7#1)
with cerebrospinal fluid##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
with cerebrovascular##7##2##(1990-6#1)(1991-11#1)(1996-11#1)(2007-10#2)(2008-7#1)(2011-1#1)
with cerium##2##2##(2008-10#2)
with cerium(IV) in sulfuric acid media##2##6##(2008-10#2)
with cerium(IV) in sulfuric acid##3##5##(2008-10#3)
with cerium(IV) in##4##3##(2008-10#4)
with cerium(IV)##6##2##(2008-10#6)
with certain types of##2##4##(2008-11#1)(2011-2#1)
with certain##28##2##(1990-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
with certainty##2##2##(1991-11#1)(1996-12#1)
with certificated seeds of improved varieties##2##6##(2008-12#2)
with certified values at##2##4##(2008-10#2)
with certified values of standard reference materials##3##7##(2008-10#3)
with certified values##16##3##(2008-10#16)
with certified##20##2##(2008-10#20)
with cervical intraepithelial neoplasia (CIN)##2##5##(1991-2#1)(2011-2#1)
with cervical intraepithelial neoplasia##4##4##(1991-2#1)(2011-2#3)
with cervical##19##2##(1991-2#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)
with cervicogenic headache##4##3##(2008-12#4)
with cesarean##2##2##(2007-2#1)(2011-2#1)
with cesium##2##2##(2007-12#1)(2008-10#1)
with cessation##5##2##(1997-4#1)(2010-2#2)(2013-1#2)
with cetuximab##4##2##(2008-7#1)(2009-5#1)(2011-2#2)
with challenges##3##2##(2009-11#1)(2012-1#1)(2013-1#1)
with challenging##2##2##(2008-3#1)(2011-1#1)
with change in 4 &quot##2##5##(1991-8#2)
with change in##4##3##(1991-8#2)(2011-1#1)(2012-12#1)
with change of##3##3##(1993-12#1)(2007-11#2)
with change##8##2##(1991-8#2)(1993-12#1)(2007-11#2)(2008-9#1)(2011-1#1)(2012-12#1)
with changed##2##2##(1992-3#1)(1995-5#1)
with changes from##2##3##(1995-11#1)(1997-7#1)
with changes in the##7##4##(1993-5#1)(1994-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
with changes in##27##3##(1990-2#1)(1991-12#1)(1993-5#1)(1994-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
with changes##32##2##(1990-2#1)(1991-12#1)(1993-5#1)(1994-3#1)(1994-7#1)(1995-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-11#1)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
with changing##4##2##(1993-3#1)(1996-2#1)(1997-3#1)(2007-12#1)
with characteristic##10##2##(1992-12#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)
with characteristics of a##2##4##(1992-6#1)(2008-2#1)
with characteristics of##7##3##(1992-6#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2013-7#1)(2013-8#1)
with characteristics that##2##3##(2008-10#1)(2008-5#1)
with characteristics typical of##2##4##(1990-5#1)(1995-8#1)
with characteristics##13##2##(1990-5#1)(1992-6#1)(1994-2#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#2)(2013-1#1)(2013-7#1)(2013-8#1)
with cheap and##2##3##(2008-10#2)
with chemical sensors##2##3##(2008-10#2)
with chemical##20##2##(1991-3#1)(1992-6#1)(2008-10#7)(2008-3#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-10#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
with chemically##5##2##(2008-10#1)(2008-5#2)(2009-8#1)(2013-1#1)
with chemicals##2##2##(1994-3#1)(2008-10#1)
with chemiluminescence (CL) detection##3##4##(1995-3#1)(2008-10#2)
with chemiluminescence (CL)##4##3##(1995-3#1)(2008-10#3)
with chemiluminescence detection is##2##4##(2008-10#2)
with chemiluminescence detection##12##3##(1990-8#1)(2008-10#11)
with chemiluminescence##17##2##(1990-8#1)(1995-3#1)(2008-10#15)
with chemiluminescent##2##2##(1992-9#1)(2008-10#1)
with chemometric##4##2##(2008-10#3)(2013-8#1)
with chemotactic responsiveness to##2##4##(1994-6#2)
with chemotactic##3##2##(1994-6#2)(1996-2#1)
with chemotherapeutic##2##2##(1997-1#1)(2010-11#1)
with chemotherapy and##3##3##(1992-8#1)(1993-2#1)(2011-2#1)
with chemotherapy for##3##3##(1991-2#1)(2008-6#1)(2010-3#1)
with chemotherapy in##3##3##(2010-8#1)(2012-2#1)(2012-3#1)
with chemotherapy only##2##3##(1992-2#1)(2011-2#1)
with chemotherapy##31##2##(1990-10#1)(1991-2#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(2008-10#1)(2008-6#3)(2008-7#5)(2009-8#1)(2010-3#3)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
with chest pain and##4##4##(2007-8#1)(2008-3#2)(2010-10#1)
with chest pain in##3##4##(1991-3#1)(2008-3#2)
with chest pain##18##3##(1991-3#1)(1992-6#1)(2007-8#1)(2008-3#10)(2010-10#1)(2011-1#1)(2012-2#2)(2013-7#1)
with chest##22##2##(1991-12#1)(1991-3#1)(1992-6#1)(2006-10#1)(2007-8#2)(2008-3#10)(2010-10#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
with chief##2##2##(1997-1#1)(2011-2#1)
with child##2##2##(1996-2#1)(1997-4#1)
with childhood##6##2##(1994-2#1)(2008-10#1)(2010-6#1)(2011-1#2)(2011-2#1)
with children and adolescents##2##4##(2010-5#2)
with children and##5##3##(1990-12#1)(1995-6#2)(2010-5#2)
with children with##4##3##(1997-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
with children##25##2##(1990-12#1)(1993-6#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#4)(2009-10#1)(2009-11#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
with children's##6##2##(2008-11#1)(2010-11#3)(2011-2#1)(2013-1#1)
with chimeric##3##2##(1997-3#1)(1997-9#1)(2008-10#1)
with chimpanzees##2##2##(2008-7#1)(2012-12#1)
with chinolon group antibiotics##2##4##(2007-11#2)
with chiral##2##2##(1990-6#1)(2011-2#1)
with chirped##2##2##(2007-11#1)(2007-12#1)
with chloramphenicol##2##2##(2008-10#1)(2013-1#1)
with chloride in##3##3##(2008-10#3)
with chloride ions##2##3##(2008-10#1)(2009-8#1)
with chloride##8##2##(1996-12#1)(2008-10#6)(2009-8#1)
with chlorine##4##2##(2008-10#4)
with chloroform and##2##3##(2008-10#2)
with chloroform##10##2##(1993-8#1)(2008-10#8)(2008-7#1)
with chlorophyll##2##2##(2008-10#1)(2008-3#1)
with chloroquine##5##2##(1992-9#1)(1993-8#1)(1994-3#1)(2009-4#1)(2011-2#1)
with cholera toxin B subunit##2##5##(2008-11#2)
with cholera toxin B##3##4##(1996-5#1)(2008-11#2)
with cholesterol oxidase##2##3##(2008-10#2)
with cholesterol##7##2##(1994-12#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-6#1)
with cholestyramine##2##2##(1992-11#1)(2008-10#1)
with chorea##3##2##(2008-7#3)
with chromatin##2##2##(1990-11#1)(1994-8#1)
with chromatomembrane cell and##2##4##(2008-10#2)
with chromatomembrane##4##2##(2008-10#4)
with chromium(VI)##3##2##(2008-10#3)
with chromosomal##3##2##(1997-4#1)(2011-2#1)(2012-3#1)
with chromosome##6##2##(1994-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-12#1)
with chromotropic acid (CA)##2##4##(2008-10#2)
with chromotropic acid##6##3##(2008-10#6)
with chronic HBV infection##2##4##(2009-8#1)(2010-8#1)
with chronic HBV##3##3##(2007-12#1)(2009-8#1)(2010-8#1)
with chronic HCV infection##2##4##(2009-4#1)(2009-8#1)
with chronic HCV##6##3##(2009-4#5)(2009-8#1)
with chronic LBP##2##3##(2010-12#2)
with chronic and##2##3##(1997-3#1)(2012-3#1)
with chronic ankle##2##3##(2010-7#1)(2013-1#1)
with chronic conditions##7##3##(1997-1#2)(1997-2#2)(2011-1#2)(2012-3#1)
with chronic gastritis##3##3##(2009-8#1)(2012-12#2)
with chronic heart failure##9##4##(1991-3#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
with chronic heart##11##3##(1991-3#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-1#2)(2012-2#1)(2013-8#1)
with chronic hepatitis B virus (HBV)##2##6##(2009-8#1)(2012-12#1)
with chronic hepatitis B##9##4##(2009-8#5)(2010-8#1)(2011-2#2)(2012-12#1)
with chronic hepatitis C virus##3##5##(2009-4#1)(2011-2#1)(2013-1#1)
with chronic hepatitis C##11##4##(1994-8#1)(2009-10#1)(2009-4#2)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#3)
with chronic hepatitis##22##3##(1994-8#1)(2009-10#1)(2009-4#2)(2009-8#6)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-1#4)
with chronic illness and##2##4##(1996-3#1)(1997-2#1)
with chronic illness or##2##4##(1992-2#1)(1997-1#1)
with chronic illness##12##3##(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1996-3#1)(1997-1#3)(1997-2#3)(2012-12#1)
with chronic illnesses##9##3##(1991-8#1)(1992-3#1)(1993-3#3)(1995-12#2)(1996-3#2)
with chronic inflammatory##4##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-4#1)
with chronic kidney disease##7##4##(2008-11#1)(2010-4#1)(2011-2#3)(2012-3#2)
with chronic kidney##8##3##(2008-11#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#2)
with chronic liver disease who are at risk for##2##9##(2008-1#2)
with chronic liver disease##10##4##(1991-11#1)(1991-8#1)(2006-10#2)(2008-1#3)(2008-10#1)(2009-4#1)(2009-8#1)
with chronic low back pain##4##5##(2008-10#1)(2012-12#2)(2013-1#1)
with chronic lymphatic##2##3##(1990-6#1)(2008-11#1)
with chronic medical conditions##3##4##(2008-7#1)(2010-2#1)(2013-8#1)
with chronic medical##5##3##(1995-1#1)(1996-12#1)(2008-7#1)(2010-2#1)(2013-8#1)
with chronic mental##2##3##(1993-3#1)(1994-2#1)
with chronic myeloid leukemia##2##4##(2008-1#1)(2010-4#1)
with chronic obstructive pulmonary disease (COPD)##5##6##(1995-12#1)(1997-7#1)(2008-7#1)(2011-2#2)
with chronic obstructive pulmonary disease##13##5##(1991-9#1)(1995-12#1)(1997-7#2)(2008-7#3)(2010-10#1)(2011-2#4)(2012-2#1)
with chronic obstructive pulmonary##14##4##(1991-9#1)(1993-11#1)(1995-12#1)(1997-7#2)(2008-7#3)(2010-10#1)(2011-2#4)(2012-2#1)
with chronic obstructive##20##3##(1991-9#1)(1993-11#1)(1995-12#1)(1997-7#2)(2008-1#1)(2008-4#4)(2008-7#4)(2010-10#1)(2011-2#4)(2012-2#1)
with chronic or##2##3##(1996-3#1)(1997-2#1)
with chronic pain and##2##4##(1997-6#1)(2008-10#1)
with chronic pain##11##3##(1992-9#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-7#1)(2012-3#1)(2013-1#2)
with chronic pancreatitis##3##3##(1991-8#1)(1992-11#2)
with chronic pelvic pain##3##4##(1991-2#1)(2008-8#2)
with chronic renal failure and secondary hyperparathyroidism##2##7##(1991-5#1)(1993-3#1)
with chronic renal failure##18##4##(1990-11#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2011-2#2)(2012-3#1)(2013-1#1)
with chronic renal##24##3##(1990-11#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-5#1)(2006-10#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
with chronic respiratory failure##2##4##(2008-1#1)(2013-1#1)
with chronic respiratory##3##3##(2008-1#1)(2013-1#2)
with chronic rhinosinusitis##2##3##(2010-6#1)(2012-1#1)
with chronic stable##4##3##(2008-1#2)(2008-3#1)(2010-10#1)
with chronic stroke##2##3##(2007-10#2)
with chronic thromboembolic pulmonary hypertension (CTEPH)##2##6##(2010-6#2)
with chronic thromboembolic pulmonary hypertension##3##5##(2010-6#2)(2013-1#1)
with chronic thromboembolic pulmonary##5##4##(2010-6#4)(2013-1#1)
with chronic venous insufficiency##2##4##(2013-1#2)
with chronic venous##3##3##(2010-7#1)(2013-1#2)
with chronic wrist pain##4##4##(2008-9#4)
with chronic##308##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-2#1)(1993-3#6)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#4)(1996-6#1)(1997-1#6)(1997-2#6)(1997-3#2)(1997-6#1)(1997-7#2)(2006-10#6)(2007-10#5)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#4)(2008-1#14)(2008-10#9)(2008-11#2)(2008-12#7)(2008-3#4)(2008-4#10)(2008-5#6)(2008-7#15)(2008-8#4)(2008-9#6)(2009-10#3)(2009-3#1)(2009-4#8)(2009-5#1)(2009-7#1)(2009-8#12)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#5)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#21)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#9)(2013-1#24)(2013-8#4)
with chronically##2##2##(1990-10#1)(1992-9#1)
with cigarette smoking##3##3##(2008-10#2)(2013-1#1)
with cigarette##5##2##(1993-8#1)(2008-10#2)(2013-1#2)
with ciprofloxacin##6##2##(1991-4#2)(1997-6#1)(2007-7#1)(2011-2#2)
with circadian##2##2##(1992-10#1)(2011-1#1)
with circular gratings##3##3##(2008-3#3)
with circular##10##2##(1995-2#1)(2008-1#1)(2008-2#1)(2008-3#7)
with circulating##4##2##(2008-10#1)(2008-7#2)(2008-9#1)
with circumferential spine fusion##2##4##(2008-8#2)
with circumferential##3##2##(2008-11#1)(2008-8#2)
with cirrhosis and##5##3##(1993-2#1)(2009-4#1)(2011-2#1)(2013-1#2)
with cirrhosis of##2##3##(1991-5#1)(2012-3#1)
with cirrhosis##13##2##(1991-5#1)(1993-2#1)(1994-7#1)(2008-7#1)(2009-4#3)(2011-2#2)(2012-3#1)(2013-1#3)
with cisplatin and##2##3##(1993-2#1)(1994-12#1)
with cisplatin##12##2##(1992-12#2)(1993-2#1)(1994-12#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
with cisplatin]##2##2##(1990-6#1)(1991-8#1)
with citrate##2##2##(1992-11#1)(2008-10#1)
with citric acid##2##3##(2008-10#2)
with claims##2##2##(1992-3#1)(1996-2#1)
with clarity##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2009-5#1)
with class I molecules##2##4##(1990-5#2)
with class I##3##3##(1990-5#2)(2008-5#1)
with class II##2##3##(1993-3#1)(2011-2#1)
with class##6##2##(1990-5#2)(1993-3#1)(2008-5#2)(2011-2#1)
with classic CAH##3##3##(2010-2#3)
with classic##11##2##(1992-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-2#4)(2011-1#1)(2011-2#1)(2012-3#1)
with classical methods##2##3##(2008-10#1)(2009-9#1)
with classical##21##2##(1990-3#1)(1991-12#2)(1997-5#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#1)(2009-8#1)(2009-9#2)(2012-3#1)
with clavulanic acid##3##3##(1990-3#3)
with clay##2##2##(2008-10#2)
with clear##11##2##(1991-8#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
with clearly##3##2##(1994-3#1)(2007-11#1)(2008-5#1)
with cleavage##2##2##(2008-4#1)(2009-6#1)
with cleft lip and palate##2##5##(2007-12#1)(2013-1#1)
with cleft lip and/or palate##2##5##(2007-12#1)(2013-1#1)
with cleft lip##5##3##(2007-12#2)(2012-12#1)(2013-1#2)
with cleft palate##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
with cleft##11##2##(2007-12#3)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#4)
with clenbuterol##3##2##(2010-6#3)
with clients##2##2##(1993-2#1)(2008-11#1)
with climacteric blooding##2##3##(2008-11#2)
with climate##2##2##(2008-8#1)(2012-9#1)
with clinical and##9##3##(1996-3#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#2)
with clinical disease##2##3##(1991-6#1)(2008-10#1)
with clinical features##2##3##(1990-12#1)(2009-6#1)
with clinical manifestation of##2##4##(2007-8#1)(2008-6#1)
with clinical manifestations##2##3##(2006-10#1)(2013-1#1)
with clinical observations##2##3##(1991-12#1)(2008-5#1)
with clinical signs of##2##4##(2011-2#1)(2012-12#1)
with clinical signs##4##3##(1992-9#1)(2008-5#1)(2011-2#1)(2012-12#1)
with clinical symptoms and##2##4##(2008-3#1)(2013-1#1)
with clinical symptoms##3##3##(2008-12#1)(2008-3#1)(2013-1#1)
with clinical##78##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#3)
with clinically diagnosed##2##3##(1996-11#1)(2008-7#1)
with clinically significant##2##3##(1992-6#1)(2010-7#1)
with clinically##14##2##(1990-2#1)(1992-3#1)(1992-6#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-3#1)
with clinicians and##3##3##(1991-12#1)(2009-11#1)(2010-4#1)
with clinicians##4##2##(1991-12#1)(2008-8#1)(2009-11#1)(2010-4#1)
with clinicopathologic##2##2##(2010-1#1)(2011-1#1)
with clofibrate##2##2##(1990-12#1)(1992-11#1)
with clonal##2##2##(2008-7#1)(2011-2#1)
with cloned##4##2##(1991-6#1)(1994-9#1)(2008-10#2)
with closed-loop##2##2##(2008-2#1)(2013-1#1)
with closely##2##2##(2009-2#1)(2009-8#1)
with clotrimazole##4##2##(2007-7#3)(2008-5#1)
with clozapine##4##2##(2008-12#3)(2008-3#1)
with clusters##2##2##(1991-2#1)(2008-10#1)
with co-occurring mental##2##3##(2008-6#1)(2012-12#1)
with co-occurring##8##2##(2008-10#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-8#4)
with coagulation##2##2##(1996-8#1)(2011-1#1)
with coagulopathy##3##2##(2007-10#2)(2009-1#1)
with coarse##3##2##(2008-6#1)(2010-12#1)(2012-12#1)
with coat##2##2##(1994-12#1)(2008-8#1)
with coated##2##2##(1991-3#1)(2008-10#1)
with cobalt##4##2##(1990-11#1)(2008-10#2)(2008-11#1)
with cobalt(II) and##2##3##(2008-10#2)
with cobalt(II)##3##2##(2008-10#3)
with cocaine##3##2##(1994-8#1)(2009-7#1)(2011-2#1)
with cochlear implant##3##3##(2008-9#3)
with cochlear implants in the##2##5##(2008-9#2)
with cochlear implants in##3##4##(2008-9#3)
with cochlear implants##31##3##(2008-9#28)(2010-10#1)(2012-2#2)
with cochlear##35##2##(2008-9#32)(2010-10#1)(2012-2#2)
with coding##2##2##(2008-12#1)(2012-12#1)
with coefficients of &gt##2##4##(2008-10#2)
with coefficients of variation##4##4##(2008-10#3)(2008-5#1)
with coefficients of##6##3##(2008-10#5)(2008-5#1)
with coefficients##9##2##(2008-10#5)(2008-3#3)(2008-5#1)
with coeliac disease##4##3##(1991-11#3)(1992-12#1)
with coexistent##6##2##(1992-3#1)(1993-1#1)(1994-11#1)(2007-12#1)(2011-2#1)(2012-2#1)
with coexisting##9##2##(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
with coffee consumption##2##3##(1990-6#2)
with coffee##3##2##(1990-6#2)(1993-9#1)
with cognitive impairment##4##3##(2008-11#2)(2008-7#1)(2010-7#1)
with cognitive impairments##2##3##(1991-1#1)(2008-12#1)
with cognitive##11##2##(1991-1#1)(1991-5#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-8#1)(2010-7#1)(2012-1#1)(2013-1#1)
with coherent light##2##3##(2007-11#1)(2008-3#1)
with coherent##6##2##(2007-11#1)(2008-3#4)(2008-6#1)
with coil embolization##2##3##(2008-1#1)(2012-3#1)
with coils##4##2##(1997-8#4)
with coincident##2##2##(2007-8#1)(2008-10#1)
with colchicine##2##2##(1995-5#1)(1997-6#1)
with cold##6##2##(1992-6#1)(1993-12#1)(1995-6#1)(2007-8#1)(2008-10#2)
with collagen##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-3#1)
with collapse of##2##3##(1995-2#1)(2008-10#1)
with collapse##4##2##(1991-11#1)(1991-8#1)(1995-2#1)(2008-10#1)
with collection##2##2##(2008-10#1)(2008-2#1)
with collocated##2##2##(2008-2#1)(2008-3#1)
with colloidal##3##2##(1992-12#1)(2008-10#1)(2010-11#1)
with colon cancer##3##3##(1990-8#1)(2010-6#1)(2010-8#1)
with colon##7##2##(1990-8#2)(1991-3#1)(1997-4#1)(2006-8#1)(2010-6#1)(2010-8#1)
with colonic##3##2##(2009-12#2)(2011-2#1)
with colonization##2##2##(2008-10#2)
with colony size##3##3##(2008-9#3)
with colony##5##2##(2008-10#2)(2008-9#3)
with colorectal cancer##7##3##(2008-10#2)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#2)
with colorectal##16##2##(1992-8#4)(1993-9#2)(2008-10#3)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
with colorimetric##3##2##(2008-10#3)
with column##3##2##(2008-10#3)
with combination chemotherapy##2##3##(2007-10#1)(2008-6#1)
with combination of##3##3##(1996-3#1)(2007-7#1)(2013-8#1)
with combination##10##2##(1990-6#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
with combinations of##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
with combinatorial##2##2##(1997-7#1)(2009-12#1)
with combined day and night capability for tropospheric water-vapor profile measurements##2##11##(2008-2#2)
with combined##18##2##(1992-6#1)(1993-6#1)(1994-3#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
with combining##2##2##(1994-8#1)(2012-12#1)
with comments on##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
with comments##4##2##(1992-3#1)(2007-12#1)(2008-3#1)(2008-8#1)
with commercial##7##2##(2008-10#3)(2008-3#2)(2008-5#1)(2011-2#1)
with commercially available##4##3##(1992-2#1)(2008-10#3)
with commercially##5##2##(1992-2#1)(2008-10#3)(2009-7#1)
with common arterial trunk##2##4##(2007-8#2)
with common##21##2##(1990-3#1)(1997-8#1)(2007-2#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#2)
with commonly used##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
with communication##3##2##(2011-1#2)(2012-12#1)
with community pharmacists in error prevention and management##2##8##(2011-1#2)
with community pharmacists##3##3##(2011-1#3)
with community##9##2##(1995-1#1)(1997-2#2)(2007-10#1)(2008-11#1)(2011-1#3)(2013-1#1)
with community-acquired pneumonia and##4##4##(2013-1#4)
with community-acquired pneumonia##5##3##(2013-1#5)
with community-based##2##2##(2008-6#2)
with comorbid##3##2##(2008-1#1)(2008-7#1)(2009-10#1)
with comorbidities##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
with compact##3##2##(2008-2#1)(2008-3#2)
with comparable##12##2##(1990-2#1)(1990-3#1)(1994-9#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-3#1)
with comparative##2##2##(2008-9#1)(2010-12#1)
with comparatively##3##2##(2008-2#1)(2011-2#2)
with comparison##3##2##(2008-7#1)(2009-4#1)(2010-12#1)
with comparisons##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
with compensated##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
with compensation##2##2##(2008-3#2)
with compensatory##2##2##(2007-11#1)(2011-1#1)
with competitive##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
with competitors##2##2##(1992-3#1)(1995-12#1)
with complaints of##15##3##(1992-2#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
with complaints##16##2##(1992-2#1)(1994-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
with complement##4##2##(1994-11#1)(1994-6#1)(2008-10#1)(2008-4#1)
with complementary##7##2##(1994-8#1)(2008-10#4)(2008-3#1)(2008-9#1)
with complete recovery##2##3##(1991-11#1)(1991-8#1)
with complete resistance to##4##4##(2008-10#4)
with complete resolution of##3##4##(2008-7#1)(2009-10#1)(2013-8#1)
with complete response##3##3##(1997-7#1)(2007-8#1)(2013-1#1)
with complete##41##2##(1990-6#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-10#9)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
with completely resected##2##3##(2008-3#1)(2008-6#1)
with completely##3##2##(1991-5#1)(2008-3#1)(2008-6#1)
with complex and##2##3##(2008-11#1)(2010-8#1)
with complex matrices##2##3##(2008-10#1)(2011-1#1)
with complex reflection coefficients##2##4##(2008-3#2)
with complex##40##2##(1992-6#1)(1993-12#1)(1994-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#1)
with complicated malaria##2##3##(2012-12#2)
with complicated urinary infection##2##4##(2007-12#2)
with complicated##9##2##(1991-6#1)(2007-12#2)(2008-3#2)(2010-12#1)(2011-2#1)(2012-12#2)
with complications such as##3##4##(1996-11#1)(2007-12#1)(2012-12#1)
with complications##9##2##(1992-2#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
with component##2##2##(2008-10#1)(2008-9#1)
with composite##8##2##(1990-9#1)(2007-8#2)(2008-10#1)(2013-1#4)
with composition##4##2##(2008-10#4)
with compost##5##2##(2008-10#5)
with composted##2##2##(2008-10#2)
with compound##4##2##(1994-5#1)(2007-11#1)(2012-2#2)
with comprehensive##4##2##(1992-2#1)(1997-8#1)(2007-11#1)(2008-7#1)
with compromised##2##2##(2008-9#1)(2009-8#1)
with computational##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
with computed tomography##7##3##(1990-3#1)(1990-9#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
with computed##8##2##(1990-3#1)(1990-9#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
with computer simulations##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
with computer##14##2##(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2012-2#1)
with computer-based##2##2##(2008-2#1)(2008-3#1)
with computer-generated##2##2##(2007-11#1)(2008-2#1)
with computer-simulated##2##2##(2008-2#1)(2008-3#1)
with computerized##3##2##(1991-12#1)(2008-12#1)(2008-2#1)
with concentrated nitric acid##2##4##(2008-10#2)
with concentrated##7##2##(2008-10#5)(2008-6#1)(2010-1#1)
with concentration and##2##3##(2008-10#1)(2008-3#1)
with concentration of##2##3##(2008-10#2)
with concentration##13##2##(1993-3#1)(2008-10#8)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
with concentrations##9##2##(1993-12#1)(1995-11#1)(2008-10#5)(2008-5#1)(2013-1#1)
with concentric##2##2##(2007-11#1)(2008-3#1)
with conclusions##2##2##(1995-2#1)(2008-2#1)
with concomitant liver##2##3##(2011-2#1)(2013-8#1)
with concomitant morphological##2##3##(1994-8#1)(2012-2#1)
with concomitant##25##2##(1990-2#1)(1992-6#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-5#2)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
with concurrent##15##2##(1990-2#1)(1992-12#1)(1997-5#1)(2007-4#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-6#1)(2009-8#2)(2012-3#1)(2013-8#1)
with conditioned reinforcement##3##3##(1993-6#3)
with conditions##4##2##(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
with conducting polymer##2##3##(1990-4#1)(2008-10#1)
with conductivity detection##2##3##(2008-10#2)
with conductivity##3##2##(2008-10#3)
with confidence##7##2##(1996-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
with confidentiality##2##2##(1997-1#1)(2011-2#1)
with confirmed##5##2##(2008-6#2)(2009-11#1)(2010-6#1)(2012-2#1)
with conflicting##2##2##(2007-11#1)(2009-11#1)
with confocal##4##2##(2007-11#1)(2008-2#1)(2008-9#1)(2010-4#1)
with congenital adrenal hyperplasia##2##4##(2008-8#1)(2012-3#1)
with congenital and acquired heart##2##5##(2009-12#1)(2012-2#1)
with congenital anomalies##3##3##(2008-11#3)
with congenital heart disease (CHD)##3##5##(2010-10#1)(2010-9#1)(2012-2#1)
with congenital heart disease##18##4##(1990-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#2)(2009-5#1)(2010-10#2)(2010-6#1)(2010-9#2)(2011-2#2)(2012-2#3)
with congenital malformations##2##3##(1995-8#1)(2011-2#1)
with congenital nephrogenic diabetes insipidus##2##5##(1994-11#2)
with congenital##48##2##(1990-11#1)(1990-12#1)(1992-5#1)(1992-6#1)(1994-11#2)(1995-8#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#5)(2008-12#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-10#2)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)
with congestive cardiac failure##2##4##(1996-6#2)
with congestive##5##2##(1996-6#2)(1996-9#1)(2008-5#1)(2012-3#1)
with conidia of##4##3##(2008-10#4)
with conidia##5##2##(2008-10#5)
with conidial suspensions of##4##4##(2008-10#4)
with conidial suspensions##5##3##(2008-10#5)
with conidial##7##2##(2008-10#7)
with conjugate##2##2##(2006-6#1)(2010-8#1)
with conjugated##3##2##(1994-6#1)(2009-10#2)
with consecutive##5##2##(1991-8#2)(2008-10#1)(2010-11#1)(2013-8#1)
with consensus##2##2##(1994-12#1)(2008-9#1)
with consequent##10##2##(1994-9#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#2)
with conservation of##2##3##(1991-7#1)(2012-1#1)
with conservative management##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
with conservative surgery and##2##4##(1995-8#1)(2011-2#1)
with conservative treatment##2##3##(2008-7#1)(2011-2#1)
with conservative##8##2##(1995-8#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
with conserved##4##2##(1993-12#1)(1997-3#1)(2008-10#1)(2009-5#1)
with considerable morbidity and##2##4##(2007-8#1)(2011-2#1)
with considerable morbidity##3##3##(2007-8#1)(2011-2#1)(2012-3#1)
with considerable##17##2##(1990-8#1)(1992-9#1)(1993-3#2)(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)
with considerably##5##2##(1990-3#1)(2006-12#1)(2008-10#2)(2008-8#1)
with consideration of##2##3##(2007-11#1)(2008-3#1)
with consideration to##2##3##(2007-11#1)(2012-2#1)
with consideration##5##2##(2007-11#2)(2008-3#1)(2011-2#1)(2012-2#1)
with considerations for##3##3##(2008-2#1)(2008-9#1)(2013-1#1)
with considerations of##2##3##(2008-8#1)(2013-1#1)
with considerations##5##2##(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#2)
with consistent##5##2##(1991-12#1)(2008-10#2)(2008-7#1)(2011-1#1)
with conspecific##2##2##(2008-8#1)(2009-9#1)
with constant##9##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#1)
with constipation##2##2##(1994-3#1)(2009-3#1)
with constitutional symptoms##2##3##(2007-5#1)(2008-9#1)
with constitutional##5##2##(2007-5#1)(2008-9#1)(2011-1#2)(2011-2#1)
with constitutive##2##2##(1992-12#1)(2012-12#1)
with constrained##2##2##(2008-3#1)(2012-1#1)
with constraints##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
with constrictive pericarditis##2##3##(2007-8#1)(2012-12#1)
with constructs##2##2##(1993-9#1)(2011-1#1)
with consumers##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
with contact dermatitis##2##3##(1997-2#1)(2012-3#1)
with contact lenses##2##3##(1993-11#2)
with contact##7##2##(1993-11#2)(1995-11#1)(1997-2#2)(2010-11#1)(2012-3#1)
with contemporary##5##2##(1990-12#1)(1992-6#1)(2008-6#1)(2010-3#1)(2010-8#1)
with content of##2##3##(2008-10#1)(2010-6#1)
with content##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2013-1#1)
with continued use##2##3##(1992-3#1)(2008-5#1)
with continued##6##2##(1992-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
with continuous ambulatory peritoneal dialysis##2##5##(1992-5#1)(2007-12#1)
with continuous ambulatory##3##3##(1992-5#1)(1997-8#1)(2007-12#1)
with continuous and##2##3##(2008-10#1)(2013-1#1)
with continuous##32##2##(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1995-2#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
with continuous-flow##3##2##(2008-10#1)(2010-6#2)
with continuous-wave laser light##2##4##(2007-12#2)
with continuous-wave##6##2##(2007-12#4)(2008-3#2)
with continuum##3##2##(1997-2#1)(2008-10#1)(2009-7#1)
with contrapropagating sound##2##3##(2008-2#2)
with contrast##8##2##(1990-9#1)(1993-2#1)(2007-10#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
with contrasting##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
with control group##2##3##(2011-3#1)(2012-2#1)
with control over##2##3##(2009-10#1)(2010-2#1)
with control plants##3##3##(2008-10#3)
with control rats##2##3##(1990-7#1)(2008-9#1)
with control##38##2##(1990-7#1)(1993-12#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-3#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-2#3)
with controllable##5##2##(1996-12#1)(2008-10#1)(2008-3#2)(2009-12#1)
with controlled phase##2##3##(2008-3#1)(2009-7#1)
with controlled##11##2##(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-7#1)(2010-7#1)(2013-1#1)
with controls##30##2##(1991-9#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-7#3)(2008-8#1)(2010-6#1)(2011-2#5)(2012-12#1)(2013-8#1)
with convective##2##2##(2008-10#1)(2008-3#1)
with conventional Soxhlet##2##3##(2008-10#2)
with conventional and##2##3##(2008-3#1)(2011-2#1)
with conventional antibiotics##2##3##(2008-5#2)
with conventional extraction##2##3##(2008-10#1)(2013-1#1)
with conventional ion-selective electrodes##2##4##(2008-10#2)
with conventional methods##4##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
with conventional osteosarcoma##2##3##(2010-3#2)
with conventional preadjusted straight wire brackets##2##6##(2009-7#2)
with conventional technique##2##3##(2007-8#1)(2008-10#1)
with conventional techniques##3##3##(1994-3#1)(1997-7#1)(2008-11#1)
with conventional therapy##3##3##(2008-1#2)(2011-2#1)
with conventional tillage##2##3##(2008-10#2)
with conventional##113##2##(1990-8#1)(1991-5#2)(1992-10#1)(1993-1#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2007-11#5)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#28)(2008-11#2)(2008-2#8)(2008-3#16)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
with conventionally##2##2##(2008-10#2)
with conversion##2##2##(1996-3#1)(2008-7#1)
with coordinating##3##2##(1994-1#2)(1997-2#1)
with coordination##2##2##(1997-7#1)(2012-12#1)
with coping##2##2##(1994-2#2)
with copper bactericides##2##3##(2008-10#2)
with copper ions##4##3##(2008-10#3)(2012-2#1)
with copper sulfate##2##3##(2008-10#2)
with copper##19##2##(1990-5#1)(2008-10#16)(2008-2#1)(2012-2#1)
with copper(II)##3##2##(2008-10#3)
with copra oil##2##3##(2013-1#2)
with cord##3##2##(2009-3#1)(2011-1#1)(2012-12#1)
with core##2##2##(2008-2#1)(2008-5#1)
with corn##2##2##(2008-5#1)(2013-1#1)
with coronal##2##2##(2013-1#2)
with coronary artery disease (CAD)##2##5##(2008-3#1)(2008-7#1)
with coronary artery disease##16##4##(1990-3#1)(1995-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-7#1)
with coronary artery##20##3##(1990-3#1)(1995-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
with coronary bypass surgery##2##4##(1996-9#1)(2008-3#1)
with coronary bypass##4##3##(1995-3#1)(1996-9#2)(2008-3#1)
with coronary disease##2##3##(1993-3#1)(2008-3#1)
with coronary heart disease##15##4##(1990-3#1)(1990-8#2)(1992-5#1)(1993-12#1)(1993-2#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
with coronary##50##2##(1990-3#2)(1990-8#2)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1995-3#2)(1996-9#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#6)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
with corporate##2##2##(1991-3#1)(1997-1#1)
with correction of the##2##4##(2011-2#1)(2013-1#1)
with correction of##3##3##(2011-2#1)(2013-1#2)
with correction##5##2##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#2)
with correlated##2##2##(2008-2#1)(2008-7#1)
with correlation coefficient of 0##5##5##(2008-10#5)
with correlation coefficient##9##3##(2008-10#7)(2009-3#1)(2013-8#1)
with correlation coefficients (r)##2##4##(2008-10#2)
with correlation coefficients##5##3##(2008-10#5)
with correlation factor of 0##2##5##(2008-10#2)
with correlation##17##2##(2008-10#15)(2009-3#1)(2013-8#1)
with correlations##2##2##(2012-2#1)(2013-8#1)
with corresponding detection limits of 0##2##6##(2008-10#2)
with corresponding##20##2##(1990-2#1)(1994-2#1)(1997-7#1)(2008-10#10)(2008-11#1)(2008-3#3)(2010-12#1)(2012-2#1)(2012-3#1)
with cortical##9##2##(1993-3#1)(1995-5#1)(1996-9#1)(2007-10#1)(2008-7#1)(2008-9#3)(2013-1#1)
with corticosteroid therapy##2##3##(1993-2#1)(2008-1#1)
with corticosteroid##6##2##(1993-2#2)(2006-10#1)(2007-11#1)(2008-1#2)
with corticosteroids and##6##3##(1994-6#1)(2006-10#1)(2007-6#1)(2008-4#1)(2008-7#1)(2011-1#1)
with corticosteroids##9##2##(1994-6#1)(1996-6#1)(2006-10#1)(2007-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#2)
with corticotrophin-releasing##3##2##(2008-3#1)(2008-4#2)
with costs of##2##3##(1995-1#1)(2008-8#1)
with costs##3##2##(1995-1#1)(2008-7#1)(2008-8#1)
with cotton leafworm##2##3##(2008-6#1)(2010-10#1)
with cotton##5##2##(2008-10#2)(2008-6#1)(2008-7#1)(2010-10#1)
with coulometric##2##2##(2008-10#1)(2009-8#1)
with counterpropagating##2##2##(2007-12#2)
with county population##2##3##(1991-3#1)(1996-3#1)
with cranial nerve##2##3##(2007-12#1)(2008-7#1)
with cranial##4##2##(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
with craniofacial##3##2##(2007-12#3)
with creating##2##2##(2007-2#1)(2008-8#1)
with crop##2##2##(2008-10#1)(2013-1#1)
with cross gratings##2##3##(2008-3#2)
with cross##3##2##(2008-10#1)(2008-3#2)
with crossed##3##2##(2007-8#1)(2008-3#2)
with crown##2##2##(2008-10#2)
with crude##2##2##(1991-9#1)(2008-10#1)
with crushed grains under the pigment layer##2##7##(2008-10#2)
with crushed##3##2##(1992-6#1)(2008-10#2)
with cryogenic##2##2##(2008-10#1)(2008-3#1)
with cryosurgery##2##2##(2007-7#2)
with cryptogenic epilepsy##2##3##(2008-8#2)
with crystal violet##2##3##(2008-10#2)
with crystal##3##2##(2008-10#2)(2008-3#1)
with cultural##3##2##(2008-1#1)(2012-12#1)(2013-8#1)
with culture##2##2##(1993-8#1)(2007-6#1)
with cultured##2##2##(1996-5#1)(2008-11#1)
with cultures of##2##3##(1996-5#1)(2008-10#1)
with cultures##5##2##(1996-5#1)(2008-10#2)(2008-6#1)(2013-8#1)
with cumulative##3##2##(1995-9#1)(2008-10#1)(2011-2#1)
with cupferron##2##2##(2008-10#2)
with curative intent##2##3##(2008-1#1)(2008-6#1)
with curative##4##2##(1991-2#1)(2008-1#1)(2008-6#1)(2010-5#1)
with current UOS evaluation##2##4##(2012-3#2)
with current and##3##3##(1995-12#1)(2008-4#1)(2012-12#1)
with current##46##2##(1990-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#3)
with currently available##2##3##(1997-3#1)(2007-12#1)
with currently##3##2##(1997-3#1)(2007-12#1)(2008-3#1)
with custom##3##2##(2007-11#1)(2008-9#1)(2009-10#1)
with cut##2##2##(2008-9#1)(2011-2#1)
with cutaneous lesions##2##3##(2008-12#1)(2012-3#1)
with cutaneous##9##2##(1997-4#1)(2007-8#1)(2008-12#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
with cutting##2##2##(2008-10#1)(2008-7#1)
with cv##3##2##(2008-10#3)
with cyanex 302##2##3##(2008-10#2)
with cyanex##3##2##(2008-10#3)
with cyanine##2##2##(2007-12#1)(2008-10#1)
with cyanogen bromide##5##3##(1990-2#1)(1990-5#2)(1991-9#1)(1994-5#1)
with cyclic voltammetry##3##3##(2008-10#2)(2008-3#1)
with cyclic##8##2##(1993-5#1)(1993-8#1)(1994-11#1)(2008-10#3)(2008-3#1)(2009-5#1)
with cyclodextrin and##2##3##(2008-10#1)(2008-5#1)
with cyclodextrin##4##2##(1995-11#1)(2008-10#2)(2008-5#1)
with cyclodextrins##4##2##(1996-5#1)(2008-10#3)
with cycloheximide##3##2##(1991-12#1)(1997-1#1)(2009-8#1)
with cyclophosphamide and##3##3##(1992-10#1)(2008-1#1)(2008-5#1)
with cyclophosphamide##15##2##(1991-8#1)(1992-10#2)(1993-2#1)(1993-9#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#1)(2013-8#1)
with cyclosporin A##2##3##(1991-5#1)(1997-2#1)
with cyclosporin##7##2##(1991-5#1)(1991-9#1)(1997-2#1)(2008-1#3)(2012-1#1)
with cylinder##2##2##(2008-10#1)(2008-2#1)
with cylindrical symmetry##3##3##(2007-12#3)
with cylindrical##6##2##(2007-12#3)(2008-10#2)(2008-3#1)
with cyst##5##2##(1997-8#2)(2006-10#1)(2007-12#1)(2013-1#1)
with cysteine##6##2##(1995-2#1)(2008-10#5)
with cystic fibrosis##19##3##(1991-12#2)(1991-2#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-9#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
with cystic hyperplasia##2##3##(1994-3#2)
with cystic##23##2##(1991-12#2)(1991-2#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-9#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-7#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
with cytochrome P450##2##3##(2011-1#1)(2012-3#1)
with cytochrome##4##2##(1993-12#1)(2009-10#1)(2011-1#1)(2012-3#1)
with cytokines##4##2##(1990-8#1)(2008-11#1)(2008-8#1)(2010-11#1)
with cytological##2##2##(2011-1#1)(2013-1#1)
with cytoplasmic##7##2##(1991-12#1)(1991-5#1)(1993-11#1)(1995-2#1)(1997-3#1)(2009-5#1)(2012-3#1)
with cytotoxic agents##2##3##(1991-9#1)(2012-3#1)
with cytotoxic##6##2##(1991-9#2)(1993-12#1)(2008-11#1)(2009-12#1)(2012-3#1)
with daily activities##2##3##(2008-11#1)(2009-11#1)
with daily##9##2##(1990-6#1)(1991-5#1)(2007-7#1)(2008-11#2)(2009-11#1)(2010-5#1)(2011-2#1)(2012-1#1)
with dandruff##2##2##(2008-5#2)
with dansyl chloride##2##3##(1990-8#1)(1996-5#1)
with dansyl##4##2##(1990-8#1)(1995-6#1)(1996-5#1)(2008-10#1)
with dark##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
with darker skin##2##3##(2008-5#1)(2010-8#1)
with darker##3##2##(2008-5#1)(2010-8#2)
with data for the##2##4##(1996-2#1)(2008-10#1)
with data for##4##3##(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#1)
with data from a##6##4##(1994-2#1)(1994-9#1)(1996-12#1)(1997-3#1)(2008-5#1)(2012-3#1)
with data from the##4##4##(1990-12#1)(2008-3#1)(2010-6#1)(2013-7#1)
with data from##24##3##(1990-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-3#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
with data obtained by atomic absorption##2##6##(2008-10#2)
with data obtained by##5##4##(1990-12#1)(2008-10#4)
with data obtained from##2##4##(2008-2#1)(2008-5#1)
with data obtained in##2##4##(1993-12#1)(2008-11#1)
with data obtained using##4##4##(2008-10#4)
with data obtained##14##3##(1990-12#1)(1993-12#1)(1995-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)
with data of##2##3##(1994-1#1)(2009-12#1)
with data on patch##2##4##(2008-9#2)
with data on##10##3##(1994-5#1)(2008-8#3)(2008-9#2)(2009-7#1)(2011-2#1)(2011-8#1)(2013-1#1)
with data##80##2##(1990-12#2)(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
with data-driven##2##2##(2007-11#1)(2010-10#1)
with databases##2##2##(2007-12#1)(2008-1#1)
with daunomycin##3##2##(2008-10#2)(2008-7#1)
with day##2##2##(2011-2#1)(2013-8#1)
with de novo##4##3##(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)
with dead##2##2##(2007-12#1)(2008-9#1)
with death##6##2##(1991-2#1)(2007-10#1)(2007-11#1)(2008-11#3)
with declining mobility##2##3##(2008-7#2)
with declining##4##2##(1992-12#1)(2008-7#2)(2011-2#1)
with decompensated##2##2##(2009-8#1)(2012-3#1)
with decortication##2##2##(2007-8#2)
with decrease in##2##3##(2007-8#1)(2008-10#1)
with decreased maternal age##3##4##(1997-3#3)
with decreased vision##2##3##(2010-10#1)(2011-1#1)
with decreased##34##2##(1996-5#1)(1997-3#3)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
with decreases in##2##3##(2008-10#1)(2013-1#1)
with decreasing pH and##3##4##(1995-2#1)(2008-5#1)(2013-1#1)
with decreasing pH##4##3##(1991-8#1)(1995-2#1)(2008-5#1)(2013-1#1)
with decreasing##23##2##(1990-8#1)(1991-8#1)(1993-8#1)(1995-2#1)(1995-6#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
with dedicated##3##2##(2008-7#1)(2012-2#1)(2013-7#1)
with deep brain stimulation##2##4##(2011-1#1)(2012-3#1)
with deep##8##2##(1992-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
with defective##5##2##(1993-9#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
with defects in##5##3##(1991-7#1)(1992-6#1)(1995-2#1)(2008-10#1)(2012-3#1)
with deficiency of##2##3##(1993-3#1)(1995-8#1)
with deficient##4##2##(1993-2#1)(1996-7#1)(1997-7#1)(2009-7#1)
with deficits in##6##3##(1993-12#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
with deficits##7##2##(1993-12#1)(2007-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
with defined##7##2##(1995-5#2)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#1)
with definitive##4##2##(1991-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
with defocus##2##2##(2008-2#2)
with deformed##3##2##(2007-11#2)(2008-3#1)
with degenerate primers##3##3##(1993-2#1)(1997-7#1)(2008-10#1)
with degenerate##5##2##(1993-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-8#1)
with degenerative##14##2##(1993-2#1)(2007-11#2)(2007-8#3)(2008-11#1)(2008-8#1)(2009-3#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
with deionized water##2##3##(2008-10#2)
with delay in the##2##4##(2007-11#1)(2013-1#1)
with delay##4##2##(2007-11#1)(2013-1#1)(2013-8#2)
with delayed diagnosis##3##3##(2008-11#1)(2010-12#2)
with delayed##8##2##(1991-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-12#2)(2011-2#2)
with deletions##3##2##(1997-3#1)(2008-4#1)(2008-9#1)
with delirium##5##2##(2010-10#3)(2012-2#1)(2013-1#1)
with delivery of a##2##4##(2007-7#1)(2008-11#1)
with delivery##3##2##(2007-7#1)(2008-11#1)(2010-11#1)
with delta##3##2##(1992-3#1)(1994-3#1)(1995-3#1)
with delusions and hallucinations##2##4##(2008-4#1)(2012-2#1)
with dementia and##5##3##(2008-11#1)(2008-6#1)(2010-10#1)(2010-11#1)(2013-8#1)
with dementia in the##2##4##(2008-6#1)(2013-8#1)
with dementia in##4##3##(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
with dementia##31##2##(1991-1#2)(1991-11#1)(1992-3#2)(1996-11#1)(2008-11#2)(2008-6#4)(2008-7#5)(2008-8#1)(2010-10#3)(2010-11#1)(2011-1#3)(2013-1#1)(2013-8#5)
with demersal eggs and##2##4##(2008-8#2)
with demographic and##2##3##(2007-10#1)(2008-12#1)
with demographic##5##2##(2007-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-2#1)
with dendritic cells##2##3##(2006-10#1)(2008-9#1)
with dendritic##7##2##(1995-12#1)(1996-5#1)(1997-2#2)(2006-10#1)(2008-9#1)(2013-1#1)
with dense mycelium##2##3##(2008-10#2)
with dense##6##2##(1990-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
with density functional##2##3##(2012-12#1)(2012-2#1)
with density##5##2##(2008-11#1)(2008-8#2)(2012-12#1)(2012-2#1)
with dental##7##2##(1993-1#1)(1993-12#2)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
with deployment##2##2##(2007-8#1)(2008-7#1)
with depolarization##2##2##(2008-3#2)
with depressed##3##2##(2008-6#1)(2011-2#2)
with depression and##4##3##(1996-11#1)(2007-7#1)(2008-12#1)(2008-7#1)
with depression##13##2##(1991-1#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-2#1)
with depressive symptoms##2##3##(2010-1#1)(2010-10#1)
with depressive##5##2##(1992-2#1)(2008-7#1)(2010-1#1)(2010-10#1)(2012-2#1)
with depth##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#2)
with depths##2##2##(2007-11#1)(2008-3#1)
with derivatives##2##2##(1994-5#1)(2008-11#1)
with dermal##3##2##(1993-2#1)(2008-9#2)
with dermatitis were##2##3##(1990-3#2)
with dermatitis##3##2##(1990-3#2)(1992-9#1)
with description of##2##3##(2007-8#1)(2008-5#1)
with description##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
with descriptions of##2##3##(2006-12#1)(2008-10#1)
with descriptive##3##2##(2008-9#1)(2011-1#1)(2012-3#1)
with desipramine##2##2##(1995-12#2)
with desirable##4##2##(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#1)
with desired##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-12#1)
with destruction of##2##3##(2011-1#2)
with detached##2##2##(2008-10#2)
with detail##2##2##(1996-12#1)(2008-10#1)
with detailed data##2##3##(1990-3#1)(1995-1#1)
with detailed##10##2##(1990-3#1)(1993-1#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)
with details##2##2##(2008-11#1)(2008-4#1)
with detectable##4##2##(1997-5#1)(2008-10#2)(2008-7#1)
with detection at##3##3##(2008-10#3)
with detection by inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
with detection by##4##3##(2008-10#4)
with detection limit of 0##5##5##(2008-10#5)
with detection limit of 1##2##5##(2008-10#2)
with detection limit of##13##4##(2008-10#13)
with detection limit##18##3##(2008-10#18)
with detection limits (S/N=3)##3##4##(2008-10#3)
with detection limits of 0##11##5##(1997-4#1)(2008-10#10)
with detection limits of 1##2##5##(1997-4#1)(2008-10#1)
with detection limits of##20##4##(1997-4#2)(2008-10#18)
with detection limits ranging from##2##5##(2008-10#2)
with detection limits within##2##4##(2008-10#2)
with detection limits##35##3##(1997-4#2)(2008-10#33)
with detection of##2##3##(2008-10#2)
with detection##66##2##(1997-4#2)(2008-10#62)(2009-9#1)(2010-2#1)
with detergent##2##2##(1994-8#1)(2008-4#1)
with detergents##3##2##(1993-11#1)(1995-2#1)(2008-10#1)
with determination of##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
with determination##7##2##(1997-2#1)(2008-10#5)(2008-7#1)
with devastating##2##2##(2009-2#1)(2011-2#1)
with developing##3##2##(1994-2#1)(2008-10#1)(2008-12#1)
with development of##11##3##(1996-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-1#2)
with development##14##2##(1996-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-1#3)
with developmental delay##2##3##(1996-5#1)(2011-2#1)
with developmental disabilities##5##3##(1991-12#1)(1993-1#1)(1993-3#1)(1997-2#1)(2010-12#1)
with developmental##15##2##(1991-12#1)(1992-1#1)(1993-1#1)(1993-3#1)(1995-1#2)(1996-5#1)(1997-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#3)(2012-3#1)
with dexamethasone##11##2##(1990-11#1)(1990-5#2)(1994-3#2)(1994-8#1)(1997-4#1)(2007-7#1)(2008-5#2)(2013-1#1)
with dexrazoxane##2##2##(2008-11#2)
with dextran-conjugated calcium indicators in##2##5##(2008-4#2)
with dextrocardia##5##2##(2008-7#3)(2010-8#2)
with diabetes and other##4##4##(2007-10#1)(2013-8#3)
with diabetes and##10##3##(1995-2#1)(2007-10#1)(2007-7#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#3)
with diabetes are##4##3##(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)
with diabetes from the##2##4##(2007-12#1)(2009-11#1)
with diabetes from##4##3##(2007-12#1)(2008-6#1)(2009-11#1)(2010-4#1)
with diabetes have##4##3##(1996-11#1)(2008-1#2)(2010-10#1)
with diabetes in the##2##4##(2009-5#1)(2011-2#1)
with diabetes in##4##3##(1994-12#1)(2008-1#1)(2009-5#1)(2011-2#1)
with diabetes mellitus in##2##4##(1994-6#1)(2008-8#1)
with diabetes mellitus is##3##4##(1992-5#1)(2008-3#2)
with diabetes mellitus was##2##4##(1992-5#1)(1994-6#1)
with diabetes mellitus##28##3##(1992-5#2)(1994-11#1)(1994-6#2)(1996-3#1)(1997-3#1)(2008-1#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
with diabetes or##2##3##(1995-3#1)(2013-8#1)
with diabetes should##2##3##(2010-4#1)(2011-1#1)
with diabetes##115##2##(1992-5#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#3)(1995-2#3)(1995-3#1)(1996-11#2)(1996-3#1)(1997-3#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#16)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-10#4)(2010-12#1)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#8)(2013-8#8)
with diabetic ketoacidosis##2##3##(2011-1#1)(2011-2#1)
with diabetic nephropathy##2##3##(2008-1#1)(2011-2#1)
with diabetic##9##2##(1991-9#1)(1994-12#1)(2008-1#2)(2011-1#2)(2011-2#2)(2012-2#1)
with diagnosed##5##2##(1992-12#1)(1993-6#1)(2011-1#1)(2011-2#2)
with diagnoses of##2##3##(1994-2#1)(2008-9#1)
with diagnosis of##7##3##(1997-8#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
with diagnosis##10##2##(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
with diagnostic##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)
with dialysis##3##2##(2008-10#1)(2008-4#2)
with diameter##2##2##(2008-7#1)(2012-1#1)
with diameters of##3##3##(2007-12#1)(2008-3#2)
with diameters ranging##2##3##(2008-3#2)
with diameters##8##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
with diarrhea##2##2##(2007-10#1)(2010-12#1)
with diarrhoea##4##2##(1990-9#1)(1997-3#1)(2008-1#1)(2013-8#1)
with diazepam##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
with diazomethane##3##2##(2008-10#3)
with dichloromethane##7##2##(2008-10#7)
with diclofenac##3##2##(2008-10#1)(2010-8#2)
with dielectric##2##2##(2007-12#1)(2008-10#1)
with diet and##3##3##(1991-8#1)(1994-12#1)(2008-3#1)
with diet##6##2##(1991-2#1)(1991-8#1)(1994-12#2)(2008-3#1)(2013-7#1)
with dietary##5##2##(1991-11#1)(1991-8#1)(2008-1#1)(2011-1#1)(2013-1#1)
with diethyl ether##4##3##(1997-2#1)(2008-10#1)(2008-11#2)
with diethyl##5##2##(1990-12#1)(1997-2#1)(2008-10#1)(2008-11#2)
with diethylpyrocarbonate##2##2##(1990-11#1)(1990-2#1)
with diethylstilbestrol (DES)##2##3##(2008-4#1)(2008-5#1)
with differences in the##5##4##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
with differences in##13##3##(2008-10#4)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#2)(2013-1#2)(2013-8#2)
with differences##18##2##(2008-10#7)(2008-11#1)(2008-3#2)(2008-9#1)(2009-12#1)(2011-2#2)(2013-1#2)(2013-8#2)
with different amounts of each chemical##2##6##(2008-10#2)
with different amounts of##8##4##(2008-10#5)(2008-3#1)(2008-9#1)(2010-4#1)
with different analytical##2##3##(2008-10#2)
with different anions and##2##4##(1993-12#2)
with different background##2##3##(2008-2#1)(2013-1#1)
with different batches##2##3##(2008-10#1)(2011-2#1)
with different behaviors##2##3##(2008-3#1)(2008-4#1)
with different cell##2##3##(2008-11#1)(2012-3#1)
with different chemical structures and##2##5##(1992-3#1)(2008-10#1)
with different chemical structures##3##4##(1992-3#1)(1995-11#1)(2008-10#1)
with different chemical##6##3##(1992-3#1)(1995-11#1)(2008-10#3)(2008-11#1)
with different clinical forms##2##4##(2008-5#1)(2013-1#1)
with different clinical##3##3##(2008-5#1)(2013-1#2)
with different concentrations and##2##4##(2008-10#1)(2013-1#1)
with different concentrations of##8##4##(1993-8#1)(1996-5#1)(2008-10#4)(2008-3#1)(2012-3#1)
with different concentrations##10##3##(1993-8#1)(1996-5#1)(2008-10#5)(2008-3#1)(2012-3#1)(2013-1#1)
with different degrees of##6##4##(1991-5#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
with different detection##3##3##(2008-10#2)(2010-5#1)
with different diameters##2##3##(2008-10#1)(2008-2#1)
with different distributions of##2##4##(2008-3#1)(2008-8#1)
with different doping##2##3##(2008-3#1)(2013-8#1)
with different doses and##2##4##(1992-2#1)(2012-2#1)
with different doses of##4##4##(1992-8#1)(2008-10#1)(2010-3#1)(2013-1#1)
with different doses##6##3##(1992-2#1)(1992-8#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
with different features##2##3##(2007-8#1)(2008-10#1)
with different forms of##4##4##(1992-2#1)(1997-2#1)(2008-12#1)(2008-7#1)
with different fractions of##2##4##(1997-1#1)(2008-10#1)
with different genetic##2##3##(2008-10#1)(2009-10#1)
with different isolates of##2##4##(2008-10#2)
with different kinds of##2##4##(2009-3#1)(2011-3#1)
with different kinds##3##3##(2008-12#1)(2009-3#1)(2011-3#1)
with different levels of##7##4##(1992-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2013-1#1)
with different levels##8##3##(1992-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
with different maximum luminance settings##2##5##(2010-9#2)
with different mechanisms##2##3##(1995-11#1)(2007-11#1)
with different molar##2##3##(1996-2#1)(2008-10#1)
with different molecular##2##3##(1996-2#2)
with different numbers of##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
with different orientations##2##3##(2008-3#1)(2012-2#1)
with different oxidation states##2##4##(2007-11#1)(2008-10#1)
with different parameters##2##3##(2007-11#1)(2008-3#1)
with different patterns of##4##4##(1994-2#1)(2009-8#1)(2010-2#1)(2011-1#1)
with different patterns##5##3##(1994-2#1)(2008-10#1)(2009-8#1)(2010-2#1)(2011-1#1)
with different permanent modifiers##2##4##(2008-10#2)
with different phenotypes##2##3##(1997-3#1)(2008-10#1)
with different polarization##2##3##(2007-11#1)(2008-3#1)
with different presentations##2##3##(1994-11#1)(2008-2#1)
with different properties##4##3##(1996-2#1)(2009-5#1)(2010-5#1)(2010-8#1)
with different responses to##2##4##(1991-2#1)(2008-10#1)
with different seed##2##3##(2008-12#1)(2013-7#1)
with different shapes##2##3##(2008-3#1)(2008-7#1)
with different size##2##3##(2008-3#1)(2011-2#1)
with different snow##2##3##(2008-3#2)
with different solutions##2##3##(2008-5#1)(2013-1#1)
with different spectral##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
with different subpupil forms##2##4##(2008-3#2)
with different substrate##2##3##(2008-10#1)(2011-2#1)
with different substrates##2##3##(1993-11#1)(2008-10#1)
with different target##2##3##(2008-10#1)(2008-11#1)
with different techniques##4##3##(1994-11#1)(2008-10#2)(2008-11#1)
with different transition##2##3##(2010-11#1)(2012-12#1)
with different type of##2##4##(2012-3#1)(2013-1#1)
with different type##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
with different types of##7##4##(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-5#1)(2011-2#2)
with different wavelengths##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
with different##457##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#5)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#3)(1997-7#3)(2006-12#1)(2007-10#2)(2007-11#12)(2007-12#7)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#128)(2008-11#18)(2008-12#9)(2008-2#19)(2008-3#36)(2008-4#3)(2008-5#15)(2008-6#6)(2008-7#9)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#5)(2010-10#1)(2010-11#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#9)
with differential absorption##2##3##(2008-3#2)
with differential pulse voltammetry (DPV)##2##5##(2008-10#2)
with differential pulse##3##3##(2008-10#3)
with differential##16##2##(1997-3#1)(2008-10#8)(2008-3#2)(2008-7#1)(2008-9#1)(2010-7#1)(2013-7#2)
with differentiated##3##2##(1992-9#1)(1994-11#1)(2013-1#1)
with differentiating##2##2##(2008-9#1)(2009-10#1)
with differentiation##2##2##(2008-5#1)(2008-8#1)
with differing##5##2##(1996-2#1)(1997-3#1)(2008-10#2)(2008-4#1)
with difficult##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
with difficulties##2##2##(2008-12#1)(2008-4#1)
with difficulty##2##2##(2008-1#1)(2011-2#1)
with diffraction##2##2##(2007-11#1)(2008-3#1)
with diffraction-limited##3##2##(2007-12#2)(2008-2#1)
with diffractive optical elements##2##4##(2008-2#2)
with diffractive optics##4##3##(2008-3#4)
with diffractive##8##2##(2008-2#3)(2008-3#5)
with diffuse leptomeningeal spread##2##4##(2012-12#2)
with diffuse systemic sclerosis##5##4##(2006-10#1)(2009-8#4)
with diffuse##22##2##(1990-9#1)(1993-8#1)(1994-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-8#5)(2010-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
with diffusion##2##2##(2008-3#1)(2013-8#1)
with digital holography##3##3##(2008-3#3)
with digital speckle photography##2##4##(2008-3#2)
with digital##11##2##(1991-12#1)(2007-11#1)(2008-3#6)(2008-7#1)(2008-9#1)(2013-7#1)
with digitonin##2##2##(1992-6#1)(2008-4#1)
with dignity##4##2##(1993-1#1)(2012-12#2)(2013-1#1)
with dihydropyridine binding##2##3##(1995-11#2)
with dilated cardiomyopathy##5##3##(1993-2#3)(2011-2#1)(2012-2#1)
with diluted##3##2##(2008-10#3)
with dimensions comparable##2##3##(2008-3#1)(2008-7#1)
with dimensions##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
with dimethyl##8##2##(1990-7#1)(1996-5#3)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
with dimethylformamide##2##2##(1992-2#1)(2008-10#1)
with dimethylglyoxime##2##2##(2008-10#2)
with diminished##4##2##(2007-7#1)(2008-3#1)(2011-2#1)(2012-5#1)
with diminishing##2##2##(1992-6#1)(2008-3#1)
with diode array detection##4##4##(2008-10#4)
with diode array detector##3##4##(2008-10#3)
with diode array##7##3##(2008-10#7)
with diode lasers##2##3##(2008-2#1)(2008-3#1)
with diode##9##2##(2008-10#7)(2008-2#1)(2008-3#1)
with diode-array##2##2##(2008-10#2)
with dioxygen##2##2##(1997-7#1)(2008-10#1)
with dipalmitoyl phosphatidylcholine (DPPC)##2##4##(2008-10#2)
with diplegia and##2##3##(2007-11#2)
with diplopia##3##2##(1996-9#1)(2008-7#1)(2011-1#1)
with dipole##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
with direct conductivity detection##2##4##(2008-10#2)
with direct determination##2##3##(1992-12#1)(2008-10#1)
with direct measurement of##2##4##(1994-9#1)(2008-10#1)
with direct measurements##2##3##(2008-2#1)(2008-3#1)
with direct numerical##2##3##(2007-11#1)(2007-12#1)
with direct sample injection##3##4##(1990-8#1)(2008-10#2)
with direct suture##2##3##(2007-8#1)(2011-3#1)
with direct##36##2##(1990-8#1)(1991-2#1)(1992-12#1)(1994-9#1)(1996-1#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#3)
with directed##2##2##(1992-9#1)(2008-7#1)
with disabilities and##3##3##(1994-2#1)(1996-1#1)(2010-12#1)
with disabilities in Medicare and Medicaid##2##6##(1997-2#2)
with disabilities in##5##3##(1995-6#1)(1996-1#2)(1997-2#2)
with disabilities to##2##3##(1994-1#1)(2013-1#1)
with disabilities##33##2##(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#2)(1996-1#9)(1997-1#1)(1997-2#3)(2009-6#3)(2010-11#3)(2010-12#2)(2012-2#1)(2013-1#1)
with disability##5##2##(1993-6#1)(1996-12#1)(1997-1#2)(2007-7#1)
with disabling##2##2##(1997-7#1)(2008-5#1)
with disc##2##2##(2008-7#1)(2011-2#1)
with discontinuation of##2##3##(1996-5#1)(2009-5#1)
with discontinuous##2##2##(2008-2#1)(2012-2#1)
with discordant##2##2##(2011-1#1)(2012-3#1)
with discrepancies in##2##3##(2008-10#1)(2012-2#1)
with discrete##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
with discriminative thermal washes##2##4##(1990-7#2)
with discussion of##4##3##(2007-8#1)(2008-4#1)(2009-3#1)(2013-8#1)
with discussion##6##2##(1996-11#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-3#1)(2013-8#1)
with disease activity and##2##4##(2006-10#1)(2012-2#1)
with disease activity##4##3##(1992-3#1)(2006-10#1)(2009-6#1)(2012-2#1)
with disease incidence##5##3##(2008-10#5)
with disease management##2##3##(1995-3#1)(2008-10#1)
with disease prevalence##2##3##(2008-10#1)(2008-8#1)
with disease progression##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
with disease severity##6##3##(1990-3#1)(2008-10#3)(2009-2#1)(2013-1#1)
with disease suppressiveness##2##3##(2008-10#2)
with disease##36##2##(1990-12#1)(1990-3#2)(1992-3#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#19)(2008-8#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
with diseased##5##2##(2008-10#5)
with disodium##3##2##(1997-6#1)(2008-10#2)
with disordered##2##2##(1997-2#1)(2008-1#1)
with disorders##3##2##(1991-12#1)(1991-5#1)(2012-2#1)
with dispersal##3##2##(2008-9#2)(2010-4#1)
with displaced fractures##2##3##(2013-1#2)
with displaced##3##2##(2012-2#1)(2013-1#2)
with displacement##2##2##(2008-11#1)(2008-3#1)
with disseminated##6##2##(1996-12#4)(2007-7#1)(2010-3#1)
with dissimilar##4##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-8#1)
with distal femoral##2##3##(2007-11#1)(2013-1#1)
with distal metaphyseal##2##3##(2013-1#2)
with distal##13##2##(1991-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
with distance from the##3##4##(2008-10#3)
with distance from##4##3##(2008-10#3)(2012-2#1)
with distance##9##2##(1991-8#1)(2008-10#5)(2008-3#1)(2008-9#1)(2012-2#1)
with distant metastases##4##3##(1993-1#2)(2008-6#2)
with distant##5##2##(1993-1#2)(1993-8#1)(2008-6#2)
with distilled water and##2##4##(2008-10#1)(2008-12#1)
with distilled water##5##3##(1996-12#1)(2008-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
with distilled##6##2##(1996-12#1)(2008-10#2)(2008-12#1)(2010-5#1)(2013-1#1)
with distinct characteristics##2##3##(2007-5#1)(2008-8#1)
with distinct##17##2##(1995-11#1)(1995-12#1)(1996-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-6#2)(2008-8#2)(2011-1#1)(2011-2#1)
with distinctive##2##2##(1991-12#1)(2009-8#1)
with distributed feedback##2##3##(2008-2#1)(2008-3#1)
with distributed##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
with disturbed##3##2##(1994-5#1)(2008-12#1)(2012-3#1)
with disulfide##2##2##(2007-7#1)(2008-4#1)
with dithionite##2##2##(1991-2#1)(1993-11#1)
with dithiothreitol (DTT)##3##3##(1990-11#1)(1990-12#1)(2012-2#1)
with dithiothreitol##4##2##(1990-11#1)(1990-12#1)(2008-5#1)(2012-2#1)
with dithizone and zinc dithizonate##2##5##(2008-10#2)
with dithizone and##3##3##(2008-10#3)
with dithizone##5##2##(2008-10#5)
with diuretics##2##2##(2009-9#1)(2010-6#1)
with diurnal##4##2##(2008-10#1)(2008-7#2)(2013-1#1)
with divalent##4##2##(1995-11#1)(2008-10#3)
with divergence timing information##2##4##(2008-1#2)
with divergence##3##2##(2008-1#2)(2009-2#1)
with divergent differentiation##3##3##(2012-12#3)
with divergent##4##2##(1995-2#1)(2012-12#3)
with diverse populations##3##3##(2008-6#1)(2010-8#1)(2012-2#1)
with diverse##19##2##(1990-12#1)(1991-5#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
with division of labor##2##4##(2008-8#2)
with dobutamine##3##2##(1994-11#2)(1996-2#1)
with docetaxel##2##2##(2008-6#1)(2011-1#1)
with doctorate##2##2##(1994-12#1)(2013-8#1)
with doctors##2##2##(2008-11#2)
with documented##9##2##(1990-3#1)(1993-2#1)(2006-10#2)(2008-11#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-2#1)
with dog##2##2##(1992-8#1)(2012-3#1)
with dominant##7##2##(1990-3#1)(1991-5#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
with domperidone##2##2##(2008-7#2)
with donor##3##2##(1994-9#1)(2011-2#2)
with dopamine##5##2##(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-7#1)
with dopaminergic##5##2##(1993-2#1)(1997-2#1)(2008-7#2)(2012-1#1)
with dose##6##2##(1993-8#1)(1996-6#1)(2008-3#1)(2008-7#2)(2013-1#1)
with doses of##2##3##(1990-2#1)(2008-10#1)
with doses##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
with double stranded DNA##2##4##(1990-12#1)(2007-11#1)
with double stranded##3##3##(1990-12#1)(2007-11#1)(2008-10#1)
with double##18##2##(1990-12#1)(1991-4#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
with double-focusing##2##2##(2008-10#2)
with double-stranded DNA in large excess##2##6##(2008-10#2)
with double-stranded##4##2##(2008-10#3)(2010-4#1)
with doxorubicin (12 mg/kg##2##4##(2011-2#2)
with doxorubicin##6##2##(1995-12#1)(2008-11#1)(2011-2#3)(2012-1#1)
with doxycycline##3##2##(1997-7#1)(2007-12#1)(2007-2#1)
with dramatic##2##2##(1995-1#1)(1997-5#1)
with drip##2##2##(2008-10#1)(2010-4#1)
with drought##2##2##(2012-7#2)
with drug addiction##4##3##(2009-7#3)(2011-1#1)
with drug treatment##3##3##(1993-6#1)(2007-7#1)(2008-4#1)
with drug##19##2##(1990-2#1)(1990-8#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#3)(2010-11#1)(2011-1#2)(2011-2#1)
with drug-eluting stents##3##3##(2008-12#1)(2009-12#2)
with drug-eluting##5##2##(2008-11#1)(2008-12#1)(2009-12#3)
with drugs and##4##3##(1994-9#1)(2008-4#1)(2011-1#1)(2013-1#1)
with drugs##20##2##(1990-10#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
with dry skin##4##3##(2008-5#4)
with dry##6##2##(2008-10#1)(2008-5#4)(2008-8#1)
with dsDNA and##2##3##(2008-10#2)
with dsDNA##3##2##(2008-10#3)
with dual##6##2##(1994-9#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
with dual-energy##2##2##(2008-12#1)(2008-7#1)
with dual-frequency##2##2##(2007-11#2)
with dual-grating##2##2##(2007-12#1)(2008-2#1)
with duodenal ulcer is##2##4##(1992-11#1)(2008-12#1)
with duodenal##5##2##(1992-11#1)(1997-1#1)(2008-12#2)(2012-3#1)
with duplex##2##2##(2007-7#1)(2011-5#1)
with durable resistance to##2##4##(2008-10#2)
with durable resistance##3##3##(2008-10#3)
with dural arteriovenous##3##3##(1996-9#3)
with dural##4##2##(1996-9#4)
with duration of ethanol exposure##2##5##(2011-2#2)
with duration of##8##3##(1991-9#1)(1994-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#3)
with duration##9##2##(1991-9#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#3)
with durations##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
with dynamic surface tension detection##2##5##(2008-10#2)
with dynamic##10##2##(1991-11#1)(1992-12#1)(1994-8#1)(2008-10#3)(2008-3#1)(2010-10#1)(2010-8#1)(2012-2#1)
with dynamically##2##2##(1996-4#1)(2008-3#1)
with dysarthria##2##2##(2007-10#1)(2007-8#1)
with dyslexia may##2##3##(2008-12#2)
with dyslexia##6##2##(2008-12#6)
with dysphagia and##4##3##(1997-8#1)(2008-1#1)(2012-3#1)(2013-1#1)
with dysphagia##12##2##(1997-8#1)(2007-10#2)(2008-1#2)(2010-7#1)(2012-3#3)(2013-1#1)(2013-8#2)
with dysplasia##2##2##(2007-11#1)(2013-1#1)
with dyspnea##2##2##(2007-8#1)(2009-1#1)
with dyspnoea##4##2##(2009-4#1)(2011-2#3)
with ePTFE##3##2##(2007-7#1)(2007-8#1)(2011-3#1)
with each antibiotic##2##3##(1996-6#2)
with each of four##2##4##(2008-4#1)(2013-7#1)
with each of the##8##4##(1990-12#1)(1992-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-6#1)
with each of these##2##4##(2008-10#1)(2012-12#1)
with each of##16##3##(1990-12#1)(1992-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
with each other and with the##4##6##(1997-4#1)(2008-10#2)(2010-7#1)
with each other and with##8##5##(1994-1#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-7#1)
with each other and##13##4##(1994-1#1)(1996-2#1)(1997-4#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)
with each other as##2##4##(1993-8#1)(1997-6#1)
with each other by##2##4##(2007-11#1)(2010-8#1)
with each other for##3##4##(1995-6#1)(1997-7#1)(2008-4#1)
with each other in a##2##5##(1995-2#1)(2012-12#1)
with each other in the##2##5##(1996-2#1)(2008-7#1)
with each other in##5##4##(1995-2#1)(1996-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
with each other on##2##4##(1997-1#1)(2008-7#1)
with each other to form a##2##6##(1995-2#1)(2008-8#1)
with each other to##4##4##(1995-2#1)(2008-8#1)(2011-1#1)(2012-3#1)
with each other##78##3##(1991-10#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
with each pathogen##2##3##(2008-10#1)(2008-3#1)
with each probe##2##3##(2008-10#1)(2008-8#1)
with each sample##3##3##(2008-10#2)(2008-7#1)
with each##160##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#2)(1995-8#3)(1996-1#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(2006-10#3)(2007-11#1)(2007-12#5)(2007-7#1)(2008-1#3)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#3)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
with ear##2##2##(2007-7#1)(2008-7#1)
with earlier findings##2##3##(1995-6#1)(2008-7#1)
with earlier reports##2##3##(1993-6#1)(1996-6#1)
with earlier work##2##3##(2008-10#2)
with earlier##19##2##(1992-10#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-6#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2013-1#1)
with early &quot##2##3##(1992-6#1)(2008-1#1)
with early breast cancer##6##4##(1991-8#2)(1994-12#1)(2011-2#3)
with early cervical cancer##2##4##(2010-11#1)(2012-3#1)
with early devices##2##3##(2007-8#2)
with early gastric##2##3##(1990-9#1)(2008-5#1)
with early onset##2##3##(1995-12#1)(2008-8#1)
with early psychosis##4##3##(2008-1#1)(2011-1#3)
with early sexual##4##3##(2012-1#1)(2013-8#3)
with early##54##2##(1990-9#1)(1991-12#1)(1991-8#2)(1992-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-5#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
with early-onset##2##2##(2012-3#1)(2013-1#1)
with easily##2##2##(2008-10#2)
with eating concerns##2##3##(2007-12#2)
with eating disorders##11##3##(1997-3#1)(1997-7#1)(2007-7#1)(2008-11#3)(2008-4#1)(2011-2#4)
with eating##15##2##(1997-3#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-11#4)(2008-4#1)(2011-2#4)(2012-1#1)
with echocardiography##2##2##(2009-1#1)(2013-1#1)
with ecological##2##2##(2008-10#1)(2008-9#1)
with ectopic ACTH##3##3##(1990-3#1)(2011-2#2)
with ectopic##5##2##(1990-3#1)(2011-2#2)(2013-1#2)
with eczema##3##2##(2007-7#1)(2010-6#1)(2013-1#1)
with edema##2##2##(1993-8#1)(2006-10#1)
with education##5##2##(1993-1#1)(1995-1#1)(1996-5#1)(2008-9#1)(2011-2#1)
with educational##4##2##(1990-9#1)(2008-11#1)(2009-7#1)(2012-3#1)
with efavirenz##2##2##(2008-5#2)
with effect of strengthening Qi##4##5##(2012-3#4)
with effect##7##2##(2008-7#1)(2008-9#1)(2012-3#4)(2013-1#1)
with effective##6##2##(1993-11#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-1#1)
with effects##7##2##(1991-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
with efficiency##3##2##(1993-11#1)(2008-10#1)(2008-3#1)
with effort##2##2##(2008-10#1)(2008-6#1)
with effusion##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
with egg##2##2##(1990-3#1)(2008-12#1)
with eight runs##2##3##(2008-10#2)
with eight##24##2##(1992-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-8#2)(2012-3#1)(2013-7#1)(2013-8#1)
with either ACh or (1S##2##5##(1996-5#2)
with either HIV##2##3##(1996-1#1)(2007-2#1)
with either S##2##3##(1995-5#1)(2008-10#1)
with either a fixed##2##4##(2008-10#1)(2008-8#1)
with either a##20##3##(1992-3#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)
with either laminectomy##2##3##(1996-9#2)
with either neuraminidase##2##3##(1990-5#2)
with either no or##2##4##(2008-3#1)(2010-1#1)
with either of two##2##4##(1997-7#1)(2008-10#1)
with either of##4##3##(1997-7#1)(2008-10#2)(2008-12#1)
with either pathogen##2##3##(2008-10#2)
with either the##12##3##(1991-5#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-2#1)(2008-10#5)(2008-4#1)(2008-6#1)
with either##177##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#1)(1994-6#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#4)(1995-6#3)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#45)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
with elastic##6##2##(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#1)(2012-2#1)
with elbow##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
with elderly##2##2##(1991-12#1)(1995-5#1)
with electric eel AChE##2##4##(2008-10#1)(2009-8#1)
with electric##4##2##(1996-8#1)(2008-10#2)(2009-8#1)
with electrical##5##2##(1994-5#3)(2008-10#1)(2008-3#1)
with electrically##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
with electrocardiographic##2##2##(2008-7#1)(2009-7#1)
with electrochemical detection for##2##4##(1991-5#1)(2008-10#1)
with electrochemical detection of##2##4##(2008-10#2)
with electrochemical detection##18##3##(1991-5#4)(2008-10#14)
with electrochemical##25##2##(1991-5#4)(2008-10#19)(2008-3#1)(2010-11#1)
with electrode I and##2##4##(2008-10#2)
with electrode##5##2##(2008-10#5)
with electrodes##2##2##(2008-9#1)(2009-3#1)
with electrogenerated##2##2##(2008-10#2)
with electromagnetic##2##2##(2008-8#1)(2013-1#1)
with electron beams##3##3##(2007-10#2)(2012-1#1)
with electron capture detection##5##4##(2008-10#5)
with electron capture##6##3##(2008-10#6)
with electron##17##2##(1995-5#1)(2007-10#3)(2008-10#10)(2008-5#1)(2009-9#1)(2012-1#1)
with electronic speckle pattern interferometry##3##5##(2008-2#1)(2008-3#2)
with electronic##9##2##(1990-11#1)(2008-10#1)(2008-2#2)(2008-3#5)
with electrons##2##2##(2007-10#1)(2007-12#1)
with electrophysiological##2##2##(2007-12#1)(2008-12#1)
with electropolymerized##2##2##(2008-10#2)
with electrospray MS detection##2##4##(2008-10#2)
with electrospray ionization mass spectrometry##2##5##(2008-10#2)
with electrospray ionization##3##3##(2008-10#2)(2011-3#1)
with electrospray mass spectrometry##2##4##(1994-12#1)(2008-10#1)
with electrospray##7##2##(1994-12#1)(2008-10#5)(2011-3#1)
with electrosurgery##2##2##(1996-1#2)
with electrothermal atomic absorption spectrometry (ETAAS)##2##6##(2008-10#2)
with electrothermal atomic absorption spectrometry##3##5##(2008-10#3)
with electrothermal##4##2##(2008-10#4)
with elemental##2##2##(2007-11#1)(2007-12#1)
with elements from the##2##4##(2008-3#1)(2011-2#1)
with elevated concentrations of##5##4##(1991-6#1)(1992-3#1)(2008-10#2)(2013-1#1)
with elevated levels of##9##4##(1990-2#1)(1990-9#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
with elevated risk##2##3##(1991-1#1)(1994-11#1)
with elevated serum levels of##2##5##(2006-10#1)(2013-1#1)
with elevated serum##6##3##(1991-8#1)(2006-10#1)(2008-3#1)(2012-5#1)(2013-1#2)
with elevated##51##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-2#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-7#1)(2012-5#1)(2012-7#2)(2013-1#4)
with elevation of the ST##2##5##(2008-10#2)
with elevation of the##3##4##(2008-10#3)
with elevation of##6##3##(1995-3#1)(2008-10#3)(2010-1#2)
with elevation##8##2##(1995-3#1)(2008-10#3)(2009-2#2)(2010-1#2)
with elimination of##2##3##(1990-5#1)(2008-3#1)
with elimination##4##2##(1990-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
with elliptical##2##2##(2007-11#1)(2008-3#1)
with elongation##2##2##(1992-8#1)(2008-10#1)
with embedded##2##2##(2008-2#1)(2009-8#1)
with embolization##2##2##(1993-6#1)(2009-9#1)
with emergence##2##2##(2007-2#1)(2011-2#1)
with emergency##5##2##(1993-12#1)(1994-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
with emerging##2##2##(1994-12#1)(1996-3#1)
with emission##2##2##(2008-3#1)(2009-12#1)
with emotional##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
with emotionally challenging##2##3##(2008-11#1)(2008-7#1)
with emotionally##4##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
with emphasis on depression##3##4##(1995-1#1)(1995-2#1)(1995-3#1)
with emphasis on the role of##2##6##(2008-10#1)(2008-11#1)
with emphasis on the##19##4##(1990-9#1)(1991-3#1)(1991-8#1)(1993-2#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-11#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
with emphasis on##56##3##(1990-12#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
with emphasis placed on the##2##5##(2008-11#1)(2008-2#1)
with emphasis##58##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
with emphysematous##2##2##(1991-12#1)(2012-3#1)
with empirical##3##2##(2008-10#3)
with employers##3##2##(1992-11#2)(1995-1#1)
with encephalitis##2##2##(2008-1#1)(2008-8#1)
with encouraging##4##2##(2007-8#1)(2008-6#1)(2010-5#1)(2011-2#1)
with end stage renal disease (ESRD)##3##6##(1995-1#1)(2007-7#2)
with end stage renal disease##4##5##(1995-1#1)(2007-7#2)(2009-5#1)
with end stage renal failure##2##5##(1997-8#1)(2008-1#1)
with end stage renal##6##4##(1995-1#1)(1997-8#1)(2007-7#2)(2008-1#1)(2009-5#1)
with end-stage PDR##4##3##(2013-1#4)
with end-stage liver disease##2##4##(2011-2#1)(2013-8#1)
with end-stage renal disease (ESRD) in##2##6##(2007-7#1)(2008-1#1)
with end-stage renal disease (ESRD)##5##5##(2007-7#3)(2008-1#2)
with end-stage renal disease##14##4##(2007-12#1)(2007-7#5)(2008-1#6)(2012-12#1)(2013-1#1)
with end-stage renal failure##4##4##(1991-11#1)(2008-1#1)(2008-4#1)(2013-1#1)
with end-stage renal##19##3##(1991-11#1)(2007-12#1)(2007-7#5)(2008-1#7)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#2)
with end-stage##32##2##(1991-11#1)(1994-3#1)(2007-12#1)(2007-7#5)(2008-1#7)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#8)(2013-8#1)
with endocrine differentiation##2##3##(1991-8#1)(1992-2#1)
with endogenous##7##2##(1993-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)
with endometrial##4##2##(1991-12#1)(1995-3#2)(2012-3#1)
with endoscopic submucosal dissection##2##4##(2013-1#1)(2013-8#1)
with endoscopic##7##2##(2006-12#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
with endothelial cells##5##3##(1991-9#1)(1993-3#1)(2008-1#1)(2008-12#1)(2008-9#1)
with endothelial##10##2##(1991-9#1)(1993-3#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#3)
with endothelin-1##2##2##(1990-2#1)(1992-3#1)
with endovascular##4##2##(1997-2#1)(2007-8#1)(2008-12#2)
with ends##2##2##(2008-5#1)(2009-5#1)
with energies as##2##3##(2007-11#1)(2007-12#1)
with energies of##5##3##(2007-11#2)(2007-12#1)(2008-3#1)(2008-7#1)
with energies##7##2##(2007-11#3)(2007-12#2)(2008-3#1)(2008-7#1)
with energy of 3##2##4##(2007-11#2)
with energy of##3##3##(2007-11#2)(2007-12#1)
with energy##5##2##(2007-11#2)(2007-12#2)(2008-5#1)
with enhanced sensitivity##2##3##(2008-3#1)(2008-5#1)
with enhanced surface##2##3##(1994-5#1)(2008-11#1)
with enhanced##38##2##(1990-12#2)(1991-12#1)(1992-11#1)(1993-2#1)(1994-3#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
with enhancement of##2##3##(2008-10#1)(2010-11#1)
with enriched stable isotopes##3##4##(2010-8#3)
with enriched##4##2##(2010-8#4)
with enrichment factor of##2##4##(2008-10#2)
with enrichment##6##2##(2008-10#4)(2008-8#2)
with enrofloxacin##2##2##(1997-3#2)
with ensuring##2##2##(1996-12#1)(1997-5#1)
with entecavir##2##2##(2009-8#1)(2013-1#1)
with enteral nutrition##2##3##(2013-1#2)
with enuresis##2##2##(2007-7#2)
with environment##2##2##(2008-8#1)(2011-1#1)
with environmental factors##2##3##(2008-4#1)(2012-3#1)
with environmental##14##2##(1991-12#2)(1992-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-3#2)(2013-1#1)
with enzyme##10##2##(1990-5#1)(1991-7#1)(1993-6#1)(1994-12#1)(2008-10#4)(2008-3#1)(2011-3#1)
with enzymes##2##2##(2008-10#2)
with epidemiological##6##2##(2008-10#2)(2008-11#3)(2013-1#1)
with epidermal growth factor (EGF)##3##5##(1992-3#1)(1992-9#1)(1995-2#1)
with epidermal growth factor##4##4##(1992-2#1)(1992-3#1)(1992-9#1)(1995-2#1)
with epidermal##5##2##(1992-2#1)(1992-3#1)(1992-9#1)(1995-2#1)(2008-5#1)
with epidermolysis bullosa##3##3##(2012-3#3)
with epidural##4##2##(1992-11#1)(1993-10#1)(2012-3#2)
with epigastric pain##2##3##(1996-8#1)(2013-1#1)
with epilepsy##12##2##(1996-3#1)(1997-8#1)(2008-11#3)(2008-12#1)(2008-2#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
with epileptic seizure##2##3##(2010-12#1)(2010-4#1)
with epileptic seizures##2##3##(2008-7#1)(2010-11#1)
with epileptic##4##2##(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)
with epinephrine and##2##3##(2008-10#1)(2010-1#1)
with epinephrine##6##2##(1990-5#1)(1991-12#1)(1993-1#2)(2008-10#1)(2010-1#1)
with epirubicin##3##2##(1990-10#1)(1991-2#1)(1991-6#1)
with episodes of##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
with episodic##2##2##(2011-1#1)(2012-3#1)
with epistaxis and##2##3##(2011-1#2)
with epistaxis##3##2##(1994-3#1)(2011-1#2)
with epithelial and myoepithelial differentiation##2##5##(2007-5#2)
with epithelial##6##2##(1994-12#1)(1994-7#1)(2007-5#2)(2008-5#1)(2008-6#1)
with epoetin alfa##2##3##(2008-7#2)
with epoetin##5##2##(2008-7#5)
with epoxy##3##2##(2008-10#2)(2009-7#1)
with equal efficiency##2##3##(1995-3#1)(2008-10#1)
with equal variances##2##3##(2008-10#1)(2012-1#1)
with equal##18##2##(1994-3#1)(1994-5#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-6#1)(2012-1#5)
with equalized##2##2##(2007-11#1)(2008-5#1)
with equimolar doses of##2##4##(1994-5#1)(2008-10#1)
with equimolar##3##2##(1994-5#1)(2008-10#2)
with equipment##3##2##(2011-1#2)(2011-2#1)
with equivalent conventional##2##3##(2008-3#2)
with equivalent frequency##2##3##(1994-11#1)(2009-5#1)
with equivalent##9##2##(1994-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2009-5#1)(2012-2#1)(2012-3#1)
with erbium hydroxide##2##3##(2008-10#2)
with ergosterol##2##2##(1997-2#2)
with errors in##2##3##(2007-12#1)(2008-3#1)
with errors##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
with erythema##2##2##(2008-7#1)(2008-8#1)
with erythrocyte##2##2##(1992-6#1)(2008-8#1)
with erythropoietic agents##2##3##(2008-7#2)
with erythropoietin##3##2##(2008-1#1)(2008-11#2)
with esophageal##5##2##(2007-8#4)(2010-12#1)
with esophagus and bronchus##2##4##(2007-8#2)
with essential hypertension##7##3##(1992-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#1)(2013-7#1)
with essential##11##2##(1992-6#1)(1993-3#1)(1995-10#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#1)(2013-1#1)(2013-7#1)
with established coronary heart disease##2##5##(2008-3#1)(2010-6#1)
with established coronary##4##3##(2008-1#1)(2008-3#1)(2009-12#1)(2010-6#1)
with established##21##2##(1991-9#1)(1993-11#3)(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#5)(2009-12#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
with estimated##5##2##(1990-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-3#1)
with estimates of the##2##4##(1992-6#1)(2008-3#1)
with estimates of##3##3##(1992-6#1)(2008-3#1)(2008-8#1)
with estimates##4##2##(1992-6#1)(1993-3#1)(2008-3#1)(2008-8#1)
with estradiol##3##2##(1992-5#3)
with estrogen receptor##3##3##(2008-11#2)(2011-2#1)
with estrogen##8##2##(1993-9#1)(1997-7#2)(2008-11#4)(2011-2#1)
with estrogenic##2##2##(2008-10#1)(2008-11#1)
with ethanol extract of##2##4##(2012-2#2)
with ethanol extract##3##3##(2008-10#1)(2012-2#2)
with ethanol or##2##3##(1994-8#1)(2008-10#1)
with ethanol##27##2##(1991-1#1)(1994-7#1)(1994-8#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-10#11)(2008-11#2)(2009-7#1)(2009-8#3)(2011-2#1)(2012-2#2)(2013-8#1)
with ether##2##2##(2008-2#1)(2008-5#1)
with ethical##5##2##(1995-1#1)(1995-5#1)(1996-2#1)(2011-2#1)(2013-1#1)
with ethidium bromide##3##3##(1990-2#1)(1990-7#1)(2006-8#1)
with ethyl acetate as the##2##5##(2008-10#2)
with ethyl acetate##8##3##(1996-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-3#1)
with ethyl iodide##2##3##(1996-2#1)(2008-11#1)
with ethyl##15##2##(1996-2#2)(1996-5#3)(2008-10#5)(2008-11#2)(2008-6#1)(2010-5#1)(2011-3#1)
with ethylenediamine##2##2##(2008-10#2)
with ethylenediaminetetraacetic##2##2##(2008-10#2)
with etiologic##2##2##(2007-10#2)
with eukaryotic##5##2##(1992-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2010-4#1)
with evaluation of##2##3##(1994-5#1)(2007-7#1)
with evanescent##2##2##(2008-3#2)
with evaporative light scattering detection##3##5##(2008-10#3)
with evaporative##4##2##(1995-3#1)(2008-10#3)
with even##2##2##(1990-8#1)(1997-2#1)
with every##9##2##(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-3#1)(2012-6#1)
with evidence from##2##3##(2008-11#1)(2010-5#1)
with evidence of##13##3##(1991-12#2)(1992-2#1)(1994-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
with evidence##18##2##(1991-12#2)(1992-2#1)(1994-6#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-7#1)
with evidence-based medicine##2##3##(2007-12#1)(2008-11#1)
with evidence-based##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
with evolution##2##2##(1994-12#1)(1997-8#1)
with evolutionary##2##2##(2008-8#1)(2010-8#1)
with evolving##2##2##(2008-1#2)
with exact solutions##2##3##(2007-12#1)(2008-6#1)
with exact##7##2##(1993-12#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-6#1)
with examples including##2##3##(2011-1#2)
with examples of##4##3##(1991-3#1)(1996-2#1)(2008-12#1)(2008-7#1)
with examples##11##2##(1991-3#1)(1996-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-1#2)
with excellent cosmetic##2##3##(2008-10#1)(2008-9#1)
with excellent function##2##3##(2008-6#1)(2008-9#1)
with excellent results##4##3##(1990-6#1)(1991-4#1)(1996-3#1)(2011-3#1)
with excellent sensitivity##2##3##(2008-10#1)(2008-9#1)
with excellent##26##2##(1990-6#1)(1991-4#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-10#9)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2011-3#1)(2013-1#2)
with exception of##3##3##(1992-3#1)(2008-10#1)(2012-2#1)
with exception##5##2##(1992-3#1)(2008-10#2)(2009-4#1)(2012-2#1)
with excess iodide in acidic medium##2##6##(2008-10#2)
with excess of##2##3##(1992-3#1)(2008-10#1)
with excess##22##2##(1991-9#1)(1992-3#4)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2011-2#2)(2012-2#1)
with excessive##4##2##(1990-9#1)(2007-8#1)(2012-4#1)(2013-1#1)
with excimer##2##2##(2008-2#1)(2008-3#1)
with excipient##2##2##(2008-5#2)
with excised##2##2##(2008-10#1)(2008-5#1)
with excision of the##2##4##(2008-10#1)(2013-8#1)
with excision of##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
with excitation and emission##2##4##(1990-8#1)(2008-10#1)
with excitation at##9##3##(1990-8#1)(1997-2#1)(2008-10#4)(2008-2#2)(2011-1#1)
with excitation##12##2##(1990-8#2)(1997-2#1)(2007-11#1)(2008-10#5)(2008-2#2)(2011-1#1)
with excited delirium##2##3##(2010-1#2)
with excited##3##2##(2010-1#2)(2012-2#1)
with executive##2##2##(2009-10#1)(2010-6#1)
with exercise##8##2##(1996-6#1)(2007-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#2)(2013-8#1)
with exercise-induced##2##2##(1997-1#1)(2008-7#1)
with existing techniques##2##3##(2008-10#1)(2008-2#1)
with existing##25##2##(1991-9#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
with exogenous##8##2##(1994-11#1)(1995-12#2)(1996-9#2)(2008-8#2)(2010-11#1)
with expanding##3##2##(1997-5#1)(2008-11#1)(2012-3#1)
with expectation##2##2##(1996-6#1)(2010-3#1)
with expectations for##2##3##(2008-10#1)(2008-8#1)
with expectations##5##2##(1997-2#1)(2008-10#2)(2008-8#1)(2008-9#1)
with expected##5##2##(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)
with experience##4##2##(1991-12#1)(1995-1#1)(1996-1#1)(2010-6#1)
with experienced##2##2##(2008-3#1)(2011-2#1)
with experiment##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
with experimental and##3##3##(2008-3#2)(2008-7#1)
with experimental data and##2##4##(1996-12#1)(2008-2#1)
with experimental data obtained##2##4##(2008-3#2)
with experimental data of##2##4##(2008-2#2)
with experimental data##20##3##(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#4)(2010-10#1)(2011-1#1)(2011-2#1)
with experimental measurements of##2##4##(2008-3#1)(2010-10#1)
with experimental measurements##8##3##(2007-12#2)(2008-3#4)(2009-7#1)(2010-10#1)
with experimental observations##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
with experimental results for##2##4##(1996-5#1)(2008-2#1)
with experimental results##16##3##(1996-5#1)(2007-11#2)(2008-2#4)(2008-3#6)(2010-2#1)(2013-1#2)
with experimental values##2##3##(1993-11#1)(2008-11#1)
with experimental##67##2##(1993-11#2)(1996-12#1)(1996-5#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#13)(2008-3#21)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#3)
with experimentally observed##2##3##(2007-12#1)(2008-2#1)
with experimentally##6##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
with experiments##6##2##(2008-10#1)(2008-3#4)(2010-10#1)
with expert##4##2##(1991-2#1)(1993-12#1)(1996-6#1)(2010-9#1)
with experts##2##2##(2012-12#1)(2012-2#1)
with explicit##3##2##(1993-11#1)(1995-1#1)(2008-11#1)
with exploratory##2##2##(1993-9#1)(2009-12#1)
with exposure to environmental##2##4##(2011-1#1)(2013-1#1)
with exposure to##9##3##(1991-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
with exposure##16##2##(1991-12#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
with expression of##5##3##(1992-6#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#1)
with expression vectors##3##3##(1994-10#1)(2008-11#1)(2008-9#1)
with expression##10##2##(1992-6#1)(1993-8#1)(1994-10#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
with exstrophy##4##2##(2008-10#4)
with extended##8##2##(1992-3#2)(1995-3#1)(1996-1#1)(1997-7#1)(2007-11#1)(2008-10#2)
with extended-release##2##2##(2010-4#2)
with extension into the##4##4##(2007-10#1)(2008-7#2)(2009-8#1)
with extension##5##2##(2007-10#1)(2008-7#2)(2009-8#1)(2013-8#1)
with extensive##29##2##(1991-9#1)(1992-11#1)(1992-2#2)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
with external##18##2##(1990-10#1)(1990-12#1)(1991-11#1)(1992-12#1)(1992-9#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-2#1)(2010-3#1)(2010-7#1)(2013-1#1)
with extinction##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
with extracellular recordings##2##3##(1996-5#1)(1997-2#1)
with extracellular##3##2##(1996-5#1)(1997-2#1)(2008-8#1)
with extracorporeal circulation##4##3##(2007-8#1)(2010-6#1)(2012-3#2)
with extracorporeal##9##2##(2007-12#2)(2007-7#1)(2007-8#1)(2010-5#1)(2010-6#1)(2012-3#3)
with extracted##4##2##(1995-2#1)(2008-8#1)(2010-5#2)
with extraction##3##2##(2008-10#2)(2013-1#1)
with extracts of##2##3##(2008-11#1)(2008-5#1)
with extracts##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
with extradural##2##2##(2006-12#1)(2008-12#1)
with extraordinary##3##2##(2008-2#2)(2012-2#1)
with extreme values in##2##4##(2008-5#1)(2012-3#1)
with extreme##13##2##(1991-6#1)(1992-5#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-7#1)(2012-2#1)(2012-3#2)
with extremely high##6##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
with extremely long##2##3##(1997-3#1)(2007-12#1)
with extremely##12##2##(1992-3#1)(1993-3#1)(1997-3#1)(2007-12#3)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)
with eye##3##2##(2008-10#2)(2012-3#1)
with eyes closed##2##3##(2008-7#2)
with fMRI##4##2##(1995-12#1)(2008-11#1)(2009-8#1)(2013-8#1)
with face##2##2##(1997-1#1)(2009-7#1)
with facial nerve palsy##2##4##(2007-8#1)(2011-2#1)
with facial nerve##5##3##(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#2)
with facial##7##2##(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#2)
with factor Xa##2##3##(1994-5#2)
with factor##8##2##(1990-5#1)(1994-5#3)(1995-12#1)(1995-2#1)(2008-5#1)(2009-6#1)
with failed##6##2##(2008-10#2)(2012-3#2)(2013-1#2)
with failure of##3##3##(1993-9#1)(2008-1#1)(2010-12#1)
with failure##6##2##(1993-9#1)(1994-2#1)(2008-1#1)(2010-12#1)(2010-6#1)(2012-3#1)
with false##3##2##(1996-6#2)(2013-8#1)
with familial AD##2##3##(1994-8#1)(1996-5#1)
with familial and##2##3##(1997-5#1)(2010-12#1)
with familial##17##2##(1990-2#1)(1990-6#1)(1992-8#3)(1993-12#1)(1994-8#1)(1996-5#2)(1997-5#1)(2007-10#2)(2008-12#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
with families##4##2##(2010-5#1)(2010-9#1)(2012-3#2)
with family members##4##3##(1993-1#1)(2007-11#1)(2010-11#1)(2013-1#1)
with family##10##2##(1990-12#1)(1993-1#1)(2007-11#1)(2007-7#1)(2008-7#2)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
with far##2##2##(1997-4#1)(2011-2#1)
with fast furnace analysis##2##4##(2008-10#2)
with fast##10##2##(1994-6#1)(1995-8#1)(2008-10#4)(2008-3#3)(2008-7#1)
with faster##2##2##(1993-2#1)(2008-10#1)
with fasting##4##2##(1990-12#1)(1992-6#1)(2008-1#1)(2008-3#1)
with fat##5##2##(2008-8#1)(2013-1#4)
with fatal outcome##2##3##(2007-8#1)(2009-1#1)
with fatal trauma in##2##4##(2012-12#2)
with fatal##6##2##(1993-6#1)(1997-3#1)(2007-8#1)(2009-1#1)(2012-12#2)
with fatigue##4##2##(1993-9#3)(2010-8#1)
with fatty acid binding protein##2##5##(1994-8#2)
with fatty acid##4##3##(1994-8#2)(2008-10#1)(2009-8#1)
with fatty acids##2##3##(1992-6#1)(1995-2#1)
with fatty##7##2##(1992-6#1)(1994-8#2)(1995-2#1)(1997-3#1)(2008-10#1)(2009-8#1)
with favorable##4##2##(1992-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
with favourable##5##2##(2008-5#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-2#1)
with fear##2##2##(2010-4#1)(2012-2#1)
with features indeterminate for MDS versus MPN&quot##3##7##(2009-8#3)
with features of##12##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#2)(2013-1#2)
with features##23##2##(1993-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
with febrile##4##2##(2011-2#2)(2012-12#2)
with feedback##2##2##(2007-11#1)(2012-2#1)
with feeding##4##2##(1994-2#1)(2007-10#1)(2009-8#1)(2013-1#1)
with female L(S)##2##3##(2010-8#2)
with female##9##2##(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-8#2)
with females##3##2##(2009-5#1)(2012-12#2)
with femoral neck##2##3##(2007-8#1)(2010-3#1)
with femoral##5##2##(2007-11#1)(2007-8#1)(2010-3#1)(2013-1#2)
with femtosecond laser pulses in##2##5##(2007-12#1)(2008-3#1)
with femtosecond laser pulses##6##4##(2007-12#4)(2008-3#2)
with femtosecond pulses##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
with femtosecond##13##2##(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#2)
with fentanyl##2##2##(1993-1#1)(2010-7#1)
with ferbam##2##2##(2008-10#2)
with ferroelectric##2##2##(2008-2#2)
with ferrozine by flow-injection analysis##2##5##(2008-10#2)
with ferrozine##3##2##(2008-10#3)
with fertility##2##2##(2008-9#1)(2011-1#1)
with fetal chromosomal abnormalities##2##4##(1995-8#2)
with fetal##13##2##(1991-2#1)(1994-3#1)(1994-5#1)(1995-8#5)(2008-11#1)(2008-3#2)(2010-3#1)(2012-3#1)
with fever##16##2##(1990-11#1)(1996-12#1)(1997-6#1)(2006-5#2)(2007-5#1)(2008-11#1)(2009-11#2)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
with few exceptions##2##3##(2007-8#1)(2008-7#1)
with few side effects##2##4##(2008-2#1)(2010-5#1)
with few##19##2##(1991-10#1)(1994-6#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
with fewer complications##2##3##(2008-7#1)(2012-3#1)
with fewer resources##2##3##(1993-2#1)(2008-11#1)
with fewer side effects##4##4##(1997-3#1)(2009-12#2)(2011-2#1)
with fewer than##3##3##(2008-1#1)(2011-2#2)
with fewer##25##2##(1993-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-12#2)(2009-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#2)
with fiber Bragg gratings##2##4##(2007-12#1)(2008-2#1)
with fiber Bragg##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
with fiber##13##2##(1992-11#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)
with fiber-optic##4##2##(2008-2#2)(2008-3#2)
with fibers##2##2##(2008-11#1)(2012-2#1)
with fibre##2##2##(1995-12#1)(2008-7#1)
with fibrin##5##2##(2007-8#1)(2008-11#4)
with fibrinogen##2##2##(2006-6#1)(2008-11#1)
with fibrinogenase activity indicated that##2##5##(1992-8#1)(1994-6#1)
with fibroblast##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
with fibroids##2##2##(1994-2#1)(2010-11#1)
with fibrosis##2##2##(2009-8#1)(2011-2#1)
with fibrous##5##2##(1991-12#1)(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
with field data##2##3##(2008-10#2)
with field observations##2##3##(2008-8#1)(2008-9#1)
with field##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2012-3#1)
with figures##2##2##(2008-9#1)(2011-7#1)
with files and##2##3##(2008-12#1)(2008-9#1)
with filgrastim##2##2##(2008-7#2)
with fill##2##2##(2008-2#2)
with films##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
with filters##2##2##(1997-1#1)(2008-6#1)
with final##6##2##(1996-5#1)(2008-10#2)(2008-12#2)(2011-2#1)
with financial support##2##3##(2008-4#1)(2010-10#1)
with financial##7##2##(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-4#1)(2010-10#1)
with findings in##4##3##(1990-12#1)(1990-6#1)(1997-3#1)(2008-3#1)
with findings of##2##3##(1993-12#1)(1997-3#1)
with findings on conventional##2##4##(2008-5#1)(2008-7#1)
with findings on##3##3##(1997-2#1)(2008-5#1)(2008-7#1)
with findings##10##2##(1990-12#1)(1990-6#1)(1993-12#1)(1997-2#1)(1997-3#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
with fine##5##2##(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)
with firm##2##2##(1992-1#1)(1993-3#1)
with first##7##2##(1990-12#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)
with first-ever stroke##2##3##(2007-10#2)
with first-ever##3##2##(2007-10#2)(2009-10#1)
with fish oil##2##3##(1990-2#1)(2008-7#1)
with fish##8##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
with fistula##2##2##(2007-8#2)
with fitness##3##2##(1995-2#1)(2008-8#2)
with five different##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
with five injections##2##3##(2008-10#2)
with five restriction enzymes##2##4##(2008-10#2)
with five##35##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#16)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-4#1)(2012-1#1)(2013-7#1)(2013-8#1)
with fixed appliances##2##3##(2013-1#1)(2013-8#1)
with fixed##11##2##(1992-2#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-9#1)(2013-1#3)(2013-8#1)
with flame atomic absorption spectrometry (FAAS)##5##6##(2008-10#5)
with flame atomic absorption spectrometry##10##5##(2008-10#9)(2013-8#1)
with flame atomic absorption##11##4##(2008-10#10)(2013-8#1)
with flame ionisation detection##2##4##(2008-10#2)
with flame ionization detection##2##4##(2008-5#2)
with flame ionization detector##2##4##(2008-10#1)(2012-1#1)
with flame ionization##4##3##(2008-10#1)(2008-5#2)(2012-1#1)
with flame photometric##2##3##(2008-10#2)
with flame##21##2##(2008-10#17)(2008-5#2)(2012-1#1)(2013-8#1)
with flapless surgery##3##3##(2013-1#3)
with flat##4##2##(1995-2#1)(2008-3#3)
with flexible##4##2##(1993-12#1)(2008-6#1)(2008-8#1)(2009-8#1)
with flow cytometry##2##3##(2008-9#1)(2011-3#1)
with flow injection (FI)##3##4##(2008-10#3)
with flow injection analysis (FIA)##2##5##(2008-10#2)
with flow injection analysis##7##4##(2008-10#7)
with flow injection##15##3##(2008-10#15)
with flow rate##2##3##(2008-5#1)(2011-2#1)
with flow##21##2##(2007-8#1)(2008-10#16)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)
with flow-injection analysis (FIA)##2##4##(2008-10#2)
with flow-injection analysis##3##3##(2008-10#3)
with flow-injection##6##2##(2008-10#5)(2010-4#1)
with flower##4##2##(2008-10#2)(2009-12#2)
with fluence rates of##2##4##(2008-7#2)
with fluence##4##2##(2007-12#2)(2008-7#2)
with fluid##4##2##(1995-11#1)(2008-10#1)(2010-10#1)(2012-12#1)
with fluorescein##6##2##(1993-6#1)(1995-5#1)(1996-5#1)(2008-10#2)(2008-9#1)
with fluorescence detection (HPLC-FD)##2##4##(2008-10#2)
with fluorescence detection and##4##4##(2008-10#4)
with fluorescence detection##20##3##(1990-8#2)(1991-5#1)(1996-5#1)(2008-10#15)(2008-11#1)
with fluorescence microscopy##2##3##(1995-5#1)(2008-11#1)
with fluorescence polarization##2##3##(2008-2#1)(2008-4#1)
with fluorescence spectroscopy and multivariate calibration##2##6##(2008-10#2)
with fluorescence spectroscopy##3##3##(2008-10#2)(2009-11#1)
with fluorescence##38##2##(1990-8#2)(1991-5#1)(1993-2#1)(1995-5#1)(1996-5#1)(2008-10#23)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)(2012-2#1)(2013-1#1)
with fluorescent dyes##2##3##(2006-6#1)(2008-10#1)
with fluorescent##8##2##(1993-11#1)(2006-6#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)
with fluoride and 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##2##4##(2008-10#2)
with fluoride##8##2##(1993-11#1)(2008-10#6)(2009-5#1)
with fluorimetric detection##10##3##(1990-8#2)(2008-10#8)
with fluorimetric##11##2##(1990-8#2)(2008-10#9)
with fluorine##2##2##(2009-9#2)
with fluorochromes##2##2##(2008-1#1)(2008-11#1)
with fluorometric##2##2##(1995-11#1)(2008-10#1)
with fluoropyrimidine##2##2##(1992-8#2)
with fluorouracil##3##2##(1992-8#2)(2008-5#1)
with fluoxetine##3##2##(1997-5#1)(2013-1#2)
with focal 6-o'-clock Nd##2##4##(2011-2#2)
with focal lengths##2##3##(2007-12#1)(2008-3#1)
with focal##18##2##(1996-5#1)(1997-3#2)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#4)(2013-1#3)(2013-8#1)
with focus on##4##3##(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
with focus##6##2##(2008-11#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
with focused##4##2##(1995-5#1)(2007-11#2)(2008-10#1)
with foetal##2##2##(2007-7#1)(2012-2#1)
with folate deficiency##2##3##(1992-9#1)(2008-7#1)
with folate##4##2##(1992-9#1)(1995-2#2)(2008-7#1)
with folic acid##6##3##(1992-9#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-1#1)
with follicular##4##2##(2010-11#2)(2010-3#1)(2012-3#1)
with follow-up of##2##3##(2008-7#1)(2012-12#1)
with follow-up##7##2##(1994-12#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
with food##11##2##(1993-6#2)(1995-10#1)(2007-12#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
with foods##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
with for##2##2##(2008-11#1)(2012-12#1)
with foreign##3##2##(1990-3#1)(1994-12#1)(1997-6#1)
with forest##2##2##(1995-3#1)(2008-10#1)
with formaldehyde and##3##3##(2008-10#3)
with formaldehyde##9##2##(1995-2#1)(2008-10#4)(2008-2#3)(2010-12#1)
with formalin##2##2##(1996-12#1)(2008-5#1)
with formation of a##4##4##(1993-11#1)(1994-5#1)(2008-10#1)(2009-2#1)
with formation of##10##3##(1991-5#1)(1993-11#1)(1994-5#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-3#1)
with formic acid##2##3##(2008-10#1)(2008-11#1)
with formic##3##2##(2008-10#2)(2008-11#1)
with forskolin or##2##3##(1995-5#1)(2008-11#1)
with forskolin##6##2##(1995-12#1)(1995-5#1)(1995-8#2)(1997-1#1)(2008-11#1)
with forward##2##2##(2008-3#1)(2008-9#1)
with four different##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
with four enzymes##2##3##(2008-10#2)
with four or five##2##4##(2008-10#1)(2008-5#1)
with four or more##2##4##(1995-5#1)(1997-7#1)
with four or##4##3##(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)
with four other##3##3##(1992-3#1)(2008-10#2)
with four oximate##2##3##(1997-7#2)
with four replications##5##3##(2008-10#1)(2008-12#4)
with four restriction enzymes##2##4##(1997-2#1)(2008-10#1)
with four to##2##3##(2008-10#1)(2008-5#1)
with four##66##2##(1992-3#1)(1993-12#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-7#3)(2007-12#2)(2008-10#22)(2008-12#6)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-3#2)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
with four-wave mixing in bismuth silicon oxide crystal by use of moving gratings##2##13##(2008-3#2)
with fractal##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
with fracture of##2##3##(2008-7#1)(2011-2#1)
with fracture##4##2##(1991-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
with fractures##2##2##(2007-11#2)
with fragments##3##2##(1990-5#1)(1992-3#1)(2010-5#1)
with free standing##2##3##(2008-10#2)
with free text data entry and limited structure##2##8##(2011-1#2)
with free##19##2##(1992-2#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-6#3)(2008-9#1)(2011-1#2)(2012-2#1)
with free-space##3##2##(2008-2#1)(2008-3#2)
with frequencies##3##2##(1994-11#1)(2007-12#1)(2010-8#1)
with frequency combs##2##3##(2007-11#2)
with frequency##5##2##(2007-11#2)(2008-10#1)(2008-3#1)(2013-1#1)
with frequency-dependent##2##2##(2007-12#1)(2008-10#1)
with frequency-domain photon migration##2##4##(2008-3#2)
with frequency-domain##3##2##(2008-3#3)
with frequency-doubled##2##2##(2007-11#1)(2008-3#1)
with frequency-modulated##2##2##(2008-3#2)
with frequent##13##2##(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-6#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
with fresh water##3##3##(2008-10#2)(2012-5#1)
with fresh##11##2##(1991-2#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-5#2)
with friends and family##2##4##(1997-2#1)(2010-8#1)
with friends and##4##3##(1997-2#1)(2010-8#2)(2011-2#1)
with frontal##3##2##(2008-4#1)(2009-6#1)(2012-12#1)
with fruit##3##2##(2008-10#3)
with full##24##2##(1991-9#1)(1992-9#1)(1994-2#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2011-2#5)(2013-1#1)
with full- and reduced-resolution correlators##2##5##(2008-3#2)
with fully##3##2##(1990-8#1)(2008-4#1)(2011-1#1)
with fulminant##2##2##(2007-5#1)(2008-11#1)
with fumigated##2##2##(2008-10#1)(2008-11#1)
with fumonisin##2##2##(2008-10#2)
with functional or##2##3##(1995-3#1)(2007-12#1)
with functional##17##2##(1993-11#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
with functionally##2##2##(2007-8#1)(2008-9#1)
with functioning##5##2##(1997-1#1)(2008-1#1)(2008-8#1)(2010-2#1)(2012-12#1)
with functions##2##2##(2008-5#1)(2008-9#1)
with funding from the##2##4##(2008-5#1)(2010-3#1)
with funding from##3##3##(2008-5#1)(2010-10#1)(2010-3#1)
with funding##5##2##(2008-11#2)(2008-5#1)(2010-10#1)(2010-3#1)
with fungal infection##2##3##(2008-10#2)
with fungal##7##2##(2007-8#1)(2008-10#4)(2009-2#1)(2010-7#1)
with fungicide##2##2##(2008-10#2)
with fungicides##4##2##(2008-10#3)(2008-12#1)
with fura-2##3##2##(1992-5#1)(1992-6#1)(1994-2#1)
with furosemide##8##2##(1991-8#1)(1992-8#5)(2008-10#1)(2012-2#1)
with furrow##3##2##(2008-10#3)
with further##20##2##(1995-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#2)(2012-12#1)(2013-8#1)
with fusion for##2##3##(2008-10#1)(2012-12#1)
with fusion##9##2##(1996-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-12#4)
with future##10##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-3#1)(2010-8#2)(2012-1#2)(2012-3#1)(2013-1#1)
with gain##4##2##(2007-11#1)(2008-3#3)
with gallbladder##3##2##(1991-8#1)(2008-5#1)(2010-1#1)
with gamma##2##2##(2008-8#1)(2010-6#1)
with gamma-aminobutyric##2##2##(1990-8#1)(1992-3#1)
with gamma-globulin##2##2##(1993-11#1)(2008-10#1)
with gamma-knife##2##2##(2008-7#2)
with gas cell measurements and##2##5##(2008-3#2)
with gas chromatography##4##3##(2008-10#3)(2008-2#1)
with gas chromatography-mass spectrometry (GC-MS)##4##5##(2008-10#4)
with gas chromatography-mass spectrometry##5##4##(2008-10#5)
with gas##20##2##(2008-10#16)(2008-2#1)(2008-3#2)(2013-1#1)
with gastric cancer##5##3##(1996-5#1)(2011-2#4)
with gastric ulcer##2##3##(2008-11#1)(2008-12#1)
with gastric##18##2##(1990-2#2)(1992-9#1)(1993-8#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-12#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
with gastroesophageal reflux disease##3##4##(2009-11#1)(2013-8#2)
with gastroesophageal reflux##5##3##(2009-11#1)(2013-1#1)(2013-8#3)
with gastroesophageal##6##2##(2009-11#1)(2013-1#2)(2013-8#3)
with gastrointestinal##10##2##(1990-6#1)(1990-8#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-7#1)(2013-8#1)
with gated##2##2##(2007-11#1)(2012-2#1)
with gel##2##2##(2008-10#1)(2011-1#1)
with gelatin using glutaraldehyde and fixed on##2##7##(2008-10#2)
with gelatin##6##2##(2008-10#5)(2008-4#1)
with gender and age##2##4##(2011-2#2)
with gender and##4##3##(2008-12#1)(2011-1#1)(2011-2#2)
with gender##7##2##(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#3)(2013-8#1)
with gene constructs##2##3##(2008-10#1)(2008-11#1)
with gene expression in##3##4##(2008-10#1)(2008-11#1)(2009-4#1)
with gene expression##6##3##(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2012-2#1)
with gene therapy##3##3##(2008-4#1)(2008-5#1)(2008-8#1)
with gene##16##2##(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2012-2#1)(2012-3#2)
with general anesthesia##2##3##(2011-2#1)(2012-3#1)
with general##11##2##(1993-1#1)(1994-11#1)(1995-8#1)(1997-3#1)(2007-10#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-3#1)
with generalised##2##2##(2008-7#1)(2011-2#1)
with generalized convulsive##2##3##(2012-2#1)(2013-8#1)
with generalized linear##2##3##(2008-10#2)
with generalized weakness and##2##4##(2010-8#1)(2012-2#1)
with generalized##19##2##(1995-2#1)(1995-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
with generally##2##2##(2007-10#1)(2008-2#1)
with generating##2##2##(1993-3#1)(2010-5#1)
with generation of##2##3##(1992-12#2)
with generation##4##2##(1992-12#2)(2008-1#1)(2008-10#1)
with genes from other organisms##2##5##(1996-3#1)(1997-6#1)
with genes##9##2##(1993-9#1)(1994-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
with genetic algorithms##2##3##(2008-3#2)
with genetic and##2##3##(2008-10#1)(2012-12#1)
with genetic##21##2##(1996-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
with genistein##3##2##(2008-10#2)(2008-4#1)
with genital herpes##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
with genital##10##2##(1996-12#1)(2007-12#1)(2008-10#5)(2008-8#1)(2011-2#1)(2013-1#1)
with genome##2##2##(2007-12#1)(2007-6#1)
with genome-wide##2##2##(2009-5#1)(2010-5#1)
with genomic DNA##5##3##(1990-12#1)(1997-7#1)(2008-10#2)(2008-2#1)
with genomic##11##2##(1990-12#1)(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2012-12#1)
with genotype 1##2##3##(2012-12#1)(2013-1#1)
with genotype##3##2##(2012-12#1)(2013-1#2)
with genotypes##3##2##(2008-5#1)(2009-3#1)(2011-2#1)
with genotypic##2##2##(2008-10#1)(2010-3#1)
with gentamicin##3##2##(2009-12#1)(2011-2#1)(2013-8#1)
with geographical##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
with geriatric clients##2##3##(1991-12#2)
with gestational diabetes mellitus##6##4##(1992-12#3)(2008-10#2)(2011-2#1)
with gestational##7##2##(1992-12#3)(1995-8#1)(2008-10#2)(2011-2#1)
with giant##7##2##(1993-9#1)(1996-9#1)(2007-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
with given##2##2##(2007-11#1)(2008-3#1)
with glass##4##2##(1990-2#1)(2008-10#2)(2013-1#1)
with glassy carbon electrode##3##4##(2008-10#3)
with glaucoma##2##2##(2010-8#1)(2011-2#1)
with glioblastoma##7##2##(2008-11#1)(2011-2#2)(2012-3#4)
with gliosis##2##2##(2008-7#2)
with global budgets##2##3##(2008-11#2)
with global##10##2##(1994-2#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2011-3#1)(2013-1#1)
with glucocorticoid##2##2##(1991-5#1)(1992-5#1)
with glucose and##5##3##(1994-12#1)(2008-10#2)(2008-11#2)
with glucose concentration##2##3##(2008-10#2)
with glucose oxidase##3##3##(2008-10#3)
with glucose##31##2##(1991-5#2)(1991-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(2008-10#10)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#3)(2010-11#1)(2012-2#1)(2012-4#1)(2013-1#1)
with glutamate##6##2##(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)
with glutamic acid##2##3##(1992-6#1)(1996-5#1)
with glutamine##2##2##(1993-9#1)(2009-2#1)
with glutaraldehyde 0##4##3##(2008-5#4)
with glutaraldehyde and##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
with glutaraldehyde##27##2##(1990-12#1)(1991-5#1)(1992-12#1)(2008-10#16)(2008-11#1)(2008-5#6)(2008-6#1)
with glutathione##5##2##(1990-12#1)(1993-6#1)(1995-6#1)(2012-2#1)(2013-1#1)
with gluteal muscle weakness##2##4##(2012-2#2)
with gluteal##3##2##(2012-2#3)
with glycemic status##3##3##(2012-2#3)
with glycemic##4##2##(2009-11#1)(2012-2#3)
with glycerol##3##2##(2008-1#1)(2008-2#1)(2008-6#1)
with glycine##5##2##(1993-8#1)(1994-11#1)(1994-5#1)(2008-10#2)
with glycogen##3##2##(1993-8#1)(2008-10#1)(2008-7#1)
with glycoproteins##2##2##(1990-12#1)(1994-9#1)
with goat##2##2##(1990-11#1)(2008-11#1)
with goblet##2##2##(1990-2#1)(2013-1#1)
with gold nanoparticles##3##3##(2008-10#2)(2008-7#1)
with gold##9##2##(1991-12#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-6#1)
with gold-labeled##2##2##(2008-10#1)(2008-5#1)
with good accuracy and precision##2##5##(2008-10#2)
with good accuracy and##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
with good accuracy##8##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)
with good agreement##4##3##(2008-10#2)(2008-3#2)
with good autocorrelation##2##3##(2008-2#1)(2008-3#1)
with good clinical results##2##4##(1997-6#1)(2008-6#1)
with good clinical##4##3##(1997-6#1)(2008-6#1)(2008-7#1)(2010-5#1)
with good correlation properties##2##4##(2008-2#2)
with good correlation##3##3##(2008-10#1)(2008-2#2)
with good evolution##2##3##(2009-1#1)(2013-1#1)
with good performance##2##3##(2007-11#1)(2008-2#1)
with good precision and accuracy##2##5##(2008-10#2)
with good precision##5##3##(2008-10#5)
with good prognosis##3##3##(1995-11#1)(2007-11#1)(2013-1#1)
with good quality##2##3##(2008-8#1)(2013-1#1)
with good recoveries##2##3##(2008-10#2)
with good repeatability##3##3##(2008-10#3)
with good reproducibility##12##3##(2008-10#12)
with good resolution##2##3##(2008-10#2)
with good response in##3##4##(1992-6#1)(2011-2#2)
with good response##6##3##(1992-6#1)(2011-2#3)(2013-1#2)
with good results in##2##4##(2008-10#2)
with good results##16##3##(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1994-9#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-9#1)(2012-2#1)
with good sensitivity and##2##4##(2008-10#1)(2011-2#1)
with good sensitivity##4##3##(2008-10#3)(2011-2#1)
with good signal##2##3##(2007-12#1)(2008-3#1)
with good stability##2##3##(2008-10#1)(2012-2#1)
with good##126##2##(1990-10#1)(1990-6#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#52)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#8)
with government##4##2##(1994-12#1)(1995-1#1)(2007-12#1)(2013-7#1)
with grade 1##2##3##(2012-2#2)
with grade 2##2##3##(2008-7#1)(2012-2#1)
with grade III in##2##4##(2008-8#2)
with grade III##3##3##(2008-7#1)(2008-8#2)
with grade IV##2##3##(2008-7#1)(2011-2#1)
with grade##15##2##(2008-7#9)(2008-8#2)(2011-2#1)(2012-2#3)
with graded doses of##2##4##(1992-11#1)(2012-2#1)
with grades##2##2##(2007-12#1)(2012-2#1)
with gradient elution##5##3##(2008-10#4)(2011-1#1)
with gradient##8##2##(2008-10#7)(2011-1#1)
with graft##2##2##(1996-2#1)(2007-11#1)
with gram-negative##2##2##(1991-11#1)(1996-12#1)
with granulomatous##3##2##(1997-8#1)(2008-5#1)(2011-1#1)
with grapevine##2##2##(2008-10#2)
with graphite furnace atomic absorption spectrometry##2##6##(2008-10#2)
with graphite##3##2##(2008-10#3)
with grass pollen##2##3##(2011-2#2)
with great success##2##3##(2008-3#1)(2008-9#1)
with great##12##2##(1990-8#1)(1991-2#1)(1994-8#1)(1995-2#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-3#1)(2012-12#1)
with greater confidence##2##3##(2008-2#1)(2008-9#1)
with greater depressive symptoms##4##4##(2010-4#4)
with greater precision##2##3##(2008-10#1)(2008-3#1)
with greater preoperative##2##3##(2010-6#1)(2013-1#1)
with greater risk##2##3##(2012-1#1)(2013-1#1)
with greater than##2##3##(2007-11#1)(2007-12#1)
with greater##64##2##(1991-6#1)(1992-2#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-4#5)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
with greatest##5##2##(1994-9#1)(1995-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
with greatly enhanced##2##3##(2008-10#2)
with greatly improved##2##3##(2008-3#2)
with greatly##6##2##(1991-12#1)(2008-10#3)(2008-3#2)
with green and##2##3##(2007-11#1)(2008-10#1)
with green##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-6#1)
with grooming##2##2##(1994-8#1)(1995-9#1)
with gross hematuria##5##3##(2008-10#2)(2008-11#3)
with gross##11##2##(1992-2#1)(1994-7#2)(2008-10#2)(2008-11#3)(2012-12#1)(2012-3#2)
with gross-exposure constraint##2##3##(2012-12#1)(2013-1#1)
with ground-based##3##2##(2008-2#3)
with group A##2##3##(2010-7#2)
with group B##3##3##(1993-10#1)(1995-12#1)(2010-1#1)
with group##13##2##(1993-10#1)(1994-12#1)(1995-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#2)(2013-1#1)
with groups##2##2##(2008-10#1)(2008-11#1)
with growing##3##2##(1996-2#1)(2007-8#1)(2008-10#1)
with growth and##2##3##(2010-10#1)(2010-11#1)
with growth factors##4##3##(1991-5#1)(2008-11#2)(2008-5#1)
with growth hormone##5##3##(1994-2#1)(2007-11#1)(2008-4#2)(2012-3#1)
with growth of##3##3##(1992-1#1)(2007-12#1)(2008-10#1)
with growth##28##2##(1991-5#1)(1992-1#1)(1992-12#1)(1994-2#1)(1994-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
with guest##2##2##(2008-10#2)
with hCG##2##2##(1993-6#1)(2008-6#1)
with habitat##3##2##(2007-5#1)(2008-8#2)
with haematological##3##2##(1990-10#1)(2008-5#1)(2009-3#1)
with haematuria##4##2##(1996-6#1)(2008-10#2)(2009-1#1)
with haemophilia##3##2##(1990-5#1)(2009-3#1)(2013-1#1)
with hair##2##2##(2008-5#2)
with half##4##2##(1992-8#1)(2007-8#1)(2008-10#1)(2008-7#1)
with half-beam##2##2##(2007-10#2)
with half-maximal##2##2##(1994-6#1)(2008-6#1)
with half-zone-plate processing##2##3##(2008-3#2)
with hallux valgus##2##3##(2010-11#1)(2012-2#1)
with haloperidol##4##2##(1995-12#4)
with halothane hepatitis##2##3##(1995-3#2)
with halothane##4##2##(1991-12#1)(1995-3#2)(2009-12#1)
with hand OA##2##3##(2013-1#2)
with hand##6##2##(2008-12#1)(2010-3#1)(2010-4#1)(2013-1#3)
with harmonic##2##2##(2007-11#1)(2008-3#1)
with having a##2##3##(2007-12#1)(2013-1#1)
with having##4##2##(2007-12#1)(2008-6#1)(2009-4#1)(2013-1#1)
with head and neck##2##4##(1995-8#1)(2010-4#1)
with head injury and##2##4##(1995-5#1)(2008-7#1)
with head injury##4##3##(1995-5#1)(2008-7#2)(2013-8#1)
with head##12##2##(1990-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-7#5)(2010-4#1)(2010-8#1)(2013-8#1)
with headache and##2##3##(2008-12#1)(2012-3#1)
with headache##6##2##(2007-10#1)(2008-1#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
with headaches##4##2##(2006-10#1)(2008-12#1)(2009-1#1)(2011-2#1)
with health and##5##3##(1997-2#1)(2008-7#1)(2008-9#2)(2012-1#1)
with health care leaders##2##4##(1994-1#1)(2008-1#1)
with health care##17##3##(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-6#1)(2013-7#2)
with health insurance##2##3##(2009-5#1)(2012-12#1)
with health professionals and##2##4##(1997-1#1)(2012-2#1)
with health services##2##3##(1996-1#1)(2012-12#1)
with health##42##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#2)(2010-5#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#2)
with healthcare##3##2##(2009-8#1)(2011-1#1)(2012-3#1)
with healthy subjects##2##3##(1990-11#1)(2013-1#1)
with healthy volunteers##2##3##(2008-5#2)
with healthy##17##2##(1990-11#1)(1990-6#1)(1991-7#1)(1991-8#2)(1997-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2010-12#1)(2012-1#3)(2012-2#1)(2013-1#1)
with hearing##4##2##(1990-12#1)(2008-1#1)(2008-9#1)(2011-2#1)
with heart disease##4##3##(2007-2#2)(2008-12#1)(2008-3#1)
with heart failure##11##3##(1990-3#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
with heart##24##2##(1990-12#1)(1990-3#1)(1993-6#1)(1996-8#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
with heat shock##2##3##(1993-8#2)
with heat##6##2##(1993-8#2)(2007-12#1)(2008-3#1)(2011-1#1)(2013-8#1)
with heating##2##2##(2007-10#1)(2008-10#1)
with heavier##2##2##(2007-12#1)(2009-9#1)
with heavily##2##2##(1992-2#1)(2008-10#1)
with heavy metal##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
with heavy##12##2##(1991-12#1)(1994-11#1)(1995-11#2)(1995-3#1)(1997-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
with height##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
with helper##2##2##(1990-5#1)(2008-10#1)
with helpers##2##2##(2008-8#1)(2008-9#1)
with hematologic malignancies##14##3##(2008-7#12)(2012-12#1)(2013-1#1)
with hematologic##17##2##(1994-12#1)(2007-2#1)(2008-7#12)(2012-12#2)(2013-1#1)
with hematological##3##2##(1993-2#1)(2011-2#1)(2012-2#1)
with hematoxylin and eosin##3##4##(2007-10#1)(2011-2#1)(2013-1#1)
with hematoxylin##5##2##(1991-2#1)(2007-10#1)(2007-12#1)(2011-2#1)(2013-1#1)
with heme##2##2##(1993-6#1)(1996-3#1)
with hemin##2##2##(2008-10#2)
with hemodialysis and##2##3##(2008-10#1)(2009-5#1)
with hemodialysis##6##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
with hemoglobin##6##2##(1992-12#1)(2008-10#4)(2008-7#1)
with hemophagocytic lymphohistiocytosis##2##3##(2011-2#1)(2012-3#1)
with hemophilia##3##2##(1996-5#1)(2007-8#1)(2008-11#1)
with hemorrhage##3##2##(2008-12#1)(2008-7#2)
with hemorrhagic##9##2##(1991-5#1)(1992-8#1)(2006-10#1)(2009-12#1)(2009-9#1)(2010-5#1)(2013-1#3)
with heparan sulfate##2##3##(1995-6#1)(2008-5#1)
with heparin and##2##3##(1993-6#1)(2013-8#1)
with heparin as##2##3##(2008-10#1)(2010-3#1)
with heparin is##2##3##(1995-5#1)(1997-4#1)
with heparin##16##2##(1991-6#1)(1993-6#1)(1994-6#2)(1995-5#2)(1997-4#2)(2007-10#2)(2008-10#3)(2010-3#2)(2013-8#1)
with heparin-induced thrombocytopenia##2##3##(1997-2#2)
with heparinized##2##2##(1991-9#1)(1996-12#1)
with hepatic##13##2##(1990-5#1)(1991-5#2)(1993-2#1)(1993-5#1)(1994-8#1)(2008-1#1)(2008-10#1)(2009-8#1)(2013-1#2)(2013-8#2)
with hepatitis B##4##3##(2007-12#1)(2007-7#1)(2012-3#1)(2013-8#1)
with hepatitis C virus infection who##2##6##(2006-10#1)(2013-1#1)
with hepatitis C virus infection##3##5##(2006-10#1)(2013-1#2)
with hepatitis C virus##5##4##(1990-3#1)(2006-10#1)(2013-1#2)(2013-8#1)
with hepatitis C##8##3##(1990-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-4#1)(2013-1#2)(2013-8#1)
with hepatitis##15##2##(1990-3#1)(1996-11#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#2)
with hepatocellular carcinoma##7##3##(1992-3#1)(2008-12#1)(2009-9#1)(2013-1#1)(2013-7#1)(2013-8#2)
with hepatocellular##8##2##(1992-3#1)(2008-12#1)(2009-8#1)(2009-9#1)(2013-1#1)(2013-7#1)(2013-8#2)
with hepatocyte growth factor##2##4##(2008-9#1)(2010-12#1)
with hepatocyte##3##2##(1992-3#1)(2008-9#1)(2010-12#1)
with her##5##2##(2007-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
with herbicide##2##2##(2006-12#1)(2008-9#1)
with herbicides##2##2##(2008-11#1)(2011-2#1)
with hereditary spherocytosis##3##3##(2008-12#3)
with hereditary##11##2##(1992-3#1)(1993-1#2)(1997-3#1)(2008-1#1)(2008-12#3)(2010-3#1)(2010-9#1)(2012-3#1)
with heredity##2##2##(2008-9#1)(2009-9#1)
with herpes##2##2##(1995-5#1)(2008-5#1)
with heterodyne detection##3##3##(2007-12#2)(2008-3#1)
with heterogeneous##2##2##(2006-10#1)(2008-12#1)
with heterologous##2##2##(2008-10#2)
with heterosexual##2##2##(2008-12#2)
with heterotrimeric G proteins##2##4##(1995-6#1)(2008-4#1)
with heterozygosity##2##2##(2008-10#1)(2008-4#1)
with hexane and##2##3##(2008-11#1)(2013-8#1)
with hexane##7##2##(2008-10#4)(2008-11#1)(2011-1#1)(2013-8#1)
with hidradenitis suppurativa##2##3##(2006-10#2)
with high As##2##3##(2008-10#1)(2010-5#1)
with high HCV##2##3##(2007-7#1)(2013-1#1)
with high ICA titers##2##4##(1994-12#2)
with high IgG##2##3##(1990-3#1)(2008-7#1)
with high SPF##2##3##(1993-11#1)(2008-5#1)
with high accuracy and precision##2##5##(2008-10#2)
with high accuracy and##5##4##(2008-10#3)(2008-7#1)(2011-2#1)
with high accuracy by##2##4##(2007-12#1)(2008-3#1)
with high accuracy##18##3##(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#5)(2008-7#1)(2009-4#1)(2011-2#2)
with high affinity (Kd =##2##5##(1993-11#1)(1996-2#1)
with high affinity (Kd##3##4##(1990-11#1)(1993-11#1)(1996-2#1)
with high affinity and selectivity##2##5##(2008-4#1)(2012-2#1)
with high affinity and##10##4##(1990-11#1)(1991-2#1)(1993-1#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-4#1)(2012-2#1)
with high affinity for##5##4##(1991-11#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-5#1)
with high affinity to the##3##5##(1990-5#1)(1995-3#1)(1996-12#1)
with high affinity to##7##4##(1990-5#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-4#1)
with high affinity##43##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2010-12#1)(2012-2#1)
with high and low##3##4##(1996-7#1)(2007-12#1)(2008-10#1)
with high and##5##3##(1996-7#1)(2007-12#1)(2008-10#1)(2009-5#2)
with high binding##2##3##(2008-5#1)(2008-8#1)
with high blood pressure##3##4##(2008-3#1)(2009-1#1)(2010-9#1)
with high blood##5##3##(1995-11#1)(1997-7#1)(2008-3#1)(2009-1#1)(2010-9#1)
with high concentration##2##3##(2007-12#1)(2013-8#1)
with high concentrations of##7##4##(1990-2#1)(1991-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
with high concentrations##9##3##(1990-2#1)(1991-2#1)(1993-12#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
with high contrast##5##3##(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-6#1)
with high correlation##2##3##(2008-10#1)(2011-1#1)
with high density##2##3##(2008-11#1)(2008-7#1)
with high diffraction efficiency##2##4##(2007-11#1)(2008-3#1)
with high diffraction##4##3##(2007-11#1)(2008-3#2)(2008-8#1)
with high discrimination##2##3##(2007-12#1)(2008-2#1)
with high dispersal##3##3##(2008-8#3)
with high dose of##2##4##(1992-5#1)(2013-1#1)
with high dose##8##3##(1990-12#1)(1991-9#1)(1992-5#2)(1994-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
with high doses of epirubicin##2##5##(1990-10#1)(1991-6#1)
with high doses of##8##4##(1990-10#1)(1991-6#1)(1994-3#1)(1997-4#1)(2006-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
with high efficiency and##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
with high efficiency is##2##4##(2007-12#1)(2008-3#1)
with high efficiency to##2##4##(1994-5#1)(2008-10#1)
with high efficiency##17##3##(1994-12#1)(1994-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#3)(2012-12#1)(2013-1#1)
with high enantioselectivity##2##3##(1995-6#1)(2009-10#1)
with high enough##2##3##(2008-2#1)(2010-12#1)
with high expression##3##3##(2009-9#2)(2012-3#1)
with high fatality##2##3##(1990-2#1)(2008-5#1)
with high frequency##7##3##(1993-11#1)(1994-6#2)(1997-2#1)(2007-11#1)(2010-7#1)(2013-8#1)
with high glass transition temperatures##2##5##(1995-3#1)(2010-4#1)
with high grade##4##3##(1994-2#1)(2008-6#2)(2010-3#1)
with high homology to the##3##5##(1992-8#1)(1994-8#1)(1995-8#1)
with high homology##4##3##(1992-8#1)(1994-8#1)(1995-8#1)(2008-4#1)
with high incidence of##2##4##(1994-2#1)(2008-10#1)
with high level of##5##4##(1992-3#1)(2008-12#1)(2011-2#3)
with high levels of##13##4##(1994-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
with high lipid##2##3##(2008-9#1)(2013-1#1)
with high local##2##3##(2008-8#1)(2010-3#1)
with high metastatic potential##2##4##(2008-6#1)(2008-9#1)
with high molecular weight##2##4##(1995-2#1)(2007-12#1)
with high molecular##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
with high morbidity and mortality##6##5##(1996-3#1)(2008-1#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
with high morbidity and##7##4##(1996-3#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
with high morbidity##8##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
with high mortality##6##3##(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
with high numerical aperture##2##4##(2007-12#1)(2012-2#1)
with high peak##3##3##(2008-3#2)(2012-2#1)
with high performance liquid chromatography (HPLC)##6##6##(2008-10#5)(2008-8#1)
with high performance liquid chromatography##10##5##(1991-4#1)(2008-10#8)(2008-8#1)
with high plasma##2##3##(1992-3#1)(2008-7#1)
with high population##2##3##(2008-10#1)(2008-8#1)
with high precision and accuracy##2##5##(2008-10#2)
with high precision and##4##4##(2008-10#3)(2008-3#1)
with high precision##9##3##(2008-10#5)(2008-3#4)
with high predictive##4##3##(2008-6#2)(2011-2#1)(2012-3#1)
with high pressure##2##3##(2008-10#2)
with high probability##2##3##(1996-4#1)(2011-3#1)
with high quality##2##3##(1991-12#1)(2008-3#1)
with high rates of##5##4##(2008-1#1)(2008-8#2)(2009-10#1)(2012-2#1)
with high recoveries##2##3##(2008-10#1)(2011-1#1)
with high reflectance##2##3##(2008-2#1)(2008-3#1)
with high refractive##2##3##(2008-10#1)(2008-3#1)
with high reliability##2##3##(2008-10#2)
with high resistance to##2##4##(1997-2#1)(2008-10#1)
with high resolution and accuracy##2##5##(2007-11#1)(2008-3#1)
with high resolution##11##3##(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-3#1)
with high risk of##4##4##(1991-11#1)(2011-2#2)(2013-1#1)
with high risk##10##3##(1990-3#1)(1991-11#1)(1997-3#1)(2008-11#1)(2010-3#2)(2011-2#2)(2013-1#2)
with high selectivity and sensitivity##2##5##(2008-10#2)
with high selectivity and##4##4##(2008-10#2)(2008-9#1)(2009-12#1)
with high selectivity##7##3##(1991-3#1)(2008-10#3)(2008-9#1)(2009-12#1)(2010-12#1)
with high sensitivity and selectivity##2##5##(2008-10#1)(2008-9#1)
with high sensitivity and##6##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)
with high sensitivity##11##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)
with high spatial and temporal##2##5##(2008-10#1)(2008-11#1)
with high spatial and##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
with high spatial resolution##3##4##(2007-11#1)(2009-1#1)(2009-9#1)
with high spatial##8##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#2)(2009-1#1)(2009-9#1)
with high specificity for##2##4##(2008-10#1)(2008-5#1)
with high specificity##10##3##(1991-5#1)(1993-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-7#1)
with high stability against external disturbances##2##6##(2007-12#1)(2008-3#1)
with high stability##6##3##(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)
with high surface area##2##4##(2008-10#1)(2008-6#1)
with high surface areas##2##4##(2008-10#2)
with high surface##5##3##(2008-10#3)(2008-3#1)(2008-6#1)
with high temporal and spatial resolution##3##6##(2007-8#1)(2010-12#1)(2011-1#1)
with high yield##3##3##(1990-5#1)(2008-10#2)
with high##531##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#6)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#4)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#2)(2006-6#1)(2007-11#16)(2007-12#16)(2007-2#2)(2007-7#7)(2007-8#3)(2008-1#3)(2008-10#85)(2008-11#16)(2008-12#4)(2008-2#12)(2008-3#43)(2008-4#9)(2008-5#18)(2008-6#8)(2008-7#16)(2008-8#20)(2008-9#11)(2009-1#3)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-9#3)(2010-1#3)(2010-10#2)(2010-12#7)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#12)(2011-2#17)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#8)
with high-affinity##2##2##(1994-8#1)(2010-5#1)
with high-density lipoprotein##2##3##(2008-10#1)(2011-1#1)
with high-density##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
with high-dose##9##2##(1992-2#1)(2008-1#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
with high-grade dysplasia##2##3##(2009-4#1)(2010-12#1)
with high-grade##9##2##(1992-6#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-3#1)(2013-8#1)
with high-index##2##2##(2007-11#1)(2008-3#1)
with high-numerical-aperture lenses##2##3##(2008-3#2)
with high-numerical-aperture##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
with high-order##3##2##(2007-11#3)
with high-performance liquid chromatography (HPLC)##4##5##(2008-10#3)(2008-6#1)
with high-performance liquid chromatography##9##4##(1990-8#1)(2008-10#7)(2008-6#1)
with high-performance##10##2##(1990-8#1)(2008-10#8)(2008-6#1)
with high-power##2##2##(2007-12#1)(2011-2#1)
with high-quality##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
with high-resolution##10##2##(2008-10#3)(2008-3#3)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
with high-risk HPV##2##3##(2011-2#2)
with high-risk acute##3##3##(2008-3#1)(2011-2#2)
with high-risk##16##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#6)(2012-12#1)(2013-1#3)
with high-speed##2##2##(2007-11#1)(2008-5#1)
with high-throughput##2##2##(2008-8#1)(2012-3#1)
with higher dimensional##3##3##(2008-10#3)
with higher educational##2##3##(2009-10#1)(2012-1#1)
with higher incidence##2##3##(2008-10#1)(2008-6#1)
with higher levels of##8##4##(1991-1#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-5#1)
with higher levels##9##3##(1991-1#1)(1994-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)
with higher likelihood##2##3##(2008-12#1)(2012-3#1)
with higher prevalence##2##3##(2011-2#1)(2013-8#1)
with higher rates of##4##4##(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
with higher resolution##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
with higher stress##2##3##(2008-8#1)(2012-1#1)
with higher##130##2##(1990-8#1)(1991-1#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-2#2)(1996-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#5)
with highest##7##2##(1990-11#1)(1996-12#1)(1997-1#1)(1997-7#1)(2007-1#1)(2008-6#1)(2008-7#1)
with highly active##2##3##(2007-7#1)(2008-1#1)
with highly variable##2##3##(2008-3#1)(2013-7#1)
with highly virulent##3##3##(2008-10#1)(2008-5#2)
with highly##26##2##(1990-6#1)(1991-12#1)(1991-2#1)(1993-3#1)(1997-2#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2012-2#3)(2012-3#1)(2013-7#1)
with hilar##4##2##(2007-8#2)(2012-2#1)(2013-1#1)
with hip fractures##2##3##(1990-2#1)(2011-2#1)
with hip##5##2##(1990-2#1)(1993-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
with his or her##2##4##(2009-10#1)(2010-10#1)
with his##12##2##(1992-12#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-3#1)(2011-2#1)
with histamine##2##2##(1992-6#1)(1994-6#1)
with histidine##3##2##(2008-10#3)
with histologic evidence of##3##4##(1992-8#1)(2008-5#2)
with histologic features##2##3##(1994-12#1)(2007-10#1)
with histologic##7##2##(1991-12#1)(1992-8#1)(1994-12#1)(2007-10#1)(2008-5#2)(2012-2#1)
with histological and##2##3##(2007-4#1)(2008-7#1)
with histological examination##2##3##(2010-5#1)(2011-1#1)
with histological##11##2##(1994-10#2)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#1)
with histologically confirmed common malignant epithelial tumors of the ovary##2##10##(1993-9#2)
with histologically confirmed first diagnosis of##2##6##(1993-9#2)
with histologically confirmed##6##3##(1993-9#4)(1994-12#1)(2011-2#1)
with histologically proven##8##3##(1990-2#1)(1990-8#1)(1991-2#1)(1994-1#1)(2007-10#1)(2008-6#1)(2008-7#1)(2010-3#1)
with histologically##16##2##(1990-2#1)(1990-8#1)(1991-2#1)(1993-9#4)(1994-1#1)(1994-12#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
with histopathological findings##2##3##(2011-2#1)(2012-2#1)
with histopathological##6##2##(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
with histopathologically##2##2##(1991-12#1)(1997-8#1)
with histoplasmin##2##2##(2008-5#2)
with historical##5##2##(1991-8#1)(1992-12#1)(1997-8#1)(2008-10#1)(2008-2#1)
with history and##2##3##(2007-7#1)(2008-10#1)
with history of##10##3##(2007-7#1)(2008-1#2)(2010-3#1)(2011-2#4)(2013-1#2)
with history##15##2##(2007-7#2)(2008-1#3)(2008-10#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#4)(2013-1#2)
with holes##2##2##(2008-3#1)(2008-6#1)
with home##5##2##(1995-2#2)(2011-2#1)(2012-12#2)
with homeless##3##2##(2009-5#1)(2012-12#2)
with homoallylic alcohols##2##3##(2007-11#1)(2009-6#1)
with homogeneous T1-SI identical to the SI of subcutaneous fat##2##10##(2012-2#2)
with homogeneous##5##2##(1990-11#1)(2007-12#1)(2008-10#1)(2012-2#2)
with homologous##5##2##(1994-8#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-9#1)
with homology to the##2##4##(1992-8#1)(2008-7#1)
with homology to##4##3##(1992-8#1)(1995-11#1)(2008-6#1)(2008-7#1)
with homology##5##2##(1992-8#1)(1995-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
with homozygous SCD##2##3##(2009-4#2)
with homozygous##5##2##(1994-12#1)(2009-10#1)(2009-4#2)(2011-2#1)
with honey##2##2##(2008-10#1)(2008-6#1)
with horizontal##2##2##(2008-10#1)(2008-3#1)
with hormone##3##2##(1991-6#1)(2008-11#1)(2013-1#1)
with hormones and##2##3##(2009-5#1)(2010-8#1)
with hormones##3##2##(1990-11#1)(2009-5#1)(2010-8#1)
with horseradish peroxidase (HRP)##3##4##(1990-5#1)(2008-10#1)(2012-2#1)
with horseradish peroxidase##11##3##(1990-5#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-4#2)(2010-5#1)(2012-2#1)
with hospital##8##2##(1993-6#2)(1994-2#1)(1995-1#2)(1997-1#1)(2008-4#1)(2011-2#1)
with hospitalized children##2##3##(1992-3#1)(2013-1#1)
with hospitalized##3##2##(1992-3#1)(1997-3#1)(2013-1#1)
with hospitals and##2##3##(1991-12#1)(1995-2#1)
with hospitals##6##2##(1991-12#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(2010-5#1)
with host cells##2##3##(2008-5#1)(2008-9#1)
with host or##2##3##(2008-10#2)
with host size##2##3##(2008-10#1)(2008-9#1)
with host##22##2##(1995-3#1)(1995-9#1)(2006-6#1)(2008-10#12)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-8#1)(2013-1#1)
with hosts##2##2##(1990-11#1)(2009-2#1)
with hot water##5##3##(2008-10#1)(2008-6#1)(2013-1#3)
with hot##6##2##(2008-10#2)(2008-6#1)(2013-1#3)
with house dust mite allergens##2##5##(2011-2#2)
with how##2##2##(2008-12#1)(2010-10#1)
with hsp90##2##2##(1990-11#1)(1993-8#1)
with human B cell line##2##5##(2008-8#2)
with human and##2##3##(1997-8#1)(2012-2#1)
with human chorionic gonadotropin##3##4##(1993-6#1)(2008-1#1)(2008-4#1)
with human immunodeficiency virus (HIV)##6##5##(1995-12#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-12#1)
with human immunodeficiency virus (HIV-1)##2##5##(2009-7#1)(2010-11#1)
with human immunodeficiency virus infection##3##5##(1993-2#1)(1995-3#1)(1996-2#1)
with human immunodeficiency virus type 1 (HIV-1) infection##2##8##(2008-2#2)
with human immunodeficiency virus type 1 (HIV-1)##4##7##(2008-2#4)
with human immunodeficiency virus type 1##5##6##(1991-2#1)(2008-2#4)
with human immunodeficiency virus##18##4##(1991-2#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#4)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#1)
with human insulin##5##3##(1991-8#2)(2008-4#1)(2008-6#1)(2011-1#1)
with human monoclonal##2##3##(1992-2#1)(1994-3#1)
with human papilloma virus (HPV)##2##5##(1991-2#1)(1996-12#1)
with human volunteers##2##3##(2008-11#1)(2008-5#1)
with human##95##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#3)(1992-2#2)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#3)(1997-9#1)(2006-10#1)(2008-1#2)(2008-10#3)(2008-11#8)(2008-2#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#1)
with humans##6##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
with humic acids##3##3##(2008-10#3)
with humic##5##2##(2008-10#5)
with humoral##2##2##(1995-12#1)(2011-2#1)
with hybrid##2##2##(1994-5#1)(2008-10#1)
with hydranencephaly##3##2##(1997-3#3)
with hydrazine hydrate##3##3##(2008-11#1)(2011-1#2)
with hydrazine##4##2##(2008-10#1)(2008-11#1)(2011-1#2)
with hydride generation atomic##2##4##(2008-10#2)
with hydride generation##6##3##(2008-10#6)
with hydride##7##2##(2008-10#7)
with hydrochloric acid##7##3##(2007-11#1)(2008-10#6)
with hydrocortisone##3##2##(1993-1#1)(2008-11#2)
with hydrodynamic##2##2##(2008-10#1)(2008-11#1)
with hydrogen peroxide as product##2##5##(2008-10#2)
with hydrogen peroxide in a##2##5##(2008-10#2)
with hydrogen peroxide in aqueous##2##5##(2008-10#1)(2009-5#1)
with hydrogen peroxide in##7##4##(1995-8#1)(2008-10#5)(2009-5#1)
with hydrogen peroxide##26##3##(1994-5#1)(1995-8#1)(2008-10#22)(2008-11#1)(2009-5#1)
with hydrogen##32##2##(1993-1#1)(1993-11#1)(1994-5#1)(1995-8#1)(2007-12#1)(2008-10#22)(2008-11#1)(2008-3#1)(2009-5#1)(2010-11#1)(2012-2#1)
with hydrolysis##2##2##(1993-8#1)(2008-4#1)
with hydronephrosis and##2##3##(2009-5#2)
with hydronephrosis##4##2##(2008-10#1)(2008-7#1)(2009-5#2)
with hydrophobic##5##2##(1993-11#1)(2008-10#2)(2008-6#1)(2012-2#1)
with hydroquinone##3##2##(2008-10#2)(2008-5#1)
with hydroxy##2##2##(2008-5#1)(2013-1#1)
with hydroxyl##3##2##(2008-10#2)(2008-4#1)
with hydroxylamine##2##2##(1992-5#1)(2009-9#1)
with hyperbilirubinemia##2##2##(1990-8#2)
with hypercalcemia##3##2##(1990-2#1)(1996-9#1)(2008-6#1)
with hypercholesterolemia##6##2##(1991-6#1)(2008-1#2)(2008-7#1)(2008-8#1)(2013-1#1)
with hypereosinophilia##2##2##(2008-11#2)
with hypereosinophilic syndrome##2##3##(2008-7#2)
with hyperlipidemia]##2##2##(1990-3#1)(2013-1#1)
with hypermethylation##2##2##(1996-10#1)(2008-7#1)
with hypertension and##3##3##(2008-7#1)(2009-9#1)(2013-1#1)
with hypertension or##2##3##(1992-6#1)(2008-8#1)
with hypertension##23##2##(1992-6#1)(1993-9#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#3)(2013-1#3)
with hyperthyroidism##3##2##(2007-8#1)(2008-4#1)(2011-1#1)
with hypertonic saline##2##3##(2010-1#1)(2010-12#1)
with hypertonic##3##2##(1994-8#1)(2010-1#1)(2010-12#1)
with hypertriglyceridemia##2##2##(1997-7#1)(2008-8#1)
with hyphal growth##2##3##(2008-10#2)
with hypoalbuminemia##3##2##(2007-7#1)(2013-1#2)
with hypobromite##3##2##(2008-10#3)
with hypochlorite and##3##3##(2008-10#3)
with hypochlorite##4##2##(2007-7#1)(2008-10#3)
with hypogammaglobulinemia##2##2##(1990-6#1)(2011-2#1)
with hypokalemia##2##2##(1997-8#1)(2011-2#1)
with hypokalemic##2##2##(2008-1#2)
with hyponatremia##2##2##(2010-6#1)(2011-2#1)
with hypoplastic##5##2##(1994-6#1)(2008-10#3)(2011-1#1)
with hyporeflexia##2##2##(2008-4#2)
with hypospadias and##2##3##(2008-10#2)
with hypospadias##5##2##(2008-10#4)(2009-5#1)
with hypothermia##2##2##(1990-9#1)(2008-8#1)
with hypotheses##2##2##(2008-6#1)(2009-5#1)
with hypothyroidism##3##2##(2008-4#1)(2008-7#1)(2009-12#1)
with hypoxanthine##2##2##(2008-11#2)
with i##3##2##(1995-11#1)(2008-5#1)(2008-7#1)
with iatrogenic##2##2##(2008-7#2)
with ibuprofen##2##2##(2012-12#2)
with ice##2##2##(1990-12#1)(2008-2#1)
with identical amino acid composition##2##5##(1994-9#2)
with identical##17##2##(1992-8#1)(1994-9#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#2)
with identification of##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
with identified##2##2##(2008-7#1)(2013-1#1)
with identities##2##2##(1990-12#1)(2008-10#1)
with idiopathic Parkinson's disease##2##4##(2008-7#2)
with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial##2##16##(1991-5#2)
with idiopathic##25##2##(1991-5#3)(1995-10#2)(1997-8#2)(2007-8#1)(2008-10#1)(2008-7#6)(2009-10#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
with ifosfamide##2##2##(2008-6#2)
with image analysis##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
with image##6##2##(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-12#1)
with images of##2##3##(2008-5#1)(2012-1#1)
with images##4##2##(2008-3#2)(2008-5#1)(2012-1#1)
with imaging##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-4#1)
with imiglucerase##3##2##(2008-10#3)
with iminodiacetic##2##2##(1997-2#1)(2008-10#1)
with immature##3##2##(2009-3#1)(2010-6#1)(2011-2#1)
with immediate##5##2##(2010-8#1)(2012-12#1)(2013-1#3)
with immobilised##4##2##(1994-12#1)(2008-10#3)
with immobilized cells##2##3##(2008-6#2)
with immobilized reagents##2##3##(2008-10#2)
with immobilized##17##2##(1992-11#1)(1995-3#1)(2008-10#12)(2008-6#2)(2008-7#1)
with immune##8##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2011-2#1)(2013-1#2)
with immunity##3##2##(1995-5#1)(2008-8#1)(2012-3#1)
with immunization##3##2##(1996-12#1)(2008-9#1)(2013-1#1)
with immunocytochemical##2##2##(1991-1#1)(2008-7#1)
with immunocytochemistry in##3##3##(1991-10#1)(1993-12#1)(2008-4#1)
with immunocytochemistry##7##2##(1990-5#1)(1991-10#1)(1993-12#2)(2008-4#2)(2008-6#1)
with immunoglobulin A nephropathy##2##4##(2008-8#1)(2013-1#1)
with immunoglobulin##4##2##(1994-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
with immunogold##2##2##(1997-2#1)(2008-5#1)
with immunohistochemical findings##2##3##(1994-8#1)(2013-7#1)
with immunohistochemical##6##2##(1991-7#1)(1994-8#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-7#1)
with immunohistochemistry##4##2##(2007-8#1)(2011-2#2)(2011-3#1)
with immunological##2##2##(1996-12#1)(2008-8#1)
with immunoreactive##2##2##(1992-8#1)(1992-9#1)
with immunosuppressive agents##2##3##(2006-10#1)(2010-12#1)
with immunosuppressive##3##2##(2006-10#1)(2009-8#1)(2010-12#1)
with impaired glucose tolerance (IGT)##3##5##(1994-12#1)(2008-3#1)(2012-3#1)
with impaired glucose tolerance##6##4##(1994-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-3#1)
with impaired glucose##7##3##(1994-12#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-3#1)
with impaired growth##2##3##(1996-6#1)(2008-10#1)
with impaired##22##2##(1990-9#1)(1991-4#1)(1994-12#1)(1994-5#1)(1996-6#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#4)(2010-10#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
with impedance recordings##2##3##(1996-5#2)
with imperfect##2##2##(2008-3#1)(2013-1#1)
with implant##2##2##(2008-9#1)(2012-12#1)
with implantation of##3##3##(1990-5#1)(1991-3#1)(2008-8#1)
with implantation##4##2##(1990-5#1)(1991-3#1)(2008-8#1)(2008-9#1)
with implanted##2##2##(2011-2#1)(2012-1#1)
with implants##3##2##(1992-5#1)(2008-11#1)(2008-5#1)
with implementing##6##2##(1991-1#1)(1992-1#1)(1993-12#1)(1994-1#1)(1996-1#1)(2008-11#1)
with implications for##5##3##(1992-6#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
with implications##7##2##(1992-6#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
with important##8##2##(1992-3#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
with improved selectivity##3##3##(1994-2#1)(2008-10#1)(2010-7#1)
with improved sensitivity and##2##4##(1990-2#1)(1996-2#1)
with improved sensitivity##6##3##(1990-2#1)(1996-2#1)(2008-10#3)(2008-3#1)
with improved understanding of##2##4##(1997-1#1)(2008-10#1)
with improved##58##2##(1990-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-1#2)(2007-11#3)(2007-12#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-11#2)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
with improvement in##2##3##(2007-2#1)(2013-1#1)
with improvement##3##2##(2006-10#1)(2007-2#1)(2013-1#1)
with improvements in##9##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2011-2#2)
with improving##2##2##(2013-1#2)
with impulse control##2##3##(2012-12#1)(2013-8#1)
with in situ measurements##2##4##(2008-2#2)
with in situ##17##3##(1994-11#1)(1996-6#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#7)(2010-2#1)(2011-1#1)(2013-1#1)
with in the##4##3##(1990-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
with in vitro activity##2##4##(1995-5#1)(2011-2#1)
with in vitro transcripts of##2##5##(2008-10#2)
with in vitro transcripts##3##4##(2008-10#3)
with in vitro##6##3##(1993-8#1)(1995-5#1)(2008-10#3)(2011-2#1)
with in vivo##8##3##(1991-1#1)(2008-10#1)(2008-5#4)(2013-1#2)
with in##46##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-9#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-6#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#4)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)
with in-depth##2##2##(2012-12#1)(2013-1#1)
with in-fiber##2##2##(2008-3#2)
with in-line##6##2##(2007-12#1)(2008-10#4)(2008-2#1)
with in-phase##2##2##(1997-8#2)
with in-situ##2##2##(2008-10#1)(2013-8#1)
with in-valve column##2##3##(2008-10#2)
with inactivated##2##2##(1996-12#1)(2008-7#1)
with inactivation##3##2##(1990-5#1)(1991-5#1)(1995-2#1)
with inadequate response##2##3##(2008-1#1)(2012-3#1)
with inadequate##6##2##(1993-12#1)(1996-11#1)(2008-1#1)(2009-10#1)(2010-8#1)(2012-3#1)
with incarceration of##3##3##(2008-12#1)(2011-2#2)
with incentives##2##2##(1996-3#1)(2008-1#1)
with incidence and##2##3##(1994-9#1)(2008-10#1)
with incidence of##2##3##(2008-10#1)(2013-1#1)
with incidence##7##2##(1994-2#1)(1994-9#1)(2008-10#3)(2008-3#1)(2013-1#1)
with incident##4##2##(2007-11#2)(2007-12#1)(2013-7#1)
with inclusion of##2##3##(2008-3#2)
with inclusion##3##2##(2008-3#2)(2009-8#1)
with incoherent light##2##3##(2007-11#2)
with incoherent##3##2##(2007-11#2)(2008-3#1)
with income##2##2##(1992-1#1)(2010-8#1)
with incompatible strains of##2##4##(2008-10#2)
with incompatible strains##3##3##(2008-10#2)(2008-9#1)
with incomplete data##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
with incomplete##10##2##(1994-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with incorporated##2##2##(2008-10#2)
with incorporation of##2##3##(1995-3#1)(2008-10#1)
with increase in nCDHA##2##4##(2012-2#2)
with increase in sample##2##4##(2008-10#2)
with increase in the##3##4##(2008-10#3)
with increase in##14##3##(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
with increase##15##2##(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
with increased ICP##2##3##(2008-12#2)
with increased blood loss##2##4##(2011-2#2)
with increased blood##3##3##(2008-11#1)(2011-2#2)
with increased body##2##3##(2008-11#1)(2011-1#1)
with increased disease severity##2##4##(2008-10#2)
with increased exposure##2##3##(1995-3#1)(2008-12#1)
with increased intracranial pressure##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
with increased levels of##3##4##(2010-6#1)(2011-1#1)(2012-12#1)
with increased mortality##3##3##(1990-6#1)(2011-2#2)
with increased muscle##2##3##(2008-12#1)(2010-6#1)
with increased plasma##2##3##(1993-6#1)(2009-12#1)
with increased potency##2##3##(1994-5#1)(2009-8#1)
with increased rates of##3##4##(1994-7#1)(2008-10#1)(2008-2#1)
with increased risk for##9##4##(1993-12#2)(1993-3#1)(2007-10#1)(2008-4#2)(2010-10#1)(2011-2#1)(2013-8#1)
with increased risk of##11##4##(1990-6#1)(1990-8#1)(1996-2#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
with increased risk##23##3##(1990-6#1)(1990-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1996-2#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with increased risks of##3##4##(2008-1#1)(2008-8#1)(2013-1#1)
with increased waist circumference##2##4##(2008-11#1)(2011-1#1)
with increased wetness duration at##2##5##(2008-10#2)
with increased##208##2##(1990-6#2)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-9#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#11)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#9)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#7)(2012-6#2)(2013-1#12)(2013-7#1)(2013-8#4)
with increases in##10##3##(1991-5#1)(1993-3#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-5#1)
with increases of##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
with increases##13##2##(1991-5#1)(1993-3#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-5#1)
with increasing PEG concentrations##2##4##(2008-12#2)
with increasing [NaOH](T)##2##3##(2008-10#2)
with increasing age and##3##4##(1990-2#1)(2008-7#1)(2012-12#1)
with increasing age as the##2##5##(1990-11#1)(2008-1#1)
with increasing age in##2##4##(2008-7#1)(2013-7#1)
with increasing age##29##3##(1990-11#1)(1990-2#1)(1990-3#1)(1992-6#2)(1994-11#1)(1994-6#2)(1996-6#1)(1996-8#1)(1996-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
with increasing amounts of##3##4##(2008-10#2)(2008-7#1)
with increasing atomic number##2##4##(2008-10#2)
with increasing concentration##4##3##(1990-8#1)(1995-6#1)(2008-10#1)(2008-11#1)
with increasing concentrations of##7##4##(1994-8#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-3#1)
with increasing concentrations##9##3##(1994-8#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2011-3#1)
with increasing depth##2##3##(2008-3#1)(2011-1#1)
with increasing dilution rate##2##4##(2008-6#2)
with increasing distance##2##3##(2008-11#1)(2008-3#1)
with increasing doses of##2##4##(1997-4#1)(2008-7#1)
with increasing doses##3##3##(1997-4#1)(2008-7#2)
with increasing duration##2##3##(1995-3#1)(2008-11#1)
with increasing experience##3##3##(2007-12#1)(2008-10#1)(2009-2#1)
with increasing exposure concentration##3##4##(2008-9#3)
with increasing exposure##5##3##(2007-11#1)(2008-7#1)(2008-9#3)
with increasing flower age at inoculation##2##6##(2008-10#2)
with increasing frequency and##2##4##(1995-5#1)(2009-5#1)
with increasing frequency in patients##2##5##(2008-3#1)(2008-6#1)
with increasing frequency in##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
with increasing frequency##9##3##(1992-4#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)
with increasing humidity##2##3##(2008-10#2)
with increasing incidence##2##3##(1994-7#1)(2013-1#1)
with increasing initial##2##3##(1995-5#1)(2008-11#1)
with increasing inoculum##2##3##(2008-10#2)
with increasing ionic strength##2##4##(1991-9#1)(1997-6#1)
with increasing ionic##3##3##(1991-9#1)(1997-6#1)(1997-7#1)
with increasing larval density##2##4##(2009-10#2)
with increasing leaf age##2##4##(2008-10#2)
with increasing leaf##5##3##(2008-10#5)
with increasing length of##2##4##(1992-8#1)(2008-8#1)
with increasing levels of##2##4##(2007-12#1)(2008-10#1)
with increasing load##2##3##(2009-7#1)(2010-12#1)
with increasing mu##3##3##(2008-10#3)
with increasing number of##4##4##(1997-7#1)(2007-8#1)(2007-9#1)(2008-8#1)
with increasing numbers of##2##4##(2008-11#1)(2008-9#1)
with increasing numbers##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
with increasing orchard block age##2##5##(2008-10#2)
with increasing osmolarity##4##3##(1991-11#4)
with increasing pCO2##2##3##(2008-11#2)
with increasing pH and##2##4##(2008-10#2)
with increasing pH##6##3##(1990-12#1)(1990-5#1)(1993-8#2)(2008-10#2)
with increasing pi acceptor##2##4##(1997-7#2)
with increasing population density##2##4##(2008-9#1)(2011-2#1)
with increasing population##3##3##(2008-9#2)(2011-2#1)
with increasing pressure##2##3##(2008-2#2)
with increasing protein concentration in the##2##6##(1990-7#2)
with increasing pulse##2##3##(2007-11#1)(2008-3#1)
with increasing rates of##2##4##(2008-1#1)(2008-10#1)
with increasing root length##2##4##(2008-10#2)
with increasing salt##3##3##(2008-10#1)(2008-12#2)
with increasing size of the##2##5##(1990-11#1)(2008-10#1)
with increasing size##4##3##(1990-11#1)(1995-5#1)(2008-10#1)(2008-8#1)
with increasing speed##2##3##(1994-8#1)(2008-9#1)
with increasing stocking rate##2##4##(1996-12#2)
with increasing strain##2##3##(2009-7#2)
with increasing temperature##14##3##(1990-9#1)(1993-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-9#1)(2009-7#2)
with increasing temperatures##2##3##(2008-10#2)
with increasing the atomic number##2##5##(2008-10#2)
with increasing the climbazole##2##4##(2008-5#2)
with increasing the concentration of cell inoculation##2##7##(2008-9#2)
with increasing the number of##3##5##(2007-8#1)(2008-10#2)
with increasing the##14##3##(1996-8#1)(2007-8#1)(2008-10#6)(2008-5#2)(2008-9#2)(2013-8#2)
with increasing time since##2##4##(1991-12#1)(2010-11#1)
with increasing time##8##3##(1990-12#1)(1991-12#1)(1992-9#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-11#1)
with increasing values of##2##4##(2008-3#1)(2008-7#1)
with increasing water activity##2##4##(2008-7#2)
with increasing water##3##3##(2008-7#3)
with increasing wavelength##2##3##(1992-4#1)(2008-3#1)
with increasing##341##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-11#4)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#3)(1995-3#1)(1995-5#4)(1995-6#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#4)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#89)(2008-11#15)(2008-12#9)(2008-2#6)(2008-3#20)(2008-5#8)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#5)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#6)
with increasingly##2##2##(1997-5#1)(2010-10#1)
with incubation##2##2##(1991-5#1)(2008-9#1)
with independent measurements##2##3##(2008-2#1)(2008-3#1)
with independent##12##2##(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2012-2#1)
with independently##2##2##(2008-10#1)(2009-7#1)
with indeterminate##3##2##(2008-10#1)(2010-8#1)(2013-7#1)
with indications##2##2##(2007-8#1)(2008-4#1)
with indices of##2##3##(1995-11#1)(2010-7#1)
with indinavir##4##2##(2008-5#2)(2008-8#2)
with indirect absorbance detection##2##4##(1996-5#2)
with indirect photometric detection##2##4##(1994-9#1)(2008-10#1)
with indirect##8##2##(1990-8#1)(1994-9#1)(1996-5#2)(2008-10#3)(2013-8#1)
with indium##2##2##(2008-10#2)
with individual##19##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-3#2)(2013-1#2)
with individualized##2##2##(1991-3#1)(2008-7#1)
with individuals##5##2##(1997-5#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-8#1)
with indomethacin##4##2##(1992-2#1)(1994-8#1)(1995-6#1)(2010-2#1)
with induced##4##2##(1993-9#1)(2008-10#2)(2010-10#1)
with inducible##2##2##(2008-11#1)(2008-2#1)
with induction##3##2##(1991-12#1)(2008-11#1)(2008-6#1)
with inductively coupled mass##2##4##(2008-10#2)
with inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
with inductively coupled plasma mass spectrometry (ICP-MS)##2##7##(2008-10#2)
with inductively coupled plasma mass spectrometry##6##6##(2008-10#5)(2010-11#1)
with inductively coupled plasma##11##4##(2008-10#10)(2010-11#1)
with inductively coupled##14##3##(2008-10#13)(2010-11#1)
with industrial and##2##3##(2008-10#1)(2008-7#1)
with industrial##4##2##(2008-10#2)(2008-7#2)
with industry##2##2##(2009-4#1)(2010-7#1)
with indwelling##2##2##(2011-2#1)(2012-2#1)
with infantile##4##2##(1991-2#1)(2009-4#2)(2012-3#1)
with infants##2##2##(1991-11#1)(1991-12#1)
with infected##7##2##(1993-8#1)(2008-10#3)(2008-12#2)(2008-6#1)
with infection##15##2##(1995-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
with infections##3##2##(2009-2#1)(2011-2#2)
with infectious##11##2##(1990-9#1)(1997-8#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)
with infective endocarditis##2##3##(2007-8#2)
with infective##3##2##(2007-8#2)(2011-2#1)
with infertility##2##2##(1992-1#1)(2012-3#1)
with infiltrating##2##2##(1995-12#1)(2007-5#1)
with infiltration of##3##3##(1994-5#1)(2010-12#1)(2011-2#1)
with inflammation and##2##3##(2007-8#1)(2013-1#1)
with inflammation##4##2##(2007-8#1)(2008-3#1)(2012-12#1)(2013-1#1)
with inflammatory bowel disease (IBD)##4##5##(2010-12#2)(2011-2#1)(2013-8#1)
with inflammatory bowel disease##18##4##(1992-6#1)(2008-10#1)(2010-12#6)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
with inflammatory bowel diseases##3##4##(2010-12#1)(2012-2#2)
with inflammatory bowel##22##3##(1992-6#1)(2008-10#1)(2010-12#7)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
with inflammatory##33##2##(1992-12#1)(1992-6#1)(1994-11#1)(1996-7#1)(2006-10#3)(2007-7#2)(2008-10#2)(2010-12#7)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
with infliximab##9##2##(2006-10#1)(2010-12#2)(2011-2#1)(2013-8#5)
with influenza A/H1N1 and A/H3N2 viruses##2##6##(2011-2#2)
with influenza##7##2##(2008-10#2)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
with influenza-like illness##3##3##(2011-2#3)
with informal##2##2##(1994-1#1)(1996-3#1)
with information about the##2##4##(2011-2#1)(2013-1#1)
with information about##3##3##(2011-2#1)(2013-1#2)
with information from##2##3##(2008-10#1)(2008-2#1)
with information obtained from##2##4##(2008-10#1)(2013-1#1)
with information on##3##3##(2007-2#1)(2010-12#1)(2012-3#1)
with information##16##2##(1992-12#1)(1997-3#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
with infrared (IR)##2##3##(2007-12#1)(2008-3#1)
with infrared##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
with infrarenal##2##2##(2008-10#1)(2011-2#1)
with infrequent##3##2##(1995-5#1)(1997-6#1)(2008-9#1)
with inhaled corticosteroids##5##3##(1996-7#1)(2007-11#1)(2008-11#2)(2011-2#1)
with inhaled insulin##3##3##(2008-8#3)
with inhaled##12##2##(1990-9#1)(1996-7#1)(2007-11#3)(2008-11#2)(2008-8#3)(2010-2#1)(2011-2#1)
with inherent##3##2##(1991-11#1)(1996-11#1)(2008-2#1)
with inherited##6##2##(1994-2#1)(1994-8#1)(1997-7#2)(2008-10#1)(2011-2#1)
with inhibition of##8##3##(1992-3#1)(1994-3#1)(1996-12#1)(1997-7#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
with inhibition##12##2##(1992-3#1)(1992-6#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
with inhibitors of##3##3##(1995-11#1)(2008-10#1)(2008-4#1)
with inhibitors##5##2##(1995-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2011-3#1)
with initial##20##2##(1990-6#1)(1993-8#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#4)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#2)
with initially##2##2##(2008-10#1)(2012-1#1)
with initiation##2##2##(1991-12#1)(2008-12#1)
with injection of##3##3##(2008-10#1)(2009-3#1)(2013-8#1)
with injection##5##2##(2008-10#1)(2008-8#1)(2009-3#1)(2013-1#1)(2013-8#1)
with injections of##2##3##(1996-3#1)(2006-10#1)
with injuries to##2##3##(1992-6#1)(2012-2#1)
with innate##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
with inoculated##2##2##(2008-10#2)
with inoculum##2##2##(2008-10#2)
with inorganic thioanions##2##3##(2008-10#2)
with inorganic##12##2##(1990-5#1)(2008-10#9)(2008-11#1)(2008-4#1)
with inosine##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
with input##3##2##(2008-2#1)(2008-3#1)(2009-4#1)
with insecticide##2##2##(1997-7#1)(2011-2#1)
with insert sizes##2##3##(1997-2#1)(2008-5#1)
with insertion of##2##3##(1991-12#1)(2009-3#1)
with insights into##2##3##(2008-6#1)(2009-3#1)
with insomnia##2##2##(2008-10#1)(2008-7#1)
with instantaneous##2##2##(2008-11#1)(2012-2#1)
with institutional##2##2##(2008-9#1)(2013-8#1)
with instructions##3##2##(1990-2#2)(1996-12#1)
with instrumental##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
with instrumentation and##2##3##(2008-8#1)(2012-12#1)
with instrumentation##3##2##(2008-8#2)(2012-12#1)
with instruments##3##2##(2007-6#2)(2013-1#1)
with insufficient##5##2##(1991-12#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-1#1)
with insulin dependent diabetes mellitus##2##5##(1997-5#1)(2012-12#1)
with insulin dependent diabetes##3##4##(1990-9#1)(1997-5#1)(2012-12#1)
with insulin receptor##2##3##(1992-12#1)(1997-6#1)
with insulin resistance and##5##4##(2008-4#1)(2010-10#1)(2011-1#2)(2013-1#1)
with insulin resistance##14##3##(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#5)(2013-1#2)
with insulin therapy##2##3##(1993-12#1)(2011-1#1)
with insulin##37##2##(1990-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-12#2)(1993-6#1)(1994-11#1)(1996-11#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-10#1)(2011-1#7)(2012-12#1)(2013-1#2)(2013-8#1)
with insulin-dependent diabetes mellitus##2##4##(1995-3#1)(1995-9#1)
with intact##10##2##(1990-11#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
with integral##3##2##(1994-12#1)(1995-5#1)(2010-9#1)
with integrated pulsed amperometric detection##2##5##(2008-10#2)
with integrated##11##2##(1997-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2010-4#2)
with integration##2##2##(2008-10#1)(2008-2#1)
with intellectual disabilities##2##3##(2009-2#1)(2012-2#1)
with intellectual disability##3##3##(2012-12#2)(2013-1#1)
with intellectual##6##2##(2009-2#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
with intense##11##2##(1991-6#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2010-6#1)
with intensities##2##2##(2008-10#1)(2008-5#1)
with intensive chemotherapy##2##3##(1990-3#1)(2008-10#1)
with intensive##10##2##(1990-3#2)(1990-9#1)(2008-10#3)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)
with interactions between##3##3##(1997-2#1)(1997-6#1)(2008-10#1)
with interactions##5##2##(1990-2#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-9#1)
with intercellular##2##2##(1990-7#1)(1995-2#1)
with interdigitated##2##2##(2008-10#2)
with interferometric##2##2##(2008-2#1)(2008-3#1)
with interferon alpha##3##3##(1997-1#1)(1997-3#2)
with interferon##6##2##(1996-6#1)(1997-1#1)(1997-3#2)(2007-5#1)(2013-1#1)
with interferon-gamma##3##2##(1993-8#1)(1996-2#1)(1997-1#1)
with interleukin-2##4##2##(1990-12#1)(1993-8#1)(1994-6#1)(1994-8#1)
with interlocking intramedullary nail##3##4##(2013-1#3)
with interlocking##5##2##(1997-3#1)(2013-1#4)
with intermediate levels of##2##4##(2008-5#1)(2008-8#1)
with intermediate sensitivity##2##3##(2007-7#1)(2008-10#1)
with intermediate##10##2##(1996-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2013-1#1)
with intermittent##10##2##(1991-9#1)(1992-4#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
with internal carotid artery##3##4##(2007-9#1)(2008-8#1)(2011-2#1)
with internal cystic##2##3##(2011-2#1)(2013-8#1)
with internal fixation##2##3##(2010-12#1)(2012-2#1)
with internal osteosynthesis##2##3##(2007-11#2)
with internal##29##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
with international##9##2##(1990-8#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-3#1)
with interrupted##2##2##(1994-12#1)(2007-7#1)
with interstitial deletion of##2##4##(1997-3#1)(2012-12#1)
with interstitial nephritis##2##3##(1997-6#1)(2008-4#1)
with interstitial##7##2##(1991-2#1)(1997-3#1)(1997-6#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-12#1)
with intervention##2##2##(2011-2#1)(2013-8#1)
with intestinal polyps##2##3##(1993-9#1)(2009-12#1)
with intestinal##8##2##(1993-9#1)(1995-10#1)(1997-1#1)(2008-12#1)(2009-12#1)(2012-3#2)(2013-1#1)
with intracavity##2##2##(2007-11#2)
with intracellular##6##2##(1994-8#1)(1995-5#1)(2006-6#1)(2007-12#1)(2008-9#1)(2011-2#1)
with intracoronary##3##2##(1994-11#1)(2011-1#1)(2012-2#1)
with intracranial##10##2##(1991-2#1)(1995-11#1)(1996-6#1)(1997-3#1)(2008-7#3)(2012-12#2)(2013-8#1)
with intractable##3##2##(1993-1#1)(1996-2#1)(2009-9#1)
with intradural##2##2##(2008-9#1)(2012-3#1)
with intrahepatic##3##2##(1997-8#1)(2008-7#1)(2009-8#1)
with intramedullary nail##2##3##(2007-11#1)(2013-1#1)
with intramedullary##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
with intramuscular##3##2##(2008-6#1)(2012-3#1)(2013-1#1)
with intranasal##4##2##(2007-10#2)(2007-11#1)(2013-1#1)
with intraocular lens##2##3##(1991-2#1)(2011-2#1)
with intraocular##4##2##(1991-2#1)(2011-2#2)(2013-1#1)
with intraoperative findings##2##3##(2007-11#2)
with intraoperative##7##2##(1994-3#1)(2007-11#2)(2007-8#1)(2008-7#1)(2011-2#2)
with intraperitoneal##2##2##(1995-12#1)(2008-12#1)
with intrapleural##2##2##(1991-6#2)
with intrathoracic##2##2##(2007-8#1)(2013-1#1)
with intrauterine##2##2##(1994-12#1)(1996-3#1)
with intravaginal##2##2##(1990-10#1)(2008-12#1)
with intravenous immunoglobulin##2##3##(2010-8#2)
with intravenous mannitol##2##3##(2008-1#2)
with intravenous midazolam##2##3##(1993-1#2)
with intravenous pulse cyclophosphamide##2##4##(2007-7#2)
with intravenous##27##2##(1991-6#1)(1993-1#2)(1993-11#1)(1995-11#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-5#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
with intraventricular##4##2##(2007-10#3)(2008-7#1)
with intriguing##2##2##(2007-11#1)(2012-3#1)
with intrinsic##4##2##(1993-9#1)(1995-2#1)(1997-8#1)(2008-5#1)
with invasion##2##2##(2008-7#1)(2012-2#1)
with invasive fungal##2##3##(2012-2#2)
with invasive growth and##2##4##(1990-11#1)(2007-8#1)
with invasive growth##3##3##(1990-11#1)(2007-8#1)(2011-1#1)
with invasive##13##2##(1990-11#1)(1992-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
with inversion##3##2##(1992-7#1)(1996-5#1)(2008-3#1)
with investigation times##2##3##(1994-3#2)
with investigation##3##2##(1994-3#2)(2008-12#1)
with involvement of the##3##4##(1994-5#1)(2007-11#1)(2008-11#1)
with involvement of##6##3##(1993-11#1)(1994-5#1)(2007-11#1)(2008-11#1)(2010-9#1)(2013-1#1)
with involvement##7##2##(1993-11#1)(1994-5#1)(2007-11#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-1#1)
with iodide in##2##3##(2008-10#2)
with iodide##9##2##(2008-10#9)
with iodine and##2##3##(2007-12#1)(2008-10#1)
with iodine##7##2##(2007-12#1)(2008-10#5)(2008-8#1)
with ion chromatography for##2##4##(2008-10#2)
with ion chromatography##5##3##(2008-10#5)
with ion exchange##2##3##(2008-10#2)
with ion##15##2##(1990-8#1)(1992-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
with ion-pair##2##2##(1995-6#1)(2008-10#1)
with ion-selective##4##2##(2008-10#4)
with ionic##2##2##(2008-10#2)
with ipsilateral##7##2##(1992-8#2)(2008-10#1)(2010-5#1)(2011-1#1)(2013-1#2)
with iron ions##3##3##(1993-8#3)
with iron##9##2##(1993-6#1)(1993-8#3)(1995-2#1)(2008-10#3)(2011-2#1)
with iron(II) in hydrochloric acid##2##5##(2008-10#2)
with iron(II)##6##2##(2008-10#6)
with iron(III) in the presence of 1##2##7##(2008-10#2)
with iron(III) in##3##3##(2008-10#3)
with iron(III)##5##2##(2008-10#5)
with irradiated##3##2##(1993-9#2)(2007-11#1)
with irregular##6##2##(1996-12#1)(1996-5#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
with irreversible##2##2##(2008-3#1)(2010-1#1)
with ischaemic heart disease##4##4##(2008-5#1)(2008-7#2)(2012-2#1)
with ischaemic heart##5##3##(2007-8#1)(2008-5#1)(2008-7#2)(2012-2#1)
with ischaemic##9##2##(2007-8#2)(2008-5#1)(2008-7#2)(2008-8#2)(2012-2#1)(2013-8#1)
with ischemic heart disease##6##4##(1996-6#1)(1996-9#3)(2008-7#1)(2012-3#1)
with ischemic stroke##9##3##(2007-10#6)(2007-9#1)(2008-8#1)(2008-9#1)
with ischemic##22##2##(1996-6#1)(1996-9#3)(2006-7#1)(2007-10#6)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
with isobaric bypivacain (5mg/ml)##2##4##(2012-3#2)
with isobaric bypivacain##3##3##(2012-3#3)
with isobutyl methyl ketone (IBMK)##3##5##(2008-10#3)
with isobutyl methyl ketone##4##4##(2008-10#4)
with isocratic##2##2##(1990-8#1)(2008-10#1)
with isolate##2##2##(1997-3#1)(2008-5#1)
with isolated Broca's##2##3##(2007-10#2)
with isolated abnormal chords of the left ventricle##2##8##(2011-1#2)
with isolated##20##2##(1991-12#1)(1992-9#1)(1994-8#1)(1996-5#1)(1997-8#1)(2007-10#3)(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
with isolates from##7##3##(2008-10#6)(2011-2#1)
with isolates of C##2##4##(2008-10#2)
with isolates of morphotype A##3##5##(2008-10#3)
with isolates of##11##3##(2008-10#11)
with isolates##24##2##(2008-10#21)(2011-2#2)(2013-8#1)
with isolation and##2##3##(2008-6#1)(2012-2#1)
with isolation##3##2##(2008-6#1)(2012-2#1)(2013-7#1)
with isoniazid##3##2##(2008-10#2)(2008-5#1)
with isopropyl##2##2##(1990-5#1)(1991-12#1)
with isopropyl-beta-D-thiogalactopyranoside##2##2##(1990-5#1)(2010-6#1)
with isotonic##2##2##(1994-8#1)(2008-10#1)
with it the##2##3##(1995-2#1)(2008-3#1)
with it##22##2##(1991-12#1)(1991-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
with itraconazole##5##2##(2007-7#2)(2008-1#1)(2008-5#2)
with its 5##3##3##(2011-2#3)
with its ability to##3##4##(1993-2#1)(1995-5#1)(2011-2#1)
with its associated##2##3##(1994-3#1)(2007-12#1)
with its cognate##2##3##(1995-8#1)(2011-1#1)
with its degradation##2##3##(2008-10#1)(2012-12#1)
with its degree##2##3##(1990-6#1)(2008-11#1)
with its improved##2##3##(2008-10#1)(2011-7#1)
with its protein##2##3##(1992-12#1)(1994-11#1)
with its receptor##3##3##(1992-3#1)(1994-8#1)(1995-6#1)
with its respective##2##3##(2011-2#1)(2013-1#1)
with its tangential plane coincident with the##2##7##(2008-3#2)
with its tangential##3##3##(2008-3#3)
with its typical##2##3##(2007-11#1)(2011-3#1)
with its unique##2##3##(2008-3#1)(2008-4#1)
with its use##3##3##(1993-1#1)(2007-8#1)(2010-8#1)
with its##215##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-2#2)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#13)(2008-9#2)(2009-10#3)(2009-5#2)(2010-10#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#50)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#9)(2013-8#1)
with jaundice##6##2##(1990-8#1)(1992-9#2)(2008-11#1)(2013-1#2)
with joint##3##2##(1997-4#1)(2007-8#1)(2013-8#1)
with just a##2##3##(2008-7#1)(2012-3#1)
with just one##2##3##(2008-4#1)(2011-2#1)
with just##5##2##(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)
with juvenile##2##2##(2012-3#1)(2013-8#1)
with kainic acid##2##3##(1993-12#2)
with keeping##2##2##(2008-10#2)
with keratoconjunctivitis##5##2##(2011-2#5)
with ketamine##2##2##(2012-12#1)(2012-3#1)
with key informants##2##3##(1996-3#1)(2008-1#1)
with key##10##2##(1995-2#1)(1996-3#1)(2008-1#1)(2008-12#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-2#1)
with kidney##5##2##(1991-3#1)(1992-5#1)(2008-7#2)(2013-1#1)
with kin##2##2##(2008-10#1)(2009-10#1)
with knee osteoarthritis##3##3##(2012-2#1)(2013-1#2)
with knee pain##2##3##(2007-8#1)(2012-3#1)
with knee##8##2##(2007-8#2)(2012-2#1)(2012-3#1)(2013-1#4)
with knowledge of the##2##4##(2008-10#1)(2012-3#1)
with knowledge of##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
with knowledge on##2##3##(2008-9#1)(2011-1#1)
with knowledge##6##2##(1992-2#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
with known AP-induced bronchospasm##2##4##(1996-12#2)
with known amounts of##5##4##(1993-6#1)(2008-10#4)
with known concentrations##2##3##(2008-10#1)(2008-3#1)
with known genes##2##3##(2008-10#1)(2008-9#1)
with known or##3##3##(1997-6#1)(1997-8#1)(2013-1#1)
with known##74##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-5#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-12#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
with l-cysteine##4##2##(2008-10#4)
with lab-at-valve (LAV) approach for on-line liquid-liquid micro-extraction##2##8##(2008-10#2)
with lab-at-valve (LAV) approach for##3##5##(2008-10#3)
with labeled DNA##3##3##(1990-5#1)(2008-4#2)
with labeled##8##2##(1990-5#1)(1991-5#1)(1997-4#1)(2008-10#2)(2008-4#2)(2008-7#1)
with labeling##3##2##(1995-6#2)(2008-4#1)
with labelled cDNA from##2##4##(2008-7#2)
with labile##2##2##(1996-2#1)(2012-2#1)
with laboratory##6##2##(1994-12#1)(2007-12#2)(2008-10#1)(2008-2#2)
with laccase##2##2##(2008-10#2)
with lack of##5##3##(1993-6#1)(2008-3#1)(2008-9#1)(2009-10#1)(2013-1#1)
with lactate##2##2##(1994-8#1)(2008-10#1)
with lactic##3##2##(1990-3#2)(2013-7#1)
with lacunar infarct##2##3##(2007-10#2)
with lacunar##4##2##(2007-10#4)
with lambda##2##2##(1992-2#1)(2008-3#1)
with laminectomy followed by radiotherapy##3##5##(1991-9#1)(1996-9#2)
with lamivudine##3##2##(1996-11#1)(2006-10#1)(2009-8#1)
with lanthanide##2##2##(2008-10#2)
with laparoscopic procedures##2##3##(2011-2#2)
with laparoscopic##5##2##(1996-9#1)(2011-2#2)(2013-1#2)
with laparotomy##4##2##(1991-3#1)(1994-3#1)(1996-1#1)(1996-3#1)
with large amount of##2##4##(2008-10#2)
with large and##2##3##(2008-2#1)(2009-9#1)
with large effects##2##3##(2008-8#1)(2012-3#1)
with large intestine##2##3##(2009-8#1)(2013-1#1)
with large numbers of##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
with large numerical aperture##2##4##(2008-3#2)
with large or##2##3##(2008-3#1)(2008-9#1)
with large quantities of##3##4##(2008-11#1)(2008-9#1)(2009-7#1)
with large##89##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-9#1)(1994-1#2)(1994-2#1)(1995-2#2)(1996-4#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#16)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
with large-scale##3##2##(1994-12#1)(2008-4#1)(2008-7#1)
with larger numbers of##3##4##(1995-12#1)(2010-5#1)(2012-2#1)
with larger sample##2##3##(2007-10#1)(2008-12#1)
with larger samples##2##3##(2008-12#1)(2013-1#1)
with larger##25##2##(1992-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(2007-10#2)(2008-10#3)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with largest##2##2##(2010-7#1)(2012-5#1)
with larvae of##2##3##(2008-2#1)(2008-9#1)
with larvae##4##2##(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)
with laryngeal##3##2##(1990-6#1)(2008-5#1)(2012-2#1)
with laser laparoscopy##2##3##(1995-2#2)
with laser light##2##3##(2008-1#1)(2012-2#1)
with laser pulses##2##3##(2008-3#2)
with laser sampling##2##3##(2008-10#2)
with laser##22##2##(1991-9#1)(1995-2#2)(1995-3#1)(1997-2#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2012-1#2)(2012-2#1)
with laser-induced fluorescence detection##5##4##(1997-2#3)(2008-10#2)
with laser-induced fluorescence##7##3##(1997-2#3)(2008-10#4)
with laser-induced##12##2##(1997-2#3)(2008-10#6)(2008-2#1)(2008-3#2)
with late##11##2##(1993-6#1)(1995-4#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
with late-onset schizophrenia##2##3##(1996-7#1)(2008-9#1)
with late-onset##6##2##(1990-11#1)(1996-7#1)(2008-7#1)(2008-9#1)(2009-8#2)
with latent porphyria##2##3##(1990-2#2)
with latent##4##2##(1990-2#2)(2008-10#2)
with later##4##2##(2008-1#1)(2008-7#1)(2008-8#1)(2012-1#1)
with lateral##4##2##(2008-12#1)(2008-3#2)(2008-5#1)
with latex##3##2##(2007-10#1)(2008-3#1)(2011-2#1)
with lattice constants a =##2##5##(1996-2#2)
with lattice parameters##2##3##(1997-7#2)
with lattice##4##2##(1996-2#2)(1997-7#2)
with lead##7##2##(1995-11#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
with lead(II)##3##2##(2008-10#3)
with leaf rust##3##3##(2008-10#3)
with leaf##7##2##(2008-10#6)(2008-9#1)
with learning and##2##3##(2008-10#1)(2008-11#1)
with learning difficulties##6##3##(2008-11#6)
with learning disabilities##6##3##(2008-12#1)(2011-1#5)
with learning##18##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2011-1#6)
with left flank pain##2##4##(2009-5#1)(2011-2#1)
with left lung hypoplasia##2##4##(2013-1#2)
with left lung##4##3##(2007-8#2)(2013-1#2)
with left sided##3##3##(1997-6#1)(2010-11#1)(2013-1#1)
with left ventricular dysfunction##3##4##(2007-8#2)(2010-6#1)
with left ventricular##5##3##(2007-8#2)(2008-12#1)(2008-7#1)(2010-6#1)
with left##38##2##(1991-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#7)(2008-11#1)(2008-12#1)(2008-7#4)(2009-10#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-3#2)(2013-1#6)
with left-sided##3##2##(2008-10#1)(2010-5#1)(2012-1#1)
with leg##2##2##(1996-7#1)(2007-11#1)
with legal##2##2##(2008-10#1)(2009-9#1)
with length##3##2##(2008-4#1)(2011-2#1)(2013-7#1)
with leprosy##8##2##(2007-7#1)(2008-7#1)(2008-8#1)(2012-12#5)
with lesbian##3##2##(2008-12#1)(2012-2#2)
with lesbian/bisexual mothers##2##3##(2009-7#2)
with lesion##5##2##(2007-7#1)(2008-10#2)(2010-6#1)(2012-2#1)
with lesions in the##2##4##(2008-10#1)(2008-11#1)
with lesions in##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
with lesions of the##2##4##(1993-12#1)(1996-5#1)
with lesions of##4##3##(1993-12#1)(1996-5#1)(2007-8#1)(2009-11#1)
with lesions##15##2##(1990-3#1)(1991-2#1)(1992-11#1)(1993-12#2)(1995-12#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-11#1)
with less severe##2##3##(2009-11#1)(2011-2#1)
with less than 0##2##4##(2008-3#1)(2012-2#1)
with less than 1%##2##4##(1992-2#1)(2008-2#1)
with less than 10%##2##4##(2008-3#2)
with less than optimal##2##4##(1996-11#1)(2013-1#1)
with less than##21##3##(1991-6#1)(1992-2#1)(1993-11#1)(1996-11#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
with less##64##2##(1991-12#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
with lesser amounts##2##3##(2008-11#1)(2008-7#1)
with lesser##4##2##(1993-6#1)(2008-11#1)(2008-3#1)(2008-7#1)
with lethal##2##2##(1990-8#1)(2011-2#1)
with leucovorin##2##2##(1990-2#1)(2010-3#1)
with leukemia##8##2##(1992-3#2)(1996-2#1)(2008-1#1)(2008-10#1)(2010-11#1)(2012-12#1)(2012-3#1)
with leukocytes##3##2##(2008-1#2)(2008-5#1)
with leukotriene receptor##2##3##(2008-1#1)(2012-12#1)
with leukotriene##3##2##(1990-11#1)(2008-1#1)(2012-12#1)
with levamisole##2##2##(1991-8#1)(1996-6#1)
with level of##3##3##(2011-1#3)
with level##6##2##(1993-3#1)(1994-12#1)(2011-1#3)(2011-2#1)
with levels of##6##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-11#1)
with levels##9##2##(1994-2#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)
with lichen planus##2##3##(2007-7#1)(2009-6#1)
with lidar##4##2##(2008-2#3)(2008-3#1)
with lidocaine##2##2##(1990-9#1)(1993-12#1)
with life in general##2##4##(1993-6#1)(2007-10#1)
with life##10##2##(1993-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-10#1)(2012-2#1)
with life-threatening##2##2##(2012-3#1)(2013-8#1)
with lifestyle##3##2##(2008-1#1)(2008-8#1)(2010-10#1)
with lifetimes of##2##3##(1996-2#1)(2008-10#1)
with ligand##3##2##(1990-8#2)(1991-8#1)
with ligands of##2##3##(1991-5#1)(2008-10#1)
with ligands##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
with light and##4##3##(2008-10#3)(2008-9#1)
with light microscopy and##2##4##(2007-7#1)(2008-10#1)
with light microscopy##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
with light##26##2##(1993-3#1)(2006-11#2)(2007-11#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
with lignin##2##2##(2008-10#1)(2008-6#1)
with like##2##2##(1996-2#1)(2011-2#1)
with likely##3##2##(1991-12#2)(2008-4#1)
with limb##4##2##(1991-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
with limited English proficiency##3##4##(2008-12#1)(2010-8#2)
with limited access to##2##4##(2008-2#1)(2008-4#1)
with limited resources##2##3##(1993-2#1)(2008-11#1)
with limited##42##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)
with limits of detection in the##2##6##(2008-10#2)
with limits of detection##5##4##(2008-10#3)(2008-3#1)(2010-11#1)
with lineage##5##2##(2008-10#2)(2008-8#1)(2010-8#2)
with linear and##4##3##(2008-10#2)(2008-3#2)
with linear best fit##2##4##(2008-10#2)
with linear##27##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#6)
with linearized##2##2##(1991-6#1)(2008-2#1)
with linearly polarized##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
with linoleic acid##3##3##(1994-12#1)(2008-11#2)
with lipase##3##2##(1995-5#1)(2010-10#2)
with lipid bilayers##4##3##(1990-5#1)(1992-6#1)(2008-10#2)
with lipid membranes##3##3##(1993-5#1)(1994-12#1)(2010-5#1)
with lipid##16##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(2008-10#5)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
with lipids##3##2##(1990-2#1)(1996-2#1)(2008-10#1)
with lipofilling technique##2##3##(2013-1#2)
with lipophilic##5##2##(1995-3#1)(2008-10#4)
with lipopolysaccharide (LPS)##2##3##(1993-3#1)(1993-9#1)
with lipopolysaccharide##8##2##(1991-2#1)(1992-3#1)(1993-3#2)(1993-9#1)(1996-12#2)(2010-5#1)
with liposomal amphotericin B##3##4##(2008-10#1)(2008-5#2)
with liposomal##5##2##(1990-2#1)(2008-10#1)(2008-5#2)(2010-3#1)
with liposomes##4##2##(1992-6#1)(1994-9#1)(1996-2#1)(2008-10#1)
with liquid chromatography##4##3##(2008-10#4)
with liquid##17##2##(1992-8#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#2)(2010-5#1)(2011-2#1)
with liquid-crystal SLM's##2##3##(2008-3#2)
with liquid-crystal##4##2##(2008-3#4)
with liquid-liquid extraction##2##3##(2008-10#2)
with literature data##4##3##(1990-5#1)(2008-10#1)(2011-2#1)(2013-7#1)
with literature review##7##3##(2007-10#3)(2007-11#1)(2008-12#1)(2010-11#1)(2013-1#1)
with literature values##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
with literature##19##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-5#1)(2007-10#3)(2007-11#3)(2008-10#3)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
with lithium##11##2##(1995-11#2)(1996-12#1)(1996-5#1)(2007-11#2)(2008-10#1)(2008-2#2)(2009-8#1)(2009-9#1)
with little activity##2##3##(1992-3#1)(1994-8#1)
with little bias##2##3##(2008-10#1)(2009-7#1)
with little effect##2##3##(1993-3#1)(1995-3#1)
with little loss##2##3##(1990-7#1)(2007-6#1)
with little or no##8##4##(1990-2#1)(1995-2#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-4#2)(2013-1#1)
with little success##3##3##(2010-1#1)(2010-11#1)(2010-3#1)
with little##59##2##(1990-2#1)(1990-7#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-2#1)(1997-1#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
with live attenuated##2##3##(1995-5#1)(2008-4#1)
with live birth##2##3##(1994-2#1)(2011-2#1)
with live related##3##3##(2008-10#1)(2008-4#2)
with live##13##2##(1991-8#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#2)(2009-5#1)(2011-2#1)
with liver cirrhosis##11##3##(1992-2#1)(2008-1#2)(2008-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
with liver disease##9##3##(1990-8#1)(1996-1#4)(2008-1#1)(2013-1#2)(2013-8#1)
with liver involvement##3##3##(2011-1#1)(2013-1#2)
with liver metastasis##3##3##(2007-5#1)(2011-2#1)(2013-7#1)
with liver microsomes##2##3##(1995-6#1)(2011-3#1)
with liver##41##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-4#1)(1995-6#2)(1996-1#4)(2007-5#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
with living cells##2##3##(1993-6#1)(2008-11#1)
with living##7##2##(1993-3#1)(1993-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
with local and##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
with local anesthesia##2##3##(1993-1#1)(2013-1#1)
with local recurrence##3##3##(2008-6#2)(2012-1#1)
with local##37##2##(1990-11#1)(1991-9#1)(1993-1#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#4)(2009-9#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
with localized scleroderma##3##3##(2011-2#3)
with localized##15##2##(1995-12#1)(1996-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-3#4)(2011-1#2)(2011-2#3)(2012-12#1)
with locally advanced breast##2##4##(1991-4#1)(2013-8#1)
with locally advanced##13##3##(1990-6#1)(1991-4#1)(1997-7#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-8#1)
with locally##15##2##(1990-6#1)(1990-8#1)(1991-4#1)(1997-7#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
with location##2##2##(2008-10#1)(2008-12#1)
with loci##2##2##(1993-12#1)(1995-5#1)
with log beta(pqr) = -2##2##5##(2008-10#2)
with log##3##2##(2008-10#2)(2009-7#1)
with logarithmic##2##2##(2008-3#2)
with lomefloxacin##2##2##(2008-10#2)
with long alkyl##2##3##(2008-10#1)(2008-5#1)
with long histories##2##3##(1991-8#1)(2013-8#1)
with long history of##4##4##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
with long lasting##2##3##(2009-3#1)(2010-9#1)
with long term##2##3##(2007-12#1)(2012-2#1)
with long##35##2##(1991-8#1)(1993-2#1)(1994-2#1)(2007-11#5)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-9#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
with long-acting agents##2##3##(2009-9#2)
with long-acting##3##2##(2008-3#1)(2009-9#2)
with long-chain##3##2##(1996-5#1)(2008-10#2)
with long-standing##9##2##(1993-6#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)
with long-term follow-up##5##3##(2008-10#2)(2008-9#1)(2012-12#2)
with long-term psychiatric backgrounds##2##4##(1993-1#2)
with long-term##26##2##(1992-11#1)(1993-1#3)(1993-2#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-5#1)(2010-8#2)(2012-12#2)(2012-2#1)(2013-1#2)
with longer follow-up##4##3##(2011-2#3)(2012-12#1)
with longer##22##2##(1991-7#1)(1995-11#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
with longstanding##3##2##(2008-12#1)(2012-3#1)(2012-4#1)
with loop##2##2##(1996-1#1)(2008-11#1)
with loose abrasives for##2##4##(2008-3#2)
with loose##3##2##(2008-3#2)(2008-5#1)
with losartan##3##2##(2011-2#3)
with loss of the##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
with loss of##15##3##(1993-3#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
with loss##20##2##(1992-5#1)(1993-3#1)(1997-1#1)(1997-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
with losses##4##2##(2007-11#3)(2008-7#1)
with lovastatin##2##2##(1992-11#2)
with low CD4/CD8 ratio##2##4##(1990-2#2)
with low affinity##2##3##(1990-5#1)(1991-11#1)
with low and high##3##4##(1997-7#1)(2008-10#1)(2012-3#1)
with low back pain##7##4##(2007-11#1)(2008-12#4)(2010-1#1)(2013-1#1)
with low birth weight##2##4##(1996-11#1)(2012-3#1)
with low birth##3##3##(1994-6#1)(1996-11#1)(2012-3#1)
with low body##2##3##(2008-7#1)(2009-5#1)
with low bone mass##2##4##(2011-1#2)
with low bone mineral density##2##5##(2012-2#2)
with low bone##4##3##(2011-1#2)(2012-2#2)
with low complication rates##2##4##(2011-2#2)
with low complications##2##3##(2007-11#1)(2012-3#1)
with low concentrations of the##2##5##(1991-5#1)(2008-5#1)
with low concentrations of##3##4##(1991-5#1)(2008-5#2)
with low concentrations##4##3##(1991-5#1)(2008-5#3)
with low contrast##2##3##(2008-2#1)(2008-3#1)
with low cost##2##3##(2008-10#1)(2009-1#1)
with low detection limits##3##4##(2008-10#3)
with low disease##3##3##(2008-10#3)
with low doses of##5##4##(1990-10#2)(1996-5#1)(2008-5#1)(2008-7#1)
with low erythrocyte mean corpuscular volume##2##6##(1993-3#2)
with low fluorescence##2##3##(2008-10#2)
with low frequency##3##3##(1990-11#1)(2008-3#1)(2009-2#1)
with low glucose degradation products##2##5##(2011-2#2)
with low grade##3##3##(2007-10#1)(2008-4#1)(2011-1#1)
with low initial##2##3##(2008-10#1)(2008-9#1)
with low level of##2##4##(1992-3#1)(2011-2#1)
with low level##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
with low levels of##10##4##(1994-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-12#2)(2012-2#1)
with low levels##11##3##(1992-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-12#2)(2012-2#1)
with low long-term survival##2##4##(2010-6#1)(2012-1#1)
with low molecular weight heparin for##2##6##(1996-6#1)(2008-8#1)
with low molecular##3##3##(1996-6#1)(2008-2#1)(2008-8#1)
with low morbidity##2##3##(1995-1#1)(2008-6#1)
with low performance status##2##4##(1993-12#1)(1994-8#1)
with low power##2##3##(2008-10#1)(2009-7#1)
with low rates##2##3##(1992-10#1)(1995-2#1)
with low risk##2##3##(2007-8#1)(2008-11#1)
with low sample##4##3##(2008-10#3)(2011-1#1)
with low serum##2##3##(2008-1#1)(2008-7#1)
with low symptoms##2##3##(2007-8#2)
with low virulence##2##3##(2008-10#2)
with low vision##3##3##(2010-8#3)
with low##234##2##(1990-10#2)(1990-11#1)(1990-2#3)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#48)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#8)(2009-1#1)(2009-11#2)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#4)(2010-12#4)(2010-4#1)(2010-6#2)(2010-8#3)(2011-1#9)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-6#2)(2013-1#9)(2013-7#1)(2013-8#1)
with low-coherence##2##2##(2007-11#1)(2008-3#1)
with low-dose alpha-2b interferon##2##4##(1990-6#2)
with low-dose interleukin-2##2##3##(1992-12#1)(1993-12#1)
with low-dose##11##2##(1990-6#2)(1992-12#2)(1993-12#1)(1994-12#1)(2011-2#3)(2012-2#2)
with low-grade##6##2##(1990-12#1)(1993-6#1)(1997-1#2)(2007-10#1)(2011-2#1)
with low-income##2##2##(2008-11#1)(2010-2#1)
with low-power##3##2##(2007-12#2)(2008-3#1)
with low-risk##4##2##(2011-2#3)(2013-1#1)
with lower abdominal##2##3##(1993-9#1)(2011-2#1)
with lower affinity##2##3##(1994-12#1)(1995-6#1)
with lower area##2##3##(2008-10#1)(2010-4#1)
with lower concentrations##2##3##(2008-10#2)
with lower detection limit of##2##5##(2008-10#2)
with lower levels of##8##4##(1995-3#1)(1996-5#1)(2008-12#1)(2008-9#1)(2009-5#2)(2009-7#1)(2012-2#1)
with lower levels##10##3##(1994-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-12#1)(2008-9#1)(2009-5#2)(2009-7#1)(2012-2#1)
with lower limits of##2##4##(2008-10#2)
with lower respiratory tract infections##2##5##(2009-2#1)(2009-3#1)
with lower risk of##2##4##(2009-3#1)(2013-1#1)
with lower total##2##3##(2008-10#1)(2008-7#1)
with lower##87##2##(1990-3#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-7#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
with lowered##2##2##(1992-9#1)(2008-5#1)
with lowest##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2012-5#1)
with lumbar lateral recess syndrome##2##5##(2011-2#2)
with lumbar spinal##2##3##(2012-12#1)(2012-2#1)
with lumbar##10##2##(1992-5#1)(1993-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)
with luminescence##4##2##(2008-10#2)(2008-2#1)(2011-1#1)
with luminol##4##2##(1995-3#1)(2008-10#3)
with lung cancer and other##2##5##(2008-7#1)(2009-7#1)
with lung cancer##9##3##(1991-12#1)(1991-2#1)(1991-8#1)(2008-7#2)(2009-11#1)(2009-7#1)(2011-1#1)(2012-1#1)
with lung disease##3##3##(1996-2#2)(2008-10#1)
with lung##23##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1996-2#2)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)
with lupus##4##2##(2006-10#1)(2008-1#1)(2010-6#1)(2013-1#1)
with lymph node metastases##2##4##(2008-9#1)(2013-8#1)
with lymph node metastasis##2##4##(2013-1#2)
with lymph node##7##3##(1991-6#1)(2008-9#1)(2010-8#1)(2013-1#2)(2013-8#2)
with lymphadenectomy##3##2##(1992-9#1)(1993-3#1)(2011-2#1)
with lymphatic##2##2##(2008-6#1)(2008-7#1)
with lymphocytic infiltrates##2##3##(2011-2#2)
with lymphoma##6##2##(1997-8#1)(2007-11#1)(2008-4#1)(2011-2#3)
with lysine##2##2##(1993-8#1)(1995-2#1)
with m-chloroperbenzoic acid##2##3##(1994-6#1)(1996-5#1)
with mRNA##5##2##(1994-11#1)(1994-8#1)(1995-2#1)(2008-2#1)(2012-1#1)
with machines##2##2##(2008-1#1)(2009-10#1)
with macrocephaly##2##2##(2012-12#2)
with macrocyclic##2##2##(2008-10#2)
with macrophage##3##2##(1995-3#1)(2011-1#1)(2012-2#1)
with macrophages##6##2##(1991-9#1)(1995-3#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-8#1)
with macroscopic hematuria##2##3##(2007-10#1)(2008-1#1)
with macroscopic##4##2##(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)
with magnesium##5##2##(1990-7#1)(1991-12#1)(1991-5#1)(1996-6#1)(2008-2#1)
with magnetic resonance imaging (MRI)##2##5##(2010-9#1)(2012-2#1)
with magnetic resonance imaging##5##4##(1992-3#1)(1995-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
with magnetic resonance##6##3##(1992-3#1)(1995-12#1)(2009-1#1)(2010-9#1)(2012-2#1)(2013-1#1)
with magnetic##10##2##(1992-3#1)(1994-2#1)(1995-12#1)(2008-7#2)(2009-1#1)(2009-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
with main##6##2##(1991-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)(2012-2#1)
with mainly##3##2##(1995-5#1)(1997-8#1)(2011-1#1)
with maize##4##2##(2008-10#3)(2012-2#1)
with major depression##5##3##(1995-11#1)(1996-7#1)(2008-6#1)(2009-8#2)
with major depressive disorder##4##4##(1996-7#2)(2013-7#2)
with major depressive##6##3##(1996-7#2)(1997-5#1)(2013-7#2)(2013-8#1)
with major emphasis on##2##4##(1990-11#1)(1991-6#1)
with major##35##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-2#1)(1995-11#1)(1995-2#3)(1996-11#1)(1996-12#1)(1996-7#3)(1997-5#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#1)
with majority##2##2##(2010-5#1)(2012-2#1)
with malaria##4##2##(2008-1#1)(2012-12#3)
with male##14##2##(1993-12#1)(1993-5#1)(2008-1#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
with maleic anhydride##2##3##(1996-5#1)(2007-11#1)
with males##6##2##(1995-6#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-12#1)
with malformations##2##2##(1992-11#1)(1993-12#1)
with malignancies##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
with malignancy##9##2##(1991-12#1)(1991-8#1)(2007-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#2)
with malignant diseases##2##3##(1990-11#1)(1990-2#1)
with malignant melanoma##5##3##(1990-6#1)(1993-8#1)(2007-5#1)(2011-2#2)
with malignant tumors##4##3##(1994-12#1)(2007-11#1)(2008-3#2)
with malignant##38##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-9#1)(1997-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-3#2)(2008-6#3)(2008-7#3)(2008-8#2)(2009-1#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
with maltose binding protein##2##4##(1997-4#1)(1997-6#1)
with mammalian cells##4##3##(2008-5#1)(2008-9#3)
with mammalian##8##2##(1991-6#1)(1996-8#1)(2008-11#1)(2008-5#1)(2008-9#4)
with mammals##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
with managed care organizations##2##4##(1997-1#1)(1997-3#1)
with managed care plans##3##4##(1994-2#1)(1995-12#2)
with managed care##12##3##(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-2#3)(1996-3#2)(1997-1#1)(1997-3#1)
with managed##13##2##(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-3#1)
with management##4##2##(1993-2#1)(1995-3#1)(2008-3#1)(2011-2#1)
with managing##2##2##(2009-5#1)(2010-5#1)
with manganese##3##2##(2007-12#1)(2008-10#2)
with manifestations##2##2##(1995-11#1)(2009-7#1)
with manipulation##2##2##(1992-9#1)(2008-12#1)
with manual##7##2##(1995-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#2)
with many common##2##3##(2008-10#1)(2012-12#1)
with many more##2##3##(1994-2#1)(2008-7#1)
with many of the##4##4##(1996-1#1)(2008-10#2)(2008-5#1)
with many other##6##3##(2008-10#1)(2008-11#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
with many potential##2##3##(1995-9#1)(2008-10#1)
with many##69##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#2)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#2)
with marginal##2##2##(1996-9#1)(2012-12#1)
with marked##25##2##(1991-12#1)(1991-5#2)(1993-11#1)(1994-7#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#2)
with markers for##2##3##(1991-8#1)(1995-6#1)
with markers of##3##3##(1990-3#1)(2009-4#1)(2012-1#1)
with markers##6##2##(1990-3#1)(1991-8#1)(1995-6#1)(1997-5#1)(2009-4#1)(2012-1#1)
with marketed##2##2##(2010-5#1)(2012-2#1)
with marketing##3##2##(1992-3#1)(1993-12#1)(1995-1#1)
with marrow##2##2##(2009-8#1)(2011-2#1)
with mass spectrometric detection##5##4##(2008-10#4)(2008-4#1)
with mass spectrometric##6##3##(2008-10#5)(2008-4#1)
with mass spectrometry (LC-MS)##2##4##(2008-10#1)(2010-4#1)
with mass spectrometry to##2##4##(2008-4#1)(2008-7#1)
with mass spectrometry##13##3##(1997-4#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)
with mass##26##2##(1996-6#2)(1997-4#2)(1997-5#1)(1997-6#1)(2008-1#1)(2008-10#10)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2010-8#2)(2012-2#1)
with massive##11##2##(1991-4#1)(1991-6#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
with matched##5##2##(1992-8#1)(2008-7#1)(2010-12#2)(2012-5#1)
with matching##2##2##(2008-10#1)(2012-12#1)
with material##3##2##(2007-11#1)(2008-7#1)(2011-1#1)
with materials##2##2##(2008-2#1)(2008-3#1)
with maternal##11##2##(1995-8#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-3#1)
with maternally derived##2##3##(1997-3#2)
with mating##3##2##(2007-12#1)(2008-8#1)(2008-9#1)
with matrix##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
with mature##4##2##(2008-10#2)(2008-5#1)(2010-10#1)
with maxillary##2##2##(2007-10#1)(2007-7#1)
with maxima##3##2##(1993-11#1)(1996-5#1)(2011-2#1)
with maximal##12##2##(1990-12#1)(1990-2#1)(1990-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
with maximizing##2##2##(2008-9#2)
with maximum absolute temperature##2##4##(2008-8#2)
with maximum adsorption capacity##2##4##(2008-10#2)
with maximum levels##2##3##(1996-12#1)(2008-5#1)
with maximum likelihood##4##3##(2012-1#2)(2012-3#2)
with maximum striga##3##3##(2008-10#3)
with maximum##31##2##(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)(2012-1#2)(2012-3#2)
with mean age of##10##4##(2008-1#1)(2008-12#1)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#2)
with mean age##11##3##(2007-7#1)(2008-1#1)(2008-12#1)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#2)
with mean##45##2##(1990-3#1)(1991-12#1)(1992-6#1)(1993-12#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-1#4)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#5)(2013-1#3)
with measurable##4##2##(1990-12#1)(2007-11#1)(2008-6#1)(2013-8#1)
with measured data##2##3##(2008-10#1)(2008-2#1)
with measured##10##2##(2008-10#2)(2008-2#1)(2008-3#7)
with measurement error##3##3##(1997-4#1)(2012-1#2)
with measurement of##4##3##(1993-11#1)(2008-9#2)(2010-7#1)
with measurement##8##2##(1993-11#1)(1997-4#1)(2008-9#2)(2010-7#1)(2012-1#3)
with measurements from##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
with measurements of##9##3##(1991-3#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)
with measurements on##2##3##(2008-3#1)(2012-2#1)
with measurements##23##2##(1991-3#1)(1992-9#1)(1993-11#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-9#1)(2009-7#1)(2012-2#1)
with measures of##4##3##(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
with measures##6##2##(1995-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
with measuring##3##2##(1994-3#1)(2007-4#1)(2008-9#1)
with meat##2##2##(1993-2#1)(2013-1#1)
with mechanical circulatory support##2##4##(2010-8#1)(2011-2#1)
with mechanical jaundice of nonneoplastic##2##5##(2011-1#2)
with mechanical jaundice##3##3##(2011-1#3)
with mechanical neck pain##3##4##(2008-12#3)
with mechanical##19##2##(1990-3#1)(1995-11#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
with media##3##2##(2007-12#1)(2008-7#1)(2011-7#1)
with medial##2##2##(1992-11#1)(2008-7#1)
with median follow-up of##2##4##(2011-2#1)(2013-1#1)
with median##7##2##(1997-8#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#1)
with mediastinal##3##2##(1996-6#1)(2008-10#1)(2009-8#1)
with medical care##4##3##(1996-2#2)(1996-3#2)
with medical procedures##3##3##(2008-11#1)(2009-9#1)(2010-4#1)
with medical therapy##4##3##(1990-11#1)(2008-7#1)(2013-1#2)
with medical treatment##3##3##(2009-9#1)(2011-1#1)(2013-1#1)
with medical##28##2##(1990-11#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#2)(2007-7#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)
with medically##3##2##(1992-2#2)(2012-2#1)
with medication##3##2##(2008-1#1)(2011-1#1)(2013-8#1)
with medications##4##2##(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
with medicinal##2##2##(2007-1#1)(2009-10#1)
with medicines##2##2##(1996-3#1)(2008-7#1)
with medium to##2##3##(2008-10#1)(2008-5#1)
with medium##9##2##(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2013-1#2)
with medulloblastoma##5##2##(1994-3#1)(1997-3#4)
with meeting##3##2##(2009-5#2)(2011-1#1)
with melanin##2##2##(2008-11#1)(2013-1#1)
with melena##3##2##(1992-6#1)(2008-7#1)(2013-8#1)
with members of the##5##4##(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-4#1)
with members of##12##3##(1991-1#1)(1994-6#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-4#2)(2009-9#1)
with membrane lipids##2##3##(1990-2#1)(1994-2#1)
with membrane vesicles##2##3##(1997-6#1)(2008-8#1)
with membrane##17##2##(1990-12#1)(1990-2#1)(1992-11#1)(1994-2#1)(1994-5#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
with membranes containing##2##3##(2008-10#2)
with membranes##6##2##(1994-5#2)(1994-6#1)(2008-10#2)(2009-10#1)
with membranous##2##2##(2008-1#1)(2009-10#1)
with men and##3##3##(2008-11#1)(2009-5#1)(2009-7#1)
with men in##2##3##(1990-2#1)(2009-5#1)
with men undergoing AS for prostate cancer##2##7##(2010-10#2)
with men with##2##3##(1991-7#1)(2011-1#1)
with men##27##2##(1990-2#1)(1991-7#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#9)(2009-7#1)(2010-10#2)(2011-1#2)(2011-2#1)(2012-1#1)
with meningitis##2##2##(1993-2#1)(2012-12#1)
with meningococcal disease in##2##4##(1991-8#1)(2007-12#1)
with menstrual##2##2##(2008-3#1)(2008-4#1)
with menstruation##2##2##(1991-3#1)(2013-1#1)
with mental disorders##2##3##(1991-8#1)(2012-12#1)
with mental health problems##10##4##(1992-1#1)(1993-1#3)(1997-5#1)(2008-11#3)(2011-1#1)(2012-12#1)
with mental health##16##3##(1992-1#1)(1993-1#3)(1997-2#1)(1997-5#1)(2007-1#2)(2008-11#3)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#2)
with mental illness and##2##4##(2011-2#1)(2012-12#1)
with mental illness##10##3##(2008-11#1)(2009-5#1)(2011-1#5)(2011-2#2)(2012-12#1)
with mental retardation##5##3##(1993-3#3)(1995-1#1)(1997-8#1)
with mental##37##2##(1990-9#1)(1991-8#1)(1992-1#1)(1993-1#3)(1993-3#3)(1995-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-1#2)(2008-11#4)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#6)(2011-2#2)(2012-12#4)(2012-3#1)(2013-8#1)
with mentally ill##2##3##(1992-3#1)(2008-4#1)
with mercuric##2##2##(2008-10#2)
with mercury##6##2##(1991-3#1)(2008-10#5)
with mesangial proliferative glomerulonephritis##2##4##(2007-7#2)
with mesothelioma##4##2##(1990-12#1)(1991-12#1)(1992-11#2)
with metabolic control##2##3##(2011-1#1)(2011-2#1)
with metabolic syndrome##8##3##(2008-11#1)(2008-3#2)(2008-5#1)(2011-1#2)(2012-2#1)(2013-8#1)
with metabolic##20##2##(1990-3#1)(1993-8#2)(1997-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
with metachromatic##3##2##(1997-3#2)(2008-5#1)
with metal ions##5##3##(1996-5#1)(2008-10#3)(2008-4#1)
with metal##13##2##(1996-5#1)(1997-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#2)
with metallic thin film##2##4##(2008-3#2)
with metallic##4##2##(2008-10#1)(2008-3#3)
with metastases in the##2##4##(2007-11#2)
with metastases in##4##3##(2007-11#4)
with metastases##11##2##(1990-12#1)(1990-8#1)(2007-11#7)(2008-6#1)(2009-5#1)
with metastasis in##3##3##(2008-4#1)(2008-6#1)(2013-1#1)
with metastasis to the##3##4##(1992-2#1)(1997-8#1)(2009-10#1)
with metastasis to##4##3##(1992-2#1)(1997-8#1)(2009-10#1)(2011-1#1)
with metastasis##13##2##(1992-2#1)(1992-5#1)(1992-9#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#2)(2011-1#1)(2013-1#1)
with metastatic disease and##2##4##(1990-11#1)(2010-3#1)
with metastatic disease##11##3##(1990-11#1)(2007-11#1)(2008-6#3)(2008-7#1)(2010-3#4)(2011-1#1)
with metastatic disease)##2##3##(2010-3#2)
with metastatic melanoma##3##3##(1990-6#1)(1992-2#1)(2012-2#1)
with metastatic potential##3##3##(1992-9#1)(1993-9#1)(2010-3#1)
with metastatic prostate cancer##4##4##(1995-11#1)(2007-5#2)(2008-11#1)
with metastatic##49##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-11#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-5#2)(2007-6#1)(2008-11#2)(2008-3#1)(2008-6#4)(2008-7#1)(2009-1#1)(2010-3#7)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with metformin##5##2##(2008-3#1)(2012-3#2)(2013-1#2)
with methanol and water##2##4##(2008-10#1)(2011-1#1)
with methanol as##2##3##(2008-10#1)(2012-2#1)
with methanol by##2##3##(2008-10#1)(2008-5#1)
with methanol in##2##3##(1996-5#1)(2008-10#1)
with methanol##18##2##(1990-8#1)(1996-5#1)(2007-12#1)(2008-10#10)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
with methanol-phosphate buffer##2##3##(2008-10#2)
with methodology##2##2##(2008-10#1)(2011-2#1)
with methods##3##2##(2008-9#2)(2009-8#1)
with methotrexate##8##2##(1993-12#3)(1995-2#1)(1997-8#1)(2007-11#1)(2008-11#1)(2013-1#1)
with methyl bromide##5##3##(2008-10#5)
with methyl jasmonate##2##3##(2008-10#1)(2011-10#1)
with methyl methacrylate##3##3##(2007-11#1)(2008-7#2)
with methyl##19##2##(1995-11#1)(1996-5#4)(2007-11#1)(2008-10#9)(2008-7#2)(2010-8#1)(2011-10#1)
with methylamine##2##2##(2007-11#1)(2008-10#1)
with methylene blue##3##3##(2008-10#3)
with methylene##4##2##(2008-10#4)
with methylprednisolone##4##2##(1993-6#1)(2008-5#1)(2013-8#2)
with methylthiosalicylate (TS-gel)##2##3##(2008-10#2)
with methylthymol blue##2##3##(2008-10#2)
with metoprolol##3##2##(1994-9#1)(1996-3#1)(2010-4#1)
with metronidazole##4##2##(1996-6#1)(1997-7#2)(2007-6#1)
with mianserin##6##2##(2008-6#6)
with micafungin##2##2##(2008-10#2)
with mice##3##2##(2008-11#1)(2008-4#1)(2011-1#1)
with micellar##2##2##(1996-5#1)(2008-10#1)
with microalbuminuria##2##2##(2008-1#1)(2008-3#1)
with microarray##3##2##(2008-2#2)(2008-7#1)
with microbial antagonists##2##3##(2008-10#2)
with microbial##5##2##(2008-10#2)(2008-4#1)(2008-7#1)(2010-2#1)
with microcephaly##2##2##(2008-1#1)(2012-3#1)
with microchip##2##2##(2008-10#1)(2008-12#1)
with microcrystalline naphthalene##2##3##(2008-10#2)
with microcrystalline phenolphthalein modified by crystal violet##2##7##(2008-10#2)
with microcrystalline##4##2##(2008-10#4)
with microdialysis and##2##3##(1995-12#1)(2008-10#1)
with microdialysis sampling##2##3##(2008-10#2)
with microdialysis##8##2##(1995-12#1)(1995-5#1)(2008-10#5)(2008-7#1)
with microelectrodes##2##2##(2008-10#2)
with microfluidic capillary electrophoresis##2##4##(2008-10#2)
with microfluidic##4##2##(2008-10#2)(2011-1#2)
with microhematuria##2##2##(1997-7#2)
with microorganisms##2##2##(2008-11#1)(2011-1#1)
with microreaction chamber##2##3##(2008-10#2)
with microsatellite##2##2##(2008-10#2)
with microscopic##3##2##(1990-11#1)(2007-8#1)(2013-8#1)
with microscopy##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
with microsomal##2##2##(1992-11#1)(1994-6#1)
with microsurgery##3##2##(1996-2#2)(2008-7#1)
with microvascular##5##2##(1995-11#1)(2007-12#1)(2011-2#3)
with microvilli##3##2##(2007-12#1)(2008-5#1)(2008-6#1)
with microwave heating##2##3##(2008-10#2)
with microwave##9##2##(2007-8#1)(2008-10#8)
with microwaves##3##2##(2008-10#3)
with migraine with aura##3##4##(2008-9#2)(2011-2#1)
with migraine##4##2##(2008-9#2)(2011-2#1)(2012-3#1)
with migration of##2##3##(2012-12#1)(2012-3#1)
with migration##7##2##(2008-3#1)(2008-7#1)(2008-8#3)(2012-12#1)(2012-3#1)
with mild TBI##3##3##(2008-6#1)(2013-8#2)
with mild anemia##4##3##(2008-7#4)
with mild asthma##2##3##(2008-11#1)(2008-7#1)
with mild blood pressure elevation##2##5##(2009-5#2)
with mild forms of von Willebrand's##2##6##(2011-1#2)
with mild forms of##3##4##(2008-5#1)(2011-1#2)
with mild to moderate##5##4##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
with mild to##6##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2013-8#1)
with mild##46##2##(1992-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-3#1)(1997-3#2)(1997-4#2)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2009-5#2)(2010-10#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#5)
with mild-to-moderate##5##2##(1991-6#1)(1992-8#3)(2013-1#1)
with milk##2##2##(1995-10#1)(2007-11#1)
with mineral trioxide aggregate##2##4##(2012-12#1)(2013-1#1)
with mineral##3##2##(2012-12#1)(2013-1#1)(2013-7#1)
with minimal amount of##2##4##(2008-10#2)
with minimal complications##2##3##(2011-2#1)(2012-12#1)
with minimal effects on##2##4##(1995-6#1)(2013-8#1)
with minimal morbidity##6##3##(2007-12#1)(2009-5#1)(2011-2#3)(2013-1#1)
with minimal overlap##2##3##(1994-2#1)(2008-7#1)
with minimal risk of##2##4##(2007-8#1)(2011-1#1)
with minimal risk##3##3##(2007-8#1)(2010-6#1)(2011-1#1)
with minimal sample##3##3##(2008-10#3)
with minimal side effects##2##4##(2008-1#1)(2012-12#1)
with minimal surgical##2##3##(2008-10#1)(2013-1#1)
with minimal##86##2##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-7#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#15)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
with minimally invasive##3##3##(2010-8#1)(2011-2#2)
with minimized##2##2##(2008-10#1)(2012-2#1)
with minimum##20##2##(1992-9#1)(1993-6#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
with minor##21##2##(1990-6#2)(1991-3#1)(1992-6#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
with minute##2##2##(2008-10#1)(2008-5#1)
with missing##2##2##(1997-8#1)(2012-3#1)
with mitochondria##2##2##(1995-6#1)(2007-12#1)
with mitochondrial##5##2##(1994-11#1)(2008-1#1)(2008-8#1)(2009-9#1)(2013-8#1)
with mitomycin C##2##3##(1993-8#1)(1994-8#1)
with mitotic##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
with mitoxantrone##3##2##(1991-6#2)(1994-12#1)
with mitral##2##2##(1995-3#1)(2011-2#1)
with mixed##10##2##(1997-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
with mixtures of##8##3##(2008-10#7)(2008-2#1)
with mixtures##11##2##(2008-10#10)(2008-2#1)
with mobile phase##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
with mobile##9##2##(1991-4#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)
with mobility##4##2##(2008-7#1)(2008-9#3)
with modal##2##2##(2007-12#1)(2008-2#1)
with model calculations##2##3##(2008-2#2)
with model lipid##2##3##(2008-10#1)(2008-5#1)
with model predictions##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
with model##17##2##(1991-9#1)(1994-12#1)(1994-5#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)
with modeled##2##2##(2008-10#1)(2008-3#1)
with modeling##2##2##(2008-2#1)(2013-8#1)
with models based on##2##4##(2007-11#1)(2008-3#1)
with models##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
with modem##2##2##(1991-12#1)(2008-8#1)
with moderate and severe##3##4##(2007-10#1)(2008-7#2)
with moderate and##6##3##(1993-8#1)(2007-10#2)(2008-7#2)(2011-2#1)
with moderate or severe asthma##3##5##(2008-11#3)
with moderate or severe##4##4##(2006-10#1)(2008-11#3)
with moderate size parameters##2##4##(2008-3#2)
with moderate to severe asthma##2##5##(2008-3#2)
with moderate to severe##9##4##(1990-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-5#1)(2012-2#2)
with moderate to##10##3##(1990-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-5#1)(2012-2#2)(2012-3#1)
with moderate##39##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-3#2)(1993-8#1)(1995-2#1)(1996-12#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
with moderately##2##2##(1993-3#1)(2008-10#1)
with modern analytical##2##3##(2008-10#1)(2010-7#1)
with modern##14##2##(1993-6#1)(1997-6#1)(2008-1#1)(2008-10#2)(2010-6#1)(2010-7#1)(2012-2#2)(2012-9#1)(2013-1#4)
with modest##4##2##(2008-10#1)(2008-2#1)(2012-1#1)(2012-3#1)
with modification of##3##3##(1990-11#1)(2008-10#1)(2008-9#1)
with modifications of##3##3##(1996-12#1)(2008-11#1)(2008-7#1)
with modifications##5##2##(1996-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
with modified Tupman plate##2##4##(2012-2#2)
with modified##13##2##(1990-3#1)(1990-7#1)(2008-10#5)(2008-7#1)(2009-4#1)(2009-6#1)(2012-2#3)
with modifier##3##2##(2008-10#3)
with modular##2##2##(2008-3#1)(2012-2#1)
with modulated##2##2##(2007-11#1)(2008-2#1)
with modulation##3##2##(2008-3#3)
with molar absorptivity being##2##4##(2008-10#2)
with molar absorptivity of 1##2##5##(2008-10#2)
with molar absorptivity of##3##4##(2008-10#3)
with molar absorptivity##8##3##(2008-10#8)
with molar##9##2##(2008-10#9)
with molecular and##2##3##(2009-10#1)(2009-8#1)
with molecular dynamics simulations##2##4##(1995-5#1)(2008-7#1)
with molecular masses of##7##4##(1990-5#1)(1992-8#1)(1993-11#1)(2008-10#3)(2008-8#1)
with molecular masses##10##3##(1990-5#1)(1992-12#1)(1992-8#2)(1993-11#1)(2008-10#4)(2008-8#1)
with molecular weight of##7##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
with molecular weights of##7##4##(1990-11#2)(1990-12#1)(1990-7#1)(1992-8#1)(1997-7#1)(2008-8#1)
with molecular##46##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#3)(1993-11#1)(1993-8#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-5#1)(2011-2#2)(2013-8#1)
with molecules of larger##2##4##(2008-10#2)
with molecules##3##2##(2007-11#1)(2008-10#2)
with molybdate##6##2##(1993-12#1)(2008-10#5)
with monitored##2##2##(2008-10#1)(2012-2#1)
with monitoring##2##2##(1994-6#1)(2008-10#1)
with monoarthritis of##2##3##(2008-12#2)
with monochromatic##2##2##(2007-11#1)(2008-11#1)
with monoclonal antibodies##9##3##(1991-12#1)(1992-6#1)(1995-12#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)
with monoclonal antibody##4##3##(1992-11#2)(2006-6#1)(2008-10#1)
with monoclonal##19##2##(1991-12#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)
with monocytes##3##2##(1991-2#1)(1992-2#1)(2012-2#1)
with monolithic##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
with monosomy##3##2##(1992-12#1)(2008-7#1)(2013-1#1)
with monovalent##2##2##(2008-10#1)(2012-3#1)
with mood##5##2##(2008-3#1)(2008-7#3)(2013-8#1)
with more complete##2##3##(2008-10#1)(2011-2#1)
with more efficient##2##3##(2008-10#2)
with more extensive##3##3##(1995-3#1)(2007-10#1)(2012-1#1)
with more or##2##3##(1993-3#1)(2013-8#1)
with more severe##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
with more species##2##3##(2008-8#1)(2013-7#1)
with more stable##2##3##(2008-10#1)(2010-10#1)
with more than 1##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
with more than 100##2##4##(1997-3#1)(2007-11#1)
with more than 200##2##4##(1993-2#1)(1997-2#1)
with more than 50##2##4##(2008-10#2)
with more than 95% of##2##5##(2008-10#1)(2012-2#1)
with more than four##3##4##(1990-12#1)(2012-12#2)
with more than one pregnancy##3##5##(2012-12#3)
with more than one##9##4##(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#5)
with more than##39##3##(1990-12#1)(1991-2#1)(1991-5#1)(1993-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)
with more##113##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-3#3)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
with morin##2##2##(2008-10#2)
with morphine and##2##3##(1995-12#1)(1995-6#1)
with morphine inhibited##2##3##(2008-12#2)
with morphine##11##2##(1991-1#1)(1995-12#2)(1995-6#1)(1996-2#1)(2007-11#1)(2008-12#3)(2008-7#1)(2009-5#1)
with morphologic##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
with morphological identification##2##3##(2008-10#2)
with morphological##8##2##(1996-6#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-8#2)
with morphology##3##2##(2008-8#1)(2010-6#1)(2012-3#1)
with mortality##7##2##(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-12#1)(2013-1#1)
with most isolates##2##3##(2008-10#2)
with most of the##9##4##(2008-1#1)(2008-10#3)(2008-4#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)
with most of##11##3##(2008-1#1)(2008-10#4)(2008-4#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)
with most##36##2##(1991-11#1)(1992-12#1)(1993-11#1)(1994-12#1)(1996-12#2)(1996-2#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#2)
with mostly viable myocardium##2##4##(2007-8#2)
with mostly##3##2##(2007-8#2)(2009-10#1)
with mothers##8##2##(1993-12#1)(2008-6#1)(2009-7#3)(2010-1#1)(2011-2#1)(2012-2#1)
with motilin##2##2##(1994-11#2)
with motor##7##2##(1993-12#1)(1995-2#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)
with mouse IgG##2##3##(2008-10#1)(2008-12#1)
with mouse and##2##3##(1991-6#1)(1997-7#1)
with mouse myeloma cells##2##4##(2008-11#2)
with mouse myeloma##3##3##(2008-11#3)
with mouse##10##2##(1991-6#1)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2011-2#1)
with movement##4##2##(1993-12#1)(1997-5#1)(2008-12#1)(2008-8#1)
with moyamoya disease##4##3##(2007-8#2)(2008-7#2)
with much greater##2##3##(1991-12#1)(2008-3#1)
with much higher##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
with much less##3##3##(1995-12#1)(2008-12#1)(2013-1#1)
with much lower##2##3##(2007-11#1)(2008-10#1)
with much##17##2##(1991-12#1)(1994-11#1)(1995-12#1)(2007-11#3)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
with mucosal dissection##2##3##(2008-5#2)
with mucosal##4##2##(1990-3#1)(2008-5#3)
with mucus-producing glands##2##3##(2009-3#2)
with multi-drug##2##2##(2011-3#1)(2012-2#1)
with multicentric##2##2##(1993-9#1)(2011-2#1)
with multichannel##2##2##(2007-12#1)(2008-2#1)
with multidetector CT##2##3##(2008-7#1)(2012-2#1)
with multidimensional##2##2##(2008-11#1)(2010-7#1)
with multidisciplinary##2##2##(2011-1#1)(2011-2#1)
with multidrug##3##2##(2012-3#1)(2013-1#1)(2013-8#1)
with multifocal##4##2##(2007-10#1)(2008-7#1)(2011-2#2)
with multilayer and gold coatings##3##5##(2008-2#2)(2008-3#1)
with multilayer##7##2##(2008-2#4)(2008-3#2)(2008-6#1)
with multilevel##5##2##(2008-3#1)(2012-12#4)
with multimode fibers##2##3##(2008-3#2)
with multimode##4##2##(2008-3#4)
with multimorbidity##4##2##(2008-4#1)(2011-2#1)(2012-3#2)
with multipass geometries in a polymer laser dye saturable amplifier##2##10##(2007-12#2)
with multiple cardiac lesions##2##4##(2008-7#2)
with multiple chronic##2##3##(2008-10#2)
with multiple congenital##2##3##(2010-7#1)(2013-1#1)
with multiple covariates##3##3##(2008-8#1)(2012-1#1)(2013-1#1)
with multiple endocrine##3##3##(2009-4#3)
with multiple lesions##2##3##(2007-7#2)
with multiple lithiasis##2##3##(1993-5#2)
with multiple males##2##3##(2008-8#2)
with multiple medical##3##3##(1994-3#1)(2008-1#1)(2013-1#1)
with multiple myeloma (MM)##2##4##(2008-1#1)(2008-7#1)
with multiple myeloma##12##3##(2008-1#1)(2008-7#4)(2011-1#1)(2011-2#5)(2012-3#1)
with multiple organ##3##3##(1995-8#1)(1997-1#1)(2007-8#1)
with multiple outputs##2##3##(2008-10#2)
with multiple partners##2##3##(1997-3#1)(2013-1#1)
with multiple primary##2##3##(2008-6#1)(2011-2#1)
with multiple rare variants##2##4##(2012-3#2)
with multiple sclerosis (MS)##3##4##(2011-7#1)(2012-3#2)
with multiple sclerosis##11##3##(2010-12#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#4)
with multiple stenoses##2##3##(1992-5#2)
with multiple supernumerary teeth##2##4##(2013-1#2)
with multiple tendinous xanthomas##2##4##(1997-8#2)
with multiple##164##2##(1990-9#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#2)(2007-10#3)(2007-11#8)(2007-12#4)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#5)(2009-3#1)(2009-4#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#8)(2013-1#9)(2013-8#1)
with multiple-scattering##2##2##(2008-3#2)
with multiples##2##2##(2008-11#2)
with multiplex##2##2##(1997-5#1)(2007-11#1)
with multisystem##2##2##(1996-12#1)(2012-12#1)
with multivariate calibration##4##3##(2008-10#3)(2010-5#1)
with multivariate##8##2##(2008-10#6)(2008-11#1)(2010-5#1)
with multiwall carbon##2##3##(2007-11#1)(2008-10#1)
with multiwavelength##2##2##(2007-12#1)(2008-3#1)
with municipal##2##2##(1995-9#1)(2010-1#1)
with mural nodule##2##3##(2012-12#2)
with murine##5##2##(1990-5#1)(1997-4#1)(2008-10#1)(2008-4#2)
with muscle##6##2##(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
with muscular##4##2##(1990-5#1)(1992-10#1)(2012-2#1)(2012-3#1)
with music##4##2##(2007-6#3)(2008-9#1)
with muskmelon##2##2##(2008-10#2)
with mutant##2##2##(2008-8#1)(2008-9#1)
with mutations at the##2##4##(1992-9#1)(2008-10#1)
with mutations in the##3##4##(2008-10#1)(2008-5#1)(2009-12#1)
with mutations in##4##3##(2008-10#1)(2008-5#1)(2009-12#1)(2012-3#1)
with mutations##10##2##(1992-9#2)(2008-10#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#1)(2012-3#1)
with mutual##4##2##(1990-12#1)(1995-6#1)(1996-2#1)(1996-3#1)
with my##4##2##(1992-3#1)(2010-1#2)(2010-10#1)
with myasthenia gravis##7##3##(1991-2#1)(2007-8#4)(2012-2#1)(2012-3#1)
with myc##2##2##(1991-5#1)(2008-11#1)
with mycelial compatibility##2##3##(2008-10#2)
with mycelial##3##2##(2008-10#3)
with mycelium of##2##3##(2008-10#2)
with mycelium##7##2##(1994-8#1)(2008-10#6)
with mycotoxins##3##2##(2008-10#2)(2010-7#1)
with myelodysplastic syndromes##2##3##(1992-12#1)(2008-11#1)
with myeloma##6##2##(1990-9#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
with myocardial infarction (MI)##2##4##(2012-12#1)(2013-1#1)
with myocardial infarction and stroke in##2##6##(2009-9#2)
with myocardial infarction and stroke##3##5##(2009-9#3)
with myocardial infarction and##6##4##(1996-9#1)(2008-8#1)(2009-9#3)(2011-1#1)
with myocardial infarction##16##3##(1993-9#1)(1994-3#1)(1996-2#3)(1996-9#3)(2008-8#1)(2009-9#4)(2011-1#1)(2012-12#1)(2013-1#1)
with myocardial##20##2##(1993-9#1)(1994-3#1)(1996-2#3)(1996-9#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#4)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
with myogenic##2##2##(1995-6#1)(2008-11#1)
with myosin##5##2##(1994-5#1)(1995-2#3)(2011-2#1)
with n##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
with n-butanol##2##2##(2008-10#1)(2008-5#1)
with n-hexane and##3##3##(2008-10#3)
with n-hexane##7##2##(1990-8#1)(2008-10#6)
with nanometer##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
with nanoparticles##4##2##(2008-10#1)(2008-7#2)(2009-11#1)
with nanotechnology##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
with naphthalene##2##2##(1994-9#1)(2008-10#1)
with naproxen##2##2##(1994-3#1)(2008-10#1)
with narrow##9##2##(2007-11#1)(2007-5#2)(2008-10#3)(2008-2#1)(2008-5#1)(2010-3#1)
with narrow-band##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#2)
with narrow-bandwidth##2##2##(2007-11#1)(2007-12#1)
with nasal##5##2##(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
with national and international##2##4##(2012-3#1)(2013-8#1)
with national and##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
with national##6##2##(2007-12#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
with native enzyme##3##3##(1990-12#1)(1992-3#1)(1995-2#1)
with native##19##2##(1990-12#1)(1990-7#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-8#2)(2008-10#6)(2008-4#2)(2008-9#1)(2009-8#1)
with natural light##2##3##(2008-3#2)
with natural stimuli##2##3##(2008-7#2)
with natural##23##2##(1991-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-9#1)(2012-12#1)(2013-1#1)
with naturally occurring##2##3##(2008-10#2)
with naturally##7##2##(2008-10#5)(2008-7#1)(2012-2#1)
with nature##2##2##(1991-6#1)(2010-12#1)
with nausea##2##2##(2008-7#1)(2011-1#1)
with near##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
with near-Nernstian slope of##2##4##(2008-10#2)
with near-Nernstian##3##2##(2008-10#3)
with near-field scanning optical microscopy##2##5##(2008-3#2)
with near-infrared light##2##3##(2007-12#1)(2008-3#1)
with near-infrared##8##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#4)
with near-unity conversion efficiency##2##4##(2007-11#2)
with nearby##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
with nearly##7##2##(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#3)
with neck pain and##3##4##(1991-8#1)(2008-12#1)(2009-3#1)
with neck pain##8##3##(1991-8#1)(2008-11#1)(2008-12#4)(2009-3#1)(2010-12#1)
with neck##16##2##(1991-8#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-7#1)(2009-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
with necrosis and##4##3##(2008-10#1)(2008-12#1)(2008-9#2)
with necrosis##6##2##(1997-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2012-1#1)
with necrotic##2##2##(2008-10#1)(2010-12#1)
with nectar##3##2##(2007-12#2)(2008-10#1)
with need of##2##3##(1991-6#1)(2013-1#1)
with need##4##2##(1991-6#1)(1996-11#1)(2007-8#1)(2013-1#1)
with needle##2##2##(2008-10#1)(2013-1#1)
with negative charges##2##3##(2008-10#1)(2008-5#1)
with negative ion electrospray##2##4##(2008-10#1)(2011-1#1)
with negative margins##2##3##(1994-6#1)(2011-2#1)
with negative nonlinear phase##2##4##(2007-12#2)
with negative##25##2##(1990-7#1)(1991-5#1)(1994-12#1)(1994-6#1)(2007-12#4)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#1)
with negatively charged##3##3##(2008-10#1)(2010-5#2)
with negligible##8##2##(1995-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)
with neighboring##3##2##(1992-9#1)(1994-3#1)(2008-12#1)
with neither##3##2##(2008-11#2)(2009-2#1)
with nematode##3##2##(2008-10#1)(2008-12#2)
with nematodes##2##2##(2008-10#2)
with neoadjuvant chemotherapy##3##3##(1990-12#1)(1994-2#1)(2009-4#1)
with neoadjuvant##6##2##(1990-12#1)(1994-2#2)(2009-4#3)
with neodymium##2##2##(2008-10#1)(2008-2#1)
with neonatal##6##2##(1994-3#1)(1994-6#1)(1997-1#2)(2008-1#1)(2010-6#1)
with neoplasia##4##2##(1991-8#1)(2011-2#1)(2013-8#2)
with neoplastic##5##2##(1992-3#1)(2007-11#2)(2012-2#1)(2012-3#1)
with neovascular ARMD##2##3##(2011-1#2)
with neovascular##4##2##(2010-2#2)(2011-1#2)
with nephrotic syndrome##5##3##(2008-1#3)(2009-6#2)
with nerve##6##2##(1994-8#1)(1995-9#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
with nesiritide##2##2##(2008-3#2)
with nested##2##2##(1992-9#1)(1994-12#1)
with net##3##2##(1996-5#1)(2007-11#1)(2008-11#1)
with network##2##2##(2008-1#1)(2009-7#1)
with neural##3##2##(2008-9#1)(2010-11#1)(2010-5#1)
with neural-network##2##2##(2008-3#2)
with neuroacanthocytosis##2##2##(2008-7#2)
with neuroblastoma##3##2##(2009-1#1)(2011-2#2)
with neuroendocrine##4##2##(1992-11#2)(2008-11#1)(2010-9#1)
with neurofibromatosis type 1##6##4##(2007-8#1)(2009-1#2)(2011-1#1)(2013-1#2)
with neurofibromatosis##9##2##(1997-3#1)(2007-8#1)(2008-6#2)(2009-1#2)(2011-1#1)(2013-1#2)
with neurogenic##2##2##(2008-10#1)(2009-3#1)
with neurological deficit due to##2##5##(2008-12#1)(2013-1#1)
with neurological deficits##2##3##(1993-12#1)(2011-2#1)
with neurological deterioration##2##3##(1996-9#1)(2012-12#1)
with neurological symptoms##3##3##(1991-8#1)(1997-6#1)(2007-11#1)
with neurological##18##2##(1990-2#2)(1991-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
with neurology##2##2##(2007-10#1)(2010-12#1)
with neuromuscular disease##2##3##(2007-10#1)(2008-7#1)
with neuromuscular disorders##2##3##(2007-10#1)(2009-3#1)
with neuromuscular##7##2##(2007-10#2)(2008-7#4)(2009-3#1)
with neuronal properties##2##3##(1992-6#2)
with neuronal##10##2##(1991-8#1)(1992-6#2)(1995-11#1)(1995-3#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-12#1)
with neurons in##2##3##(1996-2#1)(2011-2#1)
with neurons##5##2##(1996-12#1)(1996-2#1)(2009-3#1)(2011-2#2)
with neuropathic##4##2##(2008-6#1)(2008-9#2)(2013-1#1)
with neuropathology##2##2##(2008-2#1)(2008-7#1)
with neuropathy##2##2##(1990-9#1)(1997-2#1)
with neuropsychiatric##2##2##(2008-2#1)(2008-9#1)
with neurotrophins##2##2##(1996-5#1)(2009-10#1)
with neutral red##3##3##(1995-12#1)(2010-5#2)
with neutral##9##2##(1995-12#1)(2008-10#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
with neutron-induced (186)Os and (188)Os##2##5##(2008-10#2)
with new and more##2##4##(2006-10#1)(2008-11#1)
with new information##2##3##(2008-10#1)(2013-7#1)
with new procedures##2##3##(2008-10#1)(2008-7#1)
with new records for##2##4##(2008-10#1)(2008-6#1)
with new##41##2##(1990-10#1)(1990-11#1)(1990-8#1)(1992-3#1)(1994-3#1)(1997-4#1)(2006-10#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
with newer##4##2##(2006-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
with newly designed##2##3##(2008-7#1)(2008-9#1)
with newly diagnosed diabetes##2##4##(2012-3#1)(2013-1#1)
with newly diagnosed type 1 diabetes##2##6##(2009-8#1)(2011-1#1)
with newly diagnosed type##3##4##(2009-8#1)(2011-1#1)(2012-3#1)
with newly diagnosed##15##3##(1993-1#2)(1994-12#1)(1996-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
with newly##18##2##(1990-11#1)(1993-1#2)(1994-12#1)(1996-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
with nickel##3##2##(2008-10#3)
with nickel(II)##4##2##(1997-7#2)(2007-11#1)(2008-10#1)
with nicotine##2##2##(2011-1#1)(2013-1#1)
with nicotinic##2##2##(1994-6#1)(2008-8#1)
with nifedipine##4##2##(1990-8#2)(1992-2#1)(1994-11#1)
with nighttime##2##2##(2008-10#1)(2008-3#1)
with nikkomycin##2##2##(1992-8#1)(1997-4#1)
with nine known##2##3##(2013-1#2)
with nine##9##2##(1990-9#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-11#1)(2013-1#2)
with niobium(V) oxide##3##3##(2008-10#3)
with nitric acid and hydrogen peroxide##2##6##(2008-10#2)
with nitric acid and##5##4##(2008-10#4)(2008-5#1)
with nitric acid##12##3##(1995-6#1)(2008-10#10)(2008-5#1)
with nitric##13##2##(1992-3#1)(1995-6#1)(2008-10#10)(2008-5#1)
with nitrite in##2##3##(1990-6#1)(2008-10#1)
with nitrite##7##2##(1990-6#2)(2008-10#4)(2012-2#1)
with nitrogen##9##2##(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#2)(2013-1#1)
with no apparent##5##3##(1992-7#1)(1993-8#1)(1994-3#1)(1995-2#1)(2010-12#1)
with no appreciable##2##3##(2008-11#1)(2008-3#1)
with no change in##5##4##(1992-6#1)(1995-12#1)(1996-5#1)(2006-12#1)(2008-6#1)
with no change##6##3##(1992-6#1)(1995-12#1)(1996-5#1)(2006-12#1)(2008-6#1)(2009-11#1)
with no clear##2##3##(2010-8#1)(2013-8#1)
with no clinical##2##3##(2012-3#1)(2013-1#1)
with no close affected relatives##2##5##(2008-1#2)
with no complications##2##3##(2007-8#1)(2008-7#1)
with no correlation##2##3##(1991-2#1)(1993-5#1)
with no curative##2##3##(2008-5#2)
with no detectable##7##3##(1991-9#1)(1992-12#1)(1996-5#1)(2008-10#3)(2008-7#1)
with no difference between the##2##5##(1995-8#1)(1996-7#1)
with no difference in##3##4##(1993-2#1)(2008-4#1)(2008-7#1)
with no difference##6##3##(1993-2#1)(1995-8#1)(1996-7#1)(2008-4#1)(2008-7#1)(2010-1#1)
with no differences##2##3##(1996-12#1)(1996-5#1)
with no effect on the##3##5##(1993-3#1)(2007-11#1)(2013-8#1)
with no effect on##10##4##(1990-4#1)(1991-2#1)(1993-3#1)(1995-6#2)(1996-1#1)(2007-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
with no effective##2##3##(1990-9#1)(2013-1#1)
with no evidence for##2##4##(1995-2#1)(2008-9#1)
with no evidence of adverse##2##5##(2007-11#1)(2007-12#1)
with no evidence of disease##5##5##(1992-9#1)(2007-5#1)(2008-10#1)(2008-6#2)
with no evidence of recurrence##2##5##(1993-1#1)(2013-8#1)
with no evidence of##21##4##(1992-9#2)(1993-1#1)(1994-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-7#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
with no evidence##24##3##(1992-9#2)(1993-1#1)(1994-12#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
with no exposure##2##3##(1994-2#1)(2011-2#1)
with no formal##2##3##(2008-7#1)(2011-1#1)
with no further##4##3##(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
with no history of##10##4##(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
with no identifiable##3##3##(1995-1#1)(2007-10#1)(2009-5#1)
with no incidence of##2##4##(2008-7#1)(2009-12#1)
with no interference from##2##4##(2008-10#2)
with no interference##4##3##(2008-10#4)
with no known##5##3##(1997-4#1)(2008-10#2)(2010-3#1)(2012-3#1)
with no loss of##4##4##(1996-2#1)(2008-10#1)(2008-7#1)(2010-3#1)
with no loss##5##3##(1996-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)
with no measurable##2##3##(2008-10#1)(2008-2#1)
with no more than##2##4##(2011-1#1)(2013-1#1)
with no more##3##3##(2007-7#1)(2011-1#1)(2013-1#1)
with no moving parts##2##4##(2008-11#1)(2008-3#1)
with no moving##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
with no need for##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
with no need##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
with no neurological deficits##2##4##(2008-7#1)(2009-3#1)
with no observed##2##3##(2007-7#1)(2008-8#1)
with no obvious##2##3##(1996-1#1)(2011-2#1)
with no other##3##3##(1992-9#1)(2007-7#1)(2011-2#1)
with no previously##3##3##(1993-12#1)(2012-3#1)(2013-1#1)
with no prior##6##3##(2008-10#3)(2010-12#1)(2011-2#1)(2013-1#1)
with no recurrence##2##3##(2011-2#1)(2012-3#1)
with no reported##2##3##(2008-10#1)(2011-2#1)
with no restrictions##2##3##(2007-12#1)(2008-10#1)
with no sample##2##3##(2008-10#2)
with no sign of##2##4##(1992-9#1)(1994-3#1)
with no significant difference between the two groups##2##8##(2010-8#1)(2011-1#1)
with no significant difference between##3##5##(2008-10#1)(2010-8#1)(2011-1#1)
with no significant difference in##2##5##(1991-9#1)(2010-9#1)
with no significant difference##5##4##(1991-9#1)(2008-10#1)(2010-8#1)(2010-9#1)(2011-1#1)
with no significant differences##2##4##(2008-5#1)(2009-12#1)
with no significant improvement of##2##5##(2008-10#1)(2012-2#1)
with no significant loss of##2##5##(2008-10#1)(2011-2#1)
with no significant##19##3##(1990-11#1)(1990-3#1)(1991-3#1)(1991-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-12#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
with no signs of##2##4##(2006-6#1)(2012-3#1)
with no similarity to##2##4##(1993-6#1)(2013-1#1)
with no specific##3##3##(2008-10#1)(2013-1#2)
with no statistically significant difference##2##5##(2012-3#1)(2013-1#1)
with no statistically significant##3##4##(1997-7#1)(2012-3#1)(2013-1#1)
with no treatment##3##3##(2007-8#1)(2008-10#2)
with no##365##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#4)(2007-11#6)(2007-12#10)(2007-5#1)(2007-7#5)(2007-8#4)(2008-1#4)(2008-10#57)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#14)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#20)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#6)(2010-9#2)(2011-1#6)(2011-2#17)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#11)(2013-8#11)
with nocturnal##2##2##(2013-8#2)
with nodal##3##2##(2008-10#2)(2010-4#1)
with node##2##2##(2008-10#1)(2008-8#1)
with noisy##2##2##(2008-3#1)(2008-6#1)
with nominal##3##2##(2008-3#2)(2009-7#1)
with non variceal##2##3##(2011-2#2)
with non##14##2##(1990-12#1)(1991-11#1)(1992-11#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)
with non-Bayesian and Bayesian##2##4##(2008-10#2)
with non-Bayesian##3##2##(2008-10#3)
with non-HLA-B27##2##2##(2008-9#1)(2012-12#1)
with non-Hodgkin lymphoma##2##3##(1990-11#1)(2009-10#1)
with non-Hodgkin##3##2##(1990-11#1)(2009-10#1)(2011-2#1)
with non-human##3##2##(1993-12#1)(2008-10#1)(2010-10#1)
with non-malignant##3##2##(1990-2#2)(1993-2#1)
with non-specific##3##2##(1990-11#1)(2008-10#2)
with nonactin as ionophore##2##4##(2008-10#2)
with noncollinear##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
with none of##2##3##(2008-10#1)(2008-9#1)
with none##3##2##(1991-7#1)(2008-10#1)(2008-9#1)
with nonfunctional tumors##2##3##(2008-3#2)
with nonfunctional##3##2##(2008-3#2)(2012-3#1)
with nonketotic hyperglycinemia##2##3##(1990-12#2)
with nonlinear optical##2##3##(2007-12#1)(2008-3#1)
with nonlinear##10##2##(2007-11#1)(2007-12#2)(2008-3#4)(2008-4#1)(2009-7#1)(2009-8#1)
with nonmetastatic disease and##2##4##(2010-3#2)
with nonmetastatic disease##4##3##(2010-3#4)
with nonmetastatic##5##2##(2010-3#5)
with nonmyeloid malignancies##2##3##(2008-7#2)
with nonoverlapping##2##2##(2008-10#1)(2008-8#1)
with nonpathogenic##3##2##(2008-10#3)
with nonprescription##2##2##(1995-2#1)(2013-8#1)
with nonreactive##2##2##(2007-12#1)(2007-7#1)
with nonspecific##5##2##(1993-8#1)(2006-10#1)(2011-2#2)(2013-7#1)
with nonsteroidal##2##2##(2011-2#1)(2012-2#1)
with nonsyndromic hearing loss##2##4##(2008-4#2)
with nontreated##3##2##(2008-10#3)
with nonuniform duty ratios##2##4##(2008-3#2)
with nonuniform##4##2##(2008-2#1)(2008-3#2)(2010-4#1)
with nonviral##3##2##(1997-3#2)(2008-8#1)
with noradrenaline##5##2##(1995-12#3)(1996-2#2)
with norepinephrine##2##2##(2008-11#1)(2013-8#1)
with norfloxacin (P##2##3##(1993-2#2)
with norfloxacin##3##2##(1993-2#2)(2008-10#1)
with normal BMD##2##3##(2010-3#1)(2012-2#1)
with normal and##5##3##(1994-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
with normal body##4##3##(2008-10#1)(2008-3#2)(2010-3#1)
with normal cell##2##3##(2008-11#1)(2008-6#1)
with normal controls##2##3##(1997-5#1)(2008-7#1)
with normal glucose tolerance##2##4##(1994-12#1)(2012-7#1)
with normal growth##2##3##(1994-8#1)(2011-1#1)
with normal hearing##4##3##(2008-9#3)(2010-10#1)
with normal human##2##3##(1993-11#1)(2009-8#1)
with normal lung##2##3##(1996-2#2)
with normal or##2##3##(1996-6#1)(2008-1#1)
with normal renal function##4##4##(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
with normal skin and##3##4##(1990-3#2)(2008-5#1)
with normal skin##4##3##(1990-3#2)(2008-5#2)
with normal subjects##4##3##(1990-6#1)(1991-8#1)(1995-11#1)(1995-5#1)
with normal thyroid##2##3##(2009-4#1)(2013-8#1)
with normal urinary##2##3##(1997-8#1)(2008-10#1)
with normal weight##2##3##(2007-11#1)(2011-2#1)
with normal##135##2##(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-6#2)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#8)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
with normalization##2##2##(2007-8#1)(2008-7#1)
with normothermic##2##2##(1995-12#1)(1996-9#1)
with not only##2##3##(1993-11#1)(2008-10#1)
with not##4##2##(1993-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
with noticeable##2##2##(2007-12#1)(2008-5#1)
with novel##17##2##(1993-9#1)(1995-5#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with np-BNR and infected with R##2##6##(2008-10#2)
with np-BNR##7##2##(2008-10#7)
with nuclear extracts from##2##4##(1993-6#1)(2008-10#1)
with nuclear magnetic resonance##2##4##(1993-11#1)(2012-2#1)
with nuclear##15##2##(1991-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)
with nucleic acids and##2##4##(1991-5#1)(2008-10#1)
with nucleic acids was##2##4##(2008-10#2)
with nucleic acids##7##3##(1991-5#1)(2008-10#6)
with nucleic##8##2##(1991-5#1)(2008-10#6)(2008-8#1)
with nucleoside##3##2##(1996-11#1)(2008-10#1)(2008-4#1)
with nucleotide##3##2##(1992-3#1)(2008-10#2)
with null##2##2##(2008-12#1)(2009-8#1)
with number of##2##3##(1990-12#1)(1994-6#1)
with numbers of##2##3##(2008-10#1)(2008-9#1)
with numbers##4##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-9#1)
with numerical apertures##2##3##(2007-12#1)(2008-3#1)
with numerical integration##2##3##(1990-11#1)(2007-11#1)
with numerical results##2##3##(2007-11#1)(2008-2#1)
with numerical simulations##8##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2013-1#1)
with numerical solutions of the##2##5##(2007-11#1)(2008-10#1)
with numerical##18##2##(1990-11#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#5)(2013-1#1)
with numerically simulated##2##3##(2008-3#1)(2009-11#1)
with numerically##4##2##(2007-12#1)(2008-3#2)(2009-11#1)
with numerous##19##2##(1991-7#1)(1994-12#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
with nurse##5##2##(2008-1#1)(2008-11#1)(2008-12#1)(2012-3#2)
with nurses##3##2##(2007-11#1)(2008-1#1)(2008-11#1)
with nursing home##2##3##(2008-11#1)(2008-12#1)
with nursing##5##2##(1997-3#1)(2008-11#1)(2008-12#3)
with nutritional##4##2##(1991-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
with o-NPOE##3##2##(2008-10#3)
with o-phthalaldehyde (OPA)##3##3##(2008-10#3)
with o-phthalaldehyde##8##2##(1991-12#1)(1996-5#1)(2008-10#6)
with o-tolidine##2##2##(2008-10#2)
with oat##2##2##(2008-10#2)
with obesity##13##2##(2008-1#2)(2008-10#1)(2008-12#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
with objective##7##2##(1990-3#1)(1994-3#1)(2007-10#1)(2008-5#1)(2008-7#2)(2010-7#1)
with oblique##2##2##(2008-2#1)(2008-3#1)
with obliquely##2##2##(2008-2#1)(2008-3#1)
with observation##3##2##(1991-6#1)(2008-9#1)(2013-1#1)
with observational##2##2##(2007-10#1)(2009-4#1)
with observations##7##2##(1995-6#1)(1995-8#1)(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
with observed##8##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
with obsessive-compulsive disorder##3##3##(2008-1#1)(2008-3#2)
with obstetric##2##2##(2013-1#2)
with obstruction##2##2##(2009-4#1)(2013-8#1)
with obstructive coronary##2##3##(2011-2#1)(2012-2#1)
with obstructive##10##2##(1997-4#1)(2006-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#3)
with occasional##2##2##(2008-10#1)(2008-7#1)
with occlusion of the##2##4##(1996-6#1)(2013-8#1)
with occlusion of##3##3##(1996-6#1)(2013-1#1)(2013-8#1)
with occult##4##2##(1990-6#1)(2006-10#1)(2008-10#1)(2008-12#1)
with occupational##3##2##(1990-3#1)(2007-12#1)(2010-9#1)
with odds##2##2##(2006-10#1)(2011-1#1)
with oesophageal##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
with off-site backup##2##3##(2008-3#2)
with off-site##4##2##(2008-3#4)
with off-the-shelf##2##2##(2008-3#2)
with ofloxacin##2##2##(1994-3#1)(2008-5#1)
with often##2##2##(1993-12#1)(2013-1#1)
with oil##2##2##(2008-10#1)(2011-2#1)
with okadaic acid##6##3##(1992-8#1)(1994-11#2)(1995-3#1)(2008-2#1)(2008-4#1)
with olanzapine##2##2##(2008-6#2)
with old##2##2##(2008-10#1)(2013-1#1)
with older adults##2##3##(1991-12#1)(2010-11#1)
with older people in##2##4##(2010-10#2)
with older people##5##3##(1994-12#1)(2010-10#4)
with older women##3##3##(2008-3#1)(2010-10#1)(2011-1#1)
with older##16##2##(1991-12#1)(1994-12#1)(1997-3#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-10#6)(2010-11#1)(2011-1#1)(2012-12#1)
with oligonucleotide probes##2##3##(1992-3#1)(1997-2#1)
with oligonucleotide##4##2##(1992-3#2)(1993-12#1)(1997-2#1)
with oligonucleotides##3##2##(1993-8#2)(1995-2#1)
with omentum##2##2##(1995-11#2)
with omphalocele##2##2##(1997-3#2)
with on-line atomic##2##3##(2008-10#2)
with on-line detection by##2##4##(2008-10#2)
with on-line detection##3##3##(2008-10#3)
with on-line preconcentration##2##3##(2008-10#2)
with on-line sample##2##3##(2008-10#2)
with on-line solid-phase extraction##2##4##(2008-10#2)
with on-line##33##2##(1990-8#1)(2008-10#28)(2008-11#1)(2008-4#2)(2013-1#1)
with oncologists##2##2##(2008-6#1)(2013-1#1)
with one another and##3##4##(2008-11#1)(2008-3#1)(2010-5#1)
with one another##23##3##(1991-3#1)(1992-9#1)(1995-12#1)(1997-7#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-12#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
with one case of##3##4##(2007-5#1)(2008-12#1)(2011-1#1)
with one dose of##2##4##(1990-2#1)(1994-7#1)
with one enzyme##2##3##(1992-6#1)(2008-4#1)
with one exception##2##3##(2008-10#2)
with one isolate##2##3##(2008-10#2)
with one molecule of##2##4##(1991-2#1)(1994-5#1)
with one of the##6##4##(2008-10#2)(2008-4#1)(2008-5#1)(2010-2#1)(2013-1#1)
with one of these##2##4##(1993-8#1)(2012-2#1)
with one of three##3##4##(2008-10#2)(2008-4#1)
with one of two##4##4##(1997-3#1)(2008-10#1)(2009-8#1)(2013-8#1)
with one of##18##3##(1993-8#1)(1994-12#1)(1996-1#1)(1997-3#2)(2008-10#5)(2008-4#2)(2008-5#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with one or more doses of##3##6##(1995-5#3)
with one or more##16##4##(1991-7#1)(1995-2#1)(1995-5#3)(1996-9#1)(2008-1#2)(2008-10#3)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#2)
with one or two##9##4##(1991-2#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-5#1)
with one or##27##3##(1991-2#1)(1991-7#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-9#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
with one population##2##3##(2008-10#1)(2008-8#1)
with one to##2##3##(2008-10#1)(2012-12#1)
with one##167##2##(1990-12#1)(1990-2#1)(1991-2#2)(1991-3#1)(1991-7#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-1#1)(1996-12#2)(1996-2#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-1#3)(2008-10#45)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
with one-dimensional##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-6#1)
with one-photon and two-photon##2##4##(2008-3#2)
with one-way##2##2##(1997-1#1)(2008-7#1)
with ongoing##6##2##(1996-7#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
with only 0##2##3##(2007-10#1)(2008-10#1)
with only 15##2##3##(2009-3#1)(2013-1#1)
with only a few##9##4##(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
with only a minor##2##4##(2009-9#1)(2011-2#1)
with only a single##2##4##(1997-6#1)(2008-3#1)
with only a slight##4##4##(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
with only a##27##3##(1993-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#2)(2010-5#1)(2011-2#1)(2013-1#1)
with only mild##2##3##(2007-10#1)(2008-7#1)
with only minor##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
with only moderate##2##3##(2008-3#1)(2012-3#1)
with only one##16##3##(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-9#2)(2009-5#1)(2010-1#1)(2012-3#1)
with only the##7##3##(1993-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)
with only three##3##3##(2011-2#1)(2012-2#2)
with only two##5##3##(1990-10#1)(1993-1#1)(2008-10#2)(2008-8#1)
with only##121##2##(1990-10#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-1#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#3)
with onset after##2##3##(1996-7#1)(2008-7#1)
with onset in##2##3##(2007-7#1)(2008-7#1)
with onset of##2##3##(2007-7#1)(2009-10#1)
with onset##10##2##(1990-3#1)(1996-7#1)(2007-7#2)(2008-1#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-2#1)
with oocyte##2##2##(2012-12#1)(2012-3#1)
with opaque cytoplasm##2##3##(2012-2#2)
with open##13##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#3)
with open-ended questions##2##3##(2009-5#2)
with operation##2##2##(2008-6#1)(2009-9#1)
with opioid receptor antagonists##2##4##(1995-11#1)(2009-7#1)
with opioid##4##2##(1991-1#1)(1995-11#1)(1995-3#1)(2009-7#1)
with opportunistic##3##2##(1996-6#1)(2009-7#1)(2010-5#1)
with opportunities to##2##3##(2012-12#1)(2013-1#1)
with opportunities##3##2##(2009-7#1)(2012-12#1)(2013-1#1)
with opposing##3##2##(2008-2#1)(2008-4#1)(2009-7#1)
with opposite##5##2##(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
with opsonized##3##2##(1991-2#2)(1992-8#1)
with optic neuritis##3##3##(1995-12#1)(2011-1#1)(2012-3#1)
with optic##6##2##(1995-12#1)(2008-7#1)(2011-1#2)(2012-2#1)(2012-3#1)
with optical I/O##2##3##(2008-3#2)
with optical coherence tomography##3##4##(2007-11#1)(2008-3#1)(2011-7#1)
with optical coherence##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-7#1)
with optical feedback##3##3##(2007-11#1)(2008-3#2)
with optical fiber##2##3##(2007-11#1)(2008-10#1)
with optical fibers##5##3##(2008-2#3)(2008-3#2)
with optical scatterometry##2##3##(2008-3#2)
with optical techniques##2##3##(2008-3#1)(2009-9#1)
with optical tweezers##2##3##(2008-3#1)(2009-12#1)
with optical##45##2##(2007-11#6)(2007-12#4)(2008-10#2)(2008-2#8)(2008-3#20)(2009-12#1)(2009-5#1)(2009-9#1)(2011-7#1)(2013-8#1)
with optically##2##2##(2007-11#1)(2008-10#1)
with optimal##13##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-3#2)(2012-3#1)(2013-1#1)
with optimization##2##2##(2008-3#1)(2010-2#1)
with optimum##11##2##(1991-9#1)(2006-6#2)(2008-10#5)(2008-2#1)(2008-3#2)
with optoelectronic##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
with or without 1##2##4##(2008-11#1)(2012-12#1)
with or without A1 pulley release##2##6##(2008-9#2)
with or without a##9##4##(1993-9#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#1)
with or without associated##2##4##(2008-9#1)(2013-1#1)
with or without concomitant##3##4##(1993-9#1)(2008-12#1)(2013-1#1)
with or without other##2##4##(2007-11#1)(2008-3#1)
with or without prior##3##4##(1991-2#1)(2012-12#1)(2013-7#1)
with or without renaturation##2##4##(2008-10#2)
with or without the addition of##4##6##(2008-10#2)(2008-5#1)(2009-6#1)
with or without the presence of##2##6##(2008-10#1)(2008-11#1)
with or without the##10##4##(1996-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-6#1)(2012-2#1)
with or without vitamin C##2##5##(1997-3#1)(2011-1#1)
with or without##166##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#3)(1996-9#2)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#6)(2008-12#3)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#9)(2009-3#1)(2009-5#1)(2009-6#5)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#5)
with or##177##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#4)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#3)(1996-9#2)(1997-3#2)(1997-5#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#7)(2008-12#3)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#9)(2009-3#1)(2009-5#1)(2009-6#5)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#5)
with oral anticoagulants##2##3##(1990-12#1)(1996-6#1)
with oral poliovirus##2##3##(1995-3#2)
with oral potassium##2##3##(1997-8#1)(2007-7#1)
with oral prednisone##2##3##(2007-7#1)(2013-8#1)
with oral valganciclovir##2##3##(2010-12#2)
with oral##46##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-4#1)(1994-9#1)(1995-3#2)(1996-10#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
with orbital complications##2##3##(2013-1#2)
with orbital##7##2##(1991-6#1)(2008-10#1)(2008-8#1)(2013-1#4)
with ordinary##4##2##(1992-6#1)(2008-10#2)(2008-3#1)
with organ##2##2##(2008-12#1)(2009-8#1)
with organic matter and##2##4##(2008-12#1)(2008-2#1)
with organic matter##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
with organic solvent and##2##4##(2008-10#1)(2008-8#1)
with organic solvents##4##3##(1994-9#1)(2008-10#3)
with organic##19##2##(1990-7#1)(1990-8#1)(1994-9#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-4#1)(2013-8#1)
with organisms##2##2##(2008-10#1)(2008-8#1)
with organizations##2##2##(1993-12#1)(1995-3#1)
with organizing pneumonia##2##3##(2008-1#1)(2010-12#1)
with organizing##3##2##(2008-1#1)(2010-12#1)(2013-1#1)
with organophosphate##3##2##(1997-7#1)(2008-5#1)(2013-1#1)
with original##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
with orthogonal##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
with orthogonally##3##2##(1995-11#1)(2008-3#2)
with orthophosphoric acid)##2##3##(1996-5#1)(2008-5#1)
with orthophosphoric##3##2##(1996-5#2)(2008-5#1)
with osmium##2##2##(2008-10#2)
with osmotic##2##2##(2012-7#1)(2013-7#1)
with osseous##3##2##(1991-11#1)(2008-7#2)
with ossified cochleae##3##3##(2008-9#3)
with osteoarthritis of the knee##3##5##(2007-11#1)(2010-12#2)
with osteoarthritis##12##2##(1991-5#1)(2007-11#4)(2007-8#1)(2008-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#1)
with osteoblastic##2##2##(1994-2#1)(2007-11#1)
with osteogenic##2##2##(2008-11#1)(2011-1#1)
with osteoporosis and##2##3##(2007-11#1)(2010-3#1)
with osteoporosis or##2##3##(2008-4#1)(2012-12#1)
with osteoporosis##19##2##(1997-6#1)(2007-11#6)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#3)(2010-3#3)(2012-12#1)(2012-2#1)(2013-1#1)
with osteosarcoma are##2##3##(2008-6#1)(2010-3#1)
with osteosarcoma##12##2##(2008-6#2)(2010-3#10)
with other active##2##3##(1991-4#1)(2008-10#1)
with other agents##2##3##(1995-12#1)(2010-3#1)
with other amino acids##2##4##(2008-10#2)
with other approaches##2##3##(2007-11#1)(2008-2#1)
with other areas of##2##4##(2007-8#1)(2013-1#1)
with other areas##3##3##(2007-8#1)(2012-12#1)(2013-1#1)
with other aspects of##2##4##(2008-5#1)(2012-2#1)
with other authors##2##3##(1990-10#1)(2011-2#1)
with other autoimmune diseases##2##4##(2013-8#2)
with other biochemical##2##3##(1990-2#1)(1992-8#1)
with other biological##2##3##(1992-9#1)(2008-9#1)
with other cardiac##2##3##(2008-12#1)(2012-3#1)
with other cells##2##3##(2008-4#1)(2008-7#1)
with other clinical##2##3##(2008-11#1)(2012-1#1)
with other common##2##3##(2008-10#2)
with other commonly##2##3##(2008-7#1)(2012-3#1)
with other conditions##2##3##(1997-3#1)(2008-5#1)
with other conventional##2##3##(2008-10#1)(2008-2#1)
with other countries##3##3##(1990-11#1)(2008-12#2)
with other devices##2##3##(2007-11#1)(2010-10#1)
with other disease##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
with other diseases##2##3##(1997-1#1)(2008-4#1)
with other disorders##2##3##(1992-4#1)(2008-8#1)
with other drugs##5##3##(1990-2#1)(1993-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
with other established##2##3##(2008-9#1)(2012-1#1)
with other etiologies of renal failure##4##6##(2013-1#4)
with other etiologies##5##3##(2013-1#4)(2013-8#1)
with other experimental##2##3##(1997-2#1)(2008-10#1)
with other factors for##2##4##(2012-6#2)
with other factors##4##3##(1995-3#1)(2008-4#1)(2012-6#2)
with other four##2##3##(2008-10#2)
with other genes##4##3##(1996-2#1)(2008-10#2)(2008-4#1)
with other groups of##2##4##(1992-11#1)(1994-11#1)
with other groups##5##3##(1992-11#1)(1993-12#1)(1994-11#1)(2009-10#1)(2011-2#1)
with other health care##2##4##(1995-2#1)(2008-11#1)
with other health##4##3##(1994-6#1)(1995-2#1)(2008-11#1)(2010-3#1)
with other inhibitors##2##3##(1994-11#1)(1995-3#1)
with other isolates##2##3##(2008-10#1)(2011-2#1)
with other isolates/species##2##3##(2013-1#2)
with other known##6##3##(1994-8#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
with other mammals##2##3##(1992-12#1)(2013-1#1)
with other medications##3##3##(2007-11#1)(2010-12#1)(2012-3#1)
with other members of the##6##5##(1992-3#1)(1996-3#1)(2008-10#3)(2008-11#1)
with other membranes##2##3##(2007-7#1)(2008-1#1)
with other methods of##2##4##(2007-12#1)(2008-8#1)
with other methods##13##3##(1993-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
with other molecules##4##3##(1995-2#1)(2008-5#1)(2013-1#2)
with other more##2##3##(2008-10#1)(2008-6#1)
with other optical##2##3##(2008-2#1)(2008-3#1)
with other organizations##2##3##(1994-12#1)(2012-2#1)
with other proteins##3##3##(1993-3#1)(1997-7#1)(2008-4#1)
with other published##6##3##(1992-10#1)(2008-2#1)(2008-5#1)(2010-10#1)(2013-1#1)(2013-8#1)
with other reported##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
with other reports##3##3##(1990-3#1)(1991-6#1)(1997-4#1)
with other risk factors##2##4##(2007-10#1)(2010-10#1)
with other risk##3##3##(2007-10#1)(2010-10#1)(2010-12#1)
with other seasonal allergens##2##4##(2011-2#2)
with other service##2##3##(2008-11#1)(2012-3#1)
with other species of##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
with other species##5##3##(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)
with other studies in##2##4##(1994-1#1)(2013-8#1)
with other studies##11##3##(1991-12#1)(1994-1#1)(1997-4#1)(1997-9#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
with other systems##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
with other techniques##2##3##(2008-10#1)(2008-7#1)
with other tospoviruses##2##3##(2008-10#2)
with other transcription factors##2##4##(2011-2#1)(2012-2#1)
with other tumor##3##3##(1993-11#1)(2008-6#1)(2009-3#1)
with other tumors##4##3##(1997-8#1)(2007-8#1)(2008-1#1)(2011-2#1)
with other types of##8##4##(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-1#1)
with other variants##2##3##(2007-11#1)(2008-10#1)
with other##497##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#5)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#4)(1997-7#2)(1997-8#2)(1997-9#1)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#3)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#70)(2008-11#20)(2008-12#10)(2008-2#8)(2008-3#19)(2008-4#16)(2008-5#21)(2008-6#9)(2008-7#18)(2008-8#12)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#5)(2011-2#26)(2011-3#1)(2011-9#1)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#13)(2012-6#2)(2013-1#17)(2013-7#2)(2013-8#11)
with others and##2##3##(2011-2#1)(2012-1#1)
with others##15##2##(1991-5#1)(1992-1#1)(1995-9#1)(1996-7#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-11#1)(2011-2#2)(2012-1#1)
with ouabain##2##2##(1994-2#1)(2008-8#1)
with our earlier##2##3##(1991-6#1)(2013-8#1)
with our experimental##2##3##(2008-3#2)
with our model##3##3##(1995-3#1)(2007-11#1)(2008-3#1)
with our optimized##2##3##(2008-11#1)(2008-5#1)
with our previous findings##3##4##(1995-12#1)(1996-5#1)(2008-8#1)
with our previous results on##2##5##(1990-8#1)(2008-12#1)
with our previous##13##3##(1990-5#1)(1990-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#2)
with our results##2##3##(1995-6#1)(2008-10#1)
with our simple##2##3##(2007-12#1)(2008-6#1)
with our##67##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#3)(1993-9#1)(1994-1#2)(1994-12#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(2007-11#4)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
with out##2##2##(1994-12#1)(2008-7#1)
with outcome##2##2##(1992-1#1)(2013-1#1)
with outcomes##4##2##(1996-2#1)(2008-12#2)(2008-9#1)
with outpatient##2##2##(1995-12#1)(1996-3#1)
with output powers of several##2##5##(2007-11#2)
with output powers of##4##4##(2007-11#4)
with output powers##5##3##(2007-11#4)(2007-12#1)
with output##7##2##(2007-11#4)(2007-12#2)(2007-9#1)
with outside##3##2##(1991-12#1)(1992-2#1)(1997-2#1)
with ovalbumin##3##2##(1994-9#2)(2008-10#1)
with ovarian carcinoma##3##3##(1991-4#1)(1993-9#1)(2012-2#1)
with ovarian##12##2##(1990-2#1)(1991-4#1)(1991-6#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-10#1)(2007-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
with over the##2##3##(1991-1#1)(2006-12#1)
with over##12##2##(1991-1#1)(1991-3#1)(1992-11#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
with overall##6##2##(1990-8#1)(1994-3#1)(2008-10#2)(2008-3#1)(2011-2#1)
with overexpression of##2##3##(1992-12#1)(2008-11#1)
with overexpression##3##2##(1992-12#1)(2008-10#1)(2008-11#1)
with overlapping features##2##3##(2010-12#1)(2012-3#1)
with overlapping##8##2##(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
with overnight##2##2##(2011-2#1)(2012-8#1)
with overt##4##2##(2008-1#1)(2010-6#1)(2010-8#1)(2011-2#1)
with overweight##5##2##(2012-3#1)(2013-8#4)
with oxidant##3##2##(2008-10#3)
with oxidative stress##6##3##(1991-9#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#1)
with oxidative##10##2##(1991-9#1)(2008-10#1)(2008-5#2)(2009-8#1)(2009-9#2)(2010-9#1)(2011-2#1)(2012-2#1)
with oxidized LDL##2##3##(1996-2#2)
with oxidized##3##2##(1995-12#1)(1996-2#2)
with oxine##2##2##(2008-10#2)
with oxygen and##2##3##(2007-11#1)(2011-2#1)
with oxygen saturation##2##3##(2010-7#2)
with oxygen##15##2##(1990-8#1)(1993-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2010-7#2)(2011-2#2)
with oxytetracycline##2##2##(1991-3#2)
with ozone##5##2##(1996-1#1)(2007-8#1)(2008-10#2)(2013-1#1)
with p-CMBS (or NBD-Cl)##2##4##(1992-6#2)
with p-CMBS##3##2##(1992-6#3)
with p-aminoacetophenone##2##2##(2008-10#2)
with p-nitrophenyl##2##2##(1995-2#1)(2011-1#1)
with p21##2##2##(1995-6#2)
with p53##7##2##(1993-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#3)
with pH 5##2##3##(1996-5#1)(2008-10#1)
with pH 7##2##3##(2008-10#2)
with pH and##3##3##(1993-6#1)(2008-10#1)(2011-2#1)
with pH##27##2##(1990-11#1)(1992-12#1)(1993-6#1)(1996-5#1)(2008-10#17)(2008-5#3)(2010-5#1)(2011-1#1)(2011-2#1)
with pH=7##2##2##(2008-10#1)(2008-5#1)
with pI &gt##2##3##(1993-8#2)
with pI##4##2##(1992-11#1)(1993-8#2)(1996-5#1)
with pT3##2##2##(2011-2#2)
with paclitaxel and##2##3##(2012-2#1)(2013-1#1)
with paclitaxel##5##2##(2008-8#1)(2010-11#2)(2012-2#1)(2013-1#1)
with paediatric##3##2##(2007-9#1)(2008-11#1)(2008-9#1)
with pain and##5##3##(1990-6#1)(2007-7#1)(2012-12#2)(2013-1#1)
with pain in the##3##4##(2007-8#1)(2009-3#1)(2013-8#1)
with pain in##4##3##(1997-8#1)(2007-8#1)(2009-3#1)(2013-8#1)
with pain##24##2##(1990-6#1)(1994-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#3)(2008-9#2)(2009-12#3)(2009-3#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
with painful##6##2##(1991-3#1)(1991-4#1)(2007-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
with painless##3##2##(2010-11#1)(2011-2#1)(2012-12#1)
with paired##6##2##(1991-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-7#1)
with pairwise##3##2##(1994-5#1)(2008-10#2)
with palladium##3##2##(2008-10#3)
with palladium(II)##2##2##(2008-10#2)
with palliative##5##2##(1990-9#1)(2007-4#1)(2008-7#2)(2012-12#1)
with palpable##2##2##(1990-9#1)(2008-12#1)
with pamidronate##3##2##(2008-6#1)(2008-7#2)
with pancreatic##6##2##(1992-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
with panic disorder##10##3##(1990-11#1)(1993-12#2)(1996-7#2)(2007-1#1)(2013-7#1)(2013-8#3)
with panic##11##2##(1990-11#1)(1993-12#2)(1996-7#2)(2007-1#1)(2010-2#1)(2013-7#1)(2013-8#3)
with papain##2##2##(1991-12#1)(2008-1#1)
with papillary carcinoma##2##3##(1990-9#1)(1996-6#1)
with papillary thyroid##3##3##(2008-10#2)(2012-3#1)
with papillary##6##2##(1990-9#1)(1996-6#1)(2008-10#2)(2008-12#1)(2012-3#1)
with paracetamol##7##2##(1990-2#1)(1995-11#5)(2008-10#1)
with parallel##6##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-1#1)
with paramagnetic##2##2##(1992-12#1)(1996-12#1)
with parameter estimation##3##3##(2008-10#2)(2012-3#1)
with parameters##3##2##(2008-10#2)(2012-1#1)
with paranoid schizophrenia##2##3##(2009-9#1)(2010-6#1)
with parasite virulence##2##3##(2008-8#2)
with parasite##3##2##(2008-8#2)(2008-9#1)
with parasites##2##2##(2008-5#1)(2012-12#1)
with parasitic##2##2##(2008-9#1)(2012-12#1)
with parent and##2##3##(1996-2#1)(2009-11#1)
with parent##3##2##(1995-2#1)(1996-2#1)(2009-11#1)
with parental##5##2##(1992-8#1)(1993-12#1)(1994-2#1)(1996-2#1)(2008-10#1)
with parenting##2##2##(1995-1#1)(2009-11#1)
with parents in##2##3##(1994-2#1)(2013-1#1)
with parents of children##2##4##(1992-2#1)(2012-2#1)
with parents of high-risk infants##2##5##(2008-11#2)
with parents of##4##3##(1992-2#1)(2008-11#2)(2012-2#1)
with parents##14##2##(1990-6#1)(1992-11#1)(1992-2#1)(1994-2#1)(2008-11#3)(2009-7#3)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
with partial least squares regression##3##5##(2008-10#3)
with partial least squares##5##4##(2008-10#5)
with partial least-squares##2##3##(2008-10#2)
with partial resistance to##5##4##(2008-10#5)
with partial resistance##9##3##(2008-10#9)
with partial##43##2##(1990-5#1)(1992-4#1)(1992-6#2)(1994-3#1)(1994-5#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
with partially coherent light##2##4##(2007-12#1)(2008-2#1)
with partially coherent##3##3##(2007-12#2)(2008-2#1)
with partially purified##2##3##(2008-10#2)
with partially##12##2##(1994-12#1)(1995-2#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
with participants##2##2##(2007-10#1)(2012-2#1)
with participating##3##2##(1991-2#1)(2012-3#1)(2013-1#1)
with particle##3##2##(2008-10#1)(2008-3#2)
with particles of##2##3##(1996-3#1)(2008-10#1)
with particles with##2##3##(2007-11#1)(2008-3#1)
with particles##10##2##(1995-11#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-3#4)(2008-5#2)
with particular attention paid to the##2##6##(2007-11#1)(2008-2#1)
with particular attention to the##3##5##(1994-1#1)(2008-6#1)(2011-2#1)
with particular attention to##8##4##(1993-12#1)(1994-1#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#1)(2011-2#2)
with particular attention##12##3##(1993-12#1)(1994-1#1)(2007-11#2)(2007-8#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)
with particular emphasis on the##11##5##(1992-12#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-9#1)(2012-12#2)
with particular emphasis on##18##4##(1992-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2010-9#1)(2012-12#2)
with particular emphasis##19##3##(1992-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2010-9#1)(2012-12#2)
with particular focus on##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
with particular reference to the##5##5##(1996-6#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
with particular reference to their##2##5##(2008-7#1)(2008-8#1)
with particular reference to##12##4##(1990-5#1)(1992-2#1)(1996-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2012-12#1)
with particular regard to##4##4##(1991-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
with particular##65##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-6#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-3#2)
with particularly high##3##3##(1994-8#1)(2011-1#1)(2013-8#1)
with partly clustered erbium ions##2##5##(2007-12#2)
with partner##2##2##(2009-4#1)(2011-2#1)
with partners##7##2##(1995-12#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-2#1)(2012-2#1)
with passive demodulation##2##3##(2008-3#2)
with passive dosimeters##2##3##(1993-1#2)
with passive##7##2##(1993-1#2)(1994-2#1)(2007-12#1)(2008-3#2)(2008-7#1)
with past##6##2##(1994-2#1)(1996-3#1)(2008-8#1)(2010-9#1)(2012-1#2)
with patch##2##2##(2007-8#1)(2008-8#1)
with patent##3##2##(1990-3#1)(2007-7#1)(2011-2#1)
with paternal MS were significantly higher than in controls (P &lt##2##11##(2011-1#2)
with paternal##4##2##(2008-8#1)(2011-1#3)
with paternally derived deletions##2##4##(1997-3#2)
with pathogenic bacteria##2##3##(2007-7#1)(2010-5#1)
with pathogenic microorganisms##2##3##(2009-5#1)(2013-7#1)
with pathogenic##12##2##(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-9#2)(2009-5#1)(2010-5#1)(2013-7#1)
with pathogens##2##2##(2008-10#2)
with pathologic##8##2##(1993-9#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-2#2)(2013-1#1)
with pathological##7##2##(1992-5#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-9#1)(2012-3#1)
with pathologically##3##2##(2008-6#1)(2009-12#1)(2009-2#1)
with patient age##2##3##(2008-4#1)(2013-1#1)
with patient controlled##2##3##(1992-2#1)(2012-3#1)
with patient satisfaction##2##3##(1996-3#1)(2008-12#1)
with patient##18##2##(1992-12#1)(1992-2#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
with patient's general condition##2##4##(2007-11#2)
with patient's##3##2##(2007-11#3)
with patients and their##2##4##(2008-11#1)(2011-2#1)
with patients and##5##3##(1992-5#1)(1993-3#1)(2007-12#1)(2008-11#1)(2011-2#1)
with patients in the##3##4##(2007-10#1)(2008-12#1)(2008-7#1)
with patients in##4##3##(2007-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
with patients undergoing##3##3##(1996-3#1)(2012-12#1)(2012-2#1)
with patients who##6##3##(1995-9#1)(2008-3#1)(2008-4#1)(2008-9#2)(2011-2#1)
with patients with##6##3##(2008-12#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
with patients##63##2##(1990-6#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-7#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
with patients'##6##2##(1991-12#1)(1995-3#1)(2010-7#1)(2012-2#1)(2012-4#1)(2013-1#1)
with pay##3##2##(1991-8#1)(1993-2#1)(2011-2#1)
with payments##2##2##(1992-1#1)(1992-2#1)
with payors##2##2##(1992-12#1)(1994-1#1)
with peak##11##2##(1990-12#1)(1990-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2011-1#1)(2012-2#1)
with peaks at##2##3##(1990-5#1)(2008-10#1)
with peaks##3##2##(1990-5#1)(2008-10#1)(2013-7#1)
with pediatric##3##2##(1994-1#1)(1996-1#2)
with peer##2##2##(1995-12#1)(2008-12#1)
with peers##5##2##(1992-9#1)(2010-10#1)(2012-12#2)(2013-1#1)
with pelagic eggs (CV = 3##2##6##(2008-8#2)
with pelvic pain and##2##4##(1991-2#1)(2013-7#1)
with pelvic pain##3##3##(1991-2#1)(1992-1#1)(2013-7#1)
with pelvic##11##2##(1991-2#1)(1992-1#2)(1993-2#1)(1994-1#1)(1994-2#2)(2008-6#3)(2013-7#1)
with penetrating##5##2##(2008-1#2)(2008-9#1)(2010-10#1)(2010-7#1)
with penicillamine##3##2##(1991-8#1)(2008-10#2)
with penicillin##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)
with penile##3##2##(2008-10#1)(2008-6#1)(2013-8#1)
with pentaerythritol triacrylate##2##3##(2008-9#2)
with pentane##2##2##(2008-10#2)
with people who##3##3##(1992-3#1)(2009-6#1)(2013-8#1)
with people with##3##3##(1995-12#1)(2008-11#1)(2009-6#1)
with people##9##2##(1992-3#1)(1995-12#1)(2008-11#2)(2009-6#2)(2010-7#1)(2013-8#2)
with pepsin##2##2##(1996-12#1)(2008-1#1)
with peptic ulcer##3##3##(1995-10#1)(2008-12#1)(2012-12#1)
with peptide##10##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-6#1)(1994-5#2)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)
with peptides##2##2##(1992-12#1)(2008-4#1)
with percentages of##2##3##(2008-11#1)(2011-2#1)
with perchlorate##3##2##(2008-10#3)
with perchloric acid##2##3##(2008-10#2)
with perchloric##3##2##(2008-10#3)
with percutaneous##10##2##(1991-3#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
with perfect odd-periodic##2##3##(2008-2#1)(2008-3#1)
with perfect##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-8#1)
with perforated pyloric ulcer##2##4##(1990-6#2)
with performance on##3##3##(1993-12#2)(2009-10#1)
with performance##9##2##(1993-12#3)(1996-3#1)(1997-3#1)(2008-2#1)(2009-10#1)(2010-12#1)(2011-1#1)
with perinatal##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
with periodic##4##2##(2007-12#1)(2008-10#2)(2012-2#1)
with periodically poled##5##3##(2007-12#3)(2008-3#2)
with periodontitis##2##2##(2013-1#2)
with periods from##2##3##(2007-12#1)(2008-3#1)
with periods of##2##3##(1990-6#1)(2007-12#1)
with periods##6##2##(1990-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-2#1)
with peripheral blood##2##3##(2008-11#1)(2008-8#1)
with peripheral##15##2##(1991-12#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
with peritoneal dialysis##3##3##(2008-7#1)(2011-2#2)
with peritoneal##5##2##(2008-7#1)(2011-2#3)(2012-12#1)
with permanent##6##2##(1990-7#1)(1992-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)
with permanganate##2##2##(2008-10#2)
with permutation##2##2##(2008-3#1)(2008-7#1)
with peroxidase##5##2##(1995-3#1)(2008-10#4)
with peroxisome##3##2##(1990-12#1)(1995-3#2)
with peroxyl radicals##2##3##(2008-10#2)
with persistent##26##2##(1991-8#1)(1992-5#1)(1994-3#1)(1996-11#1)(1996-7#2)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
with persisting##4##2##(1992-5#1)(2008-1#1)(2010-12#1)(2013-1#1)
with personal##5##2##(1994-6#1)(1997-2#1)(2008-11#1)(2012-12#1)(2013-8#1)
with personality disorder##2##3##(2011-2#2)
with personality##3##2##(2010-12#1)(2011-2#2)
with persons##2##2##(1996-1#1)(2011-2#1)
with pertussis toxin##3##3##(1992-3#1)(1993-8#1)(2008-4#1)
with perylene##2##2##(2008-10#1)(2009-2#1)
with pesticides##2##2##(1991-6#1)(2008-12#1)
with petroleum##2##2##(2008-10#1)(2008-12#1)
with phage##3##2##(2008-8#2)(2012-2#1)
with pharmaceutical##3##2##(2009-5#1)(2011-3#1)(2013-8#1)
with pharmacological treatment##3##3##(1997-5#1)(2012-12#1)(2012-3#1)
with pharmacological##6##2##(1997-5#1)(1997-6#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
with pharmacotherapy##3##2##(1993-11#2)(2007-8#1)
with pharyngeal##2##2##(1993-2#1)(2013-1#1)
with phase jump##3##3##(2008-3#3)
with phase##9##2##(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#5)(2011-2#1)
with phase-only##2##2##(2008-3#2)
with phenobarbital##2##2##(1990-7#1)(1995-2#1)
with phenol##2##2##(2008-10#2)
with phenolic##3##2##(2008-10#2)(2011-2#1)
with phenotype##2##2##(1997-3#1)(2011-2#1)
with phenotypes p53/Ki-67##2##3##(2012-1#2)
with phenotypes##4##2##(1997-6#1)(2008-10#1)(2012-1#2)
with phenotypic##2##2##(2008-5#1)(2013-1#1)
with phenyl##4##2##(1997-7#1)(2008-10#3)
with phenylarsine oxide##2##3##(1993-6#1)(1995-5#1)
with phenylephrine##4##2##(1991-3#2)(2008-11#1)(2011-2#1)
with pheochromocytoma##3##2##(1995-12#1)(2009-1#1)(2012-12#1)
with phorbol 12-myristate 13-acetate (PMA)##3##5##(1994-3#1)(2008-11#1)(2008-5#1)
with phorbol 12-myristate 13-acetate##4##4##(1994-3#1)(2008-11#2)(2008-5#1)
with phorbol 12-myristate##5##3##(1994-3#1)(1994-8#1)(2008-11#2)(2008-5#1)
with phorbol ester##2##3##(1991-2#1)(1994-11#1)
with phorbol myristate acetate (PMA)##2##5##(1993-6#1)(1994-6#1)
with phorbol myristate##3##3##(1991-5#1)(1993-6#1)(1994-6#1)
with phorbol##12##2##(1991-2#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-11#2)(2008-5#1)(2010-12#1)
with phorbol-12-myristate-13-acetate (PMA)##2##3##(1991-9#1)(2008-11#1)
with phosphate##4##2##(1996-5#1)(2008-10#1)(2009-5#1)(2013-1#1)
with phosphatidylcholine##4##2##(1995-8#1)(1996-2#1)(1997-7#1)(2012-1#1)
with phosphatidylethanolamine##2##2##(1994-5#1)(1995-8#1)
with phosphatidylinositol 3-kinase##2##3##(1992-12#2)
with phosphatidylinositol##3##2##(1992-12#2)(2008-8#1)
with phospholipase A2##2##3##(1991-12#1)(1994-5#1)
with phospholipase##5##2##(1991-12#1)(1992-5#1)(1994-3#1)(1994-5#1)(2010-6#1)
with phospholipid bilayers##2##3##(1992-3#1)(2008-11#1)
with phospholipid monolayers and##2##4##(1994-5#2)
with phospholipid monolayers##3##3##(1994-5#3)
with phospholipid##10##2##(1990-2#1)(1992-3#1)(1992-6#1)(1994-5#4)(1997-2#1)(2008-11#1)(2008-5#1)
with phosphonoacetate##2##2##(2008-4#2)
with phosphoric##2##2##(2008-10#1)(2011-1#1)
with phosphorus##2##2##(1990-5#1)(1991-11#1)
with phosphorylated##2##2##(1992-5#1)(2010-10#1)
with photoacoustic##2##2##(2007-11#2)
with photodiode array detection##2##4##(1997-2#1)(2008-10#1)
with photodiode array##5##3##(1997-2#2)(2008-10#3)
with photodiode-array##2##2##(1997-2#1)(2008-10#1)
with photodynamic therapy##2##3##(1994-1#1)(2012-3#1)
with photographic##2##2##(2008-2#1)(2008-4#1)
with photon##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with photorefractive##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
with photosynthetic##2##2##(1996-4#1)(2010-6#1)
with photosystem II##2##3##(2008-10#1)(2008-8#1)
with photothermal deflection spectroscopy##2##4##(2008-2#1)(2008-3#1)
with photothermal deflection##3##3##(2008-2#2)(2008-3#1)
with physical activity##3##3##(2008-3#1)(2009-5#1)(2013-1#1)
with physical disabilities##5##3##(1995-12#2)(2010-12#3)
with physical or##2##3##(2008-11#1)(2008-4#1)
with physical##23##2##(1990-12#1)(1993-9#1)(1995-12#2)(1996-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#4)(2010-6#1)(2013-1#1)
with physician and##2##3##(2012-3#1)(2013-1#1)
with physician##3##2##(1993-1#1)(2012-3#1)(2013-1#1)
with physicians and patients##3##4##(1993-3#1)(1995-2#1)(1996-1#1)
with physicians and##4##3##(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)
with physicians##15##2##(1993-3#2)(1993-5#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
with physiologic##3##2##(1993-6#1)(2008-2#1)(2008-9#1)
with physiological##6##2##(1990-12#1)(1991-11#1)(1997-2#1)(2006-6#1)(2008-7#1)(2013-1#1)
with physiologically##2##2##(2008-10#1)(2009-12#1)
with physiotherapy##2##2##(2007-11#2)
with phytoplankton##2##2##(2008-3#1)(2008-9#1)
with picosecond pulses at##2##4##(2007-11#1)(2007-12#1)
with picosecond pulses##3##3##(2007-11#1)(2007-12#2)
with picosecond resolution##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
with picosecond##8##2##(2007-11#3)(2007-12#4)(2008-3#1)
with picrate anion##2##3##(2008-10#2)
with piezoelectric quartz crystal##2##4##(2008-10#2)
with piezoelectric##6##2##(1990-8#1)(2008-10#5)
with pineapple##2##2##(2012-2#2)
with pituitary resistance to thyroid hormone##2##6##(1995-8#2)
with pituitary##5##2##(1991-6#1)(1995-8#2)(2011-2#1)(2013-1#1)
with pityriasis##3##2##(2007-7#1)(2008-5#2)
with placebo##14##2##(1990-6#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-2#2)(2008-5#3)(2008-7#2)(2010-10#1)(2013-1#2)
with placebo)##2##2##(2008-3#1)(2008-8#1)
with placement of a##3##4##(1993-11#1)(2008-7#1)(2010-5#1)
with plain##3##2##(2007-7#2)(2008-10#1)
with plane-parallel Gaussian cavities##2##4##(2008-2#2)
with planned##2##2##(1991-3#1)(2013-1#1)
with plant growth##2##3##(2008-10#2)
with plant material##2##3##(2008-9#2)
with plant providing##2##3##(2008-6#2)
with plant##20##2##(2007-12#1)(2008-10#10)(2008-12#1)(2008-6#2)(2008-9#6)
with planting density in##2##4##(2008-10#2)
with planting##3##2##(2008-10#2)(2008-9#1)
with plants##11##2##(2008-10#8)(2008-8#1)(2008-9#1)(2009-12#1)
with plasma lipid levels##2##4##(1993-9#1)(1997-8#1)
with plasma membrane##2##3##(1991-9#1)(2009-10#1)
with plasma proteins##2##3##(1990-8#1)(1992-3#1)
with plasma##20##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-8#2)(1997-7#1)(1997-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
with plasmapheresis##2##2##(1995-3#1)(2010-11#1)
with plasmid DNA##3##3##(2008-10#2)(2008-11#1)
with plasmid##7##2##(1990-5#1)(1993-3#1)(1997-4#1)(2008-10#2)(2008-11#2)
with plasmids##6##2##(1990-11#1)(1994-8#1)(2008-10#2)(2008-2#2)
with plasminogen##3##2##(1993-2#1)(1995-2#2)
with plastic##9##2##(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)
with plate##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
with platelet transfusions##2##3##(2006-10#1)(2008-11#1)
with platelet##6##2##(1991-12#1)(1992-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
with platelet-activating##2##2##(1991-8#1)(1997-7#1)
with platinum##3##2##(2007-7#2)(2008-10#1)
with pleural effusion##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
with pleural##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
with pneumococcal and##2##3##(2008-7#1)(2011-2#1)
with pneumococcal meningitis##4##3##(1996-3#1)(2011-2#3)
with pneumococcal##6##2##(1996-3#1)(2008-7#1)(2011-2#4)
with pneumonia##6##2##(2007-2#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
with pneumoperitoneum##2##2##(1993-6#1)(2007-5#1)
with point##3##2##(2008-3#2)(2008-9#1)
with polar##2##2##(2008-11#1)(2008-3#1)
with polarimetric##2##2##(2008-10#1)(2008-3#1)
with polarization mode dispersion##4##4##(2007-11#1)(2007-12#3)
with polarization##10##2##(2007-11#3)(2007-12#4)(2008-3#3)
with polarization-dependent loss##3##3##(2007-11#2)(2008-3#1)
with polarization-dependent##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
with polarized##3##2##(2008-10#2)(2008-2#1)
with polarizing activity##2##3##(1993-12#2)
with polarizing##4##2##(1993-12#3)(2008-3#1)
with poly (A)##2##3##(2008-11#1)(2010-4#1)
with poly##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2010-4#1)
with polyclonal antibody##2##3##(1997-6#1)(2008-10#1)
with polyclonal antisera##2##3##(2008-10#2)
with polyclonal##8##2##(1993-12#1)(1993-6#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-4#1)
with polycystic ovarian syndrome##3##4##(2008-1#1)(2008-3#1)(2010-11#1)
with polycystic ovarian##5##3##(2008-1#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-1#1)
with polycystic ovary syndrome##4##4##(2008-3#2)(2012-12#1)(2012-3#1)
with polycystic##9##2##(2008-1#1)(2008-11#1)(2008-3#3)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
with polyelectrolyte##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
with polyethylene glycol##2##3##(1990-12#1)(2011-2#1)
with polyethylene##4##2##(1990-12#1)(1997-3#1)(2008-10#1)(2011-2#1)
with polyethyleneimine (PEI)##2##3##(1994-5#1)(2009-11#1)
with polymer##4##2##(2007-11#1)(2009-7#1)(2011-3#1)(2012-12#1)
with polymerase chain##2##3##(2008-10#1)(2009-7#1)
with polymerase##3##2##(1995-2#1)(2008-10#1)(2009-7#1)
with polymers##3##2##(2008-10#1)(2009-12#1)(2011-1#1)
with polymorphic markers##2##3##(1994-12#1)(2008-7#1)
with polymorphic##3##2##(1994-12#1)(1994-3#1)(2008-7#1)
with polypeptides##2##2##(1993-11#1)(1994-11#1)
with polyps##4##2##(2009-12#1)(2010-6#3)
with polysomes##2##2##(2008-12#1)(2012-2#1)
with polystyrene##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2010-4#1)
with polyurethane foam##3##3##(2008-10#3)
with polyvinyl alcohol (PVA)##2##4##(2008-10#1)(2012-3#1)
with polyvinyl alcohol##3##3##(2008-10#1)(2012-3#2)
with polyvinyl##4##2##(2008-10#1)(2012-2#1)(2012-3#2)
with pooled##2##2##(2008-10#1)(2012-2#1)
with poor differentiation##2##3##(1992-2#1)(1993-9#1)
with poor outcome in##2##4##(2007-12#1)(2011-2#1)
with poor outcome##7##3##(1994-12#1)(2007-12#1)(2008-7#2)(2011-2#2)(2012-12#1)
with poor outcomes##3##3##(2009-1#1)(2009-8#1)(2013-8#1)
with poor prognosis in##2##4##(2007-8#1)(2013-1#1)
with poor prognosis##11##3##(1994-11#1)(1997-5#1)(2007-8#1)(2009-5#2)(2010-11#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
with poor remyelination##2##3##(2008-12#2)
with poor sanitation##2##3##(2007-2#1)(2007-7#1)
with poor##52##2##(1990-10#1)(1990-6#1)(1991-2#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-1#1)(2009-11#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#7)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
with poorer health##2##3##(1996-2#1)(2008-1#1)
with poorer prognostic features##2##4##(2011-1#2)
with poorer##14##2##(1996-2#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
with poorly##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
with population norms##2##3##(2008-6#1)(2010-10#1)
with population##8##2##(1996-2#1)(1997-7#1)(2008-12#2)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)
with populations from##3##3##(2008-10#3)
with populations that##2##3##(2008-10#2)
with populations##7##2##(2008-10#6)(2008-9#1)
with porcine##5##2##(1991-2#1)(1991-8#2)(2009-5#1)(2012-2#1)
with pore##2##2##(2008-3#1)(2011-2#1)
with porous microcarrier##2##3##(2008-11#2)
with porous##3##2##(2008-11#3)
with portal##3##2##(1990-8#1)(2011-2#1)(2012-2#1)
with posatirelin##2##2##(2008-7#2)
with position##3##2##(1993-11#1)(2008-8#2)
with positional##2##2##(2008-10#2)
with positioning##2##2##(1993-10#1)(2012-12#1)
with positive chemical ionization##2##4##(2008-10#2)
with positive discography##4##3##(2012-12#4)
with positive margins##2##3##(2008-6#1)(2012-2#1)
with positive refractive-index perturbation##2##4##(2007-12#2)
with positive results##3##3##(1993-3#2)(2008-11#1)
with positive stool##2##3##(2007-12#1)(2012-3#1)
with positive##55##2##(1991-4#1)(1991-6#1)(1992-12#1)(1993-3#2)(1994-3#1)(1994-9#1)(1997-7#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)
with positively charged##2##3##(1995-2#1)(2006-12#1)
with positron emission tomography (PET)##3##5##(1995-2#1)(1996-5#2)
with positron emission tomography##7##4##(1995-2#1)(1996-2#2)(1996-5#3)(2013-8#1)
with possibilities for##2##3##(1993-6#1)(2008-12#1)
with possibility of##2##3##(1990-6#1)(1993-3#1)
with possible##15##2##(1990-11#1)(1990-12#1)(1991-9#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
with post-column##5##2##(1990-8#2)(2008-10#3)
with postcardiotomy phrenic nerve paresis##3##5##(2013-1#3)
with posterior lumbar-instrumented fusion##2##4##(2008-11#2)
with posterior urethral valves##2##4##(2008-1#1)(2008-10#1)
with posterior urethral##3##3##(2008-1#1)(2008-10#2)
with posterior##11##2##(1991-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-2#1)(2012-3#1)
with postlingual##3##2##(2008-9#3)
with postmeningitic deafness##2##3##(2008-9#2)
with postnatal##2##2##(1995-8#1)(2011-2#1)
with postoperative radiotherapy##2##3##(2009-3#1)(2012-2#1)
with postoperative##12##2##(1990-8#1)(1991-8#1)(1994-3#1)(1995-2#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-7#2)(2011-2#1)(2012-2#2)
with postpartum##2##2##(2012-2#1)(2013-1#1)
with postsurgical##2##2##(1990-2#1)(2011-3#1)
with posttraumatic stress disorder##2##4##(1996-7#1)(2012-12#1)
with posttraumatic##4##2##(1996-7#1)(2007-11#1)(2008-9#1)(2012-12#1)
with postural##2##2##(1992-9#1)(2011-2#1)
with potassium citrate##2##3##(1997-7#1)(2007-7#1)
with potassium dichromate##2##3##(2008-10#2)
with potassium ferricyanide##2##3##(2008-10#1)(2010-2#1)
with potassium iodide##3##3##(2008-10#3)
with potassium permanganate in##4##4##(2008-10#4)
with potassium permanganate##5##3##(2008-10#5)
with potassium##36##2##(1994-11#1)(1996-5#2)(1996-6#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-10#28)(2010-2#1)
with potassium-dihydro-bispyrazolyl-borate##2##2##(2008-10#2)
with potato##7##2##(2008-10#6)(2008-12#1)
with potent##10##2##(1992-9#1)(1994-5#1)(2008-3#1)(2008-8#1)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#1)
with potential application in##3##4##(1994-6#1)(2008-10#1)(2008-7#1)
with potential application##4##3##(1994-6#1)(2008-10#1)(2008-7#1)(2009-11#1)
with potential applications in##2##4##(2008-7#1)(2008-8#1)
with potential as##2##3##(1992-3#1)(2013-1#1)
with potential benefits##3##3##(1995-12#1)(2013-1#2)
with potential clinical##4##3##(1994-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
with potential for the##2##4##(2008-10#1)(2008-5#1)
with potential for##6##3##(1996-9#1)(1997-7#1)(2008-10#2)(2008-5#1)(2009-12#1)
with potential roles in##2##4##(2009-8#1)(2012-12#1)
with potential therapeutic##2##3##(2012-2#2)
with potential to##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
with potential##66##2##(1991-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#2)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
with potentially##10##2##(1990-8#1)(1992-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2009-4#1)(2012-3#1)
with potentiometric##2##2##(2008-10#1)(2010-5#1)
with power##2##2##(2007-11#1)(2008-3#1)
with practical##6##2##(1995-3#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-7#1)
with practice##5##2##(1991-2#1)(1993-12#1)(1994-3#1)(2008-11#1)(2010-10#1)
with practitioners to##3##3##(1996-3#1)(2008-12#2)
with practitioners##6##2##(1991-12#1)(1995-12#1)(1996-3#1)(2008-1#1)(2008-12#2)
with praseodymium##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
with pravastatin##2##2##(2008-5#1)(2011-1#1)
with pre-eclampsia##3##2##(2011-2#3)
with pre-treatment measurements##2##3##(2012-1#2)
with pre-treatment##3##2##(1991-2#1)(2012-1#2)
with precisely##2##2##(2008-5#1)(2008-8#1)
with precision##7##2##(2008-10#5)(2008-5#1)(2009-4#1)
with preconcentration##3##2##(2008-10#3)
with predetermined##2##2##(2008-10#1)(2008-3#1)
with predictable##4##2##(1995-12#1)(2008-11#1)(2013-1#1)(2013-7#1)
with predictions for##2##3##(1997-5#1)(2008-2#1)
with predictions from##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
with predictions of the##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
with predictions of##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
with predictions##14##2##(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#2)
with prednisone##5##2##(1990-11#2)(1992-2#1)(1994-12#1)(2008-7#1)
with predominance of##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
with predominance##4##2##(1991-9#1)(2008-12#1)(2011-2#1)(2012-3#1)
with predominant##2##2##(1996-2#1)(2010-12#1)
with preeclampsia##3##2##(2008-11#1)(2009-8#2)
with preferential##5##2##(1992-9#1)(1993-8#1)(1995-12#1)(1995-2#1)(2012-2#1)
with pregnancy##6##2##(2007-10#1)(2008-10#1)(2009-3#2)(2012-12#1)(2012-3#1)
with pregnancy-induced hypertension##2##3##(1990-3#1)(2011-2#1)
with pregnant women##2##3##(1995-6#1)(2009-4#1)
with preimmune serum##2##3##(1990-11#1)(1991-9#1)
with preliminary##2##2##(2008-3#2)
with prelingual deafness##2##3##(2008-9#2)
with premature##5##2##(2008-4#3)(2009-3#1)(2011-2#1)
with prenatal##2##2##(2008-12#1)(2011-5#1)
with preoperative embolization##2##3##(2008-7#2)
with preoperative##12##2##(1992-3#1)(2008-7#3)(2008-9#1)(2009-10#1)(2012-3#2)(2013-1#4)
with prescribing##2##2##(1995-8#1)(2008-8#1)
with prescription drug##2##3##(1995-1#1)(2013-8#1)
with presence of##2##3##(2008-5#1)(2013-1#1)
with presence##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
with preservation of the##3##4##(2006-12#1)(2008-6#1)(2009-3#1)
with preservation of##10##3##(1990-9#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
with preserved##4##2##(2008-11#1)(2008-7#1)(2011-2#2)
with pressure##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
with presumably##3##2##(2008-7#1)(2010-8#1)(2013-1#1)
with presumed cardioembolic stroke##3##4##(2007-10#3)
with presumed##6##2##(1997-3#1)(2007-10#3)(2008-7#2)
with preterm##2##2##(1997-2#1)(2011-2#1)
with pretreatment of##2##3##(2008-10#2)
with pretreatment##6##2##(1990-12#1)(1991-5#1)(2008-10#3)(2013-1#1)
with prevalence of##3##3##(2012-3#2)(2013-8#1)
with prevention of##2##3##(1995-5#1)(2011-2#1)
with preventive##4##2##(2007-2#1)(2008-11#1)(2010-9#1)(2012-2#1)
with previous data##2##3##(2008-10#1)(2010-11#1)
with previous estimates##2##3##(2008-10#1)(2008-9#1)
with previous findings that##2##4##(1994-5#1)(2008-8#1)
with previous findings##11##3##(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-6#1)(2008-1#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
with previous history of##2##4##(2006-10#1)(2010-8#1)
with previous life-threatening penicillin##2##4##(1996-3#2)
with previous measurements##2##3##(2008-11#1)(2008-8#1)
with previous observations that##3##4##(1993-12#1)(2008-10#1)(2010-8#1)
with previous observations##6##3##(1991-9#1)(1993-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2010-8#1)
with previous reports##5##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
with previous research##2##3##(1996-1#1)(2008-11#1)
with previous results##2##3##(2008-11#2)
with previous studies with##2##4##(2008-4#1)(2009-8#1)
with previous studies##12##3##(1995-11#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#2)
with previous theoretical predictions##2##4##(2008-3#2)
with previous treatment##2##3##(2013-8#2)
with previous work##5##3##(1992-9#1)(1996-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
with previous works##2##3##(2008-10#1)(2013-7#1)
with previous##95##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-9#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#4)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#5)(2013-7#2)(2013-8#2)
with previously described##3##3##(1990-11#1)(1993-11#1)(1993-6#1)
with previously published data on##2##5##(1996-5#1)(2007-12#1)
with previously published data##3##4##(1996-5#1)(2007-12#1)(2008-7#1)
with previously published results##2##4##(2007-11#1)(2008-3#1)
with previously published##8##3##(1994-9#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-7#1)(2010-2#1)
with previously reported results##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
with previously reported##14##3##(1993-6#1)(2007-11#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
with previously##39##2##(1990-11#1)(1991-8#1)(1993-11#1)(1993-6#2)(1994-9#1)(1996-5#1)(2007-11#4)(2007-12#3)(2008-10#11)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
with pricing##2##2##(1997-6#2)
with primarily##2##2##(1994-2#1)(2013-1#1)
with primary and secondary##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
with primary and##4##3##(2008-10#1)(2012-2#1)(2013-1#2)
with primary chemotherapy##2##3##(1992-6#1)(1993-2#1)
with primary gastric##2##3##(1992-8#1)(2013-1#1)
with primary hyperoxaluria##2##3##(1993-9#2)
with primary lung##2##3##(2008-11#1)(2011-1#1)
with primary open-angle glaucoma##2##4##(2011-1#1)(2011-2#1)
with primary tumours of the##2##5##(2008-6#2)
with primary tumours##4##3##(1997-3#1)(2008-6#3)
with primary##84##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#5)(1991-8#1)(1992-11#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#2)(1993-8#2)(1993-9#2)(1994-2#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#6)
with primer##5##2##(2008-10#2)(2008-4#1)(2008-5#2)
with primers designed##3##3##(1994-12#1)(2007-6#1)(2008-9#1)
with primers from##3##3##(1994-11#1)(2008-10#2)
with primers that amplify##2##4##(2008-10#2)
with primers##13##2##(1994-11#1)(1994-12#1)(2007-6#1)(2008-10#9)(2008-9#1)
with principles##2##2##(1994-5#1)(2009-4#1)
with prior information##2##3##(2008-8#1)(2010-2#1)
with prior##17##2##(1995-2#1)(1996-3#1)(1996-5#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
with private insurance##2##3##(1996-3#1)(1997-2#1)
with private##7##2##(1992-3#1)(1994-1#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-5#1)
with probable Alzheimer's##2##3##(1995-11#1)(2008-7#1)
with probable##6##2##(1991-12#1)(1995-11#1)(2007-8#1)(2008-7#2)(2013-1#1)
with probe RG57##2##3##(2008-10#2)
with probe##6##2##(2008-10#5)(2012-3#1)
with probes that##2##3##(1996-12#1)(2008-10#1)
with probes##6##2##(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2010-5#1)
with problem based learning##2##4##(2008-11#1)(2008-12#1)
with problem##4##2##(2008-11#1)(2008-12#2)(2013-1#1)
with problems##4##2##(1992-2#1)(2008-11#1)(2008-3#1)(2008-9#1)
with procedures##2##2##(2008-10#1)(2008-4#1)
with processed##2##2##(2007-7#1)(2008-10#1)
with processes##2##2##(1991-10#1)(2013-1#1)
with product##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
with production of##3##3##(1992-12#1)(2008-10#1)(2008-12#1)
with production##4##2##(1992-12#1)(2008-10#2)(2008-12#1)
with productivity##7##2##(2008-8#5)(2008-9#2)
with professional##6##2##(1990-12#1)(1991-3#1)(1993-3#1)(1994-2#1)(1997-2#1)(2011-2#1)
with profound hearing loss##3##4##(2008-9#3)
with profound##7##2##(1990-8#1)(2008-9#4)(2011-2#2)
with progeny##2##2##(2008-10#2)
with prognosis##4##2##(1993-9#1)(1994-10#1)(2012-3#2)
with programming##2##2##(2009-5#1)(2013-8#1)
with progress##2##2##(2008-7#1)(2012-2#1)
with progression of disease##2##4##(1991-6#1)(1992-2#1)
with progression of##9##3##(1991-6#1)(1992-2#1)(1995-12#1)(2007-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
with progression##12##2##(1990-3#1)(1991-6#1)(1992-2#1)(1995-12#1)(2006-10#1)(2007-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
with progressive disease##3##3##(1992-12#1)(2007-7#1)(2013-1#1)
with progressive neurological##2##3##(2008-7#1)(2011-2#1)
with progressive##22##2##(1991-3#1)(1992-12#1)(1992-8#2)(1994-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
with projected##2##2##(1994-3#1)(2008-3#1)
with proliferation##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
with prolonged##13##2##(1991-2#1)(1992-12#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#2)(2013-1#1)
with promising results##2##3##(2012-12#1)(2012-3#1)
with promising##4##2##(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
with prompt##3##2##(1991-6#1)(1997-8#1)(2007-7#1)
with pronounced##3##2##(2008-10#2)(2008-3#1)
with proper##9##2##(1993-6#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
with properties that##2##3##(2008-7#2)
with properties##7##2##(1990-5#1)(1993-2#1)(2008-3#1)(2008-7#2)(2010-9#1)(2012-2#1)
with prophylaxis##2##2##(1995-5#1)(2008-7#1)
with propidium iodide##2##3##(1994-2#1)(2008-9#1)
with propofol##6##2##(2010-7#2)(2011-2#3)(2012-3#1)
with proposed##2##2##(2008-10#1)(2010-8#1)
with proptosis##2##2##(2008-8#1)(2011-1#1)
with prospective##2##2##(1995-1#1)(2011-2#1)
with prostaglandin##4##2##(1993-8#1)(1994-6#1)(1995-12#1)(1995-5#1)
with prostate cancer##18##3##(2007-11#1)(2008-1#2)(2008-4#1)(2008-7#5)(2008-8#1)(2009-5#5)(2012-3#2)(2013-1#1)
with prostate##20##2##(2007-11#1)(2008-1#2)(2008-4#1)(2008-7#5)(2008-8#1)(2009-5#5)(2012-3#2)(2013-1#3)
with prostatic##8##2##(1990-3#1)(1990-9#2)(1993-6#1)(1995-11#1)(1995-12#2)(2007-10#1)
with prosthesis##4##2##(1993-11#1)(1993-3#1)(2008-1#1)(2012-1#1)
with prosthetic##2##2##(2008-6#1)(2013-1#1)
with prostitution##2##2##(1997-5#1)(2011-2#1)
with protean##2##2##(2008-7#1)(2011-2#1)
with protease inhibitors##2##3##(1990-11#1)(1992-9#1)
with protection##4##2##(1994-1#1)(1994-9#1)(2008-1#1)(2012-12#1)
with protective##5##2##(1993-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(2008-6#1)
with protein kinase C zeta##2##5##(1994-11#2)
with protein kinase##4##3##(1990-10#1)(1994-11#2)(2010-12#1)
with protein##24##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2009-8#1)(2010-12#1)(2013-1#1)
with proteinase K##4##3##(1996-12#1)(2008-10#3)
with proteinase##5##2##(1996-12#1)(2008-10#4)
with proteinaseK##2##2##(2008-8#2)
with proteins and##2##3##(2008-10#1)(2009-8#1)
with proteins##13##2##(1990-5#1)(1991-9#1)(1992-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#5)(2009-8#1)(2010-2#1)
with proteolytic##2##2##(2006-12#1)(2008-11#1)
with proteomic##2##2##(2008-7#2)
with protoheme XIII##2##3##(1990-8#2)
with protons##2##2##(2007-11#1)(2008-4#1)
with prototype##2##2##(2008-3#2)
with protruding##3##2##(1990-9#2)(2008-5#1)
with proven efficacy in##2##4##(2008-3#1)(2008-9#1)
with proven##7##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
with proximal and distal##2##4##(2007-12#1)(2008-7#1)
with proximal femur##3##3##(2007-11#2)(2007-8#1)
with proximal humeral##2##3##(2007-11#1)(2013-1#1)
with proximal##11##2##(2006-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#1)(2008-7#1)(2013-1#1)
with pruritic rashes##2##3##(2007-2#2)
with pruritic##3##2##(2007-2#2)(2010-6#1)
with psoriasis and##2##3##(2013-1#2)
with psoriasis##5##2##(2008-6#1)(2013-1#4)
with psychiatric disabilities##8##3##(1993-3#1)(1997-1#3)(2009-6#4)
with psychiatric disorders##6##3##(2007-8#1)(2011-1#2)(2012-2#1)(2013-7#2)
with psychiatric##17##2##(1993-3#1)(1997-1#3)(2007-10#1)(2007-8#1)(2009-6#4)(2010-10#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#2)
with psychoactive##2##2##(1990-3#1)(2011-2#1)
with psychological##2##2##(2008-6#1)(2012-2#1)
with psychosis##2##2##(1996-7#1)(2011-1#1)
with psychosocial##2##2##(2007-12#1)(2008-2#1)
with psychotic disorders##4##3##(2008-11#1)(2009-10#1)(2009-8#2)
with psychotic symptoms##2##3##(2007-6#1)(2013-8#1)
with psychotic##7##2##(2007-6#1)(2008-11#1)(2009-10#1)(2009-8#2)(2011-2#1)(2013-8#1)
with public##3##2##(1994-2#1)(1997-3#1)(2013-1#1)
with published data for##2##4##(1992-7#1)(2008-10#1)
with published data##6##3##(1990-3#1)(1992-7#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
with published sequences##2##3##(1994-11#1)(2008-10#1)
with published##15##2##(1990-3#1)(1990-7#1)(1990-8#1)(1992-7#1)(1994-11#1)(1997-7#2)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)
with pulmonary edema##2##3##(2008-11#1)(2010-5#1)
with pulmonary embolism##4##3##(1991-3#1)(2008-7#2)(2011-2#1)
with pulmonary hypertension##6##3##(2008-12#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-3#1)
with pulmonary metastasis in a##2##5##(2008-5#1)(2012-1#1)
with pulmonary##35##2##(1991-3#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-6#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#5)(2009-4#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
with pulsatile##3##2##(2006-12#1)(2008-7#1)(2010-6#1)
with pulse durations##2##3##(2007-12#1)(2008-3#1)
with pulse##15##2##(1993-1#1)(1993-2#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-9#1)
with pulsed amperometric detection for##2##5##(2008-10#2)
with pulsed amperometric detection##8##4##(1991-7#2)(1992-1#1)(2008-10#4)(2008-6#1)
with pulsed digital holography##3##4##(2008-3#3)
with pulsed lasers##2##3##(2008-3#2)
with pulsed##14##2##(1991-7#2)(1992-1#1)(2007-12#1)(2008-10#4)(2008-3#5)(2008-6#1)
with pump##5##2##(2007-12#3)(2007-8#1)(2008-3#1)
with pure red cell##3##4##(2008-12#2)(2013-1#1)
with pure red##4##3##(2008-12#2)(2013-1#2)
with pure##11##2##(1990-12#1)(1997-6#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-5#1)(2013-1#3)
with purified RNA##2##3##(1994-3#1)(2008-9#1)
with purified bacterial##2##3##(1992-3#1)(1992-8#1)
with purified rat##3##3##(1990-5#1)(1994-8#1)(1995-6#1)
with purified##24##2##(1990-5#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-10#5)(2008-8#1)(2008-9#1)
with puromycin##2##2##(1997-1#1)(2009-6#1)
with purulent##2##2##(2008-10#1)(2011-2#1)
with putative##3##2##(1995-1#1)(1995-9#1)(2008-10#1)
with pycnidia##2##2##(2008-10#2)
with pyogenic##2##2##(2007-8#1)(2010-6#1)
with pyramidal##2##2##(2007-12#1)(2008-2#1)
with pyrene##4##2##(1995-5#1)(2008-10#1)(2008-4#2)
with pyridine and##2##3##(2007-11#1)(2008-10#1)
with pyridine##4##2##(2007-11#1)(2008-10#3)
with pyridinium poly(hydrogen fluoride)##2##4##(1992-12#2)
with pyridoxal 5'-diphospho-5'-adenosine##2##3##(1991-12#2)
with pyridylazo##2##2##(2008-10#2)
with pyrrole##3##2##(1996-5#1)(2008-5#2)
with pyruvate##4##2##(1993-11#1)(1994-12#1)(1994-8#1)(1997-1#1)
with quadrat size##2##3##(2008-10#2)
with quadratic##2##2##(2008-3#1)(2008-6#1)
with quadrature##2##2##(2007-11#1)(2008-3#1)
with quadrupole##2##2##(2008-10#2)
with qualitative##2##2##(2008-10#1)(2012-12#1)
with quality##5##2##(1994-12#1)(1995-2#1)(1996-2#2)(2012-12#1)
with quantal##2##2##(1997-7#1)(2009-5#1)
with quantitative traits##2##3##(2008-10#1)(2012-3#1)
with quantitative##10##2##(1996-7#1)(1996-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2012-3#3)
with quantum chemical##2##3##(2008-10#1)(2010-10#1)
with quantum##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-12#1)
with quartz##2##2##(2008-10#1)(2008-3#1)
with quasi-phase-matching gratings##2##3##(2007-11#2)
with quaternary ammonium cations (Q(+))##2##5##(2008-10#2)
with quaternary ammonium counter ions##2##5##(2008-10#2)
with quaternary ammonium ions##2##4##(2008-10#2)
with quaternary ammonium##6##3##(2008-10#6)
with quaternary##7##2##(2008-10#6)(2008-6#1)
with quercetin##2##2##(2008-10#2)
with quick##2##2##(2008-2#1)(2013-8#1)
with quinine modified resin##2##4##(2008-10#2)
with quinine##3##2##(1993-8#1)(2008-10#2)
with quinoline-8-ol##2##2##(2008-10#2)
with quinolinic acid##3##3##(1994-8#1)(1995-12#1)(2008-5#1)
with quite##2##2##(2008-1#1)(2008-10#1)
with quitting##2##2##(1995-6#1)(2010-2#1)
with r##3##2##(1995-2#1)(2008-10#2)
with r(2) values of &gt##2##5##(2008-10#2)
with r(2)##4##2##(2008-10#4)
with r(2)=0##8##2##(2008-10#8)
with r=0##2##2##(2008-10#2)
with rAAV##2##2##(2008-5#1)(2008-9#1)
with rRNA##2##2##(2008-8#1)(2008-9#1)
with rabbit antibodies to##2##4##(1992-8#2)
with rabbit##10##2##(1990-5#1)(1992-8#2)(1993-2#1)(1994-9#2)(2008-10#1)(2008-11#2)(2008-5#1)
with rabies##2##2##(1996-11#1)(2013-1#1)
with race 7##2##3##(2008-10#2)
with race##9##2##(2008-10#9)
with races 1 and##2##4##(2008-10#2)
with races 1##3##3##(2008-10#3)
with races##5##2##(2008-10#5)
with racial##3##2##(1994-3#2)(2009-7#1)
with radial artery##2##3##(2007-8#1)(2008-9#1)
with radial forearm free##2##4##(2011-2#2)
with radial##12##2##(1990-9#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#3)(2013-8#1)
with radiation in##2##3##(1993-9#1)(2011-2#1)
with radiation therapy and##2##4##(2010-3#1)(2013-8#1)
with radiation##11##2##(1991-12#1)(1993-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
with radical resection##2##3##(2007-11#2)
with radical surgery##2##3##(2011-2#2)
with radical##9##2##(1990-12#1)(1992-8#1)(2007-11#2)(2011-2#4)(2013-1#1)
with radicular##2##2##(1991-11#1)(2007-11#1)
with radiculopathy##3##2##(2008-12#1)(2012-12#1)(2012-3#1)
with radio##2##2##(2008-1#1)(2013-1#1)
with radio-frequency##2##2##(1995-11#1)(2008-7#1)
with radioactive sugars##2##3##(2008-1#2)
with radioactive##7##2##(1992-8#1)(1993-11#1)(1994-8#1)(1997-2#1)(2008-1#2)(2008-10#1)
with radiofrequency lesions##2##3##(1992-11#1)(1994-3#1)
with radiofrequency##4##2##(1992-11#1)(1994-3#1)(2010-5#1)(2011-1#1)
with radiolabeled##2##2##(2008-11#1)(2008-4#1)
with radiologic##2##2##(1994-6#1)(2012-2#1)
with radiosondes##2##2##(2008-2#1)(2008-3#1)
with radiosurgery##3##2##(1997-4#1)(2008-7#2)
with radiotherapy alone##2##3##(1990-6#1)(1995-9#1)
with radiotherapy and/or chemotherapy##2##4##(1990-5#1)(2012-3#1)
with radiotherapy##21##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-8#2)(1993-6#1)(1995-9#1)(1997-3#1)(1997-7#1)(2008-11#2)(2008-6#1)(2008-7#2)(2009-3#1)(2010-3#1)(2011-1#2)(2012-3#1)(2013-1#1)
with rainfall##4##2##(2008-10#3)(2013-7#1)
with raised blood##2##3##(1990-5#1)(2010-12#1)
with raised##6##2##(1990-5#1)(1991-12#1)(2007-7#1)(2007-8#1)(2010-12#2)
with random amplified polymorphic DNA (RAPD)##2##6##(2008-10#2)
with random amplified polymorphic DNA##3##5##(2008-10#3)
with random and##2##3##(2008-2#1)(2012-2#1)
with random effects##2##3##(1996-3#1)(2011-1#1)
with random tilt errors##2##4##(2008-2#2)
with random##30##2##(1992-9#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#6)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
with randomly distributed##2##3##(2007-12#1)(2008-10#1)
with randomly##3##2##(2007-12#1)(2008-10#2)
with range##2##2##(2007-3#1)(2008-2#1)
with ranges##2##2##(2008-10#2)
with rapid progression##3##3##(2008-1#1)(2009-10#1)(2011-2#1)
with rapid##21##2##(1991-12#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-4#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#1)
with rapid-cycling bipolar disorder##3##4##(1996-7#3)
with rapidly##3##2##(1992-10#1)(2011-2#1)(2012-12#1)
with rare variants##2##3##(2012-3#2)
with rare##12##2##(1992-6#1)(1993-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2010-5#1)(2011-2#1)(2012-3#3)
with ras##2##2##(1992-11#1)(2008-11#1)
with rat ALR##2##3##(2008-8#2)
with rat and##3##3##(1990-12#1)(1990-7#1)(1996-12#1)
with rat hepatic##2##3##(1990-11#1)(1995-2#1)
with rat liver microsomes in the presence of##2##8##(1991-5#1)(1995-6#1)
with rat liver##4##3##(1991-5#1)(1993-12#1)(1994-8#1)(1995-6#1)
with rat##17##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-8#2)
with rate##4##2##(2008-10#3)(2010-11#1)
with rates of##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
with rates##7##2##(1992-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#2)
with rather high##2##3##(1991-11#1)(2008-10#1)
with ratios##2##2##(1992-3#1)(2008-2#1)
with rats##6##2##(1990-5#2)(2008-11#1)(2008-5#3)
with raw##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
with ray blight in##2##4##(2008-10#2)
with ray blight##7##3##(2008-10#7)
with ray tracing##2##3##(2008-2#1)(2008-3#1)
with ray##11##2##(2008-10#8)(2008-2#2)(2008-3#1)
with reaching##2##2##(1996-2#1)(2011-2#1)
with reaction##5##2##(1996-7#1)(2010-2#2)(2010-6#1)(2013-1#1)
with reactions##3##2##(2008-10#2)(2008-2#1)
with reactive oxygen species##3##4##(1993-11#1)(2008-7#1)(2011-1#1)
with reactive oxygen##4##3##(1993-11#1)(2008-7#1)(2009-8#1)(2011-1#1)
with reactive##5##2##(1993-11#1)(2008-7#1)(2009-8#2)(2011-1#1)
with reagent##3##2##(2008-10#3)
with real data##2##3##(2008-2#1)(2008-3#1)
with real##9##2##(1993-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2009-9#1)
with real-time PCR##2##3##(2008-10#1)(2012-2#1)
with real-time data##2##3##(2008-4#1)(2008-8#1)
with real-time polymerase chain reaction##2##5##(2008-10#2)
with real-time##11##2##(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#2)(2012-3#1)
with realistic##4##2##(2008-2#2)(2008-3#2)
with reasonable accuracy##2##3##(2008-2#1)(2008-7#1)
with reasonable##9##2##(1993-11#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-7#1)
with receiver operating characteristic##2##4##(2008-10#2)
with recent advances##2##3##(2008-8#1)(2010-5#1)
with recent experimental results##2##4##(2007-11#1)(2008-10#1)
with recent onset of##2##4##(2012-12#1)(2013-1#1)
with recent published##2##3##(1995-11#1)(2006-6#1)
with recent reports##2##3##(1990-5#1)(1991-2#1)
with recent theoretical##2##3##(2007-12#1)(2008-3#1)
with recent##34##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#1)(1995-11#1)(1996-2#1)(1996-6#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)(2010-5#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
with recent-onset##2##2##(2008-11#2)
with recently published##2##3##(2008-2#1)(2012-3#1)
with recently##9##2##(1994-2#1)(1994-6#1)(1996-4#1)(2007-11#2)(2008-2#1)(2008-6#1)(2010-8#1)(2012-3#1)
with receptor##3##2##(1990-4#1)(1992-3#1)(1996-12#1)
with receptors for##2##3##(1994-2#1)(2008-4#1)
with receptors##5##2##(1991-5#1)(1994-2#1)(2008-4#2)(2012-1#1)
with recessive##2##2##(2011-1#1)(2012-3#1)
with recipient##2##2##(2008-1#1)(2013-1#1)
with recombinant baculoviruses##3##3##(1992-8#1)(1997-8#1)(2008-7#1)
with recombinant human##5##3##(1992-9#1)(1993-9#1)(1995-12#1)(2007-7#1)(2011-2#1)
with recombinant tissue plasminogen activator##2##5##(2007-10#1)(2009-11#1)
with recombinant virus##2##3##(1994-11#1)(1997-4#1)
with recombinant##40##2##(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-4#5)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
with recombination##2##2##(2008-10#2)
with recommendations for##5##3##(1996-12#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-2#1)
with recommendations##8##2##(1995-12#1)(1996-12#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
with reconstruction##2##2##(2008-7#1)(2011-2#1)
with recoveries between##3##3##(2008-10#3)
with recoveries of##4##3##(2008-10#4)
with recoveries ranging from##2##4##(2008-10#2)
with recoveries ranging##3##3##(2008-10#3)
with recoveries##15##2##(1994-5#1)(2008-10#14)
with recovery of##3##3##(1990-3#1)(1995-11#1)(2008-10#1)
with recovery##12##2##(1990-3#1)(1995-11#1)(2008-10#7)(2008-3#1)(2008-8#1)(2009-8#1)
with rectal cancer##3##3##(2008-10#2)(2013-8#1)
with rectangular##3##2##(1996-2#1)(2008-3#1)(2012-2#1)
with recurrence and##2##3##(1995-4#1)(2010-7#1)
with recurrence##5##2##(1995-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
with recurrent atrial fibrillation##2##4##(2007-8#2)
with recurrent episodes of##3##4##(2007-5#1)(2008-6#1)(2013-1#1)
with recurrent epistaxis##2##3##(2007-10#2)
with recurrent major depression##3##4##(1995-11#1)(1996-7#2)
with recurrent meningitis##2##3##(2013-7#2)
with recurrent or##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
with recurrent pregnancy loss##3##4##(2011-2#3)
with recurrent transient ischemic attacks##2##5##(2007-8#1)(2012-3#1)
with recurrent urinary tract##3##4##(1990-11#1)(2008-10#1)(2013-1#1)
with recurrent vulvovaginal##2##3##(2007-10#1)(2008-5#1)
with recurrent##66##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-8#1)(1995-11#1)(1996-7#2)(2007-10#3)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
with recycling##2##2##(1996-1#1)(2008-10#1)
with red cells##2##3##(1992-9#1)(1993-12#1)
with red light in##2##4##(2007-12#2)
with red light##7##3##(1990-11#1)(2007-11#1)(2007-12#4)(2012-2#1)
with red##19##2##(1990-11#1)(1992-9#1)(1993-12#2)(1993-3#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)
with redox##2##2##(2008-10#1)(2011-2#1)
with reduced affinity##3##3##(1990-11#1)(1993-8#1)(2013-7#1)
with reduced growth##2##3##(2010-4#1)(2011-1#1)
with reduced incidence of##2##4##(2008-10#1)(2010-1#1)
with reduced morbidity and##2##4##(2008-7#1)(2009-4#1)
with reduced risk of##3##4##(2008-7#1)(2010-1#1)(2012-1#1)
with reduced##70##2##(1990-11#1)(1990-9#1)(1991-12#1)(1993-8#4)(1994-5#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#2)
with reducing##2##2##(1992-12#1)(2008-10#1)
with reduction in##4##3##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
with reduction of haemoglobin##2##4##(2013-1#2)
with reduction of##5##3##(2008-10#1)(2009-8#1)(2013-1#3)
with reduction##11##2##(2008-10#3)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
with reductions in the##2##4##(2008-10#2)
with reductions in##7##3##(1995-8#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
with reductions##8##2##(1995-8#1)(2008-10#3)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
with reference to the literature##2##5##(2008-10#1)(2008-11#1)
with reference to the##8##4##(1990-5#1)(1991-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
with reference to##24##3##(1990-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#2)(2013-7#2)
with reference##35##2##(1990-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-11#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#3)(2011-2#1)(2013-7#2)
with references##3##2##(1992-11#1)(2008-7#1)(2011-2#1)
with reflections##2##2##(1996-9#1)(2011-2#1)
with reflux esophagitis##2##3##(2008-12#1)(2013-8#1)
with reflux##3##2##(2008-12#1)(2008-4#1)(2013-8#1)
with reform##2##2##(1993-12#1)(1995-2#1)
with refractive index##2##3##(1991-7#1)(2008-3#1)
with refractive indices##3##3##(2008-2#3)
with refractive##7##2##(1991-7#1)(2008-2#3)(2008-3#2)(2010-8#1)
with refractory angina##2##3##(2008-12#1)(2010-6#1)
with refractory hypertension##2##3##(1990-9#1)(2008-1#1)
with refractory non-insulin mediated hypoglycaemia##2##5##(2011-1#2)
with refractory##16##2##(1990-3#1)(1990-9#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#3)
with regard to drinking##2##4##(1994-2#1)(2007-2#1)
with regard to future##3##4##(2008-12#1)(2012-1#1)(2013-8#1)
with regard to its##3##4##(2008-2#1)(2012-3#1)(2013-1#1)
with regard to prognosis##2##4##(1993-9#1)(2010-11#1)
with regard to the##28##4##(1991-5#1)(1993-3#1)(1994-11#1)(1996-11#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-3#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
with regard to their##8##4##(1995-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
with regard to these##2##4##(2008-9#1)(2011-1#1)
with regard to what##2##4##(1994-6#1)(2008-12#1)
with regard to##164##3##(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#15)(2008-12#8)(2008-2#5)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#2)(2013-8#1)
with regard##165##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#15)(2008-12#8)(2008-2#5)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#2)(2013-8#1)
with regards to the##6##4##(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-8#1)
with regards to##14##3##(2007-8#1)(2008-10#2)(2008-12#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#4)(2013-8#1)
with regional##3##2##(1992-6#1)(1994-3#1)(2011-1#1)
with regions##3##2##(2008-11#1)(2008-3#1)(2012-1#1)
with registered nurses##2##3##(2008-12#1)(2008-7#1)
with regression coefficients##3##3##(2008-10#3)
with regression##5##2##(2008-10#3)(2008-6#1)(2008-9#1)
with regular##9##2##(1990-3#1)(1991-12#1)(1996-11#1)(1996-6#1)(2008-12#1)(2008-2#1)(2010-7#1)(2011-2#1)(2013-8#1)
with regulated##2##2##(1995-12#1)(2008-10#1)
with regulatory##2##2##(1992-3#1)(1993-9#1)
with relapse##3##2##(1993-11#1)(2009-11#1)(2010-4#1)
with relapsed##4##2##(2010-11#2)(2010-4#2)
with relapses##2##2##(1995-8#1)(2010-12#1)
with related##8##2##(1990-7#1)(1992-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-4#1)(2008-5#1)(2009-9#1)
with relation to##5##3##(2007-11#1)(2008-10#2)(2009-3#1)(2013-1#1)
with relative S##2##3##(2008-10#2)
with relative ease##2##3##(2007-8#1)(2008-7#1)
with relative error##3##3##(2008-10#3)
with relative errors##2##3##(2008-10#2)
with relative risk##2##3##(1997-5#1)(2011-2#1)
with relative standard deviation (RSD)##3##5##(2008-10#3)
with relative standard deviation of 2##2##6##(2008-10#2)
with relative standard deviation of##3##5##(2008-10#3)
with relative standard deviation##10##4##(2008-10#10)
with relative standard deviations (RSDs)##2##5##(2008-10#1)(2011-1#1)
with relative standard deviations of 2##3##6##(2008-10#3)
with relative standard deviations of##6##5##(2008-10#6)
with relative standard deviations##13##4##(1994-9#1)(2008-10#10)(2008-5#1)(2011-1#1)
with relative standard##23##3##(1994-9#1)(2008-10#20)(2008-5#1)(2011-1#1)
with relative##44##2##(1990-5#1)(1993-6#1)(1994-9#1)(1995-6#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#27)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#2)
with relatively few##4##3##(1991-12#1)(2008-3#1)(2008-8#1)(2011-1#1)
with relatively high sensitivity##3##4##(2008-10#3)
with relatively high##7##3##(2008-10#5)(2008-8#1)(2012-3#1)
with relatively low##6##3##(2008-10#3)(2008-12#1)(2008-3#1)(2012-2#1)
with relatively short##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
with relatively simple##2##3##(2008-3#1)(2008-7#1)
with relatively small##3##3##(2008-1#1)(2008-10#2)
with relatively##32##2##(1991-12#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-1#1)(2012-2#2)(2012-3#1)
with relaxation##3##2##(1990-5#1)(1994-8#1)(2010-7#1)
with release of##3##3##(1994-8#1)(2008-4#1)(2008-7#1)
with relevance to##3##3##(2006-10#1)(2008-11#1)(2012-8#1)
with relevance##4##2##(2006-10#1)(2008-11#1)(2012-2#1)(2012-8#1)
with relevant##9##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#2)
with reliability##2##2##(2008-10#1)(2009-7#1)
with reliable##2##2##(2011-2#1)(2013-8#1)
with remarkable##8##2##(1991-2#1)(1994-3#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with remembering##2##2##(2013-7#2)
with removal of the##2##4##(1991-8#1)(2008-7#1)
with removal of##3##3##(1990-2#1)(1991-8#1)(2008-7#1)
with renal cell carcinoma##6##4##(1990-5#1)(1991-8#1)(1995-12#2)(1997-6#1)(2008-1#1)
with renal cell##7##3##(1990-5#1)(1991-8#1)(1995-12#2)(1997-6#1)(2008-1#1)(2011-1#1)
with renal disease##3##3##(2007-12#1)(2007-7#2)
with renal dysfunction##2##3##(2012-3#2)
with renal failure and##2##4##(1994-9#1)(1997-3#1)
with renal failure##4##3##(1994-9#1)(1997-3#1)(2008-7#1)(2013-1#1)
with renal impairment##2##3##(2008-1#1)(2013-1#1)
with renal insufficiency##2##3##(2006-10#1)(2013-1#1)
with renal transplantation##2##3##(1997-3#1)(2008-1#1)
with renal##47##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-12#2)(1996-6#1)(1997-3#2)(1997-6#1)(2006-10#4)(2007-12#1)(2007-7#2)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-3#3)(2013-1#12)
with renovascular hypertension##3##3##(2007-7#1)(2008-1#1)(2010-4#1)
with repeat##5##2##(2008-11#4)(2009-10#1)
with repeated##16##2##(1992-3#1)(1993-6#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#4)
with reperfusion##2##2##(1991-9#1)(2008-3#1)
with repetitive anoxia##2##3##(1996-9#2)
with repetitive##11##2##(1991-5#1)(1996-9#2)(2007-11#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-3#1)
with replacement of the##2##4##(2007-8#2)
with replacement##5##2##(1997-8#1)(2007-8#2)(2008-6#1)(2012-3#1)
with replicates##2##2##(2008-10#1)(2008-11#1)
with replication fork##2##3##(2012-3#2)
with reported data##2##3##(1992-5#1)(2013-8#1)
with reported values##2##3##(2008-10#1)(2009-11#1)
with reported##8##2##(1992-5#1)(2008-10#2)(2008-9#1)(2009-11#2)(2012-1#1)(2013-8#1)
with reporter gene##2##3##(1997-1#1)(2008-9#1)
with reporter##6##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-8#1)
with reports of##2##3##(1997-3#1)(2010-4#1)
with reports##4##2##(1995-12#1)(1997-3#1)(2010-4#1)(2012-1#1)
with representative##5##2##(2007-11#1)(2008-1#1)(2008-10#3)
with representatives of##2##3##(1997-2#1)(2008-10#1)
with representatives##3##2##(1997-2#1)(2008-10#2)
with reproducible##2##2##(2008-8#1)(2008-9#1)
with reproductive##7##2##(1990-6#1)(2007-5#1)(2009-7#1)(2011-2#3)(2012-3#1)
with research##5##2##(1990-11#1)(1996-2#1)(2008-7#2)(2008-9#1)
with resection##4##2##(1991-9#1)(2008-10#1)(2012-3#2)
with residents##6##2##(1992-1#1)(2008-11#3)(2011-1#1)(2011-2#1)
with residual##5##2##(2007-8#1)(2008-2#1)(2010-6#1)(2011-2#2)
with residues of the##2##4##(1994-8#1)(2008-10#1)
with residues of##4##3##(1994-8#1)(2008-10#3)
with residues##6##2##(1994-8#1)(1995-2#2)(2008-10#3)
with resilience##2##2##(2009-8#1)(2012-4#1)
with resistance and tolerance##2##4##(2011-10#2)
with resistance and##3##3##(2008-10#1)(2011-10#2)
with resistance to tan spot##2##5##(2008-10#2)
with resistance to two##2##4##(2008-10#2)
with resistance to##25##3##(2008-10#21)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)
with resistance##46##2##(2008-10#38)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-10#2)
with resistant genotypes##2##3##(2008-10#2)
with resistant##9##2##(2006-10#2)(2007-7#1)(2008-10#4)(2012-3#1)(2013-8#1)
with resolution of##5##3##(1990-3#1)(1994-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
with resolution##7##2##(1990-3#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
with resonance##2##2##(1996-7#1)(2008-2#1)
with resonant sideband extraction##3##4##(2008-2#3)
with resonant##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
with resource##3##2##(1992-3#1)(2008-8#1)(2013-7#1)
with respect to OS##2##4##(1992-10#2)
with respect to T##2##4##(2008-10#2)
with respect to W##2##4##(2008-10#2)
with respect to a large number of inorganic##2##8##(2008-10#2)
with respect to a large##4##5##(1990-12#1)(2008-10#3)
with respect to a##12##4##(1990-12#1)(1992-3#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
with respect to absorbed##2##4##(2007-11#1)(2008-2#1)
with respect to absorption##2##4##(2008-10#1)(2008-2#1)
with respect to accuracy##2##4##(2008-10#1)(2008-7#1)
with respect to age##4##4##(1991-2#1)(1994-2#1)(2008-7#1)(2013-8#1)
with respect to another##2##4##(2008-3#1)(2009-10#1)
with respect to both##5##4##(1991-12#1)(1992-12#1)(1994-2#1)(1994-9#1)(2008-5#1)
with respect to clinical##5##4##(1993-12#1)(2008-1#1)(2008-3#1)(2011-1#2)
with respect to common##3##4##(2008-10#3)
with respect to control animals##2##5##(2006-6#1)(2013-1#1)
with respect to control of##2##5##(1992-3#1)(2010-8#1)
with respect to control##4##4##(1992-3#1)(2006-6#1)(2010-8#1)(2013-1#1)
with respect to data##2##4##(2008-10#1)(2009-10#1)
with respect to different##3##4##(2008-6#2)(2008-7#1)
with respect to distance##2##4##(2007-11#1)(2009-6#1)
with respect to each other##3##5##(2007-11#1)(2008-3#1)(2011-1#1)
with respect to each##5##4##(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
with respect to escalation##2##4##(2009-10#2)
with respect to female breast cancer##2##6##(1990-12#2)
with respect to gravity##3##4##(2008-11#3)
with respect to growth##2##4##(2008-10#1)(2011-2#1)
with respect to human health##2##5##(2008-10#1)(2012-2#1)
with respect to incidence##2##4##(1991-11#1)(2008-10#1)
with respect to its##11##4##(1993-8#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
with respect to normal controls##2##5##(1995-12#2)
with respect to normal##3##4##(1995-12#2)(2009-10#1)
with respect to number of##2##5##(2008-10#1)(2008-5#1)
with respect to one##2##4##(2007-12#1)(2008-10#1)
with respect to optical##2##4##(2008-2#2)
with respect to pain and functional outcomes##2##7##(2012-12#2)
with respect to pain##3##4##(2008-9#1)(2012-12#2)
with respect to pipe length##2##5##(2008-3#2)
with respect to random##2##4##(2008-2#1)(2008-3#1)
with respect to sex##2##4##(1994-6#1)(2009-5#1)
with respect to simplicity##2##4##(2008-10#1)(2008-11#1)
with respect to substitution##2##4##(1996-2#1)(2011-1#1)
with respect to the absorbed pump power##2##7##(2007-11#2)
with respect to the absorbed##3##5##(2007-11#2)(2007-12#1)
with respect to the angle of incidence##2##7##(2008-3#2)
with respect to the corresponding##2##5##(2008-10#2)
with respect to the expression##2##5##(1992-6#1)(2008-11#1)
with respect to the fundamental##2##5##(2008-3#2)
with respect to the human##2##5##(1991-6#1)(1992-6#1)
with respect to the incident beam##2##6##(2008-2#1)(2008-3#1)
with respect to the incident##5##5##(2008-2#1)(2008-3#4)
with respect to the intensity##3##5##(1991-12#1)(2007-11#1)(2008-2#1)
with respect to the long-term##2##5##(2008-4#1)(2012-3#1)
with respect to the medium##2##5##(2008-2#2)
with respect to the nature##2##5##(2012-1#1)(2012-2#1)
with respect to the optical##2##5##(2008-3#2)
with respect to the other##7##5##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#3)
with respect to the plane of incidence##3##7##(2008-3#3)
with respect to the plane of##4##6##(2008-2#1)(2008-3#3)
with respect to the plane##5##5##(2007-11#1)(2008-2#1)(2008-3#3)
with respect to the presence or absence of overweight##2##9##(2008-10#2)
with respect to the presence##3##5##(2007-12#1)(2008-10#2)
with respect to the relative##2##5##(1992-3#1)(2008-3#1)
with respect to the##214##4##(1990-11#3)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#4)(1993-12#1)(1993-3#1)(1993-8#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-9#1)(2006-10#1)(2007-11#9)(2007-12#8)(2007-2#1)(2007-9#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#22)(2008-3#43)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
with respect to their##31##4##(1992-10#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2011-2#2)(2013-1#1)
with respect to these properties##2##5##(2008-7#1)(2010-1#1)
with respect to these##3##4##(2008-2#1)(2008-7#1)(2010-1#1)
with respect to those obtained##3##5##(2008-10#3)
with respect to those##4##4##(1991-6#1)(2008-10#3)
with respect to##576##3##(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#7)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#8)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-9#1)(2006-10#1)(2006-6#1)(2007-11#17)(2007-12#22)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#104)(2008-11#17)(2008-12#7)(2008-2#41)(2008-3#58)(2008-4#5)(2008-5#14)(2008-6#3)(2008-7#21)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#12)(2013-8#7)
with respect##580##2##(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#3)(1993-8#7)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#8)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-9#1)(2006-10#1)(2006-6#1)(2007-11#17)(2007-12#22)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#106)(2008-11#18)(2008-12#7)(2008-2#41)(2008-3#58)(2008-4#5)(2008-5#14)(2008-6#3)(2008-7#21)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#12)(2013-8#7)
with respective##7##2##(1991-12#1)(1992-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-7#1)
with respiratory disease##2##3##(1991-8#1)(1997-1#1)
with respiratory distress syndrome##3##4##(1990-12#2)(2008-12#1)
with respiratory distress##6##3##(1990-11#1)(1990-12#2)(1991-3#1)(2008-12#1)(2010-1#1)
with respiratory failure##2##3##(2008-1#1)(2013-1#1)
with respiratory##24##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-3#1)(1991-8#1)(1992-4#1)(1994-2#1)(1994-6#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
with response to##2##3##(1993-2#1)(2012-2#1)
with response##6##2##(1993-2#1)(2008-10#2)(2008-6#1)(2012-2#1)(2013-1#1)
with responses to##2##3##(1993-6#1)(1996-2#1)
with responses##3##2##(1993-6#1)(1996-2#1)(2009-8#1)
with restoration of##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
with restricted##3##2##(2008-10#2)(2008-3#1)
with restriction enzymes##4##3##(1990-3#1)(2008-10#2)(2008-5#1)
with restriction fragment length polymorphism (RFLP) markers##2##7##(2008-10#2)
with restriction fragment length polymorphism##3##5##(2008-10#3)
with restriction##10##2##(1990-3#1)(1993-6#1)(1995-6#1)(2008-10#6)(2008-5#1)
with restrictive##3##2##(2006-10#1)(2008-7#1)(2008-8#1)
with resultant##6##2##(1994-9#1)(2008-8#1)(2009-1#1)(2011-2#2)(2012-2#1)
with results comparable to those##2##5##(1991-2#1)(2008-10#1)
with results determined by##2##4##(2008-10#2)
with results for##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
with results from the##2##4##(2008-5#1)(2009-9#1)
with results from##11##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
with results obtained by##3##4##(1991-9#1)(2008-10#2)
with results obtained using##3##4##(2008-10#3)
with results obtained##11##3##(1991-9#1)(2006-6#1)(2008-10#6)(2008-3#2)(2008-8#1)
with results of##2##3##(1995-5#1)(2008-9#1)
with results that##2##3##(1994-5#1)(2008-10#1)
with results##47##2##(1991-2#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#8)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)
with resveratrol##3##2##(2008-10#2)(2012-4#1)
with retained##3##2##(1991-3#1)(2010-5#1)(2012-2#1)
with retention of##7##3##(1992-3#1)(1992-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-5#1)
with retention times of##2##4##(2008-10#2)
with retention times##3##3##(1990-12#1)(2008-10#2)
with retention##12##2##(1990-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2009-5#1)(2010-3#1)
with retinal##4##2##(1992-3#1)(2009-12#1)(2011-1#1)(2013-1#1)
with retinex coding##3##3##(2008-3#3)
with retinoic acid and cyclic AMP##2##6##(1992-9#2)
with retinoic acid##5##3##(1992-9#2)(1994-9#2)(2008-5#1)
with retinopathy##2##2##(1991-12#1)(2013-1#1)
with retrograde##7##2##(1996-5#2)(2006-12#1)(2007-8#1)(2007-9#2)(2013-1#1)
with retroviral##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
with revenue##2##2##(1992-12#2)
with reverse##6##2##(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
with reversed##2##2##(2008-10#2)
with reversible##6##2##(1992-6#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-9#1)(2012-3#1)
with review of literature##7##4##(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
with review of the literature##4##5##(2007-5#1)(2008-12#1)(2012-2#2)
with review of the##6##4##(1997-2#1)(2007-5#1)(2008-12#2)(2012-2#2)
with review of##14##3##(1997-2#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#3)(2012-3#1)
with reward##2##2##(1992-12#1)(2008-4#1)
with rhFKBP12##2##2##(2008-9#2)
with rhabdomyolysis##4##2##(2008-10#2)(2011-2#2)
with rheumatoid arthritis (RA)##2##4##(2008-8#1)(2010-12#1)
with rheumatoid arthritis##16##3##(1990-2#1)(1993-1#1)(1993-2#1)(2006-10#2)(2007-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
with rheumatoid##17##2##(1990-2#1)(1993-1#1)(1993-2#1)(2006-10#2)(2007-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
with rhodamine 6G##2##3##(2008-10#2)
with rhodamine##6##2##(1991-12#1)(1994-2#1)(2008-10#4)
with ribavirin##3##2##(1990-10#1)(1994-6#1)(2008-6#1)
with rice##4##2##(1993-11#1)(2008-10#1)(2008-9#1)(2010-2#1)
with rich {100} facets##2##4##(2013-1#2)
with rich##3##2##(2008-6#1)(2013-1#2)
with rifampicin##2##2##(2008-10#1)(2008-8#1)
with right atrial##2##3##(1997-5#1)(2012-12#1)
with right hemisphere##3##3##(1996-5#1)(2008-2#1)(2012-3#1)
with right##16##2##(1991-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
with right-sided##3##2##(1997-2#1)(2011-2#1)(2012-8#1)
with rigid##2##2##(2007-12#1)(2008-10#1)
with rigorous numerical##2##3##(2007-11#1)(2007-12#1)
with rigorous##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
with rimalkalim##4##2##(1997-7#4)
with rising##3##2##(1993-8#1)(2008-2#1)(2013-8#1)
with risk factors for##3##4##(2012-12#1)(2012-2#1)(2013-8#1)
with risk factors##9##3##(1996-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
with risk of##10##3##(1993-9#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
with risk##23##2##(1991-3#1)(1993-9#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#2)
with risperidone##3##2##(2008-3#1)(2008-8#1)(2009-9#1)
with rituximab##3##2##(2009-8#1)(2013-1#2)
with rival##2##2##(2008-10#1)(2008-8#1)
with rms##2##2##(2007-12#1)(2008-3#1)
with robotic##2##2##(2007-8#2)
with rodents##2##2##(2008-4#1)(2011-2#1)
with root mean##2##3##(1997-4#1)(2008-10#1)
with root##6##2##(1997-4#1)(2007-8#1)(2008-10#3)(2012-8#1)
with root-knot##2##2##(2008-10#2)
with roots##2##2##(2008-10#2)
with ropinirole##3##2##(2008-7#3)
with ropivacain##2##2##(2012-3#2)
with rose Bengal##2##3##(2008-10#1)(2013-7#1)
with rosuvastatin##3##2##(2010-12#1)(2011-1#2)
with rotation##3##2##(1996-2#1)(2008-3#1)(2008-6#1)
with rotational##6##2##(2007-11#2)(2008-2#2)(2008-7#1)(2011-2#1)
with rough##2##2##(2007-11#1)(2008-3#1)
with round##4##2##(1991-8#1)(1995-12#1)(1997-2#1)(2012-1#1)
with routine##9##2##(1997-3#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
with rt-PA##3##2##(2007-10#2)(2008-7#1)
with rubeanic acid##3##3##(2008-10#3)
with rubidium##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with rubisco activase##4##3##(1991-9#4)
with running##2##2##(2008-10#1)(2012-3#1)
with rupture of the##3##4##(1990-11#1)(2008-11#1)(2012-3#1)
with rupture##5##2##(1990-11#1)(1990-5#1)(2008-11#1)(2010-7#1)(2012-3#1)
with ruptured##2##2##(2010-7#1)(2011-2#1)
with rural##4##2##(1997-7#1)(2008-11#1)(2010-3#1)(2013-1#1)
with s(L)=0##2##2##(2008-10#2)
with sDON##2##2##(1995-12#2)
with sacroiliac joint dysfunction##2##4##(2012-2#2)
with sadomasochism associated##2##3##(2011-1#2)
with safety##2##2##(1995-3#1)(2008-8#1)
with salicylic acid##3##3##(2008-10#2)(2008-5#1)
with saline or 50% ethanol##2##5##(2013-8#2)
with saline or##4##3##(1995-12#1)(2008-10#1)(2013-8#2)
with saline water##6##3##(2008-10#6)
with saline##21##2##(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(2007-10#1)(2008-10#7)(2008-12#1)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#2)
with salinity##2##2##(2008-5#1)(2013-7#1)
with saliva##4##2##(2008-12#3)(2010-5#1)
with salt##3##2##(1993-6#1)(2008-9#1)(2010-8#1)
with samarium hydroxide##2##3##(2008-10#2)
with samarium##3##2##(2008-10#3)
with same##7##2##(1996-12#1)(2007-11#1)(2008-3#1)(2011-1#2)(2012-3#1)(2013-8#1)
with sample depth##2##3##(2008-2#2)
with sample##17##2##(1993-11#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-9#1)(2012-2#1)(2013-8#2)
with samples from##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2013-8#1)
with samples of##2##3##(2008-10#1)(2008-7#1)
with samples##12##2##(1990-8#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2012-12#1)(2013-8#1)
with sampling rate of about##2##5##(2008-10#2)
with sampling##3##2##(2008-10#3)
with sand##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
with sarcoma##6##2##(2008-6#5)(2010-3#1)
with satisfaction##3##2##(2009-3#1)(2010-2#1)(2010-5#1)
with satisfactory accuracy and precision in the presence of##2##9##(2008-10#2)
with satisfactory accuracy and precision##4##5##(2008-10#4)
with satisfactory accuracy##5##3##(2008-10#4)(2008-3#1)
with satisfactory results and##2##4##(2008-10#2)
with satisfactory results in##2##4##(2006-10#1)(2008-10#1)
with satisfactory results##80##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#77)
with satisfactory##91##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#86)(2008-3#1)(2009-3#1)
with saturated##3##2##(1995-5#1)(1997-2#1)(2008-10#1)
with sawdust##4##2##(2008-12#4)
with scab##2##2##(2008-10#2)
with scalp##2##2##(2008-4#1)(2012-12#1)
with scanning electron microscopy##3##4##(2008-5#2)(2013-1#1)
with scanning##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2013-1#1)
with scarce##2##2##(2007-12#1)(2008-10#1)
with scattered light##2##3##(2008-2#1)(2011-2#1)
with scattered##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
with scattering##2##2##(2007-11#1)(2008-3#1)
with sceletal cancer metastases and pathological fracture of##2##8##(2007-11#2)
with scenarios##2##2##(2010-3#1)(2013-8#1)
with schistosomiasis##3##2##(1996-12#1)(2008-8#2)
with schizophrenia and 20##2##4##(1996-7#1)(2013-1#1)
with schizophrenia and##10##3##(1996-5#1)(1996-7#3)(2008-3#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-1#1)(2013-1#1)
with schizophrenia have##2##3##(1995-12#1)(2009-6#1)
with schizophrenia treated with##2##4##(2008-7#2)
with schizophrenia treated##3##3##(2008-7#2)(2012-3#1)
with schizophrenia##69##2##(1995-11#2)(1995-12#4)(1995-5#1)(1996-5#3)(1996-7#10)(1997-5#2)(2008-11#2)(2008-3#3)(2008-6#2)(2008-7#2)(2009-12#2)(2009-6#2)(2009-7#2)(2010-1#2)(2010-6#2)(2011-1#3)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
with school##2##2##(2007-12#1)(2008-12#1)
with scleroderma##5##2##(1992-8#1)(2006-10#3)(2008-10#1)
with sclerotherapy##3##2##(2013-1#3)
with sclerotia##3##2##(2008-10#3)
with sclerotized##2##2##(2007-12#1)(2008-5#1)
with scoliosis##4##2##(2007-8#1)(2008-4#2)(2013-1#1)
with scores on##2##3##(1996-7#1)(2012-1#1)
with scores##3##2##(1992-1#1)(1996-7#1)(2012-1#1)
with scorpion##2##2##(2008-8#1)(2008-9#1)
with screening##3##2##(2008-11#1)(2008-4#1)(2013-1#1)
with screws##5##2##(2011-2#4)(2012-2#1)
with seasonal allergens##2##3##(2011-2#2)
with seasonal variation##2##3##(1997-3#1)(2012-3#1)
with seasonal##12##2##(1995-11#1)(1997-3#1)(2008-11#1)(2008-8#2)(2009-7#1)(2011-2#4)(2012-3#1)(2013-8#1)
with sebaceous##2##2##(2010-8#2)
with second##3##2##(2008-10#1)(2008-7#1)(2009-6#1)
with second-harmonic generation in##2##4##(2007-12#2)
with second-harmonic generation##3##3##(2007-12#2)(2008-3#1)
with second-harmonic##5##2##(2007-12#3)(2008-3#2)
with second-order calibration##2##3##(2008-10#2)
with second-order##5##2##(1995-6#1)(2008-10#2)(2008-2#2)
with secondary infertility##2##3##(2011-1#2)
with secondary osteoarthritis##2##3##(2013-1#2)
with secondary##24##2##(1991-11#2)(1991-3#1)(1993-3#1)(1993-6#1)(1996-11#1)(1996-3#2)(1997-2#1)(2008-1#1)(2008-3#2)(2008-9#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
with secreted##2##2##(2008-10#1)(2008-5#1)
with secretory##2##2##(1997-6#1)(2007-12#1)
with seed##4##2##(2008-10#2)(2008-5#1)(2009-10#1)
with seeking##2##2##(1995-12#1)(2008-8#1)
with segments##4##2##(2008-10#3)(2008-4#1)
with seizure##4##2##(2008-12#1)(2008-2#1)(2010-1#1)(2012-3#1)
with seizures##3##2##(1997-3#1)(2008-4#1)(2011-1#1)
with selected ion monitoring##2##4##(2008-10#2)
with selected##20##2##(1992-4#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
with selection##3##2##(1996-6#1)(2007-11#1)(2013-1#1)
with selective hypersensitivity##2##3##(2013-1#2)
with selective##16##2##(1991-2#1)(1992-8#1)(1994-5#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#2)(2013-1#2)(2013-7#1)
with selenium##3##2##(2008-10#2)(2008-4#1)
with self-assembled##3##2##(2008-10#3)
with self-injection of##2##3##(2009-3#2)
with self-report measures##2##3##(2008-8#1)(2013-1#1)
with self-reported##2##2##(1990-9#1)(2008-8#1)
with semen##2##2##(2008-7#1)(2013-1#1)
with semiconductor optical amplifiers and in-line filters##2##7##(2007-12#2)
with senescence##3##2##(1994-5#1)(1995-8#1)(2013-1#1)
with senior##3##2##(1993-2#1)(1997-3#1)(2008-12#1)
with sensilla##2##2##(2007-12#2)
with sensitive##2##2##(1997-4#1)(1997-7#1)
with sensitivity 2##2##3##(2007-12#1)(2008-10#1)
with sensitivity of##2##3##(2008-10#2)
with sensitivity to trastuzumab##2##4##(2012-3#2)
with sensitivity##12##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2011-1#1)(2012-3#2)
with sensitized##2##2##(2008-10#2)
with sensorineural##3##2##(1992-2#1)(2007-7#1)(2008-9#1)
with sensors##2##2##(2008-10#1)(2008-3#1)
with sensory##5##2##(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-2#1)
with sentence##2##2##(2008-9#1)(2009-9#1)
with separate##7##2##(1992-12#1)(1996-12#1)(2008-11#1)(2008-3#3)(2009-7#1)
with separation##3##2##(2008-10#2)(2008-3#1)
with sepsis and##2##3##(1992-12#1)(2013-1#1)
with sepsis##8##2##(1992-12#1)(1992-2#1)(2007-12#1)(2007-5#1)(2011-2#1)(2013-1#3)
with septic shock##2##3##(1995-2#1)(2011-2#1)
with septic##5##2##(1994-12#1)(1995-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
with septo-optic dysplasia##2##3##(2011-1#2)
with sequence##7##2##(1993-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-1#1)(2012-3#1)
with sequences##7##2##(1990-11#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-9#1)(2008-10#2)
with sequential injection##2##3##(2008-10#2)
with sequential##9##2##(2007-5#1)(2008-10#3)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
with sera from##2##3##(1997-3#1)(2008-4#1)
with serial dilutions of##2##4##(1994-3#2)
with serial##6##2##(1994-3#2)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
with serious and##2##3##(2011-2#1)(2013-1#1)
with serious consequences##2##3##(2007-4#1)(2008-5#1)
with serious mental##2##3##(1997-3#1)(2009-6#1)
with serious##20##2##(1990-6#1)(1992-2#2)(1997-3#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
with seronegative rheumatoid arthritis##2##4##(2006-10#1)(2013-1#1)
with seronegative##4##2##(1994-6#1)(2006-10#2)(2013-1#1)
with serotonin##2##2##(1993-12#1)(1993-9#1)
with serum creatinine##3##3##(2008-1#2)(2013-1#1)
with serum levels of##2##4##(2008-6#1)(2011-1#1)
with serum samples##2##3##(1997-4#1)(2008-5#1)
with serum##28##2##(1990-3#1)(1991-12#2)(1992-11#1)(1992-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
with serum-free medium##3##3##(2008-11#2)(2012-12#1)
with serum-free##4##2##(1994-6#1)(2008-11#2)(2012-12#1)
with service##5##2##(1993-12#1)(2008-11#1)(2009-6#1)(2011-1#1)(2012-3#1)
with services##3##2##(1992-1#1)(1996-2#1)(2008-12#1)
with seven different##2##3##(2008-3#1)(2008-6#1)
with seven##18##2##(1992-12#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
with sever hemophilia A##2##4##(2008-12#2)
with several agents##2##3##(1992-12#1)(2008-8#1)
with several clinical##2##3##(2011-2#1)(2013-1#1)
with several of the##2##4##(1990-11#1)(2008-10#1)
with several other proteins##2##4##(2009-7#1)(2012-2#1)
with several other##8##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-2#2)
with several regions of##2##4##(1992-9#1)(1993-11#1)
with several sexual partners##2##4##(2008-5#1)(2013-1#1)
with several statistical##2##3##(2008-10#1)(2011-2#1)
with several types of##2##4##(1994-11#1)(1994-3#1)
with several##100##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-4#3)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#25)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#5)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#1)
with severe abdominal pain##2##4##(2011-2#1)(2013-8#1)
with severe acute##6##3##(1990-12#1)(1992-3#1)(1997-1#1)(2009-8#1)(2013-1#1)(2013-8#1)
with severe and##3##3##(1997-2#2)(2010-1#1)
with severe anemia##2##3##(1992-3#1)(2012-3#1)
with severe aortic##2##3##(2007-8#1)(2008-11#1)
with severe aplastic##2##3##(2009-2#1)(2012-3#1)
with severe burns##2##3##(2008-10#1)(2008-7#1)
with severe chronic##2##3##(1991-3#1)(2008-4#1)
with severe coronary artery##2##4##(2011-2#1)(2013-1#1)
with severe coronary##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
with severe disease##3##3##(2011-2#2)(2013-1#1)
with severe fibrosis##2##3##(2013-1#1)(2013-8#1)
with severe haemophilia##2##3##(2009-3#2)
with severe heart failure##2##4##(2007-8#1)(2010-5#1)
with severe hemophilia##2##3##(2009-3#1)(2012-12#1)
with severe hypertension##2##3##(1990-12#1)(1995-11#1)
with severe hypothermia##2##3##(1993-3#1)(2011-2#1)
with severe lower respiratory tract##2##5##(1996-3#1)(2009-3#1)
with severe mental##4##3##(1991-3#1)(1993-1#1)(1993-3#1)(2010-1#1)
with severe mitral##2##3##(2009-5#1)(2010-5#1)
with severe obesity##3##3##(2006-8#3)
with severe pain##2##3##(2009-3#2)
with severe preeclampsia and neurologic deficits##2##6##(2007-10#2)
with severe preeclampsia##3##3##(2007-10#3)
with severe prune belly syndrome##2##5##(2008-7#2)
with severe refractory##2##3##(2010-5#1)(2012-12#1)
with severe respiratory syncytial virus bronchiolitis##2##6##(1994-6#2)
with severe respiratory##4##3##(1994-6#2)(1996-6#1)(2012-12#1)
with severe sepsis##11##3##(2007-12#2)(2009-5#1)(2009-6#5)(2011-2#3)
with severe symptomatic thyroid storm##2##5##(2012-12#2)
with severe underlying##2##3##(2008-5#1)(2011-2#1)
with severe##188##2##(1990-10#1)(1990-12#2)(1990-9#3)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1994-12#2)(1994-6#2)(1995-11#1)(1995-5#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-8#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#6)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#8)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#4)(2010-6#2)(2011-1#1)(2011-2#18)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#7)
with severely impaired##2##3##(2008-7#1)(2009-6#1)
with severely##4##2##(1992-9#1)(2008-4#1)(2008-7#1)(2009-6#1)
with severity and outcome##2##4##(2007-10#2)
with severity of##8##3##(1991-9#1)(1996-12#1)(1996-7#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
with severity##10##2##(1991-9#1)(1996-12#1)(1996-7#1)(2007-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
with sevoflurane##4##2##(2010-7#1)(2011-2#2)(2012-12#1)
with sex chromosomes##2##3##(2008-8#1)(2010-3#1)
with sex##5##2##(1991-6#1)(2008-8#1)(2010-3#1)(2011-2#2)
with sexual##10##2##(1990-7#1)(1992-2#1)(1995-12#1)(1996-5#1)(2009-5#2)(2009-7#1)(2010-4#1)(2013-1#2)
with sexually transmitted##2##3##(1996-12#2)
with sexually##3##2##(1996-12#2)(1996-5#1)
with shaking##2##2##(1996-12#2)
with sham##2##2##(1993-3#1)(2012-3#1)
with shampoo##2##2##(2008-5#2)
with sharp##5##2##(2008-3#2)(2009-11#1)(2010-11#1)(2010-7#1)
with shedding##2##2##(1996-2#1)(2012-3#1)
with sheep red blood cells (SRBC)##3##6##(2008-10#1)(2008-4#1)(2008-7#1)
with sheep red blood cells##6##5##(2008-10#3)(2008-4#1)(2008-7#2)
with sheep##7##2##(2008-10#3)(2008-4#1)(2008-7#2)(2010-4#1)
with shifts##2##2##(1995-5#1)(2010-3#1)
with short acting beta agonist use##2##6##(2012-1#2)
with short stature##3##3##(2007-11#1)(2011-1#1)(2012-2#1)
with short##25##2##(1993-12#1)(1994-1#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
with short-range##2##2##(1992-5#1)(2008-8#1)
with short-term##4##2##(1995-5#1)(1996-5#1)(2007-8#1)(2008-11#1)
with shortening##2##2##(2012-2#1)(2013-1#1)
with shorter ventilatory support##2##4##(2007-8#2)
with shorter##11##2##(1993-10#1)(1995-4#1)(1997-5#1)(2007-8#3)(2008-4#2)(2008-6#1)(2008-9#1)(2013-1#1)
with shot-noise-limited##2##2##(2007-12#1)(2008-2#1)
with shoulder##9##2##(1996-2#1)(1996-9#1)(2007-11#3)(2008-12#1)(2009-7#1)(2013-1#2)
with shrinking##2##2##(1996-2#1)(2008-12#1)
with shunt##2##2##(2012-12#2)
with sialidase##2##2##(1992-9#1)(1993-11#1)
with sickle cell anaemia and##2##5##(2009-4#2)
with sickle cell anaemia##3##4##(2009-4#3)
with sickle cell disease##5##4##(2009-2#1)(2009-4#1)(2010-11#1)(2012-12#1)(2013-1#1)
with sickle cell##8##3##(2009-2#1)(2009-4#4)(2010-11#1)(2012-12#1)(2013-1#1)
with sickle-cell disease##3##3##(2006-5#1)(2008-10#2)
with sickle-cell##5##2##(2006-5#1)(2008-10#2)(2009-10#1)(2013-1#1)
with side effects##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
with side##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
with signal##7##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
with signaling##2##2##(2009-6#1)(2011-2#1)
with significant (P&lt##3##3##(2008-5#1)(2010-5#2)
with significant changes in##2##4##(2008-3#1)(2010-6#1)
with significant clinical##2##3##(2008-4#1)(2010-8#1)
with significant differences between##2##4##(1993-2#1)(2013-7#1)
with significant differences##5##3##(1993-2#1)(2008-5#2)(2011-2#1)(2013-7#1)
with significant improvement in##2##4##(2008-1#1)(2008-3#1)
with significant increases in##3##4##(1995-5#1)(2008-1#1)(2010-12#1)
with significant increases##4##3##(1995-5#1)(2008-1#1)(2008-10#1)(2010-12#1)
with significant interaction##2##3##(2012-6#2)
with significant reduction in##3##4##(1990-5#1)(1996-12#1)(2011-1#1)
with significant reductions in##4##4##(1994-6#1)(1995-1#1)(2008-10#2)
with significant reductions##5##3##(1994-6#1)(1995-1#1)(1995-5#1)(2008-10#2)
with significant similarity to##2##4##(1991-6#1)(1994-12#1)
with significant structural##2##3##(1996-2#1)(2012-2#1)
with significant##91##2##(1990-5#2)(1990-6#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-12#3)(1996-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#4)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#2)(2012-3#2)(2012-6#2)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#3)
with significantly different##5##3##(1991-12#1)(2008-10#2)(2009-6#1)(2012-3#1)
with significantly greater##2##3##(2008-10#2)
with significantly high##2##3##(2008-10#1)(2010-5#1)
with significantly higher##6##3##(1994-2#1)(2007-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-8#1)
with significantly increased##2##3##(2008-9#1)(2012-2#1)
with significantly lower##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
with significantly more##2##3##(2008-10#1)(2012-2#1)
with significantly reduced##2##3##(1993-9#1)(2008-2#1)
with significantly##28##2##(1991-12#1)(1993-3#1)(1993-9#2)(1994-2#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
with signs and symptoms##3##4##(2007-8#1)(2008-11#2)
with signs and##4##3##(2007-8#1)(2008-1#1)(2008-11#2)
with signs of##5##3##(1991-11#1)(1995-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
with signs##9##2##(1991-11#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2013-1#1)
with silent myocardial ischemia##3##4##(1992-6#1)(2008-7#2)
with silent##6##2##(1991-11#1)(1992-6#1)(2008-7#3)(2009-8#1)
with silica gel##9##3##(2008-10#9)
with silica##14##2##(2008-10#11)(2008-12#1)(2009-8#1)(2010-7#1)
with silicon##6##2##(2007-11#1)(2008-10#3)(2008-3#1)(2010-4#1)
with silicone##2##2##(2008-10#1)(2008-9#1)
with silicotungstic acid in acidic medium to form a##2##9##(2008-10#2)
with silver##13##2##(1991-1#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-8#1)
with silylated bases##2##3##(1996-5#2)
with silylated thymine##2##3##(1996-5#2)
with silylated##4##2##(1996-5#4)
with simian##2##2##(1995-2#1)(2013-1#1)
with similar binding##3##3##(1991-5#1)(1993-6#1)(2012-2#1)
with similar characteristics##2##3##(1994-12#1)(2007-5#1)
with similar clinical##2##3##(1995-2#1)(2013-8#1)
with similar efficacy##2##3##(1994-3#1)(2008-10#1)
with similar efficiency##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
with similar expression profiles##2##4##(2008-2#2)
with similar magnitude##3##3##(2008-10#1)(2008-11#2)
with similar mechanisms##2##3##(2008-10#1)(2011-1#1)
with similar molecular##2##3##(1990-12#1)(1994-6#1)
with similar potency##3##3##(1995-12#1)(1997-1#1)(2008-12#1)
with similar results##6##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
with similar##111##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#3)(1991-5#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-7#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#2)(2013-8#1)
with similarity to##2##3##(2008-10#2)
with similarity##3##2##(2008-10#2)(2012-2#1)
with simple sequence repeat##2##4##(2008-10#1)(2008-9#1)
with simple##20##2##(1990-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
with simulated and real data##2##5##(2008-3#1)(2009-9#1)
with simulated and real##3##4##(2008-10#1)(2008-3#1)(2009-9#1)
with simulated and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
with simulated data##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
with simulated##18##2##(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#6)(2008-7#1)(2009-9#1)(2010-3#1)(2011-1#1)
with simulation##2##2##(2009-2#1)(2012-12#1)
with simulations and##2##3##(1994-9#1)(2010-1#1)
with simulations##12##2##(1994-9#1)(1995-2#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2010-1#1)
with simultaneous addition of three analytes##2##6##(2008-10#2)
with simultaneous##27##2##(1994-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
with simultaneously##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
with simvastatin##3##2##(1991-6#1)(1997-5#1)(2012-2#1)
with single amino acid##2##4##(1994-5#1)(2008-8#1)
with single dose##2##3##(1993-2#2)
with single extraction##2##3##(2008-10#2)
with single output##2##3##(2008-10#2)
with single##39##2##(1992-2#1)(1993-2#2)(1994-5#2)(2007-10#1)(2007-11#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
with single-agent##2##2##(2008-6#2)
with single-base##2##2##(2008-10#1)(2008-9#1)
with single-gene##2##2##(2009-5#2)
with single-level C-ADR##2##3##(2012-12#2)
with single-level##3##2##(2012-12#3)
with single-pass##3##2##(2007-12#1)(2008-2#2)
with single-photon##2##2##(2007-12#1)(2008-3#1)
with single-stage##2##2##(2007-11#1)(2008-8#1)
with single-stranded (ss)##2##3##(2008-10#1)(2008-2#1)
with single-walled##2##2##(2008-7#2)
with sinus##3##2##(2008-7#2)(2012-12#1)
with site##3##2##(1992-12#1)(2008-10#1)(2012-12#1)
with site-directed##2##2##(1995-2#1)(2008-4#1)
with sites of##2##3##(1996-5#1)(2008-10#1)
with sites##4##2##(1996-5#1)(2008-10#3)
with situs inversus##3##3##(1993-9#1)(2008-7#1)(2009-8#1)
with six primary##2##3##(1990-12#1)(2013-8#1)
with six##23##2##(1990-12#1)(1990-8#1)(1991-8#1)(1993-1#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-7#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
with size of##2##3##(1997-3#1)(2013-7#1)
with size parameters##2##3##(2008-2#1)(2008-3#1)
with size##7##2##(1995-6#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2013-7#1)
with sizes distributed according to##2##5##(2008-2#2)
with sizes of##2##3##(1993-2#1)(2008-7#1)
with sizes##5##2##(1992-8#1)(1993-2#1)(2008-2#2)(2008-7#1)
with skeletal metastases##3##3##(2007-11#2)(2008-7#1)
with skeletal muscle##3##3##(1994-6#1)(1995-2#1)(2011-1#1)
with skeletal##9##2##(1994-6#1)(1995-2#1)(2007-11#2)(2008-7#2)(2009-7#1)(2011-1#1)(2013-8#1)
with skilled##3##2##(1995-5#1)(2008-11#1)(2011-1#1)
with skimmer interface##3##3##(2008-10#3)
with skin and##2##3##(2007-10#1)(2008-2#1)
with skin types I##2##4##(2008-5#1)(2011-2#1)
with skin##15##2##(1991-8#1)(1992-8#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-9#1)(2010-6#1)(2011-2#1)
with sleep and##2##3##(1993-3#1)(2011-2#1)
with sleep##4##2##(1993-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
with slight##2##2##(2008-10#1)(2008-5#1)
with slightly##5##2##(1994-11#1)(2008-10#1)(2008-7#2)(2010-6#1)
with slope##5##2##(2007-11#1)(2008-10#3)(2008-9#1)
with slopes##3##2##(2008-10#3)
with slow##8##2##(1994-3#1)(1995-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
with slower##3##2##(1993-12#1)(2007-12#1)(2009-8#1)
with slowly##2##2##(2008-8#1)(2013-1#1)
with slurry##4##2##(2008-10#3)(2008-6#1)
with small cell carcinoma##3##4##(2009-1#1)(2009-3#2)
with small cell##4##3##(1996-2#1)(2009-1#1)(2009-3#2)
with small changes in##2##4##(2010-7#1)(2012-1#1)
with small doses##2##3##(2008-7#1)(2011-1#1)
with small molecule##2##3##(2010-3#1)(2010-5#1)
with small or##2##3##(1996-12#1)(2008-9#1)
with small surface##3##3##(1990-8#1)(2008-3#1)(2010-4#1)
with small##55##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-8#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
with smaller ones##2##3##(1993-9#1)(2008-10#1)
with smaller##16##2##(1990-12#2)(1993-9#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-12#1)
with smokers##3##2##(1993-11#1)(2009-7#1)(2013-1#1)
with smoking cessation##2##3##(2008-7#1)(2010-2#1)
with smoking##15##2##(1990-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#3)
with smooth muscle cells##2##4##(2010-12#1)(2012-2#1)
with smooth muscle##6##3##(1991-6#1)(1997-8#1)(2010-12#3)(2012-2#1)
with smooth##7##2##(1991-6#1)(1997-8#1)(2009-11#1)(2010-12#3)(2012-2#1)
with snow##2##2##(2008-3#2)
with so-called##2##2##(1990-8#1)(2008-10#1)
with social phobia##3##3##(2008-4#3)
with social##13##2##(1991-12#1)(1993-3#1)(1996-11#1)(2007-2#1)(2008-11#1)(2008-4#3)(2008-6#1)(2009-10#1)(2010-10#1)(2010-4#1)(2013-1#1)
with society##2##2##(1994-2#1)(2008-12#1)
with sodium borohydride##4##3##(1990-7#1)(2008-10#3)
with sodium bromide##2##3##(1991-5#1)(2008-9#1)
with sodium cyclotetramethylenedithiocarbamate##2##3##(2008-10#2)
with sodium diethyldithiocarbamate##2##3##(2008-10#2)
with sodium dodecyl sulfate##2##4##(1991-12#1)(2008-10#1)
with sodium dodecyl##4##3##(1991-12#1)(1994-2#1)(2008-10#2)
with sodium dodecylsulfate##2##3##(1991-12#1)(2013-8#1)
with sodium fluoride##4##3##(1990-2#1)(1991-11#2)(1996-2#1)
with sodium hydroxide and##2##4##(2008-10#1)(2013-1#1)
with sodium hydroxide##6##3##(2008-10#5)(2013-1#1)
with sodium tetraphenyl borate##2##4##(2008-10#2)
with sodium tetraphenylborate##2##3##(2008-10#2)
with sodium##65##2##(1990-2#2)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#2)(1991-5#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#29)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2010-11#1)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
with soft tissue sarcoma (STS)##2##5##(2008-6#2)
with soft tissue sarcoma##4##4##(2008-6#4)
with soft tissue sarcomas##7##4##(2008-6#7)
with soft tissue##17##3##(1995-2#1)(2008-12#1)(2008-4#1)(2008-6#11)(2008-9#1)(2009-3#1)(2012-12#1)
with soft##20##2##(1991-2#1)(1995-2#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-6#11)(2008-9#1)(2009-3#1)(2012-12#2)
with soft-tissue sarcoma##2##3##(1991-8#1)(2008-6#1)
with soft-tissue##3##2##(1991-8#1)(2008-6#1)(2013-7#1)
with software##2##2##(2009-12#1)(2011-2#1)
with soil##9##2##(1995-11#1)(2008-10#3)(2008-11#2)(2011-2#1)(2013-7#1)(2013-8#1)
with soils##2##2##(2008-10#2)
with solar##2##2##(2008-2#1)(2010-1#1)
with solid phase extraction##4##4##(2008-10#4)
with solid phase##5##3##(2008-10#4)(2011-2#1)
with solid tumors##6##3##(2008-7#4)(2010-10#1)(2010-11#1)
with solid##15##2##(2008-10#6)(2008-7#4)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
with solid-phase##5##2##(1997-4#1)(2008-10#4)
with solid-state##2##2##(2008-10#1)(2008-3#1)
with solitary##3##2##(1990-12#1)(2010-3#1)(2013-1#1)
with soluble##6##2##(1995-11#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
with solution##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
with solutions of##3##3##(2008-10#3)
with solutions##5##2##(2008-10#4)(2008-5#1)
with solvent##3##2##(1995-2#1)(2008-10#2)
with somatic##4##2##(1997-2#1)(2008-9#1)(2011-1#1)(2012-1#1)
with somatostatin##2##2##(1990-5#1)(1997-4#1)
with some advantages and##2##4##(2008-10#1)(2009-2#1)
with some aromatic##2##3##(2008-10#1)(2011-3#1)
with some of the##5##4##(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2011-2#1)
with some of##8##3##(1995-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)
with some other##4##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
with some practical##2##3##(1993-2#1)(2013-8#1)
with some previous##2##3##(2008-12#1)(2012-1#1)
with some promising##2##3##(1992-3#1)(2011-3#1)
with some risk##2##3##(2009-4#1)(2013-8#1)
with some specificity for##2##4##(1994-2#1)(1994-8#1)
with some success##4##3##(1991-9#1)(2009-5#1)(2010-6#1)(2012-3#1)
with some thoughts on##2##4##(2008-6#1)(2010-11#1)
with some thoughts##4##3##(2008-2#1)(2008-6#1)(2010-11#2)
with some types of##2##4##(2008-10#1)(2008-7#1)
with some##146##2##(1990-5#2)(1991-1#2)(1991-10#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#34)(2008-11#6)(2008-12#6)(2008-2#4)(2008-3#2)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-11#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#2)
with someone##3##2##(1994-2#1)(2008-6#1)(2012-12#1)
with sonography##2##2##(1997-8#1)(2008-8#1)
with soy##2##2##(1996-2#1)(2010-12#1)
with soya flour##2##3##(1993-12#1)(1997-2#1)
with soybean PC##2##3##(1995-8#2)
with soybean resulted##2##3##(2008-10#1)(2008-12#1)
with soybean##7##2##(1990-12#1)(1990-2#1)(1995-8#2)(2008-10#2)(2008-12#1)
with space group##3##3##(1992-8#1)(2008-8#1)(2013-1#1)
with sparing of##2##3##(1992-3#1)(2008-9#1)
with sparse##2##2##(2008-10#2)
with spatial##13##2##(1991-5#1)(1993-12#1)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-10#1)
with spatially incoherent##2##3##(2008-3#2)
with spatially##11##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)
with special attention to the##2##5##(1993-12#1)(2008-7#1)
with special attention to##10##4##(1993-12#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)
with special attention##11##3##(1993-12#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
with special consideration being given to##2##6##(1990-6#1)(2009-6#1)
with special consideration##4##3##(1990-6#1)(2008-2#1)(2008-6#1)(2009-6#1)
with special emphasis on the##6##5##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
with special emphasis on##26##4##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
with special emphasis##27##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
with special focus on##2##4##(1990-6#1)(2011-2#1)
with special health care needs##15##5##(1991-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2008-11#1)(2011-1#1)
with special health needs##2##4##(1992-2#1)(1994-3#1)
with special health##17##3##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2008-11#1)(2011-1#1)
with special interest##2##3##(1991-3#1)(2013-1#1)
with special needs in##2##4##(1997-2#1)(2012-3#1)
with special needs##8##3##(1991-12#1)(1991-3#1)(1997-2#2)(2008-12#1)(2012-3#3)
with special reference to##12##4##(1990-9#1)(1991-2#1)(1991-5#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
with special regard to the##2##5##(1991-6#1)(2008-10#1)
with special regard to##4##4##(1991-6#1)(2007-11#2)(2008-10#1)
with special##92##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#2)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1996-3#1)(1996-6#1)(1997-2#4)(1997-5#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
with specialised##2##2##(2008-11#1)(2011-2#1)
with specialized services##2##3##(1996-1#1)(1997-3#1)
with specialized##8##2##(1991-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-2#1)
with species##3##2##(2008-6#1)(2008-9#1)(2011-1#1)
with species-specific##3##2##(2008-12#1)(2012-2#1)(2012-8#1)
with specific antibodies##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
with specific examples##4##3##(1994-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
with specific focus on##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
with specific primers##3##3##(1997-8#1)(2008-10#2)
with specific reference to##4##4##(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)
with specific sequence##2##3##(2008-10#1)(2013-8#1)
with specific stress##2##3##(1990-6#1)(2011-2#1)
with specific virulence to major resistance genes##2##7##(2008-10#2)
with specific virulence to##3##4##(2008-10#3)
with specific##92##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#6)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
with specificity for##2##3##(1992-8#1)(2008-4#1)
with specified##2##2##(2007-12#1)(2010-12#1)
with speckle##2##2##(2008-2#1)(2008-3#1)
with spectra##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
with spectral filters and precision tinted ophthalmic lenses##3##8##(2013-1#3)
with spectral holography##2##3##(2008-3#2)
with spectral overlapping##2##3##(2008-10#2)
with spectral##14##2##(1995-5#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#3)(2013-1#3)
with spectrally##3##2##(2007-12#2)(2008-2#1)
with spectrophotometric detection is##2##4##(2008-10#2)
with spectrophotometric detection using##2##4##(2008-10#2)
with spectrophotometric detection##13##3##(2008-10#13)
with spectrophotometric##18##2##(2008-10#18)
with spectrophotometry##4##2##(2008-10#4)
with spectroscopic data##2##3##(2008-3#1)(2011-2#1)
with spectroscopic ellipsometry##2##3##(2008-2#1)(2008-3#1)
with spectroscopic##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
with speech##2##2##(2008-11#1)(2009-11#1)
with speed##2##2##(2008-11#1)(2012-12#1)
with sperm##2##2##(1997-6#1)(2012-2#1)
with spermatozoa##2##2##(2007-12#1)(2013-1#1)
with spherical surfaces and##2##4##(2008-2#1)(2008-3#1)
with spherical##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
with spiked##4##2##(2008-10#4)
with spina bifida##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
with spinal cord injuries##5##4##(1991-6#2)(2007-8#1)(2008-11#1)(2008-5#1)
with spinal cord injury##6##4##(1993-2#1)(2007-11#1)(2008-7#2)(2013-1#2)
with spinal cord##15##3##(1991-6#4)(1993-2#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#2)
with spinal fusion##2##3##(2012-12#1)(2012-3#1)
with spinal metastases##5##3##(2007-11#5)
with spinal##34##2##(1991-6#4)(1992-11#1)(1993-10#1)(1993-2#2)(2007-11#8)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
with spine##2##2##(2007-11#2)
with spleen##2##2##(1996-2#1)(1997-8#1)
with splenic##3##2##(1992-2#1)(2008-7#1)(2011-2#1)
with spondyloarthritis##2##2##(2012-12#2)
with spontaneous clearance of hepatitis C virus##2##7##(2012-2#2)
with spontaneous clearance of##3##4##(2012-2#3)
with spontaneous pneumothorax##4##3##(1991-6#1)(2006-10#1)(2008-1#1)(2008-7#1)
with spontaneous##23##2##(1990-11#1)(1991-6#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)
with sporadic AD##2##3##(1994-8#2)
with sporadic Alzheimer disease##2##4##(1990-3#2)
with sporadic##9##2##(1990-3#2)(1994-8#2)(1994-9#1)(2007-7#1)(2008-1#2)(2011-2#1)
with spore##2##2##(1995-3#1)(2008-10#1)
with spores of##2##3##(2008-10#1)(2011-2#1)
with spores##4##2##(2008-10#1)(2010-10#1)(2011-2#2)
with sporulating lesions##2##3##(2008-10#2)
with sporulation##2##2##(2008-10#2)
with spot##3##2##(2007-11#1)(2008-3#1)(2008-4#1)
with spring##2##2##(2008-10#2)
with squamous cell carcinoma of the esophagus##2##7##(1993-8#1)(2013-8#1)
with squamous cell carcinoma##6##4##(1993-8#1)(2007-7#2)(2010-8#1)(2012-1#1)(2013-8#1)
with squamous##9##2##(1993-8#1)(1994-9#1)(2007-7#2)(2009-6#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
with square-wave##2##2##(2008-10#2)
with ssDNA##4##2##(2008-10#2)(2008-4#2)
with stability##2##2##(2008-10#1)(2010-4#1)
with stable angina##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
with stable disease##2##3##(1990-2#1)(1992-12#1)
with stable##19##2##(1990-2#1)(1992-12#1)(1994-8#1)(1997-1#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#3)
with staff in##2##3##(2006-5#1)(2010-10#1)
with staff##7##2##(1996-1#1)(2006-5#1)(2008-11#1)(2010-10#2)(2012-3#1)(2013-1#1)
with stage II##2##3##(1997-7#1)(2006-10#1)
with stage III##4##3##(1990-9#1)(1991-11#1)(2008-10#1)(2008-6#1)
with stage IIIC and IV disease##2##6##(2011-2#2)
with stage IIIC and IV ovarian cancer##2##7##(2011-2#2)
with stage IIIC and IV##4##5##(2011-2#4)
with stage IIIC##5##3##(2011-2#5)
with stage##23##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1992-12#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#2)(2010-4#1)(2011-2#6)(2012-2#1)(2013-1#1)
with staghorn##2##2##(2007-7#2)
with stainless steel##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
with stakeholders##2##2##(2013-1#2)
with standard and##2##3##(2008-7#1)(2012-1#1)
with standard deviation##2##3##(2008-10#1)(2010-5#1)
with standard deviations##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
with standard methods for the##2##5##(2008-5#1)(2009-11#1)
with standard methods##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)
with standard solutions##2##3##(2008-10#2)
with standard##72##2##(1993-12#1)(1994-3#1)(1996-11#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-10#20)(2008-11#2)(2008-3#11)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#2)(2010-1#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
with standardized##6##2##(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#1)
with standards in##2##3##(2008-10#2)
with standards##4##2##(2008-10#3)(2013-1#1)
with state##2##2##(1996-12#1)(1997-1#1)
with state-of-the-art##3##2##(1997-8#1)(2008-2#1)(2008-3#1)
with static##4##2##(2008-10#1)(2008-2#1)(2011-2#2)
with statin##2##2##(2013-1#1)(2013-8#1)
with statins##5##2##(2008-1#2)(2008-3#1)(2012-2#1)(2013-8#1)
with stationary##2##2##(2008-10#1)(2008-9#1)
with statistical regression##2##3##(2008-10#1)(2011-1#1)
with statistical significance##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
with statistical##14##2##(1990-2#1)(1994-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
with statistically significant differences##2##4##(1994-2#1)(2011-2#1)
with statistically##4##2##(1994-2#1)(2008-10#1)(2010-7#1)(2011-2#1)
with statutory##2##2##(1992-12#1)(2012-1#1)
with staurosporine##3##2##(1990-12#1)(1993-6#1)(2008-11#1)
with steady-state##2##2##(1992-6#1)(2008-2#1)
with stearic acid##2##3##(1991-3#1)(2008-10#1)
with stem cell##3##3##(1996-11#1)(2008-7#1)(2013-8#1)
with stem##6##2##(1996-11#1)(2008-10#2)(2008-7#1)(2013-8#2)
with stenosis##3##2##(1990-9#1)(1993-8#2)
with stent-assisted##2##2##(2012-3#2)
with sterile##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
with steroid##6##2##(1992-11#1)(1993-8#1)(2006-10#1)(2007-7#3)
with steroids and##2##3##(2008-1#1)(2012-2#1)
with steroids##6##2##(1992-5#1)(1996-11#1)(2007-7#1)(2008-1#1)(2009-3#1)(2012-2#1)
with sterols##2##2##(1992-3#1)(1994-2#1)
with stock##2##2##(2011-2#1)(2013-7#1)
with stomach##2##2##(1992-5#1)(2007-8#1)
with straight##2##2##(1992-3#1)(1992-8#1)
with strain 2##2##3##(1991-8#2)
with strain##13##2##(1991-8#4)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)
with strained##2##2##(2007-11#1)(2012-2#1)
with strains from##5##3##(2008-10#4)(2011-2#1)
with strains in##2##3##(2008-5#1)(2012-3#1)
with strains of##3##3##(2008-10#3)
with strains##15##2##(1996-2#1)(1997-3#1)(1997-7#1)(2008-10#9)(2008-5#1)(2011-2#1)(2012-3#1)
with strategies##2##2##(2008-4#2)
with streamlined##2##2##(2008-7#1)(2009-10#1)
with streptomycin sulfate##2##3##(2008-10#1)(2008-8#1)
with streptomycin##5##2##(2008-10#3)(2008-8#1)(2010-3#1)
with stress levels##2##3##(2008-7#1)(2010-10#1)
with stress##8##2##(1994-6#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#2)(2012-2#1)
with stress-induced birefringence##3##3##(2008-2#1)(2008-3#2)
with striated skeletal muscle##2##4##(1993-12#2)
with striated##3##2##(1993-12#2)(1995-12#1)
with strict##2##2##(2008-3#1)(2009-3#1)
with strictly##2##2##(1990-6#1)(1992-3#1)
with striking##5##2##(1990-5#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
with stringent##3##2##(1995-1#1)(2008-10#1)(2008-7#1)
with stroke and##5##3##(1990-3#1)(1995-3#1)(2007-10#2)(2013-1#1)
with stroke##25##2##(1990-3#1)(1995-3#1)(2007-10#19)(2008-2#1)(2008-8#1)(2013-1#2)
with strong absorption##3##3##(2008-2#2)(2008-3#1)
with strong connections to##2##4##(1996-2#1)(2013-1#1)
with strong homology to##2##4##(1996-6#1)(1997-7#1)
with strong peer connections##2##4##(2013-1#2)
with strong##56##2##(1991-7#1)(1992-8#2)(1993-12#2)(1995-11#2)(1996-2#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
with stronger##5##2##(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)(2012-2#1)
with strongly##3##2##(1997-7#1)(2007-12#1)(2011-1#1)
with structural##6##2##(1992-6#1)(1997-9#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-7#1)
with structurally normal heart##2##4##(2008-12#1)(2008-7#1)
with structurally##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
with structure##3##2##(1990-7#1)(1992-8#1)(2010-4#1)
with structured##2##2##(2008-11#1)(2008-2#1)
with structures##4##2##(1990-7#1)(1997-6#1)(2007-12#1)(2012-2#1)
with students and##2##3##(1990-12#1)(2008-12#1)
with students who##3##3##(2008-11#2)(2011-2#1)
with students##10##2##(1990-12#1)(2008-11#2)(2008-12#3)(2010-3#1)(2011-2#2)(2012-3#1)
with studies of##2##3##(1991-5#1)(2008-8#1)
with studies##8##2##(1991-5#1)(1992-12#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)
with styrene##3##2##(1996-5#1)(2008-10#1)(2008-12#1)
with subacute##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
with subarachnoid haemorrhage (SAH)##4##4##(2008-7#4)
with subarachnoid haemorrhage##11##3##(1996-9#1)(1997-3#1)(2008-7#9)
with subarachnoid hemorrhage##2##3##(1991-8#1)(1995-11#1)
with subarachnoid hemorrhages##2##3##(2008-12#1)(2011-2#1)
with subarachnoid##15##2##(1991-8#1)(1995-11#1)(1996-9#1)(1997-3#1)(2008-12#1)(2008-7#9)(2011-2#1)
with subcutaneous##2##2##(1992-12#1)(2009-12#1)
with subcycle##2##2##(2007-11#1)(2007-12#1)
with subdivision##2##2##(2008-6#1)(2008-8#1)
with subdural##2##2##(2008-11#1)(2009-9#1)
with subjective and objective##2##4##(1992-9#1)(2008-9#1)
with subjective physical changes##2##4##(2007-12#2)
with subjective##5##2##(1992-9#1)(2007-12#2)(2008-7#1)(2008-9#1)
with subjects who##2##3##(1993-9#1)(2008-12#1)
with subjects##4##2##(1993-9#1)(2008-12#2)(2013-1#1)
with submicrometer resolution##3##3##(2007-12#1)(2008-3#2)
with submicrometer##6##2##(2007-12#2)(2008-3#4)
with submillimeter##2##2##(2008-2#1)(2008-3#1)
with subsequent acute##2##3##(2009-9#1)(2012-1#1)
with subsequent attachment of##2##4##(2008-10#2)
with subsequent determination##2##3##(2008-10#2)
with subsequent expansion of##2##4##(2007-12#1)(2013-7#1)
with subsequent fibrosis##2##3##(1992-5#1)(2013-1#1)
with subsequent joint exchange##3##4##(2007-11#3)
with subsequent joint##4##3##(2007-11#4)
with subsequent##56##2##(1990-12#2)(1990-3#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-11#7)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
with substance abuse##8##3##(1994-2#1)(1995-12#1)(1996-5#2)(2008-4#1)(2008-6#2)(2008-9#1)
with substance use disorders##5##4##(2008-6#2)(2009-10#1)(2009-9#1)(2010-6#1)
with substance use##8##3##(2008-5#1)(2008-6#2)(2009-10#1)(2009-11#2)(2009-9#1)(2010-6#1)
with substance##18##2##(1994-2#1)(1995-12#1)(1996-5#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
with substantial##8##2##(1991-2#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-8#1)
with substantially##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
with substituted##5##2##(1993-11#1)(2008-10#3)(2012-3#1)
with substitutions##3##2##(1990-7#1)(1992-6#1)(2009-3#1)
with substrate and##3##3##(1990-7#1)(1992-12#1)(2011-1#1)
with substrate binding##2##3##(1994-5#1)(2009-9#1)
with substrate##10##2##(1990-7#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2011-1#2)
with substrates##3##2##(1992-6#2)(2013-1#1)
with subtle##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
with subtotal##2##2##(2008-10#1)(2008-7#1)
with subtrochanteric femoral shortening osteotomy fixed with##2##7##(2013-1#2)
with subtrochanteric##3##2##(2009-3#1)(2013-1#2)
with subunit##2##2##(1990-8#1)(1994-8#1)
with subwavelength##6##2##(2007-12#4)(2008-3#2)
with success##9##2##(1992-11#1)(1992-3#1)(1993-3#2)(2007-11#1)(2008-6#1)(2009-2#1)(2011-2#1)(2013-8#1)
with successful##14##2##(1990-3#1)(1994-3#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#2)
with successive##2##2##(1992-3#1)(2008-11#1)
with such a##13##3##(1993-11#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2012-3#1)(2013-1#1)
with such patients##3##3##(2008-1#1)(2011-3#1)(2013-1#1)
with such##39##2##(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-2#2)(1996-3#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#5)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)
with sucrose and##3##3##(2008-10#1)(2011-2#2)
with sudden cardiac##2##3##(2008-11#1)(2013-8#1)
with sudden gains##2##3##(2009-11#2)
with sudden infant death syndrome##2##5##(1991-11#1)(1991-8#1)
with sudden onset of##5##4##(2008-10#2)(2008-7#3)
with sudden onset##7##3##(2008-10#2)(2008-7#4)(2013-1#1)
with sudden weakness##2##3##(2008-12#2)
with sudden##27##2##(1990-11#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-12#1)(2007-10#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#4)(2009-11#2)(2010-10#1)(2011-2#3)(2013-1#1)(2013-8#2)
with sufficient accuracy##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
with sufficient signal##2##3##(2008-3#2)
with sufficient##19##2##(1992-6#1)(1993-6#1)(1994-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2010-8#1)
with sufficiently##2##2##(1996-4#1)(2008-3#1)
with sugar##4##2##(1991-8#1)(2008-10#2)(2012-2#1)
with suggestions for##5##3##(1997-2#1)(2007-12#1)(2008-2#1)(2009-9#1)(2010-8#1)
with suggestions##7##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)
with suicidal##4##2##(1992-1#1)(1993-2#1)(2009-7#2)
with suitable##8##2##(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-1#1)
with suitably chosen##2##3##(2007-11#1)(2008-3#1)
with sulfanilamide and##2##3##(2008-10#2)
with sulfanilamide##3##2##(2008-10#3)
with sulfate groups of heparin##2##5##(2008-10#2)
with sulfate groups##3##3##(2008-10#3)
with sulfate##5##2##(1997-6#1)(2008-10#3)(2013-1#1)
with sulfuric acid##2##3##(2008-10#2)
with sulphuric acid and##2##4##(2008-10#1)(2008-5#1)
with sulphuric acid##3##3##(2008-10#2)(2008-5#1)
with sulpiride##3##2##(1991-1#1)(1992-9#2)
with supercritical carbon dioxide##3##4##(2008-10#3)
with supercritical fluid extraction##2##4##(2008-10#2)
with supercritical fluid##5##3##(2008-10#5)
with supercritical##9##2##(2008-10#9)
with superimposed##2##2##(2008-3#1)(2010-12#1)
with superior##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
with supernatants of##2##3##(1992-3#1)(2008-10#1)
with superoxide##5##2##(1991-9#1)(1994-6#1)(1995-6#1)(1996-5#1)(2011-2#1)
with supported entry##2##3##(2008-11#2)
with supporting##2##2##(1994-12#1)(2008-3#1)
with supportive##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
with suppressed##2##2##(2008-10#2)
with suppression of##3##3##(1993-12#2)(2008-10#1)
with suppression##5##2##(1993-12#2)(2008-10#2)(2012-3#1)
with suppressiveness##2##2##(2008-10#2)
with surface plasmons##2##3##(2007-12#1)(2008-7#1)
with surface##18##2##(1990-10#1)(1990-4#1)(1990-6#1)(1992-6#1)(1997-8#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-11#1)(2010-2#1)(2012-2#1)
with surface-breaking##2##2##(2007-11#2)
with surfaces and matrices##2##4##(1990-2#2)
with surfaces##3##2##(1990-2#2)(2009-12#1)
with surfactant##4##2##(1990-11#1)(1997-2#1)(2008-10#2)
with surgery alone##5##3##(1991-8#1)(1995-5#1)(2012-3#2)(2013-8#1)
with surgery and chemotherapy##2##4##(2012-3#2)
with surgery and##3##3##(2011-2#1)(2012-3#2)
with surgery##18##2##(1991-8#1)(1992-11#1)(1995-5#1)(2007-11#3)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-8#2)
with surgical excision##5##3##(2008-10#1)(2009-4#1)(2010-5#1)(2012-1#2)
with surgical removal of##2##4##(1996-9#1)(2011-2#1)
with surgical##20##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
with surgically resected##2##3##(2010-12#1)(2012-1#1)
with surgically##5##2##(1990-2#1)(1997-5#1)(2008-11#1)(2010-12#1)(2012-1#1)
with surrounding##4##2##(1990-11#1)(1997-8#1)(2007-8#1)(2008-7#1)
with survival rates##2##3##(2008-10#1)(2008-7#1)
with survival##11##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-3#2)
with survivors##2##2##(2008-11#1)(2011-2#1)
with susceptibility to##5##3##(1995-5#1)(2008-1#1)(2008-10#2)(2013-1#1)
with susceptibility##7##2##(1995-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
with susceptible cvs##2##3##(2008-10#2)
with susceptible##11##2##(2008-10#9)(2008-12#2)
with suspected acute##5##3##(2008-3#3)(2011-2#2)
with suspected retroperitoneal##2##3##(2008-6#1)(2011-2#1)
with suspected##37##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1993-9#1)(1995-6#2)(1997-8#1)(2007-10#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
with suspended mirrors##3##3##(2008-3#3)
with suspended##4##2##(2008-3#3)(2013-1#1)
with suspicion of##4##3##(2007-11#1)(2008-12#1)(2010-10#1)(2010-12#1)
with sustained##4##2##(1990-3#1)(1991-3#1)(2008-3#1)(2010-12#1)
with sutures##2##2##(1994-2#1)(2008-9#1)
with sweet potato##3##3##(2008-10#3)
with swelling##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
with swollen##2##2##(1997-3#1)(2011-2#1)
with symmetric##2##2##(1993-8#1)(2008-10#1)
with symmetrical peak and##2##4##(2008-10#2)
with symmetrical##6##2##(2008-10#5)(2013-1#1)
with sympathovagal##2##2##(2012-2#1)(2013-8#1)
with symptom##6##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-1#1)
with symptomatic##20##2##(1993-1#1)(1993-12#1)(1993-2#1)(1997-4#1)(2007-10#3)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-8#1)(2011-2#2)(2012-3#1)
with symptoms and signs of##2##5##(2007-7#1)(2008-11#1)
with symptoms and##7##3##(1990-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2011-1#1)(2012-12#1)
with symptoms of##23##3##(1995-5#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
with symptoms##43##2##(1990-3#1)(1992-5#1)(1992-9#1)(1995-5#1)(1996-7#1)(1997-4#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2013-8#4)
with synaptic plasticity##2##3##(2009-8#1)(2011-2#1)
with synchronous##4##2##(1990-6#1)(2008-10#1)(2008-6#1)(2009-1#1)
with synchrotron radiation##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
with syndrome of differentiated dysplasia of connective##2##7##(2013-1#2)
with syndrome##3##2##(2008-12#1)(2013-1#2)
with syndromic##2##2##(2007-12#1)(2013-1#1)
with syngeneic spinal cord and incomplete Freund's adjuvant##2##8##(1995-12#2)
with synthetic fertilizers##2##3##(2008-10#2)
with synthetic peptides##2##3##(2008-4#1)(2010-11#1)
with synthetic##19##2##(1990-2#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-11#1)(2008-10#8)(2008-4#1)(2008-6#1)(2010-11#1)(2011-2#1)(2013-1#2)
with syringe##3##2##(2008-10#3)
with systematic##3##2##(2013-1#1)(2013-8#2)
with systemic antibiotics##3##3##(1994-12#2)(2013-8#1)
with systemic corticosteroids##2##3##(2008-5#1)(2013-1#1)
with systemic inflammatory##2##3##(2008-5#1)(2008-7#1)
with systemic lupus erythematosus##11##4##(1990-12#1)(1992-5#1)(1994-9#2)(2006-10#5)(2007-12#1)(2011-2#1)
with systemic lupus##12##3##(1990-12#1)(1992-5#1)(1994-9#2)(2006-10#5)(2007-12#1)(2011-2#1)(2013-1#1)
with systemic##37##2##(1990-12#1)(1991-11#1)(1992-5#1)(1994-12#2)(1994-9#2)(1995-12#1)(1996-6#1)(2006-10#5)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#1)
with systems##3##2##(1997-3#1)(2008-10#1)(2008-3#1)
with systolic##4##2##(1992-2#1)(2007-8#1)(2011-2#1)(2013-7#1)
with t(2##2##2##(1993-2#1)(2009-2#1)
with tailorable##2##2##(2007-12#1)(2008-12#1)
with tailored##2##2##(2008-10#1)(2009-7#1)
with talc##2##2##(2006-10#1)(2008-5#1)
with tamoxifen##6##2##(1991-8#1)(1992-2#2)(1993-12#1)(1993-6#1)(1994-7#1)
with tandem##5##2##(1994-12#1)(1996-10#1)(2008-10#1)(2011-3#1)(2012-12#1)
with tangential##2##2##(2008-10#1)(2008-6#1)
with tap water##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
with target cells##2##3##(2008-11#2)
with target##5##2##(1990-11#1)(2007-11#1)(2008-11#2)(2008-2#1)
with targeted##5##2##(2007-8#1)(2008-5#2)(2010-9#2)
with tax-exempt##3##2##(1992-8#1)(1994-3#1)(2008-11#1)
with taxol##3##2##(1993-8#1)(2009-10#1)(2011-2#1)
with teachers##4##2##(2008-12#2)(2011-2#2)
with technetium-99m##2##2##(1990-12#1)(1996-5#1)
with technical##4##2##(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
with techniques##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
with technology##5##2##(1996-1#1)(1996-11#1)(2008-1#1)(2008-11#1)(2010-3#1)
with teenagers##2##2##(2008-9#1)(2013-1#1)
with temozolomide##2##2##(2011-2#1)(2011-3#1)
with temperature and##2##3##(2008-10#1)(2008-5#1)
with temperature are##2##3##(2008-10#1)(2008-2#1)
with temperature as the##2##4##(2008-10#1)(2008-3#1)
with temperature is##2##3##(2008-2#2)
with temperature up to##2##4##(2008-10#2)
with temperature##37##2##(2007-8#1)(2008-10#17)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#2)
with temperatures##3##2##(2008-10#2)(2008-3#1)
with temporal lobe##3##3##(1991-12#1)(1996-7#1)(2008-4#1)
with temporal##6##2##(1991-12#1)(1996-7#1)(2008-2#3)(2008-4#1)
with temporary or permanent##2##4##(2010-4#2)
with temporary##4##2##(2008-12#1)(2010-4#2)(2012-1#1)
with ten##5##2##(1992-11#1)(1996-12#2)(2008-12#1)(2010-3#1)
with terahertz##2##2##(2007-11#1)(2007-12#1)
with terminal##6##2##(1992-5#1)(1994-12#1)(1997-7#1)(2010-12#1)(2010-6#1)(2012-3#1)
with tertiary##2##2##(2008-6#1)(2012-12#1)
with test##4##2##(1996-12#1)(2008-10#2)(2008-3#1)
with tester isolates##2##3##(2008-10#2)
with tester strains of##2##4##(2008-10#2)
with tester##4##2##(2008-10#4)
with testicular cancer##2##3##(2009-5#2)
with testicular##5##2##(1994-5#1)(2008-1#1)(2008-10#1)(2009-5#2)
with testosterone##4##2##(1990-11#2)(2008-1#1)(2012-12#1)
with tests##2##2##(2008-10#1)(2008-12#1)
with tetanus##2##2##(1995-2#1)(1996-8#1)
with tethered##2##2##(2012-2#1)(2012-3#1)
with tetra-substituted sulphonated aluminum phthalocyanine##2##5##(2008-10#2)
with tetra-substituted##3##2##(2008-10#3)
with tetrabutylammonium##5##2##(2007-11#1)(2008-10#3)(2008-4#1)
with tetracycline##4##2##(1993-2#1)(2008-10#3)
with tetramethylammonium hydroxide (TMAH)##4##4##(2008-10#3)(2013-1#1)
with tetramethylammonium hydroxide##6##3##(2008-10#5)(2013-1#1)
with thalidomide and##2##3##(2011-1#2)
with thalidomide##3##2##(2006-10#1)(2011-1#2)
with that achieved##2##3##(2008-10#1)(2008-7#1)
with that at the##2##4##(2008-10#1)(2012-2#1)
with that at##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
with that calculated from##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
with that determined##3##3##(1997-7#1)(2008-10#2)
with that expected from##2##4##(1992-8#1)(2008-3#1)
with that expected##3##3##(1992-8#1)(2008-3#1)(2008-7#1)
with that for the##2##4##(1990-7#1)(2007-12#1)
with that for##4##3##(1990-7#1)(2007-12#1)(2008-5#1)(2012-3#1)
with that from other##2##4##(1990-6#1)(2008-4#1)
with that from the##3##4##(1992-11#1)(1993-3#1)(2008-3#1)
with that from##11##3##(1990-6#1)(1992-11#1)(1993-3#1)(1993-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#1)(2012-2#1)
with that in primary##2##4##(2008-11#2)
with that in the##7##4##(1990-2#1)(1993-1#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-3#1)
with that in##31##3##(1990-2#1)(1992-1#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
with that measured##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
with that observed at##2##4##(2008-10#2)
with that observed in##3##4##(1995-3#1)(1996-12#1)(2008-10#1)
with that observed##7##3##(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-11#1)
with that obtained##4##3##(1995-5#1)(2008-10#3)
with that of a conventional##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
with that of a##23##4##(1994-7#1)(1995-2#1)(1996-2#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-2#3)(2008-3#5)(2008-6#1)(2012-2#1)
with that of an##3##4##(1994-2#1)(2007-11#1)(2008-10#1)
with that of controls##2##4##(1992-2#1)(2013-1#1)
with that of conventional##6##4##(2007-11#1)(2007-12#2)(2008-3#3)
with that of dry##2##4##(2008-10#1)(2008-12#1)
with that of its##2##4##(1997-7#1)(2012-3#1)
with that of other##7##4##(1993-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
with that of standard##2##4##(1995-2#1)(2010-5#1)
with that of the IMCT model##2##6##(2010-2#2)
with that of the classical##2##5##(1991-12#1)(1995-12#1)
with that of the corresponding##2##5##(1995-3#1)(2008-3#1)
with that of the general population##3##6##(1991-2#1)(1993-1#1)(2008-12#1)
with that of the human##3##5##(1991-12#1)(1993-11#1)(1996-5#1)
with that of the rat##2##5##(1996-5#1)(2008-8#1)
with that of the##66##4##(1990-11#2)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-6#1)(1994-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#6)(2008-8#4)(2008-9#2)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with that of##214##3##(1990-11#2)(1990-5#3)(1990-7#1)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#3)(1993-6#3)(1994-11#2)(1994-2#1)(1994-7#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#39)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#22)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#4)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#2)
with that particular##2##3##(2008-8#1)(2009-8#1)
with that predicted by the##2##5##(2008-3#2)
with that predicted by##3##4##(2008-3#3)
with that predicted##5##3##(1991-2#1)(1993-6#1)(2008-3#3)
with that provided by##2##4##(2008-10#2)
with that reported##3##3##(1991-2#2)(1991-3#1)
with that which##2##3##(2008-10#1)(2008-3#1)
with that##339##2##(1990-11#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-1#4)(1993-11#3)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-7#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#5)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#2)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#70)(2008-11#12)(2008-12#2)(2008-2#14)(2008-3#36)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#12)(2008-9#5)(2009-2#2)(2009-3#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#5)(2013-8#3)
with the &quot##6##3##(1994-12#1)(1997-4#1)(2007-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
with the 0##3##3##(2008-10#2)(2008-2#1)
with the 1##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
with the 10##2##3##(2008-10#1)(2008-3#1)
with the 12##2##3##(2008-10#1)(2011-2#1)
with the 18q- syndrome##2##4##(1997-3#2)
with the 2nd antibody##2##4##(2008-10#2)
with the 3'##3##3##(1997-6#1)(2008-4#1)(2011-2#1)
with the 3D##2##3##(2007-11#1)(2008-11#1)
with the 40-kDa##2##3##(1993-9#1)(1997-1#1)
with the 5' half##2##4##(2008-10#1)(2008-8#1)
with the 5'##6##3##(1991-5#1)(1992-11#1)(1997-7#1)(2008-10#2)(2008-8#1)
with the 67 K protein##2##5##(1995-12#2)
with the A##2##3##(1997-2#1)(2008-6#1)
with the AFLP##3##3##(2008-10#3)
with the AIDS virus##2##4##(1991-5#1)(1993-1#1)
with the AIDS##3##3##(1991-5#1)(1993-1#1)(1994-1#1)
with the ATP##2##3##(1993-8#1)(2007-10#1)
with the American##6##3##(1991-1#1)(1996-5#1)(2008-11#1)(2008-3#3)
with the B##2##3##(1997-3#1)(2008-10#1)
with the BCR procedure##2##4##(2008-10#2)
with the Bessel##2##3##(2008-2#1)(2008-3#1)
with the Bratton-Marshall reagent##2##4##(2008-10#2)
with the C##2##3##(2008-10#2)
with the C-terminal##3##3##(1994-5#1)(2008-7#1)(2011-2#1)
with the CB##2##3##(2008-2#1)(2009-12#1)
with the CD4000##3##3##(2008-10#3)
with the CEA##2##3##(1991-4#1)(2009-11#1)
with the D##2##3##(2008-10#1)(2008-9#1)
with the D2##2##3##(1993-3#1)(2008-7#1)
with the DNA##7##3##(1991-2#1)(1992-3#1)(1993-3#1)(2008-10#2)(2008-12#1)(2012-12#1)
with the E##3##3##(1991-5#1)(1997-4#1)(2008-1#1)
with the ELISA##3##3##(1991-12#1)(1992-5#1)(1995-2#1)
with the El Niño##2##4##(2008-9#1)(2010-8#1)
with the Eurasian##2##3##(2008-9#1)(2010-8#1)
with the European##4##3##(2008-10#3)(2010-8#1)
with the FIA##2##3##(2008-10#2)
with the Fourier##2##3##(2007-12#1)(2008-3#1)
with the GM modified PLGA particles##2##6##(2009-7#2)
with the GSM##2##3##(2008-3#2)
with the GUS##2##3##(1997-2#1)(2008-10#1)
with the Gamma##2##3##(1997-4#1)(2007-8#1)
with the Glasgow##2##3##(2011-2#1)(2012-3#1)
with the HBV##2##3##(2008-8#2)
with the HPLC method##3##4##(2008-10#2)(2009-8#1)
with the HPLC##6##3##(2008-10#5)(2009-8#1)
with the ICP-MS##2##3##(2008-10#2)
with the IGF-I##2##3##(1996-2#2)
with the International##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
with the JCAHO's##2##3##(1993-2#1)(1995-1#1)
with the Kirchhoff##2##3##(2008-2#1)(2008-3#1)
with the LGB community##2##4##(2010-8#2)
with the M##2##3##(2008-10#1)(2011-10#1)
with the MAbs##2##3##(1994-3#1)(2008-10#1)
with the MS##5##3##(2008-3#5)
with the Maquet##2##3##(2008-12#1)(2011-2#1)
with the Mayo##2##3##(2008-1#1)(2009-7#1)
with the Mie##2##3##(2008-2#1)(2008-3#1)
with the Monte Carlo##3##4##(2008-2#2)(2008-3#1)
with the N##2##3##(2008-10#1)(2012-3#1)
with the N-terminal##3##3##(1991-11#1)(1992-11#1)(2010-10#1)
with the NIST lamps##2##4##(2008-3#2)
with the NMR##2##3##(1995-3#1)(2008-10#1)
with the National Cancer##2##4##(2008-5#1)(2008-7#1)
with the National##7##3##(1996-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-1#1)
with the Nd##3##3##(1991-3#2)(1994-2#1)
with the New##2##3##(1997-3#1)(2008-10#1)
with the Nucleus##7##3##(2008-9#3)(2012-2#4)
with the OIE##2##3##(2011-2#2)
with the OVA/IL12 protein produced##2##5##(2008-11#2)
with the QTL##2##3##(2008-10#2)
with the R##2##3##(1993-6#1)(2008-10#1)
with the RT##2##3##(1997-3#2)
with the Raman##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
with the S##2##3##(1993-2#1)(1996-6#1)
with the SE-9000##2##3##(2008-10#2)
with the SPR##2##3##(2008-10#1)(2008-2#1)
with the Saint##2##3##(2011-1#1)(2011-2#1)
with the Semliki Forest Virus##2##5##(2008-11#2)
with the SmartWire##2##3##(1996-6#2)
with the Spanish##2##3##(1997-6#1)(2008-10#1)
with the Spectra Optia compared with the MCS+ procedures##2##9##(2011-2#2)
with the T##4##3##(1993-8#1)(1995-2#1)(1995-8#1)(2008-10#1)
with the TEMPO+##3##3##(2008-9#3)
with the U##5##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
with the US FDA##2##4##(2008-5#2)
with the US##3##3##(2008-11#1)(2008-5#2)
with the USP##2##3##(2008-10#1)(2008-5#1)
with the Unified##3##3##(2008-7#2)(2013-8#1)
with the United States##2##4##(2008-7#1)(2012-12#1)
with the University of##3##4##(1996-2#1)(2008-12#1)(2012-3#1)
with the WHO##2##3##(1991-2#1)(2008-8#1)
with the World Health##2##4##(2008-1#1)(2011-2#1)
with the X-ray##2##3##(1993-8#1)(2013-7#1)
with the XE-2100##2##3##(2008-10#2)
with the a##3##3##(1996-12#1)(2007-11#1)(2008-11#1)
with the ability of##6##4##(1994-12#1)(1995-11#1)(2007-11#1)(2008-10#1)(2009-9#2)
with the ability to form##2##5##(1990-11#1)(1992-10#1)
with the ability to##11##4##(1990-11#1)(1992-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)
with the ability##17##3##(1990-11#1)(1992-10#1)(1994-12#1)(1995-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-8#1)(2009-9#2)(2010-3#1)(2010-7#1)(2011-1#1)
with the above mentioned##2##4##(1993-5#1)(2007-7#1)
with the above##7##3##(1993-5#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-9#1)
with the absence of##5##4##(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#2)
with the absorption##2##3##(2008-10#2)
with the academic##3##3##(1990-2#1)(2013-8#2)
with the accelerated##2##3##(2008-10#1)(2013-7#1)
with the accumulation of##2##4##(2008-10#1)(2008-11#1)
with the acetoxymethyl ester##2##4##(1992-5#2)
with the acid##2##3##(1992-12#1)(2008-10#1)
with the acquired immunodeficiency syndrome##4##5##(1990-9#1)(1991-12#1)(1992-2#1)(1993-9#1)
with the acquired##5##3##(1990-9#1)(1991-12#1)(1992-2#1)(1993-9#1)(2012-1#1)
with the acronym##2##3##(1996-12#1)(2008-3#1)
with the actions##2##3##(1993-2#1)(2008-9#1)
with the activation of##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
with the activation##4##3##(1990-2#1)(2008-10#1)(2009-12#1)(2012-2#1)
with the active site of##3##5##(1994-5#2)(2008-8#1)
with the active site##7##4##(1991-5#1)(1992-5#1)(1994-5#2)(1997-7#1)(2008-8#2)
with the activity of the##3##5##(1991-12#1)(2008-6#1)(2012-3#1)
with the activity of##8##4##(1991-12#1)(1991-3#1)(1993-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-3#1)
with the activity##9##3##(1991-12#1)(1991-3#1)(1993-8#1)(1994-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-3#1)
with the actual##4##3##(1992-2#1)(2007-5#1)(2008-10#1)(2009-4#1)
with the acute##2##3##(1992-12#1)(2006-10#1)
with the acyl##2##3##(1991-3#1)(2009-2#1)
with the added##5##3##(1990-8#1)(1991-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
with the addition of the##2##5##(1995-1#1)(2008-8#1)
with the addition of##24##4##(1992-2#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
with the additional##3##3##(1995-11#1)(2008-7#1)(2012-2#1)
with the adenovirus##2##3##(1992-8#1)(2008-11#1)
with the adjacent##3##3##(1990-5#1)(1995-6#1)(2008-12#1)
with the administration of##2##4##(1994-3#1)(2008-3#1)
with the administration##3##3##(1991-12#1)(1994-3#1)(2008-3#1)
with the adoption of##2##4##(1991-12#1)(1993-3#1)
with the adult##2##3##(1994-2#1)(1996-2#1)
with the advancement of##2##4##(2008-10#1)(2008-8#1)
with the advantage of##6##4##(1996-8#1)(1997-4#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
with the advantage##7##3##(1996-8#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
with the advantages of##4##4##(1990-9#1)(1991-3#1)(2007-12#1)(2008-10#1)
with the advantages##5##3##(1990-9#1)(1991-3#1)(1992-2#1)(2007-12#1)(2008-10#1)
with the advent of new##2##5##(2008-5#1)(2009-10#1)
with the advent of##8##4##(2006-4#1)(2008-5#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
with the aforementioned##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
with the age of the##3##5##(1990-6#1)(2007-10#1)(2008-10#1)
with the age of##6##4##(1990-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
with the age##8##3##(1990-6#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)
with the agent##2##3##(1991-3#1)(2008-7#1)
with the aggressive##2##3##(2009-3#1)(2011-2#1)
with the aid of a microscope##2##6##(2008-3#1)(2008-5#1)
with the aid of a##8##5##(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)
with the aid of an##3##5##(1990-5#1)(2008-10#1)(2008-3#1)
with the aid of chemometrics##2##5##(2008-10#2)
with the aid of the##5##5##(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#1)
with the aid of##38##4##(1990-5#1)(1990-7#1)(1991-6#1)(1992-9#1)(1994-11#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
with the aim of detecting##2##5##(2008-5#1)(2010-6#1)
with the aim of establishing##2##5##(2008-8#2)
with the aim of evaluating##2##5##(1997-3#1)(2007-7#1)
with the aim of identifying##4##5##(1994-12#1)(1995-8#1)(2008-9#1)(2011-1#1)
with the aim of improving the##2##6##(2008-10#1)(2008-7#1)
with the aim of improving##3##5##(2008-10#1)(2008-7#1)(2010-3#1)
with the aim of obtaining##3##5##(1994-11#1)(2008-10#2)
with the aim of providing##4##5##(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)
with the aim of reducing##3##5##(2008-2#1)(2011-1#1)(2013-1#1)
with the aim of studying##2##5##(2007-6#1)(2010-3#1)
with the aim of##50##4##(1990-6#1)(1990-8#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with the aim to identify##2##5##(2010-11#1)(2012-12#1)
with the aim to obtain##2##5##(2008-10#1)(2013-7#1)
with the aim to##15##4##(1990-9#1)(1992-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-7#2)
with the aim##66##3##(1990-6#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
with the aims of##3##4##(2007-4#1)(2008-10#1)(2010-4#1)
with the aims##4##3##(2007-4#1)(2008-10#1)(2008-8#1)(2010-4#1)
with the airway##3##3##(1994-2#1)(1997-2#1)(2010-12#1)
with the alkali metal##3##4##(2008-10#3)
with the alkali##4##3##(2008-10#4)
with the alpha subunit of##2##5##(1991-8#1)(1994-8#1)
with the alpha subunit##3##4##(1991-8#1)(1994-8#2)
with the alpha##6##3##(1990-5#1)(1991-5#1)(1991-8#1)(1993-2#1)(1994-8#2)
with the ambient##2##3##(2008-10#1)(2008-7#1)
with the amine##2##3##(1997-7#1)(2008-10#1)
with the amino acid##2##4##(1991-2#1)(2010-2#1)
with the amino##3##3##(1991-2#1)(1995-12#1)(2010-2#1)
with the ammonium salt of##2##5##(2008-10#2)
with the amount of##13##4##(1991-11#1)(1991-12#1)(1995-12#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)
with the analogous##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
with the analysis of##9##4##(2008-10#5)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
with the analysis##13##3##(1997-2#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
with the analyte##6##3##(2008-10#6)
with the analytical##3##3##(2008-10#3)
with the anatomical##2##3##(1995-6#1)(1996-12#1)
with the androgen##2##3##(2008-9#1)(2009-4#1)
with the anion##2##3##(1996-5#1)(2008-10#1)
with the anionic surfactant##2##4##(2008-10#2)
with the anionic##3##3##(2008-10#3)
with the antagonist##4##3##(2008-10#4)
with the anti-TNF-alpha mAb##2##4##(2008-10#2)
with the antibiotic##4##3##(1994-5#1)(1995-6#1)(2007-7#1)(2008-10#1)
with the antibody##4##3##(1991-5#1)(1991-9#1)(1995-8#1)(2008-8#1)
with the antigen receptor##2##4##(1995-6#2)
with the antigen##7##3##(1993-8#1)(1995-6#2)(2008-10#3)(2008-8#1)
with the antioxidant##4##3##(1993-12#1)(1993-6#1)(2011-1#1)(2012-12#1)
with the antisera##2##3##(1994-6#1)(1995-8#1)
with the apical##2##3##(2008-9#1)(2012-2#1)
with the apparent##3##3##(1990-9#1)(1994-11#1)(1997-2#1)
with the appearance of a##3##5##(1992-10#1)(2007-12#1)(2009-3#1)
with the appearance of##12##4##(1992-10#1)(1994-8#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
with the appearance##13##3##(1992-10#1)(1994-8#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
with the apple##3##3##(2008-10#3)
with the application of the##2##5##(2008-10#2)
with the application of##12##4##(2008-10#7)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-11#1)
with the application##14##3##(1992-5#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-11#1)
with the applied##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
with the approach##2##3##(1994-1#1)(1995-12#1)
with the appropriate##11##3##(1995-12#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-4#2)(2010-3#1)(2011-1#1)(2011-2#1)
with the aqueous##3##3##(2008-10#2)(2011-1#1)
with the area of##2##4##(1990-9#1)(2008-11#1)
with the assessment of##3##4##(1991-1#1)(2008-8#1)(2010-11#1)
with the assistance of##3##4##(2008-12#1)(2011-1#2)
with the associated##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
with the association##3##3##(2008-10#2)(2010-2#1)
with the assumption of##2##4##(2008-3#1)(2011-2#1)
with the assumption that##6##4##(1996-3#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
with the assumption##8##3##(1996-3#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)
with the atmospheric##2##3##(2008-2#1)(2008-3#1)
with the atomic##2##3##(2008-10#1)(2008-3#1)
with the attachment##2##3##(2008-4#1)(2012-2#1)
with the automatic##3##3##(1990-8#1)(2008-10#2)
with the availability of##3##4##(2008-6#1)(2011-2#1)(2012-12#1)
with the available##6##3##(1993-1#1)(1996-2#1)(2007-8#1)(2008-2#1)(2008-3#2)
with the average of##2##4##(2008-2#1)(2011-1#1)
with the average##10##3##(1992-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#1)
with the background##4##3##(2007-5#2)(2008-10#1)(2008-3#1)
with the bacterial##2##3##(1994-8#1)(2008-10#1)
with the bare##2##3##(2008-10#2)
with the barley##2##3##(1997-3#1)(2008-5#1)
with the basal transcription##3##4##(1995-2#1)(1995-6#2)
with the basal##4##3##(1995-2#1)(1995-6#2)(2008-12#1)
with the baseline##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
with the basic protein##2##4##(1997-4#2)
with the basic##7##3##(1994-11#1)(1994-2#1)(1995-11#1)(1997-4#2)(2007-12#1)(2007-7#1)
with the basolateral##2##3##(1990-5#1)(2008-11#1)
with the batch##2##3##(2008-10#1)(2012-2#1)
with the beam propagation method##2##5##(2007-11#2)
with the beam quality##2##4##(2008-3#2)
with the beam##4##3##(2007-11#2)(2008-3#2)
with the behavior of##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
with the benefits of##2##4##(2008-11#2)
with the best available##2##4##(2008-3#2)
with the best density functional performance obtained by hybrid meta-GGAs##2##10##(2012-12#2)
with the best##16##3##(1995-5#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
with the beta##2##3##(1993-12#1)(2010-6#1)
with the better##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2010-8#1)
with the binding of the##2##5##(1990-5#1)(2013-1#1)
with the binding of##5##4##(1990-5#1)(2006-6#1)(2008-8#1)(2010-10#1)(2013-1#1)
with the binding##6##3##(1990-5#1)(1993-11#1)(2006-6#1)(2008-8#1)(2010-10#1)(2013-1#1)
with the biological##3##3##(2008-4#1)(2009-3#1)(2013-8#1)
with the biosensor##2##3##(2008-10#2)
with the birds##2##3##(1991-11#2)
with the blood##3##3##(1994-3#1)(1997-5#1)(2011-2#1)
with the body and##3##4##(1991-6#1)(2008-11#1)(2008-9#1)
with the bovine##3##3##(1993-2#1)(1996-12#2)
with the brain##3##3##(2008-7#1)(2010-5#2)
with the buffer##2##3##(2008-10#2)
with the bundle##2##3##(2008-10#1)(2008-3#1)
with the c-myc gene##2##4##(1993-3#1)(2008-11#1)
with the cDNA##4##3##(1990-8#1)(1992-6#1)(1994-11#1)(1995-6#1)
with the calcium ionophore##2##4##(1993-3#1)(2012-12#1)
with the calculated##7##3##(2007-12#1)(2008-10#2)(2008-3#3)(2012-12#1)
with the calculation of##2##4##(2008-10#1)(2008-3#1)
with the calibration##3##3##(2008-10#3)
with the capability of##3##4##(2008-10#3)
with the capability to##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
with the capability##7##3##(1995-12#1)(2007-11#1)(2008-10#4)(2011-2#1)
with the capacity to##4##4##(1996-2#1)(2008-10#1)(2009-6#1)(2010-10#1)
with the capacity##6##3##(1996-2#1)(2008-10#3)(2009-6#1)(2010-10#1)
with the carbon##3##3##(1990-5#1)(1993-8#1)(2008-10#1)
with the carboxyl groups of the##2##6##(1993-6#1)(2008-10#1)
with the carboxyl##3##3##(1993-3#1)(1993-6#1)(2008-10#1)
with the cardiovascular##2##3##(1994-3#1)(2010-6#1)
with the care##3##3##(1990-10#1)(1996-3#1)(2011-2#1)
with the carrier##7##3##(1990-11#1)(1992-3#2)(1992-6#1)(2008-10#2)(2008-3#1)
with the case##3##3##(1993-3#1)(2008-1#1)(2008-2#1)
with the catalytic domain of##2##5##(1991-10#1)(1994-8#1)
with the catalytic##7##3##(1991-10#1)(1993-11#2)(1994-8#1)(1996-2#2)(2008-10#1)
with the cell surface##4##4##(1994-6#1)(1995-2#1)(2008-4#2)
with the cell##13##3##(1990-2#1)(1994-6#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)
with the cells##2##3##(2008-11#1)(2013-8#1)
with the cellular##2##3##(1990-2#1)(2008-9#1)
with the central##3##3##(1995-6#1)(2007-8#1)(2013-8#1)
with the certified ones##4##4##(2008-10#4)
with the certified or recommended values##2##6##(2008-10#2)
with the certified value of##3##5##(2008-10#3)
with the certified value##12##4##(2008-10#12)
with the certified values and the##2##6##(2008-10#2)
with the certified values and##5##5##(2008-10#5)
with the certified values##20##4##(2008-10#20)
with the certified##42##3##(2008-10#42)
with the cervical spine##2##4##(2008-12#2)
with the challenge##6##3##(1991-12#1)(1996-1#1)(2007-7#1)(2008-12#1)(2010-5#1)(2012-2#1)
with the change in##2##4##(1991-5#1)(1995-11#1)
with the change of##2##4##(1990-2#1)(2008-10#1)
with the change##4##3##(1990-2#1)(1991-5#1)(1995-11#1)(2008-10#1)
with the changes in the##2##5##(1991-12#1)(2008-7#1)
with the changes in##3##4##(1991-12#1)(1994-2#1)(2008-7#1)
with the changes##6##3##(1991-12#1)(1994-2#1)(2008-1#1)(2008-7#1)(2013-1#2)
with the characteristic##2##3##(2009-11#1)(2013-8#1)
with the charge##2##3##(2008-10#1)(2008-3#1)
with the chemical##5##3##(1993-11#1)(2008-10#2)(2008-11#2)
with the chick##2##3##(1991-9#1)(1995-5#1)
with the chicken##2##3##(1997-1#1)(2008-5#1)
with the chief complaint of##2##5##(2013-1#2)
with the chief##4##3##(2013-1#4)
with the child##3##3##(2008-11#1)(2009-11#1)(2012-2#1)
with the chlorophyll concentration##2##4##(2008-3#2)
with the choice of##2##4##(2010-11#1)(2010-12#1)
with the chromogenic reagent##2##4##(2008-10#2)
with the claimed values##2##4##(2008-10#2)
with the classical##7##3##(1990-3#1)(1996-6#1)(2008-10#2)(2008-5#2)(2012-2#1)
with the classification of##2##4##(2008-3#1)(2011-2#1)
with the classification##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
with the clinical and##3##4##(1990-2#1)(2006-10#1)(2009-8#1)
with the clinical stage##2##4##(1990-9#1)(2008-1#1)
with the clinical status of##2##5##(1995-11#1)(2009-5#1)
with the clinical symptoms##2##4##(1994-6#1)(2013-1#1)
with the clinical##21##3##(1990-2#1)(1990-9#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-7#1)(1995-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
with the coat protein##3##4##(2008-10#3)
with the coefficient##2##3##(1990-2#1)(2013-8#1)
with the colorimetric method##2##4##(2008-10#2)
with the colorimetric##3##3##(2008-10#3)
with the column##3##3##(2008-10#3)
with the combination of##15##4##(1990-9#1)(1992-8#1)(1993-8#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)
with the combination##20##3##(1990-9#1)(1992-8#1)(1993-8#1)(1993-9#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)
with the combined##4##3##(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
with the commercial##2##3##(2008-10#1)(2008-5#1)
with the common##9##3##(1992-5#1)(1992-8#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)
with the community##5##3##(1991-2#1)(1992-1#1)(1996-3#1)(2008-12#1)(2009-4#1)
with the competitive##2##3##(1992-8#1)(1995-11#1)
with the compiled##3##3##(1991-6#1)(1996-10#2)
with the complaint of##2##4##(2008-1#1)(2012-3#1)
with the complete##27##3##(1993-3#1)(2008-9#1)(2011-2#24)(2012-3#1)
with the complex##7##3##(1997-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-5#1)
with the complexation##2##3##(2008-10#2)
with the components of##2##4##(2008-10#1)(2011-2#1)
with the composition of##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
with the composition##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
with the computer##3##3##(1993-3#1)(1997-2#1)(2008-2#1)
with the concentration of##21##4##(2008-10#18)(2008-12#1)(2008-5#1)(2009-6#1)
with the concentration##27##3##(1990-5#1)(2008-10#23)(2008-12#1)(2008-5#1)(2009-6#1)
with the concentrations of##2##4##(2008-10#2)
with the concentrations##3##3##(2008-10#3)
with the concept of##3##4##(1997-1#2)(2012-12#1)
with the concept##5##3##(1992-3#1)(1992-6#1)(1997-1#2)(2012-12#1)
with the conclusion that##5##4##(1990-12#1)(1991-12#1)(1993-3#1)(1996-5#1)(2008-12#1)
with the condition##2##3##(2008-10#1)(2013-1#1)
with the conditions##2##3##(2007-11#1)(2007-12#1)
with the conductivity##2##3##(2008-10#2)
with the consensus sequence##2##4##(1993-6#1)(1997-4#1)
with the consensus##3##3##(1993-6#1)(1997-4#1)(2012-3#1)
with the consequences of##4##4##(1993-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
with the constant##3##3##(1994-2#1)(1997-2#1)(2008-10#1)
with the constraints of##2##4##(2008-10#2)
with the consumption of##2##4##(1990-6#1)(2008-10#1)
with the contents##2##3##(2008-10#1)(2011-1#1)
with the contralateral##2##3##(1992-10#1)(2009-3#1)
with the control group##16##4##(1993-3#1)(1994-3#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
with the control##52##3##(1990-6#1)(1993-1#1)(1993-12#2)(1993-3#3)(1994-3#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#3)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
with the controlled and##2##4##(2008-10#1)(2011-2#1)
with the controlled##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
with the controls##14##3##(1991-8#1)(1993-12#1)(2007-7#1)(2008-10#4)(2008-7#2)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#1)
with the conventional method##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
with the conventional methods##2##4##(2008-10#1)(2013-8#1)
with the conventional##33##3##(1995-3#1)(2007-11#1)(2007-12#4)(2008-10#16)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
with the cooperation of##2##4##(2009-12#1)(2012-1#1)
with the core##2##3##(1997-4#1)(2008-8#1)
with the correlation coefficient of##2##5##(2008-10#1)(2011-1#1)
with the correlation coefficients of 0##2##6##(2011-1#2)
with the correlation coefficients##3##4##(2011-1#3)
with the correlation##5##3##(2008-10#1)(2011-1#4)
with the corresponding rates##2##4##(2008-11#1)(2008-7#1)
with the corresponding values in the##2##6##(2008-2#1)(2008-5#1)
with the corresponding values##3##4##(2008-2#2)(2008-5#1)
with the corresponding##37##3##(1991-2#1)(1991-9#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#2)
with the costs of##2##4##(1995-12#1)(2007-12#1)
with the coupling##3##3##(2008-10#1)(2008-4#2)
with the course of the##2##5##(1991-4#1)(2008-10#1)
with the course of##3##4##(1991-4#1)(1991-9#1)(2008-10#1)
with the course##5##3##(1991-4#1)(1991-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
with the craniofacial##2##3##(2007-12#2)
with the creation of##2##4##(2008-12#1)(2008-3#1)
with the critical##2##3##(2008-10#2)
with the crystal structure##2##4##(1991-11#1)(2011-1#1)
with the crystal##3##3##(1991-11#1)(1994-5#1)(2011-1#1)
with the culture##2##3##(2008-11#2)
with the cumulative##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
with the current##13##3##(1992-3#1)(1996-1#2)(1996-4#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-3#1)
with the currently available##2##4##(1996-2#1)(2010-3#1)
with the currently##3##3##(1996-2#1)(2010-3#1)(2010-8#1)
with the cytochrome P-450##2##4##(1992-11#1)(2008-3#1)
with the cytochrome##3##3##(1992-11#1)(1994-5#1)(2008-3#1)
with the cytoplasmic##5##3##(1990-8#1)(1994-2#1)(1995-6#1)(2008-9#1)(2009-11#1)
with the cytoskeleton##3##3##(1992-11#1)(1993-11#1)(2008-11#1)
with the cytosolic form of##2##5##(1992-11#1)(1996-3#1)
with the cytosolic##3##3##(1992-11#1)(1996-3#1)(2012-12#1)
with the daily##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
with the data for##2##4##(2008-11#1)(2008-2#1)
with the data obtained by##2##5##(2008-10#2)
with the data obtained##4##4##(2008-10#3)(2013-1#1)
with the data of airborne lidar measurements for lambda = 0##2##11##(2008-2#2)
with the data##18##3##(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#2)(2008-8#1)(2013-1#2)
with the death of##2##4##(2009-7#1)(2011-2#1)
with the decision##2##3##(2008-6#1)(2008-9#1)
with the decrease in##4##4##(1992-12#1)(2006-10#1)(2008-10#1)(2009-7#1)
with the decrease of##2##4##(2008-12#1)(2010-8#1)
with the decrease##6##3##(1992-12#1)(2006-10#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-8#1)
with the deduced##3##3##(1991-6#1)(1994-8#1)(1995-6#1)
with the deep##2##3##(1995-3#1)(2013-1#1)
with the degenerate primers##2##4##(1996-8#1)(2008-10#1)
with the degree of##22##4##(1991-7#1)(1991-9#1)(1992-12#2)(1996-3#1)(1996-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-5#1)(2013-1#1)(2013-8#1)
with the degree##23##3##(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#1)(1996-3#1)(1996-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-5#1)(2013-1#1)(2013-8#1)
with the delay in t(is) and##2##6##(2008-10#2)
with the delay in##3##4##(1992-3#1)(2008-10#2)
with the delay introduced in the##2##6##(2013-8#2)
with the delay##7##3##(1992-3#1)(2008-10#2)(2013-8#4)
with the delivery of##3##4##(1993-3#1)(1994-1#1)(2008-7#1)
with the deposition of##2##4##(2008-10#2)
with the deposition##4##3##(2007-12#1)(2008-10#3)
with the depth##2##3##(2007-12#1)(2008-10#1)
with the derived##2##3##(1995-5#1)(2008-3#1)
with the described##2##3##(1994-12#1)(2008-10#1)
with the design##2##3##(2007-12#1)(2008-9#1)
with the desire##2##3##(2008-10#1)(2008-3#1)
with the detection limit of 0##3##6##(2008-10#3)
with the detection limit of 1##4##6##(2008-10#4)
with the detection limit of##10##5##(2008-10#10)
with the detection limit##13##4##(2008-10#13)
with the detection limits of 0##2##6##(2008-10#2)
with the detection limits##3##4##(2008-10#3)
with the detection of##3##4##(1997-6#1)(2008-9#1)(2013-1#1)
with the detection##21##3##(1997-6#1)(2008-10#17)(2008-9#1)(2012-12#1)(2013-1#1)
with the detectors##2##3##(2008-3#1)(2008-9#1)
with the determination of##7##4##(2008-10#6)(2010-11#1)
with the determination##12##3##(2008-10#11)(2010-11#1)
with the developed##4##3##(2008-10#3)(2008-2#1)
with the development of a##7##5##(1994-3#2)(2008-10#1)(2008-4#1)(2010-8#1)(2011-7#1)(2012-3#1)
with the development of new##3##5##(2007-10#1)(2008-7#1)(2010-6#1)
with the development of the##3##5##(2008-10#1)(2009-7#1)(2012-3#1)
with the development of##50##4##(1994-3#2)(1995-2#3)(1996-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
with the development##52##3##(1994-3#2)(1995-2#3)(1996-5#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
with the device##5##3##(2007-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
with the diagnosis and##2##4##(1992-3#1)(2008-4#1)
with the diagnosis of acute##2##5##(2007-10#1)(2013-1#1)
with the diagnosis of##13##4##(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the diagnosis##15##3##(1992-3#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the dialysis##2##3##(2007-12#1)(2008-10#1)
with the diet##2##3##(1994-11#1)(1994-9#1)
with the different##25##3##(1990-10#1)(1990-6#1)(1991-8#1)(1992-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
with the differential##2##3##(2008-3#1)(2012-1#1)
with the differentiation##2##3##(1993-6#1)(2008-7#1)
with the difficulty##2##3##(2008-5#1)(2012-12#1)
with the diffusion##5##3##(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#1)
with the dilemma of##2##4##(1992-1#1)(2008-11#1)
with the dimensions##2##3##(2008-3#2)
with the direct##4##3##(1991-12#1)(2008-10#2)(2008-3#1)
with the direction of##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
with the discharge##2##3##(2008-10#2)
with the discovery of##4##4##(1997-3#1)(2008-9#1)(2010-3#2)
with the disease##20##3##(1990-5#1)(1991-2#1)(1992-3#1)(1994-9#1)(1995-3#1)(2007-7#1)(2008-10#4)(2009-10#2)(2010-2#1)(2011-1#1)(2013-1#3)(2013-8#3)
with the disorder##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
with the dissociation##2##3##(1993-8#1)(2008-10#1)
with the distance between the##2##5##(2007-11#1)(2008-10#1)
with the distribution of the##2##5##(1991-9#1)(1992-9#1)
with the distribution of##5##4##(1991-9#1)(1992-9#1)(2008-10#1)(2008-8#1)(2010-8#1)
with the distribution##6##3##(1991-9#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
with the diurnal schedule of##2##5##(2008-6#2)
with the dopamine##3##3##(1993-3#1)(1996-2#1)(1996-5#1)
with the dopaminergic##2##3##(2008-7#1)(2012-1#1)
with the dorsal##2##3##(1997-3#1)(2007-11#1)
with the dose##2##3##(1995-12#1)(2013-1#1)
with the dramatic##2##3##(1996-2#1)(1997-4#1)
with the drug##7##3##(1990-2#2)(1990-7#1)(1995-5#2)(2008-10#1)(2008-11#1)
with the duration of motility##2##5##(2008-7#2)
with the duration of the##2##5##(1991-12#1)(2008-8#1)
with the duration of##8##4##(1991-11#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)
with the dynamics##2##3##(1997-4#1)(2008-10#1)
with the earlier##5##3##(1991-12#1)(1994-3#1)(1997-7#1)(2008-10#2)
with the earliest##2##3##(2008-10#1)(2011-2#1)
with the early##2##3##(2006-10#1)(2008-10#1)
with the educational##2##3##(2011-2#1)(2013-1#1)
with the effect of##9##4##(1990-8#1)(1996-2#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
with the effect##11##3##(1990-8#1)(1992-8#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
with the effector cells##2##4##(1990-12#1)(1993-6#1)
with the effects of the##2##5##(1993-8#1)(2008-2#1)
with the effects of##7##4##(1990-5#1)(1993-6#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)
with the effects##8##3##(1990-5#1)(1993-6#1)(1993-8#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)
with the eight##2##3##(2008-10#2)
with the electron##2##3##(1997-3#1)(2008-8#1)
with the emergence of##4##4##(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
with the emergence##5##3##(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
with the emission spectra of##2##5##(2008-10#1)(2013-8#1)
with the emission##3##3##(2008-10#2)(2013-8#1)
with the end##2##3##(2007-12#1)(2012-3#1)
with the endogenous##4##3##(1992-6#1)(1992-8#1)(2008-9#1)(2009-8#1)
with the endoplasmic reticulum##2##4##(1993-8#1)(2011-2#1)
with the energy##2##3##(1997-8#1)(2008-5#1)
with the enhanced##3##3##(1994-11#1)(1997-8#1)(2011-2#1)
with the enhancement of##3##4##(1996-2#1)(2008-10#1)(2008-8#1)
with the enrichment##2##3##(1992-9#1)(2008-10#1)
with the entire##3##3##(1995-12#1)(2008-10#1)(2012-2#1)
with the environment##6##3##(2007-6#1)(2008-1#1)(2008-6#1)(2010-4#1)(2010-5#1)(2010-7#1)
with the enzymatic##2##3##(2008-10#2)
with the enzyme from##5##4##(1992-3#4)(1996-2#1)
with the enzyme##21##3##(1990-2#1)(1991-12#1)(1992-3#4)(1992-6#1)(1992-8#2)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)
with the enzyme-linked immunosorbent assay (ELISA)##2##6##(1996-9#1)(2008-10#1)
with the enzyme-linked immunosorbent##3##4##(1996-9#1)(2008-10#2)
with the enzyme-linked##4##3##(1991-8#1)(1996-9#1)(2008-10#2)
with the errors##2##3##(2008-10#2)
with the established##4##3##(1992-3#1)(2009-11#1)(2012-12#1)(2013-8#1)
with the estimated##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2012-3#1)
with the estimation##3##3##(2010-8#1)(2012-2#1)(2013-8#1)
with the estrogen receptor##3##4##(2008-11#3)
with the evaluation##2##3##(2007-5#1)(2013-1#1)
with the evolution of##2##4##(1997-8#1)(2008-2#1)
with the exact##5##3##(2008-2#1)(2008-3#3)(2009-9#1)
with the example of##2##4##(1990-6#1)(2012-1#1)
with the exception of a##2##5##(1991-9#1)(2008-12#1)
with the exception of mancozeb##3##5##(2008-10#3)
with the exception of the##11##5##(1990-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
with the exception of those##3##5##(1994-3#1)(2008-10#2)
with the exception of##71##4##(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
with the exception that##4##4##(1992-8#1)(2008-10#2)(2010-12#1)
with the exception##75##3##(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
with the exceptions of##4##4##(1997-2#1)(2008-10#3)
with the excitation##2##3##(1995-3#1)(1996-2#1)
with the exercise##2##3##(2007-6#1)(2008-11#1)
with the existence of##3##4##(1994-8#1)(2008-10#1)(2008-2#1)
with the existence##4##3##(1994-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
with the existing##5##3##(2008-10#2)(2008-7#1)(2009-6#1)(2013-1#1)
with the expectation that##2##4##(1992-8#1)(2008-8#1)
with the expectation##3##3##(1990-10#1)(1992-8#1)(2008-8#1)
with the expected##8##3##(1992-3#1)(1992-8#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
with the experience of##2##4##(1994-12#1)(2008-3#1)
with the experiences##2##3##(1994-11#1)(2013-1#1)
with the experimental data##9##4##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
with the experimental results##16##4##(1995-3#1)(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2011-2#1)(2013-8#1)
with the experimental values##2##4##(1995-6#1)(2008-10#1)
with the experimental##36##3##(1990-6#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
with the experimentally determined##2##4##(2008-1#1)(2008-10#1)
with the experimentally##3##3##(1997-8#1)(2008-1#1)(2008-10#1)
with the experiments##5##3##(2008-10#1)(2008-2#3)(2013-8#1)
with the explanatory variables##2##4##(1992-6#2)
with the expression of the##3##5##(1990-7#1)(1991-9#1)(1995-6#1)
with the expression of these##2##5##(1994-7#1)(2009-9#1)
with the expression of##10##4##(1990-7#1)(1991-9#1)(1994-7#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)
with the expression##12##3##(1990-7#1)(1991-9#1)(1994-7#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)
with the extent of##2##4##(2008-7#1)(2009-9#1)
with the external##2##3##(2007-12#1)(2009-6#1)
with the extracellular##2##3##(2008-11#1)(2011-2#1)
with the extract##3##3##(1990-2#1)(1994-2#1)(2008-10#1)
with the extracted##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
with the extraction##3##3##(2008-10#3)
with the extracts##3##3##(2008-10#1)(2013-1#2)
with the fabricated##2##3##(2008-2#1)(2008-3#1)
with the fact that the##3##5##(1990-8#1)(2008-11#1)(2008-5#1)
with the fact that##6##4##(1990-11#1)(1990-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
with the fact##7##3##(1990-11#1)(1990-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
with the fall in##2##4##(1991-5#1)(2013-1#1)
with the family##3##3##(2007-10#1)(2008-10#1)(2009-2#1)
with the fast##2##3##(2008-2#1)(2008-9#1)
with the fastest##2##3##(2007-5#1)(2008-10#1)
with the fatty acid##2##4##(1992-10#1)(2008-10#1)
with the female##2##3##(2008-5#1)(2008-6#1)
with the fetal##2##3##(1990-5#1)(2012-2#1)
with the fewest##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
with the fiber##2##3##(2007-11#1)(2008-10#1)
with the fibril##2##3##(2008-3#1)(2009-8#1)
with the field##2##3##(2007-12#1)(2008-10#1)
with the finding that##2##4##(1996-12#1)(2008-10#1)
with the finding##3##3##(1996-12#1)(2008-10#1)(2013-1#1)
with the finite-difference time-domain##2##4##(2008-3#2)
with the first of##2##4##(1996-2#1)(2008-7#1)
with the first tumor occurring##2##5##(1997-3#2)
with the first##22##3##(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#2)(2007-10#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
with the fish##3##3##(1996-5#1)(2008-11#1)(2008-7#1)
with the five##2##3##(1993-12#1)(2008-4#1)
with the flow injection##2##4##(2008-10#2)
with the flow rate##2##4##(1991-9#1)(2008-10#1)
with the flow##10##3##(1991-9#1)(2008-10#8)(2009-7#1)
with the flowering##2##3##(1990-7#1)(2008-10#1)
with the fluorescence##5##3##(2008-10#2)(2008-2#2)(2010-4#1)
with the fluorescent probe##2##4##(1993-9#1)(2008-8#1)
with the fluorescent##6##3##(1992-3#1)(1993-9#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-8#1)
with the fluorogenic reagent##3##4##(2008-10#3)
with the focus on##2##4##(2008-10#2)
with the focus##3##3##(2008-10#2)(2013-8#1)
with the following results##3##4##(2008-6#1)(2011-2#1)(2012-3#1)
with the following##17##3##(1992-2#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#6)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
with the formation of a##4##5##(1990-5#1)(1991-9#1)(2007-12#1)(2008-10#1)
with the formation of the##5##5##(1994-12#1)(1997-7#1)(2008-10#2)(2008-5#1)
with the formation of##24##4##(1990-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
with the formation##26##3##(1990-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
with the former##5##3##(2008-10#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#1)
with the formula##2##3##(1996-2#1)(2008-5#1)
with the fraction of##2##4##(1996-12#1)(1997-4#1)
with the frequency of##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
with the frequency##5##3##(2007-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
with the full##9##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)(2012-3#2)
with the fully##3##3##(1994-12#1)(1997-4#1)(2008-7#1)
with the functional##3##3##(1994-8#1)(2008-8#2)
with the fungus##4##3##(2008-10#2)(2008-11#2)
with the gamma##2##3##(2008-2#1)(2008-7#1)
with the gelatin##4##3##(2008-2#1)(2011-2#3)
with the gene encoding##2##4##(1992-12#1)(1993-2#1)
with the gene##10##3##(1992-12#1)(1993-2#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)
with the general##11##3##(1992-12#1)(1992-2#1)(1995-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
with the generalized##4##3##(2008-10#1)(2008-2#2)(2012-3#1)
with the generated##2##3##(2008-10#1)(2008-2#1)
with the generation of##4##4##(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
with the generation##5##3##(1993-12#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
with the genetic##4##3##(1995-12#1)(1995-4#1)(2008-4#1)(2008-9#1)
with the genomic##3##3##(1990-12#1)(2008-5#1)(2013-1#1)
with the genus##2##3##(1997-4#1)(2008-10#1)
with the geographic##2##3##(2008-10#1)(2009-8#1)
with the given##2##3##(2008-10#1)(2008-3#1)
with the glass##2##3##(1995-3#1)(2008-10#1)
with the global##4##3##(1996-7#1)(2008-10#1)(2008-12#1)(2013-7#1)
with the glycolytic##2##3##(2008-7#1)(2012-2#1)
with the goal of determining##3##5##(1992-12#1)(2008-9#1)(2010-8#1)
with the goal of developing a##2##6##(2007-11#1)(2011-8#1)
with the goal of facilitating##2##5##(2008-7#1)(2012-12#1)
with the goal of##21##4##(1992-12#1)(1994-1#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2011-8#1)(2012-12#2)(2012-2#2)
with the goal##23##3##(1992-12#1)(1994-1#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-12#2)(2012-2#2)(2012-3#1)
with the goals##2##3##(1994-12#1)(1996-3#1)
with the government##2##3##(1993-3#1)(1994-9#1)
with the gradual##3##3##(2008-6#1)(2008-9#1)(2009-10#1)
with the grating##2##3##(2008-3#2)
with the greater##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
with the greatest number of##2##5##(1990-12#1)(2008-6#1)
with the greatest##18##3##(1990-12#1)(1991-9#1)(1992-2#1)(1996-3#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#1)
with the green##3##3##(2008-10#1)(2008-2#2)
with the ground state##2##4##(2009-9#1)(2012-2#1)
with the group##4##3##(1995-12#1)(2007-11#1)(2010-3#1)(2011-2#1)
with the growing##3##3##(1995-2#1)(2007-8#1)(2013-8#1)
with the growth of##2##4##(1997-3#1)(2008-10#1)
with the growth##6##3##(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)
with the guidance of##4##4##(2008-3#2)(2011-2#2)
with the hands##2##3##(1995-5#1)(2010-5#1)
with the head##2##3##(1993-3#1)(2007-12#1)
with the health care team##2##5##(1995-2#1)(2008-7#1)
with the health care##7##4##(1994-12#2)(1995-2#1)(1997-3#1)(2007-2#1)(2008-7#2)
with the health##11##3##(1990-12#1)(1994-12#2)(1995-2#1)(1997-3#2)(2007-2#1)(2008-7#3)(2013-7#1)
with the healthy##5##3##(1997-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
with the heart##2##3##(1990-9#1)(2013-1#1)
with the heat##2##3##(1991-5#1)(2008-2#1)
with the heated##2##3##(2008-10#2)
with the heavy##2##3##(2008-4#1)(2013-8#1)
with the help of a##10##5##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2009-5#1)(2011-1#1)(2012-3#1)
with the help of the##2##5##(2008-3#1)(2011-1#1)
with the help of##29##4##(1993-8#1)(1996-3#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#3)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-8#1)
with the hepatitis##2##3##(1991-6#1)(2009-7#1)
with the herbicide##2##3##(2008-10#2)
with the herbicides##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
with the heterologous##3##3##(1990-8#1)(2008-10#2)
with the high affinity##3##4##(1991-2#1)(1997-2#1)(2010-1#1)
with the high initial##2##4##(1990-3#1)(2008-10#1)
with the high level of##2##5##(2008-10#2)
with the high performance liquid chromatography (HPLC)##2##7##(2008-10#1)(2011-1#1)
with the high##21##3##(1990-3#1)(1990-8#1)(1991-2#1)(1992-9#1)(1993-1#1)(1997-2#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
with the high-level##2##3##(2008-8#1)(2010-7#1)
with the higher##10##3##(1992-5#1)(1993-12#1)(1994-2#1)(1997-4#1)(2008-10#3)(2010-2#2)(2011-2#1)
with the highest and##2##4##(2008-10#1)(2008-3#1)
with the highest concentration##3##4##(1992-8#1)(2008-5#1)(2013-1#1)
with the highest disease##2##4##(2008-10#2)
with the highest expression##2##4##(2008-9#1)(2012-2#1)
with the highest frequency##3##4##(1995-5#1)(2008-10#1)(2008-12#1)
with the highest levels of##2##5##(1994-5#1)(2008-10#1)
with the highest levels##3##4##(1994-5#1)(2008-10#1)(2008-8#1)
with the highest prevalence##4##4##(1990-6#1)(2013-8#3)
with the highest rate##2##4##(1997-8#1)(2012-2#1)
with the highest risk##2##4##(2008-4#1)(2010-5#1)
with the highest specific##2##4##(1992-6#1)(2008-10#1)
with the highest values##2##4##(2008-10#1)(2013-1#1)
with the highest##62##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-8#2)(2007-10#2)(2007-11#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
with the highly##8##3##(1991-9#1)(1993-2#1)(1996-2#1)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#1)
with the histological grading##3##4##(2013-8#3)
with the histological##4##3##(2009-7#1)(2013-8#3)
with the histopathological##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
with the history##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
with the hologram##2##3##(2007-12#1)(2008-2#1)
with the homocysteine##2##3##(2008-10#1)(2008-3#1)
with the homologous##9##3##(1990-4#1)(1992-4#1)(1992-8#1)(1995-11#1)(1995-9#1)(2008-10#3)(2008-5#1)
with the hospital##4##3##(1991-11#1)(1996-2#1)(2011-3#1)(2012-3#1)
with the host and##2##4##(2008-7#1)(2011-2#1)
with the host of origin##2##5##(2008-10#2)
with the host##11##3##(2008-10#4)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#3)(2013-1#1)
with the human TSH receptor##2##5##(1993-3#1)(1996-5#1)
with the human and##4##4##(1991-6#1)(1993-2#1)(1996-12#2)
with the human immunodeficiency virus##2##5##(1991-2#1)(2007-7#1)
with the human immunodeficiency##3##4##(1991-2#1)(1996-6#1)(2007-7#1)
with the human##23##3##(1991-2#1)(1991-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-8#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
with the hydrogen##2##3##(2008-10#2)
with the hydrophobic##3##3##(1990-8#1)(1991-12#1)(2008-3#1)
with the hypotheses##4##3##(1994-3#1)(2008-10#1)(2009-11#1)(2012-2#1)
with the hypothesis of##7##4##(2008-10#4)(2009-10#1)(2011-2#1)(2013-8#1)
with the hypothesis that a##2##5##(1990-5#1)(2008-8#1)
with the hypothesis that the##9##5##(1993-2#1)(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2012-1#1)
with the hypothesis that##39##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
with the hypothesis##46##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
with the hypovirulent Pn117 and##2##5##(2008-10#2)
with the hypovirulent Pn117##3##4##(2008-10#3)
with the idea that the##3##5##(1990-10#1)(1990-5#1)(2009-10#1)
with the idea that##8##4##(1990-10#1)(1990-11#1)(1990-5#1)(1991-9#1)(1995-3#1)(2008-10#1)(2009-10#1)(2009-11#1)
with the idea##9##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-9#1)(1995-3#1)(2008-10#2)(2009-10#1)(2009-11#1)
with the identical##3##3##(1992-8#1)(2008-11#1)(2008-7#1)
with the identification of the##2##5##(2007-12#1)(2013-7#1)
with the identification of##10##4##(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#3)(2009-8#1)(2010-12#1)(2012-12#1)(2013-7#1)
with the identification##11##3##(1992-9#1)(1993-12#1)(2007-12#1)(2008-10#3)(2009-8#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
with the image##2##3##(2007-11#1)(2010-12#1)
with the immobilized##2##3##(2008-10#2)
with the immune##2##3##(1993-3#1)(2013-1#1)
with the immunosuppressive##2##3##(1990-12#1)(2008-10#1)
with the impact of##2##4##(1997-2#1)(2010-2#1)
with the impact##4##3##(1997-2#1)(2007-10#1)(2008-12#1)(2010-2#1)
with the implant were##2##4##(2008-9#1)(2011-1#1)
with the implementation of##9##4##(1995-12#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-2#1)
with the implied##2##3##(1990-7#1)(2008-11#1)
with the importance of##3##4##(2008-8#1)(2009-8#1)(2011-1#1)
with the importance##4##3##(1995-1#1)(2008-8#1)(2009-8#1)(2011-1#1)
with the important##2##3##(2012-2#1)(2012-3#1)
with the improved Ronchi test##2##5##(2008-3#2)
with the improved##4##3##(2008-3#4)
with the improvement of##2##4##(1991-6#1)(2013-8#1)
with the improvement##3##3##(1991-6#1)(2007-10#1)(2013-8#1)
with the in vitro##3##4##(2009-6#1)(2010-5#1)(2012-1#1)
with the in vivo##3##4##(1993-12#1)(1995-5#1)(1996-12#1)
with the in##9##3##(1990-2#1)(1993-12#1)(1995-5#1)(1996-12#1)(2008-10#1)(2009-6#1)(2010-5#1)(2012-1#1)(2012-3#1)
with the inability##2##3##(2009-7#1)(2012-12#1)
with the incidence of##9##4##(1993-12#1)(1993-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-1#1)
with the incidence##12##3##(1993-12#1)(1993-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
with the inclusion of##4##4##(1990-11#1)(1990-8#1)(2008-10#2)
with the inclusion##6##3##(1990-11#1)(1990-8#1)(2008-10#3)(2013-1#1)
with the incoherent##2##3##(2008-3#2)
with the incorporation of##3##4##(1992-6#1)(1996-3#1)(2008-4#1)
with the increase in the##3##5##(1994-11#1)(2008-11#1)(2012-2#1)
with the increase in##20##4##(1990-12#1)(1993-3#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
with the increase of the##6##5##(2008-10#4)(2008-3#1)(2011-3#1)
with the increase of workload##2##5##(2011-2#2)
with the increase of##24##4##(1993-8#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)
with the increase##45##3##(1990-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(2006-10#1)(2007-11#1)(2008-10#8)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
with the increased##8##3##(1993-11#1)(1994-11#1)(1995-5#1)(2007-10#1)(2008-12#2)(2008-2#1)(2011-1#1)
with the increases in the##2##5##(1997-2#1)(2008-5#1)
with the increasing number of##2##5##(1993-2#1)(2008-10#1)
with the increasing##15##3##(1991-3#1)(1992-6#2)(1993-2#1)(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)
with the incubation##2##3##(2008-10#1)(2008-9#1)
with the independently##2##3##(1997-2#1)(2008-10#1)
with the index of##2##4##(2008-10#2)
with the index##3##3##(2008-10#2)(2008-3#1)
with the indications for##2##4##(2008-7#1)(2012-12#1)
with the individual##2##3##(1993-12#1)(2008-10#1)
with the induced##2##3##(2007-12#1)(2008-4#1)
with the induction of##7##4##(1990-5#1)(1991-3#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
with the induction##9##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
with the inflammatory##2##3##(1993-3#1)(2007-10#1)
with the influence##5##3##(1993-12#1)(1994-3#2)(2008-10#1)(2009-11#1)
with the information##6##3##(1993-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-5#1)
with the inhibition of##3##4##(1991-2#1)(1992-3#1)(2008-11#1)
with the inhibition##4##3##(1991-2#1)(1992-3#1)(2008-10#1)(2008-11#1)
with the inhibitor##3##3##(1992-2#1)(1995-2#1)(2010-10#1)
with the inhibitory##4##3##(1995-6#1)(1996-2#1)(2008-5#1)(2012-3#1)
with the initial##4##3##(2008-10#2)(2008-7#1)(2010-3#1)
with the initiation of##2##4##(2006-10#1)(2010-8#1)
with the initiation##3##3##(2006-10#1)(2008-7#1)(2010-8#1)
with the inner##3##3##(1990-5#1)(2008-10#2)
with the inorganic##3##3##(1990-5#1)(2008-10#1)(2010-4#1)
with the input##2##3##(1995-2#1)(2008-3#1)
with the insignificant biases##2##4##(2008-10#2)
with the instrument function##2##4##(2008-3#2)
with the instrument##3##3##(1992-6#1)(2008-3#2)
with the insulin##2##3##(1991-12#1)(2010-11#1)
with the integrated##2##3##(2008-10#1)(2012-3#1)
with the intensity of##2##4##(2007-11#1)(2008-5#1)
with the intensity##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
with the intent of##5##4##(1994-1#1)(1994-3#1)(2008-12#1)(2008-8#1)(2010-5#1)
with the intent##6##3##(1994-1#1)(1994-3#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-5#1)
with the intention of##2##4##(1995-3#2)
with the intention to##2##4##(2011-1#1)(2013-8#1)
with the intention##4##3##(1995-3#2)(2011-1#1)(2013-8#1)
with the interaction between##3##4##(1993-8#1)(2006-6#1)(2008-11#1)
with the interaction##5##3##(1993-8#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
with the interactions##2##3##(1993-1#1)(2008-9#1)
with the internal##2##3##(2008-1#1)(2008-3#1)
with the intracellular##3##3##(1992-6#1)(1994-3#1)(1996-12#1)
with the intravenous injection of##2##5##(1992-3#2)
with the introduction of##10##4##(1990-12#1)(1993-1#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)
with the involvement of##6##4##(1993-11#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-8#1)(2009-6#1)
with the involvement##7##3##(1993-11#1)(1994-3#1)(1995-11#1)(2008-10#2)(2008-8#1)(2009-6#1)
with the ion pair of 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol and##2##7##(2008-10#2)
with the ion pair of##4##5##(2008-10#4)
with the ion##6##3##(2008-10#5)(2009-11#1)
with the irradiation##2##3##(2008-10#2)
with the isolated##3##3##(1990-5#1)(1995-2#1)(1997-7#1)
with the issue of##5##4##(1995-12#1)(2008-11#1)(2008-12#2)(2011-2#1)
with the issue##7##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
with the job##2##3##(1991-2#1)(1996-1#1)
with the judiciary##2##3##(2011-2#2)
with the jury##2##3##(1995-6#2)
with the kainate##2##3##(1995-11#1)(1995-5#1)
with the karyosome##2##3##(2007-12#1)(2008-7#1)
with the key##2##3##(2012-12#1)(2013-1#1)
with the kinetically##2##3##(1990-8#1)(1997-2#1)
with the knowledge##2##3##(2008-10#1)(2008-9#1)
with the known##14##3##(1990-2#1)(1990-7#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-10#1)
with the label values##2##4##(2008-10#2)
with the lack of a##2##5##(1990-2#1)(1995-3#1)
with the lack of##5##4##(1990-2#1)(1992-3#1)(1995-3#1)(2008-10#1)(2008-9#1)
with the lag##2##3##(1992-11#1)(2008-11#1)
with the laparoscopic##2##3##(1995-3#1)(2013-1#1)
with the large subunit##2##4##(1993-8#1)(1995-12#1)
with the large##5##3##(1993-8#1)(1995-12#1)(1995-8#1)(2011-2#1)(2013-1#1)
with the larger##4##3##(1991-6#1)(2008-10#1)(2009-10#1)(2010-11#1)
with the largest##9##3##(1994-1#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
with the laser beam##2##4##(2008-2#1)(2008-3#1)
with the laser##9##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)
with the latest##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
with the latter##10##3##(1994-12#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
with the law##2##3##(2008-11#1)(2008-9#1)
with the learning##2##3##(1993-12#1)(2008-11#1)
with the least##4##3##(2008-10#3)(2010-2#1)
with the left##2##3##(2007-8#1)(2010-2#1)
with the length of the##2##5##(1995-5#1)(2008-3#1)
with the length of##4##4##(1995-5#1)(2008-3#1)(2012-12#1)(2013-1#1)
with the level of##12##4##(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
with the ligand##5##3##(1992-3#1)(1997-2#1)(2008-10#2)(2008-8#1)
with the light and##2##4##(1995-12#1)(2008-7#1)
with the light##7##3##(1995-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-3#1)
with the limit of##4##4##(2008-10#4)
with the limitation of##2##4##(2008-10#2)
with the limited##5##3##(1992-3#1)(1994-12#1)(1997-7#1)(2008-8#1)(2009-8#1)
with the linear range##3##4##(2008-10#3)
with the linear##5##3##(2007-12#1)(2008-10#3)(2013-1#1)
with the lipase##2##3##(1995-5#1)(2008-10#1)
with the lipid##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
with the liposomal vaccine than with a subunit vaccine for##2##10##(2007-11#2)
with the literature##8##3##(1990-3#1)(1993-3#1)(2008-10#4)(2012-2#1)(2012-3#1)
with the local##7##3##(1992-5#1)(2008-11#1)(2008-3#2)(2009-5#1)(2010-8#1)(2011-2#1)
with the location of##3##4##(1992-8#1)(2013-1#2)
with the location##4##3##(1992-8#1)(2012-2#1)(2013-1#2)
with the logarithm of##2##4##(2008-10#2)
with the long##3##3##(1990-5#1)(1993-6#1)(2011-2#1)
with the longest##4##3##(1990-8#1)(2008-2#1)(2008-9#1)(2011-2#1)
with the longitudinal##2##3##(2007-11#1)(2008-7#1)
with the loss of the##2##5##(1994-8#1)(1995-5#1)
with the loss of##6##4##(1994-8#1)(1995-2#1)(1995-5#1)(2008-11#1)(2010-7#1)(2011-3#1)
with the low##6##3##(1990-8#1)(1996-12#2)(2007-12#1)(2008-9#1)(2011-2#1)
with the lower##2##3##(1995-3#1)(2007-10#1)
with the lowest friction##2##4##(1997-3#2)
with the lowest incidence##2##4##(2008-10#2)
with the lowest infection##2##4##(2008-10#2)
with the lowest mean##2##4##(1995-12#1)(2008-10#1)
with the lowest##27##3##(1993-12#1)(1995-12#1)(1997-3#2)(2007-10#1)(2008-10#9)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
with the lung##2##3##(1992-12#1)(2010-7#1)
with the mRNA##2##3##(1994-12#1)(2008-8#1)
with the magnetic##3##3##(2008-10#3)
with the magnitude of the##2##5##(1996-6#1)(2008-3#1)
with the magnitude of##3##4##(1996-6#1)(1997-2#1)(2008-3#1)
with the magnitude##4##3##(1996-6#1)(1997-2#1)(2008-3#1)(2009-10#1)
with the main emphasis on##2##5##(2008-8#2)
with the main##13##3##(1990-7#1)(1993-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#3)(2009-5#1)(2011-2#2)(2011-3#1)
with the major##6##3##(1991-8#1)(1993-8#1)(1994-6#1)(2008-1#1)(2008-10#2)
with the majority of##9##4##(1993-8#1)(2007-11#1)(2008-10#5)(2011-10#1)(2013-1#1)
with the majority##12##3##(1993-8#1)(2007-11#1)(2008-10#5)(2008-9#1)(2009-4#1)(2010-2#1)(2011-10#1)(2013-1#1)
with the mammalian##3##3##(1990-12#1)(1995-11#1)(1997-3#1)
with the management of##3##4##(2008-9#1)(2010-9#1)(2012-3#1)
with the management##4##3##(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#1)
with the manifestation of##2##4##(2008-11#1)(2011-2#1)
with the manual##2##3##(2008-10#2)
with the materials##2##3##(1996-2#1)(2008-10#1)
with the matrix##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
with the maximum temperature as##2##5##(2011-1#2)
with the maximum temperature of##2##5##(2011-1#2)
with the maximum temperature##4##4##(2011-1#4)
with the maximum##16##3##(2007-11#1)(2008-10#8)(2009-5#1)(2011-1#4)(2013-1#2)
with the mean of##2##4##(1994-3#1)(2008-10#1)
with the mean##7##3##(1994-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)
with the measured values##2##4##(2008-2#1)(2008-3#1)
with the measured##12##3##(1996-12#1)(2007-12#1)(2008-2#4)(2008-3#6)
with the measurements##5##3##(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)
with the measures of##2##4##(2008-10#1)(2013-1#1)
with the medical##5##3##(1993-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)
with the medium##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
with the membrane and##2##4##(1990-11#1)(2008-10#1)
with the membrane##9##3##(1990-11#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-6#1)(2008-10#3)(2009-9#1)
with the membranes##3##3##(1990-7#1)(1991-10#1)(1995-6#1)
with the mental health##2##4##(1997-3#1)(2008-12#1)
with the mental##3##3##(1997-3#1)(2008-12#1)(2012-3#1)
with the metabolic syndrome and##4##5##(2008-3#1)(2008-5#1)(2010-4#2)
with the metabolic syndrome##13##4##(2008-1#4)(2008-3#1)(2008-5#1)(2010-4#3)(2011-2#3)(2012-2#1)
with the metal##4##3##(2008-10#3)(2008-5#1)
with the metastatic##2##3##(1992-9#1)(1994-5#1)
with the method of##6##4##(1990-11#1)(2008-3#1)(2010-12#1)(2011-3#1)(2013-8#2)
with the method##11##3##(1990-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-3#1)(2013-8#2)
with the methods##3##3##(1991-3#1)(2012-12#1)(2013-1#1)
with the methyl##2##3##(1990-7#1)(1991-5#1)
with the microscopic##3##3##(2008-10#2)(2008-3#1)
with the minimal##2##3##(1993-12#1)(2012-2#1)
with the minimum temperature##2##4##(2008-10#1)(2008-8#1)
with the minimum##9##3##(1996-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
with the minor##2##3##(1996-2#1)(2011-2#1)
with the mitochondrial##2##3##(1995-2#1)(2010-4#1)
with the mixed##2##3##(2008-10#1)(2009-6#1)
with the mixture of##2##4##(2008-10#2)
with the mixture##3##3##(2008-10#3)
with the mobile phase for##2##5##(1990-8#2)
with the mobile phase of##3##5##(2008-10#2)(2011-1#1)
with the mobile phase##9##4##(1990-8#2)(2008-10#4)(2011-1#2)(2011-3#1)
with the mobile##10##3##(1990-8#2)(2008-10#4)(2011-1#3)(2011-3#1)
with the model##11##3##(1990-8#1)(1991-1#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#2)
with the modeling##2##3##(2008-10#1)(2010-9#1)
with the models##2##3##(2008-10#1)(2013-8#1)
with the modified##8##3##(1990-8#1)(2008-10#5)(2008-2#1)(2008-3#1)
with the mole##2##3##(1992-6#1)(2008-10#1)
with the molecular weight##2##4##(1993-11#1)(2012-3#1)
with the molecular##3##3##(1993-11#1)(2008-11#1)(2012-3#1)
with the monoclonal antibody##2##4##(1992-12#1)(1997-7#1)
with the monoclonal##4##3##(1991-5#1)(1992-12#1)(1994-3#1)(1997-7#1)
with the more severe##2##4##(1997-3#1)(2012-2#1)
with the more##10##3##(1997-3#2)(2008-10#3)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
with the morphological##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
with the most common##5##4##(2008-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
with the most commonly##2##4##(2010-8#1)(2011-2#1)
with the most severe##5##4##(1990-8#1)(1995-2#1)(1995-9#1)(2006-10#1)(2010-8#1)
with the most##28##3##(1990-8#1)(1991-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
with the motion model##2##4##(2008-3#2)
with the motor##2##3##(1993-6#1)(2008-7#1)
with the mouse and##2##4##(1990-8#1)(2008-4#1)
with the mouse##7##3##(1990-8#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-11#1)(1997-4#1)(2008-4#1)
with the multidisciplinary##2##3##(1996-3#1)(2010-3#1)
with the murine##2##3##(1994-12#1)(1994-8#1)
with the muscle##2##3##(2008-7#1)(2009-3#1)
with the mutant##2##3##(1990-8#1)(2008-10#1)
with the mutation##2##3##(1997-7#1)(2012-12#1)
with the naked eye##3##4##(2008-10#2)(2008-3#1)
with the national##2##3##(2008-10#1)(2012-3#1)
with the native##3##3##(1990-2#1)(1992-6#1)(2008-11#1)
with the natural##9##3##(1992-3#1)(1993-2#1)(1994-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2013-8#1)
with the nature of##2##4##(1991-12#1)(2008-10#1)
with the necessary##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
with the need for##8##4##(1993-3#1)(1996-1#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
with the need to##5##4##(1994-12#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-10#1)
with the need##13##3##(1993-3#1)(1994-12#1)(1996-1#2)(1997-1#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
with the negative##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
with the nematode##3##3##(2008-10#3)
with the nephrotic syndrome##6##4##(2007-7#1)(2008-1#5)
with the nerve##2##3##(2008-11#1)(2008-5#1)
with the neurosurgeons##2##3##(2012-3#1)(2013-1#1)
with the neutral theory##2##4##(1994-8#1)(2008-8#1)
with the neutral##5##3##(1994-8#1)(1995-2#1)(2008-10#2)(2008-8#1)
with the new##22##3##(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1995-2#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
with the newly##2##3##(2010-7#1)(2013-1#1)
with the normal##18##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(2007-12#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)
with the normalized##2##3##(2008-3#1)(2008-8#1)
with the notion that##7##4##(1990-8#1)(1991-2#1)(1992-3#1)(2007-8#1)(2009-5#1)(2011-2#2)
with the notions of##2##4##(2009-3#1)(2012-2#1)
with the novel##6##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)
with the nuclear##2##3##(1994-11#1)(2008-10#1)
with the nucleotide##2##3##(1996-8#1)(2008-4#1)
with the nucleus##3##3##(1993-8#1)(1997-1#1)(2008-9#1)
with the number of naturalizations##2##5##(2008-8#2)
with the number of##33##4##(1990-11#1)(1990-2#1)(1990-6#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-3#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
with the number##34##3##(1990-11#1)(1990-2#1)(1990-6#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#4)(2008-11#2)(2008-3#6)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
with the numerical##3##3##(2007-11#1)(2008-3#1)(2008-9#1)
with the object##3##3##(1990-12#1)(2008-3#2)
with the objective of finding##2##5##(1995-3#1)(2008-7#1)
with the objective of##9##4##(1994-6#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
with the objective to##2##4##(2008-10#1)(2008-5#1)
with the objective##12##3##(1994-6#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
with the observation that##5##4##(1992-1#1)(2008-10#3)(2011-2#1)
with the observations##2##3##(1994-1#1)(2008-9#1)
with the observed data##2##4##(1995-2#1)(2011-2#1)
with the observed relative##2##4##(2008-10#1)(2012-12#1)
with the observed##17##3##(1992-11#1)(1993-3#1)(1995-2#2)(2007-1#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)
with the obtained##2##3##(2008-10#2)
with the occurrence of##10##4##(1991-10#1)(1995-2#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#2)(2012-2#1)(2013-1#1)
with the official methods##2##4##(2008-10#2)
with the official##4##3##(1995-6#1)(2008-10#3)
with the oligonucleotide probe##2##4##(1992-9#1)(2008-10#1)
with the on-axis##2##3##(2008-2#1)(2008-3#1)
with the oncologist##2##3##(2008-11#1)(2008-6#1)
with the one##2##3##(2007-2#1)(2011-2#1)
with the ones##5##3##(1990-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
with the ongoing##2##3##(1994-1#1)(2008-10#1)
with the only##7##3##(1990-2#2)(1994-9#1)(1995-11#1)(2007-12#1)(2008-6#1)(2012-12#1)
with the onset of##7##4##(1994-3#1)(1995-12#1)(1995-3#1)(2007-5#1)(2008-2#1)(2008-7#1)(2012-2#1)
with the opportunity to##4##4##(2008-11#1)(2008-5#1)(2009-4#1)(2013-8#1)
with the opportunity##5##3##(2008-1#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-8#1)
with the optic##2##3##(1993-12#1)(2008-2#1)
with the optical depth##2##4##(2008-2#1)(2008-3#1)
with the optical##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
with the optimal##3##3##(2008-6#1)(2010-10#1)(2012-3#1)
with the optimized##2##3##(2008-3#2)
with the optimum at##2##4##(2008-10#2)
with the optimum##4##3##(2008-10#3)(2008-3#1)
with the option of##4##4##(1997-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
with the order of the polynomial##2##6##(2008-3#1)(2008-6#1)
with the order of the##3##5##(2008-10#1)(2008-3#1)(2008-6#1)
with the order of##5##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
with the order##6##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
with the organic##4##3##(2007-12#1)(2008-10#2)(2009-7#1)
with the organism##2##3##(2007-12#1)(2008-7#1)
with the organisms##2##3##(2008-12#1)(2008-9#1)
with the original##6##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
with the other three##2##4##(2008-10#2)
with the other two##6##4##(1995-2#1)(2008-10#2)(2010-6#1)(2011-1#1)(2012-3#1)
with the other##37##3##(1990-5#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-2#1)(1997-7#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-10#13)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#4)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#3)
with the others##3##3##(2008-10#2)(2013-1#1)
with the outcome of##4##4##(1990-9#1)(1995-9#1)(2008-7#1)(2009-5#1)
with the outcome##7##3##(1990-9#1)(1995-9#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
with the output##2##3##(2007-12#1)(2008-2#1)
with the overall##6##3##(1995-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
with the oxygen atoms##2##4##(2008-10#1)(2011-2#1)
with the oxygen##5##3##(1990-5#1)(1997-7#1)(2008-10#2)(2011-2#1)
with the pH##8##3##(2008-10#7)(2008-6#1)
with the parabolic##3##3##(2007-11#1)(2008-3#2)
with the parallel##2##3##(2009-3#1)(2013-7#1)
with the parameter##3##3##(2008-10#1)(2008-9#2)
with the parameters##2##3##(1990-2#1)(2008-10#1)
with the parent##2##3##(2008-4#1)(2013-1#1)
with the parental##6##3##(1993-6#1)(2008-10#4)(2008-9#1)
with the participation of##2##4##(2008-8#1)(2012-1#1)
with the particle size of 3##2##6##(2013-8#2)
with the particle size##4##4##(2007-11#1)(2008-3#1)(2013-8#2)
with the particle##8##3##(2007-11#1)(2007-9#1)(2008-3#4)(2013-8#2)
with the particles'##2##3##(2008-3#1)(2009-9#1)
with the particular##3##3##(2007-8#1)(2008-4#1)(2008-9#1)
with the particulate fraction##2##4##(1992-8#1)(1997-1#1)
with the passage of##2##4##(2006-10#1)(2008-10#1)
with the pathogen##18##3##(2008-10#18)
with the pathogenesis of##3##4##(1997-3#1)(2010-12#1)(2012-12#1)
with the pathogenic##2##3##(1997-6#1)(2008-10#1)
with the pathogens##2##3##(2008-10#1)(2010-4#1)
with the patient in##2##4##(1990-6#1)(2007-8#1)
with the patient##18##3##(1990-6#1)(1991-2#1)(1993-10#1)(1997-5#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
with the patient's##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
with the patients##10##3##(1996-2#1)(2008-10#1)(2008-7#4)(2009-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
with the pattern of##2##4##(2008-8#1)(2012-2#1)
with the pattern##3##3##(2007-12#1)(2008-8#1)(2012-2#1)
with the patterns of##2##4##(2008-10#1)(2008-2#1)
with the peak heights##2##4##(2008-10#2)
with the peak##5##3##(1996-12#1)(2007-11#1)(2008-10#2)(2008-5#1)
with the peptide##5##3##(1991-1#1)(1993-11#1)(1994-5#1)(2008-10#2)
with the perception##2##3##(2008-11#1)(2012-2#1)
with the perceptual##2##3##(2007-8#2)
with the performance of the##2##5##(1991-1#1)(2008-3#1)
with the performance of##7##4##(1991-1#1)(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#3)
with the period of##2##4##(2008-10#1)(2008-5#1)
with the period##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
with the personality##2##3##(2009-5#1)(2011-2#1)
with the pharmacy was##2##4##(2010-3#2)
with the phase##2##3##(2008-3#1)(2011-2#1)
with the phenol group##2##4##(1994-5#2)
with the physical##2##3##(2008-2#1)(2008-5#1)
with the physiological##2##3##(2009-2#1)(2012-1#1)
with the physiology of##2##4##(2008-7#1)(2010-2#1)
with the placebo group##6##4##(1991-11#1)(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)
with the placebo##7##3##(1991-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2012-2#1)
with the plane of incidence##2##5##(2008-2#2)
with the plant##3##3##(2008-10#3)
with the plasma membrane##4##4##(1990-11#1)(1992-12#1)(1994-11#1)(2008-11#1)
with the plasmid expressing##2##4##(2008-11#1)(2008-9#1)
with the plasmid##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
with the plate##2##3##(2008-10#2)
with the point-spread function##2##4##(2008-3#2)
with the point-spread##3##3##(2008-3#3)
with the polar##2##3##(1991-5#1)(2013-8#1)
with the polyclonal antiserum##2##4##(2008-10#2)
with the polyclonal##3##3##(1990-8#1)(2008-10#2)
with the polymer##4##3##(2008-10#4)
with the polymerase chain##2##4##(1990-8#2)
with the polymerase##3##3##(1990-8#3)
with the polymers##2##3##(2008-10#1)(2008-4#1)
with the poor##2##3##(1993-11#1)(1995-9#1)
with the poorly##2##3##(1991-8#1)(1993-9#1)
with the population##2##3##(2008-7#1)(2012-2#1)
with the positive##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
with the possibility to prove a supposed reaction##2##8##(2008-10#2)
with the possibility to##3##4##(2008-10#2)(2010-3#1)
with the possibility##5##3##(1995-2#1)(1997-8#1)(2008-10#2)(2010-3#1)
with the possible exception of##2##5##(1990-9#1)(2008-4#1)
with the possible##4##3##(1990-9#1)(2008-4#1)(2013-1#1)(2013-8#1)
with the postero-lateral spondylodesis##2##4##(2007-11#2)
with the potency##3##3##(1991-8#1)(1993-8#1)(2008-8#1)
with the potential for##5##4##(1990-2#1)(1995-2#1)(1996-4#1)(2007-12#1)(2008-2#1)
with the potential of being##2##5##(2008-10#1)(2008-7#1)
with the potential of##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
with the potential to encode a##2##6##(1994-12#1)(2008-10#1)
with the potential to encode##3##5##(1994-12#1)(2008-10#1)(2013-8#1)
with the potential to##8##4##(1994-12#1)(1997-1#1)(2008-10#1)(2010-12#2)(2013-1#2)(2013-8#1)
with the potential##19##3##(1990-2#1)(1994-12#1)(1995-2#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
with the practical##2##3##(1993-2#1)(2008-11#1)
with the precision of##2##4##(2008-10#2)
with the precision##3##3##(2008-10#3)
with the preconcentration##4##3##(2008-10#4)
with the predicted##8##3##(1994-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
with the prediction of##2##4##(2007-11#1)(2012-3#1)
with the prediction##6##3##(1993-12#2)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
with the predictions of Mie theory##2##6##(2008-2#2)
with the predictions of a##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
with the predictions of##7##4##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
with the predictions##9##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
with the preparation of##2##4##(2008-10#1)(2009-7#1)
with the prescribed medication##2##4##(1993-11#1)(1995-2#1)
with the prescriptions##2##3##(1995-11#1)(2008-10#1)
with the presence of a##7##5##(1996-2#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-1#1)
with the presence of the##3##5##(1995-5#1)(1997-4#1)(2008-10#1)
with the presence of##42##4##(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#1)
with the presence##43##3##(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#1)
with the present chelating##2##4##(2008-10#2)
with the present method##2##4##(2008-10#2)
with the present##12##3##(1990-12#2)(1991-1#1)(1996-1#1)(2008-10#7)(2008-7#1)
with the presentation of##2##4##(1992-6#1)(2008-2#1)
with the preservation of##2##4##(1997-7#1)(2008-5#1)
with the prevalence of##4##4##(1993-5#1)(1995-8#1)(2008-3#1)(2011-2#1)
with the prevalence##6##3##(1993-5#1)(1995-8#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
with the prevalent##2##3##(2008-10#1)(2012-12#1)
with the previous introduction of##2##5##(2008-10#2)
with the previous##28##3##(1991-12#1)(1992-2#1)(1993-12#1)(1996-11#1)(1996-5#2)(1997-2#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with the previously described##3##4##(2008-10#2)(2008-3#1)
with the previously reported##5##4##(1995-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
with the previously##17##3##(1994-12#1)(1994-3#1)(1995-11#2)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#3)(2010-5#1)
with the primary##10##3##(1994-12#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2012-12#1)(2013-1#1)
with the principles and##2##4##(1993-11#1)(2008-11#1)
with the principles##3##3##(1993-11#1)(2008-11#1)(2008-2#1)
with the privacy##2##3##(1995-6#1)(2007-12#1)
with the probability of##2##4##(2008-7#1)(2008-8#1)
with the probe##4##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
with the problem of##2##4##(1993-2#1)(2013-8#1)
with the problem##8##3##(1992-1#1)(1993-2#1)(1994-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
with the problems##3##3##(1990-6#1)(1993-2#1)(1994-2#1)
with the process of##2##4##(2008-10#1)(2008-5#1)
with the process##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
with the processing of##2##4##(2008-3#1)(2010-5#1)
with the product of the##4##5##(1992-6#1)(1997-3#1)(2008-10#1)(2008-3#1)
with the product##5##3##(1992-6#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
with the production of##6##4##(1994-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-8#1)
with the production##7##3##(1992-5#1)(1994-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-8#1)
with the program##2##3##(1997-2#1)(2008-8#1)
with the progress##2##3##(2008-10#1)(2008-9#1)
with the progression of##3##4##(1993-12#1)(1997-1#1)(2008-1#1)
with the progressive##2##3##(1990-8#1)(2008-9#1)
with the propagation axis of the##2##6##(2008-3#2)
with the proper##4##3##(1994-9#1)(2007-12#1)(2008-3#1)(2008-5#1)
with the properties of##3##4##(2008-10#2)(2008-9#1)
with the proportion of##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
with the proposed flow##2##4##(2008-10#2)
with the proposed method and the##2##6##(2008-10#2)
with the proposed method##12##4##(2008-10#10)(2009-5#2)
with the proposed##25##3##(1993-9#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-3#1)(2009-5#3)
with the protein kinase C##2##5##(1992-8#1)(1994-11#1)
with the protein##8##3##(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)
with the protocol##2##3##(2009-2#1)(2012-3#1)
with the provision of##2##4##(1997-8#1)(2012-3#1)
with the published##4##3##(1993-12#1)(1995-11#1)(2008-2#1)(2011-2#1)
with the pulse##2##3##(2007-11#1)(2008-3#1)
with the pump##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
with the pure##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
with the purified##2##3##(1995-2#1)(2008-8#1)
with the purity of##3##4##(2011-1#3)
with the purpose of##2##4##(1996-5#1)(2011-3#1)
with the purpose##3##3##(1996-5#1)(2008-10#1)(2011-3#1)
with the quality of##4##4##(1994-12#1)(2008-9#1)(2012-12#1)(2012-3#1)
with the questions##2##3##(1995-2#1)(2008-7#1)
with the rabbit##3##3##(1990-12#1)(1994-8#1)(1995-6#1)
with the radial##2##3##(2007-8#1)(2011-2#1)
with the radiation##5##3##(2008-10#1)(2008-7#3)(2009-11#1)
with the radioactive##2##3##(1990-2#1)(1993-8#1)
with the range of##4##4##(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
with the range##5##3##(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
with the rapid##7##3##(1994-3#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
with the rare##9##3##(1992-6#1)(2007-5#1)(2008-10#4)(2012-3#2)(2013-8#1)
with the rat FGF-2##2##4##(1996-12#2)
with the rat##6##3##(1993-8#1)(1996-12#2)(1997-2#1)(1997-4#1)(2010-12#1)
with the rate of the##2##5##(1991-12#1)(2008-8#1)
with the rate of##6##4##(1991-12#1)(1993-8#1)(1996-3#1)(2008-8#1)(2010-8#1)(2013-1#1)
with the rate##7##3##(1991-12#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
with the ratio of##7##4##(1991-12#1)(1995-5#1)(1995-8#1)(2008-2#1)(2008-3#2)(2010-6#1)
with the ratio##10##3##(1991-12#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-6#1)
with the reaction##3##3##(1995-6#1)(2008-10#1)(2010-4#1)
with the reagent stream##3##4##(2008-10#3)
with the reagent##7##3##(2008-10#7)
with the recent##9##3##(1991-6#1)(1995-3#1)(1995-6#1)(2008-10#3)(2009-5#1)(2010-1#1)(2010-3#1)
with the recently##9##3##(1995-6#2)(1997-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)
with the receptor##4##3##(1990-4#1)(1996-2#1)(2008-4#1)(2008-8#1)
with the recognition of##2##4##(2008-10#1)(2011-2#1)
with the recognition##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
with the recombinant##5##3##(1994-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-3#1)
with the recommendations##2##3##(1990-6#1)(2013-1#1)
with the recommended##5##3##(1993-2#1)(2008-10#2)(2008-7#1)(2010-6#1)
with the reconstituted##3##3##(1992-9#1)(1995-6#1)(2008-8#1)
with the recoveries of##2##4##(2008-10#2)
with the recovery of##7##4##(2008-10#5)(2008-11#1)(2011-2#1)
with the reduced##2##3##(1995-2#1)(2012-1#1)
with the reducing agents dithiothreitol and##2##6##(1992-6#2)
with the reducing##3##3##(1992-6#2)(2013-8#1)
with the reduction in MC and##2##6##(2013-7#2)
with the reduction in##4##4##(2008-2#1)(2012-12#1)(2013-7#2)
with the reduction of the##3##5##(2008-10#1)(2008-11#1)(2011-1#1)
with the reduction of##7##4##(2008-10#5)(2008-11#1)(2011-1#1)
with the reduction##12##3##(2008-10#6)(2008-11#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-7#2)
with the reference method##2##4##(2008-10#2)
with the reference standard##2##4##(2008-10#2)
with the reference values##3##4##(2008-10#3)
with the reference##20##3##(2008-10#13)(2008-11#1)(2008-3#2)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
with the reflectance##2##3##(2008-10#1)(2008-3#1)
with the refractive index of the##2##6##(2008-10#1)(2008-3#1)
with the region##2##3##(2008-3#1)(2008-6#1)
with the regression coefficient is 0##2##6##(2008-10#2)
with the regression coefficient##3##4##(2008-10#3)
with the regression##5##3##(2008-10#5)
with the regulation of##2##4##(1997-8#1)(2013-8#1)
with the regulatory##6##3##(1990-7#1)(1996-2#1)(2009-10#1)(2009-6#1)(2010-11#1)(2012-1#1)
with the relationship##3##3##(1992-3#1)(2010-3#1)(2011-2#1)
with the relative standard deviation of 3##2##7##(2008-10#2)
with the relative standard deviation of##3##6##(2008-10#2)(2011-1#1)
with the relative standard deviation##6##5##(2008-10#5)(2011-1#1)
with the relative standard deviations##3##5##(2008-10#2)(2011-1#1)
with the relative standard##9##4##(2008-10#7)(2011-1#2)
with the relative##14##3##(1993-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2011-1#2)
with the release of##2##4##(2008-10#1)(2011-2#1)
with the release##5##3##(2008-10#3)(2009-12#1)(2011-2#1)
with the relevant##3##3##(1995-12#1)(1996-3#1)(2008-6#1)
with the remainder##4##3##(1994-12#1)(2008-10#2)(2012-2#1)
with the remaining##4##3##(1993-11#1)(1995-6#1)(2007-5#1)(2011-2#1)
with the reported##17##3##(1990-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#1)
with the reporter##3##3##(1994-2#1)(2008-11#1)(2008-9#1)
with the required##3##3##(1994-8#1)(2008-10#1)(2008-3#1)
with the requirements##3##3##(1990-8#1)(1992-3#1)(2010-3#1)
with the research##2##3##(2008-11#1)(2011-2#1)
with the residual##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
with the resin##2##3##(2008-10#2)
with the resistance gene##3##4##(2008-10#2)(2008-5#1)
with the resistance##5##3##(2008-10#4)(2008-5#1)
with the resonant##2##3##(2007-11#1)(2008-3#1)
with the resonator##2##3##(2007-11#1)(2009-5#1)
with the response of##2##4##(2008-10#1)(2010-2#1)
with the response##6##3##(2008-10#4)(2010-2#1)(2012-12#1)
with the responsibility of##2##4##(1993-1#1)(2009-10#1)
with the responsibility##3##3##(1993-1#1)(1994-12#1)(2009-10#1)
with the rest of the##9##5##(1991-1#1)(1992-11#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-10#1)(2011-2#2)(2013-1#1)
with the rest of##11##4##(1991-1#1)(1992-11#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-10#1)(2011-2#3)(2013-1#1)
with the restriction##2##3##(2006-8#1)(2008-2#1)
with the result of##4##4##(1990-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
with the result that##4##4##(1991-12#1)(1992-2#1)(1997-7#1)(2008-10#1)
with the result##9##3##(1990-2#1)(1991-12#1)(1992-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
with the results from the##2##5##(2008-10#2)
with the results from##4##4##(2008-10#2)(2008-2#2)
with the results given by##2##5##(2008-10#1)(2008-5#1)
with the results obtained by##6##5##(2008-10#6)
with the results obtained from##4##5##(2008-10#3)(2008-2#1)
with the results obtained using##3##5##(2008-10#3)
with the results obtained with##2##5##(2008-10#1)(2008-9#1)
with the results obtained##17##4##(2008-10#15)(2008-2#1)(2008-9#1)
with the results of a##4##5##(1992-2#1)(1996-11#1)(2007-12#1)(2008-7#1)
with the results of direct numerical simulation##2##7##(2007-11#1)(2008-3#1)
with the results of recent##2##5##(1996-11#1)(2008-10#1)
with the results of the proposed##2##6##(2008-10#1)(2012-1#1)
with the results of the##8##5##(2008-10#2)(2008-2#1)(2008-3#3)(2012-1#1)(2013-1#1)
with the results of##35##4##(1991-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1996-11#2)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#7)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
with the results##71##3##(1990-11#1)(1990-7#1)(1991-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1995-2#1)(1996-11#2)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#7)(2008-3#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
with the right##7##3##(1991-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#1)
with the rigorous##2##3##(1991-8#1)(2007-12#1)
with the risk of##13##4##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#2)(2010-12#2)(2010-4#1)(2011-1#1)(2013-8#1)
with the role of##3##4##(1992-6#1)(2008-4#1)(2011-2#1)
with the role##4##3##(1992-6#1)(2008-4#1)(2010-10#1)(2011-2#1)
with the root##2##3##(2008-10#2)
with the roots##2##3##(2011-2#2)
with the sag##2##3##(2008-5#2)
with the same DNA##2##4##(1993-12#1)(2009-10#1)
with the same antigen##2##4##(2008-10#2)
with the same cell line##2##5##(1992-9#1)(2013-1#1)
with the same concentration##2##4##(2007-11#1)(2008-11#1)
with the same efficiency##2##4##(1990-5#1)(2008-10#1)
with the same frequency##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
with the same genetic##2##4##(2008-9#1)(2011-2#1)
with the same number of##3##5##(2008-10#2)(2008-2#1)
with the same period##2##4##(1996-11#1)(2008-3#1)
with the same strain##2##4##(1997-6#1)(2008-5#1)
with the same system##2##4##(2008-10#1)(2008-2#1)
with the same treatment##2##4##(1994-6#1)(2008-5#1)
with the same volume##2##4##(2008-3#1)(2012-3#1)
with the same##135##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-5#2)(1994-6#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#6)(2007-12#2)(2008-10#36)(2008-11#4)(2008-2#7)(2008-3#19)(2008-5#4)(2008-6#2)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
with the sample##5##3##(1990-12#1)(2008-10#4)
with the samples##2##3##(2008-10#1)(2008-3#1)
with the sampling##3##3##(2008-10#2)(2008-8#1)
with the satisfactory results##2##4##(2008-10#2)
with the scale##2##3##(1990-2#1)(2008-3#1)
with the seasonal##2##3##(2008-7#1)(2008-9#1)
with the second harmonic##2##4##(2007-11#1)(2007-12#1)
with the second##7##3##(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
with the secondary##3##3##(1996-5#1)(2008-1#1)(2008-10#1)
with the security##2##3##(2007-12#1)(2008-4#1)
with the selected##2##3##(2007-12#1)(2008-10#1)
with the selection of##2##4##(2008-10#2)
with the selective##7##3##(1991-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#2)
with the selectivity##3##3##(2008-10#2)(2008-2#1)
with the semi-batch system##2##4##(2008-10#2)
with the sensing phase##2##4##(2008-10#2)
with the sensitivity of##4##4##(2008-10#3)(2008-9#1)
with the sensitivity##7##3##(2008-10#5)(2008-8#1)(2008-9#1)
with the sensor##5##3##(1993-12#1)(2007-11#1)(2008-3#2)(2010-2#1)
with the separation and##2##4##(2008-12#2)
with the separation of##2##4##(2008-10#2)
with the separation##4##3##(2008-10#2)(2008-12#2)
with the sequence of##5##4##(1990-11#1)(1990-5#1)(1993-8#1)(1994-11#1)(1997-7#1)
with the sequence##8##3##(1990-11#1)(1990-5#1)(1992-10#1)(1993-8#1)(1994-11#1)(1995-3#2)(1997-7#1)
with the sequences##3##3##(1997-6#1)(1997-8#1)(2011-1#1)
with the serine/threonine##2##3##(1991-2#1)(1996-2#1)
with the serotonin##2##3##(1991-1#1)(1993-12#1)
with the service##3##3##(1992-1#1)(1997-2#1)(2011-2#1)
with the severe form of the disease##2##7##(2008-7#2)
with the severe##5##3##(2008-10#1)(2008-7#2)(2009-12#1)(2010-2#1)
with the severity of the##2##5##(1997-6#1)(2008-7#1)
with the severity of##12##4##(1995-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2010-7#1)
with the severity##13##3##(1995-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2010-7#1)(2012-3#1)
with the sex##2##3##(2008-5#1)(2010-3#1)
with the sexual##2##3##(2008-10#1)(2008-9#1)
with the shift to##2##4##(2008-11#2)
with the shift##3##3##(1993-12#1)(2008-11#2)
with the short bowel syndrome##2##5##(1991-12#1)(1994-3#1)
with the short##3##3##(1991-12#1)(1994-3#1)(2008-10#1)
with the signal##4##3##(1996-2#2)(1997-8#1)(2007-12#1)
with the simpler##2##3##(2008-3#1)(2011-2#1)
with the simulated##4##3##(1994-3#1)(2008-10#2)(2008-3#1)
with the simulation##4##3##(2008-2#2)(2008-3#2)
with the simultaneous determination of##2##5##(2008-10#2)
with the simultaneous##5##3##(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
with the single##8##3##(1997-4#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-2#2)
with the situation##6##3##(1991-6#1)(1992-5#1)(1995-11#1)(2007-11#1)(2008-2#1)(2013-1#1)
with the size of the##8##5##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
with the size of##10##4##(1995-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
with the size##11##3##(1995-2#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
with the skills##2##3##(2008-11#1)(2011-1#1)
with the skin of##2##4##(1992-3#1)(2008-5#1)
with the skin##4##3##(1992-3#1)(2008-10#1)(2008-5#2)
with the slope##4##3##(1990-11#1)(2007-11#1)(2008-10#2)
with the slow##3##3##(1993-5#1)(2008-7#1)(2008-9#1)
with the small##4##3##(1996-9#1)(2008-10#1)(2008-3#1)(2010-2#1)
with the smaller##2##3##(2008-11#1)(2009-5#1)
with the smallest##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
with the soil##2##3##(2008-5#1)(2010-5#1)
with the sole##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
with the solid##2##3##(2008-10#2)
with the solvent##3##3##(1994-11#1)(2008-10#1)(2010-2#1)
with the sorbent##2##3##(2008-10#2)
with the source##3##3##(2008-10#2)(2009-2#1)
with the species##2##3##(1996-12#1)(2010-8#1)
with the specific energy dissipation rate##2##6##(2008-7#2)
with the specific energy dissipation##3##5##(2008-7#3)
with the specific##10##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#2)
with the specificity##2##3##(1991-9#1)(2011-2#1)
with the spectral##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
with the spectrophotometric##3##3##(2008-10#3)
with the sperm##3##3##(2008-7#2)(2012-12#1)
with the square root of the##2##6##(2007-12#1)(2008-10#1)
with the square root of##3##5##(2007-12#1)(2008-10#1)(2008-9#1)
with the square##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
with the stage of the##2##5##(1990-8#1)(1995-8#1)
with the stage of##3##4##(1990-8#1)(1995-8#1)(2007-12#1)
with the stage##4##3##(1990-8#1)(1992-9#1)(1995-8#1)(2007-12#1)
with the standard VAS##2##4##(2009-3#2)
with the standard addition method##2##5##(2008-10#2)
with the standard addition##4##4##(2008-10#4)
with the standard##44##3##(1991-5#1)(1994-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#3)(2011-1#1)(2012-3#2)
with the starting##2##3##(2009-7#1)(2012-3#1)
with the state of##2##4##(1993-8#1)(2008-2#1)
with the static##2##3##(2008-10#2)
with the stationary##2##3##(2008-10#1)(2008-8#1)
with the statistical##2##3##(1992-2#1)(2008-10#1)
with the sticks##2##3##(2009-2#2)
with the stimulus##2##3##(2008-7#1)(2010-4#1)
with the strain##2##3##(2007-6#1)(2008-5#1)
with the stressed##2##3##(2008-11#1)(2013-1#1)
with the strong##3##3##(2008-10#2)(2008-3#1)
with the strongest##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
with the structural##4##3##(1995-2#1)(2008-10#2)(2009-10#1)
with the structure of the##2##5##(2008-10#2)
with the structure of##3##4##(2008-10#2)(2008-12#1)
with the structures##2##3##(1990-7#1)(1994-8#1)
with the study of##4##4##(2007-7#2)(2008-10#1)(2011-2#1)
with the study##7##3##(2007-7#3)(2008-10#2)(2008-8#1)(2011-2#1)
with the subject##2##3##(2009-6#1)(2009-7#1)
with the subjective##2##3##(1996-5#1)(2011-2#1)
with the subjects##2##3##(2008-7#2)
with the subsequent##4##3##(2008-11#2)(2011-1#1)(2013-1#1)
with the substrate##5##3##(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)
with the suggestion that##2##4##(1993-12#1)(2011-2#1)
with the sulfhydryl##2##3##(1993-11#1)(2008-7#1)
with the superior##3##3##(2007-8#2)(2013-1#1)
with the supplement##3##3##(2013-8#3)
with the support of the##2##5##(1997-6#1)(2008-6#1)
with the support of##6##4##(1991-2#1)(1994-12#1)(1997-6#1)(2008-5#1)(2008-6#1)(2011-2#1)
with the support##7##3##(1991-2#1)(1994-12#1)(1997-6#1)(2008-5#1)(2008-6#1)(2011-2#2)
with the supporting##2##3##(1994-3#1)(2009-4#1)
with the surface of##2##4##(1990-5#1)(2008-10#1)
with the surface##6##3##(1990-5#1)(2008-10#3)(2008-3#1)(2010-4#1)
with the surfactant##2##3##(2008-10#1)(2008-5#1)
with the surgery##3##3##(2007-11#1)(2008-8#1)(2008-9#1)
with the surgical procedures##2##4##(1996-9#1)(2012-2#1)
with the surgical##7##3##(1994-12#1)(1995-5#1)(1996-9#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
with the surrounding##9##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-2#2)
with the survival##3##3##(1995-12#1)(2008-10#1)(2010-3#1)
with the susceptibility to##3##4##(2008-9#1)(2011-1#2)
with the susceptible##6##3##(2008-10#6)
with the suspected##2##3##(2008-4#1)(2009-1#1)
with the symptoms##2##3##(1994-3#1)(2011-1#1)
with the syndrome of##3##4##(1990-9#1)(1993-11#1)(1997-3#1)
with the syndrome##4##3##(1990-9#1)(1993-11#1)(1997-3#1)(2007-10#1)
with the synthesis of##6##4##(1994-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
with the synthesis##7##3##(1994-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
with the synthetic##4##3##(1992-12#1)(1995-9#1)(2008-4#1)(2008-5#1)
with the system##8##3##(1991-5#1)(1993-3#1)(1994-2#1)(2008-10#4)(2008-3#1)
with the systemic##2##3##(2008-10#1)(2012-3#1)
with the tail##2##3##(1993-1#1)(1997-2#1)
with the target##15##3##(2008-1#1)(2008-10#5)(2008-2#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2012-1#1)(2013-1#2)(2013-8#1)
with the task##3##3##(1995-5#1)(2008-11#1)(2008-12#1)
with the technique of##3##4##(2008-2#1)(2008-3#1)(2012-3#1)
with the technique##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
with the technology##2##3##(2007-2#1)(2008-12#1)
with the teicoplanin chiral selector##2##5##(2008-10#2)
with the temperature##7##3##(1997-2#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-7#2)
with the temporal##2##3##(1992-11#1)(1995-2#1)
with the temporally##2##3##(2008-2#1)(2010-5#1)
with the terminal##2##3##(1993-6#1)(2008-10#1)
with the test##3##3##(1990-12#2)(2008-11#1)
with the theoretical prediction##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
with the theoretical predictions##4##4##(2008-2#2)(2008-3#1)(2008-5#1)
with the theoretical results##2##4##(2007-11#1)(2008-2#1)
with the theoretical##23##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#10)(2008-5#1)(2008-7#1)
with the theoretically calculated##3##4##(1995-2#1)(2008-2#1)(2008-3#1)
with the theory of##2##4##(2007-11#1)(2008-1#1)
with the theory##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
with the therapy##3##3##(2011-2#1)(2011-3#1)(2013-7#1)
with the thickness of ca##2##5##(2008-10#2)
with the thickness of##3##4##(2008-10#3)
with the thickness##4##3##(2008-10#4)
with the third##2##3##(1993-8#1)(2008-2#1)
with the threat of##2##4##(1997-5#1)(2010-8#1)
with the three most##2##4##(2008-10#1)(2008-7#1)
with the three##14##3##(1990-7#1)(1993-2#1)(1994-6#1)(1996-2#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
with the thylakoid bioassay##2##4##(2008-11#2)
with the thymidine##2##3##(1996-5#1)(2008-5#1)
with the time##6##3##(1991-11#1)(1991-2#1)(1994-3#1)(2008-2#1)(2008-3#1)(2008-8#1)
with the time-dependent##2##3##(1992-11#1)(1997-7#1)
with the times##2##3##(1992-2#1)(1996-4#1)
with the titration##2##3##(1991-9#1)(2008-10#1)
with the tools##2##3##(2008-10#1)(2008-3#1)
with the total protein##2##4##(1993-12#1)(2008-10#1)
with the total##13##3##(1992-3#1)(1993-12#1)(2008-10#5)(2008-3#2)(2010-10#1)(2010-2#1)(2010-4#1)(2012-1#1)
with the traditional##9##3##(1992-1#1)(1996-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
with the training and##2##4##(1996-12#1)(2008-8#1)
with the training##4##3##(1996-12#1)(1996-2#1)(2008-10#1)(2008-8#1)
with the transcriptional##3##3##(1990-11#1)(2013-1#2)
with the transformed##2##3##(1990-8#1)(2008-11#1)
with the transient##2##3##(2008-10#1)(2008-7#1)
with the transition##3##3##(1997-7#1)(2007-11#1)(2007-7#1)
with the transmitted##2##3##(2008-2#2)
with the transport of##3##4##(1992-3#2)(1995-6#1)
with the transport##4##3##(1992-3#2)(1995-6#1)(2008-3#1)
with the treatment of##4##4##(1991-2#1)(1995-5#1)(2007-8#1)(2012-2#1)
with the treatment##8##3##(1991-2#1)(1995-11#1)(1995-5#1)(1996-6#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
with the tridentate##2##3##(1997-7#2)
with the true##4##3##(1992-11#1)(2008-10#1)(2008-3#1)(2012-7#1)
with the tumor##4##3##(1992-1#1)(2006-12#1)(2008-11#1)(2009-4#1)
with the two other##2##4##(1994-12#1)(2008-10#1)
with the two##24##3##(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#12)(2008-5#2)(2010-5#1)(2013-1#1)
with the type II##2##4##(2008-3#1)(2008-9#1)
with the type of##9##4##(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
with the type strain##2##4##(2008-10#2)
with the type##13##3##(1996-3#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
with the typical clinical##2##4##(2007-7#1)(2008-7#1)
with the typical##5##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
with the ultimate##4##3##(2007-12#1)(2008-10#1)(2009-9#1)(2011-2#1)
with the underlying##6##3##(1992-3#1)(2007-11#1)(2007-7#2)(2009-10#1)(2010-11#1)
with the understanding that##2##4##(1996-3#1)(2006-12#1)
with the union##2##3##(1995-12#1)(1995-3#1)
with the unmodified##2##3##(2008-10#1)(2009-7#1)
with the unusual##3##3##(2008-11#1)(2008-5#1)(2009-5#1)
with the upper##3##3##(2007-11#1)(2009-11#1)(2009-9#1)
with the uptake of##2##4##(1995-2#1)(2008-7#1)
with the uptake##3##3##(1993-11#1)(1995-2#1)(2008-7#1)
with the urinary##2##3##(1996-12#1)(2011-2#1)
with the use of a commercial##3##6##(2007-8#1)(2008-10#1)(2013-8#1)
with the use of a##20##5##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-3#1)(2013-8#1)
with the use of an##5##5##(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
with the use of antibiotics##2##5##(2009-5#1)(2011-2#1)
with the use of more##2##5##(2008-3#1)(2013-1#1)
with the use of the##18##5##(1992-1#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
with the use of thermal##2##5##(1992-7#1)(2008-10#1)
with the use of two##2##5##(1997-6#1)(2008-10#1)
with the use of##146##4##(1990-5#1)(1990-8#2)(1990-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-3#2)(2010-6#1)(2010-8#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
with the use##148##3##(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-3#2)(2010-6#1)(2010-8#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
with the usual##7##3##(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#1)
with the vaccine##2##3##(2008-10#1)(2013-8#1)
with the vaginal##2##3##(2008-10#1)(2008-8#1)
with the value obtained##3##4##(1995-6#1)(2008-10#1)(2008-11#1)
with the value of##3##4##(1995-11#1)(2007-12#1)(2009-12#1)
with the value##12##3##(1995-11#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#1)
with the values determined##2##4##(2008-3#1)(2008-5#1)
with the values from##2##4##(2008-10#1)(2008-3#1)
with the values obtained by##4##5##(2008-10#3)(2008-3#1)
with the values obtained from##3##5##(2008-10#2)(2008-3#1)
with the values obtained##8##4##(2008-10#6)(2008-3#2)
with the values of##4##4##(1991-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
with the values##19##3##(1991-12#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)
with the variation##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
with the various##4##3##(2008-10#1)(2008-11#1)(2010-10#1)(2012-1#1)
with the vascular##4##3##(1991-6#1)(1993-8#1)(2008-10#2)
with the vector##3##3##(1991-9#1)(2008-10#2)
with the vehicle group##3##4##(2011-2#1)(2013-8#2)
with the vehicle##6##3##(2008-4#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
with the view of##2##4##(1994-8#1)(2009-7#1)
with the view##4##3##(1994-8#1)(1997-9#1)(2008-10#1)(2009-7#1)
with the viral##5##3##(1994-8#2)(2008-8#1)(2013-8#2)
with the virulence##2##3##(2008-10#1)(2009-2#1)
with the virulent##2##3##(2008-10#1)(2008-9#1)
with the virus##6##3##(1991-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(2008-10#2)
with the visual##2##3##(1991-2#1)(2008-2#1)
with the vital dye##2##4##(2008-11#1)(2008-9#1)
with the volume of the##2##5##(2007-10#1)(2008-10#1)
with the volume of##3##4##(1992-2#1)(2007-10#1)(2008-10#1)
with the volume##4##3##(1992-2#1)(2007-10#1)(2008-10#1)(2008-2#1)
with the walls of the##2##5##(2008-11#1)(2008-9#1)
with the water##4##3##(2008-10#2)(2010-4#1)(2012-9#1)
with the wavelength of the##2##5##(2007-11#1)(2008-2#1)
with the wavelength of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
with the wavelength##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
with the wavelengths##2##3##(2008-3#1)(2012-2#1)
with the weight of##2##4##(2008-10#1)(2010-9#1)
with the weight##3##3##(2007-11#1)(2008-10#1)(2010-9#1)
with the well-established##2##3##(2008-10#2)
with the well-known##3##3##(1991-8#1)(2009-8#1)(2013-1#1)
with the whole##4##3##(1993-12#1)(2008-10#1)(2010-9#1)(2012-2#1)
with the whole-cell##2##3##(1997-8#1)(2008-8#1)
with the widely used##2##4##(2008-5#1)(2011-1#1)
with the widespread distribution of##2##5##(2008-10#1)(2008-11#1)
with the widespread##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
with the widest##2##3##(2008-10#1)(2008-5#1)
with the wild type##3##4##(1993-11#1)(1997-8#1)(2008-10#1)
with the wild-type enzyme##2##4##(1992-9#1)(1995-6#1)
with the wild-type strain##4##4##(2008-10#4)
with the wild-type##9##3##(1992-4#1)(1992-9#1)(1995-2#1)(1995-6#1)(2008-10#5)
with the work of##2##4##(2008-2#1)(2013-1#1)
with the yeast##2##3##(2008-10#2)
with the yeast-phase##2##3##(2008-5#2)
with the younger##2##3##(2008-5#1)(2012-1#1)
with the##8417##2##(1990-10#6)(1990-11#24)(1990-12#33)(1990-2#36)(1990-3#8)(1990-4#3)(1990-5#40)(1990-6#15)(1990-7#22)(1990-8#39)(1990-9#17)(1991-1#11)(1991-10#3)(1991-11#15)(1991-12#46)(1991-2#38)(1991-3#13)(1991-4#5)(1991-5#28)(1991-6#21)(1991-7#2)(1991-8#21)(1991-9#24)(1992-1#10)(1992-10#10)(1992-11#18)(1992-12#30)(1992-2#26)(1992-3#61)(1992-4#4)(1992-5#16)(1992-6#39)(1992-7#2)(1992-8#28)(1992-9#25)(1993-1#18)(1993-10#1)(1993-11#46)(1993-12#60)(1993-2#34)(1993-3#37)(1993-5#3)(1993-6#25)(1993-8#55)(1993-9#14)(1994-1#13)(1994-10#1)(1994-11#36)(1994-12#50)(1994-2#28)(1994-3#39)(1994-5#23)(1994-6#23)(1994-7#4)(1994-8#41)(1994-9#21)(1995-1#10)(1995-10#1)(1995-11#36)(1995-12#46)(1995-2#71)(1995-3#49)(1995-4#1)(1995-5#46)(1995-6#51)(1995-8#26)(1995-9#11)(1996-1#14)(1996-10#3)(1996-11#8)(1996-12#37)(1996-2#66)(1996-3#24)(1996-4#8)(1996-5#40)(1996-6#12)(1996-7#5)(1996-8#6)(1996-9#6)(1997-1#24)(1997-2#48)(1997-3#45)(1997-4#39)(1997-5#13)(1997-6#25)(1997-7#43)(1997-8#26)(1997-9#4)(2006-10#17)(2006-12#7)(2006-4#2)(2006-5#1)(2006-6#11)(2006-8#1)(2007-1#2)(2007-10#32)(2007-11#139)(2007-12#159)(2007-2#9)(2007-3#1)(2007-4#2)(2007-5#13)(2007-6#11)(2007-7#37)(2007-8#55)(2007-9#4)(2008-1#74)(2008-10#1978)(2008-11#250)(2008-12#78)(2008-2#273)(2008-3#526)(2008-4#89)(2008-5#196)(2008-6#75)(2008-7#217)(2008-8#189)(2008-9#169)(2009-1#2)(2009-10#30)(2009-11#28)(2009-12#14)(2009-2#16)(2009-3#23)(2009-4#15)(2009-5#37)(2009-6#27)(2009-7#38)(2009-8#36)(2009-9#25)(2010-1#8)(2010-10#22)(2010-11#15)(2010-12#29)(2010-2#34)(2010-3#34)(2010-4#32)(2010-5#30)(2010-6#12)(2010-7#16)(2010-8#50)(2010-9#7)(2011-1#100)(2011-10#2)(2011-2#275)(2011-3#15)(2011-7#2)(2011-8#1)(2012-1#35)(2012-12#69)(2012-2#117)(2012-3#108)(2012-5#3)(2012-7#2)(2012-9#1)(2013-1#179)(2013-7#23)(2013-8#133)
with their ability to produce##2##5##(1993-6#1)(2008-10#1)
with their ability to##7##4##(1992-12#2)(1993-6#1)(1993-8#1)(2008-10#2)(2010-3#1)
with their actual##2##3##(2008-10#1)(2011-2#1)
with their age-matched##2##3##(1990-3#1)(2011-1#1)
with their bodies than##3##4##(2008-9#2)(2010-10#1)
with their bodies##8##3##(2008-9#5)(2009-5#2)(2010-10#1)
with their body##3##3##(2007-12#2)(2012-2#1)
with their clinical##2##3##(1996-2#1)(2008-5#1)
with their communities##2##3##(1994-1#1)(1995-3#1)
with their complementary##2##3##(2008-10#2)
with their corresponding##5##3##(2007-12#1)(2008-10#3)(2008-4#1)
with their counterparts in##2##4##(2007-6#1)(2008-11#1)
with their counterparts##5##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)
with their dependence on##2##4##(2008-10#1)(2008-3#1)
with their effects on##2##4##(1995-6#1)(1997-7#1)
with their growth##2##3##(1990-7#1)(1992-9#1)
with their health care##3##4##(1997-1#1)(2012-3#1)(2013-7#1)
with their health##5##3##(1997-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
with their human##2##3##(1991-6#1)(1997-7#1)
with their infant##2##3##(2008-10#1)(2010-10#1)
with their mental##2##3##(2010-8#1)(2013-1#1)
with their mother##2##3##(2008-10#1)(2013-1#1)
with their overall##2##3##(1996-3#1)(2008-10#1)
with their own##5##3##(1995-2#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-12#1)
with their parents##3##3##(1990-12#1)(2009-7#2)
with their partner##2##3##(2007-12#1)(2010-5#1)
with their patients to##2##4##(2010-9#1)(2011-1#1)
with their patients##5##3##(1991-12#1)(1997-4#1)(2010-9#1)(2011-1#1)(2012-1#1)
with their peers##3##3##(2008-9#1)(2012-1#1)(2013-8#1)
with their performance in##2##4##(2007-10#1)(2008-2#1)
with their personal##2##3##(1992-6#1)(1995-3#1)
with their physician##2##3##(2008-3#1)(2008-4#1)
with their physicians##2##3##(2009-5#2)
with their potencies##2##3##(1992-8#1)(1995-11#1)
with their potential##3##3##(2008-4#1)(2012-12#1)(2012-4#1)
with their previous##2##3##(2008-11#1)(2011-10#1)
with their respective##9##3##(1995-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
with their right##2##3##(2008-6#1)(2012-12#1)
with their risk status##2##4##(1995-9#2)
with their side effects##2##4##(2008-12#1)(2009-5#1)
with their use##6##3##(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
with their##301##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-2#4)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#11)(2007-6#2)(2007-9#1)(2008-10#34)(2008-11#12)(2008-12#8)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#14)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#7)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#8)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#12)(2013-7#1)(2013-8#4)
with them##28##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1995-6#1)(1995-8#1)(1996-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
with theoretical and experimental##2##4##(2007-12#1)(2013-1#1)
with theoretical calculations##4##3##(2008-3#3)(2008-6#1)
with theoretical considerations##2##3##(2007-11#1)(2008-10#1)
with theoretical expectations##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
with theoretical patterns derived from Mie theory##2##7##(2008-3#2)
with theoretical predictions##21##3##(2007-11#3)(2007-12#6)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2012-3#1)
with theoretical results##4##3##(2007-11#1)(2008-3#3)
with theoretical values##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
with theoretical##55##2##(1996-4#1)(2007-11#10)(2007-12#8)(2008-10#2)(2008-2#7)(2008-3#19)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-3#1)(2013-1#1)
with theoretically calculated##2##3##(2008-10#1)(2008-3#1)
with theoretically##3##2##(2008-10#1)(2008-3#2)
with theory and##4##3##(2008-2#2)(2008-3#1)(2012-2#1)
with theory##20##2##(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#5)(2012-2#1)
with therapeutic##7##2##(2008-10#1)(2008-12#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
with therapy in the##2##4##(2007-10#1)(2009-6#1)
with therapy##5##2##(1997-2#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-6#1)
with thermal##12##2##(1991-2#1)(1996-5#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
with thermally##2##2##(2007-12#1)(2008-10#1)
with thermodynamic calculations##2##3##(2008-10#2)
with thermodynamic##4##2##(2008-10#3)(2009-11#1)
with thermogravimetric##2##2##(2008-10#2)
with thermostability##2##2##(2008-10#2)
with these agents##5##3##(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-7#1)
with these antibodies##2##3##(1990-11#1)(1994-11#1)
with these changes##4##3##(1990-5#1)(1992-4#1)(1993-2#1)(2009-8#1)
with these characteristics##2##3##(1996-10#1)(2008-3#1)
with these compounds##4##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
with these conditions##2##3##(2008-1#1)(2008-3#1)
with these data##2##3##(1990-7#1)(1990-8#1)
with these disorders##3##3##(1997-3#1)(1997-8#1)(2012-3#1)
with these drugs have##2##4##(2010-5#1)(2013-1#1)
with these drugs##8##3##(1991-1#1)(1994-5#2)(2008-11#1)(2010-5#2)(2012-2#1)(2013-1#1)
with these factors##3##3##(1991-2#1)(2008-9#1)(2009-12#1)
with these groups##4##3##(1994-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
with these increases##2##3##(1990-10#1)(1992-3#1)
with these lesions##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
with these methods##4##3##(2008-3#2)(2008-4#1)(2008-8#1)
with these neoplasms##2##3##(2007-11#1)(2010-8#1)
with these new##2##3##(2008-10#1)(2008-11#1)
with these problems##4##3##(2008-2#1)(2008-8#1)(2010-10#2)
with these radiations##2##3##(1991-2#2)
with these receptors##2##3##(1991-5#1)(1995-12#1)
with these results##4##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
with these systems##2##3##(2008-11#1)(2008-7#1)
with these two methods##2##4##(2008-10#1)(2008-3#1)
with these two##7##3##(1990-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
with these##189##2##(1990-10#1)(1990-11#3)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-3#3)(1992-4#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#4)(2009-11#1)(2009-12#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
with thiamine##3##2##(2008-1#1)(2008-10#2)
with thick##6##2##(2007-8#1)(2008-10#1)(2008-7#2)(2010-8#1)(2011-2#1)
with thickening##2##2##(2007-7#1)(2010-10#1)
with thicker##2##2##(1995-6#1)(1996-5#1)
with thickness##2##2##(2008-3#1)(2013-1#1)
with thin and##2##3##(2008-2#1)(2008-5#1)
with thin##14##2##(1995-12#1)(1996-5#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-8#1)(2010-6#1)(2011-1#1)(2013-1#1)
with thiocyanate##3##2##(2008-10#3)
with thiocyanates##2##2##(2007-11#2)
with thiol cotton##3##3##(2008-10#3)
with thiol groups##2##3##(2008-10#2)
with thiol##6##2##(2008-10#6)
with thiol-containing##2##2##(1991-9#1)(2008-4#1)
with thiolated oligonucleotides##2##3##(2008-10#2)
with thiols##3##2##(2008-10#1)(2008-11#2)
with thiopentone and##2##3##(2010-7#1)(2012-2#1)
with thiopentone##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
with thioridazine##2##2##(2008-10#1)(2008-7#1)
with third##3##2##(1992-12#1)(1994-5#1)(1996-11#1)
with third-order##2##2##(2008-3#2)
with third-party##2##2##(1994-2#1)(2008-9#1)
with this agent##2##3##(1991-12#1)(2008-7#1)
with this algorithm##2##3##(2008-2#2)
with this approach##5##3##(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
with this assay##2##3##(2008-10#1)(2013-1#1)
with this condition##14##3##(1994-9#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
with this diagnosis##2##3##(2008-11#1)(2010-11#1)
with this disease are##2##4##(1992-2#1)(2008-1#1)
with this disease##16##3##(1990-5#1)(1992-2#1)(1993-3#1)(1993-6#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)
with this disorder##2##3##(2008-6#1)(2013-1#1)
with this enzyme##2##3##(1990-7#1)(1991-12#1)
with this hypothesis##7##3##(1990-5#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)
with this increase in##2##4##(1990-10#1)(2009-7#1)
with this instrument##2##3##(2007-11#1)(2008-3#1)
with this issue##2##3##(1992-1#1)(1993-6#1)
with this kind of##2##4##(1996-9#1)(2008-10#1)
with this method are##2##4##(2008-6#1)(2008-9#1)
with this method were##2##4##(2008-10#1)(2008-4#1)
with this method##19##3##(1990-9#1)(1991-5#1)(1997-2#1)(1997-6#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)
with this methodology##2##3##(2008-10#1)(2008-4#1)
with this model##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
with this new technique##2##4##(1990-9#1)(2008-3#1)
with this new##5##3##(1990-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)
with this novel##2##3##(2008-3#1)(2008-8#1)
with this organism##2##3##(1995-5#1)(2007-12#1)
with this pathology##2##3##(1993-9#1)(2012-3#1)
with this phenomenon##2##3##(2010-5#1)(2013-1#1)
with this population##4##3##(1991-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
with this prediction##2##3##(2008-4#1)(2008-9#1)
with this problem##4##3##(2007-10#1)(2008-2#1)(2008-6#1)(2013-1#1)
with this procedure##4##3##(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)
with this rare##2##3##(2008-11#1)(2008-2#1)
with this regulatory##2##3##(1992-12#1)(2008-8#1)
with this result##2##3##(1991-2#1)(1995-6#1)
with this scheme##2##3##(2007-11#1)(2007-12#1)
with this sensor##2##3##(2008-10#1)(2008-3#1)
with this switch##2##3##(2008-10#1)(2008-3#1)
with this syndrome##5##3##(1991-5#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-3#1)
with this system##9##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2012-3#1)
with this tablet##2##3##(2008-10#2)
with this technique and##2##4##(1997-1#1)(2008-7#1)
with this technique are##2##4##(1991-3#1)(2007-12#1)
with this technique with##2##4##(2008-2#1)(2008-7#1)
with this technique##23##3##(1991-11#1)(1991-3#1)(1997-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2010-6#1)(2011-2#1)(2013-8#1)
with this theory##2##3##(2008-3#2)
with this tumor##2##3##(2008-10#1)(2011-2#1)
with this type of##10##4##(1991-11#1)(1993-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#2)(2010-3#1)(2010-8#1)(2013-1#1)
with this virus##2##3##(1991-3#1)(2008-10#1)
with this##368##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#2)(2006-10#1)(2006-7#1)(2007-10#3)(2007-11#6)(2007-12#13)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#58)(2008-11#9)(2008-12#11)(2008-2#17)(2008-3#27)(2008-4#13)(2008-5#11)(2008-6#6)(2008-7#16)(2008-8#7)(2008-9#4)(2009-1#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#11)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
with thoracic##11##2##(1997-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
with thoracotomy##2##2##(2007-8#1)(2010-3#1)
with those achieved by##3##4##(2008-10#3)
with those achieved with##2##4##(1991-3#1)(2007-12#1)
with those achieved##7##3##(1991-2#1)(1991-3#1)(2007-12#1)(2008-10#4)
with those at##3##3##(1997-7#1)(2007-11#1)(2008-1#1)
with those available##2##3##(2008-10#1)(2008-11#1)
with those by the##3##4##(2008-10#3)
with those by##5##3##(2008-10#4)(2010-5#1)
with those described in the##2##5##(1995-11#1)(2012-3#1)
with those described##5##3##(1991-9#1)(1995-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
with those determined by##5##4##(2008-10#3)(2008-3#1)(2011-2#1)
with those determined##7##3##(1990-9#1)(2008-10#4)(2008-3#1)(2011-2#1)
with those for the##2##4##(1993-8#1)(1996-2#1)
with those for##11##3##(1993-8#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-7#1)
with those found by##6##4##(2008-10#6)
with those found in##4##4##(1992-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
with those found##12##3##(1992-3#1)(2008-10#7)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
with those from a##7##4##(1992-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
with those from other##2##4##(2007-11#1)(2008-10#1)
with those from the##9##4##(1990-7#1)(1997-8#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
with those from##30##3##(1990-7#1)(1991-6#1)(1992-11#1)(1992-9#1)(1997-8#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
with those furnished by the reference procedure##2##7##(2008-10#2)
with those given by the##2##5##(2008-10#1)(2008-3#1)
with those given by##7##4##(2008-10#4)(2008-3#3)
with those in a##2##4##(2008-10#1)(2008-9#1)
with those in other##2##4##(2008-7#1)(2011-1#1)
with those in the##10##4##(1990-2#1)(1990-3#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-12#1)
with those in##28##3##(1990-2#1)(1990-3#1)(1991-12#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#3)(2008-9#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
with those measured##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
with those not##2##3##(2008-10#1)(2013-1#1)
with those observed##2##3##(2007-12#1)(2008-10#1)
with those obtained by HPLC##2##5##(2008-10#2)
with those obtained by ICP-AES##3##5##(2008-10#3)
with those obtained by ICP-MS##2##5##(2008-10#2)
with those obtained by a batch##2##6##(2008-10#2)
with those obtained by a conventional method##2##7##(2008-10#2)
with those obtained by a conventional##3##6##(2008-10#3)
with those obtained by a##12##5##(2008-10#11)(2008-2#1)
with those obtained by an##5##5##(2008-10#5)
with those obtained by conventional##4##5##(2008-10#3)(2008-3#1)
with those obtained by means of##4##6##(2008-10#4)
with those obtained by other##2##5##(2008-10#1)(2008-5#1)
with those obtained by the British Pharmacopoeia##2##7##(2008-10#2)
with those obtained by the British##3##6##(2008-10#3)
with those obtained by the conventional##2##6##(2008-10#2)
with those obtained by the official##2##6##(2008-10#1)(2008-11#1)
with those obtained by the reference##2##6##(2008-10#2)
with those obtained by the##30##5##(1997-7#1)(2008-10#28)(2008-11#1)
with those obtained by##99##4##(1997-7#2)(2008-10#86)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)
with those obtained for##3##4##(2008-10#2)(2009-3#1)
with those obtained from a##2##5##(2008-10#2)
with those obtained from other##2##5##(2008-5#1)(2008-7#1)
with those obtained from##15##4##(1990-12#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
with those obtained in##7##4##(1993-9#1)(1994-3#1)(1996-5#1)(2008-3#3)(2013-1#1)
with those obtained through##2##4##(2008-10#2)
with those obtained using a##5##5##(1990-8#1)(2008-10#4)
with those obtained using the##3##5##(2008-10#3)
with those obtained using##16##4##(1990-8#1)(1995-6#1)(2008-10#13)(2008-7#1)
with those obtained with a##8##5##(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)
with those obtained with the##4##5##(2008-10#4)
with those obtained with##24##4##(2007-11#1)(2007-12#1)(2008-10#16)(2008-2#3)(2008-3#2)(2008-6#1)
with those obtained##172##3##(1990-12#1)(1990-8#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-7#2)(2007-11#2)(2007-12#2)(2008-10#130)(2008-11#2)(2008-2#8)(2008-3#13)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2013-1#1)
with those of 38##2##4##(2008-10#1)(2008-7#1)
with those of P##2##4##(2008-10#1)(2008-5#1)
with those of a##12##4##(1990-6#1)(1991-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#5)
with those of age-matched##2##4##(2008-10#1)(2013-1#1)
with those of control##3##4##(1995-3#1)(2007-10#1)(2008-10#1)
with those of conventional##3##4##(2007-12#1)(2008-3#2)
with those of mammalian##2##4##(1992-12#1)(1993-6#1)
with those of normal##2##4##(1994-2#1)(2008-3#1)
with those of other small##2##5##(1993-11#1)(1997-4#1)
with those of other tospoviruses##2##5##(2008-10#2)
with those of other##23##4##(1990-11#1)(1990-2#1)(1990-3#1)(1992-11#1)(1993-11#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
with those of previous studies##2##5##(2008-10#1)(2011-2#1)
with those of previous##6##4##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-2#1)
with those of recent##2##4##(1997-6#1)(2008-7#1)
with those of reference##2##4##(2008-12#1)(2009-6#1)
with those of reported tospoviruses##2##5##(2008-10#2)
with those of the other##2##5##(1993-6#1)(1995-3#1)
with those of the##46##4##(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-6#1)(2010-7#1)(2013-1#1)
with those of##214##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#2)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#1)(1993-11#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-3#3)(1995-8#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#3)(1997-4#1)(1997-6#3)(1997-7#4)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#69)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#23)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
with those on##4##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-6#1)
with those predicted by##3##4##(2007-11#1)(2007-12#2)
with those predicted##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
with those previously##2##3##(1994-11#1)(2008-10#1)
with those provided by the##2##5##(2008-10#2)
with those provided by##3##4##(2008-10#3)
with those recently##2##3##(1991-11#1)(2008-2#1)
with those reported in the literature##2##6##(2008-10#1)(2008-8#1)
with those reported in##3##4##(2008-10#2)(2008-8#1)
with those reported##7##3##(1991-8#1)(2008-10#5)(2008-8#1)
with those seen##2##3##(1994-5#1)(2008-5#1)
with those that##6##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-9#1)
with those using##5##3##(1992-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
with those who##9##3##(1993-12#1)(1996-11#1)(2007-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2013-1#1)
with those with a##2##4##(2008-10#2)
with those with##10##3##(1991-2#1)(1996-12#1)(2008-10#3)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
with those##630##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#3)(1992-3#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-6#4)(1997-7#8)(1997-8#2)(2006-10#1)(2007-10#5)(2007-11#7)(2007-12#13)(2008-1#1)(2008-10#274)(2008-11#14)(2008-12#1)(2008-2#21)(2008-3#53)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#21)(2008-8#10)(2008-9#6)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#3)
with thousands of##3##3##(2008-2#1)(2010-10#1)(2012-3#1)
with threaded Kirschner wires##2##4##(2007-8#2)
with threatened##2##2##(1992-2#1)(2011-2#1)
with three coupling##2##3##(2013-8#2)
with three different##21##3##(1990-9#1)(1991-11#1)(1995-5#1)(1997-1#1)(2007-12#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-1#1)
with three enzymes##2##3##(2008-10#1)(2008-5#1)
with three examples##2##3##(1994-9#1)(2008-3#1)
with three independent data sets##2##5##(2008-10#1)(2008-8#1)
with three independent##4##3##(1997-7#1)(2008-10#2)(2008-8#1)
with three other##5##3##(1990-3#1)(1992-8#1)(2008-10#2)(2011-2#1)
with three replicates##4##3##(2008-10#4)
with three replications##4##3##(2008-10#1)(2008-12#2)(2010-4#1)
with three sets of##2##4##(2008-2#1)(2008-7#1)
with three successive 28-day##2##4##(2008-10#2)
with three trophic levels##3##4##(2008-9#3)
with three types of##2##4##(1991-5#1)(2010-12#1)
with three##138##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-12#5)(2007-7#2)(2007-8#2)(2008-10#46)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#11)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#7)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#4)(2013-8#3)
with three-dimensional##7##2##(2007-11#1)(2007-12#1)(2007-8#2)(2008-7#1)(2008-9#1)(2013-1#1)
with three-wavelength##2##2##(2007-12#2)
with threshold##4##2##(2008-3#1)(2008-7#2)(2011-1#1)
with thrombin and##2##3##(1992-6#1)(1994-12#1)
with thrombin##8##2##(1992-6#4)(1992-8#2)(1994-12#1)(1997-7#1)
with thrombocytopenia##3##2##(2007-2#2)(2008-11#1)
with thrombocytosis##2##2##(2006-6#1)(2011-2#1)
with thrombolysis##2##2##(2007-10#1)(2011-2#1)
with thrombolytic therapy##2##3##(2008-3#2)
with thrombolytics##2##2##(2007-10#1)(2008-2#1)
with thrombosis of the##2##4##(1993-2#1)(2006-12#1)
with thrombosis##3##2##(1992-3#1)(1993-2#1)(2006-12#1)
with thrombospondin##2##2##(1994-5#1)(2009-7#1)
with thymopentin##3##2##(1990-2#1)(1991-3#2)
with thymostimulin##4##2##(1990-2#2)(1991-5#1)(1992-5#1)
with thyroid disorders had##2##4##(2013-1#2)
with thyroid disorders##4##3##(2013-1#4)
with thyroid dysfunction##3##3##(2008-4#1)(2013-1#2)
with thyroid##19##2##(1990-12#1)(1990-6#2)(2007-5#1)(2008-4#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
with thyrotropin##2##2##(1991-12#1)(2012-12#1)
with thyroxine##3##2##(1990-8#1)(1991-5#1)(2007-8#1)
with tightly focused##2##3##(2007-12#1)(2008-3#1)
with time after inoculation##3##4##(2008-10#3)
with time after##5##3##(1994-6#1)(2008-10#4)
with time and##4##3##(1990-5#1)(2008-10#2)(2010-8#1)
with time during##2##3##(2009-11#1)(2011-2#1)
with time for##2##3##(2007-7#1)(2008-3#1)
with time in the##3##4##(1990-11#1)(2008-7#1)(2010-12#1)
with time of##4##3##(1993-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
with time since##2##3##(1993-9#1)(2008-10#1)
with time##72##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#6)(2013-1#2)(2013-8#1)
with time-of-flight mass spectrometry (GCxGC-TOFMS)##2##5##(2008-10#2)
with time-of-flight mass spectrometry##4##4##(2008-10#4)
with time-of-flight##5##2##(2008-10#4)(2009-10#1)
with time-resolved##5##2##(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
with time-varying##2##2##(1992-3#1)(2010-1#1)
with timing##3##2##(2007-12#1)(2008-7#1)(2010-2#1)
with tin(II) chloride##3##3##(2008-10#3)
with tin(II)##4##2##(2008-10#4)
with tinnitus and##2##3##(1995-6#1)(2008-7#1)
with tissue biopsy##2##3##(2008-1#1)(2012-1#1)
with tissue plasminogen activator##5##4##(2007-10#1)(2007-5#1)(2007-9#1)(2008-7#2)
with tissue##13##2##(1997-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#1)
with titanium elastic nail##2##4##(2012-2#2)
with titanium##7##2##(2008-10#1)(2008-11#1)(2008-7#2)(2012-2#2)(2013-1#1)
with tobacco##2##2##(2008-10#1)(2012-2#1)
with today's##2##2##(2006-6#1)(2008-1#1)
with tolerance##4##2##(2008-10#3)(2011-10#1)
with toluene##4##2##(1994-8#1)(2008-10#2)(2008-7#1)
with toluidine blue and##2##4##(1992-12#1)(2008-10#1)
with too many##2##3##(1994-12#1)(2008-11#1)
with too##3##2##(1991-6#1)(1994-12#1)(2008-11#1)
with tools##2##2##(2008-11#1)(2008-4#1)
with tooth##4##2##(1996-3#1)(2008-12#1)(2013-1#2)
with topical application of##4##4##(1992-8#1)(1996-10#1)(2008-5#2)
with topical##11##2##(1990-11#1)(1991-3#1)(1992-8#2)(1996-10#1)(2008-10#1)(2008-5#2)(2010-8#1)(2011-2#2)
with topics##2##2##(2008-11#1)(2011-2#1)
with topographical##2##2##(2008-3#1)(2009-9#1)
with total cell##2##3##(1995-11#1)(2008-11#1)
with total hip##2##3##(2008-8#1)(2012-2#1)
with total internal##2##3##(2008-3#1)(2011-2#1)
with total laparoscopic##2##3##(2010-3#1)(2011-2#1)
with total occlusion of the##2##5##(2008-1#1)(2008-7#1)
with total##38##2##(1991-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
with toxic##2##2##(2007-8#1)(2008-10#1)
with toxicity##2##2##(2007-5#1)(2012-3#1)
with trace##2##2##(2008-10#2)
with tracheal##2##2##(2007-8#1)(2012-12#1)
with tracheostomy##4##2##(2011-2#1)(2012-2#3)
with traditional varieties##2##3##(2008-12#2)
with traditional##30##2##(1991-2#1)(1992-1#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#6)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)
with training in##3##3##(1994-1#1)(2010-4#1)(2012-2#1)
with traits##2##2##(2008-7#1)(2008-9#1)
with trans##2##2##(1996-6#1)(2007-12#1)
with transcranial direct current stimulation##2##5##(2010-7#1)(2011-1#1)
with transcranial##3##2##(2007-12#1)(2010-7#1)(2011-1#1)
with transcription##2##2##(1994-11#1)(2008-9#1)
with transcriptional factor##2##3##(2008-9#2)
with transcriptional##7##2##(1991-2#1)(1992-12#1)(2008-9#2)(2009-10#1)(2009-5#1)(2011-2#1)
with transgenic##2##2##(2006-12#1)(2008-9#1)
with transient ischemic##2##3##(2007-10#1)(2008-8#1)
with transient##5##2##(1995-12#1)(2007-10#1)(2008-7#1)(2008-8#1)(2012-1#1)
with transitions##2##2##(1995-3#1)(2011-2#1)
with translational##2##2##(1991-12#1)(2013-1#1)
with translocation of##2##3##(1997-1#1)(2010-11#1)
with translocation##3##2##(1992-11#1)(1997-1#1)(2010-11#1)
with transmission electron microscopy##2##4##(2007-12#1)(2008-10#1)
with transmission##7##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
with transparent##2##2##(2008-3#1)(2009-10#1)
with transplanted##4##2##(1990-12#1)(1995-8#1)(2011-2#1)(2012-12#1)
with transport##2##2##(2008-7#1)(2010-4#1)
with transtibial prostheses##2##3##(2013-1#2)
with transtrapezium approach for##2##4##(2008-9#2)
with transvaginal##3##2##(1995-3#2)(2011-1#1)
with trapped##2##2##(2007-12#1)(2008-10#1)
with trastuzumab##4##2##(2011-1#1)(2012-3#2)(2013-1#1)
with trauma##2##2##(2008-7#1)(2012-1#1)
with traumatic brain injury##4##4##(1991-12#1)(1994-12#1)(2007-8#1)(2008-7#1)
with traumatic##10##2##(1991-12#1)(1991-6#1)(1992-6#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-7#2)(2011-2#1)(2013-1#1)
with treated##2##2##(2008-12#1)(2013-1#1)
with treatment and##2##3##(1991-1#1)(2009-5#1)
with treatment of##3##3##(1994-11#1)(1997-3#1)(2007-8#1)
with treatment selection##2##3##(2012-2#2)
with treatment services##2##3##(2008-5#1)(2012-1#1)
with treatment with##3##3##(1995-2#1)(2008-5#1)(2009-6#1)
with treatment##34##2##(1991-1#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
with treatments##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
with trees##2##2##(2008-10#1)(2008-9#1)
with trehalose##2##2##(2008-10#1)(2013-1#1)
with tremolite##3##2##(1991-12#3)
with trial##3##2##(2007-7#1)(2008-10#1)(2013-1#1)
with trichloroacetic##2##2##(2008-10#2)
with tricyclic##2##2##(1991-11#1)(1996-7#1)
with triethylamine##3##2##(1996-5#2)(2008-10#1)
with trifluoroacetic##2##2##(1997-2#1)(2007-11#1)
with trimeperidine and##2##3##(2012-3#2)
with trimethyl orthoformate##2##3##(1996-5#2)
with trimethylamine##2##2##(1995-2#1)(2008-11#1)
with tris(2##6##2##(2008-10#6)
with trisomy 21##2##3##(1995-8#1)(1997-4#1)
with trisomy##3##2##(1995-8#1)(1997-4#2)
with tritiated##2##2##(1991-12#1)(1996-5#1)
with true##4##2##(2008-10#1)(2008-3#2)(2008-8#1)
with trypsin and##4##3##(1990-5#1)(1994-11#1)(1997-2#1)(2008-4#1)
with trypsin##20##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-5#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)
with tryptophan##3##2##(2008-10#2)(2008-7#1)
with tubal disease##2##3##(1990-2#2)
with tubal infertility and##2##4##(1990-10#2)
with tubal##6##2##(1990-10#2)(1990-2#2)(1993-12#1)(1994-12#1)
with tuberculosis##6##2##(1996-3#2)(2008-7#1)(2009-7#1)(2011-2#2)
with tuberculous##5##2##(1997-8#3)(2011-2#1)(2013-7#1)
with tubular##3##2##(1990-12#1)(1993-3#1)(2008-8#1)
with tubulin##7##2##(1992-9#4)(1993-6#2)(2009-7#1)
with tumor cells##2##3##(1993-6#1)(2008-5#1)
with tumor necrosis factor-alpha##2##4##(2008-6#1)(2013-1#1)
with tumor necrosis##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
with tumor of##2##3##(2008-7#1)(2012-2#1)
with tumor regression##2##3##(1991-8#2)
with tumor##17##2##(1991-8#2)(1993-6#1)(1994-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
with tumors##4##2##(1992-10#1)(1995-4#1)(2011-2#1)(2013-1#1)
with tunable##5##2##(2007-12#2)(2008-3#1)(2010-4#1)(2013-1#1)
with tungsten##2##2##(2007-11#1)(2008-10#1)
with two additional##2##3##(1991-2#1)(2009-5#1)
with two cascaded##2##3##(2008-2#1)(2008-3#1)
with two cycles of##3##4##(1996-9#1)(2008-10#2)
with two different levels of##2##5##(1990-2#1)(2008-10#1)
with two different##29##3##(1990-2#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
with two distinct##5##3##(1991-11#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
with two existing##2##3##(1991-3#1)(2012-2#1)
with two experimental##2##3##(2008-10#1)(2013-8#1)
with two flow##2##3##(2008-10#2)
with two isolates of##3##4##(2008-10#3)
with two isolates##5##3##(2008-10#5)
with two major##2##3##(2008-10#1)(2008-11#1)
with two new##6##3##(2008-10#4)(2008-2#1)(2011-2#1)
with two of##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
with two or##2##3##(2008-9#1)(2013-8#1)
with two other##7##3##(1997-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#2)
with two pairs of##2##4##(2007-11#1)(2007-12#1)
with two parallel##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
with two parameters##3##3##(2008-10#2)(2008-2#1)
with two patients##2##3##(1992-2#1)(2008-7#1)
with two putative##2##3##(1995-2#1)(1997-7#1)
with two sample##2##3##(2008-10#1)(2011-2#1)
with two separate##2##3##(1994-2#1)(2007-10#1)
with two short##2##3##(1996-2#2)
with two to four##2##4##(2010-8#1)(2013-8#1)
with two treatments##2##3##(1992-9#1)(2013-7#1)
with two types of##10##4##(1992-3#1)(1993-11#1)(1994-2#1)(1997-7#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)
with two vertical##2##3##(2007-12#1)(2008-10#1)
with two##286##2##(1990-12#2)(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-9#1)(1994-11#5)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#5)(1997-8#1)(2007-10#1)(2007-11#7)(2007-12#17)(2007-8#1)(2008-1#1)(2008-10#83)(2008-11#5)(2008-12#2)(2008-2#14)(2008-3#22)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
with two-##2##2##(2007-11#1)(2008-3#1)
with two-color##2##2##(2008-3#2)
with two-dimensional geometry##4##3##(2008-11#4)
with two-dimensional##12##2##(2007-12#1)(2008-11#5)(2008-2#3)(2008-3#2)(2011-1#1)
with two-photon excitation##2##3##(2008-3#2)
with two-photon##4##2##(2008-3#4)
with two-wave mixing in##2##4##(2008-2#2)
with type 1 and##4##4##(2008-7#1)(2012-12#1)(2012-4#2)
with type 1 diabetes and##3##5##(2009-9#2)(2012-2#1)
with type 1 diabetes mellitus##4##5##(2008-7#1)(2010-11#1)(2011-1#1)(2012-1#1)
with type 1 diabetes##13##4##(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-9#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#2)
with type 1##18##3##(2008-1#2)(2008-7#2)(2008-8#1)(2009-11#2)(2009-9#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-4#2)(2013-8#2)
with type 2 DM##3##4##(2008-3#2)(2012-2#1)
with type 2 diabetes (T2DM)##2##5##(2008-3#1)(2013-1#1)
with type 2 diabetes and##2##5##(2008-7#1)(2012-3#1)
with type 2 diabetes in##4##5##(2008-7#2)(2009-7#1)(2011-1#1)
with type 2 diabetes mellitus##10##5##(2007-5#1)(2008-3#2)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
with type 2 diabetes##42##4##(1996-11#1)(2007-5#1)(2008-1#5)(2008-11#1)(2008-3#8)(2008-7#3)(2009-1#1)(2009-7#1)(2010-10#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#2)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#3)
with type 2##47##3##(1996-11#1)(2007-5#1)(2008-1#5)(2008-11#1)(2008-3#10)(2008-7#3)(2009-1#1)(2009-7#1)(2010-10#2)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#3)(2013-1#3)(2013-7#1)(2013-8#3)
with type I mucopolysaccharidosis##3##4##(2012-3#3)
with type I##10##3##(1993-3#1)(1995-2#1)(2007-11#2)(2008-1#1)(2011-2#1)(2012-3#4)
with type II diabetes mellitus##3##5##(1993-12#2)(2008-7#1)
with type II diabetes##6##4##(1993-12#2)(1994-2#1)(1995-8#1)(1996-11#1)(2008-7#1)
with type II##8##3##(1993-12#2)(1994-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(2006-10#1)(2008-7#1)
with type##90##2##(1993-12#2)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-1#8)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#10)(2008-7#6)(2008-8#1)(2009-1#1)(2009-11#3)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2012-4#2)(2012-5#3)(2013-1#3)(2013-7#1)(2013-8#5)
with type-2 diabetes##4##3##(2008-7#3)(2011-2#1)
with typical clinical##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
with typical##23##2##(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
with typically##2##2##(2007-11#1)(2008-2#1)
with tyrosinase##2##2##(2008-10#2)
with tyrosine hydroxylase##2##3##(1996-5#1)(1997-5#1)
with tyrosine##5##2##(1992-8#1)(1994-8#1)(1996-5#1)(1997-5#1)(2008-4#1)
with ulcerative colitis (UC)##2##4##(2010-12#1)(2011-2#1)
with ulcerative colitis##10##3##(1992-9#1)(1994-2#1)(2007-10#2)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#1)
with ulcerative##12##2##(1992-9#1)(1994-2#1)(2007-10#2)(2010-12#5)(2011-2#1)(2012-12#1)(2012-2#1)
with ultra##2##2##(1992-3#1)(2008-9#1)
with ultrafiltration##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
with ultrashort##2##2##(2007-12#1)(2008-2#1)
with ultrasonic nebulization##3##3##(1991-1#1)(2008-10#2)
with ultrasonic##6##2##(1991-1#1)(2007-8#1)(2008-10#3)(2012-3#1)
with ultrasound##10##2##(1990-2#1)(1994-7#1)(1995-3#1)(2007-7#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-8#2)
with ultraviolet absorbance##2##3##(2008-10#2)
with ultraviolet detection at##2##4##(1997-2#1)(2008-10#1)
with ultraviolet detection##6##3##(1997-2#1)(2008-10#5)
with ultraviolet light##4##3##(1991-8#1)(2007-11#1)(2008-10#2)
with ultraviolet##19##2##(1990-8#1)(1991-8#1)(1997-2#1)(2007-11#2)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)
with un-treated larvae##2##3##(2008-12#2)
with uncertain##2##2##(2010-12#1)(2012-3#1)
with uncertainties in##2##3##(2008-10#1)(2008-3#1)
with uncertainties##4##2##(2008-10#1)(2008-3#3)
with uncertainty##5##2##(1995-6#1)(1997-3#1)(2008-11#1)(2010-11#1)(2010-8#1)
with uncertified seeds##2##3##(2008-12#2)
with unclear##3##2##(1995-12#1)(2008-1#1)(2013-1#1)
with uncommon##3##2##(1992-8#1)(2008-7#2)
with undergraduate education and current job##2##6##(1993-3#2)
with undergraduate education##4##3##(1993-3#4)
with undergraduate##5##2##(1993-3#4)(2008-12#1)
with underlying##7##2##(1990-3#1)(1992-11#1)(2007-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
with undetectable##5##2##(1990-7#1)(1995-8#1)(2008-7#1)(2009-8#1)(2013-1#1)
with undiagnosed##2##2##(2013-1#2)
with undoped##3##2##(2007-12#1)(2008-2#2)
with unequal variances##2##3##(1995-12#1)(2012-1#1)
with unequal##12##2##(1995-12#1)(1996-3#1)(2007-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#3)
with unexpected##4##2##(1994-9#1)(1996-3#1)(2009-10#1)(2009-7#1)
with unexplained medical symptoms##2##4##(2008-11#2)
with unexplained recurrent##2##3##(2012-3#1)(2013-1#1)
with unexplained##9##2##(1992-8#1)(1996-12#1)(2007-5#1)(2008-11#3)(2008-8#1)(2012-3#1)(2013-1#1)
with unfavorable##3##2##(1990-8#1)(2009-7#1)(2013-7#1)
with unidentified##3##2##(1993-3#1)(1997-2#1)(2008-10#1)
with uniform##9##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)
with uniformly##2##2##(2008-4#1)(2009-7#1)
with unilateral Perthes##4##3##(2007-11#4)
with unilateral single##2##3##(2007-10#2)
with unilateral##21##2##(1993-12#1)(1995-4#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#4)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
with unique##11##2##(1994-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)(2011-3#1)(2012-2#1)
with unit cell##2##3##(1997-7#1)(2008-8#1)
with unit##5##2##(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
with unknown function##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
with unknown primary##4##3##(1992-11#1)(1992-12#1)(2007-11#2)
with unknown##15##2##(1992-11#1)(1992-12#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
with unlabeled##2##2##(1992-12#1)(1995-5#1)
with unlimited##5##2##(2008-10#2)(2008-3#1)(2008-9#2)
with unmodified##3##2##(1994-5#1)(2008-10#2)
with unpolarized##2##2##(2007-11#1)(2008-3#1)
with unprecedented##2##2##(2008-9#1)(2009-5#1)
with unprotected##3##2##(2008-3#1)(2011-2#1)(2013-7#1)
with unresectable##6##2##(1991-2#1)(1995-4#1)(2008-6#1)(2012-2#1)(2013-1#2)
with unsafe##2##2##(1994-9#1)(2008-11#1)
with unstable angina##9##3##(1990-12#3)(1991-9#1)(2008-10#1)(2008-5#1)(2013-1#2)(2013-8#1)
with unstable##15##2##(1990-12#3)(1991-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#2)(2013-8#2)
with untransformed##2##2##(1997-4#1)(2008-10#1)
with untreated##10##2##(1992-9#1)(1993-8#1)(1995-2#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
with unusual presentation##2##3##(2009-8#1)(2010-11#1)
with unusual##14##2##(1995-8#1)(1997-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
with up to 1##2##4##(1997-2#1)(2011-2#1)
with up to##14##3##(1993-2#1)(1994-11#1)(1995-9#1)(1997-1#1)(1997-2#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
with up##15##2##(1993-2#1)(1994-11#1)(1995-9#1)(1997-1#1)(1997-2#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-2#1)
with upper##8##2##(1991-11#1)(2008-4#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
with uranium##2##2##(2008-10#1)(2013-1#1)
with urban##3##2##(2007-12#1)(2009-7#1)(2012-1#1)
with urea and##3##3##(1994-12#1)(1997-2#1)(2008-10#1)
with urea##5##2##(1990-5#1)(1994-12#1)(1997-2#1)(2008-10#2)
with uremic parathyroid hyperplasia##2##4##(2008-5#2)
with uremic##3##2##(2008-5#2)(2011-2#1)
with urethritis and##2##3##(2012-2#1)(2013-1#1)
with urethritis##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
with urgent##2##2##(2008-4#1)(2008-6#1)
with uricase##2##2##(1997-2#1)(2008-10#1)
with urinary tract infection##4##4##(2007-7#1)(2008-4#3)
with urinary tract##5##3##(1996-12#1)(2007-7#1)(2008-4#3)
with urinary##20##2##(1990-2#2)(1993-2#1)(1995-12#2)(1996-12#4)(1997-4#1)(2007-7#2)(2008-10#3)(2008-4#3)(2009-3#1)(2013-8#1)
with urine##3##2##(1992-9#1)(2008-10#2)
with urogenital##2##2##(1990-6#1)(2007-9#1)
with urticaria##2##2##(2007-2#1)(2013-1#1)
with us##4##2##(2007-12#1)(2009-3#1)(2010-2#1)(2012-2#1)
with usage of##2##3##(2008-12#1)(2009-5#1)
with use of a##9##4##(2008-10#1)(2008-2#5)(2008-3#2)(2008-6#1)
with use of an##2##4##(1993-2#1)(2008-10#1)
with use of implants##2##4##(2007-11#2)
with use of the##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
with use of##47##3##(1992-9#1)(1993-2#1)(1993-9#2)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#6)(2008-6#2)(2010-3#3)(2011-2#3)(2013-1#2)(2013-8#1)
with use##48##2##(1992-9#1)(1993-2#1)(1993-9#2)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#1)(2008-6#2)(2010-3#3)(2011-2#3)(2013-1#2)(2013-8#1)
with useful##4##2##(2008-1#1)(2008-4#2)(2008-5#1)
with users##2##2##(2008-7#1)(2011-2#1)
with using##13##2##(1993-2#1)(1993-3#1)(1996-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2012-3#1)
with uterine atony##2##3##(1995-12#1)(2011-2#1)
with uterine##5##2##(1995-12#1)(2011-1#1)(2011-2#1)(2011-8#1)(2013-7#1)
with vaccination of##2##3##(2011-1#1)(2011-2#1)
with vaccination##6##2##(1995-5#1)(1997-6#1)(2009-12#1)(2011-1#2)(2011-2#1)
with vaccines##4##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
with vacuoles and paired-helical filaments##2##5##(2008-7#2)
with vacuoles and##3##3##(2008-5#1)(2008-7#2)
with vacuum disc##2##3##(2008-12#2)
with vacuum##3##2##(2008-12#2)(2008-7#1)
with vaginal##7##2##(1995-1#1)(1996-1#1)(1996-12#1)(2007-2#1)(2009-6#1)(2010-8#1)(2011-2#1)
with vague##2##2##(2008-1#1)(2011-1#1)
with validation##2##2##(2008-10#1)(2008-3#1)
with valine and##2##3##(1993-11#1)(1996-2#1)
with valine##4##2##(1993-11#1)(1995-2#1)(1996-2#2)
with values obtained by##3##4##(1990-2#1)(2008-10#2)
with values of 0##2##4##(2008-10#1)(2008-3#1)
with values of##5##3##(1992-5#1)(1993-2#1)(1993-8#1)(2008-10#1)(2008-3#1)
with values ranging from##4##4##(2008-10#3)(2008-3#1)
with values ranging##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
with values##23##2##(1990-2#1)(1991-8#1)(1992-5#1)(1993-2#1)(1993-8#1)(2008-10#8)(2008-2#1)(2008-3#6)(2008-5#1)(2011-2#1)(2013-1#1)
with valve repair##2##3##(2007-8#2)
with valve##4##2##(2007-8#2)(2008-10#1)(2008-4#1)
with valvular heart##3##3##(2012-2#1)(2013-1#2)
with valvular##4##2##(1995-8#1)(2012-2#1)(2013-1#2)
with van der Waals##2##4##(1991-5#1)(2008-5#1)
with vanadate##7##2##(1990-2#1)(1994-6#3)(1995-6#1)(1997-1#1)(2008-10#1)
with vanadium##2##2##(2008-10#2)
with vancomycin##5##2##(2007-12#3)(2011-1#1)(2011-2#1)
with vapour##2##2##(2008-10#1)(2008-4#1)
with variable results##3##3##(2008-9#1)(2009-5#1)(2012-3#1)
with variable##27##2##(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#4)(2008-2#5)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#2)
with variance##2##2##(1992-2#1)(2008-3#1)
with variant##3##2##(1994-11#1)(2011-2#2)
with variation in##3##3##(2007-12#1)(2007-8#1)(2008-8#1)
with variation of##2##3##(2008-10#1)(2008-3#1)
with variation##7##2##(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
with variations in the##5##4##(2008-10#1)(2008-9#1)(2011-2#2)(2013-8#1)
with variations in##10##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#2)
with varied##12##2##(1995-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2013-1#2)(2013-8#3)
with various amounts of##2##4##(2008-10#1)(2008-3#1)
with various chemical##2##3##(1992-2#1)(2008-10#1)
with various clinical##2##3##(1993-2#1)(2008-7#1)
with various concentrations of##5##4##(1994-12#1)(1996-12#1)(2008-11#1)(2008-12#1)(2013-8#1)
with various concentrations##6##3##(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
with various degrees of##2##4##(2008-10#1)(2010-4#1)
with various diseases##2##3##(1995-12#1)(2010-2#1)
with various doses of##2##4##(2008-11#1)(2008-5#1)
with various electron##2##3##(1995-3#1)(2009-11#1)
with various functions##2##3##(2008-10#1)(2008-9#1)
with various health##2##3##(1993-2#1)(2008-8#1)
with various neurological diseases##2##4##(1993-8#2)
with various pathologies##2##3##(2011-3#1)(2012-12#1)
with various shapes##2##3##(2008-10#1)(2008-3#1)
with various structures##2##3##(2008-10#2)
with various types of##7##4##(1991-12#1)(1996-3#1)(1997-4#1)(2008-3#1)(2009-9#1)(2010-3#1)(2012-2#1)
with various values##2##3##(2008-3#2)
with various##144##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-7#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#31)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#2)
with varying amounts of##2##4##(1993-12#1)(2008-6#1)
with varying concentrations of##4##4##(2008-10#1)(2009-10#1)(2009-9#1)(2013-1#1)
with varying degrees of##10##4##(1994-2#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)
with varying doses of##2##4##(1994-11#1)(2007-2#1)
with varying levels of##7##4##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
with varying results##3##3##(1990-2#1)(2008-10#1)(2008-4#1)
with varying##57##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-2#2)(1995-2#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
with vascular dementia##4##3##(1996-5#2)(2008-7#2)
with vascular disease##5##3##(1993-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-1#1)
with vascular endothelial growth factor (VEGF)##2##6##(2007-8#1)(2008-10#1)
with vascular##27##2##(1992-6#1)(1993-2#1)(1996-5#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with vascularized##3##2##(2010-10#1)(2012-2#2)
with vasopressin##2##2##(1990-12#1)(1993-12#1)
with vectors for gene therapy##2##5##(1994-5#1)(2008-4#1)
with vectors##3##2##(1994-5#1)(2008-11#1)(2008-4#1)
with vecuronium##3##2##(1993-1#1)(2010-7#2)
with vehicle##3##2##(1990-11#1)(2008-9#1)(2013-1#1)
with vein##3##2##(1991-3#1)(1996-9#1)(2008-10#1)
with venous leg ulcers##2##4##(1997-3#2)
with venous leg##3##3##(1997-3#3)
with venous##7##2##(1996-6#1)(1997-3#3)(2007-7#1)(2008-7#1)(2008-9#1)
with ventricular fibrillation##2##3##(1990-12#1)(1995-12#1)
with ventricular##7##2##(1990-12#1)(1995-12#2)(2008-11#1)(2009-5#1)(2011-1#1)(2012-3#1)
with verbal##2##2##(1993-1#1)(2013-1#1)
with versatile##2##2##(2008-10#1)(2011-2#1)
with vertebral compression fractures##2##4##(2008-7#2)
with vertebral fractures##2##3##(2007-11#1)(2008-7#1)
with vertebral##7##2##(1991-11#1)(2007-11#1)(2008-7#4)(2012-2#1)
with vertebrate##2##2##(1990-8#1)(2007-12#1)
with vertical##5##2##(1991-3#1)(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#1)
with vertical-cavity surface-emitting laser (VCSEL)##2##5##(2008-2#1)(2008-3#1)
with vertical-cavity surface-emitting##3##3##(2008-2#1)(2008-3#2)
with very active##2##3##(2013-8#2)
with very different##7##3##(1991-12#1)(1992-3#1)(1995-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
with very fast##3##3##(2007-12#3)
with very few##4##3##(1990-11#1)(1991-5#1)(2010-5#1)(2012-3#1)
with very good accuracy##2##4##(2008-10#1)(2013-8#1)
with very good results##2##4##(1993-3#1)(2008-11#1)
with very good##10##3##(1993-3#1)(1996-6#1)(2008-10#5)(2008-11#2)(2013-8#1)
with very high accuracy##2##4##(1997-7#1)(2011-2#1)
with very high affinity##2##4##(1992-11#1)(1994-2#1)
with very high hardness##2##4##(2007-12#1)(2012-2#1)
with very high mortality##2##4##(2008-5#1)(2010-5#1)
with very high##17##3##(1991-5#1)(1991-6#1)(1992-11#1)(1994-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#2)
with very large##2##3##(2007-4#1)(2008-3#1)
with very little##2##3##(2008-4#1)(2008-5#1)
with very low birth weight##3##5##(1995-6#1)(2011-1#1)(2012-1#1)
with very low birth##4##4##(1994-6#1)(1995-6#1)(2011-1#1)(2012-1#1)
with very low serum##2##4##(1993-3#1)(1995-5#1)
with very low##14##3##(1992-5#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#4)(2011-1#1)(2011-2#1)(2012-1#1)
with very poor##2##3##(2008-10#1)(2010-1#1)
with very satisfactory results##2##4##(2008-10#1)(2009-10#1)
with very##81##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
with vesicles##2##2##(2008-8#1)(2012-2#1)
with vestibular##2##2##(2008-4#1)(2012-2#1)
with viable##3##2##(2008-10#1)(2008-7#1)(2013-7#1)
with victimization##4##2##(2008-12#1)(2009-5#3)
with video##2##2##(2008-3#2)
with vigabatrin##3##2##(1992-3#2)(1996-8#1)
with villous height##3##3##(2013-1#3)
with villous##4##2##(2010-3#1)(2013-1#3)
with vinblastine##2##2##(1990-2#1)(1991-6#1)
with vincristine##2##2##(1995-3#1)(2012-1#1)
with violence##3##2##(1995-12#1)(1996-2#1)(2009-9#1)
with viral##15##2##(1994-11#1)(1995-5#1)(1995-6#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-1#1)
with virions##2##2##(1997-3#1)(2008-10#1)
with virtually no##2##3##(2007-11#1)(2008-10#1)
with virtually##5##2##(1993-6#1)(1994-9#1)(2007-11#1)(2008-10#2)
with virulence of isolates to##2##5##(2008-10#2)
with virulence of##3##3##(2007-6#1)(2008-10#2)
with virulence on##2##3##(2008-10#2)
with virulence##9##2##(2007-6#1)(2008-10#8)
with virulent isolates##2##3##(2008-10#2)
with virulent##7##2##(1995-2#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-5#1)
with viruliferous whiteflies##2##3##(2008-10#2)
with viruliferous##4##2##(2008-10#4)
with virus##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
with virus-specific##2##2##(2008-10#2)
with viruses##4##2##(1996-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
with visceral##6##2##(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
with visible##3##2##(1992-1#1)(2008-10#1)(2008-2#1)
with vision##2##2##(1994-3#1)(2010-8#1)
with visits##2##2##(2008-7#1)(2011-2#1)
with visual##16##2##(1993-2#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
with vitamin A##3##3##(2007-11#1)(2008-11#1)(2008-5#1)
with vitamin B12##3##3##(1993-12#2)(2007-9#1)
with vitamin C##3##3##(2008-1#1)(2011-1#2)
with vitamin D deficiency##2##4##(2011-1#1)(2012-2#1)
with vitamin D##4##3##(2011-1#3)(2012-2#1)
with vitamin E##7##3##(1991-12#1)(1995-12#1)(1996-3#1)(2008-5#1)(2013-1#3)
with vitamin##25##2##(1991-12#1)(1993-11#1)(1993-12#2)(1995-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-1#6)(2012-2#1)(2013-1#3)
with vitamins##3##2##(2007-7#1)(2008-3#1)(2008-8#1)
with vitiligo##3##2##(2007-7#1)(2013-1#2)
with voltammetric##2##2##(2008-10#2)
with volume##2##2##(1992-12#1)(2008-3#1)
with vomiting##8##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2009-5#2)(2010-2#1)(2013-7#1)
with von Recklinghausen's neurofibromatosis##2##4##(2008-10#2)
with von##5##2##(1992-11#1)(2008-1#1)(2008-10#2)(2008-12#1)
with voriconazole##2##2##(2009-2#1)(2012-2#1)
with wall##3##2##(2007-12#2)(2008-9#1)
with wall-jet##3##2##(2008-10#3)
with warfarin##8##2##(2007-2#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#4)
with warm temperature##2##3##(2008-10#1)(2012-4#1)
with warm##3##2##(1990-2#1)(2008-10#1)(2012-4#1)
with washed##2##2##(1990-10#1)(1992-3#1)
with water and##11##3##(2008-10#6)(2008-12#1)(2008-5#2)(2009-5#1)(2011-2#1)
with water as the##2##4##(1993-9#1)(2013-7#1)
with water as##3##3##(1993-9#1)(2011-2#1)(2013-7#1)
with water at##2##3##(2008-10#1)(2011-2#1)
with water followed by##2##4##(2008-9#1)(2011-1#1)
with water for##3##3##(2008-10#3)
with water##71##2##(1990-11#1)(1991-2#1)(1993-9#1)(2008-10#42)(2008-11#2)(2008-12#4)(2008-3#2)(2008-5#8)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-7#1)(2013-8#1)
with water)##2##2##(2008-10#2)
with water-soluble##2##2##(2008-10#2)
with wavelength##12##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#8)
with wavelength-division multiplexing##3##3##(2007-12#3)
with wavelengths##4##2##(2008-3#4)
with wavelet##2##2##(2008-10#1)(2008-3#1)
with wax##3##2##(2008-10#3)
with weak##5##2##(1994-11#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-3#1)
with weaker##3##2##(1997-5#1)(2008-10#1)(2008-11#1)
with weakly##2##2##(2007-12#1)(2008-10#1)
with wedge##4##2##(1992-9#1)(2007-10#3)
with week##2##2##(1992-6#1)(2008-7#1)
with weekly##4##2##(1990-11#1)(1990-12#1)(1992-10#1)(2011-2#1)
with weight and##3##3##(2007-12#1)(2011-2#2)
with weight gain##2##3##(1997-7#1)(2007-12#1)
with weight loss##4##3##(2008-3#3)(2008-5#1)
with weight##13##2##(1991-12#1)(1997-7#1)(2007-12#3)(2008-3#3)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#1)
with well##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
with well-controlled##3##2##(2010-4#1)(2010-9#1)(2011-2#1)
with well-defined##5##2##(1992-8#1)(1996-4#1)(2008-10#2)(2010-10#1)
with well-established##2##2##(1991-3#1)(2007-12#1)
with well-known##4##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
with western medical injections##2##4##(2011-2#2)
with western##3##2##(2011-2#3)
with what has been##2##4##(2007-12#1)(2008-5#1)
with what is##5##3##(1993-12#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-12#1)
with what we know##3##4##(1996-2#1)(2010-10#2)
with what we##7##3##(1994-2#1)(1996-2#1)(2009-9#2)(2010-10#2)(2012-2#1)
with what would be expected##2##5##(1992-6#1)(2008-7#1)
with what##20##2##(1990-8#1)(1991-12#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-9#2)(2010-10#2)(2012-12#1)(2012-2#1)
with wheat germ agglutinin##2##4##(1992-6#1)(2008-11#1)
with wheat##9##2##(1992-6#1)(2008-10#6)(2008-11#2)
with when the knee##2##4##(1997-8#2)
with which a##5##3##(1992-2#1)(1992-5#1)(1993-2#1)(2008-3#1)(2008-8#1)
with which all##2##3##(1990-9#1)(2012-12#1)
with which it shares##2##4##(1994-12#1)(1995-6#1)
with which it##6##3##(1991-9#1)(1994-12#1)(1995-6#1)(2008-10#1)(2013-1#2)
with which one can##2##4##(2008-2#1)(2008-3#1)
with which one##3##3##(2008-2#2)(2008-3#1)
with which such##2##3##(2008-3#1)(2011-1#1)
with which the##16##3##(1992-2#1)(1993-2#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-11#1)(2010-5#1)(2010-9#1)(2012-2#1)
with which they are##2##4##(1992-2#1)(2011-2#1)
with which they##9##3##(1992-2#1)(1995-3#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
with which to compare##2##4##(1997-4#1)(2008-8#1)
with which to measure##4##4##(1990-11#1)(1994-3#1)(2008-3#2)
with which to obtain##3##4##(2008-3#3)
with which to study##3##4##(1991-5#1)(1994-6#1)(2008-7#1)
with which to##30##3##(1990-11#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#1)
with which we##2##3##(2008-10#1)(2009-5#1)
with which##93##2##(1990-11#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#21)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with white light##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
with white##12##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#2)(2013-7#2)
with white-light illumination##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
with white-light##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
with whole##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
with whole-cell##2##2##(1996-12#1)(1996-5#1)
with whom family doctors participated in euthanasia or assisted suicide##2##10##(1991-8#2)
with whom patients had##2##4##(2010-4#2)
with whom the##2##3##(1990-11#1)(1993-6#1)
with whom##10##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-8#2)(1993-6#1)(1995-1#1)(2010-4#2)(2012-12#1)
with wide range of##2##4##(2009-10#1)(2010-3#1)
with wide spectrum##3##3##(1990-12#1)(2008-5#2)
with wide##18##2##(1990-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
with widely spaced##3##3##(2008-2#2)(2009-8#1)
with widely##7##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-8#1)(2013-1#1)
with widespread##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
with widths##3##2##(2008-2#1)(2008-7#2)
with wild type strain##2##4##(2008-12#1)(2008-8#1)
with wild type##6##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
with wild vegetation##3##3##(2013-1#3)
with wild##11##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#4)
with wild-type and##2##3##(2008-10#1)(2008-11#1)
with wild-type or##2##3##(1997-7#1)(2010-2#1)
with wild-type virus##2##3##(1993-6#1)(2011-3#1)
with wild-type##25##2##(1993-3#1)(1993-6#1)(1993-8#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#9)(2008-11#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
with wind##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
with wireless##2##2##(2010-8#2)
with woman&quot##2##2##(2013-1#2)
with women##7##2##(1991-11#1)(1992-3#1)(1997-3#1)(2008-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
with working##2##2##(2008-10#1)(2012-2#1)
with worse outcome##2##3##(2009-2#2)
with worse##4##2##(2006-8#1)(2009-2#2)(2010-6#1)
with worsening##3##2##(1994-12#1)(1995-8#1)(2010-10#1)
with wortmannin##2##2##(1992-6#1)(1994-11#1)
with wound##3##2##(2007-12#1)(2007-8#1)(2010-6#1)
with wrist##2##2##(1996-2#1)(2008-1#1)
with written##3##2##(2008-12#1)(2011-2#1)(2012-1#1)
with x##2##2##(2008-2#1)(2010-4#1)
with x-ray diffraction##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
with x-ray photoelectron spectroscopy##2##4##(2008-2#2)
with x-ray##8##2##(1990-12#1)(2007-12#1)(2008-2#3)(2008-3#2)(2010-5#1)
with xanthine##2##2##(1996-9#1)(2008-10#1)
with xanthogranulomatous pyelonephritis##2##3##(2008-1#1)(2013-1#1)
with xerotic skin##3##3##(2008-5#3)
with xylenol orange##3##3##(2008-10#3)
with yeast HAP2##2##3##(1995-2#1)(2008-9#1)
with yeast and mammalian cells##2##5##(2008-4#1)(2008-9#1)
with yeast and##3##3##(1992-8#1)(2008-4#1)(2008-9#1)
with yeast artificial##2##3##(1996-10#2)
with yeast two-hybrid system##2##4##(2008-8#2)
with yeast##20##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#2)(1995-2#1)(1996-10#2)(1996-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2012-3#1)
with yields of##2##3##(1990-5#1)(2013-1#1)
with you##3##2##(1993-12#1)(1993-3#1)(1994-1#1)
with young children##2##3##(2009-11#1)(2013-1#1)
with young##11##2##(1990-5#1)(1996-2#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
with younger##2##2##(2008-10#1)(2008-5#1)
with your##12##2##(1993-2#1)(1993-3#1)(1994-1#2)(1994-3#2)(1995-2#1)(2010-3#2)(2010-5#1)(2010-9#1)(2012-3#1)
with yttrium phosphate##2##3##(2008-10#2)
with zero##11##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2009-6#1)
with zidovudine##3##2##(2008-5#2)(2011-3#1)
with zinc##8##2##(1990-11#1)(1991-9#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
with zirconium permanent##2##3##(2008-10#2)
with zirconium##9##2##(2008-10#9)
with zymosan##3##2##(1991-5#1)(1992-3#1)(2008-12#1)
with##68862##1##(1990-10#52)(1990-11#208)(1990-12#305)(1990-2#239)(1990-3#148)(1990-4#11)(1990-5#234)(1990-6#150)(1990-7#147)(1990-8#253)(1990-9#136)(1991-1#62)(1991-10#15)(1991-11#136)(1991-12#337)(1991-2#236)(1991-3#172)(1991-4#56)(1991-5#220)(1991-6#168)(1991-7#34)(1991-8#205)(1991-9#174)(1992-1#74)(1992-10#60)(1992-11#176)(1992-12#256)(1992-2#181)(1992-3#356)(1992-4#41)(1992-5#130)(1992-6#258)(1992-7#14)(1992-8#233)(1992-9#210)(1993-1#143)(1993-10#11)(1993-11#274)(1993-12#327)(1993-2#217)(1993-3#242)(1993-5#40)(1993-6#248)(1993-8#285)(1993-9#176)(1994-1#77)(1994-10#16)(1994-11#229)(1994-12#336)(1994-2#235)(1994-3#244)(1994-5#190)(1994-6#222)(1994-7#40)(1994-8#280)(1994-9#168)(1995-1#86)(1995-10#16)(1995-11#233)(1995-12#387)(1995-2#415)(1995-3#313)(1995-4#18)(1995-5#261)(1995-6#257)(1995-8#176)(1995-9#63)(1996-1#121)(1996-10#24)(1996-11#85)(1996-12#330)(1996-2#399)(1996-3#187)(1996-4#32)(1996-5#335)(1996-6#134)(1996-7#81)(1996-8#64)(1996-9#107)(1997-1#179)(1997-2#321)(1997-3#357)(1997-4#228)(1997-5#145)(1997-6#204)(1997-7#311)(1997-8#240)(1997-9#16)(2006-10#203)(2006-11#5)(2006-12#52)(2006-4#6)(2006-5#12)(2006-6#38)(2006-7#5)(2006-8#15)(2007-1#18)(2007-10#431)(2007-11#1455)(2007-12#1601)(2007-2#120)(2007-3#9)(2007-4#29)(2007-5#116)(2007-6#55)(2007-7#416)(2007-8#614)(2007-9#48)(2008-1#709)(2008-10#13940)(2008-11#2016)(2008-12#945)(2008-2#1799)(2008-3#3776)(2008-4#876)(2008-5#1488)(2008-6#824)(2008-7#2356)(2008-8#1303)(2008-9#1305)(2009-1#54)(2009-10#232)(2009-11#198)(2009-12#194)(2009-2#107)(2009-3#182)(2009-4#165)(2009-5#343)(2009-6#178)(2009-7#247)(2009-8#346)(2009-9#212)(2010-1#122)(2010-10#248)(2010-11#213)(2010-12#392)(2010-2#159)(2010-3#314)(2010-4#280)(2010-5#308)(2010-6#211)(2010-7#167)(2010-8#403)(2010-9#101)(2011-1#1026)(2011-10#18)(2011-2#2621)(2011-3#126)(2011-5#2)(2011-7#17)(2011-8#4)(2011-9#2)(2012-1#327)(2012-12#899)(2012-2#1215)(2012-3#1152)(2012-4#16)(2012-5#23)(2012-6#14)(2012-7#19)(2012-8#12)(2012-9#7)(2013-1#2351)(2013-2#1)(2013-3#4)(2013-7#255)(2013-8#978)
with)##2##1##(1994-3#1)(2008-7#1)
with/without##7##1##(1997-6#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
withDrosophila GGPPS##2##2##(2008-8#2)
withanolide A and##2##3##(2012-2#2)
withanolide A##3##2##(2012-2#3)
withanolide##4##1##(2012-2#4)
withdraw##8##1##(1994-2#1)(1995-12#1)(1996-8#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-3#1)
withdrawal after##2##2##(2011-2#2)
withdrawal and##9##2##(1990-8#2)(1994-3#1)(1996-12#1)(2007-11#1)(2007-8#1)(2010-6#1)(2012-1#1)(2013-1#1)
withdrawal for##2##2##(1995-12#1)(2008-7#1)
withdrawal from cocaine##2##3##(1991-1#1)(1992-11#1)
withdrawal from the##3##3##(1995-12#1)(1997-6#1)(2007-8#1)
withdrawal from##14##2##(1991-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1995-12#2)(1997-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#2)
withdrawal in##6##2##(1991-1#4)(1991-12#1)(2013-1#1)
withdrawal movement##2##2##(2011-2#2)
withdrawal of a##2##3##(1994-9#1)(1996-2#1)
withdrawal of serum##3##3##(1994-11#1)(1996-2#2)
withdrawal of the##9##3##(1990-6#1)(1992-3#1)(1992-6#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
withdrawal of##27##2##(1990-3#1)(1990-6#1)(1991-3#1)(1992-3#2)(1992-6#1)(1994-11#1)(1994-9#1)(1996-2#3)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
withdrawal reactions##2##2##(1991-12#1)(2008-6#1)
withdrawal response##3##2##(2011-2#3)
withdrawal speed##2##2##(2008-3#2)
withdrawal symptoms##8##2##(1991-1#1)(1992-3#1)(1995-11#1)(2008-2#1)(2009-7#1)(2011-1#2)(2011-2#1)
withdrawal syndrome of##2##3##(1991-12#1)(1995-12#1)
withdrawal syndrome##8##2##(1991-12#4)(1995-12#2)(2009-5#1)(2013-1#1)
withdrawal threshold to##2##3##(2009-12#2)
withdrawal threshold##5##2##(1993-12#2)(2009-12#3)
withdrawal thresholds##3##2##(1993-12#2)(1997-2#1)
withdrawal to##3##2##(1997-2#1)(1997-6#1)(2008-8#1)
withdrawal##170##1##(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#11)(1991-12#11)(1991-3#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-6#1)(1993-12#4)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#8)(1995-12#13)(1995-2#2)(1996-1#1)(1996-12#5)(1996-2#4)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#3)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#3)(2008-10#4)(2008-11#4)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#7)(2008-7#6)(2008-8#1)(2009-11#3)(2009-12#4)(2009-5#1)(2009-7#2)(2010-11#2)(2010-6#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)
withdrawal)##2##1##(1995-8#1)(2011-2#1)
withdrawing substituents##2##2##(2009-9#1)(2010-5#1)
withdrawing the##2##2##(1992-3#1)(2011-2#1)
withdrawing##14##1##(1991-2#2)(1992-3#1)(1995-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-9#3)(2010-5#2)(2011-2#1)
withdrawn at##2##2##(1996-12#1)(2008-4#1)
withdrawn for##2##2##(1996-9#1)(2013-1#1)
withdrawn##37##1##(1990-7#1)(1992-11#1)(1992-5#1)(1993-3#1)(1994-3#1)(1996-12#1)(1996-9#2)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#12)(2008-12#1)(2008-4#1)(2008-7#2)(2010-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
withdrew from##2##2##(2008-7#1)(2013-1#1)
withdrew##6##1##(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
withheld##3##1##(1996-5#1)(1997-2#1)(2007-11#1)
withhold a##2##2##(2008-10#1)(2011-2#1)
withhold##3##1##(1993-7#1)(2008-10#1)(2011-2#1)
withholding and withdrawing life-support##2##4##(1991-2#2)
withholding##7##1##(1991-2#2)(1996-8#1)(2008-12#1)(2008-7#1)(2013-8#2)
within &quot##2##2##(2008-10#1)(2012-2#1)
within +/-0##9##2##(2008-10#2)(2008-2#2)(2008-3#5)
within +/-10%##2##2##(2008-10#1)(2008-3#1)
within +/-20%##3##2##(2008-10#3)
within 0##17##2##(1990-2#2)(1991-8#1)(1993-12#1)(2008-10#7)(2008-2#1)(2008-3#4)(2011-2#1)
within 1 h after##2##4##(1995-8#1)(2008-10#1)
within 1 h of##2##4##(1992-8#1)(1993-3#1)
within 1 h##5##3##(1992-8#1)(1993-3#1)(1995-8#1)(2008-10#2)
within 1 min##6##3##(1991-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
within 1 month after##2##4##(2008-10#1)(2011-2#1)
within 1 month##7##3##(1991-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
within 1 week##4##3##(1994-12#1)(2008-10#2)(2008-5#1)
within 1##36##2##(1991-12#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
within 1% of##2##3##(2008-1#1)(2008-3#1)
within 1%##6##2##(2008-1#1)(2008-2#1)(2008-3#4)
within 1-2##4##2##(1990-10#1)(1992-3#1)(1997-7#1)(2012-12#1)
within 10 days of##2##4##(1991-12#1)(2007-10#1)
within 10 h##2##3##(2008-10#1)(2008-11#1)
within 10 min of##2##4##(1991-2#1)(1996-12#1)
within 10 min##8##3##(1991-2#2)(1992-11#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-5#1)
within 10 minutes##2##3##(2011-1#1)(2012-2#1)
within 10 sec and##2##4##(1990-7#1)(1993-11#1)
within 10 years##3##3##(2007-7#1)(2008-1#1)(2010-12#1)
within 10##27##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
within 10% for##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
within 10% of##2##3##(2008-10#1)(2011-2#1)
within 10%##8##2##(2007-12#1)(2008-10#2)(2008-3#4)(2011-2#1)
within 100##4##2##(2008-10#2)(2010-8#1)(2012-1#1)
within 10s##2##2##(2008-10#2)
within 12 hours of##2##4##(2007-10#1)(2008-3#1)
within 12 hours##3##3##(2007-10#1)(2008-3#1)(2009-11#1)
within 12 min##3##3##(2008-10#3)
within 12 months##3##3##(2011-2#1)(2012-2#2)
within 12##12##2##(1993-8#1)(1997-7#1)(2007-10#1)(2008-10#4)(2008-3#1)(2009-11#1)(2011-2#1)(2012-2#2)
within 13##2##2##(2008-10#1)(2008-3#1)
within 14##3##2##(2008-10#2)(2010-11#1)
within 15 days##2##3##(1995-2#1)(2008-11#1)
within 15 min##6##3##(1990-12#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
within 15##9##2##(1990-12#1)(1993-9#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
within 15% of##2##3##(2008-3#2)
within 16 h##2##3##(2008-10#2)
within 16##3##2##(2008-10#2)(2012-2#1)
within 17 min##2##3##(2008-3#1)(2008-5#1)
within 18 months##2##3##(1990-6#1)(1995-2#1)
within 18##3##2##(1990-6#1)(1993-3#1)(1995-2#1)
within 2 and##2##3##(1990-6#1)(1996-2#1)
within 2 days##2##3##(1996-2#1)(2013-8#1)
within 2 h after##2##4##(2008-10#1)(2008-8#1)
within 2 h and##3##4##(1990-5#1)(1994-2#1)(2008-10#1)
within 2 h of##4##4##(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#1)
within 2 h##15##3##(1990-5#1)(1992-3#1)(1992-8#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-6#1)
within 2 kcal/mol of the benchmark results##2##7##(2012-12#2)
within 2 min of##2##4##(1992-11#1)(2009-12#1)
within 2 months##2##3##(2008-10#1)(2012-2#1)
within 2 to 6##2##4##(1992-8#1)(2008-10#1)
within 2 weeks after##3##4##(1996-12#1)(2008-10#2)
within 2 weeks of##2##4##(1995-1#1)(2008-10#1)
within 2 weeks##12##3##(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2006-12#1)(2008-10#6)(2008-11#1)
within 2 years of##2##4##(2011-2#1)(2012-12#1)
within 2 years##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
within 2##50##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-3#1)(1992-8#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-6#1)(2013-8#1)
within 2%##4##2##(2008-2#1)(2008-3#3)
within 2-3##2##2##(1993-3#1)(1994-11#1)
within 2-3%##2##2##(2008-10#2)
within 2-4##2##2##(1996-2#1)(2007-9#1)
within 20 min##3##3##(1996-9#1)(2008-10#1)(2008-6#1)
within 20##9##2##(1990-5#1)(1994-3#1)(1996-9#1)(2008-10#4)(2008-6#2)
within 20min##2##2##(2008-10#2)
within 21 days##2##3##(2008-11#1)(2011-2#1)
within 21##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
within 24 h after##5##4##(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
within 24 h of##3##4##(1990-10#1)(2008-10#1)(2008-7#1)
within 24 h##19##3##(1990-10#1)(1994-5#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
within 24 hours of the##2##5##(2007-10#1)(2011-2#1)
within 24 hours of##6##4##(1993-2#1)(2007-10#2)(2011-1#1)(2011-2#1)(2012-3#1)
within 24 hours##11##3##(1993-2#1)(1995-8#1)(2007-10#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
within 24##32##2##(1990-10#1)(1991-2#1)(1993-2#1)(1994-5#1)(1995-8#1)(1997-7#1)(2007-10#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
within 25##2##2##(1992-11#1)(2008-10#1)
within 28 days##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
within 28##4##2##(1996-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
within 2min##2##2##(2008-10#2)
within 3 h##6##3##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
within 3 hours##3##3##(2007-10#1)(2007-9#1)(2013-8#1)
within 3 min##2##3##(1990-12#1)(2008-10#1)
within 3 months of##3##4##(1991-8#1)(2008-3#1)(2008-6#1)
within 3 months##7##3##(1991-8#1)(2007-11#1)(2008-3#1)(2008-6#2)(2012-12#1)(2013-1#1)
within 3 years of diagnosis##2##5##(2008-11#1)(2008-5#1)
within 3 years of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
within 3##35##2##(1990-12#1)(1990-6#1)(1991-8#1)(1993-12#1)(1995-2#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
within 3%##2##2##(2008-3#2)
within 3-5##3##2##(2008-11#1)(2008-9#1)(2009-9#1)
within 30 days##2##3##(2008-11#1)(2012-3#1)
within 30 min##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
within 30##12##2##(1993-12#1)(1994-3#1)(1995-2#1)(2008-10#4)(2008-11#2)(2009-11#1)(2012-3#2)
within 36 h##3##3##(2008-10#3)
within 36##5##2##(2008-10#4)(2010-7#1)
within 4 days and##2##4##(1996-2#1)(2012-12#1)
within 4 days##5##3##(1994-9#1)(1996-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
within 4 h of##3##4##(1997-2#1)(2007-8#1)(2013-1#1)
within 4 h##6##3##(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(2007-8#1)(2013-1#1)
within 4 months##3##3##(1992-5#1)(2008-5#1)(2013-1#1)
within 4 to 7##2##4##(1992-8#1)(1997-5#1)
within 4 weeks##3##3##(2008-10#3)
within 4 years##2##3##(1990-9#1)(2008-7#1)
within 4##26##2##(1990-7#1)(1990-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-8#1)(2008-10#6)(2008-5#2)(2008-7#1)(2012-12#1)(2013-1#2)
within 4%##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
within 45 min##3##3##(1994-9#1)(2008-10#1)(2008-8#1)
within 48 h after##3##4##(1990-6#1)(1992-3#1)(2008-10#1)
within 48 h of##4##4##(2007-2#1)(2008-10#2)(2008-11#1)
within 48 h##9##3##(1990-6#1)(1990-7#1)(1992-3#1)(2007-2#1)(2008-10#4)(2008-11#1)
within 48 hours of##3##4##(2007-10#2)(2012-12#1)
within 48 hours##6##3##(2007-10#3)(2007-7#1)(2010-5#1)(2012-12#1)
within 48##16##2##(1990-6#1)(1990-7#1)(1992-3#1)(2007-10#3)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
within 5 h##2##3##(2007-2#1)(2008-10#1)
within 5 min of##2##4##(1996-6#1)(2008-10#1)
within 5 min##10##3##(1992-12#1)(1992-3#1)(1993-1#1)(1996-6#1)(2008-10#5)(2012-2#1)
within 5 minutes##3##3##(1991-12#1)(1994-11#1)(1995-3#1)
within 5 mm from the##2##5##(1994-12#1)(2007-8#1)
within 5 mm##3##3##(1994-12#1)(2007-8#1)(2011-2#1)
within 5 s##2##3##(1997-1#1)(1997-2#1)
within 5 x##2##3##(2008-10#1)(2008-3#1)
within 5 years of diagnosis##2##5##(1990-6#1)(2008-10#1)
within 5 years##3##3##(1990-6#1)(1995-2#1)(2008-10#1)
within 5##33##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
within 5% of##3##3##(2008-3#3)
within 50##2##2##(2008-1#1)(2008-10#1)
within 6 days after##2##4##(2008-10#2)
within 6 h after##2##4##(2008-10#1)(2008-7#1)
within 6 h##5##3##(2008-10#4)(2008-7#1)
within 6 min##2##3##(1990-2#1)(2008-10#1)
within 6 months of##2##4##(2008-6#1)(2011-2#1)
within 6 months##4##3##(1994-12#1)(2008-6#1)(2011-1#1)(2011-2#1)
within 6##17##2##(1990-2#1)(1992-12#1)(1994-12#1)(1995-2#1)(2007-9#1)(2008-10#7)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
within 6%##2##2##(2008-2#2)
within 60 days of##2##4##(2007-10#2)
within 60 min##2##3##(1990-8#1)(1993-3#1)
within 60##6##2##(1990-8#1)(1993-11#1)(1993-3#1)(2007-10#2)(2010-7#1)
within 7 days after##2##4##(1995-8#1)(2008-10#1)
within 7 days of##2##4##(2007-10#1)(2008-10#1)
within 7 days##7##3##(1995-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)
within 7##10##2##(1992-8#1)(1995-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
within 72 h of##2##4##(1990-3#1)(2008-10#1)
within 72 h##6##3##(1990-3#1)(1993-12#1)(2008-10#4)
within 72 hours after##2##4##(1997-3#1)(2013-1#1)
within 72 hours of##2##4##(2007-10#1)(2013-1#1)
within 72 hours##6##3##(1997-3#1)(2007-10#1)(2013-1#4)
within 72##12##2##(1990-3#1)(1993-12#1)(1997-3#1)(2007-10#1)(2008-10#4)(2013-1#4)
within 8 days##2##3##(1996-2#1)(2008-12#1)
within 8##6##2##(1995-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-3#2)
within 8min##2##2##(2008-10#2)
within 9##2##2##(2007-11#1)(2007-6#1)
within 90 days##3##3##(2011-2#3)
within 90##4##2##(2008-10#1)(2011-2#3)
within AG-2##3##2##(2008-10#3)
within Australia##4##2##(1992-1#1)(1994-12#2)(2008-12#1)
within C##3##2##(2008-10#3)
within Canada##2##2##(1995-12#1)(2008-11#1)
within Canadian##2##2##(1997-3#1)(2007-12#1)
within DNA##2##2##(2008-10#1)(2008-11#1)
within Europe##2##2##(2012-2#1)(2013-8#1)
within F##3##2##(2008-10#3)
within Gonyleptidae##2##2##(2007-12#2)
within Heliosperma (Sileneae##2##3##(2010-6#2)
within M##2##2##(2008-10#2)
within MPFC##2##2##(2008-11#2)
within P##3##2##(2008-10#2)(2008-12#1)
within T##2##2##(2008-10#1)(2008-2#1)
within X##2##2##(2008-10#2)
within a 1##2##3##(1997-6#1)(2009-10#1)
within a 3##2##3##(1990-11#1)(2010-8#1)
within a 3-month##2##3##(1997-8#1)(2012-12#1)
within a 79##2##3##(2008-12#2)
within a cell##2##3##(2008-2#1)(2010-11#1)
within a certain##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
within a clinical##3##3##(1994-12#1)(1995-3#1)(2008-9#1)
within a cluster of fatty acid biosynthetic genes##2##8##(1992-4#2)
within a cluster of##4##4##(1992-4#2)(2008-10#2)
within a cluster##5##3##(1992-4#2)(2008-10#3)
within a complex system##2##4##(2008-11#1)(2008-6#1)
within a complex##4##3##(2008-11#1)(2008-6#1)(2009-12#1)(2012-12#1)
within a concentration range##2##4##(1997-4#1)(2008-10#1)
within a context##2##3##(2010-10#1)(2013-8#1)
within a country##4##3##(2008-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
within a factor of 2##2##5##(2008-3#2)
within a few days##6##4##(1991-4#1)(1993-12#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#1)
within a few hours##5##4##(1990-8#1)(1990-9#1)(1994-3#1)(1995-2#1)(2011-2#1)
within a few minutes##5##4##(1990-11#1)(2007-11#1)(2008-10#2)(2012-12#1)
within a few months after##2##5##(2007-8#1)(2012-3#1)
within a few months##5##4##(1992-8#1)(2007-8#1)(2010-3#1)(2011-1#1)(2012-3#1)
within a few percent##2##4##(2008-3#2)
within a few seconds##3##4##(1992-8#1)(2008-10#2)
within a few weeks##5##4##(1993-11#1)(1996-11#1)(2007-10#1)(2008-10#1)(2012-2#1)
within a few years##2##4##(1996-4#1)(2012-12#1)
within a few##37##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-8#2)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#4)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
within a field##6##3##(2008-10#6)
within a geographic##2##3##(2008-10#1)(2008-8#1)
within a given##6##3##(1994-5#1)(1995-11#1)(2008-10#1)(2009-11#1)(2009-4#1)(2010-7#1)
within a group of##4##4##(2007-12#1)(2008-10#1)(2011-2#2)
within a health care##2##4##(1994-1#1)(1995-1#1)
within a health##4##3##(1993-1#1)(1994-1#1)(1995-1#1)(2008-11#1)
within a large##4##3##(1995-5#1)(2008-10#1)(2010-11#1)(2012-2#1)
within a layer##2##3##(1992-9#2)
within a leaf##2##3##(2008-10#2)
within a local area##3##4##(2008-10#3)
within a metapopulation##2##3##(2008-10#1)(2008-8#1)
within a much broader##2##4##(2010-3#1)(2012-3#1)
within a multilayer##2##3##(2007-12#1)(2008-3#1)
within a narrow##2##3##(2007-11#1)(2011-2#1)
within a national##2##3##(2008-9#1)(2011-2#1)
within a new##2##3##(1991-12#1)(2008-10#1)
within a period of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
within a polymer##2##3##(2008-10#1)(2008-3#1)
within a population of##5##4##(1991-12#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
within a population##11##3##(1991-12#1)(1995-5#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#2)
within a public health care##2##5##(1994-9#2)
within a range of##7##4##(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
within a range##10##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2011-2#1)(2013-1#2)
within a reasonable time##2##4##(2008-11#1)(2008-4#1)
within a reasonable##3##3##(1996-11#1)(2008-11#1)(2008-4#1)
within a region##4##3##(1990-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
within a relatively short time##2##5##(2007-7#1)(2008-11#1)
within a relatively##4##3##(2007-7#1)(2008-11#1)(2008-2#1)(2009-7#1)
within a restricted##2##3##(2008-8#1)(2008-9#1)
within a sample of##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
within a sample##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
within a set of##2##4##(2008-10#1)(2008-3#1)
within a short period of time##2##6##(2008-11#1)(2011-2#1)
within a short period##4##4##(1990-8#1)(2008-11#1)(2009-5#1)(2011-2#1)
within a short time##2##4##(1990-12#1)(2008-9#1)
within a short##8##3##(1990-12#1)(1990-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)
within a single field##2##4##(2008-10#2)
within a single season##2##4##(2008-10#1)(2008-8#1)
within a single tree##2##4##(2008-10#2)
within a single##28##3##(1992-8#1)(1994-5#1)(2007-11#1)(2007-4#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
within a small##2##3##(2008-3#1)(2008-9#1)
within a spatially##2##3##(1995-5#1)(2008-3#1)
within a species##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
within a specific##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
within a standard##2##3##(2009-11#1)(2011-2#1)
within a thick##2##3##(2008-3#1)(2011-2#1)
within a time##2##3##(2008-3#1)(2013-1#1)
within a turbid medium##2##4##(2008-3#2)
within a unique##2##3##(2008-1#1)(2008-7#1)
within a variety of##2##4##(1991-12#1)(2008-11#1)
within a wavelength range##2##4##(2007-12#1)(2008-3#1)
within a week of each other##2##6##(1991-11#1)(2008-5#1)
within a week of##3##4##(1991-11#1)(2008-11#1)(2008-5#1)
within a year##3##3##(1992-5#1)(2008-8#1)(2010-12#1)
within a##474##2##(1990-11#2)(1990-12#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#7)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-11#4)(2007-12#16)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#97)(2008-11#28)(2008-12#9)(2008-2#14)(2008-3#42)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#14)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#18)(2012-1#1)(2012-12#9)(2012-2#5)(2012-3#10)(2012-5#1)(2012-9#1)(2013-1#10)(2013-8#6)
within about 5##2##3##(1993-12#1)(2008-10#1)
within about##7##2##(1993-12#1)(1993-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)
within acceptable levels##2##3##(1992-10#1)(2008-3#1)
within acceptable##3##2##(1992-10#1)(2008-3#1)(2010-3#1)
within adjacent##3##2##(1992-12#1)(2008-3#2)
within adult##2##2##(2007-11#1)(2008-11#1)
within all##5##2##(1992-6#1)(1997-3#1)(2008-10#2)(2008-5#1)
within an acute##2##3##(2007-10#1)(2013-8#1)
within an allozyme genotype##2##4##(2008-10#2)
within an amplified##2##3##(1990-7#1)(2008-10#1)
within an error##2##3##(2007-11#1)(2008-10#1)
within an experimental##2##3##(2007-12#1)(2008-10#1)
within an individual##2##3##(2008-10#1)(2009-8#1)
within an undergraduate dental curriculum##2##5##(2012-1#2)
within an undergraduate##3##3##(2008-11#1)(2012-1#2)
within an##68##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
within and across the##2##4##(2008-10#1)(2009-7#1)
within and across##6##3##(2008-10#1)(2008-11#1)(2009-7#1)(2012-3#3)
within and adjacent to##3##4##(2008-10#2)(2008-7#1)
within and among populations##2##4##(2008-10#2)
within and among##15##3##(2008-10#11)(2008-8#1)(2008-9#1)(2010-3#2)
within and around the##2##4##(2009-5#1)(2010-10#1)
within and around##3##3##(1997-4#1)(2009-5#1)(2010-10#1)
within and between individuals##2##4##(1993-12#1)(2012-3#1)
within and between patches##3##4##(2008-8#3)
within and between species##3##4##(2009-6#1)(2012-3#2)
within and between the##4##4##(2008-10#2)(2008-7#1)(2010-7#1)
within and between##28##3##(1990-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1997-1#1)(2008-10#8)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2010-7#1)(2012-3#3)
within and outside of the##2##5##(2008-10#1)(2008-12#1)
within and outside of##3##4##(1993-1#1)(2008-10#1)(2008-12#1)
within and outside##7##3##(1991-2#1)(1993-1#1)(1995-5#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
within and##68##2##(1990-12#1)(1991-2#1)(1992-9#1)(1993-1#2)(1993-12#1)(1995-5#1)(1997-1#1)(1997-4#2)(2008-10#26)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-3#2)(2010-7#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#1)
within any given##2##3##(2010-11#1)(2012-2#1)
within any##4##2##(2008-11#1)(2008-8#1)(2010-11#1)(2012-2#1)
within approximately##5##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
within biofilms##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
within biological systems##2##3##(2009-10#1)(2010-11#1)
within biological##5##2##(2009-10#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-1#1)
within both the##2##3##(1993-11#1)(2010-8#1)
within both##5##2##(1993-11#1)(1996-6#1)(2008-10#2)(2010-8#1)
within ca##2##2##(1990-8#1)(2008-10#1)
within cankers##2##2##(2008-10#2)
within cells of##3##3##(1992-3#1)(2008-10#1)(2013-8#1)
within cells##10##2##(1992-3#1)(1993-9#1)(2008-10#1)(2008-4#3)(2008-7#1)(2010-10#1)(2012-2#1)(2013-8#1)
within certain##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
within children##2##2##(2009-12#1)(2009-8#1)
within clinical practice##3##3##(1996-3#1)(2008-11#2)
within clinical##4##2##(1994-12#1)(1996-3#1)(2008-11#2)
within cluster correlation##2##3##(2010-11#2)
within clusters##2##2##(2008-12#1)(2008-8#1)
within codons##3##2##(1993-9#1)(2008-7#2)
within collagen##2##2##(1990-12#1)(1991-2#1)
within contexts of##2##3##(1996-12#1)(2010-12#1)
within countries##4##2##(2007-7#1)(2008-10#1)(2009-7#1)(2011-1#1)
within current##4##2##(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
within cytoplasmic##2##2##(2008-9#1)(2009-2#1)
within day##4##2##(2008-10#1)(2010-12#3)
within days##7##2##(1992-12#1)(1993-2#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
within different##2##2##(2008-10#1)(2008-4#1)
within droplets##3##2##(2007-10#1)(2008-3#2)
within each community##2##3##(2008-10#1)(2008-8#1)
within each ethnic##2##3##(2008-5#1)(2009-7#1)
within each group##7##3##(1995-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)
within each of the##5##4##(1995-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-3#1)
within each of these##4##4##(2008-10#2)(2008-2#1)(2008-9#1)
within each of##11##3##(1993-1#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2012-3#1)
within each population##2##3##(2008-10#2)
within each stage##2##3##(1995-1#1)(2008-10#1)
within each subpopulation##2##3##(2008-10#2)
within each##64##2##(1990-7#1)(1991-2#1)(1993-1#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#24)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#2)
within either the##2##3##(1990-7#1)(2008-10#1)
within either##3##2##(1990-7#1)(1993-9#1)(2008-10#1)
within electropolymerized##2##2##(2008-10#2)
within eukaryotic##3##2##(2008-2#1)(2008-4#1)(2010-5#1)
within exon 19##2##3##(1990-7#2)
within experimental error##6##3##(1990-7#1)(1993-11#1)(1995-5#1)(2008-10#3)
within families##4##2##(2009-5#1)(2011-1#1)(2012-3#2)
within few##2##2##(1994-6#1)(2011-2#1)
within field##3##2##(2008-10#3)
within fields##8##2##(2008-10#8)
within fifteen##2##2##(1997-1#1)(2008-11#1)
within five##3##2##(1992-5#1)(2008-9#1)(2011-1#1)
within four##2##2##(2008-12#1)(2008-5#1)
within gene##2##2##(1997-7#1)(2012-3#1)
within genotype##2##2##(2008-10#1)(2009-9#1)
within groups##8##2##(1996-6#3)(2008-10#2)(2008-8#2)(2008-9#1)
within health care organizations##5##4##(1991-12#1)(1993-3#1)(1995-12#1)(2008-1#1)(2008-12#1)
within health care##12##3##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)
within health sectors##2##3##(2008-12#2)
within health##18##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#2)(1996-1#1)(1996-12#1)(2008-1#1)(2008-11#2)(2008-12#4)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
within highly scattering##2##3##(2008-3#2)
within hip##2##2##(2007-11#1)(2007-8#1)
within host##2##2##(2008-9#1)(2012-2#1)
within hours##5##2##(1991-9#1)(1992-12#1)(2008-10#1)(2009-4#1)(2013-1#1)
within humerus##3##2##(2007-11#3)
within hydrogen-bonding distance of##2##4##(1993-11#1)(1993-8#1)
within individual trees##2##3##(2008-10#2)
within individual##9##2##(1994-5#1)(1995-5#1)(2008-10#5)(2009-7#1)(2012-1#1)
within individuals and##2##3##(2008-5#1)(2012-2#1)
within individuals##4##2##(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)
within infected cells##2##3##(2008-10#2)
within infected##4##2##(2008-10#3)(2008-9#1)
within intact cells##3##3##(1992-12#1)(2008-11#1)(2008-9#1)
within integrated##2##2##(1992-3#1)(2012-2#1)
within interacting##2##2##(2008-8#2)
within intron##3##2##(1991-1#1)(1995-5#1)(2008-9#1)
within isolates of##3##3##(2008-10#3)
within isolates##4##2##(2008-10#4)
within it##4##2##(2007-12#1)(2008-12#1)(2008-8#1)(2010-10#1)
within its##19##2##(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-2#1)
within just a few##2##4##(2008-10#1)(2008-3#1)
within large##3##2##(2008-10#1)(2008-3#1)(2009-4#1)
within less than##2##3##(2008-10#1)(2008-3#1)
within living cells##2##3##(2007-11#1)(2008-1#1)
within local##2##2##(2008-10#1)(2008-8#1)
within mammalian##3##2##(1995-5#1)(2008-9#1)(2009-9#1)
within many##2##2##(1992-8#1)(2008-11#1)
within medical##3##2##(1996-8#1)(2008-12#1)(2009-4#1)
within mental health##2##3##(1997-2#1)(2011-1#1)
within minutes at##2##3##(2008-7#1)(2010-5#1)
within minutes##5##2##(1995-6#1)(1997-6#1)(2008-7#1)(2010-5#1)(2012-12#1)
within most##2##2##(2008-10#1)(2008-11#1)
within narrow##2##2##(2008-1#1)(2008-5#1)
within necrotic##2##2##(2008-10#2)
within normal limits##5##3##(1990-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-7#1)
within normal range in##7##4##(2007-7#3)(2008-7#3)(2013-1#1)
within normal range##12##3##(1997-5#1)(2006-6#1)(2007-7#4)(2008-7#4)(2012-2#1)(2013-1#1)
within normal##20##2##(1990-8#1)(1993-2#1)(1997-5#1)(2006-6#1)(2007-7#4)(2008-1#1)(2008-5#1)(2008-7#5)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#2)
within nursing homes##2##3##(1995-2#1)(2010-8#1)
within nursing or##2##3##(1996-1#1)(2012-3#1)
within nursing##12##2##(1995-2#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-11#3)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
within one hour of##2##4##(1992-6#1)(1996-11#1)
within one hour##4##3##(1990-12#1)(1992-6#1)(1996-11#1)(2010-11#1)
within one month##2##3##(2008-11#1)(2013-1#1)
within one species##2##3##(1993-12#1)(2013-7#1)
within one week##2##3##(2007-10#1)(2010-12#1)
within one year##3##3##(1991-2#1)(1992-5#1)(2006-8#1)
within one##33##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-11#1)(1996-11#1)(1997-1#1)(2006-8#1)(2007-10#1)(2008-11#8)(2008-2#2)(2008-3#2)(2008-5#2)(2010-11#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
within only##3##2##(2008-10#2)(2008-3#1)
within optical tweezers##2##3##(2007-11#2)
within optical##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
within or around##2##3##(1996-8#1)(2008-8#1)
within or between##2##3##(2009-7#1)(2012-2#1)
within or close to##2##4##(1992-6#1)(1996-8#1)
within or outside##2##3##(1991-6#1)(1991-9#1)
within or##12##2##(1991-6#1)(1991-9#1)(1992-6#1)(1995-8#1)(1996-8#2)(2008-10#2)(2008-8#1)(2009-12#1)(2009-7#1)(2012-2#1)
within our discipline##2##3##(2008-12#2)
within our society##2##3##(1994-12#1)(1997-2#1)
within our##13##2##(1994-12#2)(1997-2#2)(1997-3#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-9#1)(2010-10#1)
within pH##2##2##(2008-10#2)
within participants##3##2##(2009-1#1)(2010-3#2)
within pathotypes##2##2##(2008-10#2)
within phonological words may##2##4##(2008-2#2)
within physiological ranges##2##3##(2008-6#1)(2011-2#1)
within physiological##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
within plant##3##2##(2008-10#2)(2009-10#1)
within plots##3##2##(2008-10#3)
within population##2##2##(2008-10#2)
within populations and##2##3##(2008-10#1)(2008-8#1)
within populations of the##3##4##(2008-10#1)(2008-8#2)
within populations of##6##3##(2008-10#4)(2008-8#2)
within populations##24##2##(2008-10#18)(2008-8#4)(2008-9#1)(2012-7#1)
within possible##2##2##(2008-8#1)(2011-2#1)
within primary health care for older people##2##7##(2010-10#2)
within primary health care for##3##5##(2010-10#3)
within primary##4##2##(1996-12#1)(2010-10#3)
within psychiatric healthcare services##3##4##(2011-2#3)
within quadrats##2##2##(2008-10#1)(2008-8#1)
within races##2##2##(2008-10#1)(2009-12#1)
within range of##2##3##(2013-1#2)
within reach##2##2##(1992-5#1)(2008-4#1)
within reasonable##2##2##(1994-3#1)(2008-3#1)
within reference intervals##2##3##(2012-3#2)
within regions##9##2##(1994-3#1)(2008-10#7)(2011-2#1)
within restricted##2##2##(2011-2#1)(2012-2#1)
within root##2##2##(2008-10#2)
within rows##4##2##(2008-10#2)(2008-12#2)
within sampling units##2##3##(2008-10#2)
within sampling##5##2##(2008-10#5)
within schools of public health##2##5##(1997-2#2)
within schools of##3##3##(1994-3#1)(1997-2#2)
within several##7##2##(1992-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
within single##6##2##(1991-12#1)(1994-6#1)(1995-5#1)(2008-10#1)(2008-5#2)
within six hours##2##3##(1991-6#1)(2007-10#1)
within six##5##2##(1991-11#1)(1991-6#1)(2007-10#1)(2007-12#1)(2008-12#1)
within small##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
within some##8##2##(1995-3#1)(1997-3#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
within species##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
within specified##3##2##(1992-9#1)(1995-12#1)(2007-11#1)
within strong##2##2##(2008-2#1)(2009-11#1)
within sublineages##2##2##(1995-3#2)
within subpopulations##7##2##(2008-10#7)
within such##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
within that##4##2##(1997-1#1)(2008-5#1)(2008-6#1)(2010-10#1)
within the 1##2##3##(2007-12#1)(2008-10#1)
within the 3'##2##3##(1994-8#1)(2013-1#1)
within the 5'-flanking##2##3##(1993-8#1)(1994-2#1)
within the 95% confidence##2##4##(2008-10#1)(2008-9#1)
within the A##2##3##(2008-10#1)(2008-3#1)
within the CNS##2##3##(1991-12#1)(2012-3#1)
within the Central##2##3##(2008-11#1)(2013-7#1)
within the Csfm##2##3##(1990-5#2)
within the DNA region that##2##5##(1991-9#1)(1993-2#1)
within the European##2##3##(1994-3#1)(2008-10#1)
within the F##2##3##(2008-10#2)
within the Health and##3##4##(1993-11#1)(1995-6#2)
within the ITS region##2##4##(2008-10#2)
within the N-terminal##3##3##(1993-8#1)(1996-3#1)(2008-5#1)
within the NAc##2##3##(2008-7#2)
within the SC##2##3##(2008-5#2)
within the STR pairs##2##4##(2008-12#2)
within the Singapore Chinese Health Study##2##6##(2010-6#2)
within the U##4##3##(1991-8#1)(2008-10#3)
within the UK##2##3##(2008-10#1)(2010-4#1)
within the US##2##3##(2008-7#1)(2013-1#1)
within the USDA##2##3##(2008-7#2)
within the United States and##2##5##(2008-10#1)(2013-7#1)
within the United States##5##4##(2008-10#2)(2008-11#2)(2013-7#1)
within the University of##2##4##(2008-12#2)
within the University##3##3##(2008-11#1)(2008-12#2)
within the acceptable range##2##4##(2008-10#1)(2008-11#1)
within the acceptable##3##3##(2008-10#2)(2008-11#1)
within the active##2##3##(1992-6#1)(2007-12#1)
within the amygdala##2##3##(1994-2#1)(1994-8#1)
within the appropriate##2##3##(2008-3#1)(2012-3#1)
within the area of##2##4##(2008-10#1)(2013-1#1)
within the area##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
within the beta##2##3##(1992-9#1)(2008-11#1)
within the biofilms##2##3##(2008-10#1)(2013-8#1)
within the biomass##2##3##(2008-10#1)(2008-7#1)
within the body##5##3##(1994-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
within the brain##2##3##(1991-2#1)(2007-12#1)
within the broader##2##3##(2008-9#1)(2012-2#1)
within the cancer##2##3##(1994-3#1)(2010-4#1)
within the cavity of a##2##5##(2008-2#1)(2008-3#1)
within the cavity##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
within the cell and##2##4##(2008-5#1)(2008-9#1)
within the cell##17##3##(1991-6#1)(1995-11#2)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)
within the cells##3##3##(1993-9#1)(2008-11#1)(2011-2#1)
within the central metabolism##2##4##(2008-7#2)
within the central nervous system (CNS)##2##6##(2008-7#2)
within the central nervous system##7##5##(1991-7#1)(1995-2#1)(2008-7#4)(2013-1#1)
within the central##10##3##(1991-7#1)(1995-2#1)(2008-7#6)(2008-9#1)(2013-1#1)
within the channel##2##3##(1995-5#1)(2008-2#1)
within the chaotic region in##2##5##(2007-11#2)
within the city of##2##4##(1994-2#1)(2009-10#1)
within the cladding of a straight optical fiber##2##8##(2007-12#2)
within the cladding##3##3##(2007-12#3)
within the class##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
within the clinical##3##3##(1991-2#1)(2008-12#2)
within the coding region and##2##5##(1990-6#1)(1993-6#1)
within the coding region##5##4##(1990-12#1)(1990-6#1)(1991-2#1)(1993-6#1)(2008-10#1)
within the coding##6##3##(1990-12#1)(1990-6#1)(1991-2#1)(1993-6#1)(1995-8#1)(2008-10#1)
within the colonies##2##3##(2008-10#1)(2008-9#1)
within the community##8##3##(1991-12#1)(1994-1#2)(2008-11#2)(2008-12#1)(2008-6#1)(2011-2#1)
within the company##2##3##(2008-11#1)(2012-3#1)
within the complex##2##3##(1994-9#1)(2009-10#1)
within the concentration range of 0##2##6##(2008-10#2)
within the concentration range of##4##5##(2008-10#4)
within the concentration range##7##4##(2008-10#7)
within the concentration##9##3##(2008-10#9)
within the confines of##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
within the context of a##4##5##(1996-3#2)(2008-2#1)(2008-9#1)
within the context of the new##2##6##(1991-3#1)(2011-1#1)
within the context of the##15##5##(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-12#1)(2008-11#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
within the context of their##2##5##(2007-11#1)(2010-10#1)
within the context of##38##4##(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-3#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#2)
within the core##5##3##(1996-2#1)(1997-2#1)(2007-11#1)(2012-2#1)(2013-1#1)
within the cortex in the##2##5##(2008-5#1)(2008-9#1)
within the cortex##4##3##(1995-6#1)(2008-5#1)(2008-9#2)
within the country##3##3##(1994-9#1)(1997-8#1)(2008-10#1)
within the crystal##2##3##(1992-4#1)(2008-2#1)
within the current##3##3##(2008-11#1)(2008-12#1)(2010-11#1)
within the curriculum##2##3##(2008-11#1)(2008-12#1)
within the cuticle##2##3##(2008-10#1)(2008-5#1)
within the cytoplasm of##2##4##(2006-6#1)(2008-10#1)
within the cytoplasm##4##3##(2006-6#2)(2008-10#2)
within the cytosol of##2##4##(2008-9#1)(2011-1#1)
within the department##3##3##(1996-3#1)(2008-11#1)(2010-4#1)
within the developing##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
within the device##2##3##(1996-2#1)(2008-3#1)
within the discipline##2##3##(1994-2#1)(2008-12#1)
within the embryo##2##3##(2007-12#1)(2008-5#1)
within the expected##2##3##(2008-3#1)(2013-1#1)
within the experimental group##2##4##(1994-3#1)(2009-6#1)
within the experimental##5##3##(1994-3#1)(2007-11#2)(2008-3#1)(2009-6#1)
within the facility##2##3##(1991-12#2)
within the family Cucurbitaceae##2##4##(2008-10#2)
within the family Reoviridae##2##4##(1997-4#1)(2008-10#1)
within the family##12##3##(1997-4#1)(2008-1#1)(2008-10#5)(2008-12#2)(2009-5#1)(2011-1#1)(2013-1#1)
within the field of##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
within the field##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
within the first 173##2##4##(1996-5#2)
within the first 2 weeks of treatment##2##7##(2008-6#2)
within the first 2##4##4##(2008-10#1)(2008-6#2)(2008-7#1)
within the first 20##2##4##(1995-5#1)(2007-8#1)
within the first 24 h##2##5##(2008-4#1)(2012-3#1)
within the first 24##3##4##(2007-10#1)(2008-4#1)(2012-3#1)
within the first 3 months##2##5##(2011-2#1)(2012-2#1)
within the first few days##2##5##(1990-9#1)(1995-11#1)
within the first few##5##4##(1990-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(2008-9#1)
within the first second after stimulation##2##6##(2013-8#2)
within the first second after##3##5##(2013-8#3)
within the first six##2##4##(2008-2#1)(2011-1#1)
within the first three##2##4##(2007-7#1)(2008-9#1)
within the first two##4##4##(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#1)
within the first week##2##4##(1996-9#1)(2010-3#1)
within the first year of##2##5##(2008-7#1)(2012-3#1)
within the first year##4##4##(2008-7#1)(2009-10#1)(2010-8#1)(2012-3#1)
within the first##55##3##(1990-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-5#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#3)
within the five##2##3##(1992-9#1)(2011-1#1)
within the focal##2##3##(2007-11#1)(2012-3#1)
within the framework of a##7##5##(1990-8#1)(1992-1#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#2)
within the framework of our##2##5##(1993-6#1)(2007-10#1)
within the framework of the##11##5##(1990-6#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#5)
within the framework of##30##4##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-11#3)(2008-2#3)(2008-3#8)(2009-7#1)
within the gel##2##3##(2008-10#1)(2008-4#1)
within the gene##2##3##(1992-9#1)(1997-4#1)
within the genus##6##3##(2008-10#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)
within the given##2##3##(2008-10#1)(2008-7#1)
within the group of##3##4##(2008-10#1)(2009-9#1)(2011-2#1)
within the group##6##3##(1990-6#1)(2008-10#2)(2009-9#1)(2010-3#1)(2011-2#1)
within the groups##4##3##(2007-11#1)(2008-10#1)(2008-5#2)
within the growing season##2##4##(2009-2#2)
within the growing##3##3##(2008-10#1)(2009-2#2)
within the hair##2##3##(2007-12#1)(2008-5#1)
within the health care system##2##5##(1991-1#1)(2011-1#1)
within the health care##9##4##(1991-1#2)(1993-12#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-7#1)(2011-1#1)
within the health##10##3##(1991-1#2)(1991-6#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-7#1)(2011-1#1)
within the heart conduction system##2##5##(2008-7#2)
within the heart##3##3##(2008-7#2)(2010-8#1)
within the high##2##3##(2008-11#1)(2012-2#1)
within the home and##2##4##(2009-5#2)
within the hospital setting##2##4##(1994-2#1)(2010-9#1)
within the hospital##5##3##(1990-3#1)(1994-2#1)(1995-1#1)(2010-9#1)(2013-8#1)
within the host##6##3##(1991-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-1#1)
within the human respiratory tract##2##5##(2011-2#1)(2013-1#1)
within the human##7##3##(1991-11#1)(1995-3#1)(1997-9#1)(2007-12#1)(2009-12#1)(2011-2#1)(2013-1#1)
within the industry##2##3##(1991-1#1)(1992-2#1)
within the inner cavity##2##4##(2008-8#2)
within the inner##3##3##(1997-8#1)(2008-8#2)
within the instrument##3##3##(1992-6#1)(2008-3#2)
within the interval##3##3##(1994-11#1)(1995-6#1)(2013-8#1)
within the intestinal##2##3##(1996-6#1)(2008-7#1)
within the intracellular##2##3##(2008-5#1)(2008-7#1)
within the large##2##3##(1995-8#1)(2008-2#1)
within the laser##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
within the last few years##2##5##(2008-5#1)(2012-12#1)
within the last##9##3##(1990-6#1)(1995-6#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)
within the layer##2##3##(1990-2#1)(2008-10#1)
within the leading##2##3##(2008-10#2)
within the left##2##3##(1997-6#1)(2013-8#1)
within the limits of##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
within the limits##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
within the linear##3##3##(2008-10#2)(2008-5#1)
within the lipid##2##3##(1995-5#1)(2008-5#1)
within the loop##2##3##(1995-5#1)(2008-10#1)
within the lower##2##3##(1990-9#1)(2007-11#1)
within the lymphatic##2##3##(2008-9#1)(2010-1#1)
within the material##2##3##(2008-7#1)(2010-10#1)
within the matrix##5##3##(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)
within the maxillary##2##3##(2007-12#1)(2013-1#1)
within the measurement##2##3##(2008-3#2)
within the median domain##2##4##(2007-12#2)
within the medical##3##3##(2007-11#1)(2008-12#2)
within the medium##2##3##(1994-3#1)(2007-12#1)
within the membrane##6##3##(1990-12#1)(1990-5#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-5#1)
within the microenvironment##2##3##(2009-3#2)
within the middle ear cavity##2##5##(1991-3#1)(2013-7#1)
within the mouse myogenic gene##2##5##(1994-12#2)
within the mouse##4##3##(1994-12#2)(1997-9#1)(2008-9#1)
within the mucilage##2##3##(2011-1#2)
within the necrotic##2##3##(2008-10#2)
within the next few years##2##5##(2008-12#1)(2011-2#1)
within the next year##2##4##(1994-1#1)(2008-11#1)
within the next##7##3##(1993-11#1)(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
within the normal range##7##4##(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)
within the normal##9##3##(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
within the nucleus of##3##4##(1993-12#1)(1994-11#1)(1994-6#1)
within the nucleus##8##3##(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
within the nursing##3##3##(2008-11#2)(2008-12#1)
within the observed##2##3##(2007-11#1)(2008-10#1)
within the one##2##3##(1995-12#1)(2008-11#1)
within the oocyte nucleus##2##4##(2007-12#2)
within the oocyte##4##3##(1994-9#1)(2007-12#2)(2008-10#1)
within the optical##3##3##(2008-3#2)(2010-2#1)
within the orchards##2##3##(2008-10#2)
within the order##2##3##(2010-10#1)(2013-8#1)
within the organism##2##3##(1995-2#1)(2010-11#1)
within the organization##6##3##(1993-2#2)(1995-1#1)(1995-3#2)(1997-1#1)
within the pH range##3##4##(1995-5#1)(2008-10#2)
within the pH##4##3##(1995-5#1)(2008-10#3)
within the pancreas##2##3##(2011-2#1)(2012-12#1)
within the particle##2##3##(2008-10#1)(2008-2#1)
within the past 100##2##4##(1994-3#1)(2013-8#1)
within the past##3##3##(1994-3#1)(2011-2#1)(2013-8#1)
within the patch##2##3##(2008-8#2)
within the pathogen##2##3##(2008-10#2)
within the pathways##2##3##(2012-2#1)(2013-1#1)
within the pentose phosphate pathway##2##5##(1991-5#1)(2008-7#1)
within the peritoneal cavity##2##4##(2008-1#1)(2008-6#1)
within the pharmaceutical##2##3##(2008-10#1)(2008-11#1)
within the phylum##3##3##(2011-2#3)
within the physiological range##3##4##(1995-5#1)(2008-10#2)
within the physiological##5##3##(1993-8#1)(1995-5#1)(1996-12#1)(2008-10#2)
within the plant##2##3##(2008-10#2)
within the plasma membrane##2##4##(1994-8#1)(2008-8#1)
within the polymer##2##3##(2007-12#1)(2009-2#1)
within the population##7##3##(1996-3#1)(2008-10#2)(2008-8#2)(2010-5#1)(2012-3#1)
within the populations##2##3##(2008-10#2)
within the pores of##2##4##(2008-10#2)
within the pores##3##3##(2008-10#2)(2010-12#1)
within the postero-medial NAS##2##4##(1993-6#2)
within the previous 12 months##2##5##(2009-5#1)(2010-10#1)
within the previous##4##3##(2008-12#1)(2008-4#1)(2009-5#1)(2010-10#1)
within the previously##2##3##(2008-10#1)(2012-3#1)
within the primary##2##3##(2007-12#1)(2008-1#1)
within the profession##2##3##(1994-12#1)(1996-1#1)
within the program##2##3##(1994-5#1)(1995-1#1)
within the promoter##2##3##(1994-6#1)(2009-7#1)
within the proposed##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
within the protein##3##3##(1990-5#1)(1992-11#1)(1994-5#1)
within the public##2##3##(1997-3#1)(2008-12#1)
within the pulmonary arteries##2##4##(2008-7#1)(2010-6#1)
within the pyramid and##2##4##(2008-6#2)
within the quadrat##3##3##(2008-10#3)
within the range 0##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
within the range 2##2##4##(2008-10#2)
within the range of 0##5##5##(1990-7#2)(2008-10#2)(2010-11#1)
within the range of 100 to##2##6##(2008-11#1)(2010-11#1)
within the range of values##2##5##(2008-10#1)(2008-6#1)
within the range of##22##4##(1990-5#1)(1990-7#3)(1995-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#1)(2010-11#2)(2011-2#1)(2013-1#1)
within the range##42##3##(1990-12#1)(1990-5#1)(1990-7#3)(1991-2#1)(1994-6#1)(1995-2#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2010-11#2)(2010-5#1)(2011-2#1)(2013-1#1)
within the ranges of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
within the ranges##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
within the rat##3##3##(1992-3#1)(1993-6#1)(2010-6#1)
within the reach of many##2##5##(1996-1#1)(2009-8#1)
within the reach of the##2##5##(2007-12#1)(2008-3#1)
within the reach of##5##4##(1996-1#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-2#1)
within the recommended##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
within the region##4##3##(1996-12#1)(2008-11#2)(2008-8#1)
within the regions##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
within the research##2##3##(2008-7#1)(2009-4#1)
within the right##2##3##(2007-8#1)(2008-11#1)
within the same tissue##2##4##(1995-11#1)(2008-7#1)
within the same##36##3##(1990-8#1)(1991-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
within the sample##6##3##(2007-11#1)(2008-10#2)(2008-3#2)(2010-2#1)
within the sat-RNA##2##3##(2008-10#2)
within the scope of this##2##5##(2007-10#1)(2010-6#1)
within the scope of##4##4##(2007-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
within the second##2##3##(1996-10#1)(2008-10#1)
within the sensor##2##3##(2008-3#1)(2010-2#1)
within the sequence##4##3##(1991-2#1)(1992-8#1)(1997-6#1)(2008-10#1)
within the sinus##2##3##(2008-7#1)(2013-1#1)
within the space##2##3##(2008-3#1)(2013-8#1)
within the species##3##3##(2008-10#3)
within the spectrum of##2##4##(1997-8#1)(2011-1#1)
within the spinal canal##2##4##(2006-12#1)(2008-12#1)
within the subgroup##2##3##(2008-10#2)
within the system##5##3##(1996-2#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-8#1)
within the therapeutic##2##3##(1992-8#1)(2008-11#1)
within the three##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
within the thymus##2##3##(1997-9#1)(2013-7#1)
within the total##2##3##(1991-8#1)(2008-4#1)
within the tumor microenvironment##3##4##(2009-3#1)(2013-1#2)
within the tumor##10##3##(1991-6#1)(1993-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-3#2)(2010-3#1)(2013-1#2)
within the two##5##3##(1991-6#1)(1993-12#1)(1994-3#1)(2009-7#1)(2013-1#1)
within the uterine##3##3##(1993-12#3)
within the vascular##2##3##(1991-9#1)(2008-10#1)
within the vector##2##3##(2008-10#1)(2011-3#1)
within the vertebral##2##3##(2008-12#1)(2011-2#1)
within the visible##2##3##(2008-2#1)(2008-3#1)
within the whole##3##3##(1994-5#1)(2010-9#1)(2012-1#1)
within the work-family##2##3##(2009-10#2)
within the working range of the##2##6##(2008-10#2)
within the##1548##2##(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#9)(1990-6#6)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#12)(1991-2#7)(1991-3#5)(1991-5#6)(1991-6#8)(1991-7#1)(1991-8#5)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#9)(1992-4#4)(1992-5#1)(1992-6#8)(1992-8#6)(1992-9#4)(1993-1#2)(1993-11#6)(1993-12#13)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#11)(1993-8#7)(1993-9#1)(1994-1#7)(1994-11#3)(1994-12#9)(1994-2#9)(1994-3#6)(1994-5#6)(1994-6#5)(1994-8#11)(1994-9#7)(1995-1#5)(1995-11#5)(1995-12#13)(1995-2#12)(1995-3#4)(1995-4#1)(1995-5#11)(1995-6#14)(1995-8#3)(1996-1#3)(1996-10#1)(1996-12#7)(1996-2#8)(1996-3#6)(1996-5#5)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#8)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#6)(1997-9#4)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#7)(2007-11#27)(2007-12#42)(2007-2#2)(2007-5#3)(2007-7#5)(2007-8#6)(2008-1#11)(2008-10#275)(2008-11#82)(2008-12#36)(2008-2#27)(2008-3#77)(2008-4#17)(2008-5#39)(2008-6#17)(2008-7#63)(2008-8#25)(2008-9#38)(2009-10#11)(2009-11#2)(2009-12#7)(2009-2#7)(2009-3#7)(2009-4#2)(2009-5#12)(2009-6#5)(2009-7#11)(2009-8#5)(2009-9#4)(2010-1#6)(2010-10#11)(2010-11#10)(2010-12#3)(2010-2#7)(2010-3#9)(2010-4#7)(2010-5#5)(2010-6#7)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#17)(2011-2#54)(2011-3#3)(2012-1#3)(2012-12#12)(2012-2#23)(2012-3#19)(2012-6#1)(2013-1#33)(2013-7#7)(2013-8#23)
within their classical receptive field##2##5##(1995-11#2)
within their own##2##3##(1994-3#1)(2008-11#1)
within their##25##2##(1991-12#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2009-8#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
within them##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
within therapeutic##2##2##(2008-12#1)(2008-3#1)
within these cells##2##3##(1991-5#1)(2008-10#1)
within these networks##2##3##(2008-7#1)(2009-9#1)
within these##20##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2012-3#1)
within this family##2##3##(2010-5#1)(2011-2#1)
within this genus##2##3##(2008-9#1)(2010-10#1)
within this group##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
within this paper##2##3##(2007-11#1)(2008-11#1)
within this population##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
within this range##2##3##(2008-10#2)
within this region##2##3##(1994-6#1)(1997-7#1)
within this sequence##2##3##(1993-3#1)(2011-2#1)
within this species##2##3##(2008-10#2)
within this##54##2##(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-7#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-7#1)
within those##6##2##(2008-10#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)
within three months after##2##4##(2007-7#1)(2008-1#1)
within three months##6##3##(1991-9#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
within three##11##2##(1991-9#1)(1992-5#1)(1993-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
within tissue##3##2##(2008-10#1)(2008-3#2)
within trials##2##2##(2008-10#1)(2008-12#1)
within two days##2##3##(1991-9#1)(2008-11#1)
within two hours##2##3##(1990-9#1)(2010-6#1)
within two months after the##2##5##(1995-9#1)(2008-8#1)
within two months after##3##4##(1995-9#1)(2008-8#2)
within two months of##2##4##(2007-7#1)(2008-8#1)
within two months##5##3##(1995-9#1)(2007-7#1)(2008-8#3)
within two years##3##3##(1990-12#1)(2007-11#1)(2011-2#1)
within two##22##2##(1990-12#2)(1990-9#1)(1991-9#1)(1992-1#1)(1992-11#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#2)(2010-6#1)(2011-2#1)
within vessels of##2##3##(2008-10#2)
within wards that used measurement tools##2##6##(2013-1#2)
within weeks##4##2##(1991-8#2)(2008-7#1)(2008-9#1)
within which a##2##3##(1992-12#1)(1997-1#1)
within which the##2##3##(2008-1#2)
within which##20##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-2#2)(1995-1#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-1#3)(2008-10#2)(2008-7#1)(2009-9#1)(2010-8#2)(2012-12#1)(2012-2#1)
within years##3##2##(2008-10#3)
within your##3##2##(1991-2#1)(1993-12#1)(1993-2#1)
within##3956##1##(1990-10#2)(1990-11#9)(1990-12#18)(1990-2#11)(1990-3#2)(1990-5#13)(1990-6#11)(1990-7#15)(1990-8#14)(1990-9#6)(1991-1#4)(1991-10#2)(1991-11#5)(1991-12#27)(1991-2#19)(1991-3#8)(1991-4#1)(1991-5#12)(1991-6#11)(1991-7#1)(1991-8#9)(1991-9#13)(1992-1#8)(1992-10#2)(1992-11#5)(1992-12#21)(1992-2#9)(1992-3#18)(1992-4#7)(1992-5#7)(1992-6#19)(1992-8#18)(1992-9#11)(1993-1#8)(1993-11#14)(1993-12#28)(1993-2#12)(1993-3#10)(1993-5#3)(1993-6#15)(1993-8#10)(1993-9#5)(1994-1#8)(1994-11#10)(1994-12#25)(1994-2#16)(1994-3#17)(1994-5#13)(1994-6#11)(1994-8#15)(1994-9#15)(1995-1#12)(1995-11#11)(1995-12#24)(1995-2#33)(1995-3#21)(1995-4#1)(1995-5#28)(1995-6#20)(1995-8#9)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#3)(1996-12#23)(1996-2#21)(1996-3#10)(1996-4#1)(1996-5#8)(1996-6#16)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#14)(1997-2#15)(1997-3#21)(1997-4#11)(1997-5#6)(1997-6#11)(1997-7#10)(1997-8#9)(1997-9#5)(2006-10#2)(2006-12#4)(2006-6#3)(2006-8#2)(2007-1#3)(2007-10#29)(2007-11#51)(2007-12#82)(2007-2#6)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#23)(2007-8#12)(2007-9#3)(2008-1#37)(2008-10#866)(2008-11#192)(2008-12#83)(2008-2#78)(2008-3#218)(2008-4#42)(2008-5#87)(2008-6#38)(2008-7#115)(2008-8#94)(2008-9#91)(2009-1#1)(2009-10#20)(2009-11#9)(2009-12#19)(2009-2#11)(2009-3#10)(2009-4#7)(2009-5#19)(2009-6#13)(2009-7#27)(2009-8#12)(2009-9#12)(2010-1#6)(2010-10#27)(2010-11#23)(2010-12#18)(2010-2#8)(2010-3#24)(2010-4#13)(2010-5#11)(2010-6#15)(2010-7#9)(2010-8#26)(2010-9#4)(2011-1#46)(2011-2#122)(2011-3#5)(2012-1#15)(2012-12#40)(2012-2#67)(2012-3#64)(2012-5#2)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#83)(2013-7#11)(2013-8#49)
within- and##5##2##(2008-10#2)(2008-8#2)(2012-3#1)
within-brood##2##1##(2008-9#2)
within-day##7##1##(1991-2#1)(2008-10#6)
within-family##4##1##(2008-10#1)(2008-12#1)(2009-5#1)(2009-9#1)
within-field spread of##2##3##(2008-10#2)
within-field##9##1##(2008-10#9)
within-group analyses##2##2##(2008-10#1)(2008-5#1)
within-group##9##1##(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
within-host##2##1##(2008-9#1)(2013-1#1)
within-person##4##1##(1992-6#3)(2010-2#1)
within-population variation in egg size##2##5##(2008-8#2)
within-population variation in##3##3##(2008-8#3)
within-population##5##1##(2008-8#4)(2013-1#1)
within-row##3##1##(2008-10#3)
within-run and between-run##3##3##(1990-2#1)(2008-10#2)
within-run##8##1##(1990-2#1)(2008-10#7)
within-session##2##1##(2008-7#1)(2011-2#1)
within-state##2##1##(1997-1#2)
within-subject design##2##2##(1992-11#1)(2010-8#1)
within-subject variation##2##2##(1994-9#1)(2012-3#1)
within-subject##4##1##(1992-11#1)(1994-9#1)(2010-8#1)(2012-3#1)
within-subjects##2##1##(1992-6#2)
without A##4##2##(1997-5#3)(2008-5#1)
without ADHD##7##2##(2010-8#2)(2013-8#5)
without AIDS##3##2##(2011-2#3)
without BSA##3##2##(1991-5#3)
without CAD##2##2##(2008-4#2)
without CP##2##2##(2012-2#2)
without CVD##2##2##(2008-7#2)
without EGF##2##2##(1992-9#1)(2008-6#1)
without HF##2##2##(2008-10#2)
without HIV##2##2##(1997-5#1)(2007-10#1)
without MS##5##2##(2008-3#2)(2011-1#1)(2012-3#2)
without PCa##3##2##(2013-1#3)
without PD##2##2##(2009-10#1)(2013-1#1)
without PhosChol##2##2##(1990-11#2)
without S9##3##2##(1992-5#1)(2008-8#1)(2008-9#1)
without SI##2##2##(2012-2#2)
without a change in##2##4##(1991-6#1)(1992-8#1)
without a doubt##3##3##(2008-10#2)(2008-11#1)
without a family history of##4##5##(1991-1#1)(1994-2#1)(2008-3#2)
without a family##5##3##(1991-1#1)(1994-2#1)(2007-2#1)(2008-3#2)
without a high##3##3##(2008-1#1)(2010-8#1)(2011-2#1)
without a history of dysfunction##2##5##(2010-9#2)
without a history of##12##4##(1991-2#1)(1991-3#1)(1994-2#1)(2007-7#1)(2008-5#1)(2010-9#2)(2011-2#2)(2012-3#2)(2013-8#1)
without a known##2##3##(1992-12#1)(2011-2#1)
without a loss##2##3##(2008-10#1)(2008-3#1)
without a medical background##2##4##(1992-11#1)(1994-12#1)
without a priori##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-6#1)
without a significant change in##2##5##(2008-3#1)(2009-6#1)
without a significant##7##3##(1990-2#1)(1992-12#1)(1992-2#1)(2008-3#1)(2009-3#1)(2009-6#1)(2010-10#1)
without a##124##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-4#2)(1997-2#2)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-6#2)(2010-10#1)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
without access to a##2##4##(2008-4#1)(2009-5#1)
without access to##4##3##(1990-6#1)(2008-4#1)(2009-5#1)(2013-1#1)
without acetonitrile##2##2##(2008-10#2)
without activating##2##2##(1995-11#1)(2009-7#1)
without active##2##2##(1993-2#1)(2007-12#1)
without added##3##2##(1992-8#1)(2008-10#2)
without adding##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
without addition of##6##3##(2008-10#5)(2008-11#1)
without additional therapy##2##3##(1990-11#1)(2008-6#1)
without additional##13##2##(1990-11#1)(1992-10#1)(1994-12#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#2)(2012-3#1)
without additives##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
without adequate##2##2##(1997-7#1)(2012-12#1)
without adverse##2##2##(1997-1#1)(2010-4#1)
without affecting its##2##3##(2012-3#1)(2013-1#1)
without affecting quality##2##3##(1992-1#1)(2011-2#1)
without affecting that##2##3##(1991-12#1)(1994-9#1)
without affecting the binding of##2##5##(1993-3#1)(1994-6#1)
without affecting the##12##3##(1990-2#1)(1991-5#1)(1992-6#2)(1993-3#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-7#1)(2013-1#1)
without affecting##45##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-6#2)(1993-3#2)(1993-6#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)
without alterations##2##2##(1992-8#1)(1995-11#1)
without altering the##8##3##(1990-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-11#2)(2008-3#1)
without altering##11##2##(1990-12#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-6#1)(1997-2#1)(2008-11#2)(2008-3#1)(2011-2#1)
without ambiguity##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
without an entrance##2##3##(2008-2#1)(2008-3#1)
without an increase in##2##4##(2008-6#1)(2012-2#1)
without an##29##2##(1990-3#1)(1991-3#1)(1991-6#1)(1994-8#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
without and with##8##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2010-8#1)(2011-2#2)
without antibiotics##3##2##(1994-3#1)(1997-4#1)(2006-5#1)
without any a priori##2##4##(1997-6#1)(2008-3#1)
without any additional##2##3##(2008-3#1)(2011-1#1)
without any additives##2##3##(2008-10#1)(2009-11#1)
without any adverse effect##2##4##(2008-10#1)(2008-3#1)
without any adverse##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
without any apparent history of##2##5##(2007-10#2)
without any apparent##6##3##(1994-5#1)(1995-2#1)(2007-10#2)(2008-11#1)(2013-1#1)
without any appreciable##2##3##(2008-10#2)
without any change in##2##4##(1990-5#1)(2008-12#1)
without any change##3##3##(1990-5#1)(1993-12#1)(2008-12#1)
without any chemical##3##3##(2008-10#2)(2008-3#1)
without any clinical##3##3##(1991-2#1)(1993-2#1)(2007-8#1)
without any complication##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
without any complications##3##3##(1991-12#1)(1994-9#1)(2012-3#1)
without any considerable divergence in potentials##2##6##(2008-10#2)
without any considerable divergence in##4##5##(2008-10#4)
without any considerable##6##3##(2008-10#6)
without any decrease in##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
without any decrease##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
without any divergence in potential##2##5##(2008-10#2)
without any divergence in##3##4##(2008-10#3)
without any doubt##2##3##(1997-4#1)(2008-9#1)
without any effect on the##2##5##(1991-11#1)(2008-11#1)
without any effect on##3##4##(1991-11#1)(1995-3#1)(2008-11#1)
without any evidence of##4##4##(1990-7#1)(2008-5#1)(2008-9#1)(2010-12#1)
without any external##2##3##(1996-6#1)(2007-12#1)
without any further##5##3##(2007-12#1)(2008-10#3)(2012-12#1)
without any interference from##2##4##(2008-10#2)
without any interference##3##3##(2008-10#3)
without any known##2##3##(2008-10#1)(2011-1#1)
without any loss of##3##4##(1997-4#1)(2007-12#1)(2011-1#1)
without any major##2##3##(1992-2#1)(2008-10#1)
without any marked##2##3##(1993-9#1)(2008-10#1)
without any need##2##3##(2008-10#1)(2011-2#1)
without any negative##2##3##(2008-6#1)(2010-2#1)
without any observable##2##3##(1997-4#1)(2008-10#1)
without any obvious##2##3##(2007-7#1)(2008-10#1)
without any other##6##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
without any pre-treatment##5##3##(1991-5#1)(2008-10#4)
without any preliminary treatment##2##4##(2008-10#2)
without any pretreatment##7##3##(2008-10#7)
without any previous##4##3##(2008-10#4)
without any prior separation##2##4##(2008-10#2)
without any prior##4##3##(2008-10#4)
without any purification##2##3##(2008-10#2)
without any reduction##2##3##(1994-2#1)(2008-10#1)
without any relapse##2##3##(2007-8#1)(2010-12#1)
without any sample##2##3##(2008-10#2)
without any serious interference##2##4##(2007-12#1)(2008-10#1)
without any significant change in##2##5##(1996-9#1)(2009-5#1)
without any significant change##3##4##(1996-9#1)(2008-10#1)(2009-5#1)
without any significant effect on the##2##6##(2011-2#1)(2013-1#1)
without any significant effect##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
without any significant##17##3##(1990-5#1)(1993-11#1)(1996-9#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
without any signs##3##3##(1990-8#1)(1996-9#1)(2008-11#1)
without any symptom##2##3##(1990-3#1)(1994-7#1)
without any symptoms of##3##4##(1991-5#1)(2008-12#1)(2008-7#1)
without any symptoms##4##3##(1991-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
without any treatment##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
without any##269##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#2)(2006-10#1)(2006-12#2)(2007-10#3)(2007-11#7)(2007-12#7)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#84)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#14)(2008-5#4)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#19)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#4)
without apparent##4##2##(1994-6#1)(1995-12#1)(1997-1#1)(1997-8#1)
without application of##2##3##(2007-11#1)(2008-10#1)
without appreciable##3##2##(1990-12#1)(1991-5#1)(2012-2#1)
without artificial##3##2##(2007-10#1)(2007-12#1)(2008-10#1)
without associated##9##2##(1992-3#1)(1993-9#1)(1995-1#1)(1997-1#1)(2008-1#1)(2008-9#2)(2009-5#1)(2013-1#1)
without assuming##3##2##(2008-3#2)(2008-8#1)
without base##5##2##(2008-4#4)(2008-8#1)
without being processed##2##3##(1990-8#1)(1991-9#1)
without being##11##2##(1990-8#1)(1991-9#1)(1992-12#1)(1996-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#1)
without benefit##2##2##(1997-7#1)(2008-10#1)
without blood transfusion]##2##3##(1990-2#2)
without bone##6##2##(1993-11#1)(1994-12#2)(2007-12#1)(2011-2#2)
without brain##5##2##(1991-2#1)(1995-3#1)(2006-12#1)(2012-3#2)
without breast cancer##2##3##(2013-1#2)
without breast##3##2##(1994-12#1)(2013-1#2)
without broccoli##2##2##(2008-10#2)
without cardiac##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
without cardiopulmonary bypass##6##3##(2007-8#4)(2011-3#1)(2013-8#1)
without cardiovascular##2##2##(2008-7#1)(2013-3#1)
without causing a release of##2##5##(1992-11#2)
without causing any##2##3##(2008-10#2)
without causing disease##2##3##(2008-10#1)(2010-6#1)
without causing significant##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
without causing##19##2##(1992-11#2)(1994-2#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2010-6#1)(2011-2#1)(2013-1#2)
without cavity##4##2##(2007-11#1)(2007-12#1)(2013-1#2)
without cervical##2##2##(1991-2#1)(1993-12#1)
without change in the##2##4##(1997-7#1)(2008-3#1)
without change in##3##3##(1997-7#1)(2008-1#1)(2008-3#1)
without changes in the##4##4##(1991-5#1)(2008-10#1)(2008-11#2)
without changes in##9##3##(1991-5#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2012-2#1)
without changing the##10##3##(1992-3#1)(1994-5#1)(2007-12#2)(2008-10#2)(2008-3#3)(2010-4#1)
without changing##12##2##(1992-3#1)(1994-5#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-3#3)(2009-11#1)(2010-4#1)
without chemical##3##2##(1994-5#1)(2008-10#2)
without chirp control##2##3##(2007-11#2)
without chromatic##2##2##(2007-11#1)(2008-2#1)
without chronic##3##2##(1995-1#1)(2008-7#1)(2008-9#1)
without cirrhosis##5##2##(1993-2#1)(1994-7#3)(2006-10#1)
without citrate##2##2##(1992-11#2)
without clinical evidence of##3##4##(2006-10#1)(2008-10#1)(2010-11#1)
without clinical##6##2##(1997-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-8#1)
without complication##2##2##(2007-8#1)(2008-9#1)
without complications##8##2##(1990-9#1)(1996-8#1)(2010-3#1)(2012-12#1)(2013-1#4)
without compromise##2##2##(2008-10#1)(2011-2#1)
without compromising the quality##2##4##(2012-2#1)(2013-1#1)
without compromising the##9##3##(1992-2#1)(2008-2#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
without compromising##17##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
without concomitant##6##2##(1990-2#1)(1993-9#1)(2008-12#1)(2008-4#2)(2013-1#1)
without congenital##2##2##(2008-11#2)
without consent##2##2##(1995-2#1)(1996-2#1)
without considerable##2##2##(1991-6#1)(2008-10#1)
without considering##2##2##(1990-8#1)(2008-2#1)
without contamination for a long time##2##6##(2008-10#2)
without coronary##4##2##(1991-3#1)(1993-12#1)(2008-11#1)(2008-7#1)
without corresponding##2##2##(1996-5#1)(2011-10#1)
without creating##2##2##(2008-11#1)(2008-3#1)
without cross##2##2##(2008-11#1)(2009-8#1)
without culture##2##2##(2008-11#1)(2009-6#1)
without cytoplasmic fusion##2##3##(1991-5#2)
without cytotoxicity##2##2##(2008-7#1)(2009-10#1)
without damage##2##2##(2007-12#1)(2008-3#1)
without damaging##4##2##(1991-5#1)(2006-10#1)(2008-11#1)(2008-8#1)
without decreasing##2##2##(2007-12#1)(2008-10#1)
without deep##2##2##(1990-2#1)(2013-1#1)
without degradation of the##2##4##(2008-10#1)(2008-3#1)
without degradation of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
without degradation##5##2##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
without delay##6##2##(1996-6#1)(1996-8#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
without delta##2##2##(1991-8#1)(1996-5#1)
without dementia##7##2##(2008-7#5)(2012-3#1)(2013-1#1)
without derivatization##3##2##(2008-10#2)(2008-5#1)
without detectable##4##2##(1990-3#1)(1991-11#1)(1995-2#1)(2007-11#1)
without dexamethasone##2##2##(1990-5#1)(2008-5#1)
without diabetes mellitus##3##3##(1992-5#1)(2008-11#1)(2011-1#1)
without diabetes##8##2##(1992-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-3#1)
without differences in##2##3##(1991-12#1)(1993-2#1)
without differences##4##2##(1991-12#1)(1993-2#1)(2011-2#1)(2013-8#1)
without direct##2##2##(1994-2#1)(1994-8#1)
without disease progress##2##3##(2008-10#2)
without disease##3##2##(2008-10#2)(2012-12#1)
without dislocation##2##2##(2007-8#1)(2011-2#1)
without dispersion##2##2##(2008-10#1)(2008-3#1)
without dissection##2##2##(1994-3#1)(2008-10#1)
without disturbance##2##2##(2008-10#1)(2008-9#1)
without disturbing the##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
without drains##2##2##(2008-10#1)(2008-8#1)
without drug##2##2##(1996-5#1)(2008-9#1)
without eating concerns##3##3##(2007-12#3)
without effect on the##4##4##(1990-8#1)(1993-6#1)(1995-12#1)(2008-10#1)
without effect on##8##3##(1990-8#1)(1991-6#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#1)
without effect##18##2##(1990-8#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-2#1)(1997-1#1)(2006-6#1)(2007-8#1)(2008-10#1)
without effects on##3##3##(1995-5#1)(2008-10#2)
without elevation of##3##3##(2008-10#3)
without endothelium##3##2##(1994-11#1)(1995-12#2)
without evidence of disease##3##4##(1990-2#2)(2012-12#1)
without evidence of##19##3##(1990-2#2)(1990-8#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
without evidence##20##2##(1990-2#2)(1990-8#1)(1995-12#3)(1995-2#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
without examining##2##2##(1994-3#1)(2008-11#1)
without exception##5##2##(1995-12#1)(1995-3#1)(1997-4#1)(2008-8#1)(2011-2#1)
without excessive##2##2##(2007-12#1)(2008-3#1)
without exogenous##3##2##(2007-11#1)(2008-11#1)(2008-8#1)
without exposure to##2##3##(2008-11#1)(2011-2#1)
without exposure##3##2##(2008-11#1)(2011-2#2)
without extended##2##2##(2008-7#2)
without extensive##2##2##(2008-2#1)(2008-7#1)
without external##2##2##(2008-10#1)(2008-2#1)
without extraction##3##2##(2008-10#3)
without family history##2##3##(2008-7#1)(2012-1#1)
without family##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
without fear of##4##3##(1996-5#1)(2008-10#1)(2012-12#1)(2013-8#1)
without fear##5##2##(1996-5#1)(1997-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
without feedback##3##2##(1990-3#1)(2007-11#1)(2009-10#1)
without fever##5##2##(2007-12#2)(2008-7#1)(2009-10#1)(2012-12#1)
without first having to isolate the protein##3##7##(2008-2#1)(2008-4#2)
without first##4##2##(1995-12#1)(2008-2#1)(2008-4#2)
without fish##2##2##(2008-5#1)(2008-9#1)
without focal##2##2##(1997-3#1)(2007-11#1)
without forming##2##2##(1994-5#1)(2008-10#1)
without fracture##2##2##(1991-11#1)(2012-3#1)
without free##2##2##(1997-3#1)(2007-11#1)
without further##14##2##(1991-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
without gas##2##2##(2008-11#1)(2012-12#1)
without gelatin##2##2##(2013-1#2)
without genetic alteration of p53##2##5##(1994-12#2)
without genetic##3##2##(1994-12#2)(1994-3#1)
without glucose##3##2##(2008-11#1)(2008-7#1)(2010-2#1)
without glutamine##2##2##(2008-11#2)
without gluteal##2##2##(2012-2#2)
without having to increase the##2##5##(2008-3#1)(2008-5#1)
without having to##8##3##(1993-1#1)(1994-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)
without having##13##2##(1990-9#1)(1993-1#1)(1994-12#1)(1995-12#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)
without health insurance##2##3##(2011-2#1)(2013-1#1)
without hepatic##2##2##(2012-3#1)(2013-1#1)
without history of##6##3##(1990-9#1)(1992-6#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#1)
without hydrogen##2##2##(1995-3#1)(2007-12#1)
without hypertension##5##2##(1990-9#1)(2007-10#3)(2012-2#1)
without immigration##3##2##(2008-8#3)
without imposing##3##2##(1997-5#1)(2007-10#1)(2011-2#1)
without improvement##2##2##(2012-3#1)(2013-8#1)
without incident##2##2##(2008-11#1)(2008-6#1)
without increase in##2##3##(2008-7#1)(2012-3#1)
without increase##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
without increasing the risk##2##4##(1997-3#1)(2008-9#1)
without increasing the##6##3##(1994-5#1)(1996-9#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#1)
without increasing##13##2##(1990-12#1)(1990-2#1)(1994-5#1)(1996-9#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-2#1)
without inducing##6##2##(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#2)
without infection had##2##3##(2008-10#2)
without infection##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
without influencing the##2##3##(1995-11#1)(2008-10#1)
without influencing##3##2##(1995-11#1)(2008-10#1)(2008-7#1)
without inhibitor##3##2##(2008-4#2)(2010-10#1)
without initial##3##2##(2007-12#1)(2007-7#1)(2010-1#1)
without interference from##4##3##(1996-6#1)(2008-10#3)
without interference of the matrix##3##5##(2008-10#3)
without interference of##5##3##(2008-10#5)
without interference##12##2##(1990-12#1)(1996-6#1)(2008-10#10)
without interferences##2##2##(2008-10#2)
without interfering##2##2##(2008-10#1)(2008-5#1)
without intermediate##2##2##(2008-3#1)(2008-7#1)
without interrupting##2##2##(1992-10#1)(2007-12#1)
without interruption of the##2##4##(2008-10#1)(2008-11#1)
without intravenous##2##2##(1992-12#1)(2008-5#1)
without introducing additional##2##3##(2012-2#1)(2013-8#1)
without introducing##5##2##(2008-3#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
without involvement of##3##3##(1996-6#1)(2010-11#1)(2011-2#1)
without irradiation##2##2##(1995-11#1)(2008-10#1)
without it##3##2##(1994-7#1)(2008-3#1)(2013-1#1)
without its##5##2##(1991-5#1)(1993-12#1)(2008-12#2)(2010-11#1)
without jeopardizing##3##2##(1992-4#1)(1994-12#1)(2010-8#1)
without joining##2##2##(2008-8#1)(2012-12#1)
without knowing the##2##3##(2007-12#1)(2010-8#1)
without knowledge of the original##2##5##(2008-3#2)
without knowledge of the##4##4##(2008-10#1)(2008-3#3)
without known##5##2##(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
without loading##2##2##(2007-8#2)
without local##2##2##(1994-6#1)(2013-1#1)
without losing##2##2##(2008-5#1)(2013-1#1)
without loss of prediction capacity using spectrophotometric method##2##8##(2008-10#2)
without loss of##19##3##(1990-11#1)(1992-3#1)(1993-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2009-3#1)(2011-2#1)(2012-2#1)
without major complications##3##3##(1992-5#1)(2011-2#1)(2012-2#1)
without manifold##2##2##(2008-10#2)
without marked##2##2##(2011-2#1)(2012-2#1)
without matrix matching##2##3##(2008-10#2)
without matrix##5##2##(2008-10#5)
without mechanical movement##2##3##(2007-12#1)(2008-3#1)
without mechanical##6##2##(2007-11#1)(2007-12#2)(2008-3#2)(2009-8#1)
without medical##2##2##(1994-7#1)(2010-8#1)
without medication##3##2##(1992-9#1)(2008-3#1)(2008-5#1)
without metabolic activation##2##3##(1992-8#1)(1996-2#1)
without metal##2##2##(2008-10#1)(2008-2#1)
without metastasis##3##2##(1992-5#1)(1993-3#1)(2012-3#1)
without microelectrode recording for##2##4##(2008-7#2)
without microelectrode recording##3##3##(2008-7#3)
without mishap##2##2##(1997-6#1)(2008-7#1)
without mode hopping##2##3##(2007-12#1)(2008-3#1)
without mode##4##2##(2007-12#2)(2008-3#2)
without modifications##2##2##(2008-4#1)(2008-7#1)
without modifier##7##2##(2008-10#7)
without much##7##2##(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
without multiple##2##2##(2008-10#1)(2008-3#1)
without need for##2##3##(2008-10#1)(2008-11#1)
without need##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
without neurological##2##2##(1997-6#1)(2008-7#1)
without noticeable##3##2##(2008-10#3)
without observing any deviation##2##4##(2008-10#2)
without observing any##5##3##(2008-10#5)
without obvious##4##2##(1994-9#1)(2007-12#1)(2008-10#1)(2009-1#1)
without or with##4##3##(2008-10#1)(2008-12#1)(2010-2#2)
without oral candidosis##2##3##(2008-5#2)
without osteonecrosis##2##2##(1994-7#2)
without other cause##2##3##(1996-6#1)(2013-1#1)
without other##5##2##(1996-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
without overt##3##2##(2011-2#3)
without pH##2##2##(2008-10#1)(2010-5#1)
without parental##4##2##(1997-6#1)(2008-4#1)(2008-9#1)(2011-1#1)
without particular##3##2##(1991-3#1)(1993-6#1)(2007-8#1)
without pathological##2##2##(2007-11#1)(2008-5#1)
without pathology##2##2##(2008-12#1)(2013-1#1)
without perceptible##2##2##(2009-12#1)(2010-8#1)
without perforation##2##2##(1993-6#2)
without phase##2##2##(2007-11#1)(2008-12#1)
without photoradiation##2##2##(1990-6#2)
without placing##2##2##(1997-5#1)(1997-6#1)
without postoperative##2##2##(2008-7#1)(2011-1#1)
without potential##2##2##(2008-10#1)(2013-1#1)
without pre-treatment of the##2##4##(2008-10#2)
without pre-treatment##3##2##(2008-10#3)
without preconcentration and##2##3##(2008-10#2)
without preconcentration##3##2##(2008-10#3)
without pretreatment##6##2##(1990-8#2)(1995-6#1)(2008-10#3)
without previous extraction##2##3##(2008-10#2)
without previous separation##4##3##(2008-10#4)
without previous separations##2##3##(2008-10#2)
without previous treatment##3##3##(2008-10#2)(2013-8#1)
without previous##25##2##(1992-10#1)(1992-2#1)(1992-3#1)(1994-5#1)(1996-12#1)(2007-8#3)(2008-10#11)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
without primary##3##2##(1991-3#1)(1996-3#1)(2008-12#1)
without prior knowledge##2##3##(2008-3#1)(2012-1#1)
without prior sample##3##3##(2008-10#3)
without prior separation steps##3##4##(2008-10#3)
without prior separation##4##3##(2008-10#4)
without prior treatment##3##3##(1991-2#1)(2008-10#2)
without prior##28##2##(1990-5#1)(1990-8#1)(1991-2#2)(1992-3#1)(1996-1#1)(1996-12#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-7#1)
without problems##2##2##(1991-5#1)(2008-6#1)
without producing##5##2##(1994-2#1)(1997-2#1)(2008-5#1)(2009-11#1)(2013-1#1)
without progression##2##2##(1995-12#1)(2008-6#1)
without pulmonary##2##2##(2008-7#1)(2011-2#1)
without radiation##2##2##(1994-3#1)(2008-6#1)
without recourse to##8##3##(1996-8#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
without recurrence##6##2##(1995-4#1)(2006-12#1)(2008-5#1)(2008-7#2)(2012-3#1)
without reducing the##5##3##(1994-2#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#1)
without reducing##8##2##(1994-2#1)(1995-11#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
without reduction of##3##3##(2008-10#1)(2008-12#1)(2009-11#1)
without regard to the##2##4##(1996-3#1)(2011-1#1)
without regard to##3##3##(1996-3#1)(2008-10#1)(2011-1#1)
without relapse##2##2##(1993-2#1)(2008-1#1)
without relief##2##2##(1995-10#1)(2008-9#1)
without removing the##2##3##(2008-10#1)(2008-9#1)
without remuneration##2##2##(2008-1#2)
without renal##5##2##(1990-3#1)(1993-8#1)(1996-6#1)(2012-3#2)
without requiring any##2##3##(2008-2#1)(2010-5#1)
without requiring##12##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
without residents to##3##3##(2008-11#3)
without resorting to##2##3##(2007-12#1)(2008-10#1)
without restriction##3##2##(2007-8#1)(2008-3#1)(2013-8#1)
without resulting##2##2##(2008-3#1)(2008-7#1)
without risk##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
without risking##4##2##(1990-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
without sacrificing quality of##2##4##(1992-12#2)
without sacrificing quality##3##3##(1992-12#2)(2008-10#1)
without sacrificing the##2##3##(2008-10#1)(2008-3#1)
without sacrificing##10##2##(1992-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-11#1)
without sample pre-treatment##2##3##(2008-10#2)
without sample pretreatment##2##3##(2008-10#2)
without sample##6##2##(2007-11#1)(2008-10#5)
without scanning##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
without scrototomy##2##2##(1997-8#2)
without selection##3##2##(1993-9#1)(2008-10#2)
without separation##3##2##(2008-10#3)
without sequelae##2##2##(1997-6#1)(2011-2#1)
without serious##2##2##(2008-3#1)(2010-11#1)
without serum##5##2##(1996-2#1)(2008-11#4)
without showing##2##2##(1990-7#1)(2008-10#1)
without shunt##2##2##(1992-6#1)(2009-3#1)
without side effects and##2##4##(2010-1#1)(2013-8#1)
without side##3##2##(1997-3#1)(2010-1#1)(2013-8#1)
without significant change in the##2##5##(1996-5#1)(2008-3#1)
without significant change in##3##4##(1996-5#1)(2008-3#1)(2008-7#1)
without significant changes in##3##4##(1991-12#1)(1992-11#1)(2008-7#1)
without significant differences in##2##4##(2008-11#1)(2013-1#1)
without significant differences##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
without significant effect on##2##4##(1995-6#1)(2007-10#1)
without significant loss of##2##4##(1994-2#1)(2008-10#1)
without significant##34##2##(1991-12#1)(1991-2#1)(1992-11#2)(1992-4#1)(1993-2#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#3)
without significantly##2##2##(1993-9#1)(2010-3#1)
without signs of recurrence##2##4##(2008-6#1)(2012-12#1)
without signs of##5##3##(1991-11#1)(1993-1#1)(2008-6#1)(2012-12#1)(2013-1#1)
without some##3##2##(1992-12#1)(1995-5#1)(2008-11#1)
without statistical significance##2##3##(2008-12#1)(2008-5#1)
without statistically significant##2##3##(2008-10#2)
without stenosis##2##2##(1993-8#1)(2013-1#1)
without substantial##2##2##(2008-10#1)(2010-10#1)
without success##4##2##(1990-11#1)(2007-4#1)(2008-11#1)(2008-4#1)
without such an adjuvant therapy##2##5##(1990-10#2)
without such##10##2##(1990-10#2)(1991-2#1)(1994-2#1)(1996-11#1)(2008-3#3)(2008-7#1)(2012-3#1)
without sudden##2##2##(2008-7#1)(2009-11#1)
without sun##2##2##(1993-3#1)(2008-3#1)
without supplementary##2##2##(1993-2#1)(1996-2#1)
without support and##2##3##(1995-12#1)(1995-8#1)
without support##6##2##(1995-12#1)(1995-8#3)(2007-11#1)(2011-1#1)
without surgery##3##2##(1992-9#1)(2011-2#1)(2013-8#1)
without surgical##3##2##(1990-2#1)(2008-7#1)(2009-3#1)
without symptoms of##4##3##(1991-11#1)(2007-11#1)(2009-3#1)(2009-4#1)
without symptoms##9##2##(1990-6#1)(1991-11#1)(1991-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2009-4#1)
without systemic##4##2##(1994-8#1)(2008-7#1)(2013-7#1)(2013-8#1)
without taking##2##2##(1990-11#1)(2008-3#1)
without tedious sample##2##3##(1992-12#1)(2008-10#1)
without temperature##2##2##(2008-10#1)(2008-2#1)
without tenotomy##2##2##(2011-1#2)
without the addition of other##2##5##(2008-5#1)(2008-6#1)
without the addition of##13##4##(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-7#1)
without the adsorptive accumulation##2##4##(2008-10#2)
without the aid of##2##4##(2007-11#1)(2008-10#1)
without the complications of##2##4##(2008-7#1)(2011-2#1)
without the influence of##2##4##(2008-3#1)(2011-2#1)
without the interference of##3##4##(2008-10#3)
without the interference##4##3##(2008-10#4)
without the necessity of##3##4##(2007-11#1)(2008-7#1)(2008-9#1)
without the necessity##4##3##(1995-8#1)(2007-11#1)(2008-7#1)(2008-9#1)
without the need for a##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
without the need for any##3##5##(2007-12#2)(2008-10#1)
without the need for further##3##5##(1992-11#1)(1993-6#1)(2008-4#1)
without the need for separation##2##5##(2008-10#1)(2008-4#1)
without the need for tedious##2##5##(2008-10#2)
without the need for##43##4##(1992-11#1)(1993-6#1)(1995-3#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-6#1)(2012-2#1)(2013-8#1)
without the need of a##2##5##(2008-10#1)(2008-11#1)
without the need of##7##4##(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-5#1)
without the need to##7##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-9#1)(2011-1#1)
without the need##57##3##(1992-11#1)(1993-6#1)(1995-3#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
without the potential##2##3##(2010-8#1)(2013-1#1)
without the presence of##7##4##(1996-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-2#1)
without the previous accumulation##2##4##(2008-10#2)
without the requirement of##2##4##(2007-12#1)(2008-10#1)
without the routine use of ultrasonography##2##6##(2011-2#2)
without the routine use of##3##5##(2011-2#3)
without the traditional##2##3##(1993-2#1)(2013-1#1)
without the use of a##2##5##(2008-2#1)(2012-3#1)
without the use of an##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
without the use of##19##4##(1992-3#1)(1992-4#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
without the##218##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#45)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#19)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#13)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#5)
without their##2##2##(1995-12#1)(2008-7#1)
without these##4##2##(1994-12#1)(1994-6#1)(2008-4#1)(2008-9#1)
without this##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2010-3#1)
without those##2##2##(2008-10#1)(2011-1#1)
without thyroid##3##2##(2008-6#1)(2013-1#2)
without time##2##2##(1995-5#1)(2007-7#1)
without titration has been developed##2##5##(2008-10#2)
without titration##8##2##(2008-10#8)
without trauma to the##2##4##(2007-5#1)(2012-2#1)
without trauma##3##2##(2007-5#1)(2009-4#1)(2012-2#1)
without treatment##8##2##(1990-11#1)(1991-11#1)(2008-7#1)(2009-10#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
without typical##2##2##(1997-8#1)(2007-8#1)
without urinary##2##2##(2008-10#1)(2012-12#1)
without use of##4##3##(1990-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
without using a##4##3##(1991-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
without using an##2##3##(1997-2#1)(2008-3#1)
without using any##4##3##(2008-10#2)(2008-3#2)
without using internal##2##3##(1997-2#1)(2008-10#1)
without using of##2##3##(2008-10#2)
without using the##7##3##(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#1)(2010-8#1)
without using##31##2##(1990-2#1)(1991-12#1)(1991-6#1)(1996-12#1)(1996-6#1)(1997-2#2)(2007-12#2)(2007-2#1)(2008-10#11)(2008-2#1)(2008-3#4)(2008-7#2)(2010-3#1)(2010-6#1)(2010-8#1)
without vitamin##3##2##(1993-12#1)(1997-3#1)(2011-1#1)
without waiting for##2##3##(1997-2#1)(2009-12#1)
without wetness##3##2##(2008-10#3)
without white##2##2##(2008-10#1)(2008-2#1)
without yeast##2##2##(2008-10#1)(2008-12#1)
without##2918##1##(1990-10#2)(1990-11#14)(1990-12#8)(1990-2#17)(1990-3#9)(1990-5#8)(1990-6#6)(1990-7#4)(1990-8#13)(1990-9#10)(1991-1#3)(1991-10#1)(1991-11#12)(1991-12#11)(1991-2#9)(1991-3#10)(1991-4#2)(1991-5#15)(1991-6#5)(1991-8#6)(1991-9#3)(1992-1#3)(1992-10#7)(1992-11#11)(1992-12#15)(1992-2#8)(1992-3#18)(1992-4#3)(1992-5#7)(1992-6#6)(1992-8#8)(1992-9#5)(1993-1#8)(1993-11#9)(1993-12#15)(1993-2#12)(1993-3#9)(1993-5#1)(1993-6#12)(1993-8#9)(1993-9#9)(1994-11#10)(1994-12#19)(1994-2#16)(1994-3#12)(1994-5#9)(1994-6#15)(1994-7#8)(1994-8#7)(1994-9#11)(1995-1#3)(1995-10#1)(1995-11#7)(1995-12#23)(1995-2#14)(1995-3#11)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#12)(1996-1#5)(1996-11#4)(1996-12#10)(1996-2#15)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#10)(1996-7#1)(1996-8#6)(1996-9#9)(1997-1#8)(1997-2#15)(1997-3#15)(1997-4#12)(1997-5#9)(1997-6#16)(1997-7#12)(1997-8#11)(2006-10#7)(2006-12#4)(2006-5#1)(2006-6#1)(2007-10#28)(2007-11#68)(2007-12#81)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#13)(2007-8#44)(2007-9#1)(2008-1#29)(2008-10#517)(2008-11#100)(2008-12#28)(2008-2#47)(2008-3#154)(2008-4#35)(2008-5#61)(2008-6#33)(2008-7#112)(2008-8#44)(2008-9#63)(2009-1#1)(2009-10#12)(2009-11#11)(2009-12#10)(2009-2#1)(2009-3#14)(2009-4#6)(2009-5#10)(2009-6#14)(2009-7#2)(2009-8#16)(2009-9#4)(2010-1#6)(2010-10#15)(2010-11#8)(2010-12#16)(2010-2#9)(2010-3#18)(2010-4#11)(2010-5#6)(2010-6#11)(2010-7#8)(2010-8#19)(2010-9#4)(2011-1#31)(2011-10#1)(2011-2#120)(2011-3#2)(2012-1#12)(2012-12#47)(2012-2#58)(2012-3#43)(2012-4#1)(2012-7#1)(2013-1#130)(2013-3#1)(2013-7#7)(2013-8#48)
withstand a##2##2##(2008-7#1)(2012-3#1)
withstand the##2##2##(2008-11#1)(2010-12#1)
withstand##15##1##(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-2#1)(2010-12#1)(2010-8#1)(2012-3#2)
withstanding the##2##2##(2008-10#1)(2012-2#1)
withstanding##3##1##(1997-4#1)(2008-10#1)(2012-2#1)
withstands##2##1##(1997-2#1)(2008-9#1)
withstood##3##1##(1997-5#1)(2008-2#1)(2010-2#1)
withthe##2##1##(2008-11#1)(2013-7#1)
witness to conjugal violence##2##4##(2008-2#2)
witness to##3##2##(2008-2#2)(2008-8#1)
witness##11##1##(1993-12#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-8#1)(2012-2#1)(2013-8#1)
witnessed a resurgence##2##3##(2009-12#1)(2011-2#1)
witnessed a##3##2##(2008-11#1)(2009-12#1)(2011-2#1)
witnessed by##4##2##(2008-7#1)(2010-3#1)(2010-4#1)(2013-1#1)
witnessed in the##2##3##(2010-4#1)(2011-1#1)
witnessed in##4##2##(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
witnessed the##2##2##(1997-2#1)(2012-1#1)
witnessed##24##1##(1991-2#1)(1994-12#1)(1996-1#1)(1997-2#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
witnesses##7##1##(1994-2#1)(1995-12#2)(1996-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
witnessing a##3##2##(2008-6#1)(2010-8#1)(2011-1#1)
witnessing##7##1##(2008-12#1)(2008-2#1)(2008-6#1)(2009-4#2)(2010-8#1)(2011-1#1)
wives had titre##2##3##(2007-7#2)
wives##7##1##(2007-7#3)(2008-9#2)(2011-2#2)
wives'##3##1##(2008-9#3)
wk##7##1##(1993-1#1)(2008-10#2)(2008-8#1)(2013-1#3)
wk)##5##1##(1994-2#1)(1994-6#1)(1997-6#2)(2008-9#1)
wks##6##1##(2012-3#4)(2013-1#2)
wo##3##1##(1994-7#1)(2008-11#2)
wobble##4##1##(1994-12#2)(2008-3#1)(2008-9#1)
wobbler##2##1##(1996-12#2)
woc##2##1##(2012-3#2)
woefully##2##1##(1992-3#1)(2008-12#1)
woesei##5##1##(1993-9#1)(2011-2#4)
wogonin##3##1##(2013-7#3)
wolf##3##1##(1992-2#1)(2007-12#2)
wolfberry fruit of different geographic regions##2##6##(2013-8#2)
wolfberry fruit##3##2##(2013-8#3)
wolves##2##1##(1996-12#2)
woman aged##6##2##(1990-6#1)(1991-3#1)(1991-9#1)(1995-12#1)(1997-8#1)(2011-2#1)
woman and her##2##3##(1992-9#1)(2013-1#1)
woman and##8##2##(1990-2#1)(1992-9#1)(1995-6#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
woman at##2##2##(2012-8#1)(2013-1#1)
woman developed##4##2##(1991-9#1)(1994-7#1)(1995-11#1)(2013-1#1)
woman for##2##2##(1993-8#1)(2011-2#1)
woman had##4##2##(1992-12#1)(1997-5#1)(2007-5#1)(2010-6#1)
woman has##3##2##(1990-6#1)(2007-8#1)(2010-8#1)
woman in##8##2##(1991-12#1)(1993-12#1)(1993-3#1)(2008-1#1)(2008-11#1)(2009-3#1)(2012-12#1)(2012-2#1)
woman is##4##2##(1990-6#1)(1991-5#1)(1992-1#1)(2007-8#1)
woman of##3##2##(1995-11#1)(2007-7#1)(2008-7#1)
woman presented with a##4##4##(2009-3#1)(2010-6#1)(2012-3#1)(2013-7#1)
woman presented with severe##2##4##(2007-7#1)(2009-3#1)
woman presented with##22##3##(1990-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#3)(2010-11#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
woman presented##23##2##(1990-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#3)(2010-11#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
woman presenting with a##3##4##(2008-5#1)(2013-1#2)
woman presenting with##4##3##(2008-4#1)(2008-5#1)(2013-1#2)
woman presenting##5##2##(1993-2#1)(2008-4#1)(2008-5#1)(2013-1#2)
woman received##2##2##(1995-8#1)(2008-5#1)
woman receiving##2##2##(1991-8#1)(2007-10#1)
woman referred##2##2##(2008-12#1)(2009-8#1)
woman suffering from##2##3##(2012-2#1)(2013-1#1)
woman treated with##2##3##(2013-1#1)(2013-8#1)
woman was admitted to our hospital for##2##7##(1991-12#1)(2008-1#1)
woman was admitted to our hospital##3##6##(1991-12#1)(2008-1#1)(2008-7#1)
woman was admitted to##5##4##(1991-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
woman was admitted with##4##4##(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
woman was admitted##9##3##(1991-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
woman was referred because of an##2##6##(2012-3#1)(2013-1#1)
woman was referred##3##3##(2012-3#1)(2013-1#1)(2013-7#1)
woman was##18##2##(1991-12#1)(1993-6#1)(1995-2#1)(1995-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
woman who developed##5##3##(1992-2#1)(2006-10#1)(2008-7#1)(2010-3#1)(2010-4#1)
woman who had##5##3##(2007-7#1)(2008-10#1)(2009-3#1)(2010-6#1)(2013-8#1)
woman who presented with a##3##5##(2008-10#1)(2013-1#1)(2013-8#1)
woman who presented with##11##4##(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
woman who presented##14##3##(1994-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
woman who was admitted to our department with a##2##9##(2011-2#2)
woman who was diagnosed##2##4##(2011-1#1)(2012-2#1)
woman who was##6##3##(2007-8#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
woman who##44##2##(1992-2#1)(1994-12#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#4)
woman whose##4##2##(1997-7#1)(2007-10#1)(2009-5#1)(2012-12#1)
woman with a history of##2##5##(2010-7#1)(2012-3#1)
woman with a##20##3##(1990-5#1)(1990-6#1)(1991-6#1)(1992-10#1)(1994-6#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
woman with an##7##3##(1991-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
woman with bilateral##2##3##(2007-10#1)(2008-7#1)
woman with chronic##2##3##(2008-1#1)(2008-7#1)
woman with early##2##3##(2008-8#1)(2012-3#1)
woman with known##2##3##(1990-12#1)(2011-2#1)
woman with multiple##2##3##(1992-5#1)(2013-1#1)
woman with progressive##2##3##(2008-1#1)(2013-1#1)
woman with recurrent##2##3##(1991-2#1)(2007-5#1)
woman with##80##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#3)(2007-10#5)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#5)(2013-1#9)(2013-7#1)
woman without##4##2##(1991-3#1)(1993-11#1)(2007-8#1)(2008-1#1)
woman##334##1##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#6)(1990-9#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#6)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-3#1)(1996-6#2)(1996-8#1)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#4)(2007-10#9)(2007-12#1)(2007-2#2)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#18)(2008-1#8)(2008-10#6)(2008-11#6)(2008-12#5)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#1)(2008-9#1)(2009-1#5)(2009-10#2)(2009-3#8)(2009-5#1)(2009-8#2)(2010-11#3)(2010-12#3)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#24)(2012-1#1)(2012-12#9)(2012-2#5)(2012-3#11)(2012-8#1)(2013-1#28)(2013-7#6)(2013-8#10)
woman&quot##3##1##(1997-3#1)(2013-1#2)
woman's own##2##2##(1997-2#1)(2008-1#1)
woman's##19##1##(1994-7#1)(1995-1#1)(1996-8#2)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2012-1#1)(2013-1#2)
woman)##2##1##(2007-8#1)(2011-2#1)
women &gt##2##2##(1994-9#1)(1997-8#1)
women &quot##2##2##(2008-12#1)(2009-4#1)
women (1##3##2##(2008-8#1)(2010-9#1)(2011-2#1)
women (36##2##2##(1994-2#1)(2008-5#1)
women (37##2##2##(2013-1#1)(2013-8#1)
women (56##2##2##(1992-5#1)(2008-3#1)
women (62%)##2##2##(2008-1#1)(2013-1#1)
women (P &lt##2##3##(2011-1#1)(2013-1#1)
women (P from 0##2##4##(2011-1#2)
women (P##5##2##(2011-1#3)(2013-1#1)(2013-8#1)
women (age##2##2##(2008-7#1)(2012-2#1)
women (average age##2##3##(2007-11#1)(2010-9#1)
women (mean age##4##3##(1992-2#1)(2007-11#2)(2008-5#1)
women (mean##5##2##(1992-2#1)(2007-11#2)(2008-5#1)(2013-8#1)
women (n =##5##3##(1990-11#1)(1995-11#2)(2008-11#1)(2011-2#1)
women 40##2##2##(1995-9#1)(2011-2#1)
women 49 years or older##2##5##(1992-9#2)
women 50##2##2##(1990-6#1)(1997-1#1)
women about##2##2##(1992-4#1)(1995-6#1)
women admitted for##2##3##(1990-12#1)(2007-7#1)
women affected by##5##3##(1991-2#1)(1991-4#1)(1994-5#2)(2011-2#1)
women after##2##2##(2011-1#1)(2012-3#1)
women age 50 and older##2##5##(1995-2#2)
women age##3##2##(1990-6#1)(1995-2#2)
women aged 18 to 27##2##5##(1992-1#2)
women aged 18 to##3##4##(1992-1#2)(2008-1#1)
women aged 25 - 54 years in##4##7##(2011-1#4)
women aged 60##2##3##(1996-6#1)(2011-2#1)
women aged between##6##3##(1990-9#1)(1992-10#1)(2008-5#1)(2010-3#1)(2011-2#2)
women aged over 50 years##2##5##(1993-2#1)(1995-4#1)
women aged over##3##3##(1993-2#1)(1994-2#1)(1995-4#1)
women aged##44##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-1#2)(1992-10#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#2)(1994-2#2)(1994-9#1)(1995-4#1)(1996-6#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-5#1)(2009-7#1)(2010-3#2)(2011-1#4)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
women among##2##2##(1993-6#1)(2008-10#1)
women and 10%##2##3##(1991-11#1)(2010-11#1)
women and 13 men aged##2##5##(2007-11#1)(2008-7#1)
women and 13##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
women and 15##3##3##(2008-3#1)(2008-4#1)(2009-10#1)
women and 2##2##3##(1994-5#1)(2007-8#1)
women and 5##2##3##(1990-6#1)(2007-11#1)
women and 6 men)##2##4##(2007-11#1)(2007-8#1)
women and 6##3##3##(2007-11#1)(2007-8#2)
women and AIDS##2##3##(1996-12#2)
women and a##3##3##(2007-8#1)(2009-10#1)(2011-1#1)
women and children##7##3##(1990-2#3)(1995-6#1)(1997-2#1)(2008-7#1)(2009-9#1)
women and four##2##3##(1993-5#1)(2008-10#1)
women and its##3##3##(1990-9#1)(2008-11#1)(2012-12#1)
women and may##2##3##(2011-2#1)(2013-1#1)
women and men aged##3##4##(1991-6#2)(2009-10#1)
women and men from##2##4##(2011-2#1)(2012-2#1)
women and men##17##3##(1991-6#2)(1991-8#1)(1994-2#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-5#1)(2009-10#2)(2009-11#1)(2009-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
women and nine men##2##4##(1993-3#1)(2008-9#1)
women and that##2##3##(2007-10#1)(2009-5#1)
women and the##5##3##(1996-12#1)(1996-2#1)(2008-12#1)(2008-9#1)(2012-12#1)
women and their infants##2##4##(1992-12#1)(2009-9#1)
women and their offspring##2##4##(2011-2#1)(2012-2#1)
women and their##12##3##(1992-12#1)(1994-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
women and to##2##3##(2008-5#1)(2011-2#1)
women and women with##4##4##(1992-12#1)(1992-9#1)(2010-6#1)(2013-1#1)
women and##132##2##(1990-11#1)(1990-2#3)(1990-6#1)(1990-9#1)(1991-11#2)(1991-6#5)(1991-8#5)(1992-12#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-8#3)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#2)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#1)(2009-5#2)(2009-7#2)(2009-9#2)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#1)
women are affected by##2##4##(1990-6#1)(2012-3#1)
women are at a##2##4##(2008-4#1)(2012-12#1)
women are at##3##3##(2007-10#1)(2008-4#1)(2012-12#1)
women are exposed##2##3##(1991-6#1)(2012-3#1)
women are less likely to##2##5##(1991-11#1)(2011-2#1)
women are more##2##3##(2008-4#1)(2012-2#1)
women are##32##2##(1990-6#1)(1991-11#1)(1991-6#2)(1993-3#1)(1994-2#1)(1995-12#2)(1996-11#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
women around the##2##3##(2008-5#1)(2009-10#1)
women as well as##3##4##(1992-12#2)(2011-2#1)
women as##9##2##(1991-6#1)(1992-12#2)(1993-2#1)(1993-3#1)(2007-7#1)(2008-3#1)(2011-2#2)
women at high risk for##2##5##(1993-11#1)(2010-7#1)
women at high risk##6##4##(1993-11#2)(2007-2#3)(2010-7#1)
women at risk for##2##4##(2008-4#1)(2011-2#1)
women at risk##4##3##(1990-9#1)(1994-6#1)(2008-4#1)(2011-2#1)
women at the##2##3##(1996-3#1)(2008-7#1)
women at##23##2##(1990-3#1)(1990-9#1)(1993-11#2)(1994-6#1)(1996-3#1)(2007-2#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2013-1#1)
women attending a##3##3##(1993-2#1)(1996-6#1)(2010-3#1)
women attending the##2##3##(2011-2#1)(2013-1#1)
women attending##9##2##(1993-2#1)(1994-6#1)(1996-6#1)(2008-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
women before##3##2##(1991-6#1)(1997-4#1)(1997-8#1)
women better##2##2##(2011-1#1)(2011-2#1)
women between##6##2##(1990-9#1)(1991-5#1)(1995-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
women beyond##2##2##(2011-1#1)(2013-7#1)
women born##2##2##(1994-6#1)(2008-10#1)
women but##4##2##(1991-12#1)(2007-12#1)(2009-8#1)(2012-12#1)
women by##4##2##(1990-11#1)(1993-6#1)(2007-7#1)(2008-7#1)
women can##4##2##(2007-2#1)(2007-7#1)(2009-9#1)(2012-3#1)
women characterized by##2##3##(2008-3#2)
women clients##2##2##(1991-6#1)(2008-6#1)
women compared to##2##3##(1993-12#1)(2011-1#1)
women compared with##4##3##(2008-4#1)(2009-11#1)(2010-3#1)(2013-1#1)
women compared##6##2##(1993-12#1)(2008-4#1)(2009-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
women considered##3##2##(2007-7#1)(2009-3#1)(2009-4#1)
women continue to##3##3##(1995-12#1)(2007-4#1)(2008-11#1)
women demonstrated##2##2##(2011-2#1)(2013-1#1)
women diagnosed##2##2##(1993-2#1)(2008-3#1)
women did not show##2##4##(2010-6#1)(2011-1#1)
women did not##4##3##(1996-1#1)(2008-5#1)(2010-6#1)(2011-1#1)
women did##5##2##(1996-1#1)(1996-6#1)(2008-5#1)(2010-6#1)(2011-1#1)
women during the##5##3##(1992-10#1)(1995-12#1)(2008-4#3)
women during##8##2##(1992-10#1)(1995-12#1)(2008-4#4)(2010-12#1)(2010-9#1)
women each##2##2##(1996-8#1)(2008-5#1)
women enrolled in the##2##4##(1995-8#1)(2008-12#1)
women enrolled##3##2##(1995-8#1)(2008-12#1)(2011-1#1)
women evaluated##3##2##(2007-12#1)(2010-3#1)(2011-2#1)
women examined##2##2##(1990-2#1)(1997-3#1)
women experience more##2##3##(2008-7#2)
women experience##3##2##(2007-11#1)(2008-7#2)
women experienced##2##2##(1995-6#1)(2007-10#1)
women experiencing##2##2##(1991-2#1)(2010-3#1)
women for prenatal##2##3##(1996-12#1)(1996-2#1)
women for##4##2##(1990-2#1)(1996-12#1)(1996-2#1)(2008-4#1)
women from the##4##3##(1994-5#1)(2007-12#1)(2008-4#1)(2010-6#1)
women from##23##2##(1994-5#1)(1994-9#1)(1995-8#1)(1996-12#2)(2006-8#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
women had a##3##3##(1991-2#1)(1992-2#1)(2008-11#1)
women had better##2##3##(2008-3#1)(2011-2#1)
women had had##2##3##(1990-6#1)(1990-8#1)
women had##32##2##(1990-6#2)(1990-8#2)(1990-9#2)(1991-2#1)(1992-2#1)(1994-12#1)(1995-8#1)(1996-12#2)(1997-4#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-3#2)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#6)
women has##4##2##(1991-11#1)(1991-6#1)(1994-6#1)(2013-1#1)
women have been##2##3##(2008-11#1)(2011-2#1)
women have not##2##3##(1994-6#1)(2009-4#1)
women have##12##2##(1991-2#1)(1994-6#1)(2007-2#1)(2008-11#2)(2008-4#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
women having##2##2##(2007-7#1)(2008-3#1)
women identified as having##2##4##(2008-3#2)
women identified##3##2##(2008-3#2)(2013-1#1)
women in India##2##3##(1995-12#1)(1996-8#1)
women in Japan##3##3##(1994-6#1)(1997-8#1)(2011-2#1)
women in New##3##3##(1994-9#1)(2008-1#2)
women in a rural##2##4##(2010-4#1)(2010-6#1)
women in a##5##3##(1996-12#1)(1997-7#1)(2008-12#1)(2010-4#1)(2010-6#1)
women in academic##2##3##(1993-6#1)(2007-4#1)
women in most##2##3##(2009-10#1)(2012-3#1)
women in rural##2##3##(1996-12#1)(2011-2#1)
women in the##24##3##(1991-6#3)(1993-3#1)(1993-6#3)(1994-6#1)(1996-12#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
women in their##3##3##(1991-3#1)(2008-3#1)(2008-5#1)
women in this group had##2##5##(2008-11#1)(2012-3#1)
women in this##5##3##(1994-2#1)(2008-11#1)(2010-6#1)(2012-3#1)(2013-1#1)
women in whom##2##3##(1991-11#1)(2007-8#1)
women in##121##2##(1990-12#1)(1990-2#1)(1990-6#3)(1991-11#1)(1991-3#1)(1991-6#5)(1991-9#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#6)(1994-2#2)(1994-6#3)(1994-9#2)(1995-12#1)(1995-2#2)(1996-12#5)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#12)(2013-8#2)
women infected##2##2##(1996-12#1)(2012-3#1)
women is##12##2##(1992-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-10#1)(2010-3#3)(2010-8#1)(2012-2#1)(2013-1#2)
women less than##2##3##(1991-5#1)(2008-5#1)
women living in urban areas##2##5##(2008-10#1)(2012-12#1)
women living in##9##3##(1990-2#1)(1991-8#1)(1993-11#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
women living with##3##3##(1996-3#1)(2008-1#1)(2011-1#1)
women living##13##2##(1990-2#1)(1991-8#1)(1993-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)
women may be##4##3##(1996-11#1)(2007-2#1)(2008-12#2)
women may have##2##3##(2011-2#1)(2012-12#1)
women may##8##2##(1996-11#1)(2007-2#2)(2008-11#1)(2008-12#2)(2011-2#1)(2012-12#1)
women met##2##2##(1994-2#1)(2007-7#1)
women more##2##2##(1995-2#1)(2008-3#1)
women of child-bearing age##2##4##(1996-12#1)(2009-7#1)
women of childbearing##3##3##(1990-2#1)(2010-4#1)(2013-1#1)
women of fertile age##2##4##(1996-12#2)
women of lower socioeconomic status##2##5##(2011-2#2)
women of reproductive age##5##4##(1994-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
women of the##2##3##(1990-2#1)(1993-2#1)
women of##27##2##(1990-2#2)(1990-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1994-9#1)(1996-12#3)(1996-5#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-4#1)(2011-1#6)(2011-2#3)(2012-12#1)(2013-1#2)
women older than##2##3##(2008-7#1)(2013-1#1)
women on the##3##3##(1994-6#1)(2008-2#1)(2011-1#1)
women on##8##2##(1994-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-1#3)
women or##4##2##(1993-11#1)(2013-1#3)
women out of 100##2##4##(1992-2#1)(2008-11#1)
women ova##2##2##(1996-12#2)
women over 50 years of age##2##6##(1993-2#1)(1995-4#1)
women over 50##3##3##(1990-6#1)(1993-2#1)(1995-4#1)
women over##8##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-3#1)(1993-2#1)(1995-4#1)(2008-5#1)(2012-3#1)
women physicians##2##2##(1993-6#2)
women presenting for##2##3##(2008-6#1)(2012-3#1)
women presenting##3##2##(2008-3#1)(2008-6#1)(2012-3#1)
women received a##2##3##(1996-12#1)(2008-5#1)
women receiving##5##2##(1991-8#1)(2011-1#3)(2013-1#1)
women recruited from##2##3##(1995-1#1)(2011-1#1)
women referred##2##2##(1994-1#1)(2008-11#1)
women reported##7##2##(1990-12#1)(1990-6#1)(1990-8#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-5#1)
women residents##2##2##(1991-8#1)(1993-9#1)
women residing to##2##3##(2007-8#2)
women residing##4##2##(2007-8#4)
women scheduled for##2##3##(2010-3#1)(2010-8#1)
women seeking abortion##2##3##(1994-2#1)(2008-11#1)
women seeking##4##2##(1994-2#1)(2007-12#1)(2008-11#1)(2013-8#1)
women should be##2##3##(2010-6#1)(2013-1#1)
women should##4##2##(2007-2#1)(2010-6#1)(2013-1#2)
women significantly##2##2##(1996-12#1)(2012-3#1)
women since##2##2##(1994-9#1)(2008-4#1)
women still smoke##2##3##(1991-11#2)
women still##5##2##(1991-11#2)(1995-6#1)(2007-11#1)(2007-4#1)
women such as##2##3##(2008-1#1)(2010-3#1)
women suffer##2##2##(1990-6#1)(2011-2#1)
women suffered from##2##3##(1991-2#1)(2011-1#1)
women suffering from##5##3##(2008-11#1)(2008-4#1)(2013-1#3)
women taking##4##2##(2008-11#3)(2009-8#1)
women tend to##2##3##(1995-2#1)(2011-2#1)
women tended to##2##3##(2011-2#2)
women than for##2##3##(2008-12#1)(2011-2#1)
women than men##8##3##(1995-2#1)(2008-5#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
women than##17##2##(1995-2#1)(1995-5#1)(1997-6#1)(2008-12#1)(2008-3#2)(2008-5#2)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-8#2)
women that##3##2##(2007-10#1)(2012-12#1)(2013-8#1)
women the##5##2##(1994-2#1)(1994-9#1)(2007-12#1)(2008-5#1)(2011-2#1)
women to##21##2##(1990-2#1)(1991-12#1)(1992-4#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1997-7#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-12#2)(2010-10#1)(2010-12#1)(2010-2#1)(2013-1#2)
women treated with##2##3##(1993-2#1)(2008-5#1)
women treated##7##2##(1991-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-9#1)(2008-5#1)(2011-2#1)
women under##3##2##(1992-2#1)(1997-2#1)(2007-5#1)
women undergoing##8##2##(1993-12#1)(1994-9#1)(1995-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
women underwent##3##2##(1991-11#1)(1994-2#1)(2010-3#1)
women using##4##2##(1992-2#1)(1995-8#1)(2011-1#1)(2011-2#1)
women versus##3##2##(2008-12#1)(2013-1#2)
women volunteers##5##2##(1990-3#1)(1994-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
women was not##2##3##(2010-3#1)(2013-8#1)
women was##12##2##(1991-11#1)(1991-6#1)(1994-9#1)(1997-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-3#3)(2013-8#1)
women were divided into##2##4##(1995-3#1)(2010-3#1)
women were examined##2##3##(2008-1#1)(2011-2#1)
women were included##2##3##(2011-2#1)(2012-3#1)
women were more likely to##2##5##(2008-1#1)(2013-1#1)
women were more likely##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
women were more##5##3##(1990-12#1)(2007-10#1)(2008-1#1)(2008-12#1)(2013-1#1)
women were randomized to receive##2##5##(2011-2#2)
women were recruited from##2##4##(2013-1#2)
women were significantly##2##3##(1994-12#1)(2011-1#1)
women were treated with##2##4##(1996-2#1)(2008-5#1)
women were##58##2##(1990-12#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-6#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#2)
women who are medically underserved##2##5##(1997-1#2)
women who are not##2##4##(1995-9#1)(2008-5#1)
women who are obese##2##4##(2008-3#1)(2011-1#1)
women who are##12##3##(1990-9#1)(1992-3#1)(1995-6#1)(1995-9#1)(1997-1#2)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
women who completed the screening##2##5##(2013-1#2)
women who completed##3##3##(2011-2#1)(2013-1#2)
women who did not##2##4##(2007-12#1)(2007-2#1)
women who had had##3##4##(1993-10#1)(1993-2#1)(2011-2#1)
women who had##7##3##(1990-12#1)(1993-10#1)(1993-2#1)(1994-2#1)(2008-7#1)(2011-2#2)
women who have been##2##4##(2010-3#2)
women who have##5##3##(1994-9#1)(2008-2#1)(2010-3#2)(2010-8#1)
women who presented##2##3##(2008-3#1)(2010-6#1)
women who received##2##3##(2011-1#1)(2011-2#1)
women who required##2##3##(1993-1#1)(1995-8#1)
women who stalk##2##3##(2009-9#2)
women who subsequently##2##3##(1994-3#1)(1996-8#1)
women who took##2##3##(2008-3#2)
women who underwent##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
women who used the low-dose##2##5##(1994-5#2)
women who used##4##3##(1994-5#2)(2010-11#1)(2013-1#1)
women who were##5##3##(1990-6#1)(1994-2#1)(2009-3#1)(2011-2#1)(2013-1#1)
women who##80##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-1#3)(1997-4#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-3#1)(2013-1#8)
women whose##3##2##(2008-10#1)(2010-4#1)(2011-1#1)
women with 10 &lt##2##4##(2008-7#2)
women with Alzheimer's##2##3##(1995-11#2)
women with CTTH##2##3##(2010-9#2)
women with Down syndrome##4##4##(2013-1#4)
women with FGS##3##3##(1996-12#3)
women with GDM##2##3##(2009-3#2)
women with HIV##2##3##(1996-12#1)(2011-1#1)
women with HIV/AIDS##2##3##(2007-1#1)(2008-12#1)
women with MetS##2##3##(2011-1#2)
women with PCOS##4##3##(2008-3#1)(2008-4#2)(2010-11#1)
women with SUI##2##3##(2008-3#2)
women with a history of##2##5##(2012-3#1)(2013-1#1)
women with a##10##3##(1990-9#1)(2007-11#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
women with advanced ovarian cancer##2##5##(1992-2#2)
women with advanced##4##3##(1991-6#1)(1992-2#2)(1992-5#1)
women with age average##2##4##(2011-2#2)
women with an average age of##3##6##(1994-12#1)(2007-8#1)(2008-9#1)
women with an##4##3##(1994-12#1)(2007-8#1)(2008-9#1)(2012-2#1)
women with and without eating concerns##2##6##(2007-12#2)
women with and without##8##4##(1990-3#1)(1991-1#1)(1996-12#1)(2007-12#2)(2010-3#1)(2012-1#1)(2013-1#1)
women with apocrine##3##3##(1993-1#1)(2008-12#1)(2008-4#1)
women with average age##2##4##(2008-9#1)(2011-2#1)
women with breast cancer and their##2##6##(1994-3#1)(2013-1#1)
women with breast cancer and##4##5##(1990-12#1)(1994-3#1)(2008-7#1)(2013-1#1)
women with breast cancer##20##4##(1990-12#2)(1992-2#1)(1994-12#1)(1994-3#2)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#6)
women with breast##22##3##(1990-12#2)(1992-2#1)(1994-12#1)(1994-3#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)
women with cervical intraepithelial neoplasia##2##5##(2011-2#2)
women with cervical##3##3##(2007-10#1)(2011-2#2)
women with chronic##5##3##(1991-2#1)(1994-12#1)(2008-7#1)(2010-12#2)
women with cystic##2##3##(1994-3#1)(1995-9#1)
women with epilepsy##4##3##(2008-11#3)(2013-8#1)
women with fistulas##2##3##(1996-12#2)
women with gestational diabetes mellitus##4##5##(1992-12#3)(2011-2#1)
women with histologically##2##3##(1993-9#1)(1994-1#1)
women with low bone##2##4##(2011-1#1)(2012-2#1)
women with low obstetric risk##3##5##(2013-1#3)
women with low##5##3##(2011-1#1)(2012-2#1)(2013-1#3)
women with metabolic##2##3##(2011-1#1)(2013-1#1)
women with migraine with aura##2##5##(2008-9#1)(2011-2#1)
women with normal##8##3##(2007-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
women with or without##3##4##(1994-9#1)(2011-2#2)
women with osteoporosis##2##3##(2010-3#2)
women with polycystic ovarian syndrome##2##5##(2008-1#1)(2008-3#1)
women with polycystic ovarian syndrome]##2##5##(2008-11#1)(2013-1#1)
women with polycystic ovarian##4##4##(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
women with polycystic ovary syndrome##2##5##(2008-3#1)(2012-3#1)
women with polycystic##6##3##(2008-1#1)(2008-11#1)(2008-3#2)(2012-3#1)(2013-1#1)
women with recurrent##3##3##(1990-11#1)(2007-10#1)(2008-5#1)
women with risk factors for##2##5##(2012-2#1)(2013-8#1)
women with risk factors##3##4##(2012-2#2)(2013-8#1)
women with risk##4##3##(1996-6#1)(2012-2#2)(2013-8#1)
women with the##5##3##(1994-5#1)(1995-9#1)(2008-3#2)(2008-5#1)
women with this condition##2##4##(1994-9#1)(2008-10#1)
women with urinary schistosomiasis##2##4##(1996-12#2)
women with##252##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#4)(1991-6#1)(1991-8#1)(1992-12#3)(1992-2#5)(1992-3#2)(1992-5#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#3)(1995-9#3)(1996-11#2)(1996-12#13)(1996-6#1)(1996-8#1)(1997-4#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#12)(2008-12#4)(2008-3#9)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-11#2)(2009-3#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-6#1)(2010-9#2)(2011-1#13)(2011-2#22)(2011-8#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#10)(2013-1#24)(2013-8#7)
women without##3##2##(1991-3#1)(2011-1#1)(2013-1#1)
women worldwide##2##2##(2008-11#1)(2013-1#1)
women younger than 49 years##3##5##(1992-9#3)
women younger than##4##3##(1991-12#1)(1992-9#3)
women##1978##1##(1990-10#2)(1990-11#8)(1990-12#11)(1990-2#20)(1990-3#4)(1990-5#2)(1990-6#25)(1990-8#8)(1990-9#12)(1991-1#5)(1991-11#18)(1991-12#7)(1991-2#11)(1991-3#5)(1991-4#2)(1991-5#4)(1991-6#31)(1991-8#17)(1991-9#5)(1992-1#8)(1992-10#2)(1992-11#2)(1992-12#9)(1992-2#15)(1992-3#8)(1992-4#8)(1992-5#5)(1992-8#1)(1992-9#12)(1993-1#5)(1993-10#2)(1993-11#6)(1993-12#3)(1993-2#12)(1993-3#5)(1993-5#1)(1993-6#13)(1993-8#4)(1993-9#7)(1994-1#2)(1994-11#4)(1994-12#13)(1994-2#26)(1994-3#11)(1994-5#14)(1994-6#15)(1994-8#3)(1994-9#23)(1995-1#4)(1995-11#5)(1995-12#9)(1995-2#11)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#12)(1995-8#9)(1995-9#7)(1996-1#6)(1996-11#9)(1996-12#46)(1996-2#3)(1996-3#12)(1996-5#2)(1996-6#8)(1996-7#1)(1996-8#9)(1996-9#4)(1997-1#6)(1997-2#5)(1997-3#7)(1997-4#9)(1997-6#3)(1997-7#3)(1997-8#9)(2006-10#1)(2006-8#2)(2007-1#1)(2007-10#10)(2007-11#19)(2007-12#42)(2007-2#33)(2007-4#12)(2007-5#1)(2007-7#24)(2007-8#19)(2008-1#34)(2008-10#21)(2008-11#54)(2008-12#54)(2008-2#6)(2008-3#55)(2008-4#38)(2008-5#58)(2008-6#6)(2008-7#40)(2008-8#5)(2008-9#11)(2009-1#1)(2009-10#19)(2009-11#16)(2009-12#3)(2009-3#5)(2009-4#14)(2009-5#8)(2009-7#13)(2009-8#6)(2009-9#10)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#13)(2010-2#1)(2010-3#43)(2010-4#6)(2010-5#3)(2010-6#15)(2010-7#3)(2010-8#15)(2010-9#7)(2011-1#94)(2011-2#158)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#3)(2012-12#38)(2012-2#28)(2012-3#47)(2013-1#166)(2013-3#1)(2013-7#4)(2013-8#32)
women's ability to##2##3##(2008-12#1)(2009-12#1)
women's access to##2##3##(2008-11#1)(2011-2#1)
women's body##3##2##(2007-12#2)(2008-9#1)
women's experiences##3##2##(2008-12#1)(2012-1#1)(2013-8#1)
women's health and##4##3##(2008-11#2)(2008-9#1)(2009-10#1)
women's health care##2##3##(1996-3#1)(2008-10#1)
women's health in##2##3##(1991-6#1)(2010-6#1)
women's health##26##2##(1991-6#1)(1994-3#8)(1994-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#4)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-3#1)
women's journey of recovery from sexual assault##2##7##(2010-3#2)
women's journey of recovery##3##4##(2010-3#3)
women's lives##4##2##(1996-1#1)(1997-5#1)(2007-7#1)(2012-12#1)
women's mental##2##2##(2008-11#1)(2011-2#1)
women's movement##2##2##(1996-5#1)(1997-3#1)
women's personal##2##2##(1994-12#1)(1996-1#1)
women's political participation##2##3##(2011-2#2)
women's reports##2##2##(1995-8#1)(2009-5#1)
women's self-perception##2##2##(2008-5#2)
women's weight##2##2##(2008-9#1)(2009-5#1)
women's##128##1##(1990-8#1)(1991-4#1)(1991-6#5)(1994-12#2)(1994-3#12)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-6#3)(1995-8#1)(1996-1#4)(1996-11#2)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(2007-12#4)(2007-2#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#12)(2008-12#2)(2008-5#3)(2008-7#3)(2008-9#4)(2009-10#1)(2009-12#3)(2009-5#2)(2010-10#2)(2010-11#2)(2010-3#4)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#5)(2012-3#2)(2013-1#3)(2013-8#1)
women) and##3##2##(1996-7#1)(2008-7#1)(2010-9#1)
women) were##5##2##(1996-6#1)(2008-11#1)(2008-9#2)(2013-1#1)
women) who##2##2##(1990-10#1)(2008-1#1)
women) with##2##2##(2008-9#1)(2010-9#1)
women)##42##1##(1990-10#1)(1991-4#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-6#2)(1996-7#1)(2007-11#2)(2007-8#2)(2008-1#3)(2008-11#1)(2008-7#4)(2008-9#4)(2009-10#1)(2010-9#3)(2012-12#1)(2013-1#7)
women--and##2##1##(1990-6#1)(1993-11#1)
women?##2##1##(1996-9#1)(2013-1#1)
women]##17##1##(1991-11#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-4#1)(1993-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-3#2)
won the##3##2##(1994-2#1)(1994-3#1)(1996-12#1)
won##8##1##(1992-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-2#1)(2010-1#1)
won't be##2##2##(1994-3#1)(1995-12#1)
won't help##3##2##(1994-1#1)(1997-3#1)(2008-11#1)
won't##15##1##(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-1#1)(1994-3#2)(1995-12#1)(1996-1#1)(1997-3#1)(2008-11#1)(2008-2#1)(2010-9#1)
wondered##2##1##(2011-2#1)(2013-1#1)
wonderful##3##1##(1991-2#1)(2008-10#1)(2013-8#1)
wonders##3##1##(1991-6#1)(1996-5#1)(2008-4#1)
wood and##7##2##(1992-10#2)(2008-10#4)(2013-8#1)
wood ashes##2##2##(2008-10#2)
wood boards to which the scent of##2##7##(2008-5#2)
wood by##2##2##(2013-1#1)(2013-8#1)
wood decay##3##2##(2008-10#3)
wood fiber##2##2##(2008-3#2)
wood fibers were##2##3##(2009-11#2)
wood fibers##7##2##(2008-3#4)(2009-11#3)
wood foreign bodies##2##3##(2011-1#2)
wood frogs##3##2##(2008-8#3)
wood in##2##2##(2008-10#2)
wood is##3##2##(2010-4#1)(2012-9#1)(2013-1#1)
wood residue##3##2##(2009-3#3)
wood samples##3##2##(2008-10#3)
wood surfaces##2##2##(2010-4#2)
wood to##2##2##(2007-12#1)(2008-10#1)
wood were##2##2##(2008-10#2)
wood##105##1##(1990-6#1)(1992-10#2)(1995-3#1)(1997-6#1)(2007-12#1)(2007-6#2)(2008-10#28)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#3)(2009-3#3)(2009-8#2)(2010-4#13)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2012-9#1)(2013-1#7)(2013-8#6)
wood-fiber##2##1##(2008-3#2)
wood-rotting##3##1##(2008-10#2)(2013-1#1)
woodborer##3##1##(2007-12#1)(2013-8#2)
wooden object##2##2##(2013-1#2)
wooden##15##1##(2008-10#6)(2008-2#3)(2010-5#3)(2011-2#1)(2013-1#2)
woodland songbirds##2##2##(2008-9#2)
woodland##6##1##(2008-5#2)(2008-9#2)(2010-3#1)(2010-6#1)
woodlands##8##1##(2008-10#1)(2008-5#1)(2010-6#6)
woodpecker##3##1##(2008-9#2)(2013-1#1)
woodpeckers##2##1##(2008-9#1)(2013-1#1)
woodrats##4##1##(2010-6#4)
woodwasp##2##1##(2011-2#2)
woody hosts##4##2##(2008-10#4)
woody ornamental##2##2##(2008-10#2)
woody plants in##2##3##(2008-9#1)(2012-5#1)
woody plants##14##2##(2008-10#4)(2008-8#2)(2008-9#6)(2009-8#1)(2012-5#1)
woody species##6##2##(2008-10#2)(2008-8#1)(2011-10#1)(2012-5#1)(2013-7#1)
woody##35##1##(2008-10#17)(2008-8#3)(2008-9#6)(2009-8#1)(2010-8#2)(2011-10#1)(2012-5#2)(2012-6#1)(2012-7#1)(2013-7#1)
wool and##2##2##(2008-11#1)(2008-5#1)
wool fast blue BL (lambda(max)=540##2##5##(2008-10#2)
wool fast blue BL##3##4##(2008-10#3)
wool fibre##3##2##(2008-10#1)(2008-5#2)
wool##26##1##(1992-2#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#4)(2010-8#1)(2013-1#1)
word and##6##2##(1994-1#2)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
word as the nucleus##2##4##(2008-2#2)
word as##3##2##(2008-2#3)
word association##2##2##(2007-12#2)
word classes##2##2##(2008-2#1)(2008-4#1)
word identification##2##2##(2008-12#1)(2008-2#1)
word in##2##2##(2008-2#1)(2013-8#1)
word length##2##2##(2008-11#1)(2009-2#1)
word network##2##2##(2012-2#2)
word nuclei##2##2##(2008-2#2)
word of##3##2##(2008-11#1)(2008-4#1)(2011-1#1)
word on##4##2##(1993-12#1)(1994-2#1)(2011-2#2)
word pairs##2##2##(2008-9#2)
word problem##3##2##(2009-12#3)
word processing and##2##3##(2008-11#2)
word processing##8##2##(1992-12#1)(2008-11#6)(2008-12#1)
word reading efficiency in##2##4##(2012-2#2)
word reading skills##2##3##(2008-12#2)
word reading##5##2##(2008-12#3)(2012-2#2)
word recall##4##2##(2008-5#1)(2008-7#2)(2012-3#1)
word recognition##5##2##(2008-11#3)(2009-2#1)(2011-2#1)
word type##3##2##(2008-2#1)(2009-11#2)
word with all digits restricted to the set##2##8##(2008-3#2)
word with##3##2##(2008-3#2)(2008-4#1)
word##119##1##(1990-8#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-2#1)(1995-1#1)(1995-2#2)(1995-5#2)(1996-2#3)(1997-6#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-11#14)(2008-12#6)(2008-2#18)(2008-3#8)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#2)(2009-12#4)(2009-2#4)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-8#3)
word-learning##5##1##(2011-1#5)
wording##2##1##(1993-12#1)(2008-7#1)
words &quot##3##2##(1997-6#1)(2008-1#1)(2008-6#1)
words and##14##2##(1990-8#3)(1996-2#1)(2007-12#3)(2008-2#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)
words are##5##2##(1991-6#1)(2008-2#2)(2008-3#1)(2010-7#1)
words as##2##2##(2008-2#2)
words carry##2##2##(2007-12#1)(2008-2#1)
words for##3##2##(1995-3#1)(2008-2#1)(2011-1#1)
words from##2##2##(2012-3#2)
words in the##2##3##(2008-6#1)(2011-2#1)
words in##10##2##(2008-11#1)(2008-2#2)(2008-6#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#1)
words into##3##2##(2009-11#2)(2012-3#1)
words is##2##2##(2008-4#1)(2010-7#1)
words of##3##2##(1994-1#1)(2008-9#1)(2012-12#1)
words or##3##2##(2007-12#1)(2008-2#2)
words that##5##2##(2008-2#4)(2008-4#1)
words were found##2##3##(2009-11#1)(2011-1#1)
words were##4##2##(2008-2#1)(2009-11#1)(2011-1#1)(2013-1#1)
words##173##1##(1990-8#6)(1991-2#2)(1991-6#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-2#7)(1997-6#1)(2007-12#16)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#33)(2008-3#3)(2008-4#5)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#5)(2009-11#7)(2009-2#2)(2009-4#1)(2009-8#11)(2010-4#1)(2010-7#5)(2010-8#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#2)(2013-8#4)
wordt##2##1##(2012-12#2)
wore a##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
wore##10##1##(2008-5#1)(2008-9#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
work a##11##2##(2008-10#7)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
work absenteeism##2##2##(2011-2#1)(2013-1#1)
work accidents##2##2##(1991-3#1)(2009-10#1)
work addresses one##2##3##(1994-3#1)(2008-12#1)
work addresses##3##2##(1994-3#1)(2008-11#1)(2008-12#1)
work after##2##2##(2008-7#1)(2012-12#1)
work aimed to##2##3##(2008-6#1)(2008-8#1)
work aimed##3##2##(1997-4#1)(2008-6#1)(2008-8#1)
work aims to##4##3##(2007-7#1)(2008-10#1)(2012-2#2)
work aims##5##2##(2007-7#1)(2008-10#1)(2012-2#2)(2013-1#1)
work among##2##2##(1992-5#1)(2008-12#1)
work an##2##2##(2008-10#1)(2011-2#1)
work and at##2##3##(2009-10#1)(2011-2#1)
work and cost##2##3##(2007-12#1)(2008-7#1)
work and for##2##3##(1995-5#1)(2013-1#1)
work and health conditions##2##4##(2011-2#1)(2013-1#1)
work and health##3##3##(2011-2#2)(2013-1#1)
work and sleep##2##3##(1997-6#1)(2010-7#1)
work and the##5##3##(1995-5#1)(1997-3#1)(2008-10#1)(2010-5#1)(2012-12#1)
work and##62##2##(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-5#2)(1996-1#1)(1997-3#2)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
work are##7##2##(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
work area##4##2##(1991-12#1)(2010-7#3)
work as a team##2##4##(2008-11#1)(2008-12#1)
work as a##10##3##(1993-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2011-3#1)(2013-1#1)
work as##18##2##(1993-11#1)(1993-12#1)(1994-12#1)(1995-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2009-2#1)(2009-7#1)(2009-8#1)(2011-3#1)(2013-1#1)
work at all##2##3##(1995-6#1)(2008-4#1)
work at least##2##3##(2007-11#1)(2008-10#1)
work at##6##2##(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-4#1)
work because##2##2##(1995-6#1)(1997-5#1)
work being performed##2##3##(1997-2#1)(2010-5#1)
work being##4##2##(1997-2#1)(1997-3#1)(2008-4#1)(2010-5#1)
work best##2##2##(2011-1#1)(2013-1#1)
work better##2##2##(2008-9#1)(2011-2#1)
work both##2##2##(1996-5#1)(2013-1#1)
work but##2##2##(2008-10#1)(2008-12#1)
work by determining##2##3##(2008-10#1)(2009-9#1)
work by##11##2##(1993-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-3#1)
work carried out##5##3##(1994-2#1)(2008-10#3)(2011-2#1)
work closely##2##2##(2008-9#1)(2010-9#1)
work collaboratively with##3##3##(1995-3#1)(2008-12#1)(2011-1#1)
work collaboratively##4##2##(1995-3#1)(2008-12#1)(2011-1#1)(2013-1#1)
work conditions for Colombian people##2##5##(2013-1#2)
work conditions##10##2##(1991-6#1)(1995-11#1)(2010-7#1)(2013-1#7)
work continues to##2##3##(1997-4#1)(2012-3#1)
work could lead to##2##4##(2008-7#1)(2012-2#1)
work could##4##2##(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
work crisis##2##2##(2013-1#2)
work deals with the application of##2##6##(2008-10#2)
work deals with the##4##4##(2008-10#2)(2009-7#1)(2013-1#1)
work deals with##5##3##(2007-5#1)(2008-10#2)(2009-7#1)(2013-1#1)
work demonstrates that##6##3##(1995-2#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-10#1)
work demonstrates##10##2##(1995-2#1)(1997-7#1)(2008-10#2)(2008-7#3)(2009-12#1)(2009-8#1)(2010-10#1)
work demonstrating the##2##3##(2008-10#1)(2008-4#1)
work demonstrating##3##2##(2008-10#1)(2008-4#1)(2010-11#1)
work described here##3##3##(2008-10#1)(2013-1#2)
work described##5##2##(1997-3#1)(2007-12#1)(2008-10#1)(2013-1#2)
work describes a novel##2##4##(2008-10#1)(2008-11#1)
work describes a##5##3##(2008-10#4)(2008-11#1)
work describes the development##2##4##(2008-10#1)(2013-1#1)
work describes the##10##3##(2008-10#7)(2008-11#1)(2011-1#1)(2013-1#1)
work describes##21##2##(2007-12#1)(2008-10#13)(2008-11#2)(2009-7#1)(2009-8#1)(2011-1#2)(2013-1#1)
work differently##3##2##(1991-1#1)(1995-1#1)(2008-11#1)
work disability##3##2##(1991-11#1)(1995-5#1)(1996-9#1)
work done in##2##3##(2008-8#1)(2009-11#1)
work done on the##2##4##(1995-3#1)(2008-3#1)
work done##5##2##(1995-3#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)
work during##3##2##(2008-2#1)(2008-9#1)(2012-1#1)
work emphasizes##2##2##(1990-5#1)(2008-7#1)
work environment and health##2##4##(2012-12#2)
work environment and##5##3##(2009-10#1)(2012-12#3)(2012-3#1)
work environment##16##2##(1992-12#1)(1994-1#1)(1994-3#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2012-12#3)(2012-3#3)
work examining the##3##3##(1994-11#1)(2008-11#1)(2008-7#1)
work experience##4##2##(1992-2#2)(1994-2#1)(2010-10#1)
work experiences##2##2##(1995-2#1)(2010-3#1)
work focuses on##4##3##(1995-12#1)(2007-8#1)(2008-10#2)
work for the##5##3##(1992-5#1)(2008-10#3)(2011-2#1)
work for you##2##3##(1996-3#2)
work for##21##2##(1991-9#1)(1992-5#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-3#2)(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2009-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
work force planning in##2##4##(1994-1#1)(1994-2#1)
work force planning##3##3##(1994-1#1)(1994-2#2)
work force##23##2##(1991-9#1)(1992-12#2)(1993-3#1)(1994-1#2)(1994-2#4)(1995-2#1)(1996-3#1)(1997-2#6)(2007-12#1)(2008-1#2)(2008-11#2)
work from##6##2##(2009-10#1)(2009-6#1)(2009-8#1)(2011-3#1)(2013-1#2)
work gives##4##2##(1992-7#1)(2008-10#1)(2011-3#1)(2013-8#1)
work has been carried out##3##5##(2008-10#1)(2008-5#1)(2010-8#1)
work has been done##2##4##(1994-11#1)(1997-4#1)
work has been##8##3##(1994-11#1)(1997-4#1)(2008-10#4)(2008-5#1)(2010-8#1)
work has demonstrated that##2##4##(1993-6#1)(2008-10#1)
work has demonstrated##4##3##(1993-6#1)(1997-6#1)(2007-8#1)(2008-10#1)
work has examined##2##3##(2008-10#1)(2009-7#1)
work has revealed##4##3##(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
work has shown that##7##4##(1992-11#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
work has shown##9##3##(1992-11#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
work has##43##2##(1991-3#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#10)(2008-11#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
work have##3##2##(1994-3#1)(2008-11#1)(2009-3#1)
work here##2##2##(1993-2#1)(2008-11#1)
work hours##11##2##(1992-3#1)(1993-1#2)(1995-6#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#3)(2013-1#1)
work in a##2##3##(2008-10#1)(2011-2#1)
work in all##2##3##(1997-3#1)(2010-10#1)
work in partnership with##4##4##(1993-12#1)(2008-11#1)(2008-12#2)
work in partnership##6##3##(1993-12#1)(1996-2#1)(2008-11#2)(2008-12#2)
work in progress##4##3##(2008-7#1)(2011-1#2)(2012-12#1)
work in the area##2##4##(2008-11#1)(2008-12#1)
work in the field##2##4##(2008-10#1)(2013-8#1)
work in the##12##3##(1994-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#3)(2008-9#1)(2013-8#1)
work in this##3##3##(1994-1#1)(2008-11#1)(2008-6#1)
work in##84##2##(1990-3#2)(1991-12#2)(1991-2#1)(1991-6#4)(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#4)
work indicates that##2##3##(1995-2#1)(2008-10#1)
work investigates##3##2##(1997-4#1)(2008-12#1)(2008-5#1)
work involved##2##2##(1997-2#1)(2008-3#1)
work involves the##2##3##(2010-8#1)(2011-3#1)
work is a##6##3##(1996-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2010-12#1)
work is associated with##3##4##(1990-6#1)(2008-8#1)(2011-2#1)
work is based on the##2##5##(2008-10#1)(2008-4#1)
work is done##2##3##(2013-1#1)(2013-7#1)
work is necessary to##2##4##(2007-8#1)(2013-7#1)
work is needed to identify##4##5##(1994-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
work is needed to##8##4##(1994-9#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
work is needed##10##3##(1994-9#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
work is not##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
work is related to##2##4##(2012-2#1)(2012-3#1)
work is required to##3##4##(1996-5#1)(2006-6#1)(2008-10#1)
work is required##4##3##(1996-5#1)(2006-6#1)(2008-10#1)(2010-4#1)
work is still##2##3##(1997-1#1)(2008-11#1)
work is the study of##2##5##(2008-10#2)
work is the##7##3##(2008-10#6)(2008-4#1)
work is to study the##2##5##(1997-2#1)(2008-10#1)
work is to##27##3##(1995-2#1)(1995-6#1)(1997-2#1)(2007-11#3)(2008-1#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
work is##98##2##(1990-6#1)(1990-7#1)(1991-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#6)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#1)
work it is##2##3##(2008-10#1)(2008-4#1)
work it##3##2##(2008-10#2)(2008-4#1)
work itself##2##2##(1994-2#1)(1997-3#1)
work load##5##2##(1994-6#1)(1996-9#1)(2008-7#2)(2011-2#1)
work mainly##2##2##(2008-10#1)(2013-1#1)
work more closely with##2##4##(1991-12#1)(2008-12#1)
work more closely##3##3##(1991-12#1)(1996-1#1)(2008-12#1)
work now##2##2##(1992-9#1)(2011-1#1)
work of adhesion##3##3##(2008-7#3)
work of the##9##3##(1991-3#1)(1994-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2009-11#1)(2012-2#1)
work of this##2##3##(1992-12#1)(2008-10#1)
work of##63##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)
work on normal##2##3##(1994-2#2)
work on the use of##2##5##(2007-5#1)(2008-10#1)
work on the##14##3##(1992-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
work on this##2##3##(2008-11#1)(2008-2#1)
work on##54##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-2#2)(1995-3#3)(1996-2#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
work only##2##2##(2008-12#1)(2008-5#1)
work or##6##2##(1994-11#2)(1995-2#1)(2007-2#1)(2009-9#1)(2013-1#1)
work organization##2##2##(2013-1#2)
work output##2##2##(2012-2#1)(2013-1#1)
work performance##3##2##(1994-1#1)(1994-2#1)(2011-2#1)
work performed##2##2##(1990-3#1)(2008-10#1)
work pertaining to##2##3##(1994-11#1)(1997-2#1)
work place##7##2##(1993-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2009-12#1)(2010-3#1)
work presented##6##2##(1991-12#1)(1997-3#1)(2008-10#3)(2008-7#1)
work presents the##3##3##(2007-11#1)(2010-10#1)(2011-2#1)
work presents##14##2##(2007-11#1)(2008-10#8)(2008-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)
work process##3##2##(1991-6#1)(1996-2#1)(2008-9#1)
work processes##3##2##(1990-12#1)(1997-1#1)(2008-9#1)
work provides a##3##3##(2008-10#2)(2012-3#1)
work provides##10##2##(1990-7#1)(1993-9#1)(1995-5#1)(2008-10#4)(2011-3#1)(2012-3#1)(2013-8#1)
work redesign##2##2##(1995-12#1)(2008-1#1)
work related disorders##2##3##(1996-8#1)(2008-11#1)
work related injury and ill-health##2##5##(2008-11#2)
work related##7##2##(1996-8#1)(2008-11#3)(2008-12#1)(2011-1#2)
work relationships##2##2##(2013-1#2)
work remains to be done in##2##6##(2008-8#1)(2009-7#1)
work remains to##3##3##(2008-8#1)(2009-7#1)(2012-3#1)
work remains##4##2##(2008-7#1)(2008-8#1)(2009-7#1)(2012-3#1)
work reported here##5##3##(1991-5#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
work reported##6##2##(1991-5#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
work reports a##4##3##(2008-10#3)(2010-5#1)
work reports the development of a##2##6##(2008-10#1)(2008-5#1)
work reports the results##2##4##(2008-10#1)(2008-11#1)
work reports the##8##3##(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
work reports##13##2##(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
work represents##4##2##(1992-8#1)(2008-11#1)(2010-4#1)(2012-2#1)
work required to##2##3##(2008-5#1)(2008-9#1)
work required##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
work role##2##2##(1997-3#1)(2007-10#1)
work sampling##2##2##(1996-3#2)
work satisfaction##2##2##(2010-10#1)(2013-1#1)
work schedules##2##2##(2011-2#2)
work setting##3##2##(1993-1#1)(1994-2#1)(2007-1#1)
work shift##2##2##(2010-7#1)(2012-12#1)
work show##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
work showed that##2##3##(2008-10#2)
work showed##3##2##(2008-10#2)(2011-2#1)
work shows that the##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
work shows that##6##3##(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#2)
work shows the##4##3##(1996-5#1)(2008-10#3)
work shows##10##2##(1996-5#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-9#2)
work status##2##2##(1997-3#1)(2012-12#1)
work students##2##2##(1994-3#1)(2010-3#1)
work studies the##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2012-1#1)
work suggests that manipulating the##2##5##(2008-10#1)(2010-7#1)
work suggests that the##2##4##(2010-4#1)(2011-1#1)
work suggests that##6##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)
work suggests##8##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
work supports the hypothesis that##2##5##(2008-10#1)(2011-1#1)
work supports the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
work supports##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
work surface height of##2##4##(1995-1#2)
work surface height##3##3##(1995-1#3)
work tasks##2##2##(2011-1#1)(2012-3#1)
work teams##8##2##(1993-12#5)(1994-1#1)(1994-3#1)(2010-3#1)
work technologies?##2##2##(2013-1#2)
work that used##2##3##(2008-10#1)(2009-2#1)
work that##10##2##(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2009-2#1)(2012-2#1)
work the##14##2##(1990-3#1)(1993-8#1)(1995-5#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2013-1#1)
work this##2##2##(2012-2#1)(2013-1#1)
work to##21##2##(1991-12#1)(1991-9#1)(1992-10#1)(1996-2#1)(1996-5#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)
work together in a##3##4##(1993-12#1)(2008-7#1)(2013-1#1)
work together in##4##3##(1993-12#1)(1996-12#1)(2008-7#1)(2013-1#1)
work together to##10##3##(1991-3#1)(1993-1#1)(1995-1#1)(1995-2#3)(1996-2#1)(1996-3#1)(2012-2#1)(2013-8#1)
work together##20##2##(1991-12#2)(1991-3#1)(1993-1#2)(1993-12#1)(1994-3#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
work tolerance##3##2##(2008-1#1)(2011-2#2)
work toward##2##2##(1994-2#1)(2008-11#1)
work towards##3##2##(2008-11#1)(2012-12#2)
work under##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
work up of##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
work up##9##2##(1992-6#1)(2008-1#2)(2008-10#2)(2008-7#3)(2012-12#1)
work using##2##2##(2008-10#1)(2008-7#1)
work validates##2##2##(2008-10#1)(2008-7#1)
work values emerged -##2##4##(2010-10#2)
work values##8##2##(2010-10#8)
work was carried out##3##4##(1994-3#1)(2008-12#1)(2013-7#1)
work was to assess##3##4##(1993-12#1)(2009-7#1)(2010-4#1)
work was to develop a##2##5##(1997-2#1)(2011-1#1)
work was to develop and validate##2##6##(2008-10#1)(2012-2#1)
work was to develop##5##4##(1997-2#1)(2008-10#1)(2011-1#1)(2012-2#2)
work was to evaluate the##8##5##(1993-11#1)(1997-8#1)(2008-10#1)(2008-5#3)(2012-2#1)(2013-1#1)
work was to evaluate##11##4##(1993-11#1)(1997-8#1)(2008-10#2)(2008-5#4)(2012-2#1)(2013-1#1)(2013-8#1)
work was to find out##2##5##(1994-9#1)(2008-5#1)
work was to find##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
work was to investigate whether##2##5##(1992-12#1)(2008-5#1)
work was to investigate##4##4##(1990-12#1)(1992-12#1)(2007-12#1)(2008-5#1)
work was to study the##7##5##(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
work was to study##10##4##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#2)
work was to##60##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#2)(1994-9#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#13)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-7#3)(2013-8#1)
work was##97##2##(1990-12#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#4)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#1)
work we demonstrate that##2##4##(1991-12#1)(1994-12#1)
work we demonstrate##3##3##(1991-12#1)(1994-12#1)(2011-2#1)
work we extended the study to##2##6##(2009-5#1)(2012-3#1)
work we study the##3##4##(2008-10#2)(2009-8#1)
work we##38##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-8#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-10#10)(2008-11#5)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
work well for##2##3##(2008-10#1)(2008-3#1)
work well##11##2##(1991-3#1)(1994-2#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)(2011-2#1)
work were##5##2##(1995-2#1)(2008-10#3)(2011-1#1)
work which##3##2##(1991-1#1)(1997-8#1)(2012-3#1)
work will##8##2##(1991-1#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
work with a##4##3##(1996-12#1)(2008-12#1)(2008-4#2)
work with both##3##3##(1990-6#1)(2008-11#1)(2008-7#1)
work with children and##2##4##(1995-6#2)
work with the##5##3##(1995-6#1)(1997-2#1)(2008-8#1)(2009-10#1)(2011-1#1)
work with##54##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#3)(1995-5#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#2)(2011-1#1)(2012-12#1)(2013-8#1)
work within the##3##3##(2007-10#1)(2007-2#1)(2008-10#1)
work within##8##2##(1992-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-10#1)(2012-1#1)
work world and##2##3##(2013-1#2)
work world is##2##3##(2013-1#2)
work world##6##2##(1995-12#1)(2013-1#5)
work would##2##2##(1994-3#1)(2008-8#1)
work##1924##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#4)(1990-5#3)(1990-6#4)(1990-7#2)(1990-9#1)(1991-1#5)(1991-11#2)(1991-12#18)(1991-2#5)(1991-3#7)(1991-5#4)(1991-6#10)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#15)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#9)(1993-11#4)(1993-12#21)(1993-2#7)(1993-3#9)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#13)(1994-11#8)(1994-12#6)(1994-2#18)(1994-3#16)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#15)(1995-11#4)(1995-12#12)(1995-2#20)(1995-3#7)(1995-5#13)(1995-6#13)(1995-8#4)(1995-9#1)(1996-1#17)(1996-12#6)(1996-2#12)(1996-3#12)(1996-4#2)(1996-5#4)(1996-8#1)(1996-9#3)(1997-1#6)(1997-2#22)(1997-3#15)(1997-4#6)(1997-5#2)(1997-6#7)(1997-7#5)(1997-8#6)(2006-10#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#11)(2007-11#18)(2007-12#16)(2007-2#4)(2007-4#1)(2007-5#6)(2007-7#1)(2007-8#12)(2008-1#32)(2008-10#365)(2008-11#82)(2008-12#51)(2008-2#15)(2008-3#14)(2008-4#19)(2008-5#57)(2008-6#22)(2008-7#64)(2008-8#23)(2008-9#30)(2009-10#17)(2009-11#6)(2009-12#7)(2009-2#4)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#7)(2009-7#15)(2009-8#14)(2009-9#9)(2010-1#2)(2010-10#28)(2010-11#8)(2010-12#9)(2010-2#5)(2010-3#11)(2010-4#16)(2010-5#16)(2010-6#4)(2010-7#19)(2010-8#17)(2010-9#7)(2011-1#34)(2011-10#1)(2011-2#81)(2011-3#9)(2012-1#16)(2012-12#37)(2012-2#41)(2012-3#23)(2013-1#96)(2013-7#15)(2013-8#25)
work&quot##2##1##(2008-10#1)(2009-7#1)
work'##2##1##(2007-10#2)
work)##2##1##(1996-3#1)(2008-11#1)
work-based learning approach##2##3##(2008-11#2)
work-based learning##10##2##(2008-11#10)
work-based##12##1##(1992-1#1)(2008-11#11)
work-family variables##2##2##(2010-6#2)
work-family##7##1##(2009-10#5)(2010-6#2)
work-related injury##4##2##(1994-3#1)(2008-7#3)
work-related##18##1##(1994-3#1)(1995-2#1)(1996-1#1)(2008-12#1)(2008-4#1)(2008-7#5)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
work-up and##2##2##(2011-2#1)(2013-8#1)
work-up for##3##2##(2008-4#1)(2010-10#1)(2013-8#1)
work-up in##3##2##(2008-7#1)(2013-8#2)
work-up of patients with##2##4##(2008-6#1)(2012-2#1)
work-up of##8##2##(2006-10#1)(2008-10#2)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#1)
work-up procedures##2##2##(2008-10#2)
work-up showed##2##2##(1993-2#1)(1997-3#1)
work-up were##2##2##(2008-10#1)(2013-8#1)
work-up##47##1##(1991-11#2)(1992-5#1)(1993-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(2006-10#1)(2008-10#14)(2008-4#1)(2008-6#1)(2008-7#5)(2010-10#4)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#7)
work?##8##1##(1993-1#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-11#1)(2013-1#1)
work]##7##1##(1990-12#1)(1990-6#2)(1992-5#1)(1994-2#1)(1995-5#1)(2007-8#1)
workable##6##1##(1994-12#2)(1994-2#1)(2008-10#1)(2012-2#2)
workbench##2##1##(2008-9#1)(2009-7#1)
workbook##2##1##(2008-12#2)
workday##7##1##(1997-3#1)(2008-10#1)(2010-6#1)(2012-12#4)
worked as a##3##3##(1995-11#1)(2008-10#1)(2010-3#1)
worked as##5##2##(1995-11#1)(1997-5#1)(2008-10#2)(2010-3#1)
worked for the##2##3##(2008-1#1)(2012-3#1)
worked for##5##2##(1991-2#1)(1992-3#1)(1993-3#1)(2008-1#1)(2012-3#1)
worked full-time##2##2##(1993-3#1)(2008-1#1)
worked in an##2##3##(1991-6#1)(2008-1#1)
worked in the##5##3##(1991-12#1)(1992-6#2)(1994-1#1)(2008-12#1)
worked in##20##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#2)(1993-1#3)(1993-3#1)(1994-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-12#2)(2008-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
worked on##4##2##(1990-9#1)(1997-2#1)(2010-1#1)(2012-3#1)
worked out the##2##3##(2010-1#1)(2012-2#1)
worked out##15##2##(1990-2#1)(1991-11#1)(1992-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2012-2#1)
worked to##2##2##(1996-3#1)(2008-10#1)
worked very well##2##3##(2008-7#1)(2013-1#1)
worked well for##2##3##(2008-10#1)(2008-2#1)
worked well##5##2##(1993-12#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-5#1)
worked with##8##2##(1992-11#1)(1995-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
worked##100##1##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#4)(1993-12#1)(1993-3#4)(1994-1#2)(1994-12#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(2008-1#4)(2008-10#19)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
worker brood cells infested##2##4##(2008-6#2)
worker from##2##2##(1997-7#1)(2008-11#1)
worker in##2##2##(1995-11#1)(1997-5#1)
worker policing##4##2##(2008-8#4)
worker production##2##2##(2008-8#2)
worker productivity##2##2##(1993-2#1)(2008-11#1)
worker safety##2##2##(2008-10#1)(2008-11#1)
worker who##3##2##(1995-12#2)(2012-3#1)
worker with##2##2##(1992-5#1)(1996-5#1)
worker##68##1##(1991-12#2)(1991-6#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#2)(2007-12#1)(2007-3#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#6)(2008-7#1)(2008-8#8)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
worker's##3##1##(1991-2#1)(1991-6#1)(2008-8#1)
workers and other##2##3##(2011-2#1)(2013-1#1)
workers and the public##3##4##(2008-12#2)(2009-12#1)
workers and the##8##3##(1992-3#1)(1996-11#2)(2008-12#2)(2008-7#1)(2009-12#1)(2013-1#1)
workers and their families##2##4##(2013-1#2)
workers and##34##2##(1992-2#1)(1992-3#2)(1994-3#1)(1996-11#2)(1996-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#5)(2013-1#5)(2013-8#1)
workers are##9##2##(1995-2#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2012-1#1)
workers as a##3##3##(1991-12#1)(2008-8#1)(2009-12#1)
workers as##5##2##(1991-12#1)(1995-5#1)(2008-8#1)(2009-12#1)(2009-9#1)
workers at the##2##3##(2007-12#1)(2008-2#1)
workers at##5##2##(1997-2#1)(2007-12#1)(2008-2#1)(2010-8#1)(2012-12#1)
workers employed in##2##3##(2009-12#1)(2013-1#1)
workers employed##3##2##(1994-5#1)(2009-12#1)(2013-1#1)
workers exposed to##9##3##(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
workers for##2##2##(1992-2#1)(2008-6#1)
workers from a##3##3##(1991-12#1)(2012-1#1)(2012-3#1)
workers from##7##2##(1991-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
workers had significantly elevated mortality for##3##6##(2008-12#3)
workers had##7##2##(1995-2#1)(2008-12#4)(2011-2#2)
workers have been##2##3##(2008-9#1)(2009-9#1)
workers have##7##2##(1991-1#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#1)
workers in the United States##2##5##(1991-12#2)
workers in the##14##3##(1991-12#3)(1995-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#3)
workers in##46##2##(1990-11#1)(1990-9#1)(1991-12#4)(1992-2#1)(1993-2#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#5)(2012-12#8)(2012-3#1)(2013-1#5)(2013-8#1)
workers is a##3##3##(1995-11#1)(1995-2#1)(2011-2#1)
workers is##5##2##(1992-4#1)(1995-11#1)(1995-2#1)(2008-8#1)(2011-2#1)
workers may##4##2##(2008-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
workers of a##2##3##(2009-12#1)(2011-2#1)
workers of the##7##3##(1991-3#1)(2007-12#2)(2008-10#1)(2011-1#1)(2013-1#2)
workers of##13##2##(1991-12#1)(1991-3#1)(1996-3#1)(2007-12#3)(2008-10#1)(2008-2#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
workers on##2##2##(2008-8#1)(2010-4#1)
workers performing##2##2##(1991-12#1)(2008-12#1)
workers remain##3##2##(2008-11#1)(2010-8#1)(2013-1#1)
workers should##2##2##(1993-1#1)(2008-8#1)
workers that##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
workers to##5##2##(2007-12#1)(2008-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
workers was##2##2##(2007-12#1)(2008-12#1)
workers were##9##2##(1991-12#1)(1992-3#2)(1994-5#1)(2007-12#1)(2008-6#2)(2011-1#1)(2012-12#1)
workers who had ever smoked##2##5##(2008-12#2)
workers who have##2##3##(1995-12#1)(2013-1#1)
workers who##19##2##(1992-1#1)(1993-1#2)(1994-1#1)(1994-12#1)(1995-12#2)(2008-11#1)(2008-12#2)(2009-6#2)(2010-11#1)(2012-12#3)(2013-1#3)
workers with##5##2##(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
workers without##2##2##(1994-12#1)(2008-7#1)
workers working in##2##3##(2007-8#1)(2009-12#1)
workers##426##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#1)(1991-12#25)(1991-3#4)(1991-6#2)(1991-9#2)(1992-1#1)(1992-2#3)(1992-3#9)(1992-4#1)(1992-5#1)(1993-1#5)(1993-10#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#5)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-6#1)(2006-10#1)(2007-12#14)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#10)(2008-11#14)(2008-12#27)(2008-2#8)(2008-5#2)(2008-6#12)(2008-7#7)(2008-8#27)(2008-9#5)(2009-10#3)(2009-12#14)(2009-5#1)(2009-6#2)(2009-7#5)(2009-9#6)(2010-1#1)(2010-11#4)(2010-12#3)(2010-3#3)(2010-4#4)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#10)(2011-2#38)(2012-1#8)(2012-12#22)(2012-2#2)(2012-3#4)(2013-1#29)(2013-8#2)
workers' compensation cases##2##3##(1995-1#1)(1997-4#1)
workers' compensation##12##2##(1992-2#1)(1993-1#1)(1994-12#2)(1995-1#2)(1996-2#2)(1997-1#1)(1997-4#1)(2011-2#1)(2012-12#1)
workers' health##6##2##(2008-10#1)(2011-2#3)(2013-1#2)
workers' perceptions of##2##3##(2009-9#1)(2013-8#1)
workers'##40##1##(1992-2#1)(1993-1#1)(1994-12#2)(1995-1#2)(1995-2#3)(1996-2#2)(1997-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#6)(2012-12#4)(2013-1#5)(2013-8#2)
workers)##3##1##(2008-10#1)(2008-8#1)(2010-4#1)
workers]##9##1##(1990-12#1)(2008-10#1)(2008-11#1)(2010-12#4)(2012-2#1)(2013-1#1)
workflow for##3##2##(2008-9#1)(2009-12#1)(2010-3#1)
workflow##9##1##(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)
workforce data##2##2##(1992-1#1)(2012-3#1)
workforce for##2##2##(1996-2#1)(2011-1#1)
workforce in##4##2##(2008-1#1)(2008-11#1)(2012-3#1)(2013-1#1)
workforce is##3##2##(2011-1#2)(2011-2#1)
workforce of##3##2##(2008-1#1)(2008-11#1)(2010-11#1)
workforce planning##2##2##(1992-1#1)(2010-10#1)
workforce policy##2##2##(2011-1#1)(2012-2#1)
workforce strategy##2##2##(2012-3#2)
workforce##63##1##(1992-1#2)(1996-1#1)(1996-2#1)(1997-3#2)(2008-1#5)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#8)(2011-2#2)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#2)(2013-7#1)
workhorse flaps##3##2##(2012-2#3)
workhorse##5##1##(2011-2#1)(2012-2#3)(2013-8#1)
workhorses for##2##2##(2008-3#1)(2011-2#1)
workhorses##3##1##(1996-3#1)(2008-3#1)(2011-2#1)
working and learning##2##3##(2008-11#2)
working and will##2##3##(2008-11#1)(2012-12#1)
working and##13##2##(1992-2#1)(1996-9#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-7#1)(2009-2#1)(2012-12#1)
working as a##2##3##(1992-6#1)(2011-2#1)
working as##5##2##(1992-6#2)(2008-10#1)(2011-2#2)
working at the##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
working at##9##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-10#1)(2011-1#1)(2012-12#1)
working calibration range##2##3##(2008-10#2)
working calibration##5##2##(2008-10#5)
working capacity##5##2##(1990-8#1)(2008-10#1)(2012-2#3)
working characteristics##2##2##(2008-10#1)(2010-12#1)
working concentration range##6##3##(2008-10#6)
working concentration##8##2##(2008-10#8)
working conditions and##6##3##(1992-5#2)(2007-12#1)(2008-2#1)(2011-2#1)(2012-12#1)
working conditions are##2##3##(2008-10#1)(2008-2#1)
working conditions for##2##3##(1997-7#1)(2008-10#1)
working conditions of##2##3##(2008-6#1)(2009-12#1)
working conditions were##3##3##(2008-10#3)
working conditions##34##2##(1992-5#2)(1992-6#1)(1993-2#1)(1996-1#1)(1997-7#1)(2007-12#1)(2008-10#19)(2008-2#2)(2008-3#1)(2008-6#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
working curve##4##2##(2008-10#4)
working day##4##2##(2008-10#1)(2011-1#2)(2013-1#1)
working days##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
working distance of##2##3##(2007-11#1)(2011-2#1)
working distance##10##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2011-1#1)(2011-2#1)(2012-2#1)
working distances##2##2##(2008-3#2)
working electrode and the##3##4##(2008-10#3)
working electrode and##4##3##(2008-10#4)
working electrode by##2##3##(2008-10#2)
working electrode for##2##3##(2008-10#2)
working electrode in the##3##4##(2008-10#3)
working electrode in##6##3##(2008-10#6)
working electrode of##2##3##(2008-10#1)(2010-2#1)
working electrode surface##5##3##(2008-10#5)
working electrode was##6##3##(2008-10#6)
working electrode were##2##3##(2008-10#2)
working electrode##60##2##(1991-7#1)(2008-10#58)(2010-2#1)
working electrodes and##2##3##(2008-10#2)
working electrodes##6##2##(2008-10#6)
working environment for##2##3##(1994-1#1)(2010-10#1)
working environment of##2##3##(1995-8#1)(2007-10#1)
working environment##9##2##(1991-12#1)(1994-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-6#1)(2010-10#1)
working for##2##2##(1992-12#1)(1996-8#1)
working frequency##2##2##(2008-10#1)(2008-11#1)
working group on##2##3##(1993-2#1)(2008-12#1)
working group##8##2##(1993-2#1)(1995-12#1)(2008-12#2)(2008-3#1)(2008-5#2)(2013-1#1)
working groups##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#2)
working hours##3##2##(1990-11#1)(1995-6#1)(1995-8#1)
working hypothesis##7##2##(1994-5#2)(1995-6#1)(2008-12#2)(2008-3#1)(2013-8#1)
working in a##7##3##(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2010-7#1)(2013-8#1)
working in an##6##3##(2009-5#1)(2010-10#2)(2010-12#1)(2012-3#1)(2013-1#1)
working in clinical##2##3##(2008-11#1)(2012-2#1)
working in concert with##2##4##(2012-2#2)
working in the emergency##2##4##(1992-6#1)(2011-1#1)
working in the market##2##4##(2012-12#2)
working in the same##2##4##(2008-10#1)(2010-9#1)
working in the##37##3##(1991-12#1)(1991-2#1)(1992-6#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#1)(2009-11#1)(2009-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#1)(2013-8#2)
working in##96##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-1#2)(1993-12#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-4#1)(1997-4#1)(1997-5#2)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-10#3)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#6)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#4)
working knowledge##2##2##(2008-11#1)(2011-2#1)
working life##6##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-9#2)
working lives##2##2##(2008-9#1)(2013-1#1)
working medium##3##2##(2008-10#3)
working memory (WM)##2##3##(1994-8#2)
working memory and##2##3##(1993-12#1)(2007-8#1)
working memory capacity##4##3##(2012-2#1)(2012-3#3)
working memory in##2##3##(1993-12#1)(2009-9#1)
working memory processes##3##3##(1992-8#1)(2007-8#1)(2008-11#1)
working memory task##6##3##(1993-12#1)(1994-8#4)(2012-3#1)
working memory tasks##4##3##(1993-3#1)(2012-3#3)
working memory##50##2##(1992-10#2)(1992-11#1)(1992-8#1)(1993-12#5)(1993-3#2)(1994-3#1)(1994-8#8)(2007-8#3)(2008-11#4)(2008-5#1)(2008-8#2)(2009-9#2)(2012-12#2)(2012-2#1)(2012-3#13)(2013-7#1)(2013-8#1)
working memory)##2##2##(2012-12#1)(2013-1#1)
working of the##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
working of##7##2##(2008-10#5)(2008-3#1)(2012-2#1)
working on a##2##3##(1997-3#1)(2008-12#1)
working on##8##2##(1990-12#1)(1997-3#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-8#1)
working out##2##2##(1990-3#1)(2008-6#1)
working outside##2##2##(1991-12#1)(1993-1#1)
working pH range of##2##4##(2008-10#2)
working pH range##6##3##(2008-10#6)
working pH##10##2##(2008-10#9)(2008-11#1)
working parameters of##2##3##(2008-3#1)(2013-8#1)
working parameters##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
working party##2##2##(1991-9#1)(2008-11#1)
working point##2##2##(2008-2#1)(2009-2#1)
working potential##3##2##(2008-10#3)
working practice in##2##3##(2010-12#1)(2011-2#1)
working practice##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
working principle of the##2##4##(2008-10#1)(2008-3#1)
working principle##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
working properly##2##2##(2008-3#1)(2008-8#1)
working range 0##2##3##(2008-10#2)
working range for##2##3##(2008-10#2)
working range is##2##3##(2008-10#2)
working range of at least##2##5##(2008-3#2)
working range of the##5##4##(2008-10#3)(2008-3#2)
working range of##13##3##(2008-10#9)(2008-3#4)
working range##37##2##(2008-10#33)(2008-3#4)
working ranges##3##2##(2008-10#3)
working relationship##6##2##(1993-1#2)(1994-1#1)(1995-12#1)(2008-12#1)(2010-9#1)
working relationships of public health nurses and high-priority families in##2##10##(2010-9#2)
working relationships##6##2##(1991-3#1)(1994-12#1)(1996-12#1)(2010-9#2)(2012-12#1)
working solution##2##2##(2008-10#2)
working temperature##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
working time##4##2##(1992-5#1)(1995-2#1)(2008-10#2)
working to address##2##3##(1993-2#1)(1995-12#1)
working to develop##2##3##(1996-2#1)(2009-6#1)
working to improve care##2##4##(1996-1#1)(2013-8#1)
working to improve##3##3##(1996-1#1)(2013-8#2)
working to##11##2##(1993-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-11#1)(2009-6#1)(2010-1#1)(2010-9#1)(2013-8#2)
working together with the##2##4##(1995-2#1)(2008-7#1)
working together##7##2##(1995-1#2)(1995-2#1)(2007-5#1)(2008-6#2)(2008-7#1)
working towards##3##2##(2008-5#1)(2010-3#1)(2010-4#1)
working under##2##2##(2008-10#1)(2008-3#1)
working volume##2##2##(2008-11#1)(2013-1#1)
working waveband##2##2##(2013-8#2)
working wavelength##3##2##(2008-10#2)(2008-2#1)
working with health care##2##4##(1994-1#1)(1994-2#1)
working with homeless##2##3##(2012-12#2)
working with patients##3##3##(2008-12#1)(2010-3#1)(2012-12#1)
working with the##6##3##(1994-9#1)(1995-2#1)(2008-10#2)(2008-7#1)(2010-8#1)
working with this##2##3##(2008-10#1)(2008-3#1)
working with##63##2##(1991-12#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#2)(1996-8#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#6)(2010-1#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)
working within a##2##3##(1992-12#1)(1997-7#1)
working women##2##2##(2010-5#1)(2013-1#1)
working##687##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#6)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#6)(1993-12#8)(1993-2#5)(1993-3#3)(1993-8#1)(1994-1#6)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#8)(1994-9#1)(1995-1#3)(1995-12#8)(1995-2#5)(1995-3#3)(1995-6#6)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#5)(1997-7#2)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#219)(2008-11#39)(2008-12#14)(2008-2#10)(2008-3#36)(2008-4#11)(2008-5#7)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#6)(2010-10#5)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#7)(2011-1#12)(2011-2#15)(2012-12#20)(2012-2#15)(2012-3#19)(2013-1#14)(2013-7#3)(2013-8#13)
working-age##3##1##(1997-6#1)(2012-2#1)(2013-1#1)
workings##2##1##(2008-7#1)(2008-9#1)
workload and##6##2##(1991-12#1)(1994-3#2)(1996-1#1)(2008-12#1)(2010-8#1)
workload in##4##2##(1997-8#3)(2012-2#1)
workload measurement system##2##3##(1994-12#1)(1996-1#1)
workload measurement##3##2##(1994-12#1)(1996-1#2)
workload of##2##2##(2008-1#1)(2008-6#1)
workload##53##1##(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1994-12#3)(1994-3#5)(1995-2#1)(1996-1#6)(1997-8#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-10#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#6)(2012-3#1)
workloads##4##1##(1993-2#1)(2008-11#1)(2008-3#1)(2011-1#1)
workpiece##3##1##(2008-3#3)
workplace accidents##2##2##(2010-4#1)(2011-2#1)
workplace by##2##2##(2008-10#1)(2008-7#1)
workplace conversations##3##2##(2011-1#3)
workplace of##2##2##(2008-10#1)(2013-8#1)
workplace provision##2##2##(2011-2#1)(2012-2#1)
workplace relationships##2##2##(2011-1#2)
workplace substance use##2##3##(2012-12#2)
workplace substance##3##2##(1992-1#1)(2012-12#2)
workplace violence##7##2##(1996-12#1)(1996-2#1)(1997-2#1)(2008-7#3)(2010-10#1)
workplace##106##1##(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#3)(1997-4#2)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#10)(2008-12#7)(2008-6#4)(2008-7#4)(2008-9#6)(2009-4#1)(2010-10#2)(2010-4#4)(2010-5#1)(2010-6#2)(2011-1#10)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#4)(2013-8#1)
workplaces##9##1##(1992-5#1)(1995-6#1)(1997-6#1)(2008-9#1)(2010-5#2)(2011-1#1)(2012-2#2)
works and the##2##3##(1990-12#1)(2008-10#1)
works and##7##2##(1990-12#1)(1992-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
works as##2##2##(2008-10#1)(2008-3#1)
works at##2##2##(2008-10#1)(2008-2#1)
works by##4##2##(2008-1#1)(2008-3#1)(2010-8#1)(2011-2#1)
works dealing with##2##3##(2008-10#1)(2011-2#1)
works for the##2##3##(1990-5#1)(2008-2#1)
works have##6##2##(1997-7#1)(2007-12#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-3#1)
works in a##5##3##(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#1)
works in##11##2##(1994-1#1)(1994-5#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
works of art by##2##4##(2008-10#2)
works of art##10##3##(2008-10#9)(2008-2#1)
works of##15##2##(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#2)(2009-10#1)(2009-7#1)
works on##4##2##(1993-12#1)(2008-10#1)(2008-4#1)(2010-4#1)
works satisfactorily in the##3##4##(2008-10#3)
works that##2##2##(1994-1#1)(2008-4#1)
works to##3##2##(2008-11#1)(2008-6#1)(2010-8#1)
works together with##2##3##(2008-3#1)(2012-2#1)
works under##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
works well for##3##3##(2008-2#3)
works well in##5##3##(2008-10#4)(2008-3#1)
works well over a wide concentration range##2##7##(2008-10#2)
works well over a##4##4##(2008-10#4)
works well when##2##3##(2008-10#1)(2008-3#1)
works well##18##2##(1997-4#1)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#2)
works with##5##2##(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
works without##2##2##(2008-3#2)
works##151##1##(1990-12#1)(1990-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-12#2)(1994-1#3)(1994-5#1)(1995-6#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#5)(2008-12#3)(2008-2#13)(2008-3#12)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#1)(2013-7#3)
workshop at##2##2##(2008-3#1)(2008-7#1)
workshop in##2##2##(2008-8#1)(2010-5#1)
workshop included##3##2##(1996-2#1)(2008-10#1)(2013-8#1)
workshop is##2##2##(2008-11#1)(2008-3#1)
workshop on##14##2##(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-7#2)(2012-2#1)
workshop participants##3##2##(1991-8#1)(2008-10#2)
workshop to##2##2##(1995-3#1)(2012-12#1)
workshop was organized##2##3##(2008-10#1)(2011-2#1)
workshop was to##2##3##(2008-10#1)(2008-4#1)
workshop was##12##2##(1996-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-8#2)
workshop were##2##2##(2008-7#1)(2013-1#1)
workshop##88##1##(1990-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-5#3)(1993-1#2)(1994-2#1)(1994-3#1)(1995-3#3)(1996-2#4)(1996-4#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#3)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#7)(2008-8#1)(2010-5#3)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#5)
workshops and the##2##3##(2008-12#1)(2008-7#1)
workshops and##5##2##(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
workshops in##3##2##(1996-4#1)(2008-11#1)(2009-7#1)
workshops on##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
workshops to##2##2##(2010-10#1)(2010-5#1)
workshops##37##1##(1991-12#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#10)(2008-5#4)(2008-7#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
worksite tenure##4##2##(2010-6#4)
worksite##6##1##(1997-1#1)(2010-6#5)
workspace##2##1##(2012-1#2)
workstation##12##1##(1991-12#1)(1996-2#1)(1997-4#1)(2006-12#2)(2008-10#3)(2008-3#1)(2009-6#1)(2009-8#1)(2011-2#1)
workstations##13##1##(1991-12#1)(1993-12#1)(1993-2#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)
workup of patients##2##3##(1993-3#1)(2008-3#1)
workup of##4##2##(1992-1#1)(1993-3#1)(2008-3#1)(2012-2#1)
workup##18##1##(1990-3#1)(1991-6#1)(1992-1#1)(1993-3#1)(1994-9#1)(1996-3#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
world and its##2##3##(1995-5#1)(2013-1#1)
world and the##2##3##(2010-10#1)(2013-1#1)
world and##24##2##(1991-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#3)(2010-10#1)(2010-5#1)(2012-2#2)(2013-1#4)(2013-8#1)
world are##8##2##(1995-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-1#2)
world as##3##2##(2007-8#1)(2010-10#1)(2011-2#1)
world average##2##2##(2010-12#1)(2013-1#1)
world by##3##2##(1994-9#2)(1996-4#1)
world class##2##2##(1992-3#1)(1994-1#1)
world have##3##2##(2010-8#1)(2012-12#1)(2013-1#1)
world in##11##2##(1996-7#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
world is suggested##2##3##(2013-1#2)
world is##12##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#3)
world literature##20##2##(1992-2#2)(2006-10#4)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#6)(2008-8#2)(2009-4#1)(2012-3#1)
world monkeys##3##2##(2008-1#2)(2011-2#1)
world of medicine##2##3##(2008-10#1)(2008-4#1)
world of the##2##3##(2006-12#1)(2009-7#1)
world of##29##2##(1991-3#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2006-10#1)(2006-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-7#1)(2010-5#1)(2010-8#1)(2013-1#2)(2013-8#1)
world on##2##2##(1993-9#1)(2012-2#1)
world population##6##2##(1994-9#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
world requires##2##2##(1994-2#1)(2008-9#1)
world standards##2##2##(2007-8#2)
world to the##2##3##(1997-7#1)(2008-6#1)
world to##7##2##(1994-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)
world total##2##2##(1991-6#2)
world view##3##2##(1993-2#2)(2008-12#1)
world was##2##2##(1990-2#1)(2011-2#1)
world where##6##2##(1996-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
world wide##7##2##(1992-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
world with##5##2##(2007-7#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)
world##491##1##(1990-11#1)(1990-12#1)(1990-2#3)(1991-3#2)(1991-6#4)(1991-9#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-9#1)(1994-1#7)(1994-12#2)(1994-2#4)(1994-3#1)(1994-9#9)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-1#5)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#5)(1997-8#1)(2006-10#6)(2006-12#3)(2006-9#1)(2007-10#5)(2007-12#1)(2007-2#2)(2007-7#7)(2007-8#8)(2008-1#23)(2008-10#66)(2008-11#23)(2008-12#13)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#14)(2008-6#11)(2008-7#13)(2008-8#11)(2008-9#6)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#10)(2010-6#1)(2010-7#3)(2010-8#9)(2010-9#3)(2011-1#3)(2011-2#26)(2012-12#5)(2012-2#12)(2012-3#6)(2012-6#1)(2013-1#24)(2013-7#1)(2013-8#13)
world's##31##1##(1990-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(1997-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
world-wide and##2##2##(2007-7#1)(2008-11#1)
world-wide##15##1##(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#1)(2011-3#1)
world?##2##1##(1997-6#1)(2007-12#1)
worlds as##2##2##(2008-4#1)(2009-11#1)
worlds##14##1##(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#4)(2009-5#1)(2010-3#1)(2012-2#1)
worldwide airline network##2##3##(2010-3#2)
worldwide and in##2##3##(1996-7#1)(2008-10#1)
worldwide and the##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
worldwide and##13##2##(1996-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
worldwide are affected##2##3##(2008-5#1)(2013-1#1)
worldwide as a##5##3##(2008-10#2)(2008-6#1)(2010-5#1)(2013-1#1)
worldwide as##8##2##(2008-10#3)(2008-6#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
worldwide by##2##2##(2007-2#1)(2008-10#1)
worldwide collection of##7##3##(2008-10#7)
worldwide condemnation##2##2##(1992-12#2)
worldwide diffusion##2##2##(2007-12#1)(2013-1#1)
worldwide distribution of##2##3##(2008-10#2)
worldwide due to its##2##4##(2011-2#2)
worldwide for##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
worldwide from##2##2##(1990-2#1)(1994-9#1)
worldwide had##2##2##(2008-10#2)
worldwide have been treated with##2##5##(2011-1#1)(2011-2#1)
worldwide have##5##2##(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
worldwide health##2##2##(2008-7#1)(2010-6#1)
worldwide in##4##2##(2008-10#2)(2010-10#1)(2010-3#1)
worldwide is##2##2##(2011-2#1)(2012-2#1)
worldwide prevalence of##3##3##(2008-3#2)(2013-1#1)
worldwide that##2##2##(2008-10#1)(2011-2#1)
worldwide to##4##2##(1991-5#1)(2008-7#1)(2009-7#1)(2010-3#1)
worldwide were##3##2##(2008-10#2)(2012-2#1)
worldwide##282##1##(1990-12#1)(1990-2#1)(1991-5#2)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#3)(1994-1#1)(1994-3#2)(1994-9#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2008-1#6)(2008-10#90)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#1)(2009-3#4)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-3#6)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#7)(2011-10#1)(2011-2#24)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#18)(2013-7#2)(2013-8#7)
worm burdens##4##2##(1996-12#4)
worm##23##1##(1990-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1994-2#1)(1996-12#8)(1996-2#1)(1997-6#1)(1997-7#1)(2008-9#2)(2009-5#1)(2009-7#2)(2010-2#2)
worms and##2##2##(2008-5#1)(2008-7#1)
worms per##2##2##(1996-12#2)
worms##18##1##(1992-6#1)(1994-2#1)(1995-3#1)(1996-12#5)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
worn##8##1##(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#2)(2008-5#1)(2011-1#1)(2011-2#1)
worried about##2##2##(2008-11#1)(2013-1#1)
worried##4##1##(1997-6#1)(2008-1#1)(2008-11#1)(2013-1#1)
worries about##2##2##(1991-11#1)(2013-1#1)
worries##3##1##(1991-11#1)(2013-1#1)(2013-8#1)
worrisome##4##1##(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
worry about##3##2##(1990-6#1)(1994-3#1)(2008-4#1)
worry##11##1##(1990-6#1)(1994-12#2)(1994-3#1)(1995-9#1)(1996-3#1)(2008-4#3)(2011-2#2)
worry?##2##1##(2008-11#1)(2011-2#1)
worse QOL##2##2##(2008-7#2)
worse because##2##2##(1993-11#1)(2009-10#1)
worse clinical##2##2##(2011-2#1)(2013-1#1)
worse for##2##2##(2008-10#1)(2008-11#1)
worse in the##4##3##(1996-7#1)(1997-6#1)(2008-1#1)(2008-7#1)
worse in##9##2##(1990-12#1)(1991-2#1)(1996-7#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
worse on##2##2##(2008-9#1)(2009-5#1)
worse outcome in##2##3##(2009-2#1)(2011-2#1)
worse outcome##6##2##(2007-8#1)(2009-2#4)(2011-2#1)
worse performance##3##2##(2008-1#1)(2008-10#1)(2009-5#1)
worse prognosis in##3##3##(1990-8#1)(2009-10#1)(2011-2#1)
worse prognosis##13##2##(1990-12#1)(1990-8#2)(1991-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
worse quality of##2##3##(2010-12#1)(2012-3#1)
worse results##4##2##(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
worse than the##3##3##(1991-5#1)(1996-7#1)(2008-10#1)
worse than##13##2##(1991-5#1)(1992-6#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-2#1)(2013-1#1)
worse##94##1##(1990-12#2)(1990-8#2)(1991-11#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-2#3)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-6#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#6)(2008-9#4)(2009-10#3)(2009-2#4)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
worsen the##3##2##(1996-12#1)(1996-3#1)(2008-7#1)
worsen with##2##2##(2007-12#1)(2013-1#1)
worsen##13##1##(1992-12#1)(1993-12#1)(1995-2#2)(1996-12#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-1#1)
worsened by##3##2##(1993-8#1)(2009-4#1)(2012-12#1)
worsened in##3##2##(2008-7#2)(2011-2#1)
worsened significantly##2##2##(2008-10#1)(2008-7#1)
worsened with##2##2##(2006-10#1)(2008-7#1)
worsened##23##1##(1992-5#1)(1993-8#1)(1995-6#1)(1997-6#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#4)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
worsening asthma##2##2##(2008-10#1)(2012-12#1)
worsening clinical##2##2##(1994-12#1)(2013-1#1)
worsening disease##2##2##(2006-10#1)(2009-3#1)
worsening dyspnoea##2##2##(2010-10#2)
worsening of the##5##3##(1991-11#1)(2007-11#2)(2009-1#1)(2011-3#1)
worsening of##22##2##(1991-11#1)(1992-12#1)(1992-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#2)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
worsening symptoms##3##2##(2007-10#1)(2009-1#1)(2012-2#1)
worsening the##2##2##(2008-10#1)(2013-1#1)
worsening##57##1##(1991-11#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-10#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-1#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#6)(2013-7#1)
worsens with##2##2##(1993-8#1)(2010-6#1)
worsens##7##1##(1993-2#1)(1993-8#1)(2008-1#1)(2008-7#1)(2010-4#1)(2010-6#1)(2013-1#1)
worst case##4##2##(2007-12#2)(2007-7#1)(2008-3#1)
worst pain##3##2##(2008-7#2)(2010-4#1)
worst##41##1##(1990-6#1)(1991-4#1)(1991-6#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#3)(2010-4#1)(2011-2#3)(2013-8#1)
worst-case##7##1##(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#3)(2011-2#1)
worth a##2##2##(2008-3#1)(2010-9#1)
worth as##2##2##(1991-3#1)(2008-3#1)
worth being##2##2##(2008-10#1)(2008-8#1)
worth of##2##2##(2008-10#1)(2013-1#1)
worth pursuing##2##2##(2009-10#1)(2010-4#1)
worth the##5##2##(1991-6#1)(1992-3#1)(2007-4#1)(2007-8#1)(2012-1#1)
worth to##3##2##(1992-9#1)(2008-5#1)(2013-7#1)
worth##36##1##(1991-3#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
worthwhile to##5##2##(1992-5#1)(1996-4#1)(2007-7#1)(2008-4#1)(2012-2#1)
worthwhile##19##1##(1991-11#1)(1991-12#1)(1992-5#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-4#1)(2010-12#1)(2010-3#1)(2012-2#1)
worthy of further##2##3##(1991-3#1)(2008-11#1)
worthy of##7##2##(1991-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
worthy##8##1##(1991-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
wortmannin does not block the effect of these agents##2##9##(1995-6#1)(1996-2#1)
wortmannin##22##1##(1992-6#4)(1994-11#3)(1995-12#2)(1995-6#3)(1995-8#2)(1996-2#1)(1997-7#1)(2008-11#2)(2008-4#2)(2013-7#2)
wortmannin-sensitive pathway##2##2##(1994-11#2)
would abrade faster##2##3##(2008-7#2)
would achieve##2##2##(1991-6#1)(2008-3#1)
would administer##2##2##(1992-2#1)(2008-1#1)
would affect##3##2##(1992-11#1)(2008-10#2)
would allow a##4##3##(2007-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
would allow for##2##3##(2008-10#1)(2008-11#1)
would allow more##2##3##(2010-12#1)(2013-8#1)
would allow the##7##3##(1995-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
would allow##28##2##(1992-6#1)(1995-11#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
would also be##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
would also help##2##3##(2009-10#1)(2012-2#1)
would also provide##2##3##(1993-3#1)(2009-8#1)
would also##16##2##(1990-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
would appear that##6##3##(1991-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-2#1)(2011-2#1)
would appear to be##3##4##(1990-2#1)(2007-8#1)(2011-1#1)
would appear to##5##3##(1990-2#1)(1991-2#1)(2007-8#1)(2010-1#1)(2011-1#1)
would appear##18##2##(1990-2#1)(1991-11#2)(1991-2#1)(1991-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-8#2)(2008-11#1)(2008-2#1)(2009-10#1)(2010-1#1)(2011-1#1)(2011-2#1)
would avoid##3##2##(1991-8#1)(2008-10#1)(2008-3#1)
would be a##14##3##(1992-11#1)(1994-6#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#1)
would be able to##3##4##(2008-8#1)(2013-1#2)
would be adequate##3##3##(1991-12#1)(2007-12#1)(2012-3#1)
would be an effective##2##4##(2008-10#1)(2011-2#1)
would be an##11##3##(1990-11#1)(1993-1#1)(1994-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#2)(2013-1#1)
would be applicable##2##3##(2008-3#1)(2011-2#1)
would be beneficial to##2##4##(2008-9#1)(2012-12#1)
would be beneficial##6##3##(2008-10#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
would be best##4##3##(1994-2#1)(1995-1#1)(2008-10#2)
would be better##6##3##(1991-12#1)(1995-3#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
would be characterized##2##3##(1992-12#1)(2008-10#1)
would be classified as##3##4##(1991-12#1)(1993-2#1)(2008-5#1)
would be considered##4##3##(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#1)
would be desirable##4##3##(1993-11#1)(1997-4#1)(2007-11#1)(2013-1#1)
would be determined##2##3##(1995-6#1)(2008-7#1)
would be difficult##3##3##(1992-12#1)(2007-12#1)(2008-7#1)
would be effective##2##3##(1997-6#1)(2009-5#1)
would be expected based##2##4##(1992-6#1)(2008-11#1)
would be expected for##2##4##(1992-11#1)(2007-12#1)
would be expected in a##2##5##(2008-10#1)(2011-1#1)
would be expected in##3##4##(2008-10#2)(2011-1#1)
would be expected to##3##4##(1993-9#1)(2008-11#1)(2009-2#1)
would be expected##18##3##(1992-11#1)(1992-6#1)(1993-9#1)(1994-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2011-1#1)(2013-1#1)
would be extremely difficult##2##4##(1996-1#1)(2008-10#1)
would be extremely##3##3##(1994-5#1)(1996-1#1)(2008-10#1)
would be facilitated##2##3##(1993-6#1)(2008-11#1)
would be funded on a##2##5##(1996-1#1)(1996-2#1)
would be generated##2##3##(1995-8#1)(2012-3#1)
would be helpful in##2##4##(2008-10#1)(2009-8#1)
would be helpful to##2##4##(2009-4#1)(2013-8#1)
would be helpful##6##3##(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2013-8#1)
would be impractical##2##3##(1996-4#1)(2008-7#1)
would be improved##2##3##(1996-11#1)(2008-3#1)
would be in a##2##4##(2008-11#2)
would be in##3##3##(1993-2#1)(2008-11#2)
would be less##3##3##(2008-10#1)(2012-12#2)
would be made##2##3##(2009-7#1)(2011-1#1)
would be more suitable##2##4##(2010-7#1)(2012-3#1)
would be more##15##3##(1991-12#1)(1994-1#2)(2007-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-7#1)(2012-3#1)
would be most appropriate to##2##5##(1995-1#1)(2008-11#1)
would be most##4##3##(1995-1#1)(2008-1#1)(2008-11#1)(2008-7#1)
would be much##2##3##(2007-7#1)(2008-11#1)
would be necessary##6##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
would be needed to##4##4##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
would be needed##6##3##(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-7#1)
would be obtained##4##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
would be of##6##3##(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
would be possible##5##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-3#1)
would be present##2##3##(2008-10#1)(2008-8#1)
would be provided by##3##4##(1990-6#1)(1994-1#1)(2008-7#1)
would be provided##4##3##(1990-6#1)(1994-1#1)(2008-3#1)(2008-7#1)
would be prudent##2##3##(1991-12#1)(1995-1#1)
would be recommended##2##3##(2007-8#1)(2008-10#1)
would be reduced##2##3##(2008-10#1)(2013-8#1)
would be related##2##3##(1994-6#1)(1995-3#1)
would be released if##2##4##(1996-1#2)
would be required for##2##4##(1991-11#1)(2008-3#1)
would be required to##5##4##(1990-8#1)(1993-3#1)(1996-1#1)(2008-10#2)
would be required##9##3##(1990-8#1)(1991-11#1)(1993-3#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)
would be significant##2##3##(1993-3#1)(2013-1#1)
would be suitable##2##3##(2008-10#1)(2008-7#1)
would be the most##2##4##(2008-10#1)(2012-9#1)
would be the##8##3##(1992-3#1)(1996-1#2)(1997-1#1)(2008-10#1)(2008-12#1)(2012-9#1)(2013-1#1)
would be to##12##3##(1992-3#1)(1995-5#1)(1996-1#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)
would be used##3##3##(1994-9#1)(2008-5#1)(2009-6#1)
would be useful as a##2##5##(2008-10#2)
would be useful for##5##4##(1990-8#1)(2008-10#2)(2011-1#1)(2013-8#1)
would be useful in developing##2##5##(1994-11#1)(2011-3#1)
would be useful in##3##4##(1994-11#1)(2009-12#1)(2011-3#1)
would be useful to##5##4##(1994-11#1)(2008-11#1)(2008-12#1)(2010-12#1)(2013-8#1)
would be useful##16##3##(1990-8#1)(1994-11#2)(1994-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-8#2)
would be valuable##3##3##(1994-2#1)(2007-2#1)(2007-9#1)
would be very##2##3##(1996-4#1)(2010-8#1)
would be wise to##2##4##(1996-1#1)(2013-1#1)
would be##388##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#7)(1991-2#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#2)(1993-9#1)(1994-1#4)(1994-11#2)(1994-2#6)(1994-3#4)(1994-5#4)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#13)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#9)(2007-2#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#46)(2008-11#18)(2008-12#7)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#14)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#7)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#16)(2011-3#2)(2012-12#7)(2012-2#5)(2012-3#11)(2012-9#1)(2013-1#14)(2013-7#3)(2013-8#8)
would benefit from a##2##4##(1991-2#1)(2008-11#1)
would benefit from this##2##4##(1992-12#1)(2008-3#1)
would benefit from##12##3##(1991-2#1)(1992-12#1)(2007-12#2)(2008-11#2)(2008-3#1)(2010-3#1)(2010-9#1)(2012-12#2)(2013-7#1)
would benefit##15##2##(1991-2#1)(1992-12#1)(1994-12#1)(2007-12#2)(2008-11#2)(2008-3#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-7#1)
would best##2##2##(1994-12#1)(1995-9#1)
would bring##2##2##(1992-12#1)(1993-6#1)
would cause##7##2##(1997-2#1)(2008-10#2)(2008-11#1)(2008-8#2)(2012-12#1)
would choose##3##2##(1997-3#1)(2010-4#2)
would consent to##2##3##(1993-2#1)(2008-11#1)
would consider an OAH##3##4##(2008-7#3)
would consider##6##2##(1995-12#1)(1996-12#1)(2008-7#4)
would continue to##2##3##(1997-2#1)(2012-12#1)
would contribute greatly to##2##4##(2008-11#1)(2008-3#1)
would contribute to the##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
would contribute to##8##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)(2012-2#1)
would contribute##11##2##(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-2#1)
would correspond to##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
would cost##3##2##(1990-2#1)(1994-2#1)(2010-12#1)
would create##4##2##(1995-1#1)(1995-6#1)(1996-5#1)(2008-8#1)
would derive the##2##3##(2012-1#2)
would determine##2##2##(1994-9#1)(2008-11#1)
would differentiate##2##2##(2008-5#1)(2008-8#1)
would directly##2##2##(2008-8#1)(2009-6#1)
would do##3##2##(1992-2#1)(1995-5#1)(2008-8#1)
would enable the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
would enable##11##2##(1992-11#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
would encode a##2##3##(1993-2#2)
would encourage##2##2##(1997-2#1)(2008-7#1)
would eventually##5##2##(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#2)
would expand##2##2##(1990-4#1)(1995-12#1)
would explain##4##2##(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
would favor##5##2##(2007-7#1)(2008-7#1)(2008-9#2)(2009-10#1)
would find a##2##3##(1991-12#1)(1992-1#1)
would find##3##2##(1991-12#1)(1991-9#1)(1992-1#1)
would first##3##2##(1993-6#1)(2007-10#1)(2008-11#1)
would follow##2##2##(1994-8#1)(2008-1#1)
would form##2##2##(2008-10#2)
would further##6##2##(1997-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-3#1)(2013-1#1)
would gain##2##2##(2008-11#1)(2012-2#1)
would give the##2##3##(1995-5#1)(2008-11#1)
would give##4##2##(1994-12#1)(1995-5#1)(1997-8#1)(2008-11#1)
would greatly##5##2##(1990-12#1)(1996-8#1)(2008-5#1)(2008-7#1)(2009-9#1)
would guarantee##2##2##(2007-8#1)(2009-2#1)
would have a##6##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)
would have been##19##3##(1991-10#1)(1991-6#1)(1994-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#6)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
would have died if##2##4##(1992-9#1)(2008-10#1)
would have died##4##3##(1992-9#1)(1995-12#1)(2008-10#2)
would have higher##2##3##(2008-10#1)(2008-11#1)
would have increased##2##3##(1993-1#1)(2008-11#1)
would have lambda(i)##2##3##(1997-5#2)
would have reached##2##3##(1997-6#1)(2008-1#1)
would have resulted##3##3##(1994-12#1)(2008-6#1)(2008-9#1)
would have significant##2##3##(2008-7#1)(2011-1#1)
would have the##2##3##(1994-3#1)(1995-2#1)
would have to##4##3##(1995-6#2)(2008-10#1)(2008-2#1)
would have##77##2##(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-5#3)(1997-2#2)(1997-5#4)(1997-6#1)(2008-1#3)(2008-10#12)(2008-11#7)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
would help avoid##2##3##(2008-5#1)(2009-6#1)
would help in##2##3##(2009-10#1)(2010-3#1)
would help to##2##3##(2008-8#1)(2011-10#1)
would help##10##2##(1990-2#1)(1993-2#1)(1995-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-10#1)
would improve##10##2##(1994-12#1)(1996-2#1)(2008-10#2)(2008-11#2)(2011-1#1)(2012-2#3)
would in##2##2##(1992-12#1)(2012-2#1)
would include##5##2##(1992-12#1)(1996-3#1)(2008-1#1)(2008-7#1)(2011-2#1)
would increase their##2##3##(2007-10#1)(2013-1#1)
would increase##17##2##(1990-12#1)(1994-1#3)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2013-1#2)
would indicate a##2##3##(2008-10#1)(2008-7#1)
would indicate that##4##3##(1990-2#1)(2008-5#1)(2013-1#2)
would indicate##7##2##(1990-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
would induce##2##2##(1993-11#1)(2008-5#1)
would influence##6##2##(1993-1#1)(1996-2#1)(2008-12#1)(2009-5#1)(2010-10#1)(2013-8#1)
would initiate##2##2##(2008-1#1)(2013-1#1)
would involve##7##2##(1992-2#1)(1992-3#1)(2008-10#2)(2008-7#2)(2008-9#1)
would lead to the##3##4##(1993-2#1)(2008-7#1)(2013-8#1)
would lead to##14##3##(1991-12#1)(1993-2#1)(1995-6#1)(1997-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
would leave##2##2##(1990-3#1)(2010-3#1)
would like to present##2##4##(2007-8#1)(2012-12#1)
would like to see the##2##5##(1992-3#1)(2008-5#1)
would like to see##5##4##(1992-3#3)(2008-3#1)(2008-5#1)
would like to##17##3##(1991-2#1)(1992-3#3)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
would like##19##2##(1991-2#1)(1992-3#3)(1997-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
would likely be##2##3##(2008-10#1)(2008-8#1)
would likely##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
would limit the##3##3##(1990-6#1)(2007-10#1)(2008-10#1)
would limit##4##2##(1990-6#1)(2007-10#1)(2008-10#1)(2008-8#1)
would maintain##3##2##(1996-9#1)(2008-3#1)(2012-2#1)
would make it##2##3##(2008-9#1)(2009-5#1)
would make the##2##3##(1996-1#1)(2008-6#1)
would make##11##2##(1990-2#1)(1996-1#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#2)(2011-1#1)(2012-12#1)
would meet the##2##3##(1993-6#1)(1996-12#1)
would meet##3##2##(1993-6#1)(1996-12#1)(2008-3#1)
would minimize##3##2##(2008-8#1)(2013-1#2)
would most##2##2##(1997-5#1)(2011-2#1)
would need to be##5##4##(1992-2#1)(1995-6#1)(2007-12#1)(2008-8#1)(2011-1#1)
would need##6##2##(1992-2#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-8#1)(2011-1#1)
would normally be##2##3##(1991-12#1)(1993-8#1)
would normally have##2##3##(1993-3#1)(2008-5#1)
would normally##4##2##(1991-12#1)(1993-3#1)(1993-8#1)(2008-5#1)
would not be##10##3##(1990-2#1)(1991-1#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
would not have##4##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
would not only##3##3##(1991-9#1)(1995-1#1)(2007-11#1)
would not##35##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
would occur in##2##3##(2008-5#1)(2013-1#1)
would occur##6##2##(1992-3#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
would offer##2##2##(1994-1#1)(2010-10#1)
would only be##3##3##(1995-6#1)(2008-9#1)(2009-3#1)
would open##2##2##(2008-6#1)(2012-2#1)
would otherwise be considered##2##4##(1994-11#1)(2007-7#1)
would otherwise be##4##3##(1994-11#1)(2007-7#1)(2008-8#1)(2011-1#1)
would otherwise have##3##3##(1991-6#1)(1997-1#1)(2011-2#1)
would otherwise occur##2##3##(2008-8#1)(2012-12#1)
would otherwise##18##2##(1991-6#1)(1994-11#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-8#3)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)
would permit##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
would preclude##2##2##(2008-8#2)
would predict##4##2##(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
would prevent##2##2##(2007-12#1)(2012-3#1)
would probably be##3##3##(1992-4#1)(1997-8#1)(2013-1#1)
would probably lead##2##3##(1994-3#1)(1996-3#1)
would probably##6##2##(1992-4#1)(1994-3#1)(1996-3#1)(1997-8#1)(2008-11#1)(2013-1#1)
would produce a##4##3##(1992-9#1)(2008-2#1)(2008-8#1)(2010-4#1)
would produce##9##2##(1990-2#1)(1992-9#1)(1997-9#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)
would promote##4##2##(2007-10#1)(2008-4#1)(2008-6#1)(2009-9#1)
would protect##2##2##(1990-11#1)(2008-1#1)
would provide a##5##3##(1995-1#1)(2008-1#1)(2008-3#1)(2010-12#1)(2012-3#1)
would provide protection##2##3##(1995-12#1)(2013-1#1)
would provide the##4##3##(1994-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
would provide valuable information##2##4##(1996-8#1)(2012-12#1)
would provide valuable##3##3##(1996-8#1)(2008-7#1)(2012-12#1)
would provide##28##2##(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
would reach##2##2##(2010-8#1)(2011-2#1)
would receive##2##2##(1997-2#1)(2009-2#1)
would recommend a##2##3##(1996-8#1)(2009-10#1)
would recommend##4##2##(1993-3#1)(1996-8#1)(2009-10#1)(2013-7#1)
would reduce the##5##3##(1993-9#1)(1995-6#1)(2008-10#2)(2013-1#1)
would reduce##9##2##(1993-9#1)(1995-6#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-1#2)
would remain##3##2##(1996-1#1)(1996-12#1)(2013-1#1)
would represent a##2##3##(2009-3#1)(2011-2#1)
would represent##4##2##(1993-2#1)(2008-11#1)(2009-3#1)(2011-2#1)
would require a##2##3##(1996-12#1)(2009-12#1)
would require disclosure of##2##4##(1995-12#1)(2009-7#1)
would require##13##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-7#1)(2010-7#1)(2013-1#1)
would result in a##4##4##(1991-3#1)(1993-9#1)(1995-2#1)(2008-10#1)
would result in an##2##4##(1995-3#1)(2009-7#1)
would result in the##4##4##(1993-6#1)(1994-9#1)(2008-10#2)
would result in##13##3##(1991-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)
would result##15##2##(1991-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2012-12#1)
would seem to be a##3##5##(1995-1#1)(1996-2#1)(2008-11#1)
would seem to be##5##4##(1995-1#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)
would seem to##8##3##(1995-1#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
would seem##14##2##(1991-2#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2009-1#1)
would serve as##2##3##(1993-11#1)(2007-12#1)
would serve##4##2##(1993-11#1)(2007-12#1)(2008-5#1)(2009-8#1)
would show##4##2##(2007-6#1)(2008-11#1)(2008-4#1)(2009-11#1)
would significantly##2##2##(1995-1#1)(2009-11#1)
would still##2##2##(1996-2#1)(2013-1#1)
would suffer the##2##3##(2008-8#2)
would suggest a##4##3##(1992-8#1)(2008-10#1)(2012-12#2)
would suggest that the##2##4##(2008-11#1)(2008-7#1)
would suggest that##11##3##(1990-11#1)(1990-2#2)(1993-9#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2011-7#1)
would suggest the##2##3##(1990-8#1)(2008-7#1)
would suggest##17##2##(1990-11#1)(1990-2#2)(1990-8#1)(1992-8#1)(1993-9#1)(1994-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2011-7#1)(2012-12#2)
would support##2##2##(1993-3#1)(2012-3#1)
would take##6##2##(1990-2#1)(1996-1#1)(2007-10#1)(2008-1#2)(2009-7#1)
would then be##2##3##(1994-5#1)(1995-3#1)
would then##4##2##(1994-5#1)(1995-3#1)(1997-7#1)(2010-11#1)
would therefore be##3##3##(1990-5#1)(2008-11#1)(2013-1#1)
would therefore##5##2##(1990-5#1)(1990-8#1)(2008-11#1)(2008-8#1)(2013-1#1)
would thus##2##2##(1992-6#1)(1992-8#1)
would use the##2##3##(2007-12#1)(2007-7#1)
would use##4##2##(1992-12#1)(2007-12#1)(2007-7#1)(2008-1#1)
would yield##4##2##(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#1)
would##1246##1##(1990-11#5)(1990-12#4)(1990-2#11)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#6)(1990-8#4)(1990-9#1)(1991-1#7)(1991-10#1)(1991-11#3)(1991-12#12)(1991-2#8)(1991-3#2)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#5)(1992-12#13)(1992-2#8)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#5)(1993-11#6)(1993-12#5)(1993-2#10)(1993-3#12)(1993-6#6)(1993-8#1)(1993-9#4)(1994-1#8)(1994-11#5)(1994-12#10)(1994-2#9)(1994-3#6)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#6)(1995-1#10)(1995-11#3)(1995-12#17)(1995-2#5)(1995-3#6)(1995-5#5)(1995-6#17)(1995-8#2)(1995-9#2)(1996-1#19)(1996-11#2)(1996-12#7)(1996-2#8)(1996-3#7)(1996-4#4)(1996-5#6)(1996-6#2)(1996-8#5)(1996-9#4)(1997-1#6)(1997-2#12)(1997-3#8)(1997-4#3)(1997-5#7)(1997-6#4)(1997-7#2)(1997-8#6)(1997-9#1)(2007-10#5)(2007-11#6)(2007-12#22)(2007-2#6)(2007-6#1)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#24)(2008-10#122)(2008-11#68)(2008-12#17)(2008-2#14)(2008-3#33)(2008-4#8)(2008-5#25)(2008-6#15)(2008-7#51)(2008-8#45)(2008-9#24)(2009-1#2)(2009-10#8)(2009-11#3)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#5)(2009-7#12)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#5)(2010-12#13)(2010-2#2)(2010-3#8)(2010-4#9)(2010-5#3)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#20)(2011-10#1)(2011-2#41)(2011-3#3)(2011-7#1)(2012-1#5)(2012-12#23)(2012-2#21)(2012-3#19)(2012-9#1)(2013-1#47)(2013-7#6)(2013-8#18)
would-be##3##1##(1995-12#1)(2012-2#1)(2013-8#1)
wound and##9##2##(1991-6#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#2)
wound area##3##2##(2008-10#1)(2008-11#2)
wound care##4##2##(2007-12#1)(2008-7#2)(2010-4#1)
wound closure in##2##3##(1992-2#1)(2012-12#1)
wound closure##13##2##(1992-2#1)(2008-10#2)(2008-4#1)(2008-7#5)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
wound complications##9##2##(1992-1#1)(2007-7#1)(2007-8#3)(2008-8#2)(2011-2#1)(2012-2#1)
wound contraction##2##2##(2008-10#2)
wound dehiscence##4##2##(2008-7#3)(2011-2#1)
wound drainage was##2##3##(1996-9#2)
wound drainage##3##2##(1996-9#3)
wound dressing##8##2##(2008-5#2)(2011-2#5)(2013-7#1)
wound edge protector##2##3##(2007-8#2)
wound healed##2##2##(2008-12#1)(2011-1#1)
wound healing and##4##3##(1994-6#1)(2008-11#1)(2010-6#1)(2012-3#1)
wound healing are##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-9#1)
wound healing in the##2##4##(2008-9#1)(2011-2#1)
wound healing in##4##3##(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)
wound healing processes##2##3##(2008-5#1)(2009-12#1)
wound healing was##5##3##(2007-8#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
wound healing##51##2##(1990-9#1)(1994-11#1)(1994-6#1)(1995-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-12#4)(2012-3#5)(2013-1#3)
wound in##2##2##(2008-10#2)
wound infection and##3##3##(2008-7#2)(2012-2#1)
wound infection in##2##3##(1995-12#1)(2007-7#1)
wound infection incidence##2##3##(1990-3#2)
wound infection##21##2##(1990-3#2)(1995-12#1)(2007-7#3)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#3)(2012-2#4)(2013-1#1)
wound infections##7##2##(1990-3#2)(2007-8#3)(2012-2#2)
wound infiltration with bupivacaine##2##4##(2008-7#2)
wound infiltration##5##2##(1991-3#1)(2008-7#4)
wound inoculation##3##2##(2008-10#3)
wound of##2##2##(2011-2#1)(2012-12#1)
wound repair and##2##3##(2008-1#1)(2008-5#1)
wound repair##7##2##(2008-1#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#2)
wound response##2##2##(2008-4#2)
wound site pain##3##3##(2012-12#3)
wound site##9##2##(2008-10#4)(2008-9#1)(2012-12#3)(2012-3#1)
wound sites##2##2##(2008-10#1)(2012-2#1)
wound swabs##2##2##(2007-7#2)
wound was##4##2##(1991-6#1)(2008-11#2)(2013-1#1)
wound with##2##2##(2007-8#2)
wound##244##1##(1990-2#1)(1990-3#4)(1990-6#1)(1990-9#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#2)(1996-9#3)(2007-11#2)(2007-12#5)(2007-7#7)(2007-8#16)(2008-1#1)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#9)(2008-5#8)(2008-7#20)(2008-8#3)(2008-9#13)(2009-12#4)(2009-3#1)(2009-8#2)(2010-12#5)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#21)(2012-12#12)(2012-2#10)(2012-3#12)(2013-1#8)(2013-7#2)
wound-healing##8##1##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2012-12#1)
wound-induced##2##1##(2008-10#1)(2009-8#1)
wound-inducible promoter##2##2##(2008-10#2)
wound-inducible##5##1##(1997-2#2)(2008-10#2)(2008-9#1)
wounded maize##2##2##(2008-10#2)
wounded tissues##2##2##(2008-10#2)
wounded##23##1##(2007-8#1)(2008-10#19)(2008-7#1)(2009-7#1)(2011-1#1)
wounding and##5##2##(2008-10#4)(2009-8#1)
wounding machine##2##2##(2008-7#2)
wounding of##4##2##(2008-10#3)(2008-7#1)
wounding##27##1##(1993-12#1)(1997-2#4)(2008-10#14)(2008-5#1)(2008-7#5)(2009-8#1)(2012-12#1)
wounds and##9##2##(1990-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#1)(2012-12#1)
wounds are##3##2##(1990-2#1)(2011-2#1)(2012-2#1)
wounds below the fourth intercostal space##2##6##(1990-2#2)
wounds below##3##2##(1990-2#2)(2008-10#1)
wounds in rats##2##3##(2008-11#2)
wounds in##5##2##(1996-7#1)(2008-11#3)(2008-5#1)
wounds of the##4##3##(2007-8#1)(2011-2#1)(2012-12#2)
wounds of##6##2##(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#2)
wounds on##3##2##(2008-10#2)(2012-3#1)
wounds or##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
wounds that##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
wounds to the##3##3##(1995-11#2)(2011-2#1)
wounds to##4##2##(1995-11#2)(2011-2#1)(2012-3#1)
wounds were##4##2##(1992-2#1)(2008-10#2)(2008-12#1)
wounds with##5##2##(1991-8#1)(1992-6#1)(2008-5#1)(2008-9#1)(2013-8#1)
wounds##99##1##(1990-2#4)(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#3)(1992-6#2)(1995-11#2)(1996-7#1)(2007-11#1)(2007-8#3)(2008-10#28)(2008-11#7)(2008-12#2)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#13)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
woven structures##2##2##(2008-3#2)
woven##6##1##(1997-1#1)(2007-12#1)(2008-3#3)(2012-2#1)
wrap around the##2##3##(1991-2#1)(1994-5#1)
wrap around##4##2##(1991-2#1)(1994-5#1)(2008-6#1)(2008-9#1)
wrap##6##1##(1991-2#1)(1994-5#1)(2008-6#2)(2008-9#2)
wrapped around a##4##3##(2008-10#2)(2008-3#1)(2010-10#1)
wrapped around the##2##3##(1993-9#1)(2010-3#1)
wrapped around##6##2##(1993-9#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-3#1)
wrapped phase##7##2##(2008-2#4)(2008-3#3)
wrapped##20##1##(1993-9#1)(2008-10#2)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#2)(2010-10#1)(2010-3#1)(2011-2#1)
wrapping##7##1##(1993-3#1)(1995-11#2)(2008-11#1)(2008-2#2)(2008-8#1)
wraps##2##1##(2008-10#1)(2010-5#1)
wrestler##3##1##(2010-1#2)(2012-3#1)
wrightii##3##1##(2009-8#3)
wringing##5##1##(2008-3#5)
wrinkle##4##1##(2008-5#4)
wrinkled##3##1##(1994-11#1)(2009-10#1)(2012-2#1)
wrinkles in##2##2##(2008-5#2)
wrinkles were##2##2##(2008-5#2)
wrinkles##30##1##(1991-6#1)(2008-5#28)(2011-2#1)
wrinkling and##3##2##(1994-11#1)(2008-5#1)(2010-8#1)
wrinkling##8##1##(1994-11#1)(2008-5#5)(2010-8#1)(2011-2#1)
wrist and##5##2##(2008-12#2)(2008-8#1)(2008-9#1)(2012-2#1)
wrist arthroscopy##4##2##(2008-10#3)(2008-9#1)
wrist ganglion##3##2##(2008-9#3)
wrist instability##2##2##(2008-9#1)(2013-1#1)
wrist pain##12##2##(2008-10#1)(2008-9#10)(2012-3#1)
wrist radiography is not##2##4##(2008-9#2)
wrist radiography##3##2##(2008-9#3)
wrist##71##1##(1991-11#1)(1991-6#1)(1995-6#1)(1996-2#1)(1997-5#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#5)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#29)(2009-8#1)(2011-2#2)(2012-1#5)(2012-2#5)(2012-3#2)(2013-1#2)
wrists and##2##2##(2006-10#1)(2008-9#1)
wrists##6##1##(1995-6#1)(2006-10#1)(2008-9#2)(2009-3#2)
write a##3##2##(2008-3#1)(2008-9#1)(2010-7#1)
write##25##1##(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-7#1)(2013-1#1)(2013-8#2)
write-once##3##1##(2008-3#3)
writer data##2##2##(2008-6#2)
writer identification##2##2##(2008-6#2)
writer##9##1##(1995-2#1)(2008-6#6)(2009-3#1)(2011-2#1)
writers and##3##2##(1993-3#2)(2008-8#1)
writers##9##1##(1993-3#2)(2008-2#1)(2008-6#3)(2008-8#1)(2009-4#1)(2013-8#1)
writes##5##1##(1993-2#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-3#1)
writhes##3##1##(2008-12#1)(2013-7#2)
writhing method##2##2##(2011-1#1)(2013-7#1)
writhing##7##1##(1992-3#1)(1996-2#1)(2011-1#2)(2013-7#3)
writing a##3##2##(1996-6#1)(2007-12#1)(2009-4#1)
writing about##3##2##(2008-4#1)(2009-10#1)(2010-10#1)
writing an##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
writing and reading##2##3##(2007-12#1)(2008-12#1)
writing and##10##2##(1997-7#1)(2007-12#3)(2008-11#1)(2008-12#2)(2008-3#1)(2009-9#1)(2013-1#1)
writing as##2##2##(2012-2#1)(2013-1#1)
writing at##2##2##(2007-12#2)
writing beams and##3##3##(2008-2#2)(2008-3#1)
writing beams##9##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)
writing for##2##2##(1996-2#1)(2008-11#1)
writing in##2##2##(2010-10#1)(2010-6#1)
writing intensity##2##2##(2007-12#1)(2008-3#1)
writing light##2##2##(2007-12#1)(2008-3#1)
writing of the##3##3##(2007-11#1)(2008-12#1)(2011-2#1)
writing of##13##2##(1991-1#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#2)(2013-7#1)
writing power##4##2##(2008-3#4)
writing skills##2##2##(2008-12#2)
writing##108##1##(1991-1#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#8)(2007-12#13)(2008-10#1)(2008-11#7)(2008-12#9)(2008-2#7)(2008-3#19)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-9#3)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
writing-beam##3##1##(2007-11#2)(2008-2#1)
writings on the##2##3##(2008-10#1)(2008-7#1)
writings##9##1##(2008-10#3)(2008-12#2)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
written about the##8##3##(1992-1#1)(1994-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)
written about##16##2##(1991-3#1)(1992-1#1)(1994-8#1)(1995-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2010-10#1)(2011-1#1)(2012-2#2)(2013-8#1)
written and##6##2##(1992-12#1)(1994-12#1)(1996-11#1)(2008-2#1)(2008-8#1)(2010-3#1)
written at a##2##3##(2008-12#1)(2008-2#1)
written at##4##2##(2008-12#3)(2008-2#1)
written by two-wave mixing in a cerium-doped potassium sodium strontium barium niobate##2##12##(2008-3#2)
written by##12##2##(1992-2#1)(1992-6#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
written documentation##2##2##(2007-2#2)
written for the##2##3##(2008-10#2)
written for##3##2##(1991-12#1)(2008-10#2)
written in English##3##3##(1993-6#1)(2008-6#1)(2013-1#1)
written in Visual Basic##2##4##(2008-10#2)
written in an##3##3##(2007-12#1)(2008-3#2)
written in order to##3##4##(1994-3#2)(2008-11#1)
written in the##2##3##(2008-10#1)(2008-3#1)
written in this##2##3##(2007-11#2)
written in##34##2##(1993-6#1)(1994-3#2)(1997-3#1)(2007-11#7)(2007-12#5)(2008-10#10)(2008-11#1)(2008-3#5)(2008-6#1)(2013-1#1)
written informed consent##2##3##(2008-7#1)(2011-2#1)
written into##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
written materials##2##2##(1996-5#1)(2008-4#1)
written on the##3##3##(1994-2#1)(2008-1#1)(2010-2#1)
written on##4##2##(1994-2#1)(2007-12#1)(2008-1#1)(2010-2#1)
written onto##3##2##(2008-3#3)
written program##2##2##(2008-10#1)(2008-12#1)
written protocol for sedation##2##4##(2008-8#2)
written summaries##2##2##(1992-12#1)(1993-2#1)
written survey##3##2##(1995-12#1)(1996-3#1)(2012-1#1)
written to##2##2##(2010-8#1)(2011-2#1)
written with##3##2##(1996-12#1)(2008-3#1)(2013-8#1)
written##192##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#4)(1997-3#1)(1997-5#1)(2007-10#2)(2007-11#9)(2007-12#9)(2007-2#4)(2007-4#1)(2007-5#1)(2007-8#14)(2007-9#1)(2008-1#5)(2008-10#22)(2008-11#8)(2008-12#6)(2008-2#4)(2008-3#17)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
written/updated##3##1##(2012-12#3)
wrong and##2##2##(1996-11#1)(2008-1#1)
wrong way to##2##3##(1991-3#1)(1991-5#1)
wrong##31##1##(1991-3#2)(1991-5#1)(1994-1#2)(1994-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2009-10#1)(2010-11#1)(2010-12#3)(2010-8#1)(2012-2#2)(2013-8#1)
wrong?##2##1##(2009-12#1)(2011-2#1)
wrongdoing in##2##2##(2012-12#2)
wrongdoing##4##1##(2011-1#1)(2012-12#3)
wrongful termination##2##2##(1995-12#1)(1997-5#1)
wrongful##4##1##(1991-12#1)(1995-12#1)(1995-6#1)(1997-5#1)
wrongly##4##1##(1991-12#1)(1995-11#1)(1996-9#1)(2008-7#1)
wrote##11##1##(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
wrought##2##1##(2009-7#2)
ws##2##1##(2008-11#2)
wt %##2##2##(2008-10#1)(2010-4#1)
wt of##5##2##(1995-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
wt##85##1##(1990-5#2)(1992-2#1)(1992-5#4)(1992-8#2)(1993-11#1)(1993-6#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-5#1)(2007-1#1)(2007-12#1)(2007-5#9)(2008-10#22)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#4)(2008-9#1)(2009-12#3)(2009-2#1)(2010-1#2)(2010-4#1)(2012-3#1)(2013-1#10)(2013-8#2)
wt% and##2##2##(2008-5#1)(2009-7#1)
wt%##12##1##(1990-2#1)(2008-10#3)(2008-5#2)(2009-10#1)(2009-11#2)(2009-7#2)(2012-2#1)
wt%)##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
wt) for##2##2##(2008-10#1)(2008-11#1)
wt)##8##1##(1991-11#1)(1996-9#2)(2008-10#1)(2008-11#3)(2013-1#1)
wt-p53 in##2##2##(1997-7#2)
wt-p53##7##1##(1993-11#2)(1997-7#5)
wt/wt##2##1##(2008-10#1)(2008-5#1)
wt/wt)##2##1##(2008-10#2)
wt/wt/wt##3##1##(2008-10#3)
wtSSB##2##1##(1997-2#2)
wv/wv mice##4##2##(1996-12#4)
www##12##1##(2008-3#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)
x &lt##5##2##(1990-4#1)(2008-2#1)(2008-3#1)(2010-4#2)
x (1 -##2##3##(2008-10#1)(2011-2#1)
x )##2##2##(1992-5#1)(2008-11#1)
x 0##13##2##(1997-7#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#2)
x 1##13##2##(1997-8#2)(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
x 10##13##2##(1992-3#1)(1993-9#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-4#1)
x 10(-)(3) M)##2##3##(1997-7#2)
x 10(-)(3)##4##2##(1997-7#4)
x 10(-1) mol 1(-1)##3##4##(2008-10#3)
x 10(-1) mol##4##3##(2008-10#4)
x 10(-1)##7##2##(1992-12#1)(2008-10#6)
x 10(-10) M##10##3##(1990-8#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-10#2)
x 10(-10) M)##2##3##(1991-5#1)(1995-5#1)
x 10(-10) and##2##3##(1995-11#1)(2008-3#1)
x 10(-10) cm(-1) Hz(-1/2)##2##4##(2008-3#2)
x 10(-10) mol l(-1)##2##4##(2008-10#2)
x 10(-10) mol##3##3##(2008-10#2)(2013-8#1)
x 10(-10)##26##2##(1990-8#1)(1991-12#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#3)(2013-8#1)
x 10(-10)M##2##2##(1994-6#1)(2008-10#1)
x 10(-10)mol##2##2##(2008-10#2)
x 10(-11) M##2##3##(2008-10#1)(2008-11#1)
x 10(-11) mol 1(-1) (AdS-DPV)##2##5##(2008-10#2)
x 10(-11) to 1 x##2##5##(2008-10#1)(2008-2#1)
x 10(-11) to##3##3##(2008-10#2)(2008-2#1)
x 10(-11)##9##2##(1995-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)
x 10(-12)##5##2##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
x 10(-13)##2##2##(1990-12#1)(2008-3#1)
x 10(-14)##2##2##(2008-3#2)
x 10(-15)##2##2##(1997-5#1)(2007-12#1)
x 10(-16)##3##2##(2007-12#1)(2008-3#2)
x 10(-17)##2##2##(2007-12#1)(2008-3#1)
x 10(-19) cm(2)##2##3##(2008-3#2)
x 10(-19)##3##2##(2008-3#3)
x 10(-2) M##2##3##(2008-10#2)
x 10(-2) per Sv for the##2##6##(1996-6#2)
x 10(-2) per Sv##4##4##(1996-6#4)
x 10(-2)##10##2##(1996-6#4)(2008-10#4)(2008-3#1)(2009-6#1)
x 10(-2))##3##2##(2008-10#3)
x 10(-2)mol##2##2##(2008-10#2)
x 10(-20) cm(2)##5##3##(2008-2#3)(2008-3#2)
x 10(-3) in##2##3##(2008-2#1)(2008-3#1)
x 10(-3) kg m(-1) s(-1)##2##5##(2008-7#2)
x 10(-3) mg/L for##4##4##(2008-10#4)
x 10(-3) mol l(-1)##4##4##(2008-10#4)
x 10(-3) s-1##3##3##(1992-6#1)(1994-5#1)(1995-11#1)
x 10(-3) sr(-1) for the##2##5##(2008-3#2)
x 10(-3) sr(-1)##3##3##(2008-3#3)
x 10(-3)##38##2##(1990-8#1)(1991-12#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-2#1)(2008-10#11)(2008-2#6)(2008-3#12)(2008-7#2)
x 10(-3)M##2##2##(2008-10#2)
x 10(-3)mol##2##2##(2008-10#2)
x 10(-4 )pg/cell##2##3##(2008-11#2)
x 10(-4) M and##2##4##(1991-8#1)(2008-2#1)
x 10(-4) M##8##3##(1991-8#1)(1992-8#2)(2008-10#2)(2008-11#1)(2008-2#2)
x 10(-4) and##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
x 10(-4) days l-1 (S##2##5##(1993-8#2)
x 10(-4) for##3##3##(2008-10#1)(2008-3#2)
x 10(-4) m(-1) [Appl##2##4##(2008-2#2)
x 10(-4) m(-1)##3##3##(2008-2#3)
x 10(-4) mg aragonite per mm(2) of pellet at##2##9##(2008-10#2)
x 10(-4) mg##4##3##(2008-10#4)
x 10(-4) rad##2##3##(2008-3#2)
x 10(-4) s-1 for##2##4##(1992-6#2)
x 10(-4) standard liters/s##2##4##(2008-2#2)
x 10(-4) with##2##3##(2008-3#2)
x 10(-4)##53##2##(1990-8#1)(1991-8#1)(1992-6#2)(1992-8#2)(1993-8#2)(1994-5#1)(1995-11#1)(1996-12#2)(1997-2#1)(2007-11#1)(2008-10#13)(2008-11#3)(2008-2#10)(2008-3#13)
x 10(-4)M range in##3##4##(2008-10#3)
x 10(-4)M##7##2##(2008-10#7)
x 10(-4)moll(-1)##5##2##(2008-10#5)
x 10(-40) cm6/s##2##3##(2008-3#2)
x 10(-5) M and##2##4##(1992-6#1)(2008-10#1)
x 10(-5) M or greater##2##5##(1994-5#2)
x 10(-5) M##9##3##(1991-8#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-5#2)(2008-10#2)
x 10(-5) and##2##3##(2008-10#1)(2008-3#1)
x 10(-5) days l-1)##2##4##(1993-8#2)
x 10(-5) mol l(-1)##2##4##(2008-10#2)
x 10(-5) mol##4##3##(1996-5#1)(2008-10#3)
x 10(-5) to 1##4##4##(2008-10#4)
x 10(-5) to 2##3##4##(2008-10#3)
x 10(-5) to##9##3##(2008-10#9)
x 10(-5) with a##2##4##(2008-3#1)(2010-1#1)
x 10(-5)##42##2##(1990-8#1)(1991-8#1)(1992-6#2)(1993-8#3)(1994-11#1)(1994-5#2)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-2#4)(2008-3#6)(2010-1#1)(2010-4#1)
x 10(-5))##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
x 10(-5))-(1##3##2##(2008-10#3)
x 10(-5)M##5##2##(1995-8#1)(2008-10#4)
x 10(-5)mol l(-1)##2##3##(2008-10#2)
x 10(-5)mol##3##2##(2008-10#3)
x 10(-5)moll(-1)##2##2##(2008-10#2)
x 10(-6) K(-1) and##2##4##(2008-3#2)
x 10(-6) K(-1)##4##3##(2008-3#4)
x 10(-6) M with##2##4##(1991-5#1)(2008-10#1)
x 10(-6) M##9##3##(1991-5#3)(1991-8#1)(1994-5#1)(1995-11#1)(1996-12#1)(2008-10#2)
x 10(-6) M)##3##3##(1991-5#1)(1992-5#1)(2008-10#1)
x 10(-6) and 1##5##4##(1995-11#2)(2008-10#3)
x 10(-6) and##7##3##(1995-11#2)(2008-10#4)(2008-3#1)
x 10(-6) cm/s for##2##4##(1992-3#2)
x 10(-6) mol l(-1) for##2##5##(2008-10#2)
x 10(-6) mol l(-1)##5##4##(2008-10#5)
x 10(-6) mol##8##3##(2008-10#7)(2013-8#1)
x 10(-6) to 1##4##4##(2008-10#4)
x 10(-6) to##6##3##(2008-10#6)
x 10(-6)##51##2##(1990-8#2)(1991-5#4)(1991-8#1)(1992-3#2)(1992-5#1)(1994-5#1)(1995-11#3)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#22)(2008-3#9)(2008-5#1)(2009-11#1)(2013-8#1)
x 10(-6)-1 x 10(-4)M##2##4##(2008-10#2)
x 10(-6)-1 x##4##3##(2008-10#4)
x 10(-6)-1##6##2##(2008-10#6)
x 10(-6)-2 x 10(-4)M range in##2##6##(2008-10#2)
x 10(-6)-2 x 10(-4)M##3##4##(2008-10#3)
x 10(-6)M for##2##3##(2008-10#2)
x 10(-6)M with##2##3##(2008-10#2)
x 10(-6)M##7##2##(2008-10#7)
x 10(-6)mol L(-1)##3##3##(2008-10#3)
x 10(-6)mol l(-1)##3##3##(2008-10#3)
x 10(-6)mol##6##2##(2008-10#6)
x 10(-6)mug ml(-1) for##2##4##(2008-10#2)
x 10(-7) M##7##3##(1990-10#1)(1990-2#1)(1993-8#1)(1995-11#1)(2008-10#3)
x 10(-7) M)##3##3##(1992-5#1)(1994-12#1)(1994-2#1)
x 10(-7) cm(-1)##2##3##(2008-3#1)(2013-8#1)
x 10(-7) mol l(-1) for##3##5##(2008-10#3)
x 10(-7) mol l(-1)##7##4##(2008-10#7)
x 10(-7) mol##11##3##(2008-10#11)
x 10(-7) to##12##3##(2008-10#11)(2008-3#1)
x 10(-7)##45##2##(1990-10#1)(1990-2#1)(1990-8#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-5#1)(2008-10#27)(2008-12#1)(2008-2#2)(2008-3#4)(2008-9#1)(2013-8#1)
x 10(-7)M for##4##3##(2008-10#4)
x 10(-7)M##7##2##(2008-10#7)
x 10(-7)mol L(-1) and##3##4##(2008-10#3)
x 10(-7)mol l(-1)##2##3##(2008-10#2)
x 10(-7)mol##5##2##(2008-10#5)
x 10(-8) M CXB##2##4##(2008-10#2)
x 10(-8) M##12##3##(1991-5#1)(1992-5#2)(1992-8#1)(1995-5#1)(1997-4#1)(2008-10#6)
x 10(-8) cm(2)/W##2##3##(2008-3#2)
x 10(-8) g ml(-1)##3##4##(2008-10#3)
x 10(-8) mol##2##3##(2008-10#2)
x 10(-8) to 1##3##4##(2008-10#2)(2013-8#1)
x 10(-8) to 2##3##4##(1994-12#1)(2008-10#2)
x 10(-8) to##8##3##(1994-12#1)(2008-10#6)(2013-8#1)
x 10(-8)##36##2##(1991-5#1)(1992-5#2)(1992-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-4#1)(2008-10#20)(2008-3#6)(2009-11#1)(2013-8#1)
x 10(-8)M##2##2##(2008-10#2)
x 10(-8)mol L(-1)##2##3##(2008-10#2)
x 10(-8)mol/L##2##2##(2008-10#2)
x 10(-9) M##9##3##(1991-5#1)(1993-11#2)(1994-2#1)(1995-11#1)(2008-10#4)
x 10(-9) and 4##2##4##(2008-10#2)
x 10(-9) and 5##2##4##(1995-11#1)(2008-10#1)
x 10(-9) and##5##3##(1995-11#1)(2008-10#3)(2008-3#1)
x 10(-9) cm(-1)##2##3##(2008-3#2)
x 10(-9) to##2##3##(2008-10#2)
x 10(-9)##29##2##(1991-5#1)(1992-5#1)(1993-11#2)(1994-2#1)(1995-11#3)(1997-5#1)(2008-10#13)(2008-2#1)(2008-3#5)(2008-8#1)
x 10(-9)/cm##2##2##(2007-12#1)(2008-2#1)
x 10(-9)M##4##2##(1994-6#1)(2008-10#3)
x 10(-9)mol##2##2##(2008-10#2)
x 10(-9)molL(-1)##2##2##(2008-10#2)
x 10(1) TCID(50)##3##3##(2009-6#3)
x 10(10)##5##2##(1991-8#1)(2008-10#1)(2008-11#2)(2008-6#1)
x 10(11)##4##2##(2008-3#1)(2008-8#2)(2010-1#1)
x 10(12)##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
x 10(18) cm(-3)##2##3##(2008-3#2)
x 10(2)##3##2##(2008-10#1)(2009-3#1)(2009-7#1)
x 10(3) Pa##6##3##(2008-10#6)
x 10(3) Pa)##2##3##(2008-10#2)
x 10(3) and##2##3##(2008-10#2)
x 10(3) cm(-)(1) (epsilon =##2##5##(1997-7#2)
x 10(3) cm(-)(1) )##2##4##(1997-7#2)
x 10(3) cm(-)(1)##5##3##(1997-7#5)
x 10(3) to##2##3##(2008-10#2)
x 10(3)##34##2##(1992-12#1)(1996-12#3)(1996-5#1)(1997-7#5)(2008-10#20)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)
x 10(4) 1 mol(-1)##2##4##(2008-10#2)
x 10(4) M-1 and##2##4##(1994-5#2)
x 10(4) M-1##5##3##(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#1)
x 10(4) l mol(-1) cm(-1) and##3##6##(2008-10#3)
x 10(4) l mol(-1) cm(-1)##5##5##(2008-10#5)
x 10(4)##33##2##(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#2)(1997-3#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-6#1)
x 10(4))##2##2##(1991-9#1)(1995-2#1)
x 10(5) J mol(-1)##2##4##(2008-3#2)
x 10(5) and##3##3##(1994-5#1)(2008-10#2)
x 10(5) cells ml(-1)##2##4##(2008-10#1)(2008-11#1)
x 10(5) cells per##2##4##(1995-3#1)(2010-6#1)
x 10(5) cells##6##3##(1995-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)
x 10(5) conidia##2##3##(2008-10#2)
x 10(5) ml-1##2##3##(1994-5#2)
x 10(5) times##2##3##(1995-2#1)(2008-3#1)
x 10(5)##47##2##(1990-5#2)(1992-10#1)(1993-12#1)(1994-5#4)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#6)(2008-9#2)(2010-4#1)(2010-6#1)(2013-8#1)
x 10(5))##4##2##(1991-9#1)(2008-10#2)(2008-4#1)
x 10(5)CFU/ml##2##2##(2008-10#2)
x 10(6) CFU##3##3##(2008-10#3)
x 10(6) CFU/ml of##2##4##(2008-10#2)
x 10(6) IU##2##3##(1990-12#1)(1992-2#1)
x 10(6) M-1 s-1##3##4##(1993-8#1)(1994-5#2)
x 10(6) M-1##6##3##(1992-10#1)(1993-1#1)(1993-8#1)(1994-5#2)(1995-2#1)
x 10(6) M-1)##3##3##(1992-4#3)
x 10(6) U in the##3##5##(1990-8#3)
x 10(6) and##4##3##(1991-12#1)(1994-5#1)(2008-11#1)(2008-7#1)
x 10(6) c/ml##2##3##(2008-11#2)
x 10(6) cells ml(-1)##6##4##(2008-10#1)(2008-11#5)
x 10(6) cells ml(-1))##3##4##(2008-11#3)
x 10(6) cells##11##3##(1991-12#1)(2008-10#1)(2008-11#9)
x 10(6) cells/ml##4##3##(2008-11#2)(2008-7#2)
x 10(6) conidia per##3##4##(2008-10#3)
x 10(6) conidia##4##3##(2008-10#4)
x 10(6) ml(-1)##3##3##(2008-11#3)
x 10(6) ml-1##2##3##(1994-5#2)
x 10(6) to##2##3##(1994-5#1)(2008-10#1)
x 10(6) vs##2##3##(1991-12#1)(2008-11#1)
x 10(6)##79##2##(1990-12#2)(1990-8#4)(1991-12#4)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#3)(1993-1#1)(1993-8#1)(1993-9#1)(1994-5#6)(1995-2#1)(1996-5#1)(2008-10#21)(2008-11#19)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#4)(2008-9#2)(2010-4#1)
x 10(6))##2##2##(2008-10#1)(2008-11#1)
x 10(7) M-1##4##3##(1995-2#4)
x 10(7) cells ml(-1)##6##4##(2008-10#1)(2008-11#5)
x 10(7) cells##8##3##(1994-5#1)(2008-10#1)(2008-11#6)
x 10(7) conidia per ml)##2##5##(2008-10#2)
x 10(7)##30##2##(1990-8#1)(1994-5#2)(1995-2#4)(2008-10#11)(2008-11#9)(2008-2#1)(2008-7#1)(2008-9#1)
x 10(8) CFU/g of##2##4##(2008-10#2)
x 10(8) M(-1)##2##3##(2008-8#2)
x 10(8) M-1##2##3##(1991-12#1)(1993-1#1)
x 10(8) U/mg##2##3##(1990-12#2)
x 10(8) and##2##3##(1990-12#1)(1997-5#1)
x 10(8)##21##2##(1990-12#3)(1990-5#1)(1991-12#1)(1991-5#1)(1993-1#1)(1996-2#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-8#3)(2008-9#1)
x 10(9) cells in the##2##5##(2008-11#2)
x 10(9) cells##4##3##(2008-10#1)(2008-11#3)
x 10(9) s(-1)##2##3##(2008-8#2)
x 10(9)##17##2##(1990-11#2)(1995-2#1)(1997-5#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-4#1)
x 10(9)mol(-1)##2##2##(2008-10#2)
x 10(9)mol(-1))##2##2##(2008-10#2)
x 10-4##2##2##(2010-2#2)
x 100##6##2##(1990-12#1)(1992-12#1)(2007-11#1)(2009-11#2)(2011-2#1)
x 104 cell/well##2##3##(2007-11#2)
x 105##3##2##(2008-10#1)(2008-11#2)
x 108##2##2##(2008-10#2)
x 109/l##4##2##(2008-10#4)
x 12##4##2##(1994-11#1)(2008-1#1)(2008-10#1)(2012-3#1)
x 128##5##2##(1991-2#1)(1997-8#1)(2008-2#2)(2008-3#1)
x 15##3##2##(2008-12#1)(2008-3#1)(2009-11#1)
x 150##2##2##(2008-3#1)(2012-3#1)
x 18##3##2##(2008-2#2)(2009-5#1)
x 2 cm##6##3##(1994-7#1)(2008-3#2)(2010-3#1)(2010-6#1)(2011-2#1)
x 2 mm##2##3##(1997-2#1)(2008-3#1)
x 2##35##2##(1994-3#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-9#2)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#9)(2008-5#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)
x 20##2##2##(2008-12#1)(2008-8#1)
x 200##2##2##(1995-8#1)(2008-12#1)
x 21##3##2##(2008-3#3)
x 25##3##2##(2008-11#2)(2008-3#1)
x 3 cm##2##3##(2008-12#1)(2009-5#1)
x 3##15##2##(1991-5#2)(1994-2#2)(2008-10#3)(2008-12#2)(2008-3#5)(2009-5#1)
x 4 mm##4##3##(2007-12#3)(2009-7#1)
x 4##30##2##(1990-8#1)(1991-5#1)(1993-9#1)(1996-5#2)(1997-2#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-2#3)(2008-3#5)(2008-5#1)(2009-7#1)(2009-8#1)(2011-1#2)
x 40 cm)##2##3##(2008-3#1)(2008-6#1)
x 40##6##2##(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)
x 480##2##2##(2007-12#1)(2008-3#1)
x 4mm##2##2##(2008-10#2)
x 5 days) +##2##4##(1992-2#2)
x 5 mm##2##3##(2008-10#1)(2013-8#1)
x 5##13##2##(1992-2#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-9#1)(2011-2#1)(2013-8#1)
x 50 microns##2##3##(1996-5#2)
x 50##3##2##(1996-5#2)(2008-12#1)
x 6##4##2##(2008-2#1)(2008-3#2)(2011-2#1)
x 7##4##2##(1993-9#1)(2008-3#1)(2010-11#1)(2011-1#1)
x 75mum capillary using a nonaqueous solution##2##7##(2008-10#2)
x 8 cm##2##3##(1994-7#1)(2012-3#1)
x 8 x##2##3##(2008-3#1)(2011-2#1)
x 8##15##2##(1993-9#2)(1994-7#1)(2008-10#1)(2008-2#4)(2008-3#5)(2011-2#1)(2012-3#1)
x = 0##2##3##(2007-11#1)(2010-4#1)
x = 2##2##3##(1996-2#2)
x =##7##2##(1995-12#1)(1996-2#3)(2007-11#1)(2008-5#1)(2010-4#1)
x A##8##2##(1993-11#5)(2008-10#3)
x B37HtN##2##2##(2008-10#2)
x BMR##3##2##(2008-9#3)
x C##6##2##(1993-11#2)(2008-10#2)(2008-12#1)(2008-6#1)
x D##4##2##(2008-10#3)(2010-2#1)
x G##2##2##(2008-10#1)(2008-9#1)
x Hor2596##3##2##(2008-10#3)
x L##2##2##(2008-10#2)
x L(-1)##8##2##(2011-3#4)(2013-8#4)
x L(-1))##5##2##(2011-3#5)
x MX169##3##2##(2008-10#3)
x N##3##2##(2008-3#3)
x P##9##2##(2008-10#9)
x SP##5##2##(2008-10#5)
x Tex6##6##2##(2008-10#6)
x age +##2##3##(2008-3#2)
x ananassa##3##2##(2008-10#3)
x and y##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
x and##10##2##(1992-8#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)
x cm(-2)##2##2##(2011-3#2)
x cultivar interaction##2##3##(2008-10#2)
x cultivar##3##2##(2008-10#3)
x domestica##2##2##(2008-10#2)
x environment##2##2##(2008-10#2)
x g supernatant##2##3##(1992-2#1)(1994-11#1)
x g##3##2##(1992-2#1)(1992-8#1)(1994-11#1)
x g(av) pellet##2##3##(1992-11#2)
x is the##2##3##(2008-10#1)(2008-2#1)
x is##3##2##(2008-10#2)(2008-2#1)
x kg(-1) and##5##3##(2011-3#1)(2013-8#4)
x kg(-1)##12##2##(2011-3#2)(2013-8#10)
x mL(-1) for ethinylestradiol##2##4##(2011-3#2)
x mL(-1) for gestodene and etonogestrel and##2##7##(2011-3#2)
x mL(-1) for##4##3##(2011-3#4)
x mL(-1)##5##2##(2011-3#4)(2013-8#1)
x min(-1) could##2##3##(2008-3#1)(2013-8#1)
x min(-1)##11##2##(2008-3#4)(2011-3#4)(2012-3#1)(2013-8#2)
x p##2##2##(1995-12#1)(2008-3#1)
x rays are##2##3##(2008-3#2)
x rays in the##3##4##(2007-12#1)(2008-3#2)
x rays in##5##3##(2007-12#1)(2008-3#4)
x rays##20##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#12)
x shift##2##2##(2008-10#1)(2008-2#1)
x susceptible##2##2##(2008-10#2)
x##1494##1##(1990-10#2)(1990-11#3)(1990-12#9)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#17)(1991-12#7)(1991-2#1)(1991-5#13)(1991-6#2)(1991-8#4)(1991-9#2)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#6)(1992-6#5)(1992-8#8)(1993-1#3)(1993-11#9)(1993-12#2)(1993-3#1)(1993-8#14)(1993-9#10)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#23)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#16)(1995-12#5)(1995-2#15)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-12#7)(1996-2#7)(1996-3#1)(1996-5#9)(1996-6#4)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#5)(1997-7#11)(1997-8#4)(2007-11#15)(2007-12#27)(2008-1#1)(2008-10#576)(2008-11#64)(2008-12#14)(2008-2#74)(2008-3#211)(2008-4#9)(2008-5#10)(2008-6#9)(2008-7#21)(2008-8#16)(2008-9#17)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#6)(2009-7#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-2#5)(2010-3#2)(2010-4#11)(2010-6#3)(2010-8#2)(2011-1#7)(2011-2#15)(2011-3#26)(2012-12#2)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#30)
x((3))##4##1##(2007-12#4)
x(-)##3##1##(2008-11#3)
x)##3##1##(1992-5#1)(2008-10#1)(2009-10#1)
x-##2##1##(2008-10#1)(2012-3#1)
x-linked##2##1##(2007-10#1)(2007-2#1)
x-p correlation##2##2##(2007-12#2)
x-p##3##1##(2007-12#3)
x-ray absorptiometry in the##2##4##(2008-4#1)(2008-8#1)
x-ray absorptiometry##4##2##(2008-12#1)(2008-4#1)(2008-8#1)(2010-1#1)
x-ray absorption##4##2##(2008-3#1)(2012-2#3)
x-ray analysis##2##2##(2008-2#2)
x-ray and optical##2##3##(2008-2#1)(2012-12#1)
x-ray and##4##2##(2008-1#1)(2008-2#1)(2011-2#1)(2012-12#1)
x-ray beams##4##2##(1993-9#1)(2007-11#1)(2008-2#1)(2012-12#1)
x-ray computed##2##2##(1997-5#1)(2011-1#1)
x-ray crystallographic##3##2##(1991-12#1)(1991-3#1)(1994-8#1)
x-ray crystallography##3##2##(1992-12#1)(1994-8#1)(2009-10#1)
x-ray data##2##2##(2008-2#1)(2012-1#1)
x-ray diffraction (XRD)##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
x-ray diffraction analysis##2##3##(2008-2#2)
x-ray diffraction measurements##2##3##(1995-6#1)(2008-3#1)
x-ray diffraction##20##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-8#1)(1995-6#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#2)(2010-4#1)
x-ray emission##3##2##(2008-2#1)(2010-1#1)(2012-2#1)
x-ray energies##2##2##(2008-3#2)
x-ray energy##3##2##(2008-3#3)
x-ray examination##3##2##(1990-9#1)(1996-6#1)(2007-8#1)
x-ray fluorescence##2##2##(2008-3#2)
x-ray image##2##2##(2007-11#1)(2008-3#1)
x-ray images##5##2##(2007-11#1)(2007-8#1)(2008-3#3)
x-ray imaging##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
x-ray in##3##2##(2007-11#1)(2008-8#1)(2012-3#1)
x-ray laser##6##2##(1993-5#1)(2007-11#3)(2007-12#1)(2012-2#1)
x-ray microscope designs##2##3##(2008-3#2)
x-ray microscope##3##2##(2008-3#3)
x-ray of the##2##3##(1991-6#1)(2012-12#1)
x-ray optical##2##2##(2007-11#1)(2012-2#1)
x-ray optics##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
x-ray pencil beam##2##3##(2008-3#1)(2012-12#1)
x-ray photoelectron spectroscopy##5##3##(2007-12#1)(2008-2#4)
x-ray photoelectron##6##2##(2007-12#1)(2008-2#4)(2009-11#1)
x-ray pulse##2##2##(2008-3#2)
x-ray pulses##3##2##(2007-11#3)
x-ray radiation##2##2##(2007-11#1)(2008-3#1)
x-ray scattering##5##2##(2008-2#1)(2008-3#1)(2008-5#2)(2009-6#1)
x-ray source##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#1)
x-ray sources##4##2##(2008-3#3)(2010-1#1)
x-ray spectrometer for laser-fusion experiments##2##5##(2008-2#2)
x-ray spectrometer##3##2##(2008-2#2)(2008-3#1)
x-ray streak camera##2##3##(2007-11#2)
x-ray streak##3##2##(2007-11#3)
x-ray studies##2##2##(1992-6#1)(2012-12#1)
x-ray telescope##2##2##(2008-2#1)(2008-3#1)
x-ray##191##1##(1990-12#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-8#2)(1995-6#1)(1996-6#1)(1997-5#1)(2007-11#32)(2007-12#7)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#21)(2008-3#44)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-6#1)(2010-1#8)(2010-12#5)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#6)(2012-12#8)(2012-2#7)(2012-3#1)(2013-1#1)
x-rays and##4##2##(1992-6#1)(2008-9#1)(2011-1#1)(2012-12#1)
x-rays of the##3##3##(2007-11#3)
x-rays##18##1##(1992-6#1)(1995-6#1)(1995-8#1)(2007-11#6)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#3)
x// 1##3##2##(2009-1#3)
x1##2##1##(1995-12#1)(2007-11#1)
x10(-5)##2##1##(2008-2#2)
x2##2##1##(1995-12#1)(2008-10#1)
x3##3##1##(2008-10#2)(2008-11#1)
x4##5##1##(2008-10#4)(2013-1#1)
x=0##3##1##(2008-10#3)
xa5##5##1##(2008-10#5)
xagP##2##1##(2008-10#2)
xanthan gum##2##2##(2011-1#1)(2012-2#1)
xanthan##4##1##(2008-10#2)(2011-1#1)(2012-2#1)
xanthate##6##1##(2008-10#6)
xanthene dye##2##2##(2008-10#2)
xanthene dyes##3##2##(2008-10#1)(2008-3#2)
xanthene##6##1##(1993-12#1)(2008-10#3)(2008-3#2)
xanthenone##3##1##(1993-12#1)(2008-11#2)
xanthii##3##1##(2008-10#3)
xanthine amine congener##2##3##(2007-8#2)
xanthine derivatives##2##2##(1997-3#1)(2011-2#1)
xanthine oxidase (XO)##2##3##(2008-10#1)(2008-11#1)
xanthine oxidase and##2##3##(1990-5#1)(2008-11#1)
xanthine oxidase##15##2##(1990-5#1)(1991-9#4)(1993-12#2)(1993-6#1)(1996-9#2)(2008-10#2)(2008-11#3)
xanthine##30##1##(1990-5#1)(1991-9#8)(1992-8#1)(1993-12#4)(1993-6#1)(1995-12#1)(1996-9#3)(1997-3#1)(2007-8#2)(2008-10#2)(2008-11#4)(2011-1#1)(2011-2#1)
xanthoastrocytoma##6##1##(2008-12#2)(2008-7#3)(2013-8#1)
xanthogranulomatous pyelonephritis##3##2##(2008-1#1)(2013-1#2)
xanthogranulomatous##5##1##(1991-8#2)(2008-1#1)(2013-1#2)
xanthomonads##4##1##(2008-10#4)
xanthomonas strains##2##2##(2008-10#2)
xanthomonas##4##1##(2008-10#4)
xanthophores##3##1##(2008-5#3)
xanthorrhiza##2##1##(1996-9#2)
xanthosine##5##1##(1997-2#2)(2009-12#3)
xcolumbiana##5##1##(2008-10#5)
xemilofiban##3##1##(2008-5#3)
xeno-endothelial cells##2##2##(2008-8#2)
xenobiotic metabolism##2##2##(1990-3#1)(2013-1#1)
xenobiotic##9##1##(1990-3#1)(1993-11#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2013-1#1)
xenobiotic-metabolizing##3##1##(1990-7#1)(1991-9#1)(1995-9#1)
xenobiotics and##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)
xenobiotics in the##5##3##(1990-6#1)(2008-10#1)(2008-11#3)
xenobiotics in##8##2##(1990-6#1)(1994-3#1)(2008-10#1)(2008-11#5)
xenobiotics##26##1##(1990-6#1)(1994-3#1)(1994-8#1)(2008-10#5)(2008-11#11)(2008-12#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-11#1)(2012-2#1)
xenogeneic##8##1##(1995-11#1)(2011-2#3)(2012-3#3)(2013-7#1)
xenograft in##3##2##(1993-9#1)(2007-8#1)(2008-6#1)
xenograft model of##2##3##(2008-8#1)(2010-3#1)
xenograft models##6##2##(2009-4#1)(2011-1#3)(2011-2#1)(2012-2#1)
xenograft##30##1##(1993-9#6)(2007-8#6)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)
xenografted##6##1##(1993-9#1)(2008-11#3)(2013-1#2)
xenografts in nude mice##2##4##(2008-6#1)(2008-8#1)
xenografts in##7##2##(1997-7#1)(2008-6#3)(2008-8#1)(2013-1#1)(2013-7#1)
xenografts were##3##2##(1997-7#2)(2009-3#1)
xenografts##29##1##(1991-6#2)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#2)(1997-7#7)(2008-6#3)(2008-8#1)(2009-3#3)(2009-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
xenon lamp##3##2##(2007-11#1)(2008-10#2)
xenon plasma##2##2##(2008-3#2)
xenon##19##1##(1991-9#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2010-12#4)
xenotransplantation##4##1##(1995-11#3)(2008-7#1)
xenotransplants##2##1##(1992-9#2)
xenotropic##2##1##(1990-5#1)(1992-9#1)
xerogels##2##1##(2008-2#2)
xeromorphic##2##1##(2012-9#1)(2013-7#1)
xerophthalmia##5##1##(1991-8#3)(2006-10#1)(2007-7#1)
xerosis and##2##2##(2008-5#2)
xerosis##15##1##(1991-8#1)(2008-5#14)
xerostomia##6##1##(1993-9#1)(2006-10#2)(2007-7#1)(2008-5#1)(2013-1#1)
xerotic skin##7##2##(2008-5#7)
xerotic##8##1##(2008-5#8)
xi##6##1##(2007-12#1)(2008-3#5)
xii##2##1##(1990-11#1)(1990-8#1)
xipamide##2##1##(1991-8#1)(1992-11#1)
xiv##3##1##(1990-11#1)(1990-3#1)(1990-8#1)
xorIIM homolog##2##2##(2008-10#2)
xpolyantha##2##1##(2008-10#2)
xrFNDI##2##1##(2008-4#2)
xrs-6##2##1##(1996-2#2)
xuefu zhuyu##3##2##(2012-3#1)(2013-8#2)
xviii##2##1##(1990-11#1)(1990-3#1)
xylE and##2##2##(1990-5#1)(1994-12#1)
xylE gene##2##2##(1990-5#1)(1994-12#1)
xylE##7##1##(1990-5#2)(1994-12#5)
xylan and##2##2##(2011-1#1)(2013-1#1)
xylan hydrolysis in##3##3##(2013-1#3)
xylan hydrolysis##4##2##(2013-1#4)
xylan##17##1##(2008-8#2)(2011-1#6)(2013-1#9)
xylanase activity##2##2##(2008-10#1)(2008-6#1)
xylanase and##2##2##(2008-6#2)
xylanase from alkalothermophilic Bacillus sp##2##5##(1993-3#2)
xylanase from##3##2##(1993-3#2)(2008-10#1)
xylanase genes##2##2##(2008-10#1)(2013-1#1)
xylanase partition coefficient##2##3##(2008-6#2)
xylanase productivity##3##2##(2008-6#3)
xylanase##23##1##(1993-3#3)(2008-10#4)(2008-6#14)(2011-2#1)(2013-1#1)
xylanases and##2##2##(2011-2#1)(2013-1#1)
xylanases from##2##2##(2008-6#1)(2013-1#1)
xylanases##8##1##(2008-10#1)(2008-6#3)(2011-2#1)(2013-1#3)
xylanolytic bacterium##2##2##(2008-8#2)
xylanolytic##3##1##(2008-10#1)(2008-8#2)
xylariaceous##2##1##(2008-11#2)
xylazine##7##1##(2012-3#7)
xylem and phloem##4##3##(2008-10#1)(2012-8#3)
xylem and##6##2##(2008-10#2)(2008-11#1)(2012-8#3)
xylem elements##2##2##(2007-12#1)(2008-10#1)
xylem flow##2##2##(2008-11#2)
xylem of##5##2##(2008-10#1)(2008-7#1)(2012-8#3)
xylem parenchyma cells##3##3##(2008-10#1)(2008-11#2)
xylem structure##2##2##(2012-5#2)
xylem vessels and##2##3##(2007-12#1)(2008-10#1)
xylem vessels of##3##3##(2007-12#1)(2008-10#2)
xylem vessels##10##2##(2007-12#2)(2008-10#8)
xylem##50##1##(2007-12#3)(2008-10#28)(2008-11#6)(2008-7#1)(2009-8#1)(2012-5#4)(2012-8#7)
xylem-limited##3##1##(2008-10#3)
xylene and##2##2##(1994-8#1)(2008-10#1)
xylene as##3##2##(2008-10#3)
xylene in##2##2##(2008-10#2)
xylene##28##1##(1994-8#1)(2008-10#27)
xylenes##4##1##(2008-10#3)(2008-4#1)
xylenol orange (XO)##2##3##(2008-10#2)
xylenol orange##8##2##(2008-10#8)
xylitol production by biotechnological##2##4##(2008-6#2)
xylitol##8##1##(1994-8#1)(2008-6#7)
xyloglucan##2##1##(2008-9#1)(2010-5#1)
xylonic acid##3##2##(2008-6#3)
xylophilus##8##1##(2008-10#8)
xyloporosis##4##1##(2008-10#4)
xylose and arabinose##2##3##(2008-6#1)(2011-1#1)
xylose and##6##2##(2008-6#4)(2011-1#1)(2012-3#1)
xylose as a sole##2##4##(2008-10#1)(2012-3#1)
xylose fermentation##4##2##(2008-6#2)(2012-3#2)
xylose reductase from##3##3##(1995-8#1)(2008-6#2)
xylose reductase##8##2##(1995-8#2)(2008-6#6)
xylose strain##2##2##(2008-6#2)
xylose utilization of##2##3##(2012-3#2)
xylose utilization##5##2##(2008-6#2)(2012-3#3)
xylose was##2##2##(2008-6#2)
xylose##61##1##(1995-8#3)(1996-6#2)(2008-10#5)(2008-11#1)(2008-6#34)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#11)(2013-1#2)
xylose-fermenting##3##1##(2008-6#3)
xylostella on##2##2##(2011-2#2)
xylostella##13##1##(2010-4#4)(2011-2#9)
y = 0##4##3##(1993-8#1)(1995-2#3)
y =##6##2##(1993-8#1)(1995-2#3)(1995-6#1)(2007-11#1)
y is##4##2##(1995-12#1)(2008-10#2)(2008-11#1)
y##56##1##(1993-8#1)(1995-12#2)(1995-2#3)(1995-6#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#5)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
y)##8##1##(2008-10#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-10#1)(2012-2#1)
y-axis##2##1##(2008-10#1)(2013-8#1)
y/o)##4##1##(2011-2#4)
yTAFII145##2##1##(1997-3#2)
yak meat##3##2##(2010-4#3)
yak##6##1##(2010-4#6)
yaks (Bos grunniens) with keratoconjunctivitis##2##5##(2011-2#2)
yaks with keratoconjunctivitis##2##3##(2011-2#2)
yaks##11##1##(2011-2#11)
yallundae and T##5##3##(2008-10#5)
yallundae and##6##2##(2008-10#6)
yallundae##13##1##(2008-10#13)
yam##4##1##(2008-5#4)
yang##2##1##(2008-10#2)
yanguifella n##2##2##(2013-8#2)
yard##6##1##(2008-10#6)
yards##3##1##(2008-10#2)(2013-1#1)
yaw##3##1##(2008-2#1)(2008-3#1)(2010-8#1)
yb##2##1##(2008-3#2)
year 1##3##2##(1991-8#2)(2013-1#1)
year 1991##4##2##(1992-1#1)(1995-12#1)(1997-1#1)(2007-11#1)
year 1994##2##2##(1996-1#1)(1997-3#1)
year 2000##35##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-3#2)(1994-9#3)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-3#3)(1997-6#4)(2008-1#2)(2008-11#1)(2008-12#1)(2010-5#2)(2010-7#1)(2011-1#2)(2012-2#1)
year 2000]##2##2##(1993-2#1)(1996-11#1)
year 2001##4##2##(2007-6#2)(2008-5#2)
year 2002##3##2##(2008-10#1)(2008-12#2)
year 3##2##2##(2008-10#1)(2013-1#1)
year after a##4##3##(1994-12#1)(2007-10#2)(2010-3#1)
year after discharge##2##3##(2007-1#1)(2008-3#1)
year after his##2##3##(1997-6#1)(2010-1#1)
year after surgery##3##3##(2007-8#1)(2009-1#1)(2010-4#1)
year after the initial##2##4##(2013-1#2)
year after the procedure##2##4##(2008-11#1)(2010-10#1)
year after the second##3##4##(1994-7#1)(2008-6#1)(2009-5#1)
year after the##23##3##(1994-3#1)(1994-7#1)(1996-6#1)(1997-1#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-1#3)(2013-1#3)
year after transplantation##5##3##(2007-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
year after year##3##3##(2007-2#1)(2008-11#1)(2011-2#1)
year after##64##2##(1991-8#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#3)(2012-3#1)(2013-1#6)
year age group##2##3##(2008-12#2)
year and finally##2##3##(1990-10#1)(2011-2#1)
year and in##2##3##(2008-10#1)(2009-9#1)
year and location##2##3##(2008-10#2)
year and preferably indefinitely##2##4##(2009-12#2)
year and the other##2##4##(1990-12#1)(2008-8#1)
year and the##5##3##(1990-12#1)(1994-7#1)(2008-5#2)(2008-8#1)
year and then##2##3##(1995-8#1)(2008-12#1)
year and##44##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#1)(1993-9#1)(1994-3#1)(1994-7#3)(1995-8#1)(1997-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
year apart##2##2##(1994-12#1)(2008-7#1)
year are##2##2##(2006-10#1)(2008-10#1)
year as##2##2##(1992-12#1)(2008-10#1)
year at the##2##3##(2008-1#1)(2013-7#1)
year at##6##2##(1997-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-7#1)
year before the##3##3##(1990-12#1)(1990-2#1)(2010-12#1)
year before##5##2##(1990-12#1)(1990-2#1)(2010-12#1)(2011-2#1)(2013-8#1)
year by##4##2##(1992-3#1)(1994-2#1)(2007-5#1)(2012-3#1)
year duration##2##2##(2010-2#1)(2012-2#1)
year during the##3##3##(2008-1#1)(2008-10#1)(2010-8#1)
year during##6##2##(1994-1#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-8#1)
year earlier##2##2##(2008-11#1)(2011-2#1)
year experience##3##2##(2007-4#2)(2008-6#1)
year follow up##4##3##(1990-9#1)(1991-2#1)(2013-1#2)
year follow-up##8##2##(1991-2#1)(1994-2#1)(1997-8#1)(2007-8#1)(2010-3#1)(2013-1#1)(2013-8#2)
year follow-up]##2##2##(2009-5#1)(2013-1#1)
year following##4##2##(2008-10#1)(2008-6#2)(2008-9#1)
year for##10##2##(1994-12#1)(2007-9#1)(2008-10#4)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
year from the##2##3##(2007-11#1)(2008-8#1)
year from##7##2##(1992-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
year had a##3##3##(1993-9#2)(2008-10#1)
year had##6##2##(1992-6#1)(1993-9#2)(2008-10#2)(2008-11#1)
year have##2##2##(1996-2#1)(2008-7#1)
year history of##5##3##(1994-6#1)(2008-12#1)(2008-7#2)(2012-12#1)
year in France##2##3##(1991-11#1)(2012-2#1)
year in a##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
year in operation##2##3##(1994-12#2)
year in the##8##3##(1993-12#1)(1994-7#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-3#1)
year in##33##2##(1990-12#2)(1991-11#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-5#1)(1997-5#1)(2007-10#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#2)(2011-2#3)(2012-2#1)(2013-8#1)
year it##2##2##(1992-12#1)(2008-7#1)
year later##12##2##(1994-12#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-8#1)
year male##3##2##(2008-7#1)(2010-11#1)(2013-8#1)
year medical students##4##3##(2008-10#1)(2008-11#1)(2009-4#1)(2013-8#1)
year nursing##2##2##(2008-11#1)(2008-12#1)
year of a##3##3##(1995-3#1)(2008-11#1)(2008-12#1)
year of age##10##3##(1991-11#1)(1991-6#2)(1995-8#1)(2008-10#1)(2011-2#5)
year of birth##2##3##(1991-2#1)(2008-7#1)
year of diagnosis##3##3##(2011-1#2)(2012-3#1)
year of disease##2##3##(2011-1#2)
year of follow-up##3##3##(1990-5#1)(1997-4#1)(2013-1#1)
year of life##20##3##(1991-8#2)(1994-2#2)(1995-6#2)(1995-8#1)(1996-11#2)(2007-8#2)(2008-1#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2013-1#2)
year of the prospective payment system##2##6##(1991-2#1)(1992-12#1)
year of the##19##3##(1991-2#1)(1991-3#1)(1992-12#2)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
year of their##2##3##(1993-3#1)(2008-11#1)
year of transplantation##2##3##(2008-1#1)(2008-4#1)
year of treatment##4##3##(1991-11#1)(2008-5#1)(2013-1#2)
year of##123##2##(1990-11#1)(1990-5#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#3)(1992-6#1)(1993-1#1)(1993-11#2)(1993-3#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#1)(1997-1#1)(1997-4#2)(2007-10#2)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#3)(2009-12#1)(2009-7#2)(2010-3#1)(2011-1#8)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#9)(2013-8#2)
year offollow up##4##3##(2013-8#4)
year old DS cases##2##4##(1991-1#2)
year old boy with##2##4##(1991-11#1)(2010-8#1)
year old boy##7##3##(1991-11#1)(1993-6#1)(1996-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
year old child who presented with##2##6##(2007-7#1)(2010-5#1)
year old child##4##3##(1995-11#1)(2007-7#2)(2010-5#1)
year old children##2##3##(1992-1#1)(2008-1#1)
year old female with##2##4##(2011-2#1)(2012-2#1)
year old female##7##3##(1993-5#1)(1997-6#1)(2007-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
year old lady##3##3##(2007-7#2)(2010-12#1)
year old male child##2##4##(2010-4#1)(2013-1#1)
year old male##9##3##(1997-6#2)(2007-7#1)(2008-7#2)(2010-4#1)(2013-1#3)
year old man was##2##4##(2013-1#2)
year old man with##4##4##(1997-6#1)(2007-6#1)(2009-8#1)(2013-1#1)
year old man##11##3##(1990-9#1)(1992-9#1)(1997-6#1)(2007-6#1)(2007-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#3)
year old patient with##3##4##(1994-5#1)(2010-3#1)(2012-2#1)
year old patient##5##3##(1994-5#1)(2010-3#1)(2012-2#1)(2013-1#2)
year old subjects##2##3##(1994-6#1)(1996-2#1)
year old woman is presented##2##5##(1991-5#1)(2007-8#1)
year old woman##13##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-5#2)(1991-8#1)(1993-2#1)(1993-6#1)(1994-8#1)(1997-6#1)(2007-12#1)(2007-8#1)
year old##89##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#2)(1991-1#3)(1991-11#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#5)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#1)(2008-7#4)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#5)
year olds##4##2##(1997-6#1)(1997-8#1)(2009-10#1)(2013-8#1)
year on##4##2##(2008-10#2)(2009-5#1)(2010-3#1)
year or more##3##3##(1990-8#1)(2008-9#1)(2012-12#1)
year or##8##2##(1990-6#1)(1990-8#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-9#1)(2012-12#1)
year patient##3##2##(2008-1#1)(2008-8#2)
year period##33##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-9#1)(1992-11#2)(1994-2#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
year period]##2##2##(1993-9#1)(2008-10#1)
year post-treatment##2##2##(2008-6#1)(2010-8#1)
year retrospective study##2##3##(2008-8#1)(2011-1#1)
year retrospective##3##2##(2008-8#1)(2011-1#2)
year review##2##2##(2007-7#1)(2008-7#1)
year risk##2##2##(2008-1#1)(2013-7#1)
year round##3##2##(2008-5#1)(2009-4#1)(2013-7#1)
year since##5##2##(1993-9#1)(1994-9#1)(2008-2#1)(2010-10#1)(2011-2#1)
year students of##2##3##(1997-3#1)(2013-1#1)
year students##4##2##(1997-3#1)(2008-12#2)(2013-1#1)
year study was conducted##2##4##(2008-5#1)(2011-2#1)
year study was##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
year study##6##2##(2007-7#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)
year survival rate##4##3##(1990-6#2)(2008-6#2)
year survival##8##2##(1990-10#1)(1990-6#2)(1993-1#1)(2008-10#1)(2008-6#2)(2011-2#1)
year that##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
year the##5##2##(1993-8#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
year there##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
year time##2##2##(2006-8#1)(2012-3#1)
year to year##11##3##(2008-10#4)(2008-12#1)(2008-8#3)(2011-2#2)(2013-1#1)
year to##20##2##(1991-12#1)(1995-3#1)(1995-6#1)(1996-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#3)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
year two##2##2##(1997-2#1)(2008-11#1)
year undergraduate students##2##3##(2008-11#1)(2008-12#1)
year was##11##2##(1993-12#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)
year were##10##2##(1991-1#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2012-12#1)
year when##6##2##(2008-10#2)(2008-8#2)(2011-2#1)(2013-7#1)
year with a##4##3##(1994-9#1)(2008-10#2)(2011-1#1)
year with##8##2##(1994-3#1)(1994-9#1)(2008-10#4)(2011-1#1)(2012-3#1)
year without##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
year##1207##1##(1990-10#2)(1990-11#1)(1990-12#7)(1990-2#7)(1990-3#2)(1990-5#1)(1990-6#7)(1990-8#2)(1990-9#4)(1991-1#7)(1991-11#6)(1991-12#2)(1991-2#11)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#6)(1991-8#9)(1991-9#3)(1992-1#5)(1992-11#2)(1992-12#11)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#8)(1993-2#5)(1993-3#8)(1993-5#2)(1993-6#4)(1993-8#1)(1993-9#5)(1994-1#3)(1994-12#11)(1994-2#7)(1994-3#12)(1994-5#2)(1994-6#6)(1994-7#6)(1994-8#1)(1994-9#8)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#7)(1995-8#6)(1996-1#6)(1996-11#5)(1996-12#12)(1996-2#9)(1996-3#3)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#13)(1997-4#7)(1997-5#3)(1997-6#12)(1997-8#3)(2006-10#2)(2006-8#5)(2007-1#2)(2007-10#11)(2007-11#8)(2007-12#4)(2007-2#6)(2007-4#4)(2007-5#3)(2007-6#5)(2007-7#21)(2007-8#25)(2007-9#3)(2008-1#23)(2008-10#136)(2008-11#46)(2008-12#42)(2008-2#10)(2008-3#11)(2008-4#7)(2008-5#31)(2008-6#22)(2008-7#37)(2008-8#27)(2008-9#16)(2009-1#1)(2009-10#8)(2009-12#4)(2009-4#7)(2009-5#5)(2009-6#2)(2009-7#8)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#12)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#16)(2010-9#2)(2011-1#31)(2011-2#59)(2012-1#8)(2012-12#20)(2012-2#15)(2012-3#20)(2012-5#1)(2012-6#1)(2013-1#62)(2013-7#5)(2013-8#32)
year's##19##1##(1990-11#1)(1990-2#1)(1991-2#1)(1992-3#1)(1995-3#3)(2006-10#1)(2008-10#4)(2008-7#2)(2009-6#1)(2010-11#2)(2011-2#2)
year) and##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
year)##15##1##(1992-9#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-8#1)
year- old##4##2##(2007-2#1)(2007-8#2)(2013-1#1)
year-end 2009##7##2##(2011-2#7)
year-end##13##1##(2008-12#2)(2011-2#11)
year-old boy##3##2##(1996-9#1)(2007-8#1)(2011-2#1)
year-old children##4##2##(1995-8#1)(2009-8#1)(2011-2#1)(2012-12#1)
year-old group##2##2##(2008-7#2)
year-old man who presented##2##4##(2008-8#1)(2011-1#1)
year-old man who##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
year-old man with##2##3##(1992-6#1)(2008-7#1)
year-old man##9##2##(1990-8#1)(1992-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
year-old patient##2##2##(2010-12#1)(2013-1#1)
year-old woman##3##2##(1995-2#1)(2007-2#1)(2008-5#1)
year-old##35##1##(1990-8#1)(1992-4#1)(1992-6#1)(1995-2#1)(1995-8#1)(1996-9#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#5)(2008-8#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
year-round residency in##2##3##(2008-8#2)
year-round##6##1##(2008-10#1)(2008-8#2)(2011-2#1)(2011-9#1)(2013-7#1)
year-to-year##2##1##(1991-3#1)(2008-10#1)
year]##2##1##(1991-11#1)(1994-3#1)
yearling##2##1##(1993-2#1)(2008-8#1)
yearly and##2##2##(2008-10#1)(2013-1#1)
yearly applications of Pseudomonas putida 06909-rif/nal##2##6##(2008-10#2)
yearly applications of##3##3##(2008-10#3)
yearly to##2##2##(2007-11#1)(2008-10#1)
yearly##24##1##(1991-6#1)(1991-8#1)(1992-2#1)(1994-12#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-1#2)
years (22##2##2##(2008-12#1)(2013-1#1)
years (OR = 3##2##4##(2011-2#2)
years (OR =##4##3##(2011-2#4)
years (P &lt##3##3##(1996-12#1)(2007-10#2)
years (P =##4##3##(2010-2#1)(2013-1#3)
years (P##7##2##(1996-12#1)(2007-10#2)(2010-2#1)(2013-1#3)
years (average age##4##3##(1992-9#1)(2007-11#1)(2010-3#1)(2011-2#1)
years (average##7##2##(1992-9#1)(2007-11#2)(2007-8#1)(2008-5#1)(2010-3#1)(2011-2#1)
years (mean 3##2##3##(1997-3#1)(2013-1#1)
years (mean 5##2##3##(1996-11#1)(2007-11#1)
years (mean =##2##3##(2009-8#2)
years (mean age##3##3##(1990-5#1)(1993-1#1)(2007-7#1)
years (mean##20##2##(1990-5#1)(1990-6#1)(1992-9#1)(1993-1#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-9#1)(2009-8#2)(2013-1#3)
years (n =##2##3##(1995-6#1)(2007-10#1)
years (range 2##2##3##(2008-9#1)(2012-12#1)
years (range from##2##3##(2007-7#1)(2008-1#1)
years (range##56##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#4)(2008-1#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#2)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
years 1991##5##2##(2007-11#5)
years 1994##2##2##(1997-3#1)(2008-8#1)
years 1995 and##2##3##(2007-11#2)
years 1995##3##2##(1996-1#1)(2007-11#2)
years 2005##2##2##(2008-12#1)(2012-3#1)
years 4 months##2##3##(1991-11#1)(1991-8#1)
years 6 months##2##3##(2008-7#1)(2008-9#1)
years a##5##2##(2007-8#1)(2008-2#1)(2008-6#1)(2012-2#1)(2012-3#1)
years after a##3##3##(1991-11#1)(2007-10#1)(2008-7#1)
years after coronary##2##3##(1997-3#1)(2007-8#1)
years after diagnosis##4##3##(1997-3#1)(2008-7#2)(2011-2#1)
years after he had##2##4##(2007-5#1)(2008-12#1)
years after her##2##3##(2011-2#1)(2013-1#1)
years after initial##2##3##(2013-1#2)
years after it was##2##4##(2008-10#1)(2011-1#1)
years after nephrectomy##3##3##(2008-1#1)(2013-1#2)
years after operation##4##3##(1990-2#1)(1993-11#1)(2007-11#1)(2011-2#1)
years after radiation therapy##3##4##(2008-7#1)(2013-8#2)
years after receiving##2##3##(2008-7#1)(2013-8#1)
years after starting##2##3##(2007-12#1)(2013-8#1)
years after surgery##13##3##(1991-2#1)(1991-6#1)(2007-8#3)(2008-10#2)(2008-7#1)(2012-1#1)(2012-2#2)(2013-1#2)
years after surgical resection##2##4##(1991-12#1)(2011-2#1)
years after surgical##5##3##(1991-12#1)(1991-6#1)(1992-6#1)(1994-3#1)(2011-2#1)
years after the end of##2##5##(2007-8#1)(2008-10#1)
years after the first##4##4##(1994-9#1)(2007-2#1)(2008-5#1)(2013-1#1)
years after the initial operation##4##5##(2008-7#1)(2011-2#2)(2012-3#1)
years after the initial##7##4##(2007-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
years after the operation##3##4##(1991-9#1)(2007-8#1)(2008-6#1)
years after the##43##3##(1991-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-5#1)(2008-6#4)(2008-7#2)(2009-12#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
years after their##4##3##(1996-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
years after treatment of##2##4##(1990-9#1)(1997-5#1)
years after treatment##4##3##(1990-9#1)(1995-11#1)(1997-5#1)(2007-7#1)
years after wide##2##3##(1992-2#1)(2013-1#1)
years after##150##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#2)(1995-11#2)(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#13)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#7)(2008-2#2)(2008-5#1)(2008-6#4)(2008-7#11)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-3#3)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#17)(2013-8#5)
years age group##2##3##(2013-8#2)
years age##5##2##(2007-7#1)(2008-7#2)(2013-8#2)
years ago and##6##3##(1995-1#1)(2008-4#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
years ago for##2##3##(2009-12#1)(2010-12#1)
years ago from##2##3##(2008-4#1)(2011-2#1)
years ago the##2##3##(1994-12#1)(2012-2#1)
years ago to##2##3##(2008-10#1)(2008-7#1)
years ago was##2##3##(2008-1#1)(2008-10#1)
years ago with##3##3##(1997-3#1)(2008-8#1)(2013-1#1)
years ago##117##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)
years ahead##5##2##(1992-2#1)(1994-3#1)(1995-1#1)(1996-9#1)(2008-10#1)
years although##2##2##(1996-4#1)(2007-6#1)
years an##2##2##(1996-11#1)(2008-5#1)
years and 2 months##3##4##(2008-6#1)(2009-3#2)
years and 2##4##3##(2008-6#1)(2009-3#3)
years and 3##2##3##(2007-8#1)(2011-2#1)
years and 6##2##3##(2011-2#1)(2012-3#1)
years and 7##2##3##(2008-10#1)(2013-8#1)
years and 8##2##3##(2007-7#1)(2013-8#1)
years and 9##3##3##(1997-7#1)(2008-11#1)(2012-3#1)
years and an##2##3##(2007-2#1)(2007-6#1)
years and at##2##3##(2008-10#1)(2013-8#1)
years and compared##2##3##(1991-1#1)(2012-12#1)
years and more##2##3##(2012-12#1)(2013-8#1)
years and older##8##3##(1993-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
years and older)##2##3##(1993-2#1)(2010-12#1)
years and one##2##3##(2008-10#2)
years and over were##2##4##(2008-7#1)(2011-1#1)
years and over##7##3##(1990-3#1)(1994-5#1)(2008-7#3)(2011-1#2)
years and sites##2##3##(2008-10#2)
years and that##2##3##(1995-8#1)(2008-12#1)
years and the duration##2##4##(2007-7#1)(2008-1#1)
years and the##7##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)
years and with##2##3##(2008-10#1)(2012-2#1)
years and younger##3##3##(1996-3#1)(2008-3#1)(2011-1#1)
years and##139##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#2)(2011-1#7)(2011-2#7)(2011-7#1)(2012-12#2)(2012-2#7)(2012-3#6)(2013-1#6)(2013-8#6)
years are##13##2##(1996-1#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#3)(2012-12#1)
years as a means of##2##5##(1996-1#1)(2012-2#1)
years as a##5##3##(1996-1#1)(1997-5#1)(2007-11#1)(2007-8#1)(2012-2#1)
years as an##3##3##(1996-12#1)(2008-10#1)(2011-1#1)
years as the##2##3##(2008-10#1)(2009-8#1)
years as well as the##2##5##(2008-5#1)(2010-3#1)
years as well##3##3##(2007-7#1)(2008-5#1)(2010-3#1)
years as##21##2##(1990-3#1)(1993-12#1)(1995-1#3)(1996-1#1)(1996-12#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
years at the beginning of##2##5##(2008-7#1)(2011-2#1)
years at the time of##4##5##(1995-6#1)(2007-7#1)(2008-4#2)
years at the##13##3##(1995-6#1)(1996-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#2)(2012-2#2)
years at various##2##3##(1990-3#1)(2008-10#1)
years at##24##2##(1990-3#1)(1995-11#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
years been##2##2##(2008-11#1)(2009-6#1)
years before the##3##3##(1990-12#1)(1991-7#1)(1996-4#1)
years before##25##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-7#2)(1993-3#1)(1994-3#1)(1994-9#1)(1996-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
years between##4##2##(1996-11#1)(2008-2#1)(2009-10#1)(2012-12#1)
years but##2##2##(2007-11#1)(2008-10#1)
years by a##2##3##(1994-3#1)(2012-3#1)
years by the##3##3##(1997-6#1)(2009-7#1)(2013-1#1)
years by##17##2##(1990-10#1)(1994-3#2)(1996-4#1)(1997-6#1)(2008-10#6)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
years duration and##2##3##(1994-12#1)(2010-11#1)
years duration##6##2##(1994-12#2)(2007-7#2)(2009-3#1)(2010-11#1)
years during##2##2##(1997-7#1)(2008-10#1)
years earlier##17##2##(1991-12#1)(1991-6#1)(1993-12#1)(1994-7#2)(1995-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-6#1)(2011-2#2)(2013-8#2)
years experience at##2##3##(1991-2#1)(2010-11#1)
years experience in##2##3##(1990-3#1)(1994-12#1)
years experience of##2##3##(1990-6#1)(2011-2#1)
years experience##10##2##(1990-3#1)(1990-6#1)(1991-2#1)(1994-12#1)(1997-2#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#2)
years follow-up study##2##3##(1990-6#1)(1997-8#1)
years follow-up##8##2##(1990-6#1)(1997-8#1)(2008-4#2)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
years following##10##2##(1993-9#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2012-12#1)
years for boys##2##3##(1990-9#1)(2013-1#1)
years for females##2##3##(2013-1#1)(2013-7#1)
years for males and##2##4##(2013-1#1)(2013-7#1)
years for the##4##3##(1993-6#1)(2008-10#1)(2010-10#1)(2013-1#1)
years for##30##2##(1990-12#2)(1990-9#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-4#3)(2007-7#1)(2008-10#3)(2008-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#5)(2013-7#2)
years from a##3##3##(1994-6#1)(2008-12#1)(2010-5#1)
years from now##2##3##(2008-1#1)(2008-3#1)
years from the##5##3##(1991-2#1)(2007-5#1)(2008-4#1)(2009-7#1)(2011-2#1)
years from##30##2##(1991-12#1)(1991-2#1)(1993-3#2)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#3)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
years had##4##2##(1990-12#1)(1990-6#1)(1992-9#1)(2007-8#1)
years has been##2##3##(1997-4#1)(2010-6#1)
years has resulted in##2##4##(1991-12#1)(2008-4#1)
years has##12##2##(1991-12#1)(1992-11#1)(1992-8#1)(1996-11#1)(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
years have been##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
years have brought##2##3##(1992-12#1)(1994-3#1)
years have passed since the##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
years have provided##2##3##(2010-1#1)(2011-2#1)
years have seen##5##3##(1997-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-5#1)
years have witnessed##4##3##(1996-1#1)(2007-8#1)(2009-12#1)(2012-1#1)
years have##29##2##(1991-12#1)(1992-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
years having##2##2##(2007-7#1)(2012-2#1)
years in St##2##3##(1995-12#1)(2008-10#1)
years in a##3##3##(1990-6#1)(1997-2#1)(1997-8#1)
years in age##3##3##(1994-3#1)(2008-12#2)
years in four##2##3##(1991-6#1)(2008-1#1)
years in its##2##3##(1992-1#1)(2011-2#1)
years in our##2##3##(2008-10#1)(2011-2#1)
years in prison for##2##4##(1996-5#1)(1997-5#1)
years in prison##5##3##(1996-5#4)(1997-5#1)
years in the other##2##4##(1992-4#1)(1994-7#1)
years in the##14##3##(1992-4#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-7#1)(1997-2#2)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
years in two##2##3##(2008-5#1)(2012-12#1)
years in western##2##3##(2008-10#2)
years in##97##2##(1990-12#1)(1990-6#2)(1990-8#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-11#1)(1996-5#5)(1997-2#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#3)
years increased##2##2##(2007-8#1)(2008-11#1)
years indicated that the##2##4##(2007-7#1)(2008-10#1)
years into##2##2##(2008-11#1)(2008-6#1)
years is presented##4##3##(1990-9#1)(1991-9#1)(2008-10#1)(2008-7#1)
years is to##2##3##(2008-4#1)(2010-5#1)
years is##15##2##(1990-9#1)(1991-8#1)(1991-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)
years it has been shown that##2##6##(1990-11#1)(1995-9#1)
years it has been##5##4##(1990-11#1)(1994-11#1)(1995-6#1)(1995-9#1)(2008-12#1)
years it has##6##3##(1990-11#1)(1994-11#1)(1995-6#1)(1995-9#1)(2008-12#1)(2008-7#1)
years it##9##2##(1990-11#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(2008-12#1)(2008-7#1)(2009-1#1)
years later she##3##3##(2008-1#2)(2008-7#1)
years later the##2##3##(2007-4#1)(2008-10#1)
years later##53##2##(1990-6#2)(1991-1#1)(1991-11#1)(1991-6#3)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#2)(1997-5#1)(2006-10#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#6)
years male##2##2##(2008-7#1)(2010-11#1)
years many##4##2##(1990-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
years may##2##2##(2008-8#1)(2010-12#1)
years of Polish##2##3##(2007-8#2)
years of a##2##3##(1994-5#1)(1995-6#1)
years of age and##13##4##(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
years of age at##4##4##(2007-5#1)(2008-11#1)(2009-10#1)(2010-10#1)
years of age for##2##4##(1993-2#1)(2008-7#1)
years of age from##4##4##(1991-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
years of age group##2##4##(1997-3#1)(2012-3#1)
years of age in##2##4##(1995-4#1)(2011-2#1)
years of age or older##3##5##(2008-11#1)(2010-10#2)
years of age or##8##4##(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(2007-12#1)(2008-11#1)(2010-10#2)
years of age were##4##4##(1995-12#1)(1996-1#1)(2008-10#2)
years of age who were##3##5##(1993-1#1)(2008-3#1)(2011-2#1)
years of age who##4##4##(1993-1#1)(2008-3#1)(2011-2#2)
years of age with##4##4##(2007-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
years of age##168##3##(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-8#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#3)(2009-10#3)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#5)(2010-12#1)(2010-3#3)(2010-4#1)(2011-1#5)(2011-2#17)(2012-1#1)(2012-12#6)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#5)
years of age)##7##3##(1996-5#3)(2008-10#1)(2008-7#2)(2012-12#1)
years of clinical experience##2##4##(1990-3#1)(2013-1#1)
years of clinical##3##3##(1990-3#1)(2012-12#1)(2013-1#1)
years of cochlear implant##2##4##(2008-9#2)
years of data##3##3##(1992-8#1)(1995-12#1)(2008-8#1)
years of development##2##3##(2008-3#1)(2013-8#1)
years of diagnosis##5##3##(1990-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
years of education##4##3##(2008-12#2)(2010-6#1)(2011-2#1)
years of experience in##3##4##(1993-12#1)(1996-12#1)(2010-12#1)
years of experience##14##3##(1993-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
years of exposure##2##3##(1997-6#1)(2012-3#1)
years of field experiments##2##4##(2008-10#1)(2008-12#1)
years of field##4##3##(2008-10#3)(2008-12#1)
years of follow up##3##4##(2012-2#1)(2013-1#2)
years of follow-up in##2##4##(1995-11#1)(2007-8#1)
years of follow-up##16##3##(1990-3#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-11#1)(1995-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)
years of hemodialysis##2##3##(2008-1#1)(2011-2#1)
years of human##2##3##(2012-3#1)(2013-7#1)
years of investigations into##2##4##(2007-9#1)(2008-10#1)
years of life and##3##4##(1996-9#1)(2011-2#1)(2012-12#1)
years of life lost##2##4##(2012-12#1)(2013-8#1)
years of life##15##3##(1992-6#1)(1995-6#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
years of operation of the##2##5##(1990-3#1)(2011-2#1)
years of operation##5##3##(1990-3#1)(1994-2#1)(2008-2#1)(2011-2#2)
years of practice##2##3##(1992-3#1)(2008-1#1)
years of research##3##3##(2008-10#1)(2009-8#1)(2010-8#1)
years of the study##10##4##(1996-3#1)(1997-8#1)(2008-10#6)(2009-4#1)(2012-3#1)
years of the##27##3##(1990-9#1)(1991-3#1)(1993-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-3#2)(2013-8#1)
years of their##3##3##(1996-2#1)(2007-12#1)(2008-11#1)
years of this study##2##4##(2008-5#2)
years of this##3##3##(2008-1#1)(2008-5#2)
years of treatment with##2##4##(2008-4#1)(2009-8#1)
years of treatment##7##3##(1993-11#1)(1994-6#1)(2007-8#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
years of use##2##3##(1997-5#1)(2012-12#1)
years of##418##2##(1990-3#3)(1990-6#4)(1990-9#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#5)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#5)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#5)(2007-12#9)(2007-2#3)(2007-5#2)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#37)(2008-11#14)(2008-12#9)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#9)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#5)(2010-12#2)(2010-3#5)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#32)(2011-3#1)(2012-1#1)(2012-12#17)(2012-2#4)(2012-3#13)(2013-1#22)(2013-7#3)(2013-8#8)
years old and##8##3##(1991-9#1)(1997-4#1)(2007-10#1)(2008-4#1)(2008-9#1)(2012-12#2)(2013-1#1)
years old are##2##3##(2008-5#1)(2011-2#1)
years old boy with##2##4##(2008-1#1)(2008-10#1)
years old boy##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
years old female##4##3##(2007-10#1)(2011-2#2)(2013-1#1)
years old in##5##3##(1997-4#1)(1997-7#1)(2011-1#1)(2011-2#2)
years old lady##2##3##(2012-2#1)(2013-7#1)
years old male##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
years old man##3##3##(1991-11#1)(1993-2#1)(2012-3#1)
years old or##2##3##(1991-9#1)(2011-2#1)
years old patient##5##3##(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
years old were##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
years old who##3##3##(2007-2#1)(2008-7#1)(2008-8#1)
years old with##3##3##(1990-10#1)(2008-6#1)(2008-9#1)
years old woman##4##3##(1990-12#1)(2007-8#2)(2013-8#1)
years old##146##2##(1990-10#1)(1990-12#1)(1990-6#4)(1991-11#1)(1991-2#1)(1991-9#4)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-9#4)(1994-2#1)(1994-9#2)(1995-3#1)(1995-9#4)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#5)(2008-10#4)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-7#1)(2009-8#2)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#20)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#2)
years old) and##2##3##(2010-12#1)(2013-8#1)
years old) normal subjects##2##4##(2009-8#2)
years old) were##3##3##(2008-12#1)(2008-9#1)(2010-12#1)
years old) with##3##3##(2008-6#1)(2013-1#2)
years old)##24##2##(1990-10#1)(1996-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-12#2)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#4)
years old-group##2##2##(2008-4#2)
years old]##2##2##(1995-2#1)(2012-3#1)
years on PD##2##3##(2011-2#2)
years on##15##2##(1991-5#1)(1992-5#1)(1993-2#1)(1996-11#2)(1996-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#3)(2011-3#1)
years only##2##2##(1994-12#1)(2008-7#1)
years or greater##2##3##(2008-10#2)
years or less##3##3##(1990-12#1)(2012-3#1)(2013-1#1)
years or locations##2##3##(2008-10#2)
years or more##5##3##(1990-2#1)(1990-9#1)(1995-2#1)(1996-6#1)(2013-1#1)
years or older were##2##4##(1992-5#1)(2009-8#1)
years or older##11##3##(1992-5#1)(1992-9#3)(2007-10#3)(2008-11#1)(2008-3#1)(2009-8#1)(2013-8#1)
years or so##3##3##(1997-8#1)(2008-9#1)(2011-2#1)
years or##35##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-5#1)(1992-9#3)(1994-6#2)(1995-2#1)(1995-9#1)(1996-6#1)(1997-8#1)(2007-10#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
years participated in the study##2##5##(2008-12#1)(2008-9#1)
years per##2##2##(2008-8#1)(2010-3#1)
years period##5##2##(1991-5#1)(1997-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
years post-implant##4##2##(2008-9#4)
years postoperatively##8##2##(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-12#1)(2013-1#1)
years presenting##2##2##(1991-11#1)(2013-1#1)
years previously##6##2##(1994-12#1)(2008-10#2)(2009-2#1)(2010-12#1)(2010-6#1)
years prior to diagnosis##2##4##(1992-8#1)(2008-1#1)
years prior to the##2##4##(2011-1#2)
years prior to##7##3##(1992-10#1)(1992-6#1)(1992-8#1)(2008-1#1)(2011-1#2)(2013-1#1)
years respectively##5##2##(1990-9#1)(1992-4#2)(2007-8#1)(2008-4#1)
years respectively)##2##2##(1992-9#1)(2007-7#1)
years reveals##2##2##(2008-11#1)(2009-4#1)
years several##4##2##(1993-3#1)(1995-4#1)(2008-10#1)(2008-3#1)
years she##2##2##(2007-2#1)(2012-12#1)
years since the##6##3##(1993-6#1)(1997-5#1)(2007-12#1)(2008-7#1)(2010-3#1)(2013-8#1)
years since##13##2##(1991-12#1)(1993-6#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
years study##2##2##(2009-7#1)(2011-2#1)
years suggests that##2##3##(2008-1#1)(2008-10#1)
years survival##2##2##(2008-8#1)(2013-1#1)
years than in##2##3##(2008-10#1)(2008-7#1)
years than##7##2##(1992-1#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
years thanks to the##2##4##(2010-7#1)(2011-2#1)
years that##8##2##(1993-6#1)(1996-4#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)
years the##19##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2009-6#1)(2010-3#1)(2011-2#1)
years their##2##2##(1994-12#1)(2008-5#1)
years there has been##8##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-9#1)
years there have been##4##4##(1990-11#1)(1994-9#1)(2008-11#1)(2011-2#1)
years there##14##2##(1990-11#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2011-2#1)
years through##2##2##(1996-3#1)(2008-10#1)
years time##2##2##(2007-7#1)(2009-2#1)
years to a##2##3##(1995-12#1)(2008-10#1)
years to be##2##3##(1992-12#1)(2008-5#1)
years to come##9##3##(1993-2#1)(1994-6#1)(1996-3#2)(1997-1#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-6#1)
years to determine the##2##4##(2012-3#2)
years to##44##2##(1990-2#1)(1990-3#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
years two##3##2##(1996-6#1)(2008-11#1)(2010-7#1)
years using##6##2##(1992-10#1)(1993-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)
years versus##5##2##(1995-3#1)(1995-8#1)(2007-7#2)(2011-2#1)
years was carried out##2##4##(1990-12#1)(1996-12#1)
years was##31##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#2)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
years we##4##2##(1997-4#1)(2007-5#1)(2009-2#1)(2011-2#1)
years were examined##2##3##(1993-3#1)(1995-6#1)
years were identified##2##3##(2012-12#1)(2012-3#1)
years were included in##2##4##(2008-1#1)(2011-1#1)
years were included##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
years were interviewed##2##3##(1996-6#1)(2013-1#1)
years were studied##3##3##(2007-7#1)(2010-12#1)(2013-1#1)
years were##43##2##(1991-12#2)(1993-3#1)(1994-12#2)(1994-3#2)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
years when##2##2##(1996-3#1)(2008-10#1)
years which##2##2##(2008-10#1)(2008-7#1)
years while##3##2##(1991-3#1)(2008-5#1)(2013-1#1)
years who had##2##3##(1997-2#1)(2010-10#1)
years who were##2##3##(2008-9#1)(2013-1#1)
years who##7##2##(1990-9#1)(1997-2#1)(2008-9#1)(2010-10#2)(2013-1#2)
years will##2##2##(1997-6#1)(2012-3#1)
years with a mean age of##2##6##(2008-1#1)(2010-3#1)
years with a mean##3##4##(2008-1#1)(2008-4#1)(2010-3#1)
years with a##7##3##(1990-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-3#1)(2010-8#1)
years with an average##2##4##(1994-3#1)(2008-7#1)
years with clinical conditions##2##4##(2009-12#2)
years with the##3##3##(2006-4#1)(2008-8#1)(2010-3#1)
years with##41##2##(1990-3#1)(1991-12#1)(1993-11#1)(1994-3#1)(1995-6#2)(1997-6#1)(2006-4#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
years without any##4##3##(1991-12#1)(1991-5#1)(2008-11#1)(2011-2#1)
years without##9##2##(1991-12#1)(1991-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#2)
years##3708##1##(1990-10#5)(1990-11#9)(1990-12#10)(1990-2#10)(1990-3#16)(1990-5#4)(1990-6#36)(1990-8#7)(1990-9#20)(1991-1#6)(1991-11#15)(1991-12#24)(1991-2#18)(1991-3#15)(1991-4#9)(1991-5#9)(1991-6#18)(1991-7#3)(1991-8#22)(1991-9#10)(1992-1#11)(1992-10#3)(1992-11#7)(1992-12#12)(1992-2#15)(1992-3#10)(1992-4#9)(1992-5#15)(1992-6#15)(1992-7#3)(1992-8#6)(1992-9#13)(1993-1#12)(1993-11#13)(1993-12#18)(1993-2#17)(1993-3#12)(1993-5#2)(1993-6#10)(1993-8#6)(1993-9#14)(1994-1#6)(1994-11#4)(1994-12#28)(1994-2#12)(1994-3#21)(1994-5#7)(1994-6#15)(1994-7#6)(1994-8#2)(1994-9#11)(1995-1#19)(1995-10#1)(1995-11#15)(1995-12#12)(1995-2#17)(1995-3#16)(1995-4#7)(1995-5#12)(1995-6#21)(1995-8#7)(1995-9#10)(1996-1#9)(1996-11#17)(1996-12#14)(1996-2#8)(1996-3#25)(1996-4#7)(1996-5#8)(1996-6#9)(1996-7#5)(1996-8#5)(1996-9#17)(1997-1#6)(1997-2#19)(1997-3#25)(1997-4#17)(1997-5#15)(1997-6#14)(1997-7#12)(1997-8#31)(2006-10#13)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#23)(2007-11#47)(2007-12#29)(2007-2#15)(2007-4#5)(2007-5#11)(2007-6#4)(2007-7#64)(2007-8#96)(2007-9#4)(2008-1#98)(2008-10#367)(2008-11#97)(2008-12#65)(2008-2#24)(2008-3#35)(2008-4#56)(2008-5#55)(2008-6#50)(2008-7#157)(2008-8#53)(2008-9#86)(2009-1#4)(2009-10#18)(2009-11#3)(2009-12#6)(2009-2#7)(2009-3#23)(2009-4#9)(2009-5#14)(2009-6#7)(2009-7#16)(2009-8#30)(2009-9#4)(2010-1#15)(2010-10#13)(2010-11#14)(2010-12#37)(2010-2#5)(2010-3#46)(2010-4#9)(2010-5#16)(2010-6#18)(2010-7#11)(2010-8#34)(2010-9#7)(2011-1#55)(2011-2#247)(2011-3#13)(2011-7#4)(2012-1#14)(2012-12#82)(2012-2#70)(2012-3#98)(2012-5#1)(2013-1#208)(2013-7#15)(2013-8#77)
years' duration##3##2##(1990-3#1)(2007-7#2)
years' experience##5##2##(1990-2#1)(1990-3#1)(1994-9#1)(1995-11#1)(2012-12#1)
years' follow-up##2##2##(2008-11#1)(2008-7#1)
years'##16##1##(1990-2#1)(1990-3#2)(1992-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(2007-7#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)
years) and a##2##3##(1994-2#1)(2008-10#1)
years) and compared##2##3##(2007-5#1)(2008-7#1)
years) and the##2##3##(2008-5#1)(2008-9#1)
years) and##25##2##(1993-11#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2010-1#1)(2012-12#1)(2012-2#2)
years) are##2##2##(2008-10#1)(2011-2#1)
years) diagnosed##2##2##(2011-2#1)(2012-3#1)
years) from##2##2##(2008-10#1)(2008-3#1)
years) have been##2##3##(2007-11#1)(2009-8#1)
years) have##3##2##(2007-11#1)(2009-8#1)(2011-2#1)
years) in the##2##3##(2008-5#1)(2012-12#1)
years) in##5##2##(2007-12#1)(2008-10#1)(2008-5#2)(2012-12#1)
years) of##3##2##(2011-1#1)(2012-3#2)
years) participated in the##2##4##(1993-12#1)(2013-1#1)
years) participated in this study##2##5##(2007-6#1)(2013-1#1)
years) participated in##5##3##(1993-12#1)(2007-6#1)(2008-5#1)(2013-1#2)
years) received##4##2##(1997-2#2)(2010-1#1)(2013-1#1)
years) referred##2##2##(2008-12#1)(2008-7#1)
years) than##3##2##(1992-5#1)(2008-10#1)(2011-2#1)
years) to##2##2##(2008-11#1)(2012-3#1)
years) treated##5##2##(2007-8#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)
years) underwent##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
years) were randomly assigned to##2##5##(2013-1#1)(2013-8#1)
years) were recruited##2##3##(2008-2#1)(2013-8#1)
years) were##20##2##(1990-12#1)(1990-2#1)(1993-11#1)(1994-9#1)(1996-1#1)(1996-7#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-9#1)(2011-1#2)(2012-3#2)(2013-1#2)(2013-8#3)
years) who had##4##3##(1990-11#1)(1993-1#1)(2007-11#1)(2007-7#1)
years) who were##2##3##(1990-5#1)(2008-11#1)
years) who##10##2##(1990-11#1)(1990-5#1)(1993-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2011-2#2)(2012-1#1)(2012-12#1)
years) with a##2##3##(2012-3#1)(2013-1#1)
years) with chronic##2##3##(1991-8#1)(1995-3#1)
years) with##24##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-9#1)(1994-3#1)(1995-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#2)(2008-6#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
years)##287##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#4)(1992-12#2)(1992-5#3)(1992-6#4)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#12)(2008-1#17)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#18)(2008-8#1)(2008-9#10)(2009-10#3)(2009-3#2)(2009-7#5)(2009-8#2)(2010-1#4)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#21)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#5)
years-old##6##1##(2008-1#1)(2012-12#4)(2013-8#1)
years]##16##1##(1990-10#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-7#1)(1997-6#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-3#1)(2011-2#3)(2013-1#2)(2013-8#1)
years])##2##1##(2010-12#1)(2011-2#1)
yeast (Saccharomyces cerevisiae)##4##3##(1990-8#1)(2008-10#1)(2008-12#1)(2008-4#1)
yeast (Saccharomyces##5##2##(1990-8#1)(2008-10#1)(2008-12#2)(2008-4#1)
yeast Candida oleophila##3##3##(2008-10#3)
yeast Candida##8##2##(1990-5#1)(1991-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#3)
yeast HAP2 and HAP3##2##4##(1995-2#2)
yeast HAP2##4##2##(1995-2#2)(2008-9#2)
yeast ISC##2##2##(2008-7#2)
yeast L17A##2##2##(1991-6#2)
yeast P-450(14)DM##2##2##(1992-3#2)
yeast P450(14DM)##2##2##(1994-6#2)
yeast Pichia pastoris##8##3##(1994-11#1)(1994-3#2)(1997-4#1)(1997-7#1)(2008-7#1)(2009-9#1)(2010-5#1)
yeast RNA and denatured DNA##2##5##(2008-10#2)
yeast RNA##13##2##(1997-4#1)(2008-10#10)(2008-4#1)(2009-3#1)
yeast S##3##2##(2008-2#2)(2009-12#1)
yeast Saccharomyces cerevisiae##24##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
yeast Saccharomyces##25##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
yeast Schizosaccharomyces pombe##11##3##(1995-2#2)(1995-8#2)(1995-9#1)(1997-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)
yeast and bacteria##2##3##(1994-5#1)(2011-1#1)
yeast and mammalian cells##4##4##(1997-3#2)(2008-4#1)(2008-9#1)
yeast and plant##2##3##(1992-3#1)(1992-8#1)
yeast and##25##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-6#1)(1997-3#3)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2011-1#1)(2012-2#1)
yeast are##3##2##(1992-10#1)(1996-3#1)(2008-7#1)
yeast artificial chromosome (YAC)##4##4##(1994-12#1)(1996-10#1)(2008-4#1)(2008-5#1)
yeast artificial chromosome##8##3##(1991-9#1)(1994-12#1)(1996-10#1)(1996-8#1)(1997-8#2)(2008-4#1)(2008-5#1)
yeast artificial chromosomes (YACs)##4##4##(1991-9#1)(1996-10#2)(1997-2#1)
yeast artificial chromosomes##5##3##(1991-9#1)(1995-6#1)(1996-10#2)(1997-2#1)
yeast artificial##13##2##(1991-9#2)(1994-12#1)(1995-6#1)(1996-10#3)(1996-8#1)(1997-2#1)(1997-8#2)(2008-4#1)(2008-5#1)
yeast as##2##2##(2008-5#1)(2008-7#1)
yeast autonomously##2##2##(1997-8#1)(2008-8#1)
yeast beta Tub##2##3##(1993-6#2)
yeast by##6##2##(1990-5#1)(1990-8#1)(1992-6#1)(1993-8#1)(1995-6#1)(2008-10#1)
yeast cell cycle##3##3##(1991-5#1)(2008-9#1)(2010-1#1)
yeast cell is##2##3##(2007-12#1)(2009-12#1)
yeast cell##13##2##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2011-2#1)
yeast cells by##4##3##(1995-8#1)(1996-6#1)(2008-8#1)(2008-9#1)
yeast cells in##2##3##(2008-10#1)(2011-1#1)
yeast cells were##4##3##(1990-2#2)(2008-5#2)
yeast cells##50##2##(1990-2#5)(1990-5#1)(1991-7#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-2#3)(1995-8#1)(1996-6#2)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2010-10#1)(2011-1#1)
yeast chromosome VII##2##3##(1997-3#2)
yeast chromosome XIV##3##3##(1995-9#1)(1996-3#1)(1996-6#1)
yeast chromosome##8##2##(1995-9#1)(1996-3#1)(1996-6#2)(1997-3#3)(1997-4#1)
yeast chromosomes##2##2##(1997-4#1)(2008-10#1)
yeast containing human DDK##2##4##(2012-3#2)
yeast could##2##2##(1996-3#1)(2011-2#1)
yeast cytochrome##2##2##(1995-5#1)(1995-6#1)
yeast did not have any##2##5##(2008-10#1)(2008-12#1)
yeast enzyme##2##2##(1990-12#1)(1997-4#1)
yeast expressed sequence tags##2##4##(1995-9#1)(1996-6#1)
yeast expression vectors##2##3##(1993-12#2)
yeast expression##5##2##(1993-12#2)(1993-9#1)(1995-2#1)(2008-9#1)
yeast extract (YE)##2##3##(2008-11#1)(2008-6#1)
yeast extract and 0##2##4##(2008-7#2)
yeast extract and##3##3##(2008-5#1)(2008-7#2)
yeast extract##10##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#3)(2008-7#3)
yeast extracts##3##2##(1990-12#1)(1990-8#1)(1996-2#1)
yeast fermentation##2##2##(2008-7#1)(2012-3#1)
yeast flocculation##4##2##(2008-10#1)(2008-7#3)
yeast for##2##2##(1997-4#1)(2008-10#1)
yeast forms##2##2##(2008-5#1)(2008-8#1)
yeast gene encoding##2##3##(1990-5#1)(1991-6#1)
yeast gene##5##2##(1990-5#1)(1991-6#1)(1995-8#1)(1995-9#1)(1997-8#1)
yeast genes##4##2##(1995-12#1)(1995-9#1)(1997-3#1)(2008-10#1)
yeast genome##8##2##(1990-5#1)(1993-9#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-7#2)(2012-3#1)
yeast genomic##2##2##(1995-11#1)(1997-7#1)
yeast had##2##2##(1990-8#1)(2008-10#1)
yeast have been##4##3##(1991-12#1)(1995-9#1)(2008-4#1)(2008-5#1)
yeast homologues##2##2##(1995-2#2)
yeast in##6##2##(1995-9#1)(1996-12#1)(2008-10#1)(2008-8#1)(2011-1#2)
yeast invertase##4##2##(1996-3#1)(2008-7#3)
yeast is a##3##3##(2008-10#2)(2008-2#1)
yeast is##11##2##(1993-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
yeast lanosterol 14##2##3##(1991-5#1)(1992-3#1)
yeast lanosterol##4##2##(1991-5#1)(1992-3#1)(1992-8#1)(1994-6#1)
yeast may##2##2##(1994-6#1)(2008-7#1)
yeast mitochondria##2##2##(2012-2#1)(2013-8#1)
yeast mitochondrial##2##2##(1995-6#1)(1997-8#1)
yeast nuclear##3##2##(1994-12#2)(1995-2#1)
yeast of##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
yeast one-hybrid system##5##3##(1997-4#1)(2008-8#1)(2008-9#3)
yeast or##4##2##(1995-6#1)(1995-9#1)(2008-10#1)(2009-8#1)
yeast polysaccharides##2##2##(2008-10#2)
yeast populations##5##2##(1995-9#1)(1997-7#1)(2007-3#1)(2008-8#1)(2010-10#1)
yeast promoter##2##2##(1991-9#1)(1995-6#1)
yeast protein##6##2##(1997-2#1)(1997-3#2)(2008-11#1)(2009-7#1)(2012-3#1)
yeast species##4##2##(1996-6#2)(2008-4#1)(2008-5#1)
yeast strain##7##2##(1997-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
yeast strains claimed##2##3##(2010-7#2)
yeast strains were##2##3##(2008-10#1)(2010-7#1)
yeast strains with##3##3##(1993-8#1)(2008-4#1)(2008-8#1)
yeast strains##27##2##(1990-7#1)(1992-10#2)(1993-12#1)(1993-8#1)(1995-6#1)(1996-6#3)(2008-10#6)(2008-4#1)(2008-8#1)(2009-12#1)(2010-7#6)(2012-3#2)(2013-1#1)
yeast systems##2##2##(1997-4#1)(2008-11#1)
yeast tRNA##2##2##(2008-8#2)
yeast tRNA(Ala)##5##2##(2008-8#5)
yeast temperature-sensitive##2##2##(1997-3#1)(1997-8#1)
yeast to##7##2##(1995-2#1)(1995-6#1)(2008-12#1)(2008-5#1)(2011-1#2)(2012-1#1)
yeast transcriptional activator##2##3##(1991-5#1)(1996-3#1)
yeast transformants##2##2##(1997-2#1)(1997-4#1)
yeast tubulin##3##2##(1993-8#3)
yeast two-hybrid system##14##3##(1997-7#1)(2008-2#1)(2008-8#8)(2008-9#4)
yeast two-hybrid##22##2##(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#1)
yeast was##6##2##(1991-5#1)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)
yeast were##3##2##(1992-11#1)(2008-10#1)(2008-5#1)
yeast with##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-7#1)
yeast##780##1##(1990-11#3)(1990-12#6)(1990-2#9)(1990-5#15)(1990-7#3)(1990-8#5)(1991-12#2)(1991-2#3)(1991-5#8)(1991-6#3)(1991-7#1)(1991-9#10)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#5)(1992-6#3)(1992-8#7)(1992-9#1)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#5)(1993-6#7)(1993-8#15)(1993-9#11)(1994-11#6)(1994-12#8)(1994-3#3)(1994-5#1)(1994-6#8)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#22)(1995-3#3)(1995-5#4)(1995-6#21)(1995-8#11)(1995-9#13)(1996-10#3)(1996-12#5)(1996-2#6)(1996-3#9)(1996-6#20)(1996-8#1)(1997-2#8)(1997-3#21)(1997-4#18)(1997-6#4)(1997-7#11)(1997-8#11)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#2)(2008-10#95)(2008-11#16)(2008-12#10)(2008-2#11)(2008-4#15)(2008-5#24)(2008-6#17)(2008-7#40)(2008-8#38)(2008-9#24)(2009-10#3)(2009-12#8)(2009-3#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#11)(2011-1#11)(2011-2#13)(2012-1#2)(2012-2#9)(2012-3#23)(2013-1#2)(2013-8#3)
yeast)##2##1##(2008-12#1)(2008-7#1)
yeast-phase exo-antigen of##2##3##(2008-5#2)
yeast-phase exo-antigen##3##2##(2008-5#3)
yeast-phase##6##1##(2008-5#6)
yeastlike##2##1##(2007-10#1)(2008-10#1)
yeastolate##3##1##(2008-11#3)
yeasts and filamentous fungi##3##4##(2008-6#1)(2011-2#1)(2013-8#1)
yeasts and##9##2##(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
yeasts in##5##2##(1993-12#1)(1997-4#1)(2008-10#1)(2013-1#2)
yeasts of##4##2##(2008-5#3)(2013-1#1)
yeasts showed##2##2##(2013-1#2)
yeasts to##2##2##(2008-10#1)(2008-5#1)
yeasts##65##1##(1993-12#3)(1994-2#1)(1995-6#2)(1997-4#3)(2007-11#2)(2008-10#9)(2008-11#1)(2008-5#17)(2008-6#6)(2008-9#5)(2009-6#1)(2011-2#2)(2012-3#3)(2013-1#9)(2013-8#1)
yellow alleles were##2##3##(2008-8#2)
yellow and##6##2##(1995-5#1)(2008-10#5)
yellow colour##2##2##(2008-10#2)
yellow complex##3##2##(2008-10#3)
yellow dwarf disease##3##3##(2008-10#3)
yellow dwarf virus (BYDV) resistance##2##5##(2008-5#1)(2008-8#1)
yellow dwarf virus (BYDV)##10##4##(2008-10#7)(2008-5#1)(2008-8#2)
yellow dwarf virus in##2##4##(2008-10#2)
yellow dwarf virus##26##3##(2008-10#23)(2008-5#1)(2008-8#2)
yellow dwarf viruses##3##3##(2008-10#2)(2008-9#1)
yellow dwarf##43##2##(2008-10#39)(2008-5#1)(2008-8#2)(2008-9#1)
yellow fever vaccination##2##3##(2007-2#2)
yellow fever##3##2##(2007-2#2)(2010-1#1)
yellow fluorescent proteins in##2##4##(2008-10#1)(2008-3#1)
yellow fluorescent proteins##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
yellow fluorescent##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
yellow gene##4##2##(2008-8#4)
yellow leaf curl virus##20##4##(2008-10#19)(2008-8#1)
yellow leaf curl##28##3##(2008-10#27)(2008-8#1)
yellow leaf syndrome##2##3##(2008-10#2)
yellow leaf##32##2##(2008-10#31)(2008-8#1)
yellow mosaic virus (TYMV)##2##4##(1997-3#1)(2008-10#1)
yellow mosaic virus from Venezuela##2##5##(2008-10#2)
yellow mosaic virus from##3##4##(2008-10#3)
yellow mosaic virus##22##3##(1997-3#2)(2008-10#18)(2008-8#2)
yellow mosaic##24##2##(1997-3#2)(2008-10#20)(2008-8#2)
yellow mottle virus##4##3##(2008-10#3)(2008-9#1)
yellow mottle##5##2##(2008-10#4)(2008-9#1)
yellow ochre##2##2##(2008-10#2)
yellow pages advertising##2##3##(1993-12#2)
yellow pages##4##2##(1993-12#2)(1997-1#2)
yellow preovulatory follicles##3##3##(2008-12#3)
yellow ring##2##2##(2008-10#2)
yellow rust##5##2##(2008-10#5)
yellow spot virus##10##3##(2008-10#10)
yellow stripe virus##2##3##(2008-10#2)
yellow stripe##3##2##(2008-10#3)
yellow strips##2##2##(2008-10#2)
yellow stunt##4##2##(2008-10#2)(2008-8#2)
yellow stunting disorder virus##6##4##(2008-10#6)
yellow superimposed on both red and pink##2##7##(2008-10#2)
yellow vein virus##11##3##(2008-10#11)
yellow vein##17##2##(2008-10#17)
yellow vine disease##4##3##(2008-10#4)
yellow##263##1##(1990-5#1)(1990-7#1)(1992-11#1)(1992-4#1)(1993-12#2)(1994-2#1)(1995-5#2)(1997-1#2)(1997-3#2)(1997-4#1)(2007-11#5)(2007-12#2)(2007-2#2)(2008-10#189)(2008-11#3)(2008-12#8)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#4)(2009-10#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
yellow-green##4##1##(2008-10#2)(2008-2#1)(2011-1#1)
yellow-necked mice##2##2##(2012-3#2)
yellow-necked##3##1##(2011-2#1)(2012-3#2)
yellowing and##4##2##(2008-10#4)
yellowing in##2##2##(2008-10#1)(2008-11#1)
yellowing or wilting##2##3##(2008-10#2)
yellowing symptoms##2##2##(2008-10#2)
yellowing##22##1##(2008-10#15)(2008-11#3)(2008-5#2)(2008-9#2)
yellowish color of##2##3##(1996-12#1)(2008-3#1)
yellowish##7##1##(1993-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
yellows phytoplasma##6##2##(2008-10#6)
yellows virus##6##2##(2008-10#6)
yellows##44##1##(2008-10#44)
yersinia##2##1##(1990-6#1)(2008-7#1)
yes##7##1##(1991-12#1)(1992-1#1)(1993-5#1)(1995-12#1)(1996-3#1)(2007-10#1)(2008-4#1)
yes/no##3##1##(2008-11#1)(2011-2#2)
yet a##3##2##(1993-2#1)(2011-1#1)(2012-1#1)
yet another##4##2##(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
yet appear##2##2##(1996-6#1)(2012-2#1)
yet are##6##2##(2008-10#2)(2008-6#1)(2009-12#1)(2010-8#1)(2013-8#1)
yet available for##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
yet available##12##2##(1990-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)
yet be##4##2##(1991-11#2)(1996-11#1)(2008-10#1)
yet been developed##3##3##(1996-12#1)(2008-5#1)(2012-3#1)
yet been established##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
yet been identified##4##3##(1990-11#1)(1994-6#1)(2008-10#1)(2011-2#1)
yet been reached##2##3##(2008-1#1)(2013-8#1)
yet been shown to be##2##5##(1994-3#1)(2008-5#1)
yet been shown to##3##4##(1994-3#1)(2008-5#1)(2010-10#1)
yet been shown##4##3##(1990-11#1)(1994-3#1)(2008-5#1)(2010-10#1)
yet been##74##2##(1990-11#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#2)(1997-3#1)(2006-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
yet complex##2##2##(1992-8#1)(2008-10#1)
yet described##2##2##(1995-6#1)(2008-6#1)
yet did##2##2##(1991-12#1)(2010-6#1)
yet direct##2##2##(1995-12#1)(2008-5#1)
yet effective##2##2##(2008-10#1)(2008-11#1)
yet in##5##2##(1990-8#1)(1991-2#1)(2008-6#1)(2008-9#1)(2013-8#1)
yet is##2##2##(2008-11#1)(2008-9#1)
yet it is##6##3##(1994-8#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
yet it remains##2##3##(1997-7#1)(2012-3#1)
yet it##12##2##(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
yet little is known about the##2##6##(2008-12#1)(2008-5#1)
yet may##2##2##(2008-3#1)(2008-5#1)
yet most##3##2##(2008-9#1)(2010-10#1)(2013-1#1)
yet necessary##2##2##(1992-1#1)(2008-11#1)
yet no##7##2##(1991-11#1)(1995-2#1)(1995-5#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
yet not##2##2##(2008-8#1)(2010-8#1)
yet on##2##2##(1994-5#1)(2007-7#1)
yet only##4##2##(1994-2#1)(2008-10#1)(2010-11#1)(2010-3#1)
yet proved##2##2##(2009-6#1)(2012-12#1)
yet reduced##2##2##(1992-8#1)(1994-9#1)
yet reported##5##2##(1990-5#1)(1991-3#1)(2008-3#1)(2009-9#1)(2010-12#1)
yet reviewing the protective role of sports and physical activity in his masterpiece##2##13##(2013-1#2)
yet showed##2##2##(1995-12#1)(1997-3#1)
yet significant##2##2##(1992-12#1)(1996-12#1)
yet solved the##2##3##(1992-11#1)(2008-10#1)
yet solved##3##2##(1992-11#1)(1997-8#1)(2008-10#1)
yet some##2##2##(1997-7#1)(2008-10#1)
yet sufficiently##2##2##(2008-10#1)(2009-7#1)
yet the disease##2##3##(1997-7#1)(2008-10#1)
yet the##18##2##(1993-12#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
yet their reported satisfaction did not change##2##7##(2013-1#2)
yet their##4##2##(1996-12#1)(2009-5#1)(2013-1#2)
yet there is little##2##4##(2008-7#1)(2009-7#1)
yet there is no##2##4##(2008-10#1)(2010-3#1)
yet there is##6##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2012-2#1)
yet there##8##2##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
yet these##2##2##(2008-10#1)(2008-3#1)
yet they##3##2##(1995-12#1)(2009-8#1)(2010-3#1)
yet to be determined##6##4##(1994-8#1)(1995-2#1)(2008-1#1)(2008-6#1)(2009-12#1)(2013-1#1)
yet to be elucidated##4##4##(1993-5#1)(1995-6#1)(2009-9#1)(2013-1#1)
yet to be established##4##4##(2008-10#1)(2009-5#1)(2012-1#1)(2012-12#1)
yet to be explored##2##4##(2007-12#1)(2007-7#1)
yet to be fully##6##4##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
yet to be identified##6##4##(1994-12#1)(1995-2#1)(1997-7#1)(2008-10#1)(2009-6#1)(2011-2#1)
yet to be investigated##2##4##(2008-8#1)(2010-5#1)
yet to be made##2##4##(2008-10#1)(2008-3#1)
yet to be reported##2##4##(2008-10#1)(2008-12#1)
yet to be solved##2##4##(1992-9#1)(2007-11#1)
yet to be##60##3##(1990-11#1)(1991-2#1)(1991-7#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
yet to##68##2##(1990-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
yet unclear##2##2##(1991-11#1)(2011-2#1)
yet unidentified##8##2##(1994-6#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-9#1)
yet unknown mechanisms##2##3##(1990-11#1)(1993-9#1)
yet unknown##13##2##(1990-11#1)(1990-12#1)(1993-9#2)(1994-6#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-10#1)
yet well##5##2##(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
yet with##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
yet##565##1##(1990-11#6)(1990-12#1)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#5)(1991-12#4)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#5)(1994-6#5)(1994-8#7)(1994-9#5)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#4)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#7)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#3)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#13)(2008-10#60)(2008-11#24)(2008-12#8)(2008-2#11)(2008-3#14)(2008-4#4)(2008-5#18)(2008-6#9)(2008-7#19)(2008-8#11)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#2)(2010-12#6)(2010-3#5)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#5)(2011-1#5)(2011-2#20)(2012-1#3)(2012-12#13)(2012-2#11)(2012-3#9)(2013-1#26)(2013-7#3)(2013-8#11)
yet?##3##1##(2007-11#1)(2008-3#1)(2008-8#1)
yew##3##1##(1994-11#2)(2008-7#1)
yield a compact##2##3##(2007-11#1)(2008-3#1)
yield a constant##2##3##(2007-12#1)(2008-2#1)
yield a detection limit##3##4##(2007-12#1)(2008-10#2)
yield a significant##2##3##(2008-4#1)(2010-10#1)
yield a##57##2##(1992-7#1)(1994-11#1)(1995-2#1)(1995-8#2)(2007-11#7)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#7)(2008-3#11)(2008-4#2)(2008-7#4)(2008-9#1)(2009-11#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-2#2)
yield additional##2##2##(1997-6#1)(2008-10#1)
yield after##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
yield an EC(50) value of##2##5##(2008-10#2)
yield an##11##2##(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-2#1)(2012-1#1)
yield and LAI losses##3##4##(2008-12#3)
yield and grain##2##3##(2008-12#1)(2008-8#1)
yield and high##2##3##(1996-5#1)(2013-1#1)
yield and quality in##3##4##(2008-10#1)(2008-12#2)
yield and quality reductions##2##4##(2008-10#2)
yield and quality##7##3##(2008-10#4)(2008-11#1)(2008-12#2)
yield and the##3##3##(1990-3#1)(2008-10#1)(2008-4#1)
yield and yield components in wheat cultivars (Triticum sp##2##9##(2008-12#2)
yield and yield components##3##4##(2008-12#2)(2008-4#1)
yield and##49##2##(1990-3#1)(1994-6#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#11)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#2)
yield are##3##2##(2008-10#2)(2008-11#1)
yield at the##2##3##(2008-9#1)(2010-7#1)
yield at##4##2##(2008-3#1)(2008-6#1)(2008-9#1)(2010-7#1)
yield benefits##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
yield better efficiency##2##3##(2008-3#2)
yield better##4##2##(2008-3#3)(2008-7#1)
yield biased##2##2##(1997-8#1)(2009-10#1)
yield by the##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
yield by##14##2##(1990-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-2#1)
yield components in##3##3##(2008-10#1)(2008-12#2)
yield components##9##2##(2008-10#1)(2008-12#6)(2008-4#1)(2011-2#1)
yield convergence to##2##3##(2008-10#1)(2008-3#1)
yield data##4##2##(1992-12#1)(2008-3#1)(2009-11#2)
yield decreased##6##2##(2008-10#1)(2008-11#3)(2008-6#1)(2013-1#1)
yield expression##2##2##(1994-8#1)(2008-11#1)
yield for##2##2##(2008-10#1)(2008-6#1)
yield from the##4##3##(1995-3#1)(2008-10#2)(2013-1#1)
yield from##11##2##(1995-11#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-4#1)(2013-1#2)
yield gains##2##2##(2008-10#1)(2008-12#1)
yield higher##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
yield highly##2##2##(2008-3#1)(2010-12#1)
yield important insights into the##2##5##(2008-4#1)(2011-1#1)
yield important##3##2##(2007-10#1)(2008-4#1)(2011-1#1)
yield in a##2##3##(1996-2#1)(2013-1#1)
yield in farmer-managed plot##2##4##(2008-12#2)
yield in the presence of##2##5##(1996-5#1)(2008-11#1)
yield in the##4##3##(1996-5#1)(2008-10#2)(2008-11#1)
yield in##27##2##(1990-3#1)(1992-2#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-12#5)(2008-9#1)(2010-2#1)(2013-1#1)
yield increased##4##2##(2007-11#1)(2008-10#1)(2008-11#2)
yield increases##2##2##(2008-10#2)
yield information about the##2##4##(1996-3#1)(2008-4#1)
yield information##3##2##(1996-3#1)(2008-2#1)(2008-4#1)
yield insight into the##2##4##(2008-6#1)(2013-1#1)
yield insight into##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
yield insights into##2##3##(2006-12#1)(2010-1#1)
yield is##5##2##(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
yield less than##2##3##(1996-6#1)(2008-10#1)
yield less##3##2##(1996-6#1)(2008-10#2)
yield loss and##2##3##(2008-10#1)(2008-12#1)
yield loss models##3##3##(2008-10#1)(2008-12#2)
yield loss was##2##3##(2008-10#1)(2008-12#1)
yield loss##24##2##(2008-10#17)(2008-12#7)
yield losses and management efficiencies##2##5##(2008-10#2)
yield losses and##3##3##(2008-10#2)(2011-10#1)
yield losses for##2##3##(2008-10#1)(2012-2#1)
yield losses from##2##3##(2008-10#1)(2012-2#1)
yield losses in##3##3##(2008-10#3)
yield losses of up to##2##5##(2008-10#2)
yield losses##23##2##(2008-10#20)(2011-10#1)(2012-2#2)
yield measurement errors of roughly##2##5##(2008-10#2)
yield more than##2##3##(2008-10#1)(2008-3#1)
yield more##5##2##(1993-12#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-3#1)
yield nearly##2##2##(1992-7#1)(2008-11#1)
yield obtained##2##2##(2008-10#1)(2008-11#1)
yield of 0##3##3##(2007-12#1)(2008-6#1)(2013-1#1)
yield of each##2##3##(2008-2#1)(2013-1#1)
yield of plots planted with##2##5##(2008-10#2)
yield of processing##2##3##(2008-10#2)
yield of recombinant##3##3##(1993-2#1)(2008-8#1)(2011-2#1)
yield of singlet oxygen##2##4##(1992-12#1)(2008-8#1)
yield of the##13##3##(1992-11#1)(1994-3#1)(1994-8#2)(2008-10#4)(2008-11#1)(2008-9#1)(2009-12#1)(2012-1#1)(2013-1#1)
yield of##107##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-2#3)(1996-5#2)(1997-6#2)(2007-12#1)(2008-10#23)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#10)(2008-7#4)(2008-8#3)(2008-9#6)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#2)(2012-4#1)(2013-1#8)(2013-7#1)
yield on##6##2##(1994-5#2)(1996-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
yield only##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
yield optimal##2##2##(1997-3#1)(2008-6#1)
yield per##3##2##(2008-12#3)
yield point##2##2##(2013-1#2)
yield potential##2##2##(2008-10#2)
yield quality##2##2##(2008-10#2)
yield quantity##2##2##(2008-10#2)
yield reductions caused by##2##4##(2008-10#2)
yield reductions##4##2##(2008-10#4)
yield results##4##2##(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#1)
yield satisfactory results##3##3##(1992-10#1)(2008-10#1)(2010-11#1)
yield significantly##2##2##(1992-8#1)(2010-2#1)
yield similar results##5##3##(1990-8#1)(1994-9#1)(2008-1#1)(2008-2#1)(2008-3#1)
yield similar##8##2##(1990-7#1)(1990-8#1)(1991-3#1)(1994-9#1)(2008-1#1)(2008-2#2)(2008-3#1)
yield smaller##2##2##(1992-9#1)(1995-2#1)
yield specific##3##2##(1997-3#1)(2012-2#2)
yield strength of##3##3##(2009-7#2)(2012-12#1)
yield strength was##2##3##(2009-7#2)
yield strength##11##2##(2009-11#1)(2009-7#7)(2012-12#1)(2012-2#2)
yield than##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
yield that##2##2##(1992-4#1)(2008-12#1)
yield the best##2##3##(2008-10#1)(2008-2#1)
yield the##31##2##(1990-8#1)(1991-6#1)(1991-9#1)(1993-11#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)
yield tip-displacement values that are##2##5##(2010-4#2)
yield to##5##2##(1993-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
yield under##3##2##(1995-8#1)(2008-10#1)(2008-12#1)
yield useful##3##2##(1991-12#1)(1992-5#1)(2008-8#1)
yield valuable##2##2##(2008-7#1)(2011-1#1)
yield was 1##2##3##(2008-11#1)(2013-1#1)
yield was lower##2##3##(2008-10#1)(2008-11#1)
yield was not##4##3##(2008-10#4)
yield was obtained##2##3##(2008-10#1)(2008-7#1)
yield was recorded##2##3##(2008-12#2)
yield was##33##2##(1990-7#1)(1995-12#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-6#3)(2008-7#4)(2011-10#1)(2011-2#2)(2013-1#2)
yield were##7##2##(2008-10#5)(2008-12#1)(2008-7#1)
yield with##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
yield##862##1##(1990-12#1)(1990-3#4)(1990-5#1)(1990-7#6)(1990-8#3)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-6#6)(1995-8#3)(1995-9#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#11)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#16)(2007-12#11)(2007-5#1)(2008-1#3)(2008-10#222)(2008-11#47)(2008-12#65)(2008-2#33)(2008-3#50)(2008-4#18)(2008-5#11)(2008-6#30)(2008-7#29)(2008-8#12)(2008-9#26)(2009-10#2)(2009-11#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#9)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#9)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-10#2)(2011-2#21)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#20)(2012-3#2)(2012-4#1)(2013-1#27)(2013-7#1)(2013-8#4)
yield) and##2##2##(2008-10#1)(2008-8#1)
yield)##6##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
yield-limiting##2##1##(2008-10#2)
yield-per-recruit##4##1##(2013-7#4)
yielded Mycobacterium##2##2##(1997-4#1)(2008-1#1)
yielded a linear##2##3##(2008-10#2)
yielded a pA2 value of 7##2##6##(1996-2#2)
yielded a resolution##2##3##(2007-11#1)(2007-12#1)
yielded a sensitivity and specificity of##2##6##(1992-6#1)(2007-7#1)
yielded a single##2##3##(1991-12#1)(2008-10#1)
yielded a##54##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#3)(2009-10#1)(2012-3#1)(2013-1#3)
yielded additional##2##2##(2007-11#1)(2013-1#1)
yielded almost##2##2##(2008-10#1)(2008-5#1)
yielded an##6##2##(1993-8#1)(1996-7#1)(2008-10#3)(2008-2#1)
yielded as##2##2##(2008-10#1)(2008-2#1)
yielded better results##2##3##(2008-10#1)(2008-2#1)
yielded better##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
yielded by##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
yielded endocervical cells in##2##4##(1992-1#2)
yielded five##2##2##(1994-2#1)(2008-10#1)
yielded four##4##2##(1995-6#1)(1997-3#1)(2009-10#1)(2011-3#1)
yielded fragments##2##2##(2008-10#1)(2008-6#1)
yielded good##4##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
yielded more##2##2##(2008-10#1)(2010-3#1)
yielded no improvement##2##3##(2008-3#1)(2008-6#1)
yielded no##7##2##(1995-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)
yielded only##7##2##(1990-8#1)(1992-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-6#1)
yielded positive##2##2##(1994-7#1)(2008-10#1)
yielded promising##2##2##(1990-3#1)(2010-11#1)
yielded results##4##2##(2008-10#4)
yielded significant results only on##2##5##(1994-3#1)(2010-2#1)
yielded significant##3##2##(1994-3#1)(2008-6#1)(2010-2#1)
yielded similar##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
yielded slightly##2##2##(1997-2#1)(1997-7#1)
yielded spurious evidence##2##3##(1997-5#2)
yielded the best results##2##4##(2008-5#1)(2010-2#1)
yielded the desired##2##3##(1993-11#1)(1995-3#1)
yielded the following##4##3##(1995-11#1)(2008-10#2)(2008-12#1)
yielded the same##4##3##(1994-11#1)(2008-10#2)(2013-7#1)
yielded the##23##2##(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-7#1)
yielded three##3##2##(2008-10#1)(2008-5#1)(2010-9#1)
yielded two##4##2##(1990-5#1)(1997-6#1)(2008-10#2)
yielded values##2##2##(1995-2#1)(2008-10#1)
yielded very##2##2##(2008-12#1)(2008-6#1)
yielded##283##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#3)(1991-12#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-11#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#73)(2008-11#7)(2008-12#6)(2008-2#7)(2008-3#14)(2008-5#7)(2008-6#6)(2008-7#6)(2008-9#3)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
yielding 1##2##2##(1992-9#1)(2008-10#1)
yielding a maximum##2##3##(1991-8#1)(2008-7#1)
yielding a pink##2##3##(2008-10#2)
yielding a##33##2##(1991-8#1)(1993-6#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-8#1)(2007-11#3)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
yielding an overall##2##3##(2008-10#1)(2012-2#1)
yielding an##8##2##(1994-3#1)(1995-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2012-2#1)
yielding good agreement with##2##4##(2008-2#1)(2012-2#1)
yielding good##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
yielding improved##2##2##(2007-11#1)(2008-10#1)
yielding information##2##2##(2009-5#1)(2011-2#1)
yielding one##4##2##(1991-12#1)(2008-10#2)(2009-12#1)
yielding optimum##2##2##(2008-10#1)(2008-11#1)
yielding period##3##2##(2008-6#3)
yielding several##2##2##(2008-4#2)
yielding the##9##2##(1994-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2011-3#1)
yielding two##2##2##(1993-11#1)(2008-3#1)
yielding##133##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#6)(2007-12#13)(2007-5#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)
yields a fringe pattern##2##4##(2008-2#1)(2008-3#1)
yields a high frequency of both stable transformation and transient gene expression##2##12##(2008-1#1)(2008-2#1)
yields a high##3##3##(2008-1#1)(2008-2#1)(2012-2#1)
yields a##46##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#3)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#7)(2008-3#10)(2008-7#2)(2009-10#1)(2010-4#1)(2012-2#1)
yields an effective##2##3##(2007-11#1)(2008-3#1)
yields an##12##2##(1990-11#1)(1993-11#1)(1996-12#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-3#5)
yields and high##2##3##(1996-5#1)(2008-9#1)
yields and##15##2##(1992-8#1)(1996-5#3)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
yields are low##3##3##(2008-11#2)(2008-8#1)
yields are##9##2##(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)
yields as##4##2##(2008-10#1)(2008-11#2)(2012-12#1)
yields at##3##2##(1996-5#1)(2011-2#1)(2013-1#1)
yields better results than##2##4##(2008-8#1)(2010-8#1)
yields better##3##2##(2008-8#1)(2010-8#1)(2011-2#1)
yields by##6##2##(1996-5#2)(2008-10#1)(2008-4#1)(2008-5#2)
yields close##3##2##(2008-10#2)(2009-5#1)
yields could##2##2##(2007-11#1)(2008-10#1)
yields excellent##2##2##(1993-12#1)(2008-3#1)
yields for##4##2##(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
yields from##6##2##(2008-11#3)(2008-4#1)(2013-1#2)
yields good##2##2##(2012-2#1)(2012-3#1)
yields in the##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
yields in##12##2##(1994-12#1)(1997-3#1)(2008-10#5)(2008-3#1)(2008-6#2)(2011-2#1)(2012-12#1)
yields information##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
yields obtained in##2##3##(2008-11#2)
yields obtained##4##2##(2008-10#1)(2008-11#2)(2008-6#1)
yields of 0##2##3##(1990-5#1)(2008-12#1)
yields of the##5##3##(1997-4#1)(2008-10#2)(2008-4#1)(2011-1#1)
yields of##38##2##(1990-5#1)(1990-8#1)(1990-9#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#4)(2008-6#2)(2008-9#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
yields on##2##2##(2008-6#2)
yields only##2##2##(2008-11#1)(2008-3#1)
yields over##2##2##(2008-10#1)(2013-1#1)
yields reproducible##2##2##(1991-5#1)(2008-7#1)
yields sufficient##2##2##(1994-11#1)(2008-4#1)
yields than##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
yields that were##2##3##(2008-10#1)(2013-1#1)
yields the best##2##3##(2008-10#1)(2008-11#1)
yields the corresponding##2##3##(2007-11#1)(2008-5#1)
yields the following results##2##4##(1992-6#1)(2008-7#1)
yields the same##2##3##(2008-2#1)(2008-3#1)
yields the##29##2##(1992-6#1)(1993-2#2)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)
yields to##2##2##(2008-11#1)(2008-7#1)
yields under##3##2##(2007-11#1)(2008-4#2)
yields via##2##2##(2009-5#1)(2010-6#1)
yields were calculated##2##3##(2008-10#2)
yields were increased##2##3##(1995-12#1)(2008-11#1)
yields were obtained##2##3##(2008-10#1)(2008-11#1)
yields were##19##2##(1995-12#1)(2007-11#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#2)(2009-5#1)
yields with##4##2##(2008-10#1)(2010-7#2)(2013-7#1)
yields##400##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#3)(1990-8#4)(1990-9#2)(1991-11#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#10)(1997-3#4)(1997-4#3)(1997-7#3)(2006-10#1)(2007-11#24)(2007-12#9)(2008-1#2)(2008-10#74)(2008-11#31)(2008-12#10)(2008-2#23)(2008-3#43)(2008-4#15)(2008-5#6)(2008-6#19)(2008-7#10)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#11)(2013-7#1)
yin and##2##2##(2006-10#1)(2008-10#1)
yin##3##1##(2006-10#1)(2008-10#2)
ylide##4##1##(1997-4#1)(2009-5#2)(2010-6#1)
yoelii##6##1##(1994-12#4)(2008-3#1)(2012-2#1)
yoga and osteopathy##2##3##(2010-12#2)
yoga##11##1##(1991-10#1)(1991-12#1)(2008-10#1)(2008-3#2)(2010-12#6)
yoghurt##4##1##(2008-10#4)
yogic##3##1##(1991-10#1)(1991-12#1)(2008-3#1)
yogurt##2##1##(1990-8#1)(2012-2#1)
yohimbine##5##1##(1990-5#1)(1992-2#1)(1994-3#1)(2008-10#1)(2013-1#1)
yolk DNA##4##2##(2008-4#4)
yolk by##2##2##(2008-10#2)
yolk granules##7##2##(2007-12#7)
yolk proteins##4##2##(1995-2#1)(2008-12#1)(2010-5#2)
yolk sac carcinoma##3##3##(2012-1#3)
yolk sac tumor##2##3##(2008-10#2)
yolk sac##22##2##(1993-12#1)(1993-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#9)(2008-5#1)(2008-9#2)(2012-1#4)
yolk sacs##3##2##(2007-12#3)
yolk##59##1##(1990-11#1)(1991-8#1)(1993-12#1)(1993-8#1)(1995-2#1)(1997-4#1)(2007-12#11)(2008-10#7)(2008-11#1)(2008-12#12)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#2)(2010-2#4)(2010-5#2)(2011-1#1)(2012-1#4)(2012-12#1)(2012-3#2)
yolkless##2##1##(1995-2#2)
you and your##3##3##(1993-3#1)(1994-2#1)(1996-3#1)
you are##5##2##(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-2#1)
you at##2##2##(2009-12#1)(2013-7#1)
you can help##2##3##(1997-1#1)(2008-7#1)
you can##8##2##(1994-1#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-7#1)(2011-2#1)
you choose##2##2##(1995-1#1)(2011-2#1)
you do##4##2##(1993-3#1)(1994-2#1)(1995-2#1)(2008-11#1)
you don't##3##2##(1994-2#1)(1997-7#1)(2009-5#1)
you ever##3##2##(1992-1#1)(1994-2#1)(1995-12#1)
you get##3##2##(1994-3#1)(1996-3#1)(2009-5#1)
you have a##2##3##(1991-3#1)(1992-1#1)
you have to##2##3##(1991-1#1)(1994-2#1)
you have##6##2##(1991-1#1)(1991-3#1)(1992-1#2)(1994-2#1)(2008-11#1)
you know##4##2##(1993-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
you may have##2##3##(1993-12#1)(2006-10#1)
you may##4##2##(1993-12#1)(1994-2#1)(1994-3#1)(2006-10#1)
you measure##2##2##(1995-2#1)(2010-10#1)
you must##2##2##(1993-3#1)(1994-2#1)
you need to know##2##4##(2007-9#1)(2010-5#1)
you need to##5##3##(1996-1#1)(1996-3#1)(2007-9#1)(2010-5#1)(2011-2#1)
you need##8##2##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-9#1)(2010-5#1)(2011-2#1)
you ready for##2##3##(2012-3#2)
you see##2##2##(1997-7#1)(2009-12#1)
you take##2##2##(1993-2#1)(2008-11#1)
you tell me##2##3##(1992-3#1)(2008-1#1)
you think##7##2##(1993-5#1)(1996-2#1)(2008-8#3)(2009-6#1)(2013-7#1)
you to##5##2##(1993-1#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-3#1)
you treat your##2##3##(1996-6#1)(2008-4#1)
you want to##7##3##(1992-1#1)(1994-3#1)(1995-12#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
you want##8##2##(1992-1#1)(1994-3#1)(1995-12#1)(2008-1#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
you wish to##2##3##(2008-4#1)(2008-9#1)
you##196##1##(1991-1#1)(1991-12#2)(1991-3#11)(1992-1#5)(1992-3#2)(1993-1#4)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#1)(1994-1#3)(1994-12#1)(1994-2#10)(1994-3#12)(1995-1#2)(1995-12#10)(1995-2#9)(1995-3#3)(1996-1#3)(1996-2#5)(1996-3#11)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#2)(2009-5#2)(2009-6#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
you&quot##2##1##(1992-2#1)(2008-12#1)
you'll##2##1##(1994-12#1)(2010-9#1)
you've seen one##2##3##(1996-3#2)
you've seen##3##2##(1996-3#2)(2008-11#1)
you?##4##1##(1992-9#1)(1996-2#1)(2008-4#1)(2012-12#1)
young (1 and 3 months old) animals##2##7##(1993-12#2)
young (2##3##2##(2008-3#1)(2009-12#1)(2013-7#1)
young (aged##2##2##(2008-5#1)(2008-9#1)
young Black men are##2##4##(2009-9#2)
young Black##3##2##(2009-9#2)(2011-2#1)
young Indian##2##2##(2011-2#1)(2012-2#1)
young Japanese##2##2##(2008-10#2)
young adolescents'##2##2##(2009-11#1)(2013-1#1)
young adult and##2##3##(1994-11#1)(2008-5#1)
young adult survivors of##2##4##(2008-6#1)(2008-7#1)
young adult##32##2##(1990-3#1)(1991-11#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#2)(2007-12#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#6)(2011-1#1)(2012-3#1)(2013-1#1)
young adulthood##5##2##(1993-9#1)(1996-5#1)(2009-7#1)(2010-7#1)(2012-3#1)
young adults and##3##3##(1994-5#1)(2006-10#1)(2007-8#1)
young adults are##2##3##(2008-11#1)(2012-12#1)
young adults from##2##3##(2008-7#1)(2010-2#1)
young adults in a##2##4##(1995-9#2)
young adults in the##2##4##(1997-6#1)(2013-1#1)
young adults in##7##3##(1995-5#1)(1995-9#2)(1997-6#1)(2013-1#3)
young adults may##2##3##(2007-12#1)(2011-2#1)
young adults of##2##3##(1991-11#1)(2008-3#1)
young adults who##4##3##(2009-10#1)(2013-1#2)(2013-8#1)
young adults with##7##3##(1990-3#1)(1996-2#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-2#1)
young adults##84##2##(1990-12#1)(1990-3#2)(1991-1#1)(1991-11#2)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#3)(1995-5#1)(1995-9#2)(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#5)
young adults' current financial learning##2##5##(2010-10#2)
young adults'##4##2##(2008-12#1)(2009-12#1)(2010-10#2)
young age##16##2##(1991-2#1)(1992-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-8#2)
young and adult rats##2##4##(2013-7#2)
young and adult##7##3##(1997-6#1)(1997-9#1)(2008-7#1)(2012-3#2)(2013-7#2)
young and aged##6##3##(1990-5#1)(1990-7#1)(1994-6#1)(1995-5#1)(1997-6#1)(2008-5#1)
young and middle-aged adults##2##4##(2008-7#1)(2009-12#1)
young and middle-aged##3##3##(2008-7#2)(2009-12#1)
young and old rat##2##4##(1994-8#1)(2009-12#1)
young and old rats##12##4##(1991-12#3)(1994-6#3)(1994-8#1)(2008-7#4)(2009-12#1)
young and old##22##3##(1990-3#1)(1991-12#3)(1994-5#2)(1994-6#4)(1994-8#2)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#4)(2009-12#2)(2010-11#1)
young and older adults##3##4##(2008-11#1)(2008-3#1)(2009-10#1)
young and older women##2##4##(2008-3#2)
young and older##7##3##(2008-11#1)(2008-3#3)(2008-5#1)(2009-10#1)(2011-1#1)
young and##60##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#3)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-6#2)(1997-9#1)(2007-12#1)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#8)(2008-9#2)(2009-10#1)(2009-12#3)(2010-11#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
young animals##12##2##(1991-12#1)(1996-5#2)(2008-3#3)(2008-7#2)(2009-12#2)(2011-1#1)(2011-2#1)
young athletes##11##2##(1995-6#1)(1996-6#1)(2010-1#4)(2010-10#1)(2012-3#4)
young black##3##2##(2011-2#2)(2013-1#1)
young bulls##3##2##(2013-1#3)
young but##3##2##(1990-3#2)(1994-6#1)
young chicks##2##2##(1990-3#1)(2007-6#1)
young child##16##2##(1993-3#1)(1996-2#2)(1996-3#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#5)(2011-1#1)
young children and##4##3##(1996-3#1)(1997-1#1)(2008-11#1)(2012-2#1)
young children are##2##3##(1994-11#1)(2013-8#1)
young children in the##2##4##(2008-9#1)(2009-11#1)
young children in##3##3##(2008-9#1)(2009-11#1)(2012-12#1)
young children is##2##3##(2008-9#1)(2010-6#1)
young children to##2##3##(2008-6#1)(2013-1#1)
young children using cochlear implants##2##5##(2008-9#2)
young children with##5##3##(1997-1#1)(2008-4#1)(2009-3#1)(2010-10#1)(2013-1#1)
young children##65##2##(1991-12#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-1#4)(1997-3#1)(1997-8#1)(2007-12#1)(2008-1#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#11)(2009-11#1)(2009-3#2)(2009-9#2)(2010-10#2)(2010-4#1)(2010-5#3)(2010-6#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#4)
young cirrhotics##5##2##(2012-3#5)
young controls##2##2##(1994-5#1)(2008-7#1)
young deaf##2##2##(2008-9#1)(2011-2#1)
young donors##2##2##(2008-7#1)(2012-2#1)
young erythrocytes##2##2##(2008-9#2)
young female##17##2##(1992-10#1)(1994-6#1)(2007-7#1)(2008-12#3)(2008-6#2)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
young females##7##2##(1997-3#1)(1997-8#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-2#2)
young girl##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
young girls with##2##3##(2007-12#1)(2007-8#1)
young group##3##2##(2007-7#1)(2008-4#1)(2013-1#1)
young healthy##2##2##(2007-2#1)(2007-7#1)
young individuals##8##2##(1991-12#1)(1993-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)
young infants##2##2##(2008-11#1)(2010-10#1)
young injection drug users##2##4##(2013-8#2)
young kittens (postnatal##2##3##(1993-12#2)
young lady##2##2##(2007-7#1)(2010-10#1)
young leaves##5##2##(2008-10#3)(2008-5#2)
young male buffalo meat##2##4##(2010-4#2)
young male rats##2##3##(2008-7#2)
young male with##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
young male##26##2##(1990-6#2)(1996-3#2)(1996-7#1)(1996-8#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#5)(2010-4#3)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
young males##9##2##(1991-6#1)(1996-6#1)(2007-7#1)(2008-6#1)(2009-5#2)(2010-3#1)(2011-2#2)
young man with##3##3##(2009-3#1)(2012-3#2)
young man##9##2##(1991-11#1)(1992-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#2)(2013-1#1)
young maternal age is##2##4##(2009-12#2)
young maternal age##3##3##(2009-12#2)(2012-12#1)
young men in##3##3##(1990-6#1)(1991-11#1)(2008-10#1)
young men with##3##3##(1994-2#1)(2011-2#1)(2013-1#1)
young men##28##2##(1990-6#1)(1991-11#1)(1991-9#1)(1994-2#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-5#10)(2011-2#4)(2013-1#2)(2013-8#1)
young ones##4##2##(1990-5#1)(1994-6#2)(2008-7#1)
young or adult##2##3##(1997-6#1)(2013-7#1)
young or##8##2##(1996-5#1)(1997-6#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-3#2)(2013-7#1)
young patient##10##2##(1990-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#4)(2013-1#1)
young patients with severe##2##4##(2009-3#2)
young patients with##11##3##(1996-7#3)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#2)(2011-2#1)(2013-1#1)
young patients##31##2##(1990-3#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-8#1)(1995-12#1)(1996-7#3)(2007-10#3)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
young people in##6##3##(1990-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
young people is##2##3##(2009-5#1)(2013-1#1)
young people reported##2##3##(2012-12#1)(2012-3#1)
young people who have a##2##5##(2008-7#1)(2012-2#1)
young people who##5##3##(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
young people with##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
young people##47##2##(1990-3#1)(1990-6#1)(1991-6#1)(1992-5#1)(1995-8#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#6)(2009-5#2)(2009-7#1)(2011-1#2)(2011-2#3)(2012-12#5)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#2)
young persons##3##2##(1991-3#1)(1996-1#1)(2010-8#1)
young pigs##3##2##(1997-4#1)(2013-1#1)(2013-8#1)
young population##4##2##(2007-11#1)(2008-11#1)(2009-7#1)(2012-2#1)
young rat##3##2##(1990-7#1)(1994-6#1)(2009-12#1)
young rats##16##2##(1990-3#1)(1990-5#1)(1991-12#2)(1992-11#2)(1994-6#1)(1996-5#2)(2008-7#3)(2011-1#1)(2013-7#3)
young scientists##3##2##(1997-2#1)(2008-5#1)(2012-2#1)
young seedlings##3##2##(2008-10#1)(2008-5#2)
young soccer##2##2##(2008-5#1)(2012-3#1)
young speakers##2##2##(2008-2#1)(2008-4#1)
young stems##2##2##(2008-10#2)
young subjects##5##2##(1993-1#2)(2008-5#1)(2008-7#1)(2008-8#1)
young surgeons##4##2##(1993-2#1)(2008-4#2)(2013-7#1)
young volunteers##3##2##(2008-7#2)(2012-2#1)
young woman with##6##3##(1991-3#1)(2006-10#1)(2007-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
young woman##12##2##(1990-2#1)(1991-3#1)(1992-12#2)(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
young women from##2##3##(1996-12#2)
young women in##4##3##(1996-12#2)(1997-8#1)(2007-8#1)
young women to##2##3##(1996-12#1)(1997-7#1)
young women who##2##3##(1996-12#1)(2009-11#1)
young women with breast cancer##3##5##(2013-1#3)
young women with##10##3##(2007-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#5)
young women##51##2##(1991-6#1)(1991-9#1)(1992-5#1)(1994-5#4)(1996-12#7)(1996-3#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-12#3)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-3#3)(2010-7#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#8)
young women's##2##2##(2007-12#1)(2010-7#1)
young workers##2##2##(1997-2#1)(2008-6#1)
young##882##1##(1990-12#2)(1990-2#2)(1990-3#15)(1990-5#4)(1990-6#4)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#6)(1991-12#11)(1991-2#3)(1991-3#2)(1991-6#4)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#1)(1993-1#3)(1993-12#8)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#13)(1994-6#13)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#2)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#2)(1996-12#7)(1996-2#9)(1996-3#6)(1996-5#7)(1996-6#3)(1996-7#4)(1996-8#2)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#10)(1997-7#1)(1997-8#6)(1997-9#2)(2006-10#5)(2007-10#9)(2007-11#6)(2007-12#17)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#1)(2008-1#9)(2008-10#35)(2008-11#19)(2008-12#11)(2008-2#4)(2008-3#13)(2008-4#8)(2008-5#21)(2008-6#13)(2008-7#57)(2008-8#13)(2008-9#33)(2009-10#5)(2009-11#5)(2009-12#13)(2009-3#5)(2009-4#1)(2009-5#21)(2009-7#8)(2009-8#1)(2009-9#5)(2010-1#5)(2010-10#10)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#7)(2010-4#6)(2010-5#10)(2010-6#2)(2010-7#10)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#56)(2012-1#6)(2012-12#10)(2012-2#28)(2012-3#39)(2012-9#1)(2013-1#45)(2013-7#10)(2013-8#22)
younger adults##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2012-12#1)
younger age group##2##3##(1996-11#1)(2012-3#1)
younger age in##2##3##(2008-7#1)(2009-4#1)
younger age of##3##3##(1996-12#1)(1996-7#1)(2008-9#1)
younger age##16##2##(1996-11#1)(1996-12#1)(1996-7#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
younger ages##3##2##(2007-10#1)(2008-3#1)(2008-8#1)
younger and older age groups##2##5##(2008-5#1)(2011-2#1)
younger and older##11##3##(2008-4#2)(2008-5#1)(2008-6#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
younger and##23##2##(1990-3#1)(1992-9#3)(1994-5#1)(1995-3#1)(1997-5#1)(2007-5#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#1)
younger animals##3##2##(2008-3#2)(2009-12#1)
younger children##8##2##(1995-11#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#2)(2013-1#1)
younger leaves##2##2##(2008-10#2)
younger men##6##2##(2008-3#1)(2008-4#1)(2009-5#3)(2011-1#1)
younger mothers##2##2##(1990-6#1)(1997-3#1)
younger ones##2##2##(2010-2#1)(2012-1#1)
younger patients and##2##3##(2012-1#1)(2012-12#1)
younger patients with##3##3##(1991-5#1)(2007-10#1)(2007-8#1)
younger patients##29##2##(1991-12#1)(1991-2#1)(1991-5#1)(1994-6#7)(1997-3#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
younger rats##4##2##(1991-12#2)(1992-8#1)(2012-1#1)
younger subjects##6##2##(1996-2#1)(2008-12#1)(2008-3#1)(2008-5#3)
younger than 12##2##3##(1991-2#1)(1993-2#1)
younger than 2 months of age##2##6##(2006-5#2)
younger than 40 years of age##2##6##(2010-12#1)(2012-12#1)
younger than 40 years##3##4##(2010-12#2)(2012-12#1)
younger than 40##4##3##(1991-12#1)(2010-12#2)(2012-12#1)
younger than 65 years##4##4##(2009-8#3)(2011-2#1)
younger than those##3##3##(1990-6#1)(2007-10#2)
younger than three months of age##2##6##(2008-11#1)(2012-2#1)
younger than three##3##3##(2008-11#2)(2012-2#1)
younger than##45##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-9#3)(1993-2#1)(1993-8#1)(1996-12#1)(1997-3#1)(2006-5#3)(2007-10#4)(2007-12#1)(2007-8#2)(2008-11#3)(2008-12#2)(2008-9#2)(2009-8#3)(2010-12#2)(2010-3#4)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)
younger women##12##2##(1990-6#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-6#1)(1997-7#1)(2007-4#1)(2008-3#2)(2010-9#1)(2011-1#1)(2012-2#1)
younger##237##1##(1990-12#1)(1990-3#1)(1990-6#3)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#6)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#8)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#6)(1997-5#2)(1997-7#2)(2006-5#3)(2007-10#6)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#6)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#5)(2009-8#6)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#15)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#3)
youngest##19##1##(1992-6#2)(1995-4#1)(1996-2#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-8#1)
youngsters##5##1##(1993-2#1)(2009-10#1)(2011-2#1)(2012-12#2)
your Patient Focused Care program##3##5##(1994-1#1)(1994-2#2)
your Patient Focused Care program)!&quot##2##5##(1994-1#2)
your Patient Focused Care##5##4##(1994-1#3)(1994-2#2)
your Patient Focused communications##2##4##(1994-1#2)
your Patient Focused restructuring##2##4##(1994-2#1)(1994-3#1)
your Patient Focused##11##3##(1993-3#1)(1994-1#5)(1994-2#3)(1994-3#2)
your back##2##2##(1992-12#1)(1995-2#1)
your best##2##2##(1994-1#1)(2007-12#1)
your children##2##2##(1992-4#1)(1997-3#1)
your clinical##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
your community##2##2##(1995-2#2)
your company's##3##2##(1992-3#2)(1996-3#1)
your current##3##2##(1995-2#1)(1996-3#1)(2008-1#1)
your diagnosis?##7##2##(1992-6#1)(1993-11#1)(1994-5#1)(2007-12#2)(2007-2#2)
your educational##4##2##(1994-1#1)(1995-12#3)
your efforts##2##2##(1992-1#1)(1996-1#1)
your environment##2##2##(1992-2#1)(1995-2#1)
your facility##4##2##(2011-1#1)(2011-2#3)
your facility's fiscal integrity##2##4##(1992-1#2)
your facility's##4##2##(1992-1#2)(2007-10#1)(2011-2#1)
your future##2##2##(1992-2#1)(1995-12#1)
your gift##2##2##(1994-12#1)(1997-1#1)
your health care facility##2##4##(1991-1#1)(1991-12#1)
your health care organization##2##4##(1996-1#2)
your health care##5##3##(1991-1#1)(1991-12#1)(1994-3#1)(1996-1#2)
your health##7##2##(1991-1#1)(1991-12#1)(1994-3#1)(1996-1#2)(1996-3#1)(2008-10#1)
your healthcare institution##2##3##(1993-2#2)
your heart##2##2##(2007-2#1)(2012-2#1)
your hospital##11##2##(1991-1#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#2)(1995-2#1)(1997-2#1)
your hospital's##3##2##(1992-1#1)(1993-2#1)(1994-12#1)
your institution##4##2##(1994-2#1)(1994-3#1)(1996-1#1)(2011-2#1)
your life##9##2##(1996-2#1)(2007-9#1)(2008-5#7)
your medical##4##2##(1991-1#1)(1992-1#1)(2008-8#1)(2013-7#1)
your mind##2##2##(2008-10#1)(2013-8#1)
your organization is##2##3##(1994-1#1)(1996-1#1)
your organization may##2##3##(1991-2#1)(1994-1#1)
your organization##13##2##(1991-2#1)(1992-12#1)(1993-1#2)(1994-1#3)(1996-1#2)(1996-2#2)(1997-2#1)(2008-1#1)
your organizational##2##2##(1994-3#1)(1996-1#1)
your own##9##2##(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(2008-1#1)(2009-3#1)(2013-1#1)(2013-8#1)
your particular##2##2##(1992-12#1)(1993-12#1)
your patient focused care program##2##5##(1993-2#2)
your patient focused##3##3##(1993-2#3)
your patient##8##2##(1992-1#1)(1993-2#3)(1994-3#1)(1995-2#1)(2008-10#1)(2011-2#1)
your patients and##2##3##(2011-2#2)
your patients##5##2##(1994-3#1)(2008-4#1)(2011-2#2)(2012-3#1)
your practice##4##2##(2007-4#1)(2008-1#1)(2012-3#2)
your program##2##2##(1993-2#1)(1993-3#1)
your research##2##2##(2008-11#1)(2013-7#1)
your restructuring initiative##4##3##(1994-12#1)(1994-3#1)(1996-1#2)
your restructuring##5##2##(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#2)
your strategic##2##2##(1994-3#1)(1996-3#1)
your top##2##2##(1991-1#1)(1997-1#1)
your##317##1##(1991-1#7)(1991-12#1)(1991-2#2)(1991-3#4)(1992-1#8)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#10)(1993-3#8)(1993-8#1)(1994-1#14)(1994-12#6)(1994-2#11)(1994-3#23)(1994-5#1)(1995-1#1)(1995-12#8)(1995-2#19)(1995-3#2)(1996-1#15)(1996-12#3)(1996-2#8)(1996-3#9)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#1)(1997-5#1)(2006-5#1)(2007-10#4)(2007-12#5)(2007-2#3)(2007-4#2)(2007-9#3)(2008-1#6)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#8)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#5)(2011-1#1)(2011-2#18)(2012-12#2)(2012-2#2)(2012-3#9)(2013-1#2)(2013-7#4)(2013-8#9)
yours##3##1##(1992-12#1)(1993-3#1)(2013-7#1)
yourself in your##2##3##(1994-3#1)(2013-8#1)
yourself##4##1##(1994-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
youth aged##3##2##(2010-5#1)(2010-8#1)(2013-1#1)
youth and young##4##3##(2009-5#1)(2012-12#1)(2013-8#2)
youth and##11##2##(2008-11#2)(2008-3#1)(2009-5#2)(2009-7#1)(2012-12#2)(2013-1#1)(2013-8#2)
youth are##2##2##(2009-7#1)(2011-2#1)
youth as##2##2##(2008-12#1)(2008-9#1)
youth development programs##2##3##(2008-7#2)
youth development##9##2##(2008-7#5)(2009-7#2)(2013-1#2)
youth had reductions (p &lt##2##5##(2008-3#2)
youth health##3##2##(2008-11#1)(2009-5#1)(2012-2#1)
youth in##11##2##(1996-12#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-10#2)(2010-5#1)(2010-8#2)(2012-12#1)(2013-1#1)
youth is##2##2##(2008-12#1)(2012-12#1)
youth may##2##2##(2007-7#1)(2013-1#1)
youth reported##2##2##(2009-7#1)(2009-8#1)
youth spent more time##2##4##(2009-7#2)
youth to##3##2##(2008-12#1)(2009-7#1)(2012-12#1)
youth using##2##2##(2012-2#2)
youth who##8##2##(1994-2#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-12#1)
youth with a##2##3##(2008-12#1)(2010-1#1)
youth with disabilities or##3##4##(2010-11#3)
youth with##15##2##(1992-3#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#3)(2011-1#1)(2011-2#1)
youth##192##1##(1990-12#1)(1992-3#1)(1994-2#1)(1996-12#2)(1997-6#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-11#15)(2008-12#9)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#31)(2009-8#7)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#4)(2010-12#1)(2010-5#5)(2010-8#6)(2010-9#4)(2011-1#5)(2011-2#4)(2012-12#8)(2012-2#16)(2012-3#1)(2013-1#13)(2013-7#3)(2013-8#4)
youth's achievement##2##2##(2009-7#2)
youth's##10##1##(2009-7#10)
youth]##2##1##(1990-9#1)(2011-2#1)
youthful##3##1##(2009-8#1)(2010-2#1)(2011-2#1)
youths and##2##2##(1992-5#1)(2008-9#1)
youths in##2##2##(2009-7#1)(2012-12#1)
youths reported##3##2##(2008-9#3)
youths with selective mutism##2##4##(2009-11#2)
youths with##4##2##(2008-9#1)(2009-11#2)(2012-12#1)
youths##34##1##(1992-5#1)(2007-9#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-7#1)(2008-9#8)(2009-10#2)(2009-11#2)(2009-7#4)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-1#1)
youths' academic engagement##2##3##(2008-12#1)(2009-7#1)
youths' engagement##2##2##(2008-12#2)
youths'##7##1##(2008-12#4)(2008-7#1)(2009-7#2)
yperite##5##1##(2008-10#2)(2008-11#3)
yr in##2##2##(1996-4#1)(2008-9#1)
yr of field##2##3##(2008-8#1)(2011-2#1)
yr of##4##2##(2008-8#1)(2008-9#2)(2011-2#1)
yr versus##2##2##(2008-7#2)
yr##52##1##(1996-4#1)(2008-11#1)(2008-5#1)(2008-7#19)(2008-8#10)(2008-9#12)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)
yr(-1)##2##1##(2008-8#1)(2012-2#1)
yr(-2) for##3##2##(2012-2#3)
yr)##6##1##(1992-10#1)(2008-9#2)(2009-11#2)(2009-3#1)
yrs and##2##2##(2010-10#1)(2012-3#1)
yrs old##2##2##(2008-7#1)(2011-2#1)
yrs##16##1##(2007-8#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#1)
yrs)##4##1##(1997-3#1)(2008-12#1)(2012-3#2)
ytterbium codoping in heavily erbium-doped##2##5##(2007-12#2)
ytterbium codoping##3##2##(2007-12#3)
ytterbium##13##1##(1997-8#1)(2007-11#1)(2007-12#6)(2008-10#5)
ytterbium(III)##2##1##(2008-10#2)
ytterbium-doped fiber##2##2##(2008-3#2)
ytterbium-doped##8##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
yttrium aluminum garnet (YAG)##2##4##(2007-11#1)(2007-12#1)
yttrium aluminum garnet##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2010-8#1)
yttrium aluminum##7##2##(2007-11#2)(2007-12#1)(2008-2#3)(2010-8#1)
yttrium and##4##2##(1992-11#1)(2008-10#3)
yttrium in##2##2##(2008-10#2)
yttrium##28##1##(1992-11#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-2#4)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
yuan##2##1##(2008-9#1)(2013-1#1)
yunnanensis##3##1##(2012-3#1)(2013-1#2)
z = 2##2##3##(2008-10#1)(2010-2#1)
z =##4##2##(1995-8#2)(2008-10#1)(2010-2#1)
z of##2##2##(2008-10#1)(2008-3#1)
z##19##1##(1992-12#2)(1995-8#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#4)(2008-8#1)(2009-11#1)(2010-2#1)(2013-1#1)
z(r)##2##1##(2008-10#2)
z-VAD-Fmk##2##1##(2011-2#2)
z-VAD-fmk##2##1##(2013-1#2)
z-axis##2##1##(1994-11#1)(2008-4#1)
z-scan technique##2##2##(2008-3#2)
z-scan##3##1##(2007-12#1)(2008-3#2)
z-score##2##1##(2008-10#1)(2011-1#1)
z-scores##3##1##(2008-10#1)(2011-1#2)
z-spectra##3##1##(2012-7#3)
z1##2##1##(2007-11#2)
zFP538##4##1##(2009-9#4)
zNosetrade mark##6##2##(2008-10#6)
zNosetrade##7##1##(2008-10#7)
zea cell##3##2##(2008-11#3)
zea cells showed a preference for##2##6##(2008-11#2)
zea cells##4##2##(2008-11#4)
zea##9##1##(2008-11#8)(2012-2#1)
zeae from##2##2##(2008-10#2)
zeae in##4##2##(2008-10#4)
zeae is the##2##3##(2008-10#2)
zeae were collected##3##3##(2008-10#3)
zeae were##4##2##(2008-10#4)
zeae##41##1##(2008-10#40)(2008-8#1)
zeae)##4##1##(2008-10#3)(2008-8#1)
zeae-infested maize kernels##2##3##(2008-10#2)
zeae-maydis##11##1##(2008-10#11)
zeamatin##2##1##(2008-10#2)
zearalenone (ZEN)##2##2##(2008-10#1)(2013-1#1)
zearalenone determination in##2##3##(2008-10#2)
zearalenone##8##1##(1997-6#2)(2008-10#3)(2010-7#1)(2013-1#2)
zeaxanthin and##2##2##(1992-9#1)(2008-11#1)
zeaxanthin dipalmitate##2##2##(2008-11#2)
zeaxanthin##5##1##(1992-9#1)(2008-11#3)(2008-12#1)
zeaxanthins##3##1##(2008-11#3)
zebra fish##3##2##(2008-4#1)(2010-1#2)
zebra##5##1##(1997-2#2)(2008-4#1)(2010-1#2)
zebrafish (Danio rerio)##4##3##(2008-7#1)(2008-9#2)(2013-1#1)
zebrafish FSH##3##2##(2010-5#3)
zebrafish and##3##2##(1997-7#1)(2008-1#1)(2008-9#1)
zebrafish embryos/larvae##4##2##(2013-1#4)
zebrafish fibroblasts by nucleofection##2##4##(2008-11#2)
zebrafish model##3##2##(2008-7#1)(2008-8#2)
zebrafish testis##3##2##(2008-7#3)
zebrafish were##2##2##(2008-8#1)(2008-9#1)
zebrafish##58##1##(1991-9#2)(1992-9#4)(1993-12#2)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#4)(2008-7#11)(2008-8#4)(2008-9#4)(2009-5#1)(2010-5#4)(2012-12#3)(2012-3#5)(2013-1#7)
zebrin##3##1##(1992-9#3)
zeeman##2##1##(2008-2#1)(2008-3#1)
zein signal sequence##2##3##(1991-10#2)
zenith angle of##3##3##(2008-2#2)(2008-3#1)
zenith angle##14##2##(2008-2#5)(2008-3#9)
zenith angles##14##2##(2008-2#7)(2008-3#7)
zenith radiance##2##2##(2008-3#2)
zenith##40##1##(1990-7#1)(2008-2#15)(2008-3#23)(2011-2#1)
zeolite has##2##2##(1992-3#2)
zeolite##18##1##(1992-3#6)(2008-10#11)(2008-3#1)
zeolite-like products##2##2##(2008-6#2)
zeolites##13##1##(2006-4#1)(2008-1#2)(2008-10#8)(2008-6#1)(2010-12#1)
zeolitic material##2##2##(2008-10#2)
zeolitic##3##1##(2008-10#3)
zephyrinid nudibranch##2##2##(2008-5#2)
zero and##2##2##(2008-10#1)(2010-1#1)
zero as##3##2##(1993-12#1)(2008-10#2)
zero at##5##2##(1991-11#1)(2007-12#2)(2008-10#1)(2013-8#1)
zero axis of symmetry##2##4##(2008-10#2)
zero crossing##2##2##(2008-10#2)
zero crossings##2##2##(2008-2#1)(2008-3#1)
zero differential group delay##2##4##(2007-12#2)
zero for##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
zero geometric loss##2##3##(2008-3#2)
zero in##5##2##(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)
zero net##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
zero of##2##2##(2007-11#1)(2007-12#1)
zero or##5##2##(1990-8#1)(1997-7#1)(2008-2#1)(2008-9#1)(2010-12#1)
zero order and##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
zero order##14##2##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
zero point##3##2##(2008-2#3)
zero time##3##2##(1994-8#1)(2008-12#1)(2008-3#1)
zero to##6##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
zero value##2##2##(2008-10#1)(2010-1#1)
zero with##3##2##(1997-6#1)(2008-2#1)(2008-9#1)
zero##176##1##(1990-5#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-7#2)(2007-10#1)(2007-11#9)(2007-12#14)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#5)(2008-12#7)(2008-2#16)(2008-3#23)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-11#1)(2009-6#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
zero- and##2##2##(2007-11#1)(2008-7#1)
zero-background linkers##2##2##(1994-12#2)
zero-background##3##1##(1994-12#2)(2010-7#1)
zero-birefringence polymer was##2##3##(2008-3#2)
zero-birefringence polymer##4##2##(2008-3#4)
zero-birefringence##5##1##(2008-3#5)
zero-crossing first-order derivative UV-spectrophotometric technique##2##5##(2008-10#2)
zero-crossing points##2##2##(2008-10#2)
zero-crossing wavelengths##2##2##(2008-10#2)
zero-crossing##11##1##(2008-10#10)(2008-3#1)
zero-crossing' point of##2##3##(2008-10#2)
zero-dispersion wavelength##6##2##(2007-11#5)(2007-12#1)
zero-dispersion##10##1##(2007-11#6)(2007-12#2)(2008-2#2)
zero-field splitting##2##2##(1993-11#1)(1997-7#1)
zero-field##3##1##(1993-11#1)(1997-7#1)(2008-10#1)
zero-mean##2##1##(1997-4#1)(2008-2#1)
zero-order (on-axis)##2##2##(2008-2#2)
zero-order kinetics##2##2##(2008-11#1)(2008-6#1)
zero-order##18##1##(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#10)(2008-6#1)
zero-point energy##2##2##(2009-9#2)
zero-temperature##2##1##(2009-9#2)
zeros in the##2##3##(2007-12#1)(2008-2#1)
zeros##6##1##(2007-12#2)(2008-2#3)(2008-3#1)
zeta potential of##2##3##(2008-10#1)(2008-5#1)
zeta potential value##3##3##(2008-5#1)(2012-2#2)
zeta potential##12##2##(2008-10#2)(2008-5#5)(2009-11#1)(2009-12#1)(2012-2#3)
zeta##25##1##(1992-3#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#4)(2008-5#5)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#3)
zeta(1)##4##1##(2009-12#4)
zeta(2)##3##1##(2009-12#3)
zeta(x(1))##3##1##(2008-2#3)
zeta-COP##3##1##(2009-7#3)
zeta-carotene##2##1##(1990-7#2)
zeta-chain##2##1##(1993-6#2)
zeta-crystallin##3##1##(1992-11#2)(1993-3#1)
zhuyu##4##1##(2012-3#1)(2013-8#3)
zidovudine (AZT)##2##2##(1993-3#1)(2011-3#1)
zidovudine and##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
zidovudine therapy##2##2##(1992-3#1)(1992-6#1)
zidovudine##15##1##(1990-8#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-5#3)(2008-7#2)(2011-3#2)
zif 268 and c-fos##2##4##(1997-3#2)
zif/268 and CREM##2##3##(1995-12#2)
zig-zag##2##1##(2008-5#2)
zigzag path##2##2##(2007-11#1)(2008-3#1)
zigzag slab##2##2##(2007-11#1)(2008-3#1)
zigzag##21##1##(2007-11#6)(2008-10#7)(2008-11#1)(2008-3#5)(2008-7#1)(2009-11#1)
zijn##4##1##(2012-12#4)
zinc (II)##2##2##(2008-10#2)
zinc (Zn)##6##2##(1995-3#2)(1997-4#1)(2008-5#1)(2010-2#1)(2012-2#1)
zinc acetate##5##2##(2008-10#1)(2008-7#1)(2010-10#3)
zinc and copper in##2##4##(1997-4#1)(2008-10#1)
zinc and copper##7##3##(1990-8#2)(1997-4#1)(2008-10#3)(2013-7#1)
zinc and lead##3##3##(2008-10#3)
zinc and manganese##2##3##(1991-12#1)(2008-10#1)
zinc and nickel in##3##4##(2008-10#3)
zinc and nickel##5##3##(2008-10#5)
zinc and##34##2##(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-6#1)(1996-3#1)(1997-4#2)(2008-10#17)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#2)(2013-7#1)
zinc at##4##2##(1994-5#1)(2008-10#3)
zinc atom##4##2##(1990-11#1)(1991-5#1)(1992-3#1)(1997-7#1)
zinc binding##6##2##(1994-6#2)(2008-1#2)(2008-10#2)
zinc but##2##2##(1994-5#1)(2008-10#1)
zinc by##6##2##(1997-4#1)(2008-1#1)(2008-10#4)
zinc chelates##2##2##(1990-5#1)(2008-10#1)
zinc chloride##3##2##(2008-10#2)(2012-2#1)
zinc complex##3##2##(1996-2#2)(2008-10#1)
zinc compounds##4##2##(2008-10#4)
zinc concentration##4##2##(2008-10#1)(2008-7#1)(2012-2#2)
zinc concentrations##4##2##(1990-5#1)(1993-2#1)(2012-2#2)
zinc content##3##2##(2008-10#1)(2008-5#2)
zinc deficiency in##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
zinc deficiency##17##2##(2007-12#1)(2008-10#10)(2008-11#1)(2012-2#5)
zinc determination##7##2##(2008-10#7)
zinc dithizonate##3##2##(2008-10#3)
zinc finger domain##3##3##(1991-2#1)(1996-6#1)(2009-7#1)
zinc finger domains of##2##4##(1991-9#1)(2008-8#1)
zinc finger domains##4##3##(1991-2#2)(1991-9#1)(2008-8#1)
zinc finger gene##2##3##(1991-5#2)
zinc finger motif##2##3##(1991-5#1)(1992-8#1)
zinc finger protein##5##3##(1990-11#1)(1992-7#2)(1996-6#1)(2007-12#1)
zinc finger proteins##3##3##(1992-8#1)(1994-6#1)(2008-7#1)
zinc finger##35##2##(1990-11#3)(1991-10#1)(1991-2#7)(1991-5#3)(1991-9#2)(1992-6#1)(1992-7#2)(1992-8#3)(1994-6#1)(1996-6#2)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
zinc fingers##6##2##(1991-6#1)(1992-8#2)(1997-7#2)(2008-10#1)
zinc from the##2##3##(2008-10#2)
zinc from##8##2##(1997-4#1)(2008-10#7)
zinc in milkvetch##2##3##(2008-10#2)
zinc in plant samples by##2##5##(2008-10#2)
zinc in plant##3##3##(2008-10#3)
zinc in the##5##3##(2008-10#4)(2012-2#1)
zinc in##41##2##(1994-6#1)(1995-5#1)(2008-10#34)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
zinc into##3##2##(2008-10#3)
zinc ion in##2##3##(1993-11#1)(1995-5#1)
zinc ions in##3##3##(2008-10#2)(2009-7#1)
zinc ions##14##2##(1992-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2009-7#1)(2010-11#2)(2013-7#2)
zinc is##8##2##(1992-3#1)(1992-8#1)(2008-10#5)(2013-7#1)
zinc levels##2##2##(1995-3#1)(2008-5#1)
zinc ligand##2##2##(1995-5#2)
zinc nanostructured films is##2##4##(2009-12#2)
zinc nanostructured films were##2##4##(2009-12#2)
zinc nanostructured films##5##3##(2009-12#5)
zinc on the##3##3##(1994-6#1)(1995-3#1)(2008-10#1)
zinc on##8##2##(1994-6#1)(1995-3#1)(2008-10#3)(2008-7#2)(2013-8#1)
zinc oxide (ZnO)##3##3##(2008-5#1)(2009-5#1)(2009-7#1)
zinc oxide single crystals##3##4##(2008-3#3)
zinc oxide##6##2##(2008-3#3)(2008-5#1)(2009-5#1)(2009-7#1)
zinc per enzyme subunit##3##4##(1994-5#2)(1994-6#1)
zinc per##5##2##(1994-5#4)(1994-6#1)
zinc pyrithione in##2##3##(2008-10#1)(2008-5#1)
zinc pyrithione##8##2##(2008-10#1)(2008-11#1)(2008-5#6)
zinc receptors as##2##3##(2008-4#2)
zinc secretion in the##2##4##(2008-10#2)
zinc secretion##3##2##(2008-10#3)
zinc separation and##2##3##(2008-10#2)
zinc separation##3##2##(2008-10#3)
zinc sulfate##3##2##(1990-5#1)(2008-10#2)
zinc to##3##2##(1994-6#2)(2008-10#1)
zinc traces##5##2##(2008-10#5)
zinc transporter##2##2##(2008-10#2)
zinc transporters##2##2##(2008-10#2)
zinc using##4##2##(2008-10#4)
zinc was also##2##3##(1991-9#1)(2008-10#1)
zinc was##4##2##(1991-9#1)(2008-10#3)
zinc white##2##2##(2008-10#2)
zinc with##4##2##(1994-5#1)(2008-10#3)
zinc##490##1##(1990-11#8)(1990-5#7)(1990-8#4)(1991-10#2)(1991-12#2)(1991-2#7)(1991-5#7)(1991-6#1)(1991-9#6)(1992-3#9)(1992-6#4)(1992-7#2)(1992-8#6)(1992-9#4)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-5#10)(1994-6#11)(1994-9#1)(1995-3#6)(1995-5#6)(1996-2#4)(1996-3#2)(1996-6#2)(1997-4#9)(1997-7#6)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#5)(2008-10#234)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#15)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#5)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#6)(2010-11#5)(2010-2#3)(2010-5#1)(2010-6#3)(2011-2#4)(2012-12#5)(2012-2#13)(2012-3#1)(2013-1#7)(2013-7#9)(2013-8#3)
zinc's##2##1##(2008-10#1)(2012-12#1)
zinc(II) and cadmium(II)##2##3##(2008-10#2)
zinc(II) and lead(II)##2##3##(2008-10#2)
zinc(II) and##7##2##(1992-11#1)(2008-10#5)(2010-11#1)
zinc(II) sulphate##2##2##(2008-10#2)
zinc(II)##30##1##(1991-5#4)(1992-11#1)(1997-7#1)(2008-10#23)(2010-11#1)
zinc)##4##1##(1997-4#1)(2008-10#1)(2008-11#1)(2013-7#1)
zinc-binding##6##1##(1992-6#1)(2008-1#3)(2010-8#1)(2013-7#1)
zinc-containing##7##1##(1995-5#3)(1995-6#2)(2008-5#2)
zinc-finger domain##5##2##(1995-2#5)
zinc-finger genes related to##2##4##(1991-9#2)
zinc-finger##15##1##(1991-12#2)(1991-9#3)(1993-12#1)(1993-2#1)(1994-6#1)(1995-2#5)(1997-7#1)(2010-8#1)
zip code##2##2##(2011-2#2)
zipper motifs##2##2##(1996-2#1)(1996-6#1)
zipper##12##1##(1992-3#4)(1992-8#3)(1993-12#2)(1996-2#1)(1996-6#1)(2008-10#1)
zipper-like##2##1##(2007-7#1)(2008-5#1)
zippers##2##1##(2009-8#1)(2011-2#1)
ziprasidone##5##1##(2008-3#1)(2008-6#4)
ziram and zineb respectively##2##4##(2008-10#2)
ziram and zineb##4##3##(2008-10#4)
zircon##5##1##(2008-10#5)
zirconate acid##2##2##(2008-10#2)
zirconate##9##1##(2008-10#3)(2008-2#6)
zirconia and##3##2##(2008-10#1)(2009-8#1)(2010-12#1)
zirconia content of the fume##2##5##(2008-10#2)
zirconia implants##3##2##(2009-8#3)
zirconia specimens from##2##3##(2009-8#2)
zirconia stationary phase##4##3##(2008-10#4)
zirconia surface##2##2##(2008-10#2)
zirconia##34##1##(2008-10#19)(2009-8#10)(2010-12#2)(2013-1#3)
zirconia-coated silica##2##2##(2008-10#2)
zirconium and hafnium##3##3##(2008-10#3)
zirconium and##5##2##(2008-10#5)
zirconium oxide##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
zirconium oxychloride##2##2##(2008-10#2)
zirconium permanent##3##2##(2008-10#3)
zirconium phosphate##3##2##(2008-10#2)(2008-6#1)
zirconium##39##1##(1990-5#5)(2008-10#30)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
zirconium(IV) and##2##2##(2008-10#2)
zirconium(IV)##12##1##(2008-10#12)
zoledronate##2##1##(2007-11#1)(2012-1#1)
zoledronic acid (4 mg)##2##4##(2008-7#2)
zoledronic acid significantly reduced the cumulative incidence of SREs compared with##2##11##(2008-7#2)
zoledronic acid##8##2##(2008-7#6)(2013-1#1)(2013-7#1)
zoledronic##10##1##(2008-7#7)(2013-1#2)(2013-7#1)
zolpidem and##4##2##(2011-2#4)
zolpidem##9##1##(1995-11#1)(2011-2#8)
zona glomerulosa##4##2##(1990-5#1)(1996-5#1)(2008-4#2)
zona incerta##3##2##(1996-12#2)(2012-3#1)
zona pellucida##6##2##(1996-9#1)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#1)
zona##16##1##(1990-5#2)(1996-12#2)(1996-5#1)(1996-9#1)(2008-12#1)(2008-4#4)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
zonal##9##1##(1990-6#1)(1992-7#1)(2008-10#2)(2008-4#1)(2009-12#2)(2011-2#1)(2012-12#1)
zonation##2##1##(2008-3#1)(2013-7#1)
zone and a##2##3##(2007-12#1)(2008-10#1)
zone and the##2##3##(1996-4#1)(2008-3#1)
zone and##13##2##(1996-4#2)(2007-12#1)(2008-10#6)(2008-3#2)(2010-4#1)(2012-2#1)
zone are##4##2##(1996-4#1)(2008-10#1)(2008-7#1)(2010-12#1)
zone between the##2##3##(2008-10#1)(2008-11#1)
zone between##7##2##(1991-3#1)(1991-5#1)(1992-6#2)(2008-10#1)(2008-11#1)(2010-8#1)
zone by stopping##2##3##(1997-4#1)(2008-10#1)
zone by##5##2##(1997-4#1)(2008-10#2)(2008-8#2)
zone capillary electrophoresis##2##3##(1996-5#1)(2008-10#1)
zone decomposition##2##2##(2008-3#2)
zone diagrams for##2##3##(2008-10#2)
zone diagrams##4##2##(2008-10#4)
zone during##2##2##(2007-4#1)(2008-11#1)
zone electrophoresis (CZE) was used##2##5##(1996-5#1)(2008-10#1)
zone electrophoresis (CZE) with##3##4##(2008-10#3)
zone electrophoresis (CZE)##19##3##(1994-9#1)(1996-5#1)(2008-10#17)
zone electrophoresis##70##2##(1990-8#1)(1992-12#2)(1994-9#3)(1996-5#3)(2008-1#1)(2008-10#59)(2008-4#1)
zone electrophoretic##2##2##(1994-12#1)(1994-9#1)
zone for##4##2##(1994-12#1)(2008-7#1)(2010-8#1)(2011-2#1)
zone formation##3##2##(2008-10#3)
zone from the##2##3##(2008-10#2)
zone from##3##2##(2008-10#2)(2008-8#1)
zone in a##2##3##(2008-10#1)(2008-2#1)
zone in the##2##3##(2008-5#1)(2011-2#1)
zone in##6##2##(1990-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#2)
zone is##9##2##(1996-4#1)(2008-10#6)(2008-11#1)(2012-12#1)
zone of Nigeria##2##3##(2007-7#2)
zone of the ball##2##4##(2009-7#2)
zone of the brain##2##4##(2008-8#1)(2012-1#1)
zone of the traumatic cavity##2##5##(2012-1#2)
zone of the##18##3##(1996-4#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#3)(2011-2#1)(2012-1#3)(2012-12#4)(2012-2#1)
zone of##59##2##(1992-12#1)(1993-12#2)(1994-3#1)(1996-4#1)(1997-5#1)(2007-7#3)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#3)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
zone plate##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
zone plates by##2##3##(2007-11#1)(2008-2#1)
zone plates fabricated##2##3##(2007-11#1)(2008-2#1)
zone plates##14##2##(2007-11#4)(2008-2#5)(2008-3#3)(2012-2#2)
zone size##3##2##(1996-4#2)(2007-11#1)
zone surrounding##2##2##(2008-8#1)(2009-8#1)
zone to##2##2##(2007-5#1)(2008-3#1)
zone under##2##2##(1993-9#1)(2008-10#1)
zone was then##2##3##(2008-10#2)
zone was##12##2##(1991-2#1)(1996-4#1)(1997-3#1)(2008-10#9)
zone where the##2##3##(2008-8#2)
zone where##3##2##(2008-8#2)(2011-2#1)
zone with##3##2##(1990-11#1)(1996-4#1)(2008-10#1)
zone##391##1##(1990-11#4)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#3)(1992-6#3)(1993-12#2)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#4)(1996-12#3)(1996-2#3)(1996-4#20)(1996-5#7)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(2007-10#1)(2007-11#8)(2007-12#5)(2007-4#1)(2007-5#2)(2007-7#3)(2008-1#1)(2008-10#137)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#20)(2008-4#1)(2008-5#4)(2008-7#23)(2008-8#13)(2008-9#6)(2009-10#3)(2009-12#1)(2009-4#2)(2009-5#3)(2009-7#6)(2009-8#10)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#13)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#3)
zone&quot##2##1##(1994-6#1)(1995-3#1)
zone) and##2##2##(2008-10#2)
zone)##3##1##(2008-10#3)
zone-plate array##2##2##(2008-3#2)
zone-plate arrays##2##2##(2007-12#2)
zone-plate##4##1##(2007-12#2)(2008-3#2)
zone]##2##1##(1996-3#1)(1997-3#1)
zones and##7##2##(1996-4#1)(1997-7#1)(2008-10#2)(2010-3#1)(2013-1#1)(2013-8#1)
zones are##2##2##(2008-10#2)
zones as##2##2##(2008-10#1)(2008-8#1)
zones at##2##2##(2008-10#2)
zones for##2##2##(1991-3#1)(2008-12#1)
zones in the##3##3##(1996-4#1)(2007-11#1)(2011-2#1)
zones in##8##2##(1996-4#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#2)
zones is the main mechanism##2##5##(1996-4#1)(2008-3#1)
zones is##5##2##(1996-4#1)(1997-3#1)(2008-10#1)(2008-3#2)
zones of the face##2##4##(2008-5#2)
zones of the##8##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#2)(2013-8#1)
zones of##26##2##(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
zones that##2##2##(1996-4#1)(2007-12#1)
zones to##2##2##(2008-3#1)(2010-10#1)
zones was##4##2##(2008-10#2)(2008-12#2)
zones were##4##2##(1992-7#1)(1996-12#1)(2009-7#1)(2012-2#1)
zones with##9##2##(2008-10#3)(2008-3#3)(2010-4#1)(2012-3#1)(2013-1#1)
zones##157##1##(1991-3#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-4#6)(1996-5#2)(1997-3#2)(1997-4#1)(1997-7#2)(2007-11#2)(2007-12#4)(2007-5#2)(2008-10#45)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#11)(2008-5#6)(2008-7#3)(2008-8#14)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#2)(2010-10#1)(2010-3#3)(2010-4#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
zones)##2##1##(1992-3#1)(2008-10#1)
zonisamide##3##1##(2006-12#3)
zoo##4##1##(1990-3#2)(2007-12#1)(2009-4#1)
zoological##3##1##(2007-6#1)(2010-3#1)(2011-1#1)
zoology##2##1##(1990-8#1)(1993-3#1)
zooming##3##1##(2008-6#2)(2013-1#1)
zoonoses in Colombia##2##3##(2012-12#2)
zoonoses in##4##2##(2011-2#1)(2012-12#3)
zoonoses##10##1##(2007-12#4)(2011-2#2)(2012-12#4)
zoonosis##6##1##(1997-6#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
zoonotic disease##3##2##(2007-12#2)(2013-7#1)
zoonotic diseases##2##2##(2011-1#1)(2011-2#1)
zoonotic infection##2##2##(2008-10#1)(2008-4#1)
zoonotic infections##2##2##(2008-12#1)(2010-4#1)
zoonotic potential##3##2##(2010-4#1)(2011-1#1)(2013-1#1)
zoonotic transmission##2##2##(2012-12#1)(2013-1#1)
zoonotic##30##1##(1997-3#1)(2007-12#2)(2007-2#2)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#1)(2010-10#1)(2010-4#3)(2011-1#3)(2011-2#5)(2012-12#2)(2013-1#5)(2013-7#1)
zoophilic##2##1##(2010-1#2)
zooplankton##9##1##(2008-12#1)(2008-8#2)(2009-8#4)(2010-8#2)
zoosporangia##9##1##(2008-10#9)
zoospore concentrations##3##2##(2008-10#3)
zoospore inoculation##2##2##(2008-10#2)
zoospore isolates##7##2##(2008-10#7)
zoospore##17##1##(2008-10#17)
zoospores of##6##2##(1991-8#1)(2008-10#5)
zoospores per ml##2##3##(2008-10#2)
zoospores per##3##2##(2008-10#3)
zoospores##34##1##(1991-8#1)(2008-10#33)
zooxanthellae##3##1##(2008-5#3)
zorgdiagnose##3##1##(2012-12#3)
zoster##24##1##(1991-6#1)(1994-2#1)(1994-3#3)(2007-7#3)(2008-4#1)(2008-5#1)(2008-7#9)(2009-12#1)(2010-8#2)(2011-1#1)(2013-1#1)
zosteric acid##4##2##(2008-10#4)
zosteric##5##1##(2008-10#5)
zucchini squash##5##2##(2008-10#5)
zucchini##15##1##(2008-10#15)
zwitterionic detergent##3##2##(1994-9#3)
zwitterionic surfactants##2##2##(2008-10#2)
zwitterionic##16##1##(1990-5#1)(1991-5#1)(1993-11#1)(1994-9#4)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#5)(2010-8#1)
zygomycosis in##2##2##(2008-5#2)
zygomycosis which##2##2##(2007-7#2)
zygomycosis##10##1##(1992-2#1)(1997-3#1)(2007-7#4)(2008-5#4)
zygote injection##2##2##(2008-2#2)
zygote##7##1##(1994-7#1)(2008-2#2)(2008-9#1)(2010-8#1)(2012-1#2)
zygotes and##2##2##(2009-12#2)
zygotes##7##1##(2008-2#1)(2008-8#1)(2009-12#4)(2009-8#1)
zygotic embryos##2##2##(2009-12#2)
zygotic##3##1##(2009-12#3)
zymogen form##2##2##(1995-2#1)(2008-4#1)
zymogen##10##1##(1990-8#1)(1991-5#3)(1992-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-4#2)
zymogenic cells##3##2##(1995-6#3)
zymogenic##5##1##(1995-6#5)
zymogram and##2##2##(2008-11#1)(2009-6#1)
zymogram##4##1##(1994-5#1)(2008-11#1)(2009-6#2)
zymograms##2##1##(1991-8#1)(2010-10#1)
zymography##11##1##(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-3#2)(2011-2#1)(2012-3#3)(2013-8#1)
zymosan and##2##2##(1992-3#1)(1994-6#1)
zymosan particles##4##2##(1991-12#2)(1991-5#2)
zymosan with##3##2##(1994-6#1)(2008-12#2)
zymosan##16##1##(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-6#3)(2008-12#3)
zymosan-activated##2##1##(2008-10#1)(2008-12#1)
zymosan-induced peritonitis##2##2##(2008-12#2)
{1 - exp[0##2##3##(2008-10#2)
{1##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
{[HC(3##6##1##(1996-2#6)
{[Ni(2)Cl(2)(bppz)(H(2)O)(2)(CH(3)OH)(2)]Cl(2)}(n)() (2)##2##2##(1997-7#2)
|Deltabeta|##2##1##(2008-3#2)
|beta|##3##1##(2008-8#3)
|j-z|##2##1##(2008-10#2)
|z|&lt##2##1##(2008-10#2)
~ 36 y/o)##2##3##(2011-2#2)
~##7##1##(1996-9#1)(2007-11#1)(2007-12#1)(2011-2#4)
~0##41##1##(2007-11#4)(2007-12#13)(2008-2#15)(2008-3#4)(2010-4#4)(2012-12#1)
~1 cm##2##2##(2007-12#1)(2008-5#1)
~1##29##1##(2007-11#8)(2007-12#7)(2008-2#5)(2008-3#6)(2008-5#1)(2011-2#1)(2012-2#1)
~10 nm##2##2##(2007-11#2)
~10##9##1##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)(2012-12#1)
~10%##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
~100 nm##2##2##(2007-11#1)(2008-2#1)
~100##12##1##(2007-11#4)(2007-12#3)(2007-7#1)(2008-2#2)(2008-3#2)
~11##3##1##(2007-11#1)(2008-3#2)
~12##2##1##(2007-11#2)
~15##3##1##(2007-11#2)(2007-12#1)
~2 mum##2##2##(2007-12#1)(2008-3#1)
~2##10##1##(2007-12#2)(2008-2#4)(2008-3#3)(2012-12#1)
~20##4##1##(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
~200##2##1##(2007-11#1)(2011-1#1)
~21##2##1##(2007-11#2)
~3##8##1##(2007-11#2)(2007-12#1)(2008-3#5)
~30 nm##4##2##(2007-11#1)(2008-2#1)(2009-2#1)(2011-1#1)
~30##8##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-2#1)(2009-6#1)(2011-1#1)
~35##2##1##(2007-12#1)(2009-8#1)
~4##4##1##(2007-11#3)(2008-2#1)
~4%##2##1##(2007-12#1)(2008-2#1)
~40##2##1##(2008-2#1)(2008-3#1)
~400##4##1##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
~5##9##1##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)(2008-5#1)
~50##4##1##(2008-2#1)(2008-3#3)
~50%##2##1##(2007-11#1)(2007-12#1)
~6##7##1##(2007-11#3)(2008-2#1)(2008-3#3)
~60##3##1##(2007-11#1)(2008-12#1)(2008-3#1)
~7##2##1##(2007-11#1)(2007-12#1)
~70##2##1##(2007-12#1)(2008-1#1)
~70%##2##1##(2007-11#1)(2011-1#1)
  In##2##2##(2010-11#2)
  Therefore##2##2##(2010-11#2)
  We##2##2##(2010-11#2)
 ##17##1##(2010-11#16)(2013-1#1)
 0##29##1##(2011-2#1)(2012-12#2)(2012-2#3)(2012-5#7)(2012-6#3)(2012-7#2)(2013-1#5)(2013-3#1)(2013-8#5)
 2##2##1##(2012-6#2)
 21##2##1##(2012-12#2)
 9##2##1##(2012-12#2)
 africana##2##1##(2012-5#2)
 alternifolia##2##1##(2012-8#2)
 cereus##2##1##(2011-2#2)
 finmarchicus biomass##2##2##(2013-1#2)
 geophilum on##2##2##(2012-6#2)
 geophilum##8##1##(2012-6#8)
 graminearum##3##1##(2011-10#3)
 graminicola##3##1##(2011-10#3)
 hupehensis##3##1##(2011-10#3)
 ilex##2##1##(2011-10#2)
 maculans##2##1##(2011-10#2)
 oceanica##2##1##(2013-1#2)
 petraea and Q##4##3##(2012-6#1)(2012-7#1)(2012-9#2)
 petraea with##2##2##(2012-5#2)
 petraea##14##1##(2012-5#6)(2012-6#3)(2012-7#2)(2012-9#3)
 petraea)##2##1##(2012-5#2)
 pubescens had##2##2##(2012-6#1)(2012-9#1)
 pubescens##10##1##(2012-5#2)(2012-6#6)(2012-7#1)(2012-9#1)
 pubescens)##5##1##(2012-5#1)(2012-6#2)(2012-7#1)(2012-9#1)
 rhamnoides and##2##2##(2012-8#2)
 robur and Q##5##3##(2012-5#4)(2012-6#1)
 robur than##2##2##(2012-5#1)(2012-7#1)
 robur##13##1##(2012-5#7)(2012-6#2)(2012-7#2)(2012-9#2)
 sylvestris##2##1##(2011-10#2)
© 2010 American Institute of Chemical Engineers Biotechnol##16##8##(2011-2#16)
© 2010 International Society for Advancement of Cytometry##3##8##(2011-2#3)
© 2010 Wiley-Liss##24##3##(2011-2#24)
© 2010##58##2##(2011-1#1)(2011-2#55)(2012-2#2)
© 2011 American Cancer Society##2##5##(2012-3#2)
© 2011 American Institute of Chemical Engineers Biotechnol##6##8##(2011-2#6)
© 2011 American##8##3##(2011-2#6)(2012-3#2)
© 2011 IUBMB IUBMB Life##2##5##(2012-3#2)
© 2011 John Wiley &amp##7##5##(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)
© 2011 Wiley Periodicals##3##4##(2012-2#1)(2012-3#2)
© 2011##23##2##(2011-2#8)(2012-1#3)(2012-2#4)(2012-3#8)
© 2012##21##2##(2012-2#2)(2012-3#1)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#10)
©##102##1##(2011-1#1)(2011-2#63)(2012-1#3)(2012-2#8)(2012-3#9)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#10)
°C and##7##2##(2011-2#6)(2013-8#1)
°C to##3##2##(2011-2#2)(2012-12#1)
°C##21##1##(2010-12#2)(2011-1#3)(2011-2#13)(2012-12#2)(2013-8#1)
°C)##2##1##(2011-2#1)(2013-8#1)
± 0##75##2##(2010-10#4)(2010-11#6)(2010-9#5)(2011-1#7)(2011-2#4)(2012-12#7)(2012-3#7)(2013-1#21)(2013-7#6)(2013-8#8)
± 1 °C##2##3##(2011-2#2)
± 1##20##2##(2010-9#3)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#6)
± 10##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
± 11##8##2##(2012-3#3)(2013-1#4)(2013-8#1)
± 12##4##2##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
± 14##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
± 17##3##2##(2013-1#3)
± 18##3##2##(2011-2#1)(2012-3#2)
± 2##11##2##(2010-11#1)(2011-1#4)(2011-2#1)(2012-3#2)(2013-8#3)
± 20##4##2##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
± 27##2##2##(2013-1#1)(2013-8#1)
± 3##8##2##(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
± 3%##2##2##(2013-1#2)
± 4##11##2##(2010-11#3)(2010-9#1)(2011-2#3)(2012-3#1)(2013-8#3)
± 5##3##2##(2012-3#1)(2013-8#2)
± 6##5##2##(2010-9#1)(2013-1#3)(2013-8#1)
± 7##4##2##(2011-2#1)(2013-1#2)(2013-8#1)
± 8##6##2##(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
± 9##7##2##(2011-2#1)(2012-3#3)(2013-1#3)
± SD##6##2##(2012-3#1)(2013-1#3)(2013-8#2)
± standard##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
±##233##1##(2007-9#1)(2010-10#4)(2010-11#10)(2010-9#11)(2011-1#22)(2011-2#27)(2012-12#8)(2012-2#3)(2012-3#29)(2013-1#66)(2013-7#6)(2013-8#46)
²⁺##4##1##(2013-1#4)
µ(E)##5##1##(2012-2#5)
µM##6##1##(2011-2#3)(2012-12#2)(2012-2#1)
µSBS##5##1##(2013-1#5)
µg/L##6##1##(2011-1#2)(2011-2#3)(2013-1#1)
µg/d)##2##1##(2013-1#2)
µg/dl##2##1##(2013-1#2)
µg/g)##2##1##(2011-1#2)
µg/mL##4##1##(2011-1#4)
µg/ml)##3##1##(2011-1#1)(2012-12#1)(2012-2#1)
µm median##2##2##(2013-1#2)
µm##6##1##(2011-1#1)(2011-2#1)(2013-1#4)
µm)##4##1##(2010-11#1)(2010-9#1)(2011-1#2)
Å (average = 2##2##4##(1996-2#2)
Å and##2##2##(1996-2#2)
Å at##3##2##(1996-2#3)
Å resolution##2##2##(2011-1#1)(2012-2#1)
Å##154##1##(1996-2#91)(1996-5#3)(1997-7#56)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
Å(3)##18##1##(1996-2#13)(1997-7#5)
× 10##3##2##(2011-2#1)(2013-8#2)
× 10(-4)##4##2##(2010-12#1)(2011-2#1)(2013-1#2)
× 10(-7))##2##2##(2012-3#2)
× 10(6) cells##2##3##(2011-2#2)
× 10(6)##3##2##(2011-2#2)(2012-12#1)
× 10(8)##2##2##(2012-2#2)
× 10(9)##2##2##(2012-2#2)
× 10³##3##2##(2013-1#3)
× 10⁴##3##2##(2013-1#3)
× 10⁵##2##2##(2013-1#2)
× 4##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
×##45##1##(2010-11#1)(2010-12#1)(2011-1#5)(2011-2#5)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#13)(2013-8#6)
ß-cell function##2##2##(2011-2#2)
ß-cell##3##1##(2011-2#3)
ß-cells##2##1##(2010-11#2)
à l'âge adulte##2##3##(2008-11#1)(2011-2#1)
à la nicotine##3##3##(2013-1#3)
à la##7##2##(2011-2#2)(2013-1#5)
à un##2##2##(2008-11#1)(2013-1#1)
à une##5##2##(2011-2#1)(2013-1#4)
à##48##1##(1996-11#1)(2008-11#4)(2008-3#3)(2008-5#2)(2009-4#2)(2011-2#9)(2013-1#27)
âgé##3##1##(2013-1#3)
å##4##1##(2007-11#3)(2008-10#1)
étaient##3##1##(2009-4#1)(2011-2#1)(2013-1#1)
était##5##1##(2011-2#3)(2013-1#2)
étude rétrospective##2##2##(2013-1#2)
étude##4##1##(2011-2#1)(2013-1#3)
été##14##1##(2011-2#3)(2013-1#11)
évoluées##2##1##(2011-2#2)
évoqué##2##1##(2013-1#2)
être##4##1##(2011-2#1)(2013-1#3)
ďun##2##1##(2013-1#2)
Δ(9)-tetrahydrocannabinol##2##1##(2013-1#2)
ΔE##2##1##(2013-1#2)
ΔK##2##1##(2012-1#2)
Σ(2) (m)##2##2##(2013-1#2)
Φ6 phage##2##2##(2013-1#2)
Φ6##3##1##(2013-1#3)
Ψ(PD)##3##1##(2012-7#3)
α and##2##2##(2012-12#2)
α##18##1##(2009-11#2)(2010-11#4)(2010-12#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)
α(4)β(2)##2##1##(2011-2#2)
α) and##2##2##(2012-3#1)(2013-1#1)
α- and##2##2##(2011-10#1)(2011-2#1)
α-B##2##1##(2012-2#2)
α-amylase##4##1##(2011-2#1)(2013-8#3)
α-cell##2##1##(2010-11#2)
α-glucosidase activity in##3##3##(2010-11#3)
α-glucosidase##7##1##(2010-11#7)
α-helical##3##1##(2010-12#1)(2011-2#2)
α-lactalbumin##3##1##(2012-2#3)
α-smooth muscle actin##2##3##(2012-1#1)(2012-2#1)
α-tocopherol##2##1##(2012-2#1)(2013-1#1)
α7 nAChR agonists##3##3##(2011-1#3)
α7 nAChRs##4##2##(2011-1#4)
α7##9##1##(2011-1#9)
α=0##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
αv##2##1##(2012-12#2)
αvβ3##4##1##(2012-12#4)
αvβ6 and αvβ8##2##3##(2012-12#2)
αvβ6##4##1##(2012-12#4)
αvβ8##6##1##(2012-12#6)
β cell##3##2##(2013-7#2)(2013-8#1)
β cells##6##2##(2010-11#1)(2011-1#2)(2011-2#1)(2013-7#2)
β##25##1##(2010-11#2)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#9)(2013-7#5)(2013-8#2)
β(1)-##2##1##(2010-12#2)
β(2)-##2##1##(2010-12#2)
β(2)-AR gene##2##2##(2009-9#2)
β(2)-AR##4##1##(2009-9#4)
β-1a##4##1##(2013-8#4)
β-B##3##1##(2012-2#3)
β-actin mRNA##4##2##(2012-2#4)
β-actin##6##1##(2012-2#4)(2012-3#2)
β-adrenergic receptor##2##2##(2011-2#2)
β-adrenergic##3##1##(2011-2#2)(2012-12#1)
β-amyloid##2##1##(2013-1#2)
β-blocker##3##1##(2009-9#2)(2011-2#1)
β-carotene##3##1##(2011-1#1)(2013-8#2)
β-casein##3##1##(2012-2#3)
β-catenin in##3##2##(2012-2#1)(2013-1#2)
β-catenin is##2##2##(2012-2#2)
β-catenin##15##1##(2012-2#6)(2013-1#9)
β-cell damage##2##2##(2010-11#2)
β-cell destruction##2##2##(2010-11#2)
β-cell differentiation##2##2##(2012-12#2)
β-cell function##7##2##(2010-10#2)(2010-11#1)(2012-2#4)
β-cell line##2##2##(2010-11#1)(2012-2#1)
β-cell mass##7##2##(2010-11#5)(2012-12#2)
β-cell proliferation##5##2##(2010-11#5)
β-cell regeneration##3##2##(2010-11#3)
β-cell replication##2##2##(2010-11#2)
β-cell##49##1##(2010-10#5)(2010-11#32)(2012-12#5)(2012-2#6)(2013-7#1)
β-cells against apoptosis##3##3##(2010-11#3)
β-cells and##2##2##(2010-11#1)(2012-12#1)
β-cells of##2##2##(2010-11#1)(2010-12#1)
β-cells or##2##2##(2010-11#2)
β-cells to##2##2##(2010-11#2)
β-cells##38##1##(2010-10#1)(2010-11#32)(2010-12#1)(2012-12#4)
β-cyclodextrin##5##1##(2011-2#3)(2013-1#2)
β-galactosidase##2##1##(2009-12#1)(2012-12#1)
β-globin##2##1##(2013-1#2)
β-lactam antibiotics##2##2##(2011-1#1)(2013-1#1)
β-lactam##5##1##(2011-1#2)(2011-2#1)(2013-1#2)
β-lactamase##2##1##(2011-2#2)
β-lactamase-producing Escherichia coli and##2##4##(2011-2#1)(2013-8#1)
β-sheet nanocrystals##2##2##(2012-2#2)
β-sheet##6##1##(2010-10#1)(2011-2#1)(2012-2#4)
β-tropomyosin##2##1##(2010-12#2)
β-turns##2##1##(2011-2#1)(2012-2#1)
β-unsaturated nitrone-aryne [3+2] cycloaddition##2##4##(2009-11#2)
β-unsaturated##3##1##(2009-11#2)(2011-2#1)
β1-integrin##2##1##(2010-11#2)
γ##7##1##(2012-2#1)(2013-1#5)(2013-8#1)
γ-aminobutyric acid aminotransferase##2##3##(2013-1#2)
γ-aminobutyric acid##4##2##(2012-2#2)(2013-1#2)
γ-casein##2##1##(2012-2#2)
γ-radiation##3##1##(2013-1#3)
γ-ray##5##1##(2012-2#1)(2013-1#4)
γ2 chain##3##2##(2013-8#3)
γ2##4##1##(2010-10#1)(2013-8#3)
δ##2##1##(2010-11#1)(2012-2#1)
ε##2##1##(2010-12#1)(2013-8#1)
ε-supervenience##2##1##(2012-2#2)
εS278del##3##1##(2013-1#3)
λ(max)##2##1##(2012-2#2)
μM deltamethrin##2##2##(2013-1#2)
μM##9##1##(2010-11#3)(2012-2#1)(2013-1#5)
μM)##3##1##(2010-11#2)(2013-1#1)
μg Se/g##2##2##(2012-2#2)
μg bid##3##2##(2012-3#3)
μg##7##1##(2012-2#2)(2012-3#4)(2013-1#1)
μg/kg)##2##1##(2011-1#1)(2012-2#1)
μg/mL##2##1##(2012-3#2)
μg/mL)##3##1##(2011-1#2)(2012-3#1)
μg/ml)##2##1##(2011-1#2)
μg·l-1##3##1##(2013-1#3)
μm based on##3##3##(2010-10#3)
μm square pixels with 12 bit depth##2##7##(2011-1#2)
μm to 6##2##3##(2010-10#2)
μm to##4##2##(2010-10#4)
μm##21##1##(2009-12#1)(2009-6#1)(2010-10#8)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
μm)##2##1##(2011-1#1)(2011-2#1)
μmol/L##4##1##(2012-2#4)
π##3##1##(2010-11#1)(2012-3#1)(2013-1#1)
π-cations##2##1##(2009-5#2)
χ(2) =##5##2##(2011-1#5)
χ(2) rates between Aini and##2##5##(2011-1#2)
χ(2) rates##3##2##(2011-1#3)
χ(2)##8##1##(2011-1#8)
ω3##2##1##(2011-2#1)(2013-1#1)
  A descriptive##2##3##(2013-1#2)
  A survey was conducted to obtain feedback from registered nurses as end-users of standardized nursing terminology for care planning in an electronic health record##2##25##(2013-1#2)
  A total of##2##4##(2012-2#1)(2013-1#1)
  A##12##2##(2010-10#4)(2011-2#2)(2012-2#1)(2013-1#5)
  Acute pain occurs in over 50% of hospitalized children##2##10##(2013-1#2)
  All##3##2##(2011-2#2)(2012-12#1)
  An##2##2##(2010-10#1)(2013-1#1)
  Data were obtained through the author's clinical practice in emergency nursing and literature sources##2##15##(2013-1#2)
  Data were##3##3##(2012-12#1)(2013-1#2)
  Despite the increasing demands for reliable nursing data as a basis for measuring nursing effects on nursing outcomes and safety##2##21##(2013-1#2)
  Despite the##3##3##(2010-10#1)(2013-1#2)
  Diagnosis of acute pain increased in the postimplementation period##2##10##(2013-1#2)
  Genetic##2##2##(2012-12#1)(2013-1#1)
  Given the centrality of CS to interpreting research findings and applying them to practice##2##15##(2013-1#2)
  Hepatitis B virus (HBV)##2##5##(2013-1#2)
  Hepatitis B##3##3##(2013-1#3)
  In the postimplementation##2##4##(2013-1#2)
  In this##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
  In total##2##3##(2010-10#1)(2013-1#1)
  In##10##2##(2010-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
  It is##2##3##(2010-10#1)(2011-2#1)
  It##4##2##(2010-10#2)(2011-2#1)(2013-1#1)
  NANDA International Classification##2##4##(2013-1#2)
  Nurses reported a more positive agreement with the changes at 6 months compared with baseline##2##16##(2013-1#2)
  Of##3##2##(2012-12#2)(2012-2#1)
  One##2##2##(2010-10#2)
  Our results##2##3##(2010-10#1)(2011-2#1)
  Overall##4##2##(2012-12#1)(2013-1#3)
  Patients##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
  Qualitative##3##2##(2010-10#3)
  Serum##2##2##(2012-12#1)(2013-1#1)
  Staying in the stream of life##2##7##(2010-10#2)
  The C1q-deficient SLE##2##4##(2011-2#2)
  The aim of the present study was to investigate##2##10##(2010-10#1)(2012-2#1)
  The aim of the present study was to##3##9##(2010-10#2)(2012-2#1)
  The aim of the study was to##2##8##(2010-10#2)
  The aim of the##5##5##(2010-10#4)(2012-2#1)
  The aim of this##2##5##(2010-10#2)
  The aim of##7##4##(2010-10#6)(2012-2#1)
  The current literature and research studies##2##7##(2013-1#2)
  The development of strategies for improvement of diagnostic accuracy is warranted##2##12##(2013-1#2)
  The disparate uses of CS negatively impact standardizing and quantifying research outcomes to discern EBPs##2##16##(2013-1#2)
  The introduction of nonvalidated instruments in Italian hospitals needs to be restricted because of the short- and long-term negative effects these nonvalidated instruments may have##2##26##(2013-1#2)
  The main##2##3##(2010-10#1)(2012-2#1)
  The most immediate and tangible advantages to a common conceptual definition and meaning of CS terminologies by nursing##2##19##(2013-1#2)
  The most##3##3##(2012-12#1)(2013-1#2)
  The patient plan of care in the electronic record is expected to offer nurses the ability to communicate the needs of the patient and assess outcomes of care##2##29##(2013-1#2)
  The purpose of this study was to describe the implementation strategies of measurement instruments and their validity as adopted in Italian hospital nursing practice##2##25##(2013-1#2)
  The purpose of this study##3##6##(2011-2#1)(2013-1#2)
  The results show that##2##5##(2010-10#2)
  The results##3##3##(2010-10#3)
  The sample was divided into##2##6##(2013-1#2)
  The sample##3##3##(2013-1#3)
  The study aims to##2##5##(2013-1#2)
  The study##4##3##(2010-10#1)(2013-1#3)
  The survey was conducted pre-##2##6##(2013-1#2)
  The##65##2##(2010-10#22)(2011-2#5)(2012-12#4)(2012-2#8)(2013-1#26)
  This case study focused on the emergency nursing care of a 32-year-old female##2##14##(2013-1#2)
  This case study provides emergency nurses and students with the pertinent nursing diagnoses##2##14##(2013-1#2)
  This case study##4##4##(2013-1#4)
  This paper analyzes the concept of clinical significance (CS) in relation to evidence-based practice (EBP)##2##16##(2013-1#2)
  This paper##5##3##(2010-10#2)(2010-9#1)(2013-1#2)
  This study##4##3##(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
  This##19##2##(2010-10#5)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#7)
  Three##2##2##(2010-10#2)
  To assess##2##3##(2011-2#1)(2012-12#1)
  To determine##2##3##(2010-10#1)(2011-2#1)
  To explore##2##3##(2010-10#1)(2012-12#1)
  To##13##2##(2010-10#4)(2011-2#4)(2012-12#4)(2013-1#1)
  Two##2##2##(2010-10#1)(2013-1#1)
  We##4##2##(2011-2#4)
  While##2##2##(2010-10#1)(2012-12#1)
 ##265##1##(2010-10#83)(2010-9#1)(2011-2#48)(2012-12#31)(2012-2#28)(2013-1#74)
 P &lt##2##1##(2012-1#2)
 The##3##1##(2012-3#3)
 To##3##1##(2012-1#1)(2012-3#2)
 0##59##1##(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#20)(2013-1#26)
 50)##2##1##(2012-2#2)
 A systematic review of the##2##5##(2012-12#2)
 A systematic review was undertaken for articles published up to October 2011##3##12##(2012-12#3)
 A systematic review##5##3##(2012-12#5)
 A systematic search##2##3##(2012-12#2)
 A systematic##7##2##(2012-12#7)
 A##15##1##(2012-12#14)(2013-1#1)
 Articles published##2##2##(2012-12#2)
 From##5##1##(2012-12#5)
 In##2##1##(2012-12#2)
 Most##2##1##(2012-12#2)
 Retrospective##6##1##(2012-12#6)
 Systematic review##8##2##(2012-12#8)
 Systematic##9##1##(2012-12#9)
 The overall strength of evidence evaluating the diagnostic characteristics was low due to inconsistent findings between studies and uncertainty of the impact of false-negatives##2##24##(2012-12#2)
 The##10##1##(2012-12#10)
 There is##2##2##(2012-12#2)
 There##3##1##(2012-12#3)
 To describe##2##2##(2012-12#2)
 To determine##2##2##(2012-12#2)
 To report##2##2##(2012-12#2)
 To##11##1##(2012-12#11)
 Two##4##1##(2012-12#4)
 What##3##1##(2012-12#3)
 ##4##1##(2012-2#1)(2013-1#3)
 0##30##1##(2010-11#9)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#10)(2013-7#1)
•##2##1##(2011-2#2)
•  Mental health##2##3##(2011-2#2)
•  The##4##2##(2011-2#4)
• ##22##1##(2011-2#22)
∞)##2##1##(2012-12#1)(2013-8#1)
∼##2##1##(2011-1#1)(2012-2#1)
∼10##2##1##(2011-2#2)
∼25%##2##1##(2012-3#1)(2013-8#1)
∼30%##2##1##(2011-2#1)(2013-1#1)
∼4##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
≈##2##1##(2012-2#1)(2013-1#1)
≤ 0##7##2##(2011-2#1)(2012-3#3)(2013-8#3)
≤##10##1##(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
≥ 0##4##2##(2013-1#2)(2013-8#2)
≥ 1##5##2##(2011-1#2)(2012-12#2)(2013-1#1)
≥##26##1##(2010-4#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#4)(2013-1#6)(2013-8#2)
≥3##3##1##(2013-1#3)
≥65 years##2##2##(2012-12#2)
≥7 drinks/wk##2##2##(2013-1#2)
≥75 years##2##2##(2012-3#2)
・・0##7##1##(2011-2#7)
